id|nct_id|result_group_id|ctgov_group_code|period|reason|count|drop_withdraw_comment|reason_comment|count_units
147532082|NCT01241591|532103859|FG000|Overall Study|Lack of Efficacy|5|||
147532083|NCT01241591|532103860|FG001|Overall Study|Lack of Efficacy|2|||
147532084|NCT01241591|532103861|FG002|Overall Study|Lack of Efficacy|2|||
147532085|NCT01241591|532103862|FG003|Overall Study|Lack of Efficacy|3|||
147532086|NCT01241591|532103859|FG000|Overall Study|Protocol Violation|5|||
147532087|NCT01241591|532103860|FG001|Overall Study|Protocol Violation|2|||
147532088|NCT01241591|532103861|FG002|Overall Study|Protocol Violation|3|||
147532089|NCT01241591|532103862|FG003|Overall Study|Protocol Violation|0|||
147532090|NCT01241591|532103859|FG000|Overall Study|Lost to Follow-up|1|||
147532091|NCT01241591|532103860|FG001|Overall Study|Lost to Follow-up|2|||
147532092|NCT01241591|532103861|FG002|Overall Study|Lost to Follow-up|2|||
147532093|NCT01241591|532103862|FG003|Overall Study|Lost to Follow-up|2|||
147532094|NCT01241591|532103859|FG000|Overall Study|Screen Failure|3|||
147532095|NCT01241591|532103860|FG001|Overall Study|Screen Failure|2|||
147532096|NCT01241591|532103861|FG002|Overall Study|Screen Failure|1|||
147532097|NCT01241591|532103862|FG003|Overall Study|Screen Failure|0|||
147532098|NCT01241591|532103859|FG000|Overall Study|Withdrawal by Subject|6|||
147532099|NCT01241591|532103860|FG001|Overall Study|Withdrawal by Subject|4|||
147532100|NCT01241591|532103861|FG002|Overall Study|Withdrawal by Subject|2|||
147532101|NCT01241591|532103862|FG003|Overall Study|Withdrawal by Subject|2|||
147532102|NCT01241591|532103859|FG000|Overall Study|Other|0|||
147532103|NCT01241591|532103860|FG001|Overall Study|Other|1|||
147532104|NCT01241591|532103861|FG002|Overall Study|Other|0|||
147532105|NCT01241591|532103862|FG003|Overall Study|Other|1|||
147532106|NCT01241591|532103859|FG000|Overall Study|Adverse Event|3|||
147532107|NCT01241591|532103860|FG001|Overall Study|Adverse Event|11|||
147532108|NCT01241591|532103861|FG002|Overall Study|Adverse Event|12|||
147532109|NCT01241591|532103862|FG003|Overall Study|Adverse Event|4|||
147532110|NCT01945034|532103863|FG000|Overall Study|Medication Error|0|||
147532111|NCT01945034|532103864|FG001|Overall Study|Medication Error|1|||
147532112|NCT01945034|532103865|FG002|Overall Study|Medication Error|0|||
147532113|NCT01945034|532103863|FG000|Overall Study|Withdrawal by Subject|0|||
147532114|NCT01945034|532103864|FG001|Overall Study|Withdrawal by Subject|3|||
147532115|NCT01945034|532103865|FG002|Overall Study|Withdrawal by Subject|1|||
147532116|NCT01945034|532103863|FG000|Overall Study|Other|0|||
147304484|NCT01966003|531282416|FG000|Overall Study|Death|43|||
147304485|NCT01966003|531282417|FG001|Overall Study|Death|36|||
147304486|NCT01966003|531282416|FG000|Overall Study|Protocol Violation|6|||
147304487|NCT01966003|531282417|FG001|Overall Study|Protocol Violation|4|||
147304488|NCT01966003|531282416|FG000|Overall Study|Lost to Follow-up|4|||
147532117|NCT01945034|532103864|FG001|Overall Study|Other|1|||
147532118|NCT01945034|532103865|FG002|Overall Study|Other|3|||
147532119|NCT01945034|532103863|FG000|Overall Study|Lost to Follow-up|0|||
147532120|NCT01945034|532103864|FG001|Overall Study|Lost to Follow-up|0|||
147532121|NCT01945034|532103865|FG002|Overall Study|Lost to Follow-up|2|||
147532122|NCT01945034|532103863|FG000|Overall Study|Protocol Violation|1|||
147532123|NCT01945034|532103864|FG001|Overall Study|Protocol Violation|0|||
147532124|NCT01945034|532103865|FG002|Overall Study|Protocol Violation|1|||
147532125|NCT02389621|532103868|FG000|Treatment Period|Withdrawal by Subject|1|||
147532126|NCT02389621|532103869|FG001|Treatment Period|Withdrawal by Subject|1|||
147532127|NCT02389621|532103868|FG000|Posttreatment Period|Adverse Event|3|||
147532128|NCT02389621|532103869|FG001|Posttreatment Period|Adverse Event|1|||
147532129|NCT02389621|532103868|FG000|Posttreatment Period|Withdrawal by Subject|3|||
147532130|NCT02389621|532103869|FG001|Posttreatment Period|Withdrawal by Subject|2|||
147532131|NCT02389621|532103868|FG000|Posttreatment Period|Lost to Follow-up|1|||
147532132|NCT02389621|532103869|FG001|Posttreatment Period|Lost to Follow-up|1|||
147532133|NCT02389621|532103868|FG000|Posttreatment Period|Other - Miscellaneous|2|||
147532134|NCT02389621|532103869|FG001|Posttreatment Period|Other - Miscellaneous|0|||
147532135|NCT03323034|532103872|FG000|Overall Study|Lack of Efficacy|5|||
147532136|NCT03323034|532103873|FG001|Overall Study|Lack of Efficacy|5|||
147532137|NCT03323034|532103874|FG002|Overall Study|Lack of Efficacy|6|||
147532138|NCT03323034|532103875|FG003|Overall Study|Lack of Efficacy|5|||
147532139|NCT03323034|532103876|FG004|Overall Study|Lack of Efficacy|5|||
147532140|NCT03323034|532103872|FG000|Overall Study|Physician Decision|0|||
147532141|NCT03323034|532103873|FG001|Overall Study|Physician Decision|0|||
147532142|NCT03323034|532103874|FG002|Overall Study|Physician Decision|0|||
147532143|NCT03323034|532103875|FG003|Overall Study|Physician Decision|0|||
147532144|NCT03323034|532103876|FG004|Overall Study|Physician Decision|1|||
147532145|NCT03323034|532103872|FG000|Overall Study|Withdrawal by Subject|1|||
147532146|NCT03323034|532103873|FG001|Overall Study|Withdrawal by Subject|1|||
147304489|NCT01966003|531282417|FG001|Overall Study|Lost to Follow-up|3|||
147304490|NCT01966003|531282416|FG000|Overall Study|Physician Decision|12|||
147532147|NCT03323034|532103874|FG002|Overall Study|Withdrawal by Subject|0|||
147532148|NCT03323034|532103875|FG003|Overall Study|Withdrawal by Subject|1|||
147532149|NCT03323034|532103876|FG004|Overall Study|Withdrawal by Subject|0|||
147532150|NCT02526017|532103879|FG000|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
147532151|NCT02526017|532103880|FG001|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
147532152|NCT02526017|532103881|FG002|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
147532153|NCT02526017|532103882|FG003|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
147532154|NCT02526017|532103883|FG004|Overall Study|Withdrew Consent Before Receiving Study Treatment|1|||
147532155|NCT02526017|532103884|FG005|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
147532156|NCT02526017|532103885|FG006|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
147532157|NCT02526017|532103886|FG007|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
147532158|NCT02526017|532103887|FG008|Overall Study|Withdrew Consent Before Receiving Study Treatment|0|||
147532159|NCT00536991|532103889|FG000|Overall Study|Withdrawal by Subject|10|||
147532160|NCT00536991|532103889|FG000|Overall Study|Physician Decision|1|||
147532161|NCT00536991|532103889|FG000|Overall Study|patient ineligible|2|||
147532162|NCT00054639|532103890|FG000|Overall Study|Lack of Efficacy|1|||
147532163|NCT00054639|532103890|FG000|Overall Study|Physician Decision|1|||
147532164|NCT01600755|532103891|FG000|Overall Study|Withdrawal by Subject|6|||
147532165|NCT01366846|532103896|FG000|Overall Study|Withdrawal by Subject|2|||
147532166|NCT01366846|532103897|FG001|Overall Study|Withdrawal by Subject|0|||
147532167|NCT01366846|532103898|FG002|Overall Study|Withdrawal by Subject|0|||
147532168|NCT01366846|532103899|FG003|Overall Study|Withdrawal by Subject|0|||
147532169|NCT01366846|532103896|FG000|Overall Study|Communication Difficulties|1|||
147532170|NCT01366846|532103897|FG001|Overall Study|Communication Difficulties|4|||
147532171|NCT01366846|532103898|FG002|Overall Study|Communication Difficulties|0|||
147532172|NCT01366846|532103899|FG003|Overall Study|Communication Difficulties|1|||
147532173|NCT01366846|532103896|FG000|Overall Study|Scheduling Conflicts|0|||
147532174|NCT01366846|532103897|FG001|Overall Study|Scheduling Conflicts|0|||
147532175|NCT01366846|532103898|FG002|Overall Study|Scheduling Conflicts|1|||
147532176|NCT01366846|532103899|FG003|Overall Study|Scheduling Conflicts|0|||
147532177|NCT05299359|532103902|FG000|Main Part: Day 1 up to Day 366|Participants moved to extension part|129|||
147532178|NCT05299359|532103903|FG001|Main Part: Day 1 up to Day 366|Participants moved to extension part|0|||
147532179|NCT05299359|532103902|FG000|Main Part: Day 1 up to Day 366|Other|2|||
147532180|NCT05299359|532103903|FG001|Main Part: Day 1 up to Day 366|Other|0|||
147532181|NCT05299359|532103902|FG000|Main Part: Day 1 up to Day 366|Withdrawal by Subject|1|||
147532182|NCT05299359|532103903|FG001|Main Part: Day 1 up to Day 366|Withdrawal by Subject|0|||
147532183|NCT05299359|532103902|FG000|Main Part: Day 1 up to Day 366|Lost to Follow-up|1|||
147532184|NCT05299359|532103903|FG001|Main Part: Day 1 up to Day 366|Lost to Follow-up|0|||
147645450|NCT01777139|532521995|FG000|Primary Reporting Phase (Up to 4 Years)|Adverse Event|7|||
147645451|NCT01777139|532521996|FG001|Primary Reporting Phase (Up to 4 Years)|Adverse Event|0|||
147645452|NCT01777139|532521995|FG000|Primary Reporting Phase (Up to 4 Years)|Lack of Efficacy|6|||
147645453|NCT01777139|532521996|FG001|Primary Reporting Phase (Up to 4 Years)|Lack of Efficacy|0|||
147645454|NCT01777139|532521995|FG000|Primary Reporting Phase (Up to 4 Years)|Withdrawal by Subject|8|||
147645455|NCT01777139|532521996|FG001|Primary Reporting Phase (Up to 4 Years)|Withdrawal by Subject|0|||
147645456|NCT01777139|532521995|FG000|Primary Reporting Phase (Up to 4 Years)|Other (Study drug discontinued)|3|||
147645457|NCT01777139|532521996|FG001|Primary Reporting Phase (Up to 4 Years)|Other (Study drug discontinued)|0|||
147532185|NCT05299359|532103902|FG000|Extension Part: Day 1 to Day 366|Lost to Follow-up|0|||
147645458|NCT01777139|532521995|FG000|Primary Reporting Phase (Up to 4 Years)|Other (Reached stopping criteria)|2|||
147645459|NCT01777139|532521996|FG001|Primary Reporting Phase (Up to 4 Years)|Other (Reached stopping criteria)|0|||
147645460|NCT01777139|532521995|FG000|Primary Reporting Phase (Up to 4 Years)|Other (Subjects entered SFUCP)|4|||
147645461|NCT01777139|532521996|FG001|Primary Reporting Phase (Up to 4 Years)|Other (Subjects entered SFUCP)|0|||
147645462|NCT01777139|532521995|FG000|SFUCP (Up to 1.4 Years)|Withdrawal by Subject|0|||
147645463|NCT01777139|532521996|FG001|SFUCP (Up to 1.4 Years)|Withdrawal by Subject|1|||
147645464|NCT01777139|532521995|FG000|SFUCP (Up to 1.4 Years)|Other-Study drug discontinued|0|||
147645465|NCT01777139|532521996|FG001|SFUCP (Up to 1.4 Years)|Other-Study drug discontinued|3|||
147645466|NCT02542293|532521997|FG000|Overall Study|Death|367|||
147645467|NCT02542293|532521998|FG001|Overall Study|Death|377|||
147645468|NCT02542293|532521997|FG000|Overall Study|Withdrawal by Subject|8|||
147645469|NCT02542293|532521998|FG001|Overall Study|Withdrawal by Subject|19|||
147645470|NCT03030118|532521999|FG000|Overall Study|Achieved SLE Diagnosis|11|||
147532186|NCT05299359|532103903|FG001|Extension Part: Day 1 to Day 366|Lost to Follow-up|2|||
147532187|NCT05299359|532103902|FG000|Extension Part: Day 1 to Day 366|Withdrawal by Subject|0|||
147532188|NCT05299359|532103903|FG001|Extension Part: Day 1 to Day 366|Withdrawal by Subject|5|||
147532189|NCT05299359|532103902|FG000|Extension Part: Day 1 to Day 366|Other|0|||
147532190|NCT05299359|532103903|FG001|Extension Part: Day 1 to Day 366|Other|1|||
147532191|NCT04780776|532103908|FG000|Titration Week 1-5|Lost to Follow-up|2|||
147532192|NCT04780776|532103909|FG001|Titration Week 1-5|Lost to Follow-up|8|||
147532193|NCT04780776|532103908|FG000|Treatment Week 6-21|Lost to Follow-up|4|||
147532194|NCT04780776|532103909|FG001|Treatment Week 6-21|Lost to Follow-up|4|||
147532195|NCT04780776|532103908|FG000|Follow up Week 22-25|Lost to Follow-up|2|||
147532196|NCT04780776|532103909|FG001|Follow up Week 22-25|Lost to Follow-up|2|||
147532197|NCT03113760|532103910|FG000|Initial 18 Weeks Treatment Phase|Withdrawal by Subject|2|||
147532198|NCT03113760|532103911|FG001|Initial 18 Weeks Treatment Phase|Withdrawal by Subject|0|||
147532199|NCT03113760|532103912|FG002|Initial 18 Weeks Treatment Phase|Withdrawal by Subject|0|||
147532200|NCT03113760|532103913|FG003|Initial 18 Weeks Treatment Phase|Withdrawal by Subject|0|||
147532201|NCT03113760|532103910|FG000|Initial 18 Weeks Treatment Phase|Adverse Event|1|||
147532202|NCT03113760|532103911|FG001|Initial 18 Weeks Treatment Phase|Adverse Event|0|||
147532203|NCT03113760|532103912|FG002|Initial 18 Weeks Treatment Phase|Adverse Event|0|||
147532204|NCT03113760|532103913|FG003|Initial 18 Weeks Treatment Phase|Adverse Event|0|||
147532205|NCT03113760|532103910|FG000|Initial 18 Weeks Treatment Phase|Disease relapse|1|||
147532206|NCT03113760|532103911|FG001|Initial 18 Weeks Treatment Phase|Disease relapse|1|||
147532207|NCT03113760|532103912|FG002|Initial 18 Weeks Treatment Phase|Disease relapse|0|||
147532208|NCT03113760|532103913|FG003|Initial 18 Weeks Treatment Phase|Disease relapse|0|||
147532209|NCT00003526|532103917|FG000|Overall Study|Not evaluable|6|||
147304491|NCT01966003|531282417|FG001|Overall Study|Physician Decision|13|||
147304492|NCT01966003|531282416|FG000|Overall Study|Withdrawal by Subject|29|||
147304493|NCT01966003|531282417|FG001|Overall Study|Withdrawal by Subject|19|||
147304494|NCT01966003|531282416|FG000|Overall Study|Plan to Receive Other Anticancer Therapy|131|||
147304495|NCT01966003|531282417|FG001|Overall Study|Plan to Receive Other Anticancer Therapy|127|||
147304496|NCT01966003|531282416|FG000|Overall Study|Plan to Receive Commercial Bevacizumab|44|||
147304497|NCT01966003|531282417|FG001|Overall Study|Plan to Receive Commercial Bevacizumab|67|||
147304498|NCT01966003|531282416|FG000|Overall Study|Other|1|||
147304499|NCT01966003|531282417|FG001|Overall Study|Other|1|||
147304500|NCT00674570|531282418|FG000|Overall Study|Withdrawal by Subject|0|||
147304501|NCT00674570|531282419|FG001|Overall Study|Withdrawal by Subject|2|||
147304502|NCT00674570|531282420|FG002|Overall Study|Withdrawal by Subject|0|||
147304503|NCT00633932|531282421|FG000|Overall Study|Adverse Event|1|||
147304504|NCT00633932|531282422|FG001|Overall Study|Adverse Event|3|||
147304505|NCT00633932|531282423|FG002|Overall Study|Adverse Event|4|||
147304506|NCT00633932|531282421|FG000|Overall Study|Withdrawal by Subject|3|||
147304507|NCT00633932|531282422|FG001|Overall Study|Withdrawal by Subject|9|||
147304508|NCT00633932|531282423|FG002|Overall Study|Withdrawal by Subject|1|||
147304509|NCT00633932|531282421|FG000|Overall Study|Lost to Follow-up|1|||
147304510|NCT00633932|531282422|FG001|Overall Study|Lost to Follow-up|0|||
147304511|NCT00633932|531282423|FG002|Overall Study|Lost to Follow-up|2|||
147304512|NCT00633932|531282421|FG000|Overall Study|Protocol Violation|5|||
147304513|NCT00633932|531282422|FG001|Overall Study|Protocol Violation|2|||
147304514|NCT00633932|531282423|FG002|Overall Study|Protocol Violation|3|||
147304515|NCT00633932|531282421|FG000|Overall Study|Physician Decision|0|||
147304516|NCT00633932|531282422|FG001|Overall Study|Physician Decision|0|||
147304517|NCT00633932|531282423|FG002|Overall Study|Physician Decision|1|||
147304518|NCT00633932|531282421|FG000|Overall Study|Doctor's judgement|1|||
147304519|NCT00633932|531282422|FG001|Overall Study|Doctor's judgement|0|||
147304520|NCT00633932|531282423|FG002|Overall Study|Doctor's judgement|0|||
147304521|NCT00633932|531282421|FG000|Overall Study|Moved Away|1|||
147304522|NCT00633932|531282422|FG001|Overall Study|Moved Away|0|||
147304523|NCT00633932|531282423|FG002|Overall Study|Moved Away|0|||
147304524|NCT00482274|531282424|FG000|Overall Study|Adverse Event|1|||
147304525|NCT04836858|531282425|FG000|Overall Study|Adverse Event|0|||
147304526|NCT04836858|531282426|FG001|Overall Study|Adverse Event|0|||
147304527|NCT04836858|531282427|FG002|Overall Study|Adverse Event|0|||
147304528|NCT04836858|531282428|FG003|Overall Study|Adverse Event|1|||
147304529|NCT04836858|531282425|FG000|Overall Study|Lost to Follow-up|1|||
147304530|NCT04836858|531282426|FG001|Overall Study|Lost to Follow-up|0|||
147304531|NCT04836858|531282427|FG002|Overall Study|Lost to Follow-up|0|||
147304532|NCT04836858|531282428|FG003|Overall Study|Lost to Follow-up|0|||
147304533|NCT04836858|531282425|FG000|Overall Study|Subject/Guardian decision|3|||
147304534|NCT04836858|531282426|FG001|Overall Study|Subject/Guardian decision|0|||
147304535|NCT04836858|531282427|FG002|Overall Study|Subject/Guardian decision|0|||
147304536|NCT04836858|531282428|FG003|Overall Study|Subject/Guardian decision|1|||
147304537|NCT04836858|531282425|FG000|Overall Study|Randomized but not treated|4|||
147304538|NCT04836858|531282426|FG001|Overall Study|Randomized but not treated|0|||
147304539|NCT04836858|531282427|FG002|Overall Study|Randomized but not treated|0|||
147304540|NCT04836858|531282428|FG003|Overall Study|Randomized but not treated|0|||
147304541|NCT04887948|531282432|FG000|Overall Study|Death|1|||
147304542|NCT04887948|531282433|FG001|Overall Study|Death|0|||
147304543|NCT04887948|531282434|FG002|Overall Study|Death|0|||
147304544|NCT04887948|531282432|FG000|Overall Study|Lost to Follow-up|1|||
147304545|NCT04887948|531282433|FG001|Overall Study|Lost to Follow-up|0|||
147304546|NCT04887948|531282434|FG002|Overall Study|Lost to Follow-up|3|||
147304547|NCT04887948|531282432|FG000|Overall Study|Physician Decision|0|||
147304548|NCT04887948|531282433|FG001|Overall Study|Physician Decision|4|||
147304549|NCT04887948|531282434|FG002|Overall Study|Physician Decision|1|||
147304550|NCT04887948|531282432|FG000|Overall Study|Protocol Violation|1|||
147304551|NCT04887948|531282433|FG001|Overall Study|Protocol Violation|1|||
147532210|NCT02059265|532103918|FG000|Overall Study|Ineligible|4|||
147532211|NCT04196023|532103919|FG000|Overall Study|Withdrawal by Subject|0|||
147645471|NCT03030118|532522000|FG001|Overall Study|Achieved SLE Diagnosis|10|||
147645472|NCT03030118|532521999|FG000|Overall Study|Adverse Event|1|||
147304552|NCT04887948|531282434|FG002|Overall Study|Protocol Violation|0|||
147304553|NCT04887948|531282432|FG000|Overall Study|Withdrawal by Subject|0|||
147304554|NCT04887948|531282433|FG001|Overall Study|Withdrawal by Subject|6|||
147304555|NCT04887948|531282434|FG002|Overall Study|Withdrawal by Subject|1|||
147304556|NCT04887948|531282432|FG000|Overall Study|No longer met eligibility criteria|1|||
147304557|NCT04887948|531282433|FG001|Overall Study|No longer met eligibility criteria|2|||
147304558|NCT04887948|531282434|FG002|Overall Study|No longer met eligibility criteria|1|||
147304559|NCT04887948|531282432|FG000|Overall Study|Other|2|||
147645473|NCT03030118|532522000|FG001|Overall Study|Adverse Event|1|||
147645474|NCT03030118|532521999|FG000|Overall Study|Pregnancy|2|||
147645475|NCT03030118|532522000|FG001|Overall Study|Pregnancy|2|||
147645476|NCT03030118|532521999|FG000|Overall Study|Lost to Follow-up|5|||
147645477|NCT03030118|532522000|FG001|Overall Study|Lost to Follow-up|6|||
147645478|NCT03030118|532521999|FG000|Overall Study|Concomitant Medications|1|||
147645479|NCT03030118|532522000|FG001|Overall Study|Concomitant Medications|1|||
147645480|NCT03030118|532521999|FG000|Overall Study|Achieved SLE and Concomitant Meds|1|||
147645481|NCT03030118|532522000|FG001|Overall Study|Achieved SLE and Concomitant Meds|0|||
147645482|NCT03030118|532521999|FG000|Overall Study|Other|2|||
147645483|NCT03030118|532522000|FG001|Overall Study|Other|0|||
147645484|NCT03030118|532521999|FG000|Overall Study|Withdrawal by Subject|26|||
147645485|NCT03030118|532522000|FG001|Overall Study|Withdrawal by Subject|21|||
147645486|NCT03030118|532521999|FG000|Overall Study|Protocol Violation|1|||
147645487|NCT03030118|532522000|FG001|Overall Study|Protocol Violation|6|||
147645488|NCT04529850|532522001|FG000|Overall Study|Death|2|||
147645489|NCT04529850|532522001|FG000|Overall Study|Physician Decision|1|||
147645490|NCT04529850|532522001|FG000|Overall Study|Withdrawal by Subject|2|||
147304560|NCT04887948|531282433|FG001|Overall Study|Other|1|||
147304561|NCT04887948|531282434|FG002|Overall Study|Other|1|||
147304562|NCT00787319|531282435|FG000|Overall Study|Lost to Follow-up|2|||
147304563|NCT00787319|531282435|FG000|Overall Study|Withdrawal by Subject|15|||
147304564|NCT00787319|531282435|FG000|Overall Study|Adverse Event|3|||
147304565|NCT00787319|531282435|FG000|Overall Study|Objective progression or relapse|30|||
147304566|NCT00787319|531282435|FG000|Overall Study|Lack of Efficacy|1|||
147304567|NCT00787319|531282435|FG000|Overall Study|Budget exhausted/exceeded|1|||
147304568|NCT00787319|531282435|FG000|Overall Study|Unresponsiveness to visit invitation|1|||
147304569|NCT00787319|531282435|FG000|Overall Study|No health insurance reimbursement|2|||
147304570|NCT00787319|531282435|FG000|Overall Study|Stabilized disease findings|3|||
147304571|NCT00787319|531282435|FG000|Overall Study|Inactive disease|5|||
147304572|NCT03075904|531282436|FG000|Overall Study|Physician Decision|3|||
147304573|NCT03075904|531282436|FG000|Overall Study|Need for Medication not Permitted|1|||
147304574|NCT01287520|531282437|FG000|Overall Study|Adverse Event|2|||
147304575|NCT01287520|531282438|FG001|Overall Study|Adverse Event|2|||
147304576|NCT01287520|531282439|FG002|Overall Study|Adverse Event|2|||
147304577|NCT01287520|531282440|FG003|Overall Study|Adverse Event|1|||
147304578|NCT01287520|531282441|FG004|Overall Study|Adverse Event|1|||
147304579|NCT01287520|531282442|FG005|Overall Study|Adverse Event|2|||
147304580|NCT01287520|531282443|FG006|Overall Study|Adverse Event|0|||
147304581|NCT01287520|531282444|FG007|Overall Study|Adverse Event|2|||
147532212|NCT04196023|532103920|FG001|Overall Study|Withdrawal by Subject|1|||
147532213|NCT04196023|532103919|FG000|Overall Study|Adverse Event|3|||
147532214|NCT04196023|532103920|FG001|Overall Study|Adverse Event|1|||
147532215|NCT04196023|532103919|FG000|Overall Study|Lost to Follow-up|0|||
147532216|NCT04196023|532103920|FG001|Overall Study|Lost to Follow-up|1|||
147532217|NCT04366258|532103927|FG000|Baseline Assessments|Screen Failure|21|||
147532218|NCT04366258|532103927|FG000|Baseline Assessments|Early Termination|3|||
147532219|NCT02940392|532103930|FG000|Overall Study|Lost to Follow-up|3|||
147532220|NCT02940392|532103930|FG000|Overall Study|Retreatment|3|||
147532221|NCT02940392|532103930|FG000|Overall Study|Death|2|||
147532222|NCT03205046|532103931|FG000|Overall Study|Death|10|||
147532223|NCT03205046|532103932|FG001|Overall Study|Death|6|||
147532224|NCT03205046|532103931|FG000|Overall Study|Withdrawal by Subject|1|||
147532225|NCT03205046|532103932|FG001|Overall Study|Withdrawal by Subject|2|||
147532226|NCT03205046|532103931|FG000|Overall Study|Lost to Follow-up|0|||
147532227|NCT03205046|532103932|FG001|Overall Study|Lost to Follow-up|1|||
147532228|NCT03205046|532103931|FG000|Overall Study|Study terminated by sponsor|2|||
147532229|NCT03205046|532103932|FG001|Overall Study|Study terminated by sponsor|1|||
147532230|NCT01023815|532103933|FG000|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|144|||
147532231|NCT01023815|532103934|FG001|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|0|||
147532232|NCT01023815|532103935|FG002|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|0|||
147532233|NCT01023815|532103936|FG003|Pre-randomization Period (Day 1 to 90)|Did not meet inclusion criteria|0|||
147532234|NCT01023815|532103933|FG000|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|0|||
147532235|NCT01023815|532103934|FG001|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|0|||
147532236|NCT01023815|532103935|FG002|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|1|||
147304582|NCT01287520|531282445|FG008|Overall Study|Adverse Event|0|||
147532237|NCT01023815|532103936|FG003|Randomized Period (Day 90 to Month 12)|Withdrawal by Subject|1|||
147645491|NCT00593606|532522004|FG000|Overall Study|Adverse Event|13|||
147304583|NCT01287520|531282437|FG000|Overall Study|Physician Decision|1|||
147304584|NCT01287520|531282438|FG001|Overall Study|Physician Decision|1|||
147304585|NCT01287520|531282439|FG002|Overall Study|Physician Decision|2|||
147304586|NCT01287520|531282440|FG003|Overall Study|Physician Decision|0|||
147304587|NCT01287520|531282441|FG004|Overall Study|Physician Decision|1|||
147304588|NCT01287520|531282442|FG005|Overall Study|Physician Decision|1|||
147304589|NCT01287520|531282443|FG006|Overall Study|Physician Decision|0|||
147304590|NCT01287520|531282444|FG007|Overall Study|Physician Decision|1|||
147304591|NCT01287520|531282445|FG008|Overall Study|Physician Decision|0|||
147304592|NCT01287520|531282437|FG000|Overall Study|Progressive disease|0|||
147304593|NCT01287520|531282438|FG001|Overall Study|Progressive disease|4|||
147304594|NCT01287520|531282439|FG002|Overall Study|Progressive disease|1|||
147304595|NCT01287520|531282440|FG003|Overall Study|Progressive disease|6|||
147304596|NCT01287520|531282441|FG004|Overall Study|Progressive disease|1|||
147304597|NCT01287520|531282442|FG005|Overall Study|Progressive disease|0|||
147304598|NCT01287520|531282443|FG006|Overall Study|Progressive disease|2|||
147304599|NCT01287520|531282444|FG007|Overall Study|Progressive disease|2|||
147645492|NCT00593606|532522004|FG000|Overall Study|Withdrawal by Subject|1|||
147304600|NCT01287520|531282445|FG008|Overall Study|Progressive disease|4|||
147304601|NCT01287520|531282437|FG000|Overall Study|Withdrawal by Subject|0|||
147304602|NCT01287520|531282438|FG001|Overall Study|Withdrawal by Subject|0|||
147304603|NCT01287520|531282439|FG002|Overall Study|Withdrawal by Subject|0|||
147304604|NCT01287520|531282440|FG003|Overall Study|Withdrawal by Subject|0|||
147304605|NCT01287520|531282441|FG004|Overall Study|Withdrawal by Subject|0|||
147304606|NCT01287520|531282442|FG005|Overall Study|Withdrawal by Subject|1|||
147304607|NCT01287520|531282443|FG006|Overall Study|Withdrawal by Subject|0|||
147304608|NCT01287520|531282444|FG007|Overall Study|Withdrawal by Subject|0|||
147304609|NCT01287520|531282445|FG008|Overall Study|Withdrawal by Subject|1|||
147304610|NCT01800201|531282446|FG000|Overall Study|Withdrawal by Subject|2|||
147304611|NCT01800201|531282447|FG001|Overall Study|Withdrawal by Subject|0|||
147304612|NCT01800201|531282446|FG000|Overall Study|patient privacy concerns|1|||
147304613|NCT01800201|531282447|FG001|Overall Study|patient privacy concerns|1|||
147304614|NCT01800201|531282446|FG000|Overall Study|did not want to use device|0|||
147304615|NCT01800201|531282447|FG001|Overall Study|did not want to use device|1|||
147304616|NCT01800201|531282446|FG000|Overall Study|PI withdrawal, cognitive concerns|0|||
147304617|NCT01800201|531282447|FG001|Overall Study|PI withdrawal, cognitive concerns|1|||
147304618|NCT00708435|531282448|FG000|Overall Study|Death / Serious Adverse Event|10|||
147304619|NCT00708435|531282449|FG001|Overall Study|Death / Serious Adverse Event|5|||
147304620|NCT00708435|531282448|FG000|Overall Study|Lost to Follow-up|9|||
147304621|NCT00708435|531282449|FG001|Overall Study|Lost to Follow-up|4|||
147304622|NCT00708435|531282448|FG000|Overall Study|Withdrawal by Subject|3|||
147304623|NCT00708435|531282449|FG001|Overall Study|Withdrawal by Subject|7|||
147304624|NCT00708435|531282448|FG000|Overall Study|Adverse Event|1|||
147304625|NCT00708435|531282449|FG001|Overall Study|Adverse Event|0|||
147304626|NCT00708435|531282448|FG000|Overall Study|Protocol Violation|0|||
147304627|NCT00708435|531282449|FG001|Overall Study|Protocol Violation|1|||
147304628|NCT00708435|531282448|FG000|Overall Study|Intervention by primary care physician|1|||
147304629|NCT00708435|531282449|FG001|Overall Study|Intervention by primary care physician|0|||
147304630|NCT00708435|531282448|FG000|Overall Study|Refused hospitalization|1|||
147304631|NCT00708435|531282449|FG001|Overall Study|Refused hospitalization|0|||
147304632|NCT05061537|531282455|FG000|Treatment Phase|Progressive disease|0|||
147304633|NCT05061537|531282456|FG001|Treatment Phase|Progressive disease|1|||
147304634|NCT05061537|531282457|FG002|Treatment Phase|Progressive disease|2|||
147304635|NCT05061537|531282458|FG003|Treatment Phase|Progressive disease|0|||
147304636|NCT05061537|531282459|FG004|Treatment Phase|Progressive disease|0|||
147532238|NCT01023815|532103933|FG000|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|0|||
147532239|NCT01023815|532103934|FG001|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|1|||
147532240|NCT01023815|532103935|FG002|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|1|||
147532241|NCT01023815|532103936|FG003|Randomized Period (Day 90 to Month 12)|Lost to Follow-up|0|||
147532242|NCT01023815|532103933|FG000|Randomized Period (Day 90 to Month 12)|Administrative Problems|0|||
147532243|NCT01023815|532103934|FG001|Randomized Period (Day 90 to Month 12)|Administrative Problems|1|||
147532244|NCT01023815|532103935|FG002|Randomized Period (Day 90 to Month 12)|Administrative Problems|6|||
147532245|NCT01023815|532103936|FG003|Randomized Period (Day 90 to Month 12)|Administrative Problems|2|||
147532246|NCT01023815|532103933|FG000|Randomized Period (Day 90 to Month 12)|Graft Loss|0|||
147532247|NCT01023815|532103934|FG001|Randomized Period (Day 90 to Month 12)|Graft Loss|1|||
147532248|NCT01023815|532103935|FG002|Randomized Period (Day 90 to Month 12)|Graft Loss|0|||
147532249|NCT01023815|532103936|FG003|Randomized Period (Day 90 to Month 12)|Graft Loss|0|||
147532250|NCT00634933|532103947|FG000|Part A: Baseline to Week 24|Adverse Event|4|||
147532251|NCT00634933|532103948|FG001|Part A: Baseline to Week 24|Adverse Event|4|||
147532252|NCT00634933|532103949|FG002|Part A: Baseline to Week 24|Adverse Event|8|||
147532253|NCT00634933|532103950|FG003|Part A: Baseline to Week 24|Adverse Event|0|||
147645493|NCT00593606|532522004|FG000|Overall Study|Protocol Violation|3|||
147304637|NCT05061537|531282455|FG000|Treatment Phase|Adverse Event|0|||
147304638|NCT05061537|531282456|FG001|Treatment Phase|Adverse Event|0|||
147304639|NCT05061537|531282457|FG002|Treatment Phase|Adverse Event|2|||
147304640|NCT05061537|531282458|FG003|Treatment Phase|Adverse Event|0|||
147304641|NCT05061537|531282459|FG004|Treatment Phase|Adverse Event|0|||
147304642|NCT05061537|531282455|FG000|Treatment Phase|Global deterioration of health status|0|||
147304643|NCT05061537|531282456|FG001|Treatment Phase|Global deterioration of health status|1|||
147304644|NCT05061537|531282457|FG002|Treatment Phase|Global deterioration of health status|0|||
147532254|NCT00634933|532103951|FG004|Part A: Baseline to Week 24|Adverse Event|0|||
147304645|NCT05061537|531282458|FG003|Treatment Phase|Global deterioration of health status|0|||
147304646|NCT05061537|531282459|FG004|Treatment Phase|Global deterioration of health status|0|||
147191048|NCT00740220|530867513|FG000|Overall Study|screen failures (non-COPD patients)|9|||
147191049|NCT01908426|530867518|FG000|Overall Study|Adverse Event|98|||
147191050|NCT01908426|530867519|FG001|Overall Study|Adverse Event|11|||
147191051|NCT01908426|530867518|FG000|Overall Study|Clinical Deterioration|72|||
147191052|NCT01908426|530867519|FG001|Overall Study|Clinical Deterioration|38|||
147191053|NCT01908426|530867518|FG000|Overall Study|Lack of Efficacy|3|||
147191054|NCT01908426|530867519|FG001|Overall Study|Lack of Efficacy|0|||
147191055|NCT01908426|530867518|FG000|Overall Study|Lost to Follow-up|0|||
147532255|NCT00634933|532103947|FG000|Part A: Baseline to Week 24|Death|1|||
147532256|NCT00634933|532103948|FG001|Part A: Baseline to Week 24|Death|0|||
147532257|NCT00634933|532103949|FG002|Part A: Baseline to Week 24|Death|0|||
147532258|NCT00634933|532103950|FG003|Part A: Baseline to Week 24|Death|0|||
147532259|NCT00634933|532103951|FG004|Part A: Baseline to Week 24|Death|0|||
147532260|NCT00634933|532103947|FG000|Part A: Baseline to Week 24|Failed to Return|1|||
147532261|NCT00634933|532103948|FG001|Part A: Baseline to Week 24|Failed to Return|0|||
147532262|NCT00634933|532103949|FG002|Part A: Baseline to Week 24|Failed to Return|0|||
147532263|NCT00634933|532103950|FG003|Part A: Baseline to Week 24|Failed to Return|0|||
147532264|NCT00634933|532103951|FG004|Part A: Baseline to Week 24|Failed to Return|0|||
147532265|NCT00634933|532103947|FG000|Part A: Baseline to Week 24|Investigator Request|1|||
147532266|NCT00634933|532103948|FG001|Part A: Baseline to Week 24|Investigator Request|1|||
147532267|NCT00634933|532103949|FG002|Part A: Baseline to Week 24|Investigator Request|1|||
147532268|NCT00634933|532103950|FG003|Part A: Baseline to Week 24|Investigator Request|0|||
147532269|NCT00634933|532103951|FG004|Part A: Baseline to Week 24|Investigator Request|0|||
147532270|NCT00634933|532103947|FG000|Part A: Baseline to Week 24|Lost to Follow-up|0|||
147532271|NCT00634933|532103948|FG001|Part A: Baseline to Week 24|Lost to Follow-up|1|||
147191056|NCT01908426|530867519|FG001|Overall Study|Lost to Follow-up|1|||
147191057|NCT01908426|530867518|FG000|Overall Study|Physician Decision|3|||
147191058|NCT01908426|530867519|FG001|Overall Study|Physician Decision|3|||
147191059|NCT01908426|530867518|FG000|Overall Study|Withdrawal by Subject|11|||
147191060|NCT01908426|530867519|FG001|Overall Study|Withdrawal by Subject|6|||
147191061|NCT01908426|530867518|FG000|Overall Study|Progressive Disease|206|||
147191062|NCT01908426|530867519|FG001|Overall Study|Progressive Disease|152|||
147191063|NCT01908426|530867518|FG000|Overall Study|Protocol Violation|1|||
147191064|NCT01908426|530867519|FG001|Overall Study|Protocol Violation|0|||
147191065|NCT01908426|530867518|FG000|Overall Study|No Study Treatment Given|3|||
147191066|NCT01908426|530867519|FG001|Overall Study|No Study Treatment Given|0|||
147191067|NCT03346434|530867520|FG000|Overall Study|Randomized in Error|0|||
147191068|NCT03346434|530867521|FG001|Overall Study|Randomized in Error|0|||
147191069|NCT03346434|530867522|FG002|Overall Study|Randomized in Error|0|||
147532272|NCT00634933|532103949|FG002|Part A: Baseline to Week 24|Lost to Follow-up|1|||
147191070|NCT03346434|530867523|FG003|Overall Study|Randomized in Error|0|||
147191071|NCT03346434|530867524|FG004|Overall Study|Randomized in Error|1|||
147191072|NCT03346434|530867525|FG005|Overall Study|Randomized in Error|0|||
147191073|NCT03346434|530867520|FG000|Overall Study|Withdrawal by Subject|0|||
147191074|NCT03346434|530867521|FG001|Overall Study|Withdrawal by Subject|0|||
147191075|NCT03346434|530867522|FG002|Overall Study|Withdrawal by Subject|1|||
147191076|NCT03346434|530867523|FG003|Overall Study|Withdrawal by Subject|0|||
147191077|NCT03346434|530867524|FG004|Overall Study|Withdrawal by Subject|1|||
147191078|NCT03346434|530867525|FG005|Overall Study|Withdrawal by Subject|0|||
147191079|NCT03346434|530867520|FG000|Overall Study|Lost to Follow-up|0|||
147191080|NCT03346434|530867521|FG001|Overall Study|Lost to Follow-up|0|||
147191081|NCT03346434|530867522|FG002|Overall Study|Lost to Follow-up|0|||
147191082|NCT03346434|530867523|FG003|Overall Study|Lost to Follow-up|0|||
147191083|NCT03346434|530867524|FG004|Overall Study|Lost to Follow-up|1|||
147191084|NCT03346434|530867525|FG005|Overall Study|Lost to Follow-up|1|||
147191085|NCT03346434|530867520|FG000|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|0|||
147191086|NCT03346434|530867521|FG001|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|0|||
147304647|NCT05061537|531282455|FG000|Follow up|Other|2|||
147304648|NCT05061537|531282456|FG001|Follow up|Other|0|||
147304649|NCT05061537|531282457|FG002|Follow up|Other|2|||
147304650|NCT05061537|531282458|FG003|Follow up|Other|0|||
147191087|NCT03346434|530867522|FG002|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|0|||
147191088|NCT03346434|530867523|FG003|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|0|||
147532273|NCT00634933|532103950|FG003|Part A: Baseline to Week 24|Lost to Follow-up|0|||
147191089|NCT03346434|530867524|FG004|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|75|||
147191090|NCT03346434|530867525|FG005|Overall Study|Transitioned to OLE study at Week 16 (NCT02612454)|81|||
147191091|NCT04416204|530867529|FG000|Washout (3-6 Weeks)|Withdrawal by Subject|1|||
147191092|NCT04416204|530867530|FG001|Washout (3-6 Weeks)|Withdrawal by Subject|0|||
147645494|NCT00593606|532522004|FG000|Overall Study|Lost to Follow-up|2|||
147191093|NCT04416204|530867531|FG002|Washout (3-6 Weeks)|Withdrawal by Subject|1|||
147191094|NCT04416204|530867532|FG003|Washout (3-6 Weeks)|Withdrawal by Subject|1|||
147191095|NCT00812708|530867533|FG000|Overall Study|Device could not be implanted|2|||
147304651|NCT05061537|531282459|FG004|Follow up|Other|0|||
147304652|NCT05061537|531282455|FG000|Follow up|Study terminated by sponsor|0|||
147304653|NCT05061537|531282456|FG001|Follow up|Study terminated by sponsor|0|||
147304654|NCT05061537|531282457|FG002|Follow up|Study terminated by sponsor|2|||
147304655|NCT05061537|531282458|FG003|Follow up|Study terminated by sponsor|0|||
147304656|NCT05061537|531282459|FG004|Follow up|Study terminated by sponsor|0|||
147304657|NCT05061537|531282455|FG000|Long-term Follow-up|Study terminated by sponsor|2|||
147304658|NCT05061537|531282456|FG001|Long-term Follow-up|Study terminated by sponsor|2|||
147304659|NCT05061537|531282457|FG002|Long-term Follow-up|Study terminated by sponsor|2|||
147304660|NCT05061537|531282458|FG003|Long-term Follow-up|Study terminated by sponsor|0|||
147304661|NCT05061537|531282459|FG004|Long-term Follow-up|Study terminated by sponsor|0|||
147304662|NCT05061537|531282455|FG000|Long-term Follow-up|Death|0|||
147304663|NCT05061537|531282456|FG001|Long-term Follow-up|Death|1|||
147304664|NCT05061537|531282457|FG002|Long-term Follow-up|Death|0|||
147304665|NCT05061537|531282458|FG003|Long-term Follow-up|Death|0|||
147304666|NCT05061537|531282459|FG004|Long-term Follow-up|Death|0|||
147304667|NCT04503096|531282462|FG000|Overall Study|Withdrawal by Subject|3|||
147304668|NCT01480596|531282463|FG000|Overall Study|Adverse Event|3|||
147304669|NCT01480596|531282464|FG001|Overall Study|Adverse Event|0|||
147304670|NCT01480596|531282463|FG000|Overall Study|MG exacerbation or change in medication|2|||
147304671|NCT01480596|531282464|FG001|Overall Study|MG exacerbation or change in medication|2|||
147304672|NCT01576367|531282465|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
147304673|NCT01576367|531282465|FG000|Overall Study|Moved to commercial use after 6 months|1|||
147304674|NCT00988221|531282466|FG000|Part I|Adverse Event|0|||
147304675|NCT00988221|531282467|FG001|Part I|Adverse Event|1|||
147304676|NCT00988221|531282468|FG002|Part I|Adverse Event|2|||
147304677|NCT00988221|531282469|FG003|Part I|Adverse Event|0|||
147304678|NCT00988221|531282466|FG000|Part I|Insufficient Therapeutic Response|4|||
147304679|NCT00988221|531282467|FG001|Part I|Insufficient Therapeutic Response|6|||
147304680|NCT00988221|531282468|FG002|Part I|Insufficient Therapeutic Response|5|||
147304681|NCT00988221|531282469|FG003|Part I|Insufficient Therapeutic Response|0|||
147304682|NCT00988221|531282466|FG000|Part I|Refused Treatment|0|||
147304683|NCT00988221|531282467|FG001|Part I|Refused Treatment|2|||
147304684|NCT00988221|531282468|FG002|Part I|Refused Treatment|1|||
147304685|NCT00988221|531282469|FG003|Part I|Refused Treatment|0|||
147304686|NCT00988221|531282466|FG000|Part I|Lost to Follow-up|0|||
147304687|NCT00988221|531282467|FG001|Part I|Lost to Follow-up|1|||
147304688|NCT00988221|531282468|FG002|Part I|Lost to Follow-up|0|||
147304689|NCT00988221|531282469|FG003|Part I|Lost to Follow-up|0|||
147304690|NCT00988221|531282466|FG000|Part II|Adverse Event|1|||
147304691|NCT00988221|531282467|FG001|Part II|Adverse Event|0|||
147304692|NCT00988221|531282468|FG002|Part II|Adverse Event|0|||
147304693|NCT00988221|531282469|FG003|Part II|Adverse Event|1|||
147304694|NCT00988221|531282466|FG000|Part II|Withdrawal by Subject|0|||
147304695|NCT00988221|531282467|FG001|Part II|Withdrawal by Subject|0|||
147304696|NCT00988221|531282468|FG002|Part II|Withdrawal by Subject|2|||
147304697|NCT00988221|531282469|FG003|Part II|Withdrawal by Subject|2|||
147304698|NCT00988221|531282466|FG000|Part II|Reason not Specified|0|||
147304699|NCT00988221|531282467|FG001|Part II|Reason not Specified|0|||
147304700|NCT00988221|531282468|FG002|Part II|Reason not Specified|1|||
147304701|NCT00988221|531282469|FG003|Part II|Reason not Specified|0|||
147304702|NCT00988221|531282466|FG000|Part III|Adverse Event|1|||
147304703|NCT00988221|531282467|FG001|Part III|Adverse Event|0|||
147304704|NCT00988221|531282468|FG002|Part III|Adverse Event|1|||
147304705|NCT00988221|531282469|FG003|Part III|Adverse Event|0|||
147304706|NCT00988221|531282466|FG000|Part III|Insufficient Therapeutic Response|0|||
147304707|NCT00988221|531282467|FG001|Part III|Insufficient Therapeutic Response|1|||
147304708|NCT00988221|531282468|FG002|Part III|Insufficient Therapeutic Response|1|||
147304709|NCT00988221|531282469|FG003|Part III|Insufficient Therapeutic Response|0|||
147304710|NCT00988221|531282466|FG000|Part III|Refused Treatment|0|||
147304711|NCT00988221|531282467|FG001|Part III|Refused Treatment|0|||
147304712|NCT00988221|531282468|FG002|Part III|Refused Treatment|1|||
147304713|NCT00988221|531282469|FG003|Part III|Refused Treatment|0|||
147304714|NCT03592277|531282474|FG000|Overall Study|Withdrawal by Subject|6|||
147304715|NCT03592277|531282475|FG001|Overall Study|Withdrawal by Subject|8|||
147304716|NCT00954733|531282476|FG000|Overall Study|blood gas machine did not work|1|||
147304717|NCT01346514|531282477|FG000|Overall Study|Lost to Follow-up|19|||
147304718|NCT01346514|531282478|FG001|Overall Study|Lost to Follow-up|30|||
147304719|NCT01346514|531282477|FG000|Overall Study|Withdrawal by Subject|7|||
147304720|NCT01346514|531282478|FG001|Overall Study|Withdrawal by Subject|3|||
147304721|NCT01346514|531282477|FG000|Overall Study|Death|3|||
147304722|NCT01346514|531282478|FG001|Overall Study|Death|4|||
147304723|NCT00909480|531282479|FG000|Overall Study|Adverse Event|5|||
147304724|NCT00909480|531282480|FG001|Overall Study|Adverse Event|3|||
147304725|NCT00909480|531282479|FG000|Overall Study|Protocol Violation|6|||
147304726|NCT00909480|531282480|FG001|Overall Study|Protocol Violation|8|||
147304727|NCT00909480|531282479|FG000|Overall Study|Withdrawal criteria|9|||
147304728|NCT00909480|531282480|FG001|Overall Study|Withdrawal criteria|11|||
147304729|NCT00909480|531282479|FG000|Overall Study|Unclassified|18|||
147304730|NCT00909480|531282480|FG001|Overall Study|Unclassified|19|||
147304731|NCT01725386|531282488|FG000|Overall Study|Death|84|||
147304732|NCT01725386|531282489|FG001|Overall Study|Death|40|||
147304733|NCT01725386|531282488|FG000|Overall Study|Lost to Follow-up|81|||
147304734|NCT01725386|531282489|FG001|Overall Study|Lost to Follow-up|6|||
147304735|NCT01725386|531282488|FG000|Overall Study|Withdrawal by Subject|10|||
147304736|NCT01725386|531282489|FG001|Overall Study|Withdrawal by Subject|0|||
147304737|NCT00879996|531282490|FG000|Overall Study|Lost to Follow-up|7|||
147304738|NCT00879996|531282491|FG001|Overall Study|Lost to Follow-up|6|||
147304739|NCT00879996|531282490|FG000|Overall Study|non-compliance|6|||
147304740|NCT00879996|531282491|FG001|Overall Study|non-compliance|4|||
147304741|NCT00879996|531282490|FG000|Overall Study|Physician Decision|1|||
147304742|NCT00879996|531282491|FG001|Overall Study|Physician Decision|2|||
147304743|NCT00879996|531282490|FG000|Overall Study|psychiatric problem|0|||
147304744|NCT00879996|531282491|FG001|Overall Study|psychiatric problem|1|||
147645495|NCT00593606|532522004|FG000|Overall Study|Run-In Failure|5|||
147645496|NCT00593606|532522004|FG000|Overall Study|Screen Failure|3|||
147645497|NCT04643964|532522005|FG000|Overall Study|Lost to Follow-up|55|||
147645498|NCT04643964|532522006|FG001|Overall Study|Lost to Follow-up|59|||
147645499|NCT04643964|532522007|FG002|Overall Study|Lost to Follow-up|54|||
147645500|NCT04643964|532522008|FG003|Overall Study|Lost to Follow-up|129|||
147645501|NCT04643964|532522009|FG004|Overall Study|Lost to Follow-up|48|||
147645502|NCT04643964|532522005|FG000|Overall Study|Failed attention check|1|||
147645503|NCT04643964|532522006|FG001|Overall Study|Failed attention check|8|||
147645504|NCT04643964|532522007|FG002|Overall Study|Failed attention check|2|||
147645505|NCT04643964|532522008|FG003|Overall Study|Failed attention check|14|||
147645506|NCT04643964|532522009|FG004|Overall Study|Failed attention check|11|||
147645507|NCT02638129|532522010|FG000|Overall Study|Study terminated|28|||
147645508|NCT02638129|532522011|FG001|Overall Study|Study terminated|30|||
147645509|NCT00869557|532522012|FG000|Randomized Phase|Lost to Follow-up|2|||
147645510|NCT00869557|532522013|FG001|Randomized Phase|Lost to Follow-up|1|||
147645511|NCT00869557|532522012|FG000|Randomized Phase|Investigator's Discretion|1|||
147645512|NCT00869557|532522013|FG001|Randomized Phase|Investigator's Discretion|0|||
147645513|NCT00869557|532522012|FG000|Randomized Phase|Withdrew Consent|0|||
147645514|NCT00869557|532522013|FG001|Randomized Phase|Withdrew Consent|1|||
147645515|NCT00869557|532522012|FG000|Extension Phase|Adverse Event|2|||
147645516|NCT00869557|532522013|FG001|Extension Phase|Adverse Event|2|||
147645517|NCT00869557|532522012|FG000|Extension Phase|Lack of Efficacy|1|||
147645518|NCT00869557|532522013|FG001|Extension Phase|Lack of Efficacy|0|||
147645519|NCT00869557|532522012|FG000|Extension Phase|Lost to Follow-up|3|||
147304745|NCT00879996|531282490|FG000|Overall Study|put on parole|1|||
147304746|NCT00879996|531282491|FG001|Overall Study|put on parole|0|||
147645520|NCT00869557|532522013|FG001|Extension Phase|Lost to Follow-up|1|||
147645521|NCT00869557|532522012|FG000|Extension Phase|Investigator's Discretion|2|||
147645522|NCT00869557|532522013|FG001|Extension Phase|Investigator's Discretion|0|||
147645523|NCT00869557|532522012|FG000|Extension Phase|Withdrew Consent|2|||
147645524|NCT00869557|532522013|FG001|Extension Phase|Withdrew Consent|0|||
147645525|NCT00114738|532522016|FG000|Bortezomib Then Bortezomib + Induction|Withdrawal by Subject|1|||
147645526|NCT00114738|532522017|FG001|Bortezomib Then Bortezomib + Induction|Withdrawal by Subject|0|||
147645527|NCT00114738|532522018|FG002|Bortezomib Then Bortezomib + Induction|Withdrawal by Subject|0|||
147645528|NCT00114738|532522016|FG000|Bortezomib Then Bortezomib + Induction|Progressive Disease|1|||
147645529|NCT00114738|532522017|FG001|Bortezomib Then Bortezomib + Induction|Progressive Disease|0|||
147645530|NCT00114738|532522018|FG002|Bortezomib Then Bortezomib + Induction|Progressive Disease|0|||
147645531|NCT00114738|532522016|FG000|Screening for Randomization|Neuropathy|17|||
147645532|NCT00114738|532522017|FG001|Screening for Randomization|Neuropathy|0|||
147645533|NCT00114738|532522018|FG002|Screening for Randomization|Neuropathy|0|||
147304747|NCT04772053|531282503|FG000|Overall Study|Physician Decision|2|||
147304748|NCT04772053|531282503|FG000|Overall Study|Withdrawal by Subject|3|||
147304749|NCT04772053|531282503|FG000|Overall Study|Study Terminated by Sponsor|1|||
147304750|NCT04146896|531282504|FG000|Overall Study|Adverse Event|5|||
147304751|NCT04146896|531282505|FG001|Overall Study|Adverse Event|8|||
147304752|NCT04146896|531282504|FG000|Overall Study|Lack of Efficacy|3|||
147304753|NCT04146896|531282505|FG001|Overall Study|Lack of Efficacy|2|||
147304754|NCT04146896|531282504|FG000|Overall Study|Lost to Follow-up|0|||
147304755|NCT04146896|531282505|FG001|Overall Study|Lost to Follow-up|1|||
147304756|NCT04146896|531282504|FG000|Overall Study|Non-compliance|5|||
147304757|NCT04146896|531282505|FG001|Overall Study|Non-compliance|4|||
147304758|NCT04146896|531282504|FG000|Overall Study|Withdrawal by Subject|3|||
147304759|NCT04146896|531282505|FG001|Overall Study|Withdrawal by Subject|5|||
147304760|NCT04146896|531282504|FG000|Overall Study|Randomized in error|1|||
147304761|NCT04146896|531282505|FG001|Overall Study|Randomized in error|2|||
147304762|NCT02118337|531282506|FG000|Overall Study|Other|1|||
147304763|NCT02118337|531282507|FG001|Overall Study|Other|0|||
147304764|NCT02118337|531282508|FG002|Overall Study|Other|0|||
147304765|NCT02118337|531282509|FG003|Overall Study|Other|0|||
147304766|NCT02118337|531282510|FG004|Overall Study|Other|2|||
147304767|NCT02118337|531282511|FG005|Overall Study|Other|3|||
147304768|NCT02118337|531282512|FG006|Overall Study|Other|1|||
147304769|NCT02118337|531282513|FG007|Overall Study|Other|28|||
147304770|NCT02118337|531282514|FG008|Overall Study|Other|15|||
147304771|NCT02118337|531282506|FG000|Overall Study|Lost to Follow-up|0|||
147304772|NCT02118337|531282507|FG001|Overall Study|Lost to Follow-up|0|||
147304773|NCT02118337|531282508|FG002|Overall Study|Lost to Follow-up|0|||
147304774|NCT02118337|531282509|FG003|Overall Study|Lost to Follow-up|0|||
147304775|NCT02118337|531282510|FG004|Overall Study|Lost to Follow-up|0|||
147304776|NCT02118337|531282511|FG005|Overall Study|Lost to Follow-up|0|||
147304777|NCT02118337|531282512|FG006|Overall Study|Lost to Follow-up|0|||
147304778|NCT02118337|531282513|FG007|Overall Study|Lost to Follow-up|1|||
147304779|NCT02118337|531282514|FG008|Overall Study|Lost to Follow-up|0|||
147304780|NCT02118337|531282506|FG000|Overall Study|Withdrawal by Subject|1|||
147304781|NCT02118337|531282507|FG001|Overall Study|Withdrawal by Subject|3|||
147304782|NCT02118337|531282508|FG002|Overall Study|Withdrawal by Subject|2|||
147304783|NCT02118337|531282509|FG003|Overall Study|Withdrawal by Subject|1|||
147304784|NCT02118337|531282510|FG004|Overall Study|Withdrawal by Subject|2|||
147304785|NCT02118337|531282511|FG005|Overall Study|Withdrawal by Subject|2|||
147304786|NCT02118337|531282512|FG006|Overall Study|Withdrawal by Subject|1|||
147304787|NCT02118337|531282513|FG007|Overall Study|Withdrawal by Subject|4|||
147304788|NCT02118337|531282514|FG008|Overall Study|Withdrawal by Subject|2|||
147304789|NCT02118337|531282506|FG000|Overall Study|Death|2|||
147304790|NCT02118337|531282507|FG001|Overall Study|Death|2|||
147304791|NCT02118337|531282508|FG002|Overall Study|Death|1|||
147304792|NCT02118337|531282509|FG003|Overall Study|Death|2|||
147304793|NCT02118337|531282510|FG004|Overall Study|Death|5|||
147304794|NCT02118337|531282511|FG005|Overall Study|Death|1|||
147304795|NCT02118337|531282512|FG006|Overall Study|Death|2|||
147304796|NCT02118337|531282513|FG007|Overall Study|Death|9|||
147304797|NCT02118337|531282514|FG008|Overall Study|Death|4|||
147304798|NCT04296890|531282515|FG000|Overall Study|Withdrawal by Subject|1|||
147304799|NCT04296890|531282515|FG000|Overall Study|Death|62|||
147304800|NCT04296890|531282515|FG000|Overall Study|Lost to Follow-up|3|||
147304801|NCT04296890|531282515|FG000|Overall Study|Other than specified|2|||
147304802|NCT01931735|531282519|FG000|Randomized Phase|Lost to Follow-up|2|||
147304803|NCT01931735|531282520|FG001|Randomized Phase|Lost to Follow-up|2|||
147304804|NCT01931735|531282521|FG002|Randomized Phase|Lost to Follow-up|5|||
147304805|NCT01931735|531282522|FG003|Randomized Phase|Lost to Follow-up|0|||
147304806|NCT01931735|531282519|FG000|Observational Non-Randomized Phase|Adverse Event|0|||
147304807|NCT01931735|531282520|FG001|Observational Non-Randomized Phase|Adverse Event|0|||
147304808|NCT01931735|531282521|FG002|Observational Non-Randomized Phase|Adverse Event|0|||
147304809|NCT01931735|531282522|FG003|Observational Non-Randomized Phase|Adverse Event|1|||
147304810|NCT01931735|531282519|FG000|Observational Non-Randomized Phase|Withdrawal by Subject|0|||
147304811|NCT01931735|531282520|FG001|Observational Non-Randomized Phase|Withdrawal by Subject|0|||
147304812|NCT01931735|531282521|FG002|Observational Non-Randomized Phase|Withdrawal by Subject|0|||
147304813|NCT01931735|531282522|FG003|Observational Non-Randomized Phase|Withdrawal by Subject|1|||
147304814|NCT02719990|531282523|FG000|Overall Study|Physician Decision|2|||
147304815|NCT02719990|531282523|FG000|Overall Study|Withdrawal by Subject|2|||
147304816|NCT02719990|531282523|FG000|Overall Study|Study Terminated By Sponsor|32|||
147304817|NCT02404389|531282524|FG000|Overall Study|Adverse Event|1|||
147304818|NCT02404389|531282525|FG001|Overall Study|Adverse Event|0|||
147304819|NCT02404389|531282526|FG002|Overall Study|Adverse Event|1|||
147304820|NCT02404389|531282527|FG003|Overall Study|Adverse Event|0|||
147304821|NCT02404389|531282528|FG004|Overall Study|Adverse Event|2|||
147304822|NCT02404389|531282524|FG000|Overall Study|Subject/guardian decision|1|||
147304823|NCT02404389|531282525|FG001|Overall Study|Subject/guardian decision|0|||
147304824|NCT02404389|531282526|FG002|Overall Study|Subject/guardian decision|0|||
147304825|NCT02404389|531282527|FG003|Overall Study|Subject/guardian decision|1|||
147304826|NCT02404389|531282528|FG004|Overall Study|Subject/guardian decision|1|||
147304827|NCT00717314|531282532|FG000|Overall Study|Adverse Event|3|||
147304828|NCT00717314|531282533|FG001|Overall Study|Adverse Event|2|||
147304829|NCT00717314|531282532|FG000|Overall Study|Protocol Violation|1|||
147304830|NCT00717314|531282533|FG001|Overall Study|Protocol Violation|0|||
147304831|NCT00717314|531282532|FG000|Overall Study|Lost to Follow-up|1|||
147304832|NCT00717314|531282533|FG001|Overall Study|Lost to Follow-up|5|||
147304833|NCT00717314|531282532|FG000|Overall Study|Withdrawal by Subject|1|||
147304834|NCT00717314|531282533|FG001|Overall Study|Withdrawal by Subject|3|||
147304835|NCT05076149|531282534|FG000|Overall Study|Adverse Event|3|||
147304836|NCT05076149|531282535|FG001|Overall Study|Adverse Event|9|||
147304837|NCT05076149|531282534|FG000|Overall Study|Withdrawal of consent (not due to AE)|1|||
147304838|NCT05076149|531282535|FG001|Overall Study|Withdrawal of consent (not due to AE)|3|||
147304839|NCT05076149|531282534|FG000|Overall Study|Lost to Follow-up|0|||
147304840|NCT05076149|531282535|FG001|Overall Study|Lost to Follow-up|1|||
147304841|NCT05076149|531282534|FG000|Overall Study|Commercial drug is available for participant|0|||
147304842|NCT05076149|531282535|FG001|Overall Study|Commercial drug is available for participant|1|||
147304843|NCT05076149|531282534|FG000|Overall Study|Other non compliance|1|||
147304844|NCT05076149|531282535|FG001|Overall Study|Other non compliance|1|||
147304845|NCT05076149|531282534|FG000|Overall Study|Physician Decision|0|||
147304846|NCT05076149|531282535|FG001|Overall Study|Physician Decision|1|||
147304847|NCT05076149|531282534|FG000|Overall Study|Other|5|||
147304848|NCT05076149|531282535|FG001|Overall Study|Other|4|||
147304849|NCT05096208|531282536|FG000|Overall Study|Lost to Follow-up|3|||
147304850|NCT05096208|531282537|FG001|Overall Study|Lost to Follow-up|5|||
147304851|NCT05096208|531282538|FG002|Overall Study|Lost to Follow-up|5|||
147304852|NCT05096208|531282539|FG003|Overall Study|Lost to Follow-up|2|||
147304853|NCT05096208|531282536|FG000|Overall Study|Withdrawal by Subject|0|||
147304854|NCT05096208|531282537|FG001|Overall Study|Withdrawal by Subject|1|||
147304855|NCT05096208|531282538|FG002|Overall Study|Withdrawal by Subject|2|||
147304856|NCT05096208|531282539|FG003|Overall Study|Withdrawal by Subject|3|||
147304857|NCT05096208|531282536|FG000|Overall Study|No longer met eligibility criteria|1|||
147304858|NCT05096208|531282537|FG001|Overall Study|No longer met eligibility criteria|0|||
147304859|NCT05096208|531282538|FG002|Overall Study|No longer met eligibility criteria|0|||
147304860|NCT05096208|531282539|FG003|Overall Study|No longer met eligibility criteria|0|||
147304861|NCT05096208|531282536|FG000|Overall Study|Other|0|||
147304862|NCT05096208|531282537|FG001|Overall Study|Other|0|||
147304863|NCT05096208|531282538|FG002|Overall Study|Other|1|||
147304864|NCT05096208|531282539|FG003|Overall Study|Other|0|||
147304865|NCT00782496|531282540|FG000|Overall Study|Lost to Follow-up|14|||
147304866|NCT00782496|531282541|FG001|Overall Study|Lost to Follow-up|15|||
147304867|NCT00117156|531282545|FG000|Overall Study|Adverse Event|9|||
147304868|NCT00117156|531282545|FG000|Overall Study|Physician Decision|1|||
147304869|NCT00117156|531282545|FG000|Overall Study|Trt for Pre-Exist Second Primary|1|||
147304870|NCT01919970|531282546|FG000|Overall Study|Withdrawal by Subject|3|||
147304871|NCT01919970|531282547|FG001|Overall Study|Withdrawal by Subject|0|||
147304872|NCT04043962|531282548|FG000|Post-Treatment|Declined due to lack of time/interest or could not be reached|3|||
147304873|NCT04043962|531282548|FG000|Post-Treatment|Withdrawal by Subject|5|||
147304874|NCT04043962|531282548|FG000|Follow-up|Declined due to lack of time/interest or could not be reached|7|||
147304875|NCT01987817|531282550|FG000|Overall Study|Adverse Event|4|||
147304876|NCT01987817|531282551|FG001|Overall Study|Adverse Event|0|||
147304877|NCT01987817|531282550|FG000|Overall Study|Withdrawal by Subject|1|||
147304878|NCT01987817|531282551|FG001|Overall Study|Withdrawal by Subject|1|||
147304879|NCT01987817|531282550|FG000|Overall Study|Physician Decision|1|||
147304880|NCT01987817|531282551|FG001|Overall Study|Physician Decision|0|||
147304881|NCT01576718|531282554|FG000|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|49|||
147304882|NCT01576718|531282555|FG001|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
147304883|NCT01576718|531282556|FG002|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
147304884|NCT01576718|531282557|FG003|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
147304885|NCT01576718|531282558|FG004|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
147304886|NCT01576718|531282559|FG005|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
147304887|NCT01576718|531282560|FG006|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
147304888|NCT01576718|531282554|FG000|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|17|||
147304889|NCT01576718|531282555|FG001|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
147304890|NCT01576718|531282556|FG002|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
147304891|NCT01576718|531282557|FG003|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
147645534|NCT00114738|532522016|FG000|Screening for Randomization|Progressive disease|2|||
147645535|NCT00114738|532522017|FG001|Screening for Randomization|Progressive disease|0|||
147645536|NCT00114738|532522018|FG002|Screening for Randomization|Progressive disease|0|||
147645537|NCT00114738|532522016|FG000|Screening for Randomization|CNS Hemorrhage|1|||
147645538|NCT00114738|532522017|FG001|Screening for Randomization|CNS Hemorrhage|0|||
147645539|NCT00114738|532522018|FG002|Screening for Randomization|CNS Hemorrhage|0|||
147645540|NCT00114738|532522016|FG000|Screening for Randomization|Other|1|||
147645541|NCT00114738|532522017|FG001|Screening for Randomization|Other|0|||
147645542|NCT00114738|532522018|FG002|Screening for Randomization|Other|0|||
147645543|NCT02971800|532522019|FG000|Overall Study|Protocol Violation|1|||
147645544|NCT02971800|532522019|FG000|Overall Study|Withdrawal by Subject|1|||
147304892|NCT01576718|531282558|FG004|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
147304893|NCT01576718|531282559|FG005|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
147304894|NCT01576718|531282560|FG006|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
147304895|NCT01576718|531282554|FG000|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|166|||
147304896|NCT01576718|531282555|FG001|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
147304897|NCT01576718|531282556|FG002|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
147304898|NCT01576718|531282557|FG003|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
147304899|NCT01576718|531282558|FG004|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
147304900|NCT01576718|531282559|FG005|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
147304901|NCT01576718|531282560|FG006|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
147304902|NCT01576718|531282554|FG000|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|2|||
147304903|NCT01576718|531282555|FG001|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
147304904|NCT01576718|531282556|FG002|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
147304905|NCT01576718|531282557|FG003|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
147304906|NCT01576718|531282558|FG004|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
147304907|NCT01576718|531282559|FG005|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
147304908|NCT01576718|531282560|FG006|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
147304909|NCT01576718|531282554|FG000|Pre-Assignment Period (Run-In Placebo)|Other|15|||
147304910|NCT01576718|531282555|FG001|Pre-Assignment Period (Run-In Placebo)|Other|0|||
147304911|NCT01576718|531282556|FG002|Pre-Assignment Period (Run-In Placebo)|Other|0|||
147304912|NCT01576718|531282557|FG003|Pre-Assignment Period (Run-In Placebo)|Other|0|||
147304913|NCT01576718|531282558|FG004|Pre-Assignment Period (Run-In Placebo)|Other|0|||
147304914|NCT01576718|531282559|FG005|Pre-Assignment Period (Run-In Placebo)|Other|0|||
147304915|NCT01576718|531282560|FG006|Pre-Assignment Period (Run-In Placebo)|Other|0|||
147304916|NCT01576718|531282554|FG000|Treatment Period|Adverse Event|0|||
147304917|NCT01576718|531282555|FG001|Treatment Period|Adverse Event|1|||
147304918|NCT01576718|531282556|FG002|Treatment Period|Adverse Event|1|||
147304919|NCT01576718|531282557|FG003|Treatment Period|Adverse Event|1|||
147304920|NCT01576718|531282558|FG004|Treatment Period|Adverse Event|1|||
147304921|NCT01576718|531282559|FG005|Treatment Period|Adverse Event|1|||
147304922|NCT01576718|531282560|FG006|Treatment Period|Adverse Event|0|||
147304923|NCT01576718|531282554|FG000|Treatment Period|Withdrawal by Subject|0|||
147304924|NCT01576718|531282555|FG001|Treatment Period|Withdrawal by Subject|1|||
147304925|NCT01576718|531282556|FG002|Treatment Period|Withdrawal by Subject|1|||
147304926|NCT01576718|531282557|FG003|Treatment Period|Withdrawal by Subject|0|||
147304927|NCT01576718|531282558|FG004|Treatment Period|Withdrawal by Subject|2|||
147304928|NCT01576718|531282559|FG005|Treatment Period|Withdrawal by Subject|4|||
147304929|NCT01576718|531282560|FG006|Treatment Period|Withdrawal by Subject|2|||
147304930|NCT01576718|531282554|FG000|Treatment Period|Physician Decision|0|||
147304931|NCT01576718|531282555|FG001|Treatment Period|Physician Decision|1|||
147304932|NCT01576718|531282556|FG002|Treatment Period|Physician Decision|1|||
147304933|NCT01576718|531282557|FG003|Treatment Period|Physician Decision|1|||
147304934|NCT01576718|531282558|FG004|Treatment Period|Physician Decision|1|||
147304935|NCT01576718|531282559|FG005|Treatment Period|Physician Decision|0|||
147304936|NCT01576718|531282560|FG006|Treatment Period|Physician Decision|0|||
147304937|NCT01576718|531282554|FG000|Treatment Period|Protocol Violation|0|||
147304938|NCT01576718|531282555|FG001|Treatment Period|Protocol Violation|5|||
147304939|NCT01576718|531282556|FG002|Treatment Period|Protocol Violation|4|||
147304940|NCT01576718|531282557|FG003|Treatment Period|Protocol Violation|10|||
147304941|NCT01576718|531282558|FG004|Treatment Period|Protocol Violation|6|||
147304942|NCT01576718|531282559|FG005|Treatment Period|Protocol Violation|8|||
147304943|NCT01576718|531282560|FG006|Treatment Period|Protocol Violation|12|||
147304944|NCT01576718|531282554|FG000|Treatment Period|Sponsor request|0|||
147304945|NCT01576718|531282555|FG001|Treatment Period|Sponsor request|1|||
147304946|NCT01576718|531282556|FG002|Treatment Period|Sponsor request|0|||
147304947|NCT01576718|531282557|FG003|Treatment Period|Sponsor request|0|||
147304948|NCT01576718|531282558|FG004|Treatment Period|Sponsor request|0|||
147304949|NCT01576718|531282559|FG005|Treatment Period|Sponsor request|1|||
147304950|NCT01576718|531282560|FG006|Treatment Period|Sponsor request|0|||
147304951|NCT01576718|531282554|FG000|Treatment Period|Met stopping criteria|0|||
147304952|NCT01576718|531282555|FG001|Treatment Period|Met stopping criteria|16|||
147304953|NCT01576718|531282556|FG002|Treatment Period|Met stopping criteria|13|||
147304954|NCT01576718|531282557|FG003|Treatment Period|Met stopping criteria|19|||
147304955|NCT01576718|531282558|FG004|Treatment Period|Met stopping criteria|16|||
147304956|NCT01576718|531282559|FG005|Treatment Period|Met stopping criteria|33|||
147304957|NCT01576718|531282560|FG006|Treatment Period|Met stopping criteria|15|||
147304958|NCT01576718|531282554|FG000|Treatment Period|Lost to Follow-up|0|||
147304959|NCT01576718|531282555|FG001|Treatment Period|Lost to Follow-up|0|||
147304960|NCT01576718|531282556|FG002|Treatment Period|Lost to Follow-up|0|||
147304961|NCT01576718|531282557|FG003|Treatment Period|Lost to Follow-up|0|||
147304962|NCT01576718|531282558|FG004|Treatment Period|Lost to Follow-up|1|||
147304963|NCT01576718|531282559|FG005|Treatment Period|Lost to Follow-up|0|||
147304964|NCT01576718|531282560|FG006|Treatment Period|Lost to Follow-up|0|||
147304965|NCT01576718|531282554|FG000|Treatment Period|Noncompliance to study medication|0|||
147304966|NCT01576718|531282555|FG001|Treatment Period|Noncompliance to study medication|0|||
147304967|NCT01576718|531282556|FG002|Treatment Period|Noncompliance to study medication|0|||
147304968|NCT01576718|531282557|FG003|Treatment Period|Noncompliance to study medication|0|||
147304969|NCT01576718|531282558|FG004|Treatment Period|Noncompliance to study medication|0|||
147304970|NCT01576718|531282559|FG005|Treatment Period|Noncompliance to study medication|1|||
147304971|NCT01576718|531282560|FG006|Treatment Period|Noncompliance to study medication|1|||
147304972|NCT01874145|531282561|FG000|Core Period|Non-compliance|1|||
147304973|NCT01874145|531282562|FG001|Core Period|Non-compliance|0|||
147304974|NCT01874145|531282561|FG000|Core Period|Protocol Violation|1|||
147304975|NCT01874145|531282562|FG001|Core Period|Protocol Violation|1|||
147304976|NCT01874145|531282561|FG000|Core Period|Physician Decision|1|||
147304977|NCT01874145|531282562|FG001|Core Period|Physician Decision|1|||
147304978|NCT01874145|531282561|FG000|Core Period|Adverse Event|0|||
147304979|NCT01874145|531282562|FG001|Core Period|Adverse Event|1|||
147304980|NCT01874145|531282561|FG000|Core Period|Withdrawal by Subject|0|||
147304981|NCT01874145|531282562|FG001|Core Period|Withdrawal by Subject|4|||
147304982|NCT01874145|531282561|FG000|Extension Period|Adverse Event|3|||
147304983|NCT01874145|531282562|FG001|Extension Period|Adverse Event|2|||
147304984|NCT01874145|531282561|FG000|Extension Period|Withdrawal by Subject|2|||
147304985|NCT01874145|531282562|FG001|Extension Period|Withdrawal by Subject|1|||
147304986|NCT01874145|531282561|FG000|Extension Period|Lost to Follow-up|1|||
147304987|NCT01874145|531282562|FG001|Extension Period|Lost to Follow-up|1|||
147304988|NCT04631705|531282563|FG000|Overall Study|Withdrawal by Subject|0|||
147304989|NCT04631705|531282564|FG001|Overall Study|Withdrawal by Subject|0|||
147304990|NCT04631705|531282565|FG002|Overall Study|Withdrawal by Subject|0|||
147304991|NCT04631705|531282566|FG003|Overall Study|Withdrawal by Subject|0|||
147304992|NCT04631705|531282567|FG004|Overall Study|Withdrawal by Subject|0|||
147304993|NCT04631705|531282568|FG005|Overall Study|Withdrawal by Subject|0|||
147304994|NCT04631705|531282569|FG006|Overall Study|Withdrawal by Subject|1|||
147304995|NCT04631705|531282570|FG007|Overall Study|Withdrawal by Subject|0|||
147304996|NCT04631705|531282571|FG008|Overall Study|Withdrawal by Subject|0|||
147304997|NCT01816763|531284859|FG000|Overall Study|The main reason for an incomplete survey|4|||
147304998|NCT01816763|531284860|FG001|Overall Study|The main reason for an incomplete survey|15|||
147304999|NCT01816763|531284861|FG002|Overall Study|The main reason for an incomplete survey|11|||
147305000|NCT00975221|531284862|FG000|Titration Phase (Weeks 1-12)|Withdrawal by Subject|2|||
147305001|NCT00975221|531284863|FG001|Titration Phase (Weeks 1-12)|Withdrawal by Subject|3|||
147305002|NCT00975221|531284862|FG000|Titration Phase (Weeks 1-12)|Requirement for alternative therapy|1|||
147305003|NCT00975221|531284863|FG001|Titration Phase (Weeks 1-12)|Requirement for alternative therapy|0|||
147305004|NCT00975221|531284862|FG000|Titration Phase (Weeks 1-12)|Other|0|||
147305005|NCT00975221|531284863|FG001|Titration Phase (Weeks 1-12)|Other|1|||
147305006|NCT00975221|531284862|FG000|Efficacy Assessment Phase (Weeks 13-28)|Lost to Follow-up|0|||
147305007|NCT00975221|531284863|FG001|Efficacy Assessment Phase (Weeks 13-28)|Lost to Follow-up|1|||
147305008|NCT00975221|531284862|FG000|Open-label Extension Phase (Weeks 29-52)|Adverse Event|1|||
147305009|NCT00975221|531284863|FG001|Open-label Extension Phase (Weeks 29-52)|Adverse Event|1|||
147305010|NCT00975221|531284862|FG000|Open-label Extension Phase (Weeks 29-52)|Withdrawal by Subject|1|||
147305011|NCT00975221|531284863|FG001|Open-label Extension Phase (Weeks 29-52)|Withdrawal by Subject|0|||
147305012|NCT01186328|531284871|FG000|Overall Study|Death|1|||
147305013|NCT01186328|531284872|FG001|Overall Study|Death|0|||
147305014|NCT01186328|531284873|FG002|Overall Study|Death|0|||
147305015|NCT01862991|531284874|FG000|Overall Study|Lost to Follow-up|2|||
147305016|NCT01862991|531284875|FG001|Overall Study|Lost to Follow-up|1|||
147305017|NCT01862991|531284876|FG002|Overall Study|Lost to Follow-up|1|||
147305018|NCT01862991|531284874|FG000|Overall Study|Protocol Violation|1|||
147305019|NCT01862991|531284875|FG001|Overall Study|Protocol Violation|0|||
147305020|NCT01862991|531284876|FG002|Overall Study|Protocol Violation|0|||
147305021|NCT02026232|531284877|FG000|Overall Study|incomplete visit/missing data|3|||
147305022|NCT02026232|531284878|FG001|Overall Study|incomplete visit/missing data|2|||
147305023|NCT03075501|531284879|FG000|Overall Study|Scheduling difficulties|15|||
147305024|NCT03075501|531284880|FG001|Overall Study|Scheduling difficulties|9|||
147305025|NCT02762981|531284881|FG000|Overall Study|Adverse Event|2|||
147305026|NCT02762981|531284882|FG001|Overall Study|Adverse Event|3|||
147305027|NCT02762981|531284883|FG002|Overall Study|Adverse Event|1|||
147305028|NCT02762981|531284884|FG003|Overall Study|Adverse Event|1|||
147305029|NCT02762981|531284885|FG004|Overall Study|Adverse Event|3|||
147305030|NCT02762981|531284881|FG000|Overall Study|Physician Decision|0|||
147305031|NCT02762981|531284882|FG001|Overall Study|Physician Decision|1|||
147305032|NCT02762981|531284883|FG002|Overall Study|Physician Decision|0|||
147305033|NCT02762981|531284884|FG003|Overall Study|Physician Decision|0|||
147305034|NCT02762981|531284885|FG004|Overall Study|Physician Decision|1|||
147305035|NCT02762981|531284881|FG000|Overall Study|Disease progression|11|||
147305036|NCT02762981|531284882|FG001|Overall Study|Disease progression|23|||
147305037|NCT02762981|531284883|FG002|Overall Study|Disease progression|4|||
147305038|NCT02762981|531284884|FG003|Overall Study|Disease progression|10|||
147305039|NCT02762981|531284885|FG004|Overall Study|Disease progression|1|||
147305040|NCT02762981|531284881|FG000|Overall Study|Enrolled not treated|1|||
147305041|NCT02762981|531284882|FG001|Overall Study|Enrolled not treated|5|||
147305042|NCT02762981|531284883|FG002|Overall Study|Enrolled not treated|0|||
147305043|NCT02762981|531284884|FG003|Overall Study|Enrolled not treated|2|||
147305044|NCT02762981|531284885|FG004|Overall Study|Enrolled not treated|0|||
147305045|NCT02762981|531284881|FG000|Overall Study|Other|2|||
147305046|NCT02762981|531284882|FG001|Overall Study|Other|3|||
147305047|NCT02762981|531284883|FG002|Overall Study|Other|1|||
147305048|NCT02762981|531284884|FG003|Overall Study|Other|0|||
147305049|NCT02762981|531284885|FG004|Overall Study|Other|0|||
147305050|NCT02762981|531284881|FG000|Overall Study|Missing|1|||
147305051|NCT02762981|531284882|FG001|Overall Study|Missing|0|||
147305052|NCT02762981|531284883|FG002|Overall Study|Missing|0|||
147305053|NCT02762981|531284884|FG003|Overall Study|Missing|0|||
147305054|NCT02762981|531284885|FG004|Overall Study|Missing|0|||
147305055|NCT02762981|531284881|FG000|Overall Study|Withdrawal by Subject|0|||
147305056|NCT02762981|531284882|FG001|Overall Study|Withdrawal by Subject|5|||
147659386|NCT01719380|532576174|FG005|Overall Study|Physician Decision|0|||
147305057|NCT02762981|531284883|FG002|Overall Study|Withdrawal by Subject|1|||
147305058|NCT02762981|531284884|FG003|Overall Study|Withdrawal by Subject|3|||
147305059|NCT02762981|531284885|FG004|Overall Study|Withdrawal by Subject|0|||
147305060|NCT02392611|531284887|FG000|Overall Study|Adverse Event|0|||
147305061|NCT02392611|531284888|FG001|Overall Study|Adverse Event|0|||
147305062|NCT02392611|531284889|FG002|Overall Study|Adverse Event|0|||
147305063|NCT02392611|531284890|FG003|Overall Study|Adverse Event|1|||
147305064|NCT02392611|531284891|FG004|Overall Study|Adverse Event|0|||
147305065|NCT02392611|531284892|FG005|Overall Study|Adverse Event|0|||
147305066|NCT02392611|531284893|FG006|Overall Study|Adverse Event|0|||
147305067|NCT02392611|531284894|FG007|Overall Study|Adverse Event|0|||
147305068|NCT02392611|531284895|FG008|Overall Study|Adverse Event|0|||
147305069|NCT02392611|531284887|FG000|Overall Study|Progressive disease|0|||
147305070|NCT02392611|531284888|FG001|Overall Study|Progressive disease|0|||
147305071|NCT02392611|531284889|FG002|Overall Study|Progressive disease|0|||
147305072|NCT02392611|531284890|FG003|Overall Study|Progressive disease|2|||
147305073|NCT02392611|531284891|FG004|Overall Study|Progressive disease|1|||
147305074|NCT02392611|531284892|FG005|Overall Study|Progressive disease|0|||
147305075|NCT02392611|531284893|FG006|Overall Study|Progressive disease|0|||
147305076|NCT02392611|531284894|FG007|Overall Study|Progressive disease|0|||
147305077|NCT02392611|531284895|FG008|Overall Study|Progressive disease|0|||
147305078|NCT02392611|531284887|FG000|Overall Study|Death|1|||
147305079|NCT02392611|531284888|FG001|Overall Study|Death|0|||
147305080|NCT02392611|531284889|FG002|Overall Study|Death|0|||
147305081|NCT02392611|531284890|FG003|Overall Study|Death|0|||
147305082|NCT02392611|531284891|FG004|Overall Study|Death|0|||
147305083|NCT02392611|531284892|FG005|Overall Study|Death|1|||
147305084|NCT02392611|531284893|FG006|Overall Study|Death|0|||
147305085|NCT02392611|531284894|FG007|Overall Study|Death|0|||
147305086|NCT02392611|531284895|FG008|Overall Study|Death|0|||
147305087|NCT02392611|531284887|FG000|Overall Study|Withdrawal by Subject|0|||
147305088|NCT02392611|531284888|FG001|Overall Study|Withdrawal by Subject|0|||
147305089|NCT02392611|531284889|FG002|Overall Study|Withdrawal by Subject|0|||
147305090|NCT02392611|531284890|FG003|Overall Study|Withdrawal by Subject|1|||
147305091|NCT02392611|531284891|FG004|Overall Study|Withdrawal by Subject|0|||
147305092|NCT02392611|531284892|FG005|Overall Study|Withdrawal by Subject|0|||
147305093|NCT02392611|531284893|FG006|Overall Study|Withdrawal by Subject|0|||
147305094|NCT02392611|531284894|FG007|Overall Study|Withdrawal by Subject|0|||
147305095|NCT02392611|531284895|FG008|Overall Study|Withdrawal by Subject|0|||
147305096|NCT02392611|531284887|FG000|Overall Study|Lost to Follow-up|0|||
147305097|NCT02392611|531284888|FG001|Overall Study|Lost to Follow-up|0|||
147305098|NCT02392611|531284889|FG002|Overall Study|Lost to Follow-up|0|||
147305099|NCT02392611|531284890|FG003|Overall Study|Lost to Follow-up|0|||
147305100|NCT02392611|531284891|FG004|Overall Study|Lost to Follow-up|0|||
147305101|NCT02392611|531284892|FG005|Overall Study|Lost to Follow-up|0|||
147305102|NCT02392611|531284893|FG006|Overall Study|Lost to Follow-up|1|||
147305103|NCT02392611|531284894|FG007|Overall Study|Lost to Follow-up|0|||
147305104|NCT02392611|531284895|FG008|Overall Study|Lost to Follow-up|0|||
147305105|NCT02392611|531284887|FG000|Overall Study|Enrolled, not treated|0|||
147305106|NCT02392611|531284888|FG001|Overall Study|Enrolled, not treated|0|||
147305107|NCT02392611|531284889|FG002|Overall Study|Enrolled, not treated|0|||
147305108|NCT02392611|531284890|FG003|Overall Study|Enrolled, not treated|2|||
147305109|NCT02392611|531284891|FG004|Overall Study|Enrolled, not treated|0|||
147305110|NCT02392611|531284892|FG005|Overall Study|Enrolled, not treated|0|||
147305111|NCT02392611|531284893|FG006|Overall Study|Enrolled, not treated|0|||
147305112|NCT02392611|531284894|FG007|Overall Study|Enrolled, not treated|0|||
147305113|NCT02392611|531284895|FG008|Overall Study|Enrolled, not treated|0|||
147305114|NCT00605319|531284898|FG000|Overall Study|Adverse Event|6|||
147305115|NCT02991482|531284899|FG000|Overall Study|Disease progression|56|||
147305116|NCT02991482|531284900|FG001|Overall Study|Disease progression|47|||
147305117|NCT02991482|531284899|FG000|Overall Study|Death|4|||
147305118|NCT02991482|531284900|FG001|Overall Study|Death|4|||
147305119|NCT02991482|531284899|FG000|Overall Study|Adverse Event|1|||
147305120|NCT02991482|531284900|FG001|Overall Study|Adverse Event|6|||
147305121|NCT02991482|531284899|FG000|Overall Study|Patient decision|1|||
147305122|NCT02991482|531284900|FG001|Overall Study|Patient decision|1|||
147305123|NCT02991482|531284899|FG000|Overall Study|Physician Decision|0|||
147305124|NCT02991482|531284900|FG001|Overall Study|Physician Decision|6|||
147305125|NCT02991482|531284899|FG000|Overall Study|Clinical deterioration|1|||
147305126|NCT02991482|531284900|FG001|Overall Study|Clinical deterioration|0|||
147305127|NCT02991482|531284899|FG000|Overall Study|Patient feeling too unwell|1|||
147305128|NCT02991482|531284900|FG001|Overall Study|Patient feeling too unwell|0|||
147305129|NCT02991482|531284899|FG000|Overall Study|Worsening of performance status|0|||
147305130|NCT02991482|531284900|FG001|Overall Study|Worsening of performance status|1|||
147305131|NCT02991482|531284899|FG000|Overall Study|Death prior to study drug initiation|1|||
147305132|NCT02991482|531284900|FG001|Overall Study|Death prior to study drug initiation|0|||
147305133|NCT02991482|531284899|FG000|Overall Study|Consent withdrawal prior to study drug initiation|0|||
147305134|NCT02991482|531284900|FG001|Overall Study|Consent withdrawal prior to study drug initiation|1|||
147659387|NCT01719380|532576175|FG006|Overall Study|Physician Decision|0|||
147305135|NCT01250119|531284901|FG000|Diagnostic Phase|Failed to Produce a Test Results|69|||
147305136|NCT01250119|531284902|FG001|Diagnostic Phase|Failed to Produce a Test Results|0|||
147305137|NCT01250119|531284901|FG000|Diagnostic Phase|Participants Not Tested|44|||
147305138|NCT01250119|531284902|FG001|Diagnostic Phase|Participants Not Tested|0|||
147305139|NCT01250119|531284901|FG000|Treatment Phase|Progressive Disease|0|||
147305140|NCT01250119|531284902|FG001|Treatment Phase|Progressive Disease|32|||
147305141|NCT01250119|531284901|FG000|Treatment Phase|Death|0|||
147305142|NCT01250119|531284902|FG001|Treatment Phase|Death|2|||
147305143|NCT01250119|531284901|FG000|Treatment Phase|Withdrawal by Subject|0|||
147305144|NCT01250119|531284902|FG001|Treatment Phase|Withdrawal by Subject|1|||
147305145|NCT01250119|531284901|FG000|Treatment Phase|Adverse Event|0|||
147305146|NCT01250119|531284902|FG001|Treatment Phase|Adverse Event|2|||
147305147|NCT01250119|531284901|FG000|Treatment Phase|Unknown reason|0|||
147305148|NCT01250119|531284902|FG001|Treatment Phase|Unknown reason|4|||
147305149|NCT02670538|531284905|FG000|Overall Study|Withdrawal of Consent|8|||
147305150|NCT02670538|531284906|FG001|Overall Study|Withdrawal of Consent|6|||
147305151|NCT02670538|531284907|FG002|Overall Study|Withdrawal of Consent|5|||
147305152|NCT02670538|531284905|FG000|Overall Study|Lost to Follow-up|8|||
147305153|NCT02670538|531284906|FG001|Overall Study|Lost to Follow-up|12|||
147305154|NCT02670538|531284907|FG002|Overall Study|Lost to Follow-up|7|||
147305155|NCT02670538|531284905|FG000|Overall Study|Adverse Event|5|||
147305156|NCT02670538|531284906|FG001|Overall Study|Adverse Event|5|||
147305157|NCT02670538|531284907|FG002|Overall Study|Adverse Event|11|||
147305158|NCT02670538|531284905|FG000|Overall Study|Lack of Efficacy|7|||
147305159|NCT02670538|531284906|FG001|Overall Study|Lack of Efficacy|1|||
147305160|NCT02670538|531284907|FG002|Overall Study|Lack of Efficacy|2|||
147305161|NCT02670538|531284905|FG000|Overall Study|Protocol Violation|3|||
147305162|NCT02670538|531284906|FG001|Overall Study|Protocol Violation|4|||
147305163|NCT02670538|531284907|FG002|Overall Study|Protocol Violation|1|||
147305164|NCT02670538|531284905|FG000|Overall Study|Noncompliance with Study Drug|1|||
147305165|NCT02670538|531284906|FG001|Overall Study|Noncompliance with Study Drug|3|||
147305166|NCT02670538|531284907|FG002|Overall Study|Noncompliance with Study Drug|2|||
147305167|NCT02670538|531284905|FG000|Overall Study|Other Miscellaneous Reasons|0|||
147305168|NCT02670538|531284906|FG001|Overall Study|Other Miscellaneous Reasons|1|||
147305169|NCT02670538|531284907|FG002|Overall Study|Other Miscellaneous Reasons|2|||
147305170|NCT02887989|531284911|FG000|Overall Study|Withdrawal by Subject|8|||
147305171|NCT02887989|531284912|FG001|Overall Study|Withdrawal by Subject|11|||
147305172|NCT02887989|531284911|FG000|Overall Study|Death|1|||
147305173|NCT02887989|531284912|FG001|Overall Study|Death|0|||
147305174|NCT05648357|531284913|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN AE|3|||
147305175|NCT00255346|531284914|FG000|Overall Study|Adverse Event|1|||
147305176|NCT00255346|531284915|FG001|Overall Study|Adverse Event|0|||
147305177|NCT00255346|531284916|FG002|Overall Study|Adverse Event|0|||
147305178|NCT00255346|531284917|FG003|Overall Study|Adverse Event|0|||
147305179|NCT00255346|531284918|FG004|Overall Study|Adverse Event|0|||
147305180|NCT00674323|531284919|FG000|Overall Study|Adverse Event|0|||
147305181|NCT00674323|531284920|FG001|Overall Study|Adverse Event|1|||
147305182|NCT00674323|531284921|FG002|Overall Study|Adverse Event|0|||
147305183|NCT00674323|531284919|FG000|Overall Study|Protocol Violation|1|||
147305184|NCT00674323|531284920|FG001|Overall Study|Protocol Violation|0|||
147305185|NCT00674323|531284921|FG002|Overall Study|Protocol Violation|0|||
147305186|NCT02045433|531284927|FG000|Overall Study|Withdrawal by Subject|1|||
147305187|NCT01559454|531284928|FG000|Overall Study|Lost to Follow-up|3|||
147305188|NCT01559454|531284929|FG001|Overall Study|Lost to Follow-up|2|||
147305189|NCT01559454|531284928|FG000|Overall Study|Withdrawal by Subject|0|||
147305190|NCT01559454|531284929|FG001|Overall Study|Withdrawal by Subject|1|||
147305191|NCT01559454|531284928|FG000|Overall Study|Physician Decision|0|||
147305192|NCT01559454|531284929|FG001|Overall Study|Physician Decision|1|||
147305193|NCT01559454|531284928|FG000|Overall Study|Protocol Violation|0|||
147305194|NCT01559454|531284929|FG001|Overall Study|Protocol Violation|1|||
147305195|NCT01559454|531284928|FG000|Overall Study|Lack of Efficacy|0|||
147305196|NCT01559454|531284929|FG001|Overall Study|Lack of Efficacy|1|||
147305197|NCT02207725|531284930|FG000|Overall Study|Did Not Receive Treatment|0|||
147305198|NCT02207725|531284931|FG001|Overall Study|Did Not Receive Treatment|1|||
147305199|NCT02207725|531284932|FG002|Overall Study|Did Not Receive Treatment|1|||
147305200|NCT02207725|531284933|FG003|Overall Study|Did Not Receive Treatment|1|||
147305201|NCT02110732|531284939|FG000|Overall Study|Physician Decision|5|||
147305202|NCT02110732|531284940|FG001|Overall Study|Physician Decision|2|||
147305203|NCT02110732|531284939|FG000|Overall Study|Lost to Follow-up|1|||
147305204|NCT02110732|531284940|FG001|Overall Study|Lost to Follow-up|1|||
147305205|NCT02948959|531284941|FG000|52 Weeks Treatment Period|Poor compliance to protocol|0|||
147305206|NCT02948959|531284942|FG001|52 Weeks Treatment Period|Poor compliance to protocol|2|||
147305207|NCT02948959|531284941|FG000|52 Weeks Treatment Period|Adverse Event|2|||
147305208|NCT02948959|531284942|FG001|52 Weeks Treatment Period|Adverse Event|5|||
147305209|NCT02948959|531284941|FG000|52 Weeks Treatment Period|Withdrawal by Subject|2|||
147305210|NCT02948959|531284942|FG001|52 Weeks Treatment Period|Withdrawal by Subject|2|||
147305211|NCT02948959|531284941|FG000|52 Weeks Treatment Period|Participant used protocol prohibited vaccine|1|||
147305212|NCT02948959|531284942|FG001|52 Weeks Treatment Period|Participant used protocol prohibited vaccine|6|||
147305213|NCT02948959|531284941|FG000|52 Weeks Treatment Period|Randomized by error|0|||
147305214|NCT02948959|531284942|FG001|52 Weeks Treatment Period|Randomized by error|5|||
147305215|NCT02948959|531284941|FG000|52 Weeks Treatment Period|Randomized and not treated|0|||
147305216|NCT02948959|531284942|FG001|52 Weeks Treatment Period|Randomized and not treated|3|||
147305217|NCT02948959|531284941|FG000|52 Weeks Treatment Period|Non-compliant to study treatment|0|||
147305218|NCT02948959|531284942|FG001|52 Weeks Treatment Period|Non-compliant to study treatment|1|||
147305219|NCT02948959|531284941|FG000|52 Weeks Treatment Period|Change of residence location|0|||
147305220|NCT02948959|531284942|FG001|52 Weeks Treatment Period|Change of residence location|1|||
147305221|NCT02948959|531284941|FG000|12 Weeks Follow-up Period|Adverse Event|0|||
147305222|NCT02948959|531284942|FG001|12 Weeks Follow-up Period|Adverse Event|2|||
147305223|NCT02948959|531284941|FG000|12 Weeks Follow-up Period|Poor compliance to protocol|1|||
147305224|NCT02948959|531284942|FG001|12 Weeks Follow-up Period|Poor compliance to protocol|2|||
147305225|NCT02948959|531284941|FG000|12 Weeks Follow-up Period|Withdrawal by Subject|3|||
147305226|NCT02948959|531284942|FG001|12 Weeks Follow-up Period|Withdrawal by Subject|3|||
147305227|NCT02948959|531284941|FG000|12 Weeks Follow-up Period|Randomized by error|0|||
147305228|NCT02948959|531284942|FG001|12 Weeks Follow-up Period|Randomized by error|3|||
147305229|NCT02948959|531284941|FG000|12 Weeks Follow-up Period|Change of residence location|0|||
147305230|NCT02948959|531284942|FG001|12 Weeks Follow-up Period|Change of residence location|2|||
147305231|NCT02948959|531284941|FG000|12 Weeks Follow-up Period|Study site closure|1|||
147305232|NCT02948959|531284942|FG001|12 Weeks Follow-up Period|Study site closure|0|||
147305233|NCT02312856|531284943|FG000|Overall Study|Death|1|||
147305234|NCT02312856|531284943|FG000|Overall Study|Lost to Follow-up|3|||
147305235|NCT01932294|531284944|FG000|Overall Study|Death|43|||
147305236|NCT01932294|531284944|FG000|Overall Study|Lost to Follow-up|8|||
147305237|NCT01932294|531284944|FG000|Overall Study|VAD Implantation|20|||
147305238|NCT01932294|531284944|FG000|Overall Study|Heart Transplantation|16|||
147305239|NCT01932294|531284944|FG000|Overall Study|Transferred to other hospitals|12|||
147305240|NCT04415151|531284945|FG000|Overall Study|Death|1|||
147305241|NCT04415151|531284946|FG001|Overall Study|Death|1|||
147305242|NCT04415151|531284945|FG000|Overall Study|Withdrawal by Subject|1|||
147305243|NCT04415151|531284946|FG001|Overall Study|Withdrawal by Subject|0|||
147305244|NCT00409786|531284950|FG000|Overall Study|Withdrawal by Subject|3|||
147305245|NCT00638235|531284951|FG000|Overall Study|Lost to Follow-up|31|||
147305246|NCT00638235|531284952|FG001|Overall Study|Lost to Follow-up|3|||
147305247|NCT00638235|531284953|FG002|Overall Study|Lost to Follow-up|18|||
147305248|NCT00638235|531284954|FG003|Overall Study|Lost to Follow-up|10|||
147305249|NCT00638235|531284955|FG004|Overall Study|Lost to Follow-up|13|||
147305250|NCT00638235|531284956|FG005|Overall Study|Lost to Follow-up|26|||
147305251|NCT00638235|531284957|FG006|Overall Study|Lost to Follow-up|0|||
147305252|NCT00638235|531284958|FG007|Overall Study|Lost to Follow-up|1|||
147305253|NCT00638235|531284959|FG008|Overall Study|Lost to Follow-up|18|||
147305254|NCT00597714|531284964|FG000|Overall Study|Death|56|||
147305255|NCT00597714|531284965|FG001|Overall Study|Death|46|||
147305256|NCT00597714|531284966|FG002|Overall Study|Death|0|||
147305257|NCT00597714|531284964|FG000|Overall Study|Recipient death|0|||
147305258|NCT00597714|531284965|FG001|Overall Study|Recipient death|0|||
147305259|NCT00597714|531284966|FG002|Overall Study|Recipient death|10|||
147305260|NCT01350141|531284967|FG000|Overall Study|Lost to Follow-up|1|||
147305261|NCT01350141|531284968|FG001|Overall Study|Lost to Follow-up|0|||
147305262|NCT01350141|531284969|FG002|Overall Study|Lost to Follow-up|1|||
147305263|NCT01350141|531284967|FG000|Overall Study|Withdrawal by Subject|1|||
147305264|NCT01350141|531284968|FG001|Overall Study|Withdrawal by Subject|0|||
147305265|NCT01350141|531284969|FG002|Overall Study|Withdrawal by Subject|0|||
147305266|NCT01350141|531284967|FG000|Overall Study|Randomized but not treated|1|||
147305267|NCT01350141|531284968|FG001|Overall Study|Randomized but not treated|0|||
147305268|NCT01350141|531284969|FG002|Overall Study|Randomized but not treated|0|||
147305269|NCT00810082|531284970|FG000|Overall Study|Lost to Follow-up|0|||
147305270|NCT00810082|531284971|FG001|Overall Study|Lost to Follow-up|4|||
147305271|NCT01588990|531284974|FG000|Phase A|Withdrawal by Subject|5|||
147305272|NCT01588990|531284974|FG000|Phase A|Physician Decision|11|||
147305273|NCT01588990|531284974|FG000|Phase A|Other|14|||
147305274|NCT01588990|531284974|FG000|Phase A|Lost to Follow-up|1|||
147305275|NCT01588990|531284974|FG000|Phase A|Death|5|||
147305276|NCT01588990|531284974|FG000|Phase A|Adverse Event|28|||
147305277|NCT01588990|531284974|FG000|Phase A|Still on therapy at end of study|6|||
147305278|NCT01588990|531284974|FG000|Phase B|Adverse Event|2|||
147305279|NCT01588990|531284974|FG000|Phase B|Still on therapy at end of study|5|||
147305280|NCT01588990|531284974|FG000|Phase B|Withdrawal by Subject|3|||
147305281|NCT01588990|531284974|FG000|Phase B|Physician Decision|4|||
147305282|NCT01588990|531284974|FG000|Phase B|Other|2|||
147305283|NCT02367716|531284975|FG000|Overall Study|Patient did not meet inclusion criteria|1|||
147305284|NCT01473381|531284976|FG000|Overall Study|Adverse Event|8|||
147305285|NCT01473381|531284977|FG001|Overall Study|Adverse Event|20|||
147305286|NCT01473381|531284978|FG002|Overall Study|Adverse Event|25|||
147305287|NCT01473381|531284979|FG003|Overall Study|Adverse Event|17|||
147305288|NCT01473381|531284976|FG000|Overall Study|Insufficient Therapeutic Response|10|||
147305289|NCT01473381|531284977|FG001|Overall Study|Insufficient Therapeutic Response|1|||
147305290|NCT01473381|531284978|FG002|Overall Study|Insufficient Therapeutic Response|2|||
147305291|NCT01473381|531284979|FG003|Overall Study|Insufficient Therapeutic Response|3|||
147305292|NCT01473381|531284976|FG000|Overall Study|Protocol Violation|17|||
147305293|NCT01473381|531284977|FG001|Overall Study|Protocol Violation|23|||
147305294|NCT01473381|531284978|FG002|Overall Study|Protocol Violation|19|||
147305295|NCT01473381|531284979|FG003|Overall Study|Protocol Violation|17|||
147305296|NCT01473381|531284976|FG000|Overall Study|Withdrawal of Consent|20|||
147305297|NCT01473381|531284977|FG001|Overall Study|Withdrawal of Consent|21|||
147305298|NCT01473381|531284978|FG002|Overall Study|Withdrawal of Consent|20|||
147305299|NCT01473381|531284979|FG003|Overall Study|Withdrawal of Consent|26|||
147305300|NCT01473381|531284976|FG000|Overall Study|Lost to Follow-up|25|||
147305301|NCT01473381|531284977|FG001|Overall Study|Lost to Follow-up|28|||
147305302|NCT01473381|531284978|FG002|Overall Study|Lost to Follow-up|35|||
147305303|NCT01473381|531284979|FG003|Overall Study|Lost to Follow-up|23|||
147305304|NCT01473381|531284976|FG000|Overall Study|Other Reasons|0|||
147305305|NCT01473381|531284977|FG001|Overall Study|Other Reasons|0|||
147305306|NCT01473381|531284978|FG002|Overall Study|Other Reasons|1|||
147305307|NCT01473381|531284979|FG003|Overall Study|Other Reasons|3|||
147305308|NCT00539643|531284980|FG000|Overall Study|Adverse Event|1|||
147305309|NCT00539643|531284981|FG001|Overall Study|Adverse Event|0|||
147305310|NCT00539643|531284980|FG000|Overall Study|Death|2|||
147305311|NCT00539643|531284981|FG001|Overall Study|Death|1|||
147305312|NCT00539643|531284980|FG000|Overall Study|Physician Decision|3|||
147305313|NCT00539643|531284981|FG001|Overall Study|Physician Decision|1|||
147305314|NCT00539643|531284980|FG000|Overall Study|Withdrawal by Subject|0|||
147305315|NCT00539643|531284981|FG001|Overall Study|Withdrawal by Subject|1|||
147305316|NCT02341456|531284982|FG000|Overall Study|Disease progression|2|||
147305317|NCT02341456|531284983|FG001|Overall Study|Disease progression|3|||
147305318|NCT02341456|531284984|FG002|Overall Study|Disease progression|1|||
147305319|NCT02341456|531284982|FG000|Overall Study|Death|1|||
147305320|NCT02341456|531284983|FG001|Overall Study|Death|1|||
147305321|NCT02341456|531284984|FG002|Overall Study|Death|1|||
147305322|NCT02341456|531284982|FG000|Overall Study|Withdrawal by Subject|0|||
147305323|NCT02341456|531284983|FG001|Overall Study|Withdrawal by Subject|1|||
147305324|NCT02341456|531284984|FG002|Overall Study|Withdrawal by Subject|1|||
147305325|NCT02341456|531284982|FG000|Overall Study|Moved to local access programme.|0|||
147305326|NCT02341456|531284983|FG001|Overall Study|Moved to local access programme.|1|||
147305327|NCT02341456|531284984|FG002|Overall Study|Moved to local access programme.|1|||
147305328|NCT02341456|531284982|FG000|Overall Study|Physician Decision|1|||
147305329|NCT02341456|531284983|FG001|Overall Study|Physician Decision|0|||
147305330|NCT02341456|531284984|FG002|Overall Study|Physician Decision|0|||
147305331|NCT03587142|531284985|FG000|Overall Study|Lost to Follow-up|5|||
147305332|NCT03587142|531284986|FG001|Overall Study|Lost to Follow-up|3|||
147305333|NCT03587142|531284985|FG000|Overall Study|Did not complete the f4 visit|3|||
147305334|NCT03587142|531284986|FG001|Overall Study|Did not complete the f4 visit|7|||
147305335|NCT03673462|531284987|FG000|Overall Study|Adverse Event|11|||
147305336|NCT03673462|531284988|FG001|Overall Study|Adverse Event|1|||
147305337|NCT03673462|531284987|FG000|Overall Study|Protocol Violation|25|||
147305338|NCT03673462|531284988|FG001|Overall Study|Protocol Violation|11|||
147305339|NCT03673462|531284987|FG000|Overall Study|Withdrawal by Parent/Guardian|162|||
147305340|NCT03673462|531284988|FG001|Overall Study|Withdrawal by Parent/Guardian|56|||
147305341|NCT03673462|531284987|FG000|Overall Study|Lost to Follow-up|102|||
147305342|NCT03673462|531284988|FG001|Overall Study|Lost to Follow-up|19|||
147305343|NCT02768662|531284989|FG000|Overall Study|Adverse Event|1|||
147305344|NCT02768662|531284989|FG000|Overall Study|Lost to Follow-up|4|||
147305345|NCT02768662|531284989|FG000|Overall Study|Withdrawal by Subject|3|||
147305346|NCT02768662|531284989|FG000|Overall Study|Study terminated by Sponsor|78|||
147305347|NCT03528174|531284996|FG000|Overall Study|Adverse Event|1|||
147305348|NCT03528174|531284996|FG000|Overall Study|sensors dislodged|1|||
147305349|NCT03002038|531284997|FG000|Overall Study|Adverse Event|3|||
147305350|NCT03002038|531284998|FG001|Overall Study|Adverse Event|1|||
147305351|NCT03002038|531284997|FG000|Overall Study|Withdrawal by Subject|8|||
147305352|NCT03002038|531284998|FG001|Overall Study|Withdrawal by Subject|4|||
147305353|NCT03002038|531284997|FG000|Overall Study|Immigration to another region|0|||
147305354|NCT03002038|531284998|FG001|Overall Study|Immigration to another region|2|||
147305355|NCT00979602|531285005|FG000|Overall Study|Serious Adverse Event|5|||
147305356|NCT00979602|531285006|FG001|Overall Study|Serious Adverse Event|3|||
147305357|NCT00979602|531285005|FG000|Overall Study|Protocol Violation|3|||
147305358|NCT00979602|531285006|FG001|Overall Study|Protocol Violation|0|||
147305359|NCT00979602|531285005|FG000|Overall Study|Withdrawal by Subject|31|||
147305360|NCT00979602|531285006|FG001|Overall Study|Withdrawal by Subject|25|||
147305361|NCT00979602|531285005|FG000|Overall Study|Lost to Follow-up|100|||
147305362|NCT00979602|531285006|FG001|Overall Study|Lost to Follow-up|96|||
147305363|NCT00979602|531285005|FG000|Overall Study|Migrated/moved from study area|3|||
147305364|NCT00979602|531285006|FG001|Overall Study|Migrated/moved from study area|6|||
147305365|NCT00979602|531285005|FG000|Overall Study|Others|3|||
147305366|NCT00979602|531285006|FG001|Overall Study|Others|3|||
147305367|NCT02904902|531285007|FG000|Overall Study|Withdrawal by Subject|1|||
147305368|NCT02712398|531285011|FG000|Overall Study|Withdrawal by Subject|6|||
147305369|NCT02712398|531285011|FG000|Overall Study|Lost to Follow-up|6|||
147305370|NCT02712398|531285011|FG000|Overall Study|Sponsor Decision|1|||
147305371|NCT02712398|531285011|FG000|Overall Study|Physician Decision|1|||
147305372|NCT02712398|531285011|FG000|Overall Study|Death|2|||
147305373|NCT02712398|531285011|FG000|Overall Study|Re-operation|21|||
147305374|NCT02002182|531285021|FG000|Overall Study|Withdraw from study|3|||
147305375|NCT02002182|531285022|FG001|Overall Study|Withdraw from study|1|||
147305376|NCT02002182|531285021|FG000|Overall Study|Health Reasons|1|||
147305377|NCT02002182|531285022|FG001|Overall Study|Health Reasons|0|||
147305378|NCT02002182|531285021|FG000|Overall Study|Death|1|||
147305379|NCT02002182|531285022|FG001|Overall Study|Death|0|||
147305380|NCT03787680|531285024|FG000|Overall Study|Physician Decision|2|||
147305381|NCT03787680|531285025|FG001|Overall Study|Physician Decision|3|||
147305382|NCT03787680|531285024|FG000|Overall Study|Adverse Event|7|||
147305383|NCT03787680|531285025|FG001|Overall Study|Adverse Event|3|||
147305384|NCT03787680|531285024|FG000|Overall Study|Withdrawal by Subject|2|||
147305385|NCT03787680|531285025|FG001|Overall Study|Withdrawal by Subject|1|||
147305386|NCT05400746|531285026|FG000|Overall Study|Trial terminated early due to IMP availability|0|||
147305387|NCT05400746|531285027|FG001|Overall Study|Trial terminated early due to IMP availability|4|||
147305388|NCT05400746|531285028|FG002|Overall Study|Trial terminated early due to IMP availability|1|||
147305389|NCT03724396|531285029|FG000|Overall Study|Lost to Follow-up|1|||
147305390|NCT03724396|531285030|FG001|Overall Study|Lost to Follow-up|1|||
147305391|NCT03724396|531285029|FG000|Overall Study|Withdrawal by Subject|1|||
147305392|NCT03724396|531285030|FG001|Overall Study|Withdrawal by Subject|0|||
147305393|NCT01490125|531285031|FG000|Period I|Adverse Event|4|||
147305394|NCT01490125|531285032|FG001|Period I|Adverse Event|1|||
147305395|NCT01490125|531285033|FG002|Period I|Adverse Event|1|||
147305396|NCT01490125|531285034|FG003|Period I|Adverse Event|3|||
147305397|NCT01490125|531285035|FG004|Period I|Adverse Event|2|||
147305398|NCT01490125|531285036|FG005|Period I|Adverse Event|4|||
147305399|NCT01490125|531285031|FG000|Period I|Protocol Violation|1|||
147305400|NCT01490125|531285032|FG001|Period I|Protocol Violation|1|||
147305401|NCT01490125|531285033|FG002|Period I|Protocol Violation|1|||
147305402|NCT01490125|531285034|FG003|Period I|Protocol Violation|1|||
147305403|NCT01490125|531285035|FG004|Period I|Protocol Violation|0|||
147305404|NCT01490125|531285036|FG005|Period I|Protocol Violation|0|||
147305405|NCT01490125|531285031|FG000|Period I|Withdrawal by Subject|1|||
147305406|NCT01490125|531285032|FG001|Period I|Withdrawal by Subject|3|||
147305407|NCT01490125|531285033|FG002|Period I|Withdrawal by Subject|2|||
147305408|NCT01490125|531285034|FG003|Period I|Withdrawal by Subject|1|||
147305409|NCT01490125|531285035|FG004|Period I|Withdrawal by Subject|2|||
147305410|NCT01490125|531285036|FG005|Period I|Withdrawal by Subject|1|||
147305411|NCT01490125|531285031|FG000|Period II|Adverse Event|2|||
147305412|NCT01490125|531285032|FG001|Period II|Adverse Event|3|||
147305413|NCT01490125|531285033|FG002|Period II|Adverse Event|2|||
147305414|NCT01490125|531285034|FG003|Period II|Adverse Event|2|||
147305415|NCT01490125|531285035|FG004|Period II|Adverse Event|4|||
147305416|NCT01490125|531285036|FG005|Period II|Adverse Event|2|||
147305417|NCT01490125|531285031|FG000|Period II|Protocol Violation|0|||
147305418|NCT01490125|531285032|FG001|Period II|Protocol Violation|0|||
147305419|NCT01490125|531285033|FG002|Period II|Protocol Violation|1|||
147305420|NCT01490125|531285034|FG003|Period II|Protocol Violation|1|||
147305421|NCT01490125|531285035|FG004|Period II|Protocol Violation|0|||
147305422|NCT01490125|531285036|FG005|Period II|Protocol Violation|0|||
147305423|NCT01490125|531285031|FG000|Period II|Lost to Follow-up|0|||
147305424|NCT01490125|531285032|FG001|Period II|Lost to Follow-up|1|||
147305425|NCT01490125|531285033|FG002|Period II|Lost to Follow-up|0|||
147305426|NCT01490125|531285034|FG003|Period II|Lost to Follow-up|0|||
147305427|NCT01490125|531285035|FG004|Period II|Lost to Follow-up|0|||
147305428|NCT01490125|531285036|FG005|Period II|Lost to Follow-up|0|||
147305429|NCT01490125|531285031|FG000|Period II|Withdrawal by Subject|1|||
147305430|NCT01490125|531285032|FG001|Period II|Withdrawal by Subject|0|||
147305431|NCT01490125|531285033|FG002|Period II|Withdrawal by Subject|0|||
147305432|NCT01490125|531285034|FG003|Period II|Withdrawal by Subject|0|||
147305433|NCT01490125|531285035|FG004|Period II|Withdrawal by Subject|0|||
147305434|NCT01490125|531285036|FG005|Period II|Withdrawal by Subject|0|||
147305435|NCT01490125|531285031|FG000|Period III|Adverse Event|3|||
147305436|NCT01490125|531285032|FG001|Period III|Adverse Event|1|||
147305437|NCT01490125|531285033|FG002|Period III|Adverse Event|0|||
147305438|NCT01490125|531285034|FG003|Period III|Adverse Event|1|||
147305439|NCT01490125|531285035|FG004|Period III|Adverse Event|0|||
147305440|NCT01490125|531285036|FG005|Period III|Adverse Event|0|||
147305441|NCT01490125|531285031|FG000|Period III|Death|0|||
147305442|NCT01490125|531285032|FG001|Period III|Death|0|||
147305443|NCT01490125|531285033|FG002|Period III|Death|0|||
147305444|NCT01490125|531285034|FG003|Period III|Death|1|||
147305445|NCT01490125|531285035|FG004|Period III|Death|0|||
147305446|NCT01490125|531285036|FG005|Period III|Death|0|||
147305447|NCT01490125|531285031|FG000|Period III|Lack of Efficacy|0|||
147305448|NCT01490125|531285032|FG001|Period III|Lack of Efficacy|0|||
147305449|NCT01490125|531285033|FG002|Period III|Lack of Efficacy|0|||
147305450|NCT01490125|531285034|FG003|Period III|Lack of Efficacy|0|||
147305451|NCT01490125|531285035|FG004|Period III|Lack of Efficacy|1|||
147305452|NCT01490125|531285036|FG005|Period III|Lack of Efficacy|0|||
147305453|NCT04522180|531285037|FG000|Overall Study|Investigator judgement|3|||
147305454|NCT04522180|531285038|FG001|Overall Study|Investigator judgement|4|||
147305455|NCT04522180|531285037|FG000|Overall Study|Voluntary withdrawal|1|||
147305456|NCT04522180|531285038|FG001|Overall Study|Voluntary withdrawal|0|||
147305457|NCT04522180|531285037|FG000|Overall Study|Pregnancy|0|||
147305458|NCT04522180|531285038|FG001|Overall Study|Pregnancy|1|||
147305459|NCT04522180|531285037|FG000|Overall Study|Adverse Event or Serious Adverse event|1|||
147305460|NCT04522180|531285038|FG001|Overall Study|Adverse Event or Serious Adverse event|3|||
147305461|NCT04522180|531285037|FG000|Overall Study|Reason not specified|8|||
147305462|NCT04522180|531285038|FG001|Overall Study|Reason not specified|5|||
147305463|NCT05807919|531285039|FG000|Overall Study|Received antibiotics - excluded|0|||
147305464|NCT05807919|531285040|FG001|Overall Study|Received antibiotics - excluded|1|||
147305465|NCT05807919|531285039|FG000|Overall Study|Withdrawal by Subject|0|||
147305466|NCT05807919|531285040|FG001|Overall Study|Withdrawal by Subject|3|||
147305467|NCT05807919|531285039|FG000|Overall Study|Adverse Event|1|||
147305468|NCT05807919|531285040|FG001|Overall Study|Adverse Event|1|||
147305469|NCT03635489|531285045|FG000|Overall Study|Death|19|||
147305470|NCT03635489|531285046|FG001|Overall Study|Death|13|||
147305471|NCT03635489|531285045|FG000|Overall Study|Lost to Follow-up|1|||
147305472|NCT03635489|531285046|FG001|Overall Study|Lost to Follow-up|2|||
147305473|NCT03635489|531285045|FG000|Overall Study|Withdrawal by Subject|1|||
147305474|NCT03635489|531285046|FG001|Overall Study|Withdrawal by Subject|2|||
147305475|NCT03635489|531285045|FG000|Overall Study|Study Ended by Sponsor|28|||
147305476|NCT03635489|531285046|FG001|Overall Study|Study Ended by Sponsor|34|||
147305477|NCT01368900|531285047|FG000|Overall Study|Lost to Follow-up|7|||
147305478|NCT02277743|531285057|FG000|Overall Study|Protocol Violation|1|||
147305479|NCT02277743|531285058|FG001|Overall Study|Protocol Violation|1|||
147305480|NCT02277743|531285059|FG002|Overall Study|Protocol Violation|1|||
147305481|NCT02277743|531285057|FG000|Overall Study|Adverse Event|10|||
147305482|NCT02277743|531285058|FG001|Overall Study|Adverse Event|6|||
147305483|NCT02277743|531285059|FG002|Overall Study|Adverse Event|6|||
147305484|NCT02277743|531285057|FG000|Overall Study|Lack of Efficacy|11|||
147305485|NCT02277743|531285058|FG001|Overall Study|Lack of Efficacy|4|||
147305486|NCT02277743|531285059|FG002|Overall Study|Lack of Efficacy|3|||
147305487|NCT02277743|531285057|FG000|Overall Study|Other than specified above|18|||
147305488|NCT02277743|531285058|FG001|Overall Study|Other than specified above|5|||
147305489|NCT02277743|531285059|FG002|Overall Study|Other than specified above|16|||
147305490|NCT01224158|531285060|FG000|Overall Study|Withdrawal by Subject|1|||
147305491|NCT01224158|531285061|FG001|Overall Study|Withdrawal by Subject|0|||
147305492|NCT00429494|531286502|FG000|Overall Study|Withdrawal by Subject|9|||
147305493|NCT00429494|531286502|FG000|Overall Study|Death|6|||
147305494|NCT00976703|531286503|FG000|Overall Study|Physician Decision|1|||
147305495|NCT00976703|531286504|FG001|Overall Study|Physician Decision|1|||
147305496|NCT00976703|531286503|FG000|Overall Study|ineligible for study|2|||
147305497|NCT00976703|531286504|FG001|Overall Study|ineligible for study|2|||
147305498|NCT01900054|531286509|FG000|Overall Study|Physician Decision|1|||
147305499|NCT01900054|531286509|FG000|Overall Study|Withdrawal by Subject|1|||
147305500|NCT03285295|531286512|FG000|Alinity s HBsAg|Protocol Violation|11|||
147305501|NCT03285295|531286513|FG001|Alinity s HBsAg|Protocol Violation|0|||
147305502|NCT03285295|531286514|FG002|Alinity s HBsAg|Protocol Violation|0|||
147305503|NCT03285295|531286515|FG003|Alinity s HBsAg|Protocol Violation|0|||
147305504|NCT03285295|531286516|FG004|Alinity s HBsAg|Protocol Violation|0|||
147305505|NCT03285295|531286512|FG000|Alinity s HBsAg|No Result on Comparator Assay|17|||
147305506|NCT03285295|531286513|FG001|Alinity s HBsAg|No Result on Comparator Assay|0|||
147305507|NCT03285295|531286514|FG002|Alinity s HBsAg|No Result on Comparator Assay|0|||
147305508|NCT03285295|531286515|FG003|Alinity s HBsAg|No Result on Comparator Assay|0|||
147305509|NCT03285295|531286516|FG004|Alinity s HBsAg|No Result on Comparator Assay|0|||
147305510|NCT03285295|531286512|FG000|Alinity s HBsAg|No Results Generated|74|||
147305511|NCT03285295|531286513|FG001|Alinity s HBsAg|No Results Generated|6|||
147305512|NCT03285295|531286514|FG002|Alinity s HBsAg|No Results Generated|0|||
147305513|NCT03285295|531286515|FG003|Alinity s HBsAg|No Results Generated|0|||
147305514|NCT03285295|531286516|FG004|Alinity s HBsAg|No Results Generated|0|||
147305515|NCT03285295|531286512|FG000|Alinity s HTLV I/II|Protocol Violation|6|||
147305516|NCT03285295|531286513|FG001|Alinity s HTLV I/II|Protocol Violation|0|||
147305517|NCT03285295|531286514|FG002|Alinity s HTLV I/II|Protocol Violation|0|||
147305518|NCT03285295|531286515|FG003|Alinity s HTLV I/II|Protocol Violation|0|||
147305519|NCT03285295|531286516|FG004|Alinity s HTLV I/II|Protocol Violation|0|||
147305520|NCT03285295|531286512|FG000|Alinity s HTLV I/II|No Result on Comparator Assay|15|||
147305521|NCT03285295|531286513|FG001|Alinity s HTLV I/II|No Result on Comparator Assay|0|||
147305522|NCT03285295|531286514|FG002|Alinity s HTLV I/II|No Result on Comparator Assay|0|||
147305523|NCT03285295|531286515|FG003|Alinity s HTLV I/II|No Result on Comparator Assay|0|||
147305524|NCT03285295|531286516|FG004|Alinity s HTLV I/II|No Result on Comparator Assay|0|||
147305525|NCT03285295|531286512|FG000|Alinity s HTLV I/II|No Results Generated|70|||
147305526|NCT03285295|531286513|FG001|Alinity s HTLV I/II|No Results Generated|0|||
147305527|NCT03285295|531286514|FG002|Alinity s HTLV I/II|No Results Generated|0|||
147305528|NCT03285295|531286515|FG003|Alinity s HTLV I/II|No Results Generated|0|||
147305529|NCT03285295|531286516|FG004|Alinity s HTLV I/II|No Results Generated|0|||
147305530|NCT03285295|531286512|FG000|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|4|||
147305531|NCT03285295|531286513|FG001|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|0|||
147305532|NCT03285295|531286514|FG002|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|0|||
147305533|NCT03285295|531286515|FG003|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|0|||
147305534|NCT03285295|531286516|FG004|Alinity s HTLV I/II Follow-Up|Lost to Follow-up|0|||
147305535|NCT03285295|531286512|FG000|Alinity s Anti-HCV|Protocol Violation|12|||
147305536|NCT03285295|531286513|FG001|Alinity s Anti-HCV|Protocol Violation|0|||
147305537|NCT03285295|531286514|FG002|Alinity s Anti-HCV|Protocol Violation|0|||
147305538|NCT03285295|531286515|FG003|Alinity s Anti-HCV|Protocol Violation|0|||
147305539|NCT03285295|531286516|FG004|Alinity s Anti-HCV|Protocol Violation|0|||
147305540|NCT03285295|531286512|FG000|Alinity s Anti-HCV|No Results on Comparator Assay|13|||
147305541|NCT03285295|531286513|FG001|Alinity s Anti-HCV|No Results on Comparator Assay|0|||
147305542|NCT03285295|531286514|FG002|Alinity s Anti-HCV|No Results on Comparator Assay|0|||
147305543|NCT03285295|531286515|FG003|Alinity s Anti-HCV|No Results on Comparator Assay|0|||
147305544|NCT03285295|531286516|FG004|Alinity s Anti-HCV|No Results on Comparator Assay|0|||
147305545|NCT03285295|531286512|FG000|Alinity s Anti-HCV|No Results Generated|71|||
147305546|NCT03285295|531286513|FG001|Alinity s Anti-HCV|No Results Generated|0|||
147305547|NCT03285295|531286514|FG002|Alinity s Anti-HCV|No Results Generated|0|||
147305548|NCT03285295|531286515|FG003|Alinity s Anti-HCV|No Results Generated|0|||
147305549|NCT03285295|531286516|FG004|Alinity s Anti-HCV|No Results Generated|0|||
147305550|NCT03285295|531286512|FG000|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|18|||
147305551|NCT03285295|531286513|FG001|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|0|||
147305552|NCT03285295|531286514|FG002|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|0|||
147305553|NCT03285295|531286515|FG003|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|0|||
147305554|NCT03285295|531286516|FG004|Alinity s Anti-HCV Follow-Up|Lost to Follow-up|0|||
147305555|NCT03285295|531286512|FG000|Alinity s HIV Ag/Ab Combo|Protocol Violation|11|||
147305556|NCT03285295|531286513|FG001|Alinity s HIV Ag/Ab Combo|Protocol Violation|0|||
147305557|NCT03285295|531286514|FG002|Alinity s HIV Ag/Ab Combo|Protocol Violation|0|||
147305558|NCT03285295|531286515|FG003|Alinity s HIV Ag/Ab Combo|Protocol Violation|0|||
147305559|NCT03285295|531286516|FG004|Alinity s HIV Ag/Ab Combo|Protocol Violation|0|||
147305560|NCT03285295|531286512|FG000|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|16|||
147305561|NCT03285295|531286513|FG001|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|0|||
147305562|NCT03285295|531286514|FG002|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|0|||
147305563|NCT03285295|531286515|FG003|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|0|||
147305564|NCT03285295|531286516|FG004|Alinity s HIV Ag/Ab Combo|No Results on Comparator Assay|0|||
147305565|NCT03285295|531286512|FG000|Alinity s HIV Ag/Ab Combo|No Results Generated|72|||
147305566|NCT03285295|531286513|FG001|Alinity s HIV Ag/Ab Combo|No Results Generated|0|||
147305567|NCT03285295|531286514|FG002|Alinity s HIV Ag/Ab Combo|No Results Generated|0|||
147305568|NCT03285295|531286515|FG003|Alinity s HIV Ag/Ab Combo|No Results Generated|0|||
147305569|NCT03285295|531286516|FG004|Alinity s HIV Ag/Ab Combo|No Results Generated|0|||
147305570|NCT03285295|531286512|FG000|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|11|||
147305571|NCT03285295|531286513|FG001|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|0|||
147305572|NCT03285295|531286514|FG002|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|0|||
147305573|NCT03285295|531286515|FG003|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|0|||
147305574|NCT03285295|531286516|FG004|Alinity s HIV Ag/Ab Combo Follow-Up|Lost to Follow-up|0|||
147305575|NCT03285295|531286512|FG000|Alinity s Anti-HBc|Protocol Violation|8|||
147305576|NCT03285295|531286513|FG001|Alinity s Anti-HBc|Protocol Violation|0|||
147305577|NCT03285295|531286514|FG002|Alinity s Anti-HBc|Protocol Violation|0|||
147305578|NCT03285295|531286515|FG003|Alinity s Anti-HBc|Protocol Violation|0|||
147305579|NCT03285295|531286516|FG004|Alinity s Anti-HBc|Protocol Violation|0|||
147305580|NCT03285295|531286512|FG000|Alinity s Anti-HBc|No Results on Comparator Assay|13|||
147305581|NCT03285295|531286513|FG001|Alinity s Anti-HBc|No Results on Comparator Assay|1|||
147305582|NCT03285295|531286514|FG002|Alinity s Anti-HBc|No Results on Comparator Assay|0|||
147305583|NCT03285295|531286515|FG003|Alinity s Anti-HBc|No Results on Comparator Assay|0|||
147305584|NCT03285295|531286516|FG004|Alinity s Anti-HBc|No Results on Comparator Assay|0|||
147305585|NCT03285295|531286512|FG000|Alinity s Anti-HBc|No Results Generated|70|||
147305586|NCT03285295|531286513|FG001|Alinity s Anti-HBc|No Results Generated|0|||
147305587|NCT03285295|531286514|FG002|Alinity s Anti-HBc|No Results Generated|0|||
147305588|NCT03285295|531286515|FG003|Alinity s Anti-HBc|No Results Generated|0|||
147305589|NCT03285295|531286516|FG004|Alinity s Anti-HBc|No Results Generated|0|||
147305590|NCT03285295|531286512|FG000|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|14|||
147305591|NCT03285295|531286513|FG001|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|0|||
147305592|NCT03285295|531286514|FG002|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|0|||
147305593|NCT03285295|531286515|FG003|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|0|||
147305594|NCT03285295|531286516|FG004|Alinity s Anti-HBc Follow-Up|Lost to Follow-up|0|||
147305595|NCT03285295|531286512|FG000|Alinity s Chagas|Protocol Violation|76|||
147305596|NCT03285295|531286513|FG001|Alinity s Chagas|Protocol Violation|0|||
147305597|NCT03285295|531286514|FG002|Alinity s Chagas|Protocol Violation|0|||
147305598|NCT03285295|531286515|FG003|Alinity s Chagas|Protocol Violation|0|||
147305599|NCT03285295|531286516|FG004|Alinity s Chagas|Protocol Violation|0|||
147305600|NCT03285295|531286512|FG000|Alinity s Chagas|No Results on Comparator Assay|38|||
147305601|NCT03285295|531286513|FG001|Alinity s Chagas|No Results on Comparator Assay|0|||
147305602|NCT03285295|531286514|FG002|Alinity s Chagas|No Results on Comparator Assay|0|||
147305603|NCT03285295|531286515|FG003|Alinity s Chagas|No Results on Comparator Assay|0|||
147305604|NCT03285295|531286516|FG004|Alinity s Chagas|No Results on Comparator Assay|0|||
147305605|NCT03285295|531286512|FG000|Alinity s Chagas|No Results Generated|105|||
147305606|NCT03285295|531286513|FG001|Alinity s Chagas|No Results Generated|0|||
147305607|NCT03285295|531286514|FG002|Alinity s Chagas|No Results Generated|0|||
147305608|NCT03285295|531286515|FG003|Alinity s Chagas|No Results Generated|0|||
147305609|NCT03285295|531286516|FG004|Alinity s Chagas|No Results Generated|0|||
147305610|NCT03285295|531286512|FG000|Alinity s Chagas Follow-Up|Lost to Follow-up|13|||
147305611|NCT03285295|531286513|FG001|Alinity s Chagas Follow-Up|Lost to Follow-up|0|||
147305612|NCT03285295|531286514|FG002|Alinity s Chagas Follow-Up|Lost to Follow-up|0|||
147305613|NCT03285295|531286515|FG003|Alinity s Chagas Follow-Up|Lost to Follow-up|0|||
147305614|NCT03285295|531286516|FG004|Alinity s Chagas Follow-Up|Lost to Follow-up|0|||
147305615|NCT00957931|531286519|FG000|Overall Study|Death|4|||
147305616|NCT00857805|531286520|FG000|Overall Study|Withdrawal by Subject|1|||
147305617|NCT00857805|531286521|FG001|Overall Study|Withdrawal by Subject|1|||
147305618|NCT01289041|531286522|FG000|Overall Study|Adverse Event|24|||
147305619|NCT01289041|531286522|FG000|Overall Study|Physician Decision|1|||
147305620|NCT01289041|531286522|FG000|Overall Study|Progressive Disease|41|||
147305621|NCT01289041|531286522|FG000|Overall Study|Withdrawal by Subject|3|||
147305622|NCT01289041|531286522|FG000|Overall Study|Death|1|||
147305623|NCT01062763|531286523|FG000|Overall Study|Adverse Event|3|||
147305624|NCT01062763|531286524|FG001|Overall Study|Adverse Event|4|||
147305625|NCT02714868|531286536|FG000|Overall Study|Withdrawal by Subject|3|||
147305626|NCT02714868|531286537|FG001|Overall Study|Withdrawal by Subject|0|||
147305627|NCT02714868|531286536|FG000|Overall Study|PI withdrawal safety risk self/others|1|||
147305628|NCT02714868|531286537|FG001|Overall Study|PI withdrawal safety risk self/others|0|||
147305629|NCT02714868|531286536|FG000|Overall Study|PI withdraw did not meet inclusion|1|||
147305630|NCT02714868|531286537|FG001|Overall Study|PI withdraw did not meet inclusion|0|||
147305631|NCT00369681|531286538|FG000|Overall Study|Death|1|||
147305632|NCT02508532|531286543|FG000|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
147305633|NCT02508532|531286544|FG001|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
147305634|NCT02508532|531286545|FG002|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
147305635|NCT02508532|531286546|FG003|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
147305636|NCT02508532|531286547|FG004|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
147305637|NCT02508532|531286548|FG005|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
147305638|NCT02508532|531286549|FG006|Part 1 - Dose Determining Period|did not complete >21 days of treatment|1|||
147305639|NCT02508532|531286550|FG007|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
147305640|NCT02508532|531286551|FG008|Part 1 - Dose Determining Period|did not complete >21 days of treatment|0|||
147305641|NCT02508532|531286543|FG000|Part 1 - Dose Determining Period|Not Evaluable|0|||
147305642|NCT02508532|531286544|FG001|Part 1 - Dose Determining Period|Not Evaluable|0|||
147305643|NCT02508532|531286545|FG002|Part 1 - Dose Determining Period|Not Evaluable|0|||
147305644|NCT02508532|531286546|FG003|Part 1 - Dose Determining Period|Not Evaluable|0|||
147305645|NCT02508532|531286547|FG004|Part 1 - Dose Determining Period|Not Evaluable|0|||
147305646|NCT02508532|531286548|FG005|Part 1 - Dose Determining Period|Not Evaluable|0|||
147305647|NCT02508532|531286549|FG006|Part 1 - Dose Determining Period|Not Evaluable|0|||
147305648|NCT02508532|531286550|FG007|Part 1 - Dose Determining Period|Not Evaluable|1|||
147305649|NCT02508532|531286551|FG008|Part 1 - Dose Determining Period|Not Evaluable|0|||
147305650|NCT02508532|531286543|FG000|Part 2 - Treatment|Disease Progression|0|||
147305651|NCT02508532|531286544|FG001|Part 2 - Treatment|Disease Progression|0|||
147305652|NCT02508532|531286545|FG002|Part 2 - Treatment|Disease Progression|0|||
147305653|NCT02508532|531286546|FG003|Part 2 - Treatment|Disease Progression|0|||
147305654|NCT02508532|531286547|FG004|Part 2 - Treatment|Disease Progression|0|||
147305655|NCT02508532|531286548|FG005|Part 2 - Treatment|Disease Progression|0|||
147305656|NCT02508532|531286549|FG006|Part 2 - Treatment|Disease Progression|0|||
147305657|NCT02508532|531286550|FG007|Part 2 - Treatment|Disease Progression|0|||
147305658|NCT02508532|531286551|FG008|Part 2 - Treatment|Disease Progression|118|||
147305659|NCT02508532|531286543|FG000|Part 2 - Treatment|Adverse Event|0|||
147305660|NCT02508532|531286544|FG001|Part 2 - Treatment|Adverse Event|0|||
147305661|NCT02508532|531286545|FG002|Part 2 - Treatment|Adverse Event|0|||
147305662|NCT02508532|531286546|FG003|Part 2 - Treatment|Adverse Event|0|||
147305663|NCT02508532|531286547|FG004|Part 2 - Treatment|Adverse Event|0|||
147305664|NCT02508532|531286548|FG005|Part 2 - Treatment|Adverse Event|0|||
147305665|NCT02508532|531286549|FG006|Part 2 - Treatment|Adverse Event|0|||
147305666|NCT02508532|531286550|FG007|Part 2 - Treatment|Adverse Event|0|||
147305667|NCT02508532|531286551|FG008|Part 2 - Treatment|Adverse Event|49|||
147305668|NCT02508532|531286543|FG000|Part 2 - Treatment|Physician Decision|0|||
147305669|NCT02508532|531286544|FG001|Part 2 - Treatment|Physician Decision|0|||
147305670|NCT02508532|531286545|FG002|Part 2 - Treatment|Physician Decision|0|||
147305671|NCT02508532|531286546|FG003|Part 2 - Treatment|Physician Decision|0|||
147305672|NCT02508532|531286547|FG004|Part 2 - Treatment|Physician Decision|0|||
147305673|NCT02508532|531286548|FG005|Part 2 - Treatment|Physician Decision|0|||
147305674|NCT02508532|531286549|FG006|Part 2 - Treatment|Physician Decision|0|||
147305675|NCT02508532|531286550|FG007|Part 2 - Treatment|Physician Decision|0|||
147305676|NCT02508532|531286551|FG008|Part 2 - Treatment|Physician Decision|12|||
147305677|NCT02508532|531286543|FG000|Part 2 - Treatment|Administrative|0|||
147305678|NCT02508532|531286544|FG001|Part 2 - Treatment|Administrative|0|||
147305679|NCT02508532|531286545|FG002|Part 2 - Treatment|Administrative|0|||
147305680|NCT02508532|531286546|FG003|Part 2 - Treatment|Administrative|0|||
147305681|NCT02508532|531286547|FG004|Part 2 - Treatment|Administrative|0|||
147305682|NCT02508532|531286548|FG005|Part 2 - Treatment|Administrative|0|||
147305683|NCT02508532|531286549|FG006|Part 2 - Treatment|Administrative|0|||
147305684|NCT02508532|531286550|FG007|Part 2 - Treatment|Administrative|0|||
147305685|NCT02508532|531286551|FG008|Part 2 - Treatment|Administrative|3|||
147305686|NCT02508532|531286543|FG000|Part 2 - Treatment|Sponsor Decision|0|||
147305687|NCT02508532|531286544|FG001|Part 2 - Treatment|Sponsor Decision|0|||
147305688|NCT02508532|531286545|FG002|Part 2 - Treatment|Sponsor Decision|0|||
147305689|NCT02508532|531286546|FG003|Part 2 - Treatment|Sponsor Decision|0|||
147305690|NCT02508532|531286547|FG004|Part 2 - Treatment|Sponsor Decision|0|||
147305691|NCT02508532|531286548|FG005|Part 2 - Treatment|Sponsor Decision|0|||
147305692|NCT02508532|531286549|FG006|Part 2 - Treatment|Sponsor Decision|0|||
147305693|NCT02508532|531286550|FG007|Part 2 - Treatment|Sponsor Decision|0|||
147305694|NCT02508532|531286551|FG008|Part 2 - Treatment|Sponsor Decision|28|||
147305695|NCT02508532|531286543|FG000|Part 2 - Treatment|Death|0|||
147305696|NCT02508532|531286544|FG001|Part 2 - Treatment|Death|0|||
147305697|NCT02508532|531286545|FG002|Part 2 - Treatment|Death|0|||
147305698|NCT02508532|531286546|FG003|Part 2 - Treatment|Death|0|||
147305699|NCT02508532|531286547|FG004|Part 2 - Treatment|Death|0|||
147305700|NCT02508532|531286548|FG005|Part 2 - Treatment|Death|0|||
147305701|NCT02508532|531286549|FG006|Part 2 - Treatment|Death|0|||
147305702|NCT02508532|531286550|FG007|Part 2 - Treatment|Death|0|||
147305703|NCT02508532|531286551|FG008|Part 2 - Treatment|Death|1|||
147305704|NCT02508532|531286543|FG000|Part 2 - Treatment|Withdrawal by Subject|0|||
147305705|NCT02508532|531286544|FG001|Part 2 - Treatment|Withdrawal by Subject|0|||
147305706|NCT02508532|531286545|FG002|Part 2 - Treatment|Withdrawal by Subject|0|||
147305707|NCT02508532|531286546|FG003|Part 2 - Treatment|Withdrawal by Subject|0|||
147305708|NCT02508532|531286547|FG004|Part 2 - Treatment|Withdrawal by Subject|0|||
147305709|NCT02508532|531286548|FG005|Part 2 - Treatment|Withdrawal by Subject|0|||
147305710|NCT02508532|531286549|FG006|Part 2 - Treatment|Withdrawal by Subject|0|||
147305711|NCT02508532|531286550|FG007|Part 2 - Treatment|Withdrawal by Subject|0|||
147305712|NCT02508532|531286551|FG008|Part 2 - Treatment|Withdrawal by Subject|6|||
147305713|NCT02508532|531286543|FG000|Part 1 and Part 2 End of Study|Disease Progression|2|||
147305714|NCT02508532|531286544|FG001|Part 1 and Part 2 End of Study|Disease Progression|0|||
147305715|NCT02508532|531286545|FG002|Part 1 and Part 2 End of Study|Disease Progression|0|||
147305716|NCT02508532|531286546|FG003|Part 1 and Part 2 End of Study|Disease Progression|0|||
147305717|NCT02508532|531286547|FG004|Part 1 and Part 2 End of Study|Disease Progression|0|||
147305718|NCT02508532|531286548|FG005|Part 1 and Part 2 End of Study|Disease Progression|0|||
147305719|NCT02508532|531286549|FG006|Part 1 and Part 2 End of Study|Disease Progression|0|||
147305720|NCT02508532|531286550|FG007|Part 1 and Part 2 End of Study|Disease Progression|1|||
147305721|NCT02508532|531286551|FG008|Part 1 and Part 2 End of Study|Disease Progression|6|||
147305722|NCT02508532|531286543|FG000|Part 1 and Part 2 End of Study|Adverse Event|1|||
147305723|NCT02508532|531286544|FG001|Part 1 and Part 2 End of Study|Adverse Event|0|||
147305724|NCT02508532|531286545|FG002|Part 1 and Part 2 End of Study|Adverse Event|1|||
147305725|NCT02508532|531286546|FG003|Part 1 and Part 2 End of Study|Adverse Event|0|||
147305726|NCT02508532|531286547|FG004|Part 1 and Part 2 End of Study|Adverse Event|0|||
147305727|NCT02508532|531286548|FG005|Part 1 and Part 2 End of Study|Adverse Event|0|||
147305728|NCT02508532|531286549|FG006|Part 1 and Part 2 End of Study|Adverse Event|0|||
147305729|NCT02508532|531286550|FG007|Part 1 and Part 2 End of Study|Adverse Event|0|||
147305730|NCT02508532|531286551|FG008|Part 1 and Part 2 End of Study|Adverse Event|2|||
147305731|NCT02508532|531286543|FG000|Part 1 and Part 2 End of Study|Death|0|||
147305732|NCT02508532|531286544|FG001|Part 1 and Part 2 End of Study|Death|4|||
147305733|NCT02508532|531286545|FG002|Part 1 and Part 2 End of Study|Death|2|||
147305734|NCT02508532|531286546|FG003|Part 1 and Part 2 End of Study|Death|4|||
147305735|NCT02508532|531286547|FG004|Part 1 and Part 2 End of Study|Death|3|||
147305736|NCT02508532|531286548|FG005|Part 1 and Part 2 End of Study|Death|0|||
147305737|NCT02508532|531286549|FG006|Part 1 and Part 2 End of Study|Death|0|||
147305738|NCT02508532|531286550|FG007|Part 1 and Part 2 End of Study|Death|1|||
147305739|NCT02508532|531286551|FG008|Part 1 and Part 2 End of Study|Death|111|||
147305740|NCT02508532|531286543|FG000|Part 1 and Part 2 End of Study|Lost to Follow-up|1|||
147305741|NCT02508532|531286544|FG001|Part 1 and Part 2 End of Study|Lost to Follow-up|1|||
147305742|NCT02508532|531286545|FG002|Part 1 and Part 2 End of Study|Lost to Follow-up|1|||
147305743|NCT02508532|531286546|FG003|Part 1 and Part 2 End of Study|Lost to Follow-up|0|||
147305744|NCT02508532|531286547|FG004|Part 1 and Part 2 End of Study|Lost to Follow-up|0|||
147305745|NCT02508532|531286548|FG005|Part 1 and Part 2 End of Study|Lost to Follow-up|0|||
147305746|NCT02508532|531286549|FG006|Part 1 and Part 2 End of Study|Lost to Follow-up|0|||
147305747|NCT02508532|531286550|FG007|Part 1 and Part 2 End of Study|Lost to Follow-up|0|||
147305748|NCT02508532|531286551|FG008|Part 1 and Part 2 End of Study|Lost to Follow-up|6|||
147305749|NCT02508532|531286543|FG000|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
147305750|NCT02508532|531286544|FG001|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
147305751|NCT02508532|531286545|FG002|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
147305752|NCT02508532|531286546|FG003|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
147305753|NCT02508532|531286547|FG004|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
147305754|NCT02508532|531286548|FG005|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
147305755|NCT02508532|531286549|FG006|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
147305756|NCT02508532|531286550|FG007|Part 1 and Part 2 End of Study|Withdrawal by Subject|0|||
147305757|NCT02508532|531286551|FG008|Part 1 and Part 2 End of Study|Withdrawal by Subject|15|||
147305758|NCT02508532|531286543|FG000|Part 1 and Part 2 End of Study|Physician Decision|0|||
147305759|NCT02508532|531286544|FG001|Part 1 and Part 2 End of Study|Physician Decision|0|||
147305760|NCT02508532|531286545|FG002|Part 1 and Part 2 End of Study|Physician Decision|1|||
147305761|NCT02508532|531286546|FG003|Part 1 and Part 2 End of Study|Physician Decision|0|||
147305762|NCT02508532|531286547|FG004|Part 1 and Part 2 End of Study|Physician Decision|1|||
147305763|NCT02508532|531286548|FG005|Part 1 and Part 2 End of Study|Physician Decision|0|||
147305764|NCT02508532|531286549|FG006|Part 1 and Part 2 End of Study|Physician Decision|0|||
147305765|NCT02508532|531286550|FG007|Part 1 and Part 2 End of Study|Physician Decision|0|||
147305766|NCT02508532|531286551|FG008|Part 1 and Part 2 End of Study|Physician Decision|8|||
147305767|NCT02508532|531286543|FG000|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
147305768|NCT02508532|531286544|FG001|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
147305769|NCT02508532|531286545|FG002|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
147305770|NCT02508532|531286546|FG003|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
147305771|NCT02508532|531286547|FG004|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
147305772|NCT02508532|531286548|FG005|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
147305773|NCT02508532|531286549|FG006|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
147305774|NCT02508532|531286550|FG007|Part 1 and Part 2 End of Study|Initiation of another therapy|0|||
147305775|NCT02508532|531286551|FG008|Part 1 and Part 2 End of Study|Initiation of another therapy|1|||
147305776|NCT02508532|531286543|FG000|Part 1 and Part 2 End of Study|Sponsor Decision|2|||
147305777|NCT02508532|531286544|FG001|Part 1 and Part 2 End of Study|Sponsor Decision|1|||
147305778|NCT02508532|531286545|FG002|Part 1 and Part 2 End of Study|Sponsor Decision|1|||
147305779|NCT02508532|531286546|FG003|Part 1 and Part 2 End of Study|Sponsor Decision|2|||
147305780|NCT02508532|531286547|FG004|Part 1 and Part 2 End of Study|Sponsor Decision|2|||
147305781|NCT02508532|531286548|FG005|Part 1 and Part 2 End of Study|Sponsor Decision|0|||
147305782|NCT02508532|531286549|FG006|Part 1 and Part 2 End of Study|Sponsor Decision|0|||
147305783|NCT02508532|531286550|FG007|Part 1 and Part 2 End of Study|Sponsor Decision|1|||
147305784|NCT02508532|531286551|FG008|Part 1 and Part 2 End of Study|Sponsor Decision|68|||
147305785|NCT00301080|531286554|FG000|Original Version (2 Arms & 4 Weeks)|Never received drug|1|||
147305786|NCT00301080|531286555|FG001|Original Version (2 Arms & 4 Weeks)|Never received drug|0|||
147305787|NCT00301080|531286556|FG002|Original Version (2 Arms & 4 Weeks)|Never received drug|0|||
147305788|NCT00301080|531286557|FG003|Original Version (2 Arms & 4 Weeks)|Never received drug|0|||
147305789|NCT00301080|531286558|FG004|Original Version (2 Arms & 4 Weeks)|Never received drug|0|||
147305790|NCT03502616|531286559|FG000|Up to Week 16|Withdrawal by Subject|1|||
147305791|NCT03502616|531286560|FG001|Up to Week 16|Withdrawal by Subject|2|||
147305792|NCT03502616|531286559|FG000|Up to Week 16|Lost to Follow-up|0|||
147305793|NCT03502616|531286560|FG001|Up to Week 16|Lost to Follow-up|1|||
147305794|NCT03502616|531286559|FG000|Up to Week 16|Randomized, but not treated|1|||
147305795|NCT03502616|531286560|FG001|Up to Week 16|Randomized, but not treated|0|||
147305796|NCT03502616|531286559|FG000|Week 16 to Week 48|Withdrawal by Subject|6|||
147305797|NCT03502616|531286560|FG001|Week 16 to Week 48|Withdrawal by Subject|6|||
147305798|NCT03502616|531286559|FG000|Week 16 to Week 48|Lost to Follow-up|1|||
147305799|NCT03502616|531286560|FG001|Week 16 to Week 48|Lost to Follow-up|0|||
147305800|NCT04000594|531286562|FG000|Overall Study|Withdrawal by Subject|1|||
147305801|NCT04000594|531286563|FG001|Overall Study|Withdrawal by Subject|0|||
147305802|NCT04000594|531286564|FG002|Overall Study|Withdrawal by Subject|0|||
147305803|NCT02055157|531286567|FG000|Initial 6 Months|Subject discontinued due to NeedlePhobia|0|||
147305804|NCT02055157|531286568|FG001|Initial 6 Months|Subject discontinued due to NeedlePhobia|1|||
147305805|NCT02055157|531286569|FG002|Initial 6 Months|Subject discontinued due to NeedlePhobia|0|||
147305806|NCT02055157|531286570|FG003|Initial 6 Months|Subject discontinued due to NeedlePhobia|0|||
147305807|NCT02055157|531286567|FG000|Initial 6 Months|Adverse Event|0|||
147305808|NCT02055157|531286568|FG001|Initial 6 Months|Adverse Event|0|||
147305809|NCT02055157|531286569|FG002|Initial 6 Months|Adverse Event|0|||
147305810|NCT02055157|531286570|FG003|Initial 6 Months|Adverse Event|1|||
147305811|NCT02055157|531286567|FG000|Initial 6 Months|Consent withdrawn by subject|1|||
147305812|NCT02055157|531286568|FG001|Initial 6 Months|Consent withdrawn by subject|0|||
147305813|NCT02055157|531286569|FG002|Initial 6 Months|Consent withdrawn by subject|0|||
147305814|NCT02055157|531286570|FG003|Initial 6 Months|Consent withdrawn by subject|0|||
147305815|NCT02055157|531286567|FG000|18-month Extension|Investigator decision|0|||
147305816|NCT02055157|531286568|FG001|18-month Extension|Investigator decision|1|||
147305817|NCT02055157|531286569|FG002|18-month Extension|Investigator decision|0|||
147305818|NCT02055157|531286570|FG003|18-month Extension|Investigator decision|0|||
147305819|NCT02055157|531286567|FG000|18-month Extension|Subject discontinued due to NeedlePhobia|1|||
147305820|NCT02055157|531286568|FG001|18-month Extension|Subject discontinued due to NeedlePhobia|0|||
147305821|NCT02055157|531286569|FG002|18-month Extension|Subject discontinued due to NeedlePhobia|0|||
147305822|NCT02055157|531286570|FG003|18-month Extension|Subject discontinued due to NeedlePhobia|0|||
147305823|NCT03976466|531286571|FG000|Overall Study|Lost to Follow-up|1|||
147305824|NCT03976466|531286572|FG001|Overall Study|Lost to Follow-up|3|||
147305825|NCT00943306|531286577|FG000|Overall Study|Physician Decision|1|||
147305826|NCT00943306|531286577|FG000|Overall Study|Death|1|||
147305827|NCT00943306|531286577|FG000|Overall Study|Sponsor decision due to non-compliance|1|||
147305828|NCT00733499|531286578|FG000|Pre-operative|Protocol Violation|0|||
147305829|NCT00733499|531286579|FG001|Pre-operative|Protocol Violation|1|||
147305830|NCT00733499|531286578|FG000|3 Months Follow-up|Death|1|||
147305831|NCT00733499|531286579|FG001|3 Months Follow-up|Death|2|||
147305832|NCT00733499|531286578|FG000|6 Months Follow-up|Death|0|||
147305833|NCT00733499|531286579|FG001|6 Months Follow-up|Death|2|||
147305834|NCT00733499|531286578|FG000|6 Months Follow-up|Adverse Event|0|||
147305835|NCT00733499|531286579|FG001|6 Months Follow-up|Adverse Event|1|||
147305836|NCT00733499|531286578|FG000|12 Months Follow-up|Death|2|||
147305837|NCT00733499|531286579|FG001|12 Months Follow-up|Death|1|||
147305838|NCT00733499|531286578|FG000|24 Months Follow-up|Death|0|||
147305839|NCT00733499|531286579|FG001|24 Months Follow-up|Death|1|||
147305840|NCT00733499|531286578|FG000|5 Year Followup|Adverse Event|2|||
147305841|NCT00733499|531286579|FG001|5 Year Followup|Adverse Event|2|||
147305842|NCT00733499|531286578|FG000|5 Year Followup|Non device related AE|0|||
147305843|NCT00733499|531286579|FG001|5 Year Followup|Non device related AE|1|||
147305844|NCT00733499|531286578|FG000|5 Year Followup|Revision of Study Implant|0|||
147305845|NCT00733499|531286579|FG001|5 Year Followup|Revision of Study Implant|1|||
147305846|NCT00733499|531286578|FG000|5 Year Followup|Lost to Follow-up|2|||
147305847|NCT00733499|531286579|FG001|5 Year Followup|Lost to Follow-up|0|||
147305848|NCT00733499|531286578|FG000|5 Year Followup|Death|13|||
147305849|NCT00733499|531286579|FG001|5 Year Followup|Death|19|||
147305850|NCT00733499|531286578|FG000|5 Year Followup|missing, unable to locate|0|||
147305851|NCT00733499|531286579|FG001|5 Year Followup|missing, unable to locate|1|||
147305852|NCT00733499|531286578|FG000|5 Year Followup|Withdrawal by Subject|4|||
147305853|NCT00733499|531286579|FG001|5 Year Followup|Withdrawal by Subject|1|||
147305854|NCT00733499|531286578|FG000|10 Year Followup|Death|9|||
147305855|NCT00733499|531286579|FG001|10 Year Followup|Death|7|||
147305856|NCT00733499|531286578|FG000|10 Year Followup|Adverse Event|3|||
147305857|NCT00733499|531286579|FG001|10 Year Followup|Adverse Event|3|||
147305858|NCT00733499|531286578|FG000|10 Year Followup|Lost to Follow-up|3|||
147305859|NCT00733499|531286579|FG001|10 Year Followup|Lost to Follow-up|2|||
147305860|NCT00733499|531286578|FG000|10 Year Followup|Withdrawal by Subject|5|||
147305861|NCT00733499|531286579|FG001|10 Year Followup|Withdrawal by Subject|5|||
147305862|NCT00733499|531286578|FG000|10 Year Followup|missing, unable to locate|0|||
147305863|NCT00733499|531286579|FG001|10 Year Followup|missing, unable to locate|2|||
147305864|NCT00733980|531286580|FG000|Overall Study|Adverse Event|5|||
147305865|NCT00733980|531286581|FG001|Overall Study|Adverse Event|2|||
147305866|NCT00733980|531286580|FG000|Overall Study|Lack of Efficacy|0|||
147305867|NCT00733980|531286581|FG001|Overall Study|Lack of Efficacy|1|||
147305868|NCT00733980|531286580|FG000|Overall Study|Protocol Violation|2|||
147305869|NCT00733980|531286581|FG001|Overall Study|Protocol Violation|1|||
147305870|NCT00733980|531286580|FG000|Overall Study|Protocol defined stopping criteria reach|1|||
147305871|NCT00733980|531286581|FG001|Overall Study|Protocol defined stopping criteria reach|1|||
147305872|NCT00733980|531286580|FG000|Overall Study|Lost to Follow-up|6|||
147305873|NCT00733980|531286581|FG001|Overall Study|Lost to Follow-up|11|||
147305874|NCT00733980|531286580|FG000|Overall Study|Physician Decision|2|||
147305875|NCT00733980|531286581|FG001|Overall Study|Physician Decision|3|||
147305876|NCT00733980|531286580|FG000|Overall Study|Withdrawal by Subject|6|||
147305877|NCT00733980|531286581|FG001|Overall Study|Withdrawal by Subject|2|||
147305878|NCT02739347|531286582|FG000|Overall Study|Adverse Event|3|||
147305879|NCT02739347|531286583|FG001|Overall Study|Adverse Event|0|||
147305880|NCT02739347|531286582|FG000|Overall Study|Protocol Violation|0|||
147305881|NCT02739347|531286583|FG001|Overall Study|Protocol Violation|1|||
147305882|NCT02739347|531286582|FG000|Overall Study|Lost to Follow-up|0|||
147305883|NCT02739347|531286583|FG001|Overall Study|Lost to Follow-up|2|||
147305884|NCT01552954|531286584|FG000|Overall Study|Adverse Event|1|||
147305885|NCT01552954|531286585|FG001|Overall Study|Adverse Event|2|||
147305886|NCT01552954|531286584|FG000|Overall Study|Lost to Follow-up|1|||
147305887|NCT01552954|531286585|FG001|Overall Study|Lost to Follow-up|1|||
147305888|NCT01552954|531286584|FG000|Overall Study|Withdrawal by Subject|1|||
147305889|NCT01552954|531286585|FG001|Overall Study|Withdrawal by Subject|1|||
147305890|NCT01552954|531286584|FG000|Overall Study|Protocol Violation|1|||
147305891|NCT01552954|531286585|FG001|Overall Study|Protocol Violation|2|||
147305892|NCT01552954|531286584|FG000|Overall Study|diagnosed DM|1|||
147305893|NCT01552954|531286585|FG001|Overall Study|diagnosed DM|0|||
147305894|NCT00779779|531286586|FG000|Overall Study|Adverse Event|1|||
147305895|NCT00779779|531286586|FG000|Overall Study|Protocol Violation|14|||
147305896|NCT00779779|531286586|FG000|Overall Study|Withdrawal by Subject|4|||
147305897|NCT00779779|531286586|FG000|Overall Study|Lost to Follow-up|5|||
147305898|NCT01395823|531286587|FG000|Overall Study|Death|4|||
147305899|NCT01395823|531286588|FG001|Overall Study|Death|4|||
147305900|NCT01395823|531286587|FG000|Overall Study|Physician Decision|3|||
147305901|NCT01395823|531286588|FG001|Overall Study|Physician Decision|1|||
147305902|NCT01395823|531286587|FG000|Overall Study|Lost to Follow-up|1|||
147305903|NCT01395823|531286588|FG001|Overall Study|Lost to Follow-up|0|||
147305904|NCT01395823|531286587|FG000|Overall Study|Transplant|1|||
147305905|NCT01395823|531286588|FG001|Overall Study|Transplant|0|||
147305906|NCT01395823|531286587|FG000|Overall Study|GI symptoms|1|||
147305907|NCT01395823|531286588|FG001|Overall Study|GI symptoms|0|||
147305908|NCT01395823|531286587|FG000|Overall Study|Withdrawal by Subject|5|||
147305909|NCT01395823|531286588|FG001|Overall Study|Withdrawal by Subject|4|||
147305910|NCT03300570|531286590|FG000|Overall Study|Adverse Event|0|||
147305911|NCT03300570|531286591|FG001|Overall Study|Adverse Event|1|||
147305912|NCT03300570|531286590|FG000|Overall Study|Withdrawal by Subject|1|||
147305913|NCT03300570|531286591|FG001|Overall Study|Withdrawal by Subject|0|||
147305914|NCT03300570|531286590|FG000|Overall Study|Inadequate bowel prep|1|||
147305915|NCT03300570|531286591|FG001|Overall Study|Inadequate bowel prep|0|||
147305916|NCT03188120|531286592|FG000|Overall Study|Adverse Event|4|||
147305917|NCT03188120|531286592|FG000|Overall Study|Insufficient Effectiveness|8|||
147305918|NCT03188120|531286592|FG000|Overall Study|Improved|12|||
147305919|NCT03188120|531286592|FG000|Overall Study|Lost to Follow-up|7|||
147305920|NCT03188120|531286592|FG000|Overall Study|Other than specified|3|||
147305921|NCT03188120|531286592|FG000|Overall Study|No visit after the first visit|13|||
147305922|NCT01126060|531286596|FG000|Overall Study|Protocol Violation|0|||
147305923|NCT01126060|531286597|FG001|Overall Study|Protocol Violation|2|||
147305924|NCT02070484|531286598|FG000|Overall Study|Withdrawal by Subject|1|||
147305925|NCT02070484|531286599|FG001|Overall Study|Withdrawal by Subject|0|||
147305926|NCT02658630|531286600|FG000|Overall Study|Withdrawal by Subject|4|||
147305927|NCT01521884|531286601|FG000|Overall Study|Non Responders|10|||
147305928|NCT01521884|531286601|FG000|Overall Study|Adverse Event|5|||
147305929|NCT01521884|531286601|FG000|Overall Study|Pregnancy|1|||
147305930|NCT01521884|531286601|FG000|Overall Study|Withdrawal by Subject|1|||
147305931|NCT01521884|531286601|FG000|Overall Study|Physician Decision|2|||
147305932|NCT01521884|531286601|FG000|Overall Study|Protocol Violation|3|||
147305933|NCT01521884|531286601|FG000|Overall Study|Participant non-eligible|1|||
147305934|NCT01521884|531286601|FG000|Overall Study|Lost to Follow-up|4|||
147305935|NCT02821819|531286602|FG000|Overall Study|Protocol Violation|1|||
147305936|NCT04182880|531286604|FG000|Overall Study|Pregnancy|1|||
147305937|NCT04182880|531286605|FG001|Overall Study|Pregnancy|0|||
147305938|NCT03389477|531286606|FG000|Step 1|Withdrawal by Subject|1|||
147305939|NCT03389477|531286607|FG001|Step 1|Withdrawal by Subject|0|||
147305940|NCT03389477|531286606|FG000|Step 2|Withdrawal by Subject|1|||
147305941|NCT03389477|531286607|FG001|Step 2|Withdrawal by Subject|2|||
147305942|NCT03389477|531286606|FG000|Step 2|Disease progression|1|||
147305943|NCT03389477|531286607|FG001|Step 2|Disease progression|0|||
147305944|NCT03389477|531286606|FG000|Step 2|Death|0|||
147305945|NCT03389477|531286607|FG001|Step 2|Death|1|||
147305946|NCT03389477|531286606|FG000|Step 2|Poor performance status and nutrition|0|||
147305947|NCT03389477|531286607|FG001|Step 2|Poor performance status and nutrition|1|||
147305948|NCT03389477|531286606|FG000|Step 3|Withdrawal after 3 cycles|0|||
147305949|NCT03389477|531286607|FG001|Step 3|Withdrawal after 3 cycles|1|||
147305950|NCT03389477|531286606|FG000|Step 3|Still receiving active treatment|4|||
147305951|NCT03389477|531286607|FG001|Step 3|Still receiving active treatment|0|||
147305952|NCT03389477|531286606|FG000|Step 3|Progressive disease after 2 cycles|1|||
147305953|NCT03389477|531286607|FG001|Step 3|Progressive disease after 2 cycles|0|||
147532274|NCT00634933|532103951|FG004|Part A: Baseline to Week 24|Lost to Follow-up|0|||
147305954|NCT01353222|531286614|FG000|Overall Study|Death|30|||
147305955|NCT01353222|531286615|FG001|Overall Study|Death|30|||
147305956|NCT01353222|531286614|FG000|Overall Study|Withdrawal by Subject|8|||
147305957|NCT01353222|531286615|FG001|Overall Study|Withdrawal by Subject|5|||
147659388|NCT01719380|532576176|FG007|Overall Study|Physician Decision|0|||
147305958|NCT01353222|531286614|FG000|Overall Study|Study Terminated|31|||
147305959|NCT01353222|531286615|FG001|Overall Study|Study Terminated|37|||
147305960|NCT01353222|531286614|FG000|Overall Study|Site closed research department|1|||
147305961|NCT01353222|531286615|FG001|Overall Study|Site closed research department|0|||
147305962|NCT01654601|531286618|FG000|1st Administration|Withdrawal by Subject|2|||
147305963|NCT01654601|531286619|FG001|1st Administration|Withdrawal by Subject|0|||
147305964|NCT01654601|531286618|FG000|1st Administration|Protocol Violation|0|||
147305965|NCT01654601|531286619|FG001|1st Administration|Protocol Violation|2|||
147305966|NCT01654601|531286618|FG000|2nd Administration|Adverse Event|1|||
147305967|NCT01654601|531286619|FG001|2nd Administration|Adverse Event|0|||
147305968|NCT01654601|531286618|FG000|2nd Administration|Protocol Violation|0|||
147305969|NCT01654601|531286619|FG001|2nd Administration|Protocol Violation|1|||
147305970|NCT02636270|531286620|FG000|Overall Study|Adverse Event|1|||
147305971|NCT02636270|531286621|FG001|Overall Study|Adverse Event|0|||
147305972|NCT02636270|531286622|FG002|Overall Study|Adverse Event|0|||
147305973|NCT02636270|531286620|FG000|Overall Study|subject had completed growth prior to enrollment, so never started on recombinant IGF-1|1|||
147305974|NCT02636270|531286621|FG001|Overall Study|subject had completed growth prior to enrollment, so never started on recombinant IGF-1|0|||
147305975|NCT02636270|531286622|FG002|Overall Study|subject had completed growth prior to enrollment, so never started on recombinant IGF-1|0|||
147305976|NCT01119898|531286623|FG000|Overall Study|Adverse Event|4|||
147305977|NCT01119898|531286624|FG001|Overall Study|Adverse Event|5|||
147305978|NCT01119898|531286623|FG000|Overall Study|Withdrawal by Subject|1|||
147305979|NCT01119898|531286624|FG001|Overall Study|Withdrawal by Subject|4|||
147305980|NCT01119898|531286623|FG000|Overall Study|Lack of Efficacy|0|||
147305981|NCT01119898|531286624|FG001|Overall Study|Lack of Efficacy|2|||
147305982|NCT01119898|531286623|FG000|Overall Study|Protocol Violation|1|||
147305983|NCT01119898|531286624|FG001|Overall Study|Protocol Violation|1|||
147305984|NCT01119898|531286623|FG000|Overall Study|Medical procedure|1|||
147305985|NCT01119898|531286624|FG001|Overall Study|Medical procedure|0|||
147305986|NCT01119898|531286623|FG000|Overall Study|Randomized in error did not participate|1|||
147305987|NCT01119898|531286624|FG001|Overall Study|Randomized in error did not participate|0|||
147305988|NCT01806584|531286625|FG000|Overall Study|Adverse Event|2|||
147305989|NCT01806584|531286626|FG001|Overall Study|Adverse Event|1|||
147305990|NCT01806584|531286625|FG000|Overall Study|Death|1|||
147305991|NCT01806584|531286626|FG001|Overall Study|Death|0|||
147305992|NCT01806584|531286625|FG000|Overall Study|Lost to Follow-up|0|||
147305993|NCT01806584|531286626|FG001|Overall Study|Lost to Follow-up|2|||
147305994|NCT01806584|531286625|FG000|Overall Study|Study terminated by sponsor|9|||
147305995|NCT01806584|531286626|FG001|Overall Study|Study terminated by sponsor|14|||
147305996|NCT01806584|531286625|FG000|Overall Study|Withdrawal by Subject|1|||
147305997|NCT01806584|531286626|FG001|Overall Study|Withdrawal by Subject|1|||
147305998|NCT01806584|531286625|FG000|Overall Study|Other unspecified|1|||
147305999|NCT01806584|531286626|FG001|Overall Study|Other unspecified|0|||
147306000|NCT01833143|531286627|FG000|Overall Study|Not Treated|1|||
147306001|NCT03021668|531286628|FG000|Overall Study|Physician Decision|0|||
147306002|NCT03021668|531286629|FG001|Overall Study|Physician Decision|1|||
147306003|NCT00909428|531286630|FG000|Overall Study|Lost to Follow-up|13|||
147306004|NCT00909428|531286631|FG001|Overall Study|Lost to Follow-up|10|||
147306005|NCT00909428|531286632|FG002|Overall Study|Lost to Follow-up|9|||
147306006|NCT02217280|531286633|FG000|Overall Study|Withdrawal by Subject|2|||
147306007|NCT02217280|531286633|FG000|Overall Study|Post-consent sceen fail|2|||
147306008|NCT00116844|531286636|FG000|Period 1: Treatment Period 1 (60 Days)|Lost to Follow-up|1|||
147306009|NCT00116844|531286637|FG001|Period 1: Treatment Period 1 (60 Days)|Lost to Follow-up|1|||
147306010|NCT00116844|531286636|FG000|Period 1: Treatment Period 1 (60 Days)|Protocol Violation|0|||
147306011|NCT00116844|531286637|FG001|Period 1: Treatment Period 1 (60 Days)|Protocol Violation|1|||
147306012|NCT00116844|531286636|FG000|Period 1: Treatment Period 1 (60 Days)|Withdrawal by Subject|5|||
147306013|NCT00116844|531286637|FG001|Period 1: Treatment Period 1 (60 Days)|Withdrawal by Subject|0|||
147306014|NCT00116844|531286636|FG000|Period 1: Treatment Period 1 (60 Days)|Other|1|||
147306015|NCT00116844|531286637|FG001|Period 1: Treatment Period 1 (60 Days)|Other|1|||
147306016|NCT00116844|531286636|FG000|Period 1: Treatment Period 2 (60 Days)|Adverse Event|1|||
147306017|NCT00116844|531286637|FG001|Period 1: Treatment Period 2 (60 Days)|Adverse Event|0|||
147306018|NCT00116844|531286636|FG000|Period 1: Treatment Period 2 (60 Days)|Lost to Follow-up|2|||
147306019|NCT00116844|531286637|FG001|Period 1: Treatment Period 2 (60 Days)|Lost to Follow-up|1|||
147306020|NCT00116844|531286636|FG000|Period 1: Treatment Period 2 (60 Days)|Other|0|||
147306021|NCT00116844|531286637|FG001|Period 1: Treatment Period 2 (60 Days)|Other|2|||
147306022|NCT00116844|531286636|FG000|Period 1: Treatment Period 2 (60 Days)|Protocol Violation|0|||
147306023|NCT00116844|531286637|FG001|Period 1: Treatment Period 2 (60 Days)|Protocol Violation|1|||
147306024|NCT00116844|531286636|FG000|Period 1: Treatment Period 2 (60 Days)|Withdrawal by Subject|1|||
147306025|NCT00116844|531286637|FG001|Period 1: Treatment Period 2 (60 Days)|Withdrawal by Subject|1|||
147306026|NCT03995784|531286638|FG000|Overall Study|One subject discontinued on Day 7 due to injection site reactions after Day 1, 2, and 3 doses|1|||
147306027|NCT01786330|531286642|FG000|Overall Study|Withdrawal by Subject|0|||
147306028|NCT01786330|531286643|FG001|Overall Study|Withdrawal by Subject|1|||
147306029|NCT01786330|531286642|FG000|Overall Study|Lost to Follow-up|0|||
147306030|NCT01786330|531286643|FG001|Overall Study|Lost to Follow-up|1|||
147306031|NCT01786330|531286642|FG000|Overall Study|Excluded intraoperatively|0|||
147306032|NCT01786330|531286643|FG001|Overall Study|Excluded intraoperatively|1|||
147306033|NCT01786330|531286642|FG000|Overall Study|Protocol Violation|1|||
147306034|NCT01786330|531286643|FG001|Overall Study|Protocol Violation|0|||
147306035|NCT02172625|531286644|FG000|Overall Study|Adverse Event|0|||
147532275|NCT00634933|532103947|FG000|Part A: Baseline to Week 24|Withdrawal by Subject|0|||
147306036|NCT02172625|531286645|FG001|Overall Study|Adverse Event|1|||
147306037|NCT02172625|531286644|FG000|Overall Study|Pregnancy|0|||
147306038|NCT02172625|531286645|FG001|Overall Study|Pregnancy|1|||
147659389|NCT01719380|532576177|FG008|Overall Study|Physician Decision|1|||
147306039|NCT02172625|531286644|FG000|Overall Study|car accident|0|||
147306040|NCT02172625|531286645|FG001|Overall Study|car accident|1|||
147306041|NCT02764775|531288678|FG000|Overall Study|Death|1|||
147306042|NCT02764775|531288678|FG000|Overall Study|Lost to Follow-up|2|||
147306043|NCT02764775|531288678|FG000|Overall Study|Withdrawal by Subject|3|||
147306044|NCT01992549|531288680|FG000|Overall Study|Lost to Follow-up|2|||
147306045|NCT01992549|531288680|FG000|Overall Study|Serious Adverse Event|1|||
147306046|NCT01992549|531288680|FG000|Overall Study|Product Switch to Extend Half Life|1|||
147306047|NCT00767104|531288682|FG000|Overall Study|Lost to Follow-up|1|||
147306048|NCT00767104|531288683|FG001|Overall Study|Lost to Follow-up|2|||
147306049|NCT00840996|531288684|FG000|Overall Study|Withdrawal by Subject|1|||
147306050|NCT00840996|531288685|FG001|Overall Study|Withdrawal by Subject|0|||
147306051|NCT04022889|531288686|FG000|Stage 1: Period 1|Adverse Event|1|||
147306052|NCT04022889|531288687|FG001|Stage 1: Period 1|Adverse Event|0|||
147306053|NCT04022889|531288688|FG002|Stage 1: Period 1|Adverse Event|0|||
147306054|NCT04022889|531288686|FG000|Stage 1: Period 1|Platelet component did not meet input specifications|1|||
147306055|NCT04022889|531288687|FG001|Stage 1: Period 1|Platelet component did not meet input specifications|0|||
147306056|NCT04022889|531288688|FG002|Stage 1: Period 1|Platelet component did not meet input specifications|0|||
147306057|NCT04022889|531288686|FG000|Stage 1: Period 2|Site closure due to COVID-19 pandemic|1|||
147306058|NCT04022889|531288687|FG001|Stage 1: Period 2|Site closure due to COVID-19 pandemic|1|||
147306059|NCT04022889|531288688|FG002|Stage 1: Period 2|Site closure due to COVID-19 pandemic|0|||
147306060|NCT04022889|531288686|FG000|Stage 2|Screen Failure|0|||
147306061|NCT04022889|531288687|FG001|Stage 2|Screen Failure|0|||
147306062|NCT04022889|531288688|FG002|Stage 2|Screen Failure|3|||
147306063|NCT04022889|531288686|FG000|Stage 2|Ineligible for apheresis donation|0|||
147306064|NCT04022889|531288687|FG001|Stage 2|Ineligible for apheresis donation|0|||
147306065|NCT04022889|531288688|FG002|Stage 2|Ineligible for apheresis donation|2|||
147306066|NCT04022889|531288686|FG000|Stage 2|Adverse Event|0|||
147306067|NCT04022889|531288687|FG001|Stage 2|Adverse Event|0|||
147306068|NCT04022889|531288688|FG002|Stage 2|Adverse Event|2|||
147306069|NCT04022889|531288686|FG000|Stage 2|Protocol Violation|0|||
147306070|NCT04022889|531288687|FG001|Stage 2|Protocol Violation|0|||
147306071|NCT04022889|531288688|FG002|Stage 2|Protocol Violation|1|||
147306072|NCT04022889|531288686|FG000|Stage 2|Site closure due to COVID-19 pandemic|1|||
147306073|NCT04022889|531288687|FG001|Stage 2|Site closure due to COVID-19 pandemic|0|||
147306074|NCT04022889|531288688|FG002|Stage 2|Site closure due to COVID-19 pandemic|0|||
147306075|NCT03015116|531288691|FG000|Overall Study|Lost to Follow-up|3|||
147306076|NCT03015116|531288692|FG001|Overall Study|Lost to Follow-up|0|||
147306077|NCT03015116|531288693|FG002|Overall Study|Lost to Follow-up|2|||
147306078|NCT03015116|531288691|FG000|Overall Study|Withdrawal by Subject|3|||
147306079|NCT03015116|531288692|FG001|Overall Study|Withdrawal by Subject|1|||
147306080|NCT03015116|531288693|FG002|Overall Study|Withdrawal by Subject|0|||
147306081|NCT03015116|531288691|FG000|Overall Study|Subject has New Medical Status|1|||
147306082|NCT03015116|531288692|FG001|Overall Study|Subject has New Medical Status|0|||
147306083|NCT03015116|531288693|FG002|Overall Study|Subject has New Medical Status|0|||
147306084|NCT03015116|531288691|FG000|Overall Study|Physician Decision|0|||
147306085|NCT03015116|531288692|FG001|Overall Study|Physician Decision|1|||
147306086|NCT03015116|531288693|FG002|Overall Study|Physician Decision|0|||
147306087|NCT00519896|531288705|FG000|Overall Study|Protocol Violation|1|||
147418350|NCT02516332|531696447|FG000|Overall Study|Withdrawal by Subject|2|||
147418351|NCT02516332|531696448|FG001|Overall Study|Withdrawal by Subject|1|||
147418352|NCT02516332|531696449|FG002|Overall Study|Withdrawal by Subject|2|||
147418353|NCT03695237|531696450|FG000|Overall Study|Withdrawal by Subject|1|||
147418354|NCT03695237|531696451|FG001|Overall Study|Withdrawal by Subject|3|||
147418355|NCT03695237|531696450|FG000|Overall Study|Lost to Follow-up|1|||
147418356|NCT03695237|531696451|FG001|Overall Study|Lost to Follow-up|2|||
147418357|NCT03695237|531696450|FG000|Overall Study|Other, Not Specified|8|||
147418358|NCT03695237|531696451|FG001|Overall Study|Other, Not Specified|2|||
147418359|NCT00055601|531696452|FG000|Overall Study|Protocol Violation|1|||
147418360|NCT00055601|531696453|FG001|Overall Study|Protocol Violation|1|||
147418361|NCT00055601|531696452|FG000|Overall Study|No protocol treatment received|1|||
147418362|NCT00055601|531696453|FG001|Overall Study|No protocol treatment received|1|||
147418363|NCT03541174|531696456|FG000|Part 1 Double-Blind|Adverse Event|6|||
147418364|NCT03541174|531696457|FG001|Part 1 Double-Blind|Adverse Event|5|||
147532276|NCT00634933|532103948|FG001|Part A: Baseline to Week 24|Withdrawal by Subject|3|||
147418365|NCT03541174|531696458|FG002|Part 1 Double-Blind|Adverse Event|2|||
147418366|NCT03541174|531696459|FG003|Part 1 Double-Blind|Adverse Event|0|||
147418367|NCT03541174|531696460|FG004|Part 1 Double-Blind|Adverse Event|0|||
147418368|NCT03541174|531696461|FG005|Part 1 Double-Blind|Adverse Event|0|||
147418369|NCT03541174|531696456|FG000|Part 1 Double-Blind|Withdrawal by Subject|2|||
147659390|NCT01719380|532576178|FG009|Overall Study|Physician Decision|1|||
147306088|NCT00519896|531288705|FG000|Overall Study|Adverse Event|1|||
147306089|NCT01077362|531288710|FG000|Overall Study|Lack of Efficacy|13|||
147306090|NCT01077362|531288711|FG001|Overall Study|Lack of Efficacy|8|||
147306091|NCT01077362|531288712|FG002|Overall Study|Lack of Efficacy|10|||
147418370|NCT03541174|531696457|FG001|Part 1 Double-Blind|Withdrawal by Subject|2|||
147418371|NCT03541174|531696458|FG002|Part 1 Double-Blind|Withdrawal by Subject|1|||
147418372|NCT03541174|531696459|FG003|Part 1 Double-Blind|Withdrawal by Subject|0|||
147418373|NCT03541174|531696460|FG004|Part 1 Double-Blind|Withdrawal by Subject|0|||
147418374|NCT03541174|531696461|FG005|Part 1 Double-Blind|Withdrawal by Subject|0|||
147418375|NCT03541174|531696456|FG000|Part 1 Double-Blind|Other reasons|3|||
147418376|NCT03541174|531696457|FG001|Part 1 Double-Blind|Other reasons|2|||
147418377|NCT03541174|531696458|FG002|Part 1 Double-Blind|Other reasons|3|||
147418378|NCT03541174|531696459|FG003|Part 1 Double-Blind|Other reasons|0|||
147418379|NCT03541174|531696460|FG004|Part 1 Double-Blind|Other reasons|0|||
147418380|NCT03541174|531696461|FG005|Part 1 Double-Blind|Other reasons|0|||
147418381|NCT03541174|531696456|FG000|Part 2 Single-Blind|Adverse Event|0|||
147418382|NCT03541174|531696457|FG001|Part 2 Single-Blind|Adverse Event|0|||
147418383|NCT03541174|531696458|FG002|Part 2 Single-Blind|Adverse Event|0|||
147418384|NCT03541174|531696459|FG003|Part 2 Single-Blind|Adverse Event|25|||
147418385|NCT03541174|531696460|FG004|Part 2 Single-Blind|Adverse Event|0|||
147418386|NCT03541174|531696461|FG005|Part 2 Single-Blind|Adverse Event|0|||
147418387|NCT03541174|531696456|FG000|Part 2 Single-Blind|Lack of Efficacy|0|||
147418388|NCT03541174|531696457|FG001|Part 2 Single-Blind|Lack of Efficacy|0|||
147418389|NCT03541174|531696458|FG002|Part 2 Single-Blind|Lack of Efficacy|0|||
147418390|NCT03541174|531696459|FG003|Part 2 Single-Blind|Lack of Efficacy|1|||
147418391|NCT03541174|531696460|FG004|Part 2 Single-Blind|Lack of Efficacy|0|||
147418392|NCT03541174|531696461|FG005|Part 2 Single-Blind|Lack of Efficacy|0|||
147418393|NCT03541174|531696456|FG000|Part 2 Single-Blind|Withdrawal by Subject|0|||
147418394|NCT03541174|531696457|FG001|Part 2 Single-Blind|Withdrawal by Subject|0|||
147418395|NCT03541174|531696458|FG002|Part 2 Single-Blind|Withdrawal by Subject|0|||
147418396|NCT03541174|531696459|FG003|Part 2 Single-Blind|Withdrawal by Subject|19|||
147418397|NCT03541174|531696460|FG004|Part 2 Single-Blind|Withdrawal by Subject|0|||
147418398|NCT03541174|531696461|FG005|Part 2 Single-Blind|Withdrawal by Subject|0|||
147418399|NCT03541174|531696456|FG000|Part 2 Single-Blind|Lost to Follow-up|0|||
147418400|NCT03541174|531696457|FG001|Part 2 Single-Blind|Lost to Follow-up|0|||
147418401|NCT03541174|531696458|FG002|Part 2 Single-Blind|Lost to Follow-up|0|||
147418402|NCT03541174|531696459|FG003|Part 2 Single-Blind|Lost to Follow-up|8|||
147418403|NCT03541174|531696460|FG004|Part 2 Single-Blind|Lost to Follow-up|0|||
147418404|NCT03541174|531696461|FG005|Part 2 Single-Blind|Lost to Follow-up|0|||
147418405|NCT03541174|531696456|FG000|Part 2 Single-Blind|Death|0|||
147418406|NCT03541174|531696457|FG001|Part 2 Single-Blind|Death|0|||
147418407|NCT03541174|531696458|FG002|Part 2 Single-Blind|Death|0|||
147418408|NCT03541174|531696459|FG003|Part 2 Single-Blind|Death|5|||
147418409|NCT03541174|531696460|FG004|Part 2 Single-Blind|Death|0|||
147418410|NCT03541174|531696461|FG005|Part 2 Single-Blind|Death|0|||
147418411|NCT03541174|531696456|FG000|Part 2 Single-Blind|Pregnancy|0|||
147418412|NCT03541174|531696457|FG001|Part 2 Single-Blind|Pregnancy|0|||
147659391|NCT01719380|532576169|FG000|Overall Study|Lack of Efficacy|2|||
147418413|NCT03541174|531696458|FG002|Part 2 Single-Blind|Pregnancy|0|||
147418414|NCT03541174|531696459|FG003|Part 2 Single-Blind|Pregnancy|1|||
147418415|NCT03541174|531696460|FG004|Part 2 Single-Blind|Pregnancy|0|||
147418416|NCT03541174|531696461|FG005|Part 2 Single-Blind|Pregnancy|0|||
147418417|NCT03541174|531696456|FG000|Part 2 Single-Blind|Other reasons|0|||
147418418|NCT03541174|531696457|FG001|Part 2 Single-Blind|Other reasons|0|||
147418419|NCT03541174|531696458|FG002|Part 2 Single-Blind|Other reasons|0|||
147418420|NCT03541174|531696459|FG003|Part 2 Single-Blind|Other reasons|32|||
147418421|NCT03541174|531696460|FG004|Part 2 Single-Blind|Other reasons|0|||
147418422|NCT03541174|531696461|FG005|Part 2 Single-Blind|Other reasons|0|||
147418423|NCT03541174|531696456|FG000|Part 3 Double-Blind Withdrawal|Adverse Event|0|||
147418424|NCT03541174|531696457|FG001|Part 3 Double-Blind Withdrawal|Adverse Event|0|||
147418425|NCT03541174|531696458|FG002|Part 3 Double-Blind Withdrawal|Adverse Event|0|||
147418426|NCT03541174|531696459|FG003|Part 3 Double-Blind Withdrawal|Adverse Event|0|||
147418427|NCT03541174|531696460|FG004|Part 3 Double-Blind Withdrawal|Adverse Event|8|||
147418428|NCT03541174|531696461|FG005|Part 3 Double-Blind Withdrawal|Adverse Event|7|||
147418429|NCT03541174|531696456|FG000|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|0|||
147418430|NCT03541174|531696457|FG001|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|0|||
147418431|NCT03541174|531696458|FG002|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|0|||
147418432|NCT03541174|531696459|FG003|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|0|||
147418433|NCT03541174|531696460|FG004|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|1|||
147418434|NCT03541174|531696461|FG005|Part 3 Double-Blind Withdrawal|Withdrawal by Subject|4|||
147418435|NCT03541174|531696456|FG000|Part 3 Double-Blind Withdrawal|Lost to Follow-up|0|||
147418436|NCT03541174|531696457|FG001|Part 3 Double-Blind Withdrawal|Lost to Follow-up|0|||
147418437|NCT03541174|531696458|FG002|Part 3 Double-Blind Withdrawal|Lost to Follow-up|0|||
147418438|NCT03541174|531696459|FG003|Part 3 Double-Blind Withdrawal|Lost to Follow-up|0|||
147418439|NCT03541174|531696460|FG004|Part 3 Double-Blind Withdrawal|Lost to Follow-up|0|||
147418440|NCT03541174|531696461|FG005|Part 3 Double-Blind Withdrawal|Lost to Follow-up|1|||
147418441|NCT03541174|531696456|FG000|Part 3 Double-Blind Withdrawal|Other reasons|0|||
147418442|NCT03541174|531696457|FG001|Part 3 Double-Blind Withdrawal|Other reasons|0|||
147418443|NCT03541174|531696458|FG002|Part 3 Double-Blind Withdrawal|Other reasons|0|||
147418444|NCT03541174|531696459|FG003|Part 3 Double-Blind Withdrawal|Other reasons|0|||
147418445|NCT03541174|531696460|FG004|Part 3 Double-Blind Withdrawal|Other reasons|9|||
147418446|NCT03541174|531696461|FG005|Part 3 Double-Blind Withdrawal|Other reasons|6|||
147306092|NCT01077362|531288710|FG000|Overall Study|Lost to Follow-up|1|||
147306093|NCT01077362|531288711|FG001|Overall Study|Lost to Follow-up|0|||
147306094|NCT01077362|531288712|FG002|Overall Study|Lost to Follow-up|3|||
147306095|NCT01077362|531288710|FG000|Overall Study|Adverse Event|12|||
147306096|NCT01077362|531288711|FG001|Overall Study|Adverse Event|7|||
147306097|NCT01077362|531288712|FG002|Overall Study|Adverse Event|4|||
147306098|NCT01077362|531288710|FG000|Overall Study|Withdrawal by Subject|5|||
147306099|NCT01077362|531288711|FG001|Overall Study|Withdrawal by Subject|3|||
147306100|NCT01077362|531288712|FG002|Overall Study|Withdrawal by Subject|5|||
147306101|NCT01077362|531288710|FG000|Overall Study|Other|0|||
147306102|NCT01077362|531288711|FG001|Overall Study|Other|1|||
147306103|NCT01077362|531288712|FG002|Overall Study|Other|2|||
147306104|NCT02387216|531288713|FG000|Overall Study|Progressive disease|2|||
147306105|NCT02387216|531288714|FG001|Overall Study|Progressive disease|0|||
147306106|NCT02387216|531288713|FG000|Overall Study|Withdrawal by Subject|3|||
147306107|NCT02387216|531288714|FG001|Overall Study|Withdrawal by Subject|5|||
147306108|NCT02387216|531288713|FG000|Overall Study|Physician Decision|2|||
147306109|NCT02387216|531288714|FG001|Overall Study|Physician Decision|0|||
147306110|NCT02387216|531288713|FG000|Overall Study|Sponsor Decision|28|||
147306111|NCT02387216|531288714|FG001|Overall Study|Sponsor Decision|12|||
147306112|NCT02387216|531288713|FG000|Overall Study|Death|60|||
147306113|NCT02387216|531288714|FG001|Overall Study|Death|23|||
147306114|NCT02387216|531288713|FG000|Overall Study|Other|5|||
147306115|NCT02387216|531288714|FG001|Overall Study|Other|4|||
147306116|NCT02387216|531288713|FG000|Overall Study|Lost to Follow-up|0|||
147306117|NCT02387216|531288714|FG001|Overall Study|Lost to Follow-up|3|||
147306118|NCT04359771|531288715|FG000|Overall Study|Lack of Efficacy|2|||
147306119|NCT04359771|531288716|FG001|Overall Study|Lack of Efficacy|2|||
147306120|NCT02306265|531288717|FG000|Overall Study|Withdrawal by Subject|1|||
147306121|NCT02917265|531288718|FG000|Overall Study|Physician Decision|1|||
147306122|NCT02917265|531288719|FG001|Overall Study|Physician Decision|0|||
147306123|NCT02917265|531288718|FG000|Overall Study|Withdrawal by Subject|1|||
147306124|NCT02917265|531288719|FG001|Overall Study|Withdrawal by Subject|0|||
147306125|NCT01216163|531288722|FG000|Overall Study|Withdrawal by Subject|1|||
147306126|NCT01216163|531288723|FG001|Overall Study|Withdrawal by Subject|1|||
147306127|NCT01216163|531288724|FG002|Overall Study|Withdrawal by Subject|0|||
147418447|NCT03541174|531696456|FG000|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|0|||
147418448|NCT03541174|531696457|FG001|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|0|||
147418449|NCT03541174|531696458|FG002|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|0|||
147418450|NCT03541174|531696459|FG003|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|0|||
147418451|NCT03541174|531696460|FG004|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|1|||
147418452|NCT03541174|531696461|FG005|Part 3 Double-Blind Withdrawal|Re-randomized in part 3, however no drug dispensed|0|||
147418453|NCT00605215|531696462|FG000|Overall Study|Death|0|||
147418454|NCT00605215|531696463|FG001|Overall Study|Death|0|||
147418455|NCT00605215|531696464|FG002|Overall Study|Death|1|||
147418456|NCT00605215|531696462|FG000|Overall Study|Adverse Event|19|||
147418457|NCT00605215|531696463|FG001|Overall Study|Adverse Event|21|||
147418458|NCT00605215|531696464|FG002|Overall Study|Adverse Event|26|||
147418459|NCT00605215|531696462|FG000|Overall Study|Refusal to sign the re-consent form|8|||
147418460|NCT00605215|531696463|FG001|Overall Study|Refusal to sign the re-consent form|3|||
147659392|NCT01719380|532576170|FG001|Overall Study|Lack of Efficacy|6|||
147306128|NCT03107377|531288726|FG000|Overall Study|Adverse Event|3|||
147306129|NCT03107377|531288727|FG001|Overall Study|Adverse Event|3|||
147306130|NCT03107377|531288726|FG000|Overall Study|Protocol Violation|9|||
147306131|NCT03107377|531288727|FG001|Overall Study|Protocol Violation|12|||
147306132|NCT03107377|531288726|FG000|Overall Study|Physician Decision|3|||
147306133|NCT03107377|531288727|FG001|Overall Study|Physician Decision|6|||
147306134|NCT03107377|531288726|FG000|Overall Study|Pregnancy|7|||
147306135|NCT03107377|531288727|FG001|Overall Study|Pregnancy|7|||
147306136|NCT03107377|531288726|FG000|Overall Study|Withdrawal by Subject|16|||
147306137|NCT03107377|531288727|FG001|Overall Study|Withdrawal by Subject|22|||
147306138|NCT03107377|531288726|FG000|Overall Study|Lost to Follow-up|37|||
147306139|NCT03107377|531288727|FG001|Overall Study|Lost to Follow-up|34|||
147306140|NCT03107377|531288726|FG000|Overall Study|Other reason not specified|16|||
147306141|NCT03107377|531288727|FG001|Overall Study|Other reason not specified|15|||
147306142|NCT00453102|531288729|FG000|Overall Study|Withdrawal by Subject|2|||
147306143|NCT02237508|531288737|FG000|Overall Study|Withdrawal by Subject|0|||
147306144|NCT02237508|531288738|FG001|Overall Study|Withdrawal by Subject|2|||
147306145|NCT02237508|531288739|FG002|Overall Study|Withdrawal by Subject|0|||
147306146|NCT02237508|531288740|FG003|Overall Study|Withdrawal by Subject|1|||
147306147|NCT02237508|531288741|FG004|Overall Study|Withdrawal by Subject|0|||
147306148|NCT02237508|531288742|FG005|Overall Study|Withdrawal by Subject|1|||
147306149|NCT02237508|531288743|FG006|Overall Study|Withdrawal by Subject|1|||
147306150|NCT02237508|531288744|FG007|Overall Study|Withdrawal by Subject|0|||
147306151|NCT02237508|531288745|FG008|Overall Study|Withdrawal by Subject|1|||
147306152|NCT02237508|531288746|FG009|Overall Study|Withdrawal by Subject|0|||
147306153|NCT02237508|531288737|FG000|Overall Study|Physician Decision|0|||
147306154|NCT02237508|531288738|FG001|Overall Study|Physician Decision|1|||
147306155|NCT02237508|531288739|FG002|Overall Study|Physician Decision|0|||
147306156|NCT02237508|531288740|FG003|Overall Study|Physician Decision|0|||
147306157|NCT02237508|531288741|FG004|Overall Study|Physician Decision|0|||
147306158|NCT02237508|531288742|FG005|Overall Study|Physician Decision|0|||
147306159|NCT02237508|531288743|FG006|Overall Study|Physician Decision|0|||
147306160|NCT02237508|531288744|FG007|Overall Study|Physician Decision|0|||
147306161|NCT02237508|531288745|FG008|Overall Study|Physician Decision|0|||
147306162|NCT02237508|531288746|FG009|Overall Study|Physician Decision|0|||
147306163|NCT02237508|531288737|FG000|Overall Study|Protocol Violation|0|||
147306164|NCT02237508|531288738|FG001|Overall Study|Protocol Violation|0|||
147306165|NCT02237508|531288739|FG002|Overall Study|Protocol Violation|1|||
147306166|NCT02237508|531288740|FG003|Overall Study|Protocol Violation|0|||
147306167|NCT02237508|531288741|FG004|Overall Study|Protocol Violation|0|||
147306168|NCT02237508|531288742|FG005|Overall Study|Protocol Violation|0|||
147306169|NCT02237508|531288743|FG006|Overall Study|Protocol Violation|0|||
147306170|NCT02237508|531288744|FG007|Overall Study|Protocol Violation|0|||
147306171|NCT02237508|531288745|FG008|Overall Study|Protocol Violation|0|||
147306172|NCT02237508|531288746|FG009|Overall Study|Protocol Violation|0|||
147306173|NCT01650519|531288747|FG000|Overall Study|Withdrawal by Subject|1|||
147306174|NCT01650519|531288748|FG001|Overall Study|Withdrawal by Subject|0|||
147306175|NCT05458024|531288751|FG000|Overall Study|Withdrawal by Subject|1|||
147306176|NCT05458024|531288752|FG001|Overall Study|Withdrawal by Subject|1|||
147306177|NCT02954458|531288754|FG000|Overall Study|Adverse Event|0|||
147306178|NCT02954458|531288755|FG001|Overall Study|Adverse Event|0|||
147306179|NCT02954458|531288756|FG002|Overall Study|Adverse Event|0|||
147306180|NCT02954458|531288757|FG003|Overall Study|Adverse Event|1|||
147306181|NCT02954458|531288754|FG000|Overall Study|Withdrawal by Subject|0|||
147306182|NCT02954458|531288755|FG001|Overall Study|Withdrawal by Subject|0|||
147306183|NCT02954458|531288756|FG002|Overall Study|Withdrawal by Subject|0|||
147306184|NCT02954458|531288757|FG003|Overall Study|Withdrawal by Subject|1|||
147306185|NCT02954458|531288754|FG000|Overall Study|Physician Decision|0|||
147306186|NCT02954458|531288755|FG001|Overall Study|Physician Decision|0|||
147306187|NCT02954458|531288756|FG002|Overall Study|Physician Decision|1|||
147306188|NCT02954458|531288757|FG003|Overall Study|Physician Decision|1|||
147306189|NCT02954458|531288754|FG000|Overall Study|Lost to Follow-up|1|||
147306190|NCT02954458|531288755|FG001|Overall Study|Lost to Follow-up|0|||
147306191|NCT02954458|531288756|FG002|Overall Study|Lost to Follow-up|0|||
147306192|NCT02954458|531288757|FG003|Overall Study|Lost to Follow-up|1|||
147306193|NCT02954458|531288754|FG000|Overall Study|Death|0|||
147306194|NCT02954458|531288755|FG001|Overall Study|Death|0|||
147306195|NCT02954458|531288756|FG002|Overall Study|Death|0|||
147306196|NCT02954458|531288757|FG003|Overall Study|Death|1|||
147306197|NCT02954458|531288754|FG000|Overall Study|Other|0|||
147306198|NCT02954458|531288755|FG001|Overall Study|Other|0|||
147306199|NCT02954458|531288756|FG002|Overall Study|Other|0|||
147306200|NCT02954458|531288757|FG003|Overall Study|Other|7|||
147306201|NCT01905046|531288758|FG000|Months 13-24|Withdrawal by Subject|10|||
147306202|NCT01905046|531288759|FG001|Months 13-24|Withdrawal by Subject|10|||
147306203|NCT01905046|531288758|FG000|Months 13-24|Adverse Event|3|||
147306204|NCT01905046|531288759|FG001|Months 13-24|Adverse Event|2|||
147306205|NCT01905046|531288758|FG000|Months 13-24|Protocol Violation|3|||
147306206|NCT01905046|531288759|FG001|Months 13-24|Protocol Violation|3|||
147306207|NCT01905046|531288758|FG000|Months 13-24|Physician Decision|1|||
147306208|NCT01905046|531288759|FG001|Months 13-24|Physician Decision|0|||
147532277|NCT00634933|532103949|FG002|Part A: Baseline to Week 24|Withdrawal by Subject|3|||
147532278|NCT00634933|532103950|FG003|Part A: Baseline to Week 24|Withdrawal by Subject|0|||
147306209|NCT05672680|531288760|FG000|Overall Study|Patient Did Not Complete the Form|5|||
147306210|NCT05672680|531288761|FG001|Overall Study|Patient Did Not Complete the Form|4|||
147306211|NCT05672680|531288760|FG000|Overall Study|Procedure Aborted|1|||
147306212|NCT05672680|531288761|FG001|Overall Study|Procedure Aborted|0|||
147306213|NCT00747123|531288762|FG000|Overall Study|Investigator's request|0|||
147306214|NCT00747123|531288763|FG001|Overall Study|Investigator's request|0|||
147532279|NCT00634933|532103951|FG004|Part A: Baseline to Week 24|Withdrawal by Subject|0|||
147306215|NCT00747123|531288764|FG002|Overall Study|Investigator's request|1|||
147306216|NCT00747123|531288765|FG003|Overall Study|Investigator's request|0|||
147306217|NCT00747123|531288762|FG000|Overall Study|Withdrew consent|0|||
147306218|NCT00747123|531288763|FG001|Overall Study|Withdrew consent|1|||
147306219|NCT00747123|531288764|FG002|Overall Study|Withdrew consent|0|||
147306220|NCT00747123|531288765|FG003|Overall Study|Withdrew consent|0|||
147306221|NCT00747123|531288762|FG000|Overall Study|Adverse Event|0|||
147306222|NCT00747123|531288763|FG001|Overall Study|Adverse Event|1|||
147306223|NCT00747123|531288764|FG002|Overall Study|Adverse Event|0|||
147306224|NCT00747123|531288765|FG003|Overall Study|Adverse Event|1|||
147306225|NCT01778556|531288768|FG000|Intervention 1 (5 Days)|Protocol Violation|0|||
147306226|NCT01778556|531288769|FG001|Intervention 1 (5 Days)|Protocol Violation|1|||
147306227|NCT01778556|531288768|FG000|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
147306228|NCT01778556|531288769|FG001|Intervention 1 (5 Days)|Withdrawal by Subject|1|||
147306229|NCT01778556|531288768|FG000|Intervention 2 (14 Days)|Protocol Violation|1|||
147306230|NCT01778556|531288769|FG001|Intervention 2 (14 Days)|Protocol Violation|0|||
147306231|NCT01778556|531288768|FG000|Long-term Follow-up|noncompliance with metreleptin|1|||
147306232|NCT01778556|531288769|FG001|Long-term Follow-up|noncompliance with metreleptin|0|||
147306233|NCT00116272|531288770|FG000|Overall Study|Lost to Follow-up|11|||
147306234|NCT00116272|531288771|FG001|Overall Study|Lost to Follow-up|6|||
147306235|NCT00576732|531288772|FG000|DOUBLE BLIND|Adverse Event|0|||
147306236|NCT00576732|531288773|FG001|DOUBLE BLIND|Adverse Event|0|||
147306237|NCT00576732|531288774|FG002|DOUBLE BLIND|Adverse Event|1|||
147306238|NCT00576732|531288775|FG003|DOUBLE BLIND|Adverse Event|0|||
147306239|NCT00576732|531288776|FG004|DOUBLE BLIND|Adverse Event|0|||
147306240|NCT00576732|531288777|FG005|DOUBLE BLIND|Adverse Event|0|||
147306241|NCT00576732|531288772|FG000|DOUBLE BLIND|Lost to Follow-up|0|||
147306242|NCT00576732|531288773|FG001|DOUBLE BLIND|Lost to Follow-up|1|||
147306243|NCT00576732|531288774|FG002|DOUBLE BLIND|Lost to Follow-up|1|||
147306244|NCT00576732|531288775|FG003|DOUBLE BLIND|Lost to Follow-up|0|||
147306245|NCT00576732|531288776|FG004|DOUBLE BLIND|Lost to Follow-up|0|||
147306246|NCT00576732|531288777|FG005|DOUBLE BLIND|Lost to Follow-up|0|||
147306247|NCT00576732|531288772|FG000|DOUBLE BLIND|Withdrawal by Subject|1|||
147306248|NCT00576732|531288773|FG001|DOUBLE BLIND|Withdrawal by Subject|1|||
147306249|NCT00576732|531288774|FG002|DOUBLE BLIND|Withdrawal by Subject|3|||
147306250|NCT00576732|531288775|FG003|DOUBLE BLIND|Withdrawal by Subject|0|||
147306251|NCT00576732|531288776|FG004|DOUBLE BLIND|Withdrawal by Subject|0|||
147306252|NCT00576732|531288777|FG005|DOUBLE BLIND|Withdrawal by Subject|0|||
147306253|NCT00576732|531288772|FG000|DOUBLE BLIND|OTHER|0|||
147306254|NCT00576732|531288773|FG001|DOUBLE BLIND|OTHER|2|||
147306255|NCT00576732|531288774|FG002|DOUBLE BLIND|OTHER|1|||
147306256|NCT00576732|531288775|FG003|DOUBLE BLIND|OTHER|0|||
147306257|NCT00576732|531288776|FG004|DOUBLE BLIND|OTHER|0|||
147306258|NCT00576732|531288777|FG005|DOUBLE BLIND|OTHER|0|||
147306259|NCT00576732|531288772|FG000|DOUBLE BLIND|Lack of Efficacy|6|||
147306260|NCT00576732|531288773|FG001|DOUBLE BLIND|Lack of Efficacy|1|||
147306261|NCT00576732|531288774|FG002|DOUBLE BLIND|Lack of Efficacy|0|||
147306262|NCT00576732|531288775|FG003|DOUBLE BLIND|Lack of Efficacy|0|||
147306263|NCT00576732|531288776|FG004|DOUBLE BLIND|Lack of Efficacy|0|||
147306264|NCT00576732|531288777|FG005|DOUBLE BLIND|Lack of Efficacy|0|||
147306265|NCT00576732|531288772|FG000|DOUBLE BLIND|Protocol Violation|1|||
147306266|NCT00576732|531288773|FG001|DOUBLE BLIND|Protocol Violation|0|||
147306267|NCT00576732|531288774|FG002|DOUBLE BLIND|Protocol Violation|0|||
147306268|NCT00576732|531288775|FG003|DOUBLE BLIND|Protocol Violation|0|||
147306269|NCT00576732|531288776|FG004|DOUBLE BLIND|Protocol Violation|0|||
147306270|NCT00576732|531288777|FG005|DOUBLE BLIND|Protocol Violation|0|||
147306271|NCT00576732|531288772|FG000|OPEN LABEL|Adverse Event|0|||
147306272|NCT00576732|531288773|FG001|OPEN LABEL|Adverse Event|0|||
147306273|NCT00576732|531288774|FG002|OPEN LABEL|Adverse Event|0|||
147306274|NCT00576732|531288775|FG003|OPEN LABEL|Adverse Event|4|||
147306275|NCT00576732|531288776|FG004|OPEN LABEL|Adverse Event|0|||
147306276|NCT00576732|531288777|FG005|OPEN LABEL|Adverse Event|1|||
147306277|NCT00576732|531288772|FG000|OPEN LABEL|Lost to Follow-up|0|||
147306278|NCT00576732|531288773|FG001|OPEN LABEL|Lost to Follow-up|0|||
147306279|NCT00576732|531288774|FG002|OPEN LABEL|Lost to Follow-up|0|||
147306280|NCT00576732|531288775|FG003|OPEN LABEL|Lost to Follow-up|2|||
147306281|NCT00576732|531288776|FG004|OPEN LABEL|Lost to Follow-up|1|||
147306282|NCT00576732|531288777|FG005|OPEN LABEL|Lost to Follow-up|1|||
147306283|NCT00576732|531288772|FG000|OPEN LABEL|Withdrawal by Subject|0|||
147306284|NCT00576732|531288773|FG001|OPEN LABEL|Withdrawal by Subject|0|||
147306285|NCT00576732|531288774|FG002|OPEN LABEL|Withdrawal by Subject|0|||
147306286|NCT00576732|531288775|FG003|OPEN LABEL|Withdrawal by Subject|1|||
147306287|NCT00576732|531288776|FG004|OPEN LABEL|Withdrawal by Subject|0|||
147306288|NCT00576732|531288777|FG005|OPEN LABEL|Withdrawal by Subject|1|||
147306289|NCT00576732|531288772|FG000|OPEN LABEL|OTHER|0|||
147306290|NCT00576732|531288773|FG001|OPEN LABEL|OTHER|0|||
147306291|NCT00576732|531288774|FG002|OPEN LABEL|OTHER|0|||
147306292|NCT00576732|531288775|FG003|OPEN LABEL|OTHER|0|||
147306293|NCT00576732|531288776|FG004|OPEN LABEL|OTHER|0|||
147306294|NCT00576732|531288777|FG005|OPEN LABEL|OTHER|2|||
147306295|NCT00576732|531288772|FG000|OPEN LABEL|Lack of Efficacy|0|||
147306296|NCT00576732|531288773|FG001|OPEN LABEL|Lack of Efficacy|0|||
147306297|NCT00576732|531288774|FG002|OPEN LABEL|Lack of Efficacy|0|||
147306298|NCT00576732|531288775|FG003|OPEN LABEL|Lack of Efficacy|2|||
147306299|NCT00576732|531288776|FG004|OPEN LABEL|Lack of Efficacy|2|||
147306300|NCT00576732|531288777|FG005|OPEN LABEL|Lack of Efficacy|3|||
147306301|NCT00576732|531288772|FG000|OPEN LABEL|Protocol Violation|0|||
147306302|NCT00576732|531288773|FG001|OPEN LABEL|Protocol Violation|0|||
147306303|NCT00576732|531288774|FG002|OPEN LABEL|Protocol Violation|0|||
147306304|NCT00576732|531288775|FG003|OPEN LABEL|Protocol Violation|2|||
147306305|NCT00576732|531288776|FG004|OPEN LABEL|Protocol Violation|1|||
147306306|NCT00576732|531288777|FG005|OPEN LABEL|Protocol Violation|0|||
147306307|NCT01235403|531288779|FG000|Overall Study|Adverse Event|14|||
147306308|NCT01235403|531288779|FG000|Overall Study|Lost to Follow-up|2|||
147306309|NCT01235403|531288779|FG000|Overall Study|Withdrawal by Subject|4|||
147306310|NCT01235403|531288779|FG000|Overall Study|Lack of Efficacy|2|||
147306311|NCT01235403|531288779|FG000|Overall Study|Other reasons for premature termination|4|||
147306312|NCT02978443|531288780|FG000|Overall Study|Withdrawal by Subject|1|||
147306313|NCT02978443|531288780|FG000|Overall Study|Adverse Event|3|||
147306314|NCT02978443|531288780|FG000|Overall Study|Disease Progression on study|6|||
147306315|NCT02978443|531288780|FG000|Overall Study|Death|1|||
147306316|NCT02978443|531288780|FG000|Overall Study|Physician Decision|1|||
147306317|NCT02978443|531288780|FG000|Overall Study|Switch to alternative therapy|1|||
147306318|NCT02978443|531288780|FG000|Overall Study|Refused further treatment|1|||
147306319|NCT02296190|531288781|FG000|Overall Study|Lost to Follow-up|0|||
147306320|NCT02296190|531288782|FG001|Overall Study|Lost to Follow-up|0|||
147306321|NCT02296190|531288783|FG002|Overall Study|Lost to Follow-up|0|||
147306322|NCT02296190|531288784|FG003|Overall Study|Lost to Follow-up|0|||
147306323|NCT02296190|531288785|FG004|Overall Study|Lost to Follow-up|1|||
147306324|NCT02296190|531288786|FG005|Overall Study|Lost to Follow-up|0|||
147306325|NCT02296190|531288781|FG000|Overall Study|Failure to induce PSVT|6|||
147306326|NCT02296190|531288782|FG001|Overall Study|Failure to induce PSVT|10|||
147306327|NCT02296190|531288783|FG002|Overall Study|Failure to induce PSVT|5|||
147306328|NCT02296190|531288784|FG003|Overall Study|Failure to induce PSVT|13|||
147306329|NCT02296190|531288785|FG004|Overall Study|Failure to induce PSVT|8|||
147306330|NCT02296190|531288786|FG005|Overall Study|Failure to induce PSVT|0|||
147306331|NCT02296190|531288781|FG000|Overall Study|Physician Decision|1|||
147306332|NCT02296190|531288782|FG001|Overall Study|Physician Decision|1|||
147306333|NCT02296190|531288783|FG002|Overall Study|Physician Decision|0|||
147306334|NCT02296190|531288784|FG003|Overall Study|Physician Decision|1|||
147306335|NCT02296190|531288785|FG004|Overall Study|Physician Decision|2|||
147306336|NCT02296190|531288786|FG005|Overall Study|Physician Decision|0|||
147306337|NCT02296190|531288781|FG000|Overall Study|Withdrawal by Subject|0|||
147306338|NCT02296190|531288782|FG001|Overall Study|Withdrawal by Subject|1|||
147306339|NCT02296190|531288783|FG002|Overall Study|Withdrawal by Subject|0|||
147306340|NCT02296190|531288784|FG003|Overall Study|Withdrawal by Subject|0|||
147306341|NCT02296190|531288785|FG004|Overall Study|Withdrawal by Subject|0|||
147306342|NCT02296190|531288786|FG005|Overall Study|Withdrawal by Subject|0|||
147306343|NCT02296190|531288781|FG000|Overall Study|PSVT < 5 minutes|5|||
147306344|NCT02296190|531288782|FG001|Overall Study|PSVT < 5 minutes|6|||
147306345|NCT02296190|531288783|FG002|Overall Study|PSVT < 5 minutes|6|||
147306346|NCT02296190|531288784|FG003|Overall Study|PSVT < 5 minutes|6|||
147306347|NCT02296190|531288785|FG004|Overall Study|PSVT < 5 minutes|5|||
147306348|NCT02296190|531288786|FG005|Overall Study|PSVT < 5 minutes|0|||
147306349|NCT02296190|531288781|FG000|Overall Study|Patient was given Propofol|0|||
147306350|NCT02296190|531288782|FG001|Overall Study|Patient was given Propofol|1|||
147306351|NCT02296190|531288783|FG002|Overall Study|Patient was given Propofol|0|||
147306352|NCT02296190|531288784|FG003|Overall Study|Patient was given Propofol|1|||
147306353|NCT02296190|531288785|FG004|Overall Study|Patient was given Propofol|0|||
147306354|NCT02296190|531288786|FG005|Overall Study|Patient was given Propofol|0|||
147306355|NCT02296190|531288781|FG000|Overall Study|Patient with Atrial Tachycardia|0|||
147306356|NCT02296190|531288782|FG001|Overall Study|Patient with Atrial Tachycardia|0|||
147306357|NCT02296190|531288783|FG002|Overall Study|Patient with Atrial Tachycardia|0|||
147306358|NCT02296190|531288784|FG003|Overall Study|Patient with Atrial Tachycardia|1|||
147306359|NCT02296190|531288785|FG004|Overall Study|Patient with Atrial Tachycardia|0|||
147306360|NCT02296190|531288786|FG005|Overall Study|Patient with Atrial Tachycardia|0|||
147306361|NCT02296190|531288781|FG000|Overall Study|Blood pressure <100 after sedation|0|||
147306362|NCT02296190|531288782|FG001|Overall Study|Blood pressure <100 after sedation|0|||
147306363|NCT02296190|531288783|FG002|Overall Study|Blood pressure <100 after sedation|0|||
147306364|NCT02296190|531288784|FG003|Overall Study|Blood pressure <100 after sedation|1|||
147306365|NCT02296190|531288785|FG004|Overall Study|Blood pressure <100 after sedation|0|||
147532280|NCT00634933|532103947|FG000|Part A: Baseline to Week 24|Lack of Efficacy|3|||
147532281|NCT00634933|532103948|FG001|Part A: Baseline to Week 24|Lack of Efficacy|1|||
147532282|NCT00634933|532103949|FG002|Part A: Baseline to Week 24|Lack of Efficacy|0|||
147306366|NCT02296190|531288786|FG005|Overall Study|Blood pressure <100 after sedation|0|||
147306367|NCT02296190|531288781|FG000|Overall Study|Atrial Tachycardia induced not PSVT|0|||
147306368|NCT02296190|531288782|FG001|Overall Study|Atrial Tachycardia induced not PSVT|1|||
147306369|NCT02296190|531288783|FG002|Overall Study|Atrial Tachycardia induced not PSVT|1|||
147306370|NCT02296190|531288784|FG003|Overall Study|Atrial Tachycardia induced not PSVT|0|||
147306371|NCT02296190|531288785|FG004|Overall Study|Atrial Tachycardia induced not PSVT|0|||
147306372|NCT02296190|531288786|FG005|Overall Study|Atrial Tachycardia induced not PSVT|0|||
147306373|NCT02296190|531288781|FG000|Overall Study|Patient on antiarrhythmic medication|1|||
147306374|NCT02296190|531288782|FG001|Overall Study|Patient on antiarrhythmic medication|0|||
147306375|NCT02296190|531288783|FG002|Overall Study|Patient on antiarrhythmic medication|0|||
147306376|NCT02296190|531288784|FG003|Overall Study|Patient on antiarrhythmic medication|0|||
147306377|NCT02296190|531288785|FG004|Overall Study|Patient on antiarrhythmic medication|0|||
147306378|NCT02296190|531288786|FG005|Overall Study|Patient on antiarrhythmic medication|0|||
147306379|NCT02296190|531288781|FG000|Overall Study|Failed PSVT with mechanism of AVNRT|0|||
147306380|NCT02296190|531288782|FG001|Overall Study|Failed PSVT with mechanism of AVNRT|1|||
147306381|NCT02296190|531288783|FG002|Overall Study|Failed PSVT with mechanism of AVNRT|0|||
147532283|NCT00634933|532103950|FG003|Part A: Baseline to Week 24|Lack of Efficacy|0|||
147306382|NCT02296190|531288784|FG003|Overall Study|Failed PSVT with mechanism of AVNRT|0|||
147306383|NCT02296190|531288785|FG004|Overall Study|Failed PSVT with mechanism of AVNRT|0|||
147306384|NCT02296190|531288786|FG005|Overall Study|Failed PSVT with mechanism of AVNRT|0|||
147306385|NCT02296190|531288781|FG000|Overall Study|Lab result not available in time|1|||
147306386|NCT02296190|531288782|FG001|Overall Study|Lab result not available in time|0|||
147306387|NCT02296190|531288783|FG002|Overall Study|Lab result not available in time|0|||
147306388|NCT02296190|531288784|FG003|Overall Study|Lab result not available in time|0|||
147306389|NCT02296190|531288785|FG004|Overall Study|Lab result not available in time|0|||
147306390|NCT02296190|531288786|FG005|Overall Study|Lab result not available in time|0|||
147306391|NCT02087501|531288787|FG000|Overall Study|Death|7|||
147306392|NCT02087501|531288787|FG000|Overall Study|Open repair of aneurysm|1|||
147306393|NCT02087501|531288787|FG000|Overall Study|Lost to Follow-up|2|||
147306394|NCT00094328|531288788|FG000|Overall Study|Lost to Follow-up|1|||
147306395|NCT03682705|531288789|FG000|Overall Study|Adverse Event|1|||
147306396|NCT03682705|531288790|FG001|Overall Study|Adverse Event|1|||
147306397|NCT03682705|531288791|FG002|Overall Study|Adverse Event|1|||
147306398|NCT03682705|531288792|FG003|Overall Study|Adverse Event|0|||
147306399|NCT03682705|531288793|FG004|Overall Study|Adverse Event|1|||
147306400|NCT03682705|531288794|FG005|Overall Study|Adverse Event|1|||
147306401|NCT03682705|531288789|FG000|Overall Study|Withdrawal by Subject|1|||
147306402|NCT03682705|531288790|FG001|Overall Study|Withdrawal by Subject|3|||
147306403|NCT03682705|531288791|FG002|Overall Study|Withdrawal by Subject|2|||
147306404|NCT03682705|531288792|FG003|Overall Study|Withdrawal by Subject|4|||
147306405|NCT03682705|531288793|FG004|Overall Study|Withdrawal by Subject|0|||
147306406|NCT03682705|531288794|FG005|Overall Study|Withdrawal by Subject|1|||
147306407|NCT03682705|531288789|FG000|Overall Study|Other, not specified|0|||
147306408|NCT03682705|531288790|FG001|Overall Study|Other, not specified|0|||
147306409|NCT03682705|531288791|FG002|Overall Study|Other, not specified|0|||
147306410|NCT03682705|531288792|FG003|Overall Study|Other, not specified|1|||
147306411|NCT03682705|531288793|FG004|Overall Study|Other, not specified|2|||
147306412|NCT03682705|531288794|FG005|Overall Study|Other, not specified|0|||
147306413|NCT03682705|531288789|FG000|Overall Study|Lost to Follow-up|0|||
147306414|NCT03682705|531288790|FG001|Overall Study|Lost to Follow-up|0|||
147306415|NCT03682705|531288791|FG002|Overall Study|Lost to Follow-up|0|||
147306416|NCT03682705|531288792|FG003|Overall Study|Lost to Follow-up|0|||
147306417|NCT03682705|531288793|FG004|Overall Study|Lost to Follow-up|3|||
147306418|NCT03682705|531288794|FG005|Overall Study|Lost to Follow-up|0|||
147306419|NCT01483937|531288795|FG000|Overall Study|Withdrawal by Subject|4|||
147306420|NCT01483937|531288796|FG001|Overall Study|Withdrawal by Subject|3|||
147306421|NCT02213328|531288797|FG000|Overall Study|Withdrawal by Subject|10|||
147306422|NCT02213328|531288797|FG000|Overall Study|Physician Decision|2|||
147306423|NCT02213328|531288797|FG000|Overall Study|Lost to Follow-up|16|||
147306424|NCT00265330|531288798|FG000|Overall Study|Adverse Event|41|||
147306425|NCT00265330|531288798|FG000|Overall Study|Lost to Follow-up|8|||
147306426|NCT00265330|531288798|FG000|Overall Study|Withdrawal by Subject|34|||
147306427|NCT00265330|531288798|FG000|Overall Study|Patient Wanted to Start Psychotherapy|1|||
147306428|NCT00265330|531288798|FG000|Overall Study|Lack of Efficacy|4|||
147306429|NCT00265330|531288798|FG000|Overall Study|Family Scheduling Conflicts|1|||
147306430|NCT00265330|531288798|FG000|Overall Study|Began Taking Formulary Geodon|1|||
147306431|NCT00265330|531288798|FG000|Overall Study|Discharged from Unit for Long Term Care|1|||
147306432|NCT00265330|531288798|FG000|Overall Study|Site Closed by Sponsor|1|||
147306433|NCT00265330|531288798|FG000|Overall Study|Principal Investigators Request|1|||
147306434|NCT00265330|531288798|FG000|Overall Study|Withdrew Consent|1|||
147306435|NCT00265330|531288798|FG000|Overall Study|Protocol Violation|1|||
147306436|NCT00990340|531288799|FG000|First 14-day Treatment|Not Compliant|2|||
147306437|NCT00990340|531288800|FG001|First 14-day Treatment|Not Compliant|1|||
147306438|NCT00990340|531288799|FG000|First 14-day Treatment|Lost to Follow-up|2|||
147306439|NCT00990340|531288800|FG001|First 14-day Treatment|Lost to Follow-up|1|||
147306440|NCT00990340|531288799|FG000|First 14-day Treatment|Protocol Violation|2|||
147306441|NCT00990340|531288800|FG001|First 14-day Treatment|Protocol Violation|2|||
147306442|NCT04615182|531288801|FG000|Overall Study|Re-transplanted|2|||
147306443|NCT04615182|531288801|FG000|Overall Study|Protocol Violation|6|||
147306444|NCT04615182|531288801|FG000|Overall Study|Death|6|||
147306445|NCT04615182|531288801|FG000|Overall Study|Death and protocol violation|1|||
147306446|NCT01336621|531288802|FG000|Primary Reporting Phase (Upto 5.8 Years)|Adverse Event|11|||
147306447|NCT01336621|531288802|FG000|Primary Reporting Phase (Upto 5.8 Years)|Lack of Efficacy|2|||
147306448|NCT01336621|531288802|FG000|Primary Reporting Phase (Upto 5.8 Years)|Protocol Violation|12|||
147306449|NCT01336621|531288802|FG000|Primary Reporting Phase (Upto 5.8 Years)|Withdrawal by Subject|27|||
147306450|NCT01336621|531288802|FG000|Primary Reporting Phase (Upto 5.8 Years)|Other: study terminated|11|||
147306451|NCT01336621|531288802|FG000|Primary Reporting Phase (Upto 5.8 Years)|Physician Decision|2|||
147306452|NCT01336621|531288802|FG000|Primary Reporting Phase (Upto 5.8 Years)|Other: Reached stopping criteria|22|||
147306453|NCT01336621|531288802|FG000|Primary Reporting Phase (Upto 5.8 Years)|Other: lost to follow up|2|||
147306454|NCT01336621|531288802|FG000|Primary Reporting Phase (Upto 5.8 Years)|Other: Continued in SFUCP|9|||
147306455|NCT01336621|531288802|FG000|SFUCP (up to 2.6 Years)|Other: Reached stopping criteria|1|||
147306456|NCT01336621|531288802|FG000|SFUCP (up to 2.6 Years)|Adverse Event|1|||
147306457|NCT01336621|531288802|FG000|SFUCP (up to 2.6 Years)|Withdrawal by Subject|3|||
147306458|NCT01336621|531288802|FG000|SFUCP (up to 2.6 Years)|Physician Decision|1|||
147306459|NCT01336621|531288802|FG000|SFUCP (up to 2.6 Years)|Other: Study closed/terminated|3|||
147306460|NCT00402337|531288811|FG000|Overall Study|Adverse Event|0|||
147306461|NCT00402337|531288812|FG001|Overall Study|Adverse Event|2|||
147306462|NCT00402337|531288813|FG002|Overall Study|Adverse Event|2|||
147306463|NCT00402337|531288814|FG003|Overall Study|Adverse Event|3|||
147306464|NCT00402337|531288815|FG004|Overall Study|Adverse Event|2|||
147306465|NCT00402337|531288811|FG000|Overall Study|Noncompliance|0|||
147306466|NCT00402337|531288812|FG001|Overall Study|Noncompliance|0|||
147306467|NCT00402337|531288813|FG002|Overall Study|Noncompliance|0|||
147306468|NCT00402337|531288814|FG003|Overall Study|Noncompliance|0|||
147306469|NCT00402337|531288815|FG004|Overall Study|Noncompliance|2|||
147306470|NCT00402337|531288811|FG000|Overall Study|Withdrawal by Subject|5|||
147306471|NCT00402337|531288812|FG001|Overall Study|Withdrawal by Subject|3|||
147306472|NCT00402337|531288813|FG002|Overall Study|Withdrawal by Subject|1|||
147306473|NCT00402337|531288814|FG003|Overall Study|Withdrawal by Subject|6|||
147306474|NCT00402337|531288815|FG004|Overall Study|Withdrawal by Subject|4|||
147306475|NCT00402337|531288811|FG000|Overall Study|Lost to Follow-up|0|||
147306476|NCT00402337|531288812|FG001|Overall Study|Lost to Follow-up|0|||
147306477|NCT00402337|531288813|FG002|Overall Study|Lost to Follow-up|1|||
147532284|NCT00634933|532103951|FG004|Part A: Baseline to Week 24|Lack of Efficacy|0|||
147532285|NCT00634933|532103947|FG000|Part A: Baseline to Week 24|Other|1|||
147532286|NCT00634933|532103948|FG001|Part A: Baseline to Week 24|Other|8|||
147532287|NCT00634933|532103949|FG002|Part A: Baseline to Week 24|Other|5|||
147532288|NCT00634933|532103950|FG003|Part A: Baseline to Week 24|Other|0|||
147532289|NCT00634933|532103951|FG004|Part A: Baseline to Week 24|Other|0|||
147532290|NCT00634933|532103947|FG000|Between Part A and Part B|Physician Decision|0|||
147532291|NCT00634933|532103948|FG001|Between Part A and Part B|Physician Decision|1|||
147532292|NCT00634933|532103949|FG002|Between Part A and Part B|Physician Decision|0|||
147532293|NCT00634933|532103950|FG003|Between Part A and Part B|Physician Decision|0|||
147532294|NCT00634933|532103951|FG004|Between Part A and Part B|Physician Decision|0|||
147532295|NCT00634933|532103947|FG000|Part B: Week 24 to Week 52|Adverse Event|0|||
147645545|NCT02971800|532522019|FG000|Overall Study|Exclusion criteria prior intervention|1|||
147306478|NCT00402337|531288814|FG003|Overall Study|Lost to Follow-up|2|||
147306479|NCT00402337|531288815|FG004|Overall Study|Lost to Follow-up|0|||
147306480|NCT00402337|531288811|FG000|Overall Study|Physician Decision|0|||
147306481|NCT00402337|531288812|FG001|Overall Study|Physician Decision|0|||
147306482|NCT00402337|531288813|FG002|Overall Study|Physician Decision|0|||
147306483|NCT00402337|531288814|FG003|Overall Study|Physician Decision|1|||
147306484|NCT00402337|531288815|FG004|Overall Study|Physician Decision|0|||
147306485|NCT00402337|531288811|FG000|Overall Study|Other Reason|0|||
147306486|NCT00402337|531288812|FG001|Overall Study|Other Reason|1|||
147306487|NCT00402337|531288813|FG002|Overall Study|Other Reason|0|||
147306488|NCT00402337|531288814|FG003|Overall Study|Other Reason|0|||
147306489|NCT00402337|531288815|FG004|Overall Study|Other Reason|0|||
147306490|NCT02178566|531288816|FG000|Overall Study|patient did not complete due to noncompliance|0|||
147306491|NCT02178566|531288817|FG001|Overall Study|patient did not complete due to noncompliance|1|||
147306492|NCT02130284|531288825|FG000|Overall Study|Withdrawal by Subject|3|||
147306493|NCT02130284|531288825|FG000|Overall Study|Subject Withdrew Consent|1|||
147306494|NCT02130284|531288825|FG000|Overall Study|Subject's sensor failed at Visit 2, Day|1|||
147306495|NCT02130284|531288825|FG000|Overall Study|Subject was screened as backup for study|3|||
147306496|NCT02130284|531288825|FG000|Overall Study|Screen Failure|1|||
147306497|NCT00682643|531288826|FG000|Overall Study|Adverse Event|12|||
147306498|NCT00682643|531288827|FG001|Overall Study|Adverse Event|23|||
147306499|NCT00682643|531288826|FG000|Overall Study|Lack of Efficacy|2|||
147306500|NCT00682643|531288827|FG001|Overall Study|Lack of Efficacy|0|||
147306501|NCT00682643|531288826|FG000|Overall Study|Protocol Violation|38|||
147306502|NCT00682643|531288827|FG001|Overall Study|Protocol Violation|76|||
147306503|NCT00682643|531288826|FG000|Overall Study|Met Protocol-defined Stopping Criteria|3|||
147306504|NCT00682643|531288827|FG001|Overall Study|Met Protocol-defined Stopping Criteria|4|||
147306505|NCT00682643|531288826|FG000|Overall Study|Lost to Follow-up|1|||
147306506|NCT00682643|531288827|FG001|Overall Study|Lost to Follow-up|6|||
147306507|NCT00682643|531288826|FG000|Overall Study|Physician Decision|2|||
147306508|NCT00682643|531288827|FG001|Overall Study|Physician Decision|6|||
147306509|NCT00682643|531288826|FG000|Overall Study|Withdrawal by Subject|19|||
147306510|NCT00682643|531288827|FG001|Overall Study|Withdrawal by Subject|53|||
147306511|NCT00682643|531288826|FG000|Overall Study|Did Not Receive Study Drug|1|||
147306512|NCT00682643|531288827|FG001|Overall Study|Did Not Receive Study Drug|1|||
147306513|NCT01875185|531288828|FG000|Overall Study|study was terminated|52|||
147306514|NCT01875185|531288829|FG001|Overall Study|study was terminated|48|||
147306515|NCT03565068|531288830|FG000|Overall Study|Protocol Violation|0|||
147306516|NCT03565068|531288831|FG001|Overall Study|Protocol Violation|0|||
147306517|NCT03565068|531288832|FG002|Overall Study|Protocol Violation|0|||
147306518|NCT03565068|531288833|FG003|Overall Study|Protocol Violation|0|||
147306519|NCT03565068|531288834|FG004|Overall Study|Protocol Violation|1|||
147306520|NCT03565068|531288835|FG005|Overall Study|Protocol Violation|0|||
147418461|NCT00605215|531696464|FG002|Overall Study|Refusal to sign the re-consent form|3|||
147418462|NCT00605215|531696462|FG000|Overall Study|Withdrawal by Subject|39|||
147418463|NCT00605215|531696463|FG001|Overall Study|Withdrawal by Subject|37|||
147418464|NCT00605215|531696464|FG002|Overall Study|Withdrawal by Subject|27|||
147418465|NCT00605215|531696462|FG000|Overall Study|Request of Primary Care Physician or Investigator|6|||
147418466|NCT00605215|531696463|FG001|Overall Study|Request of Primary Care Physician or Investigator|4|||
147418467|NCT00605215|531696464|FG002|Overall Study|Request of Primary Care Physician or Investigator|4|||
147418468|NCT00605215|531696462|FG000|Overall Study|Protocol Violation|3|||
147418469|NCT00605215|531696463|FG001|Overall Study|Protocol Violation|4|||
147418470|NCT00605215|531696464|FG002|Overall Study|Protocol Violation|1|||
147418471|NCT00605215|531696462|FG000|Overall Study|Pregnancy|8|||
147418472|NCT00605215|531696463|FG001|Overall Study|Pregnancy|5|||
147418473|NCT00605215|531696464|FG002|Overall Study|Pregnancy|4|||
147418474|NCT00605215|531696462|FG000|Overall Study|Lost to Follow-up|8|||
147418475|NCT00605215|531696463|FG001|Overall Study|Lost to Follow-up|5|||
147418476|NCT00605215|531696464|FG002|Overall Study|Lost to Follow-up|2|||
147418477|NCT00605215|531696462|FG000|Overall Study|Other than specified|0|||
147418478|NCT00605215|531696463|FG001|Overall Study|Other than specified|2|||
147418479|NCT00605215|531696464|FG002|Overall Study|Other than specified|1|||
147532296|NCT00634933|532103948|FG001|Part B: Week 24 to Week 52|Adverse Event|1|||
147532297|NCT00634933|532103949|FG002|Part B: Week 24 to Week 52|Adverse Event|1|||
147532298|NCT00634933|532103950|FG003|Part B: Week 24 to Week 52|Adverse Event|1|||
147532299|NCT00634933|532103951|FG004|Part B: Week 24 to Week 52|Adverse Event|0|||
147532300|NCT00634933|532103947|FG000|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|0|||
147532301|NCT00634933|532103948|FG001|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|11|||
147532302|NCT00634933|532103949|FG002|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|14|||
147532303|NCT00634933|532103950|FG003|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|3|||
147532304|NCT00634933|532103951|FG004|Part B: Week 24 to Week 52|Discontinuation of Study by Sponsor|7|||
147532305|NCT00634933|532103947|FG000|Part B: Week 24 to Week 52|Physician Decision|0|||
147532306|NCT00634933|532103948|FG001|Part B: Week 24 to Week 52|Physician Decision|1|||
147532307|NCT00634933|532103949|FG002|Part B: Week 24 to Week 52|Physician Decision|1|||
147532308|NCT00634933|532103950|FG003|Part B: Week 24 to Week 52|Physician Decision|0|||
147532309|NCT00634933|532103951|FG004|Part B: Week 24 to Week 52|Physician Decision|0|||
147532310|NCT00634933|532103947|FG000|Part B: Week 24 to Week 52|Protocol Violation|0|||
147532311|NCT00634933|532103948|FG001|Part B: Week 24 to Week 52|Protocol Violation|0|||
147532312|NCT00634933|532103949|FG002|Part B: Week 24 to Week 52|Protocol Violation|0|||
147532313|NCT00634933|532103950|FG003|Part B: Week 24 to Week 52|Protocol Violation|0|||
147532314|NCT00634933|532103951|FG004|Part B: Week 24 to Week 52|Protocol Violation|1|||
147532315|NCT00634933|532103947|FG000|Part B: Week 24 to Week 52|Withdrawal by Subject|0|||
147532316|NCT00634933|532103948|FG001|Part B: Week 24 to Week 52|Withdrawal by Subject|0|||
147532317|NCT00634933|532103949|FG002|Part B: Week 24 to Week 52|Withdrawal by Subject|0|||
147532318|NCT00634933|532103950|FG003|Part B: Week 24 to Week 52|Withdrawal by Subject|2|||
147532319|NCT00634933|532103951|FG004|Part B: Week 24 to Week 52|Withdrawal by Subject|1|||
147532320|NCT00634933|532103947|FG000|Part B: Week 24 to Week 52|Lack of Efficacy|0|||
147532321|NCT00634933|532103948|FG001|Part B: Week 24 to Week 52|Lack of Efficacy|1|||
147532322|NCT00634933|532103949|FG002|Part B: Week 24 to Week 52|Lack of Efficacy|1|||
147532323|NCT00634933|532103950|FG003|Part B: Week 24 to Week 52|Lack of Efficacy|0|||
147532324|NCT00634933|532103951|FG004|Part B: Week 24 to Week 52|Lack of Efficacy|0|||
147532325|NCT00634933|532103947|FG000|Part B: Week 24 to Week 52|Other|0|||
147532326|NCT00634933|532103948|FG001|Part B: Week 24 to Week 52|Other|0|||
147532327|NCT00634933|532103949|FG002|Part B: Week 24 to Week 52|Other|5|||
147532328|NCT00634933|532103950|FG003|Part B: Week 24 to Week 52|Other|0|||
147532329|NCT00634933|532103951|FG004|Part B: Week 24 to Week 52|Other|1|||
147532330|NCT02058849|532103952|FG000|Overall Study|Hospitalization|1|||
147532331|NCT02058849|532103953|FG001|Overall Study|Hospitalization|1|||
147532332|NCT02058849|532103952|FG000|Overall Study|Death|1|||
147532333|NCT02058849|532103953|FG001|Overall Study|Death|0|||
147532334|NCT02058849|532103952|FG000|Overall Study|Lost to Follow-up|1|||
147532335|NCT02058849|532103953|FG001|Overall Study|Lost to Follow-up|0|||
147532336|NCT02058849|532103952|FG000|Overall Study|Withdrawal by Subject|4|||
147532337|NCT02058849|532103953|FG001|Overall Study|Withdrawal by Subject|0|||
147532338|NCT01694849|532103954|FG000|Treatment Period (Visit 2 to Visit 8)|Adverse Event|6|||
147532339|NCT01694849|532103955|FG001|Treatment Period (Visit 2 to Visit 8)|Adverse Event|7|||
147532340|NCT01694849|532103956|FG002|Treatment Period (Visit 2 to Visit 8)|Adverse Event|4|||
147532341|NCT01694849|532103954|FG000|Treatment Period (Visit 2 to Visit 8)|Withdrawal by Subject|1|||
147532342|NCT01694849|532103955|FG001|Treatment Period (Visit 2 to Visit 8)|Withdrawal by Subject|3|||
147532343|NCT01694849|532103956|FG002|Treatment Period (Visit 2 to Visit 8)|Withdrawal by Subject|7|||
147532344|NCT01694849|532103954|FG000|Treatment Period (Visit 2 to Visit 8)|Lost to Follow-up|0|||
147532345|NCT01694849|532103955|FG001|Treatment Period (Visit 2 to Visit 8)|Lost to Follow-up|0|||
147532346|NCT01694849|532103956|FG002|Treatment Period (Visit 2 to Visit 8)|Lost to Follow-up|1|||
147532347|NCT01694849|532103954|FG000|Treatment Period (Visit 2 to Visit 8)|Protocol Violation|1|||
147532348|NCT01694849|532103955|FG001|Treatment Period (Visit 2 to Visit 8)|Protocol Violation|0|||
147532349|NCT01694849|532103956|FG002|Treatment Period (Visit 2 to Visit 8)|Protocol Violation|1|||
147532350|NCT01694849|532103954|FG000|Treatment Period (Visit 2 to Visit 8)|Non-compliance|1|||
147532351|NCT01694849|532103955|FG001|Treatment Period (Visit 2 to Visit 8)|Non-compliance|0|||
147532352|NCT01694849|532103956|FG002|Treatment Period (Visit 2 to Visit 8)|Non-compliance|1|||
147532353|NCT01694849|532103954|FG000|Treatment Period (Visit 2 to Visit 8)|Randomized and not treated|0|||
147532354|NCT01694849|532103955|FG001|Treatment Period (Visit 2 to Visit 8)|Randomized and not treated|1|||
147532355|NCT01694849|532103956|FG002|Treatment Period (Visit 2 to Visit 8)|Randomized and not treated|0|||
147532356|NCT01694849|532103954|FG000|Follow-up Period (to Visit 9)|Withdrawal by Subject|0|||
147532357|NCT01694849|532103955|FG001|Follow-up Period (to Visit 9)|Withdrawal by Subject|1|||
147532358|NCT01694849|532103956|FG002|Follow-up Period (to Visit 9)|Withdrawal by Subject|0|||
147532359|NCT01694849|532103954|FG000|Follow-up Period (to Visit 9)|Lost to Follow-up|1|||
147532360|NCT01694849|532103955|FG001|Follow-up Period (to Visit 9)|Lost to Follow-up|2|||
147532361|NCT01694849|532103956|FG002|Follow-up Period (to Visit 9)|Lost to Follow-up|1|||
147532362|NCT02219477|532103957|FG000|Overall Study|Adverse Event|0|||
147532363|NCT02219477|532103958|FG001|Overall Study|Adverse Event|1|||
147532364|NCT02219477|532103959|FG002|Overall Study|Adverse Event|1|||
147532365|NCT02219477|532103957|FG000|Overall Study|Withdrawal by Subject|0|||
147532366|NCT02219477|532103958|FG001|Overall Study|Withdrawal by Subject|1|||
147532367|NCT02219477|532103959|FG002|Overall Study|Withdrawal by Subject|0|||
147532368|NCT01683565|532103962|FG000|Overall Study|Lost to Follow-up|2|||
147532369|NCT01683565|532103963|FG001|Overall Study|Lost to Follow-up|0|||
147532370|NCT01683565|532103962|FG000|Overall Study|Discontinued Intervention|1|||
147532371|NCT01683565|532103963|FG001|Overall Study|Discontinued Intervention|1|||
147532372|NCT04479358|532103964|FG000|Overall Study|Withdrawal by Subject|0|||
147532373|NCT04479358|532103965|FG001|Overall Study|Withdrawal by Subject|0|||
147532374|NCT04479358|532103966|FG002|Overall Study|Withdrawal by Subject|1|||
147532375|NCT04479358|532103967|FG003|Overall Study|Withdrawal by Subject|0|||
147532376|NCT04479358|532103968|FG004|Overall Study|Withdrawal by Subject|0|||
147532377|NCT04479358|532103969|FG005|Overall Study|Withdrawal by Subject|1|||
147532378|NCT04410991|532103979|FG000|Overall Study|Poor compliance to protocol|5|||
147532379|NCT04410991|532103980|FG001|Overall Study|Poor compliance to protocol|4|||
147532380|NCT04410991|532103979|FG000|Overall Study|Withdrawal by Subject|59|||
147532381|NCT04410991|532103980|FG001|Overall Study|Withdrawal by Subject|55|||
147532382|NCT04410991|532103979|FG000|Overall Study|Other|10|||
147532383|NCT04410991|532103980|FG001|Overall Study|Other|4|||
147532384|NCT00764465|532103981|FG000|Overall Study|Adverse Event|2|||
147532385|NCT00764465|532103982|FG001|Overall Study|Adverse Event|0|||
147532386|NCT00764465|532103983|FG002|Overall Study|Adverse Event|0|||
147418480|NCT00275262|531696471|FG000|Overall Study|Adverse Event|2|||
147418481|NCT00275262|531696472|FG001|Overall Study|Adverse Event|0|||
147418482|NCT00275262|531696471|FG000|Overall Study|Disease progression|2|||
147418483|NCT00275262|531696472|FG001|Overall Study|Disease progression|5|||
147418484|NCT00275262|531696471|FG000|Overall Study|Lost to Follow-up|0|||
147418485|NCT00275262|531696472|FG001|Overall Study|Lost to Follow-up|2|||
147418486|NCT00275262|531696471|FG000|Overall Study|Protocol Violation|0|||
147418487|NCT00275262|531696472|FG001|Overall Study|Protocol Violation|2|||
147418488|NCT00275262|531696471|FG000|Overall Study|Death|1|||
147418489|NCT00275262|531696472|FG001|Overall Study|Death|0|||
147418490|NCT00275262|531696471|FG000|Overall Study|Started Chemotherapy|1|||
147418491|NCT00275262|531696472|FG001|Overall Study|Started Chemotherapy|0|||
147418492|NCT02217332|531696475|FG000|Overall Study|Adverse Event|3|||
147418493|NCT02217332|531696475|FG000|Overall Study|Dose interruption >1 month|1|||
147418494|NCT02217332|531696475|FG000|Overall Study|Protocol Violation (eligibility)|1|||
147418495|NCT02217332|531696475|FG000|Overall Study|Withdrawal by Subject|1|||
147418496|NCT02217332|531696475|FG000|Overall Study|Lost to Follow-up|1|||
147418497|NCT01342341|531696476|FG000|Overall Study|Lost to Follow-up|4|||
147418498|NCT01342341|531696477|FG001|Overall Study|Lost to Follow-up|4|||
147418499|NCT01302067|531696480|FG000|Overall Study|Death|0|||
147418500|NCT01302067|531696481|FG001|Overall Study|Death|0|||
147418501|NCT01302067|531696482|FG002|Overall Study|Death|1|||
147418502|NCT01302067|531696480|FG000|Overall Study|Physician Decision|9|||
147418503|NCT01302067|531696481|FG001|Overall Study|Physician Decision|5|||
147418504|NCT01302067|531696482|FG002|Overall Study|Physician Decision|14|||
147418505|NCT01302067|531696480|FG000|Overall Study|Lack of Efficacy|8|||
147418506|NCT01302067|531696481|FG001|Overall Study|Lack of Efficacy|4|||
147418507|NCT01302067|531696482|FG002|Overall Study|Lack of Efficacy|2|||
147418508|NCT01302067|531696480|FG000|Overall Study|Lost to Follow-up|9|||
147418509|NCT01302067|531696481|FG001|Overall Study|Lost to Follow-up|4|||
147418510|NCT01302067|531696482|FG002|Overall Study|Lost to Follow-up|15|||
147418511|NCT01302067|531696480|FG000|Overall Study|Withdrawal by Subject|13|||
147418512|NCT01302067|531696481|FG001|Overall Study|Withdrawal by Subject|6|||
147532387|NCT00764465|532103984|FG003|Overall Study|Adverse Event|1|||
147532388|NCT00764465|532103985|FG004|Overall Study|Adverse Event|1|||
147418513|NCT01302067|531696482|FG002|Overall Study|Withdrawal by Subject|10|||
147418514|NCT01302067|531696480|FG000|Overall Study|Other|1|||
147418515|NCT01302067|531696481|FG001|Overall Study|Other|1|||
147532389|NCT00764465|532103986|FG005|Overall Study|Adverse Event|1|||
147532390|NCT00764465|532103981|FG000|Overall Study|Withdrawal by Subject|0|||
147532391|NCT00764465|532103982|FG001|Overall Study|Withdrawal by Subject|1|||
147532392|NCT00764465|532103983|FG002|Overall Study|Withdrawal by Subject|1|||
147532393|NCT00764465|532103984|FG003|Overall Study|Withdrawal by Subject|0|||
147532394|NCT00764465|532103985|FG004|Overall Study|Withdrawal by Subject|0|||
147532395|NCT00764465|532103986|FG005|Overall Study|Withdrawal by Subject|0|||
147532396|NCT01195662|532103987|FG000|Double Blind Treatment Period|Adverse Event|4|||
147645546|NCT02971800|532522019|FG000|Overall Study|Number evaluable participant already reached|4|||
147418516|NCT01302067|531696482|FG002|Overall Study|Other|3|||
147418517|NCT01302067|531696480|FG000|Overall Study|Protocol Violation|11|||
147418518|NCT01302067|531696481|FG001|Overall Study|Protocol Violation|0|||
147418519|NCT01302067|531696482|FG002|Overall Study|Protocol Violation|8|||
147418520|NCT01302067|531696480|FG000|Overall Study|Adverse Event|27|||
147418521|NCT01302067|531696481|FG001|Overall Study|Adverse Event|14|||
147418522|NCT01302067|531696482|FG002|Overall Study|Adverse Event|45|||
147418523|NCT00266227|531696483|FG000|Initial Treatment|Adverse Event|0|||
147418524|NCT00266227|531696484|FG001|Initial Treatment|Adverse Event|0|||
147418525|NCT00266227|531696485|FG002|Initial Treatment|Adverse Event|13|||
147418526|NCT00266227|531696483|FG000|Initial Treatment|Lost to Follow-up|0|||
147418527|NCT00266227|531696484|FG001|Initial Treatment|Lost to Follow-up|0|||
147418528|NCT00266227|531696485|FG002|Initial Treatment|Lost to Follow-up|6|||
147418529|NCT00266227|531696483|FG000|Initial Treatment|Subject/Guardian decision to withdraw|0|||
147418530|NCT00266227|531696484|FG001|Initial Treatment|Subject/Guardian decision to withdraw|0|||
147418531|NCT00266227|531696485|FG002|Initial Treatment|Subject/Guardian decision to withdraw|45|||
147418532|NCT00266227|531696483|FG000|Initial Treatment|Physician decision to withdraw|0|||
147418533|NCT00266227|531696484|FG001|Initial Treatment|Physician decision to withdraw|0|||
147418534|NCT00266227|531696485|FG002|Initial Treatment|Physician decision to withdraw|12|||
147418535|NCT00266227|531696483|FG000|Initial Treatment|Pregnancy|0|||
147418536|NCT00266227|531696484|FG001|Initial Treatment|Pregnancy|0|||
147418537|NCT00266227|531696485|FG002|Initial Treatment|Pregnancy|1|||
147418538|NCT00266227|531696483|FG000|Retreatment: Up to Week 48|Death|1|||
147418539|NCT00266227|531696484|FG001|Retreatment: Up to Week 48|Death|0|||
147418540|NCT00266227|531696485|FG002|Retreatment: Up to Week 48|Death|0|||
147418541|NCT00266227|531696483|FG000|Retreatment: Up to Week 48|Adverse Event|7|||
147418542|NCT00266227|531696484|FG001|Retreatment: Up to Week 48|Adverse Event|7|||
147418543|NCT00266227|531696485|FG002|Retreatment: Up to Week 48|Adverse Event|0|||
147418544|NCT00266227|531696483|FG000|Retreatment: Up to Week 48|Lost to Follow-up|3|||
147418545|NCT00266227|531696484|FG001|Retreatment: Up to Week 48|Lost to Follow-up|0|||
147418546|NCT00266227|531696485|FG002|Retreatment: Up to Week 48|Lost to Follow-up|0|||
147418547|NCT00266227|531696483|FG000|Retreatment: Up to Week 48|Subject/Guardian Decision to Withdraw|11|||
147418548|NCT00266227|531696484|FG001|Retreatment: Up to Week 48|Subject/Guardian Decision to Withdraw|14|||
147418549|NCT00266227|531696485|FG002|Retreatment: Up to Week 48|Subject/Guardian Decision to Withdraw|0|||
147418550|NCT00266227|531696483|FG000|Retreatment: Up to Week 48|Physician's Decision to Withdraw|4|||
147418551|NCT00266227|531696484|FG001|Retreatment: Up to Week 48|Physician's Decision to Withdraw|2|||
147418552|NCT00266227|531696485|FG002|Retreatment: Up to Week 48|Physician's Decision to Withdraw|0|||
147418553|NCT00266227|531696483|FG000|Retreatment: Up to Week 48|Pregnancy|1|||
147418554|NCT00266227|531696484|FG001|Retreatment: Up to Week 48|Pregnancy|0|||
147418555|NCT00266227|531696485|FG002|Retreatment: Up to Week 48|Pregnancy|0|||
147418556|NCT00266227|531696483|FG000|Retreatment: Week 48 to Week 72|Death|1|||
147418557|NCT00266227|531696484|FG001|Retreatment: Week 48 to Week 72|Death|1|||
147418558|NCT00266227|531696485|FG002|Retreatment: Week 48 to Week 72|Death|0|||
147418559|NCT00266227|531696483|FG000|Retreatment: Week 48 to Week 72|Adverse Event|6|||
147418560|NCT00266227|531696484|FG001|Retreatment: Week 48 to Week 72|Adverse Event|2|||
147418561|NCT00266227|531696485|FG002|Retreatment: Week 48 to Week 72|Adverse Event|0|||
147418562|NCT00266227|531696483|FG000|Retreatment: Week 48 to Week 72|Lost to Follow-up|1|||
147418563|NCT00266227|531696484|FG001|Retreatment: Week 48 to Week 72|Lost to Follow-up|0|||
147418564|NCT00266227|531696485|FG002|Retreatment: Week 48 to Week 72|Lost to Follow-up|0|||
147418565|NCT00266227|531696483|FG000|Retreatment: Week 48 to Week 72|Subject/Guardian Decision to Withdraw|41|||
147418566|NCT00266227|531696484|FG001|Retreatment: Week 48 to Week 72|Subject/Guardian Decision to Withdraw|29|||
147418567|NCT00266227|531696485|FG002|Retreatment: Week 48 to Week 72|Subject/Guardian Decision to Withdraw|0|||
147418568|NCT00266227|531696483|FG000|Retreatment: Week 48 to Week 72|Physician's Decision to Withdraw|15|||
147418569|NCT00266227|531696484|FG001|Retreatment: Week 48 to Week 72|Physician's Decision to Withdraw|10|||
147418570|NCT00266227|531696485|FG002|Retreatment: Week 48 to Week 72|Physician's Decision to Withdraw|0|||
147418571|NCT03573583|531696486|FG000|Overall Study|Lost to Follow-up|1|||
147418572|NCT03573583|531696487|FG001|Overall Study|Lost to Follow-up|0|||
147418573|NCT03573583|531696486|FG000|Overall Study|Withdrawal by Subject|1|||
147418574|NCT03573583|531696487|FG001|Overall Study|Withdrawal by Subject|1|||
147418575|NCT04343872|531696491|FG000|Overall Study|Lost to Follow-up|6|||
147418576|NCT04343872|531696492|FG001|Overall Study|Lost to Follow-up|3|||
147418577|NCT01850446|531696493|FG000|Overall Study|Lack of Efficacy|1|||
147418578|NCT01850446|531696494|FG001|Overall Study|Lack of Efficacy|0|||
147418579|NCT01850446|531696493|FG000|Overall Study|Withdrawal by Subject|4|||
147418580|NCT01850446|531696494|FG001|Overall Study|Withdrawal by Subject|0|||
147418581|NCT01850446|531696493|FG000|Overall Study|Protocol Violation|0|||
147418582|NCT01850446|531696494|FG001|Overall Study|Protocol Violation|2|||
147418583|NCT01290315|531696495|FG000|Overall Study|Adverse Event|0|||
147418584|NCT01290315|531696496|FG001|Overall Study|Adverse Event|0|||
147418585|NCT01290315|531696497|FG002|Overall Study|Adverse Event|0|||
147418586|NCT01290315|531696498|FG003|Overall Study|Adverse Event|3|||
147418587|NCT01290315|531696495|FG000|Overall Study|Selection criteria/compliance|2|||
147418588|NCT01290315|531696496|FG001|Overall Study|Selection criteria/compliance|1|||
147418589|NCT01290315|531696497|FG002|Overall Study|Selection criteria/compliance|0|||
147418590|NCT01290315|531696498|FG003|Overall Study|Selection criteria/compliance|2|||
147418591|NCT01290315|531696495|FG000|Overall Study|Lost to Follow-up|0|||
147418592|NCT01290315|531696496|FG001|Overall Study|Lost to Follow-up|1|||
147418593|NCT01290315|531696497|FG002|Overall Study|Lost to Follow-up|0|||
147418594|NCT01290315|531696498|FG003|Overall Study|Lost to Follow-up|0|||
147418595|NCT01290315|531696495|FG000|Overall Study|Withdrawal by Subject|1|||
147418596|NCT01290315|531696496|FG001|Overall Study|Withdrawal by Subject|1|||
147418597|NCT01290315|531696497|FG002|Overall Study|Withdrawal by Subject|0|||
147418598|NCT01290315|531696498|FG003|Overall Study|Withdrawal by Subject|0|||
147418599|NCT01658150|531696503|FG000|Overall Study|Withdrawal by Subject|1|||
147418600|NCT03602066|531696504|FG000|Overall Study|Withdrawal by Subject|2|||
147418601|NCT03602066|531696505|FG001|Overall Study|Withdrawal by Subject|0|||
147418602|NCT03602066|531696504|FG000|Overall Study|Physician Decision|1|||
147418603|NCT03602066|531696505|FG001|Overall Study|Physician Decision|0|||
147418604|NCT00621777|531696506|FG000|Open Phase|Adverse Event|20|||
147418605|NCT00621777|531696507|FG001|Open Phase|Adverse Event|0|||
147418606|NCT00621777|531696506|FG000|Open Phase|Did not abstain during open phase|56|||
147418607|NCT00621777|531696507|FG001|Open Phase|Did not abstain during open phase|0|||
147418608|NCT00621777|531696506|FG000|Open Phase|Withdrawal by Subject|17|||
147418609|NCT00621777|531696507|FG001|Open Phase|Withdrawal by Subject|0|||
147418610|NCT00621777|531696506|FG000|Open Phase|administrative|13|||
147418611|NCT00621777|531696507|FG001|Open Phase|administrative|0|||
147418612|NCT00621777|531696506|FG000|Open Phase|Lost to Follow-up|10|||
147418613|NCT00621777|531696507|FG001|Open Phase|Lost to Follow-up|0|||
147418614|NCT00621777|531696506|FG000|Randomized Phase|Adverse Event|3|||
147418615|NCT00621777|531696507|FG001|Randomized Phase|Adverse Event|3|||
147418616|NCT00621777|531696506|FG000|Randomized Phase|Lost to Follow-up|3|||
147418617|NCT00621777|531696507|FG001|Randomized Phase|Lost to Follow-up|3|||
147418618|NCT00621777|531696506|FG000|Randomized Phase|Withdrawal by Subject|1|||
147418619|NCT00621777|531696507|FG001|Randomized Phase|Withdrawal by Subject|9|||
147418620|NCT00621777|531696506|FG000|Randomized Phase|administrative|0|||
147418621|NCT00621777|531696507|FG001|Randomized Phase|administrative|3|||
147418622|NCT00621777|531696506|FG000|Randomized Phase|Death|0|||
147418623|NCT00621777|531696507|FG001|Randomized Phase|Death|1|||
147418624|NCT00446043|531696508|FG000|Overall Study|Adverse Event|9|||
147418625|NCT00446043|531696508|FG000|Overall Study|Withdrawal by Subject|70|||
147418626|NCT00446043|531696508|FG000|Overall Study|Protocol Violation|2|||
147418627|NCT00446043|531696508|FG000|Overall Study|Lost to Follow-up|42|||
147418628|NCT00446043|531696508|FG000|Overall Study|Pregnancy|2|||
147418629|NCT01239043|531696509|FG000|Overall Study|Protocol Violation|2|||
147418630|NCT01239043|531696510|FG001|Overall Study|Protocol Violation|1|||
147418631|NCT02929329|531696513|FG000|Overall Study|Withdrawal by Subject|24|||
147418632|NCT02929329|531696514|FG001|Overall Study|Withdrawal by Subject|21|||
147418633|NCT02929329|531696513|FG000|Overall Study|Lost to Follow-up|26|||
147418634|NCT02929329|531696514|FG001|Overall Study|Lost to Follow-up|20|||
147418635|NCT02929329|531696513|FG000|Overall Study|Death|1054|||
147418636|NCT02929329|531696514|FG001|Overall Study|Death|1051|||
147418637|NCT02121301|531696515|FG000|Overall Study|Protocol Violation|1|||
147418638|NCT02121301|531696516|FG001|Overall Study|Protocol Violation|4|||
147418639|NCT02121301|531696517|FG002|Overall Study|Protocol Violation|1|||
147418640|NCT02663518|531696520|FG000|Part 1: Phase 1a Escalation|Death|0|||
147418641|NCT02663518|531696521|FG001|Part 1: Phase 1a Escalation|Death|0|||
147418642|NCT02663518|531696522|FG002|Part 1: Phase 1a Escalation|Death|1|||
147418643|NCT02663518|531696523|FG003|Part 1: Phase 1a Escalation|Death|0|||
147418644|NCT02663518|531696524|FG004|Part 1: Phase 1a Escalation|Death|0|||
147418645|NCT02663518|531696525|FG005|Part 1: Phase 1a Escalation|Death|0|||
147418646|NCT02663518|531696526|FG006|Part 1: Phase 1a Escalation|Death|0|||
147418647|NCT02663518|531696527|FG007|Part 1: Phase 1a Escalation|Death|0|||
147418648|NCT02663518|531696528|FG008|Part 1: Phase 1a Escalation|Death|0|||
147418649|NCT02663518|531696529|FG009|Part 1: Phase 1a Escalation|Death|0|||
147418650|NCT02663518|531696530|FG010|Part 1: Phase 1a Escalation|Death|0|||
147418651|NCT02663518|531696531|FG011|Part 1: Phase 1a Escalation|Death|0|||
147418652|NCT02663518|531696532|FG012|Part 1: Phase 1a Escalation|Death|0|||
147418653|NCT02663518|531696533|FG013|Part 1: Phase 1a Escalation|Death|0|||
147418654|NCT02663518|531696520|FG000|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
147418655|NCT02663518|531696521|FG001|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
147418656|NCT02663518|531696522|FG002|Part 1: Phase 1a Escalation|Lost to Follow-up|1|||
147418657|NCT02663518|531696523|FG003|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
147418658|NCT02663518|531696524|FG004|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
147418659|NCT02663518|531696525|FG005|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
147418660|NCT02663518|531696526|FG006|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
147418661|NCT02663518|531696527|FG007|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
147418662|NCT02663518|531696528|FG008|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
147418663|NCT02663518|531696529|FG009|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
147418664|NCT02663518|531696530|FG010|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
147418665|NCT02663518|531696531|FG011|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
147418666|NCT02663518|531696532|FG012|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
147418667|NCT02663518|531696533|FG013|Part 1: Phase 1a Escalation|Lost to Follow-up|0|||
147418668|NCT02663518|531696520|FG000|Part 1: Phase 1a Escalation|Progressive Disease|2|||
147418669|NCT02663518|531696521|FG001|Part 1: Phase 1a Escalation|Progressive Disease|3|||
147418670|NCT02663518|531696522|FG002|Part 1: Phase 1a Escalation|Progressive Disease|2|||
147418671|NCT02663518|531696523|FG003|Part 1: Phase 1a Escalation|Progressive Disease|3|||
147418672|NCT02663518|531696524|FG004|Part 1: Phase 1a Escalation|Progressive Disease|0|||
147418673|NCT02663518|531696525|FG005|Part 1: Phase 1a Escalation|Progressive Disease|0|||
147418674|NCT02663518|531696526|FG006|Part 1: Phase 1a Escalation|Progressive Disease|0|||
147418675|NCT02663518|531696527|FG007|Part 1: Phase 1a Escalation|Progressive Disease|0|||
147418676|NCT02663518|531696528|FG008|Part 1: Phase 1a Escalation|Progressive Disease|0|||
147418677|NCT02663518|531696529|FG009|Part 1: Phase 1a Escalation|Progressive Disease|0|||
147418678|NCT02663518|531696530|FG010|Part 1: Phase 1a Escalation|Progressive Disease|0|||
147418679|NCT02663518|531696531|FG011|Part 1: Phase 1a Escalation|Progressive Disease|0|||
147418680|NCT02663518|531696532|FG012|Part 1: Phase 1a Escalation|Progressive Disease|0|||
147418681|NCT02663518|531696533|FG013|Part 1: Phase 1a Escalation|Progressive Disease|0|||
147418682|NCT02663518|531696520|FG000|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|1|||
147418683|NCT02663518|531696521|FG001|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
147418684|NCT02663518|531696522|FG002|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|1|||
147418685|NCT02663518|531696523|FG003|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|1|||
147418686|NCT02663518|531696524|FG004|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
147418687|NCT02663518|531696525|FG005|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
147418688|NCT02663518|531696526|FG006|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
147418689|NCT02663518|531696527|FG007|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
147418690|NCT02663518|531696528|FG008|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
147418691|NCT02663518|531696529|FG009|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
147418692|NCT02663518|531696530|FG010|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
147418693|NCT02663518|531696531|FG011|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
147418694|NCT02663518|531696532|FG012|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
147418695|NCT02663518|531696533|FG013|Part 1: Phase 1a Escalation|Informed Consent Withdrawn|0|||
147418696|NCT02663518|531696520|FG000|Part 1: Phase 1a Escalation|Other|0|||
147418697|NCT02663518|531696521|FG001|Part 1: Phase 1a Escalation|Other|0|||
147418698|NCT02663518|531696522|FG002|Part 1: Phase 1a Escalation|Other|2|||
147418699|NCT02663518|531696523|FG003|Part 1: Phase 1a Escalation|Other|0|||
147418700|NCT02663518|531696524|FG004|Part 1: Phase 1a Escalation|Other|0|||
147418701|NCT02663518|531696525|FG005|Part 1: Phase 1a Escalation|Other|0|||
147418702|NCT02663518|531696526|FG006|Part 1: Phase 1a Escalation|Other|0|||
147418703|NCT02663518|531696527|FG007|Part 1: Phase 1a Escalation|Other|0|||
147418704|NCT02663518|531696528|FG008|Part 1: Phase 1a Escalation|Other|0|||
147418705|NCT02663518|531696529|FG009|Part 1: Phase 1a Escalation|Other|0|||
147418706|NCT02663518|531696530|FG010|Part 1: Phase 1a Escalation|Other|0|||
147418707|NCT02663518|531696531|FG011|Part 1: Phase 1a Escalation|Other|0|||
147418708|NCT02663518|531696532|FG012|Part 1: Phase 1a Escalation|Other|0|||
147418709|NCT02663518|531696533|FG013|Part 1: Phase 1a Escalation|Other|0|||
147418710|NCT02663518|531696520|FG000|Part 2 and 3: Phase 1b Expansion|Death|0|||
147418711|NCT02663518|531696521|FG001|Part 2 and 3: Phase 1b Expansion|Death|0|||
147418712|NCT02663518|531696522|FG002|Part 2 and 3: Phase 1b Expansion|Death|0|||
147418713|NCT02663518|531696523|FG003|Part 2 and 3: Phase 1b Expansion|Death|0|||
147418714|NCT02663518|531696524|FG004|Part 2 and 3: Phase 1b Expansion|Death|50|||
147418715|NCT02663518|531696525|FG005|Part 2 and 3: Phase 1b Expansion|Death|0|||
147418716|NCT02663518|531696526|FG006|Part 2 and 3: Phase 1b Expansion|Death|25|||
147418717|NCT02663518|531696527|FG007|Part 2 and 3: Phase 1b Expansion|Death|16|||
147418718|NCT02663518|531696528|FG008|Part 2 and 3: Phase 1b Expansion|Death|0|||
147418719|NCT02663518|531696529|FG009|Part 2 and 3: Phase 1b Expansion|Death|0|||
147418720|NCT02663518|531696530|FG010|Part 2 and 3: Phase 1b Expansion|Death|0|||
147418721|NCT02663518|531696531|FG011|Part 2 and 3: Phase 1b Expansion|Death|0|||
147418722|NCT02663518|531696532|FG012|Part 2 and 3: Phase 1b Expansion|Death|0|||
147418723|NCT02663518|531696533|FG013|Part 2 and 3: Phase 1b Expansion|Death|0|||
147418724|NCT02663518|531696520|FG000|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
147418725|NCT02663518|531696521|FG001|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
147418726|NCT02663518|531696522|FG002|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
147418727|NCT02663518|531696523|FG003|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
147418728|NCT02663518|531696524|FG004|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|4|||
147645547|NCT01149421|532522020|FG000|Overall Study|Adverse Event|22|||
147418729|NCT02663518|531696525|FG005|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
147418730|NCT02663518|531696526|FG006|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|3|||
147418731|NCT02663518|531696527|FG007|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|3|||
147418732|NCT02663518|531696528|FG008|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
147418733|NCT02663518|531696529|FG009|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
147418734|NCT02663518|531696530|FG010|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
147418735|NCT02663518|531696531|FG011|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
147418736|NCT02663518|531696532|FG012|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
147418737|NCT02663518|531696533|FG013|Part 2 and 3: Phase 1b Expansion|Lost to Follow-up|0|||
147418738|NCT02663518|531696520|FG000|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
147418739|NCT02663518|531696521|FG001|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
147418740|NCT02663518|531696522|FG002|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
147418741|NCT02663518|531696523|FG003|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
147418742|NCT02663518|531696524|FG004|Part 2 and 3: Phase 1b Expansion|Progressive Disease|2|||
147418743|NCT02663518|531696525|FG005|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
147418744|NCT02663518|531696526|FG006|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
147418745|NCT02663518|531696527|FG007|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
147418746|NCT02663518|531696528|FG008|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
147418747|NCT02663518|531696529|FG009|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
147418748|NCT02663518|531696530|FG010|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
147418749|NCT02663518|531696531|FG011|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
147418750|NCT02663518|531696532|FG012|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
147418751|NCT02663518|531696533|FG013|Part 2 and 3: Phase 1b Expansion|Progressive Disease|0|||
147418752|NCT02663518|531696520|FG000|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
147418753|NCT02663518|531696521|FG001|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
147418754|NCT02663518|531696522|FG002|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
147418755|NCT02663518|531696523|FG003|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
147418756|NCT02663518|531696524|FG004|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|16|||
147418757|NCT02663518|531696525|FG005|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|1|||
147418758|NCT02663518|531696526|FG006|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|3|||
147418759|NCT02663518|531696527|FG007|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|8|||
147418760|NCT02663518|531696528|FG008|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
147418761|NCT02663518|531696529|FG009|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
147418762|NCT02663518|531696530|FG010|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
147418763|NCT02663518|531696531|FG011|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
147418764|NCT02663518|531696532|FG012|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
147418765|NCT02663518|531696533|FG013|Part 2 and 3: Phase 1b Expansion|Informed Consent Withdrawn|0|||
147418766|NCT02663518|531696520|FG000|Part 2 and 3: Phase 1b Expansion|Other|0|||
147418767|NCT02663518|531696521|FG001|Part 2 and 3: Phase 1b Expansion|Other|0|||
147418768|NCT02663518|531696522|FG002|Part 2 and 3: Phase 1b Expansion|Other|0|||
147418769|NCT02663518|531696523|FG003|Part 2 and 3: Phase 1b Expansion|Other|0|||
147418770|NCT02663518|531696524|FG004|Part 2 and 3: Phase 1b Expansion|Other|6|||
147418771|NCT02663518|531696525|FG005|Part 2 and 3: Phase 1b Expansion|Other|0|||
147418772|NCT02663518|531696526|FG006|Part 2 and 3: Phase 1b Expansion|Other|2|||
147418773|NCT02663518|531696527|FG007|Part 2 and 3: Phase 1b Expansion|Other|0|||
147418774|NCT02663518|531696528|FG008|Part 2 and 3: Phase 1b Expansion|Other|0|||
147418775|NCT02663518|531696529|FG009|Part 2 and 3: Phase 1b Expansion|Other|0|||
147418776|NCT02663518|531696530|FG010|Part 2 and 3: Phase 1b Expansion|Other|0|||
147418777|NCT02663518|531696531|FG011|Part 2 and 3: Phase 1b Expansion|Other|0|||
147418778|NCT02663518|531696532|FG012|Part 2 and 3: Phase 1b Expansion|Other|0|||
147418779|NCT02663518|531696533|FG013|Part 2 and 3: Phase 1b Expansion|Other|0|||
147418780|NCT02663518|531696520|FG000|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
147418781|NCT02663518|531696521|FG001|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
147418782|NCT02663518|531696522|FG002|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
147418783|NCT02663518|531696523|FG003|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
147418784|NCT02663518|531696524|FG004|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
147418785|NCT02663518|531696525|FG005|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
147418786|NCT02663518|531696526|FG006|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|1|||
147418787|NCT02663518|531696527|FG007|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
147418788|NCT02663518|531696528|FG008|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
147418789|NCT02663518|531696529|FG009|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
147418790|NCT02663518|531696530|FG010|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
147418791|NCT02663518|531696531|FG011|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
147418792|NCT02663518|531696532|FG012|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
147418793|NCT02663518|531696533|FG013|Part 2 and 3: Phase 1b Expansion|Study Terminated By Sponsor|0|||
147418794|NCT02663518|531696520|FG000|Part 4: Phase 1b Dose Optimization|Death|0|||
147418795|NCT02663518|531696521|FG001|Part 4: Phase 1b Dose Optimization|Death|0|||
147418796|NCT02663518|531696522|FG002|Part 4: Phase 1b Dose Optimization|Death|0|||
147418797|NCT02663518|531696523|FG003|Part 4: Phase 1b Dose Optimization|Death|0|||
147418798|NCT02663518|531696524|FG004|Part 4: Phase 1b Dose Optimization|Death|0|||
147418799|NCT02663518|531696525|FG005|Part 4: Phase 1b Dose Optimization|Death|0|||
147418800|NCT02663518|531696526|FG006|Part 4: Phase 1b Dose Optimization|Death|0|||
147418801|NCT02663518|531696527|FG007|Part 4: Phase 1b Dose Optimization|Death|0|||
147418802|NCT02663518|531696528|FG008|Part 4: Phase 1b Dose Optimization|Death|0|||
147418803|NCT02663518|531696529|FG009|Part 4: Phase 1b Dose Optimization|Death|0|||
147418804|NCT02663518|531696530|FG010|Part 4: Phase 1b Dose Optimization|Death|2|||
147418805|NCT02663518|531696531|FG011|Part 4: Phase 1b Dose Optimization|Death|0|||
147418806|NCT02663518|531696532|FG012|Part 4: Phase 1b Dose Optimization|Death|5|||
147418807|NCT02663518|531696533|FG013|Part 4: Phase 1b Dose Optimization|Death|1|||
147418808|NCT02663518|531696520|FG000|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
147418809|NCT02663518|531696521|FG001|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
147418810|NCT02663518|531696522|FG002|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
147418811|NCT02663518|531696523|FG003|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
147418812|NCT02663518|531696524|FG004|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
147418813|NCT02663518|531696525|FG005|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
147418814|NCT02663518|531696526|FG006|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
147418815|NCT02663518|531696527|FG007|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
147418816|NCT02663518|531696528|FG008|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
147418817|NCT02663518|531696529|FG009|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
147418818|NCT02663518|531696530|FG010|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
147418819|NCT02663518|531696531|FG011|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
147418820|NCT02663518|531696532|FG012|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|1|||
147418821|NCT02663518|531696533|FG013|Part 4: Phase 1b Dose Optimization|Lost to Follow-up|0|||
147418822|NCT02663518|531696520|FG000|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
147418823|NCT02663518|531696521|FG001|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
147418824|NCT02663518|531696522|FG002|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
147418825|NCT02663518|531696523|FG003|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
147418826|NCT02663518|531696524|FG004|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
147418827|NCT02663518|531696525|FG005|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
147418828|NCT02663518|531696526|FG006|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
147418829|NCT02663518|531696527|FG007|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
147418830|NCT02663518|531696528|FG008|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
147418831|NCT02663518|531696529|FG009|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
147418832|NCT02663518|531696530|FG010|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
147418833|NCT02663518|531696531|FG011|Part 4: Phase 1b Dose Optimization|Progressive Disease|1|||
147418834|NCT02663518|531696532|FG012|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
147418835|NCT02663518|531696533|FG013|Part 4: Phase 1b Dose Optimization|Progressive Disease|0|||
147418836|NCT02663518|531696520|FG000|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
147418837|NCT02663518|531696521|FG001|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
147418838|NCT02663518|531696522|FG002|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
147418839|NCT02663518|531696523|FG003|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
147418840|NCT02663518|531696524|FG004|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
147418841|NCT02663518|531696525|FG005|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
147418842|NCT02663518|531696526|FG006|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
147418843|NCT02663518|531696527|FG007|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
147418844|NCT02663518|531696528|FG008|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
147418845|NCT02663518|531696529|FG009|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|2|||
147418846|NCT02663518|531696530|FG010|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|0|||
147418847|NCT02663518|531696531|FG011|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|1|||
147418848|NCT02663518|531696532|FG012|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|1|||
147418849|NCT02663518|531696533|FG013|Part 4: Phase 1b Dose Optimization|Informed Consent Withdrawn|1|||
147418850|NCT02663518|531696520|FG000|Part 4: Phase 1b Dose Optimization|Other|0|||
147418851|NCT02663518|531696521|FG001|Part 4: Phase 1b Dose Optimization|Other|0|||
147418852|NCT02663518|531696522|FG002|Part 4: Phase 1b Dose Optimization|Other|0|||
147418853|NCT02663518|531696523|FG003|Part 4: Phase 1b Dose Optimization|Other|0|||
147418854|NCT02663518|531696524|FG004|Part 4: Phase 1b Dose Optimization|Other|0|||
147418855|NCT02663518|531696525|FG005|Part 4: Phase 1b Dose Optimization|Other|0|||
147418856|NCT02663518|531696526|FG006|Part 4: Phase 1b Dose Optimization|Other|0|||
147418857|NCT02663518|531696527|FG007|Part 4: Phase 1b Dose Optimization|Other|0|||
147418858|NCT02663518|531696528|FG008|Part 4: Phase 1b Dose Optimization|Other|0|||
147418859|NCT02663518|531696529|FG009|Part 4: Phase 1b Dose Optimization|Other|0|||
147418860|NCT02663518|531696530|FG010|Part 4: Phase 1b Dose Optimization|Other|1|||
147418861|NCT02663518|531696531|FG011|Part 4: Phase 1b Dose Optimization|Other|1|||
147418862|NCT02663518|531696532|FG012|Part 4: Phase 1b Dose Optimization|Other|0|||
147418863|NCT02663518|531696533|FG013|Part 4: Phase 1b Dose Optimization|Other|1|||
147418864|NCT02663518|531696520|FG000|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
147418865|NCT02663518|531696521|FG001|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
147418866|NCT02663518|531696522|FG002|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
147418867|NCT02663518|531696523|FG003|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
147418868|NCT02663518|531696524|FG004|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
147418869|NCT02663518|531696525|FG005|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
147418870|NCT02663518|531696526|FG006|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
147418871|NCT02663518|531696527|FG007|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
147418872|NCT02663518|531696528|FG008|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
147418873|NCT02663518|531696529|FG009|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
147418874|NCT02663518|531696530|FG010|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
147418875|NCT02663518|531696531|FG011|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
147418876|NCT02663518|531696532|FG012|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|1|||
147418877|NCT02663518|531696533|FG013|Part 4: Phase 1b Dose Optimization|Study terminated by sponsor|0|||
147418878|NCT01144052|531696536|FG000|Overall Study|Withdrawal by Subject|1|||
147418879|NCT01144052|531696537|FG001|Overall Study|Withdrawal by Subject|1|||
147418880|NCT03836716|531696541|FG000|Overall Study|Adverse Event|3|||
147418881|NCT03836716|531696541|FG000|Overall Study|Death|22|||
147418882|NCT03836716|531696541|FG000|Overall Study|Withdrawal by Subject|8|||
147418883|NCT03836716|531696541|FG000|Overall Study|Study terminated by sponsor|87|||
147418884|NCT01879722|531696542|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
147418885|NCT01879722|531696543|FG001|Overall Study|Pretreatment Event/Adverse Event|1|||
147418886|NCT01879722|531696544|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
147418887|NCT01879722|531696545|FG003|Overall Study|Pretreatment Event/Adverse Event|1|||
147418888|NCT01879722|531696546|FG004|Overall Study|Pretreatment Event/Adverse Event|1|||
147418889|NCT01879722|531696547|FG005|Overall Study|Pretreatment Event/Adverse Event|0|||
147418890|NCT01879722|531696548|FG006|Overall Study|Pretreatment Event/Adverse Event|0|||
147418891|NCT01879722|531696549|FG007|Overall Study|Pretreatment Event/Adverse Event|1|||
147418892|NCT01879722|531696550|FG008|Overall Study|Pretreatment Event/Adverse Event|1|||
147418893|NCT01879722|531696551|FG009|Overall Study|Pretreatment Event/Adverse Event|0|||
147418894|NCT01879722|531696542|FG000|Overall Study|Voluntary Withdrawal|0|||
147418895|NCT01879722|531696543|FG001|Overall Study|Voluntary Withdrawal|0|||
147418896|NCT01879722|531696544|FG002|Overall Study|Voluntary Withdrawal|0|||
147418897|NCT01879722|531696545|FG003|Overall Study|Voluntary Withdrawal|0|||
147418898|NCT01879722|531696546|FG004|Overall Study|Voluntary Withdrawal|0|||
147418899|NCT01879722|531696547|FG005|Overall Study|Voluntary Withdrawal|0|||
147418900|NCT01879722|531696548|FG006|Overall Study|Voluntary Withdrawal|0|||
147418901|NCT01879722|531696549|FG007|Overall Study|Voluntary Withdrawal|0|||
147418902|NCT01879722|531696550|FG008|Overall Study|Voluntary Withdrawal|1|||
147418903|NCT01879722|531696551|FG009|Overall Study|Voluntary Withdrawal|0|||
147418904|NCT01983254|531696552|FG000|Overall Study|Death|6|||
147418905|NCT01983254|531696553|FG001|Overall Study|Death|6|||
147418906|NCT01983254|531696552|FG000|Overall Study|Lost to Follow-up|17|||
147418907|NCT01983254|531696553|FG001|Overall Study|Lost to Follow-up|16|||
147418908|NCT01983254|531696552|FG000|Overall Study|too ill|11|||
147418909|NCT01983254|531696553|FG001|Overall Study|too ill|8|||
147418910|NCT00434213|531696556|FG000|Overall Study|Adverse Event|12|||
147418911|NCT00434213|531696556|FG000|Overall Study|Lack of Efficacy|9|||
147418912|NCT00434213|531696556|FG000|Overall Study|Lost to Follow-up|14|||
147418913|NCT00434213|531696556|FG000|Overall Study|Withdrawal by Subject|7|||
147418914|NCT00434213|531696556|FG000|Overall Study|Protocol Violation|3|||
147418915|NCT00434213|531696556|FG000|Overall Study|Unable to comply with study visit window|2|||
147418916|NCT00434213|531696556|FG000|Overall Study|Application site reaction|1|||
147418917|NCT00434213|531696556|FG000|Overall Study|Non-compliant to study schedule|1|||
147418918|NCT00037830|531696557|FG000|Overall Study|Adverse Event|2|||
147418919|NCT00037830|531696558|FG001|Overall Study|Adverse Event|0|||
147418920|NCT00037830|531696559|FG002|Overall Study|Adverse Event|0|||
147418921|NCT00037830|531696557|FG000|Overall Study|Withdrawal by Subject|4|||
147418922|NCT00037830|531696558|FG001|Overall Study|Withdrawal by Subject|5|||
147418923|NCT00037830|531696559|FG002|Overall Study|Withdrawal by Subject|1|||
147418924|NCT00037830|531696557|FG000|Overall Study|Protocol Violation|2|||
147418925|NCT00037830|531696558|FG001|Overall Study|Protocol Violation|2|||
147418926|NCT00037830|531696559|FG002|Overall Study|Protocol Violation|0|||
147418927|NCT00037830|531696557|FG000|Overall Study|Unrelated Medical Problem|2|||
147418928|NCT00037830|531696558|FG001|Overall Study|Unrelated Medical Problem|0|||
147418929|NCT00037830|531696559|FG002|Overall Study|Unrelated Medical Problem|0|||
147418930|NCT01253304|531696560|FG000|Overall Study|Adverse Event|0|||
147418931|NCT01253304|531696561|FG001|Overall Study|Adverse Event|0|||
147418932|NCT01253304|531696562|FG002|Overall Study|Adverse Event|0|||
147418933|NCT01253304|531696563|FG003|Overall Study|Adverse Event|1|||
147418934|NCT01699503|531696564|FG000|Overall Study|Death|31|||
147418935|NCT01699503|531696565|FG001|Overall Study|Death|40|||
147418936|NCT01699503|531696564|FG000|Overall Study|Withdrawal by Subject|65|||
147418937|NCT01699503|531696565|FG001|Overall Study|Withdrawal by Subject|57|||
147418938|NCT01699503|531696564|FG000|Overall Study|Lost to Follow-up|121|||
147418939|NCT01699503|531696565|FG001|Overall Study|Lost to Follow-up|117|||
147418940|NCT01699503|531696564|FG000|Overall Study|Excluded due to quality|783|||
147418941|NCT01699503|531696565|FG001|Overall Study|Excluded due to quality|791|||
147418942|NCT01639560|531696568|FG000|Overall Study|Withdrawal by Subject|9|||
147418943|NCT01639560|531696569|FG001|Overall Study|Withdrawal by Subject|14|||
147645548|NCT01149421|532522021|FG001|Overall Study|Adverse Event|6|||
147306521|NCT03565068|531288836|FG006|Overall Study|Protocol Violation|0|||
147306522|NCT03565068|531288837|FG007|Overall Study|Protocol Violation|1|||
147306523|NCT03565068|531288838|FG008|Overall Study|Protocol Violation|0|||
147306524|NCT03565068|531288830|FG000|Overall Study|Sponsor decision|0|||
147306525|NCT03565068|531288831|FG001|Overall Study|Sponsor decision|0|||
147306526|NCT03565068|531288832|FG002|Overall Study|Sponsor decision|0|||
147306527|NCT03565068|531288833|FG003|Overall Study|Sponsor decision|0|||
147306528|NCT03565068|531288834|FG004|Overall Study|Sponsor decision|1|||
147306529|NCT03565068|531288835|FG005|Overall Study|Sponsor decision|1|||
147306530|NCT03565068|531288836|FG006|Overall Study|Sponsor decision|0|||
147306531|NCT03565068|531288837|FG007|Overall Study|Sponsor decision|0|||
147306532|NCT03565068|531288838|FG008|Overall Study|Sponsor decision|0|||
147306533|NCT03565068|531288830|FG000|Overall Study|Withdrawal by Subject|0|||
147306534|NCT03565068|531288831|FG001|Overall Study|Withdrawal by Subject|0|||
147306535|NCT03565068|531288832|FG002|Overall Study|Withdrawal by Subject|1|||
147306536|NCT03565068|531288833|FG003|Overall Study|Withdrawal by Subject|0|||
147306537|NCT03565068|531288834|FG004|Overall Study|Withdrawal by Subject|2|||
147306538|NCT03565068|531288835|FG005|Overall Study|Withdrawal by Subject|0|||
147306539|NCT03565068|531288836|FG006|Overall Study|Withdrawal by Subject|1|||
147306540|NCT03565068|531288837|FG007|Overall Study|Withdrawal by Subject|5|||
147306541|NCT03565068|531288838|FG008|Overall Study|Withdrawal by Subject|1|||
147306542|NCT03565068|531288830|FG000|Overall Study|Physician Decision|0|||
147306543|NCT03565068|531288831|FG001|Overall Study|Physician Decision|0|||
147306544|NCT03565068|531288832|FG002|Overall Study|Physician Decision|0|||
147306545|NCT03565068|531288833|FG003|Overall Study|Physician Decision|0|||
147306546|NCT03565068|531288834|FG004|Overall Study|Physician Decision|0|||
147306547|NCT03565068|531288835|FG005|Overall Study|Physician Decision|0|||
147306548|NCT03565068|531288836|FG006|Overall Study|Physician Decision|0|||
147306549|NCT03565068|531288837|FG007|Overall Study|Physician Decision|1|||
147306550|NCT03565068|531288838|FG008|Overall Study|Physician Decision|0|||
147306551|NCT03565068|531288830|FG000|Overall Study|Lost to Follow-up|0|||
147306552|NCT03565068|531288831|FG001|Overall Study|Lost to Follow-up|0|||
147306553|NCT03565068|531288832|FG002|Overall Study|Lost to Follow-up|0|||
147306554|NCT03565068|531288833|FG003|Overall Study|Lost to Follow-up|0|||
147306555|NCT03565068|531288834|FG004|Overall Study|Lost to Follow-up|0|||
147306556|NCT03565068|531288835|FG005|Overall Study|Lost to Follow-up|0|||
147306557|NCT03565068|531288836|FG006|Overall Study|Lost to Follow-up|0|||
147306558|NCT03565068|531288837|FG007|Overall Study|Lost to Follow-up|1|||
147306559|NCT03565068|531288838|FG008|Overall Study|Lost to Follow-up|0|||
147306560|NCT05778526|531288839|FG000|Overall Study|Lost to Follow-up|0|||
147306561|NCT05778526|531288840|FG001|Overall Study|Lost to Follow-up|1|||
147306562|NCT05778526|531288841|FG002|Overall Study|Lost to Follow-up|3|||
147306563|NCT05778526|531288839|FG000|Overall Study|Protocol Violation|0|||
147306564|NCT05778526|531288840|FG001|Overall Study|Protocol Violation|0|||
147306565|NCT05778526|531288841|FG002|Overall Study|Protocol Violation|8|||
147306566|NCT00085202|531288842|FG000|Overall Study|Still on therapy|2|||
147306567|NCT00085202|531288843|FG001|Overall Study|Still on therapy|0|||
147306568|NCT00085202|531288842|FG000|Overall Study|Bone involvement confirmed by bone scan|0|||
147306569|NCT00085202|531288843|FG001|Overall Study|Bone involvement confirmed by bone scan|1|||
147306570|NCT00085202|531288842|FG000|Overall Study|Excessive toxicity|6|||
147306571|NCT00085202|531288843|FG001|Overall Study|Excessive toxicity|5|||
147306572|NCT00085202|531288842|FG000|Overall Study|Non-specified|3|||
147306573|NCT00085202|531288843|FG001|Overall Study|Non-specified|5|||
147306574|NCT00085202|531288842|FG000|Overall Study|Withdrawal by Subject|2|||
147306575|NCT00085202|531288843|FG001|Overall Study|Withdrawal by Subject|1|||
147306576|NCT00085202|531288842|FG000|Overall Study|Physician Decision|4|||
147306577|NCT00085202|531288843|FG001|Overall Study|Physician Decision|1|||
147306578|NCT00085202|531288842|FG000|Overall Study|Progressive disease|1|||
147306579|NCT00085202|531288843|FG001|Overall Study|Progressive disease|11|||
147306589|NCT03238300|531288849|FG000|Baseline (Before Intervention)|Physician Decision|0|||
147306590|NCT03238300|531288850|FG001|Baseline (Before Intervention)|Physician Decision|1|||
147306591|NCT03238300|531288849|FG000|Washout Period (11-Days)|Withdrawal by Subject|1|||
147306592|NCT03238300|531288850|FG001|Washout Period (11-Days)|Withdrawal by Subject|0|||
147306593|NCT03238300|531288849|FG000|Second Intervention (10-Days)|Lost to Follow-up|1|||
147306594|NCT03238300|531288850|FG001|Second Intervention (10-Days)|Lost to Follow-up|0|||
147306595|NCT03238300|531288849|FG000|Second Intervention (10-Days)|Withdrawal by Subject|1|||
147418944|NCT01639560|531696568|FG000|Overall Study|Lack of Efficacy|1|||
147418945|NCT01639560|531696569|FG001|Overall Study|Lack of Efficacy|2|||
147418946|NCT01639560|531696568|FG000|Overall Study|Lost to Follow-up|9|||
147418947|NCT01639560|531696569|FG001|Overall Study|Lost to Follow-up|11|||
147418948|NCT01639560|531696568|FG000|Overall Study|Adverse Event|0|||
147418949|NCT01639560|531696569|FG001|Overall Study|Adverse Event|2|||
147418950|NCT01631227|531696578|FG000|Overall Study|withdrawn consent|27|||
147418951|NCT01631227|531696579|FG001|Overall Study|withdrawn consent|21|||
147418952|NCT01631227|531696578|FG000|Overall Study|Adverse Event|1|||
147418953|NCT01631227|531696579|FG001|Overall Study|Adverse Event|0|||
147532397|NCT01195662|532103988|FG001|Double Blind Treatment Period|Adverse Event|1|||
147532398|NCT01195662|532103989|FG002|Double Blind Treatment Period|Adverse Event|2|||
147532399|NCT01195662|532103987|FG000|Double Blind Treatment Period|Withdrawal by Subject|6|||
147532400|NCT01195662|532103988|FG001|Double Blind Treatment Period|Withdrawal by Subject|4|||
147532401|NCT01195662|532103989|FG002|Double Blind Treatment Period|Withdrawal by Subject|4|||
147532402|NCT01195662|532103987|FG000|Double Blind Treatment Period|Lost to Follow-up|3|||
147532403|NCT01195662|532103988|FG001|Double Blind Treatment Period|Lost to Follow-up|2|||
147532404|NCT01195662|532103989|FG002|Double Blind Treatment Period|Lost to Follow-up|3|||
147532405|NCT01195662|532103987|FG000|Double Blind Treatment Period|Administrative reason|2|||
147532406|NCT01195662|532103988|FG001|Double Blind Treatment Period|Administrative reason|1|||
147532407|NCT01195662|532103989|FG002|Double Blind Treatment Period|Administrative reason|1|||
147532408|NCT01195662|532103987|FG000|Double Blind Treatment Period|Requested discontinue treatment|1|||
147532409|NCT01195662|532103988|FG001|Double Blind Treatment Period|Requested discontinue treatment|0|||
147532410|NCT01195662|532103989|FG002|Double Blind Treatment Period|Requested discontinue treatment|1|||
147532411|NCT01195662|532103987|FG000|Double Blind Treatment Period|No Longer Meets Criteria|1|||
147532412|NCT01195662|532103988|FG001|Double Blind Treatment Period|No Longer Meets Criteria|5|||
147532413|NCT01195662|532103989|FG002|Double Blind Treatment Period|No Longer Meets Criteria|2|||
147532414|NCT01195662|532103987|FG000|Double Blind Treatment Period|Lack of Efficacy|2|||
147532415|NCT01195662|532103988|FG001|Double Blind Treatment Period|Lack of Efficacy|0|||
147532416|NCT01195662|532103989|FG002|Double Blind Treatment Period|Lack of Efficacy|0|||
147532417|NCT01195662|532103987|FG000|Double Blind Treatment Period|Non-specified|3|||
147532418|NCT01195662|532103988|FG001|Double Blind Treatment Period|Non-specified|0|||
147532419|NCT01195662|532103989|FG002|Double Blind Treatment Period|Non-specified|0|||
147532420|NCT01195662|532103987|FG000|Double Blind Treatment Period|Missing disposition information|0|||
147532421|NCT01195662|532103988|FG001|Double Blind Treatment Period|Missing disposition information|1|||
147532422|NCT01195662|532103989|FG002|Double Blind Treatment Period|Missing disposition information|1|||
147532423|NCT01195662|532103987|FG000|Follow-Up(Week 13/1 Week Post Last Dose)|Withdrawal by Subject|2|||
147532424|NCT01195662|532103988|FG001|Follow-Up(Week 13/1 Week Post Last Dose)|Withdrawal by Subject|0|||
147532425|NCT01195662|532103989|FG002|Follow-Up(Week 13/1 Week Post Last Dose)|Withdrawal by Subject|1|||
147532426|NCT01195662|532103987|FG000|Follow-Up(Week 13/1 Week Post Last Dose)|non-specified|1|||
147532427|NCT01195662|532103988|FG001|Follow-Up(Week 13/1 Week Post Last Dose)|non-specified|0|||
147532428|NCT01195662|532103989|FG002|Follow-Up(Week 13/1 Week Post Last Dose)|non-specified|0|||
147532429|NCT00945815|532104000|FG000|Overall Study|Death|3|||
147532430|NCT00945815|532104000|FG000|Overall Study|Not protocol specified|1|||
147532431|NCT00945815|532104000|FG000|Overall Study|Ineligible|3|||
147532432|NCT00945815|532104000|FG000|Overall Study|Did not begin protocol therapy|1|||
147532433|NCT01590810|532104003|FG000|Overall Study|Physician Decision|0|||
147532434|NCT01590810|532104004|FG001|Overall Study|Physician Decision|1|||
147532435|NCT01590810|532104005|FG002|Overall Study|Physician Decision|1|||
147532436|NCT01590810|532104006|FG003|Overall Study|Physician Decision|0|||
147532437|NCT01590810|532104007|FG004|Overall Study|Physician Decision|0|||
147532438|NCT02400281|532104008|FG000|Overall Study|Adverse Event|0|||
147532439|NCT02400281|532104009|FG001|Overall Study|Adverse Event|0|||
147532440|NCT02400281|532104010|FG002|Overall Study|Adverse Event|1|||
147532441|NCT02400281|532104011|FG003|Overall Study|Adverse Event|0|||
147532442|NCT02400281|532104012|FG004|Overall Study|Adverse Event|1|||
147532443|NCT02400281|532104013|FG005|Overall Study|Adverse Event|0|||
147532444|NCT02400281|532104008|FG000|Overall Study|Physician Decision|0|||
147532445|NCT02400281|532104009|FG001|Overall Study|Physician Decision|0|||
147532446|NCT02400281|532104010|FG002|Overall Study|Physician Decision|1|||
147532447|NCT02400281|532104011|FG003|Overall Study|Physician Decision|0|||
147532448|NCT02400281|532104012|FG004|Overall Study|Physician Decision|0|||
147532449|NCT02400281|532104013|FG005|Overall Study|Physician Decision|0|||
147532450|NCT00412360|532104014|FG000|Overall Study|Lost to Follow-up|0|||
147532451|NCT00412360|532104015|FG001|Overall Study|Lost to Follow-up|1|||
147532452|NCT00412360|532104014|FG000|Overall Study|Not Transplanted|1|||
147532453|NCT00412360|532104015|FG001|Overall Study|Not Transplanted|2|||
147532454|NCT03655951|532104016|FG000|Overall Study|Lost to Follow-up|39|||
147532455|NCT03655951|532104017|FG001|Overall Study|Lost to Follow-up|20|||
147418954|NCT01631227|531696578|FG000|Overall Study|administrative|2|||
147418955|NCT01631227|531696579|FG001|Overall Study|administrative|1|||
147418956|NCT00766363|531696580|FG000|Overall Study|Withdrawal by Subject|1|||
147418957|NCT00766363|531696581|FG001|Overall Study|Withdrawal by Subject|0|||
147418958|NCT00766363|531696582|FG002|Overall Study|Withdrawal by Subject|0|||
147418959|NCT00766363|531696583|FG003|Overall Study|Withdrawal by Subject|0|||
147418960|NCT00766363|531696580|FG000|Overall Study|Adverse Event Prior to Randomization|0|||
147418961|NCT00766363|531696581|FG001|Overall Study|Adverse Event Prior to Randomization|1|||
147418962|NCT00766363|531696582|FG002|Overall Study|Adverse Event Prior to Randomization|0|||
147418963|NCT00766363|531696583|FG003|Overall Study|Adverse Event Prior to Randomization|0|||
147418964|NCT03292432|531696584|FG000|Overall Study|Lost to Follow-up|11|||
147418965|NCT03292432|531696585|FG001|Overall Study|Lost to Follow-up|8|||
147418966|NCT03292432|531696584|FG000|Overall Study|Death|2|||
147418967|NCT03292432|531696585|FG001|Overall Study|Death|1|||
147418968|NCT03292432|531696584|FG000|Overall Study|Withdrawal by Subject|1|||
147418969|NCT03292432|531696585|FG001|Overall Study|Withdrawal by Subject|2|||
147418970|NCT03292432|531696584|FG000|Overall Study|Site closed before any data collected|1|||
147418971|NCT03292432|531696585|FG001|Overall Study|Site closed before any data collected|0|||
147418972|NCT00964886|531696592|FG000|Overall Study|Lost to Follow-up|2|||
147418973|NCT00964886|531696593|FG001|Overall Study|Lost to Follow-up|2|||
147418974|NCT00964886|531696594|FG002|Overall Study|Lost to Follow-up|6|||
147418975|NCT00964886|531696595|FG003|Overall Study|Lost to Follow-up|4|||
147418976|NCT00964886|531696592|FG000|Overall Study|Withdrawal by Subject|6|||
147418977|NCT00964886|531696593|FG001|Overall Study|Withdrawal by Subject|2|||
147418978|NCT00964886|531696594|FG002|Overall Study|Withdrawal by Subject|5|||
147418979|NCT00964886|531696595|FG003|Overall Study|Withdrawal by Subject|3|||
147418980|NCT00964886|531696592|FG000|Overall Study|Adverse Event|3|||
147418981|NCT00964886|531696593|FG001|Overall Study|Adverse Event|1|||
147418982|NCT00964886|531696594|FG002|Overall Study|Adverse Event|5|||
147418983|NCT00964886|531696595|FG003|Overall Study|Adverse Event|2|||
147418984|NCT00964886|531696592|FG000|Overall Study|Protocol Violation|0|||
147418985|NCT00964886|531696593|FG001|Overall Study|Protocol Violation|2|||
147418986|NCT00964886|531696594|FG002|Overall Study|Protocol Violation|0|||
147418987|NCT00964886|531696595|FG003|Overall Study|Protocol Violation|0|||
147418988|NCT03500159|531696600|FG000|Overall Study|Study Terminated|2|||
147418989|NCT03500159|531696601|FG001|Overall Study|Study Terminated|1|||
147418990|NCT03412747|531696606|FG000|Initial Treatment Period: Wk0-Wk16|Adverse Event|2|||
147418991|NCT03412747|531696607|FG001|Initial Treatment Period: Wk0-Wk16|Adverse Event|2|||
147418992|NCT03412747|531696608|FG002|Initial Treatment Period: Wk0-Wk16|Adverse Event|3|||
147418993|NCT03412747|531696606|FG000|Initial Treatment Period: Wk0-Wk16|Death|0|||
147418994|NCT03412747|531696607|FG001|Initial Treatment Period: Wk0-Wk16|Death|0|||
147418995|NCT03412747|531696608|FG002|Initial Treatment Period: Wk0-Wk16|Death|1|||
147418996|NCT03412747|531696606|FG000|Initial Treatment Period: Wk0-Wk16|Lack of Efficacy|0|||
147418997|NCT03412747|531696607|FG001|Initial Treatment Period: Wk0-Wk16|Lack of Efficacy|0|||
147418998|NCT03412747|531696608|FG002|Initial Treatment Period: Wk0-Wk16|Lack of Efficacy|1|||
147418999|NCT03412747|531696606|FG000|Initial Treatment Period: Wk0-Wk16|Protocol Violation|0|||
147419000|NCT03412747|531696607|FG001|Initial Treatment Period: Wk0-Wk16|Protocol Violation|0|||
147419001|NCT03412747|531696608|FG002|Initial Treatment Period: Wk0-Wk16|Protocol Violation|2|||
147419002|NCT03412747|531696606|FG000|Initial Treatment Period: Wk0-Wk16|Lost to Follow-up|0|||
147419003|NCT03412747|531696607|FG001|Initial Treatment Period: Wk0-Wk16|Lost to Follow-up|2|||
147419004|NCT03412747|531696608|FG002|Initial Treatment Period: Wk0-Wk16|Lost to Follow-up|1|||
147419005|NCT03412747|531696606|FG000|Initial Treatment Period: Wk0-Wk16|Withdrawal by Subject|4|||
147419006|NCT03412747|531696607|FG001|Initial Treatment Period: Wk0-Wk16|Withdrawal by Subject|1|||
147419007|NCT03412747|531696608|FG002|Initial Treatment Period: Wk0-Wk16|Withdrawal by Subject|1|||
147419008|NCT03412747|531696606|FG000|Initial Treatment Period: Wk0-Wk16|Participant moved out of state|1|||
147419009|NCT03412747|531696607|FG001|Initial Treatment Period: Wk0-Wk16|Participant moved out of state|0|||
147419010|NCT03412747|531696608|FG002|Initial Treatment Period: Wk0-Wk16|Participant moved out of state|0|||
147419011|NCT03412747|531696606|FG000|Maintenance Treatment Period: Wk16-Wk24|Adverse Event|3|||
147419012|NCT03412747|531696607|FG001|Maintenance Treatment Period: Wk16-Wk24|Adverse Event|1|||
147419013|NCT03412747|531696608|FG002|Maintenance Treatment Period: Wk16-Wk24|Adverse Event|0|||
147419014|NCT03412747|531696606|FG000|Maintenance Treatment Period: Wk16-Wk24|Lack of Efficacy|1|||
147419015|NCT03412747|531696607|FG001|Maintenance Treatment Period: Wk16-Wk24|Lack of Efficacy|0|||
147419016|NCT03412747|531696608|FG002|Maintenance Treatment Period: Wk16-Wk24|Lack of Efficacy|0|||
147419017|NCT03412747|531696606|FG000|Maintenance Treatment Period: Wk16-Wk24|Lost to Follow-up|0|||
147419018|NCT03412747|531696607|FG001|Maintenance Treatment Period: Wk16-Wk24|Lost to Follow-up|0|||
147419019|NCT03412747|531696608|FG002|Maintenance Treatment Period: Wk16-Wk24|Lost to Follow-up|1|||
147419020|NCT03412747|531696606|FG000|Maintenance Treatment Period: Wk16-Wk24|Withdrawal by Subject|1|||
147419021|NCT03412747|531696607|FG001|Maintenance Treatment Period: Wk16-Wk24|Withdrawal by Subject|0|||
147419022|NCT03412747|531696608|FG002|Maintenance Treatment Period: Wk16-Wk24|Withdrawal by Subject|0|||
147419023|NCT03412747|531696606|FG000|Maintenance Treatment Period: Wk24-Wk56|Adverse Event|3|||
147419024|NCT03412747|531696607|FG001|Maintenance Treatment Period: Wk24-Wk56|Adverse Event|4|||
147419025|NCT03412747|531696608|FG002|Maintenance Treatment Period: Wk24-Wk56|Adverse Event|6|||
147419026|NCT03412747|531696606|FG000|Maintenance Treatment Period: Wk24-Wk56|Lack of Efficacy|0|||
147419027|NCT03412747|531696607|FG001|Maintenance Treatment Period: Wk24-Wk56|Lack of Efficacy|1|||
147419028|NCT03412747|531696608|FG002|Maintenance Treatment Period: Wk24-Wk56|Lack of Efficacy|1|||
147419029|NCT03412747|531696606|FG000|Maintenance Treatment Period: Wk24-Wk56|Lost to Follow-up|0|||
147419030|NCT03412747|531696607|FG001|Maintenance Treatment Period: Wk24-Wk56|Lost to Follow-up|2|||
147419031|NCT03412747|531696608|FG002|Maintenance Treatment Period: Wk24-Wk56|Lost to Follow-up|5|||
147419032|NCT03412747|531696606|FG000|Maintenance Treatment Period: Wk24-Wk56|Withdrawal by Subject|3|||
147419033|NCT03412747|531696607|FG001|Maintenance Treatment Period: Wk24-Wk56|Withdrawal by Subject|1|||
147419034|NCT03412747|531696608|FG002|Maintenance Treatment Period: Wk24-Wk56|Withdrawal by Subject|4|||
147419035|NCT03412747|531696606|FG000|Maintenance Treatment Period: Wk24-Wk56|Moving out of town|0|||
147419036|NCT03412747|531696607|FG001|Maintenance Treatment Period: Wk24-Wk56|Moving out of town|1|||
147419037|NCT03412747|531696608|FG002|Maintenance Treatment Period: Wk24-Wk56|Moving out of town|0|||
147419038|NCT03484273|531696609|FG000|Overall Study|Equipment Malfunction|1|||
147419039|NCT03484273|531696609|FG000|Overall Study|Data excluded from analysis|1|||
147419040|NCT00468104|531696613|FG000|First Intervention|Protocol Violation|2|||
147419041|NCT00468104|531696614|FG001|First Intervention|Protocol Violation|1|||
147419042|NCT00468104|531696613|FG000|First Intervention|bleeding at chest tube site--first dose|1|||
147419043|NCT00468104|531696614|FG001|First Intervention|bleeding at chest tube site--first dose|0|||
147419044|NCT00468104|531696613|FG000|First Intervention|died within 3 weeks|1|||
147419045|NCT00468104|531696614|FG001|First Intervention|died within 3 weeks|0|||
147419046|NCT00468104|531696613|FG000|First Intervention|malposition/blocked chest tube tube|2|||
147419047|NCT00468104|531696614|FG001|First Intervention|malposition/blocked chest tube tube|0|||
147419048|NCT00468104|531696613|FG000|First Intervention|large lung mass with minimal effusion|1|||
147419049|NCT00468104|531696614|FG001|First Intervention|large lung mass with minimal effusion|0|||
147419050|NCT00468104|531696613|FG000|First Intervention|associated prolonged pneumothorax|1|||
147419051|NCT00468104|531696614|FG001|First Intervention|associated prolonged pneumothorax|0|||
147419052|NCT00468104|531696613|FG000|First Intervention|trapped lung|1|||
147419053|NCT00468104|531696614|FG001|First Intervention|trapped lung|0|||
147419054|NCT00468104|531696613|FG000|Second Intervention|Withdrawal by Subject|5|||
147419055|NCT00468104|531696614|FG001|Second Intervention|Withdrawal by Subject|2|||
147419056|NCT00468104|531696613|FG000|Second Intervention|discarded for malposition of chest tube|0|||
147419057|NCT00468104|531696614|FG001|Second Intervention|discarded for malposition of chest tube|2|||
147419058|NCT02706899|531696617|FG000|Overall Study|Withdrawal by Subject|1|||
147419059|NCT02706899|531696618|FG001|Overall Study|Withdrawal by Subject|0|||
147419060|NCT02706899|531696617|FG000|Overall Study|Death|8|||
147419061|NCT02706899|531696618|FG001|Overall Study|Death|0|||
147419062|NCT02706899|531696617|FG000|Overall Study|Study Termination by Sponsor|4|||
147419063|NCT02706899|531696618|FG001|Overall Study|Study Termination by Sponsor|6|||
147419064|NCT00324675|531696619|FG000|Overall Study|Adverse Event|1|||
147419065|NCT00324675|531696620|FG001|Overall Study|Adverse Event|0|||
147419066|NCT00381615|531696621|FG000|Overall Study|Withdrawal by Subject|1|||
147419067|NCT00381615|531696622|FG001|Overall Study|Withdrawal by Subject|3|||
147419068|NCT00381615|531696623|FG002|Overall Study|Withdrawal by Subject|0|||
147419069|NCT00381615|531696624|FG003|Overall Study|Withdrawal by Subject|1|||
147419070|NCT00381615|531696621|FG000|Overall Study|Lost to Follow-up|3|||
147419071|NCT00381615|531696622|FG001|Overall Study|Lost to Follow-up|2|||
147419072|NCT00381615|531696623|FG002|Overall Study|Lost to Follow-up|0|||
147419073|NCT00381615|531696624|FG003|Overall Study|Lost to Follow-up|1|||
147419074|NCT00381615|531696621|FG000|Overall Study|Protocol Violation|0|||
147419075|NCT00381615|531696622|FG001|Overall Study|Protocol Violation|0|||
147419076|NCT00381615|531696623|FG002|Overall Study|Protocol Violation|1|||
147419077|NCT00381615|531696624|FG003|Overall Study|Protocol Violation|0|||
147419078|NCT02432196|531696634|FG000|Overall Study|Exit - did not receive study device|1|||
147419079|NCT02432196|531696634|FG000|Overall Study|Death|2|||
147419080|NCT02432196|531696634|FG000|Overall Study|Reoperation|3|||
147419081|NCT01905150|531696635|FG000|Overall Study|Subjects was enrolled but did not start treatment because subjects have poor physical condition.|2|||
147419082|NCT01905150|531696636|FG001|Overall Study|Subjects was enrolled but did not start treatment because subjects have poor physical condition.|0|||
147419083|NCT02592876|531696637|FG000|Overall Study|Withdrawal by Subject|3|||
147419084|NCT02592876|531696638|FG001|Overall Study|Withdrawal by Subject|3|||
147419085|NCT02592876|531696637|FG000|Overall Study|Study Termination by Sponsor|32|||
147419086|NCT02592876|531696638|FG001|Overall Study|Study Termination by Sponsor|27|||
147419087|NCT02592876|531696637|FG000|Overall Study|Lost to Follow-up|0|||
147419088|NCT02592876|531696638|FG001|Overall Study|Lost to Follow-up|1|||
147419089|NCT02592876|531696637|FG000|Overall Study|Death|6|||
147419090|NCT02592876|531696638|FG001|Overall Study|Death|9|||
147419091|NCT00611975|531696641|FG000|Overall Study|Withdrawal by Subject|3|||
147419092|NCT00611975|531696642|FG001|Overall Study|Withdrawal by Subject|7|||
147419093|NCT00611975|531696641|FG000|Overall Study|Pregnancy|2|||
147419094|NCT00611975|531696642|FG001|Overall Study|Pregnancy|1|||
147419095|NCT03465904|531696643|FG000|Overall Study|Withdrawal by Subject|9|||
147419096|NCT03465904|531696644|FG001|Overall Study|Withdrawal by Subject|5|||
147419097|NCT03465904|531696643|FG000|Overall Study|Lost to Follow-up|11|||
147419098|NCT03465904|531696644|FG001|Overall Study|Lost to Follow-up|9|||
147532456|NCT03655951|532104016|FG000|Overall Study|Withdrawal by Subject|0|||
147419099|NCT03465904|531696643|FG000|Overall Study|Protocol Violation|20|||
147419100|NCT03465904|531696644|FG001|Overall Study|Protocol Violation|15|||
147419101|NCT04625413|531696645|FG000|Overall Study|Hospice|2|||
147419102|NCT04625413|531696645|FG000|Overall Study|Distress|1|||
147419103|NCT04625413|531696645|FG000|Overall Study|Not feeling well|1|||
147419104|NCT01305200|531696646|FG000|Overall Study|Physician Decision|4|||
147419105|NCT01305200|531696647|FG001|Overall Study|Physician Decision|6|||
147419106|NCT01305200|531696648|FG002|Overall Study|Physician Decision|1|||
147419107|NCT01305200|531696646|FG000|Overall Study|Withdrawal by Subject|24|||
147419108|NCT01305200|531696647|FG001|Overall Study|Withdrawal by Subject|21|||
147419109|NCT01305200|531696648|FG002|Overall Study|Withdrawal by Subject|1|||
147419110|NCT01305200|531696646|FG000|Overall Study|Ineligible|1|||
147419111|NCT01305200|531696647|FG001|Overall Study|Ineligible|2|||
147419112|NCT01305200|531696648|FG002|Overall Study|Ineligible|1|||
147419113|NCT01305200|531696646|FG000|Overall Study|Death|0|||
147419114|NCT01305200|531696647|FG001|Overall Study|Death|2|||
147419115|NCT01305200|531696648|FG002|Overall Study|Death|0|||
147419116|NCT03981861|531696649|FG000|Overall Study|Withdrawal by Subject|3|||
147419117|NCT00432666|531698522|FG000|Main Period|Adverse Event|1|||
147419118|NCT00432666|531698523|FG001|Main Period|Adverse Event|1|||
147419119|NCT00432666|531698522|FG000|Main Period|Consent Withdrawn|1|||
147419120|NCT00432666|531698523|FG001|Main Period|Consent Withdrawn|0|||
147419121|NCT00432666|531698522|FG000|Open-Label Extension Period|Withdrawal Criteria Occurred|1|||
147419122|NCT00432666|531698523|FG001|Open-Label Extension Period|Withdrawal Criteria Occurred|0|||
147419123|NCT00432666|531698522|FG000|Open-Label Extension Period|Lack of Efficacy|6|||
147419124|NCT00432666|531698523|FG001|Open-Label Extension Period|Lack of Efficacy|0|||
147419125|NCT00432666|531698522|FG000|Open-Label Extension Period|Adverse Event|5|||
147419126|NCT00432666|531698523|FG001|Open-Label Extension Period|Adverse Event|0|||
147419127|NCT00432666|531698522|FG000|Open-Label Extension Period|Consent withdrawn|10|||
147419128|NCT00432666|531698523|FG001|Open-Label Extension Period|Consent withdrawn|0|||
147419129|NCT00432666|531698522|FG000|Open-Label Extension Period|Physician Decision|3|||
147419130|NCT00432666|531698523|FG001|Open-Label Extension Period|Physician Decision|0|||
147419131|NCT00978627|531698524|FG000|Main: Week 0 to 26 (NN5401-3594)|Adverse Event|4|||
147419132|NCT00978627|531698525|FG001|Main: Week 0 to 26 (NN5401-3594)|Adverse Event|3|||
147419133|NCT00978627|531698524|FG000|Main: Week 0 to 26 (NN5401-3594)|Lack of Efficacy|2|||
147419134|NCT00978627|531698525|FG001|Main: Week 0 to 26 (NN5401-3594)|Lack of Efficacy|0|||
147419135|NCT00978627|531698524|FG000|Main: Week 0 to 26 (NN5401-3594)|Protocol Violation|8|||
147419136|NCT00978627|531698525|FG001|Main: Week 0 to 26 (NN5401-3594)|Protocol Violation|6|||
147419137|NCT00978627|531698524|FG000|Main: Week 0 to 26 (NN5401-3594)|Withdrawal criteria|7|||
147419138|NCT00978627|531698525|FG001|Main: Week 0 to 26 (NN5401-3594)|Withdrawal criteria|5|||
147419139|NCT00978627|531698524|FG000|Main: Week 0 to 26 (NN5401-3594)|Unclassified|25|||
147419140|NCT00978627|531698525|FG001|Main: Week 0 to 26 (NN5401-3594)|Unclassified|12|||
147419141|NCT00978627|531698524|FG000|Extension: Week 27 to 52 (NN5401-3645)|Adverse Event|3|||
147419142|NCT00978627|531698525|FG001|Extension: Week 27 to 52 (NN5401-3645)|Adverse Event|0|||
147419143|NCT00978627|531698524|FG000|Extension: Week 27 to 52 (NN5401-3645)|Protocol Violation|4|||
147419144|NCT00978627|531698525|FG001|Extension: Week 27 to 52 (NN5401-3645)|Protocol Violation|1|||
147419145|NCT00978627|531698524|FG000|Extension: Week 27 to 52 (NN5401-3645)|Withdrawal criteria|2|||
147419146|NCT00978627|531698525|FG001|Extension: Week 27 to 52 (NN5401-3645)|Withdrawal criteria|1|||
147419147|NCT00978627|531698524|FG000|Extension: Week 27 to 52 (NN5401-3645)|Unclassified|12|||
147419148|NCT00978627|531698525|FG001|Extension: Week 27 to 52 (NN5401-3645)|Unclassified|7|||
147419149|NCT00565851|531698526|FG000|Chemotherapy Assignment|Never Initiated Chemotherapy|9|||
147419150|NCT00565851|531698527|FG001|Chemotherapy Assignment|Never Initiated Chemotherapy|9|||
147419151|NCT00565851|531698528|FG002|Chemotherapy Assignment|Never Initiated Chemotherapy|3|||
147419152|NCT00565851|531698529|FG003|Chemotherapy Assignment|Never Initiated Chemotherapy|18|||
147419153|NCT00565851|531698530|FG004|Chemotherapy Assignment|Never Initiated Chemotherapy|0|||
147419154|NCT00565851|531698531|FG005|Chemotherapy Assignment|Never Initiated Chemotherapy|2|||
147419155|NCT00565851|531698532|FG006|Chemotherapy Assignment|Never Initiated Chemotherapy|0|||
147419156|NCT00565851|531698533|FG007|Chemotherapy Assignment|Never Initiated Chemotherapy|2|||
147419157|NCT00565851|531698526|FG000|Chemotherapy Assignment|Still On Chemotherapy|0|||
147419158|NCT00565851|531698527|FG001|Chemotherapy Assignment|Still On Chemotherapy|14|||
147419159|NCT00565851|531698528|FG002|Chemotherapy Assignment|Still On Chemotherapy|0|||
147419160|NCT00565851|531698529|FG003|Chemotherapy Assignment|Still On Chemotherapy|18|||
147419161|NCT00565851|531698530|FG004|Chemotherapy Assignment|Still On Chemotherapy|0|||
147419162|NCT00565851|531698531|FG005|Chemotherapy Assignment|Still On Chemotherapy|1|||
147419163|NCT00565851|531698532|FG006|Chemotherapy Assignment|Still On Chemotherapy|0|||
147419164|NCT00565851|531698533|FG007|Chemotherapy Assignment|Still On Chemotherapy|1|||
147419165|NCT03730480|531698534|FG000|Overall Study|Meter displayed a HI result which is non evaluable.|1|||
147419166|NCT00006011|531698542|FG000|Overall Study|Disease progression|13|||
147419167|NCT00006011|531698543|FG001|Overall Study|Disease progression|6|||
147419168|NCT00006011|531698544|FG002|Overall Study|Disease progression|26|||
147419169|NCT00006011|531698542|FG000|Overall Study|Refused further treatment|15|||
147645549|NCT01149421|532522022|FG002|Overall Study|Adverse Event|11|||
147419170|NCT00006011|531698543|FG001|Overall Study|Refused further treatment|13|||
147419171|NCT00006011|531698544|FG002|Overall Study|Refused further treatment|26|||
147419172|NCT00006011|531698542|FG000|Overall Study|Adverse Event|15|||
147419173|NCT00006011|531698543|FG001|Overall Study|Adverse Event|39|||
147419174|NCT00006011|531698544|FG002|Overall Study|Adverse Event|5|||
147419175|NCT00006011|531698542|FG000|Overall Study|Death|0|||
147419176|NCT00006011|531698543|FG001|Overall Study|Death|1|||
147419177|NCT00006011|531698544|FG002|Overall Study|Death|2|||
147419178|NCT00006011|531698542|FG000|Overall Study|Other|4|||
147419179|NCT00006011|531698543|FG001|Overall Study|Other|2|||
147419180|NCT00006011|531698544|FG002|Overall Study|Other|5|||
147419181|NCT00006011|531698542|FG000|Overall Study|Ineligible|18|||
147419182|NCT00006011|531698543|FG001|Overall Study|Ineligible|16|||
147419183|NCT00006011|531698544|FG002|Overall Study|Ineligible|9|||
147419184|NCT00911937|531698545|FG000|Overall Study|Death|1|||
147419185|NCT00911937|531698546|FG001|Overall Study|Death|0|||
147419186|NCT00911937|531698545|FG000|Overall Study|Lost to Follow-up|8|||
147419187|NCT00911937|531698546|FG001|Overall Study|Lost to Follow-up|5|||
147419188|NCT00911937|531698545|FG000|Overall Study|Withdrawal by Subject|10|||
147419189|NCT00911937|531698546|FG001|Overall Study|Withdrawal by Subject|7|||
147419190|NCT00911937|531698545|FG000|Overall Study|Withdrawn due to pregnancy|1|||
147419191|NCT00911937|531698546|FG001|Overall Study|Withdrawn due to pregnancy|0|||
147419192|NCT00911937|531698545|FG000|Overall Study|Adverse Event|11|||
147419193|NCT00911937|531698546|FG001|Overall Study|Adverse Event|25|||
147419194|NCT00911937|531698545|FG000|Overall Study|Lack of Efficacy|11|||
147419195|NCT00911937|531698546|FG001|Overall Study|Lack of Efficacy|6|||
147419196|NCT00911937|531698545|FG000|Overall Study|Did not meet inclusion criteria|9|||
147419197|NCT00911937|531698546|FG001|Overall Study|Did not meet inclusion criteria|11|||
147419198|NCT00911937|531698545|FG000|Overall Study|Protocol Violation|14|||
147419199|NCT00911937|531698546|FG001|Overall Study|Protocol Violation|23|||
147419200|NCT00911937|531698545|FG000|Overall Study|Randomized but not treated|13|||
147419201|NCT00911937|531698546|FG001|Overall Study|Randomized but not treated|13|||
147419202|NCT00911937|531698545|FG000|Overall Study|Other|9|||
147419203|NCT00911937|531698546|FG001|Overall Study|Other|5|||
147419204|NCT02057523|531698548|FG000|Overall Study|Withdrawal by Subject|1|||
147419205|NCT02057523|531698548|FG000|Overall Study|Lack of Efficacy|1|||
147419206|NCT01263665|531698549|FG000|Overall Study|Withdrew Consent|1|||
147419207|NCT01263665|531698549|FG000|Overall Study|Lost to Follow-up|3|||
147419208|NCT01263665|531698549|FG000|Overall Study|Death|2|||
147419209|NCT01263665|531698549|FG000|Overall Study|Amputation above the ankle|1|||
147419210|NCT01263665|531698549|FG000|Overall Study|Surgical Bypass|2|||
147419211|NCT01435616|531698550|FG000|Overall Study|Adverse Event|39|||
147419212|NCT01435616|531698551|FG001|Overall Study|Adverse Event|21|||
147419213|NCT01435616|531698550|FG000|Overall Study|Death|7|||
147419214|NCT01435616|531698551|FG001|Overall Study|Death|2|||
147419215|NCT01435616|531698550|FG000|Overall Study|Lost to Follow-up|22|||
147419216|NCT01435616|531698551|FG001|Overall Study|Lost to Follow-up|13|||
147419217|NCT01435616|531698550|FG000|Overall Study|Protocol Violation|16|||
147419218|NCT01435616|531698551|FG001|Overall Study|Protocol Violation|13|||
147419219|NCT01435616|531698550|FG000|Overall Study|Withdrawal by Subject|66|||
147419220|NCT01435616|531698551|FG001|Overall Study|Withdrawal by Subject|24|||
147532457|NCT03655951|532104017|FG001|Overall Study|Withdrawal by Subject|1|||
147595919|NCT01194973|532338750|FG000|26 Week Treatment Period|Adverse Event|1|||
147595920|NCT01194973|532338750|FG000|26 Week Treatment Period|Lack of Efficacy|1|||
147595921|NCT01194973|532338750|FG000|26 Week Treatment Period|Pregnancy|1|||
147595922|NCT03096847|532338751|FG000|Overall Study|Other|2|||
147595923|NCT03096847|532338752|FG001|Overall Study|Other|1|||
147595924|NCT03096847|532338753|FG002|Overall Study|Other|2|||
147595925|NCT03096847|532338751|FG000|Overall Study|Lost to Follow-up|1|||
147419221|NCT01435616|531698550|FG000|Overall Study|Physician Decision|20|||
147419222|NCT01435616|531698551|FG001|Overall Study|Physician Decision|7|||
147419223|NCT01435616|531698550|FG000|Overall Study|Sponsor Decision|1|||
147419224|NCT01435616|531698551|FG001|Overall Study|Sponsor Decision|0|||
147419225|NCT04811131|531698557|FG000|Overall Study|Adverse Event|0|||
147419226|NCT04811131|531698558|FG001|Overall Study|Adverse Event|0|||
147419227|NCT04811131|531698559|FG002|Overall Study|Adverse Event|1|||
147419228|NCT04811131|531698560|FG003|Overall Study|Adverse Event|0|||
147419229|NCT04811131|531698557|FG000|Overall Study|Lack of Efficacy|0|||
147419230|NCT04811131|531698558|FG001|Overall Study|Lack of Efficacy|0|||
147419231|NCT04811131|531698559|FG002|Overall Study|Lack of Efficacy|0|||
147419232|NCT04811131|531698560|FG003|Overall Study|Lack of Efficacy|1|||
147419233|NCT04811131|531698557|FG000|Overall Study|Lost to Follow-up|0|||
147419234|NCT04811131|531698558|FG001|Overall Study|Lost to Follow-up|1|||
147419235|NCT04811131|531698559|FG002|Overall Study|Lost to Follow-up|0|||
147419236|NCT04811131|531698560|FG003|Overall Study|Lost to Follow-up|0|||
147419237|NCT04811131|531698557|FG000|Overall Study|Sponsor request|31|||
147419238|NCT04811131|531698558|FG001|Overall Study|Sponsor request|35|||
147419239|NCT04811131|531698559|FG002|Overall Study|Sponsor request|27|||
147419240|NCT04811131|531698560|FG003|Overall Study|Sponsor request|10|||
147595926|NCT03096847|532338752|FG001|Overall Study|Lost to Follow-up|0|||
147595927|NCT03096847|532338753|FG002|Overall Study|Lost to Follow-up|1|||
147419241|NCT04811131|531698557|FG000|Overall Study|Withdrawal by Subject|3|||
147419242|NCT04811131|531698558|FG001|Overall Study|Withdrawal by Subject|1|||
147419243|NCT04811131|531698559|FG002|Overall Study|Withdrawal by Subject|3|||
147419244|NCT04811131|531698560|FG003|Overall Study|Withdrawal by Subject|1|||
147419245|NCT00620282|531698564|FG000|Overall Study|Adverse Event|0|||
147419246|NCT00620282|531698565|FG001|Overall Study|Adverse Event|1|||
147419247|NCT00620282|531698566|FG002|Overall Study|Adverse Event|0|||
147419248|NCT00620282|531698564|FG000|Overall Study|Arterial line unable to be placed|0|||
147419249|NCT00620282|531698565|FG001|Overall Study|Arterial line unable to be placed|0|||
147419250|NCT00620282|531698566|FG002|Overall Study|Arterial line unable to be placed|1|||
147419251|NCT00620282|531698564|FG000|Overall Study|Withdrawal by Subject|0|||
147419252|NCT00620282|531698565|FG001|Overall Study|Withdrawal by Subject|1|||
147419253|NCT00620282|531698566|FG002|Overall Study|Withdrawal by Subject|0|||
147419254|NCT02217475|531698567|FG000|Treatment Period 1 (Year 1)|Protocol Deviation (with non-compliance)|0|||
147419255|NCT02217475|531698568|FG001|Treatment Period 1 (Year 1)|Protocol Deviation (with non-compliance)|1|||
147419256|NCT02217475|531698569|FG002|Treatment Period 1 (Year 1)|Protocol Deviation (with non-compliance)|0|||
147419257|NCT02217475|531698567|FG000|Treatment Period 1 (Year 1)|Adverse Event|4|||
147419258|NCT02217475|531698568|FG001|Treatment Period 1 (Year 1)|Adverse Event|5|||
147419259|NCT02217475|531698569|FG002|Treatment Period 1 (Year 1)|Adverse Event|9|||
147419260|NCT02217475|531698567|FG000|Treatment Period 1 (Year 1)|Lost to Follow-up|1|||
147419261|NCT02217475|531698568|FG001|Treatment Period 1 (Year 1)|Lost to Follow-up|0|||
147419262|NCT02217475|531698569|FG002|Treatment Period 1 (Year 1)|Lost to Follow-up|0|||
147419263|NCT02217475|531698567|FG000|Treatment Period 1 (Year 1)|Subject Withdrew Consent|5|||
147419264|NCT02217475|531698568|FG001|Treatment Period 1 (Year 1)|Subject Withdrew Consent|2|||
147419265|NCT02217475|531698569|FG002|Treatment Period 1 (Year 1)|Subject Withdrew Consent|11|||
147419266|NCT02217475|531698567|FG000|Treatment Period 1 (Year 1)|Other Miscellaneous Reasons|0|||
147419267|NCT02217475|531698568|FG001|Treatment Period 1 (Year 1)|Other Miscellaneous Reasons|0|||
147419268|NCT02217475|531698569|FG002|Treatment Period 1 (Year 1)|Other Miscellaneous Reasons|1|||
147419269|NCT02217475|531698567|FG000|Discontinued After Period 1|Adverse Event|1|||
147419270|NCT02217475|531698568|FG001|Discontinued After Period 1|Adverse Event|2|||
147419271|NCT02217475|531698569|FG002|Discontinued After Period 1|Adverse Event|0|||
147419272|NCT02217475|531698567|FG000|Discontinued After Period 1|Participant Withdrew Consent|1|||
147419273|NCT02217475|531698568|FG001|Discontinued After Period 1|Participant Withdrew Consent|1|||
147419274|NCT02217475|531698569|FG002|Discontinued After Period 1|Participant Withdrew Consent|2|||
147419275|NCT02217475|531698567|FG000|Discontinued After Period 1|Physician Decision|0|||
147419276|NCT02217475|531698568|FG001|Discontinued After Period 1|Physician Decision|0|||
147419277|NCT02217475|531698569|FG002|Discontinued After Period 1|Physician Decision|1|||
147419278|NCT02217475|531698567|FG000|Treatment Period 2 (Year 2)|Adverse Event|0|||
147419279|NCT02217475|531698568|FG001|Treatment Period 2 (Year 2)|Adverse Event|1|||
147419280|NCT02217475|531698569|FG002|Treatment Period 2 (Year 2)|Adverse Event|5|||
147419281|NCT02217475|531698567|FG000|Treatment Period 2 (Year 2)|Lost to Follow-up|0|||
147419282|NCT02217475|531698568|FG001|Treatment Period 2 (Year 2)|Lost to Follow-up|1|||
147419283|NCT02217475|531698569|FG002|Treatment Period 2 (Year 2)|Lost to Follow-up|2|||
147419284|NCT02217475|531698567|FG000|Treatment Period 2 (Year 2)|Subject Withdrew Consent|2|||
147419285|NCT02217475|531698568|FG001|Treatment Period 2 (Year 2)|Subject Withdrew Consent|0|||
147419286|NCT02217475|531698569|FG002|Treatment Period 2 (Year 2)|Subject Withdrew Consent|2|||
147419287|NCT02217475|531698567|FG000|Treatment Period 2 (Year 2)|Physician Decision|0|||
147419288|NCT02217475|531698568|FG001|Treatment Period 2 (Year 2)|Physician Decision|0|||
147419289|NCT02217475|531698569|FG002|Treatment Period 2 (Year 2)|Physician Decision|2|||
147419290|NCT02217475|531698567|FG000|Treatment Period 2 (Year 2)|Other Miscellaneous Reasons|0|||
147419291|NCT02217475|531698568|FG001|Treatment Period 2 (Year 2)|Other Miscellaneous Reasons|0|||
147419292|NCT02217475|531698569|FG002|Treatment Period 2 (Year 2)|Other Miscellaneous Reasons|1|||
147419293|NCT04738292|531698574|FG000|Overall Study|Death|1|||
147419294|NCT00371683|531698575|FG000|DB Treatment Period-Randomized Patients|Death|1|||
147419295|NCT00371683|531698576|FG001|DB Treatment Period-Randomized Patients|Death|1|||
147419296|NCT00371683|531698575|FG000|DB Treatment Period-Randomized Patients|Adverse Event|60|||
147419297|NCT00371683|531698576|FG001|DB Treatment Period-Randomized Patients|Adverse Event|58|||
147532458|NCT00509223|532105923|FG000|Overall Study|Lost to Follow-up|1|||
147532459|NCT00509223|532105924|FG001|Overall Study|Lost to Follow-up|1|||
147532460|NCT00509223|532105923|FG000|Overall Study|Adverse Event|1|||
147532461|NCT00509223|532105924|FG001|Overall Study|Adverse Event|1|||
147532462|NCT00509223|532105923|FG000|Overall Study|Withdrawal by Subject|25|||
147532463|NCT00509223|532105924|FG001|Overall Study|Withdrawal by Subject|6|||
147532464|NCT00509223|532105923|FG000|Overall Study|Including: subject change of address|5|||
147532465|NCT00509223|532105924|FG001|Overall Study|Including: subject change of address|2|||
147532466|NCT00509223|532105923|FG000|Overall Study|Did not meet revised inclusion criteria|56|||
147532467|NCT00509223|532105924|FG001|Overall Study|Did not meet revised inclusion criteria|62|||
147419298|NCT00371683|531698575|FG000|DB Treatment Period-Randomized Patients|Withdrawal by Subject|18|||
147419299|NCT00371683|531698576|FG001|DB Treatment Period-Randomized Patients|Withdrawal by Subject|37|||
147532468|NCT00437294|532105930|FG000|Overall Study|Adverse Event|5|||
147419300|NCT00371683|531698575|FG000|DB Treatment Period-Randomized Patients|Lost to Follow-up|0|||
147419301|NCT00371683|531698576|FG001|DB Treatment Period-Randomized Patients|Lost to Follow-up|1|||
147419302|NCT00371683|531698575|FG000|DB Treatment Period-Randomized Patients|No longer meets study criteria|1|||
147419303|NCT00371683|531698576|FG001|DB Treatment Period-Randomized Patients|No longer meets study criteria|2|||
147419304|NCT00371683|531698575|FG000|DB Treatment Period-Randomized Patients|Administrative reason by sponsor|1|||
147419305|NCT00371683|531698576|FG001|DB Treatment Period-Randomized Patients|Administrative reason by sponsor|0|||
147419306|NCT00371683|531698575|FG000|DB Treatment Period-Randomized Patients|non-specified|9|||
147419307|NCT00371683|531698576|FG001|DB Treatment Period-Randomized Patients|non-specified|8|||
147419308|NCT00371683|531698575|FG000|Follow-Up Period - Randomized Patients|Withdrawal by Subject|17|||
147419309|NCT00371683|531698576|FG001|Follow-Up Period - Randomized Patients|Withdrawal by Subject|19|||
147419310|NCT00371683|531698575|FG000|Follow-Up Period - Randomized Patients|Death|0|||
147419311|NCT00371683|531698576|FG001|Follow-Up Period - Randomized Patients|Death|2|||
147419312|NCT00371683|531698575|FG000|Follow-Up Period - Randomized Patients|Lost to Follow-up|38|||
147419313|NCT00371683|531698576|FG001|Follow-Up Period - Randomized Patients|Lost to Follow-up|39|||
147419314|NCT00371683|531698575|FG000|Follow-Up Period - Randomized Patients|non-specified|6|||
147419315|NCT00371683|531698576|FG001|Follow-Up Period - Randomized Patients|non-specified|12|||
147419316|NCT03181789|531698578|FG000|Overall Study|Withdrawal by Subject|0|||
147419317|NCT03181789|531698579|FG001|Overall Study|Withdrawal by Subject|1|||
147419318|NCT03181789|531698580|FG002|Overall Study|Withdrawal by Subject|1|||
147419319|NCT03181789|531698581|FG003|Overall Study|Withdrawal by Subject|0|||
147419320|NCT03181789|531698578|FG000|Overall Study|Lost to Follow-up|7|||
147419321|NCT03181789|531698579|FG001|Overall Study|Lost to Follow-up|1|||
147419322|NCT03181789|531698580|FG002|Overall Study|Lost to Follow-up|0|||
147419323|NCT03181789|531698581|FG003|Overall Study|Lost to Follow-up|0|||
147419324|NCT03181789|531698578|FG000|Overall Study|Participant unable to adhere to visit|0|||
147419325|NCT03181789|531698579|FG001|Overall Study|Participant unable to adhere to visit|1|||
147419326|NCT03181789|531698580|FG002|Overall Study|Participant unable to adhere to visit|0|||
147419327|NCT03181789|531698581|FG003|Overall Study|Participant unable to adhere to visit|0|||
147419328|NCT01131182|531698582|FG000|Overall Study|Withdrawal by Subject|1|||
147419329|NCT01131182|531698583|FG001|Overall Study|Withdrawal by Subject|1|||
147419330|NCT01131182|531698582|FG000|Overall Study|Lost to Follow-up|14|||
147419331|NCT01131182|531698583|FG001|Overall Study|Lost to Follow-up|15|||
147419332|NCT01131182|531698582|FG000|Overall Study|Other Reason|1|||
147419333|NCT01131182|531698583|FG001|Overall Study|Other Reason|0|||
147419334|NCT03001076|531698584|FG000|Overall Study|Withdrawal by patient|2|||
147419335|NCT03001076|531698585|FG001|Overall Study|Withdrawal by patient|0|||
147419336|NCT03001076|531698584|FG000|Overall Study|Other|1|||
147419337|NCT03001076|531698585|FG001|Overall Study|Other|0|||
147419338|NCT03001076|531698584|FG000|Overall Study|Adverse Event|3|||
147419339|NCT03001076|531698585|FG001|Overall Study|Adverse Event|3|||
147419340|NCT03001076|531698584|FG000|Overall Study|Sponsor decision|1|||
147419341|NCT03001076|531698585|FG001|Overall Study|Sponsor decision|0|||
147419342|NCT03001076|531698584|FG000|Overall Study|Lost to Follow-up|0|||
147419343|NCT03001076|531698585|FG001|Overall Study|Lost to Follow-up|2|||
147419344|NCT04602221|531698586|FG000|Overall Study|Discontinuation of trial treatment|0|||
147419345|NCT04602221|531698587|FG001|Overall Study|Discontinuation of trial treatment|0|||
147419346|NCT04602221|531698588|FG002|Overall Study|Discontinuation of trial treatment|1|||
147419347|NCT04602221|531698589|FG003|Overall Study|Discontinuation of trial treatment|0|||
147419348|NCT04602221|531698590|FG004|Overall Study|Discontinuation of trial treatment|0|||
147419349|NCT04602221|531698591|FG005|Overall Study|Discontinuation of trial treatment|0|||
147419350|NCT04602221|531698592|FG006|Overall Study|Discontinuation of trial treatment|0|||
147419351|NCT04602221|531698593|FG007|Overall Study|Discontinuation of trial treatment|0|||
147419352|NCT04602221|531698594|FG008|Overall Study|Discontinuation of trial treatment|0|||
147419353|NCT04602221|531698595|FG009|Overall Study|Discontinuation of trial treatment|0|||
147419354|NCT04602221|531698596|FG010|Overall Study|Discontinuation of trial treatment|0|||
147419355|NCT04602221|531698597|FG011|Overall Study|Discontinuation of trial treatment|0|||
147419356|NCT04602221|531698598|FG012|Overall Study|Discontinuation of trial treatment|0|||
147419357|NCT04602221|531698599|FG013|Overall Study|Discontinuation of trial treatment|0|||
147419358|NCT04602221|531698600|FG014|Overall Study|Discontinuation of trial treatment|0|||
147419359|NCT04602221|531698601|FG015|Overall Study|Discontinuation of trial treatment|0|||
147419360|NCT04602221|531698602|FG016|Overall Study|Discontinuation of trial treatment|0|||
147419361|NCT04602221|531698603|FG017|Overall Study|Discontinuation of trial treatment|0|||
147419362|NCT04602221|531698586|FG000|Overall Study|Other than listed|0|||
147419363|NCT04602221|531698587|FG001|Overall Study|Other than listed|0|||
147419364|NCT04602221|531698588|FG002|Overall Study|Other than listed|0|||
147419365|NCT04602221|531698589|FG003|Overall Study|Other than listed|0|||
147419366|NCT04602221|531698590|FG004|Overall Study|Other than listed|0|||
147419367|NCT04602221|531698591|FG005|Overall Study|Other than listed|0|||
147419368|NCT04602221|531698592|FG006|Overall Study|Other than listed|0|||
147419369|NCT04602221|531698593|FG007|Overall Study|Other than listed|0|||
147419370|NCT04602221|531698594|FG008|Overall Study|Other than listed|0|||
147191096|NCT00812708|530867533|FG000|Overall Study|Lack of medical insurance|1|||
147419371|NCT04602221|531698595|FG009|Overall Study|Other than listed|0|||
147419372|NCT04602221|531698596|FG010|Overall Study|Other than listed|0|||
147419373|NCT04602221|531698597|FG011|Overall Study|Other than listed|0|||
147419374|NCT04602221|531698598|FG012|Overall Study|Other than listed|0|||
147419375|NCT04602221|531698599|FG013|Overall Study|Other than listed|0|||
147419376|NCT04602221|531698600|FG014|Overall Study|Other than listed|0|||
147419377|NCT04602221|531698601|FG015|Overall Study|Other than listed|1|||
147419378|NCT04602221|531698602|FG016|Overall Study|Other than listed|0|||
147419379|NCT04602221|531698603|FG017|Overall Study|Other than listed|1|||
147419380|NCT04602221|531698586|FG000|Overall Study|Withdrawal by Subject|0|||
147419381|NCT04602221|531698587|FG001|Overall Study|Withdrawal by Subject|0|||
147419382|NCT04602221|531698588|FG002|Overall Study|Withdrawal by Subject|0|||
147419383|NCT04602221|531698589|FG003|Overall Study|Withdrawal by Subject|0|||
147419384|NCT04602221|531698590|FG004|Overall Study|Withdrawal by Subject|0|||
147419385|NCT04602221|531698591|FG005|Overall Study|Withdrawal by Subject|0|||
147419386|NCT04602221|531698592|FG006|Overall Study|Withdrawal by Subject|0|||
147419387|NCT04602221|531698593|FG007|Overall Study|Withdrawal by Subject|0|||
147419388|NCT04602221|531698594|FG008|Overall Study|Withdrawal by Subject|0|||
147419389|NCT04602221|531698595|FG009|Overall Study|Withdrawal by Subject|0|||
147419390|NCT04602221|531698596|FG010|Overall Study|Withdrawal by Subject|0|||
147419391|NCT04602221|531698597|FG011|Overall Study|Withdrawal by Subject|0|||
147419392|NCT04602221|531698598|FG012|Overall Study|Withdrawal by Subject|1|||
147419393|NCT04602221|531698599|FG013|Overall Study|Withdrawal by Subject|0|||
147419394|NCT04602221|531698600|FG014|Overall Study|Withdrawal by Subject|0|||
147419395|NCT04602221|531698601|FG015|Overall Study|Withdrawal by Subject|0|||
147419396|NCT04602221|531698602|FG016|Overall Study|Withdrawal by Subject|0|||
147419397|NCT04602221|531698603|FG017|Overall Study|Withdrawal by Subject|0|||
147419398|NCT04602221|531698586|FG000|Overall Study|Lost to Follow-up|0|||
147419399|NCT04602221|531698587|FG001|Overall Study|Lost to Follow-up|0|||
147419400|NCT04602221|531698588|FG002|Overall Study|Lost to Follow-up|0|||
147419401|NCT04602221|531698589|FG003|Overall Study|Lost to Follow-up|0|||
147419402|NCT04602221|531698590|FG004|Overall Study|Lost to Follow-up|0|||
147419403|NCT04602221|531698591|FG005|Overall Study|Lost to Follow-up|1|||
147419404|NCT04602221|531698592|FG006|Overall Study|Lost to Follow-up|0|||
147419405|NCT04602221|531698593|FG007|Overall Study|Lost to Follow-up|0|||
147419406|NCT04602221|531698594|FG008|Overall Study|Lost to Follow-up|0|||
147419407|NCT04602221|531698595|FG009|Overall Study|Lost to Follow-up|0|||
147419408|NCT04602221|531698596|FG010|Overall Study|Lost to Follow-up|0|||
147419409|NCT04602221|531698597|FG011|Overall Study|Lost to Follow-up|0|||
147419410|NCT04602221|531698598|FG012|Overall Study|Lost to Follow-up|0|||
147419411|NCT04602221|531698599|FG013|Overall Study|Lost to Follow-up|0|||
147419412|NCT04602221|531698600|FG014|Overall Study|Lost to Follow-up|0|||
147419413|NCT04602221|531698601|FG015|Overall Study|Lost to Follow-up|0|||
147419414|NCT04602221|531698602|FG016|Overall Study|Lost to Follow-up|0|||
147419415|NCT04602221|531698603|FG017|Overall Study|Lost to Follow-up|0|||
147419416|NCT01080716|531698604|FG000|Part 1|Physician Decision|1|||
147419417|NCT01080716|531698605|FG001|Part 1|Physician Decision|0|||
147419418|NCT01080716|531698606|FG002|Part 1|Physician Decision|0|||
147419419|NCT01080716|531698607|FG003|Part 1|Physician Decision|0|||
147419420|NCT01056718|531698608|FG000|Overall Study|Withdrawal by Subject|2|||
147419421|NCT01056718|531698608|FG000|Overall Study|Ischemia on baseline stress test|1|||
147419422|NCT02270515|531698609|FG000|Intervention Period 1: 0-6 Months|Withdrawal by Subject|1|||
147532469|NCT00437294|532105931|FG001|Overall Study|Adverse Event|4|||
147532470|NCT00437294|532105930|FG000|Overall Study|Death|5|||
147532471|NCT00437294|532105931|FG001|Overall Study|Death|2|||
147532472|NCT00437294|532105930|FG000|Overall Study|Physician Decision|0|||
147532473|NCT00437294|532105931|FG001|Overall Study|Physician Decision|3|||
147532474|NCT00437294|532105930|FG000|Overall Study|Withdrawal by Subject|5|||
147532475|NCT00437294|532105931|FG001|Overall Study|Withdrawal by Subject|0|||
147532476|NCT00437294|532105930|FG000|Overall Study|Progressive Disease|19|||
147532477|NCT00437294|532105931|FG001|Overall Study|Progressive Disease|23|||
147532478|NCT00437294|532105930|FG000|Overall Study|Sponsor Decision|8|||
147532479|NCT00437294|532105931|FG001|Overall Study|Sponsor Decision|9|||
147532480|NCT00437294|532105930|FG000|Overall Study|Protocol Violation|0|||
147532481|NCT00437294|532105931|FG001|Overall Study|Protocol Violation|1|||
147532482|NCT00437294|532105930|FG000|Overall Study|Entry criteria not met|1|||
147532483|NCT00437294|532105931|FG001|Overall Study|Entry criteria not met|1|||
147532484|NCT01473602|532105939|FG000|Overall Study|Adverse Event|1|||
147419423|NCT02270515|531698609|FG000|Intervention Period 1: 0-6 Months|No longer patient at study site|5|||
147419424|NCT02270515|531698609|FG000|Intervention Period 1: 0-6 Months|Received transplant|3|||
147419425|NCT02270515|531698609|FG000|Intervention Period 1: 0-6 Months|Death|7|||
147532485|NCT01473602|532105940|FG001|Overall Study|Adverse Event|2|||
147532486|NCT01473602|532105939|FG000|Overall Study|Death|0|||
147532487|NCT01473602|532105940|FG001|Overall Study|Death|1|||
147532488|NCT01473602|532105939|FG000|Overall Study|Lost to Follow-up|1|||
147419426|NCT02270515|531698609|FG000|Intervention Period 2: 6-12 Months|Withdrawal by Subject|2|||
147532489|NCT01473602|532105940|FG001|Overall Study|Lost to Follow-up|1|||
147532490|NCT01473602|532105939|FG000|Overall Study|Withdrawal by Subject|5|||
147532491|NCT01473602|532105940|FG001|Overall Study|Withdrawal by Subject|4|||
147532492|NCT01473602|532105939|FG000|Overall Study|Physician Decision|1|||
147532493|NCT01473602|532105940|FG001|Overall Study|Physician Decision|0|||
147532494|NCT00449761|532105941|FG000|Overall Study|Disease progression|12|||
147532495|NCT00449761|532105941|FG000|Overall Study|Death|5|||
147532496|NCT00449761|532105941|FG000|Overall Study|New cancer therapy|1|||
147532497|NCT00560573|532105942|FG000|Overall Study|Death|4|||
147532498|NCT00560573|532105943|FG001|Overall Study|Death|1|||
147532499|NCT00560573|532105944|FG002|Overall Study|Death|4|||
147532500|NCT00560573|532105945|FG003|Overall Study|Death|5|||
147532501|NCT00560573|532105946|FG004|Overall Study|Death|1|||
147532502|NCT00560573|532105947|FG005|Overall Study|Death|10|||
147532503|NCT00560573|532105942|FG000|Overall Study|Lost to Follow-up|0|||
147532504|NCT00560573|532105943|FG001|Overall Study|Lost to Follow-up|0|||
147532505|NCT00560573|532105944|FG002|Overall Study|Lost to Follow-up|0|||
147532506|NCT00560573|532105945|FG003|Overall Study|Lost to Follow-up|1|||
147532507|NCT00560573|532105946|FG004|Overall Study|Lost to Follow-up|1|||
147532508|NCT00560573|532105947|FG005|Overall Study|Lost to Follow-up|0|||
147532509|NCT00560573|532105942|FG000|Overall Study|Withdrawal by Subject|0|||
147532510|NCT00560573|532105943|FG001|Overall Study|Withdrawal by Subject|0|||
147532511|NCT00560573|532105944|FG002|Overall Study|Withdrawal by Subject|0|||
147532512|NCT00560573|532105945|FG003|Overall Study|Withdrawal by Subject|1|||
147532513|NCT00560573|532105946|FG004|Overall Study|Withdrawal by Subject|1|||
147532514|NCT00560573|532105947|FG005|Overall Study|Withdrawal by Subject|0|||
147532515|NCT00560573|532105942|FG000|Overall Study|Other|2|||
147532516|NCT00560573|532105943|FG001|Overall Study|Other|2|||
147532517|NCT00560573|532105944|FG002|Overall Study|Other|2|||
147532518|NCT00560573|532105945|FG003|Overall Study|Other|3|||
147532519|NCT00560573|532105946|FG004|Overall Study|Other|3|||
147532520|NCT00560573|532105947|FG005|Overall Study|Other|3|||
147532521|NCT00560573|532105942|FG000|Overall Study|Enrolled, not treated|0|||
147532522|NCT00560573|532105943|FG001|Overall Study|Enrolled, not treated|0|||
147532523|NCT00560573|532105944|FG002|Overall Study|Enrolled, not treated|0|||
147532524|NCT00560573|532105945|FG003|Overall Study|Enrolled, not treated|0|||
147532525|NCT00560573|532105946|FG004|Overall Study|Enrolled, not treated|1|||
147532526|NCT00560573|532105947|FG005|Overall Study|Enrolled, not treated|0|||
147532527|NCT01339273|532105948|FG000|Overall Study|Lost to Follow-up|8|||
147532528|NCT01339273|532105949|FG001|Overall Study|Lost to Follow-up|8|||
147532529|NCT00726882|532105950|FG000|Overall Study|Withdrawal by Subject|5|||
147532530|NCT00726882|532105950|FG000|Overall Study|Lost to Follow-up|7|||
147532531|NCT00726882|532105950|FG000|Overall Study|Other|10|||
147532532|NCT00594568|532105951|FG000|Initial Treatment|Adverse Event|51|||
147532533|NCT00594568|532105952|FG001|Initial Treatment|Adverse Event|121|||
147532534|NCT00594568|532105953|FG002|Initial Treatment|Adverse Event|144|||
147532535|NCT00594568|532105951|FG000|Initial Treatment|Death|6|||
147532536|NCT00594568|532105952|FG001|Initial Treatment|Death|11|||
147532537|NCT00594568|532105953|FG002|Initial Treatment|Death|15|||
147532538|NCT00594568|532105951|FG000|Initial Treatment|Lost to Follow-up|4|||
147532539|NCT00594568|532105952|FG001|Initial Treatment|Lost to Follow-up|1|||
147532540|NCT00594568|532105953|FG002|Initial Treatment|Lost to Follow-up|4|||
147532541|NCT00594568|532105951|FG000|Initial Treatment|Physician Decision|3|||
147532542|NCT00594568|532105952|FG001|Initial Treatment|Physician Decision|2|||
147532543|NCT00594568|532105953|FG002|Initial Treatment|Physician Decision|4|||
147532544|NCT00594568|532105951|FG000|Initial Treatment|Protocol Violation|2|||
147532545|NCT00594568|532105952|FG001|Initial Treatment|Protocol Violation|2|||
147532546|NCT00594568|532105953|FG002|Initial Treatment|Protocol Violation|5|||
147532547|NCT00594568|532105951|FG000|Initial Treatment|Withdrawal by Subject|25|||
147532548|NCT00594568|532105952|FG001|Initial Treatment|Withdrawal by Subject|31|||
147532549|NCT00594568|532105953|FG002|Initial Treatment|Withdrawal by Subject|46|||
147532550|NCT00594568|532105951|FG000|Initial Treatment|Sponsor decision|193|||
147532551|NCT00594568|532105952|FG001|Initial Treatment|Sponsor decision|142|||
147532552|NCT00594568|532105953|FG002|Initial Treatment|Sponsor decision|147|||
147532553|NCT00594568|532105951|FG000|Initial Treatment|Caregiver decision|21|||
147532554|NCT00594568|532105952|FG001|Initial Treatment|Caregiver decision|36|||
147532555|NCT00594568|532105953|FG002|Initial Treatment|Caregiver decision|36|||
147532556|NCT00594568|532105951|FG000|Initial Treatment|Abnormal lab/electrocardiogram (ECG)|7|||
147532557|NCT00594568|532105952|FG001|Initial Treatment|Abnormal lab/electrocardiogram (ECG)|7|||
147532558|NCT00594568|532105953|FG002|Initial Treatment|Abnormal lab/electrocardiogram (ECG)|6|||
147532559|NCT00594568|532105951|FG000|Initial Treatment|Entry criteria exclusion|0|||
147532560|NCT00594568|532105952|FG001|Initial Treatment|Entry criteria exclusion|1|||
147532561|NCT00594568|532105953|FG002|Initial Treatment|Entry criteria exclusion|1|||
147532562|NCT00594568|532105951|FG000|Delayed Start|Death|0|||
147532563|NCT00594568|532105952|FG001|Delayed Start|Death|0|||
147532564|NCT00594568|532105953|FG002|Delayed Start|Death|1|||
147532565|NCT00594568|532105951|FG000|Delayed Start|Adverse Event|12|||
147532566|NCT00594568|532105952|FG001|Delayed Start|Adverse Event|2|||
147532567|NCT00594568|532105953|FG002|Delayed Start|Adverse Event|2|||
147532568|NCT00594568|532105951|FG000|Delayed Start|Withdrawal by Subject|4|||
147532569|NCT00594568|532105952|FG001|Delayed Start|Withdrawal by Subject|3|||
147532570|NCT00594568|532105953|FG002|Delayed Start|Withdrawal by Subject|0|||
147532571|NCT00594568|532105951|FG000|Delayed Start|Physician Decision|0|||
147532572|NCT00594568|532105952|FG001|Delayed Start|Physician Decision|0|||
147532573|NCT00594568|532105953|FG002|Delayed Start|Physician Decision|1|||
147532574|NCT00594568|532105951|FG000|Delayed Start|Lost to Follow-up|0|||
147532575|NCT00594568|532105952|FG001|Delayed Start|Lost to Follow-up|0|||
147532576|NCT00594568|532105953|FG002|Delayed Start|Lost to Follow-up|1|||
147532577|NCT00594568|532105951|FG000|Delayed Start|Caregiver Decision|5|||
147532578|NCT00594568|532105952|FG001|Delayed Start|Caregiver Decision|6|||
147532579|NCT00594568|532105953|FG002|Delayed Start|Caregiver Decision|2|||
147532580|NCT00594568|532105951|FG000|Delayed Start|Sponsor Decision|77|||
147532581|NCT00594568|532105952|FG001|Delayed Start|Sponsor Decision|66|||
147532582|NCT00594568|532105953|FG002|Delayed Start|Sponsor Decision|59|||
147532583|NCT00594568|532105951|FG000|Safety Follow Up (SFU)-Optional|Death|0|||
147532584|NCT00594568|532105952|FG001|Safety Follow Up (SFU)-Optional|Death|1|||
147532585|NCT00594568|532105953|FG002|Safety Follow Up (SFU)-Optional|Death|0|||
147532586|NCT00594568|532105951|FG000|Safety Follow Up (SFU)-Optional|Adverse Event|5|||
147532587|NCT00594568|532105952|FG001|Safety Follow Up (SFU)-Optional|Adverse Event|0|||
147532588|NCT00594568|532105953|FG002|Safety Follow Up (SFU)-Optional|Adverse Event|0|||
147532589|NCT00594568|532105951|FG000|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|12|||
147532590|NCT00594568|532105952|FG001|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|15|||
147532591|NCT00594568|532105953|FG002|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|13|||
147532592|NCT00594568|532105951|FG000|Safety Follow Up (SFU)-Optional|Lost to Follow-up|2|||
147532593|NCT00594568|532105952|FG001|Safety Follow Up (SFU)-Optional|Lost to Follow-up|1|||
147532594|NCT00594568|532105953|FG002|Safety Follow Up (SFU)-Optional|Lost to Follow-up|2|||
147532595|NCT00594568|532105951|FG000|Safety Follow Up (SFU)-Optional|Caregiver Decision|17|||
147532596|NCT00594568|532105952|FG001|Safety Follow Up (SFU)-Optional|Caregiver Decision|16|||
147532597|NCT00594568|532105953|FG002|Safety Follow Up (SFU)-Optional|Caregiver Decision|9|||
147532598|NCT00594568|532105951|FG000|Safety Follow Up (SFU)-Optional|No safety visit or follow up|25|||
147532599|NCT00594568|532105952|FG001|Safety Follow Up (SFU)-Optional|No safety visit or follow up|22|||
147532600|NCT00594568|532105953|FG002|Safety Follow Up (SFU)-Optional|No safety visit or follow up|18|||
147532601|NCT01422876|532105955|FG000|Week 24|Lost to Follow-up|1|||
147532602|NCT01422876|532105956|FG001|Week 24|Lost to Follow-up|1|||
147532603|NCT01422876|532105957|FG002|Week 24|Lost to Follow-up|2|||
147532604|NCT01422876|532105958|FG003|Week 24|Lost to Follow-up|4|||
147532605|NCT01422876|532105959|FG004|Week 24|Lost to Follow-up|2|||
147532606|NCT01422876|532105960|FG005|Week 24|Lost to Follow-up|0|||
147532607|NCT01422876|532105961|FG006|Week 24|Lost to Follow-up|1|||
147532608|NCT01422876|532105962|FG007|Week 24|Lost to Follow-up|3|||
147532609|NCT01422876|532105963|FG008|Week 24|Lost to Follow-up|3|||
147532610|NCT01422876|532105964|FG009|Week 24|Lost to Follow-up|4|||
147532611|NCT01422876|532105955|FG000|Week 24|Consent withdrawn|5|||
147532612|NCT01422876|532105956|FG001|Week 24|Consent withdrawn|1|||
147532613|NCT01422876|532105957|FG002|Week 24|Consent withdrawn|3|||
147532614|NCT01422876|532105958|FG003|Week 24|Consent withdrawn|4|||
147532615|NCT01422876|532105959|FG004|Week 24|Consent withdrawn|5|||
147532616|NCT01422876|532105960|FG005|Week 24|Consent withdrawn|6|||
147532617|NCT01422876|532105961|FG006|Week 24|Consent withdrawn|5|||
147532618|NCT01422876|532105962|FG007|Week 24|Consent withdrawn|4|||
147532619|NCT01422876|532105963|FG008|Week 24|Consent withdrawn|3|||
147532620|NCT01422876|532105964|FG009|Week 24|Consent withdrawn|6|||
147532621|NCT01422876|532105955|FG000|Week 24|Death|0|||
147532622|NCT01422876|532105956|FG001|Week 24|Death|1|||
147532623|NCT01422876|532105957|FG002|Week 24|Death|0|||
147532624|NCT01422876|532105958|FG003|Week 24|Death|0|||
147532625|NCT01422876|532105959|FG004|Week 24|Death|0|||
147532626|NCT01422876|532105960|FG005|Week 24|Death|0|||
147532627|NCT01422876|532105961|FG006|Week 24|Death|0|||
147532628|NCT01422876|532105962|FG007|Week 24|Death|0|||
147532629|NCT01422876|532105963|FG008|Week 24|Death|0|||
147532630|NCT01422876|532105964|FG009|Week 24|Death|0|||
147532631|NCT01422876|532105955|FG000|Week 52|Lost to Follow-up|3|||
147532632|NCT01422876|532105956|FG001|Week 52|Lost to Follow-up|5|||
147532633|NCT01422876|532105957|FG002|Week 52|Lost to Follow-up|7|||
147532634|NCT01422876|532105958|FG003|Week 52|Lost to Follow-up|5|||
147532635|NCT01422876|532105959|FG004|Week 52|Lost to Follow-up|8|||
147532636|NCT01422876|532105960|FG005|Week 52|Lost to Follow-up|5|||
147532637|NCT01422876|532105961|FG006|Week 52|Lost to Follow-up|5|||
147532638|NCT01422876|532105962|FG007|Week 52|Lost to Follow-up|8|||
147532639|NCT01422876|532105963|FG008|Week 52|Lost to Follow-up|7|||
147532640|NCT01422876|532105964|FG009|Week 52|Lost to Follow-up|8|||
147532641|NCT01422876|532105955|FG000|Week 52|Consent withdrawn|9|||
147532642|NCT01422876|532105956|FG001|Week 52|Consent withdrawn|4|||
147532643|NCT01422876|532105957|FG002|Week 52|Consent withdrawn|6|||
147532644|NCT01422876|532105958|FG003|Week 52|Consent withdrawn|12|||
147532645|NCT01422876|532105959|FG004|Week 52|Consent withdrawn|7|||
147532646|NCT01422876|532105960|FG005|Week 52|Consent withdrawn|12|||
147532647|NCT01422876|532105961|FG006|Week 52|Consent withdrawn|10|||
147532648|NCT01422876|532105962|FG007|Week 52|Consent withdrawn|12|||
147532649|NCT01422876|532105963|FG008|Week 52|Consent withdrawn|13|||
147532650|NCT01422876|532105964|FG009|Week 52|Consent withdrawn|9|||
147532651|NCT01422876|532105955|FG000|Week 52|Death|0|||
147532652|NCT01422876|532105956|FG001|Week 52|Death|1|||
147532653|NCT01422876|532105957|FG002|Week 52|Death|0|||
147532654|NCT01422876|532105958|FG003|Week 52|Death|1|||
147532655|NCT01422876|532105959|FG004|Week 52|Death|0|||
147532656|NCT01422876|532105960|FG005|Week 52|Death|0|||
147532657|NCT01422876|532105961|FG006|Week 52|Death|1|||
147532658|NCT01422876|532105962|FG007|Week 52|Death|3|||
147532659|NCT01422876|532105963|FG008|Week 52|Death|1|||
147532660|NCT01422876|532105964|FG009|Week 52|Death|0|||
147532661|NCT02856282|532105965|FG000|Overall Study|Withdrawal by Subject|1|||
147532662|NCT02506101|532105970|FG000|Overall Study|Transportation issues|1|||
147532663|NCT02506101|532105971|FG001|Overall Study|Transportation issues|0|||
147532664|NCT02506101|532105970|FG000|Overall Study|No enrollment and staff unavailability|1|||
147532665|NCT02506101|532105971|FG001|Overall Study|No enrollment and staff unavailability|0|||
147532666|NCT01308476|532105972|FG000|Overall Study|Lost to Follow-up|2|||
147532667|NCT01308476|532105973|FG001|Overall Study|Lost to Follow-up|2|||
147532668|NCT01308476|532105972|FG000|Overall Study|Other|1|||
147532669|NCT01308476|532105973|FG001|Overall Study|Other|0|||
147532670|NCT02696382|532105974|FG000|Overall Study|Death|7|||
147532671|NCT02696382|532105975|FG001|Overall Study|Death|2|||
147532672|NCT02696382|532105974|FG000|Overall Study|Withdrawal by Subject|5|||
147532673|NCT02696382|532105975|FG001|Overall Study|Withdrawal by Subject|12|||
147532674|NCT02696382|532105974|FG000|Overall Study|Lost to Follow-up|4|||
147532675|NCT02696382|532105975|FG001|Overall Study|Lost to Follow-up|7|||
147532676|NCT03246152|532105977|FG000|Overall Study|Lost to Follow-up|2|||
147532677|NCT03246152|532105977|FG000|Overall Study|Protocol Violation|1|||
147532678|NCT00423137|532105978|FG000|Overall Study|Lost to Follow-up|0|||
147532679|NCT00423137|532105979|FG001|Overall Study|Lost to Follow-up|0|||
147532680|NCT00423137|532105980|FG002|Overall Study|Lost to Follow-up|1|||
147532681|NCT00423137|532105981|FG003|Overall Study|Lost to Follow-up|0|||
147532682|NCT00423137|532105978|FG000|Overall Study|Protocol Violation|0|||
147532683|NCT00423137|532105979|FG001|Overall Study|Protocol Violation|0|||
147532684|NCT00423137|532105980|FG002|Overall Study|Protocol Violation|0|||
147532685|NCT00423137|532105981|FG003|Overall Study|Protocol Violation|1|||
147532686|NCT00423137|532105978|FG000|Overall Study|Adverse Event Study disease worse|1|||
147532687|NCT00423137|532105979|FG001|Overall Study|Adverse Event Study disease worse|0|||
147532688|NCT00423137|532105980|FG002|Overall Study|Adverse Event Study disease worse|3|||
147532689|NCT00423137|532105981|FG003|Overall Study|Adverse Event Study disease worse|1|||
147532690|NCT00423137|532105978|FG000|Overall Study|Adverse Event Other|0|||
147532691|NCT00423137|532105979|FG001|Overall Study|Adverse Event Other|0|||
147532692|NCT00423137|532105980|FG002|Overall Study|Adverse Event Other|2|||
147532693|NCT00423137|532105981|FG003|Overall Study|Adverse Event Other|0|||
147532694|NCT01243762|532105982|FG000|Part 1 (Dose Escalation/MTD)|Adverse Event|0|||
147532695|NCT01243762|532105983|FG001|Part 1 (Dose Escalation/MTD)|Adverse Event|2|||
147532696|NCT01243762|532105984|FG002|Part 1 (Dose Escalation/MTD)|Adverse Event|0|||
147532697|NCT01243762|532105985|FG003|Part 1 (Dose Escalation/MTD)|Adverse Event|0|||
147532698|NCT01243762|532105986|FG004|Part 1 (Dose Escalation/MTD)|Adverse Event|1|||
147532699|NCT01243762|532105987|FG005|Part 1 (Dose Escalation/MTD)|Adverse Event|1|||
147645550|NCT01149421|532522020|FG000|Overall Study|Withdrawal by Subject|20|||
147645551|NCT01149421|532522021|FG001|Overall Study|Withdrawal by Subject|12|||
147645552|NCT01149421|532522022|FG002|Overall Study|Withdrawal by Subject|13|||
147645553|NCT01149421|532522020|FG000|Overall Study|Sponsor Decision|0|||
147645554|NCT01149421|532522021|FG001|Overall Study|Sponsor Decision|1|||
147645555|NCT01149421|532522022|FG002|Overall Study|Sponsor Decision|1|||
147645556|NCT01149421|532522020|FG000|Overall Study|Lost to Follow-up|2|||
147645557|NCT01149421|532522021|FG001|Overall Study|Lost to Follow-up|4|||
147645558|NCT01149421|532522022|FG002|Overall Study|Lost to Follow-up|5|||
147645559|NCT01149421|532522020|FG000|Overall Study|Physician Decision|5|||
147645560|NCT01149421|532522021|FG001|Overall Study|Physician Decision|3|||
147645561|NCT01149421|532522022|FG002|Overall Study|Physician Decision|6|||
147645562|NCT01149421|532522020|FG000|Overall Study|Entry Criteria Not Met|1|||
147645563|NCT01149421|532522021|FG001|Overall Study|Entry Criteria Not Met|1|||
147645564|NCT01149421|532522022|FG002|Overall Study|Entry Criteria Not Met|2|||
147645565|NCT01149421|532522020|FG000|Overall Study|Protocol Violation|2|||
147645566|NCT01149421|532522021|FG001|Overall Study|Protocol Violation|2|||
147645567|NCT01149421|532522022|FG002|Overall Study|Protocol Violation|6|||
147645568|NCT03738800|532522028|FG000|Double-blind Treatment Period|Withdrawal by Subject|2|||
147645569|NCT03738800|532522029|FG001|Double-blind Treatment Period|Withdrawal by Subject|0|||
147645570|NCT03738800|532522030|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
147645571|NCT03738800|532522028|FG000|Double-blind Treatment Period|Study Discontinued By Sponsor|5|||
147645572|NCT03738800|532522029|FG001|Double-blind Treatment Period|Study Discontinued By Sponsor|3|||
147645573|NCT03738800|532522030|FG002|Double-blind Treatment Period|Study Discontinued By Sponsor|3|||
147645574|NCT03738800|532522028|FG000|Double-blind Treatment Period|Lack of Efficacy|2|||
147645575|NCT03738800|532522029|FG001|Double-blind Treatment Period|Lack of Efficacy|0|||
147645576|NCT03738800|532522030|FG002|Double-blind Treatment Period|Lack of Efficacy|1|||
147645577|NCT02223819|532522032|FG000|Overall Study|Lost to Follow-up|2|||
147645578|NCT01917344|532522034|FG000|Overall Study|Withdrawal by Subject|1|||
147645579|NCT02956057|532522035|FG000|Overall Study|Discontinued intervention|14|||
147532700|NCT01243762|532105988|FG006|Part 1 (Dose Escalation/MTD)|Adverse Event|0|||
147645580|NCT02956057|532522036|FG001|Overall Study|Discontinued intervention|10|||
147645581|NCT02956057|532522037|FG002|Overall Study|Discontinued intervention|7|||
147645582|NCT02956057|532522038|FG003|Overall Study|Discontinued intervention|14|||
147645583|NCT02956057|532522039|FG004|Overall Study|Discontinued intervention|4|||
147645584|NCT02956057|532522040|FG005|Overall Study|Discontinued intervention|17|||
147645585|NCT02956057|532522035|FG000|Overall Study|Lost to Follow-up|0|||
147645586|NCT02956057|532522036|FG001|Overall Study|Lost to Follow-up|2|||
147645587|NCT02956057|532522037|FG002|Overall Study|Lost to Follow-up|1|||
147645588|NCT02956057|532522038|FG003|Overall Study|Lost to Follow-up|1|||
147645589|NCT02956057|532522039|FG004|Overall Study|Lost to Follow-up|1|||
147645590|NCT02956057|532522040|FG005|Overall Study|Lost to Follow-up|0|||
147645591|NCT03435224|532522043|FG000|Overall Study|Unable to achieve a minimum desaturation level|4|||
147645592|NCT00367484|532522044|FG000|Overall Study|Adverse Event|7|||
147645593|NCT00367484|532522044|FG000|Overall Study|Withdrew informed consent|5|||
147645594|NCT00367484|532522044|FG000|Overall Study|Travel to USA|1|||
147645595|NCT00367484|532522044|FG000|Overall Study|Lost to Follow-up|1|||
147645596|NCT00367484|532522044|FG000|Overall Study|Protocol Violation|1|||
147645597|NCT00367484|532522044|FG000|Overall Study|The choice of the patient|1|||
147645598|NCT00367484|532522044|FG000|Overall Study|Lack of Efficacy|1|||
147645599|NCT04472026|532522045|FG000|Overall Study|Lost to Follow-up|5|||
147645600|NCT02382796|532522046|FG000|Overall Study|Global deterioration of health status|1|||
147645601|NCT02382796|532522046|FG000|Overall Study|Objective progression or relapse|3|||
147645602|NCT02382796|532522046|FG000|Overall Study|Commercial dacomitinib became available|3|||
147645603|NCT04007107|532522051|FG000|Treatment Period 2 (Day 1)|Withdrawal by Subject|0|||
147645604|NCT04007107|532522052|FG001|Treatment Period 2 (Day 1)|Withdrawal by Subject|1|||
147645605|NCT04007107|532522053|FG002|Treatment Period 2 (Day 1)|Withdrawal by Subject|0|||
147645606|NCT04007107|532522054|FG003|Treatment Period 2 (Day 1)|Withdrawal by Subject|0|||
147645607|NCT04526574|532522055|FG000|Overall Study|Protocol Violation|3|||
147645608|NCT04526574|532522056|FG001|Overall Study|Protocol Violation|1|||
147645609|NCT04526574|532522055|FG000|Overall Study|Withdrawal by Subject|12|||
147645610|NCT04526574|532522056|FG001|Overall Study|Withdrawal by Subject|9|||
147645611|NCT04526574|532522055|FG000|Overall Study|Other|1|||
147645612|NCT04526574|532522056|FG001|Overall Study|Other|2|||
147645613|NCT04526574|532522055|FG000|Overall Study|Adverse Event|1|||
147645614|NCT04526574|532522056|FG001|Overall Study|Adverse Event|1|||
147645615|NCT04526574|532522055|FG000|Overall Study|Death|2|||
147645616|NCT04526574|532522056|FG001|Overall Study|Death|3|||
147645617|NCT04526574|532522055|FG000|Overall Study|Lost to Follow-up|9|||
147645618|NCT04526574|532522056|FG001|Overall Study|Lost to Follow-up|9|||
147645619|NCT04526574|532522055|FG000|Overall Study|No longer meets eligibility criteria|8|||
147645620|NCT04526574|532522056|FG001|Overall Study|No longer meets eligibility criteria|8|||
147645621|NCT00426660|532522062|FG000|Overall Study|Death|14|||
147645622|NCT00426660|532522062|FG000|Overall Study|Adverse Event|23|||
147645623|NCT00426660|532522062|FG000|Overall Study|Insufficient Clinical Response|22|||
147645624|NCT00426660|532522062|FG000|Overall Study|Lost to Follow-up|15|||
147645625|NCT00426660|532522062|FG000|Overall Study|Other|23|||
147645626|NCT00426660|532522062|FG000|Overall Study|Withdrawal by Subject|18|||
147645627|NCT00426660|532522062|FG000|Overall Study|Protocol Violation|1|||
147645628|NCT00426660|532522062|FG000|Overall Study|Enrolled Not Treated|15|||
147645629|NCT00980174|532522063|FG000|Overall Study|Withdrawal by Subject|1|||
147645630|NCT00980174|532522064|FG001|Overall Study|Withdrawal by Subject|4|||
147645631|NCT00980174|532522063|FG000|Overall Study|Adverse Event|0|||
147645632|NCT00980174|532522064|FG001|Overall Study|Adverse Event|3|||
147645633|NCT00980174|532522063|FG000|Overall Study|Ineligibility determined|2|||
147645634|NCT00980174|532522064|FG001|Overall Study|Ineligibility determined|1|||
147645635|NCT00980174|532522063|FG000|Overall Study|Death|1|||
147645636|NCT00980174|532522064|FG001|Overall Study|Death|1|||
147645637|NCT00980174|532522063|FG000|Overall Study|Other|0|||
147645638|NCT00980174|532522064|FG001|Overall Study|Other|1|||
147645639|NCT00329641|532522066|FG000|Overall Study|Did not start treatment|1|||
147645640|NCT00329641|532522066|FG000|Overall Study|Not eligible|1|||
147645641|NCT00329641|532522066|FG000|Overall Study|Adverse Event|3|||
147645642|NCT00329641|532522066|FG000|Overall Study|Other reason, not protocol specified|1|||
147645643|NCT03329248|532522070|FG000|Overall Study|Progressive Disease|6|||
147645644|NCT00987402|532522071|FG000|Overall Study|Insufficient data entry|86|||
147645645|NCT00987402|532522072|FG001|Overall Study|Insufficient data entry|98|||
147645646|NCT03000530|532522073|FG000|Overall Study|Adverse Event|0|||
147645647|NCT03000530|532522074|FG001|Overall Study|Adverse Event|0|||
147645648|NCT03000530|532522075|FG002|Overall Study|Adverse Event|2|||
147645649|NCT03000530|532522073|FG000|Overall Study|Lost to Follow-up|0|||
147645650|NCT03000530|532522074|FG001|Overall Study|Lost to Follow-up|3|||
147645651|NCT03000530|532522075|FG002|Overall Study|Lost to Follow-up|1|||
147645652|NCT03000530|532522073|FG000|Overall Study|Withdrawal by Subject|0|||
147645653|NCT03000530|532522074|FG001|Overall Study|Withdrawal by Subject|2|||
147645654|NCT03000530|532522075|FG002|Overall Study|Withdrawal by Subject|1|||
147645655|NCT01430624|532522078|FG000|Overall Study|Lost to Follow-up|23|||
147645656|NCT01430624|532522079|FG001|Overall Study|Lost to Follow-up|29|||
147645657|NCT01430624|532522080|FG002|Overall Study|Lost to Follow-up|27|||
147645658|NCT01430624|532522078|FG000|Overall Study|technical or eligibility|5|||
147645659|NCT01430624|532522079|FG001|Overall Study|technical or eligibility|5|||
147645660|NCT01430624|532522080|FG002|Overall Study|technical or eligibility|2|||
147645661|NCT01362517|532522081|FG000|Overall Study|Protocol Violation|1|||
147645662|NCT01362517|532522081|FG000|Overall Study|Lost to Follow-up|1|||
147645663|NCT01285492|532522086|FG000|Overall Study|Adverse Event|11|||
147645664|NCT01285492|532522087|FG001|Overall Study|Adverse Event|0|||
147645665|NCT01285492|532522086|FG000|Overall Study|Protocol Violation|3|||
147645666|NCT01285492|532522087|FG001|Overall Study|Protocol Violation|0|||
147645667|NCT01285492|532522086|FG000|Overall Study|Withdrawal by Subject|2|||
147645668|NCT01285492|532522087|FG001|Overall Study|Withdrawal by Subject|1|||
147645669|NCT01285492|532522086|FG000|Overall Study|Death|1|||
147645670|NCT01285492|532522087|FG001|Overall Study|Death|0|||
147645671|NCT03379792|532522088|FG000|Overall Study|Physician Decision|0|||
147645672|NCT03379792|532522089|FG001|Overall Study|Physician Decision|0|||
147645673|NCT03379792|532522090|FG002|Overall Study|Physician Decision|0|||
147645674|NCT03379792|532522091|FG003|Overall Study|Physician Decision|1|||
147645675|NCT03379792|532522092|FG004|Overall Study|Physician Decision|0|||
147645676|NCT03379792|532522093|FG005|Overall Study|Physician Decision|0|||
147645677|NCT03379792|532522088|FG000|Overall Study|Withdrawal by Subject|0|||
147645678|NCT03379792|532522089|FG001|Overall Study|Withdrawal by Subject|0|||
147645679|NCT03379792|532522090|FG002|Overall Study|Withdrawal by Subject|0|||
147645680|NCT03379792|532522091|FG003|Overall Study|Withdrawal by Subject|0|||
147645681|NCT03379792|532522092|FG004|Overall Study|Withdrawal by Subject|1|||
147645682|NCT03379792|532522093|FG005|Overall Study|Withdrawal by Subject|1|||
147645683|NCT01121536|532522094|FG000|Overall Study|Adverse Event|63|||
147645684|NCT01121536|532522094|FG000|Overall Study|Lack of Efficacy|35|||
147645685|NCT01121536|532522094|FG000|Overall Study|Withdrawal by Subject|65|||
147645686|NCT01121536|532522094|FG000|Overall Study|Protocol Violation|20|||
147645687|NCT01121536|532522094|FG000|Overall Study|Noncompliance with study medication|12|||
147645688|NCT01121536|532522094|FG000|Overall Study|Noncompliance with study procedures|9|||
147645689|NCT01121536|532522094|FG000|Overall Study|Lost to Follow-up|39|||
147645690|NCT01121536|532522094|FG000|Overall Study|Other|118|||
147645691|NCT01273155|532522096|FG000|Overall Study|Off study trmt prior to end of C1/PD|2|||
147645692|NCT01273155|532522097|FG001|Overall Study|Off study trmt prior to end of C1/PD|3|||
147645693|NCT01273155|532522098|FG002|Overall Study|Off study trmt prior to end of C1/PD|8|||
147645694|NCT01273155|532522099|FG003|Overall Study|Off study trmt prior to end of C1/PD|0|||
147645695|NCT01273155|532522100|FG004|Overall Study|Off study trmt prior to end of C1/PD|0|||
147645696|NCT01273155|532522101|FG005|Overall Study|Off study trmt prior to end of C1/PD|2|||
147645697|NCT01273155|532522102|FG006|Overall Study|Off study trmt prior to end of C1/PD|3|||
147645698|NCT01273155|532522096|FG000|Overall Study|Change in liver function/no longer eval.|0|||
147645699|NCT01273155|532522097|FG001|Overall Study|Change in liver function/no longer eval.|1|||
147645700|NCT01273155|532522098|FG002|Overall Study|Change in liver function/no longer eval.|0|||
147645701|NCT01273155|532522099|FG003|Overall Study|Change in liver function/no longer eval.|0|||
147645702|NCT01273155|532522100|FG004|Overall Study|Change in liver function/no longer eval.|1|||
147645703|NCT01273155|532522101|FG005|Overall Study|Change in liver function/no longer eval.|0|||
147645704|NCT01273155|532522102|FG006|Overall Study|Change in liver function/no longer eval.|0|||
147645705|NCT01273155|532522096|FG000|Overall Study|Off study prior to C1/due to toxicity|0|||
147645706|NCT01273155|532522097|FG001|Overall Study|Off study prior to C1/due to toxicity|0|||
147645707|NCT01273155|532522098|FG002|Overall Study|Off study prior to C1/due to toxicity|2|||
147645708|NCT01273155|532522099|FG003|Overall Study|Off study prior to C1/due to toxicity|0|||
147645709|NCT01273155|532522100|FG004|Overall Study|Off study prior to C1/due to toxicity|0|||
147645710|NCT01273155|532522101|FG005|Overall Study|Off study prior to C1/due to toxicity|0|||
147645711|NCT01273155|532522102|FG006|Overall Study|Off study prior to C1/due to toxicity|1|||
147645712|NCT01273155|532522096|FG000|Overall Study|Died during Cycle 1|0|||
147645713|NCT01273155|532522097|FG001|Overall Study|Died during Cycle 1|0|||
147645714|NCT01273155|532522098|FG002|Overall Study|Died during Cycle 1|1|||
147645715|NCT01273155|532522099|FG003|Overall Study|Died during Cycle 1|1|||
147645716|NCT01273155|532522100|FG004|Overall Study|Died during Cycle 1|0|||
147645717|NCT01273155|532522101|FG005|Overall Study|Died during Cycle 1|2|||
147645718|NCT01273155|532522102|FG006|Overall Study|Died during Cycle 1|2|||
147645719|NCT01273155|532522096|FG000|Overall Study|Withdrew during C1/refused further trmt|0|||
147645720|NCT01273155|532522097|FG001|Overall Study|Withdrew during C1/refused further trmt|0|||
147645721|NCT01273155|532522098|FG002|Overall Study|Withdrew during C1/refused further trmt|1|||
147645722|NCT01273155|532522099|FG003|Overall Study|Withdrew during C1/refused further trmt|0|||
147645723|NCT01273155|532522100|FG004|Overall Study|Withdrew during C1/refused further trmt|1|||
147645724|NCT01273155|532522101|FG005|Overall Study|Withdrew during C1/refused further trmt|1|||
147645725|NCT01273155|532522102|FG006|Overall Study|Withdrew during C1/refused further trmt|0|||
147645726|NCT01256385|532522103|FG000|Overall Study|Physician Decision|1|||
147645727|NCT01256385|532522104|FG001|Overall Study|Physician Decision|1|||
147645728|NCT01256385|532522103|FG000|Overall Study|Withdrawal by Subject|2|||
147645729|NCT01256385|532522104|FG001|Overall Study|Withdrawal by Subject|2|||
147645730|NCT00401960|532522105|FG000|Overall Study|Lost to Follow-up|3|||
147645731|NCT00401960|532522106|FG001|Overall Study|Lost to Follow-up|0|||
147645732|NCT00401960|532522105|FG000|Overall Study|Death|2|||
147645733|NCT00401960|532522106|FG001|Overall Study|Death|0|||
147645734|NCT02649426|532522107|FG000|Overall Study|Follow-up on going|1|||
147645735|NCT02649426|532522108|FG001|Overall Study|Follow-up on going|26|||
147645736|NCT02649426|532522109|FG002|Overall Study|Follow-up on going|28|||
147645737|NCT02649426|532522110|FG003|Overall Study|Follow-up on going|31|||
147645738|NCT01606202|532522111|FG000|Overall Study|Adverse Event|5|||
147645739|NCT01606202|532522112|FG001|Overall Study|Adverse Event|0|||
147645740|NCT01606202|532522111|FG000|Overall Study|Withdrawal by Subject|2|||
147645741|NCT01606202|532522112|FG001|Overall Study|Withdrawal by Subject|1|||
147645742|NCT01606202|532522111|FG000|Overall Study|Personal problems|0|||
147645743|NCT01606202|532522112|FG001|Overall Study|Personal problems|1|||
147645744|NCT01606202|532522111|FG000|Overall Study|Problems with administration|0|||
147645745|NCT01606202|532522112|FG001|Overall Study|Problems with administration|1|||
147645746|NCT00306787|532522113|FG000|Overall Study|Discontinued without taking study drug|208|||
147645747|NCT00306787|532522114|FG001|Overall Study|Discontinued without taking study drug|215|||
147645748|NCT00306787|532522113|FG000|Overall Study|Adverse Event|1|||
147645749|NCT00306787|532522114|FG001|Overall Study|Adverse Event|1|||
147645750|NCT00306787|532522113|FG000|Overall Study|Lack of Efficacy|1|||
147645751|NCT00306787|532522114|FG001|Overall Study|Lack of Efficacy|0|||
147645752|NCT00306787|532522113|FG000|Overall Study|Protocol Violation|8|||
147645753|NCT00306787|532522114|FG001|Overall Study|Protocol Violation|10|||
147645754|NCT00306787|532522113|FG000|Overall Study|Withdrawal by Subject|2|||
147645755|NCT00306787|532522114|FG001|Overall Study|Withdrawal by Subject|9|||
147645756|NCT00306787|532522113|FG000|Overall Study|Lost to Follow-up|9|||
147645757|NCT00306787|532522114|FG001|Overall Study|Lost to Follow-up|6|||
147645758|NCT00306787|532522113|FG000|Overall Study|Administrative problems|4|||
147645759|NCT00306787|532522114|FG001|Overall Study|Administrative problems|0|||
147645760|NCT00306787|532522113|FG000|Overall Study|Abnormal laboratory value(s)|1|||
147645761|NCT00306787|532522114|FG001|Overall Study|Abnormal laboratory value(s)|0|||
147645762|NCT01438814|532522115|FG000|Overall Study|Adverse Event|3|||
147645763|NCT01438814|532522116|FG001|Overall Study|Adverse Event|3|||
147645764|NCT01438814|532522115|FG000|Overall Study|Protocol Violation|1|||
147645765|NCT01438814|532522116|FG001|Overall Study|Protocol Violation|2|||
147645766|NCT01438814|532522115|FG000|Overall Study|Lost to Follow-up|4|||
147645767|NCT01438814|532522116|FG001|Overall Study|Lost to Follow-up|3|||
147645768|NCT01438814|532522115|FG000|Overall Study|Withdrawal by Subject|4|||
147645769|NCT01438814|532522116|FG001|Overall Study|Withdrawal by Subject|2|||
147645770|NCT01438814|532522115|FG000|Overall Study|Other|2|||
147645771|NCT01438814|532522116|FG001|Overall Study|Other|4|||
147645772|NCT02273908|532522119|FG000|Overall Study|Adverse Event|16|||
147645773|NCT02273908|532522120|FG001|Overall Study|Adverse Event|0|||
147645774|NCT02273908|532522119|FG000|Overall Study|Lost to Follow-up|10|||
147645775|NCT02273908|532522120|FG001|Overall Study|Lost to Follow-up|1|||
147645776|NCT02273908|532522119|FG000|Overall Study|Did not meet entrance criteria|3|||
147645777|NCT02273908|532522120|FG001|Overall Study|Did not meet entrance criteria|2|||
147645778|NCT02273908|532522119|FG000|Overall Study|Withdrawal by Subject|4|||
147645779|NCT02273908|532522120|FG001|Overall Study|Withdrawal by Subject|2|||
147645780|NCT00369161|532522121|FG000|Overall Study|Adverse Event|15|||
147645781|NCT00369161|532522122|FG001|Overall Study|Adverse Event|13|||
147645782|NCT00369161|532522121|FG000|Overall Study|Abnormal laboratory value|0|||
147645783|NCT00369161|532522122|FG001|Overall Study|Abnormal laboratory value|1|||
147645784|NCT00369161|532522121|FG000|Overall Study|Lack of Efficacy|3|||
147645785|NCT00369161|532522122|FG001|Overall Study|Lack of Efficacy|1|||
147645786|NCT00369161|532522121|FG000|Overall Study|Protocol Violation|0|||
147645787|NCT00369161|532522122|FG001|Overall Study|Protocol Violation|2|||
147645788|NCT00369161|532522121|FG000|Overall Study|Withdrawal by Subject|2|||
147645789|NCT00369161|532522122|FG001|Overall Study|Withdrawal by Subject|3|||
147645790|NCT00369161|532522121|FG000|Overall Study|Death|1|||
147645791|NCT00369161|532522122|FG001|Overall Study|Death|2|||
147645792|NCT00369161|532522121|FG000|Overall Study|Graft loss|4|||
147645793|NCT00369161|532522122|FG001|Overall Study|Graft loss|0|||
147645794|NCT00369161|532522121|FG000|Overall Study|Administrative Problem|2|||
147645795|NCT00369161|532522122|FG001|Overall Study|Administrative Problem|2|||
147645796|NCT04908475|532522123|FG000|Period A (Baseline to Week 16)|Lost to Follow-up|3|||
147645797|NCT04908475|532522124|FG001|Period A (Baseline to Week 16)|Lost to Follow-up|0|||
147645798|NCT04908475|532522125|FG002|Period A (Baseline to Week 16)|Lost to Follow-up|0|||
147645799|NCT04908475|532522126|FG003|Period A (Baseline to Week 16)|Lost to Follow-up|0|||
147645800|NCT04908475|532522127|FG004|Period A (Baseline to Week 16)|Lost to Follow-up|0|||
147645801|NCT04908475|532522128|FG005|Period A (Baseline to Week 16)|Lost to Follow-up|0|||
147645802|NCT04908475|532522123|FG000|Period A (Baseline to Week 16)|Withdrawal by Subject|9|||
147645803|NCT04908475|532522124|FG001|Period A (Baseline to Week 16)|Withdrawal by Subject|0|||
147645804|NCT04908475|532522125|FG002|Period A (Baseline to Week 16)|Withdrawal by Subject|0|||
147645805|NCT04908475|532522126|FG003|Period A (Baseline to Week 16)|Withdrawal by Subject|0|||
147645806|NCT04908475|532522127|FG004|Period A (Baseline to Week 16)|Withdrawal by Subject|0|||
147645807|NCT04908475|532522128|FG005|Period A (Baseline to Week 16)|Withdrawal by Subject|0|||
147645808|NCT04908475|532522123|FG000|Period A (Baseline to Week 16)|Other, Not Specified|6|||
147645809|NCT04908475|532522124|FG001|Period A (Baseline to Week 16)|Other, Not Specified|0|||
147645810|NCT04908475|532522125|FG002|Period A (Baseline to Week 16)|Other, Not Specified|0|||
147645811|NCT04908475|532522126|FG003|Period A (Baseline to Week 16)|Other, Not Specified|0|||
147645812|NCT04908475|532522127|FG004|Period A (Baseline to Week 16)|Other, Not Specified|0|||
147645813|NCT04908475|532522128|FG005|Period A (Baseline to Week 16)|Other, Not Specified|0|||
147645814|NCT04908475|532522123|FG000|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
147645815|NCT04908475|532522124|FG001|Period B (Week 16 to Week 52)|Lost to Follow-up|6|||
147645816|NCT04908475|532522125|FG002|Period B (Week 16 to Week 52)|Lost to Follow-up|4|||
147645817|NCT04908475|532522126|FG003|Period B (Week 16 to Week 52)|Lost to Follow-up|6|||
147645818|NCT04908475|532522127|FG004|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
147645819|NCT04908475|532522128|FG005|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
147645820|NCT04908475|532522123|FG000|Period B (Week 16 to Week 52)|Withdrawal by Subject|0|||
147645821|NCT04908475|532522124|FG001|Period B (Week 16 to Week 52)|Withdrawal by Subject|5|||
147645822|NCT04908475|532522125|FG002|Period B (Week 16 to Week 52)|Withdrawal by Subject|13|||
147645823|NCT04908475|532522126|FG003|Period B (Week 16 to Week 52)|Withdrawal by Subject|2|||
147645824|NCT04908475|532522127|FG004|Period B (Week 16 to Week 52)|Withdrawal by Subject|3|||
147645825|NCT04908475|532522128|FG005|Period B (Week 16 to Week 52)|Withdrawal by Subject|0|||
147645826|NCT04908475|532522123|FG000|Period B (Week 16 to Week 52)|Other, Not Specified|0|||
147645827|NCT04908475|532522124|FG001|Period B (Week 16 to Week 52)|Other, Not Specified|38|||
147645828|NCT04908475|532522125|FG002|Period B (Week 16 to Week 52)|Other, Not Specified|19|||
147645829|NCT04908475|532522126|FG003|Period B (Week 16 to Week 52)|Other, Not Specified|18|||
147645830|NCT04908475|532522127|FG004|Period B (Week 16 to Week 52)|Other, Not Specified|4|||
147645831|NCT04908475|532522128|FG005|Period B (Week 16 to Week 52)|Other, Not Specified|7|||
147645832|NCT01870297|532522131|FG000|Overall Study|Adverse Event|0|||
147645833|NCT01870297|532522132|FG001|Overall Study|Adverse Event|0|||
147645834|NCT01870297|532522133|FG002|Overall Study|Adverse Event|0|||
147645835|NCT01870297|532522134|FG003|Overall Study|Adverse Event|0|||
147645836|NCT01870297|532522135|FG004|Overall Study|Adverse Event|2|||
147645837|NCT01870297|532522136|FG005|Overall Study|Adverse Event|0|||
147645838|NCT01870297|532522137|FG006|Overall Study|Adverse Event|0|||
147645839|NCT01870297|532522131|FG000|Overall Study|Lost to Follow-up|0|||
147645840|NCT01870297|532522132|FG001|Overall Study|Lost to Follow-up|1|||
147645841|NCT01870297|532522133|FG002|Overall Study|Lost to Follow-up|1|||
147645842|NCT01870297|532522134|FG003|Overall Study|Lost to Follow-up|0|||
147645843|NCT01870297|532522135|FG004|Overall Study|Lost to Follow-up|0|||
147645844|NCT01870297|532522136|FG005|Overall Study|Lost to Follow-up|0|||
147645845|NCT01870297|532522137|FG006|Overall Study|Lost to Follow-up|0|||
147645846|NCT01870297|532522131|FG000|Overall Study|Withdrawal by Subject|0|||
147645847|NCT01870297|532522132|FG001|Overall Study|Withdrawal by Subject|0|||
147645848|NCT01870297|532522133|FG002|Overall Study|Withdrawal by Subject|0|||
147645849|NCT01870297|532522134|FG003|Overall Study|Withdrawal by Subject|0|||
147645850|NCT01870297|532522135|FG004|Overall Study|Withdrawal by Subject|1|||
147645851|NCT01870297|532522136|FG005|Overall Study|Withdrawal by Subject|1|||
147645852|NCT01870297|532522137|FG006|Overall Study|Withdrawal by Subject|1|||
147645853|NCT01870297|532522131|FG000|Overall Study|Sponsor Decision|0|||
147645854|NCT01870297|532522132|FG001|Overall Study|Sponsor Decision|6|||
147645855|NCT01870297|532522133|FG002|Overall Study|Sponsor Decision|0|||
147645856|NCT01870297|532522134|FG003|Overall Study|Sponsor Decision|0|||
147645857|NCT01870297|532522135|FG004|Overall Study|Sponsor Decision|0|||
147645858|NCT01870297|532522136|FG005|Overall Study|Sponsor Decision|0|||
147645859|NCT01870297|532522137|FG006|Overall Study|Sponsor Decision|1|||
147645860|NCT01739764|532522138|FG000|Overall Study|Adverse Event|0|||
147645861|NCT01739764|532522139|FG001|Overall Study|Adverse Event|3|||
147645862|NCT01739764|532522140|FG002|Overall Study|Adverse Event|4|||
147645863|NCT01739764|532522138|FG000|Overall Study|Death|4|||
147645864|NCT01739764|532522139|FG001|Overall Study|Death|6|||
147645865|NCT01739764|532522140|FG002|Overall Study|Death|38|||
147645866|NCT01739764|532522138|FG000|Overall Study|Lost to Follow-up|0|||
147645867|NCT01739764|532522139|FG001|Overall Study|Lost to Follow-up|0|||
147645868|NCT01739764|532522140|FG002|Overall Study|Lost to Follow-up|5|||
147645869|NCT01739764|532522138|FG000|Overall Study|Non-Compliance|0|||
147645870|NCT01739764|532522139|FG001|Overall Study|Non-Compliance|0|||
147645871|NCT01739764|532522140|FG002|Overall Study|Non-Compliance|1|||
147645872|NCT01739764|532522138|FG000|Overall Study|Multiple Reasons|3|||
147645873|NCT01739764|532522139|FG001|Overall Study|Multiple Reasons|2|||
147645874|NCT01739764|532522140|FG002|Overall Study|Multiple Reasons|3|||
147645875|NCT01739764|532522138|FG000|Overall Study|Physician Decision|2|||
147645876|NCT01739764|532522139|FG001|Overall Study|Physician Decision|2|||
147645877|NCT01739764|532522140|FG002|Overall Study|Physician Decision|4|||
147645878|NCT01739764|532522138|FG000|Overall Study|Progressive Disease|3|||
147645879|NCT01739764|532522139|FG001|Overall Study|Progressive Disease|5|||
147645880|NCT01739764|532522140|FG002|Overall Study|Progressive Disease|16|||
147645881|NCT01739764|532522138|FG000|Overall Study|Protocol Violation|0|||
147645882|NCT01739764|532522139|FG001|Overall Study|Protocol Violation|0|||
147645883|NCT01739764|532522140|FG002|Overall Study|Protocol Violation|2|||
147645884|NCT01739764|532522138|FG000|Overall Study|Study Terminated by Sponsor|8|||
147645885|NCT01739764|532522139|FG001|Overall Study|Study Terminated by Sponsor|13|||
147645886|NCT01739764|532522140|FG002|Overall Study|Study Terminated by Sponsor|26|||
147645887|NCT01739764|532522138|FG000|Overall Study|Withdrawal by Subject|6|||
147645888|NCT01739764|532522139|FG001|Overall Study|Withdrawal by Subject|5|||
147645889|NCT01739764|532522140|FG002|Overall Study|Withdrawal by Subject|27|||
147645890|NCT00337779|532522141|FG000|Overall Study|Withdrawal by Subject|10|||
147645891|NCT00337779|532522142|FG001|Overall Study|Withdrawal by Subject|12|||
147645892|NCT00337779|532522141|FG000|Overall Study|Sponsor decision|1|||
147645893|NCT00337779|532522142|FG001|Overall Study|Sponsor decision|1|||
147645894|NCT00337779|532522141|FG000|Overall Study|Physician Decision|3|||
147645895|NCT00337779|532522142|FG001|Overall Study|Physician Decision|6|||
147645896|NCT00337779|532522141|FG000|Overall Study|Protocol Violation|1|||
147645897|NCT00337779|532522142|FG001|Overall Study|Protocol Violation|1|||
147645898|NCT00337779|532522141|FG000|Overall Study|Lost to Follow-up|6|||
147645899|NCT00337779|532522142|FG001|Overall Study|Lost to Follow-up|5|||
147645900|NCT00337779|532522141|FG000|Overall Study|Adverse Event|28|||
147645901|NCT00337779|532522142|FG001|Overall Study|Adverse Event|51|||
147645902|NCT00337779|532522141|FG000|Overall Study|Pregnancy|3|||
147645903|NCT00337779|532522142|FG001|Overall Study|Pregnancy|2|||
147645904|NCT00337779|532522141|FG000|Overall Study|Death|0|||
147645905|NCT00337779|532522142|FG001|Overall Study|Death|1|||
147645906|NCT00404924|532522143|FG000|Overall Study|Adverse Event|75|||
147645907|NCT00404924|532522144|FG001|Overall Study|Adverse Event|16|||
147645908|NCT00404924|532522143|FG000|Overall Study|Condition under investigation worsened|475|||
147645909|NCT00404924|532522144|FG001|Overall Study|Condition under investigation worsened|264|||
147645910|NCT00404924|532522143|FG000|Overall Study|Lost to Follow-up|1|||
147645911|NCT00404924|532522144|FG001|Overall Study|Lost to Follow-up|1|||
147645912|NCT00404924|532522143|FG000|Overall Study|Withdrawal by Subject|26|||
147645913|NCT00404924|532522144|FG001|Overall Study|Withdrawal by Subject|13|||
147645914|NCT00404924|532522143|FG000|Overall Study|Other|25|||
147645915|NCT00404924|532522144|FG001|Overall Study|Other|11|||
147645916|NCT00404924|532522143|FG000|Overall Study|Randomised but not received treatment|1|||
147645917|NCT00404924|532522144|FG001|Overall Study|Randomised but not received treatment|1|||
147645918|NCT03008278|532522151|FG000|Overall Study|Progressive Disease|0|||
147645919|NCT03008278|532522152|FG001|Overall Study|Progressive Disease|0|||
147645920|NCT03008278|532522153|FG002|Overall Study|Progressive Disease|32|||
147645921|NCT03008278|532522151|FG000|Overall Study|Adverse Event|0|||
147645922|NCT03008278|532522152|FG001|Overall Study|Adverse Event|0|||
147645923|NCT03008278|532522153|FG002|Overall Study|Adverse Event|4|||
147645924|NCT03008278|532522151|FG000|Overall Study|Withdrawal by Subject|0|||
147645925|NCT03008278|532522152|FG001|Overall Study|Withdrawal by Subject|0|||
147645926|NCT03008278|532522153|FG002|Overall Study|Withdrawal by Subject|3|||
147645927|NCT03008278|532522151|FG000|Overall Study|Physician Decision|0|||
147645928|NCT03008278|532522152|FG001|Overall Study|Physician Decision|2|||
147645929|NCT03008278|532522153|FG002|Overall Study|Physician Decision|0|||
147645930|NCT01074255|532522154|FG000|Overall Study|Did not receive EMEND|2|||
147645931|NCT00422422|532522155|FG000|Overall Study|Lack of Efficacy|1|||
147645932|NCT00422422|532522155|FG000|Overall Study|Protocol Violation|1|||
147645933|NCT00422422|532522155|FG000|Overall Study|Withdrawal by Subject|2|||
147645934|NCT00422422|532522155|FG000|Overall Study|SAE, non-fatal|1|||
147645935|NCT00422422|532522155|FG000|Overall Study|AE, non-serious non-fatal|5|||
147645936|NCT01389258|532522156|FG000|Overall Study|Lost to Follow-up|5|||
147645937|NCT02943785|532522158|FG000|Overall Study|Adverse Event|112|||
147645938|NCT02943785|532522159|FG001|Overall Study|Adverse Event|97|||
147645939|NCT02943785|532522158|FG000|Overall Study|Withdrawal by Subject|63|||
147645940|NCT02943785|532522159|FG001|Overall Study|Withdrawal by Subject|126|||
147645941|NCT02943785|532522158|FG000|Overall Study|Physician Decision|23|||
147645942|NCT02943785|532522159|FG001|Overall Study|Physician Decision|47|||
147645943|NCT02943785|532522158|FG000|Overall Study|Death|46|||
147645944|NCT02943785|532522159|FG001|Overall Study|Death|46|||
147645945|NCT02943785|532522158|FG000|Overall Study|Lost to Follow-up|1|||
147419427|NCT02270515|531698609|FG000|Intervention Period 2: 6-12 Months|No longer patient at study site|7|||
147645946|NCT02943785|532522159|FG001|Overall Study|Lost to Follow-up|0|||
147645947|NCT02943785|532522158|FG000|Overall Study|Other|16|||
147645948|NCT02943785|532522159|FG001|Overall Study|Other|19|||
147645949|NCT02943785|532522158|FG000|Overall Study|Did not receive any study medication|21|||
147645950|NCT02943785|532522159|FG001|Overall Study|Did not receive any study medication|28|||
147645951|NCT03313310|532522160|FG000|Phase 2|Lost to Follow-up|4|||
147645952|NCT03313310|532522161|FG001|Phase 2|Lost to Follow-up|0|||
147645953|NCT03313310|532522160|FG000|Phase 3|Lost to Follow-up|0|||
147645954|NCT03313310|532522161|FG001|Phase 3|Lost to Follow-up|1|||
147645955|NCT01281956|532522162|FG000|2nd Intervention (3 Months)|Withdrawal by Subject|1|||
147645956|NCT01281956|532522163|FG001|2nd Intervention (3 Months)|Withdrawal by Subject|0|||
147645957|NCT01593254|532522165|FG000|Overall Study|Disease progression|2|||
147645958|NCT01593254|532522166|FG001|Overall Study|Disease progression|7|||
147645959|NCT01593254|532522165|FG000|Overall Study|Study drug toxicity|6|||
147645960|NCT01593254|532522166|FG001|Overall Study|Study drug toxicity|20|||
147645961|NCT01593254|532522165|FG000|Overall Study|Death|3|||
147645962|NCT01593254|532522166|FG001|Overall Study|Death|3|||
147645963|NCT01593254|532522165|FG000|Overall Study|AE unrelated to study drug|0|||
147645964|NCT01593254|532522166|FG001|Overall Study|AE unrelated to study drug|1|||
147645965|NCT01593254|532522165|FG000|Overall Study|participant request to discontinue study treatment|1|||
147645966|NCT01593254|532522166|FG001|Overall Study|participant request to discontinue study treatment|3|||
147645967|NCT01593254|532522165|FG000|Overall Study|participant withdrew consent|0|||
147645968|NCT01593254|532522166|FG001|Overall Study|participant withdrew consent|9|||
147645969|NCT01593254|532522165|FG000|Overall Study|lost to follow up|1|||
147645970|NCT01593254|532522166|FG001|Overall Study|lost to follow up|6|||
147645971|NCT01593254|532522165|FG000|Overall Study|maximum clinical benefit|1|||
147645972|NCT01593254|532522166|FG001|Overall Study|maximum clinical benefit|2|||
147645973|NCT01593254|532522165|FG000|Overall Study|Poor/non compliance|1|||
147645974|NCT01593254|532522166|FG001|Overall Study|Poor/non compliance|1|||
147645975|NCT01593254|532522165|FG000|Overall Study|Pregnancy|0|||
147645976|NCT01593254|532522166|FG001|Overall Study|Pregnancy|3|||
147645977|NCT01593254|532522165|FG000|Overall Study|participant no longer meets study criteria|1|||
147645978|NCT01593254|532522166|FG001|Overall Study|participant no longer meets study criteria|1|||
147645979|NCT01593254|532522165|FG000|Overall Study|Admin reason by sponsor|7|||
147645980|NCT01593254|532522166|FG001|Overall Study|Admin reason by sponsor|3|||
147645981|NCT01593254|532522165|FG000|Overall Study|Imatinib treatment failure|2|||
147645982|NCT01593254|532522166|FG001|Overall Study|Imatinib treatment failure|0|||
147645983|NCT01593254|532522165|FG000|Overall Study|Other Reasons|61|||
147645984|NCT01593254|532522166|FG001|Overall Study|Other Reasons|115|||
147645985|NCT02918552|532522169|FG000|Overall Study|Failed Pharmacokinetics|1|||
147645986|NCT02918552|532522170|FG001|Overall Study|Failed Pharmacokinetics|0|||
147645987|NCT02918552|532522169|FG000|Overall Study|Withdrawal by Subject|0|||
147645988|NCT02918552|532522170|FG001|Overall Study|Withdrawal by Subject|1|||
147645989|NCT02918552|532522169|FG000|Overall Study|Lost to Follow-up|0|||
147645990|NCT02918552|532522170|FG001|Overall Study|Lost to Follow-up|1|||
147645991|NCT04395274|532522171|FG000|Overall Study|Lost to Follow-up|20|||
147645992|NCT04395274|532522172|FG001|Overall Study|Lost to Follow-up|11|||
147645993|NCT04395274|532522171|FG000|Overall Study|Withdrawal by Subject|13|||
147645994|NCT04395274|532522172|FG001|Overall Study|Withdrawal by Subject|10|||
147645995|NCT04395274|532522171|FG000|Overall Study|Moved Abroad|0|||
147645996|NCT04395274|532522172|FG001|Overall Study|Moved Abroad|1|||
147645997|NCT02680834|532522173|FG000|Overall Study|Physician Decision|5|||
147645998|NCT02680834|532522174|FG001|Overall Study|Physician Decision|2|||
147645999|NCT02680834|532522173|FG000|Overall Study|Withdrawal by Subject|6|||
147646000|NCT02680834|532522174|FG001|Overall Study|Withdrawal by Subject|0|||
147646001|NCT02680834|532522173|FG000|Overall Study|Lost to Follow-up|0|||
147646002|NCT02680834|532522174|FG001|Overall Study|Lost to Follow-up|1|||
147646003|NCT01362244|532522175|FG000|Overall Study|Adverse Event|3|||
147646004|NCT01362244|532522176|FG001|Overall Study|Adverse Event|5|||
147646005|NCT01362244|532522175|FG000|Overall Study|Lack of Efficacy|5|||
147646006|NCT01362244|532522176|FG001|Overall Study|Lack of Efficacy|11|||
147646007|NCT01362244|532522175|FG000|Overall Study|Lost to Follow-up|0|||
147646008|NCT01362244|532522176|FG001|Overall Study|Lost to Follow-up|2|||
147646009|NCT01362244|532522175|FG000|Overall Study|Protocol Violation|5|||
147646010|NCT01362244|532522176|FG001|Overall Study|Protocol Violation|1|||
147646011|NCT01362244|532522175|FG000|Overall Study|Withdrawal by Subject|2|||
147646012|NCT01362244|532522176|FG001|Overall Study|Withdrawal by Subject|1|||
147646013|NCT01362244|532522175|FG000|Overall Study|Did not Meet Continuation Criteria|17|||
147646014|NCT01362244|532522176|FG001|Overall Study|Did not Meet Continuation Criteria|11|||
147646015|NCT01362244|532522175|FG000|Overall Study|Protocol Defined Stopping Criteria|0|||
147646016|NCT01362244|532522176|FG001|Overall Study|Protocol Defined Stopping Criteria|1|||
147659393|NCT01719380|532576171|FG002|Overall Study|Lack of Efficacy|5|||
147659394|NCT01719380|532576172|FG003|Overall Study|Lack of Efficacy|6|||
147659395|NCT01719380|532576173|FG004|Overall Study|Lack of Efficacy|3|||
147659396|NCT01719380|532576174|FG005|Overall Study|Lack of Efficacy|7|||
147659397|NCT01719380|532576175|FG006|Overall Study|Lack of Efficacy|10|||
147659398|NCT01719380|532576176|FG007|Overall Study|Lack of Efficacy|6|||
147659399|NCT01719380|532576177|FG008|Overall Study|Lack of Efficacy|39|||
147659400|NCT01719380|532576178|FG009|Overall Study|Lack of Efficacy|42|||
147659401|NCT01719380|532576169|FG000|Overall Study|Progressive Disease|0|||
147659402|NCT01719380|532576170|FG001|Overall Study|Progressive Disease|0|||
147659403|NCT01719380|532576171|FG002|Overall Study|Progressive Disease|0|||
147659404|NCT01719380|532576172|FG003|Overall Study|Progressive Disease|0|||
147419428|NCT02270515|531698609|FG000|Intervention Period 2: 6-12 Months|Received transplant|1|||
147659405|NCT01719380|532576173|FG004|Overall Study|Progressive Disease|0|||
147659406|NCT01719380|532576174|FG005|Overall Study|Progressive Disease|0|||
147659407|NCT01719380|532576175|FG006|Overall Study|Progressive Disease|0|||
147659408|NCT01719380|532576176|FG007|Overall Study|Progressive Disease|0|||
147659409|NCT01719380|532576177|FG008|Overall Study|Progressive Disease|1|||
147659410|NCT01719380|532576178|FG009|Overall Study|Progressive Disease|0|||
147659411|NCT01064414|532576181|FG000|Core Period: Baseline to Week 26|Adverse Event|4|||
147659412|NCT01064414|532576182|FG001|Core Period: Baseline to Week 26|Adverse Event|4|||
147659413|NCT01064414|532576183|FG002|Core Period: Baseline to Week 26|Adverse Event|2|||
147646017|NCT01709864|532523969|FG000|Overall Study|Physician Decision|0|||
147646018|NCT01709864|532523970|FG001|Overall Study|Physician Decision|1|||
147646019|NCT01709864|532523969|FG000|Overall Study|subject/guardian decision|5|||
147646020|NCT01709864|532523970|FG001|Overall Study|subject/guardian decision|6|||
147646021|NCT01709864|532523969|FG000|Overall Study|Lost to Follow-up|1|||
147646022|NCT01709864|532523970|FG001|Overall Study|Lost to Follow-up|0|||
147646023|NCT01709864|532523969|FG000|Overall Study|non-compliance with study treatment|1|||
147646024|NCT01709864|532523970|FG001|Overall Study|non-compliance with study treatment|1|||
147646025|NCT01709864|532523969|FG000|Overall Study|Adverse Event|0|||
147646026|NCT01709864|532523970|FG001|Overall Study|Adverse Event|2|||
147646027|NCT01709864|532523969|FG000|Overall Study|Death|0|||
147646028|NCT01709864|532523970|FG001|Overall Study|Death|1|||
147646029|NCT01911793|532523973|FG000|Overall Study|Physician Decision|1|||
147646030|NCT01911793|532523974|FG001|Overall Study|Physician Decision|5|||
147646031|NCT03334422|532523975|FG000|Overall Study|Adverse Event|1|||
147646032|NCT03334422|532523976|FG001|Overall Study|Adverse Event|3|||
147646033|NCT03334422|532523977|FG002|Overall Study|Adverse Event|2|||
147646034|NCT03334422|532523978|FG003|Overall Study|Adverse Event|2|||
147646035|NCT03334422|532523975|FG000|Overall Study|Lack of Efficacy|10|||
147646036|NCT03334422|532523976|FG001|Overall Study|Lack of Efficacy|2|||
147646037|NCT03334422|532523977|FG002|Overall Study|Lack of Efficacy|7|||
147646038|NCT03334422|532523978|FG003|Overall Study|Lack of Efficacy|3|||
147646039|NCT03334422|532523975|FG000|Overall Study|Withdrawal by Subject|8|||
147646040|NCT03334422|532523976|FG001|Overall Study|Withdrawal by Subject|3|||
147646041|NCT03334422|532523977|FG002|Overall Study|Withdrawal by Subject|1|||
147646042|NCT03334422|532523978|FG003|Overall Study|Withdrawal by Subject|0|||
147646043|NCT03334422|532523975|FG000|Overall Study|Lost to Follow-up|0|||
147646044|NCT03334422|532523976|FG001|Overall Study|Lost to Follow-up|0|||
147646045|NCT03334422|532523977|FG002|Overall Study|Lost to Follow-up|0|||
147646046|NCT03334422|532523978|FG003|Overall Study|Lost to Follow-up|1|||
147646047|NCT03334422|532523975|FG000|Overall Study|Inability to obtain laboratory samples|0|||
147646048|NCT03334422|532523976|FG001|Overall Study|Inability to obtain laboratory samples|1|||
147646049|NCT03334422|532523977|FG002|Overall Study|Inability to obtain laboratory samples|0|||
147646050|NCT03334422|532523978|FG003|Overall Study|Inability to obtain laboratory samples|0|||
147646051|NCT03334422|532523975|FG000|Overall Study|Pregnancy|0|||
147646052|NCT03334422|532523976|FG001|Overall Study|Pregnancy|1|||
147646053|NCT03334422|532523977|FG002|Overall Study|Pregnancy|0|||
147646054|NCT03334422|532523978|FG003|Overall Study|Pregnancy|0|||
147646055|NCT01313221|532523979|FG000|Overall Study|Protocol Violation|0|||
147646056|NCT01313221|532523980|FG001|Overall Study|Protocol Violation|1|||
147646057|NCT01313221|532523981|FG002|Overall Study|Protocol Violation|1|||
147646058|NCT01313221|532523979|FG000|Overall Study|Non-compliance|3|||
147646059|NCT01313221|532523980|FG001|Overall Study|Non-compliance|0|||
147646060|NCT01313221|532523981|FG002|Overall Study|Non-compliance|2|||
147646061|NCT01313221|532523979|FG000|Overall Study|Withdrawal by Subject|2|||
147646062|NCT01313221|532523980|FG001|Overall Study|Withdrawal by Subject|3|||
147646063|NCT01313221|532523981|FG002|Overall Study|Withdrawal by Subject|5|||
147646064|NCT01313221|532523979|FG000|Overall Study|Requirement for alternative therapy|0|||
147646065|NCT01313221|532523980|FG001|Overall Study|Requirement for alternative therapy|1|||
147646066|NCT01313221|532523981|FG002|Overall Study|Requirement for alternative therapy|1|||
147646067|NCT01313221|532523979|FG000|Overall Study|Lost to Follow-up|6|||
147646068|NCT01313221|532523980|FG001|Overall Study|Lost to Follow-up|3|||
147646069|NCT01313221|532523981|FG002|Overall Study|Lost to Follow-up|1|||
147646070|NCT01313221|532523979|FG000|Overall Study|Other|1|||
147646071|NCT01313221|532523980|FG001|Overall Study|Other|0|||
147646072|NCT01313221|532523981|FG002|Overall Study|Other|0|||
147646073|NCT01313221|532523979|FG000|Overall Study|Adverse Event|0|||
147646074|NCT01313221|532523980|FG001|Overall Study|Adverse Event|0|||
147646075|NCT01313221|532523981|FG002|Overall Study|Adverse Event|7|||
147646076|NCT01313221|532523979|FG000|Overall Study|Disease progression|0|||
147646077|NCT01313221|532523980|FG001|Overall Study|Disease progression|0|||
147646078|NCT01313221|532523981|FG002|Overall Study|Disease progression|2|||
147646079|NCT01313221|532523979|FG000|Overall Study|Physician Decision|0|||
147646080|NCT01313221|532523980|FG001|Overall Study|Physician Decision|0|||
147646081|NCT01313221|532523981|FG002|Overall Study|Physician Decision|2|||
147646082|NCT01313221|532523979|FG000|Overall Study|Pregnancy|0|||
147646083|NCT01313221|532523980|FG001|Overall Study|Pregnancy|0|||
147646084|NCT01313221|532523981|FG002|Overall Study|Pregnancy|2|||
147646085|NCT03246061|532523982|FG000|Overall Study|Still in follow-up|15|||
147646086|NCT03246061|532523983|FG001|Overall Study|Still in follow-up|21|||
147646087|NCT02864316|532523988|FG000|Overall Study|Progressive Disease|2|||
147646088|NCT02864316|532523989|FG001|Overall Study|Progressive Disease|1|||
147646089|NCT02864316|532523988|FG000|Overall Study|Adverse Event|0|||
147646090|NCT02864316|532523989|FG001|Overall Study|Adverse Event|1|||
147646091|NCT04710368|532523990|FG000|Overall Study|Withdrawal by Subject|9|||
147646092|NCT04710368|532523990|FG000|Overall Study|Lost to Follow-up|4|||
147646093|NCT04710368|532523990|FG000|Overall Study|Death|2|||
147646094|NCT04710368|532523990|FG000|Overall Study|Patient preference|11|||
147646095|NCT04710368|532523990|FG000|Overall Study|Treatment discontinuation|1|||
147646096|NCT05459558|532523991|FG000|Overall Study|Adverse Event|1|||
147646097|NCT05459558|532523992|FG001|Overall Study|Adverse Event|0|||
147646098|NCT05459558|532523993|FG002|Overall Study|Adverse Event|0|||
147646099|NCT05459558|532523991|FG000|Overall Study|Scheduling issue|0|||
147646100|NCT05459558|532523992|FG001|Overall Study|Scheduling issue|1|||
147646101|NCT05459558|532523993|FG002|Overall Study|Scheduling issue|3|||
147646102|NCT05459558|532523991|FG000|Overall Study|Withdrawal by Subject|0|||
147646103|NCT05459558|532523992|FG001|Overall Study|Withdrawal by Subject|0|||
147646104|NCT05459558|532523993|FG002|Overall Study|Withdrawal by Subject|2|||
147646105|NCT01887288|532523998|FG000|Overall Study|The study was terminated and the PI has|16|||
147646106|NCT01092637|532523999|FG000|Overall Study|Death|47|||
147646107|NCT01092637|532524000|FG001|Overall Study|Death|49|||
147646108|NCT02921750|532524001|FG000|Overall Study|Adverse Event|1|||
147646109|NCT02921750|532524002|FG001|Overall Study|Adverse Event|2|||
147646110|NCT02921750|532524001|FG000|Overall Study|Withdrawal by Subject|1|||
147646111|NCT02921750|532524002|FG001|Overall Study|Withdrawal by Subject|1|||
147646112|NCT02921750|532524001|FG000|Overall Study|Lost to Follow-up|3|||
147646113|NCT02921750|532524002|FG001|Overall Study|Lost to Follow-up|3|||
147646114|NCT02921750|532524001|FG000|Overall Study|Wound healed|3|||
147646115|NCT02921750|532524002|FG001|Overall Study|Wound healed|3|||
147646116|NCT02921750|532524001|FG000|Overall Study|Serious Adverse Event|1|||
147646117|NCT02921750|532524002|FG001|Overall Study|Serious Adverse Event|2|||
147646118|NCT03292458|532524007|FG000|Period 1|Adverse Event|2|||
147646119|NCT03292458|532524008|FG001|Period 1|Adverse Event|0|||
147646120|NCT02278367|532524009|FG000|Overall Study|Physician Decision|5|||
147646121|NCT02278367|532524010|FG001|Overall Study|Physician Decision|0|||
147646122|NCT02278367|532524009|FG000|Overall Study|Withdrawal by Subject|5|||
147646123|NCT02278367|532524010|FG001|Overall Study|Withdrawal by Subject|0|||
147646124|NCT02368210|532524012|FG000|Overall Study|Withdrawal by Subject|1|||
147646125|NCT02368210|532524013|FG001|Overall Study|Withdrawal by Subject|0|||
147646126|NCT02368210|532524012|FG000|Overall Study|Adverse Event|0|||
147646127|NCT02368210|532524013|FG001|Overall Study|Adverse Event|1|||
147646128|NCT01492101|532524014|FG000|Overall Study|Death|323|||
147646129|NCT01492101|532524015|FG001|Overall Study|Death|322|||
147646130|NCT01492101|532524014|FG000|Overall Study|Withdrawal by Subject|14|||
147646131|NCT01492101|532524015|FG001|Overall Study|Withdrawal by Subject|18|||
147646132|NCT01492101|532524014|FG000|Overall Study|Lost to Follow-up|0|||
147646133|NCT01492101|532524015|FG001|Overall Study|Lost to Follow-up|2|||
147646134|NCT00316914|532524016|FG000|Overall Study|Withdrawal by Subject|5|||
147646135|NCT00316914|532524017|FG001|Overall Study|Withdrawal by Subject|3|||
147646136|NCT00316914|532524016|FG000|Overall Study|Adverse Event|8|||
147646137|NCT00316914|532524017|FG001|Overall Study|Adverse Event|7|||
147646138|NCT00316914|532524016|FG000|Overall Study|Other Problems|6|||
147646139|NCT00316914|532524017|FG001|Overall Study|Other Problems|11|||
147646140|NCT00316914|532524016|FG000|Overall Study|Missing end of treatment documentation|14|||
147646141|NCT00316914|532524017|FG001|Overall Study|Missing end of treatment documentation|15|||
147646142|NCT01675154|532524018|FG000|Third Intervention Period (4 Weeks)|Withdrawal by Subject|0|||
147646143|NCT01675154|532524019|FG001|Third Intervention Period (4 Weeks)|Withdrawal by Subject|1|||
147646144|NCT01675154|532524020|FG002|Third Intervention Period (4 Weeks)|Withdrawal by Subject|0|||
147646145|NCT01675154|532524021|FG003|Third Intervention Period (4 Weeks)|Withdrawal by Subject|0|||
147646146|NCT05323994|532524022|FG000|Overall Study|Protocol Violation|1|||
147646147|NCT00766467|532524024|FG000|Overall Study|Withdrawal by Subject|7|||
147646148|NCT00766467|532524025|FG001|Overall Study|Withdrawal by Subject|2|||
147646149|NCT00766467|532524024|FG000|Overall Study|Adverse Event|1|||
147646150|NCT00766467|532524025|FG001|Overall Study|Adverse Event|1|||
147646151|NCT00766467|532524024|FG000|Overall Study|Protocol Violation|2|||
147646152|NCT00766467|532524025|FG001|Overall Study|Protocol Violation|4|||
147646153|NCT00766467|532524024|FG000|Overall Study|Tumor Progression on Study|0|||
147646154|NCT00766467|532524025|FG001|Overall Study|Tumor Progression on Study|1|||
147646155|NCT00766467|532524024|FG000|Overall Study|Physician Decision|1|||
147646156|NCT00766467|532524025|FG001|Overall Study|Physician Decision|0|||
147646157|NCT01420679|532524033|FG000|Overall Study|Disease Progression|3|||
147646158|NCT01420679|532524034|FG001|Overall Study|Disease Progression|2|||
147646159|NCT01420679|532524033|FG000|Overall Study|Adverse Event|4|||
147646160|NCT01420679|532524034|FG001|Overall Study|Adverse Event|0|||
147646161|NCT01420679|532524033|FG000|Overall Study|More Than 28 Days Between Doses of Drug|1|||
147646162|NCT01420679|532524034|FG001|Overall Study|More Than 28 Days Between Doses of Drug|0|||
147646163|NCT01420679|532524033|FG000|Overall Study|Patient Decision|1|||
147646164|NCT01420679|532524034|FG001|Overall Study|Patient Decision|0|||
147646165|NCT01420679|532524033|FG000|Overall Study|Investigator Decision|1|||
147646166|NCT01420679|532524034|FG001|Overall Study|Investigator Decision|2|||
147646167|NCT01420679|532524033|FG000|Overall Study|Sponsor Decision|3|||
147646168|NCT01420679|532524034|FG001|Overall Study|Sponsor Decision|3|||
147646169|NCT01420679|532524033|FG000|Overall Study|Other|1|||
147646170|NCT01420679|532524034|FG001|Overall Study|Other|0|||
147646171|NCT00943670|532524035|FG000|Single-agent Trastuzumab Emtansine|Physician Decision|2|||
147646172|NCT00943670|532524035|FG000|Single-agent Trastuzumab Emtansine|Withdrawal by Subject|3|||
147646173|NCT00943670|532524035|FG000|Single-agent Trastuzumab Emtansine|Systemic progression|15|||
147646174|NCT00943670|532524035|FG000|Single-agent Trastuzumab Emtansine|Adverse Event|2|||
147646175|NCT00943670|532524035|FG000|Single-agent Trastuzumab Emtansine|Early progressive disease|20|||
147646176|NCT00943670|532524035|FG000|Trastuzumab Emtansine + Pertuzumab|Physician Decision|1|||
147646177|NCT00943670|532524035|FG000|Trastuzumab Emtansine + Pertuzumab|Withdrawal by Subject|4|||
147646178|NCT00943670|532524035|FG000|Trastuzumab Emtansine + Pertuzumab|Systemic progression|6|||
147646179|NCT00943670|532524035|FG000|Trastuzumab Emtansine + Pertuzumab|Progression of brain metastases|2|||
147646180|NCT00943670|532524035|FG000|Trastuzumab Emtansine + Pertuzumab|Adverse Event|5|||
147646181|NCT01777295|532524036|FG000|Overall Study|Withdrawal by Subject|2|||
147646182|NCT01777295|532524037|FG001|Overall Study|Withdrawal by Subject|2|||
147646183|NCT01777295|532524036|FG000|Overall Study|Pregnancy|0|||
147646184|NCT01777295|532524037|FG001|Overall Study|Pregnancy|1|||
147646185|NCT01777295|532524036|FG000|Overall Study|Personal problem|1|||
147646186|NCT01777295|532524037|FG001|Overall Study|Personal problem|0|||
147646187|NCT01777295|532524036|FG000|Overall Study|Investigator call for AEs check|1|||
147646188|NCT01777295|532524037|FG001|Overall Study|Investigator call for AEs check|0|||
147646189|NCT00717275|532524039|FG000|Overall Study|Premature study termination.|3|||
147646190|NCT03769194|532524040|FG000|Overall Study|Withdrawal by Subject|0|||
147646191|NCT03769194|532524041|FG001|Overall Study|Withdrawal by Subject|7|||
147646192|NCT03769194|532524042|FG002|Overall Study|Withdrawal by Subject|4|||
147646193|NCT03769194|532524043|FG003|Overall Study|Withdrawal by Subject|1|||
147646194|NCT03769194|532524040|FG000|Overall Study|moved from study area|0|||
147646195|NCT03769194|532524041|FG001|Overall Study|moved from study area|2|||
147646196|NCT03769194|532524042|FG002|Overall Study|moved from study area|1|||
147646197|NCT03769194|532524043|FG003|Overall Study|moved from study area|1|||
147646198|NCT03769194|532524040|FG000|Overall Study|Lost to Follow-up|3|||
147646199|NCT03769194|532524041|FG001|Overall Study|Lost to Follow-up|6|||
147646200|NCT03769194|532524042|FG002|Overall Study|Lost to Follow-up|3|||
147646201|NCT03769194|532524043|FG003|Overall Study|Lost to Follow-up|6|||
147646202|NCT03769194|532524040|FG000|Overall Study|other|1|||
147646203|NCT03769194|532524041|FG001|Overall Study|other|3|||
147646204|NCT03769194|532524042|FG002|Overall Study|other|0|||
147646205|NCT03769194|532524043|FG003|Overall Study|other|1|||
147646206|NCT00312572|532524047|FG000|Overall Study|Adverse Event|10|||
147646207|NCT00312572|532524048|FG001|Overall Study|Adverse Event|16|||
147646208|NCT00312572|532524047|FG000|Overall Study|Lost to Follow-up|1|||
147646209|NCT00312572|532524048|FG001|Overall Study|Lost to Follow-up|1|||
147646210|NCT00312572|532524047|FG000|Overall Study|Administrative|4|||
147646211|NCT00312572|532524048|FG001|Overall Study|Administrative|2|||
147646212|NCT00312572|532524047|FG000|Overall Study|Lack of Efficacy|1|||
147646213|NCT00312572|532524048|FG001|Overall Study|Lack of Efficacy|2|||
147646214|NCT01133288|532524051|FG000|Eligibility Assessment|met exclusion criteria|5|||
147646215|NCT01133288|532524051|FG000|Intervention Allocation|study terminated|2|||
147646216|NCT00551161|532524052|FG000|Overall Study|Withdrawal by Subject|1|||
147646217|NCT01672294|532524054|FG000|Overall Study|Withdrawal by Subject|4|||
147646218|NCT01672294|532524055|FG001|Overall Study|Withdrawal by Subject|4|||
147646219|NCT01672294|532524056|FG002|Overall Study|Withdrawal by Subject|4|||
147646220|NCT01672294|532524057|FG003|Overall Study|Withdrawal by Subject|4|||
147646221|NCT01672294|532524054|FG000|Overall Study|Excluded by study|1|||
147646222|NCT01672294|532524055|FG001|Overall Study|Excluded by study|1|||
147646223|NCT01672294|532524056|FG002|Overall Study|Excluded by study|0|||
147646224|NCT01672294|532524057|FG003|Overall Study|Excluded by study|0|||
147646225|NCT01672294|532524054|FG000|Overall Study|Lost to Follow-up|1|||
147646226|NCT01672294|532524055|FG001|Overall Study|Lost to Follow-up|16|||
147646227|NCT01672294|532524056|FG002|Overall Study|Lost to Follow-up|7|||
147646228|NCT01672294|532524057|FG003|Overall Study|Lost to Follow-up|9|||
147646229|NCT03170609|532524058|FG000|Overall Study|Death|0|||
147646230|NCT03170609|532524059|FG001|Overall Study|Death|0|||
147646231|NCT03170609|532524060|FG002|Overall Study|Death|1|||
147646232|NCT03170609|532524061|FG003|Overall Study|Death|0|||
147646233|NCT03170609|532524062|FG004|Overall Study|Death|0|||
147646234|NCT03170609|532524063|FG005|Overall Study|Death|0|||
147646235|NCT03170609|532524064|FG006|Overall Study|Death|0|||
147646236|NCT03170609|532524058|FG000|Overall Study|Withdrawal by Subject|1|||
147646237|NCT03170609|532524059|FG001|Overall Study|Withdrawal by Subject|2|||
147646238|NCT03170609|532524060|FG002|Overall Study|Withdrawal by Subject|0|||
147646239|NCT03170609|532524061|FG003|Overall Study|Withdrawal by Subject|0|||
147646240|NCT03170609|532524062|FG004|Overall Study|Withdrawal by Subject|0|||
147646241|NCT03170609|532524063|FG005|Overall Study|Withdrawal by Subject|0|||
147646242|NCT03170609|532524064|FG006|Overall Study|Withdrawal by Subject|1|||
147646243|NCT03170609|532524058|FG000|Overall Study|Lost to Follow-up|1|||
147646244|NCT03170609|532524059|FG001|Overall Study|Lost to Follow-up|0|||
147306596|NCT03238300|531288850|FG001|Second Intervention (10-Days)|Withdrawal by Subject|0|||
147646245|NCT03170609|532524060|FG002|Overall Study|Lost to Follow-up|5|||
147646246|NCT03170609|532524061|FG003|Overall Study|Lost to Follow-up|2|||
147306597|NCT02917941|531288851|FG000|Treatment Period|Adverse Event|11|||
147646247|NCT03170609|532524062|FG004|Overall Study|Lost to Follow-up|1|||
147646248|NCT03170609|532524063|FG005|Overall Study|Lost to Follow-up|1|||
147646249|NCT03170609|532524064|FG006|Overall Study|Lost to Follow-up|0|||
147646250|NCT03170609|532524058|FG000|Overall Study|Other|1|||
147646251|NCT03170609|532524059|FG001|Overall Study|Other|0|||
147646252|NCT03170609|532524060|FG002|Overall Study|Other|0|||
147646253|NCT03170609|532524061|FG003|Overall Study|Other|0|||
147646254|NCT03170609|532524062|FG004|Overall Study|Other|0|||
147646255|NCT03170609|532524063|FG005|Overall Study|Other|1|||
147646256|NCT03170609|532524064|FG006|Overall Study|Other|0|||
147646257|NCT01904903|532524067|FG000|Overall Study|Withdrawal by Subject|1|||
147646258|NCT00634049|532524070|FG000|Overall Study|Never received study drug|1|||
147646259|NCT00634049|532524070|FG000|Overall Study|Died prior to receiving study drug|1|||
147646260|NCT00634049|532524070|FG000|Overall Study|Screening failure|1|||
147646261|NCT00314132|532524071|FG000|Overall Study|Lost to Follow-up|3|||
147646262|NCT00314132|532524072|FG001|Overall Study|Lost to Follow-up|13|||
147646263|NCT00314132|532524071|FG000|Overall Study|Withdrawal by Subject|3|||
147646264|NCT00314132|532524072|FG001|Overall Study|Withdrawal by Subject|5|||
147646265|NCT00314132|532524071|FG000|Overall Study|Adverse Event|1|||
147646266|NCT00314132|532524072|FG001|Overall Study|Adverse Event|0|||
147646267|NCT00314132|532524071|FG000|Overall Study|Physician Decision|1|||
147646268|NCT00314132|532524072|FG001|Overall Study|Physician Decision|0|||
147646269|NCT01260584|532524073|FG000|Period 1|Protocol Violation|0|||
147646270|NCT01260584|532524074|FG001|Period 1|Protocol Violation|0|||
147646271|NCT01260584|532524075|FG002|Period 1|Protocol Violation|1|||
147646272|NCT01260584|532524076|FG003|Period 1|Protocol Violation|1|||
147646273|NCT01260584|532524073|FG000|Period 1|Adverse Event|0|||
147646274|NCT01260584|532524074|FG001|Period 1|Adverse Event|0|||
147646275|NCT01260584|532524075|FG002|Period 1|Adverse Event|1|||
147646276|NCT01260584|532524076|FG003|Period 1|Adverse Event|0|||
147646277|NCT01260584|532524073|FG000|Period 2|Protocol Violation|0|||
147646278|NCT01260584|532524074|FG001|Period 2|Protocol Violation|2|||
147646279|NCT01260584|532524075|FG002|Period 2|Protocol Violation|3|||
147646280|NCT01260584|532524076|FG003|Period 2|Protocol Violation|1|||
147646281|NCT01260584|532524073|FG000|Period 2|Adverse Event|1|||
147646282|NCT01260584|532524074|FG001|Period 2|Adverse Event|0|||
147646283|NCT01260584|532524075|FG002|Period 2|Adverse Event|2|||
147646284|NCT01260584|532524076|FG003|Period 2|Adverse Event|0|||
147646285|NCT01260584|532524073|FG000|Period 2|Withdrawal by Subject|0|||
147646286|NCT01260584|532524074|FG001|Period 2|Withdrawal by Subject|1|||
147646287|NCT01260584|532524075|FG002|Period 2|Withdrawal by Subject|0|||
147646288|NCT01260584|532524076|FG003|Period 2|Withdrawal by Subject|0|||
147646289|NCT00586508|532524078|FG000|Overall Study|Progressive disease|52|||
147646290|NCT00586508|532524079|FG001|Overall Study|Progressive disease|8|||
147646291|NCT00586508|532524078|FG000|Overall Study|Death|0|||
147646292|NCT00586508|532524079|FG001|Overall Study|Death|1|||
147646293|NCT00586508|532524078|FG000|Overall Study|Adverse Event|12|||
147646294|NCT00586508|532524079|FG001|Overall Study|Adverse Event|4|||
147646295|NCT00586508|532524078|FG000|Overall Study|Withdrawal by Subject|4|||
147646296|NCT00586508|532524079|FG001|Overall Study|Withdrawal by Subject|0|||
147646297|NCT02079636|532524080|FG000|Overall Study|Death|2|||
147646298|NCT02079636|532524081|FG001|Overall Study|Death|1|||
147646299|NCT02079636|532524082|FG002|Overall Study|Death|0|||
147646300|NCT02079636|532524083|FG003|Overall Study|Death|5|||
147646301|NCT02079636|532524084|FG004|Overall Study|Death|1|||
147646302|NCT02079636|532524085|FG005|Overall Study|Death|2|||
147646303|NCT02079636|532524086|FG006|Overall Study|Death|1|||
147646304|NCT02079636|532524087|FG007|Overall Study|Death|0|||
147646305|NCT02079636|532524088|FG008|Overall Study|Death|0|||
147646306|NCT02079636|532524089|FG009|Overall Study|Death|0|||
147646307|NCT02079636|532524090|FG010|Overall Study|Death|0|||
147646308|NCT02079636|532524091|FG011|Overall Study|Death|1|||
147646309|NCT02079636|532524092|FG012|Overall Study|Death|1|||
147646310|NCT02079636|532524093|FG013|Overall Study|Death|0|||
147646311|NCT02079636|532524094|FG014|Overall Study|Death|2|||
147646312|NCT02079636|532524080|FG000|Overall Study|Adverse Event|1|||
147646313|NCT02079636|532524081|FG001|Overall Study|Adverse Event|1|||
147646314|NCT02079636|532524082|FG002|Overall Study|Adverse Event|0|||
147646315|NCT02079636|532524083|FG003|Overall Study|Adverse Event|1|||
147646316|NCT02079636|532524084|FG004|Overall Study|Adverse Event|1|||
147646317|NCT02079636|532524085|FG005|Overall Study|Adverse Event|2|||
147646318|NCT02079636|532524086|FG006|Overall Study|Adverse Event|0|||
147646319|NCT02079636|532524087|FG007|Overall Study|Adverse Event|0|||
147646320|NCT02079636|532524088|FG008|Overall Study|Adverse Event|0|||
147646321|NCT02079636|532524089|FG009|Overall Study|Adverse Event|0|||
147646322|NCT02079636|532524090|FG010|Overall Study|Adverse Event|0|||
147646323|NCT02079636|532524091|FG011|Overall Study|Adverse Event|0|||
147646324|NCT02079636|532524092|FG012|Overall Study|Adverse Event|0|||
147646325|NCT02079636|532524093|FG013|Overall Study|Adverse Event|0|||
147646326|NCT02079636|532524094|FG014|Overall Study|Adverse Event|0|||
147646327|NCT02079636|532524080|FG000|Overall Study|Progressive disease|0|||
147646328|NCT02079636|532524081|FG001|Overall Study|Progressive disease|0|||
147646329|NCT02079636|532524082|FG002|Overall Study|Progressive disease|0|||
147646330|NCT02079636|532524083|FG003|Overall Study|Progressive disease|2|||
147646331|NCT02079636|532524084|FG004|Overall Study|Progressive disease|0|||
147646332|NCT02079636|532524085|FG005|Overall Study|Progressive disease|0|||
147646333|NCT02079636|532524086|FG006|Overall Study|Progressive disease|0|||
147306598|NCT02917941|531288851|FG000|Treatment Period|Progressive Disease|11|||
147419429|NCT02270515|531698609|FG000|Intervention Period 2: 6-12 Months|Death|5|||
147419430|NCT02270515|531698609|FG000|Intervention Period 2: 6-12 Months|Intervention ended before follow-up|17|||
147419431|NCT02270515|531698609|FG000|Intervention Period 3: 12-18 Months|Withdrawal by Subject|1|||
147419432|NCT02270515|531698609|FG000|Intervention Period 3: 12-18 Months|No longer patient at study site|2|||
147419433|NCT02270515|531698609|FG000|Intervention Period 3: 12-18 Months|Received transplant|2|||
147419434|NCT02270515|531698609|FG000|Intervention Period 3: 12-18 Months|Death|3|||
147419435|NCT02270515|531698609|FG000|Intervention Period 3: 12-18 Months|Intervention ended before follow-up|16|||
147419436|NCT01139580|531698610|FG000|Overall Study|Adverse Event|5|||
147419437|NCT01139580|531698611|FG001|Overall Study|Adverse Event|4|||
147419438|NCT01139580|531698610|FG000|Overall Study|Lost to Follow-up|9|||
147419439|NCT01139580|531698611|FG001|Overall Study|Lost to Follow-up|1|||
147419440|NCT01139580|531698610|FG000|Overall Study|Lack of Efficacy|0|||
147646334|NCT02079636|532524087|FG007|Overall Study|Progressive disease|0|||
147646335|NCT02079636|532524088|FG008|Overall Study|Progressive disease|0|||
147646336|NCT02079636|532524089|FG009|Overall Study|Progressive disease|0|||
147646337|NCT02079636|532524090|FG010|Overall Study|Progressive disease|0|||
147646338|NCT02079636|532524091|FG011|Overall Study|Progressive disease|0|||
147646339|NCT02079636|532524092|FG012|Overall Study|Progressive disease|1|||
147646340|NCT02079636|532524093|FG013|Overall Study|Progressive disease|0|||
147646341|NCT02079636|532524094|FG014|Overall Study|Progressive disease|0|||
147646342|NCT02079636|532524080|FG000|Overall Study|Withdrawal by Subject|0|||
147646343|NCT02079636|532524081|FG001|Overall Study|Withdrawal by Subject|0|||
147646344|NCT02079636|532524082|FG002|Overall Study|Withdrawal by Subject|0|||
147646345|NCT02079636|532524083|FG003|Overall Study|Withdrawal by Subject|4|||
147646346|NCT02079636|532524084|FG004|Overall Study|Withdrawal by Subject|0|||
147646347|NCT02079636|532524085|FG005|Overall Study|Withdrawal by Subject|1|||
147646348|NCT02079636|532524086|FG006|Overall Study|Withdrawal by Subject|0|||
147646349|NCT02079636|532524087|FG007|Overall Study|Withdrawal by Subject|0|||
147646350|NCT02079636|532524088|FG008|Overall Study|Withdrawal by Subject|0|||
147646351|NCT02079636|532524089|FG009|Overall Study|Withdrawal by Subject|2|||
147646352|NCT02079636|532524090|FG010|Overall Study|Withdrawal by Subject|1|||
147646353|NCT02079636|532524091|FG011|Overall Study|Withdrawal by Subject|1|||
147646354|NCT02079636|532524092|FG012|Overall Study|Withdrawal by Subject|1|||
147646355|NCT02079636|532524093|FG013|Overall Study|Withdrawal by Subject|0|||
147646356|NCT02079636|532524094|FG014|Overall Study|Withdrawal by Subject|2|||
147646357|NCT02079636|532524080|FG000|Overall Study|Physician Decision|0|||
147646358|NCT02079636|532524081|FG001|Overall Study|Physician Decision|0|||
147646359|NCT02079636|532524082|FG002|Overall Study|Physician Decision|0|||
147646360|NCT02079636|532524083|FG003|Overall Study|Physician Decision|0|||
147646361|NCT02079636|532524084|FG004|Overall Study|Physician Decision|0|||
147646362|NCT02079636|532524085|FG005|Overall Study|Physician Decision|1|||
147646363|NCT02079636|532524086|FG006|Overall Study|Physician Decision|0|||
147646364|NCT02079636|532524087|FG007|Overall Study|Physician Decision|0|||
147646365|NCT02079636|532524088|FG008|Overall Study|Physician Decision|0|||
147646366|NCT02079636|532524089|FG009|Overall Study|Physician Decision|1|||
147646367|NCT02079636|532524090|FG010|Overall Study|Physician Decision|1|||
147646368|NCT02079636|532524091|FG011|Overall Study|Physician Decision|0|||
147646369|NCT02079636|532524092|FG012|Overall Study|Physician Decision|0|||
147646370|NCT02079636|532524093|FG013|Overall Study|Physician Decision|0|||
147646371|NCT02079636|532524094|FG014|Overall Study|Physician Decision|1|||
147646372|NCT02079636|532524080|FG000|Overall Study|Lost to Follow-up|0|||
147646373|NCT02079636|532524081|FG001|Overall Study|Lost to Follow-up|0|||
147646374|NCT02079636|532524082|FG002|Overall Study|Lost to Follow-up|0|||
147646375|NCT02079636|532524083|FG003|Overall Study|Lost to Follow-up|0|||
147646376|NCT02079636|532524084|FG004|Overall Study|Lost to Follow-up|0|||
147646377|NCT02079636|532524085|FG005|Overall Study|Lost to Follow-up|0|||
147646378|NCT02079636|532524086|FG006|Overall Study|Lost to Follow-up|0|||
147646379|NCT02079636|532524087|FG007|Overall Study|Lost to Follow-up|1|||
147646380|NCT02079636|532524088|FG008|Overall Study|Lost to Follow-up|0|||
147646381|NCT02079636|532524089|FG009|Overall Study|Lost to Follow-up|0|||
147646382|NCT02079636|532524090|FG010|Overall Study|Lost to Follow-up|0|||
147646383|NCT02079636|532524091|FG011|Overall Study|Lost to Follow-up|0|||
147646384|NCT02079636|532524092|FG012|Overall Study|Lost to Follow-up|0|||
147646385|NCT02079636|532524093|FG013|Overall Study|Lost to Follow-up|0|||
147646386|NCT02079636|532524094|FG014|Overall Study|Lost to Follow-up|0|||
147646387|NCT03434249|532524095|FG000|Overall Study|Adverse Event|1|||
147646388|NCT03434249|532524096|FG001|Overall Study|Adverse Event|0|||
147306599|NCT02917941|531288851|FG000|Treatment Period|Reason not Specified|2|||
147419441|NCT01139580|531698611|FG001|Overall Study|Lack of Efficacy|2|||
147646389|NCT03434249|532524095|FG000|Overall Study|Lost to Follow-up|0|||
147646390|NCT03434249|532524096|FG001|Overall Study|Lost to Follow-up|1|||
147646391|NCT03434249|532524095|FG000|Overall Study|Non-compliance of family|2|||
147646392|NCT03434249|532524096|FG001|Overall Study|Non-compliance of family|1|||
147646393|NCT03434249|532524095|FG000|Overall Study|Difficulties in completing daily diary|2|||
147646394|NCT03434249|532524096|FG001|Overall Study|Difficulties in completing daily diary|1|||
147419442|NCT01139580|531698610|FG000|Overall Study|Withdrawal by Subject|6|||
147419443|NCT01139580|531698611|FG001|Overall Study|Withdrawal by Subject|9|||
147419444|NCT01139580|531698610|FG000|Overall Study|Used Excluded Medicine After Enrollment|1|||
147419445|NCT01139580|531698611|FG001|Overall Study|Used Excluded Medicine After Enrollment|0|||
147419446|NCT01139580|531698610|FG000|Overall Study|Did Not Meet Exclusion Criteria|1|||
147419447|NCT01139580|531698611|FG001|Overall Study|Did Not Meet Exclusion Criteria|0|||
147419448|NCT01139580|531698610|FG000|Overall Study|Misrandomized|1|||
147419449|NCT01139580|531698611|FG001|Overall Study|Misrandomized|0|||
147419450|NCT01139580|531698610|FG000|Overall Study|Beginning Study Exclusion Treatment|0|||
147419451|NCT01139580|531698611|FG001|Overall Study|Beginning Study Exclusion Treatment|1|||
147419452|NCT01139580|531698610|FG000|Overall Study|Participant Randomization in Error|0|||
147419453|NCT01139580|531698611|FG001|Overall Study|Participant Randomization in Error|1|||
147419454|NCT00633880|531698612|FG000|Open Label Titration|Lack of Efficacy|1|||
147419455|NCT00633880|531698613|FG001|Open Label Titration|Lack of Efficacy|0|||
147419456|NCT00633880|531698614|FG002|Open Label Titration|Lack of Efficacy|0|||
147419457|NCT00633880|531698612|FG000|Open Label Titration|Adverse Event|13|||
147419458|NCT00633880|531698613|FG001|Open Label Titration|Adverse Event|0|||
147419459|NCT00633880|531698614|FG002|Open Label Titration|Adverse Event|0|||
147419460|NCT00633880|531698612|FG000|Open Label Titration|Treatment Failure|55|||
147419461|NCT00633880|531698613|FG001|Open Label Titration|Treatment Failure|0|||
147419462|NCT00633880|531698614|FG002|Open Label Titration|Treatment Failure|0|||
147419463|NCT00633880|531698612|FG000|Open Label Titration|Protocol Violation|6|||
147419464|NCT00633880|531698613|FG001|Open Label Titration|Protocol Violation|0|||
147419465|NCT00633880|531698614|FG002|Open Label Titration|Protocol Violation|0|||
147419466|NCT00633880|531698612|FG000|Open Label Titration|Physician Decision|1|||
147419467|NCT00633880|531698613|FG001|Open Label Titration|Physician Decision|0|||
147419468|NCT00633880|531698614|FG002|Open Label Titration|Physician Decision|0|||
147419469|NCT00633880|531698612|FG000|Open Label Titration|Withdrawal by Subject|4|||
147419470|NCT00633880|531698613|FG001|Open Label Titration|Withdrawal by Subject|0|||
147419471|NCT00633880|531698614|FG002|Open Label Titration|Withdrawal by Subject|0|||
147419472|NCT00700778|531698615|FG000|Overall Study|Inconclusive data due to inadequate sample collection|2|||
147419473|NCT00350103|531698616|FG000|Overall Study|Adverse Event|12|||
147419474|NCT00350103|531698617|FG001|Overall Study|Adverse Event|29|||
147419475|NCT00350103|531698618|FG002|Overall Study|Adverse Event|17|||
147419476|NCT00350103|531698616|FG000|Overall Study|Lack of Efficacy|5|||
147419477|NCT00350103|531698617|FG001|Overall Study|Lack of Efficacy|1|||
147419478|NCT00350103|531698618|FG002|Overall Study|Lack of Efficacy|3|||
147419479|NCT00350103|531698616|FG000|Overall Study|Withdrawal by Subject|6|||
147419480|NCT00350103|531698617|FG001|Overall Study|Withdrawal by Subject|6|||
147419481|NCT00350103|531698618|FG002|Overall Study|Withdrawal by Subject|8|||
147419482|NCT00350103|531698616|FG000|Overall Study|Protocol Violation|0|||
147419483|NCT00350103|531698617|FG001|Overall Study|Protocol Violation|0|||
147419484|NCT00350103|531698618|FG002|Overall Study|Protocol Violation|1|||
147419485|NCT00350103|531698616|FG000|Overall Study|Unsatisfactory Compliance|2|||
147419486|NCT00350103|531698617|FG001|Overall Study|Unsatisfactory Compliance|2|||
147419487|NCT00350103|531698618|FG002|Overall Study|Unsatisfactory Compliance|1|||
147419488|NCT00350103|531698616|FG000|Overall Study|Investigator´s decision|1|||
147419489|NCT00350103|531698617|FG001|Overall Study|Investigator´s decision|1|||
147419490|NCT00350103|531698618|FG002|Overall Study|Investigator´s decision|0|||
147419491|NCT00350103|531698616|FG000|Overall Study|Exclusion criteria met|0|||
147419492|NCT00350103|531698617|FG001|Overall Study|Exclusion criteria met|0|||
147419493|NCT00350103|531698618|FG002|Overall Study|Exclusion criteria met|1|||
147419494|NCT00350103|531698616|FG000|Overall Study|Patient relocated|0|||
147419495|NCT00350103|531698617|FG001|Overall Study|Patient relocated|0|||
147419496|NCT00350103|531698618|FG002|Overall Study|Patient relocated|1|||
147419497|NCT00350103|531698616|FG000|Overall Study|Need for prohibited medication|1|||
147419498|NCT00350103|531698617|FG001|Overall Study|Need for prohibited medication|0|||
147419499|NCT00350103|531698618|FG002|Overall Study|Need for prohibited medication|0|||
147419500|NCT00350103|531698616|FG000|Overall Study|Personal reasons|0|||
147419501|NCT00350103|531698617|FG001|Overall Study|Personal reasons|0|||
147419502|NCT00350103|531698618|FG002|Overall Study|Personal reasons|1|||
147419503|NCT00350103|531698616|FG000|Overall Study|Patient stopped feeling pain|1|||
147419504|NCT00350103|531698617|FG001|Overall Study|Patient stopped feeling pain|0|||
147419505|NCT00350103|531698618|FG002|Overall Study|Patient stopped feeling pain|0|||
147419506|NCT00350103|531698616|FG000|Overall Study|PR greater than 250ms|0|||
147419507|NCT00350103|531698617|FG001|Overall Study|PR greater than 250ms|0|||
147419508|NCT00350103|531698618|FG002|Overall Study|PR greater than 250ms|1|||
147419509|NCT00350103|531698616|FG000|Overall Study|Wrong calculation of QT interval|0|||
147419510|NCT00350103|531698617|FG001|Overall Study|Wrong calculation of QT interval|0|||
147419511|NCT00350103|531698618|FG002|Overall Study|Wrong calculation of QT interval|1|||
147419512|NCT00350103|531698616|FG000|Overall Study|Sponsor mistake|1|||
147646395|NCT03325894|532524097|FG000|Overall Study|Adverse Event|2|||
147419513|NCT00350103|531698617|FG001|Overall Study|Sponsor mistake|0|||
147419514|NCT00350103|531698618|FG002|Overall Study|Sponsor mistake|0|||
147646396|NCT03325894|532524098|FG001|Overall Study|Adverse Event|3|||
147419515|NCT00350103|531698616|FG000|Overall Study|Randomization mistake|0|||
147419516|NCT00350103|531698617|FG001|Overall Study|Randomization mistake|1|||
147419517|NCT00350103|531698618|FG002|Overall Study|Randomization mistake|1|||
147419518|NCT00350103|531698616|FG000|Overall Study|Sponsor´s decision|0|||
147419519|NCT00350103|531698617|FG001|Overall Study|Sponsor´s decision|1|||
147419520|NCT00350103|531698618|FG002|Overall Study|Sponsor´s decision|0|||
147419521|NCT00350103|531698616|FG000|Overall Study|Lost, Reason unknown|1|||
147419522|NCT00350103|531698617|FG001|Overall Study|Lost, Reason unknown|1|||
147419523|NCT00350103|531698618|FG002|Overall Study|Lost, Reason unknown|0|||
147419524|NCT02842151|531698619|FG000|Overall Study|Adverse Event|1|||
147419525|NCT02842151|531698619|FG000|Overall Study|Subject moved too far away|1|||
147419526|NCT02559895|531698620|FG000|Overall Study|Adverse Event|3|||
147419527|NCT02559895|531698621|FG001|Overall Study|Adverse Event|3|||
147419528|NCT02559895|531698622|FG002|Overall Study|Adverse Event|2|||
147419529|NCT02559895|531698623|FG003|Overall Study|Adverse Event|1|||
147419530|NCT02559895|531698620|FG000|Overall Study|Lack of Efficacy|2|||
147419531|NCT02559895|531698621|FG001|Overall Study|Lack of Efficacy|3|||
147419532|NCT02559895|531698622|FG002|Overall Study|Lack of Efficacy|2|||
147419533|NCT02559895|531698623|FG003|Overall Study|Lack of Efficacy|8|||
147419534|NCT02559895|531698620|FG000|Overall Study|Lost to Follow-up|22|||
147419535|NCT02559895|531698621|FG001|Overall Study|Lost to Follow-up|16|||
147419536|NCT02559895|531698622|FG002|Overall Study|Lost to Follow-up|12|||
147419537|NCT02559895|531698623|FG003|Overall Study|Lost to Follow-up|17|||
147419538|NCT02559895|531698620|FG000|Overall Study|Physician Decision|1|||
147419539|NCT02559895|531698621|FG001|Overall Study|Physician Decision|1|||
147419540|NCT02559895|531698622|FG002|Overall Study|Physician Decision|3|||
147419541|NCT02559895|531698623|FG003|Overall Study|Physician Decision|0|||
147419542|NCT02559895|531698620|FG000|Overall Study|Withdrawal by Subject|16|||
147419543|NCT02559895|531698621|FG001|Overall Study|Withdrawal by Subject|9|||
147419544|NCT02559895|531698622|FG002|Overall Study|Withdrawal by Subject|20|||
147419545|NCT02559895|531698623|FG003|Overall Study|Withdrawal by Subject|9|||
147419546|NCT02559895|531698620|FG000|Overall Study|Study Burden|10|||
147419547|NCT02559895|531698621|FG001|Overall Study|Study Burden|16|||
147419548|NCT02559895|531698622|FG002|Overall Study|Study Burden|12|||
147419549|NCT02559895|531698623|FG003|Overall Study|Study Burden|22|||
147419550|NCT02559895|531698620|FG000|Overall Study|Other|1|||
147419551|NCT02559895|531698621|FG001|Overall Study|Other|5|||
147419552|NCT02559895|531698622|FG002|Overall Study|Other|3|||
147419553|NCT02559895|531698623|FG003|Overall Study|Other|3|||
147419554|NCT04540887|531698627|FG000|Overall Study|Withdrawal by Subject|2|||
147419555|NCT00760474|531698628|FG000|Period 1 (P1)|Discontinued then re-entered|1|||
147419556|NCT00760474|531698629|FG001|Period 1 (P1)|Discontinued then re-entered|1|||
147419557|NCT00760474|531698628|FG000|Placebo Washout Period|Other|0|||
147419558|NCT00760474|531698629|FG001|Placebo Washout Period|Other|1|||
147419559|NCT00760474|531698628|FG000|Period 2 (P2)|Lost to Follow-up|1|||
147419560|NCT00760474|531698629|FG001|Period 2 (P2)|Lost to Follow-up|0|||
147419561|NCT00760474|531698628|FG000|Period 2 (P2)|Adverse Event|0|||
147419562|NCT00760474|531698629|FG001|Period 2 (P2)|Adverse Event|1|||
147419563|NCT00513305|531698630|FG000|Overall Study|Adverse Event|6|||
147419564|NCT00513305|531698631|FG001|Overall Study|Adverse Event|2|||
147419565|NCT00513305|531698630|FG000|Overall Study|Death (through Consolidation Treatment)|2|||
147419566|NCT00513305|531698631|FG001|Overall Study|Death (through Consolidation Treatment)|2|||
147419567|NCT00513305|531698630|FG000|Overall Study|Lack of Efficacy|8|||
147419568|NCT00513305|531698631|FG001|Overall Study|Lack of Efficacy|13|||
147419569|NCT00513305|531698630|FG000|Overall Study|Withdrawal by Subject|1|||
147419570|NCT00513305|531698631|FG001|Overall Study|Withdrawal by Subject|2|||
147419571|NCT00513305|531698630|FG000|Overall Study|Disease progression|8|||
147419572|NCT00513305|531698631|FG001|Overall Study|Disease progression|5|||
147419573|NCT00513305|531698630|FG000|Overall Study|Eligible for stem cell transplant|1|||
147419574|NCT00513305|531698631|FG001|Overall Study|Eligible for stem cell transplant|0|||
147419575|NCT00513305|531698630|FG000|Overall Study|Hematologic counts did not recover|1|||
147419576|NCT00513305|531698631|FG001|Overall Study|Hematologic counts did not recover|0|||
147419577|NCT00513305|531698630|FG000|Overall Study|Physician Decision|1|||
147419578|NCT00513305|531698631|FG001|Overall Study|Physician Decision|0|||
147419579|NCT00513305|531698630|FG000|Overall Study|Persistent hypocellularity|0|||
147419580|NCT00513305|531698631|FG001|Overall Study|Persistent hypocellularity|1|||
147419581|NCT00513305|531698630|FG000|Overall Study|Sponsor Decision|0|||
147419582|NCT00513305|531698631|FG001|Overall Study|Sponsor Decision|2|||
147419583|NCT01262027|531698632|FG000|Overall Study|Adverse Event|1|||
147419584|NCT01262027|531698632|FG000|Overall Study|Withdrawal by Subject|3|||
147419585|NCT01262027|531698632|FG000|Overall Study|Protocol Violation|1|||
147419586|NCT03014479|531698633|FG000|Overall Study|Adverse Event|0|||
147419587|NCT03014479|531698634|FG001|Overall Study|Adverse Event|1|||
147419588|NCT03014479|531698633|FG000|Overall Study|Voluntary Withdrawal|0|||
147419589|NCT03014479|531698634|FG001|Overall Study|Voluntary Withdrawal|2|||
147419590|NCT03014479|531698633|FG000|Overall Study|Unacceptable Inability of Site Visit|0|||
147419591|NCT03014479|531698634|FG001|Overall Study|Unacceptable Inability of Site Visit|1|||
147419592|NCT02217501|531698637|FG000|Overall Study|Death|3|||
147419593|NCT02217501|531698638|FG001|Overall Study|Death|4|||
147419594|NCT01394978|531698639|FG000|Overall Study|Withdrawal by Subject|2|||
147419595|NCT01394978|531698640|FG001|Overall Study|Withdrawal by Subject|4|||
147419596|NCT01394978|531698639|FG000|Overall Study|Lost to Follow-up|13|||
147419597|NCT01394978|531698640|FG001|Overall Study|Lost to Follow-up|20|||
147419598|NCT01394978|531698639|FG000|Overall Study|Death|6|||
147419599|NCT01394978|531698640|FG001|Overall Study|Death|7|||
147419600|NCT02019667|531698641|FG000|First Intervention (6 Months)|Adverse Event|0|||
147419601|NCT02019667|531698642|FG001|First Intervention (6 Months)|Adverse Event|1|||
147419602|NCT02019667|531698641|FG000|2nd Intervention (6 Months)|Adverse Event|0|||
147419603|NCT02019667|531698642|FG001|2nd Intervention (6 Months)|Adverse Event|1|||
147419604|NCT02019667|531698641|FG000|2nd Intervention (6 Months)|Physician Decision|0|||
147419605|NCT02019667|531698642|FG001|2nd Intervention (6 Months)|Physician Decision|1|||
147419606|NCT01942785|531698643|FG000|Overall Study|Adverse Event|2|||
147419607|NCT01942785|531698643|FG000|Overall Study|Withdrawal by Subject|1|||
147419608|NCT01942785|531698643|FG000|Overall Study|Protocol Violation|1|||
147419609|NCT05453201|531698647|FG000|Overall Study|Withdrawal by Subject|1|||
147419610|NCT01934790|531698648|FG000|Treatment|Adverse Event|3|||
147419611|NCT01934790|531698648|FG000|Treatment|Clinical progression|6|||
147419612|NCT01934790|531698648|FG000|Treatment|Radiological progression|4|||
147419613|NCT01934790|531698648|FG000|Treatment|Withdrawal by Subject|2|||
147419614|NCT01934790|531698648|FG000|Treatment|Study drug never administered|1|||
147419615|NCT01934790|531698648|FG000|Active Follow up|Death|20|||
147419616|NCT01934790|531698648|FG000|Active Follow up|Physician Decision|2|||
147646397|NCT03325894|532524097|FG000|Overall Study|Protocol Violation|1|||
147646398|NCT03325894|532524098|FG001|Overall Study|Protocol Violation|2|||
147646399|NCT03325894|532524097|FG000|Overall Study|Withdrawal by Subject|10|||
147646400|NCT03325894|532524098|FG001|Overall Study|Withdrawal by Subject|6|||
147646401|NCT03325894|532524097|FG000|Overall Study|Lost to Follow-up|4|||
147646402|NCT03325894|532524098|FG001|Overall Study|Lost to Follow-up|9|||
147646403|NCT03325894|532524097|FG000|Overall Study|Lack of Efficacy|8|||
147646404|NCT03325894|532524098|FG001|Overall Study|Lack of Efficacy|14|||
147646405|NCT03325894|532524097|FG000|Overall Study|Study Terminated by Sponsor|38|||
147646406|NCT03325894|532524098|FG001|Overall Study|Study Terminated by Sponsor|43|||
147646407|NCT03325894|532524097|FG000|Overall Study|Other (Not received Treatment)|1|||
147646408|NCT03325894|532524098|FG001|Overall Study|Other (Not received Treatment)|0|||
147646409|NCT03482167|532524099|FG000|Allocated to Intervention|Physician Decision|1|||
147646410|NCT03482167|532524100|FG001|Allocated to Intervention|Physician Decision|2|||
147646411|NCT03482167|532524099|FG000|Received Intervention|Adverse Event|3|||
147646412|NCT03482167|532524100|FG001|Received Intervention|Adverse Event|1|||
147646413|NCT03482167|532524099|FG000|Received Intervention|Physician Decision|1|||
147646414|NCT03482167|532524100|FG001|Received Intervention|Physician Decision|1|||
147646415|NCT03482167|532524099|FG000|Received Intervention|Withdrawal by Subject|1|||
147646416|NCT03482167|532524100|FG001|Received Intervention|Withdrawal by Subject|0|||
147646417|NCT04148287|532524106|FG000|Overall Study|Death|2|||
147646418|NCT00824382|532524108|FG000|Overall Study|Adverse Event|4|||
147646419|NCT00824382|532524109|FG001|Overall Study|Adverse Event|1|||
147646420|NCT00824382|532524110|FG002|Overall Study|Adverse Event|1|||
147646421|NCT00824382|532524111|FG003|Overall Study|Adverse Event|4|||
147646422|NCT00824382|532524108|FG000|Overall Study|Protocol Violation|1|||
147646423|NCT00824382|532524109|FG001|Overall Study|Protocol Violation|0|||
147646424|NCT00824382|532524110|FG002|Overall Study|Protocol Violation|0|||
147646425|NCT00824382|532524111|FG003|Overall Study|Protocol Violation|1|||
147646426|NCT00824382|532524108|FG000|Overall Study|Investigator's decision|0|||
147646427|NCT00824382|532524109|FG001|Overall Study|Investigator's decision|1|||
147646428|NCT00824382|532524110|FG002|Overall Study|Investigator's decision|2|||
147646429|NCT00824382|532524111|FG003|Overall Study|Investigator's decision|0|||
147646430|NCT02407054|532524112|FG000|Overall Study|Adverse Event|1|||
147646431|NCT02407054|532524113|FG001|Overall Study|Adverse Event|4|||
147646432|NCT02407054|532524114|FG002|Overall Study|Adverse Event|1|||
147419617|NCT01934790|531698648|FG000|Active Follow up|Progressive disease|1|||
147419618|NCT01934790|531698648|FG000|Active Follow up|Other reason|1|||
147419619|NCT03798691|531698651|FG000|Overall Study|Lost to Follow-up|2|||
147419620|NCT03798691|531698652|FG001|Overall Study|Lost to Follow-up|2|||
147646433|NCT02407054|532524112|FG000|Overall Study|Non-compliance with Study|0|||
147646434|NCT02407054|532524113|FG001|Overall Study|Non-compliance with Study|2|||
147646435|NCT02407054|532524114|FG002|Overall Study|Non-compliance with Study|1|||
147419621|NCT00552929|531698653|FG000|Overall Study|Lost to Follow-up|0|||
147646436|NCT02407054|532524112|FG000|Overall Study|Physician Decision|1|||
147646437|NCT02407054|532524113|FG001|Overall Study|Physician Decision|3|||
147646438|NCT02407054|532524114|FG002|Overall Study|Physician Decision|3|||
147646439|NCT02407054|532524112|FG000|Overall Study|Withdrawal by Subject|5|||
147419622|NCT00552929|531698654|FG001|Overall Study|Lost to Follow-up|0|||
147419623|NCT00552929|531698655|FG002|Overall Study|Lost to Follow-up|0|||
147419624|NCT00552929|531698656|FG003|Overall Study|Lost to Follow-up|0|||
147419625|NCT00552929|531698657|FG004|Overall Study|Lost to Follow-up|0|||
147419626|NCT00552929|531698658|FG005|Overall Study|Lost to Follow-up|0|||
147646440|NCT02407054|532524113|FG001|Overall Study|Withdrawal by Subject|9|||
147646441|NCT02407054|532524114|FG002|Overall Study|Withdrawal by Subject|2|||
147646442|NCT00415597|532524115|FG000|Enrollment|Withdrawal by Subject|1|||
147646443|NCT00415597|532524115|FG000|Enrollment|Protocol Violation|1|||
147646444|NCT00415597|532524115|FG000|Treatment|Adverse Event|110|||
147646445|NCT00415597|532524115|FG000|Treatment|Lack of Efficacy|39|||
147646446|NCT00415597|532524115|FG000|Treatment|Protocol Violation|67|||
147646447|NCT00415597|532524115|FG000|Treatment|Physician Decision|3|||
147646448|NCT00415597|532524115|FG000|Treatment|Withdrawal by Subject|51|||
147646449|NCT00415597|532524115|FG000|Treatment|Lost to Follow-up|28|||
147646450|NCT00415597|532524115|FG000|Treatment|Drug Screen|2|||
147646451|NCT00415597|532524115|FG000|Treatment|Administrative|3|||
147646452|NCT00415597|532524115|FG000|Treatment|Sponsor Decision|1|||
147646453|NCT00415597|532524115|FG000|Treatment|Multiple Reasons|1|||
147646454|NCT04102865|532524117|FG000|Overall Study|Adverse Event|4|||
147646455|NCT04102865|532524118|FG001|Overall Study|Adverse Event|0|||
147646456|NCT04102865|532524117|FG000|Overall Study|Lost to Follow-up|1|||
147646457|NCT04102865|532524118|FG001|Overall Study|Lost to Follow-up|0|||
147646458|NCT04102865|532524117|FG000|Overall Study|Withdrawal by Subject|2|||
147646459|NCT04102865|532524118|FG001|Overall Study|Withdrawal by Subject|0|||
147646460|NCT02824562|532526097|FG000|Overall Study|Lost to Follow-up|3|||
147646461|NCT02824562|532526098|FG001|Overall Study|Lost to Follow-up|4|||
147646462|NCT02824562|532526097|FG000|Overall Study|Death|0|||
147646463|NCT02824562|532526098|FG001|Overall Study|Death|1|||
147646464|NCT02168777|532526099|FG000|Overall Study|Withdrawal by Subject|1|||
147646465|NCT02168777|532526100|FG001|Overall Study|Withdrawal by Subject|0|||
147646466|NCT02168777|532526101|FG002|Overall Study|Withdrawal by Subject|2|||
147646467|NCT02168777|532526099|FG000|Overall Study|Adverse Event|1|||
147646468|NCT02168777|532526100|FG001|Overall Study|Adverse Event|0|||
147646469|NCT02168777|532526101|FG002|Overall Study|Adverse Event|1|||
147646470|NCT02168777|532526099|FG000|Overall Study|Disease recurrence|0|||
147646471|NCT02168777|532526100|FG001|Overall Study|Disease recurrence|0|||
147646472|NCT02168777|532526101|FG002|Overall Study|Disease recurrence|1|||
147646473|NCT02168777|532526099|FG000|Overall Study|Radiological disease progression|0|||
147646474|NCT02168777|532526100|FG001|Overall Study|Radiological disease progression|5|||
147646475|NCT02168777|532526101|FG002|Overall Study|Radiological disease progression|5|||
147646476|NCT02168777|532526099|FG000|Overall Study|Clinical disease progression|0|||
147646477|NCT02168777|532526100|FG001|Overall Study|Clinical disease progression|1|||
147646478|NCT02168777|532526101|FG002|Overall Study|Clinical disease progression|2|||
147646479|NCT02168777|532526099|FG000|Overall Study|Other reason|0|||
147646480|NCT02168777|532526100|FG001|Overall Study|Other reason|1|||
147646481|NCT02168777|532526101|FG002|Overall Study|Other reason|0|||
147646482|NCT01663857|532526102|FG000|Overall Study|Withdrew Consent to Study Participation|0|||
147646483|NCT01663857|532526103|FG001|Overall Study|Withdrew Consent to Study Participation|1|||
147646484|NCT01663857|532526104|FG002|Overall Study|Withdrew Consent to Study Participation|7|||
147646485|NCT01663857|532526105|FG003|Overall Study|Withdrew Consent to Study Participation|3|||
147646486|NCT01663857|532526102|FG000|Overall Study|Lost to Follow-up|0|||
147646487|NCT01663857|532526103|FG001|Overall Study|Lost to Follow-up|0|||
147646488|NCT01663857|532526104|FG002|Overall Study|Lost to Follow-up|3|||
147646489|NCT01663857|532526105|FG003|Overall Study|Lost to Follow-up|1|||
147646490|NCT01172808|532526106|FG000|Overall Study|Adverse Event|8|||
147646491|NCT01172808|532526107|FG001|Overall Study|Adverse Event|4|||
147646492|NCT01172808|532526108|FG002|Overall Study|Adverse Event|8|||
147646493|NCT01172808|532526109|FG003|Overall Study|Adverse Event|3|||
147646494|NCT01172808|532526106|FG000|Overall Study|Lack of Efficacy|1|||
147646495|NCT01172808|532526107|FG001|Overall Study|Lack of Efficacy|0|||
147646496|NCT01172808|532526108|FG002|Overall Study|Lack of Efficacy|0|||
147646497|NCT01172808|532526109|FG003|Overall Study|Lack of Efficacy|0|||
147646498|NCT01172808|532526106|FG000|Overall Study|Protocol Violation|2|||
147646499|NCT01172808|532526107|FG001|Overall Study|Protocol Violation|2|||
147646500|NCT01172808|532526108|FG002|Overall Study|Protocol Violation|2|||
147646501|NCT01172808|532526109|FG003|Overall Study|Protocol Violation|0|||
147646502|NCT01172808|532526106|FG000|Overall Study|Lost to Follow-up|0|||
147646503|NCT01172808|532526107|FG001|Overall Study|Lost to Follow-up|1|||
147646504|NCT01172808|532526108|FG002|Overall Study|Lost to Follow-up|1|||
147646505|NCT01172808|532526109|FG003|Overall Study|Lost to Follow-up|3|||
147646506|NCT01172808|532526106|FG000|Overall Study|Withdrawal by Subject|4|||
147646507|NCT01172808|532526107|FG001|Overall Study|Withdrawal by Subject|1|||
147646508|NCT01172808|532526108|FG002|Overall Study|Withdrawal by Subject|3|||
147646509|NCT01172808|532526109|FG003|Overall Study|Withdrawal by Subject|2|||
147646510|NCT01172808|532526106|FG000|Overall Study|Other|6|||
147646511|NCT01172808|532526107|FG001|Overall Study|Other|5|||
147646512|NCT01172808|532526108|FG002|Overall Study|Other|9|||
147646513|NCT01172808|532526109|FG003|Overall Study|Other|7|||
147646514|NCT01066793|532526114|FG000|Overall Study|Death|4|||
147646515|NCT01066793|532526115|FG001|Overall Study|Death|1|||
147646516|NCT01066793|532526116|FG002|Overall Study|Death|1|||
147419627|NCT00552929|531698659|FG006|Overall Study|Lost to Follow-up|0|||
147646517|NCT01066793|532526117|FG003|Overall Study|Death|0|||
147646518|NCT01066793|532526118|FG004|Overall Study|Death|0|||
147646519|NCT01066793|532526119|FG005|Overall Study|Death|0|||
147646520|NCT01066793|532526114|FG000|Overall Study|Lack of Efficacy|2|||
147646521|NCT01066793|532526115|FG001|Overall Study|Lack of Efficacy|1|||
147646522|NCT01066793|532526116|FG002|Overall Study|Lack of Efficacy|0|||
147646523|NCT01066793|532526117|FG003|Overall Study|Lack of Efficacy|0|||
147646524|NCT01066793|532526118|FG004|Overall Study|Lack of Efficacy|0|||
147646525|NCT01066793|532526119|FG005|Overall Study|Lack of Efficacy|0|||
147646526|NCT01066793|532526114|FG000|Overall Study|Lost to Follow-up|180|||
147646527|NCT01066793|532526115|FG001|Overall Study|Lost to Follow-up|39|||
147646528|NCT01066793|532526116|FG002|Overall Study|Lost to Follow-up|82|||
147646529|NCT01066793|532526117|FG003|Overall Study|Lost to Follow-up|16|||
147646530|NCT01066793|532526118|FG004|Overall Study|Lost to Follow-up|0|||
147646531|NCT01066793|532526119|FG005|Overall Study|Lost to Follow-up|1|||
147646532|NCT01066793|532526114|FG000|Overall Study|Physician Decision|3|||
147646533|NCT01066793|532526115|FG001|Overall Study|Physician Decision|0|||
147646534|NCT01066793|532526116|FG002|Overall Study|Physician Decision|0|||
147646535|NCT01066793|532526117|FG003|Overall Study|Physician Decision|0|||
147646536|NCT01066793|532526118|FG004|Overall Study|Physician Decision|0|||
147646537|NCT01066793|532526119|FG005|Overall Study|Physician Decision|0|||
147646538|NCT01066793|532526114|FG000|Overall Study|Protocol Violation|3|||
147646539|NCT01066793|532526115|FG001|Overall Study|Protocol Violation|2|||
147646540|NCT01066793|532526116|FG002|Overall Study|Protocol Violation|2|||
147646541|NCT01066793|532526117|FG003|Overall Study|Protocol Violation|0|||
147646542|NCT01066793|532526118|FG004|Overall Study|Protocol Violation|0|||
147646543|NCT01066793|532526119|FG005|Overall Study|Protocol Violation|0|||
147646544|NCT01066793|532526114|FG000|Overall Study|Withdrawal by Subject|7|||
147646545|NCT01066793|532526115|FG001|Overall Study|Withdrawal by Subject|4|||
147646546|NCT01066793|532526116|FG002|Overall Study|Withdrawal by Subject|1|||
147646547|NCT01066793|532526117|FG003|Overall Study|Withdrawal by Subject|0|||
147646548|NCT01066793|532526118|FG004|Overall Study|Withdrawal by Subject|0|||
147646549|NCT01066793|532526119|FG005|Overall Study|Withdrawal by Subject|0|||
147646550|NCT01066793|532526114|FG000|Overall Study|Early Termination|3|||
147646551|NCT01066793|532526115|FG001|Overall Study|Early Termination|0|||
147646552|NCT01066793|532526116|FG002|Overall Study|Early Termination|0|||
147646553|NCT01066793|532526117|FG003|Overall Study|Early Termination|0|||
147646554|NCT01066793|532526118|FG004|Overall Study|Early Termination|0|||
147646555|NCT01066793|532526119|FG005|Overall Study|Early Termination|0|||
147646556|NCT01066793|532526114|FG000|Overall Study|Lab test not done|7|||
147646557|NCT01066793|532526115|FG001|Overall Study|Lab test not done|0|||
147646558|NCT01066793|532526116|FG002|Overall Study|Lab test not done|0|||
147646559|NCT01066793|532526117|FG003|Overall Study|Lab test not done|1|||
147646560|NCT01066793|532526118|FG004|Overall Study|Lab test not done|0|||
147646561|NCT01066793|532526119|FG005|Overall Study|Lab test not done|0|||
147646562|NCT01066793|532526114|FG000|Overall Study|Miscellaneous|4|||
147646563|NCT01066793|532526115|FG001|Overall Study|Miscellaneous|5|||
147646564|NCT01066793|532526116|FG002|Overall Study|Miscellaneous|6|||
147646565|NCT01066793|532526117|FG003|Overall Study|Miscellaneous|0|||
147646566|NCT01066793|532526118|FG004|Overall Study|Miscellaneous|0|||
147646567|NCT01066793|532526119|FG005|Overall Study|Miscellaneous|0|||
147646568|NCT01066793|532526114|FG000|Overall Study|Non-responders|104|||
147646569|NCT01066793|532526115|FG001|Overall Study|Non-responders|5|||
147646570|NCT01066793|532526116|FG002|Overall Study|Non-responders|11|||
147646571|NCT01066793|532526117|FG003|Overall Study|Non-responders|25|||
147646572|NCT01066793|532526118|FG004|Overall Study|Non-responders|0|||
147646573|NCT01066793|532526119|FG005|Overall Study|Non-responders|0|||
147646574|NCT01066793|532526114|FG000|Overall Study|Other|15|||
147646575|NCT01066793|532526115|FG001|Overall Study|Other|5|||
147646576|NCT01066793|532526116|FG002|Overall Study|Other|6|||
147646577|NCT01066793|532526117|FG003|Overall Study|Other|2|||
147646578|NCT01066793|532526118|FG004|Overall Study|Other|0|||
147646579|NCT01066793|532526119|FG005|Overall Study|Other|0|||
147646580|NCT01066793|532526114|FG000|Overall Study|Relapse|20|||
147646581|NCT01066793|532526115|FG001|Overall Study|Relapse|8|||
147646582|NCT01066793|532526116|FG002|Overall Study|Relapse|2|||
147646583|NCT01066793|532526117|FG003|Overall Study|Relapse|3|||
147646584|NCT01066793|532526118|FG004|Overall Study|Relapse|0|||
147646585|NCT01066793|532526119|FG005|Overall Study|Relapse|0|||
147646586|NCT01066793|532526114|FG000|Overall Study|Result Not Available|1|||
147646587|NCT01066793|532526115|FG001|Overall Study|Result Not Available|0|||
147646588|NCT01066793|532526116|FG002|Overall Study|Result Not Available|0|||
147646589|NCT01066793|532526117|FG003|Overall Study|Result Not Available|0|||
147646590|NCT01066793|532526118|FG004|Overall Study|Result Not Available|0|||
147646591|NCT01066793|532526119|FG005|Overall Study|Result Not Available|0|||
147646592|NCT01066793|532526114|FG000|Overall Study|Treatment Interrupted|1|||
147646593|NCT01066793|532526115|FG001|Overall Study|Treatment Interrupted|1|||
147646594|NCT01066793|532526116|FG002|Overall Study|Treatment Interrupted|0|||
147646595|NCT01066793|532526117|FG003|Overall Study|Treatment Interrupted|0|||
147646596|NCT01066793|532526118|FG004|Overall Study|Treatment Interrupted|0|||
147646597|NCT01066793|532526119|FG005|Overall Study|Treatment Interrupted|0|||
147646598|NCT01066793|532526114|FG000|Overall Study|Treatment Never Started|18|||
147646599|NCT01066793|532526115|FG001|Overall Study|Treatment Never Started|5|||
147646600|NCT01066793|532526116|FG002|Overall Study|Treatment Never Started|4|||
147646601|NCT01066793|532526117|FG003|Overall Study|Treatment Never Started|1|||
147646602|NCT01066793|532526118|FG004|Overall Study|Treatment Never Started|0|||
147646603|NCT01066793|532526119|FG005|Overall Study|Treatment Never Started|0|||
147646604|NCT01066793|532526114|FG000|Overall Study|Treatment Stopped|2|||
147646605|NCT01066793|532526115|FG001|Overall Study|Treatment Stopped|1|||
147646606|NCT01066793|532526116|FG002|Overall Study|Treatment Stopped|0|||
147646607|NCT01066793|532526117|FG003|Overall Study|Treatment Stopped|1|||
147646608|NCT01066793|532526118|FG004|Overall Study|Treatment Stopped|0|||
147646609|NCT01066793|532526119|FG005|Overall Study|Treatment Stopped|0|||
147646610|NCT03774394|532526121|FG000|Overall Study|Withdrawal by Subject|2|||
147646611|NCT03774394|532526122|FG001|Overall Study|Withdrawal by Subject|0|||
147646612|NCT02697916|532526123|FG000|Overall Study|Death|357|||
147646613|NCT02697916|532526124|FG001|Overall Study|Death|315|||
147646614|NCT02697916|532526123|FG000|Overall Study|Withdrawal by Subject|221|||
147646615|NCT02697916|532526124|FG001|Overall Study|Withdrawal by Subject|393|||
147646616|NCT00994214|532526125|FG000|ITT (Intention-to-Treat) - Part A|Adverse Event|0|||
147646617|NCT00994214|532526126|FG001|ITT (Intention-to-Treat) - Part A|Adverse Event|1|||
147646618|NCT00994214|532526127|FG002|ITT (Intention-to-Treat) - Part A|Adverse Event|0|||
147646619|NCT00994214|532526128|FG003|ITT (Intention-to-Treat) - Part A|Adverse Event|0|||
147646620|NCT00994214|532526125|FG000|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|0|||
147646621|NCT00994214|532526126|FG001|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|0|||
147646622|NCT00994214|532526127|FG002|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|0|||
147419628|NCT00552929|531698660|FG007|Overall Study|Lost to Follow-up|0|||
147419629|NCT00552929|531698661|FG008|Overall Study|Lost to Follow-up|1|||
147419630|NCT00552929|531698662|FG009|Overall Study|Lost to Follow-up|0|||
147419631|NCT00552929|531698653|FG000|Overall Study|Not Eligible|0|||
147419632|NCT00552929|531698654|FG001|Overall Study|Not Eligible|0|||
147419633|NCT00552929|531698655|FG002|Overall Study|Not Eligible|0|||
147419634|NCT00552929|531698656|FG003|Overall Study|Not Eligible|0|||
147419635|NCT00552929|531698657|FG004|Overall Study|Not Eligible|0|||
147419636|NCT00552929|531698658|FG005|Overall Study|Not Eligible|1|||
147419637|NCT00552929|531698659|FG006|Overall Study|Not Eligible|0|||
147419638|NCT00552929|531698660|FG007|Overall Study|Not Eligible|0|||
147419639|NCT00552929|531698661|FG008|Overall Study|Not Eligible|0|||
147419640|NCT00552929|531698662|FG009|Overall Study|Not Eligible|0|||
147419641|NCT01147536|531698668|FG000|Overall Study|Administrative study close|2|||
147419642|NCT01147536|531698668|FG000|Overall Study|Death|1|||
147419643|NCT03762200|531698669|FG000|Overall Study|Death|2|||
147419644|NCT05559476|531698674|FG000|Overall Study|Adverse Event|2|||
147419645|NCT05559476|531698675|FG001|Overall Study|Adverse Event|0|||
147419646|NCT05559476|531698674|FG000|Overall Study|Lost to Follow-up|13|||
147419647|NCT05559476|531698675|FG001|Overall Study|Lost to Follow-up|12|||
147419648|NCT05559476|531698674|FG000|Overall Study|Consent withdrawal, not due to a (S)AE|8|||
147419649|NCT05559476|531698675|FG001|Overall Study|Consent withdrawal, not due to a (S)AE|14|||
147419650|NCT05559476|531698674|FG000|Overall Study|Other|0|||
147419651|NCT05559476|531698675|FG001|Overall Study|Other|2|||
147419652|NCT05110690|531698676|FG000|Eligible for Consent and Enrollment|Did not consent|5|||
147419653|NCT05110690|531698676|FG000|Started Intervention|Ineligible due to canceled surgery|1|||
147419654|NCT05110690|531698676|FG000|Completion of Intervention|Lost to Follow-up|1|||
147419655|NCT05110690|531698676|FG000|Completion of Intervention|Death|1|||
147419656|NCT05110690|531698676|FG000|Completion of Intervention|Withdrawal by Subject|2|||
147419657|NCT04058366|531700024|FG000|Overall Study|Adverse Event|14|||
147419658|NCT04058366|531700024|FG000|Overall Study|Withdrawal of Consent (not due to AE)|7|||
147419659|NCT04058366|531700024|FG000|Overall Study|Commercial drug is available for participants|6|||
147419660|NCT04058366|531700024|FG000|Overall Study|Death|1|||
147419661|NCT04058366|531700024|FG000|Overall Study|Other non-compliance|2|||
147419662|NCT04058366|531700024|FG000|Overall Study|Other|6|||
147419663|NCT02594163|531700025|FG000|Treatment Period|Progressive disease|2|||
147646623|NCT00994214|532526128|FG003|ITT (Intention-to-Treat) - Part A|Withdrawal by Subject|1|||
147646624|NCT00994214|532526125|FG000|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|1|||
147646625|NCT00994214|532526126|FG001|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|0|||
147646626|NCT00994214|532526127|FG002|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|0|||
147419664|NCT02594163|531700026|FG001|Treatment Period|Progressive disease|3|||
147419665|NCT02594163|531700025|FG000|Treatment Period|Adverse Event|1|||
147419666|NCT02594163|531700026|FG001|Treatment Period|Adverse Event|5|||
147419667|NCT02594163|531700025|FG000|Treatment Period|Physician Decision|1|||
147419668|NCT02594163|531700026|FG001|Treatment Period|Physician Decision|3|||
147419669|NCT02594163|531700025|FG000|Treatment Period|Study termination by sponsor|2|||
147419670|NCT02594163|531700026|FG001|Treatment Period|Study termination by sponsor|1|||
147419671|NCT02594163|531700025|FG000|Treatment Period|Other, Non-AE|1|||
147419672|NCT02594163|531700026|FG001|Treatment Period|Other, Non-AE|0|||
147419673|NCT02594163|531700025|FG000|Follow-up Period|Withdrawal by Subject|0|||
147646627|NCT00994214|532526128|FG003|ITT (Intention-to-Treat) - Part A|Lost to Follow-up|0|||
147419674|NCT02594163|531700026|FG001|Follow-up Period|Withdrawal by Subject|1|||
147419675|NCT02594163|531700025|FG000|Follow-up Period|Study Termination by Sponsor|6|||
147419676|NCT02594163|531700026|FG001|Follow-up Period|Study Termination by Sponsor|4|||
147419677|NCT02594163|531700025|FG000|Follow-up Period|Lost to Follow-up|1|||
147419678|NCT02594163|531700026|FG001|Follow-up Period|Lost to Follow-up|0|||
147419679|NCT02594163|531700025|FG000|Follow-up Period|Death|2|||
147419680|NCT02594163|531700026|FG001|Follow-up Period|Death|5|||
147419681|NCT02594163|531700025|FG000|Follow-up Period|Adverse Event|0|||
147419682|NCT02594163|531700026|FG001|Follow-up Period|Adverse Event|1|||
147419683|NCT02594163|531700025|FG000|Follow-up Period|Progressive Disease|2|||
147419684|NCT02594163|531700026|FG001|Follow-up Period|Progressive Disease|0|||
147419685|NCT02594163|531700025|FG000|Follow-up Period|Physician Decision|0|||
147419686|NCT02594163|531700026|FG001|Follow-up Period|Physician Decision|1|||
147419687|NCT02233543|531700029|FG000|Period 1|Withdrawal by Subject|1|||
147419688|NCT02233543|531700030|FG001|Period 1|Withdrawal by Subject|0|||
147419689|NCT02233543|531700029|FG000|Period 1|Participants required other treatment.|2|||
147419690|NCT02233543|531700030|FG001|Period 1|Participants required other treatment.|3|||
147419691|NCT02233543|531700029|FG000|Period 2|Adverse Event|1|||
147419692|NCT02233543|531700030|FG001|Period 2|Adverse Event|0|||
147419693|NCT02233543|531700029|FG000|Period 2|Participant required other treatment.|0|||
147419694|NCT02233543|531700030|FG001|Period 2|Participant required other treatment.|1|||
147419695|NCT02233543|531700029|FG000|Period 2|COPD exacerbation|1|||
147419696|NCT02233543|531700030|FG001|Period 2|COPD exacerbation|0|||
147419697|NCT00603304|531700031|FG000|Overall Study|Lost to Follow-up|5|||
147419698|NCT00603304|531700032|FG001|Overall Study|Lost to Follow-up|7|||
147419699|NCT00603304|531700031|FG000|Overall Study|Withdrawal by Subject|8|||
147419700|NCT00603304|531700032|FG001|Overall Study|Withdrawal by Subject|5|||
147419701|NCT00603304|531700031|FG000|Overall Study|Protocol Violation|1|||
147419702|NCT00603304|531700032|FG001|Overall Study|Protocol Violation|0|||
147419703|NCT00603304|531700031|FG000|Overall Study|Adverse Event|4|||
147419704|NCT00603304|531700032|FG001|Overall Study|Adverse Event|2|||
147419705|NCT00603304|531700031|FG000|Overall Study|Unacceptable Treatment Toxicity|5|||
147419706|NCT00603304|531700032|FG001|Overall Study|Unacceptable Treatment Toxicity|8|||
147419707|NCT00603304|531700031|FG000|Overall Study|Crossed Over to Open Label Therapy|3|||
147419708|NCT00603304|531700032|FG001|Overall Study|Crossed Over to Open Label Therapy|3|||
147419709|NCT00603304|531700031|FG000|Overall Study|Exclusionary Medication|2|||
147419710|NCT00603304|531700032|FG001|Overall Study|Exclusionary Medication|3|||
147419711|NCT00603304|531700031|FG000|Overall Study|Non-Compliant|0|||
147419712|NCT00603304|531700032|FG001|Overall Study|Non-Compliant|1|||
147419713|NCT00603304|531700031|FG000|Overall Study|Moved Away|0|||
147419714|NCT00603304|531700032|FG001|Overall Study|Moved Away|2|||
147419715|NCT00603304|531700031|FG000|Overall Study|Other|2|||
147419716|NCT00603304|531700032|FG001|Overall Study|Other|0|||
147419717|NCT00603304|531700031|FG000|Overall Study|Patient Decision|2|||
147419718|NCT00603304|531700032|FG001|Overall Study|Patient Decision|0|||
147419719|NCT01076192|531700033|FG000|Overall Study|Other|197|||
147419720|NCT01034176|531700034|FG000|Overall Study|Physician Decision|2|||
147419721|NCT01034176|531700035|FG001|Overall Study|Physician Decision|0|||
147419722|NCT01034176|531700034|FG000|Overall Study|Withdrawal by Subject|0|||
147419723|NCT01034176|531700035|FG001|Overall Study|Withdrawal by Subject|1|||
147419724|NCT01034176|531700034|FG000|Overall Study|Lost to Follow-up|0|||
147419725|NCT01034176|531700035|FG001|Overall Study|Lost to Follow-up|1|||
147419726|NCT05087979|531700038|FG000|Overall Study|Converted to general anesthesia|1|||
147419727|NCT05087979|531700039|FG001|Overall Study|Converted to general anesthesia|0|||
147419728|NCT00616902|531700040|FG000|Overall Study|Termination of study|6|||
147419729|NCT00616902|531700041|FG001|Overall Study|Termination of study|6|||
147646628|NCT00994214|532526125|FG000|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|13|||
147646629|NCT00994214|532526126|FG001|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|12|||
147646630|NCT00994214|532526127|FG002|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|13|||
147419730|NCT02680002|531700043|FG000|Overall Study|Lost to Follow-up|5|||
147419731|NCT02680002|531700044|FG001|Overall Study|Lost to Follow-up|1|||
147419732|NCT02680002|531700045|FG002|Overall Study|Lost to Follow-up|4|||
147419733|NCT02680002|531700046|FG003|Overall Study|Lost to Follow-up|2|||
147419734|NCT02680002|531700047|FG004|Overall Study|Lost to Follow-up|0|||
147419735|NCT02680002|531700048|FG005|Overall Study|Lost to Follow-up|2|||
147419736|NCT02680002|531700043|FG000|Overall Study|Physician Decision|5|||
147419737|NCT02680002|531700044|FG001|Overall Study|Physician Decision|1|||
147419738|NCT02680002|531700045|FG002|Overall Study|Physician Decision|1|||
147419739|NCT02680002|531700046|FG003|Overall Study|Physician Decision|1|||
147419740|NCT02680002|531700047|FG004|Overall Study|Physician Decision|1|||
147419741|NCT02680002|531700048|FG005|Overall Study|Physician Decision|1|||
147419742|NCT02680002|531700043|FG000|Overall Study|Protocol Violation|1|||
147419743|NCT02680002|531700044|FG001|Overall Study|Protocol Violation|0|||
147419744|NCT02680002|531700045|FG002|Overall Study|Protocol Violation|1|||
147419745|NCT02680002|531700046|FG003|Overall Study|Protocol Violation|0|||
147419746|NCT02680002|531700047|FG004|Overall Study|Protocol Violation|1|||
147419747|NCT02680002|531700048|FG005|Overall Study|Protocol Violation|2|||
147419748|NCT02680002|531700043|FG000|Overall Study|Withdrawal by Subject|0|||
147419749|NCT02680002|531700044|FG001|Overall Study|Withdrawal by Subject|0|||
147419750|NCT02680002|531700045|FG002|Overall Study|Withdrawal by Subject|1|||
147419751|NCT02680002|531700046|FG003|Overall Study|Withdrawal by Subject|0|||
147419752|NCT02680002|531700047|FG004|Overall Study|Withdrawal by Subject|2|||
147419753|NCT02680002|531700048|FG005|Overall Study|Withdrawal by Subject|2|||
147419754|NCT02680002|531700043|FG000|Overall Study|Missed Visit 8 (Day 201)|2|||
147646631|NCT00994214|532526128|FG003|ITT (Intention-to-Treat) - Part A|Withdrawn - Study termination by sponsor|14|||
147646632|NCT00994214|532526125|FG000|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|0|||
147646633|NCT00994214|532526126|FG001|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|0|||
147646634|NCT00994214|532526127|FG002|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|0|||
147646635|NCT00994214|532526128|FG003|ITT (Intention-to-Treat) - Part B|Withdrawal by Subject|1|||
147646636|NCT00994214|532526125|FG000|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|4|||
147419755|NCT02680002|531700044|FG001|Overall Study|Missed Visit 8 (Day 201)|1|||
147419756|NCT02680002|531700045|FG002|Overall Study|Missed Visit 8 (Day 201)|3|||
147419757|NCT02680002|531700046|FG003|Overall Study|Missed Visit 8 (Day 201)|1|||
147419758|NCT02680002|531700047|FG004|Overall Study|Missed Visit 8 (Day 201)|5|||
147419759|NCT02680002|531700048|FG005|Overall Study|Missed Visit 8 (Day 201)|0|||
147419760|NCT02680002|531700043|FG000|Overall Study|Other|0|||
147419761|NCT02680002|531700044|FG001|Overall Study|Other|1|||
147419762|NCT02680002|531700045|FG002|Overall Study|Other|0|||
147419763|NCT02680002|531700046|FG003|Overall Study|Other|0|||
147419764|NCT02680002|531700047|FG004|Overall Study|Other|1|||
147419765|NCT02680002|531700048|FG005|Overall Study|Other|0|||
147419766|NCT02680002|531700043|FG000|Overall Study|Adverse Event|0|||
147419767|NCT02680002|531700044|FG001|Overall Study|Adverse Event|0|||
147419768|NCT02680002|531700045|FG002|Overall Study|Adverse Event|0|||
147419769|NCT02680002|531700046|FG003|Overall Study|Adverse Event|0|||
147419770|NCT02680002|531700047|FG004|Overall Study|Adverse Event|1|||
147419771|NCT02680002|531700048|FG005|Overall Study|Adverse Event|2|||
147419772|NCT00705679|531700049|FG000|Overall Study|Adverse Event|1|||
147419773|NCT00705679|531700050|FG001|Overall Study|Adverse Event|1|||
147419774|NCT00705679|531700051|FG002|Overall Study|Adverse Event|0|||
147419775|NCT00705679|531700052|FG003|Overall Study|Adverse Event|0|||
147419776|NCT00705679|531700053|FG004|Overall Study|Adverse Event|0|||
147419777|NCT00705679|531700049|FG000|Overall Study|Death|0|||
147419778|NCT00705679|531700050|FG001|Overall Study|Death|0|||
147419779|NCT00705679|531700051|FG002|Overall Study|Death|3|||
147419780|NCT00705679|531700052|FG003|Overall Study|Death|2|||
147419781|NCT00705679|531700053|FG004|Overall Study|Death|1|||
147419782|NCT00705679|531700049|FG000|Overall Study|Lost to Follow-up|32|||
147419783|NCT00705679|531700050|FG001|Overall Study|Lost to Follow-up|60|||
147419784|NCT00705679|531700051|FG002|Overall Study|Lost to Follow-up|44|||
147419785|NCT00705679|531700052|FG003|Overall Study|Lost to Follow-up|30|||
147419786|NCT00705679|531700053|FG004|Overall Study|Lost to Follow-up|35|||
147419787|NCT00705679|531700049|FG000|Overall Study|Physician Decision|0|||
147419788|NCT00705679|531700050|FG001|Overall Study|Physician Decision|1|||
147419789|NCT00705679|531700051|FG002|Overall Study|Physician Decision|0|||
147419790|NCT00705679|531700052|FG003|Overall Study|Physician Decision|1|||
147419791|NCT00705679|531700053|FG004|Overall Study|Physician Decision|0|||
147419792|NCT00705679|531700049|FG000|Overall Study|Withdrawal by Subject|32|||
147419793|NCT00705679|531700050|FG001|Overall Study|Withdrawal by Subject|77|||
147419794|NCT00705679|531700051|FG002|Overall Study|Withdrawal by Subject|68|||
147419795|NCT00705679|531700052|FG003|Overall Study|Withdrawal by Subject|47|||
147419796|NCT00705679|531700053|FG004|Overall Study|Withdrawal by Subject|33|||
147419797|NCT00759915|531700054|FG000|Overall Study|Withdrawal by Subject|1|||
147419798|NCT00759915|531700055|FG001|Overall Study|Withdrawal by Subject|0|||
147419799|NCT00759915|531700054|FG000|Overall Study|Adverse Event|0|||
147419800|NCT00759915|531700055|FG001|Overall Study|Adverse Event|1|||
147419801|NCT03245151|531700056|FG000|Overall Study|Withdrawal by Subject|2|||
147419802|NCT03245151|531700057|FG001|Overall Study|Withdrawal by Subject|0|||
147419803|NCT03245151|531700058|FG002|Overall Study|Withdrawal by Subject|0|||
147646637|NCT00994214|532526126|FG001|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|3|||
147646638|NCT00994214|532526127|FG002|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|2|||
147646639|NCT00994214|532526128|FG003|ITT (Intention-to-Treat) - Part B|Withdrawn - Study termination by sponsor|2|||
147646640|NCT00290693|532526131|FG000|Overall Study|Withdrawal by Subject|2|||
147646641|NCT05625477|532526132|FG000|Overall Study|Lost to Follow-up|2|||
147646642|NCT05625477|532526133|FG001|Overall Study|Lost to Follow-up|2|||
147646643|NCT05625477|532526134|FG002|Overall Study|Lost to Follow-up|1|||
147646644|NCT05625477|532526135|FG003|Overall Study|Lost to Follow-up|1|||
147646645|NCT05625477|532526136|FG004|Overall Study|Lost to Follow-up|0|||
147646646|NCT05625477|532526132|FG000|Overall Study|Covid quarantine|1|||
147646647|NCT05625477|532526133|FG001|Overall Study|Covid quarantine|0|||
147646648|NCT05625477|532526134|FG002|Overall Study|Covid quarantine|0|||
147419804|NCT03245151|531700059|FG003|Overall Study|Withdrawal by Subject|2|||
147646649|NCT05625477|532526135|FG003|Overall Study|Covid quarantine|0|||
147419805|NCT03245151|531700060|FG004|Overall Study|Withdrawal by Subject|1|||
147419806|NCT03245151|531700056|FG000|Overall Study|Death|3|||
147419807|NCT03245151|531700057|FG001|Overall Study|Death|14|||
147419808|NCT03245151|531700058|FG002|Overall Study|Death|9|||
147419809|NCT03245151|531700059|FG003|Overall Study|Death|16|||
147419810|NCT03245151|531700060|FG004|Overall Study|Death|7|||
147419811|NCT03245151|531700056|FG000|Overall Study|Sponsor's decision|0|||
147419812|NCT03245151|531700057|FG001|Overall Study|Sponsor's decision|1|||
147419813|NCT03245151|531700058|FG002|Overall Study|Sponsor's decision|0|||
147419814|NCT03245151|531700059|FG003|Overall Study|Sponsor's decision|0|||
147419815|NCT03245151|531700060|FG004|Overall Study|Sponsor's decision|0|||
147419816|NCT04772898|531700061|FG000|Overall Study|Withdrawal by Subject|0|||
147419817|NCT04772898|531700062|FG001|Overall Study|Withdrawal by Subject|1|||
147419818|NCT01004848|531700068|FG000|Overall Study|Lost to Follow-up|55|||
147419819|NCT01004848|531700069|FG001|Overall Study|Lost to Follow-up|45|||
147419820|NCT00768079|531700070|FG000|Overall Study|Lost to Follow-up|2|||
147646650|NCT05625477|532526136|FG004|Overall Study|Covid quarantine|0|||
147646651|NCT04849416|532526139|FG000|Overall Study|Ongoing Treatment|12|||
147646652|NCT04849416|532526140|FG001|Overall Study|Ongoing Treatment|5|||
147646653|NCT04849416|532526141|FG002|Overall Study|Ongoing Treatment|3|||
147646654|NCT04849416|532526139|FG000|Overall Study|On Post-Treatment Follow-up|8|||
147646655|NCT04849416|532526140|FG001|Overall Study|On Post-Treatment Follow-up|9|||
147646656|NCT04849416|532526141|FG002|Overall Study|On Post-Treatment Follow-up|10|||
147646657|NCT04849416|532526139|FG000|Overall Study|Withdrawal by Subject|0|||
147646658|NCT04849416|532526140|FG001|Overall Study|Withdrawal by Subject|0|||
147646659|NCT04849416|532526141|FG002|Overall Study|Withdrawal by Subject|1|||
147646660|NCT04849416|532526139|FG000|Overall Study|Lost to Follow-up|1|||
147646661|NCT04849416|532526140|FG001|Overall Study|Lost to Follow-up|0|||
147646662|NCT04849416|532526141|FG002|Overall Study|Lost to Follow-up|0|||
147646663|NCT02667587|532526148|FG000|Pre-Treatment|Not reported|1|||
147646664|NCT02667587|532526149|FG001|Pre-Treatment|Not reported|0|||
147646665|NCT02667587|532526148|FG000|Pre-Treatment|Participant no longer meets study criteria|2|||
147646666|NCT02667587|532526149|FG001|Pre-Treatment|Participant no longer meets study criteria|2|||
147646667|NCT02667587|532526148|FG000|Pre-Treatment|Participant withdrew consent|0|||
147646668|NCT02667587|532526149|FG001|Pre-Treatment|Participant withdrew consent|1|||
147646669|NCT02667587|532526148|FG000|Pre-Treatment|Adverse event unrelated to study drug|1|||
147646670|NCT02667587|532526149|FG001|Pre-Treatment|Adverse event unrelated to study drug|0|||
147646671|NCT02667587|532526148|FG000|End of Treatment|Disease Progression|193|||
147646672|NCT02667587|532526149|FG001|End of Treatment|Disease Progression|226|||
147646673|NCT02667587|532526148|FG000|End of Treatment|Study Drug Toxicity|75|||
147646674|NCT02667587|532526149|FG001|End of Treatment|Study Drug Toxicity|19|||
147646675|NCT02667587|532526148|FG000|End of Treatment|Death|2|||
147419821|NCT00768079|531700071|FG001|Overall Study|Lost to Follow-up|0|||
147419822|NCT00768079|531700072|FG002|Overall Study|Lost to Follow-up|4|||
147419823|NCT00768079|531700070|FG000|Overall Study|Participant incarcerated|0|||
147419824|NCT00768079|531700071|FG001|Overall Study|Participant incarcerated|1|||
147419825|NCT00768079|531700072|FG002|Overall Study|Participant incarcerated|0|||
147419826|NCT01498679|531700073|FG000|Overall Study|Adverse Event|1|||
147419827|NCT01498679|531700074|FG001|Overall Study|Adverse Event|4|||
147419828|NCT01498679|531700073|FG000|Overall Study|Lack of Efficacy|72|||
147419829|NCT01498679|531700074|FG001|Overall Study|Lack of Efficacy|12|||
147419830|NCT01498679|531700073|FG000|Overall Study|Protocol Violation|4|||
147419831|NCT01498679|531700074|FG001|Overall Study|Protocol Violation|0|||
147419832|NCT01498679|531700073|FG000|Overall Study|Physician Decision|0|||
147419833|NCT01498679|531700074|FG001|Overall Study|Physician Decision|2|||
147419834|NCT01498679|531700073|FG000|Overall Study|Withdrawal by Subject|12|||
147419835|NCT01498679|531700074|FG001|Overall Study|Withdrawal by Subject|4|||
147419836|NCT03212989|531700076|FG000|Overall Study|Physician Decision|8|||
147419837|NCT00158860|531700079|FG000|Overall Study|Adverse Event|3|||
147419838|NCT00158860|531700080|FG001|Overall Study|Adverse Event|6|||
147419839|NCT00158860|531700079|FG000|Overall Study|Lost to Follow-up|11|||
147419840|NCT00158860|531700080|FG001|Overall Study|Lost to Follow-up|17|||
147419841|NCT00158860|531700079|FG000|Overall Study|Protocol Violation|8|||
147419842|NCT00158860|531700080|FG001|Overall Study|Protocol Violation|23|||
147419843|NCT00158860|531700079|FG000|Overall Study|Withdrawal by Subject|7|||
147419844|NCT00158860|531700080|FG001|Overall Study|Withdrawal by Subject|17|||
147419845|NCT00158860|531700079|FG000|Overall Study|MOVING OUT OF STATE|1|||
147419846|NCT00158860|531700080|FG001|Overall Study|MOVING OUT OF STATE|0|||
147419847|NCT00158860|531700079|FG000|Overall Study|Pregnancy|3|||
147419848|NCT00158860|531700080|FG001|Overall Study|Pregnancy|3|||
147419849|NCT00158860|531700079|FG000|Overall Study|SPONSOR STOPPED STUDY|2|||
147646676|NCT02667587|532526149|FG001|End of Treatment|Death|1|||
147646677|NCT02667587|532526148|FG000|End of Treatment|Adverse Event Unrelated to Study Drug|19|||
147646678|NCT02667587|532526149|FG001|End of Treatment|Adverse Event Unrelated to Study Drug|20|||
147419850|NCT00158860|531700080|FG001|Overall Study|SPONSOR STOPPED STUDY|2|||
147419851|NCT00158860|531700079|FG000|Overall Study|SPONSOR REQUEST|0|||
147419852|NCT00158860|531700080|FG001|Overall Study|SPONSOR REQUEST|1|||
147419853|NCT00158860|531700079|FG000|Overall Study|Lost to Follow up but returned per GSK|0|||
147419854|NCT00158860|531700080|FG001|Overall Study|Lost to Follow up but returned per GSK|1|||
147419855|NCT00158860|531700079|FG000|Overall Study|Closed per sponsor|0|||
147646679|NCT02667587|532526148|FG000|End of Treatment|participant request to discontinue treatment|33|||
147646680|NCT02667587|532526149|FG001|End of Treatment|participant request to discontinue treatment|35|||
147646681|NCT02667587|532526148|FG000|End of Treatment|participant withdrew consent|5|||
147646682|NCT02667587|532526149|FG001|End of Treatment|participant withdrew consent|6|||
147646683|NCT02667587|532526148|FG000|End of Treatment|Lost to Follow-up|1|||
147646684|NCT02667587|532526149|FG001|End of Treatment|Lost to Follow-up|2|||
147646685|NCT02667587|532526148|FG000|End of Treatment|maximum clinical benefit|4|||
147646686|NCT02667587|532526149|FG001|End of Treatment|maximum clinical benefit|4|||
147646687|NCT02667587|532526148|FG000|End of Treatment|poor or non compliant|0|||
147646688|NCT02667587|532526149|FG001|End of Treatment|poor or non compliant|1|||
147646689|NCT02667587|532526148|FG000|End of Treatment|participant no longer meets study criteria|1|||
147646690|NCT02667587|532526149|FG001|End of Treatment|participant no longer meets study criteria|1|||
147646691|NCT02667587|532526148|FG000|End of Treatment|administrative reason by sponsor|1|||
147646692|NCT02667587|532526149|FG001|End of Treatment|administrative reason by sponsor|29|||
147646693|NCT02667587|532526148|FG000|End of Treatment|other reasonse|21|||
147646694|NCT02667587|532526149|FG001|End of Treatment|other reasonse|10|||
147646695|NCT05940077|532526150|FG000|Overall Study|the presence of definite dementia, determined by Montreal Cognitive Assessment (MoCA < 21)|1|||
147646696|NCT00388297|532526151|FG000|Overall Study|Lost to Follow-up|16|||
147646697|NCT00388297|532526152|FG001|Overall Study|Lost to Follow-up|12|||
147646698|NCT00388297|532526153|FG002|Overall Study|Lost to Follow-up|11|||
147646699|NCT00388297|532526154|FG003|Overall Study|Lost to Follow-up|8|||
147646700|NCT02696434|532526157|FG000|Overall Study|Adverse Event|3|||
147646701|NCT02696434|532526158|FG001|Overall Study|Adverse Event|1|||
147646702|NCT02696434|532526157|FG000|Overall Study|Lost to Follow-up|5|||
147419856|NCT00158860|531700080|FG001|Overall Study|Closed per sponsor|1|||
147419857|NCT03047395|531700081|FG000|Overall Study|Adverse Event|142|||
147419858|NCT03047395|531700081|FG000|Overall Study|Withdrawal by Subject|155|||
147419859|NCT03047395|531700081|FG000|Overall Study|Lost to Follow-up|144|||
147419860|NCT03047395|531700081|FG000|Overall Study|COVID-19 Infection|2|||
147419861|NCT03047395|531700081|FG000|Overall Study|COVID-19 Logistical Restrictions|9|||
147419862|NCT03047395|531700081|FG000|Overall Study|Other, Not Specified|117|||
147419863|NCT01871805|531700086|FG000|Phase I|Death|7|||
147419864|NCT01871805|531700087|FG001|Phase I|Death|4|||
147419865|NCT01871805|531700088|FG002|Phase I|Death|6|||
147419866|NCT01871805|531700089|FG003|Phase I|Death|2|||
147419867|NCT01871805|531700090|FG004|Phase I|Death|9|||
147419868|NCT01871805|531700091|FG005|Phase I|Death|0|||
147419869|NCT01871805|531700086|FG000|Phase I|Alive in Survival Follow-up|0|||
147419870|NCT01871805|531700087|FG001|Phase I|Alive in Survival Follow-up|2|||
147419871|NCT01871805|531700088|FG002|Phase I|Alive in Survival Follow-up|4|||
147419872|NCT01871805|531700089|FG003|Phase I|Alive in Survival Follow-up|5|||
147419873|NCT01871805|531700090|FG004|Phase I|Alive in Survival Follow-up|4|||
147419874|NCT01871805|531700091|FG005|Phase I|Alive in Survival Follow-up|0|||
147419875|NCT01871805|531700086|FG000|Phase I|Lost to Follow-up|0|||
147419876|NCT01871805|531700087|FG001|Phase I|Lost to Follow-up|1|||
147419877|NCT01871805|531700088|FG002|Phase I|Lost to Follow-up|3|||
147419878|NCT01871805|531700089|FG003|Phase I|Lost to Follow-up|0|||
147419879|NCT01871805|531700090|FG004|Phase I|Lost to Follow-up|0|||
147419880|NCT01871805|531700091|FG005|Phase I|Lost to Follow-up|0|||
147419881|NCT01871805|531700086|FG000|Phase II|Death|0|||
147419882|NCT01871805|531700087|FG001|Phase II|Death|0|||
147419883|NCT01871805|531700088|FG002|Phase II|Death|0|||
147419884|NCT01871805|531700089|FG003|Phase II|Death|0|||
147419885|NCT01871805|531700090|FG004|Phase II|Death|0|||
147419886|NCT01871805|531700091|FG005|Phase II|Death|45|||
147419887|NCT01871805|531700086|FG000|Phase II|Alive in Survival Follow-up|0|||
147419888|NCT01871805|531700087|FG001|Phase II|Alive in Survival Follow-up|0|||
147419889|NCT01871805|531700088|FG002|Phase II|Alive in Survival Follow-up|0|||
147419890|NCT01871805|531700089|FG003|Phase II|Alive in Survival Follow-up|0|||
147419891|NCT01871805|531700090|FG004|Phase II|Alive in Survival Follow-up|0|||
147419892|NCT01871805|531700091|FG005|Phase II|Alive in Survival Follow-up|29|||
147419893|NCT01871805|531700086|FG000|Phase II|Lost to Follow-up|0|||
147419894|NCT01871805|531700087|FG001|Phase II|Lost to Follow-up|0|||
147419895|NCT01871805|531700088|FG002|Phase II|Lost to Follow-up|0|||
147419896|NCT01871805|531700089|FG003|Phase II|Lost to Follow-up|0|||
147419897|NCT01871805|531700090|FG004|Phase II|Lost to Follow-up|0|||
147419898|NCT01871805|531700091|FG005|Phase II|Lost to Follow-up|13|||
147419899|NCT00564889|531700092|FG000|Overall Study|Death|7|||
147419900|NCT00564889|531700092|FG000|Overall Study|Adverse Event|12|||
147419901|NCT00564889|531700092|FG000|Overall Study|Alternative treatment|3|||
147419902|NCT00564889|531700092|FG000|Overall Study|Disease progression|3|||
147419903|NCT00564889|531700092|FG000|Overall Study|Other, not specified|4|||
147646703|NCT02696434|532526158|FG001|Overall Study|Lost to Follow-up|4|||
147646704|NCT02696434|532526157|FG000|Overall Study|Withdrawal by Subject|14|||
147646705|NCT02696434|532526158|FG001|Overall Study|Withdrawal by Subject|12|||
147419904|NCT00635427|531700093|FG000|Overall Study|Refusal Of Required DiagnosticEvaluation|0|||
147419905|NCT00635427|531700094|FG001|Overall Study|Refusal Of Required DiagnosticEvaluation|0|||
147419906|NCT00635427|531700095|FG002|Overall Study|Refusal Of Required DiagnosticEvaluation|1|||
147419907|NCT00635427|531700096|FG003|Overall Study|Refusal Of Required DiagnosticEvaluation|0|||
147419908|NCT00635427|531700097|FG004|Overall Study|Refusal Of Required DiagnosticEvaluation|0|||
147419909|NCT00635427|531700093|FG000|Overall Study|Death|0|||
147419910|NCT00635427|531700094|FG001|Overall Study|Death|0|||
147419911|NCT00635427|531700095|FG002|Overall Study|Death|0|||
147419912|NCT00635427|531700096|FG003|Overall Study|Death|1|||
147419913|NCT00635427|531700097|FG004|Overall Study|Death|0|||
147419914|NCT00635427|531700093|FG000|Overall Study|Termination Of Study By Sponsor|12|||
147419915|NCT00635427|531700094|FG001|Overall Study|Termination Of Study By Sponsor|6|||
147419916|NCT00635427|531700095|FG002|Overall Study|Termination Of Study By Sponsor|10|||
147646706|NCT02696434|532526157|FG000|Overall Study|Physician Decision|0|||
147646707|NCT02696434|532526158|FG001|Overall Study|Physician Decision|1|||
147646708|NCT04105010|532526181|FG000|Overall Study|Death|3|||
147646709|NCT04105010|532526182|FG001|Overall Study|Death|1|||
147646710|NCT04105010|532526183|FG002|Overall Study|Death|1|||
147646711|NCT04105010|532526184|FG003|Overall Study|Death|54|||
147646712|NCT04105010|532526181|FG000|Overall Study|Lost to Follow-up|0|||
147646713|NCT04105010|532526182|FG001|Overall Study|Lost to Follow-up|0|||
147646714|NCT04105010|532526183|FG002|Overall Study|Lost to Follow-up|0|||
147646715|NCT04105010|532526184|FG003|Overall Study|Lost to Follow-up|4|||
147646716|NCT04105010|532526181|FG000|Overall Study|Withdrawal by Subject|8|||
147646717|NCT04105010|532526182|FG001|Overall Study|Withdrawal by Subject|1|||
147646718|NCT04105010|532526183|FG002|Overall Study|Withdrawal by Subject|1|||
147646719|NCT04105010|532526184|FG003|Overall Study|Withdrawal by Subject|4|||
147646720|NCT04105010|532526181|FG000|Overall Study|Other reason|4|||
147646721|NCT04105010|532526182|FG001|Overall Study|Other reason|7|||
147646722|NCT04105010|532526183|FG002|Overall Study|Other reason|0|||
147646723|NCT04105010|532526184|FG003|Overall Study|Other reason|19|||
147419917|NCT00635427|531700096|FG003|Overall Study|Termination Of Study By Sponsor|6|||
147419918|NCT00635427|531700097|FG004|Overall Study|Termination Of Study By Sponsor|6|||
147419919|NCT00635427|531700093|FG000|Overall Study|Withdrawal Of Consent|0|||
147419920|NCT00635427|531700094|FG001|Overall Study|Withdrawal Of Consent|0|||
147419921|NCT00635427|531700095|FG002|Overall Study|Withdrawal Of Consent|0|||
147419922|NCT00635427|531700096|FG003|Overall Study|Withdrawal Of Consent|2|||
147419923|NCT00635427|531700097|FG004|Overall Study|Withdrawal Of Consent|2|||
147419924|NCT04860297|531700100|FG000|Part A (Primary Series)|Withdrawal by Subject|0|||
147419925|NCT04860297|531700101|FG001|Part A (Primary Series)|Withdrawal by Subject|1|||
147419926|NCT04860297|531700102|FG002|Part A (Primary Series)|Withdrawal by Subject|0|||
147419927|NCT04860297|531700103|FG003|Part A (Primary Series)|Withdrawal by Subject|1|||
147419928|NCT04860297|531700104|FG004|Part A (Primary Series)|Withdrawal by Subject|0|||
147646724|NCT00427999|532526187|FG000|Overall Study|Adverse Event|6|||
147646725|NCT00427999|532526187|FG000|Overall Study|Abnormal laboratory values|1|||
147646726|NCT00427999|532526187|FG000|Overall Study|Unsatisfactory therapeutic effect|13|||
147646727|NCT00427999|532526187|FG000|Overall Study|Protocol Violation|2|||
147646728|NCT00427999|532526187|FG000|Overall Study|Withdrawal by Subject|9|||
147646729|NCT00427999|532526187|FG000|Overall Study|Death|1|||
147646730|NCT03570554|532526188|FG000|Overall Study|Non-compliance with study drug|0|||
147419929|NCT04860297|531700105|FG005|Part A (Primary Series)|Withdrawal by Subject|0|||
147419930|NCT04860297|531700106|FG006|Part A (Primary Series)|Withdrawal by Subject|0|||
147419931|NCT04860297|531700107|FG007|Part A (Primary Series)|Withdrawal by Subject|0|||
147419932|NCT04860297|531700100|FG000|Part A (Primary Series)|Lost to Follow-up|1|||
147419933|NCT04860297|531700101|FG001|Part A (Primary Series)|Lost to Follow-up|0|||
147419934|NCT04860297|531700102|FG002|Part A (Primary Series)|Lost to Follow-up|0|||
147419935|NCT04860297|531700103|FG003|Part A (Primary Series)|Lost to Follow-up|2|||
147419936|NCT04860297|531700104|FG004|Part A (Primary Series)|Lost to Follow-up|0|||
147419937|NCT04860297|531700105|FG005|Part A (Primary Series)|Lost to Follow-up|0|||
147419938|NCT04860297|531700106|FG006|Part A (Primary Series)|Lost to Follow-up|0|||
147419939|NCT04860297|531700107|FG007|Part A (Primary Series)|Lost to Follow-up|0|||
147419940|NCT04860297|531700100|FG000|Part B (Booster Dose)|Protocol Deviation|0|||
147419941|NCT04860297|531700101|FG001|Part B (Booster Dose)|Protocol Deviation|0|||
147419942|NCT04860297|531700102|FG002|Part B (Booster Dose)|Protocol Deviation|0|||
147419943|NCT04860297|531700103|FG003|Part B (Booster Dose)|Protocol Deviation|0|||
147419944|NCT04860297|531700104|FG004|Part B (Booster Dose)|Protocol Deviation|0|||
147419945|NCT04860297|531700105|FG005|Part B (Booster Dose)|Protocol Deviation|0|||
147419946|NCT04860297|531700106|FG006|Part B (Booster Dose)|Protocol Deviation|1|||
147419947|NCT04860297|531700107|FG007|Part B (Booster Dose)|Protocol Deviation|0|||
147419948|NCT04860297|531700100|FG000|Part B (Booster Dose)|Other Than Specified|0|||
147419949|NCT04860297|531700101|FG001|Part B (Booster Dose)|Other Than Specified|0|||
147419950|NCT04860297|531700102|FG002|Part B (Booster Dose)|Other Than Specified|0|||
147419951|NCT04860297|531700103|FG003|Part B (Booster Dose)|Other Than Specified|0|||
147419952|NCT04860297|531700104|FG004|Part B (Booster Dose)|Other Than Specified|0|||
147646731|NCT03570554|532526189|FG001|Overall Study|Non-compliance with study drug|0|||
147646732|NCT03570554|532526190|FG002|Overall Study|Non-compliance with study drug|1|||
147646733|NCT03570554|532526191|FG003|Overall Study|Non-compliance with study drug|0|||
147646734|NCT03570554|532526188|FG000|Overall Study|Adverse Event|0|||
147646735|NCT03570554|532526189|FG001|Overall Study|Adverse Event|0|||
147419953|NCT04860297|531700105|FG005|Part B (Booster Dose)|Other Than Specified|1|||
147419954|NCT04860297|531700106|FG006|Part B (Booster Dose)|Other Than Specified|1|||
147419955|NCT04860297|531700107|FG007|Part B (Booster Dose)|Other Than Specified|0|||
147419956|NCT04860297|531700100|FG000|Part B (Booster Dose)|Withdrawal by Subject|0|||
147419957|NCT04860297|531700101|FG001|Part B (Booster Dose)|Withdrawal by Subject|0|||
147419958|NCT04860297|531700102|FG002|Part B (Booster Dose)|Withdrawal by Subject|0|||
147419959|NCT04860297|531700103|FG003|Part B (Booster Dose)|Withdrawal by Subject|0|||
147419960|NCT04860297|531700104|FG004|Part B (Booster Dose)|Withdrawal by Subject|0|||
147419961|NCT04860297|531700105|FG005|Part B (Booster Dose)|Withdrawal by Subject|2|||
147419962|NCT04860297|531700106|FG006|Part B (Booster Dose)|Withdrawal by Subject|0|||
147419963|NCT04860297|531700107|FG007|Part B (Booster Dose)|Withdrawal by Subject|1|||
147419964|NCT04860297|531700100|FG000|Part B (Booster Dose)|Death|0|||
147419965|NCT04860297|531700101|FG001|Part B (Booster Dose)|Death|0|||
147419966|NCT04860297|531700102|FG002|Part B (Booster Dose)|Death|0|||
147419967|NCT04860297|531700103|FG003|Part B (Booster Dose)|Death|0|||
147419968|NCT04860297|531700104|FG004|Part B (Booster Dose)|Death|1|||
147419969|NCT04860297|531700105|FG005|Part B (Booster Dose)|Death|2|||
147419970|NCT04860297|531700106|FG006|Part B (Booster Dose)|Death|1|||
147419971|NCT04860297|531700107|FG007|Part B (Booster Dose)|Death|0|||
147419972|NCT04860297|531700100|FG000|Part B (Booster Dose)|Lost to Follow-up|0|||
147419973|NCT04860297|531700101|FG001|Part B (Booster Dose)|Lost to Follow-up|0|||
147419974|NCT04860297|531700102|FG002|Part B (Booster Dose)|Lost to Follow-up|0|||
147419975|NCT04860297|531700103|FG003|Part B (Booster Dose)|Lost to Follow-up|0|||
147419976|NCT04860297|531700104|FG004|Part B (Booster Dose)|Lost to Follow-up|3|||
147419977|NCT04860297|531700105|FG005|Part B (Booster Dose)|Lost to Follow-up|5|||
147419978|NCT04860297|531700106|FG006|Part B (Booster Dose)|Lost to Follow-up|1|||
147419979|NCT04860297|531700107|FG007|Part B (Booster Dose)|Lost to Follow-up|2|||
147419980|NCT02703259|531700112|FG000|24 Hours Postoperative Assessment|Lost to Follow-up|1|||
147419981|NCT02703259|531700113|FG001|24 Hours Postoperative Assessment|Lost to Follow-up|4|||
147419982|NCT02703259|531700112|FG000|24 Hours Postoperative Assessment|excluded from analysis per protocol|1|||
147419983|NCT02703259|531700113|FG001|24 Hours Postoperative Assessment|excluded from analysis per protocol|2|||
147419984|NCT02703259|531700112|FG000|2 Weeks Postoperative Assessment|Lost to Follow-up|10|||
147419985|NCT02703259|531700113|FG001|2 Weeks Postoperative Assessment|Lost to Follow-up|10|||
147419986|NCT02971761|531700114|FG000|Overall Study|GTx-024 drug supply was withdrawn|2|||
147419987|NCT02442336|531700117|FG000|Overall Study|6 patients assisted with the intervention development only.|6|||
147419988|NCT02442336|531700117|FG000|Overall Study|Of the 74 who consented, 19 did not complete baseline assessment and were withdrawn from the study.|19|||
147419989|NCT02442336|531700117|FG000|Overall Study|Lost to Follow-up|11|||
147419990|NCT00998790|531700118|FG000|Overall Study|Withdrawal by Subject|21|||
147419991|NCT01237587|531700120|FG000|Double Blind Treatment (Acute Phase)|Adverse Event|5|||
147419992|NCT01237587|531700121|FG001|Double Blind Treatment (Acute Phase)|Adverse Event|1|||
147419993|NCT01237587|531700120|FG000|Double Blind Treatment (Acute Phase)|Lack of Efficacy|1|||
147419994|NCT01237587|531700121|FG001|Double Blind Treatment (Acute Phase)|Lack of Efficacy|3|||
147419995|NCT01237587|531700120|FG000|Double Blind Treatment (Acute Phase)|Lost to Follow-up|2|||
147646736|NCT03570554|532526190|FG002|Overall Study|Adverse Event|0|||
147646737|NCT03570554|532526191|FG003|Overall Study|Adverse Event|1|||
147646738|NCT03114657|532526204|FG000|Overall Study|Adverse Event|9|||
147646739|NCT03114657|532526205|FG001|Overall Study|Adverse Event|6|||
147646740|NCT03114657|532526204|FG000|Overall Study|Death|4|||
147646741|NCT03114657|532526205|FG001|Overall Study|Death|0|||
147646742|NCT03114657|532526204|FG000|Overall Study|Multiple Reasons|1|||
147646743|NCT03114657|532526205|FG001|Overall Study|Multiple Reasons|2|||
147646744|NCT03114657|532526204|FG000|Overall Study|Physician Decision|2|||
147646745|NCT03114657|532526205|FG001|Overall Study|Physician Decision|2|||
147646746|NCT03114657|532526204|FG000|Overall Study|Study Terminated By Sponsor|355|||
147646747|NCT03114657|532526205|FG001|Overall Study|Study Terminated By Sponsor|374|||
147646748|NCT03114657|532526204|FG000|Overall Study|Symptomatic Deterioration|0|||
147646749|NCT03114657|532526205|FG001|Overall Study|Symptomatic Deterioration|1|||
147646750|NCT03114657|532526204|FG000|Overall Study|Withdrawal by Subject|28|||
147646751|NCT03114657|532526205|FG001|Overall Study|Withdrawal by Subject|22|||
147646752|NCT01179737|532526206|FG000|Cohort 1 & Cohort 2|Adverse Event|3|||
147646753|NCT01179737|532526207|FG001|Cohort 1 & Cohort 2|Adverse Event|1|||
147646754|NCT01179737|532526208|FG002|Cohort 1 & Cohort 2|Adverse Event|1|||
147646755|NCT01179737|532526209|FG003|Cohort 1 & Cohort 2|Adverse Event|0|||
147646756|NCT01179737|532526206|FG000|Cohort 1 & Cohort 2|Withdrew consent|2|||
147646757|NCT01179737|532526207|FG001|Cohort 1 & Cohort 2|Withdrew consent|0|||
147646758|NCT01179737|532526208|FG002|Cohort 1 & Cohort 2|Withdrew consent|0|||
147646759|NCT01179737|532526209|FG003|Cohort 1 & Cohort 2|Withdrew consent|0|||
147646760|NCT01179737|532526206|FG000|Cohort 1 & Cohort 2|Administrative problems|0|||
147646761|NCT01179737|532526207|FG001|Cohort 1 & Cohort 2|Administrative problems|0|||
147646762|NCT01179737|532526208|FG002|Cohort 1 & Cohort 2|Administrative problems|2|||
147646763|NCT01179737|532526209|FG003|Cohort 1 & Cohort 2|Administrative problems|4|||
147646764|NCT01179737|532526206|FG000|Cohort 1 & Cohort 2|Death|0|||
147646765|NCT01179737|532526207|FG001|Cohort 1 & Cohort 2|Death|0|||
147419996|NCT01237587|531700121|FG001|Double Blind Treatment (Acute Phase)|Lost to Follow-up|3|||
147419997|NCT01237587|531700120|FG000|Double Blind Treatment (Acute Phase)|Parent/Caregiver Decision|2|||
147419998|NCT01237587|531700121|FG001|Double Blind Treatment (Acute Phase)|Parent/Caregiver Decision|4|||
147419999|NCT01237587|531700120|FG000|Double Blind Treatment (Acute Phase)|Protocol Violation|4|||
147420000|NCT01237587|531700121|FG001|Double Blind Treatment (Acute Phase)|Protocol Violation|3|||
147420001|NCT01237587|531700120|FG000|Double Blind Treatment (Acute Phase)|Withdrawal by Subject|3|||
147420002|NCT01237587|531700121|FG001|Double Blind Treatment (Acute Phase)|Withdrawal by Subject|4|||
147420003|NCT01237587|531700120|FG000|Open Label Treatment (Extension Phase)|Lost to Follow-up|4|||
147420004|NCT01237587|531700121|FG001|Open Label Treatment (Extension Phase)|Lost to Follow-up|3|||
147420005|NCT01237587|531700120|FG000|Open Label Treatment (Extension Phase)|Adverse Event|5|||
147420006|NCT01237587|531700121|FG001|Open Label Treatment (Extension Phase)|Adverse Event|5|||
147420007|NCT01237587|531700120|FG000|Open Label Treatment (Extension Phase)|Lack of Efficacy|2|||
147420008|NCT01237587|531700121|FG001|Open Label Treatment (Extension Phase)|Lack of Efficacy|4|||
147420009|NCT01237587|531700120|FG000|Open Label Treatment (Extension Phase)|Parent/Guardian Decision|2|||
147420010|NCT01237587|531700121|FG001|Open Label Treatment (Extension Phase)|Parent/Guardian Decision|4|||
147420011|NCT01237587|531700120|FG000|Open Label Treatment (Extension Phase)|Withdrawal by Subject|0|||
147420012|NCT01237587|531700121|FG001|Open Label Treatment (Extension Phase)|Withdrawal by Subject|5|||
147420013|NCT01237587|531700120|FG000|Open Label Treatment (Extension Phase)|Sponsor Decision|1|||
147420014|NCT01237587|531700121|FG001|Open Label Treatment (Extension Phase)|Sponsor Decision|0|||
147420015|NCT01237587|531700120|FG000|Open Label Treatment (Extension Phase)|Physician Decision|4|||
147420016|NCT01237587|531700121|FG001|Open Label Treatment (Extension Phase)|Physician Decision|4|||
147420017|NCT01237587|531700120|FG000|Taper Phase|Adverse Event|0|||
147420018|NCT01237587|531700121|FG001|Taper Phase|Adverse Event|2|||
147420019|NCT01237587|531700120|FG000|Taper Phase|Protocol Violation|2|||
147420020|NCT01237587|531700121|FG001|Taper Phase|Protocol Violation|0|||
147420021|NCT01237587|531700120|FG000|Taper Phase|Lack of Efficacy|2|||
147420022|NCT01237587|531700121|FG001|Taper Phase|Lack of Efficacy|5|||
147420023|NCT01237587|531700120|FG000|Taper Phase|Parent/Guardian Decision|0|||
147420024|NCT01237587|531700121|FG001|Taper Phase|Parent/Guardian Decision|2|||
147420025|NCT01237587|531700120|FG000|Taper Phase|Sponsor Decision|1|||
147420026|NCT01237587|531700121|FG001|Taper Phase|Sponsor Decision|0|||
147420027|NCT01237587|531700120|FG000|Taper Phase|Withdrawal by Subject|0|||
147420028|NCT01237587|531700121|FG001|Taper Phase|Withdrawal by Subject|1|||
147420029|NCT01942590|531700122|FG000|Overall Study|Withdrawal by Subject|0|||
147420030|NCT01942590|531700123|FG001|Overall Study|Withdrawal by Subject|1|||
147420031|NCT01942590|531700122|FG000|Overall Study|Adverse Event|1|||
147420032|NCT01942590|531700123|FG001|Overall Study|Adverse Event|0|||
147420033|NCT01011387|531700124|FG000|Overall Study|Withdrawal by Subject|3|||
147420034|NCT01011387|531700124|FG000|Overall Study|Adverse Event|2|||
147420035|NCT01011387|531700124|FG000|Overall Study|Protocol Violation|1|||
147420036|NCT01142115|531700125|FG000|First Intervention|Lack of Efficacy|1|||
147420037|NCT01142115|531700126|FG001|First Intervention|Lack of Efficacy|1|||
147420038|NCT01142115|531700125|FG000|First Intervention|Adverse Event|1|||
147420039|NCT01142115|531700126|FG001|First Intervention|Adverse Event|0|||
147420040|NCT03208036|531700127|FG000|Baseline Assessment|Withdrawal by Subject|1|||
147420041|NCT03208036|531700128|FG001|Baseline Assessment|Withdrawal by Subject|1|||
147420042|NCT03208036|531700127|FG000|2nd Baseline Assessment|Withdrawal by Subject|1|||
147420043|NCT03208036|531700128|FG001|2nd Baseline Assessment|Withdrawal by Subject|2|||
147420044|NCT03208036|531700127|FG000|Intervention|Withdrawal by Subject|3|||
147420045|NCT03208036|531700128|FG001|Intervention|Withdrawal by Subject|2|||
147420046|NCT03208036|531700127|FG000|5.5 Month Assessment|Partial data collected due to COVID-19 pandemic and remote procedures only|1|||
147420047|NCT03208036|531700128|FG001|5.5 Month Assessment|Partial data collected due to COVID-19 pandemic and remote procedures only|2|||
147420048|NCT03406078|531700129|FG000|Overall Study|Death|1|||
147420049|NCT03406078|531700130|FG001|Overall Study|Death|0|||
147420050|NCT03406078|531700129|FG000|Overall Study|Lost to Follow-up|0|||
147420051|NCT03406078|531700130|FG001|Overall Study|Lost to Follow-up|1|||
147420052|NCT03406078|531700129|FG000|Overall Study|Withdrawal by Subject|5|||
147420053|NCT03406078|531700130|FG001|Overall Study|Withdrawal by Subject|2|||
147420054|NCT01879553|531700133|FG000|Overall Study|Withdrawal by Subject|1|||
147420055|NCT01879553|531700134|FG001|Overall Study|Withdrawal by Subject|0|||
147420056|NCT00591851|531700135|FG000|Overall Study|Withdrawal by Subject|3|||
147420057|NCT00591851|531700135|FG000|Overall Study|Adverse Event|2|||
147420058|NCT00591851|531700135|FG000|Overall Study|Progressive Disease|1|||
147420059|NCT00438672|531700136|FG000|Overall Study|Lost to Follow-up|7|||
147420060|NCT00438672|531700137|FG001|Overall Study|Lost to Follow-up|9|||
147420061|NCT00320528|531700138|FG000|Study Period II|Adverse Event|3|||
147420062|NCT00320528|531700139|FG001|Study Period II|Adverse Event|4|||
147420063|NCT00320528|531700140|FG002|Study Period II|Adverse Event|8|||
147420064|NCT00320528|531700138|FG000|Study Period II|Parent/Caregiver Decision|8|||
147420065|NCT00320528|531700139|FG001|Study Period II|Parent/Caregiver Decision|3|||
147420066|NCT00320528|531700140|FG002|Study Period II|Parent/Caregiver Decision|11|||
147420067|NCT00320528|531700138|FG000|Study Period II|Withdrawal by Subject|0|||
147420068|NCT00320528|531700139|FG001|Study Period II|Withdrawal by Subject|1|||
147646766|NCT01179737|532526208|FG002|Cohort 1 & Cohort 2|Death|1|||
147646767|NCT01179737|532526209|FG003|Cohort 1 & Cohort 2|Death|0|||
147646768|NCT01179737|532526206|FG000|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|0|||
147646769|NCT01179737|532526207|FG001|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|1|||
147646770|NCT01179737|532526208|FG002|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|0|||
147646771|NCT01179737|532526209|FG003|Cohort 1 & Cohort 2|Withdrew consent without EOS 1 visit|0|||
147646772|NCT01179737|532526206|FG000|Cohort 1 & Cohort 2 Expansion|Death|1|||
147646773|NCT01179737|532526207|FG001|Cohort 1 & Cohort 2 Expansion|Death|0|||
147646774|NCT01179737|532526208|FG002|Cohort 1 & Cohort 2 Expansion|Death|0|||
147646775|NCT01179737|532526209|FG003|Cohort 1 & Cohort 2 Expansion|Death|0|||
147646776|NCT01179737|532526206|FG000|Extension|The study was terminated|3|||
147646777|NCT01179737|532526207|FG001|Extension|The study was terminated|0|||
147646778|NCT01179737|532526208|FG002|Extension|The study was terminated|0|||
147646779|NCT01179737|532526209|FG003|Extension|The study was terminated|0|||
147646780|NCT00115037|532526210|FG000|Phase1|Lost to Follow-up|16|||
147646781|NCT00115037|532526211|FG001|Phase1|Lost to Follow-up|23|||
147646782|NCT00115037|532526212|FG002|Phase1|Lost to Follow-up|0|||
147646783|NCT00115037|532526213|FG003|Phase1|Lost to Follow-up|0|||
147646784|NCT00115037|532526214|FG004|Phase1|Lost to Follow-up|0|||
147646785|NCT00115037|532526215|FG005|Phase1|Lost to Follow-up|0|||
147646786|NCT00115037|532526210|FG000|Phase1|Withdrawal by Subject|9|||
147646787|NCT00115037|532526211|FG001|Phase1|Withdrawal by Subject|4|||
147646788|NCT00115037|532526212|FG002|Phase1|Withdrawal by Subject|0|||
147646789|NCT00115037|532526213|FG003|Phase1|Withdrawal by Subject|0|||
147646790|NCT00115037|532526214|FG004|Phase1|Withdrawal by Subject|0|||
147646791|NCT00115037|532526215|FG005|Phase1|Withdrawal by Subject|0|||
147646792|NCT00115037|532526210|FG000|Phase2|Death|0|||
147646793|NCT00115037|532526211|FG001|Phase2|Death|0|||
147646794|NCT00115037|532526212|FG002|Phase2|Death|1|||
147646795|NCT00115037|532526213|FG003|Phase2|Death|0|||
147646796|NCT00115037|532526214|FG004|Phase2|Death|0|||
147646797|NCT00115037|532526215|FG005|Phase2|Death|1|||
147646798|NCT00115037|532526210|FG000|Phase2|Withdrawal by Subject|0|||
147646799|NCT00115037|532526211|FG001|Phase2|Withdrawal by Subject|0|||
147646800|NCT00115037|532526212|FG002|Phase2|Withdrawal by Subject|2|||
147646801|NCT00115037|532526213|FG003|Phase2|Withdrawal by Subject|1|||
147646802|NCT00115037|532526214|FG004|Phase2|Withdrawal by Subject|2|||
147646803|NCT00115037|532526215|FG005|Phase2|Withdrawal by Subject|1|||
147646804|NCT00115037|532526210|FG000|Phase2|Lost to Follow-up|0|||
147646805|NCT00115037|532526211|FG001|Phase2|Lost to Follow-up|0|||
147646806|NCT00115037|532526212|FG002|Phase2|Lost to Follow-up|12|||
147646807|NCT00115037|532526213|FG003|Phase2|Lost to Follow-up|14|||
147646808|NCT00115037|532526214|FG004|Phase2|Lost to Follow-up|4|||
147646809|NCT00115037|532526215|FG005|Phase2|Lost to Follow-up|10|||
147646810|NCT01546038|532526216|FG000|Overall Study|Death|15|||
147646811|NCT01546038|532526217|FG001|Overall Study|Death|6|||
147646812|NCT01546038|532526218|FG002|Overall Study|Death|4|||
147646813|NCT01546038|532526219|FG003|Overall Study|Death|2|||
147646814|NCT01546038|532526220|FG004|Overall Study|Death|9|||
147646815|NCT01546038|532526221|FG005|Overall Study|Death|3|||
147646816|NCT01546038|532526222|FG006|Overall Study|Death|46|||
147646817|NCT01546038|532526223|FG007|Overall Study|Death|76|||
147646818|NCT01546038|532526224|FG008|Overall Study|Death|39|||
147646819|NCT01546038|532526216|FG000|Overall Study|Lost to Follow-up|0|||
147646820|NCT01546038|532526217|FG001|Overall Study|Lost to Follow-up|0|||
147646821|NCT01546038|532526218|FG002|Overall Study|Lost to Follow-up|0|||
147646822|NCT01546038|532526219|FG003|Overall Study|Lost to Follow-up|0|||
147646823|NCT01546038|532526220|FG004|Overall Study|Lost to Follow-up|1|||
147646824|NCT01546038|532526221|FG005|Overall Study|Lost to Follow-up|0|||
147646825|NCT01546038|532526222|FG006|Overall Study|Lost to Follow-up|2|||
147646826|NCT01546038|532526223|FG007|Overall Study|Lost to Follow-up|1|||
147646827|NCT01546038|532526224|FG008|Overall Study|Lost to Follow-up|0|||
147646828|NCT01546038|532526216|FG000|Overall Study|Withdrawal by Subject|1|||
147646829|NCT01546038|532526217|FG001|Overall Study|Withdrawal by Subject|0|||
147646830|NCT01546038|532526218|FG002|Overall Study|Withdrawal by Subject|0|||
147646831|NCT01546038|532526219|FG003|Overall Study|Withdrawal by Subject|1|||
147646832|NCT01546038|532526220|FG004|Overall Study|Withdrawal by Subject|0|||
147646833|NCT01546038|532526221|FG005|Overall Study|Withdrawal by Subject|1|||
147646834|NCT01546038|532526222|FG006|Overall Study|Withdrawal by Subject|3|||
147646835|NCT01546038|532526223|FG007|Overall Study|Withdrawal by Subject|3|||
147646836|NCT01546038|532526224|FG008|Overall Study|Withdrawal by Subject|1|||
147646837|NCT01546038|532526216|FG000|Overall Study|: Randomized, not treated|0|||
147646838|NCT01546038|532526217|FG001|Overall Study|: Randomized, not treated|0|||
147646839|NCT01546038|532526218|FG002|Overall Study|: Randomized, not treated|0|||
147646840|NCT01546038|532526219|FG003|Overall Study|: Randomized, not treated|0|||
147646841|NCT01546038|532526220|FG004|Overall Study|: Randomized, not treated|0|||
147646842|NCT01546038|532526221|FG005|Overall Study|: Randomized, not treated|0|||
147646843|NCT01546038|532526222|FG006|Overall Study|: Randomized, not treated|2|||
147646844|NCT01546038|532526223|FG007|Overall Study|: Randomized, not treated|4|||
147646845|NCT01546038|532526224|FG008|Overall Study|: Randomized, not treated|3|||
147646846|NCT01398410|532526225|FG000|Overall Study|Adverse Event|12|||
147646847|NCT01398410|532526226|FG001|Overall Study|Adverse Event|16|||
147646848|NCT01398410|532526225|FG000|Overall Study|Participants Choice|8|||
147646849|NCT01398410|532526226|FG001|Overall Study|Participants Choice|11|||
147646850|NCT01398410|532526225|FG000|Overall Study|Inadequate Therapeutic Effect|2|||
147646851|NCT01398410|532526226|FG001|Overall Study|Inadequate Therapeutic Effect|0|||
147646852|NCT01398410|532526225|FG000|Overall Study|Other|36|||
147646853|NCT01398410|532526226|FG001|Overall Study|Other|29|||
147646854|NCT04245202|532526227|FG000|Overall Study|Lack of Efficacy|10|||
147646855|NCT04245202|532526228|FG001|Overall Study|Lack of Efficacy|1|||
147646856|NCT03515629|532526230|FG000|Overall Study|Death|0|||
147646857|NCT03515629|532526231|FG001|Overall Study|Death|1|||
147646858|NCT03515629|532526232|FG002|Overall Study|Death|1|||
147646859|NCT03515629|532526230|FG000|Overall Study|Progressive disease|0|||
147646860|NCT03515629|532526231|FG001|Overall Study|Progressive disease|1|||
147646861|NCT03515629|532526232|FG002|Overall Study|Progressive disease|0|||
147646862|NCT01254721|532526233|FG000|Overall Study|Lost to Follow-up|0|||
147646863|NCT01254721|532526234|FG001|Overall Study|Lost to Follow-up|4|||
147646864|NCT01254721|532526233|FG000|Overall Study|Lack of Efficacy|4|||
147646865|NCT01254721|532526234|FG001|Overall Study|Lack of Efficacy|2|||
147646866|NCT01254721|532526233|FG000|Overall Study|Death|0|||
147646867|NCT01254721|532526234|FG001|Overall Study|Death|1|||
147646868|NCT01254721|532526233|FG000|Overall Study|technical problum|1|||
147646869|NCT01254721|532526234|FG001|Overall Study|technical problum|0|||
147646870|NCT01254721|532526233|FG000|Overall Study|Adverse Event|2|||
147646871|NCT01254721|532526234|FG001|Overall Study|Adverse Event|3|||
147646872|NCT01254721|532526233|FG000|Overall Study|Withdrawal by Subject|8|||
147646873|NCT01254721|532526234|FG001|Overall Study|Withdrawal by Subject|11|||
147646874|NCT01254721|532526233|FG000|Overall Study|Wrongly randomization|0|||
147646875|NCT01254721|532526234|FG001|Overall Study|Wrongly randomization|1|||
147646876|NCT00424021|532526235|FG000|NCT00046319 Study Period|Adverse Event|1|||
147646877|NCT00424021|532526236|FG001|NCT00046319 Study Period|Adverse Event|0|||
147646878|NCT00424021|532526237|FG002|NCT00046319 Study Period|Adverse Event|1|||
147646879|NCT00424021|532526238|FG003|NCT00046319 Study Period|Adverse Event|1|||
147646880|NCT00424021|532526235|FG000|NCT00046319 Study Period|Withdrawal by Subject|0|||
147646881|NCT00424021|532526236|FG001|NCT00046319 Study Period|Withdrawal by Subject|1|||
147646882|NCT00424021|532526237|FG002|NCT00046319 Study Period|Withdrawal by Subject|0|||
147646883|NCT00424021|532526238|FG003|NCT00046319 Study Period|Withdrawal by Subject|0|||
147646884|NCT00424021|532526235|FG000|NCT00046319 Study Period|Sponsor discretion|0|||
147646885|NCT00424021|532526236|FG001|NCT00046319 Study Period|Sponsor discretion|1|||
147646886|NCT00424021|532526237|FG002|NCT00046319 Study Period|Sponsor discretion|0|||
147646887|NCT00424021|532526238|FG003|NCT00046319 Study Period|Sponsor discretion|0|||
147646888|NCT00424021|532526235|FG000|NCT00046319 Study Period|Lost to Follow-up|0|||
147646889|NCT00424021|532526236|FG001|NCT00046319 Study Period|Lost to Follow-up|1|||
147646890|NCT00424021|532526237|FG002|NCT00046319 Study Period|Lost to Follow-up|0|||
147646891|NCT00424021|532526238|FG003|NCT00046319 Study Period|Lost to Follow-up|0|||
147646892|NCT00424021|532526235|FG000|AMB-220-E Study Period|Adverse Event|1|||
147646893|NCT00424021|532526236|FG001|AMB-220-E Study Period|Adverse Event|1|||
147646894|NCT00424021|532526237|FG002|AMB-220-E Study Period|Adverse Event|3|||
147646895|NCT00424021|532526238|FG003|AMB-220-E Study Period|Adverse Event|7|||
147646896|NCT00424021|532526235|FG000|AMB-220-E Study Period|Death|0|||
147646897|NCT00424021|532526236|FG001|AMB-220-E Study Period|Death|0|||
147646898|NCT00424021|532526237|FG002|AMB-220-E Study Period|Death|1|||
147646899|NCT00424021|532526238|FG003|AMB-220-E Study Period|Death|1|||
147646900|NCT00424021|532526235|FG000|AMB-220-E Study Period|Lost to Follow-up|0|||
147646901|NCT00424021|532526236|FG001|AMB-220-E Study Period|Lost to Follow-up|1|||
147646902|NCT00424021|532526237|FG002|AMB-220-E Study Period|Lost to Follow-up|1|||
147646903|NCT00424021|532526238|FG003|AMB-220-E Study Period|Lost to Follow-up|1|||
147646904|NCT00424021|532526235|FG000|AMB-220-E Study Period|Physician Decision|0|||
147646905|NCT00424021|532526236|FG001|AMB-220-E Study Period|Physician Decision|0|||
147646906|NCT00424021|532526237|FG002|AMB-220-E Study Period|Physician Decision|0|||
147646907|NCT00424021|532526238|FG003|AMB-220-E Study Period|Physician Decision|1|||
147646908|NCT03597022|532526239|FG000|Overall Study|Premature termination of the study|7|||
147646909|NCT03597022|532526240|FG001|Overall Study|Premature termination of the study|7|||
147646910|NCT03597022|532526241|FG002|Overall Study|Premature termination of the study|8|||
147646911|NCT03597022|532526239|FG000|Overall Study|Serious adverse event|1|||
147646912|NCT03597022|532526240|FG001|Overall Study|Serious adverse event|1|||
147646913|NCT03597022|532526241|FG002|Overall Study|Serious adverse event|0|||
147646914|NCT05385224|532526242|FG000|Overall Study|Unable to swallow capsule|2|||
147646915|NCT05385224|532526242|FG000|Overall Study|Withdrawal by Subject|2|||
147646916|NCT05385224|532526242|FG000|Overall Study|Did not meet study criteria|1|||
147646917|NCT00553358|532526247|FG000|Overall Study|Randomized but did not receive treatment|3|||
147646918|NCT00553358|532526248|FG001|Overall Study|Randomized but did not receive treatment|3|||
147646919|NCT00553358|532526249|FG002|Overall Study|Randomized but did not receive treatment|1|||
147646920|NCT00553358|532526247|FG000|Overall Study|Lost to Follow-up|22|||
147646921|NCT00553358|532526248|FG001|Overall Study|Lost to Follow-up|26|||
147646922|NCT00553358|532526249|FG002|Overall Study|Lost to Follow-up|18|||
147420069|NCT00320528|531700140|FG002|Study Period II|Withdrawal by Subject|1|||
147420070|NCT00320528|531700138|FG000|Study Period II|Entry Criteria Exclusion|0|||
147420071|NCT00320528|531700139|FG001|Study Period II|Entry Criteria Exclusion|2|||
147420072|NCT00320528|531700140|FG002|Study Period II|Entry Criteria Exclusion|2|||
147420073|NCT00320528|531700138|FG000|Study Period III|Adverse Event|1|||
147420074|NCT00320528|531700139|FG001|Study Period III|Adverse Event|0|||
147420075|NCT00320528|531700140|FG002|Study Period III|Adverse Event|0|||
147420076|NCT00320528|531700138|FG000|Study Period III|Lost to Follow-up|1|||
147420077|NCT00320528|531700139|FG001|Study Period III|Lost to Follow-up|0|||
147420078|NCT00320528|531700140|FG002|Study Period III|Lost to Follow-up|0|||
147420079|NCT00320528|531700138|FG000|Study Period III|Withdrawal by Subject|1|||
147420080|NCT00320528|531700139|FG001|Study Period III|Withdrawal by Subject|1|||
147420081|NCT00320528|531700140|FG002|Study Period III|Withdrawal by Subject|2|||
147420082|NCT00320528|531700138|FG000|Study Period III|Lack of Efficacy|2|||
147420083|NCT00320528|531700139|FG001|Study Period III|Lack of Efficacy|0|||
147420084|NCT00320528|531700140|FG002|Study Period III|Lack of Efficacy|0|||
147420085|NCT00320528|531700138|FG000|Study Period III|Parent/Caregiver Decision|14|||
147420086|NCT00320528|531700139|FG001|Study Period III|Parent/Caregiver Decision|3|||
147420087|NCT00320528|531700140|FG002|Study Period III|Parent/Caregiver Decision|11|||
147420088|NCT00320528|531700138|FG000|Study Period III|Protocol Violation|0|||
147420089|NCT00320528|531700139|FG001|Study Period III|Protocol Violation|1|||
147420090|NCT00320528|531700140|FG002|Study Period III|Protocol Violation|0|||
147420091|NCT00320528|531700138|FG000|Study Period III|Physician Decision|0|||
147420092|NCT00320528|531700139|FG001|Study Period III|Physician Decision|1|||
147420093|NCT00320528|531700140|FG002|Study Period III|Physician Decision|2|||
147420094|NCT00320528|531700138|FG000|Study Period III|Sponsor Decision|0|||
147420095|NCT00320528|531700139|FG001|Study Period III|Sponsor Decision|0|||
147420096|NCT00320528|531700140|FG002|Study Period III|Sponsor Decision|1|||
147420097|NCT00320528|531700138|FG000|Study Period III|Atomoxetine Commercially Available|68|||
147420098|NCT00320528|531700139|FG001|Study Period III|Atomoxetine Commercially Available|25|||
147420099|NCT00320528|531700140|FG002|Study Period III|Atomoxetine Commercially Available|90|||
147420100|NCT05038163|531700156|FG000|Stage 1|Did not complete survey|374|||
147420101|NCT05038163|531700157|FG001|Stage 1|Did not complete survey|0|||
147420102|NCT05038163|531700158|FG002|Stage 1|Did not complete survey|0|||
147420103|NCT05038163|531700159|FG003|Stage 1|Did not complete survey|0|||
147420104|NCT05038163|531700160|FG004|Stage 1|Did not complete survey|0|||
147420105|NCT05038163|531700161|FG005|Stage 1|Did not complete survey|0|||
147420106|NCT05038163|531700156|FG000|Stage 2|Did not complete Stage 2 survey|0|||
147420107|NCT05038163|531700157|FG001|Stage 2|Did not complete Stage 2 survey|29|||
147420108|NCT05038163|531700158|FG002|Stage 2|Did not complete Stage 2 survey|30|||
147420109|NCT05038163|531700159|FG003|Stage 2|Did not complete Stage 2 survey|24|||
147420110|NCT05038163|531700160|FG004|Stage 2|Did not complete Stage 2 survey|21|||
147420111|NCT05038163|531700161|FG005|Stage 2|Did not complete Stage 2 survey|100|||
147420112|NCT03562975|531700162|FG000|Overall Study|Death|1|||
147420113|NCT03562975|531700162|FG000|Overall Study|Lost to Follow-up|1|||
147420114|NCT03562975|531700162|FG000|Overall Study|Withdrawal by Subject|1|||
147420115|NCT01758900|531700168|FG000|Overall Study|difficulty for further intubation|7|||
147646923|NCT00553358|532526247|FG000|Overall Study|Withdrew completely|23|||
147646924|NCT00553358|532526248|FG001|Overall Study|Withdrew completely|33|||
147646925|NCT00553358|532526249|FG002|Overall Study|Withdrew completely|34|||
147646926|NCT00553358|532526247|FG000|Overall Study|Died during clinical follow-up|25|||
147646927|NCT00553358|532526248|FG001|Overall Study|Died during clinical follow-up|29|||
147646928|NCT00553358|532526249|FG002|Overall Study|Died during clinical follow-up|32|||
147646929|NCT00553358|532526247|FG000|Overall Study|Not dead but were last followed-up prior to 9 years + 6 months after randomization|4|||
147646930|NCT00553358|532526248|FG001|Overall Study|Not dead but were last followed-up prior to 9 years + 6 months after randomization|2|||
147646931|NCT00553358|532526249|FG002|Overall Study|Not dead but were last followed-up prior to 9 years + 6 months after randomization|2|||
147646932|NCT00553358|532526247|FG000|Overall Study|Died after clinical follow-up ended|1|||
147646933|NCT00553358|532526248|FG001|Overall Study|Died after clinical follow-up ended|2|||
147646934|NCT00553358|532526249|FG002|Overall Study|Died after clinical follow-up ended|0|||
147646935|NCT00553358|532526247|FG000|Overall Study|Withdrew (survival only) - alive at end of survival follow-up|1|||
147646936|NCT00553358|532526248|FG001|Overall Study|Withdrew (survival only) - alive at end of survival follow-up|1|||
147420116|NCT01758900|531700169|FG001|Overall Study|difficulty for further intubation|8|||
147420117|NCT00935818|531700171|FG000|Overall Study|Withdrawal by Subject|45|||
147420118|NCT00935818|531700172|FG001|Overall Study|Withdrawal by Subject|50|||
147420119|NCT00935818|531700171|FG000|Overall Study|Lost to Follow-up|40|||
147420120|NCT00935818|531700172|FG001|Overall Study|Lost to Follow-up|42|||
147420121|NCT00935818|531700171|FG000|Overall Study|Adverse Event|6|||
147420122|NCT00935818|531700172|FG001|Overall Study|Adverse Event|7|||
147420123|NCT00935818|531700171|FG000|Overall Study|Physician Decision|0|||
147420124|NCT00935818|531700172|FG001|Overall Study|Physician Decision|1|||
147420125|NCT00117845|531701622|FG000|Overall Study|stopped treatment/drug supplyinterrupted|1|||
147420126|NCT03527173|531701623|FG000|Overall Study|Lost to Follow-up|4|||
147420127|NCT03527173|531701624|FG001|Overall Study|Lost to Follow-up|2|||
147420128|NCT03527173|531701623|FG000|Overall Study|ELIGIBILITY CRITERIA NOT FULFILLED|1|||
147420129|NCT03527173|531701624|FG001|Overall Study|ELIGIBILITY CRITERIA NOT FULFILLED|0|||
147420130|NCT03527173|531701623|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|1|||
147420131|NCT03527173|531701624|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|5|||
147420132|NCT03527173|531701623|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|1|||
147420133|NCT03527173|531701624|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
147420134|NCT01248780|531701627|FG000|Overall Study|Lack of Efficacy|2|||
147420135|NCT01248780|531701628|FG001|Overall Study|Lack of Efficacy|0|||
147420136|NCT01248780|531701627|FG000|Overall Study|Lost to Follow-up|0|||
147420137|NCT01248780|531701628|FG001|Overall Study|Lost to Follow-up|1|||
147420138|NCT01248780|531701627|FG000|Overall Study|Death|0|||
147420139|NCT01248780|531701628|FG001|Overall Study|Death|1|||
147420140|NCT01248780|531701627|FG000|Overall Study|Adverse Event|2|||
147420141|NCT01248780|531701628|FG001|Overall Study|Adverse Event|7|||
147420142|NCT01248780|531701627|FG000|Overall Study|Protocol Violation|1|||
147420143|NCT01248780|531701628|FG001|Overall Study|Protocol Violation|1|||
147420144|NCT01248780|531701627|FG000|Overall Study|Withdrawal by Subject|4|||
147420145|NCT01248780|531701628|FG001|Overall Study|Withdrawal by Subject|4|||
147420146|NCT01248780|531701627|FG000|Overall Study|Not treated|0|||
147420147|NCT01248780|531701628|FG001|Overall Study|Not treated|1|||
147420148|NCT04097301|531701629|FG000|Overall Study|Death|1|||
147420149|NCT04097301|531701629|FG000|Overall Study|Withdrawal by Subject|1|||
147420150|NCT04097301|531701629|FG000|Overall Study|Screening Failure|5|||
147420151|NCT01227577|531701630|FG000|Overall Study|Protocol deviation|3|||
147420152|NCT01227577|531701630|FG000|Overall Study|Death|3|||
147420153|NCT01227577|531701630|FG000|Overall Study|Administrative problems|2|||
147420154|NCT01227577|531701630|FG000|Overall Study|Lost to Follow-up|1|||
147420155|NCT01227577|531701630|FG000|Overall Study|Withdrawal by Subject|4|||
147420156|NCT01227577|531701630|FG000|Overall Study|Lack of Efficacy|5|||
147420157|NCT01227577|531701630|FG000|Overall Study|Adverse Event|17|||
147420158|NCT02480153|531701631|FG000|Period 1: First Dose to Week 26 Pre-dose|Insufficient Clinical response|0|||
147420159|NCT02480153|531701632|FG001|Period 1: First Dose to Week 26 Pre-dose|Insufficient Clinical response|1|||
147420160|NCT02480153|531701633|FG002|Period 1: First Dose to Week 26 Pre-dose|Insufficient Clinical response|0|||
147420161|NCT02480153|531701631|FG000|Period 1: First Dose to Week 26 Pre-dose|Non-compliance with study treatment|0|||
147420162|NCT02480153|531701632|FG001|Period 1: First Dose to Week 26 Pre-dose|Non-compliance with study treatment|1|||
147420163|NCT02480153|531701633|FG002|Period 1: First Dose to Week 26 Pre-dose|Non-compliance with study treatment|0|||
147420164|NCT02480153|531701631|FG000|Period 1: First Dose to Week 26 Pre-dose|Adverse Event|1|||
147420165|NCT02480153|531701632|FG001|Period 1: First Dose to Week 26 Pre-dose|Adverse Event|2|||
147420166|NCT02480153|531701633|FG002|Period 1: First Dose to Week 26 Pre-dose|Adverse Event|0|||
147420167|NCT02480153|531701631|FG000|Period 1: First Dose to Week 26 Pre-dose|Withdrawal by Subject|3|||
147420168|NCT02480153|531701632|FG001|Period 1: First Dose to Week 26 Pre-dose|Withdrawal by Subject|8|||
147420169|NCT02480153|531701633|FG002|Period 1: First Dose to Week 26 Pre-dose|Withdrawal by Subject|0|||
147420170|NCT02480153|531701631|FG000|Period 1: First Dose to Week 26 Pre-dose|Other|0|||
147420171|NCT02480153|531701632|FG001|Period 1: First Dose to Week 26 Pre-dose|Other|1|||
147420172|NCT02480153|531701633|FG002|Period 1: First Dose to Week 26 Pre-dose|Other|0|||
147420173|NCT02480153|531701631|FG000|Period 1: First Dose to Week 26 Pre-dose|Death|0|||
147420174|NCT02480153|531701632|FG001|Period 1: First Dose to Week 26 Pre-dose|Death|1|||
147420175|NCT02480153|531701633|FG002|Period 1: First Dose to Week 26 Pre-dose|Death|0|||
147420176|NCT02480153|531701631|FG000|Period 1: First Dose to Week 26 Pre-dose|Lost to Follow-up|0|||
147420177|NCT02480153|531701632|FG001|Period 1: First Dose to Week 26 Pre-dose|Lost to Follow-up|2|||
147420178|NCT02480153|531701633|FG002|Period 1: First Dose to Week 26 Pre-dose|Lost to Follow-up|0|||
147420179|NCT02480153|531701631|FG000|Period 2: Week 26 to Week 52 Pre-dose|Insufficient clinical response|4|||
147420180|NCT02480153|531701632|FG001|Period 2: Week 26 to Week 52 Pre-dose|Insufficient clinical response|1|||
147420181|NCT02480153|531701633|FG002|Period 2: Week 26 to Week 52 Pre-dose|Insufficient clinical response|3|||
147420182|NCT02480153|531701631|FG000|Period 2: Week 26 to Week 52 Pre-dose|Non-compliance with study treatment|0|||
147420183|NCT02480153|531701632|FG001|Period 2: Week 26 to Week 52 Pre-dose|Non-compliance with study treatment|1|||
147420184|NCT02480153|531701633|FG002|Period 2: Week 26 to Week 52 Pre-dose|Non-compliance with study treatment|0|||
147420185|NCT02480153|531701631|FG000|Period 2: Week 26 to Week 52 Pre-dose|Withdrawal by Subject|8|||
147420186|NCT02480153|531701632|FG001|Period 2: Week 26 to Week 52 Pre-dose|Withdrawal by Subject|3|||
147420187|NCT02480153|531701633|FG002|Period 2: Week 26 to Week 52 Pre-dose|Withdrawal by Subject|1|||
147420188|NCT02480153|531701631|FG000|Period 2: Week 26 to Week 52 Pre-dose|Adverse Event|6|||
147420189|NCT02480153|531701632|FG001|Period 2: Week 26 to Week 52 Pre-dose|Adverse Event|7|||
147420190|NCT02480153|531701633|FG002|Period 2: Week 26 to Week 52 Pre-dose|Adverse Event|3|||
147420191|NCT02480153|531701631|FG000|Period 2: Week 26 to Week 52 Pre-dose|Other|2|||
147420192|NCT02480153|531701632|FG001|Period 2: Week 26 to Week 52 Pre-dose|Other|0|||
147420193|NCT02480153|531701633|FG002|Period 2: Week 26 to Week 52 Pre-dose|Other|0|||
147420194|NCT02480153|531701631|FG000|Period 2: Week 26 to Week 52 Pre-dose|Lost to Follow-up|0|||
147646937|NCT00553358|532526249|FG002|Overall Study|Withdrew (survival only) - alive at end of survival follow-up|1|||
147420195|NCT02480153|531701632|FG001|Period 2: Week 26 to Week 52 Pre-dose|Lost to Follow-up|1|||
147420196|NCT02480153|531701633|FG002|Period 2: Week 26 to Week 52 Pre-dose|Lost to Follow-up|0|||
147420197|NCT02480153|531701631|FG000|Period 3: Week 52 Dosing to Week 78|Withdrawal by Subject|3|||
147420198|NCT02480153|531701632|FG001|Period 3: Week 52 Dosing to Week 78|Withdrawal by Subject|2|||
147420199|NCT02480153|531701633|FG002|Period 3: Week 52 Dosing to Week 78|Withdrawal by Subject|1|||
147420200|NCT02480153|531701631|FG000|Period 3: Week 52 Dosing to Week 78|Lost to Follow-up|4|||
147420201|NCT02480153|531701632|FG001|Period 3: Week 52 Dosing to Week 78|Lost to Follow-up|0|||
147420202|NCT02480153|531701633|FG002|Period 3: Week 52 Dosing to Week 78|Lost to Follow-up|1|||
147420203|NCT02480153|531701631|FG000|Period 3: Week 52 Dosing to Week 78|Other|0|||
147420204|NCT02480153|531701632|FG001|Period 3: Week 52 Dosing to Week 78|Other|0|||
147420205|NCT02480153|531701633|FG002|Period 3: Week 52 Dosing to Week 78|Other|1|||
147420206|NCT02480153|531701631|FG000|Period 3: Week 52 Dosing to Week 78|Adverse Event|0|||
147420207|NCT02480153|531701632|FG001|Period 3: Week 52 Dosing to Week 78|Adverse Event|0|||
147420208|NCT02480153|531701633|FG002|Period 3: Week 52 Dosing to Week 78|Adverse Event|1|||
147420209|NCT02480153|531701631|FG000|Period 3: Week 52 Dosing to Week 78|Death|0|||
147420210|NCT02480153|531701632|FG001|Period 3: Week 52 Dosing to Week 78|Death|1|||
147420211|NCT02480153|531701633|FG002|Period 3: Week 52 Dosing to Week 78|Death|0|||
147420212|NCT00107120|531701634|FG000|Overall Study|Adverse Event|4|||
147420213|NCT00107120|531701635|FG001|Overall Study|Adverse Event|1|||
147420214|NCT00107120|531701634|FG000|Overall Study|Lack of Efficacy|5|||
147420215|NCT00107120|531701635|FG001|Overall Study|Lack of Efficacy|5|||
147420216|NCT00107120|531701634|FG000|Overall Study|Protocol Violation|3|||
147420217|NCT00107120|531701635|FG001|Overall Study|Protocol Violation|0|||
147420218|NCT00107120|531701634|FG000|Overall Study|Withdrawal by Subject|8|||
147420219|NCT00107120|531701635|FG001|Overall Study|Withdrawal by Subject|9|||
147420220|NCT00107120|531701634|FG000|Overall Study|Lost to Follow-up|8|||
147420221|NCT00107120|531701635|FG001|Overall Study|Lost to Follow-up|6|||
147420222|NCT00107120|531701634|FG000|Overall Study|Pregnancy|0|||
147420223|NCT00107120|531701635|FG001|Overall Study|Pregnancy|1|||
147420224|NCT00107120|531701634|FG000|Overall Study|moving away from site|1|||
147420225|NCT00107120|531701635|FG001|Overall Study|moving away from site|1|||
147420226|NCT00107120|531701634|FG000|Overall Study|death of parent|0|||
147420227|NCT00107120|531701635|FG001|Overall Study|death of parent|1|||
147420228|NCT03241225|531701636|FG000|Overall Study|Lost to Follow-up|2|||
147420229|NCT03241225|531701637|FG001|Overall Study|Lost to Follow-up|1|||
147420230|NCT03241225|531701636|FG000|Overall Study|Protocol Violation|4|||
147420231|NCT03241225|531701637|FG001|Overall Study|Protocol Violation|1|||
147420232|NCT03241225|531701636|FG000|Overall Study|Withdrawal by Subject|1|||
147420233|NCT03241225|531701637|FG001|Overall Study|Withdrawal by Subject|0|||
147420234|NCT00852540|531701638|FG000|Overall Study|Adverse Event|10|||
147420235|NCT00852540|531701639|FG001|Overall Study|Adverse Event|3|||
147420236|NCT00852540|531701638|FG000|Overall Study|Lack of Efficacy|15|||
147420237|NCT00852540|531701639|FG001|Overall Study|Lack of Efficacy|3|||
147420238|NCT00852540|531701638|FG000|Overall Study|Protocol Violation|1|||
147420239|NCT00852540|531701639|FG001|Overall Study|Protocol Violation|2|||
147420240|NCT00852540|531701638|FG000|Overall Study|Lost to Follow-up|2|||
147420241|NCT00852540|531701639|FG001|Overall Study|Lost to Follow-up|3|||
147420242|NCT00852540|531701638|FG000|Overall Study|Investigator Discretion|2|||
147420243|NCT00852540|531701639|FG001|Overall Study|Investigator Discretion|3|||
147420244|NCT00852540|531701638|FG000|Overall Study|Withdrawal by Subject|3|||
147420245|NCT00852540|531701639|FG001|Overall Study|Withdrawal by Subject|1|||
147420246|NCT00852540|531701638|FG000|Overall Study|Did Not Receive Study Drug|3|||
147420247|NCT00852540|531701639|FG001|Overall Study|Did Not Receive Study Drug|3|||
147420248|NCT01639495|531701640|FG000|Overall Study|Lost to Follow-up|6|||
147420249|NCT01639495|531701640|FG000|Overall Study|Consented but didn't have study catheter|4|||
147420250|NCT01639495|531701640|FG000|Overall Study|Not meeting inclusion/exclusion criteria|4|||
147420251|NCT01639495|531701640|FG000|Overall Study|No radiofrequency energy applied|2|||
147420252|NCT01119105|531701641|FG000|Overall Study|Withdrawal by Subject|1|||
147420253|NCT01119105|531701642|FG001|Overall Study|Withdrawal by Subject|1|||
147420254|NCT01119105|531701643|FG002|Overall Study|Withdrawal by Subject|1|||
147420255|NCT01119105|531701641|FG000|Overall Study|Lost to Follow-up|0|||
147420256|NCT01119105|531701642|FG001|Overall Study|Lost to Follow-up|2|||
147420257|NCT01119105|531701643|FG002|Overall Study|Lost to Follow-up|5|||
147420258|NCT01119105|531701641|FG000|Overall Study|Adverse Event|1|||
147420259|NCT01119105|531701642|FG001|Overall Study|Adverse Event|0|||
147420260|NCT01119105|531701643|FG002|Overall Study|Adverse Event|1|||
147420261|NCT01119105|531701641|FG000|Overall Study|study drug missed on 2 consecutive days|1|||
147420262|NCT01119105|531701642|FG001|Overall Study|study drug missed on 2 consecutive days|2|||
147420263|NCT01119105|531701643|FG002|Overall Study|study drug missed on 2 consecutive days|1|||
147420264|NCT01119105|531701641|FG000|Overall Study|Other|1|||
147420265|NCT01119105|531701642|FG001|Overall Study|Other|1|||
147420266|NCT01119105|531701643|FG002|Overall Study|Other|0|||
147420267|NCT04214600|531701646|FG000|Overall Study|Lost to Follow-up|9|||
147420268|NCT04214600|531701647|FG001|Overall Study|Lost to Follow-up|14|||
147420269|NCT02935452|531701648|FG000|Overall Study|work and life commintment|3|||
147420270|NCT02935452|531701649|FG001|Overall Study|work and life commintment|1|||
147420271|NCT01635920|531701657|FG000|Overall Study|Adverse Event|1|||
147420272|NCT01635920|531701658|FG001|Overall Study|Adverse Event|0|||
147420273|NCT01635920|531701657|FG000|Overall Study|Lost to Follow-up|0|||
147420274|NCT01635920|531701658|FG001|Overall Study|Lost to Follow-up|1|||
147420275|NCT01635920|531701657|FG000|Overall Study|Subject decision|2|||
147420276|NCT01635920|531701658|FG001|Overall Study|Subject decision|0|||
147420277|NCT01664598|531701659|FG000|Overall Study|Sponsor Decision|1|||
147420278|NCT01664598|531701659|FG000|Overall Study|Withdrawal of Informed Consent|4|||
147420279|NCT01664598|531701659|FG000|Overall Study|Adverse Event|1|||
147420280|NCT00686725|531701660|FG000|Overall Study|Adverse Event|1|||
147420281|NCT00686725|531701661|FG001|Overall Study|Adverse Event|1|||
147420282|NCT00686725|531701660|FG000|Overall Study|Progressive Disease|17|||
147420283|NCT00686725|531701661|FG001|Overall Study|Progressive Disease|23|||
147420284|NCT00686725|531701660|FG000|Overall Study|Lost to Follow-up|7|||
147420285|NCT00686725|531701661|FG001|Overall Study|Lost to Follow-up|5|||
147420286|NCT00686725|531701660|FG000|Overall Study|Death|6|||
147420287|NCT00686725|531701661|FG001|Overall Study|Death|3|||
147420288|NCT00686725|531701660|FG000|Overall Study|Withdrawal by Subject|13|||
147420289|NCT00686725|531701661|FG001|Overall Study|Withdrawal by Subject|4|||
147420290|NCT00686725|531701660|FG000|Overall Study|Protocol Violation|1|||
147420291|NCT00686725|531701661|FG001|Overall Study|Protocol Violation|3|||
147420292|NCT00686725|531701660|FG000|Overall Study|Other|1|||
147420293|NCT00686725|531701661|FG001|Overall Study|Other|3|||
147420294|NCT00092495|531701662|FG000|Base Study Vaccination Period|Randomized Not Vaccinated|1|||
147420295|NCT00092495|531701663|FG001|Base Study Vaccination Period|Randomized Not Vaccinated|1|||
147420296|NCT00092495|531701664|FG002|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
147420297|NCT00092495|531701665|FG003|Base Study Vaccination Period|Randomized Not Vaccinated|4|||
147420298|NCT00092495|531701666|FG004|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
147420299|NCT00092495|531701662|FG000|Base Study Vaccination Period|Extended|0|||
147420300|NCT00092495|531701663|FG001|Base Study Vaccination Period|Extended|0|||
147420301|NCT00092495|531701664|FG002|Base Study Vaccination Period|Extended|0|||
147420302|NCT00092495|531701665|FG003|Base Study Vaccination Period|Extended|1|||
147420303|NCT00092495|531701666|FG004|Base Study Vaccination Period|Extended|0|||
147420304|NCT00092495|531701662|FG000|Base Study Vaccination Period|*Clinical AE|1|||
147420305|NCT00092495|531701663|FG001|Base Study Vaccination Period|*Clinical AE|0|||
147420306|NCT00092495|531701664|FG002|Base Study Vaccination Period|*Clinical AE|1|||
147420307|NCT00092495|531701665|FG003|Base Study Vaccination Period|*Clinical AE|2|||
147420308|NCT00092495|531701666|FG004|Base Study Vaccination Period|*Clinical AE|0|||
147420309|NCT00092495|531701662|FG000|Base Study Vaccination Period|*Other reasons|1|||
147420310|NCT00092495|531701663|FG001|Base Study Vaccination Period|*Other reasons|0|||
147420311|NCT00092495|531701664|FG002|Base Study Vaccination Period|*Other reasons|0|||
147420312|NCT00092495|531701665|FG003|Base Study Vaccination Period|*Other reasons|1|||
147420313|NCT00092495|531701666|FG004|Base Study Vaccination Period|*Other reasons|0|||
147420314|NCT00092495|531701662|FG000|Base Study Vaccination Period|*Pregnancy|0|||
147420315|NCT00092495|531701663|FG001|Base Study Vaccination Period|*Pregnancy|2|||
147420316|NCT00092495|531701664|FG002|Base Study Vaccination Period|*Pregnancy|5|||
147420317|NCT00092495|531701665|FG003|Base Study Vaccination Period|*Pregnancy|7|||
147420318|NCT00092495|531701666|FG004|Base Study Vaccination Period|*Pregnancy|0|||
147420319|NCT00092495|531701662|FG000|Base Study Vaccination Period|Adverse Event|1|||
147420320|NCT00092495|531701663|FG001|Base Study Vaccination Period|Adverse Event|0|||
147420321|NCT00092495|531701664|FG002|Base Study Vaccination Period|Adverse Event|0|||
147420322|NCT00092495|531701665|FG003|Base Study Vaccination Period|Adverse Event|3|||
147420323|NCT00092495|531701666|FG004|Base Study Vaccination Period|Adverse Event|0|||
147420324|NCT00092495|531701662|FG000|Base Study Vaccination Period|Lost to Follow-up|16|||
147420325|NCT00092495|531701663|FG001|Base Study Vaccination Period|Lost to Follow-up|6|||
147420326|NCT00092495|531701664|FG002|Base Study Vaccination Period|Lost to Follow-up|11|||
147420327|NCT00092495|531701665|FG003|Base Study Vaccination Period|Lost to Follow-up|36|||
147420328|NCT00092495|531701666|FG004|Base Study Vaccination Period|Lost to Follow-up|0|||
147420329|NCT00092495|531701662|FG000|Base Study Vaccination Period|Moved|3|||
147420330|NCT00092495|531701663|FG001|Base Study Vaccination Period|Moved|1|||
147420331|NCT00092495|531701664|FG002|Base Study Vaccination Period|Moved|2|||
147420332|NCT00092495|531701665|FG003|Base Study Vaccination Period|Moved|2|||
147420333|NCT00092495|531701666|FG004|Base Study Vaccination Period|Moved|0|||
147420334|NCT00092495|531701662|FG000|Base Study Vaccination Period|Other|1|||
147420335|NCT00092495|531701663|FG001|Base Study Vaccination Period|Other|1|||
147420336|NCT00092495|531701664|FG002|Base Study Vaccination Period|Other|0|||
147420337|NCT00092495|531701665|FG003|Base Study Vaccination Period|Other|2|||
147420338|NCT00092495|531701666|FG004|Base Study Vaccination Period|Other|0|||
147420339|NCT00092495|531701662|FG000|Base Study Vaccination Period|Pregnancy|2|||
147420340|NCT00092495|531701663|FG001|Base Study Vaccination Period|Pregnancy|0|||
147420341|NCT00092495|531701664|FG002|Base Study Vaccination Period|Pregnancy|0|||
147420342|NCT00092495|531701665|FG003|Base Study Vaccination Period|Pregnancy|0|||
147420343|NCT00092495|531701666|FG004|Base Study Vaccination Period|Pregnancy|0|||
147420344|NCT00092495|531701662|FG000|Base Study Vaccination Period|Parent Withdrew Consent|1|||
147595928|NCT03096847|532338751|FG000|Overall Study|Death|6|||
147420345|NCT00092495|531701663|FG001|Base Study Vaccination Period|Parent Withdrew Consent|1|||
147420346|NCT00092495|531701664|FG002|Base Study Vaccination Period|Parent Withdrew Consent|1|||
147420347|NCT00092495|531701665|FG003|Base Study Vaccination Period|Parent Withdrew Consent|5|||
147420348|NCT00092495|531701666|FG004|Base Study Vaccination Period|Parent Withdrew Consent|0|||
147420349|NCT00092495|531701662|FG000|Base Study Vaccination Period|Protocol Violation|1|||
147420350|NCT00092495|531701663|FG001|Base Study Vaccination Period|Protocol Violation|0|||
147420351|NCT00092495|531701664|FG002|Base Study Vaccination Period|Protocol Violation|0|||
147420352|NCT00092495|531701665|FG003|Base Study Vaccination Period|Protocol Violation|0|||
147420353|NCT00092495|531701666|FG004|Base Study Vaccination Period|Protocol Violation|0|||
147420354|NCT00092495|531701662|FG000|Base Study Vaccination Period|Withdrawal by Subject|9|||
147420355|NCT00092495|531701663|FG001|Base Study Vaccination Period|Withdrawal by Subject|10|||
147420356|NCT00092495|531701664|FG002|Base Study Vaccination Period|Withdrawal by Subject|14|||
147420357|NCT00092495|531701665|FG003|Base Study Vaccination Period|Withdrawal by Subject|25|||
147420358|NCT00092495|531701666|FG004|Base Study Vaccination Period|Withdrawal by Subject|0|||
147420359|NCT00092495|531701662|FG000|Base Study Follow-up Period|Extended|0|||
147420360|NCT00092495|531701663|FG001|Base Study Follow-up Period|Extended|0|||
147420361|NCT00092495|531701664|FG002|Base Study Follow-up Period|Extended|1|||
147420362|NCT00092495|531701665|FG003|Base Study Follow-up Period|Extended|2|||
147420363|NCT00092495|531701666|FG004|Base Study Follow-up Period|Extended|0|||
147420364|NCT00092495|531701662|FG000|Base Study Follow-up Period|Lost to Follow-up|1|||
147420365|NCT00092495|531701663|FG001|Base Study Follow-up Period|Lost to Follow-up|3|||
147420366|NCT00092495|531701664|FG002|Base Study Follow-up Period|Lost to Follow-up|3|||
147420367|NCT00092495|531701665|FG003|Base Study Follow-up Period|Lost to Follow-up|12|||
147420368|NCT00092495|531701666|FG004|Base Study Follow-up Period|Lost to Follow-up|0|||
147420369|NCT00092495|531701662|FG000|Base Study Follow-up Period|Withdrawal by Subject|2|||
147420370|NCT00092495|531701663|FG001|Base Study Follow-up Period|Withdrawal by Subject|0|||
147420371|NCT00092495|531701664|FG002|Base Study Follow-up Period|Withdrawal by Subject|0|||
147420372|NCT00092495|531701665|FG003|Base Study Follow-up Period|Withdrawal by Subject|0|||
147420373|NCT00092495|531701666|FG004|Base Study Follow-up Period|Withdrawal by Subject|0|||
147420374|NCT03103763|531701671|FG000|Overall Study|Death|15|||
147420375|NCT03103763|531701672|FG001|Overall Study|Death|5|||
147420376|NCT03103763|531701673|FG002|Overall Study|Death|5|||
147420377|NCT03103763|531701671|FG000|Overall Study|Withdrawal by Subject|0|||
147420378|NCT03103763|531701672|FG001|Overall Study|Withdrawal by Subject|3|||
147420379|NCT03103763|531701673|FG002|Overall Study|Withdrawal by Subject|2|||
147420380|NCT00938470|531701674|FG000|Overall Study|Disease Progression|3|||
147420381|NCT00938470|531701675|FG001|Overall Study|Disease Progression|0|||
147420382|NCT00938470|531701674|FG000|Overall Study|Alternate Treatment|1|||
147420383|NCT00938470|531701675|FG001|Overall Study|Alternate Treatment|0|||
147420384|NCT00938470|531701674|FG000|Overall Study|Death|3|||
147420385|NCT00938470|531701675|FG001|Overall Study|Death|2|||
147420386|NCT00938470|531701674|FG000|Overall Study|Other Reason|0|||
147420387|NCT00938470|531701675|FG001|Overall Study|Other Reason|1|||
147420388|NCT01346475|531701680|FG000|First Intervention|Lost to Follow-up|4|||
147420389|NCT01346475|531701681|FG001|First Intervention|Lost to Follow-up|3|||
147420390|NCT01552603|531701682|FG000|Overall Study|Physician Decision|1|||
147420391|NCT00618618|531701683|FG000|Overall Study|Patient Request|0|||
147420392|NCT00618618|531701684|FG001|Overall Study|Patient Request|0|||
147420393|NCT00618618|531701685|FG002|Overall Study|Patient Request|2|||
147420394|NCT00618618|531701686|FG003|Overall Study|Patient Request|0|||
147420395|NCT00618618|531701683|FG000|Overall Study|Inability to Complete Study Procedures|0|||
147420396|NCT00618618|531701684|FG001|Overall Study|Inability to Complete Study Procedures|1|||
147420397|NCT00618618|531701685|FG002|Overall Study|Inability to Complete Study Procedures|0|||
147420398|NCT00618618|531701686|FG003|Overall Study|Inability to Complete Study Procedures|0|||
147420399|NCT00618618|531701683|FG000|Overall Study|Lost to Follow-up|3|||
147420400|NCT00618618|531701684|FG001|Overall Study|Lost to Follow-up|0|||
147420401|NCT00618618|531701685|FG002|Overall Study|Lost to Follow-up|0|||
147420402|NCT00618618|531701686|FG003|Overall Study|Lost to Follow-up|1|||
147420403|NCT00618618|531701683|FG000|Overall Study|Non-compliance|1|||
147420404|NCT00618618|531701684|FG001|Overall Study|Non-compliance|1|||
147420405|NCT00618618|531701685|FG002|Overall Study|Non-compliance|0|||
147420406|NCT00618618|531701686|FG003|Overall Study|Non-compliance|0|||
147420407|NCT00618618|531701683|FG000|Overall Study|Did Not Meet Entry Criteria|0|||
147420408|NCT00618618|531701684|FG001|Overall Study|Did Not Meet Entry Criteria|0|||
147420409|NCT00618618|531701685|FG002|Overall Study|Did Not Meet Entry Criteria|1|||
147420410|NCT00618618|531701686|FG003|Overall Study|Did Not Meet Entry Criteria|0|||
147420411|NCT00618618|531701683|FG000|Overall Study|Death|0|||
147420412|NCT00618618|531701684|FG001|Overall Study|Death|1|||
147420413|NCT00618618|531701685|FG002|Overall Study|Death|0|||
147420414|NCT00618618|531701686|FG003|Overall Study|Death|0|||
147420415|NCT01183234|531701687|FG000|First Intervention|Adverse Event|1|||
147420416|NCT01183234|531701688|FG001|First Intervention|Adverse Event|0|||
147420417|NCT00309959|531701691|FG000|Overall Study|Ineligible - no prior chemotherapy|2|||
147420418|NCT02947087|531701692|FG000|Overall Study|Withdrawal by Subject|3|||
147420419|NCT02947087|531701693|FG001|Overall Study|Withdrawal by Subject|2|||
147420420|NCT01160289|531701694|FG000|Screening, Washout, and Lead-In Period|Adverse Event|8|||
147420421|NCT01160289|531701695|FG001|Screening, Washout, and Lead-In Period|Adverse Event|0|||
147420422|NCT01160289|531701696|FG002|Screening, Washout, and Lead-In Period|Adverse Event|0|||
147420423|NCT01160289|531701697|FG003|Screening, Washout, and Lead-In Period|Adverse Event|0|||
147420424|NCT01160289|531701698|FG004|Screening, Washout, and Lead-In Period|Adverse Event|0|||
147420425|NCT01160289|531701699|FG005|Screening, Washout, and Lead-In Period|Adverse Event|0|||
147420426|NCT01160289|531701694|FG000|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|308|||
147420427|NCT01160289|531701695|FG001|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0|||
147420428|NCT01160289|531701696|FG002|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0|||
147420429|NCT01160289|531701697|FG003|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0|||
147420430|NCT01160289|531701698|FG004|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0|||
147420431|NCT01160289|531701699|FG005|Screening, Washout, and Lead-In Period|Entry Criteria Not Met|0|||
147420432|NCT01160289|531701694|FG000|Screening, Washout, and Lead-In Period|Lack of Efficacy|1|||
147420433|NCT01160289|531701695|FG001|Screening, Washout, and Lead-In Period|Lack of Efficacy|0|||
147420434|NCT01160289|531701696|FG002|Screening, Washout, and Lead-In Period|Lack of Efficacy|0|||
147420435|NCT01160289|531701697|FG003|Screening, Washout, and Lead-In Period|Lack of Efficacy|0|||
147420436|NCT01160289|531701698|FG004|Screening, Washout, and Lead-In Period|Lack of Efficacy|0|||
147420437|NCT01160289|531701699|FG005|Screening, Washout, and Lead-In Period|Lack of Efficacy|0|||
147420438|NCT01160289|531701694|FG000|Screening, Washout, and Lead-In Period|Lost to Follow-up|9|||
147420439|NCT01160289|531701695|FG001|Screening, Washout, and Lead-In Period|Lost to Follow-up|0|||
147420440|NCT01160289|531701696|FG002|Screening, Washout, and Lead-In Period|Lost to Follow-up|0|||
147420441|NCT01160289|531701697|FG003|Screening, Washout, and Lead-In Period|Lost to Follow-up|0|||
147420442|NCT01160289|531701698|FG004|Screening, Washout, and Lead-In Period|Lost to Follow-up|0|||
147420443|NCT01160289|531701699|FG005|Screening, Washout, and Lead-In Period|Lost to Follow-up|0|||
147420444|NCT01160289|531701694|FG000|Screening, Washout, and Lead-In Period|Physician Decision|26|||
147420445|NCT01160289|531701695|FG001|Screening, Washout, and Lead-In Period|Physician Decision|0|||
147420446|NCT01160289|531701696|FG002|Screening, Washout, and Lead-In Period|Physician Decision|0|||
147420447|NCT01160289|531701697|FG003|Screening, Washout, and Lead-In Period|Physician Decision|0|||
147420448|NCT01160289|531701698|FG004|Screening, Washout, and Lead-In Period|Physician Decision|0|||
147420449|NCT01160289|531701699|FG005|Screening, Washout, and Lead-In Period|Physician Decision|0|||
147420450|NCT01160289|531701694|FG000|Screening, Washout, and Lead-In Period|Protocol Violation|1|||
147420451|NCT01160289|531701695|FG001|Screening, Washout, and Lead-In Period|Protocol Violation|0|||
147420452|NCT01160289|531701696|FG002|Screening, Washout, and Lead-In Period|Protocol Violation|0|||
147420453|NCT01160289|531701697|FG003|Screening, Washout, and Lead-In Period|Protocol Violation|0|||
147420454|NCT01160289|531701698|FG004|Screening, Washout, and Lead-In Period|Protocol Violation|0|||
147420455|NCT01160289|531701699|FG005|Screening, Washout, and Lead-In Period|Protocol Violation|0|||
147420456|NCT01160289|531701694|FG000|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|67|||
147420457|NCT01160289|531701695|FG001|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0|||
147420458|NCT01160289|531701696|FG002|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0|||
147420459|NCT01160289|531701697|FG003|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0|||
147420460|NCT01160289|531701698|FG004|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0|||
147420461|NCT01160289|531701699|FG005|Screening, Washout, and Lead-In Period|Randomization Criteria Not Met|0|||
147420462|NCT01160289|531701694|FG000|Screening, Washout, and Lead-In Period|Withdrawal by Subject|64|||
147420463|NCT01160289|531701695|FG001|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0|||
147420464|NCT01160289|531701696|FG002|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0|||
147420465|NCT01160289|531701697|FG003|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0|||
147420466|NCT01160289|531701698|FG004|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0|||
147420467|NCT01160289|531701699|FG005|Screening, Washout, and Lead-In Period|Withdrawal by Subject|0|||
147420468|NCT01160289|531701694|FG000|Post-Randomization Period|Adverse Event|0|||
147420469|NCT01160289|531701695|FG001|Post-Randomization Period|Adverse Event|4|||
147420470|NCT01160289|531701696|FG002|Post-Randomization Period|Adverse Event|4|||
147420471|NCT01160289|531701697|FG003|Post-Randomization Period|Adverse Event|2|||
147420472|NCT01160289|531701698|FG004|Post-Randomization Period|Adverse Event|0|||
147420473|NCT01160289|531701699|FG005|Post-Randomization Period|Adverse Event|0|||
147420474|NCT01160289|531701694|FG000|Post-Randomization Period|Death|0|||
147420475|NCT01160289|531701695|FG001|Post-Randomization Period|Death|0|||
147420476|NCT01160289|531701696|FG002|Post-Randomization Period|Death|0|||
147420477|NCT01160289|531701697|FG003|Post-Randomization Period|Death|1|||
147420478|NCT01160289|531701698|FG004|Post-Randomization Period|Death|0|||
147420479|NCT01160289|531701699|FG005|Post-Randomization Period|Death|0|||
147420480|NCT01160289|531701694|FG000|Post-Randomization Period|Lack of Efficacy|0|||
147420481|NCT01160289|531701695|FG001|Post-Randomization Period|Lack of Efficacy|1|||
147420482|NCT01160289|531701696|FG002|Post-Randomization Period|Lack of Efficacy|0|||
147420483|NCT01160289|531701697|FG003|Post-Randomization Period|Lack of Efficacy|3|||
147420484|NCT01160289|531701698|FG004|Post-Randomization Period|Lack of Efficacy|0|||
147420485|NCT01160289|531701699|FG005|Post-Randomization Period|Lack of Efficacy|0|||
147420486|NCT01160289|531701694|FG000|Post-Randomization Period|Lost to Follow-up|0|||
147420487|NCT01160289|531701695|FG001|Post-Randomization Period|Lost to Follow-up|3|||
147420488|NCT01160289|531701696|FG002|Post-Randomization Period|Lost to Follow-up|2|||
147420489|NCT01160289|531701697|FG003|Post-Randomization Period|Lost to Follow-up|5|||
147420490|NCT01160289|531701698|FG004|Post-Randomization Period|Lost to Follow-up|3|||
147420491|NCT01160289|531701699|FG005|Post-Randomization Period|Lost to Follow-up|4|||
147420492|NCT01160289|531701694|FG000|Post-Randomization Period|Physician Decision|0|||
147420493|NCT01160289|531701695|FG001|Post-Randomization Period|Physician Decision|0|||
147420494|NCT01160289|531701696|FG002|Post-Randomization Period|Physician Decision|1|||
147420495|NCT01160289|531701697|FG003|Post-Randomization Period|Physician Decision|0|||
147420496|NCT01160289|531701698|FG004|Post-Randomization Period|Physician Decision|0|||
147420497|NCT01160289|531701699|FG005|Post-Randomization Period|Physician Decision|0|||
147420498|NCT01160289|531701694|FG000|Post-Randomization Period|Protocol Violation|0|||
147420499|NCT01160289|531701695|FG001|Post-Randomization Period|Protocol Violation|4|||
147420500|NCT01160289|531701696|FG002|Post-Randomization Period|Protocol Violation|2|||
147420501|NCT01160289|531701697|FG003|Post-Randomization Period|Protocol Violation|0|||
147420502|NCT01160289|531701698|FG004|Post-Randomization Period|Protocol Violation|1|||
147420503|NCT01160289|531701699|FG005|Post-Randomization Period|Protocol Violation|3|||
147420504|NCT01160289|531701694|FG000|Post-Randomization Period|Withdrawal by Subject|0|||
147420505|NCT01160289|531701695|FG001|Post-Randomization Period|Withdrawal by Subject|5|||
147420506|NCT01160289|531701696|FG002|Post-Randomization Period|Withdrawal by Subject|13|||
147420507|NCT01160289|531701697|FG003|Post-Randomization Period|Withdrawal by Subject|8|||
147420508|NCT01160289|531701698|FG004|Post-Randomization Period|Withdrawal by Subject|5|||
147420509|NCT01160289|531701699|FG005|Post-Randomization Period|Withdrawal by Subject|7|||
147420510|NCT01160289|531701694|FG000|Post-Randomization Period|Entry Criteria Not Met|0|||
147420511|NCT01160289|531701695|FG001|Post-Randomization Period|Entry Criteria Not Met|2|||
147420512|NCT01160289|531701696|FG002|Post-Randomization Period|Entry Criteria Not Met|2|||
147420513|NCT01160289|531701697|FG003|Post-Randomization Period|Entry Criteria Not Met|2|||
147420514|NCT01160289|531701698|FG004|Post-Randomization Period|Entry Criteria Not Met|0|||
147420515|NCT01160289|531701699|FG005|Post-Randomization Period|Entry Criteria Not Met|0|||
147420516|NCT01160289|531701694|FG000|Post-Randomization Period|Sponsor Decision|0|||
147420517|NCT01160289|531701695|FG001|Post-Randomization Period|Sponsor Decision|1|||
147420518|NCT01160289|531701696|FG002|Post-Randomization Period|Sponsor Decision|0|||
147420519|NCT01160289|531701697|FG003|Post-Randomization Period|Sponsor Decision|0|||
147420520|NCT01160289|531701698|FG004|Post-Randomization Period|Sponsor Decision|0|||
147420521|NCT01160289|531701699|FG005|Post-Randomization Period|Sponsor Decision|0|||
147420522|NCT01844687|531701702|FG000|Visit 1|Protocol Violation|3|||
147420523|NCT01844687|531701702|FG000|Visit 1|Lost to Follow-up|5|||
147420524|NCT01844687|531701702|FG000|Visit 2|Withdrawal by Subject|1|||
147420525|NCT01844687|531701702|FG000|Visit 2|Protocol Violation|1|||
147420526|NCT01844687|531701702|FG000|Visit 3|Lost to Follow-up|1|||
147420527|NCT01844687|531701702|FG000|Visit 3|Withdrawal by Subject|3|||
147420528|NCT01844687|531701702|FG000|Visit 3|child care problems|1|||
147420529|NCT01844687|531701702|FG000|Visit 4|Pregnancy|1|||
147420530|NCT01844687|531701702|FG000|Visit 4|Lost to Follow-up|1|||
147420531|NCT01844687|531701702|FG000|Visit 4|Withdrawal by Subject|2|||
147420532|NCT00938860|531701715|FG000|Overall Study|Adverse Event|2|||
147420533|NCT00938860|531701716|FG001|Overall Study|Adverse Event|1|||
147420534|NCT00938860|531701715|FG000|Overall Study|Abnormal laboratory values|2|||
147420535|NCT00938860|531701716|FG001|Overall Study|Abnormal laboratory values|2|||
147420536|NCT00938860|531701715|FG000|Overall Study|Withdrawal by Subject|11|||
147420537|NCT00938860|531701716|FG001|Overall Study|Withdrawal by Subject|8|||
147420538|NCT00938860|531701715|FG000|Overall Study|Lost to Follow-up|4|||
147420539|NCT00938860|531701716|FG001|Overall Study|Lost to Follow-up|4|||
147420540|NCT00938860|531701715|FG000|Overall Study|Administration problems|2|||
147420541|NCT00938860|531701716|FG001|Overall Study|Administration problems|0|||
147420542|NCT00938860|531701715|FG000|Overall Study|Death|1|||
147420543|NCT00938860|531701716|FG001|Overall Study|Death|1|||
147420544|NCT00938860|531701715|FG000|Overall Study|Protocol Violation|3|||
147420545|NCT00938860|531701716|FG001|Overall Study|Protocol Violation|1|||
147420546|NCT01605019|531701717|FG000|Overall Study|pt did not meet transplant endpoint|3|||
147420547|NCT01605019|531701718|FG001|Overall Study|pt did not meet transplant endpoint|0|||
147420548|NCT00324116|531701722|FG000|Overall Study|Adverse Event|5|||
147420549|NCT00324116|531701722|FG000|Overall Study|Lack of Efficacy|17|||
147420550|NCT00324116|531701722|FG000|Overall Study|Withdrawal by Subject|5|||
147420551|NCT00324116|531701722|FG000|Overall Study|Other|5|||
147420552|NCT02624791|531701723|FG000|Overall Study|Withdrawal by Subject|2|||
147420553|NCT02624791|531701724|FG001|Overall Study|Withdrawal by Subject|0|||
147420554|NCT02624791|531701725|FG002|Overall Study|Withdrawal by Subject|0|||
147420555|NCT02624791|531701726|FG003|Overall Study|Withdrawal by Subject|0|||
147420556|NCT02624791|531701727|FG004|Overall Study|Withdrawal by Subject|0|||
147420557|NCT02624791|531701728|FG005|Overall Study|Withdrawal by Subject|0|||
147420558|NCT01642251|531701729|FG000|Overall Study|Progressive disease|0|||
147420559|NCT01642251|531701730|FG001|Overall Study|Progressive disease|0|||
147420560|NCT01642251|531701731|FG002|Overall Study|Progressive disease|3|||
147420561|NCT01642251|531701732|FG003|Overall Study|Progressive disease|3|||
147420562|NCT01642251|531701729|FG000|Overall Study|Adverse Event|0|||
147420563|NCT01642251|531701730|FG001|Overall Study|Adverse Event|0|||
147420564|NCT01642251|531701731|FG002|Overall Study|Adverse Event|5|||
147420565|NCT01642251|531701732|FG003|Overall Study|Adverse Event|4|||
147420566|NCT01642251|531701729|FG000|Overall Study|Death|0|||
147420567|NCT01642251|531701730|FG001|Overall Study|Death|0|||
147420568|NCT01642251|531701731|FG002|Overall Study|Death|1|||
147420569|NCT01642251|531701732|FG003|Overall Study|Death|3|||
147420570|NCT01642251|531701729|FG000|Overall Study|Withdrawal by Subject|0|||
147420571|NCT01642251|531701730|FG001|Overall Study|Withdrawal by Subject|0|||
147420572|NCT01642251|531701731|FG002|Overall Study|Withdrawal by Subject|1|||
147420573|NCT01642251|531701732|FG003|Overall Study|Withdrawal by Subject|3|||
147420574|NCT01642251|531701729|FG000|Overall Study|Alternative therapy|0|||
147420575|NCT01642251|531701730|FG001|Overall Study|Alternative therapy|0|||
147420576|NCT01642251|531701731|FG002|Overall Study|Alternative therapy|0|||
147420577|NCT01642251|531701732|FG003|Overall Study|Alternative therapy|2|||
147420578|NCT01642251|531701729|FG000|Overall Study|Other complicating disease|0|||
147420579|NCT01642251|531701730|FG001|Overall Study|Other complicating disease|0|||
147420580|NCT01642251|531701731|FG002|Overall Study|Other complicating disease|1|||
147420581|NCT01642251|531701732|FG003|Overall Study|Other complicating disease|0|||
147420582|NCT01642251|531701729|FG000|Overall Study|Ineligible/never start protocol therapy|0|||
147420583|NCT01642251|531701730|FG001|Overall Study|Ineligible/never start protocol therapy|0|||
147420584|NCT01642251|531701731|FG002|Overall Study|Ineligible/never start protocol therapy|11|||
147420585|NCT01642251|531701732|FG003|Overall Study|Ineligible/never start protocol therapy|8|||
147420586|NCT01993927|531701733|FG000|Overall Study|Case Report Forms Uncollected|18|||
147420587|NCT01993927|531701733|FG000|Overall Study|Protocol Violation|11|||
147420588|NCT00895154|531701734|FG000|Overall Study|Lost to Follow-up|1|||
147420589|NCT00895154|531701735|FG001|Overall Study|Lost to Follow-up|1|||
147420590|NCT00895154|531701734|FG000|Overall Study|Withdrawal by Subject|0|||
147420591|NCT00895154|531701735|FG001|Overall Study|Withdrawal by Subject|1|||
147420592|NCT00287690|531701736|FG000|Overall Study|Protocol Violation|20|||
147420593|NCT00287690|531701737|FG001|Overall Study|Protocol Violation|26|||
147420594|NCT01146782|531701738|FG000|Screening Cohort|Screen Failure|187|||
147420595|NCT01146782|531701738|FG000|Screening Cohort|Lost to Follow-up|4|||
147420596|NCT01146782|531701738|FG000|Screening Cohort|Physician Decision|1|||
147420597|NCT01146782|531701738|FG000|Screening Cohort|Withdrawal by Subject|29|||
147420598|NCT01146782|531701738|FG000|Safety Cohort|Screen Failure|61|||
147420599|NCT01146782|531701738|FG000|Safety Cohort|Withdrawal by Subject|4|||
147420600|NCT01146782|531701738|FG000|Safety Cohort|Control AHI <5|4|||
147420601|NCT01146782|531701738|FG000|Safety Cohort|TST <4 hrs|14|||
147420602|NCT01146782|531701738|FG000|Primary Endpoint Cohort|Withdrawal by Subject|5|||
147420603|NCT01146782|531701738|FG000|Primary Endpoint Cohort|Physician Decision|1|||
147420604|NCT00470366|531701739|FG000|Overall Study|Adverse Event|3|||
147420605|NCT00470366|531701739|FG000|Overall Study|Poor compliance|1|||
147420606|NCT02414932|531701740|FG000|Overall Study|Withdrawal by Subject|2|||
147420607|NCT02414932|531701741|FG001|Overall Study|Withdrawal by Subject|3|||
147420608|NCT02414932|531701740|FG000|Overall Study|Adverse Event|1|||
147420609|NCT02414932|531701741|FG001|Overall Study|Adverse Event|0|||
147420610|NCT00540046|531701742|FG000|Overall Study|Lost to Follow-up|33|||
147420611|NCT00540046|531701743|FG001|Overall Study|Lost to Follow-up|23|||
147420612|NCT01021215|531701746|FG000|Overall Study|Lost to Follow-up|3|||
147420613|NCT01021215|531701747|FG001|Overall Study|Lost to Follow-up|0|||
147420614|NCT00867308|531701756|FG000|Overall Study|Death|1|||
147420615|NCT00867308|531701757|FG001|Overall Study|Death|0|||
147420616|NCT00867308|531701756|FG000|Overall Study|Adverse Event|1|||
147420617|NCT00867308|531701757|FG001|Overall Study|Adverse Event|4|||
147420618|NCT00867308|531701756|FG000|Overall Study|Lack of Efficacy|6|||
147420619|NCT00867308|531701757|FG001|Overall Study|Lack of Efficacy|12|||
147420620|NCT00867308|531701756|FG000|Overall Study|Withdrawal by Subject|1|||
147420621|NCT00867308|531701757|FG001|Overall Study|Withdrawal by Subject|2|||
147420622|NCT00604825|531701758|FG000|Overall Study|Adverse Event|2|||
147420623|NCT00604825|531701759|FG001|Overall Study|Adverse Event|6|||
147420624|NCT00604825|531701760|FG002|Overall Study|Adverse Event|7|||
147420625|NCT00604825|531701761|FG003|Overall Study|Adverse Event|4|||
147420626|NCT00604825|531701758|FG000|Overall Study|Lost to Follow-up|0|||
147420627|NCT00604825|531701759|FG001|Overall Study|Lost to Follow-up|3|||
147420628|NCT00604825|531701760|FG002|Overall Study|Lost to Follow-up|1|||
147420629|NCT00604825|531701761|FG003|Overall Study|Lost to Follow-up|0|||
147420630|NCT00604825|531701758|FG000|Overall Study|Protocol Violation|0|||
147420631|NCT00604825|531701759|FG001|Overall Study|Protocol Violation|1|||
147420632|NCT00604825|531701760|FG002|Overall Study|Protocol Violation|0|||
147420633|NCT00604825|531701761|FG003|Overall Study|Protocol Violation|0|||
147420634|NCT00604825|531701758|FG000|Overall Study|Withdrawal by Subject|4|||
147420635|NCT00604825|531701759|FG001|Overall Study|Withdrawal by Subject|3|||
147420636|NCT00604825|531701760|FG002|Overall Study|Withdrawal by Subject|5|||
147420637|NCT00604825|531701761|FG003|Overall Study|Withdrawal by Subject|5|||
147420638|NCT00604825|531701758|FG000|Overall Study|Lack of Efficacy|3|||
147420639|NCT00604825|531701759|FG001|Overall Study|Lack of Efficacy|2|||
147420640|NCT00604825|531701760|FG002|Overall Study|Lack of Efficacy|1|||
147420641|NCT00604825|531701761|FG003|Overall Study|Lack of Efficacy|0|||
147420642|NCT00604825|531701758|FG000|Overall Study|Did not meet eligibility criteria|0|||
147420643|NCT00604825|531701759|FG001|Overall Study|Did not meet eligibility criteria|0|||
147420644|NCT00604825|531701760|FG002|Overall Study|Did not meet eligibility criteria|2|||
147420645|NCT00604825|531701761|FG003|Overall Study|Did not meet eligibility criteria|0|||
147420646|NCT00604825|531701758|FG000|Overall Study|Physician Decision|0|||
147420647|NCT00604825|531701759|FG001|Overall Study|Physician Decision|0|||
147420648|NCT00604825|531701760|FG002|Overall Study|Physician Decision|0|||
147420649|NCT00604825|531701761|FG003|Overall Study|Physician Decision|1|||
147420650|NCT00604825|531701758|FG000|Overall Study|Exclusion criterion met|0|||
147420651|NCT00604825|531701759|FG001|Overall Study|Exclusion criterion met|0|||
147420652|NCT00604825|531701760|FG002|Overall Study|Exclusion criterion met|0|||
147420653|NCT00604825|531701761|FG003|Overall Study|Exclusion criterion met|1|||
147420654|NCT05593445|531701762|FG000|12-Week DBVC Period|Adverse Event|1|||
147420655|NCT05593445|531701763|FG001|12-Week DBVC Period|Adverse Event|0|||
147420656|NCT05593445|531701764|FG002|12-Week DBVC Period|Adverse Event|0|||
147420657|NCT05593445|531701765|FG003|12-Week DBVC Period|Adverse Event|0|||
147420658|NCT05593445|531701762|FG000|12-Week DBVC Period|Physician Decision|0|||
147420659|NCT05593445|531701763|FG001|12-Week DBVC Period|Physician Decision|1|||
147420660|NCT05593445|531701764|FG002|12-Week DBVC Period|Physician Decision|0|||
147420661|NCT05593445|531701765|FG003|12-Week DBVC Period|Physician Decision|0|||
147420662|NCT05593445|531701762|FG000|12-Week DBVC Period|Protocol Violation|0|||
147420663|NCT05593445|531701763|FG001|12-Week DBVC Period|Protocol Violation|1|||
147420664|NCT05593445|531701764|FG002|12-Week DBVC Period|Protocol Violation|0|||
147420665|NCT05593445|531701765|FG003|12-Week DBVC Period|Protocol Violation|0|||
147420666|NCT05593445|531701762|FG000|12-Week DBVC Period|Withdrawal by Subject|0|||
147420667|NCT05593445|531701763|FG001|12-Week DBVC Period|Withdrawal by Subject|1|||
147420668|NCT05593445|531701764|FG002|12-Week DBVC Period|Withdrawal by Subject|0|||
147420669|NCT05593445|531701765|FG003|12-Week DBVC Period|Withdrawal by Subject|0|||
147420670|NCT05593445|531701762|FG000|12-Week DBVC Period|Did Not Meet Eligibility Criteria|1|||
147420671|NCT05593445|531701763|FG001|12-Week DBVC Period|Did Not Meet Eligibility Criteria|0|||
147420672|NCT05593445|531701764|FG002|12-Week DBVC Period|Did Not Meet Eligibility Criteria|0|||
147420673|NCT05593445|531701765|FG003|12-Week DBVC Period|Did Not Meet Eligibility Criteria|0|||
147420674|NCT05593445|531701762|FG000|12-Week Open-Label Extension Period|Adverse Event|0|||
147420675|NCT05593445|531701763|FG001|12-Week Open-Label Extension Period|Adverse Event|0|||
147420676|NCT05593445|531701764|FG002|12-Week Open-Label Extension Period|Adverse Event|1|||
147420677|NCT05593445|531701765|FG003|12-Week Open-Label Extension Period|Adverse Event|1|||
147420678|NCT05593445|531701762|FG000|12-Week Open-Label Extension Period|Lost to Follow-up|0|||
147420679|NCT05593445|531701763|FG001|12-Week Open-Label Extension Period|Lost to Follow-up|0|||
147420680|NCT05593445|531701764|FG002|12-Week Open-Label Extension Period|Lost to Follow-up|1|||
147420681|NCT05593445|531701765|FG003|12-Week Open-Label Extension Period|Lost to Follow-up|1|||
147420682|NCT05593445|531701762|FG000|12-Week Open-Label Extension Period|Withdrawal by Subject|0|||
147420683|NCT05593445|531701763|FG001|12-Week Open-Label Extension Period|Withdrawal by Subject|0|||
147420684|NCT05593445|531701764|FG002|12-Week Open-Label Extension Period|Withdrawal by Subject|1|||
147420685|NCT05593445|531701765|FG003|12-Week Open-Label Extension Period|Withdrawal by Subject|0|||
147420686|NCT03647488|531703697|FG000|Overall Study|Progressive disease|10|||
147420687|NCT03647488|531703698|FG001|Overall Study|Progressive disease|0|||
147420688|NCT03647488|531703699|FG002|Overall Study|Progressive disease|0|||
147420689|NCT03647488|531703697|FG000|Overall Study|Adverse Event|5|||
147420690|NCT03647488|531703698|FG001|Overall Study|Adverse Event|0|||
147420691|NCT03647488|531703699|FG002|Overall Study|Adverse Event|0|||
147420692|NCT03647488|531703697|FG000|Overall Study|Clinical progression|2|||
147420693|NCT03647488|531703698|FG001|Overall Study|Clinical progression|0|||
147420694|NCT03647488|531703699|FG002|Overall Study|Clinical progression|0|||
147420695|NCT03647488|531703697|FG000|Overall Study|Participant refused to take investigational product|1|||
147420696|NCT03647488|531703698|FG001|Overall Study|Participant refused to take investigational product|0|||
147420697|NCT03647488|531703699|FG002|Overall Study|Participant refused to take investigational product|0|||
147420698|NCT00812331|531703700|FG000|Overall Study|Adverse Event|1|||
147420699|NCT00812331|531703701|FG001|Overall Study|Adverse Event|0|||
147420700|NCT00812331|531703702|FG002|Overall Study|Adverse Event|0|||
147420701|NCT00812331|531703703|FG003|Overall Study|Adverse Event|0|||
147420702|NCT00812331|531703704|FG004|Overall Study|Adverse Event|0|||
147420703|NCT01506453|531703705|FG000|Overall Study|Withdrawal prior to treatment|0|||
147420704|NCT01506453|531703706|FG001|Overall Study|Withdrawal prior to treatment|2|||
147420705|NCT03694275|531703707|FG000|Overall Study|Adverse Event|0|||
147420706|NCT03694275|531703708|FG001|Overall Study|Adverse Event|1|||
147306600|NCT02917941|531288851|FG000|Survival Follow-up Period|Lost to Follow-up|1|||
147420707|NCT03694275|531703707|FG000|Overall Study|Reason not Specified|0|||
147420708|NCT03694275|531703708|FG001|Overall Study|Reason not Specified|1|||
147420709|NCT02502799|531703709|FG000|Phase 1: Brief Intervention Sessions|Lost to Follow-up|0|||
147420710|NCT02502799|531703710|FG001|Phase 1: Brief Intervention Sessions|Lost to Follow-up|0|||
147420711|NCT02502799|531703711|FG002|Phase 1: Brief Intervention Sessions|Lost to Follow-up|0|||
147420712|NCT02502799|531703712|FG003|Phase 1: Brief Intervention Sessions|Lost to Follow-up|12|||
147420713|NCT02502799|531703709|FG000|Phase 1: Brief Intervention Sessions|Early termination of study|0|||
147420714|NCT02502799|531703710|FG001|Phase 1: Brief Intervention Sessions|Early termination of study|0|||
147420715|NCT02502799|531703711|FG002|Phase 1: Brief Intervention Sessions|Early termination of study|0|||
147420716|NCT02502799|531703712|FG003|Phase 1: Brief Intervention Sessions|Early termination of study|5|||
147420717|NCT02502799|531703709|FG000|Phase 2: Intervention Phase|Lost to Follow-up|3|||
147420718|NCT02502799|531703710|FG001|Phase 2: Intervention Phase|Lost to Follow-up|4|||
147420719|NCT02502799|531703711|FG002|Phase 2: Intervention Phase|Lost to Follow-up|1|||
147420720|NCT02502799|531703712|FG003|Phase 2: Intervention Phase|Lost to Follow-up|0|||
147420721|NCT02502799|531703709|FG000|Phase 2: Intervention Phase|Withdrawal by Subject|3|||
147420722|NCT02502799|531703710|FG001|Phase 2: Intervention Phase|Withdrawal by Subject|2|||
147420723|NCT02502799|531703711|FG002|Phase 2: Intervention Phase|Withdrawal by Subject|3|||
147420724|NCT02502799|531703712|FG003|Phase 2: Intervention Phase|Withdrawal by Subject|0|||
147420725|NCT02502799|531703709|FG000|Phase 2: Intervention Phase|Study terminated prior to completion|4|||
147420726|NCT02502799|531703710|FG001|Phase 2: Intervention Phase|Study terminated prior to completion|5|||
147420727|NCT02502799|531703711|FG002|Phase 2: Intervention Phase|Study terminated prior to completion|5|||
147420728|NCT02502799|531703712|FG003|Phase 2: Intervention Phase|Study terminated prior to completion|0|||
147420729|NCT00153062|531703718|FG000|Overall Study|Death|360|||
147420730|NCT00153062|531703719|FG001|Overall Study|Death|352|||
147420731|NCT00153062|531703720|FG002|Overall Study|Death|369|||
147420732|NCT00153062|531703721|FG003|Overall Study|Death|365|||
147420733|NCT00153062|531703718|FG000|Overall Study|Withdrawal by Subject|14|||
147420734|NCT00153062|531703719|FG001|Overall Study|Withdrawal by Subject|30|||
147420735|NCT00153062|531703720|FG002|Overall Study|Withdrawal by Subject|27|||
147420736|NCT00153062|531703721|FG003|Overall Study|Withdrawal by Subject|28|||
147420737|NCT00153062|531703718|FG000|Overall Study|Lost to Follow-up|12|||
147420738|NCT00153062|531703719|FG001|Overall Study|Lost to Follow-up|20|||
147420739|NCT00153062|531703720|FG002|Overall Study|Lost to Follow-up|15|||
147420740|NCT00153062|531703721|FG003|Overall Study|Lost to Follow-up|16|||
147420741|NCT00153062|531703718|FG000|Overall Study|Adverse Event|0|||
147420742|NCT00153062|531703719|FG001|Overall Study|Adverse Event|1|||
147420743|NCT00153062|531703720|FG002|Overall Study|Adverse Event|1|||
147420744|NCT00153062|531703721|FG003|Overall Study|Adverse Event|0|||
147420745|NCT00153062|531703718|FG000|Overall Study|Protocol Violation|0|||
147420746|NCT00153062|531703719|FG001|Overall Study|Protocol Violation|2|||
147420747|NCT00153062|531703720|FG002|Overall Study|Protocol Violation|1|||
147420748|NCT00153062|531703721|FG003|Overall Study|Protocol Violation|1|||
147420749|NCT00153062|531703718|FG000|Overall Study|No disposition data available|1|||
147420750|NCT00153062|531703719|FG001|Overall Study|No disposition data available|1|||
147420751|NCT00153062|531703720|FG002|Overall Study|No disposition data available|1|||
147420752|NCT00153062|531703721|FG003|Overall Study|No disposition data available|1|||
147420753|NCT00153062|531703718|FG000|Overall Study|Other|0|||
147420754|NCT00153062|531703719|FG001|Overall Study|Other|0|||
147420755|NCT00153062|531703720|FG002|Overall Study|Other|1|||
147420756|NCT00153062|531703721|FG003|Overall Study|Other|0|||
147420757|NCT01589237|531703743|FG000|Part A (52 Weeks)|Subject/guardian decision|2|||
147420758|NCT01589237|531703744|FG001|Part A (52 Weeks)|Subject/guardian decision|3|||
147420759|NCT01589237|531703745|FG002|Part A (52 Weeks)|Subject/guardian decision|2|||
147420760|NCT01589237|531703746|FG003|Part A (52 Weeks)|Subject/guardian decision|0|||
147420761|NCT01589237|531703743|FG000|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|0|||
147420762|NCT01589237|531703744|FG001|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|1|||
147420763|NCT01589237|531703745|FG002|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|0|||
147420764|NCT01589237|531703746|FG003|Part B (Planned for 78 Week-terminated)|Subject/guardian decision|0|||
147420765|NCT01589237|531703743|FG000|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|5|||
147420766|NCT01589237|531703744|FG001|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|5|||
147420767|NCT01589237|531703745|FG002|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|4|||
147420768|NCT01589237|531703746|FG003|Part B (Planned for 78 Week-terminated)|Study terminated by sponsor|3|||
147420769|NCT01589237|531703743|FG000|Part B (Planned for 78 Week-terminated)|Physician Decision|0|||
147420770|NCT01589237|531703744|FG001|Part B (Planned for 78 Week-terminated)|Physician Decision|0|||
147420771|NCT01589237|531703745|FG002|Part B (Planned for 78 Week-terminated)|Physician Decision|0|||
147420772|NCT01589237|531703746|FG003|Part B (Planned for 78 Week-terminated)|Physician Decision|1|||
147420773|NCT01022268|531703748|FG000|Overall Study|Withdrawal by Subject|1|||
147420774|NCT01022268|531703749|FG001|Overall Study|Withdrawal by Subject|0|||
147420775|NCT01022268|531703748|FG000|Overall Study|Withdrawal by Subject|1|||
147420776|NCT01022268|531703749|FG001|Overall Study|Withdrawal by Subject|0|||
147420777|NCT00734097|531703750|FG000|Screening|Protocol Violation|12|||
147420778|NCT00734097|531703750|FG000|Screening|Withdrawal by Subject|5|||
147420779|NCT00734097|531703750|FG000|Screening|Lost to Follow-up|2|||
147420780|NCT00734097|531703750|FG000|Screening|Unconfirmed pregnancy|1|||
147420781|NCT00734097|531703750|FG000|Open Label|Lost to Follow-up|7|||
147420782|NCT00734097|531703750|FG000|Open Label|Withdrawal by Subject|5|||
147420783|NCT00734097|531703750|FG000|Open Label|Protocol Violation|4|||
147420784|NCT00910689|531703751|FG000|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|2|||
147420785|NCT00910689|531703752|FG001|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|1|||
147420786|NCT00910689|531703753|FG002|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|5|||
147420787|NCT00910689|531703754|FG003|Month 1: Optimal Acute Therapy Run in|No Post OAT Run-in data|10|||
147420788|NCT00910689|531703751|FG000|Month 2- 4: Treatment Period|Lost to Follow-up|3|||
147420789|NCT00910689|531703752|FG001|Month 2- 4: Treatment Period|Lost to Follow-up|4|||
147420790|NCT00910689|531703753|FG002|Month 2- 4: Treatment Period|Lost to Follow-up|1|||
147420791|NCT00910689|531703754|FG003|Month 2- 4: Treatment Period|Lost to Follow-up|3|||
147420792|NCT00910689|531703751|FG000|Month 2- 4: Treatment Period|Adverse Event|2|||
147420793|NCT00910689|531703752|FG001|Month 2- 4: Treatment Period|Adverse Event|3|||
147420794|NCT00910689|531703753|FG002|Month 2- 4: Treatment Period|Adverse Event|2|||
147420795|NCT00910689|531703754|FG003|Month 2- 4: Treatment Period|Adverse Event|0|||
147420796|NCT00910689|531703751|FG000|Month 2- 4: Treatment Period|Time Demands|1|||
147420797|NCT00910689|531703752|FG001|Month 2- 4: Treatment Period|Time Demands|0|||
147420798|NCT00910689|531703753|FG002|Month 2- 4: Treatment Period|Time Demands|4|||
147420799|NCT00910689|531703754|FG003|Month 2- 4: Treatment Period|Time Demands|8|||
147420800|NCT00910689|531703751|FG000|Month 2- 4: Treatment Period|Lack of Efficacy|2|||
147420801|NCT00910689|531703752|FG001|Month 2- 4: Treatment Period|Lack of Efficacy|1|||
147420802|NCT00910689|531703753|FG002|Month 2- 4: Treatment Period|Lack of Efficacy|0|||
147420803|NCT00910689|531703754|FG003|Month 2- 4: Treatment Period|Lack of Efficacy|0|||
147420804|NCT00910689|531703751|FG000|Month 2- 4: Treatment Period|Perceived Improvement|0|||
147420805|NCT00910689|531703752|FG001|Month 2- 4: Treatment Period|Perceived Improvement|0|||
147420806|NCT00910689|531703753|FG002|Month 2- 4: Treatment Period|Perceived Improvement|1|||
147420807|NCT00910689|531703754|FG003|Month 2- 4: Treatment Period|Perceived Improvement|0|||
147420808|NCT00910689|531703751|FG000|Month 2- 4: Treatment Period|Pregnancy|0|||
147420809|NCT00910689|531703752|FG001|Month 2- 4: Treatment Period|Pregnancy|2|||
147420810|NCT00910689|531703753|FG002|Month 2- 4: Treatment Period|Pregnancy|0|||
147420811|NCT00910689|531703754|FG003|Month 2- 4: Treatment Period|Pregnancy|0|||
147420812|NCT00910689|531703751|FG000|Month 2- 4: Treatment Period|Protocol Violation|1|||
147420813|NCT00910689|531703752|FG001|Month 2- 4: Treatment Period|Protocol Violation|0|||
147420814|NCT00910689|531703753|FG002|Month 2- 4: Treatment Period|Protocol Violation|0|||
147420815|NCT00910689|531703754|FG003|Month 2- 4: Treatment Period|Protocol Violation|0|||
147420816|NCT00910689|531703751|FG000|Months 5 - 10: Evaluation Period I|Lost to Follow-up|2|||
147420817|NCT00910689|531703752|FG001|Months 5 - 10: Evaluation Period I|Lost to Follow-up|5|||
147420818|NCT00910689|531703753|FG002|Months 5 - 10: Evaluation Period I|Lost to Follow-up|1|||
147420819|NCT00910689|531703754|FG003|Months 5 - 10: Evaluation Period I|Lost to Follow-up|1|||
147420820|NCT00910689|531703751|FG000|Months 5 - 10: Evaluation Period I|Adverse Event|1|||
147420821|NCT00910689|531703752|FG001|Months 5 - 10: Evaluation Period I|Adverse Event|0|||
147420822|NCT00910689|531703753|FG002|Months 5 - 10: Evaluation Period I|Adverse Event|2|||
147420823|NCT00910689|531703754|FG003|Months 5 - 10: Evaluation Period I|Adverse Event|4|||
147420824|NCT00910689|531703751|FG000|Months 5 - 10: Evaluation Period I|Lack of Efficacy|0|||
147420825|NCT00910689|531703752|FG001|Months 5 - 10: Evaluation Period I|Lack of Efficacy|1|||
147420826|NCT00910689|531703753|FG002|Months 5 - 10: Evaluation Period I|Lack of Efficacy|1|||
147420827|NCT00910689|531703754|FG003|Months 5 - 10: Evaluation Period I|Lack of Efficacy|1|||
147420828|NCT00910689|531703751|FG000|Months 5 - 10: Evaluation Period I|Protocol Violation|1|||
147420829|NCT00910689|531703752|FG001|Months 5 - 10: Evaluation Period I|Protocol Violation|1|||
147420830|NCT00910689|531703753|FG002|Months 5 - 10: Evaluation Period I|Protocol Violation|0|||
147420831|NCT00910689|531703754|FG003|Months 5 - 10: Evaluation Period I|Protocol Violation|0|||
147420832|NCT00910689|531703751|FG000|Months 5 - 10: Evaluation Period I|Pregnancy|0|||
147420833|NCT00910689|531703752|FG001|Months 5 - 10: Evaluation Period I|Pregnancy|0|||
147420834|NCT00910689|531703753|FG002|Months 5 - 10: Evaluation Period I|Pregnancy|2|||
147420835|NCT00910689|531703754|FG003|Months 5 - 10: Evaluation Period I|Pregnancy|0|||
147420836|NCT00910689|531703751|FG000|Months 5 - 10: Evaluation Period I|Time Demands|0|||
147420837|NCT00910689|531703752|FG001|Months 5 - 10: Evaluation Period I|Time Demands|0|||
147420838|NCT00910689|531703753|FG002|Months 5 - 10: Evaluation Period I|Time Demands|1|||
147420839|NCT00910689|531703754|FG003|Months 5 - 10: Evaluation Period I|Time Demands|1|||
147420840|NCT00910689|531703751|FG000|Months 11- 16: Evaluation Period II|Lost to Follow-up|3|||
147420841|NCT00910689|531703752|FG001|Months 11- 16: Evaluation Period II|Lost to Follow-up|0|||
147420842|NCT00910689|531703753|FG002|Months 11- 16: Evaluation Period II|Lost to Follow-up|1|||
147420843|NCT00910689|531703754|FG003|Months 11- 16: Evaluation Period II|Lost to Follow-up|2|||
147420844|NCT00910689|531703751|FG000|Months 11- 16: Evaluation Period II|Adverse Event|2|||
147420845|NCT00910689|531703752|FG001|Months 11- 16: Evaluation Period II|Adverse Event|4|||
147420846|NCT00910689|531703753|FG002|Months 11- 16: Evaluation Period II|Adverse Event|2|||
147420847|NCT00910689|531703754|FG003|Months 11- 16: Evaluation Period II|Adverse Event|2|||
147420848|NCT00910689|531703751|FG000|Months 11- 16: Evaluation Period II|Pregnancy|1|||
147420849|NCT00910689|531703752|FG001|Months 11- 16: Evaluation Period II|Pregnancy|0|||
147420850|NCT00910689|531703753|FG002|Months 11- 16: Evaluation Period II|Pregnancy|0|||
147420851|NCT00910689|531703754|FG003|Months 11- 16: Evaluation Period II|Pregnancy|0|||
147595929|NCT03096847|532338752|FG001|Overall Study|Death|0|||
147420852|NCT00910689|531703751|FG000|Months 11- 16: Evaluation Period II|Lack of Efficacy|2|||
147420853|NCT00910689|531703752|FG001|Months 11- 16: Evaluation Period II|Lack of Efficacy|3|||
147420854|NCT00910689|531703753|FG002|Months 11- 16: Evaluation Period II|Lack of Efficacy|3|||
147420855|NCT00910689|531703754|FG003|Months 11- 16: Evaluation Period II|Lack of Efficacy|1|||
147420856|NCT00910689|531703751|FG000|Months 11- 16: Evaluation Period II|Time Demands|2|||
147420857|NCT00910689|531703752|FG001|Months 11- 16: Evaluation Period II|Time Demands|1|||
147420858|NCT00910689|531703753|FG002|Months 11- 16: Evaluation Period II|Time Demands|0|||
147420859|NCT00910689|531703754|FG003|Months 11- 16: Evaluation Period II|Time Demands|0|||
147420860|NCT00910689|531703751|FG000|Months 11- 16: Evaluation Period II|Perceived Improvement|0|||
147420861|NCT00910689|531703752|FG001|Months 11- 16: Evaluation Period II|Perceived Improvement|0|||
147420862|NCT00910689|531703753|FG002|Months 11- 16: Evaluation Period II|Perceived Improvement|0|||
147420863|NCT00910689|531703754|FG003|Months 11- 16: Evaluation Period II|Perceived Improvement|1|||
147420864|NCT00910689|531703751|FG000|Months 11- 16: Evaluation Period II|Physician Decision|0|||
147420865|NCT00910689|531703752|FG001|Months 11- 16: Evaluation Period II|Physician Decision|2|||
147420866|NCT00910689|531703753|FG002|Months 11- 16: Evaluation Period II|Physician Decision|1|||
147420867|NCT00910689|531703754|FG003|Months 11- 16: Evaluation Period II|Physician Decision|0|||
147420868|NCT03207009|531703757|FG000|Overall Study|Withdrew consent prior to conditioning|1|||
147420869|NCT00645801|531703758|FG000|Overall Study|unclear if patient took all the medication.|1|||
147420870|NCT00645801|531703759|FG001|Overall Study|unclear if patient took all the medication.|0|||
147420871|NCT00645801|531703758|FG000|Overall Study|Lost to Follow-up|19|||
147420872|NCT00645801|531703759|FG001|Overall Study|Lost to Follow-up|15|||
147420873|NCT01403610|531703762|FG000|Overall Study|Withdrawal by Subject|2|||
147420874|NCT01403610|531703763|FG001|Overall Study|Withdrawal by Subject|0|||
147420875|NCT01403610|531703764|FG002|Overall Study|Withdrawal by Subject|0|||
147420876|NCT01403610|531703765|FG003|Overall Study|Withdrawal by Subject|0|||
147420877|NCT01403610|531703762|FG000|Overall Study|Didn't recover from surgery sufficiently|0|||
147420878|NCT01403610|531703763|FG001|Overall Study|Didn't recover from surgery sufficiently|3|||
147420879|NCT01403610|531703764|FG002|Overall Study|Didn't recover from surgery sufficiently|0|||
147420880|NCT01403610|531703765|FG003|Overall Study|Didn't recover from surgery sufficiently|0|||
147420881|NCT00203476|531703766|FG000|Overall Study|Lost to Follow-up|1|||
147420882|NCT00203476|531703767|FG001|Overall Study|Lost to Follow-up|0|||
147420883|NCT00203476|531703768|FG002|Overall Study|Lost to Follow-up|0|||
147420884|NCT00203476|531703766|FG000|Overall Study|Withdrawal by Subject|0|||
147420885|NCT00203476|531703767|FG001|Overall Study|Withdrawal by Subject|1|||
147420886|NCT00203476|531703768|FG002|Overall Study|Withdrawal by Subject|0|||
147420887|NCT01190514|531703769|FG000|First Intervention (Period 1)|Adverse Event|1|||
147420888|NCT01190514|531703770|FG001|First Intervention (Period 1)|Adverse Event|0|||
147420889|NCT01190514|531703771|FG002|First Intervention (Period 1)|Adverse Event|0|||
147420890|NCT01190514|531703772|FG003|First Intervention (Period 1)|Adverse Event|0|||
147646938|NCT01832818|532526250|FG000|Overall Study|Lost to Follow-up|6|||
147646939|NCT03209518|532526251|FG000|Overall Study|Case Report Forms Uncollected|1|||
147420891|NCT01190514|531703769|FG000|Third Intervention (Period 3)|Adverse Event|1|||
147420892|NCT01190514|531703770|FG001|Third Intervention (Period 3)|Adverse Event|0|||
147420893|NCT01190514|531703771|FG002|Third Intervention (Period 3)|Adverse Event|0|||
147420894|NCT01190514|531703772|FG003|Third Intervention (Period 3)|Adverse Event|0|||
147420895|NCT01775475|531703777|FG000|Overall Study|Death|3|||
147420896|NCT01775475|531703778|FG001|Overall Study|Death|3|||
147420897|NCT00896051|531703780|FG000|Overall Study|Adverse Event|2|||
147420898|NCT00896051|531703781|FG001|Overall Study|Adverse Event|1|||
147420899|NCT00896051|531703780|FG000|Overall Study|Lost to Follow-up|3|||
147420900|NCT00896051|531703781|FG001|Overall Study|Lost to Follow-up|2|||
147420901|NCT00896051|531703780|FG000|Overall Study|Withdrawal by Subject|3|||
147420902|NCT00896051|531703781|FG001|Overall Study|Withdrawal by Subject|2|||
147420903|NCT00896051|531703780|FG000|Overall Study|Subject noncompliant|1|||
147420904|NCT00896051|531703781|FG001|Overall Study|Subject noncompliant|3|||
147420905|NCT00896051|531703780|FG000|Overall Study|Other|1|||
147420906|NCT00896051|531703781|FG001|Overall Study|Other|1|||
147420907|NCT01813929|531703782|FG000|Overall Study|Withdrawal by Subject|0|||
147420908|NCT01813929|531703783|FG001|Overall Study|Withdrawal by Subject|1|||
147420909|NCT00007345|531703784|FG000|Overall Study|Refused further treatment|0|||
147646940|NCT03209518|532526251|FG000|Overall Study|Protocol Deviation|1|||
147646941|NCT00236899|532526252|FG000|Overall Study|Adverse Event (Study Related)|1|||
147646942|NCT00236899|532526253|FG001|Overall Study|Adverse Event (Study Related)|1|||
147646943|NCT00236899|532526254|FG002|Overall Study|Adverse Event (Study Related)|2|||
147646944|NCT00236899|532526255|FG003|Overall Study|Adverse Event (Study Related)|1|||
147646945|NCT00236899|532526252|FG000|Overall Study|Adverse Event (Not Study Related)|3|||
147420910|NCT00007345|531703785|FG001|Overall Study|Refused further treatment|7|||
147420911|NCT00007345|531703784|FG000|Overall Study|Switched to alternative treatment|0|||
147420912|NCT00007345|531703785|FG001|Overall Study|Switched to alternative treatment|3|||
147420913|NCT00007345|531703784|FG000|Overall Study|Intercurrent illness|1|||
147420914|NCT00007345|531703785|FG001|Overall Study|Intercurrent illness|0|||
147646946|NCT00236899|532526253|FG001|Overall Study|Adverse Event (Not Study Related)|3|||
147420915|NCT00007345|531703784|FG000|Overall Study|Death on study|1|||
147420916|NCT00007345|531703785|FG001|Overall Study|Death on study|1|||
147420917|NCT04433585|531703786|FG000|Overall Study|Withdrawal by Subject|15|||
147420918|NCT04433585|531703787|FG001|Overall Study|Withdrawal by Subject|3|||
147420919|NCT04433585|531703788|FG002|Overall Study|Withdrawal by Subject|15|||
147420920|NCT04433585|531703789|FG003|Overall Study|Withdrawal by Subject|6|||
147420921|NCT04433585|531703786|FG000|Overall Study|Adverse Event|10|||
147420922|NCT04433585|531703787|FG001|Overall Study|Adverse Event|4|||
147420923|NCT04433585|531703788|FG002|Overall Study|Adverse Event|1|||
147420924|NCT04433585|531703789|FG003|Overall Study|Adverse Event|0|||
147420925|NCT04433585|531703786|FG000|Overall Study|Due to the conflict in Ukraine|2|||
147420926|NCT04433585|531703787|FG001|Overall Study|Due to the conflict in Ukraine|1|||
147420927|NCT04433585|531703788|FG002|Overall Study|Due to the conflict in Ukraine|1|||
147420928|NCT04433585|531703789|FG003|Overall Study|Due to the conflict in Ukraine|2|||
147420929|NCT04433585|531703786|FG000|Overall Study|Physician Decision|1|||
147420930|NCT04433585|531703787|FG001|Overall Study|Physician Decision|2|||
147420931|NCT04433585|531703788|FG002|Overall Study|Physician Decision|0|||
147420932|NCT04433585|531703789|FG003|Overall Study|Physician Decision|0|||
147420933|NCT04433585|531703786|FG000|Overall Study|Lost to Follow-up|1|||
147420934|NCT04433585|531703787|FG001|Overall Study|Lost to Follow-up|1|||
147420935|NCT04433585|531703788|FG002|Overall Study|Lost to Follow-up|1|||
147420936|NCT04433585|531703789|FG003|Overall Study|Lost to Follow-up|0|||
147420937|NCT04433585|531703786|FG000|Overall Study|Lack of Efficacy|0|||
147420938|NCT04433585|531703787|FG001|Overall Study|Lack of Efficacy|1|||
147420939|NCT04433585|531703788|FG002|Overall Study|Lack of Efficacy|1|||
147420940|NCT04433585|531703789|FG003|Overall Study|Lack of Efficacy|1|||
147420941|NCT04433585|531703786|FG000|Overall Study|Death|0|||
147420942|NCT04433585|531703787|FG001|Overall Study|Death|1|||
147420943|NCT04433585|531703788|FG002|Overall Study|Death|0|||
147420944|NCT04433585|531703789|FG003|Overall Study|Death|0|||
147420945|NCT02074553|531703790|FG000|Intervention Period 1|Family Emergency|0|||
147420946|NCT02074553|531703791|FG001|Intervention Period 1|Family Emergency|0|||
147420947|NCT02074553|531703792|FG002|Intervention Period 1|Family Emergency|0|||
147420948|NCT02074553|531703793|FG003|Intervention Period 1|Family Emergency|1|||
147420949|NCT02074553|531703794|FG004|Intervention Period 1|Family Emergency|0|||
147420950|NCT02074553|531703795|FG005|Intervention Period 1|Family Emergency|0|||
147420951|NCT02074553|531703796|FG006|Intervention Period 1|Family Emergency|0|||
147420952|NCT02074553|531703797|FG007|Intervention Period 1|Family Emergency|0|||
147420953|NCT02074553|531703790|FG000|Washout Period 1|Adverse Event|1|||
147420954|NCT02074553|531703791|FG001|Washout Period 1|Adverse Event|0|||
147420955|NCT02074553|531703792|FG002|Washout Period 1|Adverse Event|0|||
147420956|NCT02074553|531703793|FG003|Washout Period 1|Adverse Event|0|||
147420957|NCT02074553|531703794|FG004|Washout Period 1|Adverse Event|0|||
147420958|NCT02074553|531703795|FG005|Washout Period 1|Adverse Event|0|||
147420959|NCT02074553|531703796|FG006|Washout Period 1|Adverse Event|0|||
147420960|NCT02074553|531703797|FG007|Washout Period 1|Adverse Event|0|||
147420961|NCT02074553|531703790|FG000|Washout Period 1|Physician Decision|0|||
147646947|NCT00236899|532526254|FG002|Overall Study|Adverse Event (Not Study Related)|4|||
147646948|NCT00236899|532526255|FG003|Overall Study|Adverse Event (Not Study Related)|7|||
147646949|NCT00236899|532526252|FG000|Overall Study|Death (Study Disease)|1|||
147646950|NCT00236899|532526253|FG001|Overall Study|Death (Study Disease)|4|||
147646951|NCT00236899|532526254|FG002|Overall Study|Death (Study Disease)|0|||
147646952|NCT00236899|532526255|FG003|Overall Study|Death (Study Disease)|0|||
147646953|NCT00236899|532526252|FG000|Overall Study|Death (Not Study Related)|2|||
147646954|NCT00236899|532526253|FG001|Overall Study|Death (Not Study Related)|0|||
147646955|NCT00236899|532526254|FG002|Overall Study|Death (Not Study Related)|0|||
147646956|NCT00236899|532526255|FG003|Overall Study|Death (Not Study Related)|0|||
147646957|NCT00236899|532526252|FG000|Overall Study|Death (Study Drug Toxicity)|1|||
147646958|NCT00236899|532526253|FG001|Overall Study|Death (Study Drug Toxicity)|0|||
147646959|NCT00236899|532526254|FG002|Overall Study|Death (Study Drug Toxicity)|0|||
147646960|NCT00236899|532526255|FG003|Overall Study|Death (Study Drug Toxicity)|0|||
147646961|NCT00236899|532526252|FG000|Overall Study|Lost to Follow-up|0|||
147646962|NCT00236899|532526253|FG001|Overall Study|Lost to Follow-up|1|||
147646963|NCT00236899|532526254|FG002|Overall Study|Lost to Follow-up|0|||
147646964|NCT00236899|532526255|FG003|Overall Study|Lost to Follow-up|0|||
147646965|NCT00236899|532526252|FG000|Overall Study|Entry Criteria Exclusion|0|||
147646966|NCT00236899|532526253|FG001|Overall Study|Entry Criteria Exclusion|1|||
147420962|NCT02074553|531703791|FG001|Washout Period 1|Physician Decision|0|||
147420963|NCT02074553|531703792|FG002|Washout Period 1|Physician Decision|0|||
147420964|NCT02074553|531703793|FG003|Washout Period 1|Physician Decision|1|||
147420965|NCT02074553|531703794|FG004|Washout Period 1|Physician Decision|0|||
147420966|NCT02074553|531703795|FG005|Washout Period 1|Physician Decision|0|||
147420967|NCT02074553|531703796|FG006|Washout Period 1|Physician Decision|0|||
147420968|NCT02074553|531703797|FG007|Washout Period 1|Physician Decision|0|||
147420969|NCT02074553|531703790|FG000|Washout Period 1|Other|0|||
147420970|NCT02074553|531703791|FG001|Washout Period 1|Other|0|||
147420971|NCT02074553|531703792|FG002|Washout Period 1|Other|0|||
147646967|NCT00236899|532526254|FG002|Overall Study|Entry Criteria Exclusion|1|||
147646968|NCT00236899|532526255|FG003|Overall Study|Entry Criteria Exclusion|0|||
147646969|NCT00236899|532526252|FG000|Overall Study|Protocol Violation|1|||
147646970|NCT00236899|532526253|FG001|Overall Study|Protocol Violation|0|||
147646971|NCT00236899|532526254|FG002|Overall Study|Protocol Violation|0|||
147646972|NCT00236899|532526255|FG003|Overall Study|Protocol Violation|0|||
147646973|NCT00236899|532526252|FG000|Overall Study|Withdrawal by Subject|6|||
147646974|NCT00236899|532526253|FG001|Overall Study|Withdrawal by Subject|4|||
147646975|NCT00236899|532526254|FG002|Overall Study|Withdrawal by Subject|5|||
147646976|NCT00236899|532526255|FG003|Overall Study|Withdrawal by Subject|2|||
147646977|NCT00236899|532526252|FG000|Overall Study|Physician Decision|7|||
147646978|NCT00236899|532526253|FG001|Overall Study|Physician Decision|8|||
147646979|NCT00236899|532526254|FG002|Overall Study|Physician Decision|7|||
147646980|NCT00236899|532526255|FG003|Overall Study|Physician Decision|6|||
147646981|NCT00236899|532526252|FG000|Overall Study|Satisfactory Response|2|||
147646982|NCT00236899|532526253|FG001|Overall Study|Satisfactory Response|0|||
147646983|NCT00236899|532526254|FG002|Overall Study|Satisfactory Response|0|||
147646984|NCT00236899|532526255|FG003|Overall Study|Satisfactory Response|1|||
147646985|NCT00236899|532526252|FG000|Overall Study|Lack of Efficacy|18|||
147646986|NCT00236899|532526253|FG001|Overall Study|Lack of Efficacy|18|||
147646987|NCT00236899|532526254|FG002|Overall Study|Lack of Efficacy|25|||
147646988|NCT00236899|532526255|FG003|Overall Study|Lack of Efficacy|23|||
147646989|NCT03013985|532526260|FG000|Overall Study|Protocol Violation|2|||
147646990|NCT03013985|532526261|FG001|Overall Study|Protocol Violation|2|||
147646991|NCT03013985|532526260|FG000|Overall Study|Withdrawal by Subject|14|||
147646992|NCT03013985|532526261|FG001|Overall Study|Withdrawal by Subject|17|||
147646993|NCT00791492|532526262|FG000|Overall Study|Withdrawal by Subject|1|||
147646994|NCT00791492|532526263|FG001|Overall Study|Withdrawal by Subject|2|||
147646995|NCT00791492|532526262|FG000|Overall Study|Liver transplantation|5|||
147646996|NCT00791492|532526263|FG001|Overall Study|Liver transplantation|1|||
147646997|NCT00076999|532526266|FG000|Overall Study|Adverse Event|2|||
147646998|NCT00076999|532526267|FG001|Overall Study|Adverse Event|8|||
147646999|NCT00076999|532526268|FG002|Overall Study|Adverse Event|6|||
147647000|NCT00076999|532526269|FG003|Overall Study|Adverse Event|0|||
147647001|NCT00076999|532526270|FG004|Overall Study|Adverse Event|2|||
147647002|NCT00076999|532526266|FG000|Overall Study|Protocol Violation|0|||
147647003|NCT00076999|532526267|FG001|Overall Study|Protocol Violation|3|||
147647004|NCT00076999|532526268|FG002|Overall Study|Protocol Violation|4|||
147647005|NCT00076999|532526269|FG003|Overall Study|Protocol Violation|0|||
147647006|NCT00076999|532526270|FG004|Overall Study|Protocol Violation|9|||
147647007|NCT00076999|532526266|FG000|Overall Study|Lost to Follow-up|2|||
147647008|NCT00076999|532526267|FG001|Overall Study|Lost to Follow-up|1|||
147647009|NCT00076999|532526268|FG002|Overall Study|Lost to Follow-up|0|||
147647010|NCT00076999|532526269|FG003|Overall Study|Lost to Follow-up|0|||
147647011|NCT00076999|532526270|FG004|Overall Study|Lost to Follow-up|0|||
147647012|NCT00076999|532526266|FG000|Overall Study|Withdrawal by Subject|0|||
147647013|NCT00076999|532526267|FG001|Overall Study|Withdrawal by Subject|4|||
147647014|NCT00076999|532526268|FG002|Overall Study|Withdrawal by Subject|3|||
147647015|NCT00076999|532526269|FG003|Overall Study|Withdrawal by Subject|0|||
147647016|NCT00076999|532526270|FG004|Overall Study|Withdrawal by Subject|1|||
147647017|NCT00076999|532526266|FG000|Overall Study|Other reason (not specified)|8|||
147647018|NCT00076999|532526267|FG001|Overall Study|Other reason (not specified)|8|||
147647019|NCT00076999|532526268|FG002|Overall Study|Other reason (not specified)|4|||
147647020|NCT00076999|532526269|FG003|Overall Study|Other reason (not specified)|1|||
147647021|NCT00076999|532526270|FG004|Overall Study|Other reason (not specified)|13|||
147647022|NCT01217385|532526273|FG000|Overall Study|Withdrawal by Subject|3|||
147647023|NCT01217385|532526273|FG000|Overall Study|DOSI not performed/not eval|12|||
147647024|NCT01217385|532526273|FG000|Overall Study|Central Path not Available|1|||
147647025|NCT01217385|532526273|FG000|Overall Study|Normal Breast TOI not available|10|||
147647026|NCT00090987|532526274|FG000|Overall Study|Adverse Event|5|||
147647027|NCT00090987|532526274|FG000|Overall Study|Lack of Efficacy|7|||
147647028|NCT00090987|532526274|FG000|Overall Study|Withdrawal by Subject|3|||
147647029|NCT00090987|532526274|FG000|Overall Study|alternative therapy|1|||
147647030|NCT00090987|532526274|FG000|Overall Study|Non-compliance|4|||
147647031|NCT00090987|532526274|FG000|Overall Study|Incarcerated|1|||
147647032|NCT00990665|532526275|FG000|Overall Study|Unsuccessful Implant|8|||
147647033|NCT00990665|532526275|FG000|Overall Study|Death|29|||
147647034|NCT00990665|532526275|FG000|Overall Study|Heart Transplant|1|||
147647035|NCT00990665|532526275|FG000|Overall Study|Withdrawal by Subject|6|||
147647036|NCT00990665|532526275|FG000|Overall Study|Lost to Follow-up|1|||
147647037|NCT00990665|532526275|FG000|Overall Study|System Explant|3|||
147647038|NCT02603562|532526276|FG000|Overall Study|Lost to Follow-up|1|||
147647039|NCT01534208|532526280|FG000|Overall Study|Lost to Follow-up|19|||
147647040|NCT01534208|532526281|FG001|Overall Study|Lost to Follow-up|14|||
147647041|NCT01534208|532526280|FG000|Overall Study|Withdrawal by Subject|6|||
147647042|NCT01534208|532526281|FG001|Overall Study|Withdrawal by Subject|20|||
147647043|NCT01534208|532526280|FG000|Overall Study|Adverse Event|15|||
147647044|NCT01534208|532526281|FG001|Overall Study|Adverse Event|8|||
147647045|NCT01534208|532526280|FG000|Overall Study|Physician Decision|2|||
147647046|NCT01534208|532526281|FG001|Overall Study|Physician Decision|0|||
147647047|NCT01534208|532526280|FG000|Overall Study|Lack of Efficacy|0|||
147647048|NCT01534208|532526281|FG001|Overall Study|Lack of Efficacy|3|||
147647049|NCT01534208|532526280|FG000|Overall Study|Protocol Violation|2|||
147647050|NCT01534208|532526281|FG001|Overall Study|Protocol Violation|2|||
147647051|NCT01534208|532526280|FG000|Overall Study|Sponsor decision|4|||
147647052|NCT01534208|532526281|FG001|Overall Study|Sponsor decision|1|||
147647053|NCT01534208|532526280|FG000|Overall Study|Subject relocation|2|||
147647054|NCT01534208|532526281|FG001|Overall Study|Subject relocation|0|||
147647055|NCT01534208|532526280|FG000|Overall Study|Lab assessment|2|||
147647056|NCT01534208|532526281|FG001|Overall Study|Lab assessment|1|||
147647057|NCT01534208|532526280|FG000|Overall Study|Eligibility error|3|||
147647058|NCT01534208|532526281|FG001|Overall Study|Eligibility error|0|||
147647059|NCT01534208|532526280|FG000|Overall Study|PCP decision|1|||
147647060|NCT01534208|532526281|FG001|Overall Study|PCP decision|0|||
147647061|NCT01534208|532526280|FG000|Overall Study|Needed prohibited meds|1|||
147647062|NCT01534208|532526281|FG001|Overall Study|Needed prohibited meds|0|||
147647063|NCT03578146|532526284|FG000|Overall Study|Did Not Receive Treatment|1|||
147647064|NCT03578146|532526285|FG001|Overall Study|Did Not Receive Treatment|0|||
147647065|NCT03578146|532526286|FG002|Overall Study|Did Not Receive Treatment|0|||
147647066|NCT03578146|532526287|FG003|Overall Study|Did Not Receive Treatment|0|||
147647067|NCT03578146|532526288|FG004|Overall Study|Did Not Receive Treatment|0|||
147647068|NCT03578146|532526289|FG005|Overall Study|Did Not Receive Treatment|2|||
147647069|NCT03578146|532526284|FG000|Overall Study|Lost to Follow-up|0|||
147647070|NCT03578146|532526285|FG001|Overall Study|Lost to Follow-up|1|||
147647071|NCT03578146|532526286|FG002|Overall Study|Lost to Follow-up|1|||
147647072|NCT03578146|532526287|FG003|Overall Study|Lost to Follow-up|0|||
147647073|NCT03578146|532526288|FG004|Overall Study|Lost to Follow-up|0|||
147647074|NCT03578146|532526289|FG005|Overall Study|Lost to Follow-up|1|||
147647075|NCT03959488|532528054|FG000|Season 1|Other|6|||
147647076|NCT03959488|532528055|FG001|Season 1|Other|7|||
147647077|NCT03959488|532528056|FG002|Season 1|Other|0|||
147647078|NCT03959488|532528057|FG003|Season 1|Other|0|||
147647079|NCT03959488|532528058|FG004|Season 1|Other|0|||
147647080|NCT03959488|532528054|FG000|Season 1|Withdrawal by parent/guardian|43|||
147647081|NCT03959488|532528055|FG001|Season 1|Withdrawal by parent/guardian|28|||
147647082|NCT03959488|532528056|FG002|Season 1|Withdrawal by parent/guardian|0|||
147647083|NCT03959488|532528057|FG003|Season 1|Withdrawal by parent/guardian|0|||
147647084|NCT03959488|532528058|FG004|Season 1|Withdrawal by parent/guardian|0|||
147647085|NCT03959488|532528054|FG000|Season 1|Due to COVID-19 pandemic|2|||
147647086|NCT03959488|532528055|FG001|Season 1|Due to COVID-19 pandemic|3|||
147647087|NCT03959488|532528056|FG002|Season 1|Due to COVID-19 pandemic|0|||
147647088|NCT03959488|532528057|FG003|Season 1|Due to COVID-19 pandemic|0|||
147647089|NCT03959488|532528058|FG004|Season 1|Due to COVID-19 pandemic|0|||
147647090|NCT03959488|532528054|FG000|Season 1|Lost to Follow-up|17|||
147647091|NCT03959488|532528055|FG001|Season 1|Lost to Follow-up|7|||
147647092|NCT03959488|532528056|FG002|Season 1|Lost to Follow-up|0|||
147647093|NCT03959488|532528057|FG003|Season 1|Lost to Follow-up|0|||
147647094|NCT03959488|532528058|FG004|Season 1|Lost to Follow-up|0|||
147647095|NCT03959488|532528054|FG000|Season 1|Death|5|||
147420972|NCT02074553|531703793|FG003|Washout Period 1|Other|0|||
147420973|NCT02074553|531703794|FG004|Washout Period 1|Other|0|||
147420974|NCT02074553|531703795|FG005|Washout Period 1|Other|1|||
147420975|NCT02074553|531703796|FG006|Washout Period 1|Other|0|||
147420976|NCT02074553|531703797|FG007|Washout Period 1|Other|0|||
147420977|NCT02074553|531703790|FG000|Washout Period 2|Adverse Event|0|||
147420978|NCT02074553|531703791|FG001|Washout Period 2|Adverse Event|0|||
147420979|NCT02074553|531703792|FG002|Washout Period 2|Adverse Event|0|||
147647096|NCT03959488|532528055|FG001|Season 1|Death|1|||
147647097|NCT03959488|532528056|FG002|Season 1|Death|0|||
147647098|NCT03959488|532528057|FG003|Season 1|Death|0|||
147420980|NCT02074553|531703793|FG003|Washout Period 2|Adverse Event|0|||
147647099|NCT03959488|532528058|FG004|Season 1|Death|0|||
147647100|NCT03959488|532528054|FG000|Season 2|Other|0|||
147647101|NCT03959488|532528055|FG001|Season 2|Other|0|||
147647102|NCT03959488|532528056|FG002|Season 2|Other|2|||
147647103|NCT03959488|532528057|FG003|Season 2|Other|0|||
147420981|NCT02074553|531703794|FG004|Washout Period 2|Adverse Event|0|||
147420982|NCT02074553|531703795|FG005|Washout Period 2|Adverse Event|0|||
147420983|NCT02074553|531703796|FG006|Washout Period 2|Adverse Event|1|||
147647104|NCT03959488|532528058|FG004|Season 2|Other|0|||
147647105|NCT03959488|532528054|FG000|Season 2|Withdrawal by parent/guardian|0|||
147647106|NCT03959488|532528055|FG001|Season 2|Withdrawal by parent/guardian|0|||
147647107|NCT03959488|532528056|FG002|Season 2|Withdrawal by parent/guardian|3|||
147647108|NCT03959488|532528057|FG003|Season 2|Withdrawal by parent/guardian|1|||
147647109|NCT03959488|532528058|FG004|Season 2|Withdrawal by parent/guardian|1|||
147647110|NCT03959488|532528054|FG000|Season 2|Lost to Follow-up|0|||
147647111|NCT03959488|532528055|FG001|Season 2|Lost to Follow-up|0|||
147647112|NCT03959488|532528056|FG002|Season 2|Lost to Follow-up|1|||
147647113|NCT03959488|532528057|FG003|Season 2|Lost to Follow-up|0|||
147647114|NCT03959488|532528058|FG004|Season 2|Lost to Follow-up|1|||
147647115|NCT01211483|532528061|FG000|Phase 1b|Death|6|||
147647116|NCT01211483|532528062|FG001|Phase 1b|Death|0|||
147420984|NCT02074553|531703797|FG007|Washout Period 2|Adverse Event|0|||
147420985|NCT02074553|531703790|FG000|Washout Period 2|Physician Decision|0|||
147420986|NCT02074553|531703791|FG001|Washout Period 2|Physician Decision|0|||
147420987|NCT02074553|531703792|FG002|Washout Period 2|Physician Decision|0|||
147647117|NCT01211483|532528063|FG002|Phase 1b|Death|0|||
147647118|NCT01211483|532528064|FG003|Phase 1b|Death|0|||
147647119|NCT01211483|532528061|FG000|Phase 1b|Withdrawal by Subject|1|||
147420988|NCT02074553|531703793|FG003|Washout Period 2|Physician Decision|0|||
147420989|NCT02074553|531703794|FG004|Washout Period 2|Physician Decision|0|||
147420990|NCT02074553|531703795|FG005|Washout Period 2|Physician Decision|1|||
147420991|NCT02074553|531703796|FG006|Washout Period 2|Physician Decision|0|||
147420992|NCT02074553|531703797|FG007|Washout Period 2|Physician Decision|0|||
147420993|NCT02074553|531703790|FG000|Washout Period 2|Lost to Follow-up|0|||
147420994|NCT02074553|531703791|FG001|Washout Period 2|Lost to Follow-up|0|||
147420995|NCT02074553|531703792|FG002|Washout Period 2|Lost to Follow-up|1|||
147420996|NCT02074553|531703793|FG003|Washout Period 2|Lost to Follow-up|0|||
147420997|NCT02074553|531703794|FG004|Washout Period 2|Lost to Follow-up|0|||
147420998|NCT02074553|531703795|FG005|Washout Period 2|Lost to Follow-up|0|||
147420999|NCT02074553|531703796|FG006|Washout Period 2|Lost to Follow-up|0|||
147421000|NCT02074553|531703797|FG007|Washout Period 2|Lost to Follow-up|0|||
147421001|NCT02074553|531703790|FG000|Washout Period 3|Physician Decision|0|||
147421002|NCT02074553|531703791|FG001|Washout Period 3|Physician Decision|0|||
147421003|NCT02074553|531703792|FG002|Washout Period 3|Physician Decision|0|||
147421004|NCT02074553|531703793|FG003|Washout Period 3|Physician Decision|0|||
147421005|NCT02074553|531703794|FG004|Washout Period 3|Physician Decision|0|||
147421006|NCT02074553|531703795|FG005|Washout Period 3|Physician Decision|0|||
147421007|NCT02074553|531703796|FG006|Washout Period 3|Physician Decision|0|||
147421008|NCT02074553|531703797|FG007|Washout Period 3|Physician Decision|1|||
147421009|NCT00194987|531703798|FG000|Overall Study|Withdrawal by Subject|0|||
147421010|NCT00194987|531703799|FG001|Overall Study|Withdrawal by Subject|3|||
147421011|NCT02342743|531703800|FG000|Baseline Period|Withdrawal by Subject|3|||
147421012|NCT02342743|531703800|FG000|Baseline Period|Lost to Follow-up|2|||
147421013|NCT02342743|531703800|FG000|Baseline Period|Change in prophylactic medication|3|||
147421014|NCT02342743|531703800|FG000|Baseline Period|Screening failure regarding baseline|7|||
147421015|NCT02342743|531703800|FG000|Treatment Period|Withdrawal by Subject|2|||
147421016|NCT02342743|531703800|FG000|Treatment Period|Lost to Follow-up|8|||
147421017|NCT02342743|531703800|FG000|Treatment Period|Change in prophylactic medication|1|||
147421018|NCT04875676|531703801|FG000|Overall Study|Lost to Follow-up|1|||
147421019|NCT04875676|531703802|FG001|Overall Study|Lost to Follow-up|0|||
147421020|NCT04875676|531703803|FG002|Overall Study|Lost to Follow-up|0|||
147421021|NCT01970345|531703806|FG000|First Treatment Phase 12 Weeks|Withdrawal by Subject|1|||
147421022|NCT01970345|531703807|FG001|First Treatment Phase 12 Weeks|Withdrawal by Subject|1|||
147421023|NCT01970345|531703806|FG000|Second Treatment Phase 12 Weeks|Withdrawal by Subject|0|||
147421024|NCT01970345|531703807|FG001|Second Treatment Phase 12 Weeks|Withdrawal by Subject|1|||
147421025|NCT04797650|531703813|FG000|Overall Study|Reason Not Specified|5|||
147421026|NCT04797650|531703814|FG001|Overall Study|Reason Not Specified|12|||
147421027|NCT04797650|531703815|FG002|Overall Study|Reason Not Specified|5|||
147421028|NCT04797650|531703813|FG000|Overall Study|Treatment Emergent or Worsening Adverse Event|1|||
147421029|NCT04797650|531703814|FG001|Overall Study|Treatment Emergent or Worsening Adverse Event|7|||
147421030|NCT04797650|531703815|FG002|Overall Study|Treatment Emergent or Worsening Adverse Event|0|||
147421031|NCT04797650|531703813|FG000|Overall Study|Lack of Efficacy|1|||
147647120|NCT01211483|532528062|FG001|Phase 1b|Withdrawal by Subject|0|||
147647121|NCT01211483|532528063|FG002|Phase 1b|Withdrawal by Subject|0|||
147647122|NCT01211483|532528064|FG003|Phase 1b|Withdrawal by Subject|0|||
147647123|NCT01211483|532528061|FG000|Phase 2|Lost to Follow-up|0|||
147647124|NCT01211483|532528062|FG001|Phase 2|Lost to Follow-up|1|||
147647125|NCT01211483|532528063|FG002|Phase 2|Lost to Follow-up|1|||
147647126|NCT01211483|532528064|FG003|Phase 2|Lost to Follow-up|2|||
147647127|NCT01211483|532528061|FG000|Phase 2|Death|0|||
147647128|NCT01211483|532528062|FG001|Phase 2|Death|64|||
147647129|NCT01211483|532528063|FG002|Phase 2|Death|53|||
147647130|NCT01211483|532528064|FG003|Phase 2|Death|53|||
147647131|NCT01211483|532528061|FG000|Phase 2|Withdrawal by Subject|0|||
147647132|NCT01211483|532528062|FG001|Phase 2|Withdrawal by Subject|1|||
147647133|NCT01211483|532528063|FG002|Phase 2|Withdrawal by Subject|10|||
147421032|NCT04797650|531703814|FG001|Overall Study|Lack of Efficacy|0|||
147421033|NCT04797650|531703815|FG002|Overall Study|Lack of Efficacy|1|||
147421034|NCT04797650|531703813|FG000|Overall Study|Non-compliance with Study Drug|0|||
147421035|NCT04797650|531703814|FG001|Overall Study|Non-compliance with Study Drug|0|||
147595930|NCT03096847|532338753|FG002|Overall Study|Death|2|||
147647134|NCT01211483|532528064|FG003|Phase 2|Withdrawal by Subject|5|||
147647135|NCT01211483|532528061|FG000|Phase 2|Study terminated by Sponsor|0|||
147647136|NCT01211483|532528062|FG001|Phase 2|Study terminated by Sponsor|6|||
147647137|NCT01211483|532528063|FG002|Phase 2|Study terminated by Sponsor|8|||
147647138|NCT01211483|532528064|FG003|Phase 2|Study terminated by Sponsor|11|||
147647139|NCT02284568|532528065|FG000|Overall Study|Adverse Event|2|||
147647140|NCT02284568|532528066|FG001|Overall Study|Adverse Event|9|||
147647141|NCT02284568|532528067|FG002|Overall Study|Adverse Event|4|||
147647142|NCT02284568|532528065|FG000|Overall Study|Withdrawal by Subject|22|||
147647143|NCT02284568|532528066|FG001|Overall Study|Withdrawal by Subject|21|||
147647144|NCT02284568|532528067|FG002|Overall Study|Withdrawal by Subject|1|||
147647145|NCT02284568|532528065|FG000|Overall Study|Noncompliance with study drug admin|1|||
147647146|NCT02284568|532528066|FG001|Overall Study|Noncompliance with study drug admin|2|||
147647147|NCT02284568|532528067|FG002|Overall Study|Noncompliance with study drug admin|0|||
147647148|NCT02284568|532528065|FG000|Overall Study|Noncompliance|1|||
147647149|NCT02284568|532528066|FG001|Overall Study|Noncompliance|0|||
147647150|NCT02284568|532528067|FG002|Overall Study|Noncompliance|0|||
147647151|NCT02284568|532528065|FG000|Overall Study|Protocol Violation|0|||
147647152|NCT02284568|532528066|FG001|Overall Study|Protocol Violation|1|||
147647153|NCT02284568|532528067|FG002|Overall Study|Protocol Violation|0|||
147647154|NCT02284568|532528065|FG000|Overall Study|Sponsor requested patient stop treatment|0|||
147647155|NCT02284568|532528066|FG001|Overall Study|Sponsor requested patient stop treatment|0|||
147647156|NCT02284568|532528067|FG002|Overall Study|Sponsor requested patient stop treatment|90|||
147647157|NCT02284568|532528065|FG000|Overall Study|Lost to Follow-up|0|||
147647158|NCT02284568|532528066|FG001|Overall Study|Lost to Follow-up|3|||
147647159|NCT02284568|532528067|FG002|Overall Study|Lost to Follow-up|0|||
147647160|NCT02284568|532528065|FG000|Overall Study|Lack of Efficacy|4|||
147647161|NCT02284568|532528066|FG001|Overall Study|Lack of Efficacy|7|||
147647162|NCT02284568|532528067|FG002|Overall Study|Lack of Efficacy|0|||
147647163|NCT02284568|532528065|FG000|Overall Study|Other|1|||
147647164|NCT02284568|532528066|FG001|Overall Study|Other|2|||
147647165|NCT02284568|532528067|FG002|Overall Study|Other|0|||
147647166|NCT02284568|532528065|FG000|Overall Study|Withdrew before taking study drug|0|||
147647167|NCT02284568|532528066|FG001|Overall Study|Withdrew before taking study drug|1|||
147647168|NCT02284568|532528067|FG002|Overall Study|Withdrew before taking study drug|0|||
147647169|NCT00460265|532528068|FG000|Overall Study|Lost to Follow-up|14|||
147647170|NCT00460265|532528069|FG001|Overall Study|Lost to Follow-up|15|||
147647171|NCT00460265|532528068|FG000|Overall Study|Physician Decision|1|||
147647172|NCT00460265|532528069|FG001|Overall Study|Physician Decision|2|||
147647173|NCT00460265|532528068|FG000|Overall Study|Withdrawal by Subject|10|||
147647174|NCT00460265|532528069|FG001|Overall Study|Withdrawal by Subject|25|||
147647175|NCT00460265|532528068|FG000|Overall Study|Ongoing|60|||
147421036|NCT04797650|531703815|FG002|Overall Study|Non-compliance with Study Drug|2|||
147421037|NCT04797650|531703813|FG000|Overall Study|Lost to Follow-up|4|||
147421038|NCT04797650|531703814|FG001|Overall Study|Lost to Follow-up|6|||
147421039|NCT04797650|531703815|FG002|Overall Study|Lost to Follow-up|1|||
147421040|NCT00822172|531703822|FG000|Overall Study|Adverse Event|10|||
147421041|NCT00822172|531703823|FG001|Overall Study|Adverse Event|12|||
147421042|NCT00822172|531703822|FG000|Overall Study|Death|1|||
147421043|NCT00822172|531703823|FG001|Overall Study|Death|0|||
147421044|NCT00822172|531703822|FG000|Overall Study|Lost to Follow-up|3|||
147421045|NCT00822172|531703823|FG001|Overall Study|Lost to Follow-up|1|||
147421046|NCT00822172|531703822|FG000|Overall Study|Withdrawal by Subject|1|||
147421047|NCT00822172|531703823|FG001|Overall Study|Withdrawal by Subject|4|||
147421048|NCT00822172|531703822|FG000|Overall Study|site closed|0|||
147421049|NCT00822172|531703823|FG001|Overall Study|site closed|1|||
147421050|NCT00822172|531703822|FG000|Overall Study|Other|0|||
147421051|NCT00822172|531703823|FG001|Overall Study|Other|1|||
147421052|NCT00700258|531703824|FG000|Overall Study|Premature discontinuation of documentation|136|||
147421053|NCT00700258|531703824|FG000|Overall Study|Type of study end not documented|1|||
147421054|NCT00700258|531703824|FG000|Overall Study|Lost to Follow-up|81|||
147421055|NCT00700258|531703824|FG000|Overall Study|Premature discontinuation of therapy|1013|||
147421056|NCT00473265|531703825|FG000|Overall Study|Unrelated adverse event|5|||
147421057|NCT00473265|531703825|FG000|Overall Study|Off treatment early|15|||
147421058|NCT01156792|531703826|FG000|Overall Study|Adverse Event|1|||
147421059|NCT01156792|531703826|FG000|Overall Study|Lack of Efficacy|36|||
147421060|NCT01156792|531703826|FG000|Overall Study|Protocol Violation|6|||
147421061|NCT01156792|531703826|FG000|Overall Study|Lost to Follow-up|3|||
147421062|NCT01156792|531703826|FG000|Overall Study|Physician Decision|3|||
147421063|NCT01156792|531703826|FG000|Overall Study|Withdrawal by Subject|9|||
147421064|NCT01156792|531703826|FG000|Overall Study|other Sponsor Decision (Protocol Amendme|11|||
147421065|NCT01097707|531703827|FG000|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
147421066|NCT01097707|531703828|FG001|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
147647176|NCT00460265|532528069|FG001|Overall Study|Ongoing|47|||
147647177|NCT00904839|532528072|FG000|Overall Study|Adverse Event|0|||
147647178|NCT00904839|532528073|FG001|Overall Study|Adverse Event|5|||
147647179|NCT00904839|532528074|FG002|Overall Study|Adverse Event|4|||
147647180|NCT00904839|532528072|FG000|Overall Study|Protocol Violation|0|||
147647181|NCT00904839|532528073|FG001|Overall Study|Protocol Violation|1|||
147647182|NCT00904839|532528074|FG002|Overall Study|Protocol Violation|1|||
147647183|NCT00904839|532528072|FG000|Overall Study|Lost to Follow-up|0|||
147647184|NCT00904839|532528073|FG001|Overall Study|Lost to Follow-up|1|||
147647185|NCT00904839|532528074|FG002|Overall Study|Lost to Follow-up|2|||
147647186|NCT00904839|532528072|FG000|Overall Study|Withdrawal by Subject|0|||
147647187|NCT00904839|532528073|FG001|Overall Study|Withdrawal by Subject|2|||
147421067|NCT01097707|531703829|FG002|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
147421068|NCT01097707|531703830|FG003|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
147421069|NCT01097707|531703831|FG004|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
147421070|NCT01097707|531703827|FG000|Overall Study|Adverse Event|4|||
147421071|NCT01097707|531703828|FG001|Overall Study|Adverse Event|2|||
147421072|NCT01097707|531703829|FG002|Overall Study|Adverse Event|3|||
147421073|NCT01097707|531703830|FG003|Overall Study|Adverse Event|1|||
147421074|NCT01097707|531703831|FG004|Overall Study|Adverse Event|3|||
147421075|NCT01097707|531703827|FG000|Overall Study|Entry Criteria Not Met|2|||
147421076|NCT01097707|531703828|FG001|Overall Study|Entry Criteria Not Met|1|||
147421077|NCT01097707|531703829|FG002|Overall Study|Entry Criteria Not Met|1|||
147421078|NCT01097707|531703830|FG003|Overall Study|Entry Criteria Not Met|0|||
147421079|NCT01097707|531703831|FG004|Overall Study|Entry Criteria Not Met|1|||
147421080|NCT01097707|531703827|FG000|Overall Study|Lack of Efficacy|1|||
147421081|NCT01097707|531703828|FG001|Overall Study|Lack of Efficacy|0|||
147421082|NCT01097707|531703829|FG002|Overall Study|Lack of Efficacy|0|||
147421083|NCT01097707|531703830|FG003|Overall Study|Lack of Efficacy|1|||
147421084|NCT01097707|531703831|FG004|Overall Study|Lack of Efficacy|0|||
147421085|NCT01097707|531703827|FG000|Overall Study|Lost to Follow-up|1|||
147421086|NCT01097707|531703828|FG001|Overall Study|Lost to Follow-up|1|||
147421087|NCT01097707|531703829|FG002|Overall Study|Lost to Follow-up|2|||
147421088|NCT01097707|531703830|FG003|Overall Study|Lost to Follow-up|0|||
147421089|NCT01097707|531703831|FG004|Overall Study|Lost to Follow-up|3|||
147421090|NCT01097707|531703827|FG000|Overall Study|Protocol Violation|2|||
147421091|NCT01097707|531703828|FG001|Overall Study|Protocol Violation|2|||
147421092|NCT01097707|531703829|FG002|Overall Study|Protocol Violation|3|||
147421093|NCT01097707|531703830|FG003|Overall Study|Protocol Violation|2|||
147421094|NCT01097707|531703831|FG004|Overall Study|Protocol Violation|2|||
147421095|NCT01097707|531703827|FG000|Overall Study|Sponsor Decision|31|||
147421096|NCT01097707|531703828|FG001|Overall Study|Sponsor Decision|31|||
147421097|NCT01097707|531703829|FG002|Overall Study|Sponsor Decision|34|||
147421098|NCT01097707|531703830|FG003|Overall Study|Sponsor Decision|35|||
147421099|NCT01097707|531703831|FG004|Overall Study|Sponsor Decision|36|||
147421100|NCT01097707|531703827|FG000|Overall Study|Withdrawal by Subject|3|||
147421101|NCT01097707|531703828|FG001|Overall Study|Withdrawal by Subject|6|||
147421102|NCT01097707|531703829|FG002|Overall Study|Withdrawal by Subject|1|||
147421103|NCT01097707|531703830|FG003|Overall Study|Withdrawal by Subject|4|||
147421104|NCT01097707|531703831|FG004|Overall Study|Withdrawal by Subject|3|||
147421105|NCT01097707|531703827|FG000|Overall Study|Reason unknown|0|||
147421106|NCT01097707|531703828|FG001|Overall Study|Reason unknown|0|||
147421107|NCT01097707|531703829|FG002|Overall Study|Reason unknown|0|||
147421108|NCT01097707|531703830|FG003|Overall Study|Reason unknown|0|||
147421109|NCT01097707|531703831|FG004|Overall Study|Reason unknown|1|||
147421110|NCT01236534|531703832|FG000|Overall Study|Adverse Event|3|||
147421111|NCT01236534|531703833|FG001|Overall Study|Adverse Event|0|||
147421112|NCT03775434|531703835|FG000|Overall Study|Adverse Event|2|||
147421113|NCT03775434|531703835|FG000|Overall Study|Withdrawal by Subject|1|||
147421114|NCT01621568|531703836|FG000|Week 5-6 No Treatment|Participant deemed ineligible and was taken off study. Did not receive treatment.|1|||
147421115|NCT01621568|531703837|FG001|Week 5-6 No Treatment|Participant deemed ineligible and was taken off study. Did not receive treatment.|0|||
147421116|NCT01621568|531703836|FG000|Week 5-6 No Treatment|Death|1|||
147421117|NCT01621568|531703837|FG001|Week 5-6 No Treatment|Death|0|||
147421118|NCT01859988|531703838|FG000|Overall Study|Withdrawal by Subject|6|||
147421119|NCT01859988|531703839|FG001|Overall Study|Withdrawal by Subject|3|||
147421120|NCT01859988|531703840|FG002|Overall Study|Withdrawal by Subject|4|||
147421121|NCT01859988|531703841|FG003|Overall Study|Withdrawal by Subject|3|||
147421122|NCT01859988|531703842|FG004|Overall Study|Withdrawal by Subject|2|||
147421123|NCT01859988|531703843|FG005|Overall Study|Withdrawal by Subject|2|||
147421124|NCT01859988|531703838|FG000|Overall Study|Lack of Efficacy|1|||
147421125|NCT01859988|531703839|FG001|Overall Study|Lack of Efficacy|1|||
147421126|NCT01859988|531703840|FG002|Overall Study|Lack of Efficacy|5|||
147421127|NCT01859988|531703841|FG003|Overall Study|Lack of Efficacy|0|||
147421128|NCT01859988|531703842|FG004|Overall Study|Lack of Efficacy|7|||
147421129|NCT01859988|531703843|FG005|Overall Study|Lack of Efficacy|9|||
147421130|NCT01859988|531703838|FG000|Overall Study|Physician Decision|1|||
147421131|NCT01859988|531703839|FG001|Overall Study|Physician Decision|3|||
147421132|NCT01859988|531703840|FG002|Overall Study|Physician Decision|1|||
147421133|NCT01859988|531703841|FG003|Overall Study|Physician Decision|3|||
147421134|NCT01859988|531703842|FG004|Overall Study|Physician Decision|4|||
147421135|NCT01859988|531703843|FG005|Overall Study|Physician Decision|1|||
147421136|NCT01859988|531703838|FG000|Overall Study|Adverse Event|2|||
147421137|NCT01859988|531703839|FG001|Overall Study|Adverse Event|1|||
147421138|NCT01859988|531703840|FG002|Overall Study|Adverse Event|3|||
147421139|NCT01859988|531703841|FG003|Overall Study|Adverse Event|1|||
147421140|NCT01859988|531703842|FG004|Overall Study|Adverse Event|2|||
147421141|NCT01859988|531703843|FG005|Overall Study|Adverse Event|2|||
147421142|NCT01859988|531703838|FG000|Overall Study|Lost to Follow-up|1|||
147421143|NCT01859988|531703839|FG001|Overall Study|Lost to Follow-up|2|||
147421144|NCT01859988|531703840|FG002|Overall Study|Lost to Follow-up|3|||
147421145|NCT01859988|531703841|FG003|Overall Study|Lost to Follow-up|0|||
147421146|NCT01859988|531703842|FG004|Overall Study|Lost to Follow-up|3|||
147421147|NCT01859988|531703843|FG005|Overall Study|Lost to Follow-up|2|||
147421148|NCT01859988|531703838|FG000|Overall Study|Protocol Violation|0|||
147421149|NCT01859988|531703839|FG001|Overall Study|Protocol Violation|0|||
147421150|NCT01859988|531703840|FG002|Overall Study|Protocol Violation|1|||
147421151|NCT01859988|531703841|FG003|Overall Study|Protocol Violation|0|||
147421152|NCT01859988|531703842|FG004|Overall Study|Protocol Violation|0|||
147421153|NCT01859988|531703843|FG005|Overall Study|Protocol Violation|0|||
147421154|NCT01859988|531703838|FG000|Overall Study|Other than specified above|0|||
147421155|NCT01859988|531703839|FG001|Overall Study|Other than specified above|2|||
147421156|NCT01859988|531703840|FG002|Overall Study|Other than specified above|11|||
147421157|NCT01859988|531703841|FG003|Overall Study|Other than specified above|3|||
147421158|NCT01859988|531703842|FG004|Overall Study|Other than specified above|5|||
147421159|NCT01859988|531703843|FG005|Overall Study|Other than specified above|3|||
147421160|NCT01226095|531703844|FG000|Overall Study|Poor compliance|1|||
147421161|NCT01688830|531703845|FG000|Overall Study|Lost to Follow-up|0|||
147421162|NCT01688830|531703846|FG001|Overall Study|Lost to Follow-up|0|||
147421163|NCT01688830|531703847|FG002|Overall Study|Lost to Follow-up|0|||
147421164|NCT01688830|531703848|FG003|Overall Study|Lost to Follow-up|0|||
147421165|NCT01688830|531703849|FG004|Overall Study|Lost to Follow-up|0|||
147421166|NCT01688830|531703850|FG005|Overall Study|Lost to Follow-up|0|||
147421167|NCT01688830|531703851|FG006|Overall Study|Lost to Follow-up|0|||
147421168|NCT01688830|531703852|FG007|Overall Study|Lost to Follow-up|0|||
147421169|NCT01688830|531703853|FG008|Overall Study|Lost to Follow-up|0|||
147421170|NCT01688830|531703854|FG009|Overall Study|Lost to Follow-up|0|||
147421171|NCT01688830|531703855|FG010|Overall Study|Lost to Follow-up|1|||
147421172|NCT01688830|531703856|FG011|Overall Study|Lost to Follow-up|0|||
147421173|NCT01688830|531703857|FG012|Overall Study|Lost to Follow-up|0|||
147421174|NCT01688830|531703858|FG013|Overall Study|Lost to Follow-up|0|||
147421175|NCT01688830|531703859|FG014|Overall Study|Lost to Follow-up|0|||
147421176|NCT01688830|531703860|FG015|Overall Study|Lost to Follow-up|0|||
147421177|NCT01688830|531703861|FG016|Overall Study|Lost to Follow-up|0|||
147421178|NCT01688830|531703862|FG017|Overall Study|Lost to Follow-up|0|||
147421179|NCT01688830|531703863|FG018|Overall Study|Lost to Follow-up|0|||
147421180|NCT01688830|531703864|FG019|Overall Study|Lost to Follow-up|0|||
147421181|NCT01688830|531703865|FG020|Overall Study|Lost to Follow-up|0|||
147421182|NCT04822597|531703866|FG000|Overall Study|Withdrawal by Subject|0|||
147421183|NCT04822597|531703867|FG001|Overall Study|Withdrawal by Subject|1|||
147421184|NCT04822597|531703868|FG002|Overall Study|Withdrawal by Subject|1|||
147421185|NCT04822597|531703869|FG003|Overall Study|Withdrawal by Subject|0|||
147421186|NCT04822597|531703866|FG000|Overall Study|Physician Decision|0|||
147421187|NCT04822597|531703867|FG001|Overall Study|Physician Decision|0|||
147421188|NCT04822597|531703868|FG002|Overall Study|Physician Decision|1|||
147421189|NCT04822597|531703869|FG003|Overall Study|Physician Decision|1|||
147421190|NCT04822597|531703866|FG000|Overall Study|Subject withdrawn after enrollment|0|||
147421191|NCT04822597|531703867|FG001|Overall Study|Subject withdrawn after enrollment|1|||
147421192|NCT04822597|531703868|FG002|Overall Study|Subject withdrawn after enrollment|0|||
147421193|NCT04822597|531703869|FG003|Overall Study|Subject withdrawn after enrollment|1|||
147421194|NCT04822597|531703866|FG000|Overall Study|Surgery Re-scheduled, missed by study team|1|||
147421195|NCT04822597|531703867|FG001|Overall Study|Surgery Re-scheduled, missed by study team|0|||
147421196|NCT04822597|531703868|FG002|Overall Study|Surgery Re-scheduled, missed by study team|0|||
147421197|NCT04822597|531703869|FG003|Overall Study|Surgery Re-scheduled, missed by study team|0|||
147421198|NCT01285609|531703870|FG000|Randomized|Progressive Disease|41|||
147421199|NCT01285609|531703871|FG001|Randomized|Progressive Disease|61|||
147421200|NCT01285609|531703870|FG000|Randomized|Adverse Event Unrelated to Study Drug|18|||
147421201|NCT01285609|531703871|FG001|Randomized|Adverse Event Unrelated to Study Drug|18|||
147421202|NCT01285609|531703870|FG000|Randomized|Study Drug Toxicity|13|||
147421203|NCT01285609|531703871|FG001|Randomized|Study Drug Toxicity|14|||
147421204|NCT01285609|531703870|FG000|Randomized|Death|5|||
147421205|NCT01285609|531703871|FG001|Randomized|Death|7|||
147421206|NCT01285609|531703870|FG000|Randomized|Withdrawal by Subject|8|||
147421207|NCT01285609|531703871|FG001|Randomized|Withdrawal by Subject|11|||
147421208|NCT01285609|531703870|FG000|Randomized|Subject No Longer Met Study Criteria|1|||
147421209|NCT01285609|531703871|FG001|Randomized|Subject No Longer Met Study Criteria|1|||
147421210|NCT01285609|531703870|FG000|Randomized|Undisclosed Reasons|1|||
147421211|NCT01285609|531703871|FG001|Randomized|Undisclosed Reasons|0|||
147421212|NCT01285609|531703870|FG000|Randomized|Randomized but not Treated|4|||
147421213|NCT01285609|531703871|FG001|Randomized|Randomized but not Treated|4|||
147421214|NCT01285609|531703870|FG000|Treated With Blinded Therapy|Progressive Disease|223|||
147421215|NCT01285609|531703871|FG001|Treated With Blinded Therapy|Progressive Disease|305|||
147421216|NCT01285609|531703870|FG000|Treated With Blinded Therapy|Study Drug Toxicity|87|||
147421217|NCT01285609|531703871|FG001|Treated With Blinded Therapy|Study Drug Toxicity|14|||
147421218|NCT01285609|531703870|FG000|Treated With Blinded Therapy|Adverse Event Unrelated to Study Drug|36|||
147421219|NCT01285609|531703871|FG001|Treated With Blinded Therapy|Adverse Event Unrelated to Study Drug|14|||
147421220|NCT01285609|531703870|FG000|Treated With Blinded Therapy|Withdrawal by Subject|20|||
147595931|NCT03096847|532338751|FG000|Overall Study|Protocol Violation|3|||
147421221|NCT01285609|531703871|FG001|Treated With Blinded Therapy|Withdrawal by Subject|7|||
147421222|NCT01285609|531703870|FG000|Treated With Blinded Therapy|Death|11|||
147421223|NCT01285609|531703871|FG001|Treated With Blinded Therapy|Death|3|||
147421224|NCT01285609|531703870|FG000|Treated With Blinded Therapy|Maximum Clinical Benefit|2|||
147421225|NCT01285609|531703871|FG001|Treated With Blinded Therapy|Maximum Clinical Benefit|4|||
147421226|NCT01285609|531703870|FG000|Treated With Blinded Therapy|Not Reported|0|||
147421227|NCT01285609|531703871|FG001|Treated With Blinded Therapy|Not Reported|2|||
147421228|NCT01285609|531703870|FG000|Treated With Blinded Therapy|Poor/Non-Compliance|1|||
147421229|NCT01285609|531703871|FG001|Treated With Blinded Therapy|Poor/Non-Compliance|2|||
147421230|NCT01285609|531703870|FG000|Treated With Blinded Therapy|Subject No Longer Met Study Criteria|1|||
147421231|NCT01285609|531703871|FG001|Treated With Blinded Therapy|Subject No Longer Met Study Criteria|0|||
147647188|NCT00904839|532528074|FG002|Overall Study|Withdrawal by Subject|0|||
147647189|NCT00904839|532528072|FG000|Overall Study|Not treated|1|||
147647190|NCT00904839|532528073|FG001|Overall Study|Not treated|0|||
147647191|NCT00904839|532528074|FG002|Overall Study|Not treated|1|||
147647192|NCT00904839|532528072|FG000|Overall Study|Other than above|0|||
147647193|NCT00904839|532528073|FG001|Overall Study|Other than above|9|||
147647194|NCT00904839|532528074|FG002|Overall Study|Other than above|7|||
147647195|NCT04521114|532528077|FG000|Overall Study|Lost to Follow-up|1|||
147647196|NCT04521114|532528078|FG001|Overall Study|Lost to Follow-up|2|||
147647197|NCT04521114|532528079|FG002|Overall Study|Lost to Follow-up|0|||
147647198|NCT04521114|532528077|FG000|Overall Study|Withdrawal by Subject|1|||
147647199|NCT04521114|532528078|FG001|Overall Study|Withdrawal by Subject|2|||
147647200|NCT04521114|532528079|FG002|Overall Study|Withdrawal by Subject|2|||
147647201|NCT04521114|532528077|FG000|Overall Study|Adverse Event|1|||
147647202|NCT04521114|532528078|FG001|Overall Study|Adverse Event|0|||
147647203|NCT04521114|532528079|FG002|Overall Study|Adverse Event|0|||
147647204|NCT04521114|532528077|FG000|Overall Study|Sponsor Wish|1|||
147647205|NCT04521114|532528078|FG001|Overall Study|Sponsor Wish|0|||
147647206|NCT04521114|532528079|FG002|Overall Study|Sponsor Wish|0|||
147647207|NCT04521114|532528077|FG000|Overall Study|Withdrawal of Consent|2|||
147647208|NCT04521114|532528078|FG001|Overall Study|Withdrawal of Consent|2|||
147647209|NCT04521114|532528079|FG002|Overall Study|Withdrawal of Consent|0|||
147647210|NCT02854605|532528080|FG000|Overall Study|Adverse Event|1|||
147647211|NCT02854605|532528081|FG001|Overall Study|Adverse Event|5|||
147647212|NCT02854605|532528082|FG002|Overall Study|Adverse Event|2|||
147647213|NCT02854605|532528080|FG000|Overall Study|Lost to Follow-up|0|||
147647214|NCT02854605|532528081|FG001|Overall Study|Lost to Follow-up|2|||
147647215|NCT02854605|532528082|FG002|Overall Study|Lost to Follow-up|0|||
147647216|NCT02854605|532528080|FG000|Overall Study|Withdrew Consent|1|||
147647217|NCT02854605|532528081|FG001|Overall Study|Withdrew Consent|0|||
147647218|NCT02854605|532528082|FG002|Overall Study|Withdrew Consent|1|||
147647219|NCT02854605|532528080|FG000|Overall Study|Investigator's Discretion|1|||
147647220|NCT02854605|532528081|FG001|Overall Study|Investigator's Discretion|0|||
147647221|NCT02854605|532528082|FG002|Overall Study|Investigator's Discretion|0|||
147647222|NCT02854605|532528080|FG000|Overall Study|Protocol Violation|0|||
147647223|NCT02854605|532528081|FG001|Overall Study|Protocol Violation|0|||
147647224|NCT02854605|532528082|FG002|Overall Study|Protocol Violation|1|||
147647225|NCT00568334|532528083|FG000|Overall Study|Withdrawal by Subject|0|||
147647226|NCT00568334|532528084|FG001|Overall Study|Withdrawal by Subject|1|||
147647227|NCT00568334|532528083|FG000|Overall Study|Lost to Follow-up|1|||
147647228|NCT00568334|532528084|FG001|Overall Study|Lost to Follow-up|0|||
147647229|NCT01897571|532528085|FG000|Overall Study|Lost to Follow-up|3|||
147647230|NCT01897571|532528086|FG001|Overall Study|Lost to Follow-up|0|||
147647231|NCT01897571|532528087|FG002|Overall Study|Lost to Follow-up|0|||
147647232|NCT01897571|532528088|FG003|Overall Study|Lost to Follow-up|0|||
147647233|NCT01897571|532528089|FG004|Overall Study|Lost to Follow-up|2|||
147647234|NCT01897571|532528090|FG005|Overall Study|Lost to Follow-up|0|||
147647235|NCT01897571|532528091|FG006|Overall Study|Lost to Follow-up|0|||
147647236|NCT01897571|532528092|FG007|Overall Study|Lost to Follow-up|0|||
147647237|NCT01897571|532528093|FG008|Overall Study|Lost to Follow-up|1|||
147421232|NCT01285609|531703870|FG000|Treated With Blinded Therapy|Administrative Reason by Sponsor|1|||
147421233|NCT01285609|531703871|FG001|Treated With Blinded Therapy|Administrative Reason by Sponsor|3|||
147421234|NCT01285609|531703870|FG000|Treated With Blinded Therapy|Physician and Patient decision|1|||
147647238|NCT01897571|532528094|FG009|Overall Study|Lost to Follow-up|2|||
147647239|NCT01897571|532528095|FG010|Overall Study|Lost to Follow-up|4|||
147647240|NCT01897571|532528085|FG000|Overall Study|Withdrawal by Subject|0|||
147647241|NCT01897571|532528086|FG001|Overall Study|Withdrawal by Subject|0|||
147647242|NCT01897571|532528087|FG002|Overall Study|Withdrawal by Subject|0|||
147647243|NCT01897571|532528088|FG003|Overall Study|Withdrawal by Subject|0|||
147647244|NCT01897571|532528089|FG004|Overall Study|Withdrawal by Subject|0|||
147647245|NCT01897571|532528090|FG005|Overall Study|Withdrawal by Subject|0|||
147647246|NCT01897571|532528091|FG006|Overall Study|Withdrawal by Subject|0|||
147647247|NCT01897571|532528092|FG007|Overall Study|Withdrawal by Subject|1|||
147647248|NCT01897571|532528093|FG008|Overall Study|Withdrawal by Subject|4|||
147647249|NCT01897571|532528094|FG009|Overall Study|Withdrawal by Subject|3|||
147647250|NCT01897571|532528095|FG010|Overall Study|Withdrawal by Subject|1|||
147647251|NCT01897571|532528085|FG000|Overall Study|Other|1|||
147647252|NCT01897571|532528086|FG001|Overall Study|Other|0|||
147647253|NCT01897571|532528087|FG002|Overall Study|Other|0|||
147647254|NCT01897571|532528088|FG003|Overall Study|Other|3|||
147647255|NCT01897571|532528089|FG004|Overall Study|Other|3|||
147647256|NCT01897571|532528090|FG005|Overall Study|Other|4|||
147647257|NCT01897571|532528091|FG006|Overall Study|Other|7|||
147647258|NCT01897571|532528092|FG007|Overall Study|Other|0|||
147647259|NCT01897571|532528093|FG008|Overall Study|Other|0|||
147647260|NCT01897571|532528094|FG009|Overall Study|Other|0|||
147647261|NCT01897571|532528095|FG010|Overall Study|Other|0|||
147647262|NCT01897571|532528085|FG000|Overall Study|Enrolled in rollover study|0|||
147647263|NCT01897571|532528086|FG001|Overall Study|Enrolled in rollover study|0|||
147647264|NCT01897571|532528087|FG002|Overall Study|Enrolled in rollover study|0|||
147647265|NCT01897571|532528088|FG003|Overall Study|Enrolled in rollover study|0|||
147647266|NCT01897571|532528089|FG004|Overall Study|Enrolled in rollover study|0|||
147647267|NCT01897571|532528090|FG005|Overall Study|Enrolled in rollover study|0|||
147647268|NCT01897571|532528091|FG006|Overall Study|Enrolled in rollover study|0|||
147647269|NCT01897571|532528092|FG007|Overall Study|Enrolled in rollover study|9|||
147647270|NCT01897571|532528093|FG008|Overall Study|Enrolled in rollover study|7|||
147647271|NCT01897571|532528094|FG009|Overall Study|Enrolled in rollover study|9|||
147647272|NCT01897571|532528095|FG010|Overall Study|Enrolled in rollover study|1|||
147647273|NCT01897571|532528085|FG000|Overall Study|Death|2|||
147647274|NCT01897571|532528086|FG001|Overall Study|Death|2|||
147647275|NCT01897571|532528087|FG002|Overall Study|Death|3|||
147647276|NCT01897571|532528088|FG003|Overall Study|Death|6|||
147647277|NCT01897571|532528089|FG004|Overall Study|Death|7|||
147647278|NCT01897571|532528090|FG005|Overall Study|Death|9|||
147647279|NCT01897571|532528091|FG006|Overall Study|Death|5|||
147647280|NCT01897571|532528092|FG007|Overall Study|Death|22|||
147647281|NCT01897571|532528093|FG008|Overall Study|Death|23|||
147647282|NCT01897571|532528094|FG009|Overall Study|Death|129|||
147647283|NCT01897571|532528095|FG010|Overall Study|Death|59|||
147647284|NCT01797094|532528096|FG000|Overall Study|Adverse Event|1|||
147647285|NCT01797094|532528097|FG001|Overall Study|Adverse Event|1|||
147647286|NCT01797094|532528096|FG000|Overall Study|Personal Reasons|4|||
147647287|NCT01797094|532528097|FG001|Overall Study|Personal Reasons|0|||
147647288|NCT01797094|532528096|FG000|Overall Study|Protocol Violation|0|||
147647289|NCT01797094|532528097|FG001|Overall Study|Protocol Violation|1|||
147647290|NCT01797094|532528096|FG000|Overall Study|Other Miscellaneous Reasons|1|||
147647291|NCT01797094|532528097|FG001|Overall Study|Other Miscellaneous Reasons|0|||
147647292|NCT03217968|532528098|FG000|Overall Study|Withdrawal by Subject|4|||
147647293|NCT03217968|532528098|FG000|Overall Study|Lost to Follow-up|1|||
147647294|NCT03217968|532528098|FG000|Overall Study|Protocol Violation|6|||
147647295|NCT05268016|532528101|FG000|Overall Study|Unacceptable toxicity or AE|2|||
147647296|NCT05268016|532528102|FG001|Overall Study|Unacceptable toxicity or AE|2|||
147647297|NCT05268016|532528103|FG002|Overall Study|Unacceptable toxicity or AE|4|||
147647298|NCT05268016|532528104|FG003|Overall Study|Unacceptable toxicity or AE|3|||
147647299|NCT05268016|532528105|FG004|Overall Study|Unacceptable toxicity or AE|1|||
147647300|NCT05268016|532528101|FG000|Overall Study|Withdrawal by Subject|1|||
147647301|NCT05268016|532528102|FG001|Overall Study|Withdrawal by Subject|3|||
147647302|NCT05268016|532528103|FG002|Overall Study|Withdrawal by Subject|2|||
147647303|NCT05268016|532528104|FG003|Overall Study|Withdrawal by Subject|2|||
147647304|NCT05268016|532528105|FG004|Overall Study|Withdrawal by Subject|1|||
147647305|NCT05268016|532528101|FG000|Overall Study|Lost to Follow-up|4|||
147647306|NCT05268016|532528102|FG001|Overall Study|Lost to Follow-up|7|||
147647307|NCT05268016|532528103|FG002|Overall Study|Lost to Follow-up|1|||
147647308|NCT05268016|532528104|FG003|Overall Study|Lost to Follow-up|3|||
147647309|NCT05268016|532528105|FG004|Overall Study|Lost to Follow-up|5|||
147647310|NCT05268016|532528101|FG000|Overall Study|Patient fails to adhere to the major protocol requirements|1|||
147647311|NCT05268016|532528102|FG001|Overall Study|Patient fails to adhere to the major protocol requirements|0|||
147306601|NCT02917941|531288851|FG000|Survival Follow-up Period|Withdrawal by Subject|4|||
147306602|NCT01893827|531288852|FG000|Overall Study|Lost to Follow-up|19|||
147421235|NCT01285609|531703871|FG001|Treated With Blinded Therapy|Physician and Patient decision|3|||
147647312|NCT05268016|532528103|FG002|Overall Study|Patient fails to adhere to the major protocol requirements|0|||
147647313|NCT05268016|532528104|FG003|Overall Study|Patient fails to adhere to the major protocol requirements|1|||
147647314|NCT05268016|532528105|FG004|Overall Study|Patient fails to adhere to the major protocol requirements|0|||
147647315|NCT05268016|532528101|FG000|Overall Study|Lack of Efficacy|0|||
147647316|NCT05268016|532528102|FG001|Overall Study|Lack of Efficacy|0|||
147647317|NCT05268016|532528103|FG002|Overall Study|Lack of Efficacy|0|||
147647318|NCT05268016|532528104|FG003|Overall Study|Lack of Efficacy|0|||
147647319|NCT05268016|532528105|FG004|Overall Study|Lack of Efficacy|4|||
147647320|NCT05268016|532528101|FG000|Overall Study|Physician Decision|0|||
147647321|NCT05268016|532528102|FG001|Overall Study|Physician Decision|0|||
147647322|NCT05268016|532528103|FG002|Overall Study|Physician Decision|0|||
147647323|NCT05268016|532528104|FG003|Overall Study|Physician Decision|1|||
147647324|NCT05268016|532528105|FG004|Overall Study|Physician Decision|0|||
147647325|NCT05268016|532528101|FG000|Overall Study|Other|1|||
147647326|NCT05268016|532528102|FG001|Overall Study|Other|0|||
147647327|NCT05268016|532528103|FG002|Overall Study|Other|1|||
147647328|NCT05268016|532528104|FG003|Overall Study|Other|2|||
147647329|NCT05268016|532528105|FG004|Overall Study|Other|0|||
147647330|NCT03411902|532528108|FG000|Overall Study|Lost to Follow-up|3|||
147647331|NCT03411902|532528109|FG001|Overall Study|Lost to Follow-up|0|||
147647332|NCT00270231|532528118|FG000|First Intervention|Lost to Follow-up|1|||
147647333|NCT00270231|532528119|FG001|First Intervention|Lost to Follow-up|1|||
147647334|NCT00270231|532528118|FG000|Washout Period|Lost to Follow-up|1|||
147647335|NCT00270231|532528119|FG001|Washout Period|Lost to Follow-up|0|||
147647336|NCT00270231|532528118|FG000|Second Intervention|Lost to Follow-up|0|||
147647337|NCT00270231|532528119|FG001|Second Intervention|Lost to Follow-up|1|||
147647338|NCT00574795|532528128|FG000|Infant Series|Withdrawal by Subject|2|||
147647339|NCT00574795|532528128|FG000|Infant Series|Protocol Violation|2|||
147647340|NCT00574795|532528128|FG000|Infant Series|Adverse Event|1|||
147647341|NCT00574795|532528128|FG000|After Infant Series|Withdrawal by Subject|1|||
147647342|NCT00574795|532528128|FG000|After Infant Series|Adverse Event|2|||
147647343|NCT00574795|532528128|FG000|Toddler Dose|Withdrawal by Subject|1|||
147647344|NCT00672841|532528129|FG000|Overall Study|Comfort care|1|||
147647345|NCT00672841|532528130|FG001|Overall Study|Comfort care|4|||
147647346|NCT00672841|532528129|FG000|Overall Study|icteric specimens|0|||
147647347|NCT00672841|532528130|FG001|Overall Study|icteric specimens|3|||
147647348|NCT00672841|532528129|FG000|Overall Study|Antifungal therapy, negative glucan|0|||
147647349|NCT00672841|532528130|FG001|Overall Study|Antifungal therapy, negative glucan|4|||
147647350|NCT00672841|532528129|FG000|Overall Study|Adverse Event|0|||
147647351|NCT00672841|532528130|FG001|Overall Study|Adverse Event|3|||
147647352|NCT00672841|532528129|FG000|Overall Study|Pregnancy|0|||
147647353|NCT00672841|532528130|FG001|Overall Study|Pregnancy|1|||
147647354|NCT02638259|532528131|FG000|Treatment Period 1|Adverse Event|1|||
147647355|NCT02638259|532528132|FG001|Treatment Period 1|Adverse Event|5|||
147647356|NCT02638259|532528131|FG000|Treatment Period 1|Death|0|||
147647357|NCT02638259|532528132|FG001|Treatment Period 1|Death|1|||
147647358|NCT02638259|532528131|FG000|Treatment Period 1|Lack of Efficacy|0|||
147647359|NCT02638259|532528132|FG001|Treatment Period 1|Lack of Efficacy|1|||
147647360|NCT02638259|532528131|FG000|Treatment Period 1|Protocol Violation|0|||
147647361|NCT02638259|532528132|FG001|Treatment Period 1|Protocol Violation|3|||
147647362|NCT02638259|532528131|FG000|Treatment Period 1|Withdrawal by Subject|4|||
147647363|NCT02638259|532528132|FG001|Treatment Period 1|Withdrawal by Subject|6|||
147647364|NCT02638259|532528131|FG000|Treatment Period 1|Withdrawn per sponsor decision|0|||
147647365|NCT02638259|532528132|FG001|Treatment Period 1|Withdrawn per sponsor decision|2|||
147647366|NCT02638259|532528131|FG000|Treatment Period 2|Adverse Event|5|||
147647367|NCT02638259|532528132|FG001|Treatment Period 2|Adverse Event|4|||
147647368|NCT02638259|532528131|FG000|Treatment Period 2|Withdrawal by Subject|1|||
147647369|NCT02638259|532528132|FG001|Treatment Period 2|Withdrawal by Subject|7|||
147647370|NCT04299048|532528133|FG000|Overall Study|Death|1|||
147647371|NCT04299048|532528133|FG000|Overall Study|Global deterioration of health status|2|||
147647372|NCT04299048|532528133|FG000|Overall Study|Enrolled and not treated|1|||
147647373|NCT01717391|532528135|FG000|Overall Study|Withdrawal by Subject|5|||
147647374|NCT01717391|532528135|FG000|Overall Study|Physician Decision|1|||
147647375|NCT01717391|532528135|FG000|Overall Study|FLT technical failure|3|||
147647376|NCT03677934|532528136|FG000|Overall Study|Adverse Event|1|||
147647377|NCT03677934|532528137|FG001|Overall Study|Adverse Event|1|||
147647378|NCT03677934|532528136|FG000|Overall Study|Death|8|||
147647379|NCT03677934|532528137|FG001|Overall Study|Death|4|||
147647380|NCT03677934|532528136|FG000|Overall Study|Lost to Follow-up|3|||
147647381|NCT03677934|532528137|FG001|Overall Study|Lost to Follow-up|0|||
147647382|NCT03677934|532528136|FG000|Overall Study|Non-Compliance With Study Drug|1|||
147647383|NCT03677934|532528137|FG001|Overall Study|Non-Compliance With Study Drug|0|||
147647384|NCT03677934|532528136|FG000|Overall Study|Physician Decision|0|||
147647385|NCT03677934|532528137|FG001|Overall Study|Physician Decision|1|||
147647386|NCT03677934|532528136|FG000|Overall Study|Withdrawal by Subject|1|||
147647387|NCT03677934|532528137|FG001|Overall Study|Withdrawal by Subject|7|||
147647388|NCT04769739|532528154|FG000|Overall Study|Colorectal cancer obstruction|2|||
147647389|NCT04769739|532528155|FG001|Overall Study|Colorectal cancer obstruction|0|||
147647390|NCT04769739|532528156|FG002|Overall Study|Colorectal cancer obstruction|0|||
147647391|NCT04769739|532528157|FG003|Overall Study|Colorectal cancer obstruction|0|||
147647392|NCT04769739|532528154|FG000|Overall Study|Failed cecal intubation|1|||
147647393|NCT04769739|532528155|FG001|Overall Study|Failed cecal intubation|0|||
147647394|NCT04769739|532528156|FG002|Overall Study|Failed cecal intubation|0|||
147647395|NCT04769739|532528157|FG003|Overall Study|Failed cecal intubation|1|||
147647396|NCT04769739|532528154|FG000|Overall Study|Poor bowel preparation|0|||
147647397|NCT04769739|532528155|FG001|Overall Study|Poor bowel preparation|0|||
147647398|NCT04769739|532528156|FG002|Overall Study|Poor bowel preparation|0|||
147647399|NCT04769739|532528157|FG003|Overall Study|Poor bowel preparation|1|||
147647400|NCT00045734|532528158|FG000|Overall Study|Protocol Violation|1|||
147647401|NCT02069093|532528159|FG000|Overall Study|Disease progression|14|||
147647402|NCT02069093|532528159|FG000|Overall Study|New cancer therapy|1|||
147647403|NCT02069093|532528159|FG000|Overall Study|Death|1|||
147647404|NCT02069093|532528159|FG000|Overall Study|Administrative problems|1|||
147647405|NCT02069093|532528159|FG000|Overall Study|Withdrawal by Subject|2|||
147647406|NCT02069093|532528159|FG000|Overall Study|Abnormal laboratory values|1|||
147647407|NCT02069093|532528159|FG000|Overall Study|Adverse Event|10|||
147647408|NCT00561470|532528165|FG000|Overall Study|Adverse Event|74|||
147647409|NCT00561470|532528166|FG001|Overall Study|Adverse Event|163|||
147647410|NCT00561470|532528165|FG000|Overall Study|Disease progression|437|||
147647411|NCT00561470|532528166|FG001|Overall Study|Disease progression|305|||
147647412|NCT00561470|532528165|FG000|Overall Study|poor compliance to protocol|4|||
147647413|NCT00561470|532528166|FG001|Overall Study|poor compliance to protocol|4|||
147647414|NCT00561470|532528165|FG000|Overall Study|Lost to Follow-up|2|||
147647415|NCT00561470|532528166|FG001|Overall Study|Lost to Follow-up|0|||
147647416|NCT00561470|532528165|FG000|Overall Study|Physician Decision|21|||
147647417|NCT00561470|532528166|FG001|Overall Study|Physician Decision|20|||
147647418|NCT00561470|532528165|FG000|Overall Study|Consent Withdrawn|2|||
147647419|NCT00561470|532528166|FG001|Overall Study|Consent Withdrawn|6|||
147647420|NCT00561470|532528165|FG000|Overall Study|Subject request|43|||
147647421|NCT00561470|532528166|FG001|Overall Study|Subject request|77|||
147647422|NCT00561470|532528165|FG000|Overall Study|Metastatic surgery|10|||
147647423|NCT00561470|532528166|FG001|Overall Study|Metastatic surgery|12|||
147647424|NCT00561470|532528165|FG000|Overall Study|Unauthorized procedure|3|||
147647425|NCT00561470|532528166|FG001|Overall Study|Unauthorized procedure|1|||
147647426|NCT00561470|532528165|FG000|Overall Study|Randomized but not treated|5|||
147647427|NCT00561470|532528166|FG001|Overall Study|Randomized but not treated|5|||
147647428|NCT00561470|532528165|FG000|Overall Study|Missed visit window|1|||
147647429|NCT00561470|532528166|FG001|Overall Study|Missed visit window|4|||
147647430|NCT00561470|532528165|FG000|Overall Study|Planning surgery|1|||
147647431|NCT00561470|532528166|FG001|Overall Study|Planning surgery|1|||
147647432|NCT00561470|532528165|FG000|Overall Study|Ongoing Treatment|11|||
147647433|NCT00561470|532528166|FG001|Overall Study|Ongoing Treatment|14|||
147647434|NCT00335959|532528169|FG000|Overall Study|Adverse Event|2|||
147647435|NCT00335959|532528169|FG000|Overall Study|Ineligible|1|||
147647436|NCT01001598|532528173|FG000|Overall Study|Hematopoietic Stem Cell Transplant|1|||
147647437|NCT01001598|532528173|FG000|Overall Study|Adverse Event|1|||
147647438|NCT02450552|532528175|FG000|Overall Study|Withdrawal by Subject|4|||
147647439|NCT02450552|532528176|FG001|Overall Study|Withdrawal by Subject|0|||
147647440|NCT02450552|532528177|FG002|Overall Study|Withdrawal by Subject|4|||
147647441|NCT02450552|532528175|FG000|Overall Study|Physician Decision|1|||
147647442|NCT02450552|532528176|FG001|Overall Study|Physician Decision|0|||
147647443|NCT02450552|532528177|FG002|Overall Study|Physician Decision|1|||
147647444|NCT05079230|532528188|FG000|Overall Study|Study Terminated by Sponsor|101|||
147647445|NCT05079230|532528189|FG001|Overall Study|Study Terminated by Sponsor|102|||
147647446|NCT05079230|532528188|FG000|Overall Study|Death|72|||
147647447|NCT05079230|532528189|FG001|Overall Study|Death|66|||
147647448|NCT05079230|532528188|FG000|Overall Study|Withdrew Consent|16|||
147647449|NCT05079230|532528189|FG001|Overall Study|Withdrew Consent|18|||
147647450|NCT05079230|532528188|FG000|Overall Study|Lost to Follow-up|0|||
147647451|NCT05079230|532528189|FG001|Overall Study|Lost to Follow-up|3|||
147647452|NCT01524783|532528190|FG000|Blinded Period|Adverse Event|64|||
147647453|NCT01524783|532528191|FG001|Blinded Period|Adverse Event|7|||
147647454|NCT01524783|532528192|FG002|Blinded Period|Adverse Event|0|||
147647455|NCT01524783|532528190|FG000|Blinded Period|Disease Progression|89|||
147647456|NCT01524783|532528191|FG001|Blinded Period|Disease Progression|75|||
147647457|NCT01524783|532528192|FG002|Blinded Period|Disease Progression|0|||
147647458|NCT01524783|532528190|FG000|Blinded Period|Withdrawal by Subject|19|||
147647459|NCT01524783|532528191|FG001|Blinded Period|Withdrawal by Subject|6|||
147647460|NCT01524783|532528192|FG002|Blinded Period|Withdrawal by Subject|0|||
147647461|NCT01524783|532528190|FG000|Blinded Period|Protocol deviation|2|||
147647462|NCT01524783|532528191|FG001|Blinded Period|Protocol deviation|1|||
147647463|NCT01524783|532528192|FG002|Blinded Period|Protocol deviation|0|||
147647464|NCT01524783|532528190|FG000|Blinded Period|Death|5|||
147647465|NCT01524783|532528191|FG001|Blinded Period|Death|2|||
147647466|NCT01524783|532528192|FG002|Blinded Period|Death|0|||
147647467|NCT01524783|532528190|FG000|Open-label Period|Disease progression|13|||
147647468|NCT01524783|532528191|FG001|Open-label Period|Disease progression|0|||
147647469|NCT01524783|532528192|FG002|Open-label Period|Disease progression|2|||
147647470|NCT01524783|532528190|FG000|Open-label Period|Administrative problems|5|||
147647471|NCT01524783|532528191|FG001|Open-label Period|Administrative problems|0|||
147647472|NCT01524783|532528192|FG002|Open-label Period|Administrative problems|2|||
147647473|NCT01524783|532528190|FG000|Open-label Period|Adverse Event|5|||
147191097|NCT00812708|530867533|FG000|Overall Study|Switched to another study|1|||
147191098|NCT00812708|530867533|FG000|Overall Study|Surgery cancelled due to uveitis|1|||
147191099|NCT00812708|530867533|FG000|Overall Study|Signed consent but later withdrew|3|||
147191100|NCT03224130|530867539|FG000|Overall Study|consent issue|0|||
147191101|NCT03224130|530867540|FG001|Overall Study|consent issue|1|||
147191102|NCT04124939|530867545|FG000|Overall Study|Lost to Follow-up|1|||
147191103|NCT04124939|530867546|FG001|Overall Study|Lost to Follow-up|3|||
147191104|NCT04607668|530867552|FG000|Overall Study|Death|49|||
147191105|NCT04607668|530867553|FG001|Overall Study|Death|26|||
147191106|NCT04607668|530867552|FG000|Overall Study|Lost to Follow-up|3|||
147647474|NCT01524783|532528191|FG001|Open-label Period|Adverse Event|0|||
147647475|NCT01524783|532528192|FG002|Open-label Period|Adverse Event|1|||
147647476|NCT01524783|532528190|FG000|Open-label Period|Withdrawal by Subject|2|||
147647477|NCT01524783|532528191|FG001|Open-label Period|Withdrawal by Subject|0|||
147647478|NCT01524783|532528192|FG002|Open-label Period|Withdrawal by Subject|1|||
147647479|NCT01524783|532528190|FG000|Open-label Period|Protocol deviation|1|||
147647480|NCT01524783|532528191|FG001|Open-label Period|Protocol deviation|0|||
147647481|NCT01524783|532528192|FG002|Open-label Period|Protocol deviation|0|||
147647482|NCT03164265|532528194|FG000|Overall Study|Physician Decision|3|||
147647483|NCT01876979|532528195|FG000|Overall Study|Physician Decision|2|||
147647484|NCT01876979|532528196|FG001|Overall Study|Physician Decision|3|||
147647485|NCT00106639|532528197|FG000|Overall Study|Adverse Event|3|||
147647486|NCT00106639|532528198|FG001|Overall Study|Adverse Event|4|||
147647487|NCT00106639|532528199|FG002|Overall Study|Adverse Event|1|||
147647488|NCT00106639|532528197|FG000|Overall Study|Protocol Violation|0|||
147647489|NCT00106639|532528198|FG001|Overall Study|Protocol Violation|1|||
147647490|NCT00106639|532528199|FG002|Overall Study|Protocol Violation|0|||
147647491|NCT00106639|532528197|FG000|Overall Study|Withdrawal by Subject|0|||
147647492|NCT00106639|532528198|FG001|Overall Study|Withdrawal by Subject|1|||
147647493|NCT00106639|532528199|FG002|Overall Study|Withdrawal by Subject|0|||
147647494|NCT00106639|532528197|FG000|Overall Study|Participant defaulted|0|||
147647495|NCT00106639|532528198|FG001|Overall Study|Participant defaulted|1|||
147647496|NCT00106639|532528199|FG002|Overall Study|Participant defaulted|1|||
147647497|NCT02240069|532528200|FG000|Overall Study|Withdrawal by Subject|5|||
147647498|NCT02240069|532528201|FG001|Overall Study|Withdrawal by Subject|5|||
147647499|NCT02240069|532528202|FG002|Overall Study|Withdrawal by Subject|2|||
147647500|NCT01096589|532528203|FG000|Overall Study|Adverse Event|2|||
147647501|NCT01096589|532528204|FG001|Overall Study|Adverse Event|1|||
147647502|NCT01096589|532528205|FG002|Overall Study|Adverse Event|2|||
147647503|NCT01096589|532528206|FG003|Overall Study|Adverse Event|1|||
147647504|NCT01096589|532528203|FG000|Overall Study|Withdrawal by Subject|2|||
147647505|NCT01096589|532528204|FG001|Overall Study|Withdrawal by Subject|1|||
147647506|NCT01096589|532528205|FG002|Overall Study|Withdrawal by Subject|1|||
147647507|NCT01096589|532528206|FG003|Overall Study|Withdrawal by Subject|1|||
147647508|NCT01096589|532528203|FG000|Overall Study|Compliance with protocol|0|||
147647509|NCT01096589|532528204|FG001|Overall Study|Compliance with protocol|0|||
147647510|NCT01096589|532528205|FG002|Overall Study|Compliance with protocol|1|||
147647511|NCT01096589|532528206|FG003|Overall Study|Compliance with protocol|0|||
147647512|NCT01096589|532528203|FG000|Overall Study|found treatment exhausting|0|||
147647513|NCT01096589|532528204|FG001|Overall Study|found treatment exhausting|0|||
147647514|NCT01096589|532528205|FG002|Overall Study|found treatment exhausting|0|||
147647515|NCT01096589|532528206|FG003|Overall Study|found treatment exhausting|1|||
147647516|NCT00721279|532528208|FG000|Overall Study|Lack of Efficacy|6|||
147647517|NCT00721279|532528209|FG001|Overall Study|Lack of Efficacy|3|||
147647518|NCT00721279|532528208|FG000|Overall Study|Tolerability insufficient|5|||
147647519|NCT00721279|532528209|FG001|Overall Study|Tolerability insufficient|2|||
147647520|NCT00721279|532528208|FG000|Overall Study|Withdrawal by Subject|13|||
147647521|NCT00721279|532528209|FG001|Overall Study|Withdrawal by Subject|3|||
147647522|NCT00721279|532528208|FG000|Overall Study|Other|12|||
147647523|NCT00721279|532528209|FG001|Overall Study|Other|16|||
147647524|NCT00900731|532528210|FG000|Overall Study|Adverse Event|31|||
147647525|NCT00900731|532528211|FG001|Overall Study|Adverse Event|27|||
147647526|NCT00900731|532528210|FG000|Overall Study|Withdrawal by Subject|8|||
147647527|NCT00900731|532528211|FG001|Overall Study|Withdrawal by Subject|7|||
147647528|NCT00900731|532528210|FG000|Overall Study|Protocol Deviation|8|||
147647529|NCT00900731|532528211|FG001|Overall Study|Protocol Deviation|11|||
147647530|NCT00900731|532528210|FG000|Overall Study|Administrative Problems|5|||
147647531|NCT00900731|532528211|FG001|Overall Study|Administrative Problems|4|||
147647532|NCT00900731|532528210|FG000|Overall Study|Abnormal Test Procedure Result(s)|3|||
147647533|NCT00900731|532528211|FG001|Overall Study|Abnormal Test Procedure Result(s)|0|||
147647534|NCT00900731|532528210|FG000|Overall Study|Abnormal Laboratory Value(s)|2|||
147647535|NCT00900731|532528211|FG001|Overall Study|Abnormal Laboratory Value(s)|4|||
147647536|NCT00900731|532528210|FG000|Overall Study|Lost to Follow-up|2|||
147647537|NCT00900731|532528211|FG001|Overall Study|Lost to Follow-up|3|||
147647538|NCT00900731|532528210|FG000|Overall Study|Lack of Efficacy|1|||
147647539|NCT00900731|532528211|FG001|Overall Study|Lack of Efficacy|3|||
147647540|NCT00900731|532528210|FG000|Overall Study|Death|0|||
147647541|NCT00900731|532528211|FG001|Overall Study|Death|2|||
147647542|NCT03806231|532528212|FG000|Overall Study|Physician Decision|1|||
147647543|NCT03806231|532528213|FG001|Overall Study|Physician Decision|0|||
147647544|NCT03806231|532528212|FG000|Overall Study|Withdrawal by Subject|1|||
147647545|NCT03806231|532528213|FG001|Overall Study|Withdrawal by Subject|0|||
147647546|NCT02919267|532528214|FG000|Overall Study|Protocol Violation|0|||
147647547|NCT02919267|532528215|FG001|Overall Study|Protocol Violation|3|||
147647548|NCT02919267|532528216|FG002|Overall Study|Protocol Violation|3|||
147647549|NCT02919267|532528217|FG003|Overall Study|Protocol Violation|4|||
147647550|NCT03467763|532528218|FG000|Overall Study|Lost to Follow-up|1|||
147647551|NCT03467763|532528218|FG000|Overall Study|Protocol Violation|2|||
147647552|NCT02227368|532529770|FG000|Overall Study|No EVR/not PAD/PI decision/RLE bypass|0|||
147647553|NCT02227368|532529771|FG001|Overall Study|No EVR/not PAD/PI decision/RLE bypass|4|||
147647554|NCT02227368|532529770|FG000|Overall Study|Lost to Follow-up|1|||
147647555|NCT02227368|532529771|FG001|Overall Study|Lost to Follow-up|0|||
147647556|NCT02227368|532529770|FG000|Overall Study|Adverse Event|1|||
147647557|NCT02227368|532529771|FG001|Overall Study|Adverse Event|0|||
147647558|NCT03046056|532529772|FG000|Overall Study|Non-responder at Week 10|6|||
147647559|NCT03046056|532529773|FG001|Overall Study|Non-responder at Week 10|6|||
147647560|NCT03046056|532529774|FG002|Overall Study|Non-responder at Week 10|4|||
147647561|NCT03046056|532529772|FG000|Overall Study|Protocol-specified Disease Worsening|3|||
147647562|NCT03046056|532529773|FG001|Overall Study|Protocol-specified Disease Worsening|3|||
147647563|NCT03046056|532529774|FG002|Overall Study|Protocol-specified Disease Worsening|1|||
147647564|NCT03046056|532529772|FG000|Overall Study|Adverse Event|1|||
147647565|NCT03046056|532529773|FG001|Overall Study|Adverse Event|5|||
147647566|NCT03046056|532529774|FG002|Overall Study|Adverse Event|0|||
147647567|NCT03046056|532529772|FG000|Overall Study|Non-compliance With Study Drug|0|||
147647568|NCT03046056|532529773|FG001|Overall Study|Non-compliance With Study Drug|0|||
147647569|NCT03046056|532529774|FG002|Overall Study|Non-compliance With Study Drug|2|||
147647570|NCT03046056|532529772|FG000|Overall Study|Protocol Violation|1|||
147647571|NCT03046056|532529773|FG001|Overall Study|Protocol Violation|1|||
147647572|NCT03046056|532529774|FG002|Overall Study|Protocol Violation|0|||
147647573|NCT03046056|532529772|FG000|Overall Study|Investigator's Discretion|0|||
147647574|NCT03046056|532529773|FG001|Overall Study|Investigator's Discretion|1|||
147647575|NCT03046056|532529774|FG002|Overall Study|Investigator's Discretion|0|||
147647576|NCT03046056|532529772|FG000|Overall Study|Withdrew Consent|1|||
147647577|NCT03046056|532529773|FG001|Overall Study|Withdrew Consent|0|||
147647578|NCT03046056|532529774|FG002|Overall Study|Withdrew Consent|0|||
147647579|NCT05243563|532529775|FG000|Overall Study|Withdrawal by Subject|1|||
147647580|NCT05243563|532529776|FG001|Overall Study|Withdrawal by Subject|0|||
147647581|NCT05243563|532529775|FG000|Overall Study|Physician Decision|1|||
147647582|NCT05243563|532529776|FG001|Overall Study|Physician Decision|0|||
147647583|NCT00441363|532529777|FG000|Overall Study|Adverse Event|4|||
147647584|NCT00441363|532529778|FG001|Overall Study|Adverse Event|2|||
147647585|NCT00441363|532529777|FG000|Overall Study|Withdrawal by Subject|3|||
147647586|NCT00441363|532529778|FG001|Overall Study|Withdrawal by Subject|4|||
147647587|NCT00441363|532529777|FG000|Overall Study|Physician Decision|6|||
147647588|NCT00441363|532529778|FG001|Overall Study|Physician Decision|7|||
147647589|NCT00441363|532529777|FG000|Overall Study|Lost to Follow-up|2|||
147647590|NCT00441363|532529778|FG001|Overall Study|Lost to Follow-up|2|||
147647591|NCT00441363|532529777|FG000|Overall Study|Other|2|||
147647592|NCT00441363|532529778|FG001|Overall Study|Other|0|||
147647593|NCT02437188|532529781|FG000|Overall Study|Randomized but did not receive surgery|4|||
147647594|NCT02437188|532529782|FG001|Overall Study|Randomized but did not receive surgery|8|||
147647595|NCT02437188|532529781|FG000|Overall Study|Adverse Event|0|||
147647596|NCT02437188|532529782|FG001|Overall Study|Adverse Event|1|||
147647597|NCT04767529|532529786|FG000|Overall Study|Adverse Event|0|||
147647598|NCT04767529|532529787|FG001|Overall Study|Adverse Event|4|||
147647599|NCT04767529|532529788|FG002|Overall Study|Adverse Event|3|||
147647600|NCT04767529|532529786|FG000|Overall Study|clinical outcomes endpoint (excluding death)|1|||
147647601|NCT04767529|532529787|FG001|Overall Study|clinical outcomes endpoint (excluding death)|3|||
147647602|NCT04767529|532529788|FG002|Overall Study|clinical outcomes endpoint (excluding death)|3|||
147647603|NCT04767529|532529786|FG000|Overall Study|Required use of a prohibited medication|0|||
147647604|NCT04767529|532529787|FG001|Overall Study|Required use of a prohibited medication|1|||
147647605|NCT04767529|532529788|FG002|Overall Study|Required use of a prohibited medication|0|||
147647606|NCT04767529|532529786|FG000|Overall Study|Withdrawal by Subject|7|||
147647607|NCT04767529|532529787|FG001|Overall Study|Withdrawal by Subject|5|||
147647608|NCT04767529|532529788|FG002|Overall Study|Withdrawal by Subject|4|||
147647609|NCT04767529|532529786|FG000|Overall Study|At the discretion of the Investigator or Sponsor for noncompliance|1|||
147647610|NCT04767529|532529787|FG001|Overall Study|At the discretion of the Investigator or Sponsor for noncompliance|0|||
147647611|NCT04767529|532529788|FG002|Overall Study|At the discretion of the Investigator or Sponsor for noncompliance|3|||
147647612|NCT04767529|532529786|FG000|Overall Study|Lost to Follow-up|0|||
147647613|NCT04767529|532529787|FG001|Overall Study|Lost to Follow-up|2|||
147647614|NCT04767529|532529788|FG002|Overall Study|Lost to Follow-up|3|||
147647615|NCT02290925|532529794|FG000|First Period of Three Months|Lost to Follow-up|2|||
147647616|NCT02290925|532529795|FG001|First Period of Three Months|Lost to Follow-up|1|||
147647617|NCT02290925|532529794|FG000|First Period of Three Months|Death|1|||
147647618|NCT02290925|532529795|FG001|First Period of Three Months|Death|0|||
147647619|NCT02290925|532529794|FG000|First Period of Three Months|Insulin Started|1|||
147647620|NCT02290925|532529795|FG001|First Period of Three Months|Insulin Started|1|||
147647621|NCT02290925|532529794|FG000|Second Period of 3 Months|Lost to Follow-up|1|||
147647622|NCT02290925|532529795|FG001|Second Period of 3 Months|Lost to Follow-up|3|||
147647623|NCT02290925|532529794|FG000|Second Period of 3 Months|insulin started|0|||
147647624|NCT02290925|532529795|FG001|Second Period of 3 Months|insulin started|1|||
147647625|NCT01716520|532529796|FG000|Treatment Period 1 (14 Days)|Adverse Event|1|||
147647626|NCT01716520|532529797|FG001|Treatment Period 1 (14 Days)|Adverse Event|0|||
147647627|NCT01716520|532529798|FG002|Treatment Period 1 (14 Days)|Adverse Event|0|||
147647628|NCT01716520|532529799|FG003|Treatment Period 1 (14 Days)|Adverse Event|0|||
147647629|NCT01716520|532529800|FG004|Treatment Period 1 (14 Days)|Adverse Event|0|||
147647630|NCT01716520|532529801|FG005|Treatment Period 1 (14 Days)|Adverse Event|0|||
147647631|NCT01716520|532529796|FG000|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|1|||
147647632|NCT01716520|532529797|FG001|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|0|||
147647633|NCT01716520|532529798|FG002|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|2|||
147647634|NCT01716520|532529799|FG003|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|1|||
147647635|NCT01716520|532529800|FG004|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|0|||
147647636|NCT01716520|532529801|FG005|Treatment Period 1 (14 Days)|Protocol-defined Stopping Criteria|1|||
147647637|NCT01716520|532529796|FG000|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
147647638|NCT01716520|532529797|FG001|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
147647639|NCT01716520|532529798|FG002|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
147647640|NCT01716520|532529799|FG003|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
147647641|NCT01716520|532529800|FG004|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
147647642|NCT01716520|532529801|FG005|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
147647643|NCT01716520|532529796|FG000|Washout Period 1 (10 to 14 Days)|Adverse Event|0|||
147647644|NCT01716520|532529797|FG001|Washout Period 1 (10 to 14 Days)|Adverse Event|1|||
147647645|NCT01716520|532529798|FG002|Washout Period 1 (10 to 14 Days)|Adverse Event|0|||
147647646|NCT01716520|532529799|FG003|Washout Period 1 (10 to 14 Days)|Adverse Event|0|||
147647647|NCT01716520|532529800|FG004|Washout Period 1 (10 to 14 Days)|Adverse Event|0|||
147647648|NCT01716520|532529801|FG005|Washout Period 1 (10 to 14 Days)|Adverse Event|0|||
147647649|NCT01716520|532529796|FG000|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
147647650|NCT01716520|532529797|FG001|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
147647651|NCT01716520|532529798|FG002|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
147647652|NCT01716520|532529799|FG003|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
147647653|NCT01716520|532529800|FG004|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
147647654|NCT01716520|532529801|FG005|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|1|||
147647655|NCT01716520|532529796|FG000|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0|||
147647656|NCT01716520|532529797|FG001|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0|||
147647657|NCT01716520|532529798|FG002|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|1|||
147647658|NCT01716520|532529799|FG003|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0|||
147647659|NCT01716520|532529800|FG004|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|0|||
147647660|NCT01716520|532529801|FG005|Washout Period 1 (10 to 14 Days)|Withdrawal by Subject|1|||
147647661|NCT01716520|532529796|FG000|Treatment Period 2 (14 Days)|Adverse Event|0|||
147647662|NCT01716520|532529797|FG001|Treatment Period 2 (14 Days)|Adverse Event|0|||
147647663|NCT01716520|532529798|FG002|Treatment Period 2 (14 Days)|Adverse Event|0|||
147647664|NCT01716520|532529799|FG003|Treatment Period 2 (14 Days)|Adverse Event|0|||
147647665|NCT01716520|532529800|FG004|Treatment Period 2 (14 Days)|Adverse Event|1|||
147647666|NCT01716520|532529801|FG005|Treatment Period 2 (14 Days)|Adverse Event|0|||
147647667|NCT01716520|532529796|FG000|Treatment Period 2 (14 Days)|Protocol Violation|0|||
147647668|NCT01716520|532529797|FG001|Treatment Period 2 (14 Days)|Protocol Violation|0|||
147647669|NCT01716520|532529798|FG002|Treatment Period 2 (14 Days)|Protocol Violation|0|||
147647670|NCT01716520|532529799|FG003|Treatment Period 2 (14 Days)|Protocol Violation|0|||
147647671|NCT01716520|532529800|FG004|Treatment Period 2 (14 Days)|Protocol Violation|1|||
147647672|NCT01716520|532529801|FG005|Treatment Period 2 (14 Days)|Protocol Violation|0|||
147647673|NCT01716520|532529796|FG000|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0|||
147647674|NCT01716520|532529797|FG001|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0|||
147647675|NCT01716520|532529798|FG002|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0|||
147647676|NCT01716520|532529799|FG003|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|1|||
147647677|NCT01716520|532529800|FG004|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0|||
147647678|NCT01716520|532529801|FG005|Treatment Period 2 (14 Days)|Protocol-defined Stopping Criteria|0|||
147647679|NCT01716520|532529796|FG000|Washout Period 2 (10 to 14 Days)|Adverse Event|1|||
147647680|NCT01716520|532529797|FG001|Washout Period 2 (10 to 14 Days)|Adverse Event|0|||
147647681|NCT01716520|532529798|FG002|Washout Period 2 (10 to 14 Days)|Adverse Event|1|||
147647682|NCT01716520|532529799|FG003|Washout Period 2 (10 to 14 Days)|Adverse Event|0|||
147647683|NCT01716520|532529800|FG004|Washout Period 2 (10 to 14 Days)|Adverse Event|0|||
147647684|NCT01716520|532529801|FG005|Washout Period 2 (10 to 14 Days)|Adverse Event|1|||
147647685|NCT01716520|532529796|FG000|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|1|||
147647686|NCT01716520|532529797|FG001|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0|||
147647687|NCT01716520|532529798|FG002|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0|||
147647688|NCT01716520|532529799|FG003|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0|||
147647689|NCT01716520|532529800|FG004|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0|||
147647690|NCT01716520|532529801|FG005|Washout Period 2 (10 to 14 Days)|Lack of Efficacy|0|||
147647691|NCT01716520|532529796|FG000|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0|||
147647692|NCT01716520|532529797|FG001|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0|||
147647693|NCT01716520|532529798|FG002|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0|||
147647694|NCT01716520|532529799|FG003|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0|||
147647695|NCT01716520|532529800|FG004|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|0|||
147647696|NCT01716520|532529801|FG005|Washout Period 2 (10 to 14 Days)|Protocol-defined Stopping Criteria|1|||
147647697|NCT01716520|532529796|FG000|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0|||
147647698|NCT01716520|532529797|FG001|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|1|||
147647699|NCT01716520|532529798|FG002|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0|||
147647700|NCT01716520|532529799|FG003|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0|||
147647701|NCT01716520|532529800|FG004|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0|||
147647702|NCT01716520|532529801|FG005|Washout Period 2 (10 to 14 Days)|Withdrawal by Subject|0|||
147647703|NCT01716520|532529796|FG000|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
147647704|NCT01716520|532529797|FG001|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
147647705|NCT01716520|532529798|FG002|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
147647706|NCT01716520|532529799|FG003|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
147647707|NCT01716520|532529800|FG004|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
147647708|NCT01716520|532529801|FG005|Treatment Period 3 (14 Days)|Lack of Efficacy|2|||
147647709|NCT01716520|532529796|FG000|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
147647710|NCT01716520|532529797|FG001|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
147647711|NCT01716520|532529798|FG002|Treatment Period 3 (14 Days)|Withdrawal by Subject|1|||
147647712|NCT01716520|532529799|FG003|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
147647713|NCT01716520|532529800|FG004|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
147647714|NCT01716520|532529801|FG005|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
147647715|NCT00253370|532529802|FG000|Overall Study|Adverse Event|18|||
147647716|NCT00253370|532529802|FG000|Overall Study|Disease progression|13|||
147647717|NCT00253370|532529802|FG000|Overall Study|Death|2|||
147647718|NCT00253370|532529802|FG000|Overall Study|Withdrawal by Subject|6|||
147647719|NCT00253370|532529802|FG000|Overall Study|Non-protocol therapy|1|||
147647720|NCT00253370|532529802|FG000|Overall Study|Physician Decision|1|||
147647721|NCT00253370|532529802|FG000|Overall Study|Protocol Violation|1|||
147647722|NCT00253370|532529802|FG000|Overall Study|Abdominal pain due to disease|1|||
147647723|NCT00981058|532529809|FG000|Overall Study|Progressive Disease|38|||
147647724|NCT00981058|532529810|FG001|Overall Study|Progressive Disease|31|||
147647725|NCT00981058|532529809|FG000|Overall Study|Lost to Follow-up|3|||
147647726|NCT00981058|532529810|FG001|Overall Study|Lost to Follow-up|2|||
147647727|NCT00981058|532529809|FG000|Overall Study|Physician Decision|4|||
147647728|NCT00981058|532529810|FG001|Overall Study|Physician Decision|5|||
147647729|NCT00981058|532529809|FG000|Overall Study|Randomization Error|0|||
147647730|NCT00981058|532529810|FG001|Overall Study|Randomization Error|1|||
147647731|NCT00981058|532529809|FG000|Overall Study|Withdrawal by Subject|24|||
147647732|NCT00981058|532529810|FG001|Overall Study|Withdrawal by Subject|22|||
147647733|NCT05916131|532529811|FG000|Overall Study|Lost to Follow-up|0|||
147647734|NCT05916131|532529812|FG001|Overall Study|Lost to Follow-up|0|||
147647735|NCT05916131|532529813|FG002|Overall Study|Lost to Follow-up|1|||
147647736|NCT05916131|532529814|FG003|Overall Study|Lost to Follow-up|0|||
147647737|NCT02305446|532529821|FG000|Overall Study|Adverse Event|1|||
147647738|NCT01636947|532529824|FG000|Overall Study|Not Treated|2|||
147647739|NCT01636947|532529825|FG001|Overall Study|Not Treated|2|||
147647740|NCT01636947|532529824|FG000|Overall Study|Lost to Follow-up|4|||
147647741|NCT01636947|532529825|FG001|Overall Study|Lost to Follow-up|0|||
147647742|NCT01636947|532529824|FG000|Overall Study|Protocol Violation|1|||
147647743|NCT01636947|532529825|FG001|Overall Study|Protocol Violation|1|||
147647744|NCT01636947|532529824|FG000|Overall Study|Withdrawal by Subject|3|||
147647745|NCT01636947|532529825|FG001|Overall Study|Withdrawal by Subject|3|||
147647746|NCT01636947|532529824|FG000|Overall Study|Adverse Event|1|||
147647747|NCT01636947|532529825|FG001|Overall Study|Adverse Event|1|||
147647748|NCT01636947|532529824|FG000|Overall Study|Did Not Meet Eligibility Criteria|1|||
147647749|NCT01636947|532529825|FG001|Overall Study|Did Not Meet Eligibility Criteria|4|||
147647750|NCT02719353|532529836|FG000|First Intervention|Physician Decision|0|||
147647751|NCT02719353|532529837|FG001|First Intervention|Physician Decision|1|||
147647752|NCT03956615|532529839|FG000|Overall Study|No multiple myeloma confirmed|2|||
147647753|NCT03956615|532529839|FG000|Overall Study|Assessment of membrane-expressed ideotypic paraprotein not possible due to low CD38 signals|1|||
147647754|NCT03956615|532529839|FG000|Overall Study|No expression of ideotypic paraprotein on membrane|2|||
147647755|NCT03956615|532529839|FG000|Overall Study|Not selected for sdAb generation, due to limitation of total number to 3|2|||
147421236|NCT01285609|531703870|FG000|Treated With Blinded Therapy|Participant refused participation|1|||
147647756|NCT00412217|532529840|FG000|Overall Study|Insufficient Data Available|8|||
147647757|NCT00412217|532529841|FG001|Overall Study|Insufficient Data Available|3|||
147647758|NCT00412217|532529840|FG000|Overall Study|Death|5|||
147647759|NCT00412217|532529841|FG001|Overall Study|Death|4|||
147647760|NCT00412217|532529840|FG000|Overall Study|Disease Progression|2|||
147647761|NCT00412217|532529841|FG001|Overall Study|Disease Progression|3|||
147647762|NCT00412217|532529840|FG000|Overall Study|Investigator Decision|1|||
147647763|NCT00412217|532529841|FG001|Overall Study|Investigator Decision|0|||
147647764|NCT00412217|532529840|FG000|Overall Study|Withdrawal by Subject|2|||
147647765|NCT00412217|532529841|FG001|Overall Study|Withdrawal by Subject|0|||
147647766|NCT00412217|532529840|FG000|Overall Study|Lost to Follow-up|1|||
147647767|NCT00412217|532529841|FG001|Overall Study|Lost to Follow-up|4|||
147647768|NCT00412217|532529840|FG000|Overall Study|Study Terminated by Sponsor|26|||
147647769|NCT00412217|532529841|FG001|Overall Study|Study Terminated by Sponsor|33|||
147647770|NCT00412217|532529840|FG000|Overall Study|Other|1|||
147647771|NCT00412217|532529841|FG001|Overall Study|Other|1|||
147647772|NCT01069419|532529842|FG000|Overall Study|Adverse Event|233|||
147647773|NCT01069419|532529842|FG000|Overall Study|Lack of Efficacy|332|||
147647774|NCT01069419|532529842|FG000|Overall Study|Lost to Follow-up|49|||
147647775|NCT01069419|532529842|FG000|Overall Study|Remission of disease|11|||
147647776|NCT01069419|532529842|FG000|Overall Study|Withdrawal by Subject|34|||
147647777|NCT01069419|532529842|FG000|Overall Study|Other Reason|43|||
147647778|NCT01069419|532529842|FG000|Overall Study|Missing termination information|13|||
147647779|NCT03673345|532529845|FG000|Overall Study|Lost to Follow-up|1|||
147647780|NCT03673345|532529846|FG001|Overall Study|Lost to Follow-up|0|||
147647781|NCT03673345|532529847|FG002|Overall Study|Lost to Follow-up|3|||
147647782|NCT03673345|532529848|FG003|Overall Study|Lost to Follow-up|3|||
147647783|NCT03673345|532529849|FG004|Overall Study|Lost to Follow-up|2|||
147647784|NCT03673345|532529850|FG005|Overall Study|Lost to Follow-up|1|||
147647785|NCT03673345|532529851|FG006|Overall Study|Lost to Follow-up|0|||
147647786|NCT03673345|532529852|FG007|Overall Study|Lost to Follow-up|0|||
147647787|NCT03673345|532529845|FG000|Overall Study|Withdrawal by Subject|1|||
147647788|NCT03673345|532529846|FG001|Overall Study|Withdrawal by Subject|0|||
147647789|NCT03673345|532529847|FG002|Overall Study|Withdrawal by Subject|4|||
147647790|NCT03673345|532529848|FG003|Overall Study|Withdrawal by Subject|2|||
147647791|NCT03673345|532529849|FG004|Overall Study|Withdrawal by Subject|0|||
147647792|NCT03673345|532529850|FG005|Overall Study|Withdrawal by Subject|0|||
147647793|NCT03673345|532529851|FG006|Overall Study|Withdrawal by Subject|0|||
147647794|NCT03673345|532529852|FG007|Overall Study|Withdrawal by Subject|0|||
147647795|NCT03673345|532529845|FG000|Overall Study|Physician Decision|0|||
147647796|NCT03673345|532529846|FG001|Overall Study|Physician Decision|0|||
147647797|NCT03673345|532529847|FG002|Overall Study|Physician Decision|2|||
147647798|NCT03673345|532529848|FG003|Overall Study|Physician Decision|0|||
147647799|NCT03673345|532529849|FG004|Overall Study|Physician Decision|0|||
147647800|NCT03673345|532529850|FG005|Overall Study|Physician Decision|0|||
147647801|NCT03673345|532529851|FG006|Overall Study|Physician Decision|0|||
147647802|NCT03673345|532529852|FG007|Overall Study|Physician Decision|0|||
147647803|NCT05153148|532529853|FG000|Overall Study|Adverse Event|1|||
147647804|NCT05153148|532529854|FG001|Overall Study|Adverse Event|0|||
147647805|NCT05153148|532529855|FG002|Overall Study|Adverse Event|3|||
147647806|NCT05153148|532529856|FG003|Overall Study|Adverse Event|5|||
147647807|NCT05153148|532529853|FG000|Overall Study|Lost to Follow-up|1|||
147647808|NCT05153148|532529854|FG001|Overall Study|Lost to Follow-up|1|||
147647809|NCT05153148|532529855|FG002|Overall Study|Lost to Follow-up|2|||
147647810|NCT05153148|532529856|FG003|Overall Study|Lost to Follow-up|0|||
147647811|NCT05153148|532529853|FG000|Overall Study|Withdrawal by Subject|6|||
147647812|NCT05153148|532529854|FG001|Overall Study|Withdrawal by Subject|8|||
147647813|NCT05153148|532529855|FG002|Overall Study|Withdrawal by Subject|6|||
147647814|NCT05153148|532529856|FG003|Overall Study|Withdrawal by Subject|8|||
147647815|NCT05153148|532529853|FG000|Overall Study|Coronavirus Disease 2019 (COVID-19)|0|||
147647816|NCT05153148|532529854|FG001|Overall Study|Coronavirus Disease 2019 (COVID-19)|0|||
147647817|NCT05153148|532529855|FG002|Overall Study|Coronavirus Disease 2019 (COVID-19)|1|||
147647818|NCT05153148|532529856|FG003|Overall Study|Coronavirus Disease 2019 (COVID-19)|0|||
147647819|NCT05153148|532529853|FG000|Overall Study|Randomized Without Dosing due to Ineligibility|0|||
147647820|NCT05153148|532529854|FG001|Overall Study|Randomized Without Dosing due to Ineligibility|0|||
147647821|NCT05153148|532529855|FG002|Overall Study|Randomized Without Dosing due to Ineligibility|0|||
147647822|NCT05153148|532529856|FG003|Overall Study|Randomized Without Dosing due to Ineligibility|2|||
147647823|NCT05153148|532529853|FG000|Overall Study|Reason not Specified|1|||
147647824|NCT05153148|532529854|FG001|Overall Study|Reason not Specified|1|||
147647825|NCT05153148|532529855|FG002|Overall Study|Reason not Specified|1|||
147647826|NCT05153148|532529856|FG003|Overall Study|Reason not Specified|1|||
147647827|NCT00232596|532529857|FG000|6-Week Titration Phase|Adverse Event|6|||
147647828|NCT00232596|532529858|FG001|6-Week Titration Phase|Adverse Event|19|||
147647829|NCT00232596|532529857|FG000|6-Week Titration Phase|Failed to Return|2|||
147647830|NCT00232596|532529858|FG001|6-Week Titration Phase|Failed to Return|1|||
147647831|NCT00232596|532529857|FG000|6-Week Titration Phase|Unsatisfactory Response - Efficacy|1|||
147647832|NCT00232596|532529858|FG001|6-Week Titration Phase|Unsatisfactory Response - Efficacy|2|||
147647833|NCT00232596|532529857|FG000|6-Week Titration Phase|Protocol Violation|1|||
147647834|NCT00232596|532529858|FG001|6-Week Titration Phase|Protocol Violation|3|||
147647835|NCT00232596|532529857|FG000|6-Week Titration Phase|Participant Request Unrelated to Study|1|||
147647836|NCT00232596|532529858|FG001|6-Week Titration Phase|Participant Request Unrelated to Study|0|||
147647837|NCT00232596|532529857|FG000|6-Week Titration Phase|Other|3|||
147647838|NCT00232596|532529858|FG001|6-Week Titration Phase|Other|3|||
147647839|NCT00232596|532529857|FG000|6-Week Titration Phase|Participant Did Not Receive Study Drug|0|||
147647840|NCT00232596|532529858|FG001|6-Week Titration Phase|Participant Did Not Receive Study Drug|1|||
147647841|NCT00232596|532529857|FG000|12-Week Maintenance Phase|Adverse Event|7|||
147647842|NCT00232596|532529858|FG001|12-Week Maintenance Phase|Adverse Event|22|||
147647843|NCT00232596|532529857|FG000|12-Week Maintenance Phase|Unsatisfactory Response -Efficacy|1|||
147647844|NCT00232596|532529858|FG001|12-Week Maintenance Phase|Unsatisfactory Response -Efficacy|2|||
147647845|NCT00232596|532529857|FG000|12-Week Maintenance Phase|Protocol Violation|3|||
147647846|NCT00232596|532529858|FG001|12-Week Maintenance Phase|Protocol Violation|1|||
147647847|NCT00232596|532529857|FG000|12-Week Maintenance Phase|Other|1|||
147647848|NCT00232596|532529858|FG001|12-Week Maintenance Phase|Other|3|||
147647849|NCT01712334|532529859|FG000|Treatment Period 1|Randomized in Error|0|||
147647850|NCT01712334|532529860|FG001|Treatment Period 1|Randomized in Error|2|||
147647851|NCT01253174|532529861|FG000|Period 1|Randomized but not treated|0|||
147647852|NCT01253174|532529862|FG001|Period 1|Randomized but not treated|1|||
147647853|NCT01253174|532529863|FG002|Period 1|Randomized but not treated|1|||
147647854|NCT01253174|532529864|FG003|Period 1|Randomized but not treated|0|||
147647855|NCT01253174|532529865|FG004|Period 1|Randomized but not treated|1|||
147647856|NCT01253174|532529866|FG005|Period 1|Randomized but not treated|0|||
147647857|NCT01253174|532529861|FG000|Period 2|Adverse Event|0|||
147647858|NCT01253174|532529862|FG001|Period 2|Adverse Event|0|||
147647859|NCT01253174|532529863|FG002|Period 2|Adverse Event|1|||
147647860|NCT01253174|532529864|FG003|Period 2|Adverse Event|0|||
147647861|NCT01253174|532529865|FG004|Period 2|Adverse Event|0|||
147647862|NCT01253174|532529866|FG005|Period 2|Adverse Event|0|||
147647863|NCT01253174|532529861|FG000|Period 3|Withdrawal by Subject|0|||
147647864|NCT01253174|532529862|FG001|Period 3|Withdrawal by Subject|1|||
147647865|NCT01253174|532529863|FG002|Period 3|Withdrawal by Subject|0|||
147647866|NCT01253174|532529864|FG003|Period 3|Withdrawal by Subject|0|||
147647867|NCT01253174|532529865|FG004|Period 3|Withdrawal by Subject|1|||
147647868|NCT01253174|532529866|FG005|Period 3|Withdrawal by Subject|0|||
147647869|NCT01253174|532529861|FG000|Period 3|Pregnancy|0|||
147647870|NCT01253174|532529862|FG001|Period 3|Pregnancy|0|||
147647871|NCT01253174|532529863|FG002|Period 3|Pregnancy|1|||
147647872|NCT01253174|532529864|FG003|Period 3|Pregnancy|0|||
147647873|NCT01253174|532529865|FG004|Period 3|Pregnancy|0|||
147647874|NCT01253174|532529866|FG005|Period 3|Pregnancy|0|||
147647875|NCT02267135|532529867|FG000|Period 1 (Randomized Set)|Withdrawal by Subject|1|||
147647876|NCT02267135|532529868|FG001|Period 1 (Randomized Set)|Withdrawal by Subject|3|||
147647877|NCT02267135|532529867|FG000|Period 1 (Randomized Set)|Lost to Follow-up|0|||
147647878|NCT02267135|532529868|FG001|Period 1 (Randomized Set)|Lost to Follow-up|1|||
147647879|NCT02267135|532529867|FG000|Period 2 (Randomized Set)|Lost to Follow-up|1|||
147647880|NCT02267135|532529868|FG001|Period 2 (Randomized Set)|Lost to Follow-up|1|||
147647881|NCT02267135|532529867|FG000|Period 2 (Randomized Set)|Adverse Event|2|||
147647882|NCT02267135|532529868|FG001|Period 2 (Randomized Set)|Adverse Event|0|||
147647883|NCT02267135|532529867|FG000|Period 2 (Randomized Set)|Withdrawal by Subject|1|||
147647884|NCT02267135|532529868|FG001|Period 2 (Randomized Set)|Withdrawal by Subject|0|||
147647885|NCT00932698|532529871|FG000|Part 1 (Dose Escalation)|Progressive Disease|3|||
147647886|NCT00932698|532529872|FG001|Part 1 (Dose Escalation)|Progressive Disease|2|||
147647887|NCT00932698|532529873|FG002|Part 1 (Dose Escalation)|Progressive Disease|2|||
147647888|NCT00932698|532529874|FG003|Part 1 (Dose Escalation)|Progressive Disease|2|||
147647889|NCT00932698|532529875|FG004|Part 1 (Dose Escalation)|Progressive Disease|3|||
147647890|NCT00932698|532529876|FG005|Part 1 (Dose Escalation)|Progressive Disease|5|||
147647891|NCT00932698|532529877|FG006|Part 1 (Dose Escalation)|Progressive Disease|2|||
147647892|NCT00932698|532529878|FG007|Part 1 (Dose Escalation)|Progressive Disease|0|||
147647893|NCT00932698|532529879|FG008|Part 1 (Dose Escalation)|Progressive Disease|0|||
147647894|NCT00932698|532529880|FG009|Part 1 (Dose Escalation)|Progressive Disease|0|||
147647895|NCT00932698|532529881|FG010|Part 1 (Dose Escalation)|Progressive Disease|0|||
147647896|NCT00932698|532529871|FG000|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
147647897|NCT00932698|532529872|FG001|Part 1 (Dose Escalation)|Withdrawal by Participant|1|||
147647898|NCT00932698|532529873|FG002|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
147647899|NCT00932698|532529874|FG003|Part 1 (Dose Escalation)|Withdrawal by Participant|1|||
147647900|NCT00932698|532529875|FG004|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
147647901|NCT00932698|532529876|FG005|Part 1 (Dose Escalation)|Withdrawal by Participant|1|||
147647902|NCT00932698|532529877|FG006|Part 1 (Dose Escalation)|Withdrawal by Participant|1|||
147647903|NCT00932698|532529878|FG007|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
147647904|NCT00932698|532529879|FG008|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
147647905|NCT00932698|532529880|FG009|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
147647906|NCT00932698|532529881|FG010|Part 1 (Dose Escalation)|Withdrawal by Participant|0|||
147647907|NCT00932698|532529871|FG000|Part 1 (Dose Escalation)|Adverse Event|0|||
147647908|NCT00932698|532529872|FG001|Part 1 (Dose Escalation)|Adverse Event|0|||
147647909|NCT00932698|532529873|FG002|Part 1 (Dose Escalation)|Adverse Event|0|||
147647910|NCT00932698|532529874|FG003|Part 1 (Dose Escalation)|Adverse Event|0|||
147647911|NCT00932698|532529875|FG004|Part 1 (Dose Escalation)|Adverse Event|0|||
147647912|NCT00932698|532529876|FG005|Part 1 (Dose Escalation)|Adverse Event|1|||
147647913|NCT00932698|532529877|FG006|Part 1 (Dose Escalation)|Adverse Event|0|||
147647914|NCT00932698|532529878|FG007|Part 1 (Dose Escalation)|Adverse Event|0|||
147647915|NCT00932698|532529879|FG008|Part 1 (Dose Escalation)|Adverse Event|0|||
147647916|NCT00932698|532529880|FG009|Part 1 (Dose Escalation)|Adverse Event|0|||
147647917|NCT00932698|532529881|FG010|Part 1 (Dose Escalation)|Adverse Event|0|||
147647918|NCT00932698|532529871|FG000|Part 1 (Dose Escalation)|Other|0|||
147647919|NCT00932698|532529872|FG001|Part 1 (Dose Escalation)|Other|0|||
147647920|NCT00932698|532529873|FG002|Part 1 (Dose Escalation)|Other|1|||
147647921|NCT00932698|532529874|FG003|Part 1 (Dose Escalation)|Other|0|||
147647922|NCT00932698|532529875|FG004|Part 1 (Dose Escalation)|Other|0|||
147532701|NCT01243762|532105982|FG000|Part 1 (Dose Escalation/MTD)|Physician Decision|0|||
147532702|NCT01243762|532105983|FG001|Part 1 (Dose Escalation/MTD)|Physician Decision|1|||
147647923|NCT00932698|532529876|FG005|Part 1 (Dose Escalation)|Other|0|||
147647924|NCT00932698|532529877|FG006|Part 1 (Dose Escalation)|Other|1|||
147647925|NCT00932698|532529878|FG007|Part 1 (Dose Escalation)|Other|0|||
147191107|NCT04607668|530867553|FG001|Overall Study|Lost to Follow-up|4|||
147191108|NCT04607668|530867552|FG000|Overall Study|Study terminated by Sponsor|92|||
147191109|NCT04607668|530867553|FG001|Overall Study|Study terminated by Sponsor|114|||
147191110|NCT04607668|530867552|FG000|Overall Study|Withdrawal by Subject|12|||
147647926|NCT00932698|532529879|FG008|Part 1 (Dose Escalation)|Other|0|||
147647927|NCT00932698|532529880|FG009|Part 1 (Dose Escalation)|Other|0|||
147647928|NCT00932698|532529881|FG010|Part 1 (Dose Escalation)|Other|0|||
147647929|NCT00932698|532529871|FG000|Part 2 (Dose Expansion)|Progressive Disease|0|||
147647930|NCT00932698|532529872|FG001|Part 2 (Dose Expansion)|Progressive Disease|0|||
147647931|NCT00932698|532529873|FG002|Part 2 (Dose Expansion)|Progressive Disease|0|||
147647932|NCT00932698|532529874|FG003|Part 2 (Dose Expansion)|Progressive Disease|0|||
147647933|NCT00932698|532529875|FG004|Part 2 (Dose Expansion)|Progressive Disease|0|||
147647934|NCT00932698|532529876|FG005|Part 2 (Dose Expansion)|Progressive Disease|0|||
147647935|NCT00932698|532529877|FG006|Part 2 (Dose Expansion)|Progressive Disease|0|||
147647936|NCT00932698|532529878|FG007|Part 2 (Dose Expansion)|Progressive Disease|14|||
147647937|NCT00932698|532529879|FG008|Part 2 (Dose Expansion)|Progressive Disease|8|||
147647938|NCT00932698|532529880|FG009|Part 2 (Dose Expansion)|Progressive Disease|3|||
147647939|NCT00932698|532529881|FG010|Part 2 (Dose Expansion)|Progressive Disease|2|||
147647940|NCT00932698|532529871|FG000|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
147647941|NCT00932698|532529872|FG001|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
147647942|NCT00932698|532529873|FG002|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
147647943|NCT00932698|532529874|FG003|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
147647944|NCT00932698|532529875|FG004|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
147647945|NCT00932698|532529876|FG005|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
147647946|NCT00932698|532529877|FG006|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
147647947|NCT00932698|532529878|FG007|Part 2 (Dose Expansion)|Withdrawal by Subject|1|||
147647948|NCT00932698|532529879|FG008|Part 2 (Dose Expansion)|Withdrawal by Subject|3|||
147647949|NCT00932698|532529880|FG009|Part 2 (Dose Expansion)|Withdrawal by Subject|2|||
147647950|NCT00932698|532529881|FG010|Part 2 (Dose Expansion)|Withdrawal by Subject|0|||
147647951|NCT00932698|532529871|FG000|Part 2 (Dose Expansion)|Adverse Event|0|||
147647952|NCT00932698|532529872|FG001|Part 2 (Dose Expansion)|Adverse Event|0|||
147647953|NCT00932698|532529873|FG002|Part 2 (Dose Expansion)|Adverse Event|0|||
147647954|NCT00932698|532529874|FG003|Part 2 (Dose Expansion)|Adverse Event|0|||
147647955|NCT00932698|532529875|FG004|Part 2 (Dose Expansion)|Adverse Event|0|||
147647956|NCT00932698|532529876|FG005|Part 2 (Dose Expansion)|Adverse Event|0|||
147647957|NCT00932698|532529877|FG006|Part 2 (Dose Expansion)|Adverse Event|0|||
147647958|NCT00932698|532529878|FG007|Part 2 (Dose Expansion)|Adverse Event|5|||
147647959|NCT00932698|532529879|FG008|Part 2 (Dose Expansion)|Adverse Event|1|||
147647960|NCT00932698|532529880|FG009|Part 2 (Dose Expansion)|Adverse Event|1|||
147647961|NCT00932698|532529881|FG010|Part 2 (Dose Expansion)|Adverse Event|0|||
147647962|NCT00131365|532529882|FG000|Overall Study|Withdrawal by Subject|1|||
147647963|NCT00131365|532529882|FG000|Overall Study|Alternative treatment|3|||
147647964|NCT04608344|532529883|FG000|Period 1 (AB: 3 Days, BA: 11 Days)|Adverse Event|0|||
147647965|NCT04608344|532529884|FG001|Period 1 (AB: 3 Days, BA: 11 Days)|Adverse Event|1|||
147647966|NCT04608344|532529883|FG000|Period 1 (AB: 3 Days, BA: 11 Days)|Investigator's Discretion|1|||
147647967|NCT04608344|532529884|FG001|Period 1 (AB: 3 Days, BA: 11 Days)|Investigator's Discretion|0|||
147647968|NCT05249127|532529885|FG000|Overall Study|Protocol Violation|13|||
147647969|NCT05249127|532529885|FG000|Overall Study|Physician Decision|4|||
147647970|NCT05249127|532529885|FG000|Overall Study|Withdrawal by Subject|2|||
147647971|NCT05249127|532529885|FG000|Overall Study|Participant Non-compliance|1|||
147647972|NCT02908074|532529886|FG000|Overall Study|sponsor/ICON decision|0|||
147647973|NCT02908074|532529887|FG001|Overall Study|sponsor/ICON decision|0|||
147647974|NCT02908074|532529888|FG002|Overall Study|sponsor/ICON decision|1|||
147647975|NCT02908074|532529889|FG003|Overall Study|sponsor/ICON decision|0|||
147647976|NCT02908074|532529890|FG004|Overall Study|sponsor/ICON decision|0|||
147647977|NCT02908074|532529891|FG005|Overall Study|sponsor/ICON decision|0|||
147647978|NCT02908074|532529886|FG000|Overall Study|Protocol Violation|0|||
147647979|NCT02908074|532529887|FG001|Overall Study|Protocol Violation|1|||
147647980|NCT02908074|532529888|FG002|Overall Study|Protocol Violation|0|||
147647981|NCT02908074|532529889|FG003|Overall Study|Protocol Violation|0|||
147647982|NCT02908074|532529890|FG004|Overall Study|Protocol Violation|0|||
147647983|NCT02908074|532529891|FG005|Overall Study|Protocol Violation|0|||
147647984|NCT02908074|532529886|FG000|Overall Study|Adverse Event|5|||
147647985|NCT02908074|532529887|FG001|Overall Study|Adverse Event|2|||
147647986|NCT02908074|532529888|FG002|Overall Study|Adverse Event|0|||
147647987|NCT02908074|532529889|FG003|Overall Study|Adverse Event|0|||
147647988|NCT02908074|532529890|FG004|Overall Study|Adverse Event|1|||
147647989|NCT02908074|532529891|FG005|Overall Study|Adverse Event|0|||
147647990|NCT02908074|532529886|FG000|Overall Study|AESI|1|||
147647991|NCT02908074|532529887|FG001|Overall Study|AESI|0|||
147647992|NCT02908074|532529888|FG002|Overall Study|AESI|1|||
147647993|NCT02908074|532529889|FG003|Overall Study|AESI|0|||
147647994|NCT02908074|532529890|FG004|Overall Study|AESI|1|||
147647995|NCT02908074|532529891|FG005|Overall Study|AESI|0|||
147647996|NCT02908074|532529886|FG000|Overall Study|Discontinuation criteria per protocol|0|||
147647997|NCT02908074|532529887|FG001|Overall Study|Discontinuation criteria per protocol|0|||
147647998|NCT02908074|532529888|FG002|Overall Study|Discontinuation criteria per protocol|1|||
147647999|NCT02908074|532529889|FG003|Overall Study|Discontinuation criteria per protocol|0|||
147648000|NCT02908074|532529890|FG004|Overall Study|Discontinuation criteria per protocol|0|||
147648001|NCT02908074|532529891|FG005|Overall Study|Discontinuation criteria per protocol|1|||
147648002|NCT02908074|532529886|FG000|Overall Study|Withdrawal by Subject|3|||
147648003|NCT02908074|532529887|FG001|Overall Study|Withdrawal by Subject|2|||
147648004|NCT02908074|532529888|FG002|Overall Study|Withdrawal by Subject|2|||
147648005|NCT02908074|532529889|FG003|Overall Study|Withdrawal by Subject|2|||
147648006|NCT02908074|532529890|FG004|Overall Study|Withdrawal by Subject|2|||
147648007|NCT02908074|532529891|FG005|Overall Study|Withdrawal by Subject|2|||
147648008|NCT02908074|532529886|FG000|Overall Study|Lost to Follow-up|0|||
147648009|NCT02908074|532529887|FG001|Overall Study|Lost to Follow-up|1|||
147648010|NCT02908074|532529888|FG002|Overall Study|Lost to Follow-up|1|||
147648011|NCT02908074|532529889|FG003|Overall Study|Lost to Follow-up|1|||
147648012|NCT02908074|532529890|FG004|Overall Study|Lost to Follow-up|0|||
147648013|NCT02908074|532529891|FG005|Overall Study|Lost to Follow-up|1|||
147648014|NCT02073565|532529892|FG000|Cohort A|Withdrawal by Subject|1|||
147648015|NCT02073565|532529893|FG001|Cohort A|Withdrawal by Subject|0|||
147648016|NCT02073565|532529892|FG000|Cohort B|Withdrawal by Subject|1|||
147648017|NCT02073565|532529893|FG001|Cohort B|Withdrawal by Subject|2|||
147648018|NCT02073565|532529892|FG000|Cohort C|Withdrawal by Subject|0|||
147648019|NCT02073565|532529893|FG001|Cohort C|Withdrawal by Subject|2|||
147648020|NCT02073565|532529892|FG000|Cohort C|Lost to Follow-up|0|||
147648021|NCT02073565|532529893|FG001|Cohort C|Lost to Follow-up|2|||
147648022|NCT03646305|532529894|FG000|Overall Study|Lost to Follow-up|4|||
147648023|NCT03646305|532529895|FG001|Overall Study|Lost to Follow-up|2|||
147648024|NCT03646305|532529896|FG002|Overall Study|Lost to Follow-up|2|||
147648025|NCT03646305|532529897|FG003|Overall Study|Lost to Follow-up|1|||
147648026|NCT03646305|532529894|FG000|Overall Study|Withdrawal by Subject|1|||
147648027|NCT03646305|532529895|FG001|Overall Study|Withdrawal by Subject|0|||
147648028|NCT03646305|532529896|FG002|Overall Study|Withdrawal by Subject|0|||
147648029|NCT03646305|532529897|FG003|Overall Study|Withdrawal by Subject|1|||
147648030|NCT01554176|532529898|FG000|Treatment Phase|Protocol Violation|1|||
147648031|NCT01554176|532529899|FG001|Treatment Phase|Protocol Violation|2|||
147648032|NCT01554176|532529900|FG002|Treatment Phase|Protocol Violation|0|||
147648033|NCT01554176|532529901|FG003|Treatment Phase|Protocol Violation|0|||
147648034|NCT01554176|532529902|FG004|Treatment Phase|Protocol Violation|0|||
147648035|NCT01554176|532529898|FG000|Treatment Phase|Physician Decision|1|||
147648036|NCT01554176|532529899|FG001|Treatment Phase|Physician Decision|1|||
147648037|NCT01554176|532529900|FG002|Treatment Phase|Physician Decision|0|||
147648038|NCT01554176|532529901|FG003|Treatment Phase|Physician Decision|0|||
147648039|NCT01554176|532529902|FG004|Treatment Phase|Physician Decision|0|||
147648040|NCT01554176|532529898|FG000|Treatment Phase|Lack of Efficacy|0|||
147648041|NCT01554176|532529899|FG001|Treatment Phase|Lack of Efficacy|1|||
147421237|NCT01285609|531703871|FG001|Treated With Blinded Therapy|Participant refused participation|0|||
147648042|NCT01554176|532529900|FG002|Treatment Phase|Lack of Efficacy|0|||
147648043|NCT01554176|532529901|FG003|Treatment Phase|Lack of Efficacy|0|||
147648044|NCT01554176|532529902|FG004|Treatment Phase|Lack of Efficacy|0|||
147648045|NCT01554176|532529898|FG000|Treatment Phase|Adverse event, non-fatal|1|||
147648046|NCT01554176|532529899|FG001|Treatment Phase|Adverse event, non-fatal|1|||
147648047|NCT01554176|532529900|FG002|Treatment Phase|Adverse event, non-fatal|0|||
147648048|NCT01554176|532529901|FG003|Treatment Phase|Adverse event, non-fatal|0|||
147648049|NCT01554176|532529902|FG004|Treatment Phase|Adverse event, non-fatal|0|||
147648050|NCT01554176|532529898|FG000|Treatment Phase|Non-compliance with study drug|1|||
147648051|NCT01554176|532529899|FG001|Treatment Phase|Non-compliance with study drug|0|||
147648052|NCT01554176|532529900|FG002|Treatment Phase|Non-compliance with study drug|0|||
147648053|NCT01554176|532529901|FG003|Treatment Phase|Non-compliance with study drug|0|||
147648054|NCT01554176|532529902|FG004|Treatment Phase|Non-compliance with study drug|0|||
147648055|NCT01554176|532529898|FG000|Treatment Phase|Withdrawal by Subject|1|||
147648056|NCT01554176|532529899|FG001|Treatment Phase|Withdrawal by Subject|0|||
147648057|NCT01554176|532529900|FG002|Treatment Phase|Withdrawal by Subject|0|||
147648058|NCT01554176|532529901|FG003|Treatment Phase|Withdrawal by Subject|0|||
147648059|NCT01554176|532529902|FG004|Treatment Phase|Withdrawal by Subject|0|||
147648060|NCT01554176|532529898|FG000|Treatment Phase|Lost to Follow-up|3|||
147648061|NCT01554176|532529899|FG001|Treatment Phase|Lost to Follow-up|0|||
147648062|NCT01554176|532529900|FG002|Treatment Phase|Lost to Follow-up|0|||
147648063|NCT01554176|532529901|FG003|Treatment Phase|Lost to Follow-up|0|||
147648064|NCT01554176|532529902|FG004|Treatment Phase|Lost to Follow-up|0|||
147648065|NCT01554176|532529898|FG000|Run-out Phase|Protocol Violation|0|||
147648066|NCT01554176|532529899|FG001|Run-out Phase|Protocol Violation|0|||
147648067|NCT01554176|532529900|FG002|Run-out Phase|Protocol Violation|0|||
147648068|NCT01554176|532529901|FG003|Run-out Phase|Protocol Violation|1|||
147648069|NCT01554176|532529902|FG004|Run-out Phase|Protocol Violation|0|||
147648070|NCT02607306|532529905|FG000|Overall Study|Adverse Event|8|||
147648071|NCT02607306|532529906|FG001|Overall Study|Adverse Event|6|||
147648072|NCT02607306|532529907|FG002|Overall Study|Adverse Event|6|||
147648073|NCT02607306|532529905|FG000|Overall Study|Unclassified|1|||
147648074|NCT02607306|532529906|FG001|Overall Study|Unclassified|4|||
147648075|NCT02607306|532529907|FG002|Overall Study|Unclassified|0|||
147648076|NCT02607306|532529905|FG000|Overall Study|Withdrawal by Subject|8|||
147648077|NCT02607306|532529906|FG001|Overall Study|Withdrawal by Subject|10|||
147648078|NCT02607306|532529907|FG002|Overall Study|Withdrawal by Subject|2|||
147648079|NCT02607306|532529905|FG000|Overall Study|Lack of Efficacy|0|||
147648080|NCT02607306|532529906|FG001|Overall Study|Lack of Efficacy|1|||
147648081|NCT02607306|532529907|FG002|Overall Study|Lack of Efficacy|1|||
147648082|NCT02607306|532529905|FG000|Overall Study|Protocol Violation|4|||
147648083|NCT02607306|532529906|FG001|Overall Study|Protocol Violation|2|||
147648084|NCT02607306|532529907|FG002|Overall Study|Protocol Violation|1|||
147648085|NCT02333383|532529908|FG000|Overall Study|Adalimumab discontinuation|21|||
147648086|NCT02333383|532529908|FG000|Overall Study|Lost to Follow-up|15|||
147648087|NCT02333383|532529908|FG000|Overall Study|Withdrawal by Subject|3|||
147648088|NCT02333383|532529908|FG000|Overall Study|Transfer to another hospital|2|||
147648089|NCT00463840|532529909|FG000|Overall Study|Disease progression|7|||
147648090|NCT00463840|532529909|FG000|Overall Study|Withdrawal by Subject|2|||
147648091|NCT00463840|532529909|FG000|Overall Study|Adverse Event|3|||
147648092|NCT01653327|532529910|FG000|Overall Study|Withdrawal by Subject|1|||
147648093|NCT04683939|532529917|FG000|Overall Study|Study termination by the sponsor|0|||
147648094|NCT04683939|532529918|FG001|Overall Study|Study termination by the sponsor|1|||
147648095|NCT04683939|532529919|FG002|Overall Study|Study termination by the sponsor|2|||
147648096|NCT04683939|532529920|FG003|Overall Study|Study termination by the sponsor|2|||
147648097|NCT04683939|532529917|FG000|Overall Study|Death|1|||
147648098|NCT04683939|532529918|FG001|Overall Study|Death|1|||
147648099|NCT04683939|532529919|FG002|Overall Study|Death|2|||
147648100|NCT04683939|532529920|FG003|Overall Study|Death|1|||
147648101|NCT04683939|532529917|FG000|Overall Study|Withdrawal by Subject|1|||
147648102|NCT04683939|532529918|FG001|Overall Study|Withdrawal by Subject|0|||
147648103|NCT04683939|532529919|FG002|Overall Study|Withdrawal by Subject|0|||
147648104|NCT04683939|532529920|FG003|Overall Study|Withdrawal by Subject|0|||
147648105|NCT04683939|532529917|FG000|Overall Study|Physician Decision|1|||
147648106|NCT04683939|532529918|FG001|Overall Study|Physician Decision|0|||
147648107|NCT04683939|532529919|FG002|Overall Study|Physician Decision|0|||
147648108|NCT04683939|532529920|FG003|Overall Study|Physician Decision|0|||
147648109|NCT04683939|532529917|FG000|Overall Study|Lost to Follow-up|0|||
147648110|NCT04683939|532529918|FG001|Overall Study|Lost to Follow-up|1|||
147648111|NCT04683939|532529919|FG002|Overall Study|Lost to Follow-up|0|||
147648112|NCT04683939|532529920|FG003|Overall Study|Lost to Follow-up|0|||
147648113|NCT02510820|532531506|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|0|||
147648114|NCT02510820|532531507|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
147648115|NCT02510820|532531506|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
147648116|NCT02510820|532531507|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
147648117|NCT03089853|532531508|FG000|Overall Study|Lost to Follow-up|2|||
147648118|NCT03089853|532531509|FG001|Overall Study|Lost to Follow-up|1|||
147648119|NCT00642954|532531510|FG000|Overall Study|Progressive Disease|3|||
147648120|NCT00642954|532531511|FG001|Overall Study|Progressive Disease|3|||
147648121|NCT00642954|532531512|FG002|Overall Study|Progressive Disease|3|||
147648122|NCT00642954|532531513|FG003|Overall Study|Progressive Disease|3|||
147648123|NCT00642954|532531514|FG004|Overall Study|Progressive Disease|9|||
147648124|NCT00642954|532531510|FG000|Overall Study|Withdrawal by Subject|0|||
147648125|NCT00642954|532531511|FG001|Overall Study|Withdrawal by Subject|0|||
147648126|NCT00642954|532531512|FG002|Overall Study|Withdrawal by Subject|0|||
147648127|NCT00642954|532531513|FG003|Overall Study|Withdrawal by Subject|0|||
147648128|NCT00642954|532531514|FG004|Overall Study|Withdrawal by Subject|1|||
147648129|NCT00642954|532531510|FG000|Overall Study|Adverse Event|1|||
147648130|NCT00642954|532531511|FG001|Overall Study|Adverse Event|1|||
147648131|NCT00642954|532531512|FG002|Overall Study|Adverse Event|0|||
147648132|NCT00642954|532531513|FG003|Overall Study|Adverse Event|0|||
147648133|NCT00642954|532531514|FG004|Overall Study|Adverse Event|6|||
147648134|NCT02913105|532531515|FG000|Overall Study|Adverse Event|11|||
147648135|NCT02913105|532531516|FG001|Overall Study|Adverse Event|0|||
147648136|NCT02913105|532531517|FG002|Overall Study|Adverse Event|4|||
147648137|NCT02913105|532531515|FG000|Overall Study|Non-Compliance With Study Drug|0|||
147648138|NCT02913105|532531516|FG001|Overall Study|Non-Compliance With Study Drug|0|||
147648139|NCT02913105|532531517|FG002|Overall Study|Non-Compliance With Study Drug|1|||
147648140|NCT02913105|532531515|FG000|Overall Study|Reason Not Specified|3|||
147648141|NCT02913105|532531516|FG001|Overall Study|Reason Not Specified|1|||
147648142|NCT02913105|532531517|FG002|Overall Study|Reason Not Specified|1|||
147648143|NCT02913105|532531515|FG000|Overall Study|Physician Decision|1|||
147648144|NCT02913105|532531516|FG001|Overall Study|Physician Decision|1|||
147648145|NCT02913105|532531517|FG002|Overall Study|Physician Decision|0|||
147648146|NCT02913105|532531515|FG000|Overall Study|Withdrawal by Subject|0|||
147648147|NCT02913105|532531516|FG001|Overall Study|Withdrawal by Subject|3|||
147648148|NCT02913105|532531517|FG002|Overall Study|Withdrawal by Subject|1|||
147648149|NCT01317004|532531518|FG000|Overall Study|Withdrawal by Subject|1|||
147648150|NCT01317004|532531519|FG001|Overall Study|Withdrawal by Subject|4|||
147648151|NCT01317004|532531518|FG000|Overall Study|Protocol Violation|0|||
147648152|NCT01317004|532531519|FG001|Overall Study|Protocol Violation|2|||
147648153|NCT01317004|532531518|FG000|Overall Study|Adverse Event|3|||
147648154|NCT01317004|532531519|FG001|Overall Study|Adverse Event|3|||
147648155|NCT04114656|532531520|FG000|Treatment Period1+Washout(Up to 28 Days)|Withdrawal by Subject|0|||
147648156|NCT04114656|532531521|FG001|Treatment Period1+Washout(Up to 28 Days)|Withdrawal by Subject|1|||
147648157|NCT04114656|532531520|FG000|Treatment Period1+Washout(Up to 28 Days)|Study closed/terminated|0|||
147648158|NCT04114656|532531521|FG001|Treatment Period1+Washout(Up to 28 Days)|Study closed/terminated|2|||
147648159|NCT04114656|532531520|FG000|Treatment Period1+Washout(Up to 28 Days)|Participant reached protocol defined stopping criteria|1|||
147648160|NCT04114656|532531521|FG001|Treatment Period1+Washout(Up to 28 Days)|Participant reached protocol defined stopping criteria|0|||
147648161|NCT04114656|532531520|FG000|Treatment Period1+Washout(Up to 28 Days)|Protocol Violation|1|||
147648162|NCT04114656|532531521|FG001|Treatment Period1+Washout(Up to 28 Days)|Protocol Violation|0|||
147648163|NCT04114656|532531520|FG000|Treatment Period2+Washout(Up to 28 Days)|Participant reached protocol defined stopping criteria|0|||
147648164|NCT04114656|532531521|FG001|Treatment Period2+Washout(Up to 28 Days)|Participant reached protocol defined stopping criteria|1|||
147648165|NCT02661061|532531522|FG000|Overall Study|Lack of Efficacy|1|||
147648166|NCT02661061|532531523|FG001|Overall Study|Lack of Efficacy|1|||
147648167|NCT02661061|532531522|FG000|Overall Study|Withdrawal by Subject|1|||
147648168|NCT02661061|532531523|FG001|Overall Study|Withdrawal by Subject|1|||
147648169|NCT03052920|532531524|FG000|Overall Study|Withdrawal by Subject|1|||
147648170|NCT01980628|532531525|FG000|Overall Study|Adverse Event|12|||
147648171|NCT01980628|532531525|FG000|Overall Study|Physician Decision|5|||
147648172|NCT01980628|532531525|FG000|Overall Study|Withdrawal by Subject|4|||
147648173|NCT01980628|532531525|FG000|Overall Study|PD, Subj non-Compliant,Study Terminated|42|||
147648174|NCT02578940|532531526|FG000|Overall Study|Screening failure|5|||
147648175|NCT02578940|532531526|FG000|Overall Study|Lost to Follow-up|1|||
147648176|NCT01937715|532531535|FG000|Overall Study|Death|0|||
147648177|NCT01937715|532531536|FG001|Overall Study|Death|0|||
147648178|NCT01937715|532531537|FG002|Overall Study|Death|0|||
147648179|NCT01937715|532531538|FG003|Overall Study|Death|1|||
147648180|NCT01937715|532531539|FG004|Overall Study|Death|0|||
147648181|NCT01937715|532531535|FG000|Overall Study|Withdrawal by Subject|0|||
147648182|NCT01937715|532531536|FG001|Overall Study|Withdrawal by Subject|1|||
147648183|NCT01937715|532531537|FG002|Overall Study|Withdrawal by Subject|0|||
147648184|NCT01937715|532531538|FG003|Overall Study|Withdrawal by Subject|0|||
147648185|NCT01937715|532531539|FG004|Overall Study|Withdrawal by Subject|2|||
147648186|NCT01937715|532531535|FG000|Overall Study|Other|0|||
147648187|NCT01937715|532531536|FG001|Overall Study|Other|0|||
147648188|NCT01937715|532531537|FG002|Overall Study|Other|0|||
147648189|NCT01937715|532531538|FG003|Overall Study|Other|3|||
147648190|NCT01937715|532531539|FG004|Overall Study|Other|0|||
147648191|NCT01698268|532531542|FG000|Overall Study|Physician Decision|2|||
147648192|NCT01698268|532531543|FG001|Overall Study|Physician Decision|1|||
147648193|NCT02469168|532531545|FG000|Overall Study|Trial closed|1|||
147648194|NCT02469168|532531546|FG001|Overall Study|Trial closed|0|||
147648195|NCT00298363|532531547|FG000|Overall Study|Lost to Follow-up|0|||
147648196|NCT00298363|532531548|FG001|Overall Study|Lost to Follow-up|0|||
147648197|NCT00298363|532531549|FG002|Overall Study|Lost to Follow-up|1|||
147648198|NCT00298363|532531547|FG000|Overall Study|Physician Decision|4|||
147648199|NCT00298363|532531548|FG001|Overall Study|Physician Decision|1|||
147648200|NCT00298363|532531549|FG002|Overall Study|Physician Decision|0|||
147648201|NCT00298363|532531547|FG000|Overall Study|Protocol Violation|1|||
147648202|NCT00298363|532531548|FG001|Overall Study|Protocol Violation|1|||
147648203|NCT00298363|532531549|FG002|Overall Study|Protocol Violation|0|||
147648204|NCT00298363|532531547|FG000|Overall Study|Withdrawal by Subject|5|||
147648205|NCT00298363|532531548|FG001|Overall Study|Withdrawal by Subject|1|||
147648206|NCT00298363|532531549|FG002|Overall Study|Withdrawal by Subject|3|||
147648207|NCT00298363|532531547|FG000|Overall Study|Adverse Event|5|||
147648208|NCT00298363|532531548|FG001|Overall Study|Adverse Event|2|||
147648209|NCT00298363|532531549|FG002|Overall Study|Adverse Event|2|||
147648210|NCT00298363|532531547|FG000|Overall Study|Lack of Efficacy|2|||
147648211|NCT00298363|532531548|FG001|Overall Study|Lack of Efficacy|3|||
147648212|NCT00298363|532531549|FG002|Overall Study|Lack of Efficacy|0|||
147648213|NCT00135356|532531550|FG000|Overall Study|Adverse Event|6|||
147648214|NCT00135356|532531551|FG001|Overall Study|Adverse Event|2|||
147648215|NCT00135356|532531550|FG000|Overall Study|Lack of Efficacy|2|||
147648216|NCT00135356|532531551|FG001|Overall Study|Lack of Efficacy|0|||
147648217|NCT00135356|532531550|FG000|Overall Study|Lost to Follow-up|3|||
147648218|NCT00135356|532531551|FG001|Overall Study|Lost to Follow-up|1|||
147648219|NCT00135356|532531550|FG000|Overall Study|Surgery for abdominal fat|1|||
147648220|NCT00135356|532531551|FG001|Overall Study|Surgery for abdominal fat|0|||
147648221|NCT00135356|532531550|FG000|Overall Study|Change in antiviral regimen|0|||
147648222|NCT00135356|532531551|FG001|Overall Study|Change in antiviral regimen|1|||
147648223|NCT00135356|532531550|FG000|Overall Study|Poor/noncompliance|1|||
147648224|NCT00135356|532531551|FG001|Overall Study|Poor/noncompliance|1|||
147648225|NCT00135356|532531550|FG000|Overall Study|No longer meets study criteria|2|||
147648226|NCT00135356|532531551|FG001|Overall Study|No longer meets study criteria|0|||
147648227|NCT00135356|532531550|FG000|Overall Study|Withdrawal by Subject|2|||
147648228|NCT00135356|532531551|FG001|Overall Study|Withdrawal by Subject|4|||
147648229|NCT00153816|532531552|FG000|Overall Study|Death|6|||
147648230|NCT00153816|532531553|FG001|Overall Study|Death|5|||
147648231|NCT00153816|532531554|FG002|Overall Study|Death|4|||
147648232|NCT00153816|532531555|FG003|Overall Study|Death|6|||
147648233|NCT00153816|532531556|FG004|Overall Study|Death|0|||
147648234|NCT00153816|532531557|FG005|Overall Study|Death|2|||
147648235|NCT00153816|532531552|FG000|Overall Study|Lost to Follow-up|7|||
147648236|NCT00153816|532531553|FG001|Overall Study|Lost to Follow-up|8|||
147648237|NCT00153816|532531554|FG002|Overall Study|Lost to Follow-up|5|||
147648238|NCT00153816|532531555|FG003|Overall Study|Lost to Follow-up|8|||
147648239|NCT00153816|532531556|FG004|Overall Study|Lost to Follow-up|7|||
147648240|NCT00153816|532531557|FG005|Overall Study|Lost to Follow-up|9|||
147648241|NCT00153816|532531552|FG000|Overall Study|Withdrawal by Subject|9|||
147648242|NCT00153816|532531553|FG001|Overall Study|Withdrawal by Subject|9|||
147648243|NCT00153816|532531554|FG002|Overall Study|Withdrawal by Subject|9|||
147648244|NCT00153816|532531555|FG003|Overall Study|Withdrawal by Subject|4|||
147648245|NCT00153816|532531556|FG004|Overall Study|Withdrawal by Subject|1|||
147648246|NCT00153816|532531557|FG005|Overall Study|Withdrawal by Subject|5|||
147648247|NCT00153816|532531552|FG000|Overall Study|Follow-up exam not done|8|||
147648248|NCT00153816|532531553|FG001|Overall Study|Follow-up exam not done|7|||
147648249|NCT00153816|532531554|FG002|Overall Study|Follow-up exam not done|11|||
147648250|NCT00153816|532531555|FG003|Overall Study|Follow-up exam not done|10|||
147648251|NCT00153816|532531556|FG004|Overall Study|Follow-up exam not done|8|||
147648252|NCT00153816|532531557|FG005|Overall Study|Follow-up exam not done|9|||
147648253|NCT00153816|532531552|FG000|Overall Study|Follow-up exam done, histology missing|2|||
147648254|NCT00153816|532531553|FG001|Overall Study|Follow-up exam done, histology missing|3|||
147648255|NCT00153816|532531554|FG002|Overall Study|Follow-up exam done, histology missing|3|||
147648256|NCT00153816|532531555|FG003|Overall Study|Follow-up exam done, histology missing|3|||
147648257|NCT00153816|532531556|FG004|Overall Study|Follow-up exam done, histology missing|1|||
147648258|NCT00153816|532531557|FG005|Overall Study|Follow-up exam done, histology missing|2|||
147648259|NCT01533688|532531560|FG000|Overall Study|Withdrawal by Subject|5|||
147648260|NCT01533688|532531561|FG001|Overall Study|Withdrawal by Subject|4|||
147648261|NCT01533688|532531562|FG002|Overall Study|Withdrawal by Subject|3|||
147648262|NCT01533688|532531560|FG000|Overall Study|Medically unstable|1|||
147648263|NCT01533688|532531561|FG001|Overall Study|Medically unstable|3|||
147648264|NCT01533688|532531562|FG002|Overall Study|Medically unstable|3|||
147648265|NCT01533688|532531560|FG000|Overall Study|Had colonoscopy at outside hospital|2|||
147648266|NCT01533688|532531561|FG001|Overall Study|Had colonoscopy at outside hospital|3|||
147648267|NCT01533688|532531562|FG002|Overall Study|Had colonoscopy at outside hospital|2|||
147648268|NCT02263729|532531563|FG000|Overall Study|Lost to Follow-up|1|||
147648269|NCT02263729|532531564|FG001|Overall Study|Lost to Follow-up|1|||
147648270|NCT04591015|532531565|FG000|Overall Study|Death|6|||
147648271|NCT04591015|532531566|FG001|Overall Study|Death|4|||
147648272|NCT04591015|532531565|FG000|Overall Study|Withdrawal by Subject|6|||
147648273|NCT04591015|532531566|FG001|Overall Study|Withdrawal by Subject|3|||
147648274|NCT04591015|532531565|FG000|Overall Study|Lost to Follow-up|16|||
147648275|NCT04591015|532531566|FG001|Overall Study|Lost to Follow-up|11|||
147648276|NCT06226649|532531570|FG000|Overall Study|Withdrawal by Subject|4|||
147648277|NCT06226649|532531571|FG001|Overall Study|Withdrawal by Subject|1|||
147648278|NCT01955109|532531578|FG000|Overall Study|Adverse Event|2|||
147648279|NCT01955109|532531579|FG001|Overall Study|Adverse Event|0|||
147648280|NCT01955109|532531578|FG000|Overall Study|Participant unwilling to continue|35|||
147648281|NCT01955109|532531579|FG001|Overall Study|Participant unwilling to continue|7|||
147648282|NCT01955109|532531578|FG000|Overall Study|Physician Decision|2|||
147648283|NCT01955109|532531579|FG001|Overall Study|Physician Decision|0|||
147648284|NCT01955109|532531578|FG000|Overall Study|Lost to Follow-up|3|||
147648285|NCT01955109|532531579|FG001|Overall Study|Lost to Follow-up|1|||
147648286|NCT01955109|532531578|FG000|Overall Study|Non-compliance|3|||
147648287|NCT01955109|532531579|FG001|Overall Study|Non-compliance|1|||
147648288|NCT01167634|532531580|FG000|Overall Study|Lost to Follow-up|1|||
147648289|NCT01167634|532531581|FG001|Overall Study|Lost to Follow-up|3|||
147648290|NCT01167634|532531582|FG002|Overall Study|Lost to Follow-up|3|||
147648291|NCT01167634|532531583|FG003|Overall Study|Lost to Follow-up|4|||
147648292|NCT01167634|532531580|FG000|Overall Study|Withdrawal by Subject|1|||
147648293|NCT01167634|532531581|FG001|Overall Study|Withdrawal by Subject|1|||
147648294|NCT01167634|532531582|FG002|Overall Study|Withdrawal by Subject|0|||
147648295|NCT01167634|532531583|FG003|Overall Study|Withdrawal by Subject|0|||
147648296|NCT02614131|532531584|FG000|Overall Study|Withdrawal by Subject|1|||
147648297|NCT02614131|532531585|FG001|Overall Study|Withdrawal by Subject|0|||
147648298|NCT02614131|532531586|FG002|Overall Study|Withdrawal by Subject|0|||
147648299|NCT02614131|532531587|FG003|Overall Study|Withdrawal by Subject|0|||
147648300|NCT02614131|532531588|FG004|Overall Study|Withdrawal by Subject|0|||
147648301|NCT02614131|532531589|FG005|Overall Study|Withdrawal by Subject|0|||
147648302|NCT02614131|532531590|FG006|Overall Study|Withdrawal by Subject|0|||
147648303|NCT02614131|532531584|FG000|Overall Study|Adverse Event|0|||
147648304|NCT02614131|532531585|FG001|Overall Study|Adverse Event|0|||
147648305|NCT02614131|532531586|FG002|Overall Study|Adverse Event|0|||
147648306|NCT02614131|532531587|FG003|Overall Study|Adverse Event|0|||
147648307|NCT02614131|532531588|FG004|Overall Study|Adverse Event|0|||
147648308|NCT02614131|532531589|FG005|Overall Study|Adverse Event|0|||
147648309|NCT02614131|532531590|FG006|Overall Study|Adverse Event|1|||
147648310|NCT00089635|532531593|FG000|Overall Study|Adverse Event|2|||
147648311|NCT00089635|532531593|FG000|Overall Study|Death|17|||
147648312|NCT00089635|532531593|FG000|Overall Study|Disease Progression|12|||
147648313|NCT00089635|532531593|FG000|Overall Study|Lost to Follow-up|3|||
147648314|NCT00089635|532531593|FG000|Overall Study|Withdrawal by Subject|6|||
147648315|NCT00089635|532531593|FG000|Overall Study|Ineligibility determined|1|||
147648316|NCT00089635|532531593|FG000|Overall Study|Other|2|||
147648317|NCT02603107|532531594|FG000|Randomized Phase|Withdrew consent|8|||
147648318|NCT02603107|532531595|FG001|Randomized Phase|Withdrew consent|15|||
147648319|NCT02603107|532531594|FG000|Randomized Phase|Lost to Follow-up|1|||
147648320|NCT02603107|532531595|FG001|Randomized Phase|Lost to Follow-up|3|||
147648321|NCT02603107|532531594|FG000|Randomized Phase|Adverse Event|2|||
147648322|NCT02603107|532531595|FG001|Randomized Phase|Adverse Event|0|||
147648323|NCT02603107|532531594|FG000|Randomized Phase|Death|1|||
147648324|NCT02603107|532531595|FG001|Randomized Phase|Death|1|||
147648325|NCT02603107|532531594|FG000|Randomized Phase|Non-compliance with study drug|1|||
147648326|NCT02603107|532531595|FG001|Randomized Phase|Non-compliance with study drug|1|||
147648327|NCT02603107|532531594|FG000|Randomized Phase|Investigator's discretion|0|||
147648328|NCT02603107|532531595|FG001|Randomized Phase|Investigator's discretion|1|||
147648329|NCT02603107|532531594|FG000|Randomized Phase|Lack of Efficacy|1|||
147648330|NCT02603107|532531595|FG001|Randomized Phase|Lack of Efficacy|0|||
147648331|NCT02603107|532531594|FG000|Randomized Phase|Protocol Violation|1|||
147648332|NCT02603107|532531595|FG001|Randomized Phase|Protocol Violation|0|||
147648333|NCT02603107|532531594|FG000|Optional Extension Phase|Lost to Follow-up|3|||
147648334|NCT02603107|532531595|FG001|Optional Extension Phase|Lost to Follow-up|3|||
147648335|NCT02603107|532531594|FG000|Optional Extension Phase|Withdrew consent|3|||
147648336|NCT02603107|532531595|FG001|Optional Extension Phase|Withdrew consent|2|||
147648337|NCT02603107|532531594|FG000|Optional Extension Phase|Investigator's discretion|2|||
147648338|NCT02603107|532531595|FG001|Optional Extension Phase|Investigator's discretion|2|||
147648339|NCT02603107|532531594|FG000|Optional Extension Phase|Pregnancy|0|||
147648340|NCT02603107|532531595|FG001|Optional Extension Phase|Pregnancy|3|||
147648341|NCT02603107|532531594|FG000|Optional Extension Phase|Adverse Event|0|||
147648342|NCT02603107|532531595|FG001|Optional Extension Phase|Adverse Event|2|||
147648343|NCT02603107|532531594|FG000|Optional Extension Phase|Not treated in extension phase|0|||
147648344|NCT02603107|532531595|FG001|Optional Extension Phase|Not treated in extension phase|1|||
147648345|NCT02603107|532531594|FG000|Optional Extension Phase|Protocol Violation|1|||
147648346|NCT02603107|532531595|FG001|Optional Extension Phase|Protocol Violation|0|||
147648347|NCT00821015|532531600|FG000|Overall Study|Lost to Follow-up|12|||
147648348|NCT01887678|532531601|FG000|Overall Study|Adverse Event|4|||
147648349|NCT01887678|532531602|FG001|Overall Study|Adverse Event|6|||
147648350|NCT01887678|532531601|FG000|Overall Study|Exceeded rescue medication dosage|4|||
147648351|NCT01887678|532531602|FG001|Overall Study|Exceeded rescue medication dosage|5|||
147648352|NCT01887678|532531601|FG000|Overall Study|Withdrawal of consent|3|||
147648353|NCT01887678|532531602|FG001|Overall Study|Withdrawal of consent|4|||
147648354|NCT01887678|532531601|FG000|Overall Study|Lost to Follow-up|4|||
147648355|NCT01887678|532531602|FG001|Overall Study|Lost to Follow-up|2|||
147648356|NCT01887678|532531601|FG000|Overall Study|Deterioration of clinical condition|0|||
147648357|NCT01887678|532531602|FG001|Overall Study|Deterioration of clinical condition|4|||
147648358|NCT01887678|532531601|FG000|Overall Study|Lack of Efficacy|1|||
147648359|NCT01887678|532531602|FG001|Overall Study|Lack of Efficacy|2|||
147648360|NCT01887678|532531601|FG000|Overall Study|Non-compliance|0|||
147648361|NCT01887678|532531602|FG001|Overall Study|Non-compliance|3|||
147648362|NCT01887678|532531601|FG000|Overall Study|Specified|1|||
147648363|NCT01887678|532531602|FG001|Overall Study|Specified|2|||
147648364|NCT01017601|532531607|FG000|Overall Study|Disease Progression|12|||
147648365|NCT01017601|532531608|FG001|Overall Study|Disease Progression|12|||
147648366|NCT01017601|532531607|FG000|Overall Study|Withdrawal by Subject|0|||
147648367|NCT01017601|532531608|FG001|Overall Study|Withdrawal by Subject|1|||
147648368|NCT00187278|532531609|FG000|Overall Study|Protocol Violation|10|||
147648369|NCT00187278|532531610|FG001|Overall Study|Protocol Violation|13|||
147648370|NCT01857102|532531611|FG000|Period 1|No longer meets Eligibility Criteria|0|||
147648371|NCT01857102|532531612|FG001|Period 1|No longer meets Eligibility Criteria|2|||
147648372|NCT01857102|532531611|FG000|Period 1|Lost to Follow-up|0|||
147648373|NCT01857102|532531612|FG001|Period 1|Lost to Follow-up|3|||
147648374|NCT01857102|532531611|FG000|Period 1|Unsatisfactory Lens Fit|1|||
147648375|NCT01857102|532531612|FG001|Period 1|Unsatisfactory Lens Fit|0|||
147648376|NCT01857102|532531611|FG000|Period 1|Unsatisfactory Visual Response|1|||
147648377|NCT01857102|532531612|FG001|Period 1|Unsatisfactory Visual Response|0|||
147648378|NCT01857102|532531611|FG000|Period 1|Physician Decision|1|||
147648379|NCT01857102|532531612|FG001|Period 1|Physician Decision|0|||
147648380|NCT01857102|532531611|FG000|Period 2|Lens Discomfort|1|||
147648381|NCT01857102|532531612|FG001|Period 2|Lens Discomfort|0|||
147648382|NCT01857102|532531611|FG000|Period 2|Unsatisfactory Lens Fit|1|||
147648383|NCT01857102|532531612|FG001|Period 2|Unsatisfactory Lens Fit|0|||
147648384|NCT00090584|532531618|FG000|Baseline to 10 Weeks|Lost to Follow-up|15|||
147648385|NCT00090584|532531619|FG001|Baseline to 10 Weeks|Lost to Follow-up|12|||
147648386|NCT00090584|532531618|FG000|Baseline to 8 Months|Lost to Follow-up|44|||
147648387|NCT00090584|532531619|FG001|Baseline to 8 Months|Lost to Follow-up|41|||
147648388|NCT02735096|532531620|FG000|Overall Study|No symptoms in clinic/personal leave|1|||
147648389|NCT01080391|532531628|FG000|Overall Study|Randomized but not treated|7|||
147648390|NCT01080391|532531629|FG001|Overall Study|Randomized but not treated|4|||
147648391|NCT02073656|532531634|FG000|Primary Study|Lost to Follow-up|6|||
147648392|NCT02073656|532531634|FG000|Primary Study|Death|1|||
147648393|NCT02073656|532531634|FG000|Primary Study|Withdrew Consent|1|||
147648394|NCT01969084|532531636|FG000|Overall Study|Adverse Event|0|||
147648395|NCT01969084|532531637|FG001|Overall Study|Adverse Event|1|||
147648396|NCT02054910|532531638|FG000|Overall Study|Lost to Follow-up|4|||
147648397|NCT02054910|532531639|FG001|Overall Study|Lost to Follow-up|1|||
147648398|NCT02920177|532531640|FG000|Overall Study|Withdrawal by Subject|1|||
147648399|NCT02920177|532531641|FG001|Overall Study|Withdrawal by Subject|1|||
147648400|NCT02920177|532531640|FG000|Overall Study|Physician Decision|1|||
147648401|NCT02920177|532531641|FG001|Overall Study|Physician Decision|0|||
147648402|NCT02920177|532531640|FG000|Overall Study|Lost to Follow-up|0|||
147648403|NCT02920177|532531641|FG001|Overall Study|Lost to Follow-up|1|||
147648404|NCT04907227|532531642|FG000|Overall Study|Death|12|||
147648405|NCT04907227|532531643|FG001|Overall Study|Death|8|||
147648406|NCT04907227|532531642|FG000|Overall Study|Withdrawal by Subject|2|||
147648407|NCT04907227|532531643|FG001|Overall Study|Withdrawal by Subject|2|||
147648408|NCT04907227|532531642|FG000|Overall Study|Withdrawal By Parent/Guardian|1|||
147648409|NCT04907227|532531643|FG001|Overall Study|Withdrawal By Parent/Guardian|0|||
147648410|NCT04907227|532531642|FG000|Overall Study|Sponsor Decision|25|||
147648411|NCT04907227|532531643|FG001|Overall Study|Sponsor Decision|30|||
147648412|NCT04907227|532531642|FG000|Overall Study|Physician Decision|1|||
147648413|NCT04907227|532531643|FG001|Overall Study|Physician Decision|0|||
147648414|NCT03723070|532531644|FG000|Overall Study|Lost to Follow-up|2|||
147648415|NCT03723070|532531644|FG000|Overall Study|Physician Decision|1|||
147648416|NCT03723070|532531644|FG000|Overall Study|Ended the study at 1 month follow-up visit as per applicable protocol at that time|6|||
147648417|NCT03053427|532531645|FG000|Overall Study|Adverse Event|4|||
147648418|NCT03053427|532531646|FG001|Overall Study|Adverse Event|4|||
147648419|NCT03053427|532531645|FG000|Overall Study|Lack of Efficacy|1|||
147648420|NCT03053427|532531646|FG001|Overall Study|Lack of Efficacy|3|||
147648421|NCT03053427|532531645|FG000|Overall Study|Lost to Follow-up|2|||
147648422|NCT03053427|532531646|FG001|Overall Study|Lost to Follow-up|2|||
147648423|NCT03053427|532531645|FG000|Overall Study|Worsening of the target disease|0|||
147648424|NCT03053427|532531646|FG001|Overall Study|Worsening of the target disease|1|||
147648425|NCT03053427|532531645|FG000|Overall Study|Protocol Deviation|3|||
147648426|NCT03053427|532531646|FG001|Overall Study|Protocol Deviation|3|||
147648427|NCT03053427|532531645|FG000|Overall Study|Withdrawal by Subject|3|||
147648428|NCT03053427|532531646|FG001|Overall Study|Withdrawal by Subject|2|||
147648429|NCT03053427|532531645|FG000|Overall Study|Miscellaneous|0|||
147648430|NCT03053427|532531646|FG001|Overall Study|Miscellaneous|1|||
147648431|NCT00703326|532533289|FG000|Overall Study|Lost to Follow-up|47|||
147648432|NCT00703326|532533290|FG001|Overall Study|Lost to Follow-up|18|||
147648433|NCT00703326|532533289|FG000|Overall Study|Withdrawal by Subject|54|||
147648434|NCT00703326|532533290|FG001|Overall Study|Withdrawal by Subject|20|||
147648435|NCT00703326|532533289|FG000|Overall Study|Adverse Event|1|||
147648436|NCT00703326|532533290|FG001|Overall Study|Adverse Event|0|||
147648437|NCT01393106|532533292|FG000|Overall Study|Adverse Event|3|||
147648438|NCT01393106|532533292|FG000|Overall Study|Withdrawal by Subject|1|||
147648439|NCT01393106|532533292|FG000|Overall Study|Lack of Efficacy|1|||
147648440|NCT03041467|532533293|FG000|Overall Study|Death|46|||
147648441|NCT03041467|532533294|FG001|Overall Study|Death|39|||
147648442|NCT03041467|532533293|FG000|Overall Study|Withdrawal by Subject|36|||
147648443|NCT03041467|532533294|FG001|Overall Study|Withdrawal by Subject|37|||
147648444|NCT03041467|532533293|FG000|Overall Study|Lost to Follow-up|6|||
147648445|NCT03041467|532533294|FG001|Overall Study|Lost to Follow-up|8|||
147648446|NCT03041467|532533293|FG000|Overall Study|Declined consent for study extension|21|||
147648447|NCT03041467|532533294|FG001|Overall Study|Declined consent for study extension|33|||
147648448|NCT03041467|532533293|FG000|Overall Study|Exit reason other than withdrawal, death, or lost to follow up|4|||
147648449|NCT03041467|532533294|FG001|Overall Study|Exit reason other than withdrawal, death, or lost to follow up|2|||
147648450|NCT02474355|532533298|FG000|Overall Study|Other|43|||
147648451|NCT02474355|532533298|FG000|Overall Study|Eligibility Criteria not Fulfilled|2|||
147648452|NCT02474355|532533298|FG000|Overall Study|Lost to Follow-up|98|||
147648453|NCT02474355|532533298|FG000|Overall Study|Withdrawal by Subject|124|||
147648454|NCT02474355|532533298|FG000|Overall Study|Death|1361|||
147648455|NCT00734656|532533301|FG000|Lab Session 1|Withdrawal by Subject|2|||
147648456|NCT00734656|532533302|FG001|Lab Session 1|Withdrawal by Subject|0|||
147648457|NCT00734656|532533303|FG002|Lab Session 1|Withdrawal by Subject|0|||
147648458|NCT00734656|532533304|FG003|Lab Session 1|Withdrawal by Subject|0|||
147648459|NCT00734656|532533301|FG000|Washout 1|Withdrawal by Subject|1|||
147648460|NCT00734656|532533302|FG001|Washout 1|Withdrawal by Subject|5|||
147648461|NCT00734656|532533303|FG002|Washout 1|Withdrawal by Subject|2|||
147648462|NCT00734656|532533304|FG003|Washout 1|Withdrawal by Subject|3|||
147648463|NCT00734656|532533301|FG000|Lab Session 2|Withdrawal by Subject|1|||
147648464|NCT00734656|532533302|FG001|Lab Session 2|Withdrawal by Subject|0|||
147648465|NCT00734656|532533303|FG002|Lab Session 2|Withdrawal by Subject|0|||
147648466|NCT00734656|532533304|FG003|Lab Session 2|Withdrawal by Subject|1|||
147648467|NCT00734656|532533301|FG000|Washout 2|Withdrawal by Subject|1|||
147648468|NCT00734656|532533302|FG001|Washout 2|Withdrawal by Subject|1|||
147648469|NCT00734656|532533303|FG002|Washout 2|Withdrawal by Subject|1|||
147648470|NCT00734656|532533304|FG003|Washout 2|Withdrawal by Subject|0|||
147648471|NCT00734656|532533301|FG000|Washout 3|Withdrawal by Subject|1|||
147648472|NCT00734656|532533302|FG001|Washout 3|Withdrawal by Subject|0|||
147648473|NCT00734656|532533303|FG002|Washout 3|Withdrawal by Subject|0|||
147648474|NCT00734656|532533304|FG003|Washout 3|Withdrawal by Subject|1|||
147648475|NCT00734656|532533301|FG000|Lab Session 4|Withdrawal by Subject|0|||
147648476|NCT00734656|532533302|FG001|Lab Session 4|Withdrawal by Subject|0|||
147648477|NCT00734656|532533303|FG002|Lab Session 4|Withdrawal by Subject|0|||
147648478|NCT00734656|532533304|FG003|Lab Session 4|Withdrawal by Subject|1|||
147648479|NCT03214679|532533306|FG000|Overall Study|Lost to Follow-up|12|||
147648480|NCT03214679|532533307|FG001|Overall Study|Lost to Follow-up|14|||
147648481|NCT03214679|532533306|FG000|Overall Study|not eligible|2|||
147648482|NCT03214679|532533307|FG001|Overall Study|not eligible|0|||
147648483|NCT02509078|532533312|FG000|Overall Study|Protocol Violation|1|||
147648484|NCT02509078|532533313|FG001|Overall Study|Protocol Violation|1|||
147648485|NCT02686814|532533314|FG000|Overall Study|Physician Decision|14|||
147648486|NCT02686814|532533314|FG000|Overall Study|Withdrawal by Subject|4|||
147648487|NCT02686814|532533314|FG000|Overall Study|Death|1|||
147648488|NCT01760447|532533317|FG000|Weeks 0-20|Consent withdrawn by Parent/Guardian|0|||
147648489|NCT01760447|532533318|FG001|Weeks 0-20|Consent withdrawn by Parent/Guardian|0|||
147648490|NCT01760447|532533319|FG002|Weeks 0-20|Consent withdrawn by Parent/Guardian|1|||
147648491|NCT01760447|532533320|FG003|Weeks 0-20|Consent withdrawn by Parent/Guardian|3|||
147648492|NCT01760447|532533317|FG000|Weeks 0-20|Withdrawal by Subject|2|||
147648493|NCT01760447|532533318|FG001|Weeks 0-20|Withdrawal by Subject|0|||
147648494|NCT01760447|532533319|FG002|Weeks 0-20|Withdrawal by Subject|1|||
147648495|NCT01760447|532533320|FG003|Weeks 0-20|Withdrawal by Subject|0|||
147648496|NCT01760447|532533317|FG000|Weeks 0-20|Lost to Follow-up|1|||
147648497|NCT01760447|532533318|FG001|Weeks 0-20|Lost to Follow-up|0|||
147648498|NCT01760447|532533319|FG002|Weeks 0-20|Lost to Follow-up|1|||
147648499|NCT01760447|532533320|FG003|Weeks 0-20|Lost to Follow-up|1|||
147648500|NCT01760447|532533317|FG000|Weeks 0-20|Randomized but not treated|0|||
147648501|NCT01760447|532533318|FG001|Weeks 0-20|Randomized but not treated|0|||
147648502|NCT01760447|532533319|FG002|Weeks 0-20|Randomized but not treated|2|||
147648503|NCT01760447|532533320|FG003|Weeks 0-20|Randomized but not treated|0|||
147648504|NCT01760447|532533317|FG000|Weeks 20-54|Consent withdrawn by Parent/Guardian|1|||
147648505|NCT01760447|532533318|FG001|Weeks 20-54|Consent withdrawn by Parent/Guardian|1|||
147648506|NCT01760447|532533319|FG002|Weeks 20-54|Consent withdrawn by Parent/Guardian|1|||
147648507|NCT01760447|532533320|FG003|Weeks 20-54|Consent withdrawn by Parent/Guardian|0|||
147648508|NCT01760447|532533317|FG000|Weeks 20-54|Withdrawal by Subject|2|||
147648509|NCT01760447|532533318|FG001|Weeks 20-54|Withdrawal by Subject|1|||
147648510|NCT01760447|532533319|FG002|Weeks 20-54|Withdrawal by Subject|1|||
147648511|NCT01760447|532533320|FG003|Weeks 20-54|Withdrawal by Subject|2|||
147648512|NCT01760447|532533317|FG000|Weeks 20-54|Lost to Follow-up|0|||
147648513|NCT01760447|532533318|FG001|Weeks 20-54|Lost to Follow-up|0|||
147648514|NCT01760447|532533319|FG002|Weeks 20-54|Lost to Follow-up|1|||
147648515|NCT01760447|532533320|FG003|Weeks 20-54|Lost to Follow-up|2|||
147648516|NCT03341936|532533323|FG000|Overall Study|Ineligible|1|||
147648517|NCT03341936|532533323|FG000|Overall Study|Disease Progression|2|||
147648518|NCT03341936|532533323|FG000|Overall Study|Withdrew Consent|4|||
147648519|NCT03341936|532533323|FG000|Overall Study|Non-Compliance|1|||
147648520|NCT03341936|532533323|FG000|Overall Study|Physician Decision|1|||
147648521|NCT03341936|532533323|FG000|Overall Study|Withdrawal by Subject|1|||
147648522|NCT03341936|532533323|FG000|Overall Study|Other|1|||
147648523|NCT02368886|532533324|FG000|Overall Study|Cancel|1|||
147648524|NCT02368886|532533325|FG001|Overall Study|Cancel|1|||
147648525|NCT02368886|532533326|FG002|Overall Study|Cancel|1|||
147648526|NCT02368886|532533327|FG003|Overall Study|Cancel|3|||
147648527|NCT02368886|532533324|FG000|Overall Study|Ineligible|0|||
147648528|NCT02368886|532533325|FG001|Overall Study|Ineligible|0|||
147648529|NCT02368886|532533326|FG002|Overall Study|Ineligible|0|||
147648530|NCT02368886|532533327|FG003|Overall Study|Ineligible|1|||
147648531|NCT02131636|532533331|FG000|Overall Study|Personal Reasons|4|||
147648532|NCT02131636|532533332|FG001|Overall Study|Personal Reasons|4|||
147648533|NCT02131636|532533331|FG000|Overall Study|Lost to Follow-up|4|||
147648534|NCT02131636|532533332|FG001|Overall Study|Lost to Follow-up|0|||
147648535|NCT02131636|532533331|FG000|Overall Study|Adverse Event|4|||
147648536|NCT02131636|532533332|FG001|Overall Study|Adverse Event|1|||
147648537|NCT02173379|532533333|FG000|Overall Study|Lost to Follow-up|89|||
147648538|NCT02173379|532533334|FG001|Overall Study|Lost to Follow-up|81|||
147648539|NCT02173379|532533333|FG000|Overall Study|Withdrawal by Subject|24|||
147648540|NCT02173379|532533334|FG001|Overall Study|Withdrawal by Subject|29|||
147648541|NCT02173379|532533333|FG000|Overall Study|Physician Decision|8|||
147648542|NCT02173379|532533334|FG001|Overall Study|Physician Decision|8|||
147648543|NCT02173379|532533333|FG000|Overall Study|Death|75|||
147648544|NCT02173379|532533334|FG001|Overall Study|Death|72|||
147648545|NCT02173379|532533333|FG000|Overall Study|Other Reason|1|||
147648546|NCT02173379|532533334|FG001|Overall Study|Other Reason|0|||
147648547|NCT00631163|532533338|FG000|Number of Participants in Year 1|Adverse Event|12|||
147648548|NCT00631163|532533338|FG000|Number of Participants in Year 1|Withdrawal by Subject|8|||
147648549|NCT00631163|532533338|FG000|Number of Participants in Year 1|Death|6|||
147648550|NCT00631163|532533338|FG000|Number of Participants in Year 1|Lost to Follow-up|1|||
147648551|NCT00631163|532533338|FG000|Number of Participants in Year 1|Patient's condition no longer requires study drug|1|||
147648552|NCT00631163|532533338|FG000|Number of Participants in Year 1|Administrative problems|6|||
147648553|NCT00631163|532533338|FG000|Number of Participants in Year 2|Withdrawal by Subject|2|||
147648554|NCT00631163|532533338|FG000|Number of Participants in Year 2|Adverse Event|1|||
147648555|NCT00631163|532533338|FG000|Number of Participants in Year 2|Protocol Violation|1|||
147648556|NCT00631163|532533338|FG000|Number of Participants in Year 2|Abnormal laboratory value|1|||
147648557|NCT00004088|532533339|FG000|Overall Study|No C2 given due to study on hold by IRB|4|||
147648558|NCT00004088|532533339|FG000|Overall Study|Withdrawal by Subject|1|||
147648559|NCT00004088|532533339|FG000|Overall Study|Protocol Violation|3|||
147648560|NCT00004088|532533339|FG000|Overall Study|Physician Decision|1|||
147648561|NCT00419159|532533345|FG000|Overall Study|Adverse Event|7|||
147648562|NCT00419159|532533346|FG001|Overall Study|Adverse Event|15|||
147648563|NCT00419159|532533345|FG000|Overall Study|Abnormal laboratory value(s)|0|||
147648564|NCT00419159|532533346|FG001|Overall Study|Abnormal laboratory value(s)|2|||
147648565|NCT00419159|532533345|FG000|Overall Study|Subject's no longer requires study drug|0|||
147648566|NCT00419159|532533346|FG001|Overall Study|Subject's no longer requires study drug|1|||
147648567|NCT00419159|532533345|FG000|Overall Study|Protocol Violation|1|||
147648568|NCT00419159|532533346|FG001|Overall Study|Protocol Violation|0|||
147648569|NCT00419159|532533345|FG000|Overall Study|Withdrawal by Subject|10|||
147648570|NCT00419159|532533346|FG001|Overall Study|Withdrawal by Subject|3|||
147648571|NCT00419159|532533345|FG000|Overall Study|Lost to Follow-up|0|||
147648572|NCT00419159|532533346|FG001|Overall Study|Lost to Follow-up|1|||
147648573|NCT00419159|532533345|FG000|Overall Study|Death|2|||
147648574|NCT00419159|532533346|FG001|Overall Study|Death|2|||
147648575|NCT00419159|532533345|FG000|Overall Study|Disease progression|79|||
147648576|NCT00419159|532533346|FG001|Overall Study|Disease progression|76|||
147648577|NCT02117713|532533347|FG000|Week 48|Adverse Event|4|||
147648578|NCT02117713|532533347|FG000|Week 48|Withdrawal by caregiver|2|||
147648579|NCT02117713|532533347|FG000|Week 48|Did not consent to Protocol Amendment 4|2|||
147648580|NCT02117713|532533347|FG000|Long Term Follow-up Treatment|Adverse Event|3|||
147648581|NCT02117713|532533347|FG000|Long Term Follow-up Treatment|Progressive Disease|2|||
147648582|NCT02117713|532533347|FG000|Long Term Follow-up Treatment|Non-Compliance with study drug|1|||
147648583|NCT01094782|532533348|FG000|Overall Study|Withdrawal by Subject|5|||
147648584|NCT01094782|532533349|FG001|Overall Study|Withdrawal by Subject|5|||
147648585|NCT01094782|532533350|FG002|Overall Study|Withdrawal by Subject|1|||
147648586|NCT01094782|532533351|FG003|Overall Study|Withdrawal by Subject|5|||
147648587|NCT01094782|532533352|FG004|Overall Study|Withdrawal by Subject|5|||
147648588|NCT01094782|532533353|FG005|Overall Study|Withdrawal by Subject|0|||
147648589|NCT01094782|532533348|FG000|Overall Study|Lost to Follow-up|1|||
147648590|NCT01094782|532533349|FG001|Overall Study|Lost to Follow-up|0|||
147648591|NCT01094782|532533350|FG002|Overall Study|Lost to Follow-up|0|||
147648592|NCT01094782|532533351|FG003|Overall Study|Lost to Follow-up|2|||
147648593|NCT01094782|532533352|FG004|Overall Study|Lost to Follow-up|1|||
147648594|NCT01094782|532533353|FG005|Overall Study|Lost to Follow-up|4|||
147648595|NCT01094782|532533348|FG000|Overall Study|Positive Drug Screen|2|||
147306603|NCT01893827|531288853|FG001|Overall Study|Lost to Follow-up|26|||
147648596|NCT01094782|532533349|FG001|Overall Study|Positive Drug Screen|2|||
147648597|NCT01094782|532533350|FG002|Overall Study|Positive Drug Screen|1|||
147648598|NCT01094782|532533351|FG003|Overall Study|Positive Drug Screen|1|||
147648599|NCT01094782|532533352|FG004|Overall Study|Positive Drug Screen|3|||
147648600|NCT01094782|532533353|FG005|Overall Study|Positive Drug Screen|2|||
147648601|NCT01094782|532533348|FG000|Overall Study|Sensory Deficit at Site of QST|0|||
147648602|NCT01094782|532533349|FG001|Overall Study|Sensory Deficit at Site of QST|1|||
147648603|NCT01094782|532533350|FG002|Overall Study|Sensory Deficit at Site of QST|0|||
147648604|NCT01094782|532533351|FG003|Overall Study|Sensory Deficit at Site of QST|0|||
147648605|NCT01094782|532533352|FG004|Overall Study|Sensory Deficit at Site of QST|0|||
147648606|NCT01094782|532533353|FG005|Overall Study|Sensory Deficit at Site of QST|0|||
147648607|NCT01094782|532533348|FG000|Overall Study|Unable to Complete Questionnaires|0|||
147648608|NCT01094782|532533349|FG001|Overall Study|Unable to Complete Questionnaires|1|||
147648609|NCT01094782|532533350|FG002|Overall Study|Unable to Complete Questionnaires|0|||
147648610|NCT01094782|532533351|FG003|Overall Study|Unable to Complete Questionnaires|0|||
147648611|NCT01094782|532533352|FG004|Overall Study|Unable to Complete Questionnaires|0|||
147648612|NCT01094782|532533353|FG005|Overall Study|Unable to Complete Questionnaires|0|||
147648613|NCT01094782|532533348|FG000|Overall Study|Healthy Subject Had Pain|0|||
147648614|NCT01094782|532533349|FG001|Overall Study|Healthy Subject Had Pain|1|||
147648615|NCT01094782|532533350|FG002|Overall Study|Healthy Subject Had Pain|0|||
147648616|NCT01094782|532533351|FG003|Overall Study|Healthy Subject Had Pain|0|||
147648617|NCT01094782|532533352|FG004|Overall Study|Healthy Subject Had Pain|0|||
147648618|NCT01094782|532533353|FG005|Overall Study|Healthy Subject Had Pain|0|||
147648619|NCT01094782|532533348|FG000|Overall Study|Hypertension|0|||
147648620|NCT01094782|532533349|FG001|Overall Study|Hypertension|0|||
147648621|NCT01094782|532533350|FG002|Overall Study|Hypertension|1|||
147648622|NCT01094782|532533351|FG003|Overall Study|Hypertension|0|||
147648623|NCT01094782|532533352|FG004|Overall Study|Hypertension|0|||
147648624|NCT01094782|532533353|FG005|Overall Study|Hypertension|0|||
147648625|NCT01094782|532533348|FG000|Overall Study|Wrong Pain Condition|0|||
147648626|NCT01094782|532533349|FG001|Overall Study|Wrong Pain Condition|0|||
147648627|NCT01094782|532533350|FG002|Overall Study|Wrong Pain Condition|0|||
147648628|NCT01094782|532533351|FG003|Overall Study|Wrong Pain Condition|2|||
147648629|NCT01094782|532533352|FG004|Overall Study|Wrong Pain Condition|1|||
147648630|NCT01094782|532533353|FG005|Overall Study|Wrong Pain Condition|1|||
147648631|NCT01094782|532533348|FG000|Overall Study|Recent Interventional Injection|0|||
147648632|NCT01094782|532533349|FG001|Overall Study|Recent Interventional Injection|0|||
147648633|NCT01094782|532533350|FG002|Overall Study|Recent Interventional Injection|0|||
147648634|NCT01094782|532533351|FG003|Overall Study|Recent Interventional Injection|0|||
147648635|NCT01094782|532533352|FG004|Overall Study|Recent Interventional Injection|0|||
147648636|NCT01094782|532533353|FG005|Overall Study|Recent Interventional Injection|1|||
147648637|NCT01094782|532533348|FG000|Overall Study|Low Visual Analog Scale (VAS) Score|0|||
147648638|NCT01094782|532533349|FG001|Overall Study|Low Visual Analog Scale (VAS) Score|0|||
147648639|NCT01094782|532533350|FG002|Overall Study|Low Visual Analog Scale (VAS) Score|0|||
147648640|NCT01094782|532533351|FG003|Overall Study|Low Visual Analog Scale (VAS) Score|0|||
147648641|NCT01094782|532533352|FG004|Overall Study|Low Visual Analog Scale (VAS) Score|1|||
147648642|NCT01094782|532533353|FG005|Overall Study|Low Visual Analog Scale (VAS) Score|0|||
147648643|NCT01094782|532533348|FG000|Overall Study|Noncompliance With Study Schedule|0|||
147648644|NCT01094782|532533349|FG001|Overall Study|Noncompliance With Study Schedule|0|||
147648645|NCT01094782|532533350|FG002|Overall Study|Noncompliance With Study Schedule|0|||
147648646|NCT01094782|532533351|FG003|Overall Study|Noncompliance With Study Schedule|1|||
147648647|NCT01094782|532533352|FG004|Overall Study|Noncompliance With Study Schedule|0|||
147648648|NCT01094782|532533353|FG005|Overall Study|Noncompliance With Study Schedule|0|||
147648649|NCT00957905|532533355|FG000|Part B|Not Treated|0|||
147648650|NCT00957905|532533356|FG001|Part B|Not Treated|1|||
147648651|NCT00957905|532533355|FG000|Part B|Physician Decision|0|||
147648652|NCT00957905|532533356|FG001|Part B|Physician Decision|1|||
147648653|NCT00957905|532533355|FG000|Part B|Death|0|||
147648654|NCT00957905|532533356|FG001|Part B|Death|1|||
147648655|NCT00957905|532533355|FG000|Part B|Protocol Violation|0|||
147306604|NCT00399763|531288854|FG000|Overall Study|Lost to Follow-up|2|||
147648656|NCT00957905|532533356|FG001|Part B|Protocol Violation|1|||
147648657|NCT02083653|532533357|FG000|Overall Study|Randomized but not Treated|0|||
147648658|NCT02083653|532533358|FG001|Overall Study|Randomized but not Treated|2|||
147648659|NCT02083653|532533359|FG002|Overall Study|Randomized but not Treated|7|||
147648660|NCT02083653|532533357|FG000|Overall Study|Adverse Event|12|||
147648661|NCT02083653|532533358|FG001|Overall Study|Adverse Event|5|||
147648662|NCT02083653|532533359|FG002|Overall Study|Adverse Event|4|||
147648663|NCT02083653|532533357|FG000|Overall Study|Lost to Follow-up|1|||
147648664|NCT02083653|532533358|FG001|Overall Study|Lost to Follow-up|0|||
147648665|NCT02083653|532533359|FG002|Overall Study|Lost to Follow-up|0|||
147648666|NCT02083653|532533357|FG000|Overall Study|Death|2|||
147648667|NCT02083653|532533358|FG001|Overall Study|Death|2|||
147648668|NCT02083653|532533359|FG002|Overall Study|Death|2|||
147648669|NCT02083653|532533357|FG000|Overall Study|Progressive Disease|65|||
147648670|NCT02083653|532533358|FG001|Overall Study|Progressive Disease|73|||
147648671|NCT02083653|532533359|FG002|Overall Study|Progressive Disease|63|||
147648672|NCT02083653|532533357|FG000|Overall Study|Withdrawal by Subject|2|||
147648673|NCT02083653|532533358|FG001|Overall Study|Withdrawal by Subject|1|||
147648674|NCT02083653|532533359|FG002|Overall Study|Withdrawal by Subject|2|||
147648675|NCT02083653|532533357|FG000|Overall Study|Other Events|0|||
147648676|NCT02083653|532533358|FG001|Overall Study|Other Events|2|||
147648677|NCT02083653|532533359|FG002|Overall Study|Other Events|2|||
147648678|NCT02083653|532533357|FG000|Overall Study|Reason Missing|0|||
147648679|NCT02083653|532533358|FG001|Overall Study|Reason Missing|0|||
147648680|NCT02083653|532533359|FG002|Overall Study|Reason Missing|4|||
147648681|NCT01987232|532533361|FG000|Overall Study|Ongoing in Study|0|||
147648682|NCT01987232|532533362|FG001|Overall Study|Ongoing in Study|0|||
147648683|NCT01987232|532533363|FG002|Overall Study|Ongoing in Study|0|||
147648684|NCT01987232|532533364|FG003|Overall Study|Ongoing in Study|1|||
147648685|NCT01987232|532533365|FG004|Overall Study|Ongoing in Study|0|||
147648686|NCT02028169|532533366|FG000|Overall Study|Lost to Follow-up|21|||
147648687|NCT02028169|532533366|FG000|Overall Study|Lack of Efficacy|2|||
147648688|NCT02028169|532533366|FG000|Overall Study|Withdrawal by Subject|2|||
147648689|NCT02028169|532533366|FG000|Overall Study|Adverse Event|1|||
147648690|NCT02028169|532533366|FG000|Overall Study|Cessation of Drug|1|||
147648691|NCT02028169|532533366|FG000|Overall Study|Concomitant Medication Usage|1|||
147648692|NCT03564795|532533371|FG000|Overall Study|Withdrawal by Subject|3|||
147648693|NCT03564795|532533371|FG000|Overall Study|Lost to Follow-up|6|||
147648694|NCT03564795|532533371|FG000|Overall Study|Physician Decision|2|||
147648695|NCT02208050|532533374|FG000|Washout Period 1: 2 Weeks|Withdrawal by Subject|1|||
147648696|NCT02208050|532533375|FG001|Washout Period 1: 2 Weeks|Withdrawal by Subject|0|||
147648697|NCT00477607|532533376|FG000|Overall Study|Lost to Follow-up|7|||
147648698|NCT00477607|532533377|FG001|Overall Study|Lost to Follow-up|7|||
147648699|NCT00474786|532533378|FG000|Overall Study|Not Meeting Study Criteria|0|||
147648700|NCT00474786|532533379|FG001|Overall Study|Not Meeting Study Criteria|1|||
147648701|NCT00474786|532533378|FG000|Overall Study|Investigator Request|2|||
147648702|NCT00474786|532533379|FG001|Overall Study|Investigator Request|1|||
147648703|NCT00474786|532533378|FG000|Overall Study|Death|189|||
147648704|NCT00474786|532533379|FG001|Overall Study|Death|170|||
147648705|NCT00474786|532533378|FG000|Overall Study|Discontinuation of Study by Sponsor|42|||
147648706|NCT00474786|532533379|FG001|Overall Study|Discontinuation of Study by Sponsor|59|||
147648707|NCT00474786|532533378|FG000|Overall Study|Lost to Follow-up|4|||
147648708|NCT00474786|532533379|FG001|Overall Study|Lost to Follow-up|7|||
147648709|NCT00474786|532533378|FG000|Overall Study|Protocol Violation|2|||
147648710|NCT00474786|532533379|FG001|Overall Study|Protocol Violation|0|||
147648711|NCT00474786|532533378|FG000|Overall Study|Withdrawal by Subject|15|||
147648712|NCT00474786|532533379|FG001|Overall Study|Withdrawal by Subject|15|||
147648713|NCT00474786|532533378|FG000|Overall Study|Other|5|||
147648714|NCT00474786|532533379|FG001|Overall Study|Other|0|||
147648715|NCT00432276|532533380|FG000|Overall Study|Hyperglycemic Rescue|44|||
147648716|NCT00432276|532533381|FG001|Overall Study|Hyperglycemic Rescue|87|||
147648717|NCT00432276|532533380|FG000|Overall Study|Adverse Event|13|||
147648718|NCT00432276|532533381|FG001|Overall Study|Adverse Event|16|||
147648719|NCT00432276|532533380|FG000|Overall Study|Protocol Violation|25|||
147648720|NCT00432276|532533381|FG001|Overall Study|Protocol Violation|20|||
147648721|NCT00432276|532533380|FG000|Overall Study|Lost to Follow-up|6|||
147648722|NCT00432276|532533381|FG001|Overall Study|Lost to Follow-up|2|||
147648723|NCT00432276|532533380|FG000|Overall Study|Withdrawal by Subject|25|||
147648724|NCT00432276|532533381|FG001|Overall Study|Withdrawal by Subject|20|||
147648725|NCT00432276|532533380|FG000|Overall Study|Physician Decision|6|||
147648726|NCT00432276|532533381|FG001|Overall Study|Physician Decision|8|||
147648727|NCT00432276|532533380|FG000|Overall Study|Other|2|||
147648728|NCT00432276|532533381|FG001|Overall Study|Other|3|||
147648729|NCT00467961|532533382|FG000|Overall Study|Technical Failures|5|||
147648730|NCT00467961|532533382|FG000|Overall Study|Disease Progression|2|||
147648731|NCT02429310|532533383|FG000|Overall Study|Lost to Follow-up|1|||
147648732|NCT02429310|532533384|FG001|Overall Study|Lost to Follow-up|2|||
147648733|NCT02429310|532533383|FG000|Overall Study|Protocol Violation|1|||
147648734|NCT02429310|532533384|FG001|Overall Study|Protocol Violation|1|||
147648735|NCT02678000|532533385|FG000|PART 2|Adverse Event|0|||
147648736|NCT02678000|532533386|FG001|PART 2|Adverse Event|0|||
147648737|NCT02678000|532533387|FG002|PART 2|Adverse Event|2|||
147648738|NCT02678000|532533388|FG003|PART 2|Adverse Event|1|||
147648739|NCT02678000|532533389|FG004|PART 2|Adverse Event|0|||
147648740|NCT02678000|532533385|FG000|PART 2|Withdrawal by Subject|0|||
147648741|NCT02678000|532533386|FG001|PART 2|Withdrawal by Subject|0|||
147648742|NCT02678000|532533387|FG002|PART 2|Withdrawal by Subject|1|||
147648743|NCT02678000|532533388|FG003|PART 2|Withdrawal by Subject|0|||
147648744|NCT02678000|532533389|FG004|PART 2|Withdrawal by Subject|0|||
147648745|NCT01324570|532533393|FG000|Overall Study|Adverse Event|4|||
147648746|NCT01324570|532533394|FG001|Overall Study|Adverse Event|7|||
147648747|NCT01324570|532533393|FG000|Overall Study|Withdrawal by Subject|0|||
147648748|NCT01324570|532533394|FG001|Overall Study|Withdrawal by Subject|3|||
147648749|NCT01324570|532533393|FG000|Overall Study|Lack of Efficacy|0|||
147648750|NCT01324570|532533394|FG001|Overall Study|Lack of Efficacy|1|||
147648751|NCT01324570|532533393|FG000|Overall Study|Confirmed or suspected diversion|0|||
147648752|NCT01324570|532533394|FG001|Overall Study|Confirmed or suspected diversion|1|||
147648753|NCT01324570|532533393|FG000|Overall Study|Administrative|0|||
147648754|NCT01324570|532533394|FG001|Overall Study|Administrative|2|||
147648755|NCT02360475|532533395|FG000|Overall Study|Lost to Follow-up|4|||
147648756|NCT02360475|532533396|FG001|Overall Study|Lost to Follow-up|12|||
147648757|NCT02360475|532533397|FG002|Overall Study|Lost to Follow-up|6|||
147648758|NCT02360475|532533398|FG003|Overall Study|Lost to Follow-up|4|||
147648759|NCT02360475|532533395|FG000|Overall Study|Withdrawal by Subject|0|||
147648760|NCT02360475|532533396|FG001|Overall Study|Withdrawal by Subject|1|||
147648761|NCT02360475|532533397|FG002|Overall Study|Withdrawal by Subject|2|||
147648762|NCT02360475|532533398|FG003|Overall Study|Withdrawal by Subject|0|||
147648763|NCT02360475|532533395|FG000|Overall Study|Migrated/moved from study area|0|||
147648764|NCT02360475|532533396|FG001|Overall Study|Migrated/moved from study area|0|||
147648765|NCT02360475|532533397|FG002|Overall Study|Migrated/moved from study area|0|||
147648766|NCT02360475|532533398|FG003|Overall Study|Migrated/moved from study area|1|||
147648767|NCT00207727|532533400|FG000|Overall Study|Withdrawal by Subject|0|||
147648768|NCT00207727|532533401|FG001|Overall Study|Withdrawal by Subject|0|||
147648769|NCT00207727|532533402|FG002|Overall Study|Withdrawal by Subject|0|||
147648770|NCT00207727|532533403|FG003|Overall Study|Withdrawal by Subject|0|||
147648771|NCT00207727|532533404|FG004|Overall Study|Withdrawal by Subject|1|||
147648772|NCT00207727|532533400|FG000|Overall Study|Lost to Follow-up|0|||
147648773|NCT00207727|532533401|FG001|Overall Study|Lost to Follow-up|1|||
147648774|NCT00207727|532533402|FG002|Overall Study|Lost to Follow-up|0|||
147648775|NCT00207727|532533403|FG003|Overall Study|Lost to Follow-up|0|||
147648776|NCT00207727|532533404|FG004|Overall Study|Lost to Follow-up|0|||
147648777|NCT00207727|532533400|FG000|Overall Study|Other|38|||
147648778|NCT00207727|532533401|FG001|Overall Study|Other|41|||
147648779|NCT00207727|532533402|FG002|Overall Study|Other|41|||
147648780|NCT00207727|532533403|FG003|Overall Study|Other|37|||
147648781|NCT00207727|532533404|FG004|Overall Study|Other|33|||
147648782|NCT03759366|532533405|FG000|Primary Evaluation Period (26 Weeks)|Physician Decision|1|||
147648783|NCT03759366|532533405|FG000|Extension Period (Up to 208 Weeks)|Physician Decision|1|||
147648784|NCT03759366|532533405|FG000|Extension Period (Up to 208 Weeks)|Lost to Follow-up|1|||
147648785|NCT03759366|532533405|FG000|Extension Period (Up to 208 Weeks)|Participant transitioned to Ultomiris|2|||
147648786|NCT03759366|532533405|FG000|Extension Period (Up to 208 Weeks)|Participant transitioned to Soliris|1|||
147648787|NCT03759366|532533405|FG000|Extension Period (Up to 208 Weeks)|Participant transferred to another study|1|||
147648788|NCT03759366|532533405|FG000|Extension Period (Up to 208 Weeks)|Withdrawal by Subject|2|||
147648789|NCT00539032|532533409|FG000|Overall Study|Withdrawal by Subject|2|||
147648790|NCT00539032|532533410|FG001|Overall Study|Withdrawal by Subject|1|||
147648791|NCT04459598|532533411|FG000|Overall Study|Adverse Event|1|||
147648792|NCT04459598|532533412|FG001|Overall Study|Adverse Event|1|||
147648793|NCT00866333|532533419|FG000|Overall Study|Withdrawal of consent|0|||
147648794|NCT00866333|532533420|FG001|Overall Study|Withdrawal of consent|1|||
147648795|NCT00866333|532533421|FG002|Overall Study|Withdrawal of consent|2|||
147648796|NCT00866333|532533419|FG000|Overall Study|Reason not Specified|3|||
147648797|NCT00866333|532533420|FG001|Overall Study|Reason not Specified|1|||
147648798|NCT00866333|532533421|FG002|Overall Study|Reason not Specified|1|||
147648799|NCT00866333|532533419|FG000|Overall Study|Study Terminated by Sponsor|2|||
147648800|NCT00866333|532533420|FG001|Overall Study|Study Terminated by Sponsor|5|||
147648801|NCT00866333|532533421|FG002|Overall Study|Study Terminated by Sponsor|9|||
147648802|NCT02669082|532533422|FG000|Overall Study|Adverse Event|1|||
147648803|NCT04918355|532533423|FG000|Overall Study|no qualifying health encounter|497|||
147648804|NCT04918355|532533424|FG001|Overall Study|no qualifying health encounter|192|||
147648805|NCT04918355|532533425|FG002|Overall Study|no qualifying health encounter|438|||
147648806|NCT04918355|532533426|FG003|Overall Study|no qualifying health encounter|424|||
147648807|NCT04852276|532533427|FG000|Overall Study|Death|2|||
147648808|NCT04852276|532533428|FG001|Overall Study|Death|0|||
147648809|NCT04852276|532533427|FG000|Overall Study|Lost to Follow-up|15|||
147648810|NCT04852276|532533428|FG001|Overall Study|Lost to Follow-up|9|||
147648811|NCT04852276|532533427|FG000|Overall Study|Withdrawal by Subject|26|||
147648812|NCT04852276|532533428|FG001|Overall Study|Withdrawal by Subject|6|||
147648813|NCT02732015|532535215|FG000|Overall Study|Lost to Follow-up|0|||
147648814|NCT02732015|532535216|FG001|Overall Study|Lost to Follow-up|1|||
147648815|NCT05437640|532535217|FG000|Washout (1 Week)|Adverse Event|1|||
147648816|NCT05437640|532535218|FG001|Washout (1 Week)|Adverse Event|0|||
147648817|NCT04228965|532535221|FG000|Overall Study|Lost to Follow-up|26|||
147648818|NCT04228965|532535222|FG001|Overall Study|Lost to Follow-up|11|||
147648819|NCT04228965|532535221|FG000|Overall Study|Withdrawal by Subject|18|||
147648820|NCT04228965|532535222|FG001|Overall Study|Withdrawal by Subject|5|||
147648821|NCT03015194|532535223|FG000|Overall Study|Death|10|||
147648822|NCT03015194|532535223|FG000|Overall Study|Withdrawal by Subject|2|||
147648823|NCT01754766|532535228|FG000|Overall Study|Personal reasons|1|||
147648824|NCT01754766|532535229|FG001|Overall Study|Personal reasons|1|||
147306605|NCT00399763|531288855|FG001|Overall Study|Lost to Follow-up|3|||
147648825|NCT01754766|532535230|FG002|Overall Study|Personal reasons|0|||
147648826|NCT00433017|532535231|FG000|Overall Study|Adverse Event|5|||
147648827|NCT00433017|532535232|FG001|Overall Study|Adverse Event|3|||
147648828|NCT00433017|532535231|FG000|Overall Study|Withdrawal by Subject|4|||
147648829|NCT00433017|532535232|FG001|Overall Study|Withdrawal by Subject|5|||
147648830|NCT00433017|532535231|FG000|Overall Study|Lost to Follow-up|3|||
147648831|NCT00433017|532535232|FG001|Overall Study|Lost to Follow-up|4|||
147648832|NCT00433017|532535231|FG000|Overall Study|Administrative problems|80|||
147648833|NCT00433017|532535232|FG001|Overall Study|Administrative problems|86|||
147648834|NCT00433017|532535231|FG000|Overall Study|Protocol Violation|1|||
147648835|NCT00433017|532535232|FG001|Overall Study|Protocol Violation|0|||
147648836|NCT00433017|532535231|FG000|Overall Study|Death|2|||
147648837|NCT00433017|532535232|FG001|Overall Study|Death|2|||
147648838|NCT00433017|532535231|FG000|Overall Study|Subject no longer requires study drug|1|||
147648839|NCT00433017|532535232|FG001|Overall Study|Subject no longer requires study drug|1|||
147648840|NCT01306214|532535233|FG000|Overall Study|Death|0|||
147648841|NCT01306214|532535234|FG001|Overall Study|Death|0|||
147648842|NCT01306214|532535235|FG002|Overall Study|Death|1|||
147648843|NCT01306214|532535233|FG000|Overall Study|Lost to Follow-up|3|||
147648844|NCT01306214|532535234|FG001|Overall Study|Lost to Follow-up|5|||
147648845|NCT01306214|532535235|FG002|Overall Study|Lost to Follow-up|4|||
147648846|NCT01306214|532535233|FG000|Overall Study|Withdrawal by Subject|24|||
147648847|NCT01306214|532535234|FG001|Overall Study|Withdrawal by Subject|22|||
147648848|NCT01306214|532535235|FG002|Overall Study|Withdrawal by Subject|16|||
147648849|NCT01306214|532535233|FG000|Overall Study|Not treated|1|||
147648850|NCT01306214|532535234|FG001|Overall Study|Not treated|1|||
147648851|NCT01306214|532535235|FG002|Overall Study|Not treated|1|||
147648852|NCT01937884|532535236|FG000|Overall Study|Withdrawal by Subject|1|||
147648853|NCT01937884|532535237|FG001|Overall Study|Withdrawal by Subject|0|||
147648854|NCT03003000|532535245|FG000|Overall Study|Adverse Event|1|||
147648855|NCT03003000|532535246|FG001|Overall Study|Adverse Event|2|||
147648856|NCT03003000|532535247|FG002|Overall Study|Adverse Event|3|||
147648857|NCT03003000|532535245|FG000|Overall Study|Lack of Efficacy|1|||
147648858|NCT03003000|532535246|FG001|Overall Study|Lack of Efficacy|0|||
147648859|NCT03003000|532535247|FG002|Overall Study|Lack of Efficacy|0|||
147648860|NCT03003000|532535245|FG000|Overall Study|Non-compliant with protocol|0|||
147648861|NCT03003000|532535246|FG001|Overall Study|Non-compliant with protocol|1|||
147648862|NCT03003000|532535247|FG002|Overall Study|Non-compliant with protocol|1|||
147648863|NCT03003000|532535245|FG000|Overall Study|Refused to continue medication|2|||
147648864|NCT03003000|532535246|FG001|Overall Study|Refused to continue medication|0|||
147648865|NCT03003000|532535247|FG002|Overall Study|Refused to continue medication|0|||
147648866|NCT03003000|532535245|FG000|Overall Study|Other than listed|1|||
147648867|NCT03003000|532535246|FG001|Overall Study|Other than listed|1|||
147648868|NCT03003000|532535247|FG002|Overall Study|Other than listed|1|||
147648869|NCT04933617|532535249|FG000|Dose Escalation|Early closure of study|0|||
147648870|NCT04933617|532535250|FG001|Dose Escalation|Early closure of study|3|||
147648871|NCT04933617|532535251|FG002|Dose Escalation|Early closure of study|0|||
147648872|NCT04933617|532535252|FG003|Dose Escalation|Early closure of study|0|||
147648873|NCT04933617|532535253|FG004|Dose Escalation|Early closure of study|0|||
147648874|NCT02191046|532535256|FG000|Overall Study|low compliance|5|||
147648875|NCT02191046|532535257|FG001|Overall Study|low compliance|1|||
147648876|NCT02147067|532535258|FG000|Overall Study|Withdrawal by Subject|2|||
147648877|NCT02147067|532535259|FG001|Overall Study|Withdrawal by Subject|2|||
147648878|NCT02536781|532535262|FG000|Overall Study|Lost to Follow-up|2|||
147648879|NCT02536781|532535263|FG001|Overall Study|Lost to Follow-up|0|||
147648880|NCT03423147|532535264|FG000|Overall Study|Lost to Follow-up|5|||
147648881|NCT03423147|532535265|FG001|Overall Study|Lost to Follow-up|8|||
147648882|NCT03423147|532535264|FG000|Overall Study|Withdrawal by Subject|1|||
147648883|NCT03423147|532535265|FG001|Overall Study|Withdrawal by Subject|0|||
147648884|NCT03423147|532535264|FG000|Overall Study|withdrawn due to vaginal delivery|1|||
147648885|NCT03423147|532535265|FG001|Overall Study|withdrawn due to vaginal delivery|0|||
147648886|NCT03423147|532535264|FG000|Overall Study|Age < 18|1|||
147648887|NCT03423147|532535265|FG001|Overall Study|Age < 18|0|||
147648888|NCT03423147|532535264|FG000|Overall Study|No Trial of Labor|0|||
147648889|NCT03423147|532535265|FG001|Overall Study|No Trial of Labor|1|||
147648890|NCT00508157|532535266|FG000|Overall Study|Adverse Event|0|||
147648891|NCT00508157|532535267|FG001|Overall Study|Adverse Event|1|||
147648892|NCT00508157|532535266|FG000|Overall Study|Subject Withdrew Consent|1|||
147648893|NCT00508157|532535267|FG001|Overall Study|Subject Withdrew Consent|0|||
147648894|NCT00508157|532535266|FG000|Overall Study|Lost to Follow-up|1|||
147648895|NCT00508157|532535267|FG001|Overall Study|Lost to Follow-up|0|||
147648896|NCT00508157|532535266|FG000|Overall Study|Subject no longer met study criteria|0|||
147648897|NCT00508157|532535267|FG001|Overall Study|Subject no longer met study criteria|1|||
147648898|NCT00508157|532535266|FG000|Overall Study|Other known cause|0|||
147648899|NCT00508157|532535267|FG001|Overall Study|Other known cause|1|||
147648900|NCT01952080|532535269|FG000|Overall Study|Withdrawal by Subject|0|||
147595932|NCT03096847|532338752|FG001|Overall Study|Protocol Violation|0|||
147648901|NCT01952080|532535270|FG001|Overall Study|Withdrawal by Subject|0|||
147648902|NCT01952080|532535271|FG002|Overall Study|Withdrawal by Subject|0|||
147648903|NCT01952080|532535272|FG003|Overall Study|Withdrawal by Subject|1|||
147648904|NCT01952080|532535269|FG000|Overall Study|Protocol Non-compliance|0|||
147648905|NCT01952080|532535270|FG001|Overall Study|Protocol Non-compliance|1|||
147648906|NCT01952080|532535271|FG002|Overall Study|Protocol Non-compliance|0|||
147648907|NCT01952080|532535272|FG003|Overall Study|Protocol Non-compliance|0|||
147648908|NCT02258334|532535273|FG000|Overall Study|Adverse Event|1|||
147648909|NCT02258334|532535274|FG001|Overall Study|Adverse Event|0|||
147648910|NCT02258334|532535275|FG002|Overall Study|Adverse Event|0|||
147191111|NCT04607668|530867553|FG001|Overall Study|Withdrawal by Subject|11|||
147648911|NCT02258334|532535276|FG003|Overall Study|Adverse Event|0|||
147648912|NCT00862459|532535277|FG000|Overall Study|Lost to Follow-up|1|||
147648913|NCT00862459|532535278|FG001|Overall Study|Lost to Follow-up|2|||
147648914|NCT00862459|532535279|FG002|Overall Study|Lost to Follow-up|2|||
147648915|NCT00862459|532535277|FG000|Overall Study|Protocol Violation|1|||
147648916|NCT00862459|532535278|FG001|Overall Study|Protocol Violation|0|||
147648917|NCT00862459|532535279|FG002|Overall Study|Protocol Violation|0|||
147648918|NCT00862459|532535277|FG000|Overall Study|Withdrawal by Subject|1|||
147648919|NCT00862459|532535278|FG001|Overall Study|Withdrawal by Subject|1|||
147648920|NCT00862459|532535279|FG002|Overall Study|Withdrawal by Subject|3|||
147648921|NCT00862459|532535277|FG000|Overall Study|Adverse Event|0|||
147648922|NCT00862459|532535278|FG001|Overall Study|Adverse Event|1|||
147648923|NCT00862459|532535279|FG002|Overall Study|Adverse Event|0|||
147648924|NCT00862459|532535277|FG000|Overall Study|Personal reasons|1|||
147648925|NCT00862459|532535278|FG001|Overall Study|Personal reasons|0|||
147648926|NCT00862459|532535279|FG002|Overall Study|Personal reasons|0|||
147648927|NCT00862459|532535277|FG000|Overall Study|Operation|1|||
147648928|NCT00862459|532535278|FG001|Overall Study|Operation|1|||
147648929|NCT00862459|532535279|FG002|Overall Study|Operation|0|||
147648930|NCT00862459|532535277|FG000|Overall Study|Intravenous (IV) site problems|1|||
147648931|NCT00862459|532535278|FG001|Overall Study|Intravenous (IV) site problems|0|||
147648932|NCT00862459|532535279|FG002|Overall Study|Intravenous (IV) site problems|1|||
147648933|NCT00862459|532535277|FG000|Overall Study|Unable to hold still for imaging|0|||
147648934|NCT00862459|532535278|FG001|Overall Study|Unable to hold still for imaging|1|||
147648935|NCT00862459|532535279|FG002|Overall Study|Unable to hold still for imaging|0|||
147648936|NCT00862459|532535277|FG000|Overall Study|Inclusion/exclusion criteria not met|0|||
147648937|NCT00862459|532535278|FG001|Overall Study|Inclusion/exclusion criteria not met|1|||
147648938|NCT00862459|532535279|FG002|Overall Study|Inclusion/exclusion criteria not met|0|||
147648939|NCT00862459|532535277|FG000|Overall Study|Administrative problems|0|||
147648940|NCT00862459|532535278|FG001|Overall Study|Administrative problems|1|||
147648941|NCT00862459|532535279|FG002|Overall Study|Administrative problems|0|||
147648942|NCT00564395|532535284|FG000|First Intervention (10 Days)|Withdrawal by Subject|1|||
147648943|NCT00564395|532535285|FG001|First Intervention (10 Days)|Withdrawal by Subject|0|||
147648944|NCT00564395|532535284|FG000|First Intervention (10 Days)|Trouble with the CGM tracing|1|||
147648945|NCT00564395|532535285|FG001|First Intervention (10 Days)|Trouble with the CGM tracing|2|||
147648946|NCT01625689|532535292|FG000|Overall Study|Migration|2|||
147648947|NCT01625689|532535293|FG001|Overall Study|Migration|1|||
147648948|NCT01333956|532535306|FG000|Overall Study|Lost to Follow-up|1|||
147648949|NCT01333956|532535307|FG001|Overall Study|Lost to Follow-up|2|||
147648950|NCT01333956|532535308|FG002|Overall Study|Lost to Follow-up|0|||
147648951|NCT01333956|532535309|FG003|Overall Study|Lost to Follow-up|1|||
147648952|NCT01333956|532535306|FG000|Overall Study|Unable to complete study procedure|1|||
147648953|NCT01333956|532535307|FG001|Overall Study|Unable to complete study procedure|0|||
147648954|NCT01333956|532535308|FG002|Overall Study|Unable to complete study procedure|0|||
147648955|NCT01333956|532535309|FG003|Overall Study|Unable to complete study procedure|1|||
147648956|NCT01333956|532535306|FG000|Overall Study|Withdrawal by Subject|0|||
147648957|NCT01333956|532535307|FG001|Overall Study|Withdrawal by Subject|2|||
147648958|NCT01333956|532535308|FG002|Overall Study|Withdrawal by Subject|1|||
147648959|NCT01333956|532535309|FG003|Overall Study|Withdrawal by Subject|0|||
147648960|NCT02134353|532535310|FG000|Overall Study|Adverse Event|10|||
147648961|NCT02134353|532535311|FG001|Overall Study|Adverse Event|6|||
147648962|NCT02134353|532535310|FG000|Overall Study|Lost to Follow-up|1|||
147648963|NCT02134353|532535311|FG001|Overall Study|Lost to Follow-up|1|||
147648964|NCT02134353|532535310|FG000|Overall Study|Lack of Efficacy|2|||
147648965|NCT02134353|532535311|FG001|Overall Study|Lack of Efficacy|1|||
147648966|NCT02134353|532535310|FG000|Overall Study|Withdrawal by Subject|12|||
147648967|NCT02134353|532535311|FG001|Overall Study|Withdrawal by Subject|13|||
147648968|NCT02134353|532535310|FG000|Overall Study|Death|0|||
147648969|NCT02134353|532535311|FG001|Overall Study|Death|1|||
147648970|NCT02134353|532535310|FG000|Overall Study|Pregnancy|0|||
147648971|NCT02134353|532535311|FG001|Overall Study|Pregnancy|1|||
147648972|NCT02134353|532535310|FG000|Overall Study|Relocation|1|||
147648973|NCT02134353|532535311|FG001|Overall Study|Relocation|0|||
147648974|NCT02134353|532535310|FG000|Overall Study|Other - Patient's Choice|0|||
147648975|NCT02134353|532535311|FG001|Overall Study|Other - Patient's Choice|1|||
147648976|NCT01732471|532535312|FG000|Overall Study|Withdrawal by Subject|1|||
147648977|NCT03426436|532535315|FG000|Overall Study|Incorrect lead placement|12|||
147648978|NCT03426436|532535315|FG000|Overall Study|Withdrawal by Subject|2|||
147648979|NCT03426436|532535315|FG000|Overall Study|Consent issue|1|||
147648980|NCT03426436|532535315|FG000|Overall Study|ECGs not saved|4|||
147648981|NCT02892513|532535316|FG000|Overall Study|Withdrawal by Subject|0|||
147648982|NCT02892513|532535317|FG001|Overall Study|Withdrawal by Subject|1|||
147648983|NCT00655681|532535318|FG000|Overall Study|Lost to Follow-up|1|||
147648984|NCT00655681|532535319|FG001|Overall Study|Lost to Follow-up|1|||
147648985|NCT04776018|532535321|FG000|Overall Study|Death|0|||
147648986|NCT04776018|532535322|FG001|Overall Study|Death|1|||
147648987|NCT04776018|532535323|FG002|Overall Study|Death|4|||
147648988|NCT04776018|532535324|FG003|Overall Study|Death|1|||
147648989|NCT04776018|532535325|FG004|Overall Study|Death|4|||
147648990|NCT04776018|532535326|FG005|Overall Study|Death|0|||
147648991|NCT04776018|532535327|FG006|Overall Study|Death|0|||
147648992|NCT04776018|532535321|FG000|Overall Study|Study terminated by sponsor|2|||
147648993|NCT04776018|532535322|FG001|Overall Study|Study terminated by sponsor|1|||
147648994|NCT04776018|532535323|FG002|Overall Study|Study terminated by sponsor|4|||
147648995|NCT04776018|532535324|FG003|Overall Study|Study terminated by sponsor|0|||
147648996|NCT04776018|532535325|FG004|Overall Study|Study terminated by sponsor|3|||
147648997|NCT04776018|532535326|FG005|Overall Study|Study terminated by sponsor|0|||
147648998|NCT04776018|532535327|FG006|Overall Study|Study terminated by sponsor|0|||
147648999|NCT04776018|532535321|FG000|Overall Study|Withdrawal by Subject|1|||
147649000|NCT04776018|532535322|FG001|Overall Study|Withdrawal by Subject|0|||
147649001|NCT04776018|532535323|FG002|Overall Study|Withdrawal by Subject|0|||
147649002|NCT04776018|532535324|FG003|Overall Study|Withdrawal by Subject|2|||
147649003|NCT04776018|532535325|FG004|Overall Study|Withdrawal by Subject|1|||
147649004|NCT04776018|532535326|FG005|Overall Study|Withdrawal by Subject|0|||
147649005|NCT04776018|532535327|FG006|Overall Study|Withdrawal by Subject|0|||
147649006|NCT04776018|532535321|FG000|Overall Study|Other|0|||
147649007|NCT04776018|532535322|FG001|Overall Study|Other|1|||
147649008|NCT04776018|532535323|FG002|Overall Study|Other|1|||
147649009|NCT04776018|532535324|FG003|Overall Study|Other|0|||
147649010|NCT04776018|532535325|FG004|Overall Study|Other|0|||
147649011|NCT04776018|532535326|FG005|Overall Study|Other|0|||
147649012|NCT04776018|532535327|FG006|Overall Study|Other|0|||
147649013|NCT04776018|532535321|FG000|Overall Study|Lost to Follow-up|0|||
147649014|NCT04776018|532535322|FG001|Overall Study|Lost to Follow-up|0|||
147649015|NCT04776018|532535323|FG002|Overall Study|Lost to Follow-up|1|||
147649016|NCT04776018|532535324|FG003|Overall Study|Lost to Follow-up|0|||
147649017|NCT04776018|532535325|FG004|Overall Study|Lost to Follow-up|0|||
147649018|NCT04776018|532535326|FG005|Overall Study|Lost to Follow-up|0|||
147649019|NCT04776018|532535327|FG006|Overall Study|Lost to Follow-up|0|||
147649020|NCT00394433|532535331|FG000|Overall Study|Adverse Event|2|||
147649021|NCT00394433|532535331|FG000|Overall Study|Alternative Therapy|1|||
147649022|NCT00594386|532535332|FG000|Overall Study|Major protocol violation|2|||
147649023|NCT00594386|532535332|FG000|Overall Study|Lack of Efficacy|12|||
147649024|NCT00594386|532535332|FG000|Overall Study|Adverse Event|68|||
147649025|NCT00594386|532535332|FG000|Overall Study|Unsatisfactory compliance of subject|11|||
147649026|NCT00594386|532535332|FG000|Overall Study|Subject withdrew consent|35|||
147649027|NCT00594386|532535332|FG000|Overall Study|Study ended per sponsor|115|||
147649028|NCT00594386|532535332|FG000|Overall Study|Lost to Follow-up|6|||
147649029|NCT00594386|532535332|FG000|Overall Study|Other: Patient went off patch (hospital)|1|||
147649030|NCT00594386|532535332|FG000|Overall Study|Other: Subject moved to Seattle|1|||
147649031|NCT00594386|532535332|FG000|Overall Study|Other: Subject admitted to nursing home|1|||
147649032|NCT00594386|532535332|FG000|Overall Study|Other: Study terminated per investigator|2|||
147649033|NCT00594386|532535332|FG000|Overall Study|Other: Sponsor closure of study|1|||
147649034|NCT00594386|532535332|FG000|Overall Study|Other: Site terminated participation|1|||
147649035|NCT00594386|532535332|FG000|Overall Study|Other: Patient wants prescription Neupro|1|||
147649036|NCT00594386|532535332|FG000|Overall Study|Other: Loss of drivers license|1|||
147649037|NCT03417024|532535333|FG000|Overall Study|Study Termination prior to follow-up|11|||
147649038|NCT03417024|532535333|FG000|Overall Study|Physician Decision|2|||
147649039|NCT03168919|532535334|FG000|Overall Study|Withdrawal by Subject|2|||
147649040|NCT01085136|532535335|FG000|Part A|Other Adverse event|223|||
147649041|NCT01085136|532535336|FG001|Part A|Other Adverse event|0|||
147649042|NCT01085136|532535337|FG002|Part A|Other Adverse event|0|||
147649043|NCT01085136|532535335|FG000|Part A|Protocol Violation|3|||
147649044|NCT01085136|532535336|FG001|Part A|Protocol Violation|0|||
147649045|NCT01085136|532535337|FG002|Part A|Protocol Violation|0|||
147649046|NCT01085136|532535335|FG000|Part A|Lost to Follow-up|3|||
147649047|NCT01085136|532535336|FG001|Part A|Lost to Follow-up|0|||
147649048|NCT01085136|532535337|FG002|Part A|Lost to Follow-up|0|||
147649049|NCT01085136|532535335|FG000|Part A|Refusal to continue trial medication|64|||
147649050|NCT01085136|532535336|FG001|Part A|Refusal to continue trial medication|0|||
147649051|NCT01085136|532535337|FG002|Part A|Refusal to continue trial medication|0|||
147649052|NCT01085136|532535335|FG000|Part A|Other reason not defined above|30|||
147649053|NCT01085136|532535336|FG001|Part A|Other reason not defined above|0|||
147649054|NCT01085136|532535337|FG002|Part A|Other reason not defined above|0|||
147649055|NCT01085136|532535335|FG000|Part B|Other AE|0|||
147649056|NCT01085136|532535336|FG001|Part B|Other AE|29|||
147649057|NCT01085136|532535337|FG002|Part B|Other AE|8|||
147649058|NCT01085136|532535335|FG000|Part B|Refusal to continue trial medication|0|||
147649059|NCT01085136|532535336|FG001|Part B|Refusal to continue trial medication|12|||
147649060|NCT01085136|532535337|FG002|Part B|Refusal to continue trial medication|7|||
147649061|NCT01085136|532535335|FG000|Part B|Not treated|0|||
147649062|NCT01085136|532535336|FG001|Part B|Not treated|4|||
147649063|NCT01085136|532535337|FG002|Part B|Not treated|8|||
147649064|NCT01085136|532535335|FG000|Part B|Other reason not defined above|0|||
147649065|NCT01085136|532535336|FG001|Part B|Other reason not defined above|6|||
147649066|NCT01085136|532535337|FG002|Part B|Other reason not defined above|3|||
147649067|NCT02195427|532535338|FG000|Overall Study|Did not consent to study extension|13|||
147649068|NCT02195427|532535339|FG001|Overall Study|Did not consent to study extension|9|||
147649069|NCT02195427|532535338|FG000|Overall Study|Withdrawal by Subject|4|||
147649070|NCT02195427|532535339|FG001|Overall Study|Withdrawal by Subject|2|||
147649071|NCT02195427|532535338|FG000|Overall Study|Lost to Follow-up|0|||
147649072|NCT02195427|532535339|FG001|Overall Study|Lost to Follow-up|1|||
147649073|NCT02195427|532535338|FG000|Overall Study|Protocol Violation|7|||
147649074|NCT02195427|532535339|FG001|Overall Study|Protocol Violation|14|||
147649075|NCT02195427|532535338|FG000|Overall Study|Conditional re-treatment at W52|2|||
147649076|NCT02195427|532535339|FG001|Overall Study|Conditional re-treatment at W52|1|||
147649077|NCT01210144|532535340|FG000|Overall Study|Lack of ovarian response|1|||
147649078|NCT01210144|532535341|FG001|Overall Study|Lack of ovarian response|0|||
147649079|NCT01210144|532535340|FG000|Overall Study|No fertilization|1|||
147649080|NCT01210144|532535341|FG001|Overall Study|No fertilization|0|||
147649081|NCT01210144|532535340|FG000|Overall Study|No transfer|1|||
147649082|NCT01210144|532535341|FG001|Overall Study|No transfer|0|||
147649083|NCT00386425|532535345|FG000|Overall Study|Physician Decision|3|||
147649084|NCT00386425|532535346|FG001|Overall Study|Physician Decision|0|||
147649085|NCT00386425|532535347|FG002|Overall Study|Physician Decision|0|||
147649086|NCT00386425|532535345|FG000|Overall Study|Withdrawal by Subject|0|||
147649087|NCT00386425|532535346|FG001|Overall Study|Withdrawal by Subject|1|||
147649088|NCT00386425|532535347|FG002|Overall Study|Withdrawal by Subject|0|||
147649089|NCT04226495|532535348|FG000|Overall Study|Withdrawal by Subject|3|||
147649090|NCT04226495|532535349|FG001|Overall Study|Withdrawal by Subject|3|||
147649091|NCT04226495|532535348|FG000|Overall Study|PI discretion|3|||
147649092|NCT04226495|532535349|FG001|Overall Study|PI discretion|4|||
147649093|NCT00435019|532535350|FG000|Overall Study|Adverse Event|1|||
147649094|NCT00435019|532535351|FG001|Overall Study|Adverse Event|0|||
147649095|NCT00435019|532535350|FG000|Overall Study|Lack of Efficacy|1|||
147649096|NCT00435019|532535351|FG001|Overall Study|Lack of Efficacy|2|||
147649097|NCT00435019|532535350|FG000|Overall Study|Protocol Violation|3|||
147649098|NCT00435019|532535351|FG001|Overall Study|Protocol Violation|1|||
147649099|NCT00435019|532535350|FG000|Overall Study|Personal reasons for withdrawal|8|||
147649100|NCT00435019|532535351|FG001|Overall Study|Personal reasons for withdrawal|7|||
147649101|NCT00505661|532535356|FG000|Overall Study|Not Eligible|4|||
147649102|NCT03611582|532535359|FG000|Overall Study|Adverse Event|26|||
147649103|NCT03611582|532535360|FG001|Overall Study|Adverse Event|6|||
147649104|NCT03611582|532535359|FG000|Overall Study|Protocol Violation|0|||
147649105|NCT03611582|532535360|FG001|Overall Study|Protocol Violation|1|||
147649106|NCT03611582|532535359|FG000|Overall Study|Pregnancy|1|||
147649107|NCT03611582|532535360|FG001|Overall Study|Pregnancy|2|||
147649108|NCT03611582|532535359|FG000|Overall Study|Lack of Efficacy|0|||
147649109|NCT03611582|532535360|FG001|Overall Study|Lack of Efficacy|1|||
147649110|NCT03611582|532535359|FG000|Overall Study|At the discretion of the investigator|1|||
147649111|NCT03611582|532535360|FG001|Overall Study|At the discretion of the investigator|0|||
147649112|NCT03611582|532535359|FG000|Overall Study|Safety concern as judged by the investigator|1|||
147649113|NCT03611582|532535360|FG001|Overall Study|Safety concern as judged by the investigator|2|||
147649114|NCT03611582|532535359|FG000|Overall Study|Withdrawal by Subject|4|||
147649115|NCT03611582|532535360|FG001|Overall Study|Withdrawal by Subject|3|||
147649116|NCT03611582|532535359|FG000|Overall Study|Lost to Follow-up|18|||
147649117|NCT03611582|532535360|FG001|Overall Study|Lost to Follow-up|7|||
147649118|NCT03611582|532535359|FG000|Overall Study|other|17|||
147649119|NCT03611582|532535360|FG001|Overall Study|other|16|||
147649120|NCT01783821|532535361|FG000|Overall Study|Screen Failure|1|||
147649121|NCT01783821|532535362|FG001|Overall Study|Screen Failure|1|||
147649122|NCT01907217|532535363|FG000|Overall Study|Withdrawal by Subject|0|||
147649123|NCT01907217|532535364|FG001|Overall Study|Withdrawal by Subject|2|||
147649124|NCT01764659|532535365|FG000|Overall Study|Death|1|||
147649125|NCT01764659|532535365|FG000|Overall Study|Physician Decision|1|||
147649126|NCT01210352|532535366|FG000|Overall Study|Adverse Event|0|||
147649127|NCT01210352|532535367|FG001|Overall Study|Adverse Event|0|||
147649128|NCT01210352|532535368|FG002|Overall Study|Adverse Event|0|||
147649129|NCT01210352|532535369|FG003|Overall Study|Adverse Event|0|||
147649130|NCT01210352|532535370|FG004|Overall Study|Adverse Event|0|||
147649131|NCT01210352|532535371|FG005|Overall Study|Adverse Event|0|||
147649132|NCT01210352|532535372|FG006|Overall Study|Adverse Event|0|||
147649133|NCT01210352|532535373|FG007|Overall Study|Adverse Event|2|||
147649134|NCT01210352|532535374|FG008|Overall Study|Adverse Event|1|||
147649135|NCT01210352|532535366|FG000|Overall Study|Lack of Efficacy|0|||
147649136|NCT01210352|532535367|FG001|Overall Study|Lack of Efficacy|0|||
147649137|NCT01210352|532535368|FG002|Overall Study|Lack of Efficacy|0|||
147649138|NCT01210352|532535369|FG003|Overall Study|Lack of Efficacy|0|||
147649139|NCT01210352|532535370|FG004|Overall Study|Lack of Efficacy|0|||
147649140|NCT01210352|532535371|FG005|Overall Study|Lack of Efficacy|0|||
147649141|NCT01210352|532535372|FG006|Overall Study|Lack of Efficacy|1|||
147649142|NCT01210352|532535373|FG007|Overall Study|Lack of Efficacy|0|||
147649143|NCT01210352|532535374|FG008|Overall Study|Lack of Efficacy|0|||
147649144|NCT01210352|532535366|FG000|Overall Study|Physician Decision|0|||
147649145|NCT01210352|532535367|FG001|Overall Study|Physician Decision|0|||
147649146|NCT01210352|532535368|FG002|Overall Study|Physician Decision|0|||
147649147|NCT01210352|532535369|FG003|Overall Study|Physician Decision|0|||
147649148|NCT01210352|532535370|FG004|Overall Study|Physician Decision|0|||
147649149|NCT01210352|532535371|FG005|Overall Study|Physician Decision|0|||
147649150|NCT01210352|532535372|FG006|Overall Study|Physician Decision|0|||
147649151|NCT01210352|532535373|FG007|Overall Study|Physician Decision|1|||
147649152|NCT01210352|532535374|FG008|Overall Study|Physician Decision|2|||
147649153|NCT01210352|532535366|FG000|Overall Study|Withdrawal by Subject|0|||
147649154|NCT01210352|532535367|FG001|Overall Study|Withdrawal by Subject|0|||
147649155|NCT01210352|532535368|FG002|Overall Study|Withdrawal by Subject|1|||
147649156|NCT01210352|532535369|FG003|Overall Study|Withdrawal by Subject|0|||
147649157|NCT01210352|532535370|FG004|Overall Study|Withdrawal by Subject|0|||
147649158|NCT01210352|532535371|FG005|Overall Study|Withdrawal by Subject|0|||
147649159|NCT01210352|532535372|FG006|Overall Study|Withdrawal by Subject|1|||
147649160|NCT01210352|532535373|FG007|Overall Study|Withdrawal by Subject|0|||
147649161|NCT01210352|532535374|FG008|Overall Study|Withdrawal by Subject|1|||
147649162|NCT01210352|532535366|FG000|Overall Study|Patient Discharged Early|0|||
147649163|NCT01210352|532535367|FG001|Overall Study|Patient Discharged Early|0|||
147649164|NCT01210352|532535368|FG002|Overall Study|Patient Discharged Early|1|||
147649165|NCT01210352|532535369|FG003|Overall Study|Patient Discharged Early|0|||
147649166|NCT01210352|532535370|FG004|Overall Study|Patient Discharged Early|0|||
147649167|NCT01210352|532535371|FG005|Overall Study|Patient Discharged Early|0|||
147649168|NCT01210352|532535372|FG006|Overall Study|Patient Discharged Early|0|||
147649169|NCT01210352|532535373|FG007|Overall Study|Patient Discharged Early|0|||
147649170|NCT01210352|532535374|FG008|Overall Study|Patient Discharged Early|0|||
147649171|NCT00422292|532535375|FG000|Overall Study|Serious adverse events|1|||
147649172|NCT00422292|532535376|FG001|Overall Study|Serious adverse events|4|||
147649173|NCT00422292|532535377|FG002|Overall Study|Serious adverse events|0|||
147649174|NCT00422292|532535378|FG003|Overall Study|Serious adverse events|0|||
147649175|NCT00422292|532535375|FG000|Overall Study|Adverse Event|1|||
147649176|NCT00422292|532535376|FG001|Overall Study|Adverse Event|0|||
147649177|NCT00422292|532535377|FG002|Overall Study|Adverse Event|1|||
147649178|NCT00422292|532535378|FG003|Overall Study|Adverse Event|0|||
147649179|NCT00422292|532535375|FG000|Overall Study|Protocol Violation|4|||
147649180|NCT00422292|532535376|FG001|Overall Study|Protocol Violation|25|||
147649181|NCT00422292|532535377|FG002|Overall Study|Protocol Violation|8|||
147649182|NCT00422292|532535378|FG003|Overall Study|Protocol Violation|5|||
147649183|NCT00422292|532535375|FG000|Overall Study|Lost to Follow-up|6|||
147649184|NCT00422292|532535376|FG001|Overall Study|Lost to Follow-up|12|||
147649185|NCT00422292|532535377|FG002|Overall Study|Lost to Follow-up|6|||
147649186|NCT00422292|532535378|FG003|Overall Study|Lost to Follow-up|6|||
147649187|NCT00422292|532535375|FG000|Overall Study|Withdrawal by Subject|6|||
147649188|NCT00422292|532535376|FG001|Overall Study|Withdrawal by Subject|25|||
147649189|NCT00422292|532535377|FG002|Overall Study|Withdrawal by Subject|7|||
147649190|NCT00422292|532535378|FG003|Overall Study|Withdrawal by Subject|13|||
147649191|NCT02440854|532535379|FG000|Overall Study|Relocation of patient|1|||
147649192|NCT02440854|532535379|FG000|Overall Study|Death|6|||
147649193|NCT02440854|532535379|FG000|Overall Study|Lost to Follow-up|10|||
147649194|NCT02440854|532535379|FG000|Overall Study|Afatinib discontinuation|46|||
147649195|NCT02440854|532535379|FG000|Overall Study|stopped study at earlier timepoint|14|||
147649196|NCT02440854|532535379|FG000|Overall Study|Study medication not received|1|||
147649197|NCT02440854|532535379|FG000|Overall Study|Violation of inclusion criteria|2|||
147649198|NCT03338569|532535380|FG000|Overall Study|Physician Decision|8|||
147649199|NCT03338569|532535381|FG001|Overall Study|Physician Decision|3|||
147649200|NCT03338569|532535380|FG000|Overall Study|Withdrawal by Subject|0|||
147649201|NCT03338569|532535381|FG001|Overall Study|Withdrawal by Subject|1|||
147649202|NCT03338569|532535380|FG000|Overall Study|Lost to Follow-up|0|||
147649203|NCT03338569|532535381|FG001|Overall Study|Lost to Follow-up|1|||
147649204|NCT02243046|532535382|FG000|Overall Study|Lost to Follow-up|1|||
147649205|NCT02243046|532535383|FG001|Overall Study|Lost to Follow-up|1|||
147649206|NCT02243046|532535384|FG002|Overall Study|Lost to Follow-up|4|||
147649207|NCT04607980|532535385|FG000|Overall Study|Adverse Event|3|||
147649208|NCT04607980|532535386|FG001|Overall Study|Adverse Event|4|||
147649209|NCT04607980|532535385|FG000|Overall Study|Death|0|||
147649210|NCT04607980|532535386|FG001|Overall Study|Death|1|||
147649211|NCT04607980|532535385|FG000|Overall Study|Withdrawal by Subject|2|||
147649212|NCT04607980|532535386|FG001|Overall Study|Withdrawal by Subject|5|||
147649213|NCT04607980|532535385|FG000|Overall Study|Lost to Follow-up|4|||
147649214|NCT04607980|532535386|FG001|Overall Study|Lost to Follow-up|8|||
147649215|NCT04607980|532535385|FG000|Overall Study|Protocol Violation|0|||
147649216|NCT04607980|532535386|FG001|Overall Study|Protocol Violation|3|||
147649217|NCT04607980|532535385|FG000|Overall Study|Other|3|||
147649218|NCT04607980|532535386|FG001|Overall Study|Other|0|||
147649219|NCT01854879|532535387|FG000|Overall Study|Could not complete testing within the scheduled time.|1|||
147649220|NCT01854879|532535387|FG000|Overall Study|screen fail|3|||
147649221|NCT01854879|532535387|FG000|Overall Study|incomplete data set|1|||
147649222|NCT02012959|532535388|FG000|Treatment Phase A|Adverse Event|2|||
147649223|NCT02012959|532535389|FG001|Treatment Phase A|Adverse Event|0|||
147649224|NCT02012959|532535390|FG002|Treatment Phase A|Adverse Event|0|||
147649225|NCT02012959|532535391|FG003|Treatment Phase A|Adverse Event|0|||
147649226|NCT02012959|532535392|FG004|Treatment Phase A|Adverse Event|0|||
147649227|NCT01859949|532537300|FG000|Overall Study|Family Matters|0|||
147649228|NCT01859949|532537301|FG001|Overall Study|Family Matters|1|||
147649229|NCT01859949|532537300|FG000|Overall Study|Physician Decision|2|||
147649230|NCT01859949|532537301|FG001|Overall Study|Physician Decision|4|||
147649231|NCT01859949|532537300|FG000|Overall Study|Withdrawal by Subject|11|||
147649232|NCT01859949|532537301|FG001|Overall Study|Withdrawal by Subject|10|||
147649233|NCT01859949|532537300|FG000|Overall Study|Protocol Violation|1|||
147649234|NCT01859949|532537301|FG001|Overall Study|Protocol Violation|1|||
147649235|NCT01859949|532537300|FG000|Overall Study|Adverse Event|0|||
147649236|NCT01859949|532537301|FG001|Overall Study|Adverse Event|1|||
147649237|NCT01344759|532537302|FG000|Overall Study|Patients failed to reach sedation level|0|||
147649238|NCT01344759|532537303|FG001|Overall Study|Patients failed to reach sedation level|2|||
147649239|NCT01890759|532537304|FG000|Overall Study|Protocol Violation|0|||
147649240|NCT01890759|532537305|FG001|Overall Study|Protocol Violation|2|||
147649241|NCT01890759|532537304|FG000|Overall Study|Lost to Follow-up|0|||
147649242|NCT01890759|532537305|FG001|Overall Study|Lost to Follow-up|2|||
147649243|NCT01890759|532537304|FG000|Overall Study|Withdrawal by Subject|2|||
147649244|NCT01890759|532537305|FG001|Overall Study|Withdrawal by Subject|8|||
147649245|NCT04494425|532537310|FG000|Overall Study|Death|160|||
147649246|NCT04494425|532537311|FG001|Overall Study|Death|166|||
147649247|NCT04494425|532537310|FG000|Overall Study|Withdrawal by Subject|10|||
147649248|NCT04494425|532537311|FG001|Overall Study|Withdrawal by Subject|40|||
147649249|NCT04494425|532537310|FG000|Overall Study|Other|1|||
147649250|NCT04494425|532537311|FG001|Overall Study|Other|1|||
147649251|NCT04494425|532537310|FG000|Overall Study|Ongoing at the time of PCD|265|||
147649252|NCT04494425|532537311|FG001|Overall Study|Ongoing at the time of PCD|223|||
147649253|NCT01270321|532537312|FG000|Overall Study|Death|3|||
147649254|NCT01270321|532537313|FG001|Overall Study|Death|1|||
147649255|NCT01270321|532537314|FG002|Overall Study|Death|4|||
147649256|NCT01270321|532537312|FG000|Overall Study|Adverse Event|7|||
147649257|NCT01270321|532537313|FG001|Overall Study|Adverse Event|9|||
147649258|NCT01270321|532537314|FG002|Overall Study|Adverse Event|5|||
147649259|NCT04003623|532537318|FG000|Overall Study|Withdrawal by Subject|1|||
147649260|NCT04003623|532537319|FG001|Overall Study|Withdrawal by Subject|0|||
147649261|NCT01744483|532537325|FG000|Overall Study|Death|9|||
147649262|NCT01744483|532537326|FG001|Overall Study|Death|4|||
147649263|NCT01744483|532537327|FG002|Overall Study|Death|11|||
147649264|NCT01744483|532537325|FG000|Overall Study|Lost to Follow-up|8|||
147649265|NCT01744483|532537326|FG001|Overall Study|Lost to Follow-up|9|||
147649266|NCT01744483|532537327|FG002|Overall Study|Lost to Follow-up|11|||
147649267|NCT01744483|532537325|FG000|Overall Study|Protocol Violation|1|||
147649268|NCT01744483|532537326|FG001|Overall Study|Protocol Violation|2|||
147649269|NCT01744483|532537327|FG002|Overall Study|Protocol Violation|1|||
147649270|NCT01744483|532537325|FG000|Overall Study|Withdrawal by Subject|4|||
147649271|NCT01744483|532537326|FG001|Overall Study|Withdrawal by Subject|6|||
147649272|NCT01744483|532537327|FG002|Overall Study|Withdrawal by Subject|2|||
147649273|NCT01744483|532537325|FG000|Overall Study|No ICU Admit|5|||
147649274|NCT01744483|532537326|FG001|Overall Study|No ICU Admit|1|||
147649275|NCT01744483|532537327|FG002|Overall Study|No ICU Admit|2|||
147649276|NCT01744483|532537325|FG000|Overall Study|Routed to OSH|2|||
147649277|NCT01744483|532537326|FG001|Overall Study|Routed to OSH|0|||
147649278|NCT01744483|532537327|FG002|Overall Study|Routed to OSH|1|||
147649279|NCT01190189|532537328|FG000|Overall Study|Lost to Follow-up|4|||
147649280|NCT01190189|532537328|FG000|Overall Study|Withdrawal by Subject|1|||
147649281|NCT01190189|532537328|FG000|Overall Study|Migrated/moved from study area|1|||
147649282|NCT03915626|532537329|FG000|Overall Study|study was halted due to COVID-19; once started again volunteer could no longer participate|1|||
147649283|NCT05025332|532537330|FG000|Screening|Screen failure|12|||
147649284|NCT05025332|532537330|FG000|Treatment & Follow Up|Protocol Violation|1|||
147649285|NCT05025332|532537330|FG000|Treatment & Follow Up|Adverse Event|4|||
147649286|NCT01026818|532537331|FG000|Screening Period|Entry Criteria Not Met|105|||
147649287|NCT01026818|532537332|FG001|Screening Period|Entry Criteria Not Met|0|||
147649288|NCT01026818|532537333|FG002|Screening Period|Entry Criteria Not Met|0|||
147649289|NCT01026818|532537334|FG003|Screening Period|Entry Criteria Not Met|0|||
147649290|NCT01026818|532537331|FG000|Screening Period|Withdrawal by Subject|49|||
147649291|NCT01026818|532537332|FG001|Screening Period|Withdrawal by Subject|0|||
147649292|NCT01026818|532537333|FG002|Screening Period|Withdrawal by Subject|0|||
147649293|NCT01026818|532537334|FG003|Screening Period|Withdrawal by Subject|0|||
147649294|NCT01026818|532537331|FG000|Screening Period|Protocol Deviation|3|||
147421238|NCT01285609|531703870|FG000|Treated With Blinded Therapy|Participant started radiotherapy|1|||
147649295|NCT01026818|532537332|FG001|Screening Period|Protocol Deviation|0|||
147649296|NCT01026818|532537333|FG002|Screening Period|Protocol Deviation|0|||
147649297|NCT01026818|532537334|FG003|Screening Period|Protocol Deviation|0|||
147649298|NCT01026818|532537331|FG000|Screening Period|Adverse Event|2|||
147649299|NCT01026818|532537332|FG001|Screening Period|Adverse Event|0|||
147649300|NCT01026818|532537333|FG002|Screening Period|Adverse Event|0|||
147649301|NCT01026818|532537334|FG003|Screening Period|Adverse Event|0|||
147649302|NCT01026818|532537331|FG000|Screening Period|Physician Decision|1|||
147649303|NCT01026818|532537332|FG001|Screening Period|Physician Decision|0|||
147649304|NCT01026818|532537333|FG002|Screening Period|Physician Decision|0|||
147649305|NCT01026818|532537334|FG003|Screening Period|Physician Decision|0|||
147649306|NCT01026818|532537331|FG000|DB Treatment Period (Month 0 - 9)|Adverse Event|0|||
147649307|NCT01026818|532537332|FG001|DB Treatment Period (Month 0 - 9)|Adverse Event|10|||
147649308|NCT01026818|532537333|FG002|DB Treatment Period (Month 0 - 9)|Adverse Event|6|||
147649309|NCT01026818|532537334|FG003|DB Treatment Period (Month 0 - 9)|Adverse Event|4|||
147649310|NCT01026818|532537331|FG000|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|0|||
147649311|NCT01026818|532537332|FG001|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|7|||
147649312|NCT01026818|532537333|FG002|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|3|||
147649313|NCT01026818|532537334|FG003|DB Treatment Period (Month 0 - 9)|Withdrawal by Subject|3|||
147649314|NCT01026818|532537331|FG000|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|0|||
147649315|NCT01026818|532537332|FG001|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|3|||
147649316|NCT01026818|532537333|FG002|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|2|||
147649317|NCT01026818|532537334|FG003|DB Treatment Period (Month 0 - 9)|Lack of Efficacy|6|||
147649318|NCT01026818|532537331|FG000|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|0|||
147649319|NCT01026818|532537332|FG001|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|3|||
147649320|NCT01026818|532537333|FG002|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|0|||
147649321|NCT01026818|532537334|FG003|DB Treatment Period (Month 0 - 9)|Lost to Follow-up|4|||
147649322|NCT01026818|532537331|FG000|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|0|||
147649323|NCT01026818|532537332|FG001|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|2|||
147649324|NCT01026818|532537333|FG002|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|9|||
147649325|NCT01026818|532537334|FG003|DB Treatment Period (Month 0 - 9)|Entry Criteria Not Met|7|||
147649326|NCT01026818|532537331|FG000|DB Treatment Period (Month 0 - 9)|Protocol Deviation|0|||
147649327|NCT01026818|532537332|FG001|DB Treatment Period (Month 0 - 9)|Protocol Deviation|0|||
147649328|NCT01026818|532537333|FG002|DB Treatment Period (Month 0 - 9)|Protocol Deviation|1|||
147649329|NCT01026818|532537334|FG003|DB Treatment Period (Month 0 - 9)|Protocol Deviation|2|||
147649330|NCT01026818|532537331|FG000|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|0|||
147649331|NCT01026818|532537332|FG001|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|2|||
147649332|NCT01026818|532537333|FG002|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|1|||
147649333|NCT01026818|532537334|FG003|Drug-Free Washout Period (Month 9-10.5)|Entry Criteria Not Met|2|||
147649334|NCT01026818|532537331|FG000|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|0|||
147649335|NCT01026818|532537332|FG001|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|2|||
147649336|NCT01026818|532537333|FG002|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|1|||
147649337|NCT01026818|532537334|FG003|Drug-Free Washout Period (Month 9-10.5)|Lack of Efficacy|2|||
147649338|NCT01026818|532537331|FG000|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|0|||
147649339|NCT01026818|532537332|FG001|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|1|||
147649340|NCT01026818|532537333|FG002|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|0|||
147306606|NCT04512066|531288860|FG000|Double-blind Treatment Period|Adverse Event|6|||
147306607|NCT04512066|531288861|FG001|Double-blind Treatment Period|Adverse Event|4|||
147306608|NCT04512066|531288862|FG002|Double-blind Treatment Period|Adverse Event|5|||
147306609|NCT04512066|531288863|FG003|Double-blind Treatment Period|Adverse Event|1|||
147306610|NCT04512066|531288864|FG004|Double-blind Treatment Period|Adverse Event|0|||
147306611|NCT04512066|531288865|FG005|Double-blind Treatment Period|Adverse Event|0|||
147306612|NCT04512066|531288860|FG000|Double-blind Treatment Period|Lack of Efficacy|3|||
147306613|NCT04512066|531288861|FG001|Double-blind Treatment Period|Lack of Efficacy|3|||
147306614|NCT04512066|531288862|FG002|Double-blind Treatment Period|Lack of Efficacy|5|||
147306615|NCT04512066|531288863|FG003|Double-blind Treatment Period|Lack of Efficacy|1|||
147421239|NCT01285609|531703871|FG001|Treated With Blinded Therapy|Participant started radiotherapy|0|||
147421240|NCT01285609|531703870|FG000|Treated With Blinded Therapy|Participant hospitalized|1|||
147421241|NCT01285609|531703871|FG001|Treated With Blinded Therapy|Participant hospitalized|0|||
147421242|NCT01285609|531703870|FG000|Treated With Blinded Therapy|Investigator's assessment|1|||
147421243|NCT01285609|531703871|FG001|Treated With Blinded Therapy|Investigator's assessment|0|||
147421244|NCT01285609|531703870|FG000|Treated With Blinded Therapy|PI decision to discontinue|0|||
147421245|NCT01285609|531703871|FG001|Treated With Blinded Therapy|PI decision to discontinue|1|||
147421246|NCT01285609|531703870|FG000|Treated With Blinded Therapy|Worsening of general condition|0|||
147421247|NCT01285609|531703871|FG001|Treated With Blinded Therapy|Worsening of general condition|1|||
147421248|NCT00911768|531703877|FG000|Overall Study|Protocol Violation|5|||
147421249|NCT00911768|531703878|FG001|Overall Study|Protocol Violation|4|||
147421250|NCT00911768|531703877|FG000|Overall Study|Withdrawal by Subject|1|||
147421251|NCT00911768|531703878|FG001|Overall Study|Withdrawal by Subject|0|||
147421252|NCT00515853|531703880|FG000|Overall Study|Lost to Follow-up|9|||
147421253|NCT00515853|531703881|FG001|Overall Study|Lost to Follow-up|13|||
147421254|NCT00515853|531703880|FG000|Overall Study|Withdrawal by Subject|6|||
147421255|NCT00515853|531703881|FG001|Overall Study|Withdrawal by Subject|4|||
147421256|NCT02631577|531703887|FG000|Overall Study|Death|1|||
147421257|NCT02631577|531703888|FG001|Overall Study|Death|7|||
147421258|NCT02631577|531703887|FG000|Overall Study|Withdrawal by Subject|0|||
147421259|NCT02631577|531703888|FG001|Overall Study|Withdrawal by Subject|3|||
147421260|NCT00979134|531703889|FG000|Overall Study|Disease progression|18|||
147421261|NCT00979134|531703890|FG001|Overall Study|Disease progression|2|||
147421262|NCT00979134|531703891|FG002|Overall Study|Disease progression|5|||
147421263|NCT00979134|531703889|FG000|Overall Study|Adverse Event|0|||
147421264|NCT00979134|531703890|FG001|Overall Study|Adverse Event|0|||
147421265|NCT00979134|531703891|FG002|Overall Study|Adverse Event|2|||
147421266|NCT00979134|531703889|FG000|Overall Study|Withdrawal by Subject|1|||
147421267|NCT00979134|531703890|FG001|Overall Study|Withdrawal by Subject|1|||
147421268|NCT00979134|531703891|FG002|Overall Study|Withdrawal by Subject|2|||
147421269|NCT00979134|531703889|FG000|Overall Study|Lost to Follow-up|2|||
147421270|NCT00979134|531703890|FG001|Overall Study|Lost to Follow-up|2|||
147421271|NCT00979134|531703891|FG002|Overall Study|Lost to Follow-up|0|||
147421272|NCT00979134|531703889|FG000|Overall Study|Death|4|||
147421273|NCT00979134|531703890|FG001|Overall Study|Death|0|||
147421274|NCT00979134|531703891|FG002|Overall Study|Death|26|||
147421275|NCT00979134|531703889|FG000|Overall Study|Other|8|||
147421276|NCT00979134|531703890|FG001|Overall Study|Other|1|||
147421277|NCT00979134|531703891|FG002|Overall Study|Other|5|||
147421278|NCT02924428|531705711|FG000|Overall Study|Adverse Event|1|||
147421279|NCT02924428|531705712|FG001|Overall Study|Adverse Event|0|||
147421280|NCT02924428|531705711|FG000|Overall Study|Physician Decision|1|||
147421281|NCT02924428|531705712|FG001|Overall Study|Physician Decision|0|||
147421282|NCT02924428|531705711|FG000|Overall Study|Lost to Follow-up|2|||
147421283|NCT02924428|531705712|FG001|Overall Study|Lost to Follow-up|4|||
147421284|NCT02924428|531705711|FG000|Overall Study|Pregnancy|0|||
147421285|NCT02924428|531705712|FG001|Overall Study|Pregnancy|1|||
147421286|NCT00932113|531705713|FG000|Overall Study|Lost to Follow-up|1|||
147421287|NCT00932113|531705714|FG001|Overall Study|Lost to Follow-up|0|||
147421288|NCT00512317|531705715|FG000|Overall Study|Insufficient clinical response|36|||
147421289|NCT00512317|531705715|FG000|Overall Study|Withdrawal by Subject|23|||
147421290|NCT00512317|531705715|FG000|Overall Study|Sponsor closure of study|21|||
147421291|NCT00512317|531705715|FG000|Overall Study|<50% reduction in seizure frequency on or after Visit 7|18|||
147421292|NCT00512317|531705715|FG000|Overall Study|Adverse Event|13|||
147421293|NCT00512317|531705715|FG000|Overall Study|Discretion of the investigator or sponsor|2|||
147421294|NCT00512317|531705715|FG000|Overall Study|Lost to Follow-up|2|||
147421295|NCT00512317|531705715|FG000|Overall Study|Other|2|||
147421296|NCT03064035|531705718|FG000|Overall Study|Did not receive allocated intervention|4|||
147421297|NCT03064035|531705719|FG001|Overall Study|Did not receive allocated intervention|2|||
147421298|NCT03064035|531705718|FG000|Overall Study|Lost to Follow-up|1|||
147421299|NCT03064035|531705719|FG001|Overall Study|Lost to Follow-up|1|||
147421300|NCT01143038|531705720|FG000|Overall Study|Withdrawal by Subject|4|||
147421301|NCT01143038|531705720|FG000|Overall Study|Requirement for alternative therapy|5|||
147421302|NCT01143038|531705720|FG000|Overall Study|Adverse Event|3|||
147421303|NCT01143038|531705720|FG000|Overall Study|Lost to Follow-up|2|||
147421304|NCT01143038|531705720|FG000|Overall Study|Protocol Deviation|1|||
147421305|NCT01143038|531705720|FG000|Overall Study|Death|1|||
147421306|NCT00618982|531705721|FG000|Overall Study|Adverse Event|23|||
147421307|NCT00618982|531705721|FG000|Overall Study|Withdrawal by Subject|1|||
147421308|NCT00618982|531705721|FG000|Overall Study|Protocol Violation|1|||
147421309|NCT00618982|531705721|FG000|Overall Study|ongoing, still treated with study med.|25|||
147421310|NCT04289051|531705724|FG000|Overall Study|Lost to Follow-up|0|||
147421311|NCT04289051|531705725|FG001|Overall Study|Lost to Follow-up|0|||
147421312|NCT04289051|531705726|FG002|Overall Study|Lost to Follow-up|2|||
147421313|NCT00717067|531705727|FG000|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0|||
147421314|NCT00717067|531705728|FG001|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0|||
147421315|NCT00717067|531705729|FG002|Part 1a: Normal/Mild/Moderate Group|Adverse Event|1|||
147421316|NCT00717067|531705730|FG003|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0|||
147421317|NCT00717067|531705731|FG004|Part 1a: Normal/Mild/Moderate Group|Adverse Event|0|||
147421318|NCT00657020|531705732|FG000|PERIOD 1|Adverse Event|0|||
147421319|NCT00657020|531705733|FG001|PERIOD 1|Adverse Event|1|||
147421320|NCT00370331|531705736|FG000|Overall Study|Adverse Event|4|||
147421321|NCT00370331|531705737|FG001|Overall Study|Adverse Event|13|||
147421322|NCT00370331|531705736|FG000|Overall Study|Withdrawal by Subject|2|||
147421323|NCT00370331|531705737|FG001|Overall Study|Withdrawal by Subject|4|||
147191112|NCT04607668|530867552|FG000|Overall Study|Other, unspecified|8|||
147306616|NCT04512066|531288864|FG004|Double-blind Treatment Period|Lack of Efficacy|0|||
147306617|NCT04512066|531288865|FG005|Double-blind Treatment Period|Lack of Efficacy|0|||
147306618|NCT04512066|531288860|FG000|Double-blind Treatment Period|Physician Decision|1|||
147306619|NCT04512066|531288861|FG001|Double-blind Treatment Period|Physician Decision|0|||
147306620|NCT04512066|531288862|FG002|Double-blind Treatment Period|Physician Decision|1|||
147306621|NCT04512066|531288863|FG003|Double-blind Treatment Period|Physician Decision|0|||
147306622|NCT04512066|531288864|FG004|Double-blind Treatment Period|Physician Decision|0|||
147306623|NCT04512066|531288865|FG005|Double-blind Treatment Period|Physician Decision|0|||
147306624|NCT04512066|531288860|FG000|Double-blind Treatment Period|Withdrawal by Subject|7|||
147306625|NCT04512066|531288861|FG001|Double-blind Treatment Period|Withdrawal by Subject|9|||
147306626|NCT04512066|531288862|FG002|Double-blind Treatment Period|Withdrawal by Subject|5|||
147306627|NCT04512066|531288863|FG003|Double-blind Treatment Period|Withdrawal by Subject|12|||
147306628|NCT04512066|531288864|FG004|Double-blind Treatment Period|Withdrawal by Subject|0|||
147306629|NCT04512066|531288865|FG005|Double-blind Treatment Period|Withdrawal by Subject|0|||
147306630|NCT04512066|531288860|FG000|Extension Period|Adverse Event|0|||
147306631|NCT04512066|531288861|FG001|Extension Period|Adverse Event|1|||
147306632|NCT04512066|531288862|FG002|Extension Period|Adverse Event|4|||
147306633|NCT04512066|531288863|FG003|Extension Period|Adverse Event|3|||
147306634|NCT04512066|531288864|FG004|Extension Period|Adverse Event|1|||
147306635|NCT04512066|531288865|FG005|Extension Period|Adverse Event|3|||
147306636|NCT04512066|531288860|FG000|Extension Period|Death|0|||
147306637|NCT04512066|531288861|FG001|Extension Period|Death|0|||
147306638|NCT04512066|531288862|FG002|Extension Period|Death|0|||
147306639|NCT04512066|531288863|FG003|Extension Period|Death|0|||
147306640|NCT04512066|531288864|FG004|Extension Period|Death|0|||
147306641|NCT04512066|531288865|FG005|Extension Period|Death|1|||
147306642|NCT04512066|531288860|FG000|Extension Period|Lack of Efficacy|0|||
147306643|NCT04512066|531288861|FG001|Extension Period|Lack of Efficacy|4|||
147306644|NCT04512066|531288862|FG002|Extension Period|Lack of Efficacy|4|||
147306645|NCT04512066|531288863|FG003|Extension Period|Lack of Efficacy|1|||
147306646|NCT04512066|531288864|FG004|Extension Period|Lack of Efficacy|3|||
147306647|NCT04512066|531288865|FG005|Extension Period|Lack of Efficacy|3|||
147306648|NCT04512066|531288860|FG000|Extension Period|Lost to Follow-up|0|||
147306649|NCT04512066|531288861|FG001|Extension Period|Lost to Follow-up|1|||
147306650|NCT04512066|531288862|FG002|Extension Period|Lost to Follow-up|5|||
147306651|NCT04512066|531288863|FG003|Extension Period|Lost to Follow-up|2|||
147306652|NCT04512066|531288864|FG004|Extension Period|Lost to Follow-up|3|||
147306653|NCT04512066|531288865|FG005|Extension Period|Lost to Follow-up|2|||
147306654|NCT04512066|531288860|FG000|Extension Period|Non-compliance with study drug|0|||
147306655|NCT04512066|531288861|FG001|Extension Period|Non-compliance with study drug|1|||
147306656|NCT04512066|531288862|FG002|Extension Period|Non-compliance with study drug|0|||
147306657|NCT04512066|531288863|FG003|Extension Period|Non-compliance with study drug|0|||
147306658|NCT04512066|531288864|FG004|Extension Period|Non-compliance with study drug|0|||
147306659|NCT04512066|531288865|FG005|Extension Period|Non-compliance with study drug|1|||
147306660|NCT04512066|531288860|FG000|Extension Period|Other|0|||
147306661|NCT04512066|531288861|FG001|Extension Period|Other|2|||
147421324|NCT00370331|531705736|FG000|Overall Study|Lost to Follow-up|0|||
147421325|NCT00370331|531705737|FG001|Overall Study|Lost to Follow-up|3|||
147421326|NCT00370331|531705736|FG000|Overall Study|Lack of Efficacy|0|||
147421327|NCT00370331|531705737|FG001|Overall Study|Lack of Efficacy|1|||
147421328|NCT00370331|531705736|FG000|Overall Study|Non-compliance|0|||
147421329|NCT00370331|531705737|FG001|Overall Study|Non-compliance|1|||
147421330|NCT00370331|531705736|FG000|Overall Study|Protocol Violation|1|||
147421331|NCT00370331|531705737|FG001|Overall Study|Protocol Violation|1|||
147421332|NCT02937454|531705738|FG000|Overall Study|Adverse Event|0|||
147421333|NCT02937454|531705739|FG001|Overall Study|Adverse Event|1|||
147421334|NCT02937454|531705738|FG000|Overall Study|Death|98|||
147421335|NCT02937454|531705739|FG001|Overall Study|Death|95|||
147421336|NCT02937454|531705738|FG000|Overall Study|Lost to Follow-up|1|||
147421337|NCT02937454|531705739|FG001|Overall Study|Lost to Follow-up|1|||
147421338|NCT02937454|531705738|FG000|Overall Study|Physician Decision|0|||
147421339|NCT02937454|531705739|FG001|Overall Study|Physician Decision|1|||
147421340|NCT02937454|531705738|FG000|Overall Study|Protocol Violation|6|||
147421341|NCT02937454|531705739|FG001|Overall Study|Protocol Violation|10|||
147421342|NCT02937454|531705738|FG000|Overall Study|Withdrawal by Subject|27|||
147421343|NCT02937454|531705739|FG001|Overall Study|Withdrawal by Subject|15|||
147421344|NCT02937454|531705738|FG000|Overall Study|Other|8|||
147421345|NCT02937454|531705739|FG001|Overall Study|Other|5|||
147421346|NCT00993668|531705743|FG000|Single-Blind Period|Adverse Event|1|||
147421347|NCT00993668|531705744|FG001|Single-Blind Period|Adverse Event|1|||
147421348|NCT00993668|531705743|FG000|Single-Blind Period|Lack of Efficacy|0|||
147421349|NCT00993668|531705744|FG001|Single-Blind Period|Lack of Efficacy|1|||
147421350|NCT00993668|531705743|FG000|Single-Blind Period|Lost to Follow-up|3|||
147421351|NCT00993668|531705744|FG001|Single-Blind Period|Lost to Follow-up|1|||
147421352|NCT00993668|531705743|FG000|Open-Label Period|Adverse Event|9|||
147421353|NCT00993668|531705744|FG001|Open-Label Period|Adverse Event|8|||
147421354|NCT00993668|531705743|FG000|Open-Label Period|Lack of Efficacy|4|||
147421355|NCT00993668|531705744|FG001|Open-Label Period|Lack of Efficacy|3|||
147421356|NCT00993668|531705743|FG000|Open-Label Period|Withdrawal by Subject|4|||
147421357|NCT00993668|531705744|FG001|Open-Label Period|Withdrawal by Subject|3|||
147421358|NCT00993668|531705743|FG000|Open-Label Period|Lost to Follow-up|6|||
147421359|NCT00993668|531705744|FG001|Open-Label Period|Lost to Follow-up|1|||
147421360|NCT03606668|531705748|FG000|Overall Study|Screen Failure|1|||
147421361|NCT03606668|531705748|FG000|Overall Study|Lost to Follow-up|1|||
147421362|NCT01014143|531705749|FG000|Second Intervention|Lost to Follow-up|2|||
147421363|NCT01014143|531705750|FG001|Second Intervention|Lost to Follow-up|0|||
147421364|NCT01014143|531705751|FG002|Second Intervention|Lost to Follow-up|0|||
147421365|NCT03215810|531705754|FG000|Overall Study|Still responding to nivolumab|1|||
147421366|NCT03215810|531705754|FG000|Overall Study|Insufficient TIL growth|1|||
147421367|NCT03215810|531705754|FG000|Overall Study|Decline in performance status|1|||
147421368|NCT03215810|531705754|FG000|Overall Study|Withdrawal by Subject|1|||
147595933|NCT03096847|532338753|FG002|Overall Study|Protocol Violation|6|||
147421369|NCT01029652|531705758|FG000|Core Study (0-12 Weeks)|Unsatisfactory therapeutic effect|0|||
147421370|NCT01029652|531705759|FG001|Core Study (0-12 Weeks)|Unsatisfactory therapeutic effect|4|||
147306662|NCT04512066|531288862|FG002|Extension Period|Other|0|||
147306663|NCT04512066|531288863|FG003|Extension Period|Other|0|||
147306664|NCT04512066|531288864|FG004|Extension Period|Other|0|||
147306665|NCT04512066|531288865|FG005|Extension Period|Other|0|||
147306666|NCT04512066|531288860|FG000|Extension Period|Physician Decision|0|||
147306667|NCT04512066|531288861|FG001|Extension Period|Physician Decision|2|||
147306668|NCT04512066|531288862|FG002|Extension Period|Physician Decision|0|||
147306669|NCT04512066|531288863|FG003|Extension Period|Physician Decision|1|||
147306670|NCT04512066|531288864|FG004|Extension Period|Physician Decision|1|||
147306671|NCT04512066|531288865|FG005|Extension Period|Physician Decision|0|||
147306672|NCT04512066|531288860|FG000|Extension Period|Withdrawal by Subject|0|||
147306673|NCT04512066|531288861|FG001|Extension Period|Withdrawal by Subject|3|||
147306674|NCT04512066|531288862|FG002|Extension Period|Withdrawal by Subject|7|||
147306675|NCT04512066|531288863|FG003|Extension Period|Withdrawal by Subject|11|||
147306676|NCT04512066|531288864|FG004|Extension Period|Withdrawal by Subject|8|||
147306677|NCT04512066|531288865|FG005|Extension Period|Withdrawal by Subject|4|||
147306678|NCT00445679|531288868|FG000|Overall Study|Adverse Event|22|||
147306679|NCT00445679|531288869|FG001|Overall Study|Adverse Event|12|||
147306680|NCT00445679|531288870|FG002|Overall Study|Adverse Event|30|||
147306681|NCT00445679|531288871|FG003|Overall Study|Adverse Event|19|||
147306682|NCT00445679|531288868|FG000|Overall Study|Failed to return|1|||
147306683|NCT00445679|531288869|FG001|Overall Study|Failed to return|3|||
147306684|NCT00445679|531288870|FG002|Overall Study|Failed to return|2|||
147306685|NCT00445679|531288871|FG003|Overall Study|Failed to return|2|||
147306686|NCT00445679|531288868|FG000|Overall Study|Physician Decision|0|||
147306687|NCT00445679|531288869|FG001|Overall Study|Physician Decision|0|||
147306688|NCT00445679|531288870|FG002|Overall Study|Physician Decision|1|||
147306689|NCT00445679|531288871|FG003|Overall Study|Physician Decision|0|||
147306690|NCT00445679|531288868|FG000|Overall Study|Lost to Follow-up|10|||
147306691|NCT00445679|531288869|FG001|Overall Study|Lost to Follow-up|6|||
147306692|NCT00445679|531288870|FG002|Overall Study|Lost to Follow-up|6|||
147306693|NCT00445679|531288871|FG003|Overall Study|Lost to Follow-up|5|||
147306694|NCT00445679|531288868|FG000|Overall Study|Compliance|3|||
147306695|NCT00445679|531288869|FG001|Overall Study|Compliance|2|||
147306696|NCT00445679|531288870|FG002|Overall Study|Compliance|1|||
147306697|NCT00445679|531288871|FG003|Overall Study|Compliance|2|||
147306698|NCT00445679|531288868|FG000|Overall Study|Withdrawal of Informed Consent|0|||
147306699|NCT00445679|531288869|FG001|Overall Study|Withdrawal of Informed Consent|0|||
147306700|NCT00445679|531288870|FG002|Overall Study|Withdrawal of Informed Consent|1|||
147306701|NCT00445679|531288871|FG003|Overall Study|Withdrawal of Informed Consent|0|||
147306702|NCT00445679|531288868|FG000|Overall Study|Protocol Violation|2|||
147306703|NCT00445679|531288869|FG001|Overall Study|Protocol Violation|3|||
147306704|NCT00445679|531288870|FG002|Overall Study|Protocol Violation|3|||
147306705|NCT00445679|531288871|FG003|Overall Study|Protocol Violation|1|||
147306706|NCT00445679|531288868|FG000|Overall Study|Withdrawal by Subject|8|||
147306707|NCT00445679|531288869|FG001|Overall Study|Withdrawal by Subject|14|||
147306708|NCT00445679|531288870|FG002|Overall Study|Withdrawal by Subject|20|||
147306709|NCT00445679|531288871|FG003|Overall Study|Withdrawal by Subject|18|||
147306710|NCT00445679|531288868|FG000|Overall Study|Lack of Efficacy|2|||
147306711|NCT00445679|531288869|FG001|Overall Study|Lack of Efficacy|6|||
147306712|NCT00445679|531288870|FG002|Overall Study|Lack of Efficacy|2|||
147306713|NCT00445679|531288871|FG003|Overall Study|Lack of Efficacy|0|||
147421371|NCT01029652|531705758|FG000|Core Study (0-12 Weeks)|Patient Withdrew Consent|1|||
147421372|NCT01029652|531705759|FG001|Core Study (0-12 Weeks)|Patient Withdrew Consent|3|||
147421373|NCT01029652|531705758|FG000|Core Study (0-12 Weeks)|Lost to Follow-up|3|||
147421374|NCT01029652|531705759|FG001|Core Study (0-12 Weeks)|Lost to Follow-up|1|||
147421375|NCT01029652|531705758|FG000|Core Study (0-12 Weeks)|Administrative problems|2|||
147421376|NCT01029652|531705759|FG001|Core Study (0-12 Weeks)|Administrative problems|1|||
147421377|NCT01029652|531705758|FG000|Core Study (0-12 Weeks)|Death|0|||
147421378|NCT01029652|531705759|FG001|Core Study (0-12 Weeks)|Death|1|||
147421379|NCT01029652|531705758|FG000|Extension Study 1 (12-24 Weeks)|Unsatisfactory therapeutic effect|0|||
147421380|NCT01029652|531705759|FG001|Extension Study 1 (12-24 Weeks)|Unsatisfactory therapeutic effect|1|||
147421381|NCT01029652|531705758|FG000|Extension Study 1 (12-24 Weeks)|Lost to Follow-up|2|||
147421382|NCT01029652|531705759|FG001|Extension Study 1 (12-24 Weeks)|Lost to Follow-up|3|||
147421383|NCT01029652|531705758|FG000|Extension Study 1 (12-24 Weeks)|Protocol Deviation|1|||
147421384|NCT01029652|531705759|FG001|Extension Study 1 (12-24 Weeks)|Protocol Deviation|0|||
147421385|NCT01029652|531705758|FG000|Extension Study 1 (12-24 Weeks)|Withdrawal by Subject|0|||
147421386|NCT01029652|531705759|FG001|Extension Study 1 (12-24 Weeks)|Withdrawal by Subject|1|||
147421387|NCT01029652|531705758|FG000|Extension Study 2 (25-72 Weeks)|Death|1|||
147421388|NCT01029652|531705759|FG001|Extension Study 2 (25-72 Weeks)|Death|1|||
147421389|NCT01029652|531705758|FG000|Extension Study 2 (25-72 Weeks)|Unsatisfactory therapeutic effect|0|||
147421390|NCT01029652|531705759|FG001|Extension Study 2 (25-72 Weeks)|Unsatisfactory therapeutic effect|1|||
147421391|NCT01029652|531705758|FG000|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|0|||
147421392|NCT01029652|531705759|FG001|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|1|||
147421393|NCT02313233|531705763|FG000|Overall Study|Withdrawal by Subject|1|||
147421394|NCT02313233|531705764|FG001|Overall Study|Withdrawal by Subject|2|||
147421395|NCT02313233|531705763|FG000|Overall Study|Administrative reason|1|||
147421396|NCT02313233|531705764|FG001|Overall Study|Administrative reason|1|||
147421397|NCT02095951|531705765|FG000|Overall Study|NO POSITIVE BLOOD CULTURE|9|||
147421398|NCT02095951|531705766|FG001|Overall Study|NO POSITIVE BLOOD CULTURE|6|||
147421399|NCT03618823|531705767|FG000|Overall Study|Lost to Follow-up|63|||
147421400|NCT03618823|531705768|FG001|Overall Study|Lost to Follow-up|61|||
147421401|NCT04638920|531705769|FG000|Overall Study|Withdrawal by Subject|5|||
147421402|NCT05383508|531705770|FG000|Overall Study|Withdrawal by Subject|1|||
147421403|NCT05383508|531705771|FG001|Overall Study|Withdrawal by Subject|0|||
147421404|NCT05383508|531705772|FG002|Overall Study|Withdrawal by Subject|1|||
147421405|NCT05383508|531705773|FG003|Overall Study|Withdrawal by Subject|1|||
147421406|NCT05383508|531705774|FG004|Overall Study|Withdrawal by Subject|2|||
147421407|NCT05383508|531705775|FG005|Overall Study|Withdrawal by Subject|0|||
147421408|NCT02081417|531705776|FG000|Overall Study|Lost to Follow-up|26|||
147421409|NCT02081417|531705777|FG001|Overall Study|Lost to Follow-up|23|||
147421410|NCT02081417|531705776|FG000|Overall Study|Moved Away|1|||
147421411|NCT02081417|531705777|FG001|Overall Study|Moved Away|2|||
147421412|NCT02081417|531705776|FG000|Overall Study|Incarcerated|2|||
147421413|NCT02081417|531705777|FG001|Overall Study|Incarcerated|2|||
147421414|NCT02081417|531705776|FG000|Overall Study|Death|4|||
147421415|NCT02081417|531705777|FG001|Overall Study|Death|3|||
147421416|NCT02081417|531705776|FG000|Overall Study|Withdrawal by Subject|4|||
147421417|NCT02081417|531705777|FG001|Overall Study|Withdrawal by Subject|0|||
147421418|NCT02081417|531705776|FG000|Overall Study|Admitted to Residential Treatment|2|||
147421419|NCT02081417|531705777|FG001|Overall Study|Admitted to Residential Treatment|0|||
147421420|NCT02081417|531705776|FG000|Overall Study|Did not start treatment|17|||
147421421|NCT02081417|531705777|FG001|Overall Study|Did not start treatment|21|||
147421422|NCT01157676|531705781|FG000|Randomization|Death|1|||
147421423|NCT01157676|531705782|FG001|Randomization|Death|1|||
147421424|NCT01157676|531705781|FG000|Randomization|unresectable|2|||
147421425|NCT01157676|531705782|FG001|Randomization|unresectable|3|||
147421426|NCT01157676|531705781|FG000|Randomization|Withdrawal by Subject|17|||
147421427|NCT01157676|531705782|FG001|Randomization|Withdrawal by Subject|13|||
147421428|NCT01157676|531705781|FG000|Randomization|Physician Decision|1|||
147421429|NCT01157676|531705782|FG001|Randomization|Physician Decision|0|||
147421430|NCT01157676|531705781|FG000|Surgery|underwent open cystectomy|0|||
147421431|NCT01157676|531705782|FG001|Surgery|underwent open cystectomy|4|||
147421432|NCT01157676|531705781|FG000|Surgery|converted to open procedure|0|||
147421433|NCT01157676|531705782|FG001|Surgery|converted to open procedure|5|||
147421434|NCT01157676|531705781|FG000|Surgery|underwent robotic cystectomy|1|||
147421435|NCT01157676|531705782|FG001|Surgery|underwent robotic cystectomy|0|||
147421436|NCT00682890|531705783|FG000|Overall Study|Lost to Follow-up|1|||
147421437|NCT00682890|531705784|FG001|Overall Study|Lost to Follow-up|1|||
147421438|NCT00682890|531705783|FG000|Overall Study|subject moved away|0|||
147421439|NCT00682890|531705784|FG001|Overall Study|subject moved away|1|||
147421440|NCT00682890|531705783|FG000|Overall Study|heavy menstrual bleeding|1|||
147421441|NCT00682890|531705784|FG001|Overall Study|heavy menstrual bleeding|0|||
147421442|NCT00141219|531705788|FG000|Overall Study|Protocol violations|5|||
147421443|NCT00141219|531705789|FG001|Overall Study|Protocol violations|4|||
147421444|NCT00141219|531705788|FG000|Overall Study|Adverse Event|8|||
147421445|NCT00141219|531705789|FG001|Overall Study|Adverse Event|6|||
147421446|NCT00141219|531705788|FG000|Overall Study|Lack of Efficacy|5|||
147421447|NCT00141219|531705789|FG001|Overall Study|Lack of Efficacy|4|||
147421448|NCT00141219|531705788|FG000|Overall Study|Withdrawal by Subject|6|||
147421449|NCT00141219|531705789|FG001|Overall Study|Withdrawal by Subject|2|||
147421450|NCT01506609|531705790|FG000|Overall Study|Adverse Event Related to Progression|0|||
147421451|NCT01506609|531705791|FG001|Overall Study|Adverse Event Related to Progression|0|||
147421452|NCT01506609|531705792|FG002|Overall Study|Adverse Event Related to Progression|0|||
147421453|NCT01506609|531705793|FG003|Overall Study|Adverse Event Related to Progression|3|||
147421454|NCT01506609|531705794|FG004|Overall Study|Adverse Event Related to Progression|7|||
147421455|NCT01506609|531705795|FG005|Overall Study|Adverse Event Related to Progression|3|||
147421456|NCT01506609|531705790|FG000|Overall Study|Adverse Event Not Related to Progression|0|||
147421457|NCT01506609|531705791|FG001|Overall Study|Adverse Event Not Related to Progression|1|||
147421458|NCT01506609|531705792|FG002|Overall Study|Adverse Event Not Related to Progression|0|||
147421459|NCT01506609|531705793|FG003|Overall Study|Adverse Event Not Related to Progression|6|||
147421460|NCT01506609|531705794|FG004|Overall Study|Adverse Event Not Related to Progression|10|||
147421461|NCT01506609|531705795|FG005|Overall Study|Adverse Event Not Related to Progression|5|||
147421462|NCT01506609|531705790|FG000|Overall Study|Withdrawal by Subject|0|||
147421463|NCT01506609|531705791|FG001|Overall Study|Withdrawal by Subject|0|||
147421464|NCT01506609|531705792|FG002|Overall Study|Withdrawal by Subject|0|||
147421465|NCT01506609|531705793|FG003|Overall Study|Withdrawal by Subject|9|||
147421466|NCT01506609|531705794|FG004|Overall Study|Withdrawal by Subject|7|||
147421467|NCT01506609|531705795|FG005|Overall Study|Withdrawal by Subject|7|||
147421468|NCT01506609|531705790|FG000|Overall Study|Lost to Follow-up|0|||
147421469|NCT01506609|531705791|FG001|Overall Study|Lost to Follow-up|0|||
147421470|NCT01506609|531705792|FG002|Overall Study|Lost to Follow-up|0|||
147421471|NCT01506609|531705793|FG003|Overall Study|Lost to Follow-up|1|||
147421472|NCT01506609|531705794|FG004|Overall Study|Lost to Follow-up|2|||
147421473|NCT01506609|531705795|FG005|Overall Study|Lost to Follow-up|0|||
147421474|NCT01506609|531705790|FG000|Overall Study|Sponsor Discontinued Study|0|||
147421475|NCT01506609|531705791|FG001|Overall Study|Sponsor Discontinued Study|0|||
147421476|NCT01506609|531705792|FG002|Overall Study|Sponsor Discontinued Study|0|||
147421477|NCT01506609|531705793|FG003|Overall Study|Sponsor Discontinued Study|2|||
147421478|NCT01506609|531705794|FG004|Overall Study|Sponsor Discontinued Study|2|||
147421479|NCT01506609|531705795|FG005|Overall Study|Sponsor Discontinued Study|0|||
147421480|NCT01506609|531705790|FG000|Overall Study|Progressive Disease per Protocol|1|||
147421481|NCT01506609|531705791|FG001|Overall Study|Progressive Disease per Protocol|0|||
147421482|NCT01506609|531705792|FG002|Overall Study|Progressive Disease per Protocol|0|||
147421483|NCT01506609|531705793|FG003|Overall Study|Progressive Disease per Protocol|64|||
147421484|NCT01506609|531705794|FG004|Overall Study|Progressive Disease per Protocol|57|||
147421485|NCT01506609|531705795|FG005|Overall Study|Progressive Disease per Protocol|74|||
147421486|NCT01506609|531705790|FG000|Overall Study|Other, Not Specified|0|||
147421487|NCT01506609|531705791|FG001|Overall Study|Other, Not Specified|0|||
147421488|NCT01506609|531705792|FG002|Overall Study|Other, Not Specified|0|||
147421489|NCT01506609|531705793|FG003|Overall Study|Other, Not Specified|10|||
147421490|NCT01506609|531705794|FG004|Overall Study|Other, Not Specified|7|||
147421491|NCT01506609|531705795|FG005|Overall Study|Other, Not Specified|3|||
147421492|NCT01506609|531705790|FG000|Overall Study|Missing / Unknown Reason|1|||
147421493|NCT01506609|531705791|FG001|Overall Study|Missing / Unknown Reason|0|||
147421494|NCT01506609|531705792|FG002|Overall Study|Missing / Unknown Reason|1|||
147421495|NCT01506609|531705793|FG003|Overall Study|Missing / Unknown Reason|4|||
147421496|NCT01506609|531705794|FG004|Overall Study|Missing / Unknown Reason|4|||
147421497|NCT01506609|531705795|FG005|Overall Study|Missing / Unknown Reason|2|||
147421498|NCT00577473|531705800|FG000|Overall Study|Protocol Violation|1|||
147421499|NCT00577473|531705801|FG001|Overall Study|Protocol Violation|4|||
147421500|NCT00577473|531705800|FG000|Overall Study|Adverse Event|8|||
147421501|NCT00577473|531705801|FG001|Overall Study|Adverse Event|5|||
147421502|NCT00577473|531705800|FG000|Overall Study|Withdrawal by Subject|2|||
147421503|NCT00577473|531705801|FG001|Overall Study|Withdrawal by Subject|6|||
147421504|NCT00577473|531705800|FG000|Overall Study|Physician Decision|2|||
147421505|NCT00577473|531705801|FG001|Overall Study|Physician Decision|2|||
147421506|NCT00577473|531705800|FG000|Overall Study|Lack of Efficacy|8|||
147421507|NCT00577473|531705801|FG001|Overall Study|Lack of Efficacy|7|||
147421508|NCT02595073|531705804|FG000|Overall Study|Progressive Disease|0|||
147421509|NCT02595073|531705805|FG001|Overall Study|Progressive Disease|1|||
147421510|NCT02595073|531705804|FG000|Overall Study|Protocol Violation|2|||
147421511|NCT02595073|531705805|FG001|Overall Study|Protocol Violation|0|||
147421512|NCT01990560|531705808|FG000|Overall Study|Withdrawal by Subject|1|||
147421513|NCT02884908|531705809|FG000|Overall Study|Lost to Follow-up|13|||
147421514|NCT02884908|531705810|FG001|Overall Study|Lost to Follow-up|18|||
147421515|NCT01324440|531705811|FG000|Overall Study|Subject moved|0|||
147421516|NCT01324440|531705812|FG001|Overall Study|Subject moved|1|||
147421517|NCT01801735|531705818|FG000|Overall Study|Adverse Event|79|||
147421518|NCT01801735|531705818|FG000|Overall Study|Lack of Efficacy|28|||
147421519|NCT01801735|531705818|FG000|Overall Study|Withdrawal by Subject|27|||
147421520|NCT01801735|531705818|FG000|Overall Study|Protocol Violation|25|||
147421521|NCT01801735|531705818|FG000|Overall Study|Lost to Follow-up|15|||
147421522|NCT01801735|531705818|FG000|Overall Study|Non-compliance with Trial Drug|13|||
147421523|NCT01801735|531705818|FG000|Overall Study|Physician Decision|3|||
147421524|NCT01801735|531705818|FG000|Overall Study|Death|1|||
147421525|NCT01801735|531705818|FG000|Overall Study|Other, including site closure|19|||
147421526|NCT02084056|531705819|FG000|Treatment Period 1 (4 Days)|Withdrawal by Subject|1|||
147421527|NCT02084056|531705820|FG001|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
147421528|NCT02084056|531705821|FG002|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
147421529|NCT02084056|531705822|FG003|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
147421530|NCT02084056|531705819|FG000|Washout Period 1 (35 Days)|Withdrawal by Subject|1|||
147421531|NCT02084056|531705820|FG001|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
147421532|NCT02084056|531705821|FG002|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
147421533|NCT02084056|531705822|FG003|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
147421534|NCT01293487|531705824|FG000|Overall Study|Lost to Follow-up|0|||
147421535|NCT01293487|531705825|FG001|Overall Study|Lost to Follow-up|0|||
147421536|NCT01293487|531705826|FG002|Overall Study|Lost to Follow-up|0|||
147421537|NCT01293487|531705827|FG003|Overall Study|Lost to Follow-up|1|||
147421538|NCT01293487|531705828|FG004|Overall Study|Lost to Follow-up|0|||
147421539|NCT01293487|531705829|FG005|Overall Study|Lost to Follow-up|0|||
147421540|NCT01293487|531705830|FG006|Overall Study|Lost to Follow-up|0|||
147421541|NCT01293487|531705831|FG007|Overall Study|Lost to Follow-up|0|||
147421542|NCT01293487|531705824|FG000|Overall Study|Withdrawal by Subject|0|||
147421543|NCT01293487|531705825|FG001|Overall Study|Withdrawal by Subject|0|||
147421544|NCT01293487|531705826|FG002|Overall Study|Withdrawal by Subject|0|||
147421545|NCT01293487|531705827|FG003|Overall Study|Withdrawal by Subject|0|||
147421546|NCT01293487|531705828|FG004|Overall Study|Withdrawal by Subject|0|||
147421547|NCT01293487|531705829|FG005|Overall Study|Withdrawal by Subject|0|||
147421548|NCT01293487|531705830|FG006|Overall Study|Withdrawal by Subject|0|||
147421549|NCT01293487|531705831|FG007|Overall Study|Withdrawal by Subject|2|||
147421550|NCT00468559|531705833|FG000|Open-label Treatment Phase|Adverse Event|5|||
147421551|NCT00468559|531705834|FG001|Open-label Treatment Phase|Adverse Event|0|||
147421552|NCT00468559|531705835|FG002|Open-label Treatment Phase|Adverse Event|0|||
147421553|NCT00468559|531705833|FG000|Open-label Treatment Phase|Lack of Efficacy|9|||
147421554|NCT00468559|531705834|FG001|Open-label Treatment Phase|Lack of Efficacy|0|||
147421555|NCT00468559|531705835|FG002|Open-label Treatment Phase|Lack of Efficacy|0|||
147421556|NCT00468559|531705833|FG000|Open-label Treatment Phase|Withdrawal by Subject|4|||
147421557|NCT00468559|531705834|FG001|Open-label Treatment Phase|Withdrawal by Subject|0|||
147421558|NCT00468559|531705835|FG002|Open-label Treatment Phase|Withdrawal by Subject|0|||
147421559|NCT00468559|531705833|FG000|Double-blind, Treatment-withdrawal Phase|Lack of Efficacy|0|||
147421560|NCT00468559|531705834|FG001|Double-blind, Treatment-withdrawal Phase|Lack of Efficacy|8|||
147421561|NCT00468559|531705835|FG002|Double-blind, Treatment-withdrawal Phase|Lack of Efficacy|17|||
147421562|NCT00468559|531705833|FG000|Double-blind, Treatment-withdrawal Phase|Adverse Event|0|||
147421563|NCT00468559|531705834|FG001|Double-blind, Treatment-withdrawal Phase|Adverse Event|2|||
147421564|NCT00468559|531705835|FG002|Double-blind, Treatment-withdrawal Phase|Adverse Event|0|||
147421565|NCT01153958|531705836|FG000|Overall Study|Study Terminated|36|||
147191113|NCT04607668|530867553|FG001|Overall Study|Other, unspecified|7|||
147421566|NCT01153958|531705837|FG001|Overall Study|Study Terminated|32|||
147421567|NCT01034163|531705839|FG000|Overall Study|Treatment completed as per protocol|8|||
147595934|NCT03096847|532338751|FG000|Overall Study|Physician Decision|12|||
147421568|NCT01034163|531705840|FG001|Overall Study|Treatment completed as per protocol|7|||
147421569|NCT01034163|531705839|FG000|Overall Study|Withdrawal by Subject|8|||
147421570|NCT01034163|531705840|FG001|Overall Study|Withdrawal by Subject|2|||
147421571|NCT01034163|531705839|FG000|Overall Study|Protocol deviation|1|||
147421572|NCT01034163|531705840|FG001|Overall Study|Protocol deviation|0|||
147421573|NCT01034163|531705839|FG000|Overall Study|Disease progression|3|||
147421574|NCT01034163|531705840|FG001|Overall Study|Disease progression|4|||
147421575|NCT01034163|531705839|FG000|Overall Study|Adverse Event|6|||
147421576|NCT01034163|531705840|FG001|Overall Study|Adverse Event|0|||
147421577|NCT01034163|531705839|FG000|Overall Study|Administrative problems|0|||
147421578|NCT01034163|531705840|FG001|Overall Study|Administrative problems|1|||
147421579|NCT01034163|531705839|FG000|Overall Study|Abnormal laboratory value|1|||
147421580|NCT01034163|531705840|FG001|Overall Study|Abnormal laboratory value|0|||
147421581|NCT01605916|531705843|FG000|Overall Study|Adverse Event|1|||
147421582|NCT01605916|531705844|FG001|Overall Study|Adverse Event|0|||
147421583|NCT01605916|531705845|FG002|Overall Study|Adverse Event|0|||
147421584|NCT01605916|531705846|FG003|Overall Study|Adverse Event|1|||
147421585|NCT01605916|531705847|FG004|Overall Study|Adverse Event|0|||
147421586|NCT01605916|531705843|FG000|Overall Study|Lack of Efficacy|2|||
147421587|NCT01605916|531705844|FG001|Overall Study|Lack of Efficacy|3|||
147421588|NCT01605916|531705845|FG002|Overall Study|Lack of Efficacy|3|||
147421589|NCT01605916|531705846|FG003|Overall Study|Lack of Efficacy|5|||
147421590|NCT01605916|531705847|FG004|Overall Study|Lack of Efficacy|4|||
147421591|NCT01605916|531705843|FG000|Overall Study|Withdrawal by Subject|1|||
147421592|NCT01605916|531705844|FG001|Overall Study|Withdrawal by Subject|1|||
147421593|NCT01605916|531705845|FG002|Overall Study|Withdrawal by Subject|0|||
147421594|NCT01605916|531705846|FG003|Overall Study|Withdrawal by Subject|0|||
147421595|NCT01605916|531705847|FG004|Overall Study|Withdrawal by Subject|2|||
147421596|NCT01465347|531705848|FG000|Overall Study|Withdrawal by Subject|1|||
147421597|NCT01465347|531705849|FG001|Overall Study|Withdrawal by Subject|1|||
147421598|NCT01465347|531705848|FG000|Overall Study|Physician Decision|0|||
147421599|NCT01465347|531705849|FG001|Overall Study|Physician Decision|1|||
147421600|NCT01465347|531705848|FG000|Overall Study|Admitted to hospice|0|||
147421601|NCT01465347|531705849|FG001|Overall Study|Admitted to hospice|1|||
147421602|NCT02996474|531705850|FG000|Overall Study|Physician Decision|5|||
147421603|NCT04493502|531705851|FG000|Double Blind Treatment (Week 0 - 16)|Lack of Efficacy|1|||
147421604|NCT04493502|531705852|FG001|Double Blind Treatment (Week 0 - 16)|Lack of Efficacy|0|||
147421605|NCT04493502|531705851|FG000|Double Blind Treatment (Week 0 - 16)|Lost to Follow-up|3|||
147421606|NCT04493502|531705852|FG001|Double Blind Treatment (Week 0 - 16)|Lost to Follow-up|4|||
147421607|NCT04493502|531705851|FG000|Double Blind Treatment (Week 0 - 16)|Other, Relocation|0|||
147421608|NCT04493502|531705852|FG001|Double Blind Treatment (Week 0 - 16)|Other, Relocation|1|||
147421609|NCT04493502|531705851|FG000|Double Blind Treatment (Week 0 - 16)|Other, Protocol Deviation|0|||
147421610|NCT04493502|531705852|FG001|Double Blind Treatment (Week 0 - 16)|Other, Protocol Deviation|1|||
147421611|NCT04493502|531705851|FG000|Double Blind Treatment (Week 0 - 16)|Physician Decision|1|||
147421612|NCT04493502|531705852|FG001|Double Blind Treatment (Week 0 - 16)|Physician Decision|0|||
147421613|NCT04493502|531705851|FG000|Double Blind Treatment (Week 0 - 16)|Withdrawal by Subject|3|||
147421614|NCT04493502|531705852|FG001|Double Blind Treatment (Week 0 - 16)|Withdrawal by Subject|1|||
147421615|NCT04493502|531705851|FG000|Double Blind Treatment (Week 0 - 16)|Randomized but Never Treated|2|||
147421616|NCT04493502|531705852|FG001|Double Blind Treatment (Week 0 - 16)|Randomized but Never Treated|3|||
147421617|NCT04493502|531705851|FG000|Open-label Extension (Week 16 - 36)|Lost to Follow-up|1|||
147421618|NCT04493502|531705852|FG001|Open-label Extension (Week 16 - 36)|Lost to Follow-up|0|||
147421619|NCT04493502|531705851|FG000|Open-label Extension (Week 16 - 36)|Physician Decision|0|||
147421620|NCT04493502|531705852|FG001|Open-label Extension (Week 16 - 36)|Physician Decision|1|||
147421621|NCT04493502|531705851|FG000|Open-label Extension (Week 16 - 36)|Withdrawal by Subject|3|||
147421622|NCT04493502|531705852|FG001|Open-label Extension (Week 16 - 36)|Withdrawal by Subject|8|||
147421623|NCT04493502|531705851|FG000|Post-treatment Follow-up (10 Weeks)|Lost to Follow-up|0|||
147421624|NCT04493502|531705852|FG001|Post-treatment Follow-up (10 Weeks)|Lost to Follow-up|1|||
147421625|NCT04493502|531705851|FG000|Post-treatment Follow-up (10 Weeks)|Physician Decision|0|||
147421626|NCT04493502|531705852|FG001|Post-treatment Follow-up (10 Weeks)|Physician Decision|1|||
147421627|NCT04493502|531705851|FG000|Post-treatment Follow-up (10 Weeks)|Withdrawal by Subject|2|||
147421628|NCT04493502|531705852|FG001|Post-treatment Follow-up (10 Weeks)|Withdrawal by Subject|3|||
147421629|NCT02891837|531705853|FG000|Overall Study|Lost to Follow-up|2|||
147421630|NCT02891837|531705854|FG001|Overall Study|Lost to Follow-up|0|||
147421631|NCT02891837|531705853|FG000|Overall Study|Withdrawal by Subject|1|||
147421632|NCT02891837|531705854|FG001|Overall Study|Withdrawal by Subject|0|||
147421633|NCT01103362|531705858|FG000|Overall Study|study terminated|596|||
147421634|NCT02533531|531705859|FG000|Overall Study|Device did not turn on|1|||
147421635|NCT02047903|531705860|FG000|Overall Study|Adverse Event|14|||
147421636|NCT02047903|531705860|FG000|Overall Study|Serious adverse event|10|||
147421637|NCT02047903|531705860|FG000|Overall Study|Withdrawal by Subject|16|||
147421638|NCT02047903|531705860|FG000|Overall Study|Lost to Follow-up|4|||
147421639|NCT02047903|531705860|FG000|Overall Study|Reason not listed|6|||
147421640|NCT02047903|531705860|FG000|Overall Study|Not Treated|9|||
147421641|NCT03538301|531705865|FG000|Overall Study|Adverse Event|1|||
147421642|NCT03538301|531705866|FG001|Overall Study|Adverse Event|4|||
147421643|NCT03538301|531705867|FG002|Overall Study|Adverse Event|4|||
147421644|NCT03538301|531705865|FG000|Overall Study|Death|1|||
147421645|NCT03538301|531705866|FG001|Overall Study|Death|1|||
147421646|NCT03538301|531705867|FG002|Overall Study|Death|0|||
147421647|NCT03538301|531705865|FG000|Overall Study|Physician Decision|0|||
147421648|NCT03538301|531705866|FG001|Overall Study|Physician Decision|1|||
147421649|NCT03538301|531705867|FG002|Overall Study|Physician Decision|0|||
147421650|NCT03538301|531705865|FG000|Overall Study|Protocol Violation|0|||
147421651|NCT03538301|531705866|FG001|Overall Study|Protocol Violation|0|||
147421652|NCT03538301|531705867|FG002|Overall Study|Protocol Violation|1|||
147421653|NCT03538301|531705865|FG000|Overall Study|Terminated Early from the Study due to COVID-19 Impact|9|||
147421654|NCT03538301|531705866|FG001|Overall Study|Terminated Early from the Study due to COVID-19 Impact|6|||
147421655|NCT03538301|531705867|FG002|Overall Study|Terminated Early from the Study due to COVID-19 Impact|7|||
147421656|NCT03616977|531705868|FG000|Period 1|Physician Decision|0|||
147421657|NCT03616977|531705869|FG001|Period 1|Physician Decision|1|||
147421658|NCT03616977|531705868|FG000|Period 3|Adverse Event|1|||
147421659|NCT03616977|531705869|FG001|Period 3|Adverse Event|1|||
147421660|NCT05917470|531705870|FG000|Overall Study|Progressive Disease|1|||
147421661|NCT05917470|531705871|FG001|Overall Study|Progressive Disease|1|||
147421662|NCT05917470|531705872|FG002|Overall Study|Progressive Disease|2|||
147532703|NCT01243762|532105984|FG002|Part 1 (Dose Escalation/MTD)|Physician Decision|0|||
147421663|NCT05917470|531705873|FG003|Overall Study|Progressive Disease|3|||
147421664|NCT05917470|531705874|FG004|Overall Study|Progressive Disease|1|||
147421665|NCT05917470|531705875|FG005|Overall Study|Progressive Disease|1|||
147421666|NCT05917470|531705876|FG006|Overall Study|Progressive Disease|0|||
147421667|NCT05917470|531705877|FG007|Overall Study|Progressive Disease|0|||
147421668|NCT05917470|531705870|FG000|Overall Study|Withdrawal by Subject|0|||
147421669|NCT05917470|531705871|FG001|Overall Study|Withdrawal by Subject|0|||
147421670|NCT05917470|531705872|FG002|Overall Study|Withdrawal by Subject|1|||
147421671|NCT05917470|531705873|FG003|Overall Study|Withdrawal by Subject|0|||
147421672|NCT05917470|531705874|FG004|Overall Study|Withdrawal by Subject|0|||
147421673|NCT05917470|531705875|FG005|Overall Study|Withdrawal by Subject|0|||
147421674|NCT05917470|531705876|FG006|Overall Study|Withdrawal by Subject|0|||
147421675|NCT05917470|531705877|FG007|Overall Study|Withdrawal by Subject|0|||
147421676|NCT05917470|531705870|FG000|Overall Study|Sponsor Decision|0|||
147421677|NCT05917470|531705871|FG001|Overall Study|Sponsor Decision|0|||
147421678|NCT05917470|531705872|FG002|Overall Study|Sponsor Decision|1|||
147421679|NCT05917470|531705873|FG003|Overall Study|Sponsor Decision|0|||
147421680|NCT05917470|531705874|FG004|Overall Study|Sponsor Decision|2|||
147421681|NCT05917470|531705875|FG005|Overall Study|Sponsor Decision|1|||
147421682|NCT05917470|531705876|FG006|Overall Study|Sponsor Decision|3|||
147421683|NCT05917470|531705877|FG007|Overall Study|Sponsor Decision|3|||
147421684|NCT05917470|531705870|FG000|Overall Study|Adverse Event|0|||
147421685|NCT05917470|531705871|FG001|Overall Study|Adverse Event|0|||
147421686|NCT05917470|531705872|FG002|Overall Study|Adverse Event|0|||
147421687|NCT05917470|531705873|FG003|Overall Study|Adverse Event|0|||
147421688|NCT05917470|531705874|FG004|Overall Study|Adverse Event|0|||
147421689|NCT05917470|531705875|FG005|Overall Study|Adverse Event|1|||
147421690|NCT05917470|531705876|FG006|Overall Study|Adverse Event|0|||
147421691|NCT05917470|531705877|FG007|Overall Study|Adverse Event|0|||
147421692|NCT01290029|531707726|FG000|Overall Study|Other|2|||
147421693|NCT01877837|531707727|FG000|Overall Study|Lost to Follow-up|1|||
147421694|NCT01877837|531707727|FG000|Overall Study|Ineligible|4|||
147421695|NCT01773291|531707730|FG000|Overall Study|Protocol Violation|1|||
147421696|NCT01773291|531707731|FG001|Overall Study|Protocol Violation|0|||
147421697|NCT01773291|531707732|FG002|Overall Study|Protocol Violation|0|||
147421698|NCT01773291|531707730|FG000|Overall Study|Withdrawal by Subject|0|||
147421699|NCT01773291|531707731|FG001|Overall Study|Withdrawal by Subject|0|||
147421700|NCT01773291|531707732|FG002|Overall Study|Withdrawal by Subject|1|||
147421701|NCT01491672|531707733|FG000|Overall Study|Lost to Follow-up|0|||
147421702|NCT01491672|531707734|FG001|Overall Study|Lost to Follow-up|4|||
147421703|NCT01491672|531707735|FG002|Overall Study|Lost to Follow-up|1|||
147421704|NCT01491672|531707733|FG000|Overall Study|Withdrawal by Subject|6|||
147421705|NCT01491672|531707734|FG001|Overall Study|Withdrawal by Subject|7|||
147421706|NCT01491672|531707735|FG002|Overall Study|Withdrawal by Subject|0|||
147421707|NCT01491672|531707733|FG000|Overall Study|Adverse Event|8|||
147421708|NCT01491672|531707734|FG001|Overall Study|Adverse Event|10|||
147421709|NCT01491672|531707735|FG002|Overall Study|Adverse Event|4|||
147421710|NCT01491672|531707733|FG000|Overall Study|Disease progression|42|||
147421711|NCT01491672|531707734|FG001|Overall Study|Disease progression|34|||
147421712|NCT01491672|531707735|FG002|Overall Study|Disease progression|6|||
147421713|NCT01491672|531707733|FG000|Overall Study|Protocol deviation|0|||
147421714|NCT01491672|531707734|FG001|Overall Study|Protocol deviation|1|||
147421715|NCT01491672|531707735|FG002|Overall Study|Protocol deviation|0|||
147421716|NCT01491672|531707733|FG000|Overall Study|Death|0|||
147421717|NCT01491672|531707734|FG001|Overall Study|Death|4|||
147421718|NCT01491672|531707735|FG002|Overall Study|Death|0|||
147421719|NCT02336178|531707736|FG000|Overall Study|Lost to Follow-up|1|||
147421720|NCT02336178|531707736|FG000|Overall Study|Protocol Violation|1|||
147421721|NCT02336178|531707736|FG000|Overall Study|Withdrawal by Subject|1|||
147421722|NCT02336178|531707736|FG000|Overall Study|Other|1|||
147421723|NCT03310268|531707737|FG000|Overall Study|(Not specified)|1|||
147421724|NCT03310268|531707738|FG001|Overall Study|(Not specified)|5|||
147421725|NCT03310268|531707739|FG002|Overall Study|(Not specified)|0|||
147421726|NCT00706433|531707743|FG000|Overall Study|Lost to Follow-up|3|||
147421727|NCT00706433|531707744|FG001|Overall Study|Lost to Follow-up|1|||
147421728|NCT00706433|531707745|FG002|Overall Study|Lost to Follow-up|6|||
147421729|NCT00706433|531707746|FG003|Overall Study|Lost to Follow-up|0|||
147421730|NCT00706433|531707743|FG000|Overall Study|Withdrawal by Subject|1|||
147421731|NCT00706433|531707744|FG001|Overall Study|Withdrawal by Subject|2|||
147421732|NCT00706433|531707745|FG002|Overall Study|Withdrawal by Subject|3|||
147421733|NCT00706433|531707746|FG003|Overall Study|Withdrawal by Subject|1|||
147421734|NCT00706433|531707743|FG000|Overall Study|Adverse Event|0|||
147421735|NCT00706433|531707744|FG001|Overall Study|Adverse Event|0|||
147421736|NCT00706433|531707745|FG002|Overall Study|Adverse Event|1|||
147421737|NCT00706433|531707746|FG003|Overall Study|Adverse Event|0|||
147421738|NCT00706433|531707743|FG000|Overall Study|Protocol Violation|1|||
147421739|NCT00706433|531707744|FG001|Overall Study|Protocol Violation|0|||
147421740|NCT00706433|531707745|FG002|Overall Study|Protocol Violation|0|||
147421741|NCT00706433|531707746|FG003|Overall Study|Protocol Violation|0|||
147421742|NCT00706433|531707743|FG000|Overall Study|new job|0|||
147421743|NCT00706433|531707744|FG001|Overall Study|new job|0|||
147421744|NCT00706433|531707745|FG002|Overall Study|new job|0|||
147421745|NCT00706433|531707746|FG003|Overall Study|new job|1|||
147421746|NCT01236365|531707748|FG000|Overall Study|Lost to Follow-up|0|||
147421747|NCT01236365|531707749|FG001|Overall Study|Lost to Follow-up|2|||
147421748|NCT01236365|531707748|FG000|Overall Study|Moved Out of State|1|||
147421749|NCT01236365|531707749|FG001|Overall Study|Moved Out of State|0|||
147421750|NCT01236365|531707748|FG000|Overall Study|Dropped at Randomization due to high LFT|1|||
147421751|NCT01236365|531707749|FG001|Overall Study|Dropped at Randomization due to high LFT|0|||
147421752|NCT01874431|531707751|FG000|Overall Study|Physician Decision|0|||
147421753|NCT01874431|531707752|FG001|Overall Study|Physician Decision|0|||
147421754|NCT01874431|531707753|FG002|Overall Study|Physician Decision|1|||
147421755|NCT01874431|531707754|FG003|Overall Study|Physician Decision|0|||
147421756|NCT01874431|531707755|FG004|Overall Study|Physician Decision|0|||
147421757|NCT01874431|531707756|FG005|Overall Study|Physician Decision|0|||
147421758|NCT01874431|531707757|FG006|Overall Study|Physician Decision|0|||
147421759|NCT01874431|531707758|FG007|Overall Study|Physician Decision|0|||
147421760|NCT01874431|531707751|FG000|Overall Study|Adverse Event|5|||
147421761|NCT01874431|531707752|FG001|Overall Study|Adverse Event|4|||
147421762|NCT01874431|531707753|FG002|Overall Study|Adverse Event|6|||
147421763|NCT01874431|531707754|FG003|Overall Study|Adverse Event|5|||
147421764|NCT01874431|531707755|FG004|Overall Study|Adverse Event|2|||
147421765|NCT01874431|531707756|FG005|Overall Study|Adverse Event|8|||
147421766|NCT01874431|531707757|FG006|Overall Study|Adverse Event|2|||
147421767|NCT01874431|531707758|FG007|Overall Study|Adverse Event|3|||
147421768|NCT01874431|531707751|FG000|Overall Study|Protocol Violation|1|||
147421769|NCT01874431|531707752|FG001|Overall Study|Protocol Violation|1|||
147421770|NCT01874431|531707753|FG002|Overall Study|Protocol Violation|1|||
147532704|NCT01243762|532105985|FG003|Part 1 (Dose Escalation/MTD)|Physician Decision|1|||
147191114|NCT02250326|530867554|FG000|Treatment|Death|1|||
147421771|NCT01874431|531707754|FG003|Overall Study|Protocol Violation|0|||
147421772|NCT01874431|531707755|FG004|Overall Study|Protocol Violation|3|||
147421773|NCT01874431|531707756|FG005|Overall Study|Protocol Violation|2|||
147421774|NCT01874431|531707757|FG006|Overall Study|Protocol Violation|1|||
147421775|NCT01874431|531707758|FG007|Overall Study|Protocol Violation|1|||
147421776|NCT01874431|531707751|FG000|Overall Study|Non-compliance|0|||
147421777|NCT01874431|531707752|FG001|Overall Study|Non-compliance|0|||
147421778|NCT01874431|531707753|FG002|Overall Study|Non-compliance|0|||
147421779|NCT01874431|531707754|FG003|Overall Study|Non-compliance|0|||
147421780|NCT01874431|531707755|FG004|Overall Study|Non-compliance|1|||
147421781|NCT01874431|531707756|FG005|Overall Study|Non-compliance|0|||
147421782|NCT01874431|531707757|FG006|Overall Study|Non-compliance|1|||
147421783|NCT01874431|531707758|FG007|Overall Study|Non-compliance|0|||
147421784|NCT01874431|531707751|FG000|Overall Study|Logistical difficulties|0|||
147421785|NCT01874431|531707752|FG001|Overall Study|Logistical difficulties|0|||
147421786|NCT01874431|531707753|FG002|Overall Study|Logistical difficulties|0|||
147421787|NCT01874431|531707754|FG003|Overall Study|Logistical difficulties|0|||
147421788|NCT01874431|531707755|FG004|Overall Study|Logistical difficulties|0|||
147421789|NCT01874431|531707756|FG005|Overall Study|Logistical difficulties|0|||
147421790|NCT01874431|531707757|FG006|Overall Study|Logistical difficulties|1|||
147421791|NCT01874431|531707758|FG007|Overall Study|Logistical difficulties|0|||
147421792|NCT01874431|531707751|FG000|Overall Study|Withdrawal by Subject|0|||
147421793|NCT01874431|531707752|FG001|Overall Study|Withdrawal by Subject|0|||
147421794|NCT01874431|531707753|FG002|Overall Study|Withdrawal by Subject|1|||
147421795|NCT01874431|531707754|FG003|Overall Study|Withdrawal by Subject|2|||
147421796|NCT01874431|531707755|FG004|Overall Study|Withdrawal by Subject|1|||
147421797|NCT01874431|531707756|FG005|Overall Study|Withdrawal by Subject|1|||
147421798|NCT01874431|531707757|FG006|Overall Study|Withdrawal by Subject|3|||
147421799|NCT01874431|531707758|FG007|Overall Study|Withdrawal by Subject|0|||
147421800|NCT01874431|531707751|FG000|Overall Study|Sponsor decision|0|||
147421801|NCT01874431|531707752|FG001|Overall Study|Sponsor decision|0|||
147421802|NCT01874431|531707753|FG002|Overall Study|Sponsor decision|0|||
147421803|NCT01874431|531707754|FG003|Overall Study|Sponsor decision|0|||
147421804|NCT01874431|531707755|FG004|Overall Study|Sponsor decision|1|||
147421805|NCT01874431|531707756|FG005|Overall Study|Sponsor decision|0|||
147421806|NCT01874431|531707757|FG006|Overall Study|Sponsor decision|0|||
147421807|NCT01874431|531707758|FG007|Overall Study|Sponsor decision|0|||
147421808|NCT01874431|531707751|FG000|Overall Study|Lost to Follow-up|0|||
147421809|NCT01874431|531707752|FG001|Overall Study|Lost to Follow-up|0|||
147421810|NCT01874431|531707753|FG002|Overall Study|Lost to Follow-up|1|||
147421811|NCT01874431|531707754|FG003|Overall Study|Lost to Follow-up|0|||
147421812|NCT01874431|531707755|FG004|Overall Study|Lost to Follow-up|0|||
147421813|NCT01874431|531707756|FG005|Overall Study|Lost to Follow-up|0|||
147421814|NCT01874431|531707757|FG006|Overall Study|Lost to Follow-up|0|||
147421815|NCT01874431|531707758|FG007|Overall Study|Lost to Follow-up|0|||
147421816|NCT00545051|531707759|FG000|Overall Study|Adverse Event|7|||
147421817|NCT00545051|531707760|FG001|Overall Study|Adverse Event|3|||
147421818|NCT00545051|531707759|FG000|Overall Study|Death|1|||
147421819|NCT00545051|531707760|FG001|Overall Study|Death|0|||
147421820|NCT00545051|531707759|FG000|Overall Study|Violation of inclusion/exclusion|0|||
147421821|NCT00545051|531707760|FG001|Overall Study|Violation of inclusion/exclusion|2|||
147421822|NCT00545051|531707759|FG000|Overall Study|Protocol Violation|1|||
147421823|NCT00545051|531707760|FG001|Overall Study|Protocol Violation|0|||
147421824|NCT00545051|531707759|FG000|Overall Study|Withdrawal by Subject|0|||
147421825|NCT00545051|531707760|FG001|Overall Study|Withdrawal by Subject|1|||
147421826|NCT00545051|531707759|FG000|Overall Study|Administrative reasons|0|||
147421827|NCT00545051|531707760|FG001|Overall Study|Administrative reasons|1|||
147421828|NCT01375114|531707761|FG000|Overall Study|Lost to Follow-up|1|||
147421829|NCT01375114|531707762|FG001|Overall Study|Lost to Follow-up|0|||
147421830|NCT01375114|531707763|FG002|Overall Study|Lost to Follow-up|1|||
147421831|NCT01375114|531707761|FG000|Overall Study|Disease Progression|3|||
147421832|NCT01375114|531707762|FG001|Overall Study|Disease Progression|2|||
147421833|NCT01375114|531707763|FG002|Overall Study|Disease Progression|2|||
147421834|NCT01375114|531707761|FG000|Overall Study|Patient Changed Mind|0|||
147421835|NCT01375114|531707762|FG001|Overall Study|Patient Changed Mind|0|||
147421836|NCT01375114|531707763|FG002|Overall Study|Patient Changed Mind|2|||
147421837|NCT01375114|531707761|FG000|Overall Study|Pruritus|0|||
147421838|NCT01375114|531707762|FG001|Overall Study|Pruritus|0|||
147421839|NCT01375114|531707763|FG002|Overall Study|Pruritus|1|||
147421840|NCT01375114|531707761|FG000|Overall Study|Restlessness|0|||
147421841|NCT01375114|531707762|FG001|Overall Study|Restlessness|0|||
147421842|NCT01375114|531707763|FG002|Overall Study|Restlessness|1|||
147421843|NCT01375114|531707761|FG000|Overall Study|Diarrhea|0|||
147421844|NCT01375114|531707762|FG001|Overall Study|Diarrhea|0|||
147421845|NCT01375114|531707763|FG002|Overall Study|Diarrhea|1|||
147421846|NCT01375114|531707761|FG000|Overall Study|Pt enrolled in another clinical trial|0|||
147421847|NCT01375114|531707762|FG001|Overall Study|Pt enrolled in another clinical trial|1|||
147421848|NCT01375114|531707763|FG002|Overall Study|Pt enrolled in another clinical trial|0|||
147421849|NCT01375114|531707761|FG000|Overall Study|Nausea|0|||
147421850|NCT01375114|531707762|FG001|Overall Study|Nausea|1|||
147421851|NCT01375114|531707763|FG002|Overall Study|Nausea|0|||
147421852|NCT01375114|531707761|FG000|Overall Study|Increased AST/ALT|0|||
147421853|NCT01375114|531707762|FG001|Overall Study|Increased AST/ALT|1|||
147421854|NCT01375114|531707763|FG002|Overall Study|Increased AST/ALT|0|||
147421855|NCT01375114|531707761|FG000|Overall Study|Vaginal Hemorrhage|0|||
147421856|NCT01375114|531707762|FG001|Overall Study|Vaginal Hemorrhage|1|||
147421857|NCT01375114|531707763|FG002|Overall Study|Vaginal Hemorrhage|0|||
147421858|NCT01375114|531707761|FG000|Overall Study|Family problem|0|||
147421859|NCT01375114|531707762|FG001|Overall Study|Family problem|1|||
147421860|NCT01375114|531707763|FG002|Overall Study|Family problem|0|||
147421861|NCT01375114|531707761|FG000|Overall Study|Protocol Violation|2|||
147421862|NCT01375114|531707762|FG001|Overall Study|Protocol Violation|0|||
147421863|NCT01375114|531707763|FG002|Overall Study|Protocol Violation|0|||
147421864|NCT01888900|531707765|FG000|Overall Study|failed treatment|0|||
147421865|NCT01888900|531707766|FG001|Overall Study|failed treatment|2|||
147421866|NCT03271021|531707767|FG000|Overall Study|Adverse Event|3|||
147421867|NCT03271021|531707768|FG001|Overall Study|Adverse Event|2|||
147421868|NCT03271021|531707767|FG000|Overall Study|Withdrawal by Subject|36|||
147421869|NCT03271021|531707768|FG001|Overall Study|Withdrawal by Subject|53|||
147421870|NCT03271021|531707767|FG000|Overall Study|Lost to Follow-up|34|||
147421871|NCT03271021|531707768|FG001|Overall Study|Lost to Follow-up|39|||
147421872|NCT03271021|531707767|FG000|Overall Study|Protocol Violation|6|||
147421873|NCT03271021|531707768|FG001|Overall Study|Protocol Violation|4|||
147421874|NCT03271021|531707767|FG000|Overall Study|Abnormal Lab Results|1|||
147421875|NCT03271021|531707768|FG001|Overall Study|Abnormal Lab Results|0|||
147421876|NCT03271021|531707767|FG000|Overall Study|Miscellaneous|9|||
147421877|NCT03271021|531707768|FG001|Overall Study|Miscellaneous|8|||
147421878|NCT01474434|531707769|FG000|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|0|||
147421879|NCT01474434|531707770|FG001|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|0|||
147421880|NCT01474434|531707771|FG002|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|1|||
147421881|NCT01474434|531707772|FG003|Treatment Period 1 (5 Days [Day 1 - 5])|Adverse Event|1|||
147421882|NCT01474434|531707769|FG000|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|0|||
147421883|NCT01474434|531707770|FG001|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|0|||
147421884|NCT01474434|531707771|FG002|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|0|||
147421885|NCT01474434|531707772|FG003|Treatment Period 1 (5 Days [Day 1 - 5])|Withdrawal by Subject|1|||
147421886|NCT01474434|531707769|FG000|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|1|||
147421887|NCT01474434|531707770|FG001|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|0|||
147421888|NCT01474434|531707771|FG002|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|0|||
147421889|NCT01474434|531707772|FG003|Treatment Period 1 (5 Days [Day 1 - 5])|Protocol deviation|0|||
147421890|NCT02207569|531707773|FG000|1-Month|Death|6|||
147421891|NCT02207569|531707773|FG000|1-Month|Withdrawal by Subject|2|||
147449486|NCT00440947|531809507|FG002|36-Week Induction Phase|Took Exclusionary Medications|0|||
147421892|NCT02207569|531707773|FG000|1-Month|Subject anesthetized but product not onsite, for medical justification treated w/commercial device|1|||
147421893|NCT02207569|531707773|FG000|6-Month|Death|8|||
147421894|NCT02207569|531707773|FG000|6-Month|Withdrawal by Subject|2|||
147421895|NCT02207569|531707773|FG000|12-Month|Death|14|||
147421896|NCT02207569|531707773|FG000|12-Month|Withdrawal by Subject|2|||
147421897|NCT02207569|531707773|FG000|24-Month|Death|23|||
147421898|NCT02207569|531707773|FG000|24-Month|Withdrawal by Subject|3|||
147421899|NCT02207569|531707773|FG000|36-Month|Death|23|||
147421900|NCT02207569|531707773|FG000|36-Month|Withdrawal by Subject|4|||
147421901|NCT02207569|531707773|FG000|48-Month|Death|25|||
147421902|NCT02207569|531707773|FG000|48-Month|Withdrawal by Subject|2|||
147421903|NCT02207569|531707773|FG000|48-Month|Lost to Follow-up|4|||
147421904|NCT02207569|531707773|FG000|60-Month|Death|1|||
147421905|NCT02207569|531707773|FG000|60-Month|Lost to Follow-up|1|||
147421906|NCT02207569|531707773|FG000|60-Month|pt 103 years old no longer traveling for MD visits|1|||
147421907|NCT02207569|531707773|FG000|60-Month|Covid-19 pt not willing to be seen|1|||
147421908|NCT00495586|531707779|FG000|Overall Study|Withdrawal by Subject|4|||
147421909|NCT00495586|531707780|FG001|Overall Study|Withdrawal by Subject|4|||
147421910|NCT03038438|531707781|FG000|Overall Study|Death|3|||
147421911|NCT03038438|531707781|FG000|Overall Study|Lost to Follow-up|8|||
147421912|NCT03038438|531707781|FG000|Overall Study|Subject Incarcerated, Moved, or Refused|4|||
147421913|NCT03038438|531707781|FG000|Overall Study|Withdrawal by Subject|5|||
147421914|NCT03038438|531707781|FG000|Overall Study|No 36-Month Follow-Up|18|||
147421915|NCT02038543|531707784|FG000|Overall Study|Screen Failure|0|||
147421916|NCT02038543|531707785|FG001|Overall Study|Screen Failure|0|||
147421917|NCT02038543|531707786|FG002|Overall Study|Screen Failure|0|||
147421918|NCT02038543|531707787|FG003|Overall Study|Screen Failure|1|||
147421919|NCT02038543|531707784|FG000|Overall Study|Withdrawal by Subject|0|||
147421920|NCT02038543|531707785|FG001|Overall Study|Withdrawal by Subject|0|||
147421921|NCT02038543|531707786|FG002|Overall Study|Withdrawal by Subject|0|||
147421922|NCT02038543|531707787|FG003|Overall Study|Withdrawal by Subject|1|||
147421923|NCT02647866|531707788|FG000|Overall Study|Adverse Event|0|||
147421924|NCT02647866|531707789|FG001|Overall Study|Adverse Event|0|||
147421925|NCT02647866|531707790|FG002|Overall Study|Adverse Event|2|||
147421926|NCT02647866|531707791|FG003|Overall Study|Adverse Event|2|||
147421927|NCT02647866|531707792|FG004|Overall Study|Adverse Event|1|||
147421928|NCT02647866|531707788|FG000|Overall Study|Disease Worsening|3|||
147421929|NCT02647866|531707789|FG001|Overall Study|Disease Worsening|1|||
147421930|NCT02647866|531707790|FG002|Overall Study|Disease Worsening|0|||
147421931|NCT02647866|531707791|FG003|Overall Study|Disease Worsening|0|||
147421932|NCT02647866|531707792|FG004|Overall Study|Disease Worsening|1|||
147421933|NCT02647866|531707788|FG000|Overall Study|Withdrawal by Subject|1|||
147421934|NCT02647866|531707789|FG001|Overall Study|Withdrawal by Subject|1|||
147421935|NCT02647866|531707790|FG002|Overall Study|Withdrawal by Subject|2|||
147421936|NCT02647866|531707791|FG003|Overall Study|Withdrawal by Subject|4|||
147421937|NCT02647866|531707792|FG004|Overall Study|Withdrawal by Subject|4|||
147421938|NCT02647866|531707788|FG000|Overall Study|Physician Decision|0|||
147421939|NCT02647866|531707789|FG001|Overall Study|Physician Decision|1|||
147421940|NCT02647866|531707790|FG002|Overall Study|Physician Decision|1|||
147421941|NCT02647866|531707791|FG003|Overall Study|Physician Decision|0|||
147421942|NCT02647866|531707792|FG004|Overall Study|Physician Decision|2|||
147421943|NCT02647866|531707788|FG000|Overall Study|Death|0|||
147421944|NCT02647866|531707789|FG001|Overall Study|Death|1|||
147421945|NCT02647866|531707790|FG002|Overall Study|Death|0|||
147421946|NCT02647866|531707791|FG003|Overall Study|Death|0|||
147421947|NCT02647866|531707792|FG004|Overall Study|Death|0|||
147421948|NCT02647866|531707788|FG000|Overall Study|Subject moved to different country|1|||
147421949|NCT02647866|531707789|FG001|Overall Study|Subject moved to different country|0|||
147421950|NCT02647866|531707790|FG002|Overall Study|Subject moved to different country|0|||
147421951|NCT02647866|531707791|FG003|Overall Study|Subject moved to different country|0|||
147421952|NCT02647866|531707792|FG004|Overall Study|Subject moved to different country|0|||
147421953|NCT03406260|531707793|FG000|Period 1|Adverse Event|0|||
147421954|NCT03406260|531707794|FG001|Period 1|Adverse Event|0|||
147421955|NCT03406260|531707795|FG002|Period 1|Adverse Event|0|||
147191115|NCT02250326|530867555|FG001|Treatment|Death|13|||
147421956|NCT03406260|531707796|FG003|Period 1|Adverse Event|0|||
147421957|NCT03406260|531707797|FG004|Period 1|Adverse Event|1|||
147421958|NCT03406260|531707798|FG005|Period 1|Adverse Event|0|||
147421959|NCT02399254|531707801|FG000|Overall Study|Physician Decision|2|||
147421960|NCT02334423|531707802|FG000|Overall Study|Protocol Violation|10|||
147421961|NCT02334423|531707803|FG001|Overall Study|Protocol Violation|3|||
147421962|NCT02930226|531707804|FG000|Overall Study|Technical Problems: Leak in plasma bag|0|||
147421963|NCT02930226|531707805|FG001|Overall Study|Technical Problems: Leak in plasma bag|0|||
147421964|NCT02930226|531707806|FG002|Overall Study|Technical Problems: Leak in plasma bag|0|||
147421965|NCT02930226|531707807|FG003|Overall Study|Technical Problems: Leak in plasma bag|0|||
147421966|NCT02930226|531707808|FG004|Overall Study|Technical Problems: Leak in plasma bag|1|||
147421967|NCT02930226|531707809|FG005|Overall Study|Technical Problems: Leak in plasma bag|0|||
147421968|NCT00652327|531707810|FG000|Overall Study|Adverse Event|0|||
147421969|NCT00652327|531707811|FG001|Overall Study|Adverse Event|2|||
147421970|NCT00652327|531707810|FG000|Overall Study|Lost to Follow-up|0|||
147421971|NCT00652327|531707811|FG001|Overall Study|Lost to Follow-up|3|||
147421972|NCT01076647|531707812|FG000|Overall Study|Adverse Event|4|||
147421973|NCT01076647|531707813|FG001|Overall Study|Adverse Event|1|||
147421974|NCT01076647|531707812|FG000|Overall Study|Lack of Efficacy|0|||
147421975|NCT01076647|531707813|FG001|Overall Study|Lack of Efficacy|1|||
147421976|NCT01076647|531707812|FG000|Overall Study|Protocol Violation|7|||
147421977|NCT01076647|531707813|FG001|Overall Study|Protocol Violation|9|||
147421978|NCT01076647|531707812|FG000|Overall Study|Withdrawal criteria|2|||
147421979|NCT01076647|531707813|FG001|Overall Study|Withdrawal criteria|2|||
147421980|NCT01076647|531707812|FG000|Overall Study|Unclassified|12|||
147421981|NCT01076647|531707813|FG001|Overall Study|Unclassified|12|||
147421982|NCT02292927|531707823|FG000|Overall Study|Protocol Violation|13|||
147421983|NCT02292927|531707824|FG001|Overall Study|Protocol Violation|7|||
147421984|NCT01656733|531707828|FG000|Overall Study|No permission to collect birth outcomes|0|||
147421985|NCT01656733|531707829|FG001|Overall Study|No permission to collect birth outcomes|1|||
147421986|NCT01656733|531707828|FG000|Overall Study|Delivery at another hospital|0|||
147421987|NCT01656733|531707829|FG001|Overall Study|Delivery at another hospital|2|||
147421988|NCT01656733|531707828|FG000|Overall Study|Spontaneous abortion|0|||
147421989|NCT01656733|531707829|FG001|Overall Study|Spontaneous abortion|1|||
147421990|NCT01065844|531707830|FG000|Overall Study|Adverse Event|5|||
147421991|NCT02054741|531707832|FG000|Overall Study|Protocol Violation|13|||
147421992|NCT02054741|531707833|FG001|Overall Study|Protocol Violation|2|||
147421993|NCT02054741|531707832|FG000|Overall Study|Withdrawal by Subject|10|||
147421994|NCT02054741|531707833|FG001|Overall Study|Withdrawal by Subject|5|||
147421995|NCT02054741|531707832|FG000|Overall Study|Death|94|||
147421996|NCT02054741|531707833|FG001|Overall Study|Death|90|||
147421997|NCT02054741|531707832|FG000|Overall Study|Subject passively continued participation only with data obtained from their medical records|35|||
147421998|NCT02054741|531707833|FG001|Overall Study|Subject passively continued participation only with data obtained from their medical records|32|||
147421999|NCT02325557|531707837|FG000|Overall Study|Progressive disease|1|||
147422000|NCT02325557|531707838|FG001|Overall Study|Progressive disease|0|||
147422001|NCT02325557|531707839|FG002|Overall Study|Progressive disease|0|||
147422002|NCT02325557|531707840|FG003|Overall Study|Progressive disease|0|||
147422003|NCT02325557|531707837|FG000|Overall Study|Withdrawal by Subject|4|||
147422004|NCT02325557|531707838|FG001|Overall Study|Withdrawal by Subject|0|||
147422005|NCT02325557|531707839|FG002|Overall Study|Withdrawal by Subject|0|||
147422006|NCT02325557|531707840|FG003|Overall Study|Withdrawal by Subject|15|||
147422007|NCT02325557|531707837|FG000|Overall Study|Death|5|||
147422008|NCT02325557|531707838|FG001|Overall Study|Death|1|||
147422009|NCT02325557|531707839|FG002|Overall Study|Death|1|||
147422010|NCT02325557|531707840|FG003|Overall Study|Death|16|||
147422011|NCT02325557|531707837|FG000|Overall Study|Lost to Follow-up|0|||
147422012|NCT02325557|531707838|FG001|Overall Study|Lost to Follow-up|0|||
147422013|NCT02325557|531707839|FG002|Overall Study|Lost to Follow-up|1|||
147422014|NCT02325557|531707840|FG003|Overall Study|Lost to Follow-up|1|||
147422015|NCT02325557|531707837|FG000|Overall Study|Other|0|||
147422016|NCT02325557|531707838|FG001|Overall Study|Other|0|||
147422017|NCT02325557|531707839|FG002|Overall Study|Other|0|||
147422018|NCT02325557|531707840|FG003|Overall Study|Other|5|||
147422019|NCT01502631|531707841|FG000|Overall Study|Adverse Event|5|||
147422020|NCT01502631|531707842|FG001|Overall Study|Adverse Event|8|||
147422021|NCT01502631|531707841|FG000|Overall Study|Lost to Follow-up|2|||
147422022|NCT01502631|531707842|FG001|Overall Study|Lost to Follow-up|2|||
147191116|NCT02250326|530867556|FG002|Treatment|Death|2|||
147422023|NCT01502631|531707841|FG000|Overall Study|Participant withdrew consent|2|||
147422024|NCT01502631|531707842|FG001|Overall Study|Participant withdrew consent|4|||
147422025|NCT01502631|531707841|FG000|Overall Study|Participant non-compliant|1|||
147422026|NCT01502631|531707842|FG001|Overall Study|Participant non-compliant|0|||
147422027|NCT01502631|531707841|FG000|Overall Study|Investigator's decision|0|||
147422028|NCT01502631|531707842|FG001|Overall Study|Investigator's decision|1|||
147422029|NCT01502631|531707841|FG000|Overall Study|Other|10|||
147422030|NCT01502631|531707842|FG001|Overall Study|Other|5|||
147422031|NCT01488487|531707843|FG000|Overall Study|Adverse Event|6|||
147422032|NCT01488487|531707843|FG000|Overall Study|Death|1|||
147422033|NCT01488487|531707843|FG000|Overall Study|Withdrawal by Subject|2|||
147422034|NCT00395460|531707844|FG000|Overall Study|Withdrawal by Subject|1|||
147422035|NCT00395460|531707845|FG001|Overall Study|Withdrawal by Subject|0|||
147422036|NCT04223830|531707849|FG000|Overall Study|Lost to Follow-up|9|||
147422037|NCT04223830|531707849|FG000|Overall Study|Adverse Event|1|||
147422038|NCT00862719|531707850|FG000|Overall Study|Disease Progression|5|||
147422039|NCT00862719|531707851|FG001|Overall Study|Disease Progression|0|||
147422040|NCT00862719|531707852|FG002|Overall Study|Disease Progression|1|||
147422041|NCT00862719|531707853|FG003|Overall Study|Disease Progression|0|||
147422042|NCT00862719|531707850|FG000|Overall Study|Death|5|||
147422043|NCT00862719|531707851|FG001|Overall Study|Death|6|||
147422044|NCT00862719|531707852|FG002|Overall Study|Death|1|||
147422045|NCT00862719|531707853|FG003|Overall Study|Death|1|||
147422046|NCT00862719|531707850|FG000|Overall Study|Engraftment failure|0|||
147422047|NCT00862719|531707851|FG001|Overall Study|Engraftment failure|0|||
147422048|NCT00862719|531707852|FG002|Overall Study|Engraftment failure|1|||
147422049|NCT00862719|531707853|FG003|Overall Study|Engraftment failure|0|||
147422050|NCT00862719|531707850|FG000|Overall Study|Veno-Occlusive Disease|0|||
147422051|NCT00862719|531707851|FG001|Overall Study|Veno-Occlusive Disease|0|||
147422052|NCT00862719|531707852|FG002|Overall Study|Veno-Occlusive Disease|1|||
147422053|NCT00862719|531707853|FG003|Overall Study|Veno-Occlusive Disease|0|||
147422054|NCT01806623|531707854|FG000|Overall Study|Withdrawal by Subject|1|||
147422055|NCT01806623|531707854|FG000|Overall Study|Adverse Event|1|||
147422056|NCT01806623|531707854|FG000|Overall Study|Did not meet the inclusion criteria|56|||
147422057|NCT01737827|531707855|FG000|Overall Study|Adverse Event|3|||
147422058|NCT01737827|531707856|FG001|Overall Study|Adverse Event|6|||
147422059|NCT01737827|531707857|FG002|Overall Study|Adverse Event|0|||
147422060|NCT01737827|531707855|FG000|Overall Study|Lost to Follow-up|0|||
147422061|NCT01737827|531707856|FG001|Overall Study|Lost to Follow-up|1|||
147422062|NCT01737827|531707857|FG002|Overall Study|Lost to Follow-up|0|||
147422063|NCT01737827|531707855|FG000|Overall Study|Physician Decision|0|||
147422064|NCT01737827|531707856|FG001|Overall Study|Physician Decision|2|||
147422065|NCT01737827|531707857|FG002|Overall Study|Physician Decision|0|||
147422066|NCT01737827|531707855|FG000|Overall Study|Progressive Disease|5|||
147422067|NCT01737827|531707856|FG001|Overall Study|Progressive Disease|16|||
147422068|NCT01737827|531707857|FG002|Overall Study|Progressive Disease|2|||
147422069|NCT01737827|531707855|FG000|Overall Study|Study Terminated by Sponsor|0|||
147422070|NCT01737827|531707856|FG001|Overall Study|Study Terminated by Sponsor|1|||
147422071|NCT01737827|531707857|FG002|Overall Study|Study Terminated by Sponsor|0|||
147422072|NCT01737827|531707855|FG000|Overall Study|Subject/Guardian Decision|0|||
147422073|NCT01737827|531707856|FG001|Overall Study|Subject/Guardian Decision|2|||
147422074|NCT01737827|531707857|FG002|Overall Study|Subject/Guardian Decision|0|||
147422075|NCT00528645|531707858|FG000|Overall Study|Adverse Event|3|||
147422076|NCT01445301|531707859|FG000|Overall Study|Adverse Event|15|||
147422077|NCT01445301|531707860|FG001|Overall Study|Adverse Event|25|||
147422078|NCT01445301|531707861|FG002|Overall Study|Adverse Event|4|||
147422079|NCT01445301|531707859|FG000|Overall Study|Lack of Efficacy|0|||
147422080|NCT01445301|531707860|FG001|Overall Study|Lack of Efficacy|1|||
147422081|NCT01445301|531707861|FG002|Overall Study|Lack of Efficacy|0|||
147422082|NCT01445301|531707859|FG000|Overall Study|Protocol Violation|1|||
147422083|NCT01445301|531707860|FG001|Overall Study|Protocol Violation|0|||
147422084|NCT01445301|531707861|FG002|Overall Study|Protocol Violation|0|||
147422085|NCT01445301|531707859|FG000|Overall Study|Protocol-Defined Stopping Criteria|0|||
147422086|NCT01445301|531707860|FG001|Overall Study|Protocol-Defined Stopping Criteria|1|||
147422087|NCT01445301|531707861|FG002|Overall Study|Protocol-Defined Stopping Criteria|1|||
147422088|NCT01445301|531707859|FG000|Overall Study|Physician Decision|0|||
147422089|NCT01445301|531707860|FG001|Overall Study|Physician Decision|2|||
147422090|NCT01445301|531707861|FG002|Overall Study|Physician Decision|0|||
147422091|NCT01445301|531707859|FG000|Overall Study|Withdrawal by Subject|5|||
147422092|NCT01445301|531707860|FG001|Overall Study|Withdrawal by Subject|6|||
147422093|NCT01445301|531707861|FG002|Overall Study|Withdrawal by Subject|4|||
147422094|NCT00752557|531707862|FG000|Overall Study|Withdrawal by Subject|4|||
147422095|NCT00752557|531707863|FG001|Overall Study|Withdrawal by Subject|3|||
147422096|NCT00752557|531707864|FG002|Overall Study|Withdrawal by Subject|3|||
147422097|NCT00752557|531707862|FG000|Overall Study|Unspecified resaons|0|||
147422098|NCT00752557|531707863|FG001|Overall Study|Unspecified resaons|2|||
147422099|NCT00752557|531707864|FG002|Overall Study|Unspecified resaons|2|||
147422100|NCT00752557|531707862|FG000|Overall Study|Lost to Follow-up|1|||
147422101|NCT00752557|531707863|FG001|Overall Study|Lost to Follow-up|0|||
147422102|NCT00752557|531707864|FG002|Overall Study|Lost to Follow-up|1|||
147422103|NCT00190749|531707865|FG000|Overall Study|Lost to Follow-up|8|||
147422104|NCT00190749|531707866|FG001|Overall Study|Lost to Follow-up|11|||
147422105|NCT00190749|531707865|FG000|Overall Study|Withdrawal by Subject|10|||
147422106|NCT00190749|531707866|FG001|Overall Study|Withdrawal by Subject|6|||
147422107|NCT00190749|531707865|FG000|Overall Study|Protocol Violation|5|||
147422108|NCT00190749|531707866|FG001|Overall Study|Protocol Violation|4|||
147422109|NCT00190749|531707865|FG000|Overall Study|Adverse Event|0|||
147422110|NCT00190749|531707866|FG001|Overall Study|Adverse Event|5|||
147422111|NCT00190749|531707865|FG000|Overall Study|Lack of Efficacy|2|||
147422112|NCT00190749|531707866|FG001|Overall Study|Lack of Efficacy|3|||
147422113|NCT00190749|531707865|FG000|Overall Study|Reason Not Specified|0|||
147422114|NCT00190749|531707866|FG001|Overall Study|Reason Not Specified|2|||
147422115|NCT00190749|531707865|FG000|Overall Study|Sponsor Decision|1|||
147422116|NCT00190749|531707866|FG001|Overall Study|Sponsor Decision|0|||
147422117|NCT02665338|531707867|FG000|Overall Study|Withdrawal by Subject|0|||
147422118|NCT02665338|531707868|FG001|Overall Study|Withdrawal by Subject|1|||
147422119|NCT05326815|531707870|FG000|Overall Study|Withdrawal by Subject|3|||
147422120|NCT05326815|531707870|FG000|Overall Study|Did not complete required labs|6|||
147422121|NCT05326815|531707870|FG000|Overall Study|Screen fail- abnormal labs|5|||
147422122|NCT04617275|531707871|FG000|Treatment Period|Adverse Event|1|||
147422123|NCT04617275|531707872|FG001|Treatment Period|Adverse Event|6|||
147422124|NCT04617275|531707873|FG002|Treatment Period|Adverse Event|4|||
147422125|NCT04617275|531707874|FG003|Treatment Period|Adverse Event|6|||
147422126|NCT04617275|531707875|FG004|Treatment Period|Adverse Event|7|||
147422127|NCT04617275|531707876|FG005|Treatment Period|Adverse Event|8|||
147422128|NCT04617275|531707877|FG006|Treatment Period|Adverse Event|0|||
147422129|NCT04617275|531707878|FG007|Treatment Period|Adverse Event|12|||
147422130|NCT04617275|531707871|FG000|Treatment Period|Lost to Follow-up|0|||
147422131|NCT04617275|531707872|FG001|Treatment Period|Lost to Follow-up|0|||
147422132|NCT04617275|531707873|FG002|Treatment Period|Lost to Follow-up|2|||
147422133|NCT04617275|531707874|FG003|Treatment Period|Lost to Follow-up|0|||
147422134|NCT04617275|531707875|FG004|Treatment Period|Lost to Follow-up|0|||
147422135|NCT04617275|531707876|FG005|Treatment Period|Lost to Follow-up|3|||
147422136|NCT04617275|531707877|FG006|Treatment Period|Lost to Follow-up|0|||
147422137|NCT04617275|531707878|FG007|Treatment Period|Lost to Follow-up|2|||
147422138|NCT04617275|531707871|FG000|Treatment Period|No longer meets eligibility criteria|0|||
147422139|NCT04617275|531707872|FG001|Treatment Period|No longer meets eligibility criteria|0|||
147422140|NCT04617275|531707873|FG002|Treatment Period|No longer meets eligibility criteria|0|||
147422141|NCT04617275|531707874|FG003|Treatment Period|No longer meets eligibility criteria|1|||
147422142|NCT04617275|531707875|FG004|Treatment Period|No longer meets eligibility criteria|0|||
147422143|NCT04617275|531707876|FG005|Treatment Period|No longer meets eligibility criteria|0|||
147422144|NCT04617275|531707877|FG006|Treatment Period|No longer meets eligibility criteria|0|||
147422145|NCT04617275|531707878|FG007|Treatment Period|No longer meets eligibility criteria|0|||
147191117|NCT02250326|530867554|FG000|Treatment|Adverse Event|8|||
147422146|NCT04617275|531707871|FG000|Treatment Period|Other|0|||
147422147|NCT04617275|531707872|FG001|Treatment Period|Other|1|||
147422148|NCT04617275|531707873|FG002|Treatment Period|Other|0|||
147422149|NCT04617275|531707874|FG003|Treatment Period|Other|0|||
147422150|NCT04617275|531707875|FG004|Treatment Period|Other|0|||
147191118|NCT02250326|530867555|FG001|Treatment|Adverse Event|8|||
147422151|NCT04617275|531707876|FG005|Treatment Period|Other|0|||
147422152|NCT04617275|531707877|FG006|Treatment Period|Other|0|||
147422153|NCT04617275|531707878|FG007|Treatment Period|Other|0|||
147422154|NCT04617275|531707871|FG000|Treatment Period|Withdrawal by Subject|2|||
147422155|NCT04617275|531707872|FG001|Treatment Period|Withdrawal by Subject|0|||
147422156|NCT04617275|531707873|FG002|Treatment Period|Withdrawal by Subject|0|||
147422157|NCT04617275|531707874|FG003|Treatment Period|Withdrawal by Subject|2|||
147422158|NCT04617275|531707875|FG004|Treatment Period|Withdrawal by Subject|2|||
147422159|NCT04617275|531707876|FG005|Treatment Period|Withdrawal by Subject|0|||
147422160|NCT04617275|531707877|FG006|Treatment Period|Withdrawal by Subject|1|||
147422161|NCT04617275|531707878|FG007|Treatment Period|Withdrawal by Subject|2|||
147422162|NCT04617275|531707871|FG000|Follow-up Period|Adverse Event|1|||
147422163|NCT04617275|531707872|FG001|Follow-up Period|Adverse Event|1|||
147422164|NCT04617275|531707873|FG002|Follow-up Period|Adverse Event|2|||
147422165|NCT04617275|531707874|FG003|Follow-up Period|Adverse Event|3|||
147422166|NCT04617275|531707875|FG004|Follow-up Period|Adverse Event|4|||
147422167|NCT04617275|531707876|FG005|Follow-up Period|Adverse Event|3|||
147422168|NCT04617275|531707877|FG006|Follow-up Period|Adverse Event|0|||
147422169|NCT04617275|531707878|FG007|Follow-up Period|Adverse Event|3|||
147422170|NCT04617275|531707871|FG000|Follow-up Period|Lost to Follow-up|0|||
147422171|NCT04617275|531707872|FG001|Follow-up Period|Lost to Follow-up|1|||
147422172|NCT04617275|531707873|FG002|Follow-up Period|Lost to Follow-up|2|||
147422173|NCT04617275|531707874|FG003|Follow-up Period|Lost to Follow-up|0|||
147422174|NCT04617275|531707875|FG004|Follow-up Period|Lost to Follow-up|0|||
147422175|NCT04617275|531707876|FG005|Follow-up Period|Lost to Follow-up|4|||
147422176|NCT04617275|531707877|FG006|Follow-up Period|Lost to Follow-up|0|||
147422177|NCT04617275|531707878|FG007|Follow-up Period|Lost to Follow-up|3|||
147422178|NCT04617275|531707871|FG000|Follow-up Period|No longer meets eligibility criteria|0|||
147422179|NCT04617275|531707872|FG001|Follow-up Period|No longer meets eligibility criteria|0|||
147422180|NCT04617275|531707873|FG002|Follow-up Period|No longer meets eligibility criteria|0|||
147422181|NCT04617275|531707874|FG003|Follow-up Period|No longer meets eligibility criteria|1|||
147422182|NCT04617275|531707875|FG004|Follow-up Period|No longer meets eligibility criteria|0|||
147422183|NCT04617275|531707876|FG005|Follow-up Period|No longer meets eligibility criteria|0|||
147422184|NCT04617275|531707877|FG006|Follow-up Period|No longer meets eligibility criteria|0|||
147422185|NCT04617275|531707878|FG007|Follow-up Period|No longer meets eligibility criteria|0|||
147422186|NCT04617275|531707871|FG000|Follow-up Period|Other|0|||
147422187|NCT04617275|531707872|FG001|Follow-up Period|Other|1|||
147422188|NCT04617275|531707873|FG002|Follow-up Period|Other|0|||
147422189|NCT04617275|531707874|FG003|Follow-up Period|Other|0|||
147422190|NCT04617275|531707875|FG004|Follow-up Period|Other|0|||
147422191|NCT04617275|531707876|FG005|Follow-up Period|Other|0|||
147422192|NCT04617275|531707877|FG006|Follow-up Period|Other|0|||
147422193|NCT04617275|531707878|FG007|Follow-up Period|Other|0|||
147422194|NCT04617275|531707871|FG000|Follow-up Period|Withdrawal by Subject|2|||
147422195|NCT04617275|531707872|FG001|Follow-up Period|Withdrawal by Subject|0|||
147422196|NCT04617275|531707873|FG002|Follow-up Period|Withdrawal by Subject|0|||
147422197|NCT04617275|531707874|FG003|Follow-up Period|Withdrawal by Subject|2|||
147422198|NCT04617275|531707875|FG004|Follow-up Period|Withdrawal by Subject|2|||
147422199|NCT04617275|531707876|FG005|Follow-up Period|Withdrawal by Subject|0|||
147422200|NCT04617275|531707877|FG006|Follow-up Period|Withdrawal by Subject|1|||
147422201|NCT04617275|531707878|FG007|Follow-up Period|Withdrawal by Subject|2|||
147422202|NCT04927884|531707879|FG000|Overall Study|Progressive Disease|2|||
147422203|NCT02359877|531711151|FG000|Overall Study|Withdrawal by Subject|1|||
147422204|NCT02359877|531711152|FG001|Overall Study|Withdrawal by Subject|0|||
147422205|NCT02359877|531711153|FG002|Overall Study|Withdrawal by Subject|0|||
147422206|NCT02359877|531711154|FG003|Overall Study|Withdrawal by Subject|2|||
147422207|NCT02359877|531711151|FG000|Overall Study|Adverse Event|0|||
147422208|NCT02359877|531711152|FG001|Overall Study|Adverse Event|0|||
147422209|NCT02359877|531711153|FG002|Overall Study|Adverse Event|0|||
147422210|NCT02359877|531711154|FG003|Overall Study|Adverse Event|1|||
147422211|NCT00189488|531711156|FG000|Overall Study|Ineligibility determined|1|||
147422212|NCT00189488|531711157|FG001|Overall Study|Ineligibility determined|0|||
147422213|NCT00189488|531711156|FG000|Overall Study|Protocol deviation|2|||
147422214|NCT00189488|531711157|FG001|Overall Study|Protocol deviation|1|||
147422215|NCT00189488|531711156|FG000|Overall Study|Adverse Event|2|||
147422216|NCT00189488|531711157|FG001|Overall Study|Adverse Event|1|||
147422217|NCT00189488|531711156|FG000|Overall Study|Withdrawal by Subject|2|||
147422218|NCT00189488|531711157|FG001|Overall Study|Withdrawal by Subject|6|||
147422219|NCT00189488|531711156|FG000|Overall Study|Disease progression|2|||
147191119|NCT02250326|530867556|FG002|Treatment|Adverse Event|9|||
147422220|NCT00189488|531711157|FG001|Overall Study|Disease progression|4|||
147422221|NCT00189488|531711156|FG000|Overall Study|Administrative Decision|0|||
147422222|NCT00189488|531711157|FG001|Overall Study|Administrative Decision|2|||
147422223|NCT00189488|531711156|FG000|Overall Study|Death|5|||
147422224|NCT00189488|531711157|FG001|Overall Study|Death|8|||
147422225|NCT00189488|531711156|FG000|Overall Study|Other|1|||
147422226|NCT00189488|531711157|FG001|Overall Study|Other|0|||
147422227|NCT02349425|531711158|FG000|Period 1|Adverse Event|1|||
147422228|NCT02349425|531711159|FG001|Period 1|Adverse Event|1|||
147422229|NCT02349425|531711160|FG002|Period 1|Adverse Event|0|||
147422230|NCT02349425|531711161|FG003|Period 1|Adverse Event|0|||
147422231|NCT02349425|531711158|FG000|Period 2|Adverse Event|0|||
147422232|NCT02349425|531711159|FG001|Period 2|Adverse Event|1|||
147422233|NCT02349425|531711160|FG002|Period 2|Adverse Event|1|||
147422234|NCT02349425|531711161|FG003|Period 2|Adverse Event|0|||
147422235|NCT02186223|531711162|FG000|Overall Study|Not eligible for device placement|6|||
147422236|NCT02186223|531711162|FG000|Overall Study|Unable to obtain femoral access|3|||
147422237|NCT02186223|531711162|FG000|Overall Study|Death|3|||
147422238|NCT02186223|531711162|FG000|Overall Study|Device in place less than 48 hours|9|||
147422239|NCT00252733|531711163|FG000|Overall Study|Withdrawal by Subject|73|||
147422240|NCT00252733|531711164|FG001|Overall Study|Withdrawal by Subject|67|||
147422241|NCT00252733|531711163|FG000|Overall Study|Death|7|||
147422242|NCT00252733|531711164|FG001|Overall Study|Death|5|||
147422243|NCT00252733|531711163|FG000|Overall Study|Lost to Follow-up|12|||
147422244|NCT00252733|531711164|FG001|Overall Study|Lost to Follow-up|6|||
147422245|NCT00252733|531711163|FG000|Overall Study|Multiple Reasons|14|||
147422246|NCT00252733|531711164|FG001|Overall Study|Multiple Reasons|14|||
147422247|NCT02090959|531711165|FG000|Overall Study|Withdrawal by Subject|10|||
147422248|NCT02090959|531711165|FG000|Overall Study|Adverse Event|1|||
147422249|NCT02090959|531711165|FG000|Overall Study|Investigator decision|2|||
147422250|NCT02090959|531711165|FG000|Overall Study|Study termination|6|||
147422251|NCT02090959|531711165|FG000|Overall Study|Enrolled but not treated|1|||
147422252|NCT02090959|531711165|FG000|Overall Study|Transfer for compassionate use medicine|4|||
147422253|NCT02090959|531711165|FG000|Overall Study|Move to medical need program|3|||
147422254|NCT02090959|531711165|FG000|Overall Study|Entered in to other study|34|||
147422255|NCT02090959|531711165|FG000|Overall Study|Switched to commercial supply|88|||
147422256|NCT02090959|531711165|FG000|Overall Study|Other than specified|2|||
147422257|NCT02808143|531711168|FG000|Maintenance Phase|Disease recurrence|1|||
147422258|NCT02808143|531711169|FG001|Maintenance Phase|Disease recurrence|3|||
147422259|NCT02808143|531711168|FG000|Maintenance Phase|Disease progression|1|||
147422260|NCT02808143|531711169|FG001|Maintenance Phase|Disease progression|2|||
147422261|NCT02808143|531711168|FG000|Survival Follow-Up|Still in survival Follow-up|2|||
147422262|NCT02808143|531711169|FG001|Survival Follow-Up|Still in survival Follow-up|3|||
147422263|NCT02808143|531711168|FG000|Survival Follow-Up|Disease recurrence|0|||
147422264|NCT02808143|531711169|FG001|Survival Follow-Up|Disease recurrence|2|||
147422265|NCT02808143|531711168|FG000|Survival Follow-Up|Adverse Event|0|||
147422266|NCT02808143|531711169|FG001|Survival Follow-Up|Adverse Event|1|||
147422267|NCT02808143|531711168|FG000|Survival Follow-Up|Death|1|||
147422268|NCT02808143|531711169|FG001|Survival Follow-Up|Death|0|||
147422269|NCT00522873|531711170|FG000|Overall Study|Adverse Event|41|||
147422270|NCT00522873|531711171|FG001|Overall Study|Adverse Event|26|||
147422271|NCT00522873|531711170|FG000|Overall Study|Withdrawal by Subject|20|||
147422272|NCT00522873|531711171|FG001|Overall Study|Withdrawal by Subject|9|||
147422273|NCT00522873|531711170|FG000|Overall Study|Protocol Violation|14|||
147422274|NCT00522873|531711171|FG001|Overall Study|Protocol Violation|4|||
147422275|NCT00522873|531711170|FG000|Overall Study|Lost to Follow-up|11|||
147422276|NCT00522873|531711171|FG001|Overall Study|Lost to Follow-up|3|||
147422277|NCT00522873|531711170|FG000|Overall Study|Personal Reasons|8|||
147422278|NCT00522873|531711171|FG001|Overall Study|Personal Reasons|1|||
147422279|NCT00522873|531711170|FG000|Overall Study|Medication Errors|1|||
147422280|NCT00522873|531711171|FG001|Overall Study|Medication Errors|1|||
147422281|NCT00522873|531711170|FG000|Overall Study|Never Received Medication|1|||
147422282|NCT00522873|531711171|FG001|Overall Study|Never Received Medication|0|||
147422283|NCT02029846|531711172|FG000|Overall Study|n=1 each arm|1|||
147422284|NCT02029846|531711173|FG001|Overall Study|n=1 each arm|1|||
147422285|NCT02966301|531711174|FG000|Overall Study|Death|2|||
147422286|NCT02966301|531711174|FG000|Overall Study|Withdrawal by Subject|1|||
147422287|NCT00523640|531711181|FG000|Overall Study|Death|1|||
147422288|NCT02224690|531711182|FG000|Overall Study|Adverse Event|8|||
147422289|NCT02224690|531711183|FG001|Overall Study|Adverse Event|1|||
147532705|NCT01243762|532105986|FG004|Part 1 (Dose Escalation/MTD)|Physician Decision|0|||
147422290|NCT02224690|531711182|FG000|Overall Study|Met Withdrawal Criteria|4|||
147422291|NCT02224690|531711183|FG001|Overall Study|Met Withdrawal Criteria|0|||
147422292|NCT02224690|531711182|FG000|Overall Study|Use of G-tube|1|||
147422293|NCT02224690|531711183|FG001|Overall Study|Use of G-tube|0|||
147422294|NCT02224690|531711182|FG000|Overall Study|Did not meet eligibility criteria|1|||
147422295|NCT02224690|531711183|FG001|Overall Study|Did not meet eligibility criteria|0|||
147422296|NCT01577745|531711184|FG000|Overall Study|Withdrawal by Subject|0|||
147422297|NCT01577745|531711185|FG001|Overall Study|Withdrawal by Subject|1|||
147422298|NCT01577745|531711186|FG002|Overall Study|Withdrawal by Subject|0|||
147422299|NCT01577745|531711187|FG003|Overall Study|Withdrawal by Subject|3|||
147422300|NCT01577745|531711188|FG004|Overall Study|Withdrawal by Subject|2|||
147422301|NCT01577745|531711189|FG005|Overall Study|Withdrawal by Subject|0|||
147422302|NCT01577745|531711184|FG000|Overall Study|Death|3|||
147422303|NCT01577745|531711185|FG001|Overall Study|Death|2|||
147422304|NCT01577745|531711186|FG002|Overall Study|Death|2|||
147422305|NCT01577745|531711187|FG003|Overall Study|Death|1|||
147422306|NCT01577745|531711188|FG004|Overall Study|Death|1|||
147422307|NCT01577745|531711189|FG005|Overall Study|Death|3|||
147422308|NCT01577745|531711184|FG000|Overall Study|Physician Decision|0|||
147422309|NCT01577745|531711185|FG001|Overall Study|Physician Decision|0|||
147422310|NCT01577745|531711186|FG002|Overall Study|Physician Decision|0|||
147422311|NCT01577745|531711187|FG003|Overall Study|Physician Decision|1|||
147422312|NCT01577745|531711188|FG004|Overall Study|Physician Decision|1|||
147422313|NCT01577745|531711189|FG005|Overall Study|Physician Decision|0|||
147422314|NCT01577745|531711184|FG000|Overall Study|Lost to Follow-up|0|||
147422315|NCT01577745|531711185|FG001|Overall Study|Lost to Follow-up|0|||
147422316|NCT01577745|531711186|FG002|Overall Study|Lost to Follow-up|0|||
147422317|NCT01577745|531711187|FG003|Overall Study|Lost to Follow-up|0|||
147422318|NCT01577745|531711188|FG004|Overall Study|Lost to Follow-up|0|||
147422319|NCT01577745|531711189|FG005|Overall Study|Lost to Follow-up|1|||
147422320|NCT01577745|531711184|FG000|Overall Study|Alternative Therapy|0|||
147422321|NCT01577745|531711185|FG001|Overall Study|Alternative Therapy|0|||
147422322|NCT01577745|531711186|FG002|Overall Study|Alternative Therapy|0|||
147422323|NCT01577745|531711187|FG003|Overall Study|Alternative Therapy|1|||
147422324|NCT01577745|531711188|FG004|Overall Study|Alternative Therapy|1|||
147422325|NCT01577745|531711189|FG005|Overall Study|Alternative Therapy|0|||
147422326|NCT00122460|531711190|FG000|Overall Study|investigational study phase ongoing|7|||
147422327|NCT00122460|531711191|FG001|Overall Study|investigational study phase ongoing|1|||
147422328|NCT00825916|531711192|FG000|Overall Study|Lost to Follow-up|4|||
147422329|NCT00825916|531711193|FG001|Overall Study|Lost to Follow-up|2|||
147422330|NCT00825916|531711194|FG002|Overall Study|Lost to Follow-up|1|||
147422331|NCT02962960|531711195|FG000|Overall Study|Withdrawal by Subject|1|||
147422332|NCT02962960|531711196|FG001|Overall Study|Withdrawal by Subject|1|||
147422333|NCT02962960|531711197|FG002|Overall Study|Withdrawal by Subject|0|||
147422334|NCT02962960|531711195|FG000|Overall Study|Adverse Event|1|||
147422335|NCT02962960|531711196|FG001|Overall Study|Adverse Event|1|||
147422336|NCT02962960|531711197|FG002|Overall Study|Adverse Event|0|||
147422337|NCT02962960|531711195|FG000|Overall Study|Protocol Violation|1|||
147422338|NCT02962960|531711196|FG001|Overall Study|Protocol Violation|0|||
147422339|NCT02962960|531711197|FG002|Overall Study|Protocol Violation|0|||
147422340|NCT02344004|531711203|FG000|Overall Study|Adverse Event|11|||
147422341|NCT02344004|531711204|FG001|Overall Study|Adverse Event|1|||
147422342|NCT02344004|531711203|FG000|Overall Study|Death|9|||
147422343|NCT02344004|531711204|FG001|Overall Study|Death|7|||
147422344|NCT02344004|531711203|FG000|Overall Study|Physician Decision|4|||
147422345|NCT02344004|531711204|FG001|Overall Study|Physician Decision|1|||
147422346|NCT02344004|531711203|FG000|Overall Study|Withdrawal by Subject|22|||
147422347|NCT02344004|531711204|FG001|Overall Study|Withdrawal by Subject|5|||
147422348|NCT02344004|531711203|FG000|Overall Study|Rescue Medication|2|||
147422349|NCT02344004|531711204|FG001|Overall Study|Rescue Medication|0|||
147422350|NCT02344004|531711203|FG000|Overall Study|Other Not Specified|12|||
147422351|NCT02344004|531711204|FG001|Overall Study|Other Not Specified|0|||
147422352|NCT02344004|531711203|FG000|Overall Study|Protocol Violation|1|||
147422353|NCT02344004|531711204|FG001|Overall Study|Protocol Violation|0|||
147422354|NCT02319525|531711205|FG000|Overall Study|Withdrawal by Subject|2|||
147422355|NCT02319525|531711206|FG001|Overall Study|Withdrawal by Subject|1|||
147422356|NCT01451827|531711207|FG000|Overall Study|Adverse Event|2|||
147422357|NCT01451827|531711208|FG001|Overall Study|Adverse Event|0|||
147422358|NCT01451827|531711209|FG002|Overall Study|Adverse Event|1|||
147422359|NCT01451827|531711210|FG003|Overall Study|Adverse Event|1|||
147422360|NCT01451827|531711207|FG000|Overall Study|Protocol deviation|1|||
147422361|NCT01451827|531711208|FG001|Overall Study|Protocol deviation|0|||
147422362|NCT01451827|531711209|FG002|Overall Study|Protocol deviation|0|||
147422363|NCT01451827|531711210|FG003|Overall Study|Protocol deviation|0|||
147422364|NCT01451827|531711207|FG000|Overall Study|Lost to Follow-up|0|||
147422365|NCT01451827|531711208|FG001|Overall Study|Lost to Follow-up|3|||
147422366|NCT01451827|531711209|FG002|Overall Study|Lost to Follow-up|0|||
147422367|NCT01451827|531711210|FG003|Overall Study|Lost to Follow-up|2|||
147422368|NCT01451827|531711207|FG000|Overall Study|Participant met withdrawal criteria|0|||
147422369|NCT01451827|531711208|FG001|Overall Study|Participant met withdrawal criteria|2|||
147422370|NCT01451827|531711209|FG002|Overall Study|Participant met withdrawal criteria|0|||
147422371|NCT01451827|531711210|FG003|Overall Study|Participant met withdrawal criteria|0|||
147422372|NCT01451827|531711207|FG000|Overall Study|Withdrawal by Subject|0|||
147422373|NCT01451827|531711208|FG001|Overall Study|Withdrawal by Subject|0|||
147595935|NCT03096847|532338752|FG001|Overall Study|Physician Decision|2|||
147422374|NCT01451827|531711209|FG002|Overall Study|Withdrawal by Subject|1|||
147422375|NCT01451827|531711210|FG003|Overall Study|Withdrawal by Subject|1|||
147422376|NCT01964924|531711211|FG000|Trametinib Monotherapy|Progression|19|||
147422377|NCT01964924|531711212|FG001|Trametinib Monotherapy|Progression|0|||
147422378|NCT01528345|531711213|FG000|Overall Study|Adverse Event|10|||
147422379|NCT01528345|531711214|FG001|Overall Study|Adverse Event|1|||
147422380|NCT01528345|531711213|FG000|Overall Study|Death|1|||
147422381|NCT01528345|531711214|FG001|Overall Study|Death|1|||
147422382|NCT01528345|531711213|FG000|Overall Study|Non-compliance with study treatment|1|||
147422383|NCT01528345|531711214|FG001|Overall Study|Non-compliance with study treatment|0|||
147422384|NCT01528345|531711213|FG000|Overall Study|Progressive Disease|26|||
147422385|NCT01528345|531711214|FG001|Overall Study|Progressive Disease|40|||
147422386|NCT01528345|531711213|FG000|Overall Study|Study Terminated by Sponsor|4|||
147422387|NCT01528345|531711214|FG001|Overall Study|Study Terminated by Sponsor|8|||
147422388|NCT01528345|531711213|FG000|Overall Study|Subject/Guardian Decision|5|||
147422389|NCT01528345|531711214|FG001|Overall Study|Subject/Guardian Decision|0|||
147422390|NCT02424734|531711215|FG000|Overall Study|Treatment stopped to be discharged home|2|||
147422391|NCT02424734|531711216|FG001|Overall Study|Treatment stopped to be discharged home|2|||
147422392|NCT02424734|531711217|FG002|Overall Study|Treatment stopped to be discharged home|0|||
147422393|NCT02150343|531711222|FG000|Overall Study|Adverse Event|2|||
147422394|NCT02150343|531711223|FG001|Overall Study|Adverse Event|0|||
147422395|NCT02150343|531711224|FG002|Overall Study|Adverse Event|1|||
147422396|NCT02150343|531711225|FG003|Overall Study|Adverse Event|1|||
147422397|NCT02150343|531711222|FG000|Overall Study|Withdrawal by Subject|13|||
147422398|NCT02150343|531711223|FG001|Overall Study|Withdrawal by Subject|10|||
147422399|NCT02150343|531711224|FG002|Overall Study|Withdrawal by Subject|9|||
147422400|NCT02150343|531711225|FG003|Overall Study|Withdrawal by Subject|4|||
147422401|NCT02150343|531711222|FG000|Overall Study|Lost to Follow-up|4|||
147422402|NCT02150343|531711223|FG001|Overall Study|Lost to Follow-up|4|||
147422403|NCT02150343|531711224|FG002|Overall Study|Lost to Follow-up|2|||
147422404|NCT02150343|531711225|FG003|Overall Study|Lost to Follow-up|3|||
147422405|NCT02150343|531711222|FG000|Overall Study|Other|2|||
147422406|NCT02150343|531711223|FG001|Overall Study|Other|6|||
147422407|NCT02150343|531711224|FG002|Overall Study|Other|0|||
147422408|NCT02150343|531711225|FG003|Overall Study|Other|2|||
147422409|NCT02729753|531711226|FG000|Overall Study|Device Malfunction. No units in stock.|0|||
147422410|NCT02729753|531711227|FG001|Overall Study|Device Malfunction. No units in stock.|1|||
147422411|NCT01090427|531711228|FG000|After Controlled Period|Death|0|||
147422412|NCT01090427|531711229|FG001|After Controlled Period|Death|0|||
147422413|NCT01090427|531711230|FG002|After Controlled Period|Death|0|||
147422414|NCT01090427|531711231|FG003|After Controlled Period|Death|0|||
147422415|NCT01090427|531711232|FG004|After Controlled Period|Death|0|||
147422416|NCT01090427|531711233|FG005|After Controlled Period|Death|1|||
147422417|NCT01090427|531711234|FG006|After Controlled Period|Death|0|||
147422418|NCT01090427|531711228|FG000|After Controlled Period|Lack of Efficacy|0|||
147422419|NCT01090427|531711229|FG001|After Controlled Period|Lack of Efficacy|0|||
147422420|NCT01090427|531711230|FG002|After Controlled Period|Lack of Efficacy|0|||
147422421|NCT01090427|531711231|FG003|After Controlled Period|Lack of Efficacy|0|||
147422422|NCT01090427|531711232|FG004|After Controlled Period|Lack of Efficacy|0|||
147422423|NCT01090427|531711233|FG005|After Controlled Period|Lack of Efficacy|3|||
147422424|NCT01090427|531711234|FG006|After Controlled Period|Lack of Efficacy|2|||
147422425|NCT01090427|531711228|FG000|After Controlled Period|Adverse Event|0|||
147422426|NCT01090427|531711229|FG001|After Controlled Period|Adverse Event|0|||
147422427|NCT01090427|531711230|FG002|After Controlled Period|Adverse Event|0|||
147422428|NCT01090427|531711231|FG003|After Controlled Period|Adverse Event|2|||
147422429|NCT01090427|531711232|FG004|After Controlled Period|Adverse Event|0|||
147422430|NCT01090427|531711233|FG005|After Controlled Period|Adverse Event|1|||
147422431|NCT01090427|531711234|FG006|After Controlled Period|Adverse Event|0|||
147422432|NCT01154010|531711235|FG000|Overall Study|Lost to Follow-up|0|||
147422433|NCT01154010|531711236|FG001|Overall Study|Lost to Follow-up|1|||
147422434|NCT00439231|531711237|FG000|Overall Study|Lack of Efficacy|28|||
147422435|NCT02413333|531711243|FG000|Period 1|Adverse Event|1|||
147422436|NCT02413333|531711244|FG001|Period 1|Adverse Event|0|||
147422437|NCT02413333|531711243|FG000|Period 1|Reason Not Specified|0|||
147422438|NCT02413333|531711244|FG001|Period 1|Reason Not Specified|1|||
147422439|NCT02413333|531711243|FG000|Period 2|Protocol Deviation|1|||
147422440|NCT02413333|531711244|FG001|Period 2|Protocol Deviation|0|||
147422441|NCT00709852|531711245|FG000|Period 1|Adverse Event|2|||
147422442|NCT00709852|531711246|FG001|Period 1|Adverse Event|0|||
147422443|NCT00709852|531711245|FG000|Period 1|Withdrawal by Subject|4|||
147422444|NCT00709852|531711246|FG001|Period 1|Withdrawal by Subject|2|||
147422445|NCT00709852|531711245|FG000|Period 1|Protocol Violation|1|||
147422446|NCT00709852|531711246|FG001|Period 1|Protocol Violation|0|||
147422447|NCT00709852|531711245|FG000|Period 1|Defective scanner|0|||
147422448|NCT00709852|531711246|FG001|Period 1|Defective scanner|1|||
147422449|NCT00709852|531711245|FG000|Period 1|Lost to Follow-up|1|||
147422450|NCT00709852|531711246|FG001|Period 1|Lost to Follow-up|0|||
147422451|NCT00709852|531711245|FG000|Period 2|Protocol Violation|4|||
147422452|NCT00709852|531711246|FG001|Period 2|Protocol Violation|1|||
147422453|NCT00709852|531711245|FG000|Period 2|Adverse Event|1|||
147422454|NCT00709852|531711246|FG001|Period 2|Adverse Event|1|||
147422455|NCT00709852|531711245|FG000|Period 2|Lost to Follow-up|1|||
147422456|NCT00709852|531711246|FG001|Period 2|Lost to Follow-up|0|||
147422457|NCT00709852|531711245|FG000|Period 2|No 72-hour follow-up|3|||
147422458|NCT00709852|531711246|FG001|Period 2|No 72-hour follow-up|0|||
147422459|NCT01048671|531711253|FG000|Overall Study|Protocol Violation|0|||
147422460|NCT01048671|531711254|FG001|Overall Study|Protocol Violation|1|||
147422461|NCT01048671|531711255|FG002|Overall Study|Protocol Violation|1|||
147422462|NCT03814187|531711256|FG000|Overall Study|Sponsor's Administrative Decision|0|||
147422463|NCT03814187|531711257|FG001|Overall Study|Sponsor's Administrative Decision|0|||
147422464|NCT03814187|531711258|FG002|Overall Study|Sponsor's Administrative Decision|272|||
147422465|NCT03814187|531711256|FG000|Overall Study|Death|80|||
147422466|NCT03814187|531711257|FG001|Overall Study|Death|81|||
147422467|NCT03814187|531711258|FG002|Overall Study|Death|4|||
147422468|NCT03814187|531711256|FG000|Overall Study|Withdrew Consent|77|||
147422469|NCT03814187|531711257|FG001|Overall Study|Withdrew Consent|78|||
147422470|NCT03814187|531711258|FG002|Overall Study|Withdrew Consent|2|||
147422471|NCT03814187|531711256|FG000|Overall Study|Lost to Follow-up|47|||
147422472|NCT03814187|531711257|FG001|Overall Study|Lost to Follow-up|52|||
147422473|NCT03814187|531711258|FG002|Overall Study|Lost to Follow-up|1|||
147422474|NCT03814187|531711256|FG000|Overall Study|Adverse Event|22|||
147422475|NCT03814187|531711257|FG001|Overall Study|Adverse Event|23|||
147422476|NCT03814187|531711258|FG002|Overall Study|Adverse Event|0|||
147422477|NCT03814187|531711256|FG000|Overall Study|Physician Decision|7|||
147422478|NCT03814187|531711257|FG001|Overall Study|Physician Decision|4|||
147422479|NCT03814187|531711258|FG002|Overall Study|Physician Decision|2|||
147422480|NCT03814187|531711256|FG000|Overall Study|Initiation Of Protocol-Prohibited Approved PCSK9 Inhibitor|0|||
147422481|NCT03814187|531711257|FG001|Overall Study|Initiation Of Protocol-Prohibited Approved PCSK9 Inhibitor|0|||
147422482|NCT03814187|531711258|FG002|Overall Study|Initiation Of Protocol-Prohibited Approved PCSK9 Inhibitor|1|||
147422483|NCT03814187|531711256|FG000|Overall Study|Other reasons|34|||
147422484|NCT03814187|531711257|FG001|Overall Study|Other reasons|40|||
147422485|NCT03814187|531711258|FG002|Overall Study|Other reasons|2|||
147422486|NCT00296400|531711259|FG000|Overall Study|Adverse Event|7|||
147422487|NCT00296400|531711260|FG001|Overall Study|Adverse Event|7|||
147422488|NCT00296400|531711261|FG002|Overall Study|Adverse Event|7|||
147422489|NCT00296400|531711259|FG000|Overall Study|Withdrawal by Subject|5|||
147422490|NCT00296400|531711260|FG001|Overall Study|Withdrawal by Subject|6|||
147422491|NCT00296400|531711261|FG002|Overall Study|Withdrawal by Subject|2|||
147422492|NCT00296400|531711259|FG000|Overall Study|Incorrect enrollment|2|||
147422493|NCT00296400|531711260|FG001|Overall Study|Incorrect enrollment|0|||
147422494|NCT00296400|531711261|FG002|Overall Study|Incorrect enrollment|0|||
147422495|NCT00296400|531711259|FG000|Overall Study|Protocol Violation|1|||
147422496|NCT00296400|531711260|FG001|Overall Study|Protocol Violation|1|||
147422497|NCT00296400|531711261|FG002|Overall Study|Protocol Violation|1|||
147422498|NCT00296400|531711259|FG000|Overall Study|Lost to Follow-up|1|||
147422499|NCT00296400|531711260|FG001|Overall Study|Lost to Follow-up|1|||
147422500|NCT00296400|531711261|FG002|Overall Study|Lost to Follow-up|2|||
147422501|NCT00296400|531711259|FG000|Overall Study|Study specific discontinuation criteria|0|||
147422502|NCT00296400|531711260|FG001|Overall Study|Study specific discontinuation criteria|0|||
147422503|NCT00296400|531711261|FG002|Overall Study|Study specific discontinuation criteria|1|||
147422504|NCT00296400|531711259|FG000|Overall Study|Visit 10 was performed earlier|0|||
147422505|NCT00296400|531711260|FG001|Overall Study|Visit 10 was performed earlier|1|||
147422506|NCT00296400|531711261|FG002|Overall Study|Visit 10 was performed earlier|0|||
147422507|NCT00296400|531711259|FG000|Overall Study|Pregnancy|1|||
147422508|NCT00296400|531711260|FG001|Overall Study|Pregnancy|2|||
147422509|NCT00296400|531711261|FG002|Overall Study|Pregnancy|0|||
147422510|NCT01014533|531711265|FG000|Overall Study|Protocol Violation|3|||
147422511|NCT01014533|531711266|FG001|Overall Study|Protocol Violation|2|||
147422512|NCT01014533|531711265|FG000|Overall Study|Withdrawal by Subject|2|||
147422513|NCT01014533|531711266|FG001|Overall Study|Withdrawal by Subject|0|||
147422514|NCT01014533|531711265|FG000|Overall Study|unable to come to appointment|0|||
147422515|NCT01014533|531711266|FG001|Overall Study|unable to come to appointment|3|||
147422516|NCT00412061|531711268|FG000|Double Blind Phase|Disease Progression|101|||
147422517|NCT00412061|531711269|FG001|Double Blind Phase|Disease Progression|154|||
147422518|NCT00412061|531711268|FG000|Double Blind Phase|Adverse Event|61|||
147422519|NCT00412061|531711269|FG001|Double Blind Phase|Adverse Event|16|||
147422520|NCT00412061|531711268|FG000|Double Blind Phase|Final Primary Analysis|26|||
147422521|NCT00412061|531711269|FG001|Double Blind Phase|Final Primary Analysis|14|||
147422522|NCT00412061|531711268|FG000|Double Blind Phase|Withdrawal by Subject|18|||
147422523|NCT00412061|531711269|FG001|Double Blind Phase|Withdrawal by Subject|20|||
147422524|NCT00412061|531711268|FG000|Double Blind Phase|Death|6|||
147422525|NCT00412061|531711269|FG001|Double Blind Phase|Death|3|||
147422526|NCT00412061|531711268|FG000|Double Blind Phase|Protocol Violation|3|||
147422527|NCT00412061|531711269|FG001|Double Blind Phase|Protocol Violation|4|||
147422528|NCT00412061|531711268|FG000|Double Blind Phase|New Cander Therapy|1|||
147422529|NCT00412061|531711269|FG001|Double Blind Phase|New Cander Therapy|1|||
147422530|NCT00412061|531711268|FG000|Double Blind Phase|Lost to Follow-up|0|||
147422531|NCT00412061|531711269|FG001|Double Blind Phase|Lost to Follow-up|1|||
147422532|NCT00412061|531711268|FG000|Open Label Phase|Disease Progression|0|||
147422533|NCT00412061|531711269|FG001|Open Label Phase|Disease Progression|86|||
147422534|NCT00412061|531711268|FG000|Open Label Phase|Adverse Event|0|||
147422535|NCT00412061|531711269|FG001|Open Label Phase|Adverse Event|46|||
147422536|NCT00412061|531711268|FG000|Open Label Phase|Withdrawal by Subject|0|||
147422537|NCT00412061|531711269|FG001|Open Label Phase|Withdrawal by Subject|15|||
147422538|NCT00412061|531711268|FG000|Open Label Phase|Administrative Problems|0|||
147422539|NCT00412061|531711269|FG001|Open Label Phase|Administrative Problems|13|||
147422540|NCT00412061|531711268|FG000|Open Label Phase|Death|0|||
147422541|NCT00412061|531711269|FG001|Open Label Phase|Death|7|||
147422542|NCT00412061|531711268|FG000|Open Label Phase|Lost to Follow-up|0|||
147422543|NCT00412061|531711269|FG001|Open Label Phase|Lost to Follow-up|2|||
147422544|NCT00412061|531711268|FG000|Open Label Phase|New Cancer Therapy|0|||
147422545|NCT00412061|531711269|FG001|Open Label Phase|New Cancer Therapy|1|||
147422546|NCT02689518|531711271|FG000|Overall Study|Withdrawal by Subject|3|||
147422547|NCT02433340|531711276|FG000|Overall Study|Adverse Event|0|||
147422548|NCT02433340|531711277|FG001|Overall Study|Adverse Event|0|||
147422549|NCT02433340|531711278|FG002|Overall Study|Adverse Event|1|||
147422550|NCT02433340|531711279|FG003|Overall Study|Adverse Event|0|||
147422551|NCT02433340|531711276|FG000|Overall Study|Withdrawal by Subject|1|||
147422552|NCT02433340|531711277|FG001|Overall Study|Withdrawal by Subject|0|||
147422553|NCT02433340|531711278|FG002|Overall Study|Withdrawal by Subject|1|||
147422554|NCT02433340|531711279|FG003|Overall Study|Withdrawal by Subject|2|||
147422555|NCT02433340|531711276|FG000|Overall Study|Lost to Follow-up|0|||
147422556|NCT02433340|531711277|FG001|Overall Study|Lost to Follow-up|1|||
147422557|NCT02433340|531711278|FG002|Overall Study|Lost to Follow-up|0|||
147422558|NCT02433340|531711279|FG003|Overall Study|Lost to Follow-up|0|||
147422559|NCT02433340|531711276|FG000|Overall Study|Required Alternative/Prohibited Therapy|1|||
147422560|NCT02433340|531711277|FG001|Overall Study|Required Alternative/Prohibited Therapy|0|||
147422561|NCT02433340|531711278|FG002|Overall Study|Required Alternative/Prohibited Therapy|0|||
147422562|NCT02433340|531711279|FG003|Overall Study|Required Alternative/Prohibited Therapy|0|||
147422563|NCT02433340|531711276|FG000|Overall Study|Other|0|||
147422564|NCT02433340|531711277|FG001|Overall Study|Other|1|||
147422565|NCT02433340|531711278|FG002|Overall Study|Other|0|||
147422566|NCT02433340|531711279|FG003|Overall Study|Other|0|||
147422567|NCT01178385|531711280|FG000|Overall Study|Withdrawal by Subject|2|||
147422568|NCT01178385|531711281|FG001|Overall Study|Withdrawal by Subject|0|||
147422569|NCT02679508|531711285|FG000|Healing Phase|Protocol Violation|1|||
147422570|NCT02679508|531711286|FG001|Healing Phase|Protocol Violation|1|||
147422571|NCT02679508|531711285|FG000|Healing Phase|Lost to Follow-up|1|||
147422572|NCT02679508|531711286|FG001|Healing Phase|Lost to Follow-up|0|||
147422573|NCT02679508|531711285|FG000|Maintenance Phase|Adverse Event|12|||
147422574|NCT02679508|531711286|FG001|Maintenance Phase|Adverse Event|2|||
147422575|NCT02679508|531711285|FG000|Maintenance Phase|Lost to Follow-up|0|||
147422576|NCT02679508|531711286|FG001|Maintenance Phase|Lost to Follow-up|1|||
147422577|NCT02679508|531711285|FG000|Maintenance Phase|Withdrawal by Subject|15|||
147422578|NCT02679508|531711286|FG001|Maintenance Phase|Withdrawal by Subject|8|||
147422579|NCT02679508|531711285|FG000|Maintenance Phase|Other|5|||
147422580|NCT02679508|531711286|FG001|Maintenance Phase|Other|4|||
147422581|NCT03143166|531711287|FG000|Period 2 (Washout of at Least 4 Days)|Withdrawal by Subject|1|||
147422582|NCT03683823|531711289|FG000|Post-treatment Assessment|Withdrawal by Subject|1|||
147422583|NCT03683823|531711290|FG001|Post-treatment Assessment|Withdrawal by Subject|1|||
147422584|NCT03683823|531711289|FG000|Post-treatment Assessment|Lost to Follow-up|0|||
147422585|NCT03683823|531711290|FG001|Post-treatment Assessment|Lost to Follow-up|1|||
147422586|NCT03683823|531711289|FG000|1-week Follow-up|Research halted due to COVID-19 pandemic|1|||
147422587|NCT03683823|531711290|FG001|1-week Follow-up|Research halted due to COVID-19 pandemic|1|||
147422588|NCT03965351|531711291|FG000|First Intervention (4 Weeks)|Lost to Follow-up|0|||
147422589|NCT03965351|531711292|FG001|First Intervention (4 Weeks)|Lost to Follow-up|1|||
147422590|NCT03965351|531711291|FG000|Second Intervention (4 Weeks)|Adverse Event|0|||
147422591|NCT03965351|531711292|FG001|Second Intervention (4 Weeks)|Adverse Event|1|||
147422592|NCT00994682|531711294|FG000|Double Bilnd|Withdrawal by Subject|5|||
147422593|NCT00994682|531711295|FG001|Double Bilnd|Withdrawal by Subject|6|||
147422594|NCT00994682|531711294|FG000|Double Bilnd|Lost to Follow-up|3|||
147422595|NCT00994682|531711295|FG001|Double Bilnd|Lost to Follow-up|3|||
147422596|NCT00994682|531711294|FG000|Double Bilnd|Adverse Event|1|||
147422597|NCT00994682|531711295|FG001|Double Bilnd|Adverse Event|0|||
147422598|NCT00994682|531711294|FG000|Pioglitazone Open Label|Withdrawal by Subject|4|||
147422599|NCT00994682|531711295|FG001|Pioglitazone Open Label|Withdrawal by Subject|4|||
147422600|NCT00994682|531711294|FG000|Pioglitazone Open Label|Lost to Follow-up|3|||
147422601|NCT00994682|531711295|FG001|Pioglitazone Open Label|Lost to Follow-up|2|||
147422602|NCT00994682|531711294|FG000|Pioglitazone Open Label|Physician Decision|6|||
147422603|NCT00994682|531711295|FG001|Pioglitazone Open Label|Physician Decision|1|||
147422604|NCT01323972|531711296|FG000|Overall Study|Withdrawal by Subject|1|||
147422605|NCT01323972|531711297|FG001|Overall Study|Withdrawal by Subject|0|||
147422606|NCT01323972|531711298|FG002|Overall Study|Withdrawal by Subject|1|||
147422607|NCT01323972|531711299|FG003|Overall Study|Withdrawal by Subject|0|||
147422608|NCT01323972|531711296|FG000|Overall Study|Migrated/moved from study area|1|||
147422609|NCT01323972|531711297|FG001|Overall Study|Migrated/moved from study area|2|||
147422610|NCT01323972|531711298|FG002|Overall Study|Migrated/moved from study area|0|||
147422611|NCT01323972|531711299|FG003|Overall Study|Migrated/moved from study area|0|||
147422612|NCT01323972|531711296|FG000|Overall Study|Lost to Follow-up|0|||
147422613|NCT01323972|531711297|FG001|Overall Study|Lost to Follow-up|1|||
147422614|NCT01323972|531711298|FG002|Overall Study|Lost to Follow-up|1|||
147422615|NCT01323972|531711299|FG003|Overall Study|Lost to Follow-up|1|||
147422616|NCT00928018|531711300|FG000|Overall Study|Withdrawal by Subject|1|||
147422617|NCT00928018|531711301|FG001|Overall Study|Withdrawal by Subject|0|||
147422618|NCT00943111|531711304|FG000|52-Weeks Primary Analysis Period|Adverse Event|2|||
147422619|NCT00943111|531711305|FG001|52-Weeks Primary Analysis Period|Adverse Event|1|||
147422620|NCT00943111|531711306|FG002|52-Weeks Primary Analysis Period|Adverse Event|0|||
147422621|NCT00943111|531711304|FG000|52-Weeks Primary Analysis Period|Non-Compliance with Study Drug|0|||
147422622|NCT00943111|531711305|FG001|52-Weeks Primary Analysis Period|Non-Compliance with Study Drug|1|||
147422623|NCT00943111|531711306|FG002|52-Weeks Primary Analysis Period|Non-Compliance with Study Drug|0|||
147422624|NCT00943111|531711304|FG000|5 Years Long-term Treatment Period|Transition to commercial eliglustat|0|||
147422625|NCT00943111|531711305|FG001|5 Years Long-term Treatment Period|Transition to commercial eliglustat|0|||
147422626|NCT00943111|531711306|FG002|5 Years Long-term Treatment Period|Transition to commercial eliglustat|51|||
147422627|NCT00943111|531711304|FG000|5 Years Long-term Treatment Period|Adverse Event|0|||
147422628|NCT00943111|531711305|FG001|5 Years Long-term Treatment Period|Adverse Event|0|||
147422629|NCT00943111|531711306|FG002|5 Years Long-term Treatment Period|Adverse Event|9|||
147422630|NCT00943111|531711304|FG000|5 Years Long-term Treatment Period|Withdrawal by Subject|0|||
147422631|NCT00943111|531711305|FG001|5 Years Long-term Treatment Period|Withdrawal by Subject|0|||
147422632|NCT00943111|531711306|FG002|5 Years Long-term Treatment Period|Withdrawal by Subject|8|||
147422633|NCT00943111|531711304|FG000|5 Years Long-term Treatment Period|Pregnancy|0|||
147422634|NCT00943111|531711305|FG001|5 Years Long-term Treatment Period|Pregnancy|0|||
147422635|NCT00943111|531711306|FG002|5 Years Long-term Treatment Period|Pregnancy|4|||
147422636|NCT00943111|531711304|FG000|5 Years Long-term Treatment Period|Lost to Follow-up|0|||
147422637|NCT00943111|531711305|FG001|5 Years Long-term Treatment Period|Lost to Follow-up|0|||
147422638|NCT00943111|531711306|FG002|5 Years Long-term Treatment Period|Lost to Follow-up|1|||
147422639|NCT00943111|531711304|FG000|5 Years Long-term Treatment Period|Other than specified above|0|||
147422640|NCT00943111|531711305|FG001|5 Years Long-term Treatment Period|Other than specified above|0|||
147422641|NCT00943111|531711306|FG002|5 Years Long-term Treatment Period|Other than specified above|2|||
147422642|NCT02859324|531711307|FG000|Overall Study|Death|4|||
147422643|NCT02859324|531711308|FG001|Overall Study|Death|6|||
147422644|NCT02859324|531711309|FG002|Overall Study|Death|5|||
147422645|NCT02859324|531711307|FG000|Overall Study|Other reasons|3|||
147422646|NCT02859324|531711308|FG001|Overall Study|Other reasons|3|||
147422647|NCT02859324|531711309|FG002|Overall Study|Other reasons|0|||
147422648|NCT00589121|531711312|FG000|Overall Study|Protocol Violation|2|||
147422649|NCT00589121|531711313|FG001|Overall Study|Protocol Violation|6|||
147422650|NCT00589121|531711312|FG000|Overall Study|No protocol treatment received|0|||
147422651|NCT00589121|531711313|FG001|Overall Study|No protocol treatment received|1|||
147422652|NCT00998335|531711314|FG000|Randomized Period (Months 3 to 6)|Withdrawal by Subject|0|||
147422653|NCT00998335|531711315|FG001|Randomized Period (Months 3 to 6)|Withdrawal by Subject|2|||
147422654|NCT00847808|531711316|FG000|Overall Study|Adverse Event|7|||
147422655|NCT00847808|531711316|FG000|Overall Study|Protocol Violation|1|||
147422656|NCT00847808|531711316|FG000|Overall Study|Lost to Follow-up|1|||
147422657|NCT00847808|531711316|FG000|Overall Study|Withdrawal by Subject|4|||
147422658|NCT00847808|531711316|FG000|Overall Study|Participant Reported Lack of Efficacy|1|||
147422659|NCT00847808|531711316|FG000|Overall Study|Participant Took Excluded Medication|1|||
147422660|NCT00925132|531711317|FG000|Overall Study|Withdrawal by Subject|2|||
147422661|NCT00925132|531711318|FG001|Overall Study|Withdrawal by Subject|0|||
147422662|NCT00925132|531711319|FG002|Overall Study|Withdrawal by Subject|0|||
147422663|NCT00925132|531711320|FG003|Overall Study|Withdrawal by Subject|0|||
147422664|NCT00925132|531711321|FG004|Overall Study|Withdrawal by Subject|1|||
147422665|NCT00925132|531711317|FG000|Overall Study|Removed due to disease progression|0|||
147422666|NCT00925132|531711318|FG001|Overall Study|Removed due to disease progression|0|||
147422667|NCT00925132|531711319|FG002|Overall Study|Removed due to disease progression|0|||
147422668|NCT00925132|531711320|FG003|Overall Study|Removed due to disease progression|0|||
147422669|NCT00925132|531711321|FG004|Overall Study|Removed due to disease progression|4|||
147422670|NCT02545933|531711322|FG000|Overall Study|Adverse Event|3|||
147422671|NCT02545933|531711323|FG001|Overall Study|Adverse Event|0|||
147422672|NCT02545933|531711324|FG002|Overall Study|Adverse Event|0|||
147422673|NCT02545933|531711322|FG000|Overall Study|Withdrawal by Subject|2|||
147422674|NCT02545933|531711323|FG001|Overall Study|Withdrawal by Subject|3|||
147422675|NCT02545933|531711324|FG002|Overall Study|Withdrawal by Subject|3|||
147422676|NCT02545933|531711322|FG000|Overall Study|Protocol Violation|1|||
147422677|NCT02545933|531711323|FG001|Overall Study|Protocol Violation|0|||
147422678|NCT02545933|531711324|FG002|Overall Study|Protocol Violation|1|||
147422679|NCT03149549|531711325|FG000|Study Discontinuation--Treatment Period|Death|0|||
147422680|NCT03149549|531711326|FG001|Study Discontinuation--Treatment Period|Death|0|||
147422681|NCT03149549|531711327|FG002|Study Discontinuation--Treatment Period|Death|0|||
147422682|NCT03149549|531711328|FG003|Study Discontinuation--Treatment Period|Death|1|||
147422683|NCT03149549|531711329|FG004|Study Discontinuation--Treatment Period|Death|2|||
147422684|NCT03149549|531711330|FG005|Study Discontinuation--Treatment Period|Death|1|||
147422685|NCT03149549|531711331|FG006|Study Discontinuation--Treatment Period|Death|1|||
147422686|NCT03149549|531711332|FG007|Study Discontinuation--Treatment Period|Death|2|||
147422687|NCT03149549|531711333|FG008|Study Discontinuation--Treatment Period|Death|4|||
147422688|NCT03149549|531711334|FG009|Study Discontinuation--Treatment Period|Death|1|||
147422689|NCT03149549|531711335|FG010|Study Discontinuation--Treatment Period|Death|0|||
147422690|NCT03149549|531711336|FG011|Study Discontinuation--Treatment Period|Death|0|||
147422691|NCT03149549|531711337|FG012|Study Discontinuation--Treatment Period|Death|1|||
147422692|NCT03149549|531711325|FG000|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
147422693|NCT03149549|531711326|FG001|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
147422694|NCT03149549|531711327|FG002|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
147422695|NCT03149549|531711328|FG003|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
147422696|NCT03149549|531711329|FG004|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
147422697|NCT03149549|531711330|FG005|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
147422698|NCT03149549|531711331|FG006|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
147422699|NCT03149549|531711332|FG007|Study Discontinuation--Treatment Period|Termination by Sponsor|1|||
147422700|NCT03149549|531711333|FG008|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
147422701|NCT03149549|531711334|FG009|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
147422702|NCT03149549|531711335|FG010|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
147422703|NCT03149549|531711336|FG011|Study Discontinuation--Treatment Period|Termination by Sponsor|0|||
147422704|NCT03149549|531711337|FG012|Study Discontinuation--Treatment Period|Termination by Sponsor|1|||
147422705|NCT03149549|531711325|FG000|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
147422706|NCT03149549|531711326|FG001|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
147422707|NCT03149549|531711327|FG002|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
147422708|NCT03149549|531711328|FG003|Study Discontinuation--Treatment Period|Withdrawal by Subject|1|||
147422709|NCT03149549|531711329|FG004|Study Discontinuation--Treatment Period|Withdrawal by Subject|2|||
147422710|NCT03149549|531711330|FG005|Study Discontinuation--Treatment Period|Withdrawal by Subject|1|||
147422711|NCT03149549|531711331|FG006|Study Discontinuation--Treatment Period|Withdrawal by Subject|2|||
147422712|NCT03149549|531711332|FG007|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
147422713|NCT03149549|531711333|FG008|Study Discontinuation--Treatment Period|Withdrawal by Subject|2|||
147422714|NCT03149549|531711334|FG009|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
147422715|NCT03149549|531711335|FG010|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
147422716|NCT03149549|531711336|FG011|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
147422717|NCT03149549|531711337|FG012|Study Discontinuation--Treatment Period|Withdrawal by Subject|0|||
147422718|NCT03149549|531711325|FG000|Study Discontinuation--Treatment Period|Other|0|||
147422719|NCT03149549|531711326|FG001|Study Discontinuation--Treatment Period|Other|0|||
147422720|NCT03149549|531711327|FG002|Study Discontinuation--Treatment Period|Other|0|||
147422721|NCT03149549|531711328|FG003|Study Discontinuation--Treatment Period|Other|0|||
147422722|NCT03149549|531711329|FG004|Study Discontinuation--Treatment Period|Other|0|||
147422723|NCT03149549|531711330|FG005|Study Discontinuation--Treatment Period|Other|0|||
147422724|NCT03149549|531711331|FG006|Study Discontinuation--Treatment Period|Other|0|||
147422725|NCT03149549|531711332|FG007|Study Discontinuation--Treatment Period|Other|1|||
147422726|NCT03149549|531711333|FG008|Study Discontinuation--Treatment Period|Other|0|||
147422727|NCT03149549|531711334|FG009|Study Discontinuation--Treatment Period|Other|1|||
147422728|NCT03149549|531711335|FG010|Study Discontinuation--Treatment Period|Other|0|||
147422729|NCT03149549|531711336|FG011|Study Discontinuation--Treatment Period|Other|0|||
147422730|NCT03149549|531711337|FG012|Study Discontinuation--Treatment Period|Other|0|||
147422731|NCT03149549|531711325|FG000|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
147422732|NCT03149549|531711326|FG001|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
147422733|NCT03149549|531711327|FG002|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
147422734|NCT03149549|531711328|FG003|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
147422735|NCT03149549|531711329|FG004|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
147422736|NCT03149549|531711330|FG005|Study Discontinuation--Follow-Up Period|Lost to Follow-up|4|||
147422737|NCT03149549|531711331|FG006|Study Discontinuation--Follow-Up Period|Lost to Follow-up|1|||
147422738|NCT03149549|531711332|FG007|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
147595936|NCT03096847|532338753|FG002|Overall Study|Physician Decision|8|||
147422739|NCT03149549|531711333|FG008|Study Discontinuation--Follow-Up Period|Lost to Follow-up|1|||
147422740|NCT03149549|531711334|FG009|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
147422741|NCT03149549|531711335|FG010|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
147422742|NCT03149549|531711336|FG011|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
147422743|NCT03149549|531711337|FG012|Study Discontinuation--Follow-Up Period|Lost to Follow-up|0|||
147422744|NCT03149549|531711325|FG000|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
147422745|NCT03149549|531711326|FG001|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
147422746|NCT03149549|531711327|FG002|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
147422747|NCT03149549|531711328|FG003|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
147422748|NCT03149549|531711329|FG004|Study Discontinuation--Follow-Up Period|Termination by Sponsor|1|||
147422749|NCT03149549|531711330|FG005|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
147422750|NCT03149549|531711331|FG006|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
147422751|NCT03149549|531711332|FG007|Study Discontinuation--Follow-Up Period|Termination by Sponsor|1|||
147422752|NCT03149549|531711333|FG008|Study Discontinuation--Follow-Up Period|Termination by Sponsor|5|||
147422753|NCT03149549|531711334|FG009|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
147422754|NCT03149549|531711335|FG010|Study Discontinuation--Follow-Up Period|Termination by Sponsor|0|||
147422755|NCT03149549|531711336|FG011|Study Discontinuation--Follow-Up Period|Termination by Sponsor|3|||
147422756|NCT03149549|531711337|FG012|Study Discontinuation--Follow-Up Period|Termination by Sponsor|2|||
147422757|NCT03149549|531711325|FG000|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
147422758|NCT03149549|531711326|FG001|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
147422759|NCT03149549|531711327|FG002|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
147422760|NCT03149549|531711328|FG003|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
147422761|NCT03149549|531711329|FG004|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|1|||
147422762|NCT03149549|531711330|FG005|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
147422763|NCT03149549|531711331|FG006|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
147422764|NCT03149549|531711332|FG007|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|4|||
147422765|NCT03149549|531711333|FG008|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|1|||
147422766|NCT03149549|531711334|FG009|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|1|||
147422767|NCT03149549|531711335|FG010|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|3|||
147422768|NCT03149549|531711336|FG011|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|0|||
147191120|NCT02250326|530867554|FG000|Treatment|Progressive Disease|42|||
147422769|NCT03149549|531711337|FG012|Study Discontinuation--Follow-Up Period|Withdrawal by Subject|1|||
147422770|NCT03149549|531711325|FG000|Study Discontinuation--Follow-Up Period|Other|0|||
147422771|NCT03149549|531711326|FG001|Study Discontinuation--Follow-Up Period|Other|0|||
147422772|NCT03149549|531711327|FG002|Study Discontinuation--Follow-Up Period|Other|0|||
147422773|NCT03149549|531711328|FG003|Study Discontinuation--Follow-Up Period|Other|0|||
147422774|NCT03149549|531711329|FG004|Study Discontinuation--Follow-Up Period|Other|0|||
147422775|NCT03149549|531711330|FG005|Study Discontinuation--Follow-Up Period|Other|0|||
147422776|NCT03149549|531711331|FG006|Study Discontinuation--Follow-Up Period|Other|0|||
147422777|NCT03149549|531711332|FG007|Study Discontinuation--Follow-Up Period|Other|0|||
147422778|NCT03149549|531711333|FG008|Study Discontinuation--Follow-Up Period|Other|0|||
147422779|NCT03149549|531711334|FG009|Study Discontinuation--Follow-Up Period|Other|1|||
147422780|NCT03149549|531711335|FG010|Study Discontinuation--Follow-Up Period|Other|0|||
147422781|NCT03149549|531711336|FG011|Study Discontinuation--Follow-Up Period|Other|0|||
147422782|NCT03149549|531711337|FG012|Study Discontinuation--Follow-Up Period|Other|0|||
147422783|NCT03149549|531711325|FG000|Study Discontinuation--Follow-Up Period|Death|1|||
147422784|NCT03149549|531711326|FG001|Study Discontinuation--Follow-Up Period|Death|3|||
147422785|NCT03149549|531711327|FG002|Study Discontinuation--Follow-Up Period|Death|3|||
147422786|NCT03149549|531711328|FG003|Study Discontinuation--Follow-Up Period|Death|1|||
147422787|NCT03149549|531711329|FG004|Study Discontinuation--Follow-Up Period|Death|4|||
147422788|NCT03149549|531711330|FG005|Study Discontinuation--Follow-Up Period|Death|3|||
147422789|NCT03149549|531711331|FG006|Study Discontinuation--Follow-Up Period|Death|5|||
147422790|NCT03149549|531711332|FG007|Study Discontinuation--Follow-Up Period|Death|3|||
147422791|NCT03149549|531711333|FG008|Study Discontinuation--Follow-Up Period|Death|9|||
147422792|NCT03149549|531711334|FG009|Study Discontinuation--Follow-Up Period|Death|5|||
147422793|NCT03149549|531711335|FG010|Study Discontinuation--Follow-Up Period|Death|5|||
147422794|NCT03149549|531711336|FG011|Study Discontinuation--Follow-Up Period|Death|1|||
147422795|NCT03149549|531711337|FG012|Study Discontinuation--Follow-Up Period|Death|1|||
147422796|NCT01892540|531711340|FG000|Overall Study|Did not complete PET/MRI|0|||
147422797|NCT01892540|531711341|FG001|Overall Study|Did not complete PET/MRI|0|||
147422798|NCT01892540|531711342|FG002|Overall Study|Did not complete PET/MRI|2|||
147422799|NCT01892540|531711340|FG000|Overall Study|Did not fit in scanner|0|||
147422800|NCT01892540|531711341|FG001|Overall Study|Did not fit in scanner|0|||
147422801|NCT01892540|531711342|FG002|Overall Study|Did not fit in scanner|1|||
147422802|NCT01370590|531711343|FG000|Period 1|Adverse Event|8|||
147422803|NCT01370590|531711344|FG001|Period 1|Adverse Event|4|||
147422804|NCT01370590|531711343|FG000|Period 1|Lost to Follow-up|2|||
147422805|NCT01370590|531711344|FG001|Period 1|Lost to Follow-up|2|||
147422806|NCT01370590|531711343|FG000|Period 1|Protocol Violation|2|||
147422807|NCT01370590|531711344|FG001|Period 1|Protocol Violation|2|||
147422808|NCT01370590|531711343|FG000|Period 1|Withdrawal by Subject|4|||
147422809|NCT01370590|531711344|FG001|Period 1|Withdrawal by Subject|2|||
147422810|NCT01370590|531711343|FG000|Period 1|Could not access randomization system|0|||
147422811|NCT01370590|531711344|FG001|Period 1|Could not access randomization system|1|||
147422812|NCT01370590|531711343|FG000|Crossover Washout Period|Adverse Event|1|||
147422813|NCT01370590|531711344|FG001|Crossover Washout Period|Adverse Event|4|||
147422814|NCT01370590|531711343|FG000|Crossover Washout Period|Lost to Follow-up|2|||
147422815|NCT01370590|531711344|FG001|Crossover Washout Period|Lost to Follow-up|0|||
147422816|NCT01370590|531711343|FG000|Crossover Washout Period|Non-compliance with Study Drug|1|||
147422817|NCT01370590|531711344|FG001|Crossover Washout Period|Non-compliance with Study Drug|0|||
147422818|NCT01370590|531711343|FG000|Crossover Washout Period|Withdrawal by Subject|2|||
147422819|NCT01370590|531711344|FG001|Crossover Washout Period|Withdrawal by Subject|2|||
147422820|NCT01370590|531711343|FG000|Period 2|Adverse Event|0|||
147422821|NCT01370590|531711344|FG001|Period 2|Adverse Event|1|||
147422822|NCT01370590|531711343|FG000|Period 2|Withdrawal by Subject|1|||
147422823|NCT01370590|531711344|FG001|Period 2|Withdrawal by Subject|1|||
147422824|NCT05172050|531711345|FG000|Overall Study|Negative Nasopharyngeal swab|5|||
147422825|NCT05172050|531711346|FG001|Overall Study|Negative Nasopharyngeal swab|5|||
147422826|NCT05172050|531711347|FG002|Overall Study|Negative Nasopharyngeal swab|3|||
147422827|NCT05172050|531711345|FG000|Overall Study|Development of AE or unacceptable toxicity|5|||
147422828|NCT05172050|531711346|FG001|Overall Study|Development of AE or unacceptable toxicity|4|||
147422829|NCT05172050|531711347|FG002|Overall Study|Development of AE or unacceptable toxicity|7|||
147422830|NCT05172050|531711345|FG000|Overall Study|Other|2|||
147422831|NCT05172050|531711346|FG001|Overall Study|Other|2|||
147422832|NCT05172050|531711347|FG002|Overall Study|Other|1|||
147422833|NCT03141905|531711350|FG000|Overall Study|Death|3|||
147422834|NCT03141905|531711351|FG001|Overall Study|Death|2|||
147422835|NCT03141905|531711350|FG000|Overall Study|Withdrawal by Subject|1|||
147191121|NCT02250326|530867555|FG001|Treatment|Progressive Disease|40|||
147422836|NCT03141905|531711351|FG001|Overall Study|Withdrawal by Subject|0|||
147422837|NCT03141905|531711350|FG000|Overall Study|Lost to Follow-up|3|||
147422838|NCT03141905|531711351|FG001|Overall Study|Lost to Follow-up|7|||
147422839|NCT03141905|531711350|FG000|Overall Study|Randomized, but did not receive intervention. Withdrew prior to baseline visit.|17|||
147422840|NCT03141905|531711351|FG001|Overall Study|Randomized, but did not receive intervention. Withdrew prior to baseline visit.|10|||
147422841|NCT05180500|531711352|FG000|Overall Study|Adverse Event|1|||
147422842|NCT05180500|531711353|FG001|Overall Study|Adverse Event|0|||
147422843|NCT05180500|531711352|FG000|Overall Study|Withdrawal by Subject|2|||
147422844|NCT05180500|531711353|FG001|Overall Study|Withdrawal by Subject|0|||
147422845|NCT00727311|531711360|FG000|Overall Study|Did not receive drug|316|||
147422846|NCT00727311|531711360|FG000|Overall Study|Missing end of therapy data|205|||
147422847|NCT00727311|531711360|FG000|Overall Study|Adverse Event|58|||
147422848|NCT00727311|531711360|FG000|Overall Study|Lack of Efficacy|242|||
147422849|NCT00727311|531711360|FG000|Overall Study|Lost to Follow-up|73|||
147422850|NCT00727311|531711360|FG000|Overall Study|Withdrawal by Subject|77|||
147422851|NCT00727311|531711360|FG000|Overall Study|Other|97|||
147422852|NCT00727311|531711360|FG000|Overall Study|Multiple reasons|39|||
147422853|NCT03992846|531711361|FG000|Overall Study|Adverse Event|8|||
147422854|NCT03992846|531711362|FG001|Overall Study|Adverse Event|6|||
147422855|NCT03992846|531711363|FG002|Overall Study|Adverse Event|3|||
147422856|NCT03992846|531711361|FG000|Overall Study|Lost to Follow-up|0|||
147422857|NCT03992846|531711362|FG001|Overall Study|Lost to Follow-up|1|||
147422858|NCT03992846|531711363|FG002|Overall Study|Lost to Follow-up|1|||
147422859|NCT03992846|531711361|FG000|Overall Study|Pregnancy|2|||
147422860|NCT03992846|531711362|FG001|Overall Study|Pregnancy|0|||
147422861|NCT03992846|531711363|FG002|Overall Study|Pregnancy|1|||
147422862|NCT03992846|531711361|FG000|Overall Study|Protocol Violation|1|||
147422863|NCT03992846|531711362|FG001|Overall Study|Protocol Violation|2|||
147422864|NCT03992846|531711363|FG002|Overall Study|Protocol Violation|0|||
147422865|NCT03992846|531711361|FG000|Overall Study|Withdrawal by Subject|8|||
147422866|NCT03992846|531711362|FG001|Overall Study|Withdrawal by Subject|10|||
147422867|NCT03992846|531711363|FG002|Overall Study|Withdrawal by Subject|20|||
147422868|NCT03992846|531711361|FG000|Overall Study|Sponsor decided to exclude the patient|1|||
147422869|NCT03992846|531711362|FG001|Overall Study|Sponsor decided to exclude the patient|0|||
147422870|NCT03992846|531711363|FG002|Overall Study|Sponsor decided to exclude the patient|0|||
147422871|NCT00876928|531712709|FG000|Overall Study|Lost to Follow-up|2|||
147422872|NCT00876928|531712710|FG001|Overall Study|Lost to Follow-up|5|||
147422873|NCT00876928|531712709|FG000|Overall Study|Hypokalemia-affects insulin secretion|1|||
147422874|NCT00876928|531712710|FG001|Overall Study|Hypokalemia-affects insulin secretion|0|||
147422875|NCT01111474|531712711|FG000|Overall Study|Lost to Follow-up|12|||
147422876|NCT04101318|531712714|FG000|First Intervention (42 +/- 3 Days)|Lost to Follow-up|0|||
147422877|NCT04101318|531712715|FG001|First Intervention (42 +/- 3 Days)|Lost to Follow-up|1|||
147422878|NCT04101318|531712714|FG000|First Intervention (42 +/- 3 Days)|Adverse Event|0|||
147422879|NCT04101318|531712715|FG001|First Intervention (42 +/- 3 Days)|Adverse Event|1|||
147422880|NCT04101318|531712714|FG000|Second Intervention (42 +/- 3 Days)|Device deficiency not leading to an adverse event|1|||
147422881|NCT04101318|531712715|FG001|Second Intervention (42 +/- 3 Days)|Device deficiency not leading to an adverse event|1|||
147422882|NCT00558259|531712716|FG000|Overall Study|Adverse Event|50|||
147422883|NCT00558259|531712717|FG001|Overall Study|Adverse Event|81|||
147422884|NCT00558259|531712716|FG000|Overall Study|Protocol Violation|9|||
147422885|NCT00558259|531712717|FG001|Overall Study|Protocol Violation|5|||
147422886|NCT00558259|531712716|FG000|Overall Study|Withdrawal by Subject|12|||
147422887|NCT00558259|531712717|FG001|Overall Study|Withdrawal by Subject|13|||
147422888|NCT02874924|531712718|FG000|Overall Study|Adverse Event|2|||
147422889|NCT02874924|531712719|FG001|Overall Study|Adverse Event|0|||
147422890|NCT02874924|531712720|FG002|Overall Study|Adverse Event|0|||
147422891|NCT02874924|531712718|FG000|Overall Study|Withdrawal by Subject|1|||
147422892|NCT02874924|531712719|FG001|Overall Study|Withdrawal by Subject|0|||
147422893|NCT02874924|531712720|FG002|Overall Study|Withdrawal by Subject|0|||
147422894|NCT01415531|531712723|FG000|Overall Study|Adverse Event|7|||
147422895|NCT01415531|531712724|FG001|Overall Study|Adverse Event|10|||
147422896|NCT01415531|531712723|FG000|Overall Study|Lack of Efficacy|3|||
147422897|NCT01415531|531712724|FG001|Overall Study|Lack of Efficacy|2|||
147422898|NCT01415531|531712723|FG000|Overall Study|Protocol Violation|0|||
147422899|NCT01415531|531712724|FG001|Overall Study|Protocol Violation|1|||
147422900|NCT01415531|531712723|FG000|Overall Study|Withdrawal by Subject|5|||
147422901|NCT01415531|531712724|FG001|Overall Study|Withdrawal by Subject|4|||
147422902|NCT01415531|531712723|FG000|Overall Study|Lost to Follow-up|6|||
147422903|NCT01415531|531712724|FG001|Overall Study|Lost to Follow-up|14|||
147422904|NCT01415531|531712723|FG000|Overall Study|Lack of Compliance|1|||
147422905|NCT01415531|531712724|FG001|Overall Study|Lack of Compliance|4|||
147422906|NCT01415531|531712723|FG000|Overall Study|Other Reasons|3|||
147422907|NCT01415531|531712724|FG001|Overall Study|Other Reasons|2|||
147422908|NCT05753670|531712725|FG000|Overall Study|Withdrawal by Subject|6|||
147422909|NCT05753670|531712726|FG001|Overall Study|Withdrawal by Subject|8|||
147422910|NCT05753670|531712725|FG000|Overall Study|Protocol Violation|3|||
147422911|NCT05753670|531712726|FG001|Overall Study|Protocol Violation|1|||
147422912|NCT02483585|531712727|FG000|Double-blind Treatment Phase|Decision by Sponsor|1|||
147422913|NCT02483585|531712728|FG001|Double-blind Treatment Phase|Decision by Sponsor|1|||
147422914|NCT02483585|531712727|FG000|Double-blind Treatment Phase|Withdrawal by Subject|12|||
147422915|NCT02483585|531712728|FG001|Double-blind Treatment Phase|Withdrawal by Subject|12|||
147422916|NCT02483585|531712727|FG000|Double-blind Treatment Phase|Lost to Follow-up|3|||
147422917|NCT02483585|531712728|FG001|Double-blind Treatment Phase|Lost to Follow-up|2|||
147422918|NCT02483585|531712727|FG000|Open-label Treatment Phase|Protocol-specified Criteria|6|||
147422919|NCT02483585|531712728|FG001|Open-label Treatment Phase|Protocol-specified Criteria|5|||
147422920|NCT02483585|531712727|FG000|Open-label Treatment Phase|Decision by Sponsor|0|||
147422921|NCT02483585|531712728|FG001|Open-label Treatment Phase|Decision by Sponsor|1|||
147422922|NCT02483585|531712727|FG000|Open-label Treatment Phase|Withdrawal by Subject|18|||
147422923|NCT02483585|531712728|FG001|Open-label Treatment Phase|Withdrawal by Subject|14|||
147422924|NCT02483585|531712727|FG000|Open-label Treatment Phase|Lost to Follow-up|3|||
147422925|NCT02483585|531712728|FG001|Open-label Treatment Phase|Lost to Follow-up|5|||
147422926|NCT00116753|531712738|FG000|Overall Study|Adverse Event|16|||
147422927|NCT00116753|531712739|FG001|Overall Study|Adverse Event|10|||
147422928|NCT00116753|531712740|FG002|Overall Study|Adverse Event|7|||
147422929|NCT00116753|531712738|FG000|Overall Study|Withdrawal by Subject|11|||
147422930|NCT00116753|531712739|FG001|Overall Study|Withdrawal by Subject|12|||
147422931|NCT00116753|531712740|FG002|Overall Study|Withdrawal by Subject|8|||
147422932|NCT00116753|531712738|FG000|Overall Study|Lost to Follow-up|0|||
147422933|NCT00116753|531712739|FG001|Overall Study|Lost to Follow-up|2|||
147422934|NCT00116753|531712740|FG002|Overall Study|Lost to Follow-up|1|||
147422935|NCT00116753|531712738|FG000|Overall Study|Protocol Violation|0|||
147422936|NCT00116753|531712739|FG001|Overall Study|Protocol Violation|0|||
147422937|NCT00116753|531712740|FG002|Overall Study|Protocol Violation|1|||
147422938|NCT00116753|531712738|FG000|Overall Study|Did not Fulfil Eligibility Criteria|1|||
147422939|NCT00116753|531712739|FG001|Overall Study|Did not Fulfil Eligibility Criteria|1|||
147422940|NCT00116753|531712740|FG002|Overall Study|Did not Fulfil Eligibility Criteria|3|||
147422941|NCT00116753|531712738|FG000|Overall Study|Disease Progression|3|||
147422942|NCT00116753|531712739|FG001|Overall Study|Disease Progression|4|||
147422943|NCT00116753|531712740|FG002|Overall Study|Disease Progression|3|||
147422944|NCT00116753|531712738|FG000|Overall Study|Abnormal Echocardiogram|0|||
147422945|NCT00116753|531712739|FG001|Overall Study|Abnormal Echocardiogram|0|||
147422946|NCT00116753|531712740|FG002|Overall Study|Abnormal Echocardiogram|1|||
147422947|NCT00116753|531712738|FG000|Overall Study|Progressive Parkinson's Disease|1|||
147422948|NCT00116753|531712739|FG001|Overall Study|Progressive Parkinson's Disease|0|||
147422949|NCT00116753|531712740|FG002|Overall Study|Progressive Parkinson's Disease|0|||
147422950|NCT00116753|531712738|FG000|Overall Study|Dosing Error|0|||
147422951|NCT00116753|531712739|FG001|Overall Study|Dosing Error|1|||
147422952|NCT00116753|531712740|FG002|Overall Study|Dosing Error|0|||
147422953|NCT01200589|531712741|FG000|Overall Study|Withdrawal by Subject|13|||
147422954|NCT01200589|531712742|FG001|Overall Study|Withdrawal by Subject|11|||
147422955|NCT01200589|531712741|FG000|Overall Study|Physician Decision|2|||
147422956|NCT01200589|531712742|FG001|Overall Study|Physician Decision|2|||
147422957|NCT01200589|531712741|FG000|Overall Study|Lost to Follow-up|5|||
147422958|NCT01200589|531712742|FG001|Overall Study|Lost to Follow-up|4|||
147422959|NCT01200589|531712741|FG000|Overall Study|Study terminated|170|||
147422960|NCT01200589|531712742|FG001|Overall Study|Study terminated|172|||
147422961|NCT01590082|531712743|FG000|Overall Study|Withdrawal by Subject|1|||
147422962|NCT01590082|531712744|FG001|Overall Study|Withdrawal by Subject|0|||
147422963|NCT01590082|531712743|FG000|Overall Study|Ineligible|1|||
147422964|NCT01590082|531712744|FG001|Overall Study|Ineligible|0|||
147422965|NCT01853644|531712745|FG000|Registration and Treatment Start|Did not start treatment|1|||
147422966|NCT01853644|531712745|FG000|Reached First Response/Complete 2 Cycles|Adverse Event|2|||
147422967|NCT01853644|531712745|FG000|Reached First Response/Complete 2 Cycles|Withdrawal by Subject|1|||
147422968|NCT01853644|531712745|FG000|Reached First Response/Complete 2 Cycles|Other|1|||
147422969|NCT01853644|531712745|FG000|Reached First Response/Complete 2 Cycles|Progressive Disease|2|||
147422970|NCT01853644|531712745|FG000|Continued Treatment After First Response|Adverse Event|2|||
147422971|NCT01853644|531712745|FG000|Continued Treatment After First Response|Progressive Diseaes|10|||
147422972|NCT02891408|531712746|FG000|Overall Study|Lost to Follow-up|0|||
147422973|NCT02891408|531712747|FG001|Overall Study|Lost to Follow-up|0|||
147422974|NCT02891408|531712748|FG002|Overall Study|Lost to Follow-up|1|||
147422975|NCT02891408|531712749|FG003|Overall Study|Lost to Follow-up|0|||
147422976|NCT02891408|531712750|FG004|Overall Study|Lost to Follow-up|0|||
147422977|NCT02891408|531712751|FG005|Overall Study|Lost to Follow-up|0|||
147422978|NCT02891408|531712752|FG006|Overall Study|Lost to Follow-up|0|||
147422979|NCT00185965|531712753|FG000|Overall Study|Adverse Event|0|||
147422980|NCT00185965|531712754|FG001|Overall Study|Adverse Event|1|||
147422981|NCT02009761|531712756|FG000|Overall Study|Adverse Event|4|||
147422982|NCT00825825|531712757|FG000|First Medication Period (14 Days)|Adverse Event|1|||
147422983|NCT00825825|531712758|FG001|First Medication Period (14 Days)|Adverse Event|0|||
147422984|NCT00825825|531712759|FG002|First Medication Period (14 Days)|Adverse Event|0|||
147422985|NCT00825825|531712760|FG003|First Medication Period (14 Days)|Adverse Event|0|||
147422986|NCT00825825|531712761|FG004|First Medication Period (14 Days)|Adverse Event|0|||
147422987|NCT00825825|531712762|FG005|First Medication Period (14 Days)|Adverse Event|1|||
147422988|NCT00825825|531712757|FG000|First Medication Period (14 Days)|Physician Decision|2|||
147422989|NCT00825825|531712758|FG001|First Medication Period (14 Days)|Physician Decision|0|||
147422990|NCT00825825|531712759|FG002|First Medication Period (14 Days)|Physician Decision|1|||
147422991|NCT00825825|531712760|FG003|First Medication Period (14 Days)|Physician Decision|0|||
147422992|NCT00825825|531712761|FG004|First Medication Period (14 Days)|Physician Decision|0|||
147422993|NCT00825825|531712762|FG005|First Medication Period (14 Days)|Physician Decision|1|||
147422994|NCT00825825|531712757|FG000|Second Medication Period (14 Days)|Physician Decision|1|||
147422995|NCT00825825|531712758|FG001|Second Medication Period (14 Days)|Physician Decision|0|||
147422996|NCT00825825|531712759|FG002|Second Medication Period (14 Days)|Physician Decision|0|||
147422997|NCT00825825|531712760|FG003|Second Medication Period (14 Days)|Physician Decision|2|||
147422998|NCT00825825|531712761|FG004|Second Medication Period (14 Days)|Physician Decision|0|||
147422999|NCT00825825|531712762|FG005|Second Medication Period (14 Days)|Physician Decision|0|||
147423000|NCT00825825|531712757|FG000|Second Medication Period (14 Days)|Protocol Violation|1|||
147423001|NCT00825825|531712758|FG001|Second Medication Period (14 Days)|Protocol Violation|0|||
147423002|NCT00825825|531712759|FG002|Second Medication Period (14 Days)|Protocol Violation|0|||
147423003|NCT00825825|531712760|FG003|Second Medication Period (14 Days)|Protocol Violation|0|||
147423004|NCT00825825|531712761|FG004|Second Medication Period (14 Days)|Protocol Violation|1|||
147423005|NCT00825825|531712762|FG005|Second Medication Period (14 Days)|Protocol Violation|0|||
147423006|NCT00825825|531712757|FG000|Third Medication Period (14 Days)|Adverse Event|0|||
147423007|NCT00825825|531712758|FG001|Third Medication Period (14 Days)|Adverse Event|1|||
147423008|NCT00825825|531712759|FG002|Third Medication Period (14 Days)|Adverse Event|0|||
147423009|NCT00825825|531712760|FG003|Third Medication Period (14 Days)|Adverse Event|0|||
147423010|NCT00825825|531712761|FG004|Third Medication Period (14 Days)|Adverse Event|0|||
147423011|NCT00825825|531712762|FG005|Third Medication Period (14 Days)|Adverse Event|0|||
147423012|NCT00825825|531712757|FG000|Third Medication Period (14 Days)|Protocol Violation|0|||
147423013|NCT00825825|531712758|FG001|Third Medication Period (14 Days)|Protocol Violation|0|||
147423014|NCT00825825|531712759|FG002|Third Medication Period (14 Days)|Protocol Violation|0|||
147423015|NCT00825825|531712760|FG003|Third Medication Period (14 Days)|Protocol Violation|0|||
147423016|NCT00825825|531712761|FG004|Third Medication Period (14 Days)|Protocol Violation|0|||
147423017|NCT00825825|531712762|FG005|Third Medication Period (14 Days)|Protocol Violation|2|||
147423018|NCT00825825|531712757|FG000|Third Medication Period (14 Days)|poor data quality|0|||
147423019|NCT00825825|531712758|FG001|Third Medication Period (14 Days)|poor data quality|1|||
147423020|NCT00825825|531712759|FG002|Third Medication Period (14 Days)|poor data quality|0|||
147423021|NCT00825825|531712760|FG003|Third Medication Period (14 Days)|poor data quality|0|||
147423022|NCT00825825|531712761|FG004|Third Medication Period (14 Days)|poor data quality|0|||
147423023|NCT00825825|531712762|FG005|Third Medication Period (14 Days)|poor data quality|0|||
147423024|NCT00950950|531712763|FG000|Overall Study|Adverse Event|1|||
147423025|NCT00950950|531712764|FG001|Overall Study|Adverse Event|0|||
147423026|NCT00950950|531712763|FG000|Overall Study|Withdrawal by Subject|0|||
147423027|NCT00950950|531712764|FG001|Overall Study|Withdrawal by Subject|1|||
147423028|NCT01047293|531712765|FG000|Overall Study|DLT criteria not fulfilled|1|||
147423029|NCT01047293|531712766|FG001|Overall Study|DLT criteria not fulfilled|1|||
147423030|NCT01047293|531712767|FG002|Overall Study|DLT criteria not fulfilled|0|||
147423031|NCT01047293|531712768|FG003|Overall Study|DLT criteria not fulfilled|0|||
147423032|NCT01920854|531712774|FG000|Overall Study|Withdrawal by Subject|1|||
147423033|NCT01920854|531712775|FG001|Overall Study|Withdrawal by Subject|0|||
147423034|NCT01920854|531712776|FG002|Overall Study|Withdrawal by Subject|0|||
147423035|NCT01920854|531712777|FG003|Overall Study|Withdrawal by Subject|0|||
147423036|NCT01920854|531712778|FG004|Overall Study|Withdrawal by Subject|1|||
147423037|NCT01920854|531712779|FG005|Overall Study|Withdrawal by Subject|0|||
147423038|NCT01920854|531712780|FG006|Overall Study|Withdrawal by Subject|1|||
147423039|NCT00757783|531712781|FG000|Overall Study|Adverse Event|0|||
147423040|NCT00757783|531712782|FG001|Overall Study|Adverse Event|2|||
147423041|NCT00757783|531712781|FG000|Overall Study|Lost to Follow-up|1|||
147423042|NCT00757783|531712782|FG001|Overall Study|Lost to Follow-up|1|||
147423043|NCT00757783|531712781|FG000|Overall Study|Protocol Violation|1|||
147423044|NCT00757783|531712782|FG001|Overall Study|Protocol Violation|0|||
147423045|NCT00757783|531712781|FG000|Overall Study|Withdrawal by Subject|2|||
147423046|NCT00757783|531712782|FG001|Overall Study|Withdrawal by Subject|1|||
147423047|NCT00757783|531712781|FG000|Overall Study|Other|1|||
147423048|NCT00757783|531712782|FG001|Overall Study|Other|2|||
147423049|NCT02372136|531712787|FG000|Overall Study|Death|3|||
147423050|NCT02372136|531712788|FG001|Overall Study|Death|1|||
147423051|NCT00985946|531712789|FG000|Overall Study|Lost to Follow-up|6|||
147423052|NCT00985946|531712789|FG000|Overall Study|Withdrawal by Subject|1|||
147423053|NCT03265938|531712793|FG000|Overall Study|Withdrawal by Subject|1|||
147423054|NCT03265938|531712793|FG000|Overall Study|Physician Decision|1|||
147423055|NCT03265938|531712793|FG000|Overall Study|friable mass|6|||
147423056|NCT02673515|531712794|FG000|Overall Study|Lack of motivation|2|||
147423057|NCT02673515|531712795|FG001|Overall Study|Lack of motivation|1|||
147423058|NCT02008877|531712796|FG000|Overall Study|Inevaluable|0|||
147191122|NCT02250326|530867556|FG002|Treatment|Progressive Disease|47|||
147191123|NCT02250326|530867554|FG000|Treatment|Symptomatic Deterioration|9|||
147191124|NCT02250326|530867555|FG001|Treatment|Symptomatic Deterioration|4|||
147191125|NCT02250326|530867556|FG002|Treatment|Symptomatic Deterioration|10|||
147191126|NCT02250326|530867554|FG000|Treatment|Withdrawal by Subject|11|||
147191127|NCT02250326|530867555|FG001|Treatment|Withdrawal by Subject|6|||
147191128|NCT02250326|530867556|FG002|Treatment|Withdrawal by Subject|4|||
147191129|NCT02250326|530867554|FG000|Treatment|Other reasons|8|||
147191130|NCT02250326|530867555|FG001|Treatment|Other reasons|7|||
147191131|NCT02250326|530867556|FG002|Treatment|Other reasons|7|||
147191132|NCT02250326|530867554|FG000|Extension Period|Progressive Disease|0|||
147191133|NCT02250326|530867555|FG001|Extension Period|Progressive Disease|2|||
147191134|NCT02250326|530867556|FG002|Extension Period|Progressive Disease|0|||
147191135|NCT02250326|530867554|FG000|Extension Period|Withdrawal by Subject|0|||
147191136|NCT02250326|530867555|FG001|Extension Period|Withdrawal by Subject|1|||
147191137|NCT02250326|530867556|FG002|Extension Period|Withdrawal by Subject|0|||
147191138|NCT02250326|530867554|FG000|Extension Period|Withdrawal by investigator|0|||
147191139|NCT02250326|530867555|FG001|Extension Period|Withdrawal by investigator|1|||
147191140|NCT02250326|530867556|FG002|Extension Period|Withdrawal by investigator|0|||
147191141|NCT02587520|530867557|FG000|Overall Study|Protocol Violation|2|||
147191142|NCT02587520|530867558|FG001|Overall Study|Protocol Violation|0|||
147191143|NCT02587520|530867559|FG002|Overall Study|Protocol Violation|0|||
147191144|NCT02587520|530867560|FG003|Overall Study|Protocol Violation|2|||
147191145|NCT02587520|530867561|FG004|Overall Study|Protocol Violation|0|||
147191146|NCT02587520|530867562|FG005|Overall Study|Protocol Violation|1|||
147191147|NCT02587520|530867563|FG006|Overall Study|Protocol Violation|1|||
147191148|NCT02587520|530867564|FG007|Overall Study|Protocol Violation|1|||
147191149|NCT02587520|530867565|FG008|Overall Study|Protocol Violation|3|||
147191150|NCT02587520|530867566|FG009|Overall Study|Protocol Violation|3|||
147191151|NCT02587520|530867567|FG010|Overall Study|Protocol Violation|1|||
147191152|NCT02587520|530867568|FG011|Overall Study|Protocol Violation|2|||
147191153|NCT02587520|530867569|FG012|Overall Study|Protocol Violation|0|||
147191154|NCT02587520|530867570|FG013|Overall Study|Protocol Violation|0|||
147191155|NCT02587520|530867571|FG014|Overall Study|Protocol Violation|0|||
147191156|NCT02587520|530867572|FG015|Overall Study|Protocol Violation|0|||
147191157|NCT02587520|530867573|FG016|Overall Study|Protocol Violation|0|||
147191158|NCT02587520|530867574|FG017|Overall Study|Protocol Violation|0|||
147191159|NCT02587520|530867557|FG000|Overall Study|Adverse Event|0|||
147191160|NCT02587520|530867558|FG001|Overall Study|Adverse Event|0|||
147191161|NCT02587520|530867559|FG002|Overall Study|Adverse Event|0|||
147191162|NCT02587520|530867560|FG003|Overall Study|Adverse Event|0|||
147191163|NCT02587520|530867561|FG004|Overall Study|Adverse Event|0|||
147191164|NCT02587520|530867562|FG005|Overall Study|Adverse Event|0|||
147191165|NCT02587520|530867563|FG006|Overall Study|Adverse Event|0|||
147191166|NCT02587520|530867564|FG007|Overall Study|Adverse Event|0|||
147191167|NCT02587520|530867565|FG008|Overall Study|Adverse Event|0|||
147191168|NCT02587520|530867566|FG009|Overall Study|Adverse Event|0|||
147191169|NCT02587520|530867567|FG010|Overall Study|Adverse Event|0|||
147191170|NCT02587520|530867568|FG011|Overall Study|Adverse Event|1|||
147423059|NCT02008877|531712797|FG001|Overall Study|Inevaluable|1|||
147423060|NCT02008877|531712798|FG002|Overall Study|Inevaluable|0|||
147423061|NCT01049217|531712799|FG000|Overall Study|Adverse Event|2|||
147423062|NCT01049217|531712800|FG001|Overall Study|Adverse Event|1|||
147423063|NCT01049217|531712799|FG000|Overall Study|Lack of Efficacy|1|||
147423064|NCT01049217|531712800|FG001|Overall Study|Lack of Efficacy|1|||
147423065|NCT01049217|531712799|FG000|Overall Study|Lost to Follow-up|3|||
147423066|NCT01049217|531712800|FG001|Overall Study|Lost to Follow-up|8|||
147423067|NCT01049217|531712799|FG000|Overall Study|Withdrawal by Subject|4|||
147423068|NCT01049217|531712800|FG001|Overall Study|Withdrawal by Subject|3|||
147423069|NCT01049217|531712799|FG000|Overall Study|Protocol Violation|1|||
147423070|NCT01049217|531712800|FG001|Overall Study|Protocol Violation|3|||
147423071|NCT01049217|531712799|FG000|Overall Study|Pregnancy|1|||
147423072|NCT01049217|531712800|FG001|Overall Study|Pregnancy|0|||
147423073|NCT01049217|531712799|FG000|Overall Study|Study Terminated by Sponsor|43|||
147423074|NCT01049217|531712800|FG001|Overall Study|Study Terminated by Sponsor|43|||
147423075|NCT01049217|531712799|FG000|Overall Study|Other|1|||
147423076|NCT01049217|531712800|FG001|Overall Study|Other|2|||
147423077|NCT01049217|531712799|FG000|Overall Study|Randomized but not Treated|0|||
147423078|NCT01049217|531712800|FG001|Overall Study|Randomized but not Treated|2|||
147423079|NCT01946438|531712801|FG000|Overall Study|Adverse Event|0|||
147423080|NCT01946438|531712802|FG001|Overall Study|Adverse Event|0|||
147423081|NCT01946438|531712803|FG002|Overall Study|Adverse Event|0|||
147423082|NCT01946438|531712804|FG003|Overall Study|Adverse Event|1|||
147423083|NCT01946438|531712801|FG000|Overall Study|Serious Adverse event|1|||
147423084|NCT01946438|531712802|FG001|Overall Study|Serious Adverse event|0|||
147423085|NCT01946438|531712803|FG002|Overall Study|Serious Adverse event|0|||
147423086|NCT01946438|531712804|FG003|Overall Study|Serious Adverse event|0|||
147423087|NCT01946438|531712801|FG000|Overall Study|Protocol Violation|0|||
147423088|NCT01946438|531712802|FG001|Overall Study|Protocol Violation|0|||
147423089|NCT01946438|531712803|FG002|Overall Study|Protocol Violation|1|||
147423090|NCT01946438|531712804|FG003|Overall Study|Protocol Violation|0|||
147423091|NCT01946438|531712801|FG000|Overall Study|Withdrawal by Subject|1|||
147423092|NCT01946438|531712802|FG001|Overall Study|Withdrawal by Subject|0|||
147423093|NCT01946438|531712803|FG002|Overall Study|Withdrawal by Subject|0|||
147423094|NCT01946438|531712804|FG003|Overall Study|Withdrawal by Subject|0|||
147423095|NCT02412371|531712805|FG000|Overall Study|Withdrawal by Subject|0|||
147423096|NCT02412371|531712806|FG001|Overall Study|Withdrawal by Subject|2|||
147423097|NCT02412371|531712807|FG002|Overall Study|Withdrawal by Subject|0|||
147423098|NCT02412371|531712808|FG003|Overall Study|Withdrawal by Subject|1|||
147423099|NCT02412371|531712809|FG004|Overall Study|Withdrawal by Subject|1|||
147423100|NCT02412371|531712810|FG005|Overall Study|Withdrawal by Subject|0|||
147423101|NCT02412371|531712805|FG000|Overall Study|Sponsor Discontinued Study|1|||
147423102|NCT02412371|531712806|FG001|Overall Study|Sponsor Discontinued Study|4|||
147423103|NCT02412371|531712807|FG002|Overall Study|Sponsor Discontinued Study|6|||
147423104|NCT02412371|531712808|FG003|Overall Study|Sponsor Discontinued Study|4|||
147423105|NCT02412371|531712809|FG004|Overall Study|Sponsor Discontinued Study|5|||
147423106|NCT02412371|531712810|FG005|Overall Study|Sponsor Discontinued Study|0|||
147423107|NCT02412371|531712805|FG000|Overall Study|Death|4|||
147423108|NCT02412371|531712806|FG001|Overall Study|Death|2|||
147423109|NCT02412371|531712807|FG002|Overall Study|Death|1|||
147423110|NCT02412371|531712808|FG003|Overall Study|Death|3|||
147423111|NCT02412371|531712809|FG004|Overall Study|Death|5|||
147423112|NCT02412371|531712810|FG005|Overall Study|Death|2|||
147423113|NCT02412371|531712805|FG000|Overall Study|Other|2|||
147423114|NCT02412371|531712806|FG001|Overall Study|Other|1|||
147423115|NCT02412371|531712807|FG002|Overall Study|Other|0|||
147423116|NCT02412371|531712808|FG003|Overall Study|Other|0|||
147423117|NCT02412371|531712809|FG004|Overall Study|Other|1|||
147423118|NCT02412371|531712810|FG005|Overall Study|Other|3|||
147423119|NCT05000931|531712819|FG000|Overall Study|Lost to Follow-up|1|||
147423120|NCT04227704|531712823|FG000|Overall Study|due to anesthesia being changed to general anesthesia|0|||
147423121|NCT04227704|531712824|FG001|Overall Study|due to anesthesia being changed to general anesthesia|1|||
147423122|NCT04227704|531712825|FG002|Overall Study|due to anesthesia being changed to general anesthesia|0|||
147423123|NCT04227704|531712823|FG000|Overall Study|due to C/S being cancelled|1|||
147423124|NCT04227704|531712824|FG001|Overall Study|due to C/S being cancelled|0|||
147423125|NCT04227704|531712825|FG002|Overall Study|due to C/S being cancelled|0|||
147423126|NCT01775124|531712827|FG000|Core Period|Disease Progression|0|||
147423127|NCT01775124|531712828|FG001|Core Period|Disease Progression|1|||
147423128|NCT01775124|531712827|FG000|Core Period|Physician Decision|1|||
147423129|NCT01775124|531712828|FG001|Core Period|Physician Decision|1|||
147423130|NCT01775124|531712827|FG000|Core Period|Death|0|||
147423131|NCT01775124|531712828|FG001|Core Period|Death|1|||
147423132|NCT01775124|531712827|FG000|Core Period|Administrative problems|1|||
147423133|NCT01775124|531712828|FG001|Core Period|Administrative problems|0|||
147423134|NCT01775124|531712827|FG000|Core Period|Withdrawal by Subject|4|||
147423135|NCT01775124|531712828|FG001|Core Period|Withdrawal by Subject|2|||
147423136|NCT01775124|531712827|FG000|Core Period|Adverse Event|5|||
147532706|NCT01243762|532105987|FG005|Part 1 (Dose Escalation/MTD)|Physician Decision|0|||
147423137|NCT01775124|531712828|FG001|Core Period|Adverse Event|5|||
147423138|NCT01775124|531712827|FG000|Extension Period|Adverse Event|3|||
147423139|NCT01775124|531712828|FG001|Extension Period|Adverse Event|2|||
147423140|NCT01775124|531712827|FG000|Extension Period|Physician Decision|0|||
147423141|NCT01775124|531712828|FG001|Extension Period|Physician Decision|2|||
147423142|NCT01775124|531712827|FG000|Extension Period|Administrative problems|0|||
147423143|NCT01775124|531712828|FG001|Extension Period|Administrative problems|1|||
147423144|NCT01775124|531712827|FG000|Extension Period|Lost to Follow-up|0|||
147423145|NCT01775124|531712828|FG001|Extension Period|Lost to Follow-up|1|||
147423146|NCT01775124|531712827|FG000|Extension Period|Withdrawal by Subject|9|||
147191171|NCT02587520|530867569|FG012|Overall Study|Adverse Event|0|||
147191172|NCT02587520|530867570|FG013|Overall Study|Adverse Event|0|||
147191173|NCT02587520|530867571|FG014|Overall Study|Adverse Event|0|||
147191174|NCT02587520|530867572|FG015|Overall Study|Adverse Event|0|||
147191175|NCT02587520|530867573|FG016|Overall Study|Adverse Event|0|||
147191176|NCT02587520|530867574|FG017|Overall Study|Adverse Event|0|||
147191177|NCT02587520|530867557|FG000|Overall Study|Withdrawal by Subject|0|||
147191178|NCT02587520|530867558|FG001|Overall Study|Withdrawal by Subject|0|||
147191179|NCT02587520|530867559|FG002|Overall Study|Withdrawal by Subject|1|||
147191180|NCT02587520|530867560|FG003|Overall Study|Withdrawal by Subject|1|||
147191181|NCT02587520|530867561|FG004|Overall Study|Withdrawal by Subject|0|||
147191182|NCT02587520|530867562|FG005|Overall Study|Withdrawal by Subject|1|||
147191183|NCT02587520|530867563|FG006|Overall Study|Withdrawal by Subject|1|||
147191184|NCT02587520|530867564|FG007|Overall Study|Withdrawal by Subject|0|||
147191185|NCT02587520|530867565|FG008|Overall Study|Withdrawal by Subject|0|||
147191186|NCT02587520|530867566|FG009|Overall Study|Withdrawal by Subject|0|||
147191187|NCT02587520|530867567|FG010|Overall Study|Withdrawal by Subject|0|||
147191188|NCT02587520|530867568|FG011|Overall Study|Withdrawal by Subject|0|||
147191189|NCT02587520|530867569|FG012|Overall Study|Withdrawal by Subject|0|||
147191190|NCT02587520|530867570|FG013|Overall Study|Withdrawal by Subject|1|||
147191191|NCT02587520|530867571|FG014|Overall Study|Withdrawal by Subject|0|||
147191192|NCT02587520|530867572|FG015|Overall Study|Withdrawal by Subject|0|||
147191193|NCT02587520|530867573|FG016|Overall Study|Withdrawal by Subject|0|||
147191194|NCT02587520|530867574|FG017|Overall Study|Withdrawal by Subject|0|||
147191195|NCT02587520|530867557|FG000|Overall Study|Lost to Follow-up|0|||
147191196|NCT02587520|530867558|FG001|Overall Study|Lost to Follow-up|2|||
147191197|NCT02587520|530867559|FG002|Overall Study|Lost to Follow-up|0|||
147191198|NCT02587520|530867560|FG003|Overall Study|Lost to Follow-up|2|||
147191199|NCT02587520|530867561|FG004|Overall Study|Lost to Follow-up|0|||
147191200|NCT02587520|530867562|FG005|Overall Study|Lost to Follow-up|1|||
147191201|NCT02587520|530867563|FG006|Overall Study|Lost to Follow-up|1|||
147191202|NCT02587520|530867564|FG007|Overall Study|Lost to Follow-up|1|||
147191203|NCT02587520|530867565|FG008|Overall Study|Lost to Follow-up|0|||
147191204|NCT02587520|530867566|FG009|Overall Study|Lost to Follow-up|2|||
147191205|NCT02587520|530867567|FG010|Overall Study|Lost to Follow-up|2|||
147191206|NCT02587520|530867568|FG011|Overall Study|Lost to Follow-up|1|||
147191207|NCT02587520|530867569|FG012|Overall Study|Lost to Follow-up|0|||
147191208|NCT02587520|530867570|FG013|Overall Study|Lost to Follow-up|0|||
147191209|NCT02587520|530867571|FG014|Overall Study|Lost to Follow-up|0|||
147191210|NCT02587520|530867572|FG015|Overall Study|Lost to Follow-up|0|||
147191211|NCT02587520|530867573|FG016|Overall Study|Lost to Follow-up|0|||
147191212|NCT02587520|530867574|FG017|Overall Study|Lost to Follow-up|0|||
147191213|NCT04516746|530867575|FG000|Overall Study|Randomized but not Treated|51|||
147191214|NCT04516746|530867576|FG001|Overall Study|Randomized but not Treated|19|||
147191215|NCT04516746|530867575|FG000|Overall Study|Adverse Event|0|||
147191216|NCT04516746|530867576|FG001|Overall Study|Adverse Event|1|||
147191217|NCT04516746|530867575|FG000|Overall Study|Death|62|||
147191218|NCT04516746|530867576|FG001|Overall Study|Death|32|||
147191219|NCT04516746|530867575|FG000|Overall Study|Lost to Follow-up|3431|||
147191220|NCT04516746|530867576|FG001|Overall Study|Lost to Follow-up|1831|||
147191221|NCT04516746|530867575|FG000|Overall Study|Withdrawal by Subject|1946|||
147191222|NCT04516746|530867576|FG001|Overall Study|Withdrawal by Subject|1696|||
147191223|NCT04516746|530867575|FG000|Overall Study|Physician Decision|10|||
147191224|NCT04516746|530867576|FG001|Overall Study|Physician Decision|8|||
147191225|NCT04516746|530867575|FG000|Overall Study|Other|35|||
147191226|NCT04516746|530867576|FG001|Overall Study|Other|16|||
147191227|NCT01751061|530867577|FG000|Overall Study|Death|1|||
147191228|NCT01751061|530867578|FG001|Overall Study|Death|0|||
147191229|NCT01751061|530867577|FG000|Overall Study|patient death|5|||
147423147|NCT01775124|531712828|FG001|Extension Period|Withdrawal by Subject|12|||
147191230|NCT01751061|530867578|FG001|Overall Study|patient death|0|||
147191231|NCT01751061|530867577|FG000|Overall Study|Lost to Follow-up|40|||
147191232|NCT01751061|530867578|FG001|Overall Study|Lost to Follow-up|25|||
147191233|NCT01751061|530867577|FG000|Overall Study|patient regained decisional capacity|4|||
147191234|NCT01751061|530867578|FG001|Overall Study|patient regained decisional capacity|8|||
147191235|NCT01751061|530867577|FG000|Overall Study|Withdrawal by Subject|4|||
147191236|NCT01751061|530867578|FG001|Overall Study|Withdrawal by Subject|1|||
147191237|NCT01751061|530867577|FG000|Overall Study|Physician Decision|2|||
147423148|NCT02317432|531712829|FG000|Overall Study|Death|4|||
147191238|NCT01751061|530867578|FG001|Overall Study|Physician Decision|0|||
147191239|NCT00768989|530867582|FG000|Prior to Week 24|Withdrawal by Subject|1|||
147191240|NCT00768989|530867583|FG001|Prior to Week 24|Withdrawal by Subject|0|||
147191241|NCT00768989|530867582|FG000|Prior to Week 24|Adverse Event|3|||
147191242|NCT00768989|530867583|FG001|Prior to Week 24|Adverse Event|0|||
147191243|NCT00768989|530867582|FG000|Prior to Week 24|Lost to Follow-up|0|||
147191244|NCT00768989|530867583|FG001|Prior to Week 24|Lost to Follow-up|1|||
147191245|NCT00768989|530867582|FG000|Prior to Week 24|Protocol Violation|0|||
147191246|NCT00768989|530867583|FG001|Prior to Week 24|Protocol Violation|2|||
147191247|NCT00768989|530867582|FG000|Week 24 to Prior to Week 36|Adverse Event|1|||
147191248|NCT00768989|530867583|FG001|Week 24 to Prior to Week 36|Adverse Event|0|||
147191249|NCT00768989|530867582|FG000|Week 24 to Prior to Week 36|Lack of Efficacy|6|||
147191250|NCT00768989|530867583|FG001|Week 24 to Prior to Week 36|Lack of Efficacy|0|||
147191251|NCT00768989|530867582|FG000|Week 24 to Prior to Week 36|Withdrawal by Subject|1|||
147191252|NCT00768989|530867583|FG001|Week 24 to Prior to Week 36|Withdrawal by Subject|0|||
147191253|NCT00768989|530867582|FG000|On or After Week 36|Lack of Efficacy|1|||
147191254|NCT00768989|530867583|FG001|On or After Week 36|Lack of Efficacy|0|||
147191255|NCT00768989|530867582|FG000|On or After Week 36|Adverse Event|0|||
147191256|NCT00768989|530867583|FG001|On or After Week 36|Adverse Event|1|||
147191257|NCT00768989|530867582|FG000|On or After Week 36|Lost to Follow-up|1|||
147191258|NCT00768989|530867583|FG001|On or After Week 36|Lost to Follow-up|0|||
147191259|NCT00768989|530867582|FG000|On or After Week 36|Poor Compliance|1|||
147191260|NCT00768989|530867583|FG001|On or After Week 36|Poor Compliance|0|||
147191261|NCT00768989|530867582|FG000|On or After Week 36|Protocol Violation|1|||
147191262|NCT00768989|530867583|FG001|On or After Week 36|Protocol Violation|0|||
147191263|NCT00768989|530867582|FG000|On or After Week 36|Did not attend termination visit|2|||
147191264|NCT00768989|530867583|FG001|On or After Week 36|Did not attend termination visit|0|||
147191265|NCT00768989|530867582|FG000|On or After Week 36|Sponsor Termination|45|||
147191266|NCT00768989|530867583|FG001|On or After Week 36|Sponsor Termination|26|||
147191267|NCT00435409|530867589|FG000|Overall Study|Protocol Violation|1|||
147191268|NCT00435409|530867590|FG001|Overall Study|Protocol Violation|2|||
147191269|NCT00435409|530867591|FG002|Overall Study|Protocol Violation|0|||
147191270|NCT00435409|530867589|FG000|Overall Study|Lost to Follow-up|1|||
147191271|NCT00435409|530867590|FG001|Overall Study|Lost to Follow-up|2|||
147191272|NCT00435409|530867591|FG002|Overall Study|Lost to Follow-up|0|||
147191273|NCT00435409|530867589|FG000|Overall Study|Death|8|||
147191274|NCT00435409|530867590|FG001|Overall Study|Death|6|||
147191275|NCT00435409|530867591|FG002|Overall Study|Death|6|||
147191276|NCT00435409|530867589|FG000|Overall Study|Objective progression or relapse|158|||
147191277|NCT00435409|530867590|FG001|Overall Study|Objective progression or relapse|93|||
147191278|NCT00435409|530867591|FG002|Overall Study|Objective progression or relapse|58|||
147191279|NCT00435409|530867589|FG000|Overall Study|Global deterioration of health status|0|||
147191280|NCT00435409|530867590|FG001|Overall Study|Global deterioration of health status|0|||
147191281|NCT00435409|530867591|FG002|Overall Study|Global deterioration of health status|4|||
147191282|NCT00435409|530867589|FG000|Overall Study|Withdrawal by Subject|8|||
147191283|NCT00435409|530867590|FG001|Overall Study|Withdrawal by Subject|7|||
147191284|NCT00435409|530867591|FG002|Overall Study|Withdrawal by Subject|1|||
147191285|NCT00435409|530867589|FG000|Overall Study|Other|45|||
147191286|NCT00435409|530867590|FG001|Overall Study|Other|30|||
147191287|NCT00435409|530867591|FG002|Overall Study|Other|1|||
147191288|NCT00435409|530867589|FG000|Overall Study|Adverse Event|0|||
147191289|NCT00435409|530867590|FG001|Overall Study|Adverse Event|0|||
147191290|NCT00435409|530867591|FG002|Overall Study|Adverse Event|8|||
147191291|NCT00435409|530867589|FG000|Overall Study|Sponsor decision|0|||
147191292|NCT00435409|530867590|FG001|Overall Study|Sponsor decision|3|||
147191293|NCT00435409|530867591|FG002|Overall Study|Sponsor decision|0|||
147191294|NCT03661723|530867596|FG000|Overall Study|Disease Progression|4|||
147191295|NCT03661723|530867597|FG001|Overall Study|Disease Progression|24|||
147191296|NCT03661723|530867598|FG002|Overall Study|Disease Progression|4|||
147191297|NCT03661723|530867599|FG003|Overall Study|Disease Progression|19|||
147191298|NCT03661723|530867596|FG000|Overall Study|Withdrawal by Subject|1|||
147191299|NCT03661723|530867597|FG001|Overall Study|Withdrawal by Subject|0|||
147191300|NCT03661723|530867598|FG002|Overall Study|Withdrawal by Subject|2|||
147191301|NCT03661723|530867599|FG003|Overall Study|Withdrawal by Subject|4|||
147191302|NCT03661723|530867596|FG000|Overall Study|Physician Decision|1|||
147191303|NCT03661723|530867597|FG001|Overall Study|Physician Decision|0|||
147191304|NCT03661723|530867598|FG002|Overall Study|Physician Decision|0|||
147191305|NCT03661723|530867599|FG003|Overall Study|Physician Decision|0|||
147191306|NCT03661723|530867596|FG000|Overall Study|Clinical Deterioration|0|||
147191307|NCT03661723|530867597|FG001|Overall Study|Clinical Deterioration|0|||
147191308|NCT03661723|530867598|FG002|Overall Study|Clinical Deterioration|0|||
147191309|NCT03661723|530867599|FG003|Overall Study|Clinical Deterioration|1|||
147191310|NCT03562195|530867602|FG000|Overall Study|Adverse Event|0|||
147191311|NCT03562195|530867603|FG001|Overall Study|Adverse Event|6|||
147191312|NCT03562195|530867602|FG000|Overall Study|Lack of Efficacy|0|||
147191313|NCT03562195|530867603|FG001|Overall Study|Lack of Efficacy|5|||
147191314|NCT03562195|530867602|FG000|Overall Study|Protocol Violation|0|||
147191315|NCT03562195|530867603|FG001|Overall Study|Protocol Violation|1|||
147423149|NCT02317432|531712830|FG001|Overall Study|Death|1|||
147423150|NCT02317432|531712829|FG000|Overall Study|Lost to Follow-up|0|||
147423151|NCT02317432|531712830|FG001|Overall Study|Lost to Follow-up|5|||
147423152|NCT02317432|531712829|FG000|Overall Study|Did not complete any CBT/InVEST sessions or the recommended number of sessions|27|||
147423153|NCT02317432|531712830|FG001|Overall Study|Did not complete any CBT/InVEST sessions or the recommended number of sessions|0|||
147423154|NCT00031551|531715075|FG000|Overall Study|Withdrew due to chemotherapy effects|2|||
147423155|NCT00031551|531715076|FG001|Overall Study|Withdrew due to chemotherapy effects|0|||
147423156|NCT00484289|531715082|FG000|Long Term Phase|Adverse Event|1|||
147423157|NCT00484289|531715083|FG001|Long Term Phase|Adverse Event|17|||
147423158|NCT00484289|531715084|FG002|Long Term Phase|Adverse Event|5|||
147423159|NCT00484289|531715082|FG000|Long Term Phase|Withdrawal by Subject|0|||
147423160|NCT00484289|531715083|FG001|Long Term Phase|Withdrawal by Subject|7|||
147423161|NCT00484289|531715084|FG002|Long Term Phase|Withdrawal by Subject|6|||
147423162|NCT00484289|531715082|FG000|Long Term Phase|Inadequate response|2|||
147423163|NCT00484289|531715083|FG001|Long Term Phase|Inadequate response|7|||
147423164|NCT00484289|531715084|FG002|Long Term Phase|Inadequate response|4|||
147423165|NCT00484289|531715082|FG000|Long Term Phase|Other Reason|0|||
147423166|NCT00484289|531715083|FG001|Long Term Phase|Other Reason|5|||
147423167|NCT00484289|531715084|FG002|Long Term Phase|Other Reason|1|||
147423168|NCT00484289|531715082|FG000|Post Marketing Phase|Adverse Event|0|||
147423169|NCT00484289|531715083|FG001|Post Marketing Phase|Adverse Event|1|||
147423170|NCT00484289|531715084|FG002|Post Marketing Phase|Adverse Event|0|||
147423171|NCT02831387|531715085|FG000|Overall Study|Withdrawal by Subject|1|||
147423172|NCT02831387|531715086|FG001|Overall Study|Withdrawal by Subject|1|||
147423173|NCT02831387|531715085|FG000|Overall Study|Discontinued due to stock recovery|0|||
147423174|NCT02831387|531715086|FG001|Overall Study|Discontinued due to stock recovery|1|||
147423175|NCT00192647|531715087|FG000|Overall Study|Death|1|||
147423176|NCT00192647|531715088|FG001|Overall Study|Death|1|||
147423177|NCT00192647|531715087|FG000|Overall Study|Adverse Event|35|||
147423178|NCT00192647|531715088|FG001|Overall Study|Adverse Event|29|||
147423179|NCT00192647|531715087|FG000|Overall Study|Laboratory Test Abnormality|4|||
147423180|NCT00192647|531715088|FG001|Overall Study|Laboratory Test Abnormality|2|||
147423181|NCT00192647|531715087|FG000|Overall Study|Insufficient Therapeutic Response|53|||
147423182|NCT00192647|531715088|FG001|Overall Study|Insufficient Therapeutic Response|83|||
147423183|NCT00192647|531715087|FG000|Overall Study|Entry Criteria Violation|6|||
147423184|NCT00192647|531715088|FG001|Overall Study|Entry Criteria Violation|6|||
147423185|NCT00192647|531715087|FG000|Overall Study|Protocol Violation|3|||
147423186|NCT00192647|531715088|FG001|Overall Study|Protocol Violation|1|||
147423187|NCT00192647|531715087|FG000|Overall Study|Refused Treatment/Did not Cooperate|10|||
147423188|NCT00192647|531715088|FG001|Overall Study|Refused Treatment/Did not Cooperate|8|||
147423189|NCT00192647|531715087|FG000|Overall Study|Failure to Return|11|||
147423190|NCT00192647|531715088|FG001|Overall Study|Failure to Return|13|||
147423191|NCT00192647|531715087|FG000|Overall Study|Other/Administrative|5|||
147423192|NCT00192647|531715088|FG001|Overall Study|Other/Administrative|3|||
147423193|NCT00156819|531715089|FG000|Overall Study|Lost to Follow-up|1|||
147423194|NCT00156819|531715090|FG001|Overall Study|Lost to Follow-up|1|||
147423195|NCT00156819|531715091|FG002|Overall Study|Lost to Follow-up|3|||
147423196|NCT01689337|531715092|FG000|Overall Study|Study Discontinuation|1|||
147423197|NCT00642772|531715094|FG000|Overall Study|Lost to Follow-up|3|||
147423198|NCT00642772|531715094|FG000|Overall Study|Withdrawal by Subject|7|||
147423199|NCT03718533|531715095|FG000|Overall Study|Myelodysplastic syndrome and study indication|1|||
147423200|NCT03718533|531715095|FG000|Overall Study|Protocol deviation|1|||
147423201|NCT03718533|531715095|FG000|Overall Study|Disease progression|1|||
147423202|NCT03718533|531715095|FG000|Overall Study|Relapse|1|||
147423203|NCT03718533|531715095|FG000|Overall Study|Physician Decision|2|||
147423204|NCT03718533|531715095|FG000|Overall Study|Physician Decision and Adverse Event|1|||
147423205|NCT05398237|531715103|FG000|Overall Study|Withdrawal by Subject|1|||
147423206|NCT01312857|531715110|FG000|Overall Study|Adverse Event|1|||
147423207|NCT01312857|531715111|FG001|Overall Study|Adverse Event|1|||
147423208|NCT01312857|531715110|FG000|Overall Study|Lost to Follow-up|2|||
147423209|NCT01312857|531715111|FG001|Overall Study|Lost to Follow-up|0|||
147423210|NCT01312857|531715110|FG000|Overall Study|Physician Decision|3|||
147423211|NCT01312857|531715111|FG001|Overall Study|Physician Decision|0|||
147423212|NCT01312857|531715110|FG000|Overall Study|Withdrawal by Subject|2|||
147423213|NCT01312857|531715111|FG001|Overall Study|Withdrawal by Subject|0|||
147423214|NCT01248065|531715116|FG000|Overall Study|Lost to Follow-up|3|||
147423215|NCT01248065|531715117|FG001|Overall Study|Lost to Follow-up|5|||
147423216|NCT01248065|531715116|FG000|Overall Study|Withdrawal by Subject|14|||
147423217|NCT01248065|531715117|FG001|Overall Study|Withdrawal by Subject|11|||
147423218|NCT01248065|531715116|FG000|Overall Study|Adverse Event|3|||
147423219|NCT01248065|531715117|FG001|Overall Study|Adverse Event|0|||
147423220|NCT01248065|531715116|FG000|Overall Study|Third treatment failure event|3|||
147423221|NCT01248065|531715117|FG001|Overall Study|Third treatment failure event|1|||
147423222|NCT01248065|531715116|FG000|Overall Study|Other|3|||
147423223|NCT01248065|531715117|FG001|Overall Study|Other|5|||
147423224|NCT02781844|531715124|FG000|Treatment Period 1|Adverse Event|0|||
147191316|NCT03562195|530867602|FG000|Overall Study|Lost to Follow-up|0|||
147191317|NCT03562195|530867603|FG001|Overall Study|Lost to Follow-up|1|||
147191318|NCT03562195|530867602|FG000|Overall Study|Physician Decision|1|||
147191319|NCT03562195|530867603|FG001|Overall Study|Physician Decision|0|||
147191320|NCT03562195|530867602|FG000|Overall Study|Withdrawal by Subject|3|||
147191321|NCT03562195|530867603|FG001|Overall Study|Withdrawal by Subject|0|||
147191322|NCT02529852|530867604|FG000|Overall Study|Withdrawal by Subject|2|||
147191323|NCT00117637|530867605|FG000|First Intervention (Period 1)|Adverse Event|11|||
147191324|NCT00117637|530867606|FG001|First Intervention (Period 1)|Adverse Event|16|||
147191325|NCT00117637|530867605|FG000|First Intervention (Period 1)|Lost to Follow-up|0|||
147423225|NCT02781844|531715125|FG001|Treatment Period 1|Adverse Event|0|||
147423226|NCT02781844|531715126|FG002|Treatment Period 1|Adverse Event|0|||
147423227|NCT02781844|531715127|FG003|Treatment Period 1|Adverse Event|0|||
147423228|NCT02781844|531715128|FG004|Treatment Period 1|Adverse Event|0|||
147423229|NCT02781844|531715129|FG005|Treatment Period 1|Adverse Event|1|||
147423230|NCT02781844|531715130|FG006|Treatment Period 1|Adverse Event|0|||
147423231|NCT02781844|531715131|FG007|Treatment Period 1|Adverse Event|0|||
147423232|NCT02518490|531715134|FG000|Overall Study|Withdrawal by Subject|1|||
147423233|NCT02518490|531715135|FG001|Overall Study|Withdrawal by Subject|1|||
147423234|NCT04256629|531715136|FG000|Overall Study|Adverse Event|0|||
147423235|NCT04256629|531715137|FG001|Overall Study|Adverse Event|0|||
147423236|NCT04256629|531715138|FG002|Overall Study|Adverse Event|0|||
147423237|NCT04256629|531715139|FG003|Overall Study|Adverse Event|0|||
147423238|NCT04256629|531715140|FG004|Overall Study|Adverse Event|0|||
147423239|NCT04256629|531715141|FG005|Overall Study|Adverse Event|1|||
147423240|NCT04256629|531715136|FG000|Overall Study|Protocol Violation|0|||
147423241|NCT04256629|531715137|FG001|Overall Study|Protocol Violation|1|||
147423242|NCT04256629|531715138|FG002|Overall Study|Protocol Violation|0|||
147423243|NCT04256629|531715139|FG003|Overall Study|Protocol Violation|0|||
147423244|NCT04256629|531715140|FG004|Overall Study|Protocol Violation|0|||
147423245|NCT04256629|531715141|FG005|Overall Study|Protocol Violation|0|||
147423246|NCT00321373|531715142|FG000|Overall Study|Adverse Event|0|||
147423247|NCT00321373|531715143|FG001|Overall Study|Adverse Event|0|||
147423248|NCT00321373|531715144|FG002|Overall Study|Adverse Event|1|||
147423249|NCT00321373|531715142|FG000|Overall Study|Lost to Follow-up|1|||
147423250|NCT00321373|531715143|FG001|Overall Study|Lost to Follow-up|0|||
147423251|NCT00321373|531715144|FG002|Overall Study|Lost to Follow-up|1|||
147423252|NCT00321373|531715142|FG000|Overall Study|Withdrawal by Subject|1|||
147423253|NCT00321373|531715143|FG001|Overall Study|Withdrawal by Subject|0|||
147423254|NCT00321373|531715144|FG002|Overall Study|Withdrawal by Subject|0|||
147423255|NCT00321373|531715142|FG000|Overall Study|Other|0|||
147423256|NCT00321373|531715143|FG001|Overall Study|Other|0|||
147423257|NCT00321373|531715144|FG002|Overall Study|Other|1|||
147423258|NCT01383499|531715145|FG000|Period 1 (4 Weeks)|Withdrawal by Subject|1|||
147423259|NCT01383499|531715146|FG001|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
147423260|NCT01383499|531715147|FG002|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
147423261|NCT01383499|531715148|FG003|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
147423262|NCT01774487|531715149|FG000|Overall Study|Did not tolerate taste|4|||
147423263|NCT01774487|531715150|FG001|Overall Study|Did not tolerate taste|4|||
147423264|NCT00346632|531715151|FG000|Overall Study|Progressive Disease|2|||
147423265|NCT00346632|531715152|FG001|Overall Study|Progressive Disease|2|||
147423266|NCT00346632|531715153|FG002|Overall Study|Progressive Disease|4|||
147423267|NCT00346632|531715154|FG003|Overall Study|Progressive Disease|3|||
147423268|NCT00346632|531715155|FG004|Overall Study|Progressive Disease|3|||
147423269|NCT00346632|531715156|FG005|Overall Study|Progressive Disease|1|||
147423270|NCT00346632|531715157|FG006|Overall Study|Progressive Disease|2|||
147423271|NCT00346632|531715158|FG007|Overall Study|Progressive Disease|2|||
147423272|NCT00346632|531715159|FG008|Overall Study|Progressive Disease|2|||
147423273|NCT00346632|531715160|FG009|Overall Study|Progressive Disease|2|||
147423274|NCT00346632|531715151|FG000|Overall Study|Adverse Event|0|||
147423275|NCT00346632|531715152|FG001|Overall Study|Adverse Event|0|||
147423276|NCT00346632|531715153|FG002|Overall Study|Adverse Event|0|||
147423277|NCT00346632|531715154|FG003|Overall Study|Adverse Event|0|||
147423278|NCT00346632|531715155|FG004|Overall Study|Adverse Event|1|||
147423279|NCT00346632|531715156|FG005|Overall Study|Adverse Event|1|||
147423280|NCT00346632|531715157|FG006|Overall Study|Adverse Event|1|||
147423281|NCT00346632|531715158|FG007|Overall Study|Adverse Event|0|||
147423282|NCT00346632|531715159|FG008|Overall Study|Adverse Event|0|||
147423283|NCT00346632|531715160|FG009|Overall Study|Adverse Event|0|||
147423284|NCT00346632|531715151|FG000|Overall Study|Death|0|||
147423285|NCT00346632|531715152|FG001|Overall Study|Death|0|||
147423286|NCT00346632|531715153|FG002|Overall Study|Death|1|||
147423287|NCT00346632|531715154|FG003|Overall Study|Death|0|||
147423288|NCT00346632|531715155|FG004|Overall Study|Death|0|||
147423289|NCT00346632|531715156|FG005|Overall Study|Death|0|||
147423290|NCT00346632|531715157|FG006|Overall Study|Death|0|||
147423291|NCT00346632|531715158|FG007|Overall Study|Death|0|||
147423292|NCT00346632|531715159|FG008|Overall Study|Death|0|||
147423293|NCT00346632|531715160|FG009|Overall Study|Death|0|||
147423294|NCT00346632|531715151|FG000|Overall Study|Protocol Violation|0|||
147423295|NCT00346632|531715152|FG001|Overall Study|Protocol Violation|0|||
147423296|NCT00346632|531715153|FG002|Overall Study|Protocol Violation|0|||
147423297|NCT00346632|531715154|FG003|Overall Study|Protocol Violation|0|||
147423298|NCT00346632|531715155|FG004|Overall Study|Protocol Violation|0|||
147423299|NCT00346632|531715156|FG005|Overall Study|Protocol Violation|0|||
147423300|NCT00346632|531715157|FG006|Overall Study|Protocol Violation|1|||
147423301|NCT00346632|531715158|FG007|Overall Study|Protocol Violation|0|||
147423302|NCT00346632|531715159|FG008|Overall Study|Protocol Violation|0|||
147423303|NCT00346632|531715160|FG009|Overall Study|Protocol Violation|0|||
147423304|NCT00346632|531715151|FG000|Overall Study|Withdrawal by Subject|0|||
147423305|NCT00346632|531715152|FG001|Overall Study|Withdrawal by Subject|0|||
147423306|NCT00346632|531715153|FG002|Overall Study|Withdrawal by Subject|0|||
147423307|NCT00346632|531715154|FG003|Overall Study|Withdrawal by Subject|0|||
147423308|NCT00346632|531715155|FG004|Overall Study|Withdrawal by Subject|0|||
147423309|NCT00346632|531715156|FG005|Overall Study|Withdrawal by Subject|0|||
147423310|NCT00346632|531715157|FG006|Overall Study|Withdrawal by Subject|1|||
147423311|NCT00346632|531715158|FG007|Overall Study|Withdrawal by Subject|0|||
147423312|NCT00346632|531715159|FG008|Overall Study|Withdrawal by Subject|0|||
147423313|NCT00346632|531715160|FG009|Overall Study|Withdrawal by Subject|0|||
147423314|NCT00346632|531715151|FG000|Overall Study|Switched to alternative treatment|0|||
147423315|NCT00346632|531715152|FG001|Overall Study|Switched to alternative treatment|0|||
147423316|NCT00346632|531715153|FG002|Overall Study|Switched to alternative treatment|1|||
147423317|NCT00346632|531715154|FG003|Overall Study|Switched to alternative treatment|0|||
147423318|NCT00346632|531715155|FG004|Overall Study|Switched to alternative treatment|0|||
147423319|NCT00346632|531715156|FG005|Overall Study|Switched to alternative treatment|0|||
147423320|NCT00346632|531715157|FG006|Overall Study|Switched to alternative treatment|0|||
147423321|NCT00346632|531715158|FG007|Overall Study|Switched to alternative treatment|0|||
147423322|NCT00346632|531715159|FG008|Overall Study|Switched to alternative treatment|0|||
147423323|NCT00346632|531715160|FG009|Overall Study|Switched to alternative treatment|0|||
147423324|NCT00346632|531715151|FG000|Overall Study|Not Stated|1|||
147423325|NCT00346632|531715152|FG001|Overall Study|Not Stated|1|||
147423326|NCT00346632|531715153|FG002|Overall Study|Not Stated|0|||
147423327|NCT00346632|531715154|FG003|Overall Study|Not Stated|0|||
147423328|NCT00346632|531715155|FG004|Overall Study|Not Stated|0|||
147423329|NCT00346632|531715156|FG005|Overall Study|Not Stated|0|||
147423330|NCT00346632|531715157|FG006|Overall Study|Not Stated|0|||
147423331|NCT00346632|531715158|FG007|Overall Study|Not Stated|2|||
147423332|NCT00346632|531715159|FG008|Overall Study|Not Stated|2|||
147423333|NCT00346632|531715160|FG009|Overall Study|Not Stated|1|||
147423334|NCT00477334|531715161|FG000|Overall Study|Discontinued prior to taking study drug|106|||
147423335|NCT00477334|531715162|FG001|Overall Study|Discontinued prior to taking study drug|53|||
147423336|NCT00477334|531715161|FG000|Overall Study|Adverse Event|1|||
147423337|NCT00477334|531715162|FG001|Overall Study|Adverse Event|2|||
147423338|NCT00477334|531715161|FG000|Overall Study|Withdrawal by Subject|2|||
147423339|NCT00477334|531715162|FG001|Overall Study|Withdrawal by Subject|1|||
147423340|NCT00477334|531715161|FG000|Overall Study|Lost to Follow-up|15|||
147423341|NCT00477334|531715162|FG001|Overall Study|Lost to Follow-up|4|||
147423342|NCT00477334|531715161|FG000|Overall Study|Administrative Problems|39|||
147423343|NCT00477334|531715162|FG001|Overall Study|Administrative Problems|15|||
147423344|NCT00477334|531715161|FG000|Overall Study|Protocol Violation|7|||
147423345|NCT00477334|531715162|FG001|Overall Study|Protocol Violation|1|||
147423346|NCT04275089|531715163|FG000|Overall Study|Unable to be fit with Reia pessary|1|||
147423347|NCT02354508|531715167|FG000|Period 1: Core Phase|Adverse Event|1|||
147423348|NCT02354508|531715168|FG001|Period 1: Core Phase|Adverse Event|1|||
147423349|NCT02354508|531715169|FG002|Period 1: Core Phase|Adverse Event|2|||
147423350|NCT02354508|531715167|FG000|Period 1: Core Phase|Unsatisfactory therapeutic effect|1|||
147423351|NCT02354508|531715168|FG001|Period 1: Core Phase|Unsatisfactory therapeutic effect|0|||
147423352|NCT02354508|531715169|FG002|Period 1: Core Phase|Unsatisfactory therapeutic effect|2|||
147423353|NCT02354508|531715167|FG000|Period 1: Core Phase|Withdrawal by Subject|0|||
147423354|NCT02354508|531715168|FG001|Period 1: Core Phase|Withdrawal by Subject|1|||
147423355|NCT02354508|531715169|FG002|Period 1: Core Phase|Withdrawal by Subject|2|||
147191326|NCT00117637|530867606|FG001|First Intervention (Period 1)|Lost to Follow-up|2|||
147191327|NCT00117637|530867605|FG000|First Intervention (Period 1)|Protocol Violation|1|||
147423356|NCT02354508|531715167|FG000|Period 2: Extension Phase|Unsatisfactory therapeutic effect|1|||
147423357|NCT02354508|531715168|FG001|Period 2: Extension Phase|Unsatisfactory therapeutic effect|3|||
147423358|NCT02354508|531715169|FG002|Period 2: Extension Phase|Unsatisfactory therapeutic effect|2|||
147423359|NCT02354508|531715167|FG000|Period 2: Extension Phase|Withdrawal by Subject|0|||
147423360|NCT02354508|531715168|FG001|Period 2: Extension Phase|Withdrawal by Subject|1|||
147423361|NCT02354508|531715169|FG002|Period 2: Extension Phase|Withdrawal by Subject|0|||
147423362|NCT02354508|531715167|FG000|Period 2: Extension Phase|Physician Decision|5|||
147423363|NCT02354508|531715168|FG001|Period 2: Extension Phase|Physician Decision|0|||
147423364|NCT02354508|531715169|FG002|Period 2: Extension Phase|Physician Decision|1|||
147423365|NCT02354508|531715167|FG000|Period 3: Post-treatment Follow up Phase|Unsatisfactory therapeutic effect|1|||
147423366|NCT02354508|531715168|FG001|Period 3: Post-treatment Follow up Phase|Unsatisfactory therapeutic effect|2|||
147423367|NCT02354508|531715169|FG002|Period 3: Post-treatment Follow up Phase|Unsatisfactory therapeutic effect|2|||
147423368|NCT02354508|531715167|FG000|Period 3: Post-treatment Follow up Phase|Withdrawal by Subject|0|||
147423369|NCT02354508|531715168|FG001|Period 3: Post-treatment Follow up Phase|Withdrawal by Subject|1|||
147423370|NCT02354508|531715169|FG002|Period 3: Post-treatment Follow up Phase|Withdrawal by Subject|0|||
147423371|NCT02354508|531715167|FG000|Period 3: Post-treatment Follow up Phase|Physician Decision|3|||
147423372|NCT02354508|531715168|FG001|Period 3: Post-treatment Follow up Phase|Physician Decision|0|||
147423373|NCT02354508|531715169|FG002|Period 3: Post-treatment Follow up Phase|Physician Decision|1|||
147423374|NCT03587974|531715171|FG000|Overall Study|caregiver demented, care recipient died|3|||
147423375|NCT03587974|531715172|FG001|Overall Study|caregiver demented, care recipient died|3|||
147423376|NCT03587974|531715171|FG000|Overall Study|Withdrawal by Subject|2|||
147423377|NCT03587974|531715172|FG001|Overall Study|Withdrawal by Subject|1|||
147423378|NCT02585232|531715173|FG000|Overall Study|Lost to Follow-up|8|||
147423379|NCT02585232|531715174|FG001|Overall Study|Lost to Follow-up|8|||
147423380|NCT02585232|531715173|FG000|Overall Study|Withdrawal by Subject|4|||
147423381|NCT02585232|531715174|FG001|Overall Study|Withdrawal by Subject|8|||
147423382|NCT00461032|531715177|FG000|Overall Study|Adverse Event|5|||
147423383|NCT00461032|531715178|FG001|Overall Study|Adverse Event|6|||
147423384|NCT00461032|531715177|FG000|Overall Study|Lack of Efficacy|5|||
147423385|NCT00461032|531715178|FG001|Overall Study|Lack of Efficacy|1|||
147423386|NCT00461032|531715177|FG000|Overall Study|Lost to Follow-up|7|||
147423387|NCT00461032|531715178|FG001|Overall Study|Lost to Follow-up|12|||
147423388|NCT00461032|531715177|FG000|Overall Study|Protocol Violation|4|||
147423389|NCT00461032|531715178|FG001|Overall Study|Protocol Violation|4|||
147423390|NCT00461032|531715177|FG000|Overall Study|Withdrawal by Subject|7|||
147423391|NCT00461032|531715178|FG001|Overall Study|Withdrawal by Subject|15|||
147423392|NCT00461032|531715177|FG000|Overall Study|Patient Moved or Relocated|2|||
147423393|NCT00461032|531715178|FG001|Overall Study|Patient Moved or Relocated|1|||
147423394|NCT00461032|531715177|FG000|Overall Study|Other|7|||
147423395|NCT00461032|531715178|FG001|Overall Study|Other|5|||
147423396|NCT04447846|531715181|FG000|Overall Study|Withdrew due to moderate side effects (fatigue)|1|||
147423397|NCT00297232|531715183|FG000|Overall Study|Lack of Efficacy|7|||
147423398|NCT00297232|531715183|FG000|Overall Study|Lost to Follow-up|10|||
147423399|NCT00297232|531715183|FG000|Overall Study|Adverse Event|63|||
147423400|NCT00297232|531715183|FG000|Overall Study|Voluntary Withdrawal|120|||
147423401|NCT00297232|531715183|FG000|Overall Study|Subject was Noncompliant|9|||
147423402|NCT00297232|531715183|FG000|Overall Study|Death|9|||
147423403|NCT00297232|531715183|FG000|Overall Study|Anti-natalizumab Positive|8|||
147423404|NCT00297232|531715183|FG000|Overall Study|Switched to Commercial Tysabri|22|||
147423405|NCT00297232|531715183|FG000|Overall Study|Disease Progression|8|||
147423406|NCT00297232|531715183|FG000|Overall Study|Fear of PML|10|||
147423407|NCT00297232|531715183|FG000|Overall Study|Anti-JCV Antibody Positive|13|||
147423408|NCT00297232|531715183|FG000|Overall Study|Miscellaneous|5|||
147423409|NCT00297232|531715183|FG000|Overall Study|Sponsor Decision|34|||
147423410|NCT00297232|531715183|FG000|Overall Study|Subject Relocated|7|||
147423411|NCT00297232|531715183|FG000|Overall Study|Subject Withdrew Consent|37|||
147423412|NCT00297232|531715183|FG000|Overall Study|Persistently Positive Antibodies|11|||
147423413|NCT00297232|531715183|FG000|Overall Study|Investigator Withdrew From Program|19|||
147423414|NCT00297232|531715183|FG000|Overall Study|Did Not Enroll to Week 264|34|||
147423415|NCT00297232|531715183|FG000|Overall Study|Did Not Enroll to Week 480|17|||
147423416|NCT00297232|531715183|FG000|Overall Study|No data available after Week 264|161|||
147423417|NCT00297232|531715183|FG000|Overall Study|Other|1|||
147423418|NCT02257567|531715184|FG000|Overall Study|Adverse Event|0|||
147423419|NCT02257567|531715185|FG001|Overall Study|Adverse Event|0|||
147423420|NCT02257567|531715186|FG002|Overall Study|Adverse Event|0|||
147423421|NCT02257567|531715187|FG003|Overall Study|Adverse Event|1|||
147423422|NCT02257567|531715188|FG004|Overall Study|Adverse Event|1|||
147423423|NCT02257567|531715189|FG005|Overall Study|Adverse Event|0|||
147423424|NCT02257567|531715190|FG006|Overall Study|Adverse Event|0|||
147423425|NCT02257567|531715191|FG007|Overall Study|Adverse Event|0|||
147423426|NCT02257567|531715192|FG008|Overall Study|Adverse Event|1|||
147423427|NCT02257567|531715193|FG009|Overall Study|Adverse Event|0|||
147423428|NCT02257567|531715194|FG010|Overall Study|Adverse Event|0|||
147423429|NCT02257567|531715184|FG000|Overall Study|Death|2|||
147423430|NCT02257567|531715185|FG001|Overall Study|Death|2|||
147423431|NCT02257567|531715186|FG002|Overall Study|Death|2|||
147423432|NCT02257567|531715187|FG003|Overall Study|Death|4|||
147423433|NCT02257567|531715188|FG004|Overall Study|Death|15|||
147423434|NCT02257567|531715189|FG005|Overall Study|Death|11|||
147423435|NCT02257567|531715190|FG006|Overall Study|Death|26|||
147423436|NCT02257567|531715191|FG007|Overall Study|Death|30|||
147423437|NCT02257567|531715192|FG008|Overall Study|Death|2|||
147423438|NCT02257567|531715193|FG009|Overall Study|Death|18|||
147423439|NCT02257567|531715194|FG010|Overall Study|Death|65|||
147423440|NCT02257567|531715184|FG000|Overall Study|Lost to Follow-up|0|||
147423441|NCT02257567|531715185|FG001|Overall Study|Lost to Follow-up|0|||
147423442|NCT02257567|531715186|FG002|Overall Study|Lost to Follow-up|0|||
147423443|NCT02257567|531715187|FG003|Overall Study|Lost to Follow-up|0|||
147423444|NCT02257567|531715188|FG004|Overall Study|Lost to Follow-up|2|||
147423445|NCT02257567|531715189|FG005|Overall Study|Lost to Follow-up|2|||
147423446|NCT02257567|531715190|FG006|Overall Study|Lost to Follow-up|0|||
147423447|NCT02257567|531715191|FG007|Overall Study|Lost to Follow-up|0|||
147423448|NCT02257567|531715192|FG008|Overall Study|Lost to Follow-up|0|||
147423449|NCT02257567|531715193|FG009|Overall Study|Lost to Follow-up|1|||
147423450|NCT02257567|531715194|FG010|Overall Study|Lost to Follow-up|1|||
147423451|NCT02257567|531715184|FG000|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
147423452|NCT02257567|531715185|FG001|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
147423453|NCT02257567|531715186|FG002|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
147423454|NCT02257567|531715187|FG003|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
147423455|NCT02257567|531715188|FG004|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|1|||
147423456|NCT02257567|531715189|FG005|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
147423457|NCT02257567|531715190|FG006|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|2|||
147423458|NCT02257567|531715191|FG007|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
147423459|NCT02257567|531715192|FG008|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
147423460|NCT02257567|531715193|FG009|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
147423461|NCT02257567|531715194|FG010|Overall Study|Not treated/Per Sponsor Participant Could not Continue/Pathology Showed Transformation: Cycle 1Day 1|0|||
147423462|NCT02257567|531715184|FG000|Overall Study|Physician Decision|0|||
147423463|NCT02257567|531715185|FG001|Overall Study|Physician Decision|0|||
147423464|NCT02257567|531715186|FG002|Overall Study|Physician Decision|0|||
147423465|NCT02257567|531715187|FG003|Overall Study|Physician Decision|0|||
147423466|NCT02257567|531715188|FG004|Overall Study|Physician Decision|0|||
147423467|NCT02257567|531715189|FG005|Overall Study|Physician Decision|0|||
147423468|NCT02257567|531715190|FG006|Overall Study|Physician Decision|0|||
147423469|NCT02257567|531715191|FG007|Overall Study|Physician Decision|2|||
147423470|NCT02257567|531715192|FG008|Overall Study|Physician Decision|0|||
147423471|NCT02257567|531715193|FG009|Overall Study|Physician Decision|1|||
147423472|NCT02257567|531715194|FG010|Overall Study|Physician Decision|0|||
147423473|NCT02257567|531715184|FG000|Overall Study|Withdrawal by Subject|0|||
147423474|NCT02257567|531715185|FG001|Overall Study|Withdrawal by Subject|0|||
147423475|NCT02257567|531715186|FG002|Overall Study|Withdrawal by Subject|2|||
147423476|NCT02257567|531715187|FG003|Overall Study|Withdrawal by Subject|0|||
147423477|NCT02257567|531715188|FG004|Overall Study|Withdrawal by Subject|0|||
147423478|NCT02257567|531715189|FG005|Overall Study|Withdrawal by Subject|6|||
147423479|NCT02257567|531715190|FG006|Overall Study|Withdrawal by Subject|6|||
147423480|NCT02257567|531715191|FG007|Overall Study|Withdrawal by Subject|6|||
147423481|NCT02257567|531715192|FG008|Overall Study|Withdrawal by Subject|1|||
147423482|NCT02257567|531715193|FG009|Overall Study|Withdrawal by Subject|1|||
147423483|NCT02257567|531715194|FG010|Overall Study|Withdrawal by Subject|10|||
147423484|NCT03625895|531715197|FG000|Overall Study|Protocol Violation|585|||
147423485|NCT00552240|531715200|FG000|Overall Study|Adverse Event|9|||
147423486|NCT00552240|531715201|FG001|Overall Study|Adverse Event|9|||
147423487|NCT00552240|531715200|FG000|Overall Study|Protocol Violation|1|||
147423488|NCT00552240|531715201|FG001|Overall Study|Protocol Violation|1|||
147423489|NCT00552240|531715200|FG000|Overall Study|Lost to Follow-up|5|||
147423490|NCT00552240|531715201|FG001|Overall Study|Lost to Follow-up|6|||
147423491|NCT00552240|531715200|FG000|Overall Study|Withdrawal by Subject|2|||
147423492|NCT00552240|531715201|FG001|Overall Study|Withdrawal by Subject|2|||
147423493|NCT00552240|531715200|FG000|Overall Study|Lack of Efficacy|6|||
147423494|NCT00552240|531715201|FG001|Overall Study|Lack of Efficacy|0|||
147423495|NCT00552240|531715200|FG000|Overall Study|Other|1|||
147423496|NCT00552240|531715201|FG001|Overall Study|Other|0|||
147423497|NCT02679573|531715202|FG000|Overall Study|Adverse Event|13|||
147423498|NCT02679573|531715203|FG001|Overall Study|Adverse Event|6|||
147423499|NCT02679573|531715202|FG000|Overall Study|Lack of Efficacy|12|||
147423500|NCT02679573|531715203|FG001|Overall Study|Lack of Efficacy|15|||
147423501|NCT02679573|531715202|FG000|Overall Study|Could not complete required study visits|6|||
147423502|NCT02679573|531715203|FG001|Overall Study|Could not complete required study visits|2|||
147423503|NCT02679573|531715202|FG000|Overall Study|Withdrawal by Subject|2|||
147423504|NCT02679573|531715203|FG001|Overall Study|Withdrawal by Subject|9|||
147423505|NCT02679573|531715202|FG000|Overall Study|Death|2|||
147423506|NCT02679573|531715203|FG001|Overall Study|Death|0|||
147423507|NCT02679573|531715202|FG000|Overall Study|Physician Decision|2|||
147423508|NCT02679573|531715203|FG001|Overall Study|Physician Decision|4|||
147423509|NCT02679573|531715202|FG000|Overall Study|Lost to Follow-up|0|||
147423510|NCT02679573|531715203|FG001|Overall Study|Lost to Follow-up|3|||
147423511|NCT03545503|531715204|FG000|Overall Study|Protocol Violation|14|||
147423512|NCT03545503|531715205|FG001|Overall Study|Protocol Violation|16|||
147423513|NCT01236339|531715209|FG000|Overall Study|Termination of study by sponsor|11|||
147423514|NCT01236339|531715210|FG001|Overall Study|Termination of study by sponsor|13|||
147423515|NCT01098097|531715211|FG000|Overall Study|Adverse Event|17|||
147423516|NCT01098097|531715211|FG000|Overall Study|Lost to Follow-up|18|||
147423517|NCT01098097|531715211|FG000|Overall Study|Status unknown|16|||
147423518|NCT01098097|531715211|FG000|Overall Study|No reason reported|31|||
147423519|NCT00394082|531715212|FG000|Overall Study|Unacceptable toxicity|15|||
147423520|NCT00394082|531715212|FG000|Overall Study|Adverse Event|4|||
147423521|NCT00394082|531715212|FG000|Overall Study|Physician Decision|4|||
147423522|NCT00394082|531715212|FG000|Overall Study|Withdrawal by Subject|2|||
147423523|NCT00394082|531715212|FG000|Overall Study|Other|1|||
147423524|NCT01945060|531715213|FG000|Overall Study|Lost to follow up|1|||
147423525|NCT01945060|531715214|FG001|Overall Study|Lost to follow up|0|||
147423526|NCT01945060|531715213|FG000|Overall Study|Distress related to IV access|0|||
147423527|NCT01945060|531715214|FG001|Overall Study|Distress related to IV access|1|||
147423528|NCT00577577|531715216|FG000|Overall Study|Adverse Event|3|||
147423529|NCT00577577|531715217|FG001|Overall Study|Adverse Event|2|||
147423530|NCT00577577|531715216|FG000|Overall Study|Lost to Follow-up|1|||
147423531|NCT00577577|531715217|FG001|Overall Study|Lost to Follow-up|0|||
147423532|NCT00577577|531715216|FG000|Overall Study|Protocol Violation|0|||
147423533|NCT00577577|531715217|FG001|Overall Study|Protocol Violation|3|||
147423534|NCT00577577|531715216|FG000|Overall Study|Transportation|1|||
147423535|NCT00577577|531715217|FG001|Overall Study|Transportation|0|||
147423536|NCT00232544|531715218|FG000|Overall Study|Lost to Follow-up|20|||
147423537|NCT00232544|531715219|FG001|Overall Study|Lost to Follow-up|15|||
147423538|NCT00906945|531715220|FG000|Overall Study|Found to be not eligible|0|||
147423539|NCT00906945|531715221|FG001|Overall Study|Found to be not eligible|0|||
147423540|NCT00906945|531715222|FG002|Overall Study|Found to be not eligible|0|||
147423541|NCT00906945|531715223|FG003|Overall Study|Found to be not eligible|1|||
147423542|NCT00906945|531715224|FG004|Overall Study|Found to be not eligible|1|||
147423543|NCT00906945|531715225|FG005|Overall Study|Found to be not eligible|1|||
147423544|NCT00906945|531715220|FG000|Overall Study|Physician Decision|0|||
147423545|NCT00906945|531715221|FG001|Overall Study|Physician Decision|0|||
147423546|NCT00906945|531715222|FG002|Overall Study|Physician Decision|0|||
147423547|NCT00906945|531715223|FG003|Overall Study|Physician Decision|0|||
147423548|NCT00906945|531715224|FG004|Overall Study|Physician Decision|0|||
147423549|NCT00906945|531715225|FG005|Overall Study|Physician Decision|1|||
147423550|NCT01210664|531715227|FG000|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|0|||
147423551|NCT01210664|531715228|FG001|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|0|||
147423552|NCT01210664|531715229|FG002|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|1|||
147423553|NCT01210664|531715230|FG003|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Lost to Follow-up|0|||
147423554|NCT01210664|531715227|FG000|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|0|||
147423555|NCT01210664|531715228|FG001|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|0|||
147423556|NCT01210664|531715229|FG002|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|1|||
147423557|NCT01210664|531715230|FG003|Cohort 3: PolyTregs 3.2 x 10^8 Cells|Treg Manufacturing Failure|0|||
147423558|NCT01210664|531715227|FG000|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|0|||
147423559|NCT01210664|531715228|FG001|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|0|||
147423560|NCT01210664|531715229|FG002|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|0|||
147423561|NCT01210664|531715230|FG003|Cohort 4: PolyTregs 26 x 10^8 Cells|Treg Manufacturing Failure|1|||
147423562|NCT01054170|531715231|FG000|Overall Study|Protocol Violation|1|||
147423563|NCT01054170|531715232|FG001|Overall Study|Protocol Violation|0|||
147423564|NCT01054170|531715231|FG000|Overall Study|Withdrawal by Subject|3|||
147423565|NCT01054170|531715232|FG001|Overall Study|Withdrawal by Subject|2|||
147423566|NCT01054170|531715231|FG000|Overall Study|Adverse Event|0|||
147423567|NCT01054170|531715232|FG001|Overall Study|Adverse Event|4|||
147423568|NCT02951767|531715233|FG000|Overall Study|Study Terminated By Sponsor|9|||
147423569|NCT02951767|531715233|FG000|Overall Study|Withdrawal by Subject|11|||
147423570|NCT02951767|531715233|FG000|Overall Study|Death|96|||
147423571|NCT02951767|531715233|FG000|Overall Study|Lost to Follow-up|2|||
147423572|NCT02951767|531715233|FG000|Overall Study|Physician Decision|1|||
147423573|NCT02751320|531715234|FG000|Overall Study|Adverse Event|2|||
147423574|NCT02751320|531715234|FG000|Overall Study|Withdrawal by Subject|1|||
147423575|NCT02549196|531715235|FG000|Overall Study|Protocol Violation|0|||
147423576|NCT02549196|531715236|FG001|Overall Study|Protocol Violation|0|||
147423577|NCT02549196|531715237|FG002|Overall Study|Protocol Violation|0|||
147423578|NCT02549196|531715238|FG003|Overall Study|Protocol Violation|1|||
147423579|NCT02549196|531715235|FG000|Overall Study|Withdrawal by Subject|1|||
147423580|NCT02549196|531715236|FG001|Overall Study|Withdrawal by Subject|0|||
147423581|NCT02549196|531715237|FG002|Overall Study|Withdrawal by Subject|1|||
147423582|NCT02549196|531715238|FG003|Overall Study|Withdrawal by Subject|0|||
147423583|NCT01442779|531715239|FG000|Overall Study|Withdrawal by Subject|3|||
147423584|NCT01442779|531715239|FG000|Overall Study|Death|3|||
147423585|NCT01442779|531715239|FG000|Overall Study|Non-compliance|1|||
147423586|NCT05249829|531715240|FG000|Overall Study|Participant Relocation|0|||
147423587|NCT05249829|531715241|FG001|Overall Study|Participant Relocation|1|||
147423588|NCT05249829|531715242|FG002|Overall Study|Participant Relocation|2|||
147423589|NCT05249829|531715243|FG003|Overall Study|Participant Relocation|2|||
147423590|NCT05249829|531715240|FG000|Overall Study|Withdrawal by Subject|9|||
147423591|NCT05249829|531715241|FG001|Overall Study|Withdrawal by Subject|17|||
147423592|NCT05249829|531715242|FG002|Overall Study|Withdrawal by Subject|40|||
147423593|NCT05249829|531715243|FG003|Overall Study|Withdrawal by Subject|35|||
147423594|NCT05249829|531715240|FG000|Overall Study|Physician Decision|1|||
147423595|NCT05249829|531715241|FG001|Overall Study|Physician Decision|0|||
147423596|NCT05249829|531715242|FG002|Overall Study|Physician Decision|0|||
147423597|NCT05249829|531715243|FG003|Overall Study|Physician Decision|0|||
147423598|NCT05249829|531715240|FG000|Overall Study|Lost to Follow-up|16|||
147423599|NCT05249829|531715241|FG001|Overall Study|Lost to Follow-up|16|||
147423600|NCT05249829|531715242|FG002|Overall Study|Lost to Follow-up|57|||
147423601|NCT05249829|531715243|FG003|Overall Study|Lost to Follow-up|60|||
147423602|NCT05249829|531715240|FG000|Overall Study|Adverse Event|2|||
147423603|NCT05249829|531715241|FG001|Overall Study|Adverse Event|2|||
147423604|NCT05249829|531715242|FG002|Overall Study|Adverse Event|2|||
147423605|NCT05249829|531715243|FG003|Overall Study|Adverse Event|2|||
147423606|NCT05249829|531715240|FG000|Overall Study|COVID-19 Non-Infection Related|0|||
147423607|NCT05249829|531715241|FG001|Overall Study|COVID-19 Non-Infection Related|0|||
147423608|NCT05249829|531715242|FG002|Overall Study|COVID-19 Non-Infection Related|0|||
147423609|NCT05249829|531715243|FG003|Overall Study|COVID-19 Non-Infection Related|1|||
147423610|NCT05249829|531715240|FG000|Overall Study|Protocol Violation|2|||
147423611|NCT05249829|531715241|FG001|Overall Study|Protocol Violation|0|||
147423612|NCT05249829|531715242|FG002|Overall Study|Protocol Violation|5|||
147423613|NCT05249829|531715243|FG003|Overall Study|Protocol Violation|3|||
147423614|NCT05249829|531715240|FG000|Overall Study|Death|0|||
147423615|NCT05249829|531715241|FG001|Overall Study|Death|1|||
147423616|NCT05249829|531715242|FG002|Overall Study|Death|2|||
147423617|NCT05249829|531715243|FG003|Overall Study|Death|4|||
147423618|NCT00513604|531715244|FG000|Overall Study|Not treated|2|||
147423619|NCT00513604|531715245|FG001|Overall Study|Not treated|0|||
147423620|NCT00513604|531715246|FG002|Overall Study|Not treated|1|||
147423621|NCT00513604|531715247|FG003|Overall Study|Not treated|0|||
147423622|NCT00513604|531715248|FG004|Overall Study|Not treated|0|||
147423623|NCT00513604|531715244|FG000|Overall Study|Death during treatment|0|||
147423624|NCT00513604|531715245|FG001|Overall Study|Death during treatment|3|||
147423625|NCT00513604|531715246|FG002|Overall Study|Death during treatment|2|||
147423626|NCT00513604|531715247|FG003|Overall Study|Death during treatment|0|||
147423627|NCT00513604|531715248|FG004|Overall Study|Death during treatment|0|||
147423628|NCT00196976|531715249|FG000|Primary Study|Migrated from study area|0|||
147423629|NCT00196976|531715250|FG001|Primary Study|Migrated from study area|0|||
147423630|NCT00196976|531715251|FG002|Primary Study|Migrated from study area|0|||
147423631|NCT00196976|531715252|FG003|Primary Study|Migrated from study area|0|||
147423632|NCT00196976|531715253|FG004|Primary Study|Migrated from study area|0|||
147423633|NCT00196976|531715254|FG005|Primary Study|Migrated from study area|0|||
147423634|NCT00196976|531715255|FG006|Primary Study|Migrated from study area|0|||
147423635|NCT00196976|531715256|FG007|Primary Study|Migrated from study area|1|||
147423636|NCT00196976|531715257|FG008|Primary Study|Migrated from study area|0|||
147423637|NCT00196976|531715258|FG009|Primary Study|Migrated from study area|0|||
147423638|NCT00196976|531715259|FG010|Primary Study|Migrated from study area|0|||
147423639|NCT00196976|531715260|FG011|Primary Study|Migrated from study area|0|||
147423640|NCT00196976|531715261|FG012|Primary Study|Migrated from study area|0|||
147423641|NCT00196976|531715262|FG013|Primary Study|Migrated from study area|0|||
147423642|NCT00196976|531715249|FG000|Primary Study|Protocol Violation|0|||
147423643|NCT00196976|531715250|FG001|Primary Study|Protocol Violation|1|||
147423644|NCT00196976|531715251|FG002|Primary Study|Protocol Violation|1|||
147423645|NCT00196976|531715252|FG003|Primary Study|Protocol Violation|0|||
147423646|NCT00196976|531715253|FG004|Primary Study|Protocol Violation|0|||
147423647|NCT00196976|531715254|FG005|Primary Study|Protocol Violation|0|||
147423648|NCT00196976|531715255|FG006|Primary Study|Protocol Violation|0|||
147423649|NCT00196976|531715256|FG007|Primary Study|Protocol Violation|0|||
147423650|NCT00196976|531715257|FG008|Primary Study|Protocol Violation|0|||
147423651|NCT00196976|531715258|FG009|Primary Study|Protocol Violation|0|||
147423652|NCT00196976|531715259|FG010|Primary Study|Protocol Violation|0|||
147423653|NCT00196976|531715260|FG011|Primary Study|Protocol Violation|0|||
147423654|NCT00196976|531715261|FG012|Primary Study|Protocol Violation|0|||
147423655|NCT00196976|531715262|FG013|Primary Study|Protocol Violation|0|||
147423656|NCT00196976|531715249|FG000|Primary Study|Withdrawal by Subject|1|||
147423657|NCT00196976|531715250|FG001|Primary Study|Withdrawal by Subject|0|||
147423658|NCT00196976|531715251|FG002|Primary Study|Withdrawal by Subject|1|||
147423659|NCT00196976|531715252|FG003|Primary Study|Withdrawal by Subject|1|||
147423660|NCT00196976|531715253|FG004|Primary Study|Withdrawal by Subject|2|||
147423661|NCT00196976|531715254|FG005|Primary Study|Withdrawal by Subject|1|||
147423662|NCT00196976|531715255|FG006|Primary Study|Withdrawal by Subject|0|||
147423663|NCT00196976|531715256|FG007|Primary Study|Withdrawal by Subject|0|||
147423664|NCT00196976|531715257|FG008|Primary Study|Withdrawal by Subject|0|||
147423665|NCT00196976|531715258|FG009|Primary Study|Withdrawal by Subject|1|||
147423666|NCT00196976|531715259|FG010|Primary Study|Withdrawal by Subject|0|||
147423667|NCT00196976|531715260|FG011|Primary Study|Withdrawal by Subject|0|||
147423668|NCT00196976|531715261|FG012|Primary Study|Withdrawal by Subject|0|||
147423669|NCT00196976|531715262|FG013|Primary Study|Withdrawal by Subject|0|||
147423670|NCT00196976|531715249|FG000|Primary Study|Lost to Follow-up|0|||
147423671|NCT00196976|531715250|FG001|Primary Study|Lost to Follow-up|0|||
147423672|NCT00196976|531715251|FG002|Primary Study|Lost to Follow-up|0|||
147423673|NCT00196976|531715252|FG003|Primary Study|Lost to Follow-up|0|||
147423674|NCT00196976|531715253|FG004|Primary Study|Lost to Follow-up|1|||
147423675|NCT00196976|531715254|FG005|Primary Study|Lost to Follow-up|1|||
147423676|NCT00196976|531715255|FG006|Primary Study|Lost to Follow-up|0|||
147423677|NCT00196976|531715256|FG007|Primary Study|Lost to Follow-up|2|||
147423678|NCT00196976|531715257|FG008|Primary Study|Lost to Follow-up|0|||
147423679|NCT00196976|531715258|FG009|Primary Study|Lost to Follow-up|0|||
147423680|NCT00196976|531715259|FG010|Primary Study|Lost to Follow-up|0|||
147423681|NCT00196976|531715260|FG011|Primary Study|Lost to Follow-up|0|||
147423682|NCT00196976|531715261|FG012|Primary Study|Lost to Follow-up|0|||
147423683|NCT00196976|531715262|FG013|Primary Study|Lost to Follow-up|0|||
147423684|NCT00196976|531715249|FG000|Primary Study|Other|0|||
147423685|NCT00196976|531715250|FG001|Primary Study|Other|0|||
147423686|NCT00196976|531715251|FG002|Primary Study|Other|2|||
147423687|NCT00196976|531715252|FG003|Primary Study|Other|0|||
147423688|NCT00196976|531715253|FG004|Primary Study|Other|0|||
147423689|NCT00196976|531715254|FG005|Primary Study|Other|0|||
147423690|NCT00196976|531715255|FG006|Primary Study|Other|0|||
147423691|NCT00196976|531715256|FG007|Primary Study|Other|0|||
147423692|NCT00196976|531715257|FG008|Primary Study|Other|0|||
147423693|NCT00196976|531715258|FG009|Primary Study|Other|0|||
147423694|NCT00196976|531715259|FG010|Primary Study|Other|0|||
147423695|NCT00196976|531715260|FG011|Primary Study|Other|0|||
147423696|NCT00196976|531715261|FG012|Primary Study|Other|0|||
147423697|NCT00196976|531715262|FG013|Primary Study|Other|0|||
147423698|NCT00196976|531715249|FG000|Booster Study|Withdrawal by Subject|0|||
147423699|NCT00196976|531715250|FG001|Booster Study|Withdrawal by Subject|0|||
147423700|NCT00196976|531715251|FG002|Booster Study|Withdrawal by Subject|0|||
147423701|NCT00196976|531715252|FG003|Booster Study|Withdrawal by Subject|0|||
147423702|NCT00196976|531715253|FG004|Booster Study|Withdrawal by Subject|0|||
147423703|NCT00196976|531715254|FG005|Booster Study|Withdrawal by Subject|0|||
147423704|NCT00196976|531715255|FG006|Booster Study|Withdrawal by Subject|0|||
147423705|NCT00196976|531715256|FG007|Booster Study|Withdrawal by Subject|0|||
147423706|NCT00196976|531715257|FG008|Booster Study|Withdrawal by Subject|0|||
147423707|NCT00196976|531715258|FG009|Booster Study|Withdrawal by Subject|0|||
147423708|NCT00196976|531715259|FG010|Booster Study|Withdrawal by Subject|1|||
147423709|NCT00196976|531715260|FG011|Booster Study|Withdrawal by Subject|0|||
147423710|NCT00196976|531715261|FG012|Booster Study|Withdrawal by Subject|0|||
147423711|NCT00196976|531715262|FG013|Booster Study|Withdrawal by Subject|0|||
147423712|NCT00196976|531715249|FG000|Booster Study|Lost to Follow-up|0|||
147423713|NCT00196976|531715250|FG001|Booster Study|Lost to Follow-up|0|||
147423714|NCT00196976|531715251|FG002|Booster Study|Lost to Follow-up|0|||
147423715|NCT00196976|531715252|FG003|Booster Study|Lost to Follow-up|0|||
147423716|NCT00196976|531715253|FG004|Booster Study|Lost to Follow-up|0|||
147423717|NCT00196976|531715254|FG005|Booster Study|Lost to Follow-up|0|||
147423718|NCT00196976|531715255|FG006|Booster Study|Lost to Follow-up|0|||
147423719|NCT00196976|531715256|FG007|Booster Study|Lost to Follow-up|0|||
147423720|NCT00196976|531715257|FG008|Booster Study|Lost to Follow-up|0|||
147423721|NCT00196976|531715258|FG009|Booster Study|Lost to Follow-up|0|||
147423722|NCT00196976|531715259|FG010|Booster Study|Lost to Follow-up|1|||
147423723|NCT00196976|531715260|FG011|Booster Study|Lost to Follow-up|2|||
147423724|NCT00196976|531715261|FG012|Booster Study|Lost to Follow-up|0|||
147423725|NCT00196976|531715262|FG013|Booster Study|Lost to Follow-up|0|||
147423726|NCT01535560|531715263|FG000|Overall Study|Adverse Event|12|||
147423727|NCT01535560|531715264|FG001|Overall Study|Adverse Event|7|||
147423728|NCT01535560|531715263|FG000|Overall Study|Lost to Follow-up|1|||
147423729|NCT01535560|531715264|FG001|Overall Study|Lost to Follow-up|3|||
147423730|NCT01535560|531715263|FG000|Overall Study|Subj Decision Unrel to an Adverse Event|3|||
147423731|NCT01535560|531715264|FG001|Overall Study|Subj Decision Unrel to an Adverse Event|1|||
147423732|NCT01535560|531715263|FG000|Overall Study|Treatment Failure|21|||
147423733|NCT01535560|531715264|FG001|Overall Study|Treatment Failure|83|||
147423734|NCT01535560|531715263|FG000|Overall Study|Other|0|||
147423735|NCT01535560|531715264|FG001|Overall Study|Other|1|||
147423736|NCT01535560|531715263|FG000|Overall Study|Randomized in Error|0|||
147423737|NCT01535560|531715264|FG001|Overall Study|Randomized in Error|1|||
147423738|NCT00609765|531715269|FG000|Overall Study|Study ended prior to 12 months|1|||
147423739|NCT03801915|531715270|FG000|Overall Study|Screen failure|0|||
147423740|NCT03801915|531715271|FG001|Overall Study|Screen failure|0|||
147423741|NCT03801915|531715272|FG002|Overall Study|Screen failure|1|||
147423742|NCT03801915|531715270|FG000|Overall Study|Ineligible|1|||
147423743|NCT03801915|531715271|FG001|Overall Study|Ineligible|0|||
147423744|NCT03801915|531715272|FG002|Overall Study|Ineligible|0|||
147423745|NCT03801915|531715270|FG000|Overall Study|Physician Decision|2|||
147423746|NCT03801915|531715271|FG001|Overall Study|Physician Decision|1|||
147423747|NCT03801915|531715272|FG002|Overall Study|Physician Decision|0|||
147423748|NCT00729378|531717619|FG000|Baseline|Did not complete study measurements|72|||
147423749|NCT00729378|531717620|FG001|Baseline|Did not complete study measurements|33|||
147423750|NCT00729378|531717619|FG000|Baseline|Withdrawal by Subject|66|||
147423751|NCT00729378|531717620|FG001|Baseline|Withdrawal by Subject|59|||
147423752|NCT00729378|531717619|FG000|12-months|Lost to Follow-up|100|||
147423753|NCT00729378|531717620|FG001|12-months|Lost to Follow-up|65|||
147423754|NCT00729378|531717619|FG000|24-months|Lost to Follow-up|72|||
147423755|NCT00729378|531717620|FG001|24-months|Lost to Follow-up|51|||
147423756|NCT00729378|531717619|FG000|36-months|Lost to Follow-up|15|||
147423757|NCT00729378|531717620|FG001|36-months|Lost to Follow-up|6|||
147423758|NCT01586910|531717621|FG000|Overall Study|Death|4|||
147423759|NCT01586910|531717622|FG001|Overall Study|Death|4|||
147423760|NCT01586910|531717621|FG000|Overall Study|Withdrawal by Subject|6|||
147423761|NCT01586910|531717622|FG001|Overall Study|Withdrawal by Subject|43|||
147423762|NCT01586910|531717621|FG000|Overall Study|Physician withdrew Subject|5|||
147423763|NCT01586910|531717622|FG001|Overall Study|Physician withdrew Subject|24|||
147423764|NCT01328717|531717631|FG000|Overall Study|Adverse Event|1|||
147423765|NCT00346268|531717632|FG000|Overall Study|Adverse Event|1|||
147423766|NCT00346268|531717633|FG001|Overall Study|Adverse Event|0|||
147423767|NCT00346268|531717632|FG000|Overall Study|Protocol Violation|1|||
147423768|NCT00346268|531717633|FG001|Overall Study|Protocol Violation|0|||
147423769|NCT00346268|531717632|FG000|Overall Study|Participant refused|0|||
147423770|NCT00346268|531717633|FG001|Overall Study|Participant refused|3|||
147423771|NCT02164383|531717634|FG000|Overall Study|Lost to Follow-up|1|||
147423772|NCT02164383|531717635|FG001|Overall Study|Lost to Follow-up|0|||
147423773|NCT00743275|531717636|FG000|Overall Study|Protocol Violation|0|||
147423774|NCT00743275|531717637|FG001|Overall Study|Protocol Violation|1|||
147423775|NCT01672723|531717638|FG000|First Intervention|Adverse Event|3|||
147423776|NCT01672723|531717639|FG001|First Intervention|Adverse Event|0|||
147423777|NCT01828073|531717645|FG000|Overall Study|Lost to Follow-up|1|||
147423778|NCT01828073|531717646|FG001|Overall Study|Lost to Follow-up|2|||
147423779|NCT00690443|531717651|FG000|Overall Study|Adverse Event|1|||
147423780|NCT00690443|531717652|FG001|Overall Study|Adverse Event|2|||
147423781|NCT03057977|531717653|FG000|Discontinuation From Treatment|Withdrawal by Subject|124|||
147423782|NCT03057977|531717654|FG001|Discontinuation From Treatment|Withdrawal by Subject|92|||
147423783|NCT03057977|531717653|FG000|Discontinuation From Treatment|Lost to Follow-up|11|||
147423784|NCT03057977|531717654|FG001|Discontinuation From Treatment|Lost to Follow-up|17|||
147423785|NCT03057977|531717653|FG000|Discontinuation From Treatment|Protocol Violation|6|||
147423786|NCT03057977|531717654|FG001|Discontinuation From Treatment|Protocol Violation|5|||
147423787|NCT03057977|531717653|FG000|Discontinuation From Treatment|Not treated|4|||
147423788|NCT03057977|531717654|FG001|Discontinuation From Treatment|Not treated|0|||
147423789|NCT03057977|531717653|FG000|Discontinuation From Treatment|Adverse Event|343|||
147423790|NCT03057977|531717654|FG001|Discontinuation From Treatment|Adverse Event|337|||
147423791|NCT03057977|531717653|FG000|Discontinuation From Treatment|Reason Unknown|0|||
147423792|NCT03057977|531717654|FG001|Discontinuation From Treatment|Reason Unknown|1|||
147423793|NCT03057977|531717653|FG000|Discontinuation From Treatment|Personal Reasons|1|||
147423794|NCT03057977|531717654|FG001|Discontinuation From Treatment|Personal Reasons|1|||
147423795|NCT03057977|531717653|FG000|Discontinuation From Treatment|Unblinded medication|1|||
147423796|NCT03057977|531717654|FG001|Discontinuation From Treatment|Unblinded medication|0|||
147423797|NCT03057977|531717653|FG000|Discontinuation From Treatment|Patient received Empagliflozin for Diabetes|1|||
147423798|NCT03057977|531717654|FG001|Discontinuation From Treatment|Patient received Empagliflozin for Diabetes|1|||
147423799|NCT03057977|531717653|FG000|Discontinuation From Treatment|Principle Investigator Decision|2|||
147423800|NCT03057977|531717654|FG001|Discontinuation From Treatment|Principle Investigator Decision|0|||
147423801|NCT03057977|531717653|FG000|Discontinuation From Treatment|Other medical condition (no Adverse Event)|2|||
147423802|NCT03057977|531717654|FG001|Discontinuation From Treatment|Other medical condition (no Adverse Event)|4|||
147423803|NCT03057977|531717653|FG000|Discontinuation From Treatment|Patient moved away/being abroad|4|||
147423804|NCT03057977|531717654|FG001|Discontinuation From Treatment|Patient moved away/being abroad|3|||
147423805|NCT03057977|531717653|FG000|Discontinuation From Treatment|Unable to continue treatment|4|||
147423806|NCT03057977|531717654|FG001|Discontinuation From Treatment|Unable to continue treatment|1|||
147423807|NCT03057977|531717653|FG000|Discontinuation From Treatment|Not attending study visit|3|||
147423808|NCT03057977|531717654|FG001|Discontinuation From Treatment|Not attending study visit|10|||
147423809|NCT03057977|531717653|FG000|Discontinuation From Treatment|Due to Covid-19 Pandemic|1|||
147423810|NCT03057977|531717654|FG001|Discontinuation From Treatment|Due to Covid-19 Pandemic|4|||
147423811|NCT03057977|531717653|FG000|Discontinuation From Treatment|Patient decision to stop/interrupt medication|8|||
147423812|NCT03057977|531717654|FG001|Discontinuation From Treatment|Patient decision to stop/interrupt medication|6|||
147423813|NCT03057977|531717653|FG000|Discontinuation From Trial|Lost to follow-up to primary endpoint|9|||
147423814|NCT03057977|531717654|FG001|Discontinuation From Trial|Lost to follow-up to primary endpoint|9|||
147423815|NCT03057977|531717653|FG000|Discontinuation From Trial|Limited follow-up agreed|2|||
147423816|NCT03057977|531717654|FG001|Discontinuation From Trial|Limited follow-up agreed|2|||
147306714|NCT00311155|531290715|FG000|Overall Study|Adverse Event|21|||
147423817|NCT03057977|531717653|FG000|Discontinuation From Trial|Withdrawal by Subject|9|||
147423818|NCT03057977|531717654|FG001|Discontinuation From Trial|Withdrawal by Subject|11|||
147423819|NCT00953407|531717655|FG000|Overall Study|Failed inclusion criteria|1|||
147423820|NCT00953407|531717656|FG001|Overall Study|Failed inclusion criteria|1|||
147423821|NCT00953407|531717657|FG002|Overall Study|Failed inclusion criteria|1|||
147423822|NCT00953407|531717658|FG003|Overall Study|Failed inclusion criteria|1|||
147423823|NCT00953407|531717659|FG004|Overall Study|Failed inclusion criteria|1|||
147423824|NCT00953407|531717655|FG000|Overall Study|Lost to Follow-up|0|||
147423825|NCT00953407|531717656|FG001|Overall Study|Lost to Follow-up|0|||
147423826|NCT00953407|531717657|FG002|Overall Study|Lost to Follow-up|0|||
147423827|NCT00953407|531717658|FG003|Overall Study|Lost to Follow-up|1|||
147423828|NCT00953407|531717659|FG004|Overall Study|Lost to Follow-up|0|||
147423829|NCT02502097|531717660|FG000|Period 1|Adverse Event|0|||
147423830|NCT02502097|531717661|FG001|Period 1|Adverse Event|0|||
147423831|NCT02502097|531717662|FG002|Period 1|Adverse Event|1|||
147423832|NCT02502097|531717663|FG003|Period 1|Adverse Event|0|||
147423833|NCT02502097|531717660|FG000|Wash Out Period|Adverse Event|0|||
147423834|NCT02502097|531717661|FG001|Wash Out Period|Adverse Event|1|||
147423835|NCT02502097|531717662|FG002|Wash Out Period|Adverse Event|1|||
147423836|NCT02502097|531717663|FG003|Wash Out Period|Adverse Event|1|||
147423837|NCT02502097|531717660|FG000|Period 2|Adverse Event|0|||
147423838|NCT02502097|531717661|FG001|Period 2|Adverse Event|0|||
147423839|NCT02502097|531717662|FG002|Period 2|Adverse Event|1|||
147423840|NCT02502097|531717663|FG003|Period 2|Adverse Event|0|||
147423841|NCT01350336|531717664|FG000|Overall Study|Lost to Follow-up|31|||
147423842|NCT01350336|531717664|FG000|Overall Study|Withdrawal by Subject|14|||
147423843|NCT01350336|531717664|FG000|Overall Study|Physician Decision|8|||
147423844|NCT01350336|531717664|FG000|Overall Study|Death|4|||
147423845|NCT01016977|531717672|FG000|Overall Study|Lost to Follow-up|1|||
147423846|NCT01016977|531717673|FG001|Overall Study|Lost to Follow-up|0|||
147423847|NCT01016977|531717672|FG000|Overall Study|Withdrawal by Subject|2|||
147423848|NCT01016977|531717673|FG001|Overall Study|Withdrawal by Subject|2|||
147423849|NCT05081388|531717676|FG000|Overall Study|Adverse Event|1|||
147423850|NCT05081388|531717677|FG001|Overall Study|Adverse Event|0|||
147423851|NCT05081388|531717678|FG002|Overall Study|Adverse Event|0|||
147423852|NCT05081388|531717679|FG003|Overall Study|Adverse Event|0|||
147423853|NCT05081388|531717680|FG004|Overall Study|Adverse Event|0|||
147423854|NCT05081388|531717676|FG000|Overall Study|Lost to Follow-up|0|||
147423855|NCT05081388|531717677|FG001|Overall Study|Lost to Follow-up|1|||
147423856|NCT05081388|531717678|FG002|Overall Study|Lost to Follow-up|0|||
147423857|NCT05081388|531717679|FG003|Overall Study|Lost to Follow-up|0|||
147423858|NCT05081388|531717680|FG004|Overall Study|Lost to Follow-up|0|||
147423859|NCT05081388|531717676|FG000|Overall Study|Subject decision|0|||
147423860|NCT05081388|531717677|FG001|Overall Study|Subject decision|0|||
147423861|NCT05081388|531717678|FG002|Overall Study|Subject decision|0|||
147423862|NCT05081388|531717679|FG003|Overall Study|Subject decision|1|||
147423863|NCT05081388|531717680|FG004|Overall Study|Subject decision|0|||
147423864|NCT01776541|531717681|FG000|Overall Study|Administrative Reason|6|||
147423865|NCT01776541|531717682|FG001|Overall Study|Administrative Reason|2|||
147423866|NCT01776541|531717681|FG000|Overall Study|Death|4|||
147423867|NCT01776541|531717682|FG001|Overall Study|Death|0|||
147423868|NCT01776541|531717681|FG000|Overall Study|Lost to Follow-up|27|||
147423869|NCT01776541|531717682|FG001|Overall Study|Lost to Follow-up|48|||
147423870|NCT01776541|531717681|FG000|Overall Study|Unclassified|5|||
147423871|NCT01776541|531717682|FG001|Overall Study|Unclassified|4|||
147423872|NCT01776541|531717681|FG000|Overall Study|Protocol Violation|2|||
147423873|NCT01776541|531717682|FG001|Overall Study|Protocol Violation|1|||
147423874|NCT01776541|531717681|FG000|Overall Study|Withdrawal by Subject|12|||
147423875|NCT01776541|531717682|FG001|Overall Study|Withdrawal by Subject|20|||
147423876|NCT04279392|531717683|FG000|Overall Study|Physician Decision|1|||
147423877|NCT04279392|531717684|FG001|Overall Study|Physician Decision|0|||
147423878|NCT01171807|531717685|FG000|Overall Study|Treatment failure|2|||
147423879|NCT01171807|531717686|FG001|Overall Study|Treatment failure|4|||
147423880|NCT01171807|531717685|FG000|Overall Study|Non compliance|1|||
147423881|NCT01171807|531717686|FG001|Overall Study|Non compliance|0|||
147423882|NCT01171807|531717685|FG000|Overall Study|Lost to Follow-up|3|||
147423883|NCT01171807|531717686|FG001|Overall Study|Lost to Follow-up|0|||
147423884|NCT01901341|531717687|FG000|Overall Study|Adverse Event|4|||
147423885|NCT01901341|531717688|FG001|Overall Study|Adverse Event|2|||
147423886|NCT01901341|531717687|FG000|Overall Study|Lack of Efficacy|0|||
147423887|NCT01901341|531717688|FG001|Overall Study|Lack of Efficacy|2|||
147423888|NCT01901341|531717687|FG000|Overall Study|Lost to Follow-up|0|||
147423889|NCT01901341|531717688|FG001|Overall Study|Lost to Follow-up|1|||
147423890|NCT01901341|531717687|FG000|Overall Study|Protocol Violation|2|||
147423891|NCT01901341|531717688|FG001|Overall Study|Protocol Violation|0|||
147423892|NCT01901341|531717687|FG000|Overall Study|Study Terminated by Sponsor|13|||
147423893|NCT01901341|531717688|FG001|Overall Study|Study Terminated by Sponsor|15|||
147423894|NCT01901341|531717687|FG000|Overall Study|Withdrawal by Subject|1|||
147423895|NCT01901341|531717688|FG001|Overall Study|Withdrawal by Subject|1|||
147191328|NCT00117637|530867606|FG001|First Intervention (Period 1)|Protocol Violation|0|||
147423896|NCT01981473|531717689|FG000|Overall Study|Incorrect diagnosis of RA|0|||
147423897|NCT01981473|531717690|FG001|Overall Study|Incorrect diagnosis of RA|0|||
147423898|NCT01981473|531717691|FG002|Overall Study|Incorrect diagnosis of RA|1|||
147423899|NCT01981473|531717689|FG000|Overall Study|Received treatment for < 6 months|0|||
147423900|NCT01981473|531717690|FG001|Overall Study|Received treatment for < 6 months|0|||
147423901|NCT01981473|531717691|FG002|Overall Study|Received treatment for < 6 months|1|||
147423902|NCT01981473|531717689|FG000|Overall Study|Received treatment for >24 months|2|||
147423903|NCT01981473|531717690|FG001|Overall Study|Received treatment for >24 months|0|||
147423904|NCT01981473|531717691|FG002|Overall Study|Received treatment for >24 months|6|||
147423905|NCT00738582|531717692|FG000|Combination Therapy|Completed Combination Therapy|1|||
147423906|NCT00738582|531717693|FG001|Combination Therapy|Completed Combination Therapy|0|||
147423907|NCT00738582|531717692|FG000|Combination Therapy|Physician Decision|1|||
147423908|NCT00738582|531717693|FG001|Combination Therapy|Physician Decision|0|||
147423909|NCT00738582|531717692|FG000|Combination Therapy|Toxicity to Chemotherapy|1|||
147423910|NCT00738582|531717693|FG001|Combination Therapy|Toxicity to Chemotherapy|0|||
147423911|NCT00738582|531717692|FG000|Combination Therapy|Other|5|||
147423912|NCT00738582|531717693|FG001|Combination Therapy|Other|0|||
147423913|NCT00738582|531717692|FG000|Combination Therapy|Adverse Event|16|||
147423914|NCT00738582|531717693|FG001|Combination Therapy|Adverse Event|0|||
147423915|NCT00738582|531717692|FG000|Combination Therapy|Progressive Disease|9|||
147423916|NCT00738582|531717693|FG001|Combination Therapy|Progressive Disease|0|||
147423917|NCT00738582|531717692|FG000|Maintenance Therapy|Other|0|||
147423918|NCT00738582|531717693|FG001|Maintenance Therapy|Other|2|||
147423919|NCT00738582|531717692|FG000|Maintenance Therapy|Adverse Event|0|||
147423920|NCT00738582|531717693|FG001|Maintenance Therapy|Adverse Event|6|||
147423921|NCT00738582|531717692|FG000|Maintenance Therapy|Progressive Disease|0|||
147423922|NCT00738582|531717693|FG001|Maintenance Therapy|Progressive Disease|47|||
147423923|NCT00738582|531717692|FG000|Maintenance Therapy|Withdrawal by Subject|0|||
147423924|NCT00738582|531717693|FG001|Maintenance Therapy|Withdrawal by Subject|1|||
147423925|NCT00757588|531717694|FG000|Period 1: Short-term (24-week) Phase|Lack of Efficacy|3|||
147423926|NCT00757588|531717695|FG001|Period 1: Short-term (24-week) Phase|Lack of Efficacy|2|||
147423927|NCT00757588|531717694|FG000|Period 1: Short-term (24-week) Phase|Adverse Event|6|||
147423928|NCT00757588|531717695|FG001|Period 1: Short-term (24-week) Phase|Adverse Event|3|||
147423929|NCT00757588|531717694|FG000|Period 1: Short-term (24-week) Phase|Withdrawal by Subject|13|||
147423930|NCT00757588|531717695|FG001|Period 1: Short-term (24-week) Phase|Withdrawal by Subject|5|||
147423931|NCT00757588|531717694|FG000|Period 1: Short-term (24-week) Phase|Death|1|||
147423932|NCT00757588|531717695|FG001|Period 1: Short-term (24-week) Phase|Death|0|||
147423933|NCT00757588|531717694|FG000|Period 1: Short-term (24-week) Phase|Lost to Follow-up|3|||
147423934|NCT00757588|531717695|FG001|Period 1: Short-term (24-week) Phase|Lost to Follow-up|5|||
147423935|NCT00757588|531717694|FG000|Period 1: Short-term (24-week) Phase|Poor compliance or noncompliance|5|||
147423936|NCT00757588|531717695|FG001|Period 1: Short-term (24-week) Phase|Poor compliance or noncompliance|1|||
147423937|NCT00757588|531717694|FG000|Period 1: Short-term (24-week) Phase|No longer meets study criteria|5|||
147423938|NCT00757588|531717695|FG001|Period 1: Short-term (24-week) Phase|No longer meets study criteria|0|||
147423939|NCT00757588|531717694|FG000|Period 1: Short-term (24-week) Phase|Other|0|||
147423940|NCT00757588|531717695|FG001|Period 1: Short-term (24-week) Phase|Other|1|||
147423941|NCT00757588|531717694|FG000|Period 2: Long-term (52-week) Phase|Lack of Efficacy|1|||
147423942|NCT00757588|531717695|FG001|Period 2: Long-term (52-week) Phase|Lack of Efficacy|0|||
147423943|NCT00757588|531717694|FG000|Period 2: Long-term (52-week) Phase|Adverse Event|4|||
147423944|NCT00757588|531717695|FG001|Period 2: Long-term (52-week) Phase|Adverse Event|0|||
147423945|NCT00757588|531717694|FG000|Period 2: Long-term (52-week) Phase|Withdrawal by Subject|4|||
147423946|NCT00757588|531717695|FG001|Period 2: Long-term (52-week) Phase|Withdrawal by Subject|2|||
147423947|NCT00757588|531717694|FG000|Period 2: Long-term (52-week) Phase|Lost to Follow-up|1|||
147423948|NCT00757588|531717695|FG001|Period 2: Long-term (52-week) Phase|Lost to Follow-up|1|||
147423949|NCT00757588|531717694|FG000|Period 2: Long-term (52-week) Phase|Poor or noncompliance|5|||
147423950|NCT00757588|531717695|FG001|Period 2: Long-term (52-week) Phase|Poor or noncompliance|2|||
147423951|NCT00757588|531717694|FG000|Period 2: Long-term (52-week) Phase|Pregnancy|1|||
147423952|NCT00757588|531717695|FG001|Period 2: Long-term (52-week) Phase|Pregnancy|0|||
147423953|NCT00757588|531717694|FG000|Period 2: Long-term (52-week) Phase|No longer meets study criteria|5|||
147423954|NCT00757588|531717695|FG001|Period 2: Long-term (52-week) Phase|No longer meets study criteria|4|||
147423955|NCT00757588|531717694|FG000|Period 2: Long-term (52-week) Phase|Other|1|||
147423956|NCT00757588|531717695|FG001|Period 2: Long-term (52-week) Phase|Other|0|||
147423957|NCT00799513|531717700|FG000|Overall Study|Physician Decision|1|||
147423958|NCT00799513|531717700|FG000|Overall Study|Adverse Event|1|||
147423959|NCT05062759|531717701|FG000|Overall Study|Death|0|||
147423960|NCT05062759|531717702|FG001|Overall Study|Death|1|||
147423961|NCT05062759|531717701|FG000|Overall Study|Lost to Follow-up|1|||
147191329|NCT00117637|530867605|FG000|First Intervention (Period 1)|Withdrawal by Subject|2|||
147423962|NCT05062759|531717702|FG001|Overall Study|Lost to Follow-up|0|||
147423963|NCT00903006|531717703|FG000|Overall Study|Withdrawal by Subject|2|||
147423964|NCT00903006|531717704|FG001|Overall Study|Withdrawal by Subject|0|||
147423965|NCT00903006|531717705|FG002|Overall Study|Withdrawal by Subject|0|||
147423966|NCT00903006|531717706|FG003|Overall Study|Withdrawal by Subject|0|||
147423967|NCT00903006|531717703|FG000|Overall Study|Progressive Disease|0|||
147423968|NCT00903006|531717704|FG001|Overall Study|Progressive Disease|3|||
147423969|NCT00903006|531717705|FG002|Overall Study|Progressive Disease|1|||
147423970|NCT00903006|531717706|FG003|Overall Study|Progressive Disease|0|||
147423971|NCT02572882|531717709|FG000|Overall Study|Withdrawal by Subject|1|||
147423972|NCT02572882|531717709|FG000|Overall Study|Participant received kidney transplant|1|||
147423973|NCT01079663|531717712|FG000|Overall Study|Adverse Event|0|||
147423974|NCT01079663|531717713|FG001|Overall Study|Adverse Event|2|||
147423975|NCT01079663|531717712|FG000|Overall Study|Protocol Violation|0|||
147423976|NCT01079663|531717713|FG001|Overall Study|Protocol Violation|2|||
147423977|NCT03486457|531717714|FG000|Up to Month 3|Adverse Event|2|||
147423978|NCT03486457|531717715|FG001|Up to Month 3|Adverse Event|5|||
147423979|NCT03486457|531717714|FG000|Up to Month 3|Lack of Efficacy|1|||
147423980|NCT03486457|531717715|FG001|Up to Month 3|Lack of Efficacy|0|||
147423981|NCT03486457|531717714|FG000|Up to Month 3|Withdrawal by Subject|1|||
147423982|NCT03486457|531717715|FG001|Up to Month 3|Withdrawal by Subject|0|||
147423983|NCT03486457|531717714|FG000|Up to Month 3|Failure to Meet Randomization Criteria|2|||
147423984|NCT03486457|531717715|FG001|Up to Month 3|Failure to Meet Randomization Criteria|0|||
147423985|NCT03486457|531717714|FG000|Up to Month 3|Other|1|||
147423986|NCT03486457|531717715|FG001|Up to Month 3|Other|0|||
147423987|NCT03486457|531717714|FG000|Month 3 to Month 6|Adverse Event|2|||
147423988|NCT03486457|531717715|FG001|Month 3 to Month 6|Adverse Event|0|||
147423989|NCT03486457|531717714|FG000|Month 3 to Month 6|Lost to Follow-up|0|||
147423990|NCT03486457|531717715|FG001|Month 3 to Month 6|Lost to Follow-up|1|||
147423991|NCT03486457|531717714|FG000|Month 3 to Month 6|Pregnancy|0|||
147423992|NCT03486457|531717715|FG001|Month 3 to Month 6|Pregnancy|1|||
147423993|NCT03486457|531717714|FG000|Month 3 to Month 6|Other|1|||
147423994|NCT03486457|531717715|FG001|Month 3 to Month 6|Other|0|||
147423995|NCT03536143|531717716|FG000|Overall Study|Early termination, Sponsor decision|1|||
147423996|NCT01878214|531717717|FG000|Overall Study|Withdrawal by Subject|18|||
147423997|NCT01878214|531717718|FG001|Overall Study|Withdrawal by Subject|7|||
147423998|NCT01878214|531717717|FG000|Overall Study|Death|0|||
147423999|NCT01878214|531717718|FG001|Overall Study|Death|1|||
147424000|NCT01878214|531717717|FG000|Overall Study|Lost to Follow-up|35|||
147424001|NCT01878214|531717718|FG001|Overall Study|Lost to Follow-up|36|||
147424002|NCT00946101|531717719|FG000|Overall Study|Lost to Follow-up|2|||
147424003|NCT00946101|531717720|FG001|Overall Study|Lost to Follow-up|1|||
147424004|NCT00946101|531717719|FG000|Overall Study|Withdrawal of consent|2|||
147424005|NCT00946101|531717720|FG001|Overall Study|Withdrawal of consent|0|||
147424006|NCT00946101|531717719|FG000|Overall Study|Physician Decision|0|||
147424007|NCT00946101|531717720|FG001|Overall Study|Physician Decision|1|||
147424008|NCT01174160|531717721|FG000|Overall Study|Adverse Event|1|||
147424009|NCT01174160|531717722|FG001|Overall Study|Adverse Event|0|||
147424010|NCT01174160|531717721|FG000|Overall Study|Lost to Follow-up|1|||
147424011|NCT01174160|531717722|FG001|Overall Study|Lost to Follow-up|0|||
147424012|NCT01174160|531717721|FG000|Overall Study|Physician Decision|1|||
147424013|NCT01174160|531717722|FG001|Overall Study|Physician Decision|0|||
147424014|NCT01174160|531717721|FG000|Overall Study|Protocol Violation|4|||
147424015|NCT01174160|531717722|FG001|Overall Study|Protocol Violation|6|||
147424016|NCT01174160|531717721|FG000|Overall Study|Withdrawal by Subject|1|||
147424017|NCT01174160|531717722|FG001|Overall Study|Withdrawal by Subject|0|||
147424018|NCT01590017|531717723|FG000|Overall Study|Adverse Event|1|||
147424019|NCT01590017|531717723|FG000|Overall Study|Withdrawal by Subject|1|||
147424020|NCT01590017|531717723|FG000|Overall Study|Lack of Efficacy|1|||
147424021|NCT01590017|531717723|FG000|Overall Study|Physician Decision|1|||
147424022|NCT00093808|531717724|FG000|Overall Study|Cancel participation before receiving tx|1|||
147424023|NCT00093808|531717724|FG000|Overall Study|Protocol Violation|1|||
147424024|NCT00871780|531717725|FG000|Overall Study|Enrolled But Not Treated|6|||
147424025|NCT00871780|531717725|FG000|Overall Study|Withdrawal by Subject|9|||
147424026|NCT00871780|531717725|FG000|Overall Study|Adverse Event|6|||
147424027|NCT00871780|531717725|FG000|Overall Study|Voluntary Discontinuation|4|||
147424028|NCT00871780|531717725|FG000|Overall Study|Death|1|||
147424029|NCT00871780|531717725|FG000|Overall Study|Physician Decision|1|||
147424030|NCT02527343|531717726|FG000|RT Period: Weeks 1 to 52|Investigator Judgement|1|||
147424031|NCT02527343|531717727|FG001|RT Period: Weeks 1 to 52|Investigator Judgement|0|||
147424032|NCT02527343|531717728|FG002|RT Period: Weeks 1 to 52|Investigator Judgement|0|||
147424033|NCT02527343|531717729|FG003|RT Period: Weeks 1 to 52|Investigator Judgement|0|||
147424034|NCT02527343|531717730|FG004|RT Period: Weeks 1 to 52|Investigator Judgement|0|||
147424035|NCT02527343|531717731|FG005|RT Period: Weeks 1 to 52|Investigator Judgement|0|||
147424036|NCT02527343|531717726|FG000|RT Period: Weeks 1 to 52|Voluntary withdrawal|1|||
147424037|NCT02527343|531717727|FG001|RT Period: Weeks 1 to 52|Voluntary withdrawal|0|||
147424038|NCT02527343|531717728|FG002|RT Period: Weeks 1 to 52|Voluntary withdrawal|0|||
147424039|NCT02527343|531717729|FG003|RT Period: Weeks 1 to 52|Voluntary withdrawal|0|||
147424040|NCT02527343|531717730|FG004|RT Period: Weeks 1 to 52|Voluntary withdrawal|0|||
147424041|NCT02527343|531717731|FG005|RT Period: Weeks 1 to 52|Voluntary withdrawal|0|||
147424042|NCT02527343|531717726|FG000|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
147424043|NCT02527343|531717727|FG001|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|4|||
147424044|NCT02527343|531717728|FG002|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
147424045|NCT02527343|531717729|FG003|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
147424046|NCT02527343|531717730|FG004|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
147424047|NCT02527343|531717731|FG005|RT Period: Weeks 1 to 52|Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
147424048|NCT02527343|531717726|FG000|RT Period: Weeks 1 to 52|Other|4|||
147424049|NCT02527343|531717727|FG001|RT Period: Weeks 1 to 52|Other|3|||
147424050|NCT02527343|531717728|FG002|RT Period: Weeks 1 to 52|Other|0|||
147424051|NCT02527343|531717729|FG003|RT Period: Weeks 1 to 52|Other|0|||
147424052|NCT02527343|531717730|FG004|RT Period: Weeks 1 to 52|Other|0|||
147424053|NCT02527343|531717731|FG005|RT Period: Weeks 1 to 52|Other|0|||
147424054|NCT02527343|531717726|FG000|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0|||
147424055|NCT02527343|531717727|FG001|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0|||
147424056|NCT02527343|531717728|FG002|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|1|||
147424057|NCT02527343|531717729|FG003|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0|||
147424058|NCT02527343|531717730|FG004|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0|||
147424059|NCT02527343|531717731|FG005|RT Post Treatment Follow-up: Weeks 54-65|AE or SAE|0|||
147424060|NCT02527343|531717726|FG000|RT Post Treatment Follow-up: Weeks 54-65|Other|0|||
147424061|NCT02527343|531717727|FG001|RT Post Treatment Follow-up: Weeks 54-65|Other|0|||
147424062|NCT02527343|531717728|FG002|RT Post Treatment Follow-up: Weeks 54-65|Other|0|||
147424063|NCT02527343|531717729|FG003|RT Post Treatment Follow-up: Weeks 54-65|Other|2|||
147424064|NCT02527343|531717730|FG004|RT Post Treatment Follow-up: Weeks 54-65|Other|0|||
147424065|NCT02527343|531717731|FG005|RT Post Treatment Follow-up: Weeks 54-65|Other|0|||
147424066|NCT02527343|531717726|FG000|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0|||
147424067|NCT02527343|531717727|FG001|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0|||
147424068|NCT02527343|531717728|FG002|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0|||
147424069|NCT02527343|531717729|FG003|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0|||
147424070|NCT02527343|531717730|FG004|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|1|||
147424071|NCT02527343|531717731|FG005|OLE Period-Year 1: Week 53 to 104|Investigator Judgement|0|||
147424072|NCT02527343|531717726|FG000|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|0|||
147424073|NCT02527343|531717727|FG001|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|0|||
147424074|NCT02527343|531717728|FG002|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|0|||
147424075|NCT02527343|531717729|FG003|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|0|||
147424076|NCT02527343|531717730|FG004|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|3|||
147424077|NCT02527343|531717731|FG005|OLE Period-Year 1: Week 53 to 104|Voluntary Withdrawal|1|||
147424078|NCT02527343|531717726|FG000|OLE Period-Year 1: Week 53 to 104|AE or SAE|0|||
147424079|NCT02527343|531717727|FG001|OLE Period-Year 1: Week 53 to 104|AE or SAE|0|||
147424080|NCT02527343|531717728|FG002|OLE Period-Year 1: Week 53 to 104|AE or SAE|0|||
147424081|NCT02527343|531717729|FG003|OLE Period-Year 1: Week 53 to 104|AE or SAE|0|||
147424082|NCT02527343|531717730|FG004|OLE Period-Year 1: Week 53 to 104|AE or SAE|2|||
147424083|NCT02527343|531717731|FG005|OLE Period-Year 1: Week 53 to 104|AE or SAE|1|||
147424084|NCT02527343|531717726|FG000|OLE Period-Year 1: Week 53 to 104|Other|0|||
147424085|NCT02527343|531717727|FG001|OLE Period-Year 1: Week 53 to 104|Other|0|||
147424086|NCT02527343|531717728|FG002|OLE Period-Year 1: Week 53 to 104|Other|0|||
147424087|NCT02527343|531717729|FG003|OLE Period-Year 1: Week 53 to 104|Other|0|||
147424088|NCT02527343|531717730|FG004|OLE Period-Year 1: Week 53 to 104|Other|5|||
147424089|NCT02527343|531717731|FG005|OLE Period-Year 1: Week 53 to 104|Other|7|||
147424090|NCT02527343|531717726|FG000|OLE Period-Year 2: Week 105 to 156|Other|0|||
147424091|NCT02527343|531717727|FG001|OLE Period-Year 2: Week 105 to 156|Other|0|||
147424092|NCT02527343|531717728|FG002|OLE Period-Year 2: Week 105 to 156|Other|0|||
147424093|NCT02527343|531717729|FG003|OLE Period-Year 2: Week 105 to 156|Other|0|||
147424094|NCT02527343|531717730|FG004|OLE Period-Year 2: Week 105 to 156|Other|1|||
147424095|NCT02527343|531717731|FG005|OLE Period-Year 2: Week 105 to 156|Other|2|||
147424096|NCT02527343|531717726|FG000|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0|||
147424097|NCT02527343|531717727|FG001|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0|||
147424098|NCT02527343|531717728|FG002|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0|||
147424099|NCT02527343|531717729|FG003|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0|||
147424100|NCT02527343|531717730|FG004|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|1|||
147424101|NCT02527343|531717731|FG005|PT Follow-up: Weeks 104 to 169|Voluntary withdrawal|0|||
147424102|NCT02527343|531717726|FG000|PT Follow-up: Weeks 104 to 169|Other|0|||
147424103|NCT02527343|531717727|FG001|PT Follow-up: Weeks 104 to 169|Other|0|||
147424104|NCT02527343|531717728|FG002|PT Follow-up: Weeks 104 to 169|Other|0|||
147424105|NCT02527343|531717729|FG003|PT Follow-up: Weeks 104 to 169|Other|0|||
147424106|NCT02527343|531717730|FG004|PT Follow-up: Weeks 104 to 169|Other|0|||
147424107|NCT02527343|531717731|FG005|PT Follow-up: Weeks 104 to 169|Other|1|||
147424108|NCT00701220|531717732|FG000|Overall Study|Withdrawal by Subject|0|||
147424109|NCT00701220|531717733|FG001|Overall Study|Withdrawal by Subject|2|||
147424110|NCT00701220|531717732|FG000|Overall Study|Protocol Violation|2|||
147424111|NCT00701220|531717733|FG001|Overall Study|Protocol Violation|0|||
147424112|NCT05767021|531717734|FG000|Overall Study|Adverse Event|2|||
147424113|NCT05767021|531717734|FG000|Overall Study|Protocol Deviation|1|||
147424114|NCT05767021|531717734|FG000|Overall Study|Withdrawal by Subject|1|||
147424115|NCT05767021|531717734|FG000|Overall Study|Physician Decision|1|||
147424116|NCT05767021|531717734|FG000|Overall Study|Lack of Efficacy|11|||
147424117|NCT05767021|531717734|FG000|Overall Study|Assigned Treatment by Mistake|1|||
147424118|NCT06377488|531717737|FG000|Overall Study|Unsatisfactory Visual Response due to Test Article|2|||
147424119|NCT06377488|531717737|FG000|Overall Study|Unsatisfactory Lens Fitting due to Test Article|2|||
147424120|NCT06377488|531717737|FG000|Overall Study|Protocol Violation|1|||
147424121|NCT06377488|531717737|FG000|Overall Study|Lost to Follow-up|1|||
147424122|NCT06377488|531717737|FG000|Overall Study|Incorrect Lens Dispensed|2|||
147424123|NCT01831856|531717740|FG000|Overall Study|Adverse Event|5|||
147424124|NCT01831856|531717741|FG001|Overall Study|Adverse Event|8|||
147424125|NCT01831856|531717740|FG000|Overall Study|Lack of Efficacy|13|||
147424126|NCT01831856|531717741|FG001|Overall Study|Lack of Efficacy|11|||
147424127|NCT01831856|531717740|FG000|Overall Study|Unsuccessful Electrical Cardioversion|16|||
147424128|NCT01831856|531717741|FG001|Overall Study|Unsuccessful Electrical Cardioversion|18|||
147424129|NCT05208866|531717742|FG000|Maintenance Treatment Period|Sponsor Termination of Study|1|||
147424130|NCT00986973|531717743|FG000|Overall Study|Withdrawn by study team|1|||
147424131|NCT00598273|531717744|FG000|Overall Study|Adverse Event|4|||
147424132|NCT00598273|531717745|FG001|Overall Study|Adverse Event|5|||
147424133|NCT00598273|531717746|FG002|Overall Study|Adverse Event|2|||
147424134|NCT00598273|531717744|FG000|Overall Study|Death|6|||
147424135|NCT00598273|531717745|FG001|Overall Study|Death|12|||
147424136|NCT00598273|531717746|FG002|Overall Study|Death|8|||
147424137|NCT00598273|531717744|FG000|Overall Study|Lost to Follow-up|8|||
147424138|NCT00598273|531717745|FG001|Overall Study|Lost to Follow-up|3|||
147424139|NCT00598273|531717746|FG002|Overall Study|Lost to Follow-up|5|||
147424140|NCT00598273|531717744|FG000|Overall Study|Physician Decision|0|||
147424141|NCT00598273|531717745|FG001|Overall Study|Physician Decision|0|||
147424142|NCT00598273|531717746|FG002|Overall Study|Physician Decision|1|||
147424143|NCT00598273|531717744|FG000|Overall Study|Withdrawal by Subject|12|||
147424144|NCT00598273|531717745|FG001|Overall Study|Withdrawal by Subject|10|||
147424145|NCT00598273|531717746|FG002|Overall Study|Withdrawal by Subject|10|||
147424146|NCT00598273|531717744|FG000|Overall Study|Noncompliance|3|||
147424147|NCT00598273|531717745|FG001|Overall Study|Noncompliance|2|||
147424148|NCT00598273|531717746|FG002|Overall Study|Noncompliance|3|||
147424149|NCT00598273|531717744|FG000|Overall Study|Relocation|0|||
147424150|NCT00598273|531717745|FG001|Overall Study|Relocation|2|||
147424151|NCT00598273|531717746|FG002|Overall Study|Relocation|4|||
147424152|NCT00598273|531717744|FG000|Overall Study|Renal transplant|1|||
147424153|NCT00598273|531717745|FG001|Overall Study|Renal transplant|0|||
147424154|NCT00598273|531717746|FG002|Overall Study|Renal transplant|1|||
147424155|NCT00598273|531717744|FG000|Overall Study|Site elected to close|1|||
147424156|NCT00598273|531717745|FG001|Overall Study|Site elected to close|0|||
147424157|NCT00598273|531717746|FG002|Overall Study|Site elected to close|0|||
147424158|NCT00598273|531717744|FG000|Overall Study|Started dialysis|6|||
147424159|NCT00598273|531717745|FG001|Overall Study|Started dialysis|4|||
147424160|NCT00598273|531717746|FG002|Overall Study|Started dialysis|5|||
147424161|NCT02842827|531717747|FG000|Overall Study|Adverse Event|0|||
147424162|NCT02842827|531717748|FG001|Overall Study|Adverse Event|1|||
147424163|NCT02842827|531717749|FG002|Overall Study|Adverse Event|0|||
147424164|NCT02842827|531717750|FG003|Overall Study|Adverse Event|1|||
147424165|NCT02842827|531717751|FG004|Overall Study|Adverse Event|0|||
147424166|NCT02842827|531717752|FG005|Overall Study|Adverse Event|1|||
147424167|NCT02842827|531717753|FG006|Overall Study|Adverse Event|0|||
147424168|NCT02842827|531717754|FG007|Overall Study|Adverse Event|0|||
147424169|NCT02842827|531717747|FG000|Overall Study|Death|1|||
147424170|NCT02842827|531717748|FG001|Overall Study|Death|0|||
147424171|NCT02842827|531717749|FG002|Overall Study|Death|2|||
147424172|NCT02842827|531717750|FG003|Overall Study|Death|3|||
147424173|NCT02842827|531717751|FG004|Overall Study|Death|2|||
147424174|NCT02842827|531717752|FG005|Overall Study|Death|1|||
147424175|NCT02842827|531717753|FG006|Overall Study|Death|0|||
147424176|NCT02842827|531717754|FG007|Overall Study|Death|4|||
147424177|NCT02842827|531717747|FG000|Overall Study|Physician Decision|1|||
147424178|NCT02842827|531717748|FG001|Overall Study|Physician Decision|3|||
147424179|NCT02842827|531717749|FG002|Overall Study|Physician Decision|0|||
147424180|NCT02842827|531717750|FG003|Overall Study|Physician Decision|0|||
147424181|NCT02842827|531717751|FG004|Overall Study|Physician Decision|1|||
147424182|NCT02842827|531717752|FG005|Overall Study|Physician Decision|4|||
147649341|NCT01026818|532537334|FG003|Drug-Free Washout Period (Month 9-10.5)|Adverse Event|0|||
147649342|NCT01026818|532537331|FG000|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|0|||
147424183|NCT02842827|531717753|FG006|Overall Study|Physician Decision|2|||
147424184|NCT02842827|531717754|FG007|Overall Study|Physician Decision|1|||
147424185|NCT02842827|531717747|FG000|Overall Study|Protocol Defined Disease Progression|0|||
147424186|NCT02842827|531717748|FG001|Overall Study|Protocol Defined Disease Progression|0|||
147424187|NCT02842827|531717749|FG002|Overall Study|Protocol Defined Disease Progression|0|||
147424188|NCT02842827|531717750|FG003|Overall Study|Protocol Defined Disease Progression|0|||
147424189|NCT02842827|531717751|FG004|Overall Study|Protocol Defined Disease Progression|0|||
147424190|NCT02842827|531717752|FG005|Overall Study|Protocol Defined Disease Progression|1|||
147424191|NCT02842827|531717753|FG006|Overall Study|Protocol Defined Disease Progression|0|||
147424192|NCT02842827|531717754|FG007|Overall Study|Protocol Defined Disease Progression|0|||
147424193|NCT02842827|531717747|FG000|Overall Study|Participant Withdrawal of Consent|1|||
147424194|NCT02842827|531717748|FG001|Overall Study|Participant Withdrawal of Consent|2|||
147424195|NCT02842827|531717749|FG002|Overall Study|Participant Withdrawal of Consent|2|||
147424196|NCT02842827|531717750|FG003|Overall Study|Participant Withdrawal of Consent|2|||
147424197|NCT02842827|531717751|FG004|Overall Study|Participant Withdrawal of Consent|2|||
147424198|NCT02842827|531717752|FG005|Overall Study|Participant Withdrawal of Consent|1|||
147424199|NCT02842827|531717753|FG006|Overall Study|Participant Withdrawal of Consent|2|||
147424200|NCT02842827|531717754|FG007|Overall Study|Participant Withdrawal of Consent|1|||
147424201|NCT01815138|531717755|FG000|Overall Study|Withdrawal by Subject|0|||
147424202|NCT01815138|531717756|FG001|Overall Study|Withdrawal by Subject|1|||
147424203|NCT01815138|531717755|FG000|Overall Study|Physician Decision|8|||
147424204|NCT01815138|531717756|FG001|Overall Study|Physician Decision|5|||
147424205|NCT02649946|531717762|FG000|Overall Study|Withdrawal by Subject|1|||
147424206|NCT02649946|531717763|FG001|Overall Study|Withdrawal by Subject|1|||
147424207|NCT02649946|531717762|FG000|Overall Study|Death|7|||
147424208|NCT02649946|531717763|FG001|Overall Study|Death|9|||
147424209|NCT02649946|531717762|FG000|Overall Study|Physician Decision|1|||
147424210|NCT02649946|531717763|FG001|Overall Study|Physician Decision|0|||
147424211|NCT02649946|531717762|FG000|Overall Study|Lost to Follow-up|2|||
147424212|NCT02649946|531717763|FG001|Overall Study|Lost to Follow-up|1|||
147424213|NCT02649946|531717762|FG000|Overall Study|Erroneously enrolled|1|||
147424214|NCT02649946|531717763|FG001|Overall Study|Erroneously enrolled|0|||
147424215|NCT02649946|531717762|FG000|Overall Study|Missed 6-month follow-up visit|0|||
147424216|NCT02649946|531717763|FG001|Overall Study|Missed 6-month follow-up visit|4|||
147424217|NCT02054520|531717764|FG000|Overall Study|Adverse Event|1|||
147424218|NCT02054520|531717765|FG001|Overall Study|Adverse Event|4|||
147424219|NCT02054520|531717766|FG002|Overall Study|Adverse Event|2|||
147424220|NCT02054520|531717767|FG003|Overall Study|Adverse Event|1|||
147424221|NCT02054520|531717768|FG004|Overall Study|Adverse Event|1|||
147424222|NCT02054520|531717769|FG005|Overall Study|Adverse Event|0|||
147424223|NCT02054520|531717764|FG000|Overall Study|Lack of Efficacy|7|||
147424224|NCT02054520|531717765|FG001|Overall Study|Lack of Efficacy|0|||
147424225|NCT02054520|531717766|FG002|Overall Study|Lack of Efficacy|2|||
147424226|NCT02054520|531717767|FG003|Overall Study|Lack of Efficacy|1|||
147424227|NCT02054520|531717768|FG004|Overall Study|Lack of Efficacy|3|||
147424228|NCT02054520|531717769|FG005|Overall Study|Lack of Efficacy|2|||
147424229|NCT02054520|531717764|FG000|Overall Study|Withdrawal by Subject|1|||
147424230|NCT02054520|531717765|FG001|Overall Study|Withdrawal by Subject|0|||
147424231|NCT02054520|531717766|FG002|Overall Study|Withdrawal by Subject|0|||
147424232|NCT02054520|531717767|FG003|Overall Study|Withdrawal by Subject|2|||
147424233|NCT02054520|531717768|FG004|Overall Study|Withdrawal by Subject|1|||
147424234|NCT02054520|531717769|FG005|Overall Study|Withdrawal by Subject|0|||
147424235|NCT02054520|531717764|FG000|Overall Study|Physician Decision|0|||
147424236|NCT02054520|531717765|FG001|Overall Study|Physician Decision|1|||
147424237|NCT02054520|531717766|FG002|Overall Study|Physician Decision|0|||
147424238|NCT02054520|531717767|FG003|Overall Study|Physician Decision|1|||
147424239|NCT02054520|531717768|FG004|Overall Study|Physician Decision|0|||
147424240|NCT02054520|531717769|FG005|Overall Study|Physician Decision|1|||
147424241|NCT02054520|531717764|FG000|Overall Study|Study terminated by Sponsor|0|||
147424242|NCT02054520|531717765|FG001|Overall Study|Study terminated by Sponsor|0|||
147424243|NCT02054520|531717766|FG002|Overall Study|Study terminated by Sponsor|2|||
147424244|NCT02054520|531717767|FG003|Overall Study|Study terminated by Sponsor|1|||
147424245|NCT02054520|531717768|FG004|Overall Study|Study terminated by Sponsor|0|||
147424246|NCT02054520|531717769|FG005|Overall Study|Study terminated by Sponsor|0|||
147424247|NCT01272804|531717770|FG000|Overall Study|Adverse Event|1|||
147424248|NCT01272804|531717771|FG001|Overall Study|Adverse Event|0|||
147424249|NCT01272804|531717772|FG002|Overall Study|Adverse Event|0|||
147424250|NCT01272804|531717773|FG003|Overall Study|Adverse Event|0|||
147424251|NCT01272804|531717774|FG004|Overall Study|Adverse Event|2|||
147424252|NCT01272804|531717775|FG005|Overall Study|Adverse Event|1|||
147424253|NCT01588496|531717776|FG000|Overall Study|Withdrawal by Subject|0|||
147424254|NCT01588496|531717777|FG001|Overall Study|Withdrawal by Subject|1|||
147424255|NCT01588496|531717778|FG002|Overall Study|Withdrawal by Subject|0|||
147191330|NCT00117637|530867606|FG001|First Intervention (Period 1)|Withdrawal by Subject|4|||
147191331|NCT00117637|530867605|FG000|First Intervention (Period 1)|study terminated by the sponsor|3|||
147424256|NCT01551212|531717779|FG000|Overall Study|Graft loss/Retransplantation|0|||
147424257|NCT01551212|531717780|FG001|Overall Study|Graft loss/Retransplantation|1|||
147424258|NCT01551212|531717779|FG000|Overall Study|Administrative problems|1|||
147424259|NCT01551212|531717780|FG001|Overall Study|Administrative problems|2|||
147424260|NCT01551212|531717779|FG000|Overall Study|Lost to Follow-up|0|||
147424261|NCT01551212|531717780|FG001|Overall Study|Lost to Follow-up|1|||
147424262|NCT01551212|531717779|FG000|Overall Study|Protocol Violation|0|||
147424263|NCT01551212|531717780|FG001|Overall Study|Protocol Violation|1|||
147424264|NCT01551212|531717779|FG000|Overall Study|Withdrawal by Subject|0|||
147424265|NCT01551212|531717780|FG001|Overall Study|Withdrawal by Subject|7|||
147424266|NCT01551212|531717779|FG000|Overall Study|Death|2|||
147424267|NCT01551212|531717780|FG001|Overall Study|Death|4|||
147424268|NCT01551212|531717779|FG000|Overall Study|Never Received Study Treatment|2|||
147424269|NCT01551212|531717780|FG001|Overall Study|Never Received Study Treatment|4|||
147424270|NCT05924945|531717781|FG000|Overall Study|Withdrawal by Subject|3|||
147424271|NCT05924945|531717782|FG001|Overall Study|Withdrawal by Subject|4|||
147424272|NCT02471833|531717783|FG000|Overall Study|Lost to Follow-up|1|||
147424273|NCT02471833|531717784|FG001|Overall Study|Lost to Follow-up|0|||
147424274|NCT02471833|531717785|FG002|Overall Study|Lost to Follow-up|0|||
147424275|NCT02471833|531717783|FG000|Overall Study|Withdrawal by Subject|2|||
147424276|NCT02471833|531717784|FG001|Overall Study|Withdrawal by Subject|1|||
147424277|NCT02471833|531717785|FG002|Overall Study|Withdrawal by Subject|5|||
147424278|NCT02232243|531717788|FG000|Second Dose (400mg HCQ Twice Daily)|Protocol Violation|0|||
147424279|NCT02232243|531717789|FG001|Second Dose (400mg HCQ Twice Daily)|Protocol Violation|1|||
147424280|NCT02232243|531717790|FG002|Second Dose (400mg HCQ Twice Daily)|Protocol Violation|0|||
147424281|NCT00490724|531717791|FG000|Period I|Physician Decision|0|||
147424282|NCT00490724|531717792|FG001|Period I|Physician Decision|0|||
147424283|NCT00490724|531717793|FG002|Period I|Physician Decision|1|||
147424284|NCT00490724|531717791|FG000|Period II|Treatment Discontinuation|3|||
147424285|NCT00490724|531717792|FG001|Period II|Treatment Discontinuation|1|||
147424286|NCT00490724|531717793|FG002|Period II|Treatment Discontinuation|3|||
147424287|NCT05026710|531717794|FG000|Overall Study|No longer met eligibility criteria|3|||
147424288|NCT05026710|531717795|FG001|Overall Study|No longer met eligibility criteria|1|||
147424289|NCT00126503|531717796|FG000|Overall Study|disease progression|23|||
147424290|NCT00126503|531717797|FG001|Overall Study|disease progression|14|||
147424291|NCT00126503|531717796|FG000|Overall Study|Withdrawal by Subject|0|||
147424292|NCT00126503|531717797|FG001|Overall Study|Withdrawal by Subject|1|||
147424293|NCT00126503|531717796|FG000|Overall Study|alternative therapy|1|||
147424294|NCT00126503|531717797|FG001|Overall Study|alternative therapy|1|||
147424295|NCT00126503|531717796|FG000|Overall Study|other complicating disease|4|||
147424296|NCT00126503|531717797|FG001|Overall Study|other complicating disease|1|||
147424297|NCT00126503|531717796|FG000|Overall Study|Death|3|||
147424298|NCT00126503|531717797|FG001|Overall Study|Death|0|||
147424299|NCT00126503|531717796|FG000|Overall Study|Adverse Event|13|||
147424300|NCT00126503|531717797|FG001|Overall Study|Adverse Event|3|||
147424301|NCT00126503|531717796|FG000|Overall Study|non-compliant|1|||
147424302|NCT00126503|531717797|FG001|Overall Study|non-compliant|0|||
147424303|NCT00126503|531717796|FG000|Overall Study|Physician Decision|2|||
147424304|NCT00126503|531717797|FG001|Overall Study|Physician Decision|1|||
147424305|NCT01201317|531719473|FG000|Overall Study|Withdrawal by Subject|5|||
147424306|NCT01201317|531719474|FG001|Overall Study|Withdrawal by Subject|0|||
147424307|NCT01201317|531719475|FG002|Overall Study|Withdrawal by Subject|3|||
147424308|NCT01201317|531719473|FG000|Overall Study|Adverse Event|2|||
147424309|NCT01201317|531719474|FG001|Overall Study|Adverse Event|2|||
147424310|NCT01201317|531719475|FG002|Overall Study|Adverse Event|2|||
147424311|NCT01201317|531719473|FG000|Overall Study|Screen failure|1|||
147424312|NCT01201317|531719474|FG001|Overall Study|Screen failure|1|||
147424313|NCT01201317|531719475|FG002|Overall Study|Screen failure|0|||
147424314|NCT01201317|531719473|FG000|Overall Study|Protocol Violation|0|||
147424315|NCT01201317|531719474|FG001|Overall Study|Protocol Violation|1|||
147424316|NCT01201317|531719475|FG002|Overall Study|Protocol Violation|1|||
147424317|NCT01201317|531719473|FG000|Overall Study|Death|0|||
147424318|NCT01201317|531719474|FG001|Overall Study|Death|1|||
147424319|NCT01201317|531719475|FG002|Overall Study|Death|0|||
147424320|NCT01201317|531719473|FG000|Overall Study|Study-specific withdrawal criteria|0|||
147424321|NCT01201317|531719474|FG001|Overall Study|Study-specific withdrawal criteria|0|||
147424322|NCT01201317|531719475|FG002|Overall Study|Study-specific withdrawal criteria|1|||
147424323|NCT01201317|531719473|FG000|Overall Study|Painful Diabetic Neuropathy worsening|0|||
147424324|NCT01201317|531719474|FG001|Overall Study|Painful Diabetic Neuropathy worsening|1|||
147424325|NCT01201317|531719475|FG002|Overall Study|Painful Diabetic Neuropathy worsening|0|||
147424326|NCT01201317|531719473|FG000|Overall Study|Decrease in renal function|0|||
147424327|NCT01201317|531719474|FG001|Overall Study|Decrease in renal function|1|||
147424328|NCT01201317|531719475|FG002|Overall Study|Decrease in renal function|0|||
147424329|NCT01201317|531719473|FG000|Overall Study|Lack of Efficacy|1|||
147424330|NCT01201317|531719474|FG001|Overall Study|Lack of Efficacy|0|||
147424331|NCT01201317|531719475|FG002|Overall Study|Lack of Efficacy|0|||
147424332|NCT01201317|531719473|FG000|Overall Study|Safety, possible history of tuberculosis|0|||
147424333|NCT01201317|531719474|FG001|Overall Study|Safety, possible history of tuberculosis|0|||
147424334|NCT01201317|531719475|FG002|Overall Study|Safety, possible history of tuberculosis|1|||
147424335|NCT02079610|531719476|FG000|Overall Study|Withdrawal by Subject|1|||
147424336|NCT02079610|531719477|FG001|Overall Study|Withdrawal by Subject|1|||
147424337|NCT04964388|531719478|FG000|Overall Study|Lost to Follow-up|3|||
147424338|NCT04964388|531719479|FG001|Overall Study|Lost to Follow-up|2|||
147424339|NCT01052103|531719481|FG000|Overall Study|Adverse Event|10|||
147424340|NCT01052103|531719482|FG001|Overall Study|Adverse Event|6|||
147424341|NCT01052103|531719481|FG000|Overall Study|Entry Criteria Not Met|3|||
147424342|NCT01052103|531719482|FG001|Overall Study|Entry Criteria Not Met|1|||
147424343|NCT01052103|531719481|FG000|Overall Study|Lost to Follow-up|3|||
147424344|NCT01052103|531719482|FG001|Overall Study|Lost to Follow-up|5|||
147424345|NCT01052103|531719481|FG000|Overall Study|Protocol Violation|10|||
147424346|NCT01052103|531719482|FG001|Overall Study|Protocol Violation|4|||
147424347|NCT01052103|531719481|FG000|Overall Study|Scheduling conflict|2|||
147424348|NCT01052103|531719482|FG001|Overall Study|Scheduling conflict|1|||
147424349|NCT01052103|531719481|FG000|Overall Study|Sponsor Decision|2|||
147424350|NCT01052103|531719482|FG001|Overall Study|Sponsor Decision|0|||
147424351|NCT01052103|531719481|FG000|Overall Study|Withdrawal by Subject|3|||
147424352|NCT01052103|531719482|FG001|Overall Study|Withdrawal by Subject|6|||
147424353|NCT01052103|531719481|FG000|Overall Study|Perceived Lack of Efficacy|1|||
147424354|NCT01052103|531719482|FG001|Overall Study|Perceived Lack of Efficacy|0|||
147424355|NCT04874415|531719483|FG000|Overall Study|Missing Fitbit data but not lost to follow up|1|||
147424356|NCT04874415|531719484|FG001|Overall Study|Missing Fitbit data but not lost to follow up|1|||
147424357|NCT04874415|531719485|FG002|Overall Study|Missing Fitbit data but not lost to follow up|1|||
147424358|NCT04874415|531719486|FG003|Overall Study|Missing Fitbit data but not lost to follow up|1|||
147424359|NCT04874415|531719487|FG004|Overall Study|Missing Fitbit data but not lost to follow up|1|||
147424360|NCT04874415|531719488|FG005|Overall Study|Missing Fitbit data but not lost to follow up|1|||
147424361|NCT04874415|531719489|FG006|Overall Study|Missing Fitbit data but not lost to follow up|0|||
147424362|NCT04874415|531719490|FG007|Overall Study|Missing Fitbit data but not lost to follow up|1|||
147424363|NCT04874415|531719491|FG008|Overall Study|Missing Fitbit data but not lost to follow up|4|||
147424364|NCT04874415|531719492|FG009|Overall Study|Missing Fitbit data but not lost to follow up|0|||
147424365|NCT04874415|531719493|FG010|Overall Study|Missing Fitbit data but not lost to follow up|1|||
147424366|NCT04874415|531719494|FG011|Overall Study|Missing Fitbit data but not lost to follow up|0|||
147424367|NCT04874415|531719495|FG012|Overall Study|Missing Fitbit data but not lost to follow up|0|||
147424368|NCT04874415|531719496|FG013|Overall Study|Missing Fitbit data but not lost to follow up|1|||
147424369|NCT04874415|531719497|FG014|Overall Study|Missing Fitbit data but not lost to follow up|4|||
147424370|NCT04874415|531719498|FG015|Overall Study|Missing Fitbit data but not lost to follow up|0|||
147424371|NCT04874415|531719483|FG000|Overall Study|Missing Fitbit data and lost to follow up|1|||
147424372|NCT04874415|531719484|FG001|Overall Study|Missing Fitbit data and lost to follow up|0|||
147424373|NCT04874415|531719485|FG002|Overall Study|Missing Fitbit data and lost to follow up|0|||
147424374|NCT04874415|531719486|FG003|Overall Study|Missing Fitbit data and lost to follow up|1|||
147424375|NCT04874415|531719487|FG004|Overall Study|Missing Fitbit data and lost to follow up|0|||
147424376|NCT04874415|531719488|FG005|Overall Study|Missing Fitbit data and lost to follow up|0|||
147424377|NCT04874415|531719489|FG006|Overall Study|Missing Fitbit data and lost to follow up|1|||
147424378|NCT04874415|531719490|FG007|Overall Study|Missing Fitbit data and lost to follow up|1|||
147424379|NCT04874415|531719491|FG008|Overall Study|Missing Fitbit data and lost to follow up|0|||
147424380|NCT04874415|531719492|FG009|Overall Study|Missing Fitbit data and lost to follow up|3|||
147424381|NCT04874415|531719493|FG010|Overall Study|Missing Fitbit data and lost to follow up|1|||
147191332|NCT00117637|530867606|FG001|First Intervention (Period 1)|study terminated by the sponsor|1|||
147191333|NCT00117637|530867605|FG000|First Intervention (Period 1)|protocol driven decision point|1|||
147424382|NCT04874415|531719494|FG011|Overall Study|Missing Fitbit data and lost to follow up|1|||
147424383|NCT04874415|531719495|FG012|Overall Study|Missing Fitbit data and lost to follow up|1|||
147424384|NCT04874415|531719496|FG013|Overall Study|Missing Fitbit data and lost to follow up|0|||
147424385|NCT04874415|531719497|FG014|Overall Study|Missing Fitbit data and lost to follow up|0|||
147424386|NCT04874415|531719498|FG015|Overall Study|Missing Fitbit data and lost to follow up|1|||
147424387|NCT04874415|531719483|FG000|Overall Study|Did not attend final study visit but had Fitbit data|0|||
147424388|NCT04874415|531719484|FG001|Overall Study|Did not attend final study visit but had Fitbit data|0|||
147424389|NCT04874415|531719485|FG002|Overall Study|Did not attend final study visit but had Fitbit data|0|||
147424390|NCT04874415|531719486|FG003|Overall Study|Did not attend final study visit but had Fitbit data|0|||
147424391|NCT04874415|531719487|FG004|Overall Study|Did not attend final study visit but had Fitbit data|1|||
147424392|NCT04874415|531719488|FG005|Overall Study|Did not attend final study visit but had Fitbit data|0|||
147424393|NCT04874415|531719489|FG006|Overall Study|Did not attend final study visit but had Fitbit data|0|||
147424394|NCT04874415|531719490|FG007|Overall Study|Did not attend final study visit but had Fitbit data|0|||
147424395|NCT04874415|531719491|FG008|Overall Study|Did not attend final study visit but had Fitbit data|0|||
147424396|NCT04874415|531719492|FG009|Overall Study|Did not attend final study visit but had Fitbit data|0|||
147424397|NCT04874415|531719493|FG010|Overall Study|Did not attend final study visit but had Fitbit data|0|||
147424398|NCT04874415|531719494|FG011|Overall Study|Did not attend final study visit but had Fitbit data|0|||
147424399|NCT04874415|531719495|FG012|Overall Study|Did not attend final study visit but had Fitbit data|0|||
147424400|NCT04874415|531719496|FG013|Overall Study|Did not attend final study visit but had Fitbit data|0|||
147424401|NCT04874415|531719497|FG014|Overall Study|Did not attend final study visit but had Fitbit data|0|||
147424402|NCT04874415|531719498|FG015|Overall Study|Did not attend final study visit but had Fitbit data|0|||
147424403|NCT03405792|531719499|FG000|Overall Study|o Did not start or discontinued TTF during cycle 1 of TMZ for personal reasons|4|||
147424404|NCT03405792|531719500|FG001|Overall Study|o Did not start or discontinued TTF during cycle 1 of TMZ for personal reasons|0|||
147424405|NCT03405792|531719499|FG000|Overall Study|o Did not receive pembrolizumab|1|||
147424406|NCT03405792|531719500|FG001|Overall Study|o Did not receive pembrolizumab|0|||
147424407|NCT00372229|531719501|FG000|Study Phase|Graft loss|0|||
147424408|NCT00372229|531719502|FG001|Study Phase|Graft loss|3|||
147424409|NCT00372229|531719501|FG000|Study Phase|Protocol Violation|3|||
147424410|NCT00372229|531719502|FG001|Study Phase|Protocol Violation|4|||
147191334|NCT00117637|530867606|FG001|First Intervention (Period 1)|protocol driven decision point|0|||
147424411|NCT00372229|531719501|FG000|Study Phase|Consent withdrawn|16|||
147424412|NCT00372229|531719502|FG001|Study Phase|Consent withdrawn|14|||
147424413|NCT00372229|531719501|FG000|Study Phase|Refused treatment/did not cooperate|3|||
147424414|NCT00372229|531719502|FG001|Study Phase|Refused treatment/did not cooperate|1|||
147424415|NCT00372229|531719501|FG000|Study Phase|Death|3|||
147424416|NCT00372229|531719502|FG001|Study Phase|Death|2|||
147424417|NCT00372229|531719501|FG000|Study Phase|Reason not specified|3|||
147424418|NCT00372229|531719502|FG001|Study Phase|Reason not specified|2|||
147424419|NCT00372229|531719501|FG000|Study Phase|Lost to Follow-up|3|||
147424420|NCT00372229|531719502|FG001|Study Phase|Lost to Follow-up|3|||
147424421|NCT00372229|531719501|FG000|Follow-Up Phase|Graft loss|8|||
147424422|NCT00372229|531719502|FG001|Follow-Up Phase|Graft loss|7|||
147424423|NCT00372229|531719501|FG000|Follow-Up Phase|Consent withdrawn|13|||
147424424|NCT00372229|531719502|FG001|Follow-Up Phase|Consent withdrawn|19|||
147424425|NCT00372229|531719501|FG000|Follow-Up Phase|Refused treatment/did not cooperate|0|||
147424426|NCT00372229|531719502|FG001|Follow-Up Phase|Refused treatment/did not cooperate|1|||
147424427|NCT00372229|531719501|FG000|Follow-Up Phase|Adverse event/intercurrent illness|1|||
147424428|NCT00372229|531719502|FG001|Follow-Up Phase|Adverse event/intercurrent illness|0|||
147424429|NCT00372229|531719501|FG000|Follow-Up Phase|Death|9|||
147424430|NCT00372229|531719502|FG001|Follow-Up Phase|Death|12|||
147424431|NCT00372229|531719501|FG000|Follow-Up Phase|Administrative|1|||
147424432|NCT00372229|531719502|FG001|Follow-Up Phase|Administrative|0|||
147424433|NCT00372229|531719501|FG000|Follow-Up Phase|Reason not specified|2|||
147424434|NCT00372229|531719502|FG001|Follow-Up Phase|Reason not specified|3|||
147424435|NCT00372229|531719501|FG000|Follow-Up Phase|Lost to Follow-up|12|||
147424436|NCT00372229|531719502|FG001|Follow-Up Phase|Lost to Follow-up|10|||
147424437|NCT01347762|531719503|FG000|Overall Study|Lost to Follow-up|0|||
147424438|NCT01347762|531719504|FG001|Overall Study|Lost to Follow-up|1|||
147424439|NCT01347762|531719505|FG002|Overall Study|Lost to Follow-up|6|||
147424440|NCT01347762|531719506|FG003|Overall Study|Lost to Follow-up|5|||
147424441|NCT01347762|531719503|FG000|Overall Study|Withdrawal by Subject|4|||
147424442|NCT01347762|531719504|FG001|Overall Study|Withdrawal by Subject|1|||
147424443|NCT01347762|531719505|FG002|Overall Study|Withdrawal by Subject|3|||
147424444|NCT01347762|531719506|FG003|Overall Study|Withdrawal by Subject|3|||
147424445|NCT03235284|531719507|FG000|Overall Study|Adverse Event|1|||
147424446|NCT03235284|531719508|FG001|Overall Study|Adverse Event|2|||
147424447|NCT03235284|531719509|FG002|Overall Study|Adverse Event|1|||
147424448|NCT00310037|531719510|FG000|Overall Study|Adverse Event|7|||
147424449|NCT00310037|531719511|FG001|Overall Study|Adverse Event|14|||
147424450|NCT00310037|531719510|FG000|Overall Study|Withdrawal by Subject|4|||
147424451|NCT00310037|531719511|FG001|Overall Study|Withdrawal by Subject|3|||
147424452|NCT00310037|531719510|FG000|Overall Study|Progression|6|||
147424453|NCT00310037|531719511|FG001|Overall Study|Progression|0|||
147424454|NCT00310037|531719510|FG000|Overall Study|Non-protocol treatment|1|||
147424455|NCT00310037|531719511|FG001|Overall Study|Non-protocol treatment|0|||
147424456|NCT01382706|531719514|FG000|Overall Study|Adverse Event|1|||
147424457|NCT01382706|531719514|FG000|Overall Study|Withdrawal by Subject|1|||
147424458|NCT05559099|531719515|FG000|Overall Study|Death|5|||
147424459|NCT05559099|531719516|FG001|Overall Study|Death|4|||
147424460|NCT05559099|531719515|FG000|Overall Study|Lost to Follow-up|0|||
147424461|NCT05559099|531719516|FG001|Overall Study|Lost to Follow-up|2|||
147424462|NCT05559099|531719515|FG000|Overall Study|Adverse Event|1|||
147424463|NCT05559099|531719516|FG001|Overall Study|Adverse Event|1|||
147424464|NCT04018092|531719517|FG000|Overall Study|Withdrawal by Subject|1|||
147424465|NCT04018092|531719518|FG001|Overall Study|Withdrawal by Subject|1|||
147424466|NCT04018092|531719517|FG000|Overall Study|Withdrawal by Subject|1|||
147424467|NCT04018092|531719518|FG001|Overall Study|Withdrawal by Subject|1|||
147424468|NCT04055090|531719521|FG000|Overall Study|screen failure|1|||
147424469|NCT04055090|531719522|FG001|Overall Study|screen failure|0|||
147424470|NCT04055090|531719521|FG000|Overall Study|Withdrawal by Subject|1|||
147424471|NCT04055090|531719522|FG001|Overall Study|Withdrawal by Subject|0|||
147424472|NCT04745026|531719523|FG000|Overall Study|Physician Decision|1|||
147424473|NCT04745026|531719524|FG001|Overall Study|Physician Decision|0|||
147424474|NCT04745026|531719523|FG000|Overall Study|Adverse Event|2|||
147424475|NCT04745026|531719524|FG001|Overall Study|Adverse Event|2|||
147424476|NCT04745026|531719523|FG000|Overall Study|Protocol Violation|1|||
147424477|NCT04745026|531719524|FG001|Overall Study|Protocol Violation|3|||
147424478|NCT04745026|531719523|FG000|Overall Study|Lost to Follow-up|4|||
147424479|NCT04745026|531719524|FG001|Overall Study|Lost to Follow-up|3|||
147424480|NCT04745026|531719523|FG000|Overall Study|Withdrawal by Subject|5|||
147424481|NCT04745026|531719524|FG001|Overall Study|Withdrawal by Subject|5|||
147424482|NCT05478499|531719525|FG000|Placebo Controlled: Week 0 - 16|Adverse Event|4|||
147424483|NCT05478499|531719526|FG001|Placebo Controlled: Week 0 - 16|Adverse Event|2|||
147424484|NCT05478499|531719525|FG000|Placebo Controlled: Week 0 - 16|Withdrawal by Subject|3|||
147424485|NCT05478499|531719526|FG001|Placebo Controlled: Week 0 - 16|Withdrawal by Subject|2|||
147424486|NCT05478499|531719525|FG000|Placebo Controlled: Week 0 - 16|Lack of Efficacy|1|||
147424487|NCT05478499|531719526|FG001|Placebo Controlled: Week 0 - 16|Lack of Efficacy|0|||
147424488|NCT05478499|531719525|FG000|Placebo Controlled: Week 0 - 16|Lost to Follow-up|1|||
147424489|NCT05478499|531719526|FG001|Placebo Controlled: Week 0 - 16|Lost to Follow-up|0|||
147424490|NCT05478499|531719525|FG000|Placebo Controlled: Week 0 - 16|Other reasons|0|||
147424491|NCT05478499|531719526|FG001|Placebo Controlled: Week 0 - 16|Other reasons|2|||
147424492|NCT05478499|531719525|FG000|Active Treatment: Week 16 - Week 52|Withdrawal by Subject|4|||
147424493|NCT05478499|531719526|FG001|Active Treatment: Week 16 - Week 52|Withdrawal by Subject|2|||
147424494|NCT05478499|531719525|FG000|Active Treatment: Week 16 - Week 52|Lack of Efficacy|4|||
147424495|NCT05478499|531719526|FG001|Active Treatment: Week 16 - Week 52|Lack of Efficacy|1|||
147424496|NCT05478499|531719525|FG000|Active Treatment: Week 16 - Week 52|Adverse Event|4|||
147424497|NCT05478499|531719526|FG001|Active Treatment: Week 16 - Week 52|Adverse Event|0|||
147424498|NCT05478499|531719525|FG000|Active Treatment: Week 16 - Week 52|Lost to Follow-up|1|||
147424499|NCT05478499|531719526|FG001|Active Treatment: Week 16 - Week 52|Lost to Follow-up|2|||
147424500|NCT05478499|531719525|FG000|Active Treatment: Week 16 - Week 52|Death|1|||
147424501|NCT05478499|531719526|FG001|Active Treatment: Week 16 - Week 52|Death|0|||
147424502|NCT05478499|531719525|FG000|Active Treatment: Week 16 - Week 52|Non-compliance with protocol|0|||
147424503|NCT05478499|531719526|FG001|Active Treatment: Week 16 - Week 52|Non-compliance with protocol|1|||
147424504|NCT04426851|531719527|FG000|Part 2: Period 2+Washout|Withdrawal by Subject|0|||
147424505|NCT04426851|531719528|FG001|Part 2: Period 2+Washout|Withdrawal by Subject|1|||
147424506|NCT04426851|531719527|FG000|Part 2: Period 2+Washout|Adverse Event|1|||
147424507|NCT04426851|531719528|FG001|Part 2: Period 2+Washout|Adverse Event|0|||
147424508|NCT03256851|531719532|FG000|Overall Study|Withdrawal by Subject|1|||
147424509|NCT03256851|531719533|FG001|Overall Study|Withdrawal by Subject|0|||
147424510|NCT02476279|531719535|FG000|Overall Study|Lost to Follow-up|1|||
147424511|NCT02476279|531719536|FG001|Overall Study|Lost to Follow-up|1|||
147424512|NCT00319839|531719537|FG000|Overall Study|Adverse Event|5|||
147424513|NCT00319839|531719537|FG000|Overall Study|Withdrawal by Subject|1|||
147424514|NCT02128542|531719538|FG000|Overall Study|Lost to Follow-up|3|||
147424515|NCT02128542|531719539|FG001|Overall Study|Lost to Follow-up|0|||
147424516|NCT02128542|531719538|FG000|Overall Study|Withdrew Consent|1|||
147424517|NCT02128542|531719539|FG001|Overall Study|Withdrew Consent|0|||
147424518|NCT01778023|531719540|FG000|Overall Study|Withdrawal by Subject|0|||
147424519|NCT01778023|531719541|FG001|Overall Study|Withdrawal by Subject|3|||
147424520|NCT00903630|531719542|FG000|Phase 2|Adverse Event|0|||
147424521|NCT00903630|531719543|FG001|Phase 2|Adverse Event|0|||
147424522|NCT00903630|531719544|FG002|Phase 2|Adverse Event|1|||
147424523|NCT00138671|531719549|FG000|Overall Study|Death|0|||
147424524|NCT00138671|531719550|FG001|Overall Study|Death|3|||
147424525|NCT00138671|531719549|FG000|Overall Study|Adverse Event|6|||
147424526|NCT00138671|531719550|FG001|Overall Study|Adverse Event|3|||
147424527|NCT00138671|531719549|FG000|Overall Study|Lost to Follow-up|1|||
147424528|NCT00138671|531719550|FG001|Overall Study|Lost to Follow-up|2|||
147424529|NCT00138671|531719549|FG000|Overall Study|Withdrawal by Subject|3|||
147424530|NCT00138671|531719550|FG001|Overall Study|Withdrawal by Subject|5|||
147424531|NCT00138671|531719549|FG000|Overall Study|Other|3|||
147424532|NCT00138671|531719550|FG001|Overall Study|Other|3|||
147424533|NCT00402597|531719551|FG000|Overall Study|Death|15|||
147424534|NCT00402597|531719552|FG001|Overall Study|Death|7|||
147424535|NCT00402597|531719553|FG002|Overall Study|Death|6|||
147424536|NCT00402597|531719554|FG003|Overall Study|Death|4|||
147424537|NCT00402597|531719555|FG004|Overall Study|Death|6|||
147424538|NCT00402597|531719551|FG000|Overall Study|Adverse Event|81|||
147424539|NCT00402597|531719552|FG001|Overall Study|Adverse Event|18|||
147424540|NCT00402597|531719553|FG002|Overall Study|Adverse Event|106|||
147424541|NCT00402597|531719554|FG003|Overall Study|Adverse Event|39|||
147424542|NCT00402597|531719555|FG004|Overall Study|Adverse Event|71|||
147424543|NCT00402597|531719551|FG000|Overall Study|Lost to Follow-up|8|||
147424544|NCT00402597|531719552|FG001|Overall Study|Lost to Follow-up|1|||
147424545|NCT00402597|531719553|FG002|Overall Study|Lost to Follow-up|8|||
147424546|NCT00402597|531719554|FG003|Overall Study|Lost to Follow-up|2|||
147424547|NCT00402597|531719555|FG004|Overall Study|Lost to Follow-up|3|||
147424548|NCT00402597|531719551|FG000|Overall Study|Withdrawal by Subject|57|||
147424549|NCT00402597|531719552|FG001|Overall Study|Withdrawal by Subject|16|||
147424550|NCT00402597|531719553|FG002|Overall Study|Withdrawal by Subject|65|||
147424551|NCT00402597|531719554|FG003|Overall Study|Withdrawal by Subject|15|||
147424552|NCT00402597|531719555|FG004|Overall Study|Withdrawal by Subject|24|||
147424553|NCT00402597|531719551|FG000|Overall Study|reason not specified|30|||
147424554|NCT00402597|531719552|FG001|Overall Study|reason not specified|4|||
147424555|NCT00402597|531719553|FG002|Overall Study|reason not specified|27|||
147424556|NCT00402597|531719554|FG003|Overall Study|reason not specified|14|||
147424557|NCT00402597|531719555|FG004|Overall Study|reason not specified|20|||
147424558|NCT02581631|531719566|FG000|Overall Study|Disease progression|29|||
147424559|NCT02581631|531719567|FG001|Overall Study|Disease progression|19|||
147424560|NCT02581631|531719568|FG002|Overall Study|Disease progression|13|||
147424561|NCT02581631|531719569|FG003|Overall Study|Disease progression|5|||
147424562|NCT02581631|531719570|FG004|Overall Study|Disease progression|8|||
147424563|NCT02581631|531719566|FG000|Overall Study|Study drug toxicity|4|||
147424564|NCT02581631|531719567|FG001|Overall Study|Study drug toxicity|6|||
147424565|NCT02581631|531719568|FG002|Overall Study|Study drug toxicity|7|||
147424566|NCT02581631|531719569|FG003|Overall Study|Study drug toxicity|0|||
147424567|NCT02581631|531719570|FG004|Overall Study|Study drug toxicity|3|||
147424568|NCT02581631|531719566|FG000|Overall Study|AE unrelated to study drug|3|||
147424569|NCT02581631|531719567|FG001|Overall Study|AE unrelated to study drug|1|||
147424570|NCT02581631|531719568|FG002|Overall Study|AE unrelated to study drug|1|||
147424571|NCT02581631|531719569|FG003|Overall Study|AE unrelated to study drug|0|||
147424572|NCT02581631|531719570|FG004|Overall Study|AE unrelated to study drug|2|||
147424573|NCT02581631|531719566|FG000|Overall Study|Request to discontinue|1|||
147424574|NCT02581631|531719567|FG001|Overall Study|Request to discontinue|0|||
147424575|NCT02581631|531719568|FG002|Overall Study|Request to discontinue|3|||
147424576|NCT02581631|531719569|FG003|Overall Study|Request to discontinue|0|||
147424577|NCT02581631|531719570|FG004|Overall Study|Request to discontinue|1|||
147424578|NCT02581631|531719566|FG000|Overall Study|participant withdrew consent|3|||
147424579|NCT02581631|531719567|FG001|Overall Study|participant withdrew consent|0|||
147424580|NCT02581631|531719568|FG002|Overall Study|participant withdrew consent|1|||
147424581|NCT02581631|531719569|FG003|Overall Study|participant withdrew consent|0|||
147424582|NCT02581631|531719570|FG004|Overall Study|participant withdrew consent|0|||
147424583|NCT02581631|531719566|FG000|Overall Study|Maximum clinical benefit|1|||
147424584|NCT02581631|531719567|FG001|Overall Study|Maximum clinical benefit|7|||
147424585|NCT02581631|531719568|FG002|Overall Study|Maximum clinical benefit|1|||
147424586|NCT02581631|531719569|FG003|Overall Study|Maximum clinical benefit|3|||
147424587|NCT02581631|531719570|FG004|Overall Study|Maximum clinical benefit|13|||
147424588|NCT02581631|531719566|FG000|Overall Study|Other Reasons|1|||
147424589|NCT02581631|531719567|FG001|Overall Study|Other Reasons|0|||
147424590|NCT02581631|531719568|FG002|Overall Study|Other Reasons|2|||
147424591|NCT02581631|531719569|FG003|Overall Study|Other Reasons|2|||
147424592|NCT02581631|531719570|FG004|Overall Study|Other Reasons|3|||
147424593|NCT02581631|531719566|FG000|Overall Study|Poor/Non-Compliance|0|||
147424594|NCT02581631|531719567|FG001|Overall Study|Poor/Non-Compliance|0|||
147424595|NCT02581631|531719568|FG002|Overall Study|Poor/Non-Compliance|1|||
147424596|NCT02581631|531719569|FG003|Overall Study|Poor/Non-Compliance|0|||
147424597|NCT02581631|531719570|FG004|Overall Study|Poor/Non-Compliance|0|||
147424598|NCT03426605|531719571|FG000|Overall Study|AML relapse or progression|2|||
147424599|NCT03426605|531719572|FG001|Overall Study|AML relapse or progression|1|||
147424600|NCT03426605|531719573|FG002|Overall Study|AML relapse or progression|2|||
147424601|NCT03426605|531719574|FG003|Overall Study|AML relapse or progression|2|||
147424602|NCT03426605|531719571|FG000|Overall Study|Treatment failure|3|||
147424603|NCT03426605|531719572|FG001|Overall Study|Treatment failure|2|||
147424604|NCT03426605|531719573|FG002|Overall Study|Treatment failure|0|||
147424605|NCT03426605|531719574|FG003|Overall Study|Treatment failure|0|||
147424606|NCT03426605|531719571|FG000|Overall Study|Adverse Event|1|||
147424607|NCT03426605|531719572|FG001|Overall Study|Adverse Event|0|||
147424608|NCT03426605|531719573|FG002|Overall Study|Adverse Event|1|||
147532707|NCT01243762|532105988|FG006|Part 1 (Dose Escalation/MTD)|Physician Decision|0|||
147424609|NCT03426605|531719574|FG003|Overall Study|Adverse Event|1|||
147424610|NCT03426605|531719571|FG000|Overall Study|Withdrawal by Subject|0|||
147424611|NCT03426605|531719572|FG001|Overall Study|Withdrawal by Subject|0|||
147424612|NCT03426605|531719573|FG002|Overall Study|Withdrawal by Subject|1|||
147424613|NCT03426605|531719574|FG003|Overall Study|Withdrawal by Subject|1|||
147424614|NCT01211288|531719579|FG000|Overall Study|Lost to Follow-up|1|||
147424615|NCT01211288|531719580|FG001|Overall Study|Lost to Follow-up|1|||
147424616|NCT04217590|531719581|FG000|Overall Study|Other|1|||
147424617|NCT04217590|531719582|FG001|Overall Study|Other|1|||
147424618|NCT04217590|531719581|FG000|Overall Study|Withdrawal by Subject|3|||
147424619|NCT04217590|531719582|FG001|Overall Study|Withdrawal by Subject|1|||
147424620|NCT04217590|531719581|FG000|Overall Study|Death|0|||
147424621|NCT04217590|531719582|FG001|Overall Study|Death|1|||
147424622|NCT01013285|531719583|FG000|Overall Study|Death|48|||
147424623|NCT01013285|531719584|FG001|Overall Study|Death|89|||
147424624|NCT01395888|531719590|FG000|2-week Run-in Period|Adverse Event|2|||
147424625|NCT01395888|531719591|FG001|2-week Run-in Period|Adverse Event|0|||
147424626|NCT01395888|531719592|FG002|2-week Run-in Period|Adverse Event|0|||
147424627|NCT01395888|531719590|FG000|2-week Run-in Period|Continuation Criteria Not Met|13|||
147424628|NCT01395888|531719591|FG001|2-week Run-in Period|Continuation Criteria Not Met|0|||
147424629|NCT01395888|531719592|FG002|2-week Run-in Period|Continuation Criteria Not Met|0|||
147424630|NCT01395888|531719590|FG000|2-week Run-in Period|Lost to Follow-up|1|||
147424631|NCT01395888|531719591|FG001|2-week Run-in Period|Lost to Follow-up|0|||
147424632|NCT01395888|531719592|FG002|2-week Run-in Period|Lost to Follow-up|0|||
147424633|NCT01395888|531719590|FG000|2-week Run-in Period|Protocol Violation|2|||
147424634|NCT01395888|531719591|FG001|2-week Run-in Period|Protocol Violation|0|||
147424635|NCT01395888|531719592|FG002|2-week Run-in Period|Protocol Violation|0|||
147424636|NCT01395888|531719590|FG000|2-week Run-in Period|Withdrawal by Subject|4|||
147424637|NCT01395888|531719591|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
147424638|NCT01395888|531719592|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
147424639|NCT01395888|531719590|FG000|Treatment Period (TP)|Adverse Event|0|||
147424640|NCT01395888|531719591|FG001|Treatment Period (TP)|Adverse Event|7|||
147424641|NCT01395888|531719592|FG002|Treatment Period (TP)|Adverse Event|6|||
147424642|NCT01395888|531719590|FG000|Treatment Period (TP)|Lack of Efficacy|0|||
147424643|NCT01395888|531719591|FG001|Treatment Period (TP)|Lack of Efficacy|4|||
147424644|NCT01395888|531719592|FG002|Treatment Period (TP)|Lack of Efficacy|3|||
147424645|NCT01395888|531719590|FG000|Treatment Period (TP)|Protocol Violation|0|||
147424646|NCT01395888|531719591|FG001|Treatment Period (TP)|Protocol Violation|1|||
147424647|NCT01395888|531719592|FG002|Treatment Period (TP)|Protocol Violation|5|||
147424648|NCT01395888|531719590|FG000|Treatment Period (TP)|Met Protocol-defined Stopping Criteria|0|||
147424649|NCT01395888|531719591|FG001|Treatment Period (TP)|Met Protocol-defined Stopping Criteria|1|||
147424650|NCT01395888|531719592|FG002|Treatment Period (TP)|Met Protocol-defined Stopping Criteria|0|||
147424651|NCT01395888|531719590|FG000|Treatment Period (TP)|Withdrawal by Subject|0|||
147424652|NCT01395888|531719591|FG001|Treatment Period (TP)|Withdrawal by Subject|2|||
147424653|NCT01395888|531719592|FG002|Treatment Period (TP)|Withdrawal by Subject|3|||
147424654|NCT03218397|531719593|FG000|Overall Study|Prior positive blood culture|8|||
147424655|NCT03218397|531719594|FG001|Overall Study|Prior positive blood culture|13|||
147424656|NCT03218397|531719593|FG000|Overall Study|Comfort care|8|||
147424657|NCT03218397|531719594|FG001|Overall Study|Comfort care|5|||
147424658|NCT03218397|531719593|FG000|Overall Study|Comfort care and positive blood culture|1|||
147424659|NCT03218397|531719594|FG001|Overall Study|Comfort care and positive blood culture|0|||
147424660|NCT03218397|531719593|FG000|Overall Study|Comfort care and mixed culture|0|||
147424661|NCT03218397|531719594|FG001|Overall Study|Comfort care and mixed culture|1|||
147424662|NCT03218397|531719593|FG000|Overall Study|Mixed culture|2|||
147424663|NCT03218397|531719594|FG001|Overall Study|Mixed culture|2|||
147424664|NCT03218397|531719593|FG000|Overall Study|Inaccessible hospital records|2|||
147424665|NCT03218397|531719594|FG001|Overall Study|Inaccessible hospital records|5|||
147424666|NCT03218397|531719593|FG000|Overall Study|No gram-negative bacilli (GNB)|0|||
147424667|NCT03218397|531719594|FG001|Overall Study|No gram-negative bacilli (GNB)|2|||
147424668|NCT03218397|531719593|FG000|Overall Study|Randomized during laboratory off hours|2|||
147424669|NCT03218397|531719594|FG001|Overall Study|Randomized during laboratory off hours|1|||
147424670|NCT01796548|531719595|FG000|Overall Study|Lost to Follow-up|1|||
147424671|NCT01796548|531719595|FG000|Overall Study|Other|2|||
147424672|NCT02457559|531719596|FG000|Overall Study|Progressive Disease|1|||
147424673|NCT02457559|531719597|FG001|Overall Study|Progressive Disease|2|||
147424674|NCT02457559|531719598|FG002|Overall Study|Progressive Disease|3|||
147424675|NCT02457559|531719599|FG003|Overall Study|Progressive Disease|0|||
147424676|NCT02457559|531719600|FG004|Overall Study|Progressive Disease|0|||
147424677|NCT02457559|531719601|FG005|Overall Study|Progressive Disease|2|||
147424678|NCT02457559|531719602|FG006|Overall Study|Progressive Disease|1|||
147424679|NCT02457559|531719603|FG007|Overall Study|Progressive Disease|0|||
147424680|NCT02457559|531719604|FG008|Overall Study|Progressive Disease|1|||
147424681|NCT02457559|531719605|FG009|Overall Study|Progressive Disease|1|||
147424682|NCT02457559|531719606|FG010|Overall Study|Progressive Disease|1|||
147424683|NCT02457559|531719596|FG000|Overall Study|Investigator's Discretion|0|||
147424684|NCT02457559|531719597|FG001|Overall Study|Investigator's Discretion|0|||
147424685|NCT02457559|531719598|FG002|Overall Study|Investigator's Discretion|2|||
147424686|NCT02457559|531719599|FG003|Overall Study|Investigator's Discretion|0|||
147424687|NCT02457559|531719600|FG004|Overall Study|Investigator's Discretion|1|||
147424688|NCT02457559|531719601|FG005|Overall Study|Investigator's Discretion|0|||
147424689|NCT02457559|531719602|FG006|Overall Study|Investigator's Discretion|1|||
147424690|NCT02457559|531719603|FG007|Overall Study|Investigator's Discretion|0|||
147424691|NCT02457559|531719604|FG008|Overall Study|Investigator's Discretion|1|||
147424692|NCT02457559|531719605|FG009|Overall Study|Investigator's Discretion|0|||
147424693|NCT02457559|531719606|FG010|Overall Study|Investigator's Discretion|1|||
147424694|NCT02457559|531719596|FG000|Overall Study|Adverse Event|0|||
147424695|NCT02457559|531719597|FG001|Overall Study|Adverse Event|1|||
147424696|NCT02457559|531719598|FG002|Overall Study|Adverse Event|2|||
147424697|NCT02457559|531719599|FG003|Overall Study|Adverse Event|0|||
147424698|NCT02457559|531719600|FG004|Overall Study|Adverse Event|0|||
147424699|NCT02457559|531719601|FG005|Overall Study|Adverse Event|0|||
147424700|NCT02457559|531719602|FG006|Overall Study|Adverse Event|0|||
147424701|NCT02457559|531719603|FG007|Overall Study|Adverse Event|0|||
147424702|NCT02457559|531719604|FG008|Overall Study|Adverse Event|0|||
147424703|NCT02457559|531719605|FG009|Overall Study|Adverse Event|0|||
147424704|NCT02457559|531719606|FG010|Overall Study|Adverse Event|0|||
147424705|NCT02457559|531719596|FG000|Overall Study|Reason not Specified|1|||
147424706|NCT02457559|531719597|FG001|Overall Study|Reason not Specified|0|||
147424707|NCT02457559|531719598|FG002|Overall Study|Reason not Specified|0|||
147424708|NCT02457559|531719599|FG003|Overall Study|Reason not Specified|0|||
147424709|NCT02457559|531719600|FG004|Overall Study|Reason not Specified|0|||
147424710|NCT02457559|531719601|FG005|Overall Study|Reason not Specified|0|||
147424711|NCT02457559|531719602|FG006|Overall Study|Reason not Specified|0|||
147424712|NCT02457559|531719603|FG007|Overall Study|Reason not Specified|0|||
147424713|NCT02457559|531719604|FG008|Overall Study|Reason not Specified|0|||
147424714|NCT02457559|531719605|FG009|Overall Study|Reason not Specified|2|||
147424715|NCT02457559|531719606|FG010|Overall Study|Reason not Specified|0|||
147424716|NCT02457559|531719596|FG000|Overall Study|Death|0|||
147424717|NCT02457559|531719597|FG001|Overall Study|Death|0|||
147424718|NCT02457559|531719598|FG002|Overall Study|Death|0|||
147424719|NCT02457559|531719599|FG003|Overall Study|Death|0|||
147424720|NCT02457559|531719600|FG004|Overall Study|Death|0|||
147424721|NCT02457559|531719601|FG005|Overall Study|Death|0|||
147424722|NCT02457559|531719602|FG006|Overall Study|Death|0|||
147424723|NCT02457559|531719603|FG007|Overall Study|Death|0|||
147424724|NCT02457559|531719604|FG008|Overall Study|Death|1|||
147424725|NCT02457559|531719605|FG009|Overall Study|Death|1|||
147424726|NCT02457559|531719606|FG010|Overall Study|Death|0|||
147424727|NCT02374671|531719607|FG000|Observation (Deferred Implantation)|Withdrawal by Subject|0|||
147424728|NCT02374671|531719608|FG001|Observation (Deferred Implantation)|Withdrawal by Subject|0|||
147424729|NCT02374671|531719609|FG002|Observation (Deferred Implantation)|Withdrawal by Subject|4|||
147424730|NCT02374671|531719607|FG000|Observation (Deferred Implantation)|Adverse Event|0|||
147424731|NCT02374671|531719608|FG001|Observation (Deferred Implantation)|Adverse Event|0|||
147424732|NCT02374671|531719609|FG002|Observation (Deferred Implantation)|Adverse Event|1|||
147424733|NCT02374671|531719607|FG000|Implantation- Nonrandomized & Randomized|Lost to Follow-up|17|||
147424734|NCT02374671|531719608|FG001|Implantation- Nonrandomized & Randomized|Lost to Follow-up|1|||
147424735|NCT02374671|531719609|FG002|Implantation- Nonrandomized & Randomized|Lost to Follow-up|2|||
147424736|NCT02374671|531719607|FG000|Implantation- Nonrandomized & Randomized|Adverse Event|7|||
147424737|NCT02374671|531719608|FG001|Implantation- Nonrandomized & Randomized|Adverse Event|0|||
147424738|NCT02374671|531719609|FG002|Implantation- Nonrandomized & Randomized|Adverse Event|1|||
147424739|NCT02374671|531719607|FG000|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|1|||
147424740|NCT02374671|531719608|FG001|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|0|||
147424741|NCT02374671|531719609|FG002|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|0|||
147424742|NCT00903682|531719610|FG000|Overall Study|Adverse Event|6|||
147424743|NCT00903682|531719611|FG001|Overall Study|Adverse Event|13|||
147424744|NCT00903682|531719610|FG000|Overall Study|Lost to Follow-up|1|||
147424745|NCT00903682|531719611|FG001|Overall Study|Lost to Follow-up|0|||
147424746|NCT00903682|531719610|FG000|Overall Study|Withdrawal by Subject|5|||
147424747|NCT00903682|531719611|FG001|Overall Study|Withdrawal by Subject|0|||
147424748|NCT00903682|531719610|FG000|Overall Study|Pregnancy|0|||
147424749|NCT00903682|531719611|FG001|Overall Study|Pregnancy|1|||
147424750|NCT00903682|531719610|FG000|Overall Study|Subject Reached A Virologic Endpoint|1|||
147424751|NCT00903682|531719611|FG001|Overall Study|Subject Reached A Virologic Endpoint|1|||
147424752|NCT00903682|531719610|FG000|Overall Study|Subject Non-Compliant|1|||
147424753|NCT00903682|531719611|FG001|Overall Study|Subject Non-Compliant|0|||
147424754|NCT00903682|531719610|FG000|Overall Study|Patient Couldn't Come For The Visit Due|1|||
147424755|NCT00903682|531719611|FG001|Overall Study|Patient Couldn't Come For The Visit Due|0|||
147424756|NCT00903682|531719610|FG000|Overall Study|For Resistent Profile (Excl Crit 2 Met)|1|||
147424757|NCT00903682|531719611|FG001|Overall Study|For Resistent Profile (Excl Crit 2 Met)|0|||
147424758|NCT03866473|531719614|FG000|Phase 1|Death|1|||
147424759|NCT03866473|531719615|FG001|Phase 1|Death|0|||
147424760|NCT03866473|531719614|FG000|Phase 2|Death|0|||
147424761|NCT03866473|531719615|FG001|Phase 2|Death|2|||
147424762|NCT03866473|531719614|FG000|Phase 2|Dropped|1|||
147424763|NCT03866473|531719615|FG001|Phase 2|Dropped|1|||
147424764|NCT03866473|531719614|FG000|Phase 2|Completed the study by receiving alternate treatment for diabetic macular edema|1|||
147424765|NCT03866473|531719615|FG001|Phase 2|Completed the study by receiving alternate treatment for diabetic macular edema|0|||
147424766|NCT02495792|531719616|FG000|Overall Study|Lost to Follow-up|5|||
147424767|NCT02495792|531719617|FG001|Overall Study|Lost to Follow-up|9|||
147424768|NCT02495792|531719616|FG000|Overall Study|Protocol Violation|32|||
147424769|NCT02495792|531719617|FG001|Overall Study|Protocol Violation|31|||
147424770|NCT02523599|531719618|FG000|Overall Study|Adverse Event|1|||
147424771|NCT02523599|531719619|FG001|Overall Study|Adverse Event|0|||
147424772|NCT02523599|531719618|FG000|Overall Study|Physician Decision|1|||
147424773|NCT02523599|531719619|FG001|Overall Study|Physician Decision|0|||
147424774|NCT02523599|531719618|FG000|Overall Study|Lost to Follow-up|4|||
147424775|NCT02523599|531719619|FG001|Overall Study|Lost to Follow-up|1|||
147424776|NCT02523599|531719618|FG000|Overall Study|Did not return for Day 30 visit|2|||
147424777|NCT02523599|531719619|FG001|Overall Study|Did not return for Day 30 visit|0|||
147424778|NCT05590884|531719620|FG000|Overall Study|Withdrawal by Subject|1|||
147424779|NCT05590884|531719621|FG001|Overall Study|Withdrawal by Subject|0|||
147424780|NCT05590884|531719622|FG002|Overall Study|Withdrawal by Subject|0|||
147424781|NCT04443153|531719627|FG000|First intervention (8 weeks)|Withdrawal by Subject|2|||
147424782|NCT04443153|531719628|FG001|First intervention (8 weeks)|Withdrawal by Subject|0|||
147424783|NCT04443153|531719627|FG000|First intervention (8 weeks)|Lost to Follow-up|0|||
147424784|NCT04443153|531719628|FG001|First intervention (8 weeks)|Lost to Follow-up|2|||
147424785|NCT04443153|531719627|FG000|Second intervention (8 weeks)|Withdrawal by Subject|1|||
147424786|NCT04443153|531719628|FG001|Second intervention (8 weeks)|Withdrawal by Subject|1|||
147424787|NCT04443153|531719627|FG000|Second intervention (8 weeks)|Lost to Follow-up|2|||
147424788|NCT04443153|531719628|FG001|Second intervention (8 weeks)|Lost to Follow-up|0|||
147424789|NCT05182125|531719629|FG000|Overall Study|Withdrawal by Subject|0|||
147424790|NCT05182125|531719630|FG001|Overall Study|Withdrawal by Subject|0|||
147424791|NCT05182125|531719631|FG002|Overall Study|Withdrawal by Subject|0|||
147424792|NCT05182125|531719632|FG003|Overall Study|Withdrawal by Subject|0|||
147424793|NCT05182125|531719633|FG004|Overall Study|Withdrawal by Subject|2|||
147424794|NCT05182125|531719634|FG005|Overall Study|Withdrawal by Subject|0|||
147424795|NCT05182125|531719629|FG000|Overall Study|Participant unable to adhere Visit Schedule|0|||
147424796|NCT05182125|531719630|FG001|Overall Study|Participant unable to adhere Visit Schedule|0|||
147424797|NCT05182125|531719631|FG002|Overall Study|Participant unable to adhere Visit Schedule|0|||
147424798|NCT05182125|531719632|FG003|Overall Study|Participant unable to adhere Visit Schedule|1|||
147424799|NCT05182125|531719633|FG004|Overall Study|Participant unable to adhere Visit Schedule|0|||
147424800|NCT05182125|531719634|FG005|Overall Study|Participant unable to adhere Visit Schedule|0|||
147424801|NCT05182125|531719629|FG000|Overall Study|Death|0|||
147424802|NCT05182125|531719630|FG001|Overall Study|Death|0|||
147424803|NCT05182125|531719631|FG002|Overall Study|Death|0|||
147424804|NCT05182125|531719632|FG003|Overall Study|Death|0|||
147424805|NCT05182125|531719633|FG004|Overall Study|Death|1|||
147424806|NCT05182125|531719634|FG005|Overall Study|Death|0|||
147424807|NCT03519971|531719635|FG000|Overall Study|Death|142|||
147424808|NCT03519971|531719636|FG001|Overall Study|Death|69|||
147424809|NCT03519971|531719635|FG000|Overall Study|Lost to Follow-up|0|||
147424810|NCT03519971|531719636|FG001|Overall Study|Lost to Follow-up|1|||
147424811|NCT03519971|531719635|FG000|Overall Study|Ongoing treatment and in follow-up at data cut off|73|||
147424812|NCT03519971|531719636|FG001|Overall Study|Ongoing treatment and in follow-up at data cut off|37|||
147424813|NCT03519971|531719635|FG000|Overall Study|Withdrawal by Subject|3|||
147424814|NCT03519971|531719636|FG001|Overall Study|Withdrawal by Subject|2|||
147424815|NCT03519971|531719635|FG000|Overall Study|Other|1|||
147424816|NCT03519971|531719636|FG001|Overall Study|Other|0|||
147424817|NCT06729606|531719637|FG000|Overall Study|Adverse Event|0|||
147424818|NCT06729606|531719638|FG001|Overall Study|Adverse Event|2|||
147424819|NCT06729606|531719637|FG000|Overall Study|Death|1|||
147424820|NCT06729606|531719638|FG001|Overall Study|Death|0|||
147424821|NCT06729606|531719637|FG000|Overall Study|Physician Decision|0|||
147424822|NCT06729606|531719638|FG001|Overall Study|Physician Decision|1|||
147424823|NCT06729606|531719637|FG000|Overall Study|Withdrawal by Subject|2|||
147424824|NCT06729606|531719638|FG001|Overall Study|Withdrawal by Subject|4|||
147424825|NCT05195489|531721678|FG000|Overall Study|Lost to Follow-up|1|||
147424826|NCT05195489|531721679|FG001|Overall Study|Lost to Follow-up|0|||
147424827|NCT05195489|531721678|FG000|Overall Study|Protocol Violation|0|||
147424828|NCT05195489|531721679|FG001|Overall Study|Protocol Violation|2|||
147424829|NCT05195489|531721678|FG000|Overall Study|Withdrawal by Subject|1|||
147424830|NCT05195489|531721679|FG001|Overall Study|Withdrawal by Subject|1|||
147424831|NCT05195489|531721678|FG000|Overall Study|Removed|0|||
147424832|NCT05195489|531721679|FG001|Overall Study|Removed|1|||
147424833|NCT03440320|531721680|FG000|Overall Study|Withdrawal by Subject|0|||
147424834|NCT03440320|531721681|FG001|Overall Study|Withdrawal by Subject|1|||
147424835|NCT00409773|531721682|FG000|Overall Study|Adverse Event|3|||
147424836|NCT00409773|531721683|FG001|Overall Study|Adverse Event|4|||
147424837|NCT00409773|531721684|FG002|Overall Study|Adverse Event|4|||
147424838|NCT00409773|531721685|FG003|Overall Study|Adverse Event|2|||
147424839|NCT00409773|531721686|FG004|Overall Study|Adverse Event|6|||
147424840|NCT00409773|531721682|FG000|Overall Study|Lost to Follow-up|6|||
147424841|NCT00409773|531721683|FG001|Overall Study|Lost to Follow-up|1|||
147424842|NCT00409773|531721684|FG002|Overall Study|Lost to Follow-up|2|||
147424843|NCT00409773|531721685|FG003|Overall Study|Lost to Follow-up|3|||
147424844|NCT00409773|531721686|FG004|Overall Study|Lost to Follow-up|1|||
147424845|NCT00409773|531721682|FG000|Overall Study|Physician Decision|0|||
147424846|NCT00409773|531721683|FG001|Overall Study|Physician Decision|0|||
147424847|NCT00409773|531721684|FG002|Overall Study|Physician Decision|0|||
147424848|NCT00409773|531721685|FG003|Overall Study|Physician Decision|2|||
147424849|NCT00409773|531721686|FG004|Overall Study|Physician Decision|0|||
147532708|NCT01243762|532105982|FG000|Part 1 (Dose Escalation/MTD)|Progressive Disease|3|||
147532709|NCT01243762|532105983|FG001|Part 1 (Dose Escalation/MTD)|Progressive Disease|2|||
147306715|NCT00311155|531290715|FG000|Overall Study|Withdrawal by Subject|17|||
147424850|NCT00409773|531721682|FG000|Overall Study|Protocol Violation|0|||
147424851|NCT00409773|531721683|FG001|Overall Study|Protocol Violation|2|||
147424852|NCT00409773|531721684|FG002|Overall Study|Protocol Violation|3|||
147424853|NCT00409773|531721685|FG003|Overall Study|Protocol Violation|3|||
147424854|NCT00409773|531721686|FG004|Overall Study|Protocol Violation|1|||
147424855|NCT00409773|531721682|FG000|Overall Study|Withdrawal by Subject|0|||
147424856|NCT00409773|531721683|FG001|Overall Study|Withdrawal by Subject|0|||
147424857|NCT00409773|531721684|FG002|Overall Study|Withdrawal by Subject|0|||
147424858|NCT00409773|531721685|FG003|Overall Study|Withdrawal by Subject|2|||
147424859|NCT00409773|531721686|FG004|Overall Study|Withdrawal by Subject|1|||
147424860|NCT00409773|531721682|FG000|Overall Study|Lack of Eligibility|0|||
147424861|NCT00409773|531721683|FG001|Overall Study|Lack of Eligibility|0|||
147424862|NCT00409773|531721684|FG002|Overall Study|Lack of Eligibility|0|||
147424863|NCT00409773|531721685|FG003|Overall Study|Lack of Eligibility|0|||
147424864|NCT00409773|531721686|FG004|Overall Study|Lack of Eligibility|1|||
147424865|NCT01201343|531721687|FG000|Overall Study|Adverse Event|6|||
147424866|NCT01201343|531721687|FG000|Overall Study|Withdrawal by Subject|5|||
147424867|NCT01201343|531721687|FG000|Overall Study|Lost to Follow-up|2|||
147424868|NCT01201343|531721687|FG000|Overall Study|Lack of Efficacy|2|||
147424869|NCT01201343|531721687|FG000|Overall Study|Participant wrongly included in trial|1|||
147424870|NCT01201343|531721687|FG000|Overall Study|Randomized, not treated|3|||
147424871|NCT01919814|531721688|FG000|Overall Study|Adverse Event|1|||
147424872|NCT01919814|531721689|FG001|Overall Study|Adverse Event|0|||
147424873|NCT01919814|531721688|FG000|Overall Study|Protocol Violation|1|||
147424874|NCT01919814|531721689|FG001|Overall Study|Protocol Violation|0|||
147424875|NCT01919814|531721688|FG000|Overall Study|Withdrawal by Subject|1|||
147424876|NCT01919814|531721689|FG001|Overall Study|Withdrawal by Subject|0|||
147424877|NCT01177722|531721692|FG000|Overall Study|Serious Adverse Event|0|||
147424878|NCT01177722|531721693|FG001|Overall Study|Serious Adverse Event|0|||
147424879|NCT01177722|531721694|FG002|Overall Study|Serious Adverse Event|1|||
147424880|NCT01177722|531721695|FG003|Overall Study|Serious Adverse Event|0|||
147424881|NCT01177722|531721692|FG000|Overall Study|Protocol Violation|0|||
147424882|NCT01177722|531721693|FG001|Overall Study|Protocol Violation|0|||
147424883|NCT01177722|531721694|FG002|Overall Study|Protocol Violation|1|||
147424884|NCT01177722|531721695|FG003|Overall Study|Protocol Violation|0|||
147424885|NCT01177722|531721692|FG000|Overall Study|Lost to Follow-up|3|||
147424886|NCT01177722|531721693|FG001|Overall Study|Lost to Follow-up|4|||
147424887|NCT01177722|531721694|FG002|Overall Study|Lost to Follow-up|3|||
147424888|NCT01177722|531721695|FG003|Overall Study|Lost to Follow-up|1|||
147424889|NCT01177722|531721692|FG000|Overall Study|Withdrawal by Subject|10|||
147424890|NCT01177722|531721693|FG001|Overall Study|Withdrawal by Subject|6|||
147424891|NCT01177722|531721694|FG002|Overall Study|Withdrawal by Subject|4|||
147424892|NCT01177722|531721695|FG003|Overall Study|Withdrawal by Subject|6|||
147424893|NCT02563522|531721698|FG000|Overall Study|Adverse Event|2|||
147424894|NCT02563522|531721699|FG001|Overall Study|Adverse Event|3|||
147424895|NCT02563522|531721698|FG000|Overall Study|Lost to Follow-up|1|||
147424896|NCT02563522|531721699|FG001|Overall Study|Lost to Follow-up|0|||
147424897|NCT02563522|531721698|FG000|Overall Study|withdrew consent,, noncompliance, and unable to attend future visits|1|||
147424898|NCT02563522|531721699|FG001|Overall Study|withdrew consent,, noncompliance, and unable to attend future visits|2|||
147424899|NCT00918580|531721700|FG000|Up to 6-month Follow-up(FU)|Adverse Event|1|||
147424900|NCT00918580|531721700|FG000|Up to 6-month Follow-up(FU)|Lost to Follow-up|5|||
147424901|NCT00918580|531721700|FG000|Up to 6-month Follow-up(FU)|Withdrawal by Subject|2|||
147424902|NCT00918580|531721700|FG000|Up to 6-month Follow-up(FU)|Parent/Legal Guardian Request|2|||
147424903|NCT00918580|531721700|FG000|Up to 6-month Follow-up(FU)|Failed to Return|1|||
147424904|NCT00918580|531721700|FG000|After 6-month FU to 1-year FU|Did Not Continue After 6-Month FU|58|||
147424905|NCT00918580|531721700|FG000|After 6-month FU to 1-year FU|Failed to Return|2|||
147424906|NCT02208999|531721713|FG000|Overall Study|Lost to Follow-up|1|||
147424907|NCT04494256|531721714|FG000|Part 1: Double Blinded Period|Adverse Event|1|||
147424908|NCT04494256|531721715|FG001|Part 1: Double Blinded Period|Adverse Event|0|||
147424909|NCT04494256|531721716|FG002|Part 1: Double Blinded Period|Adverse Event|0|||
147424910|NCT04494256|531721717|FG003|Part 1: Double Blinded Period|Adverse Event|0|||
147424911|NCT04494256|531721718|FG004|Part 1: Double Blinded Period|Adverse Event|3|||
147424912|NCT04494256|531721719|FG005|Part 1: Double Blinded Period|Adverse Event|0|||
147424913|NCT04494256|531721720|FG006|Part 1: Double Blinded Period|Adverse Event|0|||
147424914|NCT04494256|531721714|FG000|Part 1: Double Blinded Period|Disease Progression - As Defined by the Protocol|0|||
147424915|NCT04494256|531721715|FG001|Part 1: Double Blinded Period|Disease Progression - As Defined by the Protocol|0|||
147424916|NCT04494256|531721716|FG002|Part 1: Double Blinded Period|Disease Progression - As Defined by the Protocol|0|||
147424917|NCT04494256|531721717|FG003|Part 1: Double Blinded Period|Disease Progression - As Defined by the Protocol|0|||
147424918|NCT04494256|531721718|FG004|Part 1: Double Blinded Period|Disease Progression - As Defined by the Protocol|5|||
147424919|NCT04494256|531721719|FG005|Part 1: Double Blinded Period|Disease Progression - As Defined by the Protocol|0|||
147424920|NCT04494256|531721720|FG006|Part 1: Double Blinded Period|Disease Progression - As Defined by the Protocol|0|||
147424921|NCT04494256|531721714|FG000|Part 1: Double Blinded Period|Protocol Deviation|0|||
147424922|NCT04494256|531721715|FG001|Part 1: Double Blinded Period|Protocol Deviation|0|||
147424923|NCT04494256|531721716|FG002|Part 1: Double Blinded Period|Protocol Deviation|0|||
147424924|NCT04494256|531721717|FG003|Part 1: Double Blinded Period|Protocol Deviation|0|||
147424925|NCT04494256|531721718|FG004|Part 1: Double Blinded Period|Protocol Deviation|1|||
147424926|NCT04494256|531721719|FG005|Part 1: Double Blinded Period|Protocol Deviation|0|||
147306716|NCT00311155|531290715|FG000|Overall Study|Did not meet entry criteria|55|||
147306717|NCT01478113|531290721|FG000|Overall Study|Withdrawal by Subject|0|||
147424927|NCT04494256|531721720|FG006|Part 1: Double Blinded Period|Protocol Deviation|0|||
147424928|NCT04494256|531721714|FG000|Part 1: Double Blinded Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|0|||
147424929|NCT04494256|531721715|FG001|Part 1: Double Blinded Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|0|||
147424930|NCT04494256|531721716|FG002|Part 1: Double Blinded Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|0|||
147424931|NCT04494256|531721717|FG003|Part 1: Double Blinded Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|1|||
147424932|NCT04494256|531721718|FG004|Part 1: Double Blinded Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|3|||
147424933|NCT04494256|531721719|FG005|Part 1: Double Blinded Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|0|||
147424934|NCT04494256|531721720|FG006|Part 1: Double Blinded Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|0|||
147424935|NCT04494256|531721714|FG000|Part 1: Double Blinded Period|Withdrawal by Subject - Other|1|||
147424936|NCT04494256|531721715|FG001|Part 1: Double Blinded Period|Withdrawal by Subject - Other|0|||
147424937|NCT04494256|531721716|FG002|Part 1: Double Blinded Period|Withdrawal by Subject - Other|1|||
147424938|NCT04494256|531721717|FG003|Part 1: Double Blinded Period|Withdrawal by Subject - Other|1|||
147424939|NCT04494256|531721718|FG004|Part 1: Double Blinded Period|Withdrawal by Subject - Other|1|||
147424940|NCT04494256|531721719|FG005|Part 1: Double Blinded Period|Withdrawal by Subject - Other|0|||
147424941|NCT04494256|531721720|FG006|Part 1: Double Blinded Period|Withdrawal by Subject - Other|0|||
147424942|NCT04494256|531721714|FG000|Part 1: Double Blinded Period|Reason Not Specified|0|||
147424943|NCT04494256|531721715|FG001|Part 1: Double Blinded Period|Reason Not Specified|0|||
147424944|NCT04494256|531721716|FG002|Part 1: Double Blinded Period|Reason Not Specified|0|||
147424945|NCT04494256|531721717|FG003|Part 1: Double Blinded Period|Reason Not Specified|0|||
147424946|NCT04494256|531721718|FG004|Part 1: Double Blinded Period|Reason Not Specified|1|||
147424947|NCT04494256|531721719|FG005|Part 1: Double Blinded Period|Reason Not Specified|0|||
147424948|NCT04494256|531721720|FG006|Part 1: Double Blinded Period|Reason Not Specified|0|||
147424949|NCT04494256|531721714|FG000|Part 2: Open Label Period|Death|0|||
147424950|NCT04494256|531721715|FG001|Part 2: Open Label Period|Death|0|||
147424951|NCT04494256|531721716|FG002|Part 2: Open Label Period|Death|0|||
147424952|NCT04494256|531721717|FG003|Part 2: Open Label Period|Death|0|||
147424953|NCT04494256|531721718|FG004|Part 2: Open Label Period|Death|0|||
147424954|NCT04494256|531721719|FG005|Part 2: Open Label Period|Death|4|||
147424955|NCT04494256|531721720|FG006|Part 2: Open Label Period|Death|2|||
147424956|NCT04494256|531721714|FG000|Part 2: Open Label Period|Adverse Event|0|||
147424957|NCT04494256|531721715|FG001|Part 2: Open Label Period|Adverse Event|0|||
147424958|NCT04494256|531721716|FG002|Part 2: Open Label Period|Adverse Event|0|||
147424959|NCT04494256|531721717|FG003|Part 2: Open Label Period|Adverse Event|0|||
147424960|NCT04494256|531721718|FG004|Part 2: Open Label Period|Adverse Event|0|||
147424961|NCT04494256|531721719|FG005|Part 2: Open Label Period|Adverse Event|0|||
147424962|NCT04494256|531721720|FG006|Part 2: Open Label Period|Adverse Event|2|||
147424963|NCT04494256|531721714|FG000|Part 2: Open Label Period|Disease Progression - As Defined by the Protocol|0|||
147424964|NCT04494256|531721715|FG001|Part 2: Open Label Period|Disease Progression - As Defined by the Protocol|0|||
147424965|NCT04494256|531721716|FG002|Part 2: Open Label Period|Disease Progression - As Defined by the Protocol|0|||
147424966|NCT04494256|531721717|FG003|Part 2: Open Label Period|Disease Progression - As Defined by the Protocol|0|||
147424967|NCT04494256|531721718|FG004|Part 2: Open Label Period|Disease Progression - As Defined by the Protocol|0|||
147424968|NCT04494256|531721719|FG005|Part 2: Open Label Period|Disease Progression - As Defined by the Protocol|5|||
147424969|NCT04494256|531721720|FG006|Part 2: Open Label Period|Disease Progression - As Defined by the Protocol|6|||
147424970|NCT04494256|531721714|FG000|Part 2: Open Label Period|Lack of Efficacy - Based on Subject Perception|0|||
147424971|NCT04494256|531721715|FG001|Part 2: Open Label Period|Lack of Efficacy - Based on Subject Perception|0|||
147424972|NCT04494256|531721716|FG002|Part 2: Open Label Period|Lack of Efficacy - Based on Subject Perception|0|||
147424973|NCT04494256|531721717|FG003|Part 2: Open Label Period|Lack of Efficacy - Based on Subject Perception|0|||
147424974|NCT04494256|531721718|FG004|Part 2: Open Label Period|Lack of Efficacy - Based on Subject Perception|0|||
147424975|NCT04494256|531721719|FG005|Part 2: Open Label Period|Lack of Efficacy - Based on Subject Perception|0|||
147424976|NCT04494256|531721720|FG006|Part 2: Open Label Period|Lack of Efficacy - Based on Subject Perception|1|||
147424977|NCT04494256|531721714|FG000|Part 2: Open Label Period|Study Terminated by Sponsor|0|||
147424978|NCT04494256|531721715|FG001|Part 2: Open Label Period|Study Terminated by Sponsor|0|||
147424979|NCT04494256|531721716|FG002|Part 2: Open Label Period|Study Terminated by Sponsor|0|||
147424980|NCT04494256|531721717|FG003|Part 2: Open Label Period|Study Terminated by Sponsor|0|||
147424981|NCT04494256|531721718|FG004|Part 2: Open Label Period|Study Terminated by Sponsor|0|||
147424982|NCT04494256|531721719|FG005|Part 2: Open Label Period|Study Terminated by Sponsor|4|||
147424983|NCT04494256|531721720|FG006|Part 2: Open Label Period|Study Terminated by Sponsor|35|||
147424984|NCT04494256|531721714|FG000|Part 2: Open Label Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|0|||
147424985|NCT04494256|531721715|FG001|Part 2: Open Label Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|0|||
147424986|NCT04494256|531721716|FG002|Part 2: Open Label Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|0|||
147424987|NCT04494256|531721717|FG003|Part 2: Open Label Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|0|||
147424988|NCT04494256|531721718|FG004|Part 2: Open Label Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|0|||
147424989|NCT04494256|531721719|FG005|Part 2: Open Label Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|5|||
147424990|NCT04494256|531721720|FG006|Part 2: Open Label Period|SubjectWithdrawal-VisitBurden/SchedulingConflict|4|||
147424991|NCT04494256|531721714|FG000|Part 2: Open Label Period|Withdrawal by Subject - Other|0|||
147424992|NCT04494256|531721715|FG001|Part 2: Open Label Period|Withdrawal by Subject - Other|0|||
147424993|NCT04494256|531721716|FG002|Part 2: Open Label Period|Withdrawal by Subject - Other|0|||
147424994|NCT04494256|531721717|FG003|Part 2: Open Label Period|Withdrawal by Subject - Other|0|||
147424995|NCT04494256|531721718|FG004|Part 2: Open Label Period|Withdrawal by Subject - Other|0|||
147424996|NCT04494256|531721719|FG005|Part 2: Open Label Period|Withdrawal by Subject - Other|1|||
147424997|NCT04494256|531721720|FG006|Part 2: Open Label Period|Withdrawal by Subject - Other|1|||
147424998|NCT00262951|531721721|FG000|Overall Study|Progressive disease/relapse|3|||
147424999|NCT00262951|531721721|FG000|Overall Study|Adverse Event|7|||
147425000|NCT00262951|531721721|FG000|Overall Study|Death|1|||
147425001|NCT00262951|531721721|FG000|Overall Study|Withdrawal by Subject|1|||
147425002|NCT00262951|531721721|FG000|Overall Study|Alternative treatment|3|||
147425003|NCT00262951|531721721|FG000|Overall Study|Off treatment for other disease|1|||
147425004|NCT04025580|531721722|FG000|Overall Study|COVID 19 restrictions at Clinical Center|11|||
147425005|NCT04025580|531721723|FG001|Overall Study|COVID 19 restrictions at Clinical Center|0|||
147425006|NCT04025580|531721724|FG002|Overall Study|COVID 19 restrictions at Clinical Center|0|||
147425007|NCT01768117|531721725|FG000|Overall Study|Lost to Follow-up|1|||
147425008|NCT01768117|531721725|FG000|Overall Study|Withdrawal by Subject|2|||
147425009|NCT01768117|531721725|FG000|Overall Study|Protocol Violation|3|||
147425010|NCT01249274|531721727|FG000|Overall Study|Lost to Follow-up|3|||
147425011|NCT01249274|531721728|FG001|Overall Study|Lost to Follow-up|4|||
147425012|NCT01249274|531721727|FG000|Overall Study|Received inpatient substance treatment|1|||
147425013|NCT01249274|531721728|FG001|Overall Study|Received inpatient substance treatment|2|||
147425014|NCT01000636|531721729|FG000|Overall Study|Withdrawal by Subject|1|||
147425015|NCT01000636|531721729|FG000|Overall Study|Adverse Event|1|||
147425016|NCT03658668|531721730|FG000|Overall Study|Time Commitment|1|||
147425017|NCT03658668|531721731|FG001|Overall Study|Time Commitment|1|||
147425018|NCT04634825|531721732|FG000|Overall Study|Death|10|||
147425019|NCT04634825|531721733|FG001|Overall Study|Death|3|||
147425020|NCT04634825|531721732|FG000|Overall Study|Lost to Follow-up|1|||
147425021|NCT04634825|531721733|FG001|Overall Study|Lost to Follow-up|0|||
147425022|NCT04634825|531721732|FG000|Overall Study|Study terminated by sponsor|35|||
147425023|NCT04634825|531721733|FG001|Overall Study|Study terminated by sponsor|11|||
147425024|NCT04634825|531721732|FG000|Overall Study|Withdrawal by Subject|2|||
147425025|NCT04634825|531721733|FG001|Overall Study|Withdrawal by Subject|0|||
147425026|NCT01100034|531721736|FG000|Overall Study|Lost to Follow-up|11|||
147425027|NCT01100034|531721736|FG000|Overall Study|Withdrawal of parent/guardian consent|1|||
147425028|NCT01100034|531721736|FG000|Overall Study|Withdrawal by Subject|4|||
147425029|NCT01100034|531721736|FG000|Overall Study|Sponsor decision|21|||
147425030|NCT01100034|531721736|FG000|Overall Study|Participated in another clinical trial|1|||
147425031|NCT01100034|531721736|FG000|Overall Study|Participants moved to another hospital|4|||
147425032|NCT01100034|531721736|FG000|Overall Study|Site closed due to non-responsiveness|1|||
147425033|NCT00836095|531721743|FG000|Overall Study|Physician Decision|0|||
147425034|NCT00836095|531721744|FG001|Overall Study|Physician Decision|3|||
147425035|NCT01602562|531721745|FG000|Overall Study|Adverse Event|3|||
147425036|NCT01602562|531721746|FG001|Overall Study|Adverse Event|1|||
147425037|NCT01602562|531721745|FG000|Overall Study|Physician Decision|1|||
147425038|NCT01602562|531721746|FG001|Overall Study|Physician Decision|1|||
147425039|NCT01602562|531721745|FG000|Overall Study|Withdrawal by Subject|1|||
147191335|NCT00117637|530867605|FG000|First Intervention (Period 1)|investig. decision, not protocol driven|0|||
147191336|NCT00117637|530867606|FG001|First Intervention (Period 1)|investig. decision, not protocol driven|1|||
147191337|NCT00117637|530867605|FG000|First Intervention (Period 1)|reason not reported|0|||
147191338|NCT00117637|530867606|FG001|First Intervention (Period 1)|reason not reported|1|||
147191339|NCT00117637|530867605|FG000|Second Intervention (Period 2)|Adverse Event|0|||
147191340|NCT00117637|530867606|FG001|Second Intervention (Period 2)|Adverse Event|9|||
147191341|NCT00117637|530867605|FG000|Second Intervention (Period 2)|Lost to Follow-up|1|||
147191342|NCT00117637|530867606|FG001|Second Intervention (Period 2)|Lost to Follow-up|0|||
147191343|NCT00117637|530867605|FG000|Second Intervention (Period 2)|Protocol Violation|1|||
147191344|NCT00117637|530867606|FG001|Second Intervention (Period 2)|Protocol Violation|0|||
147191345|NCT00117637|530867605|FG000|Second Intervention (Period 2)|Withdrawal by Subject|4|||
147191346|NCT00117637|530867606|FG001|Second Intervention (Period 2)|Withdrawal by Subject|3|||
147191347|NCT00117637|530867605|FG000|Second Intervention (Period 2)|study terminated by the sponsor|2|||
147191348|NCT00117637|530867606|FG001|Second Intervention (Period 2)|study terminated by the sponsor|9|||
147191349|NCT00117637|530867605|FG000|Second Intervention (Period 2)|non compliant with study medication|1|||
147191350|NCT00117637|530867606|FG001|Second Intervention (Period 2)|non compliant with study medication|1|||
147191351|NCT00117637|530867605|FG000|Second Intervention (Period 2)|reason not reported|1|||
147191352|NCT00117637|530867606|FG001|Second Intervention (Period 2)|reason not reported|0|||
147191353|NCT00097500|530867607|FG000|On-drug Period (Week 0 to Week 52)|Withdrawal of consent|1|||
147191354|NCT00097500|530867608|FG001|On-drug Period (Week 0 to Week 52)|Withdrawal of consent|1|||
147191355|NCT00097500|530867607|FG000|On-drug Period (Week 0 to Week 52)|Adverse Event|5|||
147191356|NCT00097500|530867608|FG001|On-drug Period (Week 0 to Week 52)|Adverse Event|0|||
147191357|NCT00097500|530867607|FG000|On-drug Period (Week 0 to Week 52)|Physician Decision|0|||
147191358|NCT00097500|530867608|FG001|On-drug Period (Week 0 to Week 52)|Physician Decision|1|||
147191359|NCT00097500|530867607|FG000|On-drug Period (Week 0 to Week 52)|Lost to Follow-up|0|||
147191360|NCT00097500|530867608|FG001|On-drug Period (Week 0 to Week 52)|Lost to Follow-up|1|||
147191361|NCT00097500|530867607|FG000|Off-drug Period (Week 52 to Week 64)|Withdrawal of consent|2|||
147191362|NCT00097500|530867608|FG001|Off-drug Period (Week 52 to Week 64)|Withdrawal of consent|1|||
147191363|NCT00097500|530867607|FG000|Off-drug Period (Week 52 to Week 64)|Physician Decision|0|||
147191364|NCT00097500|530867608|FG001|Off-drug Period (Week 52 to Week 64)|Physician Decision|1|||
147191365|NCT00097500|530867607|FG000|Off-drug Period (Week 52 to Week 64)|Loss of glucose control|3|||
147191366|NCT00097500|530867608|FG001|Off-drug Period (Week 52 to Week 64)|Loss of glucose control|2|||
147191367|NCT00300755|530867616|FG000|Overall Study|Adverse Event|1|||
147191368|NCT00300755|530867617|FG001|Overall Study|Adverse Event|2|||
147191369|NCT00300755|530867618|FG002|Overall Study|Adverse Event|1|||
147191370|NCT00300755|530867616|FG000|Overall Study|Withdrawal by Subject|0|||
147191371|NCT00300755|530867617|FG001|Overall Study|Withdrawal by Subject|2|||
147191372|NCT00300755|530867618|FG002|Overall Study|Withdrawal by Subject|0|||
147191373|NCT00300755|530867616|FG000|Overall Study|Protocol Violation|0|||
147191374|NCT00300755|530867617|FG001|Overall Study|Protocol Violation|0|||
147425040|NCT01602562|531721746|FG001|Overall Study|Withdrawal by Subject|1|||
147425041|NCT04964414|531721748|FG000|Overall Study|Lost to Follow-up|10|||
147425042|NCT04964414|531721749|FG001|Overall Study|Lost to Follow-up|8|||
147425043|NCT04964414|531721748|FG000|Overall Study|Withdrawal by Subject|1|||
147191375|NCT00300755|530867618|FG002|Overall Study|Protocol Violation|1|||
147425044|NCT04964414|531721749|FG001|Overall Study|Withdrawal by Subject|1|||
147425045|NCT00819390|531721750|FG000|Overall Study|Lost to Follow-up|1|||
147425046|NCT00819390|531721751|FG001|Overall Study|Lost to Follow-up|1|||
147425047|NCT00819390|531721752|FG002|Overall Study|Lost to Follow-up|0|||
147425048|NCT00819390|531721753|FG003|Overall Study|Lost to Follow-up|0|||
147425049|NCT00819390|531721750|FG000|Overall Study|Withdrawal by Subject|2|||
147425050|NCT00819390|531721751|FG001|Overall Study|Withdrawal by Subject|0|||
147425051|NCT00819390|531721752|FG002|Overall Study|Withdrawal by Subject|0|||
147425052|NCT00819390|531721753|FG003|Overall Study|Withdrawal by Subject|0|||
147425053|NCT00819390|531721750|FG000|Overall Study|Adverse Event|0|||
147425054|NCT00819390|531721751|FG001|Overall Study|Adverse Event|0|||
147425055|NCT00819390|531721752|FG002|Overall Study|Adverse Event|1|||
147425056|NCT00819390|531721753|FG003|Overall Study|Adverse Event|0|||
147425057|NCT01191268|531721754|FG000|Overall Study|Withdrawal by Subject|19|||
147425058|NCT01191268|531721755|FG001|Overall Study|Withdrawal by Subject|25|||
147425059|NCT01191268|531721756|FG002|Overall Study|Withdrawal by Subject|21|||
147425060|NCT01191268|531721754|FG000|Overall Study|Adverse Event|21|||
147425061|NCT01191268|531721755|FG001|Overall Study|Adverse Event|13|||
147425062|NCT01191268|531721756|FG002|Overall Study|Adverse Event|8|||
147425063|NCT01191268|531721754|FG000|Overall Study|Physician Decision|6|||
147425064|NCT01191268|531721755|FG001|Overall Study|Physician Decision|8|||
147425065|NCT01191268|531721756|FG002|Overall Study|Physician Decision|9|||
147425066|NCT01191268|531721754|FG000|Overall Study|Lost to Follow-up|8|||
147425067|NCT01191268|531721755|FG001|Overall Study|Lost to Follow-up|5|||
147425068|NCT01191268|531721756|FG002|Overall Study|Lost to Follow-up|9|||
147425069|NCT01191268|531721754|FG000|Overall Study|Entry Criteria Not Met|3|||
147425070|NCT01191268|531721755|FG001|Overall Study|Entry Criteria Not Met|1|||
147425071|NCT01191268|531721756|FG002|Overall Study|Entry Criteria Not Met|1|||
147425072|NCT01191268|531721754|FG000|Overall Study|Death|0|||
147425073|NCT01191268|531721755|FG001|Overall Study|Death|1|||
147425074|NCT01191268|531721756|FG002|Overall Study|Death|3|||
147425075|NCT01191268|531721754|FG000|Overall Study|Protocol Violation|1|||
147532710|NCT01243762|532105984|FG002|Part 1 (Dose Escalation/MTD)|Progressive Disease|3|||
147532711|NCT01243762|532105985|FG003|Part 1 (Dose Escalation/MTD)|Progressive Disease|5|||
147532712|NCT01243762|532105986|FG004|Part 1 (Dose Escalation/MTD)|Progressive Disease|5|||
147532713|NCT01243762|532105987|FG005|Part 1 (Dose Escalation/MTD)|Progressive Disease|2|||
147532714|NCT01243762|532105988|FG006|Part 1 (Dose Escalation/MTD)|Progressive Disease|0|||
147532715|NCT01243762|532105982|FG000|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
147532716|NCT01243762|532105983|FG001|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|3|||
147532717|NCT01243762|532105984|FG002|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
147532718|NCT01243762|532105985|FG003|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
147532719|NCT01243762|532105986|FG004|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
147532720|NCT01243762|532105987|FG005|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
147532721|NCT01243762|532105988|FG006|Part 1 (Dose Escalation/MTD)|Withdrawal by Subject|0|||
147532722|NCT01243762|532105982|FG000|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0|||
147532723|NCT01243762|532105983|FG001|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|1|||
147532724|NCT01243762|532105984|FG002|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0|||
147532725|NCT01243762|532105985|FG003|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0|||
147532726|NCT01243762|532105986|FG004|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0|||
147532727|NCT01243762|532105987|FG005|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|0|||
147532728|NCT01243762|532105988|FG006|Part 2 (Dose Confirmation/Efficacy)|Adverse Event|3|||
147532729|NCT01243762|532105982|FG000|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|1|||
147532730|NCT01243762|532105983|FG001|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|3|||
147532731|NCT01243762|532105984|FG002|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|0|||
147532732|NCT01243762|532105985|FG003|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|1|||
147532733|NCT01243762|532105986|FG004|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|2|||
147532734|NCT01243762|532105987|FG005|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|0|||
147532735|NCT01243762|532105988|FG006|Part 2 (Dose Confirmation/Efficacy)|Progressive Disease|3|||
147532736|NCT01243762|532105982|FG000|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0|||
147532737|NCT01243762|532105983|FG001|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|1|||
147532738|NCT01243762|532105984|FG002|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0|||
147532739|NCT01243762|532105985|FG003|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0|||
147532740|NCT01243762|532105986|FG004|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|1|||
147532741|NCT01243762|532105987|FG005|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0|||
147532742|NCT01243762|532105988|FG006|Part 2 (Dose Confirmation/Efficacy)|Withdrawal by Subject|0|||
147532743|NCT01243762|532105982|FG000|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0|||
147532744|NCT01243762|532105983|FG001|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0|||
147532745|NCT01243762|532105984|FG002|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0|||
147191376|NCT04571944|530867619|FG000|Overall Study|Death|1|||
147191377|NCT04571944|530867620|FG001|Overall Study|Death|0|||
147191378|NCT04571944|530867619|FG000|Overall Study|Withdrawal by Subject|3|||
147191379|NCT04571944|530867620|FG001|Overall Study|Withdrawal by Subject|0|||
147191380|NCT04571944|530867619|FG000|Overall Study|One participant canceled surgery and one participant developed delirium before the first dose.|2|||
147191381|NCT04571944|530867620|FG001|Overall Study|One participant canceled surgery and one participant developed delirium before the first dose.|0|||
147191382|NCT04079296|530867623|FG000|Dose Escalation Phase (56 Days)|Progressive disease|1|||
147191383|NCT04079296|530867624|FG001|Dose Escalation Phase (56 Days)|Progressive disease|1|||
147191384|NCT04079296|530867625|FG002|Dose Escalation Phase (56 Days)|Progressive disease|1|||
147191385|NCT04079296|530867626|FG003|Dose Escalation Phase (56 Days)|Progressive disease|0|||
147191386|NCT04079296|530867627|FG004|Dose Escalation Phase (56 Days)|Progressive disease|0|||
147191387|NCT04079296|530867623|FG000|Dose Escalation Phase (56 Days)|Lack of Efficacy|3|||
147191388|NCT04079296|530867624|FG001|Dose Escalation Phase (56 Days)|Lack of Efficacy|3|||
147191389|NCT04079296|530867625|FG002|Dose Escalation Phase (56 Days)|Lack of Efficacy|3|||
147191390|NCT04079296|530867626|FG003|Dose Escalation Phase (56 Days)|Lack of Efficacy|0|||
147191391|NCT04079296|530867627|FG004|Dose Escalation Phase (56 Days)|Lack of Efficacy|0|||
147191392|NCT04079296|530867623|FG000|Dose Expansion Phase (168 Days)|Miscellaneous|0|||
147191393|NCT04079296|530867624|FG001|Dose Expansion Phase (168 Days)|Miscellaneous|0|||
147191394|NCT04079296|530867625|FG002|Dose Expansion Phase (168 Days)|Miscellaneous|0|||
147191395|NCT04079296|530867626|FG003|Dose Expansion Phase (168 Days)|Miscellaneous|0|||
147191396|NCT04079296|530867627|FG004|Dose Expansion Phase (168 Days)|Miscellaneous|1|||
147191397|NCT04079296|530867623|FG000|Dose Expansion Phase (168 Days)|Withdrawal by Subject|0|||
147191398|NCT04079296|530867624|FG001|Dose Expansion Phase (168 Days)|Withdrawal by Subject|0|||
147191399|NCT04079296|530867625|FG002|Dose Expansion Phase (168 Days)|Withdrawal by Subject|0|||
147191400|NCT04079296|530867626|FG003|Dose Expansion Phase (168 Days)|Withdrawal by Subject|0|||
147191401|NCT04079296|530867627|FG004|Dose Expansion Phase (168 Days)|Withdrawal by Subject|1|||
147191402|NCT04079296|530867623|FG000|Dose Expansion Phase (168 Days)|Physician Decision|0|||
147191403|NCT04079296|530867624|FG001|Dose Expansion Phase (168 Days)|Physician Decision|0|||
147191404|NCT04079296|530867625|FG002|Dose Expansion Phase (168 Days)|Physician Decision|0|||
147191405|NCT04079296|530867626|FG003|Dose Expansion Phase (168 Days)|Physician Decision|1|||
147191406|NCT04079296|530867627|FG004|Dose Expansion Phase (168 Days)|Physician Decision|0|||
147191407|NCT04079296|530867623|FG000|Dose Expansion Phase (168 Days)|Progressive Disease|0|||
147191408|NCT04079296|530867624|FG001|Dose Expansion Phase (168 Days)|Progressive Disease|0|||
147191409|NCT04079296|530867625|FG002|Dose Expansion Phase (168 Days)|Progressive Disease|0|||
147191410|NCT04079296|530867626|FG003|Dose Expansion Phase (168 Days)|Progressive Disease|6|||
147191411|NCT04079296|530867627|FG004|Dose Expansion Phase (168 Days)|Progressive Disease|5|||
147191412|NCT04079296|530867623|FG000|Dose Expansion Phase (168 Days)|Lack of Efficacy|0|||
147191413|NCT04079296|530867624|FG001|Dose Expansion Phase (168 Days)|Lack of Efficacy|0|||
147191414|NCT04079296|530867625|FG002|Dose Expansion Phase (168 Days)|Lack of Efficacy|0|||
147191415|NCT04079296|530867626|FG003|Dose Expansion Phase (168 Days)|Lack of Efficacy|3|||
147191416|NCT04079296|530867627|FG004|Dose Expansion Phase (168 Days)|Lack of Efficacy|2|||
147191417|NCT04079296|530867623|FG000|Dose Expansion Phase (168 Days)|Death|0|||
147191418|NCT04079296|530867624|FG001|Dose Expansion Phase (168 Days)|Death|0|||
147191419|NCT04079296|530867625|FG002|Dose Expansion Phase (168 Days)|Death|0|||
147191420|NCT04079296|530867626|FG003|Dose Expansion Phase (168 Days)|Death|1|||
147191421|NCT04079296|530867627|FG004|Dose Expansion Phase (168 Days)|Death|0|||
147425076|NCT01191268|531721755|FG001|Overall Study|Protocol Violation|0|||
147425077|NCT01191268|531721756|FG002|Overall Study|Protocol Violation|1|||
147425078|NCT01191268|531721754|FG000|Overall Study|Sponsor Decision|0|||
147425079|NCT01191268|531721755|FG001|Overall Study|Sponsor Decision|2|||
147425080|NCT01191268|531721756|FG002|Overall Study|Sponsor Decision|0|||
147425081|NCT00336895|531721757|FG000|Overall Study|diarrhea|1|||
147425082|NCT00336895|531721757|FG000|Overall Study|nausea and upset stomach|1|||
147425083|NCT00336895|531721757|FG000|Overall Study|Physician Decision|1|||
147425084|NCT00336895|531721757|FG000|Overall Study|screen failed|1|||
147425085|NCT02308020|531721758|FG000|Overall Study|Lost to Follow-up|1|||
147425086|NCT02308020|531721759|FG001|Overall Study|Lost to Follow-up|7|||
147425087|NCT02308020|531721760|FG002|Overall Study|Lost to Follow-up|0|||
147425088|NCT02308020|531721761|FG003|Overall Study|Lost to Follow-up|0|||
147425089|NCT02308020|531721762|FG004|Overall Study|Lost to Follow-up|1|||
147425090|NCT02308020|531721763|FG005|Overall Study|Lost to Follow-up|2|||
147425091|NCT02308020|531721758|FG000|Overall Study|Sponsor Decision|0|||
147425092|NCT02308020|531721759|FG001|Overall Study|Sponsor Decision|8|||
147425093|NCT02308020|531721760|FG002|Overall Study|Sponsor Decision|0|||
147425094|NCT02308020|531721761|FG003|Overall Study|Sponsor Decision|2|||
147425095|NCT02308020|531721762|FG004|Overall Study|Sponsor Decision|2|||
147425096|NCT02308020|531721763|FG005|Overall Study|Sponsor Decision|1|||
147425097|NCT02308020|531721758|FG000|Overall Study|Withdrawal by Subject|3|||
147425098|NCT02308020|531721759|FG001|Overall Study|Withdrawal by Subject|5|||
147425099|NCT02308020|531721760|FG002|Overall Study|Withdrawal by Subject|3|||
147425100|NCT02308020|531721761|FG003|Overall Study|Withdrawal by Subject|2|||
147191422|NCT01919229|530867629|FG000|Overall Study|Subject/guardian decision|0|||
147425101|NCT02308020|531721762|FG004|Overall Study|Withdrawal by Subject|1|||
147425102|NCT02308020|531721763|FG005|Overall Study|Withdrawal by Subject|2|||
147191423|NCT01919229|530867630|FG001|Overall Study|Subject/guardian decision|0|||
147191424|NCT01919229|530867631|FG002|Overall Study|Subject/guardian decision|1|||
147191425|NCT01011673|530867632|FG000|Randomized|Secondary headache|2|||
147191426|NCT01011673|530867633|FG001|Randomized|Secondary headache|1|||
147191427|NCT01011673|530867632|FG000|24 Hour Follow-up|Lost to Follow-up|3|||
147191428|NCT01011673|530867633|FG001|24 Hour Follow-up|Lost to Follow-up|3|||
147191429|NCT03261336|530867635|FG000|Overall Study|Adverse Event|1|||
147191430|NCT00292942|530867637|FG000|Overall Study|Withdrawal by Subject|0|||
147191431|NCT00292942|530867638|FG001|Overall Study|Withdrawal by Subject|0|||
147191432|NCT00292942|530867639|FG002|Overall Study|Withdrawal by Subject|1|||
147191433|NCT00292942|530867640|FG003|Overall Study|Withdrawal by Subject|0|||
147191434|NCT00292942|530867637|FG000|Overall Study|Adverse Event|0|||
147191435|NCT00292942|530867638|FG001|Overall Study|Adverse Event|0|||
147191436|NCT00292942|530867639|FG002|Overall Study|Adverse Event|0|||
147191437|NCT00292942|530867640|FG003|Overall Study|Adverse Event|1|||
147191438|NCT00644358|530867641|FG000|Overall Study|Adverse Event|124|||
147191439|NCT00644358|530867641|FG000|Overall Study|Lost to Follow-up|105|||
147191440|NCT00644358|530867641|FG000|Overall Study|Consent Withdrawal|64|||
147191441|NCT00644358|530867641|FG000|Overall Study|Lack of Effectiveness|39|||
147191442|NCT00644358|530867641|FG000|Overall Study|Protocol Violation|5|||
147191443|NCT00644358|530867641|FG000|Overall Study|Noncompliance|14|||
147191444|NCT00644358|530867641|FG000|Overall Study|Other Unspecified|11|||
147191445|NCT00651924|530867647|FG000|Overall Study|Withdrawal by PI|0|||
147191446|NCT00651924|530867648|FG001|Overall Study|Withdrawal by PI|2|||
147191447|NCT00651924|530867647|FG000|Overall Study|Withdrawal by Subject|0|||
147191448|NCT00651924|530867648|FG001|Overall Study|Withdrawal by Subject|5|||
147191449|NCT00758771|530867649|FG000|Overall Study|Withdrawal by Subject|1|||
147191450|NCT00758771|530867650|FG001|Overall Study|Withdrawal by Subject|1|||
147191451|NCT00758771|530867649|FG000|Overall Study|Did not meet eligibility criteria|2|||
147191452|NCT00758771|530867650|FG001|Overall Study|Did not meet eligibility criteria|4|||
147191453|NCT00960063|530867651|FG000|Overall Study|Adverse Event|1|||
147191454|NCT00960063|530867652|FG001|Overall Study|Adverse Event|0|||
147191455|NCT00960063|530867653|FG002|Overall Study|Adverse Event|0|||
147191456|NCT00960063|530867651|FG000|Overall Study|Progression of Disease|0|||
147191457|NCT00960063|530867652|FG001|Overall Study|Progression of Disease|0|||
147191458|NCT00960063|530867653|FG002|Overall Study|Progression of Disease|3|||
147191459|NCT01759420|530867654|FG000|Overall Study|Screen failure|5|||
147191460|NCT01759420|530867654|FG000|Overall Study|Inaccurate EKG machine readings|1|||
147191461|NCT01129622|530867655|FG000|Overall Study|Withdrawal by Subject|2|||
147191462|NCT02051764|530867656|FG000|Overall Study|Study terminated by sponsor|0|||
147191463|NCT02051764|530867657|FG001|Overall Study|Study terminated by sponsor|7|||
147191464|NCT00591006|530867658|FG000|Overall Study|Withdrawal by Subject|0|||
147191465|NCT00591006|530867659|FG001|Overall Study|Withdrawal by Subject|0|||
147191466|NCT00591006|530867660|FG002|Overall Study|Withdrawal by Subject|0|||
147191467|NCT00591006|530867661|FG003|Overall Study|Withdrawal by Subject|0|||
147191468|NCT00591006|530867662|FG004|Overall Study|Withdrawal by Subject|0|||
147191469|NCT00591006|530867663|FG005|Overall Study|Withdrawal by Subject|0|||
147191470|NCT00591006|530867664|FG006|Overall Study|Withdrawal by Subject|0|||
147191471|NCT00591006|530867665|FG007|Overall Study|Withdrawal by Subject|0|||
147191472|NCT00591006|530867666|FG008|Overall Study|Withdrawal by Subject|0|||
147191473|NCT00591006|530867667|FG009|Overall Study|Withdrawal by Subject|0|||
147191474|NCT00591006|530867668|FG010|Overall Study|Withdrawal by Subject|0|||
147191475|NCT00591006|530867669|FG011|Overall Study|Withdrawal by Subject|0|||
147191476|NCT00591006|530867670|FG012|Overall Study|Withdrawal by Subject|0|||
147191477|NCT00591006|530867671|FG013|Overall Study|Withdrawal by Subject|0|||
147191478|NCT00591006|530867672|FG014|Overall Study|Withdrawal by Subject|0|||
147191479|NCT00591006|530867673|FG015|Overall Study|Withdrawal by Subject|1|||
147191480|NCT00591006|530867674|FG016|Overall Study|Withdrawal by Subject|0|||
147191481|NCT00591006|530867675|FG017|Overall Study|Withdrawal by Subject|0|||
147191482|NCT00591006|530867676|FG018|Overall Study|Withdrawal by Subject|0|||
147191483|NCT00591006|530867677|FG019|Overall Study|Withdrawal by Subject|0|||
147191484|NCT00591006|530867678|FG020|Overall Study|Withdrawal by Subject|0|||
147191485|NCT00591006|530867679|FG021|Overall Study|Withdrawal by Subject|0|||
147191486|NCT00591006|530867680|FG022|Overall Study|Withdrawal by Subject|0|||
147191487|NCT00591006|530867681|FG023|Overall Study|Withdrawal by Subject|1|||
147191488|NCT00591006|530867658|FG000|Overall Study|Adverse Event|0|||
147191489|NCT00591006|530867659|FG001|Overall Study|Adverse Event|0|||
147191490|NCT00591006|530867660|FG002|Overall Study|Adverse Event|0|||
147191491|NCT00591006|530867661|FG003|Overall Study|Adverse Event|0|||
147191492|NCT00591006|530867662|FG004|Overall Study|Adverse Event|0|||
147191493|NCT00591006|530867663|FG005|Overall Study|Adverse Event|0|||
147191494|NCT00591006|530867664|FG006|Overall Study|Adverse Event|0|||
147191495|NCT00591006|530867665|FG007|Overall Study|Adverse Event|0|||
147191496|NCT00591006|530867666|FG008|Overall Study|Adverse Event|0|||
147191497|NCT00591006|530867667|FG009|Overall Study|Adverse Event|0|||
147191498|NCT00591006|530867668|FG010|Overall Study|Adverse Event|0|||
147191499|NCT00591006|530867669|FG011|Overall Study|Adverse Event|0|||
147191500|NCT00591006|530867670|FG012|Overall Study|Adverse Event|0|||
147191501|NCT00591006|530867671|FG013|Overall Study|Adverse Event|0|||
147191502|NCT00591006|530867672|FG014|Overall Study|Adverse Event|0|||
147191503|NCT00591006|530867673|FG015|Overall Study|Adverse Event|0|||
147191504|NCT00591006|530867674|FG016|Overall Study|Adverse Event|0|||
147191505|NCT00591006|530867675|FG017|Overall Study|Adverse Event|0|||
147191506|NCT00591006|530867676|FG018|Overall Study|Adverse Event|0|||
147191507|NCT00591006|530867677|FG019|Overall Study|Adverse Event|0|||
147191508|NCT00591006|530867678|FG020|Overall Study|Adverse Event|0|||
147191509|NCT00591006|530867679|FG021|Overall Study|Adverse Event|0|||
147191510|NCT00591006|530867680|FG022|Overall Study|Adverse Event|1|||
147191511|NCT00591006|530867681|FG023|Overall Study|Adverse Event|0|||
147191512|NCT05190120|530867684|FG000|Overall Study|Lost to follow up for primary outcome measurement d/t lack of time to complete before surgery|1|||
147191513|NCT05190120|530867685|FG001|Overall Study|Lost to follow up for primary outcome measurement d/t lack of time to complete before surgery|1|||
147191514|NCT05190120|530867686|FG002|Overall Study|Lost to follow up for primary outcome measurement d/t lack of time to complete before surgery|1|||
147191515|NCT05190120|530867687|FG003|Overall Study|Lost to follow up for primary outcome measurement d/t lack of time to complete before surgery|3|||
147191516|NCT05190120|530867684|FG000|Overall Study|Lost to Follow-up|5|||
147191517|NCT05190120|530867685|FG001|Overall Study|Lost to Follow-up|0|||
147191518|NCT05190120|530867686|FG002|Overall Study|Lost to Follow-up|2|||
147191519|NCT05190120|530867687|FG003|Overall Study|Lost to Follow-up|3|||
147191520|NCT03062358|530867689|FG000|Overall Study|Death|269|||
147191521|NCT03062358|530867690|FG001|Overall Study|Death|145|||
147191522|NCT03062358|530867689|FG000|Overall Study|Withdrawal by Subject|2|||
147191523|NCT03062358|530867690|FG001|Overall Study|Withdrawal by Subject|1|||
147191524|NCT03062358|530867689|FG000|Overall Study|Sponsor Decision|29|||
147191525|NCT03062358|530867690|FG001|Overall Study|Sponsor Decision|7|||
147249810|NCT01288469|531083773|FG001|Overall Study|Poor compliance to protocol|1|||
147249811|NCT01288469|531083774|FG002|Overall Study|Poor compliance to protocol|0|||
147249812|NCT01288469|531083772|FG000|Overall Study|Participant Moved|1|||
147249813|NCT01288469|531083773|FG001|Overall Study|Participant Moved|0|||
147249814|NCT01288469|531083774|FG002|Overall Study|Participant Moved|0|||
147249815|NCT01288469|531083772|FG000|Overall Study|Consent withdrawn by subject|1|||
147249816|NCT01288469|531083773|FG001|Overall Study|Consent withdrawn by subject|1|||
147249817|NCT01288469|531083774|FG002|Overall Study|Consent withdrawn by subject|1|||
147249818|NCT01288469|531083772|FG000|Overall Study|Exclusion criteria finally met|1|||
147249819|NCT01288469|531083773|FG001|Overall Study|Exclusion criteria finally met|0|||
147249820|NCT01288469|531083774|FG002|Overall Study|Exclusion criteria finally met|0|||
147191526|NCT01602224|530870341|FG000|Overall Study|Adverse Event|0|||
147191527|NCT01602224|530870342|FG001|Overall Study|Adverse Event|1|||
147191528|NCT01602224|530870343|FG002|Overall Study|Adverse Event|0|||
147191529|NCT01602224|530870341|FG000|Overall Study|Investigator Decison|1|||
147191530|NCT01602224|530870342|FG001|Overall Study|Investigator Decison|0|||
147191531|NCT01602224|530870343|FG002|Overall Study|Investigator Decison|0|||
147191532|NCT01602224|530870341|FG000|Overall Study|Lost to Follow-up|0|||
147191533|NCT01602224|530870342|FG001|Overall Study|Lost to Follow-up|0|||
147191534|NCT01602224|530870343|FG002|Overall Study|Lost to Follow-up|1|||
147191535|NCT01602224|530870341|FG000|Overall Study|Protocol Violation|0|||
147191536|NCT01602224|530870342|FG001|Overall Study|Protocol Violation|1|||
147191537|NCT01602224|530870343|FG002|Overall Study|Protocol Violation|0|||
147191538|NCT01602224|530870341|FG000|Overall Study|Sponsor Decision|2|||
147191539|NCT01602224|530870342|FG001|Overall Study|Sponsor Decision|3|||
147191540|NCT01602224|530870343|FG002|Overall Study|Sponsor Decision|2|||
147191541|NCT01602224|530870341|FG000|Overall Study|Withdrawal by Subject|5|||
147191542|NCT01602224|530870342|FG001|Overall Study|Withdrawal by Subject|3|||
147191543|NCT01602224|530870343|FG002|Overall Study|Withdrawal by Subject|3|||
147191544|NCT00633477|530870344|FG000|Overall Study|Death|1|||
147191545|NCT00633477|530870345|FG001|Overall Study|Death|0|||
147191546|NCT00633477|530870344|FG000|Overall Study|Randomized but not treated|1|||
147191547|NCT00633477|530870345|FG001|Overall Study|Randomized but not treated|0|||
147191548|NCT00770653|530870349|FG000|Overall Study|Adverse Event|13|||
147191549|NCT00770653|530870350|FG001|Overall Study|Adverse Event|5|||
147191550|NCT00770653|530870349|FG000|Overall Study|Protocol Violation|8|||
147191551|NCT00770653|530870350|FG001|Overall Study|Protocol Violation|6|||
147191552|NCT00770653|530870349|FG000|Overall Study|Withdrawal by Subject|4|||
147191553|NCT00770653|530870350|FG001|Overall Study|Withdrawal by Subject|7|||
147191554|NCT00770653|530870349|FG000|Overall Study|Lack of Compliance|1|||
147191555|NCT00770653|530870350|FG001|Overall Study|Lack of Compliance|4|||
147191556|NCT00770653|530870349|FG000|Overall Study|Worsening of Glycosolated Hemoglobin|2|||
147191557|NCT00770653|530870350|FG001|Overall Study|Worsening of Glycosolated Hemoglobin|2|||
147191558|NCT00770653|530870349|FG000|Overall Study|Fasting Glucose > 240 mg/dL|2|||
147191559|NCT00770653|530870350|FG001|Overall Study|Fasting Glucose > 240 mg/dL|1|||
147191560|NCT00770653|530870349|FG000|Overall Study|> Three Moderate Hypoglycemic Episodes|0|||
147191561|NCT00770653|530870350|FG001|Overall Study|> Three Moderate Hypoglycemic Episodes|2|||
147191562|NCT00770653|530870349|FG000|Overall Study|Lost to Follow-up|1|||
147191563|NCT00770653|530870350|FG001|Overall Study|Lost to Follow-up|2|||
147191564|NCT00770653|530870349|FG000|Overall Study|Physician Decision|1|||
147191565|NCT00770653|530870350|FG001|Overall Study|Physician Decision|0|||
147191566|NCT04906499|530870352|FG000|Overall Study|Lack of time|1|||
147191567|NCT00179621|530870353|FG000|Double-Blind Period|Lack of Therapeutic Effect|59|||
147191568|NCT00179621|530870354|FG001|Double-Blind Period|Lack of Therapeutic Effect|35|||
147191569|NCT00179621|530870355|FG002|Double-Blind Period|Lack of Therapeutic Effect|19|||
147191570|NCT00179621|530870356|FG003|Double-Blind Period|Lack of Therapeutic Effect|0|||
147191571|NCT00179621|530870353|FG000|Double-Blind Period|Adverse Event|2|||
147191572|NCT00179621|530870354|FG001|Double-Blind Period|Adverse Event|7|||
147191573|NCT00179621|530870355|FG002|Double-Blind Period|Adverse Event|4|||
147191574|NCT00179621|530870356|FG003|Double-Blind Period|Adverse Event|0|||
147191575|NCT00179621|530870353|FG000|Double-Blind Period|Withdrawal by Subject|2|||
147191576|NCT00179621|530870354|FG001|Double-Blind Period|Withdrawal by Subject|1|||
147191577|NCT00179621|530870355|FG002|Double-Blind Period|Withdrawal by Subject|3|||
147191578|NCT00179621|530870356|FG003|Double-Blind Period|Withdrawal by Subject|0|||
147191579|NCT00179621|530870353|FG000|Double-Blind Period|Death|0|||
147191580|NCT00179621|530870354|FG001|Double-Blind Period|Death|1|||
147191581|NCT00179621|530870355|FG002|Double-Blind Period|Death|2|||
147191582|NCT00179621|530870356|FG003|Double-Blind Period|Death|0|||
147191583|NCT00179621|530870353|FG000|Double-Blind Period|Protocol Violation|1|||
147191584|NCT00179621|530870354|FG001|Double-Blind Period|Protocol Violation|0|||
147191585|NCT00179621|530870355|FG002|Double-Blind Period|Protocol Violation|0|||
147191586|NCT00179621|530870356|FG003|Double-Blind Period|Protocol Violation|0|||
147191587|NCT00179621|530870353|FG000|Double-Blind Period|Other|0|||
147191588|NCT00179621|530870354|FG001|Double-Blind Period|Other|2|||
147191589|NCT00179621|530870355|FG002|Double-Blind Period|Other|2|||
147191590|NCT00179621|530870356|FG003|Double-Blind Period|Other|0|||
147191591|NCT00179621|530870353|FG000|Open-Label Period|Lack of Therapeutic Effect|0|||
147191592|NCT00179621|530870354|FG001|Open-Label Period|Lack of Therapeutic Effect|19|||
147191593|NCT00179621|530870355|FG002|Open-Label Period|Lack of Therapeutic Effect|19|||
147191594|NCT00179621|530870356|FG003|Open-Label Period|Lack of Therapeutic Effect|31|||
147191595|NCT00179621|530870353|FG000|Open-Label Period|Adverse Event|0|||
147191596|NCT00179621|530870354|FG001|Open-Label Period|Adverse Event|6|||
147191597|NCT00179621|530870355|FG002|Open-Label Period|Adverse Event|5|||
147191598|NCT00179621|530870356|FG003|Open-Label Period|Adverse Event|6|||
147191599|NCT00179621|530870353|FG000|Open-Label Period|Withdrawal by Subject|0|||
147191600|NCT00179621|530870354|FG001|Open-Label Period|Withdrawal by Subject|2|||
147191601|NCT00179621|530870355|FG002|Open-Label Period|Withdrawal by Subject|2|||
147191602|NCT00179621|530870356|FG003|Open-Label Period|Withdrawal by Subject|2|||
147191603|NCT00179621|530870353|FG000|Open-Label Period|Death|0|||
147191604|NCT00179621|530870354|FG001|Open-Label Period|Death|0|||
147191605|NCT00179621|530870355|FG002|Open-Label Period|Death|1|||
147191606|NCT00179621|530870356|FG003|Open-Label Period|Death|2|||
147191607|NCT00179621|530870353|FG000|Open-Label Period|Other|0|||
147191608|NCT00179621|530870354|FG001|Open-Label Period|Other|1|||
147191609|NCT00179621|530870355|FG002|Open-Label Period|Other|1|||
147191610|NCT00179621|530870356|FG003|Open-Label Period|Other|2|||
147191611|NCT03525444|530870361|FG000|Overall Study|Adverse Event|0|||
147191612|NCT03525444|530870362|FG001|Overall Study|Adverse Event|1|||
147191613|NCT03525444|530870361|FG000|Overall Study|Withdrawal of consent (not due to AE)|0|||
147191614|NCT03525444|530870362|FG001|Overall Study|Withdrawal of consent (not due to AE)|1|||
147191615|NCT03525444|530870361|FG000|Overall Study|Other|0|||
147191616|NCT03525444|530870362|FG001|Overall Study|Other|1|||
147191617|NCT00262860|530870363|FG000|Overall Study|Adverse Event|2|||
147191618|NCT02741128|530870364|FG000|Overall Study|Protocol Violation|4|||
147191619|NCT02741128|530870365|FG001|Overall Study|Protocol Violation|1|||
147191620|NCT02741128|530870364|FG000|Overall Study|Withdrawal by Subject|2|||
147191621|NCT02741128|530870365|FG001|Overall Study|Withdrawal by Subject|0|||
147191622|NCT02741128|530870364|FG000|Overall Study|Lost to Follow-up|1|||
147191623|NCT02741128|530870365|FG001|Overall Study|Lost to Follow-up|0|||
147191624|NCT02973100|530870366|FG000|Overall Study|Adverse Event|1|||
147191625|NCT02973100|530870367|FG001|Overall Study|Adverse Event|2|||
147191626|NCT02973100|530870368|FG002|Overall Study|Adverse Event|1|||
147191627|NCT02973100|530870369|FG003|Overall Study|Adverse Event|2|||
147191628|NCT02973100|530870366|FG000|Overall Study|Lost to Follow-up|3|||
147191629|NCT02973100|530870367|FG001|Overall Study|Lost to Follow-up|1|||
147191630|NCT02973100|530870368|FG002|Overall Study|Lost to Follow-up|1|||
147191631|NCT02973100|530870369|FG003|Overall Study|Lost to Follow-up|0|||
147191632|NCT02973100|530870366|FG000|Overall Study|Withdrawal by Subject|3|||
147191633|NCT02973100|530870367|FG001|Overall Study|Withdrawal by Subject|5|||
147191634|NCT02973100|530870368|FG002|Overall Study|Withdrawal by Subject|1|||
147191635|NCT02973100|530870369|FG003|Overall Study|Withdrawal by Subject|4|||
147191636|NCT02973100|530870366|FG000|Overall Study|Notification of change in address|0|||
147191637|NCT02973100|530870367|FG001|Overall Study|Notification of change in address|0|||
147191638|NCT02973100|530870368|FG002|Overall Study|Notification of change in address|0|||
147191639|NCT02973100|530870369|FG003|Overall Study|Notification of change in address|1|||
147191640|NCT02973100|530870366|FG000|Overall Study|Failed to attend Safety followup period|0|||
147191641|NCT02973100|530870367|FG001|Overall Study|Failed to attend Safety followup period|0|||
147191642|NCT02973100|530870368|FG002|Overall Study|Failed to attend Safety followup period|1|||
147191643|NCT02973100|530870369|FG003|Overall Study|Failed to attend Safety followup period|0|||
147191644|NCT01419769|530870370|FG000|Overall Study|Did not receive the AXIOS stent|3|||
147191645|NCT01419769|530870370|FG000|Overall Study|Not evaluable due to pigtail stents|1|||
147191646|NCT00878501|530870371|FG000|Overall Study|Adverse Event|11|||
147191647|NCT00878501|530870372|FG001|Overall Study|Adverse Event|3|||
147191648|NCT00878501|530870373|FG002|Overall Study|Adverse Event|3|||
147191649|NCT00878501|530870371|FG000|Overall Study|Lack of Efficacy|2|||
147191650|NCT00878501|530870372|FG001|Overall Study|Lack of Efficacy|1|||
147191651|NCT00878501|530870373|FG002|Overall Study|Lack of Efficacy|0|||
147191652|NCT00878501|530870371|FG000|Overall Study|Withdrawal by Subject|2|||
147191653|NCT00878501|530870372|FG001|Overall Study|Withdrawal by Subject|1|||
147191654|NCT00878501|530870373|FG002|Overall Study|Withdrawal by Subject|2|||
147191655|NCT00878501|530870371|FG000|Overall Study|Protocol Violation|0|||
147191656|NCT00878501|530870372|FG001|Overall Study|Protocol Violation|0|||
147191657|NCT00878501|530870373|FG002|Overall Study|Protocol Violation|1|||
147191658|NCT00878501|530870371|FG000|Overall Study|Incorrect enrolment|1|||
147191659|NCT00878501|530870372|FG001|Overall Study|Incorrect enrolment|2|||
147191660|NCT00878501|530870373|FG002|Overall Study|Incorrect enrolment|0|||
147191661|NCT00878501|530870371|FG000|Overall Study|Intake of prohibited concom. medication|0|||
147191662|NCT00878501|530870372|FG001|Overall Study|Intake of prohibited concom. medication|0|||
147191663|NCT00878501|530870373|FG002|Overall Study|Intake of prohibited concom. medication|1|||
147191664|NCT00878501|530870371|FG000|Overall Study|Mis-randomisation of patient|1|||
147191665|NCT00878501|530870372|FG001|Overall Study|Mis-randomisation of patient|0|||
147191666|NCT00878501|530870373|FG002|Overall Study|Mis-randomisation of patient|0|||
147191667|NCT00878501|530870371|FG000|Overall Study|Administrative|0|||
147191668|NCT00878501|530870372|FG001|Overall Study|Administrative|0|||
147191669|NCT00878501|530870373|FG002|Overall Study|Administrative|1|||
147191670|NCT01959503|530870374|FG000|Overall Study|Death|2|||
147191671|NCT01959503|530870375|FG001|Overall Study|Death|1|||
147191672|NCT01959503|530870374|FG000|Overall Study|Randomized but not treated|1|||
147191673|NCT01959503|530870375|FG001|Overall Study|Randomized but not treated|1|||
147191674|NCT01419236|530870376|FG000|Overall Study|Adverse Event|1|||
147191675|NCT01419236|530870377|FG001|Overall Study|Adverse Event|0|||
147191676|NCT01419236|530870376|FG000|Overall Study|Lack of Efficacy|0|||
147191677|NCT01419236|530870377|FG001|Overall Study|Lack of Efficacy|1|||
147191678|NCT01419236|530870376|FG000|Overall Study|Lost to Follow-up|1|||
147191679|NCT01419236|530870377|FG001|Overall Study|Lost to Follow-up|0|||
147191680|NCT01419236|530870376|FG000|Overall Study|Physician Decision|1|||
147191681|NCT01419236|530870377|FG001|Overall Study|Physician Decision|0|||
147191682|NCT01419236|530870376|FG000|Overall Study|Withdrawal by Subject|1|||
147191683|NCT01419236|530870377|FG001|Overall Study|Withdrawal by Subject|4|||
147191684|NCT01419236|530870376|FG000|Overall Study|Entry Criteria Not Met|1|||
147191685|NCT01419236|530870377|FG001|Overall Study|Entry Criteria Not Met|0|||
147191686|NCT03598036|530870381|FG000|Overall Study|Withdrawal by Subject|1|||
147191687|NCT03598036|530870382|FG001|Overall Study|Withdrawal by Subject|0|||
147191688|NCT01838694|530870384|FG000|Overall Study|Adverse Event|0|||
147191689|NCT01838694|530870385|FG001|Overall Study|Adverse Event|1|||
147191690|NCT00672555|530870387|FG000|Overall Study|Lost to Follow-up|4|||
147191691|NCT00672555|530870387|FG000|Overall Study|Did not want to answer questionnaire|2|||
147191692|NCT02153086|530870393|FG000|Overall Study|Not enrolled >=28 days and <=56 days|2|||
147191693|NCT02153086|530870393|FG000|Overall Study|Other|2|||
147191694|NCT00446849|530870394|FG000|Acute Phase|Lack of Efficacy|64|||
147191695|NCT00446849|530870394|FG000|Acute Phase|Protocol Violation|10|||
147191696|NCT00446849|530870394|FG000|Acute Phase|Consent withdrawn|4|||
147191697|NCT00446849|530870394|FG000|Acute Phase|Lost to Follow-up|2|||
147191698|NCT00446849|530870394|FG000|Acute Phase|Physician Decision|1|||
147191699|NCT00446849|530870394|FG000|Acute Phase|noncompliance|1|||
147191700|NCT00446849|530870394|FG000|Maintenance Phase|Lack of Efficacy|40|||
147191701|NCT00446849|530870394|FG000|Maintenance Phase|Protocol Violation|7|||
147191702|NCT00446849|530870394|FG000|Maintenance Phase|Adverse Event|6|||
147191703|NCT00446849|530870394|FG000|Maintenance Phase|Consent withdrawn|5|||
147191704|NCT00446849|530870394|FG000|Maintenance Phase|Lost to Follow-up|3|||
147191705|NCT00446849|530870394|FG000|Maintenance Phase|Pregnancy|1|||
147191706|NCT00446849|530870394|FG000|Maintenance Phase|noncompliance|2|||
147191707|NCT00446849|530870394|FG000|Maintenance Phase|prohibited medication use|2|||
147191708|NCT00446849|530870394|FG000|Maintenance Phase|antibiotic use|1|||
147191709|NCT00446849|530870394|FG000|Maintenance Phase|study closure|1|||
147191710|NCT00446849|530870394|FG000|Maintenance Phase|hydrocodone use|1|||
147191711|NCT00446849|530870394|FG000|Maintenance Phase|concomitant medication use|1|||
147191712|NCT01194830|530870395|FG000|Overall Study|Adverse Event|3|||
147191713|NCT01194830|530870396|FG001|Overall Study|Adverse Event|2|||
147191714|NCT01194830|530870395|FG000|Overall Study|Protocol Violation|5|||
147191715|NCT01194830|530870396|FG001|Overall Study|Protocol Violation|4|||
147191716|NCT01194830|530870395|FG000|Overall Study|Lost to Follow-up|9|||
147191717|NCT01194830|530870396|FG001|Overall Study|Lost to Follow-up|7|||
147191718|NCT01194830|530870395|FG000|Overall Study|Withdrawal by Subject|2|||
147191719|NCT01194830|530870396|FG001|Overall Study|Withdrawal by Subject|1|||
147191720|NCT01194830|530870395|FG000|Overall Study|Lack of Efficacy|1|||
147191721|NCT01194830|530870396|FG001|Overall Study|Lack of Efficacy|1|||
147191722|NCT01194830|530870395|FG000|Overall Study|Non-compliance issues|4|||
147191723|NCT01194830|530870396|FG001|Overall Study|Non-compliance issues|4|||
147191724|NCT01194830|530870395|FG000|Overall Study|Other Reason|12|||
147191725|NCT01194830|530870396|FG001|Overall Study|Other Reason|8|||
147191726|NCT03115359|530870397|FG000|Overall Study|Withdrawal by Subject|29|||
147191727|NCT03115359|530870398|FG001|Overall Study|Withdrawal by Subject|39|||
147191728|NCT03115359|530870397|FG000|Overall Study|Scheduling conflict|25|||
147191729|NCT03115359|530870398|FG001|Overall Study|Scheduling conflict|23|||
147191730|NCT03115359|530870397|FG000|Overall Study|Personal reasons including health|12|||
147191731|NCT03115359|530870398|FG001|Overall Study|Personal reasons including health|9|||
147191732|NCT03115359|530870397|FG000|Overall Study|Transportation barriers|3|||
147191733|NCT03115359|530870398|FG001|Overall Study|Transportation barriers|0|||
147191734|NCT03115359|530870397|FG000|Overall Study|No longer interested|5|||
147191735|NCT03115359|530870398|FG001|Overall Study|No longer interested|4|||
147191736|NCT03115359|530870397|FG000|Overall Study|No reason provided|45|||
147191737|NCT03115359|530870398|FG001|Overall Study|No reason provided|47|||
147191738|NCT01317472|530870401|FG000|Overall Study|Withdrawal by Subject|1|||
147191739|NCT01317472|530870402|FG001|Overall Study|Withdrawal by Subject|0|||
147191740|NCT01317472|530870401|FG000|Overall Study|Unrelated hospitalization|1|||
147191741|NCT01317472|530870402|FG001|Overall Study|Unrelated hospitalization|0|||
147191742|NCT01815918|530870403|FG000|Overall Study|Patient samples not analyzable|3|||
147191743|NCT01815918|530870404|FG001|Overall Study|Patient samples not analyzable|4|||
147191744|NCT01815918|530870403|FG000|Overall Study|Lack of Efficacy|15|||
147191745|NCT01815918|530870404|FG001|Overall Study|Lack of Efficacy|15|||
147191746|NCT03284710|530870407|FG000|Overall Study|Withdrawal by Subject|1|||
147191747|NCT03284710|530870408|FG001|Overall Study|Withdrawal by Subject|0|||
147191748|NCT03284710|530870409|FG002|Overall Study|Withdrawal by Subject|1|||
147191749|NCT03284710|530870410|FG003|Overall Study|Withdrawal by Subject|6|||
147191750|NCT03284710|530870407|FG000|Overall Study|Lost to Follow-up|3|||
147191751|NCT03284710|530870408|FG001|Overall Study|Lost to Follow-up|3|||
147191752|NCT03284710|530870409|FG002|Overall Study|Lost to Follow-up|1|||
147191753|NCT03284710|530870410|FG003|Overall Study|Lost to Follow-up|0|||
147191754|NCT03284710|530870407|FG000|Overall Study|Physician Decision|1|||
147191755|NCT03284710|530870408|FG001|Overall Study|Physician Decision|0|||
147191756|NCT03284710|530870409|FG002|Overall Study|Physician Decision|0|||
147191757|NCT03284710|530870410|FG003|Overall Study|Physician Decision|0|||
147191758|NCT03284710|530870407|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|1|||
147191759|NCT03284710|530870408|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|0|||
147191760|NCT03284710|530870409|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|0|||
147191761|NCT03284710|530870410|FG003|Overall Study|Participant Unable to Adhere to Visit Schedule|1|||
147191762|NCT03284710|530870407|FG000|Overall Study|HIV Infection|0|||
147191763|NCT03284710|530870408|FG001|Overall Study|HIV Infection|2|||
147191764|NCT03284710|530870409|FG002|Overall Study|HIV Infection|2|||
147191765|NCT03284710|530870410|FG003|Overall Study|HIV Infection|1|||
147191766|NCT02412306|530870413|FG000|Overall Study|Lost to Follow-up|0|||
147191767|NCT02412306|530870414|FG001|Overall Study|Lost to Follow-up|1|||
147191768|NCT02412306|530870415|FG002|Overall Study|Lost to Follow-up|0|||
147191769|NCT02412306|530870416|FG003|Overall Study|Lost to Follow-up|0|||
147191770|NCT02412306|530870417|FG004|Overall Study|Lost to Follow-up|0|||
147191771|NCT02412306|530870413|FG000|Overall Study|Withdrawal by Subject|0|||
147191772|NCT02412306|530870414|FG001|Overall Study|Withdrawal by Subject|0|||
147191773|NCT02412306|530870415|FG002|Overall Study|Withdrawal by Subject|1|||
147191774|NCT02412306|530870416|FG003|Overall Study|Withdrawal by Subject|0|||
147191775|NCT02412306|530870417|FG004|Overall Study|Withdrawal by Subject|0|||
147191776|NCT02412306|530870413|FG000|Overall Study|Death|5|||
147191777|NCT02412306|530870414|FG001|Overall Study|Death|7|||
147191778|NCT02412306|530870415|FG002|Overall Study|Death|15|||
147191779|NCT02412306|530870416|FG003|Overall Study|Death|0|||
147191780|NCT02412306|530870417|FG004|Overall Study|Death|2|||
147191781|NCT03760029|530870427|FG000|Overall Study|Death|1|||
147191782|NCT03760029|530870428|FG001|Overall Study|Death|0|||
147191783|NCT03760029|530870429|FG002|Overall Study|Death|0|||
147191784|NCT03760029|530870427|FG000|Overall Study|Lost to Follow-up|0|||
147191785|NCT03760029|530870428|FG001|Overall Study|Lost to Follow-up|2|||
147191786|NCT03760029|530870429|FG002|Overall Study|Lost to Follow-up|1|||
147191787|NCT03760029|530870427|FG000|Overall Study|Withdrawal by Subject|1|||
147191788|NCT03760029|530870428|FG001|Overall Study|Withdrawal by Subject|4|||
147191789|NCT03760029|530870429|FG002|Overall Study|Withdrawal by Subject|1|||
147191790|NCT03760029|530870427|FG000|Overall Study|Withdrawal by parent/guardian|4|||
147191791|NCT03760029|530870428|FG001|Overall Study|Withdrawal by parent/guardian|4|||
147191792|NCT03760029|530870429|FG002|Overall Study|Withdrawal by parent/guardian|1|||
147191793|NCT03760029|530870427|FG000|Overall Study|Other|2|||
147191794|NCT03760029|530870428|FG001|Overall Study|Other|1|||
147191795|NCT03760029|530870429|FG002|Overall Study|Other|0|||
147191796|NCT03532542|530870430|FG000|Overall Study|Death|1|||
147191797|NCT03532542|530870431|FG001|Overall Study|Death|0|||
147191798|NCT03532542|530870430|FG000|Overall Study|Study Terminated by Sponsor|41|||
147191799|NCT03532542|530870431|FG001|Overall Study|Study Terminated by Sponsor|65|||
147191800|NCT03532542|530870430|FG000|Overall Study|Withdrawal by Subject|6|||
147191801|NCT03532542|530870431|FG001|Overall Study|Withdrawal by Subject|5|||
147191802|NCT00436332|530870432|FG000|Overall Study|Adverse Event|9|||
147191803|NCT00436332|530870432|FG000|Overall Study|Withdrawal by Subject|2|||
147191804|NCT00436332|530870432|FG000|Overall Study|Progression|59|||
147191805|NCT00436332|530870432|FG000|Overall Study|Death|2|||
147191806|NCT00436332|530870432|FG000|Overall Study|Not Protocol Specified|6|||
147191807|NCT00436332|530870432|FG000|Overall Study|Ineligible|2|||
147191808|NCT00436332|530870432|FG000|Overall Study|Never Received Treatment|3|||
147191809|NCT04698343|530870433|FG000|Overall Study|Withdrawal by Subject|6|||
147191810|NCT04698343|530870433|FG000|Overall Study|Physician Decision|2|||
147191811|NCT04698343|530870433|FG000|Overall Study|Failed to meet the required reduction in opioid dosage due to increased RLS symptoms|4|||
147191812|NCT04698343|530870433|FG000|Overall Study|1 was discontinued based on CGI-I score exceeding 5|1|||
147191813|NCT04698343|530870433|FG000|Overall Study|Personal reasons|3|||
147191814|NCT04698343|530870433|FG000|Overall Study|1 withdrew due to non-RLS opioid withdrawal symptoms|1|||
147191815|NCT00286442|530870434|FG000|Overall Study|Hyperglycemic Rescue|19|||
147191816|NCT00286442|530870435|FG001|Overall Study|Hyperglycemic Rescue|17|||
147191817|NCT00286442|530870436|FG002|Overall Study|Hyperglycemic Rescue|25|||
147191818|NCT00286442|530870434|FG000|Overall Study|Adverse Event|7|||
147191819|NCT00286442|530870435|FG001|Overall Study|Adverse Event|6|||
147191820|NCT00286442|530870436|FG002|Overall Study|Adverse Event|1|||
147191821|NCT00286442|530870434|FG000|Overall Study|Protocol Violation|2|||
147191822|NCT00286442|530870435|FG001|Overall Study|Protocol Violation|4|||
147191823|NCT00286442|530870436|FG002|Overall Study|Protocol Violation|2|||
147191824|NCT00286442|530870434|FG000|Overall Study|Lost to Follow-up|5|||
147191825|NCT00286442|530870435|FG001|Overall Study|Lost to Follow-up|2|||
147191826|NCT00286442|530870436|FG002|Overall Study|Lost to Follow-up|1|||
147191827|NCT00286442|530870434|FG000|Overall Study|Physician Decision|1|||
147191828|NCT00286442|530870435|FG001|Overall Study|Physician Decision|1|||
147191829|NCT00286442|530870436|FG002|Overall Study|Physician Decision|1|||
147191830|NCT00286442|530870434|FG000|Overall Study|Administrative Error|1|||
147191831|NCT00286442|530870435|FG001|Overall Study|Administrative Error|1|||
147191832|NCT00286442|530870436|FG002|Overall Study|Administrative Error|0|||
147191833|NCT00286442|530870434|FG000|Overall Study|Withdrawal by Subject|2|||
147191834|NCT00286442|530870435|FG001|Overall Study|Withdrawal by Subject|14|||
147191835|NCT00286442|530870436|FG002|Overall Study|Withdrawal by Subject|2|||
147191836|NCT02756338|530870437|FG000|Overall Study|Withdrawn by Investigator|1|||
147191837|NCT02756338|530870437|FG000|Overall Study|Device Replaced with Pacemaker|4|||
147191838|NCT01339689|530870440|FG000|Overall Study|Adverse Event|1|||
147191839|NCT01339689|530870441|FG001|Overall Study|Adverse Event|2|||
147191840|NCT01339689|530870440|FG000|Overall Study|Lost to Follow-up|9|||
147191841|NCT01339689|530870441|FG001|Overall Study|Lost to Follow-up|3|||
147191842|NCT01339689|530870440|FG000|Overall Study|Withdrawal by Subject|3|||
147191843|NCT01339689|530870441|FG001|Overall Study|Withdrawal by Subject|0|||
147191844|NCT01339689|530870440|FG000|Overall Study|Noncompliance|1|||
147191845|NCT01339689|530870441|FG001|Overall Study|Noncompliance|0|||
147191846|NCT01339689|530870440|FG000|Overall Study|Relocated out of area|0|||
147191847|NCT01339689|530870441|FG001|Overall Study|Relocated out of area|1|||
147191848|NCT01339689|530870440|FG000|Overall Study|Other|2|||
147191849|NCT01339689|530870441|FG001|Overall Study|Other|2|||
147191850|NCT01339689|530870440|FG000|Overall Study|multiple reasons|1|||
147191851|NCT01339689|530870441|FG001|Overall Study|multiple reasons|1|||
147191852|NCT00467740|530870444|FG000|Overall Study|Adverse Event|0|||
147191853|NCT00467740|530870445|FG001|Overall Study|Adverse Event|0|||
147191854|NCT00467740|530870446|FG002|Overall Study|Adverse Event|1|||
147191855|NCT00467740|530870447|FG003|Overall Study|Adverse Event|0|||
147191856|NCT00467740|530870448|FG004|Overall Study|Adverse Event|0|||
147191857|NCT00467740|530870444|FG000|Overall Study|Protocol Violation|0|||
147191858|NCT00467740|530870445|FG001|Overall Study|Protocol Violation|0|||
147191859|NCT00467740|530870446|FG002|Overall Study|Protocol Violation|1|||
147191860|NCT00467740|530870447|FG003|Overall Study|Protocol Violation|0|||
147191861|NCT00467740|530870448|FG004|Overall Study|Protocol Violation|0|||
147191862|NCT00467740|530870444|FG000|Overall Study|Lost to Follow-up|0|||
147191863|NCT00467740|530870445|FG001|Overall Study|Lost to Follow-up|1|||
147191864|NCT00467740|530870446|FG002|Overall Study|Lost to Follow-up|0|||
147191865|NCT00467740|530870447|FG003|Overall Study|Lost to Follow-up|0|||
147191866|NCT00467740|530870448|FG004|Overall Study|Lost to Follow-up|0|||
147191867|NCT00467740|530870444|FG000|Overall Study|Withdrawal by Subject|1|||
147191868|NCT00467740|530870445|FG001|Overall Study|Withdrawal by Subject|1|||
147191869|NCT00467740|530870446|FG002|Overall Study|Withdrawal by Subject|0|||
147191870|NCT00467740|530870447|FG003|Overall Study|Withdrawal by Subject|1|||
147191871|NCT00467740|530870448|FG004|Overall Study|Withdrawal by Subject|0|||
147191872|NCT00467740|530870444|FG000|Overall Study|Lack of Efficacy|0|||
147191873|NCT00467740|530870445|FG001|Overall Study|Lack of Efficacy|1|||
147191874|NCT00467740|530870446|FG002|Overall Study|Lack of Efficacy|0|||
147191875|NCT00467740|530870447|FG003|Overall Study|Lack of Efficacy|0|||
147191876|NCT00467740|530870448|FG004|Overall Study|Lack of Efficacy|0|||
147191877|NCT00730158|530870449|FG000|Overall Study|Withdrawal by Subject|1|||
147191878|NCT00730158|530870450|FG001|Overall Study|Withdrawal by Subject|1|||
147191879|NCT01632020|530870451|FG000|Overall Study|Withdrawal by Subject|1|||
147191880|NCT01632020|530870452|FG001|Overall Study|Withdrawal by Subject|0|||
147191881|NCT01632020|530870451|FG000|Overall Study|Adverse Event|1|||
147191882|NCT01632020|530870452|FG001|Overall Study|Adverse Event|0|||
147191883|NCT04999839|530870453|FG000|Overall Study|Adverse Event|1|||
147191884|NCT04999839|530870454|FG001|Overall Study|Adverse Event|1|||
147191885|NCT04999839|530870455|FG002|Overall Study|Adverse Event|1|||
147191886|NCT04999839|530870456|FG003|Overall Study|Adverse Event|1|||
147191887|NCT04999839|530870457|FG004|Overall Study|Adverse Event|1|||
147191888|NCT04999839|530870453|FG000|Overall Study|Lost to Follow-up|2|||
147191889|NCT04999839|530870454|FG001|Overall Study|Lost to Follow-up|0|||
147191890|NCT04999839|530870455|FG002|Overall Study|Lost to Follow-up|2|||
147191891|NCT04999839|530870456|FG003|Overall Study|Lost to Follow-up|4|||
147191892|NCT04999839|530870457|FG004|Overall Study|Lost to Follow-up|1|||
147191893|NCT04999839|530870453|FG000|Overall Study|Withdrawal by Subject|6|||
147191894|NCT04999839|530870454|FG001|Overall Study|Withdrawal by Subject|5|||
147191895|NCT04999839|530870455|FG002|Overall Study|Withdrawal by Subject|3|||
147191896|NCT04999839|530870456|FG003|Overall Study|Withdrawal by Subject|2|||
147191897|NCT04999839|530870457|FG004|Overall Study|Withdrawal by Subject|2|||
147191898|NCT04999839|530870453|FG000|Overall Study|Lack of Efficacy|0|||
147191899|NCT04999839|530870454|FG001|Overall Study|Lack of Efficacy|1|||
147191900|NCT04999839|530870455|FG002|Overall Study|Lack of Efficacy|0|||
147191901|NCT04999839|530870456|FG003|Overall Study|Lack of Efficacy|0|||
147191902|NCT04999839|530870457|FG004|Overall Study|Lack of Efficacy|0|||
147191903|NCT04999839|530870453|FG000|Overall Study|Physician Decision|0|||
147191904|NCT04999839|530870454|FG001|Overall Study|Physician Decision|0|||
147191905|NCT04999839|530870455|FG002|Overall Study|Physician Decision|0|||
147191906|NCT04999839|530870456|FG003|Overall Study|Physician Decision|0|||
147191907|NCT04999839|530870457|FG004|Overall Study|Physician Decision|1|||
147191908|NCT04999839|530870453|FG000|Overall Study|Sponsor request|0|||
147191909|NCT04999839|530870454|FG001|Overall Study|Sponsor request|1|||
147191910|NCT04999839|530870455|FG002|Overall Study|Sponsor request|0|||
147191911|NCT04999839|530870456|FG003|Overall Study|Sponsor request|0|||
147191912|NCT04999839|530870457|FG004|Overall Study|Sponsor request|0|||
147191913|NCT04999839|530870453|FG000|Overall Study|Other|0|||
147191914|NCT04999839|530870454|FG001|Overall Study|Other|0|||
147191915|NCT04999839|530870455|FG002|Overall Study|Other|1|||
147191916|NCT04999839|530870456|FG003|Overall Study|Other|0|||
147191917|NCT04999839|530870457|FG004|Overall Study|Other|0|||
147191918|NCT03740048|530870458|FG000|Overall Study|Withdrawal by Subject|1|||
147191919|NCT03740048|530870459|FG001|Overall Study|Withdrawal by Subject|1|||
147191920|NCT03740048|530870458|FG000|Overall Study|Death|1|||
147191921|NCT03740048|530870459|FG001|Overall Study|Death|6|||
147191922|NCT03740048|530870458|FG000|Overall Study|Switched to thrice-weekly HD|2|||
147191923|NCT03740048|530870459|FG001|Overall Study|Switched to thrice-weekly HD|0|||
147191924|NCT03740048|530870458|FG000|Overall Study|Switched to Peritoneal Dialysis|2|||
147191925|NCT03740048|530870459|FG001|Overall Study|Switched to Peritoneal Dialysis|0|||
147191926|NCT03740048|530870458|FG000|Overall Study|Lost to Follow-up|0|||
147191927|NCT03740048|530870459|FG001|Overall Study|Lost to Follow-up|1|||
147191928|NCT03740048|530870458|FG000|Overall Study|Non-compliance with HD|0|||
147191929|NCT03740048|530870459|FG001|Overall Study|Non-compliance with HD|1|||
147191930|NCT01476722|530870460|FG000|Overall Study|Adverse Event|1|||
147191931|NCT00528957|530870462|FG000|Randomized Phase (Baseline to Week 48)|Withdrew Consent|2|||
147191932|NCT00528957|530870463|FG001|Randomized Phase (Baseline to Week 48)|Withdrew Consent|1|||
147191933|NCT00528957|530870462|FG000|Randomized Phase (Baseline to Week 48)|Safety, Tolerability, or Efficacy Reason|2|||
147191934|NCT00528957|530870463|FG001|Randomized Phase (Baseline to Week 48)|Safety, Tolerability, or Efficacy Reason|0|||
147191935|NCT00528957|530870462|FG000|First Extension (Week 48 to Week 144)|Investigator's Discretion|2|||
147191936|NCT00528957|530870463|FG001|First Extension (Week 48 to Week 144)|Investigator's Discretion|0|||
147191937|NCT00528957|530870462|FG000|First Extension (Week 48 to Week 144)|Safety, Tolerability, or Efficacy Reason|1|||
147191938|NCT00528957|530870463|FG001|First Extension (Week 48 to Week 144)|Safety, Tolerability, or Efficacy Reason|0|||
147191939|NCT00528957|530870462|FG000|First Extension (Week 48 to Week 144)|Withdrew Consent|0|||
147191940|NCT00528957|530870463|FG001|First Extension (Week 48 to Week 144)|Withdrew Consent|1|||
147191941|NCT00528957|530870462|FG000|Second Extension (Week 144 to Week 240)|Safety, Tolerability, or Efficacy Reason|4|||
147191942|NCT00528957|530870463|FG001|Second Extension (Week 144 to Week 240)|Safety, Tolerability, or Efficacy Reason|3|||
147191943|NCT00528957|530870462|FG000|Second Extension (Week 144 to Week 240)|Investigator's Discretion|3|||
147191944|NCT00528957|530870463|FG001|Second Extension (Week 144 to Week 240)|Investigator's Discretion|0|||
147191945|NCT00528957|530870462|FG000|Third Extension (Week 240 to Week 336)|Safety, Tolerability, or Efficacy Reason|5|||
147191946|NCT00528957|530870463|FG001|Third Extension (Week 240 to Week 336)|Safety, Tolerability, or Efficacy Reason|4|||
147191947|NCT00528957|530870462|FG000|Third Extension (Week 240 to Week 336)|Lost to Follow-up|0|||
147191948|NCT00528957|530870463|FG001|Third Extension (Week 240 to Week 336)|Lost to Follow-up|3|||
147191949|NCT00528957|530870462|FG000|Third Extension (Week 240 to Week 336)|= 18 yr old & TDF approved in adults|1|||
147191950|NCT00528957|530870463|FG001|Third Extension (Week 240 to Week 336)|= 18 yr old & TDF approved in adults|1|||
147191951|NCT00528957|530870462|FG000|Third Extension (Week 240 to Week 336)|Investigator's Discretion|0|||
147191952|NCT00528957|530870463|FG001|Third Extension (Week 240 to Week 336)|Investigator's Discretion|1|||
147191953|NCT00528957|530870462|FG000|Third Extension (Week 240 to Week 336)|Withdrew Consent|0|||
147191954|NCT00528957|530870463|FG001|Third Extension (Week 240 to Week 336)|Withdrew Consent|1|||
147191955|NCT00528957|530870462|FG000|Long-Term Extension (Week 336 and On)|Rolled Over to Study GS-US-311-1269|4|||
147191956|NCT00528957|530870463|FG001|Long-Term Extension (Week 336 and On)|Rolled Over to Study GS-US-311-1269|10|||
147191957|NCT00528957|530870462|FG000|Long-Term Extension (Week 336 and On)|Safety, Tolerability, or Efficacy Reason|3|||
147191958|NCT00528957|530870463|FG001|Long-Term Extension (Week 336 and On)|Safety, Tolerability, or Efficacy Reason|5|||
147191959|NCT00528957|530870462|FG000|Long-Term Extension (Week 336 and On)|Withdrew Consent|2|||
147191960|NCT00528957|530870463|FG001|Long-Term Extension (Week 336 and On)|Withdrew Consent|1|||
147191961|NCT00528957|530870462|FG000|Long-Term Extension (Week 336 and On)|Investigator's Discretion|1|||
147191962|NCT00528957|530870463|FG001|Long-Term Extension (Week 336 and On)|Investigator's Discretion|1|||
147191963|NCT00539981|530870466|FG000|Overall Study|Adverse events (AE)|3|||
147191964|NCT00539981|530870467|FG001|Overall Study|Adverse events (AE)|3|||
147191965|NCT00539981|530870466|FG000|Overall Study|Lost to Follow-up|260|||
147191966|NCT00539981|530870467|FG001|Overall Study|Lost to Follow-up|251|||
147191967|NCT00539981|530870466|FG000|Overall Study|Withdrew consent|22|||
147191968|NCT00539981|530870467|FG001|Overall Study|Withdrew consent|14|||
147191969|NCT00539981|530870466|FG000|Overall Study|Death|1|||
147191970|NCT00539981|530870467|FG001|Overall Study|Death|1|||
147191971|NCT00539981|530870466|FG000|Overall Study|Other reason-unspecified|9|||
147191972|NCT00539981|530870467|FG001|Overall Study|Other reason-unspecified|13|||
147191973|NCT01323582|530870468|FG000|Weeks 1-4 (First Period)|Withdrawal by Subject|2|||
147191974|NCT01323582|530870469|FG001|Weeks 1-4 (First Period)|Withdrawal by Subject|2|||
147191975|NCT01323582|530870468|FG000|Weeks 5-7 (Washout)|Withdrawal by Subject|0|||
147191976|NCT01323582|530870469|FG001|Weeks 5-7 (Washout)|Withdrawal by Subject|1|||
147191977|NCT01323582|530870468|FG000|Weeks 8-11 (Period 2)|Withdrawal by Subject|0|||
147191978|NCT01323582|530870469|FG001|Weeks 8-11 (Period 2)|Withdrawal by Subject|1|||
147191979|NCT03473236|530870473|FG000|Overall Study|Withdrawal by Subject|0|||
147191980|NCT03473236|530870474|FG001|Overall Study|Withdrawal by Subject|0|||
147191981|NCT03473236|530870475|FG002|Overall Study|Withdrawal by Subject|0|||
147191982|NCT03473236|530870476|FG003|Overall Study|Withdrawal by Subject|0|||
147191983|NCT03473236|530870477|FG004|Overall Study|Withdrawal by Subject|0|||
147191984|NCT03473236|530870478|FG005|Overall Study|Withdrawal by Subject|1|||
147191985|NCT03473236|530870479|FG006|Overall Study|Withdrawal by Subject|0|||
147191986|NCT03473236|530870480|FG007|Overall Study|Withdrawal by Subject|0|||
147191987|NCT03473236|530870481|FG008|Overall Study|Withdrawal by Subject|1|||
147191988|NCT03473236|530870482|FG009|Overall Study|Withdrawal by Subject|0|||
147191989|NCT03155724|530870484|FG000|Overall Study|Death|3|||
147191990|NCT03155724|530870484|FG000|Overall Study|Physician Decision|1|||
147191991|NCT03155724|530870484|FG000|Overall Study|Study closure|7|||
147191992|NCT00525512|530870485|FG000|Double-Blind Phase|Adverse Event|48|||
147191993|NCT00525512|530870486|FG001|Double-Blind Phase|Adverse Event|28|||
147191994|NCT00525512|530870487|FG002|Double-Blind Phase|Adverse Event|0|||
147191995|NCT00525512|530870488|FG003|Double-Blind Phase|Adverse Event|0|||
147425103|NCT01270971|531721764|FG000|Overall Study|Withdrawal by Subject|24|||
147425104|NCT01270971|531721765|FG001|Overall Study|Withdrawal by Subject|11|||
147425105|NCT01270971|531721764|FG000|Overall Study|Lost to Follow-up|18|||
147425106|NCT01270971|531721765|FG001|Overall Study|Lost to Follow-up|5|||
147425107|NCT01270971|531721764|FG000|Overall Study|Adverse Event|1|||
147425108|NCT01270971|531721765|FG001|Overall Study|Adverse Event|2|||
147425109|NCT01270971|531721764|FG000|Overall Study|Non compliance|2|||
147425110|NCT01270971|531721765|FG001|Overall Study|Non compliance|2|||
147425111|NCT01270971|531721764|FG000|Overall Study|Non-specific|7|||
147425112|NCT01270971|531721765|FG001|Overall Study|Non-specific|3|||
147425113|NCT03333837|531721770|FG000|Overall Study|Adverse Event|2|||
147425114|NCT03333837|531721771|FG001|Overall Study|Adverse Event|1|||
147425115|NCT03333837|531721772|FG002|Overall Study|Adverse Event|1|||
147425116|NCT03333837|531721773|FG003|Overall Study|Adverse Event|1|||
147425117|NCT03333837|531721774|FG004|Overall Study|Adverse Event|0|||
147425118|NCT03333837|531721770|FG000|Overall Study|Caregiver withdrew|0|||
147425119|NCT03333837|531721771|FG001|Overall Study|Caregiver withdrew|2|||
147425120|NCT03333837|531721772|FG002|Overall Study|Caregiver withdrew|1|||
147425121|NCT03333837|531721773|FG003|Overall Study|Caregiver withdrew|0|||
147425122|NCT03333837|531721774|FG004|Overall Study|Caregiver withdrew|0|||
147425123|NCT03333837|531721770|FG000|Overall Study|Withdrawal by Subject|0|||
147249821|NCT00582166|531083778|FG000|Overall Study|Death|1|||
147425124|NCT03333837|531721771|FG001|Overall Study|Withdrawal by Subject|0|||
147425125|NCT03333837|531721772|FG002|Overall Study|Withdrawal by Subject|1|||
147425126|NCT03333837|531721773|FG003|Overall Study|Withdrawal by Subject|1|||
147425127|NCT03333837|531721774|FG004|Overall Study|Withdrawal by Subject|3|||
147425128|NCT03333837|531721770|FG000|Overall Study|COVID interrupted enrollment--had to rescreen and didn't qualify|0|||
147425129|NCT03333837|531721771|FG001|Overall Study|COVID interrupted enrollment--had to rescreen and didn't qualify|0|||
147425130|NCT03333837|531721772|FG002|Overall Study|COVID interrupted enrollment--had to rescreen and didn't qualify|2|||
147425131|NCT03333837|531721773|FG003|Overall Study|COVID interrupted enrollment--had to rescreen and didn't qualify|0|||
147425132|NCT03333837|531721774|FG004|Overall Study|COVID interrupted enrollment--had to rescreen and didn't qualify|0|||
147425133|NCT00705523|531721775|FG000|Overall Study|Lost to Follow-up|2|||
147425134|NCT00705523|531721776|FG001|Overall Study|Lost to Follow-up|3|||
147425135|NCT02003573|531721789|FG000|Overall Study|Progressive disease|2|||
147425136|NCT02003573|531721790|FG001|Overall Study|Progressive disease|0|||
147425137|NCT02003573|531721791|FG002|Overall Study|Progressive disease|1|||
147425138|NCT02003573|531721789|FG000|Overall Study|Other Adverse event|0|||
147425139|NCT02003573|531721790|FG001|Overall Study|Other Adverse event|1|||
147425140|NCT02003573|531721791|FG002|Overall Study|Other Adverse event|1|||
147425141|NCT02003573|531721789|FG000|Overall Study|Refuse to take trial medication|0|||
147425142|NCT02003573|531721790|FG001|Overall Study|Refuse to take trial medication|1|||
147425143|NCT02003573|531721791|FG002|Overall Study|Refuse to take trial medication|1|||
147425144|NCT02003573|531721789|FG000|Overall Study|Other than specified|1|||
147425145|NCT02003573|531721790|FG001|Overall Study|Other than specified|2|||
147425146|NCT02003573|531721791|FG002|Overall Study|Other than specified|3|||
147425147|NCT02112708|531721796|FG000|Baseline|Physician Decision|16|||
147425148|NCT02112708|531721797|FG001|Baseline|Physician Decision|11|||
147425149|NCT02112708|531721796|FG000|Baseline|Lost to Follow-up|12|||
147425150|NCT02112708|531721797|FG001|Baseline|Lost to Follow-up|0|||
147425151|NCT02112708|531721796|FG000|4 Month|Death|0|||
147425152|NCT02112708|531721797|FG001|4 Month|Death|1|||
147425153|NCT02112708|531721796|FG000|4 Month|Withdrawal by Subject|12|||
147425154|NCT02112708|531721797|FG001|4 Month|Withdrawal by Subject|0|||
147425155|NCT00704405|531721798|FG000|Overall Study (NC Population)|Adverse Event|1|||
147425156|NCT00704405|531721799|FG001|Overall Study (NC Population)|Adverse Event|0|||
147425157|NCT00704405|531721800|FG002|Overall Study (NC Population)|Adverse Event|0|||
147425158|NCT00704405|531721801|FG003|Overall Study (NC Population)|Adverse Event|0|||
147425159|NCT00704405|531721802|FG004|Overall Study (NC Population)|Adverse Event|0|||
147425160|NCT00704405|531721798|FG000|Overall Study (NC Population)|Lost to Follow-up|2|||
147425161|NCT00704405|531721799|FG001|Overall Study (NC Population)|Lost to Follow-up|1|||
147425162|NCT00704405|531721800|FG002|Overall Study (NC Population)|Lost to Follow-up|1|||
147425163|NCT00704405|531721801|FG003|Overall Study (NC Population)|Lost to Follow-up|2|||
147425164|NCT00704405|531721802|FG004|Overall Study (NC Population)|Lost to Follow-up|2|||
147425165|NCT00704405|531721798|FG000|Overall Study (NC Population)|Withdrawal by Subject|2|||
147425166|NCT00704405|531721799|FG001|Overall Study (NC Population)|Withdrawal by Subject|3|||
147425167|NCT00704405|531721800|FG002|Overall Study (NC Population)|Withdrawal by Subject|2|||
147425168|NCT00704405|531721801|FG003|Overall Study (NC Population)|Withdrawal by Subject|2|||
147425169|NCT00704405|531721802|FG004|Overall Study (NC Population)|Withdrawal by Subject|2|||
147425170|NCT00704405|531721798|FG000|Overall Study (NC Population)|Other|0|||
147425171|NCT00704405|531721799|FG001|Overall Study (NC Population)|Other|0|||
147425172|NCT00704405|531721800|FG002|Overall Study (NC Population)|Other|0|||
147425173|NCT00704405|531721801|FG003|Overall Study (NC Population)|Other|0|||
147425174|NCT00704405|531721802|FG004|Overall Study (NC Population)|Other|1|||
147425175|NCT00704405|531721798|FG000|Overall Study (C Population)|Withdrawal by Subject|1|||
147425176|NCT00704405|531721799|FG001|Overall Study (C Population)|Withdrawal by Subject|1|||
147425177|NCT00704405|531721800|FG002|Overall Study (C Population)|Withdrawal by Subject|1|||
147425178|NCT00704405|531721801|FG003|Overall Study (C Population)|Withdrawal by Subject|1|||
147425179|NCT00704405|531721802|FG004|Overall Study (C Population)|Withdrawal by Subject|0|||
147425180|NCT00704405|531721798|FG000|Overall Study (C Population)|Lost to Follow-up|0|||
147425181|NCT00704405|531721799|FG001|Overall Study (C Population)|Lost to Follow-up|2|||
147425182|NCT00704405|531721800|FG002|Overall Study (C Population)|Lost to Follow-up|0|||
147425183|NCT00704405|531721801|FG003|Overall Study (C Population)|Lost to Follow-up|0|||
147425184|NCT00704405|531721802|FG004|Overall Study (C Population)|Lost to Follow-up|0|||
147425185|NCT03169101|531721803|FG000|Lab Session 1 (Week 1)|Protocol Violation|0|||
147425186|NCT03169101|531721804|FG001|Lab Session 1 (Week 1)|Protocol Violation|0|||
147425187|NCT03169101|531721805|FG002|Lab Session 1 (Week 1)|Protocol Violation|0|||
147425188|NCT03169101|531721806|FG003|Lab Session 1 (Week 1)|Protocol Violation|4|||
147425189|NCT00600886|531721807|FG000|Core Phase - Full Analysis Set (FAS)|Adverse Event|14|||
147425190|NCT00600886|531721808|FG001|Core Phase - Full Analysis Set (FAS)|Adverse Event|6|||
147425191|NCT00600886|531721807|FG000|Core Phase - Full Analysis Set (FAS)|Protocol Violation|7|||
147425192|NCT00600886|531721808|FG001|Core Phase - Full Analysis Set (FAS)|Protocol Violation|8|||
147191996|NCT00525512|530870485|FG000|Double-Blind Phase|Protocol Violation|3|||
147191997|NCT00525512|530870486|FG001|Double-Blind Phase|Protocol Violation|1|||
147425193|NCT00600886|531721807|FG000|Core Phase - Full Analysis Set (FAS)|Lack of Efficacy|5|||
147425194|NCT00600886|531721808|FG001|Core Phase - Full Analysis Set (FAS)|Lack of Efficacy|8|||
147425195|NCT00600886|531721807|FG000|Core Phase - Full Analysis Set (FAS)|Withdrawal by Subject|5|||
147425196|NCT00600886|531721808|FG001|Core Phase - Full Analysis Set (FAS)|Withdrawal by Subject|3|||
147425197|NCT00600886|531721807|FG000|Core Phase - Full Analysis Set (FAS)|Administrative Problems|2|||
147425198|NCT00600886|531721808|FG001|Core Phase - Full Analysis Set (FAS)|Administrative Problems|0|||
147425199|NCT00600886|531721807|FG000|Core Phase - Full Analysis Set (FAS)|Abnormal laboratory value(s)|1|||
147425200|NCT00600886|531721808|FG001|Core Phase - Full Analysis Set (FAS)|Abnormal laboratory value(s)|0|||
147425201|NCT00600886|531721807|FG000|Core Phase - Full Analysis Set (FAS)|Lost to Follow-up|1|||
147425202|NCT00600886|531721808|FG001|Core Phase - Full Analysis Set (FAS)|Lost to Follow-up|0|||
147425203|NCT00600886|531721807|FG000|Core Phase - Full Analysis Set (FAS)|Death|0|||
147425204|NCT00600886|531721808|FG001|Core Phase - Full Analysis Set (FAS)|Death|1|||
147425205|NCT00600886|531721807|FG000|Extension - Same Treatment (FAS)|Withdrawal by Subject|16|||
147425206|NCT00600886|531721808|FG001|Extension - Same Treatment (FAS)|Withdrawal by Subject|2|||
147425207|NCT00600886|531721807|FG000|Extension - Same Treatment (FAS)|Lack of Efficacy|3|||
147425208|NCT00600886|531721808|FG001|Extension - Same Treatment (FAS)|Lack of Efficacy|3|||
147425209|NCT00600886|531721807|FG000|Extension - Same Treatment (FAS)|Administrative Problems|9|||
147425210|NCT00600886|531721808|FG001|Extension - Same Treatment (FAS)|Administrative Problems|3|||
147425211|NCT00600886|531721807|FG000|Extension - Same Treatment (FAS)|Lost to Follow-up|3|||
147425212|NCT00600886|531721808|FG001|Extension - Same Treatment (FAS)|Lost to Follow-up|1|||
147425213|NCT00600886|531721807|FG000|Extension - Same Treatment (FAS)|Adverse Event|4|||
147425214|NCT00600886|531721808|FG001|Extension - Same Treatment (FAS)|Adverse Event|1|||
147425215|NCT00600886|531721807|FG000|Extension - Same Treatment (FAS)|Abnormal Lab Value (s)|4|||
147425216|NCT00600886|531721808|FG001|Extension - Same Treatment (FAS)|Abnormal Lab Value (s)|0|||
147425217|NCT00600886|531721807|FG000|Extension - Same Treatment (FAS)|Death|1|||
147425218|NCT00600886|531721808|FG001|Extension - Same Treatment (FAS)|Death|1|||
147425219|NCT00600886|531721807|FG000|Extension - Same Treatment (FAS)|Condition no longer requires study drug|6|||
147425220|NCT00600886|531721808|FG001|Extension - Same Treatment (FAS)|Condition no longer requires study drug|0|||
147425221|NCT00600886|531721807|FG000|Extension - After Crossover (CAS)|Adverse Event|19|||
147425222|NCT00600886|531721808|FG001|Extension - After Crossover (CAS)|Adverse Event|1|||
147425223|NCT00600886|531721807|FG000|Extension - After Crossover (CAS)|Withdrawal by Subject|19|||
147425224|NCT00600886|531721808|FG001|Extension - After Crossover (CAS)|Withdrawal by Subject|4|||
147425225|NCT00600886|531721807|FG000|Extension - After Crossover (CAS)|Lack of Efficacy|13|||
147425226|NCT00600886|531721808|FG001|Extension - After Crossover (CAS)|Lack of Efficacy|4|||
147425227|NCT00600886|531721807|FG000|Extension - After Crossover (CAS)|Administrative Problems|4|||
147425228|NCT00600886|531721808|FG001|Extension - After Crossover (CAS)|Administrative Problems|4|||
147425229|NCT00600886|531721807|FG000|Extension - After Crossover (CAS)|Subject no longer requires study drug|3|||
147425230|NCT00600886|531721808|FG001|Extension - After Crossover (CAS)|Subject no longer requires study drug|0|||
147425231|NCT00600886|531721807|FG000|Extension - After Crossover (CAS)|Abnormal Lab Value (s)|3|||
147425232|NCT00600886|531721808|FG001|Extension - After Crossover (CAS)|Abnormal Lab Value (s)|0|||
147425233|NCT00600886|531721807|FG000|Extension - After Crossover (CAS)|Death|1|||
147425234|NCT00600886|531721808|FG001|Extension - After Crossover (CAS)|Death|0|||
147425235|NCT02053792|531721809|FG000|Overall Study|Physician Decision|0|||
147425236|NCT02053792|531721810|FG001|Overall Study|Physician Decision|1|||
147425237|NCT02053792|531721809|FG000|Overall Study|Development of High titer FIX inhibitor|0|||
147425238|NCT02053792|531721810|FG001|Overall Study|Development of High titer FIX inhibitor|1|||
147425239|NCT02053792|531721809|FG000|Overall Study|Lack of Efficacy|1|||
147425240|NCT02053792|531721810|FG001|Overall Study|Lack of Efficacy|0|||
147425241|NCT02053792|531721809|FG000|Overall Study|Adverse Event|1|||
147425242|NCT02053792|531721810|FG001|Overall Study|Adverse Event|0|||
147425243|NCT02053792|531721809|FG000|Overall Study|Withdrawal by Subject|2|||
147425244|NCT02053792|531721810|FG001|Overall Study|Withdrawal by Subject|2|||
147425245|NCT02053792|531721809|FG000|Overall Study|The patient was not compliant to the study procedure|1|||
147425246|NCT02053792|531721810|FG001|Overall Study|The patient was not compliant to the study procedure|0|||
147425247|NCT02053792|531721809|FG000|Overall Study|Patient reached minimum number of exposure days and was allowed to stop|1|||
147425248|NCT02053792|531721810|FG001|Overall Study|Patient reached minimum number of exposure days and was allowed to stop|0|||
147425249|NCT00790751|531721818|FG000|Overall Study|Protocol non-compliance|16|||
147425250|NCT00790751|531721819|FG001|Overall Study|Protocol non-compliance|16|||
147425251|NCT00790751|531721820|FG002|Overall Study|Protocol non-compliance|10|||
147425252|NCT00790751|531721821|FG003|Overall Study|Protocol non-compliance|11|||
147425253|NCT00790751|531721818|FG000|Overall Study|Lost to Follow-up|4|||
147425254|NCT00790751|531721819|FG001|Overall Study|Lost to Follow-up|9|||
147425255|NCT00790751|531721820|FG002|Overall Study|Lost to Follow-up|4|||
147425256|NCT00790751|531721821|FG003|Overall Study|Lost to Follow-up|5|||
147425257|NCT00790751|531721818|FG000|Overall Study|Adverse Event|5|||
147425258|NCT00790751|531721819|FG001|Overall Study|Adverse Event|3|||
147425259|NCT00790751|531721820|FG002|Overall Study|Adverse Event|5|||
147425260|NCT00790751|531721821|FG003|Overall Study|Adverse Event|4|||
147425261|NCT00790751|531721818|FG000|Overall Study|Requirement for restricted medication|0|||
147425262|NCT00790751|531721819|FG001|Overall Study|Requirement for restricted medication|2|||
147425263|NCT00790751|531721820|FG002|Overall Study|Requirement for restricted medication|0|||
147425264|NCT00790751|531721821|FG003|Overall Study|Requirement for restricted medication|0|||
147425265|NCT00790751|531721818|FG000|Overall Study|Death|0|||
147425266|NCT00790751|531721819|FG001|Overall Study|Death|0|||
147425267|NCT00790751|531721820|FG002|Overall Study|Death|1|||
147425268|NCT00790751|531721821|FG003|Overall Study|Death|0|||
147425269|NCT00790751|531721818|FG000|Overall Study|Physician Decision|0|||
147425270|NCT00790751|531721819|FG001|Overall Study|Physician Decision|0|||
147425271|NCT00790751|531721820|FG002|Overall Study|Physician Decision|0|||
147425272|NCT00790751|531721821|FG003|Overall Study|Physician Decision|1|||
147425273|NCT04976621|531721822|FG000|Overall Study|Lost to Follow-up|2|||
147425274|NCT04976621|531721823|FG001|Overall Study|Lost to Follow-up|2|||
147425275|NCT04976621|531721822|FG000|Overall Study|Withdrawal by Subject|1|||
147425276|NCT04976621|531721823|FG001|Overall Study|Withdrawal by Subject|1|||
147425277|NCT01078454|531721828|FG000|Overall Study|Adverse Event|1|||
147425278|NCT01078454|531721829|FG001|Overall Study|Adverse Event|1|||
147425279|NCT01078454|531721828|FG000|Overall Study|Death|0|||
147425280|NCT01078454|531721829|FG001|Overall Study|Death|1|||
147425281|NCT05227703|531721830|FG000|Overall Study|Adverse Event|2|||
147425282|NCT05227703|531721831|FG001|Overall Study|Adverse Event|6|||
147425283|NCT05227703|531721832|FG002|Overall Study|Adverse Event|4|||
147425284|NCT05227703|531721830|FG000|Overall Study|Lack of Efficacy|4|||
147425285|NCT05227703|531721831|FG001|Overall Study|Lack of Efficacy|0|||
147425286|NCT05227703|531721832|FG002|Overall Study|Lack of Efficacy|1|||
147425287|NCT05227703|531721830|FG000|Overall Study|Physician Decision|2|||
147425288|NCT05227703|531721831|FG001|Overall Study|Physician Decision|2|||
147425289|NCT05227703|531721832|FG002|Overall Study|Physician Decision|1|||
147425290|NCT05227703|531721830|FG000|Overall Study|Protocol Violation|2|||
147425291|NCT05227703|531721831|FG001|Overall Study|Protocol Violation|1|||
147425292|NCT05227703|531721832|FG002|Overall Study|Protocol Violation|0|||
147425293|NCT05227703|531721830|FG000|Overall Study|Withdrawal by Subject|17|||
147425294|NCT05227703|531721831|FG001|Overall Study|Withdrawal by Subject|26|||
147425295|NCT05227703|531721832|FG002|Overall Study|Withdrawal by Subject|32|||
147425296|NCT05227703|531721830|FG000|Overall Study|Non-Compliance with Study Schedule|0|||
147425297|NCT05227703|531721831|FG001|Overall Study|Non-Compliance with Study Schedule|1|||
147425298|NCT05227703|531721832|FG002|Overall Study|Non-Compliance with Study Schedule|0|||
147425299|NCT05227703|531721830|FG000|Overall Study|Other|1|||
147425300|NCT05227703|531721831|FG001|Overall Study|Other|1|||
147425301|NCT05227703|531721832|FG002|Overall Study|Other|0|||
147425302|NCT04134845|531721834|FG000|Overall Study|withdrawl by PI|12|||
147425303|NCT04134845|531721835|FG001|Overall Study|withdrawl by PI|5|||
147425304|NCT03110224|531721836|FG000|Overall Study|Death|3|||
147425305|NCT03110224|531721836|FG000|Overall Study|Lost to Follow-up|132|||
147425306|NCT03110224|531721836|FG000|Overall Study|Physician Decision|2|||
147425307|NCT03110224|531721836|FG000|Overall Study|Site Closed by Physician|35|||
147425308|NCT03110224|531721836|FG000|Overall Study|Site Closed by Sponsor|202|||
147425309|NCT03110224|531721836|FG000|Overall Study|Withdrawal by Subject|9|||
147425310|NCT05328167|531721837|FG000|Overall Study|Treatment cancelled prior to radioembolization|1|||
147425311|NCT05328167|531721837|FG000|Overall Study|imaging not obtained for primary outcome assessment|1|||
147425312|NCT00112047|531721838|FG000|Randomized Phase|Lost to Follow-up|26|||
147425313|NCT00112047|531721839|FG001|Randomized Phase|Lost to Follow-up|33|||
147425314|NCT00112047|531721838|FG000|Randomized Phase|Adverse Event|10|||
147425315|NCT00112047|531721839|FG001|Randomized Phase|Adverse Event|10|||
147425316|NCT00112047|531721838|FG000|Randomized Phase|Withrawal of consent|10|||
147425317|NCT00112047|531721839|FG001|Randomized Phase|Withrawal of consent|18|||
147425318|NCT00112047|531721838|FG000|Randomized Phase|Sub-optimal virological response|3|||
147425319|NCT00112047|531721839|FG001|Randomized Phase|Sub-optimal virological response|13|||
147425320|NCT00112047|531721838|FG000|Randomized Phase|Noncompliance|8|||
147425321|NCT00112047|531721839|FG001|Randomized Phase|Noncompliance|4|||
147425322|NCT00112047|531721838|FG000|Randomized Phase|Protocol Violation|2|||
147425323|NCT00112047|531721839|FG001|Randomized Phase|Protocol Violation|0|||
147425324|NCT00112047|531721838|FG000|Randomized Phase|Pregnancy|3|||
147425325|NCT00112047|531721839|FG001|Randomized Phase|Pregnancy|1|||
147425326|NCT00112047|531721838|FG000|Randomized Phase|Death|1|||
147425327|NCT00112047|531721839|FG001|Randomized Phase|Death|3|||
147425328|NCT00112047|531721838|FG000|Randomized Phase|Hepatitis C treatment contraindicated|0|||
147425329|NCT00112047|531721839|FG001|Randomized Phase|Hepatitis C treatment contraindicated|1|||
147425330|NCT00112047|531721838|FG000|Randomized Phase|Inability to swallow pills|0|||
147425331|NCT00112047|531721839|FG001|Randomized Phase|Inability to swallow pills|1|||
147425332|NCT00112047|531721838|FG000|Randomized Phase|Incarceration|3|||
147425333|NCT00112047|531721839|FG001|Randomized Phase|Incarceration|2|||
147425334|NCT00112047|531721838|FG000|Randomized Phase|Moved out of State|0|||
147425335|NCT00112047|531721839|FG001|Randomized Phase|Moved out of State|1|||
147425336|NCT00112047|531721838|FG000|Randomized Phase|Baseline NNRTI resistance mutations|4|||
147425337|NCT00112047|531721839|FG001|Randomized Phase|Baseline NNRTI resistance mutations|0|||
147425338|NCT00112047|531721838|FG000|Randomized Phase|High Hepatitis B DNA|0|||
147425339|NCT00112047|531721839|FG001|Randomized Phase|High Hepatitis B DNA|1|||
147425340|NCT00112047|531721838|FG000|Atripla Phase|Adverse Event|2|||
147425341|NCT00112047|531721839|FG001|Atripla Phase|Adverse Event|1|||
147425342|NCT00112047|531721838|FG000|Atripla Phase|Lost to Follow-up|5|||
147425343|NCT00112047|531721839|FG001|Atripla Phase|Lost to Follow-up|7|||
147425344|NCT00112047|531721838|FG000|Atripla Phase|Pregnancy|0|||
147425345|NCT00112047|531721839|FG001|Atripla Phase|Pregnancy|1|||
147425346|NCT00112047|531721838|FG000|Atripla Phase|Death|0|||
147425347|NCT00112047|531721839|FG001|Atripla Phase|Death|2|||
147425348|NCT00112047|531721838|FG000|Atripla Phase|Withdrew consent|7|||
147425349|NCT00112047|531721839|FG001|Atripla Phase|Withdrew consent|7|||
147425350|NCT00112047|531721838|FG000|Atripla Phase|Sub-optimal virological response|0|||
147425351|NCT00112047|531721839|FG001|Atripla Phase|Sub-optimal virological response|1|||
147425352|NCT00112047|531721838|FG000|Atripla Phase|Non-compliance|1|||
147425353|NCT00112047|531721839|FG001|Atripla Phase|Non-compliance|0|||
147425354|NCT00112047|531721838|FG000|Atripla Phase|Other|3|||
147425355|NCT00112047|531721839|FG001|Atripla Phase|Other|1|||
147425356|NCT01307579|531721840|FG000|Overall Study|Death|3|||
147425357|NCT01307579|531721841|FG001|Overall Study|Death|6|||
147425358|NCT01307579|531721840|FG000|Overall Study|Physician Decision|26|||
147425359|NCT01307579|531721841|FG001|Overall Study|Physician Decision|29|||
147425360|NCT01307579|531721840|FG000|Overall Study|Withdrawal by Subject|7|||
147425361|NCT01307579|531721841|FG001|Overall Study|Withdrawal by Subject|3|||
147425362|NCT01307579|531721840|FG000|Overall Study|Institutional diagnosis of IFD|21|||
147425363|NCT01307579|531721841|FG001|Overall Study|Institutional diagnosis of IFD|36|||
147425364|NCT01307579|531721840|FG000|Overall Study|Begin conditioning for HSCT|42|||
147425365|NCT01307579|531721841|FG001|Overall Study|Begin conditioning for HSCT|44|||
147425366|NCT01307579|531721840|FG000|Overall Study|Refractory or relapsed AML|38|||
147425367|NCT01307579|531721841|FG001|Overall Study|Refractory or relapsed AML|23|||
147425368|NCT01307579|531721840|FG000|Overall Study|Ineligible|3|||
147425369|NCT01307579|531721841|FG001|Overall Study|Ineligible|4|||
147425370|NCT03727438|531721842|FG000|Intervention Period|Did not complete at least 3 calls but remained in study|7|||
147425371|NCT03727438|531721843|FG001|Intervention Period|Did not complete at least 3 calls but remained in study|1|||
147425372|NCT03727438|531721842|FG000|Intervention Period|Excluded (health)|1|||
147425373|NCT03727438|531721843|FG001|Intervention Period|Excluded (health)|0|||
147425374|NCT03727438|531721842|FG000|Intervention Period|Withdrawal by Subject|3|||
147425375|NCT03727438|531721843|FG001|Intervention Period|Withdrawal by Subject|1|||
147425376|NCT03727438|531721842|FG000|8 Week Assessment|Did not complete assessment but remained in study|6|||
147425377|NCT03727438|531721843|FG001|8 Week Assessment|Did not complete assessment but remained in study|5|||
147425378|NCT03727438|531721842|FG000|8 Week Assessment|Did not complete due to study error, remained in study|2|||
147425379|NCT03727438|531721843|FG001|8 Week Assessment|Did not complete due to study error, remained in study|0|||
147425380|NCT03727438|531721842|FG000|8 Week Assessment|Withdrawal by Subject|6|||
147425381|NCT03727438|531721843|FG001|8 Week Assessment|Withdrawal by Subject|1|||
147425382|NCT03727438|531721842|FG000|6 mo Assessment|did not complete assessment|10|||
147191998|NCT00525512|530870487|FG002|Double-Blind Phase|Protocol Violation|0|||
147425383|NCT03727438|531721843|FG001|6 mo Assessment|did not complete assessment|11|||
147425384|NCT03170349|531721844|FG000|At 30 Days Follow-up (±7 Days Window)|Death|1|||
147425385|NCT03170349|531721844|FG000|At 6 Months Follow-up (±30 Days Window)|Death|3|||
147425386|NCT03170349|531721844|FG000|At 6 Months Follow-up (±30 Days Window)|Withdrawal by Subject|1|||
147425387|NCT03170349|531721844|FG000|At 6 Months Follow-up (±30 Days Window)|Exited for Other Reasons|5|||
147425388|NCT03170349|531721844|FG000|At 1 Year Follow-up (±45 Days Window)|Death|6|||
147425389|NCT03170349|531721844|FG000|At 1 Year Follow-up (±45 Days Window)|Exited for Other Reasons|2|||
147425390|NCT03170349|531721844|FG000|At 2 Year Follow-up (±45 Days Window)|Death|13|||
147425391|NCT03170349|531721844|FG000|At 2 Year Follow-up (±45 Days Window)|Withdrawal by Subject|1|||
147425392|NCT03170349|531721844|FG000|At 2 Year Follow-up (±45 Days Window)|Missed Visit|4|||
147425393|NCT03170349|531721844|FG000|At 3 Year Follow-up (±45 Days Window)|Death|10|||
147425394|NCT03170349|531721844|FG000|At 3 Year Follow-up (±45 Days Window)|Lost to Follow-up|2|||
147425395|NCT03170349|531721844|FG000|At 3 Year Follow-up (±45 Days Window)|Withdrawal by Subject|2|||
147425396|NCT03170349|531721844|FG000|At 3 Year Follow-up (±45 Days Window)|Missed Visit|2|||
147425397|NCT03170349|531721844|FG000|At 4-year Follow-up (±45 Days Window)|Death|13|||
147425398|NCT03170349|531721844|FG000|At 4-year Follow-up (±45 Days Window)|Missed Visit|2|||
147425399|NCT03170349|531721844|FG000|At 4-year Follow-up (±45 Days Window)|Exited for Other Reasons|2|||
147425400|NCT01440374|531723758|FG000|Part 1: Open-label Phase|Adverse Event|5|||
147425401|NCT01440374|531723759|FG001|Part 1: Open-label Phase|Adverse Event|0|||
147425402|NCT01440374|531723760|FG002|Part 1: Open-label Phase|Adverse Event|0|||
147425403|NCT01440374|531723761|FG003|Part 1: Open-label Phase|Adverse Event|0|||
147425404|NCT01440374|531723758|FG000|Part 1: Open-label Phase|Physician Decision|1|||
147425405|NCT01440374|531723759|FG001|Part 1: Open-label Phase|Physician Decision|0|||
147425406|NCT01440374|531723760|FG002|Part 1: Open-label Phase|Physician Decision|0|||
147425407|NCT01440374|531723761|FG003|Part 1: Open-label Phase|Physician Decision|0|||
147425408|NCT01440374|531723758|FG000|Part 2; Double-blind Phase|Physician Decision|0|||
147425409|NCT01440374|531723759|FG001|Part 2; Double-blind Phase|Physician Decision|8|||
147425410|NCT01440374|531723760|FG002|Part 2; Double-blind Phase|Physician Decision|17|||
147425411|NCT01440374|531723761|FG003|Part 2; Double-blind Phase|Physician Decision|0|||
147425412|NCT01440374|531723758|FG000|Part 2; Double-blind Phase|Withdrawal by Subject|0|||
147425413|NCT01440374|531723759|FG001|Part 2; Double-blind Phase|Withdrawal by Subject|4|||
147425414|NCT01440374|531723760|FG002|Part 2; Double-blind Phase|Withdrawal by Subject|5|||
147425415|NCT01440374|531723761|FG003|Part 2; Double-blind Phase|Withdrawal by Subject|0|||
147425416|NCT01440374|531723758|FG000|Part 2; Double-blind Phase|Protocol Violation|0|||
147425417|NCT01440374|531723759|FG001|Part 2; Double-blind Phase|Protocol Violation|0|||
147425418|NCT01440374|531723760|FG002|Part 2; Double-blind Phase|Protocol Violation|1|||
147425419|NCT01440374|531723761|FG003|Part 2; Double-blind Phase|Protocol Violation|0|||
147425420|NCT01440374|531723758|FG000|Part 2; Double-blind Phase|Lack of Efficacy|0|||
147425421|NCT01440374|531723759|FG001|Part 2; Double-blind Phase|Lack of Efficacy|1|||
147425422|NCT01440374|531723760|FG002|Part 2; Double-blind Phase|Lack of Efficacy|0|||
147425423|NCT01440374|531723761|FG003|Part 2; Double-blind Phase|Lack of Efficacy|0|||
147425424|NCT01440374|531723758|FG000|Part 2; Double-blind Phase|Adverse Event|0|||
147425425|NCT01440374|531723759|FG001|Part 2; Double-blind Phase|Adverse Event|7|||
147425426|NCT01440374|531723760|FG002|Part 2; Double-blind Phase|Adverse Event|31|||
147425427|NCT01440374|531723761|FG003|Part 2; Double-blind Phase|Adverse Event|0|||
147425428|NCT01440374|531723758|FG000|Part 2; Double-blind Phase|Not treated|0|||
147425429|NCT01440374|531723759|FG001|Part 2; Double-blind Phase|Not treated|0|||
147425430|NCT01440374|531723760|FG002|Part 2; Double-blind Phase|Not treated|1|||
147425431|NCT01440374|531723761|FG003|Part 2; Double-blind Phase|Not treated|0|||
147425432|NCT01440374|531723758|FG000|Part 3: Extension|Withdrawal by Subject|0|||
147425433|NCT01440374|531723759|FG001|Part 3: Extension|Withdrawal by Subject|0|||
147425434|NCT01440374|531723760|FG002|Part 3: Extension|Withdrawal by Subject|0|||
147425435|NCT01440374|531723761|FG003|Part 3: Extension|Withdrawal by Subject|5|||
147425436|NCT01440374|531723758|FG000|Part 3: Extension|Adverse Event|0|||
147425437|NCT01440374|531723759|FG001|Part 3: Extension|Adverse Event|0|||
147425438|NCT01440374|531723760|FG002|Part 3: Extension|Adverse Event|0|||
147425439|NCT01440374|531723761|FG003|Part 3: Extension|Adverse Event|13|||
147425440|NCT01440374|531723758|FG000|Part 3: Extension|Physician Decision|0|||
147425441|NCT01440374|531723759|FG001|Part 3: Extension|Physician Decision|0|||
147425442|NCT01440374|531723760|FG002|Part 3: Extension|Physician Decision|0|||
147425443|NCT01440374|531723761|FG003|Part 3: Extension|Physician Decision|14|||
147425444|NCT01036763|531723762|FG000|Overall Study|Adverse Event|25|||
147425445|NCT01036763|531723762|FG000|Overall Study|Lost to Follow-up|28|||
147425446|NCT01036763|531723762|FG000|Overall Study|Other reason (not specified)|40|||
147425447|NCT04812548|531723764|FG000|Overall Study|Adverse Event|2|||
147425448|NCT04812548|531723765|FG001|Overall Study|Adverse Event|7|||
147425449|NCT04812548|531723764|FG000|Overall Study|HSCT Planned|2|||
147425450|NCT04812548|531723765|FG001|Overall Study|HSCT Planned|3|||
147425451|NCT04812548|531723764|FG000|Overall Study|Progressive Disease|0|||
147425452|NCT04812548|531723765|FG001|Overall Study|Progressive Disease|2|||
147425453|NCT04812548|531723764|FG000|Overall Study|Death|0|||
147425454|NCT04812548|531723765|FG001|Overall Study|Death|1|||
147425455|NCT04812548|531723764|FG000|Overall Study|Post Study Access to Treatment|0|||
147425456|NCT04812548|531723765|FG001|Overall Study|Post Study Access to Treatment|1|||
147425457|NCT04812548|531723764|FG000|Overall Study|Withdrawal by Subject|0|||
147425458|NCT04812548|531723765|FG001|Overall Study|Withdrawal by Subject|1|||
147425459|NCT04812548|531723764|FG000|Overall Study|Physician Decision|1|||
147425460|NCT04812548|531723765|FG001|Overall Study|Physician Decision|0|||
147425461|NCT02141984|531723769|FG000|Overall Study|Lack of Efficacy|2|||
147425462|NCT05220254|531723770|FG000|Overall Study|Withdrawal by Subject|4|||
147425463|NCT05220254|531723770|FG000|Overall Study|Removed due to ineligibility|1|||
147425464|NCT05220254|531723770|FG000|Overall Study|Lost to Follow-up|7|||
147425465|NCT03184870|531723772|FG000|Initial Treatment|Death|6|||
147425466|NCT03184870|531723773|FG001|Initial Treatment|Death|6|||
147425467|NCT03184870|531723774|FG002|Initial Treatment|Death|8|||
147425468|NCT03184870|531723775|FG003|Initial Treatment|Death|8|||
147425469|NCT03184870|531723776|FG004|Initial Treatment|Death|6|||
147425470|NCT03184870|531723777|FG005|Initial Treatment|Death|6|||
147425471|NCT03184870|531723778|FG006|Initial Treatment|Death|6|||
147425472|NCT03184870|531723779|FG007|Initial Treatment|Death|7|||
147425473|NCT03184870|531723780|FG008|Initial Treatment|Death|1|||
147425474|NCT03184870|531723781|FG009|Initial Treatment|Death|2|||
147425475|NCT03184870|531723782|FG010|Initial Treatment|Death|26|||
147425476|NCT03184870|531723783|FG011|Initial Treatment|Death|28|||
147425477|NCT03184870|531723784|FG012|Initial Treatment|Death|10|||
147425478|NCT03184870|531723785|FG013|Initial Treatment|Death|33|||
147425479|NCT03184870|531723786|FG014|Initial Treatment|Death|34|||
147425480|NCT03184870|531723787|FG015|Initial Treatment|Death|26|||
147425481|NCT03184870|531723788|FG016|Initial Treatment|Death|20|||
147425482|NCT03184870|531723789|FG017|Initial Treatment|Death|18|||
147425483|NCT03184870|531723772|FG000|Initial Treatment|Other Reasons|2|||
147425484|NCT03184870|531723773|FG001|Initial Treatment|Other Reasons|2|||
147191999|NCT00525512|530870488|FG003|Double-Blind Phase|Protocol Violation|0|||
147192000|NCT00525512|530870485|FG000|Double-Blind Phase|Lost to Follow-up|3|||
147425485|NCT03184870|531723774|FG002|Initial Treatment|Other Reasons|0|||
147425486|NCT03184870|531723775|FG003|Initial Treatment|Other Reasons|1|||
147425487|NCT03184870|531723776|FG004|Initial Treatment|Other Reasons|0|||
147425488|NCT03184870|531723777|FG005|Initial Treatment|Other Reasons|0|||
147425489|NCT03184870|531723778|FG006|Initial Treatment|Other Reasons|0|||
147425490|NCT03184870|531723779|FG007|Initial Treatment|Other Reasons|2|||
147425491|NCT03184870|531723780|FG008|Initial Treatment|Other Reasons|0|||
147425492|NCT03184870|531723781|FG009|Initial Treatment|Other Reasons|0|||
147425493|NCT03184870|531723782|FG010|Initial Treatment|Other Reasons|4|||
147425494|NCT03184870|531723783|FG011|Initial Treatment|Other Reasons|2|||
147425495|NCT03184870|531723784|FG012|Initial Treatment|Other Reasons|2|||
147192001|NCT00525512|530870486|FG001|Double-Blind Phase|Lost to Follow-up|7|||
147425496|NCT03184870|531723785|FG013|Initial Treatment|Other Reasons|0|||
147425497|NCT03184870|531723786|FG014|Initial Treatment|Other Reasons|0|||
147425498|NCT03184870|531723787|FG015|Initial Treatment|Other Reasons|1|||
147425499|NCT03184870|531723788|FG016|Initial Treatment|Other Reasons|0|||
147425500|NCT03184870|531723789|FG017|Initial Treatment|Other Reasons|2|||
147425501|NCT03184870|531723772|FG000|Initial Treatment|Lost to Follow-up|2|||
147425502|NCT03184870|531723773|FG001|Initial Treatment|Lost to Follow-up|0|||
147425503|NCT03184870|531723774|FG002|Initial Treatment|Lost to Follow-up|0|||
147425504|NCT03184870|531723775|FG003|Initial Treatment|Lost to Follow-up|1|||
147425505|NCT03184870|531723776|FG004|Initial Treatment|Lost to Follow-up|1|||
147425506|NCT03184870|531723777|FG005|Initial Treatment|Lost to Follow-up|1|||
147425507|NCT03184870|531723778|FG006|Initial Treatment|Lost to Follow-up|0|||
147425508|NCT03184870|531723779|FG007|Initial Treatment|Lost to Follow-up|2|||
147425509|NCT03184870|531723780|FG008|Initial Treatment|Lost to Follow-up|0|||
147425510|NCT03184870|531723781|FG009|Initial Treatment|Lost to Follow-up|0|||
147425511|NCT03184870|531723782|FG010|Initial Treatment|Lost to Follow-up|2|||
147425512|NCT03184870|531723783|FG011|Initial Treatment|Lost to Follow-up|0|||
147425513|NCT03184870|531723784|FG012|Initial Treatment|Lost to Follow-up|2|||
147425514|NCT03184870|531723785|FG013|Initial Treatment|Lost to Follow-up|2|||
147425515|NCT03184870|531723786|FG014|Initial Treatment|Lost to Follow-up|0|||
147425516|NCT03184870|531723787|FG015|Initial Treatment|Lost to Follow-up|0|||
147425517|NCT03184870|531723788|FG016|Initial Treatment|Lost to Follow-up|2|||
147425518|NCT03184870|531723789|FG017|Initial Treatment|Lost to Follow-up|2|||
147306718|NCT01478113|531290722|FG001|Overall Study|Withdrawal by Subject|1|||
147425519|NCT03184870|531723772|FG000|Initial Treatment|Withdrawal by Subject|0|||
147425520|NCT03184870|531723773|FG001|Initial Treatment|Withdrawal by Subject|0|||
147425521|NCT03184870|531723774|FG002|Initial Treatment|Withdrawal by Subject|2|||
147425522|NCT03184870|531723775|FG003|Initial Treatment|Withdrawal by Subject|1|||
147425523|NCT03184870|531723776|FG004|Initial Treatment|Withdrawal by Subject|1|||
147425524|NCT03184870|531723777|FG005|Initial Treatment|Withdrawal by Subject|0|||
147425525|NCT03184870|531723778|FG006|Initial Treatment|Withdrawal by Subject|1|||
147425526|NCT03184870|531723779|FG007|Initial Treatment|Withdrawal by Subject|0|||
147425527|NCT03184870|531723780|FG008|Initial Treatment|Withdrawal by Subject|0|||
147425528|NCT03184870|531723781|FG009|Initial Treatment|Withdrawal by Subject|0|||
147425529|NCT03184870|531723782|FG010|Initial Treatment|Withdrawal by Subject|0|||
147425530|NCT03184870|531723783|FG011|Initial Treatment|Withdrawal by Subject|2|||
147425531|NCT03184870|531723784|FG012|Initial Treatment|Withdrawal by Subject|3|||
147192002|NCT00525512|530870487|FG002|Double-Blind Phase|Lost to Follow-up|0|||
147425532|NCT03184870|531723785|FG013|Initial Treatment|Withdrawal by Subject|0|||
147425533|NCT03184870|531723786|FG014|Initial Treatment|Withdrawal by Subject|1|||
147306719|NCT01478113|531290721|FG000|Overall Study|Physician Decision|1|||
147425534|NCT03184870|531723787|FG015|Initial Treatment|Withdrawal by Subject|5|||
147425535|NCT03184870|531723788|FG016|Initial Treatment|Withdrawal by Subject|2|||
147425536|NCT03184870|531723789|FG017|Initial Treatment|Withdrawal by Subject|2|||
147425537|NCT03184870|531723772|FG000|Initial Treatment|Moved to crossover treatment|0|||
147425538|NCT03184870|531723773|FG001|Initial Treatment|Moved to crossover treatment|0|||
147425539|NCT03184870|531723774|FG002|Initial Treatment|Moved to crossover treatment|0|||
147425540|NCT03184870|531723775|FG003|Initial Treatment|Moved to crossover treatment|0|||
147425541|NCT03184870|531723776|FG004|Initial Treatment|Moved to crossover treatment|0|||
147425542|NCT03184870|531723777|FG005|Initial Treatment|Moved to crossover treatment|0|||
147425543|NCT03184870|531723778|FG006|Initial Treatment|Moved to crossover treatment|0|||
147425544|NCT03184870|531723779|FG007|Initial Treatment|Moved to crossover treatment|0|||
147425545|NCT03184870|531723780|FG008|Initial Treatment|Moved to crossover treatment|0|||
147425546|NCT03184870|531723781|FG009|Initial Treatment|Moved to crossover treatment|0|||
147425547|NCT03184870|531723782|FG010|Initial Treatment|Moved to crossover treatment|0|||
147425548|NCT03184870|531723783|FG011|Initial Treatment|Moved to crossover treatment|0|||
147425549|NCT03184870|531723784|FG012|Initial Treatment|Moved to crossover treatment|9|||
147425550|NCT03184870|531723785|FG013|Initial Treatment|Moved to crossover treatment|0|||
147425551|NCT03184870|531723786|FG014|Initial Treatment|Moved to crossover treatment|0|||
147425552|NCT03184870|531723787|FG015|Initial Treatment|Moved to crossover treatment|0|||
147425553|NCT03184870|531723788|FG016|Initial Treatment|Moved to crossover treatment|0|||
147425554|NCT03184870|531723789|FG017|Initial Treatment|Moved to crossover treatment|0|||
147425555|NCT03184870|531723772|FG000|Crossover Treatment|Other reasons|0|||
147425556|NCT03184870|531723773|FG001|Crossover Treatment|Other reasons|0|||
147425557|NCT03184870|531723774|FG002|Crossover Treatment|Other reasons|0|||
147425558|NCT03184870|531723775|FG003|Crossover Treatment|Other reasons|0|||
147425559|NCT03184870|531723776|FG004|Crossover Treatment|Other reasons|0|||
147425560|NCT03184870|531723777|FG005|Crossover Treatment|Other reasons|0|||
147425561|NCT03184870|531723778|FG006|Crossover Treatment|Other reasons|0|||
147425562|NCT03184870|531723779|FG007|Crossover Treatment|Other reasons|0|||
147425563|NCT03184870|531723780|FG008|Crossover Treatment|Other reasons|0|||
147425564|NCT03184870|531723781|FG009|Crossover Treatment|Other reasons|0|||
147425565|NCT03184870|531723782|FG010|Crossover Treatment|Other reasons|0|||
147425566|NCT03184870|531723783|FG011|Crossover Treatment|Other reasons|0|||
147425567|NCT03184870|531723784|FG012|Crossover Treatment|Other reasons|0|||
147425568|NCT03184870|531723785|FG013|Crossover Treatment|Other reasons|0|||
147425569|NCT03184870|531723786|FG014|Crossover Treatment|Other reasons|0|||
147425570|NCT03184870|531723787|FG015|Crossover Treatment|Other reasons|0|||
147425571|NCT03184870|531723788|FG016|Crossover Treatment|Other reasons|0|||
147425572|NCT03184870|531723789|FG017|Crossover Treatment|Other reasons|2|||
147425573|NCT03184870|531723772|FG000|Crossover Treatment|Death|0|||
147425574|NCT03184870|531723773|FG001|Crossover Treatment|Death|0|||
147425575|NCT03184870|531723774|FG002|Crossover Treatment|Death|0|||
147425576|NCT03184870|531723775|FG003|Crossover Treatment|Death|0|||
147425577|NCT03184870|531723776|FG004|Crossover Treatment|Death|0|||
147425578|NCT03184870|531723777|FG005|Crossover Treatment|Death|0|||
147425579|NCT03184870|531723778|FG006|Crossover Treatment|Death|0|||
147425580|NCT03184870|531723779|FG007|Crossover Treatment|Death|0|||
147425581|NCT03184870|531723780|FG008|Crossover Treatment|Death|0|||
147425582|NCT03184870|531723781|FG009|Crossover Treatment|Death|0|||
147425583|NCT03184870|531723782|FG010|Crossover Treatment|Death|0|||
147425584|NCT03184870|531723783|FG011|Crossover Treatment|Death|0|||
147425585|NCT03184870|531723784|FG012|Crossover Treatment|Death|0|||
147425586|NCT03184870|531723785|FG013|Crossover Treatment|Death|0|||
147425587|NCT03184870|531723786|FG014|Crossover Treatment|Death|0|||
147425588|NCT03184870|531723787|FG015|Crossover Treatment|Death|0|||
147425589|NCT03184870|531723788|FG016|Crossover Treatment|Death|0|||
147425590|NCT03184870|531723789|FG017|Crossover Treatment|Death|7|||
147425591|NCT03786783|531723791|FG000|Overall Study|Death|1|||
147425592|NCT03786783|531723791|FG000|Overall Study|Physician Decision|6|||
147425593|NCT03786783|531723791|FG000|Overall Study|Withdrawal by Subject|2|||
147425594|NCT03786783|531723791|FG000|Overall Study|Disease Progression|7|||
147425595|NCT03786783|531723791|FG000|Overall Study|Patient/Parent Refusal|4|||
147425596|NCT04363801|531723792|FG000|Overall Study|Death|18|||
147425597|NCT04363801|531723793|FG001|Overall Study|Death|14|||
147425598|NCT04363801|531723794|FG002|Overall Study|Death|16|||
147425599|NCT04363801|531723795|FG003|Overall Study|Death|48|||
147425600|NCT04363801|531723796|FG004|Overall Study|Death|38|||
147425601|NCT04363801|531723792|FG000|Overall Study|Withdrawal by Subject|1|||
147425602|NCT04363801|531723793|FG001|Overall Study|Withdrawal by Subject|6|||
147425603|NCT04363801|531723794|FG002|Overall Study|Withdrawal by Subject|1|||
147425604|NCT04363801|531723795|FG003|Overall Study|Withdrawal by Subject|4|||
147425605|NCT04363801|531723796|FG004|Overall Study|Withdrawal by Subject|14|||
147425606|NCT04363801|531723792|FG000|Overall Study|Sponsor Decision|6|||
147425607|NCT04363801|531723793|FG001|Overall Study|Sponsor Decision|4|||
147425608|NCT04363801|531723794|FG002|Overall Study|Sponsor Decision|10|||
147425609|NCT04363801|531723795|FG003|Overall Study|Sponsor Decision|33|||
147425610|NCT04363801|531723796|FG004|Overall Study|Sponsor Decision|32|||
147425611|NCT04363801|531723792|FG000|Overall Study|Lost to Follow-up|0|||
147425612|NCT04363801|531723793|FG001|Overall Study|Lost to Follow-up|0|||
147425613|NCT04363801|531723794|FG002|Overall Study|Lost to Follow-up|1|||
147425614|NCT04363801|531723795|FG003|Overall Study|Lost to Follow-up|0|||
147425615|NCT04363801|531723796|FG004|Overall Study|Lost to Follow-up|1|||
147192003|NCT00525512|530870488|FG003|Double-Blind Phase|Lost to Follow-up|0|||
147192004|NCT00525512|530870485|FG000|Double-Blind Phase|Withdrawal by Subject|17|||
147192005|NCT00525512|530870486|FG001|Double-Blind Phase|Withdrawal by Subject|12|||
147192006|NCT00525512|530870487|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
147192007|NCT00525512|530870488|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
147192008|NCT00525512|530870485|FG000|Double-Blind Phase|Lack of Efficacy|13|||
147192009|NCT00525512|530870486|FG001|Double-Blind Phase|Lack of Efficacy|5|||
147192010|NCT00525512|530870487|FG002|Double-Blind Phase|Lack of Efficacy|0|||
147192011|NCT00525512|530870488|FG003|Double-Blind Phase|Lack of Efficacy|0|||
147192012|NCT00525512|530870485|FG000|Double-Blind Phase|Other reason (not specified)|12|||
147192013|NCT00525512|530870486|FG001|Double-Blind Phase|Other reason (not specified)|13|||
147192014|NCT00525512|530870487|FG002|Double-Blind Phase|Other reason (not specified)|0|||
147192015|NCT00525512|530870488|FG003|Double-Blind Phase|Other reason (not specified)|0|||
147192016|NCT00525512|530870485|FG000|Open-Label Phase|Adverse Event|0|||
147192017|NCT00525512|530870486|FG001|Open-Label Phase|Adverse Event|0|||
147192018|NCT00525512|530870487|FG002|Open-Label Phase|Adverse Event|1|||
147192019|NCT00525512|530870488|FG003|Open-Label Phase|Adverse Event|0|||
147192020|NCT00525512|530870485|FG000|Open-Label Phase|Lost to Follow-up|0|||
147192021|NCT00525512|530870486|FG001|Open-Label Phase|Lost to Follow-up|0|||
147192022|NCT00525512|530870487|FG002|Open-Label Phase|Lost to Follow-up|1|||
147192023|NCT00525512|530870488|FG003|Open-Label Phase|Lost to Follow-up|0|||
147192024|NCT00525512|530870485|FG000|Open-Label Phase|Other reason (not specified)|0|||
147192025|NCT00525512|530870486|FG001|Open-Label Phase|Other reason (not specified)|0|||
147192026|NCT00525512|530870487|FG002|Open-Label Phase|Other reason (not specified)|4|||
147192027|NCT00525512|530870488|FG003|Open-Label Phase|Other reason (not specified)|5|||
147192028|NCT05893862|530870493|FG000|Overall Study|Physician Decision|0|||
147425616|NCT00250679|531723799|FG000|Overall Study|Adverse Event|12|||
147425617|NCT00250679|531723800|FG001|Overall Study|Adverse Event|15|||
147425618|NCT00250679|531723801|FG002|Overall Study|Adverse Event|16|||
147425619|NCT00250679|531723799|FG000|Overall Study|Protocol Violation|2|||
147425620|NCT00250679|531723800|FG001|Overall Study|Protocol Violation|4|||
147425621|NCT00250679|531723801|FG002|Overall Study|Protocol Violation|3|||
147425622|NCT00250679|531723799|FG000|Overall Study|Withdrawal by Subject|15|||
147425623|NCT00250679|531723800|FG001|Overall Study|Withdrawal by Subject|18|||
147425624|NCT00250679|531723801|FG002|Overall Study|Withdrawal by Subject|15|||
147425625|NCT00250679|531723799|FG000|Overall Study|Lost to Follow-up|3|||
147425626|NCT00250679|531723800|FG001|Overall Study|Lost to Follow-up|4|||
147425627|NCT00250679|531723801|FG002|Overall Study|Lost to Follow-up|2|||
147425628|NCT00250679|531723799|FG000|Overall Study|Does Not Meet Entry Criteria|1|||
147425629|NCT00250679|531723800|FG001|Overall Study|Does Not Meet Entry Criteria|4|||
147425630|NCT00250679|531723801|FG002|Overall Study|Does Not Meet Entry Criteria|2|||
147425631|NCT00250679|531723799|FG000|Overall Study|Lack of Efficacy|0|||
147425632|NCT00250679|531723800|FG001|Overall Study|Lack of Efficacy|1|||
147425633|NCT00250679|531723801|FG002|Overall Study|Lack of Efficacy|3|||
147425634|NCT00250679|531723799|FG000|Overall Study|Technical Holter issues|1|||
147425635|NCT00250679|531723800|FG001|Overall Study|Technical Holter issues|0|||
147425636|NCT00250679|531723801|FG002|Overall Study|Technical Holter issues|2|||
147425637|NCT00250679|531723799|FG000|Overall Study|Moved|1|||
147425638|NCT00250679|531723800|FG001|Overall Study|Moved|1|||
147425639|NCT00250679|531723801|FG002|Overall Study|Moved|0|||
147425640|NCT00250679|531723799|FG000|Overall Study|Non-compliance|1|||
147425641|NCT00250679|531723800|FG001|Overall Study|Non-compliance|1|||
147425642|NCT00250679|531723801|FG002|Overall Study|Non-compliance|0|||
147425643|NCT00250679|531723799|FG000|Overall Study|various single events: hip surgery,diary|3|||
147425644|NCT00250679|531723800|FG001|Overall Study|various single events: hip surgery,diary|1|||
147425645|NCT00250679|531723801|FG002|Overall Study|various single events: hip surgery,diary|1|||
147425646|NCT00448279|531723802|FG000|Overall Study|Lost to Follow-up|2|||
147425647|NCT00448279|531723803|FG001|Overall Study|Lost to Follow-up|2|||
147425648|NCT00448279|531723802|FG000|Overall Study|Adverse Event|1|||
147425649|NCT00448279|531723803|FG001|Overall Study|Adverse Event|1|||
147425650|NCT00448279|531723802|FG000|Overall Study|Disease progression|16|||
147425651|NCT00448279|531723803|FG001|Overall Study|Disease progression|18|||
147425652|NCT00448279|531723802|FG000|Overall Study|Withdrawal by Subject|4|||
147425653|NCT00448279|531723803|FG001|Overall Study|Withdrawal by Subject|3|||
147425654|NCT00448279|531723802|FG000|Overall Study|Other|6|||
147425655|NCT00448279|531723803|FG001|Overall Study|Other|4|||
147192029|NCT05893862|530870494|FG001|Overall Study|Physician Decision|1|||
147192030|NCT05893862|530870495|FG002|Overall Study|Physician Decision|0|||
147192031|NCT05893862|530870496|FG003|Overall Study|Physician Decision|0|||
147192032|NCT05893862|530870497|FG004|Overall Study|Physician Decision|1|||
147192033|NCT05893862|530870498|FG005|Overall Study|Physician Decision|0|||
147192034|NCT05893862|530870493|FG000|Overall Study|Withdrawal by Subject|1|||
147192035|NCT05893862|530870494|FG001|Overall Study|Withdrawal by Subject|7|||
147192036|NCT05893862|530870495|FG002|Overall Study|Withdrawal by Subject|1|||
147192037|NCT05893862|530870496|FG003|Overall Study|Withdrawal by Subject|3|||
147192038|NCT05893862|530870497|FG004|Overall Study|Withdrawal by Subject|3|||
147192039|NCT05893862|530870498|FG005|Overall Study|Withdrawal by Subject|2|||
147192040|NCT05893862|530870493|FG000|Overall Study|Adverse Event|1|||
147192041|NCT05893862|530870494|FG001|Overall Study|Adverse Event|4|||
147192042|NCT05893862|530870495|FG002|Overall Study|Adverse Event|2|||
147192043|NCT05893862|530870496|FG003|Overall Study|Adverse Event|2|||
147192044|NCT05893862|530870497|FG004|Overall Study|Adverse Event|1|||
147192045|NCT05893862|530870498|FG005|Overall Study|Adverse Event|0|||
147192046|NCT02919761|530870499|FG000|Part 1: Open Label|Withdrawal by Subject|12|||
147192047|NCT02919761|530870500|FG001|Part 1: Open Label|Withdrawal by Subject|0|||
147192048|NCT02919761|530870501|FG002|Part 1: Open Label|Withdrawal by Subject|0|||
147192049|NCT02919761|530870499|FG000|Part 1: Open Label|Adverse Event|1|||
147192050|NCT02919761|530870500|FG001|Part 1: Open Label|Adverse Event|0|||
147192051|NCT02919761|530870501|FG002|Part 1: Open Label|Adverse Event|0|||
147192052|NCT02919761|530870499|FG000|Part 1: Open Label|Lost to Follow-up|1|||
147192053|NCT02919761|530870500|FG001|Part 1: Open Label|Lost to Follow-up|0|||
147192054|NCT02919761|530870501|FG002|Part 1: Open Label|Lost to Follow-up|0|||
147192055|NCT02919761|530870499|FG000|Part 1: Open Label|Met withdrawal criteria|5|||
147192056|NCT02919761|530870500|FG001|Part 1: Open Label|Met withdrawal criteria|0|||
147192057|NCT02919761|530870501|FG002|Part 1: Open Label|Met withdrawal criteria|0|||
147192058|NCT02919761|530870499|FG000|Part 1: Open Label|Did Not Achieve Lda At Week 12|2|||
147192059|NCT02919761|530870500|FG001|Part 1: Open Label|Did Not Achieve Lda At Week 12|0|||
147192060|NCT02919761|530870501|FG002|Part 1: Open Label|Did Not Achieve Lda At Week 12|0|||
147192061|NCT02919761|530870499|FG000|Part 1: Open Label|Dose Greater Than 20mg/Week|1|||
147192062|NCT02919761|530870500|FG001|Part 1: Open Label|Dose Greater Than 20mg/Week|0|||
147192063|NCT02919761|530870501|FG002|Part 1: Open Label|Dose Greater Than 20mg/Week|0|||
147192064|NCT02919761|530870499|FG000|Part 1: Open Label|did not meet inclusion criteria 8|1|||
147192065|NCT02919761|530870500|FG001|Part 1: Open Label|did not meet inclusion criteria 8|0|||
147192066|NCT02919761|530870501|FG002|Part 1: Open Label|did not meet inclusion criteria 8|0|||
147192067|NCT02919761|530870499|FG000|Part 1: Open Label|Termination by Sponsor|1|||
147192068|NCT02919761|530870500|FG001|Part 1: Open Label|Termination by Sponsor|0|||
147192069|NCT02919761|530870501|FG002|Part 1: Open Label|Termination by Sponsor|0|||
147192070|NCT02919761|530870499|FG000|Part 2: Double-blind|Withdrawal by Subject|0|||
147192071|NCT02919761|530870500|FG001|Part 2: Double-blind|Withdrawal by Subject|0|||
147192072|NCT02919761|530870501|FG002|Part 2: Double-blind|Withdrawal by Subject|2|||
147192073|NCT02919761|530870499|FG000|Part 2: Double-blind|Adverse Event|0|||
147192074|NCT02919761|530870500|FG001|Part 2: Double-blind|Adverse Event|1|||
147192075|NCT02919761|530870501|FG002|Part 2: Double-blind|Adverse Event|0|||
147192076|NCT02919761|530870499|FG000|Part 2: Double-blind|Lost to Follow-up|0|||
147192077|NCT02919761|530870500|FG001|Part 2: Double-blind|Lost to Follow-up|0|||
147192078|NCT02919761|530870501|FG002|Part 2: Double-blind|Lost to Follow-up|3|||
147425656|NCT00448279|531723802|FG000|Overall Study|Protocol Violation|0|||
147192079|NCT02919761|530870499|FG000|Part 2: Double-blind|Met withdrawal criteria|0|||
147425657|NCT00448279|531723803|FG001|Overall Study|Protocol Violation|1|||
147425658|NCT03907410|531723804|FG000|Overall Study|Lost to Follow-up|4|||
147425659|NCT03907410|531723805|FG001|Overall Study|Lost to Follow-up|1|||
147425660|NCT03907410|531723806|FG002|Overall Study|Lost to Follow-up|1|||
147425661|NCT03907410|531723804|FG000|Overall Study|Lost to follow-up and research burden|0|||
147425662|NCT03907410|531723805|FG001|Overall Study|Lost to follow-up and research burden|0|||
147425663|NCT03907410|531723806|FG002|Overall Study|Lost to follow-up and research burden|1|||
147425664|NCT04776148|531723807|FG000|Overall Study|Death|249|||
147425665|NCT04776148|531723808|FG001|Overall Study|Death|260|||
147425666|NCT04776148|531723807|FG000|Overall Study|Lost to Follow-up|0|||
147425667|NCT04776148|531723808|FG001|Overall Study|Lost to Follow-up|1|||
147425668|NCT04776148|531723807|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
147425669|NCT04776148|531723808|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
147425670|NCT04776148|531723807|FG000|Overall Study|Withdrawal by Subject|3|||
147425671|NCT04776148|531723808|FG001|Overall Study|Withdrawal by Subject|4|||
147425672|NCT04776148|531723807|FG000|Overall Study|Sponsor Decision|30|||
147425673|NCT04776148|531723808|FG001|Overall Study|Sponsor Decision|15|||
147425674|NCT00666679|531723812|FG000|First Intervention|Lost to Follow-up|1|||
147425675|NCT00666679|531723813|FG001|First Intervention|Lost to Follow-up|0|||
147425676|NCT00666679|531723812|FG000|First Intervention|Protocol Violation|1|||
147425677|NCT00666679|531723813|FG001|First Intervention|Protocol Violation|0|||
147425678|NCT00666679|531723812|FG000|First Intervention|Withdrawal by Subject|1|||
147425679|NCT00666679|531723813|FG001|First Intervention|Withdrawal by Subject|0|||
147425680|NCT00666679|531723812|FG000|First Intervention|Randomized did not start treatment|1|||
147425681|NCT00666679|531723813|FG001|First Intervention|Randomized did not start treatment|1|||
147425682|NCT00666679|531723812|FG000|Washout Period of 1 Week|Lost to Follow-up|0|||
147425683|NCT00666679|531723813|FG001|Washout Period of 1 Week|Lost to Follow-up|1|||
147425684|NCT00666679|531723812|FG000|Washout Period of 1 Week|Protocol Violation|0|||
147425685|NCT00666679|531723813|FG001|Washout Period of 1 Week|Protocol Violation|1|||
147425686|NCT00666679|531723812|FG000|Second Intervention|Adverse Event|1|||
147425687|NCT00666679|531723813|FG001|Second Intervention|Adverse Event|0|||
147425688|NCT00666679|531723812|FG000|Second Intervention|Death|0|||
147425689|NCT00666679|531723813|FG001|Second Intervention|Death|1|||
147425690|NCT04882995|531723816|FG000|Overall Study|Withdrawal by Subject|1|||
147425691|NCT04882995|531723817|FG001|Overall Study|Withdrawal by Subject|2|||
147425692|NCT04882995|531723816|FG000|Overall Study|Protocol Violation|4|||
147425693|NCT04882995|531723817|FG001|Overall Study|Protocol Violation|4|||
147425694|NCT04882995|531723816|FG000|Overall Study|Surgery postponed due to COVID|1|||
147425695|NCT04882995|531723817|FG001|Overall Study|Surgery postponed due to COVID|1|||
147425696|NCT04371198|531723818|FG000|Overall Study|inadequate sample|4|||
147425697|NCT04754477|531723819|FG000|Overall Study|Withdrawal by Subject|1|||
147425698|NCT00655486|531723824|FG000|Overall Study|Adverse Event|10|||
147425699|NCT00655486|531723824|FG000|Overall Study|Lack of Efficacy|8|||
147425700|NCT00655486|531723824|FG000|Overall Study|Withdrawal by Subject|4|||
147425701|NCT00655486|531723824|FG000|Overall Study|Protocol Violation|1|||
147425702|NCT00655486|531723824|FG000|Overall Study|Unsatisfactory compliance|2|||
147425703|NCT00655486|531723824|FG000|Overall Study|Other: Pregnancy|1|||
147425704|NCT00655486|531723824|FG000|Overall Study|Other: Could not tolerate BID dosing|1|||
147425705|NCT00655486|531723824|FG000|Overall Study|Other: Abnormal electrocardiogram (ECG)|1|||
147425706|NCT00440999|531723825|FG000|Overall Study|Adverse Event|0|||
147425707|NCT00440999|531723826|FG001|Overall Study|Adverse Event|2|||
147425708|NCT00440999|531723825|FG000|Overall Study|Lack of Efficacy|6|||
147425709|NCT00440999|531723826|FG001|Overall Study|Lack of Efficacy|7|||
147425710|NCT00440999|531723825|FG000|Overall Study|Lost to Follow-up|19|||
147425711|NCT00440999|531723826|FG001|Overall Study|Lost to Follow-up|12|||
147425712|NCT00440999|531723825|FG000|Overall Study|Protocol Violation|1|||
147425713|NCT00440999|531723826|FG001|Overall Study|Protocol Violation|0|||
147425714|NCT00440999|531723825|FG000|Overall Study|Withdrawal by Subject|2|||
147425715|NCT00440999|531723826|FG001|Overall Study|Withdrawal by Subject|5|||
147425716|NCT00440999|531723825|FG000|Overall Study|Subjets missed the visit|1|||
147425717|NCT00440999|531723826|FG001|Overall Study|Subjets missed the visit|0|||
147425718|NCT00440999|531723825|FG000|Overall Study|Mixed infection at entry|1|||
147425719|NCT00440999|531723826|FG001|Overall Study|Mixed infection at entry|0|||
147425720|NCT00440999|531723825|FG000|Overall Study|P. falciparum malaria|5|||
147425721|NCT00440999|531723826|FG001|Overall Study|P. falciparum malaria|14|||
147425722|NCT00440999|531723825|FG000|Overall Study|Subj left hosp without inform staff|0|||
147425723|NCT00440999|531723826|FG001|Overall Study|Subj left hosp without inform staff|1|||
147425724|NCT04572841|531723827|FG000|Overall Study|Adverse Event|1|||
147425725|NCT04572841|531723828|FG001|Overall Study|Adverse Event|1|||
147425726|NCT04572841|531723827|FG000|Overall Study|Withdrawal by Subject|2|||
147425727|NCT04572841|531723828|FG001|Overall Study|Withdrawal by Subject|1|||
147306720|NCT01478113|531290722|FG001|Overall Study|Physician Decision|0|||
147425728|NCT05041101|531723829|FG000|Overall Study|Adverse Event|1|||
147425729|NCT05041101|531723830|FG001|Overall Study|Adverse Event|0|||
147425730|NCT05041101|531723831|FG002|Overall Study|Adverse Event|0|||
147425731|NCT05041101|531723829|FG000|Overall Study|Diease Progression|5|||
147425732|NCT05041101|531723830|FG001|Overall Study|Diease Progression|0|||
147425733|NCT05041101|531723831|FG002|Overall Study|Diease Progression|0|||
147425734|NCT01205152|531723832|FG000|Overall Study|Death|1|||
147425735|NCT00249002|531723833|FG000|Overall Study|Adverse Event|2|||
147425736|NCT00249002|531723833|FG000|Overall Study|Study cancellation|3|||
147425737|NCT00249002|531723833|FG000|Overall Study|Other|2|||
147425738|NCT00069108|531723834|FG000|Overall Study|Withdrawal by Subject|5|||
147425739|NCT00069108|531723835|FG001|Overall Study|Withdrawal by Subject|9|||
147425740|NCT00069108|531723834|FG000|Overall Study|Adverse Event|64|||
147425741|NCT00069108|531723835|FG001|Overall Study|Adverse Event|42|||
147425742|NCT00069108|531723834|FG000|Overall Study|Death|6|||
147425743|NCT00069108|531723835|FG001|Overall Study|Death|6|||
147425744|NCT00069108|531723834|FG000|Overall Study|Administration|15|||
147425745|NCT00069108|531723835|FG001|Overall Study|Administration|4|||
147425746|NCT00069108|531723834|FG000|Overall Study|Insufficient therapy|117|||
147425747|NCT00069108|531723835|FG001|Overall Study|Insufficient therapy|144|||
147425748|NCT00069108|531723834|FG000|Overall Study|Violation criteria|1|||
147425749|NCT00069108|531723835|FG001|Overall Study|Violation criteria|4|||
147425750|NCT00069108|531723834|FG000|Overall Study|Refused treatment|5|||
147425751|NCT00069108|531723835|FG001|Overall Study|Refused treatment|10|||
147425752|NCT02783768|531723836|FG000|Overall Study|Lost to Follow-up|1|||
147425753|NCT02783768|531723837|FG001|Overall Study|Lost to Follow-up|0|||
147425754|NCT01323647|531723838|FG000|Overall Study|Migrated/moved from study area|2|||
147425755|NCT01323647|531723839|FG001|Overall Study|Migrated/moved from study area|0|||
147425756|NCT01323647|531723838|FG000|Overall Study|Withdrawal by Subject|5|||
147425757|NCT01323647|531723839|FG001|Overall Study|Withdrawal by Subject|0|||
147425758|NCT01323647|531723838|FG000|Overall Study|Lost to Follow-up|2|||
147425759|NCT01323647|531723839|FG001|Overall Study|Lost to Follow-up|0|||
147425760|NCT01853137|531723840|FG000|Overall Study|Lost to Follow-up|4|||
147425761|NCT01853137|531723841|FG001|Overall Study|Lost to Follow-up|1|||
147425762|NCT03401229|531723842|FG000|Overall Study|Lost to Follow-up|2|||
147425763|NCT03401229|531723843|FG001|Overall Study|Lost to Follow-up|1|||
147425764|NCT03401229|531723842|FG000|Overall Study|Other|1|||
147425765|NCT03401229|531723843|FG001|Overall Study|Other|3|||
147425766|NCT03401229|531723842|FG000|Overall Study|Adverse Event|8|||
147425767|NCT03401229|531723843|FG001|Overall Study|Adverse Event|6|||
147425768|NCT03401229|531723842|FG000|Overall Study|Withdrawal by Subject|29|||
147425769|NCT03401229|531723843|FG001|Overall Study|Withdrawal by Subject|26|||
147425770|NCT03401229|531723842|FG000|Overall Study|COVID-19|0|||
147425771|NCT03401229|531723843|FG001|Overall Study|COVID-19|1|||
147425772|NCT00690820|531723844|FG000|Period 1|Withdrawal by Subject|0|||
147425773|NCT00690820|531723845|FG001|Period 1|Withdrawal by Subject|1|||
147425774|NCT05333224|531723846|FG000|Overall Study - Infants|Lost to Follow-up|1|||
147425775|NCT05333224|531723847|FG001|Overall Study - Infants|Lost to Follow-up|1|||
147425776|NCT01411215|531723849|FG000|Overall Study|Adverse Event|1|||
147425777|NCT01411215|531723850|FG001|Overall Study|Adverse Event|2|||
147425778|NCT01411215|531723849|FG000|Overall Study|Lack of Efficacy|2|||
147425779|NCT01411215|531723850|FG001|Overall Study|Lack of Efficacy|4|||
147425780|NCT01411215|531723849|FG000|Overall Study|Lost to Follow-up|12|||
147425781|NCT01411215|531723850|FG001|Overall Study|Lost to Follow-up|18|||
147425782|NCT01411215|531723849|FG000|Overall Study|Did not meet entrance criteria|0|||
147425783|NCT01411215|531723850|FG001|Overall Study|Did not meet entrance criteria|1|||
147425784|NCT01411215|531723849|FG000|Overall Study|Study terminated by sponsor|2|||
147425785|NCT01411215|531723850|FG001|Overall Study|Study terminated by sponsor|15|||
147425786|NCT01411215|531723849|FG000|Overall Study|Protocol Violation|3|||
147425787|NCT01411215|531723850|FG001|Overall Study|Protocol Violation|5|||
147192080|NCT02919761|530870500|FG001|Part 2: Double-blind|Met withdrawal criteria|1|||
147425788|NCT01411215|531723849|FG000|Overall Study|Withdrawal by Subject|34|||
147425789|NCT01411215|531723850|FG001|Overall Study|Withdrawal by Subject|21|||
147425790|NCT01411215|531723849|FG000|Overall Study|Other|12|||
147425791|NCT01411215|531723850|FG001|Overall Study|Other|17|||
147425792|NCT01411215|531723849|FG000|Overall Study|Screen failure|0|||
147425793|NCT01411215|531723850|FG001|Overall Study|Screen failure|1|||
147425794|NCT00848926|531723851|FG000|Treatment Period|Progressive disease|45|||
147425795|NCT00848926|531723851|FG000|Treatment Period|Adverse Event|20|||
147425796|NCT00848926|531723851|FG000|Treatment Period|Physician Decision|12|||
147425797|NCT00848926|531723851|FG000|Treatment Period|Withdrawal by Subject|7|||
147425798|NCT00848926|531723851|FG000|Follow-up Period|Lost to Follow-up|7|||
147425799|NCT00848926|531723851|FG000|Follow-up Period|Withdrawal by Subject|3|||
147425800|NCT00848926|531723851|FG000|Follow-up Period|Other|2|||
147425801|NCT02203695|531723852|FG000|Overall Study|Patient withdrew consent|1|||
147425802|NCT02203695|531723853|FG001|Overall Study|Patient withdrew consent|1|||
147425803|NCT02203695|531723852|FG000|Overall Study|Started non-study treatment|1|||
147425804|NCT02203695|531723853|FG001|Overall Study|Started non-study treatment|0|||
147425805|NCT00966277|531723855|FG000|Overall Study|Withdrawal by Subject|3|||
147425806|NCT00966277|531723856|FG001|Overall Study|Withdrawal by Subject|0|||
147425807|NCT00966277|531723855|FG000|Overall Study|Ineligible|1|||
147425808|NCT00966277|531723856|FG001|Overall Study|Ineligible|3|||
147425809|NCT00966277|531723855|FG000|Overall Study|Treatment Plan Changed|0|||
147425810|NCT00966277|531723856|FG001|Overall Study|Treatment Plan Changed|1|||
147425811|NCT03451162|531723858|FG000|Overall Study|Lost to Follow-up|1|||
147425812|NCT03451162|531723859|FG001|Overall Study|Lost to Follow-up|0|||
147425813|NCT03451162|531723860|FG002|Overall Study|Lost to Follow-up|0|||
147425814|NCT03451162|531723861|FG003|Overall Study|Lost to Follow-up|0|||
147425815|NCT03451162|531723862|FG004|Overall Study|Lost to Follow-up|0|||
147425816|NCT03451162|531723858|FG000|Overall Study|Physician Decision|0|||
147425817|NCT03451162|531723859|FG001|Overall Study|Physician Decision|1|||
147425818|NCT03451162|531723860|FG002|Overall Study|Physician Decision|0|||
147425819|NCT03451162|531723861|FG003|Overall Study|Physician Decision|0|||
147425820|NCT03451162|531723862|FG004|Overall Study|Physician Decision|0|||
147425821|NCT03451162|531723858|FG000|Overall Study|Withdrawal by Subject|1|||
147425822|NCT03451162|531723859|FG001|Overall Study|Withdrawal by Subject|1|||
147425823|NCT03451162|531723860|FG002|Overall Study|Withdrawal by Subject|0|||
147425824|NCT03451162|531723861|FG003|Overall Study|Withdrawal by Subject|0|||
147425825|NCT03451162|531723862|FG004|Overall Study|Withdrawal by Subject|0|||
147425826|NCT03305731|531723863|FG000|Overall Study|Protocol Violation|1|||
147425827|NCT01952054|531723864|FG000|Overall Study|Physician Decision|1|||
147425828|NCT01127139|531723865|FG000|Overall Study|Adverse Event|40|||
147425829|NCT01127139|531723865|FG000|Overall Study|Incompliance|12|||
147425830|NCT01127139|531723865|FG000|Overall Study|Lack of Efficacy|4|||
147425831|NCT01127139|531723865|FG000|Overall Study|Reason not specified|1|||
147425832|NCT01136772|531723866|FG000|Overall Study|Adverse Event|15|||
147425833|NCT01136772|531723867|FG001|Overall Study|Adverse Event|14|||
147425834|NCT01136772|531723866|FG000|Overall Study|Lack of Efficacy|42|||
147425835|NCT01136772|531723867|FG001|Overall Study|Lack of Efficacy|39|||
147425836|NCT01136772|531723866|FG000|Overall Study|Administrative|14|||
147425837|NCT01136772|531723867|FG001|Overall Study|Administrative|12|||
147425838|NCT01136772|531723866|FG000|Overall Study|Withdrawal by Subject|33|||
147425839|NCT01136772|531723867|FG001|Overall Study|Withdrawal by Subject|36|||
147425840|NCT01136772|531723866|FG000|Overall Study|Did not receive injection|10|||
147425841|NCT01136772|531723867|FG001|Overall Study|Did not receive injection|7|||
147425842|NCT01136772|531723866|FG000|Overall Study|Did not follow up after first injection|2|||
147425843|NCT01136772|531723867|FG001|Overall Study|Did not follow up after first injection|2|||
147425844|NCT01498653|531723868|FG000|Overall Study|Adverse Event|2|||
147425845|NCT01498653|531723869|FG001|Overall Study|Adverse Event|2|||
147425846|NCT01498653|531723868|FG000|Overall Study|Lack of Efficacy|12|||
147425847|NCT01498653|531723869|FG001|Overall Study|Lack of Efficacy|26|||
147425848|NCT01498653|531723868|FG000|Overall Study|Protocol Violation|0|||
147425849|NCT01498653|531723869|FG001|Overall Study|Protocol Violation|4|||
147425850|NCT01498653|531723868|FG000|Overall Study|Lost to Follow-up|1|||
147425851|NCT01498653|531723869|FG001|Overall Study|Lost to Follow-up|0|||
147425852|NCT01498653|531723868|FG000|Overall Study|Physician Decision|2|||
147425853|NCT01498653|531723869|FG001|Overall Study|Physician Decision|0|||
147425854|NCT01498653|531723868|FG000|Overall Study|Withdrawal by Subject|2|||
147425855|NCT01498653|531723869|FG001|Overall Study|Withdrawal by Subject|3|||
147425856|NCT01718353|531723871|FG000|Overall Study|Lost to Follow-up|0|||
147192081|NCT02919761|530870501|FG002|Part 2: Double-blind|Met withdrawal criteria|2|||
147425857|NCT01718353|531723872|FG001|Overall Study|Lost to Follow-up|1|||
147425858|NCT01718353|531723871|FG000|Overall Study|Principal Investigator's Decision|10|||
147425859|NCT01718353|531723872|FG001|Overall Study|Principal Investigator's Decision|4|||
147425860|NCT01718353|531723871|FG000|Overall Study|Randomized but not treated|2|||
147425861|NCT01718353|531723872|FG001|Overall Study|Randomized but not treated|0|||
147425862|NCT01477333|531723873|FG000|Overall Study|Adverse Event|1|||
147425863|NCT01477333|531723873|FG000|Overall Study|Withdrawal by Subject|1|||
147192082|NCT02919761|530870499|FG000|Part 2: Double-blind|Worsening of disease activity|0|||
147192083|NCT02919761|530870500|FG001|Part 2: Double-blind|Worsening of disease activity|4|||
147192084|NCT02919761|530870501|FG002|Part 2: Double-blind|Worsening of disease activity|10|||
147192085|NCT02919761|530870499|FG000|Part 2: Double-blind|Did not meet LDA at Week 16|0|||
147192086|NCT02919761|530870500|FG001|Part 2: Double-blind|Did not meet LDA at Week 16|0|||
147192087|NCT02919761|530870501|FG002|Part 2: Double-blind|Did not meet LDA at Week 16|1|||
147192088|NCT02919761|530870499|FG000|Part 2: Double-blind|Did not meet LDA at Week 20|0|||
147192089|NCT02919761|530870500|FG001|Part 2: Double-blind|Did not meet LDA at Week 20|0|||
147192090|NCT02919761|530870501|FG002|Part 2: Double-blind|Did not meet LDA at Week 20|1|||
147192091|NCT02919761|530870499|FG000|Part 2: Double-blind|Discontinued exclusion 16|0|||
147192092|NCT02919761|530870500|FG001|Part 2: Double-blind|Discontinued exclusion 16|0|||
147192093|NCT02919761|530870501|FG002|Part 2: Double-blind|Discontinued exclusion 16|2|||
147192094|NCT00880698|530870504|FG000|Overall Study|Death|0|||
147192095|NCT00880698|530870505|FG001|Overall Study|Death|0|||
147192096|NCT00880698|530870506|FG002|Overall Study|Death|1|||
147192097|NCT00880698|530870507|FG003|Overall Study|Death|2|||
147192098|NCT00880698|530870504|FG000|Overall Study|Lost to Follow-up|1|||
147192099|NCT00880698|530870505|FG001|Overall Study|Lost to Follow-up|3|||
147192100|NCT00880698|530870506|FG002|Overall Study|Lost to Follow-up|0|||
147192101|NCT00880698|530870507|FG003|Overall Study|Lost to Follow-up|1|||
147192102|NCT04972162|530870508|FG000|Washout Period (5 Days)|Withdrawal by Subject|1|||
147192103|NCT04972162|530870509|FG001|Washout Period (5 Days)|Withdrawal by Subject|1|||
147192104|NCT05546476|530872044|FG000|Period 1: Part A|Adverse Event|2|||
147192105|NCT05546476|530872045|FG001|Period 1: Part A|Adverse Event|0|||
147192106|NCT05546476|530872046|FG002|Period 1: Part A|Adverse Event|0|||
147192107|NCT05546476|530872047|FG003|Period 1: Part A|Adverse Event|1|||
147192108|NCT05546476|530872044|FG000|Period 1: Part A|Death|4|||
147192109|NCT05546476|530872045|FG001|Period 1: Part A|Death|4|||
147192110|NCT05546476|530872046|FG002|Period 1: Part A|Death|5|||
147192111|NCT05546476|530872047|FG003|Period 1: Part A|Death|6|||
147192112|NCT05546476|530872044|FG000|Period 1: Part A|Lack of Efficacy|0|||
147192113|NCT05546476|530872045|FG001|Period 1: Part A|Lack of Efficacy|0|||
147192114|NCT05546476|530872046|FG002|Period 1: Part A|Lack of Efficacy|0|||
147192115|NCT05546476|530872047|FG003|Period 1: Part A|Lack of Efficacy|1|||
147192116|NCT05546476|530872044|FG000|Period 1: Part A|Lost to Follow-up|0|||
147192117|NCT05546476|530872045|FG001|Period 1: Part A|Lost to Follow-up|0|||
147192118|NCT05546476|530872046|FG002|Period 1: Part A|Lost to Follow-up|0|||
147192119|NCT05546476|530872047|FG003|Period 1: Part A|Lost to Follow-up|1|||
147192120|NCT05546476|530872044|FG000|Period 1: Part A|Physician Decision|1|||
147192121|NCT05546476|530872045|FG001|Period 1: Part A|Physician Decision|0|||
147192122|NCT05546476|530872046|FG002|Period 1: Part A|Physician Decision|0|||
147192123|NCT05546476|530872047|FG003|Period 1: Part A|Physician Decision|0|||
147192124|NCT05546476|530872044|FG000|Period 1: Part A|Progressive disease|3|||
147192125|NCT05546476|530872045|FG001|Period 1: Part A|Progressive disease|5|||
147192126|NCT05546476|530872046|FG002|Period 1: Part A|Progressive disease|0|||
147192127|NCT05546476|530872047|FG003|Period 1: Part A|Progressive disease|1|||
147192128|NCT05546476|530872044|FG000|Period 1: Part A|Withdrawal by Subject|1|||
147192129|NCT05546476|530872045|FG001|Period 1: Part A|Withdrawal by Subject|1|||
147192130|NCT05546476|530872046|FG002|Period 1: Part A|Withdrawal by Subject|1|||
147192131|NCT05546476|530872047|FG003|Period 1: Part A|Withdrawal by Subject|2|||
147192132|NCT05546476|530872044|FG000|Period 1: Part A|Global deterioration of health status|2|||
147192133|NCT05546476|530872045|FG001|Period 1: Part A|Global deterioration of health status|2|||
147192134|NCT05546476|530872046|FG002|Period 1: Part A|Global deterioration of health status|1|||
147192135|NCT05546476|530872047|FG003|Period 1: Part A|Global deterioration of health status|4|||
147192136|NCT05546476|530872044|FG000|Period 1: Part A|Other: Unspecified|0|||
147192137|NCT05546476|530872045|FG001|Period 1: Part A|Other: Unspecified|2|||
147192138|NCT05546476|530872046|FG002|Period 1: Part A|Other: Unspecified|0|||
147192139|NCT05546476|530872047|FG003|Period 1: Part A|Other: Unspecified|0|||
147192140|NCT05546476|530872044|FG000|Period 2: Part B|Ongoing|26|||
147192141|NCT05546476|530872045|FG001|Period 2: Part B|Ongoing|27|||
147192142|NCT05546476|530872046|FG002|Period 2: Part B|Ongoing|35|||
147192143|NCT05546476|530872047|FG003|Period 2: Part B|Ongoing|29|||
147192144|NCT04890652|530872057|FG000|Overall Study|Withdrawal by Subject|2|||
147192145|NCT04750824|530872062|FG000|Overall Study|Toxicity/intolerability|3|||
147192146|NCT04750824|530872063|FG001|Overall Study|Toxicity/intolerability|1|||
147192147|NCT04750824|530872062|FG000|Overall Study|Death|1|||
147192148|NCT04750824|530872063|FG001|Overall Study|Death|3|||
147192149|NCT04750824|530872062|FG000|Overall Study|Scheduled duration of therapy complete|1|||
147306721|NCT04399356|531290735|FG000|Overall Study|Lost to Follow-up|1|||
147192150|NCT04750824|530872063|FG001|Overall Study|Scheduled duration of therapy complete|9|||
147425864|NCT01477333|531723873|FG000|Overall Study|Clinical Deterioration|1|||
147425865|NCT00455325|531723874|FG000|Cohort 1: Placebo|Started exclusionary drug|1|||
147425866|NCT00455325|531723875|FG001|Cohort 1: Placebo|Started exclusionary drug|0|||
147425867|NCT00455325|531723876|FG002|Cohort 1: Placebo|Started exclusionary drug|0|||
147425868|NCT00455325|531723877|FG003|Cohort 1: Placebo|Started exclusionary drug|0|||
147425869|NCT00455325|531723874|FG000|Cohort 1: Placebo|Withdrawal by Subject|4|||
147425870|NCT00455325|531723875|FG001|Cohort 1: Placebo|Withdrawal by Subject|0|||
147425871|NCT00455325|531723876|FG002|Cohort 1: Placebo|Withdrawal by Subject|0|||
147425872|NCT00455325|531723877|FG003|Cohort 1: Placebo|Withdrawal by Subject|0|||
147425873|NCT00455325|531723874|FG000|Cohort 1: Placebo|Lost to Follow-up|1|||
147425874|NCT00455325|531723875|FG001|Cohort 1: Placebo|Lost to Follow-up|0|||
147425875|NCT00455325|531723876|FG002|Cohort 1: Placebo|Lost to Follow-up|0|||
147425876|NCT00455325|531723877|FG003|Cohort 1: Placebo|Lost to Follow-up|0|||
147425877|NCT00455325|531723874|FG000|Cohort 1: Placebo|New diagnosis of Type 2 Diabetes|1|||
147425878|NCT00455325|531723875|FG001|Cohort 1: Placebo|New diagnosis of Type 2 Diabetes|0|||
147425879|NCT00455325|531723876|FG002|Cohort 1: Placebo|New diagnosis of Type 2 Diabetes|0|||
147425880|NCT00455325|531723877|FG003|Cohort 1: Placebo|New diagnosis of Type 2 Diabetes|0|||
147425881|NCT00455325|531723874|FG000|Cohort 1: Placebo|DIFFICULTY WITH IV ACCESS|1|||
147425882|NCT00455325|531723875|FG001|Cohort 1: Placebo|DIFFICULTY WITH IV ACCESS|0|||
147425883|NCT00455325|531723876|FG002|Cohort 1: Placebo|DIFFICULTY WITH IV ACCESS|0|||
147425884|NCT00455325|531723877|FG003|Cohort 1: Placebo|DIFFICULTY WITH IV ACCESS|0|||
147425885|NCT00455325|531723874|FG000|Cohort 2: 80 mg Chloroquine Weekly|Adverse Event|0|||
147425886|NCT00455325|531723875|FG001|Cohort 2: 80 mg Chloroquine Weekly|Adverse Event|1|||
147425887|NCT00455325|531723876|FG002|Cohort 2: 80 mg Chloroquine Weekly|Adverse Event|0|||
147425888|NCT00455325|531723877|FG003|Cohort 2: 80 mg Chloroquine Weekly|Adverse Event|0|||
147425889|NCT00455325|531723874|FG000|Cohort 3: 80 mg Chloroquine Daily|Started exclusionary drug|0|||
147425890|NCT00455325|531723875|FG001|Cohort 3: 80 mg Chloroquine Daily|Started exclusionary drug|0|||
147425891|NCT00455325|531723876|FG002|Cohort 3: 80 mg Chloroquine Daily|Started exclusionary drug|1|||
147425892|NCT00455325|531723877|FG003|Cohort 3: 80 mg Chloroquine Daily|Started exclusionary drug|0|||
147425893|NCT04948333|531723880|FG000|Overall Study|Adverse Event|6|||
147425894|NCT04948333|531723881|FG001|Overall Study|Adverse Event|4|||
147425895|NCT04948333|531723882|FG002|Overall Study|Adverse Event|0|||
147425896|NCT04948333|531723883|FG003|Overall Study|Adverse Event|2|||
147425897|NCT04948333|531723880|FG000|Overall Study|Unsatisfactory Therapeutic Effect|4|||
147425898|NCT04948333|531723881|FG001|Overall Study|Unsatisfactory Therapeutic Effect|3|||
147425899|NCT04948333|531723882|FG002|Overall Study|Unsatisfactory Therapeutic Effect|0|||
147425900|NCT04948333|531723883|FG003|Overall Study|Unsatisfactory Therapeutic Effect|0|||
147425901|NCT04948333|531723880|FG000|Overall Study|Progressive Disease|1|||
147425902|NCT04948333|531723881|FG001|Overall Study|Progressive Disease|5|||
147425903|NCT04948333|531723882|FG002|Overall Study|Progressive Disease|0|||
147425904|NCT04948333|531723883|FG003|Overall Study|Progressive Disease|0|||
147425905|NCT04948333|531723880|FG000|Overall Study|Physician Decision|2|||
147425906|NCT04948333|531723881|FG001|Overall Study|Physician Decision|2|||
147425907|NCT04948333|531723882|FG002|Overall Study|Physician Decision|0|||
147425908|NCT04948333|531723883|FG003|Overall Study|Physician Decision|0|||
147425909|NCT04948333|531723880|FG000|Overall Study|Failure To Meet Continuation Criteria|2|||
147425910|NCT04948333|531723881|FG001|Overall Study|Failure To Meet Continuation Criteria|1|||
147425911|NCT04948333|531723882|FG002|Overall Study|Failure To Meet Continuation Criteria|0|||
147425912|NCT04948333|531723883|FG003|Overall Study|Failure To Meet Continuation Criteria|0|||
147425913|NCT04948333|531723880|FG000|Overall Study|Withdrawal by Subject|2|||
147425914|NCT04948333|531723881|FG001|Overall Study|Withdrawal by Subject|0|||
147425915|NCT04948333|531723882|FG002|Overall Study|Withdrawal by Subject|0|||
147425916|NCT04948333|531723883|FG003|Overall Study|Withdrawal by Subject|1|||
147425917|NCT04948333|531723880|FG000|Overall Study|Protocol Violation|0|||
147425918|NCT04948333|531723881|FG001|Overall Study|Protocol Violation|1|||
147425919|NCT04948333|531723882|FG002|Overall Study|Protocol Violation|0|||
147425920|NCT04948333|531723883|FG003|Overall Study|Protocol Violation|0|||
147425921|NCT04948333|531723880|FG000|Overall Study|Treatment ongoing at the time of the data cut-off date 12-Mar-2024|68|||
147425922|NCT04948333|531723881|FG001|Overall Study|Treatment ongoing at the time of the data cut-off date 12-Mar-2024|68|||
147425923|NCT04948333|531723882|FG002|Overall Study|Treatment ongoing at the time of the data cut-off date 12-Mar-2024|14|||
147425924|NCT04948333|531723883|FG003|Overall Study|Treatment ongoing at the time of the data cut-off date 12-Mar-2024|13|||
147425925|NCT03464097|531723892|FG000|Overall Study|Withdrawal by Subject|15|||
147425926|NCT03464097|531723893|FG001|Overall Study|Withdrawal by Subject|13|||
147425927|NCT03464097|531723894|FG002|Overall Study|Withdrawal by Subject|11|||
147425928|NCT03464097|531723892|FG000|Overall Study|Study terminated by sponsor|47|||
147425929|NCT03464097|531723893|FG001|Overall Study|Study terminated by sponsor|44|||
147425930|NCT03464097|531723894|FG002|Overall Study|Study terminated by sponsor|40|||
147425931|NCT03464097|531723892|FG000|Overall Study|Pregnancy|0|||
147425932|NCT03464097|531723893|FG001|Overall Study|Pregnancy|1|||
147425933|NCT03464097|531723894|FG002|Overall Study|Pregnancy|0|||
147425934|NCT03464097|531723892|FG000|Overall Study|Other reasons|5|||
147425935|NCT03464097|531723893|FG001|Overall Study|Other reasons|12|||
147425936|NCT03464097|531723894|FG002|Overall Study|Other reasons|14|||
147425937|NCT03464097|531723892|FG000|Overall Study|Lost to Follow-up|0|||
147425938|NCT03464097|531723893|FG001|Overall Study|Lost to Follow-up|1|||
147425939|NCT03464097|531723894|FG002|Overall Study|Lost to Follow-up|1|||
147425940|NCT03464097|531723892|FG000|Overall Study|Lack of Efficacy|11|||
147425941|NCT03464097|531723893|FG001|Overall Study|Lack of Efficacy|18|||
147425942|NCT03464097|531723894|FG002|Overall Study|Lack of Efficacy|30|||
147425943|NCT03464097|531723892|FG000|Overall Study|Death|1|||
147425944|NCT03464097|531723893|FG001|Overall Study|Death|0|||
147425945|NCT03464097|531723894|FG002|Overall Study|Death|0|||
147425946|NCT03464097|531723892|FG000|Overall Study|Adverse Event|13|||
147425947|NCT03464097|531723893|FG001|Overall Study|Adverse Event|6|||
147425948|NCT03464097|531723894|FG002|Overall Study|Adverse Event|8|||
147425949|NCT03035201|531723895|FG000|Overall Study|Death|9|||
147425950|NCT03035201|531723896|FG001|Overall Study|Death|12|||
147425951|NCT03035201|531723897|FG002|Overall Study|Death|9|||
147425952|NCT03035201|531723898|FG003|Overall Study|Death|10|||
147425953|NCT03035201|531723895|FG000|Overall Study|Withdrawal by Subject|51|||
147425954|NCT03035201|531723896|FG001|Overall Study|Withdrawal by Subject|49|||
147425955|NCT03035201|531723897|FG002|Overall Study|Withdrawal by Subject|37|||
147425956|NCT03035201|531723898|FG003|Overall Study|Withdrawal by Subject|46|||
147425957|NCT03035201|531723895|FG000|Overall Study|Lost to Follow-up|67|||
147425958|NCT03035201|531723896|FG001|Overall Study|Lost to Follow-up|51|||
147425959|NCT03035201|531723897|FG002|Overall Study|Lost to Follow-up|64|||
147425960|NCT03035201|531723898|FG003|Overall Study|Lost to Follow-up|69|||
147425961|NCT05572021|531723905|FG000|Overall Study|Study terminated - PI left the institution and no other surgeons were interested in continuing study|5|||
147425962|NCT05572021|531723906|FG001|Overall Study|Study terminated - PI left the institution and no other surgeons were interested in continuing study|0|||
147425963|NCT04576455|531723907|FG000|Overall Study|Ongoing in the Study|48|||
147425964|NCT04576455|531723908|FG001|Overall Study|Ongoing in the Study|58|||
147425965|NCT04576455|531723907|FG000|Overall Study|Death|83|||
147425966|NCT04576455|531723908|FG001|Overall Study|Death|77|||
147425967|NCT04576455|531723907|FG000|Overall Study|Lost to Follow-up|4|||
147425968|NCT04576455|531723908|FG001|Overall Study|Lost to Follow-up|5|||
147425969|NCT04576455|531723907|FG000|Overall Study|Withdrawal by Subject|16|||
147425970|NCT04576455|531723908|FG001|Overall Study|Withdrawal by Subject|12|||
147425971|NCT03432260|531723909|FG000|Overall Study|Lost to Follow-up|1|||
147425972|NCT03432260|531723910|FG001|Overall Study|Lost to Follow-up|1|||
147425973|NCT03432260|531723911|FG002|Overall Study|Lost to Follow-up|0|||
147425974|NCT03432260|531723912|FG003|Overall Study|Lost to Follow-up|0|||
147425975|NCT03432260|531723913|FG004|Overall Study|Lost to Follow-up|1|||
147425976|NCT02186847|531723914|FG000|Overall Study|Protocol Violation|3|||
147425977|NCT02186847|531723915|FG001|Overall Study|Protocol Violation|0|||
147425978|NCT04873232|531723919|FG000|Overall Study|Lost to Follow-up|1|||
147425979|NCT04873232|531723920|FG001|Overall Study|Lost to Follow-up|4|||
147425980|NCT04873232|531723919|FG000|Overall Study|Withdrawal by Subject|1|||
147425981|NCT04873232|531723920|FG001|Overall Study|Withdrawal by Subject|0|||
147425982|NCT01912456|531725505|FG000|Period 1|Physician Decision|0|||
147425983|NCT01912456|531725506|FG001|Period 1|Physician Decision|0|||
147425984|NCT01912456|531725507|FG002|Period 1|Physician Decision|1|||
147425985|NCT01912456|531725508|FG003|Period 1|Physician Decision|0|||
147425986|NCT01912456|531725505|FG000|Period 1|non-compliance|1|||
147425987|NCT01912456|531725506|FG001|Period 1|non-compliance|0|||
147425988|NCT01912456|531725507|FG002|Period 1|non-compliance|0|||
147425989|NCT01912456|531725508|FG003|Period 1|non-compliance|1|||
147425990|NCT01912456|531725505|FG000|Period 1|Adverse Event|1|||
147425991|NCT01912456|531725506|FG001|Period 1|Adverse Event|0|||
147425992|NCT01912456|531725507|FG002|Period 1|Adverse Event|0|||
147425993|NCT01912456|531725508|FG003|Period 1|Adverse Event|1|||
147425994|NCT01912456|531725505|FG000|Period 1|Withdrawal by Subject|0|||
147425995|NCT01912456|531725506|FG001|Period 1|Withdrawal by Subject|1|||
147425996|NCT01912456|531725507|FG002|Period 1|Withdrawal by Subject|1|||
147425997|NCT01912456|531725508|FG003|Period 1|Withdrawal by Subject|1|||
147425998|NCT01912456|531725505|FG000|Period 2|Lack of Efficacy|0|||
147425999|NCT01912456|531725506|FG001|Period 2|Lack of Efficacy|2|||
147426000|NCT01912456|531725507|FG002|Period 2|Lack of Efficacy|0|||
147426001|NCT01912456|531725508|FG003|Period 2|Lack of Efficacy|0|||
147426002|NCT01912456|531725505|FG000|Period 2|Adverse Event|0|||
147426003|NCT01912456|531725506|FG001|Period 2|Adverse Event|0|||
147426004|NCT01912456|531725507|FG002|Period 2|Adverse Event|0|||
147426005|NCT01912456|531725508|FG003|Period 2|Adverse Event|1|||
147426006|NCT00171704|531725513|FG000|Overall Study|Adverse Event|24|||
147426007|NCT00171704|531725514|FG001|Overall Study|Adverse Event|33|||
147192151|NCT04750824|530872062|FG000|Overall Study|Disease progression (confirmed with scan)|57|||
147192152|NCT04750824|530872063|FG001|Overall Study|Disease progression (confirmed with scan)|11|||
147192153|NCT00807911|530872064|FG000|Overall Study|Withdrawal by Subject|12|||
147192154|NCT00807911|530872065|FG001|Overall Study|Withdrawal by Subject|10|||
147192155|NCT00807911|530872064|FG000|Overall Study|Ineligible|0|||
147192156|NCT00807911|530872065|FG001|Overall Study|Ineligible|4|||
147192157|NCT04349891|530872068|FG000|First Intervention - 4 Weeks|Withdrawal by Subject|3|||
147192158|NCT04349891|530872069|FG001|First Intervention - 4 Weeks|Withdrawal by Subject|4|||
147192159|NCT04349891|530872068|FG000|First Intervention - 4 Weeks|Adverse Event|1|||
147192160|NCT04349891|530872069|FG001|First Intervention - 4 Weeks|Adverse Event|1|||
147192161|NCT04349891|530872068|FG000|Washout - 2 Weeks|Withdrawal by Subject|1|||
147192162|NCT04349891|530872069|FG001|Washout - 2 Weeks|Withdrawal by Subject|0|||
147192163|NCT04349891|530872068|FG000|Second Intervention - 4 Weeks|Withdrawal by Subject|2|||
147192164|NCT04349891|530872069|FG001|Second Intervention - 4 Weeks|Withdrawal by Subject|0|||
147192165|NCT00836589|530872074|FG000|Overall Study|Lost to Follow-up|246|||
147192166|NCT00836589|530872074|FG000|Overall Study|Death|429|||
147192167|NCT00836589|530872074|FG000|Overall Study|Withdrawal by Subject or Physician|591|||
147192168|NCT02914639|530872076|FG000|Overall Study|Withdrawal by Subject|0|||
147192169|NCT02914639|530872077|FG001|Overall Study|Withdrawal by Subject|2|||
147192170|NCT01018030|530872079|FG000|Overall Study|Adverse Event|10|||
147192171|NCT01018030|530872080|FG001|Overall Study|Adverse Event|5|||
147192172|NCT01018030|530872081|FG002|Overall Study|Adverse Event|5|||
147192173|NCT01018030|530872079|FG000|Overall Study|Withdrawal by Subject|2|||
147192174|NCT01018030|530872080|FG001|Overall Study|Withdrawal by Subject|2|||
147192175|NCT01018030|530872081|FG002|Overall Study|Withdrawal by Subject|4|||
147192176|NCT01018030|530872079|FG000|Overall Study|Lost to Follow-up|2|||
147192177|NCT01018030|530872080|FG001|Overall Study|Lost to Follow-up|0|||
147192178|NCT01018030|530872081|FG002|Overall Study|Lost to Follow-up|3|||
147192179|NCT01018030|530872079|FG000|Overall Study|Protocol Violation|2|||
147192180|NCT01018030|530872080|FG001|Overall Study|Protocol Violation|1|||
147192181|NCT01018030|530872081|FG002|Overall Study|Protocol Violation|0|||
147192182|NCT01018030|530872079|FG000|Overall Study|Physician Decision|1|||
147192183|NCT01018030|530872080|FG001|Overall Study|Physician Decision|0|||
147192184|NCT01018030|530872081|FG002|Overall Study|Physician Decision|1|||
147192185|NCT01018030|530872079|FG000|Overall Study|Lack of Efficacy|1|||
147192186|NCT01018030|530872080|FG001|Overall Study|Lack of Efficacy|0|||
147192187|NCT01018030|530872081|FG002|Overall Study|Lack of Efficacy|0|||
147192188|NCT01018030|530872079|FG000|Overall Study|Did Not Receive Study Drug|1|||
147192189|NCT01018030|530872080|FG001|Overall Study|Did Not Receive Study Drug|3|||
147192190|NCT01018030|530872081|FG002|Overall Study|Did Not Receive Study Drug|0|||
147192191|NCT01924845|530872082|FG000|Overall Study|Adverse Event|3|||
147192192|NCT01924845|530872082|FG000|Overall Study|Withdrawal by Subject|2|||
147192193|NCT01924845|530872082|FG000|Overall Study|Protocol Violation|1|||
147192194|NCT00062439|530872083|FG000|Induction Chemotherapy + Radiotherapy|Ineligible|1|||
147192195|NCT00062439|530872083|FG000|Induction Chemotherapy + Radiotherapy|Refused protocol treatment|1|||
147192196|NCT00062439|530872083|FG000|Induction Chemotherapy + Radiotherapy|Adverse Event|3|||
147192197|NCT00062439|530872083|FG000|Induction Chemotherapy + Radiotherapy|Lack of Efficacy|3|||
147192198|NCT00062439|530872083|FG000|Post Chemoradiation Assessment|Death|1|||
147192199|NCT00062439|530872083|FG000|Post Chemoradiation Assessment|Disease progression|2|||
147192200|NCT00062439|530872083|FG000|Post Chemoradiation Assessment|Withdrawal by Subject|1|||
147192201|NCT00062439|530872083|FG000|Post Chemoradiation Assessment|Physician Decision|1|||
147192202|NCT00062439|530872083|FG000|Post Chemoradiation Assessment|Not eligible to continue to surgery|4|||
147192203|NCT00062439|530872083|FG000|Surgery|Physician Decision|4|||
147192204|NCT00062439|530872083|FG000|Surgery|Death|1|||
147192205|NCT00062439|530872083|FG000|Surgery|Adverse Event|2|||
147192206|NCT00062439|530872083|FG000|Consolidation Chemotherapy|Adverse Event|2|||
147192207|NCT04529083|530872084|FG000|Overall Study|Withdrawal by Subject|3|||
147192208|NCT04196686|530872089|FG000|First Treatment (4 Minutes)|Withdrawal by Subject|0|||
147192209|NCT04196686|530872090|FG001|First Treatment (4 Minutes)|Withdrawal by Subject|3|||
147192210|NCT05106959|530872091|FG000|Overall Study|Lost to Follow-up|1|||
147192211|NCT00265564|530872094|FG000|Overall Study|Lost to Follow-up|5|||
147192212|NCT00265564|530872095|FG001|Overall Study|Lost to Follow-up|7|||
147192213|NCT00265564|530872094|FG000|Overall Study|met exclusion criteria|5|||
147426008|NCT00171704|531725513|FG000|Overall Study|Disease Progression|14|||
147192214|NCT00265564|530872095|FG001|Overall Study|met exclusion criteria|2|||
147192215|NCT01553084|530872100|FG000|Overall Study|Withdrawal by Subject|15|||
147192216|NCT01553084|530872101|FG001|Overall Study|Withdrawal by Subject|13|||
147192217|NCT01553084|530872102|FG002|Overall Study|Withdrawal by Subject|35|||
147192218|NCT00659061|530872103|FG000|Overall Study|Migration due to political unrest|21|||
147192219|NCT00659061|530872104|FG001|Overall Study|Migration due to political unrest|15|||
147192220|NCT00475670|530872108|FG000|Overall Study|Death|0|||
147426009|NCT00171704|531725514|FG001|Overall Study|Disease Progression|9|||
147426010|NCT00171704|531725513|FG000|Overall Study|New therapy for 2nd non-breast prim canc|1|||
147426011|NCT00171704|531725514|FG001|Overall Study|New therapy for 2nd non-breast prim canc|0|||
147426012|NCT00171704|531725513|FG000|Overall Study|Administrative Problems|2|||
147426013|NCT00171704|531725514|FG001|Overall Study|Administrative Problems|1|||
147426014|NCT00171704|531725513|FG000|Overall Study|Death|2|||
147426015|NCT00171704|531725514|FG001|Overall Study|Death|2|||
147426016|NCT00171704|531725513|FG000|Overall Study|Withdrawal by Subject|1|||
147426017|NCT00171704|531725514|FG001|Overall Study|Withdrawal by Subject|3|||
147426018|NCT00171704|531725513|FG000|Overall Study|Protocol Violation|0|||
147426019|NCT00171704|531725514|FG001|Overall Study|Protocol Violation|1|||
147426020|NCT03938545|531725517|FG000|Overall Study|Lost to Follow-up|0|||
147426021|NCT03938545|531725518|FG001|Overall Study|Lost to Follow-up|0|||
147426022|NCT03938545|531725519|FG002|Overall Study|Lost to Follow-up|0|||
147426023|NCT03938545|531725520|FG003|Overall Study|Lost to Follow-up|1|||
147426024|NCT03938545|531725517|FG000|Overall Study|Non-compliance with study drug|0|||
147426025|NCT03938545|531725518|FG001|Overall Study|Non-compliance with study drug|0|||
147426026|NCT03938545|531725519|FG002|Overall Study|Non-compliance with study drug|1|||
147426027|NCT03938545|531725520|FG003|Overall Study|Non-compliance with study drug|0|||
147426028|NCT03938545|531725517|FG000|Overall Study|Pregnancy|1|||
147426029|NCT03938545|531725518|FG001|Overall Study|Pregnancy|0|||
147426030|NCT03938545|531725519|FG002|Overall Study|Pregnancy|0|||
147426031|NCT03938545|531725520|FG003|Overall Study|Pregnancy|0|||
147426032|NCT03938545|531725517|FG000|Overall Study|Study terminated by sponsor|6|||
147426033|NCT03938545|531725518|FG001|Overall Study|Study terminated by sponsor|4|||
147426034|NCT03938545|531725519|FG002|Overall Study|Study terminated by sponsor|2|||
147426035|NCT03938545|531725520|FG003|Overall Study|Study terminated by sponsor|4|||
147426036|NCT03938545|531725517|FG000|Overall Study|Withdrawal by Subject|0|||
147426037|NCT03938545|531725518|FG001|Overall Study|Withdrawal by Subject|1|||
147426038|NCT03938545|531725519|FG002|Overall Study|Withdrawal by Subject|0|||
147426039|NCT03938545|531725520|FG003|Overall Study|Withdrawal by Subject|0|||
147426040|NCT03938545|531725517|FG000|Overall Study|Adverse Event|1|||
147426041|NCT03938545|531725518|FG001|Overall Study|Adverse Event|0|||
147426042|NCT03938545|531725519|FG002|Overall Study|Adverse Event|0|||
147426043|NCT03938545|531725520|FG003|Overall Study|Adverse Event|0|||
147426044|NCT01060540|531725521|FG000|Overall Study|Withdrawal by Subject|10|||
147426045|NCT01060540|531725522|FG001|Overall Study|Withdrawal by Subject|20|||
147426046|NCT01060540|531725521|FG000|Overall Study|Lost to Follow-up|52|||
147426047|NCT01060540|531725522|FG001|Overall Study|Lost to Follow-up|43|||
147426048|NCT01060540|531725521|FG000|Overall Study|Death|2|||
147426049|NCT01060540|531725522|FG001|Overall Study|Death|1|||
147426050|NCT01060540|531725521|FG000|Overall Study|Physician Decision|0|||
147426051|NCT01060540|531725522|FG001|Overall Study|Physician Decision|1|||
147426052|NCT01222507|531725526|FG000|Overall Study|Physician Decision|1|||
147426053|NCT01222507|531725526|FG000|Overall Study|Withdrawal by Subject|1|||
147426054|NCT02647320|531725527|FG000|Overall Study|Adverse Event|0|||
147426055|NCT02647320|531725528|FG001|Overall Study|Adverse Event|1|||
147426056|NCT02647320|531725529|FG002|Overall Study|Adverse Event|3|||
147426057|NCT02647320|531725530|FG003|Overall Study|Adverse Event|2|||
147426058|NCT02647320|531725531|FG004|Overall Study|Adverse Event|1|||
147426059|NCT02647320|531725527|FG000|Overall Study|Protocol Violation|0|||
147426060|NCT02647320|531725528|FG001|Overall Study|Protocol Violation|0|||
147426061|NCT02647320|531725529|FG002|Overall Study|Protocol Violation|3|||
147426062|NCT02647320|531725530|FG003|Overall Study|Protocol Violation|0|||
147426063|NCT02647320|531725531|FG004|Overall Study|Protocol Violation|0|||
147426064|NCT02647320|531725527|FG000|Overall Study|Withdrawal by Subject|7|||
147649343|NCT01026818|532537332|FG001|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|1|||
147426065|NCT02647320|531725528|FG001|Overall Study|Withdrawal by Subject|4|||
147426066|NCT02647320|531725529|FG002|Overall Study|Withdrawal by Subject|2|||
147426067|NCT02647320|531725530|FG003|Overall Study|Withdrawal by Subject|2|||
147426068|NCT02647320|531725531|FG004|Overall Study|Withdrawal by Subject|7|||
147426069|NCT02647320|531725527|FG000|Overall Study|Persistent hyperglycemia|0|||
147426070|NCT02647320|531725528|FG001|Overall Study|Persistent hyperglycemia|1|||
147426071|NCT02647320|531725529|FG002|Overall Study|Persistent hyperglycemia|1|||
147426072|NCT02647320|531725530|FG003|Overall Study|Persistent hyperglycemia|1|||
147426073|NCT02647320|531725531|FG004|Overall Study|Persistent hyperglycemia|1|||
147426074|NCT02647320|531725527|FG000|Overall Study|Study terminated by sponsor|1|||
147426075|NCT02647320|531725528|FG001|Overall Study|Study terminated by sponsor|1|||
147426076|NCT02647320|531725529|FG002|Overall Study|Study terminated by sponsor|1|||
147649344|NCT01026818|532537333|FG002|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|0|||
147649345|NCT01026818|532537334|FG003|Drug-Free Washout Period (Month 9-10.5)|Lost to Follow-up|2|||
147649346|NCT01026818|532537331|FG000|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|0|||
147649347|NCT01026818|532537332|FG001|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|1|||
147649348|NCT01026818|532537333|FG002|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|1|||
147649349|NCT01026818|532537334|FG003|Drug-Free Washout Period (Month 9-10.5)|Physician Decision|0|||
147649350|NCT01026818|532537331|FG000|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|0|||
147649351|NCT01026818|532537332|FG001|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|1|||
147426077|NCT02647320|531725530|FG003|Overall Study|Study terminated by sponsor|1|||
147426078|NCT02647320|531725531|FG004|Overall Study|Study terminated by sponsor|2|||
147426079|NCT02647320|531725527|FG000|Overall Study|Reason not provided|0|||
147426080|NCT02647320|531725528|FG001|Overall Study|Reason not provided|0|||
147426081|NCT02647320|531725529|FG002|Overall Study|Reason not provided|1|||
147426082|NCT02647320|531725530|FG003|Overall Study|Reason not provided|0|||
147426083|NCT02647320|531725531|FG004|Overall Study|Reason not provided|2|||
147426084|NCT02647320|531725527|FG000|Overall Study|Lost to Follow-up|1|||
147426085|NCT02647320|531725528|FG001|Overall Study|Lost to Follow-up|1|||
147426086|NCT02647320|531725529|FG002|Overall Study|Lost to Follow-up|0|||
147426087|NCT02647320|531725530|FG003|Overall Study|Lost to Follow-up|0|||
147426088|NCT02647320|531725531|FG004|Overall Study|Lost to Follow-up|0|||
147426089|NCT02647320|531725527|FG000|Overall Study|Develop anemia|1|||
147426090|NCT02647320|531725528|FG001|Overall Study|Develop anemia|0|||
147426091|NCT02647320|531725529|FG002|Overall Study|Develop anemia|0|||
147426092|NCT02647320|531725530|FG003|Overall Study|Develop anemia|0|||
147426093|NCT02647320|531725531|FG004|Overall Study|Develop anemia|0|||
147426094|NCT02647320|531725527|FG000|Overall Study|Lack of Efficacy|0|||
147426095|NCT02647320|531725528|FG001|Overall Study|Lack of Efficacy|0|||
147426096|NCT02647320|531725529|FG002|Overall Study|Lack of Efficacy|0|||
147426097|NCT02647320|531725530|FG003|Overall Study|Lack of Efficacy|1|||
147426098|NCT02647320|531725531|FG004|Overall Study|Lack of Efficacy|0|||
147426099|NCT02647320|531725527|FG000|Overall Study|Disposition Missing Due to Fire at Site|2|||
147426100|NCT02647320|531725528|FG001|Overall Study|Disposition Missing Due to Fire at Site|3|||
147426101|NCT02647320|531725529|FG002|Overall Study|Disposition Missing Due to Fire at Site|4|||
147426102|NCT02647320|531725530|FG003|Overall Study|Disposition Missing Due to Fire at Site|3|||
147426103|NCT02647320|531725531|FG004|Overall Study|Disposition Missing Due to Fire at Site|4|||
147426104|NCT00596427|531725533|FG000|Overall Study|Withdrawal by Subject|2|||
147426105|NCT00596427|531725534|FG001|Overall Study|Withdrawal by Subject|2|||
147426106|NCT00596427|531725533|FG000|Overall Study|Increased Fasting Triacylglycerol level|1|||
147426107|NCT00596427|531725534|FG001|Overall Study|Increased Fasting Triacylglycerol level|0|||
147426108|NCT00596427|531725533|FG000|Overall Study|Protocol Violation|1|||
147426109|NCT00596427|531725534|FG001|Overall Study|Protocol Violation|0|||
147426110|NCT00320541|531725535|FG000|Overall Study|Adverse Event|21|||
147426111|NCT00320541|531725536|FG001|Overall Study|Adverse Event|19|||
147426112|NCT00320541|531725535|FG000|Overall Study|Protocol Violation|0|||
147426113|NCT00320541|531725536|FG001|Overall Study|Protocol Violation|1|||
147426114|NCT00320541|531725535|FG000|Overall Study|Withdrawal by Subject|12|||
147426115|NCT00320541|531725536|FG001|Overall Study|Withdrawal by Subject|16|||
147426116|NCT00320541|531725535|FG000|Overall Study|Physician Decision|9|||
147426117|NCT00320541|531725536|FG001|Overall Study|Physician Decision|13|||
147426118|NCT00320541|531725535|FG000|Overall Study|Other|3|||
147426119|NCT00320541|531725536|FG001|Overall Study|Other|4|||
147426120|NCT00320541|531725535|FG000|Overall Study|Sponsor Decision|2|||
147426121|NCT00320541|531725536|FG001|Overall Study|Sponsor Decision|1|||
147426122|NCT00320541|531725535|FG000|Overall Study|Death due to Study Disease|1|||
147426123|NCT00320541|531725536|FG001|Overall Study|Death due to Study Disease|3|||
147426124|NCT00320541|531725535|FG000|Overall Study|Death due to Adverse Event(s)|1|||
147426125|NCT00320541|531725536|FG001|Overall Study|Death due to Adverse Event(s)|0|||
147426126|NCT00320541|531725535|FG000|Overall Study|Protocol Entry Criterion Not Met|1|||
147426127|NCT00320541|531725536|FG001|Overall Study|Protocol Entry Criterion Not Met|0|||
147426128|NCT02401867|531725539|FG000|Specimen Collection|Didn't receive 1 or more tests|10|||
147426129|NCT02401867|531725539|FG000|Analysis|Cervical assay could not be conducted|9|||
147426130|NCT01650246|531725540|FG000|Overall Study|Adverse Event|23|||
147426131|NCT01650246|531725540|FG000|Overall Study|Protocol Violation|5|||
147426132|NCT01650246|531725540|FG000|Overall Study|Sponsor terminated study|53|||
147426133|NCT01650246|531725540|FG000|Overall Study|Lost to Follow-up|5|||
147426134|NCT01650246|531725540|FG000|Overall Study|Withdrawal by Subject|26|||
147426135|NCT01650246|531725540|FG000|Overall Study|Death|1|||
147426136|NCT01650246|531725540|FG000|Overall Study|Lack of Efficacy|30|||
147426137|NCT00081770|531725541|FG000|Overall Study|Adverse Event|130|||
147426138|NCT00081770|531725542|FG001|Overall Study|Adverse Event|98|||
147192221|NCT00475670|530872109|FG001|Overall Study|Death|1|||
147426139|NCT00081770|531725543|FG002|Overall Study|Adverse Event|136|||
147426140|NCT00081770|531725541|FG000|Overall Study|Lack of Efficacy|262|||
147426141|NCT00081770|531725542|FG001|Overall Study|Lack of Efficacy|357|||
147426142|NCT00081770|531725543|FG002|Overall Study|Lack of Efficacy|211|||
147426143|NCT00081770|531725541|FG000|Overall Study|Lost to Follow-up|45|||
147426144|NCT00081770|531725542|FG001|Overall Study|Lost to Follow-up|34|||
147426145|NCT00081770|531725543|FG002|Overall Study|Lost to Follow-up|45|||
147426146|NCT00081770|531725541|FG000|Overall Study|Protocol Violation|15|||
147426147|NCT00081770|531725542|FG001|Overall Study|Protocol Violation|10|||
147426148|NCT00081770|531725543|FG002|Overall Study|Protocol Violation|10|||
147426149|NCT00081770|531725541|FG000|Overall Study|Withdrawal by Subject|45|||
147426150|NCT00081770|531725542|FG001|Overall Study|Withdrawal by Subject|40|||
147192222|NCT00475670|530872108|FG000|Overall Study|Lack of Efficacy|3|||
147426151|NCT00081770|531725543|FG002|Overall Study|Withdrawal by Subject|42|||
147426152|NCT00081770|531725541|FG000|Overall Study|Did not meet protocol eligibility|2|||
147426153|NCT00081770|531725542|FG001|Overall Study|Did not meet protocol eligibility|0|||
147426154|NCT00081770|531725543|FG002|Overall Study|Did not meet protocol eligibility|3|||
147426155|NCT00081770|531725541|FG000|Overall Study|Administrative|1|||
147426156|NCT00081770|531725542|FG001|Overall Study|Administrative|0|||
147426157|NCT00081770|531725543|FG002|Overall Study|Administrative|1|||
147426158|NCT00081770|531725541|FG000|Overall Study|Other|2|||
147426159|NCT00081770|531725542|FG001|Overall Study|Other|7|||
147426160|NCT00081770|531725543|FG002|Overall Study|Other|8|||
147426161|NCT03435497|531725545|FG000|Overall Study|Lost to Follow-up|1|||
147426162|NCT03435497|531725546|FG001|Overall Study|Lost to Follow-up|0|||
147426163|NCT03435497|531725545|FG000|Overall Study|Death|1|||
147426164|NCT03435497|531725546|FG001|Overall Study|Death|0|||
147426165|NCT03435497|531725545|FG000|Overall Study|Withdrawal by Subject|0|||
147426166|NCT03435497|531725546|FG001|Overall Study|Withdrawal by Subject|4|||
147426167|NCT03435497|531725545|FG000|Overall Study|Wrong survey administered|0|||
147426168|NCT03435497|531725546|FG001|Overall Study|Wrong survey administered|2|||
147426169|NCT02795429|531725556|FG000|Overall Study|Adverse Event|1|||
147426170|NCT02795429|531725557|FG001|Overall Study|Adverse Event|2|||
147426171|NCT02795429|531725558|FG002|Overall Study|Adverse Event|1|||
147426172|NCT02795429|531725559|FG003|Overall Study|Adverse Event|2|||
147426173|NCT02795429|531725560|FG004|Overall Study|Adverse Event|1|||
147426174|NCT02795429|531725556|FG000|Overall Study|Death|1|||
147426175|NCT02795429|531725557|FG001|Overall Study|Death|0|||
147426176|NCT02795429|531725558|FG002|Overall Study|Death|1|||
147426177|NCT02795429|531725559|FG003|Overall Study|Death|2|||
147426178|NCT02795429|531725560|FG004|Overall Study|Death|1|||
147426179|NCT02795429|531725556|FG000|Overall Study|Physician Decision|0|||
147426180|NCT02795429|531725557|FG001|Overall Study|Physician Decision|0|||
147426181|NCT02795429|531725558|FG002|Overall Study|Physician Decision|2|||
147426182|NCT02795429|531725559|FG003|Overall Study|Physician Decision|1|||
147426183|NCT02795429|531725560|FG004|Overall Study|Physician Decision|5|||
147426184|NCT02795429|531725556|FG000|Overall Study|Progressive disease|3|||
147426185|NCT02795429|531725557|FG001|Overall Study|Progressive disease|7|||
147426186|NCT02795429|531725558|FG002|Overall Study|Progressive disease|6|||
147426187|NCT02795429|531725559|FG003|Overall Study|Progressive disease|26|||
147426188|NCT02795429|531725560|FG004|Overall Study|Progressive disease|20|||
147426189|NCT02795429|531725556|FG000|Overall Study|Subject/guardian decision|1|||
147426190|NCT02795429|531725557|FG001|Overall Study|Subject/guardian decision|1|||
147426191|NCT02795429|531725558|FG002|Overall Study|Subject/guardian decision|1|||
147426192|NCT02795429|531725559|FG003|Overall Study|Subject/guardian decision|1|||
147426193|NCT02795429|531725560|FG004|Overall Study|Subject/guardian decision|3|||
147426194|NCT01640054|531725563|FG000|Overall Study|Study-specific disc criteria|1|||
147426195|NCT01640054|531725563|FG000|Overall Study|Lack of Efficacy|3|||
147426196|NCT01640054|531725563|FG000|Overall Study|Adverse Event|2|||
147426197|NCT02080221|531725567|FG000|Overall Study|Withdrawal by Subject|1|||
147426198|NCT02080221|531725567|FG000|Overall Study|Clinical Progression of Disease|1|||
147426199|NCT04218084|531725571|FG000|Overall Study|Adverse Event|7|||
147426200|NCT04218084|531725572|FG001|Overall Study|Adverse Event|2|||
147426201|NCT04218084|531725571|FG000|Overall Study|Withdrawal of Consent|4|||
147426202|NCT04218084|531725572|FG001|Overall Study|Withdrawal of Consent|5|||
147426203|NCT04218084|531725571|FG000|Overall Study|Physician Decision|1|||
147426204|NCT04218084|531725572|FG001|Overall Study|Physician Decision|1|||
147426205|NCT04218084|531725571|FG000|Overall Study|Lost to Follow-up|1|||
147426206|NCT04218084|531725572|FG001|Overall Study|Lost to Follow-up|1|||
147426207|NCT04218084|531725571|FG000|Overall Study|Non-compliance with study drug|1|||
147426208|NCT04218084|531725572|FG001|Overall Study|Non-compliance with study drug|1|||
147426209|NCT04218084|531725571|FG000|Overall Study|Abnormal transcranial doppler (TCD)|19|||
147426210|NCT04218084|531725572|FG001|Overall Study|Abnormal transcranial doppler (TCD)|24|||
147426211|NCT04218084|531725571|FG000|Overall Study|Other|0|||
147426212|NCT04218084|531725572|FG001|Overall Study|Other|1|||
147426213|NCT04218084|531725571|FG000|Overall Study|Ongoing at data cut-off date|62|||
147426214|NCT04218084|531725572|FG001|Overall Study|Ongoing at data cut-off date|58|||
147426215|NCT06469242|531725573|FG000|First Wear Period (Approx 14 Days)|Protocol Violation|4|||
147426216|NCT06469242|531725574|FG001|First Wear Period (Approx 14 Days)|Protocol Violation|3|||
147426217|NCT06469242|531725573|FG000|First Wear Period (Approx 14 Days)|As Per Sponsor Guidance|1|||
147426218|NCT06469242|531725574|FG001|First Wear Period (Approx 14 Days)|As Per Sponsor Guidance|1|||
147426219|NCT03421431|531725575|FG000|Overall Study|Adverse Event|2|||
147426220|NCT03421431|531725576|FG001|Overall Study|Adverse Event|1|||
147426221|NCT03421431|531725577|FG002|Overall Study|Adverse Event|12|||
147426222|NCT03421431|531725575|FG000|Overall Study|Lost to Follow-up|1|||
147426223|NCT03421431|531725576|FG001|Overall Study|Lost to Follow-up|1|||
147426224|NCT03421431|531725577|FG002|Overall Study|Lost to Follow-up|1|||
147426225|NCT03421431|531725575|FG000|Overall Study|Withdrawal by Subject|3|||
147426226|NCT03421431|531725576|FG001|Overall Study|Withdrawal by Subject|2|||
147426227|NCT03421431|531725577|FG002|Overall Study|Withdrawal by Subject|1|||
147426228|NCT03421431|531725575|FG000|Overall Study|Protocol Violation|0|||
147426229|NCT03421431|531725576|FG001|Overall Study|Protocol Violation|1|||
147426230|NCT03421431|531725577|FG002|Overall Study|Protocol Violation|0|||
147426231|NCT03421431|531725575|FG000|Overall Study|Participant met Stopping Rules|0|||
147426232|NCT03421431|531725576|FG001|Overall Study|Participant met Stopping Rules|1|||
147426233|NCT03421431|531725577|FG002|Overall Study|Participant met Stopping Rules|0|||
147426234|NCT03881553|531725578|FG000|Overall Study|Discharged prior to participation|1|||
147426235|NCT03881553|531725579|FG001|Overall Study|Discharged prior to participation|1|||
147426236|NCT03881553|531725580|FG002|Overall Study|Discharged prior to participation|0|||
147426237|NCT03881553|531725578|FG000|Overall Study|Developed infection prior to participation--excluded per protocol criteria|0|||
147426238|NCT03881553|531725579|FG001|Overall Study|Developed infection prior to participation--excluded per protocol criteria|0|||
147426239|NCT03881553|531725580|FG002|Overall Study|Developed infection prior to participation--excluded per protocol criteria|1|||
147426240|NCT01959516|531725581|FG000|Epoch 1|Adverse Event|4|||
147426241|NCT01959516|531725582|FG001|Epoch 1|Adverse Event|1|||
147426242|NCT01959516|531725581|FG000|Epoch 1|unsatisfactory therapeutic effect|1|||
147426243|NCT01959516|531725582|FG001|Epoch 1|unsatisfactory therapeutic effect|0|||
147426244|NCT01959516|531725581|FG000|Epoch 1|Subject withdrew consent|3|||
147426245|NCT01959516|531725582|FG001|Epoch 1|Subject withdrew consent|2|||
147426246|NCT01959516|531725581|FG000|Epoch 1|Administrative problems|1|||
147426247|NCT01959516|531725582|FG001|Epoch 1|Administrative problems|0|||
147426248|NCT01959516|531725581|FG000|Epoch 1|Use of prohibited treatment|1|||
147426249|NCT01959516|531725582|FG001|Epoch 1|Use of prohibited treatment|0|||
147426250|NCT01959516|531725581|FG000|Epoch 1|Moderate or severe COPD exacerbation|0|||
147426251|NCT01959516|531725582|FG001|Epoch 1|Moderate or severe COPD exacerbation|1|||
147426252|NCT01959516|531725581|FG000|Epoch 1|Protocol deviation|0|||
147426253|NCT01959516|531725582|FG001|Epoch 1|Protocol deviation|1|||
147426254|NCT01959516|531725581|FG000|Epoch 2|unsatisfactory therapeutic effect|1|||
147426255|NCT01959516|531725582|FG001|Epoch 2|unsatisfactory therapeutic effect|0|||
147426256|NCT01959516|531725581|FG000|Epoch 2|Subject withdrew consent|1|||
147426257|NCT01959516|531725582|FG001|Epoch 2|Subject withdrew consent|0|||
147426258|NCT01959516|531725581|FG000|Epoch 2|Moderate or severe COPD exacerbation|0|||
147426259|NCT01959516|531725582|FG001|Epoch 2|Moderate or severe COPD exacerbation|1|||
147426260|NCT04620811|531725583|FG000|Overall Study|Withdrawal by Subject|18|||
147426261|NCT04620811|531725584|FG001|Overall Study|Withdrawal by Subject|15|||
147426262|NCT04620811|531725583|FG000|Overall Study|Adverse Event|6|||
147426263|NCT04620811|531725584|FG001|Overall Study|Adverse Event|11|||
147426264|NCT04620811|531725583|FG000|Overall Study|Lost to Follow-up|4|||
147426265|NCT04620811|531725584|FG001|Overall Study|Lost to Follow-up|8|||
147426266|NCT04620811|531725583|FG000|Overall Study|Physician Decision|1|||
147426267|NCT04620811|531725584|FG001|Overall Study|Physician Decision|4|||
147426268|NCT04620811|531725583|FG000|Overall Study|Sponsor Decision|0|||
147426269|NCT04620811|531725584|FG001|Overall Study|Sponsor Decision|1|||
147426270|NCT04620811|531725583|FG000|Overall Study|Elevation of ALT or AST|1|||
147426271|NCT04620811|531725584|FG001|Overall Study|Elevation of ALT or AST|0|||
147426272|NCT04620811|531725583|FG000|Overall Study|Other|3|||
147426273|NCT04620811|531725584|FG001|Overall Study|Other|5|||
147426274|NCT01078675|531725585|FG000|Overall Study|Withdrawal by Subject|7|||
147426275|NCT01078675|531725586|FG001|Overall Study|Withdrawal by Subject|3|||
147426276|NCT01078675|531725585|FG000|Overall Study|Protocol Violation|56|||
147426277|NCT01078675|531725586|FG001|Overall Study|Protocol Violation|0|||
147426278|NCT01078675|531725585|FG000|Overall Study|Provided in CRF for specific reasons|2|||
147426279|NCT01078675|531725586|FG001|Overall Study|Provided in CRF for specific reasons|3|||
147426280|NCT01078675|531725585|FG000|Overall Study|Adverse Event|3|||
147426281|NCT01078675|531725586|FG001|Overall Study|Adverse Event|0|||
147426282|NCT00928746|531725596|FG000|Overall Study|Adverse Event|2|||
147426283|NCT00928746|531725596|FG000|Overall Study|Protocol Violation|1|||
147426284|NCT00928746|531725596|FG000|Overall Study|Withdrawal by Subject|1|||
147426285|NCT00928746|531725596|FG000|Overall Study|Other|2|||
147426286|NCT02745392|531725598|FG000|Overall Study|Lost to Follow-up|0|||
147426287|NCT02745392|531725599|FG001|Overall Study|Lost to Follow-up|1|||
147426288|NCT02745392|531725600|FG002|Overall Study|Lost to Follow-up|0|||
147426289|NCT02745392|531725601|FG003|Overall Study|Lost to Follow-up|0|||
147426290|NCT02004353|531725603|FG000|Overall Study|Voluntary participation|1334|||
147426291|NCT01691768|531725604|FG000|Overall Study|Death|0|||
147426292|NCT01691768|531725605|FG001|Overall Study|Death|2|||
147426293|NCT01691768|531725604|FG000|Overall Study|Lost to Follow-up|4|||
147426294|NCT01691768|531725605|FG001|Overall Study|Lost to Follow-up|3|||
147426295|NCT01691768|531725604|FG000|Overall Study|Withdrawal by Subject|10|||
147426296|NCT01691768|531725605|FG001|Overall Study|Withdrawal by Subject|9|||
147426297|NCT01691768|531725604|FG000|Overall Study|Relocated|0|||
147426298|NCT01691768|531725605|FG001|Overall Study|Relocated|1|||
147426299|NCT01691768|531725604|FG000|Overall Study|Investigator decision|1|||
147426300|NCT01691768|531725605|FG001|Overall Study|Investigator decision|1|||
147426301|NCT01759368|531725615|FG000|Overall Study|Lost to Follow-up|1|||
147426302|NCT01759368|531725616|FG001|Overall Study|Lost to Follow-up|0|||
147426303|NCT01959334|531725617|FG000|Second Dose|Adverse Event|1|||
147426304|NCT01959334|531725618|FG001|Second Dose|Adverse Event|0|||
147426305|NCT01959334|531725617|FG000|Third Dose|Adverse Event|0|||
147426306|NCT01959334|531725618|FG001|Third Dose|Adverse Event|1|||
147426307|NCT01313689|531725619|FG000|24-Week Randomization 1|Adverse Event|10|||
147426308|NCT01313689|531725620|FG001|24-Week Randomization 1|Adverse Event|5|||
147426309|NCT01313689|531725621|FG002|24-Week Randomization 1|Adverse Event|0|||
147426310|NCT01313689|531725622|FG003|24-Week Randomization 1|Adverse Event|0|||
147426311|NCT01313689|531725623|FG004|24-Week Randomization 1|Adverse Event|0|||
147426312|NCT01313689|531725619|FG000|24-Week Randomization 1|Physician Decision|4|||
147426313|NCT01313689|531725620|FG001|24-Week Randomization 1|Physician Decision|5|||
147426314|NCT01313689|531725621|FG002|24-Week Randomization 1|Physician Decision|0|||
147426315|NCT01313689|531725622|FG003|24-Week Randomization 1|Physician Decision|0|||
147426316|NCT01313689|531725623|FG004|24-Week Randomization 1|Physician Decision|0|||
147426317|NCT01313689|531725619|FG000|24-Week Randomization 1|Withdrawal by Subject|5|||
147426318|NCT01313689|531725620|FG001|24-Week Randomization 1|Withdrawal by Subject|0|||
147426319|NCT01313689|531725621|FG002|24-Week Randomization 1|Withdrawal by Subject|0|||
147426320|NCT01313689|531725622|FG003|24-Week Randomization 1|Withdrawal by Subject|0|||
147426321|NCT01313689|531725623|FG004|24-Week Randomization 1|Withdrawal by Subject|0|||
147426322|NCT01313689|531725619|FG000|24-Week Randomization 2|Adverse Event|0|||
147426323|NCT01313689|531725620|FG001|24-Week Randomization 2|Adverse Event|0|||
147426324|NCT01313689|531725621|FG002|24-Week Randomization 2|Adverse Event|2|||
147426325|NCT01313689|531725622|FG003|24-Week Randomization 2|Adverse Event|0|||
147426326|NCT01313689|531725623|FG004|24-Week Randomization 2|Adverse Event|8|||
147426327|NCT01313689|531725619|FG000|24-Week Randomization 2|Withdrawal by Subject|0|||
147426328|NCT01313689|531725620|FG001|24-Week Randomization 2|Withdrawal by Subject|0|||
147426329|NCT01313689|531725621|FG002|24-Week Randomization 2|Withdrawal by Subject|1|||
147426330|NCT01313689|531725622|FG003|24-Week Randomization 2|Withdrawal by Subject|1|||
147426331|NCT01313689|531725623|FG004|24-Week Randomization 2|Withdrawal by Subject|3|||
147426332|NCT01313689|531725619|FG000|24-Week Randomization 2|Physician Decision|0|||
147426333|NCT01313689|531725620|FG001|24-Week Randomization 2|Physician Decision|0|||
147426334|NCT01313689|531725621|FG002|24-Week Randomization 2|Physician Decision|0|||
147426335|NCT01313689|531725622|FG003|24-Week Randomization 2|Physician Decision|0|||
147426336|NCT01313689|531725623|FG004|24-Week Randomization 2|Physician Decision|4|||
147426337|NCT01768637|531725625|FG000|Overall Study|Lost to Follow-up|2|||
147426338|NCT01768637|531725626|FG001|Overall Study|Lost to Follow-up|7|||
147426339|NCT01768637|531725625|FG000|Overall Study|Difficult blood draw|1|||
147426340|NCT01768637|531725626|FG001|Overall Study|Difficult blood draw|0|||
147426341|NCT02481947|531725627|FG000|Overall Study|Withdrawal by Subject|24|||
147426342|NCT02481947|531725628|FG001|Overall Study|Withdrawal by Subject|10|||
147426343|NCT02481947|531725627|FG000|Overall Study|Lost to Follow-up|11|||
147426344|NCT02481947|531725628|FG001|Overall Study|Lost to Follow-up|5|||
147426345|NCT02481947|531725627|FG000|Overall Study|Adverse Event|6|||
147426346|NCT02481947|531725628|FG001|Overall Study|Adverse Event|11|||
147426347|NCT02481947|531725627|FG000|Overall Study|Physician Decision|4|||
147426348|NCT02481947|531725628|FG001|Overall Study|Physician Decision|5|||
147426349|NCT02481947|531725627|FG000|Overall Study|Protocol Violation|1|||
147426350|NCT02481947|531725628|FG001|Overall Study|Protocol Violation|5|||
147426351|NCT01007448|531725629|FG000|Overall Study|Continuing Prohibited Systemic Drugs|1|||
147426352|NCT01007448|531725630|FG001|Overall Study|Continuing Prohibited Systemic Drugs|0|||
147426353|NCT01007448|531725629|FG000|Overall Study|Staph Skin Infection Flare|1|||
147426354|NCT01007448|531725630|FG001|Overall Study|Staph Skin Infection Flare|0|||
147426355|NCT01007448|531725629|FG000|Overall Study|Participant Leaving the Country|1|||
147426356|NCT01007448|531725630|FG001|Overall Study|Participant Leaving the Country|0|||
147426357|NCT01007448|531725629|FG000|Overall Study|Participant Given Prohibited Medication|1|||
147426358|NCT01007448|531725630|FG001|Overall Study|Participant Given Prohibited Medication|0|||
147426359|NCT01007448|531725629|FG000|Overall Study|Progressive Disease|1|||
147426360|NCT01007448|531725630|FG001|Overall Study|Progressive Disease|2|||
147426361|NCT01007448|531725629|FG000|Overall Study|Lack of Efficacy|2|||
147426362|NCT01007448|531725630|FG001|Overall Study|Lack of Efficacy|0|||
147426363|NCT01007448|531725629|FG000|Overall Study|Withdrawal by Subject|2|||
147426364|NCT01007448|531725630|FG001|Overall Study|Withdrawal by Subject|3|||
147426365|NCT01007448|531725629|FG000|Overall Study|Adverse Event|1|||
147426366|NCT01007448|531725630|FG001|Overall Study|Adverse Event|4|||
147426367|NCT00887432|531725631|FG000|Overall Study|Start Excluded Therapy|3|||
147426368|NCT00887432|531725632|FG001|Overall Study|Start Excluded Therapy|0|||
147426369|NCT00887432|531725631|FG000|Overall Study|Did not complete treatment|6|||
147426370|NCT00887432|531725632|FG001|Overall Study|Did not complete treatment|8|||
147426371|NCT00887432|531725631|FG000|Overall Study|Protocol Violation|2|||
147426372|NCT00887432|531725632|FG001|Overall Study|Protocol Violation|3|||
147426373|NCT00887432|531725631|FG000|Overall Study|Withdrawal by Subject|3|||
147426374|NCT00887432|531725632|FG001|Overall Study|Withdrawal by Subject|2|||
147426375|NCT00887432|531725631|FG000|Overall Study|Lost to Follow-up|1|||
147426376|NCT00887432|531725632|FG001|Overall Study|Lost to Follow-up|0|||
147426377|NCT00887432|531725631|FG000|Overall Study|No reason provided|0|||
147426378|NCT00887432|531725632|FG001|Overall Study|No reason provided|1|||
147426379|NCT00899548|531725633|FG000|Overall Study|Physician Decision|3|||
147426380|NCT01337115|531725634|FG000|Overall Study|Protocol Violation|2|||
147426381|NCT01337115|531725635|FG001|Overall Study|Protocol Violation|0|||
147426382|NCT01209780|531725644|FG000|Overall Study|Adverse Event|0|||
147426383|NCT01209780|531725645|FG001|Overall Study|Adverse Event|1|||
147426384|NCT01209780|531725646|FG002|Overall Study|Adverse Event|0|||
147426385|NCT01209780|531725647|FG003|Overall Study|Adverse Event|0|||
147426386|NCT01209780|531725648|FG004|Overall Study|Adverse Event|0|||
147426387|NCT01209780|531725644|FG000|Overall Study|Withdrawal by Subject|9|||
147426388|NCT01209780|531725645|FG001|Overall Study|Withdrawal by Subject|2|||
147426389|NCT01209780|531725646|FG002|Overall Study|Withdrawal by Subject|1|||
147426390|NCT01209780|531725647|FG003|Overall Study|Withdrawal by Subject|1|||
147426391|NCT01209780|531725648|FG004|Overall Study|Withdrawal by Subject|0|||
147426392|NCT01209780|531725644|FG000|Overall Study|Lost to Follow-up|17|||
147426393|NCT01209780|531725645|FG001|Overall Study|Lost to Follow-up|12|||
147426394|NCT01209780|531725646|FG002|Overall Study|Lost to Follow-up|3|||
147426395|NCT01209780|531725647|FG003|Overall Study|Lost to Follow-up|9|||
147426396|NCT01209780|531725648|FG004|Overall Study|Lost to Follow-up|4|||
147426397|NCT01209780|531725644|FG000|Overall Study|Protocol Violation|0|||
147426398|NCT01209780|531725645|FG001|Overall Study|Protocol Violation|1|||
147426399|NCT01209780|531725646|FG002|Overall Study|Protocol Violation|0|||
147426400|NCT01209780|531725647|FG003|Overall Study|Protocol Violation|0|||
147426401|NCT01209780|531725648|FG004|Overall Study|Protocol Violation|0|||
147426402|NCT01209780|531725644|FG000|Overall Study|Inappropriate enrollment|0|||
147426403|NCT01209780|531725645|FG001|Overall Study|Inappropriate enrollment|2|||
147426404|NCT01209780|531725646|FG002|Overall Study|Inappropriate enrollment|0|||
147426405|NCT01209780|531725647|FG003|Overall Study|Inappropriate enrollment|0|||
147426406|NCT01209780|531725648|FG004|Overall Study|Inappropriate enrollment|1|||
147426407|NCT03110185|531725650|FG000|Overall Study|Death|0|||
147426408|NCT03110185|531725651|FG001|Overall Study|Death|1|||
147426409|NCT03110185|531725650|FG000|Overall Study|Withdrawal by Subject|2|||
147426410|NCT03110185|531725651|FG001|Overall Study|Withdrawal by Subject|7|||
147426411|NCT03110185|531725650|FG000|Overall Study|Time Constraints|0|||
147426412|NCT03110185|531725651|FG001|Overall Study|Time Constraints|6|||
147426413|NCT03110185|531725650|FG000|Overall Study|Conflict with care|5|||
147426414|NCT03110185|531725651|FG001|Overall Study|Conflict with care|12|||
147426415|NCT03110185|531725650|FG000|Overall Study|Protocol Violation|1|||
147426416|NCT03110185|531725651|FG001|Overall Study|Protocol Violation|4|||
147426417|NCT03110185|531725650|FG000|Overall Study|MRI Incompatible|2|||
147426418|NCT03110185|531725651|FG001|Overall Study|MRI Incompatible|0|||
147426419|NCT03110185|531725650|FG000|Overall Study|Patient Refusal|0|||
147426420|NCT03110185|531725651|FG001|Overall Study|Patient Refusal|1|||
147426421|NCT02641496|531725652|FG000|Overall Study|Lost to Follow-up|13|||
147426422|NCT02641496|531725653|FG001|Overall Study|Lost to Follow-up|12|||
147426423|NCT02641496|531725652|FG000|Overall Study|Withdrawal by Subject|1|||
147426424|NCT02641496|531725653|FG001|Overall Study|Withdrawal by Subject|0|||
147426425|NCT03075410|531725656|FG000|Part A-Period 2 (14 Days)|Personal reasons|1|||
147426426|NCT03075410|531725657|FG001|Part A-Period 2 (14 Days)|Personal reasons|0|||
147426427|NCT03075410|531725658|FG002|Part A-Period 2 (14 Days)|Personal reasons|1|||
147426428|NCT03075410|531725659|FG003|Part A-Period 2 (14 Days)|Personal reasons|0|||
147426429|NCT03075410|531725660|FG004|Part A-Period 2 (14 Days)|Personal reasons|0|||
147426430|NCT03075410|531725661|FG005|Part A-Period 2 (14 Days)|Personal reasons|0|||
147426431|NCT03075410|531725662|FG006|Part A-Period 2 (14 Days)|Personal reasons|0|||
147426432|NCT03075410|531725663|FG007|Part A-Period 2 (14 Days)|Personal reasons|0|||
147426433|NCT03075410|531725664|FG008|Part A-Period 2 (14 Days)|Personal reasons|0|||
147426434|NCT03075410|531725656|FG000|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|1|||
147426435|NCT03075410|531725657|FG001|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
147426436|NCT03075410|531725658|FG002|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
147426437|NCT03075410|531725659|FG003|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
147426438|NCT03075410|531725660|FG004|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
147426439|NCT03075410|531725661|FG005|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
147426440|NCT03075410|531725662|FG006|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
147426441|NCT03075410|531725663|FG007|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
147426442|NCT03075410|531725664|FG008|Part A-Period 3 (14 Days)|Reaction to ECG tabs causing a rash|0|||
147426443|NCT01427751|531725665|FG000|Overall Study|Adverse Event|18|||
147426444|NCT01427751|531725666|FG001|Overall Study|Adverse Event|2|||
147426445|NCT01427751|531725665|FG000|Overall Study|No further treatment benefit expected|5|||
147426446|NCT01427751|531725666|FG001|Overall Study|No further treatment benefit expected|1|||
147426447|NCT01427751|531725665|FG000|Overall Study|Lost to Follow-up|3|||
147426448|NCT01427751|531725666|FG001|Overall Study|Lost to Follow-up|1|||
147426449|NCT01427751|531725665|FG000|Overall Study|Withdrawal of consent|2|||
147426450|NCT01427751|531725666|FG001|Overall Study|Withdrawal of consent|2|||
147426451|NCT01427751|531725665|FG000|Overall Study|Protocol Violation|6|||
147426452|NCT01427751|531725666|FG001|Overall Study|Protocol Violation|4|||
147426453|NCT01427751|531725665|FG000|Overall Study|Death|2|||
147192223|NCT00475670|530872109|FG001|Overall Study|Lack of Efficacy|34|||
147192224|NCT00475670|530872108|FG000|Overall Study|Refused treatment|0|||
147426454|NCT01427751|531725666|FG001|Overall Study|Death|0|||
147426455|NCT01427751|531725665|FG000|Overall Study|Other miscellaneous reasons|6|||
147426456|NCT01427751|531725666|FG001|Overall Study|Other miscellaneous reasons|4|||
147426457|NCT01028027|531725667|FG000|Overall Study|Lost to Follow-up|4|||
147426458|NCT01028027|531725668|FG001|Overall Study|Lost to Follow-up|1|||
147426459|NCT01028027|531725667|FG000|Overall Study|Withdrawal by Subject|5|||
147426460|NCT01028027|531725668|FG001|Overall Study|Withdrawal by Subject|3|||
147426461|NCT01028027|531725667|FG000|Overall Study|Adverse Event|4|||
147426462|NCT01028027|531725668|FG001|Overall Study|Adverse Event|7|||
147426463|NCT01028027|531725667|FG000|Overall Study|Protocol Violation|3|||
147426464|NCT01028027|531725668|FG001|Overall Study|Protocol Violation|1|||
147426465|NCT01028027|531725667|FG000|Overall Study|Lack of Efficacy|0|||
147426466|NCT01028027|531725668|FG001|Overall Study|Lack of Efficacy|1|||
147426467|NCT05330312|531725670|FG000|Pilot Investigation - Part 1|Withdrawal by Subject|0|||
147426468|NCT05330312|531725671|FG001|Pilot Investigation - Part 1|Withdrawal by Subject|0|||
147426469|NCT05330312|531725672|FG002|Pilot Investigation - Part 1|Withdrawal by Subject|1|||
147426470|NCT05330312|531725670|FG000|Pivotal Investigation - Part 2|Lost to Follow-up|2|||
147426471|NCT05330312|531725671|FG001|Pivotal Investigation - Part 2|Lost to Follow-up|2|||
147426472|NCT05330312|531725672|FG002|Pivotal Investigation - Part 2|Lost to Follow-up|0|||
147426473|NCT05330312|531725670|FG000|Pivotal Investigation - Part 2|Withdrawal by Subject|5|||
147426474|NCT05330312|531725671|FG001|Pivotal Investigation - Part 2|Withdrawal by Subject|2|||
147426475|NCT05330312|531725672|FG002|Pivotal Investigation - Part 2|Withdrawal by Subject|0|||
147426476|NCT05330312|531725670|FG000|Pivotal Investigation - Part 2|Death|1|||
147426477|NCT05330312|531725671|FG001|Pivotal Investigation - Part 2|Death|4|||
147426478|NCT05330312|531725672|FG002|Pivotal Investigation - Part 2|Death|0|||
147426479|NCT02572843|531725673|FG000|Accrual|Brain metastasis retrospectively detected|1|||
147426480|NCT02572843|531725673|FG000|Neoadjuvant chemotherapy|Physician Decision|2|||
147426481|NCT02572843|531725673|FG000|Neoadjuvant chemotherapy|Starting subsequent treatment due progressive disease clinically assessed|1|||
147426482|NCT02572843|531725673|FG000|Neoadjuvant chemotherapy|Withdrawal by Subject|1|||
147426483|NCT02572843|531725673|FG000|Neoadjuvant chemotherapy|Progressive disease|1|||
147426484|NCT02572843|531725673|FG000|Neoadjuvant immunotherapy|Progressive disease|2|||
147426485|NCT02572843|531725673|FG000|Neoadjuvant immunotherapy|Withdrawal by Subject|1|||
147426486|NCT02572843|531725673|FG000|Neoadjuvant immunotherapy|General status and respiratory capacity diminution|1|||
147426487|NCT02572843|531725673|FG000|Surgery|lost to follow up|7|||
147426488|NCT02572843|531725673|FG000|Surgery|Death|1|||
147426489|NCT00001962|531727491|FG000|Overall Study|Lack of Efficacy|18|||
147426490|NCT00001962|531727491|FG000|Overall Study|Lack of Accrual|6|||
147426491|NCT00001962|531727491|FG000|Overall Study|Death|1|||
147426492|NCT00001962|531727491|FG000|Overall Study|Lost to Follow-up|2|||
147426493|NCT00001962|531727491|FG000|Overall Study|Adverse Event|1|||
147426494|NCT04281004|531727494|FG000|Overall Study|Physician Decision|1|||
147426495|NCT04281004|531727495|FG001|Overall Study|Physician Decision|0|||
147426496|NCT00701779|531727496|FG000|Overall Study|Adverse Event|6|||
147426497|NCT00701779|531727496|FG000|Overall Study|Lost to Follow-up|1|||
147426498|NCT00701779|531727496|FG000|Overall Study|Withdrawal by Subject|2|||
147426499|NCT03442985|531727497|FG000|Overall Study|Sponsor Request|55|||
147426500|NCT03442985|531727498|FG001|Overall Study|Sponsor Request|60|||
147426501|NCT03442985|531727499|FG002|Overall Study|Sponsor Request|54|||
147426502|NCT03442985|531727497|FG000|Overall Study|Lost to Follow-up|5|||
147426503|NCT03442985|531727498|FG001|Overall Study|Lost to Follow-up|2|||
147426504|NCT03442985|531727499|FG002|Overall Study|Lost to Follow-up|7|||
147426505|NCT03442985|531727497|FG000|Overall Study|Withdrawal by Subject|2|||
147426506|NCT03442985|531727498|FG001|Overall Study|Withdrawal by Subject|3|||
147426507|NCT03442985|531727499|FG002|Overall Study|Withdrawal by Subject|4|||
147426508|NCT03442985|531727497|FG000|Overall Study|Adverse Event|0|||
147426509|NCT03442985|531727498|FG001|Overall Study|Adverse Event|1|||
147426510|NCT03442985|531727499|FG002|Overall Study|Adverse Event|0|||
147426511|NCT01620255|531727500|FG000|Overall Study|Withdrawal by Subject|4|||
147426512|NCT01620255|531727501|FG001|Overall Study|Withdrawal by Subject|1|||
147426513|NCT01620255|531727502|FG002|Overall Study|Withdrawal by Subject|1|||
147426514|NCT01620255|531727503|FG003|Overall Study|Withdrawal by Subject|2|||
147426515|NCT01620255|531727504|FG004|Overall Study|Withdrawal by Subject|4|||
147426516|NCT01620255|531727500|FG000|Overall Study|Participant underwent fecal transplant|0|||
147426517|NCT01620255|531727501|FG001|Overall Study|Participant underwent fecal transplant|0|||
147426518|NCT01620255|531727502|FG002|Overall Study|Participant underwent fecal transplant|1|||
147426519|NCT01620255|531727503|FG003|Overall Study|Participant underwent fecal transplant|0|||
147426520|NCT01620255|531727504|FG004|Overall Study|Participant underwent fecal transplant|0|||
147426521|NCT01620255|531727500|FG000|Overall Study|Non-compliance|0|||
147426522|NCT01620255|531727501|FG001|Overall Study|Non-compliance|1|||
147426523|NCT01620255|531727502|FG002|Overall Study|Non-compliance|0|||
147426524|NCT01620255|531727503|FG003|Overall Study|Non-compliance|0|||
147426525|NCT01620255|531727504|FG004|Overall Study|Non-compliance|0|||
147426526|NCT01620255|531727500|FG000|Overall Study|Adverse Event|0|||
147426527|NCT01620255|531727501|FG001|Overall Study|Adverse Event|4|||
147426528|NCT01620255|531727502|FG002|Overall Study|Adverse Event|0|||
147426529|NCT01620255|531727503|FG003|Overall Study|Adverse Event|1|||
147426530|NCT01620255|531727504|FG004|Overall Study|Adverse Event|1|||
147426531|NCT01620255|531727500|FG000|Overall Study|Withdrawn at discretion of investigator|0|||
147426532|NCT01620255|531727501|FG001|Overall Study|Withdrawn at discretion of investigator|0|||
147426533|NCT01620255|531727502|FG002|Overall Study|Withdrawn at discretion of investigator|0|||
147426534|NCT01620255|531727503|FG003|Overall Study|Withdrawn at discretion of investigator|0|||
147426535|NCT01620255|531727504|FG004|Overall Study|Withdrawn at discretion of investigator|1|||
147426536|NCT01716117|531727508|FG000|Overall Study|Death|5|||
147426537|NCT01716117|531727509|FG001|Overall Study|Death|2|||
147426538|NCT01716117|531727508|FG000|Overall Study|Withdrawal by Subject|2|||
147426539|NCT01716117|531727509|FG001|Overall Study|Withdrawal by Subject|0|||
147426540|NCT01557283|531727510|FG000|Overall Study|Lost to Follow-up|7|||
147426541|NCT01557283|531727510|FG000|Overall Study|Non-responder|19|||
147426542|NCT01557283|531727510|FG000|Overall Study|Adverse Event|7|||
147426543|NCT01557283|531727510|FG000|Overall Study|Lack of Efficacy|1|||
147426544|NCT01557283|531727510|FG000|Overall Study|Non-compliance|1|||
147426545|NCT01557283|531727510|FG000|Overall Study|Withdrawal by Subject|1|||
147426546|NCT01557283|531727510|FG000|Overall Study|Participant's weight too high for dose|1|||
147426547|NCT01557283|531727510|FG000|Overall Study|Worsening of psoriasis|1|||
147426548|NCT01557283|531727510|FG000|Overall Study|Other|6|||
147426549|NCT03645057|531727511|FG000|Randomization to Baseline|Lost to Follow-up|1|||
147426550|NCT03645057|531727512|FG001|Randomization to Baseline|Lost to Follow-up|0|||
147426551|NCT03645057|531727513|FG002|Randomization to Baseline|Lost to Follow-up|1|||
147426552|NCT03645057|531727514|FG003|Randomization to Baseline|Lost to Follow-up|0|||
147426553|NCT03645057|531727511|FG000|Baseline to Six Weeks|Withdrawal by Subject|1|||
147426554|NCT03645057|531727512|FG001|Baseline to Six Weeks|Withdrawal by Subject|0|||
147426555|NCT03645057|531727513|FG002|Baseline to Six Weeks|Withdrawal by Subject|1|||
147426556|NCT03645057|531727514|FG003|Baseline to Six Weeks|Withdrawal by Subject|0|||
147426557|NCT03645057|531727511|FG000|Baseline to Six Weeks|Lost to Follow-up|5|||
147426558|NCT03645057|531727512|FG001|Baseline to Six Weeks|Lost to Follow-up|2|||
147426559|NCT03645057|531727513|FG002|Baseline to Six Weeks|Lost to Follow-up|5|||
147426560|NCT03645057|531727514|FG003|Baseline to Six Weeks|Lost to Follow-up|2|||
147426561|NCT03645057|531727511|FG000|6 Weeks to 12 Weeks|Lost to Follow-up|0|||
147426562|NCT03645057|531727512|FG001|6 Weeks to 12 Weeks|Lost to Follow-up|1|||
147426563|NCT03645057|531727513|FG002|6 Weeks to 12 Weeks|Lost to Follow-up|0|||
147426564|NCT03645057|531727514|FG003|6 Weeks to 12 Weeks|Lost to Follow-up|1|||
147426565|NCT01873495|531727515|FG000|Overall Study|Withdrawal by Subject|1|||
147426566|NCT01873495|531727515|FG000|Overall Study|Physician Decision|3|||
147426567|NCT01873495|531727515|FG000|Overall Study|Adverse Event|1|||
147426568|NCT01873495|531727515|FG000|Overall Study|Removed for Transplantation|1|||
147426569|NCT01873495|531727515|FG000|Overall Study|AML (Acute Myelogenous Leukemia) Relapse|1|||
147426570|NCT01206777|531727516|FG000|Overall Study|Death|1|||
147426571|NCT01206777|531727516|FG000|Overall Study|Adverse Event|1|||
147426572|NCT00120406|531727521|FG000|Overall Study|Death|9|||
147426573|NCT00120406|531727522|FG001|Overall Study|Death|4|||
147426574|NCT00120406|531727521|FG000|Overall Study|Withdrawal by Subject|5|||
147426575|NCT00120406|531727522|FG001|Overall Study|Withdrawal by Subject|7|||
147426576|NCT00120406|531727521|FG000|Overall Study|Lost to Follow-up|5|||
147426577|NCT00120406|531727522|FG001|Overall Study|Lost to Follow-up|2|||
147426578|NCT00120406|531727521|FG000|Overall Study|received non-study stent|0|||
147426579|NCT00120406|531727522|FG001|Overall Study|received non-study stent|2|||
147426580|NCT00120406|531727521|FG000|Overall Study|patient moved but has not withdrawn|0|||
147426581|NCT00120406|531727522|FG001|Overall Study|patient moved but has not withdrawn|1|||
147426582|NCT01155375|531727523|FG000|Overall Study|Adverse Event|1|||
147426583|NCT01155375|531727524|FG001|Overall Study|Adverse Event|0|||
147426584|NCT00762970|531727525|FG000|Overall Study|Withdrawal by Subject|7|||
147426585|NCT00762970|531727526|FG001|Overall Study|Withdrawal by Subject|4|||
147426586|NCT00762970|531727527|FG002|Overall Study|Withdrawal by Subject|0|||
147426587|NCT00762970|531727525|FG000|Overall Study|Protocol Violation|3|||
147426588|NCT00762970|531727526|FG001|Overall Study|Protocol Violation|1|||
147426589|NCT00762970|531727527|FG002|Overall Study|Protocol Violation|1|||
147426590|NCT00762970|531727525|FG000|Overall Study|Lost to Follow-up|1|||
147426591|NCT00762970|531727526|FG001|Overall Study|Lost to Follow-up|2|||
147426592|NCT00762970|531727527|FG002|Overall Study|Lost to Follow-up|0|||
147426593|NCT00762970|531727525|FG000|Overall Study|Difficulty of handling lens|1|||
147426594|NCT00762970|531727526|FG001|Overall Study|Difficulty of handling lens|2|||
147426595|NCT00762970|531727527|FG002|Overall Study|Difficulty of handling lens|0|||
147426596|NCT00975507|531727528|FG000|Overall Study|Adverse Event|1|||
147426597|NCT00975507|531727529|FG001|Overall Study|Adverse Event|0|||
147426598|NCT00975507|531727528|FG000|Overall Study|Lost to Follow-up|7|||
147426599|NCT00975507|531727529|FG001|Overall Study|Lost to Follow-up|1|||
147426600|NCT00975507|531727528|FG000|Overall Study|Protocol Violation|2|||
147426601|NCT00975507|531727529|FG001|Overall Study|Protocol Violation|0|||
147426602|NCT00975507|531727528|FG000|Overall Study|Withdrawal by Subject|10|||
147426603|NCT00975507|531727529|FG001|Overall Study|Withdrawal by Subject|3|||
147426604|NCT01295034|531727530|FG000|Overall Study|Lost to Follow-up|5|||
147426605|NCT01295034|531727531|FG001|Overall Study|Lost to Follow-up|5|||
147426606|NCT03818204|531727532|FG000|Overall Study|Could not close eye due to impaired facial nerve.|0|||
147426607|NCT03818204|531727533|FG001|Overall Study|Could not close eye due to impaired facial nerve.|0|||
147426608|NCT03818204|531727534|FG002|Overall Study|Could not close eye due to impaired facial nerve.|0|||
147426609|NCT03818204|531727535|FG003|Overall Study|Could not close eye due to impaired facial nerve.|0|||
147426610|NCT03818204|531727536|FG004|Overall Study|Could not close eye due to impaired facial nerve.|1|||
147426611|NCT03818204|531727537|FG005|Overall Study|Could not close eye due to impaired facial nerve.|0|||
147426612|NCT03818204|531727538|FG006|Overall Study|Could not close eye due to impaired facial nerve.|0|||
147426613|NCT03818204|531727539|FG007|Overall Study|Could not close eye due to impaired facial nerve.|0|||
147426614|NCT03818204|531727540|FG008|Overall Study|Could not close eye due to impaired facial nerve.|0|||
147426615|NCT03818204|531727541|FG009|Overall Study|Could not close eye due to impaired facial nerve.|0|||
147426616|NCT03818204|531727542|FG010|Overall Study|Could not close eye due to impaired facial nerve.|0|||
147426617|NCT03818204|531727543|FG011|Overall Study|Could not close eye due to impaired facial nerve.|0|||
147426618|NCT03818204|531727544|FG012|Overall Study|Could not close eye due to impaired facial nerve.|0|||
147426619|NCT03818204|531727545|FG013|Overall Study|Could not close eye due to impaired facial nerve.|1|||
147426620|NCT03818204|531727546|FG014|Overall Study|Could not close eye due to impaired facial nerve.|0|||
147426621|NCT03818204|531727547|FG015|Overall Study|Could not close eye due to impaired facial nerve.|0|||
147426622|NCT03818204|531727548|FG016|Overall Study|Could not close eye due to impaired facial nerve.|0|||
147426623|NCT03818204|531727549|FG017|Overall Study|Could not close eye due to impaired facial nerve.|0|||
147426624|NCT03818204|531727550|FG018|Overall Study|Could not close eye due to impaired facial nerve.|0|||
147426625|NCT03818204|531727532|FG000|Overall Study|Physician Decision|0|||
147426626|NCT03818204|531727533|FG001|Overall Study|Physician Decision|0|||
147426627|NCT03818204|531727534|FG002|Overall Study|Physician Decision|0|||
147426628|NCT03818204|531727535|FG003|Overall Study|Physician Decision|0|||
147426629|NCT03818204|531727536|FG004|Overall Study|Physician Decision|0|||
147426630|NCT03818204|531727537|FG005|Overall Study|Physician Decision|0|||
147426631|NCT03818204|531727538|FG006|Overall Study|Physician Decision|0|||
147426632|NCT03818204|531727539|FG007|Overall Study|Physician Decision|0|||
147426633|NCT03818204|531727540|FG008|Overall Study|Physician Decision|0|||
147426634|NCT03818204|531727541|FG009|Overall Study|Physician Decision|0|||
147426635|NCT03818204|531727542|FG010|Overall Study|Physician Decision|0|||
147426636|NCT03818204|531727543|FG011|Overall Study|Physician Decision|0|||
147192225|NCT00475670|530872109|FG001|Overall Study|Refused treatment|2|||
147192226|NCT00475670|530872108|FG000|Overall Study|Failure to Return|0|||
147192227|NCT00475670|530872109|FG001|Overall Study|Failure to Return|1|||
147192228|NCT00475670|530872108|FG000|Overall Study|Other|0|||
147192229|NCT00475670|530872109|FG001|Overall Study|Other|3|||
147192230|NCT04949191|530872110|FG000|Overall Study|Non-compliance with Study Drug|1|||
147192231|NCT04949191|530872111|FG001|Overall Study|Non-compliance with Study Drug|0|||
147426637|NCT03818204|531727544|FG012|Overall Study|Physician Decision|0|||
147426638|NCT03818204|531727545|FG013|Overall Study|Physician Decision|0|||
147426639|NCT03818204|531727546|FG014|Overall Study|Physician Decision|1|||
147426640|NCT03818204|531727547|FG015|Overall Study|Physician Decision|0|||
147192232|NCT04949191|530872112|FG002|Overall Study|Non-compliance with Study Drug|0|||
147426641|NCT03818204|531727548|FG016|Overall Study|Physician Decision|0|||
147426642|NCT03818204|531727549|FG017|Overall Study|Physician Decision|0|||
147426643|NCT03818204|531727550|FG018|Overall Study|Physician Decision|0|||
147426644|NCT00887250|531727551|FG000|Overall Study|Adverse Event|3|||
147426645|NCT00887250|531727552|FG001|Overall Study|Adverse Event|0|||
147426646|NCT00887250|531727553|FG002|Overall Study|Adverse Event|7|||
147426647|NCT00887250|531727551|FG000|Overall Study|Lack of Efficacy|9|||
147426648|NCT00887250|531727552|FG001|Overall Study|Lack of Efficacy|6|||
147426649|NCT00887250|531727553|FG002|Overall Study|Lack of Efficacy|1|||
147426650|NCT00887250|531727551|FG000|Overall Study|Lost to Follow-up|2|||
147426651|NCT00887250|531727552|FG001|Overall Study|Lost to Follow-up|3|||
147426652|NCT00887250|531727553|FG002|Overall Study|Lost to Follow-up|1|||
147192233|NCT04949191|530872113|FG003|Overall Study|Non-compliance with Study Drug|0|||
147426653|NCT00887250|531727551|FG000|Overall Study|Protocol Violation|2|||
147426654|NCT00887250|531727552|FG001|Overall Study|Protocol Violation|2|||
147426655|NCT00887250|531727553|FG002|Overall Study|Protocol Violation|1|||
147426656|NCT00887250|531727551|FG000|Overall Study|Withdrawal by Subject|2|||
147426657|NCT00887250|531727552|FG001|Overall Study|Withdrawal by Subject|1|||
147426658|NCT00887250|531727553|FG002|Overall Study|Withdrawal by Subject|2|||
147426659|NCT00887250|531727551|FG000|Overall Study|Patient uncooperative|0|||
147426660|NCT00887250|531727552|FG001|Overall Study|Patient uncooperative|0|||
147426661|NCT00887250|531727553|FG002|Overall Study|Patient uncooperative|1|||
147426662|NCT05754333|531727554|FG000|Overall Study|Miscellaneous|3|||
147426663|NCT05754333|531727555|FG001|Overall Study|Miscellaneous|0|||
147426664|NCT05754333|531727556|FG002|Overall Study|Miscellaneous|0|||
147426665|NCT05754333|531727557|FG003|Overall Study|Miscellaneous|0|||
147426666|NCT05754333|531727554|FG000|Overall Study|Lost to Follow-up|2|||
147426667|NCT05754333|531727555|FG001|Overall Study|Lost to Follow-up|1|||
147426668|NCT05754333|531727556|FG002|Overall Study|Lost to Follow-up|0|||
147426669|NCT05754333|531727557|FG003|Overall Study|Lost to Follow-up|1|||
147426670|NCT03864146|531727558|FG000|Overall Study|Lost to Follow-up|14|||
147426671|NCT03864146|531727559|FG001|Overall Study|Lost to Follow-up|23|||
147426672|NCT03864146|531727558|FG000|Overall Study|Withdrawal by Subject|3|||
147426673|NCT03864146|531727559|FG001|Overall Study|Withdrawal by Subject|2|||
147426674|NCT00824161|531727560|FG000|Overall Study|Withdrawal by Subject|1|||
147426675|NCT00824161|531727560|FG000|Overall Study|Screen Failure|1|||
147426676|NCT00879762|531727561|FG000|Overall Study|Lost to Follow-up|3|||
147426677|NCT00879762|531727562|FG001|Overall Study|Lost to Follow-up|1|||
147426678|NCT04981366|531727563|FG000|Overall Study|Withdrawal by Subject|5|||
147426679|NCT04981366|531727564|FG001|Overall Study|Withdrawal by Subject|4|||
147426680|NCT04981366|531727565|FG002|Overall Study|Withdrawal by Subject|8|||
147426681|NCT04981366|531727563|FG000|Overall Study|Health issues unrelated to the trial|1|||
147426682|NCT04981366|531727564|FG001|Overall Study|Health issues unrelated to the trial|2|||
147426683|NCT04981366|531727565|FG002|Overall Study|Health issues unrelated to the trial|0|||
147426684|NCT01112306|531727566|FG000|Overall Study|Death|175|||
147426685|NCT01112306|531727566|FG000|Overall Study|Lost to Follow-up|9|||
147426686|NCT01112306|531727566|FG000|Overall Study|Withdrawal by Subject|31|||
147426687|NCT01112306|531727566|FG000|Overall Study|Other|70|||
147426688|NCT00881608|531727567|FG000|Overall Study|Study prematurely terminated|11|||
147426689|NCT03214094|531727568|FG000|Overall Study|Case Report Forms Uncollected|14|||
147426690|NCT03214094|531727568|FG000|Overall Study|Protocol Deviation|46|||
147426691|NCT01313637|531727571|FG000|Overall Study|Adverse Event|17|||
147426692|NCT01313637|531727572|FG001|Overall Study|Adverse Event|24|||
147426693|NCT01313637|531727573|FG002|Overall Study|Adverse Event|25|||
147426694|NCT01313637|531727574|FG003|Overall Study|Adverse Event|18|||
147426695|NCT01313637|531727571|FG000|Overall Study|Lack of Efficacy|44|||
147426696|NCT01313637|531727572|FG001|Overall Study|Lack of Efficacy|38|||
147426697|NCT01313637|531727573|FG002|Overall Study|Lack of Efficacy|37|||
147426698|NCT01313637|531727574|FG003|Overall Study|Lack of Efficacy|24|||
147426699|NCT01313637|531727571|FG000|Overall Study|Protocol Violation|4|||
147426700|NCT01313637|531727572|FG001|Overall Study|Protocol Violation|3|||
147426701|NCT01313637|531727573|FG002|Overall Study|Protocol Violation|11|||
147426702|NCT01313637|531727574|FG003|Overall Study|Protocol Violation|5|||
147426703|NCT01313637|531727571|FG000|Overall Study|Met Protocol- Defined Stopping Criteria|16|||
147426704|NCT01313637|531727572|FG001|Overall Study|Met Protocol- Defined Stopping Criteria|15|||
147426705|NCT01313637|531727573|FG002|Overall Study|Met Protocol- Defined Stopping Criteria|14|||
147426706|NCT01313637|531727574|FG003|Overall Study|Met Protocol- Defined Stopping Criteria|13|||
147426707|NCT01313637|531727571|FG000|Overall Study|Lost to Follow-up|0|||
147192234|NCT04949191|530872110|FG000|Overall Study|Progressive Disease|0|||
147426708|NCT01313637|531727572|FG001|Overall Study|Lost to Follow-up|2|||
147426709|NCT01313637|531727573|FG002|Overall Study|Lost to Follow-up|1|||
147426710|NCT01313637|531727574|FG003|Overall Study|Lost to Follow-up|3|||
147192235|NCT04949191|530872111|FG001|Overall Study|Progressive Disease|1|||
147426711|NCT01313637|531727571|FG000|Overall Study|Withdrawal by Subject|11|||
147426712|NCT01313637|531727572|FG001|Overall Study|Withdrawal by Subject|13|||
147426713|NCT01313637|531727573|FG002|Overall Study|Withdrawal by Subject|18|||
147426714|NCT01313637|531727574|FG003|Overall Study|Withdrawal by Subject|15|||
147426715|NCT00795951|531727580|FG000|Overall Study|Lost to Follow-up|1|||
147426716|NCT00795951|531727580|FG000|Overall Study|Withdrawal by Subject|1|||
147426717|NCT00211185|531727585|FG000|Overall Study|Death|2|||
147426718|NCT00211185|531727585|FG000|Overall Study|Disease progression|7|||
147426719|NCT00211185|531727585|FG000|Overall Study|Withdrawal by Subject|6|||
147426720|NCT00211185|531727585|FG000|Overall Study|Physician Decision|5|||
147426721|NCT00986674|531727586|FG000|Overall Study|Lack of Efficacy|28|||
147426722|NCT00986674|531727587|FG001|Overall Study|Lack of Efficacy|25|||
147426723|NCT00986674|531727588|FG002|Overall Study|Lack of Efficacy|23|||
147426724|NCT00986674|531727586|FG000|Overall Study|Adverse Event|4|||
147426725|NCT00986674|531727587|FG001|Overall Study|Adverse Event|8|||
147426726|NCT00986674|531727588|FG002|Overall Study|Adverse Event|9|||
147426727|NCT00986674|531727586|FG000|Overall Study|Death|5|||
147426728|NCT00986674|531727587|FG001|Overall Study|Death|0|||
147426729|NCT00986674|531727588|FG002|Overall Study|Death|4|||
147426730|NCT00986674|531727586|FG000|Overall Study|Withdrawal by Subject|6|||
147426731|NCT00986674|531727587|FG001|Overall Study|Withdrawal by Subject|2|||
147426732|NCT00986674|531727588|FG002|Overall Study|Withdrawal by Subject|1|||
147426733|NCT00986674|531727586|FG000|Overall Study|alternative therapy|0|||
147426734|NCT00986674|531727587|FG001|Overall Study|alternative therapy|0|||
147426735|NCT00986674|531727588|FG002|Overall Study|alternative therapy|1|||
147426736|NCT00986674|531727586|FG000|Overall Study|not start protocol therapy|4|||
147426737|NCT00986674|531727587|FG001|Overall Study|not start protocol therapy|3|||
147426738|NCT00986674|531727588|FG002|Overall Study|not start protocol therapy|1|||
147426739|NCT00986674|531727586|FG000|Overall Study|unknown/not specify|0|||
147426740|NCT00986674|531727587|FG001|Overall Study|unknown/not specify|7|||
147426741|NCT00986674|531727588|FG002|Overall Study|unknown/not specify|9|||
147426742|NCT00842985|531727591|FG000|Screening|Did not meet entrance requirements|27|||
147426743|NCT00842985|531727591|FG000|First Intervention|Withdrawal by Subject|3|||
147426744|NCT00842985|531727591|FG000|First Intervention|Protocol Violation|3|||
147426745|NCT00842985|531727591|FG000|Washout Period of GE 4 Days|Withdrawal by Subject|2|||
147426746|NCT00842985|531727591|FG000|Washout Period of GE 4 Days|Withdrawal by Subject|2|||
147426747|NCT01037244|531727592|FG000|Overall Study|Adverse Event|3|||
147426748|NCT01037244|531727593|FG001|Overall Study|Adverse Event|2|||
147426749|NCT01037244|531727594|FG002|Overall Study|Adverse Event|6|||
147426750|NCT01037244|531727595|FG003|Overall Study|Adverse Event|3|||
147426751|NCT01037244|531727592|FG000|Overall Study|Lack of Efficacy|1|||
147426752|NCT01037244|531727593|FG001|Overall Study|Lack of Efficacy|1|||
147426753|NCT01037244|531727594|FG002|Overall Study|Lack of Efficacy|0|||
147426754|NCT01037244|531727595|FG003|Overall Study|Lack of Efficacy|1|||
147426755|NCT01037244|531727592|FG000|Overall Study|Lost to Follow-up|3|||
147426756|NCT01037244|531727593|FG001|Overall Study|Lost to Follow-up|3|||
147426757|NCT01037244|531727594|FG002|Overall Study|Lost to Follow-up|4|||
147426758|NCT01037244|531727595|FG003|Overall Study|Lost to Follow-up|4|||
147426759|NCT01037244|531727592|FG000|Overall Study|Withdrawal by Subject|1|||
147426760|NCT01037244|531727593|FG001|Overall Study|Withdrawal by Subject|5|||
147426761|NCT01037244|531727594|FG002|Overall Study|Withdrawal by Subject|3|||
147426762|NCT01037244|531727595|FG003|Overall Study|Withdrawal by Subject|5|||
147426763|NCT01037244|531727592|FG000|Overall Study|Partner Withdrew Consent|2|||
147426764|NCT01037244|531727593|FG001|Overall Study|Partner Withdrew Consent|1|||
147426765|NCT01037244|531727594|FG002|Overall Study|Partner Withdrew Consent|0|||
147426766|NCT01037244|531727595|FG003|Overall Study|Partner Withdrew Consent|0|||
147426767|NCT01037244|531727592|FG000|Overall Study|Various|3|||
147426768|NCT01037244|531727593|FG001|Overall Study|Various|2|||
147426769|NCT01037244|531727594|FG002|Overall Study|Various|1|||
147426770|NCT01037244|531727595|FG003|Overall Study|Various|1|||
147426771|NCT04507126|531727596|FG000|Overall Study|Withdrawal by Subject|1|||
147426772|NCT04507126|531727596|FG000|Overall Study|Protocol Violation|2|||
147426773|NCT04507126|531727596|FG000|Overall Study|Physician Decision|1|||
147426774|NCT02875977|531727598|FG000|Overall Study|Lost to Follow-up|42|||
147426775|NCT02875977|531727599|FG001|Overall Study|Lost to Follow-up|29|||
147426776|NCT02070588|531727602|FG000|Overall Study|Withdrawal by Subject|29|||
147426777|NCT02070588|531727603|FG001|Overall Study|Withdrawal by Subject|1|||
147426778|NCT02070588|531727604|FG002|Overall Study|Withdrawal by Subject|0|||
147426779|NCT02070588|531727602|FG000|Overall Study|Writhdrawal due to early termination|9|||
147426780|NCT02070588|531727603|FG001|Overall Study|Writhdrawal due to early termination|0|||
147426781|NCT02070588|531727604|FG002|Overall Study|Writhdrawal due to early termination|0|||
147426782|NCT02070588|531727602|FG000|Overall Study|Adverse Event|1|||
147426783|NCT02070588|531727603|FG001|Overall Study|Adverse Event|0|||
147426784|NCT02070588|531727604|FG002|Overall Study|Adverse Event|0|||
147426785|NCT00141726|531727608|FG000|Overall Study|Completed <50% Scheduled Dosing|3|||
147426786|NCT02216357|531727609|FG000|Overall Study|Inclusion or exclusion criteria not met|2|||
147426787|NCT02216357|531727610|FG001|Overall Study|Inclusion or exclusion criteria not met|1|||
147426788|NCT00235326|531727615|FG000|Overall Study|Lost to Follow-up|746|||
147426789|NCT00235326|531727616|FG001|Overall Study|Lost to Follow-up|1400|||
147426790|NCT01178671|531727617|FG000|Overall Study|Adverse Event|4|||
147426791|NCT01178671|531727618|FG001|Overall Study|Adverse Event|6|||
147426792|NCT01178671|531727617|FG000|Overall Study|Protocol Violation|1|||
147426793|NCT01178671|531727618|FG001|Overall Study|Protocol Violation|1|||
147192236|NCT04949191|530872112|FG002|Overall Study|Progressive Disease|0|||
147192237|NCT04949191|530872113|FG003|Overall Study|Progressive Disease|0|||
147192238|NCT04949191|530872110|FG000|Overall Study|Transitioned to Commercial Pemigatinib|0|||
147192239|NCT04949191|530872111|FG001|Overall Study|Transitioned to Commercial Pemigatinib|1|||
147192240|NCT04949191|530872112|FG002|Overall Study|Transitioned to Commercial Pemigatinib|0|||
147192241|NCT04949191|530872113|FG003|Overall Study|Transitioned to Commercial Pemigatinib|0|||
147192242|NCT04949191|530872110|FG000|Overall Study|Sponsor Terminated Study|0|||
147192243|NCT04949191|530872111|FG001|Overall Study|Sponsor Terminated Study|0|||
147192244|NCT04949191|530872112|FG002|Overall Study|Sponsor Terminated Study|1|||
147192245|NCT04949191|530872113|FG003|Overall Study|Sponsor Terminated Study|1|||
147192246|NCT01168349|530872114|FG000|Overall Study|Death|157|||
147192247|NCT01168349|530872114|FG000|Overall Study|Lost to Follow-up|34|||
147192248|NCT01168349|530872114|FG000|Overall Study|Withdrawal by Subject|9|||
147192249|NCT01168349|530872114|FG000|Overall Study|Kidney transplantation|3|||
147192250|NCT01168349|530872114|FG000|Overall Study|Other|22|||
147192251|NCT01168349|530872114|FG000|Overall Study|Protocol Violation|76|||
147192252|NCT02678351|530872115|FG000|Overall Study|Withdrawal by Subject|1|||
147192253|NCT02978417|530872119|FG000|Overall Study|Lost to Follow-up|2|||
147192254|NCT02978417|530872120|FG001|Overall Study|Lost to Follow-up|2|||
147192255|NCT03416868|530872128|FG000|Overall Study|Withdrawal by Subject|2|||
147192256|NCT03416868|530872128|FG000|Overall Study|Lost to Follow-up|1|||
147192257|NCT03353675|530872151|FG000|Overall Study|Adverse Event|4|||
147192258|NCT03309020|530872152|FG000|Overall Study|Death|1|||
147192259|NCT03309020|530872153|FG001|Overall Study|Death|0|||
147192260|NCT03309020|530872152|FG000|Overall Study|Did not undergo surgery|2|||
147192261|NCT03309020|530872153|FG001|Overall Study|Did not undergo surgery|1|||
147192262|NCT00402168|530872154|FG000|Randomized|Lost to Follow-up|1|||
147192263|NCT00402168|530872155|FG001|Randomized|Lost to Follow-up|0|||
147192264|NCT00402168|530872154|FG000|Randomized|Withdrawal by Subject|0|||
147192265|NCT00402168|530872155|FG001|Randomized|Withdrawal by Subject|1|||
147192266|NCT00402168|530872154|FG000|Treatment (up to 12 Months)|Death|0|||
147192267|NCT00402168|530872155|FG001|Treatment (up to 12 Months)|Death|1|||
147192268|NCT00402168|530872154|FG000|Treatment (up to 12 Months)|Lack of Efficacy|2|||
147192269|NCT00402168|530872155|FG001|Treatment (up to 12 Months)|Lack of Efficacy|0|||
147426794|NCT01178671|531727617|FG000|Overall Study|Lack of Efficacy|0|||
147426795|NCT01178671|531727618|FG001|Overall Study|Lack of Efficacy|1|||
147426796|NCT01178671|531727617|FG000|Overall Study|Lost to Follow-up|3|||
147426797|NCT01178671|531727618|FG001|Overall Study|Lost to Follow-up|1|||
147426798|NCT01178671|531727617|FG000|Overall Study|Physician Decision|4|||
147426799|NCT01178671|531727618|FG001|Overall Study|Physician Decision|6|||
147426800|NCT02435966|531727619|FG000|Overall Study|Withdrawal by Subject|0|||
147426801|NCT02435966|531727620|FG001|Overall Study|Withdrawal by Subject|1|||
147426802|NCT02435966|531727621|FG002|Overall Study|Withdrawal by Subject|0|||
147426803|NCT02513303|531727625|FG000|Overall Study|Withdrawal by Subject|9|||
147426804|NCT02513303|531727626|FG001|Overall Study|Withdrawal by Subject|7|||
147426805|NCT02513303|531727627|FG002|Overall Study|Withdrawal by Subject|2|||
147426806|NCT02513303|531727625|FG000|Overall Study|Lost to Follow-up|2|||
147426807|NCT02513303|531727626|FG001|Overall Study|Lost to Follow-up|4|||
147426808|NCT02513303|531727627|FG002|Overall Study|Lost to Follow-up|0|||
147426809|NCT02513303|531727625|FG000|Overall Study|Adverse Event|0|||
147426810|NCT02513303|531727626|FG001|Overall Study|Adverse Event|1|||
147426811|NCT02513303|531727627|FG002|Overall Study|Adverse Event|0|||
147426812|NCT02513303|531727625|FG000|Overall Study|Physician Decision|1|||
147426813|NCT02513303|531727626|FG001|Overall Study|Physician Decision|1|||
147426814|NCT02513303|531727627|FG002|Overall Study|Physician Decision|0|||
147426815|NCT02513303|531727625|FG000|Overall Study|Death|8|||
147426816|NCT02513303|531727626|FG001|Overall Study|Death|4|||
147426817|NCT02513303|531727627|FG002|Overall Study|Death|2|||
147426818|NCT02294227|531727632|FG000|Overall Study|Death|0|||
147426819|NCT02294227|531727633|FG001|Overall Study|Death|0|||
147426820|NCT02294227|531727634|FG002|Overall Study|Death|1|||
147426821|NCT02294227|531727632|FG000|Overall Study|Subject/Guardian Decision|6|||
147426822|NCT02294227|531727633|FG001|Overall Study|Subject/Guardian Decision|3|||
147426823|NCT02294227|531727634|FG002|Overall Study|Subject/Guardian Decision|7|||
147426824|NCT02294227|531727632|FG000|Overall Study|Physician Decision|1|||
147426825|NCT02294227|531727633|FG001|Overall Study|Physician Decision|2|||
147426826|NCT02294227|531727634|FG002|Overall Study|Physician Decision|1|||
147426827|NCT02294227|531727632|FG000|Overall Study|Lost to Follow-up|1|||
147426828|NCT02294227|531727633|FG001|Overall Study|Lost to Follow-up|0|||
147426829|NCT02294227|531727634|FG002|Overall Study|Lost to Follow-up|0|||
147426830|NCT02294227|531727632|FG000|Overall Study|Lack of Efficacy|11|||
147426831|NCT02294227|531727633|FG001|Overall Study|Lack of Efficacy|12|||
147426832|NCT02294227|531727634|FG002|Overall Study|Lack of Efficacy|8|||
147426833|NCT02294227|531727632|FG000|Overall Study|Adverse Event|6|||
147426834|NCT02294227|531727633|FG001|Overall Study|Adverse Event|8|||
147426835|NCT02294227|531727634|FG002|Overall Study|Adverse Event|2|||
147426836|NCT03426267|531727637|FG000|Overall Study|Physician Decision|1|||
147426837|NCT03426267|531727638|FG001|Overall Study|Physician Decision|4|||
147426838|NCT03426267|531727637|FG000|Overall Study|Lost to Follow-up|1|||
147426839|NCT03426267|531727638|FG001|Overall Study|Lost to Follow-up|0|||
147426840|NCT03426267|531727637|FG000|Overall Study|Withdrawal by Subject|4|||
147426841|NCT03426267|531727638|FG001|Overall Study|Withdrawal by Subject|10|||
147426842|NCT03426267|531727637|FG000|Overall Study|Protocol Violation|1|||
147426843|NCT03426267|531727638|FG001|Overall Study|Protocol Violation|3|||
147426844|NCT03426267|531727637|FG000|Overall Study|Adverse Event|9|||
147426845|NCT03426267|531727638|FG001|Overall Study|Adverse Event|27|||
147426846|NCT03426267|531727637|FG000|Overall Study|Prohibited Treatment Intake|2|||
147426847|NCT03426267|531727638|FG001|Overall Study|Prohibited Treatment Intake|3|||
147426848|NCT03426267|531727637|FG000|Overall Study|Lack of Efficacy|0|||
147426849|NCT03426267|531727638|FG001|Overall Study|Lack of Efficacy|25|||
147426850|NCT03426267|531727637|FG000|Overall Study|other|3|||
147426851|NCT03426267|531727638|FG001|Overall Study|other|0|||
147426852|NCT00551460|531727639|FG000|Overall Study|Adverse Event|1|||
147426853|NCT00551460|531727639|FG000|Overall Study|Withdrawal by Subject|1|||
147426854|NCT00551460|531727639|FG000|Overall Study|Physician Decision|1|||
147426855|NCT00551460|531727639|FG000|Overall Study|Death|7|||
147306722|NCT04399356|531290736|FG001|Overall Study|Lost to Follow-up|1|||
147426856|NCT00551460|531727639|FG000|Overall Study|Ineligible|4|||
147426857|NCT00551460|531727639|FG000|Overall Study|Not analyzable (did not start treatment)|4|||
147426858|NCT04781387|531727640|FG000|Overall Study|Withdrawal by Subject|1|||
147426859|NCT04781387|531727641|FG001|Overall Study|Withdrawal by Subject|0|||
147426860|NCT04781387|531727642|FG002|Overall Study|Withdrawal by Subject|1|||
147426861|NCT04781387|531727640|FG000|Overall Study|Lost to Follow-up|1|||
147426862|NCT04781387|531727641|FG001|Overall Study|Lost to Follow-up|0|||
147426863|NCT04781387|531727642|FG002|Overall Study|Lost to Follow-up|0|||
147426864|NCT01636960|531727643|FG000|Induction Phase|Adverse Event|2|||
147426865|NCT01636960|531727643|FG000|Maintenance Phase|Continued drug after regulatory approval|3|||
147426866|NCT01636960|531727643|FG000|Maintenance Phase|Adverse Event|3|||
147426867|NCT01636960|531727643|FG000|Maintenance Phase|Progressive disease|1|||
147426868|NCT01580969|531727645|FG000|Overall Study|Physician Decision|3|||
147426869|NCT01580969|531727646|FG001|Overall Study|Physician Decision|0|||
147426870|NCT01580969|531727647|FG002|Overall Study|Physician Decision|0|||
147532746|NCT01243762|532105985|FG003|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|1|||
147426871|NCT01745848|531727648|FG000|Overall Study|Adverse Event|6|||
147426872|NCT00448123|531727649|FG000|Overall Study|Lost to Follow-up|9|||
147426873|NCT00448123|531727650|FG001|Overall Study|Lost to Follow-up|6|||
147426874|NCT00448123|531727649|FG000|Overall Study|Physician Decision|6|||
147426875|NCT00448123|531727650|FG001|Overall Study|Physician Decision|6|||
147426876|NCT02027623|531727651|FG000|Overall Study|Lost to Follow-up|3|||
147426877|NCT02027623|531727652|FG001|Overall Study|Lost to Follow-up|3|||
147426878|NCT02027623|531727651|FG000|Overall Study|Withdrawal by Subject|6|||
147426879|NCT02027623|531727652|FG001|Overall Study|Withdrawal by Subject|9|||
147426880|NCT01886378|531727655|FG000|Overall Study|Adverse Event|1|||
147426881|NCT01886378|531727655|FG000|Overall Study|Withdrawal by Subject|4|||
147426882|NCT02318797|531727656|FG000|Overall Study|Death|3|||
147426883|NCT02318797|531727657|FG001|Overall Study|Death|6|||
147426884|NCT02318797|531727656|FG000|Overall Study|Lost to Follow-up|85|||
147426885|NCT02318797|531727657|FG001|Overall Study|Lost to Follow-up|96|||
147426886|NCT01079741|531727667|FG000|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0|||
147426887|NCT01079741|531727668|FG001|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|1|||
147426888|NCT01079741|531727669|FG002|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0|||
147426889|NCT01079741|531727670|FG003|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0|||
147426890|NCT01079741|531727671|FG004|Cohort 2: Dose Level 2 (Weeks 13-24)|Disease Progression|0|||
147426891|NCT01079741|531727667|FG000|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0|||
147426892|NCT01079741|531727668|FG001|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0|||
147426893|NCT01079741|531727669|FG002|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0|||
147426894|NCT01079741|531727670|FG003|Phase 2 (Weeks 37-48)|Withdrawal by Subject|0|||
147426895|NCT01079741|531727671|FG004|Phase 2 (Weeks 37-48)|Withdrawal by Subject|3|||
147426896|NCT02709096|531727672|FG000|Overall Study|non-compliance|1|||
147426897|NCT02709096|531727673|FG001|Overall Study|non-compliance|1|||
147426898|NCT00406653|531727674|FG000|Induction Period|Adverse Event|1|||
147426899|NCT00406653|531727675|FG001|Induction Period|Adverse Event|10|||
147426900|NCT00406653|531727676|FG002|Induction Period|Adverse Event|4|||
147426901|NCT00406653|531727677|FG003|Induction Period|Adverse Event|11|||
147426902|NCT00406653|531727678|FG004|Induction Period|Adverse Event|0|||
147426903|NCT00406653|531727679|FG005|Induction Period|Adverse Event|0|||
147426904|NCT00406653|531727680|FG006|Induction Period|Adverse Event|0|||
147426905|NCT00406653|531727674|FG000|Induction Period|Lack of Efficacy|11|||
147426906|NCT00406653|531727675|FG001|Induction Period|Lack of Efficacy|14|||
147426907|NCT00406653|531727676|FG002|Induction Period|Lack of Efficacy|8|||
147426908|NCT00406653|531727677|FG003|Induction Period|Lack of Efficacy|10|||
147426909|NCT00406653|531727678|FG004|Induction Period|Lack of Efficacy|0|||
147426910|NCT00406653|531727679|FG005|Induction Period|Lack of Efficacy|0|||
147426911|NCT00406653|531727680|FG006|Induction Period|Lack of Efficacy|0|||
147426912|NCT00406653|531727674|FG000|Induction Period|Lost to Follow-up|0|||
147426913|NCT00406653|531727675|FG001|Induction Period|Lost to Follow-up|2|||
147426914|NCT00406653|531727676|FG002|Induction Period|Lost to Follow-up|0|||
147426915|NCT00406653|531727677|FG003|Induction Period|Lost to Follow-up|0|||
147426916|NCT00406653|531727678|FG004|Induction Period|Lost to Follow-up|0|||
147426917|NCT00406653|531727679|FG005|Induction Period|Lost to Follow-up|0|||
147426918|NCT00406653|531727680|FG006|Induction Period|Lost to Follow-up|0|||
147426919|NCT00406653|531727674|FG000|Induction Period|Withdrawal of Consent|2|||
147426920|NCT00406653|531727675|FG001|Induction Period|Withdrawal of Consent|5|||
147426921|NCT00406653|531727676|FG002|Induction Period|Withdrawal of Consent|1|||
147426922|NCT00406653|531727677|FG003|Induction Period|Withdrawal of Consent|2|||
147426923|NCT00406653|531727678|FG004|Induction Period|Withdrawal of Consent|0|||
147426924|NCT00406653|531727679|FG005|Induction Period|Withdrawal of Consent|0|||
147426925|NCT00406653|531727680|FG006|Induction Period|Withdrawal of Consent|0|||
147426926|NCT00406653|531727674|FG000|Induction Period|Subject No Longer Meets Study Criteria|0|||
147426927|NCT00406653|531727675|FG001|Induction Period|Subject No Longer Meets Study Criteria|0|||
147426928|NCT00406653|531727676|FG002|Induction Period|Subject No Longer Meets Study Criteria|0|||
147426929|NCT00406653|531727677|FG003|Induction Period|Subject No Longer Meets Study Criteria|2|||
147426930|NCT00406653|531727678|FG004|Induction Period|Subject No Longer Meets Study Criteria|0|||
147426931|NCT00406653|531727679|FG005|Induction Period|Subject No Longer Meets Study Criteria|0|||
147426932|NCT00406653|531727680|FG006|Induction Period|Subject No Longer Meets Study Criteria|0|||
147426933|NCT00406653|531727674|FG000|Induction Period|Pregnancy|1|||
147426934|NCT00406653|531727675|FG001|Induction Period|Pregnancy|0|||
147426935|NCT00406653|531727676|FG002|Induction Period|Pregnancy|0|||
147426936|NCT00406653|531727677|FG003|Induction Period|Pregnancy|0|||
147426937|NCT00406653|531727678|FG004|Induction Period|Pregnancy|0|||
147426938|NCT00406653|531727679|FG005|Induction Period|Pregnancy|0|||
147426939|NCT00406653|531727680|FG006|Induction Period|Pregnancy|0|||
147426940|NCT00406653|531727674|FG000|Induction Period|Declined participation but followup done|0|||
147426941|NCT00406653|531727675|FG001|Induction Period|Declined participation but followup done|2|||
147426942|NCT00406653|531727676|FG002|Induction Period|Declined participation but followup done|1|||
147426943|NCT00406653|531727677|FG003|Induction Period|Declined participation but followup done|1|||
147426944|NCT00406653|531727678|FG004|Induction Period|Declined participation but followup done|0|||
147426945|NCT00406653|531727679|FG005|Induction Period|Declined participation but followup done|0|||
147426946|NCT00406653|531727680|FG006|Induction Period|Declined participation but followup done|0|||
147426947|NCT00406653|531727674|FG000|Induction Period|Given prohibited drug|0|||
147426948|NCT00406653|531727675|FG001|Induction Period|Given prohibited drug|1|||
147426949|NCT00406653|531727676|FG002|Induction Period|Given prohibited drug|2|||
147426950|NCT00406653|531727677|FG003|Induction Period|Given prohibited drug|0|||
147426951|NCT00406653|531727678|FG004|Induction Period|Given prohibited drug|0|||
147426952|NCT00406653|531727679|FG005|Induction Period|Given prohibited drug|0|||
147426953|NCT00406653|531727680|FG006|Induction Period|Given prohibited drug|0|||
147426954|NCT00406653|531727674|FG000|Induction Period|Incarcerated|0|||
147426955|NCT00406653|531727675|FG001|Induction Period|Incarcerated|0|||
147426956|NCT00406653|531727676|FG002|Induction Period|Incarcerated|1|||
147426957|NCT00406653|531727677|FG003|Induction Period|Incarcerated|0|||
147426958|NCT00406653|531727678|FG004|Induction Period|Incarcerated|0|||
147426959|NCT00406653|531727679|FG005|Induction Period|Incarcerated|0|||
147426960|NCT00406653|531727680|FG006|Induction Period|Incarcerated|0|||
147426961|NCT00406653|531727674|FG000|Induction Period|Patient relocated|0|||
147426962|NCT00406653|531727675|FG001|Induction Period|Patient relocated|0|||
147426963|NCT00406653|531727676|FG002|Induction Period|Patient relocated|1|||
147426964|NCT00406653|531727677|FG003|Induction Period|Patient relocated|0|||
147426965|NCT00406653|531727678|FG004|Induction Period|Patient relocated|0|||
147426966|NCT00406653|531727679|FG005|Induction Period|Patient relocated|0|||
147426967|NCT00406653|531727680|FG006|Induction Period|Patient relocated|0|||
147426968|NCT00406653|531727674|FG000|Maintenance Period|Adverse Event|0|||
147426969|NCT00406653|531727675|FG001|Maintenance Period|Adverse Event|0|||
147426970|NCT00406653|531727676|FG002|Maintenance Period|Adverse Event|0|||
147426971|NCT00406653|531727677|FG003|Maintenance Period|Adverse Event|0|||
147426972|NCT00406653|531727678|FG004|Maintenance Period|Adverse Event|1|||
147426973|NCT00406653|531727679|FG005|Maintenance Period|Adverse Event|1|||
147426974|NCT00406653|531727680|FG006|Maintenance Period|Adverse Event|0|||
147426975|NCT00406653|531727674|FG000|Maintenance Period|Lack of Efficacy|0|||
147426976|NCT00406653|531727675|FG001|Maintenance Period|Lack of Efficacy|0|||
147426977|NCT00406653|531727676|FG002|Maintenance Period|Lack of Efficacy|0|||
147426978|NCT00406653|531727677|FG003|Maintenance Period|Lack of Efficacy|0|||
147426979|NCT00406653|531727678|FG004|Maintenance Period|Lack of Efficacy|20|||
147426980|NCT00406653|531727679|FG005|Maintenance Period|Lack of Efficacy|26|||
147426981|NCT00406653|531727680|FG006|Maintenance Period|Lack of Efficacy|0|||
147426982|NCT00406653|531727674|FG000|Maintenance Period|Lost to Follow-up|0|||
147426983|NCT00406653|531727675|FG001|Maintenance Period|Lost to Follow-up|0|||
147426984|NCT00406653|531727676|FG002|Maintenance Period|Lost to Follow-up|0|||
147426985|NCT00406653|531727677|FG003|Maintenance Period|Lost to Follow-up|0|||
147426986|NCT00406653|531727678|FG004|Maintenance Period|Lost to Follow-up|2|||
147426987|NCT00406653|531727679|FG005|Maintenance Period|Lost to Follow-up|1|||
147426988|NCT00406653|531727680|FG006|Maintenance Period|Lost to Follow-up|0|||
147426989|NCT00406653|531727674|FG000|Maintenance Period|Withdrawal of Consent|0|||
147426990|NCT00406653|531727675|FG001|Maintenance Period|Withdrawal of Consent|0|||
147426991|NCT00406653|531727676|FG002|Maintenance Period|Withdrawal of Consent|0|||
147426992|NCT00406653|531727677|FG003|Maintenance Period|Withdrawal of Consent|0|||
147426993|NCT00406653|531727678|FG004|Maintenance Period|Withdrawal of Consent|2|||
147426994|NCT00406653|531727679|FG005|Maintenance Period|Withdrawal of Consent|0|||
147426995|NCT00406653|531727680|FG006|Maintenance Period|Withdrawal of Consent|0|||
147426996|NCT00406653|531727674|FG000|Maintenance Period|Pregnancy|0|||
147426997|NCT00406653|531727675|FG001|Maintenance Period|Pregnancy|0|||
147426998|NCT00406653|531727676|FG002|Maintenance Period|Pregnancy|0|||
147426999|NCT00406653|531727677|FG003|Maintenance Period|Pregnancy|0|||
147427000|NCT00406653|531727678|FG004|Maintenance Period|Pregnancy|0|||
147427001|NCT00406653|531727679|FG005|Maintenance Period|Pregnancy|1|||
147427002|NCT00406653|531727680|FG006|Maintenance Period|Pregnancy|0|||
147427003|NCT00406653|531727674|FG000|Maintenance Period|Administrative Reason By Sponsor|0|||
147427004|NCT00406653|531727675|FG001|Maintenance Period|Administrative Reason By Sponsor|0|||
147427005|NCT00406653|531727676|FG002|Maintenance Period|Administrative Reason By Sponsor|0|||
147427006|NCT00406653|531727677|FG003|Maintenance Period|Administrative Reason By Sponsor|0|||
147427007|NCT00406653|531727678|FG004|Maintenance Period|Administrative Reason By Sponsor|4|||
147427008|NCT00406653|531727679|FG005|Maintenance Period|Administrative Reason By Sponsor|7|||
147427009|NCT00406653|531727680|FG006|Maintenance Period|Administrative Reason By Sponsor|0|||
147427010|NCT00406653|531727674|FG000|Maintenance Period|Error in disease score evaluation|0|||
147427011|NCT00406653|531727675|FG001|Maintenance Period|Error in disease score evaluation|0|||
147427012|NCT00406653|531727676|FG002|Maintenance Period|Error in disease score evaluation|0|||
147427013|NCT00406653|531727677|FG003|Maintenance Period|Error in disease score evaluation|0|||
147427014|NCT00406653|531727678|FG004|Maintenance Period|Error in disease score evaluation|1|||
147427015|NCT00406653|531727679|FG005|Maintenance Period|Error in disease score evaluation|0|||
147427016|NCT00406653|531727680|FG006|Maintenance Period|Error in disease score evaluation|0|||
147427017|NCT00406653|531727674|FG000|Open-Label Period|Death|0|||
147427018|NCT00406653|531727675|FG001|Open-Label Period|Death|0|||
147427019|NCT00406653|531727676|FG002|Open-Label Period|Death|0|||
147427020|NCT00406653|531727677|FG003|Open-Label Period|Death|0|||
147427021|NCT00406653|531727678|FG004|Open-Label Period|Death|0|||
147427022|NCT00406653|531727679|FG005|Open-Label Period|Death|0|||
147427023|NCT00406653|531727680|FG006|Open-Label Period|Death|1|||
147427024|NCT00406653|531727674|FG000|Open-Label Period|Adverse Event|0|||
147427025|NCT00406653|531727675|FG001|Open-Label Period|Adverse Event|0|||
147427026|NCT00406653|531727676|FG002|Open-Label Period|Adverse Event|0|||
147427027|NCT00406653|531727677|FG003|Open-Label Period|Adverse Event|0|||
147427028|NCT00406653|531727678|FG004|Open-Label Period|Adverse Event|0|||
147427029|NCT00406653|531727679|FG005|Open-Label Period|Adverse Event|0|||
147427030|NCT00406653|531727680|FG006|Open-Label Period|Adverse Event|18|||
147427031|NCT00406653|531727674|FG000|Open-Label Period|Lack of Efficacy|0|||
147427032|NCT00406653|531727675|FG001|Open-Label Period|Lack of Efficacy|0|||
147427033|NCT00406653|531727676|FG002|Open-Label Period|Lack of Efficacy|0|||
147427034|NCT00406653|531727677|FG003|Open-Label Period|Lack of Efficacy|0|||
147427035|NCT00406653|531727678|FG004|Open-Label Period|Lack of Efficacy|0|||
147427036|NCT00406653|531727679|FG005|Open-Label Period|Lack of Efficacy|0|||
147427037|NCT00406653|531727680|FG006|Open-Label Period|Lack of Efficacy|160|||
147427038|NCT00406653|531727674|FG000|Open-Label Period|Lost to Follow-up|0|||
147427039|NCT00406653|531727675|FG001|Open-Label Period|Lost to Follow-up|0|||
147427040|NCT00406653|531727676|FG002|Open-Label Period|Lost to Follow-up|0|||
147427041|NCT00406653|531727677|FG003|Open-Label Period|Lost to Follow-up|0|||
147427042|NCT00406653|531727678|FG004|Open-Label Period|Lost to Follow-up|0|||
147427043|NCT00406653|531727679|FG005|Open-Label Period|Lost to Follow-up|0|||
147427044|NCT00406653|531727680|FG006|Open-Label Period|Lost to Follow-up|6|||
147427045|NCT00406653|531727674|FG000|Open-Label Period|Withdrawal of Consent|0|||
147427046|NCT00406653|531727675|FG001|Open-Label Period|Withdrawal of Consent|0|||
147427047|NCT00406653|531727676|FG002|Open-Label Period|Withdrawal of Consent|0|||
147427048|NCT00406653|531727677|FG003|Open-Label Period|Withdrawal of Consent|0|||
147427049|NCT00406653|531727678|FG004|Open-Label Period|Withdrawal of Consent|0|||
147427050|NCT00406653|531727679|FG005|Open-Label Period|Withdrawal of Consent|0|||
147427051|NCT00406653|531727680|FG006|Open-Label Period|Withdrawal of Consent|11|||
147427052|NCT00406653|531727674|FG000|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
147427053|NCT00406653|531727675|FG001|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
147427054|NCT00406653|531727676|FG002|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
147427055|NCT00406653|531727677|FG003|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
147427056|NCT00406653|531727678|FG004|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
147427057|NCT00406653|531727679|FG005|Open-Label Period|Subject No Longer Meets Study Criteria|0|||
147427058|NCT00406653|531727680|FG006|Open-Label Period|Subject No Longer Meets Study Criteria|1|||
147427059|NCT00406653|531727674|FG000|Open-Label Period|Pregnancy|0|||
147427060|NCT00406653|531727675|FG001|Open-Label Period|Pregnancy|0|||
147427061|NCT00406653|531727676|FG002|Open-Label Period|Pregnancy|0|||
147427062|NCT00406653|531727677|FG003|Open-Label Period|Pregnancy|0|||
147427063|NCT00406653|531727678|FG004|Open-Label Period|Pregnancy|0|||
147427064|NCT00406653|531727679|FG005|Open-Label Period|Pregnancy|0|||
147427065|NCT00406653|531727680|FG006|Open-Label Period|Pregnancy|2|||
147427066|NCT00406653|531727674|FG000|Open-Label Period|Administrative Reason By Sponsor|0|||
147427067|NCT00406653|531727675|FG001|Open-Label Period|Administrative Reason By Sponsor|0|||
147427068|NCT00406653|531727676|FG002|Open-Label Period|Administrative Reason By Sponsor|0|||
147427069|NCT00406653|531727677|FG003|Open-Label Period|Administrative Reason By Sponsor|0|||
147427070|NCT00406653|531727678|FG004|Open-Label Period|Administrative Reason By Sponsor|0|||
147427071|NCT00406653|531727679|FG005|Open-Label Period|Administrative Reason By Sponsor|0|||
147427072|NCT00406653|531727680|FG006|Open-Label Period|Administrative Reason By Sponsor|115|||
147427073|NCT00406653|531727674|FG000|Open-Label Period|Declined participation but followup done|0|||
147427074|NCT00406653|531727675|FG001|Open-Label Period|Declined participation but followup done|0|||
147427075|NCT00406653|531727676|FG002|Open-Label Period|Declined participation but followup done|0|||
147427076|NCT00406653|531727677|FG003|Open-Label Period|Declined participation but followup done|0|||
147427077|NCT00406653|531727678|FG004|Open-Label Period|Declined participation but followup done|0|||
147427078|NCT00406653|531727679|FG005|Open-Label Period|Declined participation but followup done|0|||
147427079|NCT00406653|531727680|FG006|Open-Label Period|Declined participation but followup done|8|||
147427080|NCT00406653|531727674|FG000|Open-Label Period|Discontinued by Sponsor|0|||
147427081|NCT00406653|531727675|FG001|Open-Label Period|Discontinued by Sponsor|0|||
147427082|NCT00406653|531727676|FG002|Open-Label Period|Discontinued by Sponsor|0|||
147427083|NCT00406653|531727677|FG003|Open-Label Period|Discontinued by Sponsor|0|||
147427084|NCT00406653|531727678|FG004|Open-Label Period|Discontinued by Sponsor|0|||
147427085|NCT00406653|531727679|FG005|Open-Label Period|Discontinued by Sponsor|0|||
147427086|NCT00406653|531727680|FG006|Open-Label Period|Discontinued by Sponsor|1|||
147427087|NCT00406653|531727674|FG000|Open-Label Period|Refused followup|0|||
147427088|NCT00406653|531727675|FG001|Open-Label Period|Refused followup|0|||
147427089|NCT00406653|531727676|FG002|Open-Label Period|Refused followup|0|||
147427090|NCT00406653|531727677|FG003|Open-Label Period|Refused followup|0|||
147427091|NCT00406653|531727678|FG004|Open-Label Period|Refused followup|0|||
147427092|NCT00406653|531727679|FG005|Open-Label Period|Refused followup|0|||
147427093|NCT00406653|531727680|FG006|Open-Label Period|Refused followup|1|||
147427094|NCT01275131|531727681|FG000|Period 1|Withdrawal by Subject|1|||
147427095|NCT01275131|531727682|FG001|Period 1|Withdrawal by Subject|0|||
147427096|NCT01275131|531727683|FG002|Period 1|Withdrawal by Subject|3|||
147427097|NCT01275131|531727684|FG003|Period 1|Withdrawal by Subject|2|||
147427098|NCT01275131|531727681|FG000|Period 1|Physician Decision|1|||
147427099|NCT01275131|531727682|FG001|Period 1|Physician Decision|0|||
147427100|NCT01275131|531727683|FG002|Period 1|Physician Decision|0|||
147427101|NCT01275131|531727684|FG003|Period 1|Physician Decision|0|||
147427102|NCT01275131|531727681|FG000|Period 2 (Crossover)|Adverse Event|0|||
147427103|NCT01275131|531727682|FG001|Period 2 (Crossover)|Adverse Event|1|||
147427104|NCT01275131|531727683|FG002|Period 2 (Crossover)|Adverse Event|0|||
147427105|NCT01275131|531727684|FG003|Period 2 (Crossover)|Adverse Event|0|||
147427106|NCT01275131|531727681|FG000|Period 2 (Crossover)|Withdrawal by Subject|1|||
147427107|NCT01275131|531727682|FG001|Period 2 (Crossover)|Withdrawal by Subject|0|||
147427108|NCT01275131|531727683|FG002|Period 2 (Crossover)|Withdrawal by Subject|1|||
147427109|NCT01275131|531727684|FG003|Period 2 (Crossover)|Withdrawal by Subject|2|||
147427110|NCT01340196|531729080|FG000|Treat. Period 3 (Faldaprevir)|Adverse Event|2|||
147427111|NCT00604279|531729085|FG000|Overall Study|Lack of Efficacy|22|||
147427112|NCT00604279|531729086|FG001|Overall Study|Lack of Efficacy|9|||
147427113|NCT00604279|531729085|FG000|Overall Study|Lost to Follow-up|9|||
147427114|NCT00604279|531729086|FG001|Overall Study|Lost to Follow-up|14|||
147427115|NCT00604279|531729085|FG000|Overall Study|Pregnancy|2|||
147427116|NCT00604279|531729086|FG001|Overall Study|Pregnancy|0|||
147427117|NCT00604279|531729085|FG000|Overall Study|Protocol Violation|3|||
147427118|NCT00604279|531729086|FG001|Overall Study|Protocol Violation|1|||
147427119|NCT00604279|531729085|FG000|Overall Study|Withdrawal by Subject|16|||
147427120|NCT00604279|531729086|FG001|Overall Study|Withdrawal by Subject|5|||
147427121|NCT00604279|531729085|FG000|Overall Study|Adverse Event|4|||
147427122|NCT00604279|531729086|FG001|Overall Study|Adverse Event|5|||
147427123|NCT00604279|531729085|FG000|Overall Study|Other|8|||
147427124|NCT00604279|531729086|FG001|Overall Study|Other|4|||
147427125|NCT00816400|531729087|FG000|Overall Study|Death|2|||
147427126|NCT00816400|531729088|FG001|Overall Study|Death|3|||
147427127|NCT00816400|531729089|FG002|Overall Study|Death|3|||
147427128|NCT00816400|531729090|FG003|Overall Study|Death|3|||
147427129|NCT00816400|531729091|FG004|Overall Study|Death|2|||
147427130|NCT00816400|531729092|FG005|Overall Study|Death|3|||
147427131|NCT00816400|531729093|FG006|Overall Study|Death|2|||
147427132|NCT00816400|531729094|FG007|Overall Study|Death|5|||
147427133|NCT00816400|531729095|FG008|Overall Study|Death|6|||
147427134|NCT00816400|531729087|FG000|Overall Study|In hospice care at the end of the study|0|||
147427135|NCT00816400|531729088|FG001|Overall Study|In hospice care at the end of the study|0|||
147427136|NCT00816400|531729089|FG002|Overall Study|In hospice care at the end of the study|2|||
147427137|NCT00816400|531729090|FG003|Overall Study|In hospice care at the end of the study|0|||
147427138|NCT00816400|531729091|FG004|Overall Study|In hospice care at the end of the study|0|||
147427139|NCT00816400|531729092|FG005|Overall Study|In hospice care at the end of the study|0|||
147427140|NCT00816400|531729093|FG006|Overall Study|In hospice care at the end of the study|0|||
147427141|NCT00816400|531729094|FG007|Overall Study|In hospice care at the end of the study|0|||
147427142|NCT00816400|531729095|FG008|Overall Study|In hospice care at the end of the study|0|||
147427143|NCT00601419|531729096|FG000|Overall Study|Lost to Follow-up|3|||
147427144|NCT00601419|531729096|FG000|Overall Study|Missed Visits|1|||
147427145|NCT01786174|531729097|FG000|Overall Study|Discontinued Study Drug|2|||
147427146|NCT01786174|531729098|FG001|Overall Study|Discontinued Study Drug|0|||
147427147|NCT01614197|531729099|FG000|Overall Study|Withdrawal by Subject|0|||
147427148|NCT01614197|531729100|FG001|Overall Study|Withdrawal by Subject|1|||
147427149|NCT01614197|531729101|FG002|Overall Study|Withdrawal by Subject|0|||
147427150|NCT01614197|531729102|FG003|Overall Study|Withdrawal by Subject|0|||
147427151|NCT03628898|531729104|FG000|Overall Study|Device deficiency|1|||
147427152|NCT01217957|531729107|FG000|Phase 1|Withdrawal by Patient|1|||
147427153|NCT01217957|531729108|FG001|Phase 1|Withdrawal by Patient|0|||
147427154|NCT01217957|531729109|FG002|Phase 1|Withdrawal by Patient|1|||
147427155|NCT01217957|531729110|FG003|Phase 1|Withdrawal by Patient|1|||
147427156|NCT01217957|531729111|FG004|Phase 1|Withdrawal by Patient|0|||
147427157|NCT01217957|531729107|FG000|Phase 2|Withdrawal by Patient|0|||
147427158|NCT01217957|531729108|FG001|Phase 2|Withdrawal by Patient|0|||
147427159|NCT01217957|531729109|FG002|Phase 2|Withdrawal by Patient|0|||
147427160|NCT01217957|531729110|FG003|Phase 2|Withdrawal by Patient|0|||
147427161|NCT01217957|531729111|FG004|Phase 2|Withdrawal by Patient|1|||
147427162|NCT00971932|531729112|FG000|Overall Study|Withdrawal by Subject|1|||
147427163|NCT00971932|531729112|FG000|Overall Study|Investigator's decision|2|||
147427164|NCT00971932|531729112|FG000|Overall Study|Ongoing|4|||
147427165|NCT00876694|531729117|FG000|Overall Study|Adverse Event|10|||
147427166|NCT00876694|531729118|FG001|Overall Study|Adverse Event|7|||
147427167|NCT00876694|531729117|FG000|Overall Study|Subject withdrew consent|6|||
147427168|NCT00876694|531729118|FG001|Overall Study|Subject withdrew consent|4|||
147427169|NCT00876694|531729117|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
147427170|NCT00876694|531729118|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
147427171|NCT00876694|531729117|FG000|Overall Study|Abnormal test procedure result(s)|1|||
147427172|NCT00876694|531729118|FG001|Overall Study|Abnormal test procedure result(s)|0|||
147427173|NCT00876694|531729117|FG000|Overall Study|Administrative problems|1|||
147427174|NCT00876694|531729118|FG001|Overall Study|Administrative problems|1|||
147427175|NCT00876694|531729117|FG000|Overall Study|Death|1|||
147427176|NCT00876694|531729118|FG001|Overall Study|Death|0|||
147427177|NCT00288509|531729119|FG000|Treatment Cycle 1|Adverse Event|1|||
147427178|NCT00288509|531729119|FG000|Treatment Cycle 1|Lack of Efficacy|1|||
147427179|NCT00288509|531729119|FG000|Treatment Cycle 1|Withdrawal by Subject|1|||
147427180|NCT00288509|531729119|FG000|Treatment Cycle 1|Lost to Follow-up|2|||
147427181|NCT00288509|531729119|FG000|Treatment Cycle 1|Treatment stopped according to protocol|1|||
147427182|NCT00288509|531729119|FG000|Treatment Cycle 2|Lack of Efficacy|1|||
147427183|NCT00288509|531729119|FG000|Treatment Cycle 2|Withdrawal by Subject|2|||
147427184|NCT00288509|531729119|FG000|Treatment Cycle 3|Lack of Efficacy|1|||
147427185|NCT00288509|531729119|FG000|Treatment Cycle 3|Withdrawal by Subject|1|||
147427186|NCT00288509|531729119|FG000|Treatment Cycle 3|Lost to Follow-up|2|||
147427187|NCT00288509|531729119|FG000|Treatment Cycle 3|Treatment stopped according to protocol|1|||
147427188|NCT00288509|531729119|FG000|Treatment Cycle 4|Withdrawal by Subject|3|||
147427189|NCT00288509|531729119|FG000|Treatment Cycle 4|Physician Decision|4|||
147427190|NCT00288509|531729119|FG000|Treatment Cycle 4|Treatment stopped according to protocol|1|||
147427191|NCT02382016|531729120|FG000|Double-blind (DB) Treatment Period|Physician Decision|3|||
147427192|NCT02382016|531729121|FG001|Double-blind (DB) Treatment Period|Physician Decision|0|||
147427193|NCT02382016|531729120|FG000|Double-blind (DB) Treatment Period|Lack of Efficacy|1|||
147427194|NCT02382016|531729121|FG001|Double-blind (DB) Treatment Period|Lack of Efficacy|0|||
147427195|NCT02382016|531729120|FG000|Double-blind (DB) Treatment Period|Withdrawal by Subject|0|||
147427196|NCT02382016|531729121|FG001|Double-blind (DB) Treatment Period|Withdrawal by Subject|1|||
147427197|NCT02382016|531729120|FG000|Open-label (OL) Treatment Period|Physician Decision|3|||
147427198|NCT02382016|531729121|FG001|Open-label (OL) Treatment Period|Physician Decision|0|||
147427199|NCT02382016|531729120|FG000|Open-label (OL) Treatment Period|Withdrawal by Subject|2|||
147427200|NCT02382016|531729121|FG001|Open-label (OL) Treatment Period|Withdrawal by Subject|0|||
147427201|NCT02382016|531729120|FG000|Open-label (OL) Treatment Period|Death|4|||
147427202|NCT02382016|531729121|FG001|Open-label (OL) Treatment Period|Death|0|||
147427203|NCT02382016|531729120|FG000|OL Extension Period|Physician Decision|3|||
147427204|NCT02382016|531729121|FG001|OL Extension Period|Physician Decision|0|||
147427205|NCT02382016|531729120|FG000|OL Extension Period|Death|2|||
147427206|NCT02382016|531729121|FG001|OL Extension Period|Death|0|||
147427207|NCT02382016|531729120|FG000|OL Extension Period|Withdrawal by Subject|1|||
147427208|NCT02382016|531729121|FG001|OL Extension Period|Withdrawal by Subject|0|||
147427209|NCT00084266|531729122|FG000|Overall Study|Death|42|||
147427210|NCT00084266|531729123|FG001|Overall Study|Death|39|||
147427211|NCT00084266|531729122|FG000|Overall Study|Adverse Event|8|||
147427212|NCT00084266|531729123|FG001|Overall Study|Adverse Event|5|||
147427213|NCT00084266|531729122|FG000|Overall Study|Lack of Efficacy|2|||
147427214|NCT00084266|531729123|FG001|Overall Study|Lack of Efficacy|4|||
147427215|NCT00084266|531729122|FG000|Overall Study|Lost to Follow-up|5|||
147427216|NCT00084266|531729123|FG001|Overall Study|Lost to Follow-up|3|||
147427217|NCT00084266|531729122|FG000|Overall Study|Participant not willing to participate|3|||
147427218|NCT00084266|531729123|FG001|Overall Study|Participant not willing to participate|8|||
147427219|NCT00084266|531729122|FG000|Overall Study|Other|360|||
147427220|NCT00084266|531729123|FG001|Overall Study|Other|344|||
147427221|NCT00084266|531729122|FG000|Overall Study|Randomized not treated|21|||
147427222|NCT00084266|531729123|FG001|Overall Study|Randomized not treated|20|||
147427223|NCT01386788|531729132|FG000|Overall Study|Lost to Follow-up|2|||
147427224|NCT05580588|531729133|FG000|Overall Study|Lack of Efficacy|12|||
147427225|NCT00679627|531729134|FG000|Overall Study|Death|41|||
147427226|NCT00679627|531729135|FG001|Overall Study|Death|29|||
147427227|NCT00679627|531729134|FG000|Overall Study|Adverse Event|43|||
147427228|NCT00679627|531729135|FG001|Overall Study|Adverse Event|53|||
147427229|NCT00679627|531729134|FG000|Overall Study|Withdrawal by Subject|168|||
147427230|NCT00679627|531729135|FG001|Overall Study|Withdrawal by Subject|172|||
147427231|NCT00679627|531729134|FG000|Overall Study|Lost to Follow-up|22|||
147427232|NCT00679627|531729135|FG001|Overall Study|Lost to Follow-up|26|||
147427233|NCT00679627|531729134|FG000|Overall Study|Early Study Closure|425|||
147427234|NCT00679627|531729135|FG001|Overall Study|Early Study Closure|405|||
147427235|NCT00511472|531729137|FG000|Overall Study|Clinical Adverse Event|1|||
147427236|NCT00511472|531729138|FG001|Overall Study|Clinical Adverse Event|2|||
147427237|NCT00511472|531729137|FG000|Overall Study|Laboratory Adverse Event|0|||
147427238|NCT00511472|531729138|FG001|Overall Study|Laboratory Adverse Event|2|||
147427239|NCT00511472|531729137|FG000|Overall Study|Not reported|2|||
147427240|NCT00511472|531729138|FG001|Overall Study|Not reported|2|||
147427241|NCT00446992|531729139|FG000|Overall Study|Adverse Event|11|||
147427242|NCT00446992|531729139|FG000|Overall Study|Lost to Follow-up|5|||
147427243|NCT00818649|531729140|FG000|Overall Study|Declining performance status|2|||
147427244|NCT00818649|531729140|FG000|Overall Study|Unrelated hip fracture-unable to proceed|1|||
147427245|NCT00818649|531729140|FG000|Overall Study|Adverse Event|1|||
147427246|NCT00505284|531729141|FG000|Overall Study|Adverse Event|3|||
147427247|NCT00505284|531729142|FG001|Overall Study|Adverse Event|7|||
147427248|NCT00505284|531729143|FG002|Overall Study|Adverse Event|9|||
147427249|NCT00505284|531729144|FG003|Overall Study|Adverse Event|14|||
147427250|NCT00505284|531729145|FG004|Overall Study|Adverse Event|22|||
147427251|NCT00505284|531729141|FG000|Overall Study|Protocol Violation|0|||
147427252|NCT00505284|531729142|FG001|Overall Study|Protocol Violation|1|||
147427253|NCT00505284|531729143|FG002|Overall Study|Protocol Violation|1|||
147427254|NCT00505284|531729144|FG003|Overall Study|Protocol Violation|0|||
147427255|NCT00505284|531729145|FG004|Overall Study|Protocol Violation|0|||
147427256|NCT00505284|531729141|FG000|Overall Study|Withdrawal by Subject|2|||
147427257|NCT00505284|531729142|FG001|Overall Study|Withdrawal by Subject|6|||
147427258|NCT00505284|531729143|FG002|Overall Study|Withdrawal by Subject|1|||
147427259|NCT00505284|531729144|FG003|Overall Study|Withdrawal by Subject|0|||
147427260|NCT00505284|531729145|FG004|Overall Study|Withdrawal by Subject|6|||
147427261|NCT00505284|531729141|FG000|Overall Study|Lack of Efficacy|0|||
147427262|NCT00505284|531729142|FG001|Overall Study|Lack of Efficacy|1|||
147427263|NCT00505284|531729143|FG002|Overall Study|Lack of Efficacy|1|||
147427264|NCT00505284|531729144|FG003|Overall Study|Lack of Efficacy|1|||
147427265|NCT00505284|531729145|FG004|Overall Study|Lack of Efficacy|1|||
147427266|NCT00505284|531729141|FG000|Overall Study|Physician Decision|0|||
147427267|NCT00505284|531729142|FG001|Overall Study|Physician Decision|1|||
147427268|NCT00505284|531729143|FG002|Overall Study|Physician Decision|0|||
147427269|NCT00505284|531729144|FG003|Overall Study|Physician Decision|0|||
147427270|NCT00505284|531729145|FG004|Overall Study|Physician Decision|0|||
147427271|NCT00505284|531729141|FG000|Overall Study|Other|5|||
147427272|NCT00505284|531729142|FG001|Overall Study|Other|0|||
147427273|NCT00505284|531729143|FG002|Overall Study|Other|0|||
147427274|NCT00505284|531729144|FG003|Overall Study|Other|4|||
147427275|NCT00505284|531729145|FG004|Overall Study|Other|4|||
147427276|NCT03513588|531729146|FG000|Overall Study|Lost to Follow-up|0|||
147427277|NCT03513588|531729147|FG001|Overall Study|Lost to Follow-up|1|||
147427278|NCT03513588|531729148|FG002|Overall Study|Lost to Follow-up|1|||
147427279|NCT03513588|531729146|FG000|Overall Study|Study dosing paused by sponsor|1|||
147427280|NCT03513588|531729147|FG001|Overall Study|Study dosing paused by sponsor|1|||
147427281|NCT03513588|531729148|FG002|Overall Study|Study dosing paused by sponsor|0|||
147427282|NCT03513588|531729146|FG000|Overall Study|Death|0|||
147427283|NCT03513588|531729147|FG001|Overall Study|Death|0|||
147427284|NCT03513588|531729148|FG002|Overall Study|Death|1|||
147427285|NCT00940108|531729149|FG000|Overall Study|Adverse Event|2|||
147427286|NCT00940108|531729150|FG001|Overall Study|Adverse Event|4|||
147427287|NCT00940108|531729151|FG002|Overall Study|Adverse Event|0|||
147427288|NCT00940108|531729152|FG003|Overall Study|Adverse Event|2|||
147427289|NCT00940108|531729149|FG000|Overall Study|Withdrew Consent|2|||
147427290|NCT00940108|531729150|FG001|Overall Study|Withdrew Consent|1|||
147427291|NCT00940108|531729151|FG002|Overall Study|Withdrew Consent|0|||
147427292|NCT00940108|531729152|FG003|Overall Study|Withdrew Consent|1|||
147427293|NCT00940108|531729149|FG000|Overall Study|Dose 2 contraindicated|1|||
147427294|NCT00940108|531729150|FG001|Overall Study|Dose 2 contraindicated|1|||
147427295|NCT00940108|531729151|FG002|Overall Study|Dose 2 contraindicated|0|||
147427296|NCT00940108|531729152|FG003|Overall Study|Dose 2 contraindicated|1|||
147427297|NCT00940108|531729149|FG000|Overall Study|Declined further vaccination|0|||
147427298|NCT00940108|531729150|FG001|Overall Study|Declined further vaccination|1|||
147427299|NCT00940108|531729151|FG002|Overall Study|Declined further vaccination|3|||
147427300|NCT00940108|531729152|FG003|Overall Study|Declined further vaccination|0|||
147427301|NCT00940108|531729149|FG000|Overall Study|Refused - pyrexia after Dose 1|0|||
147427302|NCT00940108|531729150|FG001|Overall Study|Refused - pyrexia after Dose 1|1|||
147427303|NCT00940108|531729151|FG002|Overall Study|Refused - pyrexia after Dose 1|0|||
147427304|NCT00940108|531729152|FG003|Overall Study|Refused - pyrexia after Dose 1|0|||
147427305|NCT00940108|531729149|FG000|Overall Study|Viral illness after Dose 1|0|||
147427306|NCT00940108|531729150|FG001|Overall Study|Viral illness after Dose 1|1|||
147427307|NCT00940108|531729151|FG002|Overall Study|Viral illness after Dose 1|0|||
147427308|NCT00940108|531729152|FG003|Overall Study|Viral illness after Dose 1|0|||
147427309|NCT00940108|531729149|FG000|Overall Study|Diagnosed with H1N1|0|||
147427310|NCT00940108|531729150|FG001|Overall Study|Diagnosed with H1N1|0|||
147427311|NCT00940108|531729151|FG002|Overall Study|Diagnosed with H1N1|0|||
147427312|NCT00940108|531729152|FG003|Overall Study|Diagnosed with H1N1|1|||
147427313|NCT01740323|531729156|FG000|Overall Study|Adverse Event|1|||
147427314|NCT01740323|531729157|FG001|Overall Study|Adverse Event|0|||
147427315|NCT01740323|531729156|FG000|Overall Study|Randomized but did not take study drug|1|||
147427316|NCT01740323|531729157|FG001|Overall Study|Randomized but did not take study drug|0|||
147427317|NCT00953745|531729164|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Pregnancy|1|||
147427318|NCT00953745|531729165|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Pregnancy|0|||
147427319|NCT00953745|531729164|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Withdrawal by Subject|2|||
147427320|NCT00953745|531729165|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Withdrawal by Subject|0|||
147427321|NCT00953745|531729164|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Lost to Follow-up|3|||
147427322|NCT00953745|531729165|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Lost to Follow-up|0|||
147427323|NCT00953745|531729164|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Adverse Event|1|||
147427324|NCT00953745|531729165|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Adverse Event|0|||
147427325|NCT00953745|531729164|FG000|Phase 1: 8 Weeks Escitalopram + Placebo|Screen failures|6|||
147427326|NCT00953745|531729165|FG001|Phase 1: 8 Weeks Escitalopram + Placebo|Screen failures|0|||
147427327|NCT00953745|531729164|FG000|Phase 2: 2 Weeks Escitalopram + Placebo|Pregnancy|1|||
147427328|NCT00953745|531729165|FG001|Phase 2: 2 Weeks Escitalopram + Placebo|Pregnancy|0|||
147427329|NCT02427464|531729171|FG000|Overall Study|Adverse Event|6|||
147427330|NCT02427464|531729172|FG001|Overall Study|Adverse Event|1|||
147427331|NCT02427464|531729171|FG000|Overall Study|Lost to Follow-up|16|||
147427332|NCT02427464|531729172|FG001|Overall Study|Lost to Follow-up|5|||
147427333|NCT02427464|531729171|FG000|Overall Study|Physician Decision|2|||
147427334|NCT02427464|531729172|FG001|Overall Study|Physician Decision|0|||
147427335|NCT02427464|531729171|FG000|Overall Study|Withdrawal by Subject|10|||
147427336|NCT02427464|531729172|FG001|Overall Study|Withdrawal by Subject|8|||
147427337|NCT02427464|531729171|FG000|Overall Study|Noncompliance|16|||
147427338|NCT02427464|531729172|FG001|Overall Study|Noncompliance|10|||
147427339|NCT04737187|531729174|FG000|Overall Study|Switched to marketed drug|32|||
147427340|NCT04737187|531729175|FG001|Overall Study|Switched to marketed drug|4|||
147427341|NCT04737187|531729174|FG000|Overall Study|Radiological Progressive Disease|145|||
147427342|NCT04737187|531729175|FG001|Overall Study|Radiological Progressive Disease|146|||
147427343|NCT04737187|531729174|FG000|Overall Study|Clinical Progressive Disease|20|||
147427344|NCT04737187|531729175|FG001|Overall Study|Clinical Progressive Disease|20|||
147427345|NCT04737187|531729174|FG000|Overall Study|Radiological And Clinical Progressive Disease|26|||
147427346|NCT04737187|531729175|FG001|Overall Study|Radiological And Clinical Progressive Disease|52|||
147427347|NCT04737187|531729174|FG000|Overall Study|Adverse Event|16|||
147192270|NCT00402168|530872154|FG000|Treatment (up to 12 Months)|non-specified|0|||
147427348|NCT04737187|531729175|FG001|Overall Study|Adverse Event|16|||
147427349|NCT04737187|531729174|FG000|Overall Study|Physician Decision|2|||
147427350|NCT04737187|531729175|FG001|Overall Study|Physician Decision|0|||
147427351|NCT04737187|531729174|FG000|Overall Study|Withdrawal by Subject|5|||
147427352|NCT04737187|531729175|FG001|Overall Study|Withdrawal by Subject|8|||
147427353|NCT03756129|531729176|FG000|Overall Study|Adverse Event|1|||
147427354|NCT03756129|531729177|FG001|Overall Study|Adverse Event|1|||
147427355|NCT03756129|531729178|FG002|Overall Study|Adverse Event|0|||
147427356|NCT03756129|531729179|FG003|Overall Study|Adverse Event|2|||
147427357|NCT03756129|531729180|FG004|Overall Study|Adverse Event|0|||
147427358|NCT03756129|531729181|FG005|Overall Study|Adverse Event|0|||
147427359|NCT03756129|531729176|FG000|Overall Study|Withdrawal by Subject|2|||
147427360|NCT03756129|531729177|FG001|Overall Study|Withdrawal by Subject|1|||
147427361|NCT03756129|531729178|FG002|Overall Study|Withdrawal by Subject|3|||
147427362|NCT03756129|531729179|FG003|Overall Study|Withdrawal by Subject|1|||
147427363|NCT03756129|531729180|FG004|Overall Study|Withdrawal by Subject|1|||
147427364|NCT03756129|531729181|FG005|Overall Study|Withdrawal by Subject|3|||
147427365|NCT03756129|531729176|FG000|Overall Study|Lost to Follow-up|0|||
147427366|NCT03756129|531729177|FG001|Overall Study|Lost to Follow-up|0|||
147427367|NCT03756129|531729178|FG002|Overall Study|Lost to Follow-up|0|||
147427368|NCT03756129|531729179|FG003|Overall Study|Lost to Follow-up|0|||
147427369|NCT03756129|531729180|FG004|Overall Study|Lost to Follow-up|0|||
147427370|NCT03756129|531729181|FG005|Overall Study|Lost to Follow-up|1|||
147427371|NCT03756129|531729176|FG000|Overall Study|Physician Decision|0|||
147427372|NCT03756129|531729177|FG001|Overall Study|Physician Decision|0|||
147427373|NCT03756129|531729178|FG002|Overall Study|Physician Decision|0|||
147427374|NCT03756129|531729179|FG003|Overall Study|Physician Decision|0|||
147427375|NCT03756129|531729180|FG004|Overall Study|Physician Decision|0|||
147427376|NCT03756129|531729181|FG005|Overall Study|Physician Decision|1|||
147427377|NCT03567434|531729182|FG000|Overall Study|Lost to Follow-up|1|||
147427378|NCT03567434|531729183|FG001|Overall Study|Lost to Follow-up|3|||
147427379|NCT01439360|531729184|FG000|Overall Study|Adverse Event|4|||
147427380|NCT01439360|531729185|FG001|Overall Study|Adverse Event|16|||
147427381|NCT01439360|531729184|FG000|Overall Study|Lost to Follow-up|43|||
147427382|NCT01439360|531729185|FG001|Overall Study|Lost to Follow-up|58|||
147427383|NCT01439360|531729184|FG000|Overall Study|Others|10|||
147427384|NCT01439360|531729185|FG001|Overall Study|Others|5|||
147427385|NCT01439360|531729184|FG000|Overall Study|Protocol Violation|1|||
147427386|NCT01439360|531729185|FG001|Overall Study|Protocol Violation|0|||
147427387|NCT01439360|531729184|FG000|Overall Study|Withdrawal by Subject|140|||
147427388|NCT01439360|531729185|FG001|Overall Study|Withdrawal by Subject|129|||
147427389|NCT00345293|531729186|FG000|Overall Study|Unable to access line for sample|1|||
147427390|NCT00345293|531729187|FG001|Overall Study|Unable to access line for sample|0|||
147427391|NCT00345293|531729186|FG000|Overall Study|Withdrawal by Subject|1|||
147427392|NCT00345293|531729187|FG001|Overall Study|Withdrawal by Subject|0|||
147427393|NCT03319849|531729188|FG000|Overall Study|Adverse Event|1|||
147427394|NCT03319849|531729189|FG001|Overall Study|Adverse Event|0|||
147427395|NCT03319849|531729188|FG000|Overall Study|Physician Decision|0|||
147427396|NCT03319849|531729189|FG001|Overall Study|Physician Decision|1|||
147427397|NCT03319849|531729188|FG000|Overall Study|Withdrawal by Subject|0|||
147427398|NCT03319849|531729189|FG001|Overall Study|Withdrawal by Subject|1|||
147427399|NCT03319849|531729188|FG000|Overall Study|COVID-19|0|||
147427400|NCT03319849|531729189|FG001|Overall Study|COVID-19|1|||
147427401|NCT03319849|531729188|FG000|Overall Study|Other|1|||
147427402|NCT03319849|531729189|FG001|Overall Study|Other|2|||
147427403|NCT03319849|531729188|FG000|Overall Study|Eligible and did not enroll in amendment|1|||
147427404|NCT03319849|531729189|FG001|Overall Study|Eligible and did not enroll in amendment|3|||
147427405|NCT03319849|531729188|FG000|Overall Study|Lost to Follow-up|0|||
147427406|NCT03319849|531729189|FG001|Overall Study|Lost to Follow-up|2|||
147427407|NCT01765192|531730835|FG000|Treatment Period 1|Adverse Event|0|||
147427408|NCT01765192|531730836|FG001|Treatment Period 1|Adverse Event|1|||
147427409|NCT01765192|531730835|FG000|Washout Period|Voluntary Withdrawal|1|||
147427410|NCT01765192|531730836|FG001|Washout Period|Voluntary Withdrawal|1|||
147427411|NCT01765192|531730835|FG000|Washout Period|Reason not specified|1|||
147427412|NCT01765192|531730836|FG001|Washout Period|Reason not specified|0|||
147427413|NCT01765192|531730835|FG000|Treatment Period 2|Reason not specified|0|||
147427414|NCT01765192|531730836|FG001|Treatment Period 2|Reason not specified|2|||
147427415|NCT01765192|531730835|FG000|End of Treatment Period 2 to Final Visit|Adverse Event|0|||
147427416|NCT01765192|531730836|FG001|End of Treatment Period 2 to Final Visit|Adverse Event|1|||
147427417|NCT00730171|531730839|FG000|Overall Study|Didn't Meet Inclusion/Exclusion Criteria|5|||
147427418|NCT00730171|531730839|FG000|Overall Study|Adverse Event|193|||
147427419|NCT00730171|531730839|FG000|Overall Study|Protocol Violation|48|||
147427420|NCT00730171|531730839|FG000|Overall Study|Withdrawal by Subject|202|||
147427421|NCT00730171|531730839|FG000|Overall Study|Lost to Follow-up|121|||
147427422|NCT00730171|531730839|FG000|Overall Study|Insufficient Therapeutic Response|141|||
147427423|NCT00730171|531730839|FG000|Overall Study|Other|61|||
147427424|NCT01729156|531730840|FG000|Overall Study|Withdrawal by Subject|1|||
147427425|NCT01729156|531730841|FG001|Overall Study|Withdrawal by Subject|0|||
147427426|NCT01729156|531730842|FG002|Overall Study|Withdrawal by Subject|0|||
147427427|NCT01215422|531730843|FG000|Overall Study|Relocation|1|||
147427428|NCT01215422|531730844|FG001|Overall Study|Relocation|0|||
147427429|NCT01215422|531730845|FG002|Overall Study|Relocation|0|||
147427430|NCT01215422|531730846|FG003|Overall Study|Relocation|0|||
147427431|NCT01215422|531730843|FG000|Overall Study|Failed intubations|0|||
147427432|NCT01215422|531730844|FG001|Overall Study|Failed intubations|0|||
147427433|NCT01215422|531730845|FG002|Overall Study|Failed intubations|3|||
147427434|NCT01215422|531730846|FG003|Overall Study|Failed intubations|8|||
147427435|NCT01215422|531730843|FG000|Overall Study|Did not complete all intubations|7|||
147427436|NCT01215422|531730844|FG001|Overall Study|Did not complete all intubations|0|||
147427437|NCT01215422|531730845|FG002|Overall Study|Did not complete all intubations|0|||
147427438|NCT01215422|531730846|FG003|Overall Study|Did not complete all intubations|0|||
147427439|NCT04335812|531730847|FG000|Overall Study|Withdrawal by Subject|1|||
147427440|NCT04335812|531730848|FG001|Overall Study|Withdrawal by Subject|3|||
147427441|NCT04335812|531730847|FG000|Overall Study|Lost to Follow-up|12|||
147427442|NCT04335812|531730848|FG001|Overall Study|Lost to Follow-up|12|||
147427443|NCT04335812|531730847|FG000|Overall Study|Did not engage in the intervention|22|||
147427444|NCT04335812|531730848|FG001|Overall Study|Did not engage in the intervention|18|||
147427445|NCT02901041|531730854|FG000|Overall Study|Withdrawal by PI|4|||
147427446|NCT02901041|531730855|FG001|Overall Study|Withdrawal by PI|8|||
147427447|NCT02901041|531730854|FG000|Overall Study|Withdrawal by Subject|7|||
147427448|NCT02901041|531730855|FG001|Overall Study|Withdrawal by Subject|3|||
147427449|NCT01480674|531730856|FG000|Overall Study|Death|23|||
147427450|NCT01480674|531730856|FG000|Overall Study|Lost to Follow-up|2|||
147427451|NCT01480674|531730856|FG000|Overall Study|visit not done|10|||
147427452|NCT00655863|531730864|FG000|Overall Study|Lost to Follow-up|0|||
147427453|NCT00655863|531730865|FG001|Overall Study|Lost to Follow-up|0|||
147427454|NCT00655863|531730866|FG002|Overall Study|Lost to Follow-up|1|||
147427455|NCT00712673|531730869|FG000|Overall Study|Adverse Event|3|||
147427456|NCT00712673|531730870|FG001|Overall Study|Adverse Event|3|||
147427457|NCT00712673|531730871|FG002|Overall Study|Adverse Event|21|||
147427458|NCT00712673|531730872|FG003|Overall Study|Adverse Event|26|||
147427459|NCT00712673|531730869|FG000|Overall Study|Lack of Efficacy|2|||
147427460|NCT00712673|531730870|FG001|Overall Study|Lack of Efficacy|8|||
147427461|NCT00712673|531730871|FG002|Overall Study|Lack of Efficacy|8|||
147427462|NCT00712673|531730872|FG003|Overall Study|Lack of Efficacy|6|||
147427463|NCT00712673|531730869|FG000|Overall Study|Poor Compliance to Protocol|3|||
147427464|NCT00712673|531730870|FG001|Overall Study|Poor Compliance to Protocol|3|||
147427465|NCT00712673|531730871|FG002|Overall Study|Poor Compliance to Protocol|4|||
147427466|NCT00712673|531730872|FG003|Overall Study|Poor Compliance to Protocol|16|||
147427467|NCT00712673|531730869|FG000|Overall Study|Lost to Follow-up|1|||
147427468|NCT00712673|531730870|FG001|Overall Study|Lost to Follow-up|0|||
147427469|NCT00712673|531730871|FG002|Overall Study|Lost to Follow-up|2|||
147427470|NCT00712673|531730872|FG003|Overall Study|Lost to Follow-up|0|||
147427471|NCT00712673|531730869|FG000|Overall Study|Withdrawal by Subject|6|||
147427472|NCT00712673|531730870|FG001|Overall Study|Withdrawal by Subject|7|||
147427473|NCT00712673|531730871|FG002|Overall Study|Withdrawal by Subject|15|||
147427474|NCT00712673|531730872|FG003|Overall Study|Withdrawal by Subject|20|||
147427475|NCT00712673|531730869|FG000|Overall Study|Familial and Personal Reasons|5|||
147427476|NCT00712673|531730870|FG001|Overall Study|Familial and Personal Reasons|0|||
147427477|NCT00712673|531730871|FG002|Overall Study|Familial and Personal Reasons|5|||
147427478|NCT00712673|531730872|FG003|Overall Study|Familial and Personal Reasons|2|||
147427479|NCT00712673|531730869|FG000|Overall Study|Investigator's Decision|1|||
147427480|NCT00712673|531730870|FG001|Overall Study|Investigator's Decision|0|||
147427481|NCT00712673|531730871|FG002|Overall Study|Investigator's Decision|0|||
147427482|NCT00712673|531730872|FG003|Overall Study|Investigator's Decision|0|||
147427483|NCT00712673|531730869|FG000|Overall Study|Protocol Violation|0|||
147427484|NCT00712673|531730870|FG001|Overall Study|Protocol Violation|0|||
147427485|NCT00712673|531730871|FG002|Overall Study|Protocol Violation|2|||
147427486|NCT00712673|531730872|FG003|Overall Study|Protocol Violation|0|||
147427487|NCT03603028|531730873|FG000|Overall Study|Withdrawal by Subject|1|||
147427488|NCT02963610|531730874|FG000|Overall Study|Study terminated prematurely due to funding/support being withdrawn by grantor. No analyses occurred|3|||
147427489|NCT00063154|531730875|FG000|Overall Study|Disease progression|27|||
147427490|NCT00063154|531730875|FG000|Overall Study|Adverse Event|2|||
147427491|NCT00063154|531730875|FG000|Overall Study|Physician Decision|10|||
147427492|NCT00063154|531730875|FG000|Overall Study|Death|3|||
147427493|NCT00063154|531730875|FG000|Overall Study|Reason unspecified|1|||
147427494|NCT00063154|531730875|FG000|Overall Study|Did not receive treatment|8|||
147427495|NCT01122862|531730876|FG000|Period 1|Protocol Violation|0|||
147427496|NCT01122862|531730877|FG001|Period 1|Protocol Violation|1|||
147427497|NCT01122862|531730878|FG002|Period 1|Protocol Violation|0|||
147427498|NCT01122862|531730876|FG000|Period 2|Adverse Event|0|||
147427499|NCT01122862|531730877|FG001|Period 2|Adverse Event|0|||
147427500|NCT01122862|531730878|FG002|Period 2|Adverse Event|1|||
147427501|NCT00846391|531730880|FG000|Overall Study|Physician Decision|0|||
147427502|NCT00846391|531730881|FG001|Overall Study|Physician Decision|0|||
147427503|NCT00846391|531730882|FG002|Overall Study|Physician Decision|1|||
147427504|NCT00846391|531730880|FG000|Overall Study|Study Terminated by Sponsor|1|||
147427505|NCT00846391|531730881|FG001|Overall Study|Study Terminated by Sponsor|2|||
147427506|NCT00846391|531730882|FG002|Overall Study|Study Terminated by Sponsor|2|||
147427507|NCT02924064|531730883|FG000|Overall Study|Adverse Event|2|||
147427508|NCT02924064|531730884|FG001|Overall Study|Adverse Event|2|||
147427509|NCT02924064|531730883|FG000|Overall Study|Lost to Follow-up|0|||
147427510|NCT02924064|531730884|FG001|Overall Study|Lost to Follow-up|2|||
147427511|NCT02924064|531730883|FG000|Overall Study|Physician Decision|0|||
147427512|NCT02924064|531730884|FG001|Overall Study|Physician Decision|2|||
147427513|NCT02924064|531730883|FG000|Overall Study|Protocol Violation|1|||
147427514|NCT02924064|531730884|FG001|Overall Study|Protocol Violation|3|||
147427515|NCT02924064|531730883|FG000|Overall Study|Withdrawal by Subject|4|||
147427516|NCT02924064|531730884|FG001|Overall Study|Withdrawal by Subject|5|||
147427517|NCT02924064|531730883|FG000|Overall Study|Other|17|||
147427518|NCT02924064|531730884|FG001|Overall Study|Other|29|||
147427519|NCT02699983|531730885|FG000|Overall Study|Withdrawal by Subject|1|||
147427520|NCT02699983|531730886|FG001|Overall Study|Withdrawal by Subject|0|||
147427521|NCT03575143|531730887|FG000|Overall Study|Lost to Follow-up|0|||
147427522|NCT03575143|531730888|FG001|Overall Study|Lost to Follow-up|0|||
147427523|NCT03575143|531730889|FG002|Overall Study|Lost to Follow-up|4|||
147427524|NCT03575143|531730887|FG000|Overall Study|Withdrawal by Subject|0|||
147427525|NCT03575143|531730888|FG001|Overall Study|Withdrawal by Subject|0|||
147427526|NCT03575143|531730889|FG002|Overall Study|Withdrawal by Subject|5|||
147427527|NCT03575143|531730887|FG000|Overall Study|new information provide after consent, no longer met inclusion criteria|0|||
147427528|NCT03575143|531730888|FG001|Overall Study|new information provide after consent, no longer met inclusion criteria|0|||
147427529|NCT03575143|531730889|FG002|Overall Study|new information provide after consent, no longer met inclusion criteria|2|||
147427530|NCT01790126|531730897|FG000|Overall Study|PSA Progression|12|||
147427531|NCT01790126|531730898|FG001|Overall Study|PSA Progression|16|||
147427532|NCT01790126|531730899|FG002|Overall Study|PSA Progression|16|||
147427533|NCT01790126|531730897|FG000|Overall Study|Other|5|||
147427534|NCT01790126|531730898|FG001|Overall Study|Other|4|||
147427535|NCT01790126|531730899|FG002|Overall Study|Other|8|||
147427536|NCT01790126|531730897|FG000|Overall Study|Initiation of Non-Protocol Therapy|3|||
147427537|NCT01790126|531730898|FG001|Overall Study|Initiation of Non-Protocol Therapy|4|||
147427538|NCT01790126|531730899|FG002|Overall Study|Initiation of Non-Protocol Therapy|2|||
147427539|NCT01790126|531730897|FG000|Overall Study|Withdrawal by Physician|1|||
147427540|NCT01790126|531730898|FG001|Overall Study|Withdrawal by Physician|1|||
147427541|NCT01790126|531730899|FG002|Overall Study|Withdrawal by Physician|2|||
147427542|NCT01790126|531730897|FG000|Overall Study|Withdrawal by Subject|3|||
147427543|NCT01790126|531730898|FG001|Overall Study|Withdrawal by Subject|1|||
147427544|NCT01790126|531730899|FG002|Overall Study|Withdrawal by Subject|2|||
147427545|NCT01790126|531730897|FG000|Overall Study|Lost to Follow-up|1|||
147427546|NCT01790126|531730898|FG001|Overall Study|Lost to Follow-up|0|||
147427547|NCT01790126|531730899|FG002|Overall Study|Lost to Follow-up|1|||
147427548|NCT01790126|531730897|FG000|Overall Study|Adverse Event|0|||
147427549|NCT01790126|531730898|FG001|Overall Study|Adverse Event|2|||
147427550|NCT01790126|531730899|FG002|Overall Study|Adverse Event|0|||
147427551|NCT01790126|531730897|FG000|Overall Study|Death|2|||
147427552|NCT01790126|531730898|FG001|Overall Study|Death|0|||
147427553|NCT01790126|531730899|FG002|Overall Study|Death|0|||
147427554|NCT01790126|531730897|FG000|Overall Study|Radiographic Progression|3|||
147427555|NCT01790126|531730898|FG001|Overall Study|Radiographic Progression|1|||
147427556|NCT01790126|531730899|FG002|Overall Study|Radiographic Progression|0|||
147427557|NCT02434939|531730907|FG000|Overall Study|Lack of Efficacy|34|||
147427558|NCT02434939|531730908|FG001|Overall Study|Lack of Efficacy|48|||
147427559|NCT02434939|531730907|FG000|Overall Study|Withdrawal by Subject|3|||
147427560|NCT02434939|531730908|FG001|Overall Study|Withdrawal by Subject|0|||
147427561|NCT02434939|531730907|FG000|Overall Study|Adverse Event|0|||
147427562|NCT02434939|531730908|FG001|Overall Study|Adverse Event|1|||
147427563|NCT06338462|531730909|FG000|Overall Study|No intervention received due to inaccurate contact info, no WhatsApp, no internet, or no smartphone|52|||
147427564|NCT00069238|531730911|FG000|Cohort 1 - Dose Level 1 (Weeks 1 - 18)|Toxicity|9|||
147427565|NCT00069238|531730912|FG001|Cohort 1 - Dose Level 1 (Weeks 1 - 18)|Toxicity|0|||
147427566|NCT00069238|531730913|FG002|Cohort 1 - Dose Level 1 (Weeks 1 - 18)|Toxicity|0|||
147427567|NCT00069238|531730911|FG000|Cohort 2 - Dose Level 2 (Weeks 1-18)|Toxicity|0|||
147427568|NCT00069238|531730912|FG001|Cohort 2 - Dose Level 2 (Weeks 1-18)|Toxicity|2|||
147427569|NCT00069238|531730913|FG002|Cohort 2 - Dose Level 2 (Weeks 1-18)|Toxicity|0|||
147427570|NCT00069238|531730911|FG000|Cohort 3 - Dose Level 3 (Weeks 1-18)|Toxicity|0|||
147427571|NCT00069238|531730912|FG001|Cohort 3 - Dose Level 3 (Weeks 1-18)|Toxicity|0|||
147427572|NCT00069238|531730913|FG002|Cohort 3 - Dose Level 3 (Weeks 1-18)|Toxicity|2|||
147427573|NCT01001832|531730916|FG000|Short-term Period|Adverse Event|2|||
147427574|NCT01001832|531730917|FG001|Short-term Period|Adverse Event|3|||
147427575|NCT01001832|531730916|FG000|Long-term Period|Adverse Event|2|||
147427576|NCT01001832|531730917|FG001|Long-term Period|Adverse Event|1|||
147427577|NCT01001832|531730916|FG000|Long-term Period|Withdrawal by Subject|1|||
147427578|NCT01001832|531730917|FG001|Long-term Period|Withdrawal by Subject|0|||
147427579|NCT01001832|531730916|FG000|Long-term Period|Lack of Efficacy|0|||
147427580|NCT01001832|531730917|FG001|Long-term Period|Lack of Efficacy|2|||
147427581|NCT01001832|531730916|FG000|Long-term Period|Other|1|||
147427582|NCT01001832|531730917|FG001|Long-term Period|Other|2|||
147427583|NCT01001832|531730916|FG000|Follow-up Period|Withdrawal by Subject|1|||
147427584|NCT01001832|531730917|FG001|Follow-up Period|Withdrawal by Subject|0|||
147427585|NCT01001832|531730916|FG000|Follow-up Period|Follow-up no longer required /protocol|15|||
147427586|NCT01001832|531730917|FG001|Follow-up Period|Follow-up no longer required /protocol|20|||
147427587|NCT01001832|531730916|FG000|Follow-up Period|Other|2|||
147427588|NCT01001832|531730917|FG001|Follow-up Period|Other|1|||
147427589|NCT00051363|531730924|FG000|Overall Study|Dropped Post-Rand for Any Reason|102|||
147427590|NCT00051363|531730925|FG001|Overall Study|Dropped Post-Rand for Any Reason|126|||
147427591|NCT00051363|531730924|FG000|Overall Study|Disqualified Post-Rand for Any Reason|9|||
147427592|NCT00051363|531730925|FG001|Overall Study|Disqualified Post-Rand for Any Reason|11|||
147427593|NCT00051363|531730924|FG000|Overall Study|Death|2|||
147427594|NCT00051363|531730925|FG001|Overall Study|Death|2|||
147427595|NCT00051363|531730924|FG000|Overall Study|Excluded Pre-Randomization|2|||
147427596|NCT00051363|531730925|FG001|Overall Study|Excluded Pre-Randomization|5|||
147427597|NCT01668667|531730928|FG000|Overall Study|Adverse Event|3|||
147427598|NCT01668667|531730929|FG001|Overall Study|Adverse Event|6|||
147427599|NCT01668667|531730930|FG002|Overall Study|Adverse Event|4|||
147427600|NCT01668667|531730931|FG003|Overall Study|Adverse Event|4|||
147427601|NCT01668667|531730928|FG000|Overall Study|Lack of Efficacy|3|||
147427602|NCT01668667|531730929|FG001|Overall Study|Lack of Efficacy|2|||
147427603|NCT01668667|531730930|FG002|Overall Study|Lack of Efficacy|2|||
147427604|NCT01668667|531730931|FG003|Overall Study|Lack of Efficacy|3|||
147427605|NCT01668667|531730928|FG000|Overall Study|Protocol Violation|6|||
147427606|NCT01668667|531730929|FG001|Overall Study|Protocol Violation|10|||
147427607|NCT01668667|531730930|FG002|Overall Study|Protocol Violation|12|||
147427608|NCT01668667|531730931|FG003|Overall Study|Protocol Violation|5|||
147427609|NCT01668667|531730928|FG000|Overall Study|Lost to Follow-up|9|||
147427610|NCT01668667|531730929|FG001|Overall Study|Lost to Follow-up|4|||
147427611|NCT01668667|531730930|FG002|Overall Study|Lost to Follow-up|7|||
147427612|NCT01668667|531730931|FG003|Overall Study|Lost to Follow-up|6|||
147427613|NCT01668667|531730928|FG000|Overall Study|Physician Decision|3|||
147427614|NCT01668667|531730929|FG001|Overall Study|Physician Decision|0|||
147427615|NCT01668667|531730930|FG002|Overall Study|Physician Decision|1|||
147427616|NCT01668667|531730931|FG003|Overall Study|Physician Decision|0|||
147427617|NCT01668667|531730928|FG000|Overall Study|Withdrawal by Subject|7|||
147427618|NCT01668667|531730929|FG001|Overall Study|Withdrawal by Subject|4|||
147427619|NCT01668667|531730930|FG002|Overall Study|Withdrawal by Subject|5|||
147427620|NCT01668667|531730931|FG003|Overall Study|Withdrawal by Subject|5|||
147427621|NCT00511901|531730933|FG000|Overall Study|Withdrawal by Subject|1|||
147427622|NCT00511901|531730934|FG001|Overall Study|Withdrawal by Subject|3|||
147427623|NCT04640077|531730939|FG000|Period 1|Withdrawal by Subject|4|||
147427624|NCT04640077|531730940|FG001|Period 1|Withdrawal by Subject|5|||
147427625|NCT04640077|531730941|FG002|Period 1|Withdrawal by Subject|0|||
147427626|NCT04640077|531730939|FG000|Period 1|Adverse Event|1|||
147427627|NCT04640077|531730940|FG001|Period 1|Adverse Event|1|||
147427628|NCT04640077|531730941|FG002|Period 1|Adverse Event|0|||
147427629|NCT04640077|531730939|FG000|Period 1|Screen Failure|2|||
147427630|NCT04640077|531730940|FG001|Period 1|Screen Failure|0|||
147427631|NCT04640077|531730941|FG002|Period 1|Screen Failure|0|||
147427632|NCT04640077|531730939|FG000|Period 2|Withdrawal by Subject|0|||
147427633|NCT04640077|531730940|FG001|Period 2|Withdrawal by Subject|0|||
147427634|NCT04640077|531730941|FG002|Period 2|Withdrawal by Subject|18|||
147427635|NCT04640077|531730939|FG000|Period 2|Adverse Event|0|||
147427636|NCT04640077|531730940|FG001|Period 2|Adverse Event|0|||
147427637|NCT04640077|531730941|FG002|Period 2|Adverse Event|6|||
147427638|NCT04640077|531730939|FG000|Period 2|Lost to Follow-up|0|||
147427639|NCT04640077|531730940|FG001|Period 2|Lost to Follow-up|0|||
147427640|NCT04640077|531730941|FG002|Period 2|Lost to Follow-up|2|||
147427641|NCT04640077|531730939|FG000|Period 2|Death|0|||
147427642|NCT04640077|531730940|FG001|Period 2|Death|0|||
147427643|NCT04640077|531730941|FG002|Period 2|Death|2|||
147427644|NCT04640077|531730939|FG000|Period 2|Progressive Disease|0|||
147427645|NCT04640077|531730940|FG001|Period 2|Progressive Disease|0|||
147427646|NCT04640077|531730941|FG002|Period 2|Progressive Disease|1|||
147427647|NCT04640077|531730939|FG000|Period 2|Withdrawal Due To Caregiver Circumstances|0|||
147427648|NCT04640077|531730940|FG001|Period 2|Withdrawal Due To Caregiver Circumstances|0|||
147427649|NCT04640077|531730941|FG002|Period 2|Withdrawal Due To Caregiver Circumstances|1|||
147427650|NCT01257425|531730942|FG000|Overall Study|Lack of Efficacy|3|||
147427651|NCT01257425|531730943|FG001|Overall Study|Lack of Efficacy|3|||
147427652|NCT01257425|531730942|FG000|Overall Study|Adverse Event|1|||
147427653|NCT01257425|531730943|FG001|Overall Study|Adverse Event|1|||
147427654|NCT01257425|531730942|FG000|Overall Study|Protocol Violation|1|||
147427655|NCT01257425|531730943|FG001|Overall Study|Protocol Violation|1|||
147427656|NCT01257425|531730942|FG000|Overall Study|Withdrawal by Subject|0|||
147427657|NCT01257425|531730943|FG001|Overall Study|Withdrawal by Subject|1|||
147427658|NCT01257425|531730942|FG000|Overall Study|Death|1|||
147427659|NCT01257425|531730943|FG001|Overall Study|Death|0|||
147427660|NCT00368992|531730947|FG000|Overall Study|Ineligible|5|||
147427661|NCT00368992|531730947|FG000|Overall Study|Refused treatment|3|||
147427662|NCT00368992|531730947|FG000|Overall Study|Lack of Efficacy|63|||
147427663|NCT00368992|531730947|FG000|Overall Study|Adverse Event|26|||
147427664|NCT00368992|531730947|FG000|Overall Study|Death|4|||
147427665|NCT00368992|531730947|FG000|Overall Study|Other|9|||
147427666|NCT01013597|531730954|FG000|Overall Study|Withdrawal by Subject|1|||
147427667|NCT00427895|531730955|FG000|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
147427668|NCT00427895|531730956|FG001|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
147427669|NCT00427895|531730957|FG002|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
147427670|NCT00427895|531730958|FG003|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|352|||
147427671|NCT00427895|531730959|FG004|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
147427672|NCT00427895|531730960|FG005|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
147427673|NCT00427895|531730961|FG006|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
147427674|NCT00427895|531730962|FG007|Between 6-Month Follow-up - Year 1|Did not enter 1-year blood draw|0|||
147427675|NCT00427895|531730955|FG000|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
147427676|NCT00427895|531730956|FG001|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
147427677|NCT00427895|531730957|FG002|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
147427678|NCT00427895|531730958|FG003|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
147427679|NCT00427895|531730959|FG004|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
147427680|NCT00427895|531730960|FG005|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
147427681|NCT00427895|531730961|FG006|Vax 2/Year 3 to 4|Lost to Follow-up|0|||
147427682|NCT00427895|531730962|FG007|Vax 2/Year 3 to 4|Lost to Follow-up|1|||
147427683|NCT00427895|531730955|FG000|Vax 2/Year 3 to 4|Protocol Violation|0|||
147427684|NCT00427895|531730956|FG001|Vax 2/Year 3 to 4|Protocol Violation|0|||
147427685|NCT00427895|531730957|FG002|Vax 2/Year 3 to 4|Protocol Violation|0|||
147427686|NCT00427895|531730958|FG003|Vax 2/Year 3 to 4|Protocol Violation|0|||
147427687|NCT00427895|531730959|FG004|Vax 2/Year 3 to 4|Protocol Violation|0|||
147427688|NCT00427895|531730960|FG005|Vax 2/Year 3 to 4|Protocol Violation|0|||
147427689|NCT00427895|531730961|FG006|Vax 2/Year 3 to 4|Protocol Violation|0|||
147427690|NCT00427895|531730962|FG007|Vax 2/Year 3 to 4|Protocol Violation|1|||
147427691|NCT00427895|531730955|FG000|Vax 2/Year 3 to 4|Failed to Return|0|||
147427692|NCT00427895|531730956|FG001|Vax 2/Year 3 to 4|Failed to Return|0|||
147427693|NCT00427895|531730957|FG002|Vax 2/Year 3 to 4|Failed to Return|0|||
147427694|NCT00427895|531730958|FG003|Vax 2/Year 3 to 4|Failed to Return|0|||
147427695|NCT00427895|531730959|FG004|Vax 2/Year 3 to 4|Failed to Return|1|||
147427696|NCT00427895|531730960|FG005|Vax 2/Year 3 to 4|Failed to Return|0|||
147427697|NCT00427895|531730961|FG006|Vax 2/Year 3 to 4|Failed to Return|0|||
147427698|NCT00427895|531730962|FG007|Vax 2/Year 3 to 4|Failed to Return|0|||
147427699|NCT00427895|531730955|FG000|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0|||
147427700|NCT00427895|531730956|FG001|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|1|||
147427701|NCT00427895|531730957|FG002|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|4|||
147427702|NCT00427895|531730958|FG003|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|32|||
147427703|NCT00427895|531730959|FG004|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0|||
147427704|NCT00427895|531730960|FG005|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0|||
147427705|NCT00427895|531730961|FG006|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0|||
147427706|NCT00427895|531730962|FG007|Vax 1 Baseline/6-Month Follow-up|Lost to Follow-up|0|||
147427707|NCT00427895|531730955|FG000|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|4|||
147427708|NCT00427895|531730956|FG001|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0|||
147427709|NCT00427895|531730957|FG002|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|3|||
147427710|NCT00427895|531730958|FG003|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|2|||
147427711|NCT00427895|531730959|FG004|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0|||
147427712|NCT00427895|531730960|FG005|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0|||
147427713|NCT00427895|531730961|FG006|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0|||
147427714|NCT00427895|531730962|FG007|Vax 1 Baseline/6-Month Follow-up|Protocol Violation|0|||
147427715|NCT00427895|531730955|FG000|Vax 1 Baseline/6-Month Follow-up|Physician Decision|1|||
147427716|NCT00427895|531730956|FG001|Vax 1 Baseline/6-Month Follow-up|Physician Decision|1|||
147427717|NCT00427895|531730957|FG002|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
147427718|NCT00427895|531730958|FG003|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
147427719|NCT00427895|531730959|FG004|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
147427720|NCT00427895|531730960|FG005|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
147427721|NCT00427895|531730961|FG006|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
147427722|NCT00427895|531730962|FG007|Vax 1 Baseline/6-Month Follow-up|Physician Decision|0|||
147427723|NCT00427895|531730955|FG000|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|1|||
147427724|NCT00427895|531730956|FG001|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|1|||
147427725|NCT00427895|531730957|FG002|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|4|||
147427726|NCT00427895|531730958|FG003|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|7|||
147427727|NCT00427895|531730959|FG004|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0|||
147427728|NCT00427895|531730960|FG005|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0|||
147427729|NCT00427895|531730961|FG006|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0|||
147427730|NCT00427895|531730962|FG007|Vax 1 Baseline/6-Month Follow-up|Withdrawal by Subject|0|||
147427731|NCT00427895|531730955|FG000|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
147427732|NCT00427895|531730956|FG001|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
147427733|NCT00427895|531730957|FG002|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
147427734|NCT00427895|531730958|FG003|Vax 1 Baseline/6-Month Follow-up|Failed to Return|2|||
147427735|NCT00427895|531730959|FG004|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
147427736|NCT00427895|531730960|FG005|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
147427737|NCT00427895|531730961|FG006|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
147427738|NCT00427895|531730962|FG007|Vax 1 Baseline/6-Month Follow-up|Failed to Return|0|||
147427739|NCT00427895|531730955|FG000|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|1|||
147427740|NCT00427895|531730956|FG001|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|3|||
147427741|NCT00427895|531730957|FG002|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|2|||
147427742|NCT00427895|531730958|FG003|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|1|||
147427743|NCT00427895|531730959|FG004|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0|||
147427744|NCT00427895|531730960|FG005|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0|||
147427745|NCT00427895|531730961|FG006|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0|||
147427746|NCT00427895|531730962|FG007|Vax 1 Baseline/6-Month Follow-up|Randomized, Not Vaccinated|0|||
147427747|NCT00427895|531730955|FG000|Vax 1 Baseline/6-Month Follow-up|Other|0|||
147427748|NCT00427895|531730956|FG001|Vax 1 Baseline/6-Month Follow-up|Other|0|||
147427749|NCT00427895|531730957|FG002|Vax 1 Baseline/6-Month Follow-up|Other|1|||
147427750|NCT00427895|531730958|FG003|Vax 1 Baseline/6-Month Follow-up|Other|2|||
147427751|NCT00427895|531730959|FG004|Vax 1 Baseline/6-Month Follow-up|Other|0|||
147427752|NCT00427895|531730960|FG005|Vax 1 Baseline/6-Month Follow-up|Other|0|||
147427753|NCT00427895|531730961|FG006|Vax 1 Baseline/6-Month Follow-up|Other|0|||
147427754|NCT00427895|531730962|FG007|Vax 1 Baseline/6-Month Follow-up|Other|0|||
147427755|NCT00427895|531730955|FG000|Vax 1/Year 1 Follow-up|Lost to Follow-up|0|||
147427756|NCT00427895|531730956|FG001|Vax 1/Year 1 Follow-up|Lost to Follow-up|5|||
147427757|NCT00427895|531730957|FG002|Vax 1/Year 1 Follow-up|Lost to Follow-up|2|||
147427758|NCT00427895|531730958|FG003|Vax 1/Year 1 Follow-up|Lost to Follow-up|21|||
147427759|NCT00427895|531730959|FG004|Vax 1/Year 1 Follow-up|Lost to Follow-up|0|||
147427760|NCT00427895|531730960|FG005|Vax 1/Year 1 Follow-up|Lost to Follow-up|0|||
147427761|NCT00427895|531730961|FG006|Vax 1/Year 1 Follow-up|Lost to Follow-up|0|||
147427762|NCT00427895|531730962|FG007|Vax 1/Year 1 Follow-up|Lost to Follow-up|0|||
147427763|NCT00427895|531730955|FG000|Vax 1/Year 1 Follow-up|Protocol Violation|3|||
147427764|NCT00427895|531730956|FG001|Vax 1/Year 1 Follow-up|Protocol Violation|3|||
147427765|NCT00427895|531730957|FG002|Vax 1/Year 1 Follow-up|Protocol Violation|0|||
147427766|NCT00427895|531730958|FG003|Vax 1/Year 1 Follow-up|Protocol Violation|1|||
147427767|NCT00427895|531730959|FG004|Vax 1/Year 1 Follow-up|Protocol Violation|0|||
147427768|NCT00427895|531730960|FG005|Vax 1/Year 1 Follow-up|Protocol Violation|0|||
147427769|NCT00427895|531730961|FG006|Vax 1/Year 1 Follow-up|Protocol Violation|0|||
147427770|NCT00427895|531730962|FG007|Vax 1/Year 1 Follow-up|Protocol Violation|0|||
147427771|NCT00427895|531730955|FG000|Vax 1/Year 1 Follow-up|Withdrawal by Subject|3|||
147427772|NCT00427895|531730956|FG001|Vax 1/Year 1 Follow-up|Withdrawal by Subject|6|||
147427773|NCT00427895|531730957|FG002|Vax 1/Year 1 Follow-up|Withdrawal by Subject|5|||
147427774|NCT00427895|531730958|FG003|Vax 1/Year 1 Follow-up|Withdrawal by Subject|4|||
147427775|NCT00427895|531730959|FG004|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0|||
147427776|NCT00427895|531730960|FG005|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0|||
147427777|NCT00427895|531730961|FG006|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0|||
147427778|NCT00427895|531730962|FG007|Vax 1/Year 1 Follow-up|Withdrawal by Subject|0|||
147427779|NCT00427895|531730955|FG000|Vax 1/Year 1 Follow-up|Adverse Event|0|||
147427780|NCT00427895|531730956|FG001|Vax 1/Year 1 Follow-up|Adverse Event|1|||
147427781|NCT00427895|531730957|FG002|Vax 1/Year 1 Follow-up|Adverse Event|0|||
147427782|NCT00427895|531730958|FG003|Vax 1/Year 1 Follow-up|Adverse Event|0|||
147427783|NCT00427895|531730959|FG004|Vax 1/Year 1 Follow-up|Adverse Event|0|||
147427784|NCT00427895|531730960|FG005|Vax 1/Year 1 Follow-up|Adverse Event|0|||
147427785|NCT00427895|531730961|FG006|Vax 1/Year 1 Follow-up|Adverse Event|0|||
147427786|NCT00427895|531730962|FG007|Vax 1/Year 1 Follow-up|Adverse Event|0|||
147427787|NCT00427895|531730955|FG000|Vax 1/Year 1 Follow-up|Death|1|||
147427788|NCT00427895|531730956|FG001|Vax 1/Year 1 Follow-up|Death|0|||
147427789|NCT00427895|531730957|FG002|Vax 1/Year 1 Follow-up|Death|0|||
147427790|NCT00427895|531730958|FG003|Vax 1/Year 1 Follow-up|Death|0|||
147427791|NCT00427895|531730959|FG004|Vax 1/Year 1 Follow-up|Death|0|||
147427792|NCT00427895|531730960|FG005|Vax 1/Year 1 Follow-up|Death|0|||
147427793|NCT00427895|531730961|FG006|Vax 1/Year 1 Follow-up|Death|0|||
147427794|NCT00427895|531730962|FG007|Vax 1/Year 1 Follow-up|Death|0|||
147427795|NCT00427895|531730955|FG000|Vax 1/Year 1 Follow-up|Failed to Return|0|||
147427796|NCT00427895|531730956|FG001|Vax 1/Year 1 Follow-up|Failed to Return|0|||
147427797|NCT00427895|531730957|FG002|Vax 1/Year 1 Follow-up|Failed to Return|12|||
147427798|NCT00427895|531730958|FG003|Vax 1/Year 1 Follow-up|Failed to Return|5|||
147427799|NCT00427895|531730959|FG004|Vax 1/Year 1 Follow-up|Failed to Return|0|||
147427800|NCT00427895|531730960|FG005|Vax 1/Year 1 Follow-up|Failed to Return|0|||
147427801|NCT00427895|531730961|FG006|Vax 1/Year 1 Follow-up|Failed to Return|0|||
147427802|NCT00427895|531730962|FG007|Vax 1/Year 1 Follow-up|Failed to Return|0|||
147427803|NCT00427895|531730955|FG000|Vax 1/Year 1 Follow-up|Other|0|||
147427804|NCT00427895|531730956|FG001|Vax 1/Year 1 Follow-up|Other|0|||
147427805|NCT00427895|531730957|FG002|Vax 1/Year 1 Follow-up|Other|0|||
147427806|NCT00427895|531730958|FG003|Vax 1/Year 1 Follow-up|Other|2|||
147427807|NCT00427895|531730959|FG004|Vax 1/Year 1 Follow-up|Other|0|||
147427808|NCT00427895|531730960|FG005|Vax 1/Year 1 Follow-up|Other|0|||
147427809|NCT00427895|531730961|FG006|Vax 1/Year 1 Follow-up|Other|0|||
147427810|NCT00427895|531730962|FG007|Vax 1/Year 1 Follow-up|Other|0|||
147427811|NCT00427895|531730955|FG000|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|188|||
147427812|NCT00427895|531730956|FG001|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|207|||
147427813|NCT00427895|531730957|FG002|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|159|||
147427814|NCT00427895|531730958|FG003|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|469|||
147427815|NCT00427895|531730959|FG004|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0|||
147427816|NCT00427895|531730960|FG005|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0|||
147427817|NCT00427895|531730961|FG006|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0|||
147427818|NCT00427895|531730962|FG007|Between Year 1 - Vax 2/Year 3 to 4|Did Not Consent to Receive Vax 2|0|||
147427819|NCT00585195|531730964|FG000|Overall Study|Adverse Event|0|||
147427820|NCT00585195|531730965|FG001|Overall Study|Adverse Event|0|||
147427821|NCT00585195|531730966|FG002|Overall Study|Adverse Event|0|||
147427822|NCT00585195|531730967|FG003|Overall Study|Adverse Event|0|||
147427823|NCT00585195|531730968|FG004|Overall Study|Adverse Event|2|||
147427824|NCT00585195|531730969|FG005|Overall Study|Adverse Event|1|||
147427825|NCT00585195|531730970|FG006|Overall Study|Adverse Event|0|||
147427826|NCT00585195|531730971|FG007|Overall Study|Adverse Event|1|||
147427827|NCT00585195|531730972|FG008|Overall Study|Adverse Event|0|||
147427828|NCT00585195|531730973|FG009|Overall Study|Adverse Event|0|||
147427829|NCT00585195|531730974|FG010|Overall Study|Adverse Event|3|||
147427830|NCT00585195|531730975|FG011|Overall Study|Adverse Event|0|||
147427831|NCT00585195|531730976|FG012|Overall Study|Adverse Event|8|||
147427832|NCT00585195|531730977|FG013|Overall Study|Adverse Event|6|||
147427833|NCT00585195|531730978|FG014|Overall Study|Adverse Event|4|||
147427834|NCT00585195|531730979|FG015|Overall Study|Adverse Event|1|||
147427835|NCT00585195|531730980|FG016|Overall Study|Adverse Event|14|||
147427836|NCT00585195|531730981|FG017|Overall Study|Adverse Event|9|||
147427837|NCT00585195|531730982|FG018|Overall Study|Adverse Event|2|||
147427838|NCT00585195|531730983|FG019|Overall Study|Adverse Event|3|||
147427839|NCT00585195|531730984|FG020|Overall Study|Adverse Event|1|||
147427840|NCT00585195|531730964|FG000|Overall Study|Progressive Disease|2|||
147427841|NCT00585195|531730965|FG001|Overall Study|Progressive Disease|2|||
147427842|NCT00585195|531730966|FG002|Overall Study|Progressive Disease|5|||
147427843|NCT00585195|531730967|FG003|Overall Study|Progressive Disease|4|||
147427844|NCT00585195|531730968|FG004|Overall Study|Progressive Disease|6|||
147427845|NCT00585195|531730969|FG005|Overall Study|Progressive Disease|4|||
147427846|NCT00585195|531730970|FG006|Overall Study|Progressive Disease|6|||
147427847|NCT00585195|531730971|FG007|Overall Study|Progressive Disease|3|||
147427848|NCT00585195|531730972|FG008|Overall Study|Progressive Disease|0|||
147427849|NCT00585195|531730973|FG009|Overall Study|Progressive Disease|5|||
147427850|NCT00585195|531730974|FG010|Overall Study|Progressive Disease|2|||
147427851|NCT00585195|531730975|FG011|Overall Study|Progressive Disease|25|||
147427852|NCT00585195|531730976|FG012|Overall Study|Progressive Disease|29|||
147427853|NCT00585195|531730977|FG013|Overall Study|Progressive Disease|26|||
147427854|NCT00585195|531730978|FG014|Overall Study|Progressive Disease|21|||
147427855|NCT00585195|531730979|FG015|Overall Study|Progressive Disease|12|||
147427856|NCT00585195|531730980|FG016|Overall Study|Progressive Disease|94|||
147427857|NCT00585195|531730981|FG017|Overall Study|Progressive Disease|42|||
147427858|NCT00585195|531730982|FG018|Overall Study|Progressive Disease|4|||
147427859|NCT00585195|531730983|FG019|Overall Study|Progressive Disease|9|||
147427860|NCT00585195|531730984|FG020|Overall Study|Progressive Disease|8|||
147427861|NCT00585195|531730964|FG000|Overall Study|Withdrawal by Subject|1|||
147427862|NCT00585195|531730965|FG001|Overall Study|Withdrawal by Subject|1|||
147427863|NCT00585195|531730966|FG002|Overall Study|Withdrawal by Subject|2|||
147427864|NCT00585195|531730967|FG003|Overall Study|Withdrawal by Subject|2|||
147427865|NCT00585195|531730968|FG004|Overall Study|Withdrawal by Subject|0|||
147427866|NCT00585195|531730969|FG005|Overall Study|Withdrawal by Subject|0|||
147427867|NCT00585195|531730970|FG006|Overall Study|Withdrawal by Subject|0|||
147427868|NCT00585195|531730971|FG007|Overall Study|Withdrawal by Subject|1|||
147427869|NCT00585195|531730972|FG008|Overall Study|Withdrawal by Subject|0|||
147427870|NCT00585195|531730973|FG009|Overall Study|Withdrawal by Subject|0|||
147427871|NCT00585195|531730974|FG010|Overall Study|Withdrawal by Subject|3|||
147427872|NCT00585195|531730975|FG011|Overall Study|Withdrawal by Subject|8|||
147427873|NCT00585195|531730976|FG012|Overall Study|Withdrawal by Subject|15|||
147427874|NCT00585195|531730977|FG013|Overall Study|Withdrawal by Subject|0|||
147427875|NCT00585195|531730978|FG014|Overall Study|Withdrawal by Subject|3|||
147427876|NCT00585195|531730979|FG015|Overall Study|Withdrawal by Subject|0|||
147427877|NCT00585195|531730980|FG016|Overall Study|Withdrawal by Subject|7|||
147427878|NCT00585195|531730981|FG017|Overall Study|Withdrawal by Subject|1|||
147427879|NCT00585195|531730982|FG018|Overall Study|Withdrawal by Subject|2|||
147427880|NCT00585195|531730983|FG019|Overall Study|Withdrawal by Subject|2|||
147427881|NCT00585195|531730984|FG020|Overall Study|Withdrawal by Subject|0|||
147427882|NCT00585195|531730964|FG000|Overall Study|Other|0|||
147427883|NCT00585195|531730965|FG001|Overall Study|Other|1|||
147427884|NCT00585195|531730966|FG002|Overall Study|Other|1|||
147427885|NCT00585195|531730967|FG003|Overall Study|Other|1|||
147427886|NCT00585195|531730968|FG004|Overall Study|Other|0|||
147427887|NCT00585195|531730969|FG005|Overall Study|Other|1|||
147427888|NCT00585195|531730970|FG006|Overall Study|Other|0|||
147427889|NCT00585195|531730971|FG007|Overall Study|Other|0|||
147427890|NCT00585195|531730972|FG008|Overall Study|Other|2|||
147427891|NCT00585195|531730973|FG009|Overall Study|Other|1|||
147427892|NCT00585195|531730974|FG010|Overall Study|Other|0|||
147427893|NCT00585195|531730975|FG011|Overall Study|Other|19|||
147427894|NCT00585195|531730976|FG012|Overall Study|Other|24|||
147427895|NCT00585195|531730977|FG013|Overall Study|Other|7|||
147427896|NCT00585195|531730978|FG014|Overall Study|Other|11|||
147427897|NCT00585195|531730979|FG015|Overall Study|Other|3|||
147427898|NCT00585195|531730980|FG016|Overall Study|Other|28|||
147427899|NCT00585195|531730981|FG017|Overall Study|Other|12|||
147427900|NCT00585195|531730982|FG018|Overall Study|Other|10|||
147427901|NCT00585195|531730983|FG019|Overall Study|Other|4|||
147427902|NCT00585195|531730984|FG020|Overall Study|Other|2|||
147427903|NCT00585195|531730964|FG000|Overall Study|Randomized not treated|0|||
147427904|NCT00585195|531730965|FG001|Overall Study|Randomized not treated|0|||
147427905|NCT00585195|531730966|FG002|Overall Study|Randomized not treated|1|||
147427906|NCT00585195|531730967|FG003|Overall Study|Randomized not treated|0|||
147427907|NCT00585195|531730968|FG004|Overall Study|Randomized not treated|1|||
147427908|NCT00585195|531730969|FG005|Overall Study|Randomized not treated|0|||
147427909|NCT00585195|531730970|FG006|Overall Study|Randomized not treated|1|||
147427910|NCT00585195|531730971|FG007|Overall Study|Randomized not treated|0|||
147427911|NCT00585195|531730972|FG008|Overall Study|Randomized not treated|0|||
147427912|NCT00585195|531730973|FG009|Overall Study|Randomized not treated|0|||
147427913|NCT00585195|531730974|FG010|Overall Study|Randomized not treated|2|||
147427914|NCT00585195|531730975|FG011|Overall Study|Randomized not treated|0|||
147427915|NCT00585195|531730976|FG012|Overall Study|Randomized not treated|0|||
147427916|NCT00585195|531730977|FG013|Overall Study|Randomized not treated|0|||
147427917|NCT00585195|531730978|FG014|Overall Study|Randomized not treated|0|||
147427918|NCT00585195|531730979|FG015|Overall Study|Randomized not treated|1|||
147427919|NCT00585195|531730980|FG016|Overall Study|Randomized not treated|0|||
147427920|NCT00585195|531730981|FG017|Overall Study|Randomized not treated|1|||
147427921|NCT00585195|531730982|FG018|Overall Study|Randomized not treated|3|||
147427922|NCT00585195|531730983|FG019|Overall Study|Randomized not treated|0|||
147427923|NCT00585195|531730984|FG020|Overall Study|Randomized not treated|2|||
147427924|NCT00585195|531730964|FG000|Overall Study|Death|0|||
147427925|NCT00585195|531730965|FG001|Overall Study|Death|0|||
147427926|NCT00585195|531730966|FG002|Overall Study|Death|0|||
147427927|NCT00585195|531730967|FG003|Overall Study|Death|0|||
147427928|NCT00585195|531730968|FG004|Overall Study|Death|0|||
147427929|NCT00585195|531730969|FG005|Overall Study|Death|0|||
147427930|NCT00585195|531730970|FG006|Overall Study|Death|0|||
147427931|NCT00585195|531730971|FG007|Overall Study|Death|0|||
147427932|NCT00585195|531730972|FG008|Overall Study|Death|1|||
147427933|NCT00585195|531730973|FG009|Overall Study|Death|0|||
147427934|NCT00585195|531730974|FG010|Overall Study|Death|1|||
147427935|NCT00585195|531730975|FG011|Overall Study|Death|1|||
147427936|NCT00585195|531730976|FG012|Overall Study|Death|7|||
147427937|NCT00585195|531730977|FG013|Overall Study|Death|2|||
147427938|NCT00585195|531730978|FG014|Overall Study|Death|8|||
147427939|NCT00585195|531730979|FG015|Overall Study|Death|2|||
147427940|NCT00585195|531730980|FG016|Overall Study|Death|11|||
147427941|NCT00585195|531730981|FG017|Overall Study|Death|0|||
147427942|NCT00585195|531730982|FG018|Overall Study|Death|0|||
147427943|NCT00585195|531730983|FG019|Overall Study|Death|0|||
147427944|NCT00585195|531730984|FG020|Overall Study|Death|1|||
147427945|NCT00585195|531730964|FG000|Overall Study|Lost to Follow-up|0|||
147427946|NCT00585195|531730965|FG001|Overall Study|Lost to Follow-up|0|||
147427947|NCT00585195|531730966|FG002|Overall Study|Lost to Follow-up|0|||
147427948|NCT00585195|531730967|FG003|Overall Study|Lost to Follow-up|0|||
147427949|NCT00585195|531730968|FG004|Overall Study|Lost to Follow-up|0|||
147427950|NCT00585195|531730969|FG005|Overall Study|Lost to Follow-up|0|||
147427951|NCT00585195|531730970|FG006|Overall Study|Lost to Follow-up|0|||
147427952|NCT00585195|531730971|FG007|Overall Study|Lost to Follow-up|0|||
147427953|NCT00585195|531730972|FG008|Overall Study|Lost to Follow-up|0|||
147427954|NCT00585195|531730973|FG009|Overall Study|Lost to Follow-up|0|||
147427955|NCT00585195|531730974|FG010|Overall Study|Lost to Follow-up|0|||
147427956|NCT00585195|531730975|FG011|Overall Study|Lost to Follow-up|0|||
147427957|NCT00585195|531730976|FG012|Overall Study|Lost to Follow-up|1|||
147427958|NCT00585195|531730977|FG013|Overall Study|Lost to Follow-up|0|||
147427959|NCT00585195|531730978|FG014|Overall Study|Lost to Follow-up|0|||
147427960|NCT00585195|531730979|FG015|Overall Study|Lost to Follow-up|0|||
147427961|NCT00585195|531730980|FG016|Overall Study|Lost to Follow-up|0|||
147427962|NCT00585195|531730981|FG017|Overall Study|Lost to Follow-up|2|||
147427963|NCT00585195|531730982|FG018|Overall Study|Lost to Follow-up|0|||
147427964|NCT00585195|531730983|FG019|Overall Study|Lost to Follow-up|0|||
147427965|NCT00585195|531730984|FG020|Overall Study|Lost to Follow-up|0|||
147427966|NCT00585195|531730964|FG000|Overall Study|Site Terminated by Sponsor|0|||
147427967|NCT00585195|531730965|FG001|Overall Study|Site Terminated by Sponsor|0|||
147427968|NCT00585195|531730966|FG002|Overall Study|Site Terminated by Sponsor|0|||
147427969|NCT00585195|531730967|FG003|Overall Study|Site Terminated by Sponsor|0|||
147427970|NCT00585195|531730968|FG004|Overall Study|Site Terminated by Sponsor|0|||
147427971|NCT00585195|531730969|FG005|Overall Study|Site Terminated by Sponsor|0|||
147427972|NCT00585195|531730970|FG006|Overall Study|Site Terminated by Sponsor|0|||
147427973|NCT00585195|531730971|FG007|Overall Study|Site Terminated by Sponsor|0|||
147427974|NCT00585195|531730972|FG008|Overall Study|Site Terminated by Sponsor|0|||
147427975|NCT00585195|531730973|FG009|Overall Study|Site Terminated by Sponsor|0|||
147427976|NCT00585195|531730974|FG010|Overall Study|Site Terminated by Sponsor|0|||
147427977|NCT00585195|531730975|FG011|Overall Study|Site Terminated by Sponsor|0|||
147427978|NCT00585195|531730976|FG012|Overall Study|Site Terminated by Sponsor|1|||
147427979|NCT00585195|531730977|FG013|Overall Study|Site Terminated by Sponsor|0|||
147427980|NCT00585195|531730978|FG014|Overall Study|Site Terminated by Sponsor|0|||
147427981|NCT00585195|531730979|FG015|Overall Study|Site Terminated by Sponsor|0|||
147427982|NCT00585195|531730980|FG016|Overall Study|Site Terminated by Sponsor|0|||
147427983|NCT00585195|531730981|FG017|Overall Study|Site Terminated by Sponsor|0|||
147427984|NCT00585195|531730982|FG018|Overall Study|Site Terminated by Sponsor|0|||
147427985|NCT00585195|531730983|FG019|Overall Study|Site Terminated by Sponsor|0|||
147427986|NCT00585195|531730984|FG020|Overall Study|Site Terminated by Sponsor|0|||
147427987|NCT00585195|531730964|FG000|Overall Study|Withdrawn Due to Pregnancy|0|||
147427988|NCT00585195|531730965|FG001|Overall Study|Withdrawn Due to Pregnancy|0|||
147427989|NCT00585195|531730966|FG002|Overall Study|Withdrawn Due to Pregnancy|0|||
147427990|NCT00585195|531730967|FG003|Overall Study|Withdrawn Due to Pregnancy|0|||
147427991|NCT00585195|531730968|FG004|Overall Study|Withdrawn Due to Pregnancy|0|||
147427992|NCT00585195|531730969|FG005|Overall Study|Withdrawn Due to Pregnancy|0|||
147427993|NCT00585195|531730970|FG006|Overall Study|Withdrawn Due to Pregnancy|0|||
147427994|NCT00585195|531730971|FG007|Overall Study|Withdrawn Due to Pregnancy|0|||
147427995|NCT00585195|531730972|FG008|Overall Study|Withdrawn Due to Pregnancy|0|||
147427996|NCT00585195|531730973|FG009|Overall Study|Withdrawn Due to Pregnancy|0|||
147427997|NCT00585195|531730974|FG010|Overall Study|Withdrawn Due to Pregnancy|0|||
147427998|NCT00585195|531730975|FG011|Overall Study|Withdrawn Due to Pregnancy|0|||
147427999|NCT00585195|531730976|FG012|Overall Study|Withdrawn Due to Pregnancy|0|||
147428000|NCT00585195|531730977|FG013|Overall Study|Withdrawn Due to Pregnancy|0|||
147428001|NCT00585195|531730978|FG014|Overall Study|Withdrawn Due to Pregnancy|1|||
147428002|NCT00585195|531730979|FG015|Overall Study|Withdrawn Due to Pregnancy|0|||
147428003|NCT00585195|531730980|FG016|Overall Study|Withdrawn Due to Pregnancy|0|||
147428004|NCT00585195|531730981|FG017|Overall Study|Withdrawn Due to Pregnancy|0|||
147428005|NCT00585195|531730982|FG018|Overall Study|Withdrawn Due to Pregnancy|0|||
147428006|NCT00585195|531730983|FG019|Overall Study|Withdrawn Due to Pregnancy|0|||
147428007|NCT00585195|531730984|FG020|Overall Study|Withdrawn Due to Pregnancy|0|||
147428008|NCT02796560|531730990|FG000|Overall Study|Adverse Event|2|||
147428009|NCT02796560|531730991|FG001|Overall Study|Adverse Event|0|||
147428010|NCT02796560|531730990|FG000|Overall Study|Withdrawal by Subject|2|||
147428011|NCT02796560|531730991|FG001|Overall Study|Withdrawal by Subject|2|||
147428012|NCT03534284|531730992|FG000|Overall Study|Death|2|||
147428013|NCT03534284|531730993|FG001|Overall Study|Death|3|||
147428014|NCT03534284|531730994|FG002|Overall Study|Death|3|||
147428015|NCT03534284|531730992|FG000|Overall Study|Withdrawal by Subject|5|||
147428016|NCT03534284|531730993|FG001|Overall Study|Withdrawal by Subject|0|||
147428017|NCT03534284|531730994|FG002|Overall Study|Withdrawal by Subject|0|||
147428018|NCT03316300|531730995|FG000|Overall Study|Withdrawal by Subject|3|||
147428019|NCT03316300|531730996|FG001|Overall Study|Withdrawal by Subject|2|||
147428020|NCT03316300|531730995|FG000|Overall Study|Eligible and did not enroll in amendment|4|||
147428021|NCT03316300|531730996|FG001|Overall Study|Eligible and did not enroll in amendment|4|||
147428022|NCT03316300|531730995|FG000|Overall Study|Adverse Event|1|||
147428023|NCT03316300|531730996|FG001|Overall Study|Adverse Event|0|||
147428024|NCT03316300|531730995|FG000|Overall Study|COVID-19|0|||
147428025|NCT03316300|531730996|FG001|Overall Study|COVID-19|1|||
147428026|NCT05437510|531730997|FG000|Overall Study|Adverse Event|2|||
147428027|NCT05437510|531730998|FG001|Overall Study|Adverse Event|1|||
147428028|NCT05437510|531730997|FG000|Overall Study|Protocol Deviation|1|||
147428029|NCT05437510|531730998|FG001|Overall Study|Protocol Deviation|6|||
147428030|NCT05437510|531730997|FG000|Overall Study|Withdrawal by Parent/Guardian|23|||
147428031|NCT05437510|531730998|FG001|Overall Study|Withdrawal by Parent/Guardian|23|||
147428032|NCT05437510|531730997|FG000|Overall Study|Lost to Follow-up|265|||
147428033|NCT05437510|531730998|FG001|Overall Study|Lost to Follow-up|358|||
147428034|NCT03573401|531730999|FG000|Overall Study|Withdrawal by Subject|2|||
147428035|NCT03573401|531731000|FG001|Overall Study|Withdrawal by Subject|0|||
147428036|NCT03573401|531730999|FG000|Overall Study|Subject non-compliance with study schedule|1|||
147428037|NCT03573401|531731000|FG001|Overall Study|Subject non-compliance with study schedule|0|||
147428038|NCT03573401|531730999|FG000|Overall Study|Discontinuation of study treatment due to subject decision|1|||
147428039|NCT03573401|531731000|FG001|Overall Study|Discontinuation of study treatment due to subject decision|0|||
147428040|NCT03573401|531730999|FG000|Overall Study|Subject required prohibited medication for concomitant medical condition|0|||
147428041|NCT03573401|531731000|FG001|Overall Study|Subject required prohibited medication for concomitant medical condition|1|||
147428042|NCT00355056|531732511|FG000|Randomization Period|Early Termination|4|||
147428043|NCT00355056|531732512|FG001|Randomization Period|Early Termination|6|||
147428044|NCT01072877|531732516|FG000|Overall Study|Lost to Follow-up|1|||
147428045|NCT01072877|531732517|FG001|Overall Study|Lost to Follow-up|1|||
147428046|NCT01072877|531732518|FG002|Overall Study|Lost to Follow-up|0|||
147428047|NCT01072877|531732519|FG003|Overall Study|Lost to Follow-up|2|||
147428048|NCT01072877|531732520|FG004|Overall Study|Lost to Follow-up|0|||
147428049|NCT00995020|531732521|FG000|Overall Study|margin analysis not performed|2|||
147428050|NCT00995020|531732522|FG001|Overall Study|margin analysis not performed|5|||
147428051|NCT00995020|531732521|FG000|Overall Study|specimen fragmentation, thermal damage|1|||
147428052|NCT00995020|531732522|FG001|Overall Study|specimen fragmentation, thermal damage|2|||
147428053|NCT02245672|531732523|FG000|Overall Study|Adverse Event|4|||
147428054|NCT02245672|531732524|FG001|Overall Study|Adverse Event|4|||
147428055|NCT02245672|531732525|FG002|Overall Study|Adverse Event|4|||
147428056|NCT02245672|531732523|FG000|Overall Study|Lost to Follow-up|3|||
147428057|NCT02245672|531732524|FG001|Overall Study|Lost to Follow-up|5|||
147428058|NCT02245672|531732525|FG002|Overall Study|Lost to Follow-up|1|||
147428059|NCT02245672|531732523|FG000|Overall Study|Withdrawal by Subject|6|||
147428060|NCT02245672|531732524|FG001|Overall Study|Withdrawal by Subject|3|||
147428061|NCT02245672|531732525|FG002|Overall Study|Withdrawal by Subject|0|||
147428062|NCT02245672|531732523|FG000|Overall Study|Randomized in error (not treated)|0|||
147428063|NCT02245672|531732524|FG001|Overall Study|Randomized in error (not treated)|1|||
147428064|NCT02245672|531732525|FG002|Overall Study|Randomized in error (not treated)|0|||
147428065|NCT01256658|531732529|FG000|Period 1|Lost to Follow-up|837|||
147428066|NCT01256658|531732530|FG001|Period 1|Lost to Follow-up|661|||
147428067|NCT01256658|531732529|FG000|Period 1|Withdrawal by Subject|35|||
147428068|NCT01256658|531732530|FG001|Period 1|Withdrawal by Subject|43|||
147428069|NCT01256658|531732529|FG000|Period 1|Death|48|||
147428070|NCT01256658|531732530|FG001|Period 1|Death|44|||
147428071|NCT00719563|531732535|FG000|Overall Study|Adverse Event|16|||
147428072|NCT00719563|531732536|FG001|Overall Study|Adverse Event|13|||
147428073|NCT00719563|531732535|FG000|Overall Study|Medical condition changed|3|||
147428074|NCT00719563|531732536|FG001|Overall Study|Medical condition changed|5|||
147428075|NCT00719563|531732535|FG000|Overall Study|Lack of Efficacy|3|||
147428076|NCT00719563|531732536|FG001|Overall Study|Lack of Efficacy|7|||
147428077|NCT00719563|531732535|FG000|Overall Study|Personal reasons|6|||
147428078|NCT00719563|531732536|FG001|Overall Study|Personal reasons|7|||
147428079|NCT00719563|531732535|FG000|Overall Study|Unknown reasons|4|||
147428080|NCT00719563|531732536|FG001|Overall Study|Unknown reasons|6|||
147428081|NCT00719563|531732535|FG000|Overall Study|Noncompliant|1|||
147428082|NCT00719563|531732536|FG001|Overall Study|Noncompliant|1|||
147428083|NCT00719563|531732535|FG000|Overall Study|Lost to Follow-up|5|||
147428084|NCT00719563|531732536|FG001|Overall Study|Lost to Follow-up|3|||
147428085|NCT00294554|531732537|FG000|Overall Study|Lack of Efficacy|0|||
147428086|NCT00294554|531732538|FG001|Overall Study|Lack of Efficacy|1|||
147428087|NCT00294554|531732537|FG000|Overall Study|Physician Decision|0|||
147428088|NCT00294554|531732538|FG001|Overall Study|Physician Decision|1|||
147428089|NCT00462865|531732539|FG000|Overall Study|Adverse Event|1|||
147428090|NCT02986334|531732540|FG000|Overall Study|Withdrawal by Subject|0|||
147428091|NCT02986334|531732541|FG001|Overall Study|Withdrawal by Subject|1|||
147428092|NCT02986334|531732542|FG002|Overall Study|Withdrawal by Subject|2|||
147428093|NCT02986334|531732540|FG000|Overall Study|Lost to Follow-up|1|||
147428094|NCT02986334|531732541|FG001|Overall Study|Lost to Follow-up|2|||
147428095|NCT02986334|531732542|FG002|Overall Study|Lost to Follow-up|1|||
147428096|NCT02986334|531732540|FG000|Overall Study|Adverse Event|0|||
147428097|NCT02986334|531732541|FG001|Overall Study|Adverse Event|2|||
147428098|NCT02986334|531732542|FG002|Overall Study|Adverse Event|1|||
147428099|NCT02986334|531732540|FG000|Overall Study|non compliance in phone ratings|2|||
147428100|NCT02986334|531732541|FG001|Overall Study|non compliance in phone ratings|1|||
147428101|NCT02986334|531732542|FG002|Overall Study|non compliance in phone ratings|2|||
147428102|NCT02986334|531732540|FG000|Overall Study|undisclosed comorbidities|0|||
147428103|NCT02986334|531732541|FG001|Overall Study|undisclosed comorbidities|1|||
147428104|NCT02986334|531732542|FG002|Overall Study|undisclosed comorbidities|1|||
147428105|NCT04142450|531732543|FG000|Overall Study|Screen Failure|1|||
147428106|NCT04142450|531732543|FG000|Overall Study|Lost to Follow-up|1|||
147428107|NCT06336603|531732544|FG000|Overall Study|Withdrawal by Subject|1|||
147428108|NCT06336603|531732544|FG000|Overall Study|Lost to Follow-up|2|||
147428109|NCT01146054|531732547|FG000|Overall Study|Did not meet dose constraints for SBRT|5|||
147428110|NCT01146054|531732547|FG000|Overall Study|Rapid tumor progression|2|||
147428111|NCT01146054|531732547|FG000|Overall Study|Other illness precluded treatment|2|||
147428112|NCT01146054|531732547|FG000|Overall Study|Lost to Follow-up|1|||
147428113|NCT03249714|531732551|FG000|Double-blind Treatment (Core Part)|Lack of Efficacy|1|||
147428114|NCT03249714|531732552|FG001|Double-blind Treatment (Core Part)|Lack of Efficacy|1|||
147428115|NCT03249714|531732551|FG000|Double-blind Treatment (Core Part)|Subject/guardian decision|1|||
147428116|NCT03249714|531732552|FG001|Double-blind Treatment (Core Part)|Subject/guardian decision|1|||
147428117|NCT03249714|531732551|FG000|Double-blind Treatment (Core Part)|Lost to Follow-up|1|||
147428118|NCT03249714|531732552|FG001|Double-blind Treatment (Core Part)|Lost to Follow-up|0|||
147428119|NCT03249714|531732551|FG000|Open-label Treatment (Extension Part)|Adverse Event|2|||
147428120|NCT03249714|531732552|FG001|Open-label Treatment (Extension Part)|Adverse Event|0|||
147428121|NCT03021954|531732555|FG000|Overall Study|Lost to Follow-up|10|||
147428122|NCT03021954|531732556|FG001|Overall Study|Lost to Follow-up|43|||
147428123|NCT03021954|531732555|FG000|Overall Study|Subjects had avulsion trauma|4|||
147428124|NCT03021954|531732556|FG001|Overall Study|Subjects had avulsion trauma|1|||
147428125|NCT01242800|531732557|FG000|Overall Study|Patient refusal|0|||
147428126|NCT01242800|531732558|FG001|Overall Study|Patient refusal|10|||
147428127|NCT01242800|531732557|FG000|Overall Study|Physician Decision|0|||
147428128|NCT01242800|531732558|FG001|Overall Study|Physician Decision|1|||
147428129|NCT01242800|531732557|FG000|Overall Study|Disease progression|0|||
147428130|NCT01242800|531732558|FG001|Overall Study|Disease progression|3|||
147428131|NCT01242800|531732557|FG000|Overall Study|Lack of insurance coverage for surgery|0|||
147428132|NCT01242800|531732558|FG001|Overall Study|Lack of insurance coverage for surgery|1|||
147428133|NCT01242800|531732557|FG000|Overall Study|Reasons not reported|0|||
147428134|NCT01242800|531732558|FG001|Overall Study|Reasons not reported|4|||
147428135|NCT02640157|531732560|FG000|Overall Study|Adverse Event|2|||
147428136|NCT02640157|531732561|FG001|Overall Study|Adverse Event|2|||
147428137|NCT02640157|531732562|FG002|Overall Study|Adverse Event|1|||
147428138|NCT02640157|531732560|FG000|Overall Study|Withdrew consent|2|||
147428139|NCT02640157|531732561|FG001|Overall Study|Withdrew consent|0|||
147428140|NCT02640157|531732562|FG002|Overall Study|Withdrew consent|2|||
147428141|NCT02640157|531732560|FG000|Overall Study|Lost to Follow-up|9|||
147428142|NCT02640157|531732561|FG001|Overall Study|Lost to Follow-up|2|||
147428143|NCT02640157|531732562|FG002|Overall Study|Lost to Follow-up|7|||
147428144|NCT02640157|531732560|FG000|Overall Study|Randomized in error; did not receive Tx|0|||
147428145|NCT02640157|531732561|FG001|Overall Study|Randomized in error; did not receive Tx|1|||
147428146|NCT02640157|531732562|FG002|Overall Study|Randomized in error; did not receive Tx|0|||
147428147|NCT00710021|531732563|FG000|Overall Study|Lost to Follow-up|1|||
147428148|NCT00710021|531732564|FG001|Overall Study|Lost to Follow-up|0|||
147428149|NCT00710021|531732565|FG002|Overall Study|Lost to Follow-up|0|||
147428150|NCT00710021|531732563|FG000|Overall Study|Subject's Decision|0|||
147428151|NCT00710021|531732564|FG001|Overall Study|Subject's Decision|1|||
147428152|NCT00710021|531732565|FG002|Overall Study|Subject's Decision|0|||
147428153|NCT00710021|531732563|FG000|Overall Study|Subject misrandomized|0|||
147428154|NCT00710021|531732564|FG001|Overall Study|Subject misrandomized|1|||
147428155|NCT00710021|531732565|FG002|Overall Study|Subject misrandomized|1|||
147428156|NCT00710021|531732563|FG000|Overall Study|Physician Decision|0|||
147428157|NCT00710021|531732564|FG001|Overall Study|Physician Decision|1|||
147428158|NCT00710021|531732565|FG002|Overall Study|Physician Decision|0|||
147428159|NCT01679405|531732566|FG000|Overall Study|Death|2|||
147428160|NCT01679405|531732567|FG001|Overall Study|Death|5|||
147428161|NCT04677179|531732568|FG000|Induction Treatment Period|Adverse Event|1|||
147428162|NCT04677179|531732569|FG001|Induction Treatment Period|Adverse Event|0|||
147428163|NCT04677179|531732570|FG002|Induction Treatment Period|Adverse Event|0|||
147428164|NCT04677179|531732571|FG003|Induction Treatment Period|Adverse Event|0|||
147428165|NCT04677179|531732572|FG004|Induction Treatment Period|Adverse Event|0|||
147428166|NCT04677179|531732573|FG005|Induction Treatment Period|Adverse Event|0|||
147428167|NCT04677179|531732574|FG006|Induction Treatment Period|Adverse Event|0|||
147428168|NCT04677179|531732575|FG007|Induction Treatment Period|Adverse Event|0|||
147428169|NCT04677179|531732576|FG008|Induction Treatment Period|Adverse Event|0|||
147428170|NCT04677179|531732577|FG009|Induction Treatment Period|Adverse Event|0|||
147428171|NCT04677179|531732568|FG000|Induction Treatment Period|Physician Decision|1|||
147428172|NCT04677179|531732569|FG001|Induction Treatment Period|Physician Decision|0|||
147428173|NCT04677179|531732570|FG002|Induction Treatment Period|Physician Decision|1|||
147428174|NCT04677179|531732571|FG003|Induction Treatment Period|Physician Decision|0|||
147428175|NCT04677179|531732572|FG004|Induction Treatment Period|Physician Decision|0|||
147428176|NCT04677179|531732573|FG005|Induction Treatment Period|Physician Decision|0|||
147428177|NCT04677179|531732574|FG006|Induction Treatment Period|Physician Decision|0|||
147428178|NCT04677179|531732575|FG007|Induction Treatment Period|Physician Decision|0|||
147428179|NCT04677179|531732576|FG008|Induction Treatment Period|Physician Decision|0|||
147428180|NCT04677179|531732577|FG009|Induction Treatment Period|Physician Decision|0|||
147428181|NCT04677179|531732568|FG000|Induction Treatment Period|Protocol Violation|0|||
147428182|NCT04677179|531732569|FG001|Induction Treatment Period|Protocol Violation|1|||
147428183|NCT04677179|531732570|FG002|Induction Treatment Period|Protocol Violation|0|||
147428184|NCT04677179|531732571|FG003|Induction Treatment Period|Protocol Violation|0|||
147428185|NCT04677179|531732572|FG004|Induction Treatment Period|Protocol Violation|0|||
147428186|NCT04677179|531732573|FG005|Induction Treatment Period|Protocol Violation|0|||
147428187|NCT04677179|531732574|FG006|Induction Treatment Period|Protocol Violation|0|||
147428188|NCT04677179|531732575|FG007|Induction Treatment Period|Protocol Violation|0|||
147428189|NCT04677179|531732576|FG008|Induction Treatment Period|Protocol Violation|0|||
147428190|NCT04677179|531732577|FG009|Induction Treatment Period|Protocol Violation|0|||
147428191|NCT04677179|531732568|FG000|Induction Treatment Period|Withdrawal by Subject|4|||
147428192|NCT04677179|531732569|FG001|Induction Treatment Period|Withdrawal by Subject|1|||
147428193|NCT04677179|531732570|FG002|Induction Treatment Period|Withdrawal by Subject|1|||
147428194|NCT04677179|531732571|FG003|Induction Treatment Period|Withdrawal by Subject|0|||
147428195|NCT04677179|531732572|FG004|Induction Treatment Period|Withdrawal by Subject|0|||
147428196|NCT04677179|531732573|FG005|Induction Treatment Period|Withdrawal by Subject|0|||
147428197|NCT04677179|531732574|FG006|Induction Treatment Period|Withdrawal by Subject|0|||
147428198|NCT04677179|531732575|FG007|Induction Treatment Period|Withdrawal by Subject|0|||
147428199|NCT04677179|531732576|FG008|Induction Treatment Period|Withdrawal by Subject|0|||
147428200|NCT04677179|531732577|FG009|Induction Treatment Period|Withdrawal by Subject|0|||
147428201|NCT04677179|531732568|FG000|Induction Treatment Period|Study terminated by sponsor|7|||
147428202|NCT04677179|531732569|FG001|Induction Treatment Period|Study terminated by sponsor|11|||
147428203|NCT04677179|531732570|FG002|Induction Treatment Period|Study terminated by sponsor|0|||
147428204|NCT04677179|531732571|FG003|Induction Treatment Period|Study terminated by sponsor|0|||
147428205|NCT04677179|531732572|FG004|Induction Treatment Period|Study terminated by sponsor|0|||
147428206|NCT04677179|531732573|FG005|Induction Treatment Period|Study terminated by sponsor|0|||
147428207|NCT04677179|531732574|FG006|Induction Treatment Period|Study terminated by sponsor|0|||
147428208|NCT04677179|531732575|FG007|Induction Treatment Period|Study terminated by sponsor|0|||
147428209|NCT04677179|531732576|FG008|Induction Treatment Period|Study terminated by sponsor|0|||
147428210|NCT04677179|531732577|FG009|Induction Treatment Period|Study terminated by sponsor|0|||
147428211|NCT04677179|531732568|FG000|Maintenance Treatment Period|Lack of Efficacy|0|||
147428212|NCT04677179|531732569|FG001|Maintenance Treatment Period|Lack of Efficacy|0|||
147428213|NCT04677179|531732570|FG002|Maintenance Treatment Period|Lack of Efficacy|0|||
147428214|NCT04677179|531732571|FG003|Maintenance Treatment Period|Lack of Efficacy|0|||
147428215|NCT04677179|531732572|FG004|Maintenance Treatment Period|Lack of Efficacy|1|||
147428216|NCT04677179|531732573|FG005|Maintenance Treatment Period|Lack of Efficacy|0|||
147428217|NCT04677179|531732574|FG006|Maintenance Treatment Period|Lack of Efficacy|0|||
147428218|NCT04677179|531732575|FG007|Maintenance Treatment Period|Lack of Efficacy|0|||
147428219|NCT04677179|531732576|FG008|Maintenance Treatment Period|Lack of Efficacy|0|||
147428220|NCT04677179|531732577|FG009|Maintenance Treatment Period|Lack of Efficacy|0|||
147428221|NCT04677179|531732568|FG000|Maintenance Treatment Period|Withdrawal by Subject|0|||
147428222|NCT04677179|531732569|FG001|Maintenance Treatment Period|Withdrawal by Subject|0|||
147428223|NCT04677179|531732570|FG002|Maintenance Treatment Period|Withdrawal by Subject|0|||
147428224|NCT04677179|531732571|FG003|Maintenance Treatment Period|Withdrawal by Subject|1|||
147428225|NCT04677179|531732572|FG004|Maintenance Treatment Period|Withdrawal by Subject|0|||
147428226|NCT04677179|531732573|FG005|Maintenance Treatment Period|Withdrawal by Subject|0|||
147428227|NCT04677179|531732574|FG006|Maintenance Treatment Period|Withdrawal by Subject|0|||
147428228|NCT04677179|531732575|FG007|Maintenance Treatment Period|Withdrawal by Subject|0|||
147428229|NCT04677179|531732576|FG008|Maintenance Treatment Period|Withdrawal by Subject|0|||
147428230|NCT04677179|531732577|FG009|Maintenance Treatment Period|Withdrawal by Subject|0|||
147428231|NCT04677179|531732568|FG000|Maintenance Treatment Period|Study terminated by sponsor|0|||
147428232|NCT04677179|531732569|FG001|Maintenance Treatment Period|Study terminated by sponsor|0|||
147428233|NCT04677179|531732570|FG002|Maintenance Treatment Period|Study terminated by sponsor|0|||
147428234|NCT04677179|531732571|FG003|Maintenance Treatment Period|Study terminated by sponsor|7|||
147428235|NCT04677179|531732572|FG004|Maintenance Treatment Period|Study terminated by sponsor|9|||
147428236|NCT04677179|531732573|FG005|Maintenance Treatment Period|Study terminated by sponsor|5|||
147428237|NCT04677179|531732574|FG006|Maintenance Treatment Period|Study terminated by sponsor|0|||
147428238|NCT04677179|531732575|FG007|Maintenance Treatment Period|Study terminated by sponsor|0|||
147428239|NCT04677179|531732576|FG008|Maintenance Treatment Period|Study terminated by sponsor|0|||
147428240|NCT04677179|531732577|FG009|Maintenance Treatment Period|Study terminated by sponsor|0|||
147428241|NCT04677179|531732568|FG000|Extension Treatment Period|Lack of Efficacy|0|||
147428242|NCT04677179|531732569|FG001|Extension Treatment Period|Lack of Efficacy|0|||
147428243|NCT04677179|531732570|FG002|Extension Treatment Period|Lack of Efficacy|0|||
147428244|NCT04677179|531732571|FG003|Extension Treatment Period|Lack of Efficacy|0|||
147428245|NCT04677179|531732572|FG004|Extension Treatment Period|Lack of Efficacy|0|||
147428246|NCT04677179|531732573|FG005|Extension Treatment Period|Lack of Efficacy|0|||
147428247|NCT04677179|531732574|FG006|Extension Treatment Period|Lack of Efficacy|6|||
147428248|NCT04677179|531732575|FG007|Extension Treatment Period|Lack of Efficacy|0|||
147428249|NCT04677179|531732576|FG008|Extension Treatment Period|Lack of Efficacy|0|||
147428250|NCT04677179|531732577|FG009|Extension Treatment Period|Lack of Efficacy|0|||
147428251|NCT04677179|531732568|FG000|Extension Treatment Period|Withdrawal by Subject|0|||
147428252|NCT04677179|531732569|FG001|Extension Treatment Period|Withdrawal by Subject|0|||
147428253|NCT04677179|531732570|FG002|Extension Treatment Period|Withdrawal by Subject|0|||
147428254|NCT04677179|531732571|FG003|Extension Treatment Period|Withdrawal by Subject|0|||
147428255|NCT04677179|531732572|FG004|Extension Treatment Period|Withdrawal by Subject|0|||
147428256|NCT04677179|531732573|FG005|Extension Treatment Period|Withdrawal by Subject|0|||
147428257|NCT04677179|531732574|FG006|Extension Treatment Period|Withdrawal by Subject|2|||
147428258|NCT04677179|531732575|FG007|Extension Treatment Period|Withdrawal by Subject|0|||
147428259|NCT04677179|531732576|FG008|Extension Treatment Period|Withdrawal by Subject|0|||
147428260|NCT04677179|531732577|FG009|Extension Treatment Period|Withdrawal by Subject|0|||
147428261|NCT04677179|531732568|FG000|Extension Treatment Period|Study terminated by sponsor|0|||
147428262|NCT04677179|531732569|FG001|Extension Treatment Period|Study terminated by sponsor|0|||
147428263|NCT04677179|531732570|FG002|Extension Treatment Period|Study terminated by sponsor|0|||
147428264|NCT04677179|531732571|FG003|Extension Treatment Period|Study terminated by sponsor|0|||
147428265|NCT04677179|531732572|FG004|Extension Treatment Period|Study terminated by sponsor|0|||
147428266|NCT04677179|531732573|FG005|Extension Treatment Period|Study terminated by sponsor|0|||
147428267|NCT04677179|531732574|FG006|Extension Treatment Period|Study terminated by sponsor|18|||
147428268|NCT04677179|531732575|FG007|Extension Treatment Period|Study terminated by sponsor|0|||
147428269|NCT04677179|531732576|FG008|Extension Treatment Period|Study terminated by sponsor|0|||
147428270|NCT04677179|531732577|FG009|Extension Treatment Period|Study terminated by sponsor|0|||
147428271|NCT04677179|531732568|FG000|Post-Treatment Follow-up Period|Adverse Event|0|||
147428272|NCT04677179|531732569|FG001|Post-Treatment Follow-up Period|Adverse Event|0|||
147428273|NCT04677179|531732570|FG002|Post-Treatment Follow-up Period|Adverse Event|0|||
147428274|NCT04677179|531732571|FG003|Post-Treatment Follow-up Period|Adverse Event|0|||
147428275|NCT04677179|531732572|FG004|Post-Treatment Follow-up Period|Adverse Event|0|||
147428276|NCT04677179|531732573|FG005|Post-Treatment Follow-up Period|Adverse Event|0|||
147428277|NCT04677179|531732574|FG006|Post-Treatment Follow-up Period|Adverse Event|0|||
147428278|NCT04677179|531732575|FG007|Post-Treatment Follow-up Period|Adverse Event|1|||
147428279|NCT04677179|531732576|FG008|Post-Treatment Follow-up Period|Adverse Event|0|||
147428280|NCT04677179|531732577|FG009|Post-Treatment Follow-up Period|Adverse Event|0|||
147428281|NCT04677179|531732568|FG000|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
147428282|NCT04677179|531732569|FG001|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
147428283|NCT04677179|531732570|FG002|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
147428284|NCT04677179|531732571|FG003|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
147428285|NCT04677179|531732572|FG004|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
147428286|NCT04677179|531732573|FG005|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
147428287|NCT04677179|531732574|FG006|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
147428288|NCT04677179|531732575|FG007|Post-Treatment Follow-up Period|Lack of Efficacy|2|||
147428289|NCT04677179|531732576|FG008|Post-Treatment Follow-up Period|Lack of Efficacy|3|||
147428290|NCT04677179|531732577|FG009|Post-Treatment Follow-up Period|Lack of Efficacy|0|||
147428291|NCT04677179|531732568|FG000|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
147428292|NCT04677179|531732569|FG001|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
147428293|NCT04677179|531732570|FG002|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
147428294|NCT04677179|531732571|FG003|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
147428295|NCT04677179|531732572|FG004|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
147428296|NCT04677179|531732573|FG005|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
147428297|NCT04677179|531732574|FG006|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
147428298|NCT04677179|531732575|FG007|Post-Treatment Follow-up Period|Lost to Follow-up|1|||
147428299|NCT04677179|531732576|FG008|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
147428300|NCT04677179|531732577|FG009|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
147428301|NCT04677179|531732568|FG000|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
147428302|NCT04677179|531732569|FG001|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
147428303|NCT04677179|531732570|FG002|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
147428304|NCT04677179|531732571|FG003|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
147428305|NCT04677179|531732572|FG004|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
147428306|NCT04677179|531732573|FG005|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
147428307|NCT04677179|531732574|FG006|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
147428308|NCT04677179|531732575|FG007|Post-Treatment Follow-up Period|Withdrawal by Subject|3|||
147428309|NCT04677179|531732576|FG008|Post-Treatment Follow-up Period|Withdrawal by Subject|1|||
147428310|NCT04677179|531732577|FG009|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
147428311|NCT04677179|531732568|FG000|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
147428312|NCT04677179|531732569|FG001|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
147428313|NCT04677179|531732570|FG002|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
147428314|NCT04677179|531732571|FG003|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
147428315|NCT04677179|531732572|FG004|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
147428316|NCT04677179|531732573|FG005|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
147428317|NCT04677179|531732574|FG006|Post-Treatment Follow-up Period|Study terminated by sponsor|0|||
147428318|NCT04677179|531732575|FG007|Post-Treatment Follow-up Period|Study terminated by sponsor|18|||
147428319|NCT04677179|531732576|FG008|Post-Treatment Follow-up Period|Study terminated by sponsor|26|||
147428320|NCT04677179|531732577|FG009|Post-Treatment Follow-up Period|Study terminated by sponsor|11|||
147428321|NCT01536015|531732578|FG000|Overall Study|Adverse Event|1|||
147428322|NCT01536015|531732579|FG001|Overall Study|Adverse Event|4|||
147428323|NCT01536015|531732578|FG000|Overall Study|Lost to Follow-up|0|||
147428324|NCT01536015|531732579|FG001|Overall Study|Lost to Follow-up|1|||
147428325|NCT01536015|531732578|FG000|Overall Study|Inclusion Criterion not met|2|||
147428326|NCT01536015|531732579|FG001|Overall Study|Inclusion Criterion not met|0|||
147428327|NCT01536015|531732578|FG000|Overall Study|Study closure|5|||
147428328|NCT01536015|531732579|FG001|Overall Study|Study closure|5|||
147428329|NCT04508023|531732580|FG000|Overall Study|Withdrawal by Subject|1|||
147428330|NCT04508023|531732581|FG001|Overall Study|Withdrawal by Subject|2|||
147428331|NCT03581825|531732589|FG000|Period 1|Lens Discomfort|1|||
147428332|NCT03581825|531732590|FG001|Period 1|Lens Discomfort|0|||
147428333|NCT03581825|531732589|FG000|Period 2|Unsatisfactory Vision to Test|0|||
147428334|NCT03581825|531732590|FG001|Period 2|Unsatisfactory Vision to Test|1|||
147428335|NCT02447172|531732591|FG000|Overall Study|Adverse Event|11|||
147428336|NCT02447172|531732592|FG001|Overall Study|Adverse Event|8|||
147428337|NCT02447172|531732593|FG002|Overall Study|Adverse Event|7|||
147428338|NCT02447172|531732591|FG000|Overall Study|Death|3|||
147428339|NCT02447172|531732592|FG001|Overall Study|Death|1|||
147428340|NCT02447172|531732593|FG002|Overall Study|Death|0|||
147428341|NCT02447172|531732591|FG000|Overall Study|Protocol Violation|2|||
147428342|NCT02447172|531732592|FG001|Overall Study|Protocol Violation|1|||
147428343|NCT02447172|531732593|FG002|Overall Study|Protocol Violation|2|||
147428344|NCT02447172|531732591|FG000|Overall Study|Lost to Follow-up|7|||
147428345|NCT02447172|531732592|FG001|Overall Study|Lost to Follow-up|4|||
147428346|NCT02447172|531732593|FG002|Overall Study|Lost to Follow-up|4|||
147428347|NCT02447172|531732591|FG000|Overall Study|Withdrawal by Subject|5|||
147428348|NCT02447172|531732592|FG001|Overall Study|Withdrawal by Subject|1|||
147428349|NCT02447172|531732593|FG002|Overall Study|Withdrawal by Subject|3|||
147428350|NCT02447172|531732591|FG000|Overall Study|protocol specific treatment unrelated|3|||
147428351|NCT02447172|531732592|FG001|Overall Study|protocol specific treatment unrelated|0|||
147428352|NCT02447172|531732593|FG002|Overall Study|protocol specific treatment unrelated|2|||
147428353|NCT03261700|531732597|FG000|Overall Study|The participant was not able to participate due to COVID-19 related stressors.|1|||
147428354|NCT03261700|531732598|FG001|Overall Study|The participant was not able to participate due to COVID-19 related stressors.|0|||
147428355|NCT01204398|531732599|FG000|Overall Study|Adverse Event|1|||
147428356|NCT03562247|531732600|FG000|Overall Study|Lost to Follow-up|3|||
147428357|NCT03562247|531732601|FG001|Overall Study|Lost to Follow-up|1|||
147428358|NCT03562247|531732602|FG002|Overall Study|Lost to Follow-up|1|||
147428359|NCT00983931|531732603|FG000|14 Day Washout Period|Physician Decision|1|||
147428360|NCT01723254|531732604|FG000|Overall Study|Conflict with work schedule|0|||
147428361|NCT01723254|531732605|FG001|Overall Study|Conflict with work schedule|0|||
147428362|NCT01723254|531732606|FG002|Overall Study|Conflict with work schedule|0|||
147428363|NCT01723254|531732607|FG003|Overall Study|Conflict with work schedule|0|||
147428364|NCT01723254|531732608|FG004|Overall Study|Conflict with work schedule|0|||
147428365|NCT01723254|531732609|FG005|Overall Study|Conflict with work schedule|0|||
147428366|NCT01723254|531732610|FG006|Overall Study|Conflict with work schedule|0|||
147428367|NCT01723254|531732611|FG007|Overall Study|Conflict with work schedule|1|||
147428368|NCT01723254|531732604|FG000|Overall Study|Personal issues|0|||
147428369|NCT01723254|531732605|FG001|Overall Study|Personal issues|0|||
147428370|NCT01723254|531732606|FG002|Overall Study|Personal issues|0|||
147428371|NCT01723254|531732607|FG003|Overall Study|Personal issues|0|||
147428372|NCT01723254|531732608|FG004|Overall Study|Personal issues|0|||
147428373|NCT01723254|531732609|FG005|Overall Study|Personal issues|1|||
147428374|NCT01723254|531732610|FG006|Overall Study|Personal issues|0|||
147192271|NCT00402168|530872155|FG001|Treatment (up to 12 Months)|non-specified|1|||
147192272|NCT00402168|530872154|FG000|Long Term (LT)|Adverse Event|1|||
147428375|NCT01723254|531732611|FG007|Overall Study|Personal issues|0|||
147428376|NCT01723254|531732604|FG000|Overall Study|No longer have time to participate|0|||
147428377|NCT01723254|531732605|FG001|Overall Study|No longer have time to participate|0|||
147428378|NCT01723254|531732606|FG002|Overall Study|No longer have time to participate|0|||
147428379|NCT01723254|531732607|FG003|Overall Study|No longer have time to participate|1|||
147428380|NCT01723254|531732608|FG004|Overall Study|No longer have time to participate|0|||
147428381|NCT01723254|531732609|FG005|Overall Study|No longer have time to participate|0|||
147428382|NCT01723254|531732610|FG006|Overall Study|No longer have time to participate|0|||
147428383|NCT01723254|531732611|FG007|Overall Study|No longer have time to participate|0|||
147428384|NCT01723254|531732604|FG000|Overall Study|Move/Left to another country/city|0|||
147428385|NCT01723254|531732605|FG001|Overall Study|Move/Left to another country/city|0|||
147428386|NCT01723254|531732606|FG002|Overall Study|Move/Left to another country/city|2|||
147428387|NCT01723254|531732607|FG003|Overall Study|Move/Left to another country/city|1|||
147428388|NCT01723254|531732608|FG004|Overall Study|Move/Left to another country/city|1|||
147428389|NCT01723254|531732609|FG005|Overall Study|Move/Left to another country/city|0|||
147428390|NCT01723254|531732610|FG006|Overall Study|Move/Left to another country/city|0|||
147428391|NCT01723254|531732611|FG007|Overall Study|Move/Left to another country/city|0|||
147428392|NCT01723254|531732604|FG000|Overall Study|Protocol Violation|0|||
147428393|NCT01723254|531732605|FG001|Overall Study|Protocol Violation|1|||
147428394|NCT01723254|531732606|FG002|Overall Study|Protocol Violation|0|||
147428395|NCT01723254|531732607|FG003|Overall Study|Protocol Violation|0|||
147428396|NCT01723254|531732608|FG004|Overall Study|Protocol Violation|0|||
147428397|NCT01723254|531732609|FG005|Overall Study|Protocol Violation|0|||
147428398|NCT01723254|531732610|FG006|Overall Study|Protocol Violation|0|||
147428399|NCT01723254|531732611|FG007|Overall Study|Protocol Violation|0|||
147428400|NCT01723254|531732604|FG000|Overall Study|Withdrawal by Subject|1|||
147428401|NCT01723254|531732605|FG001|Overall Study|Withdrawal by Subject|2|||
147428402|NCT01723254|531732606|FG002|Overall Study|Withdrawal by Subject|1|||
147428403|NCT01723254|531732607|FG003|Overall Study|Withdrawal by Subject|0|||
147428404|NCT01723254|531732608|FG004|Overall Study|Withdrawal by Subject|1|||
147428405|NCT01723254|531732609|FG005|Overall Study|Withdrawal by Subject|1|||
147428406|NCT01723254|531732610|FG006|Overall Study|Withdrawal by Subject|1|||
147428407|NCT01723254|531732611|FG007|Overall Study|Withdrawal by Subject|2|||
147428408|NCT02668185|531732612|FG000|First Intervention (4 Weeks)|Physician Decision|2|||
147428409|NCT02668185|531732613|FG001|First Intervention (4 Weeks)|Physician Decision|0|||
147428410|NCT02668185|531732612|FG000|Washout Period (2 Weeks)|Adverse Event|1|||
147428411|NCT02668185|531732613|FG001|Washout Period (2 Weeks)|Adverse Event|0|||
147428412|NCT02668185|531732612|FG000|Washout Period (2 Weeks)|Physician Decision|0|||
147428413|NCT02668185|531732613|FG001|Washout Period (2 Weeks)|Physician Decision|2|||
147428414|NCT02668185|531732612|FG000|Second Intervention (4 Weeks)|Physician Decision|1|||
147428415|NCT02668185|531732613|FG001|Second Intervention (4 Weeks)|Physician Decision|3|||
147428416|NCT00770341|531732614|FG000|Overall Study|Did not meet eligibility criteria|1|||
147428417|NCT00770341|531732615|FG001|Overall Study|Did not meet eligibility criteria|0|||
147428418|NCT00770341|531732616|FG002|Overall Study|Did not meet eligibility criteria|0|||
147428419|NCT00770341|531732614|FG000|Overall Study|Withdrawal by Subject|0|||
147428420|NCT00770341|531732615|FG001|Overall Study|Withdrawal by Subject|1|||
147428421|NCT00770341|531732616|FG002|Overall Study|Withdrawal by Subject|0|||
147428422|NCT00770341|531732614|FG000|Overall Study|Clinical Adverse Event|3|||
147428423|NCT00770341|531732615|FG001|Overall Study|Clinical Adverse Event|1|||
147428424|NCT00770341|531732616|FG002|Overall Study|Clinical Adverse Event|2|||
147428425|NCT00770341|531732614|FG000|Overall Study|Laboratory adverse event|3|||
147428426|NCT00770341|531732615|FG001|Overall Study|Laboratory adverse event|3|||
147428427|NCT00770341|531732616|FG002|Overall Study|Laboratory adverse event|0|||
147428428|NCT00770341|531732614|FG000|Overall Study|Lack of Efficacy|3|||
147428429|NCT00770341|531732615|FG001|Overall Study|Lack of Efficacy|0|||
147428430|NCT00770341|531732616|FG002|Overall Study|Lack of Efficacy|1|||
147428431|NCT00770341|531732614|FG000|Overall Study|Other|1|||
147428432|NCT00770341|531732615|FG001|Overall Study|Other|0|||
147428433|NCT00770341|531732616|FG002|Overall Study|Other|0|||
147428434|NCT00770341|531732614|FG000|Overall Study|Not treated|1|||
147428435|NCT00770341|531732615|FG001|Overall Study|Not treated|0|||
147428436|NCT00770341|531732616|FG002|Overall Study|Not treated|0|||
147428437|NCT02533570|531732617|FG000|Overall Study|Adverse Event|0|||
147428438|NCT02533570|531732618|FG001|Overall Study|Adverse Event|1|||
147428439|NCT02533570|531732619|FG002|Overall Study|Adverse Event|1|||
147428440|NCT00529958|531732621|FG000|2-Year Follow-up|Lost to Follow-up|1|||
147428441|NCT00529958|531732622|FG001|2-Year Follow-up|Lost to Follow-up|2|||
147428442|NCT00529958|531732623|FG002|2-Year Follow-up|Lost to Follow-up|2|||
147428443|NCT00529958|531732621|FG000|2-Year Follow-up|Withdrawal by Subject|3|||
147428444|NCT00529958|531732622|FG001|2-Year Follow-up|Withdrawal by Subject|0|||
147428445|NCT00529958|531732623|FG002|2-Year Follow-up|Withdrawal by Subject|0|||
147428446|NCT00529958|531732621|FG000|5-Year Follow-up|Lost to Follow-up|2|||
147428447|NCT00529958|531732622|FG001|5-Year Follow-up|Lost to Follow-up|3|||
147428448|NCT00529958|531732623|FG002|5-Year Follow-up|Lost to Follow-up|1|||
147428449|NCT00529958|531732621|FG000|5-Year Follow-up|Withdrawal by Subject|1|||
147428450|NCT00529958|531732622|FG001|5-Year Follow-up|Withdrawal by Subject|0|||
147428451|NCT00529958|531732623|FG002|5-Year Follow-up|Withdrawal by Subject|0|||
147428452|NCT03816332|531732624|FG000|Nivolumab, Tacrolimus, and Prednisone|Did not receive Nivolumab|2|||
147428453|NCT03816332|531732624|FG000|Nivolumab, Tacrolimus, and Prednisone|Death|2|||
147428454|NCT03164564|531732627|FG000|Overall Study|Death|3|||
147428455|NCT03164564|531732628|FG001|Overall Study|Death|0|||
147428456|NCT03164564|531732627|FG000|Overall Study|Withdrawal by Subject|20|||
147428457|NCT03164564|531732628|FG001|Overall Study|Withdrawal by Subject|15|||
147428458|NCT03164564|531732627|FG000|Overall Study|Lost to Follow-up|2|||
147428459|NCT03164564|531732628|FG001|Overall Study|Lost to Follow-up|0|||
147428460|NCT03164564|531732627|FG000|Overall Study|Physician Decision|0|||
147428461|NCT03164564|531732628|FG001|Overall Study|Physician Decision|1|||
147428462|NCT03164564|531732627|FG000|Overall Study|Adverse Event|0|||
147428463|NCT03164564|531732628|FG001|Overall Study|Adverse Event|1|||
147428464|NCT03164564|531732627|FG000|Overall Study|Ongoing|1586|||
147428465|NCT03164564|531732628|FG001|Overall Study|Ongoing|1586|||
147428466|NCT02656823|531732631|FG000|Overall Study|Adverse Event|3|||
147428467|NCT02656823|531732631|FG000|Overall Study|Lost to Follow-up|2|||
147428468|NCT01910181|531732632|FG000|Overall Study|Death|37|||
147428469|NCT01910181|531732632|FG000|Overall Study|Lost to Follow-up|3|||
147428470|NCT01910181|531732632|FG000|Overall Study|Study Terminated by Sponsor|6|||
147428471|NCT01340651|531732636|FG000|Overall Study|Adverse Event|3|||
147428472|NCT01340651|531732636|FG000|Overall Study|Consent Withdrawn|2|||
147428473|NCT01340651|531732636|FG000|Overall Study|Commercial Supply per Sponsor|12|||
147428474|NCT01315353|531732637|FG000|Overall Study|Death|2|||
147428475|NCT01315353|531732638|FG001|Overall Study|Death|1|||
147428476|NCT01315353|531732639|FG002|Overall Study|Death|0|||
147428477|NCT01315353|531732637|FG000|Overall Study|Withdrawal by Subject|2|||
147428478|NCT01315353|531732638|FG001|Overall Study|Withdrawal by Subject|6|||
147428479|NCT01315353|531732639|FG002|Overall Study|Withdrawal by Subject|1|||
147428480|NCT01315353|531732637|FG000|Overall Study|Lost to Follow-up|13|||
147428481|NCT01315353|531732638|FG001|Overall Study|Lost to Follow-up|6|||
147428482|NCT01315353|531732639|FG002|Overall Study|Lost to Follow-up|6|||
147428483|NCT01315353|531732637|FG000|Overall Study|Unwilling to adhere to requirements|5|||
147428484|NCT01315353|531732638|FG001|Overall Study|Unwilling to adhere to requirements|5|||
147428485|NCT01315353|531732639|FG002|Overall Study|Unwilling to adhere to requirements|4|||
147428486|NCT01315353|531732637|FG000|Overall Study|Site closing|7|||
147428487|NCT01315353|531732638|FG001|Overall Study|Site closing|4|||
147428488|NCT01315353|531732639|FG002|Overall Study|Site closing|0|||
147428489|NCT01315353|531732637|FG000|Overall Study|Taken off study by site in error|0|||
147428490|NCT01315353|531732638|FG001|Overall Study|Taken off study by site in error|1|||
147428491|NCT01315353|531732639|FG002|Overall Study|Taken off study by site in error|0|||
147428492|NCT01315353|531732637|FG000|Overall Study|Inadvertent randomization/assignment|0|||
147428493|NCT01315353|531732638|FG001|Overall Study|Inadvertent randomization/assignment|0|||
147428494|NCT01315353|531732639|FG002|Overall Study|Inadvertent randomization/assignment|2|||
147428495|NCT01009580|531732640|FG000|Overall Study|Adverse Event|4|||
147428496|NCT01009580|531732641|FG001|Overall Study|Adverse Event|4|||
147428497|NCT01009580|531732640|FG000|Overall Study|Lack of Efficacy|0|||
147428498|NCT01009580|531732641|FG001|Overall Study|Lack of Efficacy|1|||
147428499|NCT01009580|531732640|FG000|Overall Study|Protocol Violation|2|||
147428500|NCT01009580|531732641|FG001|Overall Study|Protocol Violation|3|||
147428501|NCT01009580|531732640|FG000|Overall Study|Withdrawal Criteria|4|||
147428502|NCT01009580|531732641|FG001|Overall Study|Withdrawal Criteria|6|||
147428503|NCT01009580|531732640|FG000|Overall Study|Unclassified|17|||
147428504|NCT01009580|531732641|FG001|Overall Study|Unclassified|21|||
147428505|NCT04469270|531732645|FG000|Overall Study|Adverse Event|2|||
147428506|NCT04469270|531732646|FG001|Overall Study|Adverse Event|0|||
147428507|NCT04469270|531732645|FG000|Overall Study|Lost to Follow-up|4|||
147428508|NCT04469270|531732646|FG001|Overall Study|Lost to Follow-up|3|||
147428509|NCT04469270|531732645|FG000|Overall Study|Withdrawal by Subject|7|||
147428510|NCT04469270|531732646|FG001|Overall Study|Withdrawal by Subject|3|||
147428511|NCT04469270|531732645|FG000|Overall Study|Not Dosed - 2 subjects misrandomized, included in ITT, but not Safety population.|2|||
147428512|NCT04469270|531732646|FG001|Overall Study|Not Dosed - 2 subjects misrandomized, included in ITT, but not Safety population.|0|||
147428513|NCT04469270|531732645|FG000|Overall Study|missing|1|||
147428514|NCT04469270|531732646|FG001|Overall Study|missing|0|||
147428515|NCT05269355|531732649|FG000|Overall Study|Progressive Disease|104|||
147428516|NCT05269355|531732650|FG001|Overall Study|Progressive Disease|68|||
147428517|NCT05269355|531732649|FG000|Overall Study|Study Terminated by Sponsor|87|||
147428518|NCT05269355|531732650|FG001|Overall Study|Study Terminated by Sponsor|29|||
147428519|NCT05269355|531732649|FG000|Overall Study|Adverse Event|15|||
147428520|NCT05269355|531732650|FG001|Overall Study|Adverse Event|8|||
147428521|NCT05269355|531732649|FG000|Overall Study|Withdrawal by Subject|18|||
147428522|NCT05269355|531732650|FG001|Overall Study|Withdrawal by Subject|5|||
147428523|NCT05269355|531732649|FG000|Overall Study|Physician Decision|6|||
147428524|NCT05269355|531732650|FG001|Overall Study|Physician Decision|4|||
147428525|NCT05269355|531732649|FG000|Overall Study|Death|3|||
147428526|NCT05269355|531732650|FG001|Overall Study|Death|5|||
147428527|NCT05269355|531732649|FG000|Overall Study|Other Than Specified|5|||
147428528|NCT05269355|531732650|FG001|Overall Study|Other Than Specified|1|||
147428529|NCT05269355|531732649|FG000|Overall Study|Randomized But Not Treated|1|||
147428530|NCT05269355|531732650|FG001|Overall Study|Randomized But Not Treated|0|||
147428531|NCT03705832|531732651|FG000|Overall Study|Physician Decision|0|||
147428532|NCT03705832|531732652|FG001|Overall Study|Physician Decision|1|||
147428533|NCT03705832|531732651|FG000|Overall Study|Withdrawal by Subject|1|||
147428534|NCT03705832|531732652|FG001|Overall Study|Withdrawal by Subject|0|||
147428535|NCT01050790|531732653|FG000|Overall Study|Adverse Event|1|||
147428536|NCT01880528|531732654|FG000|Overall Study|Other|1|||
147428537|NCT01880528|531732655|FG001|Overall Study|Other|1|||
147428538|NCT00081497|531732656|FG000|Overall Study|Adverse Event|2|||
147428539|NCT00081497|531732657|FG001|Overall Study|Adverse Event|0|||
147428540|NCT00081497|531732656|FG000|Overall Study|Death|0|||
147428541|NCT00081497|531732657|FG001|Overall Study|Death|1|||
147428542|NCT00081497|531732656|FG000|Overall Study|Withdrawal by Subject|1|||
147428543|NCT00081497|531732657|FG001|Overall Study|Withdrawal by Subject|0|||
147428544|NCT00081497|531732656|FG000|Overall Study|Non-compliance|0|||
147428545|NCT00081497|531732657|FG001|Overall Study|Non-compliance|1|||
147428546|NCT02254278|531732658|FG000|Overall Study|Protocol Violation|1|||
147428547|NCT02254278|531732659|FG001|Overall Study|Protocol Violation|1|||
147428548|NCT01138007|531734561|FG000|Overall Study|Adverse Event|4|||
147428549|NCT01138007|531734562|FG001|Overall Study|Adverse Event|12|||
147428550|NCT01138007|531734563|FG002|Overall Study|Adverse Event|9|||
147428551|NCT01138007|531734561|FG000|Overall Study|Lack of Efficacy|2|||
147428552|NCT01138007|531734562|FG001|Overall Study|Lack of Efficacy|0|||
147428553|NCT01138007|531734563|FG002|Overall Study|Lack of Efficacy|6|||
147428554|NCT01138007|531734561|FG000|Overall Study|Protocol Violation|2|||
147428555|NCT01138007|531734562|FG001|Overall Study|Protocol Violation|3|||
147428556|NCT01138007|531734563|FG002|Overall Study|Protocol Violation|2|||
147428557|NCT01138007|531734561|FG000|Overall Study|Protocol-Defined Stopping Criteria|6|||
147428558|NCT01138007|531734562|FG001|Overall Study|Protocol-Defined Stopping Criteria|1|||
147428559|NCT01138007|531734563|FG002|Overall Study|Protocol-Defined Stopping Criteria|8|||
147428560|NCT01138007|531734561|FG000|Overall Study|Lost to Follow-up|3|||
147428561|NCT01138007|531734562|FG001|Overall Study|Lost to Follow-up|3|||
147428562|NCT01138007|531734563|FG002|Overall Study|Lost to Follow-up|5|||
147428563|NCT01138007|531734561|FG000|Overall Study|Physician Decision|0|||
147428564|NCT01138007|531734562|FG001|Overall Study|Physician Decision|5|||
147428565|NCT01138007|531734563|FG002|Overall Study|Physician Decision|3|||
147428566|NCT01138007|531734561|FG000|Overall Study|Withdrawal by Subject|5|||
147428567|NCT01138007|531734562|FG001|Overall Study|Withdrawal by Subject|6|||
147428568|NCT01138007|531734563|FG002|Overall Study|Withdrawal by Subject|15|||
147428569|NCT03548987|531734564|FG000|Run-in Period (Week 0 to Week 20)|Other|9|||
147428570|NCT03548987|531734565|FG001|Run-in Period (Week 0 to Week 20)|Other|0|||
147428571|NCT03548987|531734564|FG000|Run-in Period (Week 0 to Week 20)|Lost to Follow-up|8|||
147428572|NCT03548987|531734565|FG001|Run-in Period (Week 0 to Week 20)|Lost to Follow-up|0|||
147428573|NCT03548987|531734564|FG000|Run-in Period (Week 0 to Week 20)|Withdrawal by Subject|11|||
147428574|NCT03548987|531734565|FG001|Run-in Period (Week 0 to Week 20)|Withdrawal by Subject|0|||
147428575|NCT03548987|531734564|FG000|Run-in Period (Week 0 to Week 20)|Safety concern as judged by investigator|2|||
147428576|NCT03548987|531734565|FG001|Run-in Period (Week 0 to Week 20)|Safety concern as judged by investigator|0|||
147428577|NCT03548987|531734564|FG000|Run-in Period (Week 0 to Week 20)|Run-in failure|19|||
147428578|NCT03548987|531734565|FG001|Run-in Period (Week 0 to Week 20)|Run-in failure|0|||
147428579|NCT03548987|531734564|FG000|Run-in Period (Week 0 to Week 20)|Pregnancy|1|||
147428580|NCT03548987|531734565|FG001|Run-in Period (Week 0 to Week 20)|Pregnancy|0|||
147428581|NCT03548987|531734564|FG000|Run-in Period (Week 0 to Week 20)|Protocol Violation|1|||
147428582|NCT03548987|531734565|FG001|Run-in Period (Week 0 to Week 20)|Protocol Violation|0|||
147428583|NCT03548987|531734564|FG000|Run-in Period (Week 0 to Week 20)|Adverse Event|48|||
147428584|NCT03548987|531734565|FG001|Run-in Period (Week 0 to Week 20)|Adverse Event|0|||
147428585|NCT03548987|531734564|FG000|Maintenance Period (Week 20 to Week 68)|other|12|||
147428586|NCT03548987|531734565|FG001|Maintenance Period (Week 20 to Week 68)|other|23|||
147428587|NCT03548987|531734564|FG000|Maintenance Period (Week 20 to Week 68)|Lost to Follow-up|2|||
147428588|NCT03548987|531734565|FG001|Maintenance Period (Week 20 to Week 68)|Lost to Follow-up|1|||
147428589|NCT03548987|531734564|FG000|Maintenance Period (Week 20 to Week 68)|Withdrawal by Subject|1|||
147428590|NCT03548987|531734565|FG001|Maintenance Period (Week 20 to Week 68)|Withdrawal by Subject|1|||
147428591|NCT03548987|531734564|FG000|Maintenance Period (Week 20 to Week 68)|Pregnancy|2|||
147428592|NCT03548987|531734565|FG001|Maintenance Period (Week 20 to Week 68)|Pregnancy|0|||
147428593|NCT03548987|531734564|FG000|Maintenance Period (Week 20 to Week 68)|Protocol Violation|1|||
147428594|NCT03548987|531734565|FG001|Maintenance Period (Week 20 to Week 68)|Protocol Violation|0|||
147428595|NCT03548987|531734564|FG000|Maintenance Period (Week 20 to Week 68)|Adverse Event|13|||
147428596|NCT03548987|531734565|FG001|Maintenance Period (Week 20 to Week 68)|Adverse Event|6|||
147428597|NCT04661878|531734566|FG000|Overall Study|Lost to Follow-up|6|||
147428598|NCT04661878|531734567|FG001|Overall Study|Lost to Follow-up|5|||
147428599|NCT02768870|531734570|FG000|Overall Study|Death|1|||
147428600|NCT02768870|531734570|FG000|Overall Study|Reoperation|6|||
147428601|NCT02768870|531734570|FG000|Overall Study|Lost to Follow-up|1|||
147428602|NCT02768870|531734570|FG000|Overall Study|Exit|4|||
147428603|NCT01774110|531734571|FG000|Overall Study|Lost to Follow-up|7|||
147428604|NCT00640016|531734572|FG000|Overall Study|Withdrawal by Subject|0|||
147428605|NCT00640016|531734573|FG001|Overall Study|Withdrawal by Subject|1|||
147428606|NCT00640016|531734574|FG002|Overall Study|Withdrawal by Subject|0|||
147428607|NCT00640016|531734575|FG003|Overall Study|Withdrawal by Subject|0|||
147428608|NCT00640016|531734572|FG000|Overall Study|Study termination|2|||
147428609|NCT00640016|531734573|FG001|Overall Study|Study termination|1|||
147428610|NCT00640016|531734574|FG002|Overall Study|Study termination|3|||
147428611|NCT00640016|531734575|FG003|Overall Study|Study termination|2|||
147428612|NCT00640016|531734572|FG000|Overall Study|Adverse Event|0|||
147428613|NCT00640016|531734573|FG001|Overall Study|Adverse Event|0|||
147428614|NCT00640016|531734574|FG002|Overall Study|Adverse Event|0|||
147428615|NCT00640016|531734575|FG003|Overall Study|Adverse Event|1|||
147428616|NCT01287065|531734576|FG000|Treatment Period 1|Adverse Event|0|||
147428617|NCT01287065|531734577|FG001|Treatment Period 1|Adverse Event|0|||
147428618|NCT01287065|531734578|FG002|Treatment Period 1|Adverse Event|0|||
147428619|NCT01287065|531734579|FG003|Treatment Period 1|Adverse Event|0|||
147428620|NCT01287065|531734580|FG004|Treatment Period 1|Adverse Event|1|||
147428621|NCT01287065|531734581|FG005|Treatment Period 1|Adverse Event|0|||
147428622|NCT01287065|531734576|FG000|Treatment Period 1|Withdrawal by Subject|0|||
147428623|NCT01287065|531734577|FG001|Treatment Period 1|Withdrawal by Subject|0|||
147428624|NCT01287065|531734578|FG002|Treatment Period 1|Withdrawal by Subject|0|||
147428625|NCT01287065|531734579|FG003|Treatment Period 1|Withdrawal by Subject|0|||
147428626|NCT01287065|531734580|FG004|Treatment Period 1|Withdrawal by Subject|0|||
147428627|NCT01287065|531734581|FG005|Treatment Period 1|Withdrawal by Subject|1|||
147428628|NCT01259726|531734582|FG000|Overall Study|Death|1|||
147428629|NCT01259726|531734583|FG001|Overall Study|Death|0|||
147428630|NCT01259726|531734584|FG002|Overall Study|Death|0|||
147428631|NCT01259726|531734585|FG003|Overall Study|Death|0|||
147428632|NCT01259726|531734582|FG000|Overall Study|Physician Decision|2|||
147428633|NCT01259726|531734583|FG001|Overall Study|Physician Decision|0|||
147428634|NCT01259726|531734584|FG002|Overall Study|Physician Decision|1|||
147428635|NCT01259726|531734585|FG003|Overall Study|Physician Decision|1|||
147428636|NCT01259726|531734582|FG000|Overall Study|Withdrawal by Subject|1|||
147428637|NCT01259726|531734583|FG001|Overall Study|Withdrawal by Subject|3|||
147428638|NCT01259726|531734584|FG002|Overall Study|Withdrawal by Subject|2|||
147428639|NCT01259726|531734585|FG003|Overall Study|Withdrawal by Subject|1|||
147428640|NCT01259726|531734582|FG000|Overall Study|Lost to Follow-up|1|||
147428641|NCT01259726|531734583|FG001|Overall Study|Lost to Follow-up|1|||
147428642|NCT01259726|531734584|FG002|Overall Study|Lost to Follow-up|1|||
147428643|NCT01259726|531734585|FG003|Overall Study|Lost to Follow-up|3|||
147428644|NCT00887679|531734587|FG000|Overall Study|Withdrawal by Subject|1|||
147428645|NCT00887679|531734587|FG000|Overall Study|Lost to Follow-up|4|||
147428646|NCT00887679|531734587|FG000|Overall Study|Physician Decision|5|||
147428647|NCT02683941|531734588|FG000|Double-blind Phase|Adverse Event|0|||
147428648|NCT02683941|531734589|FG001|Double-blind Phase|Adverse Event|1|||
147428649|NCT02683941|531734588|FG000|Double-blind Phase|Withdrawal by Subject|4|||
147428650|NCT02683941|531734589|FG001|Double-blind Phase|Withdrawal by Subject|2|||
147428651|NCT02683941|531734588|FG000|Double-blind Phase|Lost to Follow-up|1|||
147428652|NCT02683941|531734589|FG001|Double-blind Phase|Lost to Follow-up|0|||
147428653|NCT02683941|531734588|FG000|Double-blind Phase|Disease Progression|5|||
147428654|NCT02683941|531734589|FG001|Double-blind Phase|Disease Progression|2|||
147428655|NCT02683941|531734588|FG000|Open-label Treatment Phase|Withdrawal by Subject|0|||
147428656|NCT02683941|531734589|FG001|Open-label Treatment Phase|Withdrawal by Subject|2|||
147428657|NCT02683941|531734588|FG000|Open-label Treatment Phase|Disease Progression|1|||
147428658|NCT02683941|531734589|FG001|Open-label Treatment Phase|Disease Progression|2|||
147428659|NCT02683941|531734588|FG000|Open-label Treatment Phase|Study Termination by the Sponsor|18|||
147428660|NCT02683941|531734589|FG001|Open-label Treatment Phase|Study Termination by the Sponsor|9|||
147428661|NCT02683941|531734588|FG000|Open-label Treatment Phase|Other|1|||
147428662|NCT02683941|531734589|FG001|Open-label Treatment Phase|Other|0|||
147428663|NCT02683941|531734588|FG000|Open-label Follow-up Phase|Withdrawal by Subject|3|||
147428664|NCT02683941|531734589|FG001|Open-label Follow-up Phase|Withdrawal by Subject|3|||
147428665|NCT02683941|531734588|FG000|Open-label Follow-up Phase|Lost to Follow-up|1|||
147428666|NCT02683941|531734589|FG001|Open-label Follow-up Phase|Lost to Follow-up|0|||
147428667|NCT02683941|531734588|FG000|Open-label Follow-up Phase|Study Termination by the Sponsor|6|||
147428668|NCT02683941|531734589|FG001|Open-label Follow-up Phase|Study Termination by the Sponsor|4|||
147428669|NCT02683941|531734588|FG000|Open-label Follow-up Phase|Other|8|||
147428670|NCT02683941|531734589|FG001|Open-label Follow-up Phase|Other|1|||
147428671|NCT00261846|531734590|FG000|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|3|||
147428672|NCT00261846|531734591|FG001|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|3|||
147428673|NCT00261846|531734592|FG002|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|12|||
147428674|NCT00261846|531734593|FG003|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
147428675|NCT00261846|531734594|FG004|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
147428676|NCT00261846|531734595|FG005|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
147428677|NCT00261846|531734596|FG006|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
147428678|NCT00261846|531734597|FG007|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
147428679|NCT00261846|531734598|FG008|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
147428680|NCT00261846|531734599|FG009|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
147428681|NCT00261846|531734600|FG010|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
147428682|NCT00261846|531734601|FG011|Period 1: Part 1 (Dose Escalation)|Continued in to Part 2|0|||
147428683|NCT00261846|531734590|FG000|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
147428684|NCT00261846|531734591|FG001|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
147428685|NCT00261846|531734592|FG002|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
147428686|NCT00261846|531734593|FG003|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|1|||
147428687|NCT00261846|531734594|FG004|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
147428688|NCT00261846|531734595|FG005|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
147428689|NCT00261846|531734596|FG006|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
147428690|NCT00261846|531734597|FG007|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
147428691|NCT00261846|531734598|FG008|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|1|||
147428692|NCT00261846|531734599|FG009|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
147428693|NCT00261846|531734600|FG010|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
147428694|NCT00261846|531734601|FG011|Period 2: Part 2 (Efficacy)|Discontinuation of study by sponsor|0|||
147428695|NCT00261846|531734590|FG000|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
147428696|NCT00261846|531734591|FG001|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
147428697|NCT00261846|531734592|FG002|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
147428698|NCT00261846|531734593|FG003|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|9|||
147428699|NCT00261846|531734594|FG004|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|8|||
147428700|NCT00261846|531734595|FG005|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|1|||
147428701|NCT00261846|531734596|FG006|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|3|||
147428702|NCT00261846|531734597|FG007|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|3|||
147428703|NCT00261846|531734598|FG008|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
147428704|NCT00261846|531734599|FG009|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|2|||
147428705|NCT00261846|531734600|FG010|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
147428706|NCT00261846|531734601|FG011|Period 2: Part 2 (Efficacy)|Withdrawal by Subject|0|||
147428707|NCT00261846|531734590|FG000|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
147428708|NCT00261846|531734591|FG001|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
147428709|NCT00261846|531734592|FG002|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
147428710|NCT00261846|531734593|FG003|Period 2: Part 2 (Efficacy)|Lost to Follow-up|12|||
147428711|NCT00261846|531734594|FG004|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4|||
147428712|NCT00261846|531734595|FG005|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
147428713|NCT00261846|531734596|FG006|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4|||
147428714|NCT00261846|531734597|FG007|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
147428715|NCT00261846|531734598|FG008|Period 2: Part 2 (Efficacy)|Lost to Follow-up|1|||
147428716|NCT00261846|531734599|FG009|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4|||
147428717|NCT00261846|531734600|FG010|Period 2: Part 2 (Efficacy)|Lost to Follow-up|4|||
147428718|NCT00261846|531734601|FG011|Period 2: Part 2 (Efficacy)|Lost to Follow-up|0|||
147428719|NCT00261846|531734590|FG000|Period 2: Part 2 (Efficacy)|Other|0|||
147428720|NCT00261846|531734591|FG001|Period 2: Part 2 (Efficacy)|Other|0|||
147428721|NCT00261846|531734592|FG002|Period 2: Part 2 (Efficacy)|Other|0|||
147428722|NCT00261846|531734593|FG003|Period 2: Part 2 (Efficacy)|Other|15|||
147428723|NCT00261846|531734594|FG004|Period 2: Part 2 (Efficacy)|Other|4|||
147428724|NCT00261846|531734595|FG005|Period 2: Part 2 (Efficacy)|Other|0|||
147428725|NCT00261846|531734596|FG006|Period 2: Part 2 (Efficacy)|Other|1|||
147428726|NCT00261846|531734597|FG007|Period 2: Part 2 (Efficacy)|Other|5|||
147428727|NCT00261846|531734598|FG008|Period 2: Part 2 (Efficacy)|Other|4|||
147428728|NCT00261846|531734599|FG009|Period 2: Part 2 (Efficacy)|Other|4|||
147428729|NCT00261846|531734600|FG010|Period 2: Part 2 (Efficacy)|Other|0|||
147428730|NCT00261846|531734601|FG011|Period 2: Part 2 (Efficacy)|Other|0|||
147428731|NCT00261846|531734590|FG000|Period 2: Part 2 (Efficacy)|Death|0|||
147428732|NCT00261846|531734591|FG001|Period 2: Part 2 (Efficacy)|Death|0|||
147428733|NCT00261846|531734592|FG002|Period 2: Part 2 (Efficacy)|Death|0|||
147428734|NCT00261846|531734593|FG003|Period 2: Part 2 (Efficacy)|Death|37|||
147428735|NCT00261846|531734594|FG004|Period 2: Part 2 (Efficacy)|Death|7|||
147428736|NCT00261846|531734595|FG005|Period 2: Part 2 (Efficacy)|Death|1|||
147428737|NCT00261846|531734596|FG006|Period 2: Part 2 (Efficacy)|Death|10|||
147428738|NCT00261846|531734597|FG007|Period 2: Part 2 (Efficacy)|Death|12|||
147428739|NCT00261846|531734598|FG008|Period 2: Part 2 (Efficacy)|Death|3|||
147428740|NCT00261846|531734599|FG009|Period 2: Part 2 (Efficacy)|Death|30|||
147428741|NCT00261846|531734600|FG010|Period 2: Part 2 (Efficacy)|Death|44|||
147428742|NCT00261846|531734601|FG011|Period 2: Part 2 (Efficacy)|Death|22|||
147428743|NCT00261846|531734590|FG000|Period 2: Part 2 (Efficacy)|Extension study|0|||
147428744|NCT00261846|531734591|FG001|Period 2: Part 2 (Efficacy)|Extension study|0|||
147428745|NCT00261846|531734592|FG002|Period 2: Part 2 (Efficacy)|Extension study|0|||
147428746|NCT00261846|531734593|FG003|Period 2: Part 2 (Efficacy)|Extension study|61|||
147428747|NCT00261846|531734594|FG004|Period 2: Part 2 (Efficacy)|Extension study|27|||
147428748|NCT00261846|531734595|FG005|Period 2: Part 2 (Efficacy)|Extension study|0|||
147428749|NCT00261846|531734596|FG006|Period 2: Part 2 (Efficacy)|Extension study|4|||
147428750|NCT00261846|531734597|FG007|Period 2: Part 2 (Efficacy)|Extension study|9|||
147428751|NCT00261846|531734598|FG008|Period 2: Part 2 (Efficacy)|Extension study|5|||
147428752|NCT00261846|531734599|FG009|Period 2: Part 2 (Efficacy)|Extension study|9|||
147428753|NCT00261846|531734600|FG010|Period 2: Part 2 (Efficacy)|Extension study|1|||
147428754|NCT00261846|531734601|FG011|Period 2: Part 2 (Efficacy)|Extension study|1|||
147428755|NCT00325039|531734605|FG000|Overall Study|Lost to Follow-up|18|||
147428756|NCT00325039|531734606|FG001|Overall Study|Lost to Follow-up|14|||
147428757|NCT01009203|531734608|FG000|Overall Study|Withdrawal by Subject|1|||
147428758|NCT01009203|531734608|FG000|Overall Study|Adverse Event|5|||
147428759|NCT01009203|531734608|FG000|Overall Study|Treatment-unrelated death|1|||
147428760|NCT01776424|531734609|FG000|Antithrombotic Part (Double Blind)|Lost to Follow-up|10|||
147428761|NCT01776424|531734610|FG001|Antithrombotic Part (Double Blind)|Lost to Follow-up|8|||
147428762|NCT01776424|531734611|FG002|Antithrombotic Part (Double Blind)|Lost to Follow-up|9|||
147428763|NCT01776424|531734609|FG000|Antithrombotic Part (Double Blind)|Withdrawal by Subject|10|||
147428764|NCT01776424|531734610|FG001|Antithrombotic Part (Double Blind)|Withdrawal by Subject|11|||
147428765|NCT01776424|531734611|FG002|Antithrombotic Part (Double Blind)|Withdrawal by Subject|15|||
147428766|NCT01776424|531734609|FG000|LTOLE Part (Open Label)|Lost to Follow-up|6|||
147428767|NCT01776424|531734610|FG001|LTOLE Part (Open Label)|Lost to Follow-up|2|||
147428768|NCT01776424|531734611|FG002|LTOLE Part (Open Label)|Lost to Follow-up|5|||
147428769|NCT01776424|531734609|FG000|LTOLE Part (Open Label)|Refused|5|||
147428770|NCT01776424|531734610|FG001|LTOLE Part (Open Label)|Refused|2|||
147428771|NCT01776424|531734611|FG002|LTOLE Part (Open Label)|Refused|11|||
147428772|NCT01776424|531734609|FG000|LTOLE Part (Open Label)|Missing final visit|68|||
147428773|NCT01776424|531734610|FG001|LTOLE Part (Open Label)|Missing final visit|58|||
147428774|NCT01776424|531734611|FG002|LTOLE Part (Open Label)|Missing final visit|62|||
147428775|NCT00615836|531734614|FG000|Extension Study (FE992026 CS31)|Adverse Event|7|||
147428776|NCT00615836|531734615|FG001|Extension Study (FE992026 CS31)|Adverse Event|12|||
147428777|NCT00615836|531734616|FG002|Extension Study (FE992026 CS31)|Adverse Event|15|||
147428778|NCT00615836|531734617|FG003|Extension Study (FE992026 CS31)|Adverse Event|13|||
147428779|NCT00615836|531734618|FG004|Extension Study (FE992026 CS31)|Adverse Event|0|||
147428780|NCT00615836|531734614|FG000|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|1|||
147428781|NCT00615836|531734615|FG001|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|0|||
147428782|NCT00615836|531734616|FG002|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|3|||
147428783|NCT00615836|531734617|FG003|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|3|||
147428784|NCT00615836|531734618|FG004|Extension Study (FE992026 CS31)|Serum sodium ≤125 mmol/L|0|||
147428785|NCT00615836|531734614|FG000|Extension Study (FE992026 CS31)|Use of exclusionary medication|1|||
147428786|NCT00615836|531734615|FG001|Extension Study (FE992026 CS31)|Use of exclusionary medication|2|||
147428787|NCT00615836|531734616|FG002|Extension Study (FE992026 CS31)|Use of exclusionary medication|1|||
147428788|NCT00615836|531734617|FG003|Extension Study (FE992026 CS31)|Use of exclusionary medication|0|||
147428789|NCT00615836|531734618|FG004|Extension Study (FE992026 CS31)|Use of exclusionary medication|0|||
147428790|NCT00615836|531734614|FG000|Extension Study (FE992026 CS31)|Protocol Violation|4|||
147428791|NCT00615836|531734615|FG001|Extension Study (FE992026 CS31)|Protocol Violation|5|||
147428792|NCT00615836|531734616|FG002|Extension Study (FE992026 CS31)|Protocol Violation|2|||
147428793|NCT00615836|531734617|FG003|Extension Study (FE992026 CS31)|Protocol Violation|3|||
147428794|NCT00615836|531734618|FG004|Extension Study (FE992026 CS31)|Protocol Violation|0|||
147428795|NCT00615836|531734614|FG000|Extension Study (FE992026 CS31)|Withdrawal by Subject|37|||
147428796|NCT00615836|531734615|FG001|Extension Study (FE992026 CS31)|Withdrawal by Subject|42|||
147428797|NCT00615836|531734616|FG002|Extension Study (FE992026 CS31)|Withdrawal by Subject|38|||
147428798|NCT00615836|531734617|FG003|Extension Study (FE992026 CS31)|Withdrawal by Subject|43|||
147428799|NCT00615836|531734618|FG004|Extension Study (FE992026 CS31)|Withdrawal by Subject|0|||
147428800|NCT00615836|531734614|FG000|Extension Study (FE992026 CS31)|Lost to Follow-up|10|||
147428801|NCT00615836|531734615|FG001|Extension Study (FE992026 CS31)|Lost to Follow-up|14|||
147428802|NCT00615836|531734616|FG002|Extension Study (FE992026 CS31)|Lost to Follow-up|5|||
147428803|NCT00615836|531734617|FG003|Extension Study (FE992026 CS31)|Lost to Follow-up|10|||
147428804|NCT00615836|531734618|FG004|Extension Study (FE992026 CS31)|Lost to Follow-up|0|||
147428805|NCT00615836|531734614|FG000|Extension Study (FE992026 CS31)|Other|10|||
147428806|NCT00615836|531734615|FG001|Extension Study (FE992026 CS31)|Other|7|||
147428807|NCT00615836|531734616|FG002|Extension Study (FE992026 CS31)|Other|8|||
147428808|NCT00615836|531734617|FG003|Extension Study (FE992026 CS31)|Other|8|||
147428809|NCT00615836|531734618|FG004|Extension Study (FE992026 CS31)|Other|0|||
147428810|NCT00615836|531734614|FG000|Extension Study (FE992026 CS31)|Not reported|6|||
147428811|NCT00615836|531734615|FG001|Extension Study (FE992026 CS31)|Not reported|4|||
147428812|NCT00615836|531734616|FG002|Extension Study (FE992026 CS31)|Not reported|1|||
147428813|NCT00615836|531734617|FG003|Extension Study (FE992026 CS31)|Not reported|4|||
147428814|NCT00615836|531734618|FG004|Extension Study (FE992026 CS31)|Not reported|0|||
147428815|NCT00615836|531734614|FG000|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|65|||
147428816|NCT00615836|531734615|FG001|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0|||
147428817|NCT00615836|531734616|FG002|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0|||
147428818|NCT00615836|531734617|FG003|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0|||
147428819|NCT00615836|531734618|FG004|Extension Study (FE992026 CS31)|Re-randomized to a higher dose|0|||
147428820|NCT01630434|531734619|FG000|Overall Study|Donor lungs turned down|1|||
147428821|NCT01630434|531734620|FG001|Overall Study|Donor lungs turned down|0|||
147428822|NCT01630434|531734619|FG000|Overall Study|Protocol Violation|9|||
147428823|NCT01630434|531734620|FG001|Overall Study|Protocol Violation|4|||
147428824|NCT01630434|531734619|FG000|Overall Study|Death|20|||
147428825|NCT01630434|531734620|FG001|Overall Study|Death|26|||
147428826|NCT00687973|531734621|FG000|Overall Study|Adverse Event|18|||
147428827|NCT00687973|531734622|FG001|Overall Study|Adverse Event|28|||
147428828|NCT00687973|531734621|FG000|Overall Study|Lack of Efficacy|2|||
147428829|NCT00687973|531734622|FG001|Overall Study|Lack of Efficacy|3|||
147428830|NCT00687973|531734621|FG000|Overall Study|Protocol Violation|1|||
147428831|NCT00687973|531734622|FG001|Overall Study|Protocol Violation|2|||
147428832|NCT00687973|531734621|FG000|Overall Study|Administrative Reasons|0|||
147428833|NCT00687973|531734622|FG001|Overall Study|Administrative Reasons|2|||
147428834|NCT00687973|531734621|FG000|Overall Study|Withdrawal by Subject|3|||
147428835|NCT00687973|531734622|FG001|Overall Study|Withdrawal by Subject|3|||
147428836|NCT02121834|531734624|FG000|Overall Study|Protocol Violation|0|||
147428837|NCT02121834|531734625|FG001|Overall Study|Protocol Violation|1|||
147428838|NCT02121834|531734626|FG002|Overall Study|Protocol Violation|0|||
147428839|NCT02121834|531734627|FG003|Overall Study|Protocol Violation|0|||
147428840|NCT02121834|531734628|FG004|Overall Study|Protocol Violation|0|||
147428841|NCT02121834|531734629|FG005|Overall Study|Protocol Violation|0|||
147428842|NCT02121834|531734630|FG006|Overall Study|Protocol Violation|0|||
147428843|NCT02121834|531734624|FG000|Overall Study|Withdrawal by Subject|0|||
147428844|NCT02121834|531734625|FG001|Overall Study|Withdrawal by Subject|1|||
147428845|NCT02121834|531734626|FG002|Overall Study|Withdrawal by Subject|1|||
147428846|NCT02121834|531734627|FG003|Overall Study|Withdrawal by Subject|0|||
147428847|NCT02121834|531734628|FG004|Overall Study|Withdrawal by Subject|0|||
147428848|NCT02121834|531734629|FG005|Overall Study|Withdrawal by Subject|0|||
147428849|NCT02121834|531734630|FG006|Overall Study|Withdrawal by Subject|0|||
147428850|NCT02121834|531734624|FG000|Overall Study|Lost to Follow-up|0|||
147428851|NCT02121834|531734625|FG001|Overall Study|Lost to Follow-up|0|||
147428852|NCT02121834|531734626|FG002|Overall Study|Lost to Follow-up|1|||
147428853|NCT02121834|531734627|FG003|Overall Study|Lost to Follow-up|0|||
147428854|NCT02121834|531734628|FG004|Overall Study|Lost to Follow-up|0|||
147428855|NCT02121834|531734629|FG005|Overall Study|Lost to Follow-up|0|||
147428856|NCT02121834|531734630|FG006|Overall Study|Lost to Follow-up|0|||
147428857|NCT02578862|531734631|FG000|Overall Study|Withdrawal by Subject|0|||
147428858|NCT02578862|531734632|FG001|Overall Study|Withdrawal by Subject|1|||
147428859|NCT02578862|531734631|FG000|Overall Study|Unplanned unilateral procedure|0|||
147428860|NCT02578862|531734632|FG001|Overall Study|Unplanned unilateral procedure|1|||
147428861|NCT02075541|531734640|FG000|Overall Study|Serious Adverse Event|1|||
147428862|NCT02075541|531734641|FG001|Overall Study|Serious Adverse Event|4|||
147428863|NCT02075541|531734640|FG000|Overall Study|Protocol Violation|1|||
147428864|NCT02075541|531734641|FG001|Overall Study|Protocol Violation|0|||
147428865|NCT02075541|531734640|FG000|Overall Study|Withdrawal by Subject|1|||
147428866|NCT02075541|531734641|FG001|Overall Study|Withdrawal by Subject|3|||
147428867|NCT02075541|531734640|FG000|Overall Study|Sponsor study termination|0|||
147428868|NCT02075541|531734641|FG001|Overall Study|Sponsor study termination|1|||
147428869|NCT02075541|531734640|FG000|Overall Study|Other- unable to perform study procedure|1|||
147428870|NCT02075541|531734641|FG001|Overall Study|Other- unable to perform study procedure|0|||
147428871|NCT00343252|531734642|FG000|6 Months (All Treated Participants)|Adverse Event|17|||
147428872|NCT00343252|531734643|FG001|6 Months (All Treated Participants)|Adverse Event|11|||
147428873|NCT00343252|531734642|FG000|6 Months (All Treated Participants)|Death|0|||
147428874|NCT00343252|531734643|FG001|6 Months (All Treated Participants)|Death|2|||
147428875|NCT00343252|531734642|FG000|6 Months (All Treated Participants)|Entry Criteria Not Met|10|||
147428876|NCT00343252|531734643|FG001|6 Months (All Treated Participants)|Entry Criteria Not Met|8|||
147428877|NCT00343252|531734642|FG000|6 Months (All Treated Participants)|Lack of Efficacy|0|||
147428878|NCT00343252|531734643|FG001|6 Months (All Treated Participants)|Lack of Efficacy|1|||
147428879|NCT00343252|531734642|FG000|6 Months (All Treated Participants)|Lost to Follow-up|0|||
147428880|NCT00343252|531734643|FG001|6 Months (All Treated Participants)|Lost to Follow-up|4|||
147428881|NCT00343252|531734642|FG000|6 Months (All Treated Participants)|Physician Decision|1|||
147428882|NCT00343252|531734643|FG001|6 Months (All Treated Participants)|Physician Decision|3|||
147428883|NCT00343252|531734642|FG000|6 Months (All Treated Participants)|Protocol Violation|2|||
147428884|NCT00343252|531734643|FG001|6 Months (All Treated Participants)|Protocol Violation|2|||
147428885|NCT00343252|531734642|FG000|6 Months (All Treated Participants)|Sponsor Decision|7|||
147428886|NCT00343252|531734643|FG001|6 Months (All Treated Participants)|Sponsor Decision|4|||
147428887|NCT00343252|531734642|FG000|6 Months (All Treated Participants)|Withdrawal by Subject|19|||
147428888|NCT00343252|531734643|FG001|6 Months (All Treated Participants)|Withdrawal by Subject|9|||
147428889|NCT00343252|531734642|FG000|12 Months (All Treated Participants)|Adverse Event|22|||
147428890|NCT00343252|531734643|FG001|12 Months (All Treated Participants)|Adverse Event|20|||
147428891|NCT00343252|531734642|FG000|12 Months (All Treated Participants)|Death|3|||
147428892|NCT00343252|531734643|FG001|12 Months (All Treated Participants)|Death|3|||
147428893|NCT00343252|531734642|FG000|12 Months (All Treated Participants)|Entry Criteria Not Met|10|||
147428894|NCT00343252|531734643|FG001|12 Months (All Treated Participants)|Entry Criteria Not Met|10|||
147428895|NCT00343252|531734642|FG000|12 Months (All Treated Participants)|Lack of Efficacy|1|||
147428896|NCT00343252|531734643|FG001|12 Months (All Treated Participants)|Lack of Efficacy|1|||
147428897|NCT00343252|531734642|FG000|12 Months (All Treated Participants)|Lost to Follow-up|1|||
147428898|NCT00343252|531734643|FG001|12 Months (All Treated Participants)|Lost to Follow-up|5|||
147428899|NCT00343252|531734642|FG000|12 Months (All Treated Participants)|Physician Decision|4|||
147428900|NCT00343252|531734643|FG001|12 Months (All Treated Participants)|Physician Decision|5|||
147428901|NCT00343252|531734642|FG000|12 Months (All Treated Participants)|Protocol Violation|3|||
147428902|NCT00343252|531734643|FG001|12 Months (All Treated Participants)|Protocol Violation|2|||
147428903|NCT00343252|531734642|FG000|12 Months (All Treated Participants)|Sponsor Decision|9|||
147428904|NCT00343252|531734643|FG001|12 Months (All Treated Participants)|Sponsor Decision|6|||
147428905|NCT00343252|531734642|FG000|12 Months (All Treated Participants)|Withdrawal by Subject|33|||
147428906|NCT00343252|531734643|FG001|12 Months (All Treated Participants)|Withdrawal by Subject|17|||
147428907|NCT00343252|531734642|FG000|18 Months (All Treated Participants)|Adverse Event|31|||
147428908|NCT00343252|531734643|FG001|18 Months (All Treated Participants)|Adverse Event|23|||
147428909|NCT00343252|531734642|FG000|18 Months (All Treated Participants)|Death|4|||
147428910|NCT00343252|531734643|FG001|18 Months (All Treated Participants)|Death|5|||
147428911|NCT00343252|531734642|FG000|18 Months (All Treated Participants)|Entry Criteria Not Met|11|||
147428912|NCT00343252|531734643|FG001|18 Months (All Treated Participants)|Entry Criteria Not Met|10|||
147428913|NCT00343252|531734642|FG000|18 Months (All Treated Participants)|Lack of Efficacy|1|||
147428914|NCT00343252|531734643|FG001|18 Months (All Treated Participants)|Lack of Efficacy|1|||
147428915|NCT00343252|531734642|FG000|18 Months (All Treated Participants)|Lost to Follow-up|3|||
147428916|NCT00343252|531734643|FG001|18 Months (All Treated Participants)|Lost to Follow-up|7|||
147428917|NCT00343252|531734642|FG000|18 Months (All Treated Participants)|Physician Decision|4|||
147428918|NCT00343252|531734643|FG001|18 Months (All Treated Participants)|Physician Decision|7|||
147428919|NCT00343252|531734642|FG000|18 Months (All Treated Participants)|Protocol Violation|3|||
147428920|NCT00343252|531734643|FG001|18 Months (All Treated Participants)|Protocol Violation|3|||
147428921|NCT00343252|531734642|FG000|18 Months (All Treated Participants)|Sponsor Decision|8|||
147428922|NCT00343252|531734643|FG001|18 Months (All Treated Participants)|Sponsor Decision|5|||
147428923|NCT00343252|531734642|FG000|18 Months (All Treated Participants)|Withdrawal by Subject|36|||
147428924|NCT00343252|531734643|FG001|18 Months (All Treated Participants)|Withdrawal by Subject|20|||
147428925|NCT02076178|531734644|FG000|Oral Phase|Adverse Event|0|||
147428926|NCT02076178|531734645|FG001|Oral Phase|Adverse Event|7|||
147428927|NCT02076178|531734644|FG000|Oral Phase|Withdrawal by Subject|0|||
147428928|NCT02076178|531734645|FG001|Oral Phase|Withdrawal by Subject|4|||
147428929|NCT02076178|531734644|FG000|Oral Phase|Physician Decision|0|||
147428930|NCT02076178|531734645|FG001|Oral Phase|Physician Decision|1|||
147428931|NCT02076178|531734644|FG000|Injection Phase|Protocol defined stopping criteria|1|||
147428932|NCT02076178|531734645|FG001|Injection Phase|Protocol defined stopping criteria|0|||
147428933|NCT02076178|531734644|FG000|Injection Phase|Withdrawal by Subject|0|||
147428934|NCT02076178|531734645|FG001|Injection Phase|Withdrawal by Subject|3|||
147428935|NCT02076178|531734644|FG000|Injection Phase|Physician Decision|0|||
147428936|NCT02076178|531734645|FG001|Injection Phase|Physician Decision|3|||
147428937|NCT02076178|531734644|FG000|Injection Phase|Lost to Follow-up|0|||
147428938|NCT02076178|531734645|FG001|Injection Phase|Lost to Follow-up|1|||
147428939|NCT00731120|531734646|FG000|Overall Study|Adverse Event|7|||
147428940|NCT00731120|531734647|FG001|Overall Study|Adverse Event|6|||
147428941|NCT00731120|531734648|FG002|Overall Study|Adverse Event|8|||
147428942|NCT00731120|531734646|FG000|Overall Study|Lack of Efficacy|4|||
147428943|NCT00731120|531734647|FG001|Overall Study|Lack of Efficacy|5|||
147428944|NCT00731120|531734648|FG002|Overall Study|Lack of Efficacy|4|||
147428945|NCT00731120|531734646|FG000|Overall Study|Noncompliance with Study Drug|3|||
147428946|NCT00731120|531734647|FG001|Overall Study|Noncompliance with Study Drug|3|||
147428947|NCT00731120|531734648|FG002|Overall Study|Noncompliance with Study Drug|1|||
147428948|NCT00731120|531734646|FG000|Overall Study|Protocol Deviations|1|||
147428949|NCT00731120|531734647|FG001|Overall Study|Protocol Deviations|6|||
147428950|NCT00731120|531734648|FG002|Overall Study|Protocol Deviations|1|||
147428951|NCT00731120|531734646|FG000|Overall Study|Withdrawal of Consent|13|||
147428952|NCT00731120|531734647|FG001|Overall Study|Withdrawal of Consent|8|||
147428953|NCT00731120|531734648|FG002|Overall Study|Withdrawal of Consent|4|||
147428954|NCT00731120|531734646|FG000|Overall Study|Lost to Follow-up|10|||
147428955|NCT00731120|531734647|FG001|Overall Study|Lost to Follow-up|15|||
147428956|NCT00731120|531734648|FG002|Overall Study|Lost to Follow-up|17|||
147428957|NCT00731120|531734646|FG000|Overall Study|Other|4|||
147428958|NCT00731120|531734647|FG001|Overall Study|Other|0|||
147428959|NCT00731120|531734648|FG002|Overall Study|Other|1|||
147428960|NCT01142596|531734649|FG000|Overall Study|Withdrawal by Subject|9|||
147428961|NCT01142596|531734650|FG001|Overall Study|Withdrawal by Subject|35|||
147428962|NCT01142596|531734649|FG000|Overall Study|Adverse Event|8|||
147428963|NCT01142596|531734650|FG001|Overall Study|Adverse Event|35|||
147428964|NCT01142596|531734649|FG000|Overall Study|Lack of Efficacy|5|||
147428965|NCT01142596|531734650|FG001|Overall Study|Lack of Efficacy|9|||
147428966|NCT01142596|531734649|FG000|Overall Study|Lost to Follow-up|2|||
147428967|NCT01142596|531734650|FG001|Overall Study|Lost to Follow-up|3|||
147428968|NCT01142596|531734649|FG000|Overall Study|Other reason (not specified)|5|||
147428969|NCT01142596|531734650|FG001|Overall Study|Other reason (not specified)|4|||
147428970|NCT02019927|531734651|FG000|Overall Study|Lost to Follow-up|2|||
147428971|NCT02019927|531734652|FG001|Overall Study|Lost to Follow-up|4|||
147428972|NCT02019927|531734653|FG002|Overall Study|Lost to Follow-up|1|||
147428973|NCT02019927|531734654|FG003|Overall Study|Lost to Follow-up|2|||
147428974|NCT02019927|531734655|FG004|Overall Study|Lost to Follow-up|3|||
147428975|NCT02019927|531734656|FG005|Overall Study|Lost to Follow-up|1|||
147428976|NCT00394953|531734659|FG000|First Treatment Period|Adverse Event|1|||
147428977|NCT00394953|531734660|FG001|First Treatment Period|Adverse Event|2|||
147428978|NCT00394953|531734659|FG000|First Treatment Period|Death|6|||
147428979|NCT00394953|531734660|FG001|First Treatment Period|Death|7|||
147428980|NCT00394953|531734659|FG000|First Treatment Period|Lack of Efficacy|1|||
147428981|NCT00394953|531734660|FG001|First Treatment Period|Lack of Efficacy|1|||
147428982|NCT00394953|531734659|FG000|First Treatment Period|Withdrawal by Subject|6|||
147428983|NCT00394953|531734660|FG001|First Treatment Period|Withdrawal by Subject|3|||
147428984|NCT00394953|531734659|FG000|First Treatment Period|Lost to Follow-up|0|||
147428985|NCT00394953|531734660|FG001|First Treatment Period|Lost to Follow-up|1|||
147428986|NCT00394953|531734659|FG000|First Treatment Period|Renal transplant|11|||
147428987|NCT00394953|531734660|FG001|First Treatment Period|Renal transplant|7|||
147428988|NCT00394953|531734659|FG000|First Treatment Period|Not defined|4|||
147428989|NCT00394953|531734660|FG001|First Treatment Period|Not defined|1|||
147428990|NCT00394953|531734659|FG000|Second Treatment Period|Adverse Event|2|||
147428991|NCT00394953|531734660|FG001|Second Treatment Period|Adverse Event|5|||
147428992|NCT00394953|531734659|FG000|Second Treatment Period|Death|8|||
147428993|NCT00394953|531734660|FG001|Second Treatment Period|Death|4|||
147428994|NCT00394953|531734659|FG000|Second Treatment Period|Lack of Efficacy|9|||
147428995|NCT00394953|531734660|FG001|Second Treatment Period|Lack of Efficacy|47|||
147428996|NCT00394953|531734659|FG000|Second Treatment Period|Withdrawal by Subject|3|||
147428997|NCT00394953|531734660|FG001|Second Treatment Period|Withdrawal by Subject|3|||
147428998|NCT00394953|531734659|FG000|Second Treatment Period|Lost to Follow-up|0|||
147428999|NCT00394953|531734660|FG001|Second Treatment Period|Lost to Follow-up|1|||
147429000|NCT00394953|531734659|FG000|Second Treatment Period|Renal transplant|4|||
147429001|NCT00394953|531734660|FG001|Second Treatment Period|Renal transplant|6|||
147429002|NCT00394953|531734659|FG000|Second Treatment Period|Not defined|3|||
147429003|NCT00394953|531734660|FG001|Second Treatment Period|Not defined|8|||
147429004|NCT03181451|531734663|FG000|Overall Study|Adverse Event|0|||
147429005|NCT03181451|531734664|FG001|Overall Study|Adverse Event|1|||
147429006|NCT03181451|531734665|FG002|Overall Study|Adverse Event|0|||
147429007|NCT03181451|531734663|FG000|Overall Study|Withdrawal by Subject|0|||
147429008|NCT03181451|531734664|FG001|Overall Study|Withdrawal by Subject|1|||
147429009|NCT03181451|531734665|FG002|Overall Study|Withdrawal by Subject|0|||
147429010|NCT00928447|531734672|FG000|Overall Study|Withdrawal by Subject|1|||
147429011|NCT00928447|531734672|FG000|Overall Study|Investigator's decision|1|||
147429012|NCT01259284|531734675|FG000|Overall Study|Study Termination|2|||
147429013|NCT01259284|531734676|FG001|Overall Study|Study Termination|0|||
147429014|NCT01259284|531734677|FG002|Overall Study|Study Termination|0|||
147429015|NCT02196714|531734687|FG000|Overall Study|Protocol Violation|0|||
147429016|NCT02196714|531734688|FG001|Overall Study|Protocol Violation|0|||
147429017|NCT02196714|531734689|FG002|Overall Study|Protocol Violation|1|||
147429018|NCT02196714|531734690|FG003|Overall Study|Protocol Violation|0|||
147429019|NCT01592864|531734692|FG000|Overall Study|Withdrawal by Subject|0|||
147429020|NCT01592864|531734693|FG001|Overall Study|Withdrawal by Subject|1|||
147429021|NCT01326533|531734695|FG000|Overall Study|Lost to Follow-up|2|||
147429022|NCT01326533|531734696|FG001|Overall Study|Lost to Follow-up|0|||
147429023|NCT01326533|531734695|FG000|Overall Study|Withdrawal by Subject|1|||
147429024|NCT01326533|531734696|FG001|Overall Study|Withdrawal by Subject|0|||
147429025|NCT01326533|531734695|FG000|Overall Study|Adverse Event|1|||
147429026|NCT01326533|531734696|FG001|Overall Study|Adverse Event|0|||
147429027|NCT00307125|531734699|FG000|Screening Phase|Adverse Event|1|||
147429028|NCT00307125|531734700|FG001|Screening Phase|Adverse Event|0|||
147429029|NCT00307125|531734701|FG002|Screening Phase|Adverse Event|0|||
147429030|NCT00307125|531734699|FG000|Screening Phase|Protocol Violation|27|||
147429031|NCT00307125|531734700|FG001|Screening Phase|Protocol Violation|0|||
147429032|NCT00307125|531734701|FG002|Screening Phase|Protocol Violation|0|||
147429033|NCT00307125|531734699|FG000|Screening Phase|Lost to Follow-up|87|||
147429034|NCT00307125|531734700|FG001|Screening Phase|Lost to Follow-up|0|||
147429035|NCT00307125|531734701|FG002|Screening Phase|Lost to Follow-up|0|||
147429036|NCT00307125|531734699|FG000|Screening Phase|Death|10|||
147429037|NCT00307125|531734700|FG001|Screening Phase|Death|0|||
147429038|NCT00307125|531734701|FG002|Screening Phase|Death|0|||
147429039|NCT00307125|531734699|FG000|Screening Phase|Withdrawal by Subject|77|||
147429040|NCT00307125|531734700|FG001|Screening Phase|Withdrawal by Subject|0|||
147429041|NCT00307125|531734701|FG002|Screening Phase|Withdrawal by Subject|0|||
147429042|NCT00307125|531734699|FG000|Screening Phase|Physician Decision|26|||
147429043|NCT00307125|531734700|FG001|Screening Phase|Physician Decision|0|||
147429044|NCT00307125|531734701|FG002|Screening Phase|Physician Decision|0|||
147429045|NCT00307125|531734699|FG000|Screening Phase|Sponsor Decision|4|||
147429046|NCT00307125|531734700|FG001|Screening Phase|Sponsor Decision|0|||
147429047|NCT00307125|531734701|FG002|Screening Phase|Sponsor Decision|0|||
147429048|NCT00307125|531734699|FG000|Screening Phase|Study Terminated|17|||
147429049|NCT00307125|531734700|FG001|Screening Phase|Study Terminated|0|||
147429050|NCT00307125|531734701|FG002|Screening Phase|Study Terminated|0|||
147429051|NCT00307125|531734699|FG000|Screening Phase|Graft Loss|3|||
147429052|NCT00307125|531734700|FG001|Screening Phase|Graft Loss|0|||
147429053|NCT00307125|531734701|FG002|Screening Phase|Graft Loss|0|||
147429054|NCT00307125|531734699|FG000|Screening Phase|Graft Failure|8|||
147429055|NCT00307125|531734700|FG001|Screening Phase|Graft Failure|0|||
147429056|NCT00307125|531734701|FG002|Screening Phase|Graft Failure|0|||
147429057|NCT00307125|531734699|FG000|Screening Phase|Follow-up period ended on Dec 31, 2011|83|||
147429058|NCT00307125|531734700|FG001|Screening Phase|Follow-up period ended on Dec 31, 2011|0|||
147429059|NCT00307125|531734701|FG002|Screening Phase|Follow-up period ended on Dec 31, 2011|0|||
147429060|NCT00307125|531734699|FG000|Screening Phase|Scheduling issues/Non-compliance|55|||
147429061|NCT00307125|531734700|FG001|Screening Phase|Scheduling issues/Non-compliance|0|||
147429062|NCT00307125|531734701|FG002|Screening Phase|Scheduling issues/Non-compliance|0|||
147429063|NCT00307125|531734699|FG000|Screening Phase|Moved or transferred facilities|34|||
147429064|NCT00307125|531734700|FG001|Screening Phase|Moved or transferred facilities|0|||
147429065|NCT00307125|531734701|FG002|Screening Phase|Moved or transferred facilities|0|||
147429066|NCT00307125|531734699|FG000|Screening Phase|Received Pancreas Transplant|8|||
147429067|NCT00307125|531734700|FG001|Screening Phase|Received Pancreas Transplant|0|||
147429068|NCT00307125|531734701|FG002|Screening Phase|Received Pancreas Transplant|0|||
147429069|NCT00307125|531734699|FG000|Screening Phase|Ineligible for pilot|4|||
147429070|NCT00307125|531734700|FG001|Screening Phase|Ineligible for pilot|0|||
147429071|NCT00307125|531734701|FG002|Screening Phase|Ineligible for pilot|0|||
147429072|NCT00307125|531734699|FG000|Screening Phase|Try to get pregnant|1|||
147429073|NCT00307125|531734700|FG001|Screening Phase|Try to get pregnant|0|||
147429074|NCT00307125|531734701|FG002|Screening Phase|Try to get pregnant|0|||
147429075|NCT00307125|531734699|FG000|Screening Phase|Developed acute leukemia|1|||
147429076|NCT00307125|531734700|FG001|Screening Phase|Developed acute leukemia|0|||
147429077|NCT00307125|531734701|FG002|Screening Phase|Developed acute leukemia|0|||
147429078|NCT00307125|531734699|FG000|Screening Phase|Metastatic colon cancer|1|||
147429079|NCT00307125|531734700|FG001|Screening Phase|Metastatic colon cancer|0|||
147429080|NCT00307125|531734701|FG002|Screening Phase|Metastatic colon cancer|0|||
147429081|NCT00307125|531734699|FG000|Screening Phase|Malignancy|1|||
147429082|NCT00307125|531734700|FG001|Screening Phase|Malignancy|0|||
147429083|NCT00307125|531734701|FG002|Screening Phase|Malignancy|0|||
147429084|NCT00307125|531734699|FG000|Screening Phase|PAK|1|||
147429085|NCT00307125|531734700|FG001|Screening Phase|PAK|0|||
147429086|NCT00307125|531734701|FG002|Screening Phase|PAK|0|||
147429087|NCT00307125|531734699|FG000|Screening Phase|Ineligible|1|||
147429088|NCT00307125|531734700|FG001|Screening Phase|Ineligible|0|||
147429089|NCT00307125|531734701|FG002|Screening Phase|Ineligible|0|||
147429090|NCT00307125|531734699|FG000|Screening Phase|Screen Error|1|||
147429091|NCT00307125|531734700|FG001|Screening Phase|Screen Error|0|||
147429092|NCT00307125|531734701|FG002|Screening Phase|Screen Error|0|||
147429093|NCT00307125|531734699|FG000|Screening Phase|Sample of Anti-HLA Ab was not obtained|1|||
147429094|NCT00307125|531734700|FG001|Screening Phase|Sample of Anti-HLA Ab was not obtained|0|||
147429095|NCT00307125|531734701|FG002|Screening Phase|Sample of Anti-HLA Ab was not obtained|0|||
147429096|NCT00307125|531734699|FG000|Screening Phase|AMR and treated with rituximab|1|||
147429097|NCT00307125|531734700|FG001|Screening Phase|AMR and treated with rituximab|0|||
147429098|NCT00307125|531734701|FG002|Screening Phase|AMR and treated with rituximab|0|||
147429099|NCT00307125|531734699|FG000|Screening Phase|Coronary artery bypass|1|||
147429100|NCT00307125|531734700|FG001|Screening Phase|Coronary artery bypass|0|||
147429101|NCT00307125|531734701|FG002|Screening Phase|Coronary artery bypass|0|||
147429102|NCT00307125|531734699|FG000|Pilot Phase|Lost to Follow-up|0|||
147429103|NCT00307125|531734700|FG001|Pilot Phase|Lost to Follow-up|1|||
147429104|NCT00307125|531734701|FG002|Pilot Phase|Lost to Follow-up|0|||
147192273|NCT00402168|530872155|FG001|Long Term (LT)|Adverse Event|5|||
147429105|NCT00307125|531734699|FG000|Pilot Phase|Withdrawal by Subject|0|||
147429106|NCT00307125|531734700|FG001|Pilot Phase|Withdrawal by Subject|1|||
147429107|NCT00307125|531734701|FG002|Pilot Phase|Withdrawal by Subject|1|||
147429108|NCT00807235|531734702|FG000|Overall Study|Adverse Event|1|||
147429109|NCT00807235|531734703|FG001|Overall Study|Adverse Event|0|||
147429110|NCT00926211|531734704|FG000|Overall Study|Lost to Follow-up|1|||
147429111|NCT01032382|531734707|FG000|Overall Study|Disease dissemination|1|||
147429112|NCT01032382|531734708|FG001|Overall Study|Disease dissemination|1|||
147429113|NCT01032382|531734707|FG000|Overall Study|Treatment failure|3|||
147429114|NCT01032382|531734708|FG001|Overall Study|Treatment failure|1|||
147429115|NCT01032382|531734707|FG000|Overall Study|Index lesion relapse|1|||
147429116|NCT01032382|531734708|FG001|Overall Study|Index lesion relapse|3|||
147429117|NCT01012713|531734709|FG000|Overall Study|Lack of Efficacy|3|||
147429118|NCT01596621|531734711|FG000|Overall Study|Death|4|||
147429119|NCT01596621|531734711|FG000|Overall Study|Withdrawal by Subject|9|||
147429120|NCT01596621|531734711|FG000|Overall Study|Disease Progression|49|||
147429121|NCT01596621|531734711|FG000|Overall Study|Lost to Follow-up|3|||
147429122|NCT01596621|531734711|FG000|Overall Study|Other than specified|13|||
147429123|NCT02988622|531734712|FG000|Overall Study|Lost to Follow-up|17|||
147429124|NCT02390245|531734713|FG000|Phase 2. Randomization Into 2 Groups|Lost to Follow-up|0|||
147429125|NCT02390245|531734714|FG001|Phase 2. Randomization Into 2 Groups|Lost to Follow-up|103|||
147429126|NCT02390245|531734715|FG002|Phase 2. Randomization Into 2 Groups|Lost to Follow-up|104|||
147429127|NCT02390245|531734713|FG000|Phase 3. Ophthalmic Follow-up Adherence|Lost to Follow-up|0|||
147429128|NCT02390245|531734714|FG001|Phase 3. Ophthalmic Follow-up Adherence|Lost to Follow-up|95|||
147429129|NCT02390245|531734715|FG002|Phase 3. Ophthalmic Follow-up Adherence|Lost to Follow-up|106|||
147429130|NCT02864381|531735963|FG000|Overall Study|Death|58|||
147429131|NCT02864381|531735964|FG001|Overall Study|Death|61|||
147429132|NCT02864381|531735963|FG000|Overall Study|Withdrew Consent|5|||
147429133|NCT02864381|531735964|FG001|Overall Study|Withdrew Consent|6|||
147429134|NCT02864381|531735963|FG000|Overall Study|Reason Unknown|7|||
147429135|NCT02864381|531735964|FG001|Overall Study|Reason Unknown|3|||
147429136|NCT02864381|531735963|FG000|Overall Study|Lost to Follow-up|1|||
147429137|NCT02864381|531735964|FG001|Overall Study|Lost to Follow-up|1|||
147429138|NCT02864381|531735963|FG000|Overall Study|Investigator's Discretion|1|||
147429139|NCT02864381|531735964|FG001|Overall Study|Investigator's Discretion|0|||
147429140|NCT02864381|531735963|FG000|Overall Study|Protocol Violation|0|||
147429141|NCT02864381|531735964|FG001|Overall Study|Protocol Violation|1|||
147429142|NCT02120625|531735966|FG000|Overall Study|Physician Decision|2|||
147429143|NCT03278106|531735970|FG000|Overall Study|No protocol treatment|1|||
147429144|NCT01607554|531735972|FG000|Overall Study|Disease progression|2|||
147429145|NCT03952806|531735973|FG000|Randomization Phase (Weeks 1 Through 48)|Adverse Event|26|||
147429146|NCT03952806|531735974|FG001|Randomization Phase (Weeks 1 Through 48)|Adverse Event|15|||
147429147|NCT03952806|531735973|FG000|Randomization Phase (Weeks 1 Through 48)|Disease progression|5|||
147429148|NCT03952806|531735974|FG001|Randomization Phase (Weeks 1 Through 48)|Disease progression|0|||
147429149|NCT03952806|531735973|FG000|Randomization Phase (Weeks 1 Through 48)|Participant request|5|||
147429150|NCT03952806|531735974|FG001|Randomization Phase (Weeks 1 Through 48)|Participant request|5|||
147429151|NCT03952806|531735973|FG000|Randomization Phase (Weeks 1 Through 48)|Withdrawal by Subject|4|||
147429152|NCT03952806|531735974|FG001|Randomization Phase (Weeks 1 Through 48)|Withdrawal by Subject|2|||
147429153|NCT03952806|531735973|FG000|Randomization Phase (Weeks 1 Through 48)|Other|1|||
147429154|NCT03952806|531735974|FG001|Randomization Phase (Weeks 1 Through 48)|Other|0|||
147429155|NCT03952806|531735973|FG000|OLE Phase (48 Weeks)|Adverse Event|18|||
147429156|NCT03952806|531735974|FG001|OLE Phase (48 Weeks)|Adverse Event|29|||
147429157|NCT03952806|531735973|FG000|OLE Phase (48 Weeks)|Disease Progression|6|||
147429158|NCT03952806|531735974|FG001|OLE Phase (48 Weeks)|Disease Progression|9|||
147429159|NCT03952806|531735973|FG000|OLE Phase (48 Weeks)|Participant Request to Discontinue|35|||
147429160|NCT03952806|531735974|FG001|OLE Phase (48 Weeks)|Participant Request to Discontinue|38|||
147429161|NCT03952806|531735973|FG000|OLE Phase (48 Weeks)|Withdrawal by Subject|4|||
147429162|NCT03952806|531735974|FG001|OLE Phase (48 Weeks)|Withdrawal by Subject|5|||
147429163|NCT03952806|531735973|FG000|OLE Phase (48 Weeks)|Other|16|||
147429164|NCT03952806|531735974|FG001|OLE Phase (48 Weeks)|Other|13|||
147429165|NCT01137955|531735975|FG000|Overall Study|Withdrawal by Subject|5|||
147429166|NCT01137955|531735976|FG001|Overall Study|Withdrawal by Subject|4|||
147429167|NCT01211197|531735977|FG000|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
147429168|NCT01211197|531735978|FG001|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
147429169|NCT01211197|531735979|FG002|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
147429170|NCT01211197|531735980|FG003|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
147429171|NCT01211197|531735981|FG004|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
147429172|NCT01211197|531735982|FG005|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
147429173|NCT01211197|531735977|FG000|Washout Period 2 (7 Days)|Adverse Event|1|||
147429174|NCT01211197|531735978|FG001|Washout Period 2 (7 Days)|Adverse Event|0|||
147429175|NCT01211197|531735979|FG002|Washout Period 2 (7 Days)|Adverse Event|0|||
147429176|NCT01211197|531735980|FG003|Washout Period 2 (7 Days)|Adverse Event|0|||
147429177|NCT01211197|531735981|FG004|Washout Period 2 (7 Days)|Adverse Event|0|||
147429178|NCT01211197|531735982|FG005|Washout Period 2 (7 Days)|Adverse Event|0|||
147429179|NCT00892723|531735986|FG000|Overall Study|Lost to Follow-up|1|||
147429180|NCT00892723|531735987|FG001|Overall Study|Lost to Follow-up|3|||
147429181|NCT00892723|531735988|FG002|Overall Study|Lost to Follow-up|1|||
147429182|NCT00892723|531735986|FG000|Overall Study|Withdrawal by Subject|1|||
147429183|NCT00892723|531735987|FG001|Overall Study|Withdrawal by Subject|1|||
147429184|NCT00892723|531735988|FG002|Overall Study|Withdrawal by Subject|1|||
147429185|NCT01026454|531735990|FG000|Second Intervention|Pregnancy|1|||
147429186|NCT01026454|531735991|FG001|Second Intervention|Pregnancy|1|||
147429187|NCT01054846|531735994|FG000|Overall Study|Lost to Follow-up|76|||
147429188|NCT01054846|531735995|FG001|Overall Study|Lost to Follow-up|17|||
147429189|NCT04079803|531735998|FG000|Overall Study|Withdrawal by Subject|0|||
147429190|NCT04079803|531735999|FG001|Overall Study|Withdrawal by Subject|0|||
147429191|NCT04079803|531736000|FG002|Overall Study|Withdrawal by Subject|1|||
147429192|NCT03353350|531736001|FG000|30-week Core Treatment Period|Protocol Violation|1|||
147429193|NCT03353350|531736002|FG001|30-week Core Treatment Period|Protocol Violation|1|||
147429194|NCT03353350|531736003|FG002|30-week Core Treatment Period|Protocol Violation|1|||
147429195|NCT03353350|531736004|FG003|30-week Core Treatment Period|Protocol Violation|0|||
147429196|NCT03353350|531736001|FG000|30-week Core Treatment Period|Other: Not related to COVID-19|2|||
147429197|NCT03353350|531736002|FG001|30-week Core Treatment Period|Other: Not related to COVID-19|2|||
147429198|NCT03353350|531736003|FG002|30-week Core Treatment Period|Other: Not related to COVID-19|2|||
147429199|NCT03353350|531736004|FG003|30-week Core Treatment Period|Other: Not related to COVID-19|0|||
147429200|NCT03353350|531736001|FG000|30-week Core Treatment Period|Adverse Event|0|||
147429201|NCT03353350|531736002|FG001|30-week Core Treatment Period|Adverse Event|4|||
147429202|NCT03353350|531736003|FG002|30-week Core Treatment Period|Adverse Event|2|||
147429203|NCT03353350|531736004|FG003|30-week Core Treatment Period|Adverse Event|3|||
147429204|NCT03353350|531736001|FG000|30-week Core Treatment Period|Withdrawal by Subject|19|||
147429205|NCT03353350|531736002|FG001|30-week Core Treatment Period|Withdrawal by Subject|12|||
147429206|NCT03353350|531736003|FG002|30-week Core Treatment Period|Withdrawal by Subject|19|||
147429207|NCT03353350|531736004|FG003|30-week Core Treatment Period|Withdrawal by Subject|19|||
147429208|NCT03353350|531736001|FG000|26-week Treatment Extension Period|Protocol Violation|2|||
147429209|NCT03353350|531736002|FG001|26-week Treatment Extension Period|Protocol Violation|0|||
147429210|NCT03353350|531736003|FG002|26-week Treatment Extension Period|Protocol Violation|0|||
147429211|NCT03353350|531736004|FG003|26-week Treatment Extension Period|Protocol Violation|0|||
147429212|NCT03353350|531736001|FG000|26-week Treatment Extension Period|Other: Not related to COVID-19|0|||
147429213|NCT03353350|531736002|FG001|26-week Treatment Extension Period|Other: Not related to COVID-19|0|||
147429214|NCT03353350|531736003|FG002|26-week Treatment Extension Period|Other: Not related to COVID-19|1|||
147429215|NCT03353350|531736004|FG003|26-week Treatment Extension Period|Other: Not related to COVID-19|1|||
147429216|NCT03353350|531736001|FG000|26-week Treatment Extension Period|Adverse Event|1|||
147429217|NCT03353350|531736002|FG001|26-week Treatment Extension Period|Adverse Event|0|||
147429218|NCT03353350|531736003|FG002|26-week Treatment Extension Period|Adverse Event|0|||
147429219|NCT03353350|531736004|FG003|26-week Treatment Extension Period|Adverse Event|1|||
147429220|NCT03353350|531736001|FG000|26-week Treatment Extension Period|Withdrawal by Subject|2|||
147429221|NCT03353350|531736002|FG001|26-week Treatment Extension Period|Withdrawal by Subject|3|||
147429222|NCT03353350|531736003|FG002|26-week Treatment Extension Period|Withdrawal by Subject|3|||
147429223|NCT03353350|531736004|FG003|26-week Treatment Extension Period|Withdrawal by Subject|12|||
147429224|NCT03037619|531736005|FG000|Overall Study|Lost to Follow-up|0|||
147429225|NCT03037619|531736006|FG001|Overall Study|Lost to Follow-up|1|||
147429226|NCT01881750|531736013|FG000|Overall Study|Changes in concomitant therapies|2|||
147429227|NCT01881750|531736014|FG001|Overall Study|Changes in concomitant therapies|3|||
147429228|NCT01881750|531736013|FG000|Overall Study|Lost to Follow-up|0|||
147429229|NCT01881750|531736014|FG001|Overall Study|Lost to Follow-up|1|||
147429230|NCT01201265|531736015|FG000|Overall Study|Death|14|||
147429231|NCT01201265|531736015|FG000|Overall Study|Insufficient Therapeutic Response|3|||
147429232|NCT01201265|531736015|FG000|Overall Study|Lost to Follow-up|10|||
147429233|NCT01201265|531736015|FG000|Overall Study|Withdrawal by Subject|7|||
147429234|NCT01201265|531736015|FG000|Overall Study|Disease Progression|4|||
147429235|NCT01575028|531736016|FG000|Overall Study|Physician Decision|0|||
147429236|NCT01575028|531736017|FG001|Overall Study|Physician Decision|1|||
147429237|NCT02409368|531736018|FG000|ECOG Reclassification|Adverse event unrelated to study drug|17|||
147429238|NCT02409368|531736019|FG001|ECOG Reclassification|Adverse event unrelated to study drug|49|||
147429239|NCT02409368|531736020|FG002|ECOG Reclassification|Adverse event unrelated to study drug|12|||
147429240|NCT02409368|531736021|FG003|ECOG Reclassification|Adverse event unrelated to study drug|0|||
147429241|NCT02409368|531736018|FG000|ECOG Reclassification|Death|1|||
147429242|NCT02409368|531736019|FG001|ECOG Reclassification|Death|5|||
147429243|NCT02409368|531736020|FG002|ECOG Reclassification|Death|0|||
147429244|NCT02409368|531736021|FG003|ECOG Reclassification|Death|0|||
147429245|NCT02409368|531736018|FG000|ECOG Reclassification|Disease Progression|113|||
147429246|NCT02409368|531736019|FG001|ECOG Reclassification|Disease Progression|382|||
147429247|NCT02409368|531736020|FG002|ECOG Reclassification|Disease Progression|70|||
147429248|NCT02409368|531736021|FG003|ECOG Reclassification|Disease Progression|1|||
147429249|NCT02409368|531736018|FG000|ECOG Reclassification|Lost to Follow-up|1|||
147429250|NCT02409368|531736019|FG001|ECOG Reclassification|Lost to Follow-up|5|||
147429251|NCT02409368|531736020|FG002|ECOG Reclassification|Lost to Follow-up|0|||
147429252|NCT02409368|531736021|FG003|ECOG Reclassification|Lost to Follow-up|0|||
147429253|NCT02409368|531736018|FG000|ECOG Reclassification|Maximum clinical benefit|6|||
147429254|NCT02409368|531736019|FG001|ECOG Reclassification|Maximum clinical benefit|5|||
147429255|NCT02409368|531736020|FG002|ECOG Reclassification|Maximum clinical benefit|0|||
147429256|NCT02409368|531736021|FG003|ECOG Reclassification|Maximum clinical benefit|0|||
147429257|NCT02409368|531736018|FG000|ECOG Reclassification|Poor/non-compliance|0|||
147429258|NCT02409368|531736019|FG001|ECOG Reclassification|Poor/non-compliance|3|||
147429259|NCT02409368|531736020|FG002|ECOG Reclassification|Poor/non-compliance|2|||
147429260|NCT02409368|531736021|FG003|ECOG Reclassification|Poor/non-compliance|0|||
147429261|NCT02409368|531736018|FG000|ECOG Reclassification|Study drug toxicity|17|||
147429262|NCT02409368|531736019|FG001|ECOG Reclassification|Study drug toxicity|42|||
147429263|NCT02409368|531736020|FG002|ECOG Reclassification|Study drug toxicity|7|||
147429264|NCT02409368|531736021|FG003|ECOG Reclassification|Study drug toxicity|0|||
147429265|NCT02409368|531736018|FG000|ECOG Reclassification|Participant no longer meets study criteria|3|||
147429266|NCT02409368|531736019|FG001|ECOG Reclassification|Participant no longer meets study criteria|8|||
147429267|NCT02409368|531736020|FG002|ECOG Reclassification|Participant no longer meets study criteria|3|||
147429268|NCT02409368|531736021|FG003|ECOG Reclassification|Participant no longer meets study criteria|0|||
147429269|NCT02409368|531736018|FG000|ECOG Reclassification|Participant request to discontinue study treatment|6|||
147429270|NCT02409368|531736019|FG001|ECOG Reclassification|Participant request to discontinue study treatment|6|||
147429271|NCT02409368|531736020|FG002|ECOG Reclassification|Participant request to discontinue study treatment|2|||
147429272|NCT02409368|531736021|FG003|ECOG Reclassification|Participant request to discontinue study treatment|0|||
147429273|NCT02409368|531736018|FG000|ECOG Reclassification|Participant withdrew consent|2|||
147429274|NCT02409368|531736019|FG001|ECOG Reclassification|Participant withdrew consent|3|||
147429275|NCT02409368|531736020|FG002|ECOG Reclassification|Participant withdrew consent|4|||
147429276|NCT02409368|531736021|FG003|ECOG Reclassification|Participant withdrew consent|0|||
147192274|NCT00402168|530872154|FG000|Long Term (LT)|Withdrawal by Subject|4|||
147192275|NCT00402168|530872155|FG001|Long Term (LT)|Withdrawal by Subject|7|||
147429277|NCT02409368|531736018|FG000|ECOG Reclassification|Other Reasons|5|||
147429278|NCT02409368|531736019|FG001|ECOG Reclassification|Other Reasons|26|||
147429279|NCT02409368|531736020|FG002|ECOG Reclassification|Other Reasons|2|||
147429280|NCT02409368|531736021|FG003|ECOG Reclassification|Other Reasons|0|||
147429281|NCT02409368|531736018|FG000|ECOG Reclassification|Administrative reason by sponsor|1|||
147429282|NCT02409368|531736019|FG001|ECOG Reclassification|Administrative reason by sponsor|3|||
147429283|NCT02409368|531736020|FG002|ECOG Reclassification|Administrative reason by sponsor|0|||
147429284|NCT02409368|531736021|FG003|ECOG Reclassification|Administrative reason by sponsor|0|||
147429285|NCT01296347|531736022|FG000|Allocation|Withdrawal by Subject|1|||
147429286|NCT01296347|531736023|FG001|Allocation|Withdrawal by Subject|2|||
147429287|NCT01296347|531736022|FG000|Allocation|Lack of Efficacy|1|||
147429288|NCT01296347|531736023|FG001|Allocation|Lack of Efficacy|2|||
147429289|NCT01296347|531736022|FG000|Allocation|not received infusion|1|||
147429290|NCT01296347|531736023|FG001|Allocation|not received infusion|0|||
147429291|NCT01296347|531736022|FG000|6 Week Follow up|Death|0|||
147429292|NCT01296347|531736023|FG001|6 Week Follow up|Death|1|||
147429293|NCT01296347|531736022|FG000|3 Month Follow up|Death|1|||
147429294|NCT01296347|531736023|FG001|3 Month Follow up|Death|0|||
147429295|NCT01296347|531736022|FG000|3 Month Follow up|Lost to Follow-up|0|||
147429296|NCT01296347|531736023|FG001|3 Month Follow up|Lost to Follow-up|1|||
147429297|NCT01296347|531736022|FG000|6 Month Follow up|Death|2|||
147429298|NCT01296347|531736023|FG001|6 Month Follow up|Death|1|||
147429299|NCT01296347|531736022|FG000|6 Month Follow up|Lost to Follow-up|0|||
147429300|NCT01296347|531736023|FG001|6 Month Follow up|Lost to Follow-up|1|||
147429301|NCT01296347|531736022|FG000|12 Month Follow up|Lost to Follow-up|3|||
147429302|NCT01296347|531736023|FG001|12 Month Follow up|Lost to Follow-up|1|||
147429303|NCT01296347|531736022|FG000|12 Month Follow up|Death|1|||
147429304|NCT01296347|531736023|FG001|12 Month Follow up|Death|1|||
147429305|NCT01296347|531736022|FG000|12 Month Follow up|Withdrawal by Subject|0|||
147429306|NCT01296347|531736023|FG001|12 Month Follow up|Withdrawal by Subject|1|||
147429307|NCT02240693|531736024|FG000|Overall Study|Adverse Event|0|||
147429308|NCT02240693|531736025|FG001|Overall Study|Adverse Event|0|||
147429309|NCT02240693|531736026|FG002|Overall Study|Adverse Event|0|||
147429310|NCT02240693|531736027|FG003|Overall Study|Adverse Event|0|||
147429311|NCT02240693|531736028|FG004|Overall Study|Adverse Event|1|||
147429312|NCT02240693|531736024|FG000|Overall Study|Withdrawal by Subject|0|||
147429313|NCT02240693|531736025|FG001|Overall Study|Withdrawal by Subject|0|||
147429314|NCT02240693|531736026|FG002|Overall Study|Withdrawal by Subject|2|||
147429315|NCT02240693|531736027|FG003|Overall Study|Withdrawal by Subject|1|||
147429316|NCT02240693|531736028|FG004|Overall Study|Withdrawal by Subject|0|||
147429317|NCT02240693|531736024|FG000|Overall Study|Other than specified|0|||
147429318|NCT02240693|531736025|FG001|Overall Study|Other than specified|0|||
147429319|NCT02240693|531736026|FG002|Overall Study|Other than specified|2|||
147429320|NCT02240693|531736027|FG003|Overall Study|Other than specified|0|||
147429321|NCT02240693|531736028|FG004|Overall Study|Other than specified|0|||
147429322|NCT03343301|531736029|FG000|Overall Study|Withdrawal by Subject|1|||
147429323|NCT03343301|531736030|FG001|Overall Study|Withdrawal by Subject|1|||
147429324|NCT03343301|531736029|FG000|Overall Study|Death|0|||
147429325|NCT03343301|531736030|FG001|Overall Study|Death|2|||
147429326|NCT03343301|531736029|FG000|Overall Study|Other|0|||
147429327|NCT03343301|531736030|FG001|Overall Study|Other|6|||
147429328|NCT03343301|531736029|FG000|Overall Study|Missing|2|||
147429329|NCT03343301|531736030|FG001|Overall Study|Missing|0|||
147429330|NCT01585987|531736031|FG000|Randomized|Withdrawal by Subject|0|||
147429331|NCT01585987|531736032|FG001|Randomized|Withdrawal by Subject|4|||
147429332|NCT01585987|531736031|FG000|Randomized|No longer met criteria|0|||
147429333|NCT01585987|531736032|FG001|Randomized|No longer met criteria|2|||
147429334|NCT01585987|531736031|FG000|Treated|Disease Progression|39|||
147429335|NCT01585987|531736032|FG001|Treated|Disease Progression|36|||
147429336|NCT01585987|531736031|FG000|Treated|Study Drug Toxicity|9|||
147429337|NCT01585987|531736032|FG001|Treated|Study Drug Toxicity|5|||
147429338|NCT01585987|531736031|FG000|Treated|Adverse Event|3|||
147429339|NCT01585987|531736032|FG001|Treated|Adverse Event|0|||
147429340|NCT01585987|531736031|FG000|Treated|Withdrawal by Subject|1|||
147429341|NCT01585987|531736032|FG001|Treated|Withdrawal by Subject|2|||
147429342|NCT01585987|531736031|FG000|Treated|Death|1|||
147429343|NCT01585987|531736032|FG001|Treated|Death|0|||
147429344|NCT01585987|531736031|FG000|Treated|Lost to Follow-up|0|||
147429345|NCT01585987|531736032|FG001|Treated|Lost to Follow-up|1|||
147429346|NCT01585987|531736031|FG000|Treated|Maximum Clinical Benefit|0|||
147429347|NCT01585987|531736032|FG001|Treated|Maximum Clinical Benefit|1|||
147429348|NCT01585987|531736031|FG000|Treated|Non-Specified|1|||
147429349|NCT01585987|531736032|FG001|Treated|Non-Specified|2|||
147429350|NCT01585987|531736031|FG000|Treated|Subject Request|0|||
147429351|NCT01585987|531736032|FG001|Treated|Subject Request|1|||
147429352|NCT01585987|531736031|FG000|Treated|Poor/Non-Compliance|0|||
147429353|NCT01585987|531736032|FG001|Treated|Poor/Non-Compliance|1|||
147429354|NCT02041520|531736033|FG000|Overall Study|Adverse Event|2|||
147429355|NCT02041520|531736034|FG001|Overall Study|Adverse Event|1|||
147429356|NCT02041520|531736033|FG000|Overall Study|Withdrawal by Subject|3|||
147429357|NCT02041520|531736034|FG001|Overall Study|Withdrawal by Subject|4|||
147429358|NCT02041520|531736033|FG000|Overall Study|Protocol Violation|1|||
147429359|NCT02041520|531736034|FG001|Overall Study|Protocol Violation|0|||
147429360|NCT02041520|531736033|FG000|Overall Study|Lost to Follow-up|0|||
147429361|NCT02041520|531736034|FG001|Overall Study|Lost to Follow-up|1|||
147429362|NCT02041520|531736033|FG000|Overall Study|Hypothiroidism identified during follow-|0|||
147429363|NCT02041520|531736034|FG001|Overall Study|Hypothiroidism identified during follow-|1|||
147429364|NCT00413972|531736035|FG000|Overall Study|Adverse Event|2|||
147429365|NCT00413972|531736036|FG001|Overall Study|Adverse Event|1|||
147429366|NCT00413972|531736037|FG002|Overall Study|Adverse Event|0|||
147429367|NCT00413972|531736038|FG003|Overall Study|Adverse Event|0|||
147429368|NCT00413972|531736035|FG000|Overall Study|Lost to Follow-up|1|||
147429369|NCT00413972|531736036|FG001|Overall Study|Lost to Follow-up|2|||
147429370|NCT00413972|531736037|FG002|Overall Study|Lost to Follow-up|1|||
147429371|NCT00413972|531736038|FG003|Overall Study|Lost to Follow-up|0|||
147429372|NCT00413972|531736035|FG000|Overall Study|Withdrawal by Subject|4|||
147429373|NCT00413972|531736036|FG001|Overall Study|Withdrawal by Subject|5|||
147429374|NCT00413972|531736037|FG002|Overall Study|Withdrawal by Subject|7|||
147429375|NCT00413972|531736038|FG003|Overall Study|Withdrawal by Subject|2|||
147429376|NCT00413972|531736035|FG000|Overall Study|Protocol Violation|0|||
147429377|NCT00413972|531736036|FG001|Overall Study|Protocol Violation|0|||
147429378|NCT00413972|531736037|FG002|Overall Study|Protocol Violation|2|||
147429379|NCT00413972|531736038|FG003|Overall Study|Protocol Violation|0|||
147429380|NCT00413972|531736035|FG000|Overall Study|Other|0|||
147429381|NCT00413972|531736036|FG001|Overall Study|Other|0|||
147429382|NCT00413972|531736037|FG002|Overall Study|Other|0|||
147429383|NCT00413972|531736038|FG003|Overall Study|Other|1|||
147429384|NCT01898923|531736043|FG000|Overall Study|Lack of Efficacy|5|||
147429385|NCT01898923|531736044|FG001|Overall Study|Lack of Efficacy|6|||
147429386|NCT01898923|531736043|FG000|Overall Study|Adverse Event|3|||
147429387|NCT01898923|531736044|FG001|Overall Study|Adverse Event|1|||
147429388|NCT01898923|531736043|FG000|Overall Study|Lost to Follow-up|0|||
147429389|NCT01898923|531736044|FG001|Overall Study|Lost to Follow-up|1|||
147429390|NCT01898923|531736043|FG000|Overall Study|Withdrawal by Subject|4|||
147429391|NCT01898923|531736044|FG001|Overall Study|Withdrawal by Subject|7|||
147429392|NCT01898923|531736043|FG000|Overall Study|Physician Decision|3|||
147429393|NCT01898923|531736044|FG001|Overall Study|Physician Decision|4|||
147429394|NCT01898923|531736043|FG000|Overall Study|One of the subjects IS NO LONGER USING AQUACEL STANDARD OF CARE AND WAS REMOVED FROM THE STUDY|1|||
147429395|NCT01898923|531736044|FG001|Overall Study|One of the subjects IS NO LONGER USING AQUACEL STANDARD OF CARE AND WAS REMOVED FROM THE STUDY|2|||
147429396|NCT02678247|531736047|FG000|First Intervention (7 Weeks)|Withdrawal by Subject|0|||
147429397|NCT02678247|531736048|FG001|First Intervention (7 Weeks)|Withdrawal by Subject|2|||
147429398|NCT02678247|531736047|FG000|First Intervention (7 Weeks)|Adverse Event|1|||
147429399|NCT02678247|531736048|FG001|First Intervention (7 Weeks)|Adverse Event|2|||
147429400|NCT02678247|531736047|FG000|First Intervention (7 Weeks)|Physician Decision|1|||
147429401|NCT02678247|531736048|FG001|First Intervention (7 Weeks)|Physician Decision|0|||
147429402|NCT02678247|531736047|FG000|Second Intervention (7 Weeks)|Withdrawal by Subject|1|||
147429403|NCT02678247|531736048|FG001|Second Intervention (7 Weeks)|Withdrawal by Subject|1|||
147429404|NCT02678247|531736047|FG000|Second Intervention (7 Weeks)|Adverse Event|2|||
147429405|NCT02678247|531736048|FG001|Second Intervention (7 Weeks)|Adverse Event|1|||
147429406|NCT02678247|531736047|FG000|Second Intervention (7 Weeks)|Physician Decision|1|||
147429407|NCT02678247|531736048|FG001|Second Intervention (7 Weeks)|Physician Decision|0|||
147429408|NCT00723021|531736053|FG000|Intervention Period 4|Adverse Event|0|||
147429409|NCT00723021|531736054|FG001|Intervention Period 4|Adverse Event|0|||
147429410|NCT00723021|531736055|FG002|Intervention Period 4|Adverse Event|0|||
147429411|NCT00723021|531736056|FG003|Intervention Period 4|Adverse Event|0|||
147429412|NCT00723021|531736057|FG004|Intervention Period 4|Adverse Event|1|||
147429413|NCT02739360|531736061|FG000|Overall Study|Adverse Event|1|||
147429414|NCT02739360|531736061|FG000|Overall Study|Study terminated by Sponsor|2|||
147429415|NCT01163916|531736064|FG000|Overall Study|Withdrawal by Subject|2|||
147429416|NCT01163916|531736065|FG001|Overall Study|Withdrawal by Subject|0|||
147429417|NCT01163916|531736066|FG002|Overall Study|Withdrawal by Subject|2|||
147429418|NCT01163916|531736064|FG000|Overall Study|Adverse Event|2|||
147429419|NCT01163916|531736065|FG001|Overall Study|Adverse Event|0|||
147429420|NCT01163916|531736066|FG002|Overall Study|Adverse Event|1|||
147429421|NCT01163916|531736064|FG000|Overall Study|Lack of Efficacy|2|||
147429422|NCT01163916|531736065|FG001|Overall Study|Lack of Efficacy|0|||
147429423|NCT01163916|531736066|FG002|Overall Study|Lack of Efficacy|1|||
147429424|NCT01163916|531736064|FG000|Overall Study|Other|24|||
147429425|NCT01163916|531736065|FG001|Overall Study|Other|4|||
147429426|NCT01163916|531736066|FG002|Overall Study|Other|16|||
147429427|NCT00026208|531736067|FG000|Overall Study|Complications of auto accident|1|||
147429428|NCT00026208|531736068|FG001|Overall Study|Complications of auto accident|0|||
147429429|NCT04002401|531736069|FG000|Overall Study|Rolled Over to Long-term Follow-up Study|13|||
147429430|NCT04002401|531736069|FG000|Overall Study|Death|10|||
147429431|NCT04002401|531736069|FG000|Overall Study|Subject Withdrawal of Consent From Further Follow-up|2|||
147429432|NCT04002401|531736069|FG000|Overall Study|Enrolled but Never Treated|1|||
147429433|NCT04002401|531736069|FG000|Overall Study|Lost to Follow-up|1|||
147192276|NCT00402168|530872154|FG000|Long Term (LT)|Pregnancy|0|||
147192277|NCT00402168|530872155|FG001|Long Term (LT)|Pregnancy|1|||
147192278|NCT00402168|530872154|FG000|Long Term (LT)|Lost to Follow-up|1|||
147192279|NCT00402168|530872155|FG001|Long Term (LT)|Lost to Follow-up|0|||
147192280|NCT00402168|530872154|FG000|Long Term (LT)|Death|4|||
147192281|NCT00402168|530872155|FG001|Long Term (LT)|Death|0|||
147192282|NCT00402168|530872154|FG000|Long Term (LT)|Lack of Efficacy|0|||
147192283|NCT00402168|530872155|FG001|Long Term (LT)|Lack of Efficacy|2|||
147192284|NCT00402168|530872154|FG000|Long Term (LT)|non-specified|1|||
147192285|NCT00402168|530872155|FG001|Long Term (LT)|non-specified|2|||
147192286|NCT00402168|530872154|FG000|Switched From CNI to Belatacept in LT|Withdrawal by Subject|2|||
147192287|NCT00402168|530872155|FG001|Switched From CNI to Belatacept in LT|Withdrawal by Subject|0|||
147192288|NCT00402168|530872154|FG000|Switched From CNI to Belatacept in LT|Adverse Event|4|||
147192289|NCT00402168|530872155|FG001|Switched From CNI to Belatacept in LT|Adverse Event|0|||
147192290|NCT00601835|530872159|FG000|Overall Study|Withdrawal by Subject|9|||
147192291|NCT00601835|530872160|FG001|Overall Study|Withdrawal by Subject|6|||
147192292|NCT00601835|530872159|FG000|Overall Study|Physician Decision|1|||
147192293|NCT00601835|530872160|FG001|Overall Study|Physician Decision|0|||
147192294|NCT00601835|530872159|FG000|Overall Study|Lost to Follow-up|37|||
147429434|NCT00423930|531736070|FG000|Overall Study|Withdrawal by Subject|2|||
147429435|NCT02337751|531736071|FG000|Overall Study|Pretreatment Event/Adverse Event|2|||
147429436|NCT02337751|531736072|FG001|Overall Study|Pretreatment Event/Adverse Event|3|||
147192295|NCT00601835|530872160|FG001|Overall Study|Lost to Follow-up|5|||
147192296|NCT00601835|530872159|FG000|Overall Study|Adverse Event|1|||
147192297|NCT00601835|530872160|FG001|Overall Study|Adverse Event|1|||
147192298|NCT00601835|530872159|FG000|Overall Study|Relocate|12|||
147192299|NCT00601835|530872160|FG001|Overall Study|Relocate|2|||
147192300|NCT02370420|530872163|FG000|Overall Study|Physician Decision|3|||
147192301|NCT02370420|530872164|FG001|Overall Study|Physician Decision|3|||
147429437|NCT02337751|531736071|FG000|Overall Study|Voluntary Withdrawal|6|||
147192302|NCT02370420|530872163|FG000|Overall Study|Lost to Follow-up|11|||
147192303|NCT02370420|530872164|FG001|Overall Study|Lost to Follow-up|9|||
147192304|NCT00880620|530872165|FG000|Overall Study|Adverse Event|4|||
147192305|NCT00880620|530872166|FG001|Overall Study|Adverse Event|5|||
147192306|NCT00880620|530872167|FG002|Overall Study|Adverse Event|15|||
147192307|NCT00880620|530872168|FG003|Overall Study|Adverse Event|15|||
147192308|NCT00880620|530872165|FG000|Overall Study|Death|0|||
147192309|NCT00880620|530872166|FG001|Overall Study|Death|0|||
147192310|NCT00880620|530872167|FG002|Overall Study|Death|1|||
147192311|NCT00880620|530872168|FG003|Overall Study|Death|0|||
147192312|NCT00880620|530872165|FG000|Overall Study|Lack of Efficacy|12|||
147192313|NCT00880620|530872166|FG001|Overall Study|Lack of Efficacy|4|||
147192314|NCT00880620|530872167|FG002|Overall Study|Lack of Efficacy|0|||
147192315|NCT00880620|530872168|FG003|Overall Study|Lack of Efficacy|1|||
147192316|NCT00880620|530872165|FG000|Overall Study|Lost to Follow-up|0|||
147192317|NCT00880620|530872166|FG001|Overall Study|Lost to Follow-up|1|||
147192318|NCT00880620|530872167|FG002|Overall Study|Lost to Follow-up|1|||
147192319|NCT00880620|530872168|FG003|Overall Study|Lost to Follow-up|0|||
147192320|NCT00880620|530872165|FG000|Overall Study|Protocol Violation|0|||
147192321|NCT00880620|530872166|FG001|Overall Study|Protocol Violation|1|||
147192322|NCT00880620|530872167|FG002|Overall Study|Protocol Violation|0|||
147192323|NCT00880620|530872168|FG003|Overall Study|Protocol Violation|2|||
147192324|NCT00880620|530872165|FG000|Overall Study|Withdrawal by Subject|4|||
147192325|NCT00880620|530872166|FG001|Overall Study|Withdrawal by Subject|3|||
147192326|NCT00880620|530872167|FG002|Overall Study|Withdrawal by Subject|1|||
147192327|NCT00880620|530872168|FG003|Overall Study|Withdrawal by Subject|3|||
147192328|NCT00880620|530872165|FG000|Overall Study|Noncompliance|0|||
147192329|NCT00880620|530872166|FG001|Overall Study|Noncompliance|0|||
147192330|NCT00880620|530872167|FG002|Overall Study|Noncompliance|1|||
147192331|NCT00880620|530872168|FG003|Overall Study|Noncompliance|1|||
147192332|NCT00880620|530872165|FG000|Overall Study|Other|1|||
147192333|NCT00880620|530872166|FG001|Overall Study|Other|1|||
147192334|NCT00880620|530872167|FG002|Overall Study|Other|2|||
147192335|NCT00880620|530872168|FG003|Overall Study|Other|2|||
147192336|NCT01400698|530872169|FG000|Overall Study|Lost to Follow-up|2|||
147192337|NCT01400698|530872170|FG001|Overall Study|Lost to Follow-up|5|||
147192338|NCT01400698|530872171|FG002|Overall Study|Lost to Follow-up|2|||
147192339|NCT01400698|530872172|FG003|Overall Study|Lost to Follow-up|1|||
147192340|NCT01400698|530872173|FG004|Overall Study|Lost to Follow-up|4|||
147192341|NCT01400698|530872174|FG005|Overall Study|Lost to Follow-up|3|||
147192342|NCT01400698|530872169|FG000|Overall Study|Withdrawal by Subject|8|||
147192343|NCT01400698|530872170|FG001|Overall Study|Withdrawal by Subject|2|||
147192344|NCT01400698|530872171|FG002|Overall Study|Withdrawal by Subject|0|||
147192345|NCT01400698|530872172|FG003|Overall Study|Withdrawal by Subject|4|||
147192346|NCT01400698|530872173|FG004|Overall Study|Withdrawal by Subject|1|||
147192347|NCT01400698|530872174|FG005|Overall Study|Withdrawal by Subject|3|||
147192348|NCT01400698|530872169|FG000|Overall Study|Protocol Violation|0|||
147192349|NCT01400698|530872170|FG001|Overall Study|Protocol Violation|1|||
147192350|NCT01400698|530872171|FG002|Overall Study|Protocol Violation|0|||
147192351|NCT01400698|530872172|FG003|Overall Study|Protocol Violation|0|||
147192352|NCT01400698|530872173|FG004|Overall Study|Protocol Violation|1|||
147192353|NCT01400698|530872174|FG005|Overall Study|Protocol Violation|0|||
147192354|NCT01400698|530872169|FG000|Overall Study|Non-compliance|0|||
147192355|NCT01400698|530872170|FG001|Overall Study|Non-compliance|1|||
147192356|NCT01400698|530872171|FG002|Overall Study|Non-compliance|0|||
147192357|NCT01400698|530872172|FG003|Overall Study|Non-compliance|1|||
147192358|NCT01400698|530872173|FG004|Overall Study|Non-compliance|0|||
147192359|NCT01400698|530872174|FG005|Overall Study|Non-compliance|0|||
147192360|NCT01400698|530872169|FG000|Overall Study|Adverse Event|1|||
147192361|NCT01400698|530872170|FG001|Overall Study|Adverse Event|0|||
147192362|NCT01400698|530872171|FG002|Overall Study|Adverse Event|0|||
147192363|NCT01400698|530872172|FG003|Overall Study|Adverse Event|0|||
147192364|NCT01400698|530872173|FG004|Overall Study|Adverse Event|0|||
147192365|NCT01400698|530872174|FG005|Overall Study|Adverse Event|0|||
147192366|NCT01400698|530872169|FG000|Overall Study|Other|4|||
147192367|NCT01400698|530872170|FG001|Overall Study|Other|2|||
147192368|NCT01400698|530872171|FG002|Overall Study|Other|0|||
147192369|NCT01400698|530872172|FG003|Overall Study|Other|2|||
147192370|NCT01400698|530872173|FG004|Overall Study|Other|1|||
147192371|NCT01400698|530872174|FG005|Overall Study|Other|0|||
147192372|NCT05316597|530874339|FG000|First Session|Withdrawal by Subject|0|||
147429438|NCT02337751|531736072|FG001|Overall Study|Voluntary Withdrawal|8|||
147429439|NCT02337751|531736071|FG000|Overall Study|Lack of Efficacy|2|||
147429440|NCT02337751|531736072|FG001|Overall Study|Lack of Efficacy|5|||
147429441|NCT02337751|531736071|FG000|Overall Study|Investigator's Judgement|1|||
147429442|NCT02337751|531736072|FG001|Overall Study|Investigator's Judgement|0|||
147429443|NCT02881957|531736077|FG000|Overall Study|Comfort care|0|||
147429444|NCT02881957|531736078|FG001|Overall Study|Comfort care|1|||
147429445|NCT02881957|531736077|FG000|Overall Study|Concurrent trial enrollment|0|||
147429446|NCT02881957|531736078|FG001|Overall Study|Concurrent trial enrollment|1|||
147429447|NCT02881957|531736077|FG000|Overall Study|Discharged within 48 hours|0|||
147429448|NCT02881957|531736078|FG001|Overall Study|Discharged within 48 hours|1|||
147429449|NCT02881957|531736077|FG000|Overall Study|Withdrawal by Subject|2|||
147429450|NCT02881957|531736078|FG001|Overall Study|Withdrawal by Subject|1|||
147429451|NCT02881957|531736077|FG000|Overall Study|Protocol Violation|1|||
147429452|NCT02881957|531736078|FG001|Overall Study|Protocol Violation|0|||
147429453|NCT00959647|531736085|FG000|Overall Study|Adverse Event|2|||
147429454|NCT00959647|531736085|FG000|Overall Study|Progressive disease|6|||
147429455|NCT00959647|531736085|FG000|Overall Study|Study terminated by sponsor|4|||
147429456|NCT00959647|531736085|FG000|Overall Study|Withdrawal by Subject|7|||
147429457|NCT05959629|531736088|FG000|Overall Study|partially necrotic/technical issues|2|||
147429458|NCT05959629|531736089|FG001|Overall Study|partially necrotic/technical issues|2|||
147429459|NCT05677893|531737720|FG000|Overall Study|Withdrawal by Subject|0|||
147429460|NCT05677893|531737721|FG001|Overall Study|Withdrawal by Subject|0|||
147429461|NCT05677893|531737722|FG002|Overall Study|Withdrawal by Subject|0|||
147429462|NCT05677893|531737723|FG003|Overall Study|Withdrawal by Subject|0|||
147429463|NCT05677893|531737724|FG004|Overall Study|Withdrawal by Subject|1|||
147429464|NCT05677893|531737725|FG005|Overall Study|Withdrawal by Subject|1|||
147429465|NCT05677893|531737726|FG006|Overall Study|Withdrawal by Subject|0|||
147192373|NCT05316597|530874340|FG001|First Session|Withdrawal by Subject|1|||
147192374|NCT05316597|530874339|FG000|Washout Period|Lost to Follow-up|1|||
147192375|NCT05316597|530874340|FG001|Washout Period|Lost to Follow-up|2|||
147192376|NCT05316597|530874339|FG000|Washout Period|Physician Decision|1|||
147192377|NCT05316597|530874340|FG001|Washout Period|Physician Decision|1|||
147192378|NCT05316597|530874339|FG000|Washout Period|Excluded before second session|1|||
147192379|NCT05316597|530874340|FG001|Washout Period|Excluded before second session|1|||
147192380|NCT05316597|530874339|FG000|Washout Period|Withdrawal by Subject|0|||
147192381|NCT05316597|530874340|FG001|Washout Period|Withdrawal by Subject|4|||
147192382|NCT01706458|530874343|FG000|Overall Study|Physician Decision|3|||
147192383|NCT01706458|530874344|FG001|Overall Study|Physician Decision|4|||
147192384|NCT03547518|530874345|FG000|Overall Study|Lost to Follow-up|2|||
147192385|NCT03547518|530874346|FG001|Overall Study|Lost to Follow-up|0|||
147192386|NCT03192176|530874352|FG000|Overall Study|Adverse Event|1|||
147192387|NCT03192176|530874353|FG001|Overall Study|Adverse Event|0|||
147192388|NCT03192176|530874354|FG002|Overall Study|Adverse Event|4|||
147192389|NCT03192176|530874355|FG003|Overall Study|Adverse Event|5|||
147192390|NCT03192176|530874356|FG004|Overall Study|Adverse Event|3|||
147192391|NCT03192176|530874357|FG005|Overall Study|Adverse Event|2|||
147192392|NCT03192176|530874358|FG006|Overall Study|Adverse Event|3|||
147192393|NCT03192176|530874359|FG007|Overall Study|Adverse Event|3|||
147192394|NCT03192176|530874352|FG000|Overall Study|Lost to Follow-up|0|||
147192395|NCT03192176|530874353|FG001|Overall Study|Lost to Follow-up|0|||
147192396|NCT03192176|530874354|FG002|Overall Study|Lost to Follow-up|1|||
147192397|NCT03192176|530874355|FG003|Overall Study|Lost to Follow-up|2|||
147192398|NCT03192176|530874356|FG004|Overall Study|Lost to Follow-up|3|||
147192399|NCT03192176|530874357|FG005|Overall Study|Lost to Follow-up|1|||
147192400|NCT03192176|530874358|FG006|Overall Study|Lost to Follow-up|1|||
147192401|NCT03192176|530874359|FG007|Overall Study|Lost to Follow-up|1|||
147192402|NCT03192176|530874352|FG000|Overall Study|Physician Decision|1|||
147192403|NCT03192176|530874353|FG001|Overall Study|Physician Decision|0|||
147192404|NCT03192176|530874354|FG002|Overall Study|Physician Decision|0|||
147192405|NCT03192176|530874355|FG003|Overall Study|Physician Decision|0|||
147192406|NCT03192176|530874356|FG004|Overall Study|Physician Decision|0|||
147192407|NCT03192176|530874357|FG005|Overall Study|Physician Decision|2|||
147192408|NCT03192176|530874358|FG006|Overall Study|Physician Decision|1|||
147192409|NCT03192176|530874359|FG007|Overall Study|Physician Decision|0|||
147192410|NCT03192176|530874352|FG000|Overall Study|Protocol Deviation|1|||
147429466|NCT05677893|531737720|FG000|Overall Study|Others|1|||
147429467|NCT05677893|531737721|FG001|Overall Study|Others|0|||
147429468|NCT05677893|531737722|FG002|Overall Study|Others|0|||
147429469|NCT05677893|531737723|FG003|Overall Study|Others|0|||
147429470|NCT05677893|531737724|FG004|Overall Study|Others|0|||
147429471|NCT05677893|531737725|FG005|Overall Study|Others|0|||
147429472|NCT05677893|531737726|FG006|Overall Study|Others|0|||
147429473|NCT01717989|531737733|FG000|Overall Study|Ineligibility determined|6|||
147429474|NCT01717989|531737733|FG000|Overall Study|Protocol deviation|6|||
147429475|NCT01717989|531737733|FG000|Overall Study|Withdrawal by Subject|11|||
147429476|NCT01717989|531737733|FG000|Overall Study|Physician Decision|2|||
147429477|NCT01717989|531737733|FG000|Overall Study|Lost to Follow-up|11|||
147429478|NCT01717989|531737733|FG000|Overall Study|Death|439|||
147429479|NCT01717989|531737733|FG000|Overall Study|Protocol-specified criteria|551|||
147429480|NCT01717989|531737733|FG000|Overall Study|Other|40|||
147429481|NCT03224325|531737734|FG000|Overall Study|Adverse Event|1|||
147429482|NCT03224325|531737735|FG001|Overall Study|Adverse Event|0|||
147429483|NCT03224325|531737736|FG002|Overall Study|Adverse Event|0|||
147429484|NCT03224325|531737737|FG003|Overall Study|Adverse Event|0|||
147429485|NCT03224325|531737738|FG004|Overall Study|Adverse Event|0|||
147429486|NCT03224325|531737739|FG005|Overall Study|Adverse Event|0|||
147429487|NCT03224325|531737740|FG006|Overall Study|Adverse Event|1|||
147192411|NCT03192176|530874353|FG001|Overall Study|Protocol Deviation|1|||
147192412|NCT03192176|530874354|FG002|Overall Study|Protocol Deviation|0|||
147192413|NCT03192176|530874355|FG003|Overall Study|Protocol Deviation|0|||
147192414|NCT03192176|530874356|FG004|Overall Study|Protocol Deviation|2|||
147192415|NCT03192176|530874357|FG005|Overall Study|Protocol Deviation|0|||
147192416|NCT03192176|530874358|FG006|Overall Study|Protocol Deviation|0|||
147192417|NCT03192176|530874359|FG007|Overall Study|Protocol Deviation|0|||
147192418|NCT03192176|530874352|FG000|Overall Study|Withdrawal by Subject|3|||
147192419|NCT03192176|530874353|FG001|Overall Study|Withdrawal by Subject|4|||
147192420|NCT03192176|530874354|FG002|Overall Study|Withdrawal by Subject|0|||
147192421|NCT03192176|530874355|FG003|Overall Study|Withdrawal by Subject|4|||
147192422|NCT03192176|530874356|FG004|Overall Study|Withdrawal by Subject|3|||
147429488|NCT03224325|531737734|FG000|Overall Study|Withdrawal by Subject|0|||
147429489|NCT03224325|531737735|FG001|Overall Study|Withdrawal by Subject|0|||
147429490|NCT03224325|531737736|FG002|Overall Study|Withdrawal by Subject|0|||
147429491|NCT03224325|531737737|FG003|Overall Study|Withdrawal by Subject|1|||
147429492|NCT03224325|531737738|FG004|Overall Study|Withdrawal by Subject|0|||
147429493|NCT03224325|531737739|FG005|Overall Study|Withdrawal by Subject|0|||
147429494|NCT03224325|531737740|FG006|Overall Study|Withdrawal by Subject|0|||
147429495|NCT02525861|531737741|FG000|Overall Study|Adverse Event|1|||
147192423|NCT03192176|530874357|FG005|Overall Study|Withdrawal by Subject|4|||
147192424|NCT03192176|530874358|FG006|Overall Study|Withdrawal by Subject|4|||
147192425|NCT03192176|530874359|FG007|Overall Study|Withdrawal by Subject|2|||
147192426|NCT03192176|530874352|FG000|Overall Study|Miscellaneous|1|||
147192427|NCT03192176|530874353|FG001|Overall Study|Miscellaneous|0|||
147192428|NCT03192176|530874354|FG002|Overall Study|Miscellaneous|1|||
147192429|NCT03192176|530874355|FG003|Overall Study|Miscellaneous|1|||
147192430|NCT03192176|530874356|FG004|Overall Study|Miscellaneous|1|||
147192431|NCT03192176|530874357|FG005|Overall Study|Miscellaneous|2|||
147192432|NCT03192176|530874358|FG006|Overall Study|Miscellaneous|0|||
147192433|NCT03192176|530874359|FG007|Overall Study|Miscellaneous|1|||
147192434|NCT02384551|530874362|FG000|Overall Study|Lost to Follow-up|13|||
147192435|NCT02384551|530874363|FG001|Overall Study|Lost to Follow-up|14|||
147192436|NCT02384551|530874364|FG002|Overall Study|Lost to Follow-up|14|||
147192437|NCT02384551|530874365|FG003|Overall Study|Lost to Follow-up|14|||
147192438|NCT04247347|530874370|FG000|Overall Study|Withdrawal by Subject|2|||
147192439|NCT04247347|530874371|FG001|Overall Study|Withdrawal by Subject|3|||
147192440|NCT04247347|530874372|FG002|Overall Study|Withdrawal by Subject|3|||
147192441|NCT04247347|530874370|FG000|Overall Study|Lost to Follow-up|1|||
147192442|NCT04247347|530874371|FG001|Overall Study|Lost to Follow-up|1|||
147192443|NCT04247347|530874372|FG002|Overall Study|Lost to Follow-up|1|||
147192444|NCT03035032|530874373|FG000|Overall Study|Adverse Event|2|||
147192445|NCT03035032|530874373|FG000|Overall Study|Death|9|||
147192446|NCT03035032|530874373|FG000|Overall Study|Lost to Follow-up|1|||
147192447|NCT03035032|530874373|FG000|Overall Study|Progressive Disease|22|||
147192448|NCT03035032|530874373|FG000|Overall Study|Protocol Violation|2|||
147192449|NCT03035032|530874373|FG000|Overall Study|Withdrawal by Subject|2|||
147192450|NCT03035032|530874373|FG000|Overall Study|Physician Decision|5|||
147192451|NCT02399215|530874388|FG000|Overall Study|bowel obstruction (unrelated to dis-ease)|1|||
147192452|NCT02399215|530874388|FG000|Overall Study|Withdrawal by Subject|1|||
147192453|NCT00772538|530874389|FG000|Overall Study|Adverse Event|6|||
147192454|NCT00772538|530874390|FG001|Overall Study|Adverse Event|6|||
147192455|NCT00772538|530874389|FG000|Overall Study|Protocol Violation|3|||
147192456|NCT00772538|530874390|FG001|Overall Study|Protocol Violation|3|||
147192457|NCT00772538|530874389|FG000|Overall Study|Lost to Follow-up|1|||
147192458|NCT00772538|530874390|FG001|Overall Study|Lost to Follow-up|1|||
147192459|NCT00772538|530874389|FG000|Overall Study|Withdrawal by Subject|3|||
147192460|NCT00772538|530874390|FG001|Overall Study|Withdrawal by Subject|8|||
147192461|NCT00772538|530874389|FG000|Overall Study|Lack of Efficacy|0|||
147192462|NCT00772538|530874390|FG001|Overall Study|Lack of Efficacy|1|||
147192463|NCT00772538|530874389|FG000|Overall Study|Other|7|||
147192464|NCT00772538|530874390|FG001|Overall Study|Other|7|||
147192465|NCT00189540|530874391|FG000|Overall Study|Withdrawal by Subject|3|||
147192466|NCT00189540|530874392|FG001|Overall Study|Withdrawal by Subject|0|||
147192467|NCT00189540|530874391|FG000|Overall Study|Death|4|||
147192468|NCT00189540|530874392|FG001|Overall Study|Death|1|||
147192469|NCT01089504|530874393|FG000|Overall Study|Lost to Follow-up|1|||
147192470|NCT01089504|530874394|FG001|Overall Study|Lost to Follow-up|1|||
147192471|NCT01089504|530874393|FG000|Overall Study|Withdrawal by Subject|2|||
147192472|NCT01089504|530874394|FG001|Overall Study|Withdrawal by Subject|0|||
147192473|NCT00001832|530874395|FG000|Apheresis Period|not able to manufacture treatment cells|60|||
147192474|NCT00001832|530874396|FG001|Apheresis Period|not able to manufacture treatment cells|0|||
147192475|NCT00001832|530874397|FG002|Apheresis Period|not able to manufacture treatment cells|0|||
147192476|NCT00001832|530874398|FG003|Apheresis Period|not able to manufacture treatment cells|0|||
147192477|NCT00001832|530874399|FG004|Apheresis Period|not able to manufacture treatment cells|0|||
147429496|NCT02525861|531737742|FG001|Overall Study|Adverse Event|0|||
147429497|NCT02525861|531737741|FG000|Overall Study|Withdrawal by Subject|0|||
147429498|NCT02525861|531737742|FG001|Overall Study|Withdrawal by Subject|1|||
147429499|NCT02525861|531737741|FG000|Overall Study|Physician Decision|0|||
147192478|NCT00001832|530874400|FG005|Apheresis Period|not able to manufacture treatment cells|0|||
147192479|NCT00001832|530874401|FG006|Apheresis Period|not able to manufacture treatment cells|0|||
147192480|NCT00001832|530874402|FG007|Apheresis Period|not able to manufacture treatment cells|0|||
147192481|NCT00001832|530874403|FG008|Apheresis Period|not able to manufacture treatment cells|0|||
147192482|NCT00001832|530874404|FG009|Apheresis Period|not able to manufacture treatment cells|0|||
147192483|NCT00001832|530874405|FG010|Apheresis Period|not able to manufacture treatment cells|0|||
147192484|NCT00001832|530874406|FG011|Apheresis Period|not able to manufacture treatment cells|0|||
147192485|NCT00001832|530874407|FG012|Apheresis Period|not able to manufacture treatment cells|0|||
147192486|NCT00001832|530874408|FG013|Apheresis Period|not able to manufacture treatment cells|0|||
147192487|NCT00001832|530874409|FG014|Apheresis Period|not able to manufacture treatment cells|0|||
147192488|NCT00001832|530874395|FG000|Treatment Period|Death during treatment|0|||
147192489|NCT00001832|530874396|FG001|Treatment Period|Death during treatment|0|||
147192490|NCT00001832|530874397|FG002|Treatment Period|Death during treatment|0|||
147192491|NCT00001832|530874398|FG003|Treatment Period|Death during treatment|0|||
147192492|NCT00001832|530874399|FG004|Treatment Period|Death during treatment|0|||
147192493|NCT00001832|530874400|FG005|Treatment Period|Death during treatment|1|||
147192494|NCT00001832|530874401|FG006|Treatment Period|Death during treatment|0|||
147192495|NCT00001832|530874402|FG007|Treatment Period|Death during treatment|0|||
147192496|NCT00001832|530874403|FG008|Treatment Period|Death during treatment|0|||
147192497|NCT00001832|530874404|FG009|Treatment Period|Death during treatment|0|||
147192498|NCT00001832|530874405|FG010|Treatment Period|Death during treatment|0|||
147192499|NCT00001832|530874406|FG011|Treatment Period|Death during treatment|0|||
147192500|NCT00001832|530874407|FG012|Treatment Period|Death during treatment|0|||
147192501|NCT00001832|530874408|FG013|Treatment Period|Death during treatment|0|||
147192502|NCT00001832|530874409|FG014|Treatment Period|Death during treatment|0|||
147192503|NCT00001832|530874395|FG000|Treatment Period|Not treated|0|||
147192504|NCT00001832|530874396|FG001|Treatment Period|Not treated|0|||
147192505|NCT00001832|530874397|FG002|Treatment Period|Not treated|0|||
147192506|NCT00001832|530874398|FG003|Treatment Period|Not treated|0|||
147192507|NCT00001832|530874399|FG004|Treatment Period|Not treated|0|||
147192508|NCT00001832|530874400|FG005|Treatment Period|Not treated|0|||
147192509|NCT00001832|530874401|FG006|Treatment Period|Not treated|0|||
147192510|NCT00001832|530874402|FG007|Treatment Period|Not treated|1|||
147192511|NCT00001832|530874403|FG008|Treatment Period|Not treated|0|||
147192512|NCT00001832|530874404|FG009|Treatment Period|Not treated|0|||
147192513|NCT00001832|530874405|FG010|Treatment Period|Not treated|0|||
147192514|NCT00001832|530874406|FG011|Treatment Period|Not treated|0|||
147192515|NCT00001832|530874407|FG012|Treatment Period|Not treated|0|||
147192516|NCT00001832|530874408|FG013|Treatment Period|Not treated|0|||
147192517|NCT00001832|530874409|FG014|Treatment Period|Not treated|0|||
147192518|NCT00713609|530874410|FG000|Overall Study|Adverse Event|2|||
147192519|NCT00713609|530874411|FG001|Overall Study|Adverse Event|0|||
147192520|NCT00713609|530874412|FG002|Overall Study|Adverse Event|2|||
147192521|NCT00713609|530874413|FG003|Overall Study|Adverse Event|2|||
147192522|NCT00713609|530874414|FG004|Overall Study|Adverse Event|3|||
147192523|NCT00713609|530874415|FG005|Overall Study|Adverse Event|1|||
147429500|NCT02525861|531737742|FG001|Overall Study|Physician Decision|1|||
147429501|NCT02027701|531737746|FG000|Overall Study|Adverse Event|3|||
147429502|NCT02027701|531737746|FG000|Overall Study|Lack of Efficacy|8|||
147429503|NCT02027701|531737746|FG000|Overall Study|Physician Decision|2|||
147429504|NCT02027701|531737746|FG000|Overall Study|Withdrawal by Subject|3|||
147429505|NCT00756470|531737747|FG000|Overall Study|Withdrawal by Subject|1|||
147429506|NCT00756470|531737747|FG000|Overall Study|Adverse Event|4|||
147429507|NCT00820027|531737748|FG000|Overall Study|Adverse Event|15|||
147429508|NCT00820027|531737749|FG001|Overall Study|Adverse Event|8|||
147429509|NCT00820027|531737750|FG002|Overall Study|Adverse Event|10|||
147429510|NCT00820027|531737751|FG003|Overall Study|Adverse Event|5|||
147429511|NCT00820027|531737748|FG000|Overall Study|Lack of Efficacy|2|||
147192524|NCT00713609|530874410|FG000|Overall Study|Lost to Follow-up|5|||
147192525|NCT00713609|530874411|FG001|Overall Study|Lost to Follow-up|7|||
147192526|NCT00713609|530874412|FG002|Overall Study|Lost to Follow-up|5|||
147192527|NCT00713609|530874413|FG003|Overall Study|Lost to Follow-up|5|||
147192528|NCT00713609|530874414|FG004|Overall Study|Lost to Follow-up|7|||
147192529|NCT00713609|530874415|FG005|Overall Study|Lost to Follow-up|0|||
147192530|NCT00713609|530874410|FG000|Overall Study|Lack of Efficacy|1|||
147192531|NCT00713609|530874411|FG001|Overall Study|Lack of Efficacy|3|||
147192532|NCT00713609|530874412|FG002|Overall Study|Lack of Efficacy|0|||
147192533|NCT00713609|530874413|FG003|Overall Study|Lack of Efficacy|0|||
147192534|NCT00713609|530874414|FG004|Overall Study|Lack of Efficacy|1|||
147192535|NCT00713609|530874415|FG005|Overall Study|Lack of Efficacy|0|||
147192536|NCT00713609|530874410|FG000|Overall Study|Non-Compliance with Study Treatment|1|||
147192537|NCT00713609|530874411|FG001|Overall Study|Non-Compliance with Study Treatment|1|||
147192538|NCT00713609|530874412|FG002|Overall Study|Non-Compliance with Study Treatment|2|||
147429512|NCT00820027|531737749|FG001|Overall Study|Lack of Efficacy|1|||
147429513|NCT00820027|531737750|FG002|Overall Study|Lack of Efficacy|2|||
147429514|NCT00820027|531737751|FG003|Overall Study|Lack of Efficacy|2|||
147429515|NCT00820027|531737748|FG000|Overall Study|Physician Decision|0|||
147429516|NCT00820027|531737749|FG001|Overall Study|Physician Decision|1|||
147429517|NCT00820027|531737750|FG002|Overall Study|Physician Decision|1|||
147429518|NCT00820027|531737751|FG003|Overall Study|Physician Decision|0|||
147429519|NCT00820027|531737748|FG000|Overall Study|Protocol Violation|3|||
147429520|NCT00820027|531737749|FG001|Overall Study|Protocol Violation|0|||
147429521|NCT00820027|531737750|FG002|Overall Study|Protocol Violation|4|||
147429522|NCT00820027|531737751|FG003|Overall Study|Protocol Violation|0|||
147429523|NCT00820027|531737748|FG000|Overall Study|Withdrawal by Subject|6|||
147429524|NCT00820027|531737749|FG001|Overall Study|Withdrawal by Subject|4|||
147429525|NCT00820027|531737750|FG002|Overall Study|Withdrawal by Subject|4|||
147429526|NCT00820027|531737751|FG003|Overall Study|Withdrawal by Subject|6|||
147429527|NCT02982187|531737752|FG000|Overall Study|Withdrawal by Subject|0|||
147429528|NCT02982187|531737753|FG001|Overall Study|Withdrawal by Subject|0|||
147429529|NCT02982187|531737754|FG002|Overall Study|Withdrawal by Subject|0|||
147429530|NCT02982187|531737755|FG003|Overall Study|Withdrawal by Subject|0|||
147429531|NCT02982187|531737756|FG004|Overall Study|Withdrawal by Subject|0|||
147429532|NCT02982187|531737757|FG005|Overall Study|Withdrawal by Subject|0|||
147429533|NCT02982187|531737758|FG006|Overall Study|Withdrawal by Subject|1|||
147429534|NCT02982187|531737759|FG007|Overall Study|Withdrawal by Subject|0|||
147429535|NCT01978262|531737760|FG000|Overall Study|Withdrawal by Subject|9|||
147429536|NCT01978262|531737760|FG000|Overall Study|Lost to Follow-up|2|||
147429537|NCT02604433|531737761|FG000|Overall Study|Withdrawal by Subject|37|||
147429538|NCT02604433|531737762|FG001|Overall Study|Withdrawal by Subject|16|||
147429539|NCT02604433|531737761|FG000|Overall Study|Adverse Event|4|||
147429540|NCT02604433|531737762|FG001|Overall Study|Adverse Event|0|||
147429541|NCT02604433|531737761|FG000|Overall Study|Other reasons|3|||
147429542|NCT02604433|531737762|FG001|Overall Study|Other reasons|5|||
147429543|NCT02604433|531737761|FG000|Overall Study|Death|4|||
147429544|NCT02604433|531737762|FG001|Overall Study|Death|1|||
147429545|NCT02604433|531737761|FG000|Overall Study|Transition to Rollover Protocol|169|||
147429546|NCT02604433|531737762|FG001|Overall Study|Transition to Rollover Protocol|82|||
147429547|NCT02604433|531737761|FG000|Overall Study|Physician Decision|1|||
147429548|NCT02604433|531737762|FG001|Overall Study|Physician Decision|1|||
147429549|NCT02604433|531737761|FG000|Overall Study|Lack of Efficacy|0|||
147429550|NCT02604433|531737762|FG001|Overall Study|Lack of Efficacy|1|||
147429551|NCT03285178|531737763|FG000|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|3|||
147429552|NCT03285178|531737764|FG001|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
147429553|NCT03285178|531737765|FG002|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
147429554|NCT03285178|531737766|FG003|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
147429555|NCT03285178|531737767|FG004|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
147429556|NCT03285178|531737768|FG005|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
147429557|NCT03285178|531737769|FG006|Single-Blind Run-In Period|COVID-19 Pandemic Precautions - Suspended by Institutional Review Board (IRB)|0|||
147429558|NCT03285178|531737763|FG000|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|1|||
147429559|NCT03285178|531737764|FG001|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
147429560|NCT03285178|531737765|FG002|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
147429561|NCT03285178|531737766|FG003|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
147429562|NCT03285178|531737767|FG004|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
147429563|NCT03285178|531737768|FG005|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
147429564|NCT03285178|531737769|FG006|Single-Blind Run-In Period|COVID-19 Pandemic Precautions- Suspended per Local Guidelines|0|||
147429565|NCT03285178|531737763|FG000|Single-Blind Run-In Period|Protocol Violation|11|||
147429566|NCT03285178|531737764|FG001|Single-Blind Run-In Period|Protocol Violation|0|||
147429567|NCT03285178|531737765|FG002|Single-Blind Run-In Period|Protocol Violation|0|||
147429568|NCT03285178|531737766|FG003|Single-Blind Run-In Period|Protocol Violation|0|||
147429569|NCT03285178|531737767|FG004|Single-Blind Run-In Period|Protocol Violation|0|||
147429570|NCT03285178|531737768|FG005|Single-Blind Run-In Period|Protocol Violation|0|||
147429571|NCT03285178|531737769|FG006|Single-Blind Run-In Period|Protocol Violation|0|||
147429572|NCT03285178|531737763|FG000|Single-Blind Run-In Period|Withdrawal by Subject|1|||
147429573|NCT03285178|531737764|FG001|Single-Blind Run-In Period|Withdrawal by Subject|0|||
147429574|NCT03285178|531737765|FG002|Single-Blind Run-In Period|Withdrawal by Subject|0|||
147429575|NCT03285178|531737766|FG003|Single-Blind Run-In Period|Withdrawal by Subject|0|||
147532747|NCT01243762|532105986|FG004|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|1|||
147532748|NCT01243762|532105987|FG005|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0|||
147429576|NCT03285178|531737767|FG004|Single-Blind Run-In Period|Withdrawal by Subject|0|||
147429577|NCT03285178|531737768|FG005|Single-Blind Run-In Period|Withdrawal by Subject|0|||
147429578|NCT03285178|531737769|FG006|Single-Blind Run-In Period|Withdrawal by Subject|0|||
147429579|NCT03285178|531737763|FG000|Single-Blind Run-In Period|Physician Decision|2|||
147429580|NCT03285178|531737764|FG001|Single-Blind Run-In Period|Physician Decision|0|||
147532749|NCT01243762|532105988|FG006|Part 2 (Dose Confirmation/Efficacy)|Physician Decision|0|||
147429581|NCT03285178|531737765|FG002|Single-Blind Run-In Period|Physician Decision|0|||
147429582|NCT03285178|531737766|FG003|Single-Blind Run-In Period|Physician Decision|0|||
147429583|NCT03285178|531737767|FG004|Single-Blind Run-In Period|Physician Decision|0|||
147429584|NCT03285178|531737768|FG005|Single-Blind Run-In Period|Physician Decision|0|||
147429585|NCT03285178|531737769|FG006|Single-Blind Run-In Period|Physician Decision|0|||
147429586|NCT03285178|531737763|FG000|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|0|||
147429587|NCT03285178|531737764|FG001|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|1|||
147429588|NCT03285178|531737765|FG002|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|1|||
147429589|NCT03285178|531737766|FG003|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|0|||
147429590|NCT03285178|531737767|FG004|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|0|||
147429591|NCT03285178|531737768|FG005|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|0|||
147429592|NCT03285178|531737769|FG006|Double-Blind Treatment Period|Randomized Mistakenly During the Run-In Period - Did Not Receive Study Drug|0|||
147429593|NCT03285178|531737763|FG000|Double-Blind Treatment Period|Adverse Event|0|||
147429594|NCT03285178|531737764|FG001|Double-Blind Treatment Period|Adverse Event|0|||
147429595|NCT03285178|531737765|FG002|Double-Blind Treatment Period|Adverse Event|0|||
147429596|NCT03285178|531737766|FG003|Double-Blind Treatment Period|Adverse Event|0|||
147429597|NCT03285178|531737767|FG004|Double-Blind Treatment Period|Adverse Event|0|||
147429598|NCT03285178|531737768|FG005|Double-Blind Treatment Period|Adverse Event|0|||
147429599|NCT03285178|531737769|FG006|Double-Blind Treatment Period|Adverse Event|2|||
147429600|NCT03285178|531737763|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
147429601|NCT03285178|531737764|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
147429602|NCT03285178|531737765|FG002|Double-Blind Treatment Period|Lost to Follow-up|0|||
147429603|NCT03285178|531737766|FG003|Double-Blind Treatment Period|Lost to Follow-up|0|||
147429604|NCT03285178|531737767|FG004|Double-Blind Treatment Period|Lost to Follow-up|2|||
147429605|NCT03285178|531737768|FG005|Double-Blind Treatment Period|Lost to Follow-up|0|||
147429606|NCT03285178|531737769|FG006|Double-Blind Treatment Period|Lost to Follow-up|0|||
147429607|NCT03285178|531737763|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
147429608|NCT03285178|531737764|FG001|Double-Blind Treatment Period|Withdrawal by Subject|0|||
147429609|NCT03285178|531737765|FG002|Double-Blind Treatment Period|Withdrawal by Subject|1|||
147429610|NCT03285178|531737766|FG003|Double-Blind Treatment Period|Withdrawal by Subject|1|||
147429611|NCT03285178|531737767|FG004|Double-Blind Treatment Period|Withdrawal by Subject|0|||
147429612|NCT03285178|531737768|FG005|Double-Blind Treatment Period|Withdrawal by Subject|2|||
147429613|NCT03285178|531737769|FG006|Double-Blind Treatment Period|Withdrawal by Subject|1|||
147429614|NCT03285178|531737763|FG000|Double-Blind Treatment Period|COVID-19|0|||
147429615|NCT03285178|531737764|FG001|Double-Blind Treatment Period|COVID-19|0|||
147429616|NCT03285178|531737765|FG002|Double-Blind Treatment Period|COVID-19|1|||
147429617|NCT03285178|531737766|FG003|Double-Blind Treatment Period|COVID-19|0|||
147429618|NCT03285178|531737767|FG004|Double-Blind Treatment Period|COVID-19|0|||
147429619|NCT03285178|531737768|FG005|Double-Blind Treatment Period|COVID-19|0|||
147429620|NCT03285178|531737769|FG006|Double-Blind Treatment Period|COVID-19|0|||
147429621|NCT01128894|531737770|FG000|Overall Study|Adverse Event|31|||
147429622|NCT01128894|531737771|FG001|Overall Study|Adverse Event|41|||
147429623|NCT01128894|531737770|FG000|Overall Study|Protocol Violation|2|||
147429624|NCT01128894|531737771|FG001|Overall Study|Protocol Violation|1|||
147429625|NCT01128894|531737770|FG000|Overall Study|Noncompliance|4|||
147429626|NCT01128894|531737771|FG001|Overall Study|Noncompliance|5|||
147429627|NCT01128894|531737770|FG000|Overall Study|Lost to Follow-up|8|||
147429628|NCT01128894|531737771|FG001|Overall Study|Lost to Follow-up|8|||
147429629|NCT01128894|531737770|FG000|Overall Study|Withdrawal by Subject|10|||
147429630|NCT01128894|531737771|FG001|Overall Study|Withdrawal by Subject|12|||
147429631|NCT01128894|531737770|FG000|Overall Study|Physician Decision|2|||
147429632|NCT01128894|531737771|FG001|Overall Study|Physician Decision|1|||
147429633|NCT01128894|531737770|FG000|Overall Study|Conflicting HbA1c Results at Screening|1|||
147429634|NCT01128894|531737771|FG001|Overall Study|Conflicting HbA1c Results at Screening|0|||
147429635|NCT03437278|531737772|FG000|Overall Study|Adverse Event|0|||
147429636|NCT03437278|531737773|FG001|Overall Study|Adverse Event|0|||
147429637|NCT03437278|531737774|FG002|Overall Study|Adverse Event|1|||
147429638|NCT03437278|531737772|FG000|Overall Study|Progressive disease|1|||
147429639|NCT03437278|531737773|FG001|Overall Study|Progressive disease|0|||
147429640|NCT03437278|531737774|FG002|Overall Study|Progressive disease|0|||
147429641|NCT03437278|531737772|FG000|Overall Study|Physician Decision|1|||
147429642|NCT03437278|531737773|FG001|Overall Study|Physician Decision|0|||
147429643|NCT03437278|531737774|FG002|Overall Study|Physician Decision|1|||
147429644|NCT01128738|531737775|FG000|First Treatment Phase (TP)|Lost to Follow-up|1|||
147429645|NCT01128738|531737776|FG001|First Treatment Phase (TP)|Lost to Follow-up|0|||
147429646|NCT01128738|531737775|FG000|First Treatment Phase (TP)|Withdrawal by Subject|3|||
147532750|NCT04359758|532105989|FG000|Overall Study|Protocol Violation|3|||
147429647|NCT01128738|531737776|FG001|First Treatment Phase (TP)|Withdrawal by Subject|1|||
147429648|NCT01128738|531737775|FG000|Second TP|Lost to Follow-up|0|||
147532751|NCT04359758|532105990|FG001|Overall Study|Protocol Violation|2|||
147532752|NCT03358407|532105991|FG000|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
147532753|NCT03358407|532105992|FG001|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
147532754|NCT03358407|532105993|FG002|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|1|||
147532755|NCT03358407|532105994|FG003|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
147532756|NCT03358407|532105995|FG004|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
147532757|NCT03358407|532105996|FG005|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
147429649|NCT01128738|531737776|FG001|Second TP|Lost to Follow-up|1|||
147429650|NCT01128738|531737775|FG000|Second TP|Withdrawal by Subject|0|||
147429651|NCT01128738|531737776|FG001|Second TP|Withdrawal by Subject|2|||
147429652|NCT00973362|531737777|FG000|Baseline Evaluation|W/D, later determined to be ineligible|25|||
147429653|NCT00973362|531737778|FG001|Baseline Evaluation|W/D, later determined to be ineligible|0|||
147429654|NCT00973362|531737777|FG000|Baseline Evaluation|No colposcopy visit|62|||
147429655|NCT00973362|531737778|FG001|Baseline Evaluation|No colposcopy visit|0|||
147429656|NCT00973362|531737777|FG000|Baseline Evaluation|Inevaluable|686|||
147429657|NCT00973362|531737778|FG001|Baseline Evaluation|Inevaluable|223|||
147429658|NCT00973362|531737777|FG000|3-Year Follow-up|Lost to Follow-up|17|||
147429659|NCT00973362|531737778|FG001|3-Year Follow-up|Lost to Follow-up|0|||
147429660|NCT05116046|531737783|FG000|Overall Study|Withdrawal by parent/guardian|2|||
147429661|NCT05116046|531737784|FG001|Overall Study|Withdrawal by parent/guardian|1|||
147429662|NCT05116046|531737785|FG002|Overall Study|Withdrawal by parent/guardian|1|||
147429663|NCT05116046|531737783|FG000|Overall Study|Study terminated by sponsor|14|||
147429664|NCT05116046|531737784|FG001|Overall Study|Study terminated by sponsor|16|||
147429665|NCT05116046|531737785|FG002|Overall Study|Study terminated by sponsor|1|||
147429666|NCT02168842|531737786|FG000|Overall Study|Withdrawal by Subject|5|||
147429667|NCT02168842|531737787|FG001|Overall Study|Withdrawal by Subject|3|||
147429668|NCT02168842|531737786|FG000|Overall Study|Lost to Follow-up|0|||
147429669|NCT02168842|531737787|FG001|Overall Study|Lost to Follow-up|2|||
147429670|NCT02168842|531737786|FG000|Overall Study|Death|2|||
147429671|NCT02168842|531737787|FG001|Overall Study|Death|1|||
147429672|NCT02168842|531737786|FG000|Overall Study|Physician Decision|1|||
147429673|NCT02168842|531737787|FG001|Overall Study|Physician Decision|2|||
147429674|NCT02147353|531737788|FG000|Overall Study|Lost to Follow-up|2|||
147429675|NCT02147353|531737789|FG001|Overall Study|Lost to Follow-up|0|||
147429676|NCT02147353|531737788|FG000|Overall Study|unable to make visits|4|||
147429677|NCT02147353|531737789|FG001|Overall Study|unable to make visits|0|||
147429678|NCT02147353|531737788|FG000|Overall Study|medication noncompliance|3|||
147429679|NCT02147353|531737789|FG001|Overall Study|medication noncompliance|0|||
147429680|NCT02974088|531737790|FG000|Overall Study|Lost to Follow-up|0|||
147429681|NCT02974088|531737791|FG001|Overall Study|Lost to Follow-up|2|||
147429682|NCT02974088|531737790|FG000|Overall Study|Adverse Event|0|||
147429683|NCT02974088|531737791|FG001|Overall Study|Adverse Event|1|||
147429684|NCT00150969|531737792|FG000|24 Month Main Study|Adverse Event|3|||
147429685|NCT00150969|531737793|FG001|24 Month Main Study|Adverse Event|4|||
147429686|NCT00150969|531737792|FG000|24 Month Main Study|Death|1|||
147429687|NCT00150969|531737793|FG001|24 Month Main Study|Death|1|||
147429688|NCT00150969|531737792|FG000|24 Month Main Study|Lack of Efficacy|1|||
147429689|NCT00150969|531737793|FG001|24 Month Main Study|Lack of Efficacy|8|||
147429690|NCT00150969|531737792|FG000|24 Month Main Study|Lost to Follow-up|3|||
147429691|NCT00150969|531737793|FG001|24 Month Main Study|Lost to Follow-up|2|||
147429692|NCT00150969|531737792|FG000|24 Month Main Study|Protocol Violation|4|||
147429693|NCT00150969|531737793|FG001|24 Month Main Study|Protocol Violation|2|||
147429694|NCT00150969|531737792|FG000|24 Month Main Study|Withdrawal by Subject|7|||
147429695|NCT00150969|531737793|FG001|24 Month Main Study|Withdrawal by Subject|4|||
147429696|NCT00150969|531737792|FG000|24-48 Month Extension|Withdrawal by Subject|6|||
147429697|NCT00150969|531737793|FG001|24-48 Month Extension|Withdrawal by Subject|5|||
147429698|NCT00150969|531737792|FG000|24-48 Month Extension|Lack of Efficacy|0|||
147429699|NCT00150969|531737793|FG001|24-48 Month Extension|Lack of Efficacy|1|||
147429700|NCT00150969|531737792|FG000|24-48 Month Extension|Adverse Event|1|||
147429701|NCT00150969|531737793|FG001|24-48 Month Extension|Adverse Event|3|||
147532758|NCT03358407|532105997|FG006|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
147532759|NCT03358407|532105998|FG007|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
147532760|NCT03358407|532105999|FG008|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
147429702|NCT00150969|531737792|FG000|24-48 Month Extension|Other Reason|81|||
147429703|NCT00150969|531737793|FG001|24-48 Month Extension|Other Reason|91|||
147532761|NCT03358407|532106000|FG009|P2:PartA-Cohort1(4days)+Washout(48hours)|Adverse Event|0|||
147429704|NCT00146757|531737794|FG000|Overall Study|Death|1|||
147429705|NCT00146757|531737795|FG001|Overall Study|Death|0|||
147429706|NCT00146757|531737794|FG000|Overall Study|Adverse Event|1|||
147429707|NCT00146757|531737795|FG001|Overall Study|Adverse Event|0|||
147429708|NCT02893930|531737801|FG000|Overall Study|Adverse Event|3|||
147429709|NCT02893930|531737801|FG000|Overall Study|Death|1|||
147429710|NCT02893930|531737801|FG000|Overall Study|Disease progression|5|||
147429711|NCT02893930|531737801|FG000|Overall Study|Withdrawal by Subject|2|||
147429712|NCT02893930|531737801|FG000|Overall Study|Physician Decision|1|||
147532762|NCT03358407|532105991|FG000|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
147532763|NCT03358407|532105992|FG001|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
147192539|NCT00713609|530874413|FG003|Overall Study|Non-Compliance with Study Treatment|0|||
147192540|NCT00713609|530874414|FG004|Overall Study|Non-Compliance with Study Treatment|1|||
147429713|NCT02893930|531737801|FG000|Overall Study|Ineligible|1|||
147429714|NCT02349360|531737802|FG000|Overall Study|Withdrawal by Subject|0|||
147429715|NCT02349360|531737803|FG001|Overall Study|Withdrawal by Subject|1|||
147429716|NCT01971203|531737805|FG000|Overall Study|Protocol Violation|3|||
147429717|NCT01971203|531737806|FG001|Overall Study|Protocol Violation|2|||
147429718|NCT01971203|531737805|FG000|Overall Study|Withdrawal by Subject|5|||
147429719|NCT01971203|531737806|FG001|Overall Study|Withdrawal by Subject|6|||
147429720|NCT01971203|531737805|FG000|Overall Study|Adverse Event|1|||
147429721|NCT01971203|531737806|FG001|Overall Study|Adverse Event|0|||
147429722|NCT01294683|531737807|FG000|Precrossover (Periods I/II)|Adverse Event|49|||
147429723|NCT01294683|531737808|FG001|Precrossover (Periods I/II)|Adverse Event|52|||
147429724|NCT01294683|531737807|FG000|Precrossover (Periods I/II)|Lost to Follow-up|3|||
147429725|NCT01294683|531737808|FG001|Precrossover (Periods I/II)|Lost to Follow-up|6|||
147429726|NCT01294683|531737807|FG000|Precrossover (Periods I/II)|Non-compliance with Study Drug|1|||
147429727|NCT01294683|531737808|FG001|Precrossover (Periods I/II)|Non-compliance with Study Drug|1|||
147429728|NCT01294683|531737807|FG000|Precrossover (Periods I/II)|Physician Decision|1|||
147429729|NCT01294683|531737808|FG001|Precrossover (Periods I/II)|Physician Decision|0|||
147429730|NCT01294683|531737807|FG000|Precrossover (Periods I/II)|Protocol Violation|5|||
147429731|NCT01294683|531737808|FG001|Precrossover (Periods I/II)|Protocol Violation|5|||
147429732|NCT01294683|531737807|FG000|Precrossover (Periods I/II)|Study Terminated by Sponsor|187|||
147429733|NCT01294683|531737808|FG001|Precrossover (Periods I/II)|Study Terminated by Sponsor|192|||
147429734|NCT01294683|531737807|FG000|Precrossover (Periods I/II)|Technical Problems|0|||
147429735|NCT01294683|531737808|FG001|Precrossover (Periods I/II)|Technical Problems|1|||
147429736|NCT01294683|531737807|FG000|Precrossover (Periods I/II)|Withdrawal by Subject|11|||
147429737|NCT01294683|531737808|FG001|Precrossover (Periods I/II)|Withdrawal by Subject|9|||
147429738|NCT01294683|531737807|FG000|Post Crossover (Period III)|Adverse Event|6|||
147429739|NCT01294683|531737808|FG001|Post Crossover (Period III)|Adverse Event|6|||
147429740|NCT01294683|531737807|FG000|Post Crossover (Period III)|Lost to Follow-up|1|||
147429741|NCT01294683|531737808|FG001|Post Crossover (Period III)|Lost to Follow-up|3|||
147429742|NCT01294683|531737807|FG000|Post Crossover (Period III)|Study Terminated by Sponsor|23|||
147429743|NCT01294683|531737808|FG001|Post Crossover (Period III)|Study Terminated by Sponsor|21|||
147429744|NCT01294683|531737807|FG000|Post Crossover (Period III)|Withdrawal by Subject|3|||
147429745|NCT01294683|531737808|FG001|Post Crossover (Period III)|Withdrawal by Subject|2|||
147429746|NCT01794923|531737809|FG000|Overall Study|Adverse Event|0|||
147192541|NCT00713609|530874415|FG005|Overall Study|Non-Compliance with Study Treatment|0|||
147192542|NCT00713609|530874410|FG000|Overall Study|Withdrawal by Subject|6|||
147192543|NCT00713609|530874411|FG001|Overall Study|Withdrawal by Subject|1|||
147429747|NCT01794923|531737810|FG001|Overall Study|Adverse Event|0|||
147429748|NCT01794923|531737811|FG002|Overall Study|Adverse Event|1|||
147192544|NCT00713609|530874412|FG002|Overall Study|Withdrawal by Subject|5|||
147429749|NCT00985153|531737814|FG000|Overall Study|Lost to Follow-up|16|||
147429750|NCT00985153|531737815|FG001|Overall Study|Lost to Follow-up|19|||
147429751|NCT00985153|531737816|FG002|Overall Study|Lost to Follow-up|17|||
147429752|NCT00985153|531737817|FG003|Overall Study|Lost to Follow-up|20|||
147429753|NCT00985153|531737814|FG000|Overall Study|Protocol Violation|3|||
147429754|NCT00985153|531737815|FG001|Overall Study|Protocol Violation|2|||
147429755|NCT00985153|531737816|FG002|Overall Study|Protocol Violation|4|||
147429756|NCT00985153|531737817|FG003|Overall Study|Protocol Violation|3|||
147429757|NCT00985153|531737814|FG000|Overall Study|Withdrawal by Subject|6|||
147429758|NCT00985153|531737815|FG001|Overall Study|Withdrawal by Subject|11|||
147429759|NCT00985153|531737816|FG002|Overall Study|Withdrawal by Subject|11|||
147429760|NCT00985153|531737817|FG003|Overall Study|Withdrawal by Subject|10|||
147429761|NCT00985153|531737814|FG000|Overall Study|Missed One or More Bleeds|7|||
147429762|NCT00985153|531737815|FG001|Overall Study|Missed One or More Bleeds|7|||
147429763|NCT00985153|531737816|FG002|Overall Study|Missed One or More Bleeds|8|||
147429764|NCT00985153|531737817|FG003|Overall Study|Missed One or More Bleeds|10|||
147429765|NCT00985153|531737814|FG000|Overall Study|Incomplete Safety Follow-up|3|||
147532764|NCT03358407|532105993|FG002|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
147429766|NCT00985153|531737815|FG001|Overall Study|Incomplete Safety Follow-up|5|||
147429767|NCT00985153|531737816|FG002|Overall Study|Incomplete Safety Follow-up|4|||
147429768|NCT00985153|531737817|FG003|Overall Study|Incomplete Safety Follow-up|4|||
147429769|NCT02571049|531737818|FG000|Screening|Did not meet entry criteria|2|||
147429770|NCT02571049|531737819|FG001|Screening|Did not meet entry criteria|2|||
147429771|NCT02571049|531737818|FG000|Randomization|No migraine attack|0|||
147429772|NCT02571049|531737819|FG001|Randomization|No migraine attack|1|||
147429773|NCT02571049|531737818|FG000|Randomization|Adverse Event|0|||
147429774|NCT02571049|531737819|FG001|Randomization|Adverse Event|1|||
147192545|NCT00713609|530874413|FG003|Overall Study|Withdrawal by Subject|1|||
147192546|NCT00713609|530874414|FG004|Overall Study|Withdrawal by Subject|5|||
147429775|NCT01055262|531737822|FG000|Overall Study|Adverse Event|5|||
147429776|NCT01055262|531737822|FG000|Overall Study|Protocol Violation|3|||
147429777|NCT01055262|531737822|FG000|Overall Study|Uncooperativeness|1|||
147429778|NCT03370471|531737823|FG000|Overall Study|Withdrawal by Subject|6|||
147429779|NCT03370471|531737824|FG001|Overall Study|Withdrawal by Subject|1|||
147429780|NCT03370471|531737823|FG000|Overall Study|Unable to access veins for blood draw|0|||
147429781|NCT03370471|531737824|FG001|Overall Study|Unable to access veins for blood draw|1|||
147429782|NCT03370471|531737823|FG000|Overall Study|Screen fail|1|||
147429783|NCT03370471|531737824|FG001|Overall Study|Screen fail|0|||
147429784|NCT00561951|531737826|FG000|Overall Study|Adverse Event|11|||
147429785|NCT00561951|531737827|FG001|Overall Study|Adverse Event|14|||
147429786|NCT00561951|531737828|FG002|Overall Study|Adverse Event|14|||
147429787|NCT00561951|531737826|FG000|Overall Study|Lack of Efficacy|5|||
147429788|NCT00561951|531737827|FG001|Overall Study|Lack of Efficacy|3|||
147429789|NCT00561951|531737828|FG002|Overall Study|Lack of Efficacy|2|||
147429790|NCT00561951|531737826|FG000|Overall Study|Lost to Follow-up|1|||
147429791|NCT00561951|531737827|FG001|Overall Study|Lost to Follow-up|1|||
147429792|NCT00561951|531737828|FG002|Overall Study|Lost to Follow-up|0|||
147429793|NCT00561951|531737826|FG000|Overall Study|Withdrawal by Subject|10|||
147429794|NCT00561951|531737827|FG001|Overall Study|Withdrawal by Subject|9|||
147429795|NCT00561951|531737828|FG002|Overall Study|Withdrawal by Subject|10|||
147429796|NCT00561951|531737826|FG000|Overall Study|Protocol Violation|4|||
147429797|NCT00561951|531737827|FG001|Overall Study|Protocol Violation|3|||
147429798|NCT00561951|531737828|FG002|Overall Study|Protocol Violation|4|||
147429799|NCT00561951|531737826|FG000|Overall Study|Physician Decision|1|||
147429800|NCT00561951|531737827|FG001|Overall Study|Physician Decision|0|||
147429801|NCT00561951|531737828|FG002|Overall Study|Physician Decision|0|||
147532765|NCT03358407|532105994|FG003|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
147429802|NCT00561951|531737826|FG000|Overall Study|Pregnancy|0|||
147532766|NCT03358407|532105995|FG004|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|1|||
147532767|NCT03358407|532105996|FG005|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
147532768|NCT03358407|532105997|FG006|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
147532769|NCT03358407|532105998|FG007|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
147532770|NCT03358407|532105999|FG008|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
147532771|NCT03358407|532106000|FG009|P4:PartA-Cohort1(4days)+Washout(48hours)|Withdrawal by Subject|0|||
147532772|NCT03358407|532105991|FG000|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
147532773|NCT03358407|532105992|FG001|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
147532774|NCT03358407|532105993|FG002|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
147532775|NCT03358407|532105994|FG003|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
147532776|NCT03358407|532105995|FG004|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
147532777|NCT03358407|532105996|FG005|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|1|||
147532778|NCT03358407|532105997|FG006|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
147532779|NCT03358407|532105998|FG007|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|2|||
147532780|NCT03358407|532105999|FG008|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
147532781|NCT03358407|532106000|FG009|P1:PartA-Cohort2(4days)+Washout(48hours)|Adverse Event|0|||
147532782|NCT03358407|532105991|FG000|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
147532783|NCT03358407|532105992|FG001|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
147532784|NCT03358407|532105993|FG002|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
147532785|NCT03358407|532105994|FG003|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
147429803|NCT00561951|531737827|FG001|Overall Study|Pregnancy|1|||
147429804|NCT00561951|531737828|FG002|Overall Study|Pregnancy|0|||
147429805|NCT00561951|531737826|FG000|Overall Study|Meet Withdrawal Criterion|0|||
147429806|NCT00561951|531737827|FG001|Overall Study|Meet Withdrawal Criterion|1|||
147429807|NCT00561951|531737828|FG002|Overall Study|Meet Withdrawal Criterion|1|||
147429808|NCT00561951|531737826|FG000|Overall Study|Adverse Event Occured Before Treatment|1|||
147429809|NCT00561951|531737827|FG001|Overall Study|Adverse Event Occured Before Treatment|2|||
147429810|NCT00561951|531737828|FG002|Overall Study|Adverse Event Occured Before Treatment|1|||
147429811|NCT01765179|531737829|FG000|Overall Study|Adverse Event|3|||
147429812|NCT01765179|531737829|FG000|Overall Study|Lost to Follow-up|5|||
147429813|NCT01765179|531737829|FG000|Overall Study|Non-compliance with study drug|2|||
147429814|NCT01765179|531737829|FG000|Overall Study|Protocol Violation|1|||
147429815|NCT01765179|531737829|FG000|Overall Study|Withdrawal by Subject|8|||
147429816|NCT01765179|531737829|FG000|Overall Study|Hematocrit >54%|3|||
147429817|NCT01765179|531737829|FG000|Overall Study|prohibited med|1|||
147429818|NCT01765179|531737829|FG000|Overall Study|Out of country unable to finish study|1|||
147429819|NCT01765179|531737829|FG000|Overall Study|lack of venous access|1|||
147429820|NCT01765179|531737829|FG000|Overall Study|work conflict|1|||
147429821|NCT01765179|531737829|FG000|Overall Study|Ca elevated 10.6|1|||
147429822|NCT00392327|531737843|FG000|Overall Study|Death|1|||
147429823|NCT00392327|531737844|FG001|Overall Study|Death|0|||
147429824|NCT00392327|531737845|FG002|Overall Study|Death|1|||
147429825|NCT00392327|531737846|FG003|Overall Study|Death|0|||
147429826|NCT00392327|531737847|FG004|Overall Study|Death|0|||
147429827|NCT00392327|531737848|FG005|Overall Study|Death|0|||
147429828|NCT00392327|531737849|FG006|Overall Study|Death|0|||
147429829|NCT00392327|531737850|FG007|Overall Study|Death|0|||
147429830|NCT00392327|531737843|FG000|Overall Study|Lack of Efficacy|8|||
147429831|NCT00392327|531737844|FG001|Overall Study|Lack of Efficacy|8|||
147429832|NCT00392327|531737845|FG002|Overall Study|Lack of Efficacy|9|||
147429833|NCT00392327|531737846|FG003|Overall Study|Lack of Efficacy|6|||
147429834|NCT00392327|531737847|FG004|Overall Study|Lack of Efficacy|3|||
147429835|NCT00392327|531737848|FG005|Overall Study|Lack of Efficacy|3|||
147429836|NCT00392327|531737849|FG006|Overall Study|Lack of Efficacy|3|||
147429837|NCT00392327|531737850|FG007|Overall Study|Lack of Efficacy|3|||
147429838|NCT00392327|531737843|FG000|Overall Study|Physician Decision|3|||
147429839|NCT00392327|531737844|FG001|Overall Study|Physician Decision|5|||
147429840|NCT00392327|531737845|FG002|Overall Study|Physician Decision|2|||
147429841|NCT00392327|531737846|FG003|Overall Study|Physician Decision|2|||
147429842|NCT00392327|531737847|FG004|Overall Study|Physician Decision|0|||
147429843|NCT00392327|531737848|FG005|Overall Study|Physician Decision|1|||
147429844|NCT00392327|531737849|FG006|Overall Study|Physician Decision|5|||
147429845|NCT00392327|531737850|FG007|Overall Study|Physician Decision|3|||
147429846|NCT00392327|531737843|FG000|Overall Study|Protocol Violation|0|||
147429847|NCT00392327|531737844|FG001|Overall Study|Protocol Violation|0|||
147429848|NCT00392327|531737845|FG002|Overall Study|Protocol Violation|1|||
147429849|NCT00392327|531737846|FG003|Overall Study|Protocol Violation|0|||
147429850|NCT00392327|531737847|FG004|Overall Study|Protocol Violation|0|||
147429851|NCT00392327|531737848|FG005|Overall Study|Protocol Violation|0|||
147429852|NCT00392327|531737849|FG006|Overall Study|Protocol Violation|0|||
147429853|NCT00392327|531737850|FG007|Overall Study|Protocol Violation|0|||
147429854|NCT00392327|531737843|FG000|Overall Study|Withdrawal by Subject|3|||
147429855|NCT00392327|531737844|FG001|Overall Study|Withdrawal by Subject|2|||
147429856|NCT00392327|531737845|FG002|Overall Study|Withdrawal by Subject|4|||
147429857|NCT00392327|531737846|FG003|Overall Study|Withdrawal by Subject|6|||
147429858|NCT00392327|531737847|FG004|Overall Study|Withdrawal by Subject|0|||
147429859|NCT00392327|531737848|FG005|Overall Study|Withdrawal by Subject|1|||
147429860|NCT00392327|531737849|FG006|Overall Study|Withdrawal by Subject|1|||
147429861|NCT00392327|531737850|FG007|Overall Study|Withdrawal by Subject|5|||
147429862|NCT00392327|531737843|FG000|Overall Study|Ineligible|0|||
147429863|NCT00392327|531737844|FG001|Overall Study|Ineligible|4|||
147429864|NCT00392327|531737845|FG002|Overall Study|Ineligible|3|||
147429865|NCT00392327|531737846|FG003|Overall Study|Ineligible|2|||
147429866|NCT00392327|531737847|FG004|Overall Study|Ineligible|0|||
147429867|NCT00392327|531737848|FG005|Overall Study|Ineligible|0|||
147429868|NCT00392327|531737849|FG006|Overall Study|Ineligible|0|||
147429869|NCT00392327|531737850|FG007|Overall Study|Ineligible|0|||
147429870|NCT00986440|531737851|FG000|Overall Study|Progressive disease|27|||
147429871|NCT00986440|531737852|FG001|Overall Study|Progressive disease|37|||
147429872|NCT00986440|531737851|FG000|Overall Study|Serious adverse event or adverse event|9|||
147429873|NCT00986440|531737852|FG001|Overall Study|Serious adverse event or adverse event|2|||
147429874|NCT00986440|531737851|FG000|Overall Study|Withdrawal by Subject|1|||
147429875|NCT00986440|531737852|FG001|Overall Study|Withdrawal by Subject|2|||
147429876|NCT00986440|531737851|FG000|Overall Study|Screen failure (not dosed)|4|||
147429877|NCT00986440|531737852|FG001|Overall Study|Screen failure (not dosed)|2|||
147429878|NCT00178126|531737853|FG000|Overall Study|Lost to Follow-up|21|||
147429879|NCT00178126|531737854|FG001|Overall Study|Lost to Follow-up|21|||
147429880|NCT00178126|531737853|FG000|Overall Study|did not receive intervention|4|||
147429881|NCT00178126|531737854|FG001|Overall Study|did not receive intervention|6|||
147429882|NCT01281969|531737857|FG000|Overall Study|not randomized didn't meet criteria|0|||
147429883|NCT01281969|531737858|FG001|Overall Study|not randomized didn't meet criteria|0|||
147429884|NCT01281969|531737859|FG002|Overall Study|not randomized didn't meet criteria|7|||
147429885|NCT01281969|531737857|FG000|Overall Study|AE during LP prior to IVIG admin|1|||
147429886|NCT01281969|531737858|FG001|Overall Study|AE during LP prior to IVIG admin|0|||
147429887|NCT01281969|531737859|FG002|Overall Study|AE during LP prior to IVIG admin|3|||
147429888|NCT01281969|531737857|FG000|Overall Study|not randomized, child consent not given|0|||
147429889|NCT01281969|531737858|FG001|Overall Study|not randomized, child consent not given|0|||
147429890|NCT01281969|531737859|FG002|Overall Study|not randomized, child consent not given|2|||
147429891|NCT01323634|531737860|FG000|2-week Run-in Period|Inclusion/Exclusion Criteria not Met|125|||
147429892|NCT01323634|531737861|FG001|2-week Run-in Period|Inclusion/Exclusion Criteria not Met|0|||
147429893|NCT01323634|531737862|FG002|2-week Run-in Period|Inclusion/Exclusion Criteria not Met|0|||
147429894|NCT01323634|531737860|FG000|2-week Run-in Period|Continuation Criteria not Met|73|||
147429895|NCT01323634|531737861|FG001|2-week Run-in Period|Continuation Criteria not Met|0|||
147429896|NCT01323634|531737862|FG002|2-week Run-in Period|Continuation Criteria not Met|0|||
147429897|NCT01323634|531737860|FG000|2-week Run-in Period|Withdrawal by Subject|7|||
147429898|NCT01323634|531737861|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
147429899|NCT01323634|531737862|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
147429900|NCT01323634|531737860|FG000|2-week Run-in Period|Physician Decision|5|||
147429901|NCT01323634|531737861|FG001|2-week Run-in Period|Physician Decision|0|||
147429902|NCT01323634|531737862|FG002|2-week Run-in Period|Physician Decision|0|||
147429903|NCT01323634|531737860|FG000|2-week Run-in Period|Protocol Violation|1|||
147429904|NCT01323634|531737861|FG001|2-week Run-in Period|Protocol Violation|0|||
147429905|NCT01323634|531737862|FG002|2-week Run-in Period|Protocol Violation|0|||
147429906|NCT01323634|531737860|FG000|2-week Run-in Period|Adverse Event|1|||
147429907|NCT01323634|531737861|FG001|2-week Run-in Period|Adverse Event|0|||
147429908|NCT01323634|531737862|FG002|2-week Run-in Period|Adverse Event|0|||
147429909|NCT01323634|531737860|FG000|Double-Blind (DB) Treatment Period|Adverse Event|0|||
147429910|NCT01323634|531737861|FG001|Double-Blind (DB) Treatment Period|Adverse Event|8|||
147429911|NCT01323634|531737862|FG002|Double-Blind (DB) Treatment Period|Adverse Event|4|||
147429912|NCT01323634|531737860|FG000|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
147429913|NCT01323634|531737861|FG001|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
147429914|NCT01323634|531737862|FG002|Double-Blind (DB) Treatment Period|Lack of Efficacy|2|||
147429915|NCT01323634|531737860|FG000|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
147429916|NCT01323634|531737861|FG001|Double-Blind (DB) Treatment Period|Protocol Violation|6|||
147429917|NCT01323634|531737862|FG002|Double-Blind (DB) Treatment Period|Protocol Violation|7|||
147429918|NCT01323634|531737860|FG000|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
147429919|NCT01323634|531737861|FG001|Double-Blind (DB) Treatment Period|Lost to Follow-up|1|||
147429920|NCT01323634|531737862|FG002|Double-Blind (DB) Treatment Period|Lost to Follow-up|1|||
147429921|NCT01323634|531737860|FG000|Double-Blind (DB) Treatment Period|Physician Decision|0|||
147429922|NCT01323634|531737861|FG001|Double-Blind (DB) Treatment Period|Physician Decision|2|||
147429923|NCT01323634|531737862|FG002|Double-Blind (DB) Treatment Period|Physician Decision|3|||
147429924|NCT01323634|531737860|FG000|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
147429925|NCT01323634|531737861|FG001|Double-Blind (DB) Treatment Period|Withdrawal by Subject|7|||
147429926|NCT01323634|531737862|FG002|Double-Blind (DB) Treatment Period|Withdrawal by Subject|4|||
147429927|NCT01323634|531737860|FG000|Double-Blind (DB) Treatment Period|Did not Receive DB Study Medication|0|||
147429928|NCT01323634|531737861|FG001|Double-Blind (DB) Treatment Period|Did not Receive DB Study Medication|1|||
147429929|NCT01323634|531737862|FG002|Double-Blind (DB) Treatment Period|Did not Receive DB Study Medication|1|||
147429930|NCT05056987|531737863|FG000|First Wear Period, Day 14 or Day 28|Adverse Event|1|||
147429931|NCT05056987|531737864|FG001|First Wear Period, Day 14 or Day 28|Adverse Event|0|||
147429932|NCT05056987|531737863|FG000|First Wear Period, Day 14 or Day 28|Withdrawal by Subject|0|||
147429933|NCT05056987|531737864|FG001|First Wear Period, Day 14 or Day 28|Withdrawal by Subject|2|||
147429934|NCT01182194|531737865|FG000|Washout of 28 Days|Withdrawal by Subject|1|||
147429935|NCT01182194|531737866|FG001|Washout of 28 Days|Withdrawal by Subject|0|||
147429936|NCT02520284|531737867|FG000|Blinded Induction Phase: Up to Week 8|Adverse Event|1|||
147429937|NCT02520284|531737868|FG001|Blinded Induction Phase: Up to Week 8|Adverse Event|3|||
147429938|NCT02520284|531737869|FG002|Blinded Induction Phase: Up to Week 8|Adverse Event|0|||
147429939|NCT02520284|531737867|FG000|Blinded Induction Phase: Up to Week 8|Withdrew Consent|1|||
147429940|NCT02520284|531737868|FG001|Blinded Induction Phase: Up to Week 8|Withdrew Consent|1|||
147429941|NCT02520284|531737869|FG002|Blinded Induction Phase: Up to Week 8|Withdrew Consent|1|||
147192547|NCT00713609|530874415|FG005|Overall Study|Withdrawal by Subject|7|||
147192548|NCT00713609|530874410|FG000|Overall Study|Protocol Violation|6|||
147192549|NCT00713609|530874411|FG001|Overall Study|Protocol Violation|3|||
147192550|NCT00713609|530874412|FG002|Overall Study|Protocol Violation|1|||
147192551|NCT00713609|530874413|FG003|Overall Study|Protocol Violation|1|||
147192552|NCT00713609|530874414|FG004|Overall Study|Protocol Violation|2|||
147192553|NCT00713609|530874415|FG005|Overall Study|Protocol Violation|0|||
147192554|NCT01903356|530874416|FG000|Overall Study|Lost to Follow-up|7|||
147192555|NCT01903356|530874416|FG000|Overall Study|Violated inclusion/exclusion criteria|5|||
147192556|NCT01903356|530874416|FG000|Overall Study|Violated the dosage and administration|3|||
147192557|NCT01001221|530874417|FG000|Overall Study|Adverse Event|1|||
147532786|NCT03358407|532105995|FG004|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
147532787|NCT03358407|532105996|FG005|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|1|||
147532788|NCT03358407|532105997|FG006|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
147532789|NCT03358407|532105998|FG007|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|1|||
147532790|NCT03358407|532105999|FG008|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
147532791|NCT03358407|532106000|FG009|P1:PartA-Cohort2(4days)+Washout(48hours)|Physician Decision|0|||
147532792|NCT03358407|532105991|FG000|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
147532793|NCT03358407|532105992|FG001|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
147532794|NCT03358407|532105993|FG002|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
147532795|NCT03358407|532105994|FG003|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
147532796|NCT03358407|532105995|FG004|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
147532797|NCT03358407|532105996|FG005|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|1|||
147532798|NCT03358407|532105997|FG006|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|1|||
147532799|NCT03358407|532105998|FG007|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
147532800|NCT03358407|532105999|FG008|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
147532801|NCT03358407|532106000|FG009|P1:PartA-Cohort2(4days)+Washout(48hours)|Withdrawal by Subject|0|||
147532802|NCT03358407|532105991|FG000|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
147532803|NCT03358407|532105992|FG001|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
147532804|NCT03358407|532105993|FG002|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
147532805|NCT03358407|532105994|FG003|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
147532806|NCT03358407|532105995|FG004|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
147532807|NCT03358407|532105996|FG005|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|3|||
147532808|NCT03358407|532105997|FG006|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|3|||
147532809|NCT03358407|532105998|FG007|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|6|||
147532810|NCT03358407|532105999|FG008|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
147532811|NCT03358407|532106000|FG009|P2:PartA-Cohort2(4days)+Followup(14days)|Study closed/terminated|0|||
147532812|NCT00483574|532106001|FG000|Overall Study|Adverse Event|6|||
147532813|NCT00483574|532106002|FG001|Overall Study|Adverse Event|0|||
147532814|NCT00483574|532106001|FG000|Overall Study|Protocol Violation|28|||
147532815|NCT00483574|532106002|FG001|Overall Study|Protocol Violation|9|||
147532816|NCT00483574|532106001|FG000|Overall Study|Lost to Follow-up|16|||
147532817|NCT00483574|532106002|FG001|Overall Study|Lost to Follow-up|4|||
147532818|NCT00483574|532106001|FG000|Overall Study|Withdrawal by Subject|52|||
147532819|NCT00483574|532106002|FG001|Overall Study|Withdrawal by Subject|0|||
147532820|NCT03605758|532106003|FG000|Overall Study|Lost to Follow-up|2|||
147532821|NCT03605758|532106004|FG001|Overall Study|Lost to Follow-up|1|||
147532822|NCT03605758|532106003|FG000|Overall Study|Illness|0|||
147532823|NCT03605758|532106004|FG001|Overall Study|Illness|1|||
147532824|NCT03605758|532106003|FG000|Overall Study|Did not complete all 3 scheduled visits|20|||
147532825|NCT03605758|532106004|FG001|Overall Study|Did not complete all 3 scheduled visits|22|||
147532826|NCT02279888|532106010|FG000|Overall Study|Death|326|||
147532827|NCT02279888|532106010|FG000|Overall Study|Withdrawal by Subject|38|||
147532828|NCT02279888|532106010|FG000|Overall Study|Lost to Follow-up|21|||
147532829|NCT02279888|532106010|FG000|Overall Study|Physician Decision|62|||
147532830|NCT02279888|532106010|FG000|Overall Study|Subject Non-compliance|43|||
147532831|NCT02279888|532106010|FG000|Overall Study|Not implanted|14|||
147532832|NCT02279888|532106010|FG000|Overall Study|Visit not performed|26|||
147192558|NCT01001221|530874418|FG001|Overall Study|Adverse Event|2|||
147532833|NCT00262119|532106016|FG000|Overall Study|Lost to Follow-up|38|||
147532834|NCT00262119|532106017|FG001|Overall Study|Lost to Follow-up|51|||
147532835|NCT00262119|532106018|FG002|Overall Study|Lost to Follow-up|42|||
147192559|NCT01001221|530874419|FG002|Overall Study|Adverse Event|0|||
147192560|NCT01001221|530874420|FG003|Overall Study|Adverse Event|2|||
147532836|NCT00262119|532106016|FG000|Overall Study|Death|20|||
147532837|NCT00262119|532106017|FG001|Overall Study|Death|19|||
147532838|NCT00262119|532106018|FG002|Overall Study|Death|16|||
147532839|NCT00071006|532106019|FG000|Overall Study|Lack of Efficacy|7|||
147192561|NCT01001221|530874421|FG004|Overall Study|Adverse Event|0|||
147192562|NCT01001221|530874417|FG000|Overall Study|Disease progression|3|||
147192563|NCT01001221|530874418|FG001|Overall Study|Disease progression|2|||
147192564|NCT01001221|530874419|FG002|Overall Study|Disease progression|2|||
147192565|NCT01001221|530874420|FG003|Overall Study|Disease progression|4|||
147192566|NCT01001221|530874421|FG004|Overall Study|Disease progression|0|||
147192567|NCT01001221|530874417|FG000|Overall Study|Other|1|||
147192568|NCT01001221|530874418|FG001|Overall Study|Other|1|||
147192569|NCT01001221|530874419|FG002|Overall Study|Other|0|||
147192570|NCT01001221|530874420|FG003|Overall Study|Other|0|||
147192571|NCT01001221|530874421|FG004|Overall Study|Other|0|||
147192572|NCT01001221|530874417|FG000|Overall Study|Not treated; protocol exclusion|0|||
147192573|NCT01001221|530874418|FG001|Overall Study|Not treated; protocol exclusion|0|||
147532840|NCT00071006|532106019|FG000|Overall Study|Adverse Event|1|||
147532841|NCT00071006|532106019|FG000|Overall Study|Withdrawal by Subject|1|||
147532842|NCT00071006|532106019|FG000|Overall Study|Other|3|||
147532843|NCT05261126|532106024|FG000|Overall Study|Death|0|||
147532844|NCT05261126|532106025|FG001|Overall Study|Death|0|||
147192574|NCT01001221|530874419|FG002|Overall Study|Not treated; protocol exclusion|1|||
147532845|NCT05261126|532106026|FG002|Overall Study|Death|1|||
147532846|NCT05261126|532106027|FG003|Overall Study|Death|0|||
147532847|NCT05261126|532106028|FG004|Overall Study|Death|0|||
147532848|NCT05261126|532106024|FG000|Overall Study|Lost to Follow-up|0|||
147192575|NCT01001221|530874420|FG003|Overall Study|Not treated; protocol exclusion|0|||
147192576|NCT01001221|530874421|FG004|Overall Study|Not treated; protocol exclusion|0|||
147192577|NCT03448406|530874422|FG000|Overall Study|Noncompliance of scheduled visits|1|||
147192578|NCT03448406|530874423|FG001|Overall Study|Noncompliance of scheduled visits|2|||
147192579|NCT03448406|530874422|FG000|Overall Study|Withdrawal by Subject|1|||
147192580|NCT03448406|530874423|FG001|Overall Study|Withdrawal by Subject|2|||
147192581|NCT03448406|530874422|FG000|Overall Study|Protocol Violation|1|||
147192582|NCT03448406|530874423|FG001|Overall Study|Protocol Violation|0|||
147192583|NCT03448406|530874422|FG000|Overall Study|Adverse Event|8|||
147192584|NCT03448406|530874423|FG001|Overall Study|Adverse Event|9|||
147192585|NCT01292486|530874424|FG000|Overall Study|Protocol Violation|2|||
147192586|NCT01292486|530874424|FG000|Overall Study|Did not meet screening criteria|2|||
147192587|NCT01292486|530874424|FG000|Overall Study|Adverse Event|1|||
147192588|NCT01292486|530874424|FG000|Overall Study|Physician Decision|1|||
147192589|NCT03988400|530874430|FG000|Overall Study|Adverse Event|1|||
147192590|NCT03988400|530874431|FG001|Overall Study|Adverse Event|0|||
147192591|NCT03988400|530874430|FG000|Overall Study|Macular degeneration, unrelated to study procedures.|1|||
147192592|NCT03988400|530874431|FG001|Overall Study|Macular degeneration, unrelated to study procedures.|0|||
147192593|NCT03988400|530874430|FG000|Overall Study|Lost to Follow-up|0|||
147192594|NCT03988400|530874431|FG001|Overall Study|Lost to Follow-up|1|||
147192595|NCT02542865|530874433|FG000|Overall Study|Identified as screen failure|1|||
147192596|NCT02542865|530874434|FG001|Overall Study|Identified as screen failure|0|||
147192597|NCT02542865|530874433|FG000|Overall Study|Withdrawal by Subject|16|||
147192598|NCT02542865|530874434|FG001|Overall Study|Withdrawal by Subject|0|||
147192599|NCT03582215|530874435|FG000|Overall Study|Adverse Event|1|||
147192600|NCT03582215|530874436|FG001|Overall Study|Adverse Event|0|||
147192601|NCT03582215|530874437|FG002|Overall Study|Adverse Event|0|||
147192602|NCT03582215|530874438|FG003|Overall Study|Adverse Event|0|||
147192603|NCT03582215|530874439|FG004|Overall Study|Adverse Event|0|||
147192604|NCT03582215|530874440|FG005|Overall Study|Adverse Event|0|||
147192605|NCT03582215|530874441|FG006|Overall Study|Adverse Event|2|||
147192606|NCT03582215|530874442|FG007|Overall Study|Adverse Event|2|||
147192607|NCT04913610|530874443|FG000|Randomized Participants|Did Not Receive Treatment|0|||
147192608|NCT04913610|530874444|FG001|Randomized Participants|Did Not Receive Treatment|0|||
147192609|NCT04913610|530874445|FG002|Randomized Participants|Did Not Receive Treatment|1|||
147192610|NCT04913610|530874446|FG003|Randomized Participants|Did Not Receive Treatment|1|||
147192611|NCT04913610|530874447|FG004|Randomized Participants|Did Not Receive Treatment|0|||
147192612|NCT04913610|530874443|FG000|Treated (ITT & Safety Population)|Lost to Follow-up|1|||
147192613|NCT04913610|530874444|FG001|Treated (ITT & Safety Population)|Lost to Follow-up|0|||
147192614|NCT04913610|530874445|FG002|Treated (ITT & Safety Population)|Lost to Follow-up|0|||
147192615|NCT04913610|530874446|FG003|Treated (ITT & Safety Population)|Lost to Follow-up|0|||
147192616|NCT04913610|530874447|FG004|Treated (ITT & Safety Population)|Lost to Follow-up|1|||
147192617|NCT03186209|530874450|FG000|Overall Study|Withdrawal by Subject|11|||
147192618|NCT03186209|530874451|FG001|Overall Study|Withdrawal by Subject|22|||
147192619|NCT03186209|530874450|FG000|Overall Study|Pregnancy|1|||
147192620|NCT03186209|530874451|FG001|Overall Study|Pregnancy|0|||
147192621|NCT03186209|530874450|FG000|Overall Study|Adverse Event|4|||
147532849|NCT05261126|532106025|FG001|Overall Study|Lost to Follow-up|0|||
147192622|NCT03186209|530874451|FG001|Overall Study|Adverse Event|0|||
147192623|NCT03186209|530874450|FG000|Overall Study|V18 SKIPPED DUE TO LOGISTICS REASON|1|||
147192624|NCT03186209|530874451|FG001|Overall Study|V18 SKIPPED DUE TO LOGISTICS REASON|0|||
147192625|NCT03186209|530874450|FG000|Overall Study|PI DECIDED TO DISCONTINUE THE STUDY DUE TO THE LACK OF CRC RESOURCES|0|||
147192626|NCT03186209|530874451|FG001|Overall Study|PI DECIDED TO DISCONTINUE THE STUDY DUE TO THE LACK OF CRC RESOURCES|2|||
147192627|NCT03186209|530874450|FG000|Overall Study|Fail to meet randomization criteria|0|||
147192628|NCT03186209|530874451|FG001|Overall Study|Fail to meet randomization criteria|1|||
147192629|NCT03186209|530874450|FG000|Overall Study|Lost to Follow-up|0|||
147192630|NCT03186209|530874451|FG001|Overall Study|Lost to Follow-up|1|||
147192631|NCT01277744|530874456|FG000|Overall Study|Physician Decision|2|||
147192632|NCT01791244|530874457|FG000|Overall Study|Adverse Event|5|||
147192633|NCT01791244|530874458|FG001|Overall Study|Adverse Event|7|||
147192634|NCT01791244|530874457|FG000|Overall Study|Insufficient clinical response|10|||
147192635|NCT01791244|530874458|FG001|Overall Study|Insufficient clinical response|10|||
147192636|NCT01791244|530874457|FG000|Overall Study|Laboratory Abnormality|0|||
147192637|NCT01791244|530874458|FG001|Overall Study|Laboratory Abnormality|1|||
147192638|NCT02240485|530874463|FG000|3 Months Post-admission|Lost to Follow-up|1|||
147192639|NCT02240485|530874464|FG001|3 Months Post-admission|Lost to Follow-up|5|||
147532850|NCT05261126|532106026|FG002|Overall Study|Lost to Follow-up|0|||
147192640|NCT02240485|530874463|FG000|3 Months Post-admission|Withdrawal by Subject|2|||
147192641|NCT02240485|530874464|FG001|3 Months Post-admission|Withdrawal by Subject|1|||
147192642|NCT02240485|530874463|FG000|9 Months Post-admission|Lost to Follow-up|3|||
147192643|NCT02240485|530874464|FG001|9 Months Post-admission|Lost to Follow-up|1|||
147192644|NCT02240485|530874463|FG000|9 Months Post-admission|Withdrawal by Subject|0|||
147192645|NCT02240485|530874464|FG001|9 Months Post-admission|Withdrawal by Subject|3|||
147192646|NCT02240485|530874463|FG000|18 Months Post-admission|Lost to Follow-up|1|||
147192647|NCT02240485|530874464|FG001|18 Months Post-admission|Lost to Follow-up|1|||
147192648|NCT02240485|530874463|FG000|18 Months Post-admission|Withdrawal by Subject|2|||
147192649|NCT02240485|530874464|FG001|18 Months Post-admission|Withdrawal by Subject|4|||
147192650|NCT00953667|530874465|FG000|Overall Study|Lost to Follow-up|11|||
147192651|NCT00953667|530874465|FG000|Overall Study|Physician Decision|35|||
147192652|NCT00953667|530874465|FG000|Overall Study|Withdrawal by Subject|63|||
147192653|NCT00953667|530874465|FG000|Overall Study|Adverse Event|10|||
147192654|NCT00953667|530874465|FG000|Overall Study|poor venous access,unable to draw blood|4|||
147192655|NCT04038359|530874466|FG000|Overall Study|Consent Withdrawn Prior to Receiving Study Drug|1|||
147192656|NCT04038359|530874467|FG001|Overall Study|Consent Withdrawn Prior to Receiving Study Drug|0|||
147192657|NCT04038359|530874466|FG000|Overall Study|Death|8|||
147192658|NCT04038359|530874467|FG001|Overall Study|Death|7|||
147192659|NCT04038359|530874466|FG000|Overall Study|Lost to Follow-up|3|||
147192660|NCT04038359|530874467|FG001|Overall Study|Lost to Follow-up|0|||
147192661|NCT04038359|530874466|FG000|Overall Study|Participant Moved|1|||
147192662|NCT04038359|530874467|FG001|Overall Study|Participant Moved|0|||
147192663|NCT04038359|530874466|FG000|Overall Study|Withdrawal by Subject|4|||
147192664|NCT04038359|530874467|FG001|Overall Study|Withdrawal by Subject|3|||
147192665|NCT04038359|530874466|FG000|Overall Study|Physician Decision|3|||
147192666|NCT04038359|530874467|FG001|Overall Study|Physician Decision|2|||
147649352|NCT01026818|532537333|FG002|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|0|||
147192667|NCT04038359|530874466|FG000|Overall Study|Adverse Event|0|||
147192668|NCT04038359|530874467|FG001|Overall Study|Adverse Event|2|||
147192669|NCT04038359|530874466|FG000|Overall Study|Progressive Disease|0|||
147192670|NCT04038359|530874467|FG001|Overall Study|Progressive Disease|1|||
147192671|NCT05121766|530874468|FG000|Overall Study|Covid reinfection|3|||
147192672|NCT05121766|530874469|FG001|Overall Study|Covid reinfection|0|||
147192673|NCT05121766|530874468|FG000|Overall Study|Withdrawal by Subject|3|||
147192674|NCT05121766|530874469|FG001|Overall Study|Withdrawal by Subject|1|||
147192675|NCT05121766|530874468|FG000|Overall Study|Adverse Event|2|||
147192676|NCT05121766|530874469|FG001|Overall Study|Adverse Event|4|||
147192677|NCT05121766|530874468|FG000|Overall Study|Lost to Follow-up|0|||
147192678|NCT05121766|530874469|FG001|Overall Study|Lost to Follow-up|1|||
147192679|NCT03259230|530874470|FG000|Overall Study|Excluded from the Malignancy Analysis Set|1|||
147192680|NCT03259230|530874471|FG001|Overall Study|Excluded from the Malignancy Analysis Set|0|||
147192681|NCT05468814|530874472|FG000|Overall Study|Lost to Follow-up|5|||
147192682|NCT05468814|530874473|FG001|Overall Study|Lost to Follow-up|6|||
147192683|NCT04716426|530874477|FG000|Overall Study|Vaccination|1|||
147192684|NCT04716426|530874478|FG001|Overall Study|Vaccination|1|||
147192685|NCT04716426|530874477|FG000|Overall Study|Contamination|1|||
147192686|NCT04716426|530874478|FG001|Overall Study|Contamination|0|||
147192687|NCT01046565|530874481|FG000|Overall Study|Adverse Event|2|||
147192688|NCT01046565|530874481|FG000|Overall Study|Withdrawal by Subject|7|||
147192689|NCT01650558|530874482|FG000|Overall Study|Migration out of study area|61|||
147192690|NCT01650558|530874483|FG001|Overall Study|Migration out of study area|71|||
147192691|NCT01650558|530874484|FG002|Overall Study|Migration out of study area|56|||
147192692|NCT01650558|530874482|FG000|Overall Study|Lost to Follow-up|10|||
147192693|NCT01650558|530874483|FG001|Overall Study|Lost to Follow-up|13|||
147192694|NCT01650558|530874484|FG002|Overall Study|Lost to Follow-up|6|||
147192695|NCT01650558|530874482|FG000|Overall Study|Death|10|||
147192696|NCT01650558|530874483|FG001|Overall Study|Death|6|||
147192697|NCT01650558|530874484|FG002|Overall Study|Death|8|||
147192698|NCT01650558|530874482|FG000|Overall Study|Withdrawal by Subject|1|||
147192699|NCT01650558|530874483|FG001|Overall Study|Withdrawal by Subject|1|||
147192700|NCT01650558|530874484|FG002|Overall Study|Withdrawal by Subject|3|||
147192701|NCT01650558|530874482|FG000|Overall Study|Non-compliant participant|1|||
147192702|NCT01650558|530874483|FG001|Overall Study|Non-compliant participant|0|||
147192703|NCT01650558|530874484|FG002|Overall Study|Non-compliant participant|2|||
147192704|NCT01650558|530874482|FG000|Overall Study|Physician Decision|0|||
147192705|NCT01650558|530874483|FG001|Overall Study|Physician Decision|1|||
147192706|NCT01650558|530874484|FG002|Overall Study|Physician Decision|0|||
147192707|NCT02960217|530874485|FG000|Maintenance Phase: Treatment Period 1|Adverse Event|1|||
147192708|NCT02960217|530874486|FG001|Maintenance Phase: Treatment Period 1|Adverse Event|0|||
147192709|NCT02960217|530874485|FG000|Maintenance Phase: Treatment Period 2|Adverse Event|0|||
147192710|NCT02960217|530874486|FG001|Maintenance Phase: Treatment Period 2|Adverse Event|1|||
147192711|NCT02960217|530874485|FG000|Maintenance Phase: Treatment Period 2|Withdrawal by Subject|0|||
147192712|NCT02960217|530874486|FG001|Maintenance Phase: Treatment Period 2|Withdrawal by Subject|1|||
147192713|NCT02960217|530874485|FG000|Maintenance Phase: Treatment Period 2|Lack of Efficacy|1|||
147192714|NCT02960217|530874486|FG001|Maintenance Phase: Treatment Period 2|Lack of Efficacy|0|||
147532851|NCT05261126|532106027|FG003|Overall Study|Lost to Follow-up|0|||
147532852|NCT05261126|532106028|FG004|Overall Study|Lost to Follow-up|1|||
147532853|NCT05261126|532106024|FG000|Overall Study|Physician Decision|1|||
147192715|NCT02960217|530874485|FG000|Maintenance Phase: Treatment Period 2|Other, Not Specified|0|||
147192716|NCT02960217|530874486|FG001|Maintenance Phase: Treatment Period 2|Other, Not Specified|1|||
147192717|NCT02960217|530874485|FG000|Open-Label Extension Phase|Adverse Event|1|||
147192718|NCT02960217|530874486|FG001|Open-Label Extension Phase|Adverse Event|0|||
147192719|NCT02960217|530874485|FG000|Open-Label Extension Phase|Sponsor Decision|18|||
147192720|NCT02960217|530874486|FG001|Open-Label Extension Phase|Sponsor Decision|11|||
147192721|NCT02960217|530874485|FG000|Open-Label Extension Phase|Lack of Efficacy|1|||
147192722|NCT02960217|530874486|FG001|Open-Label Extension Phase|Lack of Efficacy|1|||
147192723|NCT02960217|530874485|FG000|Open-Label Extension Phase|Other, Not Specified|0|||
147192724|NCT02960217|530874486|FG001|Open-Label Extension Phase|Other, Not Specified|1|||
147192725|NCT01069484|530874487|FG000|Overall Study|Death-in-near-family|1|||
147192726|NCT01069484|530874488|FG001|Overall Study|Death-in-near-family|0|||
147192727|NCT01069484|530874487|FG000|Overall Study|No specific reason|8|||
147192728|NCT01069484|530874488|FG001|Overall Study|No specific reason|2|||
147192729|NCT01069484|530874487|FG000|Overall Study|Illness mother or child|3|||
147192730|NCT01069484|530874488|FG001|Overall Study|Illness mother or child|1|||
147192731|NCT05083351|530874491|FG000|Overall Study|Adverse Event|3|||
147192732|NCT05083351|530874491|FG000|Overall Study|Did not meet data inclusion criteria|8|||
147192733|NCT05083351|530874491|FG000|Overall Study|Did not meet eligibility criteria|19|||
147192734|NCT05083351|530874491|FG000|Overall Study|Study Staff Decision|19|||
147192735|NCT00960375|530874494|FG000|Overall Study|Lost to Follow-up|20|||
147192736|NCT00960375|530874495|FG001|Overall Study|Lost to Follow-up|22|||
147192737|NCT00083889|530874496|FG000|Overall Study|Adverse Event|76|||
147192738|NCT00083889|530874497|FG001|Overall Study|Adverse Event|86|||
147192739|NCT00083889|530874496|FG000|Overall Study|Protocol Violation|2|||
147192740|NCT00083889|530874497|FG001|Overall Study|Protocol Violation|2|||
147192741|NCT00083889|530874496|FG000|Overall Study|Withdrawal by Subject|22|||
147192742|NCT00083889|530874497|FG001|Overall Study|Withdrawal by Subject|24|||
147192743|NCT00083889|530874496|FG000|Overall Study|Lack of Efficacy|240|||
147192744|NCT00083889|530874497|FG001|Overall Study|Lack of Efficacy|219|||
147192745|NCT00083889|530874496|FG000|Overall Study|Decision of sponsor|32|||
147192746|NCT00083889|530874497|FG001|Overall Study|Decision of sponsor|4|||
147192747|NCT00083889|530874496|FG000|Overall Study|Randomized: did not take study drug|0|||
147192748|NCT00083889|530874497|FG001|Overall Study|Randomized: did not take study drug|15|||
147192749|NCT00083889|530874496|FG000|Overall Study|Completed on marketed sunitinub|3|||
147192750|NCT00083889|530874497|FG001|Overall Study|Completed on marketed sunitinub|0|||
147192751|NCT00083889|530874496|FG000|Overall Study|Crossover to SU011248|0|||
147192752|NCT00083889|530874497|FG001|Overall Study|Crossover to SU011248|25|||
147192753|NCT03624881|530874498|FG000|Overall Study|Screen Failure|14|||
147192754|NCT03624881|530874499|FG001|Overall Study|Screen Failure|0|||
147192755|NCT03624881|530874498|FG000|Overall Study|No Catheter Inserted|6|||
147192756|NCT03624881|530874499|FG001|Overall Study|No Catheter Inserted|1|||
147192757|NCT03624881|530874498|FG000|Overall Study|Catheter Inserted and RF Energy Delivery with No EPU System Used|2|||
147192758|NCT03624881|530874499|FG001|Overall Study|Catheter Inserted and RF Energy Delivery with No EPU System Used|0|||
147192759|NCT03624881|530874498|FG000|Overall Study|Death|2|||
147192760|NCT03624881|530874499|FG001|Overall Study|Death|0|||
147192761|NCT03624881|530874498|FG000|Overall Study|Lost to Follow-up|10|||
147192762|NCT03624881|530874499|FG001|Overall Study|Lost to Follow-up|4|||
147192763|NCT03624881|530874498|FG000|Overall Study|Withdrawal by Subject|12|||
147192764|NCT03624881|530874499|FG001|Overall Study|Withdrawal by Subject|1|||
147192765|NCT03019406|530874500|FG000|ETP: Ongoing From Week 26|Ongoing|6|||
147192766|NCT03019406|530874501|FG001|ETP: Ongoing From Week 26|Ongoing|5|||
147192767|NCT03019406|530874502|FG002|ETP: Ongoing From Week 26|Ongoing|5|||
147192768|NCT03019406|530874503|FG003|ETP: Ongoing From Week 26|Ongoing|3|||
147192769|NCT03668873|530874504|FG000|Overall Study|Lost to Follow-up|6|||
147192770|NCT03668873|530874505|FG001|Overall Study|Lost to Follow-up|3|||
147192771|NCT00849940|530874511|FG000|Overall Study|Physician Decision|4|||
147192772|NCT04258423|530874512|FG000|Overall Study|Study Closure|2|||
147192773|NCT04258423|530874513|FG001|Overall Study|Study Closure|2|||
147192774|NCT01601535|530874516|FG000|Phase 1|Adverse Event|1|||
147192775|NCT01601535|530874517|FG001|Phase 1|Adverse Event|0|||
147192776|NCT01601535|530874518|FG002|Phase 1|Adverse Event|2|||
147192777|NCT01601535|530874519|FG003|Phase 1|Adverse Event|1|||
147192778|NCT01601535|530874520|FG004|Phase 1|Adverse Event|0|||
147192779|NCT01601535|530874521|FG005|Phase 1|Adverse Event|0|||
147192780|NCT01601535|530874516|FG000|Phase 1|Withdrawal by Subject|2|||
147192781|NCT01601535|530874517|FG001|Phase 1|Withdrawal by Subject|1|||
147192782|NCT01601535|530874518|FG002|Phase 1|Withdrawal by Subject|1|||
147192783|NCT01601535|530874519|FG003|Phase 1|Withdrawal by Subject|2|||
147192784|NCT01601535|530874520|FG004|Phase 1|Withdrawal by Subject|0|||
147192785|NCT01601535|530874521|FG005|Phase 1|Withdrawal by Subject|0|||
147192786|NCT01601535|530874516|FG000|Phase 1|Progressive Disease|2|||
147192787|NCT01601535|530874517|FG001|Phase 1|Progressive Disease|3|||
147192788|NCT01601535|530874518|FG002|Phase 1|Progressive Disease|2|||
147192789|NCT01601535|530874519|FG003|Phase 1|Progressive Disease|1|||
147532854|NCT05261126|532106025|FG001|Overall Study|Physician Decision|0|||
147532855|NCT05261126|532106026|FG002|Overall Study|Physician Decision|0|||
147532856|NCT05261126|532106027|FG003|Overall Study|Physician Decision|0|||
147532857|NCT05261126|532106028|FG004|Overall Study|Physician Decision|0|||
147532858|NCT05261126|532106024|FG000|Overall Study|Screen Failure|0|||
147532859|NCT05261126|532106025|FG001|Overall Study|Screen Failure|0|||
147532860|NCT05261126|532106026|FG002|Overall Study|Screen Failure|0|||
147532861|NCT05261126|532106027|FG003|Overall Study|Screen Failure|0|||
147532862|NCT05261126|532106028|FG004|Overall Study|Screen Failure|1|||
147532863|NCT05261126|532106024|FG000|Overall Study|Withdrawal by Subject|1|||
147532864|NCT05261126|532106025|FG001|Overall Study|Withdrawal by Subject|0|||
147532865|NCT05261126|532106026|FG002|Overall Study|Withdrawal by Subject|1|||
147306723|NCT04399356|531290735|FG000|Overall Study|Discontinued Niclosamide/ Placebo|1|||
147306724|NCT04399356|531290736|FG001|Overall Study|Discontinued Niclosamide/ Placebo|2|||
147192790|NCT01601535|530874520|FG004|Phase 1|Progressive Disease|0|||
147192791|NCT01601535|530874521|FG005|Phase 1|Progressive Disease|0|||
147192792|NCT01601535|530874516|FG000|Phase 1|Started Another Treatment|1|||
147532866|NCT05261126|532106027|FG003|Overall Study|Withdrawal by Subject|1|||
147532867|NCT05261126|532106028|FG004|Overall Study|Withdrawal by Subject|0|||
147532868|NCT05261126|532106024|FG000|Overall Study|Not Recorded|0|||
147532869|NCT05261126|532106025|FG001|Overall Study|Not Recorded|0|||
147532870|NCT05261126|532106026|FG002|Overall Study|Not Recorded|0|||
147532871|NCT05261126|532106027|FG003|Overall Study|Not Recorded|1|||
147532872|NCT05261126|532106028|FG004|Overall Study|Not Recorded|0|||
147532873|NCT03901274|532106029|FG000|Overall Study|Lost to Follow-up|120|||
147532874|NCT03901274|532106030|FG001|Overall Study|Lost to Follow-up|124|||
147532875|NCT03901274|532106029|FG000|Overall Study|Withdrawal by Subject|0|||
147532876|NCT03901274|532106030|FG001|Overall Study|Withdrawal by Subject|6|||
147532877|NCT05570604|532106031|FG000|Overall Study|Lost to Follow-up|1|||
147532878|NCT05570604|532106032|FG001|Overall Study|Lost to Follow-up|5|||
147532879|NCT05570604|532106031|FG000|Overall Study|Illness|2|||
147532880|NCT05570604|532106032|FG001|Overall Study|Illness|2|||
147532881|NCT01250418|532106039|FG000|Overall Study|monitor data failure|1|||
147532882|NCT01250418|532106040|FG001|Overall Study|monitor data failure|1|||
147532883|NCT01761565|532106041|FG000|40 Consecutive Doses of SUF 15 mcg|Adverse Event|1|||
147532884|NCT05182840|532106042|FG000|Run-in Period|Not treated|0|||
147532885|NCT05182840|532106043|FG001|Run-in Period|Not treated|1|||
147532886|NCT05182840|532106044|FG002|Run-in Period|Not treated|0|||
147532887|NCT05182840|532106045|FG003|Run-in Period|Not treated|0|||
147532888|NCT05182840|532106046|FG004|Run-in Period|Not treated|0|||
147532889|NCT05182840|532106047|FG005|Run-in Period|Not treated|0|||
147532890|NCT05182840|532106048|FG006|Run-in Period|Not treated|0|||
147532891|NCT05182840|532106049|FG007|Run-in Period|Not treated|0|||
147532892|NCT05182840|532106050|FG008|Run-in Period|Not treated|0|||
147532893|NCT05182840|532106051|FG009|Run-in Period|Not treated|0|||
147532894|NCT05182840|532106042|FG000|Run-in Period|Other reason but not sponsor termination|14|||
147532895|NCT05182840|532106043|FG001|Run-in Period|Other reason but not sponsor termination|18|||
147532896|NCT05182840|532106044|FG002|Run-in Period|Other reason but not sponsor termination|0|||
147532897|NCT05182840|532106045|FG003|Run-in Period|Other reason but not sponsor termination|0|||
147532898|NCT05182840|532106046|FG004|Run-in Period|Other reason but not sponsor termination|0|||
147532899|NCT05182840|532106047|FG005|Run-in Period|Other reason but not sponsor termination|0|||
147532900|NCT05182840|532106048|FG006|Run-in Period|Other reason but not sponsor termination|0|||
147532901|NCT05182840|532106049|FG007|Run-in Period|Other reason but not sponsor termination|0|||
147532902|NCT05182840|532106050|FG008|Run-in Period|Other reason but not sponsor termination|0|||
147532903|NCT05182840|532106051|FG009|Run-in Period|Other reason but not sponsor termination|0|||
147532904|NCT05182840|532106042|FG000|Run-in Period|No reason available|2|||
147532905|NCT05182840|532106043|FG001|Run-in Period|No reason available|2|||
147532906|NCT05182840|532106044|FG002|Run-in Period|No reason available|0|||
147532907|NCT05182840|532106045|FG003|Run-in Period|No reason available|0|||
147532908|NCT05182840|532106046|FG004|Run-in Period|No reason available|0|||
147532909|NCT05182840|532106047|FG005|Run-in Period|No reason available|0|||
147532910|NCT05182840|532106048|FG006|Run-in Period|No reason available|0|||
147532911|NCT05182840|532106049|FG007|Run-in Period|No reason available|0|||
147532912|NCT05182840|532106050|FG008|Run-in Period|No reason available|0|||
147532913|NCT05182840|532106051|FG009|Run-in Period|No reason available|0|||
147532914|NCT05182840|532106042|FG000|Run-in Period|Burden of study procedures|2|||
147532915|NCT05182840|532106043|FG001|Run-in Period|Burden of study procedures|2|||
147532916|NCT05182840|532106044|FG002|Run-in Period|Burden of study procedures|0|||
147532917|NCT05182840|532106045|FG003|Run-in Period|Burden of study procedures|0|||
147532918|NCT05182840|532106046|FG004|Run-in Period|Burden of study procedures|0|||
147532919|NCT05182840|532106047|FG005|Run-in Period|Burden of study procedures|0|||
147532920|NCT05182840|532106048|FG006|Run-in Period|Burden of study procedures|0|||
147532921|NCT05182840|532106049|FG007|Run-in Period|Burden of study procedures|0|||
147532922|NCT05182840|532106050|FG008|Run-in Period|Burden of study procedures|0|||
147532923|NCT05182840|532106051|FG009|Run-in Period|Burden of study procedures|0|||
147532924|NCT05182840|532106042|FG000|Run-in Period|Change of residence|1|||
147532925|NCT05182840|532106043|FG001|Run-in Period|Change of residence|0|||
147532926|NCT05182840|532106044|FG002|Run-in Period|Change of residence|0|||
147532927|NCT05182840|532106045|FG003|Run-in Period|Change of residence|0|||
147532928|NCT05182840|532106046|FG004|Run-in Period|Change of residence|0|||
147532929|NCT05182840|532106047|FG005|Run-in Period|Change of residence|0|||
147532930|NCT05182840|532106048|FG006|Run-in Period|Change of residence|0|||
147649353|NCT01026818|532537334|FG003|Drug-Free Washout Period (Month 9-10.5)|Sponsor Decision|0|||
147532931|NCT05182840|532106049|FG007|Run-in Period|Change of residence|0|||
147532932|NCT05182840|532106050|FG008|Run-in Period|Change of residence|0|||
147532933|NCT05182840|532106051|FG009|Run-in Period|Change of residence|0|||
147532934|NCT05182840|532106042|FG000|Run-in Period|Adverse Event|5|||
147306725|NCT04399356|531290735|FG000|Overall Study|Withdrawal by Subject|1|||
147192793|NCT01601535|530874517|FG001|Phase 1|Started Another Treatment|2|||
147192794|NCT01601535|530874518|FG002|Phase 1|Started Another Treatment|0|||
147192795|NCT01601535|530874519|FG003|Phase 1|Started Another Treatment|0|||
147192796|NCT01601535|530874520|FG004|Phase 1|Started Another Treatment|0|||
147192797|NCT01601535|530874521|FG005|Phase 1|Started Another Treatment|0|||
147192798|NCT01601535|530874516|FG000|Phase 2|Adverse Event|0|||
147192799|NCT01601535|530874517|FG001|Phase 2|Adverse Event|0|||
147192800|NCT01601535|530874518|FG002|Phase 2|Adverse Event|0|||
147192801|NCT01601535|530874519|FG003|Phase 2|Adverse Event|0|||
147192802|NCT01601535|530874520|FG004|Phase 2|Adverse Event|5|||
147192803|NCT01601535|530874521|FG005|Phase 2|Adverse Event|1|||
147192804|NCT01601535|530874516|FG000|Phase 2|Withdrawal by Subject|0|||
147192805|NCT01601535|530874517|FG001|Phase 2|Withdrawal by Subject|0|||
147192806|NCT01601535|530874518|FG002|Phase 2|Withdrawal by Subject|0|||
147192807|NCT01601535|530874519|FG003|Phase 2|Withdrawal by Subject|0|||
147192808|NCT01601535|530874520|FG004|Phase 2|Withdrawal by Subject|8|||
147192809|NCT01601535|530874521|FG005|Phase 2|Withdrawal by Subject|2|||
147192810|NCT01601535|530874516|FG000|Phase 2|Progressive Disease|0|||
147192811|NCT01601535|530874517|FG001|Phase 2|Progressive Disease|0|||
147192812|NCT01601535|530874518|FG002|Phase 2|Progressive Disease|0|||
147192813|NCT01601535|530874519|FG003|Phase 2|Progressive Disease|0|||
147192814|NCT01601535|530874520|FG004|Phase 2|Progressive Disease|5|||
147192815|NCT01601535|530874521|FG005|Phase 2|Progressive Disease|7|||
147192816|NCT01601535|530874516|FG000|Phase 2|Started Another Treatment|0|||
147532935|NCT05182840|532106043|FG001|Run-in Period|Adverse Event|5|||
147192817|NCT01601535|530874517|FG001|Phase 2|Started Another Treatment|0|||
147192818|NCT01601535|530874518|FG002|Phase 2|Started Another Treatment|0|||
147192819|NCT01601535|530874519|FG003|Phase 2|Started Another Treatment|0|||
147192820|NCT01601535|530874520|FG004|Phase 2|Started Another Treatment|1|||
147192821|NCT01601535|530874521|FG005|Phase 2|Started Another Treatment|2|||
147192822|NCT04199351|530876336|FG000|Overall Study|Decision by sponsor|0|||
147192823|NCT04199351|530876337|FG001|Overall Study|Decision by sponsor|0|||
147192824|NCT04199351|530876338|FG002|Overall Study|Decision by sponsor|0|||
147192825|NCT04199351|530876339|FG003|Overall Study|Decision by sponsor|2|||
147192826|NCT04199351|530876340|FG004|Overall Study|Decision by sponsor|0|||
147532936|NCT05182840|532106044|FG002|Run-in Period|Adverse Event|0|||
147192827|NCT04199351|530876341|FG005|Overall Study|Decision by sponsor|0|||
147192828|NCT04199351|530876342|FG006|Overall Study|Decision by sponsor|0|||
147192829|NCT04199351|530876343|FG007|Overall Study|Decision by sponsor|0|||
147306726|NCT04399356|531290736|FG001|Overall Study|Withdrawal by Subject|0|||
147532937|NCT05182840|532106045|FG003|Run-in Period|Adverse Event|0|||
147192830|NCT04199351|530876344|FG008|Overall Study|Decision by sponsor|0|||
147192831|NCT04199351|530876345|FG009|Overall Study|Decision by sponsor|6|||
147532938|NCT05182840|532106046|FG004|Run-in Period|Adverse Event|0|||
147532939|NCT05182840|532106047|FG005|Run-in Period|Adverse Event|0|||
147532940|NCT05182840|532106048|FG006|Run-in Period|Adverse Event|0|||
147532941|NCT05182840|532106049|FG007|Run-in Period|Adverse Event|0|||
147532942|NCT05182840|532106050|FG008|Run-in Period|Adverse Event|0|||
147532943|NCT05182840|532106051|FG009|Run-in Period|Adverse Event|0|||
147532944|NCT05182840|532106042|FG000|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|34|||
147532945|NCT05182840|532106043|FG001|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|44|||
147532946|NCT05182840|532106044|FG002|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
147532947|NCT05182840|532106045|FG003|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
147532948|NCT05182840|532106046|FG004|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
147532949|NCT05182840|532106047|FG005|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
147532950|NCT05182840|532106048|FG006|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
147532951|NCT05182840|532106049|FG007|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
147306727|NCT03812536|531290737|FG000|Overall Study|Protocol Violation|2|||
147192832|NCT04199351|530876336|FG000|Overall Study|Lost to Follow-up|0|||
147192833|NCT04199351|530876337|FG001|Overall Study|Lost to Follow-up|0|||
147192834|NCT04199351|530876338|FG002|Overall Study|Lost to Follow-up|1|||
147192835|NCT04199351|530876339|FG003|Overall Study|Lost to Follow-up|0|||
147192836|NCT04199351|530876340|FG004|Overall Study|Lost to Follow-up|0|||
147192837|NCT04199351|530876341|FG005|Overall Study|Lost to Follow-up|1|||
147192838|NCT04199351|530876342|FG006|Overall Study|Lost to Follow-up|0|||
147192839|NCT04199351|530876343|FG007|Overall Study|Lost to Follow-up|0|||
147192840|NCT04199351|530876344|FG008|Overall Study|Lost to Follow-up|0|||
147192841|NCT04199351|530876345|FG009|Overall Study|Lost to Follow-up|0|||
147192842|NCT04199351|530876336|FG000|Overall Study|Withdrawal by Subject|0|||
147192843|NCT04199351|530876337|FG001|Overall Study|Withdrawal by Subject|1|||
147192844|NCT04199351|530876338|FG002|Overall Study|Withdrawal by Subject|0|||
147192845|NCT04199351|530876339|FG003|Overall Study|Withdrawal by Subject|0|||
147192846|NCT04199351|530876340|FG004|Overall Study|Withdrawal by Subject|1|||
147192847|NCT04199351|530876341|FG005|Overall Study|Withdrawal by Subject|4|||
147192848|NCT04199351|530876342|FG006|Overall Study|Withdrawal by Subject|2|||
147192849|NCT04199351|530876343|FG007|Overall Study|Withdrawal by Subject|0|||
147192850|NCT04199351|530876344|FG008|Overall Study|Withdrawal by Subject|3|||
147192851|NCT04199351|530876345|FG009|Overall Study|Withdrawal by Subject|0|||
147192852|NCT03623243|530876346|FG000|Overall Study|Adverse Event|15|||
147192853|NCT03623243|530876346|FG000|Overall Study|Guardian Decision|1|||
147192854|NCT03623243|530876346|FG000|Overall Study|New Therapy for Study Indication|1|||
147192855|NCT03623243|530876346|FG000|Overall Study|Protocol Deviation|3|||
147429942|NCT02520284|531737867|FG000|Blinded Induction Phase: Up to Week 8|Study Terminated by Sponsor|0|||
147192856|NCT03623243|530876346|FG000|Overall Study|Physician Decision|4|||
147192857|NCT03623243|530876346|FG000|Overall Study|Patient Decision|15|||
147192858|NCT03007966|530876347|FG000|Overall Study|Did not meeting inclusion/exclusion|1|||
147192859|NCT03007966|530876348|FG001|Overall Study|Did not meeting inclusion/exclusion|0|||
147192860|NCT00474487|530876352|FG000|Overall Study|Withdrawal by Subject|6|||
147192861|NCT00474487|530876353|FG001|Overall Study|Withdrawal by Subject|0|||
147192862|NCT00474487|530876354|FG002|Overall Study|Withdrawal by Subject|0|||
147532952|NCT05182840|532106050|FG008|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
147192863|NCT00474487|530876355|FG003|Overall Study|Withdrawal by Subject|0|||
147192864|NCT00474487|530876352|FG000|Overall Study|Lost to Follow-up|20|||
147192865|NCT00474487|530876353|FG001|Overall Study|Lost to Follow-up|1|||
147192866|NCT00474487|530876354|FG002|Overall Study|Lost to Follow-up|7|||
147192867|NCT00474487|530876355|FG003|Overall Study|Lost to Follow-up|0|||
147192868|NCT00474487|530876352|FG000|Overall Study|Inappropriate enrollment|4|||
147429943|NCT02520284|531737868|FG001|Blinded Induction Phase: Up to Week 8|Study Terminated by Sponsor|0|||
147429944|NCT02520284|531737869|FG002|Blinded Induction Phase: Up to Week 8|Study Terminated by Sponsor|1|||
147429945|NCT02520284|531737867|FG000|Blinded Maintenance Phase: Up to Week 51|Study Terminated by Sponsor|17|||
147429946|NCT02520284|531737868|FG001|Blinded Maintenance Phase: Up to Week 51|Study Terminated by Sponsor|11|||
147429947|NCT02520284|531737869|FG002|Blinded Maintenance Phase: Up to Week 51|Study Terminated by Sponsor|15|||
147429948|NCT02520284|531737867|FG000|Blinded Maintenance Phase: Up to Week 51|Disease Worsening|2|||
147429949|NCT02520284|531737868|FG001|Blinded Maintenance Phase: Up to Week 51|Disease Worsening|2|||
147429950|NCT02520284|531737869|FG002|Blinded Maintenance Phase: Up to Week 51|Disease Worsening|3|||
147429951|NCT02520284|531737867|FG000|Blinded Maintenance Phase: Up to Week 51|Adverse Event|1|||
147192869|NCT00474487|530876353|FG001|Overall Study|Inappropriate enrollment|0|||
147429952|NCT02520284|531737868|FG001|Blinded Maintenance Phase: Up to Week 51|Adverse Event|1|||
147429953|NCT02520284|531737869|FG002|Blinded Maintenance Phase: Up to Week 51|Adverse Event|0|||
147429954|NCT02520284|531737867|FG000|Blinded Maintenance Phase: Up to Week 51|Disposition Error|0|||
147429955|NCT02520284|531737868|FG001|Blinded Maintenance Phase: Up to Week 51|Disposition Error|2|||
147429956|NCT02520284|531737869|FG002|Blinded Maintenance Phase: Up to Week 51|Disposition Error|0|||
147429957|NCT02520284|531737867|FG000|Open-Label MaintenancePhase: Upto Week51|Study Terminated by Sponsor|25|||
147429958|NCT02520284|531737868|FG001|Open-Label MaintenancePhase: Upto Week51|Study Terminated by Sponsor|29|||
147429959|NCT02520284|531737869|FG002|Open-Label MaintenancePhase: Upto Week51|Study Terminated by Sponsor|28|||
147429960|NCT02520284|531737867|FG000|Open-Label MaintenancePhase: Upto Week51|Withdrew Consent|3|||
147429961|NCT02520284|531737868|FG001|Open-Label MaintenancePhase: Upto Week51|Withdrew Consent|4|||
147429962|NCT02520284|531737869|FG002|Open-Label MaintenancePhase: Upto Week51|Withdrew Consent|2|||
147429963|NCT02520284|531737867|FG000|Open-Label MaintenancePhase: Upto Week51|Adverse Event|2|||
147429964|NCT02520284|531737868|FG001|Open-Label MaintenancePhase: Upto Week51|Adverse Event|1|||
147429965|NCT02520284|531737869|FG002|Open-Label MaintenancePhase: Upto Week51|Adverse Event|3|||
147429966|NCT02520284|531737867|FG000|Open-Label MaintenancePhase: Upto Week51|Investigator's Discretion|2|||
147429967|NCT02520284|531737868|FG001|Open-Label MaintenancePhase: Upto Week51|Investigator's Discretion|1|||
147429968|NCT02520284|531737869|FG002|Open-Label MaintenancePhase: Upto Week51|Investigator's Discretion|1|||
147429969|NCT02903368|531737873|FG000|Part 1|Adverse Event|3|||
147429970|NCT02903368|531737874|FG001|Part 1|Adverse Event|0|||
147429971|NCT02903368|531737875|FG002|Part 1|Adverse Event|0|||
147429972|NCT02903368|531737876|FG003|Part 1|Adverse Event|0|||
147429973|NCT02903368|531737873|FG000|Part 1|Withdrawal by Subject|1|||
147429974|NCT02903368|531737874|FG001|Part 1|Withdrawal by Subject|0|||
147429975|NCT02903368|531737875|FG002|Part 1|Withdrawal by Subject|0|||
147429976|NCT02903368|531737876|FG003|Part 1|Withdrawal by Subject|0|||
147429977|NCT02903368|531737873|FG000|Part 2|Adverse Event|0|||
147429978|NCT02903368|531737874|FG001|Part 2|Adverse Event|0|||
147429979|NCT02903368|531737875|FG002|Part 2|Adverse Event|5|||
147429980|NCT02903368|531737876|FG003|Part 2|Adverse Event|0|||
147429981|NCT02903368|531737873|FG000|Part 2|Subject withdrew after 6 cycles of protocol therapy.|0|||
147429982|NCT02903368|531737874|FG001|Part 2|Subject withdrew after 6 cycles of protocol therapy.|0|||
147429983|NCT02903368|531737875|FG002|Part 2|Subject withdrew after 6 cycles of protocol therapy.|1|||
147429984|NCT02903368|531737876|FG003|Part 2|Subject withdrew after 6 cycles of protocol therapy.|0|||
147429985|NCT02903368|531737873|FG000|Part 2|Subject withdrew after part-2 randomization and remained on observation.|0|||
147429986|NCT02903368|531737874|FG001|Part 2|Subject withdrew after part-2 randomization and remained on observation.|0|||
147429987|NCT02903368|531737875|FG002|Part 2|Subject withdrew after part-2 randomization and remained on observation.|4|||
147429988|NCT02903368|531737876|FG003|Part 2|Subject withdrew after part-2 randomization and remained on observation.|0|||
147429989|NCT02903368|531737873|FG000|Part 2|Subject withdrew after part-2 randomization and received non-protocol therapy.|0|||
147429990|NCT02903368|531737874|FG001|Part 2|Subject withdrew after part-2 randomization and received non-protocol therapy.|0|||
147429991|NCT02903368|531737875|FG002|Part 2|Subject withdrew after part-2 randomization and received non-protocol therapy.|1|||
147429992|NCT02903368|531737876|FG003|Part 2|Subject withdrew after part-2 randomization and received non-protocol therapy.|2|||
147429993|NCT06515483|531737877|FG000|Overall Study|Subject withdraw due to family issues|1|||
147429994|NCT06515483|531737878|FG001|Overall Study|Subject withdraw due to family issues|0|||
147429995|NCT00147823|531737879|FG000|Overall Study|Lost to Follow-up|6|||
147429996|NCT00147823|531737880|FG001|Overall Study|Lost to Follow-up|12|||
147429997|NCT00147823|531737879|FG000|Overall Study|Physician Decision|1|||
147429998|NCT00147823|531737880|FG001|Overall Study|Physician Decision|0|||
147429999|NCT00147823|531737879|FG000|Overall Study|Withdrawal by Subject|0|||
147430000|NCT00147823|531737880|FG001|Overall Study|Withdrawal by Subject|1|||
147430001|NCT00147823|531737879|FG000|Overall Study|Did not receive vitoss due to infection|6|||
147430002|NCT00147823|531737880|FG001|Overall Study|Did not receive vitoss due to infection|2|||
147430003|NCT03217266|531740160|FG000|Step 1: Dose Level 1|Did not start protocol treatment|1|||
147430004|NCT03217266|531740161|FG001|Step 1: Dose Level 1|Did not start protocol treatment|0|||
147430005|NCT03217266|531740162|FG002|Step 1: Dose Level 1|Did not start protocol treatment|0|||
147430006|NCT03217266|531740163|FG003|Step 1: Dose Level 1|Did not start protocol treatment|0|||
147430007|NCT03217266|531740160|FG000|Step 1: Dose Level 2|Did not start protocol treatment|1|||
147430008|NCT03217266|531740161|FG001|Step 1: Dose Level 2|Did not start protocol treatment|2|||
147430009|NCT03217266|531740162|FG002|Step 1: Dose Level 2|Did not start protocol treatment|0|||
147430010|NCT03217266|531740163|FG003|Step 1: Dose Level 2|Did not start protocol treatment|0|||
147306728|NCT03812536|531290738|FG001|Overall Study|Protocol Violation|0|||
147430011|NCT03217266|531740160|FG000|Step 1: Dose Level 3|Did not start treatment|1|||
147430012|NCT03217266|531740161|FG001|Step 1: Dose Level 3|Did not start treatment|0|||
147430013|NCT03217266|531740162|FG002|Step 1: Dose Level 3|Did not start treatment|0|||
147430014|NCT03217266|531740163|FG003|Step 1: Dose Level 3|Did not start treatment|0|||
147430015|NCT02101034|531740164|FG000|Overall Study|Enrolled but did not start treatment|0|||
147430016|NCT02101034|531740165|FG001|Overall Study|Enrolled but did not start treatment|0|||
147192870|NCT00474487|530876354|FG002|Overall Study|Inappropriate enrollment|7|||
147192871|NCT00474487|530876355|FG003|Overall Study|Inappropriate enrollment|0|||
147192872|NCT00474487|530876352|FG000|Overall Study|Death|0|||
147192873|NCT00474487|530876353|FG001|Overall Study|Death|1|||
147192874|NCT00474487|530876354|FG002|Overall Study|Death|0|||
147192875|NCT00474487|530876355|FG003|Overall Study|Death|0|||
147192876|NCT01428258|530876356|FG000|Intervention 1|Withdrawal by Subject|2|||
147192877|NCT01428258|530876357|FG001|Intervention 1|Withdrawal by Subject|0|||
147192878|NCT00419393|530876358|FG000|Overall Study|Adverse Event|5|||
147192879|NCT00419393|530876358|FG000|Overall Study|Protocol Violation|5|||
147192880|NCT00419393|530876358|FG000|Overall Study|Withdrawal by Subject|7|||
147192881|NCT00419393|530876358|FG000|Overall Study|Other: Sponsor request|3|||
147192882|NCT00419393|530876358|FG000|Overall Study|Other: Subject had temporal lobectomy|1|||
147192883|NCT00419393|530876358|FG000|Overall Study|Other: Site closure|1|||
147192884|NCT00419393|530876358|FG000|Overall Study|Other: Other health problems|1|||
147192885|NCT00419393|530876358|FG000|Overall Study|Other: Investigator decision|1|||
147192886|NCT00979901|530876359|FG000|Overall Study|Adverse Event|1|||
147192887|NCT00979901|530876360|FG001|Overall Study|Adverse Event|3|||
147192888|NCT00979901|530876361|FG002|Overall Study|Adverse Event|9|||
147192889|NCT00979901|530876362|FG003|Overall Study|Adverse Event|2|||
147192890|NCT00979901|530876359|FG000|Overall Study|Lack of Efficacy|8|||
147192891|NCT00979901|530876360|FG001|Overall Study|Lack of Efficacy|4|||
147192892|NCT00979901|530876361|FG002|Overall Study|Lack of Efficacy|9|||
147192893|NCT00979901|530876362|FG003|Overall Study|Lack of Efficacy|0|||
147192894|NCT00979901|530876359|FG000|Overall Study|Lost to Follow-up|1|||
147192895|NCT00979901|530876360|FG001|Overall Study|Lost to Follow-up|1|||
147192896|NCT00979901|530876361|FG002|Overall Study|Lost to Follow-up|2|||
147192897|NCT00979901|530876362|FG003|Overall Study|Lost to Follow-up|0|||
147192898|NCT00979901|530876359|FG000|Overall Study|Protocol Violation|2|||
147192899|NCT00979901|530876360|FG001|Overall Study|Protocol Violation|2|||
147430017|NCT02101034|531740166|FG002|Overall Study|Enrolled but did not start treatment|1|||
147430018|NCT02101034|531740167|FG003|Overall Study|Enrolled but did not start treatment|0|||
147192900|NCT00979901|530876361|FG002|Overall Study|Protocol Violation|7|||
147192901|NCT00979901|530876362|FG003|Overall Study|Protocol Violation|1|||
147192902|NCT00979901|530876359|FG000|Overall Study|Withdrawal by Subject|2|||
147192903|NCT00979901|530876360|FG001|Overall Study|Withdrawal by Subject|1|||
147192904|NCT00979901|530876361|FG002|Overall Study|Withdrawal by Subject|1|||
147192905|NCT00979901|530876362|FG003|Overall Study|Withdrawal by Subject|1|||
147192906|NCT00979901|530876359|FG000|Overall Study|Noncompliance|1|||
147192907|NCT00979901|530876360|FG001|Overall Study|Noncompliance|0|||
147192908|NCT00979901|530876361|FG002|Overall Study|Noncompliance|0|||
147192909|NCT00979901|530876362|FG003|Overall Study|Noncompliance|0|||
147192910|NCT00979901|530876359|FG000|Overall Study|out-of-state|1|||
147192911|NCT00979901|530876360|FG001|Overall Study|out-of-state|0|||
147192912|NCT00979901|530876361|FG002|Overall Study|out-of-state|0|||
147192913|NCT00979901|530876362|FG003|Overall Study|out-of-state|0|||
147192914|NCT00979901|530876359|FG000|Overall Study|vacation|1|||
147192915|NCT00979901|530876360|FG001|Overall Study|vacation|0|||
147192916|NCT00979901|530876361|FG002|Overall Study|vacation|0|||
147430019|NCT02101034|531740168|FG004|Overall Study|Enrolled but did not start treatment|0|||
147430020|NCT01390181|531740169|FG000|Overall Study|Lost to Follow-up|1|||
147430021|NCT01390181|531740169|FG000|Overall Study|Study Terminated due to Low Accrual|3|||
147430022|NCT01101477|531740180|FG000|Overall Study|Protocol Violation|5|||
147430023|NCT01101477|531740181|FG001|Overall Study|Protocol Violation|3|||
147192917|NCT00979901|530876362|FG003|Overall Study|vacation|0|||
147192918|NCT00979901|530876359|FG000|Overall Study|elevated lab values pre-randomization|1|||
147192919|NCT00979901|530876360|FG001|Overall Study|elevated lab values pre-randomization|0|||
147192920|NCT00979901|530876361|FG002|Overall Study|elevated lab values pre-randomization|0|||
147192921|NCT00979901|530876362|FG003|Overall Study|elevated lab values pre-randomization|0|||
147430024|NCT01101477|531740182|FG002|Overall Study|Protocol Violation|1|||
147430025|NCT00720941|531740183|FG000|Overall Study|Protocol Violation|1|||
147192922|NCT00979901|530876359|FG000|Overall Study|Discontinued in Error|0|||
147192923|NCT00979901|530876360|FG001|Overall Study|Discontinued in Error|1|||
147192924|NCT00979901|530876361|FG002|Overall Study|Discontinued in Error|0|||
147192925|NCT00979901|530876362|FG003|Overall Study|Discontinued in Error|0|||
147192926|NCT00979901|530876359|FG000|Overall Study|Left Country|0|||
147192927|NCT00979901|530876360|FG001|Overall Study|Left Country|0|||
147192928|NCT00979901|530876361|FG002|Overall Study|Left Country|1|||
147192929|NCT00979901|530876362|FG003|Overall Study|Left Country|0|||
147192930|NCT00979901|530876359|FG000|Overall Study|Treatment Group Terminated by Sponsor|0|||
147192931|NCT00979901|530876360|FG001|Overall Study|Treatment Group Terminated by Sponsor|0|||
147192932|NCT00979901|530876361|FG002|Overall Study|Treatment Group Terminated by Sponsor|0|||
147430026|NCT00720941|531740184|FG001|Overall Study|Protocol Violation|2|||
147430027|NCT00720941|531740183|FG000|Overall Study|Transitioned to another mechanism of continuing pazopanib or sunitinib therapy after 30SEP2013|8|||
147430028|NCT00720941|531740184|FG001|Overall Study|Transitioned to another mechanism of continuing pazopanib or sunitinib therapy after 30SEP2013|7|||
147430029|NCT00720941|531740183|FG000|Overall Study|Lost to Follow-up|20|||
147430030|NCT00720941|531740184|FG001|Overall Study|Lost to Follow-up|15|||
147430031|NCT00720941|531740183|FG000|Overall Study|Physician Decision|14|||
147430032|NCT00720941|531740184|FG001|Overall Study|Physician Decision|12|||
147430033|NCT00720941|531740183|FG000|Overall Study|Withdrawal by Subject|29|||
147430034|NCT00720941|531740184|FG001|Overall Study|Withdrawal by Subject|36|||
147430035|NCT02544217|531740185|FG000|Overall Study|Withdrawal by Subject|1|||
147430036|NCT02544217|531740186|FG001|Overall Study|Withdrawal by Subject|1|||
147430037|NCT02544217|531740187|FG002|Overall Study|Withdrawal by Subject|0|||
147430038|NCT02544217|531740188|FG003|Overall Study|Withdrawal by Subject|0|||
147430039|NCT02544217|531740189|FG004|Overall Study|Withdrawal by Subject|0|||
147430040|NCT02544217|531740190|FG005|Overall Study|Withdrawal by Subject|0|||
147430041|NCT00667355|531740192|FG000|Overall Study|Adverse Event|5|||
147430042|NCT00667355|531740192|FG000|Overall Study|Lost to Follow-up|1|||
147430043|NCT00667355|531740192|FG000|Overall Study|Other reason was not specified|5|||
147430044|NCT00937833|531740193|FG000|Overall Study|Protocol Violation|1|||
147430045|NCT00937833|531740194|FG001|Overall Study|Protocol Violation|2|||
147430046|NCT00937833|531740193|FG000|Overall Study|Procedure delayed; enrollment closed|0|||
147430047|NCT00937833|531740194|FG001|Overall Study|Procedure delayed; enrollment closed|1|||
147430048|NCT00937833|531740193|FG000|Overall Study|Lost to Follow-up|10|||
147430049|NCT00937833|531740194|FG001|Overall Study|Lost to Follow-up|8|||
147430050|NCT00937833|531740193|FG000|Overall Study|Withdrawal by Subject|4|||
147430051|NCT00937833|531740194|FG001|Overall Study|Withdrawal by Subject|6|||
147430052|NCT02175004|531740195|FG000|Overall Study|Adverse Event or Serious Adverse Event (SAE)|5|||
147430053|NCT02175004|531740196|FG001|Overall Study|Adverse Event or Serious Adverse Event (SAE)|14|||
147430054|NCT02175004|531740195|FG000|Overall Study|Investigator Judgment|1|||
147430055|NCT02175004|531740196|FG001|Overall Study|Investigator Judgment|4|||
147430056|NCT02175004|531740195|FG000|Overall Study|Voluntary Withdrawal|6|||
147430057|NCT02175004|531740196|FG001|Overall Study|Voluntary Withdrawal|19|||
147430058|NCT02175004|531740195|FG000|Overall Study|Liver Transplant|1|||
147430059|NCT02175004|531740196|FG001|Overall Study|Liver Transplant|0|||
147430060|NCT02175004|531740195|FG000|Overall Study|Disease Progression|1|||
147430061|NCT02175004|531740196|FG001|Overall Study|Disease Progression|0|||
147430062|NCT02175004|531740195|FG000|Overall Study|Participants Started Treatment With Commercially Available/Post-study Inotersen|27|||
147430063|NCT02175004|531740196|FG001|Overall Study|Participants Started Treatment With Commercially Available/Post-study Inotersen|39|||
147430064|NCT00162032|531740197|FG000|Overall Study|Lost to Follow-up|4|||
147430065|NCT00162032|531740198|FG001|Overall Study|Lost to Follow-up|2|||
147430066|NCT00162032|531740197|FG000|Overall Study|Reason not specified|1|||
147192933|NCT00979901|530876362|FG003|Overall Study|Treatment Group Terminated by Sponsor|112|||
147430067|NCT00162032|531740198|FG001|Overall Study|Reason not specified|0|||
147430068|NCT00818389|531740199|FG000|Overall Study|Death|1|||
147430069|NCT00818389|531740200|FG001|Overall Study|Death|3|||
147430070|NCT00818389|531740199|FG000|Overall Study|ALS Disease Progression|1|||
147430071|NCT00818389|531740200|FG001|Overall Study|ALS Disease Progression|0|||
147430072|NCT00818389|531740199|FG000|Overall Study|Withdrawal by Subject|2|||
147430073|NCT00818389|531740200|FG001|Overall Study|Withdrawal by Subject|2|||
147430074|NCT00818389|531740199|FG000|Overall Study|Adverse Event|0|||
147430075|NCT00818389|531740200|FG001|Overall Study|Adverse Event|1|||
147430076|NCT04263909|531740201|FG000|Overall Study|Physician Decision|1|||
147430077|NCT04263909|531740202|FG001|Overall Study|Physician Decision|0|||
147430078|NCT04263909|531740203|FG002|Overall Study|Physician Decision|0|||
147430079|NCT04263909|531740201|FG000|Overall Study|Adverse Event|3|||
147430080|NCT04263909|531740202|FG001|Overall Study|Adverse Event|0|||
147430081|NCT04263909|531740203|FG002|Overall Study|Adverse Event|0|||
147430082|NCT04263909|531740201|FG000|Overall Study|Protocol Violation|5|||
147430083|NCT04263909|531740202|FG001|Overall Study|Protocol Violation|0|||
147430084|NCT04263909|531740203|FG002|Overall Study|Protocol Violation|0|||
147430085|NCT05193500|531740204|FG000|Overall Study|Withdrawal by Subject|7|||
147430086|NCT05193500|531740205|FG001|Overall Study|Withdrawal by Subject|4|||
147430087|NCT05193500|531740206|FG002|Overall Study|Withdrawal by Subject|3|||
147192934|NCT02814916|530876367|FG000|Overall Study|Withdrawal of consent|0|||
147192935|NCT02814916|530876368|FG001|Overall Study|Withdrawal of consent|2|||
147192936|NCT02814916|530876369|FG002|Overall Study|Withdrawal of consent|0|||
147192937|NCT02814916|530876367|FG000|Overall Study|Lost to Follow-up|0|||
147192938|NCT02814916|530876368|FG001|Overall Study|Lost to Follow-up|1|||
147192939|NCT02814916|530876369|FG002|Overall Study|Lost to Follow-up|0|||
147192940|NCT02814916|530876367|FG000|Overall Study|Other, not specified|0|||
147192941|NCT02814916|530876368|FG001|Overall Study|Other, not specified|1|||
147192942|NCT02814916|530876369|FG002|Overall Study|Other, not specified|0|||
147192943|NCT05543265|530876371|FG000|Overall Study|Lost to Follow-up|3|||
147192944|NCT05543265|530876372|FG001|Overall Study|Lost to Follow-up|3|||
147192945|NCT05543265|530876371|FG000|Overall Study|Withdrawal by Subject|0|||
147192946|NCT05543265|530876372|FG001|Overall Study|Withdrawal by Subject|1|||
147192947|NCT02766023|530876373|FG000|Overall Study|Lost to Follow-up|23|||
147192948|NCT02766023|530876374|FG001|Overall Study|Lost to Follow-up|11|||
147192949|NCT02766023|530876373|FG000|Overall Study|Pregnancy|1|||
147192950|NCT02766023|530876374|FG001|Overall Study|Pregnancy|0|||
147192951|NCT02766023|530876373|FG000|Overall Study|Adverse Event|1|||
147192952|NCT02766023|530876374|FG001|Overall Study|Adverse Event|0|||
147192953|NCT02766023|530876373|FG000|Overall Study|Withdrawal by Subject|4|||
147192954|NCT02766023|530876374|FG001|Overall Study|Withdrawal by Subject|5|||
147192955|NCT02766023|530876373|FG000|Overall Study|Physician Decision|1|||
147192956|NCT02766023|530876374|FG001|Overall Study|Physician Decision|0|||
147192957|NCT02766023|530876373|FG000|Overall Study|Not Eligible at Enrollment|0|||
147192958|NCT02766023|530876374|FG001|Overall Study|Not Eligible at Enrollment|1|||
147192959|NCT00286468|530876377|FG000|Overall Study|Hyperglycemic Rescue|28|||
147192960|NCT00286468|530876378|FG001|Overall Study|Hyperglycemic Rescue|30|||
147192961|NCT00286468|530876379|FG002|Overall Study|Hyperglycemic Rescue|31|||
147192962|NCT00286468|530876377|FG000|Overall Study|Adverse Event|2|||
147192963|NCT00286468|530876378|FG001|Overall Study|Adverse Event|6|||
147192964|NCT00286468|530876379|FG002|Overall Study|Adverse Event|4|||
147192965|NCT00286468|530876377|FG000|Overall Study|Protocol Violation|0|||
147192966|NCT00286468|530876378|FG001|Overall Study|Protocol Violation|3|||
147192967|NCT00286468|530876379|FG002|Overall Study|Protocol Violation|1|||
147192968|NCT00286468|530876377|FG000|Overall Study|Lost to Follow-up|1|||
147430088|NCT05193500|531740207|FG003|Overall Study|Withdrawal by Subject|5|||
147430089|NCT03840486|531740208|FG000|Overall Study|Withdrawal by Subject|0|||
147430090|NCT03840486|531740209|FG001|Overall Study|Withdrawal by Subject|1|||
147430091|NCT03840486|531740210|FG002|Overall Study|Withdrawal by Subject|0|||
147430092|NCT03840486|531740211|FG003|Overall Study|Withdrawal by Subject|0|||
147430093|NCT03840486|531740212|FG004|Overall Study|Withdrawal by Subject|0|||
147430094|NCT03840486|531740213|FG005|Overall Study|Withdrawal by Subject|0|||
147430095|NCT03840486|531740214|FG006|Overall Study|Withdrawal by Subject|0|||
147532953|NCT05182840|532106051|FG009|Completed RP and Randomized to TP|Did not meet additional inclusion/exclusion criteria for Treatment Period|0|||
147192969|NCT00286468|530876378|FG001|Overall Study|Lost to Follow-up|1|||
147192970|NCT00286468|530876379|FG002|Overall Study|Lost to Follow-up|2|||
147192971|NCT00286468|530876377|FG000|Overall Study|Withdrawal by Subject|3|||
147192972|NCT00286468|530876378|FG001|Overall Study|Withdrawal by Subject|8|||
147192973|NCT00286468|530876379|FG002|Overall Study|Withdrawal by Subject|11|||
147192974|NCT00286468|530876377|FG000|Overall Study|Physician Decision|3|||
147192975|NCT00286468|530876378|FG001|Overall Study|Physician Decision|2|||
147192976|NCT00286468|530876379|FG002|Overall Study|Physician Decision|1|||
147192977|NCT02953652|530876380|FG000|Overall Study|Adverse Event|18|||
147192978|NCT02953652|530876380|FG000|Overall Study|Withdrawal by Subject|6|||
147192979|NCT02953652|530876380|FG000|Overall Study|Protocol Violation|1|||
147192980|NCT02953652|530876380|FG000|Overall Study|Disease Progression|27|||
147192981|NCT02927301|530876381|FG000|Overall Study|Death|39|||
147430096|NCT03840486|531740215|FG007|Overall Study|Withdrawal by Subject|0|||
147430097|NCT03840486|531740216|FG008|Overall Study|Withdrawal by Subject|0|||
147430098|NCT03840486|531740217|FG009|Overall Study|Withdrawal by Subject|0|||
147430099|NCT03840486|531740218|FG010|Overall Study|Withdrawal by Subject|0|||
147430100|NCT03840486|531740219|FG011|Overall Study|Withdrawal by Subject|0|||
147430101|NCT04442737|531740222|FG000|Overall Study|Lost to Follow-up|1|||
147430102|NCT04442737|531740223|FG001|Overall Study|Lost to Follow-up|3|||
147430103|NCT04442737|531740222|FG000|Overall Study|Withdrawal by Subject|3|||
147430104|NCT04442737|531740223|FG001|Overall Study|Withdrawal by Subject|2|||
147430105|NCT04442737|531740222|FG000|Overall Study|Adverse Event|3|||
147430106|NCT04442737|531740223|FG001|Overall Study|Adverse Event|2|||
147430107|NCT04442737|531740222|FG000|Overall Study|Death|0|||
147430108|NCT04442737|531740223|FG001|Overall Study|Death|1|||
147430109|NCT04442737|531740222|FG000|Overall Study|Protocol Violation|0|||
147430110|NCT04442737|531740223|FG001|Overall Study|Protocol Violation|2|||
147430111|NCT04442737|531740222|FG000|Overall Study|Other|1|||
147430112|NCT04442737|531740223|FG001|Overall Study|Other|1|||
147430113|NCT03588728|531740227|FG000|Overall Study|Did not meet eligibility ctriteria|0|||
147430114|NCT03588728|531740228|FG001|Overall Study|Did not meet eligibility ctriteria|0|||
147430115|NCT03588728|531740229|FG002|Overall Study|Did not meet eligibility ctriteria|3|||
147430116|NCT03588728|531740230|FG003|Overall Study|Did not meet eligibility ctriteria|2|||
147430117|NCT03588728|531740227|FG000|Overall Study|Lab shut down due to COVID-19|0|||
147430118|NCT03588728|531740228|FG001|Overall Study|Lab shut down due to COVID-19|0|||
147430119|NCT03588728|531740229|FG002|Overall Study|Lab shut down due to COVID-19|0|||
147430120|NCT03588728|531740230|FG003|Overall Study|Lab shut down due to COVID-19|1|||
147430121|NCT03588728|531740227|FG000|Overall Study|multiple technical issues|1|||
147430122|NCT03588728|531740228|FG001|Overall Study|multiple technical issues|0|||
147430123|NCT03588728|531740229|FG002|Overall Study|multiple technical issues|0|||
147430124|NCT03588728|531740230|FG003|Overall Study|multiple technical issues|0|||
147430125|NCT03588728|531740227|FG000|Overall Study|Hospitalized for COVID|1|||
147430126|NCT03588728|531740228|FG001|Overall Study|Hospitalized for COVID|0|||
147430127|NCT03588728|531740229|FG002|Overall Study|Hospitalized for COVID|0|||
147430128|NCT03588728|531740230|FG003|Overall Study|Hospitalized for COVID|0|||
147430129|NCT03588728|531740227|FG000|Overall Study|Schedule change unable to attend sessions|1|||
147430130|NCT03588728|531740228|FG001|Overall Study|Schedule change unable to attend sessions|0|||
147430131|NCT03588728|531740229|FG002|Overall Study|Schedule change unable to attend sessions|0|||
147430132|NCT03588728|531740230|FG003|Overall Study|Schedule change unable to attend sessions|0|||
147430133|NCT01388790|531740231|FG000|Overall Study|Ongoing at data cut-off date|8|||
147430134|NCT00195507|531740232|FG000|Overall Study|Adverse Event|24|||
147430135|NCT00195507|531740233|FG001|Overall Study|Adverse Event|13|||
147430136|NCT00195507|531740232|FG000|Overall Study|Death|0|||
147430137|NCT00195507|531740233|FG001|Overall Study|Death|1|||
147430138|NCT00195507|531740232|FG000|Overall Study|Failed to Return|4|||
147430139|NCT00195507|531740233|FG001|Overall Study|Failed to Return|3|||
147430140|NCT00195507|531740232|FG000|Overall Study|Physician Decision|1|||
147430141|NCT00195507|531740233|FG001|Overall Study|Physician Decision|2|||
147430142|NCT00195507|531740232|FG000|Overall Study|Lost to Follow-up|3|||
147430143|NCT00195507|531740233|FG001|Overall Study|Lost to Follow-up|2|||
147430144|NCT00195507|531740232|FG000|Overall Study|Protocol Violation|5|||
147430145|NCT00195507|531740233|FG001|Overall Study|Protocol Violation|4|||
147430146|NCT00195507|531740232|FG000|Overall Study|Lack of Efficacy|40|||
147430147|NCT00195507|531740233|FG001|Overall Study|Lack of Efficacy|67|||
147430148|NCT00195507|531740232|FG000|Overall Study|Withdrawal by Subject|16|||
147430149|NCT00195507|531740233|FG001|Overall Study|Withdrawal by Subject|23|||
147430150|NCT00195507|531740232|FG000|Overall Study|Protocol Deviation|6|||
147430151|NCT00195507|531740233|FG001|Overall Study|Protocol Deviation|3|||
147430152|NCT02202551|531740234|FG000|Overall Study|Adverse Event|8|||
147430153|NCT02202551|531740235|FG001|Overall Study|Adverse Event|19|||
147430154|NCT02202551|531740236|FG002|Overall Study|Adverse Event|5|||
147430155|NCT02202551|531740237|FG003|Overall Study|Adverse Event|9|||
147430156|NCT02202551|531740234|FG000|Overall Study|Death|3|||
147430157|NCT02202551|531740235|FG001|Overall Study|Death|2|||
147430158|NCT02202551|531740236|FG002|Overall Study|Death|1|||
147430159|NCT02202551|531740237|FG003|Overall Study|Death|1|||
147532954|NCT05182840|532106042|FG000|Treatment Period|Reason missing|0|||
147532955|NCT05182840|532106043|FG001|Treatment Period|Reason missing|0|||
147430160|NCT02202551|531740234|FG000|Overall Study|Lost to Follow-up|0|||
147430161|NCT02202551|531740235|FG001|Overall Study|Lost to Follow-up|1|||
147430162|NCT02202551|531740236|FG002|Overall Study|Lost to Follow-up|0|||
147430163|NCT02202551|531740237|FG003|Overall Study|Lost to Follow-up|1|||
147430164|NCT02202551|531740234|FG000|Overall Study|Needed to take excluded medication|0|||
147430165|NCT02202551|531740235|FG001|Overall Study|Needed to take excluded medication|2|||
147430166|NCT02202551|531740236|FG002|Overall Study|Needed to take excluded medication|0|||
147430167|NCT02202551|531740237|FG003|Overall Study|Needed to take excluded medication|1|||
147430168|NCT02202551|531740234|FG000|Overall Study|Subject moved away|0|||
147430169|NCT02202551|531740235|FG001|Overall Study|Subject moved away|1|||
147430170|NCT02202551|531740236|FG002|Overall Study|Subject moved away|0|||
147532956|NCT05182840|532106044|FG002|Treatment Period|Reason missing|1|||
147430171|NCT02202551|531740237|FG003|Overall Study|Subject moved away|0|||
147430172|NCT02202551|531740234|FG000|Overall Study|DBS surgery|3|||
147430173|NCT02202551|531740235|FG001|Overall Study|DBS surgery|0|||
147430174|NCT02202551|531740236|FG002|Overall Study|DBS surgery|0|||
147430175|NCT02202551|531740237|FG003|Overall Study|DBS surgery|0|||
147430176|NCT02202551|531740234|FG000|Overall Study|Dyskinesia upon taper|1|||
147430177|NCT02202551|531740235|FG001|Overall Study|Dyskinesia upon taper|0|||
147430178|NCT02202551|531740236|FG002|Overall Study|Dyskinesia upon taper|0|||
147430179|NCT02202551|531740237|FG003|Overall Study|Dyskinesia upon taper|0|||
147430180|NCT02202551|531740234|FG000|Overall Study|Lack of Efficacy|0|||
147430181|NCT02202551|531740235|FG001|Overall Study|Lack of Efficacy|1|||
147430182|NCT02202551|531740236|FG002|Overall Study|Lack of Efficacy|0|||
147430183|NCT02202551|531740237|FG003|Overall Study|Lack of Efficacy|0|||
147430184|NCT02202551|531740234|FG000|Overall Study|Physician Decision|1|||
147430185|NCT02202551|531740235|FG001|Overall Study|Physician Decision|0|||
147430186|NCT02202551|531740236|FG002|Overall Study|Physician Decision|0|||
147430187|NCT02202551|531740237|FG003|Overall Study|Physician Decision|0|||
147430188|NCT02202551|531740234|FG000|Overall Study|Site closure|3|||
147430189|NCT02202551|531740235|FG001|Overall Study|Site closure|0|||
147430190|NCT02202551|531740236|FG002|Overall Study|Site closure|0|||
147430191|NCT02202551|531740237|FG003|Overall Study|Site closure|1|||
147430192|NCT02202551|531740234|FG000|Overall Study|Unable to complete visits per protocol|1|||
147430193|NCT02202551|531740235|FG001|Overall Study|Unable to complete visits per protocol|0|||
147430194|NCT02202551|531740236|FG002|Overall Study|Unable to complete visits per protocol|0|||
147430195|NCT02202551|531740237|FG003|Overall Study|Unable to complete visits per protocol|0|||
147430196|NCT02202551|531740234|FG000|Overall Study|Worsening Dyskinesia|0|||
147430197|NCT02202551|531740235|FG001|Overall Study|Worsening Dyskinesia|0|||
147430198|NCT02202551|531740236|FG002|Overall Study|Worsening Dyskinesia|0|||
147430199|NCT02202551|531740237|FG003|Overall Study|Worsening Dyskinesia|1|||
147430200|NCT02202551|531740234|FG000|Overall Study|Protocol Violation|0|||
147430201|NCT02202551|531740235|FG001|Overall Study|Protocol Violation|1|||
147430202|NCT02202551|531740236|FG002|Overall Study|Protocol Violation|0|||
147430203|NCT02202551|531740237|FG003|Overall Study|Protocol Violation|0|||
147430204|NCT02202551|531740234|FG000|Overall Study|Sponsor's decision|2|||
147430205|NCT02202551|531740235|FG001|Overall Study|Sponsor's decision|0|||
147430206|NCT02202551|531740236|FG002|Overall Study|Sponsor's decision|0|||
147430207|NCT02202551|531740237|FG003|Overall Study|Sponsor's decision|0|||
147430208|NCT02202551|531740234|FG000|Overall Study|Subject unwilling to proceed|1|||
147430209|NCT02202551|531740235|FG001|Overall Study|Subject unwilling to proceed|5|||
147430210|NCT02202551|531740236|FG002|Overall Study|Subject unwilling to proceed|3|||
147430211|NCT02202551|531740237|FG003|Overall Study|Subject unwilling to proceed|5|||
147430212|NCT02202551|531740234|FG000|Overall Study|Subject consent withdrawn|0|||
147430213|NCT02202551|531740235|FG001|Overall Study|Subject consent withdrawn|3|||
147430214|NCT02202551|531740236|FG002|Overall Study|Subject consent withdrawn|1|||
147430215|NCT02202551|531740237|FG003|Overall Study|Subject consent withdrawn|2|||
147430216|NCT02202551|531740234|FG000|Overall Study|eGFR<50mL/min/m2|2|||
147430217|NCT02202551|531740235|FG001|Overall Study|eGFR<50mL/min/m2|2|||
147430218|NCT02202551|531740236|FG002|Overall Study|eGFR<50mL/min/m2|0|||
147430219|NCT02202551|531740237|FG003|Overall Study|eGFR<50mL/min/m2|1|||
147430220|NCT01176773|531740246|FG000|Overall Study|Screen Failure|2|||
147430221|NCT01176773|531740246|FG000|Overall Study|Withdrew consent|1|||
147430222|NCT02446886|531740254|FG000|Overall Study|Adverse Event|1|||
147430223|NCT02446886|531740255|FG001|Overall Study|Adverse Event|3|||
147430224|NCT02446886|531740254|FG000|Overall Study|Withdrawal by Subject|1|||
147430225|NCT02446886|531740255|FG001|Overall Study|Withdrawal by Subject|1|||
147430226|NCT01498289|531740266|FG000|Overall Study|Adverse Event|16|||
147430227|NCT01498289|531740267|FG001|Overall Study|Adverse Event|18|||
147430228|NCT01498289|531740266|FG000|Overall Study|Death|6|||
147430229|NCT01498289|531740267|FG001|Overall Study|Death|8|||
147430230|NCT01498289|531740266|FG000|Overall Study|Withdrawal unrelated to AE|16|||
147430231|NCT01498289|531740267|FG001|Overall Study|Withdrawal unrelated to AE|16|||
147430232|NCT01498289|531740266|FG000|Overall Study|Progression/relapse|53|||
147430233|NCT01498289|531740267|FG001|Overall Study|Progression/relapse|59|||
147430234|NCT01498289|531740266|FG000|Overall Study|Not protocol specified|7|||
147430235|NCT01498289|531740267|FG001|Overall Study|Not protocol specified|2|||
147430236|NCT01498289|531740266|FG000|Overall Study|Reason under review|0|||
147430237|NCT01498289|531740267|FG001|Overall Study|Reason under review|1|||
147430238|NCT01423253|531740268|FG000|Overall Study|Adverse Event|2|||
147430239|NCT01423253|531740268|FG000|Overall Study|Lack of Efficacy|2|||
147430240|NCT01423253|531740268|FG000|Overall Study|Lost to Follow-up|1|||
147430241|NCT01423253|531740268|FG000|Overall Study|Protocol Violation|2|||
147430242|NCT01423253|531740268|FG000|Overall Study|Withdrawal by Subject|2|||
147430243|NCT02804178|531740269|FG000|Overall Study|Adverse Event|1|||
147430244|NCT01290601|531740270|FG000|Overall Study|Adverse Event|0|||
147430245|NCT01290601|531740271|FG001|Overall Study|Adverse Event|2|||
147430246|NCT01290601|531740272|FG002|Overall Study|Adverse Event|0|||
147430247|NCT01290601|531740273|FG003|Overall Study|Adverse Event|0|||
147430248|NCT01290601|531740270|FG000|Overall Study|Lack of Efficacy|2|||
147430249|NCT01290601|531740271|FG001|Overall Study|Lack of Efficacy|1|||
147430250|NCT01290601|531740272|FG002|Overall Study|Lack of Efficacy|0|||
147430251|NCT01290601|531740273|FG003|Overall Study|Lack of Efficacy|0|||
147430252|NCT01290601|531740270|FG000|Overall Study|Lost to Follow-up|7|||
147430253|NCT01290601|531740271|FG001|Overall Study|Lost to Follow-up|2|||
147430254|NCT01290601|531740272|FG002|Overall Study|Lost to Follow-up|0|||
147430255|NCT01290601|531740273|FG003|Overall Study|Lost to Follow-up|0|||
147430256|NCT01290601|531740270|FG000|Overall Study|Other|1|||
147430257|NCT01290601|531740271|FG001|Overall Study|Other|0|||
147430258|NCT01290601|531740272|FG002|Overall Study|Other|0|||
147430259|NCT01290601|531740273|FG003|Overall Study|Other|0|||
147430260|NCT01290601|531740270|FG000|Overall Study|Protocol Violation|1|||
147430261|NCT01290601|531740271|FG001|Overall Study|Protocol Violation|0|||
147430262|NCT01290601|531740272|FG002|Overall Study|Protocol Violation|0|||
147430263|NCT01290601|531740273|FG003|Overall Study|Protocol Violation|0|||
147430264|NCT00421707|531740281|FG000|Period 1: Treatment Period 1|Withdrawal by Subject|1|||
147430265|NCT00421707|531740282|FG001|Period 1: Treatment Period 1|Withdrawal by Subject|5|||
147430266|NCT00421707|531740281|FG000|Period 1: Treatment Period 1|Adverse Event|7|||
147430267|NCT00421707|531740282|FG001|Period 1: Treatment Period 1|Adverse Event|2|||
147430268|NCT00421707|531740281|FG000|Period 1: Treatment Period 1|Lost to Follow-up|2|||
147430269|NCT00421707|531740282|FG001|Period 1: Treatment Period 1|Lost to Follow-up|2|||
147430270|NCT00421707|531740281|FG000|Period 1: Treatment Period 1|Protocol Violation|1|||
147430271|NCT00421707|531740282|FG001|Period 1: Treatment Period 1|Protocol Violation|0|||
147430272|NCT00421707|531740281|FG000|Period 2: Washout|Adverse Event|1|||
147430273|NCT00421707|531740282|FG001|Period 2: Washout|Adverse Event|1|||
147430274|NCT00421707|531740281|FG000|Period 2: Washout|Withdrawal by Subject|0|||
147430275|NCT00421707|531740282|FG001|Period 2: Washout|Withdrawal by Subject|1|||
147430276|NCT00421707|531740281|FG000|Period 2: Washout|Lost to Follow-up|0|||
147430277|NCT00421707|531740282|FG001|Period 2: Washout|Lost to Follow-up|1|||
147430278|NCT00421707|531740281|FG000|Period 2: Washout|Other: Pregnancy|0|||
147430279|NCT00421707|531740282|FG001|Period 2: Washout|Other: Pregnancy|1|||
147430280|NCT00421707|531740281|FG000|Period 3:Treatment Period 2|Withdrawal by Subject|1|||
147430281|NCT00421707|531740282|FG001|Period 3:Treatment Period 2|Withdrawal by Subject|1|||
147192982|NCT02927301|530876381|FG000|Overall Study|Lost to Follow-up|8|||
147192983|NCT02927301|530876381|FG000|Overall Study|Physician Decision|2|||
147192984|NCT02927301|530876381|FG000|Overall Study|Withdrawal by Subject|12|||
147192985|NCT02927301|530876381|FG000|Overall Study|Study Ended By Sponsor While in Survival Follow-Up|5|||
147192986|NCT04742556|530876382|FG000|Overall Study|Withdrawal by Subject|0|||
147192987|NCT04742556|530876383|FG001|Overall Study|Withdrawal by Subject|1|||
147192988|NCT04742556|530876384|FG002|Overall Study|Withdrawal by Subject|0|||
147430282|NCT00421707|531740281|FG000|Period 3:Treatment Period 2|Protocol Violation|1|||
147430283|NCT00421707|531740282|FG001|Period 3:Treatment Period 2|Protocol Violation|0|||
147430284|NCT00421707|531740281|FG000|Period 3:Treatment Period 2|Adverse Event|0|||
147430285|NCT00421707|531740282|FG001|Period 3:Treatment Period 2|Adverse Event|2|||
147430286|NCT01948908|531740285|FG000|Overall Study|Protocol Violation|1|||
147430287|NCT01948908|531740286|FG001|Overall Study|Protocol Violation|0|||
147430288|NCT01948908|531740287|FG002|Overall Study|Protocol Violation|2|||
147430289|NCT01759407|531740291|FG000|Overall Study|Protocol Violation|0|||
147430290|NCT01759407|531740292|FG001|Overall Study|Protocol Violation|2|||
147430291|NCT03737474|531740293|FG000|Overall Study|Adverse Event|18|||
147430292|NCT03737474|531740294|FG001|Overall Study|Adverse Event|48|||
147430293|NCT03737474|531740293|FG000|Overall Study|Lack of Efficacy|1|||
147430294|NCT03737474|531740294|FG001|Overall Study|Lack of Efficacy|3|||
147430295|NCT03737474|531740293|FG000|Overall Study|Protocol Violation|0|||
147430296|NCT03737474|531740294|FG001|Overall Study|Protocol Violation|8|||
147430297|NCT03737474|531740293|FG000|Overall Study|Withdrawal by Subject|5|||
147430298|NCT03737474|531740294|FG001|Overall Study|Withdrawal by Subject|20|||
147192989|NCT04742556|530876382|FG000|Overall Study|Adverse Event|0|||
147192990|NCT04742556|530876383|FG001|Overall Study|Adverse Event|0|||
147430299|NCT03737474|531740293|FG000|Overall Study|Non-compliance With Study Drug|0|||
147430300|NCT03737474|531740294|FG001|Overall Study|Non-compliance With Study Drug|1|||
147532957|NCT05182840|532106045|FG003|Treatment Period|Reason missing|0|||
147430301|NCT03737474|531740293|FG000|Overall Study|Physician Decision|1|||
147430302|NCT03737474|531740294|FG001|Overall Study|Physician Decision|4|||
147430303|NCT02370043|531740296|FG000|Overall Study|Withdrawal by Subject|0|||
147430304|NCT02370043|531740297|FG001|Overall Study|Withdrawal by Subject|0|||
147430305|NCT02370043|531740298|FG002|Overall Study|Withdrawal by Subject|0|||
147430306|NCT02370043|531740299|FG003|Overall Study|Withdrawal by Subject|0|||
147430307|NCT02370043|531740300|FG004|Overall Study|Withdrawal by Subject|1|||
147430308|NCT02370043|531740301|FG005|Overall Study|Withdrawal by Subject|1|||
147430309|NCT01231516|531740302|FG000|Double-blind Phase (Up to Week [Wk] 48)|Adverse Event|4|||
147430310|NCT01231516|531740303|FG001|Double-blind Phase (Up to Week [Wk] 48)|Adverse Event|11|||
147430311|NCT01231516|531740302|FG000|Double-blind Phase (Up to Week [Wk] 48)|Lack of Efficacy|20|||
147430312|NCT01231516|531740303|FG001|Double-blind Phase (Up to Week [Wk] 48)|Lack of Efficacy|42|||
147532958|NCT05182840|532106046|FG004|Treatment Period|Reason missing|0|||
147430313|NCT01231516|531740302|FG000|Double-blind Phase (Up to Week [Wk] 48)|Protocol Violation|9|||
147192991|NCT04742556|530876384|FG002|Overall Study|Adverse Event|2|||
147192992|NCT04742556|530876382|FG000|Overall Study|Clinical disease progression|0|||
147192993|NCT04742556|530876383|FG001|Overall Study|Clinical disease progression|1|||
147192994|NCT04742556|530876384|FG002|Overall Study|Clinical disease progression|2|||
147192995|NCT04742556|530876382|FG000|Overall Study|Objective disease progression|3|||
147192996|NCT04742556|530876383|FG001|Overall Study|Objective disease progression|2|||
147192997|NCT04742556|530876384|FG002|Overall Study|Objective disease progression|4|||
147192998|NCT03305666|530876387|FG000|Overall Study|ORIF cancelled due to patient's cognitive decline, withdrawn from study at this time|2|||
147192999|NCT03305666|530876388|FG001|Overall Study|ORIF cancelled due to patient's cognitive decline, withdrawn from study at this time|0|||
147193000|NCT02546609|530876390|FG000|Overall Study|Withdrawal by Subject|0|||
147193001|NCT02546609|530876391|FG001|Overall Study|Withdrawal by Subject|1|||
147193002|NCT02546609|530876392|FG002|Overall Study|Withdrawal by Subject|2|||
147193003|NCT02546609|530876390|FG000|Overall Study|Adverse Event|0|||
147193004|NCT02546609|530876391|FG001|Overall Study|Adverse Event|6|||
147193005|NCT02546609|530876392|FG002|Overall Study|Adverse Event|1|||
147193006|NCT02546609|530876390|FG000|Overall Study|Protocol Violation|0|||
147193007|NCT02546609|530876391|FG001|Overall Study|Protocol Violation|1|||
147193008|NCT02546609|530876392|FG002|Overall Study|Protocol Violation|1|||
147193009|NCT02546609|530876390|FG000|Overall Study|Lost to Follow-up|2|||
147193010|NCT02546609|530876391|FG001|Overall Study|Lost to Follow-up|3|||
147193011|NCT02546609|530876392|FG002|Overall Study|Lost to Follow-up|1|||
147193012|NCT02546609|530876390|FG000|Overall Study|travel or work schedule restriction|0|||
147193013|NCT02546609|530876391|FG001|Overall Study|travel or work schedule restriction|0|||
147193014|NCT02546609|530876392|FG002|Overall Study|travel or work schedule restriction|2|||
147193015|NCT03780452|530876397|FG000|Overall Study|Screening failure|2|||
147193016|NCT00914849|530876398|FG000|Overall Study|Withdrawal by Subject|1|||
147193017|NCT00914849|530876399|FG001|Overall Study|Withdrawal by Subject|0|||
147193018|NCT00914849|530876398|FG000|Overall Study|Not eligible|0|||
147193019|NCT00914849|530876399|FG001|Overall Study|Not eligible|1|||
147193020|NCT02388269|530876402|FG000|Overall Study|Adverse Event|2|||
147193021|NCT02388269|530876403|FG001|Overall Study|Adverse Event|0|||
147193022|NCT02388269|530876404|FG002|Overall Study|Adverse Event|0|||
147193023|NCT02388269|530876402|FG000|Overall Study|Withdrawal by Subject|1|||
147193024|NCT02388269|530876403|FG001|Overall Study|Withdrawal by Subject|2|||
147193025|NCT02388269|530876404|FG002|Overall Study|Withdrawal by Subject|0|||
147193026|NCT02388269|530876402|FG000|Overall Study|less than 50% stimulations|1|||
147193027|NCT02388269|530876403|FG001|Overall Study|less than 50% stimulations|0|||
147193028|NCT02388269|530876404|FG002|Overall Study|less than 50% stimulations|0|||
147193029|NCT02388269|530876402|FG000|Overall Study|no diary data|3|||
147193030|NCT02388269|530876403|FG001|Overall Study|no diary data|0|||
147193031|NCT02388269|530876404|FG002|Overall Study|no diary data|0|||
147193032|NCT02388269|530876402|FG000|Overall Study|Protocol Violation|2|||
147193033|NCT02388269|530876403|FG001|Overall Study|Protocol Violation|0|||
147193034|NCT02388269|530876404|FG002|Overall Study|Protocol Violation|0|||
147193035|NCT02388269|530876402|FG000|Overall Study|Screen Failure|0|||
147193036|NCT02388269|530876403|FG001|Overall Study|Screen Failure|0|||
147193037|NCT02388269|530876404|FG002|Overall Study|Screen Failure|10|||
147193038|NCT00087152|530876405|FG000|Overall Study|Ineligible|6|||
147193039|NCT04602390|530876406|FG000|Overall Study|Withdrawal by Subject|0|||
147193040|NCT04602390|530876407|FG001|Overall Study|Withdrawal by Subject|0|||
147193041|NCT04602390|530876408|FG002|Overall Study|Withdrawal by Subject|0|||
147193042|NCT04602390|530876409|FG003|Overall Study|Withdrawal by Subject|0|||
147193043|NCT04602390|530876410|FG004|Overall Study|Withdrawal by Subject|1|||
147193044|NCT04602390|530876411|FG005|Overall Study|Withdrawal by Subject|0|||
147193045|NCT04602390|530876406|FG000|Overall Study|Adverse Event|0|||
147193046|NCT04602390|530876407|FG001|Overall Study|Adverse Event|0|||
147193047|NCT04602390|530876408|FG002|Overall Study|Adverse Event|0|||
147430314|NCT01231516|531740303|FG001|Double-blind Phase (Up to Week [Wk] 48)|Protocol Violation|6|||
147430315|NCT01231516|531740302|FG000|Double-blind Phase (Up to Week [Wk] 48)|Met Protocol-Defined Stopping Criteria|5|||
147430316|NCT01231516|531740303|FG001|Double-blind Phase (Up to Week [Wk] 48)|Met Protocol-Defined Stopping Criteria|3|||
147193048|NCT04602390|530876409|FG003|Overall Study|Adverse Event|0|||
147193049|NCT04602390|530876410|FG004|Overall Study|Adverse Event|0|||
147193050|NCT04602390|530876411|FG005|Overall Study|Adverse Event|1|||
147193051|NCT03882021|530876414|FG000|Enrollment|Procedure aborted/cancelled|2|||
147193052|NCT03882021|530876414|FG000|Enrollment|HD Grid catheter not introduced into patient|1|||
147193053|NCT03882021|530876414|FG000|Enrollment to 3-Month|Death|1|||
147193054|NCT03882021|530876414|FG000|Enrollment to 3-Month|Operator not able to achieve PVI|4|||
147193055|NCT03882021|530876414|FG000|Enrollment to 3-Month|Missed Visit|4|||
147193056|NCT03882021|530876414|FG000|3-Month to 6-Month Visit|Missed Visit|1|||
147193057|NCT03882021|530876414|FG000|6-Month to 12-Month Visit|Death|1|||
147193058|NCT03882021|530876414|FG000|6-Month to 12-Month Visit|Missed Visit|7|||
147193059|NCT01546857|530876415|FG000|Overall Study|Withdrawal by Subject|2|||
147193060|NCT01546857|530876416|FG001|Overall Study|Withdrawal by Subject|3|||
147193061|NCT01033240|530876421|FG000|Overall Study|Serious Adverse Event (SAE) or Adverse Event|10|||
147193062|NCT01033240|530876422|FG001|Overall Study|Serious Adverse Event (SAE) or Adverse Event|8|||
147430317|NCT01231516|531740302|FG000|Double-blind Phase (Up to Week [Wk] 48)|Lost to Follow-up|5|||
147430318|NCT01231516|531740303|FG001|Double-blind Phase (Up to Week [Wk] 48)|Lost to Follow-up|10|||
147430319|NCT01231516|531740302|FG000|Double-blind Phase (Up to Week [Wk] 48)|Physician Decision|1|||
147430320|NCT01231516|531740303|FG001|Double-blind Phase (Up to Week [Wk] 48)|Physician Decision|1|||
147430321|NCT01231516|531740302|FG000|Double-blind Phase (Up to Week [Wk] 48)|Withdrawal by Subject|11|||
147430322|NCT01231516|531740303|FG001|Double-blind Phase (Up to Week [Wk] 48)|Withdrawal by Subject|5|||
147430323|NCT01231516|531740302|FG000|Double-blind Phase (Up to Week [Wk] 48)|Site Closed|3|||
147430324|NCT01231516|531740303|FG001|Double-blind Phase (Up to Week [Wk] 48)|Site Closed|1|||
147430325|NCT01231516|531740302|FG000|Double-blind Phase (Up to Week [Wk] 48)|Randomized, but did not receive treatment|3|||
147430326|NCT01231516|531740303|FG001|Double-blind Phase (Up to Week [Wk] 48)|Randomized, but did not receive treatment|2|||
147430327|NCT01231516|531740302|FG000|Open-label Phase:From Wk 48 up to Wk 480|Physician Decision|5|||
147430328|NCT01231516|531740303|FG001|Open-label Phase:From Wk 48 up to Wk 480|Physician Decision|0|||
147430329|NCT01231516|531740302|FG000|Open-label Phase:From Wk 48 up to Wk 480|Lack of Efficacy|27|||
147430330|NCT01231516|531740303|FG001|Open-label Phase:From Wk 48 up to Wk 480|Lack of Efficacy|11|||
147430331|NCT01231516|531740302|FG000|Open-label Phase:From Wk 48 up to Wk 480|Protocol Violation|10|||
147430332|NCT01231516|531740303|FG001|Open-label Phase:From Wk 48 up to Wk 480|Protocol Violation|0|||
147430333|NCT01231516|531740302|FG000|Open-label Phase:From Wk 48 up to Wk 480|Withdrawal by Subject|6|||
147430334|NCT01231516|531740303|FG001|Open-label Phase:From Wk 48 up to Wk 480|Withdrawal by Subject|3|||
147430335|NCT01231516|531740302|FG000|Open-label Phase:From Wk 48 up to Wk 480|Met protocol-defined stopping criteria|2|||
147430336|NCT01231516|531740303|FG001|Open-label Phase:From Wk 48 up to Wk 480|Met protocol-defined stopping criteria|0|||
147430337|NCT01231516|531740302|FG000|Open-label Phase:From Wk 48 up to Wk 480|Adverse Event|6|||
147430338|NCT01231516|531740303|FG001|Open-label Phase:From Wk 48 up to Wk 480|Adverse Event|1|||
147430339|NCT01231516|531740302|FG000|Open-label Phase:From Wk 48 up to Wk 480|Lost to Follow-up|12|||
147430340|NCT01231516|531740303|FG001|Open-label Phase:From Wk 48 up to Wk 480|Lost to Follow-up|2|||
147430341|NCT02225353|531740304|FG000|Overall Study|Lost to Follow-up|0|||
147430342|NCT02225353|531740305|FG001|Overall Study|Lost to Follow-up|1|||
147430343|NCT02225353|531740306|FG002|Overall Study|Lost to Follow-up|3|||
147430344|NCT02225353|531740304|FG000|Overall Study|Protocol Violation|4|||
147430345|NCT02225353|531740305|FG001|Overall Study|Protocol Violation|5|||
147430346|NCT02225353|531740306|FG002|Overall Study|Protocol Violation|12|||
147430347|NCT02910739|531740307|FG000|Overall Study|Adverse Event|1|||
147430348|NCT02910739|531740308|FG001|Overall Study|Adverse Event|0|||
147430349|NCT02910739|531740309|FG002|Overall Study|Adverse Event|0|||
147430350|NCT02910739|531740310|FG003|Overall Study|Adverse Event|0|||
147430351|NCT04223856|531740313|FG000|Overall Study|Progressive disease|153|||
147430352|NCT04223856|531740314|FG001|Overall Study|Progressive disease|73|||
147430353|NCT04223856|531740313|FG000|Overall Study|Adverse Event|97|||
147430354|NCT04223856|531740314|FG001|Overall Study|Adverse Event|62|||
147430355|NCT04223856|531740313|FG000|Overall Study|Physician Decision|9|||
147430356|NCT04223856|531740314|FG001|Overall Study|Physician Decision|28|||
147430357|NCT04223856|531740313|FG000|Overall Study|Withdrawal by Subject|22|||
147430358|NCT04223856|531740314|FG001|Overall Study|Withdrawal by Subject|24|||
147430359|NCT04223856|531740313|FG000|Overall Study|Other|7|||
147430360|NCT04223856|531740314|FG001|Overall Study|Other|2|||
147430361|NCT04223856|531740313|FG000|Overall Study|Randomized but not treated|2|||
147430362|NCT04223856|531740314|FG001|Overall Study|Randomized but not treated|11|||
147430363|NCT04223856|531740313|FG000|Overall Study|On-treatment|144|||
147430364|NCT04223856|531740314|FG001|Overall Study|On-treatment|0|||
147430365|NCT03226275|531740315|FG000|Treatment Period 1 (8 Days)|Did not pass blood pressure examination|0|||
147430366|NCT03226275|531740316|FG001|Treatment Period 1 (8 Days)|Did not pass blood pressure examination|0|||
147430367|NCT03226275|531740317|FG002|Treatment Period 1 (8 Days)|Did not pass blood pressure examination|1|||
147430368|NCT03226275|531740318|FG003|Treatment Period 1 (8 Days)|Did not pass blood pressure examination|0|||
147430369|NCT03226275|531740315|FG000|Treatment Period 1 (8 Days)|Protocol non-compliance|0|||
147430370|NCT03226275|531740316|FG001|Treatment Period 1 (8 Days)|Protocol non-compliance|0|||
147430371|NCT03226275|531740317|FG002|Treatment Period 1 (8 Days)|Protocol non-compliance|0|||
147430372|NCT03226275|531740318|FG003|Treatment Period 1 (8 Days)|Protocol non-compliance|1|||
147430373|NCT03442114|531740319|FG000|Overall Study|Lost to Follow-up|13|||
147430374|NCT03442114|531740320|FG001|Overall Study|Lost to Follow-up|13|||
147430375|NCT03442114|531740319|FG000|Overall Study|Physician Decision|2|||
147430376|NCT03442114|531740320|FG001|Overall Study|Physician Decision|2|||
147430377|NCT03442114|531740319|FG000|Overall Study|Protocol Violation|0|||
147430378|NCT03442114|531740320|FG001|Overall Study|Protocol Violation|2|||
147430379|NCT03442114|531740319|FG000|Overall Study|Withdrawal by Subject|1|||
147430380|NCT03442114|531740320|FG001|Overall Study|Withdrawal by Subject|3|||
147430381|NCT03442114|531740319|FG000|Overall Study|Guardianship Change|0|||
147430382|NCT03442114|531740320|FG001|Overall Study|Guardianship Change|1|||
147430383|NCT03511053|531742292|FG000|Overall Study|Withdrawal by Subject|1|||
147430384|NCT02425644|531742293|FG000|Overall Study|Lost to Follow-up|2|||
147430385|NCT02425644|531742294|FG001|Overall Study|Lost to Follow-up|3|||
147532959|NCT05182840|532106047|FG005|Treatment Period|Reason missing|0|||
147430386|NCT02425644|531742293|FG000|Overall Study|Withdrawal by Subject|41|||
147430387|NCT02425644|531742294|FG001|Overall Study|Withdrawal by Subject|36|||
147430388|NCT02425644|531742293|FG000|Overall Study|Lack of Efficacy|3|||
147430389|NCT02425644|531742294|FG001|Overall Study|Lack of Efficacy|10|||
147430390|NCT02425644|531742293|FG000|Overall Study|Adverse Event|13|||
147430391|NCT02425644|531742294|FG001|Overall Study|Adverse Event|3|||
147430392|NCT02425644|531742293|FG000|Overall Study|Death|0|||
147430393|NCT02425644|531742294|FG001|Overall Study|Death|2|||
147430394|NCT02425644|531742293|FG000|Overall Study|Other|18|||
147430395|NCT02425644|531742294|FG001|Overall Study|Other|17|||
147430396|NCT02720536|531742297|FG000|Overall Study|Primary reason (PR) - subject withdrawal|11|||
147430397|NCT02720536|531742297|FG000|Overall Study|PR - pregnancy|2|||
147430398|NCT02720536|531742297|FG000|Overall Study|PR - unsatisfactory therapeutic effect|2|||
147430399|NCT02720536|531742297|FG000|Overall Study|PR - death|1|||
147430400|NCT02720536|531742297|FG000|Overall Study|PR - adverse event|1|||
147430401|NCT02720536|531742297|FG000|Overall Study|PR - abnormal lab value(s)|1|||
147430402|NCT02720536|531742297|FG000|Overall Study|PR- unwilling to comply with procedures|1|||
147430403|NCT01028222|531742298|FG000|Overall Study|Protocol deviation|1|||
147430404|NCT01028222|531742299|FG001|Overall Study|Protocol deviation|0|||
147430405|NCT01028222|531742298|FG000|Overall Study|Disease progression|33|||
147430406|NCT01028222|531742299|FG001|Overall Study|Disease progression|9|||
147430407|NCT01028222|531742298|FG000|Overall Study|Administrative problems|1|||
147430408|NCT01028222|531742299|FG001|Overall Study|Administrative problems|1|||
147430409|NCT01028222|531742298|FG000|Overall Study|Lost to Follow-up|0|||
147430410|NCT01028222|531742299|FG001|Overall Study|Lost to Follow-up|1|||
147430411|NCT01028222|531742298|FG000|Overall Study|Withdrawal by Subject|1|||
147430412|NCT01028222|531742299|FG001|Overall Study|Withdrawal by Subject|0|||
147430413|NCT01028222|531742298|FG000|Overall Study|Crossover to nilotinib w/out progression|0|||
147430414|NCT01028222|531742299|FG001|Overall Study|Crossover to nilotinib w/out progression|2|||
147430415|NCT01028222|531742298|FG000|Overall Study|Adverse Event|2|||
147430416|NCT01028222|531742299|FG001|Overall Study|Adverse Event|0|||
147430417|NCT00146328|531742300|FG000|Overall Study|Adverse Event|39|||
147430418|NCT00146328|531742301|FG001|Overall Study|Adverse Event|48|||
147430419|NCT00146328|531742302|FG002|Overall Study|Adverse Event|79|||
147430420|NCT00146328|531742300|FG000|Overall Study|Protocol Violation|11|||
147430421|NCT00146328|531742301|FG001|Overall Study|Protocol Violation|6|||
147430422|NCT00146328|531742302|FG002|Overall Study|Protocol Violation|12|||
147430423|NCT00146328|531742300|FG000|Overall Study|Lost to Follow-up|7|||
147430424|NCT00146328|531742301|FG001|Overall Study|Lost to Follow-up|4|||
147430425|NCT00146328|531742302|FG002|Overall Study|Lost to Follow-up|7|||
147430426|NCT00146328|531742300|FG000|Overall Study|Withdrawal by Subject|16|||
147430427|NCT00146328|531742301|FG001|Overall Study|Withdrawal by Subject|16|||
147430428|NCT00146328|531742302|FG002|Overall Study|Withdrawal by Subject|22|||
147430429|NCT00146328|531742300|FG000|Overall Study|Virologic Failure/lack of efficacy|54|||
147430430|NCT00146328|531742301|FG001|Overall Study|Virologic Failure/lack of efficacy|72|||
147430431|NCT00146328|531742302|FG002|Overall Study|Virologic Failure/lack of efficacy|142|||
147430432|NCT00146328|531742300|FG000|Overall Study|Trial ended/site closed|8|||
147430433|NCT00146328|531742301|FG001|Overall Study|Trial ended/site closed|2|||
147430434|NCT00146328|531742302|FG002|Overall Study|Trial ended/site closed|19|||
147430435|NCT00146328|531742300|FG000|Overall Study|Patient decision to end|0|||
147430436|NCT00146328|531742301|FG001|Overall Study|Patient decision to end|1|||
147430437|NCT00146328|531742302|FG002|Overall Study|Patient decision to end|6|||
147430438|NCT00146328|531742300|FG000|Overall Study|Enroll into other trial|2|||
147430439|NCT00146328|531742301|FG001|Overall Study|Enroll into other trial|4|||
147430440|NCT00146328|531742302|FG002|Overall Study|Enroll into other trial|2|||
147430441|NCT00146328|531742300|FG000|Overall Study|Death|0|||
147430442|NCT00146328|531742301|FG001|Overall Study|Death|1|||
147430443|NCT00146328|531742302|FG002|Overall Study|Death|1|||
147430444|NCT00146328|531742300|FG000|Overall Study|Moved|2|||
147430445|NCT00146328|531742301|FG001|Overall Study|Moved|0|||
147430446|NCT00146328|531742302|FG002|Overall Study|Moved|0|||
147430447|NCT00146328|531742300|FG000|Overall Study|Interaction with other medication|2|||
147430448|NCT00146328|531742301|FG001|Overall Study|Interaction with other medication|0|||
147430449|NCT00146328|531742302|FG002|Overall Study|Interaction with other medication|1|||
147430450|NCT00300781|531742303|FG000|Overall Study|Disease Progression|55|||
147430451|NCT00300781|531742304|FG001|Overall Study|Disease Progression|52|||
147430452|NCT00300781|531742303|FG000|Overall Study|Adverse Event|5|||
147430453|NCT00300781|531742304|FG001|Overall Study|Adverse Event|6|||
147430454|NCT00300781|531742303|FG000|Overall Study|Withdrawal by Subject|1|||
147430455|NCT00300781|531742304|FG001|Overall Study|Withdrawal by Subject|2|||
147430456|NCT00300781|531742303|FG000|Overall Study|Physician Decision|1|||
147430457|NCT00300781|531742304|FG001|Overall Study|Physician Decision|0|||
147430458|NCT00300781|531742303|FG000|Overall Study|Not Recorded|0|||
147430459|NCT00300781|531742304|FG001|Overall Study|Not Recorded|1|||
147430460|NCT00300781|531742303|FG000|Overall Study|Symptomatic Deterioration|1|||
147430461|NCT00300781|531742304|FG001|Overall Study|Symptomatic Deterioration|0|||
147430462|NCT00300781|531742303|FG000|Overall Study|Lost to Follow-up|0|||
147430463|NCT00300781|531742304|FG001|Overall Study|Lost to Follow-up|1|||
147430464|NCT00792805|531742305|FG000|Overall Study|Adverse Event|12|||
147430465|NCT00792805|531742306|FG001|Overall Study|Adverse Event|10|||
147430466|NCT00792805|531742307|FG002|Overall Study|Adverse Event|10|||
147193063|NCT01033240|530876423|FG002|Overall Study|Serious Adverse Event (SAE) or Adverse Event|6|||
147430467|NCT00792805|531742305|FG000|Overall Study|Subject withdrew consent|5|||
147430468|NCT00792805|531742306|FG001|Overall Study|Subject withdrew consent|6|||
147430469|NCT00792805|531742307|FG002|Overall Study|Subject withdrew consent|5|||
147430470|NCT00792805|531742305|FG000|Overall Study|Administrative problems|2|||
147430471|NCT00792805|531742306|FG001|Overall Study|Administrative problems|0|||
147430472|NCT00792805|531742307|FG002|Overall Study|Administrative problems|4|||
147430473|NCT00792805|531742305|FG000|Overall Study|Abnormal test procedure result(s)|1|||
147430474|NCT00792805|531742306|FG001|Overall Study|Abnormal test procedure result(s)|2|||
147430475|NCT00792805|531742307|FG002|Overall Study|Abnormal test procedure result(s)|0|||
147193064|NCT01033240|530876421|FG000|Overall Study|Death|2|||
147193065|NCT01033240|530876422|FG001|Overall Study|Death|0|||
147193066|NCT01033240|530876423|FG002|Overall Study|Death|0|||
147193067|NCT01033240|530876421|FG000|Overall Study|Withdrew Consent|2|||
147193068|NCT01033240|530876422|FG001|Overall Study|Withdrew Consent|9|||
147193069|NCT01033240|530876423|FG002|Overall Study|Withdrew Consent|2|||
147193070|NCT01033240|530876421|FG000|Overall Study|Disease Progression|35|||
147193071|NCT01033240|530876422|FG001|Overall Study|Disease Progression|32|||
147193072|NCT01033240|530876423|FG002|Overall Study|Disease Progression|41|||
147193073|NCT01033240|530876421|FG000|Overall Study|Investigator Discretion|0|||
147193074|NCT01033240|530876422|FG001|Overall Study|Investigator Discretion|0|||
147193075|NCT01033240|530876423|FG002|Overall Study|Investigator Discretion|2|||
147193076|NCT01033240|530876421|FG000|Overall Study|Other|0|||
147193077|NCT01033240|530876422|FG001|Overall Study|Other|1|||
147193078|NCT01033240|530876423|FG002|Overall Study|Other|2|||
147193079|NCT02913482|530876424|FG000|Overall Study|Death|0|||
147193080|NCT02913482|530876425|FG001|Overall Study|Death|2|||
147193081|NCT02913482|530876426|FG002|Overall Study|Death|2|||
147193082|NCT02913482|530876424|FG000|Overall Study|Progressive Disease|1|||
147193083|NCT02913482|530876425|FG001|Overall Study|Progressive Disease|1|||
147193084|NCT02913482|530876426|FG002|Overall Study|Progressive Disease|1|||
147430476|NCT00792805|531742305|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
147430477|NCT00792805|531742306|FG001|Overall Study|Unsatisfactory therapeutic effect|6|||
147430478|NCT00792805|531742307|FG002|Overall Study|Unsatisfactory therapeutic effect|6|||
147430479|NCT00792805|531742305|FG000|Overall Study|Lost to Follow-up|1|||
147430480|NCT00792805|531742306|FG001|Overall Study|Lost to Follow-up|1|||
147430481|NCT00792805|531742307|FG002|Overall Study|Lost to Follow-up|6|||
147430482|NCT00792805|531742305|FG000|Overall Study|Abnormal laboratory value(s)|0|||
147430483|NCT00792805|531742306|FG001|Overall Study|Abnormal laboratory value(s)|0|||
147430484|NCT00792805|531742307|FG002|Overall Study|Abnormal laboratory value(s)|1|||
147430485|NCT00792805|531742305|FG000|Overall Study|Protocol deviation|0|||
147430486|NCT00792805|531742306|FG001|Overall Study|Protocol deviation|1|||
147430487|NCT00792805|531742307|FG002|Overall Study|Protocol deviation|1|||
147532960|NCT05182840|532106048|FG006|Treatment Period|Reason missing|0|||
147193085|NCT02913482|530876424|FG000|Overall Study|Reason not specified|0|||
147193086|NCT02913482|530876425|FG001|Overall Study|Reason not specified|0|||
147532961|NCT05182840|532106049|FG007|Treatment Period|Reason missing|0|||
147193087|NCT02913482|530876426|FG002|Overall Study|Reason not specified|1|||
147193088|NCT02913482|530876424|FG000|Overall Study|Withdrawal by Subject|0|||
147430488|NCT02598557|531742308|FG000|Overall Study|Withdrawal by Subject|1|||
147430489|NCT02598557|531742309|FG001|Overall Study|Withdrawal by Subject|0|||
147430490|NCT02598557|531742310|FG002|Overall Study|Withdrawal by Subject|1|||
147430491|NCT02598557|531742308|FG000|Overall Study|Participant did not start treatment|2|||
147430492|NCT02598557|531742309|FG001|Overall Study|Participant did not start treatment|1|||
147430493|NCT02598557|531742310|FG002|Overall Study|Participant did not start treatment|1|||
147430494|NCT02598557|531742308|FG000|Overall Study|Unavailable specimen for endpoint evaluations|0|||
147430495|NCT02598557|531742309|FG001|Overall Study|Unavailable specimen for endpoint evaluations|0|||
147430496|NCT02598557|531742310|FG002|Overall Study|Unavailable specimen for endpoint evaluations|1|||
147430497|NCT02598557|531742308|FG000|Overall Study|Adverse Event|1|||
147430498|NCT02598557|531742309|FG001|Overall Study|Adverse Event|1|||
147430499|NCT02598557|531742310|FG002|Overall Study|Adverse Event|0|||
147430500|NCT02072434|531742314|FG000|Overall Study|Protocol Violation|10|||
147430501|NCT02072434|531742315|FG001|Overall Study|Protocol Violation|9|||
147430502|NCT02072434|531742314|FG000|Overall Study|Physician Decision|5|||
147430503|NCT02072434|531742315|FG001|Overall Study|Physician Decision|10|||
147430504|NCT02072434|531742314|FG000|Overall Study|Adverse event, serious fatal|1|||
147430505|NCT02072434|531742315|FG001|Overall Study|Adverse event, serious fatal|6|||
147430506|NCT02072434|531742314|FG000|Overall Study|Adverse Event|7|||
147430507|NCT02072434|531742315|FG001|Overall Study|Adverse Event|6|||
147430508|NCT02072434|531742314|FG000|Overall Study|Withdrawal by Subject|17|||
147430509|NCT02072434|531742315|FG001|Overall Study|Withdrawal by Subject|29|||
147430510|NCT02072434|531742314|FG000|Overall Study|Other|14|||
147430511|NCT02072434|531742315|FG001|Overall Study|Other|29|||
147430512|NCT02072434|531742314|FG000|Overall Study|Lost to Follow-up|0|||
147430513|NCT02072434|531742315|FG001|Overall Study|Lost to Follow-up|1|||
147430514|NCT02952001|531742320|FG000|Overall Study|Adverse Event|3|||
147430515|NCT02952001|531742321|FG001|Overall Study|Adverse Event|0|||
147430516|NCT02952001|531742320|FG000|Overall Study|Prohibited therapy|10|||
147430517|NCT02952001|531742321|FG001|Overall Study|Prohibited therapy|3|||
147430518|NCT02952001|531742320|FG000|Overall Study|Due to Posterior Capsular Opacity|1|||
147430519|NCT02952001|531742321|FG001|Overall Study|Due to Posterior Capsular Opacity|0|||
147430520|NCT00888433|531742324|FG000|Overall Study|Withdrawal by Subject|1|||
147430521|NCT00888433|531742325|FG001|Overall Study|Withdrawal by Subject|2|||
147430522|NCT00888433|531742324|FG000|Overall Study|Missed Visit|2|||
147430523|NCT00888433|531742325|FG001|Overall Study|Missed Visit|1|||
147430524|NCT02276872|531742328|FG000|Overall Study|Adverse Event|1|||
147430525|NCT02276872|531742329|FG001|Overall Study|Adverse Event|0|||
147430526|NCT02276872|531742330|FG002|Overall Study|Adverse Event|0|||
147430527|NCT04356183|531742332|FG000|Overall Study|Lost to Follow-up|1|||
147430528|NCT04356183|531742333|FG001|Overall Study|Lost to Follow-up|0|||
147430529|NCT04356183|531742332|FG000|Overall Study|Withdrawal by Subject|1|||
147430530|NCT04356183|531742333|FG001|Overall Study|Withdrawal by Subject|1|||
147430531|NCT00402363|531742334|FG000|Overall Study|Adverse Event|9|||
147430532|NCT00402363|531742335|FG001|Overall Study|Adverse Event|14|||
147430533|NCT00402363|531742336|FG002|Overall Study|Adverse Event|2|||
147430534|NCT00402363|531742337|FG003|Overall Study|Adverse Event|2|||
147430535|NCT00402363|531742334|FG000|Overall Study|Withdrew Consent|10|||
147430536|NCT00402363|531742335|FG001|Overall Study|Withdrew Consent|5|||
147430537|NCT00402363|531742336|FG002|Overall Study|Withdrew Consent|2|||
147430538|NCT00402363|531742337|FG003|Overall Study|Withdrew Consent|1|||
147430539|NCT00402363|531742334|FG000|Overall Study|Protocol Violation|3|||
147430540|NCT00402363|531742335|FG001|Overall Study|Protocol Violation|5|||
147430541|NCT00402363|531742336|FG002|Overall Study|Protocol Violation|0|||
147430542|NCT00402363|531742337|FG003|Overall Study|Protocol Violation|3|||
147430543|NCT00402363|531742334|FG000|Overall Study|Lost to Follow-up|5|||
147430544|NCT00402363|531742335|FG001|Overall Study|Lost to Follow-up|4|||
147430545|NCT00402363|531742336|FG002|Overall Study|Lost to Follow-up|0|||
147430546|NCT00402363|531742337|FG003|Overall Study|Lost to Follow-up|2|||
147430547|NCT00402363|531742334|FG000|Overall Study|"Captured as Other"|6|||
147430548|NCT00402363|531742335|FG001|Overall Study|"Captured as Other"|2|||
147532962|NCT05182840|532106050|FG008|Treatment Period|Reason missing|0|||
147532963|NCT05182840|532106051|FG009|Treatment Period|Reason missing|0|||
147532964|NCT05182840|532106042|FG000|Treatment Period|Other but not sponsor termination|0|||
147532965|NCT05182840|532106043|FG001|Treatment Period|Other but not sponsor termination|0|||
147532966|NCT05182840|532106044|FG002|Treatment Period|Other but not sponsor termination|8|||
147532967|NCT05182840|532106045|FG003|Treatment Period|Other but not sponsor termination|6|||
147532968|NCT05182840|532106046|FG004|Treatment Period|Other but not sponsor termination|6|||
147430549|NCT00402363|531742336|FG002|Overall Study|"Captured as Other"|2|||
147430550|NCT00402363|531742337|FG003|Overall Study|"Captured as Other"|2|||
147430551|NCT00744523|531742346|FG000|30 Days After the Procedure|Insufficient follow-up|0|||
147430552|NCT00744523|531742347|FG001|30 Days After the Procedure|Insufficient follow-up|5|||
147430553|NCT01139021|531742348|FG000|Overall Study|Adverse Event|0|||
147430554|NCT01139021|531742349|FG001|Overall Study|Adverse Event|0|||
147430555|NCT01139021|531742350|FG002|Overall Study|Adverse Event|0|||
147430556|NCT01139021|531742351|FG003|Overall Study|Adverse Event|0|||
147430557|NCT01139021|531742352|FG004|Overall Study|Adverse Event|1|||
147430558|NCT01139021|531742353|FG005|Overall Study|Adverse Event|0|||
147193089|NCT02913482|530876425|FG001|Overall Study|Withdrawal by Subject|1|||
147193090|NCT02913482|530876426|FG002|Overall Study|Withdrawal by Subject|1|||
147193091|NCT00918385|530876427|FG000|Monotherapy|Adverse Event|1|||
147193092|NCT00918385|530876428|FG001|Monotherapy|Adverse Event|6|||
147193093|NCT00918385|530876427|FG000|Monotherapy|Complicating illness|1|||
147193094|NCT00918385|530876428|FG001|Monotherapy|Complicating illness|0|||
147193095|NCT00918385|530876427|FG000|Combination Nilutamide and Dasatinib|Adverse Event|1|||
147193096|NCT00918385|530876428|FG001|Combination Nilutamide and Dasatinib|Adverse Event|1|||
147193097|NCT00918385|530876427|FG000|Combination Nilutamide and Dasatinib|Withdrawal by Subject|2|||
147193098|NCT00918385|530876428|FG001|Combination Nilutamide and Dasatinib|Withdrawal by Subject|0|||
147193099|NCT00918385|530876427|FG000|Combination Nilutamide and Dasatinib|Complicating illness|1|||
147430559|NCT01139021|531742348|FG000|Overall Study|Lost to Follow-up|0|||
147430560|NCT01139021|531742349|FG001|Overall Study|Lost to Follow-up|0|||
147430561|NCT01139021|531742350|FG002|Overall Study|Lost to Follow-up|0|||
147430562|NCT01139021|531742351|FG003|Overall Study|Lost to Follow-up|0|||
147430563|NCT01139021|531742352|FG004|Overall Study|Lost to Follow-up|2|||
147430564|NCT01139021|531742353|FG005|Overall Study|Lost to Follow-up|0|||
147430565|NCT01139021|531742348|FG000|Overall Study|Protocol Violation|1|||
147430566|NCT01139021|531742349|FG001|Overall Study|Protocol Violation|0|||
147430567|NCT01139021|531742350|FG002|Overall Study|Protocol Violation|0|||
147430568|NCT01139021|531742351|FG003|Overall Study|Protocol Violation|0|||
147430569|NCT01139021|531742352|FG004|Overall Study|Protocol Violation|2|||
147430570|NCT01139021|531742353|FG005|Overall Study|Protocol Violation|0|||
147430571|NCT01139021|531742348|FG000|Overall Study|Withdrawal by Subject|0|||
147430572|NCT01139021|531742349|FG001|Overall Study|Withdrawal by Subject|0|||
147430573|NCT01139021|531742350|FG002|Overall Study|Withdrawal by Subject|0|||
147532969|NCT05182840|532106047|FG005|Treatment Period|Other but not sponsor termination|7|||
147532970|NCT05182840|532106048|FG006|Treatment Period|Other but not sponsor termination|5|||
147532971|NCT05182840|532106049|FG007|Treatment Period|Other but not sponsor termination|8|||
147532972|NCT05182840|532106050|FG008|Treatment Period|Other but not sponsor termination|7|||
147532973|NCT05182840|532106051|FG009|Treatment Period|Other but not sponsor termination|2|||
147430574|NCT01139021|531742351|FG003|Overall Study|Withdrawal by Subject|1|||
147430575|NCT01139021|531742352|FG004|Overall Study|Withdrawal by Subject|4|||
147430576|NCT01139021|531742353|FG005|Overall Study|Withdrawal by Subject|0|||
147430577|NCT02349451|531742354|FG000|Overall Study|Withdrawal by Subject|0|||
147430578|NCT02349451|531742355|FG001|Overall Study|Withdrawal by Subject|1|||
147430579|NCT02349451|531742356|FG002|Overall Study|Withdrawal by Subject|2|||
147430580|NCT02349451|531742357|FG003|Overall Study|Withdrawal by Subject|1|||
147430581|NCT00412971|531742363|FG000|Overall Study|Lost to Follow-up|17|||
147430582|NCT00412971|531742364|FG001|Overall Study|Lost to Follow-up|9|||
147430583|NCT00412971|531742363|FG000|Overall Study|Protocol Violation|13|||
147430584|NCT00412971|531742364|FG001|Overall Study|Protocol Violation|1|||
147430585|NCT01106404|531742365|FG000|Period I (First 6 Weeks)|Adverse Event|2|||
147430586|NCT01106404|531742366|FG001|Period I (First 6 Weeks)|Adverse Event|0|||
147430587|NCT01106404|531742365|FG000|Period I (First 6 Weeks)|Physician Decision|1|||
147430588|NCT01106404|531742366|FG001|Period I (First 6 Weeks)|Physician Decision|0|||
147430589|NCT01106404|531742365|FG000|Period I (First 6 Weeks)|Lost to Follow-up|0|||
147430590|NCT01106404|531742366|FG001|Period I (First 6 Weeks)|Lost to Follow-up|1|||
147430591|NCT01106404|531742365|FG000|Period I (First 6 Weeks)|Lack of Efficacy|0|||
147430592|NCT01106404|531742366|FG001|Period I (First 6 Weeks)|Lack of Efficacy|1|||
147430593|NCT00775450|531742367|FG000|Overall Study|Serious Adverse Event|2|||
147430594|NCT00775450|531742368|FG001|Overall Study|Serious Adverse Event|0|||
147430595|NCT00775450|531742369|FG002|Overall Study|Serious Adverse Event|0|||
147430596|NCT00775450|531742370|FG003|Overall Study|Serious Adverse Event|0|||
147430597|NCT00775450|531742371|FG004|Overall Study|Serious Adverse Event|0|||
147430598|NCT00775450|531742367|FG000|Overall Study|Protocol Violation|0|||
147430599|NCT00775450|531742368|FG001|Overall Study|Protocol Violation|0|||
147430600|NCT00775450|531742369|FG002|Overall Study|Protocol Violation|0|||
147430601|NCT00775450|531742370|FG003|Overall Study|Protocol Violation|0|||
147430602|NCT00775450|531742371|FG004|Overall Study|Protocol Violation|1|||
147430603|NCT00775450|531742367|FG000|Overall Study|Withdrawal by Subject|1|||
147430604|NCT00775450|531742368|FG001|Overall Study|Withdrawal by Subject|0|||
147430605|NCT00775450|531742369|FG002|Overall Study|Withdrawal by Subject|0|||
147430606|NCT00775450|531742370|FG003|Overall Study|Withdrawal by Subject|0|||
147430607|NCT00775450|531742371|FG004|Overall Study|Withdrawal by Subject|1|||
147430608|NCT01749540|531742372|FG000|Overall Study|Protocol Violation|0|||
147430609|NCT01749540|531742373|FG001|Overall Study|Protocol Violation|0|||
147430610|NCT01749540|531742374|FG002|Overall Study|Protocol Violation|0|||
147430611|NCT01749540|531742375|FG003|Overall Study|Protocol Violation|0|||
147430612|NCT01749540|531742376|FG004|Overall Study|Protocol Violation|0|||
147430613|NCT01749540|531742377|FG005|Overall Study|Protocol Violation|1|||
147193100|NCT00918385|530876428|FG001|Combination Nilutamide and Dasatinib|Complicating illness|0|||
147430614|NCT01749540|531742378|FG006|Overall Study|Protocol Violation|1|||
147430615|NCT01749540|531742372|FG000|Overall Study|Withdrawal by Subject|0|||
147430616|NCT01749540|531742373|FG001|Overall Study|Withdrawal by Subject|0|||
147430617|NCT01749540|531742374|FG002|Overall Study|Withdrawal by Subject|0|||
147430618|NCT01749540|531742375|FG003|Overall Study|Withdrawal by Subject|1|||
147430619|NCT01749540|531742376|FG004|Overall Study|Withdrawal by Subject|0|||
147430620|NCT01749540|531742377|FG005|Overall Study|Withdrawal by Subject|0|||
147430621|NCT01749540|531742378|FG006|Overall Study|Withdrawal by Subject|0|||
147430622|NCT01749540|531742372|FG000|Overall Study|Initiated into extension study A536-06|0|||
147430623|NCT01749540|531742373|FG001|Overall Study|Initiated into extension study A536-06|0|||
147430624|NCT01749540|531742374|FG002|Overall Study|Initiated into extension study A536-06|0|||
147430625|NCT01749540|531742375|FG003|Overall Study|Initiated into extension study A536-06|0|||
147430626|NCT01749540|531742376|FG004|Overall Study|Initiated into extension study A536-06|0|||
147430627|NCT01749540|531742377|FG005|Overall Study|Initiated into extension study A536-06|2|||
147430628|NCT01749540|531742378|FG006|Overall Study|Initiated into extension study A536-06|24|||
147430629|NCT00752622|531742379|FG000|Induction Phase|Adverse Event|3|||
147430630|NCT00752622|531742379|FG000|Induction Phase|Other|3|||
147430631|NCT00752622|531742379|FG000|Induction Phase|Non-responder|14|||
147430632|NCT00752622|531742379|FG000|Induction Phase|Withdrawal by Subject|1|||
147430633|NCT00752622|531742379|FG000|Induction Phase|Premature study termination|14|||
147430634|NCT00752622|531742379|FG000|Observational Phase|Premature Study Termination|36|||
147430635|NCT00752622|531742379|FG000|Observational Phase|Non-responder|2|||
147430636|NCT00752622|531742379|FG000|Observational Phase|Withdrawal by Subject|2|||
147430637|NCT00752622|531742379|FG000|Observational Phase|Adverse Event|1|||
147430638|NCT00752622|531742379|FG000|Observational Phase|Other|2|||
147430639|NCT00752622|531742379|FG000|Interventional Phase|Non-responder|2|||
147430640|NCT00752622|531742379|FG000|Interventional Phase|Physician Decision|1|||
147430641|NCT00752622|531742379|FG000|Interventional Phase|Premature Study Termination|5|||
147430642|NCT00576836|531742380|FG000|Overall Study|Death|0|||
147430643|NCT00576836|531742381|FG001|Overall Study|Death|1|||
147430644|NCT00576836|531742380|FG000|Overall Study|Physician Decision|0|||
147430645|NCT00576836|531742381|FG001|Overall Study|Physician Decision|1|||
147430646|NCT00894686|531742382|FG000|Overall Study|Withdrawal by Subject|50|||
147430647|NCT00894686|531742382|FG000|Overall Study|Physician Decision|1|||
147430648|NCT00894686|531742382|FG000|Overall Study|Other|5|||
147430649|NCT00564018|531742385|FG000|Overall Study|Withdrawal by Subject|2|||
147430650|NCT00564018|531742386|FG001|Overall Study|Withdrawal by Subject|3|||
147430651|NCT00564018|531742387|FG002|Overall Study|Withdrawal by Subject|1|||
147430652|NCT03267940|531742388|FG000|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|1|||
147430653|NCT03267940|531742389|FG001|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|2|||
147430654|NCT03267940|531742390|FG002|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|0|||
147430655|NCT03267940|531742391|FG003|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|0|||
147430656|NCT03267940|531742392|FG004|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|0|||
147430657|NCT03267940|531742393|FG005|Run-in Portion (Max. Exposure: 508 Days)|Investigator or Sponsor Decision|0|||
147430658|NCT03267940|531742388|FG000|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0|||
147430659|NCT03267940|531742389|FG001|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|1|||
147430660|NCT03267940|531742390|FG002|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0|||
147430661|NCT03267940|531742391|FG003|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0|||
147430662|NCT03267940|531742392|FG004|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0|||
147430663|NCT03267940|531742393|FG005|Run-in Portion (Max. Exposure: 508 Days)|Withdrawal by Subject|0|||
147430664|NCT03267940|531742388|FG000|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0|||
147430665|NCT03267940|531742389|FG001|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|1|||
147430666|NCT03267940|531742390|FG002|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0|||
147430667|NCT03267940|531742391|FG003|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0|||
147430668|NCT03267940|531742392|FG004|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0|||
147430669|NCT03267940|531742393|FG005|Run-in Portion (Max. Exposure: 508 Days)|Sponsor Terminated Study|0|||
147430670|NCT03267940|531742388|FG000|Run-in Portion (Max. Exposure: 508 Days)|Death|7|||
147430671|NCT03267940|531742389|FG001|Run-in Portion (Max. Exposure: 508 Days)|Death|3|||
147430672|NCT03267940|531742390|FG002|Run-in Portion (Max. Exposure: 508 Days)|Death|0|||
147430673|NCT03267940|531742391|FG003|Run-in Portion (Max. Exposure: 508 Days)|Death|0|||
147430674|NCT03267940|531742392|FG004|Run-in Portion (Max. Exposure: 508 Days)|Death|0|||
147430675|NCT03267940|531742393|FG005|Run-in Portion (Max. Exposure: 508 Days)|Death|0|||
147430676|NCT03267940|531742388|FG000|Expansion (Maximum Exposure: 421 Days)|Other than specified|0|||
147430677|NCT03267940|531742389|FG001|Expansion (Maximum Exposure: 421 Days)|Other than specified|0|||
147430678|NCT03267940|531742390|FG002|Expansion (Maximum Exposure: 421 Days)|Other than specified|0|||
147430679|NCT03267940|531742391|FG003|Expansion (Maximum Exposure: 421 Days)|Other than specified|3|||
147430680|NCT03267940|531742392|FG004|Expansion (Maximum Exposure: 421 Days)|Other than specified|2|||
147430681|NCT03267940|531742393|FG005|Expansion (Maximum Exposure: 421 Days)|Other than specified|0|||
147430682|NCT03267940|531742388|FG000|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|0|||
147430683|NCT03267940|531742389|FG001|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|0|||
147430684|NCT03267940|531742390|FG002|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|2|||
147430685|NCT03267940|531742391|FG003|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|1|||
147430686|NCT03267940|531742392|FG004|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|2|||
147430687|NCT03267940|531742393|FG005|Expansion (Maximum Exposure: 421 Days)|Investigator or Sponsor Decision|0|||
147430688|NCT03267940|531742388|FG000|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|0|||
147430689|NCT03267940|531742389|FG001|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|0|||
147430690|NCT03267940|531742390|FG002|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|2|||
147430691|NCT03267940|531742391|FG003|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|1|||
147430692|NCT03267940|531742392|FG004|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|1|||
147430693|NCT03267940|531742393|FG005|Expansion (Maximum Exposure: 421 Days)|Withdrawal by Subject|1|||
147430694|NCT03267940|531742388|FG000|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|0|||
147430695|NCT03267940|531742389|FG001|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|0|||
147430696|NCT03267940|531742390|FG002|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|7|||
147430697|NCT03267940|531742391|FG003|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|4|||
147430698|NCT03267940|531742392|FG004|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|5|||
147430699|NCT03267940|531742393|FG005|Expansion (Maximum Exposure: 421 Days)|Sponsor Terminated Study|3|||
147430700|NCT03267940|531742388|FG000|Expansion (Maximum Exposure: 421 Days)|Death|0|||
147430701|NCT03267940|531742389|FG001|Expansion (Maximum Exposure: 421 Days)|Death|0|||
147430702|NCT03267940|531742390|FG002|Expansion (Maximum Exposure: 421 Days)|Death|10|||
147430703|NCT03267940|531742391|FG003|Expansion (Maximum Exposure: 421 Days)|Death|13|||
147430704|NCT03267940|531742392|FG004|Expansion (Maximum Exposure: 421 Days)|Death|0|||
147430705|NCT03267940|531742393|FG005|Expansion (Maximum Exposure: 421 Days)|Death|6|||
147430706|NCT00388154|531742400|FG000|Overall Study|Withdrawal by Subject|1|||
147430707|NCT01074216|531742401|FG000|Overall Study|Physician Decision|1|||
147430708|NCT01074216|531742401|FG000|Overall Study|Not Treated|12|||
147430709|NCT00803270|531742402|FG000|Overall Study|Lost to Follow-up|1|||
147430710|NCT00803270|531742403|FG001|Overall Study|Lost to Follow-up|2|||
147430711|NCT00960531|531742406|FG000|Overall Study|Lack of Efficacy|1|||
147430712|NCT00960531|531742407|FG001|Overall Study|Lack of Efficacy|0|||
147430713|NCT00960531|531742408|FG002|Overall Study|Lack of Efficacy|0|||
147430714|NCT00960531|531742409|FG003|Overall Study|Lack of Efficacy|0|||
147430715|NCT00960531|531742410|FG004|Overall Study|Lack of Efficacy|0|||
147430716|NCT00960531|531742411|FG005|Overall Study|Lack of Efficacy|0|||
147430717|NCT00960531|531742412|FG006|Overall Study|Lack of Efficacy|0|||
147430718|NCT00960531|531742413|FG007|Overall Study|Lack of Efficacy|0|||
147430719|NCT00960531|531742414|FG008|Overall Study|Lack of Efficacy|0|||
147430720|NCT00960531|531742415|FG009|Overall Study|Lack of Efficacy|0|||
147430721|NCT00960531|531742406|FG000|Overall Study|Withdrawal by Subject|1|||
147430722|NCT00960531|531742407|FG001|Overall Study|Withdrawal by Subject|0|||
147430723|NCT00960531|531742408|FG002|Overall Study|Withdrawal by Subject|5|||
147430724|NCT00960531|531742409|FG003|Overall Study|Withdrawal by Subject|2|||
147430725|NCT00960531|531742410|FG004|Overall Study|Withdrawal by Subject|0|||
147430726|NCT00960531|531742411|FG005|Overall Study|Withdrawal by Subject|0|||
147430727|NCT00960531|531742412|FG006|Overall Study|Withdrawal by Subject|2|||
147430728|NCT00960531|531742413|FG007|Overall Study|Withdrawal by Subject|0|||
147430729|NCT00960531|531742414|FG008|Overall Study|Withdrawal by Subject|1|||
147430730|NCT00960531|531742415|FG009|Overall Study|Withdrawal by Subject|0|||
147430731|NCT00960531|531742406|FG000|Overall Study|Caregiver Request|2|||
147430732|NCT00960531|531742407|FG001|Overall Study|Caregiver Request|0|||
147430733|NCT00960531|531742408|FG002|Overall Study|Caregiver Request|6|||
147430734|NCT00960531|531742409|FG003|Overall Study|Caregiver Request|5|||
147430735|NCT00960531|531742410|FG004|Overall Study|Caregiver Request|0|||
147430736|NCT00960531|531742411|FG005|Overall Study|Caregiver Request|2|||
147430737|NCT00960531|531742412|FG006|Overall Study|Caregiver Request|3|||
147430738|NCT00960531|531742413|FG007|Overall Study|Caregiver Request|1|||
147430739|NCT00960531|531742414|FG008|Overall Study|Caregiver Request|3|||
147430740|NCT00960531|531742415|FG009|Overall Study|Caregiver Request|0|||
147430741|NCT00960531|531742406|FG000|Overall Study|Investigator Request|0|||
147430742|NCT00960531|531742407|FG001|Overall Study|Investigator Request|0|||
147430743|NCT00960531|531742408|FG002|Overall Study|Investigator Request|1|||
147430744|NCT00960531|531742409|FG003|Overall Study|Investigator Request|0|||
147430745|NCT00960531|531742410|FG004|Overall Study|Investigator Request|0|||
147430746|NCT00960531|531742411|FG005|Overall Study|Investigator Request|0|||
147430747|NCT00960531|531742412|FG006|Overall Study|Investigator Request|0|||
147430748|NCT00960531|531742413|FG007|Overall Study|Investigator Request|0|||
147430749|NCT00960531|531742414|FG008|Overall Study|Investigator Request|0|||
147430750|NCT00960531|531742415|FG009|Overall Study|Investigator Request|0|||
147430751|NCT00960531|531742406|FG000|Overall Study|Discontinuation of Study by Sponsor|0|||
147430752|NCT00960531|531742407|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
147430753|NCT00960531|531742408|FG002|Overall Study|Discontinuation of Study by Sponsor|0|||
147430754|NCT00960531|531742409|FG003|Overall Study|Discontinuation of Study by Sponsor|0|||
147430755|NCT00960531|531742410|FG004|Overall Study|Discontinuation of Study by Sponsor|0|||
147430756|NCT00960531|531742411|FG005|Overall Study|Discontinuation of Study by Sponsor|0|||
147430757|NCT00960531|531742412|FG006|Overall Study|Discontinuation of Study by Sponsor|0|||
147430758|NCT00960531|531742413|FG007|Overall Study|Discontinuation of Study by Sponsor|1|||
147430759|NCT00960531|531742414|FG008|Overall Study|Discontinuation of Study by Sponsor|0|||
147430760|NCT00960531|531742415|FG009|Overall Study|Discontinuation of Study by Sponsor|0|||
147430761|NCT00960531|531742406|FG000|Overall Study|Lost to Follow-up|0|||
147430762|NCT00960531|531742407|FG001|Overall Study|Lost to Follow-up|0|||
147430763|NCT00960531|531742408|FG002|Overall Study|Lost to Follow-up|1|||
147430764|NCT00960531|531742409|FG003|Overall Study|Lost to Follow-up|0|||
147430765|NCT00960531|531742410|FG004|Overall Study|Lost to Follow-up|0|||
147430766|NCT00960531|531742411|FG005|Overall Study|Lost to Follow-up|0|||
147430767|NCT00960531|531742412|FG006|Overall Study|Lost to Follow-up|1|||
147430768|NCT00960531|531742413|FG007|Overall Study|Lost to Follow-up|0|||
147430769|NCT00960531|531742414|FG008|Overall Study|Lost to Follow-up|0|||
147430770|NCT00960531|531742415|FG009|Overall Study|Lost to Follow-up|0|||
147430771|NCT00960531|531742406|FG000|Overall Study|Failed to Return|2|||
147430772|NCT00960531|531742407|FG001|Overall Study|Failed to Return|0|||
147430773|NCT00960531|531742408|FG002|Overall Study|Failed to Return|0|||
147430774|NCT00960531|531742409|FG003|Overall Study|Failed to Return|0|||
147430775|NCT00960531|531742410|FG004|Overall Study|Failed to Return|0|||
147430776|NCT00960531|531742411|FG005|Overall Study|Failed to Return|0|||
147430777|NCT00960531|531742412|FG006|Overall Study|Failed to Return|0|||
147430778|NCT00960531|531742413|FG007|Overall Study|Failed to Return|2|||
147430779|NCT00960531|531742414|FG008|Overall Study|Failed to Return|0|||
147430780|NCT00960531|531742415|FG009|Overall Study|Failed to Return|0|||
147430781|NCT00960531|531742406|FG000|Overall Study|Adverse Event (AE)|2|||
147430782|NCT00960531|531742407|FG001|Overall Study|Adverse Event (AE)|0|||
147430783|NCT00960531|531742408|FG002|Overall Study|Adverse Event (AE)|0|||
147430784|NCT00960531|531742409|FG003|Overall Study|Adverse Event (AE)|0|||
147430785|NCT00960531|531742410|FG004|Overall Study|Adverse Event (AE)|0|||
147430786|NCT00960531|531742411|FG005|Overall Study|Adverse Event (AE)|1|||
147430787|NCT00960531|531742412|FG006|Overall Study|Adverse Event (AE)|2|||
147430788|NCT00960531|531742413|FG007|Overall Study|Adverse Event (AE)|0|||
147430789|NCT00960531|531742414|FG008|Overall Study|Adverse Event (AE)|2|||
147430790|NCT00960531|531742415|FG009|Overall Study|Adverse Event (AE)|0|||
147430791|NCT00960531|531742406|FG000|Overall Study|Reason not Specified|2|||
147430792|NCT00960531|531742407|FG001|Overall Study|Reason not Specified|1|||
147430793|NCT00960531|531742408|FG002|Overall Study|Reason not Specified|13|||
147430794|NCT00960531|531742409|FG003|Overall Study|Reason not Specified|1|||
147430795|NCT00960531|531742410|FG004|Overall Study|Reason not Specified|2|||
147430796|NCT00960531|531742411|FG005|Overall Study|Reason not Specified|0|||
147430797|NCT00960531|531742412|FG006|Overall Study|Reason not Specified|16|||
147430798|NCT00960531|531742413|FG007|Overall Study|Reason not Specified|0|||
147430799|NCT00960531|531742414|FG008|Overall Study|Reason not Specified|8|||
147430800|NCT00960531|531742415|FG009|Overall Study|Reason not Specified|1|||
147430801|NCT00593957|531742416|FG000|Overall Study|Physician Decision|0|||
147430802|NCT00593957|531742417|FG001|Overall Study|Physician Decision|1|||
147430803|NCT00593957|531742418|FG002|Overall Study|Physician Decision|2|||
147430804|NCT02411578|531742419|FG000|Crossover Trial Phase|Pregnancy|0|||
147430805|NCT02411578|531742420|FG001|Crossover Trial Phase|Pregnancy|1|||
147430806|NCT01030198|531742421|FG000|Overall Study|Could not measure efficacy accurately|0|||
147430807|NCT01030198|531742422|FG001|Overall Study|Could not measure efficacy accurately|7|||
147430808|NCT00332189|531742423|FG000|Overall Study|Adverse Event|3|||
147430809|NCT00332189|531742423|FG000|Overall Study|Uncooperative/Noncompliant|3|||
147430810|NCT00332189|531742423|FG000|Overall Study|Withdrawal by Subject|9|||
147430811|NCT00332189|531742423|FG000|Overall Study|Lack of Efficacy|4|||
147430812|NCT00332189|531742423|FG000|Overall Study|Moved out of country|2|||
147430813|NCT05266586|531742424|FG000|Overall Study|Adverse Event|2|||
147430814|NCT05266586|531742425|FG001|Overall Study|Adverse Event|2|||
147430815|NCT05266586|531742426|FG002|Overall Study|Adverse Event|1|||
147430816|NCT05266586|531742424|FG000|Overall Study|Withdrawal by Subject|1|||
147430817|NCT05266586|531742425|FG001|Overall Study|Withdrawal by Subject|0|||
147430818|NCT05266586|531742426|FG002|Overall Study|Withdrawal by Subject|1|||
147430819|NCT05266586|531742424|FG000|Overall Study|Non-compliance with study drug|0|||
147430820|NCT05266586|531742425|FG001|Overall Study|Non-compliance with study drug|1|||
147430821|NCT05266586|531742426|FG002|Overall Study|Non-compliance with study drug|0|||
147430822|NCT05266586|531742424|FG000|Overall Study|Subject unable to adhere to all protocol requirements|1|||
147430823|NCT05266586|531742425|FG001|Overall Study|Subject unable to adhere to all protocol requirements|0|||
147430824|NCT05266586|531742426|FG002|Overall Study|Subject unable to adhere to all protocol requirements|0|||
147430825|NCT03707925|531742427|FG000|Overall Study|Inevaluable|1|||
147430826|NCT01193920|531742428|FG000|Overall Study|Withdrawal by Subject|1|||
147430827|NCT01193920|531742429|FG001|Overall Study|Withdrawal by Subject|0|||
147193101|NCT00918385|530876427|FG000|Combination Nilutamide and Dasatinib|Withdrawal by Subject|2|||
147430828|NCT01193920|531742430|FG002|Overall Study|Withdrawal by Subject|5|||
147430829|NCT01193920|531742431|FG003|Overall Study|Withdrawal by Subject|1|||
147430830|NCT01193920|531742432|FG004|Overall Study|Withdrawal by Subject|3|||
147430831|NCT01193920|531742433|FG005|Overall Study|Withdrawal by Subject|1|||
147430832|NCT01193920|531742434|FG006|Overall Study|Withdrawal by Subject|3|||
147430833|NCT01193920|531742435|FG007|Overall Study|Withdrawal by Subject|0|||
147430834|NCT01193920|531742436|FG008|Overall Study|Withdrawal by Subject|1|||
147430835|NCT01193920|531742437|FG009|Overall Study|Withdrawal by Subject|0|||
147430836|NCT01193920|531742428|FG000|Overall Study|Lost to Follow-up|1|||
147430837|NCT01193920|531742429|FG001|Overall Study|Lost to Follow-up|0|||
147430838|NCT01193920|531742430|FG002|Overall Study|Lost to Follow-up|1|||
147430839|NCT01193920|531742431|FG003|Overall Study|Lost to Follow-up|1|||
147430840|NCT01193920|531742432|FG004|Overall Study|Lost to Follow-up|3|||
147430841|NCT01193920|531742433|FG005|Overall Study|Lost to Follow-up|3|||
147430842|NCT01193920|531742434|FG006|Overall Study|Lost to Follow-up|1|||
147430843|NCT01193920|531742435|FG007|Overall Study|Lost to Follow-up|0|||
147430844|NCT01193920|531742436|FG008|Overall Study|Lost to Follow-up|2|||
147430845|NCT01193920|531742437|FG009|Overall Study|Lost to Follow-up|3|||
147430846|NCT01193920|531742428|FG000|Overall Study|Protocol Violation|1|||
147430847|NCT01193920|531742429|FG001|Overall Study|Protocol Violation|0|||
147430848|NCT01193920|531742430|FG002|Overall Study|Protocol Violation|0|||
147430849|NCT01193920|531742431|FG003|Overall Study|Protocol Violation|0|||
147430850|NCT01193920|531742432|FG004|Overall Study|Protocol Violation|0|||
147430851|NCT01193920|531742433|FG005|Overall Study|Protocol Violation|0|||
147430852|NCT01193920|531742434|FG006|Overall Study|Protocol Violation|0|||
147430853|NCT01193920|531742435|FG007|Overall Study|Protocol Violation|0|||
147430854|NCT01193920|531742436|FG008|Overall Study|Protocol Violation|0|||
147430855|NCT01193920|531742437|FG009|Overall Study|Protocol Violation|0|||
147430856|NCT01193920|531742428|FG000|Overall Study|Death|0|||
147430857|NCT01193920|531742429|FG001|Overall Study|Death|0|||
147430858|NCT01193920|531742430|FG002|Overall Study|Death|0|||
147430859|NCT01193920|531742431|FG003|Overall Study|Death|1|||
147430860|NCT01193920|531742432|FG004|Overall Study|Death|0|||
147430861|NCT01193920|531742433|FG005|Overall Study|Death|0|||
147430862|NCT01193920|531742434|FG006|Overall Study|Death|2|||
147430863|NCT01193920|531742435|FG007|Overall Study|Death|3|||
147430864|NCT01193920|531742436|FG008|Overall Study|Death|2|||
147430865|NCT01193920|531742437|FG009|Overall Study|Death|4|||
147430866|NCT01193920|531742428|FG000|Overall Study|Unable to classify|0|||
147430867|NCT01193920|531742429|FG001|Overall Study|Unable to classify|0|||
147430868|NCT01193920|531742430|FG002|Overall Study|Unable to classify|0|||
147430869|NCT01193920|531742431|FG003|Overall Study|Unable to classify|1|||
147430870|NCT01193920|531742432|FG004|Overall Study|Unable to classify|0|||
147430871|NCT01193920|531742433|FG005|Overall Study|Unable to classify|0|||
147430872|NCT01193920|531742434|FG006|Overall Study|Unable to classify|0|||
147430873|NCT01193920|531742435|FG007|Overall Study|Unable to classify|1|||
147430874|NCT01193920|531742436|FG008|Overall Study|Unable to classify|0|||
147430875|NCT01193920|531742437|FG009|Overall Study|Unable to classify|0|||
147430876|NCT02876835|531742440|FG000|Treatment Period (51.1 Month)|Other|1|||
147430877|NCT02876835|531742441|FG001|Treatment Period (51.1 Month)|Other|0|||
147430878|NCT02876835|531742440|FG000|Treatment Period (51.1 Month)|Investigator Site Closed|6|||
147430879|NCT02876835|531742441|FG001|Treatment Period (51.1 Month)|Investigator Site Closed|13|||
147430880|NCT02876835|531742440|FG000|Treatment Period (51.1 Month)|Withdrawal by Subject|32|||
147430881|NCT02876835|531742441|FG001|Treatment Period (51.1 Month)|Withdrawal by Subject|23|||
147430882|NCT02876835|531742440|FG000|Treatment Period (51.1 Month)|Lost to Follow-up|25|||
147430883|NCT02876835|531742441|FG001|Treatment Period (51.1 Month)|Lost to Follow-up|29|||
147430884|NCT01117857|531742442|FG000|Overall Study|Lost to Follow-up|4|||
147430885|NCT01117857|531742442|FG000|Overall Study|Withdrawal by Subject|4|||
147430886|NCT01117857|531742442|FG000|Overall Study|Physician Decision|1|||
147430887|NCT04683731|531742443|FG000|Overall Study|Withdrawal by Subject|1|||
147430888|NCT04683731|531742444|FG001|Overall Study|Withdrawal by Subject|0|||
147430889|NCT04683731|531742445|FG002|Overall Study|Withdrawal by Subject|3|||
147430890|NCT04683731|531742446|FG003|Overall Study|Withdrawal by Subject|2|||
147430891|NCT04683731|531742443|FG000|Overall Study|Determined patient was not eligible|3|||
147430892|NCT04683731|531742444|FG001|Overall Study|Determined patient was not eligible|3|||
147430893|NCT04683731|531742445|FG002|Overall Study|Determined patient was not eligible|12|||
147430894|NCT04683731|531742446|FG003|Overall Study|Determined patient was not eligible|3|||
147430895|NCT00883051|531742448|FG000|Overall Study|Lost to Follow-up|0|||
147430896|NCT00883051|531742449|FG001|Overall Study|Lost to Follow-up|0|||
147430897|NCT00883051|531742450|FG002|Overall Study|Lost to Follow-up|0|||
147430898|NCT00883051|531742451|FG003|Overall Study|Lost to Follow-up|0|||
147430899|NCT00883051|531742452|FG004|Overall Study|Lost to Follow-up|1|||
147430900|NCT00883051|531742448|FG000|Overall Study|Did not use study medication|24|||
147430901|NCT00883051|531742449|FG001|Overall Study|Did not use study medication|22|||
147430902|NCT00883051|531742450|FG002|Overall Study|Did not use study medication|29|||
147430903|NCT00883051|531742451|FG003|Overall Study|Did not use study medication|29|||
147430904|NCT00883051|531742452|FG004|Overall Study|Did not use study medication|17|||
147430905|NCT01411839|531742453|FG000|Overall Study|Lost to Follow-up|4|||
147430906|NCT01411839|531742454|FG001|Overall Study|Lost to Follow-up|3|||
147430907|NCT03282240|531742455|FG000|Overall Study|Adverse Event|2|||
147430908|NCT03282240|531742456|FG001|Overall Study|Adverse Event|2|||
147430909|NCT03282240|531742457|FG002|Overall Study|Adverse Event|0|||
147430910|NCT03282240|531742455|FG000|Overall Study|Lost to Follow-up|3|||
147430911|NCT03282240|531742456|FG001|Overall Study|Lost to Follow-up|0|||
147430912|NCT03282240|531742457|FG002|Overall Study|Lost to Follow-up|0|||
147430913|NCT03282240|531742455|FG000|Overall Study|Protocol Deviation|4|||
147430914|NCT03282240|531742456|FG001|Overall Study|Protocol Deviation|1|||
147430915|NCT03282240|531742457|FG002|Overall Study|Protocol Deviation|2|||
147430916|NCT03282240|531742455|FG000|Overall Study|Withdrawal by Subject|1|||
147430917|NCT03282240|531742456|FG001|Overall Study|Withdrawal by Subject|0|||
147430918|NCT03282240|531742457|FG002|Overall Study|Withdrawal by Subject|1|||
147430919|NCT01675479|531742458|FG000|Overall Study|Lost to Follow-up|11|||
147430920|NCT04751656|531744610|FG000|Overall Study|Lost to Follow-up|1|||
147430921|NCT01485354|531744613|FG000|Overall Study|Withdrawal by Subject|5|||
147430922|NCT03566810|531744614|FG000|Treatment Period 1 (Day 1-Day 3)|Enrolled, but never treated|0|||
147430923|NCT03566810|531744615|FG001|Treatment Period 1 (Day 1-Day 3)|Enrolled, but never treated|1|||
147430924|NCT03566810|531744616|FG002|Treatment Period 1 (Day 1-Day 3)|Enrolled, but never treated|0|||
147430925|NCT03566810|531744617|FG003|Treatment Period 1 (Day 1-Day 3)|Enrolled, but never treated|0|||
147430926|NCT01103245|531744618|FG000|Overall Study|Withdrawal by Subject|1|||
147430927|NCT01103245|531744619|FG001|Overall Study|Withdrawal by Subject|0|||
147430928|NCT01103245|531744620|FG002|Overall Study|Withdrawal by Subject|3|||
147430929|NCT01103245|531744621|FG003|Overall Study|Withdrawal by Subject|0|||
147430930|NCT01103245|531744618|FG000|Overall Study|Inadequate IV access|1|||
147430931|NCT01103245|531744619|FG001|Overall Study|Inadequate IV access|0|||
147430932|NCT01103245|531744620|FG002|Overall Study|Inadequate IV access|0|||
147430933|NCT01103245|531744621|FG003|Overall Study|Inadequate IV access|0|||
147430934|NCT01103245|531744618|FG000|Overall Study|Adverse Event|0|||
147430935|NCT01103245|531744619|FG001|Overall Study|Adverse Event|2|||
147430936|NCT01103245|531744620|FG002|Overall Study|Adverse Event|1|||
147430937|NCT01103245|531744621|FG003|Overall Study|Adverse Event|0|||
147430938|NCT01103245|531744618|FG000|Overall Study|Physician Decision|1|||
147430939|NCT01103245|531744619|FG001|Overall Study|Physician Decision|0|||
147430940|NCT01103245|531744620|FG002|Overall Study|Physician Decision|0|||
147430941|NCT01103245|531744621|FG003|Overall Study|Physician Decision|0|||
147430942|NCT00826111|531744622|FG000|Overall Study|Lost to Follow-up|0|||
147430943|NCT00826111|531744623|FG001|Overall Study|Lost to Follow-up|1|||
147430944|NCT00826111|531744622|FG000|Overall Study|Protocol Violation|1|||
147430945|NCT00826111|531744623|FG001|Overall Study|Protocol Violation|0|||
147430946|NCT00826111|531744622|FG000|Overall Study|Withdrawal by Subject|5|||
147430947|NCT00826111|531744623|FG001|Overall Study|Withdrawal by Subject|0|||
147430948|NCT00826111|531744622|FG000|Overall Study|Physician Decision|1|||
147430949|NCT00826111|531744623|FG001|Overall Study|Physician Decision|1|||
147430950|NCT02805725|531744624|FG000|Phase I (Dose Escalation Part)|Clinical progression|0|||
147430951|NCT02805725|531744625|FG001|Phase I (Dose Escalation Part)|Clinical progression|0|||
147430952|NCT02805725|531744626|FG002|Phase I (Dose Escalation Part)|Clinical progression|1|||
147430953|NCT02805725|531744627|FG003|Phase I (Dose Escalation Part)|Clinical progression|0|||
147430954|NCT02805725|531744628|FG004|Phase I (Dose Escalation Part)|Clinical progression|0|||
147430955|NCT02805725|531744624|FG000|Phase I (Dose Escalation Part)|Adverse Event|0|||
147430956|NCT02805725|531744625|FG001|Phase I (Dose Escalation Part)|Adverse Event|0|||
147430957|NCT02805725|531744626|FG002|Phase I (Dose Escalation Part)|Adverse Event|1|||
147430958|NCT02805725|531744627|FG003|Phase I (Dose Escalation Part)|Adverse Event|2|||
147430959|NCT02805725|531744628|FG004|Phase I (Dose Escalation Part)|Adverse Event|0|||
147430960|NCT02805725|531744624|FG000|Phase II|Protocol Violation|0|||
147430961|NCT02805725|531744625|FG001|Phase II|Protocol Violation|0|||
147430962|NCT02805725|531744626|FG002|Phase II|Protocol Violation|0|||
147430963|NCT02805725|531744627|FG003|Phase II|Protocol Violation|0|||
147430964|NCT02805725|531744628|FG004|Phase II|Protocol Violation|6|||
147430965|NCT01195545|531744631|FG000|Overall Study|Protocol Violation|4|||
147430966|NCT00567268|531744634|FG000|Overall Study|Protocol Violation|7|||
147430967|NCT00567268|531744634|FG000|Overall Study|Lost to Follow-up|36|||
147430968|NCT00567268|531744634|FG000|Overall Study|No Visit After First Day of Treatment|2|||
147430969|NCT00567268|531744634|FG000|Overall Study|No Drug Administration|4|||
147430970|NCT00567268|531744634|FG000|Overall Study|"Safety Evaluation Not Assessable"|1|||
147430971|NCT03236246|531744635|FG000|24-Week Dose Titration Period|Withdrawal by Subject|8|||
147430972|NCT03236246|531744636|FG001|24-Week Dose Titration Period|Withdrawal by Subject|7|||
147430973|NCT03236246|531744635|FG000|24-Week Dose Titration Period|Lost to Follow-up|0|||
147430974|NCT03236246|531744636|FG001|24-Week Dose Titration Period|Lost to Follow-up|2|||
147430975|NCT03236246|531744635|FG000|24-Week Dose Titration Period|Study Drug Non-Compliance|3|||
147430976|NCT03236246|531744636|FG001|24-Week Dose Titration Period|Study Drug Non-Compliance|2|||
147430977|NCT03236246|531744635|FG000|24-Week Dose Titration Period|Investigator Judgement|1|||
147430978|NCT03236246|531744636|FG001|24-Week Dose Titration Period|Investigator Judgement|1|||
147430979|NCT03236246|531744635|FG000|24-Week Dose Titration Period|Prohibited Therapy|1|||
147430980|NCT03236246|531744636|FG001|24-Week Dose Titration Period|Prohibited Therapy|1|||
147430981|NCT03236246|531744635|FG000|24-Week Dose Titration Period|Start Chronic Dialysis/Kidney Transplant|0|||
147430982|NCT03236246|531744636|FG001|24-Week Dose Titration Period|Start Chronic Dialysis/Kidney Transplant|1|||
147532974|NCT05182840|532106042|FG000|Treatment Period|Protocol deviation|0|||
147430983|NCT03236246|531744635|FG000|24-Week Dose Titration Period|Death|3|||
147430984|NCT03236246|531744636|FG001|24-Week Dose Titration Period|Death|1|||
147430985|NCT03236246|531744635|FG000|24-Week Dose Titration Period|Protocol Violation|0|||
147430986|NCT03236246|531744636|FG001|24-Week Dose Titration Period|Protocol Violation|2|||
147430987|NCT03236246|531744635|FG000|24-Week Dose Titration Period|Adverse Event|7|||
147430988|NCT03236246|531744636|FG001|24-Week Dose Titration Period|Adverse Event|8|||
147430989|NCT03236246|531744635|FG000|24-Week Dose Titration Period|Captured as Other|1|||
147430990|NCT03236246|531744636|FG001|24-Week Dose Titration Period|Captured as Other|2|||
147430991|NCT03236246|531744635|FG000|24-Week Dose Maintenance Period|Withdrawal by Subject|1|||
147430992|NCT03236246|531744636|FG001|24-Week Dose Maintenance Period|Withdrawal by Subject|3|||
147430993|NCT03236246|531744635|FG000|24-Week Dose Maintenance Period|Lost to Follow-up|1|||
147430994|NCT03236246|531744636|FG001|24-Week Dose Maintenance Period|Lost to Follow-up|1|||
147430995|NCT03236246|531744635|FG000|24-Week Dose Maintenance Period|Prohibited Therapy|1|||
147430996|NCT03236246|531744636|FG001|24-Week Dose Maintenance Period|Prohibited Therapy|0|||
147430997|NCT03236246|531744635|FG000|24-Week Dose Maintenance Period|Death|0|||
147430998|NCT03236246|531744636|FG001|24-Week Dose Maintenance Period|Death|1|||
147430999|NCT03236246|531744635|FG000|24-Week Dose Maintenance Period|Adverse Event|0|||
147431000|NCT03236246|531744636|FG001|24-Week Dose Maintenance Period|Adverse Event|1|||
147431001|NCT01794520|531744637|FG000|Overall Study|Adverse events- related to progression|0|||
147431002|NCT01794520|531744638|FG001|Overall Study|Adverse events- related to progression|0|||
147431003|NCT01794520|531744639|FG002|Overall Study|Adverse events- related to progression|1|||
147431004|NCT01794520|531744640|FG003|Overall Study|Adverse events- related to progression|2|||
147431005|NCT01794520|531744641|FG004|Overall Study|Adverse events- related to progression|0|||
147431006|NCT01794520|531744642|FG005|Overall Study|Adverse events- related to progression|1|||
147431007|NCT01794520|531744643|FG006|Overall Study|Adverse events- related to progression|0|||
147431008|NCT01794520|531744637|FG000|Overall Study|Adverse event- not related to progression|1|||
147431009|NCT01794520|531744638|FG001|Overall Study|Adverse event- not related to progression|1|||
147431010|NCT01794520|531744639|FG002|Overall Study|Adverse event- not related to progression|0|||
147431011|NCT01794520|531744640|FG003|Overall Study|Adverse event- not related to progression|0|||
147431012|NCT01794520|531744641|FG004|Overall Study|Adverse event- not related to progression|2|||
147431013|NCT01794520|531744642|FG005|Overall Study|Adverse event- not related to progression|0|||
147431014|NCT01794520|531744643|FG006|Overall Study|Adverse event- not related to progression|0|||
147431015|NCT01794520|531744637|FG000|Overall Study|Progressive disease|5|||
147431016|NCT01794520|531744638|FG001|Overall Study|Progressive disease|6|||
147431017|NCT01794520|531744639|FG002|Overall Study|Progressive disease|2|||
147431018|NCT01794520|531744640|FG003|Overall Study|Progressive disease|5|||
147431019|NCT01794520|531744641|FG004|Overall Study|Progressive disease|27|||
147431020|NCT01794520|531744642|FG005|Overall Study|Progressive disease|18|||
147431021|NCT01794520|531744643|FG006|Overall Study|Progressive disease|0|||
147431022|NCT01794520|531744637|FG000|Overall Study|Withdrew consent|0|||
147431023|NCT01794520|531744638|FG001|Overall Study|Withdrew consent|0|||
147431024|NCT01794520|531744639|FG002|Overall Study|Withdrew consent|1|||
147431025|NCT01794520|531744640|FG003|Overall Study|Withdrew consent|1|||
147431026|NCT01794520|531744641|FG004|Overall Study|Withdrew consent|0|||
147431027|NCT01794520|531744642|FG005|Overall Study|Withdrew consent|0|||
147431028|NCT01794520|531744643|FG006|Overall Study|Withdrew consent|0|||
147431029|NCT01794520|531744637|FG000|Overall Study|Lost to Follow-up|0|||
147431030|NCT01794520|531744638|FG001|Overall Study|Lost to Follow-up|0|||
147431031|NCT01794520|531744639|FG002|Overall Study|Lost to Follow-up|0|||
147431032|NCT01794520|531744640|FG003|Overall Study|Lost to Follow-up|0|||
147431033|NCT01794520|531744641|FG004|Overall Study|Lost to Follow-up|1|||
147431034|NCT01794520|531744642|FG005|Overall Study|Lost to Follow-up|0|||
147431035|NCT01794520|531744643|FG006|Overall Study|Lost to Follow-up|0|||
147431036|NCT01794520|531744637|FG000|Overall Study|Toxicity|0|||
147431037|NCT01794520|531744638|FG001|Overall Study|Toxicity|2|||
147431038|NCT01794520|531744639|FG002|Overall Study|Toxicity|0|||
147431039|NCT01794520|531744640|FG003|Overall Study|Toxicity|0|||
147431040|NCT01794520|531744641|FG004|Overall Study|Toxicity|0|||
147431041|NCT01794520|531744642|FG005|Overall Study|Toxicity|0|||
147431042|NCT01794520|531744643|FG006|Overall Study|Toxicity|0|||
147431043|NCT01794520|531744637|FG000|Overall Study|Study terminated by sponsor|0|||
147431044|NCT01794520|531744638|FG001|Overall Study|Study terminated by sponsor|0|||
147431045|NCT01794520|531744639|FG002|Overall Study|Study terminated by sponsor|1|||
147431046|NCT01794520|531744640|FG003|Overall Study|Study terminated by sponsor|0|||
147431047|NCT01794520|531744641|FG004|Overall Study|Study terminated by sponsor|1|||
147431048|NCT01794520|531744642|FG005|Overall Study|Study terminated by sponsor|0|||
147431049|NCT01794520|531744643|FG006|Overall Study|Study terminated by sponsor|7|||
147431050|NCT01794520|531744637|FG000|Overall Study|Death|0|||
147431051|NCT01794520|531744638|FG001|Overall Study|Death|0|||
147431052|NCT01794520|531744639|FG002|Overall Study|Death|0|||
147431053|NCT01794520|531744640|FG003|Overall Study|Death|0|||
147431054|NCT01794520|531744641|FG004|Overall Study|Death|1|||
147431055|NCT01794520|531744642|FG005|Overall Study|Death|0|||
147431056|NCT01794520|531744643|FG006|Overall Study|Death|22|||
147431057|NCT01794520|531744637|FG000|Overall Study|Other, not specified|0|||
147431058|NCT01794520|531744638|FG001|Overall Study|Other, not specified|0|||
147431059|NCT01794520|531744639|FG002|Overall Study|Other, not specified|1|||
147431060|NCT01794520|531744640|FG003|Overall Study|Other, not specified|1|||
147431061|NCT01794520|531744641|FG004|Overall Study|Other, not specified|4|||
147431062|NCT01794520|531744642|FG005|Overall Study|Other, not specified|1|||
147431063|NCT01794520|531744643|FG006|Overall Study|Other, not specified|2|||
147431064|NCT04175808|531744644|FG000|Part A|Miscellaneous|2|||
147431065|NCT04175808|531744645|FG001|Part A|Miscellaneous|0|||
147431066|NCT04175808|531744646|FG002|Part A|Miscellaneous|0|||
147431067|NCT04175808|531744647|FG003|Part A|Miscellaneous|0|||
147431068|NCT04175808|531744648|FG004|Part A|Miscellaneous|0|||
147431069|NCT04175808|531744649|FG005|Part A|Miscellaneous|0|||
147431070|NCT04175808|531744650|FG006|Part A|Miscellaneous|0|||
147431071|NCT02021292|531744652|FG000|Overall Study|Physician Decision|0|||
147431072|NCT02021292|531744653|FG001|Overall Study|Physician Decision|1|||
147431073|NCT02021292|531744652|FG000|Overall Study|Lost to Follow-up|0|||
147431074|NCT02021292|531744653|FG001|Overall Study|Lost to Follow-up|1|||
147431075|NCT02021292|531744652|FG000|Overall Study|Death|0|||
147431076|NCT02021292|531744653|FG001|Overall Study|Death|1|||
147431077|NCT01386658|531744654|FG000|Initial Icatibant Exposure|Withdrawal by Subject|0|||
147431078|NCT01386658|531744655|FG001|Initial Icatibant Exposure|Withdrawal by Subject|9|||
147431079|NCT01386658|531744654|FG000|Initial Icatibant Exposure|Lack of adherence and poor compliance|0|||
147431080|NCT01386658|531744655|FG001|Initial Icatibant Exposure|Lack of adherence and poor compliance|3|||
147431081|NCT02465463|531744659|FG000|Overall Study|Lost to Follow-up|2|||
147431082|NCT02465463|531744660|FG001|Overall Study|Lost to Follow-up|1|||
147431083|NCT02465463|531744659|FG000|Overall Study|Death|1|||
147431084|NCT02465463|531744660|FG001|Overall Study|Death|0|||
147431085|NCT02465463|531744659|FG000|Overall Study|Protocol Violation|1|||
147431086|NCT02465463|531744660|FG001|Overall Study|Protocol Violation|0|||
147431087|NCT01067326|531744663|FG000|Overall Study|Adverse Event|0|||
147431088|NCT01067326|531744664|FG001|Overall Study|Adverse Event|2|||
147431089|NCT01067326|531744663|FG000|Overall Study|Withdrawal by Subject|1|||
147431090|NCT01067326|531744664|FG001|Overall Study|Withdrawal by Subject|0|||
147431091|NCT01067326|531744663|FG000|Overall Study|Early Study Termination|1|||
147431092|NCT01067326|531744664|FG001|Overall Study|Early Study Termination|1|||
147431093|NCT00769860|531744669|FG000|Overall Study|Withdrawal by Subject|2|||
147431094|NCT00769860|531744670|FG001|Overall Study|Withdrawal by Subject|0|||
147431095|NCT03291587|531744677|FG000|Overall Study|Lost to Follow-up|62|||
147431096|NCT03291587|531744678|FG001|Overall Study|Lost to Follow-up|43|||
147431097|NCT03291587|531744677|FG000|Overall Study|Refused to Answer|5|||
147431098|NCT03291587|531744678|FG001|Overall Study|Refused to Answer|2|||
147431099|NCT03291587|531744677|FG000|Overall Study|Death|2|||
147431100|NCT03291587|531744678|FG001|Overall Study|Death|4|||
147431101|NCT03291587|531744677|FG000|Overall Study|Not interested in participating|8|||
147431102|NCT03291587|531744678|FG001|Overall Study|Not interested in participating|6|||
147431103|NCT03291587|531744677|FG000|Overall Study|Too busy to participate|4|||
147431104|NCT03291587|531744678|FG001|Overall Study|Too busy to participate|2|||
147431105|NCT00796120|531744679|FG000|Overall Study|Death|3|||
147431106|NCT00796120|531744680|FG001|Overall Study|Death|0|||
147431107|NCT00796120|531744679|FG000|Overall Study|Adverse Event|11|||
147431108|NCT00796120|531744680|FG001|Overall Study|Adverse Event|6|||
147431109|NCT00796120|531744679|FG000|Overall Study|Progressive disease|22|||
147431110|NCT00796120|531744680|FG001|Overall Study|Progressive disease|13|||
147431111|NCT00796120|531744679|FG000|Overall Study|Participant refusal|3|||
147431112|NCT00796120|531744680|FG001|Overall Study|Participant refusal|4|||
147431113|NCT00796120|531744679|FG000|Overall Study|Other|6|||
147431114|NCT00796120|531744680|FG001|Overall Study|Other|17|||
147431115|NCT00796120|531744679|FG000|Overall Study|Physician Decision|16|||
147431116|NCT00796120|531744680|FG001|Overall Study|Physician Decision|17|||
147431117|NCT00796120|531744679|FG000|Overall Study|Randomized but not treated|0|||
147431118|NCT00796120|531744680|FG001|Overall Study|Randomized but not treated|3|||
147431119|NCT02513745|531744686|FG000|Overall Study|Criteria at time of surgery not met.|3|||
147431120|NCT02513745|531744687|FG001|Overall Study|Criteria at time of surgery not met.|3|||
147431121|NCT01209143|531744688|FG000|Overall Study|Adverse Event|2|||
147431122|NCT01209143|531744689|FG001|Overall Study|Adverse Event|1|||
147431123|NCT01209143|531744688|FG000|Overall Study|Death|0|||
147431124|NCT01209143|531744689|FG001|Overall Study|Death|1|||
147431125|NCT01209143|531744688|FG000|Overall Study|Physician Decision|3|||
147431126|NCT01209143|531744689|FG001|Overall Study|Physician Decision|1|||
147193102|NCT00918385|530876428|FG001|Combination Nilutamide and Dasatinib|Withdrawal by Subject|7|||
147431127|NCT01209143|531744688|FG000|Overall Study|Lost to Follow-up|1|||
147431128|NCT01209143|531744689|FG001|Overall Study|Lost to Follow-up|0|||
147431129|NCT01209143|531744688|FG000|Overall Study|Withdrawal by Subject|2|||
147431130|NCT01209143|531744689|FG001|Overall Study|Withdrawal by Subject|1|||
147431131|NCT01209143|531744688|FG000|Overall Study|Disease progression|11|||
147431132|NCT01209143|531744689|FG001|Overall Study|Disease progression|16|||
147431133|NCT00381303|531744692|FG000|Overall Study|Lost to Follow-up|25|||
147431134|NCT00381303|531744693|FG001|Overall Study|Lost to Follow-up|9|||
147431135|NCT00381303|531744692|FG000|Overall Study|AE/HIV-related event|22|||
147431136|NCT00381303|531744693|FG001|Overall Study|AE/HIV-related event|6|||
147431137|NCT00381303|531744692|FG000|Overall Study|Non-Adherence|13|||
147431138|NCT00381303|531744693|FG001|Overall Study|Non-Adherence|6|||
147431139|NCT00381303|531744692|FG000|Overall Study|Withdrawal by Subject|13|||
147431140|NCT00381303|531744693|FG001|Overall Study|Withdrawal by Subject|6|||
147431141|NCT00381303|531744692|FG000|Overall Study|Virologic failure|6|||
147431142|NCT00381303|531744693|FG001|Overall Study|Virologic failure|4|||
147431143|NCT00381303|531744692|FG000|Overall Study|Ineligible to continue the trial|2|||
147431144|NCT00381303|531744693|FG001|Overall Study|Ineligible to continue the trial|1|||
147431145|NCT00381303|531744692|FG000|Overall Study|Pregnancy|2|||
147431146|NCT00381303|531744693|FG001|Overall Study|Pregnancy|0|||
147431147|NCT00381303|531744692|FG000|Overall Study|Physician Decision|1|||
147431148|NCT00381303|531744693|FG001|Overall Study|Physician Decision|0|||
147431149|NCT00381303|531744692|FG000|Overall Study|Physician's decision to close the site|3|||
147431150|NCT00381303|531744693|FG001|Overall Study|Physician's decision to close the site|1|||
147431151|NCT00381303|531744692|FG000|Overall Study|Subject moved out of state|2|||
147431152|NCT00381303|531744693|FG001|Overall Study|Subject moved out of state|0|||
147431153|NCT00381303|531744692|FG000|Overall Study|Subject taking too many different meds|1|||
147431154|NCT00381303|531744693|FG001|Overall Study|Subject taking too many different meds|0|||
147431155|NCT00381303|531744692|FG000|Overall Study|No virologic response by week 12|1|||
147431156|NCT00381303|531744693|FG001|Overall Study|No virologic response by week 12|0|||
147431157|NCT00381303|531744692|FG000|Overall Study|Subject was too busy for appointments|1|||
147431158|NCT00381303|531744693|FG001|Overall Study|Subject was too busy for appointments|0|||
147431159|NCT00381303|531744692|FG000|Overall Study|Subject did not continue visits|1|||
147431160|NCT00381303|531744693|FG001|Overall Study|Subject did not continue visits|0|||
147431161|NCT00381303|531744692|FG000|Overall Study|Subject primary physician's decision|1|||
147431162|NCT00381303|531744693|FG001|Overall Study|Subject primary physician's decision|0|||
147431163|NCT01211522|531744694|FG000|Overall Study|Withdrawal by Subject|3|||
147431164|NCT01211522|531744695|FG001|Overall Study|Withdrawal by Subject|7|||
147431165|NCT01211522|531744696|FG002|Overall Study|Withdrawal by Subject|5|||
147431166|NCT01145755|531744698|FG000|Overall Study|Adverse Event|2|||
147431167|NCT01145755|531744699|FG001|Overall Study|Adverse Event|4|||
147431168|NCT01145755|531744700|FG002|Overall Study|Adverse Event|2|||
147431169|NCT01145755|531744698|FG000|Overall Study|Withdrawal by Subject|2|||
147431170|NCT01145755|531744699|FG001|Overall Study|Withdrawal by Subject|2|||
147431171|NCT01145755|531744700|FG002|Overall Study|Withdrawal by Subject|2|||
147431172|NCT01145755|531744698|FG000|Overall Study|Lost to Follow-up|2|||
147431173|NCT01145755|531744699|FG001|Overall Study|Lost to Follow-up|3|||
147431174|NCT01145755|531744700|FG002|Overall Study|Lost to Follow-up|1|||
147431175|NCT01145755|531744698|FG000|Overall Study|Protocol Violation|0|||
147431176|NCT01145755|531744699|FG001|Overall Study|Protocol Violation|3|||
147431177|NCT01145755|531744700|FG002|Overall Study|Protocol Violation|1|||
147431178|NCT01145755|531744698|FG000|Overall Study|Study Closure|14|||
147431179|NCT01145755|531744699|FG001|Overall Study|Study Closure|14|||
147431180|NCT01145755|531744700|FG002|Overall Study|Study Closure|17|||
147431181|NCT01145755|531744698|FG000|Overall Study|Lack of Efficacy|0|||
147431182|NCT01145755|531744699|FG001|Overall Study|Lack of Efficacy|1|||
147431183|NCT01145755|531744700|FG002|Overall Study|Lack of Efficacy|0|||
147431184|NCT01145755|531744698|FG000|Overall Study|Patient could not swollow medication|0|||
147431185|NCT01145755|531744699|FG001|Overall Study|Patient could not swollow medication|0|||
147431186|NCT01145755|531744700|FG002|Overall Study|Patient could not swollow medication|1|||
147431187|NCT01145755|531744698|FG000|Overall Study|Withdrawal by Subject|0|||
147431188|NCT01145755|531744699|FG001|Overall Study|Withdrawal by Subject|0|||
147431189|NCT01145755|531744700|FG002|Overall Study|Withdrawal by Subject|1|||
147431190|NCT01145755|531744698|FG000|Overall Study|Positive urine ethanol|0|||
147431191|NCT01145755|531744699|FG001|Overall Study|Positive urine ethanol|1|||
147431192|NCT01145755|531744700|FG002|Overall Study|Positive urine ethanol|0|||
147431193|NCT01116882|531744706|FG000|30-day|Lost to Follow-up|50|||
147431194|NCT01116882|531744707|FG001|30-day|Lost to Follow-up|21|||
147431195|NCT01116882|531744706|FG000|30-day|Withdrawal by Subject|2|||
147431196|NCT01116882|531744707|FG001|30-day|Withdrawal by Subject|4|||
147431197|NCT01116882|531744706|FG000|30-day|Other Reasons|16|||
147431198|NCT01116882|531744707|FG001|30-day|Other Reasons|6|||
147431199|NCT01116882|531744706|FG000|12-month|Lost to Follow-up|111|||
147431200|NCT01116882|531744707|FG001|12-month|Lost to Follow-up|42|||
147431201|NCT01116882|531744706|FG000|12-month|Other Reasons|151|||
147431202|NCT01116882|531744707|FG001|12-month|Other Reasons|49|||
147431203|NCT01116882|531744706|FG000|12-month|Withdrawal by Subject|5|||
147431204|NCT01116882|531744707|FG001|12-month|Withdrawal by Subject|8|||
147431205|NCT00547365|531744708|FG000|Overall Study|Physician Decision|1|||
147431206|NCT00547365|531744708|FG000|Overall Study|Lost to Follow-up|1|||
147431207|NCT00547365|531744708|FG000|Overall Study|Protocol Violation|2|||
147431208|NCT00547365|531744708|FG000|Overall Study|death (not related to study)|4|||
147431209|NCT01139658|531744709|FG000|Overall Study|Adverse Event|10|||
147431210|NCT01139658|531744710|FG001|Overall Study|Adverse Event|27|||
147431211|NCT01139658|531744709|FG000|Overall Study|Lack of Efficacy|15|||
147431212|NCT01139658|531744710|FG001|Overall Study|Lack of Efficacy|7|||
147431213|NCT01139658|531744709|FG000|Overall Study|Withdrawal by Subject|2|||
147431214|NCT01139658|531744710|FG001|Overall Study|Withdrawal by Subject|4|||
147431215|NCT01139658|531744709|FG000|Overall Study|No documentation of treatment|1|||
147431216|NCT01139658|531744710|FG001|Overall Study|No documentation of treatment|0|||
147431217|NCT01139658|531744709|FG000|Overall Study|Other|28|||
147431218|NCT01139658|531744710|FG001|Overall Study|Other|75|||
147431219|NCT01777269|531744713|FG000|Overall Study|Adverse Event|24|||
147431220|NCT01777269|531744714|FG001|Overall Study|Adverse Event|33|||
147431221|NCT01777269|531744713|FG000|Overall Study|Lack of Efficacy|8|||
147431222|NCT01777269|531744714|FG001|Overall Study|Lack of Efficacy|10|||
147431223|NCT01777269|531744713|FG000|Overall Study|Protocol Violation|4|||
147431224|NCT01777269|531744714|FG001|Overall Study|Protocol Violation|4|||
147431225|NCT01777269|531744713|FG000|Overall Study|Participants reached stopping criteria|1|||
147431226|NCT01777269|531744714|FG001|Overall Study|Participants reached stopping criteria|1|||
147431227|NCT01777269|531744713|FG000|Overall Study|Lost to Follow-up|4|||
147431228|NCT01777269|531744714|FG001|Overall Study|Lost to Follow-up|0|||
147431229|NCT01777269|531744713|FG000|Overall Study|Physician Decision|5|||
147431230|NCT01777269|531744714|FG001|Overall Study|Physician Decision|2|||
147431231|NCT01777269|531744713|FG000|Overall Study|Withdrawal by Subject|9|||
147431232|NCT01777269|531744714|FG001|Overall Study|Withdrawal by Subject|9|||
147431233|NCT00504881|531744715|FG000|Overall Study|Lack of Efficacy|1|||
147431234|NCT00504881|531744716|FG001|Overall Study|Lack of Efficacy|5|||
147431235|NCT00504881|531744715|FG000|Overall Study|Lost to Follow-up|0|||
147431236|NCT00504881|531744716|FG001|Overall Study|Lost to Follow-up|2|||
147431237|NCT00504881|531744715|FG000|Overall Study|Withdrawal by Subject|1|||
147431238|NCT00504881|531744716|FG001|Overall Study|Withdrawal by Subject|4|||
147431239|NCT00504881|531744715|FG000|Overall Study|Non-Compliance|1|||
147431240|NCT00504881|531744716|FG001|Overall Study|Non-Compliance|0|||
147431241|NCT00504881|531744715|FG000|Overall Study|No Birth Control|0|||
147431242|NCT00504881|531744716|FG001|Overall Study|No Birth Control|1|||
147431243|NCT00504881|531744715|FG000|Overall Study|Safety Visit not performed|0|||
147431244|NCT00504881|531744716|FG001|Overall Study|Safety Visit not performed|1|||
147431245|NCT00504881|531744715|FG000|Overall Study|AE, serious fatal|0|||
147431246|NCT00504881|531744716|FG001|Overall Study|AE, serious fatal|1|||
147431247|NCT00504881|531744715|FG000|Overall Study|SAE, non-fatal|2|||
147431248|NCT00504881|531744716|FG001|Overall Study|SAE, non-fatal|6|||
147431249|NCT00504881|531744715|FG000|Overall Study|AE, non-serious non-fatal|4|||
147431250|NCT00504881|531744716|FG001|Overall Study|AE, non-serious non-fatal|14|||
147431251|NCT00504881|531744715|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
147431252|NCT00504881|531744716|FG001|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|2|||
147431253|NCT00504881|531744715|FG000|Overall Study|AE of unknown type|1|||
147431254|NCT00504881|531744716|FG001|Overall Study|AE of unknown type|0|||
147431255|NCT00753272|531744724|FG000|Overall Study|Adverse Event|878|||
147431256|NCT00753272|531744725|FG001|Overall Study|Adverse Event|869|||
147431257|NCT00753272|531744724|FG000|Overall Study|Protocol Violation|28|||
147431258|NCT00753272|531744725|FG001|Overall Study|Protocol Violation|46|||
147431259|NCT00753272|531744724|FG000|Overall Study|Withdrawal by Subject|2481|||
147431260|NCT00753272|531744725|FG001|Overall Study|Withdrawal by Subject|2407|||
147431261|NCT00753272|531744724|FG000|Overall Study|Lost to Follow-up|491|||
147431262|NCT00753272|531744725|FG001|Overall Study|Lost to Follow-up|497|||
147431263|NCT00753272|531744724|FG000|Overall Study|Other|1104|||
147431264|NCT00753272|531744725|FG001|Overall Study|Other|1088|||
147431265|NCT00971243|531744726|FG000|Double Blind Period|Adverse Event|2|||
147431266|NCT00971243|531744727|FG001|Double Blind Period|Adverse Event|3|||
147431267|NCT00971243|531744728|FG002|Double Blind Period|Adverse Event|2|||
147431268|NCT00971243|531744729|FG003|Double Blind Period|Adverse Event|2|||
147431269|NCT00971243|531744730|FG004|Double Blind Period|Adverse Event|3|||
147431270|NCT00971243|531744726|FG000|Double Blind Period|Lost to Follow-up|0|||
147431271|NCT00971243|531744727|FG001|Double Blind Period|Lost to Follow-up|1|||
147431272|NCT00971243|531744728|FG002|Double Blind Period|Lost to Follow-up|1|||
147431273|NCT00971243|531744729|FG003|Double Blind Period|Lost to Follow-up|0|||
147431274|NCT00971243|531744730|FG004|Double Blind Period|Lost to Follow-up|1|||
147431275|NCT00971243|531744726|FG000|Double Blind Period|Physician Decision|10|||
147431276|NCT00971243|531744727|FG001|Double Blind Period|Physician Decision|6|||
147431277|NCT00971243|531744728|FG002|Double Blind Period|Physician Decision|7|||
147431278|NCT00971243|531744729|FG003|Double Blind Period|Physician Decision|6|||
147431279|NCT00971243|531744730|FG004|Double Blind Period|Physician Decision|7|||
147431280|NCT00971243|531744726|FG000|Double Blind Period|Protocol Violation|2|||
147431281|NCT00971243|531744727|FG001|Double Blind Period|Protocol Violation|0|||
147431282|NCT00971243|531744728|FG002|Double Blind Period|Protocol Violation|3|||
147431283|NCT00971243|531744729|FG003|Double Blind Period|Protocol Violation|2|||
147431284|NCT00971243|531744730|FG004|Double Blind Period|Protocol Violation|2|||
147431285|NCT00971243|531744726|FG000|Double Blind Period|Withdrawal by Subject|4|||
147431286|NCT00971243|531744727|FG001|Double Blind Period|Withdrawal by Subject|1|||
147431287|NCT00971243|531744728|FG002|Double Blind Period|Withdrawal by Subject|4|||
147431288|NCT00971243|531744729|FG003|Double Blind Period|Withdrawal by Subject|4|||
147431289|NCT00971243|531744730|FG004|Double Blind Period|Withdrawal by Subject|4|||
147431290|NCT00971243|531744726|FG000|Double Blind Period|Other reasons|1|||
147431291|NCT00971243|531744727|FG001|Double Blind Period|Other reasons|0|||
147431292|NCT00971243|531744728|FG002|Double Blind Period|Other reasons|2|||
147431293|NCT00971243|531744729|FG003|Double Blind Period|Other reasons|0|||
147431294|NCT00971243|531744730|FG004|Double Blind Period|Other reasons|1|||
147431295|NCT00971243|531744726|FG000|Open-label Period|Adverse Event|1|||
147431296|NCT00971243|531744727|FG001|Open-label Period|Adverse Event|0|||
147431297|NCT00971243|531744728|FG002|Open-label Period|Adverse Event|1|||
147431298|NCT00971243|531744729|FG003|Open-label Period|Adverse Event|1|||
147431299|NCT00971243|531744730|FG004|Open-label Period|Adverse Event|0|||
147431300|NCT00971243|531744726|FG000|Open-label Period|Physician Decision|5|||
147431301|NCT00971243|531744727|FG001|Open-label Period|Physician Decision|9|||
147431302|NCT00971243|531744728|FG002|Open-label Period|Physician Decision|3|||
147431303|NCT00971243|531744729|FG003|Open-label Period|Physician Decision|7|||
147431304|NCT00971243|531744730|FG004|Open-label Period|Physician Decision|2|||
147431305|NCT00971243|531744726|FG000|Open-label Period|Protocol Violation|1|||
147431306|NCT00971243|531744727|FG001|Open-label Period|Protocol Violation|1|||
147431307|NCT00971243|531744728|FG002|Open-label Period|Protocol Violation|1|||
147431308|NCT00971243|531744729|FG003|Open-label Period|Protocol Violation|0|||
147431309|NCT00971243|531744730|FG004|Open-label Period|Protocol Violation|1|||
147431310|NCT00971243|531744726|FG000|Open-label Period|Withdrawal by Subject|1|||
147431311|NCT00971243|531744727|FG001|Open-label Period|Withdrawal by Subject|0|||
147431312|NCT00971243|531744728|FG002|Open-label Period|Withdrawal by Subject|0|||
147431313|NCT00971243|531744729|FG003|Open-label Period|Withdrawal by Subject|2|||
147431314|NCT00971243|531744730|FG004|Open-label Period|Withdrawal by Subject|1|||
147431315|NCT00971243|531744726|FG000|Open-label Period|Other reason|0|||
147431316|NCT00971243|531744727|FG001|Open-label Period|Other reason|0|||
147431317|NCT00971243|531744728|FG002|Open-label Period|Other reason|0|||
147431318|NCT00971243|531744729|FG003|Open-label Period|Other reason|0|||
147431319|NCT00971243|531744730|FG004|Open-label Period|Other reason|2|||
147431320|NCT01966471|531744731|FG000|Overall Study|Death|44|||
147431321|NCT01966471|531744732|FG001|Overall Study|Death|56|||
147431322|NCT01966471|531744731|FG000|Overall Study|Lost to Follow-up|46|||
147431323|NCT01966471|531744732|FG001|Overall Study|Lost to Follow-up|39|||
147431324|NCT01966471|531744731|FG000|Overall Study|Various reasons|4|||
147431325|NCT01966471|531744732|FG001|Overall Study|Various reasons|4|||
147431326|NCT01966471|531744731|FG000|Overall Study|Physician Decision|7|||
147431327|NCT01966471|531744732|FG001|Overall Study|Physician Decision|5|||
147431328|NCT01966471|531744731|FG000|Overall Study|Study Terminated By Sponsor|758|||
147431329|NCT01966471|531744732|FG001|Overall Study|Study Terminated By Sponsor|773|||
147431330|NCT01966471|531744731|FG000|Overall Study|Withdrawal by Subject|59|||
147431331|NCT01966471|531744732|FG001|Overall Study|Withdrawal by Subject|51|||
147431332|NCT02092220|531744734|FG000|Period 1|Unrelated Illness|0|||
147431333|NCT02092220|531744735|FG001|Period 1|Unrelated Illness|2|||
147431334|NCT02092220|531744734|FG000|Period 2|Severe Hypoglycaemia|1|||
147431335|NCT02092220|531744735|FG001|Period 2|Severe Hypoglycaemia|0|||
147431336|NCT02092220|531744734|FG000|Period 2|Nausea, Anxiety, Inconvenience|0|||
147431337|NCT02092220|531744735|FG001|Period 2|Nausea, Anxiety, Inconvenience|1|||
147431338|NCT00494481|531744738|FG000|Overall Study|Condition under investigation worsened|11|||
147431339|NCT00494481|531744739|FG001|Overall Study|Condition under investigation worsened|13|||
147431340|NCT00494481|531744738|FG000|Overall Study|Adverse Event|15|||
147431341|NCT00494481|531744739|FG001|Overall Study|Adverse Event|11|||
147431342|NCT00494481|531744738|FG000|Overall Study|Other|1|||
147431343|NCT00494481|531744739|FG001|Overall Study|Other|0|||
147431344|NCT00494481|531744738|FG000|Overall Study|Never received IP|2|||
147431345|NCT00494481|531744739|FG001|Overall Study|Never received IP|0|||
147431346|NCT05245097|531744740|FG000|Overall Study|Adverse Event|13|||
147431347|NCT05245097|531744741|FG001|Overall Study|Adverse Event|2|||
147431348|NCT05245097|531744740|FG000|Overall Study|Protocol Violation|8|||
147431349|NCT05245097|531744741|FG001|Overall Study|Protocol Violation|6|||
147431350|NCT05245097|531744740|FG000|Overall Study|Withdrawal by Subject|18|||
147431351|NCT05245097|531744741|FG001|Overall Study|Withdrawal by Subject|0|||
147431352|NCT05245097|531744740|FG000|Overall Study|Death|6|||
147431353|NCT05245097|531744741|FG001|Overall Study|Death|7|||
147431354|NCT05245097|531744740|FG000|Overall Study|Physician Decision|6|||
147431355|NCT05245097|531744741|FG001|Overall Study|Physician Decision|0|||
147431356|NCT05245097|531744740|FG000|Overall Study|Relocation|4|||
147431357|NCT05245097|531744741|FG001|Overall Study|Relocation|3|||
147431358|NCT03254485|531744748|FG000|Overall Study|Adverse Event|3|||
147431359|NCT03254485|531744749|FG001|Overall Study|Adverse Event|0|||
147431360|NCT03254485|531744750|FG002|Overall Study|Adverse Event|0|||
147431361|NCT03254485|531744751|FG003|Overall Study|Adverse Event|6|||
147431362|NCT03254485|531744748|FG000|Overall Study|Protocol Violation|6|||
147431363|NCT03254485|531744749|FG001|Overall Study|Protocol Violation|0|||
147431364|NCT03254485|531744750|FG002|Overall Study|Protocol Violation|0|||
147431365|NCT03254485|531744751|FG003|Overall Study|Protocol Violation|2|||
147431366|NCT03254485|531744748|FG000|Overall Study|Withdrawal by Subject|1|||
147431367|NCT03254485|531744749|FG001|Overall Study|Withdrawal by Subject|0|||
147431368|NCT03254485|531744750|FG002|Overall Study|Withdrawal by Subject|0|||
147431369|NCT03254485|531744751|FG003|Overall Study|Withdrawal by Subject|4|||
147431370|NCT03254485|531744748|FG000|Overall Study|Death|0|||
147431371|NCT03254485|531744749|FG001|Overall Study|Death|0|||
147431372|NCT03254485|531744750|FG002|Overall Study|Death|0|||
147431373|NCT03254485|531744751|FG003|Overall Study|Death|1|||
147431374|NCT03254485|531744748|FG000|Overall Study|Lost to Follow-up|1|||
147431375|NCT03254485|531744749|FG001|Overall Study|Lost to Follow-up|0|||
147431376|NCT03254485|531744750|FG002|Overall Study|Lost to Follow-up|0|||
147431377|NCT03254485|531744751|FG003|Overall Study|Lost to Follow-up|0|||
147431378|NCT03254485|531744748|FG000|Overall Study|Other|1|||
147431379|NCT03254485|531744749|FG001|Overall Study|Other|0|||
147431380|NCT03254485|531744750|FG002|Overall Study|Other|0|||
147431381|NCT03254485|531744751|FG003|Overall Study|Other|2|||
147431382|NCT00475033|531744754|FG000|Infant Series|Failed to return|3|||
147431383|NCT00475033|531744755|FG001|Infant Series|Failed to return|4|||
147431384|NCT00475033|531744754|FG000|Infant Series|Parent or legal guardian request|1|||
147431385|NCT00475033|531744755|FG001|Infant Series|Parent or legal guardian request|5|||
147431386|NCT00475033|531744754|FG000|Infant Series|Protocol Violation|1|||
147431387|NCT00475033|531744755|FG001|Infant Series|Protocol Violation|2|||
147431388|NCT00475033|531744754|FG000|Infant Series|Lost to Follow-up|2|||
147431389|NCT00475033|531744755|FG001|Infant Series|Lost to Follow-up|0|||
147431390|NCT00475033|531744754|FG000|Infant Series|Adverse Event|0|||
147431391|NCT00475033|531744755|FG001|Infant Series|Adverse Event|2|||
147431392|NCT00475033|531744754|FG000|After the Infant Series|Adverse Event|0|||
147431393|NCT00475033|531744755|FG001|After the Infant Series|Adverse Event|4|||
147431394|NCT00475033|531744754|FG000|After the Infant Series|Parent or legal guardian request|2|||
147431395|NCT00475033|531744755|FG001|After the Infant Series|Parent or legal guardian request|2|||
147431396|NCT00475033|531744754|FG000|After the Infant Series|Failed to return|2|||
147431397|NCT00475033|531744755|FG001|After the Infant Series|Failed to return|1|||
147431398|NCT00475033|531744754|FG000|After the Infant Series|Protocol Violation|1|||
147431399|NCT00475033|531744755|FG001|After the Infant Series|Protocol Violation|0|||
147431400|NCT00475033|531744754|FG000|After the Infant Series|Lost to Follow-up|1|||
147431401|NCT00475033|531744755|FG001|After the Infant Series|Lost to Follow-up|0|||
147431402|NCT00475033|531744754|FG000|After the Infant Series|Other|0|||
147431403|NCT00475033|531744755|FG001|After the Infant Series|Other|1|||
147431404|NCT00475033|531744754|FG000|Toddler Dose|Parent or legal guardian request|2|||
147431405|NCT00475033|531744755|FG001|Toddler Dose|Parent or legal guardian request|0|||
147431406|NCT00475033|531744754|FG000|Toddler Dose|Failed to return|1|||
147431407|NCT00475033|531744755|FG001|Toddler Dose|Failed to return|0|||
147431408|NCT00475033|531744754|FG000|Toddler Dose|Lost to Follow-up|1|||
147431409|NCT00475033|531744755|FG001|Toddler Dose|Lost to Follow-up|0|||
147431410|NCT03231943|531744757|FG000|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
147431411|NCT03231943|531744758|FG001|Part 1, Period 2 (up to Day 30)|Adverse Event|1|||
147431412|NCT03231943|531744759|FG002|Part 1, Period 2 (up to Day 30)|Adverse Event|1|||
147431413|NCT03231943|531744760|FG003|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
147431414|NCT03231943|531744761|FG004|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
147431415|NCT03231943|531744762|FG005|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
147431416|NCT03231943|531744763|FG006|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
147431417|NCT03231943|531744764|FG007|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
147431418|NCT03231943|531744765|FG008|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
147431419|NCT03231943|531744766|FG009|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
147431420|NCT03231943|531744767|FG010|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
147431421|NCT03231943|531744768|FG011|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
147431422|NCT03231943|531744769|FG012|Part 1, Period 2 (up to Day 30)|Adverse Event|0|||
147431423|NCT03231943|531744757|FG000|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
147431424|NCT03231943|531744758|FG001|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|1|||
147431425|NCT03231943|531744759|FG002|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
147431426|NCT03231943|531744760|FG003|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
147431427|NCT03231943|531744761|FG004|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
147431428|NCT03231943|531744762|FG005|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
147431429|NCT03231943|531744763|FG006|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
147431430|NCT03231943|531744764|FG007|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
147431431|NCT03231943|531744765|FG008|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
147431432|NCT03231943|531744766|FG009|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
147431433|NCT03231943|531744767|FG010|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
147431434|NCT03231943|531744768|FG011|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
147431435|NCT03231943|531744769|FG012|Part 1, Period 2 (up to Day 30)|Withdrawal by Subject|0|||
147431436|NCT03231943|531744757|FG000|Part 1, Period 3 (up to Day 45)|Adverse Event|1|||
147431437|NCT03231943|531744758|FG001|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
147431438|NCT03231943|531744759|FG002|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
147431439|NCT03231943|531744760|FG003|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
147431440|NCT03231943|531744761|FG004|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
147431441|NCT03231943|531744762|FG005|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
147431442|NCT03231943|531744763|FG006|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
147431443|NCT03231943|531744764|FG007|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
147431444|NCT03231943|531744765|FG008|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
147431445|NCT03231943|531744766|FG009|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
147431446|NCT03231943|531744767|FG010|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
147431447|NCT03231943|531744768|FG011|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
147431448|NCT03231943|531744769|FG012|Part 1, Period 3 (up to Day 45)|Adverse Event|0|||
147431449|NCT03231943|531744757|FG000|Part 2|Adverse Event|0|||
147431450|NCT03231943|531744758|FG001|Part 2|Adverse Event|0|||
147431451|NCT03231943|531744759|FG002|Part 2|Adverse Event|0|||
147431452|NCT03231943|531744760|FG003|Part 2|Adverse Event|0|||
147431453|NCT03231943|531744761|FG004|Part 2|Adverse Event|0|||
147431454|NCT03231943|531744762|FG005|Part 2|Adverse Event|0|||
147431455|NCT03231943|531744763|FG006|Part 2|Adverse Event|0|||
147431456|NCT03231943|531744764|FG007|Part 2|Adverse Event|0|||
147431457|NCT03231943|531744765|FG008|Part 2|Adverse Event|0|||
147431458|NCT03231943|531744766|FG009|Part 2|Adverse Event|0|||
147431459|NCT03231943|531744767|FG010|Part 2|Adverse Event|1|||
147431460|NCT03231943|531744768|FG011|Part 2|Adverse Event|0|||
147431461|NCT03231943|531744769|FG012|Part 2|Adverse Event|0|||
147431462|NCT03231943|531744757|FG000|Part 2|Withdrawal by Subject|0|||
147431463|NCT03231943|531744758|FG001|Part 2|Withdrawal by Subject|0|||
147431464|NCT03231943|531744759|FG002|Part 2|Withdrawal by Subject|0|||
147431465|NCT03231943|531744760|FG003|Part 2|Withdrawal by Subject|0|||
147431466|NCT03231943|531744761|FG004|Part 2|Withdrawal by Subject|0|||
147431467|NCT03231943|531744762|FG005|Part 2|Withdrawal by Subject|0|||
147431468|NCT03231943|531744763|FG006|Part 2|Withdrawal by Subject|0|||
147431469|NCT03231943|531744764|FG007|Part 2|Withdrawal by Subject|0|||
147431470|NCT03231943|531744765|FG008|Part 2|Withdrawal by Subject|0|||
147431471|NCT03231943|531744766|FG009|Part 2|Withdrawal by Subject|0|||
147431472|NCT03231943|531744767|FG010|Part 2|Withdrawal by Subject|0|||
147431473|NCT03231943|531744768|FG011|Part 2|Withdrawal by Subject|1|||
147431474|NCT03231943|531744769|FG012|Part 2|Withdrawal by Subject|0|||
147431475|NCT01572922|531744770|FG000|Overall Study|Adverse Event|1|||
147431476|NCT01572922|531744770|FG000|Overall Study|Protocol Violation|1|||
147431477|NCT01572922|531744770|FG000|Overall Study|Death|1|||
147431478|NCT02818920|531744771|FG000|Overall Study|Unresectable|4|||
147431479|NCT02818920|531744771|FG000|Overall Study|Progressed After Neoadjuvant Therapy|1|||
147431480|NCT02818920|531744771|FG000|Overall Study|Went Off Study Prior to Adjuvant Therapy|8|||
147431481|NCT02818920|531744771|FG000|Overall Study|Adverse Event|3|||
147431482|NCT02818920|531744771|FG000|Overall Study|Developed Other Disease|1|||
147431483|NCT02818920|531744771|FG000|Overall Study|Refused Further Treatment|1|||
147431484|NCT01335009|531744772|FG000|Overall Study|Too ill to travel to study sites|1|||
147431485|NCT01335009|531744773|FG001|Overall Study|Too ill to travel to study sites|0|||
147431486|NCT01335009|531744772|FG000|Overall Study|Death|28|||
147431487|NCT01335009|531744773|FG001|Overall Study|Death|32|||
147431488|NCT01335009|531744772|FG000|Overall Study|Withdrawal by Subject|1|||
147431489|NCT01335009|531744773|FG001|Overall Study|Withdrawal by Subject|1|||
147431490|NCT01335009|531744772|FG000|Overall Study|Lost to Follow-up|1|||
147431491|NCT01335009|531744773|FG001|Overall Study|Lost to Follow-up|0|||
147431492|NCT00445068|531744774|FG000|Overall Study|Disease progression|26|||
147431493|NCT00445068|531744774|FG000|Overall Study|Adverse Event|5|||
147431494|NCT00445068|531744774|FG000|Overall Study|Abnormal laboratory value|2|||
147431495|NCT00445068|531744774|FG000|Overall Study|Withdrawal by Subject|2|||
147431496|NCT00445068|531744774|FG000|Overall Study|Death|1|||
147431497|NCT04824521|531744775|FG000|Overall Study|Lost to Follow-up|1|||
147431498|NCT04821869|531744776|FG000|Overall Study|Adverse Event|4|||
147431499|NCT04821869|531744776|FG000|Overall Study|Withdrawal by Subject|2|||
147431500|NCT04821869|531744776|FG000|Overall Study|Did not meet FEV1 criteria|1|||
147431501|NCT03444324|531744777|FG000|Overall Study|Withdrawal by Subject|0|||
147431502|NCT03444324|531744778|FG001|Overall Study|Withdrawal by Subject|1|||
147431503|NCT03444324|531744777|FG000|Overall Study|Lost to Follow-up|4|||
147431504|NCT03444324|531744778|FG001|Overall Study|Lost to Follow-up|2|||
147431505|NCT03444324|531744777|FG000|Overall Study|Protocol Violation|0|||
147431506|NCT03444324|531744778|FG001|Overall Study|Protocol Violation|1|||
147431507|NCT03444324|531744777|FG000|Overall Study|Lack of Trial Compliance|1|||
147431508|NCT03444324|531744778|FG001|Overall Study|Lack of Trial Compliance|1|||
147431509|NCT03444324|531744777|FG000|Overall Study|Physical disability to come to the site for the closing visit|0|||
147431510|NCT03444324|531744778|FG001|Overall Study|Physical disability to come to the site for the closing visit|1|||
147431511|NCT03769181|531746085|FG000|Overall Study|Adverse Event|1|||
147431512|NCT03769181|531746086|FG001|Overall Study|Adverse Event|0|||
147431513|NCT03769181|531746087|FG002|Overall Study|Adverse Event|2|||
147431514|NCT03769181|531746088|FG003|Overall Study|Adverse Event|4|||
147431515|NCT03769181|531746085|FG000|Overall Study|Withdrawal by Subject|1|||
147431516|NCT03769181|531746086|FG001|Overall Study|Withdrawal by Subject|0|||
147431517|NCT03769181|531746087|FG002|Overall Study|Withdrawal by Subject|2|||
147431518|NCT03769181|531746088|FG003|Overall Study|Withdrawal by Subject|1|||
147431519|NCT03769181|531746085|FG000|Overall Study|Progressive disease|9|||
147431520|NCT03769181|531746086|FG001|Overall Study|Progressive disease|7|||
147431521|NCT03769181|531746087|FG002|Overall Study|Progressive disease|13|||
147431522|NCT03769181|531746088|FG003|Overall Study|Progressive disease|6|||
147431523|NCT03769181|531746085|FG000|Overall Study|Other - Unspecified|2|||
147431524|NCT03769181|531746086|FG001|Overall Study|Other - Unspecified|1|||
147431525|NCT03769181|531746087|FG002|Overall Study|Other - Unspecified|0|||
147431526|NCT03769181|531746088|FG003|Overall Study|Other - Unspecified|0|||
147431527|NCT03971422|531746089|FG000|Overall Study|Lost to Follow-up|0|||
147431528|NCT03971422|531746090|FG001|Overall Study|Lost to Follow-up|1|||
147431529|NCT03971422|531746091|FG002|Overall Study|Lost to Follow-up|0|||
147431530|NCT03971422|531746089|FG000|Overall Study|Lack of Efficacy|5|||
147431531|NCT03971422|531746090|FG001|Overall Study|Lack of Efficacy|1|||
147431532|NCT03971422|531746091|FG002|Overall Study|Lack of Efficacy|1|||
147431533|NCT03971422|531746089|FG000|Overall Study|Adverse event, not fatal|2|||
147431534|NCT03971422|531746090|FG001|Overall Study|Adverse event, not fatal|2|||
147431535|NCT03971422|531746091|FG002|Overall Study|Adverse event, not fatal|5|||
147431536|NCT03971422|531746089|FG000|Overall Study|Worsening of MG Symptoms|1|||
147431537|NCT03971422|531746090|FG001|Overall Study|Worsening of MG Symptoms|4|||
147431538|NCT03971422|531746091|FG002|Overall Study|Worsening of MG Symptoms|2|||
147431539|NCT03971422|531746089|FG000|Overall Study|Roll over to MG0007 (NCT04650854)|10|||
147431540|NCT03971422|531746090|FG001|Overall Study|Roll over to MG0007 (NCT04650854)|6|||
147431541|NCT03971422|531746091|FG002|Overall Study|Roll over to MG0007 (NCT04650854)|9|||
147431542|NCT03971422|531746089|FG000|Overall Study|Roll over to MG0004 (NCT04124965)|7|||
147431543|NCT03971422|531746090|FG001|Overall Study|Roll over to MG0004 (NCT04124965)|8|||
147431544|NCT03971422|531746091|FG002|Overall Study|Roll over to MG0004 (NCT04124965)|6|||
147431545|NCT03971422|531746089|FG000|Overall Study|Due to COVID-19 pandemic|0|||
147431546|NCT03971422|531746090|FG001|Overall Study|Due to COVID-19 pandemic|1|||
147431547|NCT03971422|531746091|FG002|Overall Study|Due to COVID-19 pandemic|1|||
147431548|NCT01444651|531746093|FG000|Overall Study|Adverse Event|3|||
147431549|NCT01444651|531746094|FG001|Overall Study|Adverse Event|2|||
147431550|NCT01444651|531746093|FG000|Overall Study|Lost to Follow-up|5|||
147431551|NCT01444651|531746094|FG001|Overall Study|Lost to Follow-up|5|||
147431552|NCT01444651|531746093|FG000|Overall Study|Non-fasting|2|||
147431553|NCT01444651|531746094|FG001|Overall Study|Non-fasting|1|||
147431554|NCT01444651|531746093|FG000|Overall Study|Missing data|1|||
147431555|NCT01444651|531746094|FG001|Overall Study|Missing data|1|||
147431556|NCT03338192|531746095|FG000|Year One to Year Two|High Blood Pressure|7|||
147431557|NCT03338192|531746096|FG001|Year One to Year Two|High Blood Pressure|1|||
147431558|NCT03338192|531746095|FG000|Year One to Year Two|HIV +|1|||
147431559|NCT03338192|531746096|FG001|Year One to Year Two|HIV +|0|||
147431560|NCT03338192|531746095|FG000|Year Two to Year Four|High Blood Pressure|1|||
147431561|NCT03338192|531746096|FG001|Year Two to Year Four|High Blood Pressure|0|||
147431562|NCT03338192|531746095|FG000|Year Two to Year Four|HIV +|2|||
147431563|NCT03338192|531746096|FG001|Year Two to Year Four|HIV +|0|||
147431564|NCT03338192|531746095|FG000|Year Four to Year Six|High Blood Pressure|2|||
147431565|NCT03338192|531746096|FG001|Year Four to Year Six|High Blood Pressure|1|||
147431566|NCT01929980|531746097|FG000|Overall Study|Physician Decision|1|||
147431567|NCT00568321|531746104|FG000|Overall Study|Adverse Event|1|||
147431568|NCT00568321|531746105|FG001|Overall Study|Adverse Event|0|||
147431569|NCT00568321|531746106|FG002|Overall Study|Adverse Event|0|||
147431570|NCT00568321|531746104|FG000|Overall Study|Lack of Efficacy|8|||
147431571|NCT00568321|531746105|FG001|Overall Study|Lack of Efficacy|5|||
147431572|NCT00568321|531746106|FG002|Overall Study|Lack of Efficacy|6|||
147431573|NCT00568321|531746104|FG000|Overall Study|Lost to Follow-up|0|||
147431574|NCT00568321|531746105|FG001|Overall Study|Lost to Follow-up|0|||
147431575|NCT00568321|531746106|FG002|Overall Study|Lost to Follow-up|1|||
147431576|NCT00568321|531746104|FG000|Overall Study|Withdrawal by Subject|2|||
147431577|NCT00568321|531746105|FG001|Overall Study|Withdrawal by Subject|0|||
147431578|NCT00568321|531746106|FG002|Overall Study|Withdrawal by Subject|0|||
147431579|NCT00568321|531746104|FG000|Overall Study|Protocol Violation|0|||
147431580|NCT00568321|531746105|FG001|Overall Study|Protocol Violation|0|||
147431581|NCT00568321|531746106|FG002|Overall Study|Protocol Violation|1|||
147431582|NCT00568321|531746104|FG000|Overall Study|Randomized, not treated|2|||
147431583|NCT00568321|531746105|FG001|Overall Study|Randomized, not treated|0|||
147431584|NCT00568321|531746106|FG002|Overall Study|Randomized, not treated|1|||
147431585|NCT00823901|531746108|FG000|Overall Study|Adverse Event|1|||
147431586|NCT00823901|531746109|FG001|Overall Study|Adverse Event|1|||
147431587|NCT00823901|531746108|FG000|Overall Study|Lack of Efficacy|1|||
147431588|NCT00823901|531746109|FG001|Overall Study|Lack of Efficacy|0|||
147431589|NCT00823901|531746108|FG000|Overall Study|Lost to Follow-up|2|||
147431590|NCT00823901|531746109|FG001|Overall Study|Lost to Follow-up|1|||
147431591|NCT01369511|531746110|FG000|Overall Study|Adverse Event|1|||
147431592|NCT01369511|531746111|FG001|Overall Study|Adverse Event|1|||
147431593|NCT01369511|531746112|FG002|Overall Study|Adverse Event|5|||
147431594|NCT01369511|531746113|FG003|Overall Study|Adverse Event|0|||
147431595|NCT01369511|531746110|FG000|Overall Study|Entry criteria not met|2|||
147431596|NCT01369511|531746111|FG001|Overall Study|Entry criteria not met|0|||
147431597|NCT01369511|531746112|FG002|Overall Study|Entry criteria not met|0|||
147431598|NCT01369511|531746113|FG003|Overall Study|Entry criteria not met|1|||
147431599|NCT01369511|531746110|FG000|Overall Study|Lost to Follow-up|0|||
147431600|NCT01369511|531746111|FG001|Overall Study|Lost to Follow-up|1|||
147431601|NCT01369511|531746112|FG002|Overall Study|Lost to Follow-up|1|||
147431602|NCT01369511|531746113|FG003|Overall Study|Lost to Follow-up|2|||
147431603|NCT01369511|531746110|FG000|Overall Study|Protocol Violation|0|||
147431604|NCT01369511|531746111|FG001|Overall Study|Protocol Violation|1|||
147431605|NCT01369511|531746112|FG002|Overall Study|Protocol Violation|0|||
147431606|NCT01369511|531746113|FG003|Overall Study|Protocol Violation|2|||
147431607|NCT01369511|531746110|FG000|Overall Study|Physician Decision|3|||
147431608|NCT01369511|531746111|FG001|Overall Study|Physician Decision|4|||
147431609|NCT01369511|531746112|FG002|Overall Study|Physician Decision|0|||
147431610|NCT01369511|531746113|FG003|Overall Study|Physician Decision|0|||
147431611|NCT01369511|531746110|FG000|Overall Study|Sponsor decision|2|||
147431612|NCT01369511|531746111|FG001|Overall Study|Sponsor decision|0|||
147431613|NCT01369511|531746112|FG002|Overall Study|Sponsor decision|1|||
147431614|NCT01369511|531746113|FG003|Overall Study|Sponsor decision|0|||
147431615|NCT01369511|531746110|FG000|Overall Study|Withdrawal by Subject|5|||
147431616|NCT01369511|531746111|FG001|Overall Study|Withdrawal by Subject|6|||
147431617|NCT01369511|531746112|FG002|Overall Study|Withdrawal by Subject|4|||
147431618|NCT01369511|531746113|FG003|Overall Study|Withdrawal by Subject|6|||
147431619|NCT01180998|531746115|FG000|Overall Study|Poor Vision|0|||
147431620|NCT01180998|531746116|FG001|Overall Study|Poor Vision|2|||
147431621|NCT01180998|531746117|FG002|Overall Study|Poor Vision|2|||
147431622|NCT01180998|531746115|FG000|Overall Study|Lost to Follow-up|0|||
147431623|NCT01180998|531746116|FG001|Overall Study|Lost to Follow-up|0|||
147431624|NCT01180998|531746117|FG002|Overall Study|Lost to Follow-up|1|||
147431625|NCT01180998|531746115|FG000|Overall Study|Protocol Violation|1|||
147431626|NCT01180998|531746116|FG001|Overall Study|Protocol Violation|2|||
147431627|NCT01180998|531746117|FG002|Overall Study|Protocol Violation|0|||
147431628|NCT01180998|531746115|FG000|Overall Study|Withdrawal by Subject|0|||
147431629|NCT01180998|531746116|FG001|Overall Study|Withdrawal by Subject|0|||
147431630|NCT01180998|531746117|FG002|Overall Study|Withdrawal by Subject|1|||
147431631|NCT01180998|531746115|FG000|Overall Study|Poor comfort|3|||
147431632|NCT01180998|531746116|FG001|Overall Study|Poor comfort|0|||
147431633|NCT01180998|531746117|FG002|Overall Study|Poor comfort|4|||
147431634|NCT01180998|531746115|FG000|Overall Study|Poor lens handling|0|||
147431635|NCT01180998|531746116|FG001|Overall Study|Poor lens handling|0|||
147431636|NCT01180998|531746117|FG002|Overall Study|Poor lens handling|2|||
147431637|NCT01376349|531746118|FG000|Raondomized Treatment|Withdrawal by Subject|10|||
147431638|NCT01376349|531746119|FG001|Raondomized Treatment|Withdrawal by Subject|16|||
147431639|NCT01376349|531746120|FG002|Raondomized Treatment|Withdrawal by Subject|13|||
147431640|NCT01376349|531746118|FG000|Raondomized Treatment|Adverse Event|13|||
147431641|NCT01376349|531746119|FG001|Raondomized Treatment|Adverse Event|17|||
147431642|NCT01376349|531746120|FG002|Raondomized Treatment|Adverse Event|14|||
147431643|NCT01376349|531746118|FG000|Raondomized Treatment|Unkown|1|||
147431644|NCT01376349|531746119|FG001|Raondomized Treatment|Unkown|2|||
147431645|NCT01376349|531746120|FG002|Raondomized Treatment|Unkown|1|||
147431646|NCT01376349|531746118|FG000|Raondomized Treatment|Alternative Treatment|0|||
147431647|NCT01376349|531746119|FG001|Raondomized Treatment|Alternative Treatment|0|||
147431648|NCT01376349|531746120|FG002|Raondomized Treatment|Alternative Treatment|1|||
147431649|NCT01176968|531746121|FG000|Overall Study|Adverse Event|10|||
147431650|NCT01176968|531746122|FG001|Overall Study|Adverse Event|11|||
147431651|NCT01176968|531746121|FG000|Overall Study|Death|2|||
147431652|NCT01176968|531746122|FG001|Overall Study|Death|3|||
147431653|NCT01176968|531746121|FG000|Overall Study|Lack of Efficacy|0|||
147431654|NCT01176968|531746122|FG001|Overall Study|Lack of Efficacy|1|||
147431655|NCT01176968|531746121|FG000|Overall Study|Lost to Follow-up|16|||
147431656|NCT01176968|531746122|FG001|Overall Study|Lost to Follow-up|14|||
147431657|NCT01176968|531746121|FG000|Overall Study|Withdrawal by Subject|48|||
147431658|NCT01176968|531746122|FG001|Overall Study|Withdrawal by Subject|48|||
147431659|NCT01176968|531746121|FG000|Overall Study|Protocol Violation|2|||
147431660|NCT01176968|531746122|FG001|Overall Study|Protocol Violation|1|||
147431661|NCT01176968|531746121|FG000|Overall Study|Did Not Meet Entrance Criteria|1|||
147431662|NCT01176968|531746122|FG001|Overall Study|Did Not Meet Entrance Criteria|0|||
147431663|NCT01176968|531746121|FG000|Overall Study|Study terminated by sponsor|0|||
147431664|NCT01176968|531746122|FG001|Overall Study|Study terminated by sponsor|1|||
147431665|NCT01176968|531746121|FG000|Overall Study|Reason not defined|5|||
147431666|NCT01176968|531746122|FG001|Overall Study|Reason not defined|3|||
147431667|NCT00718640|531746123|FG000|Overall Study|Adverse Event|4|||
147431668|NCT00718640|531746123|FG000|Overall Study|Death|1|||
147431669|NCT00718640|531746123|FG000|Overall Study|Unresolved toxicity after 2 weeks|2|||
147431670|NCT00068588|531746126|FG000|Overall Study|Adverse Event|0|||
147431671|NCT00068588|531746127|FG001|Overall Study|Adverse Event|0|||
147431672|NCT00068588|531746128|FG002|Overall Study|Adverse Event|2|||
147431673|NCT00068588|531746126|FG000|Overall Study|Withdrawal by Subject|0|||
147431674|NCT00068588|531746127|FG001|Overall Study|Withdrawal by Subject|0|||
147431675|NCT00068588|531746128|FG002|Overall Study|Withdrawal by Subject|1|||
147431676|NCT00068588|531746126|FG000|Overall Study|Poor KPS|0|||
147431677|NCT00068588|531746127|FG001|Overall Study|Poor KPS|0|||
147431678|NCT00068588|531746128|FG002|Overall Study|Poor KPS|1|||
147431679|NCT04098068|531746129|FG000|Overall Study|Disease Progression|7|||
147431680|NCT04098068|531746129|FG000|Overall Study|Withdrawal by Subject|2|||
147431681|NCT04098068|531746129|FG000|Overall Study|New Cancer Diagnosis|1|||
147431682|NCT03871829|531746132|FG000|Overall Study|Lost to Follow-up|0|||
147431683|NCT03871829|531746133|FG001|Overall Study|Lost to Follow-up|1|||
147431684|NCT03871829|531746132|FG000|Overall Study|Withdrawal by Subject|1|||
147431685|NCT03871829|531746133|FG001|Overall Study|Withdrawal by Subject|1|||
147431686|NCT03871829|531746132|FG000|Overall Study|Death|12|||
147431687|NCT03871829|531746133|FG001|Overall Study|Death|8|||
147431688|NCT03871829|531746132|FG000|Overall Study|Study terminated by sponsor|31|||
147431689|NCT03871829|531746133|FG001|Overall Study|Study terminated by sponsor|34|||
147431690|NCT02993523|531746134|FG000|Overall Study|Withdrew Consent|0|||
147431691|NCT02993523|531746135|FG001|Overall Study|Withdrew Consent|0|||
147431692|NCT02993523|531746136|FG002|Overall Study|Withdrew Consent|2|||
147431693|NCT02993523|531746137|FG003|Overall Study|Withdrew Consent|9|||
147431694|NCT02993523|531746138|FG004|Overall Study|Withdrew Consent|0|||
147431695|NCT02993523|531746134|FG000|Overall Study|Lost to Follow-up|0|||
147431696|NCT02993523|531746135|FG001|Overall Study|Lost to Follow-up|0|||
147431697|NCT02993523|531746136|FG002|Overall Study|Lost to Follow-up|3|||
147431698|NCT02993523|531746137|FG003|Overall Study|Lost to Follow-up|6|||
147431699|NCT02993523|531746138|FG004|Overall Study|Lost to Follow-up|0|||
147431700|NCT02993523|531746134|FG000|Overall Study|Death|1|||
147431701|NCT02993523|531746135|FG001|Overall Study|Death|1|||
147431702|NCT02993523|531746136|FG002|Overall Study|Death|138|||
147431703|NCT02993523|531746137|FG003|Overall Study|Death|222|||
147431704|NCT02993523|531746138|FG004|Overall Study|Death|6|||
147431705|NCT02993523|531746134|FG000|Overall Study|Reason not Specified|0|||
147431706|NCT02993523|531746135|FG001|Overall Study|Reason not Specified|0|||
147431707|NCT02993523|531746136|FG002|Overall Study|Reason not Specified|1|||
147431708|NCT02993523|531746137|FG003|Overall Study|Reason not Specified|1|||
147431709|NCT02993523|531746138|FG004|Overall Study|Reason not Specified|0|||
147431710|NCT03694418|531746139|FG000|Overall Study|Lost to Follow-up|115|||
147431711|NCT03694418|531746140|FG001|Overall Study|Lost to Follow-up|23|||
147431712|NCT03694418|531746141|FG002|Overall Study|Lost to Follow-up|12|||
147431713|NCT03694418|531746142|FG003|Overall Study|Lost to Follow-up|12|||
147431714|NCT03694418|531746143|FG004|Overall Study|Lost to Follow-up|13|||
147431715|NCT04288778|531746144|FG000|Overall Study|Withdrawal by Subject|2|||
147431716|NCT04288778|531746144|FG000|Overall Study|Adverse Event|5|||
147431717|NCT04288778|531746144|FG000|Overall Study|Non-Compliance With Study Drug|1|||
147431718|NCT04288778|531746144|FG000|Overall Study|Other|1|||
147431719|NCT04288778|531746144|FG000|Overall Study|Started but not treated|2|||
147431720|NCT04485104|531746145|FG000|Overall Study|Physician Decision|2|||
147431721|NCT04485104|531746146|FG001|Overall Study|Physician Decision|0|||
147431722|NCT04485104|531746145|FG000|Overall Study|Decision by sponsor|0|||
147431723|NCT04485104|531746146|FG001|Overall Study|Decision by sponsor|1|||
147431724|NCT05057247|531746151|FG000|Overall Study|Death|4|||
147431725|NCT05057247|531746151|FG000|Overall Study|Physician Decision|3|||
147431726|NCT05057247|531746151|FG000|Overall Study|Progressive Disease|7|||
147431727|NCT05057247|531746151|FG000|Overall Study|Withdrawal by Subject|3|||
147431728|NCT05057247|531746151|FG000|Overall Study|Adverse Event|6|||
147431729|NCT05057247|531746151|FG000|Overall Study|Subject Non-Compliance|1|||
147431730|NCT05057247|531746151|FG000|Overall Study|On treatment|2|||
147431731|NCT00784693|531746152|FG000|Overall Study|Lost to Follow-up|0|||
147431732|NCT00784693|531746153|FG001|Overall Study|Lost to Follow-up|1|||
147431733|NCT00784693|531746152|FG000|Overall Study|Lack of Efficacy|1|||
147431734|NCT00784693|531746153|FG001|Overall Study|Lack of Efficacy|1|||
147431735|NCT00784693|531746152|FG000|Overall Study|Withdrawal by Subject|0|||
147431736|NCT00784693|531746153|FG001|Overall Study|Withdrawal by Subject|4|||
147431737|NCT00784693|531746152|FG000|Overall Study|Randomized but not Treated|1|||
147431738|NCT00784693|531746153|FG001|Overall Study|Randomized but not Treated|0|||
147431739|NCT00784693|531746152|FG000|Overall Study|Other|1|||
147431740|NCT00784693|531746153|FG001|Overall Study|Other|0|||
147431741|NCT05458479|531746154|FG000|Overall Study|Lost to Follow-up|1|||
147431742|NCT00528866|531746155|FG000|Overall Study|Protocol Violation|6|||
147431743|NCT00993915|531746159|FG000|Overall Study|Insufficient clinical response|3|||
147431744|NCT00993915|531746159|FG000|Overall Study|Withdrawal by Subject|2|||
147431745|NCT00993915|531746159|FG000|Overall Study|Other|1|||
147431746|NCT00993915|531746159|FG000|Overall Study|Ongoing|3|||
147431747|NCT02430051|531746162|FG000|Overall Study|Withdrawal by Subject|6|||
147431748|NCT02430051|531746163|FG001|Overall Study|Withdrawal by Subject|3|||
147431749|NCT02430051|531746162|FG000|Overall Study|Dropped due to not meeting scheduling requirements|6|||
147431750|NCT02430051|531746163|FG001|Overall Study|Dropped due to not meeting scheduling requirements|9|||
147431751|NCT02430051|531746162|FG000|Overall Study|Protocol Violation|1|||
147431752|NCT02430051|531746163|FG001|Overall Study|Protocol Violation|0|||
147431753|NCT02030405|531746168|FG000|Overall Study|Withdrawal by Subject|1|||
147431754|NCT02030405|531746168|FG000|Overall Study|Lost to Follow-up|1|||
147431755|NCT00132496|531746169|FG000|Overall Study|Withdrawal by Subject|1|||
147431756|NCT00132496|531746170|FG001|Overall Study|Withdrawal by Subject|2|||
147431757|NCT00132496|531746169|FG000|Overall Study|Physician Decision|1|||
147431758|NCT00132496|531746170|FG001|Overall Study|Physician Decision|0|||
147431759|NCT04526197|531746171|FG000|Period 1|Adverse Event|0|||
147431760|NCT04526197|531746172|FG001|Period 1|Adverse Event|1|||
147431761|NCT04526197|531746171|FG000|Period 1|Withdrawal by Subject|1|||
147431762|NCT04526197|531746172|FG001|Period 1|Withdrawal by Subject|0|||
147431763|NCT04526197|531746171|FG000|Period 2|Adverse Event|0|||
147431764|NCT04526197|531746172|FG001|Period 2|Adverse Event|1|||
147431765|NCT04526197|531746171|FG000|Period 2|Withdrawal by Subject|0|||
147431766|NCT04526197|531746172|FG001|Period 2|Withdrawal by Subject|1|||
147431767|NCT01136811|531746173|FG000|Overall Study|Physician Decision|11|||
147431768|NCT00372385|531746174|FG000|Overall Study|Adverse Event|6|||
147431769|NCT00372385|531746175|FG001|Overall Study|Adverse Event|11|||
147431770|NCT00372385|531746176|FG002|Overall Study|Adverse Event|9|||
147431771|NCT00372385|531746177|FG003|Overall Study|Adverse Event|7|||
147431772|NCT00372385|531746174|FG000|Overall Study|Noncompliance|0|||
147431773|NCT00372385|531746175|FG001|Overall Study|Noncompliance|1|||
147431774|NCT00372385|531746176|FG002|Overall Study|Noncompliance|1|||
147431775|NCT00372385|531746177|FG003|Overall Study|Noncompliance|1|||
147431776|NCT00372385|531746174|FG000|Overall Study|Physician Decision|1|||
147431777|NCT00372385|531746175|FG001|Overall Study|Physician Decision|0|||
147431778|NCT00372385|531746176|FG002|Overall Study|Physician Decision|0|||
147431779|NCT00372385|531746177|FG003|Overall Study|Physician Decision|0|||
147431780|NCT00372385|531746174|FG000|Overall Study|Lost to Follow-up|2|||
147431781|NCT00372385|531746175|FG001|Overall Study|Lost to Follow-up|0|||
147431782|NCT00372385|531746176|FG002|Overall Study|Lost to Follow-up|0|||
147431783|NCT00372385|531746177|FG003|Overall Study|Lost to Follow-up|0|||
147431784|NCT00372385|531746174|FG000|Overall Study|Withdrawal by Subject|2|||
147431785|NCT00372385|531746175|FG001|Overall Study|Withdrawal by Subject|1|||
147431786|NCT00372385|531746176|FG002|Overall Study|Withdrawal by Subject|0|||
147431787|NCT00372385|531746177|FG003|Overall Study|Withdrawal by Subject|0|||
147431788|NCT00372385|531746174|FG000|Overall Study|Refusal of Treatment|3|||
147431789|NCT00372385|531746175|FG001|Overall Study|Refusal of Treatment|6|||
147431790|NCT00372385|531746176|FG002|Overall Study|Refusal of Treatment|0|||
147431791|NCT00372385|531746177|FG003|Overall Study|Refusal of Treatment|0|||
147431792|NCT00372385|531746174|FG000|Overall Study|No Response|1|||
147431793|NCT00372385|531746175|FG001|Overall Study|No Response|1|||
147431794|NCT00372385|531746176|FG002|Overall Study|No Response|0|||
147431795|NCT00372385|531746177|FG003|Overall Study|No Response|0|||
147431796|NCT00372385|531746174|FG000|Overall Study|Ineligibility due to Exclusion Criterion|1|||
147431797|NCT00372385|531746175|FG001|Overall Study|Ineligibility due to Exclusion Criterion|0|||
147431798|NCT00372385|531746176|FG002|Overall Study|Ineligibility due to Exclusion Criterion|0|||
147431799|NCT00372385|531746177|FG003|Overall Study|Ineligibility due to Exclusion Criterion|0|||
147431800|NCT00372385|531746174|FG000|Overall Study|Virologic Stopping Rule|17|||
147431801|NCT00372385|531746175|FG001|Overall Study|Virologic Stopping Rule|0|||
147431802|NCT00372385|531746176|FG002|Overall Study|Virologic Stopping Rule|0|||
147431803|NCT00372385|531746177|FG003|Overall Study|Virologic Stopping Rule|0|||
147431804|NCT01119001|531746179|FG000|Overall Study|Withdrawal by Subject|2|||
147431805|NCT04343248|531746180|FG000|Overall Study|Withdrawal by Subject|5|||
147431806|NCT04343248|531746181|FG001|Overall Study|Withdrawal by Subject|6|||
147431807|NCT04343248|531746180|FG000|Overall Study|Death|1|||
147431808|NCT04343248|531746181|FG001|Overall Study|Death|2|||
147431809|NCT04343248|531746180|FG000|Overall Study|Lost to Follow-up|9|||
147431810|NCT04343248|531746181|FG001|Overall Study|Lost to Follow-up|6|||
147431811|NCT04343248|531746180|FG000|Overall Study|Physician Decision|0|||
147431812|NCT04343248|531746181|FG001|Overall Study|Physician Decision|1|||
147431813|NCT04343248|531746180|FG000|Overall Study|Adverse Event|1|||
147431814|NCT04343248|531746181|FG001|Overall Study|Adverse Event|0|||
147431815|NCT03604523|531746182|FG000|Overall Study|Physician Decision|1|||
147431816|NCT03604523|531746183|FG001|Overall Study|Physician Decision|0|||
147431817|NCT00810394|531746190|FG000|Overall Study|Withdrawal by Subject|3|||
147431818|NCT00467285|531746191|FG000|Overall Study|Lost to Follow-up|4|||
147431819|NCT00467285|531746192|FG001|Overall Study|Lost to Follow-up|4|||
147431820|NCT03891524|531746193|FG000|Overall Study|Death|0|||
147431821|NCT03891524|531746194|FG001|Overall Study|Death|0|||
147431822|NCT03891524|531746195|FG002|Overall Study|Death|0|||
147431823|NCT03891524|531746196|FG003|Overall Study|Death|0|||
147431824|NCT03891524|531746197|FG004|Overall Study|Death|0|||
147431825|NCT03891524|531746198|FG005|Overall Study|Death|0|||
147431826|NCT03891524|531746199|FG006|Overall Study|Death|0|||
147431827|NCT03891524|531746200|FG007|Overall Study|Death|1|||
147431828|NCT03891524|531746193|FG000|Overall Study|Withdrawal by Subject|0|||
147431829|NCT03891524|531746194|FG001|Overall Study|Withdrawal by Subject|1|||
147193103|NCT00625131|530876432|FG000|Overall Study|Lost to Follow-up|3|||
147431830|NCT03891524|531746195|FG002|Overall Study|Withdrawal by Subject|2|||
147431831|NCT03891524|531746196|FG003|Overall Study|Withdrawal by Subject|1|||
147431832|NCT03891524|531746197|FG004|Overall Study|Withdrawal by Subject|2|||
147431833|NCT03891524|531746198|FG005|Overall Study|Withdrawal by Subject|2|||
147431834|NCT03891524|531746199|FG006|Overall Study|Withdrawal by Subject|2|||
147431835|NCT03891524|531746200|FG007|Overall Study|Withdrawal by Subject|1|||
147431836|NCT01598311|531746201|FG000|Overall Study|Physician Decision|4|||
147431837|NCT01598311|531746202|FG001|Overall Study|Physician Decision|5|||
147431838|NCT01598311|531746201|FG000|Overall Study|Adverse Event|9|||
147431839|NCT01598311|531746202|FG001|Overall Study|Adverse Event|13|||
147431840|NCT01598311|531746201|FG000|Overall Study|Lost to Follow-up|7|||
147431841|NCT01598311|531746202|FG001|Overall Study|Lost to Follow-up|12|||
147431842|NCT01598311|531746201|FG000|Overall Study|Withdrawal by Subject|9|||
147431843|NCT01598311|531746202|FG001|Overall Study|Withdrawal by Subject|13|||
147431844|NCT01598311|531746201|FG000|Overall Study|No reason provided.|0|||
147431845|NCT01598311|531746202|FG001|Overall Study|No reason provided.|5|||
147431846|NCT01598311|531746201|FG000|Overall Study|Randomized but never treated|8|||
147431847|NCT01598311|531746202|FG001|Overall Study|Randomized but never treated|5|||
147431848|NCT01598311|531746201|FG000|Overall Study|Treated but no confirmed CDAD|9|||
147431849|NCT01598311|531746202|FG001|Overall Study|Treated but no confirmed CDAD|8|||
147431850|NCT01598311|531746201|FG000|Overall Study|Assigned to CB but received vancomycin|1|||
147431851|NCT01598311|531746202|FG001|Overall Study|Assigned to CB but received vancomycin|0|||
147431852|NCT00658684|531746203|FG000|Overall Study|Adverse Event|10|||
147431853|NCT00658684|531746204|FG001|Overall Study|Adverse Event|8|||
147431854|NCT00658684|531746205|FG002|Overall Study|Adverse Event|2|||
147431855|NCT00658684|531746206|FG003|Overall Study|Adverse Event|0|||
147431856|NCT00658684|531746203|FG000|Overall Study|Withdrawal by Subject|6|||
147431857|NCT00658684|531746204|FG001|Overall Study|Withdrawal by Subject|4|||
147431858|NCT00658684|531746205|FG002|Overall Study|Withdrawal by Subject|1|||
147431859|NCT00658684|531746206|FG003|Overall Study|Withdrawal by Subject|1|||
147431860|NCT00658684|531746203|FG000|Overall Study|Lack of Efficacy|1|||
147431861|NCT00658684|531746204|FG001|Overall Study|Lack of Efficacy|1|||
147431862|NCT00658684|531746205|FG002|Overall Study|Lack of Efficacy|0|||
147431863|NCT00658684|531746206|FG003|Overall Study|Lack of Efficacy|0|||
147431864|NCT00658684|531746203|FG000|Overall Study|Protocol Violation|1|||
147431865|NCT00658684|531746204|FG001|Overall Study|Protocol Violation|1|||
147431866|NCT00658684|531746205|FG002|Overall Study|Protocol Violation|0|||
147431867|NCT00658684|531746206|FG003|Overall Study|Protocol Violation|0|||
147431868|NCT00658684|531746203|FG000|Overall Study|Pregnancy|1|||
147431869|NCT00658684|531746204|FG001|Overall Study|Pregnancy|1|||
147431870|NCT00658684|531746205|FG002|Overall Study|Pregnancy|0|||
147431871|NCT00658684|531746206|FG003|Overall Study|Pregnancy|0|||
147431872|NCT00688103|531746207|FG000|Overall Study|Adverse Event|4|||
147431873|NCT00688103|531746208|FG001|Overall Study|Adverse Event|1|||
147431874|NCT00688103|531746207|FG000|Overall Study|Lack of Efficacy|11|||
147431875|NCT00688103|531746208|FG001|Overall Study|Lack of Efficacy|1|||
147431876|NCT00688103|531746207|FG000|Overall Study|Withdrawal by Subject|4|||
147431877|NCT00688103|531746208|FG001|Overall Study|Withdrawal by Subject|2|||
147431878|NCT00688103|531746207|FG000|Overall Study|complex reasons|11|||
147431879|NCT00688103|531746208|FG001|Overall Study|complex reasons|9|||
147431880|NCT03144804|531746210|FG000|Overall Study|4 participants had disease progression within 1 month of study treatment and were deemed unevaluable|4|||
147532975|NCT05182840|532106043|FG001|Treatment Period|Protocol deviation|0|||
147532976|NCT05182840|532106044|FG002|Treatment Period|Protocol deviation|0|||
147532977|NCT05182840|532106045|FG003|Treatment Period|Protocol deviation|0|||
147532978|NCT05182840|532106046|FG004|Treatment Period|Protocol deviation|0|||
147532979|NCT05182840|532106047|FG005|Treatment Period|Protocol deviation|0|||
147532980|NCT05182840|532106048|FG006|Treatment Period|Protocol deviation|0|||
147532981|NCT05182840|532106049|FG007|Treatment Period|Protocol deviation|0|||
147431881|NCT01672788|531747582|FG000|Washout Period 2 (7 Days)|Adverse Event|0|||
147431882|NCT01672788|531747583|FG001|Washout Period 2 (7 Days)|Adverse Event|0|||
147431883|NCT01672788|531747584|FG002|Washout Period 2 (7 Days)|Adverse Event|0|||
147431884|NCT01672788|531747585|FG003|Washout Period 2 (7 Days)|Adverse Event|1|||
147431885|NCT03329196|531747588|FG000|Overall Study|Adverse Event|10|||
147431886|NCT03329196|531747589|FG001|Overall Study|Adverse Event|5|||
147431887|NCT03329196|531747588|FG000|Overall Study|Physician Decision|2|||
147431888|NCT03329196|531747589|FG001|Overall Study|Physician Decision|2|||
147431889|NCT03329196|531747588|FG000|Overall Study|Withdrawal by Subject|11|||
147431890|NCT03329196|531747589|FG001|Overall Study|Withdrawal by Subject|3|||
147431891|NCT03329196|531747588|FG000|Overall Study|Hepatic function abnormalities|0|||
147431892|NCT03329196|531747589|FG001|Overall Study|Hepatic function abnormalities|1|||
147431893|NCT03329196|531747588|FG000|Overall Study|Conducting rescue therapy before Week 24|2|||
147431894|NCT03329196|531747589|FG001|Overall Study|Conducting rescue therapy before Week 24|1|||
147431895|NCT03329196|531747588|FG000|Overall Study|Difficult to control Hb|2|||
147431896|NCT03329196|531747589|FG001|Overall Study|Difficult to control Hb|3|||
147431897|NCT03329196|531747588|FG000|Overall Study|Dialysis or renal transplant|13|||
147431898|NCT03329196|531747589|FG001|Overall Study|Dialysis or renal transplant|15|||
147431899|NCT01128361|531747590|FG000|Overall Study|Lost to Follow-up|0|||
147431900|NCT01128361|531747591|FG001|Overall Study|Lost to Follow-up|1|||
147431901|NCT01128361|531747590|FG000|Overall Study|Withdrawal by Subject|5|||
147431902|NCT01128361|531747591|FG001|Overall Study|Withdrawal by Subject|2|||
147431903|NCT04796896|531747592|FG000|Overall Study|Adverse Event|1|||
147431904|NCT04796896|531747593|FG001|Overall Study|Adverse Event|0|||
147431905|NCT04796896|531747594|FG002|Overall Study|Adverse Event|0|||
147431906|NCT04796896|531747595|FG003|Overall Study|Adverse Event|0|||
147431907|NCT04796896|531747596|FG004|Overall Study|Adverse Event|0|||
147431908|NCT04796896|531747597|FG005|Overall Study|Adverse Event|1|||
147431909|NCT04796896|531747598|FG006|Overall Study|Adverse Event|1|||
147431910|NCT04796896|531747599|FG007|Overall Study|Adverse Event|0|||
147532982|NCT05182840|532106050|FG008|Treatment Period|Protocol deviation|1|||
147532983|NCT05182840|532106051|FG009|Treatment Period|Protocol deviation|0|||
147532984|NCT05182840|532106042|FG000|Treatment Period|No reason available|0|||
147532985|NCT05182840|532106043|FG001|Treatment Period|No reason available|0|||
147532986|NCT05182840|532106044|FG002|Treatment Period|No reason available|0|||
147532987|NCT05182840|532106045|FG003|Treatment Period|No reason available|1|||
147532988|NCT05182840|532106046|FG004|Treatment Period|No reason available|0|||
147532989|NCT05182840|532106047|FG005|Treatment Period|No reason available|2|||
147532990|NCT05182840|532106048|FG006|Treatment Period|No reason available|0|||
147532991|NCT05182840|532106049|FG007|Treatment Period|No reason available|1|||
147532992|NCT05182840|532106050|FG008|Treatment Period|No reason available|0|||
147532993|NCT05182840|532106051|FG009|Treatment Period|No reason available|0|||
147532994|NCT05182840|532106042|FG000|Treatment Period|Burden of study procedures|0|||
147532995|NCT05182840|532106043|FG001|Treatment Period|Burden of study procedures|0|||
147532996|NCT05182840|532106044|FG002|Treatment Period|Burden of study procedures|0|||
147532997|NCT05182840|532106045|FG003|Treatment Period|Burden of study procedures|0|||
147532998|NCT05182840|532106046|FG004|Treatment Period|Burden of study procedures|1|||
147532999|NCT05182840|532106047|FG005|Treatment Period|Burden of study procedures|0|||
147533000|NCT05182840|532106048|FG006|Treatment Period|Burden of study procedures|0|||
147533001|NCT05182840|532106049|FG007|Treatment Period|Burden of study procedures|0|||
147533002|NCT05182840|532106050|FG008|Treatment Period|Burden of study procedures|0|||
147533003|NCT05182840|532106051|FG009|Treatment Period|Burden of study procedures|0|||
147533004|NCT05182840|532106042|FG000|Treatment Period|Change of residence|0|||
147533005|NCT05182840|532106043|FG001|Treatment Period|Change of residence|0|||
147533006|NCT05182840|532106044|FG002|Treatment Period|Change of residence|0|||
147533007|NCT05182840|532106045|FG003|Treatment Period|Change of residence|0|||
147533008|NCT05182840|532106046|FG004|Treatment Period|Change of residence|0|||
147533009|NCT05182840|532106047|FG005|Treatment Period|Change of residence|1|||
147533010|NCT05182840|532106048|FG006|Treatment Period|Change of residence|0|||
147533011|NCT05182840|532106049|FG007|Treatment Period|Change of residence|0|||
147533012|NCT05182840|532106050|FG008|Treatment Period|Change of residence|0|||
147533013|NCT05182840|532106051|FG009|Treatment Period|Change of residence|0|||
147533014|NCT05182840|532106042|FG000|Treatment Period|Adverse Event|0|||
147533015|NCT05182840|532106043|FG001|Treatment Period|Adverse Event|0|||
147533016|NCT05182840|532106044|FG002|Treatment Period|Adverse Event|4|||
147533017|NCT05182840|532106045|FG003|Treatment Period|Adverse Event|16|||
147533018|NCT05182840|532106046|FG004|Treatment Period|Adverse Event|12|||
147533019|NCT05182840|532106047|FG005|Treatment Period|Adverse Event|6|||
147533020|NCT05182840|532106048|FG006|Treatment Period|Adverse Event|4|||
147533021|NCT05182840|532106049|FG007|Treatment Period|Adverse Event|8|||
147533022|NCT05182840|532106050|FG008|Treatment Period|Adverse Event|16|||
147533023|NCT05182840|532106051|FG009|Treatment Period|Adverse Event|5|||
147533024|NCT05182840|532106042|FG000|Treatment Period|Not treated with study drug|0|||
147533025|NCT05182840|532106043|FG001|Treatment Period|Not treated with study drug|0|||
147533026|NCT05182840|532106044|FG002|Treatment Period|Not treated with study drug|0|||
147533027|NCT05182840|532106045|FG003|Treatment Period|Not treated with study drug|1|||
147533028|NCT05182840|532106046|FG004|Treatment Period|Not treated with study drug|0|||
147533029|NCT05182840|532106047|FG005|Treatment Period|Not treated with study drug|0|||
147533030|NCT05182840|532106048|FG006|Treatment Period|Not treated with study drug|1|||
147533031|NCT05182840|532106049|FG007|Treatment Period|Not treated with study drug|1|||
147533032|NCT05182840|532106050|FG008|Treatment Period|Not treated with study drug|0|||
147533033|NCT05182840|532106051|FG009|Treatment Period|Not treated with study drug|0|||
147533034|NCT02161380|532106052|FG000|Overall Study|Lost to Follow-up|0|||
147533035|NCT02161380|532106053|FG001|Overall Study|Lost to Follow-up|1|||
147533036|NCT02161380|532106054|FG002|Overall Study|Lost to Follow-up|0|||
147431911|NCT04796896|531747600|FG008|Overall Study|Adverse Event|1|||
147431912|NCT04796896|531747601|FG009|Overall Study|Adverse Event|1|||
147431913|NCT04796896|531747602|FG010|Overall Study|Adverse Event|1|||
147431914|NCT04796896|531747603|FG011|Overall Study|Adverse Event|0|||
147431915|NCT04796896|531747592|FG000|Overall Study|Lost to Follow-up|24|||
147431916|NCT04796896|531747593|FG001|Overall Study|Lost to Follow-up|15|||
147431917|NCT04796896|531747594|FG002|Overall Study|Lost to Follow-up|6|||
147431918|NCT04796896|531747595|FG003|Overall Study|Lost to Follow-up|4|||
147533037|NCT02161380|532106055|FG003|Overall Study|Lost to Follow-up|0|||
147533038|NCT04409262|532106058|FG000|Overall Study|Adverse Event|0|||
147533039|NCT04409262|532106059|FG001|Overall Study|Adverse Event|2|||
147533040|NCT04409262|532106058|FG000|Overall Study|Death|55|||
147533041|NCT04409262|532106059|FG001|Overall Study|Death|97|||
147533042|NCT04409262|532106058|FG000|Overall Study|Lost to Follow-up|12|||
147533043|NCT04409262|532106059|FG001|Overall Study|Lost to Follow-up|23|||
147193104|NCT00625131|530876433|FG001|Overall Study|Lost to Follow-up|2|||
147533044|NCT04409262|532106058|FG000|Overall Study|Lack of Staff|0|||
147533045|NCT04409262|532106059|FG001|Overall Study|Lack of Staff|1|||
147193105|NCT00625131|530876434|FG002|Overall Study|Lost to Follow-up|0|||
147193106|NCT00625131|530876432|FG000|Overall Study|Withdrawal by Subject|1|||
147431919|NCT04796896|531747596|FG004|Overall Study|Lost to Follow-up|21|||
147431920|NCT04796896|531747597|FG005|Overall Study|Lost to Follow-up|55|||
147533046|NCT04409262|532106058|FG000|Overall Study|Protocol Violation|3|||
147533047|NCT04409262|532106059|FG001|Overall Study|Protocol Violation|1|||
147431921|NCT04796896|531747598|FG006|Overall Study|Lost to Follow-up|237|||
147431922|NCT04796896|531747599|FG007|Overall Study|Lost to Follow-up|52|||
147431923|NCT04796896|531747600|FG008|Overall Study|Lost to Follow-up|221|||
147431924|NCT04796896|531747601|FG009|Overall Study|Lost to Follow-up|43|||
147431925|NCT04796896|531747602|FG010|Overall Study|Lost to Follow-up|142|||
147431926|NCT04796896|531747603|FG011|Overall Study|Lost to Follow-up|18|||
147431927|NCT04796896|531747592|FG000|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|5|||
147431928|NCT04796896|531747593|FG001|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|4|||
147431929|NCT04796896|531747594|FG002|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|0|||
147431930|NCT04796896|531747595|FG003|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|3|||
147431931|NCT04796896|531747596|FG004|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|1|||
147431932|NCT04796896|531747597|FG005|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|194|||
147431933|NCT04796896|531747598|FG006|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|37|||
147431934|NCT04796896|531747599|FG007|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|222|||
147431935|NCT04796896|531747600|FG008|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|29|||
147431936|NCT04796896|531747601|FG009|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|115|||
147431937|NCT04796896|531747602|FG010|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|9|||
147431938|NCT04796896|531747603|FG011|Overall Study|Received Emergency Use Authorization (EUA) Vaccine|1|||
147431939|NCT04796896|531747592|FG000|Overall Study|Physician Decision|1|||
147431940|NCT04796896|531747593|FG001|Overall Study|Physician Decision|0|||
147431941|NCT04796896|531747594|FG002|Overall Study|Physician Decision|0|||
147431942|NCT04796896|531747595|FG003|Overall Study|Physician Decision|0|||
147431943|NCT04796896|531747596|FG004|Overall Study|Physician Decision|0|||
147431944|NCT04796896|531747597|FG005|Overall Study|Physician Decision|3|||
147431945|NCT04796896|531747598|FG006|Overall Study|Physician Decision|18|||
147431946|NCT04796896|531747599|FG007|Overall Study|Physician Decision|1|||
147431947|NCT04796896|531747600|FG008|Overall Study|Physician Decision|7|||
147431948|NCT04796896|531747601|FG009|Overall Study|Physician Decision|0|||
147431949|NCT04796896|531747602|FG010|Overall Study|Physician Decision|5|||
147431950|NCT04796896|531747603|FG011|Overall Study|Physician Decision|0|||
147431951|NCT04796896|531747592|FG000|Overall Study|Withdrawal by Subject|36|||
147431952|NCT04796896|531747593|FG001|Overall Study|Withdrawal by Subject|31|||
147431953|NCT04796896|531747594|FG002|Overall Study|Withdrawal by Subject|11|||
147431954|NCT04796896|531747595|FG003|Overall Study|Withdrawal by Subject|8|||
147431955|NCT04796896|531747596|FG004|Overall Study|Withdrawal by Subject|16|||
147431956|NCT04796896|531747597|FG005|Overall Study|Withdrawal by Subject|162|||
147431957|NCT04796896|531747598|FG006|Overall Study|Withdrawal by Subject|299|||
147431958|NCT04796896|531747599|FG007|Overall Study|Withdrawal by Subject|149|||
147431959|NCT04796896|531747600|FG008|Overall Study|Withdrawal by Subject|303|||
147431960|NCT04796896|531747601|FG009|Overall Study|Withdrawal by Subject|94|||
147431961|NCT04796896|531747602|FG010|Overall Study|Withdrawal by Subject|192|||
147431962|NCT04796896|531747603|FG011|Overall Study|Withdrawal by Subject|16|||
147431963|NCT04796896|531747592|FG000|Overall Study|Other Than Specified|6|||
147431964|NCT04796896|531747593|FG001|Overall Study|Other Than Specified|5|||
147431965|NCT04796896|531747594|FG002|Overall Study|Other Than Specified|3|||
147431966|NCT04796896|531747595|FG003|Overall Study|Other Than Specified|2|||
147431967|NCT04796896|531747596|FG004|Overall Study|Other Than Specified|6|||
147431968|NCT04796896|531747597|FG005|Overall Study|Other Than Specified|31|||
147431969|NCT04796896|531747598|FG006|Overall Study|Other Than Specified|86|||
147431970|NCT04796896|531747599|FG007|Overall Study|Other Than Specified|66|||
147431971|NCT04796896|531747600|FG008|Overall Study|Other Than Specified|388|||
147431972|NCT04796896|531747601|FG009|Overall Study|Other Than Specified|48|||
147431973|NCT04796896|531747602|FG010|Overall Study|Other Than Specified|258|||
147431974|NCT04796896|531747603|FG011|Overall Study|Other Than Specified|4|||
147431975|NCT04796896|531747592|FG000|Overall Study|Protocol Deviation|0|||
147431976|NCT04796896|531747593|FG001|Overall Study|Protocol Deviation|0|||
147431977|NCT04796896|531747594|FG002|Overall Study|Protocol Deviation|0|||
147431978|NCT04796896|531747595|FG003|Overall Study|Protocol Deviation|1|||
147431979|NCT04796896|531747596|FG004|Overall Study|Protocol Deviation|1|||
147431980|NCT04796896|531747597|FG005|Overall Study|Protocol Deviation|2|||
147431981|NCT04796896|531747598|FG006|Overall Study|Protocol Deviation|2|||
147431982|NCT04796896|531747599|FG007|Overall Study|Protocol Deviation|2|||
147431983|NCT04796896|531747600|FG008|Overall Study|Protocol Deviation|2|||
147431984|NCT04796896|531747601|FG009|Overall Study|Protocol Deviation|1|||
147431985|NCT04796896|531747602|FG010|Overall Study|Protocol Deviation|0|||
147431986|NCT04796896|531747603|FG011|Overall Study|Protocol Deviation|0|||
147431987|NCT04796896|531747592|FG000|Overall Study|Missing|0|||
147431988|NCT04796896|531747593|FG001|Overall Study|Missing|0|||
147431989|NCT04796896|531747594|FG002|Overall Study|Missing|0|||
147431990|NCT04796896|531747595|FG003|Overall Study|Missing|0|||
147431991|NCT04796896|531747596|FG004|Overall Study|Missing|0|||
147431992|NCT04796896|531747597|FG005|Overall Study|Missing|0|||
147431993|NCT04796896|531747598|FG006|Overall Study|Missing|2|||
147431994|NCT04796896|531747599|FG007|Overall Study|Missing|1|||
147431995|NCT04796896|531747600|FG008|Overall Study|Missing|2|||
147431996|NCT04796896|531747601|FG009|Overall Study|Missing|1|||
147431997|NCT04796896|531747602|FG010|Overall Study|Missing|1|||
147431998|NCT04796896|531747603|FG011|Overall Study|Missing|0|||
147431999|NCT04796896|531747592|FG000|Overall Study|Death|0|||
147432000|NCT04796896|531747593|FG001|Overall Study|Death|0|||
147432001|NCT04796896|531747594|FG002|Overall Study|Death|0|||
147432002|NCT04796896|531747595|FG003|Overall Study|Death|0|||
147432003|NCT04796896|531747596|FG004|Overall Study|Death|0|||
147432004|NCT04796896|531747597|FG005|Overall Study|Death|0|||
147533048|NCT04409262|532106058|FG000|Overall Study|Withdrawal by Subject|5|||
147306729|NCT03812536|531290737|FG000|Overall Study|Withdrawal by Subject|1|||
147432005|NCT04796896|531747598|FG006|Overall Study|Death|0|||
147432006|NCT04796896|531747599|FG007|Overall Study|Death|0|||
147533049|NCT04409262|532106059|FG001|Overall Study|Withdrawal by Subject|10|||
147533050|NCT03205605|532106060|FG000|Overall Study|Withdrawal by Subject|1|||
147533051|NCT02396849|532106061|FG000|Overall Study|Lost to Follow-up|1|||
147533052|NCT02396849|532106062|FG001|Overall Study|Lost to Follow-up|1|||
147533053|NCT02396849|532106061|FG000|Overall Study|Did not tolerate intervention|1|||
147533054|NCT02396849|532106062|FG001|Overall Study|Did not tolerate intervention|1|||
147533055|NCT03328325|532106063|FG000|Overall Study|Lost to Follow-up|4|||
147533056|NCT03328325|532106063|FG000|Overall Study|Physician Decision|1|||
147533057|NCT03328325|532106063|FG000|Overall Study|Withdrawal by Subject|3|||
147533058|NCT03328325|532106063|FG000|Overall Study|Early Study Termination due to COVID-19 pandemic|3|||
147533059|NCT00948896|532106066|FG000|Randomization to 24 Months of Age|Death|1|||
147533060|NCT00948896|532106067|FG001|Randomization to 24 Months of Age|Death|0|||
147533061|NCT00948896|532106068|FG002|Randomization to 24 Months of Age|Death|0|||
147533062|NCT00948896|532106069|FG003|Randomization to 24 Months of Age|Death|0|||
147533063|NCT00948896|532106070|FG004|Randomization to 24 Months of Age|Death|2|||
147533064|NCT00948896|532106071|FG005|Randomization to 24 Months of Age|Death|1|||
147533065|NCT00948896|532106072|FG006|Randomization to 24 Months of Age|Death|2|||
147533066|NCT00948896|532106073|FG007|Randomization to 24 Months of Age|Death|1|||
147533067|NCT00948896|532106066|FG000|Randomization to 24 Months of Age|Withdrawal by Subject|3|||
147533068|NCT00948896|532106067|FG001|Randomization to 24 Months of Age|Withdrawal by Subject|5|||
147533069|NCT00948896|532106068|FG002|Randomization to 24 Months of Age|Withdrawal by Subject|4|||
147533070|NCT00948896|532106069|FG003|Randomization to 24 Months of Age|Withdrawal by Subject|4|||
147533071|NCT00948896|532106070|FG004|Randomization to 24 Months of Age|Withdrawal by Subject|0|||
147533072|NCT00948896|532106071|FG005|Randomization to 24 Months of Age|Withdrawal by Subject|1|||
147533073|NCT00948896|532106072|FG006|Randomization to 24 Months of Age|Withdrawal by Subject|0|||
147533074|NCT00948896|532106073|FG007|Randomization to 24 Months of Age|Withdrawal by Subject|0|||
147533075|NCT00948896|532106066|FG000|Randomization to 24 Months of Age|Lost to Follow-up|4|||
147533076|NCT00948896|532106067|FG001|Randomization to 24 Months of Age|Lost to Follow-up|4|||
147533077|NCT00948896|532106068|FG002|Randomization to 24 Months of Age|Lost to Follow-up|2|||
147533078|NCT00948896|532106069|FG003|Randomization to 24 Months of Age|Lost to Follow-up|5|||
147533079|NCT00948896|532106070|FG004|Randomization to 24 Months of Age|Lost to Follow-up|0|||
147533080|NCT00948896|532106071|FG005|Randomization to 24 Months of Age|Lost to Follow-up|0|||
147533081|NCT00948896|532106072|FG006|Randomization to 24 Months of Age|Lost to Follow-up|1|||
147533082|NCT00948896|532106073|FG007|Randomization to 24 Months of Age|Lost to Follow-up|0|||
147533083|NCT00948896|532106066|FG000|Randomization to 24 Months of Age|Protocol Violation|0|||
147533084|NCT00948896|532106067|FG001|Randomization to 24 Months of Age|Protocol Violation|1|||
147533085|NCT00948896|532106068|FG002|Randomization to 24 Months of Age|Protocol Violation|0|||
147533086|NCT00948896|532106069|FG003|Randomization to 24 Months of Age|Protocol Violation|1|||
147533087|NCT00948896|532106070|FG004|Randomization to 24 Months of Age|Protocol Violation|0|||
147533088|NCT00948896|532106071|FG005|Randomization to 24 Months of Age|Protocol Violation|0|||
147533089|NCT00948896|532106072|FG006|Randomization to 24 Months of Age|Protocol Violation|1|||
147533090|NCT00948896|532106073|FG007|Randomization to 24 Months of Age|Protocol Violation|1|||
147533091|NCT00948896|532106066|FG000|Randomization to 24 Months of Age|Moved out of Study Area|0|||
147533092|NCT00948896|532106067|FG001|Randomization to 24 Months of Age|Moved out of Study Area|3|||
147533093|NCT00948896|532106068|FG002|Randomization to 24 Months of Age|Moved out of Study Area|3|||
147533094|NCT00948896|532106069|FG003|Randomization to 24 Months of Age|Moved out of Study Area|1|||
147533095|NCT00948896|532106070|FG004|Randomization to 24 Months of Age|Moved out of Study Area|0|||
147533096|NCT00948896|532106071|FG005|Randomization to 24 Months of Age|Moved out of Study Area|2|||
147533097|NCT00948896|532106072|FG006|Randomization to 24 Months of Age|Moved out of Study Area|0|||
147533098|NCT00948896|532106073|FG007|Randomization to 24 Months of Age|Moved out of Study Area|0|||
147533099|NCT00948896|532106066|FG000|24 Months of Age to 36 Months of Age|Death|0|||
147533100|NCT00948896|532106067|FG001|24 Months of Age to 36 Months of Age|Death|2|||
147533101|NCT00948896|532106068|FG002|24 Months of Age to 36 Months of Age|Death|2|||
147533102|NCT00948896|532106069|FG003|24 Months of Age to 36 Months of Age|Death|0|||
147533103|NCT00948896|532106070|FG004|24 Months of Age to 36 Months of Age|Death|0|||
147533104|NCT00948896|532106071|FG005|24 Months of Age to 36 Months of Age|Death|1|||
147432007|NCT04796896|531747600|FG008|Overall Study|Death|1|||
147432008|NCT04796896|531747601|FG009|Overall Study|Death|0|||
147432009|NCT04796896|531747602|FG010|Overall Study|Death|0|||
147432010|NCT04796896|531747603|FG011|Overall Study|Death|0|||
147432011|NCT05972733|531747604|FG000|Overall Study|Lost to Follow-up|2|||
147432012|NCT05972733|531747604|FG000|Overall Study|Withdrawal by Subject|1|||
147432013|NCT01177787|531747607|FG000|Cryolipolysis on Thigh|Protocol Violation|4|||
147432014|NCT01177787|531747607|FG000|Cryolipolysis on Thigh|Lack of Efficacy|9|||
147533105|NCT00948896|532106072|FG006|24 Months of Age to 36 Months of Age|Death|0|||
147533106|NCT00948896|532106073|FG007|24 Months of Age to 36 Months of Age|Death|0|||
147432015|NCT01177787|531747607|FG000|Cryolipolysis on Thigh|Lost to Follow-up|1|||
147432016|NCT01637623|531747610|FG000|Overall Study|Lost to Follow-up|0|||
147432017|NCT01637623|531747611|FG001|Overall Study|Lost to Follow-up|0|||
147432018|NCT01637623|531747612|FG002|Overall Study|Lost to Follow-up|2|||
147432019|NCT01637623|531747610|FG000|Overall Study|Physician Decision|1|||
147432020|NCT01637623|531747611|FG001|Overall Study|Physician Decision|0|||
147432021|NCT01637623|531747612|FG002|Overall Study|Physician Decision|1|||
147432022|NCT02824263|531747613|FG000|Washout (1 to 4 Weeks)|Withdrawal by Subject|2|||
147432023|NCT02824263|531747614|FG001|Washout (1 to 4 Weeks)|Withdrawal by Subject|6|||
147432024|NCT02824263|531747613|FG000|Second Intervention (1 Night)|Withdrawal by Subject|4|||
147432025|NCT02824263|531747614|FG001|Second Intervention (1 Night)|Withdrawal by Subject|3|||
147432026|NCT01676909|531747615|FG000|Overall Study|Withdrawal by Subject|3|||
147432027|NCT01676909|531747616|FG001|Overall Study|Withdrawal by Subject|5|||
147432028|NCT01676909|531747615|FG000|Overall Study|Lost to Follow-up|15|||
147432029|NCT01676909|531747616|FG001|Overall Study|Lost to Follow-up|9|||
147432030|NCT02076113|531747617|FG000|Overall Study|Lost to Follow-up|4|||
147432031|NCT02076113|531747618|FG001|Overall Study|Lost to Follow-up|1|||
147432032|NCT02076113|531747617|FG000|Overall Study|Withdrawal by Subject|2|||
147432033|NCT02076113|531747618|FG001|Overall Study|Withdrawal by Subject|3|||
147432034|NCT02076113|531747617|FG000|Overall Study|Death|1|||
147432035|NCT02076113|531747618|FG001|Overall Study|Death|3|||
147432036|NCT03170154|531747637|FG000|Overall Study|Lost to Follow-up|4|||
147432037|NCT03170154|531747637|FG000|Overall Study|Death|2|||
147432038|NCT03170154|531747637|FG000|Overall Study|Withdrawal by Subject|2|||
147432039|NCT02279862|531747638|FG000|Overall Study|Study drug toxicity|3|||
147432040|NCT02279862|531747639|FG001|Overall Study|Study drug toxicity|6|||
147432041|NCT02279862|531747638|FG000|Overall Study|No longer meets criteria|0|||
147432042|NCT02279862|531747639|FG001|Overall Study|No longer meets criteria|1|||
147432043|NCT02279862|531747638|FG000|Overall Study|Administrative reason by sponsor|0|||
147432044|NCT02279862|531747639|FG001|Overall Study|Administrative reason by sponsor|1|||
147432045|NCT02279862|531747638|FG000|Overall Study|Disease progression|5|||
147432046|NCT02279862|531747639|FG001|Overall Study|Disease progression|2|||
147432047|NCT02279862|531747638|FG000|Overall Study|Study closed by sponsor|16|||
147432048|NCT02279862|531747639|FG001|Overall Study|Study closed by sponsor|13|||
147432049|NCT02279862|531747638|FG000|Overall Study|Other|1|||
147432050|NCT02279862|531747639|FG001|Overall Study|Other|2|||
147432051|NCT02279862|531747638|FG000|Overall Study|Withdrawal by Subject|1|||
147432052|NCT02279862|531747639|FG001|Overall Study|Withdrawal by Subject|0|||
147432053|NCT03431857|531747642|FG000|Overall Study|Death|6|||
147432054|NCT03431857|531747642|FG000|Overall Study|Lost to Follow-up|41|||
147432055|NCT03431857|531747642|FG000|Overall Study|Adverse Event|6|||
147432056|NCT03431857|531747642|FG000|Overall Study|Withdrawal by Subject|1|||
147432057|NCT01323621|531747643|FG000|2-week, Single-blind Run In Period|Not Met Inclusion/Exclusion Criteria|121|||
147432058|NCT01323621|531747644|FG001|2-week, Single-blind Run In Period|Not Met Inclusion/Exclusion Criteria|0|||
147432059|NCT01323621|531747645|FG002|2-week, Single-blind Run In Period|Not Met Inclusion/Exclusion Criteria|0|||
147432060|NCT01323621|531747643|FG000|2-week, Single-blind Run In Period|Physician Decision|7|||
147432061|NCT01323621|531747644|FG001|2-week, Single-blind Run In Period|Physician Decision|0|||
147432062|NCT01323621|531747645|FG002|2-week, Single-blind Run In Period|Physician Decision|0|||
147432063|NCT01323621|531747643|FG000|2-week, Single-blind Run In Period|Withdrawal by Subject|12|||
147432064|NCT01323621|531747644|FG001|2-week, Single-blind Run In Period|Withdrawal by Subject|0|||
147432065|NCT01323621|531747645|FG002|2-week, Single-blind Run In Period|Withdrawal by Subject|0|||
147432066|NCT01323621|531747643|FG000|2-week, Single-blind Run In Period|Protocol Violation|1|||
147432067|NCT01323621|531747644|FG001|2-week, Single-blind Run In Period|Protocol Violation|0|||
147432068|NCT01323621|531747645|FG002|2-week, Single-blind Run In Period|Protocol Violation|0|||
147432069|NCT01323621|531747643|FG000|2-week, Single-blind Run In Period|Lost to Follow-up|1|||
147432070|NCT01323621|531747644|FG001|2-week, Single-blind Run In Period|Lost to Follow-up|0|||
147432071|NCT01323621|531747645|FG002|2-week, Single-blind Run In Period|Lost to Follow-up|0|||
147432072|NCT01323621|531747643|FG000|2-week, Single-blind Run In Period|Did Not Meet Continuation Criteria|86|||
147432073|NCT01323621|531747644|FG001|2-week, Single-blind Run In Period|Did Not Meet Continuation Criteria|0|||
147432074|NCT01323621|531747645|FG002|2-week, Single-blind Run In Period|Did Not Meet Continuation Criteria|0|||
147432075|NCT01323621|531747643|FG000|12-week, Double-blind Treatment Period|Adverse Event|0|||
147432076|NCT01323621|531747644|FG001|12-week, Double-blind Treatment Period|Adverse Event|1|||
147432077|NCT01323621|531747645|FG002|12-week, Double-blind Treatment Period|Adverse Event|5|||
147432078|NCT01323621|531747643|FG000|12-week, Double-blind Treatment Period|Lack of Efficacy|0|||
147432079|NCT01323621|531747644|FG001|12-week, Double-blind Treatment Period|Lack of Efficacy|2|||
147432080|NCT01323621|531747645|FG002|12-week, Double-blind Treatment Period|Lack of Efficacy|6|||
147432081|NCT01323621|531747643|FG000|12-week, Double-blind Treatment Period|Protocol Violation|0|||
147432082|NCT01323621|531747644|FG001|12-week, Double-blind Treatment Period|Protocol Violation|4|||
147432083|NCT01323621|531747645|FG002|12-week, Double-blind Treatment Period|Protocol Violation|4|||
147432084|NCT01323621|531747643|FG000|12-week, Double-blind Treatment Period|Lost to Follow-up|0|||
147432085|NCT01323621|531747644|FG001|12-week, Double-blind Treatment Period|Lost to Follow-up|1|||
147432086|NCT01323621|531747645|FG002|12-week, Double-blind Treatment Period|Lost to Follow-up|0|||
147432087|NCT01323621|531747643|FG000|12-week, Double-blind Treatment Period|Physician Decision|0|||
147432088|NCT01323621|531747644|FG001|12-week, Double-blind Treatment Period|Physician Decision|2|||
147432089|NCT01323621|531747645|FG002|12-week, Double-blind Treatment Period|Physician Decision|1|||
147432090|NCT01323621|531747643|FG000|12-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
147432091|NCT01323621|531747644|FG001|12-week, Double-blind Treatment Period|Withdrawal by Subject|5|||
147432092|NCT01323621|531747645|FG002|12-week, Double-blind Treatment Period|Withdrawal by Subject|4|||
147432093|NCT00651157|531747646|FG000|Overall Study|Death|1|||
147432094|NCT00651157|531747646|FG000|Overall Study|Protocol Violation|1|||
147432095|NCT01163721|531747651|FG000|Overall Study|Adverse Event|5|||
147432096|NCT01163721|531747652|FG001|Overall Study|Adverse Event|6|||
147432097|NCT01163721|531747651|FG000|Overall Study|Withdrawal by Subject|3|||
147432098|NCT01163721|531747652|FG001|Overall Study|Withdrawal by Subject|4|||
147432099|NCT01163721|531747651|FG000|Overall Study|Lost to Follow-up|0|||
147432100|NCT01163721|531747652|FG001|Overall Study|Lost to Follow-up|1|||
147432101|NCT01163721|531747651|FG000|Overall Study|Physician Decision|0|||
147432102|NCT01163721|531747652|FG001|Overall Study|Physician Decision|1|||
147432103|NCT00688181|531747653|FG000|Overall Study|Lost to Follow-up|17|||
147432104|NCT00688181|531747653|FG000|Overall Study|Unknown Reason|4|||
147432105|NCT00688181|531747653|FG000|Overall Study|Non-clinical Reason|2|||
147432106|NCT01050205|531747654|FG000|Overall Study|Lost to Follow-up|7|||
147432107|NCT01050205|531747655|FG001|Overall Study|Lost to Follow-up|1|||
147432108|NCT01050205|531747654|FG000|Overall Study|Withdrawal by Subject|1|||
147432109|NCT01050205|531747655|FG001|Overall Study|Withdrawal by Subject|1|||
147432110|NCT01050205|531747654|FG000|Overall Study|Relocated from area|1|||
147432111|NCT01050205|531747655|FG001|Overall Study|Relocated from area|2|||
147432112|NCT01050205|531747654|FG000|Overall Study|Discontinued Intervention|2|||
147432113|NCT01050205|531747655|FG001|Overall Study|Discontinued Intervention|0|||
147432114|NCT01295281|531747658|FG000|First Intervention (7 Days)|Death|0|||
147432115|NCT01295281|531747659|FG001|First Intervention (7 Days)|Death|1|||
147432116|NCT00292461|531747660|FG000|Overall Study|Adverse Event|4|||
147432117|NCT00292461|531747661|FG001|Overall Study|Adverse Event|2|||
147432118|NCT00292461|531747660|FG000|Overall Study|Lack of Efficacy|1|||
147432119|NCT00292461|531747661|FG001|Overall Study|Lack of Efficacy|0|||
147432120|NCT00292461|531747660|FG000|Overall Study|Withdrawal by Subject|0|||
147432121|NCT00292461|531747661|FG001|Overall Study|Withdrawal by Subject|1|||
147432122|NCT00292461|531747660|FG000|Overall Study|Protocol Violation|4|||
147432123|NCT00292461|531747661|FG001|Overall Study|Protocol Violation|3|||
147432124|NCT00292461|531747660|FG000|Overall Study|Lost to Follow-up|1|||
147432125|NCT00292461|531747661|FG001|Overall Study|Lost to Follow-up|0|||
147432126|NCT00954421|531747662|FG000|Screening|screen failures|3|||
147432127|NCT00954421|531747662|FG000|6 Months of DBS|Withdrawal by Subject|1|||
147432128|NCT00954421|531747662|FG000|VIM=ON VO=OFF at 6 Months|Withdrawal by Subject|1|||
147432129|NCT01891721|531747663|FG000|Overall Study|Lost to Follow-up|10|||
147432130|NCT01891721|531747664|FG001|Overall Study|Lost to Follow-up|5|||
147432131|NCT01891721|531747665|FG002|Overall Study|Lost to Follow-up|1|||
147432132|NCT00633061|531747666|FG000|Overall Study|Study closed|86|||
147432133|NCT00633061|531747667|FG001|Overall Study|Study closed|0|||
147432134|NCT02708095|531747670|FG000|Overall Study|Adverse Event|4|||
147432135|NCT02708095|531747671|FG001|Overall Study|Adverse Event|10|||
147432136|NCT02708095|531747672|FG002|Overall Study|Adverse Event|11|||
147432137|NCT02708095|531747670|FG000|Overall Study|Lack of Efficacy|9|||
147432138|NCT02708095|531747671|FG001|Overall Study|Lack of Efficacy|3|||
147432139|NCT02708095|531747672|FG002|Overall Study|Lack of Efficacy|0|||
147432140|NCT02708095|531747670|FG000|Overall Study|Lost to Follow-up|2|||
147432141|NCT02708095|531747671|FG001|Overall Study|Lost to Follow-up|0|||
147432142|NCT02708095|531747672|FG002|Overall Study|Lost to Follow-up|0|||
147432143|NCT02708095|531747670|FG000|Overall Study|Physician Decision|2|||
147432144|NCT02708095|531747671|FG001|Overall Study|Physician Decision|3|||
147432145|NCT02708095|531747672|FG002|Overall Study|Physician Decision|2|||
147432146|NCT02708095|531747670|FG000|Overall Study|Protocol Violation|0|||
147432147|NCT02708095|531747671|FG001|Overall Study|Protocol Violation|0|||
147432148|NCT02708095|531747672|FG002|Overall Study|Protocol Violation|1|||
147432149|NCT02708095|531747670|FG000|Overall Study|Withdrawal by Subject|5|||
147432150|NCT02708095|531747671|FG001|Overall Study|Withdrawal by Subject|3|||
147432151|NCT02708095|531747672|FG002|Overall Study|Withdrawal by Subject|4|||
147432152|NCT00458341|531747689|FG000|Cycle 1|Adverse Event|1|||
147432153|NCT00458341|531747690|FG001|Cycle 1|Adverse Event|0|||
147432154|NCT05461794|531747691|FG000|Overall Study|Withdrawal by Subject|1|||
147432155|NCT05461794|531747692|FG001|Overall Study|Withdrawal by Subject|1|||
147432156|NCT05461794|531747693|FG002|Overall Study|Withdrawal by Subject|3|||
147432157|NCT05461794|531747691|FG000|Overall Study|Study Terminated By Sponsor|18|||
147432158|NCT05461794|531747692|FG001|Overall Study|Study Terminated By Sponsor|13|||
147432159|NCT05461794|531747693|FG002|Overall Study|Study Terminated By Sponsor|16|||
147432160|NCT05461794|531747691|FG000|Overall Study|Death|20|||
147432161|NCT05461794|531747692|FG001|Overall Study|Death|5|||
147432162|NCT05461794|531747693|FG002|Overall Study|Death|19|||
147432163|NCT02730598|531747696|FG000|Overall Study|Withdrawal by Subject|3|||
147432164|NCT02730598|531747697|FG001|Overall Study|Withdrawal by Subject|3|||
147432165|NCT02730598|531747696|FG000|Overall Study|Protocol Violation|0|||
147432166|NCT02730598|531747697|FG001|Overall Study|Protocol Violation|1|||
147432167|NCT02730598|531747696|FG000|Overall Study|Unrelated Injury affecting outcomes.|1|||
147432168|NCT02730598|531747697|FG001|Overall Study|Unrelated Injury affecting outcomes.|0|||
147432169|NCT01210118|531747701|FG000|Overall Study|Lost to Follow-up|1|||
147432170|NCT01210118|531747702|FG001|Overall Study|Lost to Follow-up|1|||
147432171|NCT01210118|531747701|FG000|Overall Study|Protocol Violation|1|||
147432172|NCT01210118|531747702|FG001|Overall Study|Protocol Violation|1|||
147432173|NCT01210118|531747701|FG000|Overall Study|Spontaneous abortion|1|||
147432174|NCT01210118|531747702|FG001|Overall Study|Spontaneous abortion|3|||
147432175|NCT02958267|531747703|FG000|Enrollment to Actual Treatment Complete|Withdrawal by Subject|1|||
147432176|NCT02958267|531747704|FG001|Enrollment to Actual Treatment Complete|Withdrawal by Subject|0|||
147432177|NCT02958267|531747703|FG000|Enrollment to Actual Treatment Complete|Physician Decision|1|||
147432178|NCT02958267|531747704|FG001|Enrollment to Actual Treatment Complete|Physician Decision|0|||
147432179|NCT02958267|531747703|FG000|Follow-up Visits|Additional treatment pursued|2|||
147432180|NCT02958267|531747704|FG001|Follow-up Visits|Additional treatment pursued|1|||
147432181|NCT00777946|531747705|FG000|Overall Study|Adverse Event|11|||
147432182|NCT00777946|531747706|FG001|Overall Study|Adverse Event|1|||
147432183|NCT00777946|531747707|FG002|Overall Study|Adverse Event|3|||
147432184|NCT00777946|531747705|FG000|Overall Study|Lack of Efficacy|0|||
147432185|NCT00777946|531747706|FG001|Overall Study|Lack of Efficacy|0|||
147432186|NCT00777946|531747707|FG002|Overall Study|Lack of Efficacy|9|||
147432187|NCT00777946|531747705|FG000|Overall Study|Condition no longer required study drug|1|||
147432188|NCT00777946|531747706|FG001|Overall Study|Condition no longer required study drug|0|||
147432189|NCT00777946|531747707|FG002|Overall Study|Condition no longer required study drug|0|||
147432190|NCT00777946|531747705|FG000|Overall Study|Patient withdrew consent|3|||
147432191|NCT00777946|531747706|FG001|Overall Study|Patient withdrew consent|2|||
147432192|NCT00777946|531747707|FG002|Overall Study|Patient withdrew consent|3|||
147432193|NCT00777946|531747705|FG000|Overall Study|Lost to Follow-up|3|||
147432194|NCT00777946|531747706|FG001|Overall Study|Lost to Follow-up|1|||
147432195|NCT00777946|531747707|FG002|Overall Study|Lost to Follow-up|0|||
147432196|NCT00777946|531747705|FG000|Overall Study|Protocol deviation|2|||
147432197|NCT00777946|531747706|FG001|Overall Study|Protocol deviation|1|||
147432198|NCT00777946|531747707|FG002|Overall Study|Protocol deviation|1|||
147432199|NCT00777946|531747705|FG000|Overall Study|Randomized in error|1|||
147432200|NCT00777946|531747706|FG001|Overall Study|Randomized in error|1|||
147432201|NCT00777946|531747707|FG002|Overall Study|Randomized in error|0|||
147432202|NCT05066724|531747709|FG000|Overall Study|Adverse Event|1|||
147432203|NCT05066724|531747709|FG000|Overall Study|Non-Compliance With Study Drug|5|||
147432204|NCT05066724|531747709|FG000|Overall Study|Withdrawal by Subject|6|||
147432205|NCT05066724|531747709|FG000|Overall Study|Physician Decision|2|||
147432206|NCT01696942|531747728|FG000|Overall Study|Withdrawal by Subject|1|||
147533107|NCT00948896|532106066|FG000|24 Months of Age to 36 Months of Age|Withdrawal by Subject|1|||
147533108|NCT00948896|532106067|FG001|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0|||
147533109|NCT00948896|532106068|FG002|24 Months of Age to 36 Months of Age|Withdrawal by Subject|1|||
147533110|NCT00948896|532106069|FG003|24 Months of Age to 36 Months of Age|Withdrawal by Subject|1|||
147533111|NCT00948896|532106070|FG004|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0|||
147533112|NCT00948896|532106071|FG005|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0|||
147533113|NCT00948896|532106072|FG006|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0|||
147533114|NCT00948896|532106073|FG007|24 Months of Age to 36 Months of Age|Withdrawal by Subject|0|||
147533115|NCT00948896|532106066|FG000|24 Months of Age to 36 Months of Age|Lost to Follow-up|2|||
147533116|NCT00948896|532106067|FG001|24 Months of Age to 36 Months of Age|Lost to Follow-up|0|||
147533117|NCT00948896|532106068|FG002|24 Months of Age to 36 Months of Age|Lost to Follow-up|1|||
147533118|NCT00948896|532106069|FG003|24 Months of Age to 36 Months of Age|Lost to Follow-up|0|||
147533119|NCT00948896|532106070|FG004|24 Months of Age to 36 Months of Age|Lost to Follow-up|1|||
147533120|NCT00948896|532106071|FG005|24 Months of Age to 36 Months of Age|Lost to Follow-up|0|||
147533121|NCT00948896|532106072|FG006|24 Months of Age to 36 Months of Age|Lost to Follow-up|0|||
147533122|NCT00948896|532106073|FG007|24 Months of Age to 36 Months of Age|Lost to Follow-up|0|||
147533123|NCT00948896|532106066|FG000|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
147432207|NCT01696942|531747729|FG001|Overall Study|Withdrawal by Subject|0|||
147432208|NCT01696942|531747728|FG000|Overall Study|Protocol Violation|1|||
147432209|NCT01696942|531747729|FG001|Overall Study|Protocol Violation|2|||
147432210|NCT01696942|531747728|FG000|Overall Study|screen failure|0|||
147432211|NCT01696942|531747729|FG001|Overall Study|screen failure|1|||
147432212|NCT01422850|531747730|FG000|Overall Study|Physician Decision|3|||
147432213|NCT04484831|531747731|FG000|Overall Study|Withdrawal by Subject|1|||
147432214|NCT04484831|531747732|FG001|Overall Study|Withdrawal by Subject|0|||
147432215|NCT02244996|531747734|FG000|Overall Study|Lack of Efficacy|2|||
147432216|NCT02244996|531747735|FG001|Overall Study|Lack of Efficacy|6|||
147432217|NCT00174265|531747736|FG000|Overall Study|Adverse Event|7|||
147432218|NCT00174265|531747737|FG001|Overall Study|Adverse Event|4|||
147432219|NCT00174265|531747736|FG000|Overall Study|Lack of Efficacy|2|||
147432220|NCT00174265|531747737|FG001|Overall Study|Lack of Efficacy|2|||
147432221|NCT00174265|531747736|FG000|Overall Study|Withdrawal by Subject|3|||
147432222|NCT00174265|531747737|FG001|Overall Study|Withdrawal by Subject|5|||
147432223|NCT00174265|531747736|FG000|Overall Study|Lost to Follow-up|1|||
147432224|NCT00174265|531747737|FG001|Overall Study|Lost to Follow-up|0|||
147432225|NCT00174265|531747736|FG000|Overall Study|Other (Not specified)|16|||
147432226|NCT00174265|531747737|FG001|Overall Study|Other (Not specified)|10|||
147432227|NCT00047320|531747739|FG000|Overall Study|Lack of Efficacy|8|||
147432228|NCT00047320|531747739|FG000|Overall Study|Lost to Follow-up|1|||
147432229|NCT00047320|531747739|FG000|Overall Study|Physician Decision|8|||
147432230|NCT00047320|531747739|FG000|Overall Study|Withdrawal by Subject|9|||
147432231|NCT00047320|531747739|FG000|Overall Study|Ineligible|2|||
147432232|NCT03471871|531747740|FG000|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|0|||
147432233|NCT03471871|531747741|FG001|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|0|||
147432234|NCT03471871|531747742|FG002|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|1|||
147432235|NCT03471871|531747743|FG003|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|0|||
147432236|NCT03471871|531747744|FG004|Treatment Period 1(HV:1 Day, OSA:8 Days)|Work Demand: Return to work|0|||
147432237|NCT03471871|531747740|FG000|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|0|||
147432238|NCT03471871|531747741|FG001|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|0|||
147432239|NCT03471871|531747742|FG002|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|0|||
147432240|NCT03471871|531747743|FG003|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|1|||
147432241|NCT03471871|531747744|FG004|Treatment Period 1(HV:1 Day, OSA:8 Days)|Protocol deviation|1|||
147432242|NCT03471871|531747740|FG000|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|0|||
147432243|NCT03471871|531747741|FG001|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|0|||
147432244|NCT03471871|531747742|FG002|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|0|||
147432245|NCT03471871|531747743|FG003|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|0|||
147432246|NCT03471871|531747744|FG004|Treatment Period 2(HV:1 Day, OSA:8 Days)|Other|1|||
147432247|NCT03471871|531747740|FG000|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|0|||
147432248|NCT03471871|531747741|FG001|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|0|||
147432249|NCT03471871|531747742|FG002|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|0|||
147432250|NCT03471871|531747743|FG003|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|0|||
147432251|NCT03471871|531747744|FG004|Follow Up (14 Days for Both HV and OSA)|Protocol Deviation|1|||
147432252|NCT03471871|531747740|FG000|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|0|||
147432253|NCT03471871|531747741|FG001|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|0|||
147432254|NCT03471871|531747742|FG002|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|0|||
147432255|NCT03471871|531747743|FG003|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|1|||
147533124|NCT00948896|532106067|FG001|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
147432256|NCT03471871|531747744|FG004|Follow Up (14 Days for Both HV and OSA)|Did Return to Clinic|0|||
147533125|NCT00948896|532106068|FG002|24 Months of Age to 36 Months of Age|Protocol Violation|1|||
147533126|NCT00948896|532106069|FG003|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
147533127|NCT00948896|532106070|FG004|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
147533128|NCT00948896|532106071|FG005|24 Months of Age to 36 Months of Age|Protocol Violation|1|||
147533129|NCT00948896|532106072|FG006|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
147533130|NCT00948896|532106073|FG007|24 Months of Age to 36 Months of Age|Protocol Violation|0|||
147533131|NCT00948896|532106066|FG000|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
147533132|NCT00948896|532106067|FG001|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
147533133|NCT00948896|532106068|FG002|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
147533134|NCT00948896|532106069|FG003|24 Months of Age to 36 Months of Age|Moved out of Study Area|1|||
147533135|NCT00948896|532106070|FG004|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
147533136|NCT00948896|532106071|FG005|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
147533137|NCT00948896|532106072|FG006|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
147533138|NCT00948896|532106073|FG007|24 Months of Age to 36 Months of Age|Moved out of Study Area|0|||
147533139|NCT01869959|532106074|FG000|Randomization Period|Physician Decision|0|||
147533140|NCT01869959|532106075|FG001|Randomization Period|Physician Decision|0|||
147533141|NCT01869959|532106076|FG002|Randomization Period|Physician Decision|0|||
147533142|NCT01869959|532106077|FG003|Randomization Period|Physician Decision|0|||
147533143|NCT01869959|532106078|FG004|Randomization Period|Physician Decision|1|||
147533144|NCT01869959|532106074|FG000|Treatment Period|Adverse Event|1|||
147533145|NCT01869959|532106075|FG001|Treatment Period|Adverse Event|0|||
147533146|NCT01869959|532106076|FG002|Treatment Period|Adverse Event|3|||
147533147|NCT01869959|532106077|FG003|Treatment Period|Adverse Event|1|||
147533148|NCT01869959|532106078|FG004|Treatment Period|Adverse Event|0|||
147533149|NCT01869959|532106074|FG000|Treatment Period|Sponsor decision|0|||
147533150|NCT01869959|532106075|FG001|Treatment Period|Sponsor decision|1|||
147533151|NCT01869959|532106076|FG002|Treatment Period|Sponsor decision|0|||
147533152|NCT01869959|532106077|FG003|Treatment Period|Sponsor decision|1|||
147533153|NCT01869959|532106078|FG004|Treatment Period|Sponsor decision|0|||
147533154|NCT01869959|532106074|FG000|Treatment Period|Withdrawal by Subject|0|||
147533155|NCT01869959|532106075|FG001|Treatment Period|Withdrawal by Subject|1|||
147533156|NCT01869959|532106076|FG002|Treatment Period|Withdrawal by Subject|0|||
147533157|NCT01869959|532106077|FG003|Treatment Period|Withdrawal by Subject|0|||
147533158|NCT01869959|532106078|FG004|Treatment Period|Withdrawal by Subject|0|||
147533159|NCT01965600|532106079|FG000|Washout Period of Approximately 15 Days|Study terminated by Sponsor|1|||
147533160|NCT01965600|532106080|FG001|Washout Period of Approximately 15 Days|Study terminated by Sponsor|3|||
147533161|NCT01965600|532106081|FG002|Washout Period of Approximately 15 Days|Study terminated by Sponsor|2|||
147533162|NCT01965600|532106082|FG003|Washout Period of Approximately 15 Days|Study terminated by Sponsor|1|||
147533163|NCT01965600|532106079|FG000|Washout Period of Approximately 15 Days|Withdrawal by Subject|0|||
147533164|NCT01965600|532106080|FG001|Washout Period of Approximately 15 Days|Withdrawal by Subject|1|||
147533165|NCT01965600|532106081|FG002|Washout Period of Approximately 15 Days|Withdrawal by Subject|0|||
147533166|NCT01965600|532106082|FG003|Washout Period of Approximately 15 Days|Withdrawal by Subject|0|||
147533167|NCT01965600|532106079|FG000|Washout Period of Approximately 15 Days|Did not meet entrance criteria|1|||
147533168|NCT01965600|532106080|FG001|Washout Period of Approximately 15 Days|Did not meet entrance criteria|0|||
147533169|NCT01965600|532106081|FG002|Washout Period of Approximately 15 Days|Did not meet entrance criteria|0|||
147533170|NCT01965600|532106082|FG003|Washout Period of Approximately 15 Days|Did not meet entrance criteria|0|||
147533171|NCT01965600|532106079|FG000|Washout Period of Approximately 15 Days|Adverse Event|0|||
147533172|NCT01965600|532106080|FG001|Washout Period of Approximately 15 Days|Adverse Event|0|||
147533173|NCT01965600|532106081|FG002|Washout Period of Approximately 15 Days|Adverse Event|0|||
147533174|NCT01965600|532106082|FG003|Washout Period of Approximately 15 Days|Adverse Event|1|||
147533175|NCT01965600|532106079|FG000|Second Intervention|Study terminated by Sponsor|0|||
147533176|NCT01965600|532106080|FG001|Second Intervention|Study terminated by Sponsor|0|||
147533177|NCT01965600|532106081|FG002|Second Intervention|Study terminated by Sponsor|2|||
147533178|NCT01965600|532106082|FG003|Second Intervention|Study terminated by Sponsor|2|||
147533179|NCT04678557|532106083|FG000|Overall Study|Withdrawal by Subject|1|||
147533180|NCT04678557|532106084|FG001|Overall Study|Withdrawal by Subject|0|||
147533181|NCT04678557|532106083|FG000|Overall Study|Lack of Efficacy|0|||
147533182|NCT04678557|532106084|FG001|Overall Study|Lack of Efficacy|13|||
147533183|NCT04678557|532106083|FG000|Overall Study|Safety Evaluation|0|||
147533184|NCT04678557|532106084|FG001|Overall Study|Safety Evaluation|1|||
147533185|NCT00157157|532106085|FG000|Overall Study|Withdrawal by Subject|6|||
147533186|NCT00157157|532106085|FG000|Overall Study|Physician Decision|1|||
147533187|NCT00157157|532106085|FG000|Overall Study|Lost to Follow-up|1|||
147533188|NCT00157157|532106085|FG000|Overall Study|Enrolled in another study|1|||
147533189|NCT00157157|532106085|FG000|Overall Study|Met exclusion criteria|1|||
147533190|NCT00157157|532106085|FG000|Overall Study|Inclusion not met- baseline FVIII value|1|||
147533191|NCT02260804|532106089|FG000|Induction Study Period|Protocol Violation|2|||
147306730|NCT03812536|531290738|FG001|Overall Study|Withdrawal by Subject|1|||
147306731|NCT01735396|531290741|FG000|Overall Study|not evaluable|1|||
147432257|NCT03040622|531747746|FG000|Overall Study|unable to implant device|3|||
147432258|NCT03078907|531748972|FG000|Overall Study|Adverse Event|2|||
147533192|NCT02260804|532106090|FG001|Induction Study Period|Protocol Violation|0|||
147432259|NCT03078907|531748973|FG001|Overall Study|Adverse Event|0|||
147432260|NCT03078907|531748972|FG000|Overall Study|Other|1|||
147432261|NCT03078907|531748973|FG001|Overall Study|Other|0|||
147432262|NCT03078907|531748972|FG000|Overall Study|Protocol Violation|0|||
147432263|NCT03078907|531748973|FG001|Overall Study|Protocol Violation|1|||
147432264|NCT01955122|531748974|FG000|Overall Study|Physician Decision|5|||
147432265|NCT01955122|531748975|FG001|Overall Study|Physician Decision|5|||
147432266|NCT00985166|531748976|FG000|Overall Study|Lost to Follow-up|3|||
147432267|NCT00985166|531748977|FG001|Overall Study|Lost to Follow-up|2|||
147432268|NCT00985166|531748978|FG002|Overall Study|Lost to Follow-up|2|||
147432269|NCT00985166|531748976|FG000|Overall Study|Withdrawal by Subject|3|||
147432270|NCT00985166|531748977|FG001|Overall Study|Withdrawal by Subject|2|||
147432271|NCT00985166|531748978|FG002|Overall Study|Withdrawal by Subject|0|||
147432272|NCT00985166|531748976|FG000|Overall Study|Test not done|2|||
147533193|NCT02260804|532106089|FG000|1st Year of the Maintenance Period (MP1)|Lack of Efficacy|6|||
147533194|NCT02260804|532106090|FG001|1st Year of the Maintenance Period (MP1)|Lack of Efficacy|9|||
147533195|NCT02260804|532106089|FG000|1st Year of the Maintenance Period (MP1)|Adverse Event|3|||
147432273|NCT00985166|531748977|FG001|Overall Study|Test not done|0|||
147432274|NCT00985166|531748978|FG002|Overall Study|Test not done|4|||
147432275|NCT00985166|531748976|FG000|Overall Study|Other|1|||
147533196|NCT02260804|532106090|FG001|1st Year of the Maintenance Period (MP1)|Adverse Event|1|||
147533197|NCT02260804|532106089|FG000|1st Year of the Maintenance Period (MP1)|Physician Decision|1|||
147533198|NCT02260804|532106090|FG001|1st Year of the Maintenance Period (MP1)|Physician Decision|3|||
147533199|NCT02260804|532106089|FG000|1st Year of the Maintenance Period (MP1)|Protocol Violation|1|||
147533200|NCT02260804|532106090|FG001|1st Year of the Maintenance Period (MP1)|Protocol Violation|0|||
147533201|NCT02260804|532106089|FG000|1st Year of the Maintenance Period (MP1)|Withdrawal by Subject|1|||
147533202|NCT02260804|532106090|FG001|1st Year of the Maintenance Period (MP1)|Withdrawal by Subject|0|||
147533203|NCT02260804|532106089|FG000|1st Year of the Maintenance Period (MP1)|Death|0|||
147533204|NCT02260804|532106090|FG001|1st Year of the Maintenance Period (MP1)|Death|1|||
147533205|NCT02260804|532106089|FG000|1st Year of the Maintenance Period (MP1)|Lost to Follow-up|0|||
147533206|NCT02260804|532106090|FG001|1st Year of the Maintenance Period (MP1)|Lost to Follow-up|1|||
147533207|NCT02260804|532106089|FG000|2nd Year of the Maintenance Period (MP2)|Lack of Efficacy|6|||
147533208|NCT02260804|532106090|FG001|2nd Year of the Maintenance Period (MP2)|Lack of Efficacy|5|||
147533209|NCT02260804|532106089|FG000|2nd Year of the Maintenance Period (MP2)|Adverse Event|3|||
147533210|NCT02260804|532106090|FG001|2nd Year of the Maintenance Period (MP2)|Adverse Event|0|||
147533211|NCT02260804|532106089|FG000|2nd Year of the Maintenance Period (MP2)|Withdrawal by Subject|0|||
147533212|NCT02260804|532106090|FG001|2nd Year of the Maintenance Period (MP2)|Withdrawal by Subject|1|||
147533213|NCT02983305|532107732|FG000|Overall Study|incomplete data|2|||
147533214|NCT02983305|532107733|FG001|Overall Study|incomplete data|0|||
147533215|NCT00822237|532107734|FG000|Dose 1 Vaccination|Not vaccinated|3|||
147533216|NCT00822237|532107735|FG001|Dose 1 Vaccination|Not vaccinated|0|||
147533217|NCT00822237|532107734|FG000|Dose 1 Vaccination|Withdrawal by Subject|13|||
147533218|NCT00822237|532107735|FG001|Dose 1 Vaccination|Withdrawal by Subject|14|||
147533219|NCT00822237|532107734|FG000|Dose 1 Vaccination|Lost to Follow-up|9|||
147533220|NCT00822237|532107735|FG001|Dose 1 Vaccination|Lost to Follow-up|12|||
147533221|NCT00822237|532107734|FG000|Dose 2 Vaccination|Withdrawal by Subject|2|||
147533222|NCT00822237|532107735|FG001|Dose 2 Vaccination|Withdrawal by Subject|2|||
147533223|NCT00822237|532107734|FG000|Dose 2 Vaccination|Lost to Follow-up|2|||
147533224|NCT00822237|532107735|FG001|Dose 2 Vaccination|Lost to Follow-up|9|||
147533225|NCT01519635|532107736|FG000|Overall Study|Withdrawal by Subject|0|||
147533226|NCT01519635|532107737|FG001|Overall Study|Withdrawal by Subject|1|||
147533227|NCT01519635|532107736|FG000|Overall Study|No possibility to put a catheter|1|||
147533228|NCT01519635|532107737|FG001|Overall Study|No possibility to put a catheter|2|||
147533229|NCT00518531|532107740|FG000|Treatment Period 1|Adverse Event|5|||
147533230|NCT00518531|532107741|FG001|Treatment Period 1|Adverse Event|0|||
147533231|NCT00518531|532107740|FG000|Treatment Period 1|Lost to Follow-up|5|||
147533232|NCT00518531|532107741|FG001|Treatment Period 1|Lost to Follow-up|3|||
147533233|NCT00518531|532107740|FG000|Treatment Period 1|Physician Decision|1|||
147533234|NCT00518531|532107741|FG001|Treatment Period 1|Physician Decision|0|||
147533235|NCT00518531|532107740|FG000|Treatment Period 1|Protocol Violation|2|||
147533236|NCT00518531|532107741|FG001|Treatment Period 1|Protocol Violation|0|||
147533237|NCT00518531|532107740|FG000|Treatment Period 1|Withdrawal by Subject|4|||
147533238|NCT00518531|532107741|FG001|Treatment Period 1|Withdrawal by Subject|6|||
147533239|NCT00518531|532107740|FG000|Treatment Period 1|Early crossover|1|||
147533240|NCT00518531|532107741|FG001|Treatment Period 1|Early crossover|3|||
147533241|NCT00518531|532107740|FG000|Treatment Period 2|Withdrawal by Subject|0|||
147533242|NCT00518531|532107741|FG001|Treatment Period 2|Withdrawal by Subject|8|||
147533243|NCT00518531|532107740|FG000|Treatment Period 2|Complete out of scheduled visit window|1|||
147533244|NCT00518531|532107741|FG001|Treatment Period 2|Complete out of scheduled visit window|2|||
147533245|NCT00518531|532107740|FG000|Treatment Period 2|Adverse Event|1|||
147533246|NCT00518531|532107741|FG001|Treatment Period 2|Adverse Event|7|||
147432276|NCT00985166|531748977|FG001|Overall Study|Other|0|||
147432277|NCT00985166|531748978|FG002|Overall Study|Other|1|||
147432278|NCT02464228|531748979|FG000|Overall Study|Termination for Symptomatic Deterioration|1|||
147432279|NCT02464228|531748980|FG001|Overall Study|Termination for Symptomatic Deterioration|1|||
147432280|NCT02464228|531748981|FG002|Overall Study|Termination for Symptomatic Deterioration|0|||
147432281|NCT02464228|531748982|FG003|Overall Study|Termination for Symptomatic Deterioration|0|||
147432282|NCT02464228|531748979|FG000|Overall Study|Physician Decision|2|||
147432283|NCT02464228|531748980|FG001|Overall Study|Physician Decision|0|||
147432284|NCT02464228|531748981|FG002|Overall Study|Physician Decision|1|||
147432285|NCT02464228|531748982|FG003|Overall Study|Physician Decision|0|||
147432286|NCT02464228|531748979|FG000|Overall Study|Miscellaneous|1|||
147432287|NCT02464228|531748980|FG001|Overall Study|Miscellaneous|0|||
147432288|NCT02464228|531748981|FG002|Overall Study|Miscellaneous|1|||
147432289|NCT02464228|531748982|FG003|Overall Study|Miscellaneous|0|||
147432290|NCT02464228|531748979|FG000|Overall Study|Adverse Event|9|||
147432291|NCT02464228|531748980|FG001|Overall Study|Adverse Event|0|||
147432292|NCT02464228|531748981|FG002|Overall Study|Adverse Event|3|||
147432293|NCT02464228|531748982|FG003|Overall Study|Adverse Event|0|||
147432294|NCT02464228|531748979|FG000|Overall Study|Withdrawal by Subject|1|||
147432295|NCT02464228|531748980|FG001|Overall Study|Withdrawal by Subject|1|||
147432296|NCT02464228|531748981|FG002|Overall Study|Withdrawal by Subject|1|||
147432297|NCT02464228|531748982|FG003|Overall Study|Withdrawal by Subject|0|||
147432298|NCT02464228|531748979|FG000|Overall Study|Disease Progression|22|||
147432299|NCT02464228|531748980|FG001|Overall Study|Disease Progression|12|||
147432300|NCT02464228|531748981|FG002|Overall Study|Disease Progression|5|||
147432301|NCT02464228|531748982|FG003|Overall Study|Disease Progression|2|||
147432302|NCT01117454|531748985|FG000|Overall Study|Pregnancy|0|||
147432303|NCT01117454|531748986|FG001|Overall Study|Pregnancy|1|||
147432304|NCT01681628|531748991|FG000|Time 1 (Entry) to Time 2 One Week Later.|Lost to Follow-up|14|||
147432305|NCT01681628|531748992|FG001|Time 1 (Entry) to Time 2 One Week Later.|Lost to Follow-up|6|||
147432306|NCT01681628|531748991|FG000|Time 2 to Time 3 (One Week Later).|Lost to Follow-up|0|||
147432307|NCT01681628|531748992|FG001|Time 2 to Time 3 (One Week Later).|Lost to Follow-up|15|||
147432308|NCT01681628|531748991|FG000|19 Months Follow-up|Death|1|||
147432309|NCT01681628|531748992|FG001|19 Months Follow-up|Death|0|||
147432310|NCT01681628|531748991|FG000|19 Months Follow-up|Lost to Follow-up|61|||
147432311|NCT01681628|531748992|FG001|19 Months Follow-up|Lost to Follow-up|43|||
147432312|NCT03422172|531749005|FG000|Oral lead-in Phase (4 Weeks)|Adverse Event|1|||
147432313|NCT03422172|531749005|FG000|Injection Phase (Week 5 to Week 41)|Lost to Follow-up|1|||
147432314|NCT03422172|531749005|FG000|Injection Phase (Week 5 to Week 41)|Withdrawal by Subject|3|||
147432315|NCT05736211|531749007|FG000|Overall Study|Lost to Follow-up|6|||
147432316|NCT05736211|531749008|FG001|Overall Study|Lost to Follow-up|0|||
147432317|NCT00992511|531749010|FG000|Overall Study|Migrated/moved from study area|1|||
147432318|NCT00992511|531749011|FG001|Overall Study|Migrated/moved from study area|0|||
147432319|NCT00992511|531749012|FG002|Overall Study|Migrated/moved from study area|1|||
147432320|NCT00992511|531749013|FG003|Overall Study|Migrated/moved from study area|2|||
147432321|NCT00992511|531749010|FG000|Overall Study|Lost to Follow-up|1|||
147432322|NCT00992511|531749011|FG001|Overall Study|Lost to Follow-up|0|||
147432323|NCT00992511|531749012|FG002|Overall Study|Lost to Follow-up|0|||
147432324|NCT00992511|531749013|FG003|Overall Study|Lost to Follow-up|2|||
147432325|NCT00992511|531749010|FG000|Overall Study|Withdrawal by Subject|0|||
147432326|NCT00992511|531749011|FG001|Overall Study|Withdrawal by Subject|0|||
147432327|NCT00992511|531749012|FG002|Overall Study|Withdrawal by Subject|1|||
147432328|NCT00992511|531749013|FG003|Overall Study|Withdrawal by Subject|1|||
147432329|NCT04615247|531749014|FG000|Overall Study|Adverse Event|0|||
147432330|NCT04615247|531749015|FG001|Overall Study|Adverse Event|2|||
147432331|NCT04615247|531749014|FG000|Overall Study|Withdrawal by Subject|1|||
147432332|NCT04615247|531749015|FG001|Overall Study|Withdrawal by Subject|1|||
147432333|NCT04658186|531749020|FG000|Overall Study|Adverse Event|4|||
147432334|NCT04658186|531749021|FG001|Overall Study|Adverse Event|18|||
147432335|NCT04658186|531749022|FG002|Overall Study|Adverse Event|15|||
147432336|NCT04658186|531749020|FG000|Overall Study|Lack of Efficacy|1|||
147432337|NCT04658186|531749021|FG001|Overall Study|Lack of Efficacy|1|||
147432338|NCT04658186|531749022|FG002|Overall Study|Lack of Efficacy|0|||
147432339|NCT04658186|531749020|FG000|Overall Study|Protocol Violation|0|||
147432340|NCT04658186|531749021|FG001|Overall Study|Protocol Violation|0|||
147432341|NCT04658186|531749022|FG002|Overall Study|Protocol Violation|1|||
147432342|NCT04658186|531749020|FG000|Overall Study|Lost to Follow-up|0|||
147432343|NCT04658186|531749021|FG001|Overall Study|Lost to Follow-up|0|||
147432344|NCT04658186|531749022|FG002|Overall Study|Lost to Follow-up|2|||
147432345|NCT04658186|531749020|FG000|Overall Study|Participant Not Eligible. Randomized In Error|1|||
147432346|NCT04658186|531749021|FG001|Overall Study|Participant Not Eligible. Randomized In Error|0|||
147432347|NCT04658186|531749022|FG002|Overall Study|Participant Not Eligible. Randomized In Error|1|||
147432348|NCT04658186|531749020|FG000|Overall Study|Participant is Moving in Another Province|0|||
147432349|NCT04658186|531749021|FG001|Overall Study|Participant is Moving in Another Province|1|||
147432350|NCT04658186|531749022|FG002|Overall Study|Participant is Moving in Another Province|0|||
147432351|NCT04658186|531749020|FG000|Overall Study|Non-Compliance|0|||
147432352|NCT04658186|531749021|FG001|Overall Study|Non-Compliance|1|||
147432353|NCT04658186|531749022|FG002|Overall Study|Non-Compliance|1|||
147432354|NCT04658186|531749020|FG000|Overall Study|Site Closure; Participant declined transfer|0|||
147432355|NCT04658186|531749021|FG001|Overall Study|Site Closure; Participant declined transfer|1|||
147432356|NCT04658186|531749022|FG002|Overall Study|Site Closure; Participant declined transfer|0|||
147432357|NCT04658186|531749020|FG000|Overall Study|Dropout on the Promotor's Decision|0|||
147432358|NCT04658186|531749021|FG001|Overall Study|Dropout on the Promotor's Decision|0|||
147432359|NCT04658186|531749022|FG002|Overall Study|Dropout on the Promotor's Decision|1|||
147432360|NCT04658186|531749020|FG000|Overall Study|Worsening Symptoms; Participant Withdrew|0|||
147432361|NCT04658186|531749021|FG001|Overall Study|Worsening Symptoms; Participant Withdrew|0|||
147432362|NCT04658186|531749022|FG002|Overall Study|Worsening Symptoms; Participant Withdrew|1|||
147432363|NCT04658186|531749020|FG000|Overall Study|PI Decision due to Participant Safety|0|||
147432364|NCT04658186|531749021|FG001|Overall Study|PI Decision due to Participant Safety|0|||
147432365|NCT04658186|531749022|FG002|Overall Study|PI Decision due to Participant Safety|1|||
147432366|NCT04658186|531749020|FG000|Overall Study|Consent Withdrawn by Participant (not due to adverse event)|5|||
147432367|NCT04658186|531749021|FG001|Overall Study|Consent Withdrawn by Participant (not due to adverse event)|6|||
147432368|NCT04658186|531749022|FG002|Overall Study|Consent Withdrawn by Participant (not due to adverse event)|3|||
147432369|NCT00954174|531749026|FG000|Overall Study|Adverse Event|28|||
147432370|NCT00954174|531749027|FG001|Overall Study|Adverse Event|23|||
147432371|NCT00954174|531749028|FG002|Overall Study|Adverse Event|4|||
147432372|NCT00954174|531749029|FG003|Overall Study|Adverse Event|9|||
147432373|NCT00954174|531749026|FG000|Overall Study|Death|4|||
147432374|NCT00954174|531749027|FG001|Overall Study|Death|2|||
147432375|NCT00954174|531749028|FG002|Overall Study|Death|0|||
147432376|NCT00954174|531749029|FG003|Overall Study|Death|0|||
147432377|NCT00954174|531749026|FG000|Overall Study|Lack of Efficacy|32|||
147432378|NCT00954174|531749027|FG001|Overall Study|Lack of Efficacy|22|||
147432379|NCT00954174|531749028|FG002|Overall Study|Lack of Efficacy|8|||
147432380|NCT00954174|531749029|FG003|Overall Study|Lack of Efficacy|6|||
147432381|NCT00954174|531749026|FG000|Overall Study|Withdrawal by Subject|14|||
147432382|NCT00954174|531749027|FG001|Overall Study|Withdrawal by Subject|10|||
147432383|NCT00954174|531749028|FG002|Overall Study|Withdrawal by Subject|4|||
147432384|NCT00954174|531749029|FG003|Overall Study|Withdrawal by Subject|3|||
147432385|NCT00954174|531749026|FG000|Overall Study|Medical Reason|4|||
147533247|NCT00518531|532107740|FG000|Treatment Period 2|Protocol-specified criteria|0|||
147533248|NCT00518531|532107741|FG001|Treatment Period 2|Protocol-specified criteria|1|||
147533249|NCT00518531|532107740|FG000|Treatment Period 2|Non-compliance|1|||
147533250|NCT00518531|532107741|FG001|Treatment Period 2|Non-compliance|2|||
147533251|NCT04621227|532107744|FG000|Period 3 (29 Days)|Physician decision due to inappropriate behavior and noncompliance|1|||
147533252|NCT04621227|532107744|FG000|Period 3 (29 Days)|Adverse Event|1|||
147533253|NCT04621227|532107744|FG000|Period 8 (2 Days)|Adverse Event|1|||
147533254|NCT01728376|532107745|FG000|Overall Study|Adverse Event|1|||
147533255|NCT01728376|532107746|FG001|Overall Study|Adverse Event|1|||
147533256|NCT01728376|532107747|FG002|Overall Study|Adverse Event|1|||
147533257|NCT01728376|532107748|FG003|Overall Study|Adverse Event|1|||
147533258|NCT01728376|532107749|FG004|Overall Study|Adverse Event|1|||
147533259|NCT01728376|532107750|FG005|Overall Study|Adverse Event|0|||
147533260|NCT01728376|532107745|FG000|Overall Study|Persistent Positive Blood Cultures|1|||
147533261|NCT01728376|532107746|FG001|Overall Study|Persistent Positive Blood Cultures|0|||
147533262|NCT01728376|532107747|FG002|Overall Study|Persistent Positive Blood Cultures|1|||
147533263|NCT01728376|532107748|FG003|Overall Study|Persistent Positive Blood Cultures|0|||
147533264|NCT01728376|532107749|FG004|Overall Study|Persistent Positive Blood Cultures|0|||
147533265|NCT01728376|532107750|FG005|Overall Study|Persistent Positive Blood Cultures|0|||
147533266|NCT01728376|532107745|FG000|Overall Study|No relevant bacteria|2|||
147533267|NCT01728376|532107746|FG001|Overall Study|No relevant bacteria|0|||
147533268|NCT01728376|532107747|FG002|Overall Study|No relevant bacteria|0|||
147533269|NCT01728376|532107748|FG003|Overall Study|No relevant bacteria|0|||
147533270|NCT01728376|532107749|FG004|Overall Study|No relevant bacteria|1|||
147533271|NCT01728376|532107750|FG005|Overall Study|No relevant bacteria|1|||
147533272|NCT01728376|532107745|FG000|Overall Study|Did not receive treatment|0|||
147533273|NCT01728376|532107746|FG001|Overall Study|Did not receive treatment|1|||
147533274|NCT01728376|532107747|FG002|Overall Study|Did not receive treatment|0|||
147533275|NCT01728376|532107748|FG003|Overall Study|Did not receive treatment|0|||
147533276|NCT01728376|532107749|FG004|Overall Study|Did not receive treatment|0|||
147533277|NCT01728376|532107750|FG005|Overall Study|Did not receive treatment|0|||
147533278|NCT01728376|532107745|FG000|Overall Study|Subject/Parent/Legal Guardian Decision|0|||
147533279|NCT01728376|532107746|FG001|Overall Study|Subject/Parent/Legal Guardian Decision|0|||
147533280|NCT01728376|532107747|FG002|Overall Study|Subject/Parent/Legal Guardian Decision|0|||
147533281|NCT01728376|532107748|FG003|Overall Study|Subject/Parent/Legal Guardian Decision|1|||
147533282|NCT01728376|532107749|FG004|Overall Study|Subject/Parent/Legal Guardian Decision|0|||
147533283|NCT01728376|532107750|FG005|Overall Study|Subject/Parent/Legal Guardian Decision|1|||
147533284|NCT00057330|532107756|FG000|Overall Study|Adverse Event|9|||
147533285|NCT00057330|532107757|FG001|Overall Study|Adverse Event|12|||
147533286|NCT00057330|532107756|FG000|Overall Study|Death|1|||
147533287|NCT00057330|532107757|FG001|Overall Study|Death|0|||
147533288|NCT00057330|532107756|FG000|Overall Study|Protocol Violation|1|||
147432386|NCT00954174|531749027|FG001|Overall Study|Medical Reason|2|||
147432387|NCT00954174|531749028|FG002|Overall Study|Medical Reason|1|||
147432388|NCT00954174|531749029|FG003|Overall Study|Medical Reason|0|||
147432389|NCT00954174|531749026|FG000|Overall Study|Ineligible|40|||
147432390|NCT00954174|531749027|FG001|Overall Study|Ineligible|47|||
147432391|NCT00954174|531749028|FG002|Overall Study|Ineligible|7|||
147432392|NCT00954174|531749029|FG003|Overall Study|Ineligible|4|||
147432393|NCT00954174|531749026|FG000|Overall Study|Never Treated|4|||
147432394|NCT00954174|531749027|FG001|Overall Study|Never Treated|17|||
147432395|NCT00954174|531749028|FG002|Overall Study|Never Treated|0|||
147432396|NCT00954174|531749029|FG003|Overall Study|Never Treated|3|||
147533289|NCT00057330|532107757|FG001|Overall Study|Protocol Violation|1|||
147533290|NCT00057330|532107756|FG000|Overall Study|Withdrawal by Subject|115|||
147533291|NCT00057330|532107757|FG001|Overall Study|Withdrawal by Subject|84|||
147533292|NCT00057330|532107756|FG000|Overall Study|Lost to Follow-up|745|||
147533293|NCT00057330|532107757|FG001|Overall Study|Lost to Follow-up|617|||
147533294|NCT00057330|532107756|FG000|Overall Study|Physician Decision|1|||
147533295|NCT00057330|532107757|FG001|Overall Study|Physician Decision|0|||
147533296|NCT00057330|532107756|FG000|Overall Study|Other|260|||
147533297|NCT00057330|532107757|FG001|Overall Study|Other|206|||
147533298|NCT04888377|532107760|FG000|Overall Study|Incomplete Follow-up or No Study Data|1|||
147533299|NCT04888377|532107761|FG001|Overall Study|Incomplete Follow-up or No Study Data|3|||
147533300|NCT04888377|532107760|FG000|Overall Study|Physician Decision|6|||
147533301|NCT04888377|532107761|FG001|Overall Study|Physician Decision|6|||
147533302|NCT04888377|532107760|FG000|Overall Study|Withdrawal by Subject|7|||
147533303|NCT04888377|532107761|FG001|Overall Study|Withdrawal by Subject|3|||
147533304|NCT00812968|532107762|FG000|Overall Study|Relapse after erythroid response|6|||
147432397|NCT02234323|531749030|FG000|All Enrolled|Not Treated: Completed study in database|2|||
147533305|NCT00812968|532107762|FG000|Overall Study|Disease progression|1|||
147533306|NCT00812968|532107762|FG000|Overall Study|No further treatment required|1|||
147533307|NCT00812968|532107762|FG000|Overall Study|Study closed due to marketing approval|3|||
147533308|NCT00494234|532107763|FG000|Overall Study|Withdrawal by Subject|1|||
147533309|NCT00494234|532107764|FG001|Overall Study|Withdrawal by Subject|0|||
147533310|NCT00494234|532107763|FG000|Overall Study|Disease progression|11|||
147533311|NCT00494234|532107764|FG001|Overall Study|Disease progression|8|||
147533312|NCT00494234|532107763|FG000|Overall Study|Death|2|||
147533313|NCT00494234|532107764|FG001|Overall Study|Death|1|||
147533314|NCT04753606|532107774|FG000|Overall Study|Adverse Event|1|||
147533315|NCT04753606|532107775|FG001|Overall Study|Adverse Event|0|||
147533316|NCT04753606|532107776|FG002|Overall Study|Adverse Event|0|||
147533317|NCT01012609|532107779|FG000|Overall Study|Withdrawal by Subject|1|||
147533318|NCT01012609|532107780|FG001|Overall Study|Withdrawal by Subject|1|||
147533319|NCT00761969|532107781|FG000|Overall Study|Death|112|||
147533320|NCT00761969|532107782|FG001|Overall Study|Death|47|||
147533321|NCT00761969|532107781|FG000|Overall Study|Lost to Follow-up|88|||
147533322|NCT00761969|532107782|FG001|Overall Study|Lost to Follow-up|93|||
147533323|NCT01725217|532107783|FG000|Overall Study|Withdrawal by Subject|1|||
147533324|NCT01725217|532107784|FG001|Overall Study|Withdrawal by Subject|0|||
147533325|NCT01725217|532107785|FG002|Overall Study|Withdrawal by Subject|0|||
147533326|NCT03253809|532107786|FG000|Overall Study|Unable to obtain study related data|14|||
147533327|NCT03992456|532107789|FG000|Overall Study|Withdrawal by Subject|1|||
147533328|NCT03992456|532107790|FG001|Overall Study|Withdrawal by Subject|0|||
147533329|NCT03992456|532107789|FG000|Overall Study|Disease progression|4|||
147533330|NCT03992456|532107790|FG001|Overall Study|Disease progression|5|||
147533331|NCT03992456|532107789|FG000|Overall Study|Emergency surgery unrelated to treatment|0|||
147533332|NCT03992456|532107790|FG001|Overall Study|Emergency surgery unrelated to treatment|1|||
147533333|NCT01068418|532107791|FG000|Overall Study|Physician Decision|12|||
147533334|NCT00910000|532107792|FG000|Overall Study|Adverse Event|0|||
147533335|NCT00910000|532107793|FG001|Overall Study|Adverse Event|3|||
147533336|NCT00910000|532107794|FG002|Overall Study|Adverse Event|2|||
147533337|NCT00910000|532107795|FG003|Overall Study|Adverse Event|2|||
147533338|NCT00910000|532107796|FG004|Overall Study|Adverse Event|0|||
147533339|NCT00910000|532107797|FG005|Overall Study|Adverse Event|1|||
147533340|NCT00910000|532107792|FG000|Overall Study|Withdrawal by Subject|0|||
147533341|NCT00910000|532107793|FG001|Overall Study|Withdrawal by Subject|0|||
147533342|NCT00910000|532107794|FG002|Overall Study|Withdrawal by Subject|1|||
147533343|NCT00910000|532107795|FG003|Overall Study|Withdrawal by Subject|0|||
147533344|NCT00910000|532107796|FG004|Overall Study|Withdrawal by Subject|1|||
147533345|NCT00910000|532107797|FG005|Overall Study|Withdrawal by Subject|0|||
147533346|NCT04637815|532107798|FG000|Overall Study|Death|1|||
147533347|NCT04637815|532107799|FG001|Overall Study|Death|0|||
147533348|NCT04637815|532107798|FG000|Overall Study|Lost to Follow-up|5|||
147533349|NCT04637815|532107799|FG001|Overall Study|Lost to Follow-up|2|||
147533350|NCT01977625|532107800|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|3|||
147533351|NCT01977625|532107801|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|0|||
147533352|NCT01977625|532107800|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
147533353|NCT01977625|532107801|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
147533354|NCT02594384|532107802|FG000|Overall Study|Disease Progression|3|||
147533355|NCT02594384|532107803|FG001|Overall Study|Disease Progression|7|||
147533356|NCT02594384|532107804|FG002|Overall Study|Disease Progression|0|||
147533357|NCT02594384|532107805|FG003|Overall Study|Disease Progression|2|||
147533358|NCT02594384|532107806|FG004|Overall Study|Disease Progression|2|||
147533359|NCT02594384|532107807|FG005|Overall Study|Disease Progression|12|||
147533360|NCT02594384|532107808|FG006|Overall Study|Disease Progression|5|||
147533361|NCT02594384|532107809|FG007|Overall Study|Disease Progression|5|||
147533362|NCT02594384|532107802|FG000|Overall Study|Adverse Event|0|||
147533363|NCT02594384|532107803|FG001|Overall Study|Adverse Event|1|||
147533364|NCT02594384|532107804|FG002|Overall Study|Adverse Event|4|||
147533365|NCT02594384|532107805|FG003|Overall Study|Adverse Event|1|||
147533366|NCT02594384|532107806|FG004|Overall Study|Adverse Event|0|||
147533367|NCT02594384|532107807|FG005|Overall Study|Adverse Event|6|||
147533368|NCT02594384|532107808|FG006|Overall Study|Adverse Event|1|||
147533369|NCT02594384|532107809|FG007|Overall Study|Adverse Event|1|||
147533370|NCT02594384|532107802|FG000|Overall Study|Withdrawal by Subject|0|||
147533371|NCT02594384|532107803|FG001|Overall Study|Withdrawal by Subject|0|||
147533372|NCT02594384|532107804|FG002|Overall Study|Withdrawal by Subject|0|||
147533373|NCT02594384|532107805|FG003|Overall Study|Withdrawal by Subject|1|||
147533374|NCT02594384|532107806|FG004|Overall Study|Withdrawal by Subject|0|||
147533375|NCT02594384|532107807|FG005|Overall Study|Withdrawal by Subject|0|||
147533376|NCT02594384|532107808|FG006|Overall Study|Withdrawal by Subject|0|||
147533377|NCT02594384|532107809|FG007|Overall Study|Withdrawal by Subject|1|||
147533378|NCT02594384|532107802|FG000|Overall Study|Physician Decision|0|||
147533379|NCT02594384|532107803|FG001|Overall Study|Physician Decision|0|||
147533380|NCT02594384|532107804|FG002|Overall Study|Physician Decision|0|||
147533381|NCT02594384|532107805|FG003|Overall Study|Physician Decision|0|||
147533382|NCT02594384|532107806|FG004|Overall Study|Physician Decision|0|||
147533383|NCT02594384|532107807|FG005|Overall Study|Physician Decision|1|||
147533384|NCT02594384|532107808|FG006|Overall Study|Physician Decision|2|||
147533385|NCT02594384|532107809|FG007|Overall Study|Physician Decision|0|||
147533386|NCT02594384|532107802|FG000|Overall Study|Progressive Leukocytosis|0|||
147533387|NCT02594384|532107803|FG001|Overall Study|Progressive Leukocytosis|0|||
147533388|NCT02594384|532107804|FG002|Overall Study|Progressive Leukocytosis|1|||
147533389|NCT02594384|532107805|FG003|Overall Study|Progressive Leukocytosis|0|||
147533390|NCT02594384|532107806|FG004|Overall Study|Progressive Leukocytosis|0|||
147533391|NCT02594384|532107807|FG005|Overall Study|Progressive Leukocytosis|0|||
147533392|NCT02594384|532107808|FG006|Overall Study|Progressive Leukocytosis|0|||
147533393|NCT02594384|532107809|FG007|Overall Study|Progressive Leukocytosis|0|||
147533394|NCT02594384|532107802|FG000|Overall Study|Lack of Efficacy|0|||
147533395|NCT02594384|532107803|FG001|Overall Study|Lack of Efficacy|0|||
147533396|NCT02594384|532107804|FG002|Overall Study|Lack of Efficacy|0|||
147533397|NCT02594384|532107805|FG003|Overall Study|Lack of Efficacy|0|||
147533398|NCT02594384|532107806|FG004|Overall Study|Lack of Efficacy|1|||
147533399|NCT02594384|532107807|FG005|Overall Study|Lack of Efficacy|0|||
147533400|NCT02594384|532107808|FG006|Overall Study|Lack of Efficacy|0|||
147533401|NCT02594384|532107809|FG007|Overall Study|Lack of Efficacy|0|||
147533402|NCT02594384|532107802|FG000|Overall Study|Substantial noncompliance|0|||
147533403|NCT02594384|532107803|FG001|Overall Study|Substantial noncompliance|0|||
147533404|NCT02594384|532107804|FG002|Overall Study|Substantial noncompliance|0|||
147533405|NCT02594384|532107805|FG003|Overall Study|Substantial noncompliance|0|||
147533406|NCT02594384|532107806|FG004|Overall Study|Substantial noncompliance|0|||
147533407|NCT02594384|532107807|FG005|Overall Study|Substantial noncompliance|0|||
147533408|NCT02594384|532107808|FG006|Overall Study|Substantial noncompliance|1|||
147533409|NCT02594384|532107809|FG007|Overall Study|Substantial noncompliance|0|||
147533410|NCT03919669|532107813|FG000|Overall Study|Withdrawal by Subject|1|||
147533411|NCT03919669|532107814|FG001|Overall Study|Withdrawal by Subject|0|||
147533412|NCT03919669|532107815|FG002|Overall Study|Withdrawal by Subject|0|||
147533413|NCT01265875|532107816|FG000|Overall Study|Uncooperative/unreliable|1|||
147533414|NCT00483119|532107817|FG000|Overall Study|Adverse Event|0|||
147533415|NCT00483119|532107818|FG001|Overall Study|Adverse Event|1|||
147533416|NCT00483119|532107817|FG000|Overall Study|Physician Decision|1|||
147533417|NCT00483119|532107818|FG001|Overall Study|Physician Decision|0|||
147533418|NCT04409509|532107819|FG000|Overall Study|Failure to meet randomization requirement|1|||
147533419|NCT04409509|532107820|FG001|Overall Study|Failure to meet randomization requirement|0|||
147533420|NCT04409509|532107819|FG000|Overall Study|Adverse Event|0|||
147533421|NCT04409509|532107820|FG001|Overall Study|Adverse Event|1|||
147533422|NCT04409509|532107819|FG000|Overall Study|Death|11|||
147533423|NCT04409509|532107820|FG001|Overall Study|Death|10|||
147533424|NCT04409509|532107819|FG000|Overall Study|Non-compliance with study drug|0|||
147533425|NCT04409509|532107820|FG001|Overall Study|Non-compliance with study drug|1|||
147533426|NCT04409509|532107819|FG000|Overall Study|Lost to Follow-up|0|||
147533427|NCT04409509|532107820|FG001|Overall Study|Lost to Follow-up|3|||
147533428|NCT04409509|532107819|FG000|Overall Study|Withdrawal by Subject|0|||
147533429|NCT04409509|532107820|FG001|Overall Study|Withdrawal by Subject|3|||
147533430|NCT04409509|532107819|FG000|Overall Study|Randomized by mistake|0|||
147533431|NCT04409509|532107820|FG001|Overall Study|Randomized by mistake|1|||
147533432|NCT04409509|532107819|FG000|Overall Study|Other|1|||
147533433|NCT04409509|532107820|FG001|Overall Study|Other|1|||
147533434|NCT04668066|532107821|FG000|Part 1: Treatment Phase|Adverse Event|0|||
147533435|NCT04668066|532107822|FG001|Part 1: Treatment Phase|Adverse Event|0|||
147533436|NCT04668066|532107823|FG002|Part 1: Treatment Phase|Adverse Event|0|||
147533437|NCT04668066|532107824|FG003|Part 1: Treatment Phase|Adverse Event|0|||
147533438|NCT04668066|532107825|FG004|Part 1: Treatment Phase|Adverse Event|0|||
147533439|NCT04668066|532107826|FG005|Part 1: Treatment Phase|Adverse Event|0|||
147533440|NCT04668066|532107827|FG006|Part 1: Treatment Phase|Adverse Event|0|||
147533441|NCT04668066|532107828|FG007|Part 1: Treatment Phase|Adverse Event|0|||
147533442|NCT04668066|532107829|FG008|Part 1: Treatment Phase|Adverse Event|0|||
147533443|NCT04668066|532107830|FG009|Part 1: Treatment Phase|Adverse Event|0|||
147533444|NCT04668066|532107831|FG010|Part 1: Treatment Phase|Adverse Event|0|||
147533445|NCT04668066|532107832|FG011|Part 1: Treatment Phase|Adverse Event|1|||
147533446|NCT04668066|532107833|FG012|Part 1: Treatment Phase|Adverse Event|1|||
147533447|NCT04668066|532107834|FG013|Part 1: Treatment Phase|Adverse Event|0|||
147533448|NCT04668066|532107835|FG014|Part 1: Treatment Phase|Adverse Event|0|||
147533449|NCT04668066|532107836|FG015|Part 1: Treatment Phase|Adverse Event|0|||
147533450|NCT04668066|532107837|FG016|Part 1: Treatment Phase|Adverse Event|0|||
147533451|NCT04668066|532107838|FG017|Part 1: Treatment Phase|Adverse Event|0|||
147533452|NCT04668066|532107839|FG018|Part 1: Treatment Phase|Adverse Event|0|||
147533453|NCT04668066|532107821|FG000|Part 1: Treatment Phase|Lost to Follow-up|0|||
147533454|NCT04668066|532107822|FG001|Part 1: Treatment Phase|Lost to Follow-up|0|||
147533455|NCT04668066|532107823|FG002|Part 1: Treatment Phase|Lost to Follow-up|1|||
147533456|NCT04668066|532107824|FG003|Part 1: Treatment Phase|Lost to Follow-up|0|||
147533457|NCT04668066|532107825|FG004|Part 1: Treatment Phase|Lost to Follow-up|0|||
147533458|NCT04668066|532107826|FG005|Part 1: Treatment Phase|Lost to Follow-up|0|||
147533459|NCT04668066|532107827|FG006|Part 1: Treatment Phase|Lost to Follow-up|0|||
147533460|NCT04668066|532107828|FG007|Part 1: Treatment Phase|Lost to Follow-up|0|||
147533461|NCT04668066|532107829|FG008|Part 1: Treatment Phase|Lost to Follow-up|0|||
147533462|NCT04668066|532107830|FG009|Part 1: Treatment Phase|Lost to Follow-up|0|||
147533463|NCT04668066|532107831|FG010|Part 1: Treatment Phase|Lost to Follow-up|0|||
147533464|NCT04668066|532107832|FG011|Part 1: Treatment Phase|Lost to Follow-up|0|||
147533465|NCT04668066|532107833|FG012|Part 1: Treatment Phase|Lost to Follow-up|0|||
147533466|NCT04668066|532107834|FG013|Part 1: Treatment Phase|Lost to Follow-up|0|||
147533467|NCT04668066|532107835|FG014|Part 1: Treatment Phase|Lost to Follow-up|0|||
147533468|NCT04668066|532107836|FG015|Part 1: Treatment Phase|Lost to Follow-up|0|||
147533469|NCT04668066|532107837|FG016|Part 1: Treatment Phase|Lost to Follow-up|0|||
147432398|NCT02234323|531749030|FG000|All Enrolled|Not Treated:Consent withdrawn by subject|2|||
147432399|NCT02234323|531749030|FG000|All Enrolled|Not Treated: Exceeded lab value limit|1|||
147432400|NCT02234323|531749030|FG000|All Treated|Death|1|||
147432401|NCT02234323|531749030|FG000|All Treated|Physician Decision|5|||
147533470|NCT04668066|532107838|FG017|Part 1: Treatment Phase|Lost to Follow-up|0|||
147533471|NCT04668066|532107839|FG018|Part 1: Treatment Phase|Lost to Follow-up|0|||
147533472|NCT04668066|532107821|FG000|Part 1: Treatment Phase|Other|0|||
147533473|NCT04668066|532107822|FG001|Part 1: Treatment Phase|Other|0|||
147533474|NCT04668066|532107823|FG002|Part 1: Treatment Phase|Other|0|||
147533475|NCT04668066|532107824|FG003|Part 1: Treatment Phase|Other|0|||
147533476|NCT04668066|532107825|FG004|Part 1: Treatment Phase|Other|0|||
147533477|NCT04668066|532107826|FG005|Part 1: Treatment Phase|Other|0|||
147533478|NCT04668066|532107827|FG006|Part 1: Treatment Phase|Other|0|||
147533479|NCT04668066|532107828|FG007|Part 1: Treatment Phase|Other|0|||
147533480|NCT04668066|532107829|FG008|Part 1: Treatment Phase|Other|0|||
147533481|NCT04668066|532107830|FG009|Part 1: Treatment Phase|Other|0|||
147533482|NCT04668066|532107831|FG010|Part 1: Treatment Phase|Other|0|||
147533483|NCT04668066|532107832|FG011|Part 1: Treatment Phase|Other|1|||
147533484|NCT04668066|532107833|FG012|Part 1: Treatment Phase|Other|0|||
147533485|NCT04668066|532107834|FG013|Part 1: Treatment Phase|Other|0|||
147533486|NCT04668066|532107835|FG014|Part 1: Treatment Phase|Other|0|||
147533487|NCT04668066|532107836|FG015|Part 1: Treatment Phase|Other|0|||
147533488|NCT04668066|532107837|FG016|Part 1: Treatment Phase|Other|0|||
147533489|NCT04668066|532107838|FG017|Part 1: Treatment Phase|Other|0|||
147533490|NCT04668066|532107839|FG018|Part 1: Treatment Phase|Other|0|||
147533491|NCT04668066|532107821|FG000|Part 1: Treatment Phase|Withdrawal by Subject|0|||
147533492|NCT04668066|532107822|FG001|Part 1: Treatment Phase|Withdrawal by Subject|0|||
147533493|NCT04668066|532107823|FG002|Part 1: Treatment Phase|Withdrawal by Subject|0|||
147533494|NCT04668066|532107824|FG003|Part 1: Treatment Phase|Withdrawal by Subject|0|||
147533495|NCT04668066|532107825|FG004|Part 1: Treatment Phase|Withdrawal by Subject|0|||
147533496|NCT04668066|532107826|FG005|Part 1: Treatment Phase|Withdrawal by Subject|0|||
147533497|NCT04668066|532107827|FG006|Part 1: Treatment Phase|Withdrawal by Subject|0|||
147533498|NCT04668066|532107828|FG007|Part 1: Treatment Phase|Withdrawal by Subject|0|||
147533499|NCT04668066|532107829|FG008|Part 1: Treatment Phase|Withdrawal by Subject|0|||
147533500|NCT04668066|532107830|FG009|Part 1: Treatment Phase|Withdrawal by Subject|0|||
147533501|NCT04668066|532107831|FG010|Part 1: Treatment Phase|Withdrawal by Subject|0|||
147533502|NCT04668066|532107832|FG011|Part 1: Treatment Phase|Withdrawal by Subject|0|||
147533503|NCT04668066|532107833|FG012|Part 1: Treatment Phase|Withdrawal by Subject|1|||
147533504|NCT04668066|532107834|FG013|Part 1: Treatment Phase|Withdrawal by Subject|0|||
147533505|NCT04668066|532107835|FG014|Part 1: Treatment Phase|Withdrawal by Subject|0|||
147533506|NCT04668066|532107836|FG015|Part 1: Treatment Phase|Withdrawal by Subject|2|||
147533507|NCT04668066|532107837|FG016|Part 1: Treatment Phase|Withdrawal by Subject|0|||
147533508|NCT04668066|532107838|FG017|Part 1: Treatment Phase|Withdrawal by Subject|0|||
147533509|NCT04668066|532107839|FG018|Part 1: Treatment Phase|Withdrawal by Subject|0|||
147533510|NCT04668066|532107821|FG000|Part 1: Follow-Up|Adverse Event|0|||
147533511|NCT04668066|532107822|FG001|Part 1: Follow-Up|Adverse Event|0|||
147533512|NCT04668066|532107823|FG002|Part 1: Follow-Up|Adverse Event|0|||
147432402|NCT02234323|531749030|FG000|All Treated|Lack of Efficacy|3|||
147432403|NCT02234323|531749030|FG000|All Treated|Exceeded lab value limit|2|||
147432404|NCT02234323|531749030|FG000|All Treated|Other|7|||
147432405|NCT00867113|531749031|FG000|Treatment Period|Adverse Event|15|||
147432406|NCT00867113|531749031|FG000|Treatment Period|Death|2|||
147432407|NCT00867113|531749031|FG000|Treatment Period|Withdrawal by Subject|19|||
147432408|NCT00867113|531749031|FG000|Treatment Period|Lost to Follow-up|3|||
147432409|NCT00867113|531749031|FG000|Treatment Period|Administrative problems|1|||
147432410|NCT00867113|531749031|FG000|Treatment Period|Disease progression/relapse|1|||
147432411|NCT00867113|531749031|FG000|Treatment Period|Protocol Violation|4|||
147432412|NCT00867113|531749031|FG000|Post Treatment After Survival Follow-up|Death|1|||
147432413|NCT00867113|531749031|FG000|Post Treatment After Survival Follow-up|Withdrawal by Subject|1|||
147432414|NCT00867113|531749031|FG000|Post Treatment After Survival Follow-up|Lost to Follow-up|5|||
147432415|NCT00867113|531749031|FG000|Post Treatment After Survival Follow-up|Administrative problems|4|||
147432416|NCT01886313|531749032|FG000|Overall Study|Adverse Event|1|||
147432417|NCT01886313|531749033|FG001|Overall Study|Adverse Event|1|||
147432418|NCT04614662|531749034|FG000|Overall Study|Withdrawal by Subject|0|||
147432419|NCT04614662|531749035|FG001|Overall Study|Withdrawal by Subject|1|||
147533513|NCT04668066|532107824|FG003|Part 1: Follow-Up|Adverse Event|0|||
147533514|NCT04668066|532107825|FG004|Part 1: Follow-Up|Adverse Event|0|||
147533515|NCT04668066|532107826|FG005|Part 1: Follow-Up|Adverse Event|0|||
147533516|NCT04668066|532107827|FG006|Part 1: Follow-Up|Adverse Event|0|||
147533517|NCT04668066|532107828|FG007|Part 1: Follow-Up|Adverse Event|0|||
147533518|NCT04668066|532107829|FG008|Part 1: Follow-Up|Adverse Event|0|||
147432420|NCT01774084|531749039|FG000|Overall Study|Personal reasons|1|||
147432421|NCT01774084|531749040|FG001|Overall Study|Personal reasons|0|||
147432422|NCT02973048|531749041|FG000|Overall Study|Epidural catheter insertion failure|1|||
147432423|NCT02973048|531749042|FG001|Overall Study|Epidural catheter insertion failure|0|||
147432424|NCT02973048|531749041|FG000|Overall Study|Withdrawal by Subject|0|||
147432425|NCT02973048|531749042|FG001|Overall Study|Withdrawal by Subject|3|||
147432426|NCT01906346|531749046|FG000|Overall Study|AEs|1|||
147432427|NCT00364156|531749049|FG000|Overall Study|Withdrawal by Subject|73|||
147432428|NCT00364156|531749050|FG001|Overall Study|Withdrawal by Subject|80|||
147432429|NCT00364156|531749049|FG000|Overall Study|Protocol Violation|6|||
147432430|NCT00364156|531749050|FG001|Overall Study|Protocol Violation|1|||
147432431|NCT02511678|531749051|FG000|Overall Study|Withdrawal by Subject|2|||
147432432|NCT02511678|531749051|FG000|Overall Study|Lost to Follow-up|4|||
147432433|NCT02511678|531749051|FG000|Overall Study|Death|19|||
147432434|NCT02511678|531749051|FG000|Overall Study|Adverse Event|1|||
147432435|NCT02511678|531749051|FG000|Overall Study|Targeted Therapy to Index Tumor Required|5|||
147432436|NCT02511678|531749051|FG000|Overall Study|Oncologist Cancelled Study Cryoablation|1|||
147432437|NCT02511678|531749051|FG000|Overall Study|Required Radiofrequency Ablation|1|||
147432438|NCT02511678|531749051|FG000|Overall Study|Biopsy was Negative|1|||
147432439|NCT02511678|531749051|FG000|Overall Study|Protocol Violation|1|||
147432440|NCT02511678|531749051|FG000|Overall Study|Received Radiation Treatment|1|||
147432441|NCT05125679|531749057|FG000|Overall Study|Study Terminated by Sponsor|2|||
147432442|NCT05125679|531749058|FG001|Overall Study|Study Terminated by Sponsor|5|||
147432443|NCT04908189|531749059|FG000|Placebo-Controlled (Week 0 - Week 16)|Lack of Efficacy|1|||
147432444|NCT04908189|531749060|FG001|Placebo-Controlled (Week 0 - Week 16)|Lack of Efficacy|3|||
147432445|NCT04908189|531749061|FG002|Placebo-Controlled (Week 0 - Week 16)|Lack of Efficacy|0|||
147432446|NCT04908189|531749059|FG000|Placebo-Controlled (Week 0 - Week 16)|Adverse Event|6|||
147432447|NCT04908189|531749060|FG001|Placebo-Controlled (Week 0 - Week 16)|Adverse Event|4|||
147432448|NCT04908189|531749061|FG002|Placebo-Controlled (Week 0 - Week 16)|Adverse Event|10|||
147432449|NCT04908189|531749059|FG000|Placebo-Controlled (Week 0 - Week 16)|Participant request to discontinue study treatment|2|||
147432450|NCT04908189|531749060|FG001|Placebo-Controlled (Week 0 - Week 16)|Participant request to discontinue study treatment|4|||
147432451|NCT04908189|531749061|FG002|Placebo-Controlled (Week 0 - Week 16)|Participant request to discontinue study treatment|2|||
147432452|NCT04908189|531749059|FG000|Placebo-Controlled (Week 0 - Week 16)|Withdrawal by Subject|6|||
147432453|NCT04908189|531749060|FG001|Placebo-Controlled (Week 0 - Week 16)|Withdrawal by Subject|8|||
147432454|NCT04908189|531749061|FG002|Placebo-Controlled (Week 0 - Week 16)|Withdrawal by Subject|3|||
147432455|NCT04908189|531749059|FG000|Placebo-Controlled (Week 0 - Week 16)|Administrative reason by sponsor|3|||
147432456|NCT04908189|531749060|FG001|Placebo-Controlled (Week 0 - Week 16)|Administrative reason by sponsor|0|||
147432457|NCT04908189|531749061|FG002|Placebo-Controlled (Week 0 - Week 16)|Administrative reason by sponsor|0|||
147432458|NCT04908189|531749059|FG000|Placebo-Controlled (Week 0 - Week 16)|Other reasons|2|||
147432459|NCT04908189|531749060|FG001|Placebo-Controlled (Week 0 - Week 16)|Other reasons|0|||
147432460|NCT04908189|531749061|FG002|Placebo-Controlled (Week 0 - Week 16)|Other reasons|0|||
147432461|NCT04908189|531749059|FG000|Active Treatment (Week 16 - Week 52)|Lack of Efficacy|6|||
147432462|NCT04908189|531749060|FG001|Active Treatment (Week 16 - Week 52)|Lack of Efficacy|6|||
147432463|NCT04908189|531749061|FG002|Active Treatment (Week 16 - Week 52)|Lack of Efficacy|1|||
147432464|NCT04908189|531749059|FG000|Active Treatment (Week 16 - Week 52)|Adverse Event|9|||
147432465|NCT04908189|531749060|FG001|Active Treatment (Week 16 - Week 52)|Adverse Event|7|||
147432466|NCT04908189|531749061|FG002|Active Treatment (Week 16 - Week 52)|Adverse Event|3|||
147432467|NCT04908189|531749059|FG000|Active Treatment (Week 16 - Week 52)|Participant request to discontinue study treatment|3|||
147432468|NCT04908189|531749060|FG001|Active Treatment (Week 16 - Week 52)|Participant request to discontinue study treatment|3|||
147432469|NCT04908189|531749061|FG002|Active Treatment (Week 16 - Week 52)|Participant request to discontinue study treatment|4|||
147432470|NCT04908189|531749059|FG000|Active Treatment (Week 16 - Week 52)|Withdrawal by Subject|5|||
147432471|NCT04908189|531749060|FG001|Active Treatment (Week 16 - Week 52)|Withdrawal by Subject|5|||
147432472|NCT04908189|531749061|FG002|Active Treatment (Week 16 - Week 52)|Withdrawal by Subject|2|||
147432473|NCT04908189|531749059|FG000|Active Treatment (Week 16 - Week 52)|Lost to Follow-up|2|||
147432474|NCT04908189|531749060|FG001|Active Treatment (Week 16 - Week 52)|Lost to Follow-up|1|||
147432475|NCT04908189|531749061|FG002|Active Treatment (Week 16 - Week 52)|Lost to Follow-up|0|||
147432476|NCT04908189|531749059|FG000|Active Treatment (Week 16 - Week 52)|Other reasons|1|||
147432477|NCT04908189|531749060|FG001|Active Treatment (Week 16 - Week 52)|Other reasons|1|||
147432478|NCT04908189|531749061|FG002|Active Treatment (Week 16 - Week 52)|Other reasons|1|||
147432479|NCT00607022|531749063|FG000|Overall Study|Withdrawal by Subject|1|||
147432480|NCT00607022|531749064|FG001|Overall Study|Withdrawal by Subject|0|||
147432481|NCT00607022|531749065|FG002|Overall Study|Withdrawal by Subject|0|||
147432482|NCT04540133|531749066|FG000|Overall Study|Lost to Follow-up|1|||
147432483|NCT04540133|531749067|FG001|Overall Study|Lost to Follow-up|0|||
147432484|NCT02673619|531749072|FG000|Overall Study|Lost to Follow-up|1|||
147432485|NCT02673619|531749073|FG001|Overall Study|Lost to Follow-up|0|||
147432486|NCT02673619|531749074|FG002|Overall Study|Lost to Follow-up|0|||
147432487|NCT02673619|531749075|FG003|Overall Study|Lost to Follow-up|0|||
147432488|NCT02673619|531749072|FG000|Overall Study|Withdrawal by Subject|1|||
147432489|NCT02673619|531749073|FG001|Overall Study|Withdrawal by Subject|1|||
147432490|NCT02673619|531749074|FG002|Overall Study|Withdrawal by Subject|1|||
147432491|NCT02673619|531749075|FG003|Overall Study|Withdrawal by Subject|0|||
147432492|NCT02673619|531749072|FG000|Overall Study|Adverse Event|0|||
147432493|NCT02673619|531749073|FG001|Overall Study|Adverse Event|0|||
147432494|NCT02673619|531749074|FG002|Overall Study|Adverse Event|1|||
147432495|NCT02673619|531749075|FG003|Overall Study|Adverse Event|0|||
147432496|NCT02673619|531749072|FG000|Overall Study|Lack of Efficacy|0|||
147432497|NCT02673619|531749073|FG001|Overall Study|Lack of Efficacy|0|||
147432498|NCT02673619|531749074|FG002|Overall Study|Lack of Efficacy|1|||
147432499|NCT02673619|531749075|FG003|Overall Study|Lack of Efficacy|0|||
147432500|NCT01313117|531749077|FG000|Cohort 2: Dose Level 2 (ALA 600mg Daily)|Adverse Event|1|||
147432501|NCT01313117|531749077|FG000|Cohort 5: Dose Level 2 (ALA 600mg Daily)|Adverse Event|1|||
147432502|NCT03602261|531749082|FG000|Overall Study|Adverse Event|5|||
147432503|NCT03602261|531749083|FG001|Overall Study|Adverse Event|1|||
147432504|NCT03602261|531749082|FG000|Overall Study|Physician Decision|1|||
147432505|NCT03602261|531749083|FG001|Overall Study|Physician Decision|0|||
147432506|NCT03602261|531749082|FG000|Overall Study|Withdrawal by Subject|1|||
147432507|NCT03602261|531749083|FG001|Overall Study|Withdrawal by Subject|1|||
147432508|NCT03602261|531749082|FG000|Overall Study|Lack of Efficacy|0|||
147432509|NCT03602261|531749083|FG001|Overall Study|Lack of Efficacy|1|||
147432510|NCT03602261|531749082|FG000|Overall Study|Subject moving out of state|1|||
147432511|NCT03602261|531749083|FG001|Overall Study|Subject moving out of state|0|||
147432512|NCT00909792|531751007|FG000|Period 1|Did not meet inclusion criteria|0|||
147432513|NCT00909792|531751008|FG001|Period 1|Did not meet inclusion criteria|1|||
147432514|NCT00909792|531751007|FG000|Period 2|Biomicroscopy|1|||
147432515|NCT00909792|531751008|FG001|Period 2|Biomicroscopy|0|||
147432516|NCT00909792|531751007|FG000|Period 2|Lost to Follow-up|0|||
147432517|NCT00909792|531751008|FG001|Period 2|Lost to Follow-up|1|||
147432518|NCT03434353|531751009|FG000|Overall Study|Started commercial Hepatitis B virus therapy|10|||
147432519|NCT03434353|531751010|FG001|Overall Study|Started commercial Hepatitis B virus therapy|3|||
147432520|NCT03434353|531751011|FG002|Overall Study|Started commercial Hepatitis B virus therapy|11|||
147432521|NCT03434353|531751012|FG003|Overall Study|Started commercial Hepatitis B virus therapy|3|||
147432522|NCT03434353|531751013|FG004|Overall Study|Started commercial Hepatitis B virus therapy|17|||
147432523|NCT03434353|531751009|FG000|Overall Study|Withdrew consent|1|||
147432524|NCT03434353|531751010|FG001|Overall Study|Withdrew consent|0|||
147432525|NCT03434353|531751011|FG002|Overall Study|Withdrew consent|3|||
147432526|NCT03434353|531751012|FG003|Overall Study|Withdrew consent|0|||
147432527|NCT03434353|531751013|FG004|Overall Study|Withdrew consent|0|||
147432528|NCT03434353|531751009|FG000|Overall Study|Adverse Event|1|||
147432529|NCT03434353|531751010|FG001|Overall Study|Adverse Event|0|||
147432530|NCT03434353|531751011|FG002|Overall Study|Adverse Event|0|||
147432531|NCT03434353|531751012|FG003|Overall Study|Adverse Event|0|||
147432532|NCT03434353|531751013|FG004|Overall Study|Adverse Event|1|||
147432533|NCT03434353|531751009|FG000|Overall Study|Lost to Follow-up|2|||
147432534|NCT03434353|531751010|FG001|Overall Study|Lost to Follow-up|0|||
147432535|NCT03434353|531751011|FG002|Overall Study|Lost to Follow-up|0|||
147432536|NCT03434353|531751012|FG003|Overall Study|Lost to Follow-up|0|||
147432537|NCT03434353|531751013|FG004|Overall Study|Lost to Follow-up|0|||
147432538|NCT01990534|531751014|FG000|Overall Study|Death|22|||
147432539|NCT01990534|531751014|FG000|Overall Study|Progressive disease|3|||
147432540|NCT01990534|531751014|FG000|Overall Study|Protocol Violation|1|||
147432541|NCT01990534|531751014|FG000|Overall Study|Withdrawal of Informed Consent|2|||
147432542|NCT01990534|531751014|FG000|Overall Study|Symptomatic Deterioration|1|||
147432543|NCT01990534|531751014|FG000|Overall Study|Withdrawal by Subject|3|||
147432544|NCT01990534|531751014|FG000|Overall Study|Reason not Specified|2|||
147432545|NCT01990534|531751014|FG000|Overall Study|Lost to Follow-up|1|||
147432546|NCT00234494|531751015|FG000|Overall Study|Protocol Violation|2|||
147432547|NCT01831544|531751016|FG000|Overall Study|Death|1|||
147432548|NCT01831544|531751016|FG000|Overall Study|Still on original MVAD device|2|||
147432549|NCT01521897|531751017|FG000|Overall Study|Protocol Violation|18|||
147432550|NCT01521897|531751017|FG000|Overall Study|Lost to Follow-up|5|||
147432551|NCT02194062|531751018|FG000|Overall Study|Lost to Follow-up|2|||
147432552|NCT02194062|531751019|FG001|Overall Study|Lost to Follow-up|2|||
147533519|NCT04668066|532107830|FG009|Part 1: Follow-Up|Adverse Event|0|||
147533520|NCT04668066|532107831|FG010|Part 1: Follow-Up|Adverse Event|0|||
147533521|NCT04668066|532107832|FG011|Part 1: Follow-Up|Adverse Event|1|||
147533522|NCT04668066|532107833|FG012|Part 1: Follow-Up|Adverse Event|0|||
147533523|NCT04668066|532107834|FG013|Part 1: Follow-Up|Adverse Event|0|||
147533524|NCT04668066|532107835|FG014|Part 1: Follow-Up|Adverse Event|0|||
147533525|NCT04668066|532107836|FG015|Part 1: Follow-Up|Adverse Event|0|||
147533526|NCT04668066|532107837|FG016|Part 1: Follow-Up|Adverse Event|0|||
147533527|NCT04668066|532107838|FG017|Part 1: Follow-Up|Adverse Event|0|||
147533528|NCT04668066|532107839|FG018|Part 1: Follow-Up|Adverse Event|0|||
147533529|NCT04668066|532107821|FG000|Part 1: Follow-Up|Other|0|||
147533530|NCT04668066|532107822|FG001|Part 1: Follow-Up|Other|0|||
147533531|NCT04668066|532107823|FG002|Part 1: Follow-Up|Other|0|||
147533532|NCT04668066|532107824|FG003|Part 1: Follow-Up|Other|0|||
147533533|NCT04668066|532107825|FG004|Part 1: Follow-Up|Other|0|||
147533534|NCT04668066|532107826|FG005|Part 1: Follow-Up|Other|0|||
147533535|NCT04668066|532107827|FG006|Part 1: Follow-Up|Other|0|||
147533536|NCT04668066|532107828|FG007|Part 1: Follow-Up|Other|0|||
147533537|NCT04668066|532107829|FG008|Part 1: Follow-Up|Other|0|||
147533538|NCT04668066|532107830|FG009|Part 1: Follow-Up|Other|0|||
147533539|NCT04668066|532107831|FG010|Part 1: Follow-Up|Other|0|||
147533540|NCT04668066|532107832|FG011|Part 1: Follow-Up|Other|1|||
147533541|NCT04668066|532107833|FG012|Part 1: Follow-Up|Other|1|||
147533542|NCT04668066|532107834|FG013|Part 1: Follow-Up|Other|0|||
147533543|NCT04668066|532107835|FG014|Part 1: Follow-Up|Other|0|||
147533544|NCT04668066|532107836|FG015|Part 1: Follow-Up|Other|0|||
147533545|NCT04668066|532107837|FG016|Part 1: Follow-Up|Other|0|||
147533546|NCT04668066|532107838|FG017|Part 1: Follow-Up|Other|0|||
147533547|NCT04668066|532107839|FG018|Part 1: Follow-Up|Other|0|||
147533548|NCT04668066|532107821|FG000|Part 1: Follow-Up|Withdrawal by Subject|0|||
147533549|NCT04668066|532107822|FG001|Part 1: Follow-Up|Withdrawal by Subject|0|||
147533550|NCT04668066|532107823|FG002|Part 1: Follow-Up|Withdrawal by Subject|0|||
147533551|NCT04668066|532107824|FG003|Part 1: Follow-Up|Withdrawal by Subject|0|||
147533552|NCT04668066|532107825|FG004|Part 1: Follow-Up|Withdrawal by Subject|0|||
147533553|NCT04668066|532107826|FG005|Part 1: Follow-Up|Withdrawal by Subject|0|||
147533554|NCT04668066|532107827|FG006|Part 1: Follow-Up|Withdrawal by Subject|0|||
147533555|NCT04668066|532107828|FG007|Part 1: Follow-Up|Withdrawal by Subject|0|||
147533556|NCT04668066|532107829|FG008|Part 1: Follow-Up|Withdrawal by Subject|0|||
147533557|NCT04668066|532107830|FG009|Part 1: Follow-Up|Withdrawal by Subject|0|||
147533558|NCT04668066|532107831|FG010|Part 1: Follow-Up|Withdrawal by Subject|0|||
147533559|NCT04668066|532107832|FG011|Part 1: Follow-Up|Withdrawal by Subject|0|||
147533560|NCT04668066|532107833|FG012|Part 1: Follow-Up|Withdrawal by Subject|1|||
147533561|NCT04668066|532107834|FG013|Part 1: Follow-Up|Withdrawal by Subject|0|||
147533562|NCT04668066|532107835|FG014|Part 1: Follow-Up|Withdrawal by Subject|0|||
147533563|NCT04668066|532107836|FG015|Part 1: Follow-Up|Withdrawal by Subject|2|||
147533564|NCT04668066|532107837|FG016|Part 1: Follow-Up|Withdrawal by Subject|0|||
147533565|NCT04668066|532107838|FG017|Part 1: Follow-Up|Withdrawal by Subject|0|||
147533566|NCT04668066|532107839|FG018|Part 1: Follow-Up|Withdrawal by Subject|0|||
147533567|NCT04668066|532107821|FG000|Part 2: Treatment Phase|Withdrawal by Subject|0|||
147533568|NCT04668066|532107822|FG001|Part 2: Treatment Phase|Withdrawal by Subject|0|||
147533569|NCT04668066|532107823|FG002|Part 2: Treatment Phase|Withdrawal by Subject|0|||
147533570|NCT04668066|532107824|FG003|Part 2: Treatment Phase|Withdrawal by Subject|0|||
147533571|NCT04668066|532107825|FG004|Part 2: Treatment Phase|Withdrawal by Subject|0|||
147533572|NCT04668066|532107826|FG005|Part 2: Treatment Phase|Withdrawal by Subject|0|||
147533573|NCT04668066|532107827|FG006|Part 2: Treatment Phase|Withdrawal by Subject|0|||
147533574|NCT04668066|532107828|FG007|Part 2: Treatment Phase|Withdrawal by Subject|0|||
147533575|NCT04668066|532107829|FG008|Part 2: Treatment Phase|Withdrawal by Subject|0|||
147533576|NCT04668066|532107830|FG009|Part 2: Treatment Phase|Withdrawal by Subject|0|||
147533577|NCT04668066|532107831|FG010|Part 2: Treatment Phase|Withdrawal by Subject|0|||
147533578|NCT04668066|532107832|FG011|Part 2: Treatment Phase|Withdrawal by Subject|0|||
147533579|NCT04668066|532107833|FG012|Part 2: Treatment Phase|Withdrawal by Subject|0|||
147533580|NCT04668066|532107834|FG013|Part 2: Treatment Phase|Withdrawal by Subject|0|||
147533581|NCT04668066|532107835|FG014|Part 2: Treatment Phase|Withdrawal by Subject|0|||
147533582|NCT04668066|532107836|FG015|Part 2: Treatment Phase|Withdrawal by Subject|0|||
147533583|NCT04668066|532107837|FG016|Part 2: Treatment Phase|Withdrawal by Subject|0|||
147533584|NCT04668066|532107838|FG017|Part 2: Treatment Phase|Withdrawal by Subject|0|||
147533585|NCT04668066|532107839|FG018|Part 2: Treatment Phase|Withdrawal by Subject|1|||
147533586|NCT04668066|532107821|FG000|Part 2: Treatment Phase|Lost to Follow-up|0|||
147533587|NCT04668066|532107822|FG001|Part 2: Treatment Phase|Lost to Follow-up|0|||
147533588|NCT04668066|532107823|FG002|Part 2: Treatment Phase|Lost to Follow-up|0|||
147649354|NCT01026818|532537331|FG000|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|0|||
147533589|NCT04668066|532107824|FG003|Part 2: Treatment Phase|Lost to Follow-up|0|||
147533590|NCT04668066|532107825|FG004|Part 2: Treatment Phase|Lost to Follow-up|0|||
147533591|NCT04668066|532107826|FG005|Part 2: Treatment Phase|Lost to Follow-up|0|||
147533592|NCT04668066|532107827|FG006|Part 2: Treatment Phase|Lost to Follow-up|0|||
147533593|NCT04668066|532107828|FG007|Part 2: Treatment Phase|Lost to Follow-up|0|||
147533594|NCT04668066|532107829|FG008|Part 2: Treatment Phase|Lost to Follow-up|0|||
147432553|NCT02194062|531751020|FG002|Overall Study|Lost to Follow-up|5|||
147432554|NCT00293722|531751021|FG000|Overall Study|Other|427|||
147432555|NCT02634346|531751027|FG000|Overall Study|Withdrawal by Subject|8|||
147432556|NCT02634346|531751028|FG001|Overall Study|Withdrawal by Subject|9|||
147432557|NCT02634346|531751029|FG002|Overall Study|Withdrawal by Subject|8|||
147432558|NCT02634346|531751027|FG000|Overall Study|Adverse Event|2|||
147432559|NCT02634346|531751028|FG001|Overall Study|Adverse Event|2|||
147432560|NCT02634346|531751029|FG002|Overall Study|Adverse Event|7|||
147432561|NCT02634346|531751027|FG000|Overall Study|Lack of Efficacy|1|||
147432562|NCT02634346|531751028|FG001|Overall Study|Lack of Efficacy|2|||
147432563|NCT02634346|531751029|FG002|Overall Study|Lack of Efficacy|8|||
147432564|NCT02634346|531751027|FG000|Overall Study|Lost to Follow-up|1|||
147432565|NCT02634346|531751028|FG001|Overall Study|Lost to Follow-up|0|||
147432566|NCT02634346|531751029|FG002|Overall Study|Lost to Follow-up|0|||
147432567|NCT02634346|531751027|FG000|Overall Study|Protocol Violation|0|||
147432568|NCT02634346|531751028|FG001|Overall Study|Protocol Violation|1|||
147432569|NCT02634346|531751029|FG002|Overall Study|Protocol Violation|0|||
147432570|NCT04498169|531751030|FG000|Study Completion|Adverse Event|1|||
147432571|NCT04498169|531751031|FG001|Study Completion|Adverse Event|1|||
147432572|NCT03118674|531751039|FG000|Overall Study|Lost to Follow-up|2|||
147432573|NCT03118674|531751039|FG000|Overall Study|Screen Faliure|8|||
147432574|NCT03118674|531751039|FG000|Overall Study|Withdrawal by Subject|5|||
147432575|NCT01324323|531751040|FG000|Overall Study|Withdrawal by Subject|1|||
147432576|NCT00908232|531751041|FG000|Cycle 1 to 4|Death|5|||
147432577|NCT00908232|531751042|FG001|Cycle 1 to 4|Death|0|||
147432578|NCT00908232|531751043|FG002|Cycle 1 to 4|Death|0|||
147432579|NCT00908232|531751044|FG003|Cycle 1 to 4|Death|0|||
147432580|NCT00908232|531751041|FG000|Cycle 1 to 4|Withdrawal by Subject|4|||
147432581|NCT00908232|531751042|FG001|Cycle 1 to 4|Withdrawal by Subject|0|||
147432582|NCT00908232|531751043|FG002|Cycle 1 to 4|Withdrawal by Subject|0|||
147432583|NCT00908232|531751044|FG003|Cycle 1 to 4|Withdrawal by Subject|0|||
147432584|NCT00908232|531751041|FG000|Cycle 1 to 4|Progressive Disease|6|||
147432585|NCT00908232|531751042|FG001|Cycle 1 to 4|Progressive Disease|0|||
147432586|NCT00908232|531751043|FG002|Cycle 1 to 4|Progressive Disease|0|||
147432587|NCT00908232|531751044|FG003|Cycle 1 to 4|Progressive Disease|0|||
147432588|NCT00908232|531751041|FG000|Cycle 1 to 4|Adverse Event|12|||
147432589|NCT00908232|531751042|FG001|Cycle 1 to 4|Adverse Event|0|||
147432590|NCT00908232|531751043|FG002|Cycle 1 to 4|Adverse Event|0|||
147432591|NCT00908232|531751044|FG003|Cycle 1 to 4|Adverse Event|0|||
147432592|NCT00908232|531751041|FG000|Cycle 1 to 4|Other|1|||
147432593|NCT00908232|531751042|FG001|Cycle 1 to 4|Other|0|||
147432594|NCT00908232|531751043|FG002|Cycle 1 to 4|Other|0|||
147432595|NCT00908232|531751044|FG003|Cycle 1 to 4|Other|0|||
147432596|NCT00908232|531751041|FG000|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|1|||
147432597|NCT00908232|531751042|FG001|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|0|||
147432598|NCT00908232|531751043|FG002|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|0|||
147432599|NCT00908232|531751044|FG003|Randomization (Cycle 5) to Cycle 8|Complete Response/Partial Response|0|||
147432600|NCT00908232|531751041|FG000|Randomization (Cycle 5) to Cycle 8|Progressive Disease|5|||
147432601|NCT00908232|531751042|FG001|Randomization (Cycle 5) to Cycle 8|Progressive Disease|0|||
147432602|NCT00908232|531751043|FG002|Randomization (Cycle 5) to Cycle 8|Progressive Disease|0|||
147432603|NCT00908232|531751044|FG003|Randomization (Cycle 5) to Cycle 8|Progressive Disease|0|||
147432604|NCT00908232|531751041|FG000|Randomization (Cycle 5) to Cycle 8|Death|2|||
147432605|NCT00908232|531751042|FG001|Randomization (Cycle 5) to Cycle 8|Death|0|||
147432606|NCT00908232|531751043|FG002|Randomization (Cycle 5) to Cycle 8|Death|0|||
147432607|NCT00908232|531751044|FG003|Randomization (Cycle 5) to Cycle 8|Death|0|||
147432608|NCT00908232|531751041|FG000|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|4|||
147432609|NCT00908232|531751042|FG001|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|0|||
147432610|NCT00908232|531751043|FG002|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|1|||
147533595|NCT04668066|532107830|FG009|Part 2: Treatment Phase|Lost to Follow-up|0|||
147533596|NCT04668066|532107831|FG010|Part 2: Treatment Phase|Lost to Follow-up|0|||
147533597|NCT04668066|532107832|FG011|Part 2: Treatment Phase|Lost to Follow-up|0|||
147432611|NCT00908232|531751044|FG003|Randomization (Cycle 5) to Cycle 8|Withdrawal by Subject|0|||
147432612|NCT00908232|531751041|FG000|Randomization (Cycle 5) to Cycle 8|Adverse Event|17|||
147432613|NCT00908232|531751042|FG001|Randomization (Cycle 5) to Cycle 8|Adverse Event|2|||
147432614|NCT00908232|531751043|FG002|Randomization (Cycle 5) to Cycle 8|Adverse Event|0|||
147432615|NCT00908232|531751044|FG003|Randomization (Cycle 5) to Cycle 8|Adverse Event|0|||
147432616|NCT00908232|531751041|FG000|Randomization (Cycle 5) to Cycle 8|Physician Decision|2|||
147432617|NCT00908232|531751042|FG001|Randomization (Cycle 5) to Cycle 8|Physician Decision|0|||
147432618|NCT00908232|531751043|FG002|Randomization (Cycle 5) to Cycle 8|Physician Decision|0|||
147432619|NCT00908232|531751044|FG003|Randomization (Cycle 5) to Cycle 8|Physician Decision|0|||
147432620|NCT00908232|531751041|FG000|Randomization (Cycle 5) to Cycle 8|Other|3|||
147432621|NCT00908232|531751042|FG001|Randomization (Cycle 5) to Cycle 8|Other|1|||
147432622|NCT00908232|531751043|FG002|Randomization (Cycle 5) to Cycle 8|Other|0|||
147533598|NCT04668066|532107833|FG012|Part 2: Treatment Phase|Lost to Follow-up|0|||
147533599|NCT04668066|532107834|FG013|Part 2: Treatment Phase|Lost to Follow-up|0|||
147533600|NCT04668066|532107835|FG014|Part 2: Treatment Phase|Lost to Follow-up|0|||
147533601|NCT04668066|532107836|FG015|Part 2: Treatment Phase|Lost to Follow-up|0|||
147533602|NCT04668066|532107837|FG016|Part 2: Treatment Phase|Lost to Follow-up|0|||
147533603|NCT04668066|532107838|FG017|Part 2: Treatment Phase|Lost to Follow-up|0|||
147533604|NCT04668066|532107839|FG018|Part 2: Treatment Phase|Lost to Follow-up|1|||
147533605|NCT04668066|532107821|FG000|Part 2: Treatment Phase|Other|0|||
147533606|NCT04668066|532107822|FG001|Part 2: Treatment Phase|Other|0|||
147533607|NCT04668066|532107823|FG002|Part 2: Treatment Phase|Other|0|||
147533608|NCT04668066|532107824|FG003|Part 2: Treatment Phase|Other|0|||
147533609|NCT04668066|532107825|FG004|Part 2: Treatment Phase|Other|0|||
147533610|NCT04668066|532107826|FG005|Part 2: Treatment Phase|Other|0|||
147533611|NCT04668066|532107827|FG006|Part 2: Treatment Phase|Other|0|||
147533612|NCT04668066|532107828|FG007|Part 2: Treatment Phase|Other|0|||
147533613|NCT04668066|532107829|FG008|Part 2: Treatment Phase|Other|0|||
147533614|NCT04668066|532107830|FG009|Part 2: Treatment Phase|Other|0|||
147533615|NCT04668066|532107831|FG010|Part 2: Treatment Phase|Other|0|||
147533616|NCT04668066|532107832|FG011|Part 2: Treatment Phase|Other|0|||
147533617|NCT04668066|532107833|FG012|Part 2: Treatment Phase|Other|0|||
147533618|NCT04668066|532107834|FG013|Part 2: Treatment Phase|Other|0|||
147533619|NCT04668066|532107835|FG014|Part 2: Treatment Phase|Other|0|||
147533620|NCT04668066|532107836|FG015|Part 2: Treatment Phase|Other|0|||
147533621|NCT04668066|532107837|FG016|Part 2: Treatment Phase|Other|0|||
147533622|NCT04668066|532107838|FG017|Part 2: Treatment Phase|Other|0|||
147533623|NCT04668066|532107839|FG018|Part 2: Treatment Phase|Other|1|||
147533624|NCT04668066|532107821|FG000|Part 2: Follow-Up|Withdrawal by Subject|0|||
147533625|NCT04668066|532107822|FG001|Part 2: Follow-Up|Withdrawal by Subject|0|||
147533626|NCT04668066|532107823|FG002|Part 2: Follow-Up|Withdrawal by Subject|0|||
147533627|NCT04668066|532107824|FG003|Part 2: Follow-Up|Withdrawal by Subject|0|||
147533628|NCT04668066|532107825|FG004|Part 2: Follow-Up|Withdrawal by Subject|0|||
147432623|NCT00908232|531751044|FG003|Randomization (Cycle 5) to Cycle 8|Other|0|||
147432624|NCT00908232|531751041|FG000|Randomization (Cycle 5) to Cycle 8|Protocol Violation|1|||
147432625|NCT00908232|531751042|FG001|Randomization (Cycle 5) to Cycle 8|Protocol Violation|0|||
147533629|NCT04668066|532107826|FG005|Part 2: Follow-Up|Withdrawal by Subject|0|||
147533630|NCT04668066|532107827|FG006|Part 2: Follow-Up|Withdrawal by Subject|0|||
147533631|NCT04668066|532107828|FG007|Part 2: Follow-Up|Withdrawal by Subject|0|||
147432626|NCT00908232|531751043|FG002|Randomization (Cycle 5) to Cycle 8|Protocol Violation|0|||
147432627|NCT00908232|531751044|FG003|Randomization (Cycle 5) to Cycle 8|Protocol Violation|0|||
147432628|NCT03153137|531751045|FG000|Overall Study|Lost to Follow-up|1|||
147432629|NCT03153137|531751046|FG001|Overall Study|Lost to Follow-up|0|||
147432630|NCT03153137|531751045|FG000|Overall Study|Withdrawal by Subject|2|||
147432631|NCT03153137|531751046|FG001|Overall Study|Withdrawal by Subject|1|||
147432632|NCT03153137|531751045|FG000|Overall Study|Physician Decision|0|||
147432633|NCT03153137|531751046|FG001|Overall Study|Physician Decision|3|||
147432634|NCT02260882|531751050|FG000|Overall Study|Protocol Violation|0|||
147432635|NCT02260882|531751051|FG001|Overall Study|Protocol Violation|1|||
147432636|NCT01601847|531751052|FG000|Overall Study|Death|1|||
147432637|NCT01601847|531751053|FG001|Overall Study|Death|0|||
147432638|NCT01601847|531751052|FG000|Overall Study|Withdrawal by Subject|11|||
147432639|NCT01601847|531751053|FG001|Overall Study|Withdrawal by Subject|7|||
147432640|NCT01601847|531751052|FG000|Overall Study|Lost to Follow-up|1|||
147432641|NCT01601847|531751053|FG001|Overall Study|Lost to Follow-up|3|||
147432642|NCT01284062|531751065|FG000|Overall Study|Adverse Event|4|||
147432643|NCT01284062|531751066|FG001|Overall Study|Adverse Event|5|||
147432644|NCT01284062|531751067|FG002|Overall Study|Adverse Event|0|||
147432645|NCT01284062|531751068|FG003|Overall Study|Adverse Event|5|||
147432646|NCT01284062|531751065|FG000|Overall Study|Lack of Efficacy|3|||
147432647|NCT01284062|531751066|FG001|Overall Study|Lack of Efficacy|2|||
147432648|NCT01284062|531751067|FG002|Overall Study|Lack of Efficacy|2|||
147432649|NCT01284062|531751068|FG003|Overall Study|Lack of Efficacy|1|||
147432650|NCT01284062|531751065|FG000|Overall Study|Medication error without adverse event|0|||
147432651|NCT01284062|531751066|FG001|Overall Study|Medication error without adverse event|0|||
147432652|NCT01284062|531751067|FG002|Overall Study|Medication error without adverse event|1|||
147432653|NCT01284062|531751068|FG003|Overall Study|Medication error without adverse event|0|||
147432654|NCT01284062|531751065|FG000|Overall Study|Protocol Violation|1|||
147432655|NCT01284062|531751066|FG001|Overall Study|Protocol Violation|0|||
147533632|NCT04668066|532107829|FG008|Part 2: Follow-Up|Withdrawal by Subject|0|||
147533633|NCT04668066|532107830|FG009|Part 2: Follow-Up|Withdrawal by Subject|0|||
147533634|NCT04668066|532107831|FG010|Part 2: Follow-Up|Withdrawal by Subject|0|||
147533635|NCT04668066|532107832|FG011|Part 2: Follow-Up|Withdrawal by Subject|0|||
147533636|NCT04668066|532107833|FG012|Part 2: Follow-Up|Withdrawal by Subject|0|||
147432656|NCT01284062|531751067|FG002|Overall Study|Protocol Violation|0|||
147432657|NCT01284062|531751068|FG003|Overall Study|Protocol Violation|2|||
147533637|NCT04668066|532107834|FG013|Part 2: Follow-Up|Withdrawal by Subject|0|||
147533638|NCT04668066|532107835|FG014|Part 2: Follow-Up|Withdrawal by Subject|0|||
147533639|NCT04668066|532107836|FG015|Part 2: Follow-Up|Withdrawal by Subject|0|||
147533640|NCT04668066|532107837|FG016|Part 2: Follow-Up|Withdrawal by Subject|0|||
147432658|NCT01284062|531751065|FG000|Overall Study|Withdrawal by Subject|3|||
147432659|NCT01284062|531751066|FG001|Overall Study|Withdrawal by Subject|1|||
147432660|NCT01284062|531751067|FG002|Overall Study|Withdrawal by Subject|2|||
147432661|NCT01284062|531751068|FG003|Overall Study|Withdrawal by Subject|5|||
147432662|NCT01284062|531751065|FG000|Overall Study|Other|0|||
147432663|NCT01284062|531751066|FG001|Overall Study|Other|0|||
147432664|NCT01284062|531751067|FG002|Overall Study|Other|0|||
147432665|NCT01284062|531751068|FG003|Overall Study|Other|1|||
147432666|NCT01284062|531751065|FG000|Overall Study|Site Closed|0|||
147432667|NCT01284062|531751066|FG001|Overall Study|Site Closed|0|||
147432668|NCT01284062|531751067|FG002|Overall Study|Site Closed|1|||
147432669|NCT01284062|531751068|FG003|Overall Study|Site Closed|0|||
147432670|NCT00559585|531751071|FG000|Double Blind ST Period Main Study|Adverse Event|17|||
147432671|NCT00559585|531751072|FG001|Double Blind ST Period Main Study|Adverse Event|25|||
147432672|NCT00559585|531751071|FG000|Double Blind ST Period Main Study|Withdrawal by Subject|11|||
147432673|NCT00559585|531751072|FG001|Double Blind ST Period Main Study|Withdrawal by Subject|5|||
147432674|NCT00559585|531751071|FG000|Double Blind ST Period Main Study|Lost to Follow-up|0|||
147432675|NCT00559585|531751072|FG001|Double Blind ST Period Main Study|Lost to Follow-up|6|||
147432676|NCT00559585|531751071|FG000|Double Blind ST Period Main Study|Administrative Reason By Sponsor|1|||
147432677|NCT00559585|531751072|FG001|Double Blind ST Period Main Study|Administrative Reason By Sponsor|0|||
147432678|NCT00559585|531751071|FG000|Double Blind ST Period Main Study|Death|1|||
147432679|NCT00559585|531751072|FG001|Double Blind ST Period Main Study|Death|1|||
147432680|NCT00559585|531751071|FG000|Double Blind ST Period Main Study|No Longer Meets Study Criteria|2|||
147432681|NCT00559585|531751072|FG001|Double Blind ST Period Main Study|No Longer Meets Study Criteria|1|||
147432682|NCT00559585|531751071|FG000|Double Blind ST Period Main Study|Lack of Efficacy|6|||
147432683|NCT00559585|531751072|FG001|Double Blind ST Period Main Study|Lack of Efficacy|1|||
147432684|NCT00559585|531751071|FG000|Double Blind ST Period Main Study|Poor/Non-Compliance|3|||
147432685|NCT00559585|531751072|FG001|Double Blind ST Period Main Study|Poor/Non-Compliance|0|||
147432686|NCT00559585|531751071|FG000|Double Blind ST Period Main Study|Missed Doses|0|||
147432687|NCT00559585|531751072|FG001|Double Blind ST Period Main Study|Missed Doses|1|||
147432688|NCT00559585|531751071|FG000|Double Blind ST Period Main Study|Incomplete Breast Exam|0|||
147432689|NCT00559585|531751072|FG001|Double Blind ST Period Main Study|Incomplete Breast Exam|1|||
147432690|NCT00559585|531751071|FG000|Double Blind ST Period Main Study|Suspended Drug Due To Surgery|0|||
147432691|NCT00559585|531751072|FG001|Double Blind ST Period Main Study|Suspended Drug Due To Surgery|1|||
147432692|NCT00559585|531751071|FG000|Double Blind ST Period Main Study|Early Discontinuation|0|||
147432693|NCT00559585|531751072|FG001|Double Blind ST Period Main Study|Early Discontinuation|1|||
147432694|NCT00559585|531751071|FG000|Double Blind ST Period Main Study|Participant Weight Gain|1|||
147432695|NCT00559585|531751072|FG001|Double Blind ST Period Main Study|Participant Weight Gain|0|||
147432696|NCT00559585|531751071|FG000|Double Blind ST Period Main Study|Participant Withdrew-Recurrent Infection|0|||
147432697|NCT00559585|531751072|FG001|Double Blind ST Period Main Study|Participant Withdrew-Recurrent Infection|1|||
147432698|NCT00559585|531751071|FG000|Double Blind ST Period Main Study|Investigator Decision|0|||
147432699|NCT00559585|531751072|FG001|Double Blind ST Period Main Study|Investigator Decision|1|||
147432700|NCT00559585|531751071|FG000|Double Blind ST Period Main Study|Ongoing Infection Risk|1|||
147432701|NCT00559585|531751072|FG001|Double Blind ST Period Main Study|Ongoing Infection Risk|0|||
147432702|NCT00559585|531751071|FG000|Anti-TNF Sub-Study in ST Period|Lack of Efficacy|1|||
147432703|NCT00559585|531751072|FG001|Anti-TNF Sub-Study in ST Period|Lack of Efficacy|1|||
147432704|NCT00559585|531751071|FG000|Open Label LT Period Main + Sub-Study|Adverse Event|100|||
147432705|NCT00559585|531751072|FG001|Open Label LT Period Main + Sub-Study|Adverse Event|0|||
147432706|NCT00559585|531751071|FG000|Open Label LT Period Main + Sub-Study|Withdrawal by Subject|81|||
147432707|NCT00559585|531751072|FG001|Open Label LT Period Main + Sub-Study|Withdrawal by Subject|0|||
147432708|NCT00559585|531751071|FG000|Open Label LT Period Main + Sub-Study|Pregnancy|16|||
147432709|NCT00559585|531751072|FG001|Open Label LT Period Main + Sub-Study|Pregnancy|0|||
147432710|NCT00559585|531751071|FG000|Open Label LT Period Main + Sub-Study|Lost to Follow-up|32|||
147432711|NCT00559585|531751072|FG001|Open Label LT Period Main + Sub-Study|Lost to Follow-up|0|||
147432712|NCT00559585|531751071|FG000|Open Label LT Period Main + Sub-Study|Administrative reason by Sponsor|9|||
147432713|NCT00559585|531751072|FG001|Open Label LT Period Main + Sub-Study|Administrative reason by Sponsor|0|||
147432714|NCT00559585|531751071|FG000|Open Label LT Period Main + Sub-Study|Death|20|||
147432715|NCT00559585|531751072|FG001|Open Label LT Period Main + Sub-Study|Death|0|||
147533641|NCT04668066|532107838|FG017|Part 2: Follow-Up|Withdrawal by Subject|0|||
147533642|NCT04668066|532107839|FG018|Part 2: Follow-Up|Withdrawal by Subject|1|||
147533643|NCT02331680|532107840|FG000|Overall Study|Adverse Event|3|||
147432716|NCT00559585|531751071|FG000|Open Label LT Period Main + Sub-Study|No longer met criteria|1|||
147432717|NCT00559585|531751072|FG001|Open Label LT Period Main + Sub-Study|No longer met criteria|0|||
147432718|NCT00559585|531751071|FG000|Open Label LT Period Main + Sub-Study|Lack of Efficacy|89|||
147432719|NCT00559585|531751072|FG001|Open Label LT Period Main + Sub-Study|Lack of Efficacy|0|||
147432720|NCT00559585|531751071|FG000|Open Label LT Period Main + Sub-Study|Poor/non-compliance|8|||
147432721|NCT00559585|531751072|FG001|Open Label LT Period Main + Sub-Study|Poor/non-compliance|0|||
147432722|NCT00559585|531751071|FG000|Open Label LT Period Main + Sub-Study|non-specified|71|||
147533644|NCT02331680|532107841|FG001|Overall Study|Adverse Event|0|||
147533645|NCT02331680|532107842|FG002|Overall Study|Adverse Event|2|||
147533646|NCT02331680|532107840|FG000|Overall Study|Physician Decision|1|||
147533647|NCT02331680|532107841|FG001|Overall Study|Physician Decision|1|||
147533648|NCT02331680|532107842|FG002|Overall Study|Physician Decision|2|||
147533649|NCT02331680|532107840|FG000|Overall Study|Withdrawal by Subject|0|||
147533650|NCT02331680|532107841|FG001|Overall Study|Withdrawal by Subject|1|||
147533651|NCT02331680|532107842|FG002|Overall Study|Withdrawal by Subject|2|||
147533652|NCT02331680|532107840|FG000|Overall Study|Met withdrawal criteria|2|||
147533653|NCT02331680|532107841|FG001|Overall Study|Met withdrawal criteria|2|||
147533654|NCT02331680|532107842|FG002|Overall Study|Met withdrawal criteria|5|||
147533655|NCT02331680|532107840|FG000|Overall Study|Non-compliance with study drug|0|||
147533656|NCT02331680|532107841|FG001|Overall Study|Non-compliance with study drug|0|||
147533657|NCT02331680|532107842|FG002|Overall Study|Non-compliance with study drug|1|||
147533658|NCT02331680|532107840|FG000|Overall Study|Protocol Violation|0|||
147533659|NCT02331680|532107841|FG001|Overall Study|Protocol Violation|0|||
147533660|NCT02331680|532107842|FG002|Overall Study|Protocol Violation|3|||
147533661|NCT05147311|532107843|FG000|Overall Study|Did not complete survey|2|||
147533662|NCT05147311|532107844|FG001|Overall Study|Did not complete survey|1|||
147533663|NCT05147311|532107843|FG000|Overall Study|Patient too sick|1|||
147533664|NCT05147311|532107844|FG001|Overall Study|Patient too sick|2|||
147533665|NCT05147311|532107843|FG000|Overall Study|Death|0|||
147533666|NCT05147311|532107844|FG001|Overall Study|Death|1|||
147533667|NCT05147311|532107843|FG000|Overall Study|Declined survey|1|||
147533668|NCT05147311|532107844|FG001|Overall Study|Declined survey|0|||
147533669|NCT04505592|532107846|FG000|Overall Study|Death|2|||
147533670|NCT04505592|532107847|FG001|Overall Study|Death|1|||
147533671|NCT03522506|532107849|FG000|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
147533672|NCT03522506|532107850|FG001|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
147533673|NCT03522506|532107851|FG002|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
147533674|NCT03522506|532107852|FG003|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
147533675|NCT03522506|532107849|FG000|Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
147533676|NCT03522506|532107850|FG001|Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
147533677|NCT03522506|532107851|FG002|Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
147533678|NCT03522506|532107852|FG003|Washout Period 2 (7 Days)|Withdrawal by Subject|1|||
147533679|NCT03480243|532107853|FG000|Padsevonil (Period 2)|Consent withdrawal by subject|1|||
147533680|NCT03480243|532107853|FG000|Padsevonil and Erythromycin (Period 3b)|Un-cooperative behaviour|1|||
147533681|NCT02388906|532107862|FG000|Pre-Treatment Period|Participant withdrew consent|1|||
147533682|NCT02388906|532107863|FG001|Pre-Treatment Period|Participant withdrew consent|0|||
147533683|NCT02388906|532107862|FG000|Treatment Period|Disease progression|121|||
147649355|NCT01026818|532537332|FG001|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|1|||
147649356|NCT01026818|532537333|FG002|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|2|||
147649357|NCT01026818|532537334|FG003|Drug-Free Washout Period (Month 9-10.5)|Withdrawal by Subject|0|||
147649358|NCT01026818|532537331|FG000|Drug-Free Washout Period (Month 9-10.5)|Death|0|||
147649359|NCT01026818|532537332|FG001|Drug-Free Washout Period (Month 9-10.5)|Death|0|||
147649360|NCT01026818|532537333|FG002|Drug-Free Washout Period (Month 9-10.5)|Death|0|||
147649361|NCT01026818|532537334|FG003|Drug-Free Washout Period (Month 9-10.5)|Death|1|||
147649362|NCT01026818|532537331|FG000|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|0|||
147649363|NCT01026818|532537332|FG001|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|2|||
147649364|NCT01026818|532537333|FG002|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|0|||
147649365|NCT01026818|532537334|FG003|OL Period (Month 10.5 - 13.5)|Entry Criteria Not Met|0|||
147649366|NCT01026818|532537331|FG000|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|0|||
147649367|NCT01026818|532537332|FG001|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|1|||
147649368|NCT01026818|532537333|FG002|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|0|||
147649369|NCT01026818|532537334|FG003|OL Period (Month 10.5 - 13.5)|Lack of Efficacy|0|||
147649370|NCT01026818|532537331|FG000|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|0|||
147649371|NCT01026818|532537332|FG001|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|1|||
147649372|NCT01026818|532537333|FG002|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|2|||
147649373|NCT01026818|532537334|FG003|OL Period (Month 10.5 - 13.5)|Lost to Follow-up|1|||
147649374|NCT01026818|532537331|FG000|OL Period (Month 10.5 - 13.5)|Protocol Deviation|0|||
147649375|NCT01026818|532537332|FG001|OL Period (Month 10.5 - 13.5)|Protocol Deviation|1|||
147649376|NCT01026818|532537333|FG002|OL Period (Month 10.5 - 13.5)|Protocol Deviation|3|||
147649377|NCT01026818|532537334|FG003|OL Period (Month 10.5 - 13.5)|Protocol Deviation|1|||
147649378|NCT01026818|532537331|FG000|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|0|||
147649379|NCT01026818|532537332|FG001|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|2|||
147649380|NCT01026818|532537333|FG002|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|0|||
147649381|NCT01026818|532537334|FG003|OL Period (Month 10.5 - 13.5)|Withdrawal by Subject|1|||
147649382|NCT04575584|532537335|FG000|Overall Study|Death|6|||
147533684|NCT02388906|532107863|FG001|Treatment Period|Disease progression|100|||
147533685|NCT02388906|532107862|FG000|Treatment Period|Study drug toxicity|41|||
147533686|NCT02388906|532107863|FG001|Treatment Period|Study drug toxicity|208|||
147533687|NCT02388906|532107862|FG000|Treatment Period|Adverse Event (AE) unrelated to study drug|5|||
147533688|NCT02388906|532107863|FG001|Treatment Period|Adverse Event (AE) unrelated to study drug|5|||
147432723|NCT00559585|531751072|FG001|Open Label LT Period Main + Sub-Study|non-specified|0|||
147432724|NCT00559585|531751071|FG000|Open Label LT Period Main + Sub-Study|no end of study status page|1|||
147432725|NCT00559585|531751072|FG001|Open Label LT Period Main + Sub-Study|no end of study status page|0|||
147432726|NCT04209621|531751073|FG000|Overall Study|Death|1|||
147432727|NCT04209621|531751073|FG000|Overall Study|Study Terminated Early|2|||
147432728|NCT02249767|531751074|FG000|Overall Study|Did not use medication|8|||
147432729|NCT02249767|531751075|FG001|Overall Study|Did not use medication|9|||
147432730|NCT02249767|531751076|FG002|Overall Study|Did not use medication|8|||
147432731|NCT01372410|531751077|FG000|Treatment Period 1 (7 Days)|Lack of Efficacy|1|||
147432732|NCT01372410|531751078|FG001|Treatment Period 1 (7 Days)|Lack of Efficacy|1|||
147432733|NCT01372410|531751079|FG002|Treatment Period 1 (7 Days)|Lack of Efficacy|0|||
147432734|NCT01372410|531751080|FG003|Treatment Period 1 (7 Days)|Lack of Efficacy|0|||
147432735|NCT01372410|531751081|FG004|Treatment Period 1 (7 Days)|Lack of Efficacy|1|||
147432736|NCT01372410|531751082|FG005|Treatment Period 1 (7 Days)|Lack of Efficacy|0|||
147432737|NCT01372410|531751083|FG006|Treatment Period 1 (7 Days)|Lack of Efficacy|0|||
147432738|NCT01372410|531751084|FG007|Treatment Period 1 (7 Days)|Lack of Efficacy|0|||
147432739|NCT01372410|531751077|FG000|Treatment Period 1 (7 Days)|Adverse Event|0|||
147432740|NCT01372410|531751078|FG001|Treatment Period 1 (7 Days)|Adverse Event|1|||
147432741|NCT01372410|531751079|FG002|Treatment Period 1 (7 Days)|Adverse Event|0|||
147432742|NCT01372410|531751080|FG003|Treatment Period 1 (7 Days)|Adverse Event|0|||
147432743|NCT01372410|531751081|FG004|Treatment Period 1 (7 Days)|Adverse Event|0|||
147432744|NCT01372410|531751082|FG005|Treatment Period 1 (7 Days)|Adverse Event|0|||
147432745|NCT01372410|531751083|FG006|Treatment Period 1 (7 Days)|Adverse Event|1|||
147432746|NCT01372410|531751084|FG007|Treatment Period 1 (7 Days)|Adverse Event|0|||
147432747|NCT01372410|531751077|FG000|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
147432748|NCT01372410|531751078|FG001|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
147432749|NCT01372410|531751079|FG002|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
147432750|NCT01372410|531751080|FG003|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
147432751|NCT01372410|531751081|FG004|Treatment Period 1 (7 Days)|Lost to Follow-up|1|||
147432752|NCT01372410|531751082|FG005|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
147432753|NCT01372410|531751083|FG006|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
147432754|NCT01372410|531751084|FG007|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
147432755|NCT01372410|531751077|FG000|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
147432756|NCT01372410|531751078|FG001|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
147432757|NCT01372410|531751079|FG002|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
147432758|NCT01372410|531751080|FG003|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
147432759|NCT01372410|531751081|FG004|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
147432760|NCT01372410|531751082|FG005|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
147432761|NCT01372410|531751083|FG006|Treatment Period 1 (7 Days)|Participant Withdrew Consent|1|||
147432762|NCT01372410|531751084|FG007|Treatment Period 1 (7 Days)|Participant Withdrew Consent|0|||
147432763|NCT01372410|531751077|FG000|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|1|||
147432764|NCT01372410|531751078|FG001|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
147432765|NCT01372410|531751079|FG002|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
147432766|NCT01372410|531751080|FG003|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
147432767|NCT01372410|531751081|FG004|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
147432768|NCT01372410|531751082|FG005|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
147432769|NCT01372410|531751083|FG006|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|0|||
147432770|NCT01372410|531751084|FG007|Washout Period 1 (10-14 Days)|Participant Withdrew Consent|1|||
147432771|NCT01372410|531751077|FG000|Washout Period 2 (10-14 Days)|Adverse Event|0|||
147432772|NCT01372410|531751078|FG001|Washout Period 2 (10-14 Days)|Adverse Event|0|||
147432773|NCT01372410|531751079|FG002|Washout Period 2 (10-14 Days)|Adverse Event|0|||
147432774|NCT01372410|531751080|FG003|Washout Period 2 (10-14 Days)|Adverse Event|0|||
147432775|NCT01372410|531751081|FG004|Washout Period 2 (10-14 Days)|Adverse Event|1|||
147432776|NCT01372410|531751082|FG005|Washout Period 2 (10-14 Days)|Adverse Event|0|||
147432777|NCT01372410|531751083|FG006|Washout Period 2 (10-14 Days)|Adverse Event|0|||
147432778|NCT01372410|531751084|FG007|Washout Period 2 (10-14 Days)|Adverse Event|0|||
147432779|NCT01372410|531751077|FG000|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0|||
147432780|NCT01372410|531751078|FG001|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0|||
147432781|NCT01372410|531751079|FG002|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0|||
147432782|NCT01372410|531751080|FG003|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0|||
147432783|NCT01372410|531751081|FG004|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|1|||
147432784|NCT01372410|531751082|FG005|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|0|||
147432785|NCT01372410|531751083|FG006|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|1|||
147432786|NCT01372410|531751084|FG007|Washout Period 2 (10-14 Days)|Participant Withdrew Consent|1|||
147432787|NCT01372410|531751077|FG000|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
147432788|NCT01372410|531751078|FG001|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
147432789|NCT01372410|531751079|FG002|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
147533689|NCT02388906|532107862|FG000|Treatment Period|Participant request to stop treatment|5|||
147432790|NCT01372410|531751080|FG003|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
147432791|NCT01372410|531751081|FG004|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
147432792|NCT01372410|531751082|FG005|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
147432793|NCT01372410|531751083|FG006|Washout Period 2 (10-14 Days)|Lack of Efficacy|0|||
147432794|NCT01372410|531751084|FG007|Washout Period 2 (10-14 Days)|Lack of Efficacy|1|||
147432795|NCT01372410|531751077|FG000|Treatment Period 3 (7 Days)|Adverse Event|0|||
147432796|NCT01372410|531751078|FG001|Treatment Period 3 (7 Days)|Adverse Event|0|||
147432797|NCT01372410|531751079|FG002|Treatment Period 3 (7 Days)|Adverse Event|1|||
147432798|NCT01372410|531751080|FG003|Treatment Period 3 (7 Days)|Adverse Event|0|||
147432799|NCT01372410|531751081|FG004|Treatment Period 3 (7 Days)|Adverse Event|0|||
147432800|NCT01372410|531751082|FG005|Treatment Period 3 (7 Days)|Adverse Event|0|||
147432801|NCT01372410|531751083|FG006|Treatment Period 3 (7 Days)|Adverse Event|0|||
147432802|NCT01372410|531751084|FG007|Treatment Period 3 (7 Days)|Adverse Event|0|||
147432803|NCT01372410|531751077|FG000|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
147432804|NCT01372410|531751078|FG001|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
147432805|NCT01372410|531751079|FG002|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
147432806|NCT01372410|531751080|FG003|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
147432807|NCT01372410|531751081|FG004|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
147432808|NCT01372410|531751082|FG005|Treatment Period 3 (7 Days)|Protocol Deviation|1|||
147432809|NCT01372410|531751083|FG006|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
147432810|NCT01372410|531751084|FG007|Treatment Period 3 (7 Days)|Protocol Deviation|0|||
147432811|NCT02644941|531751085|FG000|18 Months|Subjects lost graft during the study up to the data cut-off|49|||
147432812|NCT02644941|531751086|FG001|18 Months|Subjects lost graft during the study up to the data cut-off|52|||
147432813|NCT04585646|531751087|FG000|First Intervention|Physician Decision|1|||
147432814|NCT04585646|531751088|FG001|First Intervention|Physician Decision|0|||
147432815|NCT04585646|531751087|FG000|First Intervention|Lost to Follow-up|0|||
147432816|NCT04585646|531751088|FG001|First Intervention|Lost to Follow-up|3|||
147432817|NCT04585646|531751087|FG000|First Intervention|Withdrawal by Subject|0|||
147432818|NCT04585646|531751088|FG001|First Intervention|Withdrawal by Subject|1|||
147432819|NCT01145495|531751089|FG000|Overall Study|Adverse Event|6|||
147432820|NCT01145495|531751089|FG000|Overall Study|Withdrawal by Subject|6|||
147432821|NCT01145495|531751089|FG000|Overall Study|Disease progression after respone|2|||
147432822|NCT01230788|531751094|FG000|Overall Study|Prescribed exclusion drug|1|||
147533690|NCT02388906|532107863|FG001|Treatment Period|Participant request to stop treatment|9|||
147533691|NCT02388906|532107862|FG000|Treatment Period|Participant withdrew consent|2|||
147533692|NCT02388906|532107863|FG001|Treatment Period|Participant withdrew consent|3|||
147533693|NCT02388906|532107862|FG000|Treatment Period|Poor/non-compliance|0|||
147533694|NCT02388906|532107863|FG001|Treatment Period|Poor/non-compliance|1|||
147533695|NCT02388906|532107862|FG000|Treatment Period|Participant no longer meets study criteria|0|||
147432823|NCT04226833|531751095|FG000|Overall Study|Death|0|||
147432824|NCT04226833|531751096|FG001|Overall Study|Death|0|||
147432825|NCT04226833|531751097|FG002|Overall Study|Death|1|||
147432826|NCT04226833|531751098|FG003|Overall Study|Death|0|||
147432827|NCT01472380|531751099|FG000|Efavirenz Alone|Withdrawal by Subject|1|||
147432828|NCT01472380|531751099|FG000|1 Day Period Between Dosing|Protocol Violation|1|||
147432829|NCT03829319|531751100|FG000|Overall Study|Sponsor's Decision|4|||
147533696|NCT02388906|532107863|FG001|Treatment Period|Participant no longer meets study criteria|1|||
147533697|NCT02388906|532107862|FG000|Treatment Period|Other reasons|3|||
147533698|NCT02388906|532107863|FG001|Treatment Period|Other reasons|3|||
147533699|NCT05770401|532107872|FG000|Overall Study|Lost to Follow-up|5|||
147533700|NCT05770401|532107873|FG001|Overall Study|Lost to Follow-up|4|||
147533701|NCT00402298|532107874|FG000|Overall Study|Withdrawal by Subject|1|||
147533702|NCT00402298|532107875|FG001|Overall Study|Withdrawal by Subject|0|||
147533703|NCT04784455|532107876|FG000|Overall Study|Death|4|||
147533704|NCT04298229|532107877|FG000|Overall Study|Physician Decision|1|||
147533705|NCT04298229|532107878|FG001|Overall Study|Physician Decision|1|||
147533706|NCT04298229|532107877|FG000|Overall Study|Withdrawal by Subject|1|||
147533707|NCT04298229|532107878|FG001|Overall Study|Withdrawal by Subject|1|||
147533708|NCT04298229|532107877|FG000|Overall Study|Did not receive IV loop diuretics|2|||
147533709|NCT04298229|532107878|FG001|Overall Study|Did not receive IV loop diuretics|0|||
147533710|NCT00859313|532107879|FG000|Overall Study|Lack of Efficacy|2|||
147533711|NCT00859313|532107879|FG000|Overall Study|Adverse Event|1|||
147533712|NCT00859313|532107879|FG000|Overall Study|staff error|1|||
147533713|NCT05643573|532107882|FG000|Overall Study|Adverse Event|117|||
147533714|NCT05643573|532107883|FG001|Overall Study|Adverse Event|90|||
147533715|NCT05643573|532107882|FG000|Overall Study|Death|53|||
147533716|NCT05643573|532107883|FG001|Overall Study|Death|57|||
147533717|NCT05643573|532107882|FG000|Overall Study|Lost to Follow-up|6|||
147432830|NCT03829319|531751101|FG001|Overall Study|Sponsor's Decision|90|||
147432831|NCT03829319|531751102|FG002|Overall Study|Sponsor's Decision|102|||
147432832|NCT03829319|531751100|FG000|Overall Study|Withdrawal by Subject|1|||
147432833|NCT03829319|531751101|FG001|Overall Study|Withdrawal by Subject|5|||
147432834|NCT03829319|531751102|FG002|Overall Study|Withdrawal by Subject|4|||
147432835|NCT03829319|531751100|FG000|Overall Study|Physician Decision|0|||
147533718|NCT05643573|532107883|FG001|Overall Study|Lost to Follow-up|3|||
147533719|NCT05643573|532107882|FG000|Overall Study|Other|18|||
147533720|NCT05643573|532107883|FG001|Overall Study|Other|15|||
147533721|NCT05643573|532107882|FG000|Overall Study|Outcome event|64|||
147533722|NCT05643573|532107883|FG001|Overall Study|Outcome event|36|||
147533723|NCT05643573|532107882|FG000|Overall Study|Physician Decision|33|||
147533724|NCT05643573|532107883|FG001|Overall Study|Physician Decision|19|||
147533725|NCT05643573|532107882|FG000|Overall Study|Protocol-specified withdrawal criterion met|2|||
147533726|NCT05643573|532107883|FG001|Overall Study|Protocol-specified withdrawal criterion met|2|||
147533727|NCT05643573|532107882|FG000|Overall Study|Site terminated by sponsor|10|||
147533728|NCT05643573|532107883|FG001|Overall Study|Site terminated by sponsor|10|||
147533729|NCT05643573|532107882|FG000|Overall Study|Study terminated by sponsor|1|||
147533730|NCT05643573|532107883|FG001|Overall Study|Study terminated by sponsor|0|||
147533731|NCT05643573|532107882|FG000|Overall Study|Withdrawal by Subject|178|||
147533732|NCT05643573|532107883|FG001|Overall Study|Withdrawal by Subject|130|||
147533733|NCT02500732|532107884|FG000|Overall Study|Physician Decision|0|||
147533734|NCT02500732|532107885|FG001|Overall Study|Physician Decision|1|||
147533735|NCT04794491|532107888|FG000|Overall Study|Adverse Event|1|||
147533736|NCT04794491|532107888|FG000|Overall Study|Alcohol or Urine Drug Screen Result Is Positive|4|||
147533737|NCT04794491|532107888|FG000|Overall Study|Noncompliance With Study Intervention|1|||
147533738|NCT04794491|532107888|FG000|Overall Study|Withdrawal by Subject|2|||
147533739|NCT00931515|532107889|FG000|Overall Study|Lost to Follow-up|2|||
147533740|NCT00931515|532107890|FG001|Overall Study|Lost to Follow-up|5|||
147533741|NCT03145207|532107894|FG000|Overall Study|volunteer started taking allergy shots|1|||
147533742|NCT03145207|532107894|FG000|Overall Study|baseline blood pressure high|1|||
147533743|NCT01396434|532107896|FG000|Overall Study|Lost to Follow-up|1|||
147533744|NCT01396434|532107897|FG001|Overall Study|Lost to Follow-up|0|||
147533745|NCT01396434|532107898|FG002|Overall Study|Lost to Follow-up|0|||
147533746|NCT01396434|532107896|FG000|Overall Study|Other|10|||
147533747|NCT01396434|532107897|FG001|Overall Study|Other|0|||
147533748|NCT01396434|532107898|FG002|Overall Study|Other|0|||
147533749|NCT00347776|532109493|FG000|1.5 Month Follow-up|Death|2|||
147533750|NCT00347776|532109494|FG001|1.5 Month Follow-up|Death|0|||
147533751|NCT00347776|532109495|FG002|1.5 Month Follow-up|Death|0|||
147533752|NCT00347776|532109493|FG000|1.5 Month Follow-up|reached the endpoint|12|||
147533753|NCT00347776|532109494|FG001|1.5 Month Follow-up|reached the endpoint|8|||
147533754|NCT00347776|532109495|FG002|1.5 Month Follow-up|reached the endpoint|12|||
147533755|NCT00347776|532109493|FG000|6 Month Follow-up|Death|2|||
147533756|NCT00347776|532109494|FG001|6 Month Follow-up|Death|1|||
147533757|NCT00347776|532109495|FG002|6 Month Follow-up|Death|3|||
147533758|NCT00347776|532109493|FG000|6 Month Follow-up|reached endpont|20|||
147533759|NCT00347776|532109494|FG001|6 Month Follow-up|reached endpont|12|||
147533760|NCT00347776|532109495|FG002|6 Month Follow-up|reached endpont|15|||
147533761|NCT00347776|532109493|FG000|12 Month Follow-up|Lost to Follow-up|7|||
147533762|NCT00347776|532109494|FG001|12 Month Follow-up|Lost to Follow-up|6|||
147533763|NCT00347776|532109495|FG002|12 Month Follow-up|Lost to Follow-up|6|||
147533764|NCT00347776|532109493|FG000|12 Month Follow-up|Death|3|||
147533765|NCT00347776|532109494|FG001|12 Month Follow-up|Death|4|||
147432836|NCT03829319|531751101|FG001|Overall Study|Physician Decision|3|||
147432837|NCT03829319|531751102|FG002|Overall Study|Physician Decision|0|||
147432838|NCT03829319|531751100|FG000|Overall Study|Lost to Follow-up|0|||
147432839|NCT03829319|531751101|FG001|Overall Study|Lost to Follow-up|0|||
147432840|NCT03829319|531751102|FG002|Overall Study|Lost to Follow-up|1|||
147432841|NCT03829319|531751100|FG000|Overall Study|Death|8|||
147432842|NCT03829319|531751101|FG001|Overall Study|Death|277|||
147432843|NCT03829319|531751102|FG002|Overall Study|Death|266|||
147432844|NCT02846532|531751103|FG000|Overall Study|Lost to Follow-up|0|||
147432845|NCT02846532|531751104|FG001|Overall Study|Lost to Follow-up|1|||
147432846|NCT02846532|531751105|FG002|Overall Study|Lost to Follow-up|1|||
147432847|NCT02846532|531751103|FG000|Overall Study|Withdrawal by Subject|1|||
147432848|NCT02846532|531751104|FG001|Overall Study|Withdrawal by Subject|2|||
147432849|NCT02846532|531751105|FG002|Overall Study|Withdrawal by Subject|0|||
147432850|NCT04484259|531751106|FG000|Run-in Phase With Aspirin and Ticagrelor|Adverse Event|0|||
147432851|NCT04484259|531751107|FG001|Run-in Phase With Aspirin and Ticagrelor|Adverse Event|0|||
147432852|NCT04484259|531751108|FG002|Run-in Phase With Aspirin and Ticagrelor|Adverse Event|0|||
147432853|NCT04484259|531751109|FG003|Run-in Phase With Aspirin and Ticagrelor|Adverse Event|9|||
147432854|NCT04484259|531751110|FG004|Run-in Phase With Aspirin and Ticagrelor|Adverse Event|0|||
147432855|NCT04484259|531751106|FG000|Run-in Phase With Aspirin and Ticagrelor|Withdrawal by Subject|0|||
147432856|NCT04484259|531751107|FG001|Run-in Phase With Aspirin and Ticagrelor|Withdrawal by Subject|0|||
147432857|NCT04484259|531751108|FG002|Run-in Phase With Aspirin and Ticagrelor|Withdrawal by Subject|0|||
147533766|NCT00347776|532109495|FG002|12 Month Follow-up|Death|4|||
147533767|NCT00347776|532109493|FG000|12 Month Follow-up|Reached endpoint|13|||
147533768|NCT00347776|532109494|FG001|12 Month Follow-up|Reached endpoint|6|||
147533769|NCT00347776|532109495|FG002|12 Month Follow-up|Reached endpoint|9|||
147432858|NCT04484259|531751109|FG003|Run-in Phase With Aspirin and Ticagrelor|Withdrawal by Subject|4|||
147432859|NCT04484259|531751110|FG004|Run-in Phase With Aspirin and Ticagrelor|Withdrawal by Subject|0|||
147432860|NCT04484259|531751106|FG000|Run-in Phase With Aspirin and Ticagrelor|Physician Decision|0|||
147432861|NCT04484259|531751107|FG001|Run-in Phase With Aspirin and Ticagrelor|Physician Decision|0|||
147432862|NCT04484259|531751108|FG002|Run-in Phase With Aspirin and Ticagrelor|Physician Decision|0|||
147432863|NCT04484259|531751109|FG003|Run-in Phase With Aspirin and Ticagrelor|Physician Decision|2|||
147432864|NCT04484259|531751110|FG004|Run-in Phase With Aspirin and Ticagrelor|Physician Decision|0|||
147432865|NCT04484259|531751106|FG000|Run-in Phase With Aspirin and Ticagrelor|Lost to Follow-up|0|||
147432866|NCT04484259|531751107|FG001|Run-in Phase With Aspirin and Ticagrelor|Lost to Follow-up|0|||
147432867|NCT04484259|531751108|FG002|Run-in Phase With Aspirin and Ticagrelor|Lost to Follow-up|0|||
147432868|NCT04484259|531751109|FG003|Run-in Phase With Aspirin and Ticagrelor|Lost to Follow-up|4|||
147432869|NCT04484259|531751110|FG004|Run-in Phase With Aspirin and Ticagrelor|Lost to Follow-up|0|||
147432870|NCT04484259|531751106|FG000|Run-in Phase With Ticagrelor Monotherapy|Adverse Event|0|||
147432871|NCT04484259|531751107|FG001|Run-in Phase With Ticagrelor Monotherapy|Adverse Event|0|||
147432872|NCT04484259|531751108|FG002|Run-in Phase With Ticagrelor Monotherapy|Adverse Event|0|||
147432873|NCT04484259|531751109|FG003|Run-in Phase With Ticagrelor Monotherapy|Adverse Event|0|||
147432874|NCT04484259|531751110|FG004|Run-in Phase With Ticagrelor Monotherapy|Adverse Event|1|||
147432875|NCT04484259|531751106|FG000|Randomized Treatment|Withdrawal by Subject|1|||
147432876|NCT04484259|531751107|FG001|Randomized Treatment|Withdrawal by Subject|0|||
147432877|NCT04484259|531751108|FG002|Randomized Treatment|Withdrawal by Subject|0|||
147432878|NCT04484259|531751109|FG003|Randomized Treatment|Withdrawal by Subject|0|||
147432879|NCT04484259|531751110|FG004|Randomized Treatment|Withdrawal by Subject|0|||
147432880|NCT03951220|531751111|FG000|Overall Study|Withdrawal by Subject|9|||
147432881|NCT03951220|531751112|FG001|Overall Study|Withdrawal by Subject|2|||
147432882|NCT03951220|531751113|FG002|Overall Study|Withdrawal by Subject|0|||
147432883|NCT05359003|531751114|FG000|Overall Study|Withdrawal by Subject|1|||
147432884|NCT05359003|531751115|FG001|Overall Study|Withdrawal by Subject|3|||
147432885|NCT06268288|531751118|FG000|Overall Study|Withdrawal by Subject|1|||
147432886|NCT06268288|531751119|FG001|Overall Study|Withdrawal by Subject|2|||
147432887|NCT03049735|531751120|FG000|Overall Study|Discontinued due to AE (not dosed)|0|||
147432888|NCT03049735|531751121|FG001|Overall Study|Discontinued due to AE (not dosed)|0|||
147432889|NCT03049735|531751122|FG002|Overall Study|Discontinued due to AE (not dosed)|1|||
147432890|NCT03049735|531751120|FG000|Overall Study|Other|5|||
147432891|NCT03049735|531751121|FG001|Overall Study|Other|3|||
147432892|NCT03049735|531751122|FG002|Overall Study|Other|1|||
147432893|NCT03049735|531751120|FG000|Overall Study|Lack of Efficacy|4|||
147432894|NCT03049735|531751121|FG001|Overall Study|Lack of Efficacy|0|||
147432895|NCT03049735|531751122|FG002|Overall Study|Lack of Efficacy|3|||
147432896|NCT03049735|531751120|FG000|Overall Study|Protocol deviation|1|||
147432897|NCT03049735|531751121|FG001|Overall Study|Protocol deviation|0|||
147432898|NCT03049735|531751122|FG002|Overall Study|Protocol deviation|0|||
147432899|NCT03049735|531751120|FG000|Overall Study|Pregnancy|0|||
147432900|NCT03049735|531751121|FG001|Overall Study|Pregnancy|0|||
147432901|NCT03049735|531751122|FG002|Overall Study|Pregnancy|1|||
147432902|NCT03049735|531751120|FG000|Overall Study|Adverse Event|7|||
147432903|NCT03049735|531751121|FG001|Overall Study|Adverse Event|18|||
147432904|NCT03049735|531751122|FG002|Overall Study|Adverse Event|5|||
147432905|NCT03049735|531751120|FG000|Overall Study|Withdrawal by Subject|10|||
147432906|NCT03049735|531751121|FG001|Overall Study|Withdrawal by Subject|3|||
147432907|NCT03049735|531751122|FG002|Overall Study|Withdrawal by Subject|7|||
147432908|NCT03049735|531751120|FG000|Overall Study|Lost to Follow-up|1|||
147432909|NCT03049735|531751121|FG001|Overall Study|Lost to Follow-up|5|||
147432910|NCT03049735|531751122|FG002|Overall Study|Lost to Follow-up|5|||
147432911|NCT02146326|531751123|FG000|Overall Study|Lost to Follow-up|3|||
147432912|NCT02146326|531751124|FG001|Overall Study|Lost to Follow-up|3|||
147432913|NCT02146326|531751125|FG002|Overall Study|Lost to Follow-up|11|||
147432914|NCT02146326|531751126|FG003|Overall Study|Lost to Follow-up|19|||
147432915|NCT02146326|531751123|FG000|Overall Study|Withdrawal by Subject|2|||
147432916|NCT02146326|531751124|FG001|Overall Study|Withdrawal by Subject|1|||
147432917|NCT02146326|531751125|FG002|Overall Study|Withdrawal by Subject|15|||
147193107|NCT00625131|530876433|FG001|Overall Study|Withdrawal by Subject|0|||
147432918|NCT02146326|531751126|FG003|Overall Study|Withdrawal by Subject|11|||
147432919|NCT02146326|531751123|FG000|Overall Study|Separated from mental health center|23|||
147432920|NCT02146326|531751124|FG001|Overall Study|Separated from mental health center|33|||
147432921|NCT02146326|531751125|FG002|Overall Study|Separated from mental health center|0|||
147432922|NCT02146326|531751126|FG003|Overall Study|Separated from mental health center|0|||
147432923|NCT02146326|531751123|FG000|Overall Study|Incarcerated|0|||
147432924|NCT02146326|531751124|FG001|Overall Study|Incarcerated|0|||
147432925|NCT02146326|531751125|FG002|Overall Study|Incarcerated|3|||
147432926|NCT02146326|531751126|FG003|Overall Study|Incarcerated|8|||
147432927|NCT02146326|531751123|FG000|Overall Study|Death|0|||
147432928|NCT02146326|531751124|FG001|Overall Study|Death|0|||
147432929|NCT02146326|531751125|FG002|Overall Study|Death|4|||
147432930|NCT02146326|531751126|FG003|Overall Study|Death|4|||
147533770|NCT00938392|532109496|FG000|Overall Study|Adverse Event|0|||
147533771|NCT00938392|532109497|FG001|Overall Study|Adverse Event|1|||
147533772|NCT00938392|532109496|FG000|Overall Study|Withdrawal by Subject|0|||
147533773|NCT00938392|532109497|FG001|Overall Study|Withdrawal by Subject|1|||
147533774|NCT00938392|532109496|FG000|Overall Study|Lost to Follow-up|2|||
147533775|NCT00938392|532109497|FG001|Overall Study|Lost to Follow-up|2|||
147533776|NCT05644756|532109501|FG000|Aim 1 Activities (Ethnography)|Withdrawal by Subject|1|||
147533777|NCT05644756|532109501|FG000|Aim 2 Activities (Fidelity to MBC)|Lost to Follow-up|5|||
147533778|NCT03985982|532109502|FG000|Double-Blind Phase|Lost to Follow-up|4|||
147533779|NCT03985982|532109503|FG001|Double-Blind Phase|Lost to Follow-up|3|||
147533780|NCT03985982|532109504|FG002|Double-Blind Phase|Lost to Follow-up|0|||
147533781|NCT03985982|532109502|FG000|Double-Blind Phase|Physician Decision|1|||
147533782|NCT03985982|532109503|FG001|Double-Blind Phase|Physician Decision|0|||
147533783|NCT03985982|532109504|FG002|Double-Blind Phase|Physician Decision|0|||
147533784|NCT03985982|532109502|FG000|Double-Blind Phase|Withdrawal by Subject|9|||
147533785|NCT03985982|532109503|FG001|Double-Blind Phase|Withdrawal by Subject|2|||
147533786|NCT03985982|532109504|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
147533787|NCT03985982|532109502|FG000|Double-Blind Phase|COVID-19|1|||
147533788|NCT03985982|532109503|FG001|Double-Blind Phase|COVID-19|0|||
147533789|NCT03985982|532109504|FG002|Double-Blind Phase|COVID-19|0|||
147533790|NCT03985982|532109502|FG000|Double-Blind Phase|Early Termination due to Botox Injection while Participating in the Study|1|||
147533791|NCT03985982|532109503|FG001|Double-Blind Phase|Early Termination due to Botox Injection while Participating in the Study|0|||
147533792|NCT03985982|532109504|FG002|Double-Blind Phase|Early Termination due to Botox Injection while Participating in the Study|0|||
147533793|NCT03985982|532109502|FG000|Open-Label Phase|Lost to Follow-up|0|||
147533794|NCT03985982|532109503|FG001|Open-Label Phase|Lost to Follow-up|0|||
147533795|NCT03985982|532109504|FG002|Open-Label Phase|Lost to Follow-up|13|||
147533796|NCT03985982|532109502|FG000|Open-Label Phase|Physician Decision|0|||
147533797|NCT03985982|532109503|FG001|Open-Label Phase|Physician Decision|0|||
147533798|NCT03985982|532109504|FG002|Open-Label Phase|Physician Decision|2|||
147533799|NCT03985982|532109502|FG000|Open-Label Phase|Withdrawal by Subject|0|||
147533800|NCT03985982|532109503|FG001|Open-Label Phase|Withdrawal by Subject|0|||
147533801|NCT03985982|532109504|FG002|Open-Label Phase|Withdrawal by Subject|11|||
147533802|NCT01298362|532109508|FG000|Overall Study|Did not provide 12month BMD measurements|38|||
147533803|NCT01298362|532109509|FG001|Overall Study|Did not provide 12month BMD measurements|43|||
147533804|NCT00505765|532109520|FG000|Overall Study|Withdrawal by Subject|1|||
147533805|NCT00505765|532109521|FG001|Overall Study|Withdrawal by Subject|0|||
147533806|NCT00505765|532109522|FG002|Overall Study|Withdrawal by Subject|0|||
147533807|NCT00505765|532109520|FG000|Overall Study|Adverse Event|1|||
147533808|NCT00505765|532109521|FG001|Overall Study|Adverse Event|2|||
147533809|NCT00505765|532109522|FG002|Overall Study|Adverse Event|0|||
147533810|NCT00505765|532109520|FG000|Overall Study|Noncompliance|0|||
147533811|NCT00505765|532109521|FG001|Overall Study|Noncompliance|1|||
147533812|NCT00505765|532109522|FG002|Overall Study|Noncompliance|3|||
147533813|NCT02743117|532109523|FG000|Overall Study|Lost to Follow-up|0|||
147533814|NCT02743117|532109524|FG001|Overall Study|Lost to Follow-up|1|||
147533815|NCT02743117|532109523|FG000|Overall Study|Other|1|||
147533816|NCT02743117|532109524|FG001|Overall Study|Other|0|||
147533817|NCT01207219|532109526|FG000|Overall Study|changed diagnosis during study period|5|||
147533818|NCT01207219|532109527|FG001|Overall Study|changed diagnosis during study period|3|||
147533819|NCT01207219|532109528|FG002|Overall Study|changed diagnosis during study period|1|||
147533820|NCT01207219|532109526|FG000|Overall Study|Lost to Follow-up|6|||
147533821|NCT01207219|532109527|FG001|Overall Study|Lost to Follow-up|8|||
147533822|NCT01207219|532109528|FG002|Overall Study|Lost to Follow-up|6|||
147533823|NCT01453296|532109529|FG000|Treatment Period 1|Adverse Event|0|||
147533824|NCT01453296|532109530|FG001|Treatment Period 1|Adverse Event|1|||
147533825|NCT01453296|532109529|FG000|Treatment Period 1|Met Protocol-Defined Stopping Criteria|1|||
147533826|NCT01453296|532109530|FG001|Treatment Period 1|Met Protocol-Defined Stopping Criteria|0|||
147533827|NCT01453296|532109529|FG000|Treatment Period 2|Adverse Event|1|||
147533828|NCT01453296|532109530|FG001|Treatment Period 2|Adverse Event|0|||
147533829|NCT01453296|532109529|FG000|Treatment Period 2|Withdrawal by Subject|1|||
147533830|NCT01453296|532109530|FG001|Treatment Period 2|Withdrawal by Subject|0|||
147533831|NCT00620776|532109531|FG000|Overall Study|Did not receive treatment|3|||
147533832|NCT00620776|532109532|FG001|Overall Study|Did not receive treatment|5|||
147533833|NCT00620776|532109531|FG000|Overall Study|Adverse Event|2|||
147533834|NCT00620776|532109532|FG001|Overall Study|Adverse Event|3|||
147533835|NCT00620776|532109531|FG000|Overall Study|Lack of Efficacy|2|||
147533836|NCT00620776|532109532|FG001|Overall Study|Lack of Efficacy|1|||
147533837|NCT00620776|532109531|FG000|Overall Study|Lost to Follow-up|2|||
147533838|NCT00620776|532109532|FG001|Overall Study|Lost to Follow-up|5|||
147533839|NCT00620776|532109531|FG000|Overall Study|Withdrawal by Subject|3|||
147533840|NCT00620776|532109532|FG001|Overall Study|Withdrawal by Subject|2|||
147533841|NCT00183170|532109537|FG000|First Intervention|Did not complete study|1|||
147533842|NCT00183170|532109538|FG001|First Intervention|Did not complete study|0|||
147533843|NCT00183170|532109537|FG000|First Intervention|Did not meet targeted BrAC|1|||
147649383|NCT04575584|532537336|FG001|Overall Study|Death|4|||
147533844|NCT00183170|532109538|FG001|First Intervention|Did not meet targeted BrAC|0|||
147306732|NCT00572624|531290742|FG000|Overall Study|Lost to Follow-up|10|||
147306733|NCT00572624|531290743|FG001|Overall Study|Lost to Follow-up|4|||
147306734|NCT00572624|531290742|FG000|Overall Study|Wanted to do a different diet program|1|||
147306735|NCT00572624|531290743|FG001|Overall Study|Wanted to do a different diet program|0|||
147306736|NCT00572624|531290742|FG000|Overall Study|Medication change|1|||
147306737|NCT00572624|531290743|FG001|Overall Study|Medication change|0|||
147306738|NCT00572624|531290742|FG000|Overall Study|Started a new job-- no time for study|1|||
147306739|NCT00572624|531290743|FG001|Overall Study|Started a new job-- no time for study|0|||
147306740|NCT00572624|531290742|FG000|Overall Study|Admitted to being a smoker|1|||
147306741|NCT00572624|531290743|FG001|Overall Study|Admitted to being a smoker|0|||
147306742|NCT00572624|531290742|FG000|Overall Study|Refused to do the stress test|1|||
147306743|NCT00572624|531290743|FG001|Overall Study|Refused to do the stress test|0|||
147306744|NCT00572624|531290742|FG000|Overall Study|Problem with vascular access|1|||
147306745|NCT00572624|531290743|FG001|Overall Study|Problem with vascular access|0|||
147306746|NCT00572624|531290742|FG000|Overall Study|Health issues unrelated to the study|1|||
147306747|NCT00572624|531290743|FG001|Overall Study|Health issues unrelated to the study|0|||
147306748|NCT01436201|531290757|FG000|Overall Study|Adverse Event|2|||
147306749|NCT01436201|531290757|FG000|Overall Study|Withdrawal by Subject|1|||
147306750|NCT01436201|531290757|FG000|Overall Study|Protocol Violation|1|||
147306751|NCT01435655|531290758|FG000|Overall Study|Death|2|||
147306752|NCT01435655|531290758|FG000|Overall Study|Other|1|||
147306753|NCT00110890|531290760|FG000|Overall Study|Adverse Event|30|||
147306754|NCT00110890|531290761|FG001|Overall Study|Adverse Event|7|||
147306755|NCT00110890|531290760|FG000|Overall Study|Death|16|||
147306756|NCT00110890|531290761|FG001|Overall Study|Death|9|||
147306757|NCT00110890|531290760|FG000|Overall Study|Lost to Follow-up|3|||
147306758|NCT00110890|531290761|FG001|Overall Study|Lost to Follow-up|1|||
147306759|NCT00110890|531290760|FG000|Overall Study|Physician Decision|4|||
147306760|NCT00110890|531290761|FG001|Overall Study|Physician Decision|5|||
147306761|NCT00110890|531290760|FG000|Overall Study|Withdrawal by Subject|17|||
147306762|NCT00110890|531290761|FG001|Overall Study|Withdrawal by Subject|5|||
147306763|NCT00110890|531290760|FG000|Overall Study|Protocol Deviation|1|||
147306764|NCT00110890|531290761|FG001|Overall Study|Protocol Deviation|0|||
147306765|NCT00110890|531290760|FG000|Overall Study|Noncompliance|10|||
147306766|NCT00110890|531290761|FG001|Overall Study|Noncompliance|0|||
147306767|NCT00110890|531290760|FG000|Overall Study|Kidney Transplant|16|||
147306768|NCT00110890|531290761|FG001|Overall Study|Kidney Transplant|12|||
147306769|NCT00110890|531290760|FG000|Overall Study|Invest. Product Commercially Available|217|||
147306770|NCT00110890|531290761|FG001|Overall Study|Invest. Product Commercially Available|110|||
147306771|NCT00110890|531290760|FG000|Overall Study|Other|34|||
147306772|NCT00110890|531290761|FG001|Overall Study|Other|23|||
147306773|NCT00110890|531290760|FG000|Overall Study|Ineligibility determined|3|||
147306774|NCT00110890|531290761|FG001|Overall Study|Ineligibility determined|0|||
147306775|NCT00110890|531290760|FG000|Overall Study|Requirement for alternative therapy|0|||
147533845|NCT00183170|532109537|FG000|Washout 1 Week|Did not complete study|6|||
147533846|NCT00183170|532109538|FG001|Washout 1 Week|Did not complete study|8|||
147533847|NCT00183170|532109537|FG000|Second Intervention|Did not complete study|1|||
147533848|NCT00183170|532109538|FG001|Second Intervention|Did not complete study|0|||
147533849|NCT00183170|532109537|FG000|Second Intervention|Did not meet targeted BrAC|0|||
147533850|NCT00183170|532109538|FG001|Second Intervention|Did not meet targeted BrAC|2|||
147533851|NCT00924820|532109539|FG000|Overall Study|Death|2|||
147533852|NCT00924820|532109539|FG000|Overall Study|Ineligible, Screen Failure|5|||
147533853|NCT04983589|532109540|FG000|Overall Study|Withdrawal by Subject|0|||
147533854|NCT04983589|532109541|FG001|Overall Study|Withdrawal by Subject|3|||
147533855|NCT04983589|532109540|FG000|Overall Study|COVID-19 Infection|1|||
147533856|NCT04983589|532109541|FG001|Overall Study|COVID-19 Infection|0|||
147533857|NCT04983589|532109540|FG000|Overall Study|COVID-19 Logistical Restrictions|2|||
147533858|NCT04983589|532109541|FG001|Overall Study|COVID-19 Logistical Restrictions|0|||
147533859|NCT00585468|532109542|FG000|First Intervention|Withdrawal by Subject|1|||
147533860|NCT00585468|532109543|FG001|First Intervention|Withdrawal by Subject|1|||
147533861|NCT00978120|532109548|FG000|Overall Study|Death|0|||
147533862|NCT00978120|532109549|FG001|Overall Study|Death|0|||
147533863|NCT00978120|532109550|FG002|Overall Study|Death|0|||
147533864|NCT00978120|532109551|FG003|Overall Study|Death|1|||
147533865|NCT00978120|532109548|FG000|Overall Study|Lost to Follow-up|0|||
147533866|NCT00978120|532109549|FG001|Overall Study|Lost to Follow-up|0|||
147533867|NCT00978120|532109550|FG002|Overall Study|Lost to Follow-up|3|||
147533868|NCT00978120|532109551|FG003|Overall Study|Lost to Follow-up|0|||
147533869|NCT00978120|532109548|FG000|Overall Study|Withdrawal by Subject|2|||
147533870|NCT00978120|532109549|FG001|Overall Study|Withdrawal by Subject|0|||
147533871|NCT00978120|532109550|FG002|Overall Study|Withdrawal by Subject|0|||
147533872|NCT00978120|532109551|FG003|Overall Study|Withdrawal by Subject|0|||
147533873|NCT00978120|532109548|FG000|Overall Study|Moved out of state|0|||
147533874|NCT00978120|532109549|FG001|Overall Study|Moved out of state|0|||
147533875|NCT00978120|532109550|FG002|Overall Study|Moved out of state|0|||
147533876|NCT00978120|532109551|FG003|Overall Study|Moved out of state|1|||
147533877|NCT00762073|532109552|FG000|Overall Study|Lack of Efficacy|1|||
147533878|NCT00762073|532109553|FG001|Overall Study|Lack of Efficacy|1|||
147533879|NCT00762073|532109554|FG002|Overall Study|Lack of Efficacy|0|||
147533880|NCT00762073|532109555|FG003|Overall Study|Lack of Efficacy|0|||
147533881|NCT00762073|532109552|FG000|Overall Study|Adverse Event|1|||
147533882|NCT00762073|532109553|FG001|Overall Study|Adverse Event|0|||
147533883|NCT00762073|532109554|FG002|Overall Study|Adverse Event|1|||
147533884|NCT00762073|532109555|FG003|Overall Study|Adverse Event|1|||
147533885|NCT00762073|532109552|FG000|Overall Study|Significant Subject Noncompliance|0|||
147533886|NCT00762073|532109553|FG001|Overall Study|Significant Subject Noncompliance|1|||
147533887|NCT00762073|532109554|FG002|Overall Study|Significant Subject Noncompliance|0|||
147533888|NCT00762073|532109555|FG003|Overall Study|Significant Subject Noncompliance|1|||
147533889|NCT00762073|532109552|FG000|Overall Study|Withdrawal by Subject|1|||
147533890|NCT00762073|532109553|FG001|Overall Study|Withdrawal by Subject|2|||
147533891|NCT00762073|532109554|FG002|Overall Study|Withdrawal by Subject|1|||
147533892|NCT00762073|532109555|FG003|Overall Study|Withdrawal by Subject|1|||
147533893|NCT00762073|532109552|FG000|Overall Study|Not on treatment for >/= 77 days|1|||
147533894|NCT00762073|532109553|FG001|Overall Study|Not on treatment for >/= 77 days|0|||
147533895|NCT00762073|532109554|FG002|Overall Study|Not on treatment for >/= 77 days|0|||
147533896|NCT00762073|532109555|FG003|Overall Study|Not on treatment for >/= 77 days|0|||
147533897|NCT03155269|532109562|FG000|Overall Study|Withdrawal by Subject|4|||
147533898|NCT03155269|532109563|FG001|Overall Study|Withdrawal by Subject|5|||
147533899|NCT03155269|532109562|FG000|Overall Study|Lost to Follow-up|1|||
147533900|NCT03155269|532109563|FG001|Overall Study|Lost to Follow-up|2|||
147533901|NCT02319642|532109564|FG000|Overall Study|Adverse Event|2|||
147533902|NCT02319642|532109565|FG001|Overall Study|Adverse Event|4|||
147533903|NCT02319642|532109564|FG000|Overall Study|Lack of Efficacy|1|||
147533904|NCT02319642|532109565|FG001|Overall Study|Lack of Efficacy|1|||
147533905|NCT02319642|532109564|FG000|Overall Study|Withdrawal by Subject|1|||
147533906|NCT02319642|532109565|FG001|Overall Study|Withdrawal by Subject|1|||
147533907|NCT02369874|532109568|FG000|Overall Study|Lost to Follow-up|2|||
147533908|NCT02369874|532109569|FG001|Overall Study|Lost to Follow-up|2|||
147533909|NCT02369874|532109570|FG002|Overall Study|Lost to Follow-up|2|||
147533910|NCT02369874|532109568|FG000|Overall Study|Withdrawal by Subject|7|||
147533911|NCT02369874|532109569|FG001|Overall Study|Withdrawal by Subject|9|||
147533912|NCT02369874|532109570|FG002|Overall Study|Withdrawal by Subject|27|||
147533913|NCT02369874|532109568|FG000|Overall Study|Miscellaneous|1|||
147533914|NCT02369874|532109569|FG001|Overall Study|Miscellaneous|1|||
147533915|NCT02369874|532109570|FG002|Overall Study|Miscellaneous|0|||
147533916|NCT02369874|532109568|FG000|Overall Study|On Treatment/Off Study|34|||
147533917|NCT02369874|532109569|FG001|Overall Study|On Treatment/Off Study|45|||
147533918|NCT02369874|532109570|FG002|Overall Study|On Treatment/Off Study|32|||
147533919|NCT00596466|532109571|FG000|Overall Study|Lack of Efficacy|5|||
147533920|NCT00596466|532109571|FG000|Overall Study|Adverse Event|4|||
147533921|NCT00596466|532109571|FG000|Overall Study|Withdrawal by Subject|2|||
147432931|NCT02146326|531751123|FG000|Overall Study|Unable to complete interview|0|||
147432932|NCT02146326|531751124|FG001|Overall Study|Unable to complete interview|0|||
147432933|NCT02146326|531751125|FG002|Overall Study|Unable to complete interview|10|||
147432934|NCT02146326|531751126|FG003|Overall Study|Unable to complete interview|6|||
147432935|NCT03153111|531751127|FG000|Overall Study|Death|2|||
147432936|NCT03153111|531751128|FG001|Overall Study|Death|5|||
147432937|NCT03153111|531751127|FG000|Overall Study|Lost to Follow-up|1|||
147432938|NCT03153111|531751128|FG001|Overall Study|Lost to Follow-up|0|||
147432939|NCT03153111|531751127|FG000|Overall Study|Physician Decision|5|||
147432940|NCT03153111|531751128|FG001|Overall Study|Physician Decision|1|||
147432941|NCT03153111|531751127|FG000|Overall Study|Withdrawal by Subject|3|||
147432942|NCT03153111|531751128|FG001|Overall Study|Withdrawal by Subject|3|||
147432943|NCT01079130|531751131|FG000|Overall Study|Adverse Event|1|||
147432944|NCT01079130|531751132|FG001|Overall Study|Adverse Event|1|||
147432945|NCT01079130|531751133|FG002|Overall Study|Adverse Event|0|||
147432946|NCT01079130|531751134|FG003|Overall Study|Adverse Event|1|||
147432947|NCT01079130|531751135|FG004|Overall Study|Adverse Event|5|||
147432948|NCT01079130|531751136|FG005|Overall Study|Adverse Event|1|||
147432949|NCT01079130|531751131|FG000|Overall Study|Administrative problems|1|||
147432950|NCT01079130|531751132|FG001|Overall Study|Administrative problems|3|||
147432951|NCT01079130|531751133|FG002|Overall Study|Administrative problems|0|||
147432952|NCT01079130|531751134|FG003|Overall Study|Administrative problems|0|||
147432953|NCT01079130|531751135|FG004|Overall Study|Administrative problems|0|||
147432954|NCT01079130|531751136|FG005|Overall Study|Administrative problems|1|||
147432955|NCT01079130|531751131|FG000|Overall Study|Withdrawal by Subject|0|||
147432956|NCT01079130|531751132|FG001|Overall Study|Withdrawal by Subject|1|||
147432957|NCT01079130|531751133|FG002|Overall Study|Withdrawal by Subject|0|||
147432958|NCT01079130|531751134|FG003|Overall Study|Withdrawal by Subject|0|||
147432959|NCT01079130|531751135|FG004|Overall Study|Withdrawal by Subject|1|||
147432960|NCT01079130|531751136|FG005|Overall Study|Withdrawal by Subject|3|||
147432961|NCT01079130|531751131|FG000|Overall Study|Protocol deviation|0|||
147432962|NCT01079130|531751132|FG001|Overall Study|Protocol deviation|2|||
147432963|NCT01079130|531751133|FG002|Overall Study|Protocol deviation|1|||
147432964|NCT01079130|531751134|FG003|Overall Study|Protocol deviation|2|||
147432965|NCT01079130|531751135|FG004|Overall Study|Protocol deviation|0|||
147432966|NCT01079130|531751136|FG005|Overall Study|Protocol deviation|0|||
147432967|NCT01079130|531751131|FG000|Overall Study|Abnormal test procedure result(s)|0|||
147432968|NCT01079130|531751132|FG001|Overall Study|Abnormal test procedure result(s)|0|||
147432969|NCT01079130|531751133|FG002|Overall Study|Abnormal test procedure result(s)|0|||
147432970|NCT01079130|531751134|FG003|Overall Study|Abnormal test procedure result(s)|0|||
147432971|NCT01079130|531751135|FG004|Overall Study|Abnormal test procedure result(s)|1|||
147432972|NCT01079130|531751136|FG005|Overall Study|Abnormal test procedure result(s)|0|||
147432973|NCT01079130|531751131|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
147432974|NCT01079130|531751132|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
147432975|NCT01079130|531751133|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
147432976|NCT01079130|531751134|FG003|Overall Study|Unsatisfactory therapeutic effect|2|||
147432977|NCT01079130|531751135|FG004|Overall Study|Unsatisfactory therapeutic effect|0|||
147432978|NCT01079130|531751136|FG005|Overall Study|Unsatisfactory therapeutic effect|0|||
147432979|NCT01079130|531751131|FG000|Overall Study|Lost to Follow-up|0|||
147432980|NCT01079130|531751132|FG001|Overall Study|Lost to Follow-up|0|||
147432981|NCT01079130|531751133|FG002|Overall Study|Lost to Follow-up|0|||
147432982|NCT01079130|531751134|FG003|Overall Study|Lost to Follow-up|0|||
147432983|NCT01079130|531751135|FG004|Overall Study|Lost to Follow-up|1|||
147432984|NCT01079130|531751136|FG005|Overall Study|Lost to Follow-up|0|||
147432985|NCT01853982|531751137|FG000|Overall Study|Withdrawal by Subject|1|||
147432986|NCT01853982|531751138|FG001|Overall Study|Withdrawal by Subject|0|||
147432987|NCT01853982|531751137|FG000|Overall Study|Death|1|||
147432988|NCT01853982|531751138|FG001|Overall Study|Death|0|||
147432989|NCT01853982|531751137|FG000|Overall Study|Lost to Follow-up|0|||
147432990|NCT01853982|531751138|FG001|Overall Study|Lost to Follow-up|1|||
147432991|NCT00390910|531751139|FG000|Overall Study|Adverse Event|1|||
147432992|NCT00390910|531751140|FG001|Overall Study|Adverse Event|0|||
147432993|NCT00390910|531751141|FG002|Overall Study|Adverse Event|0|||
147432994|NCT00390910|531751139|FG000|Overall Study|Lost to Follow-up|0|||
147432995|NCT00390910|531751140|FG001|Overall Study|Lost to Follow-up|1|||
147432996|NCT00390910|531751141|FG002|Overall Study|Lost to Follow-up|5|||
147432997|NCT00390910|531751139|FG000|Overall Study|Withdrawal by Subject|1|||
147432998|NCT00390910|531751140|FG001|Overall Study|Withdrawal by Subject|3|||
147432999|NCT00390910|531751141|FG002|Overall Study|Withdrawal by Subject|2|||
147433000|NCT00390910|531751139|FG000|Overall Study|Migrated/moved from study area|0|||
147433001|NCT00390910|531751140|FG001|Overall Study|Migrated/moved from study area|0|||
147433002|NCT00390910|531751141|FG002|Overall Study|Migrated/moved from study area|3|||
147433003|NCT01839487|531751142|FG000|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|1|||
147433004|NCT01839487|531751143|FG001|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0|||
147433005|NCT01839487|531751144|FG002|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0|||
147433006|NCT01839487|531751145|FG003|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0|||
147433007|NCT01839487|531751146|FG004|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0|||
147433008|NCT01839487|531751147|FG005|Run-in Phase (Maximum Exposure:295 Days)|Withdrawal by Subject|0|||
147433009|NCT01839487|531751142|FG000|Run-in Phase (Maximum Exposure:295 Days)|Death|14|||
147433010|NCT01839487|531751143|FG001|Run-in Phase (Maximum Exposure:295 Days)|Death|6|||
147433011|NCT01839487|531751144|FG002|Run-in Phase (Maximum Exposure:295 Days)|Death|0|||
147433012|NCT01839487|531751145|FG003|Run-in Phase (Maximum Exposure:295 Days)|Death|0|||
147533922|NCT00596466|532109571|FG000|Overall Study|Protocol Violation|2|||
147533923|NCT00596466|532109571|FG000|Overall Study|Unpecified|2|||
147533924|NCT00596466|532109571|FG000|Overall Study|Enrolled, not treated|2|||
147533925|NCT00145795|532109572|FG000|Overall Study|Adverse Event|1|||
147533926|NCT00145795|532109573|FG001|Overall Study|Adverse Event|0|||
147533927|NCT01891669|532109574|FG000|Overall Study|Death|0|||
147433013|NCT01839487|531751146|FG004|Run-in Phase (Maximum Exposure:295 Days)|Death|0|||
147433014|NCT01839487|531751147|FG005|Run-in Phase (Maximum Exposure:295 Days)|Death|0|||
147433015|NCT01839487|531751142|FG000|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0|||
147433016|NCT01839487|531751143|FG001|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|1|||
147433017|NCT01839487|531751144|FG002|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0|||
147433018|NCT01839487|531751145|FG003|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0|||
147433019|NCT01839487|531751146|FG004|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0|||
147433020|NCT01839487|531751147|FG005|Run-in Phase (Maximum Exposure:295 Days)|Study Terminated by Sponsor|0|||
147433021|NCT01839487|531751142|FG000|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|1|||
147433022|NCT01839487|531751143|FG001|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0|||
147433023|NCT01839487|531751144|FG002|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0|||
147433024|NCT01839487|531751145|FG003|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0|||
147533928|NCT01891669|532109575|FG001|Overall Study|Death|0|||
147533929|NCT01891669|532109576|FG002|Overall Study|Death|0|||
147433025|NCT01839487|531751146|FG004|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0|||
147433026|NCT01839487|531751147|FG005|Run-in Phase (Maximum Exposure:295 Days)|Other than specified|0|||
147433027|NCT01839487|531751142|FG000|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|0|||
147433028|NCT01839487|531751143|FG001|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|0|||
147433029|NCT01839487|531751144|FG002|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|12|||
147433030|NCT01839487|531751145|FG003|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|9|||
147433031|NCT01839487|531751146|FG004|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|4|||
147433032|NCT01839487|531751147|FG005|Phase 2 (Maximum Exposure:935 Days)|Withdrawal by Subject|8|||
147433033|NCT01839487|531751142|FG000|Phase 2 (Maximum Exposure:935 Days)|Death|0|||
147433034|NCT01839487|531751143|FG001|Phase 2 (Maximum Exposure:935 Days)|Death|0|||
147433035|NCT01839487|531751144|FG002|Phase 2 (Maximum Exposure:935 Days)|Death|46|||
147433036|NCT01839487|531751145|FG003|Phase 2 (Maximum Exposure:935 Days)|Death|49|||
147433037|NCT01839487|531751146|FG004|Phase 2 (Maximum Exposure:935 Days)|Death|71|||
147433038|NCT01839487|531751147|FG005|Phase 2 (Maximum Exposure:935 Days)|Death|32|||
147433039|NCT01839487|531751142|FG000|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|0|||
147433040|NCT01839487|531751143|FG001|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|0|||
147433041|NCT01839487|531751144|FG002|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|2|||
147433042|NCT01839487|531751145|FG003|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|0|||
147433043|NCT01839487|531751146|FG004|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|1|||
147433044|NCT01839487|531751147|FG005|Phase 2 (Maximum Exposure:935 Days)|Lost to Follow-up|0|||
147433045|NCT01839487|531751142|FG000|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|0|||
147433046|NCT01839487|531751143|FG001|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|0|||
147433047|NCT01839487|531751144|FG002|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|0|||
147433048|NCT01839487|531751145|FG003|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|1|||
147433049|NCT01839487|531751146|FG004|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|10|||
147433050|NCT01839487|531751147|FG005|Phase 2 (Maximum Exposure:935 Days)|Study Terminated by Sponsor|3|||
147433051|NCT01839487|531751142|FG000|Phase 2 (Maximum Exposure:935 Days)|Other than specified|0|||
147433052|NCT01839487|531751143|FG001|Phase 2 (Maximum Exposure:935 Days)|Other than specified|0|||
147433053|NCT01839487|531751144|FG002|Phase 2 (Maximum Exposure:935 Days)|Other than specified|1|||
147433054|NCT01839487|531751145|FG003|Phase 2 (Maximum Exposure:935 Days)|Other than specified|3|||
147433055|NCT01839487|531751146|FG004|Phase 2 (Maximum Exposure:935 Days)|Other than specified|2|||
147433056|NCT01839487|531751147|FG005|Phase 2 (Maximum Exposure:935 Days)|Other than specified|1|||
147433057|NCT01658826|531751153|FG000|Period 1: First Intervention (28 Days)|Withdrawal by Subject|1|||
147533930|NCT01891669|532109577|FG003|Overall Study|Death|0|||
147533931|NCT01891669|532109578|FG004|Overall Study|Death|0|||
147533932|NCT01891669|532109579|FG005|Overall Study|Death|0|||
147533933|NCT01891669|532109580|FG006|Overall Study|Death|0|||
147533934|NCT01891669|532109581|FG007|Overall Study|Death|1|||
147533935|NCT01891669|532109582|FG008|Overall Study|Death|0|||
147533936|NCT01891669|532109583|FG009|Overall Study|Death|1|||
147533937|NCT01891669|532109574|FG000|Overall Study|Withdrawal by Subject|1|||
147533938|NCT01891669|532109575|FG001|Overall Study|Withdrawal by Subject|1|||
147533939|NCT01891669|532109576|FG002|Overall Study|Withdrawal by Subject|0|||
147533940|NCT01891669|532109577|FG003|Overall Study|Withdrawal by Subject|0|||
147533941|NCT01891669|532109578|FG004|Overall Study|Withdrawal by Subject|0|||
147533942|NCT01891669|532109579|FG005|Overall Study|Withdrawal by Subject|0|||
147533943|NCT01891669|532109580|FG006|Overall Study|Withdrawal by Subject|1|||
147533944|NCT01891669|532109581|FG007|Overall Study|Withdrawal by Subject|2|||
147533945|NCT01891669|532109582|FG008|Overall Study|Withdrawal by Subject|1|||
147533946|NCT01891669|532109583|FG009|Overall Study|Withdrawal by Subject|1|||
147533947|NCT01891669|532109574|FG000|Overall Study|Other|1|||
147533948|NCT01891669|532109575|FG001|Overall Study|Other|0|||
147533949|NCT01891669|532109576|FG002|Overall Study|Other|0|||
147533950|NCT01891669|532109577|FG003|Overall Study|Other|0|||
147533951|NCT01891669|532109578|FG004|Overall Study|Other|0|||
147533952|NCT01891669|532109579|FG005|Overall Study|Other|0|||
147533953|NCT01891669|532109580|FG006|Overall Study|Other|0|||
147533954|NCT01891669|532109581|FG007|Overall Study|Other|1|||
147533955|NCT01891669|532109582|FG008|Overall Study|Other|0|||
147533956|NCT01891669|532109583|FG009|Overall Study|Other|0|||
147533957|NCT01015118|532109584|FG000|Overall Study|Protocol Violation|5|||
147533958|NCT01015118|532109585|FG001|Overall Study|Protocol Violation|6|||
147533959|NCT01015118|532109584|FG000|Overall Study|Withdrawal by Subject|103|||
147533960|NCT01015118|532109585|FG001|Overall Study|Withdrawal by Subject|27|||
147533961|NCT01015118|532109584|FG000|Overall Study|Other Adverse Event (AE)|141|||
147533962|NCT01015118|532109585|FG001|Overall Study|Other Adverse Event (AE)|33|||
147533963|NCT01015118|532109584|FG000|Overall Study|Worsening or AE of underlying disease|5|||
147533964|NCT01015118|532109585|FG001|Overall Study|Worsening or AE of underlying disease|4|||
147533965|NCT01015118|532109584|FG000|Overall Study|Progressive disease|364|||
147533966|NCT01015118|532109585|FG001|Overall Study|Progressive disease|229|||
147533967|NCT01015118|532109584|FG000|Overall Study|Not treated|9|||
147533968|NCT01015118|532109585|FG001|Overall Study|Not treated|5|||
147533969|NCT01015118|532109584|FG000|Overall Study|Other than stated above|42|||
147533970|NCT01015118|532109585|FG001|Overall Study|Other than stated above|23|||
147533971|NCT04365387|532109586|FG000|Overall Study|Adverse Event|4|||
147533972|NCT04365387|532109587|FG001|Overall Study|Adverse Event|2|||
147533973|NCT04365387|532109586|FG000|Overall Study|Participants request|14|||
147533974|NCT04365387|532109587|FG001|Overall Study|Participants request|14|||
147533975|NCT04365387|532109586|FG000|Overall Study|Lost to Follow-up|8|||
147533976|NCT04365387|532109587|FG001|Overall Study|Lost to Follow-up|5|||
147533977|NCT04365387|532109586|FG000|Overall Study|Protocol deviation|3|||
147533978|NCT04365387|532109587|FG001|Overall Study|Protocol deviation|4|||
147533979|NCT04365387|532109586|FG000|Overall Study|Participant compliance with visit schedule|1|||
147533980|NCT04365387|532109587|FG001|Overall Study|Participant compliance with visit schedule|0|||
147533981|NCT04365387|532109586|FG000|Overall Study|Participant incarcerated|1|||
147533982|NCT04365387|532109587|FG001|Overall Study|Participant incarcerated|0|||
147533983|NCT04365387|532109586|FG000|Overall Study|Participant moved out of town (relocated)|0|||
147533984|NCT04365387|532109587|FG001|Overall Study|Participant moved out of town (relocated)|1|||
147193108|NCT00625131|530876434|FG002|Overall Study|Withdrawal by Subject|5|||
147193109|NCT00168844|530876437|FG000|Overall Study|Adverse Event|31|||
147193110|NCT00168844|530876438|FG001|Overall Study|Adverse Event|32|||
147193111|NCT00168844|530876439|FG002|Overall Study|Adverse Event|48|||
147193112|NCT00168844|530876437|FG000|Overall Study|Lost to Follow-up|4|||
147193113|NCT00168844|530876438|FG001|Overall Study|Lost to Follow-up|5|||
147193114|NCT00168844|530876439|FG002|Overall Study|Lost to Follow-up|11|||
147193115|NCT00168844|530876437|FG000|Overall Study|Withdrawal by Subject|12|||
147193116|NCT00168844|530876438|FG001|Overall Study|Withdrawal by Subject|9|||
147193117|NCT00168844|530876439|FG002|Overall Study|Withdrawal by Subject|19|||
147193118|NCT00168844|530876437|FG000|Overall Study|Protocol Violation|2|||
147193119|NCT00168844|530876438|FG001|Overall Study|Protocol Violation|2|||
147193120|NCT00168844|530876439|FG002|Overall Study|Protocol Violation|4|||
147193121|NCT00168844|530876437|FG000|Overall Study|Other|6|||
147193122|NCT00168844|530876438|FG001|Overall Study|Other|7|||
147533985|NCT04365387|532109586|FG000|Overall Study|Participant PEF not eligible per sponsor|1|||
147533986|NCT04365387|532109587|FG001|Overall Study|Participant PEF not eligible per sponsor|0|||
147533987|NCT04365387|532109586|FG000|Overall Study|Due to working hours, could not return to other visits|1|||
147533988|NCT04365387|532109587|FG001|Overall Study|Due to working hours, could not return to other visits|0|||
147533989|NCT00480077|532109588|FG000|Overall Study|Death|19|||
147193123|NCT00168844|530876439|FG002|Overall Study|Other|9|||
147193124|NCT03557970|530876444|FG000|Overall Study|Study closure|1|||
147193125|NCT03557970|530876445|FG001|Overall Study|Study closure|0|||
147533990|NCT00480077|532109589|FG001|Overall Study|Death|15|||
147533991|NCT00480077|532109588|FG000|Overall Study|early exit|12|||
147433058|NCT01658826|531751154|FG001|Period 1: First Intervention (28 Days)|Withdrawal by Subject|0|||
147433059|NCT01658826|531751153|FG000|Period 1: First Intervention (28 Days)|Adverse Event|1|||
147433060|NCT01658826|531751154|FG001|Period 1: First Intervention (28 Days)|Adverse Event|2|||
147433061|NCT01658826|531751153|FG000|Period 1: First Intervention (28 Days)|Termination of the Study by the Investigator or Sponsor|5|||
147433062|NCT01658826|531751154|FG001|Period 1: First Intervention (28 Days)|Termination of the Study by the Investigator or Sponsor|6|||
147433063|NCT01658826|531751153|FG000|Period 1: First Intervention (28 Days)|Protocol Violation|0|||
147433064|NCT01658826|531751154|FG001|Period 1: First Intervention (28 Days)|Protocol Violation|1|||
147433065|NCT01658826|531751153|FG000|Period 1: First Intervention (28 Days)|Patient was non-compliant with study medication, swabbing and maintaining diary|0|||
147433066|NCT01658826|531751154|FG001|Period 1: First Intervention (28 Days)|Patient was non-compliant with study medication, swabbing and maintaining diary|1|||
147433067|NCT01658826|531751153|FG000|Washout Period: 28 Days|Withdrawal by Subject|1|||
147433068|NCT01658826|531751154|FG001|Washout Period: 28 Days|Withdrawal by Subject|1|||
147433069|NCT01658826|531751153|FG000|Washout Period: 28 Days|Termination of the Study by the Investigator or Sponsor|5|||
147433070|NCT01658826|531751154|FG001|Washout Period: 28 Days|Termination of the Study by the Investigator or Sponsor|3|||
147433071|NCT01658826|531751153|FG000|Period 2: Second Intervention (28 Days)|Withdrawal by Subject|0|||
147433072|NCT01658826|531751154|FG001|Period 2: Second Intervention (28 Days)|Withdrawal by Subject|1|||
147433073|NCT01658826|531751153|FG000|Period 2: Second Intervention (28 Days)|Termination of the Study by the Investigator or Sponsor|3|||
147433074|NCT01658826|531751154|FG001|Period 2: Second Intervention (28 Days)|Termination of the Study by the Investigator or Sponsor|4|||
147433075|NCT06071754|531751157|FG000|Overall Study|Device rhythm classifications not obtained from subjects due to protocol not being completed|9|||
147433076|NCT01306890|531753183|FG000|Overall Study|Adverse Event|2|||
147433077|NCT01306890|531753183|FG000|Overall Study|Death|1223|||
147433078|NCT01306890|531753183|FG000|Overall Study|Lost to Follow-up|58|||
147433079|NCT01306890|531753183|FG000|Overall Study|Withdrawal by Subject|88|||
147433080|NCT01306890|531753183|FG000|Overall Study|Unspecified reasons|104|||
147433081|NCT01306890|531753183|FG000|Overall Study|Study Termination|3|||
147433082|NCT01306890|531753183|FG000|Overall Study|No discontinuation documentation|41|||
147433083|NCT02217436|531753184|FG000|Overall Study|Protocol Violation|1|||
147433084|NCT02217436|531753185|FG001|Overall Study|Protocol Violation|1|||
147433085|NCT02217436|531753184|FG000|Overall Study|Incomplete data|0|||
147433086|NCT02217436|531753185|FG001|Overall Study|Incomplete data|1|||
147433087|NCT03739762|531753186|FG000|Overall Study|Lost to Follow-up|1|||
147433088|NCT03739762|531753187|FG001|Overall Study|Lost to Follow-up|1|||
147433089|NCT03739762|531753186|FG000|Overall Study|Withdrawal by Subject|2|||
147433090|NCT03739762|531753187|FG001|Overall Study|Withdrawal by Subject|6|||
147433091|NCT00607880|531753188|FG000|Overall Study|Unable to place port due to occlusion|1|||
147433092|NCT00607880|531753189|FG001|Overall Study|Unable to place port due to occlusion|0|||
147433093|NCT02170389|531753190|FG000|Overall Study|Study terminated prior to start of treat|1|||
147433094|NCT01008696|531753191|FG000|Overall Study|Participant's evasion of hospital visit|5|||
147433095|NCT01008696|531753192|FG001|Overall Study|Participant's evasion of hospital visit|4|||
147433096|NCT01008696|531753191|FG000|Overall Study|Withdrawal by Subject|2|||
147433097|NCT01008696|531753192|FG001|Overall Study|Withdrawal by Subject|4|||
147433098|NCT01008696|531753191|FG000|Overall Study|Physician Decision|5|||
147433099|NCT01008696|531753192|FG001|Overall Study|Physician Decision|1|||
147433100|NCT01008696|531753191|FG000|Overall Study|Adverse Event|1|||
147433101|NCT01008696|531753192|FG001|Overall Study|Adverse Event|0|||
147433102|NCT01008696|531753191|FG000|Overall Study|Participants' non-cooperation|2|||
147433103|NCT01008696|531753192|FG001|Overall Study|Participants' non-cooperation|3|||
147433104|NCT01008696|531753191|FG000|Overall Study|Other|2|||
147433105|NCT01008696|531753192|FG001|Overall Study|Other|3|||
147433106|NCT01008696|531753191|FG000|Overall Study|Other|0|||
147433107|NCT01008696|531753192|FG001|Overall Study|Other|2|||
147533992|NCT00480077|532109589|FG001|Overall Study|early exit|11|||
147533993|NCT05939388|532109590|FG000|Overall Study|Lost to Follow-up|1|||
147433108|NCT02366728|531753193|FG000|Overall Study|Death|0|||
147433109|NCT02366728|531753194|FG001|Overall Study|Death|0|||
147433110|NCT02366728|531753195|FG002|Overall Study|Death|1|||
147433111|NCT02366728|531753193|FG000|Overall Study|Adverse Event|1|||
147433112|NCT02366728|531753194|FG001|Overall Study|Adverse Event|0|||
147433113|NCT02366728|531753195|FG002|Overall Study|Adverse Event|0|||
147433114|NCT02366728|531753193|FG000|Overall Study|Screen Failure|2|||
147433115|NCT02366728|531753194|FG001|Overall Study|Screen Failure|1|||
147433116|NCT02366728|531753195|FG002|Overall Study|Screen Failure|0|||
147433117|NCT02366728|531753193|FG000|Overall Study|Only yielded 2 vaccines|1|||
147433118|NCT02366728|531753194|FG001|Overall Study|Only yielded 2 vaccines|0|||
147433119|NCT02366728|531753195|FG002|Overall Study|Only yielded 2 vaccines|0|||
147433120|NCT02960854|531753196|FG000|Overall Study|Not Disclosed|2|||
147433121|NCT02960854|531753197|FG001|Overall Study|Not Disclosed|2|||
147533994|NCT04527380|532109593|FG000|Overall Study|Lack of Efficacy|0|||
147193126|NCT03557970|530876444|FG000|Overall Study|Physician Decision|0|||
147193127|NCT03557970|530876445|FG001|Overall Study|Physician Decision|1|||
147193128|NCT03557970|530876444|FG000|Overall Study|Death|0|||
147193129|NCT03557970|530876445|FG001|Overall Study|Death|1|||
147193130|NCT00112736|530876446|FG000|Overall Study|1 pt never had had RX due rapid decline|1|||
147193131|NCT00112736|530876447|FG001|Overall Study|1 pt never had had RX due rapid decline|0|||
147193132|NCT02138890|530876448|FG000|Overall Study|Adverse Event|1|||
147193133|NCT02138890|530876449|FG001|Overall Study|Adverse Event|0|||
147193134|NCT05435339|530876450|FG000|Overall Study|Death|1|||
147193135|NCT05435339|530876451|FG001|Overall Study|Death|0|||
147193136|NCT05435339|530876452|FG002|Overall Study|Death|3|||
147193137|NCT05435339|530876453|FG003|Overall Study|Death|1|||
147193138|NCT05435339|530876454|FG004|Overall Study|Death|3|||
147193139|NCT05435339|530876455|FG005|Overall Study|Death|2|||
147193140|NCT05435339|530876456|FG006|Overall Study|Death|4|||
147193141|NCT05435339|530876457|FG007|Overall Study|Death|6|||
147193142|NCT05435339|530876450|FG000|Overall Study|Sponsor Decision|0|||
147193143|NCT05435339|530876451|FG001|Overall Study|Sponsor Decision|1|||
147193144|NCT05435339|530876452|FG002|Overall Study|Sponsor Decision|0|||
147193145|NCT05435339|530876453|FG003|Overall Study|Sponsor Decision|0|||
147193146|NCT05435339|530876454|FG004|Overall Study|Sponsor Decision|2|||
147193147|NCT05435339|530876455|FG005|Overall Study|Sponsor Decision|1|||
147193148|NCT05435339|530876456|FG006|Overall Study|Sponsor Decision|2|||
147193149|NCT05435339|530876457|FG007|Overall Study|Sponsor Decision|2|||
147193150|NCT05435339|530876450|FG000|Overall Study|Withdrawal by Subject|0|||
147193151|NCT05435339|530876451|FG001|Overall Study|Withdrawal by Subject|0|||
147193152|NCT05435339|530876452|FG002|Overall Study|Withdrawal by Subject|0|||
147193153|NCT05435339|530876453|FG003|Overall Study|Withdrawal by Subject|0|||
147193154|NCT05435339|530876454|FG004|Overall Study|Withdrawal by Subject|1|||
147193155|NCT05435339|530876455|FG005|Overall Study|Withdrawal by Subject|0|||
147193156|NCT05435339|530876456|FG006|Overall Study|Withdrawal by Subject|1|||
147193157|NCT05435339|530876457|FG007|Overall Study|Withdrawal by Subject|1|||
147193158|NCT00537394|530876458|FG000|First Year of Follow-up|Death|7|||
147193159|NCT00537394|530876459|FG001|First Year of Follow-up|Death|0|||
147193160|NCT00537394|530876460|FG002|First Year of Follow-up|Death|0|||
147193161|NCT00537394|530876458|FG000|First Year of Follow-up|Severe debilitation|1|||
147193162|NCT00537394|530876459|FG001|First Year of Follow-up|Severe debilitation|0|||
147193163|NCT00537394|530876460|FG002|First Year of Follow-up|Severe debilitation|1|||
147193164|NCT00537394|530876458|FG000|First Year of Follow-up|Withdrawal by Subject|3|||
147193165|NCT00537394|530876459|FG001|First Year of Follow-up|Withdrawal by Subject|6|||
147193166|NCT00537394|530876460|FG002|First Year of Follow-up|Withdrawal by Subject|1|||
147193167|NCT00537394|530876458|FG000|First Year of Follow-up|Lost to Follow-up|1|||
147193168|NCT00537394|530876459|FG001|First Year of Follow-up|Lost to Follow-up|5|||
147193169|NCT00537394|530876460|FG002|First Year of Follow-up|Lost to Follow-up|1|||
147193170|NCT00537394|530876458|FG000|2nd Year of Follow-up|Death|4|||
147193171|NCT00537394|530876459|FG001|2nd Year of Follow-up|Death|1|||
147193172|NCT00537394|530876460|FG002|2nd Year of Follow-up|Death|2|||
147193173|NCT00537394|530876458|FG000|2nd Year of Follow-up|Withdrawal by Subject|0|||
147193174|NCT00537394|530876459|FG001|2nd Year of Follow-up|Withdrawal by Subject|1|||
147193175|NCT00537394|530876460|FG002|2nd Year of Follow-up|Withdrawal by Subject|2|||
147193176|NCT00537394|530876458|FG000|2nd Year of Follow-up|Lost to Follow-up|6|||
147193177|NCT00537394|530876459|FG001|2nd Year of Follow-up|Lost to Follow-up|7|||
147193178|NCT00537394|530876460|FG002|2nd Year of Follow-up|Lost to Follow-up|2|||
147193179|NCT00537394|530876458|FG000|2nd Year of Follow-up|Clinic site closure|1|||
147193180|NCT00537394|530876459|FG001|2nd Year of Follow-up|Clinic site closure|0|||
147193181|NCT00537394|530876460|FG002|2nd Year of Follow-up|Clinic site closure|0|||
147193182|NCT04764162|530876462|FG000|Overall Study|Did not complete oral glucose tolerance tests due to low BP. Did complete other study measures.|0|||
147193183|NCT04764162|530876463|FG001|Overall Study|Did not complete oral glucose tolerance tests due to low BP. Did complete other study measures.|1|||
147433122|NCT02960854|531753196|FG000|Overall Study|Subject No Longer Meets Study Criteria|1|||
147433123|NCT02960854|531753197|FG001|Overall Study|Subject No Longer Meets Study Criteria|0|||
147433124|NCT02960854|531753196|FG000|Overall Study|Subject Withdrew Consent|0|||
147433125|NCT02960854|531753197|FG001|Overall Study|Subject Withdrew Consent|1|||
147433126|NCT02960854|531753196|FG000|Overall Study|Death|4|||
147193184|NCT05556265|530876464|FG000|Placebo-Controlled (Day 1 to Week 24)|Withdrawal by Subject|0|||
147193185|NCT05556265|530876465|FG001|Placebo-Controlled (Day 1 to Week 24)|Withdrawal by Subject|1|||
147193186|NCT05556265|530876466|FG002|Placebo-Controlled (Day 1 to Week 24)|Withdrawal by Subject|0|||
147193187|NCT05556265|530876467|FG003|Placebo-Controlled (Day 1 to Week 24)|Withdrawal by Subject|0|||
147193188|NCT05556265|530876468|FG004|Placebo-Controlled (Day 1 to Week 24)|Withdrawal by Subject|0|||
147193189|NCT05556265|530876464|FG000|Placebo-Controlled (Day 1 to Week 24)|Participant request to discontinue study treatment|0|||
147193190|NCT05556265|530876465|FG001|Placebo-Controlled (Day 1 to Week 24)|Participant request to discontinue study treatment|2|||
147193191|NCT05556265|530876466|FG002|Placebo-Controlled (Day 1 to Week 24)|Participant request to discontinue study treatment|0|||
147433127|NCT02960854|531753197|FG001|Overall Study|Death|6|||
147433128|NCT00221195|531753198|FG000|Therapy 1 (Months 1-6)|Withdrawal by Subject|3|||
147433129|NCT00221195|531753199|FG001|Therapy 1 (Months 1-6)|Withdrawal by Subject|1|||
147433130|NCT00221195|531753198|FG000|Therapy 1 (Months 1-6)|Lost to Follow-up|0|||
147433131|NCT00221195|531753199|FG001|Therapy 1 (Months 1-6)|Lost to Follow-up|1|||
147433132|NCT00221195|531753198|FG000|Washout Period (Months 7-9)|Death|0|||
147433133|NCT00221195|531753199|FG001|Washout Period (Months 7-9)|Death|1|||
147433134|NCT00221195|531753198|FG000|Therapy 2 (Months 10-15)|Death|1|||
147433135|NCT00221195|531753199|FG001|Therapy 2 (Months 10-15)|Death|0|||
147433136|NCT00221195|531753198|FG000|Therapy 2 (Months 10-15)|Adverse Event|1|||
147193192|NCT05556265|530876467|FG003|Placebo-Controlled (Day 1 to Week 24)|Participant request to discontinue study treatment|0|||
147193193|NCT05556265|530876468|FG004|Placebo-Controlled (Day 1 to Week 24)|Participant request to discontinue study treatment|0|||
147193194|NCT05556265|530876464|FG000|Placebo-Controlled (Day 1 to Week 24)|Adverse Event|0|||
147433137|NCT00221195|531753199|FG001|Therapy 2 (Months 10-15)|Adverse Event|0|||
147433138|NCT01383161|531753201|FG000|Overall Study|Adverse Event|5|||
147433139|NCT01383161|531753202|FG001|Overall Study|Adverse Event|1|||
147433140|NCT01383161|531753201|FG000|Overall Study|Withdrawal by Subject|0|||
147433141|NCT01383161|531753202|FG001|Overall Study|Withdrawal by Subject|2|||
147433142|NCT01383161|531753201|FG000|Overall Study|Lack of Efficacy|0|||
147433143|NCT01383161|531753202|FG001|Overall Study|Lack of Efficacy|1|||
147433144|NCT00833911|531753203|FG000|Titration|Adverse Event|18|||
147433145|NCT00833911|531753203|FG000|Titration|Withdrawal by Subject|3|||
147433146|NCT00833911|531753203|FG000|Maintenance Phase I|Adverse Event|73|||
147433147|NCT00833911|531753203|FG000|Maintenance Phase I|Withdrawal by Subject|11|||
147433148|NCT00833911|531753203|FG000|Maintenance Phase I|Physician Decision|10|||
147433149|NCT00833911|531753203|FG000|Maintenance Phase I|Lack of Efficacy|4|||
147433150|NCT00833911|531753203|FG000|Maintenance Phase II|Adverse Event|6|||
147433151|NCT00833911|531753203|FG000|Maintenance Phase II|Physician Decision|2|||
147433152|NCT00833911|531753203|FG000|Maintenance Phase II|Withdrawal by Subject|1|||
147433153|NCT00833911|531753203|FG000|Maintenance Phase II|Lack of Efficacy|1|||
147433154|NCT03942406|531753212|FG000|Overall Study|Lost to Follow-up|4|||
147433155|NCT03942406|531753213|FG001|Overall Study|Lost to Follow-up|5|||
147433156|NCT03942406|531753214|FG002|Overall Study|Lost to Follow-up|3|||
147433157|NCT03942406|531753215|FG003|Overall Study|Lost to Follow-up|7|||
147433158|NCT03942406|531753216|FG004|Overall Study|Lost to Follow-up|1|||
147433159|NCT03942406|531753217|FG005|Overall Study|Lost to Follow-up|0|||
147433160|NCT03942406|531753218|FG006|Overall Study|Lost to Follow-up|0|||
147433161|NCT03942406|531753212|FG000|Overall Study|Withdrawal by Subject|3|||
147433162|NCT03942406|531753213|FG001|Overall Study|Withdrawal by Subject|1|||
147433163|NCT03942406|531753214|FG002|Overall Study|Withdrawal by Subject|1|||
147533995|NCT04527380|532109594|FG001|Overall Study|Lack of Efficacy|1|||
147433164|NCT03942406|531753215|FG003|Overall Study|Withdrawal by Subject|3|||
147433165|NCT03942406|531753216|FG004|Overall Study|Withdrawal by Subject|0|||
147533996|NCT04527380|532109593|FG000|Overall Study|Withdrawal by Subject|1|||
147193195|NCT05556265|530876465|FG001|Placebo-Controlled (Day 1 to Week 24)|Adverse Event|2|||
147193196|NCT05556265|530876466|FG002|Placebo-Controlled (Day 1 to Week 24)|Adverse Event|0|||
147193197|NCT05556265|530876467|FG003|Placebo-Controlled (Day 1 to Week 24)|Adverse Event|0|||
147193198|NCT05556265|530876468|FG004|Placebo-Controlled (Day 1 to Week 24)|Adverse Event|0|||
147193199|NCT05556265|530876464|FG000|Active Treatment (Week 25 to Week 52)|Withdrawal by Subject|2|||
147193200|NCT05556265|530876465|FG001|Active Treatment (Week 25 to Week 52)|Withdrawal by Subject|2|||
147193201|NCT05556265|530876466|FG002|Active Treatment (Week 25 to Week 52)|Withdrawal by Subject|0|||
147193202|NCT05556265|530876467|FG003|Active Treatment (Week 25 to Week 52)|Withdrawal by Subject|3|||
147193203|NCT05556265|530876468|FG004|Active Treatment (Week 25 to Week 52)|Withdrawal by Subject|1|||
147193204|NCT05556265|530876464|FG000|Active Treatment (Week 25 to Week 52)|Participant request to discontinue study treatment|1|||
147193205|NCT05556265|530876465|FG001|Active Treatment (Week 25 to Week 52)|Participant request to discontinue study treatment|3|||
147193206|NCT05556265|530876466|FG002|Active Treatment (Week 25 to Week 52)|Participant request to discontinue study treatment|0|||
147193207|NCT05556265|530876467|FG003|Active Treatment (Week 25 to Week 52)|Participant request to discontinue study treatment|0|||
147193208|NCT05556265|530876468|FG004|Active Treatment (Week 25 to Week 52)|Participant request to discontinue study treatment|1|||
147193209|NCT05556265|530876464|FG000|Active Treatment (Week 25 to Week 52)|Study terminated by sponsor|19|||
147193210|NCT05556265|530876465|FG001|Active Treatment (Week 25 to Week 52)|Study terminated by sponsor|12|||
147193211|NCT05556265|530876466|FG002|Active Treatment (Week 25 to Week 52)|Study terminated by sponsor|0|||
147193212|NCT05556265|530876467|FG003|Active Treatment (Week 25 to Week 52)|Study terminated by sponsor|6|||
147193213|NCT05556265|530876468|FG004|Active Treatment (Week 25 to Week 52)|Study terminated by sponsor|9|||
147193214|NCT05556265|530876464|FG000|Active Treatment (Week 25 to Week 52)|Lost to Follow-up|0|||
147193215|NCT05556265|530876465|FG001|Active Treatment (Week 25 to Week 52)|Lost to Follow-up|2|||
147193216|NCT05556265|530876466|FG002|Active Treatment (Week 25 to Week 52)|Lost to Follow-up|0|||
147193217|NCT05556265|530876467|FG003|Active Treatment (Week 25 to Week 52)|Lost to Follow-up|0|||
147433166|NCT03942406|531753217|FG005|Overall Study|Withdrawal by Subject|0|||
147433167|NCT03942406|531753218|FG006|Overall Study|Withdrawal by Subject|0|||
147433168|NCT03942406|531753212|FG000|Overall Study|Other: early termination, telemedicine visits|4|||
147433169|NCT03942406|531753213|FG001|Overall Study|Other: early termination, telemedicine visits|1|||
147433170|NCT03942406|531753214|FG002|Overall Study|Other: early termination, telemedicine visits|1|||
147433171|NCT03942406|531753215|FG003|Overall Study|Other: early termination, telemedicine visits|0|||
147433172|NCT03942406|531753216|FG004|Overall Study|Other: early termination, telemedicine visits|1|||
147433173|NCT03942406|531753217|FG005|Overall Study|Other: early termination, telemedicine visits|1|||
147433174|NCT03942406|531753218|FG006|Overall Study|Other: early termination, telemedicine visits|0|||
147433175|NCT01207596|531753219|FG000|Overall Study|Physician Decision|4|||
147433176|NCT01207596|531753219|FG000|Overall Study|Lack of Efficacy|1|||
147433177|NCT01207596|531753219|FG000|Overall Study|Adverse Event|3|||
147433178|NCT01207596|531753219|FG000|Overall Study|Withdrawal by Subject|1|||
147433179|NCT00216203|531753220|FG000|Overall Study|Withdrawal by Subject|2|||
147433180|NCT02596620|531753223|FG000|Overall Study|Lost to Follow-up|1|||
147433181|NCT02596620|531753224|FG001|Overall Study|Lost to Follow-up|1|||
147433182|NCT01054144|531753225|FG000|Overall Study|Death|2|||
147433183|NCT02748018|531753226|FG000|Study Period|Adverse Event|1|||
147433184|NCT02748018|531753227|FG001|Study Period|Adverse Event|3|||
147433185|NCT02748018|531753228|FG002|Study Period|Adverse Event|4|||
147433186|NCT02748018|531753229|FG003|Study Period|Adverse Event|0|||
147433187|NCT02748018|531753230|FG004|Study Period|Adverse Event|3|||
147433188|NCT02748018|531753231|FG005|Study Period|Adverse Event|3|||
147433189|NCT02748018|531753226|FG000|Study Period|Withdrawal by Subject|7|||
147433190|NCT02748018|531753227|FG001|Study Period|Withdrawal by Subject|4|||
147433191|NCT02748018|531753228|FG002|Study Period|Withdrawal by Subject|4|||
147433192|NCT02748018|531753229|FG003|Study Period|Withdrawal by Subject|11|||
147649384|NCT04575584|532537337|FG002|Overall Study|Death|6|||
147193218|NCT05556265|530876468|FG004|Active Treatment (Week 25 to Week 52)|Lost to Follow-up|1|||
147193219|NCT05556265|530876464|FG000|Active Treatment (Week 25 to Week 52)|Lack of Efficacy|1|||
147193220|NCT05556265|530876465|FG001|Active Treatment (Week 25 to Week 52)|Lack of Efficacy|1|||
147193221|NCT05556265|530876466|FG002|Active Treatment (Week 25 to Week 52)|Lack of Efficacy|0|||
147193222|NCT05556265|530876467|FG003|Active Treatment (Week 25 to Week 52)|Lack of Efficacy|1|||
147193223|NCT05556265|530876468|FG004|Active Treatment (Week 25 to Week 52)|Lack of Efficacy|0|||
147193224|NCT05556265|530876464|FG000|Active Treatment (Week 25 to Week 52)|Adverse Event|1|||
147193225|NCT05556265|530876465|FG001|Active Treatment (Week 25 to Week 52)|Adverse Event|1|||
147193226|NCT05556265|530876466|FG002|Active Treatment (Week 25 to Week 52)|Adverse Event|0|||
147193227|NCT05556265|530876467|FG003|Active Treatment (Week 25 to Week 52)|Adverse Event|1|||
147193228|NCT05556265|530876468|FG004|Active Treatment (Week 25 to Week 52)|Adverse Event|0|||
147193229|NCT03980730|530876469|FG000|Overall Study|Study Terminated by Sponsor|0|||
147193230|NCT03980730|530876470|FG001|Overall Study|Study Terminated by Sponsor|3|||
147193231|NCT03980730|530876469|FG000|Overall Study|Adverse Event|2|||
147193232|NCT03980730|530876470|FG001|Overall Study|Adverse Event|0|||
147193233|NCT03980730|530876469|FG000|Overall Study|Sponsor Request|0|||
147193234|NCT03980730|530876470|FG001|Overall Study|Sponsor Request|1|||
147193235|NCT02016781|530876475|FG000|Interim Look for Primary Analysis|Alive and on study|71|||
147193236|NCT02016781|530876476|FG001|Interim Look for Primary Analysis|Alive and on study|23|||
147193237|NCT02016781|530876475|FG000|Interim Look for Primary Analysis|Withdrawal by Subject|2|||
147193238|NCT02016781|530876476|FG001|Interim Look for Primary Analysis|Withdrawal by Subject|1|||
147193239|NCT02016781|530876475|FG000|Final Database Lock|Withdrawal by Subject|2|||
147193240|NCT02016781|530876476|FG001|Final Database Lock|Withdrawal by Subject|1|||
147193241|NCT02016781|530876475|FG000|Final Database Lock|Lost to Follow-up|11|||
147433193|NCT02748018|531753230|FG004|Study Period|Withdrawal by Subject|12|||
147433194|NCT02748018|531753231|FG005|Study Period|Withdrawal by Subject|10|||
147533997|NCT04527380|532109594|FG001|Overall Study|Withdrawal by Subject|0|||
147533998|NCT00938366|532109595|FG000|Overall Study|Withdrawal by Subject|1|||
147533999|NCT00938366|532109596|FG001|Overall Study|Withdrawal by Subject|0|||
147193242|NCT02016781|530876476|FG001|Final Database Lock|Lost to Follow-up|4|||
147433195|NCT02748018|531753226|FG000|Study Period|Pregnancy|0|||
147433196|NCT02748018|531753227|FG001|Study Period|Pregnancy|1|||
147433197|NCT02748018|531753228|FG002|Study Period|Pregnancy|0|||
147433198|NCT02748018|531753229|FG003|Study Period|Pregnancy|0|||
147433199|NCT02748018|531753230|FG004|Study Period|Pregnancy|1|||
147433200|NCT02748018|531753231|FG005|Study Period|Pregnancy|0|||
147433201|NCT02748018|531753226|FG000|Study Period|Physician Decision|2|||
147433202|NCT02748018|531753227|FG001|Study Period|Physician Decision|2|||
147433203|NCT02748018|531753228|FG002|Study Period|Physician Decision|1|||
147433204|NCT02748018|531753229|FG003|Study Period|Physician Decision|0|||
147433205|NCT02748018|531753230|FG004|Study Period|Physician Decision|2|||
147433206|NCT02748018|531753231|FG005|Study Period|Physician Decision|0|||
147433207|NCT02748018|531753226|FG000|Study Period|Lost to Follow-up|0|||
147433208|NCT02748018|531753227|FG001|Study Period|Lost to Follow-up|0|||
147433209|NCT02748018|531753228|FG002|Study Period|Lost to Follow-up|0|||
147433210|NCT02748018|531753229|FG003|Study Period|Lost to Follow-up|2|||
147433211|NCT02748018|531753230|FG004|Study Period|Lost to Follow-up|0|||
147433212|NCT02748018|531753231|FG005|Study Period|Lost to Follow-up|1|||
147433213|NCT02748018|531753226|FG000|Continuation Period|Adverse Event|2|||
147433214|NCT02748018|531753227|FG001|Continuation Period|Adverse Event|0|||
147433215|NCT02748018|531753228|FG002|Continuation Period|Adverse Event|1|||
147433216|NCT02748018|531753229|FG003|Continuation Period|Adverse Event|1|||
147433217|NCT02748018|531753230|FG004|Continuation Period|Adverse Event|1|||
147433218|NCT02748018|531753231|FG005|Continuation Period|Adverse Event|4|||
147433219|NCT02748018|531753226|FG000|Continuation Period|Withdrawal by Subject|3|||
147433220|NCT02748018|531753227|FG001|Continuation Period|Withdrawal by Subject|5|||
147433221|NCT02748018|531753228|FG002|Continuation Period|Withdrawal by Subject|3|||
147433222|NCT02748018|531753229|FG003|Continuation Period|Withdrawal by Subject|9|||
147433223|NCT02748018|531753230|FG004|Continuation Period|Withdrawal by Subject|11|||
147433224|NCT02748018|531753231|FG005|Continuation Period|Withdrawal by Subject|1|||
147433225|NCT02748018|531753226|FG000|Continuation Period|Lost to Follow-up|0|||
147433226|NCT02748018|531753227|FG001|Continuation Period|Lost to Follow-up|2|||
147433227|NCT02748018|531753228|FG002|Continuation Period|Lost to Follow-up|1|||
147433228|NCT02748018|531753229|FG003|Continuation Period|Lost to Follow-up|0|||
147433229|NCT02748018|531753230|FG004|Continuation Period|Lost to Follow-up|1|||
147193243|NCT02016781|530876475|FG000|Final Database Lock|Missing data|0|||
147193244|NCT02016781|530876476|FG001|Final Database Lock|Missing data|3|||
147433230|NCT02748018|531753231|FG005|Continuation Period|Lost to Follow-up|0|||
147433231|NCT02748018|531753226|FG000|Continuation Period|Pregnancy|1|||
147433232|NCT02748018|531753227|FG001|Continuation Period|Pregnancy|2|||
147433233|NCT02748018|531753228|FG002|Continuation Period|Pregnancy|0|||
147433234|NCT02748018|531753229|FG003|Continuation Period|Pregnancy|0|||
147433235|NCT02748018|531753230|FG004|Continuation Period|Pregnancy|0|||
147433236|NCT02748018|531753231|FG005|Continuation Period|Pregnancy|0|||
147433237|NCT02748018|531753226|FG000|Continuation Period|Physician Decision|0|||
147433238|NCT02748018|531753227|FG001|Continuation Period|Physician Decision|1|||
147193245|NCT03724942|530876480|FG000|Overall Study|Adverse Event|20|||
147193246|NCT03724942|530876481|FG001|Overall Study|Adverse Event|14|||
147193247|NCT03724942|530876480|FG000|Overall Study|Lack of Efficacy|0|||
147193248|NCT03724942|530876481|FG001|Overall Study|Lack of Efficacy|1|||
147193249|NCT03724942|530876480|FG000|Overall Study|Physician Decision|5|||
147193250|NCT03724942|530876481|FG001|Overall Study|Physician Decision|2|||
147193251|NCT03724942|530876480|FG000|Overall Study|Protocol Violation|1|||
147193252|NCT03724942|530876481|FG001|Overall Study|Protocol Violation|0|||
147193253|NCT03724942|530876480|FG000|Overall Study|Bedridden All Day and Required Full Assistance for Excretion, Meals and Change of Clothes|0|||
147193254|NCT03724942|530876481|FG001|Overall Study|Bedridden All Day and Required Full Assistance for Excretion, Meals and Change of Clothes|1|||
147193255|NCT03724942|530876480|FG000|Overall Study|Withdrawal by Legal Representative|3|||
147193256|NCT03724942|530876481|FG001|Overall Study|Withdrawal by Legal Representative|0|||
147193257|NCT02429830|530876482|FG000|Overall Study|Lost to Follow-up|1|||
147193258|NCT02429830|530876482|FG000|Overall Study|Device Explant|2|||
147193259|NCT01352117|530878774|FG000|Overall Study|Death|15|||
147193260|NCT01352117|530878775|FG001|Overall Study|Death|16|||
147193261|NCT01352117|530878774|FG000|Overall Study|Withdrawal by Subject|1|||
147193262|NCT01352117|530878775|FG001|Overall Study|Withdrawal by Subject|0|||
147193263|NCT01352117|530878774|FG000|Overall Study|Lost to Follow-up|2|||
147193264|NCT01352117|530878775|FG001|Overall Study|Lost to Follow-up|7|||
147193265|NCT01352117|530878774|FG000|Overall Study|Non-adherent to study requirements|1|||
147193266|NCT01352117|530878775|FG001|Overall Study|Non-adherent to study requirements|1|||
147193267|NCT01352117|530878774|FG000|Overall Study|Did not initiate study treatment|1|||
147193268|NCT01352117|530878775|FG001|Overall Study|Did not initiate study treatment|0|||
147193269|NCT01352117|530878774|FG000|Overall Study|Ineligible (no KS diagnosis)|1|||
147193270|NCT01352117|530878775|FG001|Overall Study|Ineligible (no KS diagnosis)|0|||
147193271|NCT01766050|530878776|FG000|Overall Study|Adverse Event|1|||
147193272|NCT01766050|530878776|FG000|Overall Study|Lost to Follow-up|1|||
147193273|NCT01766050|530878776|FG000|Overall Study|Withdrawal by Subject|2|||
147193274|NCT02081677|530878778|FG000|Overall Study|Adverse Event|0|||
147193275|NCT02081677|530878779|FG001|Overall Study|Adverse Event|0|||
147193276|NCT02081677|530878780|FG002|Overall Study|Adverse Event|1|||
147193277|NCT02081677|530878781|FG003|Overall Study|Adverse Event|0|||
147193278|NCT02081677|530878778|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
147193279|NCT02081677|530878779|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
147193280|NCT02081677|530878780|FG002|Overall Study|No Longer Meets Eligibility Criteria|1|||
147193281|NCT02081677|530878781|FG003|Overall Study|No Longer Meets Eligibility Criteria|0|||
147193282|NCT02081677|530878778|FG000|Overall Study|Not comfortable with lens care system|1|||
147193283|NCT02081677|530878779|FG001|Overall Study|Not comfortable with lens care system|0|||
147193284|NCT02081677|530878780|FG002|Overall Study|Not comfortable with lens care system|0|||
147193285|NCT02081677|530878781|FG003|Overall Study|Not comfortable with lens care system|0|||
147193286|NCT02081677|530878778|FG000|Overall Study|Unsatisfactory Lens Fitting|0|||
147193287|NCT02081677|530878779|FG001|Overall Study|Unsatisfactory Lens Fitting|1|||
147433239|NCT02748018|531753228|FG002|Continuation Period|Physician Decision|2|||
147433240|NCT02748018|531753229|FG003|Continuation Period|Physician Decision|0|||
147433241|NCT02748018|531753230|FG004|Continuation Period|Physician Decision|2|||
147433242|NCT02748018|531753231|FG005|Continuation Period|Physician Decision|1|||
147433243|NCT02748018|531753226|FG000|Continuation Period|Protocol Violation|0|||
147433244|NCT02748018|531753227|FG001|Continuation Period|Protocol Violation|1|||
147433245|NCT02748018|531753228|FG002|Continuation Period|Protocol Violation|0|||
147433246|NCT02748018|531753229|FG003|Continuation Period|Protocol Violation|0|||
147433247|NCT02748018|531753230|FG004|Continuation Period|Protocol Violation|0|||
147433248|NCT02748018|531753231|FG005|Continuation Period|Protocol Violation|0|||
147433249|NCT06069778|531753232|FG000|Overall Study|Withdrawal by Subject|1|||
147433250|NCT02856893|531753233|FG000|Overall Study|Lack of Efficacy|27|||
147433251|NCT02856893|531753234|FG001|Overall Study|Lack of Efficacy|15|||
147433252|NCT02856893|531753235|FG002|Overall Study|Lack of Efficacy|19|||
147433253|NCT02856893|531753233|FG000|Overall Study|Death|1|||
147433254|NCT02856893|531753234|FG001|Overall Study|Death|0|||
147433255|NCT02856893|531753235|FG002|Overall Study|Death|0|||
147433256|NCT02856893|531753233|FG000|Overall Study|Adverse Event|2|||
147534000|NCT01215968|532109599|FG000|Overall Study|Adverse Event|0|||
147193288|NCT02081677|530878780|FG002|Overall Study|Unsatisfactory Lens Fitting|0|||
147193289|NCT02081677|530878781|FG003|Overall Study|Unsatisfactory Lens Fitting|0|||
147193290|NCT00089297|530878782|FG000|Overall Study|Adverse Event|9|||
147193291|NCT00089297|530878782|FG000|Overall Study|Death|1|||
147193292|NCT00089297|530878782|FG000|Overall Study|Withdrawal by Subject|12|||
147193293|NCT00089297|530878782|FG000|Overall Study|Disease progression|2|||
147193294|NCT00089297|530878782|FG000|Overall Study|Ineligible|11|||
147193295|NCT00089297|530878782|FG000|Overall Study|Secondary malignancy|1|||
147193296|NCT00089297|530878782|FG000|Overall Study|IRB approval not ready|1|||
147433257|NCT02856893|531753234|FG001|Overall Study|Adverse Event|0|||
147433258|NCT02856893|531753235|FG002|Overall Study|Adverse Event|0|||
147433259|NCT02856893|531753233|FG000|Overall Study|Physician Decision|0|||
147433260|NCT02856893|531753234|FG001|Overall Study|Physician Decision|2|||
147193297|NCT00089297|530878782|FG000|Overall Study|Non-compliance|1|||
147193298|NCT01097668|530878783|FG000|Overall Study|Withdrawal by Subject|1|||
147193299|NCT01097668|530878784|FG001|Overall Study|Withdrawal by Subject|2|||
147193300|NCT01097668|530878783|FG000|Overall Study|Lost to Follow-up|1|||
147433261|NCT02856893|531753235|FG002|Overall Study|Physician Decision|3|||
147433262|NCT02856893|531753233|FG000|Overall Study|Withdrawal by Subject|1|||
147433263|NCT02856893|531753234|FG001|Overall Study|Withdrawal by Subject|1|||
147433264|NCT02856893|531753235|FG002|Overall Study|Withdrawal by Subject|0|||
147433265|NCT02856893|531753233|FG000|Overall Study|Other reasons|2|||
147433266|NCT02856893|531753234|FG001|Overall Study|Other reasons|1|||
147433267|NCT02856893|531753235|FG002|Overall Study|Other reasons|2|||
147433268|NCT03801902|531753236|FG000|Overall Study|Did not receive protocol treatment.|1|||
147433269|NCT03801902|531753237|FG001|Overall Study|Did not receive protocol treatment.|0|||
147433270|NCT03801902|531753238|FG002|Overall Study|Did not receive protocol treatment.|0|||
147433271|NCT03801902|531753239|FG003|Overall Study|Did not receive protocol treatment.|0|||
147433272|NCT02310672|531753240|FG000|Overall Study|Death|1|||
147433273|NCT02310672|531753240|FG000|Overall Study|Lost to Follow-up|1|||
147433274|NCT02310672|531753240|FG000|Overall Study|Withdrawal by Subject|1|||
147433275|NCT02310672|531753240|FG000|Overall Study|Sponsor's decision|12|||
147433276|NCT04704336|531753244|FG000|Overall Study|Death|2|||
147433277|NCT04704336|531753245|FG001|Overall Study|Death|2|||
147433278|NCT04704336|531753244|FG000|Overall Study|Lost to Follow-up|33|||
147433279|NCT04704336|531753245|FG001|Overall Study|Lost to Follow-up|40|||
147433280|NCT00537485|531753246|FG000|Overall Study|Adverse Event|10|||
147433281|NCT00537485|531753247|FG001|Overall Study|Adverse Event|5|||
147433282|NCT00537485|531753246|FG000|Overall Study|Withdrawal by Subject|3|||
147433283|NCT00537485|531753247|FG001|Overall Study|Withdrawal by Subject|2|||
147433284|NCT00537485|531753246|FG000|Overall Study|Withdrawal by Subject|1|||
147433285|NCT00537485|531753247|FG001|Overall Study|Withdrawal by Subject|3|||
147433286|NCT00537485|531753246|FG000|Overall Study|Physician Decision|1|||
147433287|NCT00537485|531753247|FG001|Overall Study|Physician Decision|0|||
147433288|NCT02119325|531753248|FG000|Washout Period 1|Adverse Event|0|||
147433289|NCT02119325|531753249|FG001|Washout Period 1|Adverse Event|1|||
147433290|NCT00323297|531753256|FG000|Part A (Double Blind Randomized)|Reason unspecified|0|||
147433291|NCT00323297|531753257|FG001|Part A (Double Blind Randomized)|Reason unspecified|1|||
147433292|NCT00323297|531753256|FG000|Part A (Double Blind Randomized)|Death|0|||
147433293|NCT00323297|531753257|FG001|Part A (Double Blind Randomized)|Death|1|||
147433294|NCT00323297|531753256|FG000|Part A (Double Blind Randomized)|Protocol Violation|1|||
147433295|NCT00323297|531753257|FG001|Part A (Double Blind Randomized)|Protocol Violation|3|||
147433296|NCT00323297|531753256|FG000|Part A (Double Blind Randomized)|Unrelated adverse event|1|||
147433297|NCT00323297|531753257|FG001|Part A (Double Blind Randomized)|Unrelated adverse event|0|||
147433298|NCT00323297|531753256|FG000|Part A (Double Blind Randomized)|Related and Unrelated adverse event|1|||
147433299|NCT00323297|531753257|FG001|Part A (Double Blind Randomized)|Related and Unrelated adverse event|0|||
147433300|NCT00323297|531753256|FG000|Part A (Double Blind Randomized)|Related adverse event|2|||
147433301|NCT00323297|531753257|FG001|Part A (Double Blind Randomized)|Related adverse event|2|||
147433302|NCT00323297|531753256|FG000|Part B (Open-label)|Death|0|||
147433303|NCT00323297|531753257|FG001|Part B (Open-label)|Death|1|||
147433304|NCT00323297|531753256|FG000|Part B (Open-label)|Reason unspecified|0|||
147433305|NCT00323297|531753257|FG001|Part B (Open-label)|Reason unspecified|1|||
147433306|NCT00323297|531753256|FG000|Part B (Open-label)|Withdrawal by Subject|1|||
147433307|NCT00323297|531753257|FG001|Part B (Open-label)|Withdrawal by Subject|3|||
147433308|NCT00323297|531753256|FG000|Part B (Open-label)|Lack of Efficacy|3|||
147433309|NCT00323297|531753257|FG001|Part B (Open-label)|Lack of Efficacy|1|||
147433310|NCT00323297|531753256|FG000|Part B (Open-label)|Adverse Event|5|||
147433311|NCT00323297|531753257|FG001|Part B (Open-label)|Adverse Event|5|||
147433312|NCT00323297|531753256|FG000|Part B (Open-label)|Protocol Violation|0|||
147433313|NCT00323297|531753257|FG001|Part B (Open-label)|Protocol Violation|1|||
147433314|NCT01603082|531753259|FG000|Overall Study|Adverse Event|0|||
147433315|NCT01603082|531753260|FG001|Overall Study|Adverse Event|1|||
147433316|NCT01603082|531753259|FG000|Overall Study|Withdrawal by Subject|1|||
147433317|NCT01603082|531753260|FG001|Overall Study|Withdrawal by Subject|0|||
147433318|NCT01603082|531753259|FG000|Overall Study|Failed inclusion criterion after dosed|1|||
147433319|NCT01603082|531753260|FG001|Overall Study|Failed inclusion criterion after dosed|0|||
147534001|NCT01215968|532109600|FG001|Overall Study|Adverse Event|2|||
147433320|NCT00634010|531753265|FG000|Overall Study|Adverse Event|2|||
147193301|NCT01097668|530878784|FG001|Overall Study|Lost to Follow-up|0|||
147193302|NCT00385671|530878785|FG000|Overall Study|Adverse Event|14|||
147433321|NCT00634010|531753266|FG001|Overall Study|Adverse Event|5|||
147433322|NCT00634010|531753265|FG000|Overall Study|Withdrawal by Subject|5|||
147433323|NCT00634010|531753266|FG001|Overall Study|Withdrawal by Subject|6|||
147433324|NCT00634010|531753265|FG000|Overall Study|Physician Decision|1|||
147433325|NCT00634010|531753266|FG001|Overall Study|Physician Decision|1|||
147433326|NCT00634010|531753265|FG000|Overall Study|Disease Progression|1|||
147433327|NCT00634010|531753266|FG001|Overall Study|Disease Progression|1|||
147534002|NCT01215968|532109599|FG000|Overall Study|Protocol Violation|2|||
147193303|NCT00385671|530878786|FG001|Overall Study|Adverse Event|27|||
147433328|NCT00634010|531753265|FG000|Overall Study|Non-Compliant|1|||
147433329|NCT00634010|531753266|FG001|Overall Study|Non-Compliant|1|||
147433330|NCT01026142|531753267|FG000|Overall Study|Death|136|||
147433331|NCT01026142|531753268|FG001|Overall Study|Death|134|||
147433332|NCT01026142|531753267|FG000|Overall Study|Withdrew consent or lost to follow-up|36|||
147433333|NCT01026142|531753268|FG001|Overall Study|Withdrew consent or lost to follow-up|29|||
147433334|NCT01862640|531753273|FG000|Overall Study|Adverse Event|4|||
147433335|NCT01862640|531753274|FG001|Overall Study|Adverse Event|10|||
147433336|NCT01862640|531753275|FG002|Overall Study|Adverse Event|6|||
147433337|NCT01862640|531753276|FG003|Overall Study|Adverse Event|8|||
147433338|NCT01862640|531753273|FG000|Overall Study|Participant Met Withdrawal Criteria|1|||
147433339|NCT01862640|531753274|FG001|Overall Study|Participant Met Withdrawal Criteria|1|||
147433340|NCT01862640|531753275|FG002|Overall Study|Participant Met Withdrawal Criteria|2|||
147433341|NCT01862640|531753276|FG003|Overall Study|Participant Met Withdrawal Criteria|1|||
147433342|NCT01862640|531753273|FG000|Overall Study|Participant Withdrawn by Investigator|0|||
147433343|NCT01862640|531753274|FG001|Overall Study|Participant Withdrawn by Investigator|1|||
147433344|NCT01862640|531753275|FG002|Overall Study|Participant Withdrawn by Investigator|1|||
147433345|NCT01862640|531753276|FG003|Overall Study|Participant Withdrawn by Investigator|1|||
147433346|NCT01862640|531753273|FG000|Overall Study|Withdrawal by Subject|2|||
147433347|NCT01862640|531753274|FG001|Overall Study|Withdrawal by Subject|4|||
147433348|NCT01862640|531753275|FG002|Overall Study|Withdrawal by Subject|8|||
147433349|NCT01862640|531753276|FG003|Overall Study|Withdrawal by Subject|5|||
147433350|NCT01862640|531753273|FG000|Overall Study|Protocol Deviation|0|||
147433351|NCT01862640|531753274|FG001|Overall Study|Protocol Deviation|0|||
147433352|NCT01862640|531753275|FG002|Overall Study|Protocol Deviation|1|||
147433353|NCT01862640|531753276|FG003|Overall Study|Protocol Deviation|0|||
147433354|NCT01019317|531753279|FG000|Overall Study|Not Eligible|4|||
147433355|NCT02178553|531753280|FG000|Overall Study|Did not proceed to open thoracotomy|7|||
147433356|NCT02178553|531753281|FG001|Overall Study|Did not proceed to open thoracotomy|3|||
147433357|NCT02178553|531753280|FG000|Overall Study|Physician Decision|0|||
147433358|NCT02178553|531753281|FG001|Overall Study|Physician Decision|4|||
147433359|NCT02178553|531753280|FG000|Overall Study|Technical problem with injection|1|||
147433360|NCT02178553|531753281|FG001|Overall Study|Technical problem with injection|3|||
147433361|NCT05085665|531753282|FG000|Overall Study|Physician Decision|2|||
147433362|NCT01641809|531753284|FG000|Induction Phase (Day 1 to Week 24)|Withdrawal by Subject|1|||
147433363|NCT01641809|531753285|FG001|Induction Phase (Day 1 to Week 24)|Withdrawal by Subject|1|||
147433364|NCT01641809|531753286|FG002|Induction Phase (Day 1 to Week 24)|Withdrawal by Subject|0|||
147433365|NCT01641809|531753287|FG003|Induction Phase (Day 1 to Week 24)|Withdrawal by Subject|1|||
147193304|NCT00385671|530878787|FG002|Overall Study|Adverse Event|18|||
147193305|NCT00385671|530878785|FG000|Overall Study|Lack of Efficacy|5|||
147193306|NCT00385671|530878786|FG001|Overall Study|Lack of Efficacy|9|||
147193307|NCT00385671|530878787|FG002|Overall Study|Lack of Efficacy|5|||
147193308|NCT00385671|530878785|FG000|Overall Study|Lost to Follow-up|6|||
147193309|NCT00385671|530878786|FG001|Overall Study|Lost to Follow-up|6|||
147193310|NCT00385671|530878787|FG002|Overall Study|Lost to Follow-up|5|||
147433366|NCT01641809|531753284|FG000|Induction Phase (Day 1 to Week 24)|Physician Decision|0|||
147433367|NCT01641809|531753285|FG001|Induction Phase (Day 1 to Week 24)|Physician Decision|1|||
147193311|NCT00385671|530878785|FG000|Overall Study|Physician Decision|2|||
147433368|NCT01641809|531753286|FG002|Induction Phase (Day 1 to Week 24)|Physician Decision|0|||
147433369|NCT01641809|531753287|FG003|Induction Phase (Day 1 to Week 24)|Physician Decision|1|||
147433370|NCT01641809|531753284|FG000|Induction Phase (Day 1 to Week 24)|Lost to Follow-up|1|||
147433371|NCT01641809|531753285|FG001|Induction Phase (Day 1 to Week 24)|Lost to Follow-up|2|||
147193312|NCT00385671|530878786|FG001|Overall Study|Physician Decision|1|||
147193313|NCT00385671|530878787|FG002|Overall Study|Physician Decision|2|||
147433372|NCT01641809|531753286|FG002|Induction Phase (Day 1 to Week 24)|Lost to Follow-up|0|||
147433373|NCT01641809|531753287|FG003|Induction Phase (Day 1 to Week 24)|Lost to Follow-up|3|||
147433374|NCT01641809|531753284|FG000|Induction Phase (Day 1 to Week 24)|Protocol Violation|2|||
147433375|NCT01641809|531753285|FG001|Induction Phase (Day 1 to Week 24)|Protocol Violation|1|||
147433376|NCT01641809|531753286|FG002|Induction Phase (Day 1 to Week 24)|Protocol Violation|1|||
147433377|NCT01641809|531753287|FG003|Induction Phase (Day 1 to Week 24)|Protocol Violation|0|||
147433378|NCT01641809|531753284|FG000|Induction Phase (Day 1 to Week 24)|Lack of Efficacy|4|||
147433379|NCT01641809|531753285|FG001|Induction Phase (Day 1 to Week 24)|Lack of Efficacy|1|||
147193314|NCT00385671|530878785|FG000|Overall Study|Protocol Violation|5|||
147193315|NCT00385671|530878786|FG001|Overall Study|Protocol Violation|2|||
147193316|NCT00385671|530878787|FG002|Overall Study|Protocol Violation|1|||
147193317|NCT00385671|530878785|FG000|Overall Study|Sponsor Decision|2|||
147193318|NCT00385671|530878786|FG001|Overall Study|Sponsor Decision|2|||
147193319|NCT00385671|530878787|FG002|Overall Study|Sponsor Decision|1|||
147193320|NCT00385671|530878785|FG000|Overall Study|Withdrawal by Subject|4|||
147193321|NCT00385671|530878786|FG001|Overall Study|Withdrawal by Subject|4|||
147193322|NCT00385671|530878787|FG002|Overall Study|Withdrawal by Subject|4|||
147193323|NCT01910298|530878788|FG000|Overall Study|Adverse Event|1|||
147193324|NCT01910298|530878789|FG001|Overall Study|Adverse Event|0|||
147193325|NCT01910298|530878788|FG000|Overall Study|Withdrawal by Subject|2|||
147193326|NCT01910298|530878789|FG001|Overall Study|Withdrawal by Subject|7|||
147193327|NCT01910298|530878788|FG000|Overall Study|Protocol Deviation|0|||
147193328|NCT01910298|530878789|FG001|Overall Study|Protocol Deviation|5|||
147433380|NCT01641809|531753286|FG002|Induction Phase (Day 1 to Week 24)|Lack of Efficacy|2|||
147433381|NCT01641809|531753287|FG003|Induction Phase (Day 1 to Week 24)|Lack of Efficacy|3|||
147433382|NCT01641809|531753284|FG000|Induction Phase (Day 1 to Week 24)|Adverse Event|0|||
147433383|NCT01641809|531753285|FG001|Induction Phase (Day 1 to Week 24)|Adverse Event|1|||
147433384|NCT01641809|531753286|FG002|Induction Phase (Day 1 to Week 24)|Adverse Event|3|||
147433385|NCT01641809|531753287|FG003|Induction Phase (Day 1 to Week 24)|Adverse Event|7|||
147433386|NCT01641809|531753284|FG000|Maintenance Phase (Week 24 to Week 96)|Withdrawal by Subject|2|||
147534003|NCT01215968|532109600|FG001|Overall Study|Protocol Violation|4|||
147193329|NCT01910298|530878788|FG000|Overall Study|Lost to Follow-up|1|||
147193330|NCT01910298|530878789|FG001|Overall Study|Lost to Follow-up|1|||
147193331|NCT01910298|530878788|FG000|Overall Study|Study Terminated by Sponsor|1|||
147193332|NCT01910298|530878789|FG001|Overall Study|Study Terminated by Sponsor|17|||
147193333|NCT01910298|530878788|FG000|Overall Study|Other Miscellaneous Reasons|0|||
147193334|NCT01910298|530878789|FG001|Overall Study|Other Miscellaneous Reasons|2|||
147193335|NCT03037385|530878792|FG000|Overall Study|Adverse Event|0|||
147193336|NCT03037385|530878793|FG001|Overall Study|Adverse Event|0|||
147193337|NCT03037385|530878794|FG002|Overall Study|Adverse Event|1|||
147193338|NCT03037385|530878795|FG003|Overall Study|Adverse Event|0|||
147193339|NCT03037385|530878796|FG004|Overall Study|Adverse Event|0|||
147193340|NCT03037385|530878797|FG005|Overall Study|Adverse Event|0|||
147193341|NCT03037385|530878798|FG006|Overall Study|Adverse Event|0|||
147193342|NCT03037385|530878799|FG007|Overall Study|Adverse Event|0|||
147193343|NCT03037385|530878800|FG008|Overall Study|Adverse Event|0|||
147193344|NCT03037385|530878801|FG009|Overall Study|Adverse Event|6|||
147193345|NCT03037385|530878792|FG000|Overall Study|Death|1|||
147193346|NCT03037385|530878793|FG001|Overall Study|Death|4|||
147193347|NCT03037385|530878794|FG002|Overall Study|Death|2|||
147193348|NCT03037385|530878795|FG003|Overall Study|Death|2|||
147193349|NCT03037385|530878796|FG004|Overall Study|Death|5|||
147193350|NCT03037385|530878797|FG005|Overall Study|Death|2|||
147193351|NCT03037385|530878798|FG006|Overall Study|Death|1|||
147193352|NCT03037385|530878799|FG007|Overall Study|Death|4|||
147193353|NCT03037385|530878800|FG008|Overall Study|Death|3|||
147193354|NCT03037385|530878801|FG009|Overall Study|Death|240|||
147193355|NCT03037385|530878792|FG000|Overall Study|Initiation of Another Therapy|1|||
147193356|NCT03037385|530878793|FG001|Overall Study|Initiation of Another Therapy|0|||
147193357|NCT03037385|530878794|FG002|Overall Study|Initiation of Another Therapy|0|||
147193358|NCT03037385|530878795|FG003|Overall Study|Initiation of Another Therapy|0|||
147193359|NCT03037385|530878796|FG004|Overall Study|Initiation of Another Therapy|0|||
147193360|NCT03037385|530878797|FG005|Overall Study|Initiation of Another Therapy|0|||
147193361|NCT03037385|530878798|FG006|Overall Study|Initiation of Another Therapy|0|||
147193362|NCT03037385|530878799|FG007|Overall Study|Initiation of Another Therapy|1|||
147193363|NCT03037385|530878800|FG008|Overall Study|Initiation of Another Therapy|0|||
147193364|NCT03037385|530878801|FG009|Overall Study|Initiation of Another Therapy|2|||
147193365|NCT03037385|530878792|FG000|Overall Study|Lost to Follow-up|0|||
147193366|NCT03037385|530878793|FG001|Overall Study|Lost to Follow-up|0|||
147193367|NCT03037385|530878794|FG002|Overall Study|Lost to Follow-up|0|||
147193368|NCT03037385|530878795|FG003|Overall Study|Lost to Follow-up|0|||
147193369|NCT03037385|530878796|FG004|Overall Study|Lost to Follow-up|0|||
147193370|NCT03037385|530878797|FG005|Overall Study|Lost to Follow-up|1|||
147193371|NCT03037385|530878798|FG006|Overall Study|Lost to Follow-up|0|||
147193372|NCT03037385|530878799|FG007|Overall Study|Lost to Follow-up|0|||
147193373|NCT03037385|530878800|FG008|Overall Study|Lost to Follow-up|0|||
147193374|NCT03037385|530878801|FG009|Overall Study|Lost to Follow-up|16|||
147193375|NCT03037385|530878792|FG000|Overall Study|Physician Decision|0|||
147193376|NCT03037385|530878793|FG001|Overall Study|Physician Decision|0|||
147193377|NCT03037385|530878794|FG002|Overall Study|Physician Decision|0|||
147193378|NCT03037385|530878795|FG003|Overall Study|Physician Decision|0|||
147193379|NCT03037385|530878796|FG004|Overall Study|Physician Decision|0|||
147193380|NCT03037385|530878797|FG005|Overall Study|Physician Decision|0|||
147193381|NCT03037385|530878798|FG006|Overall Study|Physician Decision|0|||
147193382|NCT03037385|530878799|FG007|Overall Study|Physician Decision|0|||
147193383|NCT03037385|530878800|FG008|Overall Study|Physician Decision|0|||
147193384|NCT03037385|530878801|FG009|Overall Study|Physician Decision|1|||
147193385|NCT03037385|530878792|FG000|Overall Study|Progressive Disease|0|||
147193386|NCT03037385|530878793|FG001|Overall Study|Progressive Disease|1|||
147193387|NCT03037385|530878794|FG002|Overall Study|Progressive Disease|1|||
147193388|NCT03037385|530878795|FG003|Overall Study|Progressive Disease|5|||
147193389|NCT03037385|530878796|FG004|Overall Study|Progressive Disease|2|||
147193390|NCT03037385|530878797|FG005|Overall Study|Progressive Disease|0|||
147193391|NCT03037385|530878798|FG006|Overall Study|Progressive Disease|1|||
147433387|NCT01641809|531753285|FG001|Maintenance Phase (Week 24 to Week 96)|Withdrawal by Subject|3|||
147433388|NCT01641809|531753286|FG002|Maintenance Phase (Week 24 to Week 96)|Withdrawal by Subject|1|||
147433389|NCT01641809|531753287|FG003|Maintenance Phase (Week 24 to Week 96)|Withdrawal by Subject|0|||
147433390|NCT01641809|531753284|FG000|Maintenance Phase (Week 24 to Week 96)|Physician Decision|0|||
147433391|NCT01641809|531753285|FG001|Maintenance Phase (Week 24 to Week 96)|Physician Decision|1|||
147433392|NCT01641809|531753286|FG002|Maintenance Phase (Week 24 to Week 96)|Physician Decision|0|||
147193392|NCT03037385|530878799|FG007|Overall Study|Progressive Disease|0|||
147193393|NCT03037385|530878800|FG008|Overall Study|Progressive Disease|0|||
147193394|NCT03037385|530878801|FG009|Overall Study|Progressive Disease|30|||
147193395|NCT03037385|530878792|FG000|Overall Study|Withdrawal by Subject|0|||
147193396|NCT03037385|530878793|FG001|Overall Study|Withdrawal by Subject|0|||
147193397|NCT03037385|530878794|FG002|Overall Study|Withdrawal by Subject|1|||
147193398|NCT03037385|530878795|FG003|Overall Study|Withdrawal by Subject|2|||
147193399|NCT03037385|530878796|FG004|Overall Study|Withdrawal by Subject|1|||
147433393|NCT01641809|531753287|FG003|Maintenance Phase (Week 24 to Week 96)|Physician Decision|0|||
147433394|NCT01641809|531753284|FG000|Maintenance Phase (Week 24 to Week 96)|Lost to Follow-up|2|||
147193400|NCT03037385|530878797|FG005|Overall Study|Withdrawal by Subject|3|||
147193401|NCT03037385|530878798|FG006|Overall Study|Withdrawal by Subject|0|||
147193402|NCT03037385|530878799|FG007|Overall Study|Withdrawal by Subject|0|||
147193403|NCT03037385|530878800|FG008|Overall Study|Withdrawal by Subject|0|||
147193404|NCT03037385|530878801|FG009|Overall Study|Withdrawal by Subject|52|||
147193405|NCT03037385|530878792|FG000|Overall Study|Reason Not Specified|0|||
147433395|NCT01641809|531753285|FG001|Maintenance Phase (Week 24 to Week 96)|Lost to Follow-up|0|||
147433396|NCT01641809|531753286|FG002|Maintenance Phase (Week 24 to Week 96)|Lost to Follow-up|1|||
147433397|NCT01641809|531753287|FG003|Maintenance Phase (Week 24 to Week 96)|Lost to Follow-up|2|||
147433398|NCT01641809|531753284|FG000|Maintenance Phase (Week 24 to Week 96)|Lack of Efficacy|1|||
147433399|NCT01641809|531753285|FG001|Maintenance Phase (Week 24 to Week 96)|Lack of Efficacy|1|||
147433400|NCT01641809|531753286|FG002|Maintenance Phase (Week 24 to Week 96)|Lack of Efficacy|0|||
147433401|NCT01641809|531753287|FG003|Maintenance Phase (Week 24 to Week 96)|Lack of Efficacy|2|||
147433402|NCT01641809|531753284|FG000|Maintenance Phase (Week 24 to Week 96)|Adverse Event|1|||
147433403|NCT01641809|531753285|FG001|Maintenance Phase (Week 24 to Week 96)|Adverse Event|0|||
147433404|NCT01641809|531753286|FG002|Maintenance Phase (Week 24 to Week 96)|Adverse Event|1|||
147433405|NCT01641809|531753287|FG003|Maintenance Phase (Week 24 to Week 96)|Adverse Event|2|||
147433406|NCT01641809|531753284|FG000|Open-label (Week 96 to Week 324)|Withdrawal by Subject|2|||
147433407|NCT01641809|531753285|FG001|Open-label (Week 96 to Week 324)|Withdrawal by Subject|3|||
147433408|NCT01641809|531753286|FG002|Open-label (Week 96 to Week 324)|Withdrawal by Subject|1|||
147433409|NCT01641809|531753287|FG003|Open-label (Week 96 to Week 324)|Withdrawal by Subject|0|||
147433410|NCT01641809|531753284|FG000|Open-label (Week 96 to Week 324)|Physician Decision|0|||
147433411|NCT01641809|531753285|FG001|Open-label (Week 96 to Week 324)|Physician Decision|1|||
147433412|NCT01641809|531753286|FG002|Open-label (Week 96 to Week 324)|Physician Decision|1|||
147433413|NCT01641809|531753287|FG003|Open-label (Week 96 to Week 324)|Physician Decision|0|||
147433414|NCT01641809|531753284|FG000|Open-label (Week 96 to Week 324)|Lost to Follow-up|5|||
147433415|NCT01641809|531753285|FG001|Open-label (Week 96 to Week 324)|Lost to Follow-up|4|||
147433416|NCT01641809|531753286|FG002|Open-label (Week 96 to Week 324)|Lost to Follow-up|5|||
147433417|NCT01641809|531753287|FG003|Open-label (Week 96 to Week 324)|Lost to Follow-up|0|||
147433418|NCT01641809|531753284|FG000|Open-label (Week 96 to Week 324)|Site closed|1|||
147433419|NCT01641809|531753285|FG001|Open-label (Week 96 to Week 324)|Site closed|0|||
147433420|NCT01641809|531753286|FG002|Open-label (Week 96 to Week 324)|Site closed|0|||
147433421|NCT01641809|531753287|FG003|Open-label (Week 96 to Week 324)|Site closed|0|||
147433422|NCT01641809|531753284|FG000|Open-label (Week 96 to Week 324)|Protocol Violation|1|||
147433423|NCT01641809|531753285|FG001|Open-label (Week 96 to Week 324)|Protocol Violation|1|||
147433424|NCT01641809|531753286|FG002|Open-label (Week 96 to Week 324)|Protocol Violation|0|||
147433425|NCT01641809|531753287|FG003|Open-label (Week 96 to Week 324)|Protocol Violation|0|||
147433426|NCT01641809|531753284|FG000|Open-label (Week 96 to Week 324)|Lack of Efficacy|4|||
147433427|NCT01641809|531753285|FG001|Open-label (Week 96 to Week 324)|Lack of Efficacy|1|||
147433428|NCT01641809|531753286|FG002|Open-label (Week 96 to Week 324)|Lack of Efficacy|0|||
147433429|NCT01641809|531753287|FG003|Open-label (Week 96 to Week 324)|Lack of Efficacy|0|||
147433430|NCT01641809|531753284|FG000|Open-label (Week 96 to Week 324)|Adverse Event|3|||
147433431|NCT01641809|531753285|FG001|Open-label (Week 96 to Week 324)|Adverse Event|2|||
147433432|NCT01641809|531753286|FG002|Open-label (Week 96 to Week 324)|Adverse Event|1|||
147534004|NCT01215968|532109599|FG000|Overall Study|Not received study drug|0|||
147534005|NCT01215968|532109600|FG001|Overall Study|Not received study drug|1|||
147433433|NCT01641809|531753287|FG003|Open-label (Week 96 to Week 324)|Adverse Event|0|||
147433434|NCT03294109|531753288|FG000|Overall Study|Withdrawal by Subject|6|||
147534006|NCT01958619|532109603|FG000|Overall Study|Protocol Violation|2|||
147534007|NCT01958619|532109604|FG001|Overall Study|Protocol Violation|0|||
147534008|NCT01958619|532109605|FG002|Overall Study|Protocol Violation|1|||
147433435|NCT03294109|531753289|FG001|Overall Study|Withdrawal by Subject|5|||
147433436|NCT03690141|531753292|FG000|Overall Study|Adverse Event|5|||
147433437|NCT03690141|531753292|FG000|Overall Study|Withdrawal by Subject|3|||
147433438|NCT03690141|531753292|FG000|Overall Study|Physician Decision|4|||
147433439|NCT03690141|531753292|FG000|Overall Study|Disease progression|4|||
147433440|NCT04744285|531753293|FG000|Overall Study|Withdrawal by Subject|1|||
147433441|NCT04744285|531753294|FG001|Overall Study|Withdrawal by Subject|1|||
147433442|NCT04744285|531753295|FG002|Overall Study|Withdrawal by Subject|2|||
147306776|NCT00110890|531290761|FG001|Overall Study|Requirement for alternative therapy|1|||
147433443|NCT04744285|531753296|FG003|Overall Study|Withdrawal by Subject|1|||
147433444|NCT01717768|531753297|FG000|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
147534009|NCT01958619|532109606|FG003|Overall Study|Protocol Violation|0|||
147534010|NCT03759340|532109609|FG000|Overall Study|Adverse Event|2|||
147433445|NCT01717768|531753298|FG001|Part 1 (Duration of 15 Days)|Lost to Follow-up|1|||
147433446|NCT01717768|531753299|FG002|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
147433447|NCT01717768|531753300|FG003|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
147433448|NCT01717768|531753301|FG004|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
147433449|NCT01717768|531753302|FG005|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
147433450|NCT01717768|531753303|FG006|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
147433451|NCT01717768|531753304|FG007|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
147534011|NCT03759340|532109609|FG000|Overall Study|Lost to Follow-up|1|||
147534012|NCT03759340|532109609|FG000|Overall Study|Withdrawal by Subject|15|||
147534013|NCT03759340|532109609|FG000|Overall Study|Study Terminated by Sponsor|38|||
147534014|NCT03795233|532109610|FG000|Overall Study|Withdrawal by Subject|2|||
147534015|NCT03795233|532109611|FG001|Overall Study|Withdrawal by Subject|1|||
147534016|NCT03795233|532109610|FG000|Overall Study|Lost to Follow-up|1|||
147534017|NCT03795233|532109611|FG001|Overall Study|Lost to Follow-up|0|||
147534018|NCT03795233|532109610|FG000|Overall Study|Death|1|||
147534019|NCT03795233|532109611|FG001|Overall Study|Death|0|||
147306777|NCT00110890|531290760|FG000|Overall Study|Disease progression|0|||
147433452|NCT01717768|531753305|FG008|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
147433453|NCT01717768|531753306|FG009|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
147433454|NCT01717768|531753307|FG010|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
147433455|NCT01717768|531753308|FG011|Part 1 (Duration of 15 Days)|Lost to Follow-up|0|||
147433456|NCT01717768|531753297|FG000|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
147433457|NCT01717768|531753298|FG001|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
147433458|NCT01717768|531753299|FG002|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
147433459|NCT01717768|531753300|FG003|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
147433460|NCT01717768|531753301|FG004|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
147433461|NCT01717768|531753302|FG005|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
147433462|NCT01717768|531753303|FG006|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
147433463|NCT01717768|531753304|FG007|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
147433464|NCT01717768|531753305|FG008|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
147433465|NCT01717768|531753306|FG009|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
147433466|NCT01717768|531753307|FG010|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|0|||
147433467|NCT01717768|531753308|FG011|Part 4-Treatment 1 (Duration of 15 Days)|Protocol Violation|1|||
147433468|NCT01717768|531753297|FG000|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
147433469|NCT01717768|531753298|FG001|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
147433470|NCT01717768|531753299|FG002|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
147433471|NCT01717768|531753300|FG003|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
147433472|NCT01717768|531753301|FG004|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
147433473|NCT01717768|531753302|FG005|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
147433474|NCT01717768|531753303|FG006|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
147433475|NCT01717768|531753304|FG007|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|2|||
147433476|NCT01717768|531753305|FG008|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
147433477|NCT01717768|531753306|FG009|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
147433478|NCT01717768|531753307|FG010|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
147433479|NCT01717768|531753308|FG011|Part 4-Treatment 2 (Duration of 15 Days)|Withdrawal by Subject|0|||
147433480|NCT01717768|531753297|FG000|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
147433481|NCT01717768|531753298|FG001|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
147433482|NCT01717768|531753299|FG002|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
147433483|NCT01717768|531753300|FG003|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
147433484|NCT01717768|531753301|FG004|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
147433485|NCT01717768|531753302|FG005|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
147534020|NCT01054443|532109612|FG000|Overall Study|Withdrawal by Subject|0|||
147534021|NCT01054443|532109613|FG001|Overall Study|Withdrawal by Subject|0|||
147534022|NCT01054443|532109614|FG002|Overall Study|Withdrawal by Subject|0|||
147649385|NCT04575584|532537338|FG003|Overall Study|Death|2|||
147649386|NCT04575584|532537339|FG004|Overall Study|Death|0|||
147649387|NCT04575584|532537340|FG005|Overall Study|Death|0|||
147649388|NCT04575584|532537335|FG000|Overall Study|Lost to Follow-up|1|||
147649389|NCT04575584|532537336|FG001|Overall Study|Lost to Follow-up|1|||
147649390|NCT04575584|532537337|FG002|Overall Study|Lost to Follow-up|1|||
147649391|NCT04575584|532537338|FG003|Overall Study|Lost to Follow-up|1|||
147649392|NCT04575584|532537339|FG004|Overall Study|Lost to Follow-up|0|||
147649393|NCT04575584|532537340|FG005|Overall Study|Lost to Follow-up|0|||
147649394|NCT04575584|532537335|FG000|Overall Study|Physician Decision|0|||
147649395|NCT04575584|532537336|FG001|Overall Study|Physician Decision|1|||
147649396|NCT04575584|532537337|FG002|Overall Study|Physician Decision|1|||
147649397|NCT04575584|532537338|FG003|Overall Study|Physician Decision|1|||
147649398|NCT04575584|532537339|FG004|Overall Study|Physician Decision|0|||
147649399|NCT04575584|532537340|FG005|Overall Study|Physician Decision|0|||
147649400|NCT04575584|532537335|FG000|Overall Study|Withdrawal by Subject|7|||
147534023|NCT01054443|532109615|FG003|Overall Study|Withdrawal by Subject|1|||
147534024|NCT00985114|532109617|FG000|Overall Study|Adverse Event|1|||
147534025|NCT00985114|532109618|FG001|Overall Study|Adverse Event|0|||
147534026|NCT00985114|532109617|FG000|Overall Study|Withdrawal by Subject|0|||
147534027|NCT00985114|532109618|FG001|Overall Study|Withdrawal by Subject|2|||
147534028|NCT02950831|532109619|FG000|Overall Study|Lost to Follow-up|1|||
147534029|NCT02950831|532109619|FG000|Overall Study|Withdrawal by Subject|3|||
147534030|NCT02950831|532109619|FG000|Overall Study|stimulation trail failure|5|||
147534031|NCT01119118|532109620|FG000|Overall Study|Adverse Event|1|||
147534032|NCT02711306|532109626|FG000|Overall Study|Withdrawal by Subject|2|||
147534033|NCT02711306|532109627|FG001|Overall Study|Withdrawal by Subject|2|||
147534034|NCT04075656|532109631|FG000|Overall Study|Withdrawal by Subject|5|||
147534035|NCT04075656|532109632|FG001|Overall Study|Withdrawal by Subject|5|||
147534036|NCT00563706|532111338|FG000|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|4|||
147534037|NCT00563706|532111339|FG001|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1|||
147534038|NCT00563706|532111340|FG002|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1|||
147534039|NCT00563706|532111341|FG003|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1|||
147534040|NCT00563706|532111342|FG004|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|0|||
147534041|NCT00563706|532111343|FG005|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|0|||
147433486|NCT01717768|531753303|FG006|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
147433487|NCT01717768|531753304|FG007|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
147433488|NCT01717768|531753305|FG008|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
147433489|NCT01717768|531753306|FG009|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|1|||
147433490|NCT01717768|531753307|FG010|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
147433491|NCT01717768|531753308|FG011|Part 4-Treatment 2 (Duration of 15 Days)|Lost to Follow-up|0|||
147433492|NCT00448435|531753309|FG000|Washout Period - 2 Weeks|Withdrawal by Subject|1|||
147433493|NCT00448435|531753310|FG001|Washout Period - 2 Weeks|Withdrawal by Subject|0|||
147433494|NCT04195581|531753313|FG000|Comfilcon A With All in One Light|Withdrawal by Subject|4|||
147433495|NCT04195581|531753313|FG000|Comfilcon A With Hy-Care|Withdrawal by Subject|5|||
147433496|NCT04195581|531753313|FG000|Comfilcon A With Refine One Step|Withdrawal by Subject|1|||
147433497|NCT04195581|531753313|FG000|Fanfilcon A With All in One Light|Withdrawal by Subject|1|||
147433498|NCT04195581|531753313|FG000|Fanfilcon A With Hy-Care|Withdrawal by Subject|3|||
147433499|NCT04195581|531753313|FG000|Fanfilcon A With Refine One Step|Withdrawal by Subject|2|||
147433500|NCT00821431|531753314|FG000|Overall Study|Adverse Event|6|||
147433501|NCT00821431|531753315|FG001|Overall Study|Adverse Event|3|||
147433502|NCT00821431|531753314|FG000|Overall Study|Withdrawal by Subject|5|||
147433503|NCT00821431|531753315|FG001|Overall Study|Withdrawal by Subject|0|||
147433504|NCT00821431|531753314|FG000|Overall Study|Lost to Follow-up|1|||
147433505|NCT00821431|531753315|FG001|Overall Study|Lost to Follow-up|0|||
147433506|NCT00821431|531753314|FG000|Overall Study|Protocol Violation|3|||
147433507|NCT00821431|531753315|FG001|Overall Study|Protocol Violation|1|||
147433508|NCT00821431|531753314|FG000|Overall Study|Physician Decision|0|||
147433509|NCT00821431|531753315|FG001|Overall Study|Physician Decision|1|||
147433510|NCT01387230|531753316|FG000|Overall Study|Adverse Event|0|||
147433511|NCT01387230|531753317|FG001|Overall Study|Adverse Event|1|||
147433512|NCT01387230|531753318|FG002|Overall Study|Adverse Event|3|||
147433513|NCT01387230|531753316|FG000|Overall Study|Lack of Efficacy|8|||
147433514|NCT01387230|531753317|FG001|Overall Study|Lack of Efficacy|5|||
147433515|NCT01387230|531753318|FG002|Overall Study|Lack of Efficacy|4|||
147433516|NCT01387230|531753316|FG000|Overall Study|Protocol-defined Stopping Criteria|6|||
147433517|NCT01387230|531753317|FG001|Overall Study|Protocol-defined Stopping Criteria|0|||
147433518|NCT01387230|531753318|FG002|Overall Study|Protocol-defined Stopping Criteria|5|||
147433519|NCT01387230|531753316|FG000|Overall Study|Lost to Follow-up|0|||
147433520|NCT01387230|531753317|FG001|Overall Study|Lost to Follow-up|0|||
147433521|NCT01387230|531753318|FG002|Overall Study|Lost to Follow-up|1|||
147433522|NCT01387230|531753316|FG000|Overall Study|Withdrawal by Subject|4|||
147433523|NCT01387230|531753317|FG001|Overall Study|Withdrawal by Subject|1|||
147433524|NCT01387230|531753318|FG002|Overall Study|Withdrawal by Subject|0|||
147433525|NCT03026127|531753321|FG000|CRISP R61|Adverse Event|5|||
147433526|NCT03026127|531753322|FG001|CRISP R61|Adverse Event|0|||
147433527|NCT03026127|531753323|FG002|CRISP R61|Adverse Event|0|||
147433528|NCT03026127|531753321|FG000|CRISP R61|Lost to Follow-up|2|||
147433529|NCT03026127|531753322|FG001|CRISP R61|Lost to Follow-up|0|||
147534042|NCT00563706|532111344|FG006|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|0|||
147534043|NCT00563706|532111345|FG007|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|1|||
147433530|NCT03026127|531753323|FG002|CRISP R61|Lost to Follow-up|0|||
147433531|NCT03026127|531753321|FG000|CRISP R61|Dropped before therapy|5|||
147433532|NCT03026127|531753322|FG001|CRISP R61|Dropped before therapy|0|||
147433533|NCT03026127|531753323|FG002|CRISP R61|Dropped before therapy|0|||
147433534|NCT03026127|531753321|FG000|CRISP R33|Lost to Follow-up|0|||
147433535|NCT03026127|531753322|FG001|CRISP R33|Lost to Follow-up|5|||
147433536|NCT03026127|531753323|FG002|CRISP R33|Lost to Follow-up|4|||
147433537|NCT03026127|531753321|FG000|CRISP R33|Adverse Event|0|||
147433538|NCT03026127|531753322|FG001|CRISP R33|Adverse Event|9|||
147433539|NCT03026127|531753323|FG002|CRISP R33|Adverse Event|5|||
147433540|NCT03026127|531753321|FG000|CRISP R33|Withdrawal by Subject|0|||
147433541|NCT03026127|531753322|FG001|CRISP R33|Withdrawal by Subject|9|||
147433542|NCT03026127|531753323|FG002|CRISP R33|Withdrawal by Subject|1|||
147433543|NCT03026127|531753321|FG000|CRISP R33|Lack of Efficacy|0|||
147433544|NCT03026127|531753322|FG001|CRISP R33|Lack of Efficacy|3|||
147433545|NCT03026127|531753323|FG002|CRISP R33|Lack of Efficacy|2|||
147193406|NCT03037385|530878793|FG001|Overall Study|Reason Not Specified|1|||
147193407|NCT03037385|530878794|FG002|Overall Study|Reason Not Specified|0|||
147193408|NCT03037385|530878795|FG003|Overall Study|Reason Not Specified|4|||
147433546|NCT03026127|531753321|FG000|CRISP R33|Physician Decision|0|||
147433547|NCT03026127|531753322|FG001|CRISP R33|Physician Decision|3|||
147433548|NCT03026127|531753323|FG002|CRISP R33|Physician Decision|1|||
147433549|NCT03026127|531753321|FG000|CRISP R33|Transportation|0|||
147433550|NCT03026127|531753322|FG001|CRISP R33|Transportation|2|||
147433551|NCT03026127|531753323|FG002|CRISP R33|Transportation|1|||
147433552|NCT01182766|531753327|FG000|Overall Study|Lost to Follow-up|32|||
147534044|NCT00563706|532111346|FG008|DB Treatment Period (Day 1 up to Day 28)|Adverse Event|5|||
147534045|NCT00563706|532111338|FG000|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2|||
147534046|NCT00563706|532111339|FG001|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|1|||
147534047|NCT00563706|532111340|FG002|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2|||
147534048|NCT00563706|532111341|FG003|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|4|||
147534049|NCT00563706|532111342|FG004|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|1|||
147534050|NCT00563706|532111343|FG005|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2|||
147534051|NCT00563706|532111344|FG006|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|2|||
147534052|NCT00563706|532111345|FG007|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|5|||
147534053|NCT00563706|532111346|FG008|DB Treatment Period (Day 1 up to Day 28)|Lack of Efficacy|1|||
147534054|NCT00563706|532111338|FG000|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|9|||
147534055|NCT00563706|532111339|FG001|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|3|||
147534056|NCT00563706|532111340|FG002|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|2|||
147534057|NCT00563706|532111341|FG003|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|5|||
147534058|NCT00563706|532111342|FG004|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|4|||
147534059|NCT00563706|532111343|FG005|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|3|||
147534060|NCT00563706|532111344|FG006|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|1|||
147534061|NCT00563706|532111345|FG007|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|6|||
147534062|NCT00563706|532111346|FG008|DB Treatment Period (Day 1 up to Day 28)|Withdrawal by Subject|3|||
147534063|NCT00563706|532111338|FG000|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|2|||
147534064|NCT00563706|532111339|FG001|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
147534065|NCT00563706|532111340|FG002|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
147534066|NCT00563706|532111341|FG003|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
147193409|NCT03037385|530878796|FG004|Overall Study|Reason Not Specified|3|||
147193410|NCT03037385|530878797|FG005|Overall Study|Reason Not Specified|6|||
147433553|NCT01182766|531753328|FG001|Overall Study|Lost to Follow-up|36|||
147433554|NCT01182766|531753329|FG002|Overall Study|Lost to Follow-up|29|||
147433555|NCT01182766|531753327|FG000|Overall Study|Withdrawal by Subject|14|||
147433556|NCT01182766|531753328|FG001|Overall Study|Withdrawal by Subject|3|||
147433557|NCT01182766|531753329|FG002|Overall Study|Withdrawal by Subject|6|||
147433558|NCT01182766|531753327|FG000|Overall Study|Physician Decision|1|||
147433559|NCT01182766|531753328|FG001|Overall Study|Physician Decision|0|||
147433560|NCT01182766|531753329|FG002|Overall Study|Physician Decision|0|||
147433561|NCT01182766|531753327|FG000|Overall Study|Non-compliance|1|||
147433562|NCT01182766|531753328|FG001|Overall Study|Non-compliance|1|||
147433563|NCT01182766|531753329|FG002|Overall Study|Non-compliance|1|||
147433564|NCT03027557|531753330|FG000|Overall Study|Adverse Event|1|||
147433565|NCT03027557|531753331|FG001|Overall Study|Adverse Event|0|||
147433566|NCT03027557|531753332|FG002|Overall Study|Adverse Event|0|||
147433567|NCT02510560|531753335|FG000|Overall Study|Discontinued from Treatment|27|||
147433568|NCT02510560|531753336|FG001|Overall Study|Discontinued from Treatment|18|||
147433569|NCT02510560|531753337|FG002|Overall Study|Discontinued from Treatment|19|||
147433570|NCT02510560|531753335|FG000|Overall Study|Other|4|||
147433571|NCT02510560|531753336|FG001|Overall Study|Other|4|||
147433572|NCT02510560|531753337|FG002|Overall Study|Other|3|||
147433573|NCT01699789|531753338|FG000|Overall Study|Withdrawal by Subject|18|||
147433574|NCT01699789|531753339|FG001|Overall Study|Withdrawal by Subject|23|||
147433575|NCT01699789|531753338|FG000|Overall Study|Death|1|||
147433576|NCT01699789|531753339|FG001|Overall Study|Death|2|||
147433577|NCT01699789|531753338|FG000|Overall Study|Lost to Follow-up|83|||
147433578|NCT01699789|531753339|FG001|Overall Study|Lost to Follow-up|101|||
147433579|NCT02554903|531753340|FG000|Overall Study|Death|1|||
147433580|NCT02554903|531753341|FG001|Overall Study|Death|1|||
147433581|NCT02554903|531753340|FG000|Overall Study|Physician Decision|2|||
147433582|NCT02554903|531753341|FG001|Overall Study|Physician Decision|2|||
147433583|NCT02554903|531753340|FG000|Overall Study|Heart Transplant|1|||
147433584|NCT02554903|531753341|FG001|Overall Study|Heart Transplant|2|||
147433585|NCT04427501|531753344|FG000|Overall Study|Death|0|||
147433586|NCT04427501|531753345|FG001|Overall Study|Death|0|||
147433587|NCT04427501|531753346|FG002|Overall Study|Death|0|||
147433588|NCT04427501|531753347|FG003|Overall Study|Death|0|||
147433589|NCT04427501|531753348|FG004|Overall Study|Death|0|||
147433590|NCT04427501|531753349|FG005|Overall Study|Death|15|||
147433591|NCT04427501|531753350|FG006|Overall Study|Death|0|||
147433592|NCT04427501|531753351|FG007|Overall Study|Death|0|||
147433593|NCT04427501|531753352|FG008|Overall Study|Death|0|||
147433594|NCT04427501|531753353|FG009|Overall Study|Death|0|||
147433595|NCT04427501|531753354|FG010|Overall Study|Death|0|||
147433596|NCT04427501|531753355|FG011|Overall Study|Death|0|||
147433597|NCT04427501|531753344|FG000|Overall Study|Lost to Follow-up|5|||
147433598|NCT04427501|531753345|FG001|Overall Study|Lost to Follow-up|1|||
147433599|NCT04427501|531753346|FG002|Overall Study|Lost to Follow-up|2|||
147433600|NCT04427501|531753347|FG003|Overall Study|Lost to Follow-up|0|||
147433601|NCT04427501|531753348|FG004|Overall Study|Lost to Follow-up|2|||
147433602|NCT04427501|531753349|FG005|Overall Study|Lost to Follow-up|11|||
147193411|NCT03037385|530878798|FG006|Overall Study|Reason Not Specified|2|||
147193412|NCT03037385|530878799|FG007|Overall Study|Reason Not Specified|0|||
147193413|NCT03037385|530878800|FG008|Overall Study|Reason Not Specified|1|||
147193414|NCT03037385|530878801|FG009|Overall Study|Reason Not Specified|181|||
147193415|NCT04515771|530878802|FG000|Period 1: 6 Month Randomized Period|Lost to Follow-up|9|||
147193416|NCT04515771|530878803|FG001|Period 1: 6 Month Randomized Period|Lost to Follow-up|1|||
147193417|NCT04515771|530878802|FG000|Period 1: 6 Month Randomized Period|Withdrawal by Subject|3|||
147193418|NCT04515771|530878803|FG001|Period 1: 6 Month Randomized Period|Withdrawal by Subject|1|||
147193419|NCT04515771|530878802|FG000|Period 2. 6 Month Waitlist Crossover|Lost to Follow-up|0|||
147193420|NCT04515771|530878803|FG001|Period 2. 6 Month Waitlist Crossover|Lost to Follow-up|5|||
147193421|NCT01021020|530878805|FG000|Period I|Protocol Violation|1|||
147193422|NCT01021020|530878805|FG000|Period I|Withdrawal by Subject|1|||
147193423|NCT01021020|530878805|FG000|14 Day Washout Period A|Physician Decision|1|||
147193424|NCT00948246|530878808|FG000|Overall Study|Lost to Follow-up|11|||
147193425|NCT00948246|530878808|FG000|Overall Study|Adverse Event|11|||
147193426|NCT00948246|530878808|FG000|Overall Study|Death|1|||
147193427|NCT00948246|530878808|FG000|Overall Study|Withdrawal by Subject|1|||
147193428|NCT00148317|530878809|FG000|Mobilization (VEL+CYTOXAN+FILGRASTIM)|Adverse Event|8|||
147193429|NCT00148317|530878809|FG000|Mobilization (VEL+CYTOXAN+FILGRASTIM)|Lack of Efficacy|2|||
147193430|NCT00148317|530878809|FG000|Mobilization (VEL+CYTOXAN+FILGRASTIM)|unable to tolerate|1|||
147193431|NCT03924622|530878810|FG000|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|2|||
147193432|NCT03924622|530878811|FG001|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|3|||
147193433|NCT03924622|530878812|FG002|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|3|||
147193434|NCT03924622|530878813|FG003|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|4|||
147193435|NCT03924622|530878814|FG004|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|3|||
147193436|NCT03924622|530878815|FG005|Overall Study|Study closed due to pandemic with approval of funding agency/IRB|3|||
147193437|NCT02923726|530878817|FG000|Overall Study|Death|196|||
147193438|NCT02923726|530878818|FG001|Overall Study|Death|175|||
147193439|NCT02923726|530878817|FG000|Overall Study|Withdrawal by Subject|337|||
147193440|NCT02923726|530878818|FG001|Overall Study|Withdrawal by Subject|307|||
147193441|NCT03617172|530878828|FG000|Overall Study|Lost to Follow-up|1|||
147193442|NCT03617172|530878829|FG001|Overall Study|Lost to Follow-up|0|||
147193443|NCT02587221|530878832|FG000|Overall Study|Adverse Event|3|||
147193444|NCT02587221|530878833|FG001|Overall Study|Adverse Event|3|||
147193445|NCT02587221|530878832|FG000|Overall Study|Death|33|||
147193446|NCT02587221|530878833|FG001|Overall Study|Death|34|||
147193447|NCT02587221|530878832|FG000|Overall Study|Withdrawal by Subject|66|||
147193448|NCT02587221|530878833|FG001|Overall Study|Withdrawal by Subject|61|||
147193449|NCT02587221|530878832|FG000|Overall Study|Lost to Follow-up|21|||
147193450|NCT02587221|530878833|FG001|Overall Study|Lost to Follow-up|19|||
147193451|NCT02587221|530878832|FG000|Overall Study|Protocol Violation|6|||
147193452|NCT02587221|530878833|FG001|Overall Study|Protocol Violation|5|||
147193453|NCT02587221|530878832|FG000|Overall Study|Other Reason or Unspecified|2|||
147193454|NCT02587221|530878833|FG001|Overall Study|Other Reason or Unspecified|1|||
147193455|NCT01176032|530878835|FG000|Overall Study|Adverse Event|1|||
147193456|NCT01176032|530878836|FG001|Overall Study|Adverse Event|0|||
147193457|NCT01176032|530878835|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
147193458|NCT01176032|530878836|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
147193459|NCT01176032|530878835|FG000|Overall Study|Protocol Violation|1|||
147193460|NCT01176032|530878836|FG001|Overall Study|Protocol Violation|0|||
147193461|NCT01176032|530878835|FG000|Overall Study|Informed consent withdrawn|3|||
147193462|NCT01176032|530878836|FG001|Overall Study|Informed consent withdrawn|0|||
147193463|NCT01176032|530878835|FG000|Overall Study|Other|1|||
147193464|NCT01176032|530878836|FG001|Overall Study|Other|0|||
147193465|NCT01469221|530878837|FG000|Double Blind Phase|Protocol Violation|1|||
147193466|NCT01469221|530878838|FG001|Double Blind Phase|Protocol Violation|0|||
147193467|NCT01469221|530878839|FG002|Double Blind Phase|Protocol Violation|0|||
147193468|NCT01469221|530878837|FG000|Double Blind Phase|Physician Decision|1|||
147193469|NCT01469221|530878838|FG001|Double Blind Phase|Physician Decision|1|||
147433603|NCT04427501|531753350|FG006|Overall Study|Lost to Follow-up|10|||
147433604|NCT04427501|531753351|FG007|Overall Study|Lost to Follow-up|10|||
147433605|NCT04427501|531753352|FG008|Overall Study|Lost to Follow-up|2|||
147433606|NCT04427501|531753353|FG009|Overall Study|Lost to Follow-up|5|||
147433607|NCT04427501|531753354|FG010|Overall Study|Lost to Follow-up|2|||
147433608|NCT04427501|531753355|FG011|Overall Study|Lost to Follow-up|0|||
147433609|NCT04427501|531753344|FG000|Overall Study|Physician Decision|0|||
147433610|NCT04427501|531753345|FG001|Overall Study|Physician Decision|3|||
147433611|NCT04427501|531753346|FG002|Overall Study|Physician Decision|0|||
147193470|NCT01469221|530878839|FG002|Double Blind Phase|Physician Decision|0|||
147193471|NCT01469221|530878837|FG000|Double Blind Phase|Sponsor Terminate Study|12|||
147193472|NCT01469221|530878838|FG001|Double Blind Phase|Sponsor Terminate Study|16|||
147193473|NCT01469221|530878839|FG002|Double Blind Phase|Sponsor Terminate Study|0|||
147433612|NCT04427501|531753347|FG003|Overall Study|Physician Decision|0|||
147433613|NCT04427501|531753348|FG004|Overall Study|Physician Decision|0|||
147193474|NCT01149096|530878842|FG000|Overall Study|Lost to Follow-up|0|||
147193475|NCT01149096|530878843|FG001|Overall Study|Lost to Follow-up|1|||
147193476|NCT04914364|530878844|FG000|Overall Study|No longer eligible for study|1|||
147193477|NCT04914364|530878844|FG000|Overall Study|Lost to Follow-up|2|||
147193478|NCT02358473|530878845|FG000|Overall Study|Disease Progession|6|||
147193479|NCT02358473|530878845|FG000|Overall Study|Adverse Event|3|||
147193480|NCT02358473|530878845|FG000|Overall Study|Withdrawal by Subject|2|||
147193481|NCT02358473|530878845|FG000|Overall Study|Physician Decision|2|||
147193482|NCT04819945|530878860|FG000|Overall Study|Lost to Follow-up|1|||
147193483|NCT00703014|530878861|FG000|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|33|||
147193484|NCT00703014|530878862|FG001|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|32|||
147193485|NCT00703014|530878863|FG002|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|0|||
147193486|NCT00703014|530878864|FG003|Mothers Follow Up Trial P05712|Did not complete follow up in P05712|0|||
147193487|NCT00703014|530878861|FG000|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|0|||
147193488|NCT00703014|530878862|FG001|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|0|||
147193489|NCT00703014|530878863|FG002|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|47|||
147193490|NCT00703014|530878864|FG003|Fetuses/Infants Follow Up Trial P05712|Did not complete follow up in P05712|42|||
147193491|NCT02004236|530878865|FG000|Overall Study|Lack of Efficacy|0|||
147193492|NCT02004236|530878866|FG001|Overall Study|Lack of Efficacy|0|||
147193493|NCT02004236|530878867|FG002|Overall Study|Lack of Efficacy|16|||
147193494|NCT00918281|530878872|FG000|Overall Study|Physician Decision|29|||
147193495|NCT01446159|530878873|FG000|Overall Study|Withdrawal by Subject|1|||
147193496|NCT01446159|530878874|FG001|Overall Study|Withdrawal by Subject|0|||
147193497|NCT01446159|530878875|FG002|Overall Study|Withdrawal by Subject|14|||
147193498|NCT01446159|530878876|FG003|Overall Study|Withdrawal by Subject|11|||
147193499|NCT01446159|530878873|FG000|Overall Study|Lost to Follow-up|0|||
147193500|NCT01446159|530878874|FG001|Overall Study|Lost to Follow-up|0|||
147193501|NCT01446159|530878875|FG002|Overall Study|Lost to Follow-up|1|||
147193502|NCT01446159|530878876|FG003|Overall Study|Lost to Follow-up|2|||
147193503|NCT01446159|530878873|FG000|Overall Study|Death|2|||
147193504|NCT01446159|530878874|FG001|Overall Study|Death|3|||
147193505|NCT01446159|530878875|FG002|Overall Study|Death|43|||
147193506|NCT01446159|530878876|FG003|Overall Study|Death|36|||
147193507|NCT01446159|530878873|FG000|Overall Study|Other|0|||
147193508|NCT01446159|530878874|FG001|Overall Study|Other|0|||
147193509|NCT01446159|530878875|FG002|Overall Study|Other|13|||
147193510|NCT01446159|530878876|FG003|Overall Study|Other|13|||
147193511|NCT01283139|530878877|FG000|Overall Study|Lost to Follow-up|5|||
147193512|NCT01283139|530878878|FG001|Overall Study|Lost to Follow-up|2|||
147193513|NCT01283139|530878879|FG002|Overall Study|Lost to Follow-up|3|||
147193514|NCT01283139|530878880|FG003|Overall Study|Lost to Follow-up|1|||
147193515|NCT01283139|530878877|FG000|Overall Study|Withdrawal by Subject|8|||
147193516|NCT01283139|530878878|FG001|Overall Study|Withdrawal by Subject|8|||
147193517|NCT01283139|530878879|FG002|Overall Study|Withdrawal by Subject|6|||
147193518|NCT01283139|530878880|FG003|Overall Study|Withdrawal by Subject|8|||
147193519|NCT01283139|530878877|FG000|Overall Study|Death|2|||
147193520|NCT01283139|530878878|FG001|Overall Study|Death|0|||
147193521|NCT01283139|530878879|FG002|Overall Study|Death|2|||
147193522|NCT01283139|530878880|FG003|Overall Study|Death|2|||
147193523|NCT01283139|530878877|FG000|Overall Study|Lack of Efficacy|1|||
147193524|NCT01283139|530878878|FG001|Overall Study|Lack of Efficacy|2|||
147193525|NCT01283139|530878879|FG002|Overall Study|Lack of Efficacy|2|||
147193526|NCT01283139|530878880|FG003|Overall Study|Lack of Efficacy|1|||
147193527|NCT01283139|530878877|FG000|Overall Study|Early termination due to AE/SAE|1|||
147193528|NCT01283139|530878878|FG001|Overall Study|Early termination due to AE/SAE|1|||
147193529|NCT01283139|530878879|FG002|Overall Study|Early termination due to AE/SAE|0|||
147193530|NCT01283139|530878880|FG003|Overall Study|Early termination due to AE/SAE|0|||
147193531|NCT01283139|530878877|FG000|Overall Study|Participant's refusal to continue|0|||
147193532|NCT01283139|530878878|FG001|Overall Study|Participant's refusal to continue|3|||
147193533|NCT01283139|530878879|FG002|Overall Study|Participant's refusal to continue|1|||
147193534|NCT01283139|530878880|FG003|Overall Study|Participant's refusal to continue|1|||
147193535|NCT01283139|530878877|FG000|Overall Study|Pregnancy|0|||
147534067|NCT00563706|532111342|FG004|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
147534068|NCT00563706|532111343|FG005|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
147534069|NCT00563706|532111344|FG006|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
147193536|NCT01283139|530878878|FG001|Overall Study|Pregnancy|1|||
147193537|NCT01283139|530878879|FG002|Overall Study|Pregnancy|1|||
147193538|NCT01283139|530878880|FG003|Overall Study|Pregnancy|0|||
147193539|NCT01283139|530878877|FG000|Overall Study|Missed follow-up visit|0|||
147193540|NCT01283139|530878878|FG001|Overall Study|Missed follow-up visit|1|||
147193541|NCT01283139|530878879|FG002|Overall Study|Missed follow-up visit|2|||
147193542|NCT01283139|530878880|FG003|Overall Study|Missed follow-up visit|2|||
147193543|NCT01283139|530878877|FG000|Overall Study|Participant randomized in error|0|||
147193544|NCT01283139|530878878|FG001|Overall Study|Participant randomized in error|0|||
147193545|NCT01283139|530878879|FG002|Overall Study|Participant randomized in error|1|||
147193546|NCT01283139|530878880|FG003|Overall Study|Participant randomized in error|0|||
147193547|NCT00004563|530878881|FG000|Overall Study|Withdrawal by Subject|20|||
147193548|NCT00004563|530878882|FG001|Overall Study|Withdrawal by Subject|16|||
147193549|NCT00004563|530878881|FG000|Overall Study|Lack of Efficacy|3|||
147193550|NCT00004563|530878882|FG001|Overall Study|Lack of Efficacy|5|||
147193551|NCT00004563|530878881|FG000|Overall Study|Death|2|||
147193552|NCT00004563|530878882|FG001|Overall Study|Death|3|||
147193553|NCT00762164|530878884|FG000|Overall Study|Lost to Follow-up|1|||
147193554|NCT00762164|530878885|FG001|Overall Study|Lost to Follow-up|1|||
147193555|NCT00762164|530878884|FG000|Overall Study|Discontinued medication|2|||
147193556|NCT00762164|530878885|FG001|Overall Study|Discontinued medication|0|||
147193557|NCT00762164|530878884|FG000|Overall Study|Withdrawal by Subject|0|||
147193558|NCT00762164|530878885|FG001|Overall Study|Withdrawal by Subject|1|||
147193559|NCT00321789|530878890|FG000|Overall Study|Lost to Follow-up|4|||
147193560|NCT00321789|530878891|FG001|Overall Study|Lost to Follow-up|7|||
147433614|NCT04427501|531753349|FG005|Overall Study|Physician Decision|0|||
147433615|NCT04427501|531753350|FG006|Overall Study|Physician Decision|2|||
147433616|NCT04427501|531753351|FG007|Overall Study|Physician Decision|0|||
147433617|NCT04427501|531753352|FG008|Overall Study|Physician Decision|0|||
147433618|NCT04427501|531753353|FG009|Overall Study|Physician Decision|0|||
147433619|NCT04427501|531753354|FG010|Overall Study|Physician Decision|0|||
147433620|NCT04427501|531753355|FG011|Overall Study|Physician Decision|0|||
147433621|NCT04427501|531753344|FG000|Overall Study|Withdrawal by Subject|9|||
147433622|NCT04427501|531753345|FG001|Overall Study|Withdrawal by Subject|2|||
147433623|NCT04427501|531753346|FG002|Overall Study|Withdrawal by Subject|2|||
147433624|NCT04427501|531753347|FG003|Overall Study|Withdrawal by Subject|3|||
147433625|NCT04427501|531753348|FG004|Overall Study|Withdrawal by Subject|7|||
147433626|NCT04427501|531753349|FG005|Overall Study|Withdrawal by Subject|25|||
147433627|NCT04427501|531753350|FG006|Overall Study|Withdrawal by Subject|15|||
147433628|NCT04427501|531753351|FG007|Overall Study|Withdrawal by Subject|7|||
147433629|NCT04427501|531753352|FG008|Overall Study|Withdrawal by Subject|4|||
147433630|NCT04427501|531753353|FG009|Overall Study|Withdrawal by Subject|1|||
147433631|NCT04427501|531753354|FG010|Overall Study|Withdrawal by Subject|4|||
147433632|NCT04427501|531753355|FG011|Overall Study|Withdrawal by Subject|0|||
147433633|NCT04427501|531753344|FG000|Overall Study|Other - as reported by the investigator|1|||
147433634|NCT04427501|531753345|FG001|Overall Study|Other - as reported by the investigator|0|||
147433635|NCT04427501|531753346|FG002|Overall Study|Other - as reported by the investigator|0|||
147433636|NCT04427501|531753347|FG003|Overall Study|Other - as reported by the investigator|0|||
147433637|NCT04427501|531753348|FG004|Overall Study|Other - as reported by the investigator|0|||
147433638|NCT04427501|531753349|FG005|Overall Study|Other - as reported by the investigator|6|||
147433639|NCT04427501|531753350|FG006|Overall Study|Other - as reported by the investigator|6|||
147433640|NCT04427501|531753351|FG007|Overall Study|Other - as reported by the investigator|0|||
147433641|NCT04427501|531753352|FG008|Overall Study|Other - as reported by the investigator|0|||
147433642|NCT04427501|531753353|FG009|Overall Study|Other - as reported by the investigator|0|||
147433643|NCT04427501|531753354|FG010|Overall Study|Other - as reported by the investigator|0|||
147433644|NCT04427501|531753355|FG011|Overall Study|Other - as reported by the investigator|0|||
147433645|NCT04427501|531753344|FG000|Overall Study|Other|0|||
147433646|NCT04427501|531753345|FG001|Overall Study|Other|0|||
147433647|NCT04427501|531753346|FG002|Overall Study|Other|0|||
147433648|NCT04427501|531753347|FG003|Overall Study|Other|0|||
147433649|NCT04427501|531753348|FG004|Overall Study|Other|0|||
147433650|NCT04427501|531753349|FG005|Overall Study|Other|0|||
147433651|NCT04427501|531753350|FG006|Overall Study|Other|0|||
147433652|NCT04427501|531753351|FG007|Overall Study|Other|0|||
147433653|NCT04427501|531753352|FG008|Overall Study|Other|0|||
147433654|NCT04427501|531753353|FG009|Overall Study|Other|0|||
147433655|NCT04427501|531753354|FG010|Overall Study|Other|0|||
147433656|NCT04427501|531753355|FG011|Overall Study|Other|1|||
147433657|NCT00639223|531753358|FG000|Overall Study|Lost to Follow-up|0|||
147433658|NCT00639223|531753359|FG001|Overall Study|Lost to Follow-up|2|||
147433659|NCT04936841|531753360|FG000|Overall Study|Death|1|||
147433660|NCT02540538|531753363|FG000|Overall Study|Pregnancy|0|||
147433661|NCT02540538|531753364|FG001|Overall Study|Pregnancy|1|||
147433662|NCT02540538|531753365|FG002|Overall Study|Pregnancy|0|||
147433663|NCT01557348|531753369|FG000|Overall Study|Adverse Event|6|||
147433664|NCT01557348|531753370|FG001|Overall Study|Adverse Event|16|||
147433665|NCT01557348|531753369|FG000|Overall Study|Infusion reaction event|5|||
147433666|NCT01557348|531753370|FG001|Overall Study|Infusion reaction event|5|||
147433667|NCT01557348|531753369|FG000|Overall Study|Death|7|||
147433668|NCT01557348|531753370|FG001|Overall Study|Death|4|||
147433669|NCT01557348|531753369|FG000|Overall Study|Insufficient Therapeutic Response|13|||
147193561|NCT00321789|530878890|FG000|Overall Study|Withdrawal by Subject|6|||
147193562|NCT00321789|530878891|FG001|Overall Study|Withdrawal by Subject|6|||
147193563|NCT00321789|530878890|FG000|Overall Study|Protocol Violation|5|||
147193564|NCT00321789|530878891|FG001|Overall Study|Protocol Violation|3|||
147193565|NCT04576988|530878892|FG000|Double Blind Placebo Controlled (DBPC)|Adverse Event|1|||
147193566|NCT04576988|530878893|FG001|Double Blind Placebo Controlled (DBPC)|Adverse Event|1|||
147193567|NCT04576988|530878892|FG000|Double Blind Placebo Controlled (DBPC)|Withdrawal by Subject|2|||
147193568|NCT04576988|530878893|FG001|Double Blind Placebo Controlled (DBPC)|Withdrawal by Subject|3|||
147193569|NCT04576988|530878892|FG000|Double Blind Placebo Controlled (DBPC)|Protocol Violation|1|||
147193570|NCT04576988|530878893|FG001|Double Blind Placebo Controlled (DBPC)|Protocol Violation|1|||
147193571|NCT04576988|530878892|FG000|Double Blind Placebo Controlled (DBPC)|Death|0|||
147193572|NCT04576988|530878893|FG001|Double Blind Placebo Controlled (DBPC)|Death|5|||
147193573|NCT04576988|530878892|FG000|Double Blind Placebo Controlled (DBPC)|Clinical worsening event|0|||
147193574|NCT04576988|530878893|FG001|Double Blind Placebo Controlled (DBPC)|Clinical worsening event|2|||
147193575|NCT04576988|530878892|FG000|Long Term Double Blind (LTDB)|Adverse Event|2|||
147193576|NCT04576988|530878893|FG001|Long Term Double Blind (LTDB)|Adverse Event|0|||
147193577|NCT04576988|530878892|FG000|Long Term Double Blind (LTDB)|Withdrawal by Subject|0|||
147193578|NCT04576988|530878893|FG001|Long Term Double Blind (LTDB)|Withdrawal by Subject|3|||
147193579|NCT04576988|530878892|FG000|Long Term Double Blind (LTDB)|Protocol Violation|0|||
147193580|NCT04576988|530878893|FG001|Long Term Double Blind (LTDB)|Protocol Violation|1|||
147193581|NCT04576988|530878892|FG000|Long Term Double Blind (LTDB)|Death|2|||
147193582|NCT04576988|530878893|FG001|Long Term Double Blind (LTDB)|Death|1|||
147193583|NCT04576988|530878892|FG000|Long Term Double Blind (LTDB)|Sponsor decision|0|||
147193584|NCT04576988|530878893|FG001|Long Term Double Blind (LTDB)|Sponsor decision|1|||
147193585|NCT02362724|530878902|FG000|Overall Study|Withdrawal by Subject|3|||
147193586|NCT02362724|530878903|FG001|Overall Study|Withdrawal by Subject|1|||
147193587|NCT02362724|530878902|FG000|Overall Study|Adverse Event|3|||
147193588|NCT02362724|530878903|FG001|Overall Study|Adverse Event|0|||
147193589|NCT02025179|530878904|FG000|Overall Study|Lost to Follow-up|0|||
147193590|NCT02025179|530878905|FG001|Overall Study|Lost to Follow-up|0|||
147193591|NCT02025179|530878906|FG002|Overall Study|Lost to Follow-up|1|||
147193592|NCT00556075|530878907|FG000|Overall Study|Lost to Follow-up|3|||
147193593|NCT00556075|530878908|FG001|Overall Study|Lost to Follow-up|0|||
147193594|NCT00556075|530878909|FG002|Overall Study|Lost to Follow-up|3|||
147193595|NCT00556075|530878907|FG000|Overall Study|Withdrawal by Subject|3|||
147193596|NCT00556075|530878908|FG001|Overall Study|Withdrawal by Subject|3|||
147193597|NCT00556075|530878909|FG002|Overall Study|Withdrawal by Subject|0|||
147193598|NCT00556075|530878907|FG000|Overall Study|Protocol Violation|1|||
147193599|NCT00556075|530878908|FG001|Overall Study|Protocol Violation|1|||
147193600|NCT00556075|530878909|FG002|Overall Study|Protocol Violation|3|||
147193601|NCT00556075|530878907|FG000|Overall Study|Not eligible|1|||
147193602|NCT00556075|530878908|FG001|Overall Study|Not eligible|1|||
147193603|NCT00556075|530878909|FG002|Overall Study|Not eligible|2|||
147193604|NCT00556075|530878907|FG000|Overall Study|Adverse Event|1|||
147193605|NCT00556075|530878908|FG001|Overall Study|Adverse Event|2|||
147193606|NCT00556075|530878909|FG002|Overall Study|Adverse Event|0|||
147193607|NCT00556075|530878907|FG000|Overall Study|Personal issues|4|||
147193608|NCT00556075|530878908|FG001|Overall Study|Personal issues|1|||
147193609|NCT00556075|530878909|FG002|Overall Study|Personal issues|0|||
147193610|NCT00556075|530878907|FG000|Overall Study|Endometrial stripe not viewed on 2 tvu|0|||
147193611|NCT00556075|530878908|FG001|Overall Study|Endometrial stripe not viewed on 2 tvu|1|||
147193612|NCT00556075|530878909|FG002|Overall Study|Endometrial stripe not viewed on 2 tvu|0|||
147193613|NCT01927497|530878912|FG000|Overall Study|Death|0|||
147193614|NCT01927497|530878913|FG001|Overall Study|Death|1|||
147193615|NCT01927497|530878912|FG000|Overall Study|Protocol Violation|2|||
147193616|NCT01927497|530878913|FG001|Overall Study|Protocol Violation|0|||
147193617|NCT00395746|530878914|FG000|Overall Study|Adverse Event|5|||
147193618|NCT00395746|530878915|FG001|Overall Study|Adverse Event|2|||
147193619|NCT00395746|530878916|FG002|Overall Study|Adverse Event|2|||
147193620|NCT00395746|530878914|FG000|Overall Study|Protocol Violation|0|||
147193621|NCT00395746|530878915|FG001|Overall Study|Protocol Violation|1|||
147193622|NCT00395746|530878916|FG002|Overall Study|Protocol Violation|0|||
147193623|NCT00395746|530878914|FG000|Overall Study|Lack of Efficacy|2|||
147193624|NCT00395746|530878915|FG001|Overall Study|Lack of Efficacy|0|||
147193625|NCT00395746|530878916|FG002|Overall Study|Lack of Efficacy|17|||
147193626|NCT00395746|530878914|FG000|Overall Study|Hypoglycaemia|2|||
147193627|NCT00395746|530878915|FG001|Overall Study|Hypoglycaemia|1|||
147193628|NCT00395746|530878916|FG002|Overall Study|Hypoglycaemia|0|||
147193629|NCT00395746|530878914|FG000|Overall Study|Subject decision|0|||
147193630|NCT00395746|530878915|FG001|Overall Study|Subject decision|0|||
147193631|NCT00395746|530878916|FG002|Overall Study|Subject decision|1|||
147193632|NCT00395746|530878914|FG000|Overall Study|Withdrawal of consent|0|||
147193633|NCT00395746|530878915|FG001|Overall Study|Withdrawal of consent|0|||
147193634|NCT00395746|530878916|FG002|Overall Study|Withdrawal of consent|1|||
147193635|NCT00395746|530878914|FG000|Overall Study|Difficultulty in use of device|0|||
147306778|NCT00110890|531290761|FG001|Overall Study|Disease progression|1|||
147193636|NCT00395746|530878915|FG001|Overall Study|Difficultulty in use of device|0|||
147193637|NCT00395746|530878916|FG002|Overall Study|Difficultulty in use of device|1|||
147193638|NCT00395746|530878914|FG000|Overall Study|Unable to visit site on schedule|1|||
147193639|NCT00395746|530878915|FG001|Overall Study|Unable to visit site on schedule|0|||
147193640|NCT00395746|530878916|FG002|Overall Study|Unable to visit site on schedule|0|||
147193641|NCT04528641|530878917|FG000|Overall Study|Withdrawal by Subject|0|||
147193642|NCT04528641|530878918|FG001|Overall Study|Withdrawal by Subject|0|||
147193643|NCT04528641|530878919|FG002|Overall Study|Withdrawal by Subject|0|||
147193644|NCT04528641|530878920|FG003|Overall Study|Withdrawal by Subject|1|||
147193645|NCT04528641|530878921|FG004|Overall Study|Withdrawal by Subject|0|||
147193646|NCT04528641|530878922|FG005|Overall Study|Withdrawal by Subject|1|||
147193647|NCT00517296|530878923|FG000|Overall Study|Withdrawal by Subject|1|||
147193648|NCT00517296|530878924|FG001|Overall Study|Withdrawal by Subject|0|||
147193649|NCT03137992|530878927|FG000|Washout Period 1|Adverse Event|1|||
147193650|NCT03137992|530878928|FG001|Washout Period 1|Adverse Event|1|||
147193651|NCT03137992|530878929|FG002|Washout Period 1|Adverse Event|0|||
147193652|NCT03137992|530878930|FG003|Washout Period 1|Adverse Event|0|||
147193653|NCT03137992|530878931|FG004|Washout Period 1|Adverse Event|0|||
147193654|NCT03137992|530878932|FG005|Washout Period 1|Adverse Event|1|||
147193655|NCT03137992|530878927|FG000|Washout Period 1|Withdrawal by Subject|0|||
147193656|NCT03137992|530878928|FG001|Washout Period 1|Withdrawal by Subject|1|||
147193657|NCT03137992|530878929|FG002|Washout Period 1|Withdrawal by Subject|1|||
147193658|NCT03137992|530878930|FG003|Washout Period 1|Withdrawal by Subject|0|||
147193659|NCT03137992|530878931|FG004|Washout Period 1|Withdrawal by Subject|0|||
147193660|NCT03137992|530878932|FG005|Washout Period 1|Withdrawal by Subject|0|||
147193661|NCT03137992|530878927|FG000|Washout Period 1|Principal Investigator Discretion|0|||
147193662|NCT03137992|530878928|FG001|Washout Period 1|Principal Investigator Discretion|1|||
147193663|NCT03137992|530878929|FG002|Washout Period 1|Principal Investigator Discretion|0|||
147193664|NCT03137992|530878930|FG003|Washout Period 1|Principal Investigator Discretion|0|||
147193665|NCT03137992|530878931|FG004|Washout Period 1|Principal Investigator Discretion|0|||
147193666|NCT03137992|530878932|FG005|Washout Period 1|Principal Investigator Discretion|0|||
147193667|NCT03137992|530878927|FG000|Washout Period 1|COPD Exacerbation|1|||
147193668|NCT03137992|530878928|FG001|Washout Period 1|COPD Exacerbation|1|||
147193669|NCT03137992|530878929|FG002|Washout Period 1|COPD Exacerbation|1|||
147193670|NCT03137992|530878930|FG003|Washout Period 1|COPD Exacerbation|0|||
147193671|NCT03137992|530878931|FG004|Washout Period 1|COPD Exacerbation|1|||
147193672|NCT03137992|530878932|FG005|Washout Period 1|COPD Exacerbation|1|||
147193673|NCT03137992|530878927|FG000|Washout Period 1|Subject Noncompliance|1|||
147193674|NCT03137992|530878928|FG001|Washout Period 1|Subject Noncompliance|0|||
147193675|NCT03137992|530878929|FG002|Washout Period 1|Subject Noncompliance|0|||
147193676|NCT03137992|530878930|FG003|Washout Period 1|Subject Noncompliance|0|||
147193677|NCT03137992|530878931|FG004|Washout Period 1|Subject Noncompliance|1|||
147193678|NCT03137992|530878932|FG005|Washout Period 1|Subject Noncompliance|0|||
147193679|NCT03137992|530878927|FG000|Period 2 (Visit 3)|COPD Exacerbation|1|||
147193680|NCT03137992|530878928|FG001|Period 2 (Visit 3)|COPD Exacerbation|1|||
147193681|NCT03137992|530878929|FG002|Period 2 (Visit 3)|COPD Exacerbation|0|||
147193682|NCT03137992|530878930|FG003|Period 2 (Visit 3)|COPD Exacerbation|0|||
147193683|NCT03137992|530878931|FG004|Period 2 (Visit 3)|COPD Exacerbation|0|||
147193684|NCT03137992|530878932|FG005|Period 2 (Visit 3)|COPD Exacerbation|1|||
147193685|NCT03137992|530878927|FG000|Period 2 (Visit 3)|Did not meet continuation criteria|2|||
147193686|NCT03137992|530878928|FG001|Period 2 (Visit 3)|Did not meet continuation criteria|3|||
147433670|NCT01557348|531753370|FG001|Overall Study|Insufficient Therapeutic Response|28|||
147433671|NCT01557348|531753369|FG000|Overall Study|Withdrawal by Subject|5|||
147433672|NCT01557348|531753370|FG001|Overall Study|Withdrawal by Subject|4|||
147433673|NCT01557348|531753369|FG000|Overall Study|Lost to Follow-up|26|||
147433674|NCT01557348|531753370|FG001|Overall Study|Lost to Follow-up|22|||
147433675|NCT01557348|531753369|FG000|Overall Study|Administrative|18|||
147306779|NCT00110890|531290760|FG000|Overall Study|Parathyroidectomy|0|||
147306780|NCT00110890|531290761|FG001|Overall Study|Parathyroidectomy|1|||
147306781|NCT00110890|531290760|FG000|Overall Study|Did not enter follow-up phase|10|||
147193687|NCT03137992|530878929|FG002|Period 2 (Visit 3)|Did not meet continuation criteria|3|||
147193688|NCT03137992|530878930|FG003|Period 2 (Visit 3)|Did not meet continuation criteria|4|||
147193689|NCT03137992|530878931|FG004|Period 2 (Visit 3)|Did not meet continuation criteria|3|||
147433676|NCT01557348|531753370|FG001|Overall Study|Administrative|11|||
147433677|NCT00403754|531753371|FG000|Core Treatment Period 1|Withdrawal by Subject|0|||
147433678|NCT00403754|531753372|FG001|Core Treatment Period 1|Withdrawal by Subject|1|||
147193690|NCT03137992|530878932|FG005|Period 2 (Visit 3)|Did not meet continuation criteria|7|||
147193691|NCT03137992|530878927|FG000|Period 2 (Visit 3)|Adverse Event|0|||
147193692|NCT03137992|530878928|FG001|Period 2 (Visit 3)|Adverse Event|1|||
147193693|NCT03137992|530878929|FG002|Period 2 (Visit 3)|Adverse Event|0|||
147306782|NCT00110890|531290761|FG001|Overall Study|Did not enter follow-up phase|4|||
147433679|NCT00403754|531753373|FG002|Core Treatment Period 1|Withdrawal by Subject|0|||
147433680|NCT00403754|531753374|FG003|Core Treatment Period 1|Withdrawal by Subject|0|||
147433681|NCT00403754|531753371|FG000|Core Treatment Period 2|Lack of Efficacy|0|||
147193694|NCT03137992|530878930|FG003|Period 2 (Visit 3)|Adverse Event|0|||
147193695|NCT03137992|530878931|FG004|Period 2 (Visit 3)|Adverse Event|0|||
147193696|NCT03137992|530878932|FG005|Period 2 (Visit 3)|Adverse Event|0|||
147193697|NCT03137992|530878927|FG000|Period 2 (Visit 3)|Lost to Follow-up|0|||
147193698|NCT03137992|530878928|FG001|Period 2 (Visit 3)|Lost to Follow-up|0|||
147193699|NCT03137992|530878929|FG002|Period 2 (Visit 3)|Lost to Follow-up|0|||
147193700|NCT03137992|530878930|FG003|Period 2 (Visit 3)|Lost to Follow-up|1|||
147193701|NCT03137992|530878931|FG004|Period 2 (Visit 3)|Lost to Follow-up|0|||
147193702|NCT03137992|530878932|FG005|Period 2 (Visit 3)|Lost to Follow-up|0|||
147193703|NCT03137992|530878927|FG000|Period 2 (Visit 3)|Withdrawal by Subject|0|||
147193704|NCT03137992|530878928|FG001|Period 2 (Visit 3)|Withdrawal by Subject|2|||
147193705|NCT03137992|530878929|FG002|Period 2 (Visit 3)|Withdrawal by Subject|0|||
147193706|NCT03137992|530878930|FG003|Period 2 (Visit 3)|Withdrawal by Subject|0|||
147193707|NCT03137992|530878931|FG004|Period 2 (Visit 3)|Withdrawal by Subject|1|||
147193708|NCT03137992|530878932|FG005|Period 2 (Visit 3)|Withdrawal by Subject|0|||
147193709|NCT03137992|530878927|FG000|Washout Period 2|COPD Exacerbation|1|||
147193710|NCT03137992|530878928|FG001|Washout Period 2|COPD Exacerbation|1|||
147193711|NCT03137992|530878929|FG002|Washout Period 2|COPD Exacerbation|0|||
147193712|NCT03137992|530878930|FG003|Washout Period 2|COPD Exacerbation|0|||
147193713|NCT03137992|530878931|FG004|Washout Period 2|COPD Exacerbation|1|||
147193714|NCT03137992|530878932|FG005|Washout Period 2|COPD Exacerbation|0|||
147193715|NCT03137992|530878927|FG000|Washout Period 2|Subject Non-compliance|0|||
147193716|NCT03137992|530878928|FG001|Washout Period 2|Subject Non-compliance|1|||
147193717|NCT03137992|530878929|FG002|Washout Period 2|Subject Non-compliance|0|||
147193718|NCT03137992|530878930|FG003|Washout Period 2|Subject Non-compliance|0|||
147193719|NCT03137992|530878931|FG004|Washout Period 2|Subject Non-compliance|0|||
147193720|NCT03137992|530878932|FG005|Washout Period 2|Subject Non-compliance|0|||
147193721|NCT03137992|530878927|FG000|Washout Period 2|Adverse Event|0|||
147193722|NCT03137992|530878928|FG001|Washout Period 2|Adverse Event|0|||
147193723|NCT03137992|530878929|FG002|Washout Period 2|Adverse Event|0|||
147193724|NCT03137992|530878930|FG003|Washout Period 2|Adverse Event|1|||
147193725|NCT03137992|530878931|FG004|Washout Period 2|Adverse Event|1|||
147193726|NCT03137992|530878932|FG005|Washout Period 2|Adverse Event|0|||
147193727|NCT03137992|530878927|FG000|Washout Period 2|Withdrawal by Subject|1|||
147193728|NCT03137992|530878928|FG001|Washout Period 2|Withdrawal by Subject|0|||
147193729|NCT03137992|530878929|FG002|Washout Period 2|Withdrawal by Subject|0|||
147193730|NCT03137992|530878930|FG003|Washout Period 2|Withdrawal by Subject|0|||
147193731|NCT03137992|530878931|FG004|Washout Period 2|Withdrawal by Subject|1|||
147193732|NCT03137992|530878932|FG005|Washout Period 2|Withdrawal by Subject|0|||
147193733|NCT03137992|530878927|FG000|Washout Period 2|Sponsor Decision|0|||
147193734|NCT03137992|530878928|FG001|Washout Period 2|Sponsor Decision|0|||
147193735|NCT03137992|530878929|FG002|Washout Period 2|Sponsor Decision|0|||
147193736|NCT03137992|530878930|FG003|Washout Period 2|Sponsor Decision|0|||
147193737|NCT03137992|530878931|FG004|Washout Period 2|Sponsor Decision|0|||
147193738|NCT03137992|530878932|FG005|Washout Period 2|Sponsor Decision|1|||
147193739|NCT03137992|530878927|FG000|Period 3 (Visit 04)|Did not meet continuation criteria|6|||
147193740|NCT03137992|530878928|FG001|Period 3 (Visit 04)|Did not meet continuation criteria|0|||
147193741|NCT03137992|530878929|FG002|Period 3 (Visit 04)|Did not meet continuation criteria|2|||
147193742|NCT03137992|530878930|FG003|Period 3 (Visit 04)|Did not meet continuation criteria|0|||
147193743|NCT03137992|530878931|FG004|Period 3 (Visit 04)|Did not meet continuation criteria|2|||
147193744|NCT03137992|530878932|FG005|Period 3 (Visit 04)|Did not meet continuation criteria|3|||
147193745|NCT03137992|530878927|FG000|Period 3 (Visit 04)|Withdrawal by Subject|0|||
147193746|NCT03137992|530878928|FG001|Period 3 (Visit 04)|Withdrawal by Subject|2|||
147193747|NCT03137992|530878929|FG002|Period 3 (Visit 04)|Withdrawal by Subject|1|||
147193748|NCT03137992|530878930|FG003|Period 3 (Visit 04)|Withdrawal by Subject|0|||
147193749|NCT03137992|530878931|FG004|Period 3 (Visit 04)|Withdrawal by Subject|1|||
147193750|NCT03137992|530878932|FG005|Period 3 (Visit 04)|Withdrawal by Subject|0|||
147193751|NCT03137992|530878927|FG000|Part 2 (Open-label Extension)|Withdrawal by Subject|1|||
147193752|NCT03137992|530878928|FG001|Part 2 (Open-label Extension)|Withdrawal by Subject|0|||
147193753|NCT03137992|530878929|FG002|Part 2 (Open-label Extension)|Withdrawal by Subject|1|||
147193754|NCT03137992|530878930|FG003|Part 2 (Open-label Extension)|Withdrawal by Subject|0|||
147193755|NCT03137992|530878931|FG004|Part 2 (Open-label Extension)|Withdrawal by Subject|0|||
147193756|NCT03137992|530878932|FG005|Part 2 (Open-label Extension)|Withdrawal by Subject|0|||
147193757|NCT03137992|530878927|FG000|Part 2 (Open-label Extension)|COPD exacerbation|0|||
147193758|NCT03137992|530878928|FG001|Part 2 (Open-label Extension)|COPD exacerbation|0|||
147193759|NCT03137992|530878929|FG002|Part 2 (Open-label Extension)|COPD exacerbation|0|||
147193760|NCT03137992|530878930|FG003|Part 2 (Open-label Extension)|COPD exacerbation|1|||
147193761|NCT03137992|530878931|FG004|Part 2 (Open-label Extension)|COPD exacerbation|0|||
147193762|NCT03137992|530878932|FG005|Part 2 (Open-label Extension)|COPD exacerbation|0|||
147193763|NCT03137992|530878927|FG000|Part 2 (Open-label Extension)|Per study team|1|||
147193764|NCT03137992|530878928|FG001|Part 2 (Open-label Extension)|Per study team|0|||
147193765|NCT03137992|530878929|FG002|Part 2 (Open-label Extension)|Per study team|0|||
147193766|NCT03137992|530878930|FG003|Part 2 (Open-label Extension)|Per study team|0|||
147193767|NCT03137992|530878931|FG004|Part 2 (Open-label Extension)|Per study team|0|||
147193768|NCT03137992|530878932|FG005|Part 2 (Open-label Extension)|Per study team|0|||
147193769|NCT03137992|530878927|FG000|Part 2 (Open-label Extension)|Prohibited Medication|0|||
147193770|NCT03137992|530878928|FG001|Part 2 (Open-label Extension)|Prohibited Medication|0|||
147193771|NCT03137992|530878929|FG002|Part 2 (Open-label Extension)|Prohibited Medication|0|||
147193772|NCT03137992|530878930|FG003|Part 2 (Open-label Extension)|Prohibited Medication|0|||
147193773|NCT03137992|530878931|FG004|Part 2 (Open-label Extension)|Prohibited Medication|0|||
147193774|NCT03137992|530878932|FG005|Part 2 (Open-label Extension)|Prohibited Medication|1|||
147193775|NCT03077542|530878935|FG000|Overall Study|Death|4|||
147193776|NCT03077542|530878936|FG001|Overall Study|Death|0|||
147193777|NCT03077542|530878935|FG000|Overall Study|Physician Decision|6|||
147193778|NCT03077542|530878936|FG001|Overall Study|Physician Decision|1|||
147193779|NCT03077542|530878935|FG000|Overall Study|Withdrawal by Subject|0|||
147193780|NCT03077542|530878936|FG001|Overall Study|Withdrawal by Subject|1|||
147193781|NCT00795704|530878939|FG000|Overall Study|Withdrawal by Subject|3|||
147193782|NCT00795704|530878940|FG001|Overall Study|Withdrawal by Subject|2|||
147193783|NCT00795704|530878939|FG000|Overall Study|Adverse Event|1|||
147193784|NCT00795704|530878940|FG001|Overall Study|Adverse Event|1|||
147193785|NCT01300728|530878941|FG000|Overall Study|Withdrawal by Subject|1|||
147193786|NCT01300728|530878942|FG001|Overall Study|Withdrawal by Subject|1|||
147193787|NCT01300728|530878941|FG000|Overall Study|Physician Decision|1|||
147193788|NCT01300728|530878942|FG001|Overall Study|Physician Decision|0|||
147193789|NCT01247324|530878943|FG000|Overall Study|Death|6|||
147193790|NCT01247324|530878944|FG001|Overall Study|Death|10|||
147193791|NCT01247324|530878943|FG000|Overall Study|Physician Decision|2|||
147193792|NCT01247324|530878944|FG001|Overall Study|Physician Decision|3|||
147193793|NCT01247324|530878943|FG000|Overall Study|Non-compliance with study drug|3|||
147193794|NCT01247324|530878944|FG001|Overall Study|Non-compliance with study drug|0|||
147193795|NCT01247324|530878943|FG000|Overall Study|Lack of Efficacy|24|||
147193796|NCT01247324|530878944|FG001|Overall Study|Lack of Efficacy|14|||
147193797|NCT01247324|530878943|FG000|Overall Study|Non-compliance|3|||
147193798|NCT01247324|530878944|FG001|Overall Study|Non-compliance|2|||
147193799|NCT01247324|530878943|FG000|Overall Study|Pregnancy|5|||
147193800|NCT01247324|530878944|FG001|Overall Study|Pregnancy|10|||
147193801|NCT01247324|530878943|FG000|Overall Study|Protocol Violation|1|||
147193802|NCT01247324|530878944|FG001|Overall Study|Protocol Violation|1|||
147193803|NCT01247324|530878943|FG000|Overall Study|Reason not specified|42|||
147193804|NCT01247324|530878944|FG001|Overall Study|Reason not specified|32|||
147193805|NCT01247324|530878943|FG000|Overall Study|Consent withdrawn by participant|41|||
147193806|NCT01247324|530878944|FG001|Overall Study|Consent withdrawn by participant|56|||
147193807|NCT01247324|530878943|FG000|Overall Study|Adverse Event|49|||
147193808|NCT01247324|530878944|FG001|Overall Study|Adverse Event|35|||
147193809|NCT01247324|530878943|FG000|Overall Study|Lost to Follow-up|3|||
147193810|NCT01247324|530878944|FG001|Overall Study|Lost to Follow-up|6|||
147193811|NCT01247324|530878943|FG000|Overall Study|Study Terminated by Sponsor|4|||
147193812|NCT01247324|530878944|FG001|Overall Study|Study Terminated by Sponsor|1|||
147193813|NCT01247324|530878943|FG000|Overall Study|Missing|2|||
147193814|NCT01247324|530878944|FG001|Overall Study|Missing|1|||
147193815|NCT01486966|530878945|FG000|Overall Study|Adverse Event|0|||
147193816|NCT01486966|530878946|FG001|Overall Study|Adverse Event|1|||
147193817|NCT01486966|530878945|FG000|Overall Study|Withdrawal by Subject|0|||
147193818|NCT01486966|530878946|FG001|Overall Study|Withdrawal by Subject|1|||
147193819|NCT00301808|530878948|FG000|Overall Study|Adverse Event|5|||
147193820|NCT00301808|530878948|FG000|Overall Study|Death|3|||
147193821|NCT00301808|530878948|FG000|Overall Study|Lack of Efficacy|4|||
147193822|NCT01607957|530878949|FG000|Overall Study|Not treated|1|||
147193823|NCT01607957|530878950|FG001|Overall Study|Not treated|1|||
147193824|NCT01607957|530878949|FG000|Overall Study|Death|367|||
147193825|NCT01607957|530878950|FG001|Overall Study|Death|211|||
147193826|NCT01607957|530878949|FG000|Overall Study|Lost to Follow-up|3|||
147193827|NCT01607957|530878950|FG001|Overall Study|Lost to Follow-up|3|||
147193828|NCT01607957|530878949|FG000|Overall Study|Participant refusal|1|||
147193829|NCT01607957|530878950|FG001|Overall Study|Participant refusal|0|||
147193830|NCT04972786|530878953|FG000|First Intervention (1 Day)|Adverse Event|1|||
147193831|NCT04972786|530878954|FG001|First Intervention (1 Day)|Adverse Event|0|||
147193832|NCT03905096|530878955|FG000|Period 2 for Trial Part 1 and 2|Adverse Event|1|||
147193833|NCT03905096|530878956|FG001|Period 2 for Trial Part 1 and 2|Adverse Event|0|||
147193834|NCT02994108|530880820|FG000|Intervention Messages|Withdrawal by Subject|2|||
147193835|NCT02994108|530880821|FG001|Intervention Messages|Withdrawal by Subject|0|||
147193836|NCT02994108|530880820|FG000|Phase 1 Assessment|Lost to Follow-up|5|||
147193837|NCT02994108|530880821|FG001|Phase 1 Assessment|Lost to Follow-up|3|||
147193838|NCT02994108|530880820|FG000|Phase 2 Assessment|Lost to Follow-up|8|||
147193839|NCT02994108|530880821|FG001|Phase 2 Assessment|Lost to Follow-up|7|||
147193840|NCT02994108|530880820|FG000|Phase 2 Assessment|Withdrawal by Subject|1|||
147193841|NCT02994108|530880821|FG001|Phase 2 Assessment|Withdrawal by Subject|0|||
147193842|NCT00904969|530880822|FG000|Overall Study|Lost to Follow-up|4|||
147193843|NCT00904969|530880822|FG000|Overall Study|Withdrawal by Subject|3|||
147193844|NCT00904969|530880822|FG000|Overall Study|Additional Treatments|11|||
147433682|NCT00403754|531753372|FG001|Core Treatment Period 2|Lack of Efficacy|0|||
147193845|NCT00904969|530880822|FG000|Overall Study|Case Aborted; Subject Exited|1|||
147193846|NCT00755183|530880836|FG000|Overall Study|Adverse Event|5|||
147193847|NCT00755183|530880837|FG001|Overall Study|Adverse Event|2|||
147193848|NCT00755183|530880836|FG000|Overall Study|Protocol Violation|0|||
147193849|NCT00755183|530880837|FG001|Overall Study|Protocol Violation|1|||
147193850|NCT00755183|530880836|FG000|Overall Study|Withdrawal by Subject|0|||
147193851|NCT00755183|530880837|FG001|Overall Study|Withdrawal by Subject|2|||
147193852|NCT00755183|530880836|FG000|Overall Study|Administrative|2|||
147193853|NCT00755183|530880837|FG001|Overall Study|Administrative|1|||
147193854|NCT00804908|530880839|FG000|Overall Study|Other|115|||
147193855|NCT00804908|530880840|FG001|Overall Study|Other|116|||
147193856|NCT00804908|530880841|FG002|Overall Study|Other|114|||
147193857|NCT02118584|530880844|FG000|Part 1: Open Label Extension Period|Adverse Event|79|||
147193858|NCT02118584|530880845|FG001|Part 1: Open Label Extension Period|Adverse Event|0|||
147193859|NCT02118584|530880846|FG002|Part 1: Open Label Extension Period|Adverse Event|0|||
147193860|NCT02118584|530880844|FG000|Part 1: Open Label Extension Period|Death|9|||
147193861|NCT02118584|530880845|FG001|Part 1: Open Label Extension Period|Death|0|||
147193862|NCT02118584|530880846|FG002|Part 1: Open Label Extension Period|Death|0|||
147193863|NCT02118584|530880844|FG000|Part 1: Open Label Extension Period|Lost to Follow-up|53|||
147193864|NCT02118584|530880845|FG001|Part 1: Open Label Extension Period|Lost to Follow-up|0|||
147193865|NCT02118584|530880846|FG002|Part 1: Open Label Extension Period|Lost to Follow-up|0|||
147193866|NCT02118584|530880844|FG000|Part 1: Open Label Extension Period|Non-compliance|12|||
147193867|NCT02118584|530880845|FG001|Part 1: Open Label Extension Period|Non-compliance|0|||
147193868|NCT02118584|530880846|FG002|Part 1: Open Label Extension Period|Non-compliance|0|||
147193869|NCT02118584|530880844|FG000|Part 1: Open Label Extension Period|Other|135|||
147193870|NCT02118584|530880845|FG001|Part 1: Open Label Extension Period|Other|0|||
147193871|NCT02118584|530880846|FG002|Part 1: Open Label Extension Period|Other|0|||
147193872|NCT02118584|530880844|FG000|Part 1: Open Label Extension Period|Physician Decision|128|||
147193873|NCT02118584|530880845|FG001|Part 1: Open Label Extension Period|Physician Decision|0|||
147193874|NCT02118584|530880846|FG002|Part 1: Open Label Extension Period|Physician Decision|0|||
147193875|NCT02118584|530880844|FG000|Part 1: Open Label Extension Period|Protocol Violation|1|||
147193876|NCT02118584|530880845|FG001|Part 1: Open Label Extension Period|Protocol Violation|0|||
147193877|NCT02118584|530880846|FG002|Part 1: Open Label Extension Period|Protocol Violation|0|||
147193878|NCT02118584|530880844|FG000|Part 1: Open Label Extension Period|Study Terminated by Sponsor|29|||
147193879|NCT02118584|530880845|FG001|Part 1: Open Label Extension Period|Study Terminated by Sponsor|0|||
147193880|NCT02118584|530880846|FG002|Part 1: Open Label Extension Period|Study Terminated by Sponsor|0|||
147193881|NCT02118584|530880844|FG000|Part 1: Open Label Extension Period|Other|3|||
147193882|NCT02118584|530880845|FG001|Part 1: Open Label Extension Period|Other|0|||
147193883|NCT02118584|530880846|FG002|Part 1: Open Label Extension Period|Other|0|||
147193884|NCT02118584|530880844|FG000|Part 1: Open Label Extension Period|Withdrawal by Subject|568|||
147193885|NCT02118584|530880845|FG001|Part 1: Open Label Extension Period|Withdrawal by Subject|0|||
147193886|NCT02118584|530880846|FG002|Part 1: Open Label Extension Period|Withdrawal by Subject|0|||
147193887|NCT02118584|530880844|FG000|Part 2: PML Safety Monitoring Period|Adverse Event|0|||
147193888|NCT02118584|530880845|FG001|Part 2: PML Safety Monitoring Period|Adverse Event|5|||
147193889|NCT02118584|530880846|FG002|Part 2: PML Safety Monitoring Period|Adverse Event|0|||
147193890|NCT02118584|530880844|FG000|Part 2: PML Safety Monitoring Period|Death|0|||
147193891|NCT02118584|530880845|FG001|Part 2: PML Safety Monitoring Period|Death|1|||
147193892|NCT02118584|530880846|FG002|Part 2: PML Safety Monitoring Period|Death|0|||
147193893|NCT02118584|530880844|FG000|Part 2: PML Safety Monitoring Period|Lost to Follow-up|0|||
147193894|NCT02118584|530880845|FG001|Part 2: PML Safety Monitoring Period|Lost to Follow-up|22|||
147193895|NCT02118584|530880846|FG002|Part 2: PML Safety Monitoring Period|Lost to Follow-up|3|||
147193896|NCT02118584|530880844|FG000|Part 2: PML Safety Monitoring Period|Non-Compliance|0|||
147433683|NCT00403754|531753373|FG002|Core Treatment Period 2|Lack of Efficacy|1|||
147433684|NCT00403754|531753374|FG003|Core Treatment Period 2|Lack of Efficacy|0|||
147433685|NCT02000427|531753375|FG000|Overall Study|Death|22|||
147433686|NCT04498832|531753376|FG000|Overall Study|Adverse Event|1|||
147433687|NCT04498832|531753377|FG001|Overall Study|Adverse Event|3|||
147433688|NCT04498832|531753376|FG000|Overall Study|Withdrawal by Subject|0|||
147433689|NCT04498832|531753377|FG001|Overall Study|Withdrawal by Subject|1|||
147433690|NCT02684357|531753378|FG000|Part A|Adverse Event (Worsening of Disease)|1|||
147433691|NCT02684357|531753379|FG001|Part A|Adverse Event (Worsening of Disease)|0|||
147433692|NCT02684357|531753380|FG002|Part A|Adverse Event (Worsening of Disease)|0|||
147433693|NCT02684357|531753381|FG003|Part A|Adverse Event (Worsening of Disease)|0|||
147433694|NCT02684357|531753382|FG004|Part A|Adverse Event (Worsening of Disease)|0|||
147433695|NCT02684357|531753383|FG005|Part A|Adverse Event (Worsening of Disease)|0|||
147433696|NCT02684357|531753378|FG000|Part A|Lost to Follow-up|0|||
147649401|NCT04575584|532537336|FG001|Overall Study|Withdrawal by Subject|9|||
147193897|NCT02118584|530880845|FG001|Part 2: PML Safety Monitoring Period|Non-Compliance|0|||
147193898|NCT02118584|530880846|FG002|Part 2: PML Safety Monitoring Period|Non-Compliance|1|||
147193899|NCT02118584|530880844|FG000|Part 2: PML Safety Monitoring Period|Reason Not Specified|0|||
147193900|NCT02118584|530880845|FG001|Part 2: PML Safety Monitoring Period|Reason Not Specified|6|||
147193901|NCT02118584|530880846|FG002|Part 2: PML Safety Monitoring Period|Reason Not Specified|0|||
147193902|NCT02118584|530880844|FG000|Part 2: PML Safety Monitoring Period|Physician Decision|0|||
147193903|NCT02118584|530880845|FG001|Part 2: PML Safety Monitoring Period|Physician Decision|10|||
147433697|NCT02684357|531753379|FG001|Part A|Lost to Follow-up|2|||
147433698|NCT02684357|531753380|FG002|Part A|Lost to Follow-up|2|||
147433699|NCT02684357|531753381|FG003|Part A|Lost to Follow-up|0|||
147193904|NCT02118584|530880846|FG002|Part 2: PML Safety Monitoring Period|Physician Decision|1|||
147193905|NCT02118584|530880844|FG000|Part 2: PML Safety Monitoring Period|Study Terminated by Sponsor|0|||
147193906|NCT02118584|530880845|FG001|Part 2: PML Safety Monitoring Period|Study Terminated by Sponsor|354|||
147193907|NCT02118584|530880846|FG002|Part 2: PML Safety Monitoring Period|Study Terminated by Sponsor|0|||
147193908|NCT02118584|530880844|FG000|Part 2: PML Safety Monitoring Period|Withdrawal by Subject|0|||
147193909|NCT02118584|530880845|FG001|Part 2: PML Safety Monitoring Period|Withdrawal by Subject|32|||
147193910|NCT02118584|530880846|FG002|Part 2: PML Safety Monitoring Period|Withdrawal by Subject|1|||
147193911|NCT00671658|530880851|FG000|Overall Study|Physician Decision|5|||
147193912|NCT01680341|530880855|FG000|Overall Study|Adverse Event|3|||
147193913|NCT01680341|530880856|FG001|Overall Study|Adverse Event|2|||
147193914|NCT01680341|530880855|FG000|Overall Study|Unclassified|18|||
147193915|NCT01680341|530880856|FG001|Overall Study|Unclassified|15|||
147193916|NCT00499486|530880857|FG000|Overall Study|Withdrawal by Subject|16|||
147193917|NCT03796728|530880859|FG000|Overall Study|Lost to Follow-up|8|||
147193918|NCT03796728|530880859|FG000|Overall Study|Reason not Specified|16|||
147193919|NCT02476617|530880861|FG000|Overall Study|Adverse Event|1|||
147193920|NCT02476617|530880861|FG000|Overall Study|Lost to Follow-up|1|||
147193921|NCT01383928|530880862|FG000|Overall Study|Initiation of ASCT|2|||
147193922|NCT01383928|530880863|FG001|Overall Study|Initiation of ASCT|1|||
147193923|NCT01383928|530880864|FG002|Overall Study|Initiation of ASCT|18|||
147193924|NCT01383928|530880862|FG000|Overall Study|Adverse Event|1|||
147193925|NCT01383928|530880863|FG001|Overall Study|Adverse Event|2|||
147193926|NCT01383928|530880864|FG002|Overall Study|Adverse Event|8|||
147193927|NCT01383928|530880862|FG000|Overall Study|Other|1|||
147193928|NCT01383928|530880863|FG001|Overall Study|Other|3|||
147193929|NCT01383928|530880864|FG002|Overall Study|Other|4|||
147193930|NCT01383928|530880862|FG000|Overall Study|Progressive Disease|1|||
147193931|NCT01383928|530880863|FG001|Overall Study|Progressive Disease|1|||
147193932|NCT01383928|530880864|FG002|Overall Study|Progressive Disease|5|||
147193933|NCT01383928|530880862|FG000|Overall Study|Withdrawal by Subject|0|||
147193934|NCT01383928|530880863|FG001|Overall Study|Withdrawal by Subject|0|||
147193935|NCT01383928|530880864|FG002|Overall Study|Withdrawal by Subject|4|||
147193936|NCT01383928|530880862|FG000|Overall Study|Unsatisfactory Therapeutic Response|0|||
147193937|NCT01383928|530880863|FG001|Overall Study|Unsatisfactory Therapeutic Response|0|||
147193938|NCT01383928|530880864|FG002|Overall Study|Unsatisfactory Therapeutic Response|1|||
147193939|NCT01263769|530880867|FG000|Overall Study|Non-Compliant with treatment|1|||
147193940|NCT01346358|530880868|FG000|Overall Study|Withdrawal by Subject|1|||
147193941|NCT01346358|530880869|FG001|Overall Study|Withdrawal by Subject|0|||
147433700|NCT02684357|531753382|FG004|Part A|Lost to Follow-up|0|||
147433701|NCT02684357|531753383|FG005|Part A|Lost to Follow-up|0|||
147433702|NCT02684357|531753378|FG000|Part A|Withdrawal by Subject|3|||
147433703|NCT02684357|531753379|FG001|Part A|Withdrawal by Subject|0|||
147433704|NCT02684357|531753380|FG002|Part A|Withdrawal by Subject|0|||
147433705|NCT02684357|531753381|FG003|Part A|Withdrawal by Subject|0|||
147433706|NCT02684357|531753382|FG004|Part A|Withdrawal by Subject|0|||
147433707|NCT02684357|531753383|FG005|Part A|Withdrawal by Subject|0|||
147433708|NCT02684357|531753378|FG000|Part A|Other|0|||
147433709|NCT02684357|531753379|FG001|Part A|Other|1|||
147433710|NCT02684357|531753380|FG002|Part A|Other|0|||
147433711|NCT02684357|531753381|FG003|Part A|Other|0|||
147433712|NCT02684357|531753382|FG004|Part A|Other|0|||
147433713|NCT02684357|531753383|FG005|Part A|Other|0|||
147433714|NCT02684357|531753378|FG000|Part B|Adverse Event (Other)|0|||
147433715|NCT02684357|531753379|FG001|Part B|Adverse Event (Other)|0|||
147433716|NCT02684357|531753380|FG002|Part B|Adverse Event (Other)|0|||
147433717|NCT02684357|531753381|FG003|Part B|Adverse Event (Other)|1|||
147433718|NCT02684357|531753382|FG004|Part B|Adverse Event (Other)|1|||
147433719|NCT02684357|531753383|FG005|Part B|Adverse Event (Other)|1|||
147433720|NCT02684357|531753378|FG000|Part B|Lost to Follow-up|0|||
147433721|NCT02684357|531753379|FG001|Part B|Lost to Follow-up|0|||
147193942|NCT01346358|530880870|FG002|Overall Study|Withdrawal by Subject|1|||
147193943|NCT01346358|530880871|FG003|Overall Study|Withdrawal by Subject|1|||
147193944|NCT01346358|530880872|FG004|Overall Study|Withdrawal by Subject|0|||
147193945|NCT01346358|530880873|FG005|Overall Study|Withdrawal by Subject|2|||
147433722|NCT02684357|531753380|FG002|Part B|Lost to Follow-up|0|||
147433723|NCT02684357|531753381|FG003|Part B|Lost to Follow-up|1|||
147433724|NCT02684357|531753382|FG004|Part B|Lost to Follow-up|1|||
147433725|NCT02684357|531753383|FG005|Part B|Lost to Follow-up|7|||
147433726|NCT02684357|531753378|FG000|Part B|Withdrawal by Subject|0|||
147433727|NCT02684357|531753379|FG001|Part B|Withdrawal by Subject|0|||
147433728|NCT02684357|531753380|FG002|Part B|Withdrawal by Subject|0|||
147433729|NCT02684357|531753381|FG003|Part B|Withdrawal by Subject|0|||
147193946|NCT01346358|530880874|FG006|Overall Study|Withdrawal by Subject|1|||
147193947|NCT01346358|530880875|FG007|Overall Study|Withdrawal by Subject|1|||
147193948|NCT01346358|530880876|FG008|Overall Study|Withdrawal by Subject|1|||
147193949|NCT01346358|530880868|FG000|Overall Study|Adverse Event|1|||
147193950|NCT01346358|530880869|FG001|Overall Study|Adverse Event|0|||
147193951|NCT01346358|530880870|FG002|Overall Study|Adverse Event|0|||
147193952|NCT01346358|530880871|FG003|Overall Study|Adverse Event|0|||
147193953|NCT01346358|530880872|FG004|Overall Study|Adverse Event|1|||
147193954|NCT01346358|530880873|FG005|Overall Study|Adverse Event|0|||
147193955|NCT01346358|530880874|FG006|Overall Study|Adverse Event|0|||
147193956|NCT01346358|530880875|FG007|Overall Study|Adverse Event|0|||
147193957|NCT01346358|530880876|FG008|Overall Study|Adverse Event|1|||
147193958|NCT01346358|530880868|FG000|Overall Study|Non-Compliance|0|||
147193959|NCT01346358|530880869|FG001|Overall Study|Non-Compliance|0|||
147193960|NCT01346358|530880870|FG002|Overall Study|Non-Compliance|0|||
147193961|NCT01346358|530880871|FG003|Overall Study|Non-Compliance|0|||
147193962|NCT01346358|530880872|FG004|Overall Study|Non-Compliance|0|||
147193963|NCT01346358|530880873|FG005|Overall Study|Non-Compliance|0|||
147193964|NCT01346358|530880874|FG006|Overall Study|Non-Compliance|0|||
147534070|NCT00563706|532111345|FG007|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|1|||
147534071|NCT00563706|532111346|FG008|DB Treatment Period (Day 1 up to Day 28)|Discontinuation of Study by Sponsor|0|||
147534072|NCT00563706|532111338|FG000|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
147534073|NCT00563706|532111339|FG001|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
147534074|NCT00563706|532111340|FG002|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
147534075|NCT00563706|532111341|FG003|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
147534076|NCT00563706|532111342|FG004|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
147534077|NCT00563706|532111343|FG005|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
147534078|NCT00563706|532111344|FG006|DB Treatment Period (Day 1 up to Day 28)|Other|0|||
147534079|NCT00563706|532111345|FG007|DB Treatment Period (Day 1 up to Day 28)|Other|1|||
147534080|NCT00563706|532111346|FG008|DB Treatment Period (Day 1 up to Day 28)|Other|2|||
147534081|NCT03280628|532111349|FG000|Overall Study|Lost to Follow-up|8|||
147534082|NCT03280628|532111350|FG001|Overall Study|Lost to Follow-up|6|||
147534083|NCT03280628|532111351|FG002|Overall Study|Lost to Follow-up|11|||
147534084|NCT01361308|532111354|FG000|Overall Study|Withdrawal by Subject|9|||
147534085|NCT01361308|532111355|FG001|Overall Study|Withdrawal by Subject|13|||
147534086|NCT01361308|532111354|FG000|Overall Study|Physician Decision|3|||
147193965|NCT01346358|530880875|FG007|Overall Study|Non-Compliance|2|||
147193966|NCT01346358|530880876|FG008|Overall Study|Non-Compliance|0|||
147193967|NCT01346358|530880868|FG000|Overall Study|Physician Decision|0|||
147193968|NCT01346358|530880869|FG001|Overall Study|Physician Decision|1|||
147193969|NCT01346358|530880870|FG002|Overall Study|Physician Decision|0|||
147193970|NCT01346358|530880871|FG003|Overall Study|Physician Decision|0|||
147193971|NCT01346358|530880872|FG004|Overall Study|Physician Decision|0|||
147193972|NCT01346358|530880873|FG005|Overall Study|Physician Decision|0|||
147193973|NCT01346358|530880874|FG006|Overall Study|Physician Decision|0|||
147193974|NCT01346358|530880875|FG007|Overall Study|Physician Decision|1|||
147193975|NCT01346358|530880876|FG008|Overall Study|Physician Decision|1|||
147193976|NCT05058365|530880877|FG000|Overall Study|Migration|1|||
147193977|NCT05058365|530880878|FG001|Overall Study|Migration|1|||
147193978|NCT00702702|530880881|FG000|Overall Study|Study prematurely terminated|56|||
147193979|NCT00551759|530880882|FG000|Overall Study|Adverse Event|7|||
147193980|NCT00551759|530880882|FG000|Overall Study|Death|5|||
147193981|NCT00551759|530880882|FG000|Overall Study|Ineligible|1|||
147193982|NCT01667900|530880883|FG000|Part B|Death|0|||
147193983|NCT01667900|530880884|FG001|Part B|Death|0|||
147534087|NCT01361308|532111355|FG001|Overall Study|Physician Decision|3|||
147193984|NCT01667900|530880885|FG002|Part B|Death|0|||
147193985|NCT01667900|530880886|FG003|Part B|Death|0|||
147193986|NCT01667900|530880887|FG004|Part B|Death|0|||
147193987|NCT01667900|530880888|FG005|Part B|Death|0|||
147534088|NCT01361308|532111354|FG000|Overall Study|Lack of Efficacy|2|||
147534089|NCT01361308|532111355|FG001|Overall Study|Lack of Efficacy|0|||
147534090|NCT01361308|532111354|FG000|Overall Study|Protocol Violation|1|||
147534091|NCT01361308|532111355|FG001|Overall Study|Protocol Violation|0|||
147193988|NCT01667900|530880889|FG006|Part B|Death|0|||
147193989|NCT01667900|530880890|FG007|Part B|Death|0|||
147193990|NCT01667900|530880891|FG008|Part B|Death|0|||
147193991|NCT01667900|530880892|FG009|Part B|Death|0|||
147193992|NCT01667900|530880893|FG010|Part B|Death|0|||
147193993|NCT01667900|530880894|FG011|Part B|Death|0|||
147193994|NCT01667900|530880895|FG012|Part B|Death|0|||
147193995|NCT01667900|530880896|FG013|Part B|Death|0|||
147193996|NCT01667900|530880897|FG014|Part B|Death|0|||
147193997|NCT01667900|530880898|FG015|Part B|Death|0|||
147193998|NCT01667900|530880899|FG016|Part B|Death|1|||
147193999|NCT01667900|530880900|FG017|Part B|Death|0|||
147194000|NCT01667900|530880901|FG018|Part B|Death|0|||
147194001|NCT01667900|530880902|FG019|Part B|Death|0|||
147194002|NCT02954536|530880905|FG000|Overall Study|Adverse Event|2|||
147194003|NCT02954536|530880905|FG000|Overall Study|Death|12|||
147194004|NCT00685165|530880910|FG000|Washout Period of 14 Days|Adverse Event|1|||
147194005|NCT00685165|530880911|FG001|Washout Period of 14 Days|Adverse Event|0|||
147194006|NCT01576341|530880918|FG000|Overall Study|Withdrawal by Subject|24|||
147194007|NCT01576341|530880918|FG000|Overall Study|Adverse Event|10|||
147194008|NCT01576341|530880918|FG000|Overall Study|Death|21|||
147194009|NCT01576341|530880918|FG000|Overall Study|Physician Decision|2|||
147194010|NCT01576341|530880918|FG000|Overall Study|Lost to Follow-up|2|||
147194011|NCT01576341|530880918|FG000|Overall Study|Kidney transplantation|10|||
147194012|NCT01576341|530880918|FG000|Overall Study|Protocol Violation|12|||
147194013|NCT01576341|530880918|FG000|Overall Study|Other|12|||
147194014|NCT01844765|530880919|FG000|Overall Study|Adverse Event|6|||
147194015|NCT01844765|530880920|FG001|Overall Study|Adverse Event|8|||
147194016|NCT01844765|530880919|FG000|Overall Study|Withdrawal by Subject|2|||
147194017|NCT01844765|530880920|FG001|Overall Study|Withdrawal by Subject|3|||
147194018|NCT01844765|530880919|FG000|Overall Study|Disease progression|1|||
147194019|NCT01844765|530880920|FG001|Overall Study|Disease progression|0|||
147194020|NCT01844765|530880919|FG000|Overall Study|Administrative problems|3|||
147194021|NCT01844765|530880920|FG001|Overall Study|Administrative problems|4|||
147194022|NCT01844765|530880919|FG000|Overall Study|Protocol deviation|2|||
147194023|NCT01844765|530880920|FG001|Overall Study|Protocol deviation|0|||
147194024|NCT01844765|530880919|FG000|Overall Study|Untreated|1|||
147194025|NCT01844765|530880920|FG001|Overall Study|Untreated|0|||
147194026|NCT03914417|530880923|FG000|Overall Study|Withdrawal by Subject|2|||
147194027|NCT03836625|530880926|FG000|Overall Study|Lost to Follow-up|9|||
147194028|NCT03836625|530880927|FG001|Overall Study|Lost to Follow-up|9|||
147194029|NCT03836625|530880926|FG000|Overall Study|Investigator withdrawn at/near time of enrollment|6|||
147194030|NCT03836625|530880927|FG001|Overall Study|Investigator withdrawn at/near time of enrollment|1|||
147194031|NCT03836625|530880926|FG000|Overall Study|Death|0|||
147194032|NCT03836625|530880927|FG001|Overall Study|Death|1|||
147194033|NCT03836625|530880926|FG000|Overall Study|Refused follow-up|0|||
147194034|NCT03836625|530880927|FG001|Overall Study|Refused follow-up|1|||
147194035|NCT03361137|530880930|FG000|Overall Study|Reason not specified|1|||
147194036|NCT03361137|530880931|FG001|Overall Study|Reason not specified|0|||
147194037|NCT03361137|530880932|FG002|Overall Study|Reason not specified|0|||
147194038|NCT03361137|530880933|FG003|Overall Study|Reason not specified|0|||
147194039|NCT03361137|530880934|FG004|Overall Study|Reason not specified|0|||
147433730|NCT02684357|531753382|FG004|Part B|Withdrawal by Subject|2|||
147433731|NCT02684357|531753383|FG005|Part B|Withdrawal by Subject|4|||
147433732|NCT02684357|531753378|FG000|Part B|Other|0|||
147433733|NCT02684357|531753379|FG001|Part B|Other|0|||
147433734|NCT02684357|531753380|FG002|Part B|Other|0|||
147433735|NCT02684357|531753381|FG003|Part B|Other|1|||
147433736|NCT02684357|531753382|FG004|Part B|Other|0|||
147433737|NCT02684357|531753383|FG005|Part B|Other|1|||
147433738|NCT04567615|531753384|FG000|Randomization|Participant withdrew consent|1|||
147194040|NCT00791934|530880935|FG000|Overall Study|Withdrawal by Subject|2|||
147194041|NCT00791934|530880935|FG000|Overall Study|Did not consent for extended follow-up|13|||
147194042|NCT03413891|530880937|FG000|Overall Study|Lost to Follow-up|2|||
147194043|NCT03413891|530880938|FG001|Overall Study|Lost to Follow-up|1|||
147194044|NCT03413891|530880937|FG000|Overall Study|Protocol Violation|0|||
147194045|NCT03413891|530880938|FG001|Overall Study|Protocol Violation|1|||
147194046|NCT04905134|530880939|FG000|Exam With Standard Nasopharyngoscope|Study device not available|2|||
147194047|NCT04905134|530880939|FG000|Exam With Standard Nasopharyngoscope|Withdrawal by Subject|1|||
147194048|NCT03009058|530880940|FG000|Overall Study|Study terminated soon after initiation for commercial reasons|2|||
147194049|NCT03221556|530880941|FG000|Allocation|post-randomization exclusion|0|||
147194050|NCT03221556|530880942|FG001|Allocation|post-randomization exclusion|1|||
147194051|NCT03221556|530880941|FG000|Follow-Up|Withdrawal by Subject|0|||
147194052|NCT03221556|530880942|FG001|Follow-Up|Withdrawal by Subject|1|||
147194053|NCT02234843|530880945|FG000|Overall Study|Death|1|||
147194054|NCT02234843|530880946|FG001|Overall Study|Death|0|||
147194055|NCT02234843|530880947|FG002|Overall Study|Death|0|||
147194056|NCT02234843|530880948|FG003|Overall Study|Death|0|||
147194057|NCT02234843|530880949|FG004|Overall Study|Death|0|||
147194058|NCT02234843|530880950|FG005|Overall Study|Death|0|||
147194059|NCT02234843|530880951|FG006|Overall Study|Death|0|||
147194060|NCT02234843|530880952|FG007|Overall Study|Death|0|||
147194061|NCT02234843|530880953|FG008|Overall Study|Death|0|||
147194062|NCT02234843|530880954|FG009|Overall Study|Death|0|||
147194063|NCT02234843|530880945|FG000|Overall Study|Protocol Violation|1|||
147194064|NCT02234843|530880946|FG001|Overall Study|Protocol Violation|0|||
147194065|NCT02234843|530880947|FG002|Overall Study|Protocol Violation|1|||
147194066|NCT02234843|530880948|FG003|Overall Study|Protocol Violation|0|||
147194067|NCT02234843|530880949|FG004|Overall Study|Protocol Violation|0|||
147194068|NCT02234843|530880950|FG005|Overall Study|Protocol Violation|0|||
147194069|NCT02234843|530880951|FG006|Overall Study|Protocol Violation|0|||
147194070|NCT02234843|530880952|FG007|Overall Study|Protocol Violation|0|||
147194071|NCT02234843|530880953|FG008|Overall Study|Protocol Violation|0|||
147194072|NCT02234843|530880954|FG009|Overall Study|Protocol Violation|0|||
147194073|NCT02234843|530880945|FG000|Overall Study|Efficacy outcome reached|2|||
147194074|NCT02234843|530880946|FG001|Overall Study|Efficacy outcome reached|0|||
147194075|NCT02234843|530880947|FG002|Overall Study|Efficacy outcome reached|0|||
147194076|NCT02234843|530880948|FG003|Overall Study|Efficacy outcome reached|0|||
147194077|NCT02234843|530880949|FG004|Overall Study|Efficacy outcome reached|0|||
147194078|NCT02234843|530880950|FG005|Overall Study|Efficacy outcome reached|2|||
147194079|NCT02234843|530880951|FG006|Overall Study|Efficacy outcome reached|0|||
147194080|NCT02234843|530880952|FG007|Overall Study|Efficacy outcome reached|0|||
147194081|NCT02234843|530880953|FG008|Overall Study|Efficacy outcome reached|0|||
147194082|NCT02234843|530880954|FG009|Overall Study|Efficacy outcome reached|0|||
147194083|NCT02234843|530880945|FG000|Overall Study|Patient convenience|2|||
147194084|NCT02234843|530880946|FG001|Overall Study|Patient convenience|0|||
147194085|NCT02234843|530880947|FG002|Overall Study|Patient convenience|0|||
147194086|NCT02234843|530880948|FG003|Overall Study|Patient convenience|0|||
147194087|NCT02234843|530880949|FG004|Overall Study|Patient convenience|0|||
147194088|NCT02234843|530880950|FG005|Overall Study|Patient convenience|1|||
147194089|NCT02234843|530880951|FG006|Overall Study|Patient convenience|0|||
147194090|NCT02234843|530880952|FG007|Overall Study|Patient convenience|0|||
147194091|NCT02234843|530880953|FG008|Overall Study|Patient convenience|0|||
147194092|NCT02234843|530880954|FG009|Overall Study|Patient convenience|0|||
147194093|NCT02234843|530880945|FG000|Overall Study|Withdrawal by Subject|5|||
147194094|NCT02234843|530880946|FG001|Overall Study|Withdrawal by Subject|1|||
147194095|NCT02234843|530880947|FG002|Overall Study|Withdrawal by Subject|1|||
147194096|NCT02234843|530880948|FG003|Overall Study|Withdrawal by Subject|0|||
147194097|NCT02234843|530880949|FG004|Overall Study|Withdrawal by Subject|0|||
147194098|NCT02234843|530880950|FG005|Overall Study|Withdrawal by Subject|7|||
147194099|NCT02234843|530880951|FG006|Overall Study|Withdrawal by Subject|0|||
147194100|NCT02234843|530880952|FG007|Overall Study|Withdrawal by Subject|0|||
147194101|NCT02234843|530880953|FG008|Overall Study|Withdrawal by Subject|0|||
147194102|NCT02234843|530880954|FG009|Overall Study|Withdrawal by Subject|0|||
147194103|NCT02234843|530880945|FG000|Overall Study|Recovery|1|||
147194104|NCT02234843|530880946|FG001|Overall Study|Recovery|0|||
147194105|NCT02234843|530880947|FG002|Overall Study|Recovery|0|||
147194106|NCT02234843|530880948|FG003|Overall Study|Recovery|0|||
147194107|NCT02234843|530880949|FG004|Overall Study|Recovery|0|||
147194108|NCT02234843|530880950|FG005|Overall Study|Recovery|0|||
147194109|NCT02234843|530880951|FG006|Overall Study|Recovery|0|||
147194110|NCT02234843|530880952|FG007|Overall Study|Recovery|0|||
147194111|NCT02234843|530880953|FG008|Overall Study|Recovery|0|||
147194112|NCT02234843|530880954|FG009|Overall Study|Recovery|0|||
147194113|NCT02234843|530880945|FG000|Overall Study|Other|0|||
147194114|NCT02234843|530880946|FG001|Overall Study|Other|2|||
147194115|NCT02234843|530880947|FG002|Overall Study|Other|0|||
147194116|NCT02234843|530880948|FG003|Overall Study|Other|1|||
147194117|NCT02234843|530880949|FG004|Overall Study|Other|0|||
147194118|NCT02234843|530880950|FG005|Overall Study|Other|1|||
147194119|NCT02234843|530880951|FG006|Overall Study|Other|0|||
147194120|NCT02234843|530880952|FG007|Overall Study|Other|1|||
147194121|NCT02234843|530880953|FG008|Overall Study|Other|0|||
147194122|NCT02234843|530880954|FG009|Overall Study|Other|0|||
147194123|NCT02234843|530880945|FG000|Overall Study|Physician Decision|4|||
147194124|NCT02234843|530880946|FG001|Overall Study|Physician Decision|1|||
147194125|NCT02234843|530880947|FG002|Overall Study|Physician Decision|0|||
147194126|NCT02234843|530880948|FG003|Overall Study|Physician Decision|1|||
147194127|NCT02234843|530880949|FG004|Overall Study|Physician Decision|0|||
147194128|NCT02234843|530880950|FG005|Overall Study|Physician Decision|0|||
147194129|NCT02234843|530880951|FG006|Overall Study|Physician Decision|0|||
147194130|NCT02234843|530880952|FG007|Overall Study|Physician Decision|1|||
147194131|NCT02234843|530880953|FG008|Overall Study|Physician Decision|0|||
147194132|NCT02234843|530880954|FG009|Overall Study|Physician Decision|0|||
147194133|NCT02234843|530880945|FG000|Overall Study|Adverse Event|5|||
147194134|NCT02234843|530880946|FG001|Overall Study|Adverse Event|1|||
147194135|NCT02234843|530880947|FG002|Overall Study|Adverse Event|1|||
147194136|NCT02234843|530880948|FG003|Overall Study|Adverse Event|3|||
147194137|NCT02234843|530880949|FG004|Overall Study|Adverse Event|2|||
147194138|NCT02234843|530880950|FG005|Overall Study|Adverse Event|1|||
147194139|NCT02234843|530880951|FG006|Overall Study|Adverse Event|0|||
147194140|NCT02234843|530880952|FG007|Overall Study|Adverse Event|0|||
147194141|NCT02234843|530880953|FG008|Overall Study|Adverse Event|1|||
147194142|NCT02234843|530880954|FG009|Overall Study|Adverse Event|0|||
147194143|NCT02234843|530880945|FG000|Overall Study|Non-compliance with study drug|1|||
147194144|NCT02234843|530880946|FG001|Overall Study|Non-compliance with study drug|0|||
147194145|NCT02234843|530880947|FG002|Overall Study|Non-compliance with study drug|0|||
147194146|NCT02234843|530880948|FG003|Overall Study|Non-compliance with study drug|0|||
147194147|NCT02234843|530880949|FG004|Overall Study|Non-compliance with study drug|0|||
147194148|NCT02234843|530880950|FG005|Overall Study|Non-compliance with study drug|1|||
147194149|NCT02234843|530880951|FG006|Overall Study|Non-compliance with study drug|1|||
147194150|NCT02234843|530880952|FG007|Overall Study|Non-compliance with study drug|0|||
147194151|NCT02234843|530880953|FG008|Overall Study|Non-compliance with study drug|0|||
147194152|NCT02234843|530880954|FG009|Overall Study|Non-compliance with study drug|0|||
147194153|NCT02234843|530880945|FG000|Overall Study|Lost to Follow-up|0|||
147194154|NCT02234843|530880946|FG001|Overall Study|Lost to Follow-up|1|||
147194155|NCT02234843|530880947|FG002|Overall Study|Lost to Follow-up|0|||
147194156|NCT02234843|530880948|FG003|Overall Study|Lost to Follow-up|0|||
147194157|NCT02234843|530880949|FG004|Overall Study|Lost to Follow-up|0|||
147194158|NCT02234843|530880950|FG005|Overall Study|Lost to Follow-up|0|||
147194159|NCT02234843|530880951|FG006|Overall Study|Lost to Follow-up|1|||
147194160|NCT02234843|530880952|FG007|Overall Study|Lost to Follow-up|0|||
147194161|NCT02234843|530880953|FG008|Overall Study|Lost to Follow-up|0|||
147194162|NCT02234843|530880954|FG009|Overall Study|Lost to Follow-up|0|||
147194163|NCT00506350|530880957|FG000|Overall Study|Serious Adverse Event|1|||
147194164|NCT00506350|530880958|FG001|Overall Study|Serious Adverse Event|0|||
147194165|NCT00506350|530880959|FG002|Overall Study|Serious Adverse Event|0|||
147194166|NCT00506350|530880960|FG003|Overall Study|Serious Adverse Event|0|||
147194167|NCT00506350|530880961|FG004|Overall Study|Serious Adverse Event|0|||
147194168|NCT00506350|530880962|FG005|Overall Study|Serious Adverse Event|0|||
147194169|NCT00506350|530880963|FG006|Overall Study|Serious Adverse Event|0|||
147194170|NCT00506350|530880964|FG007|Overall Study|Serious Adverse Event|0|||
147194171|NCT00506350|530880965|FG008|Overall Study|Serious Adverse Event|0|||
147194172|NCT00506350|530880957|FG000|Overall Study|Adverse Event|0|||
147194173|NCT00506350|530880958|FG001|Overall Study|Adverse Event|0|||
147194174|NCT00506350|530880959|FG002|Overall Study|Adverse Event|0|||
147194175|NCT00506350|530880960|FG003|Overall Study|Adverse Event|0|||
147194176|NCT00506350|530880961|FG004|Overall Study|Adverse Event|0|||
147194177|NCT00506350|530880962|FG005|Overall Study|Adverse Event|0|||
147194178|NCT00506350|530880963|FG006|Overall Study|Adverse Event|0|||
147194179|NCT00506350|530880964|FG007|Overall Study|Adverse Event|1|||
147194180|NCT00506350|530880965|FG008|Overall Study|Adverse Event|1|||
147194181|NCT00506350|530880957|FG000|Overall Study|Protocol Violation|0|||
147194182|NCT00506350|530880958|FG001|Overall Study|Protocol Violation|0|||
147194183|NCT00506350|530880959|FG002|Overall Study|Protocol Violation|1|||
147194184|NCT00506350|530880960|FG003|Overall Study|Protocol Violation|0|||
147194185|NCT00506350|530880961|FG004|Overall Study|Protocol Violation|0|||
147194186|NCT00506350|530880962|FG005|Overall Study|Protocol Violation|0|||
147194187|NCT00506350|530880963|FG006|Overall Study|Protocol Violation|1|||
147194188|NCT00506350|530880964|FG007|Overall Study|Protocol Violation|0|||
147194189|NCT00506350|530880965|FG008|Overall Study|Protocol Violation|0|||
147194190|NCT00506350|530880957|FG000|Overall Study|Withdrawal by Subject|0|||
147194191|NCT00506350|530880958|FG001|Overall Study|Withdrawal by Subject|1|||
147194192|NCT00506350|530880959|FG002|Overall Study|Withdrawal by Subject|1|||
147194193|NCT00506350|530880960|FG003|Overall Study|Withdrawal by Subject|1|||
147194194|NCT00506350|530880961|FG004|Overall Study|Withdrawal by Subject|4|||
147194195|NCT00506350|530880962|FG005|Overall Study|Withdrawal by Subject|1|||
147194196|NCT00506350|530880963|FG006|Overall Study|Withdrawal by Subject|1|||
147194197|NCT00506350|530880964|FG007|Overall Study|Withdrawal by Subject|2|||
147194198|NCT00506350|530880965|FG008|Overall Study|Withdrawal by Subject|0|||
147194199|NCT00506350|530880957|FG000|Overall Study|Lost to Follow-up|1|||
147194200|NCT00506350|530880958|FG001|Overall Study|Lost to Follow-up|1|||
147194201|NCT00506350|530880959|FG002|Overall Study|Lost to Follow-up|1|||
147194202|NCT00506350|530880960|FG003|Overall Study|Lost to Follow-up|1|||
147194203|NCT00506350|530880961|FG004|Overall Study|Lost to Follow-up|2|||
147194204|NCT00506350|530880962|FG005|Overall Study|Lost to Follow-up|1|||
147194205|NCT00506350|530880963|FG006|Overall Study|Lost to Follow-up|0|||
147194206|NCT00506350|530880964|FG007|Overall Study|Lost to Follow-up|0|||
147194207|NCT00506350|530880965|FG008|Overall Study|Lost to Follow-up|2|||
147194208|NCT00506350|530880957|FG000|Overall Study|Medical Reason|0|||
147194209|NCT00506350|530880958|FG001|Overall Study|Medical Reason|0|||
147194210|NCT00506350|530880959|FG002|Overall Study|Medical Reason|0|||
147194211|NCT00506350|530880960|FG003|Overall Study|Medical Reason|0|||
147194212|NCT00506350|530880961|FG004|Overall Study|Medical Reason|1|||
147194213|NCT00506350|530880962|FG005|Overall Study|Medical Reason|0|||
147194214|NCT00506350|530880963|FG006|Overall Study|Medical Reason|0|||
147194215|NCT00506350|530880964|FG007|Overall Study|Medical Reason|0|||
147194216|NCT00506350|530880965|FG008|Overall Study|Medical Reason|0|||
147194217|NCT00506350|530880957|FG000|Overall Study|Other|1|||
147194218|NCT00506350|530880958|FG001|Overall Study|Other|1|||
147194219|NCT00506350|530880959|FG002|Overall Study|Other|3|||
147194220|NCT00506350|530880960|FG003|Overall Study|Other|0|||
147194221|NCT00506350|530880961|FG004|Overall Study|Other|3|||
147194222|NCT00506350|530880962|FG005|Overall Study|Other|0|||
147194223|NCT00506350|530880963|FG006|Overall Study|Other|0|||
147194224|NCT00506350|530880964|FG007|Overall Study|Other|2|||
147194225|NCT00506350|530880965|FG008|Overall Study|Other|2|||
147194226|NCT03474588|530880966|FG000|Overall Study|Withdrawal by Subject|4|||
147194227|NCT03474588|530880967|FG001|Overall Study|Withdrawal by Subject|3|||
147194228|NCT03474588|530880966|FG000|Overall Study|Death|0|||
147194229|NCT03474588|530880967|FG001|Overall Study|Death|1|||
147194230|NCT01691794|530880969|FG000|Overall Study|Poor/Non-Compliance|1|||
147194231|NCT01691794|530880970|FG001|Overall Study|Poor/Non-Compliance|4|||
147194232|NCT01691794|530880971|FG002|Overall Study|Poor/Non-Compliance|1|||
147194233|NCT01691794|530880969|FG000|Overall Study|Death|0|||
147194234|NCT01691794|530880970|FG001|Overall Study|Death|0|||
147194235|NCT01691794|530880971|FG002|Overall Study|Death|1|||
147194236|NCT01691794|530880969|FG000|Overall Study|Lack of Efficacy|0|||
147194237|NCT01691794|530880970|FG001|Overall Study|Lack of Efficacy|7|||
147194238|NCT01691794|530880971|FG002|Overall Study|Lack of Efficacy|1|||
147194239|NCT01691794|530880969|FG000|Overall Study|Participant request to discontinue|0|||
147534092|NCT01361308|532111354|FG000|Overall Study|Lost to Follow-up|5|||
147534093|NCT01361308|532111355|FG001|Overall Study|Lost to Follow-up|4|||
147194240|NCT01691794|530880970|FG001|Overall Study|Participant request to discontinue|1|||
147194241|NCT01691794|530880971|FG002|Overall Study|Participant request to discontinue|0|||
147194242|NCT01691794|530880969|FG000|Overall Study|Adverse Event|0|||
147194243|NCT01691794|530880970|FG001|Overall Study|Adverse Event|1|||
147194244|NCT01691794|530880971|FG002|Overall Study|Adverse Event|1|||
147194245|NCT01691794|530880969|FG000|Overall Study|Completed Only first 24 weeks of study|0|||
147194246|NCT01691794|530880970|FG001|Overall Study|Completed Only first 24 weeks of study|2|||
147194247|NCT01691794|530880971|FG002|Overall Study|Completed Only first 24 weeks of study|3|||
147194248|NCT01691794|530880969|FG000|Overall Study|Did not complete first 24 weeks of study|0|||
147194249|NCT01691794|530880970|FG001|Overall Study|Did not complete first 24 weeks of study|3|||
147194250|NCT01691794|530880971|FG002|Overall Study|Did not complete first 24 weeks of study|3|||
147194251|NCT00844844|530880972|FG000|Treatment Period (26 Weeks)|Adverse Event|1|||
147194252|NCT00844844|530880972|FG000|Treatment Period (26 Weeks)|Protocol Violation|1|||
147194253|NCT00844844|530880972|FG000|Extension Treatment Period|Adverse Event|2|||
147194254|NCT00844844|530880972|FG000|Post Treatment Period|Withdrawal by Subject|1|||
147194255|NCT00945009|530880975|FG000|Overall Study|Lack of Efficacy|10|||
147194256|NCT00945009|530880976|FG001|Overall Study|Lack of Efficacy|0|||
147194257|NCT00945009|530880977|FG002|Overall Study|Lack of Efficacy|0|||
147194258|NCT00945009|530880975|FG000|Overall Study|Physician Decision|21|||
147194259|NCT00945009|530880976|FG001|Overall Study|Physician Decision|4|||
147194260|NCT00945009|530880977|FG002|Overall Study|Physician Decision|3|||
147194261|NCT00945009|530880975|FG000|Overall Study|Protocol Violation|6|||
147194262|NCT00945009|530880976|FG001|Overall Study|Protocol Violation|1|||
147194263|NCT00945009|530880977|FG002|Overall Study|Protocol Violation|0|||
147194264|NCT00945009|530880975|FG000|Overall Study|Withdrawal by Subject|1|||
147194265|NCT00945009|530880976|FG001|Overall Study|Withdrawal by Subject|0|||
147194266|NCT00945009|530880977|FG002|Overall Study|Withdrawal by Subject|0|||
147194267|NCT00945009|530880975|FG000|Overall Study|Ineligible|6|||
147194268|NCT00945009|530880976|FG001|Overall Study|Ineligible|1|||
147194269|NCT00945009|530880977|FG002|Overall Study|Ineligible|0|||
147194270|NCT00945009|530880975|FG000|Overall Study|Inevaluable|0|||
147194271|NCT00945009|530880976|FG001|Overall Study|Inevaluable|1|||
147194272|NCT00945009|530880977|FG002|Overall Study|Inevaluable|0|||
147194273|NCT00945009|530880975|FG000|Overall Study|Refusal of further protocol|1|||
147194274|NCT00945009|530880976|FG001|Overall Study|Refusal of further protocol|0|||
147194275|NCT00945009|530880977|FG002|Overall Study|Refusal of further protocol|0|||
147194276|NCT04886154|530880978|FG000|Overall Study|Adverse Event|0|||
147194277|NCT04886154|530880979|FG001|Overall Study|Adverse Event|0|||
147194278|NCT04886154|530880980|FG002|Overall Study|Adverse Event|0|||
147194279|NCT04886154|530880981|FG003|Overall Study|Adverse Event|0|||
147194280|NCT04886154|530880982|FG004|Overall Study|Adverse Event|1|||
147194281|NCT04886154|530880983|FG005|Overall Study|Adverse Event|0|||
147194282|NCT04886154|530880984|FG006|Overall Study|Adverse Event|0|||
147194283|NCT04886154|530880985|FG007|Overall Study|Adverse Event|1|||
147194284|NCT04886154|530880986|FG008|Overall Study|Adverse Event|1|||
147194285|NCT04886154|530880987|FG009|Overall Study|Adverse Event|0|||
147194286|NCT04886154|530880988|FG010|Overall Study|Adverse Event|0|||
147194287|NCT04886154|530880989|FG011|Overall Study|Adverse Event|1|||
147194288|NCT04886154|530880990|FG012|Overall Study|Adverse Event|0|||
147194289|NCT04886154|530880991|FG013|Overall Study|Adverse Event|0|||
147194290|NCT04886154|530880992|FG014|Overall Study|Adverse Event|3|||
147194291|NCT04886154|530880978|FG000|Overall Study|Lost to Follow-up|1|||
147194292|NCT04886154|530880979|FG001|Overall Study|Lost to Follow-up|0|||
147194293|NCT04886154|530880980|FG002|Overall Study|Lost to Follow-up|2|||
147194294|NCT04886154|530880981|FG003|Overall Study|Lost to Follow-up|0|||
147194295|NCT04886154|530880982|FG004|Overall Study|Lost to Follow-up|17|||
147194296|NCT04886154|530880983|FG005|Overall Study|Lost to Follow-up|7|||
147534094|NCT01361308|532111354|FG000|Overall Study|Adverse Event|8|||
147534095|NCT01361308|532111355|FG001|Overall Study|Adverse Event|4|||
147534096|NCT01361308|532111354|FG000|Overall Study|Eligibility Criteria Not Met|2|||
147534097|NCT01361308|532111355|FG001|Overall Study|Eligibility Criteria Not Met|3|||
147194297|NCT04886154|530880984|FG006|Overall Study|Lost to Follow-up|8|||
147194298|NCT04886154|530880985|FG007|Overall Study|Lost to Follow-up|7|||
147194299|NCT04886154|530880986|FG008|Overall Study|Lost to Follow-up|8|||
147194300|NCT04886154|530880987|FG009|Overall Study|Lost to Follow-up|0|||
147194301|NCT04886154|530880988|FG010|Overall Study|Lost to Follow-up|2|||
147194302|NCT04886154|530880989|FG011|Overall Study|Lost to Follow-up|0|||
147194303|NCT04886154|530880990|FG012|Overall Study|Lost to Follow-up|0|||
147194304|NCT04886154|530880991|FG013|Overall Study|Lost to Follow-up|0|||
147194305|NCT04886154|530880992|FG014|Overall Study|Lost to Follow-up|0|||
147194306|NCT04886154|530880978|FG000|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
147194307|NCT04886154|530880979|FG001|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
147194308|NCT04886154|530880980|FG002|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
147194309|NCT04886154|530880981|FG003|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
147194310|NCT04886154|530880982|FG004|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
147534098|NCT01361308|532111354|FG000|Overall Study|Failed C-SSRS|5|||
147534099|NCT01361308|532111355|FG001|Overall Study|Failed C-SSRS|2|||
147534100|NCT01361308|532111354|FG000|Overall Study|Other|0|||
147534101|NCT01361308|532111355|FG001|Overall Study|Other|1|||
147534102|NCT03839693|532111360|FG000|Overall Study|Lost to Follow-up|0|||
147534103|NCT03839693|532111361|FG001|Overall Study|Lost to Follow-up|2|||
147534104|NCT03839693|532111362|FG002|Overall Study|Lost to Follow-up|2|||
147534105|NCT03839693|532111360|FG000|Overall Study|Withdrawal by Subject|1|||
147534106|NCT03839693|532111361|FG001|Overall Study|Withdrawal by Subject|0|||
147534107|NCT03839693|532111362|FG002|Overall Study|Withdrawal by Subject|2|||
147534108|NCT03839693|532111360|FG000|Overall Study|subject moved out of the area|1|||
147534109|NCT03839693|532111361|FG001|Overall Study|subject moved out of the area|0|||
147534110|NCT03839693|532111362|FG002|Overall Study|subject moved out of the area|0|||
147534111|NCT00700115|532111371|FG000|Overall Study|Withdrawal by Subject|1|||
147534112|NCT00700115|532111372|FG001|Overall Study|Withdrawal by Subject|0|||
147534113|NCT00700115|532111371|FG000|Overall Study|Lost to Follow-up|0|||
147534114|NCT00700115|532111372|FG001|Overall Study|Lost to Follow-up|1|||
147534115|NCT00706901|532111373|FG000|Overall Study|Lost to Follow-up|2|||
147534116|NCT00706901|532111374|FG001|Overall Study|Lost to Follow-up|3|||
147534117|NCT00706901|532111375|FG002|Overall Study|Lost to Follow-up|2|||
147534118|NCT00706901|532111373|FG000|Overall Study|Withdrawal by Subject|4|||
147534119|NCT00706901|532111374|FG001|Overall Study|Withdrawal by Subject|2|||
147534120|NCT00706901|532111375|FG002|Overall Study|Withdrawal by Subject|5|||
147534121|NCT00706901|532111373|FG000|Overall Study|In Jail|1|||
147534122|NCT00706901|532111374|FG001|Overall Study|In Jail|0|||
147534123|NCT00706901|532111375|FG002|Overall Study|In Jail|1|||
147534124|NCT00706901|532111373|FG000|Overall Study|Death|1|||
147534125|NCT00706901|532111374|FG001|Overall Study|Death|0|||
147534126|NCT00706901|532111375|FG002|Overall Study|Death|0|||
147534127|NCT00457249|532111378|FG000|Overall Study|Lost to Follow-up|3|||
147534128|NCT00457249|532111379|FG001|Overall Study|Lost to Follow-up|0|||
147534129|NCT00457249|532111378|FG000|Overall Study|Protocol Violation|4|||
147534130|NCT00457249|532111379|FG001|Overall Study|Protocol Violation|1|||
147534131|NCT00457249|532111378|FG000|Overall Study|Withdrawal by Subject|3|||
147534132|NCT00457249|532111379|FG001|Overall Study|Withdrawal by Subject|1|||
147534133|NCT00457249|532111378|FG000|Overall Study|Serious Adverse Events|2|||
147534134|NCT00457249|532111379|FG001|Overall Study|Serious Adverse Events|0|||
147534135|NCT02916056|532111380|FG000|Overall Study|Adverse Event|6|||
147534136|NCT02916056|532111380|FG000|Overall Study|Lost to Follow-up|1|||
147534137|NCT02916056|532111380|FG000|Overall Study|Other|12|||
147534138|NCT02916056|532111380|FG000|Overall Study|Protocol Violation|1|||
147534139|NCT02916056|532111380|FG000|Overall Study|Withdrawal by Subject|8|||
147534140|NCT02916056|532111380|FG000|Overall Study|Study Terminated by Sponsor|269|||
147534141|NCT00124709|532111381|FG000|Overall Study|Randomized but did not take medication|3|||
147534142|NCT00124709|532111382|FG001|Overall Study|Randomized but did not take medication|1|||
147534143|NCT00124709|532111381|FG000|Overall Study|Adverse Event|3|||
147534144|NCT00124709|532111382|FG001|Overall Study|Adverse Event|0|||
147534145|NCT00124709|532111381|FG000|Overall Study|Lack of Efficacy|5|||
147534146|NCT00124709|532111382|FG001|Overall Study|Lack of Efficacy|10|||
147534147|NCT00124709|532111381|FG000|Overall Study|Protocol Violation|3|||
147534148|NCT00124709|532111382|FG001|Overall Study|Protocol Violation|5|||
147534149|NCT00124709|532111381|FG000|Overall Study|Withdrawal by Subject|127|||
147534150|NCT00124709|532111382|FG001|Overall Study|Withdrawal by Subject|136|||
147534151|NCT00124709|532111381|FG000|Overall Study|Lost to Follow-up|114|||
147534152|NCT00124709|532111382|FG001|Overall Study|Lost to Follow-up|120|||
147534153|NCT00122954|532111383|FG000|Overall Study|Withdrawal by Subject|2|||
147534154|NCT00122954|532111384|FG001|Overall Study|Withdrawal by Subject|2|||
147534155|NCT00122954|532111383|FG000|Overall Study|Protocol Violation|0|||
147534156|NCT00122954|532111384|FG001|Overall Study|Protocol Violation|1|||
147534157|NCT04341727|532111388|FG000|Overall Study|Withdrawal by Subject|0|||
147534158|NCT04341727|532111389|FG001|Overall Study|Withdrawal by Subject|0|||
147534159|NCT04341727|532111390|FG002|Overall Study|Withdrawal by Subject|1|||
147534160|NCT04341727|532111391|FG003|Overall Study|Withdrawal by Subject|0|||
147534161|NCT04341727|532111388|FG000|Overall Study|Lost to Follow-up|0|||
147534162|NCT04341727|532111389|FG001|Overall Study|Lost to Follow-up|0|||
147534163|NCT04341727|532111390|FG002|Overall Study|Lost to Follow-up|0|||
147534164|NCT04341727|532111391|FG003|Overall Study|Lost to Follow-up|1|||
147534165|NCT05604521|532111392|FG000|Overall Study|Trial terminated early due to an extended gap between the 2nd and 3rd doses (3rd dose not given).|23|||
147534166|NCT05604521|532111393|FG001|Overall Study|Trial terminated early due to an extended gap between the 2nd and 3rd doses (3rd dose not given).|7|||
147534167|NCT05604521|532111392|FG000|Overall Study|Adverse Event|1|||
147534168|NCT05604521|532111393|FG001|Overall Study|Adverse Event|0|||
147534169|NCT01491737|532111394|FG000|Overall Study|Withdrawal by Subject|20|||
147534170|NCT01491737|532111395|FG001|Overall Study|Withdrawal by Subject|17|||
147534171|NCT01491737|532111394|FG000|Overall Study|Lost to Follow-up|2|||
147534172|NCT01491737|532111395|FG001|Overall Study|Lost to Follow-up|10|||
147534173|NCT01491737|532111394|FG000|Overall Study|Death|63|||
147534174|NCT01491737|532111395|FG001|Overall Study|Death|57|||
147534175|NCT01491737|532111394|FG000|Overall Study|Study Termination by Sponsor|36|||
147194311|NCT04886154|530880983|FG005|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
147194312|NCT04886154|530880984|FG006|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|1|||
147194313|NCT04886154|530880985|FG007|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
147194314|NCT04886154|530880986|FG008|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
147194315|NCT04886154|530880987|FG009|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
147194316|NCT04886154|530880988|FG010|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
147194317|NCT04886154|530880989|FG011|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
147194318|NCT04886154|530880990|FG012|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
147194319|NCT04886154|530880991|FG013|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
147194320|NCT04886154|530880992|FG014|Overall Study|ADVERSE EVENT REQUIRING EXPEDITED REPORT|0|||
147194321|NCT04886154|530880978|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
147194322|NCT04886154|530880979|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
147194323|NCT04886154|530880980|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
147194324|NCT04886154|530880981|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
147194325|NCT04886154|530880982|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
147194326|NCT04886154|530880983|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
147194327|NCT04886154|530880984|FG006|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
147194328|NCT04886154|530880985|FG007|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
147194329|NCT04886154|530880986|FG008|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
147194330|NCT04886154|530880987|FG009|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
147194331|NCT04886154|530880988|FG010|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
147194332|NCT04886154|530880989|FG011|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
147194333|NCT04886154|530880990|FG012|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
147194334|NCT04886154|530880991|FG013|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
147194335|NCT04886154|530880992|FG014|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
147194336|NCT04886154|530880978|FG000|Overall Study|Other, Not Specified|0|||
147194337|NCT04886154|530880979|FG001|Overall Study|Other, Not Specified|0|||
147194338|NCT04886154|530880980|FG002|Overall Study|Other, Not Specified|0|||
147194339|NCT04886154|530880981|FG003|Overall Study|Other, Not Specified|0|||
147194340|NCT04886154|530880982|FG004|Overall Study|Other, Not Specified|11|||
147194341|NCT04886154|530880983|FG005|Overall Study|Other, Not Specified|8|||
147194342|NCT04886154|530880984|FG006|Overall Study|Other, Not Specified|9|||
147194343|NCT04886154|530880985|FG007|Overall Study|Other, Not Specified|10|||
147194344|NCT04886154|530880986|FG008|Overall Study|Other, Not Specified|6|||
147194345|NCT04886154|530880987|FG009|Overall Study|Other, Not Specified|1|||
147194346|NCT04886154|530880988|FG010|Overall Study|Other, Not Specified|1|||
147194347|NCT04886154|530880989|FG011|Overall Study|Other, Not Specified|2|||
147194348|NCT04886154|530880990|FG012|Overall Study|Other, Not Specified|1|||
147194349|NCT04886154|530880991|FG013|Overall Study|Other, Not Specified|2|||
147194350|NCT04886154|530880992|FG014|Overall Study|Other, Not Specified|3|||
147433739|NCT04567615|531753385|FG001|Randomization|Participant withdrew consent|0|||
147433740|NCT04567615|531753386|FG002|Randomization|Participant withdrew consent|0|||
147433741|NCT04567615|531753384|FG000|Randomization|Adverse event unrelated to study drug|0|||
147433742|NCT04567615|531753385|FG001|Randomization|Adverse event unrelated to study drug|1|||
147433743|NCT04567615|531753386|FG002|Randomization|Adverse event unrelated to study drug|0|||
147433744|NCT04567615|531753384|FG000|Treatment Period|Participant Withdrew Consent|2|||
147433745|NCT04567615|531753385|FG001|Treatment Period|Participant Withdrew Consent|5|||
147433746|NCT04567615|531753386|FG002|Treatment Period|Participant Withdrew Consent|1|||
147433747|NCT04567615|531753384|FG000|Treatment Period|Death|1|||
147433748|NCT04567615|531753385|FG001|Treatment Period|Death|2|||
147433749|NCT04567615|531753386|FG002|Treatment Period|Death|0|||
147433750|NCT04567615|531753384|FG000|Treatment Period|Lost to Follow-up|0|||
147433751|NCT04567615|531753385|FG001|Treatment Period|Lost to Follow-up|1|||
147433752|NCT04567615|531753386|FG002|Treatment Period|Lost to Follow-up|0|||
147433753|NCT04567615|531753384|FG000|Treatment Period|Participant No Longer Meets Study Criteria|0|||
147433754|NCT04567615|531753385|FG001|Treatment Period|Participant No Longer Meets Study Criteria|1|||
147433755|NCT04567615|531753386|FG002|Treatment Period|Participant No Longer Meets Study Criteria|0|||
147433756|NCT04567615|531753384|FG000|Treatment Period|Disease Progression|85|||
147433757|NCT04567615|531753385|FG001|Treatment Period|Disease Progression|63|||
147433758|NCT04567615|531753386|FG002|Treatment Period|Disease Progression|16|||
147433759|NCT04567615|531753384|FG000|Treatment Period|Study Drug Toxicity|3|||
147433760|NCT04567615|531753385|FG001|Treatment Period|Study Drug Toxicity|10|||
147433761|NCT04567615|531753386|FG002|Treatment Period|Study Drug Toxicity|4|||
147433762|NCT04567615|531753384|FG000|Treatment Period|Adverse Event Unrelated to Study Drug|11|||
147194351|NCT03919773|530881001|FG000|First Intervention- (12 Weeks)|Adverse Event|1|||
147194352|NCT03919773|530881002|FG001|First Intervention- (12 Weeks)|Adverse Event|1|||
147194353|NCT03919773|530881001|FG000|First Intervention- (12 Weeks)|Protocol Violation|0|||
147194354|NCT03919773|530881002|FG001|First Intervention- (12 Weeks)|Protocol Violation|1|||
147433763|NCT04567615|531753385|FG001|Treatment Period|Adverse Event Unrelated to Study Drug|6|||
147433764|NCT04567615|531753386|FG002|Treatment Period|Adverse Event Unrelated to Study Drug|1|||
147534176|NCT01491737|532111395|FG001|Overall Study|Study Termination by Sponsor|36|||
147534177|NCT01491737|532111394|FG000|Overall Study|Reason Not Specified|8|||
147534178|NCT01491737|532111395|FG001|Overall Study|Reason Not Specified|9|||
147534179|NCT03587116|532111398|FG000|Overall Study|Lost to Follow-up|0|||
147534180|NCT03587116|532111399|FG001|Overall Study|Lost to Follow-up|1|||
147534181|NCT03587116|532111398|FG000|Overall Study|No Longer Met Eligibility Criteria|0|||
147534182|NCT03587116|532111399|FG001|Overall Study|No Longer Met Eligibility Criteria|1|||
147534183|NCT03587116|532111398|FG000|Overall Study|Withdrawal by Subject|4|||
147534184|NCT03587116|532111399|FG001|Overall Study|Withdrawal by Subject|0|||
147534185|NCT05993299|532111400|FG000|Overall Study|Did not meet treatment eligibility criteria|2|||
147534186|NCT05993299|532111400|FG000|Overall Study|Ongoing|4|||
147534187|NCT03110107|532111401|FG000|Treatment Period|Disease Progression|3|||
147534188|NCT03110107|532111402|FG001|Treatment Period|Disease Progression|9|||
147534189|NCT03110107|532111403|FG002|Treatment Period|Disease Progression|8|||
147534190|NCT03110107|532111404|FG003|Treatment Period|Disease Progression|11|||
147534191|NCT03110107|532111405|FG004|Treatment Period|Disease Progression|8|||
147534192|NCT03110107|532111406|FG005|Treatment Period|Disease Progression|4|||
147534193|NCT03110107|532111407|FG006|Treatment Period|Disease Progression|6|||
147534194|NCT03110107|532111408|FG007|Treatment Period|Disease Progression|7|||
147534195|NCT03110107|532111409|FG008|Treatment Period|Disease Progression|2|||
147534196|NCT03110107|532111410|FG009|Treatment Period|Disease Progression|10|||
147534197|NCT03110107|532111411|FG010|Treatment Period|Disease Progression|5|||
147534198|NCT03110107|532111412|FG011|Treatment Period|Disease Progression|2|||
147534199|NCT03110107|532111413|FG012|Treatment Period|Disease Progression|0|||
147534200|NCT03110107|532111414|FG013|Treatment Period|Disease Progression|5|||
147534201|NCT03110107|532111415|FG014|Treatment Period|Disease Progression|14|||
147534202|NCT03110107|532111416|FG015|Treatment Period|Disease Progression|14|||
147534203|NCT03110107|532111417|FG016|Treatment Period|Disease Progression|4|||
147534204|NCT03110107|532111418|FG017|Treatment Period|Disease Progression|3|||
147194355|NCT04659044|530881003|FG000|Induction|Physician Decision|1|||
147194356|NCT04659044|530881003|FG000|Induction|Adverse Event|2|||
147194357|NCT04966013|530881004|FG000|Overall Study|Withdrawal by Subject|0|||
147194358|NCT04966013|530881005|FG001|Overall Study|Withdrawal by Subject|2|||
147194359|NCT04966013|530881006|FG002|Overall Study|Withdrawal by Subject|1|||
147194360|NCT04966013|530881004|FG000|Overall Study|Adverse Event|2|||
147194361|NCT04966013|530881005|FG001|Overall Study|Adverse Event|1|||
147194362|NCT04966013|530881006|FG002|Overall Study|Adverse Event|1|||
147194363|NCT02336282|530881010|FG000|Overall Study|Unrelated illness|1|||
147194364|NCT02336282|530881010|FG000|Overall Study|Uncomfortable with technology|1|||
147194365|NCT02336282|530881010|FG000|Overall Study|Lost to Follow-up|1|||
147194366|NCT02336282|530881010|FG000|Overall Study|Not enough time to complete sessions|2|||
147194367|NCT04875975|530881026|FG000|Overall Study|Adverse Event|1|||
147194368|NCT04875975|530881027|FG001|Overall Study|Adverse Event|2|||
147194369|NCT04875975|530881026|FG000|Overall Study|Lack of Efficacy|2|||
147194370|NCT04875975|530881027|FG001|Overall Study|Lack of Efficacy|2|||
147194371|NCT04875975|530881026|FG000|Overall Study|Permanently left due to seizure recurrence|1|||
147194372|NCT04875975|530881027|FG001|Overall Study|Permanently left due to seizure recurrence|0|||
147194373|NCT04875975|530881026|FG000|Overall Study|Relapse With Insults|0|||
147194374|NCT04875975|530881027|FG001|Overall Study|Relapse With Insults|1|||
147194375|NCT04875975|530881026|FG000|Overall Study|Permanently left due to new seizure recurrence|0|||
147194376|NCT04875975|530881027|FG001|Overall Study|Permanently left due to new seizure recurrence|1|||
147194377|NCT02177695|530882282|FG000|ITT Analysis|Ineligible|5|||
147194378|NCT02177695|530882283|FG001|ITT Analysis|Ineligible|5|||
147194379|NCT02177695|530882282|FG000|Primary COXEN Analysis|inadequate tissue submitted|5|||
147194380|NCT02177695|530882283|FG001|Primary COXEN Analysis|inadequate tissue submitted|6|||
147194381|NCT02177695|530882282|FG000|Primary COXEN Analysis|insufficient amount of chemotherapy received|15|||
147194382|NCT02177695|530882283|FG001|Primary COXEN Analysis|insufficient amount of chemotherapy received|8|||
147194383|NCT02177695|530882282|FG000|Primary COXEN Analysis|Pathologic response not evaluated|13|||
147194384|NCT02177695|530882283|FG001|Primary COXEN Analysis|Pathologic response not evaluated|13|||
147194385|NCT00248625|530882286|FG000|Overall Study|Withdrawal by Subject|0|||
147194386|NCT00248625|530882287|FG001|Overall Study|Withdrawal by Subject|2|||
147194387|NCT05176314|530882294|FG000|Overall Study|Lost to Follow-up|2|||
147194388|NCT05176314|530882294|FG000|Overall Study|Physician Decision|1|||
147194389|NCT05176314|530882294|FG000|Overall Study|Adverse Event|1|||
147194390|NCT03103542|530882299|FG000|Overall Study|Physician Decision|2|||
147194391|NCT03103542|530882299|FG000|Overall Study|Adverse Event|2|||
147194392|NCT03103542|530882299|FG000|Overall Study|Other|2|||
147194393|NCT03103542|530882299|FG000|Overall Study|Withdrawal by Subject|1|||
147194394|NCT02939287|530882303|FG000|Overall Study|met exclusion criteria|1|||
147194395|NCT02939287|530882304|FG001|Overall Study|met exclusion criteria|1|||
147194396|NCT02939287|530882305|FG002|Overall Study|met exclusion criteria|1|||
147194397|NCT02939287|530882303|FG000|Overall Study|Did not complete survey|2|||
147194398|NCT02939287|530882304|FG001|Overall Study|Did not complete survey|2|||
147194399|NCT02939287|530882305|FG002|Overall Study|Did not complete survey|0|||
147194400|NCT02939287|530882303|FG000|Overall Study|Withdrawal by Subject|1|||
147194401|NCT02939287|530882304|FG001|Overall Study|Withdrawal by Subject|1|||
147194402|NCT02939287|530882305|FG002|Overall Study|Withdrawal by Subject|0|||
147194403|NCT00333775|530882308|FG000|Overall Study|Death|144|||
147194404|NCT00333775|530882309|FG001|Overall Study|Death|149|||
147194405|NCT00333775|530882310|FG002|Overall Study|Death|143|||
147194406|NCT00333775|530882308|FG000|Overall Study|In Follow-up When Study Stopped|87|||
147194407|NCT00333775|530882309|FG001|Overall Study|In Follow-up When Study Stopped|92|||
147194408|NCT00333775|530882310|FG002|Overall Study|In Follow-up When Study Stopped|96|||
147194409|NCT00333775|530882308|FG000|Overall Study|Lost to Follow-up|10|||
147194410|NCT00333775|530882309|FG001|Overall Study|Lost to Follow-up|7|||
147194411|NCT00333775|530882310|FG002|Overall Study|Lost to Follow-up|8|||
147194412|NCT02491684|530882314|FG000|Treatment Phase|Adverse Event|2|||
147194413|NCT02491684|530882315|FG001|Treatment Phase|Adverse Event|2|||
147194414|NCT02491684|530882314|FG000|Treatment Phase|Incorrect randomisation|1|||
147194415|NCT02491684|530882315|FG001|Treatment Phase|Incorrect randomisation|0|||
147194416|NCT02491684|530882314|FG000|Treatment Phase|Investigator and Sponsor decision|0|||
147194417|NCT02491684|530882315|FG001|Treatment Phase|Investigator and Sponsor decision|1|||
147194418|NCT04739982|530882317|FG000|Overall Study|Lost to Follow-up|176|||
147194419|NCT04739982|530882318|FG001|Overall Study|Lost to Follow-up|65|||
147194420|NCT04739982|530882317|FG000|Overall Study|Withdrawal by Subject|19|||
147194421|NCT04739982|530882318|FG001|Overall Study|Withdrawal by Subject|0|||
147194422|NCT04739982|530882317|FG000|Overall Study|Protocol Violation|0|||
147194423|NCT04739982|530882318|FG001|Overall Study|Protocol Violation|5|||
147433765|NCT04567615|531753384|FG000|Treatment Period|Other Reasons|1|||
147433766|NCT04567615|531753385|FG001|Treatment Period|Other Reasons|2|||
147433767|NCT04567615|531753386|FG002|Treatment Period|Other Reasons|0|||
147433768|NCT04567615|531753384|FG000|Treatment Period|Still On-going Treatment|21|||
147433769|NCT04567615|531753385|FG001|Treatment Period|Still On-going Treatment|22|||
147194424|NCT03651765|530882319|FG000|Overall Study|Adverse Event|6|||
147433770|NCT04567615|531753386|FG002|Treatment Period|Still On-going Treatment|2|||
147534205|NCT03110107|532111419|FG018|Treatment Period|Disease Progression|16|||
147534206|NCT03110107|532111420|FG019|Treatment Period|Disease Progression|14|||
147534207|NCT03110107|532111421|FG020|Treatment Period|Disease Progression|12|||
147534208|NCT03110107|532111422|FG021|Treatment Period|Disease Progression|16|||
147534209|NCT03110107|532111423|FG022|Treatment Period|Disease Progression|18|||
147534210|NCT03110107|532111424|FG023|Treatment Period|Disease Progression|13|||
147534211|NCT03110107|532111425|FG024|Treatment Period|Disease Progression|16|||
147534212|NCT03110107|532111426|FG025|Treatment Period|Disease Progression|31|||
147534213|NCT03110107|532111401|FG000|Treatment Period|Study drug toxicity|1|||
147534214|NCT03110107|532111402|FG001|Treatment Period|Study drug toxicity|0|||
147534215|NCT03110107|532111403|FG002|Treatment Period|Study drug toxicity|1|||
147534216|NCT03110107|532111404|FG003|Treatment Period|Study drug toxicity|2|||
147534217|NCT03110107|532111405|FG004|Treatment Period|Study drug toxicity|0|||
147534218|NCT03110107|532111406|FG005|Treatment Period|Study drug toxicity|3|||
147534219|NCT03110107|532111407|FG006|Treatment Period|Study drug toxicity|1|||
147534220|NCT03110107|532111408|FG007|Treatment Period|Study drug toxicity|1|||
147534221|NCT03110107|532111409|FG008|Treatment Period|Study drug toxicity|3|||
147534222|NCT03110107|532111410|FG009|Treatment Period|Study drug toxicity|2|||
147534223|NCT03110107|532111411|FG010|Treatment Period|Study drug toxicity|0|||
147534224|NCT03110107|532111412|FG011|Treatment Period|Study drug toxicity|2|||
147534225|NCT03110107|532111413|FG012|Treatment Period|Study drug toxicity|0|||
147534226|NCT03110107|532111414|FG013|Treatment Period|Study drug toxicity|0|||
147534227|NCT03110107|532111415|FG014|Treatment Period|Study drug toxicity|2|||
147534228|NCT03110107|532111416|FG015|Treatment Period|Study drug toxicity|3|||
147534229|NCT03110107|532111417|FG016|Treatment Period|Study drug toxicity|3|||
147534230|NCT03110107|532111418|FG017|Treatment Period|Study drug toxicity|3|||
147534231|NCT03110107|532111419|FG018|Treatment Period|Study drug toxicity|1|||
147534232|NCT03110107|532111420|FG019|Treatment Period|Study drug toxicity|2|||
147534233|NCT03110107|532111421|FG020|Treatment Period|Study drug toxicity|2|||
147534234|NCT03110107|532111422|FG021|Treatment Period|Study drug toxicity|0|||
147534235|NCT03110107|532111423|FG022|Treatment Period|Study drug toxicity|2|||
147534236|NCT03110107|532111424|FG023|Treatment Period|Study drug toxicity|6|||
147534237|NCT03110107|532111425|FG024|Treatment Period|Study drug toxicity|7|||
147534238|NCT03110107|532111426|FG025|Treatment Period|Study drug toxicity|6|||
147534239|NCT03110107|532111401|FG000|Treatment Period|Death|0|||
147534240|NCT03110107|532111402|FG001|Treatment Period|Death|0|||
147534241|NCT03110107|532111403|FG002|Treatment Period|Death|0|||
147534242|NCT03110107|532111404|FG003|Treatment Period|Death|0|||
147534243|NCT03110107|532111405|FG004|Treatment Period|Death|0|||
147534244|NCT03110107|532111406|FG005|Treatment Period|Death|0|||
147534245|NCT03110107|532111407|FG006|Treatment Period|Death|0|||
147534246|NCT03110107|532111408|FG007|Treatment Period|Death|0|||
147534247|NCT03110107|532111409|FG008|Treatment Period|Death|0|||
147534248|NCT03110107|532111410|FG009|Treatment Period|Death|0|||
147534249|NCT03110107|532111411|FG010|Treatment Period|Death|0|||
147534250|NCT03110107|532111412|FG011|Treatment Period|Death|0|||
147534251|NCT03110107|532111413|FG012|Treatment Period|Death|1|||
147534252|NCT03110107|532111414|FG013|Treatment Period|Death|0|||
147534253|NCT03110107|532111415|FG014|Treatment Period|Death|0|||
147534254|NCT03110107|532111416|FG015|Treatment Period|Death|0|||
147534255|NCT03110107|532111417|FG016|Treatment Period|Death|0|||
147534256|NCT03110107|532111418|FG017|Treatment Period|Death|0|||
147534257|NCT03110107|532111419|FG018|Treatment Period|Death|0|||
147649402|NCT04575584|532537337|FG002|Overall Study|Withdrawal by Subject|5|||
147534258|NCT03110107|532111420|FG019|Treatment Period|Death|0|||
147534259|NCT03110107|532111421|FG020|Treatment Period|Death|0|||
147534260|NCT03110107|532111422|FG021|Treatment Period|Death|0|||
147534261|NCT03110107|532111423|FG022|Treatment Period|Death|0|||
147534262|NCT03110107|532111424|FG023|Treatment Period|Death|0|||
147534263|NCT03110107|532111425|FG024|Treatment Period|Death|0|||
147534264|NCT03110107|532111426|FG025|Treatment Period|Death|0|||
147534265|NCT03110107|532111401|FG000|Treatment Period|Adverse Event|0|||
147534266|NCT03110107|532111402|FG001|Treatment Period|Adverse Event|0|||
147534267|NCT03110107|532111403|FG002|Treatment Period|Adverse Event|1|||
147534268|NCT03110107|532111404|FG003|Treatment Period|Adverse Event|0|||
147534269|NCT03110107|532111405|FG004|Treatment Period|Adverse Event|0|||
147534270|NCT03110107|532111406|FG005|Treatment Period|Adverse Event|2|||
147534271|NCT03110107|532111407|FG006|Treatment Period|Adverse Event|0|||
147194425|NCT03651765|530882319|FG000|Overall Study|Lack of Efficacy|18|||
147194426|NCT03651765|530882319|FG000|Overall Study|Lost to Follow-up|5|||
147194427|NCT03651765|530882319|FG000|Overall Study|Non-Compliance with Study Drug|4|||
147194428|NCT03651765|530882319|FG000|Overall Study|Physician Decision|6|||
147194429|NCT03651765|530882319|FG000|Overall Study|Pregnancy|1|||
147194430|NCT03651765|530882319|FG000|Overall Study|Discontinued by Sponsor|40|||
147194431|NCT03651765|530882319|FG000|Overall Study|Withdrawal by Parent/Guardian|6|||
147194432|NCT03651765|530882319|FG000|Overall Study|Withdrawal by Subject|24|||
147194433|NCT03651765|530882319|FG000|Overall Study|Miscellaneous|6|||
147194434|NCT03521570|530882325|FG000|Overall Study|Not eligible|11|||
147194435|NCT03279081|530882326|FG000|Overall Study|Withdrawal by Subject|12|||
147194436|NCT03279081|530882327|FG001|Overall Study|Withdrawal by Subject|20|||
147194437|NCT03279081|530882326|FG000|Overall Study|Physician Decision|4|||
147194438|NCT03279081|530882327|FG001|Overall Study|Physician Decision|1|||
147194439|NCT03279081|530882326|FG000|Overall Study|Lost to Follow-up|8|||
147194440|NCT03279081|530882327|FG001|Overall Study|Lost to Follow-up|8|||
147194441|NCT03279081|530882326|FG000|Overall Study|Death|0|||
147194442|NCT03279081|530882327|FG001|Overall Study|Death|1|||
147194443|NCT03279081|530882326|FG000|Overall Study|Adverse Event|1|||
147194444|NCT03279081|530882327|FG001|Overall Study|Adverse Event|0|||
147194445|NCT03279081|530882326|FG000|Overall Study|Reason not Specified|14|||
147194446|NCT03279081|530882327|FG001|Overall Study|Reason not Specified|4|||
147194447|NCT00322881|530882328|FG000|Overall Study|Death|2|||
147194448|NCT00322881|530882328|FG000|Overall Study|Adverse Event|1|||
147433771|NCT05028517|531753387|FG000|Overall Study|Lost to Follow-up|13|||
147433772|NCT05028517|531753388|FG001|Overall Study|Lost to Follow-up|20|||
147433773|NCT05028517|531753389|FG002|Overall Study|Lost to Follow-up|12|||
147433774|NCT05028517|531753387|FG000|Overall Study|Withdrawal by Subject|0|||
147433775|NCT05028517|531753388|FG001|Overall Study|Withdrawal by Subject|0|||
147433776|NCT05028517|531753389|FG002|Overall Study|Withdrawal by Subject|1|||
147433777|NCT05104476|531754216|FG000|Overall Study|Randomized But Not Treated|1|||
147433778|NCT05104476|531754217|FG001|Overall Study|Randomized But Not Treated|2|||
147433779|NCT05104476|531754216|FG000|Overall Study|Adverse Event|2|||
147433780|NCT05104476|531754217|FG001|Overall Study|Adverse Event|2|||
147433781|NCT05104476|531754216|FG000|Overall Study|Withdrawal by Subject|3|||
147433782|NCT05104476|531754217|FG001|Overall Study|Withdrawal by Subject|3|||
147433783|NCT05104476|531754216|FG000|Overall Study|Other Than Specified|0|||
147433784|NCT05104476|531754217|FG001|Overall Study|Other Than Specified|3|||
147433785|NCT04964960|531754218|FG000|Overall Study|Withdrawal by Subject|1|||
147433786|NCT04964960|531754218|FG000|Overall Study|Did not complete cycles|1|||
147433787|NCT01423812|531754219|FG000|Overall Study|Lost to Follow-up|2|||
147433788|NCT01423812|531754220|FG001|Overall Study|Lost to Follow-up|2|||
147433789|NCT01423812|531754219|FG000|Overall Study|Withdrawal by Subject|1|||
147433790|NCT01423812|531754220|FG001|Overall Study|Withdrawal by Subject|2|||
147433791|NCT03155373|531754221|FG000|Overall Study|No longer required surgery|1|||
147433792|NCT03155373|531754221|FG000|Overall Study|Protocol Violation|1|||
147433793|NCT03155373|531754221|FG000|Overall Study|Death|2|||
147433794|NCT03155373|531754221|FG000|Overall Study|Withdrawal by Subject|3|||
147433795|NCT02616614|531754222|FG000|Overall Study|Withdrawal by Subject|10|||
147433796|NCT02616614|531754223|FG001|Overall Study|Withdrawal by Subject|5|||
147433797|NCT02616614|531754224|FG002|Overall Study|Withdrawal by Subject|6|||
147433798|NCT02616614|531754222|FG000|Overall Study|Physician Decision|2|||
147433799|NCT02616614|531754223|FG001|Overall Study|Physician Decision|1|||
147433800|NCT02616614|531754224|FG002|Overall Study|Physician Decision|0|||
147433801|NCT02616614|531754222|FG000|Overall Study|Adverse Event|1|||
147433802|NCT02616614|531754223|FG001|Overall Study|Adverse Event|4|||
147433803|NCT02616614|531754224|FG002|Overall Study|Adverse Event|1|||
147433804|NCT02616614|531754222|FG000|Overall Study|Protocol Violation|0|||
147433805|NCT02616614|531754223|FG001|Overall Study|Protocol Violation|3|||
147194449|NCT00322881|530882328|FG000|Overall Study|Disease Progression|2|||
147194450|NCT00771914|530882332|FG000|Overall Study|Physician Decision|0|||
147194451|NCT00771914|530882333|FG001|Overall Study|Physician Decision|0|||
147194452|NCT00771914|530882334|FG002|Overall Study|Physician Decision|0|||
147194453|NCT00771914|530882335|FG003|Overall Study|Physician Decision|1|||
147194454|NCT00771914|530882332|FG000|Overall Study|Lost to Follow-up|0|||
147194455|NCT00771914|530882333|FG001|Overall Study|Lost to Follow-up|0|||
147433806|NCT02616614|531754224|FG002|Overall Study|Protocol Violation|1|||
147433807|NCT02616614|531754222|FG000|Overall Study|Prohibited Medication|12|||
147433808|NCT02616614|531754223|FG001|Overall Study|Prohibited Medication|9|||
147433809|NCT02616614|531754224|FG002|Overall Study|Prohibited Medication|5|||
147433810|NCT02616614|531754222|FG000|Overall Study|More than 3 applications missed|6|||
147433811|NCT02616614|531754223|FG001|Overall Study|More than 3 applications missed|8|||
147433812|NCT02616614|531754224|FG002|Overall Study|More than 3 applications missed|1|||
147433813|NCT02616614|531754222|FG000|Overall Study|Lost to Follow-up|31|||
147194456|NCT00771914|530882334|FG002|Overall Study|Lost to Follow-up|0|||
147194457|NCT00771914|530882335|FG003|Overall Study|Lost to Follow-up|1|||
147534272|NCT03110107|532111408|FG007|Treatment Period|Adverse Event|2|||
147194458|NCT00468169|530882337|FG000|Overall Study|Withdrawal by Subject|1|||
147534273|NCT03110107|532111409|FG008|Treatment Period|Adverse Event|0|||
147194459|NCT00468169|530882338|FG001|Overall Study|Withdrawal by Subject|0|||
147194460|NCT01521117|530882343|FG000|First Intervention (6 Weeks)|Adverse Event|5|||
147194461|NCT01521117|530882344|FG001|First Intervention (6 Weeks)|Adverse Event|1|||
147194462|NCT01521117|530882343|FG000|First Intervention (6 Weeks)|Scheduling Issues|0|||
147194463|NCT01521117|530882344|FG001|First Intervention (6 Weeks)|Scheduling Issues|2|||
147194464|NCT01521117|530882343|FG000|Second Intervention (6 Weeks)|Adverse Event|0|||
147194465|NCT01521117|530882344|FG001|Second Intervention (6 Weeks)|Adverse Event|3|||
147194466|NCT01056822|530882345|FG000|Overall Study|Adverse Event|0|||
147194467|NCT01056822|530882346|FG001|Overall Study|Adverse Event|1|||
147194468|NCT01056822|530882345|FG000|Overall Study|Protocol Violation|6|||
147194469|NCT01056822|530882346|FG001|Overall Study|Protocol Violation|5|||
147194470|NCT01056822|530882345|FG000|Overall Study|Withdrawal by Subject|1|||
147194471|NCT01056822|530882346|FG001|Overall Study|Withdrawal by Subject|1|||
147194472|NCT01056822|530882345|FG000|Overall Study|Lost to Follow-up|1|||
147194473|NCT01056822|530882346|FG001|Overall Study|Lost to Follow-up|0|||
147194474|NCT00784563|530882347|FG000|Years 1 & 2|Withdrawal by Subject|3|||
147194475|NCT00784563|530882348|FG001|Years 1 & 2|Withdrawal by Subject|2|||
147194476|NCT00784563|530882349|FG002|Years 1 & 2|Withdrawal by Subject|0|||
147194477|NCT00784563|530882347|FG000|Years 1 & 2|Adverse Event|0|||
147194478|NCT00784563|530882348|FG001|Years 1 & 2|Adverse Event|3|||
147194479|NCT00784563|530882349|FG002|Years 1 & 2|Adverse Event|0|||
147194480|NCT00784563|530882347|FG000|Year 3|Withdrawal by Subject|0|||
147194481|NCT00784563|530882348|FG001|Year 3|Withdrawal by Subject|0|||
147194482|NCT00784563|530882349|FG002|Year 3|Withdrawal by Subject|2|||
147194483|NCT00784563|530882347|FG000|Year 3|Adverse Event|0|||
147194484|NCT00784563|530882348|FG001|Year 3|Adverse Event|0|||
147194485|NCT00784563|530882349|FG002|Year 3|Adverse Event|1|||
147194486|NCT02946580|530882350|FG000|Overall Study|Withdrawal by Subject|1|||
147194487|NCT02946580|530882351|FG001|Overall Study|Withdrawal by Subject|2|||
147194488|NCT02946580|530882350|FG000|Overall Study|Adverse Event|0|||
147194489|NCT02946580|530882351|FG001|Overall Study|Adverse Event|2|||
147194490|NCT02946580|530882350|FG000|Overall Study|Did not undergo posterior spinal fusion|0|||
147194491|NCT02946580|530882351|FG001|Overall Study|Did not undergo posterior spinal fusion|1|||
147194492|NCT01668784|530882352|FG000|Randomized (Pre-treatment)|Disease Progression|0|||
147194493|NCT01668784|530882353|FG001|Randomized (Pre-treatment)|Disease Progression|1|||
147194494|NCT01668784|530882352|FG000|Randomized (Pre-treatment)|Request to Discontinue Study Treatment|0|||
147194495|NCT01668784|530882353|FG001|Randomized (Pre-treatment)|Request to Discontinue Study Treatment|3|||
147194496|NCT01668784|530882352|FG000|Randomized (Pre-treatment)|Withdrawal by Subject|1|||
147194497|NCT01668784|530882353|FG001|Randomized (Pre-treatment)|Withdrawal by Subject|8|||
147194498|NCT01668784|530882352|FG000|Randomized (Pre-treatment)|Poor/Non-Compliance|1|||
147194499|NCT01668784|530882353|FG001|Randomized (Pre-treatment)|Poor/Non-Compliance|0|||
147194500|NCT01668784|530882352|FG000|Randomized (Pre-treatment)|No Longer Meets Study Criteria|2|||
147194501|NCT01668784|530882353|FG001|Randomized (Pre-treatment)|No Longer Meets Study Criteria|1|||
147194502|NCT01668784|530882352|FG000|Randomized (Pre-treatment)|participant requested to be treated a local facility|0|||
147194503|NCT01668784|530882353|FG001|Randomized (Pre-treatment)|participant requested to be treated a local facility|1|||
147194504|NCT01668784|530882352|FG000|Treatment Period|Disease Progression|316|||
147194505|NCT01668784|530882353|FG001|Treatment Period|Disease Progression|293|||
147194506|NCT01668784|530882352|FG000|Treatment Period|Study Drug Toxicity|46|||
147194507|NCT01668784|530882353|FG001|Treatment Period|Study Drug Toxicity|53|||
147194508|NCT01668784|530882352|FG000|Treatment Period|Death|1|||
147194509|NCT01668784|530882353|FG001|Treatment Period|Death|1|||
147194510|NCT01668784|530882352|FG000|Treatment Period|Adverse Event Unrelated to Study Drug|14|||
147194511|NCT01668784|530882353|FG001|Treatment Period|Adverse Event Unrelated to Study Drug|14|||
147194512|NCT01668784|530882352|FG000|Treatment Period|Request to Discontinue Study Treatment|14|||
147194513|NCT01668784|530882353|FG001|Treatment Period|Request to Discontinue Study Treatment|21|||
147194514|NCT01668784|530882352|FG000|Treatment Period|Withdrawal by Subject|5|||
147194515|NCT01668784|530882353|FG001|Treatment Period|Withdrawal by Subject|3|||
147194516|NCT01668784|530882352|FG000|Treatment Period|Maximal Clinical Benefit|3|||
147194517|NCT01668784|530882353|FG001|Treatment Period|Maximal Clinical Benefit|3|||
147194518|NCT01668784|530882352|FG000|Treatment Period|Other|2|||
147194519|NCT01668784|530882353|FG001|Treatment Period|Other|8|||
147194520|NCT01668784|530882352|FG000|Treatment Period|Administrative Reason by Sponsor|5|||
147194521|NCT01668784|530882353|FG001|Treatment Period|Administrative Reason by Sponsor|1|||
147194522|NCT05135871|530882356|FG000|Overall Study|1 subject withdrew from the study before administration of the IMP due to pre-dose abnormal ECG|1|||
147194523|NCT05135871|530882357|FG001|Overall Study|1 subject withdrew from the study before administration of the IMP due to pre-dose abnormal ECG|0|||
147194524|NCT05135871|530882358|FG002|Overall Study|1 subject withdrew from the study before administration of the IMP due to pre-dose abnormal ECG|0|||
147194525|NCT05135871|530882359|FG003|Overall Study|1 subject withdrew from the study before administration of the IMP due to pre-dose abnormal ECG|0|||
147194526|NCT00374140|530882364|FG000|Overall Study|Lost to Follow-up|1|||
147194527|NCT00374140|530882364|FG000|Overall Study|Protocol Violation|1|||
147194528|NCT00617734|530882365|FG000|Overall Study|Withdrew Consent|2|||
147194529|NCT00617734|530882366|FG001|Overall Study|Withdrew Consent|0|||
147194530|NCT00617734|530882365|FG000|Overall Study|Adverse Event|4|||
147194531|NCT00617734|530882366|FG001|Overall Study|Adverse Event|1|||
147194532|NCT00617734|530882365|FG000|Overall Study|Protocol Violation|1|||
147194533|NCT00617734|530882366|FG001|Overall Study|Protocol Violation|0|||
147194534|NCT00617734|530882365|FG000|Overall Study|Found Ineligible After Randomization|1|||
147194535|NCT00617734|530882366|FG001|Overall Study|Found Ineligible After Randomization|4|||
147194536|NCT00617734|530882365|FG000|Overall Study|Lost to Follow-up|0|||
147194537|NCT00617734|530882366|FG001|Overall Study|Lost to Follow-up|1|||
147194538|NCT02485691|530882367|FG000|Overall Study|Adverse Event|25|||
147194539|NCT02485691|530882368|FG001|Overall Study|Adverse Event|11|||
147194540|NCT02485691|530882367|FG000|Overall Study|Poor compliance to protocol|0|||
147194541|NCT02485691|530882368|FG001|Overall Study|Poor compliance to protocol|1|||
147194542|NCT02485691|530882367|FG000|Overall Study|Disease progression|57|||
147194543|NCT02485691|530882368|FG001|Overall Study|Disease progression|92|||
147194544|NCT02485691|530882367|FG000|Overall Study|Investigator's decision|23|||
147194545|NCT02485691|530882368|FG001|Overall Study|Investigator's decision|5|||
147194546|NCT02485691|530882367|FG000|Overall Study|Participant's request|13|||
147194547|NCT02485691|530882368|FG001|Overall Study|Participant's request|6|||
147194548|NCT02485691|530882367|FG000|Overall Study|Other reason|8|||
147194549|NCT02485691|530882368|FG001|Overall Study|Other reason|9|||
147194550|NCT02485691|530882367|FG000|Overall Study|Randomized and not treated|3|||
147194551|NCT02485691|530882368|FG001|Overall Study|Randomized and not treated|2|||
147194552|NCT00604565|530882369|FG000|Overall Study|Study terminated|0|||
147194553|NCT00604565|530882370|FG001|Overall Study|Study terminated|3|||
147194554|NCT04292535|530882372|FG000|Overall Study|Withdrawal by Subject|0|||
147194555|NCT04292535|530882373|FG001|Overall Study|Withdrawal by Subject|0|||
147194556|NCT04292535|530882374|FG002|Overall Study|Withdrawal by Subject|0|||
147194557|NCT04292535|530882375|FG003|Overall Study|Withdrawal by Subject|0|||
147194558|NCT04292535|530882376|FG004|Overall Study|Withdrawal by Subject|0|||
147194559|NCT04292535|530882377|FG005|Overall Study|Withdrawal by Subject|0|||
147194560|NCT04292535|530882378|FG006|Overall Study|Withdrawal by Subject|0|||
147194561|NCT04292535|530882379|FG007|Overall Study|Withdrawal by Subject|1|||
147194562|NCT04292535|530882380|FG008|Overall Study|Withdrawal by Subject|0|||
147194563|NCT04292535|530882381|FG009|Overall Study|Withdrawal by Subject|0|||
147194564|NCT04292535|530882382|FG010|Overall Study|Withdrawal by Subject|0|||
147194565|NCT04292535|530882383|FG011|Overall Study|Withdrawal by Subject|0|||
147194566|NCT04292535|530882384|FG012|Overall Study|Withdrawal by Subject|0|||
147194567|NCT04292535|530882385|FG013|Overall Study|Withdrawal by Subject|0|||
147194568|NCT04292535|530882372|FG000|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
147194569|NCT04292535|530882373|FG001|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
147194570|NCT04292535|530882374|FG002|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
147194571|NCT04292535|530882375|FG003|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
147194572|NCT04292535|530882376|FG004|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
147194573|NCT04292535|530882377|FG005|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
147194574|NCT04292535|530882378|FG006|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
147194575|NCT04292535|530882379|FG007|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|1|||
147194576|NCT04292535|530882380|FG008|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
147194577|NCT04292535|530882381|FG009|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
147194578|NCT04292535|530882382|FG010|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
147194579|NCT04292535|530882383|FG011|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|0|||
147194580|NCT04292535|530882384|FG012|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|1|||
147194581|NCT04292535|530882385|FG013|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL|1|||
147194582|NCT04292535|530882372|FG000|Overall Study|Report of Dizziness|0|||
147194583|NCT04292535|530882373|FG001|Overall Study|Report of Dizziness|0|||
147649403|NCT04575584|532537338|FG003|Overall Study|Withdrawal by Subject|3|||
147194584|NCT04292535|530882374|FG002|Overall Study|Report of Dizziness|0|||
147194585|NCT04292535|530882375|FG003|Overall Study|Report of Dizziness|0|||
147194586|NCT04292535|530882376|FG004|Overall Study|Report of Dizziness|0|||
147194587|NCT04292535|530882377|FG005|Overall Study|Report of Dizziness|0|||
147194588|NCT04292535|530882378|FG006|Overall Study|Report of Dizziness|0|||
147194589|NCT04292535|530882379|FG007|Overall Study|Report of Dizziness|0|||
147194590|NCT04292535|530882380|FG008|Overall Study|Report of Dizziness|0|||
147194591|NCT04292535|530882381|FG009|Overall Study|Report of Dizziness|0|||
147194592|NCT04292535|530882382|FG010|Overall Study|Report of Dizziness|0|||
147194593|NCT04292535|530882383|FG011|Overall Study|Report of Dizziness|0|||
147194594|NCT04292535|530882384|FG012|Overall Study|Report of Dizziness|0|||
147194595|NCT04292535|530882385|FG013|Overall Study|Report of Dizziness|1|||
147194596|NCT04292535|530882372|FG000|Overall Study|Equipment Failure|0|||
147194597|NCT04292535|530882373|FG001|Overall Study|Equipment Failure|0|||
147194598|NCT04292535|530882374|FG002|Overall Study|Equipment Failure|0|||
147194599|NCT04292535|530882375|FG003|Overall Study|Equipment Failure|0|||
147433814|NCT02616614|531754223|FG001|Overall Study|Lost to Follow-up|28|||
147433815|NCT02616614|531754224|FG002|Overall Study|Lost to Follow-up|13|||
147433816|NCT02616614|531754222|FG000|Overall Study|Pregnancy|2|||
147433817|NCT02616614|531754223|FG001|Overall Study|Pregnancy|0|||
147433818|NCT02616614|531754224|FG002|Overall Study|Pregnancy|1|||
147433819|NCT02616614|531754222|FG000|Overall Study|Other|1|||
147433820|NCT02616614|531754223|FG001|Overall Study|Other|2|||
147433821|NCT02616614|531754224|FG002|Overall Study|Other|1|||
147433822|NCT04598477|531754231|FG000|Overall Study|Adverse Event|2|||
147433823|NCT04598477|531754232|FG001|Overall Study|Adverse Event|0|||
147433824|NCT04598477|531754231|FG000|Overall Study|Death|0|||
147433825|NCT04598477|531754232|FG001|Overall Study|Death|1|||
147433826|NCT04598477|531754231|FG000|Overall Study|Lost to Follow-up|1|||
147433827|NCT04598477|531754232|FG001|Overall Study|Lost to Follow-up|0|||
147433828|NCT04598477|531754231|FG000|Overall Study|Physician Decision|7|||
147433829|NCT04598477|531754232|FG001|Overall Study|Physician Decision|2|||
147433830|NCT04598477|531754231|FG000|Overall Study|Pregnancy|0|||
147433831|NCT04598477|531754232|FG001|Overall Study|Pregnancy|1|||
147433832|NCT04598477|531754231|FG000|Overall Study|Requires Prohibited Medication|0|||
147433833|NCT04598477|531754232|FG001|Overall Study|Requires Prohibited Medication|1|||
147433834|NCT04598477|531754231|FG000|Overall Study|Study Terminated by Sponsor|18|||
147433835|NCT04598477|531754232|FG001|Overall Study|Study Terminated by Sponsor|12|||
147433836|NCT04598477|531754231|FG000|Overall Study|Withdrawal by Subject|16|||
147433837|NCT04598477|531754232|FG001|Overall Study|Withdrawal by Subject|12|||
147433838|NCT04598477|531754231|FG000|Overall Study|Other|15|||
147433839|NCT04598477|531754232|FG001|Overall Study|Other|8|||
147433840|NCT05579990|531754238|FG000|Overall Study|Lost to Follow-up|3|||
147433841|NCT05118204|531754239|FG000|Overall Study|Lost to Follow-up|3|||
147433842|NCT05118204|531754240|FG001|Overall Study|Lost to Follow-up|2|||
147433843|NCT05118204|531754239|FG000|Overall Study|Withdrawal by Subject|0|||
147433844|NCT05118204|531754240|FG001|Overall Study|Withdrawal by Subject|2|||
147433845|NCT01313650|531754242|FG000|Overall Study|Adverse Event|9|||
147433846|NCT01313650|531754243|FG001|Overall Study|Adverse Event|34|||
147433847|NCT01313650|531754244|FG002|Overall Study|Adverse Event|24|||
147194600|NCT04292535|530882376|FG004|Overall Study|Equipment Failure|0|||
147194601|NCT04292535|530882377|FG005|Overall Study|Equipment Failure|0|||
147194602|NCT04292535|530882378|FG006|Overall Study|Equipment Failure|0|||
147194603|NCT04292535|530882379|FG007|Overall Study|Equipment Failure|0|||
147194604|NCT04292535|530882380|FG008|Overall Study|Equipment Failure|0|||
147194605|NCT04292535|530882381|FG009|Overall Study|Equipment Failure|0|||
147194606|NCT04292535|530882382|FG010|Overall Study|Equipment Failure|0|||
147194607|NCT04292535|530882383|FG011|Overall Study|Equipment Failure|1|||
147194608|NCT04292535|530882384|FG012|Overall Study|Equipment Failure|0|||
147194609|NCT04292535|530882385|FG013|Overall Study|Equipment Failure|0|||
147194610|NCT01420861|530882390|FG000|Overall Study|Adverse Event|2|||
147194611|NCT01420861|530882390|FG000|Overall Study|Study terminated by Sponsor|7|||
147194612|NCT01420861|530882390|FG000|Overall Study|Screen failure|7|||
147194613|NCT01420861|530882390|FG000|Overall Study|Randomized not Treated|2|||
147194614|NCT05472090|530882401|FG000|Overall Study|Adverse Event|2|||
147194615|NCT05472090|530882402|FG001|Overall Study|Adverse Event|3|||
147433848|NCT01313650|531754245|FG003|Overall Study|Adverse Event|23|||
147433849|NCT01313650|531754242|FG000|Overall Study|Lack of Efficacy|37|||
147433850|NCT01313650|531754243|FG001|Overall Study|Lack of Efficacy|20|||
147433851|NCT01313650|531754244|FG002|Overall Study|Lack of Efficacy|32|||
147433852|NCT01313650|531754245|FG003|Overall Study|Lack of Efficacy|20|||
147194616|NCT05472090|530882401|FG000|Overall Study|Lack of Efficacy|1|||
147194617|NCT05472090|530882402|FG001|Overall Study|Lack of Efficacy|0|||
147194618|NCT05472090|530882401|FG000|Overall Study|Physician Decision|1|||
147194619|NCT05472090|530882402|FG001|Overall Study|Physician Decision|0|||
147433853|NCT01313650|531754242|FG000|Overall Study|Lost to Follow-up|1|||
147194620|NCT05472090|530882401|FG000|Overall Study|Withdrawal by Subject|2|||
147433854|NCT01313650|531754243|FG001|Overall Study|Lost to Follow-up|0|||
147433855|NCT01313650|531754244|FG002|Overall Study|Lost to Follow-up|3|||
147433856|NCT01313650|531754245|FG003|Overall Study|Lost to Follow-up|2|||
147433857|NCT01313650|531754242|FG000|Overall Study|Withdrawal by Subject|16|||
147534274|NCT03110107|532111410|FG009|Treatment Period|Adverse Event|1|||
147534275|NCT03110107|532111411|FG010|Treatment Period|Adverse Event|0|||
147534276|NCT03110107|532111412|FG011|Treatment Period|Adverse Event|0|||
147534277|NCT03110107|532111413|FG012|Treatment Period|Adverse Event|0|||
147534278|NCT03110107|532111414|FG013|Treatment Period|Adverse Event|0|||
147534279|NCT03110107|532111415|FG014|Treatment Period|Adverse Event|0|||
147534280|NCT03110107|532111416|FG015|Treatment Period|Adverse Event|2|||
147534281|NCT03110107|532111417|FG016|Treatment Period|Adverse Event|0|||
147534282|NCT03110107|532111418|FG017|Treatment Period|Adverse Event|1|||
147534283|NCT03110107|532111419|FG018|Treatment Period|Adverse Event|2|||
147534284|NCT03110107|532111420|FG019|Treatment Period|Adverse Event|1|||
147534285|NCT03110107|532111421|FG020|Treatment Period|Adverse Event|4|||
147534286|NCT03110107|532111422|FG021|Treatment Period|Adverse Event|2|||
147534287|NCT03110107|532111423|FG022|Treatment Period|Adverse Event|2|||
147534288|NCT03110107|532111424|FG023|Treatment Period|Adverse Event|2|||
147534289|NCT03110107|532111425|FG024|Treatment Period|Adverse Event|2|||
147534290|NCT03110107|532111426|FG025|Treatment Period|Adverse Event|4|||
147534291|NCT03110107|532111401|FG000|Treatment Period|Participant request to discontinue study treatment|0|||
147433858|NCT01313650|531754243|FG001|Overall Study|Withdrawal by Subject|20|||
147433859|NCT01313650|531754244|FG002|Overall Study|Withdrawal by Subject|15|||
147433860|NCT01313650|531754245|FG003|Overall Study|Withdrawal by Subject|15|||
147433861|NCT01313650|531754242|FG000|Overall Study|Protocol Violation|4|||
147433862|NCT01313650|531754243|FG001|Overall Study|Protocol Violation|7|||
147433863|NCT01313650|531754244|FG002|Overall Study|Protocol Violation|5|||
147433864|NCT01313650|531754245|FG003|Overall Study|Protocol Violation|6|||
147433865|NCT01313650|531754242|FG000|Overall Study|Met Protocol-defined Stopping Criteria|9|||
147433866|NCT01313650|531754243|FG001|Overall Study|Met Protocol-defined Stopping Criteria|13|||
147433867|NCT01313650|531754244|FG002|Overall Study|Met Protocol-defined Stopping Criteria|24|||
147433868|NCT01313650|531754245|FG003|Overall Study|Met Protocol-defined Stopping Criteria|15|||
147433869|NCT05393037|531754248|FG000|Part A|Death|1|||
147433870|NCT05393037|531754249|FG001|Part A|Death|0|||
147433871|NCT05393037|531754248|FG000|Part A|Lost to Follow-up|1|||
147433872|NCT05393037|531754249|FG001|Part A|Lost to Follow-up|1|||
147433873|NCT05393037|531754248|FG000|Part A|Withdrawal by Subject|2|||
147433874|NCT05393037|531754249|FG001|Part A|Withdrawal by Subject|4|||
147433875|NCT05393037|531754248|FG000|Part B|Lost to Follow-up|1|||
147433876|NCT05393037|531754249|FG001|Part B|Lost to Follow-up|0|||
147433877|NCT01012739|531754250|FG000|Treatment Period 1|Adverse Event|0|||
147433878|NCT01012739|531754251|FG001|Treatment Period 1|Adverse Event|0|||
147433879|NCT01012739|531754252|FG002|Treatment Period 1|Adverse Event|0|||
147433880|NCT01012739|531754253|FG003|Treatment Period 1|Adverse Event|1|||
147433881|NCT01012739|531754250|FG000|Treatment Period 2|Abnormal test procedure results|0|||
147595937|NCT03096847|532338751|FG000|Overall Study|Withdrawal by Subject|24|||
147433882|NCT01012739|531754251|FG001|Treatment Period 2|Abnormal test procedure results|0|||
147433883|NCT01012739|531754252|FG002|Treatment Period 2|Abnormal test procedure results|0|||
147433884|NCT01012739|531754253|FG003|Treatment Period 2|Abnormal test procedure results|1|||
147433885|NCT04029480|531754254|FG000|Overall Study|Physician Decision|0|||
147433886|NCT04029480|531754255|FG001|Overall Study|Physician Decision|0|||
147433887|NCT04029480|531754256|FG002|Overall Study|Physician Decision|2|||
147433888|NCT04029480|531754257|FG003|Overall Study|Physician Decision|1|||
147433889|NCT04029480|531754254|FG000|Overall Study|Withdrawal by Subject|2|||
147433890|NCT04029480|531754255|FG001|Overall Study|Withdrawal by Subject|0|||
147433891|NCT04029480|531754256|FG002|Overall Study|Withdrawal by Subject|1|||
147433892|NCT04029480|531754257|FG003|Overall Study|Withdrawal by Subject|1|||
147433893|NCT04786119|531754258|FG000|Overall Study|Withdrawal by Subject|4|||
147433894|NCT04786119|531754259|FG001|Overall Study|Withdrawal by Subject|5|||
147433895|NCT04786119|531754258|FG000|Overall Study|Lost to Follow-up|5|||
147433896|NCT04786119|531754259|FG001|Overall Study|Lost to Follow-up|5|||
147433897|NCT04786119|531754258|FG000|Overall Study|Subject withdrawn due to exclusion criteria (bilateral knee)|1|||
147433898|NCT04786119|531754259|FG001|Overall Study|Subject withdrawn due to exclusion criteria (bilateral knee)|0|||
147433899|NCT02593786|531754264|FG000|Overall Study|Disease progression|12|||
147433900|NCT02593786|531754265|FG001|Overall Study|Disease progression|16|||
147433901|NCT02593786|531754266|FG002|Overall Study|Disease progression|10|||
147433902|NCT02593786|531754267|FG003|Overall Study|Disease progression|7|||
147433903|NCT02593786|531754264|FG000|Overall Study|Study drug toxicity|1|||
147433904|NCT02593786|531754265|FG001|Overall Study|Study drug toxicity|0|||
147433905|NCT02593786|531754266|FG002|Overall Study|Study drug toxicity|0|||
147433906|NCT02593786|531754267|FG003|Overall Study|Study drug toxicity|0|||
147433907|NCT02593786|531754264|FG000|Overall Study|Adverse event unrelated to study drug|1|||
147433908|NCT02593786|531754265|FG001|Overall Study|Adverse event unrelated to study drug|1|||
147433909|NCT02593786|531754266|FG002|Overall Study|Adverse event unrelated to study drug|1|||
147433910|NCT02593786|531754267|FG003|Overall Study|Adverse event unrelated to study drug|0|||
147433911|NCT02593786|531754264|FG000|Overall Study|Participant request to discontinue study therapy|0|||
147433912|NCT02593786|531754265|FG001|Overall Study|Participant request to discontinue study therapy|2|||
147433913|NCT02593786|531754266|FG002|Overall Study|Participant request to discontinue study therapy|0|||
147433914|NCT02593786|531754267|FG003|Overall Study|Participant request to discontinue study therapy|0|||
147433915|NCT02593786|531754264|FG000|Overall Study|Other reasons|1|||
147433916|NCT02593786|531754265|FG001|Overall Study|Other reasons|1|||
147433917|NCT02593786|531754266|FG002|Overall Study|Other reasons|0|||
147433918|NCT02593786|531754267|FG003|Overall Study|Other reasons|5|||
147433919|NCT03901053|531754277|FG000|Overall Study|Lost to Follow-up|6|||
147433920|NCT03901053|531754278|FG001|Overall Study|Lost to Follow-up|2|||
147433921|NCT03901053|531754277|FG000|Overall Study|Withdrawal by Subject|4|||
147433922|NCT03901053|531754278|FG001|Overall Study|Withdrawal by Subject|3|||
147433923|NCT03901053|531754277|FG000|Overall Study|Unsatisfactory Device|1|||
147433924|NCT03901053|531754278|FG001|Overall Study|Unsatisfactory Device|2|||
147433925|NCT03901053|531754277|FG000|Overall Study|No longer meets study criteria|1|||
147433926|NCT03901053|531754278|FG001|Overall Study|No longer meets study criteria|3|||
147433927|NCT03901053|531754277|FG000|Overall Study|Subject's Medical Status|0|||
147433928|NCT03901053|531754278|FG001|Overall Study|Subject's Medical Status|1|||
147433929|NCT03901053|531754277|FG000|Overall Study|Screening Failure|1|||
147433930|NCT03901053|531754278|FG001|Overall Study|Screening Failure|0|||
147433931|NCT02408861|531754279|FG000|Overall Study|Death|0|||
147433932|NCT02408861|531754280|FG001|Overall Study|Death|3|||
147433933|NCT02408861|531754281|FG002|Overall Study|Death|1|||
147433934|NCT02408861|531754282|FG003|Overall Study|Death|2|||
147433935|NCT02408861|531754283|FG004|Overall Study|Death|4|||
147433936|NCT02408861|531754284|FG005|Overall Study|Death|1|||
147649404|NCT04575584|532537339|FG004|Overall Study|Withdrawal by Subject|0|||
147433937|NCT02408861|531754285|FG006|Overall Study|Death|0|||
147433938|NCT02408861|531754279|FG000|Overall Study|Lost to Follow-up|0|||
147433939|NCT02408861|531754280|FG001|Overall Study|Lost to Follow-up|0|||
147433940|NCT02408861|531754281|FG002|Overall Study|Lost to Follow-up|1|||
147433941|NCT02408861|531754282|FG003|Overall Study|Lost to Follow-up|1|||
147433942|NCT02408861|531754283|FG004|Overall Study|Lost to Follow-up|4|||
147433943|NCT02408861|531754284|FG005|Overall Study|Lost to Follow-up|2|||
147433944|NCT02408861|531754285|FG006|Overall Study|Lost to Follow-up|1|||
147433945|NCT02408861|531754279|FG000|Overall Study|Disease Progression|0|||
147433946|NCT02408861|531754280|FG001|Overall Study|Disease Progression|0|||
147433947|NCT02408861|531754281|FG002|Overall Study|Disease Progression|1|||
147433948|NCT02408861|531754282|FG003|Overall Study|Disease Progression|0|||
147433949|NCT02408861|531754283|FG004|Overall Study|Disease Progression|3|||
147433950|NCT02408861|531754284|FG005|Overall Study|Disease Progression|1|||
147433951|NCT02408861|531754285|FG006|Overall Study|Disease Progression|1|||
147433952|NCT02408861|531754279|FG000|Overall Study|Adverse Event|1|||
147433953|NCT02408861|531754280|FG001|Overall Study|Adverse Event|0|||
147433954|NCT02408861|531754281|FG002|Overall Study|Adverse Event|1|||
147433955|NCT02408861|531754282|FG003|Overall Study|Adverse Event|0|||
147433956|NCT02408861|531754283|FG004|Overall Study|Adverse Event|2|||
147433957|NCT02408861|531754284|FG005|Overall Study|Adverse Event|0|||
147433958|NCT02408861|531754285|FG006|Overall Study|Adverse Event|0|||
147433959|NCT02408861|531754279|FG000|Overall Study|Physician Decision|1|||
147433960|NCT02408861|531754280|FG001|Overall Study|Physician Decision|1|||
147433961|NCT02408861|531754281|FG002|Overall Study|Physician Decision|1|||
147433962|NCT02408861|531754282|FG003|Overall Study|Physician Decision|0|||
147433963|NCT02408861|531754283|FG004|Overall Study|Physician Decision|0|||
147433964|NCT02408861|531754284|FG005|Overall Study|Physician Decision|1|||
147433965|NCT02408861|531754285|FG006|Overall Study|Physician Decision|0|||
147433966|NCT02408861|531754279|FG000|Overall Study|Protocol Violation|1|||
147433967|NCT02408861|531754280|FG001|Overall Study|Protocol Violation|0|||
147433968|NCT02408861|531754281|FG002|Overall Study|Protocol Violation|0|||
147433969|NCT02408861|531754282|FG003|Overall Study|Protocol Violation|0|||
147433970|NCT02408861|531754283|FG004|Overall Study|Protocol Violation|0|||
147433971|NCT02408861|531754284|FG005|Overall Study|Protocol Violation|0|||
147433972|NCT02408861|531754285|FG006|Overall Study|Protocol Violation|0|||
147433973|NCT02408861|531754279|FG000|Overall Study|Withdrawal by Subject|0|||
147433974|NCT02408861|531754280|FG001|Overall Study|Withdrawal by Subject|0|||
147433975|NCT02408861|531754281|FG002|Overall Study|Withdrawal by Subject|0|||
147433976|NCT02408861|531754282|FG003|Overall Study|Withdrawal by Subject|0|||
147433977|NCT02408861|531754283|FG004|Overall Study|Withdrawal by Subject|1|||
147433978|NCT02408861|531754284|FG005|Overall Study|Withdrawal by Subject|1|||
147433979|NCT02408861|531754285|FG006|Overall Study|Withdrawal by Subject|0|||
147433980|NCT02408861|531754279|FG000|Overall Study|Other Treatment|0|||
147433981|NCT02408861|531754280|FG001|Overall Study|Other Treatment|0|||
147433982|NCT02408861|531754281|FG002|Overall Study|Other Treatment|0|||
147433983|NCT02408861|531754282|FG003|Overall Study|Other Treatment|0|||
147433984|NCT02408861|531754283|FG004|Overall Study|Other Treatment|0|||
147433985|NCT02408861|531754284|FG005|Overall Study|Other Treatment|1|||
147433986|NCT02408861|531754285|FG006|Overall Study|Other Treatment|1|||
147433987|NCT01940354|531756232|FG000|Overall Study|Withdrawal by Subject|4|||
147433988|NCT01940354|531756233|FG001|Overall Study|Withdrawal by Subject|2|||
147534292|NCT03110107|532111402|FG001|Treatment Period|Participant request to discontinue study treatment|0|||
147433989|NCT01890148|531756234|FG000|Overall Study|Adverse Event|1|||
147433990|NCT01215175|531756235|FG000|Overall Study|Lost to Follow-up|0|||
147433991|NCT01215175|531756236|FG001|Overall Study|Lost to Follow-up|1|||
147433992|NCT01215175|531756237|FG002|Overall Study|Lost to Follow-up|0|||
147433993|NCT01215175|531756238|FG003|Overall Study|Lost to Follow-up|1|||
147433994|NCT01215175|531756239|FG004|Overall Study|Lost to Follow-up|0|||
147433995|NCT03872453|531756240|FG000|Overall Study|Adverse Event|1|||
147433996|NCT03872453|531756241|FG001|Overall Study|Adverse Event|1|||
147433997|NCT03872453|531756242|FG002|Overall Study|Adverse Event|0|||
147433998|NCT03872453|531756243|FG003|Overall Study|Adverse Event|0|||
147433999|NCT03872453|531756240|FG000|Overall Study|Lost to Follow-up|8|||
147194621|NCT05472090|530882402|FG001|Overall Study|Withdrawal by Subject|0|||
147194622|NCT05472090|530882401|FG000|Overall Study|Lost to Follow-up|0|||
147194623|NCT05472090|530882402|FG001|Overall Study|Lost to Follow-up|3|||
147194624|NCT03414983|530884110|FG000|Pre-Treatment|Other reasons|1|||
147194625|NCT03414983|530884111|FG001|Pre-Treatment|Other reasons|0|||
147194626|NCT03414983|530884110|FG000|Pre-Treatment|Participant no longer meets study criteria|2|||
147194627|NCT03414983|530884111|FG001|Pre-Treatment|Participant no longer meets study criteria|3|||
147194628|NCT03414983|530884110|FG000|Pre-Treatment|Participant withdrew consent|1|||
147194629|NCT03414983|530884111|FG001|Pre-Treatment|Participant withdrew consent|3|||
147194630|NCT03414983|530884110|FG000|Treatment|Participant withdrew consent|4|||
147194631|NCT03414983|530884111|FG001|Treatment|Participant withdrew consent|3|||
147194632|NCT03414983|530884110|FG000|Treatment|Participant request to discontinue study treatment|8|||
147194633|NCT03414983|530884111|FG001|Treatment|Participant request to discontinue study treatment|10|||
147194634|NCT03414983|530884110|FG000|Treatment|Adverse Event Unrelated to Study Drug|5|||
147194635|NCT03414983|530884111|FG001|Treatment|Adverse Event Unrelated to Study Drug|2|||
147194636|NCT03414983|530884110|FG000|Treatment|Death|0|||
147194637|NCT03414983|530884111|FG001|Treatment|Death|1|||
147194638|NCT03414983|530884110|FG000|Treatment|Study Drug Toxicity|10|||
147194639|NCT03414983|530884111|FG001|Treatment|Study Drug Toxicity|5|||
147194640|NCT03414983|530884110|FG000|Treatment|Disease Progression|75|||
147194641|NCT03414983|530884111|FG001|Treatment|Disease Progression|29|||
147194642|NCT03414983|530884110|FG000|Treatment|Not reported|1|||
147194643|NCT03414983|530884111|FG001|Treatment|Not reported|0|||
147194644|NCT03414983|530884110|FG000|Treatment|Other reasons|3|||
147194645|NCT03414983|530884111|FG001|Treatment|Other reasons|2|||
147194646|NCT03414983|530884110|FG000|Treatment|Poor/non-compliance|2|||
147194647|NCT03414983|530884111|FG001|Treatment|Poor/non-compliance|0|||
147194648|NCT03414983|530884110|FG000|Treatment|Maximum clinical benefit|5|||
147194649|NCT03414983|530884111|FG001|Treatment|Maximum clinical benefit|9|||
147194650|NCT03414983|530884110|FG000|Treatment|Lost to Follow-up|0|||
147194651|NCT03414983|530884111|FG001|Treatment|Lost to Follow-up|1|||
147194652|NCT03414983|530884110|FG000|Treatment|Administrative reasons by sponsor|1|||
147194653|NCT03414983|530884111|FG001|Treatment|Administrative reasons by sponsor|0|||
147194654|NCT02608684|530884112|FG000|Overall Study|Physician Decision|2|||
147194655|NCT02608684|530884112|FG000|Overall Study|Withdrawal by Subject|1|||
147194656|NCT00751296|530884113|FG000|Overall Study|Adverse Event|2|||
147194657|NCT01775501|530884118|FG000|Overall Study|Discontinued prior to treatment|1|||
147194658|NCT02318706|530884119|FG000|Double-blind Phase|Adverse Event|7|||
147194659|NCT02318706|530884120|FG001|Double-blind Phase|Adverse Event|4|||
147194660|NCT02318706|530884121|FG002|Double-blind Phase|Adverse Event|3|||
147194661|NCT02318706|530884122|FG003|Double-blind Phase|Adverse Event|10|||
147194662|NCT02318706|530884123|FG004|Double-blind Phase|Adverse Event|0|||
147194663|NCT02318706|530884119|FG000|Double-blind Phase|Lost to Follow-up|1|||
147194664|NCT02318706|530884120|FG001|Double-blind Phase|Lost to Follow-up|0|||
147194665|NCT02318706|530884121|FG002|Double-blind Phase|Lost to Follow-up|0|||
147194666|NCT02318706|530884122|FG003|Double-blind Phase|Lost to Follow-up|0|||
147194667|NCT02318706|530884123|FG004|Double-blind Phase|Lost to Follow-up|0|||
147194668|NCT02318706|530884119|FG000|Double-blind Phase|Protocol Violation|4|||
147194669|NCT02318706|530884120|FG001|Double-blind Phase|Protocol Violation|2|||
147194670|NCT02318706|530884121|FG002|Double-blind Phase|Protocol Violation|4|||
147194671|NCT02318706|530884122|FG003|Double-blind Phase|Protocol Violation|3|||
147194672|NCT02318706|530884123|FG004|Double-blind Phase|Protocol Violation|0|||
147194673|NCT02318706|530884119|FG000|Double-blind Phase|Withdrawal by Subject|9|||
147194674|NCT02318706|530884120|FG001|Double-blind Phase|Withdrawal by Subject|5|||
147194675|NCT02318706|530884121|FG002|Double-blind Phase|Withdrawal by Subject|7|||
147194676|NCT02318706|530884122|FG003|Double-blind Phase|Withdrawal by Subject|10|||
147194677|NCT02318706|530884123|FG004|Double-blind Phase|Withdrawal by Subject|0|||
147194678|NCT02318706|530884119|FG000|Double-blind Phase|Other|4|||
147194679|NCT02318706|530884120|FG001|Double-blind Phase|Other|1|||
147194680|NCT02318706|530884121|FG002|Double-blind Phase|Other|2|||
147194681|NCT02318706|530884122|FG003|Double-blind Phase|Other|1|||
147194682|NCT02318706|530884123|FG004|Double-blind Phase|Other|0|||
147194683|NCT02318706|530884119|FG000|Double-blind Phase|Death|0|||
147194684|NCT02318706|530884120|FG001|Double-blind Phase|Death|0|||
147194685|NCT02318706|530884121|FG002|Double-blind Phase|Death|2|||
147194686|NCT02318706|530884122|FG003|Double-blind Phase|Death|0|||
147194687|NCT02318706|530884123|FG004|Double-blind Phase|Death|0|||
147194688|NCT02318706|530884119|FG000|Open-label Extension Phase|Adverse Event|0|||
147194689|NCT02318706|530884120|FG001|Open-label Extension Phase|Adverse Event|0|||
147194690|NCT02318706|530884121|FG002|Open-label Extension Phase|Adverse Event|0|||
147194691|NCT02318706|530884122|FG003|Open-label Extension Phase|Adverse Event|0|||
147194692|NCT02318706|530884123|FG004|Open-label Extension Phase|Adverse Event|21|||
147194693|NCT02318706|530884119|FG000|Open-label Extension Phase|Lack of Efficacy|0|||
147194694|NCT02318706|530884120|FG001|Open-label Extension Phase|Lack of Efficacy|0|||
147194695|NCT02318706|530884121|FG002|Open-label Extension Phase|Lack of Efficacy|0|||
147194696|NCT02318706|530884122|FG003|Open-label Extension Phase|Lack of Efficacy|0|||
147194697|NCT02318706|530884123|FG004|Open-label Extension Phase|Lack of Efficacy|1|||
147194698|NCT02318706|530884119|FG000|Open-label Extension Phase|Death|0|||
147194699|NCT02318706|530884120|FG001|Open-label Extension Phase|Death|0|||
147194700|NCT02318706|530884121|FG002|Open-label Extension Phase|Death|0|||
147194701|NCT02318706|530884122|FG003|Open-label Extension Phase|Death|0|||
147194702|NCT02318706|530884123|FG004|Open-label Extension Phase|Death|1|||
147194703|NCT02318706|530884119|FG000|Open-label Extension Phase|Withdrawal by Subject|0|||
147194704|NCT02318706|530884120|FG001|Open-label Extension Phase|Withdrawal by Subject|0|||
147194705|NCT02318706|530884121|FG002|Open-label Extension Phase|Withdrawal by Subject|0|||
147194706|NCT02318706|530884122|FG003|Open-label Extension Phase|Withdrawal by Subject|0|||
147194707|NCT02318706|530884123|FG004|Open-label Extension Phase|Withdrawal by Subject|19|||
147194708|NCT01702311|530884124|FG000|Overall Study|Withdrawal by Subject|3|||
147194709|NCT01702311|530884125|FG001|Overall Study|Withdrawal by Subject|2|||
147194710|NCT01702311|530884124|FG000|Overall Study|Discharge less than 24 hours|10|||
147194711|NCT01702311|530884125|FG001|Overall Study|Discharge less than 24 hours|7|||
147194712|NCT01702311|530884124|FG000|Overall Study|Physician Decision|3|||
147194713|NCT01702311|530884125|FG001|Overall Study|Physician Decision|4|||
147194714|NCT03714672|530884130|FG000|Overall Study|Adverse Event|0|||
147194715|NCT03714672|530884131|FG001|Overall Study|Adverse Event|0|||
147194716|NCT03714672|530884132|FG002|Overall Study|Adverse Event|3|||
147194717|NCT03714672|530884133|FG003|Overall Study|Adverse Event|0|||
147194718|NCT03714672|530884130|FG000|Overall Study|Physician Decision|0|||
147194719|NCT03714672|530884131|FG001|Overall Study|Physician Decision|1|||
147194720|NCT03714672|530884132|FG002|Overall Study|Physician Decision|0|||
147194721|NCT03714672|530884133|FG003|Overall Study|Physician Decision|0|||
147194722|NCT03714672|530884130|FG000|Overall Study|Other Reason|1|||
147194723|NCT03714672|530884131|FG001|Overall Study|Other Reason|2|||
147194724|NCT03714672|530884132|FG002|Overall Study|Other Reason|1|||
147194725|NCT03714672|530884133|FG003|Overall Study|Other Reason|1|||
147194726|NCT03714672|530884130|FG000|Overall Study|Lost to Follow-up|1|||
147194727|NCT03714672|530884131|FG001|Overall Study|Lost to Follow-up|1|||
147194728|NCT03714672|530884132|FG002|Overall Study|Lost to Follow-up|0|||
147434000|NCT03872453|531756241|FG001|Overall Study|Lost to Follow-up|7|||
147194729|NCT03714672|530884133|FG003|Overall Study|Lost to Follow-up|0|||
147194730|NCT01054885|530884135|FG000|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|246|||
147194731|NCT01054885|530884136|FG001|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
147434001|NCT03872453|531756242|FG002|Overall Study|Lost to Follow-up|4|||
147434002|NCT03872453|531756243|FG003|Overall Study|Lost to Follow-up|4|||
147434003|NCT03872453|531756240|FG000|Overall Study|Never Treated Migraine|19|||
147434004|NCT03872453|531756241|FG001|Overall Study|Never Treated Migraine|17|||
147434005|NCT03872453|531756242|FG002|Overall Study|Never Treated Migraine|13|||
147434006|NCT03872453|531756243|FG003|Overall Study|Never Treated Migraine|12|||
147434007|NCT03872453|531756240|FG000|Overall Study|Pregnancy|1|||
147434008|NCT03872453|531756241|FG001|Overall Study|Pregnancy|0|||
147434009|NCT03872453|531756242|FG002|Overall Study|Pregnancy|0|||
147434010|NCT03872453|531756243|FG003|Overall Study|Pregnancy|0|||
147434011|NCT03872453|531756240|FG000|Overall Study|Protocol Deviation|2|||
147434012|NCT03872453|531756241|FG001|Overall Study|Protocol Deviation|0|||
147434013|NCT03872453|531756242|FG002|Overall Study|Protocol Deviation|0|||
147434014|NCT03872453|531756243|FG003|Overall Study|Protocol Deviation|2|||
147434015|NCT03872453|531756240|FG000|Overall Study|Withdrawal by Subject|0|||
147434016|NCT03872453|531756241|FG001|Overall Study|Withdrawal by Subject|1|||
147434017|NCT03872453|531756242|FG002|Overall Study|Withdrawal by Subject|2|||
147434018|NCT03872453|531756243|FG003|Overall Study|Withdrawal by Subject|0|||
147434019|NCT03872453|531756240|FG000|Overall Study|Other Than Specified|1|||
147434020|NCT03872453|531756241|FG001|Overall Study|Other Than Specified|0|||
147434021|NCT03872453|531756242|FG002|Overall Study|Other Than Specified|0|||
147434022|NCT03872453|531756243|FG003|Overall Study|Other Than Specified|0|||
147434023|NCT01678209|531756244|FG000|Overall Study|could not scan twice|1|||
147434024|NCT01678209|531756245|FG001|Overall Study|could not scan twice|1|||
147434025|NCT01678209|531756246|FG002|Overall Study|could not scan twice|1|||
147434026|NCT01678209|531756244|FG000|Overall Study|scheduling conflicts|0|||
147434027|NCT01678209|531756245|FG001|Overall Study|scheduling conflicts|0|||
147434028|NCT01678209|531756246|FG002|Overall Study|scheduling conflicts|1|||
147194732|NCT01054885|530884137|FG002|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
147194733|NCT01054885|530884138|FG003|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
147194734|NCT01054885|530884139|FG004|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
147194735|NCT01054885|530884140|FG005|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
147194736|NCT01054885|530884141|FG006|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
147434029|NCT01678209|531756244|FG000|Overall Study|screen fail|16|||
147434030|NCT01678209|531756245|FG001|Overall Study|screen fail|17|||
147434031|NCT01678209|531756246|FG002|Overall Study|screen fail|16|||
147434032|NCT03756350|531756247|FG000|Overall Study|Lost to Follow-up|1|||
147434033|NCT01096342|531756250|FG000|Overall Study|Protocol Violation|1|||
147434034|NCT00929656|531756251|FG000|Overall Study|Lost to Follow-up|0|||
147434035|NCT00929656|531756252|FG001|Overall Study|Lost to Follow-up|1|||
147434036|NCT03308942|531756253|FG000|Stage 1 (Up to a Maximum of 45 Months)|Withdrawal by Subject|3|||
147434037|NCT03308942|531756254|FG001|Stage 1 (Up to a Maximum of 45 Months)|Withdrawal by Subject|3|||
147434038|NCT03308942|531756255|FG002|Stage 1 (Up to a Maximum of 45 Months)|Withdrawal by Subject|2|||
147434039|NCT03308942|531756256|FG003|Stage 1 (Up to a Maximum of 45 Months)|Withdrawal by Subject|0|||
147434040|NCT03308942|531756257|FG004|Stage 1 (Up to a Maximum of 45 Months)|Withdrawal by Subject|0|||
147434041|NCT03308942|531756253|FG000|Stage 1 (Up to a Maximum of 45 Months)|Death|11|||
147434042|NCT03308942|531756254|FG001|Stage 1 (Up to a Maximum of 45 Months)|Death|16|||
147434043|NCT03308942|531756255|FG002|Stage 1 (Up to a Maximum of 45 Months)|Death|1|||
147434044|NCT03308942|531756256|FG003|Stage 1 (Up to a Maximum of 45 Months)|Death|0|||
147434045|NCT03308942|531756257|FG004|Stage 1 (Up to a Maximum of 45 Months)|Death|0|||
147434046|NCT03308942|531756253|FG000|Stage 1 (Up to a Maximum of 45 Months)|Lost to Follow-up|0|||
147434047|NCT03308942|531756254|FG001|Stage 1 (Up to a Maximum of 45 Months)|Lost to Follow-up|1|||
147434048|NCT03308942|531756255|FG002|Stage 1 (Up to a Maximum of 45 Months)|Lost to Follow-up|0|||
147434049|NCT03308942|531756256|FG003|Stage 1 (Up to a Maximum of 45 Months)|Lost to Follow-up|0|||
147434050|NCT03308942|531756257|FG004|Stage 1 (Up to a Maximum of 45 Months)|Lost to Follow-up|0|||
147434051|NCT03308942|531756253|FG000|Stage 1 (Up to a Maximum of 45 Months)|Sponsor Decision|3|||
147434052|NCT03308942|531756254|FG001|Stage 1 (Up to a Maximum of 45 Months)|Sponsor Decision|1|||
147434053|NCT03308942|531756255|FG002|Stage 1 (Up to a Maximum of 45 Months)|Sponsor Decision|0|||
147434054|NCT03308942|531756256|FG003|Stage 1 (Up to a Maximum of 45 Months)|Sponsor Decision|0|||
147434055|NCT03308942|531756257|FG004|Stage 1 (Up to a Maximum of 45 Months)|Sponsor Decision|0|||
147434056|NCT03308942|531756253|FG000|Stage 2 (Up to a Maximum of 29 Months)|Withdrawal by Subject|0|||
147434057|NCT03308942|531756254|FG001|Stage 2 (Up to a Maximum of 29 Months)|Withdrawal by Subject|0|||
147434058|NCT03308942|531756255|FG002|Stage 2 (Up to a Maximum of 29 Months)|Withdrawal by Subject|0|||
147434059|NCT03308942|531756256|FG003|Stage 2 (Up to a Maximum of 29 Months)|Withdrawal by Subject|3|||
147434060|NCT03308942|531756257|FG004|Stage 2 (Up to a Maximum of 29 Months)|Withdrawal by Subject|0|||
147434061|NCT03308942|531756253|FG000|Stage 2 (Up to a Maximum of 29 Months)|Death|0|||
147434062|NCT03308942|531756254|FG001|Stage 2 (Up to a Maximum of 29 Months)|Death|0|||
147434063|NCT03308942|531756255|FG002|Stage 2 (Up to a Maximum of 29 Months)|Death|0|||
147434064|NCT03308942|531756256|FG003|Stage 2 (Up to a Maximum of 29 Months)|Death|6|||
147434065|NCT03308942|531756257|FG004|Stage 2 (Up to a Maximum of 29 Months)|Death|0|||
147434066|NCT03308942|531756253|FG000|Stage 2 (Up to a Maximum of 29 Months)|Sponsor Decision|0|||
147434067|NCT03308942|531756254|FG001|Stage 2 (Up to a Maximum of 29 Months)|Sponsor Decision|0|||
147434068|NCT03308942|531756255|FG002|Stage 2 (Up to a Maximum of 29 Months)|Sponsor Decision|0|||
147434069|NCT03308942|531756256|FG003|Stage 2 (Up to a Maximum of 29 Months)|Sponsor Decision|3|||
147434070|NCT03308942|531756257|FG004|Stage 2 (Up to a Maximum of 29 Months)|Sponsor Decision|0|||
147434071|NCT01131351|531756258|FG000|Overall Study|Adverse Event|0|||
147434072|NCT01131351|531756259|FG001|Overall Study|Adverse Event|2|||
147434073|NCT01131351|531756258|FG000|Overall Study|Protocol Deviation|0|||
147434074|NCT01131351|531756259|FG001|Overall Study|Protocol Deviation|1|||
147434075|NCT04147234|531756262|FG000|Overall Study|Clinical deterioration|0|||
147434076|NCT04147234|531756263|FG001|Overall Study|Clinical deterioration|0|||
147434077|NCT04147234|531756264|FG002|Overall Study|Clinical deterioration|1|||
147434078|NCT04147234|531756265|FG003|Overall Study|Clinical deterioration|0|||
147434079|NCT04147234|531756266|FG004|Overall Study|Clinical deterioration|0|||
147434080|NCT04147234|531756267|FG005|Overall Study|Clinical deterioration|0|||
147434081|NCT04147234|531756268|FG006|Overall Study|Clinical deterioration|0|||
147434082|NCT04147234|531756262|FG000|Overall Study|Withdrawal by Subject|0|||
147434083|NCT04147234|531756263|FG001|Overall Study|Withdrawal by Subject|1|||
147434084|NCT04147234|531756264|FG002|Overall Study|Withdrawal by Subject|1|||
147434085|NCT04147234|531756265|FG003|Overall Study|Withdrawal by Subject|0|||
147434086|NCT04147234|531756266|FG004|Overall Study|Withdrawal by Subject|0|||
147434087|NCT04147234|531756267|FG005|Overall Study|Withdrawal by Subject|0|||
147434088|NCT04147234|531756268|FG006|Overall Study|Withdrawal by Subject|0|||
147434089|NCT04147234|531756262|FG000|Overall Study|Clinical disease progression|1|||
147434090|NCT04147234|531756263|FG001|Overall Study|Clinical disease progression|3|||
147434091|NCT04147234|531756264|FG002|Overall Study|Clinical disease progression|1|||
147434092|NCT04147234|531756265|FG003|Overall Study|Clinical disease progression|1|||
147434093|NCT04147234|531756266|FG004|Overall Study|Clinical disease progression|0|||
147434094|NCT04147234|531756267|FG005|Overall Study|Clinical disease progression|1|||
147434095|NCT04147234|531756268|FG006|Overall Study|Clinical disease progression|0|||
147434096|NCT04147234|531756262|FG000|Overall Study|Objective disease progression|6|||
147434097|NCT04147234|531756263|FG001|Overall Study|Objective disease progression|4|||
147434098|NCT04147234|531756264|FG002|Overall Study|Objective disease progression|3|||
147434099|NCT04147234|531756265|FG003|Overall Study|Objective disease progression|3|||
147434100|NCT04147234|531756266|FG004|Overall Study|Objective disease progression|5|||
147434101|NCT04147234|531756267|FG005|Overall Study|Objective disease progression|2|||
147434102|NCT04147234|531756268|FG006|Overall Study|Objective disease progression|3|||
147434103|NCT04147234|531756262|FG000|Overall Study|Adverse Event|0|||
147434104|NCT04147234|531756263|FG001|Overall Study|Adverse Event|0|||
147434105|NCT04147234|531756264|FG002|Overall Study|Adverse Event|0|||
147434106|NCT04147234|531756265|FG003|Overall Study|Adverse Event|0|||
147434107|NCT04147234|531756266|FG004|Overall Study|Adverse Event|1|||
147194737|NCT01054885|530884135|FG000|2-week, Single-blind Run-In Period|Physician Decision|6|||
147194738|NCT01054885|530884136|FG001|2-week, Single-blind Run-In Period|Physician Decision|0|||
147194739|NCT01054885|530884137|FG002|2-week, Single-blind Run-In Period|Physician Decision|0|||
147194740|NCT01054885|530884138|FG003|2-week, Single-blind Run-In Period|Physician Decision|0|||
147194741|NCT01054885|530884139|FG004|2-week, Single-blind Run-In Period|Physician Decision|0|||
147194742|NCT01054885|530884140|FG005|2-week, Single-blind Run-In Period|Physician Decision|0|||
147194743|NCT01054885|530884141|FG006|2-week, Single-blind Run-In Period|Physician Decision|0|||
147194744|NCT01054885|530884135|FG000|2-week, Single-blind Run-In Period|Withdrawal by Subject|23|||
147194745|NCT01054885|530884136|FG001|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
147194746|NCT01054885|530884137|FG002|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
147194747|NCT01054885|530884138|FG003|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
147194748|NCT01054885|530884139|FG004|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
147194749|NCT01054885|530884140|FG005|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
147194750|NCT01054885|530884141|FG006|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
147194751|NCT01054885|530884135|FG000|2-week, Single-blind Run-In Period|Lost to Follow-up|1|||
147194752|NCT01054885|530884136|FG001|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
147194753|NCT01054885|530884137|FG002|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
147194754|NCT01054885|530884138|FG003|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
147194755|NCT01054885|530884139|FG004|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
147194756|NCT01054885|530884140|FG005|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
147194757|NCT01054885|530884141|FG006|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
147194758|NCT01054885|530884135|FG000|2-week, Single-blind Run-In Period|Adverse Event|7|||
147194759|NCT01054885|530884136|FG001|2-week, Single-blind Run-In Period|Adverse Event|0|||
147194760|NCT01054885|530884137|FG002|2-week, Single-blind Run-In Period|Adverse Event|0|||
147194761|NCT01054885|530884138|FG003|2-week, Single-blind Run-In Period|Adverse Event|0|||
147194762|NCT01054885|530884139|FG004|2-week, Single-blind Run-In Period|Adverse Event|0|||
147194763|NCT01054885|530884140|FG005|2-week, Single-blind Run-In Period|Adverse Event|0|||
147194764|NCT01054885|530884141|FG006|2-week, Single-blind Run-In Period|Adverse Event|0|||
147194765|NCT01054885|530884135|FG000|2-week, Single-blind Run-In Period|Study Closed/Terminated|68|||
147194766|NCT01054885|530884136|FG001|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
147194767|NCT01054885|530884137|FG002|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
147194768|NCT01054885|530884138|FG003|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
147194769|NCT01054885|530884139|FG004|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
147194770|NCT01054885|530884140|FG005|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
147194771|NCT01054885|530884141|FG006|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
147194772|NCT01054885|530884135|FG000|24-week, Double-blind Treatment Period|Adverse Event|0|||
147194773|NCT01054885|530884136|FG001|24-week, Double-blind Treatment Period|Adverse Event|18|||
147194774|NCT01054885|530884137|FG002|24-week, Double-blind Treatment Period|Adverse Event|12|||
147194775|NCT01054885|530884138|FG003|24-week, Double-blind Treatment Period|Adverse Event|15|||
147194776|NCT01054885|530884139|FG004|24-week, Double-blind Treatment Period|Adverse Event|15|||
147194777|NCT01054885|530884140|FG005|24-week, Double-blind Treatment Period|Adverse Event|17|||
147194778|NCT01054885|530884141|FG006|24-week, Double-blind Treatment Period|Adverse Event|19|||
147194779|NCT01054885|530884135|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
147194780|NCT01054885|530884136|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
147194781|NCT01054885|530884137|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|3|||
147194782|NCT01054885|530884138|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|1|||
147194783|NCT01054885|530884139|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
147194784|NCT01054885|530884140|FG005|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|1|||
147194785|NCT01054885|530884141|FG006|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
147194786|NCT01054885|530884135|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|0|||
147194787|NCT01054885|530884136|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|12|||
147194788|NCT01054885|530884137|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|2|||
147194789|NCT01054885|530884138|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|5|||
147194790|NCT01054885|530884139|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|11|||
147194791|NCT01054885|530884140|FG005|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|7|||
147194792|NCT01054885|530884141|FG006|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|7|||
147534293|NCT03110107|532111403|FG002|Treatment Period|Participant request to discontinue study treatment|0|||
147534294|NCT03110107|532111404|FG003|Treatment Period|Participant request to discontinue study treatment|0|||
147194793|NCT01054885|530884135|FG000|24-week, Double-blind Treatment Period|Protocol Violation|0|||
147194794|NCT01054885|530884136|FG001|24-week, Double-blind Treatment Period|Protocol Violation|7|||
147194795|NCT01054885|530884137|FG002|24-week, Double-blind Treatment Period|Protocol Violation|7|||
147306783|NCT01686581|531290762|FG000|Overall Study|Side-effects or Health Problems|15|||
147534295|NCT03110107|532111405|FG004|Treatment Period|Participant request to discontinue study treatment|0|||
147534296|NCT03110107|532111406|FG005|Treatment Period|Participant request to discontinue study treatment|0|||
147534297|NCT03110107|532111407|FG006|Treatment Period|Participant request to discontinue study treatment|0|||
147534298|NCT03110107|532111408|FG007|Treatment Period|Participant request to discontinue study treatment|1|||
147534299|NCT03110107|532111409|FG008|Treatment Period|Participant request to discontinue study treatment|0|||
147194796|NCT01054885|530884138|FG003|24-week, Double-blind Treatment Period|Protocol Violation|2|||
147194797|NCT01054885|530884139|FG004|24-week, Double-blind Treatment Period|Protocol Violation|3|||
147194798|NCT01054885|530884140|FG005|24-week, Double-blind Treatment Period|Protocol Violation|8|||
147194799|NCT01054885|530884141|FG006|24-week, Double-blind Treatment Period|Protocol Violation|4|||
147194800|NCT01054885|530884135|FG000|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|0|||
147194801|NCT01054885|530884136|FG001|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|7|||
147534300|NCT03110107|532111410|FG009|Treatment Period|Participant request to discontinue study treatment|0|||
147534301|NCT03110107|532111411|FG010|Treatment Period|Participant request to discontinue study treatment|1|||
147534302|NCT03110107|532111412|FG011|Treatment Period|Participant request to discontinue study treatment|0|||
147534303|NCT03110107|532111413|FG012|Treatment Period|Participant request to discontinue study treatment|0|||
147534304|NCT03110107|532111414|FG013|Treatment Period|Participant request to discontinue study treatment|0|||
147534305|NCT03110107|532111415|FG014|Treatment Period|Participant request to discontinue study treatment|0|||
147534306|NCT03110107|532111416|FG015|Treatment Period|Participant request to discontinue study treatment|0|||
147534307|NCT03110107|532111417|FG016|Treatment Period|Participant request to discontinue study treatment|0|||
147534308|NCT03110107|532111418|FG017|Treatment Period|Participant request to discontinue study treatment|0|||
147534309|NCT03110107|532111419|FG018|Treatment Period|Participant request to discontinue study treatment|0|||
147534310|NCT03110107|532111420|FG019|Treatment Period|Participant request to discontinue study treatment|0|||
147534311|NCT03110107|532111421|FG020|Treatment Period|Participant request to discontinue study treatment|0|||
147534312|NCT03110107|532111422|FG021|Treatment Period|Participant request to discontinue study treatment|0|||
147534313|NCT03110107|532111423|FG022|Treatment Period|Participant request to discontinue study treatment|0|||
147534314|NCT03110107|532111424|FG023|Treatment Period|Participant request to discontinue study treatment|0|||
147534315|NCT03110107|532111425|FG024|Treatment Period|Participant request to discontinue study treatment|3|||
147534316|NCT03110107|532111426|FG025|Treatment Period|Participant request to discontinue study treatment|0|||
147534317|NCT03110107|532111401|FG000|Treatment Period|Participant withdrew consent|0|||
147534318|NCT03110107|532111402|FG001|Treatment Period|Participant withdrew consent|0|||
147534319|NCT03110107|532111403|FG002|Treatment Period|Participant withdrew consent|1|||
147534320|NCT03110107|532111404|FG003|Treatment Period|Participant withdrew consent|0|||
147534321|NCT03110107|532111405|FG004|Treatment Period|Participant withdrew consent|4|||
147534322|NCT03110107|532111406|FG005|Treatment Period|Participant withdrew consent|3|||
147534323|NCT03110107|532111407|FG006|Treatment Period|Participant withdrew consent|0|||
147534324|NCT03110107|532111408|FG007|Treatment Period|Participant withdrew consent|0|||
147534325|NCT03110107|532111409|FG008|Treatment Period|Participant withdrew consent|0|||
147534326|NCT03110107|532111410|FG009|Treatment Period|Participant withdrew consent|1|||
147534327|NCT03110107|532111411|FG010|Treatment Period|Participant withdrew consent|0|||
147534328|NCT03110107|532111412|FG011|Treatment Period|Participant withdrew consent|0|||
147434108|NCT04147234|531756267|FG005|Overall Study|Adverse Event|0|||
147434109|NCT04147234|531756268|FG006|Overall Study|Adverse Event|0|||
147434110|NCT01233869|531756273|FG000|Initial Treatment Period (24 Months)|Death|1|||
147434111|NCT01233869|531756274|FG001|Initial Treatment Period (24 Months)|Death|0|||
147434112|NCT01233869|531756275|FG002|Initial Treatment Period (24 Months)|Death|0|||
147434113|NCT01233869|531756276|FG003|Initial Treatment Period (24 Months)|Death|0|||
147434114|NCT01233869|531756273|FG000|Initial Treatment Period (24 Months)|Adverse Event|9|||
147434115|NCT01233869|531756274|FG001|Initial Treatment Period (24 Months)|Adverse Event|17|||
147434116|NCT01233869|531756275|FG002|Initial Treatment Period (24 Months)|Adverse Event|0|||
147434117|NCT01233869|531756276|FG003|Initial Treatment Period (24 Months)|Adverse Event|3|||
147434118|NCT01233869|531756273|FG000|Initial Treatment Period (24 Months)|Not Related to Study Drug|14|||
147434119|NCT01233869|531756274|FG001|Initial Treatment Period (24 Months)|Not Related to Study Drug|11|||
147434120|NCT01233869|531756275|FG002|Initial Treatment Period (24 Months)|Not Related to Study Drug|2|||
147434121|NCT01233869|531756276|FG003|Initial Treatment Period (24 Months)|Not Related to Study Drug|19|||
147434122|NCT01233869|531756273|FG000|Extended Treatment Period (46 Months)|Lost to Follow-up|0|||
147434123|NCT01233869|531756274|FG001|Extended Treatment Period (46 Months)|Lost to Follow-up|0|||
147434124|NCT01233869|531756275|FG002|Extended Treatment Period (46 Months)|Lost to Follow-up|0|||
147434125|NCT01233869|531756276|FG003|Extended Treatment Period (46 Months)|Lost to Follow-up|1|||
147434126|NCT01233869|531756273|FG000|Extended Treatment Period (46 Months)|Withdrawal by Subject|10|||
147434127|NCT01233869|531756274|FG001|Extended Treatment Period (46 Months)|Withdrawal by Subject|3|||
147434128|NCT01233869|531756275|FG002|Extended Treatment Period (46 Months)|Withdrawal by Subject|5|||
147434129|NCT01233869|531756276|FG003|Extended Treatment Period (46 Months)|Withdrawal by Subject|11|||
147434130|NCT01233869|531756273|FG000|Extended Treatment Period (46 Months)|Other|3|||
147434131|NCT01233869|531756274|FG001|Extended Treatment Period (46 Months)|Other|0|||
147434132|NCT01233869|531756275|FG002|Extended Treatment Period (46 Months)|Other|0|||
147434133|NCT01233869|531756276|FG003|Extended Treatment Period (46 Months)|Other|3|||
147434134|NCT01233869|531756273|FG000|Extended Treatment Period (46 Months)|Adverse Event|1|||
147434135|NCT01233869|531756274|FG001|Extended Treatment Period (46 Months)|Adverse Event|0|||
147434136|NCT01233869|531756275|FG002|Extended Treatment Period (46 Months)|Adverse Event|0|||
147434137|NCT01233869|531756276|FG003|Extended Treatment Period (46 Months)|Adverse Event|1|||
147434138|NCT02378220|531756278|FG000|Overall Study|Death|6|||
147434139|NCT02378220|531756279|FG001|Overall Study|Death|1|||
147434140|NCT00866723|531756280|FG000|Overall Study|Withdrawal by Subject|1|||
147434141|NCT00866723|531756280|FG000|Overall Study|Disease Progression|4|||
147434142|NCT01975428|531756284|FG000|Overall Study|Lost to Follow-up|17|||
147434143|NCT01975428|531756285|FG001|Overall Study|Lost to Follow-up|4|||
147434144|NCT01975428|531756284|FG000|Overall Study|Withdrawal by Subject|3|||
147434145|NCT01975428|531756285|FG001|Overall Study|Withdrawal by Subject|10|||
147434146|NCT00628251|531756286|FG000|Randomised Part|Withdrawal by Subject|0|||
147434147|NCT00628251|531756287|FG001|Randomised Part|Withdrawal by Subject|0|||
147434148|NCT00628251|531756288|FG002|Randomised Part|Withdrawal by Subject|1|||
147434149|NCT00628251|531756286|FG000|Ongoing Initial Study Treatment at DCO|Adverse Event|1|||
147434150|NCT00628251|531756287|FG001|Ongoing Initial Study Treatment at DCO|Adverse Event|2|||
147434151|NCT00628251|531756288|FG002|Ongoing Initial Study Treatment at DCO|Adverse Event|3|||
147434152|NCT00628251|531756286|FG000|Ongoing Initial Study Treatment at DCO|Condition under investigation worsened|19|||
147434153|NCT00628251|531756287|FG001|Ongoing Initial Study Treatment at DCO|Condition under investigation worsened|15|||
147434154|NCT00628251|531756288|FG002|Ongoing Initial Study Treatment at DCO|Condition under investigation worsened|13|||
147434155|NCT00628251|531756286|FG000|Ongoing Initial Study Treatment at DCO|Withdrawal by Subject|1|||
147434156|NCT00628251|531756287|FG001|Ongoing Initial Study Treatment at DCO|Withdrawal by Subject|2|||
147434157|NCT00628251|531756288|FG002|Ongoing Initial Study Treatment at DCO|Withdrawal by Subject|1|||
147434158|NCT00628251|531756286|FG000|Ongoing Initial Study Treatment at DCO|Other reason|0|||
147434159|NCT00628251|531756287|FG001|Ongoing Initial Study Treatment at DCO|Other reason|1|||
147434160|NCT00628251|531756288|FG002|Ongoing Initial Study Treatment at DCO|Other reason|6|||
147434161|NCT00628251|531756286|FG000|Ongoing Initial Study Treatment at DCO|Other|1|||
147434162|NCT00628251|531756287|FG001|Ongoing Initial Study Treatment at DCO|Other|0|||
147434163|NCT00628251|531756288|FG002|Ongoing Initial Study Treatment at DCO|Other|2|||
147434164|NCT01822522|531756289|FG000|Overall Study|Adverse Event|1|||
147434165|NCT01822522|531756290|FG001|Overall Study|Adverse Event|1|||
147434166|NCT01822522|531756291|FG002|Overall Study|Adverse Event|1|||
147434167|NCT01822522|531756292|FG003|Overall Study|Adverse Event|0|||
147434168|NCT01822522|531756293|FG004|Overall Study|Adverse Event|0|||
147434169|NCT01822522|531756294|FG005|Overall Study|Adverse Event|1|||
147434170|NCT01822522|531756289|FG000|Overall Study|Death|3|||
147434171|NCT01822522|531756290|FG001|Overall Study|Death|0|||
147434172|NCT01822522|531756291|FG002|Overall Study|Death|2|||
147434173|NCT01822522|531756292|FG003|Overall Study|Death|0|||
147434174|NCT01822522|531756293|FG004|Overall Study|Death|0|||
147434175|NCT01822522|531756294|FG005|Overall Study|Death|0|||
147434176|NCT01822522|531756289|FG000|Overall Study|Lost to Follow-up|0|||
147434177|NCT01822522|531756290|FG001|Overall Study|Lost to Follow-up|0|||
147194802|NCT01054885|530884137|FG002|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|12|||
147194803|NCT01054885|530884138|FG003|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|7|||
147194804|NCT01054885|530884139|FG004|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|7|||
147194805|NCT01054885|530884140|FG005|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|15|||
147194806|NCT01054885|530884141|FG006|24-week, Double-blind Treatment Period|Protocol Defined Stopping Criteria|12|||
147194807|NCT01054885|530884135|FG000|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0|||
147194808|NCT01054885|530884136|FG001|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0|||
147194809|NCT01054885|530884137|FG002|24-week, Double-blind Treatment Period|Study Closed/ Terminated|1|||
147194810|NCT01054885|530884138|FG003|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0|||
147194811|NCT01054885|530884139|FG004|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0|||
147194812|NCT01054885|530884140|FG005|24-week, Double-blind Treatment Period|Study Closed/ Terminated|0|||
147194813|NCT01054885|530884141|FG006|24-week, Double-blind Treatment Period|Study Closed/ Terminated|1|||
147194814|NCT01054885|530884135|FG000|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
147194815|NCT01054885|530884136|FG001|24-week, Double-blind Treatment Period|Lost to Follow-up|3|||
147194816|NCT01054885|530884137|FG002|24-week, Double-blind Treatment Period|Lost to Follow-up|2|||
147194817|NCT01054885|530884138|FG003|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
147194818|NCT01054885|530884139|FG004|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
147306784|NCT01686581|531290762|FG000|Overall Study|Lack of Efficacy|90|||
147434178|NCT01822522|531756291|FG002|Overall Study|Lost to Follow-up|1|||
147434179|NCT01822522|531756292|FG003|Overall Study|Lost to Follow-up|1|||
147434180|NCT01822522|531756293|FG004|Overall Study|Lost to Follow-up|0|||
147434181|NCT01822522|531756294|FG005|Overall Study|Lost to Follow-up|1|||
147434182|NCT01822522|531756289|FG000|Overall Study|Withdrawal by Subject|0|||
147434183|NCT01822522|531756290|FG001|Overall Study|Withdrawal by Subject|0|||
147434184|NCT01822522|531756291|FG002|Overall Study|Withdrawal by Subject|0|||
147194819|NCT01054885|530884140|FG005|24-week, Double-blind Treatment Period|Lost to Follow-up|2|||
147194820|NCT01054885|530884141|FG006|24-week, Double-blind Treatment Period|Lost to Follow-up|1|||
147194821|NCT01054885|530884135|FG000|24-week, Double-blind Treatment Period|Physician Decision|0|||
147194822|NCT01054885|530884136|FG001|24-week, Double-blind Treatment Period|Physician Decision|4|||
147194823|NCT01054885|530884137|FG002|24-week, Double-blind Treatment Period|Physician Decision|1|||
147194824|NCT01054885|530884138|FG003|24-week, Double-blind Treatment Period|Physician Decision|6|||
147194825|NCT01054885|530884139|FG004|24-week, Double-blind Treatment Period|Physician Decision|3|||
147194826|NCT01054885|530884140|FG005|24-week, Double-blind Treatment Period|Physician Decision|1|||
147194827|NCT01054885|530884141|FG006|24-week, Double-blind Treatment Period|Physician Decision|1|||
147194828|NCT01054885|530884135|FG000|24-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
147194829|NCT01054885|530884136|FG001|24-week, Double-blind Treatment Period|Withdrawal by Subject|8|||
147194830|NCT01054885|530884137|FG002|24-week, Double-blind Treatment Period|Withdrawal by Subject|9|||
147194831|NCT01054885|530884138|FG003|24-week, Double-blind Treatment Period|Withdrawal by Subject|7|||
147194832|NCT01054885|530884139|FG004|24-week, Double-blind Treatment Period|Withdrawal by Subject|3|||
147194833|NCT01054885|530884140|FG005|24-week, Double-blind Treatment Period|Withdrawal by Subject|9|||
147194834|NCT01054885|530884141|FG006|24-week, Double-blind Treatment Period|Withdrawal by Subject|2|||
147194835|NCT01280903|530884142|FG000|Overall Study|Lost to Follow-up|23|||
147194836|NCT01280903|530884143|FG001|Overall Study|Lost to Follow-up|16|||
147194837|NCT03453164|530884144|FG000|Overall Study|Lack of Efficacy|16|||
147194838|NCT03453164|530884144|FG000|Overall Study|3 cases did not meet the criteria for nivolumab initiation.|3|||
147194839|NCT01074502|530884147|FG000|Overall Study|Withdrawal by Subject|1|||
147194840|NCT02220920|530884155|FG000|Overall Study|Adverse Event|1|||
147194841|NCT02220920|530884156|FG001|Overall Study|Adverse Event|0|||
147194842|NCT02220920|530884155|FG000|Overall Study|Lack of Efficacy|0|||
147194843|NCT02220920|530884156|FG001|Overall Study|Lack of Efficacy|1|||
147194844|NCT02220920|530884155|FG000|Overall Study|Withdrawal by Subject|1|||
147194845|NCT02220920|530884156|FG001|Overall Study|Withdrawal by Subject|0|||
147194846|NCT02220920|530884155|FG000|Overall Study|Conflict with the stopping criteria|1|||
147194847|NCT02220920|530884156|FG001|Overall Study|Conflict with the stopping criteria|2|||
147194848|NCT04945733|530884157|FG000|Overall Study|Physician Decision|1|||
147194849|NCT04945733|530884158|FG001|Overall Study|Physician Decision|3|||
147194850|NCT04945733|530884159|FG002|Overall Study|Physician Decision|0|||
147194851|NCT04945733|530884157|FG000|Overall Study|Withdrawal by Subject|3|||
147194852|NCT04945733|530884158|FG001|Overall Study|Withdrawal by Subject|3|||
147194853|NCT04945733|530884159|FG002|Overall Study|Withdrawal by Subject|0|||
147194854|NCT00726063|530884160|FG000|Overall Study|Adverse Event|9|||
147194855|NCT00726063|530884161|FG001|Overall Study|Adverse Event|7|||
147194856|NCT02007096|530884162|FG000|Overall Study|medication not available|2|||
147194857|NCT02007096|530884163|FG001|Overall Study|medication not available|0|||
147194858|NCT02007096|530884162|FG000|Overall Study|did not inject saline|0|||
147194859|NCT02007096|530884163|FG001|Overall Study|did not inject saline|3|||
147194860|NCT02007096|530884162|FG000|Overall Study|did not follow postoperative protocol|8|||
147194861|NCT02007096|530884163|FG001|Overall Study|did not follow postoperative protocol|11|||
147194862|NCT02007096|530884162|FG000|Overall Study|converted to open surgery|1|||
147194863|NCT02007096|530884163|FG001|Overall Study|converted to open surgery|1|||
147194864|NCT02007096|530884162|FG000|Overall Study|no mesh placed|0|||
147194865|NCT02007096|530884163|FG001|Overall Study|no mesh placed|1|||
147306785|NCT01686581|531290762|FG000|Overall Study|Participant Concerned about Risks|6|||
147434185|NCT01822522|531756292|FG003|Overall Study|Withdrawal by Subject|1|||
147434186|NCT01822522|531756293|FG004|Overall Study|Withdrawal by Subject|0|||
147434187|NCT01822522|531756294|FG005|Overall Study|Withdrawal by Subject|0|||
147434188|NCT01822522|531756289|FG000|Overall Study|Lack of Efficacy|0|||
147434189|NCT01822522|531756290|FG001|Overall Study|Lack of Efficacy|0|||
147434190|NCT01822522|531756291|FG002|Overall Study|Lack of Efficacy|0|||
147434191|NCT01822522|531756292|FG003|Overall Study|Lack of Efficacy|0|||
147434192|NCT01822522|531756293|FG004|Overall Study|Lack of Efficacy|0|||
147434193|NCT01822522|531756294|FG005|Overall Study|Lack of Efficacy|2|||
147434194|NCT01807923|531756295|FG000|Overall Study|Adverse Event|2|||
147434195|NCT01807923|531756296|FG001|Overall Study|Adverse Event|1|||
147434196|NCT01807923|531756297|FG002|Overall Study|Adverse Event|2|||
147434197|NCT01807923|531756295|FG000|Overall Study|Withdrawal of Consent (not due to AE)|0|||
147434198|NCT01807923|531756296|FG001|Overall Study|Withdrawal of Consent (not due to AE)|3|||
147434199|NCT01807923|531756297|FG002|Overall Study|Withdrawal of Consent (not due to AE)|2|||
147434200|NCT01807923|531756295|FG000|Overall Study|Physician Decision|0|||
147434201|NCT01807923|531756296|FG001|Overall Study|Physician Decision|0|||
147434202|NCT01807923|531756297|FG002|Overall Study|Physician Decision|1|||
147434203|NCT01807923|531756295|FG000|Overall Study|Not Eligible (Genotype)|0|||
147434204|NCT01807923|531756296|FG001|Overall Study|Not Eligible (Genotype)|0|||
147434205|NCT01807923|531756297|FG002|Overall Study|Not Eligible (Genotype)|1|||
147434206|NCT01807923|531756295|FG000|Overall Study|Randomized But Not Treated|3|||
147434207|NCT01807923|531756296|FG001|Overall Study|Randomized But Not Treated|2|||
147434208|NCT01807923|531756297|FG002|Overall Study|Randomized But Not Treated|5|||
147194866|NCT01231984|530884164|FG000|Study Period 1|Withdrawal by Subject|0|||
147434209|NCT02558231|531756299|FG000|Overall Study|Death|4|||
147434210|NCT02558231|531756300|FG001|Overall Study|Death|12|||
147434211|NCT02558231|531756299|FG000|Overall Study|Lost to Follow-up|7|||
147434212|NCT02558231|531756300|FG001|Overall Study|Lost to Follow-up|4|||
147434213|NCT02558231|531756299|FG000|Overall Study|Withdrawal by Subject|7|||
147434214|NCT02558231|531756300|FG001|Overall Study|Withdrawal by Subject|4|||
147434215|NCT02558231|531756299|FG000|Overall Study|Physician Decision|7|||
147434216|NCT02558231|531756300|FG001|Overall Study|Physician Decision|5|||
147434217|NCT02558231|531756299|FG000|Overall Study|Sponsor Decision|0|||
147434218|NCT02558231|531756300|FG001|Overall Study|Sponsor Decision|1|||
147434219|NCT00995007|531756301|FG000|Overall Study|Withdrew consent|1|||
147434220|NCT00995007|531756302|FG001|Overall Study|Withdrew consent|0|||
147434221|NCT00995007|531756301|FG000|Overall Study|Refused further treatment|8|||
147434222|NCT00995007|531756302|FG001|Overall Study|Refused further treatment|2|||
147434223|NCT00995007|531756301|FG000|Overall Study|Toxicity|8|||
147434224|NCT00995007|531756302|FG001|Overall Study|Toxicity|0|||
147434225|NCT03933397|531756303|FG000|Overall Study|No emergency department visit|65|||
147434226|NCT03933397|531756304|FG001|Overall Study|No emergency department visit|71|||
147434227|NCT03933397|531756303|FG000|Overall Study|Missed emergency department visit|25|||
147434228|NCT03933397|531756304|FG001|Overall Study|Missed emergency department visit|30|||
147434229|NCT03933397|531756303|FG000|Overall Study|Emergency Department visit for non vaso-occlusive episode diagnosis|18|||
147434230|NCT03933397|531756304|FG001|Overall Study|Emergency Department visit for non vaso-occlusive episode diagnosis|15|||
147434231|NCT03933397|531756303|FG000|Overall Study|Withdrawal by Subject|1|||
147434232|NCT03933397|531756304|FG001|Overall Study|Withdrawal by Subject|0|||
147434233|NCT03933397|531756303|FG000|Overall Study|Physician Decision|1|||
147434234|NCT03933397|531756304|FG001|Overall Study|Physician Decision|1|||
147434235|NCT03933397|531756303|FG000|Overall Study|missing pain score|1|||
147434236|NCT03933397|531756304|FG001|Overall Study|missing pain score|1|||
147434237|NCT03933397|531756303|FG000|Overall Study|Confirmed COVID-19|1|||
147434238|NCT03933397|531756304|FG001|Overall Study|Confirmed COVID-19|2|||
147434239|NCT02066051|531756307|FG000|Overall Study|Subject developed active GVHD|1|||
147434240|NCT01237340|531756314|FG000|Overall Study|Adverse Event|3|||
147434241|NCT01237340|531756314|FG000|Overall Study|Withdrawal by Subject|1|||
147434242|NCT01237340|531756314|FG000|Overall Study|Early termination of the trial|36|||
147434243|NCT01610687|531756315|FG000|Overall Study|Lack of Efficacy|26|||
147434244|NCT01610687|531756315|FG000|Overall Study|Adverse Event|18|||
147434245|NCT01610687|531756315|FG000|Overall Study|Moved out of area|6|||
147434246|NCT01610687|531756315|FG000|Overall Study|Withdrawal by Subject|7|||
147434247|NCT01610687|531756315|FG000|Overall Study|Lost to Follow-up|4|||
147434248|NCT01610687|531756315|FG000|Overall Study|Symptom control without study medication|2|||
147434249|NCT01610687|531756315|FG000|Overall Study|Unable to make journey|1|||
147434250|NCT01610687|531756315|FG000|Overall Study|Death|1|||
147434251|NCT01610687|531756315|FG000|Overall Study|Cannabis affecting job|1|||
147434252|NCT01610687|531756315|FG000|Overall Study|Felt more alter without study medication|1|||
147434253|NCT03836807|531756316|FG000|Overall Study|Physician Decision|1|||
147434254|NCT03836807|531756317|FG001|Overall Study|Physician Decision|0|||
147434255|NCT00685685|531756318|FG000|Washout Period of 7 Days|Adverse Event|2|||
147434256|NCT00685685|531756319|FG001|Washout Period of 7 Days|Adverse Event|0|||
147434257|NCT00685685|531756318|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
147434258|NCT00685685|531756319|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
147434259|NCT04029116|531756320|FG000|Overall Study|Adverse Event|0|||
147434260|NCT04029116|531756321|FG001|Overall Study|Adverse Event|2|||
147434261|NCT04029116|531756320|FG000|Overall Study|Lost to Follow-up|3|||
147434262|NCT04029116|531756321|FG001|Overall Study|Lost to Follow-up|5|||
147434263|NCT04029116|531756320|FG000|Overall Study|Physician Decision|2|||
147434264|NCT04029116|531756321|FG001|Overall Study|Physician Decision|0|||
147434265|NCT04029116|531756320|FG000|Overall Study|Pregnancy|1|||
147434266|NCT04029116|531756321|FG001|Overall Study|Pregnancy|2|||
147434267|NCT04029116|531756320|FG000|Overall Study|Withdrawal by Subject|4|||
147434268|NCT04029116|531756321|FG001|Overall Study|Withdrawal by Subject|6|||
147434269|NCT04029116|531756320|FG000|Overall Study|Other|2|||
147434270|NCT04029116|531756321|FG001|Overall Study|Other|1|||
147434271|NCT01272947|531756322|FG000|Overall Study|Abnormal Laboratory Value|2|||
147434272|NCT01272947|531756323|FG001|Overall Study|Abnormal Laboratory Value|2|||
147434273|NCT02469896|531756326|FG000|Overall Study|Withdrawal by Subject|2|||
147434274|NCT02469896|531756327|FG001|Overall Study|Withdrawal by Subject|0|||
147434275|NCT02019420|531756328|FG000|Overall Study|Did not receive study drug|2|||
147434276|NCT02019420|531756329|FG001|Overall Study|Did not receive study drug|2|||
147434277|NCT02019420|531756328|FG000|Overall Study|Withdrawal by Subject|1|||
147434278|NCT02019420|531756329|FG001|Overall Study|Withdrawal by Subject|3|||
147434279|NCT02019420|531756328|FG000|Overall Study|At request of sponsor or investigator|0|||
147434280|NCT02019420|531756329|FG001|Overall Study|At request of sponsor or investigator|1|||
147434281|NCT02019420|531756328|FG000|Overall Study|Death|104|||
147434282|NCT02019420|531756329|FG001|Overall Study|Death|99|||
147434283|NCT02019420|531756328|FG000|Overall Study|Transferred to other care facility|1|||
147434284|NCT02019420|531756329|FG001|Overall Study|Transferred to other care facility|1|||
147434285|NCT02401412|531756330|FG000|Overall Study|Lost to Follow-up|1|||
147434286|NCT02401412|531756331|FG001|Overall Study|Lost to Follow-up|0|||
147434287|NCT02401412|531756330|FG000|Overall Study|Discontinued Intervention|15|||
147434288|NCT02401412|531756331|FG001|Overall Study|Discontinued Intervention|21|||
147434289|NCT02401412|531756330|FG000|Overall Study|Withdrawal by Subject|4|||
147434290|NCT02401412|531756331|FG001|Overall Study|Withdrawal by Subject|4|||
147434291|NCT02401412|531756330|FG000|Overall Study|Subject withdrawal prior to intervention|0|||
147434292|NCT02401412|531756331|FG001|Overall Study|Subject withdrawal prior to intervention|1|||
147434293|NCT02401412|531756330|FG000|Overall Study|Improper Enrollment per In/Ex Criteria|10|||
147434294|NCT02401412|531756331|FG001|Overall Study|Improper Enrollment per In/Ex Criteria|6|||
147434295|NCT00882310|531756336|FG000|Overall Study|Screen Failure|10|||
147434296|NCT00882310|531756336|FG000|Overall Study|Never received treatment|1|||
147434297|NCT00882310|531756336|FG000|Overall Study|Death|6|||
147434298|NCT00882310|531756336|FG000|Overall Study|Progression of disease|4|||
147434299|NCT00882310|531756336|FG000|Overall Study|Adverse Event|1|||
147434300|NCT01093625|531756337|FG000|Baseline and Dispensed|Withdrawal by Subject|2|||
147434301|NCT01093625|531756338|FG001|Baseline and Dispensed|Withdrawal by Subject|0|||
147434302|NCT01093625|531756337|FG000|2-Week Visit|Withdrawal by Subject|1|||
147434303|NCT01093625|531756338|FG001|2-Week Visit|Withdrawal by Subject|0|||
147434304|NCT01093625|531756337|FG000|1-Month Visit|Lost to Follow-up|2|||
147434305|NCT01093625|531756338|FG001|1-Month Visit|Lost to Follow-up|0|||
147434306|NCT01093625|531756337|FG000|3-Month Visit|Lost to Follow-up|2|||
147434307|NCT01093625|531756338|FG001|3-Month Visit|Lost to Follow-up|0|||
147434308|NCT01093625|531756337|FG000|6-Month Visit|Withdrawal by Subject|6|||
147434309|NCT01093625|531756338|FG001|6-Month Visit|Withdrawal by Subject|7|||
147434310|NCT01093625|531756337|FG000|6-Month Visit|Lost to Follow-up|2|||
147434311|NCT01093625|531756338|FG001|6-Month Visit|Lost to Follow-up|2|||
147434312|NCT01093625|531756337|FG000|1-Year Visit|Lost to Follow-up|5|||
147434313|NCT01093625|531756338|FG001|1-Year Visit|Lost to Follow-up|3|||
147434314|NCT04233164|531756345|FG000|Overall Study|Unable to obtain specimen|0|||
147434315|NCT04233164|531756346|FG001|Overall Study|Unable to obtain specimen|1|||
147434316|NCT01843218|531756351|FG000|Overall Study|Withdrawal by Subject|5|||
147434317|NCT01431534|531756352|FG000|Treatment Phase|Adverse Event|0|||
147434318|NCT01431534|531756353|FG001|Treatment Phase|Adverse Event|0|||
147434319|NCT01431534|531756354|FG002|Treatment Phase|Adverse Event|1|||
147434320|NCT01431534|531756352|FG000|Treatment Phase|Progressive Disease|4|||
147434321|NCT01431534|531756353|FG001|Treatment Phase|Progressive Disease|3|||
147434322|NCT01431534|531756354|FG002|Treatment Phase|Progressive Disease|10|||
147434323|NCT01009554|531756355|FG000|Overall Study|Adverse Event|1|||
147434324|NCT01009554|531756356|FG001|Overall Study|Adverse Event|1|||
147434325|NCT01009554|531756355|FG000|Overall Study|Withdrawal by Subject|1|||
147434326|NCT01009554|531756356|FG001|Overall Study|Withdrawal by Subject|3|||
147434327|NCT01009554|531756355|FG000|Overall Study|Noncompliant with Study Product|0|||
147434328|NCT01009554|531756356|FG001|Overall Study|Noncompliant with Study Product|3|||
147434329|NCT01605253|531756357|FG000|Overall Study|Physician Decision|3|||
147434330|NCT01605253|531756358|FG001|Overall Study|Physician Decision|2|||
147434331|NCT01605253|531756357|FG000|Overall Study|Lost to Follow-up|3|||
147434332|NCT01605253|531756358|FG001|Overall Study|Lost to Follow-up|1|||
147434333|NCT04201821|531756363|FG000|Overall Study|Withdrawal by Subject|2|||
147434334|NCT00835120|531756365|FG000|Overall Study|Lack of Efficacy|1|||
147434335|NCT00835120|531756365|FG000|Overall Study|Lost to Follow-up|3|||
147434336|NCT00835120|531756365|FG000|Overall Study|Adverse Event|2|||
147434337|NCT00835120|531756365|FG000|Overall Study|Withdrawal by Subject|2|||
147434338|NCT01019980|531756369|FG000|Overall Study|Drug not available.|2|||
147434339|NCT01019980|531756370|FG001|Overall Study|Drug not available.|0|||
147434340|NCT00708175|531756376|FG000|Overall Study|Adverse Event|4|||
147434341|NCT00708175|531756377|FG001|Overall Study|Adverse Event|5|||
147434342|NCT00708175|531756376|FG000|Overall Study|Protocol Violation|2|||
147434343|NCT00708175|531756377|FG001|Overall Study|Protocol Violation|3|||
147434344|NCT00708175|531756376|FG000|Overall Study|Lost to Follow-up|5|||
147434345|NCT00708175|531756377|FG001|Overall Study|Lost to Follow-up|3|||
147434346|NCT00708175|531756376|FG000|Overall Study|Withdrawal by Subject|5|||
147434347|NCT00708175|531756377|FG001|Overall Study|Withdrawal by Subject|7|||
147434348|NCT00708175|531756376|FG000|Overall Study|BMD loss >7%|2|||
147434349|NCT00708175|531756377|FG001|Overall Study|BMD loss >7%|3|||
147434350|NCT02038920|531756378|FG000|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|3|||
147434351|NCT02038920|531756379|FG001|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|11|||
147194867|NCT01231984|530884165|FG001|Study Period 1|Withdrawal by Subject|0|||
147194868|NCT01231984|530884166|FG002|Study Period 1|Withdrawal by Subject|0|||
147194869|NCT01231984|530884167|FG003|Study Period 1|Withdrawal by Subject|1|||
147194870|NCT01231984|530884164|FG000|Study Period 1|Lost to Follow-up|1|||
147194871|NCT01231984|530884165|FG001|Study Period 1|Lost to Follow-up|1|||
147194872|NCT01231984|530884166|FG002|Study Period 1|Lost to Follow-up|1|||
147194873|NCT01231984|530884167|FG003|Study Period 1|Lost to Follow-up|0|||
147194874|NCT01231984|530884164|FG000|Study Period 1|Did not continue to meet I/E Criteria|2|||
147194875|NCT01231984|530884165|FG001|Study Period 1|Did not continue to meet I/E Criteria|2|||
147194876|NCT01231984|530884166|FG002|Study Period 1|Did not continue to meet I/E Criteria|2|||
147194877|NCT01231984|530884167|FG003|Study Period 1|Did not continue to meet I/E Criteria|2|||
147194878|NCT01231984|530884164|FG000|Study Period 1|Screen Failure|0|||
147194879|NCT01231984|530884165|FG001|Study Period 1|Screen Failure|0|||
147194880|NCT01231984|530884166|FG002|Study Period 1|Screen Failure|0|||
147194881|NCT01231984|530884167|FG003|Study Period 1|Screen Failure|1|||
147194882|NCT01231984|530884164|FG000|Study Period 1|Non-compliance with study requirements|5|||
147194883|NCT01231984|530884165|FG001|Study Period 1|Non-compliance with study requirements|0|||
147194884|NCT01231984|530884166|FG002|Study Period 1|Non-compliance with study requirements|2|||
147194885|NCT01231984|530884167|FG003|Study Period 1|Non-compliance with study requirements|1|||
147194886|NCT01231984|530884164|FG000|Study Period 1|Protocol Violation|3|||
147194887|NCT01231984|530884165|FG001|Study Period 1|Protocol Violation|4|||
147194888|NCT01231984|530884166|FG002|Study Period 1|Protocol Violation|2|||
147194889|NCT01231984|530884167|FG003|Study Period 1|Protocol Violation|3|||
147194890|NCT01231984|530884164|FG000|Study Period 1|Adverse Event|1|||
147194891|NCT01231984|530884165|FG001|Study Period 1|Adverse Event|0|||
147194892|NCT01231984|530884166|FG002|Study Period 1|Adverse Event|0|||
147194893|NCT01231984|530884167|FG003|Study Period 1|Adverse Event|0|||
147194894|NCT01231984|530884164|FG000|Study Period 1|Other|0|||
147194895|NCT01231984|530884165|FG001|Study Period 1|Other|0|||
147194896|NCT01231984|530884166|FG002|Study Period 1|Other|0|||
147194897|NCT01231984|530884167|FG003|Study Period 1|Other|1|||
147194898|NCT01231984|530884164|FG000|Study Period 2|Withdrawal by Subject|1|||
147194899|NCT01231984|530884165|FG001|Study Period 2|Withdrawal by Subject|1|||
147194900|NCT01231984|530884166|FG002|Study Period 2|Withdrawal by Subject|0|||
147194901|NCT01231984|530884167|FG003|Study Period 2|Withdrawal by Subject|0|||
147194902|NCT01231984|530884164|FG000|Study Period 2|Lost to Follow-up|1|||
147194903|NCT01231984|530884165|FG001|Study Period 2|Lost to Follow-up|0|||
147194904|NCT01231984|530884166|FG002|Study Period 2|Lost to Follow-up|0|||
147194905|NCT01231984|530884167|FG003|Study Period 2|Lost to Follow-up|3|||
147194906|NCT01231984|530884164|FG000|Study Period 2|Did not continue to meet I/E Criteria|1|||
147194907|NCT01231984|530884165|FG001|Study Period 2|Did not continue to meet I/E Criteria|1|||
147194908|NCT01231984|530884166|FG002|Study Period 2|Did not continue to meet I/E Criteria|0|||
147194909|NCT01231984|530884167|FG003|Study Period 2|Did not continue to meet I/E Criteria|1|||
147194910|NCT02182895|530884170|FG000|Overall Study|Discharged from hospital within 24 hours|2|||
147194911|NCT02182895|530884171|FG001|Overall Study|Discharged from hospital within 24 hours|4|||
147194912|NCT03566511|530884173|FG000|1st Intervention (1 Day)|Study terminated and participant never received Diazoxide (DZX)|1|||
147194913|NCT03566511|530884174|FG001|1st Intervention (1 Day)|Study terminated and participant never received Diazoxide (DZX)|0|||
147194914|NCT04026113|530884175|FG000|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|1|||
147194915|NCT04026113|530884176|FG001|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|2|||
147194916|NCT04026113|530884177|FG002|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
147194917|NCT04026113|530884178|FG003|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|1|||
147194918|NCT04026113|530884175|FG000|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|7|||
147194919|NCT04026113|530884176|FG001|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|5|||
147194920|NCT04026113|530884177|FG002|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|1|||
147194921|NCT04026113|530884178|FG003|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|5|||
147194922|NCT04026113|530884175|FG000|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|4|||
147194923|NCT04026113|530884176|FG001|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|0|||
147194924|NCT04026113|530884177|FG002|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|1|||
147194925|NCT04026113|530884178|FG003|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|0|||
147194926|NCT04026113|530884175|FG000|Double-Blind Treatment Period (12 Weeks)|Physician Decision|1|||
147194927|NCT04026113|530884176|FG001|Double-Blind Treatment Period (12 Weeks)|Physician Decision|1|||
147194928|NCT04026113|530884177|FG002|Double-Blind Treatment Period (12 Weeks)|Physician Decision|1|||
147194929|NCT04026113|530884178|FG003|Double-Blind Treatment Period (12 Weeks)|Physician Decision|0|||
147194930|NCT04026113|530884175|FG000|Double-Blind Treatment Period (12 Weeks)|Other, not specified|4|||
147194931|NCT04026113|530884176|FG001|Double-Blind Treatment Period (12 Weeks)|Other, not specified|3|||
147194932|NCT04026113|530884177|FG002|Double-Blind Treatment Period (12 Weeks)|Other, not specified|0|||
147194933|NCT04026113|530884178|FG003|Double-Blind Treatment Period (12 Weeks)|Other, not specified|1|||
147194934|NCT04026113|530884175|FG000|Double-Blind Treatment Period (12 Weeks)|Adverse Event|2|||
147194935|NCT04026113|530884176|FG001|Double-Blind Treatment Period (12 Weeks)|Adverse Event|2|||
147194936|NCT04026113|530884177|FG002|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
147194937|NCT04026113|530884178|FG003|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
147194938|NCT04026113|530884175|FG000|Double-Blind Treatment Period (12 Weeks)|Non-compliance with study drug|0|||
147534329|NCT03110107|532111413|FG012|Treatment Period|Participant withdrew consent|0|||
147534330|NCT03110107|532111414|FG013|Treatment Period|Participant withdrew consent|0|||
147534331|NCT03110107|532111415|FG014|Treatment Period|Participant withdrew consent|0|||
147534332|NCT03110107|532111416|FG015|Treatment Period|Participant withdrew consent|0|||
147534333|NCT03110107|532111417|FG016|Treatment Period|Participant withdrew consent|0|||
147534334|NCT03110107|532111418|FG017|Treatment Period|Participant withdrew consent|0|||
147534335|NCT03110107|532111419|FG018|Treatment Period|Participant withdrew consent|0|||
147534336|NCT03110107|532111420|FG019|Treatment Period|Participant withdrew consent|1|||
147534337|NCT03110107|532111421|FG020|Treatment Period|Participant withdrew consent|0|||
147534338|NCT03110107|532111422|FG021|Treatment Period|Participant withdrew consent|2|||
147534339|NCT03110107|532111423|FG022|Treatment Period|Participant withdrew consent|0|||
147534340|NCT03110107|532111424|FG023|Treatment Period|Participant withdrew consent|0|||
147534341|NCT03110107|532111425|FG024|Treatment Period|Participant withdrew consent|0|||
147534342|NCT03110107|532111426|FG025|Treatment Period|Participant withdrew consent|2|||
147534343|NCT03110107|532111401|FG000|Treatment Period|Participants no longer meets study criteria|0|||
147534344|NCT03110107|532111402|FG001|Treatment Period|Participants no longer meets study criteria|0|||
147534345|NCT03110107|532111403|FG002|Treatment Period|Participants no longer meets study criteria|0|||
147194939|NCT04026113|530884176|FG001|Double-Blind Treatment Period (12 Weeks)|Non-compliance with study drug|4|||
147194940|NCT04026113|530884177|FG002|Double-Blind Treatment Period (12 Weeks)|Non-compliance with study drug|0|||
147194941|NCT04026113|530884178|FG003|Double-Blind Treatment Period (12 Weeks)|Non-compliance with study drug|0|||
147194942|NCT04026113|530884175|FG000|Double-Blind Treatment Period (12 Weeks)|Protocol Violation|0|||
147194943|NCT04026113|530884176|FG001|Double-Blind Treatment Period (12 Weeks)|Protocol Violation|1|||
147194944|NCT04026113|530884177|FG002|Double-Blind Treatment Period (12 Weeks)|Protocol Violation|0|||
147194945|NCT04026113|530884178|FG003|Double-Blind Treatment Period (12 Weeks)|Protocol Violation|0|||
147194946|NCT04026113|530884175|FG000|Post-Intervention Period (1 Week)|Other, not specified|1|||
147194947|NCT04026113|530884176|FG001|Post-Intervention Period (1 Week)|Other, not specified|0|||
147194948|NCT04026113|530884177|FG002|Post-Intervention Period (1 Week)|Other, not specified|1|||
147194949|NCT04026113|530884178|FG003|Post-Intervention Period (1 Week)|Other, not specified|0|||
147194950|NCT04613362|530884179|FG000|3 Month Follow-up|Lost to Follow-up|1|||
147194951|NCT04613362|530884180|FG001|3 Month Follow-up|Lost to Follow-up|2|||
147194952|NCT04613362|530884179|FG000|6 Month Follow-up|Lost to Follow-up|0|||
147194953|NCT04613362|530884180|FG001|6 Month Follow-up|Lost to Follow-up|1|||
147194954|NCT02218372|530884181|FG000|Overall Study|Adverse Event|1|||
147194955|NCT02218372|530884182|FG001|Overall Study|Adverse Event|1|||
147194956|NCT02218372|530884181|FG000|Overall Study|Miscellaneous|2|||
147194957|NCT02218372|530884182|FG001|Overall Study|Miscellaneous|1|||
147194958|NCT02218372|530884181|FG000|Overall Study|Randomized but did not receive treatment|2|||
147534346|NCT03110107|532111404|FG003|Treatment Period|Participants no longer meets study criteria|0|||
147534347|NCT03110107|532111405|FG004|Treatment Period|Participants no longer meets study criteria|0|||
147534348|NCT03110107|532111406|FG005|Treatment Period|Participants no longer meets study criteria|0|||
147534349|NCT03110107|532111407|FG006|Treatment Period|Participants no longer meets study criteria|0|||
147534350|NCT03110107|532111408|FG007|Treatment Period|Participants no longer meets study criteria|0|||
147534351|NCT03110107|532111409|FG008|Treatment Period|Participants no longer meets study criteria|0|||
147534352|NCT03110107|532111410|FG009|Treatment Period|Participants no longer meets study criteria|0|||
147534353|NCT03110107|532111411|FG010|Treatment Period|Participants no longer meets study criteria|0|||
147534354|NCT03110107|532111412|FG011|Treatment Period|Participants no longer meets study criteria|0|||
147534355|NCT03110107|532111413|FG012|Treatment Period|Participants no longer meets study criteria|0|||
147534356|NCT03110107|532111414|FG013|Treatment Period|Participants no longer meets study criteria|0|||
147534357|NCT03110107|532111415|FG014|Treatment Period|Participants no longer meets study criteria|0|||
147534358|NCT03110107|532111416|FG015|Treatment Period|Participants no longer meets study criteria|0|||
147534359|NCT03110107|532111417|FG016|Treatment Period|Participants no longer meets study criteria|0|||
147534360|NCT03110107|532111418|FG017|Treatment Period|Participants no longer meets study criteria|0|||
147534361|NCT03110107|532111419|FG018|Treatment Period|Participants no longer meets study criteria|0|||
147534362|NCT03110107|532111420|FG019|Treatment Period|Participants no longer meets study criteria|0|||
147534363|NCT03110107|532111421|FG020|Treatment Period|Participants no longer meets study criteria|0|||
147534364|NCT03110107|532111422|FG021|Treatment Period|Participants no longer meets study criteria|0|||
147534365|NCT03110107|532111423|FG022|Treatment Period|Participants no longer meets study criteria|0|||
147534366|NCT03110107|532111424|FG023|Treatment Period|Participants no longer meets study criteria|1|||
147534367|NCT03110107|532111425|FG024|Treatment Period|Participants no longer meets study criteria|0|||
147194959|NCT02218372|530884182|FG001|Overall Study|Randomized but did not receive treatment|3|||
147534368|NCT03110107|532111426|FG025|Treatment Period|Participants no longer meets study criteria|0|||
147534369|NCT03110107|532111401|FG000|Treatment Period|Other Reasons|0|||
147194960|NCT02218372|530884181|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
147534370|NCT03110107|532111402|FG001|Treatment Period|Other Reasons|0|||
147194961|NCT02218372|530884182|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
147194962|NCT03406780|530884183|FG000|Overall Study|Withdrawal by Subject|1|||
147194963|NCT03406780|530884184|FG001|Overall Study|Withdrawal by Subject|1|||
147194964|NCT03406780|530884183|FG000|Overall Study|Other|0|||
147194965|NCT03406780|530884184|FG001|Overall Study|Other|2|||
147194966|NCT01488045|530884186|FG000|Overall Study|Withdrawal by Subject|6|||
147194967|NCT01488045|530884187|FG001|Overall Study|Withdrawal by Subject|11|||
147194968|NCT01488045|530884186|FG000|Overall Study|Failure to present for colonoscopy|3|||
147194969|NCT01488045|530884187|FG001|Overall Study|Failure to present for colonoscopy|6|||
147194970|NCT01488045|530884186|FG000|Overall Study|Failure to report exclusion criteria|0|||
147194971|NCT01488045|530884187|FG001|Overall Study|Failure to report exclusion criteria|1|||
147194972|NCT05365217|530884189|FG000|Treatment Period 1|Withdrawal by Subject|1|||
147194973|NCT05365217|530884190|FG001|Treatment Period 1|Withdrawal by Subject|0|||
147194974|NCT01527149|530884191|FG000|Overall Study|Death|2|||
147194975|NCT02230410|530884192|FG000|Overall Study|Screen Failure|3|||
147194976|NCT04558125|530884196|FG000|Overall Study|Death|1|||
147194977|NCT03199976|530884197|FG000|Overall Study|Lack of Efficacy|3|||
147194978|NCT03199976|530884198|FG001|Overall Study|Lack of Efficacy|6|||
147194979|NCT03199976|530884199|FG002|Overall Study|Lack of Efficacy|13|||
147194980|NCT03199976|530884197|FG000|Overall Study|Withdrawal by Subject|1|||
147194981|NCT03199976|530884198|FG001|Overall Study|Withdrawal by Subject|0|||
147194982|NCT03199976|530884199|FG002|Overall Study|Withdrawal by Subject|0|||
147194983|NCT03199976|530884197|FG000|Overall Study|Lost to Follow-up|0|||
147194984|NCT03199976|530884198|FG001|Overall Study|Lost to Follow-up|1|||
147194985|NCT03199976|530884199|FG002|Overall Study|Lost to Follow-up|1|||
147194986|NCT01761877|530884200|FG000|Overall Study|Adverse Event|7|||
147194987|NCT01761877|530884201|FG001|Overall Study|Adverse Event|0|||
147194988|NCT01761877|530884200|FG000|Overall Study|Withdrawal by Subject|6|||
147194989|NCT01761877|530884201|FG001|Overall Study|Withdrawal by Subject|4|||
147194990|NCT01761877|530884200|FG000|Overall Study|Stopped taking AI Aromatase Inhibitor|1|||
147194991|NCT01761877|530884201|FG001|Overall Study|Stopped taking AI Aromatase Inhibitor|5|||
147194992|NCT01761877|530884200|FG000|Overall Study|Death|0|||
147194993|NCT01761877|530884201|FG001|Overall Study|Death|1|||
147194994|NCT01761877|530884200|FG000|Overall Study|MRI intolerant|1|||
147194995|NCT01761877|530884201|FG001|Overall Study|MRI intolerant|6|||
147194996|NCT00561652|530884207|FG000|Overall Study|Withdrawal by Subject|0|||
147194997|NCT00561652|530884208|FG001|Overall Study|Withdrawal by Subject|1|||
147194998|NCT04842747|530884209|FG000|Overall Study|Withdrawal by Subject|6|||
147194999|NCT04842747|530884210|FG001|Overall Study|Withdrawal by Subject|2|||
147195000|NCT04842747|530884209|FG000|Overall Study|Lost to Follow-up|1|||
147195001|NCT04842747|530884210|FG001|Overall Study|Lost to Follow-up|2|||
147195002|NCT04842747|530884209|FG000|Overall Study|Physician Decision|1|||
147195003|NCT04842747|530884210|FG001|Overall Study|Physician Decision|0|||
147195004|NCT04842747|530884209|FG000|Overall Study|Subject refused all care decision was made to withdraw subject.No study IP given.IRB was consulted .|1|||
147195005|NCT04842747|530884210|FG001|Overall Study|Subject refused all care decision was made to withdraw subject.No study IP given.IRB was consulted .|0|||
147195006|NCT01743469|530884211|FG000|Active Treatment Phase|Adverse Event|10|||
147195007|NCT01743469|530884212|FG001|Active Treatment Phase|Adverse Event|5|||
147195008|NCT01743469|530884213|FG002|Active Treatment Phase|Adverse Event|8|||
147195009|NCT01743469|530884214|FG003|Active Treatment Phase|Adverse Event|1|||
147195010|NCT01743469|530884211|FG000|Active Treatment Phase|Disease Progression|40|||
147195011|NCT01743469|530884212|FG001|Active Treatment Phase|Disease Progression|47|||
147195012|NCT01743469|530884213|FG002|Active Treatment Phase|Disease Progression|30|||
147195013|NCT01743469|530884214|FG003|Active Treatment Phase|Disease Progression|20|||
147195014|NCT01743469|530884211|FG000|Active Treatment Phase|Withdrawal by Subject|2|||
147195015|NCT01743469|530884212|FG001|Active Treatment Phase|Withdrawal by Subject|3|||
147195016|NCT01743469|530884213|FG002|Active Treatment Phase|Withdrawal by Subject|0|||
147434352|NCT02038920|531756380|FG002|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|0|||
147434353|NCT02038920|531756381|FG003|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|0|||
147434354|NCT02038920|531756382|FG004|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|0|||
147434355|NCT02038920|531756383|FG005|Induction Phase (Week 0 to 14)|Pretreatment Event/Adverse Event|0|||
147434356|NCT02038920|531756378|FG000|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|2|||
147434357|NCT02038920|531756379|FG001|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0|||
147434358|NCT02038920|531756380|FG002|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0|||
147434359|NCT02038920|531756381|FG003|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0|||
147434360|NCT02038920|531756382|FG004|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0|||
147434361|NCT02038920|531756383|FG005|Induction Phase (Week 0 to 14)|Voluntary Withdrawal|0|||
147434362|NCT02038920|531756378|FG000|Induction Phase (Week 0 to 14)|Lack of Efficacy|1|||
147434363|NCT02038920|531756379|FG001|Induction Phase (Week 0 to 14)|Lack of Efficacy|1|||
147534371|NCT03110107|532111403|FG002|Treatment Period|Other Reasons|1|||
147195017|NCT01743469|530884214|FG003|Active Treatment Phase|Withdrawal by Subject|0|||
147195018|NCT01743469|530884211|FG000|Active Treatment Phase|Missing|1|||
147195019|NCT01743469|530884212|FG001|Active Treatment Phase|Missing|0|||
147195020|NCT01743469|530884213|FG002|Active Treatment Phase|Missing|0|||
147534372|NCT03110107|532111404|FG003|Treatment Period|Other Reasons|1|||
147534373|NCT03110107|532111405|FG004|Treatment Period|Other Reasons|0|||
147534374|NCT03110107|532111406|FG005|Treatment Period|Other Reasons|1|||
147534375|NCT03110107|532111407|FG006|Treatment Period|Other Reasons|0|||
147534376|NCT03110107|532111408|FG007|Treatment Period|Other Reasons|0|||
147534377|NCT03110107|532111409|FG008|Treatment Period|Other Reasons|0|||
147534378|NCT03110107|532111410|FG009|Treatment Period|Other Reasons|0|||
147534379|NCT03110107|532111411|FG010|Treatment Period|Other Reasons|0|||
147534380|NCT03110107|532111412|FG011|Treatment Period|Other Reasons|0|||
147534381|NCT03110107|532111413|FG012|Treatment Period|Other Reasons|0|||
147534382|NCT03110107|532111414|FG013|Treatment Period|Other Reasons|0|||
147534383|NCT03110107|532111415|FG014|Treatment Period|Other Reasons|0|||
147534384|NCT03110107|532111416|FG015|Treatment Period|Other Reasons|0|||
147534385|NCT03110107|532111417|FG016|Treatment Period|Other Reasons|0|||
147534386|NCT03110107|532111418|FG017|Treatment Period|Other Reasons|0|||
147534387|NCT03110107|532111419|FG018|Treatment Period|Other Reasons|0|||
147534388|NCT03110107|532111420|FG019|Treatment Period|Other Reasons|0|||
147534389|NCT03110107|532111421|FG020|Treatment Period|Other Reasons|0|||
147534390|NCT03110107|532111422|FG021|Treatment Period|Other Reasons|0|||
147534391|NCT03110107|532111423|FG022|Treatment Period|Other Reasons|0|||
147534392|NCT03110107|532111424|FG023|Treatment Period|Other Reasons|0|||
147534393|NCT03110107|532111425|FG024|Treatment Period|Other Reasons|1|||
147195021|NCT01743469|530884214|FG003|Active Treatment Phase|Missing|0|||
147195022|NCT01743469|530884211|FG000|Follow-up Period - Post-Treatment|Withdrawal by Subject|1|||
147195023|NCT01743469|530884212|FG001|Follow-up Period - Post-Treatment|Withdrawal by Subject|0|||
147195024|NCT01743469|530884213|FG002|Follow-up Period - Post-Treatment|Withdrawal by Subject|1|||
147195025|NCT01743469|530884214|FG003|Follow-up Period - Post-Treatment|Withdrawal by Subject|0|||
147195026|NCT01743469|530884211|FG000|Follow-up Period - Post-Treatment|Death|43|||
147195027|NCT01743469|530884212|FG001|Follow-up Period - Post-Treatment|Death|47|||
147195028|NCT01743469|530884213|FG002|Follow-up Period - Post-Treatment|Death|22|||
147195029|NCT01743469|530884214|FG003|Follow-up Period - Post-Treatment|Death|16|||
147195030|NCT01743469|530884211|FG000|Follow-up Period - Post-Treatment|Lost to Follow-up|1|||
147195031|NCT01743469|530884212|FG001|Follow-up Period - Post-Treatment|Lost to Follow-up|1|||
147195032|NCT01743469|530884213|FG002|Follow-up Period - Post-Treatment|Lost to Follow-up|0|||
147195033|NCT01743469|530884214|FG003|Follow-up Period - Post-Treatment|Lost to Follow-up|0|||
147195034|NCT00317473|530884215|FG000|Overall Study|Withdrawal by Subject|2|||
147195035|NCT00317473|530884216|FG001|Overall Study|Withdrawal by Subject|1|||
147195036|NCT00317473|530884217|FG002|Overall Study|Withdrawal by Subject|2|||
147195037|NCT00317473|530884218|FG003|Overall Study|Withdrawal by Subject|1|||
147195038|NCT00317473|530884219|FG004|Overall Study|Withdrawal by Subject|3|||
147534394|NCT03110107|532111426|FG025|Treatment Period|Other Reasons|0|||
147534395|NCT03526549|532111428|FG000|180 Days Observational Phase|Participants who Received Placebo in Parent Studies were Discontinued|0|||
147534396|NCT03526549|532111429|FG001|180 Days Observational Phase|Participants who Received Placebo in Parent Studies were Discontinued|238|||
147534397|NCT03526549|532111428|FG000|180 Days Observational Phase|Withdrawal by Subject|40|||
147534398|NCT03526549|532111429|FG001|180 Days Observational Phase|Withdrawal by Subject|2|||
147534399|NCT03526549|532111428|FG000|180 Days Observational Phase|Lost to Follow-up|1|||
147195039|NCT00317473|530884220|FG005|Overall Study|Withdrawal by Subject|1|||
147195040|NCT00317473|530884215|FG000|Overall Study|Relocation|1|||
147195041|NCT00317473|530884216|FG001|Overall Study|Relocation|0|||
147195042|NCT00317473|530884217|FG002|Overall Study|Relocation|1|||
147195043|NCT00317473|530884218|FG003|Overall Study|Relocation|1|||
147195044|NCT00317473|530884219|FG004|Overall Study|Relocation|5|||
147195045|NCT00317473|530884220|FG005|Overall Study|Relocation|2|||
147195046|NCT00317473|530884215|FG000|Overall Study|Death|1|||
147195047|NCT00317473|530884216|FG001|Overall Study|Death|0|||
147195048|NCT00317473|530884217|FG002|Overall Study|Death|0|||
147534400|NCT03526549|532111429|FG001|180 Days Observational Phase|Lost to Follow-up|0|||
147534401|NCT03526549|532111428|FG000|Open-label Phase|Adverse Event|4|||
147534402|NCT03526549|532111429|FG001|Open-label Phase|Adverse Event|0|||
147534403|NCT03526549|532111428|FG000|Open-label Phase|Withdrawal by Subject|54|||
147534404|NCT03526549|532111429|FG001|Open-label Phase|Withdrawal by Subject|0|||
147534405|NCT03526549|532111428|FG000|Open-label Phase|Lost to Follow-up|35|||
147534406|NCT03526549|532111429|FG001|Open-label Phase|Lost to Follow-up|0|||
147534407|NCT03526549|532111428|FG000|Open-label Phase|Other than Specified|5|||
147534408|NCT03526549|532111429|FG001|Open-label Phase|Other than Specified|0|||
147534409|NCT03927989|532111433|FG000|Overall Study|Withdrawal by Subject|0|||
147534410|NCT03927989|532111434|FG001|Overall Study|Withdrawal by Subject|1|||
147534411|NCT02593175|532111435|FG000|Overall Study|Adverse Event|5|||
147534412|NCT02593175|532111435|FG000|Overall Study|Disease progression|4|||
147534413|NCT00478933|532111439|FG000|Overall Study|Protocol Violation|22|||
147195049|NCT00317473|530884218|FG003|Overall Study|Death|0|||
147195050|NCT00317473|530884219|FG004|Overall Study|Death|0|||
147195051|NCT00317473|530884220|FG005|Overall Study|Death|0|||
147195052|NCT00317473|530884215|FG000|Overall Study|Other|0|||
147195053|NCT00317473|530884216|FG001|Overall Study|Other|2|||
147195054|NCT00317473|530884217|FG002|Overall Study|Other|0|||
147195055|NCT00317473|530884218|FG003|Overall Study|Other|0|||
147195056|NCT00317473|530884219|FG004|Overall Study|Other|0|||
147195057|NCT00317473|530884220|FG005|Overall Study|Other|0|||
147195058|NCT01502293|530884223|FG000|Overall Study|Progressive Disease|20|||
147195059|NCT01502293|530884224|FG001|Overall Study|Progressive Disease|12|||
147195060|NCT01502293|530884225|FG002|Overall Study|Progressive Disease|2|||
147195061|NCT01502293|530884223|FG000|Overall Study|Withdrawal by Subject|3|||
147195062|NCT01502293|530884224|FG001|Overall Study|Withdrawal by Subject|3|||
147195063|NCT01502293|530884225|FG002|Overall Study|Withdrawal by Subject|1|||
147195064|NCT01502293|530884223|FG000|Overall Study|Adverse Event|0|||
147195065|NCT01502293|530884224|FG001|Overall Study|Adverse Event|2|||
147195066|NCT01502293|530884225|FG002|Overall Study|Adverse Event|0|||
147195067|NCT01502293|530884223|FG000|Overall Study|Reason Not Specified|2|||
147195068|NCT01502293|530884224|FG001|Overall Study|Reason Not Specified|0|||
147195069|NCT01502293|530884225|FG002|Overall Study|Reason Not Specified|0|||
147195070|NCT01502293|530884223|FG000|Overall Study|Physician Decision|0|||
147195071|NCT01502293|530884224|FG001|Overall Study|Physician Decision|0|||
147195072|NCT01502293|530884225|FG002|Overall Study|Physician Decision|1|||
147195073|NCT01126749|530884229|FG000|Phase 1b|Other|0|||
147195074|NCT01126749|530884230|FG001|Phase 1b|Other|1|||
147195075|NCT01126749|530884231|FG002|Phase 1b|Other|0|||
147195076|NCT01126749|530884232|FG003|Phase 1b|Other|0|||
147195077|NCT01126749|530884229|FG000|Phase 1b|Withdrawal by Subject|0|||
147195078|NCT01126749|530884230|FG001|Phase 1b|Withdrawal by Subject|1|||
147195079|NCT01126749|530884231|FG002|Phase 1b|Withdrawal by Subject|0|||
147195080|NCT01126749|530884232|FG003|Phase 1b|Withdrawal by Subject|0|||
147195081|NCT01126749|530884229|FG000|Phase 1b|Death|3|||
147195082|NCT01126749|530884230|FG001|Phase 1b|Death|4|||
147195083|NCT01126749|530884231|FG002|Phase 1b|Death|0|||
147195084|NCT01126749|530884232|FG003|Phase 1b|Death|0|||
147195085|NCT01126749|530884229|FG000|Phase 2|Completed 1 Year Follow-Up Per Protocol|0|||
147195086|NCT01126749|530884230|FG001|Phase 2|Completed 1 Year Follow-Up Per Protocol|0|||
147195087|NCT01126749|530884231|FG002|Phase 2|Completed 1 Year Follow-Up Per Protocol|4|||
147195088|NCT01126749|530884232|FG003|Phase 2|Completed 1 Year Follow-Up Per Protocol|7|||
147195089|NCT01126749|530884229|FG000|Phase 2|Study Termination by Sponsor|0|||
147195090|NCT01126749|530884230|FG001|Phase 2|Study Termination by Sponsor|0|||
147195091|NCT01126749|530884231|FG002|Phase 2|Study Termination by Sponsor|12|||
147195092|NCT01126749|530884232|FG003|Phase 2|Study Termination by Sponsor|6|||
147195093|NCT01126749|530884229|FG000|Phase 2|Other|0|||
147195094|NCT01126749|530884230|FG001|Phase 2|Other|0|||
147195095|NCT01126749|530884231|FG002|Phase 2|Other|4|||
147195096|NCT01126749|530884232|FG003|Phase 2|Other|2|||
147195097|NCT01126749|530884229|FG000|Phase 2|Withdrawal by Subject|0|||
147195098|NCT01126749|530884230|FG001|Phase 2|Withdrawal by Subject|0|||
147195099|NCT01126749|530884231|FG002|Phase 2|Withdrawal by Subject|0|||
147195100|NCT01126749|530884232|FG003|Phase 2|Withdrawal by Subject|2|||
147195101|NCT01126749|530884229|FG000|Phase 2|Lost to Follow-up|0|||
147195102|NCT01126749|530884230|FG001|Phase 2|Lost to Follow-up|0|||
147195103|NCT01126749|530884231|FG002|Phase 2|Lost to Follow-up|0|||
147195104|NCT01126749|530884232|FG003|Phase 2|Lost to Follow-up|1|||
147195105|NCT01126749|530884229|FG000|Phase 2|Death|0|||
147195106|NCT01126749|530884230|FG001|Phase 2|Death|0|||
147195107|NCT01126749|530884231|FG002|Phase 2|Death|22|||
147195108|NCT01126749|530884232|FG003|Phase 2|Death|22|||
147195109|NCT01126749|530884229|FG000|Phase 2|Adverse Event|0|||
147195110|NCT01126749|530884230|FG001|Phase 2|Adverse Event|0|||
147195111|NCT01126749|530884231|FG002|Phase 2|Adverse Event|0|||
147195112|NCT01126749|530884232|FG003|Phase 2|Adverse Event|1|||
147195113|NCT00976274|530884234|FG000|Overall Study|Lost to Follow-up|5|||
147534414|NCT00478933|532111439|FG000|Overall Study|Informed consent not verified|3|||
147195114|NCT00976274|530884235|FG001|Overall Study|Lost to Follow-up|5|||
147195115|NCT00976274|530884234|FG000|Overall Study|Withdrawal by Subject|1|||
147195116|NCT00976274|530884235|FG001|Overall Study|Withdrawal by Subject|1|||
147195117|NCT00976274|530884234|FG000|Overall Study|Physician Decision|1|||
147195118|NCT00976274|530884235|FG001|Overall Study|Physician Decision|2|||
147195119|NCT00627393|530884236|FG000|Intention-To-Treat Analysis|Adjudication indeterminate|5|||
147195120|NCT00627393|530884237|FG001|Intention-To-Treat Analysis|Adjudication indeterminate|3|||
147195121|NCT00627393|530884236|FG000|Intention-To-Treat Analysis|Withdrawal by patient/family/physician|4|||
147195122|NCT00627393|530884237|FG001|Intention-To-Treat Analysis|Withdrawal by patient/family/physician|5|||
147195123|NCT00627393|530884236|FG000|Per-Protocol Analysis|Received unstimulated/no granulocytes|6|||
147195124|NCT00627393|530884237|FG001|Per-Protocol Analysis|Received unstimulated/no granulocytes|3|||
147534415|NCT00478933|532111439|FG000|Overall Study|Inadequate data available|53|||
147534416|NCT00643006|532111441|FG000|Overall Study|Lost to Follow-up|5|||
147534417|NCT00643006|532111442|FG001|Overall Study|Lost to Follow-up|4|||
147534418|NCT03772574|532111443|FG000|Overall Study|Protocol Violation|2|||
147534419|NCT03772574|532111444|FG001|Overall Study|Protocol Violation|0|||
147534420|NCT03772574|532111445|FG002|Overall Study|Protocol Violation|0|||
147534421|NCT03772574|532111443|FG000|Overall Study|Discomfort|0|||
147534422|NCT03772574|532111444|FG001|Overall Study|Discomfort|5|||
147534423|NCT03772574|532111445|FG002|Overall Study|Discomfort|4|||
147534424|NCT03586427|532111451|FG000|Overall Study|Lost to Follow-up|0|||
147534425|NCT03586427|532111452|FG001|Overall Study|Lost to Follow-up|3|||
147534426|NCT03586427|532111453|FG002|Overall Study|Lost to Follow-up|1|||
147195125|NCT00627393|530884236|FG000|Per-Protocol Analysis|Withdrawal by patient/family/physician|4|||
147195126|NCT00627393|530884237|FG001|Per-Protocol Analysis|Withdrawal by patient/family/physician|10|||
147195127|NCT02183675|530884238|FG000|Treatment Period 2 (10 Days)|Adverse Event|0|||
147195128|NCT02183675|530884239|FG001|Treatment Period 2 (10 Days)|Adverse Event|0|||
147195129|NCT02183675|530884240|FG002|Treatment Period 2 (10 Days)|Adverse Event|0|||
147195130|NCT02183675|530884241|FG003|Treatment Period 2 (10 Days)|Adverse Event|0|||
147534427|NCT03586427|532111454|FG003|Overall Study|Lost to Follow-up|3|||
147195131|NCT02183675|530884242|FG004|Treatment Period 2 (10 Days)|Adverse Event|0|||
147195132|NCT02183675|530884243|FG005|Treatment Period 2 (10 Days)|Adverse Event|2|||
147195133|NCT03337308|530884244|FG000|Overall Study|Adverse Event|2|||
147195134|NCT03337308|530884245|FG001|Overall Study|Adverse Event|3|||
147195135|NCT03337308|530884246|FG002|Overall Study|Adverse Event|3|||
147195136|NCT03337308|530884247|FG003|Overall Study|Adverse Event|1|||
147195137|NCT03337308|530884244|FG000|Overall Study|Lost to Follow-up|1|||
147195138|NCT03337308|530884245|FG001|Overall Study|Lost to Follow-up|2|||
147195139|NCT03337308|530884246|FG002|Overall Study|Lost to Follow-up|0|||
147195140|NCT03337308|530884247|FG003|Overall Study|Lost to Follow-up|0|||
147195141|NCT03337308|530884244|FG000|Overall Study|Withdrawal by Subject|2|||
147195142|NCT03337308|530884245|FG001|Overall Study|Withdrawal by Subject|1|||
147195143|NCT03337308|530884246|FG002|Overall Study|Withdrawal by Subject|2|||
147195144|NCT03337308|530884247|FG003|Overall Study|Withdrawal by Subject|1|||
147195145|NCT03337308|530884244|FG000|Overall Study|Protocol Violation|0|||
147195146|NCT03337308|530884245|FG001|Overall Study|Protocol Violation|1|||
147195147|NCT03337308|530884246|FG002|Overall Study|Protocol Violation|0|||
147195148|NCT03337308|530884247|FG003|Overall Study|Protocol Violation|0|||
147195149|NCT01614249|530884251|FG000|Overall Study|Lost to Follow-up|11|||
147195150|NCT01614249|530884252|FG001|Overall Study|Lost to Follow-up|23|||
147195151|NCT02761330|530884264|FG000|Treatment Week 1|Withdrawal by Subject|0|||
147195152|NCT02761330|530884265|FG001|Treatment Week 1|Withdrawal by Subject|0|||
147195153|NCT02761330|530884266|FG002|Treatment Week 1|Withdrawal by Subject|0|||
147195154|NCT02761330|530884267|FG003|Treatment Week 1|Withdrawal by Subject|1|||
147195155|NCT02761330|530884268|FG004|Treatment Week 1|Withdrawal by Subject|0|||
147195156|NCT02761330|530884269|FG005|Treatment Week 1|Withdrawal by Subject|1|||
147195157|NCT00888134|530884270|FG000|Treatment With Study Drug|Withdrawal by Subject|1|||
147195158|NCT00888134|530884270|FG000|Follow-up|being followed for long-term survival|1|||
147195159|NCT03043313|530884271|FG000|Overall Study|Withdrawal by Subject|5|||
147195160|NCT03043313|530884272|FG001|Overall Study|Withdrawal by Subject|1|||
147195161|NCT03043313|530884273|FG002|Overall Study|Withdrawal by Subject|1|||
147195162|NCT03043313|530884271|FG000|Overall Study|Lost to Follow-up|1|||
147195163|NCT03043313|530884272|FG001|Overall Study|Lost to Follow-up|1|||
147195164|NCT03043313|530884273|FG002|Overall Study|Lost to Follow-up|0|||
147195165|NCT03043313|530884271|FG000|Overall Study|Death|28|||
147195166|NCT03043313|530884272|FG001|Overall Study|Death|26|||
147195167|NCT03043313|530884273|FG002|Overall Study|Death|17|||
147195168|NCT03043313|530884271|FG000|Overall Study|Participation terminated by sponsor|11|||
147195169|NCT03043313|530884272|FG001|Overall Study|Participation terminated by sponsor|13|||
147195170|NCT03043313|530884273|FG002|Overall Study|Participation terminated by sponsor|13|||
147195171|NCT02657889|530884274|FG000|Phase 1: (Up to a Maximum of 22 Months)|Death|5|||
147195172|NCT02657889|530884275|FG001|Phase 1: (Up to a Maximum of 22 Months)|Death|5|||
147195173|NCT02657889|530884276|FG002|Phase 1: (Up to a Maximum of 22 Months)|Death|0|||
147195174|NCT02657889|530884277|FG003|Phase 1: (Up to a Maximum of 22 Months)|Death|0|||
147195175|NCT02657889|530884274|FG000|Phase 1: (Up to a Maximum of 22 Months)|Lost to Follow-up|2|||
147195176|NCT02657889|530884275|FG001|Phase 1: (Up to a Maximum of 22 Months)|Lost to Follow-up|0|||
147195177|NCT02657889|530884276|FG002|Phase 1: (Up to a Maximum of 22 Months)|Lost to Follow-up|0|||
147195178|NCT02657889|530884277|FG003|Phase 1: (Up to a Maximum of 22 Months)|Lost to Follow-up|0|||
147195179|NCT02657889|530884274|FG000|Phase 1: (Up to a Maximum of 22 Months)|Sponsor decision|0|||
147195180|NCT02657889|530884275|FG001|Phase 1: (Up to a Maximum of 22 Months)|Sponsor decision|1|||
147195181|NCT02657889|530884276|FG002|Phase 1: (Up to a Maximum of 22 Months)|Sponsor decision|0|||
147195182|NCT02657889|530884277|FG003|Phase 1: (Up to a Maximum of 22 Months)|Sponsor decision|0|||
147195183|NCT02657889|530884274|FG000|Phase 1: (Up to a Maximum of 22 Months)|Radiologic Disease Progression|0|||
147195184|NCT02657889|530884275|FG001|Phase 1: (Up to a Maximum of 22 Months)|Radiologic Disease Progression|1|||
147195185|NCT02657889|530884276|FG002|Phase 1: (Up to a Maximum of 22 Months)|Radiologic Disease Progression|0|||
147195186|NCT02657889|530884277|FG003|Phase 1: (Up to a Maximum of 22 Months)|Radiologic Disease Progression|0|||
147195187|NCT02657889|530884274|FG000|Phase 2: (Up to a Maximum of 54 Months)|Death|0|||
147195188|NCT02657889|530884275|FG001|Phase 2: (Up to a Maximum of 54 Months)|Death|0|||
147195189|NCT02657889|530884276|FG002|Phase 2: (Up to a Maximum of 54 Months)|Death|30|||
147195190|NCT02657889|530884277|FG003|Phase 2: (Up to a Maximum of 54 Months)|Death|42|||
147195191|NCT02657889|530884274|FG000|Phase 2: (Up to a Maximum of 54 Months)|Lost to Follow-up|0|||
147195192|NCT02657889|530884275|FG001|Phase 2: (Up to a Maximum of 54 Months)|Lost to Follow-up|0|||
147195193|NCT02657889|530884276|FG002|Phase 2: (Up to a Maximum of 54 Months)|Lost to Follow-up|5|||
147195194|NCT02657889|530884277|FG003|Phase 2: (Up to a Maximum of 54 Months)|Lost to Follow-up|2|||
147195195|NCT02657889|530884274|FG000|Phase 2: (Up to a Maximum of 54 Months)|Withdrawal by Subject|0|||
147195196|NCT02657889|530884275|FG001|Phase 2: (Up to a Maximum of 54 Months)|Withdrawal by Subject|0|||
147195197|NCT02657889|530884276|FG002|Phase 2: (Up to a Maximum of 54 Months)|Withdrawal by Subject|8|||
147195198|NCT02657889|530884277|FG003|Phase 2: (Up to a Maximum of 54 Months)|Withdrawal by Subject|2|||
147195199|NCT02657889|530884274|FG000|Phase 2: (Up to a Maximum of 54 Months)|Sponsor decision|0|||
147195200|NCT02657889|530884275|FG001|Phase 2: (Up to a Maximum of 54 Months)|Sponsor decision|0|||
147195201|NCT02657889|530884276|FG002|Phase 2: (Up to a Maximum of 54 Months)|Sponsor decision|2|||
147534428|NCT03586427|532111455|FG004|Overall Study|Lost to Follow-up|3|||
147195202|NCT02657889|530884277|FG003|Phase 2: (Up to a Maximum of 54 Months)|Sponsor decision|2|||
147195203|NCT02657889|530884274|FG000|Phase 2: (Up to a Maximum of 54 Months)|Radiologic Disease Progression|0|||
147195204|NCT02657889|530884275|FG001|Phase 2: (Up to a Maximum of 54 Months)|Radiologic Disease Progression|0|||
147195205|NCT02657889|530884276|FG002|Phase 2: (Up to a Maximum of 54 Months)|Radiologic Disease Progression|6|||
147195206|NCT02657889|530884277|FG003|Phase 2: (Up to a Maximum of 54 Months)|Radiologic Disease Progression|1|||
147195207|NCT02657889|530884274|FG000|Phase 2: (Up to a Maximum of 54 Months)|Physician Decision|0|||
147195208|NCT02657889|530884275|FG001|Phase 2: (Up to a Maximum of 54 Months)|Physician Decision|0|||
147195209|NCT02657889|530884276|FG002|Phase 2: (Up to a Maximum of 54 Months)|Physician Decision|0|||
147195210|NCT02657889|530884277|FG003|Phase 2: (Up to a Maximum of 54 Months)|Physician Decision|1|||
147195211|NCT02657889|530884274|FG000|Phase 2: (Up to a Maximum of 54 Months)|Participant request|0|||
147195212|NCT02657889|530884275|FG001|Phase 2: (Up to a Maximum of 54 Months)|Participant request|0|||
147195213|NCT02657889|530884276|FG002|Phase 2: (Up to a Maximum of 54 Months)|Participant request|2|||
147195214|NCT02657889|530884277|FG003|Phase 2: (Up to a Maximum of 54 Months)|Participant request|1|||
147195215|NCT02657889|530884274|FG000|Phase 2: (Up to a Maximum of 54 Months)|Participants went on Rollover Study|0|||
147195216|NCT02657889|530884275|FG001|Phase 2: (Up to a Maximum of 54 Months)|Participants went on Rollover Study|0|||
147195217|NCT02657889|530884276|FG002|Phase 2: (Up to a Maximum of 54 Months)|Participants went on Rollover Study|0|||
147195218|NCT02657889|530884277|FG003|Phase 2: (Up to a Maximum of 54 Months)|Participants went on Rollover Study|4|||
147195219|NCT00795535|530884278|FG000|Overall Study|incomplete data and technical problems|20|||
147195220|NCT03341299|530884279|FG000|Washout (A Minimum of 21 Hours)|Adverse Event|0|||
147195221|NCT03341299|530884280|FG001|Washout (A Minimum of 21 Hours)|Adverse Event|0|||
147195222|NCT03341299|530884281|FG002|Washout (A Minimum of 21 Hours)|Adverse Event|1|||
147195223|NCT03341299|530884282|FG003|Washout (A Minimum of 21 Hours)|Adverse Event|0|||
147195224|NCT02702492|530884283|FG000|Overall Study|Disease progression|3|||
147195225|NCT02702492|530884284|FG001|Overall Study|Disease progression|3|||
147195226|NCT02702492|530884285|FG002|Overall Study|Disease progression|2|||
147195227|NCT02702492|530884286|FG003|Overall Study|Disease progression|4|||
147195228|NCT02702492|530884287|FG004|Overall Study|Disease progression|4|||
147195229|NCT02702492|530884288|FG005|Overall Study|Disease progression|1|||
147195230|NCT02702492|530884289|FG006|Overall Study|Disease progression|2|||
147195231|NCT02702492|530884290|FG007|Overall Study|Disease progression|8|||
147195232|NCT02702492|530884291|FG008|Overall Study|Disease progression|5|||
147195233|NCT02702492|530884292|FG009|Overall Study|Disease progression|1|||
147195234|NCT02702492|530884293|FG010|Overall Study|Disease progression|0|||
147195235|NCT02702492|530884294|FG011|Overall Study|Disease progression|3|||
147195236|NCT02702492|530884295|FG012|Overall Study|Disease progression|2|||
147195237|NCT02702492|530884283|FG000|Overall Study|Clinical progression|0|||
147195238|NCT02702492|530884284|FG001|Overall Study|Clinical progression|0|||
147195239|NCT02702492|530884285|FG002|Overall Study|Clinical progression|2|||
147195240|NCT02702492|530884286|FG003|Overall Study|Clinical progression|1|||
147195241|NCT02702492|530884287|FG004|Overall Study|Clinical progression|0|||
147195242|NCT02702492|530884288|FG005|Overall Study|Clinical progression|2|||
147195243|NCT02702492|530884289|FG006|Overall Study|Clinical progression|1|||
147195244|NCT02702492|530884290|FG007|Overall Study|Clinical progression|4|||
147195245|NCT02702492|530884291|FG008|Overall Study|Clinical progression|0|||
147195246|NCT02702492|530884292|FG009|Overall Study|Clinical progression|0|||
147195247|NCT02702492|530884293|FG010|Overall Study|Clinical progression|1|||
147195248|NCT02702492|530884294|FG011|Overall Study|Clinical progression|2|||
147195249|NCT02702492|530884295|FG012|Overall Study|Clinical progression|0|||
147195250|NCT02702492|530884283|FG000|Overall Study|Adverse Event|0|||
147195251|NCT02702492|530884284|FG001|Overall Study|Adverse Event|0|||
147195252|NCT02702492|530884285|FG002|Overall Study|Adverse Event|1|||
147195253|NCT02702492|530884286|FG003|Overall Study|Adverse Event|2|||
147195254|NCT02702492|530884287|FG004|Overall Study|Adverse Event|1|||
147195255|NCT02702492|530884288|FG005|Overall Study|Adverse Event|0|||
147195256|NCT02702492|530884289|FG006|Overall Study|Adverse Event|1|||
147195257|NCT02702492|530884290|FG007|Overall Study|Adverse Event|0|||
147195258|NCT02702492|530884291|FG008|Overall Study|Adverse Event|2|||
147195259|NCT02702492|530884292|FG009|Overall Study|Adverse Event|0|||
147195260|NCT02702492|530884293|FG010|Overall Study|Adverse Event|0|||
147195261|NCT02702492|530884294|FG011|Overall Study|Adverse Event|0|||
147195262|NCT02702492|530884295|FG012|Overall Study|Adverse Event|1|||
147195263|NCT02702492|530884283|FG000|Overall Study|Other|0|||
147195264|NCT02702492|530884284|FG001|Overall Study|Other|0|||
147195265|NCT02702492|530884285|FG002|Overall Study|Other|0|||
147195266|NCT02702492|530884286|FG003|Overall Study|Other|0|||
147195267|NCT02702492|530884287|FG004|Overall Study|Other|0|||
147195268|NCT02702492|530884288|FG005|Overall Study|Other|0|||
147195269|NCT02702492|530884289|FG006|Overall Study|Other|0|||
147195270|NCT02702492|530884290|FG007|Overall Study|Other|0|||
147195271|NCT02702492|530884291|FG008|Overall Study|Other|0|||
147195272|NCT02702492|530884292|FG009|Overall Study|Other|0|||
147195273|NCT02702492|530884293|FG010|Overall Study|Other|0|||
147195274|NCT02702492|530884294|FG011|Overall Study|Other|0|||
147195275|NCT02702492|530884295|FG012|Overall Study|Other|1|||
147195276|NCT00781768|530886499|FG000|Overall Study|Not transplanted.|0|||
147195277|NCT00781768|530886500|FG001|Overall Study|Not transplanted.|2|||
147195278|NCT02458313|530886509|FG000|Overall Study|Withdrawal by Subject|6|||
147195279|NCT02458313|530886510|FG001|Overall Study|Withdrawal by Subject|8|||
147195280|NCT02458313|530886509|FG000|Overall Study|Excluded for motion during MRI|1|||
147195281|NCT02458313|530886510|FG001|Overall Study|Excluded for motion during MRI|2|||
147195282|NCT00199381|530886511|FG000|Overall Study|Withdrawal by Subject|38|||
147195283|NCT00199381|530886511|FG000|Overall Study|Adverse Event|73|||
147195284|NCT00199381|530886511|FG000|Overall Study|Protocol Violation|6|||
147195285|NCT00199381|530886511|FG000|Overall Study|Lack of Efficacy|27|||
147195286|NCT00199381|530886511|FG000|Overall Study|Not including due to early termination|37|||
147195287|NCT00199381|530886511|FG000|Overall Study|Study termination by Sponsor|323|||
147195288|NCT02892344|530886513|FG000|Overall Study|Protocol deviation|3|||
147195289|NCT02892344|530886514|FG001|Overall Study|Protocol deviation|4|||
147195290|NCT02892344|530886513|FG000|Overall Study|Adverse Event|1|||
147195291|NCT02892344|530886514|FG001|Overall Study|Adverse Event|8|||
147195292|NCT02892344|530886513|FG000|Overall Study|Lost to Follow-up|0|||
147195293|NCT02892344|530886514|FG001|Overall Study|Lost to Follow-up|1|||
147195294|NCT02892344|530886513|FG000|Overall Study|Non-compliance with study treatment|0|||
147195295|NCT02892344|530886514|FG001|Overall Study|Non-compliance with study treatment|1|||
147195296|NCT02892344|530886513|FG000|Overall Study|Physician Decision|0|||
147195297|NCT02892344|530886514|FG001|Overall Study|Physician Decision|2|||
147195298|NCT02892344|530886513|FG000|Overall Study|Subject/guardian decision|0|||
147195299|NCT02892344|530886514|FG001|Overall Study|Subject/guardian decision|4|||
147195300|NCT02892344|530886513|FG000|Overall Study|Technical problems|0|||
147195301|NCT02892344|530886514|FG001|Overall Study|Technical problems|1|||
147195302|NCT01295814|530886515|FG000|Overall Study|Lack of Efficacy|0|||
147195303|NCT01295814|530886516|FG001|Overall Study|Lack of Efficacy|2|||
147195304|NCT01295814|530886515|FG000|Overall Study|Withdrawal by Subject|2|||
147195305|NCT01295814|530886516|FG001|Overall Study|Withdrawal by Subject|0|||
147195306|NCT04106557|530886522|FG000|Overall Study|Physician Decision|0|||
147195307|NCT04106557|530886523|FG001|Overall Study|Physician Decision|1|||
147195308|NCT04106557|530886524|FG002|Overall Study|Physician Decision|0|||
147195309|NCT04106557|530886522|FG000|Overall Study|Protocol Violation|0|||
147195310|NCT04106557|530886523|FG001|Overall Study|Protocol Violation|1|||
147195311|NCT04106557|530886524|FG002|Overall Study|Protocol Violation|0|||
147195312|NCT02326155|530886525|FG000|Overall Study|Adverse Event|21|||
147195313|NCT02326155|530886526|FG001|Overall Study|Adverse Event|5|||
147195314|NCT02326155|530886525|FG000|Overall Study|Death|3|||
147195315|NCT02326155|530886526|FG001|Overall Study|Death|0|||
147195316|NCT02326155|530886525|FG000|Overall Study|Lack of Efficacy|49|||
147195317|NCT02326155|530886526|FG001|Overall Study|Lack of Efficacy|5|||
147195318|NCT02326155|530886525|FG000|Overall Study|Lost to Follow-up|14|||
147195319|NCT02326155|530886526|FG001|Overall Study|Lost to Follow-up|3|||
147195320|NCT02326155|530886525|FG000|Overall Study|Protocol Violation|2|||
147195321|NCT02326155|530886526|FG001|Overall Study|Protocol Violation|0|||
147195322|NCT02326155|530886525|FG000|Overall Study|Withdrawal by Subject|34|||
147195323|NCT02326155|530886526|FG001|Overall Study|Withdrawal by Subject|11|||
147195324|NCT02326155|530886525|FG000|Overall Study|Disease progression|37|||
147195325|NCT02326155|530886526|FG001|Overall Study|Disease progression|4|||
147195326|NCT02326155|530886525|FG000|Overall Study|Study close|188|||
147195327|NCT02326155|530886526|FG001|Overall Study|Study close|21|||
147195328|NCT02326155|530886525|FG000|Overall Study|except for study close|46|||
147195329|NCT02326155|530886526|FG001|Overall Study|except for study close|13|||
147195330|NCT05024032|530886527|FG000|Overall Study|Withdrawal by Subject|0|||
147195331|NCT05024032|530886528|FG001|Overall Study|Withdrawal by Subject|3|||
147195332|NCT05024032|530886529|FG002|Overall Study|Withdrawal by Subject|4|||
147195333|NCT05024032|530886527|FG000|Overall Study|Adverse Event|0|||
147195334|NCT05024032|530886528|FG001|Overall Study|Adverse Event|1|||
147195335|NCT05024032|530886529|FG002|Overall Study|Adverse Event|0|||
147195336|NCT05024032|530886527|FG000|Overall Study|Protocol Deviation|1|||
147195337|NCT05024032|530886528|FG001|Overall Study|Protocol Deviation|0|||
147195338|NCT05024032|530886529|FG002|Overall Study|Protocol Deviation|0|||
147195339|NCT01209689|530886530|FG000|Overall Study|Insufficient Therapeutic Response|7|||
147195340|NCT01209689|530886531|FG001|Overall Study|Insufficient Therapeutic Response|2|||
147195341|NCT01209689|530886530|FG000|Overall Study|Refused Treatment|8|||
147195342|NCT01209689|530886531|FG001|Overall Study|Refused Treatment|3|||
147195343|NCT01209689|530886530|FG000|Overall Study|Adverse Event|4|||
147195344|NCT01209689|530886531|FG001|Overall Study|Adverse Event|0|||
147195345|NCT01209689|530886530|FG000|Overall Study|Violation of Selection Criteria at Entry|1|||
147195346|NCT01209689|530886531|FG001|Overall Study|Violation of Selection Criteria at Entry|0|||
147195347|NCT01209689|530886530|FG000|Overall Study|Failure to Return|3|||
147195348|NCT01209689|530886531|FG001|Overall Study|Failure to Return|0|||
147195349|NCT01209689|530886530|FG000|Overall Study|Sponsor's Decision to Stop the Study|68|||
147195350|NCT01209689|530886531|FG001|Overall Study|Sponsor's Decision to Stop the Study|17|||
147195351|NCT03780244|530886532|FG000|Overall Study|Lost to Follow-up|1|||
147195352|NCT03780244|530886533|FG001|Overall Study|Lost to Follow-up|0|||
147195353|NCT03175367|530886534|FG000|Double-blind Treatment Period (DBTP)|Protocol Violation|0|||
147195354|NCT03175367|530886535|FG001|Double-blind Treatment Period (DBTP)|Protocol Violation|0|||
147195355|NCT03175367|530886536|FG002|Double-blind Treatment Period (DBTP)|Protocol Violation|1|||
147195356|NCT03175367|530886537|FG003|Double-blind Treatment Period (DBTP)|Protocol Violation|2|||
147195357|NCT03175367|530886538|FG004|Double-blind Treatment Period (DBTP)|Protocol Violation|0|||
147195358|NCT03175367|530886539|FG005|Double-blind Treatment Period (DBTP)|Protocol Violation|0|||
147195359|NCT03175367|530886540|FG006|Double-blind Treatment Period (DBTP)|Protocol Violation|2|||
147195360|NCT03175367|530886534|FG000|Double-blind Treatment Period (DBTP)|Adverse Event|2|||
147195361|NCT03175367|530886535|FG001|Double-blind Treatment Period (DBTP)|Adverse Event|2|||
147195362|NCT03175367|530886536|FG002|Double-blind Treatment Period (DBTP)|Adverse Event|0|||
147195363|NCT03175367|530886537|FG003|Double-blind Treatment Period (DBTP)|Adverse Event|0|||
147195364|NCT03175367|530886538|FG004|Double-blind Treatment Period (DBTP)|Adverse Event|1|||
147195365|NCT03175367|530886539|FG005|Double-blind Treatment Period (DBTP)|Adverse Event|2|||
147195366|NCT03175367|530886540|FG006|Double-blind Treatment Period (DBTP)|Adverse Event|2|||
147195367|NCT03175367|530886534|FG000|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
147195368|NCT03175367|530886535|FG001|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
147195369|NCT03175367|530886536|FG002|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|2|||
147195370|NCT03175367|530886537|FG003|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|2|||
147195371|NCT03175367|530886538|FG004|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
147195372|NCT03175367|530886539|FG005|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
147195373|NCT03175367|530886540|FG006|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
147195374|NCT03175367|530886534|FG000|Double-blind Treatment Period (DBTP)|Physician Decision|6|||
147195375|NCT03175367|530886535|FG001|Double-blind Treatment Period (DBTP)|Physician Decision|5|||
147195376|NCT03175367|530886536|FG002|Double-blind Treatment Period (DBTP)|Physician Decision|8|||
147195377|NCT03175367|530886537|FG003|Double-blind Treatment Period (DBTP)|Physician Decision|6|||
147195378|NCT03175367|530886538|FG004|Double-blind Treatment Period (DBTP)|Physician Decision|0|||
147195379|NCT03175367|530886539|FG005|Double-blind Treatment Period (DBTP)|Physician Decision|0|||
147195380|NCT03175367|530886540|FG006|Double-blind Treatment Period (DBTP)|Physician Decision|0|||
147195381|NCT03175367|530886534|FG000|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
147195382|NCT03175367|530886535|FG001|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
147195383|NCT03175367|530886536|FG002|Double-blind Treatment Period (DBTP)|Lost to Follow-up|1|||
147195384|NCT03175367|530886537|FG003|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
147195385|NCT03175367|530886538|FG004|Double-blind Treatment Period (DBTP)|Lost to Follow-up|1|||
147195386|NCT03175367|530886539|FG005|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
147195387|NCT03175367|530886540|FG006|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
147195388|NCT03175367|530886534|FG000|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
147195389|NCT03175367|530886535|FG001|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
147195390|NCT03175367|530886536|FG002|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
147195391|NCT03175367|530886537|FG003|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
147195392|NCT03175367|530886538|FG004|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
147195393|NCT03175367|530886539|FG005|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|0|||
147195394|NCT03175367|530886540|FG006|Open-Label Treatment Period (OLTP)|Noncompliance with protocol|1|||
147195395|NCT03175367|530886534|FG000|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
147195396|NCT03175367|530886535|FG001|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
147195397|NCT03175367|530886536|FG002|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
147195398|NCT03175367|530886537|FG003|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
147195399|NCT03175367|530886538|FG004|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
147195400|NCT03175367|530886539|FG005|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|2|||
147195401|NCT03175367|530886540|FG006|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|1|||
147195402|NCT03085095|530886545|FG000|Overall Study|Adverse Event|23|||
147195403|NCT03085095|530886546|FG001|Overall Study|Adverse Event|8|||
147195404|NCT03085095|530886545|FG000|Overall Study|Protocol Violation|0|||
147195405|NCT03085095|530886546|FG001|Overall Study|Protocol Violation|1|||
147195406|NCT03085095|530886545|FG000|Overall Study|Lost to Follow-up|2|||
147195407|NCT03085095|530886546|FG001|Overall Study|Lost to Follow-up|1|||
147195408|NCT03085095|530886545|FG000|Overall Study|Withdrawal by Subject|17|||
147195409|NCT03085095|530886546|FG001|Overall Study|Withdrawal by Subject|6|||
147195410|NCT03085095|530886545|FG000|Overall Study|Physician Decision|9|||
147195411|NCT03085095|530886546|FG001|Overall Study|Physician Decision|3|||
147195412|NCT03085095|530886545|FG000|Overall Study|Testosterone Suppression Level Not Met|7|||
147195413|NCT03085095|530886546|FG001|Overall Study|Testosterone Suppression Level Not Met|13|||
147195414|NCT03085095|530886545|FG000|Overall Study|Did not Receive Study Drug|2|||
147195415|NCT03085095|530886546|FG001|Overall Study|Did not Receive Study Drug|2|||
147195416|NCT03085095|530886545|FG000|Overall Study|Dosing Interruption (Logistical Reason)|1|||
147195417|NCT03085095|530886546|FG001|Overall Study|Dosing Interruption (Logistical Reason)|0|||
147195418|NCT03459079|530886548|FG000|Overall Study|Adverse Event|4|||
147195419|NCT03459079|530886549|FG001|Overall Study|Adverse Event|2|||
147195420|NCT03459079|530886550|FG002|Overall Study|Adverse Event|0|||
147195421|NCT03459079|530886548|FG000|Overall Study|Withdrawal by Subject|2|||
147195422|NCT03459079|530886549|FG001|Overall Study|Withdrawal by Subject|2|||
147195423|NCT03459079|530886550|FG002|Overall Study|Withdrawal by Subject|0|||
147195424|NCT00674817|530886551|FG000|Period 1|Withdrawal by Subject|2|||
147195425|NCT00674817|530886551|FG000|Period 1|Protocol Violation|1|||
147195426|NCT00674817|530886551|FG000|Period 3|Adverse Event|1|||
147195427|NCT00674817|530886551|FG000|Period 3|Protocol Violation|1|||
147195428|NCT00674817|530886551|FG000|Period 4|Adverse Event|1|||
147195429|NCT02379728|530886552|FG000|Overall Study|Lost to Follow-up|1|||
147195430|NCT02379728|530886553|FG001|Overall Study|Lost to Follow-up|0|||
147195431|NCT02379728|530886554|FG002|Overall Study|Lost to Follow-up|3|||
147195432|NCT02379728|530886555|FG003|Overall Study|Lost to Follow-up|0|||
147195433|NCT02379728|530886552|FG000|Overall Study|Withdrawal by Subject|5|||
147195434|NCT02379728|530886553|FG001|Overall Study|Withdrawal by Subject|0|||
147195435|NCT02379728|530886554|FG002|Overall Study|Withdrawal by Subject|5|||
147195436|NCT02379728|530886555|FG003|Overall Study|Withdrawal by Subject|3|||
147195437|NCT02379728|530886552|FG000|Overall Study|Protocol Violation|0|||
147195438|NCT02379728|530886553|FG001|Overall Study|Protocol Violation|0|||
147195439|NCT02379728|530886554|FG002|Overall Study|Protocol Violation|2|||
147195440|NCT02379728|530886555|FG003|Overall Study|Protocol Violation|0|||
147195441|NCT01112917|530886556|FG000|Overall Study|Death|2|||
147195442|NCT01112917|530886557|FG001|Overall Study|Death|11|||
147195443|NCT01112917|530886556|FG000|Overall Study|Lost to Follow-up|1|||
147195444|NCT01112917|530886557|FG001|Overall Study|Lost to Follow-up|1|||
147195445|NCT01112917|530886556|FG000|Overall Study|Withdrawal by Subject|1|||
147195446|NCT01112917|530886557|FG001|Overall Study|Withdrawal by Subject|3|||
147195447|NCT01112917|530886556|FG000|Overall Study|Unable to Convert Filter|3|||
147195448|NCT01112917|530886557|FG001|Overall Study|Unable to Convert Filter|0|||
147195449|NCT05101122|530886558|FG000|Atomoxetine Only|Withdrawal by Subject|1|||
147195450|NCT05101122|530886558|FG000|AD313 40/2.5|Withdrawal by Subject|2|||
147195451|NCT05101122|530886558|FG000|AD313 80/5|Withdrawal by Subject|1|||
147195452|NCT05101122|530886558|FG000|AD313 80/10|Physician Decision|1|||
147195453|NCT03363841|530886559|FG000|Overall Study|Adverse Event|1|||
147195454|NCT03363841|530886559|FG000|Overall Study|Withdrawal by Subject|1|||
147195455|NCT03363841|530886559|FG000|Overall Study|Death|7|||
147195456|NCT03363841|530886559|FG000|Overall Study|Physician Decision|1|||
147195457|NCT02156076|530886562|FG000|Treatment Period|no longer meets study criteria|0|||
147195458|NCT02156076|530886563|FG001|Treatment Period|no longer meets study criteria|0|||
147195459|NCT02156076|530886564|FG002|Treatment Period|no longer meets study criteria|1|||
147195460|NCT02156076|530886565|FG003|Treatment Period|no longer meets study criteria|0|||
147195461|NCT02156076|530886562|FG000|Treatment Period|Poor/non-compliance|0|||
147195462|NCT02156076|530886563|FG001|Treatment Period|Poor/non-compliance|1|||
147195463|NCT02156076|530886564|FG002|Treatment Period|Poor/non-compliance|0|||
147195464|NCT02156076|530886565|FG003|Treatment Period|Poor/non-compliance|0|||
147195465|NCT02156076|530886562|FG000|Treatment Period|Lost to Follow-up|0|||
147195466|NCT02156076|530886563|FG001|Treatment Period|Lost to Follow-up|0|||
147195467|NCT02156076|530886564|FG002|Treatment Period|Lost to Follow-up|0|||
147195468|NCT02156076|530886565|FG003|Treatment Period|Lost to Follow-up|1|||
147195469|NCT02156076|530886562|FG000|Treatment Period|Withdrawal by Subject|0|||
147195470|NCT02156076|530886563|FG001|Treatment Period|Withdrawal by Subject|0|||
147195471|NCT02156076|530886564|FG002|Treatment Period|Withdrawal by Subject|1|||
147195472|NCT02156076|530886565|FG003|Treatment Period|Withdrawal by Subject|0|||
147195473|NCT02156076|530886562|FG000|Treatment Period|Subject request to discontinue treatment|0|||
147195474|NCT02156076|530886563|FG001|Treatment Period|Subject request to discontinue treatment|1|||
147195475|NCT02156076|530886564|FG002|Treatment Period|Subject request to discontinue treatment|0|||
147195476|NCT02156076|530886565|FG003|Treatment Period|Subject request to discontinue treatment|0|||
147195477|NCT02156076|530886562|FG000|Treatment Period|Adverse Event|0|||
147195478|NCT02156076|530886563|FG001|Treatment Period|Adverse Event|0|||
147195479|NCT02156076|530886564|FG002|Treatment Period|Adverse Event|0|||
147195480|NCT02156076|530886565|FG003|Treatment Period|Adverse Event|1|||
147195481|NCT02156076|530886562|FG000|Follow-up Period|Withdrawal by Subject|1|||
147195482|NCT02156076|530886563|FG001|Follow-up Period|Withdrawal by Subject|0|||
147195483|NCT02156076|530886564|FG002|Follow-up Period|Withdrawal by Subject|0|||
147195484|NCT02156076|530886565|FG003|Follow-up Period|Withdrawal by Subject|0|||
147195485|NCT06271993|530886566|FG000|Overall Study|Not reactive to histamine|5|||
147195486|NCT06271993|530886567|FG001|Overall Study|Not reactive to histamine|5|||
147195487|NCT06271993|530886568|FG002|Overall Study|Not reactive to histamine|5|||
147195488|NCT00687596|530886570|FG000|Overall Study|Adverse Event (AE)|10|||
147195489|NCT00687596|530886571|FG001|Overall Study|Adverse Event (AE)|3|||
147195490|NCT00687596|530886570|FG000|Overall Study|Radiological Disease Progression|6|||
147195491|NCT00687596|530886571|FG001|Overall Study|Radiological Disease Progression|2|||
147195492|NCT00687596|530886570|FG000|Overall Study|Clinical Disease Progression|1|||
147195493|NCT00687596|530886571|FG001|Overall Study|Clinical Disease Progression|3|||
147195494|NCT00687596|530886570|FG000|Overall Study|Investigator Discretion|3|||
147195495|NCT00687596|530886571|FG001|Overall Study|Investigator Discretion|1|||
147195496|NCT00687596|530886570|FG000|Overall Study|Sponsor Terminated Study|6|||
147195497|NCT00687596|530886571|FG001|Overall Study|Sponsor Terminated Study|17|||
147195498|NCT03331315|530886576|FG000|Overall Study|Physician Decision|18|||
147195499|NCT03331315|530886577|FG001|Overall Study|Physician Decision|14|||
147195500|NCT02558894|530886580|FG000|Overall Study|Death; any cause, entire study duration|28|||
147195501|NCT02558894|530886581|FG001|Overall Study|Death; any cause, entire study duration|31|||
147195502|NCT02558894|530886580|FG000|Overall Study|Withdrawal by Subject|2|||
147195503|NCT02558894|530886581|FG001|Overall Study|Withdrawal by Subject|1|||
147195504|NCT02558894|530886580|FG000|Overall Study|Closure of Part A|2|||
147195505|NCT02558894|530886581|FG001|Overall Study|Closure of Part A|1|||
147195506|NCT02992288|530886582|FG000|Overall Study|Adverse Event|8|||
147195507|NCT02992288|530886583|FG001|Overall Study|Adverse Event|2|||
147195508|NCT02992288|530886584|FG002|Overall Study|Adverse Event|2|||
147195509|NCT02992288|530886585|FG003|Overall Study|Adverse Event|2|||
147195510|NCT02992288|530886586|FG004|Overall Study|Adverse Event|2|||
147195511|NCT02992288|530886587|FG005|Overall Study|Adverse Event|7|||
147195512|NCT02992288|530886582|FG000|Overall Study|Non-compliance with study drug|0|||
147195513|NCT02992288|530886583|FG001|Overall Study|Non-compliance with study drug|1|||
147195514|NCT02992288|530886584|FG002|Overall Study|Non-compliance with study drug|1|||
147195515|NCT02992288|530886585|FG003|Overall Study|Non-compliance with study drug|0|||
147195516|NCT02992288|530886586|FG004|Overall Study|Non-compliance with study drug|1|||
147195517|NCT02992288|530886587|FG005|Overall Study|Non-compliance with study drug|0|||
147195518|NCT02992288|530886582|FG000|Overall Study|Physician Decision|3|||
147195519|NCT02992288|530886583|FG001|Overall Study|Physician Decision|0|||
147195520|NCT02992288|530886584|FG002|Overall Study|Physician Decision|1|||
147195521|NCT02992288|530886585|FG003|Overall Study|Physician Decision|0|||
147195522|NCT02992288|530886586|FG004|Overall Study|Physician Decision|0|||
147195523|NCT02992288|530886587|FG005|Overall Study|Physician Decision|1|||
147195524|NCT02992288|530886582|FG000|Overall Study|Death|2|||
147195525|NCT02992288|530886583|FG001|Overall Study|Death|0|||
147195526|NCT02992288|530886584|FG002|Overall Study|Death|2|||
147195527|NCT02992288|530886585|FG003|Overall Study|Death|1|||
147195528|NCT02992288|530886586|FG004|Overall Study|Death|2|||
147195529|NCT02992288|530886587|FG005|Overall Study|Death|0|||
147195530|NCT02992288|530886582|FG000|Overall Study|Lost to Follow-up|0|||
147195531|NCT02992288|530886583|FG001|Overall Study|Lost to Follow-up|0|||
147195532|NCT02992288|530886584|FG002|Overall Study|Lost to Follow-up|0|||
147195533|NCT02992288|530886585|FG003|Overall Study|Lost to Follow-up|1|||
147195534|NCT02992288|530886586|FG004|Overall Study|Lost to Follow-up|0|||
147195535|NCT02992288|530886587|FG005|Overall Study|Lost to Follow-up|0|||
147195536|NCT02992288|530886582|FG000|Overall Study|Protocol Violation|0|||
147195537|NCT02992288|530886583|FG001|Overall Study|Protocol Violation|0|||
147195538|NCT02992288|530886584|FG002|Overall Study|Protocol Violation|0|||
147195539|NCT02992288|530886585|FG003|Overall Study|Protocol Violation|0|||
147195540|NCT02992288|530886586|FG004|Overall Study|Protocol Violation|0|||
147195541|NCT02992288|530886587|FG005|Overall Study|Protocol Violation|1|||
147195542|NCT02992288|530886582|FG000|Overall Study|Withdrawal by Subject|4|||
147195543|NCT02992288|530886583|FG001|Overall Study|Withdrawal by Subject|2|||
147195544|NCT02992288|530886584|FG002|Overall Study|Withdrawal by Subject|1|||
147195545|NCT02992288|530886585|FG003|Overall Study|Withdrawal by Subject|5|||
147195546|NCT02992288|530886586|FG004|Overall Study|Withdrawal by Subject|3|||
147195547|NCT02992288|530886587|FG005|Overall Study|Withdrawal by Subject|4|||
147195548|NCT00656513|530886588|FG000|Overall Study|Protocol Violation|1|||
147195549|NCT00656513|530886589|FG001|Overall Study|Protocol Violation|0|||
147195550|NCT00656513|530886590|FG002|Overall Study|Protocol Violation|2|||
147195551|NCT00656513|530886588|FG000|Overall Study|Withdrawal by Subject|0|||
147195552|NCT00656513|530886589|FG001|Overall Study|Withdrawal by Subject|11|||
147195553|NCT00656513|530886590|FG002|Overall Study|Withdrawal by Subject|4|||
147195554|NCT00656513|530886588|FG000|Overall Study|Death|0|||
147195555|NCT00656513|530886589|FG001|Overall Study|Death|0|||
147195556|NCT00656513|530886590|FG002|Overall Study|Death|1|||
147195557|NCT00656513|530886588|FG000|Overall Study|Missing data|0|||
147195558|NCT00656513|530886589|FG001|Overall Study|Missing data|11|||
147195559|NCT00656513|530886590|FG002|Overall Study|Missing data|9|||
147195560|NCT00656513|530886588|FG000|Overall Study|Incomplete treatment|3|||
147195561|NCT00656513|530886589|FG001|Overall Study|Incomplete treatment|0|||
147195562|NCT00656513|530886590|FG002|Overall Study|Incomplete treatment|0|||
147195563|NCT00656513|530886588|FG000|Overall Study|Treatment completed outside of timeframe|0|||
147195564|NCT00656513|530886589|FG001|Overall Study|Treatment completed outside of timeframe|3|||
147195565|NCT00656513|530886590|FG002|Overall Study|Treatment completed outside of timeframe|1|||
147195566|NCT00656513|530886588|FG000|Overall Study|Missing baseline form|0|||
147195567|NCT00656513|530886589|FG001|Overall Study|Missing baseline form|5|||
147195568|NCT00656513|530886590|FG002|Overall Study|Missing baseline form|5|||
147195569|NCT03379818|530886591|FG000|Overall Study|Closures due to the Covid-19 pandemic|2|||
147434364|NCT02038920|531756380|FG002|Induction Phase (Week 0 to 14)|Lack of Efficacy|0|||
147434365|NCT02038920|531756381|FG003|Induction Phase (Week 0 to 14)|Lack of Efficacy|0|||
147434366|NCT02038920|531756382|FG004|Induction Phase (Week 0 to 14)|Lack of Efficacy|0|||
147434367|NCT02038920|531756383|FG005|Induction Phase (Week 0 to 14)|Lack of Efficacy|0|||
147534429|NCT03586427|532111451|FG000|Overall Study|Withdrawal by Subject|0|||
147434368|NCT02038920|531756378|FG000|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|0|||
147434369|NCT02038920|531756379|FG001|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|0|||
147434370|NCT02038920|531756380|FG002|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|2|||
147434371|NCT02038920|531756381|FG003|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|4|||
147434372|NCT02038920|531756382|FG004|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|2|||
147195570|NCT03379818|530886592|FG001|Overall Study|Closures due to the Covid-19 pandemic|2|||
147195571|NCT03379818|530886591|FG000|Overall Study|Withdrawal by Subject|2|||
147195572|NCT03379818|530886592|FG001|Overall Study|Withdrawal by Subject|3|||
147195573|NCT03379818|530886591|FG000|Overall Study|Diagnosis or suspected diagnosis of Autism spectrum disorder (ASD)|1|||
147195574|NCT03379818|530886592|FG001|Overall Study|Diagnosis or suspected diagnosis of Autism spectrum disorder (ASD)|2|||
147195575|NCT03962491|530886593|FG000|Overall Study|Lost to Follow-up|4|||
147195576|NCT03962491|530886594|FG001|Overall Study|Lost to Follow-up|5|||
147195577|NCT03697252|530886601|FG000|Overall Study|Adverse Event|3|||
147195578|NCT03697252|530886602|FG001|Overall Study|Adverse Event|2|||
147195579|NCT03697252|530886601|FG000|Overall Study|Withdrawal by Subject|14|||
147195580|NCT03697252|530886602|FG001|Overall Study|Withdrawal by Subject|14|||
147195581|NCT03697252|530886601|FG000|Overall Study|Lost to Follow-up|0|||
147195582|NCT03697252|530886602|FG001|Overall Study|Lost to Follow-up|1|||
147195583|NCT03697252|530886601|FG000|Overall Study|Physician Decision|1|||
147195584|NCT03697252|530886602|FG001|Overall Study|Physician Decision|1|||
147195585|NCT03697252|530886601|FG000|Overall Study|Other|0|||
147195586|NCT03697252|530886602|FG001|Overall Study|Other|1|||
147195587|NCT01867671|530886606|FG000|Overall Study|Adverse Event|5|||
147195588|NCT01867671|530886607|FG001|Overall Study|Adverse Event|3|||
147195589|NCT01867671|530886606|FG000|Overall Study|Anaphylaxis|0|||
147534430|NCT03586427|532111452|FG001|Overall Study|Withdrawal by Subject|1|||
147534431|NCT03586427|532111453|FG002|Overall Study|Withdrawal by Subject|2|||
147534432|NCT03586427|532111454|FG003|Overall Study|Withdrawal by Subject|1|||
147534433|NCT03586427|532111455|FG004|Overall Study|Withdrawal by Subject|1|||
147534434|NCT03586427|532111451|FG000|Overall Study|Adverse Event|0|||
147534435|NCT03586427|532111452|FG001|Overall Study|Adverse Event|0|||
147534436|NCT03586427|532111453|FG002|Overall Study|Adverse Event|1|||
147534437|NCT03586427|532111454|FG003|Overall Study|Adverse Event|0|||
147534438|NCT03586427|532111455|FG004|Overall Study|Adverse Event|0|||
147534439|NCT03586427|532111451|FG000|Overall Study|Protocol Violation|0|||
147534440|NCT03586427|532111452|FG001|Overall Study|Protocol Violation|0|||
147534441|NCT03586427|532111453|FG002|Overall Study|Protocol Violation|1|||
147534442|NCT03586427|532111454|FG003|Overall Study|Protocol Violation|0|||
147534443|NCT03586427|532111455|FG004|Overall Study|Protocol Violation|1|||
147534444|NCT03586427|532111451|FG000|Overall Study|Noncompliance with study drug|0|||
147534445|NCT03586427|532111452|FG001|Overall Study|Noncompliance with study drug|0|||
147534446|NCT03586427|532111453|FG002|Overall Study|Noncompliance with study drug|1|||
147534447|NCT03586427|532111454|FG003|Overall Study|Noncompliance with study drug|0|||
147534448|NCT03586427|532111455|FG004|Overall Study|Noncompliance with study drug|0|||
147534449|NCT00593385|532111460|FG000|Overall Study|Death|14|||
147534450|NCT00593385|532111460|FG000|Overall Study|Lost to Follow-up|17|||
147534451|NCT00593385|532111460|FG000|Overall Study|Withdrawal by Subject|9|||
147534452|NCT01471197|532111461|FG000|Overall Study|Disease Progression|4|||
147534453|NCT01471197|532111462|FG001|Overall Study|Disease Progression|2|||
147195590|NCT01867671|530886607|FG001|Overall Study|Anaphylaxis|1|||
147195591|NCT01867671|530886606|FG000|Overall Study|Inability to reach 3 mg peanut/placebo|2|||
147195592|NCT01867671|530886607|FG001|Overall Study|Inability to reach 3 mg peanut/placebo|0|||
147195593|NCT01867671|530886606|FG000|Overall Study|Lost to Follow-up|0|||
147195594|NCT01867671|530886607|FG001|Overall Study|Lost to Follow-up|1|||
147195595|NCT01867671|530886606|FG000|Overall Study|Non-compliance with Study Drug|1|||
147195596|NCT01867671|530886607|FG001|Overall Study|Non-compliance with Study Drug|2|||
147195597|NCT01867671|530886606|FG000|Overall Study|Withdrawal by Subject|21|||
147195598|NCT01867671|530886607|FG001|Overall Study|Withdrawal by Subject|21|||
147195599|NCT05236270|530886610|FG000|Overall Study|Lost to Follow-up|3|||
147195600|NCT05236270|530886611|FG001|Overall Study|Lost to Follow-up|2|||
147195601|NCT05236270|530886612|FG002|Overall Study|Lost to Follow-up|0|||
147195602|NCT05236270|530886613|FG003|Overall Study|Lost to Follow-up|0|||
147195603|NCT05236270|530886614|FG004|Overall Study|Lost to Follow-up|2|||
147195604|NCT05236270|530886615|FG005|Overall Study|Lost to Follow-up|0|||
147195605|NCT05236270|530886616|FG006|Overall Study|Lost to Follow-up|1|||
147195606|NCT05236270|530886617|FG007|Overall Study|Lost to Follow-up|3|||
147195607|NCT04097678|530886618|FG000|Overall Study|No Radiographs Obtained During Surgery|17|||
147195608|NCT04097678|530886619|FG001|Overall Study|No Radiographs Obtained During Surgery|18|||
147195609|NCT03694678|530886620|FG000|Overall Study|Withdrawal by Subject|2|||
147195610|NCT03694678|530886621|FG001|Overall Study|Withdrawal by Subject|0|||
147195611|NCT03694678|530886620|FG000|Overall Study|Lost to Follow-up|2|||
147195612|NCT03694678|530886621|FG001|Overall Study|Lost to Follow-up|3|||
147195613|NCT02435212|530886622|FG000|Core Phase|Adverse Event|8|||
147195614|NCT02435212|530886623|FG001|Core Phase|Adverse Event|5|||
147195615|NCT02435212|530886622|FG000|Core Phase|Withdrawal by Subject|3|||
147195616|NCT02435212|530886623|FG001|Core Phase|Withdrawal by Subject|0|||
147534454|NCT01471197|532111461|FG000|Overall Study|Death|1|||
147534455|NCT01471197|532111462|FG001|Overall Study|Death|0|||
147534456|NCT01471197|532111461|FG000|Overall Study|Study Drug Toxicity|1|||
147195617|NCT02435212|530886622|FG000|Core Phase|Withdrawal by parent/guardian|9|||
147195618|NCT02435212|530886623|FG001|Core Phase|Withdrawal by parent/guardian|4|||
147195619|NCT02435212|530886622|FG000|Core Phase|Protocol Violation|1|||
147195620|NCT02435212|530886623|FG001|Core Phase|Protocol Violation|2|||
147195621|NCT02435212|530886622|FG000|Core Phase|Physician Decision|3|||
147195622|NCT02435212|530886623|FG001|Core Phase|Physician Decision|0|||
147195623|NCT02435212|530886622|FG000|Core Phase|Lost to Follow-up|0|||
147195624|NCT02435212|530886623|FG001|Core Phase|Lost to Follow-up|1|||
147195625|NCT02435212|530886622|FG000|Core Phase|Lack of Efficacy|0|||
147534457|NCT01471197|532111462|FG001|Overall Study|Study Drug Toxicity|0|||
147195626|NCT02435212|530886623|FG001|Core Phase|Lack of Efficacy|1|||
147534458|NCT00924313|532111465|FG000|Overall Study|not imaged due to failed tracer imaging|1|||
147534459|NCT01283009|532111466|FG000|Overall Study|Death|83|||
147534460|NCT01283009|532111467|FG001|Overall Study|Death|78|||
147534461|NCT01283009|532111466|FG000|Overall Study|Study ended early|23|||
147534462|NCT01283009|532111467|FG001|Overall Study|Study ended early|26|||
147534463|NCT01283009|532111466|FG000|Overall Study|Withdrawal by Subject|10|||
147534464|NCT01283009|532111467|FG001|Overall Study|Withdrawal by Subject|8|||
147195627|NCT02435212|530886622|FG000|Core Phase|Recovery|1|||
147195628|NCT02435212|530886623|FG001|Core Phase|Recovery|0|||
147195629|NCT02435212|530886622|FG000|Optional Extension Phase|Adverse Event|3|||
147195630|NCT02435212|530886623|FG001|Optional Extension Phase|Adverse Event|9|||
147195631|NCT02435212|530886622|FG000|Optional Extension Phase|Physician Decision|6|||
147195632|NCT02435212|530886623|FG001|Optional Extension Phase|Physician Decision|8|||
147195633|NCT02435212|530886622|FG000|Optional Extension Phase|Withdrawal by parent/guardian|10|||
147195634|NCT02435212|530886623|FG001|Optional Extension Phase|Withdrawal by parent/guardian|7|||
147195635|NCT02435212|530886622|FG000|Optional Extension Phase|Lack of Efficacy|2|||
147195636|NCT02435212|530886623|FG001|Optional Extension Phase|Lack of Efficacy|3|||
147195637|NCT02435212|530886622|FG000|Optional Extension Phase|Withdrawal by Subject|2|||
147195638|NCT02435212|530886623|FG001|Optional Extension Phase|Withdrawal by Subject|2|||
147195639|NCT02435212|530886622|FG000|Optional Extension Phase|Protocol Violation|0|||
147195640|NCT02435212|530886623|FG001|Optional Extension Phase|Protocol Violation|1|||
147195641|NCT02435212|530886622|FG000|Optional Extension Phase|Recovery|1|||
147195642|NCT02435212|530886623|FG001|Optional Extension Phase|Recovery|1|||
147195643|NCT02435212|530886622|FG000|Optional Extension Phase|Death|1|||
147195644|NCT02435212|530886623|FG001|Optional Extension Phase|Death|0|||
147195645|NCT02435212|530886622|FG000|Optional Extension Phase|Technical problems|2|||
147195646|NCT02435212|530886623|FG001|Optional Extension Phase|Technical problems|0|||
147195647|NCT04711850|530886624|FG000|Overall Study|Graft loss|2|||
147195648|NCT04711850|530886625|FG001|Overall Study|Graft loss|1|||
147195649|NCT04711850|530886624|FG000|Overall Study|Patient not eligible as no AMR in feeder trial|1|||
147195650|NCT04711850|530886625|FG001|Overall Study|Patient not eligible as no AMR in feeder trial|0|||
147195651|NCT04711850|530886624|FG000|Overall Study|Study terminated by sponsor|5|||
147195652|NCT04711850|530886625|FG001|Overall Study|Study terminated by sponsor|3|||
147195653|NCT04711850|530886624|FG000|Overall Study|Sponsor decision|0|||
147195654|NCT04711850|530886625|FG001|Overall Study|Sponsor decision|2|||
147195655|NCT04531176|530886643|FG000|Overall Study|Study was stopped early|24|||
147195656|NCT04531176|530886644|FG001|Overall Study|Study was stopped early|26|||
147195657|NCT04531176|530886645|FG002|Overall Study|Study was stopped early|24|||
147195658|NCT02718898|530886648|FG000|Blinded Treatment Period|Adverse Event|5|||
147195659|NCT02718898|530886649|FG001|Blinded Treatment Period|Adverse Event|1|||
147195660|NCT02718898|530886650|FG002|Blinded Treatment Period|Adverse Event|0|||
147195661|NCT02718898|530886651|FG003|Blinded Treatment Period|Adverse Event|0|||
147195662|NCT02718898|530886652|FG004|Blinded Treatment Period|Adverse Event|0|||
147195663|NCT02718898|530886653|FG005|Blinded Treatment Period|Adverse Event|0|||
147195664|NCT02718898|530886654|FG006|Blinded Treatment Period|Adverse Event|0|||
147195665|NCT02718898|530886648|FG000|Blinded Treatment Period|Physician Decision|1|||
147195666|NCT02718898|530886649|FG001|Blinded Treatment Period|Physician Decision|0|||
147195667|NCT02718898|530886650|FG002|Blinded Treatment Period|Physician Decision|0|||
147195668|NCT02718898|530886651|FG003|Blinded Treatment Period|Physician Decision|0|||
147195669|NCT02718898|530886652|FG004|Blinded Treatment Period|Physician Decision|0|||
147195670|NCT02718898|530886653|FG005|Blinded Treatment Period|Physician Decision|0|||
147195671|NCT02718898|530886654|FG006|Blinded Treatment Period|Physician Decision|0|||
147195672|NCT02718898|530886648|FG000|Blinded Treatment Period|Lack of Efficacy|1|||
147195673|NCT02718898|530886649|FG001|Blinded Treatment Period|Lack of Efficacy|0|||
147195674|NCT02718898|530886650|FG002|Blinded Treatment Period|Lack of Efficacy|0|||
147195675|NCT02718898|530886651|FG003|Blinded Treatment Period|Lack of Efficacy|0|||
147195676|NCT02718898|530886652|FG004|Blinded Treatment Period|Lack of Efficacy|0|||
147195677|NCT02718898|530886653|FG005|Blinded Treatment Period|Lack of Efficacy|0|||
147195678|NCT02718898|530886654|FG006|Blinded Treatment Period|Lack of Efficacy|0|||
147195679|NCT02718898|530886648|FG000|Blinded Treatment Period|Lost to Follow-up|2|||
147195680|NCT02718898|530886649|FG001|Blinded Treatment Period|Lost to Follow-up|0|||
147534465|NCT01283009|532111466|FG000|Overall Study|Physician Decision|1|||
147534466|NCT01283009|532111467|FG001|Overall Study|Physician Decision|1|||
147534467|NCT01283009|532111466|FG000|Overall Study|Lost to Follow-up|1|||
147195681|NCT02718898|530886650|FG002|Blinded Treatment Period|Lost to Follow-up|0|||
147195682|NCT02718898|530886651|FG003|Blinded Treatment Period|Lost to Follow-up|0|||
147195683|NCT02718898|530886652|FG004|Blinded Treatment Period|Lost to Follow-up|0|||
147195684|NCT02718898|530886653|FG005|Blinded Treatment Period|Lost to Follow-up|0|||
147534468|NCT01283009|532111467|FG001|Overall Study|Lost to Follow-up|0|||
147534469|NCT01283009|532111466|FG000|Overall Study|Patient Withdrawn by LAR/DPOA|0|||
147195685|NCT02718898|530886654|FG006|Blinded Treatment Period|Lost to Follow-up|0|||
147195686|NCT02718898|530886648|FG000|Open Label Treatment Period (OLTP)|Adverse Event|0|||
147195687|NCT02718898|530886649|FG001|Open Label Treatment Period (OLTP)|Adverse Event|0|||
147534470|NCT01283009|532111467|FG001|Overall Study|Patient Withdrawn by LAR/DPOA|4|||
147534471|NCT00455923|532111475|FG000|Overall Study|Pregnancy|0|||
147534472|NCT00455923|532111476|FG001|Overall Study|Pregnancy|2|||
147534473|NCT00455923|532111475|FG000|Overall Study|Other|3|||
147534474|NCT00455923|532111476|FG001|Overall Study|Other|1|||
147534475|NCT02686749|532111478|FG000|Overall Study|terminated for poor enrollment|2|||
147534476|NCT02686749|532111479|FG001|Overall Study|terminated for poor enrollment|2|||
147534477|NCT00145119|532111484|FG000|Overall Study|Death|45|||
147534478|NCT01676818|532111489|FG000|Overall Study|Physician Decision|1|||
147534479|NCT01676818|532111489|FG000|Overall Study|Withdrawal by Subject|1|||
147534480|NCT02503215|532113048|FG000|Overall Study|Unable to wear compression stockings|1|||
147534481|NCT02503215|532113048|FG000|Overall Study|Unable to use positive airway pressure|2|||
147534482|NCT03433482|532113049|FG000|Overall Study|Lost to Follow-up|1|||
147534483|NCT03433482|532113050|FG001|Overall Study|Lost to Follow-up|0|||
147534484|NCT03433482|532113051|FG002|Overall Study|Lost to Follow-up|1|||
147534485|NCT03433482|532113052|FG003|Overall Study|Lost to Follow-up|1|||
147534486|NCT03433482|532113049|FG000|Overall Study|Withdrawal by Subject|0|||
147534487|NCT03433482|532113050|FG001|Overall Study|Withdrawal by Subject|0|||
147534488|NCT03433482|532113051|FG002|Overall Study|Withdrawal by Subject|1|||
147534489|NCT03433482|532113052|FG003|Overall Study|Withdrawal by Subject|0|||
147534490|NCT03433482|532113049|FG000|Overall Study|Unknown reason|0|||
147534491|NCT03433482|532113050|FG001|Overall Study|Unknown reason|0|||
147534492|NCT03433482|532113051|FG002|Overall Study|Unknown reason|2|||
147534493|NCT03433482|532113052|FG003|Overall Study|Unknown reason|0|||
147534494|NCT01646268|532113053|FG000|Overall Study|Adverse Event|6|||
147534495|NCT01646268|532113054|FG001|Overall Study|Adverse Event|7|||
147534496|NCT01646268|532113053|FG000|Overall Study|Lack of Efficacy|1|||
147534497|NCT01646268|532113054|FG001|Overall Study|Lack of Efficacy|3|||
147534498|NCT01646268|532113053|FG000|Overall Study|Protocol Violation|0|||
147534499|NCT01646268|532113054|FG001|Overall Study|Protocol Violation|1|||
147534500|NCT01646268|532113053|FG000|Overall Study|Withdrawal by Subject|2|||
147534501|NCT01646268|532113054|FG001|Overall Study|Withdrawal by Subject|5|||
147534502|NCT01646268|532113053|FG000|Overall Study|Other|2|||
147534503|NCT01646268|532113054|FG001|Overall Study|Other|0|||
147534504|NCT04478994|532113057|FG000|Overall Study|Withdrawal by Subject|1|||
147534505|NCT04478994|532113058|FG001|Overall Study|Withdrawal by Subject|1|||
147534506|NCT01100073|532113059|FG000|Overall Study|Lack of Efficacy|4|||
147534507|NCT01100073|532113059|FG000|Overall Study|Insufficient Tolerability|21|||
147534508|NCT01100073|532113059|FG000|Overall Study|Withdrawal by Subject|13|||
147534509|NCT01100073|532113059|FG000|Overall Study|Lost to Follow-up|39|||
147534510|NCT01100073|532113059|FG000|Overall Study|Lack of effect + patient's wish|2|||
147534511|NCT01100073|532113059|FG000|Overall Study|Insufficient tolerability +patients wish|8|||
147534512|NCT01100073|532113059|FG000|Overall Study|Other|8|||
147534513|NCT01100073|532113059|FG000|Overall Study|Missing|5|||
147534514|NCT00299546|532113060|FG000|Overall Study|Death|3|||
147534515|NCT00299546|532113061|FG001|Overall Study|Death|2|||
147534516|NCT00299546|532113062|FG002|Overall Study|Death|0|||
147534517|NCT00299546|532113060|FG000|Overall Study|Lost to Follow-up|2|||
147534518|NCT00299546|532113061|FG001|Overall Study|Lost to Follow-up|2|||
147534519|NCT00299546|532113062|FG002|Overall Study|Lost to Follow-up|5|||
147534520|NCT00299546|532113060|FG000|Overall Study|Adverse Event|37|||
147534521|NCT00299546|532113061|FG001|Overall Study|Adverse Event|22|||
147534522|NCT00299546|532113062|FG002|Overall Study|Adverse Event|27|||
147534523|NCT00299546|532113060|FG000|Overall Study|Unsatisfactory therapeutic effect|34|||
147534524|NCT00299546|532113061|FG001|Overall Study|Unsatisfactory therapeutic effect|39|||
147534525|NCT00299546|532113062|FG002|Overall Study|Unsatisfactory therapeutic effect|34|||
147534526|NCT00299546|532113060|FG000|Overall Study|Other|24|||
147534527|NCT00299546|532113061|FG001|Overall Study|Other|26|||
147534528|NCT00299546|532113062|FG002|Overall Study|Other|19|||
147534529|NCT00299546|532113060|FG000|Overall Study|Not treated|0|||
147534530|NCT00299546|532113061|FG001|Overall Study|Not treated|1|||
147534531|NCT00299546|532113062|FG002|Overall Study|Not treated|1|||
147534532|NCT03099265|532113063|FG000|Overall Study|Adverse Event|1|||
147534533|NCT00968539|532113067|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|1|||
147534534|NCT00968539|532113068|FG001|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
147534535|NCT00326118|532113069|FG000|Active Phase|Withdrawal by Subject|4|||
147534536|NCT00326118|532113070|FG001|Active Phase|Withdrawal by Subject|1|||
147534537|NCT01741259|532113071|FG000|Overall Study|Protocol Violation|6|||
147534538|NCT01741259|532113072|FG001|Overall Study|Protocol Violation|4|||
147534539|NCT01741259|532113071|FG000|Overall Study|Withdrawal by Subject|0|||
147534540|NCT01741259|532113072|FG001|Overall Study|Withdrawal by Subject|2|||
147534541|NCT02074982|532113077|FG000|Overall Study|Adverse Event|15|||
147534542|NCT02074982|532113078|FG001|Overall Study|Adverse Event|7|||
147534543|NCT02074982|532113077|FG000|Overall Study|Lack of Efficacy|6|||
147534544|NCT02074982|532113078|FG001|Overall Study|Lack of Efficacy|1|||
147534545|NCT02074982|532113077|FG000|Overall Study|Lost to Follow-up|9|||
147534546|NCT02074982|532113078|FG001|Overall Study|Lost to Follow-up|10|||
147534547|NCT02074982|532113077|FG000|Overall Study|Non-compliance with study treatment|0|||
147195688|NCT02718898|530886650|FG002|Open Label Treatment Period (OLTP)|Adverse Event|1|||
147195689|NCT02718898|530886651|FG003|Open Label Treatment Period (OLTP)|Adverse Event|1|||
147195690|NCT02718898|530886652|FG004|Open Label Treatment Period (OLTP)|Adverse Event|0|||
147195691|NCT02718898|530886653|FG005|Open Label Treatment Period (OLTP)|Adverse Event|0|||
147195692|NCT02718898|530886654|FG006|Open Label Treatment Period (OLTP)|Adverse Event|0|||
147195693|NCT02718898|530886648|FG000|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
147195694|NCT02718898|530886649|FG001|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
147195695|NCT02718898|530886650|FG002|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
147195696|NCT02718898|530886651|FG003|Open Label Treatment Period (OLTP)|Lost to Follow-up|2|||
147195697|NCT02718898|530886652|FG004|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
147195698|NCT02718898|530886653|FG005|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
147195699|NCT02718898|530886654|FG006|Open Label Treatment Period (OLTP)|Lost to Follow-up|0|||
147195700|NCT02718898|530886648|FG000|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
147195701|NCT02718898|530886649|FG001|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
147195702|NCT02718898|530886650|FG002|Open Label Treatment Period (OLTP)|Withdrawal by Subject|1|||
147195703|NCT02718898|530886651|FG003|Open Label Treatment Period (OLTP)|Withdrawal by Subject|3|||
147195704|NCT02718898|530886652|FG004|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
147195705|NCT02718898|530886653|FG005|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
147195706|NCT02718898|530886654|FG006|Open Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
147195707|NCT02718898|530886648|FG000|Open Label Treatment Period (OLTP)|Lack of Efficacy|0|||
147195708|NCT02718898|530886649|FG001|Open Label Treatment Period (OLTP)|Lack of Efficacy|0|||
147195709|NCT02718898|530886650|FG002|Open Label Treatment Period (OLTP)|Lack of Efficacy|1|||
147195710|NCT02718898|530886651|FG003|Open Label Treatment Period (OLTP)|Lack of Efficacy|2|||
147195711|NCT02718898|530886652|FG004|Open Label Treatment Period (OLTP)|Lack of Efficacy|0|||
147195712|NCT02718898|530886653|FG005|Open Label Treatment Period (OLTP)|Lack of Efficacy|0|||
147195713|NCT02718898|530886654|FG006|Open Label Treatment Period (OLTP)|Lack of Efficacy|0|||
147195714|NCT02718898|530886648|FG000|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
147195715|NCT02718898|530886649|FG001|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
147195716|NCT02718898|530886650|FG002|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
147195717|NCT02718898|530886651|FG003|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|1|||
147195718|NCT02718898|530886652|FG004|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
147195719|NCT02718898|530886653|FG005|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
147195720|NCT02718898|530886654|FG006|Open Label Treatment Period (OLTP)|Subject discontinued in OLTP|0|||
147195721|NCT02718898|530886648|FG000|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
147195722|NCT02718898|530886649|FG001|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
147195723|NCT02718898|530886650|FG002|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
147195724|NCT02718898|530886651|FG003|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|1|||
147195725|NCT02718898|530886652|FG004|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
147195726|NCT02718898|530886653|FG005|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
147195727|NCT02718898|530886654|FG006|Open Label Treatment Period (OLTP)|Ttt of undisclosed addiction-Pt withdrew|0|||
147195728|NCT02718898|530886648|FG000|Post Treatment Follow-up Period|Adverse Event|0|||
147195729|NCT02718898|530886649|FG001|Post Treatment Follow-up Period|Adverse Event|0|||
147195730|NCT02718898|530886650|FG002|Post Treatment Follow-up Period|Adverse Event|0|||
147195731|NCT02718898|530886651|FG003|Post Treatment Follow-up Period|Adverse Event|0|||
147195732|NCT02718898|530886652|FG004|Post Treatment Follow-up Period|Adverse Event|0|||
147195733|NCT02718898|530886653|FG005|Post Treatment Follow-up Period|Adverse Event|1|||
147195734|NCT02718898|530886654|FG006|Post Treatment Follow-up Period|Adverse Event|1|||
147195735|NCT02718898|530886648|FG000|Post Treatment Follow-up Period|Lost to Follow-up|0|||
147195736|NCT02718898|530886649|FG001|Post Treatment Follow-up Period|Lost to Follow-up|0|||
147195737|NCT02718898|530886650|FG002|Post Treatment Follow-up Period|Lost to Follow-up|0|||
147195738|NCT02718898|530886651|FG003|Post Treatment Follow-up Period|Lost to Follow-up|0|||
147195739|NCT02718898|530886652|FG004|Post Treatment Follow-up Period|Lost to Follow-up|1|||
147195740|NCT02718898|530886653|FG005|Post Treatment Follow-up Period|Lost to Follow-up|5|||
147195741|NCT02718898|530886654|FG006|Post Treatment Follow-up Period|Lost to Follow-up|1|||
147195742|NCT02718898|530886648|FG000|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
147195743|NCT02718898|530886649|FG001|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
147195744|NCT02718898|530886650|FG002|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
147195745|NCT02718898|530886651|FG003|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
147195746|NCT02718898|530886652|FG004|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
147534548|NCT02074982|532113078|FG001|Overall Study|Non-compliance with study treatment|2|||
147534549|NCT02074982|532113077|FG000|Overall Study|Physician Decision|1|||
147534550|NCT02074982|532113078|FG001|Overall Study|Physician Decision|1|||
147534551|NCT02074982|532113077|FG000|Overall Study|Pregnancy|1|||
147195747|NCT02718898|530886653|FG005|Post Treatment Follow-up Period|Withdrawal by Subject|5|||
147195748|NCT02718898|530886654|FG006|Post Treatment Follow-up Period|Withdrawal by Subject|3|||
147195749|NCT01451606|530886655|FG000|Overall Study|Withdrawal by Subject|4|||
147195750|NCT01451606|530886656|FG001|Overall Study|Withdrawal by Subject|3|||
147195751|NCT02559622|530886660|FG000|Overall Study|Progressive disease|0|||
147195752|NCT02559622|530886661|FG001|Overall Study|Progressive disease|1|||
147195753|NCT02559622|530886662|FG002|Overall Study|Progressive disease|0|||
147195754|NCT02559622|530886663|FG003|Overall Study|Progressive disease|0|||
147195755|NCT02559622|530886660|FG000|Overall Study|Adverse Event|0|||
147195756|NCT02559622|530886661|FG001|Overall Study|Adverse Event|2|||
147195757|NCT02559622|530886662|FG002|Overall Study|Adverse Event|2|||
147195758|NCT02559622|530886663|FG003|Overall Study|Adverse Event|2|||
147195759|NCT02559622|530886660|FG000|Overall Study|Patient/guardian decision|1|||
147195760|NCT02559622|530886661|FG001|Overall Study|Patient/guardian decision|2|||
147195761|NCT02559622|530886662|FG002|Overall Study|Patient/guardian decision|0|||
147195762|NCT02559622|530886663|FG003|Overall Study|Patient/guardian decision|1|||
147195763|NCT02163538|530886664|FG000|Overall Study|Protocol Violation|1|||
147534552|NCT02074982|532113078|FG001|Overall Study|Pregnancy|2|||
147534553|NCT02074982|532113077|FG000|Overall Study|Protocol deviation|4|||
147534554|NCT02074982|532113078|FG001|Overall Study|Protocol deviation|3|||
147534555|NCT02074982|532113077|FG000|Overall Study|Technical problems|0|||
147534556|NCT02074982|532113078|FG001|Overall Study|Technical problems|2|||
147534557|NCT02074982|532113077|FG000|Overall Study|Subject/guardian decision|15|||
147534558|NCT02074982|532113078|FG001|Overall Study|Subject/guardian decision|24|||
147534559|NCT02074982|532113077|FG000|Overall Study|Death|0|||
147195764|NCT02163538|530886665|FG001|Overall Study|Protocol Violation|0|||
147195765|NCT02163538|530886664|FG000|Overall Study|Physician Decision|0|||
147195766|NCT02163538|530886665|FG001|Overall Study|Physician Decision|1|||
147195767|NCT04484961|530886668|FG000|Overall Study|Lost to Follow-up|9|||
147534560|NCT02074982|532113078|FG001|Overall Study|Death|2|||
147534561|NCT02094573|532113081|FG000|Overall Study|Adverse Event|4|||
147534562|NCT02094573|532113082|FG001|Overall Study|Adverse Event|14|||
147534563|NCT02094573|532113081|FG000|Overall Study|Clinical Progressive Disease|9|||
147534564|NCT02094573|532113082|FG001|Overall Study|Clinical Progressive Disease|13|||
147534565|NCT02094573|532113081|FG000|Overall Study|Death|11|||
147534566|NCT02094573|532113082|FG001|Overall Study|Death|3|||
147534567|NCT02094573|532113081|FG000|Overall Study|Documented Progressive Disease (RECIST 1.1)|63|||
147534568|NCT02094573|532113082|FG001|Overall Study|Documented Progressive Disease (RECIST 1.1)|50|||
147534569|NCT02094573|532113081|FG000|Overall Study|Non-compliance with Study Drug|1|||
147534570|NCT02094573|532113082|FG001|Overall Study|Non-compliance with Study Drug|1|||
147534571|NCT02094573|532113081|FG000|Overall Study|Subject Received a New Systemic Anticancer Therapy|1|||
147534572|NCT02094573|532113082|FG001|Overall Study|Subject Received a New Systemic Anticancer Therapy|0|||
147534573|NCT02094573|532113081|FG000|Overall Study|Physician Decision|4|||
147534574|NCT02094573|532113082|FG001|Overall Study|Physician Decision|4|||
147534575|NCT02094573|532113081|FG000|Overall Study|Site Terminated by Sponsor|10|||
147534576|NCT02094573|532113082|FG001|Overall Study|Site Terminated by Sponsor|17|||
147534577|NCT02094573|532113081|FG000|Overall Study|Withdrawal by Subject|6|||
147534578|NCT02094573|532113082|FG001|Overall Study|Withdrawal by Subject|8|||
147534579|NCT02094573|532113081|FG000|Overall Study|Randomized but not Treated|3|||
147534580|NCT02094573|532113082|FG001|Overall Study|Randomized but not Treated|0|||
147534581|NCT01817764|532113083|FG000|Overall Study|Adverse Event|7|||
147534582|NCT01817764|532113084|FG001|Overall Study|Adverse Event|10|||
147534583|NCT01817764|532113083|FG000|Overall Study|Lack of Efficacy|9|||
147534584|NCT01817764|532113084|FG001|Overall Study|Lack of Efficacy|7|||
147534585|NCT01817764|532113083|FG000|Overall Study|Protocol Violation|7|||
147534586|NCT01817764|532113084|FG001|Overall Study|Protocol Violation|5|||
147534587|NCT01817764|532113083|FG000|Overall Study|Lost to Follow-up|1|||
147534588|NCT01817764|532113084|FG001|Overall Study|Lost to Follow-up|4|||
147534589|NCT01817764|532113083|FG000|Overall Study|Withdrawal by Subject|10|||
147195768|NCT04484961|530886669|FG001|Overall Study|Lost to Follow-up|9|||
147195769|NCT00388349|530886670|FG000|Phase I Dose Escalation|Dose reduction due to DLT|0|||
147195770|NCT00388349|530886671|FG001|Phase I Dose Escalation|Dose reduction due to DLT|3|||
147195771|NCT01345240|530886675|FG000|Overall Study|Adverse Event|3|||
147195772|NCT01345240|530886676|FG001|Overall Study|Adverse Event|5|||
147534590|NCT01817764|532113084|FG001|Overall Study|Withdrawal by Subject|12|||
147195773|NCT01345240|530886677|FG002|Overall Study|Adverse Event|4|||
147195774|NCT01345240|530886678|FG003|Overall Study|Adverse Event|2|||
147195775|NCT01345240|530886679|FG004|Overall Study|Adverse Event|1|||
147534591|NCT02411110|532113087|FG000|Treatment Period 1|Adverse Event|4|||
147534592|NCT02411110|532113088|FG001|Treatment Period 1|Adverse Event|2|||
147534593|NCT02411110|532113087|FG000|Treatment Period 1|Lost to Follow-up|1|||
147534594|NCT02411110|532113088|FG001|Treatment Period 1|Lost to Follow-up|0|||
147534595|NCT02411110|532113087|FG000|Treatment Period 1|Personal Reasons|2|||
147534596|NCT02411110|532113088|FG001|Treatment Period 1|Personal Reasons|5|||
147195776|NCT01345240|530886675|FG000|Overall Study|Lost to Follow-up|8|||
147195777|NCT01345240|530886676|FG001|Overall Study|Lost to Follow-up|9|||
147195778|NCT01345240|530886677|FG002|Overall Study|Lost to Follow-up|14|||
147195779|NCT01345240|530886678|FG003|Overall Study|Lost to Follow-up|7|||
147195780|NCT01345240|530886679|FG004|Overall Study|Lost to Follow-up|9|||
147195781|NCT04011540|530886680|FG000|Overall Study|Lost to Follow-up|9|||
147195782|NCT04011540|530886681|FG001|Overall Study|Lost to Follow-up|6|||
147195783|NCT01339832|530886686|FG000|Overall Study|Lost to Follow-up|3|||
147195784|NCT01339832|530886686|FG000|Overall Study|Death|11|||
147195785|NCT00231816|530886687|FG000|Overall Study|Adverse Event|1|||
147195786|NCT00231816|530886688|FG001|Overall Study|Adverse Event|0|||
147195787|NCT00231816|530886687|FG000|Overall Study|Lost to Follow-up|8|||
147195788|NCT00231816|530886688|FG001|Overall Study|Lost to Follow-up|5|||
147195789|NCT00231816|530886687|FG000|Overall Study|Protocol Violation|2|||
147195790|NCT00231816|530886688|FG001|Overall Study|Protocol Violation|3|||
147195791|NCT00231816|530886687|FG000|Overall Study|Withdrawal by Subject|3|||
147195792|NCT00231816|530886688|FG001|Overall Study|Withdrawal by Subject|3|||
147195793|NCT00231816|530886687|FG000|Overall Study|Other|2|||
147195794|NCT00231816|530886688|FG001|Overall Study|Other|1|||
147195795|NCT00774046|530886689|FG000|Screening|Not eligible|56|||
147195796|NCT00774046|530886689|FG000|Enrollment|Desired other therapy/refused|28|||
147195797|NCT00774046|530886689|FG000|Stem Cell Mobilization|Count too low (2), sudden death (1)|3|||
147195798|NCT05498649|530886690|FG000|Overall Study|Lost to Follow-up|1|||
147195799|NCT04609319|530886691|FG000|Overall Study|Death|64|||
147195800|NCT04609319|530886692|FG001|Overall Study|Death|49|||
147195801|NCT04609319|530886693|FG002|Overall Study|Death|1|||
147195802|NCT04609319|530886691|FG000|Overall Study|Withdrawal of consent|15|||
147195803|NCT04609319|530886692|FG001|Overall Study|Withdrawal of consent|3|||
147195804|NCT04609319|530886693|FG002|Overall Study|Withdrawal of consent|0|||
147195805|NCT04609319|530886691|FG000|Overall Study|Lost to Follow-up|20|||
147195806|NCT04609319|530886692|FG001|Overall Study|Lost to Follow-up|33|||
147195807|NCT04609319|530886693|FG002|Overall Study|Lost to Follow-up|0|||
147195808|NCT04609319|530886691|FG000|Overall Study|Alive until end of follow-up|60|||
147195809|NCT04609319|530886692|FG001|Overall Study|Alive until end of follow-up|53|||
147195810|NCT04609319|530886693|FG002|Overall Study|Alive until end of follow-up|1|||
147195811|NCT03804528|530886694|FG000|Overall Study|Time Commitment|18|||
147195812|NCT03804528|530886694|FG000|Overall Study|Health Reasons|5|||
147195813|NCT04607005|530886695|FG000|Overall Study|Adverse Event|0|||
147195814|NCT04607005|530886696|FG001|Overall Study|Adverse Event|1|||
147195815|NCT04607005|530886695|FG000|Overall Study|Lack of Efficacy|1|||
147195816|NCT04607005|530886696|FG001|Overall Study|Lack of Efficacy|6|||
147195817|NCT04607005|530886695|FG000|Overall Study|Withdrawal by Subject|4|||
147195818|NCT04607005|530886696|FG001|Overall Study|Withdrawal by Subject|9|||
147195819|NCT04607005|530886695|FG000|Overall Study|Participant reached protocol-defined stopping criteria|1|||
147195820|NCT04607005|530886696|FG001|Overall Study|Participant reached protocol-defined stopping criteria|0|||
147195821|NCT00668148|530886697|FG000|Overall Study|Adverse Event|5|||
147195822|NCT00668148|530886697|FG000|Overall Study|Subject Non-compliance|1|||
147195823|NCT00668148|530886697|FG000|Overall Study|Progressive Disease Before Treatment|2|||
147195824|NCT00668148|530886697|FG000|Overall Study|Withdrawal of Consent|2|||
147195825|NCT04944992|530888175|FG000|Overall Study|Lost to Follow-up|1|||
147195826|NCT04944992|530888176|FG001|Overall Study|Lost to Follow-up|1|||
147195827|NCT04944992|530888175|FG000|Overall Study|Physician Decision|1|||
147195828|NCT04944992|530888176|FG001|Overall Study|Physician Decision|0|||
147195829|NCT04944992|530888175|FG000|Overall Study|Withdrawal by Subject|6|||
147195830|NCT04944992|530888176|FG001|Overall Study|Withdrawal by Subject|1|||
147195831|NCT00303069|530888177|FG000|Overall Study|Lost to Follow-up|1|||
147195832|NCT00303069|530888178|FG001|Overall Study|Lost to Follow-up|0|||
147195833|NCT00303069|530888179|FG002|Overall Study|Lost to Follow-up|0|||
147195834|NCT00303069|530888180|FG003|Overall Study|Lost to Follow-up|2|||
147195835|NCT00303069|530888177|FG000|Overall Study|subject moved|1|||
147195836|NCT00303069|530888178|FG001|Overall Study|subject moved|0|||
147195837|NCT00303069|530888179|FG002|Overall Study|subject moved|0|||
147195838|NCT00303069|530888180|FG003|Overall Study|subject moved|0|||
147195839|NCT00303069|530888177|FG000|Overall Study|Recruitment into Army Reserves|0|||
147195840|NCT00303069|530888178|FG001|Overall Study|Recruitment into Army Reserves|0|||
147195841|NCT00303069|530888179|FG002|Overall Study|Recruitment into Army Reserves|1|||
147195842|NCT00303069|530888180|FG003|Overall Study|Recruitment into Army Reserves|0|||
147195843|NCT01972217|530888183|FG000|Part A: Open-label Safety Run-in Period|Withdrawal by Subject|0|||
147195844|NCT01972217|530888184|FG001|Part A: Open-label Safety Run-in Period|Withdrawal by Subject|1|||
147195845|NCT01972217|530888185|FG002|Part A: Open-label Safety Run-in Period|Withdrawal by Subject|0|||
147195846|NCT01972217|530888186|FG003|Part A: Open-label Safety Run-in Period|Withdrawal by Subject|0|||
147195847|NCT01972217|530888183|FG000|Part A: Open-label Safety Run-in Period|Condition under investigation worsened|1|||
147195848|NCT01972217|530888184|FG001|Part A: Open-label Safety Run-in Period|Condition under investigation worsened|9|||
147195849|NCT01972217|530888185|FG002|Part A: Open-label Safety Run-in Period|Condition under investigation worsened|0|||
147195850|NCT01972217|530888186|FG003|Part A: Open-label Safety Run-in Period|Condition under investigation worsened|0|||
147195851|NCT01972217|530888183|FG000|Part A: Open-label Safety Run-in Period|Adverse Event|0|||
147195852|NCT01972217|530888184|FG001|Part A: Open-label Safety Run-in Period|Adverse Event|1|||
147195853|NCT01972217|530888185|FG002|Part A: Open-label Safety Run-in Period|Adverse Event|0|||
147195854|NCT01972217|530888186|FG003|Part A: Open-label Safety Run-in Period|Adverse Event|0|||
147195855|NCT01972217|530888183|FG000|Part A: Open-label Safety Run-in Period|Death|0|||
147195856|NCT01972217|530888184|FG001|Part A: Open-label Safety Run-in Period|Death|1|||
147195857|NCT01972217|530888185|FG002|Part A: Open-label Safety Run-in Period|Death|0|||
147195858|NCT01972217|530888186|FG003|Part A: Open-label Safety Run-in Period|Death|0|||
147195859|NCT01972217|530888183|FG000|Part B Double-blind, Randomised Period|Death|0|||
147195860|NCT01972217|530888184|FG001|Part B Double-blind, Randomised Period|Death|0|||
147195861|NCT01972217|530888185|FG002|Part B Double-blind, Randomised Period|Death|43|||
147195862|NCT01972217|530888186|FG003|Part B Double-blind, Randomised Period|Death|44|||
147195863|NCT01972217|530888183|FG000|Part B Double-blind, Randomised Period|Reason not recorded|0|||
147195864|NCT01972217|530888184|FG001|Part B Double-blind, Randomised Period|Reason not recorded|0|||
147195865|NCT01972217|530888185|FG002|Part B Double-blind, Randomised Period|Reason not recorded|1|||
147195866|NCT01972217|530888186|FG003|Part B Double-blind, Randomised Period|Reason not recorded|0|||
147434373|NCT02038920|531756383|FG005|Maintenance Phase (Week 14 to 60)|Pretreatment Event/Adverse Event|0|||
147434374|NCT02038920|531756378|FG000|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0|||
147434375|NCT02038920|531756379|FG001|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0|||
147434376|NCT02038920|531756380|FG002|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|1|||
147434377|NCT02038920|531756381|FG003|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0|||
147434378|NCT02038920|531756382|FG004|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0|||
147434379|NCT02038920|531756383|FG005|Maintenance Phase (Week 14 to 60)|Lost to Follow-up|0|||
147434380|NCT02038920|531756378|FG000|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|0|||
147434381|NCT02038920|531756379|FG001|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|0|||
147434382|NCT02038920|531756380|FG002|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|2|||
147434383|NCT02038920|531756381|FG003|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|4|||
147434384|NCT02038920|531756382|FG004|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|10|||
147434385|NCT02038920|531756383|FG005|Maintenance Phase (Week 14 to 60)|Lack of Efficacy|0|||
147434386|NCT02038920|531756378|FG000|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0|||
147434387|NCT02038920|531756379|FG001|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0|||
147434388|NCT02038920|531756380|FG002|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0|||
147434389|NCT02038920|531756381|FG003|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0|||
147434390|NCT02038920|531756382|FG004|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|0|||
147434391|NCT02038920|531756383|FG005|Open Label Cohort (Week 10 to 154)|Pretreatment Event/Adverse Event|43|||
147434392|NCT02038920|531756378|FG000|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0|||
147434393|NCT02038920|531756379|FG001|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0|||
147434394|NCT02038920|531756380|FG002|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0|||
147434395|NCT02038920|531756381|FG003|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0|||
147434396|NCT02038920|531756382|FG004|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|0|||
147434397|NCT02038920|531756383|FG005|Open Label Cohort (Week 10 to 154)|Lost to Follow-up|1|||
147434398|NCT02038920|531756378|FG000|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0|||
147434399|NCT02038920|531756379|FG001|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0|||
147434400|NCT02038920|531756380|FG002|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0|||
147434401|NCT02038920|531756381|FG003|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0|||
147434402|NCT02038920|531756382|FG004|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|0|||
147434403|NCT02038920|531756383|FG005|Open Label Cohort (Week 10 to 154)|Voluntary Withdrawal|7|||
147434404|NCT02038920|531756378|FG000|Open Label Cohort (Week 10 to 154)|Pregnancy|0|||
147434405|NCT02038920|531756379|FG001|Open Label Cohort (Week 10 to 154)|Pregnancy|0|||
147434406|NCT02038920|531756380|FG002|Open Label Cohort (Week 10 to 154)|Pregnancy|0|||
147434407|NCT02038920|531756381|FG003|Open Label Cohort (Week 10 to 154)|Pregnancy|0|||
147434408|NCT02038920|531756382|FG004|Open Label Cohort (Week 10 to 154)|Pregnancy|0|||
147434409|NCT02038920|531756383|FG005|Open Label Cohort (Week 10 to 154)|Pregnancy|1|||
147434410|NCT02038920|531756378|FG000|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0|||
147434411|NCT02038920|531756379|FG001|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0|||
147434412|NCT02038920|531756380|FG002|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0|||
147434413|NCT02038920|531756381|FG003|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0|||
147434414|NCT02038920|531756382|FG004|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|0|||
147434415|NCT02038920|531756383|FG005|Open Label Cohort (Week 10 to 154)|Lack of Efficacy|23|||
147434416|NCT02038920|531756378|FG000|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0|||
147434417|NCT02038920|531756379|FG001|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0|||
147434418|NCT02038920|531756380|FG002|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0|||
147434419|NCT02038920|531756381|FG003|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0|||
147434420|NCT02038920|531756382|FG004|Open Label Cohort (Week 10 to 154)|Reason Not Specified|0|||
147434421|NCT02038920|531756383|FG005|Open Label Cohort (Week 10 to 154)|Reason Not Specified|2|||
147434422|NCT02383589|531756385|FG000|Treatment Period|Adverse Event|1|||
147195867|NCT01972217|530888183|FG000|Part B Double-blind, Randomised Period|Screen failure|0|||
147534597|NCT02411110|532113087|FG000|Treatment Period 1|Other Miscellaneous Reasons|2|||
147534598|NCT02411110|532113088|FG001|Treatment Period 1|Other Miscellaneous Reasons|0|||
147534599|NCT02411110|532113087|FG000|Treatment Period 2|Adverse Event|1|||
147534600|NCT02411110|532113088|FG001|Treatment Period 2|Adverse Event|0|||
147534601|NCT02411110|532113087|FG000|Treatment Period 2|Lost to Follow-up|0|||
147534602|NCT02411110|532113088|FG001|Treatment Period 2|Lost to Follow-up|2|||
147534603|NCT02411110|532113087|FG000|Treatment Period 2|Personal Reasons|0|||
147534604|NCT02411110|532113088|FG001|Treatment Period 2|Personal Reasons|2|||
147534605|NCT00526162|532113089|FG000|Overall Study|Device not implanted|3|||
147534606|NCT05279807|532113090|FG000|Overall Study|Withdrawal by Subject|1|||
147534607|NCT05279807|532113091|FG001|Overall Study|Withdrawal by Subject|0|||
147534608|NCT05279807|532113090|FG000|Overall Study|Adverse Event|0|||
147534609|NCT05279807|532113091|FG001|Overall Study|Adverse Event|1|||
147534610|NCT05279807|532113090|FG000|Overall Study|Laboratory Abnormal Results|1|||
147534611|NCT05279807|532113091|FG001|Overall Study|Laboratory Abnormal Results|0|||
147534612|NCT04242446|532113096|FG000|Initial Treatment Period: Week 0-16|Adverse Event|1|||
147534613|NCT04242446|532113097|FG001|Initial Treatment Period: Week 0-16|Adverse Event|5|||
147534614|NCT04242446|532113098|FG002|Initial Treatment Period: Week 0-16|Adverse Event|7|||
147534615|NCT04242446|532113099|FG003|Initial Treatment Period: Week 0-16|Adverse Event|0|||
147534616|NCT04242446|532113100|FG004|Initial Treatment Period: Week 0-16|Adverse Event|0|||
147534617|NCT04242446|532113101|FG005|Initial Treatment Period: Week 0-16|Adverse Event|0|||
147534618|NCT04242446|532113102|FG006|Initial Treatment Period: Week 0-16|Adverse Event|0|||
147534619|NCT04242446|532113096|FG000|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
147534620|NCT04242446|532113097|FG001|Initial Treatment Period: Week 0-16|Protocol Violation|2|||
147534621|NCT04242446|532113098|FG002|Initial Treatment Period: Week 0-16|Protocol Violation|2|||
147534622|NCT04242446|532113099|FG003|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
147534623|NCT04242446|532113100|FG004|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
147534624|NCT04242446|532113101|FG005|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
147534625|NCT04242446|532113102|FG006|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
147534626|NCT04242446|532113096|FG000|Initial Treatment Period: Week 0-16|Lost to Follow-up|1|||
147534627|NCT04242446|532113097|FG001|Initial Treatment Period: Week 0-16|Lost to Follow-up|3|||
147534628|NCT04242446|532113098|FG002|Initial Treatment Period: Week 0-16|Lost to Follow-up|2|||
147534629|NCT04242446|532113099|FG003|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
147534630|NCT04242446|532113100|FG004|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
147534631|NCT04242446|532113101|FG005|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
147534632|NCT04242446|532113102|FG006|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
147534633|NCT04242446|532113096|FG000|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|4|||
147534634|NCT04242446|532113097|FG001|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|6|||
147534635|NCT04242446|532113098|FG002|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|14|||
147534636|NCT04242446|532113099|FG003|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
147534637|NCT04242446|532113100|FG004|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
147534638|NCT04242446|532113101|FG005|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
147534639|NCT04242446|532113102|FG006|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
147534640|NCT04242446|532113096|FG000|Initial Treatment Period: Week 0-16|Country Relocation|1|||
147534641|NCT04242446|532113097|FG001|Initial Treatment Period: Week 0-16|Country Relocation|0|||
147534642|NCT04242446|532113098|FG002|Initial Treatment Period: Week 0-16|Country Relocation|0|||
147534643|NCT04242446|532113099|FG003|Initial Treatment Period: Week 0-16|Country Relocation|0|||
147534644|NCT04242446|532113100|FG004|Initial Treatment Period: Week 0-16|Country Relocation|0|||
147534645|NCT04242446|532113101|FG005|Initial Treatment Period: Week 0-16|Country Relocation|0|||
147534646|NCT04242446|532113102|FG006|Initial Treatment Period: Week 0-16|Country Relocation|0|||
147534647|NCT04242446|532113096|FG000|Initial Treatment Period: Week 0-16|Withdrawn based to Exclusion Criterion|0|||
147534648|NCT04242446|532113097|FG001|Initial Treatment Period: Week 0-16|Withdrawn based to Exclusion Criterion|0|||
147534649|NCT04242446|532113098|FG002|Initial Treatment Period: Week 0-16|Withdrawn based to Exclusion Criterion|1|||
147649405|NCT04575584|532537340|FG005|Overall Study|Withdrawal by Subject|0|||
147649406|NCT04575584|532537335|FG000|Overall Study|Not recorded|0|||
147195868|NCT01972217|530888184|FG001|Part B Double-blind, Randomised Period|Screen failure|0|||
147195869|NCT01972217|530888185|FG002|Part B Double-blind, Randomised Period|Screen failure|0|||
147195870|NCT01972217|530888186|FG003|Part B Double-blind, Randomised Period|Screen failure|1|||
147195871|NCT01972217|530888183|FG000|Part B Double-blind, Randomised Period|Lost to Follow-up|0|||
147195872|NCT01972217|530888184|FG001|Part B Double-blind, Randomised Period|Lost to Follow-up|0|||
147195873|NCT01972217|530888185|FG002|Part B Double-blind, Randomised Period|Lost to Follow-up|2|||
147195874|NCT01972217|530888186|FG003|Part B Double-blind, Randomised Period|Lost to Follow-up|1|||
147195875|NCT01972217|530888183|FG000|Part B Double-blind, Randomised Period|Withdrawal by Subject|0|||
147195876|NCT01972217|530888184|FG001|Part B Double-blind, Randomised Period|Withdrawal by Subject|0|||
147195877|NCT01972217|530888185|FG002|Part B Double-blind, Randomised Period|Withdrawal by Subject|0|||
147195878|NCT01972217|530888186|FG003|Part B Double-blind, Randomised Period|Withdrawal by Subject|1|||
147195879|NCT04328077|530888188|FG000|Overall Study|Lost to Follow-up|0|||
147195880|NCT04328077|530888189|FG001|Overall Study|Lost to Follow-up|1|||
147195881|NCT04328077|530888190|FG002|Overall Study|Lost to Follow-up|0|||
147195882|NCT04328077|530888191|FG003|Overall Study|Lost to Follow-up|0|||
147195883|NCT04328077|530888188|FG000|Overall Study|Withdrawal by Subject|0|||
147195884|NCT04328077|530888189|FG001|Overall Study|Withdrawal by Subject|1|||
147195885|NCT04328077|530888190|FG002|Overall Study|Withdrawal by Subject|1|||
147195886|NCT04328077|530888191|FG003|Overall Study|Withdrawal by Subject|3|||
147195887|NCT01456039|530888192|FG000|Phase 1 (First Step)|Disease Progression|1|||
147195888|NCT01456039|530888193|FG001|Phase 1 (First Step)|Disease Progression|1|||
147195889|NCT01456039|530888194|FG002|Phase 1 (First Step)|Disease Progression|0|||
147195890|NCT01456039|530888192|FG000|Phase 1 (First Step)|Withdrawal by Subject|1|||
147195891|NCT01456039|530888193|FG001|Phase 1 (First Step)|Withdrawal by Subject|2|||
147195892|NCT01456039|530888194|FG002|Phase 1 (First Step)|Withdrawal by Subject|0|||
147195893|NCT01456039|530888192|FG000|Phase 1 (First Step)|Adverse Event|0|||
147195894|NCT01456039|530888193|FG001|Phase 1 (First Step)|Adverse Event|3|||
147195895|NCT01456039|530888194|FG002|Phase 1 (First Step)|Adverse Event|0|||
147195896|NCT01456039|530888192|FG000|Phase 1 (First Step)|Other|0|||
147195897|NCT01456039|530888193|FG001|Phase 1 (First Step)|Other|1|||
147195898|NCT01456039|530888194|FG002|Phase 1 (First Step)|Other|0|||
147195899|NCT01456039|530888192|FG000|Phase 2 (Second Step)|Disease Progression|0|||
147195900|NCT01456039|530888193|FG001|Phase 2 (Second Step)|Disease Progression|0|||
147195901|NCT01456039|530888194|FG002|Phase 2 (Second Step)|Disease Progression|17|||
147195902|NCT01456039|530888192|FG000|Phase 2 (Second Step)|Adverse Event|0|||
147195903|NCT01456039|530888193|FG001|Phase 2 (Second Step)|Adverse Event|0|||
147195904|NCT01456039|530888194|FG002|Phase 2 (Second Step)|Adverse Event|10|||
147195905|NCT01456039|530888192|FG000|Phase 2 (Second Step)|Withdrawal by Subject|0|||
147195906|NCT01456039|530888193|FG001|Phase 2 (Second Step)|Withdrawal by Subject|0|||
147195907|NCT01456039|530888194|FG002|Phase 2 (Second Step)|Withdrawal by Subject|4|||
147195908|NCT01456039|530888192|FG000|Phase 2 (Second Step)|Protocol Violation|0|||
147195909|NCT01456039|530888193|FG001|Phase 2 (Second Step)|Protocol Violation|0|||
147195910|NCT01456039|530888194|FG002|Phase 2 (Second Step)|Protocol Violation|1|||
147195911|NCT01456039|530888192|FG000|Phase 2 (Second Step)|Other|0|||
147195912|NCT01456039|530888193|FG001|Phase 2 (Second Step)|Other|0|||
147195913|NCT01456039|530888194|FG002|Phase 2 (Second Step)|Other|1|||
147195914|NCT00335777|530888197|FG000|Enrolled and Dispensed Study Medication|Lost to Follow-up|5|||
147195915|NCT00335777|530888197|FG000|Enrolled and Dispensed Study Medication|Withdrawal by Subject|6|||
147195916|NCT00335777|530888197|FG000|Enrolled and Dispensed Study Medication|Treated only 1 or no headaches|18|||
147195917|NCT00335777|530888197|FG000|Treated 2 Headaches Per Protocol|Treated 2 early or 2 late headaches|1|||
147195918|NCT00335777|530888197|FG000|Treated 2 Headaches Per Protocol|Treated out of protocol for early and late|12|||
147195919|NCT00939393|530888205|FG000|Overall Study|Withdrawal by Subject|1|||
147195920|NCT00939393|530888206|FG001|Overall Study|Withdrawal by Subject|0|||
147195921|NCT00939393|530888205|FG000|Overall Study|Lost to Follow-up|3|||
147195922|NCT00939393|530888206|FG001|Overall Study|Lost to Follow-up|0|||
147195923|NCT02851615|530888207|FG000|Overall Study|Cognitive Issue|1|||
147195924|NCT02851615|530888208|FG001|Overall Study|Cognitive Issue|0|||
147195925|NCT02851615|530888207|FG000|Overall Study|Lost to Follow-up|0|||
147195926|NCT02851615|530888208|FG001|Overall Study|Lost to Follow-up|4|||
147195927|NCT00313014|530888209|FG000|Overall Study|Withdrawal by Subject|11|||
147195928|NCT00313014|530888210|FG001|Overall Study|Withdrawal by Subject|7|||
147195929|NCT00313014|530888211|FG002|Overall Study|Withdrawal by Subject|5|||
147195930|NCT00313014|530888209|FG000|Overall Study|Adverse Event|14|||
147195931|NCT00313014|530888210|FG001|Overall Study|Adverse Event|29|||
147434423|NCT02383589|531756386|FG001|Treatment Period|Adverse Event|3|||
147434424|NCT02383589|531756385|FG000|Treatment Period|Lost to Follow-up|0|||
147434425|NCT02383589|531756386|FG001|Treatment Period|Lost to Follow-up|1|||
147434426|NCT02383589|531756385|FG000|Treatment Period|Withdrawal by Subject|0|||
147434427|NCT02383589|531756386|FG001|Treatment Period|Withdrawal by Subject|5|||
147434428|NCT02383589|531756385|FG000|Treatment Period|Non-compliance with study drug|0|||
147434429|NCT02383589|531756386|FG001|Treatment Period|Non-compliance with study drug|1|||
147434430|NCT02383589|531756385|FG000|Safety Follow-up (SFU)|Lost to Follow-up|2|||
147434431|NCT02383589|531756386|FG001|Safety Follow-up (SFU)|Lost to Follow-up|4|||
147434432|NCT02383589|531756385|FG000|Safety Follow-up (SFU)|Withdrawal by Subject|5|||
147434433|NCT02383589|531756386|FG001|Safety Follow-up (SFU)|Withdrawal by Subject|0|||
147434434|NCT02383589|531756385|FG000|Safety Follow-up (SFU)|Treated by not accepted treatment|0|||
147434435|NCT02383589|531756386|FG001|Safety Follow-up (SFU)|Treated by not accepted treatment|1|||
147434436|NCT00866697|531756387|FG000|Overall Study|Study closed/terminated|156|||
147434437|NCT00866697|531756388|FG001|Overall Study|Study closed/terminated|138|||
147195932|NCT00313014|530888211|FG002|Overall Study|Adverse Event|16|||
147195933|NCT00313014|530888209|FG000|Overall Study|Lost to Follow-up|7|||
147195934|NCT00313014|530888210|FG001|Overall Study|Lost to Follow-up|6|||
147195935|NCT00313014|530888211|FG002|Overall Study|Lost to Follow-up|10|||
147195936|NCT00313014|530888209|FG000|Overall Study|Administrative|9|||
147195937|NCT00313014|530888210|FG001|Overall Study|Administrative|6|||
147195938|NCT00313014|530888211|FG002|Overall Study|Administrative|14|||
147195939|NCT00313014|530888209|FG000|Overall Study|Lack of Efficacy|52|||
147195940|NCT00313014|530888210|FG001|Overall Study|Lack of Efficacy|25|||
147195941|NCT00313014|530888211|FG002|Overall Study|Lack of Efficacy|16|||
147195942|NCT00371150|530888213|FG000|Overall Study|Lost to Follow-up|3|||
147195943|NCT00371150|530888214|FG001|Overall Study|Lost to Follow-up|2|||
147195944|NCT02345070|530888215|FG000|Overall Study|Adverse Event|12|||
147195945|NCT02345070|530888216|FG001|Overall Study|Adverse Event|8|||
147195946|NCT02345070|530888217|FG002|Overall Study|Adverse Event|16|||
147195947|NCT02345070|530888215|FG000|Overall Study|Poor compliance to protocol|2|||
147195948|NCT02345070|530888216|FG001|Overall Study|Poor compliance to protocol|0|||
147195949|NCT02345070|530888217|FG002|Overall Study|Poor compliance to protocol|0|||
147195950|NCT02345070|530888215|FG000|Overall Study|Other than specified above|6|||
147195951|NCT02345070|530888216|FG001|Overall Study|Other than specified above|3|||
147195952|NCT02345070|530888217|FG002|Overall Study|Other than specified above|7|||
147195953|NCT00473564|530888220|FG000|Overall Study|robot surgery aborted in OR|23|||
147195954|NCT03131219|530888221|FG000|Initial Evaluation Period|Adverse Event|2|||
147195955|NCT03131219|530888222|FG001|Initial Evaluation Period|Adverse Event|0|||
147195956|NCT03131219|530888221|FG000|Initial Evaluation Period|Protocol Violation|1|||
147195957|NCT03131219|530888222|FG001|Initial Evaluation Period|Protocol Violation|0|||
147195958|NCT03131219|530888221|FG000|Initial Evaluation Period|Deemed Ineligible Post Treatment|3|||
147195959|NCT03131219|530888222|FG001|Initial Evaluation Period|Deemed Ineligible Post Treatment|0|||
147195960|NCT03131219|530888221|FG000|Initial Evaluation Period|Physician Decision|1|||
147195961|NCT03131219|530888222|FG001|Initial Evaluation Period|Physician Decision|0|||
147195962|NCT03131219|530888221|FG000|Extension Period|Physician Decision|1|||
147195963|NCT03131219|530888222|FG001|Extension Period|Physician Decision|0|||
147195964|NCT00616759|530888223|FG000|Overall Study|Physician Decision|2|||
147195965|NCT00616759|530888224|FG001|Overall Study|Physician Decision|0|||
147195966|NCT00616759|530888223|FG000|Overall Study|Withdrawal by Subject|1|||
147195967|NCT00616759|530888224|FG001|Overall Study|Withdrawal by Subject|2|||
147195968|NCT00981656|530888237|FG000|Overall Study|Protocol Violation|1|||
147195969|NCT00981656|530888237|FG000|Overall Study|Did not start protocol treatment|2|||
147195970|NCT02903771|530888238|FG000|Part A: Dose Escalation Cohort|Adverse Event|1|||
147195971|NCT02903771|530888239|FG001|Part A: Dose Escalation Cohort|Adverse Event|0|||
147195972|NCT02903771|530888240|FG002|Part A: Dose Escalation Cohort|Adverse Event|0|||
147195973|NCT02903771|530888241|FG003|Part A: Dose Escalation Cohort|Adverse Event|0|||
147195974|NCT02903771|530888242|FG004|Part A: Dose Escalation Cohort|Adverse Event|0|||
147195975|NCT02903771|530888243|FG005|Part A: Dose Escalation Cohort|Adverse Event|0|||
147195976|NCT02903771|530888244|FG006|Part A: Dose Escalation Cohort|Adverse Event|1|||
147195977|NCT02903771|530888238|FG000|Part A: Dose Escalation Cohort|Progressive disease|0|||
147195978|NCT02903771|530888239|FG001|Part A: Dose Escalation Cohort|Progressive disease|1|||
147195979|NCT02903771|530888240|FG002|Part A: Dose Escalation Cohort|Progressive disease|0|||
147195980|NCT02903771|530888241|FG003|Part A: Dose Escalation Cohort|Progressive disease|0|||
147195981|NCT02903771|530888242|FG004|Part A: Dose Escalation Cohort|Progressive disease|0|||
147195982|NCT02903771|530888243|FG005|Part A: Dose Escalation Cohort|Progressive disease|0|||
147195983|NCT02903771|530888244|FG006|Part A: Dose Escalation Cohort|Progressive disease|0|||
147195984|NCT02903771|530888238|FG000|Part A: Dose Escalation Cohort|Withdrawal by Subject|0|||
147195985|NCT02903771|530888239|FG001|Part A: Dose Escalation Cohort|Withdrawal by Subject|0|||
147195986|NCT02903771|530888240|FG002|Part A: Dose Escalation Cohort|Withdrawal by Subject|1|||
147195987|NCT02903771|530888241|FG003|Part A: Dose Escalation Cohort|Withdrawal by Subject|0|||
147195988|NCT02903771|530888242|FG004|Part A: Dose Escalation Cohort|Withdrawal by Subject|0|||
147195989|NCT02903771|530888243|FG005|Part A: Dose Escalation Cohort|Withdrawal by Subject|1|||
147195990|NCT02903771|530888244|FG006|Part A: Dose Escalation Cohort|Withdrawal by Subject|0|||
147195991|NCT02903771|530888238|FG000|Part A: Dose Escalation Cohort|Lost to Follow-up|0|||
147195992|NCT02903771|530888239|FG001|Part A: Dose Escalation Cohort|Lost to Follow-up|0|||
147195993|NCT02903771|530888240|FG002|Part A: Dose Escalation Cohort|Lost to Follow-up|0|||
147195994|NCT02903771|530888241|FG003|Part A: Dose Escalation Cohort|Lost to Follow-up|0|||
147195995|NCT02903771|530888242|FG004|Part A: Dose Escalation Cohort|Lost to Follow-up|1|||
147195996|NCT02903771|530888243|FG005|Part A: Dose Escalation Cohort|Lost to Follow-up|0|||
147195997|NCT02903771|530888244|FG006|Part A: Dose Escalation Cohort|Lost to Follow-up|0|||
147195998|NCT02903771|530888238|FG000|Part A: Dose Escalation Cohort|Physician Decision|0|||
147195999|NCT02903771|530888239|FG001|Part A: Dose Escalation Cohort|Physician Decision|0|||
147196000|NCT02903771|530888240|FG002|Part A: Dose Escalation Cohort|Physician Decision|0|||
147196001|NCT02903771|530888241|FG003|Part A: Dose Escalation Cohort|Physician Decision|0|||
147196002|NCT02903771|530888242|FG004|Part A: Dose Escalation Cohort|Physician Decision|0|||
147196003|NCT02903771|530888243|FG005|Part A: Dose Escalation Cohort|Physician Decision|1|||
147196004|NCT02903771|530888244|FG006|Part A: Dose Escalation Cohort|Physician Decision|0|||
147196005|NCT02903771|530888238|FG000|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|0|||
147196006|NCT02903771|530888239|FG001|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|0|||
147196007|NCT02903771|530888240|FG002|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|0|||
147196008|NCT02903771|530888241|FG003|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|0|||
147196009|NCT02903771|530888242|FG004|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|2|||
147196010|NCT02903771|530888243|FG005|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|0|||
147196011|NCT02903771|530888244|FG006|Part B: Expansion Cohort (5 mg/kg)|Adverse Event|0|||
147196012|NCT02903771|530888238|FG000|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|0|||
147196013|NCT02903771|530888239|FG001|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|0|||
147196014|NCT02903771|530888240|FG002|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|0|||
147196015|NCT02903771|530888241|FG003|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|0|||
147196016|NCT02903771|530888242|FG004|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|3|||
147196017|NCT02903771|530888243|FG005|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|0|||
147196018|NCT02903771|530888244|FG006|Part B: Expansion Cohort (5 mg/kg)|Withdrawal by Subject|0|||
147196019|NCT02903771|530888238|FG000|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|0|||
147196020|NCT02903771|530888239|FG001|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|0|||
147196021|NCT02903771|530888240|FG002|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|0|||
147196022|NCT02903771|530888241|FG003|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|0|||
147196023|NCT02903771|530888242|FG004|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|2|||
147196024|NCT02903771|530888243|FG005|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|0|||
147196025|NCT02903771|530888244|FG006|Part B: Expansion Cohort (5 mg/kg)|Physician Decision|0|||
147196026|NCT02903771|530888238|FG000|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|0|||
147196027|NCT02903771|530888239|FG001|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|0|||
147196028|NCT02903771|530888240|FG002|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|0|||
147196029|NCT02903771|530888241|FG003|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|0|||
147196030|NCT02903771|530888242|FG004|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|1|||
147196031|NCT02903771|530888243|FG005|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|0|||
147196032|NCT02903771|530888244|FG006|Part B: Expansion Cohort (5 mg/kg)|Lost to Follow-up|0|||
147196033|NCT02903771|530888238|FG000|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|0|||
147196034|NCT02903771|530888239|FG001|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|0|||
147196035|NCT02903771|530888240|FG002|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|0|||
147196036|NCT02903771|530888241|FG003|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|0|||
147196037|NCT02903771|530888242|FG004|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|2|||
147196038|NCT02903771|530888243|FG005|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|0|||
147196039|NCT02903771|530888244|FG006|Part B: Expansion Cohort (5 mg/kg)|Progressive disease|0|||
147196040|NCT02903771|530888238|FG000|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|0|||
147196041|NCT02903771|530888239|FG001|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|0|||
147196042|NCT02903771|530888240|FG002|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|0|||
147196043|NCT02903771|530888241|FG003|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|0|||
147196044|NCT02903771|530888242|FG004|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|2|||
147196045|NCT02903771|530888243|FG005|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|0|||
147196046|NCT02903771|530888244|FG006|Part B: Expansion Cohort (5 mg/kg)|Death due to progressive disease|0|||
147196047|NCT01709721|530888248|FG000|Open Label Phase|Withdrawal by Subject|0|||
147196048|NCT01709721|530888249|FG001|Open Label Phase|Withdrawal by Subject|0|||
147196049|NCT01709721|530888250|FG002|Open Label Phase|Withdrawal by Subject|5|||
147196050|NCT01709721|530888248|FG000|Open Label Phase|Adverse Event|0|||
147196051|NCT01709721|530888249|FG001|Open Label Phase|Adverse Event|0|||
147196052|NCT01709721|530888250|FG002|Open Label Phase|Adverse Event|8|||
147196053|NCT01709721|530888248|FG000|Open Label Phase|Non-compliance With Study Drug|0|||
147196054|NCT01709721|530888249|FG001|Open Label Phase|Non-compliance With Study Drug|0|||
147196055|NCT01709721|530888250|FG002|Open Label Phase|Non-compliance With Study Drug|3|||
147196056|NCT01709721|530888248|FG000|Open Label Phase|Investigator Decision|0|||
147196057|NCT01709721|530888249|FG001|Open Label Phase|Investigator Decision|0|||
147196058|NCT01709721|530888250|FG002|Open Label Phase|Investigator Decision|1|||
147196059|NCT01709721|530888248|FG000|Open Label Phase|Sponsor Decision|0|||
147196060|NCT01709721|530888249|FG001|Open Label Phase|Sponsor Decision|0|||
147196061|NCT01709721|530888250|FG002|Open Label Phase|Sponsor Decision|2|||
147196062|NCT01709721|530888248|FG000|Open Label Phase|Protocol Violation|0|||
147534650|NCT04242446|532113099|FG003|Initial Treatment Period: Week 0-16|Withdrawn based to Exclusion Criterion|0|||
147534651|NCT04242446|532113100|FG004|Initial Treatment Period: Week 0-16|Withdrawn based to Exclusion Criterion|0|||
147534652|NCT04242446|532113101|FG005|Initial Treatment Period: Week 0-16|Withdrawn based to Exclusion Criterion|0|||
147534653|NCT04242446|532113102|FG006|Initial Treatment Period: Week 0-16|Withdrawn based to Exclusion Criterion|0|||
147534654|NCT04242446|532113096|FG000|Initial Treatment Period: Week 0-16|Per Sponsors Request Due To Covid 19 Pandemic|0|||
147534655|NCT04242446|532113097|FG001|Initial Treatment Period: Week 0-16|Per Sponsors Request Due To Covid 19 Pandemic|0|||
147534656|NCT04242446|532113098|FG002|Initial Treatment Period: Week 0-16|Per Sponsors Request Due To Covid 19 Pandemic|1|||
147534657|NCT04242446|532113099|FG003|Initial Treatment Period: Week 0-16|Per Sponsors Request Due To Covid 19 Pandemic|0|||
147534658|NCT04242446|532113100|FG004|Initial Treatment Period: Week 0-16|Per Sponsors Request Due To Covid 19 Pandemic|0|||
147534659|NCT04242446|532113101|FG005|Initial Treatment Period: Week 0-16|Per Sponsors Request Due To Covid 19 Pandemic|0|||
147196063|NCT01709721|530888249|FG001|Open Label Phase|Protocol Violation|0|||
147196064|NCT01709721|530888250|FG002|Open Label Phase|Protocol Violation|1|||
147534660|NCT04242446|532113102|FG006|Initial Treatment Period: Week 0-16|Per Sponsors Request Due To Covid 19 Pandemic|0|||
147534661|NCT04242446|532113096|FG000|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
147534662|NCT04242446|532113097|FG001|Initial Treatment Period: Week 0-16|Randomized, not treated|1|||
147534663|NCT04242446|532113098|FG002|Initial Treatment Period: Week 0-16|Randomized, not treated|3|||
147534664|NCT04242446|532113099|FG003|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
147534665|NCT04242446|532113100|FG004|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
147534666|NCT04242446|532113101|FG005|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
147534667|NCT04242446|532113102|FG006|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
147534668|NCT04242446|532113096|FG000|Maintenance Treatment Period: Week 16-48|Adverse Event|0|||
147534669|NCT04242446|532113097|FG001|Maintenance Treatment Period: Week 16-48|Adverse Event|0|||
147534670|NCT04242446|532113098|FG002|Maintenance Treatment Period: Week 16-48|Adverse Event|0|||
147534671|NCT04242446|532113099|FG003|Maintenance Treatment Period: Week 16-48|Adverse Event|9|||
147534672|NCT04242446|532113100|FG004|Maintenance Treatment Period: Week 16-48|Adverse Event|7|||
147534673|NCT04242446|532113101|FG005|Maintenance Treatment Period: Week 16-48|Adverse Event|5|||
147534674|NCT04242446|532113102|FG006|Maintenance Treatment Period: Week 16-48|Adverse Event|6|||
147534675|NCT04242446|532113096|FG000|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|0|||
147534676|NCT04242446|532113097|FG001|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|0|||
147534677|NCT04242446|532113098|FG002|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|0|||
147534678|NCT04242446|532113099|FG003|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|1|||
147534679|NCT04242446|532113100|FG004|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|7|||
147534680|NCT04242446|532113101|FG005|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|3|||
147534681|NCT04242446|532113102|FG006|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|3|||
147534682|NCT04242446|532113096|FG000|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
147534683|NCT04242446|532113097|FG001|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
147534684|NCT04242446|532113098|FG002|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
147534685|NCT04242446|532113099|FG003|Maintenance Treatment Period: Week 16-48|Protocol Violation|1|||
147534686|NCT04242446|532113100|FG004|Maintenance Treatment Period: Week 16-48|Protocol Violation|2|||
147534687|NCT04242446|532113101|FG005|Maintenance Treatment Period: Week 16-48|Protocol Violation|1|||
147534688|NCT04242446|532113102|FG006|Maintenance Treatment Period: Week 16-48|Protocol Violation|2|||
147534689|NCT04242446|532113096|FG000|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|0|||
147534690|NCT04242446|532113097|FG001|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|0|||
147534691|NCT04242446|532113098|FG002|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|0|||
147534692|NCT04242446|532113099|FG003|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|2|||
147196065|NCT01709721|530888248|FG000|Open Label Phase|Changes In The Subject's Condition Render The Subject Unacceptable For Further Treatment|0|||
147196066|NCT01709721|530888249|FG001|Open Label Phase|Changes In The Subject's Condition Render The Subject Unacceptable For Further Treatment|0|||
147196067|NCT01709721|530888250|FG002|Open Label Phase|Changes In The Subject's Condition Render The Subject Unacceptable For Further Treatment|1|||
147196068|NCT01709721|530888248|FG000|Open Label Phase|Inadequate Pain Control|0|||
147196069|NCT01709721|530888249|FG001|Open Label Phase|Inadequate Pain Control|0|||
147196070|NCT01709721|530888250|FG002|Open Label Phase|Inadequate Pain Control|37|||
147196071|NCT01709721|530888248|FG000|Open Label Phase|Other, Specify in text field in database|0|||
147196072|NCT01709721|530888249|FG001|Open Label Phase|Other, Specify in text field in database|0|||
147196073|NCT01709721|530888250|FG002|Open Label Phase|Other, Specify in text field in database|14|||
147196074|NCT01709721|530888248|FG000|Randomized Phase|Adverse Event|0|||
147196075|NCT01709721|530888249|FG001|Randomized Phase|Adverse Event|1|||
147196076|NCT01709721|530888250|FG002|Randomized Phase|Adverse Event|0|||
147196077|NCT01709721|530888248|FG000|Randomized Phase|Lost to Follow-up|1|||
147196078|NCT01709721|530888249|FG001|Randomized Phase|Lost to Follow-up|0|||
147196079|NCT01709721|530888250|FG002|Randomized Phase|Lost to Follow-up|0|||
147196080|NCT01709721|530888248|FG000|Randomized Phase|Inadequate Pain Control|1|||
147196081|NCT01709721|530888249|FG001|Randomized Phase|Inadequate Pain Control|2|||
147196082|NCT01709721|530888250|FG002|Randomized Phase|Inadequate Pain Control|0|||
147196083|NCT01709721|530888248|FG000|Randomized Phase|Other, Specify text field in database|1|||
147196084|NCT01709721|530888249|FG001|Randomized Phase|Other, Specify text field in database|3|||
147196085|NCT01709721|530888250|FG002|Randomized Phase|Other, Specify text field in database|0|||
147196086|NCT03137381|530888251|FG000|Overall Study|Adverse Event|3|||
147196087|NCT03137381|530888252|FG001|Overall Study|Adverse Event|0|||
147196088|NCT03137381|530888253|FG002|Overall Study|Adverse Event|2|||
147196089|NCT03137381|530888254|FG003|Overall Study|Adverse Event|0|||
147196090|NCT03137381|530888251|FG000|Overall Study|Lost to Follow-up|2|||
147196091|NCT03137381|530888252|FG001|Overall Study|Lost to Follow-up|1|||
147196092|NCT03137381|530888253|FG002|Overall Study|Lost to Follow-up|1|||
147196093|NCT03137381|530888254|FG003|Overall Study|Lost to Follow-up|0|||
147196094|NCT03137381|530888251|FG000|Overall Study|Protocol deviation|1|||
147196095|NCT03137381|530888252|FG001|Overall Study|Protocol deviation|1|||
147196096|NCT03137381|530888253|FG002|Overall Study|Protocol deviation|0|||
147196097|NCT03137381|530888254|FG003|Overall Study|Protocol deviation|1|||
147196098|NCT03137381|530888251|FG000|Overall Study|Withdrawal by Investigator|0|||
147196099|NCT03137381|530888252|FG001|Overall Study|Withdrawal by Investigator|1|||
147196100|NCT03137381|530888253|FG002|Overall Study|Withdrawal by Investigator|1|||
147434438|NCT00866697|531756387|FG000|Overall Study|Lost to Follow-up|22|||
147434439|NCT00866697|531756388|FG001|Overall Study|Lost to Follow-up|28|||
147434440|NCT00866697|531756387|FG000|Overall Study|Physician Decision|3|||
147434441|NCT00866697|531756388|FG001|Overall Study|Physician Decision|5|||
147434442|NCT00866697|531756387|FG000|Overall Study|Withdrawal by Subject|33|||
147434443|NCT00866697|531756388|FG001|Overall Study|Withdrawal by Subject|57|||
147434444|NCT02906787|531756392|FG000|Overall Study|Withdrawal by Subject|12|||
147434445|NCT02906787|531756393|FG001|Overall Study|Withdrawal by Subject|10|||
147434446|NCT02906787|531756392|FG000|Overall Study|Missed|24|||
147434447|NCT02906787|531756393|FG001|Overall Study|Missed|22|||
147434448|NCT04275297|531756394|FG000|Overall Study|Lost to Follow-up|1|||
147434449|NCT04275297|531756395|FG001|Overall Study|Lost to Follow-up|1|||
147434450|NCT00447382|531756398|FG000|Overall Study|Adverse Event|1|||
147434451|NCT00447382|531756399|FG001|Overall Study|Adverse Event|1|||
147434452|NCT00447382|531756398|FG000|Overall Study|Lack of Efficacy|1|||
147434453|NCT00447382|531756399|FG001|Overall Study|Lack of Efficacy|0|||
147434454|NCT00447382|531756398|FG000|Overall Study|Protocol Violation|2|||
147434455|NCT00447382|531756399|FG001|Overall Study|Protocol Violation|0|||
147434456|NCT00447382|531756398|FG000|Overall Study|Unclassified|2|||
147434457|NCT00447382|531756399|FG001|Overall Study|Unclassified|5|||
147434458|NCT04600336|531756404|FG000|Initial Treatment|Withdrawal by Subject|1|||
147434459|NCT04600336|531756405|FG001|Initial Treatment|Withdrawal by Subject|2|||
147434460|NCT04600336|531756406|FG002|Initial Treatment|Withdrawal by Subject|0|||
147434461|NCT04600336|531756407|FG003|Initial Treatment|Withdrawal by Subject|0|||
147434462|NCT04600336|531756404|FG000|Initial Treatment|Adverse Event|0|||
147434463|NCT04600336|531756405|FG001|Initial Treatment|Adverse Event|2|||
147434464|NCT04600336|531756406|FG002|Initial Treatment|Adverse Event|0|||
147434465|NCT04600336|531756407|FG003|Initial Treatment|Adverse Event|0|||
147434466|NCT04600336|531756404|FG000|Initial Treatment|Other complicating disease|0|||
147434467|NCT04600336|531756405|FG001|Initial Treatment|Other complicating disease|0|||
147434468|NCT04600336|531756406|FG002|Initial Treatment|Other complicating disease|1|||
147434469|NCT04600336|531756407|FG003|Initial Treatment|Other complicating disease|0|||
147196101|NCT03137381|530888254|FG003|Overall Study|Withdrawal by Investigator|0|||
147434470|NCT04600336|531756404|FG000|Crossover Treatment|Withdrawal by Subject|0|||
147434471|NCT04600336|531756405|FG001|Crossover Treatment|Withdrawal by Subject|0|||
147196102|NCT03137381|530888251|FG000|Overall Study|Withdrawal by Subject|3|||
147434472|NCT04600336|531756406|FG002|Crossover Treatment|Withdrawal by Subject|2|||
147434473|NCT04600336|531756407|FG003|Crossover Treatment|Withdrawal by Subject|1|||
147434474|NCT04600336|531756404|FG000|Crossover Treatment|Adverse Event|0|||
147196103|NCT03137381|530888252|FG001|Overall Study|Withdrawal by Subject|4|||
147196104|NCT03137381|530888253|FG002|Overall Study|Withdrawal by Subject|3|||
147196105|NCT03137381|530888254|FG003|Overall Study|Withdrawal by Subject|0|||
147196106|NCT03137381|530888251|FG000|Overall Study|Pregnancy|0|||
147196107|NCT03137381|530888252|FG001|Overall Study|Pregnancy|0|||
147196108|NCT03137381|530888253|FG002|Overall Study|Pregnancy|1|||
147196109|NCT03137381|530888254|FG003|Overall Study|Pregnancy|0|||
147196110|NCT03044106|530888259|FG000|Washout (1 Week)|Withdrawal by Subject|0|||
147196111|NCT03044106|530888260|FG001|Washout (1 Week)|Withdrawal by Subject|2|||
147196112|NCT01748292|530888261|FG000|Overall Study|Adverse Event|2|||
147196113|NCT01748292|530888262|FG001|Overall Study|Adverse Event|4|||
147196114|NCT01748292|530888261|FG000|Overall Study|Lost to Follow-up|0|||
147196115|NCT01748292|530888262|FG001|Overall Study|Lost to Follow-up|3|||
147196116|NCT01748292|530888261|FG000|Overall Study|Death|0|||
147196117|NCT01748292|530888262|FG001|Overall Study|Death|3|||
147196118|NCT01748292|530888261|FG000|Overall Study|Withdrawal by Subject|0|||
147196119|NCT01748292|530888262|FG001|Overall Study|Withdrawal by Subject|2|||
147196120|NCT01435382|530888265|FG000|Overall Study|Lost to Follow-up|1|||
147196121|NCT01435382|530888266|FG001|Overall Study|Lost to Follow-up|0|||
147196122|NCT01435382|530888267|FG002|Overall Study|Lost to Follow-up|1|||
147196123|NCT01435382|530888268|FG003|Overall Study|Lost to Follow-up|0|||
147196124|NCT01435382|530888265|FG000|Overall Study|Withdrawal by Subject|0|||
147434475|NCT04600336|531756405|FG001|Crossover Treatment|Adverse Event|0|||
147434476|NCT04600336|531756406|FG002|Crossover Treatment|Adverse Event|1|||
147434477|NCT04600336|531756407|FG003|Crossover Treatment|Adverse Event|1|||
147434478|NCT04225806|531756408|FG000|Overall Study|Trial termination|15|||
147434479|NCT04890054|531758077|FG000|Overall Study|Lost to Follow-up|202|||
147434480|NCT04890054|531758078|FG001|Overall Study|Lost to Follow-up|219|||
147434481|NCT02113579|531758082|FG000|Overall Study|Adverse Event|1|||
147434482|NCT02113579|531758083|FG001|Overall Study|Adverse Event|0|||
147434483|NCT02113579|531758082|FG000|Overall Study|Withdrawal by Subject|3|||
147434484|NCT02113579|531758083|FG001|Overall Study|Withdrawal by Subject|2|||
147434485|NCT02113579|531758082|FG000|Overall Study|Lost to Follow-up|6|||
147434486|NCT02113579|531758083|FG001|Overall Study|Lost to Follow-up|2|||
147434487|NCT01436071|531758084|FG000|Overall Study|Adverse Event|1|||
147434488|NCT01436071|531758085|FG001|Overall Study|Adverse Event|0|||
147434489|NCT01436071|531758084|FG000|Overall Study|Lack of Efficacy|16|||
147434490|NCT01436071|531758085|FG001|Overall Study|Lack of Efficacy|7|||
147434491|NCT01436071|531758084|FG000|Overall Study|Protocol Violation|0|||
147434492|NCT01436071|531758085|FG001|Overall Study|Protocol Violation|1|||
147434493|NCT01436071|531758084|FG000|Overall Study|Lost to Follow-up|3|||
147434494|NCT01436071|531758085|FG001|Overall Study|Lost to Follow-up|1|||
147434495|NCT01436071|531758084|FG000|Overall Study|Physician Decision|1|||
147434496|NCT01436071|531758085|FG001|Overall Study|Physician Decision|0|||
147434497|NCT01436071|531758084|FG000|Overall Study|Withdrawal by Subject|2|||
147434498|NCT01436071|531758085|FG001|Overall Study|Withdrawal by Subject|2|||
147434499|NCT01436071|531758084|FG000|Overall Study|Did Not Receive Trial Medication|3|||
147434500|NCT01436071|531758085|FG001|Overall Study|Did Not Receive Trial Medication|3|||
147434501|NCT00726622|531758088|FG000|Overall Study|Withdrawal by Subject|16|||
147434502|NCT00726622|531758089|FG001|Overall Study|Withdrawal by Subject|2|||
147434503|NCT00726622|531758088|FG000|Overall Study|Physician Decision|0|||
147434504|NCT00726622|531758089|FG001|Overall Study|Physician Decision|1|||
147434505|NCT00726622|531758088|FG000|Overall Study|Metastasis|2|||
147434506|NCT00726622|531758089|FG001|Overall Study|Metastasis|0|||
147434507|NCT03808688|531758090|FG000|Overall Study|Adverse Event|13|||
147434508|NCT03808688|531758091|FG001|Overall Study|Adverse Event|17|||
147434509|NCT03808688|531758090|FG000|Overall Study|Lack of Efficacy|2|||
147434510|NCT03808688|531758091|FG001|Overall Study|Lack of Efficacy|0|||
147434511|NCT03808688|531758090|FG000|Overall Study|Lost to Follow-up|0|||
147434512|NCT03808688|531758091|FG001|Overall Study|Lost to Follow-up|2|||
147434513|NCT03808688|531758090|FG000|Overall Study|Withdrawal by Subject|1|||
147434514|NCT03808688|531758091|FG001|Overall Study|Withdrawal by Subject|0|||
147196125|NCT01435382|530888266|FG001|Overall Study|Withdrawal by Subject|2|||
147196126|NCT01435382|530888267|FG002|Overall Study|Withdrawal by Subject|0|||
147196127|NCT01435382|530888268|FG003|Overall Study|Withdrawal by Subject|1|||
147196128|NCT00423579|530888270|FG000|Overall Study|Lost to Follow-up|3|||
147196129|NCT00423579|530888271|FG001|Overall Study|Lost to Follow-up|0|||
147434515|NCT03808688|531758090|FG000|Overall Study|Intolerance to Conjunctival Hyperemia|1|||
147196130|NCT00423579|530888270|FG000|Overall Study|Protocol Violation|1|||
147434516|NCT03808688|531758091|FG001|Overall Study|Intolerance to Conjunctival Hyperemia|0|||
147434517|NCT03808688|531758090|FG000|Overall Study|IOP Too High|1|||
147434518|NCT03808688|531758091|FG001|Overall Study|IOP Too High|1|||
147434519|NCT03808688|531758090|FG000|Overall Study|IOP Too High, Nerve/Visual Field Changes|0|||
147434520|NCT03808688|531758091|FG001|Overall Study|IOP Too High, Nerve/Visual Field Changes|1|||
147196131|NCT00423579|530888271|FG001|Overall Study|Protocol Violation|3|||
147196132|NCT00423579|530888270|FG000|Overall Study|Diagnosis of diabetes|0|||
147434521|NCT03808688|531758090|FG000|Overall Study|Visit Out of Window|0|||
147434522|NCT03808688|531758091|FG001|Overall Study|Visit Out of Window|1|||
147196133|NCT00423579|530888271|FG001|Overall Study|Diagnosis of diabetes|1|||
147534693|NCT04242446|532113100|FG004|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|5|||
147534694|NCT04242446|532113101|FG005|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|3|||
147534695|NCT04242446|532113102|FG006|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|3|||
147534696|NCT04242446|532113096|FG000|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|0|||
147534697|NCT04242446|532113097|FG001|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|0|||
147534698|NCT04242446|532113098|FG002|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|0|||
147534699|NCT04242446|532113099|FG003|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|7|||
147534700|NCT04242446|532113100|FG004|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|12|||
147534701|NCT04242446|532113101|FG005|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|11|||
147534702|NCT04242446|532113102|FG006|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|14|||
147534703|NCT04242446|532113096|FG000|Maintenance Treatment Period: Week 16-48|Subject Is Moving A Long Distance From Clinic|0|||
147534704|NCT04242446|532113097|FG001|Maintenance Treatment Period: Week 16-48|Subject Is Moving A Long Distance From Clinic|0|||
147534705|NCT04242446|532113098|FG002|Maintenance Treatment Period: Week 16-48|Subject Is Moving A Long Distance From Clinic|0|||
147534706|NCT04242446|532113099|FG003|Maintenance Treatment Period: Week 16-48|Subject Is Moving A Long Distance From Clinic|1|||
147534707|NCT04242446|532113100|FG004|Maintenance Treatment Period: Week 16-48|Subject Is Moving A Long Distance From Clinic|0|||
147534708|NCT04242446|532113101|FG005|Maintenance Treatment Period: Week 16-48|Subject Is Moving A Long Distance From Clinic|0|||
147534709|NCT04242446|532113102|FG006|Maintenance Treatment Period: Week 16-48|Subject Is Moving A Long Distance From Clinic|0|||
147534710|NCT04242446|532113096|FG000|Maintenance Treatment Period: Week 16-48|Study Schedule Too Demanding, Clashing With Work|0|||
147534711|NCT04242446|532113097|FG001|Maintenance Treatment Period: Week 16-48|Study Schedule Too Demanding, Clashing With Work|0|||
147534712|NCT04242446|532113098|FG002|Maintenance Treatment Period: Week 16-48|Study Schedule Too Demanding, Clashing With Work|0|||
147534713|NCT04242446|532113099|FG003|Maintenance Treatment Period: Week 16-48|Study Schedule Too Demanding, Clashing With Work|0|||
147595938|NCT03096847|532338752|FG001|Overall Study|Withdrawal by Subject|1|||
147534714|NCT04242446|532113100|FG004|Maintenance Treatment Period: Week 16-48|Study Schedule Too Demanding, Clashing With Work|1|||
147534715|NCT04242446|532113101|FG005|Maintenance Treatment Period: Week 16-48|Study Schedule Too Demanding, Clashing With Work|0|||
147534716|NCT04242446|532113102|FG006|Maintenance Treatment Period: Week 16-48|Study Schedule Too Demanding, Clashing With Work|0|||
147534717|NCT04242446|532113096|FG000|Maintenance Treatment Period: Week 16-48|Subject Moved A Long Distance From Clinic|0|||
147196134|NCT01310777|530888276|FG000|Overall Study|Adverse Event|23|||
147196135|NCT01310777|530888277|FG001|Overall Study|Adverse Event|1|||
147196136|NCT01310777|530888278|FG002|Overall Study|Adverse Event|15|||
147196137|NCT01310777|530888276|FG000|Overall Study|Lost to Follow-up|0|||
147196138|NCT01310777|530888277|FG001|Overall Study|Lost to Follow-up|4|||
147196139|NCT01310777|530888278|FG002|Overall Study|Lost to Follow-up|1|||
147196140|NCT01310777|530888276|FG000|Overall Study|Patient's Decision Unrelated to AE|1|||
147196141|NCT01310777|530888277|FG001|Overall Study|Patient's Decision Unrelated to AE|1|||
147196142|NCT01310777|530888278|FG002|Overall Study|Patient's Decision Unrelated to AE|2|||
147196143|NCT01310777|530888276|FG000|Overall Study|Inadequate Control of IOP|5|||
147196144|NCT01310777|530888277|FG001|Overall Study|Inadequate Control of IOP|7|||
147534718|NCT04242446|532113097|FG001|Maintenance Treatment Period: Week 16-48|Subject Moved A Long Distance From Clinic|0|||
147534719|NCT04242446|532113098|FG002|Maintenance Treatment Period: Week 16-48|Subject Moved A Long Distance From Clinic|0|||
147534720|NCT04242446|532113099|FG003|Maintenance Treatment Period: Week 16-48|Subject Moved A Long Distance From Clinic|0|||
147196145|NCT01310777|530888278|FG002|Overall Study|Inadequate Control of IOP|10|||
147196146|NCT01310777|530888276|FG000|Overall Study|Other|4|||
147196147|NCT01310777|530888277|FG001|Overall Study|Other|1|||
147196148|NCT01310777|530888278|FG002|Overall Study|Other|2|||
147196149|NCT03125395|530888279|FG000|Overall Study|Adverse Event|2|||
147196150|NCT03125395|530888279|FG000|Overall Study|Withdrawal of consent (not due to AE)|1|||
147196151|NCT03125395|530888279|FG000|Overall Study|Physician Decision|2|||
147196152|NCT03125395|530888279|FG000|Overall Study|Commercial drug is available|5|||
147196153|NCT00106704|530888280|FG000|Overall Study|Adverse Event|10|||
147196154|NCT00106704|530888281|FG001|Overall Study|Adverse Event|7|||
147196155|NCT00106704|530888280|FG000|Overall Study|Death|2|||
147196156|NCT00106704|530888281|FG001|Overall Study|Death|1|||
147196157|NCT00106704|530888280|FG000|Overall Study|Lack of Efficacy|67|||
147196158|NCT00106704|530888281|FG001|Overall Study|Lack of Efficacy|69|||
147196159|NCT00106704|530888280|FG000|Overall Study|Lost to Follow-up|7|||
147196160|NCT00106704|530888281|FG001|Overall Study|Lost to Follow-up|3|||
147196161|NCT00106704|530888280|FG000|Overall Study|Pregnancy|1|||
147196162|NCT00106704|530888281|FG001|Overall Study|Pregnancy|0|||
147196163|NCT00106704|530888280|FG000|Overall Study|Protocol Violation|4|||
147196164|NCT00106704|530888281|FG001|Overall Study|Protocol Violation|7|||
147196165|NCT00106704|530888280|FG000|Overall Study|Withdrawal by Subject|14|||
147196166|NCT00106704|530888281|FG001|Overall Study|Withdrawal by Subject|21|||
147196167|NCT00106704|530888280|FG000|Overall Study|Patient moved|1|||
147196168|NCT00106704|530888281|FG001|Overall Study|Patient moved|0|||
147196169|NCT00106704|530888280|FG000|Overall Study|Site terminated|0|||
147196170|NCT00106704|530888281|FG001|Overall Study|Site terminated|1|||
147196171|NCT00106704|530888280|FG000|Overall Study|Planned major surgery|1|||
147196172|NCT00106704|530888281|FG001|Overall Study|Planned major surgery|0|||
147196173|NCT00106704|530888280|FG000|Overall Study|Patient Received Glycemic Medication|22|||
147196174|NCT00106704|530888281|FG001|Overall Study|Patient Received Glycemic Medication|41|||
147196175|NCT00106704|530888280|FG000|Overall Study|Unable to re-enter US|1|||
147196176|NCT00106704|530888281|FG001|Overall Study|Unable to re-enter US|0|||
147196177|NCT00106704|530888280|FG000|Overall Study|Laboratory test|1|||
147196178|NCT00106704|530888281|FG001|Overall Study|Laboratory test|1|||
147196179|NCT01780506|530888282|FG000|Double-Blind Phase|Randomized but not Treated|3|||
147196180|NCT01780506|530888283|FG001|Double-Blind Phase|Randomized but not Treated|2|||
147196181|NCT01780506|530888282|FG000|Double-Blind Phase|Adverse Event|4|||
147196182|NCT01780506|530888283|FG001|Double-Blind Phase|Adverse Event|14|||
147196183|NCT01780506|530888282|FG000|Double-Blind Phase|Death|1|||
147196184|NCT01780506|530888283|FG001|Double-Blind Phase|Death|2|||
147196185|NCT01780506|530888282|FG000|Double-Blind Phase|Pregnancy|2|||
147196186|NCT01780506|530888283|FG001|Double-Blind Phase|Pregnancy|1|||
147196187|NCT01780506|530888282|FG000|Double-Blind Phase|Lack of Efficacy|1|||
147196188|NCT01780506|530888283|FG001|Double-Blind Phase|Lack of Efficacy|1|||
147196189|NCT01780506|530888282|FG000|Double-Blind Phase|Investigator's Discretion|5|||
147196190|NCT01780506|530888283|FG001|Double-Blind Phase|Investigator's Discretion|2|||
147196191|NCT01780506|530888282|FG000|Double-Blind Phase|Non-Compliance with Study Drug|4|||
147196192|NCT01780506|530888283|FG001|Double-Blind Phase|Non-Compliance with Study Drug|3|||
147196193|NCT01780506|530888282|FG000|Double-Blind Phase|Protocol Violation|4|||
147196194|NCT01780506|530888283|FG001|Double-Blind Phase|Protocol Violation|3|||
147196195|NCT01780506|530888282|FG000|Double-Blind Phase|Withdrew Consent|23|||
147196196|NCT01780506|530888283|FG001|Double-Blind Phase|Withdrew Consent|24|||
147196197|NCT01780506|530888282|FG000|Double-Blind Phase|Lost to Follow-up|23|||
147196198|NCT01780506|530888283|FG001|Double-Blind Phase|Lost to Follow-up|26|||
147196199|NCT01780506|530888282|FG000|Open-Label Extension Phase|Enrolled but not Treated|0|||
147196200|NCT01780506|530888283|FG001|Open-Label Extension Phase|Enrolled but not Treated|1|||
147534721|NCT04242446|532113100|FG004|Maintenance Treatment Period: Week 16-48|Subject Moved A Long Distance From Clinic|1|||
147534722|NCT04242446|532113101|FG005|Maintenance Treatment Period: Week 16-48|Subject Moved A Long Distance From Clinic|0|||
147434523|NCT03808688|531758090|FG000|Overall Study|Medication Non-Compliance|0|||
147434524|NCT03808688|531758091|FG001|Overall Study|Medication Non-Compliance|1|||
147434525|NCT01016964|531758101|FG000|Overall Study|Lost to Follow-up|3|||
147434526|NCT01016964|531758102|FG001|Overall Study|Lost to Follow-up|3|||
147434527|NCT03873493|531758103|FG000|Overall Study|Withdrawal by Subject|1|||
147434528|NCT03873493|531758103|FG000|Overall Study|Death|9|||
147434529|NCT03873493|531758103|FG000|Overall Study|Lost to Follow-up|1|||
147434530|NCT03873493|531758103|FG000|Overall Study|Study Terminated by Sponsor|1|||
147434531|NCT03873493|531758103|FG000|Overall Study|Other|2|||
147434532|NCT00702845|531758104|FG000|Overall Study|No/too few/bad quality oocytes retrieved|2|||
147434533|NCT00702845|531758105|FG001|Overall Study|No/too few/bad quality oocytes retrieved|2|||
147434534|NCT00702845|531758104|FG000|Overall Study|Too high ovarian response|5|||
147434535|NCT00702845|531758105|FG001|Overall Study|Too high ovarian response|1|||
147434536|NCT00702845|531758104|FG000|Overall Study|Risk of ovarian hyperstimulation synd.|1|||
147434537|NCT00702845|531758105|FG001|Overall Study|Risk of ovarian hyperstimulation synd.|0|||
147434538|NCT00702845|531758104|FG000|Overall Study|Insufficient ovarian response|1|||
147434539|NCT00702845|531758105|FG001|Overall Study|Insufficient ovarian response|0|||
147434540|NCT00702845|531758104|FG000|Overall Study|No/too few/bad quality embryos retrieved|7|||
147434541|NCT00702845|531758105|FG001|Overall Study|No/too few/bad quality embryos retrieved|1|||
147434542|NCT00702845|531758104|FG000|Overall Study|No or abnormal fertilization|4|||
147434543|NCT00702845|531758105|FG001|Overall Study|No or abnormal fertilization|2|||
147434544|NCT00702845|531758104|FG000|Overall Study|Patient's decision|2|||
147434545|NCT00702845|531758105|FG001|Overall Study|Patient's decision|1|||
147434546|NCT00702845|531758104|FG000|Overall Study|Not randomized|0|||
147434547|NCT00702845|531758105|FG001|Overall Study|Not randomized|1|||
147434548|NCT00440700|531758106|FG000|Overall Study|Withdrawal by Subject|8|||
147434549|NCT00440700|531758107|FG001|Overall Study|Withdrawal by Subject|8|||
147434550|NCT00440700|531758108|FG002|Overall Study|Withdrawal by Subject|4|||
147434551|NCT00928564|531758109|FG000|Overall Study|Lost to Follow-up|6|||
147434552|NCT00928564|531758110|FG001|Overall Study|Lost to Follow-up|0|||
147434553|NCT04906616|531758112|FG000|Overall Study|Divorce|3|||
147434554|NCT04906616|531758113|FG001|Overall Study|Divorce|2|||
147434555|NCT00385203|531758116|FG000|Overall Study|Adverse Event|5|||
147434556|NCT00385203|531758117|FG001|Overall Study|Adverse Event|4|||
147434557|NCT00385203|531758116|FG000|Overall Study|Death|1|||
147434558|NCT00385203|531758117|FG001|Overall Study|Death|0|||
147434559|NCT00385203|531758116|FG000|Overall Study|Condition under investigation worsened|18|||
147434560|NCT00385203|531758117|FG001|Overall Study|Condition under investigation worsened|3|||
147434561|NCT00385203|531758116|FG000|Overall Study|Incorrect enrollment|2|||
147434562|NCT00385203|531758117|FG001|Overall Study|Incorrect enrollment|0|||
147434563|NCT01524133|531758124|FG000|Treatment Phase|Withdrawal by Subject|13|||
147434564|NCT01524133|531758125|FG001|Treatment Phase|Withdrawal by Subject|28|||
147649407|NCT04575584|532537336|FG001|Overall Study|Not recorded|0|||
147434565|NCT01524133|531758126|FG002|Treatment Phase|Withdrawal by Subject|31|||
147434566|NCT01524133|531758124|FG000|Treatment Phase|Physician Decision|6|||
147434567|NCT01524133|531758125|FG001|Treatment Phase|Physician Decision|3|||
147434568|NCT01524133|531758126|FG002|Treatment Phase|Physician Decision|3|||
147196201|NCT03486912|530888287|FG000|Randomized (Pre-Treatment)|Withdrawal by Subject|0|||
147196202|NCT03486912|530888288|FG001|Randomized (Pre-Treatment)|Withdrawal by Subject|1|||
147196203|NCT03486912|530888289|FG002|Randomized (Pre-Treatment)|Withdrawal by Subject|0|||
147196204|NCT03486912|530888290|FG003|Randomized (Pre-Treatment)|Withdrawal by Subject|0|||
147196205|NCT03486912|530888287|FG000|Treatment Period|Withdrawal by Subject|3|||
147196206|NCT03486912|530888288|FG001|Treatment Period|Withdrawal by Subject|3|||
147196207|NCT03486912|530888289|FG002|Treatment Period|Withdrawal by Subject|3|||
147196208|NCT03486912|530888290|FG003|Treatment Period|Withdrawal by Subject|2|||
147196209|NCT03486912|530888287|FG000|Treatment Period|Other Reasons|0|||
147434569|NCT01524133|531758124|FG000|Treatment Phase|Lost to Follow-up|0|||
147434570|NCT01524133|531758125|FG001|Treatment Phase|Lost to Follow-up|1|||
147434571|NCT01524133|531758126|FG002|Treatment Phase|Lost to Follow-up|2|||
147434572|NCT01524133|531758124|FG000|Overall Study 52 Weeks|Withdrawal by Subject|4|||
147434573|NCT01524133|531758125|FG001|Overall Study 52 Weeks|Withdrawal by Subject|5|||
147434574|NCT01524133|531758126|FG002|Overall Study 52 Weeks|Withdrawal by Subject|10|||
147434575|NCT01524133|531758124|FG000|Overall Study 52 Weeks|Physician Decision|1|||
147434576|NCT01524133|531758125|FG001|Overall Study 52 Weeks|Physician Decision|0|||
147434577|NCT01524133|531758126|FG002|Overall Study 52 Weeks|Physician Decision|2|||
147434578|NCT01524133|531758124|FG000|Overall Study 52 Weeks|Lost to Follow-up|16|||
147434579|NCT01524133|531758125|FG001|Overall Study 52 Weeks|Lost to Follow-up|15|||
147434580|NCT01524133|531758126|FG002|Overall Study 52 Weeks|Lost to Follow-up|15|||
147434581|NCT04606771|531758127|FG000|Overall Study|Patients ongoing study at data cut-off|9|||
147434582|NCT04606771|531758128|FG001|Overall Study|Patients ongoing study at data cut-off|9|||
147434583|NCT04606771|531758127|FG000|Overall Study|Death|5|||
147434584|NCT04606771|531758128|FG001|Overall Study|Death|6|||
147434585|NCT04606771|531758127|FG000|Overall Study|Wrong randomisation|0|||
147434586|NCT04606771|531758128|FG001|Overall Study|Wrong randomisation|1|||
147434587|NCT03083847|531758134|FG000|Main|Physician Decision|0|||
147434588|NCT03083847|531758135|FG001|Main|Physician Decision|0|||
147434589|NCT03083847|531758136|FG002|Main|Physician Decision|0|||
147434590|NCT03083847|531758137|FG003|Main|Physician Decision|0|||
147434591|NCT03083847|531758138|FG004|Main|Physician Decision|0|||
147434592|NCT03083847|531758139|FG005|Main|Physician Decision|1|||
147434593|NCT03083847|531758140|FG006|Main|Physician Decision|0|||
147434594|NCT03083847|531758141|FG007|Main|Physician Decision|0|||
147434595|NCT03083847|531758142|FG008|Main|Physician Decision|0|||
147434596|NCT03083847|531758143|FG009|Main|Physician Decision|0|||
147434597|NCT03083847|531758134|FG000|Main|Pregnancy|0|||
147434598|NCT03083847|531758135|FG001|Main|Pregnancy|0|||
147434599|NCT03083847|531758136|FG002|Main|Pregnancy|0|||
147434600|NCT03083847|531758137|FG003|Main|Pregnancy|0|||
147434601|NCT03083847|531758138|FG004|Main|Pregnancy|0|||
147434602|NCT03083847|531758139|FG005|Main|Pregnancy|0|||
147434603|NCT03083847|531758140|FG006|Main|Pregnancy|0|||
147434604|NCT03083847|531758141|FG007|Main|Pregnancy|1|||
147434605|NCT03083847|531758142|FG008|Main|Pregnancy|0|||
147434606|NCT03083847|531758143|FG009|Main|Pregnancy|0|||
147434607|NCT03083847|531758134|FG000|Main|Adverse Event|0|||
147434608|NCT03083847|531758135|FG001|Main|Adverse Event|0|||
147434609|NCT03083847|531758136|FG002|Main|Adverse Event|0|||
147434610|NCT03083847|531758137|FG003|Main|Adverse Event|0|||
147434611|NCT03083847|531758138|FG004|Main|Adverse Event|0|||
147434612|NCT03083847|531758139|FG005|Main|Adverse Event|0|||
147434613|NCT03083847|531758140|FG006|Main|Adverse Event|0|||
147434614|NCT03083847|531758141|FG007|Main|Adverse Event|2|||
147434615|NCT03083847|531758142|FG008|Main|Adverse Event|0|||
147434616|NCT03083847|531758143|FG009|Main|Adverse Event|0|||
147434617|NCT03083847|531758134|FG000|Main|Withdrawal by Subject|0|||
147434618|NCT03083847|531758135|FG001|Main|Withdrawal by Subject|0|||
147434619|NCT03083847|531758136|FG002|Main|Withdrawal by Subject|0|||
147434620|NCT03083847|531758137|FG003|Main|Withdrawal by Subject|0|||
147434621|NCT03083847|531758138|FG004|Main|Withdrawal by Subject|0|||
147434622|NCT03083847|531758139|FG005|Main|Withdrawal by Subject|0|||
147434623|NCT03083847|531758140|FG006|Main|Withdrawal by Subject|1|||
147434624|NCT03083847|531758141|FG007|Main|Withdrawal by Subject|1|||
147434625|NCT03083847|531758142|FG008|Main|Withdrawal by Subject|0|||
147434626|NCT03083847|531758143|FG009|Main|Withdrawal by Subject|0|||
147434627|NCT01187550|531758144|FG000|Overall Study|Protocol Violation|3|||
147434628|NCT01187550|531758145|FG001|Overall Study|Protocol Violation|1|||
147434629|NCT01187550|531758144|FG000|Overall Study|Other|3|||
147434630|NCT01187550|531758145|FG001|Overall Study|Other|0|||
147434631|NCT01187550|531758144|FG000|Overall Study|Randomized but not treated|8|||
147434632|NCT01187550|531758145|FG001|Overall Study|Randomized but not treated|0|||
147434633|NCT00733304|531758146|FG000|Overall Study|Adverse Event|3|||
147196210|NCT03486912|530888288|FG001|Treatment Period|Other Reasons|2|||
147196211|NCT03486912|530888289|FG002|Treatment Period|Other Reasons|1|||
147434634|NCT00733304|531758147|FG001|Overall Study|Adverse Event|0|||
147434635|NCT00733304|531758148|FG002|Overall Study|Adverse Event|0|||
147434636|NCT00733304|531758146|FG000|Overall Study|Lack of Efficacy|0|||
147434637|NCT00733304|531758147|FG001|Overall Study|Lack of Efficacy|0|||
147434638|NCT00733304|531758148|FG002|Overall Study|Lack of Efficacy|2|||
147434639|NCT00733304|531758146|FG000|Overall Study|Lost to Follow-up|0|||
147534723|NCT04242446|532113102|FG006|Maintenance Treatment Period: Week 16-48|Subject Moved A Long Distance From Clinic|0|||
147534724|NCT04242446|532113096|FG000|Maintenance Treatment Period: Week 16-48|Subject Withdrew Due To Custody Issue & Relocation|0|||
147534725|NCT04242446|532113097|FG001|Maintenance Treatment Period: Week 16-48|Subject Withdrew Due To Custody Issue & Relocation|0|||
147534726|NCT04242446|532113098|FG002|Maintenance Treatment Period: Week 16-48|Subject Withdrew Due To Custody Issue & Relocation|0|||
147534727|NCT04242446|532113099|FG003|Maintenance Treatment Period: Week 16-48|Subject Withdrew Due To Custody Issue & Relocation|0|||
147534728|NCT04242446|532113100|FG004|Maintenance Treatment Period: Week 16-48|Subject Withdrew Due To Custody Issue & Relocation|1|||
147534729|NCT04242446|532113101|FG005|Maintenance Treatment Period: Week 16-48|Subject Withdrew Due To Custody Issue & Relocation|0|||
147534730|NCT04242446|532113102|FG006|Maintenance Treatment Period: Week 16-48|Subject Withdrew Due To Custody Issue & Relocation|0|||
147534731|NCT04242446|532113096|FG000|Maintenance Treatment Period: Week 16-48|Relocation|0|||
147534732|NCT04242446|532113097|FG001|Maintenance Treatment Period: Week 16-48|Relocation|0|||
147534733|NCT04242446|532113098|FG002|Maintenance Treatment Period: Week 16-48|Relocation|0|||
147534734|NCT04242446|532113099|FG003|Maintenance Treatment Period: Week 16-48|Relocation|0|||
147534735|NCT04242446|532113100|FG004|Maintenance Treatment Period: Week 16-48|Relocation|1|||
147534736|NCT04242446|532113101|FG005|Maintenance Treatment Period: Week 16-48|Relocation|0|||
147534737|NCT04242446|532113102|FG006|Maintenance Treatment Period: Week 16-48|Relocation|0|||
147534738|NCT04242446|532113096|FG000|Maintenance Treatment Period: Week 16-48|Patient Relocated And Withdrew Consent|0|||
147534739|NCT04242446|532113097|FG001|Maintenance Treatment Period: Week 16-48|Patient Relocated And Withdrew Consent|0|||
147534740|NCT04242446|532113098|FG002|Maintenance Treatment Period: Week 16-48|Patient Relocated And Withdrew Consent|0|||
147534741|NCT04242446|532113099|FG003|Maintenance Treatment Period: Week 16-48|Patient Relocated And Withdrew Consent|0|||
147534742|NCT04242446|532113100|FG004|Maintenance Treatment Period: Week 16-48|Patient Relocated And Withdrew Consent|1|||
147534743|NCT04242446|532113101|FG005|Maintenance Treatment Period: Week 16-48|Patient Relocated And Withdrew Consent|0|||
147534744|NCT04242446|532113102|FG006|Maintenance Treatment Period: Week 16-48|Patient Relocated And Withdrew Consent|0|||
147534745|NCT04242446|532113096|FG000|Maintenance Treatment Period: Week 16-48|Patient Move Away|0|||
147534746|NCT04242446|532113097|FG001|Maintenance Treatment Period: Week 16-48|Patient Move Away|0|||
147534747|NCT04242446|532113098|FG002|Maintenance Treatment Period: Week 16-48|Patient Move Away|0|||
147534748|NCT04242446|532113099|FG003|Maintenance Treatment Period: Week 16-48|Patient Move Away|0|||
147534749|NCT04242446|532113100|FG004|Maintenance Treatment Period: Week 16-48|Patient Move Away|0|||
147534750|NCT04242446|532113101|FG005|Maintenance Treatment Period: Week 16-48|Patient Move Away|1|||
147534751|NCT04242446|532113102|FG006|Maintenance Treatment Period: Week 16-48|Patient Move Away|0|||
147196212|NCT03486912|530888290|FG003|Treatment Period|Other Reasons|1|||
147196213|NCT03486912|530888287|FG000|Treatment Period|Adverse Event|0|||
147196214|NCT03486912|530888288|FG001|Treatment Period|Adverse Event|1|||
147196215|NCT03486912|530888289|FG002|Treatment Period|Adverse Event|1|||
147196216|NCT03486912|530888290|FG003|Treatment Period|Adverse Event|0|||
147196217|NCT03486912|530888287|FG000|Treatment Period|Lost to Follow-up|1|||
147196218|NCT03486912|530888288|FG001|Treatment Period|Lost to Follow-up|0|||
147196219|NCT03486912|530888289|FG002|Treatment Period|Lost to Follow-up|0|||
147196220|NCT03486912|530888290|FG003|Treatment Period|Lost to Follow-up|2|||
147196221|NCT00412984|530888291|FG000|Overall Study|Death|331|||
147196222|NCT00412984|530888292|FG001|Overall Study|Death|349|||
147196223|NCT00412984|530888291|FG000|Overall Study|Adverse Event|679|||
147196224|NCT00412984|530888292|FG001|Overall Study|Adverse Event|738|||
147196225|NCT00412984|530888291|FG000|Overall Study|Withdrawal by Subject|921|||
147196226|NCT00412984|530888292|FG001|Overall Study|Withdrawal by Subject|989|||
147196227|NCT00412984|530888291|FG000|Overall Study|Lost to Follow-up|51|||
147196228|NCT00412984|530888292|FG001|Overall Study|Lost to Follow-up|39|||
147196229|NCT00412984|530888291|FG000|Overall Study|Poor/Noncompliance|57|||
147196230|NCT00412984|530888292|FG001|Overall Study|Poor/Noncompliance|77|||
147196231|NCT00412984|530888291|FG000|Overall Study|Pregnancy|1|||
147196232|NCT00412984|530888292|FG001|Overall Study|Pregnancy|0|||
147196233|NCT00412984|530888291|FG000|Overall Study|Subject No Longer Meets Study Criteria|87|||
147196234|NCT00412984|530888292|FG001|Overall Study|Subject No Longer Meets Study Criteria|100|||
147196235|NCT00412984|530888291|FG000|Overall Study|Administrative Reason by Sponsor|11|||
147196236|NCT00412984|530888292|FG001|Overall Study|Administrative Reason by Sponsor|8|||
147196237|NCT00412984|530888291|FG000|Overall Study|Physician Refused to Continue Treatment|81|||
147196238|NCT00412984|530888292|FG001|Overall Study|Physician Refused to Continue Treatment|89|||
147196239|NCT00412984|530888291|FG000|Overall Study|Other Reason|80|||
147196240|NCT00412984|530888292|FG001|Overall Study|Other Reason|92|||
147196241|NCT00412984|530888291|FG000|Overall Study|Not Reported|11|||
147196242|NCT00412984|530888292|FG001|Overall Study|Not Reported|12|||
147196243|NCT01499940|530888293|FG000|Overall Study|Study was withdrawn before completion.|9|||
147196244|NCT02383576|530888295|FG000|Overall Study|Death|53|||
147196245|NCT02383576|530888296|FG001|Overall Study|Death|33|||
147196246|NCT02383576|530888295|FG000|Overall Study|Lost to Follow-up|7|||
147196247|NCT02383576|530888296|FG001|Overall Study|Lost to Follow-up|1|||
147196248|NCT02383576|530888295|FG000|Overall Study|Withdrew Consent|1|||
147196249|NCT02383576|530888296|FG001|Overall Study|Withdrew Consent|6|||
147196250|NCT02383576|530888295|FG000|Overall Study|Investigator's Decision|0|||
147196251|NCT02383576|530888296|FG001|Overall Study|Investigator's Decision|1|||
147196252|NCT02383576|530888295|FG000|Overall Study|Administrative/Other|2|||
147196253|NCT02383576|530888296|FG001|Overall Study|Administrative/Other|4|||
147196254|NCT02285855|530888297|FG000|Overall Study|Withdrawal by Subject|2|||
147196255|NCT02285855|530888298|FG001|Overall Study|Withdrawal by Subject|1|||
147196256|NCT00528112|530888299|FG000|Treatment up to 3 Years|Adverse Event|313|||
147196257|NCT00528112|530888300|FG001|Treatment up to 3 Years|Adverse Event|278|||
147196258|NCT00528112|530888299|FG000|Treatment up to 3 Years|Withdrawal by Subject|26|||
147196259|NCT00528112|530888300|FG001|Treatment up to 3 Years|Withdrawal by Subject|31|||
147196260|NCT00528112|530888299|FG000|Treatment up to 3 Years|Protocol Violation|16|||
147196261|NCT00528112|530888300|FG001|Treatment up to 3 Years|Protocol Violation|16|||
147196262|NCT00528112|530888299|FG000|Treatment up to 3 Years|Death|0|||
147196263|NCT00528112|530888300|FG001|Treatment up to 3 Years|Death|1|||
147196264|NCT00528112|530888299|FG000|Treatment up to 3 Years|Lost to Follow-up|63|||
147196265|NCT00528112|530888300|FG001|Treatment up to 3 Years|Lost to Follow-up|61|||
147196266|NCT00528112|530888299|FG000|Treatment up to 3 Years|Pregnancy|9|||
147196267|NCT00528112|530888300|FG001|Treatment up to 3 Years|Pregnancy|10|||
147196268|NCT00528112|530888299|FG000|Treatment up to 3 Years|Other reasons|186|||
147196269|NCT00528112|530888300|FG001|Treatment up to 3 Years|Other reasons|186|||
147196270|NCT00528112|530888299|FG000|Extension Phase|Withdrawal by Subject|0|||
147196271|NCT00528112|530888300|FG001|Extension Phase|Withdrawal by Subject|3|||
147196272|NCT00528112|530888299|FG000|Extension Phase|Other reasons|0|||
147196273|NCT00528112|530888300|FG001|Extension Phase|Other reasons|100|||
147196274|NCT00528112|530888299|FG000|Extension Phase|Pregnancy|0|||
147196275|NCT00528112|530888300|FG001|Extension Phase|Pregnancy|3|||
147196276|NCT00528112|530888299|FG000|Extension Phase|Lost to Follow-up|0|||
147196277|NCT00528112|530888300|FG001|Extension Phase|Lost to Follow-up|12|||
147196278|NCT00528112|530888299|FG000|Extension Phase|Death|0|||
147196279|NCT00528112|530888300|FG001|Extension Phase|Death|1|||
147196280|NCT00528112|530888299|FG000|Extension Phase|Adverse Event|0|||
147196281|NCT00528112|530888300|FG001|Extension Phase|Adverse Event|36|||
147196282|NCT00528112|530888299|FG000|Extension Phase|Protocol Violation|0|||
147196283|NCT00528112|530888300|FG001|Extension Phase|Protocol Violation|2|||
147196284|NCT03050801|530888303|FG000|Experiment 1|Lost to Follow-up|0|||
147196285|NCT03050801|530888304|FG001|Experiment 1|Lost to Follow-up|1|||
147196286|NCT03050801|530888305|FG002|Experiment 1|Lost to Follow-up|0|||
147196287|NCT03050801|530888306|FG003|Experiment 1|Lost to Follow-up|0|||
147196288|NCT03050801|530888307|FG004|Experiment 1|Lost to Follow-up|0|||
147196289|NCT03050801|530888308|FG005|Experiment 1|Lost to Follow-up|0|||
147434640|NCT00733304|531758147|FG001|Overall Study|Lost to Follow-up|1|||
147434641|NCT00733304|531758148|FG002|Overall Study|Lost to Follow-up|0|||
147434642|NCT00733304|531758146|FG000|Overall Study|Physician Decision|3|||
147434643|NCT00733304|531758147|FG001|Overall Study|Physician Decision|1|||
147434644|NCT00733304|531758148|FG002|Overall Study|Physician Decision|3|||
147434645|NCT00733304|531758146|FG000|Overall Study|Withdrawal by Subject|1|||
147434646|NCT00733304|531758147|FG001|Overall Study|Withdrawal by Subject|1|||
147434647|NCT00733304|531758148|FG002|Overall Study|Withdrawal by Subject|0|||
147434648|NCT00129623|531758149|FG000|Overall Study|Adverse Event|3|||
147434649|NCT00129623|531758150|FG001|Overall Study|Adverse Event|7|||
147434650|NCT00129623|531758149|FG000|Overall Study|Refused Treatment|5|||
147434651|NCT00129623|531758150|FG001|Overall Study|Refused Treatment|3|||
147434652|NCT00129623|531758149|FG000|Overall Study|Failure to Return|1|||
147434653|NCT00129623|531758150|FG001|Overall Study|Failure to Return|1|||
147434654|NCT00129623|531758149|FG000|Overall Study|Relocated job out of state|1|||
147434655|NCT00129623|531758150|FG001|Overall Study|Relocated job out of state|0|||
147434656|NCT00129623|531758149|FG000|Overall Study|Uncertainty to return|0|||
147434657|NCT00129623|531758150|FG001|Overall Study|Uncertainty to return|1|||
147434658|NCT02445755|531758160|FG000|Overall Study|Withdrawal by Subject|2|||
147434659|NCT02445755|531758160|FG000|Overall Study|Protocol Violation|6|||
147434660|NCT02445755|531758160|FG000|Overall Study|Screen Failure|5|||
147434661|NCT05352048|531758161|FG000|Overall Study|Lost to Follow-up|1|||
147434662|NCT05352048|531758161|FG000|Overall Study|did not get EMG-MMG readings intraoperatively|3|||
147434663|NCT01214187|531758162|FG000|Overall Study|Adverse Event|6|||
147434664|NCT01214187|531758163|FG001|Overall Study|Adverse Event|2|||
147434665|NCT01214187|531758162|FG000|Overall Study|Death|1|||
147434666|NCT01214187|531758163|FG001|Overall Study|Death|1|||
147434667|NCT01214187|531758162|FG000|Overall Study|Withdrawal by Subject|0|||
147434668|NCT01214187|531758163|FG001|Overall Study|Withdrawal by Subject|3|||
147434669|NCT00631189|531758172|FG000|Initial Phase|Protocol Violation|347|||
147434670|NCT00631189|531758173|FG001|Initial Phase|Protocol Violation|0|||
147434671|NCT00631189|531758174|FG002|Initial Phase|Protocol Violation|0|||
147434672|NCT00631189|531758175|FG003|Initial Phase|Protocol Violation|0|||
147434673|NCT00631189|531758172|FG000|Initial Phase|Withdrawal by Subject|4|||
147434674|NCT00631189|531758173|FG001|Initial Phase|Withdrawal by Subject|0|||
147434675|NCT00631189|531758174|FG002|Initial Phase|Withdrawal by Subject|0|||
147434676|NCT00631189|531758175|FG003|Initial Phase|Withdrawal by Subject|0|||
147434677|NCT00631189|531758172|FG000|Treatment Phase|Withdrawal by Subject|0|||
147434678|NCT00631189|531758173|FG001|Treatment Phase|Withdrawal by Subject|2|||
147434679|NCT00631189|531758174|FG002|Treatment Phase|Withdrawal by Subject|1|||
147434680|NCT00631189|531758175|FG003|Treatment Phase|Withdrawal by Subject|1|||
147434681|NCT00631189|531758172|FG000|Treatment Phase|Protocol Violation|0|||
147434682|NCT00631189|531758173|FG001|Treatment Phase|Protocol Violation|1|||
147434683|NCT00631189|531758174|FG002|Treatment Phase|Protocol Violation|6|||
147434684|NCT00631189|531758175|FG003|Treatment Phase|Protocol Violation|2|||
147434685|NCT00631189|531758172|FG000|Treatment Phase|Adverse Event|0|||
147434686|NCT00631189|531758173|FG001|Treatment Phase|Adverse Event|3|||
147434687|NCT00631189|531758174|FG002|Treatment Phase|Adverse Event|2|||
147434688|NCT00631189|531758175|FG003|Treatment Phase|Adverse Event|4|||
147434689|NCT00631189|531758172|FG000|Treatment Phase|Lost to Follow-up|0|||
147434690|NCT00631189|531758173|FG001|Treatment Phase|Lost to Follow-up|1|||
147434691|NCT00631189|531758174|FG002|Treatment Phase|Lost to Follow-up|0|||
147434692|NCT00631189|531758175|FG003|Treatment Phase|Lost to Follow-up|0|||
147434693|NCT00631189|531758172|FG000|Treatment Phase|Pregnancy|0|||
147434694|NCT00631189|531758173|FG001|Treatment Phase|Pregnancy|0|||
147434695|NCT00631189|531758174|FG002|Treatment Phase|Pregnancy|1|||
147434696|NCT00631189|531758175|FG003|Treatment Phase|Pregnancy|0|||
147434697|NCT00631189|531758172|FG000|Treatment Phase|patient did not take pravastatin|0|||
147434698|NCT00631189|531758173|FG001|Treatment Phase|patient did not take pravastatin|0|||
147649408|NCT04575584|532537337|FG002|Overall Study|Not recorded|0|||
147434699|NCT00631189|531758174|FG002|Treatment Phase|patient did not take pravastatin|1|||
147434700|NCT00631189|531758175|FG003|Treatment Phase|patient did not take pravastatin|0|||
147434701|NCT04464265|531758176|FG000|Overall Study|Physician Decision|2|||
147434702|NCT00974090|531758177|FG000|Period 1: Double Blind Period|Adverse Event|2|||
147434703|NCT00974090|531758178|FG001|Period 1: Double Blind Period|Adverse Event|1|||
147434704|NCT00974090|531758177|FG000|Period 1: Double Blind Period|Physician Decision|1|||
147434705|NCT00974090|531758178|FG001|Period 1: Double Blind Period|Physician Decision|0|||
147534752|NCT04242446|532113096|FG000|Maintenance Treatment Period: Week 16-48|Patient Relocated Last Minute Decision|0|||
147534753|NCT04242446|532113097|FG001|Maintenance Treatment Period: Week 16-48|Patient Relocated Last Minute Decision|0|||
147196290|NCT03050801|530888303|FG000|Experiment 1|Physician Decision|0|||
147196291|NCT03050801|530888304|FG001|Experiment 1|Physician Decision|3|||
147196292|NCT03050801|530888305|FG002|Experiment 1|Physician Decision|0|||
147534754|NCT04242446|532113098|FG002|Maintenance Treatment Period: Week 16-48|Patient Relocated Last Minute Decision|0|||
147534755|NCT04242446|532113099|FG003|Maintenance Treatment Period: Week 16-48|Patient Relocated Last Minute Decision|0|||
147196293|NCT03050801|530888306|FG003|Experiment 1|Physician Decision|0|||
147196294|NCT03050801|530888307|FG004|Experiment 1|Physician Decision|0|||
147196295|NCT03050801|530888308|FG005|Experiment 1|Physician Decision|0|||
147196296|NCT03050801|530888303|FG000|Experiment 1|Change of experimental design|0|||
147196297|NCT03050801|530888304|FG001|Experiment 1|Change of experimental design|3|||
147196298|NCT03050801|530888305|FG002|Experiment 1|Change of experimental design|0|||
147196299|NCT03050801|530888306|FG003|Experiment 1|Change of experimental design|0|||
147196300|NCT03050801|530888307|FG004|Experiment 1|Change of experimental design|0|||
147196301|NCT03050801|530888308|FG005|Experiment 1|Change of experimental design|0|||
147196302|NCT03050801|530888303|FG000|Experiment 1|Unable to obtain critical rTMS measure|0|||
147196303|NCT03050801|530888304|FG001|Experiment 1|Unable to obtain critical rTMS measure|0|||
147196304|NCT03050801|530888305|FG002|Experiment 1|Unable to obtain critical rTMS measure|2|||
147196305|NCT03050801|530888306|FG003|Experiment 1|Unable to obtain critical rTMS measure|0|||
147196306|NCT03050801|530888307|FG004|Experiment 1|Unable to obtain critical rTMS measure|0|||
147196307|NCT03050801|530888308|FG005|Experiment 1|Unable to obtain critical rTMS measure|0|||
147196308|NCT03050801|530888303|FG000|Experiment 2|Lost to Follow-up|0|||
147196309|NCT03050801|530888304|FG001|Experiment 2|Lost to Follow-up|0|||
147196310|NCT03050801|530888305|FG002|Experiment 2|Lost to Follow-up|0|||
147196311|NCT03050801|530888306|FG003|Experiment 2|Lost to Follow-up|1|||
147196312|NCT03050801|530888307|FG004|Experiment 2|Lost to Follow-up|1|||
147196313|NCT03050801|530888308|FG005|Experiment 2|Lost to Follow-up|0|||
147196314|NCT03050801|530888303|FG000|Experiment 2|Physician Decision|0|||
147196315|NCT03050801|530888304|FG001|Experiment 2|Physician Decision|0|||
147196316|NCT03050801|530888305|FG002|Experiment 2|Physician Decision|0|||
147196317|NCT03050801|530888306|FG003|Experiment 2|Physician Decision|0|||
147196318|NCT03050801|530888307|FG004|Experiment 2|Physician Decision|1|||
147196319|NCT03050801|530888308|FG005|Experiment 2|Physician Decision|0|||
147196320|NCT03050801|530888303|FG000|Experiment 2|Pregnancy|0|||
147196321|NCT03050801|530888304|FG001|Experiment 2|Pregnancy|0|||
147196322|NCT03050801|530888305|FG002|Experiment 2|Pregnancy|0|||
147196323|NCT03050801|530888306|FG003|Experiment 2|Pregnancy|0|||
147196324|NCT03050801|530888307|FG004|Experiment 2|Pregnancy|1|||
147196325|NCT03050801|530888308|FG005|Experiment 2|Pregnancy|0|||
147196326|NCT03050801|530888303|FG000|Experiment 2|Withdrawal by Subject|0|||
147196327|NCT03050801|530888304|FG001|Experiment 2|Withdrawal by Subject|0|||
147196328|NCT03050801|530888305|FG002|Experiment 2|Withdrawal by Subject|0|||
147196329|NCT03050801|530888306|FG003|Experiment 2|Withdrawal by Subject|1|||
147196330|NCT03050801|530888307|FG004|Experiment 2|Withdrawal by Subject|0|||
147196331|NCT03050801|530888308|FG005|Experiment 2|Withdrawal by Subject|0|||
147196332|NCT03050801|530888303|FG000|Experiment 2|Poor data quality|0|||
147196333|NCT03050801|530888304|FG001|Experiment 2|Poor data quality|0|||
147196334|NCT03050801|530888305|FG002|Experiment 2|Poor data quality|0|||
147196335|NCT03050801|530888306|FG003|Experiment 2|Poor data quality|4|||
147196336|NCT03050801|530888307|FG004|Experiment 2|Poor data quality|1|||
147196337|NCT03050801|530888308|FG005|Experiment 2|Poor data quality|0|||
147196338|NCT03050801|530888303|FG000|Experiment 2|Discomfort during stimulation|0|||
147196339|NCT03050801|530888304|FG001|Experiment 2|Discomfort during stimulation|0|||
147196340|NCT03050801|530888305|FG002|Experiment 2|Discomfort during stimulation|0|||
147196341|NCT03050801|530888306|FG003|Experiment 2|Discomfort during stimulation|0|||
147196342|NCT03050801|530888307|FG004|Experiment 2|Discomfort during stimulation|0|||
147196343|NCT03050801|530888308|FG005|Experiment 2|Discomfort during stimulation|2|||
147196344|NCT04825574|530888311|FG000|Overall Study|Commercial treatment became available|1|||
147196345|NCT04825574|530888311|FG000|Overall Study|Disease progression|1|||
147196346|NCT03518086|530888312|FG000|Overall Study|Adverse Event|23|||
147534756|NCT04242446|532113100|FG004|Maintenance Treatment Period: Week 16-48|Patient Relocated Last Minute Decision|0|||
147196347|NCT03518086|530888313|FG001|Overall Study|Adverse Event|15|||
147196348|NCT03518086|530888314|FG002|Overall Study|Adverse Event|3|||
147196349|NCT03518086|530888315|FG003|Overall Study|Adverse Event|2|||
147196350|NCT03518086|530888312|FG000|Overall Study|Withdrawal by Subject|8|||
147196351|NCT03518086|530888313|FG001|Overall Study|Withdrawal by Subject|5|||
147196352|NCT03518086|530888314|FG002|Overall Study|Withdrawal by Subject|1|||
147196353|NCT03518086|530888315|FG003|Overall Study|Withdrawal by Subject|0|||
147196354|NCT03518086|530888312|FG000|Overall Study|Lack of Efficacy|5|||
147196355|NCT03518086|530888313|FG001|Overall Study|Lack of Efficacy|5|||
147196356|NCT03518086|530888314|FG002|Overall Study|Lack of Efficacy|0|||
147196357|NCT03518086|530888315|FG003|Overall Study|Lack of Efficacy|2|||
147196358|NCT03518086|530888312|FG000|Overall Study|Protocol Violation|1|||
147196359|NCT03518086|530888313|FG001|Overall Study|Protocol Violation|5|||
147196360|NCT03518086|530888314|FG002|Overall Study|Protocol Violation|1|||
147534757|NCT04242446|532113101|FG005|Maintenance Treatment Period: Week 16-48|Patient Relocated Last Minute Decision|1|||
147534758|NCT04242446|532113102|FG006|Maintenance Treatment Period: Week 16-48|Patient Relocated Last Minute Decision|0|||
147534759|NCT04242446|532113096|FG000|Maintenance Treatment Period: Week 16-48|Needs Systemic Therapy Incompatible With Protocol|0|||
147534760|NCT04242446|532113097|FG001|Maintenance Treatment Period: Week 16-48|Needs Systemic Therapy Incompatible With Protocol|0|||
147534761|NCT04242446|532113098|FG002|Maintenance Treatment Period: Week 16-48|Needs Systemic Therapy Incompatible With Protocol|0|||
147534762|NCT04242446|532113099|FG003|Maintenance Treatment Period: Week 16-48|Needs Systemic Therapy Incompatible With Protocol|0|||
147534763|NCT04242446|532113100|FG004|Maintenance Treatment Period: Week 16-48|Needs Systemic Therapy Incompatible With Protocol|0|||
147534764|NCT04242446|532113101|FG005|Maintenance Treatment Period: Week 16-48|Needs Systemic Therapy Incompatible With Protocol|0|||
147196361|NCT03518086|530888315|FG003|Overall Study|Protocol Violation|3|||
147196362|NCT03518086|530888312|FG000|Overall Study|Lost to Follow-up|0|||
147196363|NCT03518086|530888313|FG001|Overall Study|Lost to Follow-up|3|||
147196364|NCT03518086|530888314|FG002|Overall Study|Lost to Follow-up|0|||
147196365|NCT03518086|530888315|FG003|Overall Study|Lost to Follow-up|0|||
147196366|NCT03518086|530888312|FG000|Overall Study|Insufficient Diary Data|0|||
147196367|NCT03518086|530888313|FG001|Overall Study|Insufficient Diary Data|2|||
147196368|NCT03518086|530888314|FG002|Overall Study|Insufficient Diary Data|0|||
147196369|NCT03518086|530888315|FG003|Overall Study|Insufficient Diary Data|0|||
147196370|NCT03518086|530888312|FG000|Overall Study|Non- compliance to Protocol|0|||
147196371|NCT03518086|530888313|FG001|Overall Study|Non- compliance to Protocol|1|||
147196372|NCT03518086|530888314|FG002|Overall Study|Non- compliance to Protocol|0|||
147196373|NCT03518086|530888315|FG003|Overall Study|Non- compliance to Protocol|0|||
147196374|NCT03518086|530888312|FG000|Overall Study|COVID-19 Related Study Disruption|0|||
147196375|NCT03518086|530888313|FG001|Overall Study|COVID-19 Related Study Disruption|2|||
147196376|NCT03518086|530888314|FG002|Overall Study|COVID-19 Related Study Disruption|0|||
147196377|NCT03518086|530888315|FG003|Overall Study|COVID-19 Related Study Disruption|0|||
147196378|NCT03518086|530888312|FG000|Overall Study|Site Terminated by Sponsor|0|||
147196379|NCT03518086|530888313|FG001|Overall Study|Site Terminated by Sponsor|1|||
147196380|NCT03518086|530888314|FG002|Overall Study|Site Terminated by Sponsor|0|||
147196381|NCT03518086|530888315|FG003|Overall Study|Site Terminated by Sponsor|0|||
147196382|NCT03518086|530888312|FG000|Overall Study|Pregnancy|0|||
147196383|NCT03518086|530888313|FG001|Overall Study|Pregnancy|0|||
147196384|NCT03518086|530888314|FG002|Overall Study|Pregnancy|0|||
147196385|NCT03518086|530888315|FG003|Overall Study|Pregnancy|2|||
147196386|NCT03204188|530888320|FG000|Immunotherapy Phase (1 Year)|Adverse Event|4|||
147196387|NCT03204188|530888320|FG000|Immunotherapy Phase (1 Year)|Death|1|||
147196388|NCT03204188|530888320|FG000|Follow-up Phase (Extension Study)|Progression of Disease|4|||
147196389|NCT03204188|530888320|FG000|Follow-up Phase (Extension Study)|Adverse Event|2|||
147196390|NCT02151058|530890386|FG000|Overall Study|Withdrawal by Subject|1|||
147196391|NCT02151058|530890387|FG001|Overall Study|Withdrawal by Subject|1|||
147196392|NCT02151058|530890388|FG002|Overall Study|Withdrawal by Subject|3|||
147196393|NCT02151058|530890386|FG000|Overall Study|Lost to Follow-up|1|||
147196394|NCT02151058|530890387|FG001|Overall Study|Lost to Follow-up|0|||
147196395|NCT02151058|530890388|FG002|Overall Study|Lost to Follow-up|2|||
147196396|NCT00124943|530890389|FG000|Phase II|Adverse Event|0|||
147196397|NCT00124943|530890390|FG001|Phase II|Adverse Event|2|||
147196398|NCT00124943|530890391|FG002|Phase II|Adverse Event|0|||
147196399|NCT00124943|530890392|FG003|Phase II|Adverse Event|1|||
147196400|NCT00124943|530890389|FG000|Phase II|Protocol Violation|0|||
147196401|NCT00124943|530890390|FG001|Phase II|Protocol Violation|0|||
147196402|NCT00124943|530890391|FG002|Phase II|Protocol Violation|0|||
147196403|NCT00124943|530890392|FG003|Phase II|Protocol Violation|1|||
147196404|NCT00124943|530890389|FG000|Phase II|Lost to Follow-up|0|||
147196405|NCT00124943|530890390|FG001|Phase II|Lost to Follow-up|0|||
147196406|NCT00124943|530890391|FG002|Phase II|Lost to Follow-up|0|||
147196407|NCT00124943|530890392|FG003|Phase II|Lost to Follow-up|1|||
147196408|NCT00124943|530890389|FG000|Phase II|Withdrawal by Subject|0|||
147196409|NCT00124943|530890390|FG001|Phase II|Withdrawal by Subject|0|||
147196410|NCT00124943|530890391|FG002|Phase II|Withdrawal by Subject|0|||
147196411|NCT00124943|530890392|FG003|Phase II|Withdrawal by Subject|2|||
147196412|NCT03829228|530890393|FG000|Overall Study|Protocol Violation|1|||
147196413|NCT03337477|530890394|FG000|Overall Study|not categorized into the listed ones|11|||
147196414|NCT03337477|530890395|FG001|Overall Study|not categorized into the listed ones|9|||
147196415|NCT03337477|530890394|FG000|Overall Study|Withdrawal by Subject|0|||
147196416|NCT03337477|530890395|FG001|Overall Study|Withdrawal by Subject|1|||
147196417|NCT03337477|530890394|FG000|Overall Study|Death|0|||
147196418|NCT03337477|530890395|FG001|Overall Study|Death|1|||
147196419|NCT03337477|530890394|FG000|Overall Study|Lost to Follow-up|0|||
147196420|NCT03337477|530890395|FG001|Overall Study|Lost to Follow-up|2|||
147196421|NCT02443688|530890398|FG000|Overall Study|Adverse Event|2|||
147196422|NCT02443688|530890399|FG001|Overall Study|Adverse Event|3|||
147196423|NCT02443688|530890400|FG002|Overall Study|Adverse Event|2|||
147196424|NCT02443688|530890398|FG000|Overall Study|Lost to Follow-up|1|||
147196425|NCT02443688|530890399|FG001|Overall Study|Lost to Follow-up|0|||
147196426|NCT02443688|530890400|FG002|Overall Study|Lost to Follow-up|0|||
147196427|NCT02443688|530890398|FG000|Overall Study|Physician Decision|3|||
147196428|NCT02443688|530890399|FG001|Overall Study|Physician Decision|0|||
147196429|NCT02443688|530890400|FG002|Overall Study|Physician Decision|1|||
147196430|NCT02443688|530890398|FG000|Overall Study|Pregnancy|0|||
147196431|NCT02443688|530890399|FG001|Overall Study|Pregnancy|0|||
147196432|NCT02443688|530890400|FG002|Overall Study|Pregnancy|1|||
147196433|NCT02443688|530890398|FG000|Overall Study|Withdrawal by Subject|3|||
147196434|NCT02443688|530890399|FG001|Overall Study|Withdrawal by Subject|3|||
147196435|NCT02443688|530890400|FG002|Overall Study|Withdrawal by Subject|4|||
147196436|NCT02443688|530890398|FG000|Overall Study|Non-compliance with study drug|1|||
147196437|NCT02443688|530890399|FG001|Overall Study|Non-compliance with study drug|2|||
147196438|NCT02443688|530890400|FG002|Overall Study|Non-compliance with study drug|4|||
147196439|NCT02443688|530890398|FG000|Overall Study|Sponsor Request|2|||
147196440|NCT02443688|530890399|FG001|Overall Study|Sponsor Request|1|||
147196441|NCT02443688|530890400|FG002|Overall Study|Sponsor Request|0|||
147196442|NCT00408317|530890402|FG000|First Intervention Period|Adverse Event|0|||
147196443|NCT00408317|530890403|FG001|First Intervention Period|Adverse Event|1|||
147196444|NCT00408317|530890402|FG000|Second Intervention Period|Adverse Event|2|||
147196445|NCT00408317|530890403|FG001|Second Intervention Period|Adverse Event|0|||
147196446|NCT00408317|530890402|FG000|Second Intervention Period|Protocol Violation|0|||
147196447|NCT00408317|530890403|FG001|Second Intervention Period|Protocol Violation|1|||
147196448|NCT00408317|530890402|FG000|Second Intervention Period|Withdrawal of consent|0|||
147196449|NCT00408317|530890403|FG001|Second Intervention Period|Withdrawal of consent|1|||
147196450|NCT02177123|530890411|FG000|Overall Study|Lost to Follow-up|6|||
147196451|NCT02177123|530890411|FG000|Overall Study|Withdrawal by Subject|4|||
147196452|NCT02177123|530890411|FG000|Overall Study|Adverse Event|4|||
147196453|NCT02177123|530890411|FG000|Overall Study|Physician Decision|3|||
147196454|NCT02177123|530890411|FG000|Overall Study|Excluded by Sponsor - other reason|2|||
147196455|NCT02177123|530890411|FG000|Overall Study|Excluded for medical reasons|2|||
147196456|NCT02177123|530890411|FG000|Overall Study|Death|1|||
147196457|NCT02177123|530890411|FG000|Overall Study|Other|1|||
147196458|NCT02177123|530890411|FG000|Overall Study|Excl. #31 Ocular pathology or medical condition which would place subject at increased risk|1|||
147196459|NCT05660577|530890412|FG000|Overall Study|Discontinued|9|||
147196460|NCT00481832|530890417|FG000|Enrollment|Physician Decision|8|||
147196461|NCT00481832|530890417|FG000|Enrollment|Unable to collect enough stem cells|2|||
147196462|NCT00481832|530890417|FG000|Inter-transplant Period|Adverse Event|4|||
147196463|NCT00481832|530890417|FG000|Inter-transplant Period|Death|3|||
147196464|NCT00481832|530890417|FG000|Inter-transplant Period|Physician Decision|4|||
147434706|NCT00974090|531758177|FG000|Period 2: Open-label Period|Adverse Event|4|||
147434707|NCT00974090|531758178|FG001|Period 2: Open-label Period|Adverse Event|6|||
147434708|NCT00974090|531758177|FG000|Period 2: Open-label Period|Lack of Efficacy|3|||
147434709|NCT00974090|531758178|FG001|Period 2: Open-label Period|Lack of Efficacy|1|||
147434710|NCT00974090|531758177|FG000|Period 2: Open-label Period|Physician Decision|0|||
147434711|NCT00974090|531758178|FG001|Period 2: Open-label Period|Physician Decision|3|||
147434712|NCT00974090|531758177|FG000|Period 2: Open-label Period|Withdrawal by Subject|1|||
147434713|NCT00974090|531758178|FG001|Period 2: Open-label Period|Withdrawal by Subject|0|||
147434714|NCT03189862|531758179|FG000|Overall Study|Withdrawal by Subject|1|||
147434715|NCT03189862|531758180|FG001|Overall Study|Withdrawal by Subject|0|||
147434716|NCT03189862|531758179|FG000|Overall Study|Lost to Follow-up|54|||
147434717|NCT03189862|531758180|FG001|Overall Study|Lost to Follow-up|62|||
147434718|NCT00056862|531758181|FG000|Overall Study|Protocol Violation|1|||
147434719|NCT00056862|531758182|FG001|Overall Study|Protocol Violation|0|||
147434720|NCT01438151|531758185|FG000|Overall Study|study terminated|8|||
147434721|NCT02459769|531758189|FG000|Overall Study|Withdrawal by Subject|7|||
147434722|NCT02459769|531758190|FG001|Overall Study|Withdrawal by Subject|4|||
147434723|NCT02459769|531758191|FG002|Overall Study|Withdrawal by Subject|8|||
147434724|NCT02459769|531758192|FG003|Overall Study|Withdrawal by Subject|5|||
147434725|NCT02459769|531758189|FG000|Overall Study|Lost to Follow-up|1|||
147434726|NCT02459769|531758190|FG001|Overall Study|Lost to Follow-up|0|||
147434727|NCT02459769|531758191|FG002|Overall Study|Lost to Follow-up|1|||
147434728|NCT02459769|531758192|FG003|Overall Study|Lost to Follow-up|0|||
147434729|NCT00312221|531758193|FG000|Open-label Run-in Period|Withdrawal by Subject|6|||
147434730|NCT00312221|531758194|FG001|Open-label Run-in Period|Withdrawal by Subject|0|||
147196465|NCT00481832|530890417|FG000|Inter-transplant Period|Disease relapse|11|||
147196466|NCT00481832|530890417|FG000|Inter-transplant Period|Lack of allogeneic donor|5|||
147196467|NCT00581308|530890421|FG000|Pre Discharge|Lost to Follow-up|1|||
147534765|NCT04242446|532113102|FG006|Maintenance Treatment Period: Week 16-48|Needs Systemic Therapy Incompatible With Protocol|1|||
147196468|NCT00581308|530890421|FG000|Pre Discharge|Device Removed|1|||
147196469|NCT00581308|530890421|FG000|Month 1|Lost to Follow-up|3|||
147196470|NCT00581308|530890421|FG000|Month 1|Withdrawal by Subject|2|||
147196471|NCT00581308|530890421|FG000|Month 1|Device Removed|2|||
147196472|NCT00581308|530890421|FG000|Month 1|Uknown|1|||
147196473|NCT00581308|530890421|FG000|Month 6|Lost to Follow-up|1|||
147196474|NCT00581308|530890421|FG000|Month 6|Withdrawal by Subject|2|||
147434731|NCT00312221|531758195|FG002|Open-label Run-in Period|Withdrawal by Subject|0|||
147196475|NCT00581308|530890421|FG000|Month 12|Death|1|||
147196476|NCT00581308|530890421|FG000|Month 12|Lost to Follow-up|14|||
147196477|NCT00581308|530890421|FG000|Month 12|Withdrawal by Subject|3|||
147196478|NCT00581308|530890421|FG000|Month 12|Device Removed|1|||
147196479|NCT00581308|530890421|FG000|Month 12|Other|1|||
147196480|NCT02006472|530890422|FG000|Period 1 (Through Week 26)|Protocol Violation|1|||
147196481|NCT02006472|530890423|FG001|Period 1 (Through Week 26)|Protocol Violation|1|||
147196482|NCT02006472|530890424|FG002|Period 1 (Through Week 26)|Protocol Violation|1|||
147196483|NCT02006472|530890425|FG003|Period 1 (Through Week 26)|Protocol Violation|1|||
147196484|NCT02006472|530890426|FG004|Period 1 (Through Week 26)|Protocol Violation|0|||
147196485|NCT02006472|530890422|FG000|Period 1 (Through Week 26)|Lack of Efficacy|0|||
147196486|NCT02006472|530890423|FG001|Period 1 (Through Week 26)|Lack of Efficacy|0|||
147196487|NCT02006472|530890424|FG002|Period 1 (Through Week 26)|Lack of Efficacy|1|||
147196488|NCT02006472|530890425|FG003|Period 1 (Through Week 26)|Lack of Efficacy|0|||
147196489|NCT02006472|530890426|FG004|Period 1 (Through Week 26)|Lack of Efficacy|0|||
147196490|NCT02006472|530890422|FG000|Period 1 (Through Week 26)|Noncompliance|2|||
147196491|NCT02006472|530890423|FG001|Period 1 (Through Week 26)|Noncompliance|1|||
147196492|NCT02006472|530890424|FG002|Period 1 (Through Week 26)|Noncompliance|1|||
147196493|NCT02006472|530890425|FG003|Period 1 (Through Week 26)|Noncompliance|0|||
147196494|NCT02006472|530890426|FG004|Period 1 (Through Week 26)|Noncompliance|0|||
147196495|NCT02006472|530890422|FG000|Period 1 (Through Week 26)|Other|1|||
147196496|NCT02006472|530890423|FG001|Period 1 (Through Week 26)|Other|5|||
147196497|NCT02006472|530890424|FG002|Period 1 (Through Week 26)|Other|0|||
147196498|NCT02006472|530890425|FG003|Period 1 (Through Week 26)|Other|2|||
147196499|NCT02006472|530890426|FG004|Period 1 (Through Week 26)|Other|3|||
147196500|NCT02006472|530890422|FG000|Period 1 (Through Week 26)|Adverse Event|5|||
147196501|NCT02006472|530890423|FG001|Period 1 (Through Week 26)|Adverse Event|6|||
147196502|NCT02006472|530890424|FG002|Period 1 (Through Week 26)|Adverse Event|11|||
147196503|NCT02006472|530890425|FG003|Period 1 (Through Week 26)|Adverse Event|11|||
147196504|NCT02006472|530890426|FG004|Period 1 (Through Week 26)|Adverse Event|14|||
147196505|NCT02006472|530890422|FG000|Period 1 (Through Week 26)|Withdrawal by Subject|3|||
147196506|NCT02006472|530890423|FG001|Period 1 (Through Week 26)|Withdrawal by Subject|9|||
147196507|NCT02006472|530890424|FG002|Period 1 (Through Week 26)|Withdrawal by Subject|3|||
147196508|NCT02006472|530890425|FG003|Period 1 (Through Week 26)|Withdrawal by Subject|0|||
147196509|NCT02006472|530890426|FG004|Period 1 (Through Week 26)|Withdrawal by Subject|3|||
147196510|NCT02006472|530890422|FG000|Period 2 (Through Week 52)|Lack of Efficacy|1|||
147196511|NCT02006472|530890423|FG001|Period 2 (Through Week 52)|Lack of Efficacy|0|||
147196512|NCT02006472|530890424|FG002|Period 2 (Through Week 52)|Lack of Efficacy|0|||
147196513|NCT02006472|530890425|FG003|Period 2 (Through Week 52)|Lack of Efficacy|1|||
147196514|NCT02006472|530890426|FG004|Period 2 (Through Week 52)|Lack of Efficacy|1|||
147196515|NCT02006472|530890422|FG000|Period 2 (Through Week 52)|Noncompliance|1|||
147196516|NCT02006472|530890423|FG001|Period 2 (Through Week 52)|Noncompliance|0|||
147196517|NCT02006472|530890424|FG002|Period 2 (Through Week 52)|Noncompliance|0|||
147196518|NCT02006472|530890425|FG003|Period 2 (Through Week 52)|Noncompliance|0|||
147434732|NCT00312221|531758196|FG003|Open-label Run-in Period|Withdrawal by Subject|0|||
147434733|NCT00312221|531758193|FG000|Open-label Run-in Period|Adverse Event|74|||
147434734|NCT00312221|531758194|FG001|Open-label Run-in Period|Adverse Event|0|||
147434735|NCT00312221|531758195|FG002|Open-label Run-in Period|Adverse Event|0|||
147434736|NCT00312221|531758196|FG003|Open-label Run-in Period|Adverse Event|0|||
147434737|NCT00312221|531758193|FG000|Open-label Run-in Period|Lost to Follow-up|5|||
147434738|NCT00312221|531758194|FG001|Open-label Run-in Period|Lost to Follow-up|0|||
147434739|NCT00312221|531758195|FG002|Open-label Run-in Period|Lost to Follow-up|0|||
147434740|NCT00312221|531758196|FG003|Open-label Run-in Period|Lost to Follow-up|0|||
147434741|NCT00312221|531758193|FG000|Open-label Run-in Period|Administrative|42|||
147434742|NCT00312221|531758194|FG001|Open-label Run-in Period|Administrative|0|||
147434743|NCT00312221|531758195|FG002|Open-label Run-in Period|Administrative|0|||
147434744|NCT00312221|531758196|FG003|Open-label Run-in Period|Administrative|0|||
147434745|NCT00312221|531758193|FG000|Open-label Run-in Period|Lack of Efficacy|102|||
147434746|NCT00312221|531758194|FG001|Open-label Run-in Period|Lack of Efficacy|0|||
147434747|NCT00312221|531758195|FG002|Open-label Run-in Period|Lack of Efficacy|0|||
147434748|NCT00312221|531758196|FG003|Open-label Run-in Period|Lack of Efficacy|0|||
147434749|NCT00312221|531758193|FG000|Open-label Run-in Period|Did not qualify|5|||
147434750|NCT00312221|531758194|FG001|Open-label Run-in Period|Did not qualify|0|||
147434751|NCT00312221|531758195|FG002|Open-label Run-in Period|Did not qualify|0|||
147196519|NCT02006472|530890426|FG004|Period 2 (Through Week 52)|Noncompliance|0|||
147196520|NCT02006472|530890422|FG000|Period 2 (Through Week 52)|Adverse Event|1|||
147196521|NCT02006472|530890423|FG001|Period 2 (Through Week 52)|Adverse Event|4|||
147196522|NCT02006472|530890424|FG002|Period 2 (Through Week 52)|Adverse Event|5|||
147196523|NCT02006472|530890425|FG003|Period 2 (Through Week 52)|Adverse Event|1|||
147196524|NCT02006472|530890426|FG004|Period 2 (Through Week 52)|Adverse Event|1|||
147196525|NCT02006472|530890422|FG000|Period 2 (Through Week 52)|Other|0|||
147196526|NCT02006472|530890423|FG001|Period 2 (Through Week 52)|Other|1|||
147196527|NCT02006472|530890424|FG002|Period 2 (Through Week 52)|Other|0|||
147434752|NCT00312221|531758196|FG003|Open-label Run-in Period|Did not qualify|0|||
147434753|NCT00312221|531758193|FG000|Double-blind Phase|Withdrawal by Subject|0|||
147649409|NCT04575584|532537338|FG003|Overall Study|Not recorded|1|||
147196528|NCT02006472|530890425|FG003|Period 2 (Through Week 52)|Other|1|||
147196529|NCT02006472|530890426|FG004|Period 2 (Through Week 52)|Other|0|||
147196530|NCT02006472|530890422|FG000|Period 2 (Through Week 52)|Not treated|0|||
147196531|NCT02006472|530890423|FG001|Period 2 (Through Week 52)|Not treated|0|||
147196532|NCT02006472|530890424|FG002|Period 2 (Through Week 52)|Not treated|2|||
147196533|NCT02006472|530890425|FG003|Period 2 (Through Week 52)|Not treated|0|||
147196534|NCT02006472|530890426|FG004|Period 2 (Through Week 52)|Not treated|0|||
147196535|NCT02006472|530890422|FG000|Period 2 (Through Week 52)|Withdrawal by Subject|2|||
147196536|NCT02006472|530890423|FG001|Period 2 (Through Week 52)|Withdrawal by Subject|1|||
147196537|NCT02006472|530890424|FG002|Period 2 (Through Week 52)|Withdrawal by Subject|2|||
147196538|NCT02006472|530890425|FG003|Period 2 (Through Week 52)|Withdrawal by Subject|0|||
147196539|NCT02006472|530890426|FG004|Period 2 (Through Week 52)|Withdrawal by Subject|0|||
147196540|NCT02006472|530890422|FG000|Period 2 (Through Week 52)|Sponsor decision|0|||
147196541|NCT02006472|530890423|FG001|Period 2 (Through Week 52)|Sponsor decision|0|||
147196542|NCT02006472|530890424|FG002|Period 2 (Through Week 52)|Sponsor decision|1|||
147196543|NCT02006472|530890425|FG003|Period 2 (Through Week 52)|Sponsor decision|0|||
147196544|NCT02006472|530890426|FG004|Period 2 (Through Week 52)|Sponsor decision|0|||
147196545|NCT00886379|530890427|FG000|Overall Study|Transferred Schools|0|||
147196546|NCT00886379|530890428|FG001|Overall Study|Transferred Schools|0|||
147196547|NCT00886379|530890429|FG002|Overall Study|Transferred Schools|2|||
147196548|NCT00886379|530890430|FG003|Overall Study|Transferred Schools|1|||
147196549|NCT00886379|530890431|FG004|Overall Study|Transferred Schools|1|||
147196550|NCT00886379|530890427|FG000|Overall Study|Final blood draw not obtained|3|||
147196551|NCT00886379|530890428|FG001|Overall Study|Final blood draw not obtained|3|||
147196552|NCT00886379|530890429|FG002|Overall Study|Final blood draw not obtained|4|||
147196553|NCT00886379|530890430|FG003|Overall Study|Final blood draw not obtained|2|||
147196554|NCT00886379|530890431|FG004|Overall Study|Final blood draw not obtained|2|||
147196555|NCT03219723|530890432|FG000|Overall Study|Case Report Forms Uncollected|6|||
147196556|NCT03219723|530890432|FG000|Overall Study|Protocol Deviation|4|||
147196557|NCT00459316|530890433|FG000|Steps 1 & 2|Other eligibility failure|1|||
147196558|NCT00459316|530890434|FG001|Steps 1 & 2|Other eligibility failure|1|||
147196559|NCT00459316|530890435|FG002|Steps 1 & 2|Other eligibility failure|0|||
147196560|NCT00459316|530890433|FG000|Steps 1 & 2|Death|1|||
147196561|NCT00459316|530890434|FG001|Steps 1 & 2|Death|1|||
147196562|NCT00459316|530890435|FG002|Steps 1 & 2|Death|0|||
147196563|NCT00459316|530890433|FG000|Steps 1 & 2|Not able to get to clinic|7|||
147196564|NCT00459316|530890434|FG001|Steps 1 & 2|Not able to get to clinic|4|||
147196565|NCT00459316|530890435|FG002|Steps 1 & 2|Not able to get to clinic|0|||
147196566|NCT00459316|530890433|FG000|Steps 1 & 2|Withdrawal by Subject|6|||
147196567|NCT00459316|530890434|FG001|Steps 1 & 2|Withdrawal by Subject|1|||
147196568|NCT00459316|530890435|FG002|Steps 1 & 2|Withdrawal by Subject|0|||
147196569|NCT00459316|530890433|FG000|Steps 1 & 2|Not willing to adhere to regulations|1|||
147196570|NCT00459316|530890434|FG001|Steps 1 & 2|Not willing to adhere to regulations|0|||
147196571|NCT00459316|530890435|FG002|Steps 1 & 2|Not willing to adhere to regulations|0|||
147196572|NCT00459316|530890433|FG000|Steps 1 & 2|Lost to Follow-up|5|||
147196573|NCT00459316|530890434|FG001|Steps 1 & 2|Lost to Follow-up|0|||
147196574|NCT00459316|530890435|FG002|Steps 1 & 2|Lost to Follow-up|2|||
147196575|NCT00459316|530890433|FG000|Step 3|Withdrawal by Subject|3|||
147196576|NCT00459316|530890434|FG001|Step 3|Withdrawal by Subject|0|||
147196577|NCT00459316|530890435|FG002|Step 3|Withdrawal by Subject|1|||
147196578|NCT01980017|530890436|FG000|Overall Study|Lost to Follow-up|30|||
147196579|NCT01980017|530890437|FG001|Overall Study|Lost to Follow-up|21|||
147196580|NCT01980017|530890436|FG000|Overall Study|Death|0|||
147196581|NCT01980017|530890437|FG001|Overall Study|Death|1|||
147196582|NCT01207414|530890439|FG000|Overall Study|Adverse Event|25|||
147196583|NCT01207414|530890440|FG001|Overall Study|Adverse Event|39|||
147196584|NCT01207414|530890439|FG000|Overall Study|Abnormal test procedure results|0|||
147196585|NCT01207414|530890440|FG001|Overall Study|Abnormal test procedure results|1|||
147196586|NCT01207414|530890439|FG000|Overall Study|Unsatisfactory therapeutic effect|5|||
147196587|NCT01207414|530890440|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
147434754|NCT00312221|531758194|FG001|Double-blind Phase|Withdrawal by Subject|6|||
147434755|NCT00312221|531758195|FG002|Double-blind Phase|Withdrawal by Subject|8|||
147434756|NCT00312221|531758196|FG003|Double-blind Phase|Withdrawal by Subject|7|||
147434757|NCT00312221|531758193|FG000|Double-blind Phase|Adverse Event|0|||
147434758|NCT00312221|531758194|FG001|Double-blind Phase|Adverse Event|10|||
147434759|NCT00312221|531758195|FG002|Double-blind Phase|Adverse Event|19|||
147434760|NCT00312221|531758196|FG003|Double-blind Phase|Adverse Event|18|||
147434761|NCT00312221|531758193|FG000|Double-blind Phase|Lost to Follow-up|0|||
147434762|NCT00312221|531758194|FG001|Double-blind Phase|Lost to Follow-up|0|||
147434763|NCT00312221|531758195|FG002|Double-blind Phase|Lost to Follow-up|2|||
147434764|NCT00312221|531758196|FG003|Double-blind Phase|Lost to Follow-up|2|||
147434765|NCT00312221|531758193|FG000|Double-blind Phase|Administrative|0|||
147434766|NCT00312221|531758194|FG001|Double-blind Phase|Administrative|26|||
147434767|NCT00312221|531758195|FG002|Double-blind Phase|Administrative|37|||
147434768|NCT00312221|531758196|FG003|Double-blind Phase|Administrative|33|||
147434769|NCT00312221|531758193|FG000|Double-blind Phase|Lack of Efficacy|0|||
147196588|NCT01207414|530890439|FG000|Overall Study|Patient withdrew consent|14|||
147196589|NCT01207414|530890440|FG001|Overall Study|Patient withdrew consent|11|||
147196590|NCT01207414|530890439|FG000|Overall Study|Lost to Follow-up|15|||
147196591|NCT01207414|530890440|FG001|Overall Study|Lost to Follow-up|17|||
147196592|NCT01207414|530890439|FG000|Overall Study|Administrative problems|1|||
147196593|NCT01207414|530890440|FG001|Overall Study|Administrative problems|1|||
147196594|NCT01207414|530890439|FG000|Overall Study|Protocol deviation|12|||
147196595|NCT01207414|530890440|FG001|Overall Study|Protocol deviation|9|||
147196596|NCT01207414|530890439|FG000|Overall Study|Randomized in error|1|||
147196597|NCT01207414|530890440|FG001|Overall Study|Randomized in error|0|||
147196598|NCT02057250|530890441|FG000|AID Assessment Phase|Adverse Event|3|||
147196599|NCT02057250|530890442|FG001|AID Assessment Phase|Adverse Event|2|||
147196600|NCT02057250|530890443|FG002|AID Assessment Phase|Adverse Event|6|||
147196601|NCT02057250|530890444|FG003|AID Assessment Phase|Adverse Event|1|||
147196602|NCT02057250|530890445|FG004|AID Assessment Phase|Adverse Event|0|||
147196603|NCT02057250|530890441|FG000|AID Assessment Phase|Other than specified above|1|||
147196604|NCT02057250|530890442|FG001|AID Assessment Phase|Other than specified above|1|||
147196605|NCT02057250|530890443|FG002|AID Assessment Phase|Other than specified above|1|||
147196606|NCT02057250|530890444|FG003|AID Assessment Phase|Other than specified above|1|||
147196607|NCT02057250|530890445|FG004|AID Assessment Phase|Other than specified above|0|||
147196608|NCT02057250|530890441|FG000|Extension Phase|Adverse Event|0|||
147434770|NCT00312221|531758194|FG001|Double-blind Phase|Lack of Efficacy|17|||
147434771|NCT00312221|531758195|FG002|Double-blind Phase|Lack of Efficacy|6|||
147534766|NCT04242446|532113096|FG000|Maintenance Treatment Period: Week 16-48|Sponsor's Decision|0|||
147534767|NCT04242446|532113097|FG001|Maintenance Treatment Period: Week 16-48|Sponsor's Decision|0|||
147534768|NCT04242446|532113098|FG002|Maintenance Treatment Period: Week 16-48|Sponsor's Decision|0|||
147534769|NCT04242446|532113099|FG003|Maintenance Treatment Period: Week 16-48|Sponsor's Decision|0|||
147534770|NCT04242446|532113100|FG004|Maintenance Treatment Period: Week 16-48|Sponsor's Decision|0|||
147534771|NCT04242446|532113101|FG005|Maintenance Treatment Period: Week 16-48|Sponsor's Decision|0|||
147534772|NCT04242446|532113102|FG006|Maintenance Treatment Period: Week 16-48|Sponsor's Decision|1|||
147534773|NCT04242446|532113096|FG000|Maintenance Treatment Period: Week 16-48|Develop Illness Would Interfere With Participation|0|||
147534774|NCT04242446|532113097|FG001|Maintenance Treatment Period: Week 16-48|Develop Illness Would Interfere With Participation|0|||
147534775|NCT04242446|532113098|FG002|Maintenance Treatment Period: Week 16-48|Develop Illness Would Interfere With Participation|0|||
147534776|NCT04242446|532113099|FG003|Maintenance Treatment Period: Week 16-48|Develop Illness Would Interfere With Participation|0|||
147534777|NCT04242446|532113100|FG004|Maintenance Treatment Period: Week 16-48|Develop Illness Would Interfere With Participation|0|||
147534778|NCT04242446|532113101|FG005|Maintenance Treatment Period: Week 16-48|Develop Illness Would Interfere With Participation|0|||
147534779|NCT04242446|532113102|FG006|Maintenance Treatment Period: Week 16-48|Develop Illness Would Interfere With Participation|1|||
147534780|NCT05981365|532113108|FG000|Period 1|Adverse Event|1|||
147534781|NCT05981365|532113109|FG001|Period 1|Adverse Event|0|||
147534782|NCT03193996|532113111|FG000|Overall Study|Withdrawal by Subject|4|||
147534783|NCT03193996|532113111|FG000|Overall Study|Lost to Follow-up|4|||
147534784|NCT03193996|532113111|FG000|Overall Study|Physician Decision|2|||
147434772|NCT00312221|531758196|FG003|Double-blind Phase|Lack of Efficacy|10|||
147434773|NCT02060721|531758197|FG000|Overall Study|Lost to Follow-up|1|||
147434774|NCT02060721|531758197|FG000|Overall Study|Physician Decision|2|||
147434775|NCT02060721|531758197|FG000|Overall Study|Death|14|||
147434776|NCT02060721|531758197|FG000|Overall Study|Withdrawal by Subject|2|||
147434777|NCT02060721|531758197|FG000|Overall Study|Compliance with local regulation: enrolled in China|19|||
147434778|NCT05105789|531758198|FG000|Overall Study|Laboratory's lab collection device damaged|1|||
147434779|NCT01271803|531758199|FG000|Overall Study|Progressive disease|0|||
147434780|NCT01271803|531758200|FG001|Overall Study|Progressive disease|0|||
147434781|NCT01271803|531758201|FG002|Overall Study|Progressive disease|2|||
147434782|NCT01271803|531758199|FG000|Overall Study|Death|53|||
147434783|NCT01271803|531758200|FG001|Overall Study|Death|34|||
147434784|NCT01271803|531758201|FG002|Overall Study|Death|0|||
147434785|NCT01271803|531758199|FG000|Overall Study|Withdrawal by Subject|1|||
147434786|NCT01271803|531758200|FG001|Overall Study|Withdrawal by Subject|5|||
147434787|NCT01271803|531758201|FG002|Overall Study|Withdrawal by Subject|0|||
147434788|NCT01271803|531758199|FG000|Overall Study|Lost to Follow-up|1|||
147196609|NCT02057250|530890442|FG001|Extension Phase|Adverse Event|0|||
147196610|NCT02057250|530890443|FG002|Extension Phase|Adverse Event|0|||
147196611|NCT02057250|530890444|FG003|Extension Phase|Adverse Event|0|||
147196612|NCT02057250|530890445|FG004|Extension Phase|Adverse Event|15|||
147196613|NCT02057250|530890441|FG000|Extension Phase|Lack of Efficacy|0|||
147196614|NCT02057250|530890442|FG001|Extension Phase|Lack of Efficacy|0|||
147196615|NCT02057250|530890443|FG002|Extension Phase|Lack of Efficacy|0|||
147196616|NCT02057250|530890444|FG003|Extension Phase|Lack of Efficacy|0|||
147434789|NCT01271803|531758200|FG001|Overall Study|Lost to Follow-up|0|||
147196617|NCT02057250|530890445|FG004|Extension Phase|Lack of Efficacy|10|||
147196618|NCT02057250|530890441|FG000|Extension Phase|Entered in this period but not treated|0|||
147434790|NCT01271803|531758201|FG002|Overall Study|Lost to Follow-up|0|||
147434791|NCT04178967|531758202|FG000|Induction Period|Adverse Event|4|||
147534785|NCT03193996|532113111|FG000|Overall Study|Pregnancy|1|||
147534786|NCT03193996|532113111|FG000|Overall Study|Subject did not proceed to reconstructive surgery.|1|||
147534787|NCT03193996|532113111|FG000|Overall Study|Complicating disease|1|||
147534788|NCT01353586|532113112|FG000|Overall Study|Procedure terminated prior to ablation|3|||
147534789|NCT01353586|532113113|FG001|Overall Study|Procedure terminated prior to ablation|0|||
147534790|NCT01353586|532113112|FG000|Overall Study|Never had insertion of study catheter|4|||
147534791|NCT01353586|532113113|FG001|Overall Study|Never had insertion of study catheter|1|||
147534792|NCT01353586|532113112|FG000|Overall Study|Neurological exam not done|0|||
147534793|NCT01353586|532113113|FG001|Overall Study|Neurological exam not done|1|||
147534794|NCT05027958|532113114|FG000|Overall Study|Lost to Follow-up|1|||
147534795|NCT05027958|532113115|FG001|Overall Study|Lost to Follow-up|1|||
147534796|NCT05027958|532113114|FG000|Overall Study|Non-compliance (missed one or more study visits)|1|||
147534797|NCT05027958|532113115|FG001|Overall Study|Non-compliance (missed one or more study visits)|0|||
147534798|NCT05027958|532113114|FG000|Overall Study|Physician Decision|1|||
147196619|NCT02057250|530890442|FG001|Extension Phase|Entered in this period but not treated|0|||
147196620|NCT02057250|530890443|FG002|Extension Phase|Entered in this period but not treated|0|||
147196621|NCT02057250|530890444|FG003|Extension Phase|Entered in this period but not treated|0|||
147196622|NCT02057250|530890445|FG004|Extension Phase|Entered in this period but not treated|4|||
147196623|NCT02057250|530890441|FG000|Extension Phase|Other than specified above|0|||
147534799|NCT05027958|532113115|FG001|Overall Study|Physician Decision|4|||
147534800|NCT05027958|532113114|FG000|Overall Study|Adverse Event|0|||
147534801|NCT05027958|532113115|FG001|Overall Study|Adverse Event|1|||
147534802|NCT00491322|532113117|FG000|Overall Study|Protocol Violation|1|||
147534803|NCT00491322|532113118|FG001|Overall Study|Protocol Violation|0|||
147196624|NCT02057250|530890442|FG001|Extension Phase|Other than specified above|0|||
147196625|NCT02057250|530890443|FG002|Extension Phase|Other than specified above|0|||
147196626|NCT02057250|530890444|FG003|Extension Phase|Other than specified above|0|||
147196627|NCT02057250|530890445|FG004|Extension Phase|Other than specified above|7|||
147196628|NCT03367793|530890446|FG000|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0|||
147196629|NCT03367793|530890447|FG001|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0|||
147196630|NCT03367793|530890448|FG002|Treatment 2 Dispense to 2 Months Wear|Physician Decision|1|||
147196631|NCT03367793|530890449|FG003|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0|||
147196632|NCT03367793|530890450|FG004|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0|||
147196633|NCT03367793|530890451|FG005|Treatment 2 Dispense to 2 Months Wear|Physician Decision|0|||
147196634|NCT00260533|530890452|FG000|Overall Study|Other|3|||
147196635|NCT00260533|530890453|FG001|Overall Study|Other|3|||
147196636|NCT00003475|530890454|FG000|Overall Study|Not evaluable|13|||
147196637|NCT04852302|530890469|FG000|Overall Study|Withdrawal by Subject|2|||
147196638|NCT04852302|530890469|FG000|Overall Study|Did not complete CALM therapy.|2|||
147196639|NCT05249582|530890470|FG000|Overall Study|Technical Problems with virtual reality prevented completion|2|||
147196640|NCT05249582|530890471|FG001|Overall Study|Technical Problems with virtual reality prevented completion|0|||
147196641|NCT05249582|530890470|FG000|Overall Study|Internet connectivity prevented completion of the condition|0|||
147196642|NCT05249582|530890471|FG001|Overall Study|Internet connectivity prevented completion of the condition|1|||
147196643|NCT05249582|530890470|FG000|Overall Study|Declined to use virtual reality headset|1|||
147196644|NCT05249582|530890471|FG001|Overall Study|Declined to use virtual reality headset|0|||
147196645|NCT03267277|530890472|FG000|Overall Study|Withdrawal by Subject|1|||
147196646|NCT01436149|530890473|FG000|Antidepressant Lead-in Phase|Adverse Event|39|||
147196647|NCT01436149|530890474|FG001|Antidepressant Lead-in Phase|Adverse Event|0|||
147196648|NCT01436149|530890475|FG002|Antidepressant Lead-in Phase|Adverse Event|0|||
147196649|NCT01436149|530890473|FG000|Antidepressant Lead-in Phase|Protocol Violation|29|||
147196650|NCT01436149|530890474|FG001|Antidepressant Lead-in Phase|Protocol Violation|0|||
147196651|NCT01436149|530890475|FG002|Antidepressant Lead-in Phase|Protocol Violation|0|||
147196652|NCT01436149|530890473|FG000|Antidepressant Lead-in Phase|Withdrawal by Subject|61|||
147196653|NCT01436149|530890474|FG001|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
147196654|NCT01436149|530890475|FG002|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
147196655|NCT01436149|530890473|FG000|Antidepressant Lead-in Phase|Lost to Follow-up|96|||
147196656|NCT01436149|530890474|FG001|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
147196657|NCT01436149|530890475|FG002|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
147196658|NCT01436149|530890473|FG000|Antidepressant Lead-in Phase|Met BP Or Pulse Withdrawal Criteria|22|||
147196659|NCT01436149|530890474|FG001|Antidepressant Lead-in Phase|Met BP Or Pulse Withdrawal Criteria|0|||
147196660|NCT01436149|530890475|FG002|Antidepressant Lead-in Phase|Met BP Or Pulse Withdrawal Criteria|0|||
147196661|NCT01436149|530890473|FG000|Antidepressant Lead-in Phase|Other|119|||
147196662|NCT01436149|530890474|FG001|Antidepressant Lead-in Phase|Other|0|||
147534804|NCT00491322|532113117|FG000|Overall Study|Pregnancy|0|||
147534805|NCT00491322|532113118|FG001|Overall Study|Pregnancy|1|||
147196663|NCT01436149|530890475|FG002|Antidepressant Lead-in Phase|Other|0|||
147196664|NCT01436149|530890473|FG000|Randomized Phase|Adverse Event|9|||
147534806|NCT00807040|532113121|FG000|Overall Study|Death|24|||
147534807|NCT00807040|532113122|FG001|Overall Study|Death|29|||
147534808|NCT00807040|532113121|FG000|Overall Study|Withdrawal by Subject|8|||
147196665|NCT01436149|530890474|FG001|Randomized Phase|Adverse Event|10|||
147196666|NCT01436149|530890475|FG002|Randomized Phase|Adverse Event|11|||
147196667|NCT01436149|530890473|FG000|Randomized Phase|Protocol Violation|4|||
147196668|NCT01436149|530890474|FG001|Randomized Phase|Protocol Violation|5|||
147196669|NCT01436149|530890475|FG002|Randomized Phase|Protocol Violation|0|||
147196670|NCT01436149|530890473|FG000|Randomized Phase|Withdrawal by Subject|16|||
147196671|NCT01436149|530890474|FG001|Randomized Phase|Withdrawal by Subject|10|||
147196672|NCT01436149|530890475|FG002|Randomized Phase|Withdrawal by Subject|10|||
147196673|NCT01436149|530890473|FG000|Randomized Phase|Lost to Follow-up|34|||
147196674|NCT01436149|530890474|FG001|Randomized Phase|Lost to Follow-up|5|||
147196675|NCT01436149|530890475|FG002|Randomized Phase|Lost to Follow-up|6|||
147196676|NCT01436149|530890473|FG000|Randomized Phase|Lack of Efficacy|0|||
147196677|NCT01436149|530890474|FG001|Randomized Phase|Lack of Efficacy|0|||
147196678|NCT01436149|530890475|FG002|Randomized Phase|Lack of Efficacy|1|||
147196679|NCT01436149|530890473|FG000|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|2|||
147196680|NCT01436149|530890474|FG001|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|3|||
147196681|NCT01436149|530890475|FG002|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|3|||
147196682|NCT01436149|530890473|FG000|Randomized Phase|Other|12|||
147196683|NCT01436149|530890474|FG001|Randomized Phase|Other|5|||
147196684|NCT01436149|530890475|FG002|Randomized Phase|Other|11|||
147196685|NCT04849364|530890477|FG000|Overall Study|Eligibility criteria not meet|0|||
147196686|NCT04849364|530890478|FG001|Overall Study|Eligibility criteria not meet|1|||
147196687|NCT04849364|530890479|FG002|Overall Study|Eligibility criteria not meet|0|||
147196688|NCT02738801|530890488|FG000|Overall Study|Adverse Event|1|||
147196689|NCT02738801|530890489|FG001|Overall Study|Adverse Event|1|||
147196690|NCT02738801|530890488|FG000|Overall Study|Withdrawal by Subject|0|||
147196691|NCT02738801|530890489|FG001|Overall Study|Withdrawal by Subject|1|||
147196692|NCT01643668|530890490|FG000|Overall Study|Death|1|||
147196693|NCT03253796|530890499|FG000|Period 1: Run-In|Adverse Event|4|||
147196694|NCT03253796|530890500|FG001|Period 1: Run-In|Adverse Event|0|||
147196695|NCT03253796|530890501|FG002|Period 1: Run-In|Adverse Event|0|||
147196696|NCT03253796|530890502|FG003|Period 1: Run-In|Adverse Event|0|||
147196697|NCT03253796|530890503|FG004|Period 1: Run-In|Adverse Event|0|||
147196698|NCT03253796|530890499|FG000|Period 1: Run-In|Lack of Efficacy|1|||
147196699|NCT03253796|530890500|FG001|Period 1: Run-In|Lack of Efficacy|0|||
147196700|NCT03253796|530890501|FG002|Period 1: Run-In|Lack of Efficacy|0|||
147196701|NCT03253796|530890502|FG003|Period 1: Run-In|Lack of Efficacy|0|||
147196702|NCT03253796|530890503|FG004|Period 1: Run-In|Lack of Efficacy|0|||
147196703|NCT03253796|530890499|FG000|Period 1: Run-In|Lack of Qualifying Event|98|||
147196704|NCT03253796|530890500|FG001|Period 1: Run-In|Lack of Qualifying Event|0|||
147196705|NCT03253796|530890501|FG002|Period 1: Run-In|Lack of Qualifying Event|0|||
147196706|NCT03253796|530890502|FG003|Period 1: Run-In|Lack of Qualifying Event|0|||
147196707|NCT03253796|530890503|FG004|Period 1: Run-In|Lack of Qualifying Event|0|||
147196708|NCT03253796|530890499|FG000|Period 1: Run-In|Protocol Violation|5|||
147196709|NCT03253796|530890500|FG001|Period 1: Run-In|Protocol Violation|0|||
147196710|NCT03253796|530890501|FG002|Period 1: Run-In|Protocol Violation|0|||
147196711|NCT03253796|530890502|FG003|Period 1: Run-In|Protocol Violation|0|||
147196712|NCT03253796|530890503|FG004|Period 1: Run-In|Protocol Violation|0|||
147196713|NCT03253796|530890499|FG000|Period 1: Run-In|Withdrawal by Subject|8|||
147434792|NCT04178967|531758203|FG001|Induction Period|Adverse Event|6|||
147434793|NCT04178967|531758204|FG002|Induction Period|Adverse Event|0|||
147434794|NCT04178967|531758205|FG003|Induction Period|Adverse Event|0|||
147434795|NCT04178967|531758206|FG004|Induction Period|Adverse Event|0|||
147434796|NCT04178967|531758207|FG005|Induction Period|Adverse Event|0|||
147434797|NCT04178967|531758208|FG006|Induction Period|Adverse Event|0|||
147434798|NCT04178967|531758209|FG007|Induction Period|Adverse Event|0|||
147434799|NCT04178967|531758210|FG008|Induction Period|Adverse Event|0|||
147434800|NCT04178967|531758211|FG009|Induction Period|Adverse Event|0|||
147434801|NCT04178967|531758212|FG010|Induction Period|Adverse Event|0|||
147434802|NCT04178967|531758202|FG000|Induction Period|Due to Epidemic/Pandemic|1|||
147434803|NCT04178967|531758203|FG001|Induction Period|Due to Epidemic/Pandemic|4|||
147434804|NCT04178967|531758204|FG002|Induction Period|Due to Epidemic/Pandemic|0|||
147434805|NCT04178967|531758205|FG003|Induction Period|Due to Epidemic/Pandemic|0|||
147434806|NCT04178967|531758206|FG004|Induction Period|Due to Epidemic/Pandemic|0|||
147434807|NCT04178967|531758207|FG005|Induction Period|Due to Epidemic/Pandemic|0|||
147196714|NCT03253796|530890500|FG001|Period 1: Run-In|Withdrawal by Subject|0|||
147196715|NCT03253796|530890501|FG002|Period 1: Run-In|Withdrawal by Subject|0|||
147196716|NCT03253796|530890502|FG003|Period 1: Run-In|Withdrawal by Subject|0|||
147196717|NCT03253796|530890503|FG004|Period 1: Run-In|Withdrawal by Subject|0|||
147196718|NCT03253796|530890499|FG000|Period 2: Withdrawal vs Continued Tx|Adverse Event|0|||
147196719|NCT03253796|530890500|FG001|Period 2: Withdrawal vs Continued Tx|Adverse Event|0|||
147434808|NCT04178967|531758208|FG006|Induction Period|Due to Epidemic/Pandemic|0|||
147649410|NCT04575584|532537339|FG004|Overall Study|Not recorded|0|||
147196720|NCT03253796|530890501|FG002|Period 2: Withdrawal vs Continued Tx|Adverse Event|2|||
147434809|NCT04178967|531758209|FG007|Induction Period|Due to Epidemic/Pandemic|0|||
147434810|NCT04178967|531758210|FG008|Induction Period|Due to Epidemic/Pandemic|0|||
147434811|NCT04178967|531758211|FG009|Induction Period|Due to Epidemic/Pandemic|0|||
147196721|NCT03253796|530890502|FG003|Period 2: Withdrawal vs Continued Tx|Adverse Event|0|||
147196722|NCT03253796|530890503|FG004|Period 2: Withdrawal vs Continued Tx|Adverse Event|0|||
147196723|NCT03253796|530890499|FG000|Period 2: Withdrawal vs Continued Tx|Physician Decision|0|||
147196724|NCT03253796|530890500|FG001|Period 2: Withdrawal vs Continued Tx|Physician Decision|0|||
147196725|NCT03253796|530890501|FG002|Period 2: Withdrawal vs Continued Tx|Physician Decision|1|||
147196726|NCT03253796|530890502|FG003|Period 2: Withdrawal vs Continued Tx|Physician Decision|0|||
147196727|NCT03253796|530890503|FG004|Period 2: Withdrawal vs Continued Tx|Physician Decision|0|||
147196728|NCT03253796|530890499|FG000|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|0|||
147196729|NCT03253796|530890500|FG001|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|0|||
147196730|NCT03253796|530890501|FG002|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|2|||
147196731|NCT03253796|530890502|FG003|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|3|||
147196732|NCT03253796|530890503|FG004|Period 2: Withdrawal vs Continued Tx|Withdrawal by Subject|0|||
147196733|NCT03253796|530890499|FG000|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|0|||
147196734|NCT03253796|530890500|FG001|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|0|||
147196735|NCT03253796|530890501|FG002|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|1|||
147196736|NCT03253796|530890502|FG003|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|0|||
147196737|NCT03253796|530890503|FG004|Period 2: Withdrawal vs Continued Tx|Did not attain inactive disease in Period 1|0|||
147196738|NCT03253796|530890499|FG000|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|0|||
147196739|NCT03253796|530890500|FG001|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|10|||
147196740|NCT03253796|530890501|FG002|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|15|||
147196741|NCT03253796|530890502|FG003|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|38|||
147196742|NCT03253796|530890503|FG004|Period 2: Withdrawal vs Continued Tx|Disease Flare, transitioned to Open-label retreatment|0|||
147196743|NCT03253796|530890499|FG000|Period 2: Open-Label Retreatment|Withdrawal by Subject|0|||
147196744|NCT03253796|530890500|FG001|Period 2: Open-Label Retreatment|Withdrawal by Subject|0|||
147196745|NCT03253796|530890501|FG002|Period 2: Open-Label Retreatment|Withdrawal by Subject|0|||
147196746|NCT03253796|530890502|FG003|Period 2: Open-Label Retreatment|Withdrawal by Subject|0|||
147196747|NCT03253796|530890503|FG004|Period 2: Open-Label Retreatment|Withdrawal by Subject|5|||
147196748|NCT01075243|530890505|FG000|Overall Study|Lost to Follow-up|5|||
147196749|NCT01075243|530890506|FG001|Overall Study|Lost to Follow-up|2|||
147196750|NCT01075243|530890507|FG002|Overall Study|Lost to Follow-up|0|||
147196751|NCT01075243|530890505|FG000|Overall Study|Withdrawal by Subject|1|||
147196752|NCT01075243|530890506|FG001|Overall Study|Withdrawal by Subject|1|||
147196753|NCT01075243|530890507|FG002|Overall Study|Withdrawal by Subject|0|||
147196754|NCT03600909|530890513|FG000|Overall Study|Not treated|0|||
147196755|NCT03600909|530890514|FG001|Overall Study|Not treated|3|||
147196756|NCT03600909|530890515|FG002|Overall Study|Not treated|0|||
147196757|NCT02651675|530890516|FG000|Overall Study|Death|0|||
147196758|NCT02651675|530890517|FG001|Overall Study|Death|0|||
147196759|NCT02651675|530890518|FG002|Overall Study|Death|1|||
147196760|NCT02246530|530890519|FG000|Overall Study|Lost to Follow-up|4|||
147196761|NCT02246530|530890520|FG001|Overall Study|Lost to Follow-up|0|||
147196762|NCT01506596|530890522|FG000|Overall Study|ineligible pathology|1|||
147196763|NCT01488890|530890525|FG000|Overall Study|Serious adverse event|2|||
147196764|NCT01488890|530890526|FG001|Overall Study|Serious adverse event|0|||
147196765|NCT01488890|530890527|FG002|Overall Study|Serious adverse event|0|||
147196766|NCT01488890|530890528|FG003|Overall Study|Serious adverse event|0|||
147196767|NCT01488890|530890525|FG000|Overall Study|Protocol Violation|3|||
147196768|NCT01488890|530890526|FG001|Overall Study|Protocol Violation|0|||
147196769|NCT01488890|530890527|FG002|Overall Study|Protocol Violation|4|||
147196770|NCT01488890|530890528|FG003|Overall Study|Protocol Violation|0|||
147196771|NCT01488890|530890525|FG000|Overall Study|Lost to Follow-up|13|||
147196772|NCT01488890|530890526|FG001|Overall Study|Lost to Follow-up|10|||
147196773|NCT01488890|530890527|FG002|Overall Study|Lost to Follow-up|20|||
147196774|NCT01488890|530890528|FG003|Overall Study|Lost to Follow-up|3|||
147196775|NCT01488890|530890525|FG000|Overall Study|Withdrawal by Subject|14|||
147196776|NCT01488890|530890526|FG001|Overall Study|Withdrawal by Subject|10|||
147196777|NCT01488890|530890527|FG002|Overall Study|Withdrawal by Subject|11|||
147196778|NCT01488890|530890528|FG003|Overall Study|Withdrawal by Subject|2|||
147196779|NCT05712460|530890529|FG000|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
147196780|NCT05712460|530890530|FG001|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
147196781|NCT05712460|530890531|FG002|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
147434812|NCT04178967|531758212|FG010|Induction Period|Due to Epidemic/Pandemic|0|||
147434813|NCT04178967|531758202|FG000|Induction Period|Lack of Efficacy|4|||
147196782|NCT05712460|530890532|FG003|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
147196783|NCT05712460|530890533|FG004|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
147196784|NCT05712460|530890534|FG005|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
147196785|NCT05712460|530890535|FG006|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
147196786|NCT05712460|530890536|FG007|Part 1 Period 3 (4 Days)|Refused further treatment|1|||
147434814|NCT04178967|531758203|FG001|Induction Period|Lack of Efficacy|1|||
147196787|NCT05712460|530890537|FG008|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
147196788|NCT05712460|530890538|FG009|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
147196789|NCT05712460|530890539|FG010|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
147196790|NCT05712460|530890540|FG011|Part 1 Period 3 (4 Days)|Refused further treatment|0|||
147196791|NCT05135767|530890543|FG000|Baseline|Lost to Follow-up|1|||
147196792|NCT05135767|530890544|FG001|Baseline|Lost to Follow-up|1|||
147196793|NCT05135767|530890543|FG000|Baseline|Withdrawal by Subject|0|||
147196794|NCT05135767|530890544|FG001|Baseline|Withdrawal by Subject|2|||
147196795|NCT05135767|530890543|FG000|Active Study Phase|Lost to Follow-up|2|||
147196796|NCT05135767|530890544|FG001|Active Study Phase|Lost to Follow-up|0|||
147196797|NCT02694185|530890545|FG000|Overall Study|Withdrawal by Subject|45|||
147196798|NCT02694185|530890546|FG001|Overall Study|Withdrawal by Subject|0|||
147196799|NCT05082857|530890547|FG000|Overall Study|participants relocated and could not continue|2|||
147196800|NCT05082857|530890548|FG001|Overall Study|participants relocated and could not continue|1|||
147196801|NCT05082857|530890547|FG000|Overall Study|Lost to Follow-up|1|||
147196802|NCT05082857|530890548|FG001|Overall Study|Lost to Follow-up|3|||
147196803|NCT02260934|530890555|FG000|Overall Study|Lost to Follow-up|2|||
147196804|NCT02260934|530890556|FG001|Overall Study|Lost to Follow-up|1|||
147196805|NCT02260934|530890555|FG000|Overall Study|Withdrawal by Subject|0|||
147196806|NCT02260934|530890556|FG001|Overall Study|Withdrawal by Subject|2|||
147196807|NCT02260934|530890555|FG000|Overall Study|Participant Relocated|1|||
147196808|NCT02260934|530890556|FG001|Overall Study|Participant Relocated|0|||
147196809|NCT02260934|530890555|FG000|Overall Study|Site error|0|||
147196810|NCT02260934|530890556|FG001|Overall Study|Site error|1|||
147196811|NCT04366349|530890557|FG000|Overall Study|Withdrawal by Subject|1|||
147196812|NCT04366349|530890558|FG001|Overall Study|Withdrawal by Subject|0|||
147196813|NCT04366349|530890559|FG002|Overall Study|Withdrawal by Subject|0|||
147196814|NCT04366349|530890560|FG003|Overall Study|Withdrawal by Subject|0|||
147196815|NCT04366349|530890561|FG004|Overall Study|Withdrawal by Subject|0|||
147196816|NCT04366349|530890562|FG005|Overall Study|Withdrawal by Subject|0|||
147196817|NCT02532517|530890569|FG000|Overall Study|Did not complete 24-Month visit|4|||
147196818|NCT02532517|530890569|FG000|Overall Study|Failed Angiographic eligibility|1|||
147196819|NCT02532517|530890569|FG000|Overall Study|Lost to Follow-up|4|||
147196820|NCT02532517|530890569|FG000|Overall Study|Withdrawal by Subject|4|||
147196821|NCT02532517|530890569|FG000|Overall Study|Death|4|||
147196822|NCT05138653|530890572|FG000|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|1|||
147196823|NCT05138653|530890573|FG001|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
147196824|NCT05138653|530890574|FG002|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
147196825|NCT05138653|530890575|FG003|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
147196826|NCT05138653|530890576|FG004|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
147196827|NCT05138653|530890577|FG005|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
147196828|NCT05138653|530890578|FG006|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
147196829|NCT05138653|530890579|FG007|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
147196830|NCT05138653|530890580|FG008|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
147196831|NCT05138653|530890581|FG009|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
147196832|NCT05138653|530890582|FG010|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
147196833|NCT05138653|530890583|FG011|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
147434815|NCT04178967|531758204|FG002|Induction Period|Lack of Efficacy|0|||
147434816|NCT04178967|531758205|FG003|Induction Period|Lack of Efficacy|0|||
147434817|NCT04178967|531758206|FG004|Induction Period|Lack of Efficacy|0|||
147434818|NCT04178967|531758207|FG005|Induction Period|Lack of Efficacy|0|||
147434819|NCT04178967|531758208|FG006|Induction Period|Lack of Efficacy|0|||
147434820|NCT04178967|531758209|FG007|Induction Period|Lack of Efficacy|0|||
147434821|NCT04178967|531758210|FG008|Induction Period|Lack of Efficacy|0|||
147434822|NCT04178967|531758211|FG009|Induction Period|Lack of Efficacy|0|||
147434823|NCT04178967|531758212|FG010|Induction Period|Lack of Efficacy|0|||
147434824|NCT04178967|531758202|FG000|Induction Period|Protocol Violation|0|||
147434825|NCT04178967|531758203|FG001|Induction Period|Protocol Violation|6|||
147434826|NCT04178967|531758204|FG002|Induction Period|Protocol Violation|0|||
147434827|NCT04178967|531758205|FG003|Induction Period|Protocol Violation|0|||
147434828|NCT04178967|531758206|FG004|Induction Period|Protocol Violation|0|||
147434829|NCT04178967|531758207|FG005|Induction Period|Protocol Violation|0|||
147434830|NCT04178967|531758208|FG006|Induction Period|Protocol Violation|0|||
147434831|NCT04178967|531758209|FG007|Induction Period|Protocol Violation|0|||
147434832|NCT04178967|531758210|FG008|Induction Period|Protocol Violation|0|||
147434833|NCT04178967|531758211|FG009|Induction Period|Protocol Violation|0|||
147434834|NCT04178967|531758212|FG010|Induction Period|Protocol Violation|0|||
147434835|NCT04178967|531758202|FG000|Induction Period|Withdrawal by Subject|6|||
147434836|NCT04178967|531758203|FG001|Induction Period|Withdrawal by Subject|4|||
147434837|NCT04178967|531758204|FG002|Induction Period|Withdrawal by Subject|0|||
147434838|NCT04178967|531758205|FG003|Induction Period|Withdrawal by Subject|0|||
147434839|NCT04178967|531758206|FG004|Induction Period|Withdrawal by Subject|0|||
147434840|NCT04178967|531758207|FG005|Induction Period|Withdrawal by Subject|0|||
147196834|NCT05138653|530890584|FG012|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
147196835|NCT05138653|530890585|FG013|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
147196836|NCT05138653|530890586|FG014|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
147196837|NCT05138653|530890587|FG015|Single Ascending Dose (Up to 13 Weeks)|Adverse Event|0|||
147196838|NCT05138653|530890572|FG000|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
147196839|NCT05138653|530890573|FG001|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|1|||
147196840|NCT05138653|530890574|FG002|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
147196841|NCT05138653|530890575|FG003|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
147196842|NCT05138653|530890576|FG004|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
147196843|NCT05138653|530890577|FG005|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
147196844|NCT05138653|530890578|FG006|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
147196845|NCT05138653|530890579|FG007|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
147196846|NCT05138653|530890580|FG008|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|1|||
147196847|NCT05138653|530890581|FG009|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
147196848|NCT05138653|530890582|FG010|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
147196849|NCT05138653|530890583|FG011|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
147196850|NCT05138653|530890584|FG012|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
147196851|NCT05138653|530890585|FG013|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
147196852|NCT05138653|530890586|FG014|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
147196853|NCT05138653|530890587|FG015|Single Ascending Dose (Up to 13 Weeks)|Investigator's Discretion|0|||
147196854|NCT05138653|530890572|FG000|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
147196855|NCT05138653|530890573|FG001|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|1|||
147196856|NCT05138653|530890574|FG002|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
147196857|NCT05138653|530890575|FG003|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
147196858|NCT05138653|530890576|FG004|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|1|||
147196859|NCT05138653|530890577|FG005|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
147196860|NCT05138653|530890578|FG006|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
147196861|NCT05138653|530890579|FG007|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
147196862|NCT05138653|530890580|FG008|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
147196863|NCT05138653|530890581|FG009|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
147196864|NCT05138653|530890582|FG010|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
147196865|NCT05138653|530890583|FG011|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
147196866|NCT05138653|530890584|FG012|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
147196867|NCT05138653|530890585|FG013|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
147196868|NCT05138653|530890586|FG014|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
147196869|NCT05138653|530890587|FG015|Single Ascending Dose (Up to 13 Weeks)|Withdrawal of Consent|0|||
147196870|NCT05138653|530890572|FG000|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
147196871|NCT05138653|530890573|FG001|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
147196872|NCT05138653|530890574|FG002|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
147196873|NCT05138653|530890575|FG003|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
147196874|NCT05138653|530890576|FG004|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
147196875|NCT05138653|530890577|FG005|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
147196876|NCT05138653|530890578|FG006|Single Ascending Dose (Up to 13 Weeks)|Other|1|||
147196877|NCT05138653|530890579|FG007|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
147196878|NCT05138653|530890580|FG008|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
147196879|NCT05138653|530890581|FG009|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
147534809|NCT00807040|532113122|FG001|Overall Study|Withdrawal by Subject|6|||
147534810|NCT00807040|532113121|FG000|Overall Study|Lost to Follow-up|4|||
147534811|NCT00807040|532113122|FG001|Overall Study|Lost to Follow-up|6|||
147534812|NCT00890409|532113125|FG000|Overall Study|Lost to Follow-up|20|||
147534813|NCT00890409|532113126|FG001|Overall Study|Lost to Follow-up|21|||
147534814|NCT02242942|532113134|FG000|Overall Study|Death|17|||
147534815|NCT02242942|532113135|FG001|Overall Study|Death|20|||
147534816|NCT02242942|532113136|FG002|Overall Study|Death|2|||
147534817|NCT02242942|532113134|FG000|Overall Study|Physician Decision|1|||
147534818|NCT02242942|532113135|FG001|Overall Study|Physician Decision|0|||
147534819|NCT02242942|532113136|FG002|Overall Study|Physician Decision|0|||
147534820|NCT02242942|532113134|FG000|Overall Study|Withdrawal by Subject|8|||
147534821|NCT02242942|532113135|FG001|Overall Study|Withdrawal by Subject|10|||
147534822|NCT02242942|532113136|FG002|Overall Study|Withdrawal by Subject|0|||
147534823|NCT02242942|532113134|FG000|Overall Study|On-going in Study|190|||
147534824|NCT02242942|532113135|FG001|Overall Study|On-going in Study|186|||
147534825|NCT02242942|532113136|FG002|Overall Study|On-going in Study|11|||
147534826|NCT04882085|532113137|FG000|Overall Study|Death|6|||
147534827|NCT04882085|532113138|FG001|Overall Study|Death|9|||
147534828|NCT04882085|532113137|FG000|Overall Study|Withdrawal by Subject|0|||
147534829|NCT04882085|532113138|FG001|Overall Study|Withdrawal by Subject|3|||
147534830|NCT04882085|532113137|FG000|Overall Study|Randomized not treated|1|||
147196880|NCT05138653|530890582|FG010|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
147196881|NCT05138653|530890583|FG011|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
147196882|NCT05138653|530890584|FG012|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
147196883|NCT05138653|530890585|FG013|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
147196884|NCT05138653|530890586|FG014|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
147196885|NCT05138653|530890587|FG015|Single Ascending Dose (Up to 13 Weeks)|Other|0|||
147196886|NCT05138653|530890572|FG000|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
147196887|NCT05138653|530890573|FG001|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
147196888|NCT05138653|530890574|FG002|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
147196889|NCT05138653|530890575|FG003|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
147196890|NCT05138653|530890576|FG004|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
147196891|NCT05138653|530890577|FG005|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
147196892|NCT05138653|530890578|FG006|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
147196893|NCT05138653|530890579|FG007|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
147196894|NCT05138653|530890580|FG008|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
147196895|NCT05138653|530890581|FG009|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
147196896|NCT05138653|530890582|FG010|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|1|||
147196897|NCT05138653|530890583|FG011|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
147196898|NCT05138653|530890584|FG012|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|1|||
147196899|NCT05138653|530890585|FG013|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
147196900|NCT05138653|530890586|FG014|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|1|||
147196901|NCT05138653|530890587|FG015|Multiple Ascending Dose (Up to 12 Weeks)|Adverse Event|0|||
147196902|NCT05138653|530890572|FG000|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
147196903|NCT05138653|530890573|FG001|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
147196904|NCT05138653|530890574|FG002|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
147196905|NCT05138653|530890575|FG003|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
147196906|NCT05138653|530890576|FG004|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
147196907|NCT05138653|530890577|FG005|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
147196908|NCT05138653|530890578|FG006|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
147196909|NCT05138653|530890579|FG007|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
147196910|NCT05138653|530890580|FG008|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
147196911|NCT05138653|530890581|FG009|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
147196912|NCT05138653|530890582|FG010|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
147434841|NCT04178967|531758208|FG006|Induction Period|Withdrawal by Subject|0|||
147434842|NCT04178967|531758209|FG007|Induction Period|Withdrawal by Subject|0|||
147534831|NCT04882085|532113138|FG001|Overall Study|Randomized not treated|0|||
147534832|NCT05681715|532113146|FG000|Training Period (6-weeks)|Adverse Event|3|||
147434843|NCT04178967|531758210|FG008|Induction Period|Withdrawal by Subject|0|||
147534833|NCT05681715|532113147|FG001|Training Period (6-weeks)|Adverse Event|0|||
147534834|NCT05681715|532113148|FG002|Training Period (6-weeks)|Adverse Event|0|||
147534835|NCT05681715|532113146|FG000|Training Period (6-weeks)|Consent withdrawn by participant (not due to AE)|1|||
147534836|NCT05681715|532113147|FG001|Training Period (6-weeks)|Consent withdrawn by participant (not due to AE)|0|||
147534837|NCT05681715|532113148|FG002|Training Period (6-weeks)|Consent withdrawn by participant (not due to AE)|0|||
147534838|NCT05681715|532113146|FG000|Training Period (6-weeks)|Not Eligible for SA but continued in study|3|||
147534839|NCT05681715|532113147|FG001|Training Period (6-weeks)|Not Eligible for SA but continued in study|0|||
147534840|NCT05681715|532113148|FG002|Training Period (6-weeks)|Not Eligible for SA but continued in study|0|||
147534841|NCT05681715|532113146|FG000|Self-administration Period 1 (6 Weeks)|Diagnosis change to amyotrophic lateral sclerosis|0|||
147595939|NCT03096847|532338753|FG002|Overall Study|Withdrawal by Subject|12|||
147434844|NCT04178967|531758211|FG009|Induction Period|Withdrawal by Subject|0|||
147434845|NCT04178967|531758212|FG010|Induction Period|Withdrawal by Subject|0|||
147434846|NCT04178967|531758202|FG000|Induction Period|Lost to Follow-up|2|||
147434847|NCT04178967|531758203|FG001|Induction Period|Lost to Follow-up|0|||
147434848|NCT04178967|531758204|FG002|Induction Period|Lost to Follow-up|0|||
147434849|NCT04178967|531758205|FG003|Induction Period|Lost to Follow-up|0|||
147434850|NCT04178967|531758206|FG004|Induction Period|Lost to Follow-up|0|||
147434851|NCT04178967|531758207|FG005|Induction Period|Lost to Follow-up|0|||
147434852|NCT04178967|531758208|FG006|Induction Period|Lost to Follow-up|0|||
147434853|NCT04178967|531758209|FG007|Induction Period|Lost to Follow-up|0|||
147434854|NCT04178967|531758210|FG008|Induction Period|Lost to Follow-up|0|||
147434855|NCT04178967|531758211|FG009|Induction Period|Lost to Follow-up|0|||
147434856|NCT04178967|531758212|FG010|Induction Period|Lost to Follow-up|0|||
147434857|NCT04178967|531758202|FG000|Induction Period|Participant Missed Study Visits|0|||
147434858|NCT04178967|531758203|FG001|Induction Period|Participant Missed Study Visits|1|||
147434859|NCT04178967|531758204|FG002|Induction Period|Participant Missed Study Visits|0|||
147434860|NCT04178967|531758205|FG003|Induction Period|Participant Missed Study Visits|0|||
147434861|NCT04178967|531758206|FG004|Induction Period|Participant Missed Study Visits|0|||
147434862|NCT04178967|531758207|FG005|Induction Period|Participant Missed Study Visits|0|||
147196913|NCT05138653|530890583|FG011|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
147196914|NCT05138653|530890584|FG012|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
147196915|NCT05138653|530890585|FG013|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
147196916|NCT05138653|530890586|FG014|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|0|||
147196917|NCT05138653|530890587|FG015|Multiple Ascending Dose (Up to 12 Weeks)|Withdrawal of Consent|1|||
147196918|NCT05138653|530890572|FG000|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
147434863|NCT04178967|531758208|FG006|Induction Period|Participant Missed Study Visits|0|||
147434864|NCT04178967|531758209|FG007|Induction Period|Participant Missed Study Visits|0|||
147434865|NCT04178967|531758210|FG008|Induction Period|Participant Missed Study Visits|0|||
147434866|NCT04178967|531758211|FG009|Induction Period|Participant Missed Study Visits|0|||
147434867|NCT04178967|531758212|FG010|Induction Period|Participant Missed Study Visits|0|||
147434868|NCT04178967|531758202|FG000|Maintenance Blinded Treatment Period|Adverse Event|0|||
147434869|NCT04178967|531758203|FG001|Maintenance Blinded Treatment Period|Adverse Event|0|||
147434870|NCT04178967|531758204|FG002|Maintenance Blinded Treatment Period|Adverse Event|0|||
147434871|NCT04178967|531758205|FG003|Maintenance Blinded Treatment Period|Adverse Event|0|||
147434872|NCT04178967|531758206|FG004|Maintenance Blinded Treatment Period|Adverse Event|0|||
147434873|NCT04178967|531758207|FG005|Maintenance Blinded Treatment Period|Adverse Event|1|||
147434874|NCT04178967|531758208|FG006|Maintenance Blinded Treatment Period|Adverse Event|2|||
147434875|NCT04178967|531758209|FG007|Maintenance Blinded Treatment Period|Adverse Event|1|||
147434876|NCT04178967|531758210|FG008|Maintenance Blinded Treatment Period|Adverse Event|0|||
147434877|NCT04178967|531758211|FG009|Maintenance Blinded Treatment Period|Adverse Event|0|||
147434878|NCT04178967|531758212|FG010|Maintenance Blinded Treatment Period|Adverse Event|0|||
147434879|NCT04178967|531758202|FG000|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
147434880|NCT04178967|531758203|FG001|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
147434881|NCT04178967|531758204|FG002|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
147434882|NCT04178967|531758205|FG003|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
147434883|NCT04178967|531758206|FG004|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
147434884|NCT04178967|531758207|FG005|Maintenance Blinded Treatment Period|Lack of Efficacy|1|||
147434885|NCT04178967|531758208|FG006|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
147434886|NCT04178967|531758209|FG007|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
147434887|NCT04178967|531758210|FG008|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
147434888|NCT04178967|531758211|FG009|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
147434889|NCT04178967|531758212|FG010|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
147434890|NCT04178967|531758202|FG000|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
147434891|NCT04178967|531758203|FG001|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
147434892|NCT04178967|531758204|FG002|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
147434893|NCT04178967|531758205|FG003|Maintenance Blinded Treatment Period|Lost to Follow-up|1|||
147434894|NCT04178967|531758206|FG004|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
147434895|NCT04178967|531758207|FG005|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
147434896|NCT04178967|531758208|FG006|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
147434897|NCT04178967|531758209|FG007|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
147434898|NCT04178967|531758210|FG008|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
147434899|NCT04178967|531758211|FG009|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
147434900|NCT04178967|531758212|FG010|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
147434901|NCT04178967|531758202|FG000|Maintenance Blinded Treatment Period|Physician Decision|0|||
147434902|NCT04178967|531758203|FG001|Maintenance Blinded Treatment Period|Physician Decision|0|||
147434903|NCT04178967|531758204|FG002|Maintenance Blinded Treatment Period|Physician Decision|0|||
147434904|NCT04178967|531758205|FG003|Maintenance Blinded Treatment Period|Physician Decision|0|||
147434905|NCT04178967|531758206|FG004|Maintenance Blinded Treatment Period|Physician Decision|0|||
147434906|NCT04178967|531758207|FG005|Maintenance Blinded Treatment Period|Physician Decision|0|||
147434907|NCT04178967|531758208|FG006|Maintenance Blinded Treatment Period|Physician Decision|1|||
147434908|NCT04178967|531758209|FG007|Maintenance Blinded Treatment Period|Physician Decision|0|||
147434909|NCT04178967|531758210|FG008|Maintenance Blinded Treatment Period|Physician Decision|0|||
147434910|NCT04178967|531758211|FG009|Maintenance Blinded Treatment Period|Physician Decision|0|||
147434911|NCT04178967|531758212|FG010|Maintenance Blinded Treatment Period|Physician Decision|0|||
147434912|NCT04178967|531758202|FG000|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
147434913|NCT04178967|531758203|FG001|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
147434914|NCT04178967|531758204|FG002|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
147434915|NCT04178967|531758205|FG003|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
147434916|NCT04178967|531758206|FG004|Maintenance Blinded Treatment Period|Withdrawal by Subject|1|||
147434917|NCT04178967|531758207|FG005|Maintenance Blinded Treatment Period|Withdrawal by Subject|2|||
147434918|NCT04178967|531758208|FG006|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
147434919|NCT04178967|531758209|FG007|Maintenance Blinded Treatment Period|Withdrawal by Subject|4|||
147434920|NCT04178967|531758210|FG008|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
147434921|NCT04178967|531758211|FG009|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
147196919|NCT05138653|530890573|FG001|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
147196920|NCT05138653|530890574|FG002|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
147196921|NCT05138653|530890575|FG003|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
147196922|NCT05138653|530890576|FG004|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
147196923|NCT05138653|530890577|FG005|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
147196924|NCT05138653|530890578|FG006|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
147196925|NCT05138653|530890579|FG007|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
147196926|NCT05138653|530890580|FG008|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
147196927|NCT05138653|530890581|FG009|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
147196928|NCT05138653|530890582|FG010|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
147196929|NCT05138653|530890583|FG011|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
147196930|NCT05138653|530890584|FG012|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
147196931|NCT05138653|530890585|FG013|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|1|||
147196932|NCT05138653|530890586|FG014|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
147196933|NCT05138653|530890587|FG015|Multiple Ascending Dose (Up to 12 Weeks)|Disciplinary Reason|0|||
147196934|NCT02331134|530890588|FG000|Overall Study|Withdrawal by Subject|1|||
147196935|NCT05967260|530890589|FG000|First Arm Start-up Visit (4 Weeks)|Dexcom CGM failed while participant out of town without ability to receive a replacement|0|||
147196936|NCT05967260|530890590|FG001|First Arm Start-up Visit (4 Weeks)|Dexcom CGM failed while participant out of town without ability to receive a replacement|1|||
147196937|NCT01350999|530890593|FG000|Overall Study|Adverse Event|4|||
147196938|NCT01350999|530890594|FG001|Overall Study|Adverse Event|9|||
147196939|NCT01350999|530890595|FG002|Overall Study|Adverse Event|10|||
147196940|NCT01350999|530890593|FG000|Overall Study|Voluntary withdrawal|3|||
147196941|NCT01350999|530890594|FG001|Overall Study|Voluntary withdrawal|4|||
147196942|NCT01350999|530890595|FG002|Overall Study|Voluntary withdrawal|6|||
147196943|NCT01350999|530890593|FG000|Overall Study|Difficulty Making it to Study Visit|1|||
147196944|NCT01350999|530890594|FG001|Overall Study|Difficulty Making it to Study Visit|1|||
147196945|NCT01350999|530890595|FG002|Overall Study|Difficulty Making it to Study Visit|5|||
147196946|NCT00079417|530893003|FG000|Overall Study|Physician Decision|2|||
147196947|NCT00079417|530893003|FG000|Overall Study|Ineligible|7|||
147196948|NCT01615939|530893004|FG000|Overall Study|Lost to Follow-up|5|||
147196949|NCT01615939|530893005|FG001|Overall Study|Lost to Follow-up|0|||
147196950|NCT02121535|530893009|FG000|Period 1 (8 Trial Days)|Withdrawal by Subject|0|||
147196951|NCT02121535|530893010|FG001|Period 1 (8 Trial Days)|Withdrawal by Subject|1|||
147196952|NCT02121535|530893009|FG000|Period 3 (8 Trial Days)|Withdrawal by Subject|1|||
147196953|NCT02121535|530893010|FG001|Period 3 (8 Trial Days)|Withdrawal by Subject|0|||
147196954|NCT00092417|530893011|FG000|Overall Study|Lost to Follow-up|2|||
147196955|NCT00092417|530893012|FG001|Overall Study|Lost to Follow-up|0|||
147196956|NCT00092417|530893011|FG000|Overall Study|Withdrawal by Subject|2|||
147196957|NCT00092417|530893012|FG001|Overall Study|Withdrawal by Subject|1|||
147196958|NCT00092417|530893011|FG000|Overall Study|Other|1|||
147196959|NCT00092417|530893012|FG001|Overall Study|Other|0|||
147434922|NCT04178967|531758212|FG010|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
147434923|NCT04178967|531758202|FG000|Maintenance Blinded Treatment Period|Sponsor Decision|0|||
147434924|NCT04178967|531758203|FG001|Maintenance Blinded Treatment Period|Sponsor Decision|0|||
147434925|NCT04178967|531758204|FG002|Maintenance Blinded Treatment Period|Sponsor Decision|1|||
147434926|NCT04178967|531758205|FG003|Maintenance Blinded Treatment Period|Sponsor Decision|1|||
147434927|NCT04178967|531758206|FG004|Maintenance Blinded Treatment Period|Sponsor Decision|1|||
147434928|NCT04178967|531758207|FG005|Maintenance Blinded Treatment Period|Sponsor Decision|1|||
147434929|NCT04178967|531758208|FG006|Maintenance Blinded Treatment Period|Sponsor Decision|4|||
147434930|NCT04178967|531758209|FG007|Maintenance Blinded Treatment Period|Sponsor Decision|6|||
147434931|NCT04178967|531758210|FG008|Maintenance Blinded Treatment Period|Sponsor Decision|0|||
147434932|NCT04178967|531758211|FG009|Maintenance Blinded Treatment Period|Sponsor Decision|0|||
147434933|NCT04178967|531758212|FG010|Maintenance Blinded Treatment Period|Sponsor Decision|0|||
147434934|NCT04178967|531758202|FG000|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
147434935|NCT04178967|531758203|FG001|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
147434936|NCT04178967|531758204|FG002|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
147434937|NCT04178967|531758205|FG003|Maintenance Blinded Treatment Period|Entered Escape Arm|1|||
147434938|NCT04178967|531758206|FG004|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
147434939|NCT04178967|531758207|FG005|Maintenance Blinded Treatment Period|Entered Escape Arm|3|||
147434940|NCT04178967|531758208|FG006|Maintenance Blinded Treatment Period|Entered Escape Arm|1|||
147434941|NCT04178967|531758209|FG007|Maintenance Blinded Treatment Period|Entered Escape Arm|6|||
147434942|NCT04178967|531758210|FG008|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
147434943|NCT04178967|531758211|FG009|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
147434944|NCT04178967|531758212|FG010|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
147434945|NCT04178967|531758202|FG000|Maintenance Open Label Escape Arm|Adverse Event|0|||
147434946|NCT04178967|531758203|FG001|Maintenance Open Label Escape Arm|Adverse Event|0|||
147434947|NCT04178967|531758204|FG002|Maintenance Open Label Escape Arm|Adverse Event|0|||
147196960|NCT01520506|530893013|FG000|Overall Study|Missed Visit|4|||
147196961|NCT01520506|530893013|FG000|Overall Study|Lost to Follow-up|1|||
147196962|NCT01520506|530893013|FG000|Overall Study|Withdrawal by Subject|1|||
147196963|NCT00425269|530893014|FG000|Overall Study|Pregnancy|5|||
147196964|NCT00425269|530893015|FG001|Overall Study|Pregnancy|7|||
147534842|NCT05681715|532113147|FG001|Self-administration Period 1 (6 Weeks)|Diagnosis change to amyotrophic lateral sclerosis|1|||
147534843|NCT05681715|532113148|FG002|Self-administration Period 1 (6 Weeks)|Diagnosis change to amyotrophic lateral sclerosis|0|||
147534844|NCT05681715|532113146|FG000|Self-administration Period 1 (6 Weeks)|Consent withdrawn by participant (not due to AE)|0|||
147534845|NCT05681715|532113147|FG001|Self-administration Period 1 (6 Weeks)|Consent withdrawn by participant (not due to AE)|0|||
147534846|NCT05681715|532113148|FG002|Self-administration Period 1 (6 Weeks)|Consent withdrawn by participant (not due to AE)|1|||
147534847|NCT05681715|532113146|FG000|Self-administration Period 1 (6 Weeks)|Adverse Event|0|||
147534848|NCT05681715|532113147|FG001|Self-administration Period 1 (6 Weeks)|Adverse Event|1|||
147534849|NCT05681715|532113148|FG002|Self-administration Period 1 (6 Weeks)|Adverse Event|0|||
147534850|NCT05681715|532113146|FG000|Self-administration Period 1 (6 Weeks)|Participant became ineligible for SA|0|||
147534851|NCT05681715|532113147|FG001|Self-administration Period 1 (6 Weeks)|Participant became ineligible for SA|1|||
147534852|NCT05681715|532113148|FG002|Self-administration Period 1 (6 Weeks)|Participant became ineligible for SA|0|||
147196965|NCT00425269|530893014|FG000|Overall Study|Lost to Follow-up|9|||
147196966|NCT00425269|530893015|FG001|Overall Study|Lost to Follow-up|9|||
147196967|NCT00425269|530893014|FG000|Overall Study|moved or medical reason|5|||
147196968|NCT00425269|530893015|FG001|Overall Study|moved or medical reason|4|||
147196969|NCT01084655|530893016|FG000|Overall Study|Radiographic disease progression|3|||
147196970|NCT01084655|530893017|FG001|Overall Study|Radiographic disease progression|2|||
147196971|NCT01084655|530893018|FG002|Overall Study|Radiographic disease progression|8|||
147196972|NCT01084655|530893016|FG000|Overall Study|Withdrawal by Subject|1|||
147196973|NCT01084655|530893017|FG001|Overall Study|Withdrawal by Subject|0|||
147196974|NCT01084655|530893018|FG002|Overall Study|Withdrawal by Subject|4|||
147196975|NCT01084655|530893016|FG000|Overall Study|Adverse Event|2|||
147196976|NCT01084655|530893017|FG001|Overall Study|Adverse Event|1|||
147196977|NCT01084655|530893018|FG002|Overall Study|Adverse Event|2|||
147196978|NCT01084655|530893016|FG000|Overall Study|Other|0|||
147196979|NCT01084655|530893017|FG001|Overall Study|Other|3|||
147196980|NCT01084655|530893018|FG002|Overall Study|Other|2|||
147196981|NCT01084655|530893016|FG000|Overall Study|Symptomatic deterioration|0|||
147196982|NCT01084655|530893017|FG001|Overall Study|Symptomatic deterioration|0|||
147196983|NCT01084655|530893018|FG002|Overall Study|Symptomatic deterioration|2|||
147196984|NCT01084655|530893016|FG000|Overall Study|Prostate-specificAntigen(PSA)progression|0|||
147196985|NCT01084655|530893017|FG001|Overall Study|Prostate-specificAntigen(PSA)progression|0|||
147196986|NCT01084655|530893018|FG002|Overall Study|Prostate-specificAntigen(PSA)progression|1|||
147196987|NCT00906204|530893019|FG000|Primary Endpoint (Early Safety)|Physician Decision|1|||
147196988|NCT00906204|530893020|FG001|Primary Endpoint (Early Safety)|Physician Decision|0|||
147196989|NCT00906204|530893019|FG000|Primary Endpoint (Early Safety)|Untransplantable donor kidney|0|||
147196990|NCT00906204|530893020|FG001|Primary Endpoint (Early Safety)|Untransplantable donor kidney|1|||
147196991|NCT00906204|530893019|FG000|Primary Endpoint (Early Safety)|Withdrawal by Subject|1|||
147196992|NCT00906204|530893020|FG001|Primary Endpoint (Early Safety)|Withdrawal by Subject|0|||
147196993|NCT00906204|530893019|FG000|Secondary Endpoints (Long-term Safety)|Adverse Event|2|||
147196994|NCT00906204|530893020|FG001|Secondary Endpoints (Long-term Safety)|Adverse Event|2|||
147196995|NCT00906204|530893019|FG000|Secondary Endpoints (Long-term Safety)|Death|0|||
147196996|NCT00906204|530893020|FG001|Secondary Endpoints (Long-term Safety)|Death|1|||
147196997|NCT03181932|530893023|FG000|Period 1 (Double-blind Period)|Adverse Event|5|||
147196998|NCT03181932|530893024|FG001|Period 1 (Double-blind Period)|Adverse Event|1|||
147196999|NCT03181932|530893023|FG000|Period 1 (Double-blind Period)|Lost to Follow-up|0|||
147197000|NCT03181932|530893024|FG001|Period 1 (Double-blind Period)|Lost to Follow-up|1|||
147197001|NCT03181932|530893023|FG000|Period 1 (Double-blind Period)|Protocol Violation|1|||
147197002|NCT03181932|530893024|FG001|Period 1 (Double-blind Period)|Protocol Violation|2|||
147197003|NCT03181932|530893023|FG000|Period 1 (Double-blind Period)|Withdrawal by Subject|5|||
147534853|NCT05681715|532113146|FG000|Self-administration Period 1 (6 Weeks)|Missed infusion at Visit 13, SA Period1 incomplete|0|||
147534854|NCT05681715|532113147|FG001|Self-administration Period 1 (6 Weeks)|Missed infusion at Visit 13, SA Period1 incomplete|2|||
147534855|NCT05681715|532113148|FG002|Self-administration Period 1 (6 Weeks)|Missed infusion at Visit 13, SA Period1 incomplete|0|||
147534856|NCT02951130|532113149|FG000|Overall Study|Protocol Violation|1|||
147534857|NCT02951130|532113150|FG001|Overall Study|Protocol Violation|1|||
147534858|NCT02756182|532113151|FG000|Overall Study|StudyTechnical Difficulties|4|||
147197004|NCT03181932|530893024|FG001|Period 1 (Double-blind Period)|Withdrawal by Subject|9|||
147197005|NCT03181932|530893023|FG000|Period 2 (Open-label Period)|Adverse Event|1|||
147197006|NCT03181932|530893024|FG001|Period 2 (Open-label Period)|Adverse Event|6|||
147197007|NCT03181932|530893023|FG000|Period 2 (Open-label Period)|Lost to Follow-up|0|||
147197008|NCT03181932|530893024|FG001|Period 2 (Open-label Period)|Lost to Follow-up|1|||
147197009|NCT03181932|530893023|FG000|Period 2 (Open-label Period)|Protocol Violation|3|||
147197010|NCT03181932|530893024|FG001|Period 2 (Open-label Period)|Protocol Violation|1|||
147197011|NCT03181932|530893023|FG000|Period 2 (Open-label Period)|Withdrawal by Subject|2|||
147197012|NCT03181932|530893024|FG001|Period 2 (Open-label Period)|Withdrawal by Subject|5|||
147197013|NCT03181932|530893023|FG000|Period 2 (Open-label Period)|Reason missing|2|||
147197014|NCT03181932|530893024|FG001|Period 2 (Open-label Period)|Reason missing|0|||
147197015|NCT03304626|530893025|FG000|Overall Study|Adverse Event|1|||
147197016|NCT03304626|530893026|FG001|Overall Study|Adverse Event|0|||
147197017|NCT03304626|530893025|FG000|Overall Study|Lack of Efficacy|1|||
147197018|NCT03304626|530893026|FG001|Overall Study|Lack of Efficacy|1|||
147197019|NCT00744497|530893027|FG000|Overall Study|Withdrawal by Subject|21|||
147197020|NCT00744497|530893028|FG001|Overall Study|Withdrawal by Subject|18|||
147197021|NCT00744497|530893027|FG000|Overall Study|Death|11|||
147197022|NCT00744497|530893028|FG001|Overall Study|Death|9|||
147534859|NCT01003691|532113152|FG000|Overall Study|Adverse Event|0|||
147534860|NCT01003691|532113153|FG001|Overall Study|Adverse Event|0|||
147534861|NCT01003691|532113154|FG002|Overall Study|Adverse Event|0|||
147534862|NCT01003691|532113155|FG003|Overall Study|Adverse Event|1|||
147197023|NCT00744497|530893027|FG000|Overall Study|Lost to Follow-up|4|||
147197024|NCT00744497|530893028|FG001|Overall Study|Lost to Follow-up|2|||
147197025|NCT00744497|530893027|FG000|Overall Study|Poor compliance/noncompliance|9|||
147197026|NCT00744497|530893028|FG001|Overall Study|Poor compliance/noncompliance|5|||
147197027|NCT00744497|530893027|FG000|Overall Study|No longer meets study criteria|7|||
147197028|NCT00744497|530893028|FG001|Overall Study|No longer meets study criteria|3|||
147197029|NCT00744497|530893027|FG000|Overall Study|Administrative Reason By Sponsor|25|||
147534863|NCT00828009|532113160|FG000|Step 1 - Chemo RT/Consolidation Chemo|Adverse Event|10|||
147534864|NCT00828009|532113160|FG000|Step 1 - Chemo RT/Consolidation Chemo|Death|2|||
147534865|NCT00828009|532113160|FG000|Step 1 - Chemo RT/Consolidation Chemo|Withdrawal by Subject|3|||
147534866|NCT00828009|532113160|FG000|Step 1 - Chemo RT/Consolidation Chemo|Progressive disease|11|||
147534867|NCT00828009|532113160|FG000|Step 1 - Chemo RT/Consolidation Chemo|Complicating disease|1|||
147534868|NCT00828009|532113160|FG000|Step 1 - Chemo RT/Consolidation Chemo|No show/Patient moved|2|||
147534869|NCT00828009|532113160|FG000|Step 1 - Chemo RT/Consolidation Chemo|Never started therapy|2|||
147534870|NCT00828009|532113160|FG000|Step 2 - Maintenance Therapy|Progressive disease|12|||
147534871|NCT00828009|532113160|FG000|Step 2 - Maintenance Therapy|Adverse Event|13|||
147534872|NCT00828009|532113160|FG000|Step 2 - Maintenance Therapy|Death|1|||
147534873|NCT00828009|532113160|FG000|Step 2 - Maintenance Therapy|Withdrawal by Subject|4|||
147534874|NCT00828009|532113160|FG000|Step 2 - Maintenance Therapy|Complicating disease|2|||
147534875|NCT00828009|532113160|FG000|Step 2 - Maintenance Therapy|Other|1|||
147534876|NCT04814654|532113163|FG000|Overall Study|due to administrative issues, implementation partner was unable to continue study activities.|170|||
147534877|NCT04814654|532113164|FG001|Overall Study|due to administrative issues, implementation partner was unable to continue study activities.|167|||
147534878|NCT04814654|532113165|FG002|Overall Study|due to administrative issues, implementation partner was unable to continue study activities.|157|||
147534879|NCT02207413|532113168|FG000|Overall Study|Withdrawal by Subject|1|||
147534880|NCT02207413|532113169|FG001|Overall Study|Withdrawal by Subject|0|||
147534881|NCT02207413|532113170|FG002|Overall Study|Withdrawal by Subject|0|||
147534882|NCT02207413|532113171|FG003|Overall Study|Withdrawal by Subject|0|||
147534883|NCT02207413|532113172|FG004|Overall Study|Withdrawal by Subject|3|||
147534884|NCT02207413|532113173|FG005|Overall Study|Withdrawal by Subject|7|||
147534885|NCT02207413|532113168|FG000|Overall Study|Lost to Follow-up|0|||
147534886|NCT02207413|532113169|FG001|Overall Study|Lost to Follow-up|0|||
147534887|NCT02207413|532113170|FG002|Overall Study|Lost to Follow-up|0|||
147534888|NCT02207413|532113171|FG003|Overall Study|Lost to Follow-up|1|||
147534889|NCT02207413|532113172|FG004|Overall Study|Lost to Follow-up|1|||
147534890|NCT02207413|532113173|FG005|Overall Study|Lost to Follow-up|5|||
147534891|NCT02207413|532113168|FG000|Overall Study|Adverse Event|0|||
147197030|NCT00744497|530893028|FG001|Overall Study|Administrative Reason By Sponsor|8|||
147197031|NCT00744497|530893027|FG000|Overall Study|Disease progression|312|||
147197032|NCT00744497|530893028|FG001|Overall Study|Disease progression|219|||
147197033|NCT00744497|530893027|FG000|Overall Study|Study drug toxicity|68|||
147197034|NCT00744497|530893028|FG001|Overall Study|Study drug toxicity|141|||
147197035|NCT00744497|530893027|FG000|Overall Study|Adverse event unrelated to study drug|78|||
147197036|NCT00744497|530893028|FG001|Overall Study|Adverse event unrelated to study drug|122|||
147197037|NCT00744497|530893027|FG000|Overall Study|Patient requested to stop study drug|65|||
147197038|NCT00744497|530893028|FG001|Overall Study|Patient requested to stop study drug|80|||
147197039|NCT00744497|530893027|FG000|Overall Study|Maximum clinical benefit|141|||
147197040|NCT00744497|530893028|FG001|Overall Study|Maximum clinical benefit|142|||
147197041|NCT00744497|530893027|FG000|Overall Study|Not defined|19|||
147197042|NCT00744497|530893028|FG001|Overall Study|Not defined|13|||
147197043|NCT03182374|530893033|FG000|Overall Study|Lost to Follow-up|3|||
147197044|NCT03182374|530893034|FG001|Overall Study|Lost to Follow-up|2|||
147197045|NCT03182374|530893033|FG000|Overall Study|Lack of Efficacy|8|||
147197046|NCT03182374|530893034|FG001|Overall Study|Lack of Efficacy|14|||
147197047|NCT03182374|530893033|FG000|Overall Study|Withdrawal by Subject|1|||
147197048|NCT03182374|530893034|FG001|Overall Study|Withdrawal by Subject|1|||
147197049|NCT03182374|530893033|FG000|Overall Study|exit for non-compliance|1|||
147197050|NCT03182374|530893034|FG001|Overall Study|exit for non-compliance|1|||
147197051|NCT03182374|530893033|FG000|Overall Study|one subject was randomized but not treated|1|||
147197052|NCT03182374|530893034|FG001|Overall Study|one subject was randomized but not treated|0|||
147197053|NCT03182374|530893033|FG000|Overall Study|Other reasons|0|||
147197054|NCT03182374|530893034|FG001|Overall Study|Other reasons|3|||
147197055|NCT01462370|530893035|FG000|Overall Study|Lack of Qualifying Event|1|||
147197056|NCT01462370|530893036|FG001|Overall Study|Lack of Qualifying Event|1|||
147197057|NCT01462370|530893035|FG000|Overall Study|Physician Decision|0|||
147197058|NCT01462370|530893036|FG001|Overall Study|Physician Decision|1|||
147197059|NCT01462370|530893035|FG000|Overall Study|Withdrawal by Subject|0|||
147197060|NCT01462370|530893036|FG001|Overall Study|Withdrawal by Subject|3|||
147197061|NCT03198715|530893037|FG000|Overall Study|Death|0|||
147534892|NCT02207413|532113169|FG001|Overall Study|Adverse Event|0|||
147534893|NCT02207413|532113170|FG002|Overall Study|Adverse Event|0|||
147534894|NCT02207413|532113171|FG003|Overall Study|Adverse Event|0|||
147197062|NCT03198715|530893038|FG001|Overall Study|Death|0|||
147197063|NCT03198715|530893039|FG002|Overall Study|Death|1|||
147197064|NCT03198715|530893040|FG003|Overall Study|Death|0|||
147197065|NCT03198715|530893041|FG004|Overall Study|Death|2|||
147197066|NCT03198715|530893037|FG000|Overall Study|Other|0|||
147197067|NCT03198715|530893038|FG001|Overall Study|Other|1|||
147197068|NCT03198715|530893039|FG002|Overall Study|Other|1|||
147197069|NCT03198715|530893040|FG003|Overall Study|Other|0|||
147197070|NCT03198715|530893041|FG004|Overall Study|Other|0|||
147197071|NCT00853307|530893044|FG000|Overall Study|Adverse Event|1|||
147197072|NCT00853307|530893045|FG001|Overall Study|Adverse Event|2|||
147197073|NCT00853307|530893044|FG000|Overall Study|Withdrawal by Subject|1|||
147197074|NCT00853307|530893045|FG001|Overall Study|Withdrawal by Subject|2|||
147197075|NCT00853307|530893044|FG000|Overall Study|Reason Not Specified|0|||
147197076|NCT00853307|530893045|FG001|Overall Study|Reason Not Specified|1|||
147197077|NCT00914316|530893046|FG000|Phase 1|Physician Decision|4|||
147197078|NCT00914316|530893047|FG001|Phase 1|Physician Decision|0|||
147197079|NCT00914316|530893048|FG002|Phase 1|Physician Decision|1|||
147197080|NCT00914316|530893049|FG003|Phase 1|Physician Decision|2|||
147197081|NCT00914316|530893046|FG000|Phase 1|Withdrawal by Subject|0|||
147197082|NCT00914316|530893047|FG001|Phase 1|Withdrawal by Subject|2|||
147197083|NCT00914316|530893048|FG002|Phase 1|Withdrawal by Subject|4|||
147197084|NCT00914316|530893049|FG003|Phase 1|Withdrawal by Subject|0|||
147197085|NCT00914316|530893046|FG000|Phase 1|Adverse Event|1|||
147197086|NCT00914316|530893047|FG001|Phase 1|Adverse Event|0|||
147197087|NCT00914316|530893048|FG002|Phase 1|Adverse Event|0|||
147197088|NCT00914316|530893049|FG003|Phase 1|Adverse Event|0|||
147197089|NCT00914316|530893046|FG000|Phase 2|Withdrawal by Subject|1|||
147197090|NCT00914316|530893047|FG001|Phase 2|Withdrawal by Subject|0|||
147197091|NCT00914316|530893048|FG002|Phase 2|Withdrawal by Subject|1|||
147197092|NCT00914316|530893049|FG003|Phase 2|Withdrawal by Subject|0|||
147197093|NCT02399163|530893052|FG000|Overall Study|Adverse Event|2|||
147197094|NCT02399163|530893052|FG000|Overall Study|Protocol Deviation|2|||
147197095|NCT02399163|530893052|FG000|Overall Study|Withdrawal by Participant|5|||
147197096|NCT01391546|530893058|FG000|Overall Study|History of Herpes Zoster (HZ)|1|||
147197097|NCT01391546|530893059|FG001|Overall Study|History of Herpes Zoster (HZ)|0|||
147197098|NCT04225897|530893065|FG000|Part A (Screening Visit to Day 7)|Adverse Event|0|||
147197099|NCT04225897|530893066|FG001|Part A (Screening Visit to Day 7)|Adverse Event|1|||
147197100|NCT04225897|530893067|FG002|Part A (Screening Visit to Day 7)|Adverse Event|0|||
147197101|NCT04225897|530893068|FG003|Part A (Screening Visit to Day 7)|Adverse Event|0|||
147197102|NCT04225897|530893069|FG004|Part A (Screening Visit to Day 7)|Adverse Event|0|||
147197103|NCT04225897|530893070|FG005|Part A (Screening Visit to Day 7)|Adverse Event|0|||
147197104|NCT04225897|530893071|FG006|Part A (Screening Visit to Day 7)|Adverse Event|0|||
147197105|NCT04225897|530893072|FG007|Part A (Screening Visit to Day 7)|Adverse Event|0|||
147197106|NCT04225897|530893073|FG008|Part A (Screening Visit to Day 7)|Adverse Event|0|||
147197107|NCT04225897|530893074|FG009|Part A (Screening Visit to Day 7)|Adverse Event|0|||
147197108|NCT04225897|530893075|FG010|Part A (Screening Visit to Day 7)|Adverse Event|0|||
147197109|NCT04225897|530893076|FG011|Part A (Screening Visit to Day 7)|Adverse Event|0|||
147197110|NCT04225897|530893065|FG000|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
147197111|NCT04225897|530893066|FG001|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
147197112|NCT04225897|530893067|FG002|Part A (Screening Visit to Day 7)|Lost to Follow-up|1|||
147197113|NCT04225897|530893068|FG003|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
147197114|NCT04225897|530893069|FG004|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
147197115|NCT04225897|530893070|FG005|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
147197116|NCT04225897|530893071|FG006|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
147197117|NCT04225897|530893072|FG007|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
147197118|NCT04225897|530893073|FG008|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
147197119|NCT04225897|530893074|FG009|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
147197120|NCT04225897|530893075|FG010|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
147197121|NCT04225897|530893076|FG011|Part A (Screening Visit to Day 7)|Lost to Follow-up|0|||
147197122|NCT04225897|530893065|FG000|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
147197123|NCT04225897|530893066|FG001|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
147197124|NCT04225897|530893067|FG002|Part A (Screening Visit to Day 7)|Parent/legal guardian request|1|||
147197125|NCT04225897|530893068|FG003|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
147197126|NCT04225897|530893069|FG004|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
147197127|NCT04225897|530893070|FG005|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
147197128|NCT04225897|530893071|FG006|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
147197129|NCT04225897|530893072|FG007|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
147197130|NCT04225897|530893073|FG008|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
147434948|NCT04178967|531758205|FG003|Maintenance Open Label Escape Arm|Adverse Event|0|||
147434949|NCT04178967|531758206|FG004|Maintenance Open Label Escape Arm|Adverse Event|0|||
147434950|NCT04178967|531758207|FG005|Maintenance Open Label Escape Arm|Adverse Event|0|||
147434951|NCT04178967|531758208|FG006|Maintenance Open Label Escape Arm|Adverse Event|0|||
147434952|NCT04178967|531758209|FG007|Maintenance Open Label Escape Arm|Adverse Event|0|||
147434953|NCT04178967|531758210|FG008|Maintenance Open Label Escape Arm|Adverse Event|3|||
147434954|NCT04178967|531758211|FG009|Maintenance Open Label Escape Arm|Adverse Event|3|||
147197131|NCT04225897|530893074|FG009|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
147197132|NCT04225897|530893075|FG010|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
147197133|NCT04225897|530893076|FG011|Part A (Screening Visit to Day 7)|Parent/legal guardian request|0|||
147434955|NCT04178967|531758212|FG010|Maintenance Open Label Escape Arm|Adverse Event|0|||
147434956|NCT04178967|531758202|FG000|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
147434957|NCT04178967|531758203|FG001|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
147434958|NCT04178967|531758204|FG002|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
147434959|NCT04178967|531758205|FG003|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
147434960|NCT04178967|531758206|FG004|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
147434961|NCT04178967|531758207|FG005|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
147434962|NCT04178967|531758208|FG006|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
147434963|NCT04178967|531758209|FG007|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
147434964|NCT04178967|531758210|FG008|Maintenance Open Label Escape Arm|Lack of Efficacy|16|||
147434965|NCT04178967|531758211|FG009|Maintenance Open Label Escape Arm|Lack of Efficacy|27|||
147434966|NCT04178967|531758212|FG010|Maintenance Open Label Escape Arm|Lack of Efficacy|2|||
147434967|NCT04178967|531758202|FG000|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
147434968|NCT04178967|531758203|FG001|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
147534895|NCT02207413|532113172|FG004|Overall Study|Adverse Event|2|||
147534896|NCT02207413|532113173|FG005|Overall Study|Adverse Event|1|||
147197134|NCT04225897|530893065|FG000|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
147197135|NCT04225897|530893066|FG001|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
147197136|NCT04225897|530893067|FG002|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
147197137|NCT04225897|530893068|FG003|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
147197138|NCT04225897|530893069|FG004|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
147197139|NCT04225897|530893070|FG005|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
147197140|NCT04225897|530893071|FG006|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
147197141|NCT04225897|530893072|FG007|Part B (Screening Visit to Day 12)|Parent/legal guardian request|1|||
147197142|NCT04225897|530893073|FG008|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
147197143|NCT04225897|530893074|FG009|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
147197144|NCT04225897|530893075|FG010|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
147197145|NCT04225897|530893076|FG011|Part B (Screening Visit to Day 12)|Parent/legal guardian request|0|||
147197146|NCT00074711|530893078|FG000|Overall Study|Withdrawal by Subject|1|||
147197147|NCT00074711|530893079|FG001|Overall Study|Withdrawal by Subject|1|||
147197148|NCT00074711|530893078|FG000|Overall Study|Lost to Follow-up|10|||
147197149|NCT00074711|530893079|FG001|Overall Study|Lost to Follow-up|8|||
147197150|NCT00074711|530893078|FG000|Overall Study|Participant stopped study drug|4|||
147197151|NCT00074711|530893079|FG001|Overall Study|Participant stopped study drug|6|||
147197152|NCT03466658|530893080|FG000|Overall Study|Withdrawal by Subject|3|||
147197153|NCT00837434|530893081|FG000|Overall Study|Physician Decision|3|||
147197154|NCT00837434|530893082|FG001|Overall Study|Physician Decision|0|||
147197155|NCT00837434|530893081|FG000|Overall Study|Lost to Follow-up|1|||
147197156|NCT00837434|530893082|FG001|Overall Study|Lost to Follow-up|1|||
147197157|NCT00837434|530893081|FG000|Overall Study|Withdrawn by sponsor/regulatory agency|1|||
147197158|NCT00837434|530893082|FG001|Overall Study|Withdrawn by sponsor/regulatory agency|0|||
147197159|NCT00837434|530893081|FG000|Overall Study|Noncompliant|2|||
147197160|NCT00837434|530893082|FG001|Overall Study|Noncompliant|0|||
147197161|NCT00837434|530893081|FG000|Overall Study|Baseline assessments not done in time|1|||
147197162|NCT00837434|530893082|FG001|Overall Study|Baseline assessments not done in time|0|||
147197163|NCT00837434|530893081|FG000|Overall Study|Unable to obtain study drug|1|||
147197164|NCT00837434|530893082|FG001|Overall Study|Unable to obtain study drug|0|||
147197165|NCT01921205|530893083|FG000|Overall Study|Adverse Event|12|||
147197166|NCT01921205|530893084|FG001|Overall Study|Adverse Event|7|||
147197167|NCT01921205|530893083|FG000|Overall Study|Lack of Efficacy|1|||
147197168|NCT01921205|530893084|FG001|Overall Study|Lack of Efficacy|0|||
147197169|NCT01921205|530893083|FG000|Overall Study|Protocol Violation|1|||
147197170|NCT01921205|530893084|FG001|Overall Study|Protocol Violation|3|||
147197171|NCT01921205|530893083|FG000|Overall Study|Lost to Follow-up|1|||
147197172|NCT01921205|530893084|FG001|Overall Study|Lost to Follow-up|1|||
147197173|NCT01921205|530893083|FG000|Overall Study|Withdrawal by Subject|6|||
147197174|NCT01921205|530893084|FG001|Overall Study|Withdrawal by Subject|5|||
147197175|NCT01921205|530893083|FG000|Overall Study|Use Of Prohibited Medication|0|||
147197176|NCT01921205|530893084|FG001|Overall Study|Use Of Prohibited Medication|1|||
147197177|NCT01921205|530893083|FG000|Overall Study|The Excessive Use Of Rescue Medication|0|||
147197178|NCT01921205|530893084|FG001|Overall Study|The Excessive Use Of Rescue Medication|1|||
147197179|NCT01921205|530893083|FG000|Overall Study|Non Compliance Of The Parent|0|||
147197180|NCT01921205|530893084|FG001|Overall Study|Non Compliance Of The Parent|1|||
147197181|NCT01921205|530893083|FG000|Overall Study|Non Compliance Of Child|0|||
147197182|NCT01921205|530893084|FG001|Overall Study|Non Compliance Of Child|1|||
147197183|NCT00360230|530893085|FG000|Overall Study|Withdrawal by Subject|1|||
147197184|NCT00360230|530893086|FG001|Overall Study|Withdrawal by Subject|1|||
147197185|NCT00360230|530893087|FG002|Overall Study|Withdrawal by Subject|0|||
147197186|NCT00360230|530893088|FG003|Overall Study|Withdrawal by Subject|1|||
147197187|NCT00360230|530893089|FG004|Overall Study|Withdrawal by Subject|1|||
147197188|NCT00360230|530893090|FG005|Overall Study|Withdrawal by Subject|1|||
147197189|NCT00360230|530893091|FG006|Overall Study|Withdrawal by Subject|0|||
147197190|NCT00360230|530893085|FG000|Overall Study|Migrated|4|||
147197191|NCT00360230|530893086|FG001|Overall Study|Migrated|1|||
147197192|NCT00360230|530893087|FG002|Overall Study|Migrated|3|||
147197193|NCT00360230|530893088|FG003|Overall Study|Migrated|1|||
147197194|NCT00360230|530893089|FG004|Overall Study|Migrated|4|||
147197195|NCT00360230|530893090|FG005|Overall Study|Migrated|1|||
147197196|NCT00360230|530893091|FG006|Overall Study|Migrated|1|||
147197197|NCT00360230|530893085|FG000|Overall Study|Other|1|||
147197198|NCT00360230|530893086|FG001|Overall Study|Other|0|||
147197199|NCT00360230|530893087|FG002|Overall Study|Other|0|||
147197200|NCT00360230|530893088|FG003|Overall Study|Other|0|||
147197201|NCT00360230|530893089|FG004|Overall Study|Other|0|||
147197202|NCT00360230|530893090|FG005|Overall Study|Other|0|||
147197203|NCT00360230|530893091|FG006|Overall Study|Other|0|||
147197204|NCT00360230|530893085|FG000|Overall Study|Protocol Violation|0|||
147197205|NCT00360230|530893086|FG001|Overall Study|Protocol Violation|0|||
147197206|NCT00360230|530893087|FG002|Overall Study|Protocol Violation|0|||
147197207|NCT00360230|530893088|FG003|Overall Study|Protocol Violation|0|||
147197208|NCT00360230|530893089|FG004|Overall Study|Protocol Violation|0|||
147197209|NCT00360230|530893090|FG005|Overall Study|Protocol Violation|1|||
147197210|NCT00360230|530893091|FG006|Overall Study|Protocol Violation|0|||
147197211|NCT00360230|530893085|FG000|Overall Study|Death|0|||
147197212|NCT00360230|530893086|FG001|Overall Study|Death|1|||
147197213|NCT00360230|530893087|FG002|Overall Study|Death|0|||
147197214|NCT00360230|530893088|FG003|Overall Study|Death|0|||
147197215|NCT00360230|530893089|FG004|Overall Study|Death|0|||
147197216|NCT00360230|530893090|FG005|Overall Study|Death|1|||
147197217|NCT00360230|530893091|FG006|Overall Study|Death|1|||
147197218|NCT00456846|530893092|FG000|Overall Study|Adverse Event|2|||
147197219|NCT00456846|530893093|FG001|Overall Study|Adverse Event|15|||
147197220|NCT00456846|530893092|FG000|Overall Study|Physician Decision|11|||
147197221|NCT00456846|530893093|FG001|Overall Study|Physician Decision|6|||
147197222|NCT00456846|530893092|FG000|Overall Study|Protocol Deviation|2|||
147197223|NCT00456846|530893093|FG001|Overall Study|Protocol Deviation|0|||
147197224|NCT00456846|530893092|FG000|Overall Study|Participant Discretion|1|||
147197225|NCT00456846|530893093|FG001|Overall Study|Participant Discretion|5|||
147197226|NCT00456846|530893092|FG000|Overall Study|Other|0|||
147197227|NCT00456846|530893093|FG001|Overall Study|Other|2|||
147197228|NCT00910650|530893094|FG000|Overall Study|Death|2|||
147197229|NCT04682366|530893095|FG000|Overall Study|Lost to Follow-up|1|||
147197230|NCT04682366|530893096|FG001|Overall Study|Lost to Follow-up|1|||
147197231|NCT02224560|530893098|FG000|Overall Study|Protocol Deviation|1|||
147197232|NCT02224560|530893099|FG001|Overall Study|Protocol Deviation|0|||
147197233|NCT02224560|530893100|FG002|Overall Study|Protocol Deviation|0|||
147197234|NCT02224560|530893098|FG000|Overall Study|Withdrawal by Subject|2|||
147197235|NCT02224560|530893099|FG001|Overall Study|Withdrawal by Subject|0|||
147197236|NCT02224560|530893100|FG002|Overall Study|Withdrawal by Subject|1|||
147197237|NCT02224560|530893098|FG000|Overall Study|Met Withdrawal Criteria|1|||
147197238|NCT02224560|530893099|FG001|Overall Study|Met Withdrawal Criteria|0|||
147197239|NCT02224560|530893100|FG002|Overall Study|Met Withdrawal Criteria|0|||
147197240|NCT02224560|530893098|FG000|Overall Study|Adverse Event|4|||
147197241|NCT02224560|530893099|FG001|Overall Study|Adverse Event|1|||
147434969|NCT04178967|531758204|FG002|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
147434970|NCT04178967|531758205|FG003|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
147434971|NCT04178967|531758206|FG004|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
147434972|NCT04178967|531758207|FG005|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
147434973|NCT04178967|531758208|FG006|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
147434974|NCT04178967|531758209|FG007|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
147434975|NCT04178967|531758210|FG008|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
147434976|NCT04178967|531758211|FG009|Maintenance Open Label Escape Arm|Lost to Follow-up|1|||
147434977|NCT04178967|531758212|FG010|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
147434978|NCT04178967|531758202|FG000|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
147434979|NCT04178967|531758203|FG001|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
147434980|NCT04178967|531758204|FG002|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
147434981|NCT04178967|531758205|FG003|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
147434982|NCT04178967|531758206|FG004|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
147434983|NCT04178967|531758207|FG005|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
147434984|NCT04178967|531758208|FG006|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
147434985|NCT04178967|531758209|FG007|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
147434986|NCT04178967|531758210|FG008|Maintenance Open Label Escape Arm|Withdrawal by Subject|4|||
147434987|NCT04178967|531758211|FG009|Maintenance Open Label Escape Arm|Withdrawal by Subject|9|||
147434988|NCT04178967|531758212|FG010|Maintenance Open Label Escape Arm|Withdrawal by Subject|1|||
147434989|NCT04178967|531758202|FG000|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
147434990|NCT04178967|531758203|FG001|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
147434991|NCT04178967|531758204|FG002|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
147434992|NCT04178967|531758205|FG003|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
147434993|NCT04178967|531758206|FG004|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
147434994|NCT04178967|531758207|FG005|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
147434995|NCT04178967|531758208|FG006|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
147434996|NCT04178967|531758209|FG007|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
147434997|NCT04178967|531758210|FG008|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
147434998|NCT04178967|531758211|FG009|Maintenance Open Label Escape Arm|Sponsor Decision|1|||
147434999|NCT04178967|531758212|FG010|Maintenance Open Label Escape Arm|Sponsor Decision|0|||
147435000|NCT04178967|531758202|FG000|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
147435001|NCT04178967|531758203|FG001|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
147595940|NCT03096847|532338751|FG000|Overall Study|Adverse Event|72|||
147197242|NCT02224560|530893100|FG002|Overall Study|Adverse Event|1|||
147197243|NCT02224560|530893098|FG000|Overall Study|Withdrawn by Investigator|1|||
147197244|NCT02224560|530893099|FG001|Overall Study|Withdrawn by Investigator|1|||
147197245|NCT02224560|530893100|FG002|Overall Study|Withdrawn by Investigator|0|||
147197246|NCT04543279|530893101|FG000|Overall Study|Withdrawal by Subject|1|||
147197247|NCT04543279|530893102|FG001|Overall Study|Withdrawal by Subject|0|||
147197248|NCT04543279|530893101|FG000|Overall Study|Adverse Event|1|||
147534897|NCT02207413|532113168|FG000|Overall Study|Migrated/moved from study area|0|||
147534898|NCT02207413|532113169|FG001|Overall Study|Migrated/moved from study area|0|||
147197249|NCT04543279|530893102|FG001|Overall Study|Adverse Event|0|||
147197250|NCT04543279|530893101|FG000|Overall Study|Physician Decision|1|||
147534899|NCT02207413|532113170|FG002|Overall Study|Migrated/moved from study area|0|||
147534900|NCT02207413|532113171|FG003|Overall Study|Migrated/moved from study area|0|||
147534901|NCT02207413|532113172|FG004|Overall Study|Migrated/moved from study area|1|||
147197251|NCT04543279|530893102|FG001|Overall Study|Physician Decision|0|||
147197252|NCT00929695|530893103|FG000|Overall Study|Death|2|||
147197253|NCT00929695|530893104|FG001|Overall Study|Death|1|||
147197254|NCT00929695|530893103|FG000|Overall Study|Withdrawal by Subject|0|||
147534902|NCT02207413|532113173|FG005|Overall Study|Migrated/moved from study area|0|||
147534903|NCT05102162|532114793|FG000|Overall Study|Withdrawal by Subject|3|||
147534904|NCT05102162|532114794|FG001|Overall Study|Withdrawal by Subject|0|||
147534905|NCT05102162|532114793|FG000|Overall Study|Baseline cultures negative|4|||
147534906|NCT05102162|532114794|FG001|Overall Study|Baseline cultures negative|2|||
147534907|NCT05102162|532114793|FG000|Overall Study|<72 Hours on study beta-lactam|7|||
147534908|NCT05102162|532114794|FG001|Overall Study|<72 Hours on study beta-lactam|0|||
147197255|NCT00929695|530893104|FG001|Overall Study|Withdrawal by Subject|2|||
147197256|NCT00929695|530893103|FG000|Overall Study|discharge home|4|||
147197257|NCT00929695|530893104|FG001|Overall Study|discharge home|3|||
147197258|NCT00929695|530893103|FG000|Overall Study|incorrect stratification|2|||
147197259|NCT00929695|530893104|FG001|Overall Study|incorrect stratification|0|||
147197260|NCT04030143|530893105|FG000|Overall Study|Adverse Event|5|||
147197261|NCT04030143|530893106|FG001|Overall Study|Adverse Event|10|||
147197262|NCT04030143|530893105|FG000|Overall Study|Lost to Follow-up|3|||
147534909|NCT05102162|532114793|FG000|Overall Study|Baseline cultures resistant to all study beta-lactams|0|||
147534910|NCT05102162|532114794|FG001|Overall Study|Baseline cultures resistant to all study beta-lactams|1|||
147534911|NCT02871921|532114797|FG000|Overall Study|Withdrawal by Subject|34|||
147197263|NCT04030143|530893106|FG001|Overall Study|Lost to Follow-up|7|||
147534912|NCT02871921|532114798|FG001|Overall Study|Withdrawal by Subject|27|||
147534913|NCT02871921|532114799|FG002|Overall Study|Withdrawal by Subject|27|||
147197264|NCT04030143|530893105|FG000|Overall Study|Protocol Deviation|2|||
147197265|NCT04030143|530893106|FG001|Overall Study|Protocol Deviation|2|||
147197266|NCT04030143|530893105|FG000|Overall Study|Withdrawal by Subject|16|||
147197267|NCT04030143|530893106|FG001|Overall Study|Withdrawal by Subject|18|||
147197268|NCT04030143|530893105|FG000|Overall Study|Physician Decision|1|||
147197269|NCT04030143|530893106|FG001|Overall Study|Physician Decision|1|||
147197270|NCT04030143|530893105|FG000|Overall Study|Due to Covid-19|2|||
147197271|NCT04030143|530893106|FG001|Overall Study|Due to Covid-19|3|||
147197272|NCT04030143|530893105|FG000|Overall Study|Not Due to Covid-19|1|||
147197273|NCT04030143|530893106|FG001|Overall Study|Not Due to Covid-19|1|||
147197274|NCT03216226|530893107|FG000|Overall Study|Adverse Event|3|||
147197275|NCT03216226|530893108|FG001|Overall Study|Adverse Event|0|||
147197276|NCT03216226|530893107|FG000|Overall Study|Protocol Violation|1|||
147197277|NCT03216226|530893108|FG001|Overall Study|Protocol Violation|3|||
147197278|NCT03216226|530893107|FG000|Overall Study|Patient unable to take time off work to come in for the third injection|1|||
147197279|NCT03216226|530893108|FG001|Overall Study|Patient unable to take time off work to come in for the third injection|0|||
147197280|NCT03216226|530893107|FG000|Overall Study|Deviation from protocol window during visit as patient had to leave for work|0|||
147197281|NCT03216226|530893108|FG001|Overall Study|Deviation from protocol window during visit as patient had to leave for work|1|||
147197282|NCT03216226|530893107|FG000|Overall Study|Patient withdrawn prior to treatment. Patient veins unsuitable for blood draws|0|||
147197283|NCT03216226|530893108|FG001|Overall Study|Patient withdrawn prior to treatment. Patient veins unsuitable for blood draws|1|||
147197284|NCT04218240|530893109|FG000|Overall Study|Withdrawal by Subject|6|||
147197285|NCT04218240|530893110|FG001|Overall Study|Withdrawal by Subject|0|||
147197286|NCT04218240|530893109|FG000|Overall Study|Lack of Efficacy|24|||
147197287|NCT04218240|530893110|FG001|Overall Study|Lack of Efficacy|19|||
147197288|NCT04218240|530893109|FG000|Overall Study|Physician Decision|0|||
147197289|NCT04218240|530893110|FG001|Overall Study|Physician Decision|1|||
147197290|NCT04218240|530893109|FG000|Overall Study|Not Dosed Never met WD criteria|4|||
147197291|NCT04218240|530893110|FG001|Overall Study|Not Dosed Never met WD criteria|1|||
147197292|NCT05966142|530893114|FG000|Overall Study|Death|3|||
147197293|NCT05966142|530893115|FG001|Overall Study|Death|3|||
147197294|NCT05966142|530893114|FG000|Overall Study|Lost to Follow-up|55|||
147197295|NCT05966142|530893115|FG001|Overall Study|Lost to Follow-up|52|||
147197296|NCT05966142|530893114|FG000|Overall Study|Physician Decision|1|||
147197297|NCT05966142|530893115|FG001|Overall Study|Physician Decision|0|||
147197298|NCT05966142|530893114|FG000|Overall Study|Withdrawal by Subject|9|||
147197299|NCT05966142|530893115|FG001|Overall Study|Withdrawal by Subject|8|||
147197300|NCT05966142|530893114|FG000|Overall Study|Duplicate Enrollment|1|||
147197301|NCT05966142|530893115|FG001|Overall Study|Duplicate Enrollment|0|||
147197302|NCT05966142|530893114|FG000|Overall Study|Study Logistical Reason|1|||
147197303|NCT05966142|530893115|FG001|Overall Study|Study Logistical Reason|0|||
147197304|NCT05966142|530893114|FG000|Overall Study|Unable to complete follow up due to change in health|1|||
147197305|NCT05966142|530893115|FG001|Overall Study|Unable to complete follow up due to change in health|1|||
147197306|NCT00894803|530893118|FG000|Overall Study|Death|20|||
147197307|NCT00894803|530893119|FG001|Overall Study|Death|4|||
147197308|NCT00894803|530893118|FG000|Overall Study|Lost to Follow-up|0|||
147197309|NCT00894803|530893119|FG001|Overall Study|Lost to Follow-up|1|||
147197310|NCT03094416|530893125|FG000|Run-in|Screening failure|8|||
147197311|NCT03094416|530893125|FG000|Run-in|Sponsor Decision To Discontinue Due To Global Covid-19 Pandemic|8|||
147197312|NCT03094416|530893125|FG000|Run-in|Withdrawal by Subject|3|||
147197313|NCT03094416|530893125|FG000|Treatment Period|Withdrawal by Subject|2|||
147197314|NCT02158442|530893128|FG000|Overall Study|Withdrawal by Subject|1|||
147197315|NCT02158442|530893129|FG001|Overall Study|Withdrawal by Subject|0|||
147197316|NCT02158442|530893128|FG000|Overall Study|Perfusion staff not available|1|||
147197317|NCT02158442|530893129|FG001|Overall Study|Perfusion staff not available|0|||
147197318|NCT01409707|530893130|FG000|Overall Study|Withdrawal by Subject|5|||
147197319|NCT01409707|530893131|FG001|Overall Study|Withdrawal by Subject|17|||
147197320|NCT01409707|530893132|FG002|Overall Study|Withdrawal by Subject|16|||
147197321|NCT01217229|530893133|FG000|Overall Study|Adverse Event|1|||
147197322|NCT01217229|530893133|FG000|Overall Study|Disease progression, deterioration|2|||
147197323|NCT01217229|530893133|FG000|Overall Study|Disease progression, Cheson criteria|14|||
147197324|NCT01217229|530893133|FG000|Overall Study|Protocol Violation|1|||
147197325|NCT01217229|530893133|FG000|Overall Study|Disease progression not confirmed|2|||
147197326|NCT05386329|530893134|FG000|Overall Study|Lost to Follow-up|3|||
147197327|NCT00521079|530893137|FG000|Overall Study|Adverse Event|7|||
147197328|NCT00521079|530893138|FG001|Overall Study|Adverse Event|1|||
147197329|NCT00521079|530893137|FG000|Overall Study|Lost to Follow-up|2|||
147197330|NCT00521079|530893138|FG001|Overall Study|Lost to Follow-up|1|||
147197331|NCT00521079|530893137|FG000|Overall Study|Withdrawal by Subject|5|||
147197332|NCT00521079|530893138|FG001|Overall Study|Withdrawal by Subject|3|||
147197333|NCT04408989|530893139|FG000|Overall Study|Lost to Follow-up|0|||
147197334|NCT04408989|530893140|FG001|Overall Study|Lost to Follow-up|0|||
147197335|NCT04408989|530893141|FG002|Overall Study|Lost to Follow-up|1|||
147197336|NCT04408989|530893139|FG000|Overall Study|Withdrawal by Subject|0|||
147197337|NCT04408989|530893140|FG001|Overall Study|Withdrawal by Subject|0|||
147197338|NCT04408989|530893141|FG002|Overall Study|Withdrawal by Subject|2|||
147197339|NCT04363320|530893142|FG000|Overall Study|Lost to Follow-up|43|||
147197340|NCT04363320|530893143|FG001|Overall Study|Lost to Follow-up|42|||
147197341|NCT04363320|530893144|FG002|Overall Study|Lost to Follow-up|24|||
147197342|NCT04363320|530893145|FG003|Overall Study|Lost to Follow-up|29|||
147197343|NCT04363320|530893142|FG000|Overall Study|Death|0|||
147197344|NCT04363320|530893143|FG001|Overall Study|Death|0|||
147197345|NCT04363320|530893144|FG002|Overall Study|Death|1|||
147197346|NCT04363320|530893145|FG003|Overall Study|Death|0|||
147197347|NCT03605667|530893151|FG000|Randomization Phase (Weeks 1 Through 48)|Withdrawal by Subject|18|||
147197348|NCT03605667|530893152|FG001|Randomization Phase (Weeks 1 Through 48)|Withdrawal by Subject|19|||
147197349|NCT03605667|530893151|FG000|Randomization Phase (Weeks 1 Through 48)|Adverse Event|14|||
147197350|NCT03605667|530893152|FG001|Randomization Phase (Weeks 1 Through 48)|Adverse Event|3|||
147197351|NCT03605667|530893151|FG000|Randomization Phase (Weeks 1 Through 48)|Other|1|||
147197352|NCT03605667|530893152|FG001|Randomization Phase (Weeks 1 Through 48)|Other|4|||
147197353|NCT03605667|530893151|FG000|Randomization Phase (Weeks 1 Through 48)|Progressive disease|3|||
147197354|NCT03605667|530893152|FG001|Randomization Phase (Weeks 1 Through 48)|Progressive disease|2|||
147197355|NCT03605667|530893151|FG000|Randomization Phase (Weeks 1 Through 48)|Lack of Efficacy|2|||
147197356|NCT03605667|530893152|FG001|Randomization Phase (Weeks 1 Through 48)|Lack of Efficacy|2|||
147197357|NCT03605667|530893151|FG000|Randomization Phase (Weeks 1 Through 48)|Physician Decision|2|||
147197358|NCT03605667|530893152|FG001|Randomization Phase (Weeks 1 Through 48)|Physician Decision|3|||
147197359|NCT03605667|530893151|FG000|Randomization Phase (Weeks 1 Through 48)|Non-compliance with study drug|4|||
147197360|NCT03605667|530893152|FG001|Randomization Phase (Weeks 1 Through 48)|Non-compliance with study drug|0|||
147197361|NCT03605667|530893151|FG000|Randomization Phase (Weeks 1 Through 48)|Protocol Violation|1|||
147197362|NCT03605667|530893152|FG001|Randomization Phase (Weeks 1 Through 48)|Protocol Violation|1|||
147197363|NCT03605667|530893151|FG000|Randomization Phase (Weeks 1 Through 48)|Lost to Follow-up|2|||
147197364|NCT03605667|530893152|FG001|Randomization Phase (Weeks 1 Through 48)|Lost to Follow-up|3|||
147197365|NCT03605667|530893151|FG000|Randomization Phase (Weeks 1 Through 48)|Death|1|||
147435002|NCT04178967|531758204|FG002|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
147595941|NCT03096847|532338752|FG001|Overall Study|Adverse Event|6|||
147197366|NCT03605667|530893152|FG001|Randomization Phase (Weeks 1 Through 48)|Death|2|||
147197367|NCT03605667|530893151|FG000|OLE Phase (48 Weeks)|Withdrawal by Subject|30|||
147197368|NCT03605667|530893152|FG001|OLE Phase (48 Weeks)|Withdrawal by Subject|51|||
147197369|NCT03605667|530893151|FG000|OLE Phase (48 Weeks)|Other|6|||
147197370|NCT03605667|530893152|FG001|OLE Phase (48 Weeks)|Other|8|||
147197371|NCT03605667|530893151|FG000|OLE Phase (48 Weeks)|Lack of Efficacy|6|||
147197372|NCT03605667|530893152|FG001|OLE Phase (48 Weeks)|Lack of Efficacy|5|||
147197373|NCT03605667|530893151|FG000|OLE Phase (48 Weeks)|Adverse Event|5|||
147197374|NCT03605667|530893152|FG001|OLE Phase (48 Weeks)|Adverse Event|5|||
147197375|NCT03605667|530893151|FG000|OLE Phase (48 Weeks)|Progressive Disease|2|||
147197376|NCT03605667|530893152|FG001|OLE Phase (48 Weeks)|Progressive Disease|0|||
147197377|NCT03605667|530893151|FG000|OLE Phase (48 Weeks)|Physician Decision|5|||
147197378|NCT03605667|530893152|FG001|OLE Phase (48 Weeks)|Physician Decision|7|||
147197379|NCT03605667|530893151|FG000|OLE Phase (48 Weeks)|Protocol Violation|0|||
147197380|NCT03605667|530893152|FG001|OLE Phase (48 Weeks)|Protocol Violation|1|||
147197381|NCT03605667|530893151|FG000|OLE Phase (48 Weeks)|Study Terminated By Sponsor|0|||
147197382|NCT03605667|530893152|FG001|OLE Phase (48 Weeks)|Study Terminated By Sponsor|1|||
147197383|NCT03605667|530893151|FG000|OLE Phase (48 Weeks)|Death|0|||
147197384|NCT03605667|530893152|FG001|OLE Phase (48 Weeks)|Death|2|||
147197385|NCT03605667|530893151|FG000|OLE Phase (48 Weeks)|Lost to Follow-up|1|||
147197386|NCT03605667|530893152|FG001|OLE Phase (48 Weeks)|Lost to Follow-up|0|||
147197387|NCT05632211|530893153|FG000|Overall Study|Withdrawal by Subject|2|||
147197388|NCT05632211|530893154|FG001|Overall Study|Withdrawal by Subject|0|||
147197389|NCT05632211|530893155|FG002|Overall Study|Withdrawal by Subject|2|||
147197390|NCT05632211|530893153|FG000|Overall Study|Other reasons|1|||
147197391|NCT05632211|530893154|FG001|Overall Study|Other reasons|1|||
147197392|NCT05632211|530893155|FG002|Overall Study|Other reasons|1|||
147197393|NCT05194124|530893158|FG000|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
147197394|NCT05194124|530893159|FG001|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
147197395|NCT05194124|530893160|FG002|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
147197396|NCT05194124|530893161|FG003|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|1|||
147197397|NCT05194124|530893162|FG004|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
147197398|NCT05194124|530893163|FG005|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|2|||
147197399|NCT05194124|530893164|FG006|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
147197400|NCT05194124|530893165|FG007|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
147197401|NCT05194124|530893166|FG008|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
147197402|NCT05194124|530893167|FG009|Double Blind (DB) Period (13 Weeks)|Withdrawal by parent/guardian|0|||
147197403|NCT05194124|530893158|FG000|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
147197404|NCT05194124|530893159|FG001|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
147197405|NCT05194124|530893160|FG002|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
147197406|NCT05194124|530893161|FG003|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
147197407|NCT05194124|530893162|FG004|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
147197408|NCT05194124|530893163|FG005|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
147197409|NCT05194124|530893164|FG006|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
147197410|NCT05194124|530893165|FG007|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
147197411|NCT05194124|530893166|FG008|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|0|||
147197412|NCT05194124|530893167|FG009|Open Label (OL) Period (13 Weeks)|Lack of Efficacy|1|||
147197413|NCT03642873|530893168|FG000|Third Intervention (1 Day)|Screen failure|0|||
147197414|NCT03642873|530893169|FG001|Third Intervention (1 Day)|Screen failure|0|||
147197415|NCT03642873|530893170|FG002|Third Intervention (1 Day)|Screen failure|0|||
147197416|NCT03642873|530893171|FG003|Third Intervention (1 Day)|Screen failure|0|||
147197417|NCT03642873|530893172|FG004|Third Intervention (1 Day)|Screen failure|1|||
147197418|NCT03642873|530893173|FG005|Third Intervention (1 Day)|Screen failure|0|||
147197419|NCT03312231|530893174|FG000|Overall Study|Lost to Follow-up|2|||
147197420|NCT03312231|530893175|FG001|Overall Study|Lost to Follow-up|6|||
147197421|NCT03312231|530893176|FG002|Overall Study|Lost to Follow-up|1|||
147197422|NCT03312231|530893177|FG003|Overall Study|Lost to Follow-up|3|||
147197423|NCT03312231|530893178|FG004|Overall Study|Lost to Follow-up|1|||
147197424|NCT03312231|530893174|FG000|Overall Study|Withdrawal by Subject|0|||
147197425|NCT03312231|530893175|FG001|Overall Study|Withdrawal by Subject|3|||
147197426|NCT03312231|530893176|FG002|Overall Study|Withdrawal by Subject|1|||
147197427|NCT03312231|530893177|FG003|Overall Study|Withdrawal by Subject|0|||
147197428|NCT03312231|530893178|FG004|Overall Study|Withdrawal by Subject|0|||
147197429|NCT03312231|530893174|FG000|Overall Study|Death|0|||
147197430|NCT03312231|530893175|FG001|Overall Study|Death|1|||
147197431|NCT03312231|530893176|FG002|Overall Study|Death|1|||
147197432|NCT03312231|530893177|FG003|Overall Study|Death|0|||
147197433|NCT03312231|530893178|FG004|Overall Study|Death|0|||
147197434|NCT03312231|530893174|FG000|Overall Study|Study Vaccination not Received|1|||
147197435|NCT03312231|530893175|FG001|Overall Study|Study Vaccination not Received|1|||
147197436|NCT03312231|530893176|FG002|Overall Study|Study Vaccination not Received|1|||
147197437|NCT03312231|530893177|FG003|Overall Study|Study Vaccination not Received|0|||
147197438|NCT03312231|530893178|FG004|Overall Study|Study Vaccination not Received|0|||
147197439|NCT03157830|530893183|FG000|Overall Study|Lost to Follow-up|1|||
147197440|NCT03157830|530893183|FG000|Overall Study|Withdrawal by Subject|1|||
147197441|NCT03694353|530893184|FG000|Overall Study|Withdrawal by Subject|1|||
147197442|NCT03694353|530893184|FG000|Overall Study|Subject received <= 40 mg/day for > 32 weeks|1|||
147197443|NCT05720897|530893186|FG000|Overall Study|Two patients did not complete Endodontic Treatment & there was technical VR difficulties for pts.|2|||
147197444|NCT05720897|530893187|FG001|Overall Study|Two patients did not complete Endodontic Treatment & there was technical VR difficulties for pts.|0|||
147197445|NCT00400179|530893188|FG000|Overall Study|Adverse Event|2|||
147197446|NCT00400179|530893189|FG001|Overall Study|Adverse Event|2|||
147197447|NCT00400179|530893188|FG000|Overall Study|Death|1|||
147197448|NCT00400179|530893189|FG001|Overall Study|Death|2|||
147197449|NCT00400179|530893188|FG000|Overall Study|Withdrew Consent|1|||
147197450|NCT00400179|530893189|FG001|Overall Study|Withdrew Consent|5|||
147197451|NCT00400179|530893188|FG000|Overall Study|Disease progression|1|||
147197452|NCT00400179|530893189|FG001|Overall Study|Disease progression|1|||
147197453|NCT00400179|530893188|FG000|Overall Study|Intercurrent illness|0|||
147197454|NCT00400179|530893189|FG001|Overall Study|Intercurrent illness|1|||
147197455|NCT00400179|530893188|FG000|Overall Study|Investigator judgment|0|||
147197456|NCT00400179|530893189|FG001|Overall Study|Investigator judgment|1|||
147197457|NCT00400179|530893188|FG000|Overall Study|Randomization error/patient ineligible|1|||
147197458|NCT00400179|530893189|FG001|Overall Study|Randomization error/patient ineligible|6|||
147197459|NCT04780061|530893190|FG000|Overall Study|Withdrawal by Subject|5|||
147197460|NCT04780061|530893191|FG001|Overall Study|Withdrawal by Subject|8|||
147197461|NCT04780061|530893190|FG000|Overall Study|Adverse Event|2|||
147197462|NCT04780061|530893191|FG001|Overall Study|Adverse Event|2|||
147197463|NCT04780061|530893190|FG000|Overall Study|Lost to Follow-up|1|||
147197464|NCT04780061|530893191|FG001|Overall Study|Lost to Follow-up|5|||
147197465|NCT00734149|530893192|FG000|Overall Study|Withdrawal by Subject|1|||
147197466|NCT00626106|530893195|FG000|Overall Study|Withdrawal by Subject|2|||
147197467|NCT00626106|530893196|FG001|Overall Study|Withdrawal by Subject|1|||
147197468|NCT00626106|530893195|FG000|Overall Study|Lost to Follow-up|1|||
147197469|NCT00626106|530893196|FG001|Overall Study|Lost to Follow-up|4|||
147197470|NCT00626106|530893195|FG000|Overall Study|Death|64|||
147534914|NCT02871921|532114800|FG003|Overall Study|Withdrawal by Subject|30|||
147534915|NCT00320801|532114801|FG000|Open-label Run-in Period|Withdrawal by Subject|2|||
147534916|NCT00320801|532114802|FG001|Open-label Run-in Period|Withdrawal by Subject|0|||
147534917|NCT00320801|532114803|FG002|Open-label Run-in Period|Withdrawal by Subject|0|||
147534918|NCT00320801|532114804|FG003|Open-label Run-in Period|Withdrawal by Subject|0|||
147534919|NCT00320801|532114801|FG000|Open-label Run-in Period|Adverse Event|33|||
147534920|NCT00320801|532114802|FG001|Open-label Run-in Period|Adverse Event|0|||
147534921|NCT00320801|532114803|FG002|Open-label Run-in Period|Adverse Event|0|||
147534922|NCT00320801|532114804|FG003|Open-label Run-in Period|Adverse Event|0|||
147534923|NCT00320801|532114801|FG000|Open-label Run-in Period|Administrative|10|||
147534924|NCT00320801|532114802|FG001|Open-label Run-in Period|Administrative|0|||
147534925|NCT00320801|532114803|FG002|Open-label Run-in Period|Administrative|0|||
147534926|NCT00320801|532114804|FG003|Open-label Run-in Period|Administrative|0|||
147534927|NCT00320801|532114801|FG000|Open-label Run-in Period|Lack of Efficacy|44|||
147534928|NCT00320801|532114802|FG001|Open-label Run-in Period|Lack of Efficacy|0|||
147534929|NCT00320801|532114803|FG002|Open-label Run-in Period|Lack of Efficacy|0|||
147197471|NCT00626106|530893196|FG001|Overall Study|Death|19|||
147197472|NCT03253393|530893197|FG000|Washout (Minimum 48 Hours)|13 participants exited study after first two visits/interventions|6|||
147197473|NCT03253393|530893198|FG001|Washout (Minimum 48 Hours)|13 participants exited study after first two visits/interventions|7|||
147197474|NCT03253393|530893199|FG002|Washout (Minimum 48 Hours)|13 participants exited study after first two visits/interventions|0|||
147197475|NCT01586364|530894366|FG000|Overall Study|Withdrawal by Subject|40|||
147197476|NCT01586364|530894366|FG000|Overall Study|Adverse Event|37|||
147197477|NCT01586364|530894366|FG000|Overall Study|Lost to Follow-up|17|||
147197478|NCT01586364|530894366|FG000|Overall Study|Protocol Violation|16|||
147534930|NCT00320801|532114804|FG003|Open-label Run-in Period|Lack of Efficacy|0|||
147534931|NCT00320801|532114801|FG000|Open-label Run-in Period|Lost to Follow-up|2|||
147197479|NCT01586364|530894366|FG000|Overall Study|Lack of Efficacy|1|||
147197480|NCT01586364|530894366|FG000|Overall Study|Other-Did not feel better post-treatment|1|||
147197481|NCT01586364|530894366|FG000|Overall Study|Other-Subject wasn't getting much relief|1|||
147197482|NCT01586364|530894366|FG000|Overall Study|Other-Site closure due to PI illness|1|||
147197483|NCT01586364|530894366|FG000|Overall Study|Other-PI discretion, site closing|2|||
147197484|NCT01586364|530894366|FG000|Overall Study|Other-Not specified|1|||
147197485|NCT00091949|530894367|FG000|Overall Study|Withdrawal by Subject|117|||
147197486|NCT00091949|530894368|FG001|Overall Study|Withdrawal by Subject|110|||
147197487|NCT00091949|530894367|FG000|Overall Study|Lost to Follow-up|58|||
147197488|NCT00091949|530894368|FG001|Overall Study|Lost to Follow-up|41|||
147197489|NCT01256788|530894369|FG000|Overall Study|Lost to Follow-up|5|||
147197490|NCT01256788|530894370|FG001|Overall Study|Lost to Follow-up|8|||
147197491|NCT01256788|530894371|FG002|Overall Study|Lost to Follow-up|3|||
147197492|NCT05366738|530894372|FG000|Overall Study|Adverse Event|0|||
147197493|NCT05366738|530894373|FG001|Overall Study|Adverse Event|1|||
147197494|NCT05366738|530894374|FG002|Overall Study|Adverse Event|0|||
147197495|NCT05291520|530894375|FG000|Overall Study|Lost to Follow-up|0|||
147197496|NCT05291520|530894376|FG001|Overall Study|Lost to Follow-up|0|||
147197497|NCT05291520|530894377|FG002|Overall Study|Lost to Follow-up|1|||
147197498|NCT01347112|530894378|FG000|Overall Study|Withdrawal by Subject|1|||
147197499|NCT01347112|530894379|FG001|Overall Study|Withdrawal by Subject|7|||
147197500|NCT01347112|530894378|FG000|Overall Study|Lost to Follow-up|3|||
147197501|NCT01347112|530894379|FG001|Overall Study|Lost to Follow-up|5|||
147197502|NCT00696072|530894380|FG000|Overall Study|continuing active treatment|10|||
147197503|NCT00696072|530894381|FG001|Overall Study|continuing active treatment|13|||
147197504|NCT00696072|530894380|FG000|Overall Study|Adverse Event|10|||
147197505|NCT00696072|530894381|FG001|Overall Study|Adverse Event|6|||
147197506|NCT00696072|530894380|FG000|Overall Study|Patient Request|3|||
147197507|NCT00696072|530894381|FG001|Overall Study|Patient Request|7|||
147197508|NCT00696072|530894380|FG000|Overall Study|Investigator Request|1|||
147197509|NCT00696072|530894381|FG001|Overall Study|Investigator Request|4|||
147197510|NCT00696072|530894380|FG000|Overall Study|Sponsor Request|0|||
147197511|NCT00696072|530894381|FG001|Overall Study|Sponsor Request|1|||
147197512|NCT00696072|530894380|FG000|Overall Study|Disease Progression|32|||
147197513|NCT00696072|530894381|FG001|Overall Study|Disease Progression|30|||
147197514|NCT00696072|530894380|FG000|Overall Study|Non-specified|1|||
147197515|NCT00696072|530894381|FG001|Overall Study|Non-specified|2|||
147197516|NCT01597596|530894382|FG000|Overall Study|Study terminated by sponsor|1|||
147197517|NCT01597596|530894383|FG001|Overall Study|Study terminated by sponsor|0|||
147197518|NCT01597596|530894382|FG000|Overall Study|Physician Decision|0|||
147197519|NCT01597596|530894383|FG001|Overall Study|Physician Decision|1|||
147197520|NCT00992108|530894390|FG000|Overall Study|Lost to Follow-up|0|||
147197521|NCT00992108|530894391|FG001|Overall Study|Lost to Follow-up|1|||
147197522|NCT04639245|530894392|FG000|Overall Study|Death|1|||
147197523|NCT02419001|530894395|FG000|Period 1- Ceftriaxone Without SYN-004|AE w/ ceftriaxone, not dosed w/ IP|1|||
147197524|NCT02419001|530894396|FG001|Period 1- Ceftriaxone Without SYN-004|AE w/ ceftriaxone, not dosed w/ IP|0|||
147197525|NCT00535496|530894397|FG000|Overall Study|Lost to Follow-up|0|||
147197526|NCT00535496|530894398|FG001|Overall Study|Lost to Follow-up|1|||
147197527|NCT00535496|530894399|FG002|Overall Study|Lost to Follow-up|0|||
147197528|NCT00535496|530894400|FG003|Overall Study|Lost to Follow-up|0|||
147197529|NCT00535496|530894397|FG000|Overall Study|Not treated with sugammadex|0|||
147197530|NCT00535496|530894398|FG001|Overall Study|Not treated with sugammadex|1|||
147197531|NCT00535496|530894399|FG002|Overall Study|Not treated with sugammadex|0|||
147197532|NCT00535496|530894400|FG003|Overall Study|Not treated with sugammadex|0|||
147197533|NCT03591406|530894402|FG000|Overall Study|Adverse Event|5|||
147197534|NCT03591406|530894403|FG001|Overall Study|Adverse Event|3|||
147197535|NCT03591406|530894402|FG000|Overall Study|Protocol Violation|2|||
147197536|NCT03591406|530894403|FG001|Overall Study|Protocol Violation|1|||
147197537|NCT03591406|530894402|FG000|Overall Study|Withdrawal by Subject|0|||
147197538|NCT03591406|530894403|FG001|Overall Study|Withdrawal by Subject|5|||
147197539|NCT01083771|530894404|FG000|Overall Study|non-compliant|2|||
147197540|NCT01083771|530894404|FG000|Overall Study|Withdrawal by Subject|3|||
147197541|NCT00321620|530894407|FG000|Overall Study|Death|269|||
147197542|NCT00321620|530894408|FG001|Overall Study|Death|294|||
147197543|NCT00321620|530894407|FG000|Overall Study|Withdrawal by Subject|164|||
147197544|NCT00321620|530894408|FG001|Overall Study|Withdrawal by Subject|147|||
147197545|NCT00321620|530894407|FG000|Overall Study|Disease progression|113|||
147197546|NCT00321620|530894408|FG001|Overall Study|Disease progression|117|||
147197547|NCT00321620|530894407|FG000|Overall Study|Adverse Event|43|||
147435003|NCT04178967|531758205|FG003|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
147435004|NCT04178967|531758206|FG004|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
147435005|NCT04178967|531758207|FG005|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
147435006|NCT04178967|531758208|FG006|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
147435007|NCT04178967|531758209|FG007|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
147435008|NCT04178967|531758210|FG008|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
147435009|NCT04178967|531758211|FG009|Maintenance Open Label Escape Arm|Participant Missed Study Visits|1|||
147435010|NCT04178967|531758212|FG010|Maintenance Open Label Escape Arm|Participant Missed Study Visits|0|||
147435011|NCT02545322|531758213|FG000|Overall Study|Withdrawal by Subject|3|||
147435012|NCT01251120|531758215|FG000|Overall Study|Lack of Efficacy|0|||
147435013|NCT01251120|531758216|FG001|Overall Study|Lack of Efficacy|1|||
147435014|NCT04409353|531758217|FG000|Overall Study|Discontinued intervention prior to end of follow-up|4|||
147435015|NCT04409353|531758218|FG001|Overall Study|Discontinued intervention prior to end of follow-up|11|||
147435016|NCT04409353|531758219|FG002|Overall Study|Discontinued intervention prior to end of follow-up|6|||
147435017|NCT04409353|531758217|FG000|Overall Study|Lost to Follow-up|6|||
147435018|NCT04409353|531758218|FG001|Overall Study|Lost to Follow-up|8|||
147435019|NCT04409353|531758219|FG002|Overall Study|Lost to Follow-up|7|||
147435020|NCT04409353|531758217|FG000|Overall Study|Major surgery during participation window|4|||
147435021|NCT04409353|531758218|FG001|Overall Study|Major surgery during participation window|3|||
147435022|NCT04409353|531758219|FG002|Overall Study|Major surgery during participation window|3|||
147435023|NCT04409353|531758217|FG000|Overall Study|Life event occurred during participation window|3|||
147197548|NCT00321620|530894408|FG001|Overall Study|Adverse Event|56|||
147197549|NCT00321620|530894407|FG000|Overall Study|Lost to Follow-up|13|||
147197550|NCT00321620|530894408|FG001|Overall Study|Lost to Follow-up|9|||
147197551|NCT00321620|530894407|FG000|Overall Study|Physician Decision|4|||
147197552|NCT00321620|530894408|FG001|Overall Study|Physician Decision|1|||
147197553|NCT00321620|530894407|FG000|Overall Study|Noncompliance|14|||
147197554|NCT00321620|530894408|FG001|Overall Study|Noncompliance|7|||
147197555|NCT00321620|530894407|FG000|Overall Study|Protocol deviation|4|||
147197556|NCT00321620|530894408|FG001|Overall Study|Protocol deviation|3|||
147197557|NCT00321620|530894407|FG000|Overall Study|Ineligibility determined|2|||
147197558|NCT00321620|530894408|FG001|Overall Study|Ineligibility determined|3|||
147197559|NCT00321620|530894407|FG000|Overall Study|Participant request|75|||
147197560|NCT00321620|530894408|FG001|Overall Study|Participant request|52|||
147197561|NCT00321620|530894407|FG000|Overall Study|Other|42|||
147197562|NCT00321620|530894408|FG001|Overall Study|Other|33|||
147197563|NCT01747876|530894412|FG000|Overall Study|Adverse Event|1|||
147197564|NCT01747876|530894413|FG001|Overall Study|Adverse Event|0|||
147197565|NCT01747876|530894414|FG002|Overall Study|Adverse Event|2|||
147197566|NCT01747876|530894412|FG000|Overall Study|Withdrawal by Subject|0|||
147197567|NCT01747876|530894413|FG001|Overall Study|Withdrawal by Subject|1|||
147197568|NCT01747876|530894414|FG002|Overall Study|Withdrawal by Subject|1|||
147197569|NCT01747876|530894412|FG000|Overall Study|Disease progression|4|||
147197570|NCT01747876|530894413|FG001|Overall Study|Disease progression|13|||
147197571|NCT01747876|530894414|FG002|Overall Study|Disease progression|8|||
147197572|NCT01747876|530894412|FG000|Overall Study|Trtment duration compl. as per protocol|0|||
147197573|NCT01747876|530894413|FG001|Overall Study|Trtment duration compl. as per protocol|1|||
147197574|NCT01747876|530894414|FG002|Overall Study|Trtment duration compl. as per protocol|1|||
147197575|NCT02703597|530894439|FG000|Assignment to Baseline|Lost to Follow-up|17|||
147197576|NCT02703597|530894440|FG001|Assignment to Baseline|Lost to Follow-up|16|||
147197577|NCT02703597|530894439|FG000|Baseline to First Post-test|Lost to Follow-up|61|||
147197578|NCT02703597|530894440|FG001|Baseline to First Post-test|Lost to Follow-up|92|||
147197579|NCT02703597|530894439|FG000|First Post-test to First Follow-up|Lost to Follow-up|5|||
147197580|NCT02703597|530894440|FG001|First Post-test to First Follow-up|Lost to Follow-up|3|||
147197581|NCT02703597|530894439|FG000|First Post-test to First Follow-up|Site drop out|0|||
147197582|NCT02703597|530894440|FG001|First Post-test to First Follow-up|Site drop out|58|||
147197583|NCT02703597|530894439|FG000|Recruitment Period for Assessment 5|Withdrawal by Site|16|||
147197584|NCT02703597|530894440|FG001|Recruitment Period for Assessment 5|Withdrawal by Site|0|||
147197585|NCT02703597|530894439|FG000|Recruitment Period for Assessment 5|Were not expected to participate in this stage as per protocol|0|||
147197586|NCT02703597|530894440|FG001|Recruitment Period for Assessment 5|Were not expected to participate in this stage as per protocol|71|||
147197587|NCT02703597|530894439|FG000|Assessment 5 to Second Post-test|Lost to Follow-up|27|||
147197588|NCT02703597|530894440|FG001|Assessment 5 to Second Post-test|Lost to Follow-up|0|||
147197589|NCT01614886|530894441|FG000|Overall Study|Adverse Event|15|||
147197590|NCT01614886|530894442|FG001|Overall Study|Adverse Event|20|||
147197591|NCT01614886|530894441|FG000|Overall Study|Withdrawal by Subject|4|||
147197592|NCT01614886|530894442|FG001|Overall Study|Withdrawal by Subject|4|||
147197593|NCT01614886|530894441|FG000|Overall Study|Death|1|||
147197594|NCT01614886|530894442|FG001|Overall Study|Death|0|||
147197595|NCT01614886|530894441|FG000|Overall Study|Protocol deviation|0|||
147197596|NCT01614886|530894442|FG001|Overall Study|Protocol deviation|2|||
147197597|NCT01523366|530894444|FG000|Treatment Period 1|Withdrawal by Subject|1|||
147197598|NCT01523366|530894445|FG001|Treatment Period 1|Withdrawal by Subject|0|||
147197599|NCT01523366|530894444|FG000|Treatment Period 2|Not completed at least 7 days treatment|1|||
147197600|NCT01523366|530894445|FG001|Treatment Period 2|Not completed at least 7 days treatment|0|||
147197601|NCT02461758|530894446|FG000|Overall Study|Lost to Follow-up|0|||
147197602|NCT02461758|530894447|FG001|Overall Study|Lost to Follow-up|1|||
147197603|NCT02461758|530894448|FG002|Overall Study|Lost to Follow-up|1|||
147197604|NCT02461758|530894449|FG003|Overall Study|Lost to Follow-up|0|||
147197605|NCT01710345|530894450|FG000|Overall Study|Adverse Event|0|||
147197606|NCT01710345|530894451|FG001|Overall Study|Adverse Event|2|||
147197607|NCT01710345|530894452|FG002|Overall Study|Adverse Event|0|||
147197608|NCT01710345|530894450|FG000|Overall Study|Lack of Efficacy|2|||
147197609|NCT01710345|530894451|FG001|Overall Study|Lack of Efficacy|3|||
147197610|NCT01710345|530894452|FG002|Overall Study|Lack of Efficacy|1|||
147197611|NCT01710345|530894450|FG000|Overall Study|Drug Dosing Error|1|||
147197612|NCT01710345|530894451|FG001|Overall Study|Drug Dosing Error|0|||
147197613|NCT01710345|530894452|FG002|Overall Study|Drug Dosing Error|0|||
147197614|NCT00449696|530894454|FG000|Overall Study|Other Treatment Required|6|||
147197615|NCT00449696|530894455|FG001|Overall Study|Other Treatment Required|1|||
147197616|NCT00449696|530894454|FG000|Overall Study|Withdrawal by Subject|5|||
147197617|NCT00449696|530894455|FG001|Overall Study|Withdrawal by Subject|5|||
147197618|NCT00449696|530894454|FG000|Overall Study|Lost to Follow-up|2|||
147197619|NCT00449696|530894455|FG001|Overall Study|Lost to Follow-up|3|||
147197620|NCT00449696|530894454|FG000|Overall Study|Others|7|||
147197621|NCT00449696|530894455|FG001|Overall Study|Others|0|||
147197622|NCT01033019|530894456|FG000|Overall Study|Withdrawal by Subject|1|||
147197623|NCT01033019|530894457|FG001|Overall Study|Withdrawal by Subject|0|||
147197624|NCT00551642|530894463|FG000|Treatment Period|Protocol Deviation|6|||
147197625|NCT00551642|530894464|FG001|Treatment Period|Protocol Deviation|11|||
147197626|NCT00551642|530894463|FG000|Treatment Period|Delivery device failure|1|||
147197627|NCT00551642|530894464|FG001|Treatment Period|Delivery device failure|3|||
147197628|NCT00551642|530894463|FG000|Treatment Period|Physician Decision|0|||
147197629|NCT00551642|530894464|FG001|Treatment Period|Physician Decision|1|||
147197630|NCT00551642|530894463|FG000|Treatment Period|Death|33|||
147197631|NCT00551642|530894464|FG001|Treatment Period|Death|31|||
147197632|NCT00551642|530894463|FG000|Treatment Period|Inclusion/Exclusion criteria|4|||
147197633|NCT00551642|530894464|FG001|Treatment Period|Inclusion/Exclusion criteria|4|||
147435024|NCT04409353|531758218|FG001|Overall Study|Life event occurred during participation window|2|||
147435025|NCT04409353|531758219|FG002|Overall Study|Life event occurred during participation window|4|||
147435026|NCT04409353|531758217|FG000|Overall Study|Lack of Efficacy|4|||
147435027|NCT04409353|531758218|FG001|Overall Study|Lack of Efficacy|1|||
147435028|NCT04409353|531758219|FG002|Overall Study|Lack of Efficacy|3|||
147435029|NCT04409353|531758217|FG000|Overall Study|Adverse Event|2|||
147435030|NCT04409353|531758218|FG001|Overall Study|Adverse Event|1|||
147435031|NCT04409353|531758219|FG002|Overall Study|Adverse Event|1|||
147435032|NCT04409353|531758217|FG000|Overall Study|Disease burden - unable to participate|0|||
147435033|NCT04409353|531758218|FG001|Overall Study|Disease burden - unable to participate|1|||
147435034|NCT04409353|531758219|FG002|Overall Study|Disease burden - unable to participate|1|||
147435035|NCT04409353|531758217|FG000|Overall Study|Intervention too complicated|1|||
147435036|NCT04409353|531758218|FG001|Overall Study|Intervention too complicated|0|||
147435037|NCT04409353|531758219|FG002|Overall Study|Intervention too complicated|1|||
147435038|NCT02499770|531758222|FG000|Overall Study|Death|17|||
147435039|NCT02499770|531758223|FG001|Overall Study|Death|56|||
147435040|NCT02499770|531758222|FG000|Overall Study|Study completion|1|||
147435041|NCT02499770|531758223|FG001|Overall Study|Study completion|10|||
147435042|NCT02499770|531758222|FG000|Overall Study|Withdrawal by Subject|0|||
147435043|NCT02499770|531758223|FG001|Overall Study|Withdrawal by Subject|7|||
147435044|NCT02499770|531758222|FG000|Overall Study|Lost to Follow-up|0|||
147435045|NCT02499770|531758223|FG001|Overall Study|Lost to Follow-up|2|||
147435046|NCT02499770|531758222|FG000|Overall Study|Subject declined further treatment|1|||
147435047|NCT02499770|531758223|FG001|Overall Study|Subject declined further treatment|0|||
147435048|NCT02499770|531758222|FG000|Overall Study|Withdrawn by PI for compassionate reason|0|||
147435049|NCT02499770|531758223|FG001|Overall Study|Withdrawn by PI for compassionate reason|1|||
147435050|NCT02499770|531758222|FG000|Overall Study|Randomized but not enrolled|0|||
147435051|NCT02499770|531758223|FG001|Overall Study|Randomized but not enrolled|1|||
147435052|NCT00671554|531758230|FG000|Overall Study|Disease progression|3|||
147435053|NCT07052682|531758231|FG000|Overall Study|Withdrawal by Subject|4|||
147435054|NCT04667247|531758232|FG000|Overall Study|Withdrawal by Subject|0|||
147435055|NCT04667247|531758233|FG001|Overall Study|Withdrawal by Subject|1|||
147435056|NCT04124614|531758234|FG000|Placebo Run-in Period|Not Randomized|34|||
147435057|NCT04124614|531758235|FG001|Placebo Run-in Period|Not Randomized|0|||
147435058|NCT04124614|531758236|FG002|Placebo Run-in Period|Not Randomized|0|||
147435059|NCT04124614|531758234|FG000|Double Blind Treatment Period|Adverse Event|0|||
147435060|NCT04124614|531758235|FG001|Double Blind Treatment Period|Adverse Event|7|||
147435061|NCT04124614|531758236|FG002|Double Blind Treatment Period|Adverse Event|22|||
147435062|NCT04124614|531758234|FG000|Double Blind Treatment Period|Death|0|||
147435063|NCT04124614|531758235|FG001|Double Blind Treatment Period|Death|0|||
147435064|NCT04124614|531758236|FG002|Double Blind Treatment Period|Death|1|||
147435065|NCT04124614|531758234|FG000|Double Blind Treatment Period|Lost to Follow-up|0|||
147435066|NCT04124614|531758235|FG001|Double Blind Treatment Period|Lost to Follow-up|18|||
147435067|NCT04124614|531758236|FG002|Double Blind Treatment Period|Lost to Follow-up|25|||
147435068|NCT04124614|531758234|FG000|Double Blind Treatment Period|Non-Compliance With Study Drug|0|||
147435069|NCT04124614|531758235|FG001|Double Blind Treatment Period|Non-Compliance With Study Drug|5|||
147435070|NCT04124614|531758236|FG002|Double Blind Treatment Period|Non-Compliance With Study Drug|5|||
147435071|NCT04124614|531758234|FG000|Double Blind Treatment Period|Physician Decision|0|||
147435072|NCT04124614|531758235|FG001|Double Blind Treatment Period|Physician Decision|0|||
147435073|NCT04124614|531758236|FG002|Double Blind Treatment Period|Physician Decision|3|||
147435074|NCT04124614|531758234|FG000|Double Blind Treatment Period|Protocol Deviation|0|||
147435075|NCT04124614|531758235|FG001|Double Blind Treatment Period|Protocol Deviation|10|||
147435076|NCT04124614|531758236|FG002|Double Blind Treatment Period|Protocol Deviation|4|||
147435077|NCT04124614|531758234|FG000|Double Blind Treatment Period|Withdrawal by Subject|0|||
147435078|NCT04124614|531758235|FG001|Double Blind Treatment Period|Withdrawal by Subject|26|||
147435079|NCT04124614|531758236|FG002|Double Blind Treatment Period|Withdrawal by Subject|22|||
147435080|NCT04124614|531758234|FG000|Double Blind Treatment Period|Reason Not Specified|0|||
147435081|NCT04124614|531758235|FG001|Double Blind Treatment Period|Reason Not Specified|11|||
147435082|NCT04124614|531758236|FG002|Double Blind Treatment Period|Reason Not Specified|7|||
147435083|NCT04313153|531760360|FG000|Overall Study|Adverse Event (includes Death)|14|||
147435084|NCT04313153|531760361|FG001|Overall Study|Adverse Event (includes Death)|19|||
147435085|NCT04313153|531760362|FG002|Overall Study|Adverse Event (includes Death)|10|||
147435086|NCT04313153|531760360|FG000|Overall Study|Physician Decision|4|||
147435087|NCT04313153|531760361|FG001|Overall Study|Physician Decision|2|||
147435088|NCT04313153|531760362|FG002|Overall Study|Physician Decision|1|||
147435089|NCT04313153|531760360|FG000|Overall Study|Withdrawal by Subject|7|||
147435090|NCT04313153|531760361|FG001|Overall Study|Withdrawal by Subject|6|||
147435091|NCT04313153|531760362|FG002|Overall Study|Withdrawal by Subject|2|||
147435092|NCT04313153|531760360|FG000|Overall Study|Lack of Efficacy|3|||
147435093|NCT04313153|531760361|FG001|Overall Study|Lack of Efficacy|3|||
147435094|NCT04313153|531760362|FG002|Overall Study|Lack of Efficacy|0|||
147197634|NCT00551642|530894463|FG000|Treatment Period|Adverse Event|15|||
147197635|NCT00551642|530894464|FG001|Treatment Period|Adverse Event|12|||
147197636|NCT00551642|530894463|FG000|Treatment Period|Withdrawal by Subject|2|||
147197637|NCT00551642|530894464|FG001|Treatment Period|Withdrawal by Subject|1|||
147197638|NCT03011099|530894465|FG000|Overall Study|Withdrawal by Subject|0|||
147197639|NCT03011099|530894466|FG001|Overall Study|Withdrawal by Subject|2|||
147197640|NCT01903460|530894469|FG000|Overall Study|Adverse Event|0|||
147197641|NCT01903460|530894470|FG001|Overall Study|Adverse Event|0|||
147197642|NCT01903460|530894471|FG002|Overall Study|Adverse Event|0|||
147197643|NCT01903460|530894472|FG003|Overall Study|Adverse Event|1|||
147197644|NCT03104868|530894473|FG000|6 Week Follow up|Lost to Follow-up|5|||
147197645|NCT03104868|530894474|FG001|6 Week Follow up|Lost to Follow-up|8|||
147197646|NCT03104868|530894473|FG000|6 Week Follow up|Death|1|||
147197647|NCT03104868|530894474|FG001|6 Week Follow up|Death|1|||
147197648|NCT03104868|530894473|FG000|6 Week Follow up|Withdrawal by Subject|7|||
147197649|NCT03104868|530894474|FG001|6 Week Follow up|Withdrawal by Subject|6|||
147197650|NCT03104868|530894473|FG000|6 Week Follow up|Completed Later Timepoint|24|||
147197651|NCT03104868|530894474|FG001|6 Week Follow up|Completed Later Timepoint|22|||
147197652|NCT03104868|530894473|FG000|6 Month Follow up|Lost to Follow-up|2|||
147197653|NCT03104868|530894474|FG001|6 Month Follow up|Lost to Follow-up|2|||
147197654|NCT03104868|530894473|FG000|6 Month Follow up|Death|0|||
147197655|NCT03104868|530894474|FG001|6 Month Follow up|Death|1|||
147197656|NCT03104868|530894473|FG000|6 Month Follow up|Completed Later Timepoint|22|||
147197657|NCT03104868|530894474|FG001|6 Month Follow up|Completed Later Timepoint|32|||
147197658|NCT03104868|530894473|FG000|12 Month Follow up|Lost to Follow-up|1|||
147197659|NCT03104868|530894474|FG001|12 Month Follow up|Lost to Follow-up|2|||
147197660|NCT03104868|530894473|FG000|12 Month Follow up|Death|0|||
147197661|NCT03104868|530894474|FG001|12 Month Follow up|Death|1|||
147197662|NCT03104868|530894473|FG000|12 Month Follow up|Withdrawal by Subject|0|||
147197663|NCT03104868|530894474|FG001|12 Month Follow up|Withdrawal by Subject|3|||
147197664|NCT03104868|530894473|FG000|12 Month Follow up|Completed Later Timepoint|32|||
147197665|NCT03104868|530894474|FG001|12 Month Follow up|Completed Later Timepoint|29|||
147197666|NCT03104868|530894473|FG000|18 Month Follow up|Lost to Follow-up|7|||
147197667|NCT03104868|530894474|FG001|18 Month Follow up|Lost to Follow-up|11|||
147197668|NCT03104868|530894473|FG000|18 Month Follow up|Death|2|||
147197669|NCT03104868|530894474|FG001|18 Month Follow up|Death|1|||
147197670|NCT03104868|530894473|FG000|18 Month Follow up|Withdrawal by Subject|1|||
147197671|NCT03104868|530894474|FG001|18 Month Follow up|Withdrawal by Subject|2|||
147197672|NCT03104868|530894473|FG000|18 Month Follow up|Graft Loss|1|||
147197673|NCT03104868|530894474|FG001|18 Month Follow up|Graft Loss|1|||
147197674|NCT03104868|530894473|FG000|18 Month Follow up|Completed Later Timepoint|19|||
147197675|NCT03104868|530894474|FG001|18 Month Follow up|Completed Later Timepoint|20|||
147197676|NCT03104868|530894473|FG000|24 Month Follow up|Lost to Follow-up|15|||
147197677|NCT03104868|530894474|FG001|24 Month Follow up|Lost to Follow-up|16|||
147197678|NCT03104868|530894473|FG000|24 Month Follow up|Death|3|||
147197679|NCT03104868|530894474|FG001|24 Month Follow up|Death|2|||
147197680|NCT03104868|530894473|FG000|24 Month Follow up|Withdrawal by Subject|1|||
147197681|NCT03104868|530894474|FG001|24 Month Follow up|Withdrawal by Subject|0|||
147197682|NCT03104868|530894473|FG000|24 Month Follow up|Graft Loss|2|||
147197683|NCT03104868|530894474|FG001|24 Month Follow up|Graft Loss|0|||
147197684|NCT01253291|530894475|FG000|Overall Study|Withdrawal by Subject|1|||
147197685|NCT01253291|530894476|FG001|Overall Study|Withdrawal by Subject|1|||
147197686|NCT01253291|530894477|FG002|Overall Study|Withdrawal by Subject|0|||
147197687|NCT01253291|530894478|FG003|Overall Study|Withdrawal by Subject|0|||
147197688|NCT01253291|530894479|FG004|Overall Study|Withdrawal by Subject|0|||
147197689|NCT01253291|530894475|FG000|Overall Study|Adverse Event|0|||
147197690|NCT01253291|530894476|FG001|Overall Study|Adverse Event|1|||
147197691|NCT01253291|530894477|FG002|Overall Study|Adverse Event|0|||
147197692|NCT01253291|530894478|FG003|Overall Study|Adverse Event|0|||
147197693|NCT01253291|530894479|FG004|Overall Study|Adverse Event|0|||
147197694|NCT01253291|530894475|FG000|Overall Study|Lack of Efficacy|1|||
147197695|NCT01253291|530894476|FG001|Overall Study|Lack of Efficacy|0|||
147197696|NCT01253291|530894477|FG002|Overall Study|Lack of Efficacy|0|||
147197697|NCT01253291|530894478|FG003|Overall Study|Lack of Efficacy|0|||
147197698|NCT01253291|530894479|FG004|Overall Study|Lack of Efficacy|0|||
147197699|NCT01253291|530894475|FG000|Overall Study|Physician Decision|2|||
147197700|NCT01253291|530894476|FG001|Overall Study|Physician Decision|0|||
147197701|NCT01253291|530894477|FG002|Overall Study|Physician Decision|0|||
147197702|NCT01253291|530894478|FG003|Overall Study|Physician Decision|0|||
147197703|NCT01253291|530894479|FG004|Overall Study|Physician Decision|2|||
147197704|NCT01838395|530894483|FG000|Overall Study|Withdrawal by Subject|0|||
147197705|NCT01838395|530894484|FG001|Overall Study|Withdrawal by Subject|0|||
147197706|NCT01838395|530894485|FG002|Overall Study|Withdrawal by Subject|0|||
147197707|NCT01838395|530894486|FG003|Overall Study|Withdrawal by Subject|0|||
147197708|NCT01838395|530894487|FG004|Overall Study|Withdrawal by Subject|1|||
147197709|NCT01838395|530894488|FG005|Overall Study|Withdrawal by Subject|0|||
147197710|NCT01838395|530894483|FG000|Overall Study|Death|0|||
147197711|NCT01838395|530894484|FG001|Overall Study|Death|0|||
147197712|NCT01838395|530894485|FG002|Overall Study|Death|1|||
147197713|NCT01838395|530894486|FG003|Overall Study|Death|0|||
147197714|NCT01838395|530894487|FG004|Overall Study|Death|0|||
147197715|NCT01838395|530894488|FG005|Overall Study|Death|0|||
147197716|NCT01838395|530894483|FG000|Overall Study|started conditioning regimen prior to hematopoietic stem cell transplant|0|||
147197717|NCT01838395|530894484|FG001|Overall Study|started conditioning regimen prior to hematopoietic stem cell transplant|1|||
147197718|NCT01838395|530894485|FG002|Overall Study|started conditioning regimen prior to hematopoietic stem cell transplant|0|||
147197719|NCT01838395|530894486|FG003|Overall Study|started conditioning regimen prior to hematopoietic stem cell transplant|0|||
147197720|NCT01838395|530894487|FG004|Overall Study|started conditioning regimen prior to hematopoietic stem cell transplant|0|||
147197721|NCT01838395|530894488|FG005|Overall Study|started conditioning regimen prior to hematopoietic stem cell transplant|0|||
147197722|NCT02023086|530894495|FG000|Overall Study|Withdrawal by Subject|2|||
147197723|NCT02023086|530894496|FG001|Overall Study|Withdrawal by Subject|0|||
147197724|NCT03589859|530894499|FG000|Overall Study|Withdrawal by Subject|0|||
147197725|NCT03589859|530894500|FG001|Overall Study|Withdrawal by Subject|6|||
147197726|NCT05565742|530894502|FG000|Overall Study|Withdrawal by Subject|0|||
147197727|NCT05565742|530894503|FG001|Overall Study|Withdrawal by Subject|0|||
147197728|NCT05565742|530894504|FG002|Overall Study|Withdrawal by Subject|2|||
147197729|NCT05565742|530894505|FG003|Overall Study|Withdrawal by Subject|2|||
147197730|NCT05565742|530894506|FG004|Overall Study|Withdrawal by Subject|2|||
147197731|NCT05565742|530894502|FG000|Overall Study|Death|1|||
147197732|NCT05565742|530894503|FG001|Overall Study|Death|0|||
147197733|NCT05565742|530894504|FG002|Overall Study|Death|0|||
147197734|NCT05565742|530894505|FG003|Overall Study|Death|0|||
147197735|NCT05565742|530894506|FG004|Overall Study|Death|0|||
147197736|NCT05565742|530894502|FG000|Overall Study|Participant Travelled Abroad|0|||
147197737|NCT05565742|530894503|FG001|Overall Study|Participant Travelled Abroad|0|||
147197738|NCT05565742|530894504|FG002|Overall Study|Participant Travelled Abroad|0|||
147197739|NCT05565742|530894505|FG003|Overall Study|Participant Travelled Abroad|0|||
147197740|NCT05565742|530894506|FG004|Overall Study|Participant Travelled Abroad|1|||
147197741|NCT04163341|530894507|FG000|Overall Study|Withdrawal by Subject|2|||
147197742|NCT04163341|530894508|FG001|Overall Study|Withdrawal by Subject|0|||
147197743|NCT04163341|530894507|FG000|Overall Study|Lost to Follow-up|3|||
147197744|NCT04163341|530894508|FG001|Overall Study|Lost to Follow-up|4|||
147197745|NCT05417438|530894509|FG000|Overall Study|Withdrawal by Subject|3|||
147197746|NCT04272242|530894510|FG000|Overall Study|Withdrawal by Subject|3|||
147197747|NCT04272242|530894510|FG000|Overall Study|Lost to Follow-up|1|||
147197748|NCT04272242|530894510|FG000|Overall Study|Adverse Event|1|||
147197749|NCT02681523|530894513|FG000|Overall Study|Adverse Event|1|||
147197750|NCT02681523|530894513|FG000|Overall Study|Patient Non-compliance|1|||
147197751|NCT00129402|530896061|FG000|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0|||
147197752|NCT00129402|530896062|FG001|Start Period1 to End Period1 (Week 1-6)|Adverse Event|1|||
147197753|NCT00129402|530896063|FG002|Start Period1 to End Period1 (Week 1-6)|Adverse Event|1|||
147197754|NCT00129402|530896064|FG003|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0|||
147197755|NCT00129402|530896065|FG004|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0|||
147197756|NCT00129402|530896066|FG005|Start Period1 to End Period1 (Week 1-6)|Adverse Event|1|||
147197757|NCT00129402|530896067|FG006|Start Period1 to End Period1 (Week 1-6)|Adverse Event|0|||
147197758|NCT00129402|530896061|FG000|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
147197759|NCT00129402|530896062|FG001|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
147197760|NCT00129402|530896063|FG002|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
147197761|NCT00129402|530896064|FG003|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
147197762|NCT00129402|530896065|FG004|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
147197763|NCT00129402|530896066|FG005|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|1|||
147197764|NCT00129402|530896067|FG006|Start Period1 to End Period1 (Week 1-6)|Lost to Follow-up|0|||
147197765|NCT00129402|530896061|FG000|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
147197766|NCT00129402|530896062|FG001|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
147197767|NCT00129402|530896063|FG002|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
147197768|NCT00129402|530896064|FG003|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|1|||
147197769|NCT00129402|530896065|FG004|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
147197770|NCT00129402|530896066|FG005|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
147197771|NCT00129402|530896067|FG006|Start Period1 to End Period1 (Week 1-6)|Protocol Violation|0|||
147197772|NCT00129402|530896061|FG000|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0|||
147197773|NCT00129402|530896062|FG001|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0|||
147197774|NCT00129402|530896063|FG002|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|1|||
147197775|NCT00129402|530896064|FG003|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0|||
147197776|NCT00129402|530896065|FG004|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|1|||
147197777|NCT00129402|530896066|FG005|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0|||
147197778|NCT00129402|530896067|FG006|Start Period1 to End Period1 (Week 1-6)|Withdrawal by Subject|0|||
147197779|NCT00129402|530896061|FG000|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
147435095|NCT04313153|531760360|FG000|Overall Study|Lost to Follow-up|1|||
147306786|NCT01686581|531290762|FG000|Overall Study|Thinks Injections Too Painful|8|||
147435096|NCT04313153|531760361|FG001|Overall Study|Lost to Follow-up|0|||
147435097|NCT04313153|531760362|FG002|Overall Study|Lost to Follow-up|2|||
147435098|NCT04313153|531760360|FG000|Overall Study|Receipt of a Solid Organ, Hematopoietic Stem Cell, or Bone Marrow Transplantation|0|||
147435099|NCT04313153|531760361|FG001|Overall Study|Receipt of a Solid Organ, Hematopoietic Stem Cell, or Bone Marrow Transplantation|2|||
147435100|NCT04313153|531760362|FG002|Overall Study|Receipt of a Solid Organ, Hematopoietic Stem Cell, or Bone Marrow Transplantation|3|||
147435101|NCT04313153|531760360|FG000|Overall Study|Meeting Criteria for Trial Medication Stopping Rules|16|||
147435102|NCT04313153|531760361|FG001|Overall Study|Meeting Criteria for Trial Medication Stopping Rules|20|||
147435103|NCT04313153|531760362|FG002|Overall Study|Meeting Criteria for Trial Medication Stopping Rules|19|||
147435104|NCT04313153|531760360|FG000|Overall Study|Change in Dialysis Modality|0|||
147435105|NCT04313153|531760361|FG001|Overall Study|Change in Dialysis Modality|1|||
147435106|NCT04313153|531760362|FG002|Overall Study|Change in Dialysis Modality|2|||
147435107|NCT04313153|531760360|FG000|Overall Study|Permanent Change in Frequency of In-center Hemodialysis from TIW|1|||
147435108|NCT04313153|531760361|FG001|Overall Study|Permanent Change in Frequency of In-center Hemodialysis from TIW|0|||
147435109|NCT04313153|531760362|FG002|Overall Study|Permanent Change in Frequency of In-center Hemodialysis from TIW|0|||
147435110|NCT04313153|531760360|FG000|Overall Study|Other|5|||
147435111|NCT04313153|531760361|FG001|Overall Study|Other|3|||
147435112|NCT04313153|531760362|FG002|Overall Study|Other|2|||
147435113|NCT05586269|531760363|FG000|First Intervention (6 Weeks)|Lost to Follow-up|4|||
147435114|NCT05586269|531760364|FG001|First Intervention (6 Weeks)|Lost to Follow-up|4|||
147435115|NCT05586269|531760365|FG002|First Intervention (6 Weeks)|Lost to Follow-up|3|||
147435116|NCT05586269|531760366|FG003|First Intervention (6 Weeks)|Lost to Follow-up|3|||
147435117|NCT05586269|531760363|FG000|Second Intervention (6 Weeks)|Lost to Follow-up|0|||
147435118|NCT05586269|531760364|FG001|Second Intervention (6 Weeks)|Lost to Follow-up|0|||
147435119|NCT05586269|531760365|FG002|Second Intervention (6 Weeks)|Lost to Follow-up|1|||
147435120|NCT05586269|531760366|FG003|Second Intervention (6 Weeks)|Lost to Follow-up|1|||
147435121|NCT04752475|531760367|FG000|Overall Study|Withdrawal by Subject|1|||
147435122|NCT04752475|531760368|FG001|Overall Study|Withdrawal by Subject|1|||
147435123|NCT00523718|531760374|FG000|Overall Study|Withdrawal by Subject|1|||
147435124|NCT00523718|531760375|FG001|Overall Study|Withdrawal by Subject|0|||
147435125|NCT00523718|531760374|FG000|Overall Study|Protocol Violation|2|||
147435126|NCT00523718|531760375|FG001|Overall Study|Protocol Violation|0|||
147435127|NCT04641299|531760376|FG000|Overall Study|Adverse Event|0|||
147435128|NCT04641299|531760377|FG001|Overall Study|Adverse Event|0|||
147435129|NCT04641299|531760378|FG002|Overall Study|Adverse Event|2|||
147435130|NCT04641299|531760379|FG003|Overall Study|Adverse Event|0|||
147435131|NCT04641299|531760376|FG000|Overall Study|Lost to Follow-up|0|||
147435132|NCT04641299|531760377|FG001|Overall Study|Lost to Follow-up|1|||
147435133|NCT04641299|531760378|FG002|Overall Study|Lost to Follow-up|0|||
147435134|NCT04641299|531760379|FG003|Overall Study|Lost to Follow-up|0|||
147435135|NCT04641299|531760376|FG000|Overall Study|Withdrawal by Subject|1|||
147435136|NCT04641299|531760377|FG001|Overall Study|Withdrawal by Subject|0|||
147435137|NCT04641299|531760378|FG002|Overall Study|Withdrawal by Subject|0|||
147435138|NCT04641299|531760379|FG003|Overall Study|Withdrawal by Subject|0|||
147435139|NCT04641299|531760376|FG000|Overall Study|Reason not given|1|||
147435140|NCT04641299|531760377|FG001|Overall Study|Reason not given|0|||
147435141|NCT04641299|531760378|FG002|Overall Study|Reason not given|0|||
147435142|NCT04641299|531760379|FG003|Overall Study|Reason not given|0|||
147435143|NCT03335163|531760384|FG000|Overall Study|Not eligible due to laboratory criteria|3|||
147435144|NCT03335163|531760384|FG000|Overall Study|Withdrawal by Subject|18|||
147435145|NCT02020863|531760386|FG000|Overall Study|Discovery of Metastatic disease|4|||
147435146|NCT02020863|531760386|FG000|Overall Study|Team chose not to place an a line|1|||
147435147|NCT00352885|531760387|FG000|Overall Study|Withdrawal by Subject|0|||
147435148|NCT00352885|531760388|FG001|Overall Study|Withdrawal by Subject|3|||
147435149|NCT00352885|531760387|FG000|Overall Study|Development of major depression|0|||
147435150|NCT00352885|531760388|FG001|Overall Study|Development of major depression|1|||
147435151|NCT00352885|531760387|FG000|Overall Study|Progression of metastatic melanoma|5|||
147435152|NCT00352885|531760388|FG001|Overall Study|Progression of metastatic melanoma|3|||
147435153|NCT00352885|531760387|FG000|Overall Study|Side effects of IL-2 administration|1|||
147435154|NCT00352885|531760388|FG001|Overall Study|Side effects of IL-2 administration|0|||
147435155|NCT01920594|531760389|FG000|Overall Study|Adverse Event|4|||
147435156|NCT01920594|531760390|FG001|Overall Study|Adverse Event|2|||
147435157|NCT01920594|531760389|FG000|Overall Study|Lost to Follow-up|1|||
147435158|NCT01920594|531760390|FG001|Overall Study|Lost to Follow-up|0|||
147435159|NCT01920594|531760389|FG000|Overall Study|Recovery|2|||
147435160|NCT01920594|531760390|FG001|Overall Study|Recovery|0|||
147435161|NCT01920594|531760389|FG000|Overall Study|Investigator discretion|0|||
147435162|NCT01920594|531760390|FG001|Overall Study|Investigator discretion|1|||
147534932|NCT00320801|532114802|FG001|Open-label Run-in Period|Lost to Follow-up|0|||
147595942|NCT03096847|532338753|FG002|Overall Study|Adverse Event|28|||
147435163|NCT02973425|531760397|FG000|Overall Study|Lost to Follow-up|49|||
147435164|NCT02973425|531760398|FG001|Overall Study|Lost to Follow-up|53|||
147435165|NCT01448213|531760403|FG000|Overall Study|Lost to Follow-up|12|||
147197780|NCT00129402|530896062|FG001|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
147197781|NCT00129402|530896063|FG002|Start Period2 to End Period2 (Week 7-33)|Adverse Event|2|||
147197782|NCT00129402|530896064|FG003|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
147197783|NCT00129402|530896065|FG004|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
147197784|NCT00129402|530896066|FG005|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
147197785|NCT00129402|530896067|FG006|Start Period2 to End Period2 (Week 7-33)|Adverse Event|0|||
147197786|NCT00129402|530896061|FG000|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0|||
147197787|NCT00129402|530896062|FG001|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0|||
147197788|NCT00129402|530896063|FG002|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|3|||
147197789|NCT00129402|530896064|FG003|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0|||
147197790|NCT00129402|530896065|FG004|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0|||
147197791|NCT00129402|530896066|FG005|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|1|||
147197792|NCT00129402|530896067|FG006|Start Period2 to End Period2 (Week 7-33)|Laboratory Adverse Event|0|||
147197793|NCT00129402|530896061|FG000|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
147197794|NCT00129402|530896062|FG001|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
147197795|NCT00129402|530896063|FG002|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|1|||
147197796|NCT00129402|530896064|FG003|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
147197797|NCT00129402|530896065|FG004|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
147197798|NCT00129402|530896066|FG005|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
147197799|NCT00129402|530896067|FG006|Start Period2 to End Period2 (Week 7-33)|Lost to Follow-up|0|||
147197800|NCT00129402|530896061|FG000|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0|||
147197801|NCT00129402|530896062|FG001|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0|||
147197802|NCT00129402|530896063|FG002|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|1|||
147197803|NCT00129402|530896064|FG003|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0|||
147197804|NCT00129402|530896065|FG004|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0|||
147197805|NCT00129402|530896066|FG005|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|3|||
147197806|NCT00129402|530896067|FG006|Start Period2 to End Period2 (Week 7-33)|Withdrawal by Subject|0|||
147197807|NCT00129402|530896061|FG000|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0|||
147197808|NCT00129402|530896062|FG001|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0|||
147197809|NCT00129402|530896063|FG002|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|1|||
147197810|NCT00129402|530896064|FG003|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0|||
147197811|NCT00129402|530896065|FG004|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0|||
147197812|NCT00129402|530896066|FG005|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|1|||
147197813|NCT00129402|530896067|FG006|Start Period2 to End Period2 (Week 7-33)|Protocol Violation|0|||
147197814|NCT00129402|530896061|FG000|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
147197815|NCT00129402|530896062|FG001|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
147197816|NCT00129402|530896063|FG002|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
147197817|NCT00129402|530896064|FG003|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
147197818|NCT00129402|530896065|FG004|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
147197819|NCT00129402|530896066|FG005|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|0|||
147197820|NCT00129402|530896067|FG006|Start Period3 to End Period3(Week 34-53)|Lost to Follow-up|1|||
147197821|NCT00129402|530896061|FG000|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
147197822|NCT00129402|530896062|FG001|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
147197823|NCT00129402|530896063|FG002|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
147197824|NCT00129402|530896064|FG003|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
147197825|NCT00129402|530896065|FG004|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
147197826|NCT00129402|530896066|FG005|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|0|||
147197827|NCT00129402|530896067|FG006|Start Period3 to End Period3(Week 34-53)|Withdrawal by Subject|3|||
147197828|NCT00129402|530896061|FG000|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
147197829|NCT00129402|530896062|FG001|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
147197830|NCT00129402|530896063|FG002|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
147197831|NCT00129402|530896064|FG003|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
147197832|NCT00129402|530896065|FG004|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
147197833|NCT00129402|530896066|FG005|Start Period3 to End Period3(Week 34-53)|Subject moved|0|||
147197834|NCT00129402|530896067|FG006|Start Period3 to End Period3(Week 34-53)|Subject moved|1|||
147197835|NCT00129402|530896061|FG000|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
147197836|NCT00129402|530896062|FG001|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
147197837|NCT00129402|530896063|FG002|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
147197838|NCT00129402|530896064|FG003|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
147197839|NCT00129402|530896065|FG004|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
147306787|NCT01686581|531290762|FG000|Overall Study|Thinks Injections Take Too Much Time|2|||
147306788|NCT01686581|531290762|FG000|Overall Study|Trying to get Pregnant or Nursing|2|||
147306789|NCT01686581|531290762|FG000|Overall Study|Thinks it is Inconvenient|17|||
147197840|NCT00129402|530896066|FG005|Start Period3 to End Period3(Week 34-53)|Protocol Violation|0|||
147197841|NCT00129402|530896067|FG006|Start Period3 to End Period3(Week 34-53)|Protocol Violation|1|||
147197842|NCT03041038|530896068|FG000|Overall Study|Withdrawal by Subject|4|||
147197843|NCT03041038|530896069|FG001|Overall Study|Withdrawal by Subject|0|||
147197844|NCT03041038|530896068|FG000|Overall Study|Lost to Follow-up|1|||
147197845|NCT03041038|530896069|FG001|Overall Study|Lost to Follow-up|1|||
147197846|NCT03041038|530896068|FG000|Overall Study|Protocol Violation|1|||
147197847|NCT03041038|530896069|FG001|Overall Study|Protocol Violation|1|||
147197848|NCT02131259|530896070|FG000|Overall Study|Progressive disease|751|||
147197849|NCT02131259|530896070|FG000|Overall Study|Adverse Event|341|||
147197850|NCT02131259|530896070|FG000|Overall Study|Lost to Follow-up|7|||
147197851|NCT02131259|530896070|FG000|Overall Study|Relocation|32|||
147435166|NCT01448213|531760404|FG001|Overall Study|Lost to Follow-up|10|||
147435167|NCT01448213|531760403|FG000|Overall Study|Adverse Event|4|||
147435168|NCT01448213|531760404|FG001|Overall Study|Adverse Event|10|||
147435169|NCT01448213|531760403|FG000|Overall Study|Protocol Violation|1|||
147435170|NCT01448213|531760404|FG001|Overall Study|Protocol Violation|2|||
147435171|NCT03503513|531760405|FG000|Overall Study|First cohort faced a clinical hold which caused disruption in treatment;|4|||
147435172|NCT03503513|531760405|FG000|Overall Study|Second cohort faced changes due to pandemic, resulting in declining participant count|2|||
147435173|NCT03503513|531760405|FG000|Overall Study|Physician Decision|3|||
147435174|NCT03503513|531760405|FG000|Overall Study|Withdrawal by Subject|2|||
147435175|NCT03503513|531760405|FG000|Overall Study|Lost to Follow-up|1|||
147435176|NCT00059839|531760411|FG000|Overall Study|Death|1|||
147435177|NCT00059839|531760412|FG001|Overall Study|Death|1|||
147435178|NCT00059839|531760411|FG000|Overall Study|Lack of Efficacy|6|||
147435179|NCT00059839|531760412|FG001|Overall Study|Lack of Efficacy|5|||
147435180|NCT00059839|531760411|FG000|Overall Study|Lost to Follow-up|2|||
147435181|NCT00059839|531760412|FG001|Overall Study|Lost to Follow-up|0|||
147435182|NCT00059839|531760411|FG000|Overall Study|Physician Decision|1|||
147435183|NCT00059839|531760412|FG001|Overall Study|Physician Decision|2|||
147435184|NCT00059839|531760411|FG000|Overall Study|Withdrawal by Subject|1|||
147435185|NCT00059839|531760412|FG001|Overall Study|Withdrawal by Subject|6|||
147435186|NCT00059839|531760411|FG000|Overall Study|Ineligible|1|||
147435187|NCT00059839|531760412|FG001|Overall Study|Ineligible|3|||
147435188|NCT03842163|531760413|FG000|Overall Study|Did not meet inclusion criteria (age less than 50 years)|2|||
147435189|NCT03842163|531760413|FG000|Overall Study|Scintigraphy was not performed|44|||
147435190|NCT03829241|531760414|FG000|Randomization Phase (Week 1 to Week 8)|Withdrawal of Consent|16|||
147435191|NCT03829241|531760415|FG001|Randomization Phase (Week 1 to Week 8)|Withdrawal of Consent|19|||
147435192|NCT03829241|531760414|FG000|Randomization Phase (Week 1 to Week 8)|Lost to Follow-up|5|||
147435193|NCT03829241|531760415|FG001|Randomization Phase (Week 1 to Week 8)|Lost to Follow-up|11|||
147435194|NCT03829241|531760414|FG000|Randomization Phase (Week 1 to Week 8)|Sponsor Request|0|||
147435195|NCT03829241|531760415|FG001|Randomization Phase (Week 1 to Week 8)|Sponsor Request|1|||
147435196|NCT03829241|531760414|FG000|Randomization Phase (Week 1 to Week 8)|Adverse Event|8|||
147435197|NCT03829241|531760415|FG001|Randomization Phase (Week 1 to Week 8)|Adverse Event|9|||
147435198|NCT03829241|531760414|FG000|Randomization Phase (Week 1 to Week 8)|Non compliance|2|||
147435199|NCT03829241|531760415|FG001|Randomization Phase (Week 1 to Week 8)|Non compliance|1|||
147435200|NCT03829241|531760414|FG000|Randomization Phase (Week 1 to Week 8)|Pregnancy|0|||
147435201|NCT03829241|531760415|FG001|Randomization Phase (Week 1 to Week 8)|Pregnancy|1|||
147435202|NCT03829241|531760414|FG000|Extension Phase (Week 9 up to Week 48)|Withdrawal of Consent|20|||
147435203|NCT03829241|531760415|FG001|Extension Phase (Week 9 up to Week 48)|Withdrawal of Consent|24|||
147435204|NCT03829241|531760414|FG000|Extension Phase (Week 9 up to Week 48)|Lost to Follow-up|9|||
147435205|NCT03829241|531760415|FG001|Extension Phase (Week 9 up to Week 48)|Lost to Follow-up|7|||
147435206|NCT03829241|531760414|FG000|Extension Phase (Week 9 up to Week 48)|Physician Decision|1|||
147435207|NCT03829241|531760415|FG001|Extension Phase (Week 9 up to Week 48)|Physician Decision|0|||
147435208|NCT03829241|531760414|FG000|Extension Phase (Week 9 up to Week 48)|Sponsor Request|117|||
147435209|NCT03829241|531760415|FG001|Extension Phase (Week 9 up to Week 48)|Sponsor Request|108|||
147435210|NCT03829241|531760414|FG000|Extension Phase (Week 9 up to Week 48)|Significant Protocol Violation|0|||
147435211|NCT03829241|531760415|FG001|Extension Phase (Week 9 up to Week 48)|Significant Protocol Violation|1|||
147435212|NCT03829241|531760414|FG000|Extension Phase (Week 9 up to Week 48)|Adverse Event|11|||
147435213|NCT03829241|531760415|FG001|Extension Phase (Week 9 up to Week 48)|Adverse Event|11|||
147435214|NCT03829241|531760414|FG000|Extension Phase (Week 9 up to Week 48)|Non compliance|1|||
147435215|NCT03829241|531760415|FG001|Extension Phase (Week 9 up to Week 48)|Non compliance|1|||
147435216|NCT03829241|531760414|FG000|Extension Phase (Week 9 up to Week 48)|Pregnancy|0|||
147197852|NCT02131259|530896070|FG000|Overall Study|Other|63|||
147197853|NCT02131259|530896070|FG000|Overall Study|Progressive disease/Adverse Event (AE)|22|||
147197854|NCT02131259|530896070|FG000|Overall Study|Progressive disease/relocation|1|||
147197855|NCT02131259|530896070|FG000|Overall Study|Progressive disease/other|2|||
147435217|NCT03829241|531760415|FG001|Extension Phase (Week 9 up to Week 48)|Pregnancy|2|||
147435218|NCT00698451|531760416|FG000|Overall Study|Adverse Event|22|||
147435219|NCT00698451|531760416|FG000|Overall Study|Physician Decision|2|||
147435220|NCT00698451|531760416|FG000|Overall Study|Protocol Violation|6|||
147197856|NCT02131259|530896070|FG000|Overall Study|AE/lost to follow-up|1|||
147197857|NCT02131259|530896070|FG000|Overall Study|AE/other|1|||
147197858|NCT02131259|530896070|FG000|Overall Study|Progressive disease/AE/other|1|||
147197859|NCT02131259|530896070|FG000|Overall Study|Missing|3|||
147197860|NCT02796170|530896071|FG000|Overall Study|Lost to Follow-up|3|||
147197861|NCT02796170|530896072|FG001|Overall Study|Lost to Follow-up|0|||
147197862|NCT01527370|530896075|FG000|Overall Study|Withdrawal by Subject|4|||
147197863|NCT01527370|530896075|FG000|Overall Study|Physician Decision|1|||
147197864|NCT01527370|530896075|FG000|Overall Study|Death|1|||
147197865|NCT01352715|530896077|FG000|Overall Study|Death|3|||
147197866|NCT01352715|530896078|FG001|Overall Study|Death|3|||
147197867|NCT01352715|530896077|FG000|Overall Study|Lost to Follow-up|5|||
147197868|NCT01352715|530896078|FG001|Overall Study|Lost to Follow-up|7|||
147197869|NCT01352715|530896077|FG000|Overall Study|Withdrawal by Subject|4|||
147197870|NCT01352715|530896078|FG001|Overall Study|Withdrawal by Subject|8|||
147197871|NCT01352715|530896077|FG000|Overall Study|site closure|16|||
147197872|NCT01352715|530896078|FG001|Overall Study|site closure|15|||
147197873|NCT01352715|530896077|FG000|Overall Study|no final visit in closeout period|15|||
147197874|NCT01352715|530896078|FG001|Overall Study|no final visit in closeout period|12|||
147197875|NCT01352715|530896077|FG000|Overall Study|major ineligibility|2|||
147197876|NCT01352715|530896078|FG001|Overall Study|major ineligibility|1|||
147197877|NCT04596267|530896079|FG000|Medication Dispense/Exposure Period 1|Lost to Follow-up|1|||
147197878|NCT04596267|530896080|FG001|Medication Dispense/Exposure Period 1|Lost to Follow-up|0|||
147197879|NCT04596267|530896079|FG000|Medication Dispense/Exposure Period 1|Physician Decision|0|||
147197880|NCT04596267|530896080|FG001|Medication Dispense/Exposure Period 1|Physician Decision|1|||
147197881|NCT00071058|530896081|FG000|Overall Study|brain tumor-removed from study|1|||
147197882|NCT02000440|530896087|FG000|Overall Study|Adverse Event|3|||
147197883|NCT02000440|530896087|FG000|Overall Study|Other-Protocol-defined Stopping Criteria|1|||
147197884|NCT01690143|530896088|FG000|Overall Study|Withdrawal by Subject|1|||
147197885|NCT00870740|530896094|FG000|Overall Study|Adverse Event|2|||
147197886|NCT00870740|530896095|FG001|Overall Study|Adverse Event|1|||
147197887|NCT00870740|530896096|FG002|Overall Study|Adverse Event|3|||
147197888|NCT00870740|530896097|FG003|Overall Study|Adverse Event|2|||
147197889|NCT00870740|530896098|FG004|Overall Study|Adverse Event|1|||
147197890|NCT00870740|530896099|FG005|Overall Study|Adverse Event|6|||
147197891|NCT00870740|530896094|FG000|Overall Study|Consent Withdrawn|6|||
147197892|NCT00870740|530896095|FG001|Overall Study|Consent Withdrawn|3|||
147197893|NCT00870740|530896096|FG002|Overall Study|Consent Withdrawn|4|||
147197894|NCT00870740|530896097|FG003|Overall Study|Consent Withdrawn|6|||
147197895|NCT00870740|530896098|FG004|Overall Study|Consent Withdrawn|6|||
147197896|NCT00870740|530896099|FG005|Overall Study|Consent Withdrawn|5|||
147197897|NCT00870740|530896094|FG000|Overall Study|Investigator Decision|2|||
147197898|NCT00870740|530896095|FG001|Overall Study|Investigator Decision|0|||
147197899|NCT00870740|530896096|FG002|Overall Study|Investigator Decision|1|||
147197900|NCT00870740|530896097|FG003|Overall Study|Investigator Decision|0|||
147197901|NCT00870740|530896098|FG004|Overall Study|Investigator Decision|0|||
147197902|NCT00870740|530896099|FG005|Overall Study|Investigator Decision|0|||
147197903|NCT00870740|530896094|FG000|Overall Study|Subject Non-compliance|0|||
147197904|NCT00870740|530896095|FG001|Overall Study|Subject Non-compliance|0|||
147197905|NCT00870740|530896096|FG002|Overall Study|Subject Non-compliance|0|||
147197906|NCT00870740|530896097|FG003|Overall Study|Subject Non-compliance|0|||
147197907|NCT00870740|530896098|FG004|Overall Study|Subject Non-compliance|0|||
147197908|NCT00870740|530896099|FG005|Overall Study|Subject Non-compliance|1|||
147197909|NCT00870740|530896094|FG000|Overall Study|Death|0|||
147197910|NCT00870740|530896095|FG001|Overall Study|Death|0|||
147197911|NCT00870740|530896096|FG002|Overall Study|Death|0|||
147197912|NCT00870740|530896097|FG003|Overall Study|Death|0|||
147197913|NCT00870740|530896098|FG004|Overall Study|Death|1|||
147197914|NCT00870740|530896099|FG005|Overall Study|Death|0|||
147197915|NCT00870740|530896094|FG000|Overall Study|Other|2|||
147197916|NCT00870740|530896095|FG001|Overall Study|Other|5|||
147197917|NCT00870740|530896096|FG002|Overall Study|Other|2|||
147197918|NCT00870740|530896097|FG003|Overall Study|Other|4|||
147197919|NCT00870740|530896098|FG004|Overall Study|Other|3|||
147197920|NCT00870740|530896099|FG005|Overall Study|Other|5|||
147197921|NCT00283296|530896109|FG000|Overall Study|in-home trial not completed|5|||
147197922|NCT01353898|530896110|FG000|Overall Study|Study site terminated|0|||
147197923|NCT01353898|530896111|FG001|Overall Study|Study site terminated|0|||
147197924|NCT01353898|530896112|FG002|Overall Study|Study site terminated|0|||
147197925|NCT01353898|530896113|FG003|Overall Study|Study site terminated|0|||
147197926|NCT01353898|530896114|FG004|Overall Study|Study site terminated|0|||
147197927|NCT01353898|530896115|FG005|Overall Study|Study site terminated|1|||
147197928|NCT02668653|530896116|FG000|Overall Study|Refractory disease|41|||
147197929|NCT02668653|530896117|FG001|Overall Study|Refractory disease|70|||
147197930|NCT02668653|530896116|FG000|Overall Study|Relapse|44|||
147197931|NCT02668653|530896117|FG001|Overall Study|Relapse|65|||
147197932|NCT02668653|530896116|FG000|Overall Study|Adverse Event|58|||
147197933|NCT02668653|530896117|FG001|Overall Study|Adverse Event|23|||
147197934|NCT02668653|530896116|FG000|Overall Study|Subject decision to stop study drug|25|||
147197935|NCT02668653|530896117|FG001|Overall Study|Subject decision to stop study drug|23|||
147197936|NCT02668653|530896116|FG000|Overall Study|Other reasons not specified|16|||
147197937|NCT02668653|530896117|FG001|Overall Study|Other reasons not specified|11|||
147197938|NCT02668653|530896116|FG000|Overall Study|Non-protocol-specified AML therapy|12|||
147197939|NCT02668653|530896117|FG001|Overall Study|Non-protocol-specified AML therapy|6|||
147197940|NCT02668653|530896116|FG000|Overall Study|Investigator decision|10|||
147197941|NCT02668653|530896117|FG001|Overall Study|Investigator decision|7|||
147197942|NCT02668653|530896116|FG000|Overall Study|Failure to meet continuation criteria|5|||
147197943|NCT02668653|530896117|FG001|Overall Study|Failure to meet continuation criteria|12|||
147197944|NCT02668653|530896116|FG000|Overall Study|Lost to Follow-up|1|||
147197945|NCT02668653|530896117|FG001|Overall Study|Lost to Follow-up|0|||
147197946|NCT02668653|530896116|FG000|Overall Study|Pregnancy|0|||
147197947|NCT02668653|530896117|FG001|Overall Study|Pregnancy|1|||
147197948|NCT02668653|530896116|FG000|Overall Study|Death|0|||
147197949|NCT02668653|530896117|FG001|Overall Study|Death|1|||
147197950|NCT03558737|530896118|FG000|Overall Study|Death|1|||
147197951|NCT03558737|530896119|FG001|Overall Study|Death|1|||
147197952|NCT01294553|530896120|FG000|Overall Study|Duplicated Participants|1|||
147197953|NCT01294553|530896120|FG000|Overall Study|Protocol Violation|268|||
147197954|NCT03041181|530896121|FG000|Overall Study|Disease Progression|1|||
147197955|NCT03041181|530896122|FG001|Overall Study|Disease Progression|2|||
147197956|NCT03224819|530896123|FG000|Overall Study|Withdrawal by Subject|0|||
147197957|NCT03224819|530896124|FG001|Overall Study|Withdrawal by Subject|0|||
147197958|NCT03224819|530896125|FG002|Overall Study|Withdrawal by Subject|0|||
147197959|NCT03224819|530896126|FG003|Overall Study|Withdrawal by Subject|0|||
147197960|NCT03224819|530896127|FG004|Overall Study|Withdrawal by Subject|0|||
147197961|NCT03224819|530896128|FG005|Overall Study|Withdrawal by Subject|0|||
147197962|NCT03224819|530896129|FG006|Overall Study|Withdrawal by Subject|0|||
147197963|NCT03224819|530896130|FG007|Overall Study|Withdrawal by Subject|0|||
147197964|NCT03224819|530896131|FG008|Overall Study|Withdrawal by Subject|0|||
147197965|NCT03224819|530896132|FG009|Overall Study|Withdrawal by Subject|0|||
147197966|NCT03224819|530896133|FG010|Overall Study|Withdrawal by Subject|0|||
147197967|NCT03224819|530896134|FG011|Overall Study|Withdrawal by Subject|0|||
147197968|NCT03224819|530896135|FG012|Overall Study|Withdrawal by Subject|1|||
147197969|NCT03224819|530896136|FG013|Overall Study|Withdrawal by Subject|0|||
147197970|NCT03224819|530896123|FG000|Overall Study|Sponsor Decision|0|||
147197971|NCT03224819|530896124|FG001|Overall Study|Sponsor Decision|0|||
147197972|NCT03224819|530896125|FG002|Overall Study|Sponsor Decision|0|||
147197973|NCT03224819|530896126|FG003|Overall Study|Sponsor Decision|1|||
147197974|NCT03224819|530896127|FG004|Overall Study|Sponsor Decision|1|||
147197975|NCT03224819|530896128|FG005|Overall Study|Sponsor Decision|2|||
147197976|NCT03224819|530896129|FG006|Overall Study|Sponsor Decision|1|||
147197977|NCT03224819|530896130|FG007|Overall Study|Sponsor Decision|1|||
147197978|NCT03224819|530896131|FG008|Overall Study|Sponsor Decision|1|||
147197979|NCT03224819|530896132|FG009|Overall Study|Sponsor Decision|2|||
147197980|NCT03224819|530896133|FG010|Overall Study|Sponsor Decision|1|||
147197981|NCT03224819|530896134|FG011|Overall Study|Sponsor Decision|1|||
147197982|NCT03224819|530896135|FG012|Overall Study|Sponsor Decision|1|||
147197983|NCT03224819|530896136|FG013|Overall Study|Sponsor Decision|0|||
147197984|NCT03224819|530896123|FG000|Overall Study|Lost to Follow-up|0|||
147197985|NCT03224819|530896124|FG001|Overall Study|Lost to Follow-up|0|||
147197986|NCT03224819|530896125|FG002|Overall Study|Lost to Follow-up|0|||
147197987|NCT03224819|530896126|FG003|Overall Study|Lost to Follow-up|0|||
147197988|NCT03224819|530896127|FG004|Overall Study|Lost to Follow-up|0|||
147197989|NCT03224819|530896128|FG005|Overall Study|Lost to Follow-up|0|||
147197990|NCT03224819|530896129|FG006|Overall Study|Lost to Follow-up|0|||
147197991|NCT03224819|530896130|FG007|Overall Study|Lost to Follow-up|0|||
147197992|NCT03224819|530896131|FG008|Overall Study|Lost to Follow-up|1|||
147197993|NCT03224819|530896132|FG009|Overall Study|Lost to Follow-up|0|||
147197994|NCT03224819|530896133|FG010|Overall Study|Lost to Follow-up|0|||
147197995|NCT03224819|530896134|FG011|Overall Study|Lost to Follow-up|0|||
147197996|NCT03224819|530896135|FG012|Overall Study|Lost to Follow-up|0|||
147197997|NCT03224819|530896136|FG013|Overall Study|Lost to Follow-up|0|||
147197998|NCT03224819|530896123|FG000|Overall Study|Death|0|||
147197999|NCT03224819|530896124|FG001|Overall Study|Death|1|||
147198000|NCT03224819|530896125|FG002|Overall Study|Death|0|||
147198001|NCT03224819|530896126|FG003|Overall Study|Death|0|||
147435221|NCT00698451|531760416|FG000|Overall Study|Withdrawal by Subject|6|||
147198002|NCT03224819|530896127|FG004|Overall Study|Death|0|||
147198003|NCT03224819|530896128|FG005|Overall Study|Death|0|||
147198004|NCT03224819|530896129|FG006|Overall Study|Death|0|||
147198005|NCT03224819|530896130|FG007|Overall Study|Death|1|||
147198006|NCT03224819|530896131|FG008|Overall Study|Death|0|||
147198007|NCT03224819|530896132|FG009|Overall Study|Death|0|||
147198008|NCT03224819|530896133|FG010|Overall Study|Death|0|||
147198009|NCT03224819|530896134|FG011|Overall Study|Death|1|||
147198010|NCT03224819|530896135|FG012|Overall Study|Death|0|||
147198011|NCT03224819|530896136|FG013|Overall Study|Death|0|||
147198012|NCT00005780|530896139|FG000|Vaccine Administration Following EPOCH-R|Participant progressed before receiving the last vaccine.|1|||
147435222|NCT00698451|531760416|FG000|Overall Study|Disease progression|3|||
147198013|NCT04973449|530896140|FG000|Overall Study|Withdrawal by Subject|3|||
147198014|NCT04973449|530896141|FG001|Overall Study|Withdrawal by Subject|3|||
147198015|NCT04973449|530896142|FG002|Overall Study|Withdrawal by Subject|2|||
147198016|NCT04973449|530896143|FG003|Overall Study|Withdrawal by Subject|5|||
147198017|NCT04973449|530896144|FG004|Overall Study|Withdrawal by Subject|5|||
147198018|NCT04973449|530896145|FG005|Overall Study|Withdrawal by Subject|4|||
147198019|NCT04973449|530896146|FG006|Overall Study|Withdrawal by Subject|7|||
147198020|NCT04973449|530896147|FG007|Overall Study|Withdrawal by Subject|5|||
147198021|NCT04973449|530896140|FG000|Overall Study|Lost to Follow-up|15|||
147198022|NCT04973449|530896141|FG001|Overall Study|Lost to Follow-up|16|||
147198023|NCT04973449|530896142|FG002|Overall Study|Lost to Follow-up|16|||
147198024|NCT04973449|530896143|FG003|Overall Study|Lost to Follow-up|13|||
147198025|NCT04973449|530896144|FG004|Overall Study|Lost to Follow-up|5|||
147198026|NCT04973449|530896145|FG005|Overall Study|Lost to Follow-up|6|||
147198027|NCT04973449|530896146|FG006|Overall Study|Lost to Follow-up|10|||
147198028|NCT04973449|530896147|FG007|Overall Study|Lost to Follow-up|6|||
147198029|NCT04973449|530896140|FG000|Overall Study|Death|1|||
147198030|NCT04973449|530896141|FG001|Overall Study|Death|0|||
147198031|NCT04973449|530896142|FG002|Overall Study|Death|0|||
147198032|NCT04973449|530896143|FG003|Overall Study|Death|0|||
147198033|NCT04973449|530896144|FG004|Overall Study|Death|0|||
147198034|NCT04973449|530896145|FG005|Overall Study|Death|1|||
147198035|NCT04973449|530896146|FG006|Overall Study|Death|0|||
147198036|NCT04973449|530896147|FG007|Overall Study|Death|0|||
147198037|NCT04973449|530896140|FG000|Overall Study|Other|1|||
147198038|NCT04973449|530896141|FG001|Overall Study|Other|1|||
147198039|NCT04973449|530896142|FG002|Overall Study|Other|2|||
147198040|NCT04973449|530896143|FG003|Overall Study|Other|1|||
147198041|NCT04973449|530896144|FG004|Overall Study|Other|4|||
147198042|NCT04973449|530896145|FG005|Overall Study|Other|0|||
147198043|NCT04973449|530896146|FG006|Overall Study|Other|2|||
147198044|NCT04973449|530896147|FG007|Overall Study|Other|2|||
147198045|NCT00829426|530896152|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
147198046|NCT00829426|530896153|FG001|Washout: 7 Days|Withdrawal by Subject|0|||
147198047|NCT03955146|530896154|FG000|DB Period (48 Weeks)|Study terminated by sponsor|0|||
147198048|NCT03955146|530896155|FG001|DB Period (48 Weeks)|Study terminated by sponsor|0|||
147435223|NCT02224599|531760419|FG000|Overall Study|Physician Decision|1|||
147435224|NCT02224599|531760419|FG000|Overall Study|Progression of Disease|1|||
147435225|NCT01330914|531760422|FG000|Overall Study|Withdrawal by Subject|4|||
147435226|NCT01330914|531760422|FG000|Overall Study|No longer eligible (sleeve gastrectomy)|3|||
147435227|NCT02308007|531760434|FG000|Overall Study|Normal Gram stain or neg yeast culture|66|||
147435228|NCT02308007|531760435|FG001|Overall Study|Normal Gram stain or neg yeast culture|64|||
147435229|NCT02308007|531760436|FG002|Overall Study|Normal Gram stain or neg yeast culture|67|||
147435230|NCT02308007|531760434|FG000|Overall Study|Positive for STD at Baseline|7|||
147435231|NCT02308007|531760435|FG001|Overall Study|Positive for STD at Baseline|11|||
147435232|NCT02308007|531760436|FG002|Overall Study|Positive for STD at Baseline|7|||
147435233|NCT02308007|531760434|FG000|Overall Study|Lost to Follow-up|3|||
147435234|NCT02308007|531760435|FG001|Overall Study|Lost to Follow-up|0|||
147435235|NCT02308007|531760436|FG002|Overall Study|Lost to Follow-up|1|||
147435236|NCT00528567|531760437|FG000|Overall Study|Death|4|||
147435237|NCT00528567|531760438|FG001|Overall Study|Death|5|||
147435238|NCT00528567|531760437|FG000|Overall Study|Breast Cancer Recurrence/2nd Primary|30|||
147435239|NCT00528567|531760438|FG001|Overall Study|Breast Cancer Recurrence/2nd Primary|60|||
147435240|NCT00528567|531760437|FG000|Overall Study|Adverse Event/Intermittent Illness|255|||
147435241|NCT00528567|531760438|FG001|Overall Study|Adverse Event/Intermittent Illness|29|||
147435242|NCT00528567|531760437|FG000|Overall Study|Violation Criteria at Entry|3|||
147435243|NCT00528567|531760438|FG001|Overall Study|Violation Criteria at Entry|17|||
147435244|NCT00528567|531760437|FG000|Overall Study|Withdrew Consent|59|||
147435245|NCT00528567|531760438|FG001|Overall Study|Withdrew Consent|55|||
147435246|NCT00528567|531760437|FG000|Overall Study|Refused Treatment/Did Not Cooperate|52|||
147435247|NCT00528567|531760438|FG001|Overall Study|Refused Treatment/Did Not Cooperate|42|||
147435248|NCT00528567|531760437|FG000|Overall Study|Failure to Return|1|||
147435249|NCT00528567|531760438|FG001|Overall Study|Failure to Return|4|||
147435250|NCT00528567|531760437|FG000|Overall Study|Other Protocol Violation|5|||
147435251|NCT00528567|531760438|FG001|Overall Study|Other Protocol Violation|21|||
147435252|NCT00528567|531760437|FG000|Overall Study|Administrative/Other|22|||
147435253|NCT00528567|531760438|FG001|Overall Study|Administrative/Other|75|||
147435254|NCT03085758|531760441|FG000|Overall Study|Death|26|||
147435255|NCT03085758|531760442|FG001|Overall Study|Death|24|||
147198049|NCT03955146|530896156|FG002|DB Period (48 Weeks)|Study terminated by sponsor|1|||
147198050|NCT03955146|530896157|FG003|DB Period (48 Weeks)|Study terminated by sponsor|4|||
147198051|NCT03955146|530896154|FG000|DB Period (48 Weeks)|Adverse Event|2|||
147198052|NCT03955146|530896155|FG001|DB Period (48 Weeks)|Adverse Event|5|||
147198053|NCT03955146|530896156|FG002|DB Period (48 Weeks)|Adverse Event|1|||
147198054|NCT03955146|530896157|FG003|DB Period (48 Weeks)|Adverse Event|2|||
147435256|NCT03085758|531760443|FG002|Overall Study|Death|53|||
147435257|NCT03085758|531760441|FG000|Overall Study|Lost to Follow-up|1|||
147198055|NCT03955146|530896154|FG000|DB Period (48 Weeks)|Death|13|||
147198056|NCT03955146|530896155|FG001|DB Period (48 Weeks)|Death|17|||
147198057|NCT03955146|530896156|FG002|DB Period (48 Weeks)|Death|1|||
147198058|NCT03955146|530896157|FG003|DB Period (48 Weeks)|Death|0|||
147198059|NCT03955146|530896154|FG000|DB Period (48 Weeks)|Investigator Decision|2|||
147198060|NCT03955146|530896155|FG001|DB Period (48 Weeks)|Investigator Decision|2|||
147198061|NCT03955146|530896156|FG002|DB Period (48 Weeks)|Investigator Decision|0|||
147198062|NCT03955146|530896157|FG003|DB Period (48 Weeks)|Investigator Decision|0|||
147198063|NCT03955146|530896154|FG000|DB Period (48 Weeks)|Disease Progression|2|||
147198064|NCT03955146|530896155|FG001|DB Period (48 Weeks)|Disease Progression|0|||
147198065|NCT03955146|530896156|FG002|DB Period (48 Weeks)|Disease Progression|0|||
147198066|NCT03955146|530896157|FG003|DB Period (48 Weeks)|Disease Progression|0|||
147198067|NCT03955146|530896154|FG000|DB Period (48 Weeks)|Withdrawal by Subject|6|||
147198068|NCT03955146|530896155|FG001|DB Period (48 Weeks)|Withdrawal by Subject|3|||
147198069|NCT03955146|530896156|FG002|DB Period (48 Weeks)|Withdrawal by Subject|0|||
147198070|NCT03955146|530896157|FG003|DB Period (48 Weeks)|Withdrawal by Subject|1|||
147198071|NCT03955146|530896154|FG000|DB Period (48 Weeks)|Noncompliance with the Study Drug|1|||
147198072|NCT03955146|530896155|FG001|DB Period (48 Weeks)|Noncompliance with the Study Drug|1|||
147198073|NCT03955146|530896156|FG002|DB Period (48 Weeks)|Noncompliance with the Study Drug|0|||
147198074|NCT03955146|530896157|FG003|DB Period (48 Weeks)|Noncompliance with the Study Drug|0|||
147198075|NCT03955146|530896154|FG000|DB Period (48 Weeks)|Lung Transplant|0|||
147198076|NCT03955146|530896155|FG001|DB Period (48 Weeks)|Lung Transplant|1|||
147435258|NCT03085758|531760442|FG001|Overall Study|Lost to Follow-up|1|||
147435259|NCT03085758|531760443|FG002|Overall Study|Lost to Follow-up|1|||
147198077|NCT03955146|530896156|FG002|DB Period (48 Weeks)|Lung Transplant|0|||
147198078|NCT03955146|530896157|FG003|DB Period (48 Weeks)|Lung Transplant|0|||
147198079|NCT03955146|530896154|FG000|DB Period (48 Weeks)|Participant Decision|9|||
147198080|NCT03955146|530896155|FG001|DB Period (48 Weeks)|Participant Decision|12|||
147198081|NCT03955146|530896156|FG002|DB Period (48 Weeks)|Participant Decision|1|||
147198082|NCT03955146|530896157|FG003|DB Period (48 Weeks)|Participant Decision|1|||
147198083|NCT03955146|530896154|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Adverse Event|7|||
147198084|NCT03955146|530896155|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Adverse Event|1|||
147198085|NCT03955146|530896156|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Adverse Event|0|||
147198086|NCT03955146|530896157|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Adverse Event|0|||
147198087|NCT03955146|530896154|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Death|12|||
147198088|NCT03955146|530896155|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Death|12|||
147198089|NCT03955146|530896156|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Death|0|||
147198090|NCT03955146|530896157|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Death|0|||
147198091|NCT03955146|530896154|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Lost to Follow-up|0|||
147198092|NCT03955146|530896155|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Lost to Follow-up|1|||
147198093|NCT03955146|530896156|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Lost to Follow-up|0|||
147198094|NCT03955146|530896157|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Lost to Follow-up|0|||
147198095|NCT03955146|530896154|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Investigator Decision|2|||
147198096|NCT03955146|530896155|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Investigator Decision|2|||
147198097|NCT03955146|530896156|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Investigator Decision|0|||
147198098|NCT03955146|530896157|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Investigator Decision|0|||
147198099|NCT03955146|530896154|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Study terminated by sponsor|84|||
147198100|NCT03955146|530896155|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Study terminated by sponsor|88|||
147198101|NCT03955146|530896156|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Study terminated by sponsor|0|||
147198102|NCT03955146|530896157|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Study terminated by sponsor|0|||
147198103|NCT03955146|530896154|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Disease Progression|1|||
147198104|NCT03955146|530896155|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Disease Progression|0|||
147198105|NCT03955146|530896156|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Disease Progression|0|||
147198106|NCT03955146|530896157|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Disease Progression|0|||
147198107|NCT03955146|530896154|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Withdrawal by Subject|7|||
147198108|NCT03955146|530896155|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Withdrawal by Subject|5|||
147198109|NCT03955146|530896156|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Withdrawal by Subject|0|||
147198110|NCT03955146|530896157|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Withdrawal by Subject|0|||
147198111|NCT03955146|530896154|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Lung Transplant|2|||
147198112|NCT03955146|530896155|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Lung Transplant|1|||
147198113|NCT03955146|530896156|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Lung Transplant|0|||
147198114|NCT03955146|530896157|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Lung Transplant|0|||
147198115|NCT03955146|530896154|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Protocol Deviation|1|||
147198116|NCT03955146|530896155|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Protocol Deviation|0|||
147198117|NCT03955146|530896156|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Protocol Deviation|0|||
147198118|NCT03955146|530896157|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Protocol Deviation|0|||
147198119|NCT03955146|530896154|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Participant Decision|12|||
147198120|NCT03955146|530896155|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Participant Decision|13|||
147198121|NCT03955146|530896156|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Participant Decision|0|||
147198122|NCT03955146|530896157|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Participant Decision|0|||
147198123|NCT03955146|530896154|FG000|OLE (Maximum Exposure: 153.1 Weeks)|Other than specified|1|||
147198124|NCT03955146|530896155|FG001|OLE (Maximum Exposure: 153.1 Weeks)|Other than specified|0|||
147198125|NCT03955146|530896156|FG002|OLE (Maximum Exposure: 153.1 Weeks)|Other than specified|0|||
147198126|NCT03955146|530896157|FG003|OLE (Maximum Exposure: 153.1 Weeks)|Other than specified|0|||
147198127|NCT02628873|530896158|FG000|Break (1 Hour)|Withdrawal by Subject|0|||
147198128|NCT02628873|530896159|FG001|Break (1 Hour)|Withdrawal by Subject|1|||
147198129|NCT02628873|530896158|FG000|Second Test (1 Hour)|Physician Decision|1|||
147198130|NCT02628873|530896159|FG001|Second Test (1 Hour)|Physician Decision|0|||
147198131|NCT03597347|530896163|FG000|Overall Study|Withdrawal by Subject|1|||
147198132|NCT03597347|530896164|FG001|Overall Study|Withdrawal by Subject|1|||
147198133|NCT03597347|530896165|FG002|Overall Study|Withdrawal by Subject|0|||
147198134|NCT03597347|530896163|FG000|Overall Study|Withdrawal due to Covid-19|3|||
147198135|NCT03597347|530896164|FG001|Overall Study|Withdrawal due to Covid-19|0|||
147198136|NCT03597347|530896165|FG002|Overall Study|Withdrawal due to Covid-19|0|||
147198137|NCT03597347|530896163|FG000|Overall Study|Sponsor decision to terminate study|3|||
147198138|NCT03597347|530896164|FG001|Overall Study|Sponsor decision to terminate study|2|||
147198139|NCT03597347|530896165|FG002|Overall Study|Sponsor decision to terminate study|4|||
147198140|NCT04606134|530896166|FG000|Overall Study|Adverse Event|0|||
147198141|NCT04606134|530896167|FG001|Overall Study|Adverse Event|1|||
147198142|NCT00107653|530896168|FG000|Overall Study|Adverse Event|24|||
147198143|NCT00107653|530896169|FG001|Overall Study|Adverse Event|43|||
147198144|NCT00107653|530896168|FG000|Overall Study|Insufficient Therapeutic Response|25|||
147198145|NCT00107653|530896169|FG001|Overall Study|Insufficient Therapeutic Response|11|||
147198146|NCT00107653|530896168|FG000|Overall Study|Violation of Selection Criteria at Entry|1|||
147198147|NCT00107653|530896169|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
147198148|NCT00107653|530896168|FG000|Overall Study|Protocol Violation|1|||
147198149|NCT00107653|530896169|FG001|Overall Study|Protocol Violation|0|||
147198150|NCT00107653|530896168|FG000|Overall Study|Withdrawal by Subject|12|||
147198151|NCT00107653|530896169|FG001|Overall Study|Withdrawal by Subject|13|||
147198152|NCT00107653|530896168|FG000|Overall Study|Lost to Follow-up|13|||
147198153|NCT00107653|530896169|FG001|Overall Study|Lost to Follow-up|5|||
147198154|NCT00107653|530896168|FG000|Overall Study|Administrative Reasons|3|||
147198155|NCT00107653|530896169|FG001|Overall Study|Administrative Reasons|3|||
147198156|NCT01099267|530896171|FG000|MDS-003 Study|Adverse Event|37|||
147198157|NCT01099267|530896171|FG000|MDS-003 Study|Lack of Efficacy|52|||
147198158|NCT01099267|530896171|FG000|MDS-003 Study|Withdrawal by Subject|8|||
147198159|NCT01099267|530896171|FG000|MDS-003 Study|Lost to Follow-up|1|||
147198160|NCT01099267|530896171|FG000|MDS-003 Study|Death|11|||
147198161|NCT01099267|530896171|FG000|MDS-003 Study|Study Closed by Sponsor|2|||
147198162|NCT01099267|530896171|FG000|MDS-003 Study|Disease Progression|7|||
147198163|NCT01099267|530896171|FG000|MDS-003 Study|Investigator Decision|2|||
147198164|NCT01099267|530896171|FG000|MDS-003 Study|Non-Compliance|2|||
147198165|NCT01099267|530896171|FG000|MDS-003 Study|Loss of Response|1|||
147198166|NCT01099267|530896171|FG000|MDS-003 Study|Secondary Malign Disease|1|||
147198167|NCT04986904|530896172|FG000|Overall Study|Lost to Follow-up|11|||
147198168|NCT04986904|530896172|FG000|Overall Study|Withdrawal by Subject|1|||
147198169|NCT02018562|530896177|FG000|Overall Study|Withdrawal by Subject|2|||
147198170|NCT02018562|530896178|FG001|Overall Study|Withdrawal by Subject|0|||
147198171|NCT02018562|530896177|FG000|Overall Study|Discharged prior to study completion|1|||
147198172|NCT02018562|530896178|FG001|Overall Study|Discharged prior to study completion|0|||
147198173|NCT04050553|530896188|FG000|Period 1|Physician Decision|2|||
147198174|NCT04050553|530896189|FG001|Period 1|Physician Decision|2|||
147198175|NCT04050553|530896188|FG000|Period 1|Adverse Event|1|||
147198176|NCT04050553|530896189|FG001|Period 1|Adverse Event|1|||
147198177|NCT04050553|530896188|FG000|Period 1|Withdrawal by Subject|0|||
147198178|NCT04050553|530896189|FG001|Period 1|Withdrawal by Subject|1|||
147198179|NCT04050553|530896188|FG000|Wash-out|Adverse Event|0|||
147198180|NCT04050553|530896189|FG001|Wash-out|Adverse Event|1|||
147198181|NCT04050553|530896188|FG000|Wash-out|Withdrawal by Subject|0|||
147198182|NCT04050553|530896189|FG001|Wash-out|Withdrawal by Subject|1|||
147198183|NCT05430854|530896190|FG000|Overall Study|Trial terminated by Sponsor|39|||
147198184|NCT05430854|530896191|FG001|Overall Study|Trial terminated by Sponsor|50|||
147198185|NCT05430854|530896192|FG002|Overall Study|Trial terminated by Sponsor|46|||
147198186|NCT05430854|530896190|FG000|Overall Study|Withdrawal by Subject|0|||
147198187|NCT05430854|530896191|FG001|Overall Study|Withdrawal by Subject|3|||
147198188|NCT05430854|530896192|FG002|Overall Study|Withdrawal by Subject|0|||
147198189|NCT04314284|530896193|FG000|Overall Study|Withdrawal by Subject|4|||
147198190|NCT04314284|530896194|FG001|Overall Study|Withdrawal by Subject|7|||
147198191|NCT04314284|530896193|FG000|Overall Study|Consented but did not complete survey|0|||
147198192|NCT04314284|530896194|FG001|Overall Study|Consented but did not complete survey|6|||
147198193|NCT01652235|530896198|FG000|Overall Study|Death|9|||
147198194|NCT01652235|530896198|FG000|Overall Study|Lost to Follow-up|5|||
147198195|NCT01652235|530896198|FG000|Overall Study|Withdrawal by Subject|2|||
147198196|NCT03472885|530896199|FG000|24-Week Treatment Period|Adverse Event|1|||
147198197|NCT02201953|530896200|FG000|Overall Study|Randomized but Never Treated|1|||
147198198|NCT02201953|530896201|FG001|Overall Study|Randomized but Never Treated|5|||
147198199|NCT02201953|530896200|FG000|Overall Study|Lack of Efficacy|9|||
147198200|NCT02201953|530896201|FG001|Overall Study|Lack of Efficacy|30|||
147198201|NCT02201953|530896200|FG000|Overall Study|Lost to Follow-up|8|||
147198202|NCT02201953|530896201|FG001|Overall Study|Lost to Follow-up|8|||
147198203|NCT02201953|530896200|FG000|Overall Study|Withdrew Consent|2|||
147198204|NCT02201953|530896201|FG001|Overall Study|Withdrew Consent|5|||
147198205|NCT02201953|530896200|FG000|Overall Study|Adverse Event|0|||
147198206|NCT02201953|530896201|FG001|Overall Study|Adverse Event|5|||
147198207|NCT02201953|530896200|FG000|Overall Study|Death|0|||
147534933|NCT00320801|532114803|FG002|Open-label Run-in Period|Lost to Follow-up|0|||
147198208|NCT02201953|530896201|FG001|Overall Study|Death|3|||
147198209|NCT01710501|530898792|FG000|Overall Study|Lost to Follow-up|2|||
147198210|NCT01710501|530898793|FG001|Overall Study|Lost to Follow-up|0|||
147198211|NCT01710501|530898794|FG002|Overall Study|Lost to Follow-up|0|||
147198212|NCT02536976|530898795|FG000|Overall Study|Physician Decision|0|||
147198213|NCT02536976|530898796|FG001|Overall Study|Physician Decision|1|||
147198214|NCT01198795|530898797|FG000|Overall Study|Did not meet InclusionExclusion criteria|30|||
147198215|NCT01198795|530898797|FG000|Overall Study|Withdrawal by Subject|17|||
147198216|NCT01198795|530898797|FG000|Overall Study|Lost to Follow-up|15|||
147198217|NCT01198795|530898797|FG000|Overall Study|Adverse Event|9|||
147198218|NCT01198795|530898797|FG000|Overall Study|Lack of Efficacy|5|||
147198219|NCT01198795|530898797|FG000|Overall Study|Protocol Violation|2|||
147198220|NCT01198795|530898797|FG000|Overall Study|Other Reason|4|||
147198221|NCT01472289|530898800|FG000|Overall Study|Death|2|||
147198222|NCT02435992|530898801|FG000|Overall Study|non compliance with protocol|2|||
147198223|NCT02435992|530898802|FG001|Overall Study|non compliance with protocol|0|||
147198224|NCT02435992|530898803|FG002|Overall Study|non compliance with protocol|1|||
147198225|NCT02435992|530898804|FG003|Overall Study|non compliance with protocol|0|||
147198226|NCT02435992|530898805|FG004|Overall Study|non compliance with protocol|0|||
147198227|NCT02435992|530898801|FG000|Overall Study|Adverse Event|11|||
147198228|NCT02435992|530898802|FG001|Overall Study|Adverse Event|6|||
147198229|NCT02435992|530898803|FG002|Overall Study|Adverse Event|12|||
147198230|NCT02435992|530898804|FG003|Overall Study|Adverse Event|0|||
147198231|NCT02435992|530898805|FG004|Overall Study|Adverse Event|0|||
147198232|NCT02435992|530898801|FG000|Overall Study|Lack of Efficacy|4|||
147198233|NCT02435992|530898802|FG001|Overall Study|Lack of Efficacy|10|||
147198234|NCT02435992|530898803|FG002|Overall Study|Lack of Efficacy|9|||
147198235|NCT02435992|530898804|FG003|Overall Study|Lack of Efficacy|0|||
147198236|NCT02435992|530898805|FG004|Overall Study|Lack of Efficacy|0|||
147198237|NCT02435992|530898801|FG000|Overall Study|Withdrawal by Subject|10|||
147198238|NCT02435992|530898802|FG001|Overall Study|Withdrawal by Subject|8|||
147198239|NCT02435992|530898803|FG002|Overall Study|Withdrawal by Subject|20|||
147198240|NCT02435992|530898804|FG003|Overall Study|Withdrawal by Subject|0|||
147198241|NCT02435992|530898805|FG004|Overall Study|Withdrawal by Subject|0|||
147198242|NCT02435992|530898801|FG000|Overall Study|Other Reason|1|||
147198243|NCT02435992|530898802|FG001|Overall Study|Other Reason|0|||
147198244|NCT02435992|530898803|FG002|Overall Study|Other Reason|0|||
147198245|NCT02435992|530898804|FG003|Overall Study|Other Reason|0|||
147198246|NCT02435992|530898805|FG004|Overall Study|Other Reason|0|||
147198247|NCT02435992|530898801|FG000|Overall Study|Physician Decision|0|||
147198248|NCT02435992|530898802|FG001|Overall Study|Physician Decision|0|||
147198249|NCT02435992|530898803|FG002|Overall Study|Physician Decision|1|||
147198250|NCT02435992|530898804|FG003|Overall Study|Physician Decision|0|||
147198251|NCT02435992|530898805|FG004|Overall Study|Physician Decision|0|||
147198252|NCT04004988|530898806|FG000|Period 1|Physician Decision|2|||
147198253|NCT04004988|530898807|FG001|Period 1|Physician Decision|0|||
147198254|NCT04004988|530898806|FG000|Period 1|Withdrawal by Subject|0|||
147198255|NCT04004988|530898807|FG001|Period 1|Withdrawal by Subject|1|||
147198256|NCT04004988|530898806|FG000|Period 1|Adverse Event|1|||
147198257|NCT04004988|530898807|FG001|Period 1|Adverse Event|2|||
147198258|NCT00912808|530898808|FG000|First Intervention (6 Weeks)|Adverse Event|2|||
147198259|NCT00912808|530898809|FG001|First Intervention (6 Weeks)|Adverse Event|1|||
147198260|NCT00912808|530898808|FG000|Washout|Withdrawal by Subject|0|||
147198261|NCT00912808|530898809|FG001|Washout|Withdrawal by Subject|1|||
147198262|NCT00912808|530898808|FG000|Second Intervention (6 Weeks)|Adverse Event|0|||
147198263|NCT00912808|530898809|FG001|Second Intervention (6 Weeks)|Adverse Event|1|||
147198264|NCT00912808|530898808|FG000|Second Intervention (6 Weeks)|Withdrawal by Subject|1|||
147198265|NCT00912808|530898809|FG001|Second Intervention (6 Weeks)|Withdrawal by Subject|0|||
147198266|NCT03873116|530898810|FG000|Part 1|Study drug discontinuation due to rash|0|||
147198267|NCT03873116|530898811|FG001|Part 1|Study drug discontinuation due to rash|0|||
147198268|NCT03873116|530898812|FG002|Part 1|Study drug discontinuation due to rash|0|||
147198269|NCT03873116|530898813|FG003|Part 1|Study drug discontinuation due to rash|0|||
147198270|NCT03873116|530898814|FG004|Part 1|Study drug discontinuation due to rash|0|||
147198271|NCT03873116|530898815|FG005|Part 1|Study drug discontinuation due to rash|1|||
147198272|NCT03873116|530898810|FG000|Part 2|Withdrawal by Subject|0|||
147198273|NCT03873116|530898811|FG001|Part 2|Withdrawal by Subject|0|||
147198274|NCT03873116|530898812|FG002|Part 2|Withdrawal by Subject|1|||
147198275|NCT03873116|530898813|FG003|Part 2|Withdrawal by Subject|0|||
147198276|NCT03873116|530898814|FG004|Part 2|Withdrawal by Subject|0|||
147198277|NCT03873116|530898815|FG005|Part 2|Withdrawal by Subject|0|||
147198278|NCT03873116|530898810|FG000|Part 2|Lab abnormality or AE|0|||
147198279|NCT03873116|530898811|FG001|Part 2|Lab abnormality or AE|0|||
147198280|NCT03873116|530898812|FG002|Part 2|Lab abnormality or AE|0|||
147198281|NCT03873116|530898813|FG003|Part 2|Lab abnormality or AE|0|||
147198282|NCT03873116|530898814|FG004|Part 2|Lab abnormality or AE|1|||
147198283|NCT03873116|530898815|FG005|Part 2|Lab abnormality or AE|0|||
147198284|NCT03873116|530898810|FG000|Part 3|Withdrawal by Subject|0|||
147198285|NCT03873116|530898811|FG001|Part 3|Withdrawal by Subject|0|||
147198286|NCT03873116|530898812|FG002|Part 3|Withdrawal by Subject|0|||
147198287|NCT03873116|530898813|FG003|Part 3|Withdrawal by Subject|0|||
147198288|NCT03873116|530898814|FG004|Part 3|Withdrawal by Subject|1|||
147534934|NCT00320801|532114804|FG003|Open-label Run-in Period|Lost to Follow-up|0|||
147534935|NCT00320801|532114801|FG000|Open-label Run-in Period|Did not qualify|1|||
147198289|NCT03873116|530898815|FG005|Part 3|Withdrawal by Subject|0|||
147198290|NCT02531802|530898818|FG000|Received Vaccination 2|Medication interfering with study taken|0|||
147198291|NCT02531802|530898819|FG001|Received Vaccination 2|Medication interfering with study taken|0|||
147198292|NCT02531802|530898820|FG002|Received Vaccination 2|Medication interfering with study taken|1|||
147198293|NCT02531802|530898821|FG003|Received Vaccination 2|Medication interfering with study taken|0|||
147198294|NCT02531802|530898822|FG004|Received Vaccination 2|Medication interfering with study taken|0|||
147198295|NCT02531802|530898823|FG005|Received Vaccination 2|Medication interfering with study taken|0|||
147198296|NCT02531802|530898824|FG006|Received Vaccination 2|Medication interfering with study taken|0|||
147198297|NCT02531802|530898825|FG007|Received Vaccination 2|Medication interfering with study taken|0|||
147198298|NCT02531802|530898826|FG008|Received Vaccination 2|Medication interfering with study taken|0|||
147198299|NCT02531802|530898827|FG009|Received Vaccination 2|Medication interfering with study taken|1|||
147198300|NCT02531802|530898828|FG010|Received Vaccination 2|Medication interfering with study taken|1|||
147198301|NCT02531802|530898829|FG011|Received Vaccination 2|Medication interfering with study taken|0|||
147198302|NCT02531802|530898830|FG012|Received Vaccination 2|Medication interfering with study taken|1|||
147198303|NCT02531802|530898831|FG013|Received Vaccination 2|Medication interfering with study taken|0|||
147198304|NCT02531802|530898832|FG014|Received Vaccination 2|Medication interfering with study taken|0|||
147198305|NCT02531802|530898833|FG015|Received Vaccination 2|Medication interfering with study taken|0|||
147198306|NCT02531802|530898834|FG016|Received Vaccination 2|Medication interfering with study taken|0|||
147198307|NCT02531802|530898835|FG017|Received Vaccination 2|Medication interfering with study taken|0|||
147198308|NCT02531802|530898836|FG018|Received Vaccination 2|Medication interfering with study taken|1|||
147198309|NCT02531802|530898837|FG019|Received Vaccination 2|Medication interfering with study taken|0|||
147198310|NCT02531802|530898838|FG020|Received Vaccination 2|Medication interfering with study taken|0|||
147198311|NCT02531802|530898818|FG000|Received Vaccination 2|Physician Decision|0|||
147198312|NCT02531802|530898819|FG001|Received Vaccination 2|Physician Decision|0|||
147198313|NCT02531802|530898820|FG002|Received Vaccination 2|Physician Decision|0|||
147198314|NCT02531802|530898821|FG003|Received Vaccination 2|Physician Decision|0|||
147198315|NCT02531802|530898822|FG004|Received Vaccination 2|Physician Decision|0|||
147198316|NCT02531802|530898823|FG005|Received Vaccination 2|Physician Decision|1|||
147198317|NCT02531802|530898824|FG006|Received Vaccination 2|Physician Decision|0|||
147198318|NCT02531802|530898825|FG007|Received Vaccination 2|Physician Decision|0|||
147198319|NCT02531802|530898826|FG008|Received Vaccination 2|Physician Decision|0|||
147198320|NCT02531802|530898827|FG009|Received Vaccination 2|Physician Decision|2|||
147198321|NCT02531802|530898828|FG010|Received Vaccination 2|Physician Decision|0|||
147198322|NCT02531802|530898829|FG011|Received Vaccination 2|Physician Decision|0|||
147198323|NCT02531802|530898830|FG012|Received Vaccination 2|Physician Decision|0|||
147198324|NCT02531802|530898831|FG013|Received Vaccination 2|Physician Decision|1|||
147198325|NCT02531802|530898832|FG014|Received Vaccination 2|Physician Decision|0|||
147198326|NCT02531802|530898833|FG015|Received Vaccination 2|Physician Decision|0|||
147198327|NCT02531802|530898834|FG016|Received Vaccination 2|Physician Decision|0|||
147198328|NCT02531802|530898835|FG017|Received Vaccination 2|Physician Decision|1|||
147198329|NCT02531802|530898836|FG018|Received Vaccination 2|Physician Decision|0|||
147198330|NCT02531802|530898837|FG019|Received Vaccination 2|Physician Decision|0|||
147198331|NCT02531802|530898838|FG020|Received Vaccination 2|Physician Decision|0|||
147198332|NCT02531802|530898818|FG000|Received Vaccination 2|Adverse Event|0|||
147198333|NCT02531802|530898819|FG001|Received Vaccination 2|Adverse Event|0|||
147198334|NCT02531802|530898820|FG002|Received Vaccination 2|Adverse Event|0|||
147198335|NCT02531802|530898821|FG003|Received Vaccination 2|Adverse Event|0|||
147198336|NCT02531802|530898822|FG004|Received Vaccination 2|Adverse Event|0|||
147198337|NCT02531802|530898823|FG005|Received Vaccination 2|Adverse Event|2|||
147198338|NCT02531802|530898824|FG006|Received Vaccination 2|Adverse Event|0|||
147198339|NCT02531802|530898825|FG007|Received Vaccination 2|Adverse Event|0|||
147198340|NCT02531802|530898826|FG008|Received Vaccination 2|Adverse Event|0|||
147198341|NCT02531802|530898827|FG009|Received Vaccination 2|Adverse Event|0|||
147198342|NCT02531802|530898828|FG010|Received Vaccination 2|Adverse Event|0|||
147198343|NCT02531802|530898829|FG011|Received Vaccination 2|Adverse Event|0|||
147198344|NCT02531802|530898830|FG012|Received Vaccination 2|Adverse Event|0|||
147198345|NCT02531802|530898831|FG013|Received Vaccination 2|Adverse Event|0|||
147198346|NCT02531802|530898832|FG014|Received Vaccination 2|Adverse Event|0|||
147198347|NCT02531802|530898833|FG015|Received Vaccination 2|Adverse Event|0|||
147198348|NCT02531802|530898834|FG016|Received Vaccination 2|Adverse Event|0|||
147198349|NCT02531802|530898835|FG017|Received Vaccination 2|Adverse Event|2|||
147198350|NCT02531802|530898836|FG018|Received Vaccination 2|Adverse Event|1|||
147198351|NCT02531802|530898837|FG019|Received Vaccination 2|Adverse Event|0|||
147198352|NCT02531802|530898838|FG020|Received Vaccination 2|Adverse Event|1|||
147198353|NCT02531802|530898818|FG000|Received Vaccination 2|Withdrawal by Subject|0|||
147198354|NCT02531802|530898819|FG001|Received Vaccination 2|Withdrawal by Subject|0|||
147198355|NCT02531802|530898820|FG002|Received Vaccination 2|Withdrawal by Subject|0|||
147198356|NCT02531802|530898821|FG003|Received Vaccination 2|Withdrawal by Subject|0|||
147198357|NCT02531802|530898822|FG004|Received Vaccination 2|Withdrawal by Subject|0|||
147198358|NCT02531802|530898823|FG005|Received Vaccination 2|Withdrawal by Subject|0|||
147198359|NCT02531802|530898824|FG006|Received Vaccination 2|Withdrawal by Subject|0|||
147198360|NCT02531802|530898825|FG007|Received Vaccination 2|Withdrawal by Subject|0|||
147198361|NCT02531802|530898826|FG008|Received Vaccination 2|Withdrawal by Subject|0|||
147198362|NCT02531802|530898827|FG009|Received Vaccination 2|Withdrawal by Subject|0|||
147198363|NCT02531802|530898828|FG010|Received Vaccination 2|Withdrawal by Subject|1|||
147198364|NCT02531802|530898829|FG011|Received Vaccination 2|Withdrawal by Subject|0|||
147198365|NCT02531802|530898830|FG012|Received Vaccination 2|Withdrawal by Subject|1|||
147198366|NCT02531802|530898831|FG013|Received Vaccination 2|Withdrawal by Subject|1|||
147198367|NCT02531802|530898832|FG014|Received Vaccination 2|Withdrawal by Subject|1|||
147198368|NCT02531802|530898833|FG015|Received Vaccination 2|Withdrawal by Subject|0|||
147198369|NCT02531802|530898834|FG016|Received Vaccination 2|Withdrawal by Subject|0|||
147198370|NCT02531802|530898835|FG017|Received Vaccination 2|Withdrawal by Subject|1|||
147198371|NCT02531802|530898836|FG018|Received Vaccination 2|Withdrawal by Subject|1|||
147198372|NCT02531802|530898837|FG019|Received Vaccination 2|Withdrawal by Subject|1|||
147198373|NCT02531802|530898838|FG020|Received Vaccination 2|Withdrawal by Subject|0|||
147198374|NCT00538902|530898848|FG000|DB Wk 0 Through 12 (Primary D/C Reasons)|Adverse Event|1|||
147198375|NCT00538902|530898849|FG001|DB Wk 0 Through 12 (Primary D/C Reasons)|Adverse Event|2|||
147198376|NCT00538902|530898850|FG002|DB Wk 0 Through 12 (Primary D/C Reasons)|Adverse Event|3|||
147198377|NCT00538902|530898848|FG000|DB Wk 0 Through 12 (Primary D/C Reasons)|Withdrawal by Subject|0|||
147198378|NCT00538902|530898849|FG001|DB Wk 0 Through 12 (Primary D/C Reasons)|Withdrawal by Subject|0|||
147198379|NCT00538902|530898850|FG002|DB Wk 0 Through 12 (Primary D/C Reasons)|Withdrawal by Subject|1|||
147198380|NCT00538902|530898848|FG000|DB Wk 0 Through 12 (Primary D/C Reasons)|Lost to Follow-up|0|||
147198381|NCT00538902|530898849|FG001|DB Wk 0 Through 12 (Primary D/C Reasons)|Lost to Follow-up|0|||
147198382|NCT00538902|530898850|FG002|DB Wk 0 Through 12 (Primary D/C Reasons)|Lost to Follow-up|1|||
147198383|NCT00538902|530898848|FG000|DB Wk 0 Through 12 (Primary D/C Reasons)|Various|0|||
147198384|NCT00538902|530898849|FG001|DB Wk 0 Through 12 (Primary D/C Reasons)|Various|0|||
147198385|NCT00538902|530898850|FG002|DB Wk 0 Through 12 (Primary D/C Reasons)|Various|0|||
147198386|NCT00538902|530898848|FG000|OL Wk 24 to End (Primary D/C Reasons)|Adverse Event|2|||
147198387|NCT00538902|530898849|FG001|OL Wk 24 to End (Primary D/C Reasons)|Adverse Event|10|||
147198388|NCT00538902|530898850|FG002|OL Wk 24 to End (Primary D/C Reasons)|Adverse Event|11|||
147198389|NCT00538902|530898848|FG000|OL Wk 24 to End (Primary D/C Reasons)|Withdrawal by Subject|15|||
147198390|NCT00538902|530898849|FG001|OL Wk 24 to End (Primary D/C Reasons)|Withdrawal by Subject|19|||
147198391|NCT00538902|530898850|FG002|OL Wk 24 to End (Primary D/C Reasons)|Withdrawal by Subject|25|||
147198392|NCT00538902|530898848|FG000|OL Wk 24 to End (Primary D/C Reasons)|Lost to Follow-up|1|||
147198393|NCT00538902|530898849|FG001|OL Wk 24 to End (Primary D/C Reasons)|Lost to Follow-up|10|||
147198394|NCT00538902|530898850|FG002|OL Wk 24 to End (Primary D/C Reasons)|Lost to Follow-up|6|||
147198395|NCT00538902|530898848|FG000|OL Wk 24 to End (Primary D/C Reasons)|Various|18|||
147198396|NCT00538902|530898849|FG001|OL Wk 24 to End (Primary D/C Reasons)|Various|25|||
147198397|NCT00538902|530898850|FG002|OL Wk 24 to End (Primary D/C Reasons)|Various|22|||
147198398|NCT03131570|530898852|FG000|Overall Study|Adverse Event|1|||
147198399|NCT03131570|530898853|FG001|Overall Study|Adverse Event|0|||
147198400|NCT04109547|530898856|FG000|Overall Study|Withdrawal by Subject|3|||
147198401|NCT04109547|530898857|FG001|Overall Study|Withdrawal by Subject|2|||
147198402|NCT04109547|530898858|FG002|Overall Study|Withdrawal by Subject|6|||
147198403|NCT04109547|530898859|FG003|Overall Study|Withdrawal by Subject|6|||
147198404|NCT04109547|530898856|FG000|Overall Study|Lost to Follow-up|0|||
147198405|NCT04109547|530898857|FG001|Overall Study|Lost to Follow-up|0|||
147198406|NCT04109547|530898858|FG002|Overall Study|Lost to Follow-up|0|||
147198407|NCT04109547|530898859|FG003|Overall Study|Lost to Follow-up|1|||
147198408|NCT04109547|530898856|FG000|Overall Study|Physician Decision|1|||
147198409|NCT04109547|530898857|FG001|Overall Study|Physician Decision|2|||
147198410|NCT04109547|530898858|FG002|Overall Study|Physician Decision|0|||
147198411|NCT04109547|530898859|FG003|Overall Study|Physician Decision|0|||
147198412|NCT00871975|530898860|FG000|Overall Study|Technical difficulty w155-1ith equipment|3|||
147198413|NCT00871975|530898860|FG000|Overall Study|Catheters could not be inserted|1|||
147198414|NCT00871975|530898860|FG000|Overall Study|Patient unable to void/insufficient vol|13|||
147198415|NCT00871975|530898860|FG000|Overall Study|Motion artifact, tracing uninterpretable|5|||
147198416|NCT01210313|530898861|FG000|Overall Study|Withdrawal by Subject|3|||
147198417|NCT01210313|530898861|FG000|Overall Study|Adverse Event|2|||
147198418|NCT01210313|530898861|FG000|Overall Study|Distant recurrence|4|||
147198419|NCT01210313|530898861|FG000|Overall Study|Non-compliance|7|||
147198420|NCT03773978|530898864|FG000|PK/Safety and OLLI Period|Adverse Event|1|||
147198421|NCT03773978|530898865|FG001|PK/Safety and OLLI Period|Adverse Event|0|||
147198422|NCT03773978|530898864|FG000|PK/Safety and OLLI Period|Failure to Meet Randomization Criteria|39|||
147198423|NCT03773978|530898865|FG001|PK/Safety and OLLI Period|Failure to Meet Randomization Criteria|0|||
147198424|NCT03773978|530898864|FG000|PK/Safety and OLLI Period|Lost to Follow-up|1|||
147198425|NCT03773978|530898865|FG001|PK/Safety and OLLI Period|Lost to Follow-up|0|||
147198426|NCT03773978|530898864|FG000|PK/Safety and OLLI Period|Withdrawal by Subject|3|||
147198427|NCT03773978|530898865|FG001|PK/Safety and OLLI Period|Withdrawal by Subject|0|||
147198428|NCT03773978|530898864|FG000|PK/Safety and OLLI Period|Due to epidemic or pandemic|6|||
147198429|NCT03773978|530898865|FG001|PK/Safety and OLLI Period|Due to epidemic or pandemic|0|||
147198430|NCT03773978|530898864|FG000|PK/Safety and OLLI Period|unexplainable flare disease|1|||
147198431|NCT03773978|530898865|FG001|PK/Safety and OLLI Period|unexplainable flare disease|0|||
147435260|NCT03085758|531760441|FG000|Overall Study|Withdrawal by Subject|2|||
147435261|NCT03085758|531760442|FG001|Overall Study|Withdrawal by Subject|2|||
147435262|NCT03085758|531760443|FG002|Overall Study|Withdrawal by Subject|1|||
147435263|NCT03085758|531760441|FG000|Overall Study|Refusal to recall it up to day 90|0|||
147435264|NCT03085758|531760442|FG001|Overall Study|Refusal to recall it up to day 90|0|||
147435265|NCT03085758|531760443|FG002|Overall Study|Refusal to recall it up to day 90|1|||
147198432|NCT03773978|530898864|FG000|PK/Safety and OLLI Period|Protocol Violation|4|||
147198433|NCT03773978|530898865|FG001|PK/Safety and OLLI Period|Protocol Violation|0|||
147198434|NCT03773978|530898864|FG000|PK/Safety and OLLI Period|Participant transitioned to JAHX|1|||
147198435|NCT03773978|530898865|FG001|PK/Safety and OLLI Period|Participant transitioned to JAHX|0|||
147198436|NCT03773978|530898864|FG000|PK/Safety and OLLI Period|Investigational product was not delivered to the site|1|||
147198437|NCT03773978|530898865|FG001|PK/Safety and OLLI Period|Investigational product was not delivered to the site|0|||
147198438|NCT03773978|530898864|FG000|DBW Period|Adverse Event|2|||
147198439|NCT03773978|530898865|FG001|DBW Period|Adverse Event|2|||
147198440|NCT03773978|530898864|FG000|DBW Period|Failure to Meet Continuation Criteria|16|||
147198441|NCT03773978|530898865|FG001|DBW Period|Failure to Meet Continuation Criteria|40|||
147198442|NCT03773978|530898864|FG000|DBW Period|Withdrawal by Subject|2|||
147198443|NCT03773978|530898865|FG001|DBW Period|Withdrawal by Subject|1|||
147198444|NCT03773978|530898864|FG000|DBW Period|Due to epidemic or pandemic|5|||
147198445|NCT03773978|530898865|FG001|DBW Period|Due to epidemic or pandemic|6|||
147198446|NCT03773978|530898864|FG000|DBW Period|Study team decision|1|||
147198447|NCT03773978|530898865|FG001|DBW Period|Study team decision|0|||
147198448|NCT03592186|530898866|FG000|Overall Study|Withdrawal by Subject|1|||
147198449|NCT03592186|530898867|FG001|Overall Study|Withdrawal by Subject|0|||
147198450|NCT03592186|530898866|FG000|Overall Study|Lost to Follow-up|16|||
147198451|NCT03592186|530898867|FG001|Overall Study|Lost to Follow-up|11|||
147198452|NCT03755934|530898868|FG000|Overall Study|Adverse Event|4|||
147198453|NCT03755934|530898869|FG001|Overall Study|Adverse Event|1|||
147198454|NCT03755934|530898870|FG002|Overall Study|Adverse Event|1|||
147198455|NCT03755934|530898871|FG003|Overall Study|Adverse Event|3|||
147198456|NCT03755934|530898868|FG000|Overall Study|Physician Decision|2|||
147198457|NCT03755934|530898869|FG001|Overall Study|Physician Decision|0|||
147198458|NCT03755934|530898870|FG002|Overall Study|Physician Decision|0|||
147198459|NCT03755934|530898871|FG003|Overall Study|Physician Decision|1|||
147198460|NCT03755934|530898868|FG000|Overall Study|Withdrawal by Subject|5|||
147198461|NCT03755934|530898869|FG001|Overall Study|Withdrawal by Subject|0|||
147198462|NCT03755934|530898870|FG002|Overall Study|Withdrawal by Subject|0|||
147198463|NCT03755934|530898871|FG003|Overall Study|Withdrawal by Subject|1|||
147198464|NCT03755934|530898868|FG000|Overall Study|Other|3|||
147198465|NCT03755934|530898869|FG001|Overall Study|Other|1|||
147198466|NCT03755934|530898870|FG002|Overall Study|Other|3|||
147198467|NCT03755934|530898871|FG003|Overall Study|Other|1|||
147198468|NCT01052493|530898874|FG000|Intervention 1 (Up to 10 Days)|Withdrawal by Subject|1|||
147198469|NCT01052493|530898875|FG001|Intervention 1 (Up to 10 Days)|Withdrawal by Subject|0|||
147198470|NCT01052493|530898876|FG002|Intervention 1 (Up to 10 Days)|Withdrawal by Subject|0|||
147198471|NCT00307801|530898877|FG000|Overall Study|Adverse Event|12|||
147198472|NCT00307801|530898878|FG001|Overall Study|Adverse Event|4|||
147198473|NCT00307801|530898877|FG000|Overall Study|Withdrawal by Subject|9|||
147198474|NCT00307801|530898878|FG001|Overall Study|Withdrawal by Subject|4|||
147198475|NCT00307801|530898877|FG000|Overall Study|Non-compliance, not taken all tablets|1|||
147198476|NCT00307801|530898878|FG001|Overall Study|Non-compliance, not taken all tablets|2|||
147198477|NCT00307801|530898877|FG000|Overall Study|Adverse event (AE)/Withdrawal of consent|2|||
147198478|NCT00307801|530898878|FG001|Overall Study|Adverse event (AE)/Withdrawal of consent|0|||
147198479|NCT00307801|530898877|FG000|Overall Study|Decreased Libido (AE at discontinuation)|0|||
147198480|NCT00307801|530898878|FG001|Overall Study|Decreased Libido (AE at discontinuation)|1|||
147198481|NCT00307801|530898877|FG000|Overall Study|Wrong Randomization|1|||
147198482|NCT00307801|530898878|FG001|Overall Study|Wrong Randomization|0|||
147198483|NCT00307801|530898877|FG000|Overall Study|Lack of Efficacy|0|||
147198484|NCT00307801|530898878|FG001|Overall Study|Lack of Efficacy|2|||
147198485|NCT00307801|530898877|FG000|Overall Study|Lost to Follow-up, moved abroad|1|||
147198486|NCT00307801|530898878|FG001|Overall Study|Lost to Follow-up, moved abroad|1|||
147198487|NCT00307801|530898877|FG000|Overall Study|Frustration with e-diary|1|||
147198488|NCT00307801|530898878|FG001|Overall Study|Frustration with e-diary|0|||
147198489|NCT00307801|530898877|FG000|Overall Study|Protocol Violation|3|||
147198490|NCT00307801|530898878|FG001|Overall Study|Protocol Violation|2|||
147198491|NCT00307801|530898877|FG000|Overall Study|No reason specified|2|||
147198492|NCT00307801|530898878|FG001|Overall Study|No reason specified|0|||
147198493|NCT00307801|530898877|FG000|Overall Study|Pregnancy|0|||
147198494|NCT00307801|530898878|FG001|Overall Study|Pregnancy|1|||
147198495|NCT01498068|530898879|FG000|Overall Study|Withdrawal by Subject|1|||
147198496|NCT01498068|530898880|FG001|Overall Study|Withdrawal by Subject|1|||
147198497|NCT03944577|530898881|FG000|Overall Study|Adverse Event|3|||
147198498|NCT00391586|530898883|FG000|Overall Study|Progressive disease|13|||
147198499|NCT00391586|530898883|FG000|Overall Study|Adverse Event|5|||
147198500|NCT00391586|530898883|FG000|Overall Study|Physician Decision|2|||
147198501|NCT00391586|530898883|FG000|Overall Study|Death|4|||
147198502|NCT00198822|530898884|FG000|Overall Study|Lost to Follow-up|14|||
147198503|NCT00198822|530898885|FG001|Overall Study|Lost to Follow-up|20|||
147198504|NCT00198822|530898886|FG002|Overall Study|Lost to Follow-up|21|||
147198505|NCT00453206|530898889|FG000|Overall Study|Death|1|||
147198506|NCT00577889|530898890|FG000|Overall Study|Withdrawal by Subject|1|||
147198507|NCT00577889|530898891|FG001|Overall Study|Withdrawal by Subject|0|||
147198508|NCT00577889|530898892|FG002|Overall Study|Withdrawal by Subject|0|||
147198509|NCT01467960|530898893|FG000|Overall Study|Enrollment of patients (PD) in 09/2013|0|||
147198510|NCT01467960|530898894|FG001|Overall Study|Enrollment of patients (PD) in 09/2013|0|||
147198511|NCT01467960|530898895|FG002|Overall Study|Enrollment of patients (PD) in 09/2013|0|||
147198512|NCT01467960|530898896|FG003|Overall Study|Enrollment of patients (PD) in 09/2013|30|||
147198513|NCT01467960|530898897|FG004|Overall Study|Enrollment of patients (PD) in 09/2013|30|||
147198514|NCT01467960|530898898|FG005|Overall Study|Enrollment of patients (PD) in 09/2013|30|||
147198515|NCT00888173|530898899|FG000|Overall Study|Wrong Primary|1|||
147198516|NCT00888173|530898899|FG000|Overall Study|Ineligible: required test not done|1|||
147198517|NCT00737672|530898906|FG000|Overall Study|Graft Abandonment|48|||
147198518|NCT00737672|530898907|FG001|Overall Study|Graft Abandonment|56|||
147198519|NCT00737672|530898906|FG000|Overall Study|Death|23|||
147198520|NCT00737672|530898907|FG001|Overall Study|Death|22|||
147198521|NCT00737672|530898906|FG000|Overall Study|Withdrawal by Subject|1|||
147198522|NCT00737672|530898907|FG001|Overall Study|Withdrawal by Subject|2|||
147198523|NCT00737672|530898906|FG000|Overall Study|Lost to Follow-up|1|||
147198524|NCT00737672|530898907|FG001|Overall Study|Lost to Follow-up|0|||
147198525|NCT00737672|530898906|FG000|Overall Study|Miscellaneous|7|||
147198526|NCT00737672|530898907|FG001|Overall Study|Miscellaneous|1|||
147198527|NCT00737672|530898906|FG000|Overall Study|Physician Decision|0|||
147198528|NCT00737672|530898907|FG001|Overall Study|Physician Decision|2|||
147198529|NCT02002598|530898913|FG000|Dose Level 1|Withdrawal by Subject|1|||
147198530|NCT02002598|530898914|FG001|Dose Level 1|Withdrawal by Subject|0|||
147198531|NCT02002598|530898915|FG002|Dose Level 1|Withdrawal by Subject|0|||
147198532|NCT02002598|530898916|FG003|Dose Level 1|Withdrawal by Subject|0|||
147198533|NCT02002598|530898917|FG004|Dose Level 1|Withdrawal by Subject|0|||
147198534|NCT04672239|530898918|FG000|Week 2 Survey|Failed survey check items|1|||
147198535|NCT04672239|530898919|FG001|Week 2 Survey|Failed survey check items|2|||
147198536|NCT04672239|530898920|FG002|Week 2 Survey|Failed survey check items|3|||
147198537|NCT04672239|530898918|FG000|Week 2 Survey|Partially completed survey|7|||
147198538|NCT04672239|530898919|FG001|Week 2 Survey|Partially completed survey|1|||
147198539|NCT04672239|530898920|FG002|Week 2 Survey|Partially completed survey|4|||
147198540|NCT04672239|530898918|FG000|Week 2 Survey|Withdrawal by Subject|0|||
147198541|NCT04672239|530898919|FG001|Week 2 Survey|Withdrawal by Subject|1|||
147198542|NCT04672239|530898920|FG002|Week 2 Survey|Withdrawal by Subject|0|||
147198543|NCT04672239|530898918|FG000|Week 2 Survey|Lost to Follow-up|3|||
147198544|NCT04672239|530898919|FG001|Week 2 Survey|Lost to Follow-up|2|||
147198545|NCT04672239|530898920|FG002|Week 2 Survey|Lost to Follow-up|5|||
147198546|NCT04672239|530898918|FG000|Week 6 Survey|Failed survey check items|2|||
147198547|NCT04672239|530898919|FG001|Week 6 Survey|Failed survey check items|2|||
147198548|NCT04672239|530898920|FG002|Week 6 Survey|Failed survey check items|2|||
147198549|NCT04672239|530898918|FG000|Week 6 Survey|Partially completed survey|3|||
147198550|NCT04672239|530898919|FG001|Week 6 Survey|Partially completed survey|3|||
147198551|NCT04672239|530898920|FG002|Week 6 Survey|Partially completed survey|2|||
147198552|NCT04672239|530898918|FG000|Week 6 Survey|Withdrawal by Subject|1|||
147198553|NCT04672239|530898919|FG001|Week 6 Survey|Withdrawal by Subject|1|||
147198554|NCT04672239|530898920|FG002|Week 6 Survey|Withdrawal by Subject|1|||
147198555|NCT04672239|530898918|FG000|Week 6 Survey|Withdrawn by PI|0|||
147198556|NCT04672239|530898919|FG001|Week 6 Survey|Withdrawn by PI|1|||
147198557|NCT04672239|530898920|FG002|Week 6 Survey|Withdrawn by PI|0|||
147198558|NCT04672239|530898918|FG000|Week 6 Survey|Lost to Follow-up|12|||
147198559|NCT04672239|530898919|FG001|Week 6 Survey|Lost to Follow-up|2|||
147198560|NCT04672239|530898920|FG002|Week 6 Survey|Lost to Follow-up|5|||
147198561|NCT04672239|530898918|FG000|3-Month Follow-up Survey|Failed survey check items|2|||
147198562|NCT04672239|530898919|FG001|3-Month Follow-up Survey|Failed survey check items|3|||
147198563|NCT04672239|530898920|FG002|3-Month Follow-up Survey|Failed survey check items|2|||
147198564|NCT04672239|530898918|FG000|3-Month Follow-up Survey|Partially completed survey|3|||
147198565|NCT04672239|530898919|FG001|3-Month Follow-up Survey|Partially completed survey|1|||
147198566|NCT04672239|530898920|FG002|3-Month Follow-up Survey|Partially completed survey|3|||
147198567|NCT04672239|530898918|FG000|3-Month Follow-up Survey|Withdrawal by Subject|0|||
147198568|NCT04672239|530898919|FG001|3-Month Follow-up Survey|Withdrawal by Subject|1|||
147198569|NCT04672239|530898920|FG002|3-Month Follow-up Survey|Withdrawal by Subject|1|||
147198570|NCT04672239|530898918|FG000|3-Month Follow-up Survey|Lost to Follow-up|17|||
147198571|NCT04672239|530898919|FG001|3-Month Follow-up Survey|Lost to Follow-up|5|||
147198572|NCT04672239|530898920|FG002|3-Month Follow-up Survey|Lost to Follow-up|11|||
147198573|NCT04672239|530898918|FG000|6-Month Follow-up Survey|Failed survey check items|2|||
147198574|NCT04672239|530898919|FG001|6-Month Follow-up Survey|Failed survey check items|0|||
147198575|NCT04672239|530898920|FG002|6-Month Follow-up Survey|Failed survey check items|0|||
147198576|NCT04672239|530898918|FG000|6-Month Follow-up Survey|Partially completed survey|7|||
147198577|NCT04672239|530898919|FG001|6-Month Follow-up Survey|Partially completed survey|0|||
147198578|NCT04672239|530898920|FG002|6-Month Follow-up Survey|Partially completed survey|2|||
147198579|NCT04672239|530898918|FG000|6-Month Follow-up Survey|Lost to Follow-up|13|||
147198580|NCT04672239|530898919|FG001|6-Month Follow-up Survey|Lost to Follow-up|12|||
147595943|NCT03096847|532338751|FG000|Overall Study|Progressive disease|97|||
147198581|NCT04672239|530898920|FG002|6-Month Follow-up Survey|Lost to Follow-up|9|||
147198582|NCT00541658|530898921|FG000|Overall Study|Adverse Event|28|||
147198583|NCT00541658|530898922|FG001|Overall Study|Adverse Event|37|||
147198584|NCT00541658|530898923|FG002|Overall Study|Adverse Event|25|||
147198585|NCT00541658|530898921|FG000|Overall Study|Physician Decision|0|||
147198586|NCT00541658|530898922|FG001|Overall Study|Physician Decision|0|||
147198587|NCT00541658|530898923|FG002|Overall Study|Physician Decision|4|||
147198588|NCT00541658|530898921|FG000|Overall Study|Lost to Follow-up|3|||
147198589|NCT00541658|530898922|FG001|Overall Study|Lost to Follow-up|3|||
147198590|NCT00541658|530898923|FG002|Overall Study|Lost to Follow-up|6|||
147198591|NCT00541658|530898921|FG000|Overall Study|Protocol Violation|0|||
147198592|NCT00541658|530898922|FG001|Overall Study|Protocol Violation|1|||
147198593|NCT00541658|530898923|FG002|Overall Study|Protocol Violation|1|||
147198594|NCT00541658|530898921|FG000|Overall Study|Withdrawal by Subject|28|||
147198595|NCT00541658|530898922|FG001|Overall Study|Withdrawal by Subject|32|||
147198596|NCT00541658|530898923|FG002|Overall Study|Withdrawal by Subject|32|||
147198597|NCT00541658|530898921|FG000|Overall Study|Took No Study Drug|1|||
147198598|NCT00541658|530898922|FG001|Overall Study|Took No Study Drug|0|||
147198599|NCT00541658|530898923|FG002|Overall Study|Took No Study Drug|0|||
147198600|NCT04123470|530898926|FG000|Group 1: LOAd703 Dose Level 1x10e11 VP|Death|4|||
147198601|NCT04123470|530898927|FG001|Group 1: LOAd703 Dose Level 1x10e11 VP|Death|0|||
147198602|NCT04123470|530898926|FG000|Group 2: LOAd703 Dose Level 5x10e11 VP|Withdrawal by Subject|0|||
147198603|NCT04123470|530898927|FG001|Group 2: LOAd703 Dose Level 5x10e11 VP|Withdrawal by Subject|1|||
147198604|NCT04123470|530898926|FG000|Group 2: LOAd703 Dose Level 5x10e11 VP|Death|0|||
147198605|NCT04123470|530898927|FG001|Group 2: LOAd703 Dose Level 5x10e11 VP|Death|7|||
147198606|NCT04123470|530898926|FG000|Group 2: LOAd703 Dose Level 5x10e11 VP|Lost to Follow-up|0|||
147198607|NCT04123470|530898927|FG001|Group 2: LOAd703 Dose Level 5x10e11 VP|Lost to Follow-up|1|||
147198608|NCT05972993|530898933|FG000|Overall Study|Lost to Follow-up|2|||
147198609|NCT05972993|530898934|FG001|Overall Study|Lost to Follow-up|0|||
147198610|NCT05972993|530898935|FG002|Overall Study|Lost to Follow-up|1|||
147198611|NCT05972993|530898936|FG003|Overall Study|Lost to Follow-up|0|||
147198612|NCT05972993|530898937|FG004|Overall Study|Lost to Follow-up|0|||
147198613|NCT05972993|530898938|FG005|Overall Study|Lost to Follow-up|0|||
147198614|NCT05972993|530898939|FG006|Overall Study|Lost to Follow-up|0|||
147198615|NCT05972993|530898940|FG007|Overall Study|Lost to Follow-up|2|||
147198616|NCT05972993|530898941|FG008|Overall Study|Lost to Follow-up|0|||
147198617|NCT03866577|530898944|FG000|Overall Study|Protocol Violation|0|||
147198618|NCT03866577|530898945|FG001|Overall Study|Protocol Violation|0|||
147198619|NCT03866577|530898946|FG002|Overall Study|Protocol Violation|0|||
147198620|NCT03866577|530898947|FG003|Overall Study|Protocol Violation|0|||
147198621|NCT03866577|530898948|FG004|Overall Study|Protocol Violation|0|||
147198622|NCT03866577|530898949|FG005|Overall Study|Protocol Violation|0|||
147198623|NCT03866577|530898950|FG006|Overall Study|Protocol Violation|0|||
147198624|NCT03866577|530898951|FG007|Overall Study|Protocol Violation|0|||
147198625|NCT03866577|530898952|FG008|Overall Study|Protocol Violation|0|||
147198626|NCT03866577|530898953|FG009|Overall Study|Protocol Violation|0|||
147198627|NCT03866577|530898954|FG010|Overall Study|Protocol Violation|0|||
147198628|NCT03866577|530898955|FG011|Overall Study|Protocol Violation|1|||
147198629|NCT03866577|530898956|FG012|Overall Study|Protocol Violation|0|||
147198630|NCT03866577|530898944|FG000|Overall Study|Withdrawal by Subject|0|||
147198631|NCT03866577|530898945|FG001|Overall Study|Withdrawal by Subject|0|||
147198632|NCT03866577|530898946|FG002|Overall Study|Withdrawal by Subject|0|||
147198633|NCT03866577|530898947|FG003|Overall Study|Withdrawal by Subject|0|||
147198634|NCT03866577|530898948|FG004|Overall Study|Withdrawal by Subject|0|||
147198635|NCT03866577|530898949|FG005|Overall Study|Withdrawal by Subject|0|||
147198636|NCT03866577|530898950|FG006|Overall Study|Withdrawal by Subject|0|||
147198637|NCT03866577|530898951|FG007|Overall Study|Withdrawal by Subject|0|||
147198638|NCT03866577|530898952|FG008|Overall Study|Withdrawal by Subject|1|||
147198639|NCT03866577|530898953|FG009|Overall Study|Withdrawal by Subject|1|||
147198640|NCT03866577|530898954|FG010|Overall Study|Withdrawal by Subject|0|||
147198641|NCT03866577|530898955|FG011|Overall Study|Withdrawal by Subject|0|||
147198642|NCT03866577|530898956|FG012|Overall Study|Withdrawal by Subject|0|||
147198643|NCT03866577|530898944|FG000|Overall Study|Not qualified for IVIg infusion|0|||
147198644|NCT03866577|530898945|FG001|Overall Study|Not qualified for IVIg infusion|0|||
147198645|NCT03866577|530898946|FG002|Overall Study|Not qualified for IVIg infusion|0|||
147198646|NCT03866577|530898947|FG003|Overall Study|Not qualified for IVIg infusion|0|||
147198647|NCT03866577|530898948|FG004|Overall Study|Not qualified for IVIg infusion|0|||
147198648|NCT03866577|530898949|FG005|Overall Study|Not qualified for IVIg infusion|0|||
147198649|NCT03866577|530898950|FG006|Overall Study|Not qualified for IVIg infusion|0|||
147198650|NCT03866577|530898951|FG007|Overall Study|Not qualified for IVIg infusion|0|||
147198651|NCT03866577|530898952|FG008|Overall Study|Not qualified for IVIg infusion|0|||
147198652|NCT03866577|530898953|FG009|Overall Study|Not qualified for IVIg infusion|1|||
147198653|NCT03866577|530898954|FG010|Overall Study|Not qualified for IVIg infusion|0|||
147198654|NCT03866577|530898955|FG011|Overall Study|Not qualified for IVIg infusion|0|||
147198655|NCT03866577|530898956|FG012|Overall Study|Not qualified for IVIg infusion|0|||
147198656|NCT05530252|530898957|FG000|Overall Study|Lost to Follow-up|1|||
147198657|NCT05530252|530898958|FG001|Overall Study|Lost to Follow-up|1|||
147198658|NCT05530252|530898959|FG002|Overall Study|Lost to Follow-up|1|||
147198659|NCT01535040|530898965|FG000|Overall Study|Physician Decision|0|||
147198660|NCT01535040|530898966|FG001|Overall Study|Physician Decision|1|||
147198661|NCT01535040|530898965|FG000|Overall Study|Withdrawal by Subject|13|||
147198662|NCT01535040|530898966|FG001|Overall Study|Withdrawal by Subject|10|||
147198663|NCT01535040|530898965|FG000|Overall Study|Never Started|9|||
147198664|NCT01535040|530898966|FG001|Overall Study|Never Started|4|||
147198665|NCT01535040|530898965|FG000|Overall Study|Toxicity|7|||
147198666|NCT01535040|530898966|FG001|Overall Study|Toxicity|5|||
147198667|NCT01535040|530898965|FG000|Overall Study|Multiple Reasons|1|||
147198668|NCT01535040|530898966|FG001|Overall Study|Multiple Reasons|1|||
147198669|NCT01074970|530898967|FG000|Overall Study|Never Treated|0|||
147198670|NCT01074970|530898968|FG001|Overall Study|Never Treated|0|||
147198671|NCT01074970|530898969|FG002|Overall Study|Never Treated|8|||
147198672|NCT01074970|530898970|FG003|Overall Study|Never Treated|1|||
147198673|NCT01074970|530898967|FG000|Overall Study|Adverse Event|1|||
147198674|NCT01074970|530898968|FG001|Overall Study|Adverse Event|0|||
147198675|NCT01074970|530898969|FG002|Overall Study|Adverse Event|4|||
147198676|NCT01074970|530898970|FG003|Overall Study|Adverse Event|3|||
147198677|NCT01074970|530898967|FG000|Overall Study|Disease progression during treatment|3|||
147198678|NCT01074970|530898968|FG001|Overall Study|Disease progression during treatment|1|||
147198679|NCT01074970|530898969|FG002|Overall Study|Disease progression during treatment|2|||
147198680|NCT01074970|530898970|FG003|Overall Study|Disease progression during treatment|9|||
147198681|NCT01074970|530898967|FG000|Overall Study|Lost to Follow-up|0|||
147198682|NCT01074970|530898968|FG001|Overall Study|Lost to Follow-up|0|||
147198683|NCT01074970|530898969|FG002|Overall Study|Lost to Follow-up|1|||
147198684|NCT01074970|530898970|FG003|Overall Study|Lost to Follow-up|0|||
147198685|NCT01074970|530898967|FG000|Overall Study|Withdrawal by Subject|0|||
147198686|NCT01074970|530898968|FG001|Overall Study|Withdrawal by Subject|0|||
147198687|NCT01074970|530898969|FG002|Overall Study|Withdrawal by Subject|6|||
147198688|NCT01074970|530898970|FG003|Overall Study|Withdrawal by Subject|4|||
147198689|NCT05523089|530898973|FG000|Overall Study|Withdrawal by Subject|1|||
147198690|NCT05523089|530898974|FG001|Overall Study|Withdrawal by Subject|0|||
147198691|NCT05523089|530898975|FG002|Overall Study|Withdrawal by Subject|0|||
147198692|NCT05523089|530898973|FG000|Overall Study|Lost to Follow-up|1|||
147198693|NCT05523089|530898974|FG001|Overall Study|Lost to Follow-up|0|||
147198694|NCT05523089|530898975|FG002|Overall Study|Lost to Follow-up|0|||
147198695|NCT02514083|530898976|FG000|Overall Study|Adverse Event|1|||
147198696|NCT01899040|530898977|FG000|Overall Study|Randomized in error|0|||
147198697|NCT01899040|530898978|FG001|Overall Study|Randomized in error|1|||
147198698|NCT01899040|530898979|FG002|Overall Study|Randomized in error|1|||
147198699|NCT01899040|530898977|FG000|Overall Study|Adverse Event|3|||
147198700|NCT01899040|530898978|FG001|Overall Study|Adverse Event|1|||
147198701|NCT01899040|530898979|FG002|Overall Study|Adverse Event|2|||
147198702|NCT01899040|530898977|FG000|Overall Study|Unspecified reasons|4|||
147198703|NCT01899040|530898978|FG001|Overall Study|Unspecified reasons|4|||
147198704|NCT01899040|530898979|FG002|Overall Study|Unspecified reasons|0|||
147198705|NCT01899040|530898977|FG000|Overall Study|Compliance issues|1|||
147198706|NCT01899040|530898978|FG001|Overall Study|Compliance issues|2|||
147198707|NCT01899040|530898979|FG002|Overall Study|Compliance issues|0|||
147198708|NCT02638220|530898980|FG000|Overall Study|Lost to Follow-up|6|||
147198709|NCT02638220|530898980|FG000|Overall Study|Withdrawal by Subject|3|||
147198710|NCT02638220|530898980|FG000|Overall Study|Physician Decision|1|||
147198711|NCT02638220|530898980|FG000|Overall Study|Withdrawn, sample error, non-adherence, illness|6|||
147198712|NCT02144610|530900736|FG000|Overall Study|Physician Decision|1|||
147198713|NCT02144610|530900737|FG001|Overall Study|Physician Decision|0|||
147198714|NCT02144610|530900736|FG000|Overall Study|Withdrawal by Subject|1|||
147198715|NCT02144610|530900737|FG001|Overall Study|Withdrawal by Subject|5|||
147198716|NCT02144610|530900736|FG000|Overall Study|Death|2|||
147198717|NCT02144610|530900737|FG001|Overall Study|Death|2|||
147198718|NCT02144610|530900736|FG000|Overall Study|Study Discontinuation by Sponsor|19|||
147198719|NCT02144610|530900737|FG001|Overall Study|Study Discontinuation by Sponsor|14|||
147534936|NCT00320801|532114802|FG001|Open-label Run-in Period|Did not qualify|0|||
147534937|NCT00320801|532114803|FG002|Open-label Run-in Period|Did not qualify|0|||
147534938|NCT00320801|532114804|FG003|Open-label Run-in Period|Did not qualify|0|||
147534939|NCT00320801|532114801|FG000|Double-blind Phase|Withdrawal by Subject|0|||
147534940|NCT00320801|532114802|FG001|Double-blind Phase|Withdrawal by Subject|0|||
147534941|NCT00320801|532114803|FG002|Double-blind Phase|Withdrawal by Subject|1|||
147534942|NCT00320801|532114804|FG003|Double-blind Phase|Withdrawal by Subject|0|||
147534943|NCT00320801|532114801|FG000|Double-blind Phase|Adverse Event|0|||
147534944|NCT00320801|532114802|FG001|Double-blind Phase|Adverse Event|2|||
147534945|NCT00320801|532114803|FG002|Double-blind Phase|Adverse Event|8|||
147534946|NCT00320801|532114804|FG003|Double-blind Phase|Adverse Event|0|||
147534947|NCT00320801|532114801|FG000|Double-blind Phase|Administrative|0|||
147534948|NCT00320801|532114802|FG001|Double-blind Phase|Administrative|0|||
147534949|NCT00320801|532114803|FG002|Double-blind Phase|Administrative|4|||
147534950|NCT00320801|532114804|FG003|Double-blind Phase|Administrative|0|||
147534951|NCT00320801|532114801|FG000|Double-blind Phase|Lack of Efficacy|0|||
147534952|NCT00320801|532114802|FG001|Double-blind Phase|Lack of Efficacy|9|||
147534953|NCT00320801|532114803|FG002|Double-blind Phase|Lack of Efficacy|1|||
147534954|NCT00320801|532114804|FG003|Double-blind Phase|Lack of Efficacy|0|||
147534955|NCT00320801|532114801|FG000|Extension Phase|Withdrawal by Subject|0|||
147534956|NCT00320801|532114802|FG001|Extension Phase|Withdrawal by Subject|0|||
147534957|NCT00320801|532114803|FG002|Extension Phase|Withdrawal by Subject|0|||
147198720|NCT02144610|530900736|FG000|Overall Study|Other|0|||
147198721|NCT02144610|530900737|FG001|Overall Study|Other|1|||
147198722|NCT01432730|530900739|FG000|Period 1|Adverse Event|2|||
147198723|NCT01432730|530900740|FG001|Period 1|Adverse Event|0|||
147198724|NCT01432730|530900739|FG000|Period 2|Adverse Event|0|||
147198725|NCT01432730|530900740|FG001|Period 2|Adverse Event|4|||
147198726|NCT03038100|530900754|FG000|Overall Study|Death|289|||
147198727|NCT03038100|530900755|FG001|Overall Study|Death|272|||
147198728|NCT03038100|530900754|FG000|Overall Study|Lost to Follow-up|9|||
147198729|NCT03038100|530900755|FG001|Overall Study|Lost to Follow-up|10|||
147198730|NCT03038100|530900754|FG000|Overall Study|Protocol Deviation|1|||
147534958|NCT00320801|532114804|FG003|Extension Phase|Withdrawal by Subject|6|||
147534959|NCT00320801|532114801|FG000|Extension Phase|Adverse Event|0|||
147534960|NCT00320801|532114802|FG001|Extension Phase|Adverse Event|0|||
147198731|NCT03038100|530900755|FG001|Overall Study|Protocol Deviation|4|||
147198732|NCT03038100|530900754|FG000|Overall Study|Withdrawal by Subject|45|||
147198733|NCT03038100|530900755|FG001|Overall Study|Withdrawal by Subject|51|||
147534961|NCT00320801|532114803|FG002|Extension Phase|Adverse Event|0|||
147534962|NCT00320801|532114804|FG003|Extension Phase|Adverse Event|8|||
147534963|NCT00320801|532114801|FG000|Extension Phase|Administrative|0|||
147534964|NCT00320801|532114802|FG001|Extension Phase|Administrative|0|||
147534965|NCT00320801|532114803|FG002|Extension Phase|Administrative|0|||
147534966|NCT00320801|532114804|FG003|Extension Phase|Administrative|29|||
147534967|NCT00320801|532114801|FG000|Extension Phase|Lack of Efficacy|0|||
147534968|NCT00320801|532114802|FG001|Extension Phase|Lack of Efficacy|0|||
147534969|NCT00320801|532114803|FG002|Extension Phase|Lack of Efficacy|0|||
147534970|NCT00320801|532114804|FG003|Extension Phase|Lack of Efficacy|2|||
147534971|NCT00320801|532114801|FG000|Extension Phase|Lost to Follow-up|0|||
147534972|NCT00320801|532114802|FG001|Extension Phase|Lost to Follow-up|0|||
147534973|NCT00320801|532114803|FG002|Extension Phase|Lost to Follow-up|0|||
147534974|NCT00320801|532114804|FG003|Extension Phase|Lost to Follow-up|3|||
147534975|NCT02353572|532114807|FG000|Overall Study|Withdrawal by Subject|1|||
147534976|NCT02353572|532114807|FG000|Overall Study|Study terminated|2|||
147534977|NCT01870921|532114808|FG000|Overall Study|Subject decision|80|||
147534978|NCT01870921|532114808|FG000|Overall Study|Severe non-compliance to protocol|7|||
147534979|NCT01870921|532114808|FG000|Overall Study|Subject Lost to Follow up|2|||
147534980|NCT01870921|532114808|FG000|Overall Study|Other|1|||
147534981|NCT02060188|532114809|FG000|Overall Study|Disease Progression|36|||
147534982|NCT02060188|532114810|FG001|Overall Study|Disease Progression|42|||
147534983|NCT02060188|532114811|FG002|Overall Study|Disease Progression|8|||
147534984|NCT02060188|532114812|FG003|Overall Study|Disease Progression|5|||
147534985|NCT02060188|532114813|FG004|Overall Study|Disease Progression|6|||
147534986|NCT02060188|532114814|FG005|Overall Study|Disease Progression|3|||
147534987|NCT02060188|532114815|FG006|Overall Study|Disease Progression|23|||
147534988|NCT02060188|532114816|FG007|Overall Study|Disease Progression|20|||
147534989|NCT02060188|532114817|FG008|Overall Study|Disease Progression|43|||
147534990|NCT02060188|532114809|FG000|Overall Study|Study Drug Toxicity|10|||
147534991|NCT02060188|532114810|FG001|Overall Study|Study Drug Toxicity|18|||
147534992|NCT02060188|532114811|FG002|Overall Study|Study Drug Toxicity|7|||
147534993|NCT02060188|532114812|FG003|Overall Study|Study Drug Toxicity|4|||
147534994|NCT02060188|532114813|FG004|Overall Study|Study Drug Toxicity|3|||
147534995|NCT02060188|532114814|FG005|Overall Study|Study Drug Toxicity|0|||
147534996|NCT02060188|532114815|FG006|Overall Study|Study Drug Toxicity|2|||
147534997|NCT02060188|532114816|FG007|Overall Study|Study Drug Toxicity|5|||
147534998|NCT02060188|532114817|FG008|Overall Study|Study Drug Toxicity|0|||
147534999|NCT02060188|532114809|FG000|Overall Study|Adverse event unrelated to study drug|2|||
147535000|NCT02060188|532114810|FG001|Overall Study|Adverse event unrelated to study drug|5|||
147535001|NCT02060188|532114811|FG002|Overall Study|Adverse event unrelated to study drug|6|||
147535002|NCT02060188|532114812|FG003|Overall Study|Adverse event unrelated to study drug|0|||
147535003|NCT02060188|532114813|FG004|Overall Study|Adverse event unrelated to study drug|1|||
147535004|NCT02060188|532114814|FG005|Overall Study|Adverse event unrelated to study drug|0|||
147535005|NCT02060188|532114815|FG006|Overall Study|Adverse event unrelated to study drug|4|||
147535006|NCT02060188|532114816|FG007|Overall Study|Adverse event unrelated to study drug|4|||
147535007|NCT02060188|532114817|FG008|Overall Study|Adverse event unrelated to study drug|1|||
147535008|NCT02060188|532114809|FG000|Overall Study|Participant request to discontinue study treatment|7|||
147535009|NCT02060188|532114810|FG001|Overall Study|Participant request to discontinue study treatment|7|||
147535010|NCT02060188|532114811|FG002|Overall Study|Participant request to discontinue study treatment|4|||
147535011|NCT02060188|532114812|FG003|Overall Study|Participant request to discontinue study treatment|0|||
147535012|NCT02060188|532114813|FG004|Overall Study|Participant request to discontinue study treatment|0|||
147535013|NCT02060188|532114814|FG005|Overall Study|Participant request to discontinue study treatment|0|||
147198734|NCT03038100|530900754|FG000|Overall Study|Study Terminated By Sponsor|305|||
147198735|NCT03038100|530900755|FG001|Overall Study|Study Terminated By Sponsor|311|||
147198736|NCT03038100|530900754|FG000|Overall Study|Physician Decision|1|||
147198737|NCT03038100|530900755|FG001|Overall Study|Physician Decision|3|||
147198738|NCT03250273|530900788|FG000|Overall Study|Disease Progression|2|||
147198739|NCT03250273|530900789|FG001|Overall Study|Disease Progression|11|||
147198740|NCT03250273|530900788|FG000|Overall Study|Death|0|||
147198741|NCT03250273|530900789|FG001|Overall Study|Death|1|||
147198742|NCT04154904|530900790|FG000|At Home Period (28 Days)|Withdrawal by Subject|0|||
147198743|NCT04154904|530900791|FG001|At Home Period (28 Days)|Withdrawal by Subject|0|||
147198744|NCT04154904|530900792|FG002|At Home Period (28 Days)|Withdrawal by Subject|1|||
147198745|NCT02392624|530900793|FG000|Overall Study|Withdrawal by Subject|15|||
147198746|NCT02392624|530900794|FG001|Overall Study|Withdrawal by Subject|12|||
147198747|NCT02392624|530900795|FG002|Overall Study|Withdrawal by Subject|9|||
147198748|NCT02392624|530900793|FG000|Overall Study|Adverse Event|4|||
147198749|NCT02392624|530900794|FG001|Overall Study|Adverse Event|1|||
147198750|NCT02392624|530900795|FG002|Overall Study|Adverse Event|2|||
147198751|NCT02392624|530900793|FG000|Overall Study|Pregnancy|1|||
147198752|NCT02392624|530900794|FG001|Overall Study|Pregnancy|0|||
147198753|NCT02392624|530900795|FG002|Overall Study|Pregnancy|0|||
147198754|NCT02392624|530900793|FG000|Overall Study|Protocol Violation|0|||
147198755|NCT02392624|530900794|FG001|Overall Study|Protocol Violation|0|||
147198756|NCT02392624|530900795|FG002|Overall Study|Protocol Violation|1|||
147198757|NCT02392624|530900793|FG000|Overall Study|Sponsor/Investigator Decision|2|||
147198758|NCT02392624|530900794|FG001|Overall Study|Sponsor/Investigator Decision|1|||
147198759|NCT02392624|530900795|FG002|Overall Study|Sponsor/Investigator Decision|0|||
147198760|NCT02392624|530900793|FG000|Overall Study|Other|49|||
147198761|NCT02392624|530900794|FG001|Overall Study|Other|1|||
147198762|NCT02392624|530900795|FG002|Overall Study|Other|1|||
147198763|NCT00936715|530900796|FG000|Overall Study|Investigators Discretion|1|||
147198764|NCT00936715|530900796|FG000|Overall Study|Protocol Violation|1|||
147198765|NCT00936715|530900796|FG000|Overall Study|Safety or Tolerability Reasons|4|||
147198766|NCT03841604|530900797|FG000|Overall Study|Withdrawal by Subject|3|||
147198767|NCT03841604|530900798|FG001|Overall Study|Withdrawal by Subject|1|||
147198768|NCT03841604|530900797|FG000|Overall Study|Adverse Event|4|||
147198769|NCT03841604|530900798|FG001|Overall Study|Adverse Event|2|||
147198770|NCT03841604|530900797|FG000|Overall Study|Physician Decision|1|||
147198771|NCT03841604|530900798|FG001|Overall Study|Physician Decision|0|||
147198772|NCT02492763|530900799|FG000|Overall Study|Withdrawal by Subject|0|||
147198773|NCT02492763|530900800|FG001|Overall Study|Withdrawal by Subject|2|||
147198774|NCT02492763|530900801|FG002|Overall Study|Withdrawal by Subject|1|||
147198775|NCT02492763|530900802|FG003|Overall Study|Withdrawal by Subject|0|||
147198776|NCT02492763|530900799|FG000|Overall Study|Adverse Event|3|||
147198777|NCT02492763|530900800|FG001|Overall Study|Adverse Event|1|||
147198778|NCT02492763|530900801|FG002|Overall Study|Adverse Event|1|||
147198779|NCT02492763|530900802|FG003|Overall Study|Adverse Event|2|||
147198780|NCT02492763|530900799|FG000|Overall Study|Death|0|||
147198781|NCT02492763|530900800|FG001|Overall Study|Death|0|||
147198782|NCT02492763|530900801|FG002|Overall Study|Death|1|||
147198783|NCT02492763|530900802|FG003|Overall Study|Death|0|||
147198784|NCT02492763|530900799|FG000|Overall Study|Hyperglycemia Discontinuation Criteria|0|||
147198785|NCT02492763|530900800|FG001|Overall Study|Hyperglycemia Discontinuation Criteria|1|||
147198786|NCT02492763|530900801|FG002|Overall Study|Hyperglycemia Discontinuation Criteria|0|||
147198787|NCT02492763|530900802|FG003|Overall Study|Hyperglycemia Discontinuation Criteria|0|||
147198788|NCT02492763|530900799|FG000|Overall Study|Lost to Follow-up|0|||
147198789|NCT02492763|530900800|FG001|Overall Study|Lost to Follow-up|0|||
147198790|NCT02492763|530900801|FG002|Overall Study|Lost to Follow-up|1|||
147198791|NCT02492763|530900802|FG003|Overall Study|Lost to Follow-up|0|||
147198792|NCT02492763|530900799|FG000|Overall Study|Non-Compliance With Study Drug|0|||
147198793|NCT02492763|530900800|FG001|Overall Study|Non-Compliance With Study Drug|1|||
147198794|NCT02492763|530900801|FG002|Overall Study|Non-Compliance With Study Drug|0|||
147198795|NCT02492763|530900802|FG003|Overall Study|Non-Compliance With Study Drug|0|||
147198796|NCT02492763|530900799|FG000|Overall Study|Screen Failure|0|||
147198797|NCT02492763|530900800|FG001|Overall Study|Screen Failure|0|||
147198798|NCT02492763|530900801|FG002|Overall Study|Screen Failure|0|||
147198799|NCT02492763|530900802|FG003|Overall Study|Screen Failure|1|||
147198800|NCT02492763|530900799|FG000|Overall Study|Study Terminated by Sponsor|13|||
147198801|NCT02492763|530900800|FG001|Overall Study|Study Terminated by Sponsor|10|||
147198802|NCT02492763|530900801|FG002|Overall Study|Study Terminated by Sponsor|6|||
147198803|NCT02492763|530900802|FG003|Overall Study|Study Terminated by Sponsor|10|||
147198804|NCT01337960|530900803|FG000|Overall Study|Lost to Follow-up|1|||
147198805|NCT01337960|530900804|FG001|Overall Study|Lost to Follow-up|0|||
147198806|NCT01337960|530900805|FG002|Overall Study|Lost to Follow-up|0|||
147198807|NCT01337960|530900803|FG000|Overall Study|Withdrawal by Subject|1|||
147198808|NCT01337960|530900804|FG001|Overall Study|Withdrawal by Subject|0|||
147198809|NCT01337960|530900805|FG002|Overall Study|Withdrawal by Subject|0|||
147198810|NCT03877510|530900806|FG000|Overall Study|Death|6|||
147198811|NCT03877510|530900806|FG000|Overall Study|Lost to Follow-up|2|||
147198812|NCT03877510|530900806|FG000|Overall Study|Non-compliance with study drug|2|||
147198813|NCT03877510|530900806|FG000|Overall Study|Lack of Efficacy|14|||
147198814|NCT03877510|530900806|FG000|Overall Study|Adverse Event|20|||
147198815|NCT03877510|530900806|FG000|Overall Study|Withdrawal by Subject|22|||
147198816|NCT03877510|530900806|FG000|Overall Study|Miscellaneous|1|||
147198817|NCT02085161|530900808|FG000|Overall Study|Not Treated|1|||
147198818|NCT02085161|530900809|FG001|Overall Study|Not Treated|0|||
147198819|NCT02085161|530900810|FG002|Overall Study|Not Treated|0|||
147198820|NCT02085161|530900811|FG003|Overall Study|Not Treated|0|||
147198821|NCT02085161|530900808|FG000|Overall Study|Adverse Event|8|||
147198822|NCT02085161|530900809|FG001|Overall Study|Adverse Event|5|||
147198823|NCT02085161|530900810|FG002|Overall Study|Adverse Event|4|||
147198824|NCT02085161|530900811|FG003|Overall Study|Adverse Event|5|||
147198825|NCT02085161|530900808|FG000|Overall Study|Protocol Violation|0|||
147198826|NCT02085161|530900809|FG001|Overall Study|Protocol Violation|1|||
147198827|NCT02085161|530900810|FG002|Overall Study|Protocol Violation|0|||
147198828|NCT02085161|530900811|FG003|Overall Study|Protocol Violation|1|||
147198829|NCT02085161|530900808|FG000|Overall Study|Withdrawal by Subject|2|||
147198830|NCT02085161|530900809|FG001|Overall Study|Withdrawal by Subject|4|||
147198831|NCT02085161|530900810|FG002|Overall Study|Withdrawal by Subject|0|||
147198832|NCT02085161|530900811|FG003|Overall Study|Withdrawal by Subject|3|||
147198833|NCT02085161|530900808|FG000|Overall Study|Other Reason|1|||
147198834|NCT02085161|530900809|FG001|Overall Study|Other Reason|0|||
147198835|NCT02085161|530900810|FG002|Overall Study|Other Reason|1|||
147198836|NCT02085161|530900811|FG003|Overall Study|Other Reason|1|||
147198837|NCT01936870|530900816|FG000|Overall Study|No Visit After Treatment|176|||
147198838|NCT01936870|530900816|FG000|Overall Study|Protocol Violation|12|||
147198839|NCT01936870|530900816|FG000|Overall Study|No Drug Administration|1|||
147198840|NCT00628108|530900822|FG000|Overall Study|Adverse Event|0|||
147198841|NCT00628108|530900823|FG001|Overall Study|Adverse Event|3|||
147198842|NCT00628108|530900822|FG000|Overall Study|Withdrawal by Subject|1|||
147198843|NCT00628108|530900823|FG001|Overall Study|Withdrawal by Subject|0|||
147198844|NCT03848832|530900824|FG000|Overall Study|Withdrawal of Consent Due To Covid-19|0|||
147198845|NCT03848832|530900825|FG001|Overall Study|Withdrawal of Consent Due To Covid-19|0|||
147198846|NCT03848832|530900826|FG002|Overall Study|Withdrawal of Consent Due To Covid-19|1|||
147198847|NCT03848832|530900824|FG000|Overall Study|Withdrawal by Subject|0|||
147198848|NCT03848832|530900825|FG001|Overall Study|Withdrawal by Subject|0|||
147198849|NCT03848832|530900826|FG002|Overall Study|Withdrawal by Subject|1|||
147198850|NCT03848832|530900824|FG000|Overall Study|Withdrawal (Covid-19)|0|||
147198851|NCT03848832|530900825|FG001|Overall Study|Withdrawal (Covid-19)|2|||
147198852|NCT03848832|530900826|FG002|Overall Study|Withdrawal (Covid-19)|0|||
147198853|NCT03848832|530900824|FG000|Overall Study|Physician Decision|2|||
147198854|NCT03848832|530900825|FG001|Overall Study|Physician Decision|1|||
147198855|NCT03848832|530900826|FG002|Overall Study|Physician Decision|3|||
147198856|NCT03848832|530900824|FG000|Overall Study|Sponsor Decision - Covid-19 Precaution|0|||
147198857|NCT03848832|530900825|FG001|Overall Study|Sponsor Decision - Covid-19 Precaution|0|||
147198858|NCT03848832|530900826|FG002|Overall Study|Sponsor Decision - Covid-19 Precaution|1|||
147198859|NCT03848832|530900824|FG000|Overall Study|Adverse Event|1|||
147198860|NCT03848832|530900825|FG001|Overall Study|Adverse Event|0|||
147198861|NCT03848832|530900826|FG002|Overall Study|Adverse Event|0|||
147198862|NCT00719472|530900828|FG000|Enrolled in Study|Physician decision to withdraw patient|1|||
147198863|NCT00719472|530900828|FG000|Enrolled in Study|Subject decision to withdraw|8|||
147198864|NCT00719472|530900828|FG000|Enrolled in Study|Various Reasons|17|||
147198865|NCT00719472|530900828|FG000|Received Cycle 1 Treatment|Adverse Event|8|||
147198866|NCT00719472|530900828|FG000|Received Cycle 1 Treatment|Death|5|||
147198867|NCT00719472|530900828|FG000|Received Cycle 1 Treatment|Eligibility criteria for Cycle 2 not met|11|||
147198868|NCT00719472|530900828|FG000|Received Cycle 1 Treatment|Physician decision to withdraw patient|7|||
147198869|NCT00719472|530900828|FG000|Received Cycle 1 Treatment|Subject decision to withdraw|9|||
147198870|NCT00719472|530900828|FG000|Received Cycle 1 Treatment|Various Reasons|13|||
147198871|NCT00719472|530900828|FG000|Received Cycle 2 Treatment|Adverse Event|12|||
147198872|NCT00719472|530900828|FG000|Received Cycle 2 Treatment|Death|6|||
147198873|NCT00719472|530900828|FG000|Received Cycle 2 Treatment|Disease progression|3|||
147198874|NCT00719472|530900828|FG000|Received Cycle 2 Treatment|Lost to Follow-up|3|||
147198875|NCT00719472|530900828|FG000|Received Cycle 2 Treatment|Physician decision to withdraw patient|13|||
147198876|NCT00719472|530900828|FG000|Received Cycle 2 Treatment|Subject decision to withdraw|6|||
147198877|NCT00719472|530900828|FG000|Received Cycle 2 Treatment|Various Reasons|25|||
147198878|NCT00711191|530900831|FG000|Overall Study|Adverse Event|1|||
147198879|NCT00711191|530900832|FG001|Overall Study|Adverse Event|1|||
147198880|NCT00711191|530900833|FG002|Overall Study|Adverse Event|2|||
147198881|NCT00711191|530900831|FG000|Overall Study|Objective progression or relapse|2|||
147198882|NCT00711191|530900832|FG001|Overall Study|Objective progression or relapse|3|||
147198883|NCT00711191|530900833|FG002|Overall Study|Objective progression or relapse|7|||
147198884|NCT00711191|530900831|FG000|Overall Study|Withdrawal by Subject|0|||
147198885|NCT00711191|530900832|FG001|Overall Study|Withdrawal by Subject|1|||
147198886|NCT00711191|530900833|FG002|Overall Study|Withdrawal by Subject|3|||
147198887|NCT01744977|530900834|FG000|Overall Study|Withdrawal by Subject|1|||
147198888|NCT01744977|530900835|FG001|Overall Study|Withdrawal by Subject|2|||
147198889|NCT01744977|530900834|FG000|Overall Study|Death|2|||
147198890|NCT01744977|530900835|FG001|Overall Study|Death|3|||
147198891|NCT01744977|530900834|FG000|Overall Study|Lost to Follow-up|2|||
147198892|NCT01744977|530900835|FG001|Overall Study|Lost to Follow-up|0|||
147198893|NCT01744977|530900834|FG000|Overall Study|No longer meets inclusion|6|||
147198894|NCT01744977|530900835|FG001|Overall Study|No longer meets inclusion|0|||
147198895|NCT01213472|530900836|FG000|Overall Study|Recurrence/Progressive disease|25|||
147198896|NCT01213472|530900836|FG000|Overall Study|Withdrawal by Subject|1|||
147198897|NCT01213472|530900836|FG000|Overall Study|Physician Decision|1|||
147198898|NCT03345784|530900839|FG000|Overall Study|Withdrawal by Subject|2|||
147198899|NCT03345784|530900840|FG001|Overall Study|Withdrawal by Subject|1|||
147198900|NCT00482053|530900845|FG000|Inter-treatment Period|Disease progression|1|||
147198901|NCT00728689|530900846|FG000|Washout Period (Days 4 - 10)|Death in family|1|||
147198902|NCT00728689|530900847|FG001|Washout Period (Days 4 - 10)|Death in family|0|||
147198903|NCT01055197|530900850|FG000|Overall Study|Protocol Violation|7|||
147198904|NCT01055197|530900851|FG001|Overall Study|Protocol Violation|2|||
147198905|NCT01055197|530900850|FG000|Overall Study|Withdrawal by Subject|2|||
147198906|NCT01055197|530900851|FG001|Overall Study|Withdrawal by Subject|0|||
147198907|NCT00389610|530900852|FG000|Overall Study|Disease Progression|0|||
147198908|NCT00389610|530900853|FG001|Overall Study|Disease Progression|19|||
147198909|NCT00389610|530900852|FG000|Overall Study|Death|0|||
147198910|NCT00389610|530900853|FG001|Overall Study|Death|1|||
147198911|NCT00389610|530900852|FG000|Overall Study|Physician Decision|0|||
147198912|NCT00389610|530900853|FG001|Overall Study|Physician Decision|1|||
147198913|NCT00389610|530900852|FG000|Overall Study|Withdrawal by Subject|0|||
147198914|NCT00389610|530900853|FG001|Overall Study|Withdrawal by Subject|1|||
147198915|NCT00887809|530900854|FG000|Overall Study|Patient Not Treated|3|||
147198916|NCT00887809|530900855|FG001|Overall Study|Patient Not Treated|0|||
147198917|NCT00887809|530900854|FG000|Overall Study|Death|1|||
147198918|NCT00887809|530900855|FG001|Overall Study|Death|0|||
147198919|NCT01550003|530900858|FG000|Overall Study|Adverse Event|0|||
147198920|NCT01550003|530900859|FG001|Overall Study|Adverse Event|9|||
147198921|NCT01550003|530900860|FG002|Overall Study|Adverse Event|15|||
147198922|NCT01550003|530900858|FG000|Overall Study|Lack of Efficacy|4|||
147198923|NCT01550003|530900859|FG001|Overall Study|Lack of Efficacy|11|||
147198924|NCT01550003|530900860|FG002|Overall Study|Lack of Efficacy|15|||
147198925|NCT01550003|530900858|FG000|Overall Study|Protocol Violation|0|||
147198926|NCT01550003|530900859|FG001|Overall Study|Protocol Violation|3|||
147198927|NCT01550003|530900860|FG002|Overall Study|Protocol Violation|2|||
147198928|NCT01550003|530900858|FG000|Overall Study|Lost to Follow-up|1|||
147198929|NCT01550003|530900859|FG001|Overall Study|Lost to Follow-up|4|||
147198930|NCT01550003|530900860|FG002|Overall Study|Lost to Follow-up|8|||
147198931|NCT01550003|530900858|FG000|Overall Study|Consent withdrawn|2|||
147198932|NCT01550003|530900859|FG001|Overall Study|Consent withdrawn|11|||
147198933|NCT01550003|530900860|FG002|Overall Study|Consent withdrawn|23|||
147198934|NCT01550003|530900858|FG000|Overall Study|Missing|1|||
147198935|NCT01550003|530900859|FG001|Overall Study|Missing|0|||
147198936|NCT01550003|530900860|FG002|Overall Study|Missing|2|||
147198937|NCT01550003|530900858|FG000|Overall Study|Study closure as announced by sponsor|7|||
147198938|NCT01550003|530900859|FG001|Overall Study|Study closure as announced by sponsor|6|||
147198939|NCT01550003|530900860|FG002|Overall Study|Study closure as announced by sponsor|24|||
147198940|NCT01550003|530900858|FG000|Overall Study|Protocol Noncompliance|1|||
147198941|NCT01550003|530900859|FG001|Overall Study|Protocol Noncompliance|0|||
147198942|NCT01550003|530900860|FG002|Overall Study|Protocol Noncompliance|0|||
147198943|NCT01550003|530900858|FG000|Overall Study|Study closure|0|||
147198944|NCT01550003|530900859|FG001|Overall Study|Study closure|1|||
147198945|NCT01550003|530900860|FG002|Overall Study|Study closure|1|||
147198946|NCT01550003|530900858|FG000|Overall Study|Patient reached adulthood|0|||
147198947|NCT01550003|530900859|FG001|Overall Study|Patient reached adulthood|1|||
147198948|NCT01550003|530900860|FG002|Overall Study|Patient reached adulthood|0|||
147198949|NCT01550003|530900858|FG000|Overall Study|Early discontinuation at request of sponsor|0|||
147535014|NCT02060188|532114815|FG006|Overall Study|Participant request to discontinue study treatment|1|||
147198950|NCT01550003|530900859|FG001|Overall Study|Early discontinuation at request of sponsor|2|||
147198951|NCT01550003|530900860|FG002|Overall Study|Early discontinuation at request of sponsor|4|||
147198952|NCT01550003|530900858|FG000|Overall Study|Sponsor's order|0|||
147198953|NCT01550003|530900859|FG001|Overall Study|Sponsor's order|3|||
147198954|NCT01550003|530900860|FG002|Overall Study|Sponsor's order|3|||
147198955|NCT01550003|530900858|FG000|Overall Study|Sponsor's decision|1|||
147198956|NCT01550003|530900859|FG001|Overall Study|Sponsor's decision|5|||
147198957|NCT01550003|530900860|FG002|Overall Study|Sponsor's decision|4|||
147198958|NCT01550003|530900858|FG000|Overall Study|Subject mother passed away|0|||
147198959|NCT01550003|530900859|FG001|Overall Study|Subject mother passed away|1|||
147198960|NCT01550003|530900860|FG002|Overall Study|Subject mother passed away|0|||
147198961|NCT01550003|530900858|FG000|Overall Study|Discontinuation|0|||
147198962|NCT01550003|530900859|FG001|Overall Study|Discontinuation|1|||
147198963|NCT01550003|530900860|FG002|Overall Study|Discontinuation|0|||
147198964|NCT01550003|530900858|FG000|Overall Study|Subject moved to rheumatology and out of study|0|||
147198965|NCT01550003|530900859|FG001|Overall Study|Subject moved to rheumatology and out of study|1|||
147198966|NCT01550003|530900860|FG002|Overall Study|Subject moved to rheumatology and out of study|1|||
147198967|NCT01550003|530900858|FG000|Overall Study|Site closure|0|||
147198968|NCT01550003|530900859|FG001|Overall Study|Site closure|2|||
147198969|NCT01550003|530900860|FG002|Overall Study|Site closure|0|||
147198970|NCT01550003|530900858|FG000|Overall Study|Pregnancy|0|||
147198971|NCT01550003|530900859|FG001|Overall Study|Pregnancy|1|||
147198972|NCT01550003|530900860|FG002|Overall Study|Pregnancy|0|||
147198973|NCT01550003|530900858|FG000|Overall Study|By medical decision and approved by the sponsor|0|||
147198974|NCT01550003|530900859|FG001|Overall Study|By medical decision and approved by the sponsor|0|||
147198975|NCT01550003|530900860|FG002|Overall Study|By medical decision and approved by the sponsor|1|||
147198976|NCT01550003|530900858|FG000|Overall Study|Subject is in college/unable to come to visits|0|||
147198977|NCT01550003|530900859|FG001|Overall Study|Subject is in college/unable to come to visits|0|||
147198978|NCT01550003|530900860|FG002|Overall Study|Subject is in college/unable to come to visits|1|||
147198979|NCT01550003|530900858|FG000|Overall Study|Switching to adult rheumatologist|0|||
147198980|NCT01550003|530900859|FG001|Overall Study|Switching to adult rheumatologist|0|||
147198981|NCT01550003|530900860|FG002|Overall Study|Switching to adult rheumatologist|1|||
147198982|NCT01550003|530900858|FG000|Overall Study|Patient transition to adult care|0|||
147198983|NCT01550003|530900859|FG001|Overall Study|Patient transition to adult care|0|||
147198984|NCT01550003|530900860|FG002|Overall Study|Patient transition to adult care|1|||
147198985|NCT01550003|530900858|FG000|Overall Study|Subject was able to obtain commercial cimzia|0|||
147198986|NCT01550003|530900859|FG001|Overall Study|Subject was able to obtain commercial cimzia|0|||
147198987|NCT01550003|530900860|FG002|Overall Study|Subject was able to obtain commercial cimzia|1|||
147198988|NCT01550003|530900858|FG000|Overall Study|Treatment or 12 week follow up visit completed|0|||
147198989|NCT01550003|530900859|FG001|Overall Study|Treatment or 12 week follow up visit completed|0|||
147198990|NCT01550003|530900860|FG002|Overall Study|Treatment or 12 week follow up visit completed|1|||
147198991|NCT01550003|530900858|FG000|Overall Study|Per Sponsor request|1|||
147198992|NCT01550003|530900859|FG001|Overall Study|Per Sponsor request|0|||
147198993|NCT01550003|530900860|FG002|Overall Study|Per Sponsor request|1|||
147198994|NCT01550003|530900858|FG000|Overall Study|Patient not compliance|0|||
147198995|NCT01550003|530900859|FG001|Overall Study|Patient not compliance|0|||
147198996|NCT01550003|530900860|FG002|Overall Study|Patient not compliance|1|||
147198997|NCT01550003|530900858|FG000|Overall Study|Non-compliance|0|||
147198998|NCT01550003|530900859|FG001|Overall Study|Non-compliance|0|||
147198999|NCT01550003|530900860|FG002|Overall Study|Non-compliance|1|||
147199000|NCT01550003|530900858|FG000|Overall Study|Study closed|0|||
147199001|NCT01550003|530900859|FG001|Overall Study|Study closed|1|||
147199002|NCT01550003|530900860|FG002|Overall Study|Study closed|0|||
147199003|NCT01550003|530900858|FG000|Overall Study|Transitioned to adult rheumatology|0|||
147199004|NCT01550003|530900859|FG001|Overall Study|Transitioned to adult rheumatology|0|||
147199005|NCT01550003|530900860|FG002|Overall Study|Transitioned to adult rheumatology|1|||
147199006|NCT05567783|530900861|FG000|Overall Study|Death|2|||
147199007|NCT05567783|530900862|FG001|Overall Study|Death|3|||
147199008|NCT05567783|530900863|FG002|Overall Study|Death|0|||
147199009|NCT05567783|530900861|FG000|Overall Study|Lost to Follow-up|25|||
147199010|NCT05567783|530900862|FG001|Overall Study|Lost to Follow-up|19|||
147199011|NCT05567783|530900863|FG002|Overall Study|Lost to Follow-up|17|||
147199012|NCT05567783|530900861|FG000|Overall Study|Physician Decision|10|||
147199013|NCT05567783|530900862|FG001|Overall Study|Physician Decision|7|||
147199014|NCT05567783|530900863|FG002|Overall Study|Physician Decision|9|||
147199015|NCT05567783|530900861|FG000|Overall Study|Study Terminated by Sponsor|924|||
147199016|NCT05567783|530900862|FG001|Overall Study|Study Terminated by Sponsor|937|||
147199017|NCT05567783|530900863|FG002|Overall Study|Study Terminated by Sponsor|941|||
147199018|NCT05567783|530900861|FG000|Overall Study|Withdrawal by Subject|23|||
147199019|NCT05567783|530900862|FG001|Overall Study|Withdrawal by Subject|27|||
147199020|NCT05567783|530900863|FG002|Overall Study|Withdrawal by Subject|24|||
147199021|NCT05567783|530900861|FG000|Overall Study|Incarcerated|1|||
147199022|NCT05567783|530900862|FG001|Overall Study|Incarcerated|0|||
147199023|NCT05567783|530900863|FG002|Overall Study|Incarcerated|0|||
147199024|NCT05567783|530900861|FG000|Overall Study|Participant randomized in error|4|||
147199025|NCT05567783|530900862|FG001|Overall Study|Participant randomized in error|2|||
147199026|NCT05567783|530900863|FG002|Overall Study|Participant randomized in error|2|||
147199027|NCT03675126|530900866|FG000|Overall Study|Study Terminated by Sponsor|9|||
147199028|NCT03675126|530900866|FG000|Overall Study|Death|2|||
147199029|NCT03675126|530900866|FG000|Overall Study|Withdrawal by Subject|4|||
147199030|NCT00001959|530900867|FG000|Overall Study|newly diagnosed colon cancer|1|||
147199031|NCT00001959|530900867|FG000|Overall Study|disabling sedation|1|||
147199032|NCT00001959|530900867|FG000|Overall Study|non-compliance|1|||
147199033|NCT03113487|530900868|FG000|Overall Study|After cycle 1 sepsis was deemed present at baseline, so the patient was ineligible|1|||
147199034|NCT03777982|530900869|FG000|Overall Study|Physician Decision|0|||
147199035|NCT03777982|530900870|FG001|Overall Study|Physician Decision|1|||
147199036|NCT04189952|530900873|FG000|Follow-up Period|Death|1|||
147199037|NCT04189952|530900873|FG000|Follow-up Period|Withdrawal by Subject|1|||
147199038|NCT04298697|530900876|FG000|Overall Study|Lost to Follow-up|5|||
147199039|NCT04298697|530900877|FG001|Overall Study|Lost to Follow-up|5|||
147199040|NCT04298697|530900878|FG002|Overall Study|Lost to Follow-up|1|||
147199041|NCT04298697|530900879|FG003|Overall Study|Lost to Follow-up|0|||
147199042|NCT04298697|530900876|FG000|Overall Study|Withdrawal by Subject|0|||
147199043|NCT04298697|530900877|FG001|Overall Study|Withdrawal by Subject|3|||
147199044|NCT04298697|530900878|FG002|Overall Study|Withdrawal by Subject|2|||
147199045|NCT04298697|530900879|FG003|Overall Study|Withdrawal by Subject|3|||
147199046|NCT03995368|530900880|FG000|Overall Study|Lost to Follow-up|1|||
147199047|NCT03995368|530900881|FG001|Overall Study|Lost to Follow-up|4|||
147199048|NCT03995368|530900882|FG002|Overall Study|Lost to Follow-up|1|||
147199049|NCT03995368|530900880|FG000|Overall Study|Did not meet inclusion criteria|1|||
147199050|NCT03995368|530900881|FG001|Overall Study|Did not meet inclusion criteria|6|||
147199051|NCT03995368|530900882|FG002|Overall Study|Did not meet inclusion criteria|3|||
147199052|NCT03995368|530900880|FG000|Overall Study|Withdrawal by Subject|0|||
147199053|NCT03995368|530900881|FG001|Overall Study|Withdrawal by Subject|1|||
147199054|NCT03995368|530900882|FG002|Overall Study|Withdrawal by Subject|1|||
147199055|NCT00361296|530900885|FG000|Overall Study|Physician Decision|1|||
147199056|NCT00361296|530900885|FG000|Overall Study|Lack of Efficacy|2|||
147199057|NCT03058146|530900888|FG000|Overall Study|Withdrawal by Subject|4|||
147199058|NCT03058146|530900889|FG001|Overall Study|Withdrawal by Subject|1|||
147199059|NCT03058146|530900888|FG000|Overall Study|Coronavirus (COVID)-19 shutdown|0|||
147199060|NCT03058146|530900889|FG001|Overall Study|Coronavirus (COVID)-19 shutdown|1|||
147199061|NCT00632229|530900890|FG000|Overall Study|Adverse Event|6|||
147199062|NCT00632229|530900891|FG001|Overall Study|Adverse Event|0|||
147199063|NCT00632229|530900890|FG000|Overall Study|Lost to Follow-up|0|||
147199064|NCT00632229|530900891|FG001|Overall Study|Lost to Follow-up|3|||
147199065|NCT00632229|530900890|FG000|Overall Study|Lack of Efficacy|0|||
147199066|NCT00632229|530900891|FG001|Overall Study|Lack of Efficacy|2|||
147199067|NCT00632229|530900890|FG000|Overall Study|Undisclosed reasons within the first wee|0|||
147199068|NCT00632229|530900891|FG001|Overall Study|Undisclosed reasons within the first wee|1|||
147199069|NCT00993967|530900896|FG000|Overall Study|Adverse Event|8|||
147199070|NCT00993967|530900896|FG000|Overall Study|Death|1|||
147199071|NCT00993967|530900896|FG000|Overall Study|Lost to Follow-up|14|||
147199072|NCT00993967|530900896|FG000|Overall Study|Withdrawal by Subject|36|||
147199073|NCT00993967|530900896|FG000|Overall Study|Protocol Violation|2|||
147199074|NCT03783078|530900897|FG000|Overall Study|Death|31|||
147199075|NCT03783078|530900897|FG000|Overall Study|Sponsor Decision|23|||
147199076|NCT03783078|530900897|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
147199077|NCT04825678|530900900|FG000|Overall Study|Decision by Sponsor|2|||
147199078|NCT04825678|530900901|FG001|Overall Study|Decision by Sponsor|3|||
147199079|NCT04825678|530900900|FG000|Overall Study|Withdrawal of Consent From Study|7|||
147199080|NCT04825678|530900901|FG001|Overall Study|Withdrawal of Consent From Study|9|||
147199081|NCT04825678|530900900|FG000|Overall Study|Lost to Follow-up|3|||
147199082|NCT04825678|530900901|FG001|Overall Study|Lost to Follow-up|4|||
147199083|NCT04825678|530900900|FG000|Overall Study|Never Received Investigational Product|1|||
147199084|NCT04825678|530900901|FG001|Overall Study|Never Received Investigational Product|1|||
147199085|NCT00651742|530900902|FG000|Overall Study|Objective Disease Progression|22|||
147199086|NCT00651742|530900902|FG000|Overall Study|Toxicity|3|||
147199087|NCT00651742|530900902|FG000|Overall Study|Investigator Judgment|1|||
147199088|NCT00651742|530900902|FG000|Overall Study|Withdrawal of Consent|1|||
147199089|NCT00651742|530900902|FG000|Overall Study|Enrolled but not treated|1|||
147199090|NCT00911170|530900903|FG000|Treatment Period|Randomized in error|1|||
147199091|NCT00911170|530900904|FG001|Treatment Period|Randomized in error|1|||
147199092|NCT00911170|530900903|FG000|Treatment Period|Ineligibility determined|1|||
147199093|NCT00911170|530900904|FG001|Treatment Period|Ineligibility determined|3|||
147199094|NCT00911170|530900903|FG000|Treatment Period|Protocol deviation|1|||
147199095|NCT00911170|530900904|FG001|Treatment Period|Protocol deviation|2|||
147199096|NCT00911170|530900903|FG000|Treatment Period|Adverse Event|9|||
147199097|NCT00911170|530900904|FG001|Treatment Period|Adverse Event|10|||
147199098|NCT00911170|530900903|FG000|Treatment Period|Withdrawal by Subject|4|||
147199099|NCT00911170|530900904|FG001|Treatment Period|Withdrawal by Subject|4|||
147199100|NCT00911170|530900903|FG000|Treatment Period|Disease progression|0|||
147199101|NCT00911170|530900904|FG001|Treatment Period|Disease progression|2|||
147199102|NCT00911170|530900903|FG000|Treatment Period|Physician Decision|5|||
147199103|NCT00911170|530900904|FG001|Treatment Period|Physician Decision|5|||
147199104|NCT00911170|530900903|FG000|Treatment Period|Lost to Follow-up|0|||
147199105|NCT00911170|530900904|FG001|Treatment Period|Lost to Follow-up|1|||
147199106|NCT00911170|530900903|FG000|Treatment Period|Death|6|||
147199107|NCT00911170|530900904|FG001|Treatment Period|Death|9|||
147199108|NCT00911170|530900903|FG000|Long Term Follow-Up|Continuing in study|274|||
147199109|NCT00911170|530900904|FG001|Long Term Follow-Up|Continuing in study|269|||
147199110|NCT00911170|530900903|FG000|Long Term Follow-Up|Withdrawal by Subject|20|||
147199111|NCT00911170|530900904|FG001|Long Term Follow-Up|Withdrawal by Subject|21|||
147199112|NCT00911170|530900903|FG000|Long Term Follow-Up|Physician Decision|5|||
147595944|NCT03096847|532338752|FG001|Overall Study|Progressive disease|10|||
147199113|NCT00911170|530900904|FG001|Long Term Follow-Up|Physician Decision|4|||
147199114|NCT00911170|530900903|FG000|Long Term Follow-Up|Lost to Follow-up|8|||
147199115|NCT00911170|530900904|FG001|Long Term Follow-Up|Lost to Follow-up|7|||
147199116|NCT00911170|530900903|FG000|Long Term Follow-Up|Death|116|||
147199117|NCT00911170|530900904|FG001|Long Term Follow-Up|Death|121|||
147199118|NCT02594124|530900905|FG000|Overall Study|Adverse Event|0|||
147199119|NCT02594124|530900906|FG001|Overall Study|Adverse Event|5|||
147199120|NCT02594124|530900907|FG002|Overall Study|Adverse Event|8|||
147199121|NCT02594124|530900908|FG003|Overall Study|Adverse Event|1|||
147199122|NCT02594124|530900909|FG004|Overall Study|Adverse Event|0|||
147199123|NCT02594124|530900910|FG005|Overall Study|Adverse Event|0|||
147199124|NCT02594124|530900911|FG006|Overall Study|Adverse Event|2|||
147199125|NCT02594124|530900912|FG007|Overall Study|Adverse Event|2|||
147199126|NCT02594124|530900913|FG008|Overall Study|Adverse Event|0|||
147199127|NCT02594124|530900905|FG000|Overall Study|Withdrawal by Subject|2|||
147199128|NCT02594124|530900906|FG001|Overall Study|Withdrawal by Subject|3|||
147199129|NCT02594124|530900907|FG002|Overall Study|Withdrawal by Subject|5|||
147199130|NCT02594124|530900908|FG003|Overall Study|Withdrawal by Subject|1|||
147199131|NCT02594124|530900909|FG004|Overall Study|Withdrawal by Subject|8|||
147199132|NCT02594124|530900910|FG005|Overall Study|Withdrawal by Subject|4|||
147199133|NCT02594124|530900911|FG006|Overall Study|Withdrawal by Subject|13|||
147199134|NCT02594124|530900912|FG007|Overall Study|Withdrawal by Subject|19|||
147199135|NCT02594124|530900913|FG008|Overall Study|Withdrawal by Subject|0|||
147199136|NCT02594124|530900905|FG000|Overall Study|Physician Decision|0|||
147199137|NCT02594124|530900906|FG001|Overall Study|Physician Decision|2|||
147199138|NCT02594124|530900907|FG002|Overall Study|Physician Decision|0|||
147199139|NCT02594124|530900908|FG003|Overall Study|Physician Decision|0|||
147199140|NCT02594124|530900909|FG004|Overall Study|Physician Decision|0|||
147199141|NCT02594124|530900910|FG005|Overall Study|Physician Decision|0|||
147199142|NCT02594124|530900911|FG006|Overall Study|Physician Decision|0|||
147199143|NCT02594124|530900912|FG007|Overall Study|Physician Decision|1|||
147199144|NCT02594124|530900913|FG008|Overall Study|Physician Decision|0|||
147199145|NCT02594124|530900905|FG000|Overall Study|Commercial drug|0|||
147199146|NCT02594124|530900906|FG001|Overall Study|Commercial drug|1|||
147199147|NCT02594124|530900907|FG002|Overall Study|Commercial drug|6|||
147199148|NCT02594124|530900908|FG003|Overall Study|Commercial drug|3|||
147199149|NCT02594124|530900909|FG004|Overall Study|Commercial drug|0|||
147199150|NCT02594124|530900910|FG005|Overall Study|Commercial drug|0|||
147199151|NCT02594124|530900911|FG006|Overall Study|Commercial drug|7|||
147199152|NCT02594124|530900912|FG007|Overall Study|Commercial drug|11|||
147199153|NCT02594124|530900913|FG008|Overall Study|Commercial drug|2|||
147199154|NCT02594124|530900905|FG000|Overall Study|Reason Not Specified|1|||
147199155|NCT02594124|530900906|FG001|Overall Study|Reason Not Specified|3|||
147199156|NCT02594124|530900907|FG002|Overall Study|Reason Not Specified|4|||
147199157|NCT02594124|530900908|FG003|Overall Study|Reason Not Specified|0|||
147199158|NCT02594124|530900909|FG004|Overall Study|Reason Not Specified|0|||
147199159|NCT02594124|530900910|FG005|Overall Study|Reason Not Specified|1|||
147199160|NCT02594124|530900911|FG006|Overall Study|Reason Not Specified|1|||
147199161|NCT02594124|530900912|FG007|Overall Study|Reason Not Specified|6|||
147199162|NCT02594124|530900913|FG008|Overall Study|Reason Not Specified|1|||
147199163|NCT01824836|530900914|FG000|Overall Study|Adverse Event|48|||
147199164|NCT01824836|530900914|FG000|Overall Study|Withdrawal by Subject|63|||
147199165|NCT01824836|530900914|FG000|Overall Study|Other complicating disease|116|||
147199166|NCT01824836|530900914|FG000|Overall Study|Disease progression|5|||
147199167|NCT01824836|530900914|FG000|Overall Study|Alternative therapy|2|||
147199168|NCT01824836|530900914|FG000|Overall Study|Depression|1|||
147199169|NCT01824836|530900914|FG000|Overall Study|Non-compliance|3|||
147199170|NCT01824836|530900914|FG000|Overall Study|Patient regained ovarian function|3|||
147199171|NCT01824836|530900914|FG000|Overall Study|Lost to Follow-up|8|||
147199172|NCT01824836|530900914|FG000|Overall Study|Physician Decision|2|||
147199173|NCT01824836|530900914|FG000|Overall Study|Research office was closed|3|||
147199174|NCT01824836|530900914|FG000|Overall Study|Relocation|3|||
147199175|NCT01824836|530900914|FG000|Overall Study|Insurance-related issue|1|||
147199176|NCT01824836|530900914|FG000|Overall Study|Transportation issue|1|||
147199177|NCT01824836|530900914|FG000|Overall Study|Patient transferred care|1|||
147199178|NCT01824836|530900914|FG000|Overall Study|Unknown reasons|4|||
147199179|NCT01824836|530900914|FG000|Overall Study|Never started treatment|16|||
147199180|NCT04323124|530900918|FG000|Overall Study|Adverse Event|0|||
147199181|NCT04323124|530900919|FG001|Overall Study|Adverse Event|0|||
147199182|NCT04323124|530900920|FG002|Overall Study|Adverse Event|0|||
147199183|NCT04323124|530900921|FG003|Overall Study|Adverse Event|0|||
147199184|NCT04323124|530900922|FG004|Overall Study|Adverse Event|0|||
147199185|NCT04323124|530900923|FG005|Overall Study|Adverse Event|1|||
147199186|NCT04323124|530900924|FG006|Overall Study|Adverse Event|0|||
147199187|NCT04323124|530900925|FG007|Overall Study|Adverse Event|1|||
147649411|NCT04575584|532537340|FG005|Overall Study|Not recorded|0|||
147199188|NCT04323124|530900926|FG008|Overall Study|Adverse Event|1|||
147199189|NCT04323124|530900927|FG009|Overall Study|Adverse Event|0|||
147199190|NCT04323124|530900928|FG010|Overall Study|Adverse Event|0|||
147199191|NCT04323124|530900929|FG011|Overall Study|Adverse Event|0|||
147199192|NCT04323124|530900930|FG012|Overall Study|Adverse Event|0|||
147199193|NCT04323124|530900931|FG013|Overall Study|Adverse Event|0|||
147199194|NCT04323124|530900932|FG014|Overall Study|Adverse Event|0|||
147199195|NCT04323124|530900918|FG000|Overall Study|Other|0|||
147199196|NCT04323124|530900919|FG001|Overall Study|Other|0|||
147199197|NCT04323124|530900920|FG002|Overall Study|Other|0|||
147199198|NCT04323124|530900921|FG003|Overall Study|Other|0|||
147199199|NCT04323124|530900922|FG004|Overall Study|Other|1|||
147199200|NCT04323124|530900923|FG005|Overall Study|Other|0|||
147199201|NCT04323124|530900924|FG006|Overall Study|Other|0|||
147199202|NCT04323124|530900925|FG007|Overall Study|Other|0|||
147199203|NCT04323124|530900926|FG008|Overall Study|Other|1|||
147199204|NCT04323124|530900927|FG009|Overall Study|Other|0|||
147199205|NCT04323124|530900928|FG010|Overall Study|Other|0|||
147199206|NCT04323124|530900929|FG011|Overall Study|Other|0|||
147199207|NCT04323124|530900930|FG012|Overall Study|Other|0|||
147199208|NCT04323124|530900931|FG013|Overall Study|Other|0|||
147199209|NCT04323124|530900932|FG014|Overall Study|Other|0|||
147199210|NCT04323124|530900918|FG000|Overall Study|Coming from a red zone (COVID)|0|||
147199211|NCT04323124|530900919|FG001|Overall Study|Coming from a red zone (COVID)|0|||
147199212|NCT04323124|530900920|FG002|Overall Study|Coming from a red zone (COVID)|0|||
147199213|NCT04323124|530900921|FG003|Overall Study|Coming from a red zone (COVID)|0|||
147199214|NCT04323124|530900922|FG004|Overall Study|Coming from a red zone (COVID)|1|||
147199215|NCT04323124|530900923|FG005|Overall Study|Coming from a red zone (COVID)|1|||
147199216|NCT04323124|530900924|FG006|Overall Study|Coming from a red zone (COVID)|0|||
147199217|NCT04323124|530900925|FG007|Overall Study|Coming from a red zone (COVID)|0|||
147199218|NCT04323124|530900926|FG008|Overall Study|Coming from a red zone (COVID)|0|||
147199219|NCT04323124|530900927|FG009|Overall Study|Coming from a red zone (COVID)|0|||
147199220|NCT04323124|530900928|FG010|Overall Study|Coming from a red zone (COVID)|0|||
147199221|NCT04323124|530900929|FG011|Overall Study|Coming from a red zone (COVID)|0|||
147199222|NCT04323124|530900930|FG012|Overall Study|Coming from a red zone (COVID)|0|||
147199223|NCT04323124|530900931|FG013|Overall Study|Coming from a red zone (COVID)|0|||
147199224|NCT04323124|530900932|FG014|Overall Study|Coming from a red zone (COVID)|0|||
147199225|NCT04323124|530900918|FG000|Overall Study|No longer meets eligibility criteria|0|||
147199226|NCT04323124|530900919|FG001|Overall Study|No longer meets eligibility criteria|0|||
147199227|NCT04323124|530900920|FG002|Overall Study|No longer meets eligibility criteria|0|||
147199228|NCT04323124|530900921|FG003|Overall Study|No longer meets eligibility criteria|0|||
147199229|NCT04323124|530900922|FG004|Overall Study|No longer meets eligibility criteria|0|||
147199230|NCT04323124|530900923|FG005|Overall Study|No longer meets eligibility criteria|0|||
147199231|NCT04323124|530900924|FG006|Overall Study|No longer meets eligibility criteria|0|||
147199232|NCT04323124|530900925|FG007|Overall Study|No longer meets eligibility criteria|1|||
147199233|NCT04323124|530900926|FG008|Overall Study|No longer meets eligibility criteria|0|||
147199234|NCT04323124|530900927|FG009|Overall Study|No longer meets eligibility criteria|0|||
147199235|NCT04323124|530900928|FG010|Overall Study|No longer meets eligibility criteria|0|||
147199236|NCT04323124|530900929|FG011|Overall Study|No longer meets eligibility criteria|0|||
147199237|NCT04323124|530900930|FG012|Overall Study|No longer meets eligibility criteria|0|||
147199238|NCT04323124|530900931|FG013|Overall Study|No longer meets eligibility criteria|1|||
147199239|NCT04323124|530900932|FG014|Overall Study|No longer meets eligibility criteria|1|||
147199240|NCT04323124|530900918|FG000|Overall Study|Study terminated by sponsor|0|||
147199241|NCT04323124|530900919|FG001|Overall Study|Study terminated by sponsor|0|||
147199242|NCT04323124|530900920|FG002|Overall Study|Study terminated by sponsor|0|||
147199243|NCT04323124|530900921|FG003|Overall Study|Study terminated by sponsor|0|||
147199244|NCT04323124|530900922|FG004|Overall Study|Study terminated by sponsor|0|||
147199245|NCT04323124|530900923|FG005|Overall Study|Study terminated by sponsor|0|||
147199246|NCT04323124|530900924|FG006|Overall Study|Study terminated by sponsor|0|||
147199247|NCT04323124|530900925|FG007|Overall Study|Study terminated by sponsor|0|||
147199248|NCT04323124|530900926|FG008|Overall Study|Study terminated by sponsor|0|||
147199249|NCT04323124|530900927|FG009|Overall Study|Study terminated by sponsor|0|||
147199250|NCT04323124|530900928|FG010|Overall Study|Study terminated by sponsor|0|||
147199251|NCT04323124|530900929|FG011|Overall Study|Study terminated by sponsor|2|||
147199252|NCT04323124|530900930|FG012|Overall Study|Study terminated by sponsor|1|||
147199253|NCT04323124|530900931|FG013|Overall Study|Study terminated by sponsor|0|||
147199254|NCT04323124|530900932|FG014|Overall Study|Study terminated by sponsor|0|||
147199255|NCT02083354|530903118|FG000|Overall Study|Withdrawal by Subject|9|||
147199256|NCT02083354|530903118|FG000|Overall Study|Lost to Follow-up|1|||
147199257|NCT02083354|530903118|FG000|Overall Study|Adverse Event|3|||
147199258|NCT02083354|530903118|FG000|Overall Study|Disease progression|46|||
147199259|NCT02083354|530903118|FG000|Overall Study|Study closed/terminated|5|||
147199260|NCT02066181|530903133|FG000|Overall Study|Withdrawal by Subject|1|||
147199261|NCT02066181|530903134|FG001|Overall Study|Withdrawal by Subject|1|||
147199262|NCT02141295|530903138|FG000|Overall Study|Adverse Event|1|||
147199263|NCT02141295|530903139|FG001|Overall Study|Adverse Event|18|||
147199264|NCT02141295|530903140|FG002|Overall Study|Adverse Event|11|||
147199265|NCT02141295|530903138|FG000|Overall Study|Physician Decision|2|||
147199266|NCT02141295|530903139|FG001|Overall Study|Physician Decision|19|||
147199267|NCT02141295|530903140|FG002|Overall Study|Physician Decision|14|||
147199268|NCT02141295|530903138|FG000|Overall Study|Study terminated by sponsor|0|||
147199269|NCT02141295|530903139|FG001|Overall Study|Study terminated by sponsor|6|||
147199270|NCT02141295|530903140|FG002|Overall Study|Study terminated by sponsor|6|||
147199271|NCT02141295|530903138|FG000|Overall Study|Non-compliance|0|||
147199272|NCT02141295|530903139|FG001|Overall Study|Non-compliance|1|||
147199273|NCT02141295|530903140|FG002|Overall Study|Non-compliance|0|||
147199274|NCT02141295|530903138|FG000|Overall Study|Progressive disease|3|||
147199275|NCT02141295|530903139|FG001|Overall Study|Progressive disease|32|||
147199276|NCT02141295|530903140|FG002|Overall Study|Progressive disease|50|||
147199277|NCT02141295|530903138|FG000|Overall Study|Reason not specified|0|||
147199278|NCT02141295|530903139|FG001|Overall Study|Reason not specified|9|||
147199279|NCT02141295|530903140|FG002|Overall Study|Reason not specified|10|||
147199280|NCT02141295|530903138|FG000|Overall Study|Withdrawal by Subject|0|||
147199281|NCT02141295|530903139|FG001|Overall Study|Withdrawal by Subject|9|||
147199282|NCT02141295|530903140|FG002|Overall Study|Withdrawal by Subject|4|||
147199283|NCT01671319|530903141|FG000|Overall Study|Withdrawal by Subject|1|||
147199284|NCT01389596|530903142|FG000|Overall Study|Protocol Violation|3|||
147199285|NCT01389596|530903143|FG001|Overall Study|Protocol Violation|4|||
147199286|NCT01389596|530903144|FG002|Overall Study|Protocol Violation|3|||
147199287|NCT01389596|530903142|FG000|Overall Study|Withdrawal by Subject|1|||
147199288|NCT01389596|530903143|FG001|Overall Study|Withdrawal by Subject|2|||
147199289|NCT01389596|530903144|FG002|Overall Study|Withdrawal by Subject|2|||
147199290|NCT01389596|530903142|FG000|Overall Study|Insufficient Clinical Response|3|||
147199291|NCT01389596|530903143|FG001|Overall Study|Insufficient Clinical Response|4|||
147199292|NCT01389596|530903144|FG002|Overall Study|Insufficient Clinical Response|5|||
147199293|NCT01389596|530903142|FG000|Overall Study|Adverse Event|1|||
147199294|NCT01389596|530903143|FG001|Overall Study|Adverse Event|4|||
147199295|NCT01389596|530903144|FG002|Overall Study|Adverse Event|0|||
147199296|NCT01389596|530903142|FG000|Overall Study|Death|0|||
147199297|NCT01389596|530903143|FG001|Overall Study|Death|1|||
147199298|NCT01389596|530903144|FG002|Overall Study|Death|0|||
147199299|NCT01389596|530903142|FG000|Overall Study|Other Unspecified|2|||
147199300|NCT01389596|530903143|FG001|Overall Study|Other Unspecified|1|||
147199301|NCT01389596|530903144|FG002|Overall Study|Other Unspecified|0|||
147199302|NCT00214201|530903145|FG000|Overall Study|Withdrawal by Subject|2|||
147199303|NCT00214201|530903146|FG001|Overall Study|Withdrawal by Subject|0|||
147199304|NCT00214201|530903145|FG000|Overall Study|Death|0|||
147199305|NCT00214201|530903146|FG001|Overall Study|Death|2|||
147199306|NCT01354899|530903147|FG000|Overall Study|discharge from the hospital|2|||
147199307|NCT01354899|530903147|FG000|Overall Study|Protocol Violation|1|||
147199308|NCT00463567|530903148|FG000|Overall Study|Adverse Event|29|||
147199309|NCT00463567|530903149|FG001|Overall Study|Adverse Event|26|||
147199310|NCT00463567|530903150|FG002|Overall Study|Adverse Event|17|||
147199311|NCT00463567|530903151|FG003|Overall Study|Adverse Event|46|||
147199312|NCT00463567|530903152|FG004|Overall Study|Adverse Event|10|||
147199313|NCT00463567|530903153|FG005|Overall Study|Adverse Event|10|||
147199314|NCT00463567|530903154|FG006|Overall Study|Adverse Event|4|||
147199315|NCT00463567|530903148|FG000|Overall Study|Withdrawal by Subject|29|||
147199316|NCT00463567|530903149|FG001|Overall Study|Withdrawal by Subject|22|||
147199317|NCT00463567|530903150|FG002|Overall Study|Withdrawal by Subject|20|||
147199318|NCT00463567|530903151|FG003|Overall Study|Withdrawal by Subject|37|||
147199319|NCT00463567|530903152|FG004|Overall Study|Withdrawal by Subject|6|||
147199320|NCT00463567|530903153|FG005|Overall Study|Withdrawal by Subject|5|||
147199321|NCT00463567|530903154|FG006|Overall Study|Withdrawal by Subject|1|||
147199322|NCT00463567|530903148|FG000|Overall Study|Protocol Deviation|13|||
147199323|NCT00463567|530903149|FG001|Overall Study|Protocol Deviation|9|||
147199324|NCT00463567|530903150|FG002|Overall Study|Protocol Deviation|14|||
147199325|NCT00463567|530903151|FG003|Overall Study|Protocol Deviation|11|||
147199326|NCT00463567|530903152|FG004|Overall Study|Protocol Deviation|1|||
147199327|NCT00463567|530903153|FG005|Overall Study|Protocol Deviation|1|||
147199328|NCT00463567|530903154|FG006|Overall Study|Protocol Deviation|2|||
147595945|NCT03096847|532338753|FG002|Overall Study|Progressive disease|78|||
147199329|NCT00463567|530903148|FG000|Overall Study|Lost to Follow-up|12|||
147199330|NCT00463567|530903149|FG001|Overall Study|Lost to Follow-up|6|||
147199331|NCT00463567|530903150|FG002|Overall Study|Lost to Follow-up|13|||
147199332|NCT00463567|530903151|FG003|Overall Study|Lost to Follow-up|8|||
147199333|NCT00463567|530903152|FG004|Overall Study|Lost to Follow-up|1|||
147199334|NCT00463567|530903153|FG005|Overall Study|Lost to Follow-up|1|||
147199335|NCT00463567|530903154|FG006|Overall Study|Lost to Follow-up|1|||
147199336|NCT00463567|530903148|FG000|Overall Study|Administrative problems|5|||
147199337|NCT00463567|530903149|FG001|Overall Study|Administrative problems|3|||
147199338|NCT00463567|530903150|FG002|Overall Study|Administrative problems|6|||
147199339|NCT00463567|530903151|FG003|Overall Study|Administrative problems|9|||
147199340|NCT00463567|530903152|FG004|Overall Study|Administrative problems|3|||
147199341|NCT00463567|530903153|FG005|Overall Study|Administrative problems|2|||
147199342|NCT00463567|530903154|FG006|Overall Study|Administrative problems|2|||
147199343|NCT00463567|530903148|FG000|Overall Study|Lack of Efficacy|4|||
147199344|NCT00463567|530903149|FG001|Overall Study|Lack of Efficacy|9|||
147199345|NCT00463567|530903150|FG002|Overall Study|Lack of Efficacy|9|||
147199346|NCT00463567|530903151|FG003|Overall Study|Lack of Efficacy|17|||
147199347|NCT00463567|530903152|FG004|Overall Study|Lack of Efficacy|1|||
147199348|NCT00463567|530903153|FG005|Overall Study|Lack of Efficacy|0|||
147199349|NCT00463567|530903154|FG006|Overall Study|Lack of Efficacy|1|||
147199350|NCT00463567|530903148|FG000|Overall Study|Abnormal lab value(s)|1|||
147199351|NCT00463567|530903149|FG001|Overall Study|Abnormal lab value(s)|1|||
147199352|NCT00463567|530903150|FG002|Overall Study|Abnormal lab value(s)|2|||
147199353|NCT00463567|530903151|FG003|Overall Study|Abnormal lab value(s)|1|||
147199354|NCT00463567|530903152|FG004|Overall Study|Abnormal lab value(s)|1|||
147199355|NCT00463567|530903153|FG005|Overall Study|Abnormal lab value(s)|0|||
147199356|NCT00463567|530903154|FG006|Overall Study|Abnormal lab value(s)|0|||
147199357|NCT00463567|530903148|FG000|Overall Study|Abnormal test procedure result(s)|1|||
147199358|NCT00463567|530903149|FG001|Overall Study|Abnormal test procedure result(s)|1|||
147199359|NCT00463567|530903150|FG002|Overall Study|Abnormal test procedure result(s)|6|||
147199360|NCT00463567|530903151|FG003|Overall Study|Abnormal test procedure result(s)|2|||
147199361|NCT00463567|530903152|FG004|Overall Study|Abnormal test procedure result(s)|0|||
147199362|NCT00463567|530903153|FG005|Overall Study|Abnormal test procedure result(s)|2|||
147199363|NCT00463567|530903154|FG006|Overall Study|Abnormal test procedure result(s)|0|||
147199364|NCT00463567|530903148|FG000|Overall Study|Death|1|||
147199365|NCT00463567|530903149|FG001|Overall Study|Death|0|||
147199366|NCT00463567|530903150|FG002|Overall Study|Death|2|||
147199367|NCT00463567|530903151|FG003|Overall Study|Death|0|||
147199368|NCT00463567|530903152|FG004|Overall Study|Death|0|||
147199369|NCT00463567|530903153|FG005|Overall Study|Death|0|||
147199370|NCT00463567|530903154|FG006|Overall Study|Death|0|||
147199371|NCT00641667|530903155|FG000|Overall Study|Withdrawal by Subject|1|||
147199372|NCT00641667|530903155|FG000|Overall Study|Adverse Event|1|||
147199373|NCT00641667|530903155|FG000|Overall Study|Physician Decision|1|||
147199374|NCT00641667|530903155|FG000|Overall Study|Worsening of underlying disease|3|||
147199375|NCT01235741|530903156|FG000|Non-Randomized Low Calorie Diet Lead-In|Withdrawal by Subject|9|||
147199376|NCT01235741|530903157|FG001|Non-Randomized Low Calorie Diet Lead-In|Withdrawal by Subject|0|||
147199377|NCT01235741|530903158|FG002|Non-Randomized Low Calorie Diet Lead-In|Withdrawal by Subject|0|||
147199378|NCT01235741|530903156|FG000|Non-Randomized Low Calorie Diet Lead-In|Sponsor terminated study|121|||
147199379|NCT01235741|530903157|FG001|Non-Randomized Low Calorie Diet Lead-In|Sponsor terminated study|0|||
147199380|NCT01235741|530903158|FG002|Non-Randomized Low Calorie Diet Lead-In|Sponsor terminated study|0|||
147199381|NCT01235741|530903156|FG000|Non-Randomized Low Calorie Diet Lead-In|Physician Decision|1|||
147199382|NCT01235741|530903157|FG001|Non-Randomized Low Calorie Diet Lead-In|Physician Decision|0|||
147199383|NCT01235741|530903158|FG002|Non-Randomized Low Calorie Diet Lead-In|Physician Decision|0|||
147199384|NCT01235741|530903156|FG000|Non-Randomized Low Calorie Diet Lead-In|Protocol Violation|1|||
147199385|NCT01235741|530903157|FG001|Non-Randomized Low Calorie Diet Lead-In|Protocol Violation|0|||
147199386|NCT01235741|530903158|FG002|Non-Randomized Low Calorie Diet Lead-In|Protocol Violation|0|||
147199387|NCT01235741|530903156|FG000|Non-Randomized Low Calorie Diet Lead-In|Lost to Follow-up|5|||
147199388|NCT01235741|530903157|FG001|Non-Randomized Low Calorie Diet Lead-In|Lost to Follow-up|0|||
147199389|NCT01235741|530903158|FG002|Non-Randomized Low Calorie Diet Lead-In|Lost to Follow-up|0|||
147199390|NCT01235741|530903156|FG000|Non-Randomized Low Calorie Diet Lead-In|Failed to meet weight loss in Period 1|4|||
147199391|NCT01235741|530903157|FG001|Non-Randomized Low Calorie Diet Lead-In|Failed to meet weight loss in Period 1|0|||
147199392|NCT01235741|530903158|FG002|Non-Randomized Low Calorie Diet Lead-In|Failed to meet weight loss in Period 1|0|||
147199393|NCT01235741|530903156|FG000|Randomized to Treatment|Withdrawal by Subject|0|||
147199394|NCT01235741|530903157|FG001|Randomized to Treatment|Withdrawal by Subject|0|||
147199395|NCT01235741|530903158|FG002|Randomized to Treatment|Withdrawal by Subject|1|||
147199396|NCT01235741|530903156|FG000|Randomized to Treatment|Adverse Event|0|||
147199397|NCT01235741|530903157|FG001|Randomized to Treatment|Adverse Event|1|||
147199398|NCT01235741|530903158|FG002|Randomized to Treatment|Adverse Event|1|||
147199399|NCT01235741|530903156|FG000|Randomized to Treatment|Sponsor terminated study|0|||
147199400|NCT01235741|530903157|FG001|Randomized to Treatment|Sponsor terminated study|35|||
147199401|NCT01235741|530903158|FG002|Randomized to Treatment|Sponsor terminated study|34|||
147199402|NCT01235741|530903156|FG000|Follow-Up Post Treatment up to Month 6|Withdrawal by Subject|0|||
147199403|NCT01235741|530903157|FG001|Follow-Up Post Treatment up to Month 6|Withdrawal by Subject|3|||
147199404|NCT01235741|530903158|FG002|Follow-Up Post Treatment up to Month 6|Withdrawal by Subject|6|||
147199405|NCT01235741|530903156|FG000|Follow-Up Post Treatment up to Month 6|Lost to Follow-up|0|||
147199406|NCT01235741|530903157|FG001|Follow-Up Post Treatment up to Month 6|Lost to Follow-up|5|||
147199407|NCT01235741|530903158|FG002|Follow-Up Post Treatment up to Month 6|Lost to Follow-up|1|||
147199408|NCT01235741|530903156|FG000|Follow-Up Post Treatment up to Month 6|Other|0|||
147199409|NCT01235741|530903157|FG001|Follow-Up Post Treatment up to Month 6|Other|1|||
147199410|NCT01235741|530903158|FG002|Follow-Up Post Treatment up to Month 6|Other|0|||
147199411|NCT01421719|530903159|FG000|Overall Study|Withdrawal by Subject|4|||
147199412|NCT01124006|530903160|FG000|Overall Study|Withdrawal by Subject|2|||
147199413|NCT01124006|530903161|FG001|Overall Study|Withdrawal by Subject|2|||
147199414|NCT01124006|530903162|FG002|Overall Study|Withdrawal by Subject|0|||
147199415|NCT01124006|530903160|FG000|Overall Study|Lost to Follow-up|1|||
147199416|NCT01124006|530903161|FG001|Overall Study|Lost to Follow-up|0|||
147199417|NCT01124006|530903162|FG002|Overall Study|Lost to Follow-up|1|||
147199418|NCT01124006|530903160|FG000|Overall Study|Other|0|||
147199419|NCT01124006|530903161|FG001|Overall Study|Other|0|||
147199420|NCT01124006|530903162|FG002|Overall Study|Other|1|||
147199421|NCT01712399|530903166|FG000|Overall Study|Lost to Follow-up|1|||
147199422|NCT01712399|530903166|FG000|Overall Study|Withdrawal by Subject|39|||
147199423|NCT01712399|530903166|FG000|Overall Study|Death|1|||
147199424|NCT01712399|530903166|FG000|Overall Study|Adverse Event|11|||
147199425|NCT01712399|530903166|FG000|Overall Study|Study closure|345|||
147199426|NCT01357850|530903167|FG000|Overall Study|Lost to Follow-up|1|||
147199427|NCT01357850|530903168|FG001|Overall Study|Lost to Follow-up|0|||
147199428|NCT01357850|530903169|FG002|Overall Study|Lost to Follow-up|0|||
147199429|NCT01357850|530903170|FG003|Overall Study|Lost to Follow-up|0|||
147199430|NCT04610281|530903171|FG000|Overall Study|Improvement in their condition no longer justifies care in the Children's Hospital Unit|1|||
147199431|NCT04610281|530903172|FG001|Overall Study|Improvement in their condition no longer justifies care in the Children's Hospital Unit|4|||
147199432|NCT01803607|530903174|FG000|Overall Study|Adverse Event|5|||
147199433|NCT01803607|530903175|FG001|Overall Study|Adverse Event|3|||
147199434|NCT01803607|530903174|FG000|Overall Study|Lack of Efficacy|0|||
147199435|NCT01803607|530903175|FG001|Overall Study|Lack of Efficacy|1|||
147199436|NCT01803607|530903174|FG000|Overall Study|Protocol Violation|3|||
147199437|NCT01803607|530903175|FG001|Overall Study|Protocol Violation|2|||
147199438|NCT01803607|530903174|FG000|Overall Study|Study terminated by sponsor|54|||
147199439|NCT01803607|530903175|FG001|Overall Study|Study terminated by sponsor|56|||
147199440|NCT01803607|530903174|FG000|Overall Study|Withdrawal by Subject|6|||
147199441|NCT01803607|530903175|FG001|Overall Study|Withdrawal by Subject|5|||
147199442|NCT00706238|530903182|FG000|Overall Study|Disease progression|4|||
147199443|NCT00706238|530903182|FG000|Overall Study|Other|1|||
147199444|NCT03819114|530903183|FG000|Overall Study|Protocol Violation|0|||
147199445|NCT03819114|530903184|FG001|Overall Study|Protocol Violation|1|||
147199446|NCT03819114|530903185|FG002|Overall Study|Protocol Violation|1|||
147199447|NCT03819114|530903186|FG003|Overall Study|Protocol Violation|0|||
147199448|NCT03819114|530903183|FG000|Overall Study|Lost to Follow-up|0|||
147199449|NCT03819114|530903184|FG001|Overall Study|Lost to Follow-up|0|||
147199450|NCT03819114|530903185|FG002|Overall Study|Lost to Follow-up|1|||
147199451|NCT03819114|530903186|FG003|Overall Study|Lost to Follow-up|0|||
147199452|NCT01772316|530903187|FG000|Overall Study|Serious adverse event|1|||
147199453|NCT01772316|530903187|FG000|Overall Study|Inform consent withdrawn|1|||
147199454|NCT01772316|530903187|FG000|Overall Study|Withdrawn by sponsor decision|5|||
147199455|NCT04646044|530903193|FG000|Overall Study|Lost to Follow-up|0|||
147199456|NCT04646044|530903194|FG001|Overall Study|Lost to Follow-up|0|||
147199457|NCT04646044|530903195|FG002|Overall Study|Lost to Follow-up|1|||
147199458|NCT04646044|530903196|FG003|Overall Study|Lost to Follow-up|0|||
147199459|NCT04646044|530903193|FG000|Overall Study|Withdrawal by Subject|0|||
147199460|NCT04646044|530903194|FG001|Overall Study|Withdrawal by Subject|1|||
147199461|NCT04646044|530903195|FG002|Overall Study|Withdrawal by Subject|0|||
147199462|NCT04646044|530903196|FG003|Overall Study|Withdrawal by Subject|0|||
147199463|NCT03038880|530903202|FG000|Overall Study|Death|1|||
147199464|NCT03038880|530903203|FG001|Overall Study|Death|2|||
147199465|NCT03038880|530903204|FG002|Overall Study|Death|0|||
147199466|NCT03038880|530903202|FG000|Overall Study|Physician Decision|2|||
147199467|NCT03038880|530903203|FG001|Overall Study|Physician Decision|1|||
147199468|NCT03038880|530903204|FG002|Overall Study|Physician Decision|0|||
147199469|NCT02803580|530903205|FG000|Overall Study|Death|13|||
147199470|NCT02803580|530903205|FG000|Overall Study|Lost to Follow-up|19|||
147199471|NCT02803580|530903205|FG000|Overall Study|Withdrawal by Subject|3|||
147199472|NCT02803580|530903205|FG000|Overall Study|Inclusion in clinical trial|1|||
147199473|NCT02633306|530903206|FG000|Overall Study|Withdrawal by Subject|3|||
147199474|NCT03910244|530903207|FG000|Overall Study|Adverse Event|14|||
147199475|NCT03910244|530903208|FG001|Overall Study|Adverse Event|0|||
147199476|NCT03910244|530903207|FG000|Overall Study|Death|1|||
147199477|NCT03910244|530903208|FG001|Overall Study|Death|0|||
147199478|NCT03910244|530903207|FG000|Overall Study|Lost to Follow-up|0|||
147199479|NCT03910244|530903208|FG001|Overall Study|Lost to Follow-up|2|||
147199480|NCT03910244|530903207|FG000|Overall Study|Joint withdrawal decision|1|||
147199481|NCT03910244|530903208|FG001|Overall Study|Joint withdrawal decision|0|||
147199482|NCT03910244|530903207|FG000|Overall Study|Study Terminated by Sponsor|7|||
147199483|NCT03910244|530903208|FG001|Overall Study|Study Terminated by Sponsor|4|||
147199484|NCT03910244|530903207|FG000|Overall Study|Physician Decision|1|||
147199485|NCT03910244|530903208|FG001|Overall Study|Physician Decision|0|||
147199486|NCT03910244|530903207|FG000|Overall Study|Protocol Violation|1|||
147199487|NCT03910244|530903208|FG001|Overall Study|Protocol Violation|0|||
147199488|NCT03910244|530903207|FG000|Overall Study|Withdrawal by Subject|7|||
147199489|NCT03910244|530903208|FG001|Overall Study|Withdrawal by Subject|2|||
147199490|NCT03774576|530903211|FG000|Period 2|Adverse Event|1|||
147199491|NCT01746901|530903212|FG000|Naloxone Challenge Phase|Adverse Event|2|||
147199492|NCT01746901|530903213|FG001|Naloxone Challenge Phase|Adverse Event|0|||
147199493|NCT01746901|530903214|FG002|Naloxone Challenge Phase|Adverse Event|0|||
147199494|NCT01746901|530903215|FG003|Naloxone Challenge Phase|Adverse Event|0|||
147199495|NCT01746901|530903216|FG004|Naloxone Challenge Phase|Adverse Event|0|||
147199496|NCT01746901|530903217|FG005|Naloxone Challenge Phase|Adverse Event|0|||
147199497|NCT01746901|530903218|FG006|Naloxone Challenge Phase|Adverse Event|0|||
147199498|NCT01746901|530903219|FG007|Naloxone Challenge Phase|Adverse Event|0|||
147199499|NCT01746901|530903220|FG008|Naloxone Challenge Phase|Adverse Event|0|||
147199500|NCT01746901|530903212|FG000|Naloxone Challenge Phase|Did not meet entrance criteria|1|||
147199501|NCT01746901|530903213|FG001|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
147199502|NCT01746901|530903214|FG002|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
147199503|NCT01746901|530903215|FG003|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
147199504|NCT01746901|530903216|FG004|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
147199505|NCT01746901|530903217|FG005|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
147199506|NCT01746901|530903218|FG006|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
147199507|NCT01746901|530903219|FG007|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
147199508|NCT01746901|530903220|FG008|Naloxone Challenge Phase|Did not meet entrance criteria|0|||
147199509|NCT01746901|530903212|FG000|Drug Discrimination Phase: Day 1|Adverse Event|0|||
147199510|NCT01746901|530903213|FG001|Drug Discrimination Phase: Day 1|Adverse Event|3|||
147199511|NCT01746901|530903214|FG002|Drug Discrimination Phase: Day 1|Adverse Event|0|||
147199512|NCT01746901|530903215|FG003|Drug Discrimination Phase: Day 1|Adverse Event|0|||
147199513|NCT01746901|530903216|FG004|Drug Discrimination Phase: Day 1|Adverse Event|0|||
147199514|NCT01746901|530903217|FG005|Drug Discrimination Phase: Day 1|Adverse Event|0|||
147199515|NCT01746901|530903218|FG006|Drug Discrimination Phase: Day 1|Adverse Event|0|||
147199516|NCT01746901|530903219|FG007|Drug Discrimination Phase: Day 1|Adverse Event|0|||
147199517|NCT01746901|530903220|FG008|Drug Discrimination Phase: Day 1|Adverse Event|0|||
147199518|NCT01746901|530903212|FG000|Drug Discrimination Phase: Day 2|Adverse Event|0|||
147199519|NCT01746901|530903213|FG001|Drug Discrimination Phase: Day 2|Adverse Event|2|||
147199520|NCT01746901|530903214|FG002|Drug Discrimination Phase: Day 2|Adverse Event|1|||
147199521|NCT01746901|530903215|FG003|Drug Discrimination Phase: Day 2|Adverse Event|0|||
147199522|NCT01746901|530903216|FG004|Drug Discrimination Phase: Day 2|Adverse Event|0|||
147199523|NCT01746901|530903217|FG005|Drug Discrimination Phase: Day 2|Adverse Event|0|||
147199524|NCT01746901|530903218|FG006|Drug Discrimination Phase: Day 2|Adverse Event|0|||
147199525|NCT01746901|530903219|FG007|Drug Discrimination Phase: Day 2|Adverse Event|0|||
147199526|NCT01746901|530903220|FG008|Drug Discrimination Phase: Day 2|Adverse Event|0|||
147199527|NCT01746901|530903212|FG000|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
147199528|NCT01746901|530903213|FG001|Drug Discrimination Phase: Day 2|Did not met entrance criteria|9|||
147199529|NCT01746901|530903214|FG002|Drug Discrimination Phase: Day 2|Did not met entrance criteria|10|||
147199530|NCT01746901|530903215|FG003|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
147199531|NCT01746901|530903216|FG004|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
147199532|NCT01746901|530903217|FG005|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
147199533|NCT01746901|530903218|FG006|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
147199534|NCT01746901|530903219|FG007|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
147199535|NCT01746901|530903220|FG008|Drug Discrimination Phase: Day 2|Did not met entrance criteria|0|||
147199536|NCT01746901|530903212|FG000|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
147199537|NCT01746901|530903213|FG001|Drug Discrimination Phase: Day 2|Protocol Violation|3|||
147199538|NCT01746901|530903214|FG002|Drug Discrimination Phase: Day 2|Protocol Violation|3|||
147199539|NCT01746901|530903215|FG003|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
147199540|NCT01746901|530903216|FG004|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
147199541|NCT01746901|530903217|FG005|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
147199542|NCT01746901|530903218|FG006|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
147199543|NCT01746901|530903219|FG007|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
147199544|NCT01746901|530903220|FG008|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
147199545|NCT01746901|530903212|FG000|Treatment Phase: First Intervention|Protocol Violation|0|||
147199546|NCT01746901|530903213|FG001|Treatment Phase: First Intervention|Protocol Violation|0|||
147199547|NCT01746901|530903214|FG002|Treatment Phase: First Intervention|Protocol Violation|0|||
147199548|NCT01746901|530903215|FG003|Treatment Phase: First Intervention|Protocol Violation|0|||
147199549|NCT01746901|530903216|FG004|Treatment Phase: First Intervention|Protocol Violation|0|||
147199550|NCT01746901|530903217|FG005|Treatment Phase: First Intervention|Protocol Violation|0|||
147199551|NCT01746901|530903218|FG006|Treatment Phase: First Intervention|Protocol Violation|1|||
147199552|NCT01746901|530903219|FG007|Treatment Phase: First Intervention|Protocol Violation|0|||
147199553|NCT01746901|530903220|FG008|Treatment Phase: First Intervention|Protocol Violation|0|||
147199554|NCT01746901|530903212|FG000|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
147199555|NCT01746901|530903213|FG001|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
147199556|NCT01746901|530903214|FG002|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
147199557|NCT01746901|530903215|FG003|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
147199558|NCT01746901|530903216|FG004|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
147199559|NCT01746901|530903217|FG005|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
147199560|NCT01746901|530903218|FG006|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
147199561|NCT01746901|530903219|FG007|Treatment Phase: Second Intervention|Withdrawal by Subject|1|||
147199562|NCT01746901|530903220|FG008|Treatment Phase: Second Intervention|Withdrawal by Subject|0|||
147199563|NCT01746901|530903212|FG000|Treatment Phase: Third Intervention|Protocol Violation|0|||
147199564|NCT01746901|530903213|FG001|Treatment Phase: Third Intervention|Protocol Violation|0|||
147199565|NCT01746901|530903214|FG002|Treatment Phase: Third Intervention|Protocol Violation|0|||
147199566|NCT01746901|530903215|FG003|Treatment Phase: Third Intervention|Protocol Violation|0|||
147199567|NCT01746901|530903216|FG004|Treatment Phase: Third Intervention|Protocol Violation|0|||
147199568|NCT01746901|530903217|FG005|Treatment Phase: Third Intervention|Protocol Violation|1|||
147199569|NCT01746901|530903218|FG006|Treatment Phase: Third Intervention|Protocol Violation|1|||
147199570|NCT01746901|530903219|FG007|Treatment Phase: Third Intervention|Protocol Violation|0|||
147199571|NCT01746901|530903220|FG008|Treatment Phase: Third Intervention|Protocol Violation|0|||
147199572|NCT01746901|530903212|FG000|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
147199573|NCT01746901|530903213|FG001|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
147199574|NCT01746901|530903214|FG002|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
147199575|NCT01746901|530903215|FG003|Treatment Phase: Fourth Intervention|Lost to Follow-up|1|||
147199576|NCT01746901|530903216|FG004|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
147199577|NCT01746901|530903217|FG005|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
147199578|NCT01746901|530903218|FG006|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
147199579|NCT01746901|530903219|FG007|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
147199580|NCT01746901|530903220|FG008|Treatment Phase: Fourth Intervention|Lost to Follow-up|0|||
147199581|NCT01746901|530903212|FG000|Treatment Phase: Fourth Intervention|Adverse Event|0|||
147199582|NCT01746901|530903213|FG001|Treatment Phase: Fourth Intervention|Adverse Event|0|||
147199583|NCT01746901|530903214|FG002|Treatment Phase: Fourth Intervention|Adverse Event|0|||
147199584|NCT01746901|530903215|FG003|Treatment Phase: Fourth Intervention|Adverse Event|0|||
147199585|NCT01746901|530903216|FG004|Treatment Phase: Fourth Intervention|Adverse Event|0|||
147199586|NCT01746901|530903217|FG005|Treatment Phase: Fourth Intervention|Adverse Event|1|||
147199587|NCT01746901|530903218|FG006|Treatment Phase: Fourth Intervention|Adverse Event|0|||
147199588|NCT01746901|530903219|FG007|Treatment Phase: Fourth Intervention|Adverse Event|0|||
147199589|NCT01746901|530903220|FG008|Treatment Phase: Fourth Intervention|Adverse Event|1|||
147199590|NCT01746901|530903212|FG000|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
147199591|NCT01746901|530903213|FG001|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
147199592|NCT01746901|530903214|FG002|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
147199593|NCT01746901|530903215|FG003|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
147199594|NCT01746901|530903216|FG004|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
147199595|NCT01746901|530903217|FG005|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
147199596|NCT01746901|530903218|FG006|Treatment Phase: Fourth Intervention|Protocol Violation|1|||
147199597|NCT01746901|530903219|FG007|Treatment Phase: Fourth Intervention|Protocol Violation|0|||
147199598|NCT01746901|530903220|FG008|Treatment Phase: Fourth Intervention|Protocol Violation|1|||
147199599|NCT03594110|530903224|FG000|Interventional Part|Participant concerned about study treatment|23|||
147199600|NCT03594110|530903225|FG001|Interventional Part|Participant concerned about study treatment|28|||
147199601|NCT03594110|530903224|FG000|Interventional Part|Doctor advice|38|||
147199602|NCT03594110|530903225|FG001|Interventional Part|Doctor advice|40|||
147199603|NCT03594110|530903224|FG000|Interventional Part|Participants' wish|89|||
147199604|NCT03594110|530903225|FG001|Interventional Part|Participants' wish|68|||
147199605|NCT03594110|530903224|FG000|Interventional Part|Adverse event-non-fatal events|119|||
147199606|NCT03594110|530903225|FG001|Interventional Part|Adverse event-non-fatal events|116|||
147199607|NCT03594110|530903224|FG000|Interventional Part|Study drug stopped, reason missing|336|||
147199608|NCT03594110|530903225|FG001|Interventional Part|Study drug stopped, reason missing|294|||
147199609|NCT03594110|530903224|FG000|Interventional Part|Cannot attend clinic because of personal problems|8|||
147199610|NCT03594110|530903225|FG001|Interventional Part|Cannot attend clinic because of personal problems|16|||
147199611|NCT03594110|530903224|FG000|Interventional Part|Cannot attend clinic because moving out of the area|15|||
147199612|NCT03594110|530903225|FG001|Interventional Part|Cannot attend clinic because moving out of the area|9|||
147199613|NCT03594110|530903224|FG000|Interventional Part|Contraindicated drug started|32|||
147199614|NCT03594110|530903225|FG001|Interventional Part|Contraindicated drug started|18|||
147199615|NCT03594110|530903224|FG000|Interventional Part|Other reasons (include any category with a frequency <20 patients in total)|58|||
147199616|NCT03594110|530903225|FG001|Interventional Part|Other reasons (include any category with a frequency <20 patients in total)|45|||
147199617|NCT03594110|530903224|FG000|Interventional Part|Adverse event-Serious fatal events|130|||
147199618|NCT03594110|530903225|FG001|Interventional Part|Adverse event-Serious fatal events|121|||
147199619|NCT03594110|530903224|FG000|Non-interventional Part|Withdrawal by Subject|3|||
147199620|NCT03594110|530903225|FG001|Non-interventional Part|Withdrawal by Subject|4|||
147199621|NCT03594110|530903224|FG000|Non-interventional Part|Lost to Follow-up|45|||
147199622|NCT03594110|530903225|FG001|Non-interventional Part|Lost to Follow-up|41|||
147199623|NCT02085460|530903227|FG000|Overall Study|Adverse Event|2|||
147199624|NCT02085460|530903228|FG001|Overall Study|Adverse Event|2|||
147199625|NCT02085460|530903229|FG002|Overall Study|Adverse Event|1|||
147199626|NCT02085460|530903227|FG000|Overall Study|Physician Decision|1|||
147199627|NCT02085460|530903228|FG001|Overall Study|Physician Decision|1|||
147199628|NCT02085460|530903229|FG002|Overall Study|Physician Decision|2|||
147199629|NCT02085460|530903227|FG000|Overall Study|Withdrawal by Subject|11|||
147199630|NCT02085460|530903228|FG001|Overall Study|Withdrawal by Subject|5|||
147199631|NCT02085460|530903229|FG002|Overall Study|Withdrawal by Subject|7|||
147199632|NCT00907335|530903232|FG000|Overall Study|Withdrawal by Subject|2|||
147199633|NCT00907335|530903233|FG001|Overall Study|Withdrawal by Subject|0|||
147199634|NCT00907335|530903232|FG000|Overall Study|Adverse Event|4|||
147199635|NCT00907335|530903233|FG001|Overall Study|Adverse Event|1|||
147199636|NCT00907335|530903232|FG000|Overall Study|Lost to Follow-up|2|||
147199637|NCT00907335|530903233|FG001|Overall Study|Lost to Follow-up|0|||
147199638|NCT03879772|530903234|FG000|Overall Study|Adverse Event|2|||
147199639|NCT03879772|530903235|FG001|Overall Study|Adverse Event|2|||
147199640|NCT03879772|530903236|FG002|Overall Study|Adverse Event|3|||
147199641|NCT03879772|530903237|FG003|Overall Study|Adverse Event|4|||
147199642|NCT03879772|530903238|FG004|Overall Study|Adverse Event|3|||
147199643|NCT03879772|530903234|FG000|Overall Study|Treatment Failure|1|||
147199644|NCT03879772|530903235|FG001|Overall Study|Treatment Failure|0|||
147199645|NCT03879772|530903236|FG002|Overall Study|Treatment Failure|0|||
147199646|NCT03879772|530903237|FG003|Overall Study|Treatment Failure|2|||
147199647|NCT03879772|530903238|FG004|Overall Study|Treatment Failure|1|||
147199648|NCT03879772|530903234|FG000|Overall Study|Lost to Follow-up|0|||
147199649|NCT03879772|530903235|FG001|Overall Study|Lost to Follow-up|0|||
147199650|NCT03879772|530903236|FG002|Overall Study|Lost to Follow-up|0|||
147199651|NCT03879772|530903237|FG003|Overall Study|Lost to Follow-up|0|||
147199652|NCT03879772|530903238|FG004|Overall Study|Lost to Follow-up|1|||
147199653|NCT03879772|530903234|FG000|Overall Study|Withdrawal by Subject|0|||
147199654|NCT03879772|530903235|FG001|Overall Study|Withdrawal by Subject|1|||
147199655|NCT03879772|530903236|FG002|Overall Study|Withdrawal by Subject|3|||
147199656|NCT03879772|530903237|FG003|Overall Study|Withdrawal by Subject|1|||
147199657|NCT03879772|530903238|FG004|Overall Study|Withdrawal by Subject|1|||
147199658|NCT03879772|530903234|FG000|Overall Study|Protocol Violation|0|||
147199659|NCT03879772|530903235|FG001|Overall Study|Protocol Violation|0|||
147199660|NCT03879772|530903236|FG002|Overall Study|Protocol Violation|3|||
147199661|NCT03879772|530903237|FG003|Overall Study|Protocol Violation|1|||
147199662|NCT03879772|530903238|FG004|Overall Study|Protocol Violation|2|||
147199663|NCT03879772|530903234|FG000|Overall Study|Did Not Meet Entry Requirements|1|||
147199664|NCT03879772|530903235|FG001|Overall Study|Did Not Meet Entry Requirements|0|||
147199665|NCT03879772|530903236|FG002|Overall Study|Did Not Meet Entry Requirements|1|||
147199666|NCT03879772|530903237|FG003|Overall Study|Did Not Meet Entry Requirements|0|||
147199667|NCT03879772|530903238|FG004|Overall Study|Did Not Meet Entry Requirements|0|||
147199668|NCT00930046|530903239|FG000|Overall Study|Wound catheter malfunctioned|1|||
147199669|NCT00930046|530903240|FG001|Overall Study|Wound catheter malfunctioned|2|||
147199670|NCT01598532|530903241|FG000|Overall Study|Lost to Follow-up|3|||
147199671|NCT01598532|530903241|FG000|Overall Study|Did not meet inclusion criteria|8|||
147199672|NCT00702221|530903242|FG000|Overall Study|Adverse Event|4|||
147199673|NCT00702221|530903243|FG001|Overall Study|Adverse Event|3|||
147435266|NCT03085758|531760441|FG000|Overall Study|Pt seen by doctor in digestive surgery|0|||
147435267|NCT03085758|531760442|FG001|Overall Study|Pt seen by doctor in digestive surgery|1|||
147435268|NCT03085758|531760443|FG002|Overall Study|Pt seen by doctor in digestive surgery|0|||
147435269|NCT01122576|531760444|FG000|Pre-Cataract Surgery|Withdrawal by Subject|0|||
147435270|NCT01122576|531760445|FG001|Pre-Cataract Surgery|Withdrawal by Subject|1|||
147435271|NCT01122576|531760446|FG002|Pre-Cataract Surgery|Withdrawal by Subject|2|||
147435272|NCT01122576|531760444|FG000|Post-Cataract Surgery|Central Macular Edema|0|||
147199674|NCT04798196|530903247|FG000|Overall Study|Lost to Follow-up|3|||
147199675|NCT04798196|530903248|FG001|Overall Study|Lost to Follow-up|1|||
147199676|NCT04798196|530903249|FG002|Overall Study|Lost to Follow-up|3|||
147199677|NCT01249261|530903250|FG000|Overall Study|Withdrawal by Subject|1|||
147199678|NCT01249261|530903251|FG001|Overall Study|Withdrawal by Subject|0|||
147199679|NCT01967940|530903253|FG000|Part 2|Enrolled in Part 2 and Never Treated|0|||
147199680|NCT01967940|530903254|FG001|Part 2|Enrolled in Part 2 and Never Treated|0|||
147199681|NCT01967940|530903255|FG002|Part 2|Enrolled in Part 2 and Never Treated|0|||
147199682|NCT01967940|530903256|FG003|Part 2|Enrolled in Part 2 and Never Treated|1|||
147199683|NCT01967940|530903253|FG000|Part 2|Adverse Event|0|||
147199684|NCT01967940|530903254|FG001|Part 2|Adverse Event|0|||
147199685|NCT01967940|530903255|FG002|Part 2|Adverse Event|0|||
147199686|NCT01967940|530903256|FG003|Part 2|Adverse Event|1|||
147199687|NCT01967940|530903253|FG000|Part 2|Unknown Reason|0|||
147199688|NCT01967940|530903254|FG001|Part 2|Unknown Reason|0|||
147199689|NCT01967940|530903255|FG002|Part 2|Unknown Reason|0|||
147199690|NCT01967940|530903256|FG003|Part 2|Unknown Reason|1|||
147199691|NCT00904982|530903258|FG000|Overall Study|Withdrawal by Subject|2|||
147199692|NCT00904982|530903259|FG001|Overall Study|Withdrawal by Subject|0|||
147199693|NCT00904982|530903260|FG002|Overall Study|Withdrawal by Subject|0|||
147199694|NCT00904982|530903261|FG003|Overall Study|Withdrawal by Subject|0|||
147199695|NCT02072668|530903266|FG000|Second Intervention|Lost to Follow-up|1|||
147199696|NCT02072668|530903267|FG001|Second Intervention|Lost to Follow-up|0|||
147199697|NCT01352793|530903277|FG000|Overall Study|Lost to Follow-up|289|||
147199698|NCT01352793|530903278|FG001|Overall Study|Lost to Follow-up|125|||
147199699|NCT01352793|530903277|FG000|Overall Study|Withdrawal by Subject|120|||
147199700|NCT01352793|530903278|FG001|Overall Study|Withdrawal by Subject|55|||
147199701|NCT01352793|530903277|FG000|Overall Study|Protocol Violation|44|||
147199702|NCT01352793|530903278|FG001|Overall Study|Protocol Violation|23|||
147199703|NCT01352793|530903277|FG000|Overall Study|Adverse Event|44|||
147199704|NCT01352793|530903278|FG001|Overall Study|Adverse Event|10|||
147199705|NCT01352793|530903277|FG000|Overall Study|Physician Decision|1|||
147199706|NCT01352793|530903278|FG001|Overall Study|Physician Decision|0|||
147199707|NCT01352793|530903277|FG000|Overall Study|Pregnancy|26|||
147199708|NCT01352793|530903278|FG001|Overall Study|Pregnancy|8|||
147199709|NCT01352793|530903277|FG000|Overall Study|Other|25|||
147199710|NCT01352793|530903278|FG001|Overall Study|Other|7|||
147199711|NCT01352793|530903277|FG000|Overall Study|Medication error|2|||
147199712|NCT01352793|530903278|FG001|Overall Study|Medication error|2|||
147199713|NCT01352793|530903277|FG000|Overall Study|Death|1|||
147199714|NCT01352793|530903278|FG001|Overall Study|Death|0|||
147199715|NCT01352793|530903277|FG000|Overall Study|Randomized but not vaccinated|8|||
147199716|NCT01352793|530903278|FG001|Overall Study|Randomized but not vaccinated|0|||
147199717|NCT01352793|530903277|FG000|Overall Study|No longer meets eligibility criteria|25|||
147199718|NCT01352793|530903278|FG001|Overall Study|No longer meets eligibility criteria|15|||
147199719|NCT01929317|530903281|FG000|Dose Increase Effect Verification Phase|Adverse Event|5|||
147199720|NCT01929317|530903282|FG001|Dose Increase Effect Verification Phase|Adverse Event|1|||
147199721|NCT01929317|530903281|FG000|Dose Increase Effect Verification Phase|Physician Decision|1|||
147199722|NCT01929317|530903282|FG001|Dose Increase Effect Verification Phase|Physician Decision|0|||
147199723|NCT01929317|530903281|FG000|Dose Increase Effect Verification Phase|Withdrawal by Subject|3|||
147199724|NCT01929317|530903282|FG001|Dose Increase Effect Verification Phase|Withdrawal by Subject|0|||
147199725|NCT01929317|530903281|FG000|Long-term Phase|Adverse Event|5|||
147199726|NCT01929317|530903282|FG001|Long-term Phase|Adverse Event|1|||
147199727|NCT01929317|530903281|FG000|Long-term Phase|Physician Decision|3|||
147199728|NCT01929317|530903282|FG001|Long-term Phase|Physician Decision|0|||
147199729|NCT01929317|530903281|FG000|Long-term Phase|Withdrawal by Subject|4|||
147199730|NCT01929317|530903282|FG001|Long-term Phase|Withdrawal by Subject|0|||
147199731|NCT01929317|530903281|FG000|Long-term Phase|Protocol Violation|1|||
147199732|NCT01929317|530903282|FG001|Long-term Phase|Protocol Violation|0|||
147199733|NCT01929317|530903281|FG000|Long-term Phase|Protocol-defined Stopping Criteria|1|||
147199734|NCT01929317|530903282|FG001|Long-term Phase|Protocol-defined Stopping Criteria|0|||
147199735|NCT01929317|530903281|FG000|Long-term Phase|Study Closed/Terminated|5|||
147199736|NCT01929317|530903282|FG001|Long-term Phase|Study Closed/Terminated|3|||
147199737|NCT02667119|530903283|FG000|Overall Study|Lost to Follow-up|3|||
147199738|NCT02667119|530903284|FG001|Overall Study|Lost to Follow-up|0|||
147199739|NCT03205423|530903287|FG000|Overall Study|Personal|1|||
147199740|NCT03205423|530903288|FG001|Overall Study|Personal|1|||
147199741|NCT03205423|530903287|FG000|Overall Study|Physician Decision|0|||
147199742|NCT03205423|530903288|FG001|Overall Study|Physician Decision|2|||
147199743|NCT04467905|530903289|FG000|Overall Study|Baseline heart rate <110 bpm|0|||
147199744|NCT04467905|530903290|FG001|Overall Study|Baseline heart rate <110 bpm|0|||
147199745|NCT04467905|530903291|FG002|Overall Study|Baseline heart rate <110 bpm|5|||
147199746|NCT04467905|530903289|FG000|Overall Study|Conversion to SR|0|||
147199747|NCT04467905|530903290|FG001|Overall Study|Conversion to SR|0|||
147199748|NCT04467905|530903291|FG002|Overall Study|Conversion to SR|3|||
147199749|NCT04467905|530903289|FG000|Overall Study|Technical issue with Holter ECG|0|||
147199750|NCT04467905|530903290|FG001|Overall Study|Technical issue with Holter ECG|0|||
147199751|NCT04467905|530903291|FG002|Overall Study|Technical issue with Holter ECG|3|||
147199752|NCT04467905|530903289|FG000|Overall Study|Hemodynamic instability|0|||
147199753|NCT04467905|530903290|FG001|Overall Study|Hemodynamic instability|0|||
147199754|NCT04467905|530903291|FG002|Overall Study|Hemodynamic instability|1|||
147199755|NCT04467905|530903289|FG000|Overall Study|Site misinterpretation of protocol|0|||
147199756|NCT04467905|530903290|FG001|Overall Study|Site misinterpretation of protocol|0|||
147199757|NCT04467905|530903291|FG002|Overall Study|Site misinterpretation of protocol|1|||
147199758|NCT04145349|530904860|FG000|Overall Study|Withdrawal by Subject|3|||
147199759|NCT04145349|530904861|FG001|Overall Study|Withdrawal by Subject|0|||
147199760|NCT04145349|530904860|FG000|Overall Study|Lost to Follow-up|0|||
147199761|NCT04145349|530904861|FG001|Overall Study|Lost to Follow-up|1|||
147199762|NCT04145349|530904860|FG000|Overall Study|On study treatment (Ongoing)|0|||
147199763|NCT04145349|530904861|FG001|Overall Study|On study treatment (Ongoing)|1|||
147199764|NCT03312634|530904862|FG000|Overall Study|Adverse Event|11|||
147199765|NCT03312634|530904863|FG001|Overall Study|Adverse Event|0|||
147199766|NCT03312634|530904862|FG000|Overall Study|Sponsor request|2|||
147199767|NCT03312634|530904863|FG001|Overall Study|Sponsor request|0|||
147199768|NCT03312634|530904862|FG000|Overall Study|Withdrawal by Subject|31|||
147306790|NCT01686581|531290762|FG000|Overall Study|Other Miscellaneous Reasons|36|||
147306791|NCT01686581|531290762|FG000|Overall Study|Reason Missing|1|||
147535015|NCT02060188|532114816|FG007|Overall Study|Participant request to discontinue study treatment|1|||
147535016|NCT02060188|532114817|FG008|Overall Study|Participant request to discontinue study treatment|0|||
147535017|NCT02060188|532114809|FG000|Overall Study|Participant withdrew consent|3|||
147535018|NCT02060188|532114810|FG001|Overall Study|Participant withdrew consent|0|||
147535019|NCT02060188|532114811|FG002|Overall Study|Participant withdrew consent|0|||
147535020|NCT02060188|532114812|FG003|Overall Study|Participant withdrew consent|0|||
147535021|NCT02060188|532114813|FG004|Overall Study|Participant withdrew consent|0|||
147199769|NCT03312634|530904863|FG001|Overall Study|Withdrawal by Subject|9|||
147199770|NCT03312634|530904862|FG000|Overall Study|Enrolled in an interventional study|0|||
147199771|NCT03312634|530904863|FG001|Overall Study|Enrolled in an interventional study|52|||
147199772|NCT03312634|530904862|FG000|Overall Study|Enrolled in an interventional study at time of a flare-up|0|||
147199773|NCT03312634|530904863|FG001|Overall Study|Enrolled in an interventional study at time of a flare-up|9|||
147199774|NCT03312634|530904862|FG000|Overall Study|Death|0|||
147199775|NCT03312634|530904863|FG001|Overall Study|Death|1|||
147199776|NCT03312634|530904862|FG000|Overall Study|Non-compliance|0|||
147199777|NCT03312634|530904863|FG001|Overall Study|Non-compliance|2|||
147199778|NCT03312634|530904862|FG000|Overall Study|Lost to Follow-up|0|||
147199779|NCT03312634|530904863|FG001|Overall Study|Lost to Follow-up|1|||
147199780|NCT03312634|530904862|FG000|Overall Study|Enrolled into non-interventional study|0|||
147199781|NCT03312634|530904863|FG001|Overall Study|Enrolled into non-interventional study|5|||
147199782|NCT03312634|530904862|FG000|Overall Study|Worsening clinical condition|0|||
147199783|NCT03312634|530904863|FG001|Overall Study|Worsening clinical condition|1|||
147199784|NCT03312634|530904862|FG000|Overall Study|Participant did not want to travel|0|||
147199785|NCT03312634|530904863|FG001|Overall Study|Participant did not want to travel|1|||
147199786|NCT03312634|530904862|FG000|Overall Study|Physician Decision|1|||
147199787|NCT03312634|530904863|FG001|Overall Study|Physician Decision|0|||
147199788|NCT03312634|530904862|FG000|Overall Study|Other|13|||
147199789|NCT03312634|530904863|FG001|Overall Study|Other|0|||
147199790|NCT01148979|530904872|FG000|Overall Study|Lost to Follow-up|0|||
147199791|NCT01148979|530904873|FG001|Overall Study|Lost to Follow-up|1|||
147199792|NCT00777153|530904874|FG000|Overall Study|Lost to Follow-up|1|||
147199793|NCT00777153|530904875|FG001|Overall Study|Lost to Follow-up|1|||
147199794|NCT00777153|530904876|FG002|Overall Study|Lost to Follow-up|0|||
147199795|NCT00777153|530904874|FG000|Overall Study|Death|85|||
147199796|NCT00777153|530904875|FG001|Overall Study|Death|73|||
147199797|NCT00777153|530904876|FG002|Overall Study|Death|33|||
147199798|NCT00777153|530904874|FG000|Overall Study|Withdrawal by Subject|3|||
147199799|NCT00777153|530904875|FG001|Overall Study|Withdrawal by Subject|4|||
147199800|NCT00777153|530904876|FG002|Overall Study|Withdrawal by Subject|3|||
147199801|NCT00777153|530904874|FG000|Overall Study|Incorrect enrol/elig crit not fulfilled|1|||
147199802|NCT00777153|530904875|FG001|Overall Study|Incorrect enrol/elig crit not fulfilled|5|||
147199803|NCT00777153|530904876|FG002|Overall Study|Incorrect enrol/elig crit not fulfilled|1|||
147199804|NCT00554216|530904877|FG000|Overall Study|Lost to Follow-up|92|||
147199805|NCT00554216|530904878|FG001|Overall Study|Lost to Follow-up|31|||
147199806|NCT00554216|530904879|FG002|Overall Study|Lost to Follow-up|63|||
147199807|NCT00554216|530904877|FG000|Overall Study|Adverse Event|16|||
147199808|NCT00554216|530904878|FG001|Overall Study|Adverse Event|16|||
147199809|NCT00554216|530904879|FG002|Overall Study|Adverse Event|36|||
147199810|NCT00554216|530904877|FG000|Overall Study|Withdrawal by Subject|92|||
147199811|NCT00554216|530904878|FG001|Overall Study|Withdrawal by Subject|31|||
147199812|NCT00554216|530904879|FG002|Overall Study|Withdrawal by Subject|43|||
147199813|NCT00554216|530904877|FG000|Overall Study|Non compliance|10|||
147199814|NCT00554216|530904878|FG001|Overall Study|Non compliance|4|||
147199815|NCT00554216|530904879|FG002|Overall Study|Non compliance|5|||
147199816|NCT00554216|530904877|FG000|Overall Study|Pregnancy|2|||
147199817|NCT00554216|530904878|FG001|Overall Study|Pregnancy|1|||
147199818|NCT00554216|530904879|FG002|Overall Study|Pregnancy|14|||
147199819|NCT00554216|530904877|FG000|Overall Study|Restricted med|3|||
147199820|NCT00554216|530904878|FG001|Overall Study|Restricted med|1|||
147199821|NCT00554216|530904879|FG002|Overall Study|Restricted med|1|||
147199822|NCT00554216|530904877|FG000|Overall Study|Other|12|||
147199823|NCT00554216|530904878|FG001|Overall Study|Other|7|||
147199824|NCT00554216|530904879|FG002|Overall Study|Other|10|||
147199825|NCT00554216|530904877|FG000|Overall Study|Lack of Efficacy|15|||
147199826|NCT00554216|530904878|FG001|Overall Study|Lack of Efficacy|3|||
147199827|NCT00554216|530904879|FG002|Overall Study|Lack of Efficacy|0|||
147199828|NCT05462756|530904882|FG000|Treatment Period|Adverse Event|3|||
147199829|NCT05462756|530904883|FG001|Treatment Period|Adverse Event|0|||
147199830|NCT05462756|530904882|FG000|Treatment Period|Assigned Treatment by Mistake|4|||
147199831|NCT05462756|530904883|FG001|Treatment Period|Assigned Treatment by Mistake|3|||
147199832|NCT05462756|530904882|FG000|Treatment Period|Death|0|||
147199833|NCT05462756|530904883|FG001|Treatment Period|Death|1|||
147199834|NCT05462756|530904882|FG000|Treatment Period|Lost to Follow-up|2|||
147199835|NCT05462756|530904883|FG001|Treatment Period|Lost to Follow-up|1|||
147199836|NCT05462756|530904882|FG000|Treatment Period|Non-Compliance with Study Drug|1|||
147199837|NCT05462756|530904883|FG001|Treatment Period|Non-Compliance with Study Drug|3|||
147199838|NCT05462756|530904882|FG000|Treatment Period|Physician Decision|2|||
147199839|NCT05462756|530904883|FG001|Treatment Period|Physician Decision|0|||
147199840|NCT05462756|530904882|FG000|Treatment Period|Protocol Violation|0|||
147199841|NCT05462756|530904883|FG001|Treatment Period|Protocol Violation|1|||
147199842|NCT05462756|530904882|FG000|Treatment Period|Withdrawal by Subject|5|||
147199843|NCT05462756|530904883|FG001|Treatment Period|Withdrawal by Subject|12|||
147199844|NCT05462756|530904882|FG000|Follow-Up Period|Adverse Event|1|||
147199845|NCT05462756|530904883|FG001|Follow-Up Period|Adverse Event|0|||
147199846|NCT05462756|530904882|FG000|Follow-Up Period|Death|1|||
147199847|NCT05462756|530904883|FG001|Follow-Up Period|Death|0|||
147199848|NCT05462756|530904882|FG000|Follow-Up Period|Lost to Follow-up|3|||
147199849|NCT05462756|530904883|FG001|Follow-Up Period|Lost to Follow-up|1|||
147199850|NCT05462756|530904882|FG000|Follow-Up Period|Withdrawal by Subject|0|||
147199851|NCT05462756|530904883|FG001|Follow-Up Period|Withdrawal by Subject|4|||
147199852|NCT02079246|530904884|FG000|OLEX|Withdrawal before treatment|1|||
147199853|NCT02079246|530904885|FG001|OLEX|Withdrawal before treatment|0|||
147199854|NCT02079246|530904884|FG000|OLEX|Death|11|||
147199855|NCT02079246|530904885|FG001|OLEX|Death|0|||
147199856|NCT02079246|530904884|FG000|OLEX|Adverse Event|66|||
147199857|NCT02079246|530904885|FG001|OLEX|Adverse Event|0|||
147199858|NCT02079246|530904884|FG000|OLEX|Withdrawal by Subject|60|||
147199859|NCT02079246|530904885|FG001|OLEX|Withdrawal by Subject|0|||
147199860|NCT02079246|530904884|FG000|OLEX|Lost to Follow-up|6|||
147199861|NCT02079246|530904885|FG001|OLEX|Lost to Follow-up|0|||
147199862|NCT02079246|530904884|FG000|OLEX|Protocol Violation|6|||
147199863|NCT02079246|530904885|FG001|OLEX|Protocol Violation|0|||
147199864|NCT02079246|530904884|FG000|OLEX|Lack of Efficacy|3|||
147199865|NCT02079246|530904885|FG001|OLEX|Lack of Efficacy|0|||
147199866|NCT02079246|530904884|FG000|OLEX|Results of the lead-in studies|58|||
147199867|NCT02079246|530904885|FG001|OLEX|Results of the lead-in studies|0|||
147199868|NCT02079246|530904884|FG000|OLEX|Other: Disallowed medication|8|||
147199869|NCT02079246|530904885|FG001|OLEX|Other: Disallowed medication|0|||
147199870|NCT02079246|530904884|FG000|OLEX|Other: Insufficient compliance|2|||
147199871|NCT02079246|530904885|FG001|OLEX|Other: Insufficient compliance|0|||
147199872|NCT02079246|530904884|FG000|OLEX|Other: Caregiver unavailable|3|||
147199873|NCT02079246|530904885|FG001|OLEX|Other: Caregiver unavailable|0|||
147199874|NCT02079246|530904884|FG000|OLEX|Other: Coordinator decision|1|||
147199875|NCT02079246|530904885|FG001|OLEX|Other: Coordinator decision|0|||
147199876|NCT02079246|530904884|FG000|OLEX|Other: Worsening of condition|1|||
147199877|NCT02079246|530904885|FG001|OLEX|Other: Worsening of condition|0|||
147199878|NCT02079246|530904884|FG000|OLEX|Other: Moved to nursing home|1|||
147199879|NCT02079246|530904885|FG001|OLEX|Other: Moved to nursing home|0|||
147199880|NCT02079246|530904884|FG000|OLEX|Other: Withdrawal of caregiver consent|1|||
147199881|NCT02079246|530904885|FG001|OLEX|Other: Withdrawal of caregiver consent|0|||
147199882|NCT02079246|530904884|FG000|OLEX-MEM|Adverse Event|0|||
147199883|NCT02079246|530904885|FG001|OLEX-MEM|Adverse Event|6|||
147199884|NCT02079246|530904884|FG000|OLEX-MEM|Withdrawal by Subject|0|||
147199885|NCT02079246|530904885|FG001|OLEX-MEM|Withdrawal by Subject|7|||
147199886|NCT02079246|530904884|FG000|OLEX-MEM|Protocol Violation|0|||
147199887|NCT02079246|530904885|FG001|OLEX-MEM|Protocol Violation|2|||
147199888|NCT02079246|530904884|FG000|OLEX-MEM|Lost to Follow-up|0|||
147199889|NCT02079246|530904885|FG001|OLEX-MEM|Lost to Follow-up|1|||
147199890|NCT02079246|530904884|FG000|OLEX-MEM|Other: Moved to nursing home|0|||
147199891|NCT02079246|530904885|FG001|OLEX-MEM|Other: Moved to nursing home|3|||
147199892|NCT04040933|530904890|FG000|Overall Study|Protocol Violation|1|||
147199893|NCT04040933|530904890|FG000|Overall Study|Withdrawal by Subject|2|||
147199894|NCT00775190|530904891|FG000|Overall Study|Lost to Follow-up|2|||
147199895|NCT00775190|530904892|FG001|Overall Study|Lost to Follow-up|3|||
147199896|NCT00775190|530904891|FG000|Overall Study|Withdrawal by Subject|1|||
147199897|NCT00775190|530904892|FG001|Overall Study|Withdrawal by Subject|2|||
147199898|NCT00775190|530904891|FG000|Overall Study|Protocol Violation|1|||
147199899|NCT00775190|530904892|FG001|Overall Study|Protocol Violation|0|||
147199900|NCT01709084|530904893|FG000|Overall Study|Lost to Follow-up|4|||
147199901|NCT01709084|530904894|FG001|Overall Study|Lost to Follow-up|7|||
147199902|NCT01709084|530904893|FG000|Overall Study|Withdrawal by Subject|2|||
147199903|NCT01709084|530904894|FG001|Overall Study|Withdrawal by Subject|2|||
147199904|NCT01709084|530904893|FG000|Overall Study|Adverse Event|5|||
147199905|NCT01709084|530904894|FG001|Overall Study|Adverse Event|0|||
147199906|NCT01709084|530904893|FG000|Overall Study|Other|5|||
147199907|NCT01709084|530904894|FG001|Overall Study|Other|3|||
147199908|NCT01709084|530904893|FG000|Overall Study|Participant Reached a Virologic Endpoint|0|||
147199909|NCT01709084|530904894|FG001|Overall Study|Participant Reached a Virologic Endpoint|1|||
147306792|NCT01975220|531290763|FG000|Test Period 1|Not treated|0|||
147199910|NCT01709084|530904893|FG000|Overall Study|Not Treated|0|||
147199911|NCT01709084|530904894|FG001|Overall Study|Not Treated|2|||
147199912|NCT00753506|530904904|FG000|Overall Study|Withdrawal by Subject|4|||
147199913|NCT00753506|530904905|FG001|Overall Study|Withdrawal by Subject|1|||
147199914|NCT00753506|530904904|FG000|Overall Study|Lost to Follow-up|2|||
147199915|NCT00753506|530904905|FG001|Overall Study|Lost to Follow-up|0|||
147199916|NCT00753506|530904904|FG000|Overall Study|Other reason|1|||
147199917|NCT00753506|530904905|FG001|Overall Study|Other reason|1|||
147199918|NCT04226742|530904908|FG000|Overall Study|Lost to Follow-up|16|||
147199919|NCT04226742|530904909|FG001|Overall Study|Lost to Follow-up|13|||
147199920|NCT04226742|530904908|FG000|Overall Study|Withdrawal by Subject|5|||
147199921|NCT04226742|530904909|FG001|Overall Study|Withdrawal by Subject|3|||
147199922|NCT01193244|530904910|FG000|Overall Study|Withdrawal by Subject|79|||
147199923|NCT01193244|530904911|FG001|Overall Study|Withdrawal by Subject|97|||
147199924|NCT01193244|530904910|FG000|Overall Study|Other|303|||
147199925|NCT01193244|530904911|FG001|Overall Study|Other|278|||
147199926|NCT01193244|530904910|FG000|Overall Study|Lost to Follow-up|6|||
147199927|NCT01193244|530904911|FG001|Overall Study|Lost to Follow-up|15|||
147199928|NCT01417377|530904912|FG000|Overall Study|Lost to Follow-up|12|||
147199929|NCT01417377|530904912|FG000|Overall Study|Enrolled, but not treated|1|||
147199930|NCT02113982|530904913|FG000|Stage 1: Dose Escalation|Adverse Event|0|||
147199931|NCT02113982|530904914|FG001|Stage 1: Dose Escalation|Adverse Event|0|||
147199932|NCT02113982|530904915|FG002|Stage 1: Dose Escalation|Adverse Event|2|||
147199933|NCT02113982|530904916|FG003|Stage 1: Dose Escalation|Adverse Event|4|||
147199934|NCT02113982|530904917|FG004|Stage 1: Dose Escalation|Adverse Event|1|||
147199935|NCT02113982|530904918|FG005|Stage 1: Dose Escalation|Adverse Event|0|||
147199936|NCT02113982|530904919|FG006|Stage 1: Dose Escalation|Adverse Event|0|||
147199937|NCT02113982|530904920|FG007|Stage 1: Dose Escalation|Adverse Event|0|||
147199938|NCT02113982|530904921|FG008|Stage 1: Dose Escalation|Adverse Event|0|||
147199939|NCT02113982|530904922|FG009|Stage 1: Dose Escalation|Adverse Event|0|||
147199940|NCT02113982|530904923|FG010|Stage 1: Dose Escalation|Adverse Event|0|||
147199941|NCT02113982|530904924|FG011|Stage 1: Dose Escalation|Adverse Event|0|||
147199942|NCT02113982|530904925|FG012|Stage 1: Dose Escalation|Adverse Event|0|||
147199943|NCT02113982|530904926|FG013|Stage 1: Dose Escalation|Adverse Event|0|||
147199944|NCT02113982|530904913|FG000|Stage 1: Dose Escalation|Progressive Disease|3|||
147199945|NCT02113982|530904914|FG001|Stage 1: Dose Escalation|Progressive Disease|1|||
147199946|NCT02113982|530904915|FG002|Stage 1: Dose Escalation|Progressive Disease|0|||
147199947|NCT02113982|530904916|FG003|Stage 1: Dose Escalation|Progressive Disease|2|||
147199948|NCT02113982|530904917|FG004|Stage 1: Dose Escalation|Progressive Disease|2|||
147199949|NCT02113982|530904918|FG005|Stage 1: Dose Escalation|Progressive Disease|1|||
147199950|NCT02113982|530904919|FG006|Stage 1: Dose Escalation|Progressive Disease|2|||
147199951|NCT02113982|530904920|FG007|Stage 1: Dose Escalation|Progressive Disease|0|||
147199952|NCT02113982|530904921|FG008|Stage 1: Dose Escalation|Progressive Disease|0|||
147199953|NCT02113982|530904922|FG009|Stage 1: Dose Escalation|Progressive Disease|0|||
147199954|NCT02113982|530904923|FG010|Stage 1: Dose Escalation|Progressive Disease|0|||
147199955|NCT02113982|530904924|FG011|Stage 1: Dose Escalation|Progressive Disease|0|||
147199956|NCT02113982|530904925|FG012|Stage 1: Dose Escalation|Progressive Disease|0|||
147199957|NCT02113982|530904926|FG013|Stage 1: Dose Escalation|Progressive Disease|0|||
147199958|NCT02113982|530904913|FG000|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
147199959|NCT02113982|530904914|FG001|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
147199960|NCT02113982|530904915|FG002|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
147199961|NCT02113982|530904916|FG003|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
147199962|NCT02113982|530904917|FG004|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
147199963|NCT02113982|530904918|FG005|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
147199964|NCT02113982|530904919|FG006|Stage 1: Dose Escalation|Withdrawal by Subject|1|||
147199965|NCT02113982|530904920|FG007|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
147199966|NCT02113982|530904921|FG008|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
147199967|NCT02113982|530904922|FG009|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
147199968|NCT02113982|530904923|FG010|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
147199969|NCT02113982|530904924|FG011|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
147199970|NCT02113982|530904925|FG012|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
147199971|NCT02113982|530904926|FG013|Stage 1: Dose Escalation|Withdrawal by Subject|0|||
147199972|NCT02113982|530904913|FG000|Stage 1: Dose Escalation|Transplant|0|||
147199973|NCT02113982|530904914|FG001|Stage 1: Dose Escalation|Transplant|1|||
147199974|NCT02113982|530904915|FG002|Stage 1: Dose Escalation|Transplant|0|||
147199975|NCT02113982|530904916|FG003|Stage 1: Dose Escalation|Transplant|0|||
147199976|NCT02113982|530904917|FG004|Stage 1: Dose Escalation|Transplant|0|||
147199977|NCT02113982|530904918|FG005|Stage 1: Dose Escalation|Transplant|1|||
147199978|NCT02113982|530904919|FG006|Stage 1: Dose Escalation|Transplant|0|||
147199979|NCT02113982|530904920|FG007|Stage 1: Dose Escalation|Transplant|0|||
147199980|NCT02113982|530904921|FG008|Stage 1: Dose Escalation|Transplant|0|||
147199981|NCT02113982|530904922|FG009|Stage 1: Dose Escalation|Transplant|0|||
147199982|NCT02113982|530904923|FG010|Stage 1: Dose Escalation|Transplant|0|||
147199983|NCT02113982|530904924|FG011|Stage 1: Dose Escalation|Transplant|0|||
147199984|NCT02113982|530904925|FG012|Stage 1: Dose Escalation|Transplant|0|||
147199985|NCT02113982|530904926|FG013|Stage 1: Dose Escalation|Transplant|0|||
147199986|NCT02113982|530904913|FG000|Stage 1: Dose Escalation|Other Therapy|0|||
147199987|NCT02113982|530904914|FG001|Stage 1: Dose Escalation|Other Therapy|0|||
147199988|NCT02113982|530904915|FG002|Stage 1: Dose Escalation|Other Therapy|0|||
147199989|NCT02113982|530904916|FG003|Stage 1: Dose Escalation|Other Therapy|0|||
147199990|NCT02113982|530904917|FG004|Stage 1: Dose Escalation|Other Therapy|0|||
147199991|NCT02113982|530904918|FG005|Stage 1: Dose Escalation|Other Therapy|1|||
147199992|NCT02113982|530904919|FG006|Stage 1: Dose Escalation|Other Therapy|0|||
147199993|NCT02113982|530904920|FG007|Stage 1: Dose Escalation|Other Therapy|0|||
147199994|NCT02113982|530904921|FG008|Stage 1: Dose Escalation|Other Therapy|0|||
147199995|NCT02113982|530904922|FG009|Stage 1: Dose Escalation|Other Therapy|0|||
147199996|NCT02113982|530904923|FG010|Stage 1: Dose Escalation|Other Therapy|0|||
147199997|NCT02113982|530904924|FG011|Stage 1: Dose Escalation|Other Therapy|0|||
147199998|NCT02113982|530904925|FG012|Stage 1: Dose Escalation|Other Therapy|0|||
147199999|NCT02113982|530904926|FG013|Stage 1: Dose Escalation|Other Therapy|0|||
147200000|NCT02113982|530904913|FG000|Stage 1: Dose Escalation|Complicating Disease|0|||
147200001|NCT02113982|530904914|FG001|Stage 1: Dose Escalation|Complicating Disease|1|||
147200002|NCT02113982|530904915|FG002|Stage 1: Dose Escalation|Complicating Disease|0|||
147200003|NCT02113982|530904916|FG003|Stage 1: Dose Escalation|Complicating Disease|0|||
147200004|NCT02113982|530904917|FG004|Stage 1: Dose Escalation|Complicating Disease|0|||
147200005|NCT02113982|530904918|FG005|Stage 1: Dose Escalation|Complicating Disease|0|||
147200006|NCT02113982|530904919|FG006|Stage 1: Dose Escalation|Complicating Disease|0|||
147200007|NCT02113982|530904920|FG007|Stage 1: Dose Escalation|Complicating Disease|0|||
147200008|NCT02113982|530904921|FG008|Stage 1: Dose Escalation|Complicating Disease|0|||
147200009|NCT02113982|530904922|FG009|Stage 1: Dose Escalation|Complicating Disease|0|||
147200010|NCT02113982|530904923|FG010|Stage 1: Dose Escalation|Complicating Disease|0|||
147200011|NCT02113982|530904924|FG011|Stage 1: Dose Escalation|Complicating Disease|0|||
147200012|NCT02113982|530904925|FG012|Stage 1: Dose Escalation|Complicating Disease|0|||
147200013|NCT02113982|530904926|FG013|Stage 1: Dose Escalation|Complicating Disease|0|||
147200014|NCT02113982|530904913|FG000|Stage 2: Cohort Expansion|Adverse Event|0|||
147200015|NCT02113982|530904914|FG001|Stage 2: Cohort Expansion|Adverse Event|0|||
147200016|NCT02113982|530904915|FG002|Stage 2: Cohort Expansion|Adverse Event|0|||
147200017|NCT02113982|530904916|FG003|Stage 2: Cohort Expansion|Adverse Event|0|||
147200018|NCT02113982|530904917|FG004|Stage 2: Cohort Expansion|Adverse Event|0|||
147200019|NCT02113982|530904918|FG005|Stage 2: Cohort Expansion|Adverse Event|0|||
147200020|NCT02113982|530904919|FG006|Stage 2: Cohort Expansion|Adverse Event|0|||
147200021|NCT02113982|530904920|FG007|Stage 2: Cohort Expansion|Adverse Event|1|||
147200022|NCT02113982|530904921|FG008|Stage 2: Cohort Expansion|Adverse Event|1|||
147200023|NCT02113982|530904922|FG009|Stage 2: Cohort Expansion|Adverse Event|1|||
147200024|NCT02113982|530904923|FG010|Stage 2: Cohort Expansion|Adverse Event|0|||
147200025|NCT02113982|530904924|FG011|Stage 2: Cohort Expansion|Adverse Event|0|||
147200026|NCT02113982|530904925|FG012|Stage 2: Cohort Expansion|Adverse Event|0|||
147200027|NCT02113982|530904926|FG013|Stage 2: Cohort Expansion|Adverse Event|0|||
147200028|NCT02113982|530904913|FG000|Stage 2: Cohort Expansion|Physician Decision|0|||
147200029|NCT02113982|530904914|FG001|Stage 2: Cohort Expansion|Physician Decision|0|||
147200030|NCT02113982|530904915|FG002|Stage 2: Cohort Expansion|Physician Decision|0|||
147200031|NCT02113982|530904916|FG003|Stage 2: Cohort Expansion|Physician Decision|0|||
147200032|NCT02113982|530904917|FG004|Stage 2: Cohort Expansion|Physician Decision|0|||
147200033|NCT02113982|530904918|FG005|Stage 2: Cohort Expansion|Physician Decision|0|||
147200034|NCT02113982|530904919|FG006|Stage 2: Cohort Expansion|Physician Decision|0|||
147200035|NCT02113982|530904920|FG007|Stage 2: Cohort Expansion|Physician Decision|7|||
147200036|NCT02113982|530904921|FG008|Stage 2: Cohort Expansion|Physician Decision|0|||
147200037|NCT02113982|530904922|FG009|Stage 2: Cohort Expansion|Physician Decision|1|||
147200038|NCT02113982|530904923|FG010|Stage 2: Cohort Expansion|Physician Decision|0|||
147200039|NCT02113982|530904924|FG011|Stage 2: Cohort Expansion|Physician Decision|0|||
147200040|NCT02113982|530904925|FG012|Stage 2: Cohort Expansion|Physician Decision|0|||
147200041|NCT02113982|530904926|FG013|Stage 2: Cohort Expansion|Physician Decision|0|||
147200042|NCT02113982|530904913|FG000|Stage 2: Cohort Expansion|Progressive Disease|0|||
147200043|NCT02113982|530904914|FG001|Stage 2: Cohort Expansion|Progressive Disease|0|||
147200044|NCT02113982|530904915|FG002|Stage 2: Cohort Expansion|Progressive Disease|0|||
147200045|NCT02113982|530904916|FG003|Stage 2: Cohort Expansion|Progressive Disease|0|||
147200046|NCT02113982|530904917|FG004|Stage 2: Cohort Expansion|Progressive Disease|0|||
147200047|NCT02113982|530904918|FG005|Stage 2: Cohort Expansion|Progressive Disease|0|||
147200048|NCT02113982|530904919|FG006|Stage 2: Cohort Expansion|Progressive Disease|0|||
147200049|NCT02113982|530904920|FG007|Stage 2: Cohort Expansion|Progressive Disease|19|||
147200050|NCT02113982|530904921|FG008|Stage 2: Cohort Expansion|Progressive Disease|0|||
147200051|NCT02113982|530904922|FG009|Stage 2: Cohort Expansion|Progressive Disease|5|||
147200052|NCT02113982|530904923|FG010|Stage 2: Cohort Expansion|Progressive Disease|7|||
147200053|NCT02113982|530904924|FG011|Stage 2: Cohort Expansion|Progressive Disease|0|||
147200054|NCT02113982|530904925|FG012|Stage 2: Cohort Expansion|Progressive Disease|0|||
147200055|NCT02113982|530904926|FG013|Stage 2: Cohort Expansion|Progressive Disease|0|||
147200056|NCT02113982|530904913|FG000|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
147200057|NCT02113982|530904914|FG001|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
147200058|NCT02113982|530904915|FG002|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
147200059|NCT02113982|530904916|FG003|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
147200060|NCT02113982|530904917|FG004|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
147200061|NCT02113982|530904918|FG005|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
147200062|NCT02113982|530904919|FG006|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
147200063|NCT02113982|530904920|FG007|Stage 2: Cohort Expansion|Withdrawal by Subject|4|||
147200064|NCT02113982|530904921|FG008|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
147200065|NCT02113982|530904922|FG009|Stage 2: Cohort Expansion|Withdrawal by Subject|1|||
147200066|NCT02113982|530904923|FG010|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
147200067|NCT02113982|530904924|FG011|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
147200068|NCT02113982|530904925|FG012|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
147200069|NCT02113982|530904926|FG013|Stage 2: Cohort Expansion|Withdrawal by Subject|0|||
147200070|NCT02113982|530904913|FG000|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
147200071|NCT02113982|530904914|FG001|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
147200072|NCT02113982|530904915|FG002|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
147200073|NCT02113982|530904916|FG003|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
147200074|NCT02113982|530904917|FG004|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
147200075|NCT02113982|530904918|FG005|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
147200076|NCT02113982|530904919|FG006|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
147200077|NCT02113982|530904920|FG007|Stage 2: Cohort Expansion|Lack of Efficacy|2|||
147200078|NCT02113982|530904921|FG008|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
147200079|NCT02113982|530904922|FG009|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
147200080|NCT02113982|530904923|FG010|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
147200081|NCT02113982|530904924|FG011|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
147200082|NCT02113982|530904925|FG012|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
147200083|NCT02113982|530904926|FG013|Stage 2: Cohort Expansion|Lack of Efficacy|0|||
147200084|NCT02113982|530904913|FG000|Stage 2: Cohort Expansion|Transplant|0|||
147200085|NCT02113982|530904914|FG001|Stage 2: Cohort Expansion|Transplant|0|||
147200086|NCT02113982|530904915|FG002|Stage 2: Cohort Expansion|Transplant|0|||
147200087|NCT02113982|530904916|FG003|Stage 2: Cohort Expansion|Transplant|0|||
147200088|NCT02113982|530904917|FG004|Stage 2: Cohort Expansion|Transplant|0|||
147200089|NCT02113982|530904918|FG005|Stage 2: Cohort Expansion|Transplant|0|||
147200090|NCT02113982|530904919|FG006|Stage 2: Cohort Expansion|Transplant|0|||
147200091|NCT02113982|530904920|FG007|Stage 2: Cohort Expansion|Transplant|0|||
147200092|NCT02113982|530904921|FG008|Stage 2: Cohort Expansion|Transplant|0|||
147200093|NCT02113982|530904922|FG009|Stage 2: Cohort Expansion|Transplant|4|||
147200094|NCT02113982|530904923|FG010|Stage 2: Cohort Expansion|Transplant|2|||
147200095|NCT02113982|530904924|FG011|Stage 2: Cohort Expansion|Transplant|0|||
147200096|NCT02113982|530904925|FG012|Stage 2: Cohort Expansion|Transplant|0|||
147200097|NCT02113982|530904926|FG013|Stage 2: Cohort Expansion|Transplant|0|||
147200098|NCT02113982|530904913|FG000|Stage 2: Cohort Expansion|Patient Preference|0|||
147200099|NCT02113982|530904914|FG001|Stage 2: Cohort Expansion|Patient Preference|0|||
147200100|NCT02113982|530904915|FG002|Stage 2: Cohort Expansion|Patient Preference|0|||
147200101|NCT02113982|530904916|FG003|Stage 2: Cohort Expansion|Patient Preference|0|||
147200102|NCT02113982|530904917|FG004|Stage 2: Cohort Expansion|Patient Preference|0|||
147200103|NCT02113982|530904918|FG005|Stage 2: Cohort Expansion|Patient Preference|0|||
147200104|NCT02113982|530904919|FG006|Stage 2: Cohort Expansion|Patient Preference|0|||
147200105|NCT02113982|530904920|FG007|Stage 2: Cohort Expansion|Patient Preference|1|||
147200106|NCT02113982|530904921|FG008|Stage 2: Cohort Expansion|Patient Preference|0|||
147200107|NCT02113982|530904922|FG009|Stage 2: Cohort Expansion|Patient Preference|0|||
147200108|NCT02113982|530904923|FG010|Stage 2: Cohort Expansion|Patient Preference|1|||
147200109|NCT02113982|530904924|FG011|Stage 2: Cohort Expansion|Patient Preference|0|||
147200110|NCT02113982|530904925|FG012|Stage 2: Cohort Expansion|Patient Preference|0|||
147200111|NCT02113982|530904926|FG013|Stage 2: Cohort Expansion|Patient Preference|0|||
147200112|NCT02113982|530904913|FG000|Stage 2: Cohort Expansion|Other Therapy|0|||
147200113|NCT02113982|530904914|FG001|Stage 2: Cohort Expansion|Other Therapy|0|||
147200114|NCT02113982|530904915|FG002|Stage 2: Cohort Expansion|Other Therapy|0|||
147200115|NCT02113982|530904916|FG003|Stage 2: Cohort Expansion|Other Therapy|0|||
147200116|NCT02113982|530904917|FG004|Stage 2: Cohort Expansion|Other Therapy|0|||
147200117|NCT02113982|530904918|FG005|Stage 2: Cohort Expansion|Other Therapy|0|||
147200118|NCT02113982|530904919|FG006|Stage 2: Cohort Expansion|Other Therapy|0|||
147200119|NCT02113982|530904920|FG007|Stage 2: Cohort Expansion|Other Therapy|0|||
147200120|NCT02113982|530904921|FG008|Stage 2: Cohort Expansion|Other Therapy|0|||
147200121|NCT02113982|530904922|FG009|Stage 2: Cohort Expansion|Other Therapy|1|||
147200122|NCT02113982|530904923|FG010|Stage 2: Cohort Expansion|Other Therapy|0|||
147435273|NCT01122576|531760445|FG001|Post-Cataract Surgery|Central Macular Edema|0|||
147435274|NCT01122576|531760446|FG002|Post-Cataract Surgery|Central Macular Edema|1|||
147435275|NCT01122576|531760444|FG000|Post-Cataract Surgery|Fellow Eye Explanted|0|||
147435276|NCT01122576|531760445|FG001|Post-Cataract Surgery|Fellow Eye Explanted|0|||
147200123|NCT02113982|530904924|FG011|Stage 2: Cohort Expansion|Other Therapy|0|||
147200124|NCT02113982|530904925|FG012|Stage 2: Cohort Expansion|Other Therapy|0|||
147200125|NCT02113982|530904926|FG013|Stage 2: Cohort Expansion|Other Therapy|0|||
147200126|NCT02113982|530904913|FG000|Stage 3: Efficacy Cohort|Adverse Event|0|||
147200127|NCT02113982|530904914|FG001|Stage 3: Efficacy Cohort|Adverse Event|0|||
147200128|NCT02113982|530904915|FG002|Stage 3: Efficacy Cohort|Adverse Event|0|||
147200129|NCT02113982|530904916|FG003|Stage 3: Efficacy Cohort|Adverse Event|0|||
147200130|NCT02113982|530904917|FG004|Stage 3: Efficacy Cohort|Adverse Event|0|||
147200131|NCT02113982|530904918|FG005|Stage 3: Efficacy Cohort|Adverse Event|0|||
147200132|NCT02113982|530904919|FG006|Stage 3: Efficacy Cohort|Adverse Event|0|||
147200133|NCT02113982|530904920|FG007|Stage 3: Efficacy Cohort|Adverse Event|0|||
147200134|NCT02113982|530904921|FG008|Stage 3: Efficacy Cohort|Adverse Event|0|||
147200135|NCT02113982|530904922|FG009|Stage 3: Efficacy Cohort|Adverse Event|0|||
147200136|NCT02113982|530904923|FG010|Stage 3: Efficacy Cohort|Adverse Event|0|||
147200137|NCT02113982|530904924|FG011|Stage 3: Efficacy Cohort|Adverse Event|1|||
147200138|NCT02113982|530904925|FG012|Stage 3: Efficacy Cohort|Adverse Event|0|||
147200139|NCT02113982|530904926|FG013|Stage 3: Efficacy Cohort|Adverse Event|0|||
147200140|NCT02113982|530904913|FG000|Stage 3: Efficacy Cohort|Physician Decision|0|||
147200141|NCT02113982|530904914|FG001|Stage 3: Efficacy Cohort|Physician Decision|0|||
147200142|NCT02113982|530904915|FG002|Stage 3: Efficacy Cohort|Physician Decision|0|||
147200143|NCT02113982|530904916|FG003|Stage 3: Efficacy Cohort|Physician Decision|0|||
147200144|NCT02113982|530904917|FG004|Stage 3: Efficacy Cohort|Physician Decision|0|||
147200145|NCT02113982|530904918|FG005|Stage 3: Efficacy Cohort|Physician Decision|0|||
147200146|NCT02113982|530904919|FG006|Stage 3: Efficacy Cohort|Physician Decision|0|||
147200147|NCT02113982|530904920|FG007|Stage 3: Efficacy Cohort|Physician Decision|0|||
147200148|NCT02113982|530904921|FG008|Stage 3: Efficacy Cohort|Physician Decision|0|||
147200149|NCT02113982|530904922|FG009|Stage 3: Efficacy Cohort|Physician Decision|0|||
147200150|NCT02113982|530904923|FG010|Stage 3: Efficacy Cohort|Physician Decision|0|||
147200151|NCT02113982|530904924|FG011|Stage 3: Efficacy Cohort|Physician Decision|3|||
147200152|NCT02113982|530904925|FG012|Stage 3: Efficacy Cohort|Physician Decision|0|||
147200153|NCT02113982|530904926|FG013|Stage 3: Efficacy Cohort|Physician Decision|0|||
147200154|NCT02113982|530904913|FG000|Stage 3: Efficacy Cohort|Progressive Disease|0|||
147200155|NCT02113982|530904914|FG001|Stage 3: Efficacy Cohort|Progressive Disease|0|||
147200156|NCT02113982|530904915|FG002|Stage 3: Efficacy Cohort|Progressive Disease|0|||
147200157|NCT02113982|530904916|FG003|Stage 3: Efficacy Cohort|Progressive Disease|0|||
147200158|NCT02113982|530904917|FG004|Stage 3: Efficacy Cohort|Progressive Disease|0|||
147200159|NCT02113982|530904918|FG005|Stage 3: Efficacy Cohort|Progressive Disease|0|||
147200160|NCT02113982|530904919|FG006|Stage 3: Efficacy Cohort|Progressive Disease|0|||
147200161|NCT02113982|530904920|FG007|Stage 3: Efficacy Cohort|Progressive Disease|0|||
147200162|NCT02113982|530904921|FG008|Stage 3: Efficacy Cohort|Progressive Disease|0|||
147200163|NCT02113982|530904922|FG009|Stage 3: Efficacy Cohort|Progressive Disease|0|||
147200164|NCT02113982|530904923|FG010|Stage 3: Efficacy Cohort|Progressive Disease|0|||
147200165|NCT02113982|530904924|FG011|Stage 3: Efficacy Cohort|Progressive Disease|4|||
147200166|NCT02113982|530904925|FG012|Stage 3: Efficacy Cohort|Progressive Disease|0|||
147200167|NCT02113982|530904926|FG013|Stage 3: Efficacy Cohort|Progressive Disease|0|||
147200168|NCT02113982|530904913|FG000|Stage 3: Efficacy Cohort|Transplant|0|||
147200169|NCT02113982|530904914|FG001|Stage 3: Efficacy Cohort|Transplant|0|||
147200170|NCT02113982|530904915|FG002|Stage 3: Efficacy Cohort|Transplant|0|||
147200171|NCT02113982|530904916|FG003|Stage 3: Efficacy Cohort|Transplant|0|||
147200172|NCT02113982|530904917|FG004|Stage 3: Efficacy Cohort|Transplant|0|||
147200173|NCT02113982|530904918|FG005|Stage 3: Efficacy Cohort|Transplant|0|||
147200174|NCT02113982|530904919|FG006|Stage 3: Efficacy Cohort|Transplant|0|||
147200175|NCT02113982|530904920|FG007|Stage 3: Efficacy Cohort|Transplant|0|||
147200176|NCT02113982|530904921|FG008|Stage 3: Efficacy Cohort|Transplant|0|||
147200177|NCT02113982|530904922|FG009|Stage 3: Efficacy Cohort|Transplant|0|||
147200178|NCT02113982|530904923|FG010|Stage 3: Efficacy Cohort|Transplant|0|||
147200179|NCT02113982|530904924|FG011|Stage 3: Efficacy Cohort|Transplant|5|||
147200180|NCT02113982|530904925|FG012|Stage 3: Efficacy Cohort|Transplant|0|||
147200181|NCT02113982|530904926|FG013|Stage 3: Efficacy Cohort|Transplant|0|||
147200182|NCT02113982|530904913|FG000|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
147200183|NCT02113982|530904914|FG001|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
147200184|NCT02113982|530904915|FG002|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
147200185|NCT02113982|530904916|FG003|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
147200186|NCT02113982|530904917|FG004|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
147200187|NCT02113982|530904918|FG005|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
147200188|NCT02113982|530904919|FG006|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
147200189|NCT02113982|530904920|FG007|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
147200190|NCT02113982|530904921|FG008|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
147200191|NCT02113982|530904922|FG009|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
147200192|NCT02113982|530904923|FG010|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
147200193|NCT02113982|530904924|FG011|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
147200194|NCT02113982|530904925|FG012|Stage 4: First-line and R/R BPDCN|Adverse Event|4|||
147200195|NCT02113982|530904926|FG013|Stage 4: First-line and R/R BPDCN|Adverse Event|0|||
147200196|NCT02113982|530904913|FG000|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
147200197|NCT02113982|530904914|FG001|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
147200198|NCT02113982|530904915|FG002|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
147200199|NCT02113982|530904916|FG003|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
147200200|NCT02113982|530904917|FG004|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
147200201|NCT02113982|530904918|FG005|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
147200202|NCT02113982|530904919|FG006|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
147200203|NCT02113982|530904920|FG007|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
147200204|NCT02113982|530904921|FG008|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
147200205|NCT02113982|530904922|FG009|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
147200206|NCT02113982|530904923|FG010|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
147200207|NCT02113982|530904924|FG011|Stage 4: First-line and R/R BPDCN|Physician Decision|0|||
147200208|NCT02113982|530904925|FG012|Stage 4: First-line and R/R BPDCN|Physician Decision|7|||
147200209|NCT02113982|530904926|FG013|Stage 4: First-line and R/R BPDCN|Physician Decision|2|||
147200210|NCT02113982|530904913|FG000|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
147200211|NCT02113982|530904914|FG001|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
147200212|NCT02113982|530904915|FG002|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
147200213|NCT02113982|530904916|FG003|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
147200214|NCT02113982|530904917|FG004|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
147200215|NCT02113982|530904918|FG005|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
147200216|NCT02113982|530904919|FG006|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
147200217|NCT02113982|530904920|FG007|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
147200218|NCT02113982|530904921|FG008|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
147200219|NCT02113982|530904922|FG009|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
147200220|NCT02113982|530904923|FG010|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
147200221|NCT02113982|530904924|FG011|Stage 4: First-line and R/R BPDCN|Progressive Disease|0|||
147200222|NCT02113982|530904925|FG012|Stage 4: First-line and R/R BPDCN|Progressive Disease|14|||
147200223|NCT02113982|530904926|FG013|Stage 4: First-line and R/R BPDCN|Progressive Disease|3|||
147200224|NCT02113982|530904913|FG000|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
147200225|NCT02113982|530904914|FG001|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
147200226|NCT02113982|530904915|FG002|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
147200227|NCT02113982|530904916|FG003|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
147200228|NCT02113982|530904917|FG004|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
147200229|NCT02113982|530904918|FG005|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
147200230|NCT02113982|530904919|FG006|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
147200231|NCT02113982|530904920|FG007|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
147200232|NCT02113982|530904921|FG008|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
147200233|NCT02113982|530904922|FG009|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
147200234|NCT02113982|530904923|FG010|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
147200235|NCT02113982|530904924|FG011|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|0|||
147200236|NCT02113982|530904925|FG012|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|4|||
147200237|NCT02113982|530904926|FG013|Stage 4: First-line and R/R BPDCN|Withdrawal by Subject|2|||
147200238|NCT02113982|530904913|FG000|Stage 4: First-line and R/R BPDCN|Transplant|0|||
147200239|NCT02113982|530904914|FG001|Stage 4: First-line and R/R BPDCN|Transplant|0|||
147200240|NCT02113982|530904915|FG002|Stage 4: First-line and R/R BPDCN|Transplant|0|||
147200241|NCT02113982|530904916|FG003|Stage 4: First-line and R/R BPDCN|Transplant|0|||
147200242|NCT02113982|530904917|FG004|Stage 4: First-line and R/R BPDCN|Transplant|0|||
147200243|NCT02113982|530904918|FG005|Stage 4: First-line and R/R BPDCN|Transplant|0|||
147200244|NCT02113982|530904919|FG006|Stage 4: First-line and R/R BPDCN|Transplant|0|||
147200245|NCT02113982|530904920|FG007|Stage 4: First-line and R/R BPDCN|Transplant|0|||
147200246|NCT02113982|530904921|FG008|Stage 4: First-line and R/R BPDCN|Transplant|0|||
147200247|NCT02113982|530904922|FG009|Stage 4: First-line and R/R BPDCN|Transplant|0|||
147200248|NCT02113982|530904923|FG010|Stage 4: First-line and R/R BPDCN|Transplant|0|||
147200249|NCT02113982|530904924|FG011|Stage 4: First-line and R/R BPDCN|Transplant|0|||
147200250|NCT02113982|530904925|FG012|Stage 4: First-line and R/R BPDCN|Transplant|5|||
147200251|NCT02113982|530904926|FG013|Stage 4: First-line and R/R BPDCN|Transplant|0|||
147200252|NCT02113982|530904913|FG000|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
147200253|NCT02113982|530904914|FG001|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
147200254|NCT02113982|530904915|FG002|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
147200255|NCT02113982|530904916|FG003|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
147200256|NCT02113982|530904917|FG004|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
147200257|NCT02113982|530904918|FG005|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
147200258|NCT02113982|530904919|FG006|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
147200259|NCT02113982|530904920|FG007|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
147200260|NCT02113982|530904921|FG008|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
147306793|NCT01975220|531290764|FG001|Test Period 1|Not treated|1|||
147200261|NCT02113982|530904922|FG009|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
147200262|NCT02113982|530904923|FG010|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
147200263|NCT02113982|530904924|FG011|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
147200264|NCT02113982|530904925|FG012|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|2|||
147200265|NCT02113982|530904926|FG013|Stage 4: First-line and R/R BPDCN|Radiation Consolidation|0|||
147200266|NCT02113982|530904913|FG000|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
147200267|NCT02113982|530904914|FG001|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
147200268|NCT02113982|530904915|FG002|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
147200269|NCT02113982|530904916|FG003|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
147200270|NCT02113982|530904917|FG004|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
147200271|NCT02113982|530904918|FG005|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
147200272|NCT02113982|530904919|FG006|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
147200273|NCT02113982|530904920|FG007|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
147200274|NCT02113982|530904921|FG008|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
147200275|NCT02113982|530904922|FG009|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
147200276|NCT02113982|530904923|FG010|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
147200277|NCT02113982|530904924|FG011|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
147200278|NCT02113982|530904925|FG012|Stage 4: First-line and R/R BPDCN|Patient Preference|1|||
147200279|NCT02113982|530904926|FG013|Stage 4: First-line and R/R BPDCN|Patient Preference|0|||
147200280|NCT03763877|530904928|FG000|Overall Study|Withdrawal by Subject|3|||
147200281|NCT03763877|530904929|FG001|Overall Study|Withdrawal by Subject|1|||
147200282|NCT03763877|530904930|FG002|Overall Study|Withdrawal by Subject|3|||
147200283|NCT03763877|530904931|FG003|Overall Study|Withdrawal by Subject|4|||
147200284|NCT03763877|530904928|FG000|Overall Study|Adverse Event|1|||
147200285|NCT03763877|530904929|FG001|Overall Study|Adverse Event|1|||
147200286|NCT03763877|530904930|FG002|Overall Study|Adverse Event|3|||
147200287|NCT03763877|530904931|FG003|Overall Study|Adverse Event|1|||
147200288|NCT03763877|530904928|FG000|Overall Study|Protocol Violation|1|||
147200289|NCT03763877|530904929|FG001|Overall Study|Protocol Violation|1|||
147200290|NCT03763877|530904930|FG002|Overall Study|Protocol Violation|0|||
147200291|NCT03763877|530904931|FG003|Overall Study|Protocol Violation|0|||
147200292|NCT03763877|530904928|FG000|Overall Study|Lost to Follow-up|0|||
147200293|NCT03763877|530904929|FG001|Overall Study|Lost to Follow-up|1|||
147200294|NCT03763877|530904930|FG002|Overall Study|Lost to Follow-up|1|||
147200295|NCT03763877|530904931|FG003|Overall Study|Lost to Follow-up|0|||
147200296|NCT03040336|530904932|FG000|Overall Study|Death|1|||
147200297|NCT03040336|530904933|FG001|Overall Study|Death|0|||
147200298|NCT03040336|530904932|FG000|Overall Study|Withdrawal by Subject|2|||
147200299|NCT03040336|530904933|FG001|Overall Study|Withdrawal by Subject|3|||
147200300|NCT01774721|530904936|FG000|Overall Study|Death|133|||
147200301|NCT01774721|530904937|FG001|Overall Study|Death|152|||
147200302|NCT01774721|530904936|FG000|Overall Study|Withdrawal by Subject|20|||
147200303|NCT01774721|530904937|FG001|Overall Study|Withdrawal by Subject|14|||
147200304|NCT01774721|530904936|FG000|Overall Study|Lost to Follow-up|6|||
147200305|NCT01774721|530904937|FG001|Overall Study|Lost to Follow-up|7|||
147200306|NCT01774721|530904936|FG000|Overall Study|Did not meet eligibility criteria|0|||
147200307|NCT01774721|530904937|FG001|Overall Study|Did not meet eligibility criteria|3|||
147200308|NCT01774721|530904936|FG000|Overall Study|Other reasons and patients who completed the 48-month follow-up period|58|||
147200309|NCT01774721|530904937|FG001|Overall Study|Other reasons and patients who completed the 48-month follow-up period|49|||
147200310|NCT01774721|530904936|FG000|Overall Study|Study terminated by sponsor|5|||
147200311|NCT01774721|530904937|FG001|Overall Study|Study terminated by sponsor|0|||
147200312|NCT01774721|530904936|FG000|Overall Study|Disease progression|5|||
147200313|NCT01774721|530904937|FG001|Overall Study|Disease progression|0|||
147200314|NCT02453321|530904938|FG000|Overall Study|Weakness|1|||
147200315|NCT02453321|530904939|FG001|Overall Study|Weakness|1|||
147200316|NCT02453321|530904940|FG002|Overall Study|Weakness|2|||
147200317|NCT02453321|530904938|FG000|Overall Study|Deep Venous Thrombosis|0|||
147200318|NCT02453321|530904939|FG001|Overall Study|Deep Venous Thrombosis|1|||
147200319|NCT02453321|530904940|FG002|Overall Study|Deep Venous Thrombosis|0|||
147200320|NCT02054104|530904942|FG000|Overall Study|Did not want to continue due to college classes|1|||
147200321|NCT02054104|530904943|FG001|Overall Study|Did not want to continue due to college classes|0|||
147200322|NCT02054104|530904942|FG000|Overall Study|Biopsy positive for malignancy, appears to be new primary|1|||
147200323|NCT02054104|530904943|FG001|Overall Study|Biopsy positive for malignancy, appears to be new primary|0|||
147200324|NCT02054104|530904942|FG000|Overall Study|No evidence of immunologic response|2|||
147200325|NCT02054104|530904943|FG001|Overall Study|No evidence of immunologic response|2|||
147200326|NCT02054104|530904942|FG000|Overall Study|Disease Progression On Study|4|||
147200327|NCT02054104|530904943|FG001|Overall Study|Disease Progression On Study|5|||
147200328|NCT02054104|530904942|FG000|Overall Study|Diagnosis of lymphoma|0|||
147200329|NCT02054104|530904943|FG001|Overall Study|Diagnosis of lymphoma|1|||
147200330|NCT02054104|530904942|FG000|Overall Study|Inconclusive response|0|||
147200331|NCT02054104|530904943|FG001|Overall Study|Inconclusive response|1|||
147200332|NCT00763035|530904947|FG000|First Intervention|Did not meeting inclusion/exclusion|1|||
147200333|NCT00763035|530904948|FG001|First Intervention|Did not meeting inclusion/exclusion|0|||
147200334|NCT00763035|530904947|FG000|First Intervention|Adverse Event|0|||
147200335|NCT00763035|530904948|FG001|First Intervention|Adverse Event|1|||
147200336|NCT00763035|530904947|FG000|Second Intervention|Adverse Event|1|||
147200337|NCT00763035|530904948|FG001|Second Intervention|Adverse Event|0|||
147200338|NCT00763035|530904947|FG000|Second Intervention|Physician Decision|2|||
147200339|NCT00763035|530904948|FG001|Second Intervention|Physician Decision|0|||
147200340|NCT01658436|530904959|FG000|Overall Study|Adverse Event|6|||
147200341|NCT01658436|530904960|FG001|Overall Study|Adverse Event|5|||
147200342|NCT01658436|530904959|FG000|Overall Study|Physician Decision|1|||
147200343|NCT01658436|530904960|FG001|Overall Study|Physician Decision|0|||
147200344|NCT01658436|530904959|FG000|Overall Study|Progressive disease|12|||
147200345|NCT01658436|530904960|FG001|Overall Study|Progressive disease|4|||
147306794|NCT01975220|531290765|FG002|Test Period 1|Not treated|0|||
147535022|NCT02060188|532114814|FG005|Overall Study|Participant withdrew consent|0|||
147200346|NCT01658436|530904959|FG000|Overall Study|Study terminated by sponsor|0|||
147200347|NCT01658436|530904960|FG001|Overall Study|Study terminated by sponsor|1|||
147200348|NCT01658436|530904959|FG000|Overall Study|Subject/guardian decision|0|||
147200349|NCT01658436|530904960|FG001|Overall Study|Subject/guardian decision|1|||
147200350|NCT01658436|530904959|FG000|Overall Study|Death|1|||
147200351|NCT01658436|530904960|FG001|Overall Study|Death|0|||
147200352|NCT00686712|530904961|FG000|Overall Study|Protocol Violation|8|||
147200353|NCT00686712|530904962|FG001|Overall Study|Protocol Violation|8|||
147200354|NCT00686712|530904963|FG002|Overall Study|Protocol Violation|10|||
147200355|NCT00686712|530904961|FG000|Overall Study|Lost to Follow-up|1|||
147200356|NCT00686712|530904962|FG001|Overall Study|Lost to Follow-up|2|||
147200357|NCT00686712|530904963|FG002|Overall Study|Lost to Follow-up|3|||
147200358|NCT00686712|530904961|FG000|Overall Study|Adverse Event|1|||
147200359|NCT00686712|530904962|FG001|Overall Study|Adverse Event|1|||
147200360|NCT00686712|530904963|FG002|Overall Study|Adverse Event|0|||
147200361|NCT01318915|530904966|FG000|Overall Study|Lost to Follow-up|1|||
147200362|NCT00926237|530904967|FG000|Overall Study|Withdrawal by Subject|2|||
147200363|NCT00926237|530904968|FG001|Overall Study|Withdrawal by Subject|1|||
147200364|NCT04119414|530904969|FG000|Overall Study|300 couples did not have a male child, and 4 clinics were only observed|300|||
147200365|NCT04322526|530904971|FG000|First Intervention (1 Day)|Withdrawal by Subject|1|||
147200366|NCT04322526|530904972|FG001|First Intervention (1 Day)|Withdrawal by Subject|1|||
147200367|NCT04322526|530904971|FG000|Washout (1 Week)|Lost to Follow-up|1|||
147200368|NCT04322526|530904972|FG001|Washout (1 Week)|Lost to Follow-up|2|||
147200369|NCT01716234|530904973|FG000|Overall Study|Protocol Violation|0|||
147200370|NCT01716234|530904974|FG001|Overall Study|Protocol Violation|0|||
147200371|NCT01716234|530904975|FG002|Overall Study|Protocol Violation|0|||
147200372|NCT01716234|530904976|FG003|Overall Study|Protocol Violation|1|||
147200373|NCT01716234|530904977|FG004|Overall Study|Protocol Violation|1|||
147200374|NCT01716234|530904978|FG005|Overall Study|Protocol Violation|1|||
147200375|NCT01716234|530904979|FG006|Overall Study|Protocol Violation|0|||
147200376|NCT01716234|530904973|FG000|Overall Study|Lack of Efficacy|0|||
147200377|NCT01716234|530904974|FG001|Overall Study|Lack of Efficacy|0|||
147200378|NCT01716234|530904975|FG002|Overall Study|Lack of Efficacy|0|||
147200379|NCT01716234|530904976|FG003|Overall Study|Lack of Efficacy|1|||
147200380|NCT01716234|530904977|FG004|Overall Study|Lack of Efficacy|0|||
147200381|NCT01716234|530904978|FG005|Overall Study|Lack of Efficacy|0|||
147200382|NCT01716234|530904979|FG006|Overall Study|Lack of Efficacy|0|||
147200383|NCT01716234|530904973|FG000|Overall Study|Did not meet protocol eligibility|0|||
147200384|NCT01716234|530904974|FG001|Overall Study|Did not meet protocol eligibility|0|||
147200385|NCT01716234|530904975|FG002|Overall Study|Did not meet protocol eligibility|1|||
147200386|NCT01716234|530904976|FG003|Overall Study|Did not meet protocol eligibility|0|||
147200387|NCT01716234|530904977|FG004|Overall Study|Did not meet protocol eligibility|0|||
147200388|NCT01716234|530904978|FG005|Overall Study|Did not meet protocol eligibility|4|||
147200389|NCT01716234|530904979|FG006|Overall Study|Did not meet protocol eligibility|0|||
147200390|NCT01716234|530904973|FG000|Overall Study|Adverse Event|7|||
147200391|NCT01716234|530904974|FG001|Overall Study|Adverse Event|10|||
147200392|NCT01716234|530904975|FG002|Overall Study|Adverse Event|2|||
147200393|NCT01716234|530904976|FG003|Overall Study|Adverse Event|8|||
147200394|NCT01716234|530904977|FG004|Overall Study|Adverse Event|3|||
147200395|NCT01716234|530904978|FG005|Overall Study|Adverse Event|6|||
147200396|NCT01716234|530904979|FG006|Overall Study|Adverse Event|0|||
147200397|NCT01716234|530904973|FG000|Overall Study|Withdrawal by Subject|3|||
147200398|NCT01716234|530904974|FG001|Overall Study|Withdrawal by Subject|0|||
147200399|NCT01716234|530904975|FG002|Overall Study|Withdrawal by Subject|2|||
147200400|NCT01716234|530904976|FG003|Overall Study|Withdrawal by Subject|2|||
147200401|NCT01716234|530904977|FG004|Overall Study|Withdrawal by Subject|1|||
147200402|NCT01716234|530904978|FG005|Overall Study|Withdrawal by Subject|3|||
147200403|NCT01716234|530904979|FG006|Overall Study|Withdrawal by Subject|0|||
147200404|NCT01523756|530904980|FG000|Baseline Period|Adverse Event|0|||
147200405|NCT01523756|530904981|FG001|Baseline Period|Adverse Event|1|||
147200406|NCT01523756|530904980|FG000|Test Period 1|Adverse Event|1|||
147200407|NCT01523756|530904981|FG001|Test Period 1|Adverse Event|0|||
147200408|NCT01523756|530904980|FG000|Test Period 2|Withdrawal by Subject|0|||
147200409|NCT01523756|530904981|FG001|Test Period 2|Withdrawal by Subject|1|||
147200410|NCT00474812|530904987|FG000|Overall Study|Withdrawal by Subject|5|||
147200411|NCT00474812|530904987|FG000|Overall Study|No Initiation of treatment|2|||
147200412|NCT02059278|530904988|FG000|Overall Study|Adverse Event|1|||
147200413|NCT02059278|530904989|FG001|Overall Study|Adverse Event|1|||
147200414|NCT02059278|530904988|FG000|Overall Study|Lost to Follow-up|1|||
147200415|NCT02059278|530904989|FG001|Overall Study|Lost to Follow-up|0|||
147200416|NCT02059278|530904988|FG000|Overall Study|Withdrawal by Subject|0|||
147200417|NCT02059278|530904989|FG001|Overall Study|Withdrawal by Subject|3|||
147200418|NCT02059278|530904988|FG000|Overall Study|Ran out of IP and decided to discontinue|1|||
147200419|NCT02059278|530904989|FG001|Overall Study|Ran out of IP and decided to discontinue|0|||
147200420|NCT05408429|530904992|FG000|Overall Study|Lost to Follow-up|1|||
147200421|NCT05408429|530904993|FG001|Overall Study|Lost to Follow-up|1|||
147200422|NCT05408429|530904994|FG002|Overall Study|Lost to Follow-up|0|||
147200423|NCT05408429|530904992|FG000|Overall Study|Withdrawal by Subject|5|||
147200424|NCT05408429|530904993|FG001|Overall Study|Withdrawal by Subject|0|||
147200425|NCT05408429|530904994|FG002|Overall Study|Withdrawal by Subject|1|||
147200426|NCT03435211|530904995|FG000|Overall Study|Unable to achieve minimum desaturation level|1|||
147200427|NCT02195518|530904996|FG000|Overall Study|Adverse Event|1|||
147200428|NCT02195518|530904996|FG000|Overall Study|Protocol Violation|4|||
147200429|NCT02195518|530904996|FG000|Overall Study|Pregnancy|2|||
147200430|NCT02195518|530904996|FG000|Overall Study|Withdrawal by Subject|1|||
147200431|NCT02195518|530904996|FG000|Overall Study|Lost to Follow-up|1|||
147200432|NCT03818256|530904997|FG000|Overall Study|Withdrawal by Subject|2|||
147200433|NCT03818256|530904998|FG001|Overall Study|Withdrawal by Subject|2|||
147200434|NCT03818256|530904997|FG000|Overall Study|Adverse Event|3|||
147200435|NCT03818256|530904998|FG001|Overall Study|Adverse Event|1|||
147200436|NCT03818256|530904997|FG000|Overall Study|Lost to Follow-up|0|||
147200437|NCT03818256|530904998|FG001|Overall Study|Lost to Follow-up|5|||
147200438|NCT03818256|530904997|FG000|Overall Study|Gaining weight without prohibited medication vyvanse|1|||
147200439|NCT03818256|530904998|FG001|Overall Study|Gaining weight without prohibited medication vyvanse|0|||
147200440|NCT03818256|530904997|FG000|Overall Study|Not reporting for scheduled visits|1|||
147200441|NCT03818256|530904998|FG001|Overall Study|Not reporting for scheduled visits|0|||
147200442|NCT03818256|530904997|FG000|Overall Study|Non-compliant with investigational product|1|||
147200443|NCT03818256|530904998|FG001|Overall Study|Non-compliant with investigational product|0|||
147200444|NCT01342211|530904999|FG000|Overall Study|Lost to Follow-up|0|||
147200445|NCT01342211|530905000|FG001|Overall Study|Lost to Follow-up|0|||
147200446|NCT01342211|530905001|FG002|Overall Study|Lost to Follow-up|0|||
147200447|NCT01342211|530905002|FG003|Overall Study|Lost to Follow-up|1|||
147200448|NCT01342211|530905003|FG004|Overall Study|Lost to Follow-up|0|||
147200449|NCT01342211|530904999|FG000|Overall Study|Adverse Event|0|||
147200450|NCT01342211|530905000|FG001|Overall Study|Adverse Event|0|||
147200451|NCT01342211|530905001|FG002|Overall Study|Adverse Event|0|||
147200452|NCT01342211|530905002|FG003|Overall Study|Adverse Event|0|||
147200453|NCT01342211|530905003|FG004|Overall Study|Adverse Event|1|||
147200454|NCT01342211|530904999|FG000|Overall Study|Withdrawal by Subject|0|||
147200455|NCT01342211|530905000|FG001|Overall Study|Withdrawal by Subject|0|||
147200456|NCT01342211|530905001|FG002|Overall Study|Withdrawal by Subject|0|||
147200457|NCT01342211|530905002|FG003|Overall Study|Withdrawal by Subject|1|||
147200458|NCT01342211|530905003|FG004|Overall Study|Withdrawal by Subject|0|||
147200459|NCT01342211|530904999|FG000|Overall Study|Randomized, but not Treated|0|||
147200460|NCT01342211|530905000|FG001|Overall Study|Randomized, but not Treated|2|||
147200461|NCT01342211|530905001|FG002|Overall Study|Randomized, but not Treated|0|||
147200462|NCT01342211|530905002|FG003|Overall Study|Randomized, but not Treated|0|||
147200463|NCT01342211|530905003|FG004|Overall Study|Randomized, but not Treated|1|||
147200464|NCT01588522|530905008|FG000|Overall Study|Withdrawal by Subject|1|||
147200465|NCT01588522|530905009|FG001|Overall Study|Withdrawal by Subject|5|||
147200466|NCT01588522|530905010|FG002|Overall Study|Withdrawal by Subject|3|||
147200467|NCT01588522|530905011|FG003|Overall Study|Withdrawal by Subject|1|||
147200468|NCT01588522|530905012|FG004|Overall Study|Withdrawal by Subject|2|||
147200469|NCT01588522|530905013|FG005|Overall Study|Withdrawal by Subject|0|||
147200470|NCT01588522|530905008|FG000|Overall Study|Lack of Efficacy|0|||
147200471|NCT01588522|530905009|FG001|Overall Study|Lack of Efficacy|0|||
147200472|NCT01588522|530905010|FG002|Overall Study|Lack of Efficacy|0|||
147200473|NCT01588522|530905011|FG003|Overall Study|Lack of Efficacy|0|||
147200474|NCT01588522|530905012|FG004|Overall Study|Lack of Efficacy|1|||
147200475|NCT01588522|530905013|FG005|Overall Study|Lack of Efficacy|0|||
147200476|NCT01588522|530905008|FG000|Overall Study|Adverse Event|0|||
147200477|NCT01588522|530905009|FG001|Overall Study|Adverse Event|0|||
147200478|NCT01588522|530905010|FG002|Overall Study|Adverse Event|0|||
147200479|NCT01588522|530905011|FG003|Overall Study|Adverse Event|1|||
147200480|NCT01588522|530905012|FG004|Overall Study|Adverse Event|0|||
147200481|NCT01588522|530905013|FG005|Overall Study|Adverse Event|0|||
147200482|NCT01588522|530905008|FG000|Overall Study|Grade 2 alopecia|1|||
147200483|NCT01588522|530905009|FG001|Overall Study|Grade 2 alopecia|0|||
147200484|NCT01588522|530905010|FG002|Overall Study|Grade 2 alopecia|0|||
147200485|NCT01588522|530905011|FG003|Overall Study|Grade 2 alopecia|0|||
147200486|NCT01588522|530905012|FG004|Overall Study|Grade 2 alopecia|0|||
147200487|NCT01588522|530905013|FG005|Overall Study|Grade 2 alopecia|0|||
147200488|NCT01588522|530905008|FG000|Overall Study|Severe toxicity of chemotherapy|0|||
147200489|NCT01588522|530905009|FG001|Overall Study|Severe toxicity of chemotherapy|0|||
147200490|NCT01588522|530905010|FG002|Overall Study|Severe toxicity of chemotherapy|1|||
147200491|NCT01588522|530905011|FG003|Overall Study|Severe toxicity of chemotherapy|0|||
147200492|NCT01588522|530905012|FG004|Overall Study|Severe toxicity of chemotherapy|0|||
147200493|NCT01588522|530905013|FG005|Overall Study|Severe toxicity of chemotherapy|0|||
147200494|NCT01588522|530905008|FG000|Overall Study|Taken off taxane-based regimen|0|||
147200495|NCT01588522|530905009|FG001|Overall Study|Taken off taxane-based regimen|0|||
147200496|NCT01588522|530905010|FG002|Overall Study|Taken off taxane-based regimen|0|||
147200497|NCT01588522|530905011|FG003|Overall Study|Taken off taxane-based regimen|1|||
147200498|NCT01588522|530905012|FG004|Overall Study|Taken off taxane-based regimen|0|||
147200499|NCT01588522|530905013|FG005|Overall Study|Taken off taxane-based regimen|0|||
147200500|NCT01588522|530905008|FG000|Overall Study|Did not initiate chemotherapy|0|||
147200501|NCT01588522|530905009|FG001|Overall Study|Did not initiate chemotherapy|0|||
147200502|NCT01588522|530905010|FG002|Overall Study|Did not initiate chemotherapy|0|||
147535023|NCT02060188|532114815|FG006|Overall Study|Participant withdrew consent|0|||
147535024|NCT02060188|532114816|FG007|Overall Study|Participant withdrew consent|0|||
147535025|NCT02060188|532114817|FG008|Overall Study|Participant withdrew consent|0|||
147535026|NCT02060188|532114809|FG000|Overall Study|Maximum clinical benefit|13|||
147200503|NCT01588522|530905011|FG003|Overall Study|Did not initiate chemotherapy|0|||
147200504|NCT01588522|530905012|FG004|Overall Study|Did not initiate chemotherapy|1|||
147200505|NCT01588522|530905013|FG005|Overall Study|Did not initiate chemotherapy|0|||
147200506|NCT03043794|530905014|FG000|Overall Study|Lost to Follow-up|1|||
147200507|NCT02749422|530905017|FG000|Overall Study|Lost to Follow-up|0|||
147200508|NCT02749422|530905018|FG001|Overall Study|Lost to Follow-up|2|||
147200509|NCT02749422|530905017|FG000|Overall Study|Ineligible|0|||
147200510|NCT02749422|530905018|FG001|Overall Study|Ineligible|1|||
147200511|NCT02855125|530905019|FG000|Overall Study|Withdrawal by Subject|2|||
147200512|NCT02855125|530905020|FG001|Overall Study|Withdrawal by Subject|2|||
147200513|NCT02855125|530905019|FG000|Overall Study|Clinical Disease Progression|5|||
147200514|NCT02855125|530905020|FG001|Overall Study|Clinical Disease Progression|4|||
147200515|NCT02855125|530905019|FG000|Overall Study|Radiologic Disease Progression|36|||
147200516|NCT02855125|530905020|FG001|Overall Study|Radiologic Disease Progression|39|||
147200517|NCT02855125|530905019|FG000|Overall Study|Adverse Event|11|||
147200518|NCT02855125|530905020|FG001|Overall Study|Adverse Event|7|||
147200519|NCT02855125|530905019|FG000|Overall Study|Physician Decision|1|||
147200520|NCT02855125|530905020|FG001|Overall Study|Physician Decision|0|||
147200521|NCT02855125|530905019|FG000|Overall Study|On Treatment|9|||
147200522|NCT02855125|530905020|FG001|Overall Study|On Treatment|11|||
147200523|NCT02855125|530905019|FG000|Overall Study|Randomized but not treated|0|||
147200524|NCT02855125|530905020|FG001|Overall Study|Randomized but not treated|1|||
147200525|NCT04586205|530905030|FG000|Baseline With MRI Scan, and SST and IAPS|Withdrawal by Subject|1|||
147200526|NCT04586205|530905031|FG001|Baseline With MRI Scan, and SST and IAPS|Withdrawal by Subject|2|||
147200527|NCT01646125|530906574|FG000|Overall Study|Untreated|2|||
147200528|NCT01646125|530906575|FG001|Overall Study|Untreated|5|||
147200529|NCT01646125|530906574|FG000|Overall Study|Adverse Event|2|||
147200530|NCT01646125|530906575|FG001|Overall Study|Adverse Event|1|||
147200531|NCT01646125|530906574|FG000|Overall Study|Death|1|||
147200532|NCT01646125|530906575|FG001|Overall Study|Death|1|||
147200533|NCT01646125|530906574|FG000|Overall Study|Physician Decision|1|||
147200534|NCT01646125|530906575|FG001|Overall Study|Physician Decision|3|||
147200535|NCT01646125|530906574|FG000|Overall Study|Progressive disease|22|||
147200536|NCT01646125|530906575|FG001|Overall Study|Progressive disease|16|||
147200537|NCT01646125|530906574|FG000|Overall Study|Study terminated by sponsor|2|||
147200538|NCT01646125|530906575|FG001|Overall Study|Study terminated by sponsor|1|||
147200539|NCT01646125|530906574|FG000|Overall Study|Subject/Guardian decision|1|||
147200540|NCT01646125|530906575|FG001|Overall Study|Subject/Guardian decision|1|||
147200541|NCT01942837|530906584|FG000|Overall Study|Death|1|||
147200542|NCT01942837|530906584|FG000|Overall Study|Symptomatic or radiographic progression|49|||
147200543|NCT01942837|530906584|FG000|Overall Study|Adverse Event|6|||
147200544|NCT01942837|530906584|FG000|Overall Study|Physician Decision|3|||
147200545|NCT01942837|530906584|FG000|Overall Study|Withdrawal by Subject|2|||
147200546|NCT01942837|530906584|FG000|Overall Study|Intercurrent Illness|1|||
147200547|NCT01942837|530906584|FG000|Overall Study|On treatment|3|||
147200548|NCT01942837|530906584|FG000|Overall Study|Never initiate the treatment|2|||
147200549|NCT01298648|530906585|FG000|Overall Study|Withdrawal by Subject|2|||
147200550|NCT01298648|530906585|FG000|Overall Study|Lost to Follow-up|21|||
147200551|NCT03077412|530906589|FG000|Overall Study|Non-Responder [Crohn's Disease Activity Index (CDAI) and Perianal CDAI non-response] at Week 10|1|||
147200552|NCT03077412|530906590|FG001|Overall Study|Non-Responder [Crohn's Disease Activity Index (CDAI) and Perianal CDAI non-response] at Week 10|5|||
147200553|NCT03077412|530906591|FG002|Overall Study|Non-Responder [Crohn's Disease Activity Index (CDAI) and Perianal CDAI non-response] at Week 10|3|||
147200554|NCT03077412|530906589|FG000|Overall Study|Protocol-Specified Disease Worsening|1|||
147200555|NCT03077412|530906590|FG001|Overall Study|Protocol-Specified Disease Worsening|3|||
147200556|NCT03077412|530906591|FG002|Overall Study|Protocol-Specified Disease Worsening|3|||
147200557|NCT03077412|530906589|FG000|Overall Study|Adverse Event|1|||
147200558|NCT03077412|530906590|FG001|Overall Study|Adverse Event|2|||
147200559|NCT03077412|530906591|FG002|Overall Study|Adverse Event|2|||
147200560|NCT03077412|530906589|FG000|Overall Study|Investigator's Discretion|0|||
147200561|NCT03077412|530906590|FG001|Overall Study|Investigator's Discretion|1|||
147200562|NCT03077412|530906591|FG002|Overall Study|Investigator's Discretion|1|||
147200563|NCT03077412|530906589|FG000|Overall Study|Withdrew Consent|0|||
147200564|NCT03077412|530906590|FG001|Overall Study|Withdrew Consent|2|||
147200565|NCT03077412|530906591|FG002|Overall Study|Withdrew Consent|0|||
147200566|NCT02266888|530906593|FG000|Overall Study|Death|2|||
147200567|NCT02266888|530906594|FG001|Overall Study|Death|2|||
147200568|NCT02266888|530906595|FG002|Overall Study|Death|4|||
147200569|NCT02266888|530906596|FG003|Overall Study|Death|2|||
147200570|NCT02266888|530906593|FG000|Overall Study|Physician Decision|0|||
147200571|NCT02266888|530906594|FG001|Overall Study|Physician Decision|1|||
147200572|NCT02266888|530906595|FG002|Overall Study|Physician Decision|2|||
147200573|NCT02266888|530906596|FG003|Overall Study|Physician Decision|2|||
147200574|NCT02266888|530906593|FG000|Overall Study|Study Terminated|5|||
147200575|NCT02266888|530906594|FG001|Overall Study|Study Terminated|1|||
147200576|NCT02266888|530906595|FG002|Overall Study|Study Terminated|0|||
147200577|NCT02266888|530906596|FG003|Overall Study|Study Terminated|0|||
147200578|NCT02266888|530906593|FG000|Overall Study|No Longer Eligible|0|||
147535027|NCT02060188|532114810|FG001|Overall Study|Maximum clinical benefit|38|||
147200579|NCT02266888|530906594|FG001|Overall Study|No Longer Eligible|0|||
147200580|NCT02266888|530906595|FG002|Overall Study|No Longer Eligible|0|||
147200581|NCT02266888|530906596|FG003|Overall Study|No Longer Eligible|2|||
147200582|NCT02266888|530906593|FG000|Overall Study|Randomization Closed|0|||
147200583|NCT02266888|530906594|FG001|Overall Study|Randomization Closed|0|||
147200584|NCT02266888|530906595|FG002|Overall Study|Randomization Closed|4|||
147200585|NCT02266888|530906596|FG003|Overall Study|Randomization Closed|0|||
147200586|NCT02266888|530906593|FG000|Overall Study|Personnel unavailable at transplant|0|||
147200587|NCT02266888|530906594|FG001|Overall Study|Personnel unavailable at transplant|0|||
147200588|NCT02266888|530906595|FG002|Overall Study|Personnel unavailable at transplant|0|||
147200589|NCT02266888|530906596|FG003|Overall Study|Personnel unavailable at transplant|1|||
147200590|NCT02266888|530906593|FG000|Overall Study|Transfer of care|0|||
147200591|NCT02266888|530906594|FG001|Overall Study|Transfer of care|0|||
147200592|NCT02266888|530906595|FG002|Overall Study|Transfer of care|1|||
147200593|NCT02266888|530906596|FG003|Overall Study|Transfer of care|0|||
147200594|NCT02351856|530906597|FG000|Overall Study|Adverse Event|2|||
147200595|NCT02351856|530906597|FG000|Overall Study|Physician Decision|5|||
147200596|NCT02351856|530906597|FG000|Overall Study|Study terminated by sponsor|1|||
147200597|NCT01458392|530906600|FG000|Overall Study|Death|2|||
147200598|NCT01458392|530906601|FG001|Overall Study|Death|11|||
147200599|NCT01458392|530906602|FG002|Overall Study|Death|22|||
147200600|NCT01458392|530906600|FG000|Overall Study|At the discretion of the sponsor|0|||
147200601|NCT01458392|530906601|FG001|Overall Study|At the discretion of the sponsor|2|||
147200602|NCT01458392|530906602|FG002|Overall Study|At the discretion of the sponsor|7|||
147200603|NCT01458392|530906600|FG000|Overall Study|Patient unwilling to comply with protoco|0|||
147200604|NCT01458392|530906601|FG001|Overall Study|Patient unwilling to comply with protoco|0|||
147200605|NCT01458392|530906602|FG002|Overall Study|Patient unwilling to comply with protoco|2|||
147200606|NCT01281124|530906605|FG000|Overall Study|Death|1|||
147200607|NCT00918255|530906606|FG000|Overall Study|Adverse Event|1|||
147200608|NCT00918255|530906607|FG001|Overall Study|Adverse Event|0|||
147200609|NCT00918255|530906608|FG002|Overall Study|Adverse Event|0|||
147200610|NCT00918255|530906606|FG000|Overall Study|Withdrawal by Subject|1|||
147200611|NCT00918255|530906607|FG001|Overall Study|Withdrawal by Subject|0|||
147200612|NCT00918255|530906608|FG002|Overall Study|Withdrawal by Subject|2|||
147200613|NCT00918255|530906606|FG000|Overall Study|Lack of Efficacy|1|||
147200614|NCT00918255|530906607|FG001|Overall Study|Lack of Efficacy|0|||
147200615|NCT00918255|530906608|FG002|Overall Study|Lack of Efficacy|0|||
147200616|NCT00918255|530906606|FG000|Overall Study|Lost to Follow-up|1|||
147200617|NCT00918255|530906607|FG001|Overall Study|Lost to Follow-up|0|||
147200618|NCT00918255|530906608|FG002|Overall Study|Lost to Follow-up|2|||
147200619|NCT00918255|530906606|FG000|Overall Study|Exceeded allowed number of interventions|0|||
147200620|NCT00918255|530906607|FG001|Overall Study|Exceeded allowed number of interventions|0|||
147200621|NCT00918255|530906608|FG002|Overall Study|Exceeded allowed number of interventions|1|||
147200622|NCT00918255|530906606|FG000|Overall Study|Non-compliance|1|||
147200623|NCT00918255|530906607|FG001|Overall Study|Non-compliance|0|||
147200624|NCT00918255|530906608|FG002|Overall Study|Non-compliance|0|||
147200625|NCT00918255|530906606|FG000|Overall Study|Investigator discretion|1|||
147200626|NCT00918255|530906607|FG001|Overall Study|Investigator discretion|0|||
147200627|NCT00918255|530906608|FG002|Overall Study|Investigator discretion|0|||
147200628|NCT02038933|530906609|FG000|Overall Study|Disease progression|104|||
147200629|NCT02038933|530906609|FG000|Overall Study|Study drug toxicity|6|||
147200630|NCT02038933|530906609|FG000|Overall Study|Adverse event unrelated to study drug|6|||
147200631|NCT02038933|530906609|FG000|Overall Study|Participant request to discontinue treatment|2|||
147200632|NCT02038933|530906609|FG000|Overall Study|Lost to Follow-up|1|||
147200633|NCT02038933|530906609|FG000|Overall Study|Other reasons|2|||
147200634|NCT00068692|530906622|FG000|Step 1: Registration|Disese progression/relapse|5|||
147200635|NCT00068692|530906623|FG001|Step 1: Registration|Disese progression/relapse|0|||
147200636|NCT00068692|530906624|FG002|Step 1: Registration|Disese progression/relapse|0|||
147200637|NCT00068692|530906625|FG003|Step 1: Registration|Disese progression/relapse|0|||
147200638|NCT00068692|530906626|FG004|Step 1: Registration|Disese progression/relapse|0|||
147200639|NCT00068692|530906627|FG005|Step 1: Registration|Disese progression/relapse|0|||
147200640|NCT00068692|530906628|FG006|Step 1: Registration|Disese progression/relapse|0|||
147200641|NCT00068692|530906629|FG007|Step 1: Registration|Disese progression/relapse|0|||
147200642|NCT00068692|530906622|FG000|Step 1: Registration|Adverse Event|7|||
147200643|NCT00068692|530906623|FG001|Step 1: Registration|Adverse Event|0|||
147200644|NCT00068692|530906624|FG002|Step 1: Registration|Adverse Event|0|||
147200645|NCT00068692|530906625|FG003|Step 1: Registration|Adverse Event|0|||
147200646|NCT00068692|530906626|FG004|Step 1: Registration|Adverse Event|0|||
147200647|NCT00068692|530906627|FG005|Step 1: Registration|Adverse Event|0|||
147200648|NCT00068692|530906628|FG006|Step 1: Registration|Adverse Event|0|||
147200649|NCT00068692|530906629|FG007|Step 1: Registration|Adverse Event|0|||
147200650|NCT00068692|530906622|FG000|Step 1: Registration|Death|1|||
147200651|NCT00068692|530906623|FG001|Step 1: Registration|Death|0|||
147200652|NCT00068692|530906624|FG002|Step 1: Registration|Death|0|||
147200653|NCT00068692|530906625|FG003|Step 1: Registration|Death|0|||
147200654|NCT00068692|530906626|FG004|Step 1: Registration|Death|0|||
147200655|NCT00068692|530906627|FG005|Step 1: Registration|Death|0|||
147200656|NCT00068692|530906628|FG006|Step 1: Registration|Death|0|||
147200657|NCT00068692|530906629|FG007|Step 1: Registration|Death|0|||
147200658|NCT00068692|530906622|FG000|Step 1: Registration|Withdrawal by Subject|11|||
147200659|NCT00068692|530906623|FG001|Step 1: Registration|Withdrawal by Subject|0|||
147200660|NCT00068692|530906624|FG002|Step 1: Registration|Withdrawal by Subject|0|||
147200661|NCT00068692|530906625|FG003|Step 1: Registration|Withdrawal by Subject|0|||
147200662|NCT00068692|530906626|FG004|Step 1: Registration|Withdrawal by Subject|0|||
147200663|NCT00068692|530906627|FG005|Step 1: Registration|Withdrawal by Subject|0|||
147200664|NCT00068692|530906628|FG006|Step 1: Registration|Withdrawal by Subject|0|||
147200665|NCT00068692|530906629|FG007|Step 1: Registration|Withdrawal by Subject|0|||
147200666|NCT00068692|530906622|FG000|Step 1: Registration|Alternative therapy|2|||
147200667|NCT00068692|530906623|FG001|Step 1: Registration|Alternative therapy|0|||
147200668|NCT00068692|530906624|FG002|Step 1: Registration|Alternative therapy|0|||
147200669|NCT00068692|530906625|FG003|Step 1: Registration|Alternative therapy|0|||
147200670|NCT00068692|530906626|FG004|Step 1: Registration|Alternative therapy|0|||
147200671|NCT00068692|530906627|FG005|Step 1: Registration|Alternative therapy|0|||
147200672|NCT00068692|530906628|FG006|Step 1: Registration|Alternative therapy|0|||
147200673|NCT00068692|530906629|FG007|Step 1: Registration|Alternative therapy|0|||
147200674|NCT00068692|530906622|FG000|Step 1: Registration|Complicating disease|2|||
147200675|NCT00068692|530906623|FG001|Step 1: Registration|Complicating disease|0|||
147200676|NCT00068692|530906624|FG002|Step 1: Registration|Complicating disease|0|||
147200677|NCT00068692|530906625|FG003|Step 1: Registration|Complicating disease|0|||
147200678|NCT00068692|530906626|FG004|Step 1: Registration|Complicating disease|0|||
147200679|NCT00068692|530906627|FG005|Step 1: Registration|Complicating disease|0|||
147200680|NCT00068692|530906628|FG006|Step 1: Registration|Complicating disease|0|||
147200681|NCT00068692|530906629|FG007|Step 1: Registration|Complicating disease|0|||
147200682|NCT00068692|530906622|FG000|Step 1: Registration|Protocol Violation|1|||
147200683|NCT00068692|530906623|FG001|Step 1: Registration|Protocol Violation|0|||
147200684|NCT00068692|530906624|FG002|Step 1: Registration|Protocol Violation|0|||
147200685|NCT00068692|530906625|FG003|Step 1: Registration|Protocol Violation|0|||
147200686|NCT00068692|530906626|FG004|Step 1: Registration|Protocol Violation|0|||
147200687|NCT00068692|530906627|FG005|Step 1: Registration|Protocol Violation|0|||
147200688|NCT00068692|530906628|FG006|Step 1: Registration|Protocol Violation|0|||
147200689|NCT00068692|530906629|FG007|Step 1: Registration|Protocol Violation|0|||
147200690|NCT00068692|530906622|FG000|Step 1: Registration|Not eligible|6|||
147200691|NCT00068692|530906623|FG001|Step 1: Registration|Not eligible|0|||
147200692|NCT00068692|530906624|FG002|Step 1: Registration|Not eligible|0|||
147200693|NCT00068692|530906625|FG003|Step 1: Registration|Not eligible|0|||
147200694|NCT00068692|530906626|FG004|Step 1: Registration|Not eligible|0|||
147200695|NCT00068692|530906627|FG005|Step 1: Registration|Not eligible|0|||
147200696|NCT00068692|530906628|FG006|Step 1: Registration|Not eligible|0|||
147200697|NCT00068692|530906629|FG007|Step 1: Registration|Not eligible|0|||
147200698|NCT00068692|530906622|FG000|Step 1: Registration|Other|2|||
147200699|NCT00068692|530906623|FG001|Step 1: Registration|Other|0|||
147200700|NCT00068692|530906624|FG002|Step 1: Registration|Other|0|||
147200701|NCT00068692|530906625|FG003|Step 1: Registration|Other|0|||
147200702|NCT00068692|530906626|FG004|Step 1: Registration|Other|0|||
147200703|NCT00068692|530906627|FG005|Step 1: Registration|Other|0|||
147200704|NCT00068692|530906628|FG006|Step 1: Registration|Other|0|||
147200705|NCT00068692|530906629|FG007|Step 1: Registration|Other|0|||
147200706|NCT00068692|530906622|FG000|Step 1: Registration|Not start protocol therapy|3|||
147200707|NCT00068692|530906623|FG001|Step 1: Registration|Not start protocol therapy|0|||
147200708|NCT00068692|530906624|FG002|Step 1: Registration|Not start protocol therapy|0|||
147200709|NCT00068692|530906625|FG003|Step 1: Registration|Not start protocol therapy|0|||
147200710|NCT00068692|530906626|FG004|Step 1: Registration|Not start protocol therapy|0|||
147306795|NCT01975220|531290766|FG003|Test Period 1|Not treated|0|||
147200711|NCT00068692|530906627|FG005|Step 1: Registration|Not start protocol therapy|0|||
147200712|NCT00068692|530906628|FG006|Step 1: Registration|Not start protocol therapy|0|||
147200713|NCT00068692|530906629|FG007|Step 1: Registration|Not start protocol therapy|0|||
147200714|NCT00068692|530906622|FG000|Step 1: Registration|Registered but not randomized|0|||
147200715|NCT00068692|530906623|FG001|Step 1: Registration|Registered but not randomized|1|||
147200716|NCT00068692|530906624|FG002|Step 1: Registration|Registered but not randomized|0|||
147200717|NCT00068692|530906625|FG003|Step 1: Registration|Registered but not randomized|0|||
147200718|NCT00068692|530906626|FG004|Step 1: Registration|Registered but not randomized|0|||
147200719|NCT00068692|530906627|FG005|Step 1: Registration|Registered but not randomized|0|||
147200720|NCT00068692|530906628|FG006|Step 1: Registration|Registered but not randomized|0|||
147200721|NCT00068692|530906629|FG007|Step 1: Registration|Registered but not randomized|0|||
147200722|NCT00068692|530906622|FG000|Step 2: Randomization|Disesae progression/replase|0|||
147200723|NCT00068692|530906623|FG001|Step 2: Randomization|Disesae progression/replase|0|||
147200724|NCT00068692|530906624|FG002|Step 2: Randomization|Disesae progression/replase|1|||
147200725|NCT00068692|530906625|FG003|Step 2: Randomization|Disesae progression/replase|1|||
147200726|NCT00068692|530906626|FG004|Step 2: Randomization|Disesae progression/replase|0|||
147200727|NCT00068692|530906627|FG005|Step 2: Randomization|Disesae progression/replase|0|||
147200728|NCT00068692|530906628|FG006|Step 2: Randomization|Disesae progression/replase|0|||
147200729|NCT00068692|530906629|FG007|Step 2: Randomization|Disesae progression/replase|0|||
147200730|NCT00068692|530906622|FG000|Step 2: Randomization|Adverse Event|0|||
147200731|NCT00068692|530906623|FG001|Step 2: Randomization|Adverse Event|0|||
147200732|NCT00068692|530906624|FG002|Step 2: Randomization|Adverse Event|4|||
147200733|NCT00068692|530906625|FG003|Step 2: Randomization|Adverse Event|2|||
147200734|NCT00068692|530906626|FG004|Step 2: Randomization|Adverse Event|2|||
147200735|NCT00068692|530906627|FG005|Step 2: Randomization|Adverse Event|3|||
147200736|NCT00068692|530906628|FG006|Step 2: Randomization|Adverse Event|4|||
147200737|NCT00068692|530906629|FG007|Step 2: Randomization|Adverse Event|4|||
147200738|NCT00068692|530906622|FG000|Step 2: Randomization|Death|0|||
147200739|NCT00068692|530906623|FG001|Step 2: Randomization|Death|0|||
147200740|NCT00068692|530906624|FG002|Step 2: Randomization|Death|0|||
147200741|NCT00068692|530906625|FG003|Step 2: Randomization|Death|0|||
147200742|NCT00068692|530906626|FG004|Step 2: Randomization|Death|1|||
147200743|NCT00068692|530906627|FG005|Step 2: Randomization|Death|0|||
147200744|NCT00068692|530906628|FG006|Step 2: Randomization|Death|0|||
147200745|NCT00068692|530906629|FG007|Step 2: Randomization|Death|1|||
147200746|NCT00068692|530906622|FG000|Step 2: Randomization|Withdrawal by Subject|0|||
147200747|NCT00068692|530906623|FG001|Step 2: Randomization|Withdrawal by Subject|0|||
147200748|NCT00068692|530906624|FG002|Step 2: Randomization|Withdrawal by Subject|4|||
147200749|NCT00068692|530906625|FG003|Step 2: Randomization|Withdrawal by Subject|6|||
147200750|NCT00068692|530906626|FG004|Step 2: Randomization|Withdrawal by Subject|3|||
147200751|NCT00068692|530906627|FG005|Step 2: Randomization|Withdrawal by Subject|2|||
147200752|NCT00068692|530906628|FG006|Step 2: Randomization|Withdrawal by Subject|0|||
147200753|NCT00068692|530906629|FG007|Step 2: Randomization|Withdrawal by Subject|3|||
147200754|NCT00068692|530906622|FG000|Step 2: Randomization|alternative therapy|0|||
147200755|NCT00068692|530906623|FG001|Step 2: Randomization|alternative therapy|0|||
147200756|NCT00068692|530906624|FG002|Step 2: Randomization|alternative therapy|0|||
147200757|NCT00068692|530906625|FG003|Step 2: Randomization|alternative therapy|1|||
147200758|NCT00068692|530906626|FG004|Step 2: Randomization|alternative therapy|1|||
147200759|NCT00068692|530906627|FG005|Step 2: Randomization|alternative therapy|0|||
147200760|NCT00068692|530906628|FG006|Step 2: Randomization|alternative therapy|0|||
147200761|NCT00068692|530906629|FG007|Step 2: Randomization|alternative therapy|0|||
147200762|NCT00068692|530906622|FG000|Step 2: Randomization|Physician Decision|0|||
147200763|NCT00068692|530906623|FG001|Step 2: Randomization|Physician Decision|0|||
147200764|NCT00068692|530906624|FG002|Step 2: Randomization|Physician Decision|0|||
147200765|NCT00068692|530906625|FG003|Step 2: Randomization|Physician Decision|1|||
147200766|NCT00068692|530906626|FG004|Step 2: Randomization|Physician Decision|1|||
147200767|NCT00068692|530906627|FG005|Step 2: Randomization|Physician Decision|0|||
147200768|NCT00068692|530906628|FG006|Step 2: Randomization|Physician Decision|0|||
147200769|NCT00068692|530906629|FG007|Step 2: Randomization|Physician Decision|0|||
147200770|NCT00068692|530906622|FG000|Step 2: Randomization|Other|0|||
147200771|NCT00068692|530906623|FG001|Step 2: Randomization|Other|0|||
147200772|NCT00068692|530906624|FG002|Step 2: Randomization|Other|0|||
147200773|NCT00068692|530906625|FG003|Step 2: Randomization|Other|1|||
147200774|NCT00068692|530906626|FG004|Step 2: Randomization|Other|0|||
147200775|NCT00068692|530906627|FG005|Step 2: Randomization|Other|1|||
147200776|NCT00068692|530906628|FG006|Step 2: Randomization|Other|0|||
147200777|NCT00068692|530906629|FG007|Step 2: Randomization|Other|0|||
147200778|NCT00068692|530906622|FG000|Step 2: Randomization|never start protocol therapy|0|||
147200779|NCT00068692|530906623|FG001|Step 2: Randomization|never start protocol therapy|0|||
147200780|NCT00068692|530906624|FG002|Step 2: Randomization|never start protocol therapy|1|||
147200781|NCT00068692|530906625|FG003|Step 2: Randomization|never start protocol therapy|0|||
147306796|NCT01975220|531290767|FG004|Test Period 1|Not treated|0|||
147200782|NCT00068692|530906626|FG004|Step 2: Randomization|never start protocol therapy|1|||
147200783|NCT00068692|530906627|FG005|Step 2: Randomization|never start protocol therapy|0|||
147200784|NCT00068692|530906628|FG006|Step 2: Randomization|never start protocol therapy|0|||
147200785|NCT00068692|530906629|FG007|Step 2: Randomization|never start protocol therapy|0|||
147200786|NCT01600716|530906631|FG000|Overall Study|Other Reasons|3|||
147200787|NCT01600716|530906632|FG001|Overall Study|Other Reasons|1|||
147200788|NCT01600716|530906631|FG000|Overall Study|Personal Reasons|0|||
147200789|NCT01600716|530906632|FG001|Overall Study|Personal Reasons|2|||
147200790|NCT01600716|530906631|FG000|Overall Study|Lost to Follow-up|0|||
147200791|NCT01600716|530906632|FG001|Overall Study|Lost to Follow-up|2|||
147200792|NCT01600716|530906631|FG000|Overall Study|Pregnancy|1|||
147200793|NCT01600716|530906632|FG001|Overall Study|Pregnancy|0|||
147200794|NCT01600716|530906631|FG000|Overall Study|Lack of Efficacy|2|||
147200795|NCT01600716|530906632|FG001|Overall Study|Lack of Efficacy|1|||
147200796|NCT01600716|530906631|FG000|Overall Study|Adverse Event|1|||
147200797|NCT01600716|530906632|FG001|Overall Study|Adverse Event|1|||
147200798|NCT00248040|530906633|FG000|Overall Study|transplantectomy|2|||
147200799|NCT00248040|530906634|FG001|Overall Study|transplantectomy|1|||
147200800|NCT00248040|530906635|FG002|Overall Study|transplantectomy|3|||
147200801|NCT00248040|530906633|FG000|Overall Study|transplant cancelled post treat start|1|||
147200802|NCT00248040|530906634|FG001|Overall Study|transplant cancelled post treat start|0|||
147200803|NCT00248040|530906635|FG002|Overall Study|transplant cancelled post treat start|0|||
147200804|NCT00248040|530906633|FG000|Overall Study|Death|0|||
147200805|NCT00248040|530906634|FG001|Overall Study|Death|0|||
147200806|NCT00248040|530906635|FG002|Overall Study|Death|1|||
147200807|NCT03557034|530906640|FG000|Overall Study|Withdrawal by Subject|1|||
147200808|NCT03557034|530906641|FG001|Overall Study|Withdrawal by Subject|0|||
147200809|NCT01759446|530906644|FG000|Overall Study|Protocol Violation|1|||
147200810|NCT01759446|530906645|FG001|Overall Study|Protocol Violation|0|||
147200811|NCT01759446|530906646|FG002|Overall Study|Protocol Violation|1|||
147200812|NCT01759446|530906647|FG003|Overall Study|Protocol Violation|0|||
147200813|NCT01759446|530906648|FG004|Overall Study|Protocol Violation|0|||
147200814|NCT01759446|530906644|FG000|Overall Study|Withdrawal by Subject|0|||
147200815|NCT01759446|530906645|FG001|Overall Study|Withdrawal by Subject|1|||
147200816|NCT01759446|530906646|FG002|Overall Study|Withdrawal by Subject|0|||
147200817|NCT01759446|530906647|FG003|Overall Study|Withdrawal by Subject|1|||
147200818|NCT01759446|530906648|FG004|Overall Study|Withdrawal by Subject|0|||
147200819|NCT01760733|530906649|FG000|Waiting List|Death|18|||
147200820|NCT01760733|530906649|FG000|Waiting List|Removed from waiting list|41|||
147200821|NCT01760733|530906649|FG000|Waiting List|Not received a transplant yet|13|||
147200822|NCT01760733|530906649|FG000|Transplanted|Not reached 10 years post transplant|184|||
147200823|NCT01760733|530906649|FG000|Transplanted|Death|26|||
147200824|NCT01760733|530906649|FG000|Transplanted|Graft loss|7|||
147200825|NCT00815659|530906650|FG000|Overall Study|Adverse Event|9|||
147200826|NCT00815659|530906650|FG000|Overall Study|Withdrawal by Subject|9|||
147200827|NCT00815659|530906650|FG000|Overall Study|Lost to Follow-up|4|||
147200828|NCT00815659|530906650|FG000|Overall Study|Protocol Violation|1|||
147200829|NCT03847896|530906651|FG000|Overall Study|Randomized in error and did not receive randomized study treatment|0|||
147200830|NCT03847896|530906652|FG001|Overall Study|Randomized in error and did not receive randomized study treatment|0|||
147200831|NCT03847896|530906653|FG002|Overall Study|Randomized in error and did not receive randomized study treatment|1|||
147200832|NCT03847896|530906654|FG003|Overall Study|Randomized in error and did not receive randomized study treatment|0|||
147200833|NCT03847896|530906655|FG004|Overall Study|Randomized in error and did not receive randomized study treatment|0|||
147200834|NCT03847896|530906651|FG000|Overall Study|Withdrawal by Subject|2|||
147200835|NCT03847896|530906652|FG001|Overall Study|Withdrawal by Subject|10|||
147200836|NCT03847896|530906653|FG002|Overall Study|Withdrawal by Subject|5|||
147200837|NCT03847896|530906654|FG003|Overall Study|Withdrawal by Subject|9|||
147200838|NCT03847896|530906655|FG004|Overall Study|Withdrawal by Subject|8|||
147200839|NCT03847896|530906651|FG000|Overall Study|Withdrawal by parent/guardian|0|||
147200840|NCT03847896|530906652|FG001|Overall Study|Withdrawal by parent/guardian|0|||
147200841|NCT03847896|530906653|FG002|Overall Study|Withdrawal by parent/guardian|1|||
147200842|NCT03847896|530906654|FG003|Overall Study|Withdrawal by parent/guardian|0|||
147200843|NCT03847896|530906655|FG004|Overall Study|Withdrawal by parent/guardian|0|||
147200844|NCT03847896|530906651|FG000|Overall Study|Adverse Event|2|||
147200845|NCT03847896|530906652|FG001|Overall Study|Adverse Event|1|||
147200846|NCT03847896|530906653|FG002|Overall Study|Adverse Event|3|||
147200847|NCT03847896|530906654|FG003|Overall Study|Adverse Event|2|||
147200848|NCT03847896|530906655|FG004|Overall Study|Adverse Event|4|||
147200849|NCT03847896|530906651|FG000|Overall Study|A severe exacerbation event|0|||
147200850|NCT03847896|530906652|FG001|Overall Study|A severe exacerbation event|0|||
147200851|NCT03847896|530906653|FG002|Overall Study|A severe exacerbation event|0|||
147200852|NCT03847896|530906654|FG003|Overall Study|A severe exacerbation event|0|||
147200853|NCT03847896|530906655|FG004|Overall Study|A severe exacerbation event|3|||
147200854|NCT03847896|530906651|FG000|Overall Study|Protocol Violation|0|||
147200855|NCT03847896|530906652|FG001|Overall Study|Protocol Violation|2|||
147200856|NCT03847896|530906653|FG002|Overall Study|Protocol Violation|1|||
147200857|NCT03847896|530906654|FG003|Overall Study|Protocol Violation|0|||
147200858|NCT03847896|530906655|FG004|Overall Study|Protocol Violation|2|||
147200859|NCT03847896|530906651|FG000|Overall Study|Lost to Follow-up|0|||
147200860|NCT03847896|530906652|FG001|Overall Study|Lost to Follow-up|0|||
147200861|NCT03847896|530906653|FG002|Overall Study|Lost to Follow-up|0|||
147200862|NCT03847896|530906654|FG003|Overall Study|Lost to Follow-up|1|||
147200863|NCT03847896|530906655|FG004|Overall Study|Lost to Follow-up|0|||
147200864|NCT03847896|530906651|FG000|Overall Study|Condition under investigation worsened|0|||
147200865|NCT03847896|530906652|FG001|Overall Study|Condition under investigation worsened|0|||
147200866|NCT03847896|530906653|FG002|Overall Study|Condition under investigation worsened|0|||
147200867|NCT03847896|530906654|FG003|Overall Study|Condition under investigation worsened|1|||
147200868|NCT03847896|530906655|FG004|Overall Study|Condition under investigation worsened|1|||
147200869|NCT03847896|530906651|FG000|Overall Study|Lack of Efficacy|0|||
147200870|NCT03847896|530906652|FG001|Overall Study|Lack of Efficacy|0|||
147200871|NCT03847896|530906653|FG002|Overall Study|Lack of Efficacy|0|||
147200872|NCT03847896|530906654|FG003|Overall Study|Lack of Efficacy|2|||
147200873|NCT03847896|530906655|FG004|Overall Study|Lack of Efficacy|2|||
147200874|NCT03847896|530906651|FG000|Overall Study|Other reasons|3|||
147200875|NCT03847896|530906652|FG001|Overall Study|Other reasons|3|||
147200876|NCT03847896|530906653|FG002|Overall Study|Other reasons|1|||
147200877|NCT03847896|530906654|FG003|Overall Study|Other reasons|2|||
147200878|NCT03847896|530906655|FG004|Overall Study|Other reasons|1|||
147200879|NCT02395471|530906656|FG000|Overall Study|Lost to Follow-up|2|||
147200880|NCT02395471|530906657|FG001|Overall Study|Lost to Follow-up|0|||
147200881|NCT02395471|530906656|FG000|Overall Study|Withdrawal by Subject|2|||
147200882|NCT02395471|530906657|FG001|Overall Study|Withdrawal by Subject|1|||
147200883|NCT02395471|530906656|FG000|Overall Study|Physician Decision|1|||
147200884|NCT02395471|530906657|FG001|Overall Study|Physician Decision|0|||
147200885|NCT02395471|530906656|FG000|Overall Study|Protocol Violation|0|||
147200886|NCT02395471|530906657|FG001|Overall Study|Protocol Violation|1|||
147200887|NCT02395471|530906656|FG000|Overall Study|Failure to swollow sponge twice|1|||
147200888|NCT02395471|530906657|FG001|Overall Study|Failure to swollow sponge twice|0|||
147200889|NCT02395471|530906656|FG000|Overall Study|Patient did not return for procedure|0|||
147200890|NCT02395471|530906657|FG001|Overall Study|Patient did not return for procedure|1|||
147306797|NCT01975220|531290768|FG005|Test Period 1|Not treated|0|||
147435277|NCT01122576|531760446|FG002|Post-Cataract Surgery|Fellow Eye Explanted|1|||
147435278|NCT05696236|531760447|FG000|Overall Study|Lost to Follow-up|1|||
147435279|NCT05696236|531760448|FG001|Overall Study|Lost to Follow-up|0|||
147435280|NCT05696236|531760447|FG000|Overall Study|Later determined to not be eligible for participation|0|||
147435281|NCT05696236|531760448|FG001|Overall Study|Later determined to not be eligible for participation|1|||
147435282|NCT05696236|531760447|FG000|Overall Study|Withdrawal by Subject|2|||
147435283|NCT05696236|531760448|FG001|Overall Study|Withdrawal by Subject|2|||
147435284|NCT01829360|531760449|FG000|Overall Study|Protocol Violation|0|||
147435285|NCT01829360|531760450|FG001|Overall Study|Protocol Violation|0|||
147200891|NCT02395471|530906656|FG000|Overall Study|Subject not eligible|1|||
147200892|NCT02395471|530906657|FG001|Overall Study|Subject not eligible|0|||
147200893|NCT00118417|530906658|FG000|Phase I (Weeks 0 to 6)|Remission|8|||
147200894|NCT00118417|530906659|FG001|Phase I (Weeks 0 to 6)|Remission|0|||
147200895|NCT00118417|530906658|FG000|Phase I (Weeks 0 to 6)|Lost to Follow-up|6|||
147200896|NCT00118417|530906659|FG001|Phase I (Weeks 0 to 6)|Lost to Follow-up|0|||
147200897|NCT00118417|530906658|FG000|Phase I (Weeks 0 to 6)|Loss of Eligibility for Phase 2|4|||
147200898|NCT00118417|530906659|FG001|Phase I (Weeks 0 to 6)|Loss of Eligibility for Phase 2|0|||
147200899|NCT00118417|530906658|FG000|Phase II (Weeks 6 to 12)|Withdrawal by Subject|1|||
147200900|NCT00118417|530906659|FG001|Phase II (Weeks 6 to 12)|Withdrawal by Subject|1|||
147200901|NCT00118417|530906658|FG000|Phase II (Weeks 6 to 12)|Remission|1|||
147200902|NCT00118417|530906659|FG001|Phase II (Weeks 6 to 12)|Remission|2|||
147200903|NCT02978781|530906660|FG000|Part A|Adverse Event|1|||
147200904|NCT02978781|530906661|FG001|Part A|Adverse Event|1|||
147200905|NCT02978781|530906662|FG002|Part A|Adverse Event|0|||
147200906|NCT02978781|530906663|FG003|Part A|Adverse Event|0|||
147200907|NCT02978781|530906664|FG004|Part A|Adverse Event|0|||
147200908|NCT02978781|530906660|FG000|Part A|Withdrawal by Subject|0|||
147200909|NCT02978781|530906661|FG001|Part A|Withdrawal by Subject|1|||
147200910|NCT02978781|530906662|FG002|Part A|Withdrawal by Subject|0|||
147200911|NCT02978781|530906663|FG003|Part A|Withdrawal by Subject|0|||
147200912|NCT02978781|530906664|FG004|Part A|Withdrawal by Subject|0|||
147200913|NCT02978781|530906660|FG000|Part B|Withdrawal by Subject|0|||
147200914|NCT02978781|530906661|FG001|Part B|Withdrawal by Subject|0|||
147200915|NCT02978781|530906662|FG002|Part B|Withdrawal by Subject|0|||
147200916|NCT02978781|530906663|FG003|Part B|Withdrawal by Subject|1|||
147200917|NCT02978781|530906664|FG004|Part B|Withdrawal by Subject|0|||
147200918|NCT02978781|530906660|FG000|Part C|Adverse Event|0|||
147200919|NCT02978781|530906661|FG001|Part C|Adverse Event|0|||
147200920|NCT02978781|530906662|FG002|Part C|Adverse Event|0|||
147200921|NCT02978781|530906663|FG003|Part C|Adverse Event|0|||
147200922|NCT02978781|530906664|FG004|Part C|Adverse Event|2|||
147200923|NCT02978781|530906660|FG000|Part C|Withdrawal by Subject|0|||
147200924|NCT02978781|530906661|FG001|Part C|Withdrawal by Subject|0|||
147200925|NCT02978781|530906662|FG002|Part C|Withdrawal by Subject|0|||
147200926|NCT02978781|530906663|FG003|Part C|Withdrawal by Subject|0|||
147200927|NCT02978781|530906664|FG004|Part C|Withdrawal by Subject|1|||
147200928|NCT02978781|530906660|FG000|Part C|Tremor not improved due to Topamax discontinuation|0|||
147200929|NCT02978781|530906661|FG001|Part C|Tremor not improved due to Topamax discontinuation|0|||
147200930|NCT02978781|530906662|FG002|Part C|Tremor not improved due to Topamax discontinuation|0|||
147200931|NCT02978781|530906663|FG003|Part C|Tremor not improved due to Topamax discontinuation|0|||
147200932|NCT02978781|530906664|FG004|Part C|Tremor not improved due to Topamax discontinuation|1|||
147200933|NCT00785785|530906665|FG000|Core Phase up to 36 Months|Patients didn't receive 1st line therapy|3|||
147200934|NCT00785785|530906666|FG001|Core Phase up to 36 Months|Patients didn't receive 1st line therapy|4|||
147200935|NCT00785785|530906665|FG000|Core Phase up to 36 Months|Adverse Event|31|||
147200936|NCT00785785|530906666|FG001|Core Phase up to 36 Months|Adverse Event|21|||
147200937|NCT00785785|530906665|FG000|Core Phase up to 36 Months|Abnormal laboratory value|1|||
147200938|NCT00785785|530906666|FG001|Core Phase up to 36 Months|Abnormal laboratory value|0|||
147200939|NCT00785785|530906665|FG000|Core Phase up to 36 Months|Abnormal test procedure result|2|||
147200940|NCT00785785|530906666|FG001|Core Phase up to 36 Months|Abnormal test procedure result|2|||
147200941|NCT00785785|530906665|FG000|Core Phase up to 36 Months|Withdrawal by Subject|16|||
147200942|NCT00785785|530906666|FG001|Core Phase up to 36 Months|Withdrawal by Subject|17|||
147200943|NCT00785785|530906665|FG000|Core Phase up to 36 Months|Lost to Follow-up|3|||
147200944|NCT00785785|530906666|FG001|Core Phase up to 36 Months|Lost to Follow-up|7|||
147200945|NCT00785785|530906665|FG000|Core Phase up to 36 Months|Administrative problems|3|||
147200946|NCT00785785|530906666|FG001|Core Phase up to 36 Months|Administrative problems|3|||
147200947|NCT00785785|530906665|FG000|Core Phase up to 36 Months|Death|5|||
147200948|NCT00785785|530906666|FG001|Core Phase up to 36 Months|Death|8|||
147200949|NCT00785785|530906665|FG000|Core Phase up to 36 Months|Disease progression|139|||
147200950|NCT00785785|530906666|FG001|Core Phase up to 36 Months|Disease progression|119|||
147200951|NCT00785785|530906665|FG000|Core Phase up to 36 Months|Protocol deviation|5|||
147200952|NCT00785785|530906666|FG001|Core Phase up to 36 Months|Protocol deviation|6|||
147200953|NCT00785785|530906665|FG000|Core Phase up to 36 Months|Study terminated by sponsor|116|||
147200954|NCT00785785|530906666|FG001|Core Phase up to 36 Months|Study terminated by sponsor|133|||
147200955|NCT00785785|530906665|FG000|Optional Extension Phase|Adverse Event|4|||
147200956|NCT00785785|530906666|FG001|Optional Extension Phase|Adverse Event|5|||
147200957|NCT00785785|530906665|FG000|Optional Extension Phase|Withdrawal by Subject|6|||
147200958|NCT00785785|530906666|FG001|Optional Extension Phase|Withdrawal by Subject|6|||
147200959|NCT00785785|530906665|FG000|Optional Extension Phase|Lost to Follow-up|1|||
147200960|NCT00785785|530906666|FG001|Optional Extension Phase|Lost to Follow-up|0|||
147200961|NCT00785785|530906665|FG000|Optional Extension Phase|Administrative problems|2|||
147200962|NCT00785785|530906666|FG001|Optional Extension Phase|Administrative problems|0|||
147200963|NCT00785785|530906665|FG000|Optional Extension Phase|Death|1|||
147200964|NCT00785785|530906666|FG001|Optional Extension Phase|Death|5|||
147200965|NCT00785785|530906665|FG000|Optional Extension Phase|Disease progression|22|||
147200966|NCT00785785|530906666|FG001|Optional Extension Phase|Disease progression|70|||
147200967|NCT00785785|530906665|FG000|Optional Extension Phase|Protocol deviation|0|||
147200968|NCT00785785|530906666|FG001|Optional Extension Phase|Protocol deviation|2|||
147200969|NCT00785785|530906665|FG000|Optional Extension Phase|Study terminated by sponsor|3|||
147200970|NCT00785785|530906666|FG001|Optional Extension Phase|Study terminated by sponsor|37|||
147200971|NCT01244893|530906667|FG000|Baseline|Protocol Violation|0|||
147200972|NCT01244893|530906668|FG001|Baseline|Protocol Violation|1|||
147200973|NCT01244893|530906667|FG000|1-Week Follow Up|Lost to Follow-up|1|||
147200974|NCT01244893|530906668|FG001|1-Week Follow Up|Lost to Follow-up|0|||
147200975|NCT00357552|530906669|FG000|Screening|Did not meet eligibility criteria|84|||
147200976|NCT00357552|530906669|FG000|Weeks 0 to 24|Death|1|||
147200977|NCT00357552|530906669|FG000|Weeks 24 to 104|Death|3|||
147200978|NCT00357552|530906669|FG000|Weeks 24 to 104|Not able to get to clinic|2|||
147200979|NCT00882557|530906676|FG000|Overall Study|Withdrawal by Subject|1|||
147200980|NCT00882557|530906677|FG001|Overall Study|Withdrawal by Subject|0|||
147200981|NCT00882557|530906676|FG000|Overall Study|Trouble with Vein Access|1|||
147200982|NCT00882557|530906677|FG001|Overall Study|Trouble with Vein Access|0|||
147200983|NCT00882557|530906676|FG000|Overall Study|Randomized Not Treated|0|||
147200984|NCT00882557|530906677|FG001|Overall Study|Randomized Not Treated|1|||
147200985|NCT02282605|530906679|FG000|Overall Study|negative SA result on Day -1|3|||
147200986|NCT02282605|530906680|FG001|Overall Study|negative SA result on Day -1|0|||
147200987|NCT02282605|530906681|FG002|Overall Study|negative SA result on Day -1|0|||
147200988|NCT01528969|530906682|FG000|Overall Study|absent from the school at baseline|2|||
147200989|NCT01528969|530906683|FG001|Overall Study|absent from the school at baseline|0|||
147200990|NCT03584789|530906688|FG000|Overall Study|refused EHR permission|19|||
147200991|NCT03584789|530906689|FG001|Overall Study|refused EHR permission|28|||
147200992|NCT03584789|530906690|FG002|Overall Study|refused EHR permission|23|||
147200993|NCT03584789|530906688|FG000|Overall Study|patients tied to a provider who retired|0|||
147200994|NCT03584789|530906689|FG001|Overall Study|patients tied to a provider who retired|0|||
147200995|NCT03584789|530906690|FG002|Overall Study|patients tied to a provider who retired|3|||
147200996|NCT02035267|530906692|FG000|Overall Study|Withdrawal consent-subject convenience|0|||
147200997|NCT02035267|530906693|FG001|Overall Study|Withdrawal consent-subject convenience|0|||
147200998|NCT02035267|530906694|FG002|Overall Study|Withdrawal consent-subject convenience|1|||
147200999|NCT02035267|530906695|FG003|Overall Study|Withdrawal consent-subject convenience|0|||
147201000|NCT02035267|530906692|FG000|Overall Study|Adverse Event|0|||
147201001|NCT02035267|530906693|FG001|Overall Study|Adverse Event|0|||
147201002|NCT02035267|530906694|FG002|Overall Study|Adverse Event|1|||
147201003|NCT02035267|530906695|FG003|Overall Study|Adverse Event|0|||
147201004|NCT02035267|530906692|FG000|Overall Study|Lost to Follow-up|0|||
147201005|NCT02035267|530906693|FG001|Overall Study|Lost to Follow-up|0|||
147201006|NCT02035267|530906694|FG002|Overall Study|Lost to Follow-up|0|||
147201007|NCT02035267|530906695|FG003|Overall Study|Lost to Follow-up|1|||
147201008|NCT02035267|530906692|FG000|Overall Study|Other unspecified|0|||
147201009|NCT02035267|530906693|FG001|Overall Study|Other unspecified|1|||
147201010|NCT02035267|530906694|FG002|Overall Study|Other unspecified|0|||
147201011|NCT02035267|530906695|FG003|Overall Study|Other unspecified|0|||
147201012|NCT02404025|530906696|FG000|Overall Study|Adverse Event|1|||
147201013|NCT02404025|530906696|FG000|Overall Study|Lack of Efficacy|3|||
147201014|NCT00823615|530906697|FG000|Period 2|Lost to Follow-up|2|||
147201015|NCT00823615|530906698|FG001|Period 2|Lost to Follow-up|0|||
147201016|NCT00823615|530906697|FG000|Period 2|Time/Job Conflict|1|||
147201017|NCT00823615|530906698|FG001|Period 2|Time/Job Conflict|2|||
147201018|NCT00084136|530906702|FG000|PI Comparison|Death|10|||
147201019|NCT00084136|530906703|FG001|PI Comparison|Death|9|||
147201020|NCT00084136|530906704|FG002|PI Comparison|Death|0|||
147201021|NCT00084136|530906702|FG000|PI Comparison|Lost to Follow-up|11|||
147201022|NCT00084136|530906703|FG001|PI Comparison|Lost to Follow-up|8|||
147201023|NCT00084136|530906704|FG002|PI Comparison|Lost to Follow-up|0|||
147201024|NCT00084136|530906702|FG000|PI Comparison|Withdrawal by Subject|33|||
147201025|NCT00084136|530906703|FG001|PI Comparison|Withdrawal by Subject|30|||
147201026|NCT00084136|530906704|FG002|PI Comparison|Withdrawal by Subject|0|||
147201027|NCT00084136|530906702|FG000|PI Comparison|Clinic site closed|1|||
147201028|NCT00084136|530906703|FG001|PI Comparison|Clinic site closed|0|||
147201029|NCT00084136|530906704|FG002|PI Comparison|Clinic site closed|0|||
147201030|NCT00084136|530906702|FG000|NRTI Comparison|Death|20|||
147201031|NCT00084136|530906703|FG001|NRTI Comparison|Death|0|||
147201032|NCT00084136|530906704|FG002|NRTI Comparison|Death|18|||
147201033|NCT00084136|530906702|FG000|NRTI Comparison|Lost to Follow-up|14|||
147201034|NCT00084136|530906703|FG001|NRTI Comparison|Lost to Follow-up|0|||
147201035|NCT00084136|530906704|FG002|NRTI Comparison|Lost to Follow-up|12|||
147201036|NCT00084136|530906702|FG000|NRTI Comparison|Withdrawal by Subject|54|||
147201037|NCT00084136|530906703|FG001|NRTI Comparison|Withdrawal by Subject|0|||
147201038|NCT00084136|530906704|FG002|NRTI Comparison|Withdrawal by Subject|38|||
147201039|NCT00084136|530906702|FG000|NRTI Comparison|Clinic site closed|12|||
147201040|NCT00084136|530906703|FG001|NRTI Comparison|Clinic site closed|0|||
147435286|NCT01829360|531760451|FG002|Overall Study|Protocol Violation|1|||
147435287|NCT01829360|531760452|FG003|Overall Study|Protocol Violation|0|||
147435288|NCT03974334|531760457|FG000|Overall Study|Lost to Follow-up|1|||
147435289|NCT00931944|531760458|FG000|Overall Study|Adverse Event|4|||
147435290|NCT00931944|531760458|FG000|Overall Study|W/D Consent (due to ALS progression))|19|||
147435291|NCT00931944|531760458|FG000|Overall Study|Withdrawal Consent (due to other)|2|||
147435292|NCT00931944|531760458|FG000|Overall Study|Death|28|||
147435293|NCT00931944|531760458|FG000|Overall Study|Other|2|||
147435294|NCT01109173|531760459|FG000|Overall Study|Adverse Event|15|||
147435295|NCT01109173|531760460|FG001|Overall Study|Adverse Event|17|||
147435296|NCT01109173|531760461|FG002|Overall Study|Adverse Event|9|||
147435297|NCT01109173|531760462|FG003|Overall Study|Adverse Event|6|||
147435298|NCT01109173|531760459|FG000|Overall Study|Lost to Follow-up|0|||
147435299|NCT01109173|531760460|FG001|Overall Study|Lost to Follow-up|1|||
147435300|NCT01109173|531760461|FG002|Overall Study|Lost to Follow-up|0|||
147435301|NCT01109173|531760462|FG003|Overall Study|Lost to Follow-up|0|||
147435302|NCT01109173|531760459|FG000|Overall Study|Patient Decision Unrelated to Advrs Evnt|5|||
147435303|NCT01109173|531760460|FG001|Overall Study|Patient Decision Unrelated to Advrs Evnt|0|||
147435304|NCT01109173|531760461|FG002|Overall Study|Patient Decision Unrelated to Advrs Evnt|2|||
147435305|NCT01109173|531760462|FG003|Overall Study|Patient Decision Unrelated to Advrs Evnt|0|||
147435306|NCT01109173|531760459|FG000|Overall Study|Noncompliance|0|||
147435307|NCT01109173|531760460|FG001|Overall Study|Noncompliance|1|||
147435308|NCT01109173|531760461|FG002|Overall Study|Noncompliance|0|||
147435309|NCT01109173|531760462|FG003|Overall Study|Noncompliance|0|||
147435310|NCT01109173|531760459|FG000|Overall Study|Treatment Failure|25|||
147435311|NCT01109173|531760460|FG001|Overall Study|Treatment Failure|32|||
147435312|NCT01109173|531760461|FG002|Overall Study|Treatment Failure|69|||
147435313|NCT01109173|531760462|FG003|Overall Study|Treatment Failure|64|||
147435314|NCT01109173|531760459|FG000|Overall Study|Protocol Violation|4|||
147435315|NCT01109173|531760460|FG001|Overall Study|Protocol Violation|5|||
147435316|NCT01109173|531760461|FG002|Overall Study|Protocol Violation|1|||
147435317|NCT01109173|531760462|FG003|Overall Study|Protocol Violation|2|||
147435318|NCT01109173|531760459|FG000|Overall Study|Patient Did Not Use Study Medication|34|||
147435319|NCT01109173|531760460|FG001|Overall Study|Patient Did Not Use Study Medication|26|||
147435320|NCT01109173|531760461|FG002|Overall Study|Patient Did Not Use Study Medication|11|||
147435321|NCT01109173|531760462|FG003|Overall Study|Patient Did Not Use Study Medication|7|||
147435322|NCT01109173|531760459|FG000|Overall Study|Not Specifiied|5|||
147435323|NCT01109173|531760460|FG001|Overall Study|Not Specifiied|4|||
147435324|NCT01109173|531760461|FG002|Overall Study|Not Specifiied|9|||
147435325|NCT01109173|531760462|FG003|Overall Study|Not Specifiied|14|||
147435326|NCT01132612|531760463|FG000|Overall Study|Death|0|||
147201041|NCT00084136|530906704|FG002|NRTI Comparison|Clinic site closed|14|||
147201042|NCT00084136|530906702|FG000|NRTI Comparison|Not reason above|1|||
147201043|NCT00084136|530906703|FG001|NRTI Comparison|Not reason above|0|||
147201044|NCT00084136|530906704|FG002|NRTI Comparison|Not reason above|0|||
147201045|NCT01524796|530906705|FG000|Overall Study|Adverse Event|13|||
147201046|NCT01524796|530906705|FG000|Overall Study|Lack of Efficacy|3|||
147201047|NCT01524796|530906705|FG000|Overall Study|Lost to Follow-up|1|||
147201048|NCT01524796|530906705|FG000|Overall Study|The price|1|||
147201049|NCT01524796|530906705|FG000|Overall Study|Withdrawal by Subject|4|||
147201050|NCT01524796|530906705|FG000|Overall Study|Move|1|||
147201051|NCT01524796|530906705|FG000|Overall Study|Deterioration of pains|1|||
147201052|NCT01524796|530906705|FG000|Overall Study|Gall stone surgery|1|||
147201053|NCT01524796|530906705|FG000|Overall Study|Nervous about confidentiality|1|||
147201054|NCT01524796|530906705|FG000|Overall Study|Switch to carbamazapine|1|||
147201055|NCT01524796|530906705|FG000|Overall Study|Adverse Event and Lack of Efficacy|1|||
147201056|NCT03938259|530906710|FG000|Overall Study|unable to establish baseline for ventilation|1|||
147201057|NCT03938259|530906711|FG001|Overall Study|unable to establish baseline for ventilation|1|||
147201058|NCT00836693|530906712|FG000|Overall Study|Adverse Event|4|||
147201059|NCT00836693|530906713|FG001|Overall Study|Adverse Event|1|||
147201060|NCT00836693|530906712|FG000|Overall Study|Sponsor Decision|0|||
147201061|NCT00836693|530906713|FG001|Overall Study|Sponsor Decision|1|||
147201062|NCT00836693|530906712|FG000|Overall Study|Physician Decision|2|||
147201063|NCT00836693|530906713|FG001|Overall Study|Physician Decision|0|||
147201064|NCT00836693|530906712|FG000|Overall Study|Withdrawal by Subject|9|||
147201065|NCT00836693|530906713|FG001|Overall Study|Withdrawal by Subject|4|||
147201066|NCT00836693|530906712|FG000|Overall Study|Protocol Violation|1|||
147201067|NCT00836693|530906713|FG001|Overall Study|Protocol Violation|0|||
147201068|NCT00836693|530906712|FG000|Overall Study|Lost to Follow-up|1|||
147201069|NCT00836693|530906713|FG001|Overall Study|Lost to Follow-up|0|||
147201070|NCT02612779|530906714|FG000|Overall Study|Administrative reason by sponsor|4|||
147201071|NCT02612779|530906715|FG001|Overall Study|Administrative reason by sponsor|1|||
147201072|NCT02612779|530906714|FG000|Overall Study|No longer meet study criteria|0|||
147201073|NCT02612779|530906715|FG001|Overall Study|No longer meet study criteria|1|||
147201074|NCT02612779|530906714|FG000|Overall Study|Disease progression|29|||
147201075|NCT02612779|530906715|FG001|Overall Study|Disease progression|2|||
147201076|NCT02612779|530906714|FG000|Overall Study|Study drug toxicity|10|||
147201077|NCT02612779|530906715|FG001|Overall Study|Study drug toxicity|1|||
147201078|NCT02612779|530906714|FG000|Overall Study|Death|1|||
147201079|NCT02612779|530906715|FG001|Overall Study|Death|0|||
147201080|NCT02612779|530906714|FG000|Overall Study|Adverse event unrelated to study drug|5|||
147201081|NCT02612779|530906715|FG001|Overall Study|Adverse event unrelated to study drug|0|||
147201082|NCT02612779|530906714|FG000|Overall Study|Participant withdrew consent|4|||
147201083|NCT02612779|530906715|FG001|Overall Study|Participant withdrew consent|0|||
147201084|NCT02612779|530906714|FG000|Overall Study|Lost to Follow-up|1|||
147201085|NCT02612779|530906715|FG001|Overall Study|Lost to Follow-up|0|||
147201086|NCT02612779|530906714|FG000|Overall Study|Maximum clinical benefit|10|||
147201087|NCT02612779|530906715|FG001|Overall Study|Maximum clinical benefit|1|||
147201088|NCT02612779|530906714|FG000|Overall Study|Other reasons|4|||
147201089|NCT02612779|530906715|FG001|Overall Study|Other reasons|0|||
147201090|NCT02420821|530906718|FG000|Overall Study|Lost to Follow-up|6|||
147201091|NCT02420821|530906719|FG001|Overall Study|Lost to Follow-up|6|||
147201092|NCT02420821|530906718|FG000|Overall Study|Non-compliance|0|||
147201093|NCT02420821|530906719|FG001|Overall Study|Non-compliance|2|||
147201094|NCT02420821|530906718|FG000|Overall Study|Physician Decision|6|||
147201095|NCT02420821|530906719|FG001|Overall Study|Physician Decision|2|||
147201096|NCT02420821|530906718|FG000|Overall Study|Withdrawal by Subject|32|||
147201097|NCT02420821|530906719|FG001|Overall Study|Withdrawal by Subject|25|||
147201098|NCT02420821|530906718|FG000|Overall Study|Death|270|||
147201099|NCT02420821|530906719|FG001|Overall Study|Death|263|||
147201100|NCT02420821|530906718|FG000|Overall Study|Study Terminated By Sponsor|145|||
147201101|NCT02420821|530906719|FG001|Overall Study|Study Terminated By Sponsor|149|||
147201102|NCT02420821|530906718|FG000|Overall Study|Patient refused end of treatment visit due to Covid-19|0|||
147201103|NCT02420821|530906719|FG001|Overall Study|Patient refused end of treatment visit due to Covid-19|1|||
147201104|NCT02420821|530906718|FG000|Overall Study|Adverse Event|0|||
147201105|NCT02420821|530906719|FG001|Overall Study|Adverse Event|1|||
147201106|NCT02420821|530906718|FG000|Overall Study|Protinuria|0|||
147201107|NCT02420821|530906719|FG001|Overall Study|Protinuria|1|||
147201108|NCT02420821|530906718|FG000|Overall Study|Progressive Disease|1|||
147201109|NCT02420821|530906719|FG001|Overall Study|Progressive Disease|1|||
147201110|NCT02420821|530906718|FG000|Overall Study|Disease Progression|0|||
147201111|NCT02420821|530906719|FG001|Overall Study|Disease Progression|1|||
147201112|NCT02420821|530906718|FG000|Overall Study|Patient missing record of discontinuation from Atezo.|0|||
147201113|NCT02420821|530906719|FG001|Overall Study|Patient missing record of discontinuation from Atezo.|1|||
147201114|NCT03815929|530906724|FG000|Overall Study|Lost to Follow-up|2|||
147201115|NCT03815929|530906725|FG001|Overall Study|Lost to Follow-up|1|||
147201116|NCT03815929|530906726|FG002|Overall Study|Lost to Follow-up|0|||
147201117|NCT03815929|530906724|FG000|Overall Study|Physician Decision|2|||
147201118|NCT03815929|530906725|FG001|Overall Study|Physician Decision|2|||
147201119|NCT03815929|530906726|FG002|Overall Study|Physician Decision|0|||
147201120|NCT03815929|530906724|FG000|Overall Study|Withdrawal by Subject|0|||
147201121|NCT03815929|530906725|FG001|Overall Study|Withdrawal by Subject|0|||
147201122|NCT03815929|530906726|FG002|Overall Study|Withdrawal by Subject|1|||
147201123|NCT03313037|530906727|FG000|Overall Study|Protocol Violation|4|||
147201124|NCT03313037|530906728|FG001|Overall Study|Protocol Violation|1|||
147201125|NCT03313037|530906727|FG000|Overall Study|Other|1|||
147201126|NCT03313037|530906728|FG001|Overall Study|Other|1|||
147201127|NCT03313037|530906727|FG000|Overall Study|Withdrawal by Subject|4|||
147201128|NCT03313037|530906728|FG001|Overall Study|Withdrawal by Subject|3|||
147201129|NCT03313037|530906727|FG000|Overall Study|No longer meets eligibility criteria|1|||
147201130|NCT03313037|530906728|FG001|Overall Study|No longer meets eligibility criteria|7|||
147201131|NCT03313037|530906727|FG000|Overall Study|Lost to Follow-up|9|||
147201132|NCT03313037|530906728|FG001|Overall Study|Lost to Follow-up|8|||
147201133|NCT03313037|530906727|FG000|Overall Study|Randomized but not treated|1|||
147201134|NCT03313037|530906728|FG001|Overall Study|Randomized but not treated|0|||
147201135|NCT02760498|530906729|FG000|Overall Study|Adverse Event|3|||
147201136|NCT02760498|530906730|FG001|Overall Study|Adverse Event|3|||
147201137|NCT02760498|530906731|FG002|Overall Study|Adverse Event|1|||
147201138|NCT02760498|530906732|FG003|Overall Study|Adverse Event|1|||
147201139|NCT02760498|530906733|FG004|Overall Study|Adverse Event|0|||
147201140|NCT02760498|530906734|FG005|Overall Study|Adverse Event|6|||
147201141|NCT02760498|530906729|FG000|Overall Study|Death|7|||
147201142|NCT02760498|530906730|FG001|Overall Study|Death|5|||
147201143|NCT02760498|530906731|FG002|Overall Study|Death|5|||
147201144|NCT02760498|530906732|FG003|Overall Study|Death|7|||
147201145|NCT02760498|530906733|FG004|Overall Study|Death|0|||
147201146|NCT02760498|530906734|FG005|Overall Study|Death|23|||
147201147|NCT02760498|530906729|FG000|Overall Study|Lost to Follow-up|0|||
147201148|NCT02760498|530906730|FG001|Overall Study|Lost to Follow-up|0|||
147201149|NCT02760498|530906731|FG002|Overall Study|Lost to Follow-up|0|||
147201150|NCT02760498|530906732|FG003|Overall Study|Lost to Follow-up|0|||
147201151|NCT02760498|530906733|FG004|Overall Study|Lost to Follow-up|0|||
147201152|NCT02760498|530906734|FG005|Overall Study|Lost to Follow-up|3|||
147201153|NCT02760498|530906729|FG000|Overall Study|Non-compliance with study drug|0|||
147201154|NCT02760498|530906730|FG001|Overall Study|Non-compliance with study drug|2|||
147201155|NCT02760498|530906731|FG002|Overall Study|Non-compliance with study drug|0|||
147201156|NCT02760498|530906732|FG003|Overall Study|Non-compliance with study drug|0|||
147201157|NCT02760498|530906733|FG004|Overall Study|Non-compliance with study drug|0|||
147201158|NCT02760498|530906734|FG005|Overall Study|Non-compliance with study drug|0|||
147201159|NCT02760498|530906729|FG000|Overall Study|Participant decision|1|||
147201160|NCT02760498|530906730|FG001|Overall Study|Participant decision|4|||
147201161|NCT02760498|530906731|FG002|Overall Study|Participant decision|2|||
147535028|NCT02060188|532114811|FG002|Overall Study|Maximum clinical benefit|19|||
147535029|NCT02060188|532114812|FG003|Overall Study|Maximum clinical benefit|0|||
147535030|NCT02060188|532114813|FG004|Overall Study|Maximum clinical benefit|0|||
147535031|NCT02060188|532114814|FG005|Overall Study|Maximum clinical benefit|0|||
147535032|NCT02060188|532114815|FG006|Overall Study|Maximum clinical benefit|0|||
147535033|NCT02060188|532114816|FG007|Overall Study|Maximum clinical benefit|10|||
147535034|NCT02060188|532114817|FG008|Overall Study|Maximum clinical benefit|0|||
147535035|NCT02060188|532114809|FG000|Overall Study|Other reason|3|||
147535036|NCT02060188|532114810|FG001|Overall Study|Other reason|7|||
147535037|NCT02060188|532114811|FG002|Overall Study|Other reason|0|||
147535038|NCT02060188|532114812|FG003|Overall Study|Other reason|1|||
147535039|NCT02060188|532114813|FG004|Overall Study|Other reason|0|||
147535040|NCT02060188|532114814|FG005|Overall Study|Other reason|0|||
147535041|NCT02060188|532114815|FG006|Overall Study|Other reason|0|||
147535042|NCT02060188|532114816|FG007|Overall Study|Other reason|9|||
147535043|NCT02060188|532114817|FG008|Overall Study|Other reason|0|||
147535044|NCT02060188|532114809|FG000|Overall Study|Death|0|||
147535045|NCT02060188|532114810|FG001|Overall Study|Death|1|||
147535046|NCT02060188|532114811|FG002|Overall Study|Death|0|||
147535047|NCT02060188|532114812|FG003|Overall Study|Death|0|||
147535048|NCT02060188|532114813|FG004|Overall Study|Death|0|||
147535049|NCT02060188|532114814|FG005|Overall Study|Death|0|||
147535050|NCT02060188|532114815|FG006|Overall Study|Death|0|||
147535051|NCT02060188|532114816|FG007|Overall Study|Death|1|||
147201162|NCT02760498|530906732|FG003|Overall Study|Participant decision|2|||
147201163|NCT02760498|530906733|FG004|Overall Study|Participant decision|1|||
147201164|NCT02760498|530906734|FG005|Overall Study|Participant decision|6|||
147535052|NCT02060188|532114817|FG008|Overall Study|Death|0|||
147535053|NCT02060188|532114809|FG000|Overall Study|Administrative reasons by sponsor|0|||
147201165|NCT02760498|530906729|FG000|Overall Study|Sponsor decision|0|||
147201166|NCT02760498|530906730|FG001|Overall Study|Sponsor decision|0|||
147201167|NCT02760498|530906731|FG002|Overall Study|Sponsor decision|0|||
147201168|NCT02760498|530906732|FG003|Overall Study|Sponsor decision|3|||
147201169|NCT02760498|530906733|FG004|Overall Study|Sponsor decision|0|||
147535054|NCT02060188|532114810|FG001|Overall Study|Administrative reasons by sponsor|1|||
147201170|NCT02760498|530906734|FG005|Overall Study|Sponsor decision|0|||
147201171|NCT02760498|530906729|FG000|Overall Study|Physician Decision|3|||
147201172|NCT02760498|530906730|FG001|Overall Study|Physician Decision|4|||
147201173|NCT02760498|530906731|FG002|Overall Study|Physician Decision|1|||
147201174|NCT02760498|530906732|FG003|Overall Study|Physician Decision|4|||
147201175|NCT02760498|530906733|FG004|Overall Study|Physician Decision|0|||
147201176|NCT02760498|530906734|FG005|Overall Study|Physician Decision|2|||
147201177|NCT02760498|530906729|FG000|Overall Study|Disease progression|21|||
147201178|NCT02760498|530906730|FG001|Overall Study|Disease progression|19|||
147201179|NCT02760498|530906731|FG002|Overall Study|Disease progression|20|||
147201180|NCT02760498|530906732|FG003|Overall Study|Disease progression|18|||
147201181|NCT02760498|530906733|FG004|Overall Study|Disease progression|4|||
147201182|NCT02760498|530906734|FG005|Overall Study|Disease progression|55|||
147201183|NCT02760498|530906729|FG000|Overall Study|Withdrawal by Subject|4|||
147201184|NCT02760498|530906730|FG001|Overall Study|Withdrawal by Subject|7|||
147201185|NCT02760498|530906731|FG002|Overall Study|Withdrawal by Subject|5|||
147201186|NCT02760498|530906732|FG003|Overall Study|Withdrawal by Subject|1|||
147201187|NCT02760498|530906733|FG004|Overall Study|Withdrawal by Subject|0|||
147201188|NCT02760498|530906734|FG005|Overall Study|Withdrawal by Subject|6|||
147201189|NCT02760498|530906729|FG000|Overall Study|Other than specified|1|||
147201190|NCT02760498|530906730|FG001|Overall Study|Other than specified|6|||
147201191|NCT02760498|530906731|FG002|Overall Study|Other than specified|0|||
147201192|NCT02760498|530906732|FG003|Overall Study|Other than specified|3|||
147201193|NCT02760498|530906733|FG004|Overall Study|Other than specified|1|||
147201194|NCT02760498|530906734|FG005|Overall Study|Other than specified|0|||
147201195|NCT02760498|530906729|FG000|Overall Study|Not treated|0|||
147201196|NCT02760498|530906730|FG001|Overall Study|Not treated|0|||
147201197|NCT02760498|530906731|FG002|Overall Study|Not treated|0|||
147201198|NCT02760498|530906732|FG003|Overall Study|Not treated|0|||
147201199|NCT02760498|530906733|FG004|Overall Study|Not treated|0|||
147201200|NCT02760498|530906734|FG005|Overall Study|Not treated|2|||
147201201|NCT02205736|530906735|FG000|Overall Study|Lost to Follow-up|106|||
147201202|NCT05786651|530906738|FG000|Overall Study|fire alarm during testing session, incomplete testing|1|||
147535055|NCT02060188|532114811|FG002|Overall Study|Administrative reasons by sponsor|0|||
147535056|NCT02060188|532114812|FG003|Overall Study|Administrative reasons by sponsor|0|||
147201203|NCT00904033|530908906|FG000|Overall Study|Withdrawal by Subject|1|||
147201204|NCT00904033|530908907|FG001|Overall Study|Withdrawal by Subject|1|||
147201205|NCT00904033|530908908|FG002|Overall Study|Withdrawal by Subject|0|||
147201206|NCT00904033|530908909|FG003|Overall Study|Withdrawal by Subject|0|||
147201207|NCT00904033|530908906|FG000|Overall Study|Physician Decision|0|||
147201208|NCT00904033|530908907|FG001|Overall Study|Physician Decision|0|||
147201209|NCT00904033|530908908|FG002|Overall Study|Physician Decision|1|||
147201210|NCT00904033|530908909|FG003|Overall Study|Physician Decision|0|||
147201211|NCT00904033|530908906|FG000|Overall Study|Unable to obtain final blood draw|0|||
147201212|NCT00904033|530908907|FG001|Overall Study|Unable to obtain final blood draw|0|||
147201213|NCT00904033|530908908|FG002|Overall Study|Unable to obtain final blood draw|0|||
147201214|NCT00904033|530908909|FG003|Overall Study|Unable to obtain final blood draw|2|||
147201215|NCT00865566|530908910|FG000|Overall Study|Death|1|||
147201216|NCT00865566|530908911|FG001|Overall Study|Death|11|||
147201217|NCT00865566|530908910|FG000|Overall Study|Lost to Follow-up|314|||
147201218|NCT00865566|530908911|FG001|Overall Study|Lost to Follow-up|315|||
147201219|NCT00865566|530908910|FG000|Overall Study|Withdrawal by Subject|45|||
147201220|NCT00865566|530908911|FG001|Overall Study|Withdrawal by Subject|65|||
147201221|NCT00865566|530908910|FG000|Overall Study|Physician Decision|0|||
147201222|NCT00865566|530908911|FG001|Overall Study|Physician Decision|1|||
147201223|NCT00865566|530908910|FG000|Overall Study|Participant relocated|78|||
147535057|NCT02060188|532114813|FG004|Overall Study|Administrative reasons by sponsor|0|||
147535058|NCT02060188|532114814|FG005|Overall Study|Administrative reasons by sponsor|0|||
147535059|NCT02060188|532114815|FG006|Overall Study|Administrative reasons by sponsor|0|||
147535060|NCT02060188|532114816|FG007|Overall Study|Administrative reasons by sponsor|0|||
147535061|NCT02060188|532114817|FG008|Overall Study|Administrative reasons by sponsor|0|||
147201224|NCT00865566|530908911|FG001|Overall Study|Participant relocated|107|||
147201225|NCT00865566|530908910|FG000|Overall Study|Participant unable to adhere|27|||
147201226|NCT00865566|530908911|FG001|Overall Study|Participant unable to adhere|42|||
147535062|NCT02060188|532114809|FG000|Overall Study|Lost to Follow-up|0|||
147535063|NCT02060188|532114810|FG001|Overall Study|Lost to Follow-up|0|||
147201227|NCT00865566|530908910|FG000|Overall Study|Other; N=245 due to early study closure|154|||
147201228|NCT00865566|530908911|FG001|Overall Study|Other; N=245 due to early study closure|139|||
147201229|NCT00865566|530908910|FG000|Overall Study|HIV infection|5|||
147201230|NCT00865566|530908911|FG001|Overall Study|HIV infection|7|||
147201231|NCT03252925|530908914|FG000|Overall Study|Withdrawal by Subject|1|||
147201232|NCT03252925|530908915|FG001|Overall Study|Withdrawal by Subject|0|||
147201233|NCT03252925|530908914|FG000|Overall Study|Protocol Violation|6|||
147201234|NCT03252925|530908915|FG001|Overall Study|Protocol Violation|0|||
147201235|NCT03252925|530908914|FG000|Overall Study|Adverse Event|1|||
147201236|NCT03252925|530908915|FG001|Overall Study|Adverse Event|0|||
147201237|NCT03252925|530908914|FG000|Overall Study|Lost to Follow-up|6|||
147535064|NCT02060188|532114811|FG002|Overall Study|Lost to Follow-up|1|||
147535065|NCT02060188|532114812|FG003|Overall Study|Lost to Follow-up|0|||
147535066|NCT02060188|532114813|FG004|Overall Study|Lost to Follow-up|0|||
147535067|NCT02060188|532114814|FG005|Overall Study|Lost to Follow-up|0|||
147535068|NCT02060188|532114815|FG006|Overall Study|Lost to Follow-up|0|||
147535069|NCT02060188|532114816|FG007|Overall Study|Lost to Follow-up|0|||
147535070|NCT02060188|532114817|FG008|Overall Study|Lost to Follow-up|0|||
147535071|NCT02335411|532114818|FG000|Overall Study|Death|223|||
147535072|NCT02335411|532114819|FG001|Overall Study|Death|22|||
147535073|NCT02335411|532114820|FG002|Overall Study|Death|26|||
147535074|NCT02335411|532114818|FG000|Overall Study|Physician Decision|3|||
147535075|NCT02335411|532114819|FG001|Overall Study|Physician Decision|0|||
147535076|NCT02335411|532114820|FG002|Overall Study|Physician Decision|0|||
147535077|NCT02335411|532114818|FG000|Overall Study|Protocol Violation|1|||
147535078|NCT02335411|532114819|FG001|Overall Study|Protocol Violation|0|||
147535079|NCT02335411|532114820|FG002|Overall Study|Protocol Violation|0|||
147535080|NCT02335411|532114818|FG000|Overall Study|Withdrawal by Subject|11|||
147535081|NCT02335411|532114819|FG001|Overall Study|Withdrawal by Subject|0|||
147535082|NCT02335411|532114820|FG002|Overall Study|Withdrawal by Subject|3|||
147535083|NCT02335411|532114818|FG000|Overall Study|Sponsor Decision|12|||
147535084|NCT02335411|532114819|FG001|Overall Study|Sponsor Decision|3|||
147535085|NCT02335411|532114820|FG002|Overall Study|Sponsor Decision|2|||
147535086|NCT02335411|532114818|FG000|Overall Study|Adverse Event|9|||
147535087|NCT02335411|532114819|FG001|Overall Study|Adverse Event|0|||
147535088|NCT02335411|532114820|FG002|Overall Study|Adverse Event|0|||
147535089|NCT03075826|532114822|FG000|Overall Study|Withdrawal by Subject|1|||
147535090|NCT03075826|532114822|FG000|Overall Study|Received less than 3 cycles of study drug|5|||
147535091|NCT00650806|532114823|FG000|Overall Study|Adverse Event|0|||
147535092|NCT00650806|532114824|FG001|Overall Study|Adverse Event|5|||
147535093|NCT00650806|532114825|FG002|Overall Study|Adverse Event|3|||
147535094|NCT00650806|532114826|FG003|Overall Study|Adverse Event|4|||
147535095|NCT00650806|532114823|FG000|Overall Study|Lost to Follow-up|7|||
147535096|NCT00650806|532114824|FG001|Overall Study|Lost to Follow-up|6|||
147535097|NCT00650806|532114825|FG002|Overall Study|Lost to Follow-up|11|||
147535098|NCT00650806|532114826|FG003|Overall Study|Lost to Follow-up|10|||
147535099|NCT00650806|532114823|FG000|Overall Study|Protocol Violation|0|||
147535100|NCT00650806|532114824|FG001|Overall Study|Protocol Violation|0|||
147535101|NCT00650806|532114825|FG002|Overall Study|Protocol Violation|0|||
147535102|NCT00650806|532114826|FG003|Overall Study|Protocol Violation|1|||
147201238|NCT03252925|530908915|FG001|Overall Study|Lost to Follow-up|6|||
147535103|NCT00650806|532114823|FG000|Overall Study|Pregnancy|0|||
147535104|NCT00650806|532114824|FG001|Overall Study|Pregnancy|0|||
147535105|NCT00650806|532114825|FG002|Overall Study|Pregnancy|0|||
147535106|NCT00650806|532114826|FG003|Overall Study|Pregnancy|1|||
147535107|NCT00650806|532114823|FG000|Overall Study|Withdrawal by Subject|7|||
147201239|NCT00521404|530908916|FG000|Overall Study|Adverse Event|13|||
147201240|NCT00521404|530908916|FG000|Overall Study|Disease Progression|33|||
147201241|NCT00521404|530908916|FG000|Overall Study|Investigator decision|5|||
147201242|NCT00521404|530908916|FG000|Overall Study|Withdrawal of consent|3|||
147201243|NCT00521404|530908916|FG000|Overall Study|Noncompliance or lack of cooperation|1|||
147201244|NCT00521404|530908916|FG000|Overall Study|Other|7|||
147201245|NCT01383356|530908917|FG000|Period 1|Adverse Event|5|||
147201246|NCT01383356|530908918|FG001|Period 1|Adverse Event|3|||
147201247|NCT01383356|530908917|FG000|Period 1|Non-compliance|3|||
147201248|NCT01383356|530908918|FG001|Period 1|Non-compliance|0|||
147201249|NCT01383356|530908917|FG000|Period 1|Out of Range Mid-study-Test|0|||
147201250|NCT01383356|530908918|FG001|Period 1|Out of Range Mid-study-Test|1|||
147201251|NCT01383356|530908917|FG000|Period 1|Personal|0|||
147201252|NCT01383356|530908918|FG001|Period 1|Personal|2|||
147201253|NCT00602472|530908919|FG000|Overall Study|Adverse Event|5|||
147201254|NCT00602472|530908920|FG001|Overall Study|Adverse Event|23|||
147435327|NCT01132612|531760464|FG001|Overall Study|Death|0|||
147435328|NCT01132612|531760465|FG002|Overall Study|Death|1|||
147435329|NCT01132612|531760463|FG000|Overall Study|Protocol deviation|0|||
147435330|NCT01132612|531760464|FG001|Overall Study|Protocol deviation|0|||
147435331|NCT01132612|531760465|FG002|Overall Study|Protocol deviation|3|||
147435332|NCT01132612|531760463|FG000|Overall Study|Lost to Follow-up|2|||
147435333|NCT01132612|531760464|FG001|Overall Study|Lost to Follow-up|2|||
147435334|NCT01132612|531760465|FG002|Overall Study|Lost to Follow-up|7|||
147435335|NCT01132612|531760463|FG000|Overall Study|Adverse Event|5|||
147435336|NCT01132612|531760464|FG001|Overall Study|Adverse Event|2|||
147435337|NCT01132612|531760465|FG002|Overall Study|Adverse Event|15|||
147435338|NCT01132612|531760463|FG000|Overall Study|Withdrawal by Subject|5|||
147435339|NCT01132612|531760464|FG001|Overall Study|Withdrawal by Subject|8|||
147435340|NCT01132612|531760465|FG002|Overall Study|Withdrawal by Subject|19|||
147435341|NCT01132612|531760463|FG000|Overall Study|Administrative problems|5|||
147435342|NCT01132612|531760464|FG001|Overall Study|Administrative problems|1|||
147435343|NCT01132612|531760465|FG002|Overall Study|Administrative problems|52|||
147435344|NCT01132612|531760463|FG000|Overall Study|Lack of Efficacy|23|||
147435345|NCT01132612|531760464|FG001|Overall Study|Lack of Efficacy|22|||
147435346|NCT01132612|531760465|FG002|Overall Study|Lack of Efficacy|73|||
147435347|NCT02252536|531760469|FG000|Overall Study|Lost to Follow-up|5|||
147435348|NCT02252536|531760470|FG001|Overall Study|Lost to Follow-up|3|||
147435349|NCT00006392|531760476|FG000|Overall Study|Ineligible|11|||
147435350|NCT00006392|531760477|FG001|Overall Study|Ineligible|3|||
147435351|NCT00006392|531760478|FG002|Overall Study|Ineligible|5|||
147435352|NCT00006392|531760479|FG003|Overall Study|Ineligible|5|||
147435353|NCT00006392|531760476|FG000|Overall Study|Poor data/ppt mgmt, regulatory problems|156|||
147435354|NCT00006392|531760477|FG001|Overall Study|Poor data/ppt mgmt, regulatory problems|155|||
147435355|NCT00006392|531760478|FG002|Overall Study|Poor data/ppt mgmt, regulatory problems|155|||
147435356|NCT00006392|531760479|FG003|Overall Study|Poor data/ppt mgmt, regulatory problems|155|||
147435357|NCT00578786|531760480|FG000|Overall Study|Adverse Event|27|||
147435358|NCT00578786|531760481|FG001|Overall Study|Adverse Event|37|||
147435359|NCT00578786|531760482|FG002|Overall Study|Adverse Event|17|||
147435360|NCT00578786|531760480|FG000|Overall Study|Lack of Efficacy|2|||
147435361|NCT00578786|531760481|FG001|Overall Study|Lack of Efficacy|5|||
147435362|NCT00578786|531760482|FG002|Overall Study|Lack of Efficacy|2|||
147435363|NCT00578786|531760480|FG000|Overall Study|Early Escape from Prior Study|2|||
147435364|NCT00578786|531760481|FG001|Overall Study|Early Escape from Prior Study|1|||
147435365|NCT00578786|531760482|FG002|Overall Study|Early Escape from Prior Study|2|||
147435366|NCT00578786|531760480|FG000|Overall Study|Withdrawal by Subject|7|||
147435367|NCT00578786|531760481|FG001|Overall Study|Withdrawal by Subject|8|||
147435368|NCT00578786|531760482|FG002|Overall Study|Withdrawal by Subject|5|||
147435369|NCT00578786|531760480|FG000|Overall Study|Protocol Violation|0|||
147435370|NCT00578786|531760481|FG001|Overall Study|Protocol Violation|3|||
147435371|NCT00578786|531760482|FG002|Overall Study|Protocol Violation|1|||
147435372|NCT00578786|531760480|FG000|Overall Study|Physician Decision|1|||
147435373|NCT00578786|531760481|FG001|Overall Study|Physician Decision|0|||
147435374|NCT00578786|531760482|FG002|Overall Study|Physician Decision|1|||
147435375|NCT00578786|531760480|FG000|Overall Study|Sponsor Decision|0|||
147435376|NCT00578786|531760481|FG001|Overall Study|Sponsor Decision|0|||
147435377|NCT00578786|531760482|FG002|Overall Study|Sponsor Decision|1|||
147435378|NCT00578786|531760480|FG000|Overall Study|Lost to Follow-up|0|||
147435379|NCT00578786|531760481|FG001|Overall Study|Lost to Follow-up|4|||
147435380|NCT00578786|531760482|FG002|Overall Study|Lost to Follow-up|0|||
147435381|NCT00578786|531760480|FG000|Overall Study|Pregnancy|0|||
147435382|NCT00578786|531760481|FG001|Overall Study|Pregnancy|1|||
147435383|NCT00578786|531760482|FG002|Overall Study|Pregnancy|0|||
147435384|NCT00578786|531760480|FG000|Overall Study|Not Otherwise Specified|0|||
147435385|NCT00578786|531760481|FG001|Overall Study|Not Otherwise Specified|4|||
147435386|NCT00578786|531760482|FG002|Overall Study|Not Otherwise Specified|1|||
147201255|NCT00602472|530908919|FG000|Overall Study|Protocol Violation|4|||
147201256|NCT00602472|530908920|FG001|Overall Study|Protocol Violation|19|||
147435387|NCT00578786|531760480|FG000|Overall Study|Qualified but Not Enrolled in Extension|0|||
147201257|NCT00602472|530908919|FG000|Overall Study|Withdrawal by Subject|8|||
147201258|NCT00602472|530908920|FG001|Overall Study|Withdrawal by Subject|14|||
147201259|NCT00602472|530908919|FG000|Overall Study|Other incl. lack of efficacy|4|||
147201260|NCT00602472|530908920|FG001|Overall Study|Other incl. lack of efficacy|2|||
147201261|NCT01908803|530908927|FG000|Overall Study|Adverse Event|1|||
147201262|NCT01908803|530908928|FG001|Overall Study|Adverse Event|0|||
147201263|NCT01908803|530908927|FG000|Overall Study|Physician Decision|0|||
147201264|NCT01908803|530908928|FG001|Overall Study|Physician Decision|1|||
147201265|NCT01908803|530908927|FG000|Overall Study|Withdrawal by Subject|1|||
147201266|NCT01908803|530908928|FG001|Overall Study|Withdrawal by Subject|0|||
147201267|NCT01908803|530908927|FG000|Overall Study|Randomization Error|1|||
147201268|NCT01908803|530908928|FG001|Overall Study|Randomization Error|0|||
147201269|NCT01908803|530908927|FG000|Overall Study|Adverse Event (pre-treatment)|1|||
147201270|NCT01908803|530908928|FG001|Overall Study|Adverse Event (pre-treatment)|0|||
147201271|NCT00098813|530908929|FG000|Overall Study|Death|8|||
147201272|NCT00098813|530908929|FG000|Overall Study|Protocol Violation|1|||
147201273|NCT00098813|530908929|FG000|Overall Study|Withdrawal by Subject|7|||
147201274|NCT00098813|530908929|FG000|Overall Study|Progression of Disease|1|||
147201275|NCT00098813|530908929|FG000|Overall Study|Other complicating disease|1|||
147201276|NCT00098813|530908929|FG000|Overall Study|Reversal of RAI resistance|1|||
147201277|NCT03926611|530908930|FG000|Overall Study|Adverse Event|0|||
147201278|NCT03926611|530908931|FG001|Overall Study|Adverse Event|0|||
147201279|NCT03926611|530908932|FG002|Overall Study|Adverse Event|0|||
147201280|NCT03926611|530908933|FG003|Overall Study|Adverse Event|3|||
147201281|NCT03926611|530908934|FG004|Overall Study|Adverse Event|1|||
147201282|NCT03926611|530908935|FG005|Overall Study|Adverse Event|3|||
147201283|NCT03926611|530908936|FG006|Overall Study|Adverse Event|0|||
147201284|NCT03926611|530908930|FG000|Overall Study|Lack of Efficacy|1|||
147201285|NCT03926611|530908931|FG001|Overall Study|Lack of Efficacy|2|||
147201286|NCT03926611|530908932|FG002|Overall Study|Lack of Efficacy|0|||
147201287|NCT03926611|530908933|FG003|Overall Study|Lack of Efficacy|0|||
147201288|NCT03926611|530908934|FG004|Overall Study|Lack of Efficacy|1|||
147201289|NCT03926611|530908935|FG005|Overall Study|Lack of Efficacy|0|||
147201290|NCT03926611|530908936|FG006|Overall Study|Lack of Efficacy|1|||
147201291|NCT03926611|530908930|FG000|Overall Study|Physician Decision|0|||
147201292|NCT03926611|530908931|FG001|Overall Study|Physician Decision|0|||
147201293|NCT03926611|530908932|FG002|Overall Study|Physician Decision|0|||
147201294|NCT03926611|530908933|FG003|Overall Study|Physician Decision|0|||
147201295|NCT03926611|530908934|FG004|Overall Study|Physician Decision|0|||
147201296|NCT03926611|530908935|FG005|Overall Study|Physician Decision|1|||
147201297|NCT03926611|530908936|FG006|Overall Study|Physician Decision|0|||
147201298|NCT03926611|530908930|FG000|Overall Study|Protocol Violation|1|||
147201299|NCT03926611|530908931|FG001|Overall Study|Protocol Violation|0|||
147201300|NCT03926611|530908932|FG002|Overall Study|Protocol Violation|0|||
147201301|NCT03926611|530908933|FG003|Overall Study|Protocol Violation|1|||
147201302|NCT03926611|530908934|FG004|Overall Study|Protocol Violation|1|||
147201303|NCT03926611|530908935|FG005|Overall Study|Protocol Violation|1|||
147201304|NCT03926611|530908936|FG006|Overall Study|Protocol Violation|1|||
147201305|NCT03926611|530908930|FG000|Overall Study|Technical problems|0|||
147201306|NCT03926611|530908931|FG001|Overall Study|Technical problems|0|||
147201307|NCT03926611|530908932|FG002|Overall Study|Technical problems|0|||
147201308|NCT03926611|530908933|FG003|Overall Study|Technical problems|0|||
147201309|NCT03926611|530908934|FG004|Overall Study|Technical problems|0|||
147201310|NCT03926611|530908935|FG005|Overall Study|Technical problems|1|||
147201311|NCT03926611|530908936|FG006|Overall Study|Technical problems|0|||
147201312|NCT03926611|530908930|FG000|Overall Study|Withdrawal by Subject|1|||
147201313|NCT03926611|530908931|FG001|Overall Study|Withdrawal by Subject|1|||
147201314|NCT03926611|530908932|FG002|Overall Study|Withdrawal by Subject|1|||
147201315|NCT03926611|530908933|FG003|Overall Study|Withdrawal by Subject|0|||
147201316|NCT03926611|530908934|FG004|Overall Study|Withdrawal by Subject|0|||
147201317|NCT03926611|530908935|FG005|Overall Study|Withdrawal by Subject|1|||
147201318|NCT03926611|530908936|FG006|Overall Study|Withdrawal by Subject|3|||
147201319|NCT03926611|530908930|FG000|Overall Study|Covid-19 pandemic|0|||
147201320|NCT03926611|530908931|FG001|Overall Study|Covid-19 pandemic|0|||
147201321|NCT03926611|530908932|FG002|Overall Study|Covid-19 pandemic|1|||
147201322|NCT03926611|530908933|FG003|Overall Study|Covid-19 pandemic|0|||
147201323|NCT03926611|530908934|FG004|Overall Study|Covid-19 pandemic|1|||
147201324|NCT03926611|530908935|FG005|Overall Study|Covid-19 pandemic|2|||
147201325|NCT03926611|530908936|FG006|Overall Study|Covid-19 pandemic|0|||
147201326|NCT02230670|530908937|FG000|Overall Study|Adverse Event|1|||
147201327|NCT02230670|530908938|FG001|Overall Study|Adverse Event|2|||
147201328|NCT02230670|530908937|FG000|Overall Study|Withdrawal by Subject|2|||
147201329|NCT02230670|530908938|FG001|Overall Study|Withdrawal by Subject|2|||
147201330|NCT02230670|530908937|FG000|Overall Study|Physician Decision|0|||
147201331|NCT02230670|530908938|FG001|Overall Study|Physician Decision|1|||
147201332|NCT02230670|530908937|FG000|Overall Study|Protocol Violation|0|||
147201333|NCT02230670|530908938|FG001|Overall Study|Protocol Violation|1|||
147201334|NCT02230670|530908937|FG000|Overall Study|Progression to Child-Pugh C|1|||
147201335|NCT02230670|530908938|FG001|Overall Study|Progression to Child-Pugh C|2|||
147201336|NCT01002339|530908939|FG000|Overall Study|Withdrawal by Subject|0|||
147201337|NCT01002339|530908940|FG001|Overall Study|Withdrawal by Subject|1|||
147201338|NCT01002339|530908941|FG002|Overall Study|Withdrawal by Subject|0|||
147201339|NCT01002339|530908939|FG000|Overall Study|Incorrect treatment assignment|0|||
147201340|NCT01002339|530908940|FG001|Overall Study|Incorrect treatment assignment|0|||
147201341|NCT01002339|530908941|FG002|Overall Study|Incorrect treatment assignment|1|||
147201342|NCT01002339|530908939|FG000|Overall Study|Protocol Violation|0|||
147306798|NCT02839343|531290769|FG000|Overall Study|Withdrawal by Subject|3|||
147201343|NCT01002339|530908940|FG001|Overall Study|Protocol Violation|0|||
147201344|NCT01002339|530908941|FG002|Overall Study|Protocol Violation|2|||
147201345|NCT01002339|530908939|FG000|Overall Study|Lung cancer detected before transplant|0|||
147201346|NCT01002339|530908940|FG001|Overall Study|Lung cancer detected before transplant|0|||
147201347|NCT01002339|530908941|FG002|Overall Study|Lung cancer detected before transplant|1|||
147201348|NCT01002339|530908939|FG000|Overall Study|Randomized. Not transplanted|0|||
147201349|NCT01002339|530908940|FG001|Overall Study|Randomized. Not transplanted|0|||
147201350|NCT01002339|530908941|FG002|Overall Study|Randomized. Not transplanted|1|||
147201351|NCT01907854|530908942|FG000|Overall Study|Protocol Violation|1|||
147201352|NCT01907854|530908943|FG001|Overall Study|Protocol Violation|1|||
147201353|NCT01907854|530908942|FG000|Overall Study|Withdrawal by Subject|9|||
147201354|NCT01907854|530908943|FG001|Overall Study|Withdrawal by Subject|7|||
147201355|NCT01907854|530908942|FG000|Overall Study|Lost to Follow-up|2|||
147201356|NCT01907854|530908943|FG001|Overall Study|Lost to Follow-up|2|||
147201357|NCT01907854|530908942|FG000|Overall Study|Unclassified|4|||
147201358|NCT01907854|530908943|FG001|Overall Study|Unclassified|3|||
147201359|NCT02215252|530908944|FG000|Overall Study|Adverse Event|1|||
147201360|NCT02215252|530908945|FG001|Overall Study|Adverse Event|5|||
147201361|NCT02215252|530908946|FG002|Overall Study|Adverse Event|2|||
147201362|NCT02215252|530908944|FG000|Overall Study|Lost to Follow-up|0|||
147201363|NCT02215252|530908945|FG001|Overall Study|Lost to Follow-up|0|||
147201364|NCT02215252|530908946|FG002|Overall Study|Lost to Follow-up|1|||
147201365|NCT02215252|530908944|FG000|Overall Study|Does not Meet Entrance Criteria|0|||
147201366|NCT02215252|530908945|FG001|Overall Study|Does not Meet Entrance Criteria|1|||
147201367|NCT02215252|530908946|FG002|Overall Study|Does not Meet Entrance Criteria|0|||
147201368|NCT02215252|530908944|FG000|Overall Study|Protocol Violation|0|||
147201369|NCT02215252|530908945|FG001|Overall Study|Protocol Violation|1|||
147201370|NCT02215252|530908946|FG002|Overall Study|Protocol Violation|0|||
147201371|NCT02215252|530908944|FG000|Overall Study|Withdrawal by Subject|1|||
147201372|NCT02215252|530908945|FG001|Overall Study|Withdrawal by Subject|0|||
147201373|NCT02215252|530908946|FG002|Overall Study|Withdrawal by Subject|0|||
147201374|NCT02215252|530908944|FG000|Overall Study|Other|0|||
147201375|NCT02215252|530908945|FG001|Overall Study|Other|1|||
147201376|NCT02215252|530908946|FG002|Overall Study|Other|1|||
147201377|NCT00892099|530908947|FG000|Overall Study|Death|1|||
147201378|NCT00892099|530908948|FG001|Overall Study|Death|0|||
147201379|NCT00892099|530908949|FG002|Overall Study|Death|1|||
147201380|NCT00892099|530908947|FG000|Overall Study|Adverse Event|1|||
147201381|NCT00892099|530908948|FG001|Overall Study|Adverse Event|0|||
147201382|NCT00892099|530908949|FG002|Overall Study|Adverse Event|0|||
147201383|NCT00892099|530908947|FG000|Overall Study|replocated|1|||
147201384|NCT00892099|530908948|FG001|Overall Study|replocated|0|||
147201385|NCT00892099|530908949|FG002|Overall Study|replocated|2|||
147201386|NCT00892099|530908947|FG000|Overall Study|Prolonged hospitalization|1|||
147201387|NCT00892099|530908948|FG001|Overall Study|Prolonged hospitalization|0|||
147201388|NCT00892099|530908949|FG002|Overall Study|Prolonged hospitalization|1|||
147201389|NCT00892099|530908947|FG000|Overall Study|no further details|1|||
147201390|NCT00892099|530908948|FG001|Overall Study|no further details|0|||
147201391|NCT00892099|530908949|FG002|Overall Study|no further details|1|||
147201392|NCT00892099|530908947|FG000|Overall Study|kidney function recovered|0|||
147201393|NCT00892099|530908948|FG001|Overall Study|kidney function recovered|1|||
147201394|NCT00892099|530908949|FG002|Overall Study|kidney function recovered|0|||
147201395|NCT00892099|530908947|FG000|Overall Study|investigator decision|0|||
147201396|NCT00892099|530908948|FG001|Overall Study|investigator decision|0|||
147201397|NCT00892099|530908949|FG002|Overall Study|investigator decision|1|||
147201398|NCT00892099|530908947|FG000|Overall Study|Lost to Follow-up|0|||
147201399|NCT00892099|530908948|FG001|Overall Study|Lost to Follow-up|0|||
147201400|NCT00892099|530908949|FG002|Overall Study|Lost to Follow-up|1|||
147201401|NCT01657019|530908950|FG000|Overall Study|Withdrawal by Subject|65|||
147201402|NCT01657019|530908950|FG000|Overall Study|Adverse Event|55|||
147201403|NCT01657019|530908950|FG000|Overall Study|Lost to Follow-up|48|||
147201404|NCT01657019|530908950|FG000|Overall Study|Protocol Violation|6|||
147201405|NCT01657019|530908950|FG000|Overall Study|Lack of Efficacy|3|||
147201406|NCT01657019|530908950|FG000|Overall Study|Other|58|||
147201407|NCT00956007|530908951|FG000|Overall Study|Protocol Violation|27|||
147201408|NCT00956007|530908952|FG001|Overall Study|Protocol Violation|23|||
147201409|NCT01750229|530908953|FG000|Randomized Crossover Phase|Adverse Event|1|||
147535108|NCT00650806|532114824|FG001|Overall Study|Withdrawal by Subject|5|||
147535109|NCT00650806|532114825|FG002|Overall Study|Withdrawal by Subject|8|||
147535110|NCT00650806|532114826|FG003|Overall Study|Withdrawal by Subject|6|||
147201410|NCT01750229|530908953|FG000|Randomized Crossover Phase|Withdrawal by Subject|1|||
147201411|NCT01750229|530908953|FG000|Long-term Follow-up Phase|Adverse Event|2|||
147201412|NCT01750229|530908953|FG000|Long-term Follow-up Phase|Withdrawal by Subject|1|||
147201413|NCT02346721|530908954|FG000|Overall Study|Withdrew Consent|3|||
147201414|NCT02346721|530908954|FG000|Overall Study|Lack of Efficacy|1|||
147201415|NCT01285323|530908955|FG000|Overall Study|Adverse Event|9|||
147201416|NCT01285323|530908956|FG001|Overall Study|Adverse Event|8|||
147201417|NCT01285323|530908955|FG000|Overall Study|Lack of Efficacy|4|||
147306799|NCT02839343|531290770|FG001|Overall Study|Withdrawal by Subject|1|||
147201418|NCT01285323|530908956|FG001|Overall Study|Lack of Efficacy|2|||
147201419|NCT01285323|530908955|FG000|Overall Study|Withdrawal by Subject|15|||
147201420|NCT01285323|530908956|FG001|Overall Study|Withdrawal by Subject|11|||
147201421|NCT01285323|530908955|FG000|Overall Study|Protocol Violation|1|||
147201422|NCT01285323|530908956|FG001|Overall Study|Protocol Violation|2|||
147201423|NCT01285323|530908955|FG000|Overall Study|Non-compliance with study procedures|2|||
147201424|NCT01285323|530908956|FG001|Overall Study|Non-compliance with study procedures|3|||
147201425|NCT01285323|530908955|FG000|Overall Study|Lost to Follow-up|1|||
147201426|NCT01285323|530908956|FG001|Overall Study|Lost to Follow-up|1|||
147201427|NCT01285323|530908955|FG000|Overall Study|Other|1|||
147201428|NCT01285323|530908956|FG001|Overall Study|Other|3|||
147201429|NCT02158546|530908958|FG000|Overall Study|Physician Decision|0|||
147201430|NCT02158546|530908959|FG001|Overall Study|Physician Decision|1|||
147201431|NCT02158546|530908960|FG002|Overall Study|Physician Decision|0|||
147201432|NCT02158546|530908961|FG003|Overall Study|Physician Decision|0|||
147201433|NCT02158546|530908958|FG000|Overall Study|Non-compliance|0|||
147201434|NCT02158546|530908959|FG001|Overall Study|Non-compliance|1|||
147201435|NCT02158546|530908960|FG002|Overall Study|Non-compliance|0|||
147201436|NCT02158546|530908961|FG003|Overall Study|Non-compliance|1|||
147201437|NCT02158546|530908958|FG000|Overall Study|Failure to meet eligibility criteria|0|||
147201438|NCT02158546|530908959|FG001|Overall Study|Failure to meet eligibility criteria|1|||
147201439|NCT02158546|530908960|FG002|Overall Study|Failure to meet eligibility criteria|0|||
147201440|NCT02158546|530908961|FG003|Overall Study|Failure to meet eligibility criteria|0|||
147201441|NCT02158546|530908958|FG000|Overall Study|Lack of Efficacy|1|||
147201442|NCT02158546|530908959|FG001|Overall Study|Lack of Efficacy|1|||
147201443|NCT02158546|530908960|FG002|Overall Study|Lack of Efficacy|0|||
147201444|NCT02158546|530908961|FG003|Overall Study|Lack of Efficacy|0|||
147201445|NCT02158546|530908958|FG000|Overall Study|Adverse Event|2|||
147201446|NCT02158546|530908959|FG001|Overall Study|Adverse Event|2|||
147201447|NCT02158546|530908960|FG002|Overall Study|Adverse Event|0|||
147201448|NCT02158546|530908961|FG003|Overall Study|Adverse Event|0|||
147201449|NCT02158546|530908958|FG000|Overall Study|Withdrawal by Subject|6|||
147201450|NCT02158546|530908959|FG001|Overall Study|Withdrawal by Subject|2|||
147201451|NCT02158546|530908960|FG002|Overall Study|Withdrawal by Subject|1|||
147201452|NCT02158546|530908961|FG003|Overall Study|Withdrawal by Subject|0|||
147201453|NCT02158546|530908958|FG000|Overall Study|Lost to Follow-up|5|||
147201454|NCT02158546|530908959|FG001|Overall Study|Lost to Follow-up|4|||
147201455|NCT02158546|530908960|FG002|Overall Study|Lost to Follow-up|0|||
147535111|NCT00650806|532114823|FG000|Overall Study|Noncompliance with study drug regimen|1|||
147535112|NCT00650806|532114824|FG001|Overall Study|Noncompliance with study drug regimen|1|||
147535113|NCT00650806|532114825|FG002|Overall Study|Noncompliance with study drug regimen|0|||
147535114|NCT00650806|532114826|FG003|Overall Study|Noncompliance with study drug regimen|0|||
147535115|NCT00650806|532114823|FG000|Overall Study|Study terminated by sponsor|2|||
147535116|NCT00650806|532114824|FG001|Overall Study|Study terminated by sponsor|3|||
147535117|NCT00650806|532114825|FG002|Overall Study|Study terminated by sponsor|5|||
147535118|NCT00650806|532114826|FG003|Overall Study|Study terminated by sponsor|4|||
147535119|NCT00650806|532114823|FG000|Overall Study|Other|1|||
147201456|NCT02158546|530908961|FG003|Overall Study|Lost to Follow-up|1|||
147201457|NCT02158546|530908958|FG000|Overall Study|Site Excluded|5|||
147201458|NCT02158546|530908959|FG001|Overall Study|Site Excluded|5|||
147201459|NCT02158546|530908960|FG002|Overall Study|Site Excluded|3|||
147201460|NCT02158546|530908961|FG003|Overall Study|Site Excluded|4|||
147201461|NCT02351817|530908963|FG000|Period 1|Adverse Event|1|||
147201462|NCT02351817|530908964|FG001|Period 1|Adverse Event|2|||
147201463|NCT02351817|530908963|FG000|Period 1|Lack of Efficacy|0|||
147201464|NCT02351817|530908964|FG001|Period 1|Lack of Efficacy|1|||
147201465|NCT02351817|530908963|FG000|Period 2|Adverse Event|0|||
147201466|NCT02351817|530908964|FG001|Period 2|Adverse Event|2|||
147201467|NCT02351817|530908963|FG000|Period 2|Protocol Violation|1|||
147201468|NCT02351817|530908964|FG001|Period 2|Protocol Violation|0|||
147201469|NCT00803569|530908965|FG000|Overall Study|Progressive Disease|3|||
147201470|NCT00803569|530908965|FG000|Overall Study|Noncompliance|1|||
147201471|NCT02488915|530908968|FG000|Overall Study|Death|21|||
147201472|NCT02488915|530908968|FG000|Overall Study|Lost to Follow-up|4|||
147201473|NCT02488915|530908968|FG000|Overall Study|Withdrawal by Subject|1|||
147201474|NCT00885170|530908973|FG000|Overall Study|Adverse Event|12|||
147201475|NCT00885170|530908974|FG001|Overall Study|Adverse Event|4|||
147201476|NCT00885170|530908973|FG000|Overall Study|Excessive bone loss|6|||
147201477|NCT00885170|530908974|FG001|Overall Study|Excessive bone loss|3|||
147201478|NCT00885170|530908973|FG000|Overall Study|Lost to Follow-up|2|||
147201479|NCT00885170|530908974|FG001|Overall Study|Lost to Follow-up|1|||
147201480|NCT00885170|530908973|FG000|Overall Study|Physician Decision|2|||
147201481|NCT00885170|530908974|FG001|Overall Study|Physician Decision|1|||
147201482|NCT00885170|530908973|FG000|Overall Study|Protocol Violation|3|||
147201483|NCT00885170|530908974|FG001|Overall Study|Protocol Violation|1|||
147201484|NCT00885170|530908973|FG000|Overall Study|Withdrawal by Subject|13|||
147201485|NCT00885170|530908974|FG001|Overall Study|Withdrawal by Subject|13|||
147201486|NCT03771664|530908975|FG000|Overall Study|Adverse Event|1|||
147201487|NCT03771664|530908976|FG001|Overall Study|Adverse Event|0|||
147201488|NCT03771664|530908975|FG000|Overall Study|Lost to Follow-up|1|||
147201489|NCT03771664|530908976|FG001|Overall Study|Lost to Follow-up|0|||
147201490|NCT03771664|530908975|FG000|Overall Study|Withdrawal by Participant|1|||
147201491|NCT03771664|530908976|FG001|Overall Study|Withdrawal by Participant|4|||
147201492|NCT03771664|530908975|FG000|Overall Study|Randomized but not Treated|0|||
147201493|NCT03771664|530908976|FG001|Overall Study|Randomized but not Treated|1|||
147201494|NCT04041414|530908979|FG000|Overall Study|Lost to Follow-up|1|||
147535120|NCT00650806|532114824|FG001|Overall Study|Other|1|||
147201495|NCT04041414|530908980|FG001|Overall Study|Lost to Follow-up|2|||
147201496|NCT00665652|530908981|FG000|Overall Study|Adverse Event|4|||
147201497|NCT00665652|530908981|FG000|Overall Study|Death|1|||
147201498|NCT00665652|530908981|FG000|Overall Study|No longer met inclusion criteria.|1|||
147201499|NCT02900378|530908987|FG000|Randomization (Visit 2)|Adverse Event|14|||
147201500|NCT02900378|530908988|FG001|Randomization (Visit 2)|Adverse Event|11|||
147201501|NCT02900378|530908987|FG000|Randomization (Visit 2)|Death|1|||
147201502|NCT02900378|530908988|FG001|Randomization (Visit 2)|Death|4|||
147201503|NCT02900378|530908987|FG000|Randomization (Visit 2)|Lost to Follow-up|1|||
147201504|NCT02900378|530908988|FG001|Randomization (Visit 2)|Lost to Follow-up|0|||
147201505|NCT02900378|530908987|FG000|Randomization (Visit 2)|Non-compliance with Study Drug|1|||
147201506|NCT02900378|530908988|FG001|Randomization (Visit 2)|Non-compliance with Study Drug|1|||
147201507|NCT02900378|530908987|FG000|Randomization (Visit 2)|Protocol Deviation|1|||
147201508|NCT02900378|530908988|FG001|Randomization (Visit 2)|Protocol Deviation|7|||
147201509|NCT02900378|530908987|FG000|Randomization (Visit 2)|Withdrawal by Parent/Guardian|5|||
147201510|NCT02900378|530908988|FG001|Randomization (Visit 2)|Withdrawal by Parent/Guardian|3|||
147201511|NCT02900378|530908987|FG000|Randomization (Visit 2)|Withdrawal of Informed Consent|0|||
147201512|NCT02900378|530908988|FG001|Randomization (Visit 2)|Withdrawal of Informed Consent|2|||
147201513|NCT03818321|530908989|FG000|Overall Study|Withdrawal by Subject|1|||
147201514|NCT03818321|530908990|FG001|Overall Study|Withdrawal by Subject|2|||
147201515|NCT01134055|530908991|FG000|Overall Study|Adverse Event|5|||
147201516|NCT01134055|530908992|FG001|Overall Study|Adverse Event|2|||
147201517|NCT01134055|530908993|FG002|Overall Study|Adverse Event|2|||
147201518|NCT01134055|530908994|FG003|Overall Study|Adverse Event|2|||
147201519|NCT01134055|530908995|FG004|Overall Study|Adverse Event|5|||
147201520|NCT01134055|530908996|FG005|Overall Study|Adverse Event|7|||
147201521|NCT01134055|530908997|FG006|Overall Study|Adverse Event|2|||
147201522|NCT01134055|530908991|FG000|Overall Study|Lost to Follow-up|0|||
147201523|NCT01134055|530908992|FG001|Overall Study|Lost to Follow-up|1|||
147201524|NCT01134055|530908993|FG002|Overall Study|Lost to Follow-up|0|||
147201525|NCT01134055|530908994|FG003|Overall Study|Lost to Follow-up|1|||
147201526|NCT01134055|530908995|FG004|Overall Study|Lost to Follow-up|0|||
147201527|NCT01134055|530908996|FG005|Overall Study|Lost to Follow-up|0|||
147201528|NCT01134055|530908997|FG006|Overall Study|Lost to Follow-up|0|||
147201529|NCT01134055|530908991|FG000|Overall Study|Withdrawal by Subject|3|||
147201530|NCT01134055|530908992|FG001|Overall Study|Withdrawal by Subject|3|||
147201531|NCT01134055|530908993|FG002|Overall Study|Withdrawal by Subject|1|||
147201532|NCT01134055|530908994|FG003|Overall Study|Withdrawal by Subject|2|||
147201533|NCT01134055|530908995|FG004|Overall Study|Withdrawal by Subject|0|||
147201534|NCT01134055|530908996|FG005|Overall Study|Withdrawal by Subject|0|||
147201535|NCT01134055|530908997|FG006|Overall Study|Withdrawal by Subject|8|||
147201536|NCT01134055|530908991|FG000|Overall Study|Protocol Violation|0|||
147201537|NCT01134055|530908992|FG001|Overall Study|Protocol Violation|0|||
147201538|NCT01134055|530908993|FG002|Overall Study|Protocol Violation|0|||
147201539|NCT01134055|530908994|FG003|Overall Study|Protocol Violation|1|||
147201540|NCT01134055|530908995|FG004|Overall Study|Protocol Violation|1|||
147201541|NCT01134055|530908996|FG005|Overall Study|Protocol Violation|0|||
147435388|NCT00578786|531760481|FG001|Overall Study|Qualified but Not Enrolled in Extension|3|||
147435389|NCT00578786|531760482|FG002|Overall Study|Qualified but Not Enrolled in Extension|0|||
147435390|NCT00728481|531760486|FG000|Overall Study|Withdrawal by Subject|0|||
147435391|NCT00728481|531760487|FG001|Overall Study|Withdrawal by Subject|1|||
147435392|NCT00728481|531760486|FG000|Overall Study|Adverse Event|0|||
147435393|NCT00728481|531760487|FG001|Overall Study|Adverse Event|1|||
147435394|NCT00728481|531760486|FG000|Overall Study|Study medication non-compliance|0|||
147435395|NCT00728481|531760487|FG001|Overall Study|Study medication non-compliance|2|||
147435396|NCT00728481|531760486|FG000|Overall Study|Incorrectly assigned to opposite arm|1|||
147435397|NCT00728481|531760487|FG001|Overall Study|Incorrectly assigned to opposite arm|0|||
147435398|NCT00041067|531760488|FG000|Overall Study|Adverse Event|20|||
147435399|NCT00041067|531760488|FG000|Overall Study|Progression|19|||
147435400|NCT00041067|531760488|FG000|Overall Study|Patient refusal|12|||
147435401|NCT00041067|531760488|FG000|Overall Study|Other reasons|23|||
147435402|NCT00041067|531760488|FG000|Overall Study|Ineligible|2|||
147435403|NCT00778622|531760489|FG000|Overall Study|Adverse Event|5|||
147435404|NCT00778622|531760490|FG001|Overall Study|Adverse Event|4|||
147435405|NCT00778622|531760491|FG002|Overall Study|Adverse Event|7|||
147435406|NCT00778622|531760489|FG000|Overall Study|Withdrawal by Subject|4|||
147435407|NCT00778622|531760490|FG001|Overall Study|Withdrawal by Subject|5|||
147435408|NCT00778622|531760491|FG002|Overall Study|Withdrawal by Subject|5|||
147435409|NCT00778622|531760489|FG000|Overall Study|Lost to Follow-up|3|||
147435410|NCT00778622|531760490|FG001|Overall Study|Lost to Follow-up|3|||
147435411|NCT00778622|531760491|FG002|Overall Study|Lost to Follow-up|2|||
147435412|NCT00778622|531760489|FG000|Overall Study|Protocol Violation|0|||
147435413|NCT00778622|531760490|FG001|Overall Study|Protocol Violation|3|||
147435414|NCT00778622|531760491|FG002|Overall Study|Protocol Violation|0|||
147201542|NCT01134055|530908997|FG006|Overall Study|Protocol Violation|0|||
147201543|NCT01134055|530908991|FG000|Overall Study|Physician Decision|0|||
147201544|NCT01134055|530908992|FG001|Overall Study|Physician Decision|0|||
147201545|NCT01134055|530908993|FG002|Overall Study|Physician Decision|0|||
147201546|NCT01134055|530908994|FG003|Overall Study|Physician Decision|0|||
147201547|NCT01134055|530908995|FG004|Overall Study|Physician Decision|0|||
147435415|NCT00778622|531760489|FG000|Overall Study|Lack of Efficacy|2|||
147535121|NCT00650806|532114825|FG002|Overall Study|Other|2|||
147535122|NCT00650806|532114826|FG003|Overall Study|Other|0|||
147535123|NCT03707145|532114832|FG000|Overall Study|Lost to Follow-up|0|||
147535124|NCT03707145|532114833|FG001|Overall Study|Lost to Follow-up|1|||
147535125|NCT03707145|532114834|FG002|Overall Study|Lost to Follow-up|1|||
147535126|NCT03707145|532114835|FG003|Overall Study|Lost to Follow-up|0|||
147201548|NCT01134055|530908996|FG005|Overall Study|Physician Decision|0|||
147201549|NCT01134055|530908997|FG006|Overall Study|Physician Decision|1|||
147535127|NCT04221477|532114836|FG000|Overall Study|Adverse Event|1|||
147535128|NCT04221477|532114837|FG001|Overall Study|Adverse Event|1|||
147535129|NCT04221477|532114836|FG000|Overall Study|Death|5|||
147535130|NCT04221477|532114837|FG001|Overall Study|Death|4|||
147535131|NCT04221477|532114836|FG000|Overall Study|Lack of Efficacy|1|||
147535132|NCT04221477|532114837|FG001|Overall Study|Lack of Efficacy|2|||
147535133|NCT04221477|532114836|FG000|Overall Study|Lost to Follow-up|1|||
147535134|NCT04221477|532114837|FG001|Overall Study|Lost to Follow-up|2|||
147535135|NCT04221477|532114836|FG000|Overall Study|Non-compliance with Study Drug|1|||
147535136|NCT04221477|532114837|FG001|Overall Study|Non-compliance with Study Drug|0|||
147435416|NCT00778622|531760490|FG001|Overall Study|Lack of Efficacy|0|||
147435417|NCT00778622|531760491|FG002|Overall Study|Lack of Efficacy|0|||
147435418|NCT00778622|531760489|FG000|Overall Study|immigration|1|||
147435419|NCT00778622|531760490|FG001|Overall Study|immigration|0|||
147435420|NCT00778622|531760491|FG002|Overall Study|immigration|0|||
147435421|NCT00778622|531760489|FG000|Overall Study|Other|1|||
147435422|NCT00778622|531760490|FG001|Overall Study|Other|0|||
147435423|NCT00778622|531760491|FG002|Overall Study|Other|1|||
147435424|NCT01968070|531760492|FG000|Period 1|Withdrawal by Subject|0|||
147435425|NCT01968070|531760493|FG001|Period 1|Withdrawal by Subject|1|||
147435426|NCT01968070|531760494|FG002|Period 1|Withdrawal by Subject|0|||
147435427|NCT01968070|531760495|FG003|Period 1|Withdrawal by Subject|0|||
147435428|NCT01968070|531760496|FG004|Period 1|Withdrawal by Subject|0|||
147435429|NCT01968070|531760497|FG005|Period 1|Withdrawal by Subject|0|||
147435430|NCT01968070|531760498|FG006|Period 1|Withdrawal by Subject|1|||
147435431|NCT01968070|531760499|FG007|Period 1|Withdrawal by Subject|0|||
147435432|NCT01968070|531760500|FG008|Period 1|Withdrawal by Subject|0|||
147435433|NCT01968070|531760501|FG009|Period 1|Withdrawal by Subject|0|||
147435434|NCT01968070|531760502|FG010|Period 1|Withdrawal by Subject|0|||
147435435|NCT01968070|531760503|FG011|Period 1|Withdrawal by Subject|0|||
147201550|NCT05038982|530908998|FG000|Overall Study|Withdrawal by Subject|0|||
147201551|NCT05038982|530908999|FG001|Overall Study|Withdrawal by Subject|2|||
147201552|NCT01454102|530909001|FG000|Overall Study|Continuing in the treatment period|0|||
147201553|NCT01454102|530909002|FG001|Overall Study|Continuing in the treatment period|0|||
147201554|NCT01454102|530909003|FG002|Overall Study|Continuing in the treatment period|0|||
147201555|NCT01454102|530909004|FG003|Overall Study|Continuing in the treatment period|0|||
147201556|NCT01454102|530909005|FG004|Overall Study|Continuing in the treatment period|3|||
147201557|NCT01454102|530909006|FG005|Overall Study|Continuing in the treatment period|3|||
147201558|NCT01454102|530909007|FG006|Overall Study|Continuing in the treatment period|2|||
147201559|NCT01454102|530909008|FG007|Overall Study|Continuing in the treatment period|0|||
147201560|NCT01454102|530909009|FG008|Overall Study|Continuing in the treatment period|1|||
147201561|NCT01454102|530909010|FG009|Overall Study|Continuing in the treatment period|0|||
147201562|NCT01454102|530909011|FG010|Overall Study|Continuing in the treatment period|0|||
147201563|NCT01454102|530909012|FG011|Overall Study|Continuing in the treatment period|4|||
147201564|NCT01454102|530909013|FG012|Overall Study|Continuing in the treatment period|7|||
147201565|NCT01454102|530909014|FG013|Overall Study|Continuing in the treatment period|4|||
147201566|NCT01454102|530909015|FG014|Overall Study|Continuing in the treatment period|3|||
147201567|NCT01454102|530909016|FG015|Overall Study|Continuing in the treatment period|1|||
147201568|NCT03739203|530909017|FG000|Double-blind Treatment Period (6 Weeks)|Adverse Event|6|||
147201569|NCT03739203|530909018|FG001|Double-blind Treatment Period (6 Weeks)|Adverse Event|9|||
147201570|NCT03739203|530909019|FG002|Double-blind Treatment Period (6 Weeks)|Adverse Event|13|||
147201571|NCT03739203|530909017|FG000|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|1|||
147201572|NCT03739203|530909018|FG001|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
147201573|NCT03739203|530909019|FG002|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|1|||
147201574|NCT03739203|530909017|FG000|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|1|||
147201575|NCT03739203|530909018|FG001|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|1|||
147201576|NCT03739203|530909019|FG002|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|2|||
147201577|NCT03739203|530909017|FG000|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|4|||
147201578|NCT03739203|530909018|FG001|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|4|||
147201579|NCT03739203|530909019|FG002|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|6|||
147201580|NCT03739203|530909017|FG000|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|1|||
147201581|NCT03739203|530909018|FG001|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|0|||
147201582|NCT03739203|530909019|FG002|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|1|||
147435436|NCT01968070|531760504|FG012|Period 1|Withdrawal by Subject|0|||
147435437|NCT01968070|531760505|FG013|Period 1|Withdrawal by Subject|0|||
147435438|NCT01968070|531760506|FG014|Period 1|Withdrawal by Subject|0|||
147435439|NCT01968070|531760507|FG015|Period 1|Withdrawal by Subject|1|||
147435440|NCT01968070|531760508|FG016|Period 1|Withdrawal by Subject|0|||
147435441|NCT01968070|531760509|FG017|Period 1|Withdrawal by Subject|0|||
147435442|NCT01968070|531760492|FG000|Period 1|Protocol Violation|0|||
147435443|NCT01968070|531760493|FG001|Period 1|Protocol Violation|0|||
147435444|NCT01968070|531760494|FG002|Period 1|Protocol Violation|0|||
147435445|NCT01968070|531760495|FG003|Period 1|Protocol Violation|1|||
147435446|NCT01968070|531760496|FG004|Period 1|Protocol Violation|1|||
147435447|NCT01968070|531760497|FG005|Period 1|Protocol Violation|0|||
147435448|NCT01968070|531760498|FG006|Period 1|Protocol Violation|0|||
147435449|NCT01968070|531760499|FG007|Period 1|Protocol Violation|0|||
147435450|NCT01968070|531760500|FG008|Period 1|Protocol Violation|0|||
147435451|NCT01968070|531760501|FG009|Period 1|Protocol Violation|0|||
147435452|NCT01968070|531760502|FG010|Period 1|Protocol Violation|0|||
147435453|NCT01968070|531760503|FG011|Period 1|Protocol Violation|0|||
147435454|NCT01968070|531760504|FG012|Period 1|Protocol Violation|0|||
147435455|NCT01968070|531760505|FG013|Period 1|Protocol Violation|0|||
147435456|NCT01968070|531760506|FG014|Period 1|Protocol Violation|0|||
147435457|NCT01968070|531760507|FG015|Period 1|Protocol Violation|0|||
147435458|NCT01968070|531760508|FG016|Period 1|Protocol Violation|0|||
147435459|NCT01968070|531760509|FG017|Period 1|Protocol Violation|0|||
147435460|NCT01968070|531760492|FG000|Period 1|Lost to Follow-up|0|||
147435461|NCT01968070|531760493|FG001|Period 1|Lost to Follow-up|0|||
147435462|NCT01968070|531760494|FG002|Period 1|Lost to Follow-up|0|||
147435463|NCT01968070|531760495|FG003|Period 1|Lost to Follow-up|1|||
147435464|NCT01968070|531760496|FG004|Period 1|Lost to Follow-up|0|||
147435465|NCT01968070|531760497|FG005|Period 1|Lost to Follow-up|0|||
147435466|NCT01968070|531760498|FG006|Period 1|Lost to Follow-up|0|||
147435467|NCT01968070|531760499|FG007|Period 1|Lost to Follow-up|0|||
147435468|NCT01968070|531760500|FG008|Period 1|Lost to Follow-up|0|||
147435469|NCT01968070|531760501|FG009|Period 1|Lost to Follow-up|0|||
147435470|NCT01968070|531760502|FG010|Period 1|Lost to Follow-up|0|||
147435471|NCT01968070|531760503|FG011|Period 1|Lost to Follow-up|0|||
147435472|NCT01968070|531760504|FG012|Period 1|Lost to Follow-up|0|||
147435473|NCT01968070|531760505|FG013|Period 1|Lost to Follow-up|0|||
147435474|NCT01968070|531760506|FG014|Period 1|Lost to Follow-up|0|||
147435475|NCT01968070|531760507|FG015|Period 1|Lost to Follow-up|0|||
147201583|NCT03739203|530909017|FG000|Double-blind Treatment Period (6 Weeks)|Non-compliance With Study Drug|1|||
147201584|NCT03739203|530909018|FG001|Double-blind Treatment Period (6 Weeks)|Non-compliance With Study Drug|3|||
147201585|NCT03739203|530909019|FG002|Double-blind Treatment Period (6 Weeks)|Non-compliance With Study Drug|1|||
147201586|NCT03739203|530909017|FG000|Double-blind Treatment Period (6 Weeks)|Reason not Specified|1|||
147201587|NCT03739203|530909018|FG001|Double-blind Treatment Period (6 Weeks)|Reason not Specified|0|||
147201588|NCT03739203|530909019|FG002|Double-blind Treatment Period (6 Weeks)|Reason not Specified|1|||
147201589|NCT03739203|530909017|FG000|Safety Follow-Up Period (4 Weeks)|Withdrawal by Subject|1|||
147201590|NCT03739203|530909018|FG001|Safety Follow-Up Period (4 Weeks)|Withdrawal by Subject|2|||
147201591|NCT03739203|530909019|FG002|Safety Follow-Up Period (4 Weeks)|Withdrawal by Subject|0|||
147201592|NCT03739203|530909017|FG000|Safety Follow-Up Period (4 Weeks)|Lost to Follow-up|0|||
147201593|NCT03739203|530909018|FG001|Safety Follow-Up Period (4 Weeks)|Lost to Follow-up|0|||
147201594|NCT03739203|530909019|FG002|Safety Follow-Up Period (4 Weeks)|Lost to Follow-up|2|||
147201595|NCT03739203|530909017|FG000|Safety Follow-Up Period (4 Weeks)|Death|1|||
147201596|NCT03739203|530909018|FG001|Safety Follow-Up Period (4 Weeks)|Death|0|||
147201597|NCT03739203|530909019|FG002|Safety Follow-Up Period (4 Weeks)|Death|0|||
147201598|NCT03739203|530909017|FG000|Safety Follow-Up Period (4 Weeks)|Reason not Specified|0|||
147201599|NCT03739203|530909018|FG001|Safety Follow-Up Period (4 Weeks)|Reason not Specified|0|||
147201600|NCT03739203|530909019|FG002|Safety Follow-Up Period (4 Weeks)|Reason not Specified|2|||
147201601|NCT01782378|530909020|FG000|First Series|Lost to Follow-up|7|||
147201602|NCT01782378|530909021|FG001|First Series|Lost to Follow-up|8|||
147201603|NCT01782378|530909020|FG000|Second Series|Partial Crossover Design- no Sham 2nd|0|||
147201604|NCT01782378|530909021|FG001|Second Series|Partial Crossover Design- no Sham 2nd|25|||
147201605|NCT01782378|530909020|FG000|Second Series|Lost to Follow-up|8|||
147201606|NCT01782378|530909021|FG001|Second Series|Lost to Follow-up|7|||
147201607|NCT01782378|530909020|FG000|Second Series|Did not choose to complete S2 Optional|18|||
147201608|NCT01782378|530909021|FG001|Second Series|Did not choose to complete S2 Optional|0|||
147201609|NCT01663103|530909024|FG000|Overall Study|Withdrawal by Subject|1|||
147201610|NCT01663103|530909025|FG001|Overall Study|Withdrawal by Subject|2|||
147201611|NCT01663103|530909024|FG000|Overall Study|Adverse Event|1|||
147201612|NCT01663103|530909025|FG001|Overall Study|Adverse Event|0|||
147201613|NCT01663103|530909024|FG000|Overall Study|dog bite|1|||
147201614|NCT01663103|530909025|FG001|Overall Study|dog bite|0|||
147201615|NCT01656408|530909026|FG000|Overall Study|Adverse Event|0|||
147201616|NCT01656408|530909027|FG001|Overall Study|Adverse Event|0|||
147201617|NCT01656408|530909028|FG002|Overall Study|Adverse Event|1|||
147201618|NCT01656408|530909029|FG003|Overall Study|Adverse Event|0|||
147201619|NCT01656408|530909030|FG004|Overall Study|Adverse Event|0|||
147201620|NCT01656408|530909031|FG005|Overall Study|Adverse Event|1|||
147201621|NCT01656408|530909032|FG006|Overall Study|Adverse Event|1|||
147201622|NCT01656408|530909033|FG007|Overall Study|Adverse Event|0|||
147201623|NCT01656408|530909034|FG008|Overall Study|Adverse Event|1|||
147201624|NCT01656408|530909035|FG009|Overall Study|Adverse Event|0|||
147201625|NCT01656408|530909026|FG000|Overall Study|Physician Decision|1|||
147201626|NCT01656408|530909027|FG001|Overall Study|Physician Decision|0|||
147201627|NCT01656408|530909028|FG002|Overall Study|Physician Decision|1|||
147201628|NCT01656408|530909029|FG003|Overall Study|Physician Decision|0|||
147201629|NCT01656408|530909030|FG004|Overall Study|Physician Decision|1|||
147201630|NCT01656408|530909031|FG005|Overall Study|Physician Decision|1|||
147201631|NCT01656408|530909032|FG006|Overall Study|Physician Decision|0|||
147201632|NCT01656408|530909033|FG007|Overall Study|Physician Decision|1|||
147201633|NCT01656408|530909034|FG008|Overall Study|Physician Decision|1|||
147201634|NCT01656408|530909035|FG009|Overall Study|Physician Decision|3|||
147201635|NCT00888940|530909046|FG000|Overall Study|Adverse Event|12|||
147201636|NCT00888940|530909047|FG001|Overall Study|Adverse Event|3|||
147201637|NCT00888940|530909046|FG000|Overall Study|Lost to Follow-up|5|||
147201638|NCT00888940|530909047|FG001|Overall Study|Lost to Follow-up|5|||
147201639|NCT00888940|530909046|FG000|Overall Study|Randomized Not Treated|11|||
147201640|NCT00888940|530909047|FG001|Overall Study|Randomized Not Treated|13|||
147201641|NCT03326713|530909048|FG000|Overall Study|Death|2|||
147201642|NCT03326713|530909049|FG001|Overall Study|Death|1|||
147201643|NCT03326713|530909050|FG002|Overall Study|Death|0|||
147201644|NCT03326713|530909048|FG000|Overall Study|Lost to Follow-up|20|||
147201645|NCT03326713|530909049|FG001|Overall Study|Lost to Follow-up|21|||
147201646|NCT03326713|530909050|FG002|Overall Study|Lost to Follow-up|33|||
147201647|NCT03326713|530909048|FG000|Overall Study|Withdrawal by Subject|1|||
147201648|NCT03326713|530909049|FG001|Overall Study|Withdrawal by Subject|2|||
147201649|NCT03326713|530909050|FG002|Overall Study|Withdrawal by Subject|11|||
147201650|NCT03326713|530909048|FG000|Overall Study|Found Ineligible|11|||
147201651|NCT03326713|530909049|FG001|Overall Study|Found Ineligible|11|||
147201652|NCT03326713|530909050|FG002|Overall Study|Found Ineligible|8|||
147201653|NCT00771758|530909051|FG000|Overall Study|Adverse Event|2|||
147201654|NCT00771758|530909052|FG001|Overall Study|Adverse Event|8|||
147201655|NCT00771758|530909053|FG002|Overall Study|Adverse Event|1|||
147201656|NCT00771758|530909051|FG000|Overall Study|Lack of Efficacy|0|||
147201657|NCT00771758|530909052|FG001|Overall Study|Lack of Efficacy|2|||
147201658|NCT00771758|530909053|FG002|Overall Study|Lack of Efficacy|1|||
147201659|NCT00771758|530909051|FG000|Overall Study|Lost to Follow-up|1|||
147201660|NCT00771758|530909052|FG001|Overall Study|Lost to Follow-up|0|||
147201661|NCT00771758|530909053|FG002|Overall Study|Lost to Follow-up|0|||
147201662|NCT00771758|530909051|FG000|Overall Study|Protocol Violation|1|||
147201663|NCT00771758|530909052|FG001|Overall Study|Protocol Violation|0|||
147201664|NCT00771758|530909053|FG002|Overall Study|Protocol Violation|0|||
147201665|NCT00771758|530909051|FG000|Overall Study|Withdrawal by Subject|1|||
147201666|NCT00771758|530909052|FG001|Overall Study|Withdrawal by Subject|0|||
147435476|NCT01968070|531760508|FG016|Period 1|Lost to Follow-up|0|||
147435477|NCT01968070|531760509|FG017|Period 1|Lost to Follow-up|0|||
147435478|NCT01968070|531760492|FG000|Period 1|Adverse Event|0|||
147435479|NCT01968070|531760493|FG001|Period 1|Adverse Event|0|||
147435480|NCT01968070|531760494|FG002|Period 1|Adverse Event|0|||
147435481|NCT01968070|531760495|FG003|Period 1|Adverse Event|0|||
147435482|NCT01968070|531760496|FG004|Period 1|Adverse Event|0|||
147435483|NCT01968070|531760497|FG005|Period 1|Adverse Event|0|||
147435484|NCT01968070|531760498|FG006|Period 1|Adverse Event|1|||
147435485|NCT01968070|531760499|FG007|Period 1|Adverse Event|0|||
147435486|NCT01968070|531760500|FG008|Period 1|Adverse Event|0|||
147435487|NCT01968070|531760501|FG009|Period 1|Adverse Event|0|||
147435488|NCT01968070|531760502|FG010|Period 1|Adverse Event|0|||
147435489|NCT01968070|531760503|FG011|Period 1|Adverse Event|0|||
147435490|NCT01968070|531760504|FG012|Period 1|Adverse Event|0|||
147435491|NCT01968070|531760505|FG013|Period 1|Adverse Event|0|||
147435492|NCT01968070|531760506|FG014|Period 1|Adverse Event|0|||
147435493|NCT01968070|531760507|FG015|Period 1|Adverse Event|0|||
147435494|NCT01968070|531760508|FG016|Period 1|Adverse Event|0|||
147435495|NCT01968070|531760509|FG017|Period 1|Adverse Event|0|||
147435496|NCT01968070|531760492|FG000|Period 1|Physician Decision|0|||
147435497|NCT01968070|531760493|FG001|Period 1|Physician Decision|0|||
147435498|NCT01968070|531760494|FG002|Period 1|Physician Decision|0|||
147435499|NCT01968070|531760495|FG003|Period 1|Physician Decision|0|||
147435500|NCT01968070|531760496|FG004|Period 1|Physician Decision|0|||
147435501|NCT01968070|531760497|FG005|Period 1|Physician Decision|0|||
147435502|NCT01968070|531760498|FG006|Period 1|Physician Decision|0|||
147435503|NCT01968070|531760499|FG007|Period 1|Physician Decision|0|||
147435504|NCT01968070|531760500|FG008|Period 1|Physician Decision|0|||
147435505|NCT01968070|531760501|FG009|Period 1|Physician Decision|0|||
147435506|NCT01968070|531760502|FG010|Period 1|Physician Decision|0|||
147435507|NCT01968070|531760503|FG011|Period 1|Physician Decision|1|||
147435508|NCT01968070|531760504|FG012|Period 1|Physician Decision|0|||
147435509|NCT01968070|531760505|FG013|Period 1|Physician Decision|0|||
147435510|NCT01968070|531760506|FG014|Period 1|Physician Decision|0|||
147435511|NCT01968070|531760507|FG015|Period 1|Physician Decision|0|||
147435512|NCT01968070|531760508|FG016|Period 1|Physician Decision|0|||
147435513|NCT01968070|531760509|FG017|Period 1|Physician Decision|0|||
147435514|NCT01968070|531760492|FG000|Period 2|Withdrawal by Subject|0|||
147435515|NCT01968070|531760493|FG001|Period 2|Withdrawal by Subject|0|||
147435516|NCT01968070|531760494|FG002|Period 2|Withdrawal by Subject|0|||
147435517|NCT01968070|531760495|FG003|Period 2|Withdrawal by Subject|0|||
147435518|NCT01968070|531760496|FG004|Period 2|Withdrawal by Subject|1|||
147435519|NCT01968070|531760497|FG005|Period 2|Withdrawal by Subject|0|||
147435520|NCT01968070|531760498|FG006|Period 2|Withdrawal by Subject|0|||
147435521|NCT01968070|531760499|FG007|Period 2|Withdrawal by Subject|0|||
147435522|NCT01968070|531760500|FG008|Period 2|Withdrawal by Subject|0|||
147435523|NCT01968070|531760501|FG009|Period 2|Withdrawal by Subject|0|||
147435524|NCT01968070|531760502|FG010|Period 2|Withdrawal by Subject|0|||
147435525|NCT01968070|531760503|FG011|Period 2|Withdrawal by Subject|0|||
147435526|NCT01968070|531760504|FG012|Period 2|Withdrawal by Subject|0|||
147435527|NCT01968070|531760505|FG013|Period 2|Withdrawal by Subject|0|||
147435528|NCT01968070|531760506|FG014|Period 2|Withdrawal by Subject|0|||
147435529|NCT01968070|531760507|FG015|Period 2|Withdrawal by Subject|0|||
147435530|NCT01968070|531760508|FG016|Period 2|Withdrawal by Subject|0|||
147435531|NCT01968070|531760509|FG017|Period 2|Withdrawal by Subject|0|||
147435532|NCT00890929|531760512|FG000|Overall Study|Death before treatment|2|||
147435533|NCT00890929|531760512|FG000|Overall Study|Withdrawal by Subject|3|||
147435534|NCT00890929|531760512|FG000|Overall Study|Physician Decision|1|||
147435535|NCT00108069|531760513|FG000|Overall Study|Never rec'd study drug|0|||
147435536|NCT00108069|531760514|FG001|Overall Study|Never rec'd study drug|1|||
147435537|NCT00108069|531760513|FG000|Overall Study|Adverse Event|1|||
147201667|NCT00771758|530909053|FG002|Overall Study|Withdrawal by Subject|0|||
147201668|NCT00771758|530909051|FG000|Overall Study|Other|3|||
147201669|NCT00771758|530909052|FG001|Overall Study|Other|2|||
147435538|NCT00108069|531760514|FG001|Overall Study|Adverse Event|1|||
147435539|NCT00108069|531760513|FG000|Overall Study|Withdrawal by Subject|1|||
147201670|NCT00771758|530909053|FG002|Overall Study|Other|0|||
147435540|NCT00108069|531760514|FG001|Overall Study|Withdrawal by Subject|0|||
147435541|NCT00108069|531760513|FG000|Overall Study|Death|1|||
147435542|NCT00108069|531760514|FG001|Overall Study|Death|0|||
147435543|NCT00108069|531760513|FG000|Overall Study|Progessive disease|27|||
147435544|NCT00108069|531760514|FG001|Overall Study|Progessive disease|11|||
147435545|NCT02014740|531760515|FG000|Overall Study|Lost to Follow-up|4|||
147201671|NCT03067077|530909054|FG000|Overall Study|Did not receive surgery|4|||
147201672|NCT03067077|530909055|FG001|Overall Study|Did not receive surgery|5|||
147201673|NCT03067077|530909054|FG000|Overall Study|Lost to Follow-up|3|||
147201674|NCT03067077|530909055|FG001|Overall Study|Lost to Follow-up|2|||
147201675|NCT00935584|530909058|FG000|Overall Study|Withdrawal by Subject|9|||
147201676|NCT00935584|530909059|FG001|Overall Study|Withdrawal by Subject|0|||
147201677|NCT00935584|530909058|FG000|Overall Study|Death|3|||
147201678|NCT00935584|530909059|FG001|Overall Study|Death|0|||
147201679|NCT00935584|530909058|FG000|Overall Study|Lost to Follow-up|8|||
147201680|NCT00935584|530909059|FG001|Overall Study|Lost to Follow-up|0|||
147201681|NCT00935584|530909058|FG000|Overall Study|No show|9|||
147201682|NCT00935584|530909059|FG001|Overall Study|No show|0|||
147201683|NCT00935584|530909058|FG000|Overall Study|Relocated|3|||
147201684|NCT00935584|530909059|FG001|Overall Study|Relocated|0|||
147201685|NCT00935584|530909058|FG000|Overall Study|Patient changed provider|3|||
147201686|NCT00935584|530909059|FG001|Overall Study|Patient changed provider|0|||
147201687|NCT00935584|530909058|FG000|Overall Study|Provider dropped out of study|14|||
147201688|NCT00935584|530909059|FG001|Overall Study|Provider dropped out of study|4|||
147201689|NCT00174187|530909066|FG000|Period 1 (up to 3 Years)|Serious adverse event|0|||
147201690|NCT00174187|530909067|FG001|Period 1 (up to 3 Years)|Serious adverse event|1|||
147201691|NCT00174187|530909068|FG002|Period 1 (up to 3 Years)|Serious adverse event|0|||
147201692|NCT00174187|530909066|FG000|Period 1 (up to 3 Years)|Non compliance|0|||
147201693|NCT00174187|530909067|FG001|Period 1 (up to 3 Years)|Non compliance|1|||
147201694|NCT00174187|530909068|FG002|Period 1 (up to 3 Years)|Non compliance|0|||
147201695|NCT00174187|530909066|FG000|Period 1 (up to 3 Years)|Withdrawal by Subject|0|||
147201696|NCT00174187|530909067|FG001|Period 1 (up to 3 Years)|Withdrawal by Subject|1|||
147201697|NCT00174187|530909068|FG002|Period 1 (up to 3 Years)|Withdrawal by Subject|0|||
147201698|NCT00174187|530909066|FG000|Period 1 (up to 3 Years)|Other|0|||
147201699|NCT00174187|530909067|FG001|Period 1 (up to 3 Years)|Other|1|||
147201700|NCT00174187|530909068|FG002|Period 1 (up to 3 Years)|Other|0|||
147201701|NCT00174187|530909066|FG000|Between Period 1 and Period 2|Did not consent to continue treatment|0|||
147201702|NCT00174187|530909067|FG001|Between Period 1 and Period 2|Did not consent to continue treatment|0|||
147201703|NCT00174187|530909068|FG002|Between Period 1 and Period 2|Did not consent to continue treatment|2|||
147201704|NCT00174187|530909066|FG000|Between Period 1 and Period 2|Consented, not assigned to treatment|0|||
147201705|NCT00174187|530909067|FG001|Between Period 1 and Period 2|Consented, not assigned to treatment|0|||
147201706|NCT00174187|530909068|FG002|Between Period 1 and Period 2|Consented, not assigned to treatment|3|||
147201707|NCT00174187|530909066|FG000|Period 2 (After 3 Years)|Lost to Follow-up|0|||
147201708|NCT00174187|530909067|FG001|Period 2 (After 3 Years)|Lost to Follow-up|0|||
147201709|NCT00174187|530909068|FG002|Period 2 (After 3 Years)|Lost to Follow-up|2|||
147201710|NCT00174187|530909066|FG000|Period 2 (After 3 Years)|Withdrawal by Subject|0|||
147201711|NCT00174187|530909067|FG001|Period 2 (After 3 Years)|Withdrawal by Subject|0|||
147201712|NCT00174187|530909068|FG002|Period 2 (After 3 Years)|Withdrawal by Subject|1|||
147201713|NCT00174187|530909066|FG000|Period 2 (After 3 Years)|Other|0|||
147201714|NCT00174187|530909067|FG001|Period 2 (After 3 Years)|Other|0|||
147201715|NCT00174187|530909068|FG002|Period 2 (After 3 Years)|Other|5|||
147201716|NCT01198977|530909070|FG000|Overall Study|Lost to Follow-up|1|||
147201717|NCT01198977|530909071|FG001|Overall Study|Lost to Follow-up|0|||
147201718|NCT01285557|530909072|FG000|Overall Study|Death|173|||
147201719|NCT01285557|530909073|FG001|Overall Study|Death|90|||
147201720|NCT01285557|530909072|FG000|Overall Study|Lost to Follow-up|6|||
147201721|NCT01285557|530909073|FG001|Overall Study|Lost to Follow-up|2|||
147201722|NCT01285557|530909072|FG000|Overall Study|Withdrew Consent|6|||
147201723|NCT01285557|530909073|FG001|Overall Study|Withdrew Consent|1|||
147201724|NCT01285557|530909072|FG000|Overall Study|Sponsor Study Termination|23|||
147201725|NCT01285557|530909073|FG001|Overall Study|Sponsor Study Termination|13|||
147201726|NCT01285557|530909072|FG000|Overall Study|Randomized but not treated|1|||
147201727|NCT01285557|530909073|FG001|Overall Study|Randomized but not treated|1|||
147201728|NCT01285557|530909072|FG000|Overall Study|Study follow-up ongoing|28|||
147201729|NCT01285557|530909073|FG001|Overall Study|Study follow-up ongoing|14|||
147201730|NCT01285557|530909072|FG000|Overall Study|Sponsor Decision|2|||
147535137|NCT04221477|532114836|FG000|Overall Study|Reason not Specified|0|||
147535138|NCT04221477|532114837|FG001|Overall Study|Reason not Specified|5|||
147535139|NCT04221477|532114836|FG000|Overall Study|Physician Decision|0|||
147535140|NCT04221477|532114837|FG001|Overall Study|Physician Decision|6|||
147201731|NCT01285557|530909073|FG001|Overall Study|Sponsor Decision|1|||
147201732|NCT01648751|530909080|FG000|Overall Study|Withdrawal by Subject|2|||
147201733|NCT01648751|530909081|FG001|Overall Study|Withdrawal by Subject|3|||
147201734|NCT02484391|530909086|FG000|Overall Study|Lack of Efficacy|15|||
147201735|NCT02484391|530909087|FG001|Overall Study|Lack of Efficacy|14|||
147201736|NCT02484391|530909088|FG002|Overall Study|Lack of Efficacy|3|||
147201737|NCT02484391|530909086|FG000|Overall Study|Lost to Follow-up|0|||
147201738|NCT02484391|530909087|FG001|Overall Study|Lost to Follow-up|0|||
147201739|NCT02484391|530909088|FG002|Overall Study|Lost to Follow-up|2|||
147201740|NCT02484391|530909086|FG000|Overall Study|Physician Decision|1|||
147201741|NCT02484391|530909087|FG001|Overall Study|Physician Decision|3|||
147201742|NCT02484391|530909088|FG002|Overall Study|Physician Decision|0|||
147201743|NCT02484391|530909086|FG000|Overall Study|Went to Transplant|5|||
147201744|NCT02484391|530909087|FG001|Overall Study|Went to Transplant|3|||
147201745|NCT02484391|530909088|FG002|Overall Study|Went to Transplant|2|||
147201746|NCT00905164|530909089|FG000|Period 1|Protocol Violation|0|||
147201747|NCT00905164|530909090|FG001|Period 1|Protocol Violation|1|||
147201748|NCT00790842|530910501|FG000|Dose Level 1|Adverse Event|1|||
147201749|NCT00790842|530910502|FG001|Dose Level 1|Adverse Event|0|||
147201750|NCT00790842|530910503|FG002|Dose Level 1|Adverse Event|0|||
147201751|NCT00790842|530910504|FG003|Dose Level 1|Adverse Event|2|||
147201752|NCT00790842|530910505|FG004|Dose Level 1|Adverse Event|0|||
147201753|NCT00790842|530910506|FG005|Dose Level 1|Adverse Event|0|||
147201754|NCT00790842|530910507|FG006|Dose Level 1|Adverse Event|0|||
147201755|NCT00790842|530910508|FG007|Dose Level 1|Adverse Event|1|||
147201756|NCT00790842|530910509|FG008|Dose Level 1|Adverse Event|0|||
147201757|NCT00790842|530910510|FG009|Dose Level 1|Adverse Event|0|||
147201758|NCT00790842|530910511|FG010|Dose Level 1|Adverse Event|0|||
147201759|NCT00790842|530910501|FG000|Dose Level 1|Physician Decision|1|||
147201760|NCT00790842|530910502|FG001|Dose Level 1|Physician Decision|0|||
147535141|NCT04221477|532114836|FG000|Overall Study|Withdrawal by Subject|10|||
147535142|NCT04221477|532114837|FG001|Overall Study|Withdrawal by Subject|14|||
147535143|NCT04221477|532114836|FG000|Overall Study|Ongoing in the Study|116|||
147201761|NCT00790842|530910503|FG002|Dose Level 1|Physician Decision|0|||
147201762|NCT00790842|530910504|FG003|Dose Level 1|Physician Decision|0|||
147201763|NCT00790842|530910505|FG004|Dose Level 1|Physician Decision|0|||
147201764|NCT00790842|530910506|FG005|Dose Level 1|Physician Decision|0|||
147201765|NCT00790842|530910507|FG006|Dose Level 1|Physician Decision|0|||
147201766|NCT00790842|530910508|FG007|Dose Level 1|Physician Decision|1|||
147201767|NCT00790842|530910509|FG008|Dose Level 1|Physician Decision|0|||
147201768|NCT00790842|530910510|FG009|Dose Level 1|Physician Decision|0|||
147201769|NCT00790842|530910511|FG010|Dose Level 1|Physician Decision|0|||
147201770|NCT00790842|530910501|FG000|Dose Level 1|Withdrawal by Subject|1|||
147201771|NCT00790842|530910502|FG001|Dose Level 1|Withdrawal by Subject|0|||
147201772|NCT00790842|530910503|FG002|Dose Level 1|Withdrawal by Subject|0|||
147201773|NCT00790842|530910504|FG003|Dose Level 1|Withdrawal by Subject|0|||
147535144|NCT04221477|532114837|FG001|Overall Study|Ongoing in the Study|102|||
147535145|NCT04455620|532114838|FG000|Overall Study|Withdrawal by Subject|0|||
147535146|NCT04455620|532114839|FG001|Overall Study|Withdrawal by Subject|0|||
147535147|NCT04455620|532114840|FG002|Overall Study|Withdrawal by Subject|2|||
147535148|NCT04455620|532114841|FG003|Overall Study|Withdrawal by Subject|0|||
147535149|NCT04455620|532114842|FG004|Overall Study|Withdrawal by Subject|1|||
147535150|NCT04455620|532114838|FG000|Overall Study|Lost to Follow-up|0|||
147535151|NCT04455620|532114839|FG001|Overall Study|Lost to Follow-up|0|||
147535152|NCT04455620|532114840|FG002|Overall Study|Lost to Follow-up|1|||
147535153|NCT04455620|532114841|FG003|Overall Study|Lost to Follow-up|1|||
147535154|NCT04455620|532114842|FG004|Overall Study|Lost to Follow-up|0|||
147535155|NCT04455620|532114838|FG000|Overall Study|Death|1|||
147535156|NCT04455620|532114839|FG001|Overall Study|Death|6|||
147535157|NCT04455620|532114840|FG002|Overall Study|Death|20|||
147535158|NCT04455620|532114841|FG003|Overall Study|Death|1|||
147535159|NCT04455620|532114842|FG004|Overall Study|Death|7|||
147535160|NCT04455620|532114838|FG000|Overall Study|Study Termination|0|||
147535161|NCT04455620|532114839|FG001|Overall Study|Study Termination|2|||
147535162|NCT04455620|532114840|FG002|Overall Study|Study Termination|1|||
147535163|NCT04455620|532114841|FG003|Overall Study|Study Termination|0|||
147535164|NCT04455620|532114842|FG004|Overall Study|Study Termination|6|||
147201774|NCT00790842|530910505|FG004|Dose Level 1|Withdrawal by Subject|0|||
147201775|NCT00790842|530910506|FG005|Dose Level 1|Withdrawal by Subject|0|||
147201776|NCT00790842|530910507|FG006|Dose Level 1|Withdrawal by Subject|0|||
147535165|NCT05012943|532114844|FG000|Overall Study|Adverse Event|2|||
147201777|NCT00790842|530910508|FG007|Dose Level 1|Withdrawal by Subject|0|||
147535166|NCT05012943|532114845|FG001|Overall Study|Adverse Event|1|||
147535167|NCT05012943|532114846|FG002|Overall Study|Adverse Event|0|||
147535168|NCT05012943|532114844|FG000|Overall Study|Withdrawal by Subject|1052|||
147435546|NCT02014740|531760516|FG001|Overall Study|Lost to Follow-up|4|||
147435547|NCT02014740|531760515|FG000|Overall Study|Withdrawal by Subject|2|||
147435548|NCT02014740|531760516|FG001|Overall Study|Withdrawal by Subject|1|||
147435549|NCT02608879|531760517|FG000|Overall Study|Lost to Follow-up|1|||
147435550|NCT02608879|531760518|FG001|Overall Study|Lost to Follow-up|0|||
147435551|NCT02608879|531760519|FG002|Overall Study|Lost to Follow-up|0|||
147435552|NCT02608879|531760517|FG000|Overall Study|Did not meet continuation criteria|0|||
147535169|NCT05012943|532114845|FG001|Overall Study|Withdrawal by Subject|1006|||
147535170|NCT05012943|532114846|FG002|Overall Study|Withdrawal by Subject|20|||
147535171|NCT05012943|532114844|FG000|Overall Study|Death|25|||
147535172|NCT05012943|532114845|FG001|Overall Study|Death|17|||
147535173|NCT05012943|532114846|FG002|Overall Study|Death|4|||
147201778|NCT00790842|530910509|FG008|Dose Level 1|Withdrawal by Subject|0|||
147201779|NCT00790842|530910510|FG009|Dose Level 1|Withdrawal by Subject|0|||
147201780|NCT00790842|530910511|FG010|Dose Level 1|Withdrawal by Subject|0|||
147201781|NCT00790842|530910501|FG000|Dose Level 2|Death|0|||
147201782|NCT00790842|530910502|FG001|Dose Level 2|Death|1|||
147201783|NCT00790842|530910503|FG002|Dose Level 2|Death|0|||
147201784|NCT00790842|530910504|FG003|Dose Level 2|Death|0|||
147201785|NCT00790842|530910505|FG004|Dose Level 2|Death|1|||
147201786|NCT00790842|530910506|FG005|Dose Level 2|Death|0|||
147201787|NCT00790842|530910507|FG006|Dose Level 2|Death|0|||
147201788|NCT00790842|530910508|FG007|Dose Level 2|Death|0|||
147201789|NCT00790842|530910509|FG008|Dose Level 2|Death|0|||
147201790|NCT00790842|530910510|FG009|Dose Level 2|Death|0|||
147201791|NCT00790842|530910511|FG010|Dose Level 2|Death|0|||
147201792|NCT00790842|530910501|FG000|Dose Level 2|Physician Decision|0|||
147201793|NCT00790842|530910502|FG001|Dose Level 2|Physician Decision|1|||
147201794|NCT00790842|530910503|FG002|Dose Level 2|Physician Decision|0|||
147201795|NCT00790842|530910504|FG003|Dose Level 2|Physician Decision|0|||
147201796|NCT00790842|530910505|FG004|Dose Level 2|Physician Decision|0|||
147201797|NCT00790842|530910506|FG005|Dose Level 2|Physician Decision|0|||
147201798|NCT00790842|530910507|FG006|Dose Level 2|Physician Decision|0|||
147201799|NCT00790842|530910508|FG007|Dose Level 2|Physician Decision|0|||
147201800|NCT00790842|530910509|FG008|Dose Level 2|Physician Decision|0|||
147201801|NCT00790842|530910510|FG009|Dose Level 2|Physician Decision|0|||
147201802|NCT00790842|530910511|FG010|Dose Level 2|Physician Decision|0|||
147201803|NCT00790842|530910501|FG000|Dose Level 2|Withdrawal by Subject|0|||
147201804|NCT00790842|530910502|FG001|Dose Level 2|Withdrawal by Subject|1|||
147201805|NCT00790842|530910503|FG002|Dose Level 2|Withdrawal by Subject|0|||
147201806|NCT00790842|530910504|FG003|Dose Level 2|Withdrawal by Subject|0|||
147201807|NCT00790842|530910505|FG004|Dose Level 2|Withdrawal by Subject|0|||
147201808|NCT00790842|530910506|FG005|Dose Level 2|Withdrawal by Subject|0|||
147201809|NCT00790842|530910507|FG006|Dose Level 2|Withdrawal by Subject|0|||
147201810|NCT00790842|530910508|FG007|Dose Level 2|Withdrawal by Subject|0|||
147201811|NCT00790842|530910509|FG008|Dose Level 2|Withdrawal by Subject|0|||
147201812|NCT00790842|530910510|FG009|Dose Level 2|Withdrawal by Subject|0|||
147201813|NCT00790842|530910511|FG010|Dose Level 2|Withdrawal by Subject|0|||
147201814|NCT00790842|530910501|FG000|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
147201815|NCT00790842|530910502|FG001|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
147201816|NCT00790842|530910503|FG002|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
147201817|NCT00790842|530910504|FG003|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
147201818|NCT00790842|530910505|FG004|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
147201819|NCT00790842|530910506|FG005|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
147201820|NCT00790842|530910507|FG006|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
147201821|NCT00790842|530910508|FG007|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
147201822|NCT00790842|530910509|FG008|Dose Level 2|Intercurrent Illness/Other Treatment|2|||
147201823|NCT00790842|530910510|FG009|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
147201824|NCT00790842|530910511|FG010|Dose Level 2|Intercurrent Illness/Other Treatment|0|||
147201825|NCT00790842|530910501|FG000|Dose Level 3|Adverse Event|0|||
147201826|NCT00790842|530910502|FG001|Dose Level 3|Adverse Event|0|||
147201827|NCT00790842|530910503|FG002|Dose Level 3|Adverse Event|1|||
147201828|NCT00790842|530910504|FG003|Dose Level 3|Adverse Event|0|||
147306800|NCT02839343|531290769|FG000|Overall Study|Disease Progression Prior to Treatment|1|||
147435553|NCT02608879|531760518|FG001|Overall Study|Did not meet continuation criteria|0|||
147435554|NCT02608879|531760519|FG002|Overall Study|Did not meet continuation criteria|3|||
147435555|NCT03684642|531760520|FG000|Overall Study|Adverse Event|6|||
147435556|NCT03684642|531760521|FG001|Overall Study|Adverse Event|15|||
147435557|NCT03684642|531760522|FG002|Overall Study|Adverse Event|11|||
147435558|NCT03684642|531760520|FG000|Overall Study|Withdrawal by Subject|35|||
147435559|NCT03684642|531760521|FG001|Overall Study|Withdrawal by Subject|53|||
147435560|NCT03684642|531760522|FG002|Overall Study|Withdrawal by Subject|23|||
147435561|NCT03684642|531760520|FG000|Overall Study|Lack of Efficacy|0|||
147435562|NCT03684642|531760521|FG001|Overall Study|Lack of Efficacy|0|||
147435563|NCT03684642|531760522|FG002|Overall Study|Lack of Efficacy|1|||
147435564|NCT03684642|531760520|FG000|Overall Study|Poor compliance to protocol|0|||
147435565|NCT03684642|531760521|FG001|Overall Study|Poor compliance to protocol|4|||
147435566|NCT03684642|531760522|FG002|Overall Study|Poor compliance to protocol|1|||
147435567|NCT03684642|531760520|FG000|Overall Study|Other than specified|62|||
147435568|NCT03684642|531760521|FG001|Overall Study|Other than specified|60|||
147435569|NCT03684642|531760522|FG002|Overall Study|Other than specified|67|||
147435570|NCT03684642|531760520|FG000|Overall Study|Randomized and not treated|0|||
147435571|NCT03684642|531760521|FG001|Overall Study|Randomized and not treated|0|||
147435572|NCT03684642|531760522|FG002|Overall Study|Randomized and not treated|1|||
147435573|NCT03684642|531760520|FG000|Overall Study|Missing completion status but alive at last contact|0|||
147435574|NCT03684642|531760521|FG001|Overall Study|Missing completion status but alive at last contact|1|||
147435575|NCT03684642|531760522|FG002|Overall Study|Missing completion status but alive at last contact|2|||
147435576|NCT02742766|531760523|FG000|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
147435577|NCT02742766|531760524|FG001|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
147435578|NCT02742766|531760525|FG002|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
147435579|NCT02742766|531760526|FG003|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
147435580|NCT02742766|531760527|FG004|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
147435581|NCT02742766|531760528|FG005|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
147435582|NCT02742766|531760529|FG006|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
147435583|NCT02742766|531760530|FG007|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
147435584|NCT02742766|531760531|FG008|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
147435585|NCT02742766|531760532|FG009|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
147435586|NCT02742766|531760533|FG010|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
147435587|NCT02742766|531760534|FG011|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
147435588|NCT02742766|531760535|FG012|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
147435589|NCT02742766|531760536|FG013|Part 2 (Up to 22 Days)|Withdrawal by Subject|1|||
147435590|NCT02742766|531760537|FG014|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
147435591|NCT02742766|531760538|FG015|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
147435592|NCT02742766|531760539|FG016|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
147435593|NCT02742766|531760540|FG017|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
147435594|NCT02742766|531760541|FG018|Part 2 (Up to 22 Days)|Withdrawal by Subject|0|||
147435595|NCT02742766|531760523|FG000|Part 2 (Up to 22 Days)|Physician Decision|0|||
147435596|NCT02742766|531760524|FG001|Part 2 (Up to 22 Days)|Physician Decision|0|||
147435597|NCT02742766|531760525|FG002|Part 2 (Up to 22 Days)|Physician Decision|0|||
147435598|NCT02742766|531760526|FG003|Part 2 (Up to 22 Days)|Physician Decision|0|||
147435599|NCT02742766|531760527|FG004|Part 2 (Up to 22 Days)|Physician Decision|0|||
147435600|NCT02742766|531760528|FG005|Part 2 (Up to 22 Days)|Physician Decision|0|||
147435601|NCT02742766|531760529|FG006|Part 2 (Up to 22 Days)|Physician Decision|0|||
147435602|NCT02742766|531760530|FG007|Part 2 (Up to 22 Days)|Physician Decision|0|||
147435603|NCT02742766|531760531|FG008|Part 2 (Up to 22 Days)|Physician Decision|0|||
147435604|NCT02742766|531760532|FG009|Part 2 (Up to 22 Days)|Physician Decision|0|||
147435605|NCT02742766|531760533|FG010|Part 2 (Up to 22 Days)|Physician Decision|0|||
147435606|NCT02742766|531760534|FG011|Part 2 (Up to 22 Days)|Physician Decision|0|||
147435607|NCT02742766|531760535|FG012|Part 2 (Up to 22 Days)|Physician Decision|2|||
147435608|NCT02742766|531760536|FG013|Part 2 (Up to 22 Days)|Physician Decision|5|||
147435609|NCT02742766|531760537|FG014|Part 2 (Up to 22 Days)|Physician Decision|0|||
147435610|NCT02742766|531760538|FG015|Part 2 (Up to 22 Days)|Physician Decision|1|||
147435611|NCT02742766|531760539|FG016|Part 2 (Up to 22 Days)|Physician Decision|0|||
147435612|NCT02742766|531760540|FG017|Part 2 (Up to 22 Days)|Physician Decision|0|||
147435613|NCT02742766|531760541|FG018|Part 2 (Up to 22 Days)|Physician Decision|0|||
147435614|NCT01840605|531760544|FG000|Overall Study|Adverse Event|0|||
147435615|NCT01840605|531760545|FG001|Overall Study|Adverse Event|1|||
147435616|NCT01840605|531760544|FG000|Overall Study|Physician Decision|2|||
147435617|NCT01840605|531760545|FG001|Overall Study|Physician Decision|1|||
147435618|NCT03739437|531760546|FG000|Overall Study|Lost to Follow-up|2|||
147435619|NCT03739437|531760547|FG001|Overall Study|Lost to Follow-up|5|||
147435620|NCT01351623|531760549|FG000|Overall Study|Protocol Violation|2|||
147435621|NCT01351623|531760549|FG000|Overall Study|Adverse Event|4|||
147435622|NCT01351623|531760549|FG000|Overall Study|Withdrawal by Subject|1|||
147435623|NCT01351623|531760549|FG000|Overall Study|Death|2|||
147435624|NCT01130974|531760550|FG000|Overall Study|Protocol Violation|10|||
147435625|NCT01130974|531760551|FG001|Overall Study|Protocol Violation|10|||
147435626|NCT01130974|531760550|FG000|Overall Study|Withdrawal by Subject|0|||
147435627|NCT01130974|531760551|FG001|Overall Study|Withdrawal by Subject|1|||
147435628|NCT01130974|531760550|FG000|Overall Study|Ineligibility criteria|5|||
147435629|NCT01130974|531760551|FG001|Overall Study|Ineligibility criteria|2|||
147435630|NCT01395316|531760552|FG000|Overall Study|Lost to Follow-up|2|||
147435631|NCT01395316|531760552|FG000|Overall Study|poor MRI quality|1|||
147435632|NCT03359590|531760553|FG000|First Intervention|Withdrawal by Subject|1|||
147435633|NCT03359590|531760554|FG001|First Intervention|Withdrawal by Subject|1|||
147435634|NCT03359590|531760553|FG000|First Intervention|Protocol Violation|0|||
147435635|NCT03359590|531760554|FG001|First Intervention|Protocol Violation|1|||
147435636|NCT06132425|531760555|FG000|Overall Study|Withdrawal by Subject|3|||
147435637|NCT06132425|531760556|FG001|Overall Study|Withdrawal by Subject|0|||
147435638|NCT06132425|531760555|FG000|Overall Study|Did not follow study instructions|0|||
147435639|NCT06132425|531760556|FG001|Overall Study|Did not follow study instructions|2|||
147535174|NCT05012943|532114844|FG000|Overall Study|Lost to Follow-up|11|||
147201829|NCT00790842|530910505|FG004|Dose Level 3|Adverse Event|0|||
147201830|NCT00790842|530910506|FG005|Dose Level 3|Adverse Event|0|||
147201831|NCT00790842|530910507|FG006|Dose Level 3|Adverse Event|0|||
147201832|NCT00790842|530910508|FG007|Dose Level 3|Adverse Event|0|||
147201833|NCT00790842|530910509|FG008|Dose Level 3|Adverse Event|0|||
147201834|NCT00790842|530910510|FG009|Dose Level 3|Adverse Event|0|||
147201835|NCT00790842|530910511|FG010|Dose Level 3|Adverse Event|0|||
147201836|NCT00790842|530910501|FG000|Dose Level 3|Withdrawal by Subject|0|||
147201837|NCT00790842|530910502|FG001|Dose Level 3|Withdrawal by Subject|0|||
147201838|NCT00790842|530910503|FG002|Dose Level 3|Withdrawal by Subject|3|||
147201839|NCT00790842|530910504|FG003|Dose Level 3|Withdrawal by Subject|0|||
147201840|NCT00790842|530910505|FG004|Dose Level 3|Withdrawal by Subject|0|||
147201841|NCT00790842|530910506|FG005|Dose Level 3|Withdrawal by Subject|0|||
147201842|NCT00790842|530910507|FG006|Dose Level 3|Withdrawal by Subject|0|||
147201843|NCT00790842|530910508|FG007|Dose Level 3|Withdrawal by Subject|0|||
147201844|NCT00790842|530910509|FG008|Dose Level 3|Withdrawal by Subject|0|||
147201845|NCT00790842|530910510|FG009|Dose Level 3|Withdrawal by Subject|2|||
147201846|NCT00790842|530910511|FG010|Dose Level 3|Withdrawal by Subject|0|||
147201847|NCT00790842|530910501|FG000|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
147201848|NCT00790842|530910502|FG001|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
147201849|NCT00790842|530910503|FG002|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
147201850|NCT00790842|530910504|FG003|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
147201851|NCT00790842|530910505|FG004|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
147201852|NCT00790842|530910506|FG005|Dose Level 3|Intercurrent Illness/Alternative Therapy|1|||
147201853|NCT00790842|530910507|FG006|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
147201854|NCT00790842|530910508|FG007|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
147201855|NCT00790842|530910509|FG008|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
147201856|NCT00790842|530910510|FG009|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
147201857|NCT00790842|530910511|FG010|Dose Level 3|Intercurrent Illness/Alternative Therapy|0|||
147201858|NCT00790842|530910501|FG000|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
147201859|NCT00790842|530910502|FG001|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
147201860|NCT00790842|530910503|FG002|Dose Level 3|Ineligible/Withdrew before Treatment|1|||
147201861|NCT00790842|530910504|FG003|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
147201862|NCT00790842|530910505|FG004|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
147201863|NCT00790842|530910506|FG005|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
147201864|NCT00790842|530910507|FG006|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
147201865|NCT00790842|530910508|FG007|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
147201866|NCT00790842|530910509|FG008|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
147201867|NCT00790842|530910510|FG009|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
147201868|NCT00790842|530910511|FG010|Dose Level 3|Ineligible/Withdrew before Treatment|0|||
147201869|NCT00790842|530910501|FG000|Dose Level 4|Adverse Event|0|||
147201870|NCT00790842|530910502|FG001|Dose Level 4|Adverse Event|0|||
147201871|NCT00790842|530910503|FG002|Dose Level 4|Adverse Event|0|||
147201872|NCT00790842|530910504|FG003|Dose Level 4|Adverse Event|0|||
147201873|NCT00790842|530910505|FG004|Dose Level 4|Adverse Event|0|||
147201874|NCT00790842|530910506|FG005|Dose Level 4|Adverse Event|0|||
147201875|NCT00790842|530910507|FG006|Dose Level 4|Adverse Event|1|||
147201876|NCT00790842|530910508|FG007|Dose Level 4|Adverse Event|0|||
147201877|NCT00790842|530910509|FG008|Dose Level 4|Adverse Event|0|||
147201878|NCT00790842|530910510|FG009|Dose Level 4|Adverse Event|0|||
147201879|NCT00790842|530910511|FG010|Dose Level 4|Adverse Event|0|||
147201880|NCT00790842|530910501|FG000|Dose Level 4|Physician Decision|0|||
147201881|NCT00790842|530910502|FG001|Dose Level 4|Physician Decision|0|||
147201882|NCT00790842|530910503|FG002|Dose Level 4|Physician Decision|0|||
147201883|NCT00790842|530910504|FG003|Dose Level 4|Physician Decision|0|||
147201884|NCT00790842|530910505|FG004|Dose Level 4|Physician Decision|0|||
147201885|NCT00790842|530910506|FG005|Dose Level 4|Physician Decision|0|||
147201886|NCT00790842|530910507|FG006|Dose Level 4|Physician Decision|1|||
147201887|NCT00790842|530910508|FG007|Dose Level 4|Physician Decision|0|||
147201888|NCT00790842|530910509|FG008|Dose Level 4|Physician Decision|0|||
147201889|NCT00790842|530910510|FG009|Dose Level 4|Physician Decision|0|||
147201890|NCT00790842|530910511|FG010|Dose Level 4|Physician Decision|1|||
147201891|NCT00790842|530910501|FG000|Dose Level 4|Withdrawal by Subject|0|||
147201892|NCT00790842|530910502|FG001|Dose Level 4|Withdrawal by Subject|0|||
147201893|NCT00790842|530910503|FG002|Dose Level 4|Withdrawal by Subject|0|||
147201894|NCT00790842|530910504|FG003|Dose Level 4|Withdrawal by Subject|0|||
147201895|NCT00790842|530910505|FG004|Dose Level 4|Withdrawal by Subject|0|||
147201896|NCT00790842|530910506|FG005|Dose Level 4|Withdrawal by Subject|0|||
147201897|NCT00790842|530910507|FG006|Dose Level 4|Withdrawal by Subject|0|||
147201898|NCT00790842|530910508|FG007|Dose Level 4|Withdrawal by Subject|0|||
147201899|NCT00790842|530910509|FG008|Dose Level 4|Withdrawal by Subject|0|||
147201900|NCT00790842|530910510|FG009|Dose Level 4|Withdrawal by Subject|0|||
147201901|NCT00790842|530910511|FG010|Dose Level 4|Withdrawal by Subject|1|||
147201902|NCT00790842|530910501|FG000|Expansion Cohort|Adverse Event|0|||
147201903|NCT00790842|530910502|FG001|Expansion Cohort|Adverse Event|0|||
147201904|NCT00790842|530910503|FG002|Expansion Cohort|Adverse Event|0|||
147201905|NCT00790842|530910504|FG003|Expansion Cohort|Adverse Event|0|||
147201906|NCT00790842|530910505|FG004|Expansion Cohort|Adverse Event|0|||
147201907|NCT00790842|530910506|FG005|Expansion Cohort|Adverse Event|0|||
147201908|NCT00790842|530910507|FG006|Expansion Cohort|Adverse Event|1|||
147201909|NCT00790842|530910508|FG007|Expansion Cohort|Adverse Event|0|||
147201910|NCT00790842|530910509|FG008|Expansion Cohort|Adverse Event|0|||
147201911|NCT00790842|530910510|FG009|Expansion Cohort|Adverse Event|0|||
147201912|NCT00790842|530910511|FG010|Expansion Cohort|Adverse Event|0|||
147201913|NCT00790842|530910501|FG000|Expansion Cohort|Death|0|||
147201914|NCT00790842|530910502|FG001|Expansion Cohort|Death|0|||
147201915|NCT00790842|530910503|FG002|Expansion Cohort|Death|2|||
147201916|NCT00790842|530910504|FG003|Expansion Cohort|Death|0|||
147201917|NCT00790842|530910505|FG004|Expansion Cohort|Death|0|||
147201918|NCT00790842|530910506|FG005|Expansion Cohort|Death|0|||
147201919|NCT00790842|530910507|FG006|Expansion Cohort|Death|0|||
147201920|NCT00790842|530910508|FG007|Expansion Cohort|Death|0|||
147201921|NCT00790842|530910509|FG008|Expansion Cohort|Death|0|||
147201922|NCT00790842|530910510|FG009|Expansion Cohort|Death|0|||
147201923|NCT00790842|530910511|FG010|Expansion Cohort|Death|0|||
147201924|NCT00790842|530910501|FG000|Expansion Cohort|Physician Decision|0|||
147201925|NCT00790842|530910502|FG001|Expansion Cohort|Physician Decision|0|||
147201926|NCT00790842|530910503|FG002|Expansion Cohort|Physician Decision|1|||
147201927|NCT00790842|530910504|FG003|Expansion Cohort|Physician Decision|0|||
147201928|NCT00790842|530910505|FG004|Expansion Cohort|Physician Decision|0|||
147201929|NCT00790842|530910506|FG005|Expansion Cohort|Physician Decision|0|||
147201930|NCT00790842|530910507|FG006|Expansion Cohort|Physician Decision|0|||
147201931|NCT00790842|530910508|FG007|Expansion Cohort|Physician Decision|0|||
147201932|NCT00790842|530910509|FG008|Expansion Cohort|Physician Decision|0|||
147201933|NCT00790842|530910510|FG009|Expansion Cohort|Physician Decision|0|||
147201934|NCT00790842|530910511|FG010|Expansion Cohort|Physician Decision|0|||
147201935|NCT00790842|530910501|FG000|Expansion Cohort|Withdrawal by Subject|0|||
147201936|NCT00790842|530910502|FG001|Expansion Cohort|Withdrawal by Subject|0|||
147201937|NCT00790842|530910503|FG002|Expansion Cohort|Withdrawal by Subject|3|||
147201938|NCT00790842|530910504|FG003|Expansion Cohort|Withdrawal by Subject|0|||
147201939|NCT00790842|530910505|FG004|Expansion Cohort|Withdrawal by Subject|0|||
147201940|NCT00790842|530910506|FG005|Expansion Cohort|Withdrawal by Subject|0|||
147201941|NCT00790842|530910507|FG006|Expansion Cohort|Withdrawal by Subject|0|||
147201942|NCT00790842|530910508|FG007|Expansion Cohort|Withdrawal by Subject|0|||
147201943|NCT00790842|530910509|FG008|Expansion Cohort|Withdrawal by Subject|0|||
147201944|NCT00790842|530910510|FG009|Expansion Cohort|Withdrawal by Subject|0|||
147201945|NCT00790842|530910511|FG010|Expansion Cohort|Withdrawal by Subject|0|||
147201946|NCT00790842|530910501|FG000|Expansion Cohort|Study Closure|0|||
147201947|NCT00790842|530910502|FG001|Expansion Cohort|Study Closure|0|||
147201948|NCT00790842|530910503|FG002|Expansion Cohort|Study Closure|1|||
147201949|NCT00790842|530910504|FG003|Expansion Cohort|Study Closure|0|||
147201950|NCT00790842|530910505|FG004|Expansion Cohort|Study Closure|0|||
147201951|NCT00790842|530910506|FG005|Expansion Cohort|Study Closure|0|||
147201952|NCT00790842|530910507|FG006|Expansion Cohort|Study Closure|0|||
147201953|NCT00790842|530910508|FG007|Expansion Cohort|Study Closure|0|||
147201954|NCT00790842|530910509|FG008|Expansion Cohort|Study Closure|0|||
147201955|NCT00790842|530910510|FG009|Expansion Cohort|Study Closure|0|||
147201956|NCT00790842|530910511|FG010|Expansion Cohort|Study Closure|0|||
147201957|NCT02968004|530910512|FG000|Main Study Phase|Adverse Event|1|||
147201958|NCT02968004|530910513|FG001|Main Study Phase|Adverse Event|0|||
147201959|NCT02968004|530910512|FG000|Main Study Phase|Withdrawal by Subject|0|||
147201960|NCT02968004|530910513|FG001|Main Study Phase|Withdrawal by Subject|1|||
147201961|NCT02968004|530910512|FG000|Open Label Extension (OLE) Year 1|Adverse Event|0|||
147201962|NCT02968004|530910513|FG001|Open Label Extension (OLE) Year 1|Adverse Event|6|||
147201963|NCT02968004|530910512|FG000|Open Label Extension (OLE) Year 1|Withdrawal by Subject|2|||
147201964|NCT02968004|530910513|FG001|Open Label Extension (OLE) Year 1|Withdrawal by Subject|2|||
147201965|NCT02968004|530910512|FG000|Open Label Extension (OLE) Year 1|Miscellaneous|0|||
147201966|NCT02968004|530910513|FG001|Open Label Extension (OLE) Year 1|Miscellaneous|1|||
147201967|NCT02968004|530910512|FG000|Open Label Extension (OLE) Year 2|Adverse Event|1|||
147201968|NCT02968004|530910513|FG001|Open Label Extension (OLE) Year 2|Adverse Event|1|||
147201969|NCT02968004|530910512|FG000|Open Label Extension (OLE) Year 2|Withdrawal by Subject|2|||
147201970|NCT02968004|530910513|FG001|Open Label Extension (OLE) Year 2|Withdrawal by Subject|2|||
147201971|NCT02968004|530910512|FG000|Open Label Extension (OLE) Year 2|Miscellaneous|0|||
147201972|NCT02968004|530910513|FG001|Open Label Extension (OLE) Year 2|Miscellaneous|1|||
147201973|NCT02968004|530910512|FG000|Open Label Extension (OLE) Year 3|Adverse Event|1|||
147201974|NCT02968004|530910513|FG001|Open Label Extension (OLE) Year 3|Adverse Event|0|||
147201975|NCT02968004|530910512|FG000|Open Label Extension (OLE) Year 3|Withdrawal by Subject|2|||
147201976|NCT02968004|530910513|FG001|Open Label Extension (OLE) Year 3|Withdrawal by Subject|1|||
147201977|NCT02968004|530910512|FG000|Open Label Extension (OLE) Year 3|Prohibited Treatments|0|||
147201978|NCT02968004|530910513|FG001|Open Label Extension (OLE) Year 3|Prohibited Treatments|1|||
147201979|NCT02968004|530910512|FG000|Open Label Extension (OLE) Year 3|Local Crisis|1|||
147535175|NCT05012943|532114845|FG001|Overall Study|Lost to Follow-up|24|||
147535176|NCT05012943|532114846|FG002|Overall Study|Lost to Follow-up|3|||
147535177|NCT05012943|532114844|FG000|Overall Study|Physician Decision|1|||
147535178|NCT05012943|532114845|FG001|Overall Study|Physician Decision|1|||
147535179|NCT05012943|532114846|FG002|Overall Study|Physician Decision|0|||
147535180|NCT05012943|532114844|FG000|Overall Study|Other than Specified|2|||
147535181|NCT05012943|532114845|FG001|Overall Study|Other than Specified|1|||
147535182|NCT05012943|532114846|FG002|Overall Study|Other than Specified|0|||
147535183|NCT04228107|532114847|FG000|Overall Study|Protocol Violation|1|||
147649412|NCT02634801|532537341|FG000|Treatment Period (Weeks 0 to 24)|Adverse Event|2|||
147535184|NCT04228107|532114848|FG001|Overall Study|Protocol Violation|0|||
147535185|NCT04228107|532114847|FG000|Overall Study|Withdrawal by Subject|6|||
147535186|NCT04228107|532114848|FG001|Overall Study|Withdrawal by Subject|0|||
147535187|NCT04228107|532114847|FG000|Overall Study|Lost to Follow-up|18|||
147535188|NCT04228107|532114848|FG001|Overall Study|Lost to Follow-up|0|||
147535189|NCT04228107|532114847|FG000|Overall Study|No controller use data|1|||
147535190|NCT04228107|532114848|FG001|Overall Study|No controller use data|0|||
147535191|NCT04228107|532114847|FG000|Overall Study|No medication data collected|1|||
147535192|NCT04228107|532114848|FG001|Overall Study|No medication data collected|0|||
147535193|NCT03792633|532114849|FG000|Overall Study|Alternative Treatment|17|||
147535194|NCT03792633|532114850|FG001|Overall Study|Alternative Treatment|19|||
147535195|NCT03792633|532114849|FG000|Overall Study|Death|2|||
147535196|NCT03792633|532114850|FG001|Overall Study|Death|0|||
147535197|NCT03792633|532114849|FG000|Overall Study|Disease progression|8|||
147535198|NCT03792633|532114850|FG001|Overall Study|Disease progression|9|||
147535199|NCT03792633|532114849|FG000|Overall Study|Lost to Follow-up|1|||
147535200|NCT03792633|532114850|FG001|Overall Study|Lost to Follow-up|1|||
147535201|NCT03792633|532114849|FG000|Overall Study|Screen fail|1|||
147535202|NCT03792633|532114850|FG001|Overall Study|Screen fail|0|||
147535203|NCT03792633|532114849|FG000|Overall Study|Second malignancy|0|||
147535204|NCT03792633|532114850|FG001|Overall Study|Second malignancy|1|||
147535205|NCT05455684|532114852|FG000|Overall Study|Withdrawal by Subject|7|||
147535206|NCT05455684|532114853|FG001|Overall Study|Withdrawal by Subject|4|||
147535207|NCT05455684|532114852|FG000|Overall Study|Lost to Follow-up|3|||
147535208|NCT05455684|532114853|FG001|Overall Study|Lost to Follow-up|3|||
147535209|NCT05455684|532114852|FG000|Overall Study|Adverse Event|2|||
147535210|NCT05455684|532114853|FG001|Overall Study|Adverse Event|3|||
147535211|NCT05455684|532114852|FG000|Overall Study|Protocol Violation|1|||
147535212|NCT05455684|532114853|FG001|Overall Study|Protocol Violation|1|||
147535213|NCT05455684|532114852|FG000|Overall Study|Non-Compliant with study drug|0|||
147535214|NCT05455684|532114853|FG001|Overall Study|Non-Compliant with study drug|1|||
147535215|NCT05455684|532114852|FG000|Overall Study|Other|1|||
147535216|NCT05455684|532114853|FG001|Overall Study|Other|2|||
147535217|NCT05455684|532114852|FG000|Overall Study|Randomized but not treated|1|||
147535218|NCT05455684|532114853|FG001|Overall Study|Randomized but not treated|0|||
147535219|NCT05116241|532114854|FG000|Study|Withdrawal by Subject|5|||
147535220|NCT05116241|532114855|FG001|Study|Withdrawal by Subject|2|||
147535221|NCT05116241|532114856|FG002|Study|Withdrawal by Subject|1|||
147535222|NCT05116241|532114854|FG000|Study|Lost to Follow-up|0|||
147535223|NCT05116241|532114855|FG001|Study|Lost to Follow-up|2|||
147535224|NCT05116241|532114856|FG002|Study|Lost to Follow-up|2|||
147535225|NCT02268214|532114859|FG000|Overall Study|Subject no longer meets study criteria|0|||
147535226|NCT02268214|532114860|FG001|Overall Study|Subject no longer meets study criteria|2|||
147535227|NCT02268214|532114861|FG002|Overall Study|Subject no longer meets study criteria|0|||
147535228|NCT02268214|532114859|FG000|Overall Study|Pregnancy|2|||
147535229|NCT02268214|532114860|FG001|Overall Study|Pregnancy|2|||
147535230|NCT02268214|532114861|FG002|Overall Study|Pregnancy|1|||
147535231|NCT02268214|532114859|FG000|Overall Study|Lost to Follow-up|3|||
147535232|NCT02268214|532114860|FG001|Overall Study|Lost to Follow-up|3|||
147535233|NCT02268214|532114861|FG002|Overall Study|Lost to Follow-up|4|||
147535234|NCT02268214|532114859|FG000|Overall Study|Lack of Efficacy|1|||
147535235|NCT02268214|532114860|FG001|Overall Study|Lack of Efficacy|0|||
147535236|NCT02268214|532114861|FG002|Overall Study|Lack of Efficacy|2|||
147535237|NCT02268214|532114859|FG000|Overall Study|Adverse Event|11|||
147535238|NCT02268214|532114860|FG001|Overall Study|Adverse Event|14|||
147435640|NCT06132425|531760555|FG000|Overall Study|Lost to Follow-up|3|||
147435641|NCT06132425|531760556|FG001|Overall Study|Lost to Follow-up|5|||
147435642|NCT06308666|531760557|FG000|Overall Study|Withdrawal by Subject|1|||
147435643|NCT06308666|531760557|FG000|Overall Study|Protocol Violation|2|||
147435644|NCT04376060|531760558|FG000|Overall Study|Physician Decision|1|||
147435645|NCT00977574|531760559|FG000|Overall Study|Never Treated|4|||
147435646|NCT00977574|531760560|FG001|Overall Study|Never Treated|2|||
147435647|NCT00977574|531760561|FG002|Overall Study|Never Treated|4|||
147435648|NCT05460273|531760562|FG000|Overall Study|Death|43|||
147435649|NCT05460273|531760563|FG001|Overall Study|Death|9|||
147435650|NCT05460273|531760562|FG000|Overall Study|Lost to Follow-up|7|||
147435651|NCT05460273|531760563|FG001|Overall Study|Lost to Follow-up|0|||
147435652|NCT05460273|531760562|FG000|Overall Study|Ongoing participants at NSCLC primary analysis DCO|0|||
147435653|NCT05460273|531760563|FG001|Overall Study|Ongoing participants at NSCLC primary analysis DCO|31|||
147435654|NCT05749952|531760564|FG000|Symphonie Aqua System - Non-Digital|Lost to Follow-up|2|||
147435655|NCT06950879|531760565|FG000|Overall Study|Unable to complete task due to motor impairment|1|||
147435656|NCT01310803|531762162|FG000|Overall Study|Subject terminated by Sponsor|1|||
147435657|NCT01310803|531762163|FG001|Overall Study|Subject terminated by Sponsor|0|||
147435658|NCT00332839|531762164|FG000|Core (Months 0 - 12)|Administrative problems|1|||
147435659|NCT00332839|531762165|FG001|Core (Months 0 - 12)|Administrative problems|1|||
147435660|NCT00332839|531762164|FG000|Core (Months 0 - 12)|Withdrawal by Subject|3|||
147435661|NCT00332839|531762165|FG001|Core (Months 0 - 12)|Withdrawal by Subject|1|||
147435662|NCT00332839|531762164|FG000|Core (Months 0 - 12)|Protocol deviation|1|||
147535239|NCT02268214|532114861|FG002|Overall Study|Adverse Event|9|||
147535240|NCT02268214|532114859|FG000|Overall Study|Withdrawal by Subject|4|||
147535241|NCT02268214|532114860|FG001|Overall Study|Withdrawal by Subject|5|||
147535242|NCT02268214|532114861|FG002|Overall Study|Withdrawal by Subject|10|||
147535243|NCT02268214|532114859|FG000|Overall Study|Subject request to discontinue treatment|10|||
147535244|NCT02268214|532114860|FG001|Overall Study|Subject request to discontinue treatment|8|||
147535245|NCT02268214|532114861|FG002|Overall Study|Subject request to discontinue treatment|6|||
147535246|NCT02268214|532114859|FG000|Overall Study|Poor/non-compliance|2|||
147535247|NCT02268214|532114860|FG001|Overall Study|Poor/non-compliance|1|||
147535248|NCT02268214|532114861|FG002|Overall Study|Poor/non-compliance|2|||
147535249|NCT02268214|532114859|FG000|Overall Study|Other reasons|7|||
147535250|NCT02268214|532114860|FG001|Overall Study|Other reasons|3|||
147535251|NCT02268214|532114861|FG002|Overall Study|Other reasons|3|||
147535252|NCT02268214|532114859|FG000|Overall Study|Not entering long-term period|2|||
147535253|NCT02268214|532114860|FG001|Overall Study|Not entering long-term period|3|||
147535254|NCT02268214|532114861|FG002|Overall Study|Not entering long-term period|5|||
147535255|NCT04584294|532114865|FG000|Enrollment to Post-Visit - PATIENTS|Withdrawal by Subject|3|||
147535256|NCT04584294|532114866|FG001|Enrollment to Post-Visit - PATIENTS|Withdrawal by Subject|4|||
147535257|NCT04584294|532114865|FG000|Enrollment to Post-Visit - PATIENTS|Did not attend scheduled appointment with primary care provider|16|||
147535258|NCT04584294|532114866|FG001|Enrollment to Post-Visit - PATIENTS|Did not attend scheduled appointment with primary care provider|18|||
147535259|NCT04584294|532114865|FG000|Enrollment to Post-Visit - PATIENTS|Pregnancy|0|||
147535260|NCT04584294|532114866|FG001|Enrollment to Post-Visit - PATIENTS|Pregnancy|1|||
147535261|NCT04584294|532114865|FG000|3-month Follow-up - PATIENTS|Withdrawal by Subject|2|||
147535262|NCT04584294|532114866|FG001|3-month Follow-up - PATIENTS|Withdrawal by Subject|1|||
147535263|NCT04584294|532114865|FG000|6-month Follow-up - PATIENTS|Withdrawal by Subject|4|||
147535264|NCT04584294|532114866|FG001|6-month Follow-up - PATIENTS|Withdrawal by Subject|2|||
147535265|NCT04584294|532114865|FG000|Enrollment to Post-Visit - PROVIDERS|No Veterans Enrolled in Study|3|||
147535266|NCT04584294|532114866|FG001|Enrollment to Post-Visit - PROVIDERS|No Veterans Enrolled in Study|5|||
147535267|NCT04242498|532114869|FG000|Initial Treatment Period: Week 0-16|Adverse Event|1|||
147535268|NCT04242498|532114870|FG001|Initial Treatment Period: Week 0-16|Adverse Event|1|||
147535269|NCT04242498|532114871|FG002|Initial Treatment Period: Week 0-16|Adverse Event|9|||
147535270|NCT04242498|532114872|FG003|Initial Treatment Period: Week 0-16|Adverse Event|0|||
147535271|NCT04242498|532114873|FG004|Initial Treatment Period: Week 0-16|Adverse Event|0|||
147535272|NCT04242498|532114874|FG005|Initial Treatment Period: Week 0-16|Adverse Event|0|||
147535273|NCT04242498|532114875|FG006|Initial Treatment Period: Week 0-16|Adverse Event|0|||
147535274|NCT04242498|532114869|FG000|Initial Treatment Period: Week 0-16|Lack of Efficacy|0|||
147535275|NCT04242498|532114870|FG001|Initial Treatment Period: Week 0-16|Lack of Efficacy|0|||
147535276|NCT04242498|532114871|FG002|Initial Treatment Period: Week 0-16|Lack of Efficacy|1|||
147535277|NCT04242498|532114872|FG003|Initial Treatment Period: Week 0-16|Lack of Efficacy|0|||
147535278|NCT04242498|532114873|FG004|Initial Treatment Period: Week 0-16|Lack of Efficacy|0|||
147535279|NCT04242498|532114874|FG005|Initial Treatment Period: Week 0-16|Lack of Efficacy|0|||
147535280|NCT04242498|532114875|FG006|Initial Treatment Period: Week 0-16|Lack of Efficacy|0|||
147535281|NCT04242498|532114869|FG000|Initial Treatment Period: Week 0-16|Protocol Violation|1|||
147535282|NCT04242498|532114870|FG001|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
147535283|NCT04242498|532114871|FG002|Initial Treatment Period: Week 0-16|Protocol Violation|1|||
147535284|NCT04242498|532114872|FG003|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
147535285|NCT04242498|532114873|FG004|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
147535286|NCT04242498|532114874|FG005|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
147535287|NCT04242498|532114875|FG006|Initial Treatment Period: Week 0-16|Protocol Violation|0|||
147535288|NCT04242498|532114869|FG000|Initial Treatment Period: Week 0-16|Lost to Follow-up|1|||
147535289|NCT04242498|532114870|FG001|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
147535290|NCT04242498|532114871|FG002|Initial Treatment Period: Week 0-16|Lost to Follow-up|3|||
147535291|NCT04242498|532114872|FG003|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
147535292|NCT04242498|532114873|FG004|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
147535293|NCT04242498|532114874|FG005|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
147535294|NCT04242498|532114875|FG006|Initial Treatment Period: Week 0-16|Lost to Follow-up|0|||
147535295|NCT04242498|532114869|FG000|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|2|||
147535296|NCT04242498|532114870|FG001|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|8|||
147535297|NCT04242498|532114871|FG002|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|12|||
147535298|NCT04242498|532114872|FG003|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
147535299|NCT04242498|532114873|FG004|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
147535300|NCT04242498|532114874|FG005|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
147535301|NCT04242498|532114875|FG006|Initial Treatment Period: Week 0-16|Consent withdrawn by subject, not due to AE|0|||
147535302|NCT04242498|532114869|FG000|Initial Treatment Period: Week 0-16|Subject Moved Long Distance From Clinic (Abroad)|0|||
147535303|NCT04242498|532114870|FG001|Initial Treatment Period: Week 0-16|Subject Moved Long Distance From Clinic (Abroad)|0|||
147435663|NCT00332839|531762165|FG001|Core (Months 0 - 12)|Protocol deviation|1|||
147435664|NCT00332839|531762164|FG000|Core (Months 0 - 12)|Adverse Event|5|||
147435665|NCT00332839|531762165|FG001|Core (Months 0 - 12)|Adverse Event|15|||
147435666|NCT00332839|531762164|FG000|Follow-up (Months 12 - 60)|Withdrawal by Subject|1|||
147435667|NCT00332839|531762165|FG001|Follow-up (Months 12 - 60)|Withdrawal by Subject|1|||
147435668|NCT00332839|531762164|FG000|Follow-up (Months 12 - 60)|Lost to Follow-up|2|||
147435669|NCT00332839|531762165|FG001|Follow-up (Months 12 - 60)|Lost to Follow-up|1|||
147435670|NCT00332839|531762164|FG000|Follow-up (Months 12 - 60)|Death|1|||
147435671|NCT00332839|531762165|FG001|Follow-up (Months 12 - 60)|Death|1|||
147435672|NCT03047551|531762169|FG000|Overall Study|Did not receive TAS|1|||
147435673|NCT03047551|531762170|FG001|Overall Study|Did not receive TAS|0|||
147435674|NCT03047551|531762169|FG000|Overall Study|Physician Decision|1|||
147435675|NCT03047551|531762170|FG001|Overall Study|Physician Decision|0|||
147435676|NCT03047551|531762169|FG000|Overall Study|Withdrawal by Subject|0|||
147435677|NCT03047551|531762170|FG001|Overall Study|Withdrawal by Subject|1|||
147435678|NCT03047551|531762169|FG000|Overall Study|Probe malfunction|0|||
147435679|NCT03047551|531762170|FG001|Overall Study|Probe malfunction|1|||
147435680|NCT03047551|531762169|FG000|Overall Study|Ineligible|0|||
147435681|NCT03047551|531762170|FG001|Overall Study|Ineligible|1|||
147435682|NCT00594516|531762172|FG000|Open Label (OL): Tapentadol IR|Withdrawal by Subject|4|||
147435683|NCT00594516|531762173|FG001|Open Label (OL): Tapentadol IR|Withdrawal by Subject|0|||
147435684|NCT00594516|531762174|FG002|Open Label (OL): Tapentadol IR|Withdrawal by Subject|0|||
147435685|NCT00594516|531762172|FG000|Open Label (OL): Tapentadol IR|Lost to Follow-up|2|||
147435686|NCT00594516|531762173|FG001|Open Label (OL): Tapentadol IR|Lost to Follow-up|0|||
147435687|NCT00594516|531762174|FG002|Open Label (OL): Tapentadol IR|Lost to Follow-up|0|||
147435688|NCT00594516|531762172|FG000|Open Label (OL): Tapentadol IR|Adverse Event|16|||
147435689|NCT00594516|531762173|FG001|Open Label (OL): Tapentadol IR|Adverse Event|0|||
147435690|NCT00594516|531762174|FG002|Open Label (OL): Tapentadol IR|Adverse Event|0|||
147435691|NCT00594516|531762172|FG000|Open Label (OL): Tapentadol IR|Lack of Efficacy|1|||
147435692|NCT00594516|531762173|FG001|Open Label (OL): Tapentadol IR|Lack of Efficacy|0|||
147435693|NCT00594516|531762174|FG002|Open Label (OL): Tapentadol IR|Lack of Efficacy|0|||
147435694|NCT00594516|531762172|FG000|Open Label (OL): Tapentadol IR|Study Medication Non Compliant|6|||
147435695|NCT00594516|531762173|FG001|Open Label (OL): Tapentadol IR|Study Medication Non Compliant|0|||
147435696|NCT00594516|531762174|FG002|Open Label (OL): Tapentadol IR|Study Medication Non Compliant|0|||
147435697|NCT00594516|531762172|FG000|DB: Tapentadol IR to ER & ER to IR|Withdrawal by Subject|0|||
147435698|NCT00594516|531762173|FG001|DB: Tapentadol IR to ER & ER to IR|Withdrawal by Subject|3|||
147435699|NCT00594516|531762174|FG002|DB: Tapentadol IR to ER & ER to IR|Withdrawal by Subject|3|||
147435700|NCT00594516|531762172|FG000|DB: Tapentadol IR to ER & ER to IR|Study Medication Non compliant|0|||
147435701|NCT00594516|531762173|FG001|DB: Tapentadol IR to ER & ER to IR|Study Medication Non compliant|3|||
147435702|NCT00594516|531762174|FG002|DB: Tapentadol IR to ER & ER to IR|Study Medication Non compliant|2|||
147435703|NCT00594516|531762172|FG000|DB: Tapentadol IR to ER & ER to IR|Lack of Efficacy|0|||
147435704|NCT00594516|531762173|FG001|DB: Tapentadol IR to ER & ER to IR|Lack of Efficacy|1|||
147435705|NCT00594516|531762174|FG002|DB: Tapentadol IR to ER & ER to IR|Lack of Efficacy|1|||
147435706|NCT00594516|531762172|FG000|DB: Tapentadol IR to ER & ER to IR|Adverse Event|0|||
147435707|NCT00594516|531762173|FG001|DB: Tapentadol IR to ER & ER to IR|Adverse Event|0|||
147435708|NCT00594516|531762174|FG002|DB: Tapentadol IR to ER & ER to IR|Adverse Event|2|||
147435709|NCT02462928|531762175|FG000|Overall Study|Screen Failure:Missed Exclusion Criteria|1|||
147435710|NCT02462928|531762176|FG001|Overall Study|Screen Failure:Missed Exclusion Criteria|1|||
147435711|NCT02462928|531762177|FG002|Overall Study|Screen Failure:Missed Exclusion Criteria|2|||
147435712|NCT02462928|531762175|FG000|Overall Study|Adverse Event|47|||
147435713|NCT02462928|531762176|FG001|Overall Study|Adverse Event|51|||
147435714|NCT02462928|531762177|FG002|Overall Study|Adverse Event|25|||
147435715|NCT02462928|531762175|FG000|Overall Study|Lack of Efficacy|3|||
147435716|NCT02462928|531762176|FG001|Overall Study|Lack of Efficacy|8|||
147435717|NCT02462928|531762177|FG002|Overall Study|Lack of Efficacy|3|||
147435718|NCT02462928|531762175|FG000|Overall Study|Lost to Follow-up|4|||
147435719|NCT02462928|531762176|FG001|Overall Study|Lost to Follow-up|4|||
147435720|NCT02462928|531762177|FG002|Overall Study|Lost to Follow-up|1|||
147435721|NCT02462928|531762175|FG000|Overall Study|Withdrawal by Patient|31|||
147435722|NCT02462928|531762176|FG001|Overall Study|Withdrawal by Patient|21|||
147435723|NCT02462928|531762177|FG002|Overall Study|Withdrawal by Patient|21|||
147435724|NCT02462928|531762175|FG000|Overall Study|Protocol Violation|0|||
147435725|NCT02462928|531762176|FG001|Overall Study|Protocol Violation|1|||
147435726|NCT02462928|531762177|FG002|Overall Study|Protocol Violation|0|||
147435727|NCT02462928|531762175|FG000|Overall Study|Reason not Specified|4|||
147435728|NCT02462928|531762176|FG001|Overall Study|Reason not Specified|6|||
147435729|NCT02462928|531762177|FG002|Overall Study|Reason not Specified|5|||
147435730|NCT01493557|531762178|FG000|Not Randomized to Management Strategies|Worsening of events associate with NVAF.|0|||
147435731|NCT01493557|531762179|FG001|Not Randomized to Management Strategies|Worsening of events associate with NVAF.|0|||
147435732|NCT01493557|531762180|FG002|Not Randomized to Management Strategies|Worsening of events associate with NVAF.|1|||
147535304|NCT04242498|532114871|FG002|Initial Treatment Period: Week 0-16|Subject Moved Long Distance From Clinic (Abroad)|1|||
147535305|NCT04242498|532114872|FG003|Initial Treatment Period: Week 0-16|Subject Moved Long Distance From Clinic (Abroad)|0|||
147535306|NCT04242498|532114873|FG004|Initial Treatment Period: Week 0-16|Subject Moved Long Distance From Clinic (Abroad)|0|||
147535307|NCT04242498|532114874|FG005|Initial Treatment Period: Week 0-16|Subject Moved Long Distance From Clinic (Abroad)|0|||
147535308|NCT04242498|532114875|FG006|Initial Treatment Period: Week 0-16|Subject Moved Long Distance From Clinic (Abroad)|0|||
147535309|NCT04242498|532114869|FG000|Initial Treatment Period: Week 0-16|Withdrawn by investigator's decision|0|||
147535310|NCT04242498|532114870|FG001|Initial Treatment Period: Week 0-16|Withdrawn by investigator's decision|0|||
147535311|NCT04242498|532114871|FG002|Initial Treatment Period: Week 0-16|Withdrawn by investigator's decision|1|||
147535312|NCT04242498|532114872|FG003|Initial Treatment Period: Week 0-16|Withdrawn by investigator's decision|0|||
147535313|NCT04242498|532114873|FG004|Initial Treatment Period: Week 0-16|Withdrawn by investigator's decision|0|||
147535314|NCT04242498|532114874|FG005|Initial Treatment Period: Week 0-16|Withdrawn by investigator's decision|0|||
147535315|NCT04242498|532114875|FG006|Initial Treatment Period: Week 0-16|Withdrawn by investigator's decision|0|||
147535316|NCT04242498|532114869|FG000|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
147535317|NCT04242498|532114870|FG001|Initial Treatment Period: Week 0-16|Randomized, not treated|2|||
147535318|NCT04242498|532114871|FG002|Initial Treatment Period: Week 0-16|Randomized, not treated|1|||
147535319|NCT04242498|532114872|FG003|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
147535320|NCT04242498|532114873|FG004|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
147535321|NCT04242498|532114874|FG005|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
147535322|NCT04242498|532114875|FG006|Initial Treatment Period: Week 0-16|Randomized, not treated|0|||
147535323|NCT04242498|532114869|FG000|Maintenance Treatment Period: Week 16-48|Adverse Event|0|||
147535324|NCT04242498|532114870|FG001|Maintenance Treatment Period: Week 16-48|Adverse Event|0|||
147535325|NCT04242498|532114871|FG002|Maintenance Treatment Period: Week 16-48|Adverse Event|0|||
147535326|NCT04242498|532114872|FG003|Maintenance Treatment Period: Week 16-48|Adverse Event|0|||
147535327|NCT04242498|532114873|FG004|Maintenance Treatment Period: Week 16-48|Adverse Event|7|||
147535328|NCT04242498|532114874|FG005|Maintenance Treatment Period: Week 16-48|Adverse Event|6|||
147535329|NCT04242498|532114875|FG006|Maintenance Treatment Period: Week 16-48|Adverse Event|4|||
147535330|NCT04242498|532114869|FG000|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|0|||
147535331|NCT04242498|532114870|FG001|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|0|||
147535332|NCT04242498|532114871|FG002|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|0|||
147535333|NCT04242498|532114872|FG003|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|0|||
147535334|NCT04242498|532114873|FG004|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|4|||
147535335|NCT04242498|532114874|FG005|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|2|||
147535336|NCT04242498|532114875|FG006|Maintenance Treatment Period: Week 16-48|Lack of Efficacy|2|||
147535337|NCT04242498|532114869|FG000|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
147535338|NCT04242498|532114870|FG001|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
147535339|NCT04242498|532114871|FG002|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
147535340|NCT04242498|532114872|FG003|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
147535341|NCT04242498|532114873|FG004|Maintenance Treatment Period: Week 16-48|Protocol Violation|0|||
147535342|NCT04242498|532114874|FG005|Maintenance Treatment Period: Week 16-48|Protocol Violation|2|||
147535343|NCT04242498|532114875|FG006|Maintenance Treatment Period: Week 16-48|Protocol Violation|1|||
147535344|NCT04242498|532114869|FG000|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|0|||
147535345|NCT04242498|532114870|FG001|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|0|||
147535346|NCT04242498|532114871|FG002|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|0|||
147535347|NCT04242498|532114872|FG003|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|2|||
147535348|NCT04242498|532114873|FG004|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|3|||
147535349|NCT04242498|532114874|FG005|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|1|||
147535350|NCT04242498|532114875|FG006|Maintenance Treatment Period: Week 16-48|Lost to Follow-up|2|||
147535351|NCT04242498|532114869|FG000|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|0|||
147535352|NCT04242498|532114870|FG001|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|0|||
147535353|NCT04242498|532114871|FG002|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|0|||
147535354|NCT04242498|532114872|FG003|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|6|||
147535355|NCT04242498|532114873|FG004|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|9|||
147535356|NCT04242498|532114874|FG005|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|10|||
147535357|NCT04242498|532114875|FG006|Maintenance Treatment Period: Week 16-48|Consent withdrawn by subject, not due to AE|11|||
147535358|NCT04242498|532114869|FG000|Maintenance Treatment Period: Week 16-48|Change In Address-Patient Not Wanting To Continue|0|||
147535359|NCT04242498|532114870|FG001|Maintenance Treatment Period: Week 16-48|Change In Address-Patient Not Wanting To Continue|0|||
147306801|NCT02839343|531290770|FG001|Overall Study|Disease Progression Prior to Treatment|0|||
147306802|NCT02839343|531290769|FG000|Overall Study|Adverse Event|1|||
147535360|NCT04242498|532114871|FG002|Maintenance Treatment Period: Week 16-48|Change In Address-Patient Not Wanting To Continue|0|||
147535361|NCT04242498|532114872|FG003|Maintenance Treatment Period: Week 16-48|Change In Address-Patient Not Wanting To Continue|0|||
147535362|NCT04242498|532114873|FG004|Maintenance Treatment Period: Week 16-48|Change In Address-Patient Not Wanting To Continue|1|||
147535363|NCT04242498|532114874|FG005|Maintenance Treatment Period: Week 16-48|Change In Address-Patient Not Wanting To Continue|0|||
147535364|NCT04242498|532114875|FG006|Maintenance Treatment Period: Week 16-48|Change In Address-Patient Not Wanting To Continue|0|||
147535365|NCT04242498|532114869|FG000|Maintenance Treatment Period: Week 16-48|Visits Too Time-Consuming, Only SFU Will Be Done|0|||
147535366|NCT04242498|532114870|FG001|Maintenance Treatment Period: Week 16-48|Visits Too Time-Consuming, Only SFU Will Be Done|0|||
147535367|NCT04242498|532114871|FG002|Maintenance Treatment Period: Week 16-48|Visits Too Time-Consuming, Only SFU Will Be Done|0|||
147535368|NCT04242498|532114872|FG003|Maintenance Treatment Period: Week 16-48|Visits Too Time-Consuming, Only SFU Will Be Done|0|||
147535369|NCT04242498|532114873|FG004|Maintenance Treatment Period: Week 16-48|Visits Too Time-Consuming, Only SFU Will Be Done|0|||
147535370|NCT04242498|532114874|FG005|Maintenance Treatment Period: Week 16-48|Visits Too Time-Consuming, Only SFU Will Be Done|1|||
147535371|NCT04242498|532114875|FG006|Maintenance Treatment Period: Week 16-48|Visits Too Time-Consuming, Only SFU Will Be Done|0|||
147535372|NCT04242498|532114869|FG000|Maintenance Treatment Period: Week 16-48|Subject Relocated|0|||
147535373|NCT04242498|532114870|FG001|Maintenance Treatment Period: Week 16-48|Subject Relocated|0|||
147535374|NCT04242498|532114871|FG002|Maintenance Treatment Period: Week 16-48|Subject Relocated|0|||
147535375|NCT04242498|532114872|FG003|Maintenance Treatment Period: Week 16-48|Subject Relocated|0|||
147535376|NCT04242498|532114873|FG004|Maintenance Treatment Period: Week 16-48|Subject Relocated|0|||
147535377|NCT04242498|532114874|FG005|Maintenance Treatment Period: Week 16-48|Subject Relocated|1|||
147535378|NCT04242498|532114875|FG006|Maintenance Treatment Period: Week 16-48|Subject Relocated|1|||
147535379|NCT05153629|532114877|FG000|Overall Study|Withdrawal by Subject|0|||
147535380|NCT05153629|532114878|FG001|Overall Study|Withdrawal by Subject|2|||
147535381|NCT04089566|532114881|FG000|Overall Study|Death|0|||
147535382|NCT04089566|532114882|FG001|Overall Study|Death|6|||
147535383|NCT04089566|532114883|FG002|Overall Study|Death|10|||
147535384|NCT04089566|532114884|FG003|Overall Study|Death|0|||
147535385|NCT04089566|532114885|FG004|Overall Study|Death|0|||
147535386|NCT04089566|532114886|FG005|Overall Study|Death|0|||
147535387|NCT04089566|532114881|FG000|Overall Study|Withdrawal by Parent or Guardian|0|||
147535388|NCT04089566|532114882|FG001|Overall Study|Withdrawal by Parent or Guardian|2|||
147535389|NCT04089566|532114883|FG002|Overall Study|Withdrawal by Parent or Guardian|1|||
147535390|NCT04089566|532114884|FG003|Overall Study|Withdrawal by Parent or Guardian|0|||
147535391|NCT04089566|532114885|FG004|Overall Study|Withdrawal by Parent or Guardian|0|||
147535392|NCT04089566|532114886|FG005|Overall Study|Withdrawal by Parent or Guardian|0|||
147535393|NCT04089566|532114881|FG000|Overall Study|Reason not Specified|0|||
147535394|NCT04089566|532114882|FG001|Overall Study|Reason not Specified|4|||
147535395|NCT04089566|532114883|FG002|Overall Study|Reason not Specified|4|||
147535396|NCT04089566|532114884|FG003|Overall Study|Reason not Specified|1|||
147535397|NCT04089566|532114885|FG004|Overall Study|Reason not Specified|0|||
147535398|NCT04089566|532114886|FG005|Overall Study|Reason not Specified|0|||
147535399|NCT01083121|532114887|FG000|Overall Study|Use of Humira outside the approved label|81|||
147535400|NCT03743571|532114890|FG000|Overall Study|Withdrawal by Subject|1|||
147535401|NCT03743571|532114891|FG001|Overall Study|Withdrawal by Subject|1|||
147535402|NCT03743571|532114890|FG000|Overall Study|Lost to Follow-up|1|||
147535403|NCT03743571|532114891|FG001|Overall Study|Lost to Follow-up|2|||
147535404|NCT04115488|532114892|FG000|Overall Study|Adverse Event|8|||
147535405|NCT04115488|532114893|FG001|Overall Study|Adverse Event|4|||
147535406|NCT04115488|532114892|FG000|Overall Study|Withdrawal by Subject|3|||
147535407|NCT04115488|532114893|FG001|Overall Study|Withdrawal by Subject|6|||
147535408|NCT04115488|532114892|FG000|Overall Study|Investigator/ Sponsor Decision|2|||
147535409|NCT04115488|532114893|FG001|Overall Study|Investigator/ Sponsor Decision|0|||
147535410|NCT04115488|532114892|FG000|Overall Study|Patient 's location change|1|||
147535411|NCT04115488|532114893|FG001|Overall Study|Patient 's location change|0|||
147535412|NCT04115488|532114892|FG000|Overall Study|Due to COVID-19 restrictions at site|0|||
147535413|NCT04115488|532114893|FG001|Overall Study|Due to COVID-19 restrictions at site|1|||
147535414|NCT00885677|532114894|FG000|Overall Study|Death|40|||
147535415|NCT00885677|532114895|FG001|Overall Study|Death|34|||
147535416|NCT00885677|532114894|FG000|Overall Study|Lost to Follow-up|15|||
147535417|NCT00885677|532114895|FG001|Overall Study|Lost to Follow-up|13|||
147535418|NCT00885677|532114894|FG000|Overall Study|Protocol Violation|54|||
147535419|NCT00885677|532114895|FG001|Overall Study|Protocol Violation|54|||
147535420|NCT00885677|532114894|FG000|Overall Study|premature study closure|41|||
147535421|NCT00885677|532114895|FG001|Overall Study|premature study closure|44|||
147535422|NCT00885677|532114894|FG000|Overall Study|device/lead revision or replacement|7|||
147535423|NCT00885677|532114895|FG001|Overall Study|device/lead revision or replacement|6|||
147535424|NCT00885677|532114894|FG000|Overall Study|Heart transplantation|1|||
147535425|NCT00885677|532114895|FG001|Overall Study|Heart transplantation|0|||
147535426|NCT00885677|532114894|FG000|Overall Study|Inclusion/exclusion not met|25|||
147535427|NCT00885677|532114895|FG001|Overall Study|Inclusion/exclusion not met|27|||
147535428|NCT01233284|532114910|FG000|Period 1 (4 Weeks)|Lost to Follow-up|1|||
147535429|NCT01233284|532114911|FG001|Period 1 (4 Weeks)|Lost to Follow-up|0|||
147535430|NCT01233284|532114912|FG002|Period 1 (4 Weeks)|Lost to Follow-up|0|||
147535431|NCT01233284|532114913|FG003|Period 1 (4 Weeks)|Lost to Follow-up|0|||
147535432|NCT01233284|532114914|FG004|Period 1 (4 Weeks)|Lost to Follow-up|0|||
147535433|NCT01233284|532114910|FG000|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
147535434|NCT01233284|532114911|FG001|Period 1 (4 Weeks)|Withdrawal by Subject|1|||
147535435|NCT01233284|532114912|FG002|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
147535436|NCT01233284|532114913|FG003|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
147535437|NCT01233284|532114914|FG004|Period 1 (4 Weeks)|Withdrawal by Subject|0|||
147535438|NCT01233284|532114910|FG000|Period 1 (4 Weeks)|Other|0|||
147535439|NCT01233284|532114911|FG001|Period 1 (4 Weeks)|Other|0|||
147535440|NCT01233284|532114912|FG002|Period 1 (4 Weeks)|Other|1|||
147535441|NCT01233284|532114913|FG003|Period 1 (4 Weeks)|Other|0|||
147535442|NCT01233284|532114914|FG004|Period 1 (4 Weeks)|Other|0|||
147535443|NCT01233284|532114910|FG000|Period 2 (4 Weeks)|Withdrawal by Subject|0|||
147535444|NCT01233284|532114911|FG001|Period 2 (4 Weeks)|Withdrawal by Subject|0|||
147535445|NCT01233284|532114912|FG002|Period 2 (4 Weeks)|Withdrawal by Subject|1|||
147535446|NCT01233284|532114913|FG003|Period 2 (4 Weeks)|Withdrawal by Subject|0|||
147535447|NCT01233284|532114914|FG004|Period 2 (4 Weeks)|Withdrawal by Subject|0|||
147535448|NCT01233284|532114910|FG000|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
147535449|NCT01233284|532114911|FG001|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
147535450|NCT01233284|532114912|FG002|Period 3 (4 Weeks)|Withdrawal by Subject|1|||
147535451|NCT01233284|532114913|FG003|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
147535452|NCT01233284|532114914|FG004|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
147535453|NCT01233284|532114910|FG000|Period 3 (4 Weeks)|Other|0|||
147535454|NCT01233284|532114911|FG001|Period 3 (4 Weeks)|Other|0|||
147535455|NCT01233284|532114912|FG002|Period 3 (4 Weeks)|Other|0|||
147535456|NCT01233284|532114913|FG003|Period 3 (4 Weeks)|Other|1|||
147535457|NCT01233284|532114914|FG004|Period 3 (4 Weeks)|Other|0|||
147535458|NCT01233284|532114910|FG000|Period 4 (4 Weeks)|Adverse Event|0|||
147535459|NCT01233284|532114911|FG001|Period 4 (4 Weeks)|Adverse Event|1|||
147535460|NCT01233284|532114912|FG002|Period 4 (4 Weeks)|Adverse Event|0|||
147535461|NCT01233284|532114913|FG003|Period 4 (4 Weeks)|Adverse Event|0|||
147535462|NCT01233284|532114914|FG004|Period 4 (4 Weeks)|Adverse Event|0|||
147535463|NCT01233284|532114910|FG000|Period 4 (4 Weeks)|Lost to Follow-up|0|||
147535464|NCT01233284|532114911|FG001|Period 4 (4 Weeks)|Lost to Follow-up|0|||
147535465|NCT01233284|532114912|FG002|Period 4 (4 Weeks)|Lost to Follow-up|0|||
147535466|NCT01233284|532114913|FG003|Period 4 (4 Weeks)|Lost to Follow-up|1|||
147535467|NCT01233284|532114914|FG004|Period 4 (4 Weeks)|Lost to Follow-up|0|||
147535468|NCT05403502|532114915|FG000|Humalog Lead-In Period|Withdrawal by Subject|1|||
147535469|NCT05403502|532114915|FG000|Humalog Lead-In Period|Physician Decision|2|||
147535470|NCT05403502|532114915|FG000|Humalog Lead-In Period|Protocol Violation|1|||
147535471|NCT05403502|532114915|FG000|Lyumjev Treatment Period|Withdrawal by Subject|4|||
147535472|NCT05403502|532114915|FG000|Lyumjev Treatment Period|Physician Decision|2|||
147535473|NCT01058707|532114917|FG000|Overall Study|Disease Progression|15|||
147535474|NCT01058707|532114918|FG001|Overall Study|Disease Progression|20|||
147535475|NCT01058707|532114919|FG002|Overall Study|Disease Progression|20|||
147535476|NCT01058707|532114920|FG003|Overall Study|Disease Progression|15|||
147535477|NCT01058707|532114921|FG004|Overall Study|Disease Progression|23|||
147535478|NCT01058707|532114922|FG005|Overall Study|Disease Progression|10|||
147535479|NCT01058707|532114923|FG006|Overall Study|Disease Progression|12|||
147535480|NCT01058707|532114917|FG000|Overall Study|Adverse Event|11|||
147535481|NCT01058707|532114918|FG001|Overall Study|Adverse Event|4|||
147535482|NCT01058707|532114919|FG002|Overall Study|Adverse Event|7|||
147535483|NCT01058707|532114920|FG003|Overall Study|Adverse Event|6|||
147535484|NCT01058707|532114921|FG004|Overall Study|Adverse Event|7|||
147535485|NCT01058707|532114922|FG005|Overall Study|Adverse Event|3|||
147535486|NCT01058707|532114923|FG006|Overall Study|Adverse Event|1|||
147535487|NCT01058707|532114917|FG000|Overall Study|Subject Decision|5|||
147535488|NCT01058707|532114918|FG001|Overall Study|Subject Decision|3|||
147535489|NCT01058707|532114919|FG002|Overall Study|Subject Decision|3|||
147535490|NCT01058707|532114920|FG003|Overall Study|Subject Decision|1|||
147535491|NCT01058707|532114921|FG004|Overall Study|Subject Decision|2|||
147535492|NCT01058707|532114922|FG005|Overall Study|Subject Decision|3|||
147535493|NCT01058707|532114923|FG006|Overall Study|Subject Decision|6|||
147535494|NCT01058707|532114917|FG000|Overall Study|Lost to Follow-up|0|||
147535495|NCT01058707|532114918|FG001|Overall Study|Lost to Follow-up|0|||
147535496|NCT01058707|532114919|FG002|Overall Study|Lost to Follow-up|1|||
147535497|NCT01058707|532114920|FG003|Overall Study|Lost to Follow-up|0|||
147535498|NCT01058707|532114921|FG004|Overall Study|Lost to Follow-up|0|||
147535499|NCT01058707|532114922|FG005|Overall Study|Lost to Follow-up|0|||
147535500|NCT01058707|532114923|FG006|Overall Study|Lost to Follow-up|0|||
147535501|NCT01058707|532114917|FG000|Overall Study|Reason Not Specified|0|||
147535502|NCT01058707|532114918|FG001|Overall Study|Reason Not Specified|3|||
147535503|NCT01058707|532114919|FG002|Overall Study|Reason Not Specified|2|||
147535504|NCT01058707|532114920|FG003|Overall Study|Reason Not Specified|0|||
147535505|NCT01058707|532114921|FG004|Overall Study|Reason Not Specified|7|||
147535506|NCT01058707|532114922|FG005|Overall Study|Reason Not Specified|1|||
147535507|NCT01058707|532114923|FG006|Overall Study|Reason Not Specified|7|||
147535508|NCT00167414|532114925|FG000|Overall Study|Death|10|||
147535509|NCT01875731|532114930|FG000|Overall Study|Fail to obtain lab sample|1|||
147535510|NCT01875731|532114931|FG001|Overall Study|Fail to obtain lab sample|0|||
147535511|NCT03417102|532114932|FG000|Overall Study|Adverse Event|0|||
147535512|NCT03417102|532114933|FG001|Overall Study|Adverse Event|1|||
147535513|NCT03417102|532114932|FG000|Overall Study|Related to Coronavirus Pandemic (Covid-19)|0|||
147535514|NCT03417102|532114933|FG001|Overall Study|Related to Coronavirus Pandemic (Covid-19)|3|||
147535515|NCT03417102|532114932|FG000|Overall Study|Other|0|||
147535516|NCT03417102|532114933|FG001|Overall Study|Other|1|||
147535517|NCT03188991|532114934|FG000|Overall Study|Withdrawal by Subject|0|||
147535518|NCT03188991|532114935|FG001|Overall Study|Withdrawal by Subject|0|||
147535519|NCT03188991|532114936|FG002|Overall Study|Withdrawal by Subject|0|||
147535520|NCT03188991|532114937|FG003|Overall Study|Withdrawal by Subject|1|||
147535521|NCT01656850|532116640|FG000|First Intervention (3 Months)|Withdrawal by Subject|3|||
147535522|NCT01656850|532116641|FG001|First Intervention (3 Months)|Withdrawal by Subject|4|||
147535523|NCT00396318|532116642|FG000|At Least One Dose of Tenecteplase (MITT)|Subject withdrew consent|5|||
147535524|NCT03255226|532116646|FG000|Overall Study|Adverse Event|2|||
147535525|NCT03255226|532116646|FG000|Overall Study|Physician Decision|3|||
147535526|NCT03255226|532116646|FG000|Overall Study|Withdrawal by Subject|1|||
147535527|NCT03255226|532116646|FG000|Overall Study|Serum or blood sodium increased|4|||
147535528|NCT03255226|532116646|FG000|Overall Study|Serum or blood potassium increased|4|||
147535529|NCT00602927|532116647|FG000|Period 1: 13 Days|Protocol Violation|2|||
147535530|NCT00602927|532116648|FG001|Period 1: 13 Days|Protocol Violation|4|||
147535531|NCT00602927|532116647|FG000|Period 1: 13 Days|MRI scanner technical issue|1|||
147535532|NCT00602927|532116648|FG001|Period 1: 13 Days|MRI scanner technical issue|0|||
147535533|NCT00602927|532116647|FG000|Period 1: 13 Days|Time|1|||
147535534|NCT00602927|532116648|FG001|Period 1: 13 Days|Time|0|||
147535535|NCT00602927|532116647|FG000|Period 1: 13 Days|Claustrophobia|0|||
147535536|NCT00602927|532116648|FG001|Period 1: 13 Days|Claustrophobia|1|||
147535537|NCT00602927|532116647|FG000|Period 2: 14 Days|Protocol Violation|0|||
147535538|NCT00602927|532116648|FG001|Period 2: 14 Days|Protocol Violation|2|||
147535539|NCT00602927|532116647|FG000|Period 3: 13 Days|Protocol Violation|0|||
147535540|NCT00602927|532116648|FG001|Period 3: 13 Days|Protocol Violation|1|||
147201980|NCT02968004|530910513|FG001|Open Label Extension (OLE) Year 3|Local Crisis|0|||
147201981|NCT02968004|530910512|FG000|Open Label Extension (OLE) Year 4|Withdrawal by Subject|3|||
147201982|NCT02968004|530910513|FG001|Open Label Extension (OLE) Year 4|Withdrawal by Subject|4|||
147435733|NCT01493557|531762178|FG000|Not Randomized to Management Strategies|Worsening of other pre-existing disease|0|||
147435734|NCT01493557|531762179|FG001|Not Randomized to Management Strategies|Worsening of other pre-existing disease|0|||
147435735|NCT01493557|531762180|FG002|Not Randomized to Management Strategies|Worsening of other pre-existing disease|9|||
147435736|NCT01493557|531762178|FG000|Not Randomized to Management Strategies|Other adverse event|0|||
147435737|NCT01493557|531762179|FG001|Not Randomized to Management Strategies|Other adverse event|0|||
147435738|NCT01493557|531762180|FG002|Not Randomized to Management Strategies|Other adverse event|54|||
147435739|NCT01493557|531762178|FG000|Not Randomized to Management Strategies|Protocol Violation|0|||
147435740|NCT01493557|531762179|FG001|Not Randomized to Management Strategies|Protocol Violation|0|||
147435741|NCT01493557|531762180|FG002|Not Randomized to Management Strategies|Protocol Violation|1|||
147435742|NCT01493557|531762178|FG000|Not Randomized to Management Strategies|Lost to Follow-up|0|||
147435743|NCT01493557|531762179|FG001|Not Randomized to Management Strategies|Lost to Follow-up|0|||
147435744|NCT01493557|531762180|FG002|Not Randomized to Management Strategies|Lost to Follow-up|4|||
147435745|NCT01493557|531762178|FG000|Not Randomized to Management Strategies|Withdrawal by Subject|0|||
147435746|NCT01493557|531762179|FG001|Not Randomized to Management Strategies|Withdrawal by Subject|0|||
147435747|NCT01493557|531762180|FG002|Not Randomized to Management Strategies|Withdrawal by Subject|10|||
147435748|NCT01493557|531762178|FG000|Not Randomized to Management Strategies|Early termination|0|||
147435749|NCT01493557|531762179|FG001|Not Randomized to Management Strategies|Early termination|0|||
147435750|NCT01493557|531762180|FG002|Not Randomized to Management Strategies|Early termination|34|||
147435751|NCT01493557|531762178|FG000|Not Randomized to Management Strategies|Other than stated above|0|||
147435752|NCT01493557|531762179|FG001|Not Randomized to Management Strategies|Other than stated above|0|||
147435753|NCT01493557|531762180|FG002|Not Randomized to Management Strategies|Other than stated above|21|||
147435754|NCT01493557|531762178|FG000|Randomized to Management Strategies|Worsening of events associate with GIS|3|||
147535541|NCT00602927|532116647|FG000|Period 3: 13 Days|MRI data quality|2|||
147535542|NCT00602927|532116648|FG001|Period 3: 13 Days|MRI data quality|2|||
147201983|NCT02968004|530910512|FG000|Open Label Extension (OLE) Year 4|Non-Compliance With Study Drug|0|||
147306803|NCT02839343|531290770|FG001|Overall Study|Adverse Event|0|||
147535543|NCT00685763|532116655|FG000|Overall Study|Intercurrent death-incomplete treatment|1|||
147535544|NCT00685763|532116655|FG000|Overall Study|Protocol Violation|1|||
147535545|NCT02525627|532116656|FG000|Overall Study|Revision|1|||
147649413|NCT02634801|532537342|FG001|Treatment Period (Weeks 0 to 24)|Adverse Event|20|||
147649414|NCT02634801|532537343|FG002|Treatment Period (Weeks 0 to 24)|Adverse Event|0|||
147535546|NCT02525627|532116657|FG001|Overall Study|Revision|1|||
147435755|NCT01493557|531762179|FG001|Randomized to Management Strategies|Worsening of events associate with GIS|2|||
147435756|NCT01493557|531762180|FG002|Randomized to Management Strategies|Worsening of events associate with GIS|0|||
147435757|NCT01493557|531762178|FG000|Randomized to Management Strategies|Other adverse event|8|||
147435758|NCT01493557|531762179|FG001|Randomized to Management Strategies|Other adverse event|5|||
147435759|NCT01493557|531762180|FG002|Randomized to Management Strategies|Other adverse event|0|||
147435760|NCT01493557|531762178|FG000|Randomized to Management Strategies|Protocol Violation|3|||
147435761|NCT01493557|531762179|FG001|Randomized to Management Strategies|Protocol Violation|0|||
147435762|NCT01493557|531762180|FG002|Randomized to Management Strategies|Protocol Violation|0|||
147435763|NCT01493557|531762178|FG000|Randomized to Management Strategies|Withdrawal by Subject|0|||
147435764|NCT01493557|531762179|FG001|Randomized to Management Strategies|Withdrawal by Subject|1|||
147435765|NCT01493557|531762180|FG002|Randomized to Management Strategies|Withdrawal by Subject|0|||
147435766|NCT01493557|531762178|FG000|Randomized to Management Strategies|Other than stated above|1|||
147435767|NCT01493557|531762179|FG001|Randomized to Management Strategies|Other than stated above|3|||
147435768|NCT01493557|531762180|FG002|Randomized to Management Strategies|Other than stated above|0|||
147435769|NCT01493557|531762178|FG000|Adding the Second Strategy|Worsening of events associate with GIS|1|||
147435770|NCT01493557|531762179|FG001|Adding the Second Strategy|Worsening of events associate with GIS|1|||
147435771|NCT01493557|531762180|FG002|Adding the Second Strategy|Worsening of events associate with GIS|0|||
147435772|NCT01493557|531762178|FG000|Adding the Second Strategy|Other adverse event|1|||
147435773|NCT01493557|531762179|FG001|Adding the Second Strategy|Other adverse event|2|||
147435774|NCT01493557|531762180|FG002|Adding the Second Strategy|Other adverse event|0|||
147435775|NCT01493557|531762178|FG000|Adding the Second Strategy|Withdrawal by Subject|0|||
147435776|NCT01493557|531762179|FG001|Adding the Second Strategy|Withdrawal by Subject|1|||
147435777|NCT01493557|531762180|FG002|Adding the Second Strategy|Withdrawal by Subject|0|||
147435778|NCT03876171|531762185|FG000|Overall Study|Withdrawal by Subject|3|||
147435779|NCT03876171|531762186|FG001|Overall Study|Withdrawal by Subject|3|||
147435780|NCT03876171|531762185|FG000|Overall Study|Re-arrest|0|||
147435781|NCT03876171|531762186|FG001|Overall Study|Re-arrest|4|||
147435782|NCT02012296|531762187|FG000|Overall Study|Lack of Efficacy|0|||
147435783|NCT02012296|531762188|FG001|Overall Study|Lack of Efficacy|0|||
147435784|NCT02012296|531762189|FG002|Overall Study|Lack of Efficacy|15|||
147435785|NCT02012296|531762187|FG000|Overall Study|Adverse Event|0|||
147435786|NCT02012296|531762188|FG001|Overall Study|Adverse Event|0|||
147435787|NCT02012296|531762189|FG002|Overall Study|Adverse Event|2|||
147435788|NCT02012296|531762187|FG000|Overall Study|Early study closure|0|||
147435789|NCT02012296|531762188|FG001|Overall Study|Early study closure|0|||
147435790|NCT02012296|531762189|FG002|Overall Study|Early study closure|5|||
147435791|NCT02012296|531762187|FG000|Overall Study|Protocol Violation|0|||
147435792|NCT02012296|531762188|FG001|Overall Study|Protocol Violation|1|||
147435793|NCT02012296|531762189|FG002|Overall Study|Protocol Violation|0|||
147435794|NCT01170039|531762192|FG000|Overall Study|Withdrawal by Subject|5|||
147435795|NCT01170039|531762193|FG001|Overall Study|Withdrawal by Subject|3|||
147435796|NCT01170039|531762192|FG000|Overall Study|Lack of funding, drug not available|3|||
147435797|NCT01170039|531762193|FG001|Overall Study|Lack of funding, drug not available|3|||
147435798|NCT00908583|531762194|FG000|Phase 1|Withdrawal by Subject|1|||
147435799|NCT00908583|531762194|FG000|Phase 1|Adverse Event|4|||
147435800|NCT00908583|531762194|FG000|Phase 2|Physician Decision|1|||
147435801|NCT00908583|531762194|FG000|Phase 2|Adverse Event|1|||
147435802|NCT00908583|531762194|FG000|Phase 3|Adverse Event|2|||
147435803|NCT00908583|531762194|FG000|Phase 4|Adverse Event|1|||
147435804|NCT00908583|531762194|FG000|Phase 4|Physician Decision|1|||
147435805|NCT00908583|531762194|FG000|Phase 5|Adverse Event|3|||
147435806|NCT00993954|531762195|FG000|Overall Study|Protocol Violation|21|||
147435807|NCT00993954|531762196|FG001|Overall Study|Protocol Violation|2|||
147435808|NCT00860951|531762197|FG000|Overall Study|Withdrawal by Subject|2|||
147435809|NCT00860951|531762197|FG000|Overall Study|Lost to Follow-up|5|||
147435810|NCT00727649|531762198|FG000|First Intervention (4-weeks)|Lost to Follow-up|1|||
147435811|NCT00727649|531762199|FG001|First Intervention (4-weeks)|Lost to Follow-up|2|||
147435812|NCT00727649|531762198|FG000|First Intervention (4-weeks)|Withdrawal by Subject|2|||
147435813|NCT00727649|531762199|FG001|First Intervention (4-weeks)|Withdrawal by Subject|1|||
147435814|NCT00727649|531762198|FG000|Wash-out (2-weeks)|Lost to Follow-up|3|||
147435815|NCT00727649|531762199|FG001|Wash-out (2-weeks)|Lost to Follow-up|1|||
147435816|NCT00727649|531762198|FG000|Wash-out (2-weeks)|Withdrawal by Subject|1|||
147435817|NCT00727649|531762199|FG001|Wash-out (2-weeks)|Withdrawal by Subject|2|||
147435818|NCT00727649|531762198|FG000|Second Intervention (4-weeks)|Death|1|||
147435819|NCT00727649|531762199|FG001|Second Intervention (4-weeks)|Death|0|||
147435820|NCT00727649|531762198|FG000|Second Intervention (4-weeks)|Lost to Follow-up|0|||
147435821|NCT00727649|531762199|FG001|Second Intervention (4-weeks)|Lost to Follow-up|1|||
147435822|NCT00727649|531762198|FG000|Second Intervention (4-weeks)|Withdrawal by Subject|0|||
147435823|NCT00727649|531762199|FG001|Second Intervention (4-weeks)|Withdrawal by Subject|2|||
147435824|NCT02953639|531762202|FG000|Overall Study|Adverse Event|2|||
147435825|NCT02953639|531762203|FG001|Overall Study|Adverse Event|0|||
147435826|NCT02953639|531762204|FG002|Overall Study|Adverse Event|1|||
147435827|NCT02953639|531762202|FG000|Overall Study|Lost to Follow-up|8|||
147435828|NCT02953639|531762203|FG001|Overall Study|Lost to Follow-up|4|||
147435829|NCT02953639|531762204|FG002|Overall Study|Lost to Follow-up|3|||
147435830|NCT02953639|531762202|FG000|Overall Study|Non-Compliance With Study Drug|0|||
147435831|NCT02953639|531762203|FG001|Overall Study|Non-Compliance With Study Drug|2|||
147435832|NCT02953639|531762204|FG002|Overall Study|Non-Compliance With Study Drug|1|||
147435833|NCT02953639|531762202|FG000|Overall Study|Multiple Reasons|1|||
147435834|NCT02953639|531762203|FG001|Overall Study|Multiple Reasons|0|||
147435835|NCT02953639|531762204|FG002|Overall Study|Multiple Reasons|1|||
147435836|NCT02953639|531762202|FG000|Overall Study|Physician Decision|1|||
147435837|NCT02953639|531762203|FG001|Overall Study|Physician Decision|0|||
147435838|NCT02953639|531762204|FG002|Overall Study|Physician Decision|0|||
147435839|NCT02953639|531762202|FG000|Overall Study|Withdrawal by Subject|7|||
147435840|NCT02953639|531762203|FG001|Overall Study|Withdrawal by Subject|8|||
147435841|NCT02953639|531762204|FG002|Overall Study|Withdrawal by Subject|10|||
147435842|NCT02953639|531762202|FG000|Overall Study|Completed or Discontinued information is missing|1|||
147435843|NCT02953639|531762203|FG001|Overall Study|Completed or Discontinued information is missing|0|||
147435844|NCT02953639|531762204|FG002|Overall Study|Completed or Discontinued information is missing|0|||
147435845|NCT01830855|531762205|FG000|Overall Study|Other|7|||
147435846|NCT01830855|531762206|FG001|Overall Study|Other|1|||
147435847|NCT01830855|531762207|FG002|Overall Study|Other|4|||
147435848|NCT01830855|531762208|FG003|Overall Study|Other|4|||
147435849|NCT01830855|531762205|FG000|Overall Study|Medication error without associated AE|1|||
147435850|NCT01830855|531762206|FG001|Overall Study|Medication error without associated AE|0|||
147435851|NCT01830855|531762207|FG002|Overall Study|Medication error without associated AE|0|||
147435852|NCT01830855|531762208|FG003|Overall Study|Medication error without associated AE|1|||
147435853|NCT01830855|531762205|FG000|Overall Study|Pregnancy|3|||
147435854|NCT01830855|531762206|FG001|Overall Study|Pregnancy|1|||
147435855|NCT01830855|531762207|FG002|Overall Study|Pregnancy|2|||
147435856|NCT01830855|531762208|FG003|Overall Study|Pregnancy|1|||
147435857|NCT01830855|531762205|FG000|Overall Study|No longer meets eligibility criteria|11|||
147435858|NCT01830855|531762206|FG001|Overall Study|No longer meets eligibility criteria|2|||
147435859|NCT01830855|531762207|FG002|Overall Study|No longer meets eligibility criteria|3|||
147435860|NCT01830855|531762208|FG003|Overall Study|No longer meets eligibility criteria|5|||
147435861|NCT01830855|531762205|FG000|Overall Study|Adverse Event|11|||
147435862|NCT01830855|531762206|FG001|Overall Study|Adverse Event|5|||
147435863|NCT01830855|531762207|FG002|Overall Study|Adverse Event|6|||
147435864|NCT01830855|531762208|FG003|Overall Study|Adverse Event|3|||
147435865|NCT01830855|531762205|FG000|Overall Study|Protocol deviation|10|||
147435866|NCT01830855|531762206|FG001|Overall Study|Protocol deviation|5|||
147435867|NCT01830855|531762207|FG002|Overall Study|Protocol deviation|6|||
147435868|NCT01830855|531762208|FG003|Overall Study|Protocol deviation|6|||
147435869|NCT01830855|531762205|FG000|Overall Study|Withdrawal by Subject|33|||
147435870|NCT01830855|531762206|FG001|Overall Study|Withdrawal by Subject|14|||
147435871|NCT01830855|531762207|FG002|Overall Study|Withdrawal by Subject|10|||
147435872|NCT01830855|531762208|FG003|Overall Study|Withdrawal by Subject|12|||
147435873|NCT01830855|531762205|FG000|Overall Study|No longer willing to participate|32|||
147435874|NCT01830855|531762206|FG001|Overall Study|No longer willing to participate|13|||
147435875|NCT01830855|531762207|FG002|Overall Study|No longer willing to participate|12|||
147435876|NCT01830855|531762208|FG003|Overall Study|No longer willing to participate|17|||
147435877|NCT01830855|531762205|FG000|Overall Study|Lost to Follow-up|47|||
147435878|NCT01830855|531762206|FG001|Overall Study|Lost to Follow-up|20|||
147435879|NCT01830855|531762207|FG002|Overall Study|Lost to Follow-up|23|||
147435880|NCT01830855|531762208|FG003|Overall Study|Lost to Follow-up|33|||
147435881|NCT00295633|531762211|FG000|Overall Study|Lack of Efficacy|19|||
147435882|NCT00295633|531762212|FG001|Overall Study|Lack of Efficacy|7|||
147435883|NCT00295633|531762213|FG002|Overall Study|Lack of Efficacy|16|||
147435884|NCT00295633|531762211|FG000|Overall Study|Withdrawal of consent by subject|16|||
147435885|NCT00295633|531762212|FG001|Overall Study|Withdrawal of consent by subject|16|||
147435886|NCT00295633|531762213|FG002|Overall Study|Withdrawal of consent by subject|26|||
147435887|NCT00295633|531762211|FG000|Overall Study|Adverse Event|9|||
147435888|NCT00295633|531762212|FG001|Overall Study|Adverse Event|17|||
147435889|NCT00295633|531762213|FG002|Overall Study|Adverse Event|9|||
147435890|NCT00295633|531762211|FG000|Overall Study|Lost to Follow-up|6|||
147435891|NCT00295633|531762212|FG001|Overall Study|Lost to Follow-up|11|||
147435892|NCT00295633|531762213|FG002|Overall Study|Lost to Follow-up|7|||
147435893|NCT00295633|531762211|FG000|Overall Study|Physician Decision|9|||
147435894|NCT00295633|531762212|FG001|Overall Study|Physician Decision|10|||
147435895|NCT00295633|531762213|FG002|Overall Study|Physician Decision|8|||
147435896|NCT00295633|531762211|FG000|Overall Study|Poor/Noncompliance|2|||
147435897|NCT00295633|531762212|FG001|Overall Study|Poor/Noncompliance|2|||
147435898|NCT00295633|531762213|FG002|Overall Study|Poor/Noncompliance|6|||
147435899|NCT00295633|531762211|FG000|Overall Study|Subject No Longer Meets Study Criteria|0|||
147435900|NCT00295633|531762212|FG001|Overall Study|Subject No Longer Meets Study Criteria|3|||
147435901|NCT00295633|531762213|FG002|Overall Study|Subject No Longer Meets Study Criteria|3|||
147435902|NCT00295633|531762211|FG000|Overall Study|Death|1|||
147435903|NCT00295633|531762212|FG001|Overall Study|Death|1|||
147535547|NCT02525627|532116656|FG000|Overall Study|Withdrawal by Subject|1|||
147535548|NCT02525627|532116657|FG001|Overall Study|Withdrawal by Subject|2|||
147201984|NCT02968004|530910513|FG001|Open Label Extension (OLE) Year 4|Non-Compliance With Study Drug|1|||
147435904|NCT00295633|531762213|FG002|Overall Study|Death|0|||
147435905|NCT00295633|531762211|FG000|Overall Study|Administrative reason by sponsor|0|||
147435906|NCT00295633|531762212|FG001|Overall Study|Administrative reason by sponsor|0|||
147435907|NCT00295633|531762213|FG002|Overall Study|Administrative reason by sponsor|1|||
147435908|NCT02294682|531762214|FG000|Overall Study|Could not swallow pills|1|||
147435909|NCT02294682|531762215|FG001|Overall Study|Could not swallow pills|0|||
147435910|NCT01516970|531762216|FG000|Overall Study|Lost to Follow-up|7|||
147435911|NCT01516970|531762217|FG001|Overall Study|Lost to Follow-up|8|||
147435912|NCT01516970|531762216|FG000|Overall Study|Adverse Event|1|||
147435913|NCT01516970|531762217|FG001|Overall Study|Adverse Event|5|||
147435914|NCT01516970|531762216|FG000|Overall Study|Withdrawal by Subject|1|||
147435915|NCT01516970|531762217|FG001|Overall Study|Withdrawal by Subject|1|||
147435916|NCT01516970|531762216|FG000|Overall Study|Other|9|||
147435917|NCT01516970|531762217|FG001|Overall Study|Other|7|||
147435918|NCT01186796|531762219|FG000|Overall Study|Adverse Event|3|||
147435919|NCT01186796|531762220|FG001|Overall Study|Adverse Event|0|||
147435920|NCT01186796|531762219|FG000|Overall Study|Withdrawal by Subject|1|||
147435921|NCT01186796|531762220|FG001|Overall Study|Withdrawal by Subject|1|||
147435922|NCT01186796|531762219|FG000|Overall Study|Protocol Violation|0|||
147435923|NCT01186796|531762220|FG001|Overall Study|Protocol Violation|1|||
147435924|NCT03838198|531762221|FG000|Phase 2: Added Booster Call or Not|Withdrawal by Subject|0|||
147435925|NCT03838198|531762222|FG001|Phase 2: Added Booster Call or Not|Withdrawal by Subject|0|||
147435926|NCT03838198|531762223|FG002|Phase 2: Added Booster Call or Not|Withdrawal by Subject|1|||
147435927|NCT03838198|531762224|FG003|Phase 2: Added Booster Call or Not|Withdrawal by Subject|0|||
147435928|NCT03838198|531762221|FG000|Phase 2: Added Booster Call or Not|"In this SMART trial design, this group was randomized to no booster call."|0|||
147435929|NCT03838198|531762222|FG001|Phase 2: Added Booster Call or Not|"In this SMART trial design, this group was randomized to no booster call."|22|||
147435930|NCT03838198|531762223|FG002|Phase 2: Added Booster Call or Not|"In this SMART trial design, this group was randomized to no booster call."|0|||
147435931|NCT03838198|531762224|FG003|Phase 2: Added Booster Call or Not|"In this SMART trial design, this group was randomized to no booster call."|22|||
147435932|NCT03606980|531762225|FG000|Overall Study|Lost to Follow-up|3|||
147435933|NCT03606980|531762226|FG001|Overall Study|Lost to Follow-up|2|||
147435934|NCT03606980|531762227|FG002|Overall Study|Lost to Follow-up|3|||
147435935|NCT03606980|531762225|FG000|Overall Study|Withdrawal by Subject|1|||
147435936|NCT03606980|531762226|FG001|Overall Study|Withdrawal by Subject|0|||
147435937|NCT03606980|531762227|FG002|Overall Study|Withdrawal by Subject|4|||
147435938|NCT01294150|531762230|FG000|Overall Study|Physician Decision|2|||
147435939|NCT01294150|531762231|FG001|Overall Study|Physician Decision|2|||
147435940|NCT03675776|531762232|FG000|Double Blind Treatment Period|Study Terminated by Sponsor|5|||
147435941|NCT03675776|531762233|FG001|Double Blind Treatment Period|Study Terminated by Sponsor|6|||
147435942|NCT03675776|531762234|FG002|Double Blind Treatment Period|Study Terminated by Sponsor|8|||
147435943|NCT03675776|531762232|FG000|Double Blind Treatment Period|Lack of Efficacy|1|||
147435944|NCT03675776|531762233|FG001|Double Blind Treatment Period|Lack of Efficacy|0|||
147435945|NCT03675776|531762234|FG002|Double Blind Treatment Period|Lack of Efficacy|0|||
147435946|NCT04513665|531762235|FG000|Overall Study|Adverse Event|2|||
147435947|NCT04513665|531762236|FG001|Overall Study|Adverse Event|0|||
147435948|NCT04513665|531762235|FG000|Overall Study|Lack of Efficacy|14|||
147435949|NCT04513665|531762236|FG001|Overall Study|Lack of Efficacy|0|||
147435950|NCT00999713|531762240|FG000|Overall Study|Physician Decision|2|||
147435951|NCT00999713|531762241|FG001|Overall Study|Physician Decision|0|||
147435952|NCT03427125|531762247|FG000|2 to 4 Week Washout Period|Screen failure (did not meet study entry requirements)|0|||
147435953|NCT03427125|531762248|FG001|2 to 4 Week Washout Period|Screen failure (did not meet study entry requirements)|995|||
147435954|NCT03427125|531762249|FG002|2 to 4 Week Washout Period|Screen failure (did not meet study entry requirements)|0|||
147435955|NCT05390580|531762252|FG000|Overall Study|Physician Decision|3|||
147435956|NCT05390580|531762253|FG001|Overall Study|Physician Decision|2|||
147435957|NCT04014361|531762254|FG000|Period 2|Physician Decision|0|||
147435958|NCT04014361|531762255|FG001|Period 2|Physician Decision|0|||
147435959|NCT04014361|531762256|FG002|Period 2|Physician Decision|0|||
147435960|NCT04014361|531762257|FG003|Period 2|Physician Decision|1|||
147435961|NCT04014361|531762258|FG004|Period 2|Physician Decision|0|||
147435962|NCT04014361|531762259|FG005|Period 2|Physician Decision|0|||
147435963|NCT04014361|531762260|FG006|Period 2|Physician Decision|0|||
147435964|NCT04014361|531762261|FG007|Period 2|Physician Decision|0|||
147435965|NCT01130051|531762263|FG000|Washout Period of 14 Days|Withdrawal by Subject|0|||
147435966|NCT01130051|531762264|FG001|Washout Period of 14 Days|Withdrawal by Subject|1|||
147435967|NCT01130051|531762263|FG000|Washout Period of 14 Days|Protocol Violation|1|||
147435968|NCT01130051|531762264|FG001|Washout Period of 14 Days|Protocol Violation|1|||
147435969|NCT04252287|531762267|FG000|Overall Study|Death|5|||
147435970|NCT04252287|531762268|FG001|Overall Study|Death|3|||
147535549|NCT02525627|532116656|FG000|Overall Study|Death|1|||
147535550|NCT02525627|532116657|FG001|Overall Study|Death|0|||
147535551|NCT02525627|532116656|FG000|Overall Study|Site terminated|11|||
147435971|NCT04252287|531762267|FG000|Overall Study|Lost to Follow-up|4|||
147435972|NCT04252287|531762268|FG001|Overall Study|Lost to Follow-up|6|||
147435973|NCT04252287|531762267|FG000|Overall Study|Withdrawal by Subject|19|||
147435974|NCT04252287|531762268|FG001|Overall Study|Withdrawal by Subject|16|||
147435975|NCT04252287|531762267|FG000|Overall Study|Protocol Violation|3|||
147435976|NCT04252287|531762268|FG001|Overall Study|Protocol Violation|4|||
147435977|NCT01298518|531762272|FG000|Overall Study|Withdrawal by Subject|0|||
147435978|NCT01298518|531762273|FG001|Overall Study|Withdrawal by Subject|0|||
147435979|NCT01298518|531762274|FG002|Overall Study|Withdrawal by Subject|1|||
147435980|NCT03610165|531762275|FG000|Overall Study|Device didn't work|0|||
147435981|NCT03610165|531762276|FG001|Overall Study|Device didn't work|1|||
147435982|NCT02129205|531762277|FG000|Overall Study|Withdrawal by Subject|0|||
147435983|NCT02129205|531762278|FG001|Overall Study|Withdrawal by Subject|0|||
147435984|NCT02129205|531762279|FG002|Overall Study|Withdrawal by Subject|0|||
147435985|NCT02129205|531762280|FG003|Overall Study|Withdrawal by Subject|0|||
147435986|NCT02129205|531762281|FG004|Overall Study|Withdrawal by Subject|1|||
147435987|NCT02129205|531762282|FG005|Overall Study|Withdrawal by Subject|1|||
147435988|NCT02129205|531762283|FG006|Overall Study|Withdrawal by Subject|1|||
147435989|NCT02129205|531762284|FG007|Overall Study|Withdrawal by Subject|0|||
147435990|NCT02129205|531762285|FG008|Overall Study|Withdrawal by Subject|1|||
147435991|NCT02129205|531762286|FG009|Overall Study|Withdrawal by Subject|0|||
147435992|NCT02129205|531762277|FG000|Overall Study|Other|1|||
147435993|NCT02129205|531762278|FG001|Overall Study|Other|0|||
147435994|NCT02129205|531762279|FG002|Overall Study|Other|0|||
147435995|NCT02129205|531762280|FG003|Overall Study|Other|0|||
147435996|NCT02129205|531762281|FG004|Overall Study|Other|2|||
147435997|NCT02129205|531762282|FG005|Overall Study|Other|3|||
147435998|NCT02129205|531762283|FG006|Overall Study|Other|3|||
147435999|NCT02129205|531762284|FG007|Overall Study|Other|2|||
147436000|NCT02129205|531762285|FG008|Overall Study|Other|1|||
147436001|NCT02129205|531762286|FG009|Overall Study|Other|0|||
147436002|NCT04435782|531762291|FG000|Overall Study|Study terminated by sponsor|4|||
147436003|NCT03672461|531762292|FG000|Overall Study|COVID Related|4|||
147436004|NCT03672461|531762293|FG001|Overall Study|COVID Related|2|||
147436005|NCT03672461|531762292|FG000|Overall Study|Adverse Event|2|||
147436006|NCT03672461|531762293|FG001|Overall Study|Adverse Event|0|||
147436007|NCT03672461|531762292|FG000|Overall Study|Serious Adverse Event|0|||
147436008|NCT03672461|531762293|FG001|Overall Study|Serious Adverse Event|1|||
147436009|NCT03672461|531762292|FG000|Overall Study|Too Busy|3|||
147436010|NCT03672461|531762293|FG001|Overall Study|Too Busy|1|||
147436011|NCT03672461|531762292|FG000|Overall Study|Lost to Follow-up|1|||
147436012|NCT03672461|531762293|FG001|Overall Study|Lost to Follow-up|2|||
147436013|NCT03672461|531762292|FG000|Overall Study|Family|2|||
147436014|NCT03672461|531762293|FG001|Overall Study|Family|2|||
147436015|NCT03672461|531762292|FG000|Overall Study|No remote technology access|0|||
147436016|NCT03672461|531762293|FG001|Overall Study|No remote technology access|1|||
147436017|NCT03672461|531762292|FG000|Overall Study|Withdrawal by Subject|1|||
147436018|NCT03672461|531762293|FG001|Overall Study|Withdrawal by Subject|0|||
147436019|NCT03672461|531762292|FG000|Overall Study|Cannot tolerate intervention|1|||
147436020|NCT03672461|531762293|FG001|Overall Study|Cannot tolerate intervention|0|||
147436021|NCT03672461|531762292|FG000|Overall Study|Incomplete outcome data|6|||
147436022|NCT03672461|531762293|FG001|Overall Study|Incomplete outcome data|1|||
147436023|NCT04223791|531762296|FG000|Overall Study|Lost to Follow-up|0|||
147436024|NCT04223791|531762297|FG001|Overall Study|Lost to Follow-up|4|||
147436025|NCT04223791|531762296|FG000|Overall Study|Physician Decision|5|||
147436026|NCT04223791|531762297|FG001|Overall Study|Physician Decision|1|||
147436027|NCT04223791|531762296|FG000|Overall Study|Protocol Violation|1|||
147436028|NCT04223791|531762297|FG001|Overall Study|Protocol Violation|1|||
147436029|NCT04223791|531762296|FG000|Overall Study|Withdrawal by Subject|10|||
147436030|NCT04223791|531762297|FG001|Overall Study|Withdrawal by Subject|12|||
147436031|NCT04223791|531762296|FG000|Overall Study|Pregnancy|1|||
147201985|NCT02968004|530910512|FG000|Open Label Extension (OLE) Year 4|Sponsor Discontinuation of Study|27|||
147436032|NCT04223791|531762297|FG001|Overall Study|Pregnancy|1|||
147436033|NCT04223791|531762296|FG000|Overall Study|Ongoing in Study|305|||
147436034|NCT04223791|531762297|FG001|Overall Study|Ongoing in Study|302|||
147436035|NCT00395863|531763390|FG000|Overall Study|Patients did not complete both exams|2|||
147436036|NCT00395863|531763391|FG001|Overall Study|Patients did not complete both exams|3|||
147436037|NCT02592551|531763392|FG000|Overall Study|Not evaluable|1|||
147436038|NCT02592551|531763393|FG001|Overall Study|Not evaluable|3|||
147436039|NCT02592551|531763394|FG002|Overall Study|Not evaluable|0|||
147436040|NCT01876251|531763397|FG000|Overall Study|Clinical progression|1|||
147436041|NCT01876251|531763398|FG001|Overall Study|Clinical progression|0|||
147436042|NCT01876251|531763399|FG002|Overall Study|Clinical progression|0|||
147436043|NCT01876251|531763397|FG000|Overall Study|Death|2|||
147436044|NCT01876251|531763398|FG001|Overall Study|Death|0|||
147436045|NCT01876251|531763399|FG002|Overall Study|Death|1|||
147436046|NCT01876251|531763397|FG000|Overall Study|Participant started new treatment|1|||
147436047|NCT01876251|531763398|FG001|Overall Study|Participant started new treatment|0|||
147436048|NCT01876251|531763399|FG002|Overall Study|Participant started new treatment|1|||
147535552|NCT02525627|532116657|FG001|Overall Study|Site terminated|10|||
147535553|NCT02875340|532116658|FG000|Overall Study|Death|2|||
147535554|NCT02875340|532116658|FG000|Overall Study|Withdrawal by Subject|2|||
147535555|NCT02875340|532116658|FG000|Overall Study|Physician Decision|3|||
147535556|NCT02875340|532116658|FG000|Overall Study|Adverse Event|1|||
147535557|NCT01160770|532116659|FG000|Overall Study|Adverse Event|10|||
147535558|NCT01160770|532116659|FG000|Overall Study|Protocol Violation|2|||
147535559|NCT01160770|532116659|FG000|Overall Study|Subject/parent/caregiver request|33|||
147535560|NCT01160770|532116659|FG000|Overall Study|Physician Decision|1|||
147535561|NCT01160770|532116659|FG000|Overall Study|Lost to Follow-up|7|||
147535562|NCT01160770|532116659|FG000|Overall Study|Study termination or sponsor request|1|||
147535563|NCT01160770|532116659|FG000|Overall Study|Death|9|||
147535564|NCT01160770|532116659|FG000|Overall Study|Lack of Efficacy|15|||
147535565|NCT01160770|532116659|FG000|Overall Study|Other Reasons|1|||
147535566|NCT04930536|532116662|FG000|Overall Study|Adverse Event|1|||
147535567|NCT04930536|532116663|FG001|Overall Study|Adverse Event|0|||
147535568|NCT04930536|532116662|FG000|Overall Study|Disease Progression|2|||
147535569|NCT04930536|532116663|FG001|Overall Study|Disease Progression|0|||
147535570|NCT04930536|532116662|FG000|Overall Study|Patient Decision|4|||
147535571|NCT04930536|532116663|FG001|Overall Study|Patient Decision|2|||
147535572|NCT04930536|532116662|FG000|Overall Study|Death, Serious Adverse Event, Screen Failure|1|||
147535573|NCT04930536|532116663|FG001|Overall Study|Death, Serious Adverse Event, Screen Failure|3|||
147535574|NCT01432600|532116664|FG000|Overall Study|Rapid PD, allocated intv. not rec'd|0|||
147535575|NCT01432600|532116665|FG001|Overall Study|Rapid PD, allocated intv. not rec'd|1|||
147535576|NCT01432600|532116666|FG002|Overall Study|Rapid PD, allocated intv. not rec'd|1|||
147535577|NCT00848965|532116667|FG000|Overall Study|Adverse Event|1|||
147535578|NCT00848965|532116667|FG000|Overall Study|Withdrawal by Subject|1|||
147535579|NCT01605370|532116672|FG000|Overall Study|Adverse Event|1|||
147535580|NCT01605370|532116673|FG001|Overall Study|Adverse Event|0|||
147535581|NCT01976104|532116674|FG000|Overall Study|Adverse Event|0|||
147535582|NCT01976104|532116675|FG001|Overall Study|Adverse Event|0|||
147535583|NCT01976104|532116676|FG002|Overall Study|Adverse Event|1|||
147535584|NCT01976104|532116677|FG003|Overall Study|Adverse Event|0|||
147535585|NCT01976104|532116674|FG000|Overall Study|Lost to Follow-up|3|||
147535586|NCT01976104|532116675|FG001|Overall Study|Lost to Follow-up|0|||
147535587|NCT01976104|532116676|FG002|Overall Study|Lost to Follow-up|1|||
147535588|NCT01976104|532116677|FG003|Overall Study|Lost to Follow-up|1|||
147535589|NCT01976104|532116674|FG000|Overall Study|Subject Choice|0|||
147535590|NCT01976104|532116675|FG001|Overall Study|Subject Choice|1|||
147535591|NCT01976104|532116676|FG002|Overall Study|Subject Choice|0|||
147535592|NCT01976104|532116677|FG003|Overall Study|Subject Choice|1|||
147535593|NCT01976104|532116674|FG000|Overall Study|Withdrawal by Subject|3|||
147535594|NCT01976104|532116675|FG001|Overall Study|Withdrawal by Subject|0|||
147535595|NCT01976104|532116676|FG002|Overall Study|Withdrawal by Subject|0|||
147535596|NCT01976104|532116677|FG003|Overall Study|Withdrawal by Subject|1|||
147535597|NCT01976104|532116674|FG000|Overall Study|Other|0|||
147535598|NCT01976104|532116675|FG001|Overall Study|Other|1|||
147535599|NCT01976104|532116676|FG002|Overall Study|Other|0|||
147535600|NCT01976104|532116677|FG003|Overall Study|Other|0|||
147535601|NCT02181673|532116681|FG000|Up to Week 24|Adverse Event|2|||
147535602|NCT02181673|532116682|FG001|Up to Week 24|Adverse Event|0|||
147535603|NCT02181673|532116683|FG002|Up to Week 24|Adverse Event|3|||
147535604|NCT02181673|532116681|FG000|Up to Week 24|Death|1|||
147535605|NCT02181673|532116682|FG001|Up to Week 24|Death|0|||
147535606|NCT02181673|532116683|FG002|Up to Week 24|Death|0|||
147535607|NCT02181673|532116681|FG000|Up to Week 24|Lack of Efficacy|1|||
147201986|NCT02968004|530910513|FG001|Open Label Extension (OLE) Year 4|Sponsor Discontinuation of Study|21|||
147201987|NCT02968004|530910512|FG000|Open Label Extension (OLE) Year 4|Bone Age Reached|3|||
147201988|NCT02968004|530910513|FG001|Open Label Extension (OLE) Year 4|Bone Age Reached|1|||
147201989|NCT02968004|530910512|FG000|Open Label Extension (OLE) Year 4|Local Crisis|10|||
147201990|NCT02968004|530910513|FG001|Open Label Extension (OLE) Year 4|Local Crisis|9|||
147201991|NCT02968004|530910512|FG000|Open Label Extension (OLE) Year 4|Miscellaneous|2|||
147201992|NCT02968004|530910513|FG001|Open Label Extension (OLE) Year 4|Miscellaneous|0|||
147201993|NCT02968004|530910512|FG000|Open Label Extension (OLE) Year 5|Withdrawal by Subject|1|||
147201994|NCT02968004|530910513|FG001|Open Label Extension (OLE) Year 5|Withdrawal by Subject|0|||
147201995|NCT02968004|530910512|FG000|Open Label Extension (OLE) Year 5|Sponsor Discontinuation of Study|2|||
147306804|NCT01852058|531290773|FG000|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|1|||
147535608|NCT02181673|532116682|FG001|Up to Week 24|Lack of Efficacy|0|||
147535609|NCT02181673|532116683|FG002|Up to Week 24|Lack of Efficacy|0|||
147535610|NCT02181673|532116681|FG000|Up to Week 24|Lost to Follow-up|1|||
147535611|NCT02181673|532116682|FG001|Up to Week 24|Lost to Follow-up|0|||
147535612|NCT02181673|532116683|FG002|Up to Week 24|Lost to Follow-up|0|||
147535613|NCT02181673|532116681|FG000|Up to Week 24|Physician Decision|0|||
147535614|NCT02181673|532116682|FG001|Up to Week 24|Physician Decision|0|||
147535615|NCT02181673|532116683|FG002|Up to Week 24|Physician Decision|3|||
147535616|NCT02181673|532116681|FG000|Up to Week 24|Withdrawal by Subject|10|||
147535617|NCT02181673|532116682|FG001|Up to Week 24|Withdrawal by Subject|0|||
147436049|NCT01876251|531763397|FG000|Overall Study|Participant refused further follow-up|0|||
147436050|NCT01876251|531763398|FG001|Overall Study|Participant refused further follow-up|0|||
147436051|NCT01876251|531763399|FG002|Overall Study|Participant refused further follow-up|1|||
147436052|NCT01876251|531763397|FG000|Overall Study|Study terminated|1|||
147436053|NCT01876251|531763398|FG001|Overall Study|Study terminated|0|||
147436054|NCT01876251|531763399|FG002|Overall Study|Study terminated|0|||
147436055|NCT01876251|531763397|FG000|Overall Study|Objective progression or relapse|10|||
147436056|NCT01876251|531763398|FG001|Overall Study|Objective progression or relapse|3|||
147436057|NCT01876251|531763399|FG002|Overall Study|Objective progression or relapse|8|||
147436058|NCT01667081|531763402|FG000|Overall Study|Death|43|||
147436059|NCT01667081|531763403|FG001|Overall Study|Death|3|||
147436060|NCT01667081|531763402|FG000|Overall Study|Lost to Follow-up|99|||
147436061|NCT01667081|531763403|FG001|Overall Study|Lost to Follow-up|48|||
147436062|NCT01667081|531763402|FG000|Overall Study|Physician Decision|16|||
147436063|NCT01667081|531763403|FG001|Overall Study|Physician Decision|2|||
147436064|NCT01667081|531763402|FG000|Overall Study|Participants were discontinued due to amendment 3 which modified the study discontinuation criteria|1529|||
147436065|NCT01667081|531763403|FG001|Overall Study|Participants were discontinued due to amendment 3 which modified the study discontinuation criteria|269|||
147436066|NCT01667081|531763402|FG000|Overall Study|Withdrawal by Subject|90|||
147436067|NCT01667081|531763403|FG001|Overall Study|Withdrawal by Subject|35|||
147436068|NCT03034460|531763404|FG000|Overall Study|Adverse Event|0|||
147436069|NCT03034460|531763405|FG001|Overall Study|Adverse Event|1|||
147436070|NCT03034460|531763404|FG000|Overall Study|Withdrawal by Subject|2|||
147436071|NCT03034460|531763405|FG001|Overall Study|Withdrawal by Subject|2|||
147436072|NCT03034460|531763404|FG000|Overall Study|Personal Reasons|1|||
147436073|NCT03034460|531763405|FG001|Overall Study|Personal Reasons|0|||
147436074|NCT01798992|531763406|FG000|Overall Study|Administrative withdrawal|0|||
147436075|NCT01798992|531763407|FG001|Overall Study|Administrative withdrawal|1|||
147436076|NCT01798992|531763408|FG002|Overall Study|Administrative withdrawal|0|||
147436077|NCT01798992|531763409|FG003|Overall Study|Administrative withdrawal|1|||
147436078|NCT01798992|531763406|FG000|Overall Study|Lost to Follow-up|0|||
147436079|NCT01798992|531763407|FG001|Overall Study|Lost to Follow-up|1|||
147436080|NCT01798992|531763408|FG002|Overall Study|Lost to Follow-up|1|||
147436081|NCT01798992|531763409|FG003|Overall Study|Lost to Follow-up|0|||
147436082|NCT01798992|531763406|FG000|Overall Study|Insufficient biopsy tissue|0|||
147436083|NCT01798992|531763407|FG001|Overall Study|Insufficient biopsy tissue|0|||
147436084|NCT01798992|531763408|FG002|Overall Study|Insufficient biopsy tissue|1|||
147436085|NCT01798992|531763409|FG003|Overall Study|Insufficient biopsy tissue|0|||
147436086|NCT00434421|531763410|FG000|Overall Study|Withdrawal by Subject|1|||
147436087|NCT00434421|531763410|FG000|Overall Study|Non-compliance with study treatment|1|||
147436088|NCT01205438|531763411|FG000|Overall Study|Adverse Event|19|||
147436089|NCT01205438|531763412|FG001|Overall Study|Adverse Event|17|||
147436090|NCT01205438|531763413|FG002|Overall Study|Adverse Event|24|||
147436091|NCT01205438|531763411|FG000|Overall Study|Death|1|||
147436092|NCT01205438|531763412|FG001|Overall Study|Death|1|||
147436093|NCT01205438|531763413|FG002|Overall Study|Death|3|||
147436094|NCT01205438|531763411|FG000|Overall Study|Entry Criteria Not Met|16|||
147436095|NCT01205438|531763412|FG001|Overall Study|Entry Criteria Not Met|15|||
147436096|NCT01205438|531763413|FG002|Overall Study|Entry Criteria Not Met|13|||
147436097|NCT01205438|531763411|FG000|Overall Study|Lack of Efficacy|14|||
147436098|NCT01205438|531763412|FG001|Overall Study|Lack of Efficacy|11|||
147436099|NCT01205438|531763413|FG002|Overall Study|Lack of Efficacy|14|||
147436100|NCT01205438|531763411|FG000|Overall Study|Lost to Follow-up|6|||
147436101|NCT01205438|531763412|FG001|Overall Study|Lost to Follow-up|7|||
147436102|NCT01205438|531763413|FG002|Overall Study|Lost to Follow-up|8|||
147436103|NCT01205438|531763411|FG000|Overall Study|Withdrawal by Subject|19|||
147436104|NCT01205438|531763412|FG001|Overall Study|Withdrawal by Subject|25|||
147436105|NCT01205438|531763413|FG002|Overall Study|Withdrawal by Subject|19|||
147436106|NCT01205438|531763411|FG000|Overall Study|Physician Decision|0|||
147436107|NCT01205438|531763412|FG001|Overall Study|Physician Decision|3|||
147436108|NCT01205438|531763413|FG002|Overall Study|Physician Decision|2|||
147436109|NCT01205438|531763411|FG000|Overall Study|Protocol Violation|2|||
147436110|NCT01205438|531763412|FG001|Overall Study|Protocol Violation|7|||
147436111|NCT01205438|531763413|FG002|Overall Study|Protocol Violation|4|||
147436112|NCT01205438|531763411|FG000|Overall Study|Sponsor Decision|0|||
147436113|NCT01205438|531763412|FG001|Overall Study|Sponsor Decision|1|||
147436114|NCT01205438|531763413|FG002|Overall Study|Sponsor Decision|1|||
147436115|NCT03823404|531763414|FG000|Overall Study|Lost to Follow-up|1|||
147436116|NCT03823404|531763415|FG001|Overall Study|Lost to Follow-up|2|||
147436117|NCT03823404|531763416|FG002|Overall Study|Lost to Follow-up|3|||
147436118|NCT03823404|531763414|FG000|Overall Study|Protocol Violation|2|||
147436119|NCT03823404|531763415|FG001|Overall Study|Protocol Violation|0|||
147436120|NCT03823404|531763416|FG002|Overall Study|Protocol Violation|2|||
147436121|NCT03823404|531763414|FG000|Overall Study|Adverse Event|35|||
147436122|NCT03823404|531763415|FG001|Overall Study|Adverse Event|38|||
147436123|NCT03823404|531763416|FG002|Overall Study|Adverse Event|8|||
147436124|NCT03823404|531763414|FG000|Overall Study|Withdrawal by Subject|38|||
147436125|NCT03823404|531763415|FG001|Overall Study|Withdrawal by Subject|40|||
147201996|NCT02968004|530910513|FG001|Open Label Extension (OLE) Year 5|Sponsor Discontinuation of Study|6|||
147201997|NCT02968004|530910512|FG000|Open Label Extension (OLE) Year 5|Bone Age Reached,|1|||
147201998|NCT02968004|530910513|FG001|Open Label Extension (OLE) Year 5|Bone Age Reached,|0|||
147201999|NCT02968004|530910512|FG000|Open Label Extension (OLE) Year 5|Closure of Epiphyseal Plates|1|||
147202000|NCT02968004|530910513|FG001|Open Label Extension (OLE) Year 5|Closure of Epiphyseal Plates|0|||
147202001|NCT02968004|530910512|FG000|Open Label Extension (OLE) Year 5|Local Crisis|1|||
147202002|NCT02968004|530910513|FG001|Open Label Extension (OLE) Year 5|Local Crisis|0|||
147202003|NCT05029362|530910514|FG000|Overall Study|Lost to Follow-up|9|||
147202004|NCT00419952|530910517|FG000|Overall Study|Adverse Event|8|||
147202005|NCT00419952|530910518|FG001|Overall Study|Adverse Event|10|||
147202006|NCT00419952|530910517|FG000|Overall Study|Withdrawal by Subject|44|||
147202007|NCT00419952|530910518|FG001|Overall Study|Withdrawal by Subject|43|||
147436126|NCT03823404|531763416|FG002|Overall Study|Withdrawal by Subject|35|||
147436127|NCT03823404|531763414|FG000|Overall Study|Death|4|||
147436128|NCT03823404|531763415|FG001|Overall Study|Death|0|||
147436129|NCT03823404|531763416|FG002|Overall Study|Death|0|||
147436130|NCT03823404|531763414|FG000|Overall Study|Other: Various reasons provided|5|||
147436131|NCT03823404|531763415|FG001|Overall Study|Other: Various reasons provided|5|||
147436132|NCT03823404|531763416|FG002|Overall Study|Other: Various reasons provided|6|||
147436133|NCT03631667|531763423|FG000|Overall Study|Withdrawal by Subject|3|||
147436134|NCT00892177|531763424|FG000|Phase II|Ineligible|0|||
147436135|NCT00892177|531763425|FG001|Phase II|Ineligible|0|||
147436136|NCT00892177|531763426|FG002|Phase II|Ineligible|0|||
147436137|NCT00892177|531763427|FG003|Phase II|Ineligible|0|||
147436138|NCT00892177|531763428|FG004|Phase II|Ineligible|1|||
147436139|NCT00892177|531763429|FG005|Phase II|Ineligible|1|||
147436140|NCT00892177|531763424|FG000|Phase II|Withdrawal by Subject|0|||
147436141|NCT00892177|531763425|FG001|Phase II|Withdrawal by Subject|0|||
147436142|NCT00892177|531763426|FG002|Phase II|Withdrawal by Subject|0|||
147436143|NCT00892177|531763427|FG003|Phase II|Withdrawal by Subject|0|||
147436144|NCT00892177|531763428|FG004|Phase II|Withdrawal by Subject|4|||
147436145|NCT00892177|531763429|FG005|Phase II|Withdrawal by Subject|1|||
147436146|NCT00404066|531763435|FG000|Overall Study|Withdrawal by Subject - Pre-treatment|1|||
147436147|NCT00404066|531763435|FG000|Overall Study|Withdrawal by Subject - Adverse event|2|||
147436148|NCT01754857|531763436|FG000|Overall Study|Adverse Event|7|||
147436149|NCT01754857|531763436|FG000|Overall Study|Disease progression|3|||
147436150|NCT01754857|531763436|FG000|Overall Study|Physician Decision|2|||
147436151|NCT01754857|531763436|FG000|Overall Study|Withdrawal by Subject|3|||
147436152|NCT01754857|531763436|FG000|Overall Study|other complicating disease|1|||
147436153|NCT01754857|531763436|FG000|Overall Study|ineligible to continue onto maintenance|1|||
147436154|NCT01754857|531763436|FG000|Overall Study|Patient does not wish to be treated, but will continue to be followed for survival|1|||
147436155|NCT01754857|531763436|FG000|Overall Study|Patient decided not to begin maintenance therapy|1|||
147436156|NCT01399190|531763437|FG000|Overall Study|Not Eligible for Final Analysis|5|||
147436157|NCT01399190|531763437|FG000|Overall Study|Adverse Event|8|||
147436158|NCT01399190|531763437|FG000|Overall Study|Participant's Request|5|||
147436159|NCT01399190|531763437|FG000|Overall Study|Physician Decision|2|||
147436160|NCT00596934|531763442|FG000|Overall Study|Protocol Violation|1|||
147436161|NCT00596934|531763442|FG000|Overall Study|Withdrawal by Subject|1|||
147436162|NCT02315898|531763443|FG000|Overall Study|2 in the treatment arm did not meet treatment eligibility; a healthy control screen failed|2|||
147436163|NCT02315898|531763444|FG001|Overall Study|2 in the treatment arm did not meet treatment eligibility; a healthy control screen failed|0|||
147436164|NCT02315898|531763445|FG002|Overall Study|2 in the treatment arm did not meet treatment eligibility; a healthy control screen failed|0|||
147436165|NCT02315898|531763446|FG003|Overall Study|2 in the treatment arm did not meet treatment eligibility; a healthy control screen failed|1|||
147436166|NCT03239483|531763447|FG000|Overall Study|Lost to Follow-up|1|||
147436167|NCT03239483|531763448|FG001|Overall Study|Lost to Follow-up|0|||
147436168|NCT03239483|531763447|FG000|Overall Study|Withdrawal by Subject|1|||
147436169|NCT03239483|531763448|FG001|Overall Study|Withdrawal by Subject|0|||
147436170|NCT01296035|531763450|FG000|Overall Study|Withdrawal by Subject|1|||
147436171|NCT01674712|531763453|FG000|Overall Study|Adverse Event|5|||
147436172|NCT01674712|531763454|FG001|Overall Study|Adverse Event|6|||
147202008|NCT00419952|530910517|FG000|Overall Study|Lost to Follow-up|43|||
147202009|NCT00419952|530910518|FG001|Overall Study|Lost to Follow-up|34|||
147436173|NCT01674712|531763455|FG002|Overall Study|Adverse Event|3|||
147436174|NCT01674712|531763456|FG003|Overall Study|Adverse Event|4|||
147202010|NCT00419952|530910517|FG000|Overall Study|Protocol Violation|32|||
147202011|NCT00419952|530910518|FG001|Overall Study|Protocol Violation|24|||
147436175|NCT01674712|531763457|FG004|Overall Study|Adverse Event|6|||
147436176|NCT01674712|531763453|FG000|Overall Study|Lost to Follow-up|1|||
147436177|NCT01674712|531763454|FG001|Overall Study|Lost to Follow-up|0|||
147436178|NCT01674712|531763455|FG002|Overall Study|Lost to Follow-up|0|||
147535618|NCT02181673|532116683|FG002|Up to Week 24|Withdrawal by Subject|1|||
147202012|NCT00419952|530910517|FG000|Overall Study|Pregnancy|4|||
147436179|NCT01674712|531763456|FG003|Overall Study|Lost to Follow-up|0|||
147436180|NCT01674712|531763457|FG004|Overall Study|Lost to Follow-up|0|||
147535619|NCT02181673|532116681|FG000|Up to Week 24|Other|2|||
147535620|NCT02181673|532116682|FG001|Up to Week 24|Other|0|||
147535621|NCT02181673|532116683|FG002|Up to Week 24|Other|3|||
147535622|NCT02181673|532116681|FG000|Up to Week 24|Randomized not Treated|0|||
147535623|NCT02181673|532116682|FG001|Up to Week 24|Randomized not Treated|0|||
147535624|NCT02181673|532116683|FG002|Up to Week 24|Randomized not Treated|1|||
147535625|NCT02181673|532116681|FG000|Week 24-Week 60|Adverse Event|0|||
147535626|NCT02181673|532116682|FG001|Week 24-Week 60|Adverse Event|4|||
147535627|NCT02181673|532116683|FG002|Week 24-Week 60|Adverse Event|10|||
147535628|NCT02181673|532116681|FG000|Week 24-Week 60|Other|0|||
147535629|NCT02181673|532116682|FG001|Week 24-Week 60|Other|2|||
147535630|NCT02181673|532116683|FG002|Week 24-Week 60|Other|1|||
147535631|NCT02181673|532116681|FG000|Week 24-Week 60|Withdrawal by Subject|0|||
147535632|NCT02181673|532116682|FG001|Week 24-Week 60|Withdrawal by Subject|2|||
147535633|NCT02181673|532116683|FG002|Week 24-Week 60|Withdrawal by Subject|2|||
147535634|NCT02181673|532116681|FG000|Week 24-Week 60|Pregnancy|0|||
147535635|NCT02181673|532116682|FG001|Week 24-Week 60|Pregnancy|0|||
147535636|NCT02181673|532116683|FG002|Week 24-Week 60|Pregnancy|1|||
147535637|NCT02181673|532116681|FG000|Week 24-Week 60|Lack of Efficacy|0|||
147535638|NCT02181673|532116682|FG001|Week 24-Week 60|Lack of Efficacy|0|||
147535639|NCT02181673|532116683|FG002|Week 24-Week 60|Lack of Efficacy|1|||
147535640|NCT02181673|532116681|FG000|Week 24-Week 60|Lost to Follow-up|0|||
147535641|NCT02181673|532116682|FG001|Week 24-Week 60|Lost to Follow-up|0|||
147535642|NCT02181673|532116683|FG002|Week 24-Week 60|Lost to Follow-up|1|||
147535643|NCT02181673|532116681|FG000|Week 24-Week 60|Physician Decision|0|||
147535644|NCT02181673|532116682|FG001|Week 24-Week 60|Physician Decision|0|||
147535645|NCT02181673|532116683|FG002|Week 24-Week 60|Physician Decision|1|||
147535646|NCT00337727|532116684|FG000|Overall Study|Adverse Event|5|||
147535647|NCT00337727|532116685|FG001|Overall Study|Adverse Event|3|||
147535648|NCT00337727|532116684|FG000|Overall Study|Lost to Follow-up|5|||
147535649|NCT00337727|532116685|FG001|Overall Study|Lost to Follow-up|4|||
147535650|NCT00337727|532116684|FG000|Overall Study|Physician Decision|1|||
147535651|NCT00337727|532116685|FG001|Overall Study|Physician Decision|0|||
147535652|NCT00337727|532116684|FG000|Overall Study|Protocol Violation|4|||
147535653|NCT00337727|532116685|FG001|Overall Study|Protocol Violation|0|||
147535654|NCT00337727|532116684|FG000|Overall Study|Withdrawal by Subject|3|||
147535655|NCT00337727|532116685|FG001|Overall Study|Withdrawal by Subject|5|||
147535656|NCT00326625|532116686|FG000|Overall Study|Adverse Event|20|||
147535657|NCT00326625|532116687|FG001|Overall Study|Adverse Event|9|||
147535658|NCT00326625|532116686|FG000|Overall Study|Withdrawal by Subject|15|||
147535659|NCT00326625|532116687|FG001|Overall Study|Withdrawal by Subject|12|||
147535660|NCT00326625|532116686|FG000|Overall Study|Death|18|||
147535661|NCT00326625|532116687|FG001|Overall Study|Death|16|||
147535662|NCT00326625|532116686|FG000|Overall Study|Lost to Follow-up|1|||
147535663|NCT00326625|532116687|FG001|Overall Study|Lost to Follow-up|0|||
147535664|NCT00326625|532116686|FG000|Overall Study|prescheduled medical intervention|0|||
147535665|NCT00326625|532116687|FG001|Overall Study|prescheduled medical intervention|1|||
147535666|NCT06067191|532116688|FG000|Overall Study|Withdrawal by Subject|0|||
147535667|NCT06067191|532116689|FG001|Overall Study|Withdrawal by Subject|1|||
147535668|NCT04764669|532116691|FG000|Overall Study|Adverse Event|1|||
147535669|NCT04764669|532116692|FG001|Overall Study|Adverse Event|0|||
147535670|NCT04764669|532116693|FG002|Overall Study|Adverse Event|1|||
147535671|NCT04764669|532116694|FG003|Overall Study|Adverse Event|0|||
147535672|NCT04764669|532116691|FG000|Overall Study|Subject Choice|0|||
147535673|NCT04764669|532116692|FG001|Overall Study|Subject Choice|0|||
147535674|NCT04764669|532116693|FG002|Overall Study|Subject Choice|1|||
147535675|NCT04764669|532116694|FG003|Overall Study|Subject Choice|0|||
147535676|NCT04764669|532116691|FG000|Overall Study|Withdrawal by Subject|2|||
147535677|NCT04764669|532116692|FG001|Overall Study|Withdrawal by Subject|0|||
147535678|NCT04764669|532116693|FG002|Overall Study|Withdrawal by Subject|0|||
147535679|NCT04764669|532116694|FG003|Overall Study|Withdrawal by Subject|0|||
147535680|NCT00625846|532116695|FG000|Overall Study|Withdrawal by Subject|2|||
147535681|NCT00625846|532116696|FG001|Overall Study|Withdrawal by Subject|0|||
147535682|NCT00625846|532116697|FG002|Overall Study|Withdrawal by Subject|1|||
147202013|NCT00419952|530910518|FG001|Overall Study|Pregnancy|2|||
147535683|NCT00625846|532116698|FG003|Overall Study|Withdrawal by Subject|2|||
147535684|NCT03426995|532116699|FG000|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
147535685|NCT03426995|532116700|FG001|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
147535686|NCT03426995|532116701|FG002|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|1|||
147535687|NCT03426995|532116702|FG003|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
147535688|NCT03426995|532116703|FG004|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
147535689|NCT03426995|532116704|FG005|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
147535690|NCT03426995|532116705|FG006|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
147535691|NCT03426995|532116706|FG007|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
147535692|NCT03426995|532116707|FG008|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
147535693|NCT03426995|532116708|FG009|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
147535694|NCT03426995|532116709|FG010|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
147535695|NCT03426995|532116710|FG011|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
147535696|NCT03426995|532116711|FG012|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
147535697|NCT03426995|532116712|FG013|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
147535698|NCT03426995|532116713|FG014|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
147535699|NCT03426995|532116714|FG015|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
147535700|NCT03426995|532116715|FG016|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
147535701|NCT03426995|532116716|FG017|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
147535702|NCT03426995|532116717|FG018|Part A: Cohort 1-Period 1 (Day1)|Protocol defined stopping criteria|0|||
147535703|NCT03426995|532116699|FG000|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
147535704|NCT03426995|532116700|FG001|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
147535705|NCT03426995|532116701|FG002|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
147535706|NCT03426995|532116702|FG003|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
147535707|NCT03426995|532116703|FG004|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
147535708|NCT03426995|532116704|FG005|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|1|||
147535709|NCT03426995|532116705|FG006|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
147535710|NCT03426995|532116706|FG007|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
147535711|NCT03426995|532116707|FG008|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
147535712|NCT03426995|532116708|FG009|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
147535713|NCT03426995|532116709|FG010|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
147535714|NCT03426995|532116710|FG011|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
147535715|NCT03426995|532116711|FG012|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
147535716|NCT03426995|532116712|FG013|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
147535717|NCT03426995|532116713|FG014|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
147535718|NCT03426995|532116714|FG015|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
147535719|NCT03426995|532116715|FG016|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
147535720|NCT03426995|532116716|FG017|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
147535721|NCT03426995|532116717|FG018|Part A: Cohort 1-Period 2 (Day1)|Protocol Violation|0|||
147535722|NCT03426995|532116699|FG000|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
147535723|NCT03426995|532116700|FG001|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
147535724|NCT03426995|532116701|FG002|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
147535725|NCT03426995|532116702|FG003|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
147535726|NCT03426995|532116703|FG004|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|1|||
147535727|NCT03426995|532116704|FG005|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|1|||
147535728|NCT03426995|532116705|FG006|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
147535729|NCT03426995|532116706|FG007|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
147535730|NCT03426995|532116707|FG008|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
147535731|NCT03426995|532116708|FG009|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
147535732|NCT03426995|532116709|FG010|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
147535733|NCT03426995|532116710|FG011|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
147535734|NCT03426995|532116711|FG012|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
147535735|NCT03426995|532116712|FG013|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
147535736|NCT03426995|532116713|FG014|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
147535737|NCT03426995|532116714|FG015|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
147535738|NCT03426995|532116715|FG016|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
147535739|NCT03426995|532116716|FG017|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
147535740|NCT03426995|532116717|FG018|Part A: Cohort 1-Period 2 (Day1)|Adverse Event|0|||
147535741|NCT03426995|532116699|FG000|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
147535742|NCT03426995|532116700|FG001|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
147535743|NCT03426995|532116701|FG002|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
147535744|NCT03426995|532116702|FG003|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
147535745|NCT03426995|532116703|FG004|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
147535746|NCT03426995|532116704|FG005|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
147535747|NCT03426995|532116705|FG006|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
147535748|NCT03426995|532116706|FG007|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
147535749|NCT03426995|532116707|FG008|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
147535750|NCT03426995|532116708|FG009|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
147535751|NCT03426995|532116709|FG010|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|1|||
147535752|NCT03426995|532116710|FG011|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
147535753|NCT03426995|532116711|FG012|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
147535754|NCT03426995|532116712|FG013|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
147535755|NCT03426995|532116713|FG014|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
147535756|NCT03426995|532116714|FG015|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
147535757|NCT03426995|532116715|FG016|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
147535758|NCT03426995|532116716|FG017|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
147535759|NCT03426995|532116717|FG018|Part A: Cohort 2-Period 4 (Day1)|Lost to Follow-up|0|||
147535760|NCT03426995|532116699|FG000|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
147202014|NCT00419952|530910517|FG000|Overall Study|Physician Decision|1|||
147202015|NCT00419952|530910518|FG001|Overall Study|Physician Decision|3|||
147436181|NCT01674712|531763453|FG000|Overall Study|Protocol Violation|2|||
147436182|NCT01674712|531763454|FG001|Overall Study|Protocol Violation|0|||
147436183|NCT01674712|531763455|FG002|Overall Study|Protocol Violation|0|||
147436184|NCT01674712|531763456|FG003|Overall Study|Protocol Violation|0|||
147436185|NCT01674712|531763457|FG004|Overall Study|Protocol Violation|0|||
147436186|NCT01674712|531763453|FG000|Overall Study|Withdrawal by Subject|2|||
147436187|NCT01674712|531763454|FG001|Overall Study|Withdrawal by Subject|2|||
147436188|NCT01674712|531763455|FG002|Overall Study|Withdrawal by Subject|5|||
147436189|NCT01674712|531763456|FG003|Overall Study|Withdrawal by Subject|4|||
147436190|NCT01674712|531763457|FG004|Overall Study|Withdrawal by Subject|3|||
147436191|NCT01674712|531763453|FG000|Overall Study|Administrative|0|||
147436192|NCT01674712|531763454|FG001|Overall Study|Administrative|1|||
147436193|NCT01674712|531763455|FG002|Overall Study|Administrative|0|||
147436194|NCT01674712|531763456|FG003|Overall Study|Administrative|0|||
147436195|NCT01674712|531763457|FG004|Overall Study|Administrative|1|||
147436196|NCT01674712|531763453|FG000|Overall Study|Lack of Efficacy|0|||
147436197|NCT01674712|531763454|FG001|Overall Study|Lack of Efficacy|0|||
147436198|NCT01674712|531763455|FG002|Overall Study|Lack of Efficacy|1|||
147436199|NCT01674712|531763456|FG003|Overall Study|Lack of Efficacy|0|||
147436200|NCT01674712|531763457|FG004|Overall Study|Lack of Efficacy|1|||
147436201|NCT05395104|531763460|FG000|Overall Study|Met Liver Stopping Criteria|1|||
147436202|NCT05395104|531763460|FG000|Overall Study|Withdrawal by Subject|1|||
147436203|NCT00381563|531763461|FG000|Overall Study|Withdrawal by Subject|5|||
147436204|NCT00381563|531763462|FG001|Overall Study|Withdrawal by Subject|5|||
147436205|NCT00381563|531763461|FG000|Overall Study|Lost to Follow-up|2|||
147436206|NCT00381563|531763462|FG001|Overall Study|Lost to Follow-up|0|||
147436207|NCT00381563|531763461|FG000|Overall Study|Protocol Violation|0|||
147202016|NCT00419952|530910517|FG000|Overall Study|Incorrectly enrolled|10|||
147202017|NCT00419952|530910518|FG001|Overall Study|Incorrectly enrolled|3|||
147436208|NCT00381563|531763462|FG001|Overall Study|Protocol Violation|1|||
147436209|NCT01287364|531763464|FG000|Overall Study|Adverse Event|0|||
147436210|NCT01287364|531763465|FG001|Overall Study|Adverse Event|3|||
147436211|NCT01287364|531763464|FG000|Overall Study|Protocol Violation|5|||
147436212|NCT01287364|531763465|FG001|Overall Study|Protocol Violation|5|||
147436213|NCT01287364|531763464|FG000|Overall Study|Other Reason|4|||
147436214|NCT01287364|531763465|FG001|Overall Study|Other Reason|2|||
147436215|NCT05372653|531763474|FG000|Overall Study|Study treatment terminated by parent/guardian|1|||
147436216|NCT05372653|531763475|FG001|Overall Study|Study treatment terminated by parent/guardian|3|||
147436217|NCT05372653|531763474|FG000|Overall Study|Adverse Event|0|||
147436218|NCT05372653|531763475|FG001|Overall Study|Adverse Event|1|||
147436219|NCT01003990|531763478|FG000|Overall Study|Adverse Event|8|||
147436220|NCT01003990|531763479|FG001|Overall Study|Adverse Event|5|||
147436221|NCT01003990|531763480|FG002|Overall Study|Adverse Event|11|||
147436222|NCT01003990|531763478|FG000|Overall Study|Death|0|||
147436223|NCT01003990|531763479|FG001|Overall Study|Death|8|||
147436224|NCT01003990|531763480|FG002|Overall Study|Death|1|||
147436225|NCT01003990|531763478|FG000|Overall Study|Lack of Efficacy|10|||
147436226|NCT01003990|531763479|FG001|Overall Study|Lack of Efficacy|2|||
147436227|NCT01003990|531763480|FG002|Overall Study|Lack of Efficacy|3|||
147436228|NCT01003990|531763478|FG000|Overall Study|Lost to Follow-up|30|||
147436229|NCT01003990|531763479|FG001|Overall Study|Lost to Follow-up|12|||
147436230|NCT01003990|531763480|FG002|Overall Study|Lost to Follow-up|7|||
147436231|NCT01003990|531763478|FG000|Overall Study|Reasons Not Identified|14|||
147436232|NCT01003990|531763479|FG001|Overall Study|Reasons Not Identified|13|||
147436233|NCT01003990|531763480|FG002|Overall Study|Reasons Not Identified|8|||
147436234|NCT01003990|531763478|FG000|Overall Study|Poor/Non-compliance|4|||
147436235|NCT01003990|531763479|FG001|Overall Study|Poor/Non-compliance|3|||
147436236|NCT01003990|531763480|FG002|Overall Study|Poor/Non-compliance|2|||
147436237|NCT01003990|531763478|FG000|Overall Study|Pregnancy|10|||
147436238|NCT01003990|531763479|FG001|Overall Study|Pregnancy|2|||
147436239|NCT01003990|531763480|FG002|Overall Study|Pregnancy|4|||
147436240|NCT01003990|531763478|FG000|Overall Study|No Longer Met Study Criteria|4|||
147436241|NCT01003990|531763479|FG001|Overall Study|No Longer Met Study Criteria|1|||
147436242|NCT01003990|531763480|FG002|Overall Study|No Longer Met Study Criteria|0|||
147436243|NCT01003990|531763478|FG000|Overall Study|Subject Withdrew Consent|12|||
147436244|NCT01003990|531763479|FG001|Overall Study|Subject Withdrew Consent|5|||
147436245|NCT01003990|531763480|FG002|Overall Study|Subject Withdrew Consent|7|||
147436246|NCT01829425|531763481|FG000|Overall Study|Withdrawal by Subject|4|||
147436247|NCT01829425|531763482|FG001|Overall Study|Withdrawal by Subject|3|||
147436248|NCT01829425|531763481|FG000|Overall Study|Lost to Follow-up|2|||
147436249|NCT01829425|531763482|FG001|Overall Study|Lost to Follow-up|1|||
147436250|NCT05211739|531763483|FG000|First Wear Period (Approx 30 Days)|Adverse Event|0|||
147436251|NCT05211739|531763484|FG001|First Wear Period (Approx 30 Days)|Adverse Event|1|||
147436252|NCT05211739|531763483|FG000|First Wear Period (Approx 30 Days)|Withdrawal by Subject Prior to Exposure to the Study Lenses|1|||
147436253|NCT05211739|531763484|FG001|First Wear Period (Approx 30 Days)|Withdrawal by Subject Prior to Exposure to the Study Lenses|0|||
147436254|NCT05211739|531763483|FG000|First Wear Period (Approx 30 Days)|Withdrawal by Subject|0|||
147436255|NCT05211739|531763484|FG001|First Wear Period (Approx 30 Days)|Withdrawal by Subject|1|||
147436256|NCT05211739|531763483|FG000|Second Wear Period (Approx 30 Days)|Adverse Event|1|||
147436257|NCT05211739|531763484|FG001|Second Wear Period (Approx 30 Days)|Adverse Event|0|||
147436258|NCT01505010|531763485|FG000|Overall Study|Protocol Violation|0|||
147436259|NCT01505010|531763486|FG001|Overall Study|Protocol Violation|1|||
147436260|NCT01505010|531763485|FG000|Overall Study|Lost to Follow-up|0|||
147436261|NCT01505010|531763486|FG001|Overall Study|Lost to Follow-up|1|||
147436262|NCT01006265|531763495|FG000|Overall Study|Lost to Follow-up|1|||
147436263|NCT01006265|531763496|FG001|Overall Study|Lost to Follow-up|0|||
147436264|NCT01006265|531763497|FG002|Overall Study|Lost to Follow-up|1|||
147436265|NCT01006265|531763498|FG003|Overall Study|Lost to Follow-up|0|||
147436266|NCT01006265|531763495|FG000|Overall Study|Withdrawal by Subject|4|||
147436267|NCT01006265|531763496|FG001|Overall Study|Withdrawal by Subject|7|||
147436268|NCT01006265|531763497|FG002|Overall Study|Withdrawal by Subject|5|||
147436269|NCT01006265|531763498|FG003|Overall Study|Withdrawal by Subject|5|||
147436270|NCT01006265|531763495|FG000|Overall Study|Administrative reason|1|||
147436271|NCT01006265|531763496|FG001|Overall Study|Administrative reason|2|||
147436272|NCT01006265|531763497|FG002|Overall Study|Administrative reason|3|||
147436273|NCT01006265|531763498|FG003|Overall Study|Administrative reason|0|||
147436274|NCT00698932|531763499|FG000|Overall Study|Adverse Event|0|||
147436275|NCT00698932|531763500|FG001|Overall Study|Adverse Event|2|||
147436276|NCT00698932|531763499|FG000|Overall Study|Incorrect enrollment|0|||
147436277|NCT00698932|531763500|FG001|Overall Study|Incorrect enrollment|2|||
147436278|NCT00698932|531763499|FG000|Overall Study|Study specific discontinuation criteria|3|||
147436279|NCT00698932|531763500|FG001|Overall Study|Study specific discontinuation criteria|4|||
147436280|NCT00698932|531763499|FG000|Overall Study|Withdrawal by Subject|11|||
147436281|NCT00698932|531763500|FG001|Overall Study|Withdrawal by Subject|23|||
147436282|NCT00698932|531763499|FG000|Overall Study|Lost to Follow-up|6|||
147436283|NCT00698932|531763500|FG001|Overall Study|Lost to Follow-up|1|||
147436284|NCT00698932|531763499|FG000|Overall Study|Severe non-compliance to protocol|1|||
147436285|NCT00698932|531763500|FG001|Overall Study|Severe non-compliance to protocol|2|||
147436286|NCT00698932|531763499|FG000|Overall Study|Safety reasons|0|||
147436287|NCT00698932|531763500|FG001|Overall Study|Safety reasons|2|||
147436288|NCT00698932|531763499|FG000|Overall Study|Death|1|||
147436289|NCT00698932|531763500|FG001|Overall Study|Death|0|||
147436290|NCT00757003|531763501|FG000|Overall Study|Death|33|||
147436291|NCT00757003|531763501|FG000|Overall Study|Lost to Follow-up|9|||
147436292|NCT00757003|531763501|FG000|Overall Study|Withdrawal by Subject|4|||
147436293|NCT00757003|531763501|FG000|Overall Study|Surgically explanted|2|||
147436294|NCT00757003|531763501|FG000|Overall Study|Not implanted|1|||
147436295|NCT02966223|531763502|FG000|Overall Study|Physician Decision|3|||
147436296|NCT02966223|531763502|FG000|Overall Study|Withdrawal by Subject|11|||
147436297|NCT02966223|531763502|FG000|Overall Study|Lost to Follow-up|1|||
147436298|NCT01326728|531763503|FG000|Overall Study|Death|13|||
147202018|NCT00419952|530910517|FG000|Overall Study|Intake of prohibited medication|2|||
147202019|NCT00419952|530910518|FG001|Overall Study|Intake of prohibited medication|2|||
147202020|NCT00419952|530910517|FG000|Overall Study|Occurence of 2 or more exacerbations|2|||
147202021|NCT00419952|530910518|FG001|Overall Study|Occurence of 2 or more exacerbations|0|||
147202022|NCT00419952|530910517|FG000|Overall Study|Diary or medication non-compliance|2|||
147202023|NCT00419952|530910518|FG001|Overall Study|Diary or medication non-compliance|4|||
147202024|NCT00419952|530910517|FG000|Overall Study|Abnormal ECG|1|||
147202025|NCT00419952|530910518|FG001|Overall Study|Abnormal ECG|0|||
147202026|NCT03126591|530910519|FG000|Overall Study|Death|6|||
147202027|NCT03126591|530910520|FG001|Overall Study|Death|3|||
147202028|NCT03126591|530910521|FG002|Overall Study|Death|17|||
147202029|NCT03126591|530910519|FG000|Overall Study|Progressive Disease|0|||
147202030|NCT03126591|530910520|FG001|Overall Study|Progressive Disease|1|||
147202031|NCT03126591|530910521|FG002|Overall Study|Progressive Disease|2|||
147202032|NCT03126591|530910519|FG000|Overall Study|Terminated by Sponsor|0|||
147202033|NCT03126591|530910520|FG001|Overall Study|Terminated by Sponsor|1|||
147202034|NCT03126591|530910521|FG002|Overall Study|Terminated by Sponsor|4|||
147202035|NCT03126591|530910519|FG000|Overall Study|Withdrawal by Subject|1|||
147202036|NCT03126591|530910520|FG001|Overall Study|Withdrawal by Subject|1|||
147436299|NCT01326728|531763504|FG001|Overall Study|Death|0|||
147436300|NCT01326728|531763503|FG000|Overall Study|Early closure of study|34|||
147436301|NCT01326728|531763504|FG001|Overall Study|Early closure of study|9|||
147202037|NCT03126591|530910521|FG002|Overall Study|Withdrawal by Subject|4|||
147202038|NCT02606643|530910522|FG000|Overall Study|did not meet inclusion criteria|1|||
147202039|NCT02606643|530910523|FG001|Overall Study|did not meet inclusion criteria|3|||
147202040|NCT01208207|530910530|FG000|Part I|Adverse Event|19|||
147202041|NCT01208207|530910531|FG001|Part I|Adverse Event|2|||
147202042|NCT01208207|530910532|FG002|Part I|Adverse Event|6|||
147202043|NCT01208207|530910533|FG003|Part I|Adverse Event|0|||
147202044|NCT01208207|530910534|FG004|Part I|Adverse Event|0|||
147202045|NCT01208207|530910535|FG005|Part I|Adverse Event|0|||
147202046|NCT01208207|530910536|FG006|Part I|Adverse Event|0|||
147202047|NCT01208207|530910530|FG000|Part I|Lack of Efficacy|21|||
147202048|NCT01208207|530910531|FG001|Part I|Lack of Efficacy|3|||
147202049|NCT01208207|530910532|FG002|Part I|Lack of Efficacy|2|||
147202050|NCT01208207|530910533|FG003|Part I|Lack of Efficacy|0|||
147202051|NCT01208207|530910534|FG004|Part I|Lack of Efficacy|0|||
147202052|NCT01208207|530910535|FG005|Part I|Lack of Efficacy|0|||
147202053|NCT01208207|530910536|FG006|Part I|Lack of Efficacy|0|||
147202054|NCT01208207|530910530|FG000|Part I|Lost to Follow-up|6|||
147202055|NCT01208207|530910531|FG001|Part I|Lost to Follow-up|1|||
147202056|NCT01208207|530910532|FG002|Part I|Lost to Follow-up|0|||
147202057|NCT01208207|530910533|FG003|Part I|Lost to Follow-up|0|||
147202058|NCT01208207|530910534|FG004|Part I|Lost to Follow-up|0|||
147202059|NCT01208207|530910535|FG005|Part I|Lost to Follow-up|0|||
147202060|NCT01208207|530910536|FG006|Part I|Lost to Follow-up|0|||
147202061|NCT01208207|530910530|FG000|Part I|Non-Compliance With Study Drug|1|||
147202062|NCT01208207|530910531|FG001|Part I|Non-Compliance With Study Drug|0|||
147202063|NCT01208207|530910532|FG002|Part I|Non-Compliance With Study Drug|1|||
147202064|NCT01208207|530910533|FG003|Part I|Non-Compliance With Study Drug|0|||
147202065|NCT01208207|530910534|FG004|Part I|Non-Compliance With Study Drug|0|||
147202066|NCT01208207|530910535|FG005|Part I|Non-Compliance With Study Drug|0|||
147202067|NCT01208207|530910536|FG006|Part I|Non-Compliance With Study Drug|0|||
147202068|NCT01208207|530910530|FG000|Part I|Physician Decision|0|||
147202069|NCT01208207|530910531|FG001|Part I|Physician Decision|1|||
147202070|NCT01208207|530910532|FG002|Part I|Physician Decision|0|||
147202071|NCT01208207|530910533|FG003|Part I|Physician Decision|0|||
147202072|NCT01208207|530910534|FG004|Part I|Physician Decision|0|||
147202073|NCT01208207|530910535|FG005|Part I|Physician Decision|0|||
147202074|NCT01208207|530910536|FG006|Part I|Physician Decision|0|||
147202075|NCT01208207|530910530|FG000|Part I|Progressive Disease|1|||
147202076|NCT01208207|530910531|FG001|Part I|Progressive Disease|0|||
147202077|NCT01208207|530910532|FG002|Part I|Progressive Disease|0|||
147202078|NCT01208207|530910533|FG003|Part I|Progressive Disease|0|||
147202079|NCT01208207|530910534|FG004|Part I|Progressive Disease|0|||
147202080|NCT01208207|530910535|FG005|Part I|Progressive Disease|0|||
147202081|NCT01208207|530910536|FG006|Part I|Progressive Disease|0|||
147202082|NCT01208207|530910530|FG000|Part I|Protocol Violation|8|||
147202083|NCT01208207|530910531|FG001|Part I|Protocol Violation|0|||
147202084|NCT01208207|530910532|FG002|Part I|Protocol Violation|2|||
147202085|NCT01208207|530910533|FG003|Part I|Protocol Violation|0|||
147202086|NCT01208207|530910534|FG004|Part I|Protocol Violation|0|||
147202087|NCT01208207|530910535|FG005|Part I|Protocol Violation|0|||
147202088|NCT01208207|530910536|FG006|Part I|Protocol Violation|0|||
147202089|NCT01208207|530910530|FG000|Part I|Withdrawal by Subject|14|||
147202090|NCT01208207|530910531|FG001|Part I|Withdrawal by Subject|4|||
147202091|NCT01208207|530910532|FG002|Part I|Withdrawal by Subject|4|||
147202092|NCT01208207|530910533|FG003|Part I|Withdrawal by Subject|0|||
147202093|NCT01208207|530910534|FG004|Part I|Withdrawal by Subject|0|||
147202094|NCT01208207|530910535|FG005|Part I|Withdrawal by Subject|0|||
147202095|NCT01208207|530910536|FG006|Part I|Withdrawal by Subject|0|||
147202096|NCT01208207|530910530|FG000|Part II|Withdrawal by Subject|0|||
147202097|NCT01208207|530910531|FG001|Part II|Withdrawal by Subject|0|||
147202098|NCT01208207|530910532|FG002|Part II|Withdrawal by Subject|0|||
147202099|NCT01208207|530910533|FG003|Part II|Withdrawal by Subject|10|||
147202100|NCT01208207|530910534|FG004|Part II|Withdrawal by Subject|9|||
147436302|NCT01184053|531763505|FG000|Overall Study|progression while on treatment|3|||
147436303|NCT03785678|531763506|FG000|Overall Study|Death|44|||
147202101|NCT01208207|530910535|FG005|Part II|Withdrawal by Subject|3|||
147306805|NCT01852058|531290774|FG001|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
147436304|NCT03785678|531763507|FG001|Overall Study|Death|42|||
147202102|NCT01208207|530910536|FG006|Part II|Withdrawal by Subject|5|||
147202103|NCT01208207|530910530|FG000|Part II|Adverse Event|0|||
147202104|NCT01208207|530910531|FG001|Part II|Adverse Event|0|||
147202105|NCT01208207|530910532|FG002|Part II|Adverse Event|0|||
147202106|NCT01208207|530910533|FG003|Part II|Adverse Event|5|||
147202107|NCT01208207|530910534|FG004|Part II|Adverse Event|9|||
147202108|NCT01208207|530910535|FG005|Part II|Adverse Event|4|||
147202109|NCT01208207|530910536|FG006|Part II|Adverse Event|2|||
147202110|NCT01208207|530910530|FG000|Part II|Lack of Efficacy|0|||
147202111|NCT01208207|530910531|FG001|Part II|Lack of Efficacy|0|||
147202112|NCT01208207|530910532|FG002|Part II|Lack of Efficacy|0|||
147202113|NCT01208207|530910533|FG003|Part II|Lack of Efficacy|6|||
147202114|NCT01208207|530910534|FG004|Part II|Lack of Efficacy|4|||
147202115|NCT01208207|530910535|FG005|Part II|Lack of Efficacy|3|||
147202116|NCT01208207|530910536|FG006|Part II|Lack of Efficacy|3|||
147535761|NCT03426995|532116700|FG001|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
147535762|NCT03426995|532116701|FG002|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
147535763|NCT03426995|532116702|FG003|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
147535764|NCT03426995|532116703|FG004|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
147535765|NCT03426995|532116704|FG005|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
147535766|NCT03426995|532116705|FG006|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
147535767|NCT03426995|532116706|FG007|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|1|||
147535768|NCT03426995|532116707|FG008|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
147535769|NCT03426995|532116708|FG009|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
147535770|NCT03426995|532116709|FG010|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
147535771|NCT03426995|532116710|FG011|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
147535772|NCT03426995|532116711|FG012|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
147535773|NCT03426995|532116712|FG013|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
147535774|NCT03426995|532116713|FG014|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
147535775|NCT03426995|532116714|FG015|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
147535776|NCT03426995|532116715|FG016|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
147535777|NCT03426995|532116716|FG017|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
147535778|NCT03426995|532116717|FG018|Part A: Cohort 2-Period 4 (Day1)|Adverse Event|0|||
147436305|NCT03785678|531763506|FG000|Overall Study|Lost to Follow-up|4|||
147436306|NCT03785678|531763507|FG001|Overall Study|Lost to Follow-up|2|||
147436307|NCT03785678|531763506|FG000|Overall Study|Physician Decision|0|||
147436308|NCT03785678|531763507|FG001|Overall Study|Physician Decision|2|||
147436309|NCT03785678|531763506|FG000|Overall Study|Withdrawal by Subject|5|||
147436310|NCT03785678|531763507|FG001|Overall Study|Withdrawal by Subject|3|||
147436311|NCT00375219|531763508|FG000|Overall Study|Failure to achieve a response|16|||
147436312|NCT00375219|531763509|FG001|Overall Study|Failure to achieve a response|2|||
147436313|NCT00375219|531763510|FG002|Overall Study|Failure to achieve a response|0|||
147436314|NCT00375219|531763508|FG000|Overall Study|Adverse Event|8|||
147436315|NCT00375219|531763509|FG001|Overall Study|Adverse Event|2|||
147436316|NCT00375219|531763510|FG002|Overall Study|Adverse Event|1|||
147436317|NCT00375219|531763508|FG000|Overall Study|Protocol Violation|1|||
147436318|NCT00375219|531763509|FG001|Overall Study|Protocol Violation|0|||
147436319|NCT00375219|531763510|FG002|Overall Study|Protocol Violation|1|||
147436320|NCT00375219|531763508|FG000|Overall Study|Request of Patient, PI, Sponsor or RA|5|||
147436321|NCT00375219|531763509|FG001|Overall Study|Request of Patient, PI, Sponsor or RA|3|||
147436322|NCT00375219|531763510|FG002|Overall Study|Request of Patient, PI, Sponsor or RA|0|||
147436323|NCT00375219|531763508|FG000|Overall Study|Lost to Follow-up|1|||
147436324|NCT00375219|531763509|FG001|Overall Study|Lost to Follow-up|1|||
147436325|NCT00375219|531763510|FG002|Overall Study|Lost to Follow-up|0|||
147436326|NCT00375219|531763508|FG000|Overall Study|Disease progression|18|||
147436327|NCT00375219|531763509|FG001|Overall Study|Disease progression|9|||
147436328|NCT00375219|531763510|FG002|Overall Study|Disease progression|12|||
147436329|NCT00375219|531763508|FG000|Overall Study|Death|4|||
147436330|NCT00375219|531763509|FG001|Overall Study|Death|3|||
147436331|NCT00375219|531763510|FG002|Overall Study|Death|7|||
147436332|NCT00375219|531763508|FG000|Overall Study|Hematologic resistance|1|||
147436333|NCT00375219|531763509|FG001|Overall Study|Hematologic resistance|0|||
147436334|NCT00375219|531763510|FG002|Overall Study|Hematologic resistance|0|||
147436335|NCT00375219|531763508|FG000|Overall Study|Specific tyrosine kinase inhibitor avail|1|||
147436336|NCT00375219|531763509|FG001|Overall Study|Specific tyrosine kinase inhibitor avail|0|||
147436337|NCT00375219|531763510|FG002|Overall Study|Specific tyrosine kinase inhibitor avail|0|||
147436338|NCT00375219|531763508|FG000|Overall Study|Allograft|2|||
147436339|NCT00375219|531763509|FG001|Overall Study|Allograft|0|||
147436340|NCT00375219|531763510|FG002|Overall Study|Allograft|0|||
147436341|NCT00375219|531763508|FG000|Overall Study|Cord blood transplantation|1|||
147436342|NCT00375219|531763509|FG001|Overall Study|Cord blood transplantation|0|||
147436343|NCT00375219|531763510|FG002|Overall Study|Cord blood transplantation|0|||
147436344|NCT00375219|531763508|FG000|Overall Study|Withdrawal by Subject|1|||
147436345|NCT00375219|531763509|FG001|Overall Study|Withdrawal by Subject|0|||
147436346|NCT00375219|531763510|FG002|Overall Study|Withdrawal by Subject|0|||
147436347|NCT01667107|531763511|FG000|Overall Study|Adverse Event|4|||
147436348|NCT01667107|531763512|FG001|Overall Study|Adverse Event|3|||
147436349|NCT01667107|531763511|FG000|Overall Study|Tolerability issues|0|||
147535779|NCT03426995|532116699|FG000|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
147202117|NCT01208207|530910530|FG000|Part II|Lost to Follow-up|0|||
147436350|NCT01667107|531763512|FG001|Overall Study|Tolerability issues|2|||
147436351|NCT01667107|531763511|FG000|Overall Study|Protocol Violation|0|||
147436352|NCT01667107|531763512|FG001|Overall Study|Protocol Violation|1|||
147436353|NCT01667107|531763511|FG000|Overall Study|Lack of Efficacy|0|||
147436354|NCT01667107|531763512|FG001|Overall Study|Lack of Efficacy|1|||
147202118|NCT01208207|530910531|FG001|Part II|Lost to Follow-up|0|||
147436355|NCT01791803|531763513|FG000|Overall Study|Withdrawal by Subject|0|||
147436356|NCT01791803|531763514|FG001|Overall Study|Withdrawal by Subject|0|||
147436357|NCT01791803|531763515|FG002|Overall Study|Withdrawal by Subject|0|||
147436358|NCT01791803|531763516|FG003|Overall Study|Withdrawal by Subject|2|||
147202119|NCT01208207|530910532|FG002|Part II|Lost to Follow-up|0|||
147202120|NCT01208207|530910533|FG003|Part II|Lost to Follow-up|4|||
147436359|NCT01791803|531763513|FG000|Overall Study|Physician Decision|0|||
147436360|NCT01791803|531763514|FG001|Overall Study|Physician Decision|2|||
147436361|NCT01791803|531763515|FG002|Overall Study|Physician Decision|0|||
147436362|NCT01791803|531763516|FG003|Overall Study|Physician Decision|1|||
147436363|NCT01791803|531763513|FG000|Overall Study|Death|0|||
147436364|NCT01791803|531763514|FG001|Overall Study|Death|0|||
147436365|NCT01791803|531763515|FG002|Overall Study|Death|2|||
147436366|NCT01791803|531763516|FG003|Overall Study|Death|2|||
147436367|NCT04572854|531763517|FG000|Part A: Non-controlled: Weeks 13 to 52|Adverse Event|0|||
147436368|NCT04572854|531763518|FG001|Part A: Non-controlled: Weeks 13 to 52|Adverse Event|0|||
147436369|NCT04572854|531763519|FG002|Part A: Non-controlled: Weeks 13 to 52|Adverse Event|1|||
147436370|NCT04572854|531763520|FG003|Part A: Non-controlled: Weeks 13 to 52|Adverse Event|1|||
147436371|NCT04572854|531763517|FG000|Part A: Non-controlled: Weeks 13 to 52|Physician Decision|0|||
147436372|NCT04572854|531763518|FG001|Part A: Non-controlled: Weeks 13 to 52|Physician Decision|0|||
147436373|NCT04572854|531763519|FG002|Part A: Non-controlled: Weeks 13 to 52|Physician Decision|1|||
147436374|NCT04572854|531763520|FG003|Part A: Non-controlled: Weeks 13 to 52|Physician Decision|0|||
147436375|NCT00972777|531763521|FG000|Overall Study|Adverse Event|3|||
147436376|NCT00972777|531763522|FG001|Overall Study|Adverse Event|2|||
147436377|NCT00972777|531763521|FG000|Overall Study|Lost to Follow-up|0|||
147436378|NCT00972777|531763522|FG001|Overall Study|Lost to Follow-up|4|||
147436379|NCT00972777|531763521|FG000|Overall Study|Withdrawal by Subject|4|||
147436380|NCT00972777|531763522|FG001|Overall Study|Withdrawal by Subject|5|||
147436381|NCT00972777|531763521|FG000|Overall Study|Physician Decision|4|||
147436382|NCT00972777|531763522|FG001|Overall Study|Physician Decision|0|||
147436383|NCT00972777|531763521|FG000|Overall Study|Protocol Violation|0|||
147436384|NCT00972777|531763522|FG001|Overall Study|Protocol Violation|2|||
147436385|NCT00972777|531763521|FG000|Overall Study|Screening Failure|2|||
147436386|NCT00972777|531763522|FG001|Overall Study|Screening Failure|1|||
147436387|NCT00972777|531763521|FG000|Overall Study|Missed visit|1|||
147436388|NCT00972777|531763522|FG001|Overall Study|Missed visit|0|||
147436389|NCT01093326|531763523|FG000|Overall Study|Death|0|||
147436390|NCT01093326|531763524|FG001|Overall Study|Death|1|||
147436391|NCT01093326|531763525|FG002|Overall Study|Death|0|||
147436392|NCT01093326|531763523|FG000|Overall Study|Lack of Efficacy|7|||
147436393|NCT01093326|531763524|FG001|Overall Study|Lack of Efficacy|6|||
147436394|NCT01093326|531763525|FG002|Overall Study|Lack of Efficacy|3|||
147436395|NCT01093326|531763523|FG000|Overall Study|Lost to Follow-up|2|||
147436396|NCT01093326|531763524|FG001|Overall Study|Lost to Follow-up|5|||
147436397|NCT01093326|531763525|FG002|Overall Study|Lost to Follow-up|4|||
147436398|NCT01093326|531763523|FG000|Overall Study|Physician Decision|3|||
147436399|NCT01093326|531763524|FG001|Overall Study|Physician Decision|1|||
147436400|NCT01093326|531763525|FG002|Overall Study|Physician Decision|3|||
147436401|NCT01093326|531763523|FG000|Overall Study|Withdrawal by Subject|30|||
147436402|NCT01093326|531763524|FG001|Overall Study|Withdrawal by Subject|27|||
147436403|NCT01093326|531763525|FG002|Overall Study|Withdrawal by Subject|26|||
147436404|NCT01093326|531763523|FG000|Overall Study|Adverse Event|2|||
147436405|NCT01093326|531763524|FG001|Overall Study|Adverse Event|1|||
147436406|NCT01093326|531763525|FG002|Overall Study|Adverse Event|4|||
147436407|NCT01093326|531763523|FG000|Overall Study|Other|0|||
147436408|NCT01093326|531763524|FG001|Overall Study|Other|0|||
147436409|NCT01093326|531763525|FG002|Overall Study|Other|1|||
147436410|NCT02460497|531765054|FG000|Overall Study|Participant Requested Withdrawal|4|||
147436411|NCT02460497|531765054|FG000|Overall Study|Non-Compliance|1|||
147436412|NCT02460497|531765054|FG000|Overall Study|Did not Meet Protocol Criteria|1|||
147436413|NCT02460497|531765054|FG000|Overall Study|Lost to Follow-up|2|||
147202121|NCT01208207|530910534|FG004|Part II|Lost to Follow-up|0|||
147436414|NCT02460497|531765054|FG000|Overall Study|Investigator Decision|1|||
147436415|NCT01650285|531765055|FG000|Overall Study|Adverse Event|1|||
147436416|NCT00283049|531765059|FG000|Overall Study|Adverse Event|6|||
147535780|NCT03426995|532116700|FG001|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
147535781|NCT03426995|532116701|FG002|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
147202122|NCT01208207|530910535|FG005|Part II|Lost to Follow-up|2|||
147202123|NCT01208207|530910536|FG006|Part II|Lost to Follow-up|1|||
147202124|NCT01208207|530910530|FG000|Part II|Non-Compliance With Study Drug|0|||
147202125|NCT01208207|530910531|FG001|Part II|Non-Compliance With Study Drug|0|||
147202126|NCT01208207|530910532|FG002|Part II|Non-Compliance With Study Drug|0|||
147202127|NCT01208207|530910533|FG003|Part II|Non-Compliance With Study Drug|4|||
147202128|NCT01208207|530910534|FG004|Part II|Non-Compliance With Study Drug|1|||
147202129|NCT01208207|530910535|FG005|Part II|Non-Compliance With Study Drug|1|||
147202130|NCT01208207|530910536|FG006|Part II|Non-Compliance With Study Drug|0|||
147202131|NCT01208207|530910530|FG000|Part II|Physician Decision|0|||
147202132|NCT01208207|530910531|FG001|Part II|Physician Decision|0|||
147535782|NCT03426995|532116702|FG003|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
147535783|NCT03426995|532116703|FG004|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
147535784|NCT03426995|532116704|FG005|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
147535785|NCT03426995|532116705|FG006|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
147535786|NCT03426995|532116706|FG007|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
147535787|NCT03426995|532116707|FG008|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
147535788|NCT03426995|532116708|FG009|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
147535789|NCT03426995|532116709|FG010|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
147535790|NCT03426995|532116710|FG011|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
147535791|NCT03426995|532116711|FG012|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
147535792|NCT03426995|532116712|FG013|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
147535793|NCT03426995|532116713|FG014|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|8|||
147535794|NCT03426995|532116714|FG015|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|9|||
147535795|NCT03426995|532116715|FG016|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
147535796|NCT03426995|532116716|FG017|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
147535797|NCT03426995|532116717|FG018|Part C: Cohorts 4 to 8 (Days 1 to 14)|Study Closed/Terminated|0|||
147535798|NCT03426995|532116699|FG000|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
147535799|NCT03426995|532116700|FG001|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
147535800|NCT03426995|532116701|FG002|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
147535801|NCT03426995|532116702|FG003|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
147535802|NCT03426995|532116703|FG004|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
147535803|NCT03426995|532116704|FG005|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
147535804|NCT03426995|532116705|FG006|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
147535805|NCT03426995|532116706|FG007|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
147535806|NCT03426995|532116707|FG008|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
147535807|NCT03426995|532116708|FG009|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
147535808|NCT03426995|532116709|FG010|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
147535809|NCT03426995|532116710|FG011|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
147535810|NCT03426995|532116711|FG012|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
147535811|NCT03426995|532116712|FG013|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
147535812|NCT03426995|532116713|FG014|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|1|||
147535813|NCT03426995|532116714|FG015|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|3|||
147535814|NCT03426995|532116715|FG016|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
147535815|NCT03426995|532116716|FG017|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
147535816|NCT03426995|532116717|FG018|Part C: Cohorts 4 to 8 (Days 1 to 14)|Adverse Event|0|||
147535817|NCT04150107|532116720|FG000|Period 3 Crossover-Treatment B or A|Adverse Event|2|||
147535818|NCT04150107|532116721|FG001|Period 3 Crossover-Treatment B or A|Adverse Event|0|||
147535819|NCT04150107|532116720|FG000|Period 3 Crossover-Treatment B or A|Patient non-compliance|0|||
147535820|NCT04150107|532116721|FG001|Period 3 Crossover-Treatment B or A|Patient non-compliance|1|||
147535821|NCT04456998|532116723|FG000|Overall Study|Adverse Event|0|||
147535822|NCT04456998|532116724|FG001|Overall Study|Adverse Event|4|||
147535823|NCT04456998|532116723|FG000|Overall Study|Protocol Deviation|0|||
147535824|NCT04456998|532116724|FG001|Overall Study|Protocol Deviation|1|||
147535825|NCT04456998|532116723|FG000|Overall Study|Withdrawal by Subject|0|||
147535826|NCT04456998|532116724|FG001|Overall Study|Withdrawal by Subject|1|||
147535827|NCT00400985|532116725|FG000|Overall Study|Withdrawal by Subject|5|||
147535828|NCT00400985|532116725|FG000|Overall Study|system modification|8|||
147535829|NCT00400985|532116725|FG000|Overall Study|Death|30|||
147535830|NCT00400985|532116725|FG000|Overall Study|Lost to Follow-up|9|||
147202133|NCT01208207|530910532|FG002|Part II|Physician Decision|0|||
147535831|NCT00965562|532116726|FG000|Overall Study|Lost to Follow-up|1|||
147535832|NCT00965562|532116727|FG001|Overall Study|Lost to Follow-up|2|||
147535833|NCT00965562|532116728|FG002|Overall Study|Lost to Follow-up|3|||
147535834|NCT00965562|532116726|FG000|Overall Study|Withdrawal by Subject|2|||
147202134|NCT01208207|530910533|FG003|Part II|Physician Decision|1|||
147202135|NCT01208207|530910534|FG004|Part II|Physician Decision|0|||
147202136|NCT01208207|530910535|FG005|Part II|Physician Decision|2|||
147202137|NCT01208207|530910536|FG006|Part II|Physician Decision|0|||
147202138|NCT01208207|530910530|FG000|Part II|Protocol Violation|0|||
147202139|NCT01208207|530910531|FG001|Part II|Protocol Violation|0|||
147202140|NCT01208207|530910532|FG002|Part II|Protocol Violation|0|||
147202141|NCT01208207|530910533|FG003|Part II|Protocol Violation|1|||
147202142|NCT01208207|530910534|FG004|Part II|Protocol Violation|0|||
147202143|NCT01208207|530910535|FG005|Part II|Protocol Violation|0|||
147202144|NCT01208207|530910536|FG006|Part II|Protocol Violation|0|||
147436417|NCT00283049|531765060|FG001|Overall Study|Adverse Event|1|||
147436418|NCT00283049|531765061|FG002|Overall Study|Adverse Event|4|||
147436419|NCT00283049|531765059|FG000|Overall Study|Protocol Violation|3|||
147436420|NCT00283049|531765060|FG001|Overall Study|Protocol Violation|0|||
147436421|NCT00283049|531765061|FG002|Overall Study|Protocol Violation|3|||
147436422|NCT00283049|531765059|FG000|Overall Study|Death|1|||
147436423|NCT00283049|531765060|FG001|Overall Study|Death|1|||
147436424|NCT00283049|531765061|FG002|Overall Study|Death|1|||
147436425|NCT00283049|531765059|FG000|Overall Study|Lack of Efficacy|0|||
147436426|NCT00283049|531765060|FG001|Overall Study|Lack of Efficacy|1|||
147436427|NCT00283049|531765061|FG002|Overall Study|Lack of Efficacy|1|||
147436428|NCT00283049|531765059|FG000|Overall Study|Lost to Follow-up|4|||
147436429|NCT00283049|531765060|FG001|Overall Study|Lost to Follow-up|2|||
147436430|NCT00283049|531765061|FG002|Overall Study|Lost to Follow-up|5|||
147436431|NCT00283049|531765059|FG000|Overall Study|Withdrawal by Subject|26|||
147436432|NCT00283049|531765060|FG001|Overall Study|Withdrawal by Subject|24|||
147436433|NCT00283049|531765061|FG002|Overall Study|Withdrawal by Subject|19|||
147436434|NCT00283049|531765059|FG000|Overall Study|Discontinuation of Study|18|||
147436435|NCT00283049|531765060|FG001|Overall Study|Discontinuation of Study|16|||
147436436|NCT00283049|531765061|FG002|Overall Study|Discontinuation of Study|20|||
147436437|NCT00283049|531765059|FG000|Overall Study|No longer requires study treatment|0|||
147436438|NCT00283049|531765060|FG001|Overall Study|No longer requires study treatment|0|||
147436439|NCT00283049|531765061|FG002|Overall Study|No longer requires study treatment|1|||
147436440|NCT00884325|531765062|FG000|Overall Study|Lost to Follow-up|1|||
147436441|NCT00884325|531765063|FG001|Overall Study|Lost to Follow-up|2|||
147436442|NCT00884325|531765062|FG000|Overall Study|Lack of Efficacy|0|||
147436443|NCT00884325|531765063|FG001|Overall Study|Lack of Efficacy|1|||
147436444|NCT00884325|531765062|FG000|Overall Study|Withdrawal by Subject|1|||
147436445|NCT00884325|531765063|FG001|Overall Study|Withdrawal by Subject|1|||
147436446|NCT00884325|531765062|FG000|Overall Study|Not provided|1|||
147436447|NCT00884325|531765063|FG001|Overall Study|Not provided|0|||
147436448|NCT04439071|531765064|FG000|Overall Study|Lost to Follow-up|0|||
147436449|NCT04439071|531765065|FG001|Overall Study|Lost to Follow-up|3|||
147436450|NCT04439071|531765064|FG000|Overall Study|Withdrawal by Subject|3|||
147436451|NCT04439071|531765065|FG001|Overall Study|Withdrawal by Subject|8|||
147436452|NCT04439071|531765064|FG000|Overall Study|Death|6|||
147436453|NCT04439071|531765065|FG001|Overall Study|Death|4|||
147436454|NCT04439071|531765064|FG000|Overall Study|Other than specified|3|||
147436455|NCT04439071|531765065|FG001|Overall Study|Other than specified|3|||
147436456|NCT04439071|531765064|FG000|Overall Study|Randomized but not treated|2|||
147436457|NCT04439071|531765065|FG001|Overall Study|Randomized but not treated|0|||
147436458|NCT01446016|531765066|FG000|Overall Study|Lost to Follow-up|3|||
147436459|NCT01446016|531765066|FG000|Overall Study|Withdrawal by Subject|1|||
147436460|NCT01446016|531765066|FG000|Overall Study|Toxicity|3|||
147436461|NCT01087957|531765073|FG000|Overall Study|Death|2|||
147436462|NCT01087957|531765074|FG001|Overall Study|Death|2|||
147436463|NCT01087957|531765073|FG000|Overall Study|Lost to Follow-up|3|||
147436464|NCT01087957|531765074|FG001|Overall Study|Lost to Follow-up|4|||
147436465|NCT01087957|531765073|FG000|Overall Study|Protocol Violation|13|||
147436466|NCT01087957|531765074|FG001|Overall Study|Protocol Violation|25|||
147436467|NCT01087957|531765073|FG000|Overall Study|Withdrawal by Subject|18|||
147436468|NCT01087957|531765074|FG001|Overall Study|Withdrawal by Subject|15|||
147436469|NCT01087957|531765073|FG000|Overall Study|Physician Decision|5|||
147436470|NCT01087957|531765074|FG001|Overall Study|Physician Decision|9|||
147436471|NCT01835015|531765078|FG000|Overall Study|Adverse Event|0|||
147436472|NCT01835015|531765079|FG001|Overall Study|Adverse Event|0|||
147436473|NCT01835015|531765080|FG002|Overall Study|Adverse Event|1|||
147436474|NCT01835015|531765081|FG003|Overall Study|Adverse Event|0|||
147436475|NCT01835015|531765082|FG004|Overall Study|Adverse Event|0|||
147436476|NCT03678103|531765086|FG000|Overall Study|Withdrawn prior to completion|4|||
147436477|NCT01241552|531765088|FG000|Overall Study|Lack of Efficacy|1|||
147436478|NCT01241552|531765089|FG001|Overall Study|Lack of Efficacy|0|||
147436479|NCT01241552|531765090|FG002|Overall Study|Lack of Efficacy|0|||
147202145|NCT01208207|530910530|FG000|Part II|Technical Problems|0|||
147436480|NCT01241552|531765091|FG003|Overall Study|Lack of Efficacy|0|||
147436481|NCT01241552|531765088|FG000|Overall Study|Death|26|||
147436482|NCT01241552|531765089|FG001|Overall Study|Death|30|||
147436483|NCT01241552|531765090|FG002|Overall Study|Death|20|||
147436484|NCT01241552|531765091|FG003|Overall Study|Death|25|||
147436485|NCT01241552|531765088|FG000|Overall Study|Adverse Event|1|||
147436486|NCT01241552|531765089|FG001|Overall Study|Adverse Event|1|||
147535835|NCT00965562|532116727|FG001|Overall Study|Withdrawal by Subject|2|||
147535836|NCT00965562|532116728|FG002|Overall Study|Withdrawal by Subject|0|||
147535837|NCT05048875|532116729|FG000|Overall Study|Withdrawal by Subject|1|||
147535838|NCT05048875|532116730|FG001|Overall Study|Withdrawal by Subject|0|||
147535839|NCT05048875|532116731|FG002|Overall Study|Withdrawal by Subject|0|||
147535840|NCT05048875|532116732|FG003|Overall Study|Withdrawal by Subject|0|||
147535841|NCT05048875|532116733|FG004|Overall Study|Withdrawal by Subject|0|||
147535842|NCT05048875|532116734|FG005|Overall Study|Withdrawal by Subject|0|||
147535843|NCT05048875|532116735|FG006|Overall Study|Withdrawal by Subject|0|||
147535844|NCT05048875|532116736|FG007|Overall Study|Withdrawal by Subject|0|||
147535845|NCT05048875|532116729|FG000|Overall Study|Adverse Event|0|||
147535846|NCT05048875|532116730|FG001|Overall Study|Adverse Event|0|||
147535847|NCT05048875|532116731|FG002|Overall Study|Adverse Event|0|||
147535848|NCT05048875|532116732|FG003|Overall Study|Adverse Event|1|||
147535849|NCT05048875|532116733|FG004|Overall Study|Adverse Event|0|||
147535850|NCT05048875|532116734|FG005|Overall Study|Adverse Event|0|||
147535851|NCT05048875|532116735|FG006|Overall Study|Adverse Event|0|||
147535852|NCT05048875|532116736|FG007|Overall Study|Adverse Event|0|||
147535853|NCT05204563|532116741|FG000|Overall Study|Other than Specified|2|||
147535854|NCT05204563|532116742|FG001|Overall Study|Other than Specified|1|||
147535855|NCT05204563|532116741|FG000|Overall Study|Death|18|||
147535856|NCT05204563|532116742|FG001|Overall Study|Death|4|||
147535857|NCT05204563|532116741|FG000|Overall Study|Lost to Follow-up|6|||
147535858|NCT05204563|532116742|FG001|Overall Study|Lost to Follow-up|3|||
147535859|NCT05204563|532116741|FG000|Overall Study|Withdrawal by Subject|12|||
147535860|NCT05204563|532116742|FG001|Overall Study|Withdrawal by Subject|3|||
147535861|NCT05204563|532116741|FG000|Overall Study|Enrolled, Not Treated|1|||
147535862|NCT05204563|532116742|FG001|Overall Study|Enrolled, Not Treated|0|||
147535863|NCT04411641|532116743|FG000|DB Period|Other|7|||
147535864|NCT04411641|532116744|FG001|DB Period|Other|27|||
147535865|NCT04411641|532116745|FG002|DB Period|Other|0|||
147535866|NCT04411641|532116746|FG003|DB Period|Other|0|||
147535867|NCT04411641|532116743|FG000|DB Period|Withdrawal by Subject|67|||
147535868|NCT04411641|532116744|FG001|DB Period|Withdrawal by Subject|122|||
147535869|NCT04411641|532116745|FG002|DB Period|Withdrawal by Subject|0|||
147535870|NCT04411641|532116746|FG003|DB Period|Withdrawal by Subject|0|||
147535871|NCT04411641|532116743|FG000|DB Period|Progressive disease|76|||
147535872|NCT04411641|532116744|FG001|DB Period|Progressive disease|116|||
147535873|NCT04411641|532116745|FG002|DB Period|Progressive disease|0|||
147535874|NCT04411641|532116746|FG003|DB Period|Progressive disease|0|||
147535875|NCT04411641|532116743|FG000|DB Period|Poor compliance to protocol|1|||
147535876|NCT04411641|532116744|FG001|DB Period|Poor compliance to protocol|5|||
147535877|NCT04411641|532116745|FG002|DB Period|Poor compliance to protocol|0|||
147535878|NCT04411641|532116746|FG003|DB Period|Poor compliance to protocol|0|||
147535879|NCT04411641|532116743|FG000|DB Period|Lack of Efficacy|19|||
147535880|NCT04411641|532116744|FG001|DB Period|Lack of Efficacy|19|||
147535881|NCT04411641|532116745|FG002|DB Period|Lack of Efficacy|0|||
147535882|NCT04411641|532116746|FG003|DB Period|Lack of Efficacy|0|||
147535883|NCT04411641|532116743|FG000|DB Period|Adverse Event|13|||
147535884|NCT04411641|532116744|FG001|DB Period|Adverse Event|29|||
147535885|NCT04411641|532116745|FG002|DB Period|Adverse Event|0|||
147535886|NCT04411641|532116746|FG003|DB Period|Adverse Event|0|||
147535887|NCT04411641|532116743|FG000|DB Period|Randomized and not treated|2|||
147535888|NCT04411641|532116744|FG001|DB Period|Randomized and not treated|2|||
147535889|NCT04411641|532116745|FG002|DB Period|Randomized and not treated|0|||
147535890|NCT04411641|532116746|FG003|DB Period|Randomized and not treated|0|||
147535891|NCT04411641|532116743|FG000|OL|Withdrawal by Subject|0|||
147535892|NCT04411641|532116744|FG001|OL|Withdrawal by Subject|0|||
147535893|NCT04411641|532116745|FG002|OL|Withdrawal by Subject|6|||
147535894|NCT04411641|532116746|FG003|OL|Withdrawal by Subject|17|||
147535895|NCT04411641|532116743|FG000|OL|Progressive disease|0|||
147535896|NCT04411641|532116744|FG001|OL|Progressive disease|0|||
147535897|NCT04411641|532116745|FG002|OL|Progressive disease|1|||
147535898|NCT04411641|532116746|FG003|OL|Progressive disease|2|||
147535899|NCT04411641|532116743|FG000|OL|Poor compliance to protocol|0|||
147535900|NCT04411641|532116744|FG001|OL|Poor compliance to protocol|0|||
147535901|NCT04411641|532116745|FG002|OL|Poor compliance to protocol|1|||
147535902|NCT04411641|532116746|FG003|OL|Poor compliance to protocol|0|||
147535903|NCT04411641|532116743|FG000|OL|Adverse Event|0|||
147535904|NCT04411641|532116744|FG001|OL|Adverse Event|0|||
147535905|NCT04411641|532116745|FG002|OL|Adverse Event|1|||
147535906|NCT04411641|532116746|FG003|OL|Adverse Event|0|||
147535907|NCT04411641|532116743|FG000|OL|Other|0|||
147535908|NCT04411641|532116744|FG001|OL|Other|0|||
147535909|NCT04411641|532116745|FG002|OL|Other|0|||
147535910|NCT04411641|532116746|FG003|OL|Other|6|||
147535911|NCT04755283|532116747|FG000|Overall Study|Withdrawal by Subject|14|||
147535912|NCT04755283|532116748|FG001|Overall Study|Withdrawal by Subject|3|||
147535913|NCT04755283|532116749|FG002|Overall Study|Withdrawal by Subject|6|||
147535914|NCT04755283|532116747|FG000|Overall Study|Lost to Follow-up|0|||
147535915|NCT04755283|532116748|FG001|Overall Study|Lost to Follow-up|0|||
147535916|NCT04755283|532116749|FG002|Overall Study|Lost to Follow-up|1|||
147535917|NCT04755283|532116747|FG000|Overall Study|Death|31|||
147535918|NCT04755283|532116748|FG001|Overall Study|Death|36|||
147535919|NCT04755283|532116749|FG002|Overall Study|Death|34|||
147535920|NCT04342390|532116757|FG000|Overall Study|Lost to Follow-up|3|||
147535921|NCT04342390|532116758|FG001|Overall Study|Lost to Follow-up|0|||
147535922|NCT04410978|532116766|FG000|Overall Study|Poor compliance to protocol|2|||
147535923|NCT04410978|532116767|FG001|Overall Study|Poor compliance to protocol|4|||
147535924|NCT04410978|532116766|FG000|Overall Study|Withdrawal by Subject|64|||
147535925|NCT04410978|532116767|FG001|Overall Study|Withdrawal by Subject|66|||
147535926|NCT04410978|532116766|FG000|Overall Study|Other|6|||
147535927|NCT04410978|532116767|FG001|Overall Study|Other|7|||
147535928|NCT04410978|532116766|FG000|Overall Study|Missing study status|1|||
147535929|NCT04410978|532116767|FG001|Overall Study|Missing study status|0|||
147535930|NCT02684162|532116768|FG000|Overall Study|Physician Decision|0|||
147535931|NCT02684162|532116769|FG001|Overall Study|Physician Decision|1|||
147535932|NCT02684162|532116770|FG002|Overall Study|Physician Decision|0|||
147535933|NCT01489865|532116778|FG000|Overall Study|Progression of Disease|4|||
147535934|NCT01489865|532116779|FG001|Overall Study|Progression of Disease|2|||
147535935|NCT01489865|532116780|FG002|Overall Study|Progression of Disease|2|||
147535936|NCT01489865|532116781|FG003|Overall Study|Progression of Disease|3|||
147535937|NCT01489865|532116782|FG004|Overall Study|Progression of Disease|1|||
147535938|NCT01489865|532116783|FG005|Overall Study|Progression of Disease|6|||
147535939|NCT01489865|532116784|FG006|Overall Study|Progression of Disease|3|||
147535940|NCT01489865|532116785|FG007|Overall Study|Progression of Disease|0|||
147535941|NCT01489865|532116786|FG008|Overall Study|Progression of Disease|23|||
147535942|NCT01489865|532116778|FG000|Overall Study|Adverse Event|2|||
147535943|NCT01489865|532116779|FG001|Overall Study|Adverse Event|0|||
147535944|NCT01489865|532116780|FG002|Overall Study|Adverse Event|0|||
147535945|NCT01489865|532116781|FG003|Overall Study|Adverse Event|0|||
147535946|NCT01489865|532116782|FG004|Overall Study|Adverse Event|1|||
147535947|NCT01489865|532116783|FG005|Overall Study|Adverse Event|0|||
147535948|NCT01489865|532116784|FG006|Overall Study|Adverse Event|2|||
147535949|NCT01489865|532116785|FG007|Overall Study|Adverse Event|0|||
147535950|NCT01489865|532116786|FG008|Overall Study|Adverse Event|5|||
147535951|NCT01489865|532116778|FG000|Overall Study|Death|0|||
147436487|NCT01241552|531765090|FG002|Overall Study|Adverse Event|0|||
147436488|NCT01241552|531765091|FG003|Overall Study|Adverse Event|0|||
147436489|NCT01241552|531765088|FG000|Overall Study|Technical Problems|2|||
147436490|NCT01241552|531765089|FG001|Overall Study|Technical Problems|0|||
147436491|NCT01241552|531765090|FG002|Overall Study|Technical Problems|2|||
147436492|NCT01241552|531765091|FG003|Overall Study|Technical Problems|2|||
147436493|NCT01241552|531765088|FG000|Overall Study|Progressive Disease|0|||
147436494|NCT01241552|531765089|FG001|Overall Study|Progressive Disease|0|||
147436495|NCT01241552|531765090|FG002|Overall Study|Progressive Disease|1|||
147436496|NCT01241552|531765091|FG003|Overall Study|Progressive Disease|2|||
147436497|NCT01241552|531765088|FG000|Overall Study|Protocol Violation|0|||
147535952|NCT01489865|532116779|FG001|Overall Study|Death|1|||
147535953|NCT01489865|532116780|FG002|Overall Study|Death|0|||
147535954|NCT01489865|532116781|FG003|Overall Study|Death|0|||
147535955|NCT01489865|532116782|FG004|Overall Study|Death|1|||
147535956|NCT01489865|532116783|FG005|Overall Study|Death|0|||
147535957|NCT01489865|532116784|FG006|Overall Study|Death|0|||
147535958|NCT01489865|532116785|FG007|Overall Study|Death|0|||
147535959|NCT01489865|532116786|FG008|Overall Study|Death|2|||
147535960|NCT01489865|532116778|FG000|Overall Study|Withdrawal by Subject|0|||
147535961|NCT01489865|532116779|FG001|Overall Study|Withdrawal by Subject|0|||
147535962|NCT01489865|532116780|FG002|Overall Study|Withdrawal by Subject|0|||
147535963|NCT01489865|532116781|FG003|Overall Study|Withdrawal by Subject|0|||
147535964|NCT01489865|532116782|FG004|Overall Study|Withdrawal by Subject|0|||
147535965|NCT01489865|532116783|FG005|Overall Study|Withdrawal by Subject|1|||
147535966|NCT01489865|532116784|FG006|Overall Study|Withdrawal by Subject|1|||
147535967|NCT01489865|532116785|FG007|Overall Study|Withdrawal by Subject|0|||
147535968|NCT01489865|532116786|FG008|Overall Study|Withdrawal by Subject|2|||
147535969|NCT01489865|532116778|FG000|Overall Study|Shifted|0|||
147535970|NCT01489865|532116779|FG001|Overall Study|Shifted|0|||
147535971|NCT01489865|532116780|FG002|Overall Study|Shifted|1|||
147535972|NCT01489865|532116781|FG003|Overall Study|Shifted|0|||
147535973|NCT01489865|532116782|FG004|Overall Study|Shifted|0|||
147535974|NCT01489865|532116783|FG005|Overall Study|Shifted|0|||
147535975|NCT01489865|532116784|FG006|Overall Study|Shifted|0|||
147535976|NCT01489865|532116785|FG007|Overall Study|Shifted|0|||
147535977|NCT01489865|532116786|FG008|Overall Study|Shifted|0|||
147535978|NCT01593761|532116787|FG000|Overall Study|Lost to Follow-up|1|||
147535979|NCT01593761|532116787|FG000|Overall Study|culture negative for MRSA at baseline|5|||
147535980|NCT01593761|532116787|FG000|Overall Study|positive for hepatitis C virus|1|||
147535981|NCT01593761|532116787|FG000|Overall Study|secondary cellulitis|1|||
147535982|NCT00795886|532116788|FG000|Overall Study|Death|10|||
147535983|NCT05554471|532116789|FG000|Overall Study|Physician Decision|2|||
147535984|NCT05554471|532116790|FG001|Overall Study|Physician Decision|1|||
147535985|NCT05554471|532116789|FG000|Overall Study|Lost to Follow-up|2|||
147535986|NCT05554471|532116790|FG001|Overall Study|Lost to Follow-up|1|||
147535987|NCT05554471|532116789|FG000|Overall Study|Death|0|||
147202146|NCT01208207|530910531|FG001|Part II|Technical Problems|0|||
147202147|NCT01208207|530910532|FG002|Part II|Technical Problems|0|||
147535988|NCT05554471|532116790|FG001|Overall Study|Death|1|||
147535989|NCT02576951|532116792|FG000|Overall Study|Lost to Follow-up|0|||
147535990|NCT02576951|532116793|FG001|Overall Study|Lost to Follow-up|0|||
147649415|NCT02634801|532537341|FG000|Treatment Period (Weeks 0 to 24)|Lack of Efficacy|0|||
147649416|NCT02634801|532537342|FG001|Treatment Period (Weeks 0 to 24)|Lack of Efficacy|2|||
147202148|NCT01208207|530910533|FG003|Part II|Technical Problems|1|||
147535991|NCT02576951|532116794|FG002|Overall Study|Lost to Follow-up|2|||
147535992|NCT02576951|532116795|FG003|Overall Study|Lost to Follow-up|2|||
147535993|NCT02576951|532116792|FG000|Overall Study|Withdrawal by Subject|1|||
147535994|NCT02576951|532116793|FG001|Overall Study|Withdrawal by Subject|0|||
147535995|NCT02576951|532116794|FG002|Overall Study|Withdrawal by Subject|0|||
147535996|NCT02576951|532116795|FG003|Overall Study|Withdrawal by Subject|2|||
147535997|NCT02576951|532116792|FG000|Overall Study|Protocol Violation|0|||
147436498|NCT01241552|531765089|FG001|Overall Study|Protocol Violation|2|||
147436499|NCT01241552|531765090|FG002|Overall Study|Protocol Violation|6|||
147436500|NCT01241552|531765091|FG003|Overall Study|Protocol Violation|1|||
147436501|NCT01241552|531765088|FG000|Overall Study|Withdrawal by Subject|7|||
147436502|NCT01241552|531765089|FG001|Overall Study|Withdrawal by Subject|15|||
147436503|NCT01241552|531765090|FG002|Overall Study|Withdrawal by Subject|14|||
147436504|NCT01241552|531765091|FG003|Overall Study|Withdrawal by Subject|15|||
147436505|NCT01241552|531765088|FG000|Overall Study|Physician Decision|2|||
147436506|NCT01241552|531765089|FG001|Overall Study|Physician Decision|4|||
147436507|NCT01241552|531765090|FG002|Overall Study|Physician Decision|2|||
147436508|NCT01241552|531765091|FG003|Overall Study|Physician Decision|3|||
147436509|NCT01241552|531765088|FG000|Overall Study|Lost to Follow-up|2|||
147436510|NCT01241552|531765089|FG001|Overall Study|Lost to Follow-up|11|||
147436511|NCT01241552|531765090|FG002|Overall Study|Lost to Follow-up|15|||
147436512|NCT01241552|531765091|FG003|Overall Study|Lost to Follow-up|16|||
147436513|NCT02606461|531765092|FG000|Period 1: Double-blinded Period|Randomized but no treatment|0|||
147436514|NCT02606461|531765093|FG001|Period 1: Double-blinded Period|Randomized but no treatment|0|||
147436515|NCT02606461|531765094|FG002|Period 1: Double-blinded Period|Randomized but no treatment|1|||
147436516|NCT02606461|531765095|FG003|Period 1: Double-blinded Period|Randomized but no treatment|0|||
147436517|NCT02606461|531765096|FG004|Period 1: Double-blinded Period|Randomized but no treatment|0|||
147436518|NCT02606461|531765097|FG005|Period 1: Double-blinded Period|Randomized but no treatment|0|||
147436519|NCT02092350|531765098|FG000|Overall Study|Adverse Event|0|||
147436520|NCT02092350|531765099|FG001|Overall Study|Adverse Event|3|||
147436521|NCT02092350|531765098|FG000|Overall Study|Death|2|||
147436522|NCT02092350|531765099|FG001|Overall Study|Death|5|||
147436523|NCT02092350|531765098|FG000|Overall Study|Lost to Follow-up|3|||
147436524|NCT02092350|531765099|FG001|Overall Study|Lost to Follow-up|1|||
147436525|NCT02092350|531765098|FG000|Overall Study|Protocol Violation|1|||
147436526|NCT02092350|531765099|FG001|Overall Study|Protocol Violation|0|||
147436527|NCT02092350|531765098|FG000|Overall Study|Physician Decision|1|||
147436528|NCT02092350|531765099|FG001|Overall Study|Physician Decision|1|||
147436529|NCT02092350|531765098|FG000|Overall Study|Screen Failure|1|||
147436530|NCT02092350|531765099|FG001|Overall Study|Screen Failure|0|||
147436531|NCT02092350|531765098|FG000|Overall Study|Withdrawal by Subject|2|||
147436532|NCT02092350|531765099|FG001|Overall Study|Withdrawal by Subject|2|||
147436533|NCT00024167|531765100|FG000|Overall Study|Death|53|||
147436534|NCT00024167|531765101|FG001|Overall Study|Death|47|||
147436535|NCT00770770|531765117|FG000|Overall Study|Lost to Follow-up|1|||
147436536|NCT00770770|531765118|FG001|Overall Study|Lost to Follow-up|0|||
147436537|NCT00770770|531765117|FG000|Overall Study|Withdrawal by Subject|1|||
147436538|NCT00770770|531765118|FG001|Overall Study|Withdrawal by Subject|0|||
147436539|NCT00770770|531765117|FG000|Overall Study|Death|0|||
147436540|NCT00770770|531765118|FG001|Overall Study|Death|1|||
147436541|NCT00770770|531765117|FG000|Overall Study|Study Terminated|8|||
147436542|NCT00770770|531765118|FG001|Overall Study|Study Terminated|0|||
147436543|NCT00117507|531765120|FG000|Overall Study|Adverse Event|4|||
147436544|NCT00117507|531765120|FG000|Overall Study|Abnormal laboratory values|3|||
147436545|NCT00117507|531765120|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
147436546|NCT00117507|531765120|FG000|Overall Study|Patient withdrew consent|4|||
147436547|NCT00117507|531765120|FG000|Overall Study|Death|3|||
147436548|NCT00800436|531765121|FG000|Overall Study|Withdrawal by Subject|0|||
147436549|NCT00800436|531765122|FG001|Overall Study|Withdrawal by Subject|0|||
147436550|NCT00800436|531765123|FG002|Overall Study|Withdrawal by Subject|1|||
147436551|NCT00800436|531765124|FG003|Overall Study|Withdrawal by Subject|1|||
147436552|NCT00800436|531765125|FG004|Overall Study|Withdrawal by Subject|0|||
147436553|NCT00800436|531765126|FG005|Overall Study|Withdrawal by Subject|0|||
147436554|NCT00800436|531765127|FG006|Overall Study|Withdrawal by Subject|0|||
147436555|NCT00711529|531765134|FG000|Overall Study|Protocol Violation|2|||
147436556|NCT00711529|531765135|FG001|Overall Study|Protocol Violation|0|||
147436557|NCT00711529|531765134|FG000|Overall Study|Withdrawal by Subject|2|||
147436558|NCT00711529|531765135|FG001|Overall Study|Withdrawal by Subject|6|||
147436559|NCT03740997|531765138|FG000|Overall Study|Withdrawal by Subject|1|||
147436560|NCT03740997|531765139|FG001|Overall Study|Withdrawal by Subject|0|||
147436561|NCT03740997|531765138|FG000|Overall Study|Participant was unable to complete study procedures|1|||
147436562|NCT03740997|531765139|FG001|Overall Study|Participant was unable to complete study procedures|0|||
147436563|NCT03681951|531765143|FG000|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|1|||
147436564|NCT03681951|531765144|FG001|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
147436565|NCT03681951|531765145|FG002|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
147436566|NCT03681951|531765146|FG003|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
147436567|NCT03681951|531765147|FG004|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
147436568|NCT03681951|531765148|FG005|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
147436569|NCT03681951|531765149|FG006|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
147436570|NCT03681951|531765150|FG007|Part1: Monotherapy DE (Up to Day 95)|Lost to Follow-up|0|||
147202149|NCT01208207|530910534|FG004|Part II|Technical Problems|0|||
147202150|NCT01208207|530910535|FG005|Part II|Technical Problems|1|||
147202151|NCT01208207|530910536|FG006|Part II|Technical Problems|0|||
147202152|NCT02161016|530910539|FG000|Overall Study|withdrawn by IRB|1|||
147436571|NCT03681951|531765143|FG000|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|4|||
147436572|NCT03681951|531765144|FG001|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
147436573|NCT03681951|531765145|FG002|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
147436574|NCT03681951|531765146|FG003|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
147436575|NCT03681951|531765147|FG004|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
147436576|NCT03681951|531765148|FG005|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
147436577|NCT03681951|531765149|FG006|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
147436578|NCT03681951|531765150|FG007|Part1: Monotherapy DE (Up to Day 95)|Physician Decision|0|||
147436579|NCT03681951|531765143|FG000|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|3|||
147436580|NCT03681951|531765144|FG001|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
147436581|NCT03681951|531765145|FG002|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
147436582|NCT03681951|531765146|FG003|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
147436583|NCT03681951|531765147|FG004|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
147436584|NCT03681951|531765148|FG005|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
147436585|NCT03681951|531765149|FG006|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
147436586|NCT03681951|531765150|FG007|Part1: Monotherapy DE (Up to Day 95)|Withdrawal by Subject|0|||
147436587|NCT02187809|531765151|FG000|Overall Study|The study was terminated|3|||
147436588|NCT01020448|531765152|FG000|Pre-assignment|Adverse Event|6|||
147436589|NCT01020448|531765152|FG000|Pre-assignment|Withdrawal by Subject|5|||
147436590|NCT01020448|531765152|FG000|Pre-assignment|Does Not Meet Entry Criteria|2|||
147436591|NCT01020448|531765152|FG000|Treatment|Adverse Event|11|||
147436592|NCT01020448|531765152|FG000|Treatment|Consent Withdrawn|3|||
147436593|NCT01020448|531765152|FG000|Treatment|Disease Progression|2|||
147436594|NCT01020448|531765152|FG000|Treatment|Lack of Efficacy|8|||
147436595|NCT01020448|531765152|FG000|Treatment|Lost to Follow-up|2|||
147436596|NCT00601705|531765153|FG000|Overall Study|Withdrawal by Subject|1|||
147436597|NCT02146599|531765157|FG000|Overall Study|Failed to meet inclusion criteria|5|||
147436598|NCT02101021|531765161|FG000|Overall Study|Death|4|||
147436599|NCT02101021|531765162|FG001|Overall Study|Death|3|||
147436600|NCT02101021|531765163|FG002|Overall Study|Death|6|||
147436601|NCT02101021|531765164|FG003|Overall Study|Death|0|||
147436602|NCT02101021|531765165|FG004|Overall Study|Death|3|||
147436603|NCT02101021|531765161|FG000|Overall Study|Withdrew Consent from study|1|||
147436604|NCT02101021|531765162|FG001|Overall Study|Withdrew Consent from study|1|||
147436605|NCT02101021|531765163|FG002|Overall Study|Withdrew Consent from study|0|||
147436606|NCT02101021|531765164|FG003|Overall Study|Withdrew Consent from study|2|||
147436607|NCT02101021|531765165|FG004|Overall Study|Withdrew Consent from study|0|||
147436608|NCT02101021|531765161|FG000|Overall Study|Lost to Follow-up|1|||
147436609|NCT02101021|531765162|FG001|Overall Study|Lost to Follow-up|0|||
147436610|NCT02101021|531765163|FG002|Overall Study|Lost to Follow-up|0|||
147436611|NCT02101021|531765164|FG003|Overall Study|Lost to Follow-up|0|||
147436612|NCT02101021|531765165|FG004|Overall Study|Lost to Follow-up|0|||
147436613|NCT02101021|531765161|FG000|Overall Study|Study Terminated by Sponsor|1|||
147436614|NCT02101021|531765162|FG001|Overall Study|Study Terminated by Sponsor|0|||
147436615|NCT02101021|531765163|FG002|Overall Study|Study Terminated by Sponsor|1|||
147436616|NCT02101021|531765164|FG003|Overall Study|Study Terminated by Sponsor|1|||
147436617|NCT02101021|531765165|FG004|Overall Study|Study Terminated by Sponsor|1|||
147436618|NCT00387764|531765166|FG000|Overall Study|Adverse Event|12|||
147436619|NCT00387764|531765166|FG000|Overall Study|Withdrawal by Subject|8|||
147436620|NCT00387764|531765166|FG000|Overall Study|Sponsor Terminated Study|1|||
147436621|NCT00387764|531765166|FG000|Overall Study|Physician Decision|1|||
147436622|NCT00387764|531765166|FG000|Overall Study|Other|2|||
147436623|NCT00387764|531765166|FG000|Overall Study|Death|7|||
147436624|NCT04399122|531765167|FG000|Overall Study|Lost to Follow-up|2|||
147436625|NCT04399122|531765168|FG001|Overall Study|Lost to Follow-up|0|||
147436626|NCT04399122|531765167|FG000|Overall Study|Withdrawal by Subject|1|||
147436627|NCT04399122|531765168|FG001|Overall Study|Withdrawal by Subject|0|||
147436628|NCT02536755|531765173|FG000|Overall Study|Adverse Event|4|||
147436629|NCT01174238|531765174|FG000|Overall Study|Lost to Follow-up|2|||
147436630|NCT02301936|531765175|FG000|Overall Study|Lost to Follow-up|1|||
147436631|NCT02301936|531765176|FG001|Overall Study|Lost to Follow-up|0|||
147436632|NCT02322229|531765178|FG000|Overall Study|Physician Decision|2|||
147436633|NCT00705432|531765179|FG000|Treatment Period|Adverse Event|45|||
147436634|NCT00705432|531765180|FG001|Treatment Period|Adverse Event|37|||
147436635|NCT00705432|531765181|FG002|Treatment Period|Adverse Event|51|||
147202153|NCT00380367|530910555|FG000|Overall Study|Lost to Follow-up|1|||
147436636|NCT00705432|531765182|FG003|Treatment Period|Adverse Event|12|||
147436637|NCT00705432|531765183|FG004|Treatment Period|Adverse Event|8|||
147436638|NCT00705432|531765184|FG005|Treatment Period|Adverse Event|9|||
147436639|NCT00705432|531765179|FG000|Treatment Period|Treatment failure|92|||
147202154|NCT00380367|530910555|FG000|Overall Study|Withdrawal by Subject|1|||
147535998|NCT02576951|532116793|FG001|Overall Study|Protocol Violation|0|||
147535999|NCT02576951|532116794|FG002|Overall Study|Protocol Violation|0|||
147536000|NCT02576951|532116795|FG003|Overall Study|Protocol Violation|1|||
147536001|NCT00157820|532116801|FG000|Randomized|Physician Decision|4|||
147536002|NCT00157820|532116802|FG001|Randomized|Physician Decision|2|||
147536003|NCT00157820|532116803|FG002|Randomized|Physician Decision|3|||
147536004|NCT00157820|532116801|FG000|Randomized|Withdrawal by Subject|1|||
147536005|NCT00157820|532116802|FG001|Randomized|Withdrawal by Subject|2|||
147536006|NCT00157820|532116803|FG002|Randomized|Withdrawal by Subject|3|||
147536007|NCT00157820|532116801|FG000|Randomized|Protocol Violation|2|||
147536008|NCT00157820|532116802|FG001|Randomized|Protocol Violation|1|||
147536009|NCT00157820|532116803|FG002|Randomized|Protocol Violation|2|||
147536010|NCT00157820|532116801|FG000|1st 8 Month|Death|7|||
147536011|NCT00157820|532116802|FG001|1st 8 Month|Death|8|||
147536012|NCT00157820|532116803|FG002|1st 8 Month|Death|3|||
147536013|NCT00157820|532116801|FG000|1st 8 Month|Lost to Follow-up|1|||
147536014|NCT00157820|532116802|FG001|1st 8 Month|Lost to Follow-up|2|||
147536015|NCT00157820|532116803|FG002|1st 8 Month|Lost to Follow-up|1|||
147202155|NCT01605799|530910556|FG000|Overall Study|Withdrawal by Subject|2|||
147202156|NCT01605799|530910557|FG001|Overall Study|Withdrawal by Subject|1|||
147202157|NCT00830440|530910568|FG000|Overall Study|Protocol Violation|1|||
147202158|NCT00830440|530910569|FG001|Overall Study|Protocol Violation|0|||
147202159|NCT00830440|530910568|FG000|Overall Study|Withdrawal by Subject|1|||
147202160|NCT00830440|530910569|FG001|Overall Study|Withdrawal by Subject|0|||
147202161|NCT00830440|530910568|FG000|Overall Study|unsuccessful procedure|4|||
147202162|NCT00830440|530910569|FG001|Overall Study|unsuccessful procedure|0|||
147202163|NCT00830440|530910568|FG000|Overall Study|Adverse Event|2|||
147202164|NCT00830440|530910569|FG001|Overall Study|Adverse Event|0|||
147202165|NCT02592798|530910570|FG000|Double-Blind Period 1 (DB1)|Pregnancy|1|||
147202166|NCT02592798|530910571|FG001|Double-Blind Period 1 (DB1)|Pregnancy|0|||
147202167|NCT02592798|530910570|FG000|Double-Blind Period 1 (DB1)|No longer meeting study criteria|0|||
147202168|NCT02592798|530910571|FG001|Double-Blind Period 1 (DB1)|No longer meeting study criteria|1|||
147202169|NCT02592798|530910570|FG000|Double-Blind Period 1 (DB1)|Lack of Efficacy|1|||
147202170|NCT02592798|530910571|FG001|Double-Blind Period 1 (DB1)|Lack of Efficacy|3|||
147202171|NCT02592798|530910570|FG000|Double-Blind Period 1 (DB1)|Adverse Event|1|||
147202172|NCT02592798|530910571|FG001|Double-Blind Period 1 (DB1)|Adverse Event|2|||
147202173|NCT02592798|530910570|FG000|Transition From DB1 to DB2|Skipped DB2 and moved into subsequent OLE|3|||
147202174|NCT02592798|530910571|FG001|Transition From DB1 to DB2|Skipped DB2 and moved into subsequent OLE|2|||
147202175|NCT02592798|530910570|FG000|Double-Blind Period 2 (DB2)|Other reasons|1|||
147202176|NCT02592798|530910571|FG001|Double-Blind Period 2 (DB2)|Other reasons|0|||
147202177|NCT02592798|530910570|FG000|Double-Blind Period 2 (DB2)|Participant request to discontinue|1|||
147202178|NCT02592798|530910571|FG001|Double-Blind Period 2 (DB2)|Participant request to discontinue|0|||
147202179|NCT02592798|530910570|FG000|Double-Blind Period 2 (DB2)|No longer meeting study criteria|1|||
147202180|NCT02592798|530910571|FG001|Double-Blind Period 2 (DB2)|No longer meeting study criteria|0|||
147202181|NCT02592798|530910570|FG000|Double-Blind Period 2 (DB2)|Lack of Efficacy|1|||
147202182|NCT02592798|530910571|FG001|Double-Blind Period 2 (DB2)|Lack of Efficacy|2|||
147202183|NCT02592798|530910570|FG000|Double-Blind Period 2 (DB2)|Adverse Event|1|||
147202184|NCT02592798|530910571|FG001|Double-Blind Period 2 (DB2)|Adverse Event|0|||
147202185|NCT02592798|530910570|FG000|Transition From DB2 to OLE|Other reasons|1|||
147202186|NCT02592798|530910571|FG001|Transition From DB2 to OLE|Other reasons|0|||
147202187|NCT02592798|530910570|FG000|Open Label Period (OLE)|Other reasons|0|||
147202188|NCT02592798|530910571|FG001|Open Label Period (OLE)|Other reasons|2|||
147202189|NCT02592798|530910570|FG000|Open Label Period (OLE)|Participant request to discontinue|1|||
147202190|NCT02592798|530910571|FG001|Open Label Period (OLE)|Participant request to discontinue|0|||
147202191|NCT02592798|530910570|FG000|Open Label Period (OLE)|Lost to Follow-up|0|||
147202192|NCT02592798|530910571|FG001|Open Label Period (OLE)|Lost to Follow-up|1|||
147202193|NCT02592798|530910570|FG000|Open Label Period (OLE)|Lack of Efficacy|3|||
147202194|NCT02592798|530910571|FG001|Open Label Period (OLE)|Lack of Efficacy|5|||
147202195|NCT02592798|530910570|FG000|Open Label Period (OLE)|Adverse Event|0|||
147202196|NCT02592798|530910571|FG001|Open Label Period (OLE)|Adverse Event|1|||
147536016|NCT00157820|532116801|FG000|1st 8 Month|Premature cross-over|0|||
147536017|NCT00157820|532116802|FG001|1st 8 Month|Premature cross-over|2|||
147536018|NCT00157820|532116803|FG002|1st 8 Month|Premature cross-over|2|||
147536019|NCT00157820|532116801|FG000|2nd 8 Months|Death|3|||
147536020|NCT00157820|532116802|FG001|2nd 8 Months|Death|1|||
147536021|NCT00157820|532116803|FG002|2nd 8 Months|Death|3|||
147649417|NCT02634801|532537343|FG002|Treatment Period (Weeks 0 to 24)|Lack of Efficacy|0|||
147202197|NCT00942604|530910572|FG000|Overall Study|Protocol Violation|1|||
147202198|NCT00942604|530910573|FG001|Overall Study|Protocol Violation|1|||
147202199|NCT00942604|530910572|FG000|Overall Study|Adverse Event|0|||
147202200|NCT00942604|530910573|FG001|Overall Study|Adverse Event|1|||
147202201|NCT00942604|530910572|FG000|Overall Study|Withdrawal by Subject|0|||
147536022|NCT00157820|532116801|FG000|2nd 8 Months|Lost to Follow-up|1|||
147536023|NCT00157820|532116802|FG001|2nd 8 Months|Lost to Follow-up|5|||
147536024|NCT00157820|532116803|FG002|2nd 8 Months|Lost to Follow-up|2|||
147536025|NCT00157820|532116801|FG000|2nd 8 Months|Premature cross-over|1|||
147536026|NCT00157820|532116802|FG001|2nd 8 Months|Premature cross-over|7|||
147306806|NCT01852058|531290775|FG002|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
147436640|NCT00705432|531765180|FG001|Treatment Period|Treatment failure|42|||
147436641|NCT00705432|531765181|FG002|Treatment Period|Treatment failure|33|||
147436642|NCT00705432|531765182|FG003|Treatment Period|Treatment failure|25|||
147436643|NCT00705432|531765183|FG004|Treatment Period|Treatment failure|13|||
147436644|NCT00705432|531765184|FG005|Treatment Period|Treatment failure|14|||
147436645|NCT00705432|531765179|FG000|Treatment Period|Non medical reason|26|||
147436646|NCT00705432|531765180|FG001|Treatment Period|Non medical reason|32|||
147436647|NCT00705432|531765181|FG002|Treatment Period|Non medical reason|37|||
147436648|NCT00705432|531765182|FG003|Treatment Period|Non medical reason|4|||
147436649|NCT00705432|531765183|FG004|Treatment Period|Non medical reason|7|||
147436650|NCT00705432|531765184|FG005|Treatment Period|Non medical reason|7|||
147436651|NCT00705432|531765179|FG000|Follow-up Period (Upto Week 72)|Adverse Event|2|||
147436652|NCT00705432|531765180|FG001|Follow-up Period (Upto Week 72)|Adverse Event|1|||
147436653|NCT00705432|531765181|FG002|Follow-up Period (Upto Week 72)|Adverse Event|1|||
147436654|NCT00705432|531765182|FG003|Follow-up Period (Upto Week 72)|Adverse Event|0|||
147436655|NCT00705432|531765183|FG004|Follow-up Period (Upto Week 72)|Adverse Event|0|||
147436656|NCT00705432|531765184|FG005|Follow-up Period (Upto Week 72)|Adverse Event|0|||
147436657|NCT00705432|531765179|FG000|Follow-up Period (Upto Week 72)|Non medical reason|69|||
147436658|NCT00705432|531765180|FG001|Follow-up Period (Upto Week 72)|Non medical reason|42|||
147436659|NCT00705432|531765181|FG002|Follow-up Period (Upto Week 72)|Non medical reason|24|||
147436660|NCT00705432|531765182|FG003|Follow-up Period (Upto Week 72)|Non medical reason|14|||
147436661|NCT00705432|531765183|FG004|Follow-up Period (Upto Week 72)|Non medical reason|6|||
147436662|NCT00705432|531765184|FG005|Follow-up Period (Upto Week 72)|Non medical reason|7|||
147436663|NCT01102803|531765185|FG000|Baseline to Post-Treatment|Lost to Follow-up|3|||
147436664|NCT01102803|531765186|FG001|Baseline to Post-Treatment|Lost to Follow-up|0|||
147436665|NCT01102803|531765185|FG000|Post to Follow-Up|Lost to Follow-up|1|||
147436666|NCT01102803|531765186|FG001|Post to Follow-Up|Lost to Follow-up|3|||
147436667|NCT00521053|531765187|FG000|Observation Phase|Disease Progression|55|||
147436668|NCT00521053|531765187|FG000|Observation Phase|Additional PV-10 via alternate protocol|8|||
147436669|NCT00521053|531765187|FG000|Observation Phase|Death|2|||
147436670|NCT00521053|531765187|FG000|Observation Phase|Adverse Event|1|||
147436671|NCT00521053|531765187|FG000|Observation Phase|Other non-study melanoma treatment|1|||
147436672|NCT00521053|531765187|FG000|Observation Phase|Physician Decision|1|||
147436673|NCT02281357|531765190|FG000|Overall Study|Adverse Event|2|||
147436674|NCT02281357|531765191|FG001|Overall Study|Adverse Event|1|||
147436675|NCT02281357|531765190|FG000|Overall Study|Lost to Follow-up|1|||
147436676|NCT02281357|531765191|FG001|Overall Study|Lost to Follow-up|0|||
147436677|NCT02281357|531765190|FG000|Overall Study|Withdrawal by Subject|4|||
147436678|NCT02281357|531765191|FG001|Overall Study|Withdrawal by Subject|3|||
147436679|NCT02684279|531765192|FG000|Overall Study|Adverse Event|87|||
147436680|NCT02684279|531765192|FG000|Overall Study|Lack of Efficacy|4|||
147436681|NCT02684279|531765192|FG000|Overall Study|Lost to Follow-up|61|||
147436682|NCT02684279|531765192|FG000|Overall Study|Protocol Violation|6|||
147436683|NCT02684279|531765192|FG000|Overall Study|Pregnancy|8|||
147436684|NCT02684279|531765192|FG000|Overall Study|Withdrawal by Subject|92|||
147436685|NCT02684279|531765192|FG000|Overall Study|non-compliance with study drug|9|||
147436686|NCT02684279|531765192|FG000|Overall Study|non compliance with study visits|2|||
147436687|NCT02684279|531765192|FG000|Overall Study|subject to have surgery|1|||
147436688|NCT02684279|531765192|FG000|Overall Study|family emergency|1|||
147436689|NCT02684279|531765192|FG000|Overall Study|Site closures|7|||
147436690|NCT02684279|531765192|FG000|Overall Study|Physician Decision|1|||
147436691|NCT01162239|531765193|FG000|Treatment Phase|Withdrawal by Subject|1|||
147436692|NCT01162239|531765194|FG001|Treatment Phase|Withdrawal by Subject|3|||
147436693|NCT01162239|531765195|FG002|Treatment Phase|Withdrawal by Subject|2|||
147436694|NCT01162239|531765196|FG003|Treatment Phase|Withdrawal by Subject|3|||
147436695|NCT01162239|531765193|FG000|Treatment Phase|Death|0|||
147436696|NCT01162239|531765194|FG001|Treatment Phase|Death|0|||
147436697|NCT01162239|531765195|FG002|Treatment Phase|Death|0|||
147436698|NCT01162239|531765196|FG003|Treatment Phase|Death|1|||
147436699|NCT01162239|531765193|FG000|Treatment Phase|Lost to Follow-up|5|||
147436700|NCT01162239|531765194|FG001|Treatment Phase|Lost to Follow-up|4|||
147436701|NCT01162239|531765195|FG002|Treatment Phase|Lost to Follow-up|2|||
147536027|NCT00157820|532116803|FG002|2nd 8 Months|Premature cross-over|9|||
147436702|NCT01162239|531765196|FG003|Treatment Phase|Lost to Follow-up|1|||
147436703|NCT01162239|531765193|FG000|Extended Follow-up|Lost to Follow-up|8|||
147436704|NCT01162239|531765194|FG001|Extended Follow-up|Lost to Follow-up|13|||
147436705|NCT01162239|531765195|FG002|Extended Follow-up|Lost to Follow-up|8|||
147436706|NCT01162239|531765196|FG003|Extended Follow-up|Lost to Follow-up|6|||
147436707|NCT04448756|531765199|FG000|Overall Study|Adverse Event|0|||
147436708|NCT04448756|531765200|FG001|Overall Study|Adverse Event|1|||
147436709|NCT04448756|531765201|FG002|Overall Study|Adverse Event|0|||
147436710|NCT04448756|531765199|FG000|Overall Study|Participant unable to attend Day 60 visit|1|||
147536028|NCT03457727|532118216|FG000|Part 2, Washout Period 1 (5 Days)|Adverse Event|0|||
147536029|NCT03457727|532118217|FG001|Part 2, Washout Period 1 (5 Days)|Adverse Event|0|||
147536030|NCT03457727|532118218|FG002|Part 2, Washout Period 1 (5 Days)|Adverse Event|0|||
147536031|NCT03457727|532118219|FG003|Part 2, Washout Period 1 (5 Days)|Adverse Event|1|||
147536032|NCT00242567|532118220|FG000|Overall Study|Adverse Event|70|||
147536033|NCT00242567|532118221|FG001|Overall Study|Adverse Event|43|||
147536034|NCT00242567|532118220|FG000|Overall Study|Disease Progression|17|||
147536035|NCT00242567|532118221|FG001|Overall Study|Disease Progression|22|||
147536036|NCT00242567|532118220|FG000|Overall Study|Symptomatic deterioration|9|||
147536037|NCT00242567|532118221|FG001|Overall Study|Symptomatic deterioration|3|||
147536038|NCT00242567|532118220|FG000|Overall Study|Lack of Efficacy|2|||
147536039|NCT00242567|532118221|FG001|Overall Study|Lack of Efficacy|2|||
147536040|NCT00242567|532118220|FG000|Overall Study|Lost to Follow-up|9|||
147536041|NCT00242567|532118221|FG001|Overall Study|Lost to Follow-up|19|||
147536042|NCT00242567|532118220|FG000|Overall Study|Withdrawal by Subject|33|||
147536043|NCT00242567|532118221|FG001|Overall Study|Withdrawal by Subject|28|||
147536044|NCT00242567|532118220|FG000|Overall Study|Protocol Violation|12|||
147536045|NCT00242567|532118221|FG001|Overall Study|Protocol Violation|12|||
147536046|NCT00242567|532118220|FG000|Overall Study|Use of an inhibitor of bone resorption|0|||
147536047|NCT00242567|532118221|FG001|Overall Study|Use of an inhibitor of bone resorption|2|||
147536048|NCT00242567|532118220|FG000|Overall Study|Other|14|||
147536049|NCT00242567|532118221|FG001|Overall Study|Other|9|||
147536050|NCT00464308|532118222|FG000|Overall Study|Adverse Event|22|||
147536051|NCT00464308|532118223|FG001|Overall Study|Adverse Event|27|||
147536052|NCT00464308|532118224|FG002|Overall Study|Adverse Event|16|||
147536053|NCT00464308|532118222|FG000|Overall Study|Lost to Follow-up|29|||
147536054|NCT00464308|532118223|FG001|Overall Study|Lost to Follow-up|19|||
147536055|NCT00464308|532118224|FG002|Overall Study|Lost to Follow-up|20|||
147536056|NCT00464308|532118222|FG000|Overall Study|Patient discontinued and other reasons|17|||
147536057|NCT00464308|532118223|FG001|Overall Study|Patient discontinued and other reasons|17|||
147536058|NCT00464308|532118224|FG002|Overall Study|Patient discontinued and other reasons|23|||
147536059|NCT00464308|532118222|FG000|Overall Study|Physician Decision|1|||
147536060|NCT00464308|532118223|FG001|Overall Study|Physician Decision|0|||
147536061|NCT00464308|532118224|FG002|Overall Study|Physician Decision|0|||
147536062|NCT01721200|532118225|FG000|Overall Study|Lost to Follow-up|3|||
147536063|NCT01721200|532118226|FG001|Overall Study|Lost to Follow-up|5|||
147536064|NCT00630994|532118227|FG000|Overall Study|Adverse Event|1|||
147536065|NCT00630994|532118227|FG000|Overall Study|Disease Progression|1|||
147536066|NCT00630994|532118227|FG000|Overall Study|Lack of Efficacy|1|||
147536067|NCT00630994|532118227|FG000|Overall Study|Other|1|||
147536068|NCT03722849|532118230|FG000|Overall Study|Withdrawal by Subject|1|||
147536069|NCT03722849|532118231|FG001|Overall Study|Withdrawal by Subject|1|||
147536070|NCT03533608|532118232|FG000|Overall Study|Withdrawal by Subject|3|||
147536071|NCT03533608|532118232|FG000|Overall Study|Physician Decision|2|||
147536072|NCT03286426|532118233|FG000|Overall Study|Physician Decision|3|||
147536073|NCT03514121|532118234|FG000|Overall Study|Withdrawal by Subject|0|||
147536074|NCT03514121|532118235|FG001|Overall Study|Withdrawal by Subject|0|||
147536075|NCT03514121|532118236|FG002|Overall Study|Withdrawal by Subject|0|||
147536076|NCT03514121|532118237|FG003|Overall Study|Withdrawal by Subject|0|||
147536077|NCT03514121|532118238|FG004|Overall Study|Withdrawal by Subject|1|||
147536078|NCT03514121|532118239|FG005|Overall Study|Withdrawal by Subject|2|||
147536079|NCT03514121|532118240|FG006|Overall Study|Withdrawal by Subject|1|||
147536080|NCT03514121|532118241|FG007|Overall Study|Withdrawal by Subject|1|||
147536081|NCT03514121|532118242|FG008|Overall Study|Withdrawal by Subject|7|||
147536082|NCT03514121|532118243|FG009|Overall Study|Withdrawal by Subject|2|||
147536083|NCT03514121|532118234|FG000|Overall Study|Death|0|||
147536084|NCT03514121|532118235|FG001|Overall Study|Death|0|||
147536085|NCT03514121|532118236|FG002|Overall Study|Death|0|||
147536086|NCT03514121|532118237|FG003|Overall Study|Death|0|||
147536087|NCT03514121|532118238|FG004|Overall Study|Death|0|||
147536088|NCT03514121|532118239|FG005|Overall Study|Death|3|||
147536089|NCT03514121|532118240|FG006|Overall Study|Death|2|||
147536090|NCT03514121|532118241|FG007|Overall Study|Death|1|||
147536091|NCT03514121|532118242|FG008|Overall Study|Death|26|||
147536092|NCT03514121|532118243|FG009|Overall Study|Death|3|||
147536093|NCT03514121|532118234|FG000|Overall Study|Lost to Follow-up|0|||
147536094|NCT03514121|532118235|FG001|Overall Study|Lost to Follow-up|0|||
147536095|NCT03514121|532118236|FG002|Overall Study|Lost to Follow-up|1|||
147536096|NCT03514121|532118237|FG003|Overall Study|Lost to Follow-up|0|||
147536097|NCT03514121|532118238|FG004|Overall Study|Lost to Follow-up|0|||
147536098|NCT03514121|532118239|FG005|Overall Study|Lost to Follow-up|0|||
147536099|NCT03514121|532118240|FG006|Overall Study|Lost to Follow-up|0|||
147536100|NCT03514121|532118241|FG007|Overall Study|Lost to Follow-up|0|||
147536101|NCT03514121|532118242|FG008|Overall Study|Lost to Follow-up|1|||
147536102|NCT03514121|532118243|FG009|Overall Study|Lost to Follow-up|0|||
147536103|NCT03514121|532118234|FG000|Overall Study|Adverse Event|0|||
147536104|NCT03514121|532118235|FG001|Overall Study|Adverse Event|0|||
147536105|NCT03514121|532118236|FG002|Overall Study|Adverse Event|0|||
147536106|NCT03514121|532118237|FG003|Overall Study|Adverse Event|0|||
147536107|NCT03514121|532118238|FG004|Overall Study|Adverse Event|0|||
147536108|NCT03514121|532118239|FG005|Overall Study|Adverse Event|0|||
147536109|NCT03514121|532118240|FG006|Overall Study|Adverse Event|1|||
147536110|NCT03514121|532118241|FG007|Overall Study|Adverse Event|0|||
147536111|NCT03514121|532118242|FG008|Overall Study|Adverse Event|0|||
147536112|NCT03514121|532118243|FG009|Overall Study|Adverse Event|0|||
147536113|NCT03514121|532118234|FG000|Overall Study|Other|0|||
147536114|NCT03514121|532118235|FG001|Overall Study|Other|1|||
147536115|NCT03514121|532118236|FG002|Overall Study|Other|1|||
147536116|NCT03514121|532118237|FG003|Overall Study|Other|0|||
147536117|NCT03514121|532118238|FG004|Overall Study|Other|1|||
147536118|NCT03514121|532118239|FG005|Overall Study|Other|2|||
147536119|NCT03514121|532118240|FG006|Overall Study|Other|3|||
147536120|NCT03514121|532118241|FG007|Overall Study|Other|2|||
147536121|NCT03514121|532118242|FG008|Overall Study|Other|7|||
147536122|NCT03514121|532118243|FG009|Overall Study|Other|3|||
147536123|NCT03514121|532118234|FG000|Overall Study|Study termination by Sponsor|0|||
147536124|NCT03514121|532118235|FG001|Overall Study|Study termination by Sponsor|0|||
147202202|NCT00942604|530910573|FG001|Overall Study|Withdrawal by Subject|1|||
147202203|NCT00942604|530910572|FG000|Overall Study|Patient relocation|1|||
147436711|NCT04448756|531765200|FG001|Overall Study|Participant unable to attend Day 60 visit|0|||
147436712|NCT04448756|531765201|FG002|Overall Study|Participant unable to attend Day 60 visit|0|||
147436713|NCT04448756|531765199|FG000|Overall Study|Withdrawal by Subject|0|||
147436714|NCT04448756|531765200|FG001|Overall Study|Withdrawal by Subject|3|||
147436715|NCT04448756|531765201|FG002|Overall Study|Withdrawal by Subject|1|||
147436716|NCT04448756|531765199|FG000|Overall Study|Death|2|||
147436717|NCT04448756|531765200|FG001|Overall Study|Death|1|||
147436718|NCT04448756|531765201|FG002|Overall Study|Death|0|||
147436719|NCT02733185|531765202|FG000|Overall Study|Withdrawal by Subject|12|||
147436720|NCT02733185|531765203|FG001|Overall Study|Withdrawal by Subject|10|||
147436721|NCT02733185|531765204|FG002|Overall Study|Withdrawal by Subject|17|||
147436722|NCT02733185|531765205|FG003|Overall Study|Withdrawal by Subject|21|||
147436723|NCT02733185|531765202|FG000|Overall Study|Death|46|||
147436724|NCT02733185|531765203|FG001|Overall Study|Death|34|||
147436725|NCT02733185|531765204|FG002|Overall Study|Death|35|||
147436726|NCT02733185|531765205|FG003|Overall Study|Death|43|||
147436727|NCT02733185|531765202|FG000|Overall Study|Lost to Follow-up|17|||
147436728|NCT02733185|531765203|FG001|Overall Study|Lost to Follow-up|18|||
147436729|NCT02733185|531765204|FG002|Overall Study|Lost to Follow-up|16|||
147436730|NCT02733185|531765205|FG003|Overall Study|Lost to Follow-up|11|||
147436731|NCT02877927|531765206|FG000|Overall Study|Adverse Event|1|||
147436732|NCT02877927|531765207|FG001|Overall Study|Adverse Event|0|||
147436733|NCT02877927|531765206|FG000|Overall Study|Lost to Follow-up|37|||
147436734|NCT02877927|531765207|FG001|Overall Study|Lost to Follow-up|38|||
147436735|NCT02877927|531765206|FG000|Overall Study|Withdrawal by Subject|11|||
147536125|NCT03514121|532118236|FG002|Overall Study|Study termination by Sponsor|0|||
147536126|NCT03514121|532118237|FG003|Overall Study|Study termination by Sponsor|0|||
147436736|NCT02877927|531765207|FG001|Overall Study|Withdrawal by Subject|12|||
147436737|NCT02877927|531765206|FG000|Overall Study|Physician Decision|0|||
147536127|NCT03514121|532118238|FG004|Overall Study|Study termination by Sponsor|0|||
147536128|NCT03514121|532118239|FG005|Overall Study|Study termination by Sponsor|0|||
147536129|NCT03514121|532118240|FG006|Overall Study|Study termination by Sponsor|0|||
147536130|NCT03514121|532118241|FG007|Overall Study|Study termination by Sponsor|0|||
147536131|NCT03514121|532118242|FG008|Overall Study|Study termination by Sponsor|11|||
147536132|NCT03514121|532118243|FG009|Overall Study|Study termination by Sponsor|3|||
147536133|NCT03514121|532118234|FG000|Overall Study|Investigator decision|0|||
147536134|NCT03514121|532118235|FG001|Overall Study|Investigator decision|0|||
147536135|NCT03514121|532118236|FG002|Overall Study|Investigator decision|0|||
147536136|NCT03514121|532118237|FG003|Overall Study|Investigator decision|0|||
147536137|NCT03514121|532118238|FG004|Overall Study|Investigator decision|0|||
147536138|NCT03514121|532118239|FG005|Overall Study|Investigator decision|0|||
147536139|NCT03514121|532118240|FG006|Overall Study|Investigator decision|0|||
147536140|NCT03514121|532118241|FG007|Overall Study|Investigator decision|0|||
147536141|NCT03514121|532118242|FG008|Overall Study|Investigator decision|1|||
147536142|NCT03514121|532118243|FG009|Overall Study|Investigator decision|0|||
147536143|NCT05553600|532118244|FG000|Prior to First Menstrual Cycle Starting|Withdrawal by Subject|4|||
147536144|NCT05553600|532118245|FG001|Prior to First Menstrual Cycle Starting|Withdrawal by Subject|8|||
147536145|NCT05553600|532118246|FG002|Prior to First Menstrual Cycle Starting|Withdrawal by Subject|6|||
147536146|NCT05553600|532118247|FG003|Prior to First Menstrual Cycle Starting|Withdrawal by Subject|7|||
147536147|NCT05553600|532118244|FG000|Prior to First Menstrual Cycle Starting|Protocol Violation|0|||
147536148|NCT05553600|532118245|FG001|Prior to First Menstrual Cycle Starting|Protocol Violation|1|||
147536149|NCT05553600|532118246|FG002|Prior to First Menstrual Cycle Starting|Protocol Violation|0|||
147536150|NCT05553600|532118247|FG003|Prior to First Menstrual Cycle Starting|Protocol Violation|2|||
147536151|NCT05553600|532118244|FG000|Prior to First Menstrual Cycle Starting|Physician Decision|0|||
147536152|NCT05553600|532118245|FG001|Prior to First Menstrual Cycle Starting|Physician Decision|0|||
147536153|NCT05553600|532118246|FG002|Prior to First Menstrual Cycle Starting|Physician Decision|0|||
147536154|NCT05553600|532118247|FG003|Prior to First Menstrual Cycle Starting|Physician Decision|1|||
147536155|NCT05553600|532118244|FG000|Prior to First Menstrual Cycle Starting|Lost to Follow-up|16|||
147536156|NCT05553600|532118245|FG001|Prior to First Menstrual Cycle Starting|Lost to Follow-up|13|||
147536157|NCT05553600|532118246|FG002|Prior to First Menstrual Cycle Starting|Lost to Follow-up|12|||
147536158|NCT05553600|532118247|FG003|Prior to First Menstrual Cycle Starting|Lost to Follow-up|10|||
147536159|NCT05553600|532118244|FG000|Prior to First Menstrual Cycle Starting|Other various reasons|7|||
147536160|NCT05553600|532118245|FG001|Prior to First Menstrual Cycle Starting|Other various reasons|8|||
147536161|NCT05553600|532118246|FG002|Prior to First Menstrual Cycle Starting|Other various reasons|3|||
147536162|NCT05553600|532118247|FG003|Prior to First Menstrual Cycle Starting|Other various reasons|2|||
147536163|NCT05553600|532118244|FG000|Prior to Second Menstrual Cycle Starting|Adverse Event|0|||
147536164|NCT05553600|532118245|FG001|Prior to Second Menstrual Cycle Starting|Adverse Event|0|||
147536165|NCT05553600|532118246|FG002|Prior to Second Menstrual Cycle Starting|Adverse Event|1|||
147536166|NCT05553600|532118247|FG003|Prior to Second Menstrual Cycle Starting|Adverse Event|0|||
147536167|NCT05553600|532118244|FG000|Prior to Second Menstrual Cycle Starting|Withdrawal by Subject|2|||
147536168|NCT05553600|532118245|FG001|Prior to Second Menstrual Cycle Starting|Withdrawal by Subject|2|||
147536169|NCT05553600|532118246|FG002|Prior to Second Menstrual Cycle Starting|Withdrawal by Subject|4|||
147536170|NCT05553600|532118247|FG003|Prior to Second Menstrual Cycle Starting|Withdrawal by Subject|1|||
147536171|NCT05553600|532118244|FG000|Prior to Second Menstrual Cycle Starting|Protocol Violation|1|||
147536172|NCT05553600|532118245|FG001|Prior to Second Menstrual Cycle Starting|Protocol Violation|3|||
147536173|NCT05553600|532118246|FG002|Prior to Second Menstrual Cycle Starting|Protocol Violation|0|||
147536174|NCT05553600|532118247|FG003|Prior to Second Menstrual Cycle Starting|Protocol Violation|1|||
147536175|NCT05553600|532118244|FG000|Prior to Second Menstrual Cycle Starting|Physician Decision|6|||
147536176|NCT05553600|532118245|FG001|Prior to Second Menstrual Cycle Starting|Physician Decision|4|||
147536177|NCT05553600|532118246|FG002|Prior to Second Menstrual Cycle Starting|Physician Decision|1|||
147536178|NCT05553600|532118247|FG003|Prior to Second Menstrual Cycle Starting|Physician Decision|6|||
147536179|NCT05553600|532118244|FG000|Prior to Second Menstrual Cycle Starting|Lost to Follow-up|5|||
147536180|NCT05553600|532118245|FG001|Prior to Second Menstrual Cycle Starting|Lost to Follow-up|6|||
147536181|NCT05553600|532118246|FG002|Prior to Second Menstrual Cycle Starting|Lost to Follow-up|4|||
147536182|NCT05553600|532118247|FG003|Prior to Second Menstrual Cycle Starting|Lost to Follow-up|3|||
147536183|NCT05553600|532118244|FG000|Prior to Second Menstrual Cycle Starting|Other various reasons|4|||
147536184|NCT05553600|532118245|FG001|Prior to Second Menstrual Cycle Starting|Other various reasons|7|||
147536185|NCT05553600|532118246|FG002|Prior to Second Menstrual Cycle Starting|Other various reasons|3|||
147536186|NCT05553600|532118247|FG003|Prior to Second Menstrual Cycle Starting|Other various reasons|8|||
147536187|NCT05553600|532118244|FG000|After Second Menstrual Cycle Began|Adverse Event|1|||
147536188|NCT05553600|532118245|FG001|After Second Menstrual Cycle Began|Adverse Event|0|||
147536189|NCT05553600|532118246|FG002|After Second Menstrual Cycle Began|Adverse Event|0|||
147536190|NCT05553600|532118247|FG003|After Second Menstrual Cycle Began|Adverse Event|0|||
147536191|NCT04292171|532118248|FG000|Overall Study|Pharmacy error|2|||
147536192|NCT04292171|532118249|FG001|Overall Study|Pharmacy error|0|||
147536193|NCT04292171|532118248|FG000|Overall Study|Delivered prior to procedure|0|||
147536194|NCT04292171|532118249|FG001|Overall Study|Delivered prior to procedure|1|||
147536195|NCT03079869|532118253|FG000|Overall Study|Adverse Event|6|||
147536196|NCT03079869|532118254|FG001|Overall Study|Adverse Event|8|||
147536197|NCT03079869|532118253|FG000|Overall Study|Withdrawal by Subject|4|||
147536198|NCT03079869|532118254|FG001|Overall Study|Withdrawal by Subject|1|||
147536199|NCT03079869|532118253|FG000|Overall Study|Protocol withdrawal criteria-off drug > 2 weeks|3|||
147536200|NCT03079869|532118254|FG001|Overall Study|Protocol withdrawal criteria-off drug > 2 weeks|2|||
147536201|NCT04633434|532118255|FG000|Overall Study|Lost to Follow-up|32|||
147536202|NCT04633434|532118256|FG001|Overall Study|Lost to Follow-up|32|||
147536203|NCT00348348|532118262|FG000|Overall Study|Adverse event - unrelated to study drug|0|||
147536204|NCT00348348|532118263|FG001|Overall Study|Adverse event - unrelated to study drug|1|||
147536205|NCT00348348|532118262|FG000|Overall Study|Lack of Efficacy|1|||
147536206|NCT00348348|532118263|FG001|Overall Study|Lack of Efficacy|1|||
147536207|NCT00348348|532118262|FG000|Overall Study|Lost to Follow-up|8|||
147536208|NCT00348348|532118263|FG001|Overall Study|Lost to Follow-up|10|||
147536209|NCT00348348|532118262|FG000|Overall Study|Withdrawal by Subject|4|||
147536210|NCT00348348|532118263|FG001|Overall Study|Withdrawal by Subject|1|||
147536211|NCT00348348|532118262|FG000|Overall Study|Other|7|||
147536212|NCT00348348|532118263|FG001|Overall Study|Other|4|||
147536213|NCT00348348|532118262|FG000|Overall Study|Dissallowed Meds - unrelated to study|1|||
147536214|NCT00348348|532118263|FG001|Overall Study|Dissallowed Meds - unrelated to study|3|||
147536215|NCT00348348|532118262|FG000|Overall Study|Dissallowed Meds - unlikley related|1|||
147536216|NCT00348348|532118263|FG001|Overall Study|Dissallowed Meds - unlikley related|1|||
147536217|NCT00348348|532118262|FG000|Overall Study|Dissallowed Meds - possibly releated|1|||
147536218|NCT00348348|532118263|FG001|Overall Study|Dissallowed Meds - possibly releated|1|||
147536219|NCT00348348|532118262|FG000|Overall Study|Worsening of BC - Unrelated to study|0|||
147536220|NCT00348348|532118263|FG001|Overall Study|Worsening of BC - Unrelated to study|3|||
147536221|NCT00348348|532118262|FG000|Overall Study|Worsening of BC - Unlikely related|1|||
147536222|NCT00348348|532118263|FG001|Overall Study|Worsening of BC - Unlikely related|2|||
147536223|NCT00348348|532118262|FG000|Overall Study|Adverse event probably related to study|1|||
147536224|NCT00348348|532118263|FG001|Overall Study|Adverse event probably related to study|0|||
147536225|NCT01301625|532118267|FG000|Overall Study|Death|5|||
147536226|NCT01301625|532118267|FG000|Overall Study|Not Due|21|||
147536227|NCT01301625|532118267|FG000|Overall Study|Expected|8|||
147536228|NCT01301625|532118267|FG000|Overall Study|Lost to Follow-up|1|||
147536229|NCT02684370|532118269|FG000|Part A|Adverse Event|2|||
147536230|NCT02684370|532118270|FG001|Part A|Adverse Event|0|||
147536231|NCT02684370|532118271|FG002|Part A|Adverse Event|1|||
147536232|NCT02684370|532118272|FG003|Part A|Adverse Event|0|||
147536233|NCT02684370|532118273|FG004|Part A|Adverse Event|0|||
147536234|NCT02684370|532118274|FG005|Part A|Adverse Event|0|||
147536235|NCT02684370|532118269|FG000|Part A|Lost to Follow-up|1|||
147536236|NCT02684370|532118270|FG001|Part A|Lost to Follow-up|1|||
147536237|NCT02684370|532118271|FG002|Part A|Lost to Follow-up|0|||
147536238|NCT02684370|532118272|FG003|Part A|Lost to Follow-up|0|||
147536239|NCT02684370|532118273|FG004|Part A|Lost to Follow-up|0|||
147536240|NCT02684370|532118274|FG005|Part A|Lost to Follow-up|0|||
147536241|NCT02684370|532118269|FG000|Part A|Subject Withdrawal|1|||
147536242|NCT02684370|532118270|FG001|Part A|Subject Withdrawal|0|||
147536243|NCT02684370|532118271|FG002|Part A|Subject Withdrawal|3|||
147536244|NCT02684370|532118272|FG003|Part A|Subject Withdrawal|0|||
147536245|NCT02684370|532118273|FG004|Part A|Subject Withdrawal|0|||
147536246|NCT02684370|532118274|FG005|Part A|Subject Withdrawal|0|||
147536247|NCT02684370|532118269|FG000|Part A|Other|0|||
147536248|NCT02684370|532118270|FG001|Part A|Other|0|||
147202204|NCT00942604|530910573|FG001|Overall Study|Patient relocation|1|||
147202205|NCT01143246|530910574|FG000|Overall Study|Adverse Event|24|||
147202206|NCT01143246|530910575|FG001|Overall Study|Adverse Event|28|||
147536249|NCT02684370|532118271|FG002|Part A|Other|1|||
147536250|NCT02684370|532118272|FG003|Part A|Other|0|||
147536251|NCT02684370|532118273|FG004|Part A|Other|0|||
147536252|NCT02684370|532118274|FG005|Part A|Other|0|||
147536253|NCT02684370|532118269|FG000|Part B|Adverse Event|0|||
147536254|NCT02684370|532118270|FG001|Part B|Adverse Event|0|||
147536255|NCT02684370|532118271|FG002|Part B|Adverse Event|0|||
147536256|NCT02684370|532118272|FG003|Part B|Adverse Event|0|||
147536257|NCT02684370|532118273|FG004|Part B|Adverse Event|2|||
147536258|NCT02684370|532118274|FG005|Part B|Adverse Event|1|||
147536259|NCT02684370|532118269|FG000|Part B|Lost to Follow-up|0|||
147536260|NCT02684370|532118270|FG001|Part B|Lost to Follow-up|0|||
147536261|NCT02684370|532118271|FG002|Part B|Lost to Follow-up|0|||
147536262|NCT02684370|532118272|FG003|Part B|Lost to Follow-up|1|||
147536263|NCT02684370|532118273|FG004|Part B|Lost to Follow-up|2|||
147536264|NCT02684370|532118274|FG005|Part B|Lost to Follow-up|5|||
147536265|NCT02684370|532118269|FG000|Part B|Subject Withdrawal|0|||
147202207|NCT01143246|530910574|FG000|Overall Study|Participant Withdrew Informed Consent|2|||
147202208|NCT01143246|530910575|FG001|Overall Study|Participant Withdrew Informed Consent|2|||
147202209|NCT01143246|530910574|FG000|Overall Study|Lost to Follow-up|0|||
147202210|NCT01143246|530910575|FG001|Overall Study|Lost to Follow-up|1|||
147202211|NCT01143246|530910574|FG000|Overall Study|Death|16|||
147202212|NCT01143246|530910575|FG001|Overall Study|Death|15|||
147202213|NCT01143246|530910574|FG000|Overall Study|Reason not Specified|3|||
147202214|NCT01143246|530910575|FG001|Overall Study|Reason not Specified|5|||
147202215|NCT03987503|530910577|FG000|Overall Study|Lost to Follow-up|20|||
147536266|NCT02684370|532118270|FG001|Part B|Subject Withdrawal|0|||
147536267|NCT02684370|532118271|FG002|Part B|Subject Withdrawal|0|||
147536268|NCT02684370|532118272|FG003|Part B|Subject Withdrawal|1|||
147536269|NCT02684370|532118273|FG004|Part B|Subject Withdrawal|1|||
147536270|NCT02684370|532118274|FG005|Part B|Subject Withdrawal|2|||
147536271|NCT01165424|532118278|FG000|Overall Study|Clinical adverse experiences|1|||
147536272|NCT01165424|532118278|FG000|Overall Study|Laboratory adverse experiences|1|||
147536273|NCT01165424|532118278|FG000|Overall Study|Did not meet entry criteria|1|||
147536274|NCT01165424|532118278|FG000|Overall Study|Participant moved (relocated)|1|||
147536275|NCT00433771|532118279|FG000|Overall Study|screen fail|14|||
147536276|NCT00433771|532118279|FG000|Overall Study|Treated and later found to be ineligible|2|||
147536277|NCT00433771|532118279|FG000|Overall Study|Death|2|||
147536278|NCT00433771|532118279|FG000|Overall Study|Failure to deploy stent|1|||
147536279|NCT00943826|532118280|FG000|Concurrent Phase|Adverse Event|50|||
147536280|NCT00943826|532118281|FG001|Concurrent Phase|Adverse Event|27|||
147536281|NCT00943826|532118280|FG000|Concurrent Phase|Withdrew consent|3|||
147536282|NCT00943826|532118281|FG001|Concurrent Phase|Withdrew consent|7|||
147536283|NCT00943826|532118280|FG000|Concurrent Phase|Refused treatment/Did not cooperate|5|||
147536284|NCT00943826|532118281|FG001|Concurrent Phase|Refused treatment/Did not cooperate|7|||
147536285|NCT00943826|532118280|FG000|Concurrent Phase|Administrative reasons|2|||
147536286|NCT00943826|532118281|FG001|Concurrent Phase|Administrative reasons|1|||
147536287|NCT00943826|532118280|FG000|Concurrent Phase|Protocol Violation|1|||
147536288|NCT00943826|532118281|FG001|Concurrent Phase|Protocol Violation|0|||
147536289|NCT00943826|532118280|FG000|Maintenance Phase|Adverse Event|31|||
147536290|NCT00943826|532118281|FG001|Maintenance Phase|Adverse Event|30|||
147536291|NCT00943826|532118280|FG000|Maintenance Phase|Withdrew consent|2|||
147536292|NCT00943826|532118281|FG001|Maintenance Phase|Withdrew consent|4|||
147536293|NCT00943826|532118280|FG000|Maintenance Phase|Refused treatment/Did not cooperate|6|||
147536294|NCT00943826|532118281|FG001|Maintenance Phase|Refused treatment/Did not cooperate|3|||
147536295|NCT00943826|532118280|FG000|Maintenance Phase|Administrative reasons|4|||
147536296|NCT00943826|532118281|FG001|Maintenance Phase|Administrative reasons|1|||
147536297|NCT00943826|532118280|FG000|Maintenance Phase|Failure to return|0|||
147536298|NCT00943826|532118281|FG001|Maintenance Phase|Failure to return|1|||
147536299|NCT00943826|532118280|FG000|Monotherapy Phase|Adverse Event|42|||
147536300|NCT00943826|532118281|FG001|Monotherapy Phase|Adverse Event|5|||
147536301|NCT00943826|532118280|FG000|Monotherapy Phase|Administrative reasons|11|||
147536302|NCT00943826|532118281|FG001|Monotherapy Phase|Administrative reasons|5|||
147536303|NCT00943826|532118280|FG000|Monotherapy Phase|Refused treatment/ Did not cooperate|8|||
147536304|NCT00943826|532118281|FG001|Monotherapy Phase|Refused treatment/ Did not cooperate|2|||
147536305|NCT00943826|532118280|FG000|Monotherapy Phase|Withdrew Consent|2|||
147536306|NCT00943826|532118281|FG001|Monotherapy Phase|Withdrew Consent|3|||
147536307|NCT00943826|532118280|FG000|Monotherapy Phase|Failure to return|2|||
147536308|NCT00943826|532118281|FG001|Monotherapy Phase|Failure to return|1|||
147536309|NCT00943826|532118280|FG000|After Primary Overall Survival Analysis|Adverse Event|11|||
147536310|NCT00943826|532118281|FG001|After Primary Overall Survival Analysis|Adverse Event|0|||
147536311|NCT00943826|532118280|FG000|After Primary Overall Survival Analysis|Administrative reasons|10|||
147536312|NCT00943826|532118281|FG001|After Primary Overall Survival Analysis|Administrative reasons|16|||
147536313|NCT00943826|532118280|FG000|After Primary Overall Survival Analysis|Progression of Disease|2|||
147536314|NCT00943826|532118281|FG001|After Primary Overall Survival Analysis|Progression of Disease|4|||
147536315|NCT00943826|532118280|FG000|After Primary Overall Survival Analysis|Withdrew Consent|4|||
147536316|NCT00943826|532118281|FG001|After Primary Overall Survival Analysis|Withdrew Consent|0|||
147536317|NCT01833897|532118291|FG000|Overall Study|Lack of Efficacy|1|||
147536318|NCT00669110|532118292|FG000|Overall Study|Adverse Event|4|||
147536319|NCT00669110|532118293|FG001|Overall Study|Adverse Event|3|||
147536320|NCT00669110|532118292|FG000|Overall Study|Caregiver request|3|||
147536321|NCT00669110|532118293|FG001|Overall Study|Caregiver request|2|||
147536322|NCT00669110|532118292|FG000|Overall Study|Physician Decision|0|||
147536323|NCT00669110|532118293|FG001|Overall Study|Physician Decision|1|||
147536324|NCT00669110|532118292|FG000|Overall Study|Lost to Follow-up|1|||
147536325|NCT00669110|532118293|FG001|Overall Study|Lost to Follow-up|0|||
147536326|NCT00669110|532118292|FG000|Overall Study|Protocol Violation|0|||
147649418|NCT02634801|532537341|FG000|Treatment Period (Weeks 0 to 24)|Lost to Follow-up|2|||
147202216|NCT03987503|530910577|FG000|Overall Study|Withdrawal by Subject|2|||
147202217|NCT03133793|530910579|FG000|Overall Study|Withdrawal by Subject|0|||
147536327|NCT00669110|532118293|FG001|Overall Study|Protocol Violation|5|||
147536328|NCT00669110|532118292|FG000|Overall Study|Withdrawal by Subject|0|||
147536329|NCT00669110|532118293|FG001|Overall Study|Withdrawal by Subject|2|||
147536330|NCT01244516|532118294|FG000|Period 1 (Baseline to 1-week Visit)|Protocol Violation|4|||
147536331|NCT01244516|532118295|FG001|Period 1 (Baseline to 1-week Visit)|Protocol Violation|5|||
147536332|NCT01244516|532118296|FG002|Period 1 (Baseline to 1-week Visit)|Protocol Violation|2|||
147536333|NCT01244516|532118294|FG000|Period 1 (Baseline to 1-week Visit)|Poor Vision|0|||
147536334|NCT01244516|532118295|FG001|Period 1 (Baseline to 1-week Visit)|Poor Vision|1|||
147536335|NCT01244516|532118296|FG002|Period 1 (Baseline to 1-week Visit)|Poor Vision|0|||
147536336|NCT01244516|532118294|FG000|Period 1 (Baseline to 1-week Visit)|Poor comfort|0|||
147536337|NCT01244516|532118295|FG001|Period 1 (Baseline to 1-week Visit)|Poor comfort|0|||
147536338|NCT01244516|532118296|FG002|Period 1 (Baseline to 1-week Visit)|Poor comfort|1|||
147536339|NCT01244516|532118294|FG000|Period 2 (1-week to 2-week Visit)|Adverse Event|2|||
147536340|NCT01244516|532118295|FG001|Period 2 (1-week to 2-week Visit)|Adverse Event|0|||
147536341|NCT01244516|532118296|FG002|Period 2 (1-week to 2-week Visit)|Adverse Event|0|||
147536342|NCT01244516|532118294|FG000|Period 2 (1-week to 2-week Visit)|Protocol Violation|1|||
147536343|NCT01244516|532118295|FG001|Period 2 (1-week to 2-week Visit)|Protocol Violation|0|||
147536344|NCT01244516|532118296|FG002|Period 2 (1-week to 2-week Visit)|Protocol Violation|1|||
147536345|NCT01244516|532118294|FG000|Period 2 (1-week to 2-week Visit)|Lost to Follow-up|0|||
147536346|NCT01244516|532118295|FG001|Period 2 (1-week to 2-week Visit)|Lost to Follow-up|1|||
147536347|NCT01244516|532118296|FG002|Period 2 (1-week to 2-week Visit)|Lost to Follow-up|0|||
147536348|NCT01244516|532118294|FG000|Period 2 (1-week to 2-week Visit)|Poor Comfort|0|||
147536349|NCT01244516|532118295|FG001|Period 2 (1-week to 2-week Visit)|Poor Comfort|0|||
147536350|NCT01244516|532118296|FG002|Period 2 (1-week to 2-week Visit)|Poor Comfort|1|||
147536351|NCT00077766|532118302|FG000|Overall Study|Adverse Event|1|||
147536352|NCT00077766|532118303|FG001|Overall Study|Adverse Event|1|||
147536353|NCT00077766|532118302|FG000|Overall Study|Withdrawal by Subject|4|||
147536354|NCT00077766|532118303|FG001|Overall Study|Withdrawal by Subject|3|||
147536355|NCT00077766|532118302|FG000|Overall Study|Death|12|||
147536356|NCT00077766|532118303|FG001|Overall Study|Death|10|||
147536357|NCT00077766|532118302|FG000|Overall Study|Lost to Follow-up|2|||
147536358|NCT00077766|532118303|FG001|Overall Study|Lost to Follow-up|0|||
147536359|NCT00077766|532118302|FG000|Overall Study|Protocol Violation|1|||
147536360|NCT00077766|532118303|FG001|Overall Study|Protocol Violation|0|||
147536361|NCT00077766|532118302|FG000|Overall Study|Kidney Transplantation|9|||
147536362|NCT00077766|532118303|FG001|Overall Study|Kidney Transplantation|5|||
147536363|NCT00077766|532118302|FG000|Overall Study|Transplantation|5|||
147536364|NCT00077766|532118303|FG001|Overall Study|Transplantation|1|||
147536365|NCT00077766|532118302|FG000|Overall Study|Investigators Discretion|1|||
147536366|NCT00077766|532118303|FG001|Overall Study|Investigators Discretion|0|||
147536367|NCT00077766|532118302|FG000|Overall Study|Participant's decision|1|||
147536368|NCT00077766|532118303|FG001|Overall Study|Participant's decision|0|||
147536369|NCT00077766|532118302|FG000|Overall Study|Dialysis Discontinued|1|||
147536370|NCT00077766|532118303|FG001|Overall Study|Dialysis Discontinued|0|||
147536371|NCT00077766|532118302|FG000|Overall Study|Dialysis|0|||
147536372|NCT00077766|532118303|FG001|Overall Study|Dialysis|1|||
147536373|NCT00077766|532118302|FG000|Overall Study|Enrolled in Nocturnal Hemodialysis Study|0|||
147536374|NCT00077766|532118303|FG001|Overall Study|Enrolled in Nocturnal Hemodialysis Study|1|||
147536375|NCT00077766|532118302|FG000|Overall Study|Started Nocturnal Dialysis|0|||
147536376|NCT00077766|532118303|FG001|Overall Study|Started Nocturnal Dialysis|1|||
147536377|NCT00077766|532118302|FG000|Overall Study|Stop Dialysis|0|||
147536378|NCT00077766|532118303|FG001|Overall Study|Stop Dialysis|1|||
147536379|NCT00077766|532118302|FG000|Overall Study|Participants Vacation|2|||
147536380|NCT00077766|532118303|FG001|Overall Study|Participants Vacation|1|||
147536381|NCT00972309|532118313|FG000|Overall Study|Switched to alternative treatment|0|||
147536382|NCT00972309|532118314|FG001|Overall Study|Switched to alternative treatment|2|||
147536383|NCT00972309|532118313|FG000|Overall Study|Refused further treatment|0|||
147536384|NCT00972309|532118314|FG001|Overall Study|Refused further treatment|1|||
147536385|NCT00972309|532118313|FG000|Overall Study|Late determination of ineligibility|0|||
147536386|NCT00972309|532118314|FG001|Overall Study|Late determination of ineligibility|1|||
147536387|NCT00972309|532118313|FG000|Overall Study|Second malignancy|1|||
147536388|NCT00972309|532118314|FG001|Overall Study|Second malignancy|1|||
147536389|NCT00972309|532118313|FG000|Overall Study|Visa issues|0|||
147536390|NCT00972309|532118314|FG001|Overall Study|Visa issues|1|||
147536391|NCT00972309|532118313|FG000|Overall Study|Secondary cancer (SCC)|0|||
147536392|NCT00972309|532118314|FG001|Overall Study|Secondary cancer (SCC)|1|||
147536393|NCT00972309|532118313|FG000|Overall Study|Met off study prostate specific antigen doubling time (PSADT) criteria|0|||
147536394|NCT00972309|532118314|FG001|Overall Study|Met off study prostate specific antigen doubling time (PSADT) criteria|1|||
147536395|NCT00972309|532118313|FG000|Overall Study|Lost to Follow-up|1|||
147536396|NCT00972309|532118314|FG001|Overall Study|Lost to Follow-up|1|||
147536397|NCT00972309|532118313|FG000|Overall Study|Disease progression on study|10|||
147536398|NCT00972309|532118314|FG001|Overall Study|Disease progression on study|4|||
147536399|NCT02062385|532118316|FG000|Overall Study|Adverse Event|19|||
147536400|NCT02062385|532118317|FG001|Overall Study|Adverse Event|13|||
147536401|NCT02062385|532118318|FG002|Overall Study|Adverse Event|1|||
147536402|NCT02062385|532118319|FG003|Overall Study|Adverse Event|0|||
147536403|NCT02062385|532118316|FG000|Overall Study|Protocol Violation|1|||
147536404|NCT02062385|532118317|FG001|Overall Study|Protocol Violation|0|||
147536405|NCT02062385|532118318|FG002|Overall Study|Protocol Violation|0|||
147536406|NCT02062385|532118319|FG003|Overall Study|Protocol Violation|0|||
147536407|NCT02062385|532118316|FG000|Overall Study|Incomplete EPI by database lock|2|||
147536408|NCT02062385|532118317|FG001|Overall Study|Incomplete EPI by database lock|0|||
147536409|NCT02062385|532118318|FG002|Overall Study|Incomplete EPI by database lock|0|||
147536410|NCT02062385|532118319|FG003|Overall Study|Incomplete EPI by database lock|0|||
147536411|NCT02062385|532118316|FG000|Overall Study|Moved|10|||
147536412|NCT02062385|532118317|FG001|Overall Study|Moved|11|||
147536413|NCT02062385|532118318|FG002|Overall Study|Moved|1|||
147536414|NCT02062385|532118319|FG003|Overall Study|Moved|0|||
147536415|NCT02062385|532118316|FG000|Overall Study|Withdrawn by parent/guardian|46|||
147536416|NCT02062385|532118317|FG001|Overall Study|Withdrawn by parent/guardian|41|||
147536417|NCT02062385|532118318|FG002|Overall Study|Withdrawn by parent/guardian|9|||
147536418|NCT02062385|532118319|FG003|Overall Study|Withdrawn by parent/guardian|8|||
147536419|NCT02062385|532118316|FG000|Overall Study|Death|0|||
147536420|NCT02062385|532118317|FG001|Overall Study|Death|0|||
147536421|NCT02062385|532118318|FG002|Overall Study|Death|0|||
147536422|NCT02062385|532118319|FG003|Overall Study|Death|1|||
147536423|NCT02062385|532118316|FG000|Overall Study|Lost to Follow-up|0|||
147536424|NCT02062385|532118317|FG001|Overall Study|Lost to Follow-up|0|||
147536425|NCT02062385|532118318|FG002|Overall Study|Lost to Follow-up|1|||
147536426|NCT02062385|532118319|FG003|Overall Study|Lost to Follow-up|0|||
147536427|NCT00223990|532118322|FG000|Overall Study|Moved from area|2|||
147536428|NCT00223990|532118323|FG001|Overall Study|Moved from area|1|||
147536429|NCT00223990|532118322|FG000|Overall Study|Withdrawal by Subject|4|||
147536430|NCT00223990|532118323|FG001|Overall Study|Withdrawal by Subject|8|||
147536431|NCT00223990|532118322|FG000|Overall Study|Lost to Follow-up|1|||
147536432|NCT00223990|532118323|FG001|Overall Study|Lost to Follow-up|0|||
147536433|NCT01319994|532120208|FG000|Overall Study|Protocol Violation|7|||
147536434|NCT01319994|532120209|FG001|Overall Study|Protocol Violation|6|||
147536435|NCT01340794|532120210|FG000|Overall Study|Withdrawal by Subject|0|||
147536436|NCT01340794|532120211|FG001|Overall Study|Withdrawal by Subject|1|||
147536437|NCT02674568|532120213|FG000|Overall Study|Withdrawal by Subject|5|||
147536438|NCT02674568|532120213|FG000|Overall Study|Death|303|||
147536439|NCT02674568|532120213|FG000|Overall Study|Physician Decision|2|||
147536440|NCT02674568|532120213|FG000|Overall Study|Lost to Follow-up|9|||
147536441|NCT02674568|532120213|FG000|Overall Study|Other, Not Specified|20|||
147536442|NCT01808508|532120216|FG000|Overall Study|Lost to Follow-up|1|||
147536443|NCT01808508|532120217|FG001|Overall Study|Lost to Follow-up|0|||
147536444|NCT01808508|532120218|FG002|Overall Study|Lost to Follow-up|0|||
147436738|NCT02877927|531765207|FG001|Overall Study|Physician Decision|1|||
147436739|NCT02877927|531765206|FG000|Overall Study|Missed EOT/PTE Visit|5|||
147436740|NCT02877927|531765207|FG001|Overall Study|Missed EOT/PTE Visit|6|||
147436741|NCT00601250|531765208|FG000|Overall Study|Adverse Event|3|||
147436742|NCT00601250|531765209|FG001|Overall Study|Adverse Event|9|||
147436743|NCT00601250|531765208|FG000|Overall Study|Protocol Violation|3|||
147436744|NCT00601250|531765209|FG001|Overall Study|Protocol Violation|2|||
147436745|NCT00601250|531765208|FG000|Overall Study|Lost to Follow-up|2|||
147436746|NCT00601250|531765209|FG001|Overall Study|Lost to Follow-up|6|||
147436747|NCT00601250|531765208|FG000|Overall Study|Withdrawal by Subject|4|||
147436748|NCT00601250|531765209|FG001|Overall Study|Withdrawal by Subject|13|||
147436749|NCT00601250|531765208|FG000|Overall Study|Other incl. lack of efficacy|2|||
147436750|NCT00601250|531765209|FG001|Overall Study|Other incl. lack of efficacy|9|||
147536445|NCT01118949|532120219|FG000|Overall Study|Adverse Event|5|||
147536446|NCT01118949|532120219|FG000|Overall Study|Withdrawal by Subject|4|||
147536447|NCT01035229|532120220|FG000|Overall Study|Adverse Event|61|||
147536448|NCT01035229|532120221|FG001|Overall Study|Adverse Event|14|||
147536449|NCT01035229|532120220|FG000|Overall Study|Withdrawal by Subject|20|||
147436751|NCT01810016|531765210|FG000|Overall Study|Progressive disease|1|||
147536450|NCT01035229|532120221|FG001|Overall Study|Withdrawal by Subject|7|||
147536451|NCT01035229|532120220|FG000|Overall Study|Lost to Follow-up|1|||
147436752|NCT01810016|531765211|FG001|Overall Study|Progressive disease|1|||
147436753|NCT01810016|531765212|FG002|Overall Study|Progressive disease|0|||
147536452|NCT01035229|532120221|FG001|Overall Study|Lost to Follow-up|0|||
147536453|NCT01035229|532120220|FG000|Overall Study|Administrative problems|1|||
147536454|NCT01035229|532120221|FG001|Overall Study|Administrative problems|1|||
147536455|NCT01035229|532120220|FG000|Overall Study|Death|13|||
147536456|NCT01035229|532120221|FG001|Overall Study|Death|5|||
147536457|NCT01035229|532120220|FG000|Overall Study|New cancer therapy|2|||
147536458|NCT01035229|532120221|FG001|Overall Study|New cancer therapy|0|||
147536459|NCT01035229|532120220|FG000|Overall Study|Protocol Violation|0|||
147536460|NCT01035229|532120221|FG001|Overall Study|Protocol Violation|2|||
147536461|NCT01035229|532120220|FG000|Overall Study|Sponsor's decision to end study|3|||
147536462|NCT01035229|532120221|FG001|Overall Study|Sponsor's decision to end study|3|||
147536463|NCT01035229|532120220|FG000|Overall Study|Disease Progression|261|||
147536464|NCT01035229|532120221|FG001|Overall Study|Disease Progression|152|||
147536465|NCT03387423|532120227|FG000|Overall Study|Lost to Follow-up|16|||
147536466|NCT03387423|532120228|FG001|Overall Study|Lost to Follow-up|12|||
147536467|NCT03387423|532120229|FG002|Overall Study|Lost to Follow-up|1|||
147536468|NCT03387423|532120230|FG003|Overall Study|Lost to Follow-up|0|||
147536469|NCT03387423|532120227|FG000|Overall Study|Other|0|||
147536470|NCT03387423|532120228|FG001|Overall Study|Other|3|||
147536471|NCT03387423|532120229|FG002|Overall Study|Other|0|||
147536472|NCT03387423|532120230|FG003|Overall Study|Other|0|||
147536473|NCT03387423|532120227|FG000|Overall Study|Administrative Reason|166|||
147536474|NCT03387423|532120228|FG001|Overall Study|Administrative Reason|89|||
147536475|NCT03387423|532120229|FG002|Overall Study|Administrative Reason|17|||
147536476|NCT03387423|532120230|FG003|Overall Study|Administrative Reason|19|||
147536477|NCT03387423|532120227|FG000|Overall Study|Revocation Consent|76|||
147536478|NCT03387423|532120228|FG001|Overall Study|Revocation Consent|32|||
147536479|NCT03387423|532120229|FG002|Overall Study|Revocation Consent|3|||
147536480|NCT03387423|532120230|FG003|Overall Study|Revocation Consent|5|||
147536481|NCT01473589|532120233|FG000|Overall Study|Adverse Event|1|||
147536482|NCT01473589|532120234|FG001|Overall Study|Adverse Event|1|||
147536483|NCT01473589|532120233|FG000|Overall Study|Death|2|||
147536484|NCT01473589|532120234|FG001|Overall Study|Death|0|||
147536485|NCT01473589|532120233|FG000|Overall Study|Lost to Follow-up|2|||
147536486|NCT01473589|532120234|FG001|Overall Study|Lost to Follow-up|2|||
147536487|NCT01473589|532120233|FG000|Overall Study|Protocol Violation|1|||
147536488|NCT01473589|532120234|FG001|Overall Study|Protocol Violation|0|||
147536489|NCT01473589|532120233|FG000|Overall Study|Withdrawal by Subject|5|||
147536490|NCT01473589|532120234|FG001|Overall Study|Withdrawal by Subject|11|||
147536491|NCT01473589|532120233|FG000|Overall Study|Physician Decision|0|||
147536492|NCT01473589|532120234|FG001|Overall Study|Physician Decision|1|||
147536493|NCT01473589|532120233|FG000|Overall Study|Entry criteria not met|0|||
147536494|NCT01473589|532120234|FG001|Overall Study|Entry criteria not met|1|||
147536495|NCT00929201|532120235|FG000|Period 1|Withdrawal by Subject|0|||
147536496|NCT00929201|532120236|FG001|Period 1|Withdrawal by Subject|1|||
147536497|NCT01299272|532120237|FG000|Acute Open-label (OL) Period|Remission Criteria Not Met|140|||
147536498|NCT01299272|532120238|FG001|Acute Open-label (OL) Period|Remission Criteria Not Met|0|||
147536499|NCT01299272|532120239|FG002|Acute Open-label (OL) Period|Remission Criteria Not Met|0|||
147536500|NCT01299272|532120240|FG003|Acute Open-label (OL) Period|Remission Criteria Not Met|0|||
147536501|NCT01299272|532120237|FG000|Acute Open-label (OL) Period|Adverse Event|140|||
147536502|NCT01299272|532120238|FG001|Acute Open-label (OL) Period|Adverse Event|0|||
147536503|NCT01299272|532120239|FG002|Acute Open-label (OL) Period|Adverse Event|0|||
147536504|NCT01299272|532120240|FG003|Acute Open-label (OL) Period|Adverse Event|0|||
147536505|NCT01299272|532120237|FG000|Acute Open-label (OL) Period|Withdrawal by Subject|56|||
147536506|NCT01299272|532120238|FG001|Acute Open-label (OL) Period|Withdrawal by Subject|0|||
147536507|NCT01299272|532120239|FG002|Acute Open-label (OL) Period|Withdrawal by Subject|0|||
147536508|NCT01299272|532120240|FG003|Acute Open-label (OL) Period|Withdrawal by Subject|0|||
147536509|NCT01299272|532120237|FG000|Acute Open-label (OL) Period|Protocol Violation|36|||
147536510|NCT01299272|532120238|FG001|Acute Open-label (OL) Period|Protocol Violation|0|||
147536511|NCT01299272|532120239|FG002|Acute Open-label (OL) Period|Protocol Violation|0|||
147536512|NCT01299272|532120240|FG003|Acute Open-label (OL) Period|Protocol Violation|0|||
147536513|NCT01299272|532120237|FG000|Acute Open-label (OL) Period|Lost to Follow-up|14|||
147536514|NCT01299272|532120238|FG001|Acute Open-label (OL) Period|Lost to Follow-up|0|||
147536515|NCT01299272|532120239|FG002|Acute Open-label (OL) Period|Lost to Follow-up|0|||
147536516|NCT01299272|532120240|FG003|Acute Open-label (OL) Period|Lost to Follow-up|0|||
147536517|NCT01299272|532120237|FG000|Acute Open-label (OL) Period|Sponsor Decision|13|||
147536518|NCT01299272|532120238|FG001|Acute Open-label (OL) Period|Sponsor Decision|0|||
147536519|NCT01299272|532120239|FG002|Acute Open-label (OL) Period|Sponsor Decision|0|||
147536520|NCT01299272|532120240|FG003|Acute Open-label (OL) Period|Sponsor Decision|0|||
147536521|NCT01299272|532120237|FG000|Acute Open-label (OL) Period|Lack of Efficacy|10|||
147536522|NCT01299272|532120238|FG001|Acute Open-label (OL) Period|Lack of Efficacy|0|||
147536523|NCT01299272|532120239|FG002|Acute Open-label (OL) Period|Lack of Efficacy|0|||
147536524|NCT01299272|532120240|FG003|Acute Open-label (OL) Period|Lack of Efficacy|0|||
147536525|NCT01299272|532120237|FG000|Acute Open-label (OL) Period|Physician Decision|5|||
147536526|NCT01299272|532120238|FG001|Acute Open-label (OL) Period|Physician Decision|0|||
147536527|NCT01299272|532120239|FG002|Acute Open-label (OL) Period|Physician Decision|0|||
147536528|NCT01299272|532120240|FG003|Acute Open-label (OL) Period|Physician Decision|0|||
147536529|NCT01299272|532120237|FG000|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|0|||
147536530|NCT01299272|532120238|FG001|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|80|||
147536531|NCT01299272|532120239|FG002|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|0|||
147202218|NCT03133793|530910580|FG001|Overall Study|Withdrawal by Subject|4|||
147436754|NCT01810016|531765210|FG000|Overall Study|Death|0|||
147436755|NCT01810016|531765211|FG001|Overall Study|Death|0|||
147436756|NCT01810016|531765212|FG002|Overall Study|Death|1|||
147436757|NCT05162027|531767185|FG000|Overall Study|Adverse Event|1|||
147436758|NCT05162027|531767186|FG001|Overall Study|Adverse Event|0|||
147436759|NCT02553265|531767187|FG000|Enrollment|Death|0|||
147436760|NCT02553265|531767188|FG001|Enrollment|Death|0|||
147436761|NCT02553265|531767189|FG002|Enrollment|Death|1|||
147436762|NCT02553265|531767187|FG000|First Intervention (28 Days)|Adverse Event|1|||
147436763|NCT02553265|531767188|FG001|First Intervention (28 Days)|Adverse Event|0|||
147436764|NCT02553265|531767189|FG002|First Intervention (28 Days)|Adverse Event|0|||
147436765|NCT02553265|531767187|FG000|First Intervention (28 Days)|Withdrawal by Subject|0|||
147436766|NCT02553265|531767188|FG001|First Intervention (28 Days)|Withdrawal by Subject|0|||
147436767|NCT02553265|531767189|FG002|First Intervention (28 Days)|Withdrawal by Subject|1|||
147436768|NCT02553265|531767187|FG000|Second Intervention (28 Days)|Adverse Event|1|||
147436769|NCT02553265|531767188|FG001|Second Intervention (28 Days)|Adverse Event|0|||
147436770|NCT02553265|531767189|FG002|Second Intervention (28 Days)|Adverse Event|0|||
147436771|NCT02553265|531767187|FG000|Third Intervention (28 Days)|Adverse Event|1|||
147436772|NCT02553265|531767188|FG001|Third Intervention (28 Days)|Adverse Event|0|||
147436773|NCT02553265|531767189|FG002|Third Intervention (28 Days)|Adverse Event|0|||
147436774|NCT02553265|531767187|FG000|Third Intervention (28 Days)|Lost to Follow-up|0|||
147436775|NCT02553265|531767188|FG001|Third Intervention (28 Days)|Lost to Follow-up|0|||
147436776|NCT02553265|531767189|FG002|Third Intervention (28 Days)|Lost to Follow-up|1|||
147436777|NCT00659529|531767193|FG000|Overall Study|Withdrawal by Subject|4|||
147436778|NCT00659529|531767193|FG000|Overall Study|Protocol Violation|3|||
147436779|NCT00659529|531767193|FG000|Overall Study|Screen failure|9|||
147436780|NCT01086410|531767196|FG000|Overall Study|Adverse Event|1|||
147436781|NCT01086410|531767197|FG001|Overall Study|Adverse Event|0|||
147436782|NCT01086410|531767198|FG002|Overall Study|Adverse Event|0|||
147436783|NCT01086410|531767199|FG003|Overall Study|Adverse Event|2|||
147436784|NCT01086410|531767196|FG000|Overall Study|Lack of Efficacy|1|||
147436785|NCT01086410|531767197|FG001|Overall Study|Lack of Efficacy|1|||
147436786|NCT01086410|531767198|FG002|Overall Study|Lack of Efficacy|0|||
147436787|NCT01086410|531767199|FG003|Overall Study|Lack of Efficacy|0|||
147436788|NCT01086410|531767196|FG000|Overall Study|Protocol Violation|1|||
147436789|NCT01086410|531767197|FG001|Overall Study|Protocol Violation|1|||
147436790|NCT01086410|531767198|FG002|Overall Study|Protocol Violation|0|||
147436791|NCT01086410|531767199|FG003|Overall Study|Protocol Violation|0|||
147436792|NCT01086410|531767196|FG000|Overall Study|Lost to Follow-up|0|||
147436793|NCT01086410|531767197|FG001|Overall Study|Lost to Follow-up|0|||
147436794|NCT01086410|531767198|FG002|Overall Study|Lost to Follow-up|1|||
147436795|NCT01086410|531767199|FG003|Overall Study|Lost to Follow-up|0|||
147436796|NCT04196803|531767200|FG000|Overall Study|Withdrawal by Subject|1|||
147436797|NCT04196803|531767201|FG001|Overall Study|Withdrawal by Subject|3|||
147436798|NCT04196803|531767200|FG000|Overall Study|Adverse Event|4|||
147436799|NCT04196803|531767201|FG001|Overall Study|Adverse Event|2|||
147436800|NCT04196803|531767200|FG000|Overall Study|Lost to Follow-up|0|||
147436801|NCT04196803|531767201|FG001|Overall Study|Lost to Follow-up|1|||
147436802|NCT01022996|531767202|FG000|Overall Study|Adverse Event|14|||
147436803|NCT01022996|531767202|FG000|Overall Study|Withdrawal by Subject|3|||
147436804|NCT01022996|531767202|FG000|Overall Study|Lost to Follow-up|1|||
147436805|NCT01022996|531767202|FG000|Overall Study|Administrative problems|6|||
147436806|NCT01022996|531767202|FG000|Overall Study|Disease Progression|32|||
147436807|NCT01022996|531767202|FG000|Overall Study|Protocol Violation|1|||
147436808|NCT01950247|531767204|FG000|Overall Study|Withdrawal by Subject|28|||
147436809|NCT01950247|531767205|FG001|Overall Study|Withdrawal by Subject|13|||
147436810|NCT01950247|531767204|FG000|Overall Study|Lost to Follow-up|18|||
147202219|NCT03133793|530910581|FG002|Overall Study|Withdrawal by Subject|2|||
147202220|NCT03133793|530910582|FG003|Overall Study|Withdrawal by Subject|4|||
147436811|NCT01950247|531767205|FG001|Overall Study|Lost to Follow-up|16|||
147436812|NCT01950247|531767204|FG000|Overall Study|Physician Decision|3|||
147436813|NCT01950247|531767205|FG001|Overall Study|Physician Decision|4|||
147436814|NCT01950247|531767204|FG000|Overall Study|Adverse Event|3|||
147436815|NCT01950247|531767205|FG001|Overall Study|Adverse Event|2|||
147436816|NCT01950247|531767204|FG000|Overall Study|Death|1|||
147436817|NCT01950247|531767205|FG001|Overall Study|Death|1|||
147436818|NCT01950247|531767204|FG000|Overall Study|Not Defined|4|||
147436819|NCT01950247|531767205|FG001|Overall Study|Not Defined|10|||
147436820|NCT00763971|531767206|FG000|Overall Study|Adverse Event|5|||
147436821|NCT00763971|531767207|FG001|Overall Study|Adverse Event|2|||
147436822|NCT00763971|531767208|FG002|Overall Study|Adverse Event|4|||
147436823|NCT00763971|531767206|FG000|Overall Study|Protocol Violation|3|||
147436824|NCT00763971|531767207|FG001|Overall Study|Protocol Violation|3|||
147202221|NCT03133793|530910579|FG000|Overall Study|Lost to Follow-up|1|||
147436825|NCT00763971|531767208|FG002|Overall Study|Protocol Violation|2|||
147436826|NCT00763971|531767206|FG000|Overall Study|Withdrawal by Subject|4|||
147436827|NCT00763971|531767207|FG001|Overall Study|Withdrawal by Subject|5|||
147436828|NCT00763971|531767208|FG002|Overall Study|Withdrawal by Subject|5|||
147536532|NCT01299272|532120240|FG003|Stabilization Open-label (OL) Period|Randomization Criteria Not Met|0|||
147536533|NCT01299272|532120237|FG000|Stabilization Open-label (OL) Period|Protocol Violation|0|||
147536534|NCT01299272|532120238|FG001|Stabilization Open-label (OL) Period|Protocol Violation|44|||
147536535|NCT01299272|532120239|FG002|Stabilization Open-label (OL) Period|Protocol Violation|0|||
147536536|NCT01299272|532120240|FG003|Stabilization Open-label (OL) Period|Protocol Violation|0|||
147536537|NCT01299272|532120237|FG000|Stabilization Open-label (OL) Period|Adverse Event|0|||
147536538|NCT01299272|532120238|FG001|Stabilization Open-label (OL) Period|Adverse Event|42|||
147536539|NCT01299272|532120239|FG002|Stabilization Open-label (OL) Period|Adverse Event|0|||
147536540|NCT01299272|532120240|FG003|Stabilization Open-label (OL) Period|Adverse Event|0|||
147536541|NCT01299272|532120237|FG000|Stabilization Open-label (OL) Period|Withdrawal by Subject|0|||
147536542|NCT01299272|532120238|FG001|Stabilization Open-label (OL) Period|Withdrawal by Subject|42|||
147536543|NCT01299272|532120239|FG002|Stabilization Open-label (OL) Period|Withdrawal by Subject|0|||
147536544|NCT01299272|532120240|FG003|Stabilization Open-label (OL) Period|Withdrawal by Subject|0|||
147536545|NCT01299272|532120237|FG000|Stabilization Open-label (OL) Period|Sponsor Decision|0|||
147536546|NCT01299272|532120238|FG001|Stabilization Open-label (OL) Period|Sponsor Decision|12|||
147536547|NCT01299272|532120239|FG002|Stabilization Open-label (OL) Period|Sponsor Decision|0|||
147536548|NCT01299272|532120240|FG003|Stabilization Open-label (OL) Period|Sponsor Decision|0|||
147536549|NCT01299272|532120237|FG000|Stabilization Open-label (OL) Period|Lack of Efficacy|0|||
147536550|NCT01299272|532120238|FG001|Stabilization Open-label (OL) Period|Lack of Efficacy|11|||
147536551|NCT01299272|532120239|FG002|Stabilization Open-label (OL) Period|Lack of Efficacy|0|||
147536552|NCT01299272|532120240|FG003|Stabilization Open-label (OL) Period|Lack of Efficacy|0|||
147536553|NCT01299272|532120237|FG000|Stabilization Open-label (OL) Period|Lost to Follow-up|0|||
147536554|NCT01299272|532120238|FG001|Stabilization Open-label (OL) Period|Lost to Follow-up|9|||
147536555|NCT01299272|532120239|FG002|Stabilization Open-label (OL) Period|Lost to Follow-up|0|||
147536556|NCT01299272|532120240|FG003|Stabilization Open-label (OL) Period|Lost to Follow-up|0|||
147536557|NCT01299272|532120237|FG000|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|0|||
147536558|NCT01299272|532120238|FG001|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|6|||
147536559|NCT01299272|532120239|FG002|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|0|||
147536560|NCT01299272|532120240|FG003|Stabilization Open-label (OL) Period|Reemergence of Study Condition Symptoms|0|||
147536561|NCT01299272|532120237|FG000|Stabilization Open-label (OL) Period|Physician Decision|0|||
147536562|NCT01299272|532120238|FG001|Stabilization Open-label (OL) Period|Physician Decision|3|||
147536563|NCT01299272|532120239|FG002|Stabilization Open-label (OL) Period|Physician Decision|0|||
147536564|NCT01299272|532120240|FG003|Stabilization Open-label (OL) Period|Physician Decision|0|||
147536565|NCT01299272|532120237|FG000|Double-blind (DB) Randomized Period|Withdrawal by Subject|0|||
147536566|NCT01299272|532120238|FG001|Double-blind (DB) Randomized Period|Withdrawal by Subject|0|||
147536567|NCT01299272|532120239|FG002|Double-blind (DB) Randomized Period|Withdrawal by Subject|22|||
147649419|NCT02634801|532537342|FG001|Treatment Period (Weeks 0 to 24)|Lost to Follow-up|1|||
147436829|NCT00763971|531767206|FG000|Overall Study|Lost to Follow-up|0|||
147436830|NCT00763971|531767207|FG001|Overall Study|Lost to Follow-up|1|||
147436831|NCT00763971|531767208|FG002|Overall Study|Lost to Follow-up|0|||
147436832|NCT00763971|531767206|FG000|Overall Study|Lack of Efficacy|11|||
147436833|NCT00763971|531767207|FG001|Overall Study|Lack of Efficacy|22|||
147436834|NCT00763971|531767208|FG002|Overall Study|Lack of Efficacy|54|||
147436835|NCT00763971|531767206|FG000|Overall Study|Unable to swallow capsule|2|||
147436836|NCT00763971|531767207|FG001|Overall Study|Unable to swallow capsule|1|||
147436837|NCT00763971|531767208|FG002|Overall Study|Unable to swallow capsule|1|||
147436838|NCT00763971|531767206|FG000|Overall Study|Personal reason|3|||
147436839|NCT00763971|531767207|FG001|Overall Study|Personal reason|0|||
147436840|NCT00763971|531767208|FG002|Overall Study|Personal reason|0|||
147436841|NCT00763971|531767206|FG000|Overall Study|Exclusion criteria met|1|||
147436842|NCT00763971|531767207|FG001|Overall Study|Exclusion criteria met|0|||
147436843|NCT00763971|531767208|FG002|Overall Study|Exclusion criteria met|0|||
147436844|NCT00763971|531767206|FG000|Overall Study|Sponsor decision|1|||
147436845|NCT00763971|531767207|FG001|Overall Study|Sponsor decision|0|||
147436846|NCT00763971|531767208|FG002|Overall Study|Sponsor decision|0|||
147436847|NCT00763971|531767206|FG000|Overall Study|Due to holiday season|2|||
147436848|NCT00763971|531767207|FG001|Overall Study|Due to holiday season|0|||
147436849|NCT00763971|531767208|FG002|Overall Study|Due to holiday season|1|||
147436850|NCT00763971|531767206|FG000|Overall Study|Randomization error|0|||
147436851|NCT00763971|531767207|FG001|Overall Study|Randomization error|0|||
147436852|NCT00763971|531767208|FG002|Overall Study|Randomization error|1|||
147436853|NCT00763971|531767206|FG000|Overall Study|Medical monitor decision|0|||
147436854|NCT00763971|531767207|FG001|Overall Study|Medical monitor decision|0|||
147436855|NCT00763971|531767208|FG002|Overall Study|Medical monitor decision|1|||
147436856|NCT00763971|531767206|FG000|Overall Study|Moved to another country|0|||
147436857|NCT00763971|531767207|FG001|Overall Study|Moved to another country|1|||
147436858|NCT00763971|531767208|FG002|Overall Study|Moved to another country|0|||
147436859|NCT00763971|531767206|FG000|Overall Study|Subject wanted dose reduction|0|||
147536568|NCT01299272|532120240|FG003|Double-blind (DB) Randomized Period|Withdrawal by Subject|15|||
147436860|NCT00763971|531767207|FG001|Overall Study|Subject wanted dose reduction|1|||
147436861|NCT00763971|531767208|FG002|Overall Study|Subject wanted dose reduction|0|||
147436862|NCT00763971|531767206|FG000|Overall Study|Lack of availability|0|||
147436863|NCT00763971|531767207|FG001|Overall Study|Lack of availability|1|||
147436864|NCT00763971|531767208|FG002|Overall Study|Lack of availability|0|||
147436865|NCT00763971|531767206|FG000|Overall Study|Performed final visit on phone|0|||
147436866|NCT00763971|531767207|FG001|Overall Study|Performed final visit on phone|1|||
147436867|NCT00763971|531767208|FG002|Overall Study|Performed final visit on phone|0|||
147436868|NCT00763971|531767206|FG000|Overall Study|Participation in 489-326 required|1|||
147436869|NCT00763971|531767207|FG001|Overall Study|Participation in 489-326 required|0|||
147436870|NCT00763971|531767208|FG002|Overall Study|Participation in 489-326 required|0|||
147436871|NCT00710879|531767209|FG000|Overall Study|Lost to Follow-up|2|||
147436872|NCT00710879|531767210|FG001|Overall Study|Lost to Follow-up|1|||
147436873|NCT00710879|531767209|FG000|Overall Study|Protocol Violation|0|||
147436874|NCT00710879|531767210|FG001|Overall Study|Protocol Violation|3|||
147436875|NCT03383289|531767213|FG000|Overall Study|Death|83|||
147436876|NCT03383289|531767214|FG001|Overall Study|Death|78|||
147436877|NCT03383289|531767213|FG000|Overall Study|discharge from facility|84|||
147436878|NCT03383289|531767214|FG001|Overall Study|discharge from facility|84|||
147436879|NCT03383289|531767213|FG000|Overall Study|Withdrawal by Subject|4|||
147436880|NCT03383289|531767214|FG001|Overall Study|Withdrawal by Subject|1|||
147436881|NCT00832117|531767215|FG000|Overall Study|Death|1|||
147436882|NCT00832117|531767215|FG000|Overall Study|Disease Progression|11|||
147436883|NCT01186939|531767216|FG000|Overall Study|Death|7|||
147436884|NCT01186939|531767216|FG000|Overall Study|Withdrawal by Subject|2|||
147436885|NCT01186939|531767216|FG000|Overall Study|No longer receiving clinical benefit|17|||
147436886|NCT01186939|531767216|FG000|Overall Study|Program closed|5|||
147436887|NCT01186939|531767216|FG000|Overall Study|Sponsor decision|4|||
147436888|NCT01186939|531767216|FG000|Overall Study|Started additional treatment|1|||
147436889|NCT01186939|531767216|FG000|Overall Study|NCI CTC Grade 3 or 4 toxicity|1|||
147436890|NCT01186939|531767216|FG000|Overall Study|Myocardial infarction|1|||
147436891|NCT01186939|531767216|FG000|Overall Study|Bone marrow transplant|1|||
147436892|NCT01186939|531767216|FG000|Overall Study|Transformation to AML|1|||
147436893|NCT03945591|531767221|FG000|Overall Study|Participant not transplanted|1|||
147436894|NCT03945591|531767221|FG000|Overall Study|Change in treatment plan|3|||
147436895|NCT03945591|531767221|FG000|Overall Study|Adverse Event|1|||
147436896|NCT00698204|531767222|FG000|Overall Study|Withdrawal by Subject|1|||
147436897|NCT00698204|531767223|FG001|Overall Study|Withdrawal by Subject|0|||
147436898|NCT01179672|531767224|FG000|Overall Study|Adverse Event|17|||
147436899|NCT01179672|531767225|FG001|Overall Study|Adverse Event|8|||
147436900|NCT01179672|531767224|FG000|Overall Study|Withdrawal by Subject|10|||
147436901|NCT01179672|531767225|FG001|Overall Study|Withdrawal by Subject|12|||
147436902|NCT01179672|531767224|FG000|Overall Study|Entry Criteria Not Met|0|||
147436903|NCT01179672|531767225|FG001|Overall Study|Entry Criteria Not Met|2|||
147436904|NCT01179672|531767224|FG000|Overall Study|Lost to Follow-up|0|||
147436905|NCT01179672|531767225|FG001|Overall Study|Lost to Follow-up|1|||
147436906|NCT01179672|531767224|FG000|Overall Study|Protocol Violation|2|||
147436907|NCT01179672|531767225|FG001|Overall Study|Protocol Violation|2|||
147436908|NCT01179672|531767224|FG000|Overall Study|Physician Decision|1|||
147436909|NCT01179672|531767225|FG001|Overall Study|Physician Decision|1|||
147436910|NCT00314249|531767226|FG000|Overall Study|Adverse Event|73|||
147436911|NCT00314249|531767227|FG001|Overall Study|Adverse Event|94|||
147436912|NCT00314249|531767226|FG000|Overall Study|Lack of Efficacy|33|||
147436913|NCT00314249|531767227|FG001|Overall Study|Lack of Efficacy|24|||
147436914|NCT00314249|531767226|FG000|Overall Study|Withdrawal by Subject|21|||
147436915|NCT00314249|531767227|FG001|Overall Study|Withdrawal by Subject|28|||
147436916|NCT00314249|531767226|FG000|Overall Study|Lost to Follow-up|15|||
147436917|NCT00314249|531767227|FG001|Overall Study|Lost to Follow-up|9|||
147436918|NCT00314249|531767226|FG000|Overall Study|Physician Decision|1|||
147436919|NCT00314249|531767227|FG001|Overall Study|Physician Decision|1|||
147436920|NCT00314249|531767226|FG000|Overall Study|Withdrawn for other reasons|4|||
147436921|NCT00314249|531767227|FG001|Overall Study|Withdrawn for other reasons|1|||
147436922|NCT00314249|531767226|FG000|Overall Study|Non-Compliant|5|||
147436923|NCT00314249|531767227|FG001|Overall Study|Non-Compliant|6|||
147436924|NCT01949155|531767228|FG000|Overall Study|Lost to Follow-up|1|||
147436925|NCT01949155|531767229|FG001|Overall Study|Lost to Follow-up|0|||
147436926|NCT01949155|531767228|FG000|Overall Study|Protocol Violation|1|||
147436927|NCT01949155|531767229|FG001|Overall Study|Protocol Violation|0|||
147436928|NCT04667377|531767230|FG000|Dose Escalation Period|Other not specified below|3|||
147436929|NCT04667377|531767231|FG001|Dose Escalation Period|Other not specified below|3|||
147436930|NCT04667377|531767232|FG002|Dose Escalation Period|Other not specified below|2|||
147436931|NCT04667377|531767233|FG003|Dose Escalation Period|Other not specified below|1|||
147436932|NCT04667377|531767234|FG004|Dose Escalation Period|Other not specified below|3|||
147436933|NCT04667377|531767230|FG000|Dose Escalation Period|Protocol Violation|2|||
147436934|NCT04667377|531767231|FG001|Dose Escalation Period|Protocol Violation|2|||
147436935|NCT04667377|531767232|FG002|Dose Escalation Period|Protocol Violation|0|||
147436936|NCT04667377|531767233|FG003|Dose Escalation Period|Protocol Violation|2|||
147536569|NCT01299272|532120237|FG000|Double-blind (DB) Randomized Period|Lack of Efficacy|0|||
147536570|NCT01299272|532120238|FG001|Double-blind (DB) Randomized Period|Lack of Efficacy|0|||
147536571|NCT01299272|532120239|FG002|Double-blind (DB) Randomized Period|Lack of Efficacy|20|||
147536572|NCT01299272|532120240|FG003|Double-blind (DB) Randomized Period|Lack of Efficacy|10|||
147536573|NCT01299272|532120237|FG000|Double-blind (DB) Randomized Period|Adverse Event|0|||
147536574|NCT01299272|532120238|FG001|Double-blind (DB) Randomized Period|Adverse Event|0|||
147536575|NCT01299272|532120239|FG002|Double-blind (DB) Randomized Period|Adverse Event|8|||
147536576|NCT01299272|532120240|FG003|Double-blind (DB) Randomized Period|Adverse Event|9|||
147536577|NCT01299272|532120237|FG000|Double-blind (DB) Randomized Period|Protocol Violation|0|||
147536578|NCT01299272|532120238|FG001|Double-blind (DB) Randomized Period|Protocol Violation|0|||
147536579|NCT01299272|532120239|FG002|Double-blind (DB) Randomized Period|Protocol Violation|8|||
147536580|NCT01299272|532120240|FG003|Double-blind (DB) Randomized Period|Protocol Violation|7|||
147536581|NCT01299272|532120237|FG000|Double-blind (DB) Randomized Period|Lost to Follow-up|0|||
147536582|NCT01299272|532120238|FG001|Double-blind (DB) Randomized Period|Lost to Follow-up|0|||
147536583|NCT01299272|532120239|FG002|Double-blind (DB) Randomized Period|Lost to Follow-up|5|||
147536584|NCT01299272|532120240|FG003|Double-blind (DB) Randomized Period|Lost to Follow-up|5|||
147536585|NCT01299272|532120237|FG000|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|0|||
147536586|NCT01299272|532120238|FG001|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|0|||
147536587|NCT01299272|532120239|FG002|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|4|||
147536588|NCT01299272|532120240|FG003|Double-blind (DB) Randomized Period|Reemergence of Study Condition Symptoms|10|||
147536589|NCT01299272|532120237|FG000|Double-blind (DB) Randomized Period|Physician Decision|0|||
147536590|NCT01299272|532120238|FG001|Double-blind (DB) Randomized Period|Physician Decision|0|||
147536591|NCT01299272|532120239|FG002|Double-blind (DB) Randomized Period|Physician Decision|2|||
147536592|NCT01299272|532120240|FG003|Double-blind (DB) Randomized Period|Physician Decision|1|||
147536593|NCT01299272|532120237|FG000|Double-blind (DB) Randomized Period|Sponsor Decision|0|||
147536594|NCT01299272|532120238|FG001|Double-blind (DB) Randomized Period|Sponsor Decision|0|||
147536595|NCT01299272|532120239|FG002|Double-blind (DB) Randomized Period|Sponsor Decision|1|||
147536596|NCT01299272|532120240|FG003|Double-blind (DB) Randomized Period|Sponsor Decision|1|||
147536597|NCT00297882|532120250|FG000|Day 14|Lack of Efficacy|12|||
147536598|NCT00297882|532120251|FG001|Day 14|Lack of Efficacy|49|||
147536599|NCT00297882|532120250|FG000|Day 28|Lost to Follow-up|13|||
147536600|NCT00297882|532120251|FG001|Day 28|Lost to Follow-up|23|||
147536601|NCT00297882|532120250|FG000|Day 28|Lack of Efficacy|3|||
147536602|NCT00297882|532120251|FG001|Day 28|Lack of Efficacy|0|||
147536603|NCT04242264|532120252|FG000|Overall Study|Lost to Follow-up|2|||
147536604|NCT04242264|532120253|FG001|Overall Study|Lost to Follow-up|2|||
147536605|NCT04242264|532120254|FG002|Overall Study|Lost to Follow-up|1|||
147536606|NCT04242264|532120255|FG003|Overall Study|Lost to Follow-up|1|||
147536607|NCT04242264|532120252|FG000|Overall Study|Withdrawal by Subject|1|||
147536608|NCT04242264|532120253|FG001|Overall Study|Withdrawal by Subject|0|||
147536609|NCT04242264|532120254|FG002|Overall Study|Withdrawal by Subject|0|||
147536610|NCT04242264|532120255|FG003|Overall Study|Withdrawal by Subject|0|||
147536611|NCT03710824|532120256|FG000|Overall Study|Withdrawal by Subject|1|||
147536612|NCT03710824|532120256|FG000|Overall Study|Lost to Follow-up|3|||
147536613|NCT03710824|532120256|FG000|Overall Study|Adverse Event|25|||
147536614|NCT03710824|532120256|FG000|Overall Study|Treatment discontinuation|2|||
147536615|NCT01353209|532120257|FG000|Overall Study|Adverse Event|1|||
147536616|NCT01353209|532120258|FG001|Overall Study|Adverse Event|1|||
147536617|NCT03237325|532120263|FG000|Overall Study|Lost to Follow-up|3|||
147536618|NCT03237325|532120264|FG001|Overall Study|Lost to Follow-up|5|||
147536619|NCT03237325|532120263|FG000|Overall Study|Physician Decision|2|||
147536620|NCT03237325|532120264|FG001|Overall Study|Physician Decision|4|||
147536621|NCT03237325|532120263|FG000|Overall Study|Withdrawal by Subject|9|||
147536622|NCT03237325|532120264|FG001|Overall Study|Withdrawal by Subject|12|||
147536623|NCT03237325|532120263|FG000|Overall Study|Noncompliance with Study Procedures|1|||
147536624|NCT03237325|532120264|FG001|Overall Study|Noncompliance with Study Procedures|1|||
147536625|NCT03237325|532120263|FG000|Overall Study|Termination by Sponsor|0|||
147536626|NCT03237325|532120264|FG001|Overall Study|Termination by Sponsor|1|||
147536627|NCT03237325|532120263|FG000|Overall Study|Reason other than described|0|||
147536628|NCT03237325|532120264|FG001|Overall Study|Reason other than described|2|||
147536629|NCT04139642|532120267|FG000|First Intervention (9 Months)|Permission denied to use the device by clinic manager|0|||
147536630|NCT04139642|532120268|FG001|First Intervention (9 Months)|Permission denied to use the device by clinic manager|1|||
147536631|NCT03733301|532120271|FG000|Overall Study|Screen Fail|1|||
147536632|NCT03733301|532120272|FG001|Overall Study|Screen Fail|0|||
147536633|NCT03733301|532120273|FG002|Overall Study|Screen Fail|0|||
147536634|NCT03733301|532120271|FG000|Overall Study|Non-compliance|1|||
147649420|NCT02634801|532537343|FG002|Treatment Period (Weeks 0 to 24)|Lost to Follow-up|1|||
147536635|NCT03733301|532120272|FG001|Overall Study|Non-compliance|0|||
147536636|NCT03733301|532120273|FG002|Overall Study|Non-compliance|0|||
147536637|NCT03733301|532120271|FG000|Overall Study|Lack of Efficacy|2|||
147536638|NCT03733301|532120272|FG001|Overall Study|Lack of Efficacy|3|||
147536639|NCT03733301|532120273|FG002|Overall Study|Lack of Efficacy|0|||
147536640|NCT03733301|532120271|FG000|Overall Study|Adverse Event|0|||
147536641|NCT03733301|532120272|FG001|Overall Study|Adverse Event|1|||
147536642|NCT03733301|532120273|FG002|Overall Study|Adverse Event|3|||
147536643|NCT03733301|532120271|FG000|Overall Study|Withdrawal by Subject|3|||
147536644|NCT03733301|532120272|FG001|Overall Study|Withdrawal by Subject|5|||
147536645|NCT03733301|532120273|FG002|Overall Study|Withdrawal by Subject|1|||
147536646|NCT02050373|532120274|FG000|Overall Study|Adverse Event|4|||
147536647|NCT02050373|532120275|FG001|Overall Study|Adverse Event|7|||
147536648|NCT02050373|532120274|FG000|Overall Study|Death|3|||
147536649|NCT02050373|532120275|FG001|Overall Study|Death|3|||
147536650|NCT00557830|532120282|FG000|Screening Treatment Phase|Withdrawal by Subject|1|||
147536651|NCT00557830|532120283|FG001|Screening Treatment Phase|Withdrawal by Subject|0|||
147536652|NCT00557830|532120284|FG002|Screening Treatment Phase|Withdrawal by Subject|0|||
147536653|NCT00557830|532120282|FG000|Screening Treatment Phase|Adverse Event|2|||
147536654|NCT00557830|532120283|FG001|Screening Treatment Phase|Adverse Event|0|||
147536655|NCT00557830|532120284|FG002|Screening Treatment Phase|Adverse Event|0|||
147536656|NCT00557830|532120282|FG000|Screening Treatment Phase|Unable to tolerate standard dose|3|||
147536657|NCT00557830|532120283|FG001|Screening Treatment Phase|Unable to tolerate standard dose|0|||
147536658|NCT00557830|532120284|FG002|Screening Treatment Phase|Unable to tolerate standard dose|0|||
147536659|NCT01803464|532120288|FG000|Overall Study|Incomplete data|0|||
147536660|NCT01803464|532120289|FG001|Overall Study|Incomplete data|0|||
147536661|NCT01803464|532120290|FG002|Overall Study|Incomplete data|4|||
147536662|NCT01803464|532120291|FG003|Overall Study|Incomplete data|0|||
147536663|NCT01803464|532120288|FG000|Overall Study|Withdrawal by Subject|1|||
147536664|NCT01803464|532120289|FG001|Overall Study|Withdrawal by Subject|0|||
147536665|NCT01803464|532120290|FG002|Overall Study|Withdrawal by Subject|0|||
147536666|NCT01803464|532120291|FG003|Overall Study|Withdrawal by Subject|0|||
147536667|NCT02860039|532120294|FG000|Overall Study|Death|4|||
147536668|NCT02860039|532120295|FG001|Overall Study|Death|0|||
147536669|NCT02860039|532120294|FG000|Overall Study|Lost to Follow-up|2|||
147536670|NCT02860039|532120295|FG001|Overall Study|Lost to Follow-up|2|||
147536671|NCT02860039|532120294|FG000|Overall Study|Protocol Violation|3|||
147536672|NCT02860039|532120295|FG001|Overall Study|Protocol Violation|1|||
147536673|NCT02860039|532120294|FG000|Overall Study|Withdrawal by Subject|1|||
147536674|NCT02860039|532120295|FG001|Overall Study|Withdrawal by Subject|0|||
147536675|NCT02860039|532120294|FG000|Overall Study|Not otherwise eligible|1|||
147536676|NCT02860039|532120295|FG001|Overall Study|Not otherwise eligible|1|||
147536677|NCT01856257|532120299|FG000|Overall Study|Death|2|||
147536678|NCT01856257|532120300|FG001|Overall Study|Death|0|||
147202222|NCT03133793|530910580|FG001|Overall Study|Lost to Follow-up|0|||
147202223|NCT03133793|530910581|FG002|Overall Study|Lost to Follow-up|2|||
147202224|NCT03133793|530910582|FG003|Overall Study|Lost to Follow-up|0|||
147202225|NCT03133793|530910579|FG000|Overall Study|Death|0|||
147202226|NCT03133793|530910580|FG001|Overall Study|Death|0|||
147202227|NCT03133793|530910581|FG002|Overall Study|Death|0|||
147202228|NCT03133793|530910582|FG003|Overall Study|Death|1|||
147202229|NCT03486834|530910583|FG000|Overall Study|Withdrawal by Subject|46|||
147202230|NCT03486834|530910584|FG001|Overall Study|Withdrawal by Subject|46|||
147202231|NCT03486834|530910585|FG002|Overall Study|Withdrawal by Subject|52|||
147202232|NCT03486834|530910583|FG000|Overall Study|Adverse Event|8|||
147202233|NCT03486834|530910584|FG001|Overall Study|Adverse Event|7|||
147202234|NCT03486834|530910585|FG002|Overall Study|Adverse Event|0|||
147202235|NCT03486834|530910583|FG000|Overall Study|Lost to Follow-up|41|||
147202236|NCT03486834|530910584|FG001|Overall Study|Lost to Follow-up|24|||
147202237|NCT03486834|530910585|FG002|Overall Study|Lost to Follow-up|39|||
147202238|NCT03486834|530910583|FG000|Overall Study|Non-compliance with Study Drug|2|||
147202239|NCT03486834|530910584|FG001|Overall Study|Non-compliance with Study Drug|2|||
147202240|NCT03486834|530910585|FG002|Overall Study|Non-compliance with Study Drug|0|||
147202241|NCT03486834|530910583|FG000|Overall Study|Physician Decision|5|||
147202242|NCT03486834|530910584|FG001|Overall Study|Physician Decision|2|||
147202243|NCT03486834|530910585|FG002|Overall Study|Physician Decision|3|||
147202244|NCT03486834|530910583|FG000|Overall Study|Pregnancy|10|||
147202245|NCT03486834|530910584|FG001|Overall Study|Pregnancy|12|||
147536679|NCT01856257|532120301|FG002|Overall Study|Death|0|||
147536680|NCT01856257|532120302|FG003|Overall Study|Death|0|||
147536681|NCT01856257|532120299|FG000|Overall Study|Physician Decision|0|||
147536682|NCT01856257|532120300|FG001|Overall Study|Physician Decision|0|||
147536683|NCT01856257|532120301|FG002|Overall Study|Physician Decision|0|||
147202246|NCT03486834|530910585|FG002|Overall Study|Pregnancy|12|||
147202247|NCT03486834|530910583|FG000|Overall Study|Protocol Deviation|2|||
147202248|NCT03486834|530910584|FG001|Overall Study|Protocol Deviation|3|||
147202249|NCT03486834|530910585|FG002|Overall Study|Protocol Deviation|3|||
147536684|NCT01856257|532120302|FG003|Overall Study|Physician Decision|1|||
147536685|NCT01856257|532120299|FG000|Overall Study|Withdrawal by Subject|1|||
147536686|NCT01856257|532120300|FG001|Overall Study|Withdrawal by Subject|1|||
147536687|NCT01856257|532120301|FG002|Overall Study|Withdrawal by Subject|0|||
147536688|NCT01856257|532120302|FG003|Overall Study|Withdrawal by Subject|0|||
147536689|NCT01856257|532120299|FG000|Overall Study|Donor complication|0|||
147202250|NCT03486834|530910583|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
147536690|NCT01856257|532120300|FG001|Overall Study|Donor complication|0|||
147536691|NCT01856257|532120301|FG002|Overall Study|Donor complication|0|||
147536692|NCT01856257|532120302|FG003|Overall Study|Donor complication|1|||
147536693|NCT03664024|532120303|FG000|Overall Study|Follow-up discontinued by sponsor|34|||
147536694|NCT03664024|532120303|FG000|Overall Study|Lost to Follow-up|2|||
147536695|NCT03664024|532120303|FG000|Overall Study|Withdrawal by Subject|2|||
147536696|NCT03664024|532120303|FG000|Overall Study|Death|80|||
147536697|NCT01157065|532120304|FG000|Overall Study|Death|0|||
147536698|NCT01157065|532120305|FG001|Overall Study|Death|1|||
147536699|NCT05275673|532120308|FG000|Overall Study|Study Termination by Sponsor|2|||
147536700|NCT05275673|532120309|FG001|Overall Study|Study Termination by Sponsor|3|||
147536701|NCT05275673|532120308|FG000|Overall Study|Death|1|||
147536702|NCT05275673|532120309|FG001|Overall Study|Death|0|||
147536703|NCT05275673|532120308|FG000|Overall Study|Withdrawal by Subject|1|||
147536704|NCT05275673|532120309|FG001|Overall Study|Withdrawal by Subject|0|||
147536705|NCT02325739|532120310|FG000|Phase I Part|Adverse Event|1|||
147536706|NCT02325739|532120311|FG001|Phase I Part|Adverse Event|0|||
147536707|NCT02325739|532120312|FG002|Phase I Part|Adverse Event|1|||
147536708|NCT02325739|532120313|FG003|Phase I Part|Adverse Event|2|||
147536709|NCT02325739|532120314|FG004|Phase I Part|Adverse Event|3|||
147536710|NCT02325739|532120315|FG005|Phase I Part|Adverse Event|1|||
147536711|NCT02325739|532120316|FG006|Phase I Part|Adverse Event|0|||
147536712|NCT02325739|532120317|FG007|Phase I Part|Adverse Event|2|||
147536713|NCT02325739|532120318|FG008|Phase I Part|Adverse Event|0|||
147536714|NCT02325739|532120319|FG009|Phase I Part|Adverse Event|0|||
147536715|NCT02325739|532120320|FG010|Phase I Part|Adverse Event|0|||
147536716|NCT02325739|532120310|FG000|Phase I Part|Progressive disease|9|||
147536717|NCT02325739|532120311|FG001|Phase I Part|Progressive disease|6|||
147536718|NCT02325739|532120312|FG002|Phase I Part|Progressive disease|3|||
147536719|NCT02325739|532120313|FG003|Phase I Part|Progressive disease|23|||
147536720|NCT02325739|532120314|FG004|Phase I Part|Progressive disease|14|||
147536721|NCT02325739|532120315|FG005|Phase I Part|Progressive disease|6|||
147536722|NCT02325739|532120316|FG006|Phase I Part|Progressive disease|6|||
147536723|NCT02325739|532120317|FG007|Phase I Part|Progressive disease|3|||
147536724|NCT02325739|532120318|FG008|Phase I Part|Progressive disease|0|||
147536725|NCT02325739|532120319|FG009|Phase I Part|Progressive disease|0|||
147536726|NCT02325739|532120320|FG010|Phase I Part|Progressive disease|0|||
147536727|NCT02325739|532120310|FG000|Phase I Part|Subject/guardian decision|1|||
147536728|NCT02325739|532120311|FG001|Phase I Part|Subject/guardian decision|0|||
147536729|NCT02325739|532120312|FG002|Phase I Part|Subject/guardian decision|1|||
147536730|NCT02325739|532120313|FG003|Phase I Part|Subject/guardian decision|1|||
147536731|NCT02325739|532120314|FG004|Phase I Part|Subject/guardian decision|0|||
147536732|NCT02325739|532120315|FG005|Phase I Part|Subject/guardian decision|0|||
147536733|NCT02325739|532120316|FG006|Phase I Part|Subject/guardian decision|0|||
147536734|NCT02325739|532120317|FG007|Phase I Part|Subject/guardian decision|1|||
147536735|NCT02325739|532120318|FG008|Phase I Part|Subject/guardian decision|0|||
147536736|NCT02325739|532120319|FG009|Phase I Part|Subject/guardian decision|0|||
147536737|NCT02325739|532120320|FG010|Phase I Part|Subject/guardian decision|0|||
147536738|NCT02325739|532120310|FG000|Phase I Part|Death|0|||
147536739|NCT02325739|532120311|FG001|Phase I Part|Death|0|||
147536740|NCT02325739|532120312|FG002|Phase I Part|Death|0|||
147536741|NCT02325739|532120313|FG003|Phase I Part|Death|0|||
147536742|NCT02325739|532120314|FG004|Phase I Part|Death|2|||
147536743|NCT02325739|532120315|FG005|Phase I Part|Death|0|||
147536744|NCT02325739|532120316|FG006|Phase I Part|Death|0|||
147536745|NCT02325739|532120317|FG007|Phase I Part|Death|0|||
147536746|NCT02325739|532120318|FG008|Phase I Part|Death|0|||
147536747|NCT02325739|532120319|FG009|Phase I Part|Death|0|||
147536748|NCT02325739|532120320|FG010|Phase I Part|Death|0|||
147536749|NCT02325739|532120310|FG000|Phase II Part|Adverse Event|0|||
147536750|NCT02325739|532120311|FG001|Phase II Part|Adverse Event|0|||
147536751|NCT02325739|532120312|FG002|Phase II Part|Adverse Event|0|||
147536752|NCT02325739|532120313|FG003|Phase II Part|Adverse Event|0|||
147536753|NCT02325739|532120314|FG004|Phase II Part|Adverse Event|0|||
147536754|NCT02325739|532120315|FG005|Phase II Part|Adverse Event|0|||
147536755|NCT02325739|532120316|FG006|Phase II Part|Adverse Event|0|||
147536756|NCT02325739|532120317|FG007|Phase II Part|Adverse Event|0|||
147536757|NCT02325739|532120318|FG008|Phase II Part|Adverse Event|4|||
147536758|NCT02325739|532120319|FG009|Phase II Part|Adverse Event|5|||
147536759|NCT02325739|532120320|FG010|Phase II Part|Adverse Event|1|||
147536760|NCT02325739|532120310|FG000|Phase II Part|Physician Decision|0|||
147536761|NCT02325739|532120311|FG001|Phase II Part|Physician Decision|0|||
147536762|NCT02325739|532120312|FG002|Phase II Part|Physician Decision|0|||
147536763|NCT02325739|532120313|FG003|Phase II Part|Physician Decision|0|||
147536764|NCT02325739|532120314|FG004|Phase II Part|Physician Decision|0|||
147536765|NCT02325739|532120315|FG005|Phase II Part|Physician Decision|0|||
147536766|NCT02325739|532120316|FG006|Phase II Part|Physician Decision|0|||
147536767|NCT02325739|532120317|FG007|Phase II Part|Physician Decision|0|||
147536768|NCT02325739|532120318|FG008|Phase II Part|Physician Decision|0|||
147536769|NCT02325739|532120319|FG009|Phase II Part|Physician Decision|1|||
147536770|NCT02325739|532120320|FG010|Phase II Part|Physician Decision|0|||
147536771|NCT02325739|532120310|FG000|Phase II Part|Progressive disease|0|||
147536772|NCT02325739|532120311|FG001|Phase II Part|Progressive disease|0|||
147536773|NCT02325739|532120312|FG002|Phase II Part|Progressive disease|0|||
147536774|NCT02325739|532120313|FG003|Phase II Part|Progressive disease|0|||
147536775|NCT02325739|532120314|FG004|Phase II Part|Progressive disease|0|||
147536776|NCT02325739|532120315|FG005|Phase II Part|Progressive disease|0|||
147536777|NCT02325739|532120316|FG006|Phase II Part|Progressive disease|0|||
147536778|NCT02325739|532120317|FG007|Phase II Part|Progressive disease|0|||
147536779|NCT02325739|532120318|FG008|Phase II Part|Progressive disease|22|||
147536780|NCT02325739|532120319|FG009|Phase II Part|Progressive disease|29|||
147536781|NCT02325739|532120320|FG010|Phase II Part|Progressive disease|18|||
147536782|NCT02325739|532120310|FG000|Phase II Part|Subject/guardian decision|0|||
147536783|NCT02325739|532120311|FG001|Phase II Part|Subject/guardian decision|0|||
147536784|NCT02325739|532120312|FG002|Phase II Part|Subject/guardian decision|0|||
147536785|NCT02325739|532120313|FG003|Phase II Part|Subject/guardian decision|0|||
147536786|NCT02325739|532120314|FG004|Phase II Part|Subject/guardian decision|0|||
147536787|NCT02325739|532120315|FG005|Phase II Part|Subject/guardian decision|0|||
147536788|NCT02325739|532120316|FG006|Phase II Part|Subject/guardian decision|0|||
147536789|NCT02325739|532120317|FG007|Phase II Part|Subject/guardian decision|0|||
147536790|NCT02325739|532120318|FG008|Phase II Part|Subject/guardian decision|4|||
147536791|NCT02325739|532120319|FG009|Phase II Part|Subject/guardian decision|1|||
147536792|NCT02325739|532120320|FG010|Phase II Part|Subject/guardian decision|1|||
147536793|NCT00227591|532120321|FG000|Overall Study|Withdrawal by Subject|1|||
147536794|NCT01886105|532120322|FG000|Overall Study|Lack of Efficacy|3|||
147536795|NCT02057549|532120326|FG000|Overall Study|Lost to Follow-up|1|||
147536796|NCT02057549|532120327|FG001|Overall Study|Lost to Follow-up|0|||
147536797|NCT02057549|532120326|FG000|Overall Study|Physician Decision|1|||
147536798|NCT02057549|532120327|FG001|Overall Study|Physician Decision|0|||
147536799|NCT02057549|532120326|FG000|Overall Study|Withdrawal by Subject|1|||
147536800|NCT02057549|532120327|FG001|Overall Study|Withdrawal by Subject|0|||
147536801|NCT03843775|532120328|FG000|Overall Study|Adverse Event|1|||
147536802|NCT03843775|532120329|FG001|Overall Study|Adverse Event|1|||
147536803|NCT03843775|532120328|FG000|Overall Study|Lack of Efficacy|2|||
147536804|NCT03843775|532120329|FG001|Overall Study|Lack of Efficacy|6|||
147536805|NCT03843775|532120328|FG000|Overall Study|Withdrawal by Subject|0|||
147536806|NCT03843775|532120329|FG001|Overall Study|Withdrawal by Subject|1|||
147536807|NCT00530621|532120333|FG000|Overall Study|Adverse Event|11|||
147536808|NCT00530621|532120334|FG001|Overall Study|Adverse Event|8|||
147536809|NCT00530621|532120333|FG000|Overall Study|Physician Decision|2|||
147536810|NCT00530621|532120334|FG001|Overall Study|Physician Decision|4|||
147536811|NCT00530621|532120333|FG000|Overall Study|Progressive Disease (PD)|47|||
147536812|NCT00530621|532120334|FG001|Overall Study|Progressive Disease (PD)|40|||
147536813|NCT00530621|532120333|FG000|Overall Study|Sponsor Decision|12|||
147536814|NCT00530621|532120334|FG001|Overall Study|Sponsor Decision|15|||
147536815|NCT00530621|532120333|FG000|Overall Study|Subject Decision|4|||
147536816|NCT00530621|532120334|FG001|Overall Study|Subject Decision|7|||
147536817|NCT00530621|532120333|FG000|Overall Study|Death|3|||
147536818|NCT00530621|532120334|FG001|Overall Study|Death|6|||
147536819|NCT00530621|532120333|FG000|Overall Study|Not Treated Due to PD Prior to Dosing|1|||
147536820|NCT00530621|532120334|FG001|Overall Study|Not Treated Due to PD Prior to Dosing|0|||
147536821|NCT04611152|532120337|FG000|Overall Study|Adverse Event|9|||
147536822|NCT04611152|532120338|FG001|Overall Study|Adverse Event|8|||
147536823|NCT04611152|532120337|FG000|Overall Study|Non-compliance with study schedule|1|||
147536824|NCT04611152|532120338|FG001|Overall Study|Non-compliance with study schedule|3|||
147536825|NCT04611152|532120337|FG000|Overall Study|Withdrawal by Subject|5|||
147536826|NCT04611152|532120338|FG001|Overall Study|Withdrawal by Subject|6|||
147536827|NCT04611152|532120337|FG000|Overall Study|Lost to Follow-up|11|||
147536828|NCT04611152|532120338|FG001|Overall Study|Lost to Follow-up|2|||
147536829|NCT00605839|532120344|FG000|Overall Study|Protocol Violation|1|||
147536830|NCT00605839|532120345|FG001|Overall Study|Protocol Violation|0|||
147536831|NCT00605839|532120346|FG002|Overall Study|Protocol Violation|0|||
147536832|NCT03917654|532120347|FG000|Year 1|Withdrawal by Subject|1|||
147536833|NCT03917654|532120348|FG001|Year 1|Withdrawal by Subject|0|||
147536834|NCT03917654|532120349|FG002|Year 1|Withdrawal by Subject|0|||
147536835|NCT03917654|532120350|FG003|Year 1|Withdrawal by Subject|0|||
147536836|NCT03917654|532120351|FG004|Year 1|Withdrawal by Subject|0|||
147536837|NCT03917654|532120352|FG005|Year 1|Withdrawal by Subject|1|||
147536838|NCT03917654|532120353|FG006|Year 1|Withdrawal by Subject|6|||
147536839|NCT03917654|532120354|FG007|Year 1|Withdrawal by Subject|2|||
147536840|NCT03917654|532120355|FG008|Year 1|Withdrawal by Subject|5|||
147536841|NCT03917654|532120356|FG009|Year 1|Withdrawal by Subject|3|||
147536842|NCT03917654|532120357|FG010|Year 1|Withdrawal by Subject|1|||
147536843|NCT03917654|532120358|FG011|Year 1|Withdrawal by Subject|0|||
147536844|NCT03917654|532120347|FG000|Year 1|Travel|0|||
147536845|NCT03917654|532120348|FG001|Year 1|Travel|1|||
147536846|NCT03917654|532120349|FG002|Year 1|Travel|1|||
147649421|NCT02634801|532537341|FG000|Treatment Period (Weeks 0 to 24)|Protocol Violation|0|||
147536847|NCT03917654|532120350|FG003|Year 1|Travel|0|||
147536848|NCT03917654|532120351|FG004|Year 1|Travel|4|||
147536849|NCT03917654|532120352|FG005|Year 1|Travel|4|||
147536850|NCT03917654|532120353|FG006|Year 1|Travel|10|||
147536851|NCT03917654|532120354|FG007|Year 1|Travel|8|||
147536852|NCT03917654|532120355|FG008|Year 1|Travel|2|||
147536853|NCT03917654|532120356|FG009|Year 1|Travel|5|||
147536854|NCT03917654|532120357|FG010|Year 1|Travel|3|||
147536855|NCT03917654|532120358|FG011|Year 1|Travel|3|||
147536856|NCT03917654|532120347|FG000|Year 1|Subject moved away from site|0|||
147536857|NCT03917654|532120348|FG001|Year 1|Subject moved away from site|1|||
147536858|NCT03917654|532120349|FG002|Year 1|Subject moved away from site|0|||
147536859|NCT03917654|532120350|FG003|Year 1|Subject moved away from site|0|||
147536860|NCT03917654|532120351|FG004|Year 1|Subject moved away from site|0|||
147536861|NCT03917654|532120352|FG005|Year 1|Subject moved away from site|0|||
147536862|NCT03917654|532120353|FG006|Year 1|Subject moved away from site|1|||
147536863|NCT03917654|532120354|FG007|Year 1|Subject moved away from site|2|||
147536864|NCT03917654|532120355|FG008|Year 1|Subject moved away from site|1|||
147536865|NCT03917654|532120356|FG009|Year 1|Subject moved away from site|0|||
147536866|NCT03917654|532120357|FG010|Year 1|Subject moved away from site|0|||
147536867|NCT03917654|532120358|FG011|Year 1|Subject moved away from site|3|||
147536868|NCT03917654|532120347|FG000|Year 1|Spouse/Family member request|0|||
147536869|NCT03917654|532120348|FG001|Year 1|Spouse/Family member request|0|||
147536870|NCT03917654|532120349|FG002|Year 1|Spouse/Family member request|1|||
147536871|NCT03917654|532120350|FG003|Year 1|Spouse/Family member request|0|||
147536872|NCT03917654|532120351|FG004|Year 1|Spouse/Family member request|1|||
147536873|NCT03917654|532120352|FG005|Year 1|Spouse/Family member request|0|||
147536874|NCT03917654|532120353|FG006|Year 1|Spouse/Family member request|0|||
147536875|NCT03917654|532120354|FG007|Year 1|Spouse/Family member request|2|||
147536876|NCT03917654|532120355|FG008|Year 1|Spouse/Family member request|0|||
147536877|NCT03917654|532120356|FG009|Year 1|Spouse/Family member request|0|||
147536878|NCT03917654|532120357|FG010|Year 1|Spouse/Family member request|0|||
147536879|NCT03917654|532120358|FG011|Year 1|Spouse/Family member request|1|||
147536880|NCT03917654|532120347|FG000|Year 1|Death|0|||
147536881|NCT03917654|532120348|FG001|Year 1|Death|0|||
147536882|NCT03917654|532120349|FG002|Year 1|Death|0|||
147536883|NCT03917654|532120350|FG003|Year 1|Death|0|||
147536884|NCT03917654|532120351|FG004|Year 1|Death|0|||
147536885|NCT03917654|532120352|FG005|Year 1|Death|0|||
147536886|NCT03917654|532120353|FG006|Year 1|Death|0|||
147536887|NCT03917654|532120354|FG007|Year 1|Death|0|||
147536888|NCT03917654|532120355|FG008|Year 1|Death|1|||
147536889|NCT03917654|532120356|FG009|Year 1|Death|1|||
147536890|NCT03917654|532120357|FG010|Year 1|Death|0|||
147536891|NCT03917654|532120358|FG011|Year 1|Death|0|||
147536892|NCT03917654|532120347|FG000|Year 1|Lost to Follow-up|0|||
147536893|NCT03917654|532120348|FG001|Year 1|Lost to Follow-up|0|||
147536894|NCT03917654|532120349|FG002|Year 1|Lost to Follow-up|0|||
147536895|NCT03917654|532120350|FG003|Year 1|Lost to Follow-up|0|||
147536896|NCT03917654|532120351|FG004|Year 1|Lost to Follow-up|0|||
147536897|NCT03917654|532120352|FG005|Year 1|Lost to Follow-up|0|||
147536898|NCT03917654|532120353|FG006|Year 1|Lost to Follow-up|2|||
147536899|NCT03917654|532120354|FG007|Year 1|Lost to Follow-up|0|||
147536900|NCT03917654|532120355|FG008|Year 1|Lost to Follow-up|0|||
147536901|NCT03917654|532120356|FG009|Year 1|Lost to Follow-up|0|||
147536902|NCT03917654|532120357|FG010|Year 1|Lost to Follow-up|0|||
147536903|NCT03917654|532120358|FG011|Year 1|Lost to Follow-up|0|||
147536904|NCT03917654|532120347|FG000|Year 1|Missed visits|0|||
147536905|NCT03917654|532120348|FG001|Year 1|Missed visits|0|||
147536906|NCT03917654|532120349|FG002|Year 1|Missed visits|0|||
147536907|NCT03917654|532120350|FG003|Year 1|Missed visits|0|||
147536908|NCT03917654|532120351|FG004|Year 1|Missed visits|0|||
147536909|NCT03917654|532120352|FG005|Year 1|Missed visits|0|||
147536910|NCT03917654|532120353|FG006|Year 1|Missed visits|0|||
147536911|NCT03917654|532120354|FG007|Year 1|Missed visits|0|||
147536912|NCT03917654|532120355|FG008|Year 1|Missed visits|0|||
147536913|NCT03917654|532120356|FG009|Year 1|Missed visits|0|||
147536914|NCT03917654|532120357|FG010|Year 1|Missed visits|1|||
147536915|NCT03917654|532120358|FG011|Year 1|Missed visits|1|||
147536916|NCT03917654|532120347|FG000|Year 1|Pregnancy|0|||
147536917|NCT03917654|532120348|FG001|Year 1|Pregnancy|0|||
147536918|NCT03917654|532120349|FG002|Year 1|Pregnancy|0|||
147536919|NCT03917654|532120350|FG003|Year 1|Pregnancy|0|||
147536920|NCT03917654|532120351|FG004|Year 1|Pregnancy|0|||
147536921|NCT03917654|532120352|FG005|Year 1|Pregnancy|0|||
147536922|NCT03917654|532120353|FG006|Year 1|Pregnancy|0|||
147536923|NCT03917654|532120354|FG007|Year 1|Pregnancy|1|||
147536924|NCT03917654|532120355|FG008|Year 1|Pregnancy|0|||
147536925|NCT03917654|532120356|FG009|Year 1|Pregnancy|1|||
147536926|NCT03917654|532120357|FG010|Year 1|Pregnancy|0|||
147536927|NCT03917654|532120358|FG011|Year 1|Pregnancy|0|||
147536928|NCT03917654|532120347|FG000|Year 2|Travel|1|||
147536929|NCT03917654|532120348|FG001|Year 2|Travel|0|||
147536930|NCT03917654|532120349|FG002|Year 2|Travel|0|||
147536931|NCT03917654|532120350|FG003|Year 2|Travel|0|||
147536932|NCT03917654|532120351|FG004|Year 2|Travel|1|||
147536933|NCT03917654|532120352|FG005|Year 2|Travel|1|||
147536934|NCT03917654|532120353|FG006|Year 2|Travel|2|||
147202251|NCT03486834|530910584|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
147202252|NCT03486834|530910585|FG002|Overall Study|Withdrawal by Parent/Guardian|2|||
147436937|NCT04667377|531767234|FG004|Dose Escalation Period|Protocol Violation|1|||
147436938|NCT04667377|531767230|FG000|Dose Escalation Period|Burden of study procedures|2|||
147436939|NCT04667377|531767231|FG001|Dose Escalation Period|Burden of study procedures|1|||
147436940|NCT04667377|531767232|FG002|Dose Escalation Period|Burden of study procedures|1|||
147436941|NCT04667377|531767233|FG003|Dose Escalation Period|Burden of study procedures|1|||
147436942|NCT04667377|531767234|FG004|Dose Escalation Period|Burden of study procedures|5|||
147436943|NCT04667377|531767230|FG000|Dose Escalation Period|Change of residence|0|||
147436944|NCT04667377|531767231|FG001|Dose Escalation Period|Change of residence|0|||
147436945|NCT04667377|531767232|FG002|Dose Escalation Period|Change of residence|1|||
147436946|NCT04667377|531767233|FG003|Dose Escalation Period|Change of residence|0|||
147436947|NCT04667377|531767234|FG004|Dose Escalation Period|Change of residence|0|||
147436948|NCT04667377|531767230|FG000|Dose Escalation Period|Perceived lack of efficacy|0|||
147436949|NCT04667377|531767231|FG001|Dose Escalation Period|Perceived lack of efficacy|0|||
147436950|NCT04667377|531767232|FG002|Dose Escalation Period|Perceived lack of efficacy|0|||
147436951|NCT04667377|531767233|FG003|Dose Escalation Period|Perceived lack of efficacy|0|||
147436952|NCT04667377|531767234|FG004|Dose Escalation Period|Perceived lack of efficacy|6|||
147436953|NCT04667377|531767230|FG000|Dose Escalation Period|Adverse Event|9|||
147436954|NCT04667377|531767231|FG001|Dose Escalation Period|Adverse Event|10|||
147436955|NCT04667377|531767232|FG002|Dose Escalation Period|Adverse Event|12|||
147436956|NCT04667377|531767233|FG003|Dose Escalation Period|Adverse Event|17|||
147436957|NCT04667377|531767234|FG004|Dose Escalation Period|Adverse Event|3|||
147436958|NCT04667377|531767230|FG000|Dose Escalation Period|Adverse event: COVID-infection|4|||
147436959|NCT04667377|531767231|FG001|Dose Escalation Period|Adverse event: COVID-infection|1|||
147436960|NCT04667377|531767232|FG002|Dose Escalation Period|Adverse event: COVID-infection|2|||
147436961|NCT04667377|531767233|FG003|Dose Escalation Period|Adverse event: COVID-infection|1|||
147436962|NCT04667377|531767234|FG004|Dose Escalation Period|Adverse event: COVID-infection|0|||
147436963|NCT04667377|531767230|FG000|Dose Escalation Period|Not treated|1|||
147436964|NCT04667377|531767231|FG001|Dose Escalation Period|Not treated|0|||
147436965|NCT04667377|531767232|FG002|Dose Escalation Period|Not treated|0|||
147436966|NCT04667377|531767233|FG003|Dose Escalation Period|Not treated|0|||
147436967|NCT04667377|531767234|FG004|Dose Escalation Period|Not treated|0|||
147436968|NCT04667377|531767230|FG000|Dose Escalation Period|Withdrawal by Subject|2|||
147436969|NCT04667377|531767231|FG001|Dose Escalation Period|Withdrawal by Subject|0|||
147436970|NCT04667377|531767232|FG002|Dose Escalation Period|Withdrawal by Subject|0|||
147436971|NCT04667377|531767233|FG003|Dose Escalation Period|Withdrawal by Subject|0|||
147436972|NCT04667377|531767234|FG004|Dose Escalation Period|Withdrawal by Subject|2|||
147436973|NCT04667377|531767230|FG000|Dose Escalation Period|Lost to Follow-up|0|||
147436974|NCT04667377|531767231|FG001|Dose Escalation Period|Lost to Follow-up|1|||
147436975|NCT04667377|531767232|FG002|Dose Escalation Period|Lost to Follow-up|0|||
147436976|NCT04667377|531767233|FG003|Dose Escalation Period|Lost to Follow-up|0|||
147436977|NCT04667377|531767234|FG004|Dose Escalation Period|Lost to Follow-up|0|||
147436978|NCT04667377|531767230|FG000|Maintenance Period|Perceived lack of efficacy|0|||
147436979|NCT04667377|531767231|FG001|Maintenance Period|Perceived lack of efficacy|2|||
147436980|NCT04667377|531767232|FG002|Maintenance Period|Perceived lack of efficacy|1|||
147436981|NCT04667377|531767233|FG003|Maintenance Period|Perceived lack of efficacy|0|||
147436982|NCT04667377|531767234|FG004|Maintenance Period|Perceived lack of efficacy|1|||
147436983|NCT04667377|531767230|FG000|Maintenance Period|Adverse Event|2|||
147436984|NCT04667377|531767231|FG001|Maintenance Period|Adverse Event|8|||
147436985|NCT04667377|531767232|FG002|Maintenance Period|Adverse Event|5|||
147436986|NCT04667377|531767233|FG003|Maintenance Period|Adverse Event|4|||
147436987|NCT04667377|531767234|FG004|Maintenance Period|Adverse Event|1|||
147436988|NCT04667377|531767230|FG000|Maintenance Period|Adverse event: COVID infection|0|||
147436989|NCT04667377|531767231|FG001|Maintenance Period|Adverse event: COVID infection|1|||
147436990|NCT04667377|531767232|FG002|Maintenance Period|Adverse event: COVID infection|0|||
147436991|NCT04667377|531767233|FG003|Maintenance Period|Adverse event: COVID infection|0|||
147436992|NCT04667377|531767234|FG004|Maintenance Period|Adverse event: COVID infection|0|||
147436993|NCT04667377|531767230|FG000|Maintenance Period|COVID-related|0|||
147436994|NCT04667377|531767231|FG001|Maintenance Period|COVID-related|0|||
147436995|NCT04667377|531767232|FG002|Maintenance Period|COVID-related|1|||
147436996|NCT04667377|531767233|FG003|Maintenance Period|COVID-related|1|||
147436997|NCT04667377|531767234|FG004|Maintenance Period|COVID-related|0|||
147436998|NCT04667377|531767230|FG000|Maintenance Period|Protocol Violation|1|||
147436999|NCT04667377|531767231|FG001|Maintenance Period|Protocol Violation|0|||
147437000|NCT04667377|531767232|FG002|Maintenance Period|Protocol Violation|0|||
147437001|NCT04667377|531767233|FG003|Maintenance Period|Protocol Violation|0|||
147437002|NCT04667377|531767234|FG004|Maintenance Period|Protocol Violation|1|||
147437003|NCT04667377|531767230|FG000|Maintenance Period|Burden of study procedures|1|||
147437004|NCT04667377|531767231|FG001|Maintenance Period|Burden of study procedures|2|||
147437005|NCT04667377|531767232|FG002|Maintenance Period|Burden of study procedures|0|||
147437006|NCT04667377|531767233|FG003|Maintenance Period|Burden of study procedures|1|||
147536935|NCT03917654|532120354|FG007|Year 2|Travel|1|||
147536936|NCT03917654|532120355|FG008|Year 2|Travel|0|||
147536937|NCT03917654|532120356|FG009|Year 2|Travel|1|||
147536938|NCT03917654|532120357|FG010|Year 2|Travel|0|||
147536939|NCT03917654|532120358|FG011|Year 2|Travel|1|||
147536940|NCT03917654|532120347|FG000|Year 2|Married|1|||
147536941|NCT03917654|532120348|FG001|Year 2|Married|0|||
147536942|NCT03917654|532120349|FG002|Year 2|Married|0|||
147536943|NCT03917654|532120350|FG003|Year 2|Married|0|||
147536944|NCT03917654|532120351|FG004|Year 2|Married|0|||
147536945|NCT03917654|532120352|FG005|Year 2|Married|0|||
147536946|NCT03917654|532120353|FG006|Year 2|Married|1|||
147536947|NCT03917654|532120354|FG007|Year 2|Married|1|||
147536948|NCT03917654|532120355|FG008|Year 2|Married|0|||
147536949|NCT03917654|532120356|FG009|Year 2|Married|0|||
147536950|NCT03917654|532120357|FG010|Year 2|Married|0|||
147536951|NCT03917654|532120358|FG011|Year 2|Married|0|||
147536952|NCT03917654|532120347|FG000|Year 2|Subject moved away from site|1|||
147536953|NCT03917654|532120348|FG001|Year 2|Subject moved away from site|0|||
147536954|NCT03917654|532120349|FG002|Year 2|Subject moved away from site|0|||
147536955|NCT03917654|532120350|FG003|Year 2|Subject moved away from site|0|||
147536956|NCT03917654|532120351|FG004|Year 2|Subject moved away from site|1|||
147536957|NCT03917654|532120352|FG005|Year 2|Subject moved away from site|0|||
147536958|NCT03917654|532120353|FG006|Year 2|Subject moved away from site|2|||
147536959|NCT03917654|532120354|FG007|Year 2|Subject moved away from site|3|||
147536960|NCT03917654|532120355|FG008|Year 2|Subject moved away from site|0|||
147536961|NCT03917654|532120356|FG009|Year 2|Subject moved away from site|2|||
147536962|NCT03917654|532120357|FG010|Year 2|Subject moved away from site|0|||
147536963|NCT03917654|532120358|FG011|Year 2|Subject moved away from site|1|||
147536964|NCT03917654|532120347|FG000|Year 2|Year 2 Screening failure|0|||
147536965|NCT03917654|532120348|FG001|Year 2|Year 2 Screening failure|1|||
147536966|NCT03917654|532120349|FG002|Year 2|Year 2 Screening failure|0|||
147536967|NCT03917654|532120350|FG003|Year 2|Year 2 Screening failure|0|||
147536968|NCT03917654|532120351|FG004|Year 2|Year 2 Screening failure|2|||
147536969|NCT03917654|532120352|FG005|Year 2|Year 2 Screening failure|0|||
147536970|NCT03917654|532120353|FG006|Year 2|Year 2 Screening failure|4|||
147536971|NCT03917654|532120354|FG007|Year 2|Year 2 Screening failure|3|||
147536972|NCT03917654|532120355|FG008|Year 2|Year 2 Screening failure|10|||
147536973|NCT03917654|532120356|FG009|Year 2|Year 2 Screening failure|2|||
147536974|NCT03917654|532120357|FG010|Year 2|Year 2 Screening failure|1|||
147536975|NCT03917654|532120358|FG011|Year 2|Year 2 Screening failure|1|||
147536976|NCT03917654|532120347|FG000|Year 2|Death|0|||
147536977|NCT03917654|532120348|FG001|Year 2|Death|0|||
147536978|NCT03917654|532120349|FG002|Year 2|Death|0|||
147536979|NCT03917654|532120350|FG003|Year 2|Death|0|||
147536980|NCT03917654|532120351|FG004|Year 2|Death|0|||
147536981|NCT03917654|532120352|FG005|Year 2|Death|1|||
147536982|NCT03917654|532120353|FG006|Year 2|Death|0|||
147536983|NCT03917654|532120354|FG007|Year 2|Death|0|||
147536984|NCT03917654|532120355|FG008|Year 2|Death|1|||
147536985|NCT03917654|532120356|FG009|Year 2|Death|1|||
147536986|NCT03917654|532120357|FG010|Year 2|Death|0|||
147536987|NCT03917654|532120358|FG011|Year 2|Death|0|||
147536988|NCT03917654|532120347|FG000|Year 2|Withdrawal by Subject|0|||
147536989|NCT03917654|532120348|FG001|Year 2|Withdrawal by Subject|0|||
147536990|NCT03917654|532120349|FG002|Year 2|Withdrawal by Subject|0|||
147536991|NCT03917654|532120350|FG003|Year 2|Withdrawal by Subject|0|||
147536992|NCT03917654|532120351|FG004|Year 2|Withdrawal by Subject|0|||
147536993|NCT03917654|532120352|FG005|Year 2|Withdrawal by Subject|0|||
147536994|NCT03917654|532120353|FG006|Year 2|Withdrawal by Subject|3|||
147536995|NCT03917654|532120354|FG007|Year 2|Withdrawal by Subject|0|||
147536996|NCT03917654|532120355|FG008|Year 2|Withdrawal by Subject|2|||
147536997|NCT03917654|532120356|FG009|Year 2|Withdrawal by Subject|5|||
147536998|NCT03917654|532120357|FG010|Year 2|Withdrawal by Subject|0|||
147536999|NCT03917654|532120358|FG011|Year 2|Withdrawal by Subject|0|||
147537000|NCT03917654|532120347|FG000|Year 2|Spouse/family member request|0|||
147537001|NCT03917654|532120348|FG001|Year 2|Spouse/family member request|0|||
147537002|NCT03917654|532120349|FG002|Year 2|Spouse/family member request|0|||
147649422|NCT02634801|532537342|FG001|Treatment Period (Weeks 0 to 24)|Protocol Violation|0|||
147649423|NCT02634801|532537343|FG002|Treatment Period (Weeks 0 to 24)|Protocol Violation|1|||
147537003|NCT03917654|532120350|FG003|Year 2|Spouse/family member request|0|||
147537004|NCT03917654|532120351|FG004|Year 2|Spouse/family member request|0|||
147537005|NCT03917654|532120352|FG005|Year 2|Spouse/family member request|0|||
147537006|NCT03917654|532120353|FG006|Year 2|Spouse/family member request|1|||
147537007|NCT03917654|532120354|FG007|Year 2|Spouse/family member request|0|||
147537008|NCT03917654|532120355|FG008|Year 2|Spouse/family member request|0|||
147537009|NCT03917654|532120356|FG009|Year 2|Spouse/family member request|0|||
147537010|NCT03917654|532120357|FG010|Year 2|Spouse/family member request|0|||
147537011|NCT03917654|532120358|FG011|Year 2|Spouse/family member request|0|||
147537012|NCT03917654|532120347|FG000|Year 2|Lost to Follow-up|0|||
147537013|NCT03917654|532120348|FG001|Year 2|Lost to Follow-up|0|||
147537014|NCT03917654|532120349|FG002|Year 2|Lost to Follow-up|0|||
147537015|NCT03917654|532120350|FG003|Year 2|Lost to Follow-up|0|||
147537016|NCT03917654|532120351|FG004|Year 2|Lost to Follow-up|0|||
147537017|NCT03917654|532120352|FG005|Year 2|Lost to Follow-up|0|||
147537018|NCT03917654|532120353|FG006|Year 2|Lost to Follow-up|1|||
147537019|NCT03917654|532120354|FG007|Year 2|Lost to Follow-up|0|||
147537020|NCT03917654|532120355|FG008|Year 2|Lost to Follow-up|1|||
147537021|NCT03917654|532120356|FG009|Year 2|Lost to Follow-up|0|||
147537022|NCT03917654|532120357|FG010|Year 2|Lost to Follow-up|0|||
147537023|NCT03917654|532120358|FG011|Year 2|Lost to Follow-up|1|||
147537024|NCT03917654|532120347|FG000|Year 2|Adverse Event|0|||
147537025|NCT03917654|532120348|FG001|Year 2|Adverse Event|0|||
147537026|NCT03917654|532120349|FG002|Year 2|Adverse Event|0|||
147537027|NCT03917654|532120350|FG003|Year 2|Adverse Event|0|||
147537028|NCT03917654|532120351|FG004|Year 2|Adverse Event|0|||
147537029|NCT03917654|532120352|FG005|Year 2|Adverse Event|0|||
147537030|NCT03917654|532120353|FG006|Year 2|Adverse Event|0|||
147537031|NCT03917654|532120354|FG007|Year 2|Adverse Event|0|||
147537032|NCT03917654|532120355|FG008|Year 2|Adverse Event|0|||
147537033|NCT03917654|532120356|FG009|Year 2|Adverse Event|1|||
147537034|NCT03917654|532120357|FG010|Year 2|Adverse Event|0|||
147537035|NCT03917654|532120358|FG011|Year 2|Adverse Event|0|||
147537036|NCT02255422|532120359|FG000|Overall Study|Withdrawal by Subject|0|||
147537037|NCT02255422|532120360|FG001|Overall Study|Withdrawal by Subject|0|||
147537038|NCT02255422|532120361|FG002|Overall Study|Withdrawal by Subject|0|||
147537039|NCT02255422|532120362|FG003|Overall Study|Withdrawal by Subject|0|||
147537040|NCT02255422|532120363|FG004|Overall Study|Withdrawal by Subject|0|||
147537041|NCT02255422|532120364|FG005|Overall Study|Withdrawal by Subject|0|||
147537042|NCT02255422|532120365|FG006|Overall Study|Withdrawal by Subject|2|||
147537043|NCT02255422|532120359|FG000|Overall Study|Lost to Follow-up|0|||
147537044|NCT02255422|532120360|FG001|Overall Study|Lost to Follow-up|0|||
147537045|NCT02255422|532120361|FG002|Overall Study|Lost to Follow-up|1|||
147537046|NCT02255422|532120362|FG003|Overall Study|Lost to Follow-up|0|||
147537047|NCT02255422|532120363|FG004|Overall Study|Lost to Follow-up|0|||
147537048|NCT02255422|532120364|FG005|Overall Study|Lost to Follow-up|0|||
147537049|NCT02255422|532120365|FG006|Overall Study|Lost to Follow-up|0|||
147537050|NCT00602667|532120366|FG000|Overall Study|Still on Therapy|0|||
147537051|NCT00602667|532120367|FG001|Overall Study|Still on Therapy|2|||
147537052|NCT00602667|532120368|FG002|Overall Study|Still on Therapy|2|||
147537053|NCT00602667|532120366|FG000|Overall Study|Death|0|||
147537054|NCT00602667|532120367|FG001|Overall Study|Death|1|||
147537055|NCT00602667|532120368|FG002|Overall Study|Death|1|||
147537056|NCT00602667|532120366|FG000|Overall Study|Family request|3|||
147537057|NCT00602667|532120367|FG001|Overall Study|Family request|25|||
147537058|NCT00602667|532120368|FG002|Overall Study|Family request|6|||
147537059|NCT00602667|532120366|FG000|Overall Study|Excessive toxicity|1|||
147537060|NCT00602667|532120367|FG001|Overall Study|Excessive toxicity|1|||
147537061|NCT00602667|532120368|FG002|Overall Study|Excessive toxicity|0|||
147537062|NCT00602667|532120366|FG000|Overall Study|Second malignancy|0|||
147537063|NCT00602667|532120367|FG001|Overall Study|Second malignancy|1|||
147537064|NCT00602667|532120368|FG002|Overall Study|Second malignancy|0|||
147537065|NCT00602667|532120366|FG000|Overall Study|Physician Decision|2|||
147537066|NCT00602667|532120367|FG001|Overall Study|Physician Decision|3|||
147537067|NCT00602667|532120368|FG002|Overall Study|Physician Decision|8|||
147537068|NCT00602667|532120366|FG000|Overall Study|Progressive disease|13|||
147537069|NCT00602667|532120367|FG001|Overall Study|Progressive disease|48|||
147537070|NCT00602667|532120368|FG002|Overall Study|Progressive disease|45|||
147537071|NCT00602667|532120366|FG000|Overall Study|Progressive disease prior to therapy|0|||
147537072|NCT00602667|532120367|FG001|Overall Study|Progressive disease prior to therapy|0|||
147537073|NCT00602667|532120368|FG002|Overall Study|Progressive disease prior to therapy|1|||
147537074|NCT03179462|532120374|FG000|Overall Study|screening failure|1|||
147537075|NCT03179462|532120375|FG001|Overall Study|screening failure|2|||
147537076|NCT03179462|532120376|FG002|Overall Study|screening failure|0|||
147537077|NCT04636437|532120377|FG000|Overall Study|Eligibility failure discovered after study entry|2|||
147537078|NCT04636437|532120378|FG001|Overall Study|Eligibility failure discovered after study entry|1|||
147537079|NCT04636437|532120379|FG002|Overall Study|Eligibility failure discovered after study entry|0|||
147537080|NCT04636437|532120377|FG000|Overall Study|Started weight loss drug/program|2|||
147537081|NCT04636437|532120378|FG001|Overall Study|Started weight loss drug/program|1|||
147537082|NCT04636437|532120379|FG002|Overall Study|Started weight loss drug/program|1|||
147537083|NCT04636437|532120377|FG000|Overall Study|Lost to Follow-up|3|||
147537084|NCT04636437|532120378|FG001|Overall Study|Lost to Follow-up|1|||
147537085|NCT04636437|532120379|FG002|Overall Study|Lost to Follow-up|4|||
147537086|NCT04636437|532120377|FG000|Overall Study|Participant or physician decision|3|||
147537087|NCT04636437|532120378|FG001|Overall Study|Participant or physician decision|1|||
147537088|NCT04636437|532120379|FG002|Overall Study|Participant or physician decision|1|||
147537089|NCT00816166|532120383|FG000|Overall Study|Lost to Follow-up|6|||
147537090|NCT00816166|532120384|FG001|Overall Study|Lost to Follow-up|10|||
147537091|NCT00816166|532120383|FG000|Overall Study|Death|4|||
147537092|NCT00816166|532120384|FG001|Overall Study|Death|2|||
147537093|NCT02851069|532120385|FG000|Overall Study|Failure to Return|3|||
147537094|NCT02851069|532120385|FG000|Overall Study|Other|3|||
147537095|NCT00352664|532120386|FG000|Overall Study|Withdrawal by Subject|7|||
147537096|NCT00352664|532120387|FG001|Overall Study|Withdrawal by Subject|0|||
147537097|NCT02146365|532120388|FG000|Overall Study|Lost to Follow-up|2|||
147537098|NCT02146365|532120389|FG001|Overall Study|Lost to Follow-up|1|||
147537099|NCT02146365|532120390|FG002|Overall Study|Lost to Follow-up|3|||
147537100|NCT02146365|532120391|FG003|Overall Study|Lost to Follow-up|3|||
147537101|NCT02146365|532120392|FG004|Overall Study|Lost to Follow-up|1|||
147537102|NCT02146365|532120393|FG005|Overall Study|Lost to Follow-up|1|||
147537103|NCT02146365|532120394|FG006|Overall Study|Lost to Follow-up|0|||
147537104|NCT02146365|532120395|FG007|Overall Study|Lost to Follow-up|1|||
147537105|NCT02146365|532120388|FG000|Overall Study|Withdrawal by Subject|1|||
147537106|NCT02146365|532120389|FG001|Overall Study|Withdrawal by Subject|2|||
147537107|NCT02146365|532120390|FG002|Overall Study|Withdrawal by Subject|1|||
147537108|NCT02146365|532120391|FG003|Overall Study|Withdrawal by Subject|5|||
147537109|NCT02146365|532120392|FG004|Overall Study|Withdrawal by Subject|1|||
147537110|NCT02146365|532120393|FG005|Overall Study|Withdrawal by Subject|0|||
147537111|NCT02146365|532120394|FG006|Overall Study|Withdrawal by Subject|0|||
147537112|NCT02146365|532120395|FG007|Overall Study|Withdrawal by Subject|0|||
147537113|NCT02146365|532120388|FG000|Overall Study|Unable to Comply with Protocol|0|||
147537114|NCT02146365|532120389|FG001|Overall Study|Unable to Comply with Protocol|1|||
147537115|NCT02146365|532120390|FG002|Overall Study|Unable to Comply with Protocol|1|||
147537116|NCT02146365|532120391|FG003|Overall Study|Unable to Comply with Protocol|0|||
147537117|NCT02146365|532120392|FG004|Overall Study|Unable to Comply with Protocol|0|||
147537118|NCT02146365|532120393|FG005|Overall Study|Unable to Comply with Protocol|0|||
147537119|NCT02146365|532120394|FG006|Overall Study|Unable to Comply with Protocol|0|||
147537120|NCT02146365|532120395|FG007|Overall Study|Unable to Comply with Protocol|0|||
147537121|NCT02146365|532120388|FG000|Overall Study|Other|1|||
147537122|NCT02146365|532120389|FG001|Overall Study|Other|0|||
147537123|NCT02146365|532120390|FG002|Overall Study|Other|2|||
147537124|NCT02146365|532120391|FG003|Overall Study|Other|1|||
147537125|NCT02146365|532120392|FG004|Overall Study|Other|0|||
147537126|NCT02146365|532120393|FG005|Overall Study|Other|0|||
147537127|NCT02146365|532120394|FG006|Overall Study|Other|0|||
147537128|NCT02146365|532120395|FG007|Overall Study|Other|0|||
147537129|NCT03222856|532120396|FG000|Overall Study|Adverse Event|6|||
147537130|NCT03222856|532120396|FG000|Overall Study|Death|1|||
147537131|NCT00698009|532121988|FG000|Overall Study|Withdrawal by Subject|1|||
147537132|NCT03862807|532121989|FG000|Overall Study|Not Treated Due to Eligibility Criteria Failure|1|||
147537133|NCT00798707|532121992|FG000|Overall Study|Adverse Event|6|||
147537134|NCT00798707|532121993|FG001|Overall Study|Adverse Event|8|||
147537135|NCT00798707|532121994|FG002|Overall Study|Adverse Event|8|||
147537136|NCT00798707|532121992|FG000|Overall Study|Failed to return|2|||
147537137|NCT00798707|532121993|FG001|Overall Study|Failed to return|2|||
147537138|NCT00798707|532121994|FG002|Overall Study|Failed to return|0|||
147537139|NCT00798707|532121992|FG000|Overall Study|Investigator|0|||
147537140|NCT00798707|532121993|FG001|Overall Study|Investigator|1|||
147537141|NCT00798707|532121994|FG002|Overall Study|Investigator|2|||
147537142|NCT00798707|532121992|FG000|Overall Study|Lack of Efficacy|2|||
147537143|NCT00798707|532121993|FG001|Overall Study|Lack of Efficacy|2|||
147537144|NCT00798707|532121994|FG002|Overall Study|Lack of Efficacy|1|||
147537145|NCT00798707|532121992|FG000|Overall Study|Lost to Follow-up|5|||
147537146|NCT00798707|532121993|FG001|Overall Study|Lost to Follow-up|6|||
147537147|NCT00798707|532121994|FG002|Overall Study|Lost to Follow-up|6|||
147537148|NCT00798707|532121992|FG000|Overall Study|Other|0|||
147537149|NCT00798707|532121993|FG001|Overall Study|Other|1|||
147537150|NCT00798707|532121994|FG002|Overall Study|Other|0|||
147537151|NCT00798707|532121992|FG000|Overall Study|Protocol Violation|4|||
147537152|NCT00798707|532121993|FG001|Overall Study|Protocol Violation|0|||
147537153|NCT00798707|532121994|FG002|Overall Study|Protocol Violation|2|||
147537154|NCT00798707|532121992|FG000|Overall Study|Withdrawal by Subject|3|||
147537155|NCT00798707|532121993|FG001|Overall Study|Withdrawal by Subject|8|||
147537156|NCT00798707|532121994|FG002|Overall Study|Withdrawal by Subject|2|||
147537157|NCT00798707|532121992|FG000|Overall Study|Randomized not treated|4|||
147537158|NCT00798707|532121993|FG001|Overall Study|Randomized not treated|5|||
147537159|NCT00798707|532121994|FG002|Overall Study|Randomized not treated|1|||
147537160|NCT01513759|532122000|FG000|Overall Study|Protocol Violation|4|||
147537161|NCT01513759|532122000|FG000|Overall Study|Death during catheter placement|1|||
147537162|NCT03606109|532122001|FG000|Overall Study|Lost to Follow-up|2|||
147537163|NCT03606109|532122002|FG001|Overall Study|Lost to Follow-up|1|||
147537164|NCT03669640|532122007|FG000|Overall Study|Study Terminated by Sponsor|0|||
147537165|NCT03669640|532122008|FG001|Overall Study|Study Terminated by Sponsor|0|||
147537166|NCT03669640|532122009|FG002|Overall Study|Study Terminated by Sponsor|0|||
147537167|NCT03669640|532122010|FG003|Overall Study|Study Terminated by Sponsor|0|||
147537168|NCT03669640|532122011|FG004|Overall Study|Study Terminated by Sponsor|1|||
147537169|NCT03669640|532122012|FG005|Overall Study|Study Terminated by Sponsor|0|||
147537170|NCT03669640|532122007|FG000|Overall Study|Lost to Follow-up|0|||
147537171|NCT03669640|532122008|FG001|Overall Study|Lost to Follow-up|0|||
147537172|NCT03669640|532122009|FG002|Overall Study|Lost to Follow-up|2|||
147537173|NCT03669640|532122010|FG003|Overall Study|Lost to Follow-up|0|||
147537174|NCT03669640|532122011|FG004|Overall Study|Lost to Follow-up|0|||
147537175|NCT03669640|532122012|FG005|Overall Study|Lost to Follow-up|0|||
147537176|NCT03669640|532122007|FG000|Overall Study|Death|0|||
147537177|NCT03669640|532122008|FG001|Overall Study|Death|0|||
147537178|NCT03669640|532122009|FG002|Overall Study|Death|1|||
147537179|NCT03669640|532122010|FG003|Overall Study|Death|0|||
147537180|NCT03669640|532122011|FG004|Overall Study|Death|0|||
147537181|NCT03669640|532122012|FG005|Overall Study|Death|0|||
147537182|NCT03669640|532122007|FG000|Overall Study|Withdrawal by Subject|1|||
147537183|NCT03669640|532122008|FG001|Overall Study|Withdrawal by Subject|2|||
147537184|NCT03669640|532122009|FG002|Overall Study|Withdrawal by Subject|1|||
147537185|NCT03669640|532122010|FG003|Overall Study|Withdrawal by Subject|0|||
147537186|NCT03669640|532122011|FG004|Overall Study|Withdrawal by Subject|1|||
147537187|NCT03669640|532122012|FG005|Overall Study|Withdrawal by Subject|3|||
147537188|NCT03669640|532122007|FG000|Overall Study|Protocol Violation|1|||
147537189|NCT03669640|532122008|FG001|Overall Study|Protocol Violation|0|||
147537190|NCT03669640|532122009|FG002|Overall Study|Protocol Violation|0|||
147537191|NCT03669640|532122010|FG003|Overall Study|Protocol Violation|0|||
147537192|NCT03669640|532122011|FG004|Overall Study|Protocol Violation|0|||
147537193|NCT03669640|532122012|FG005|Overall Study|Protocol Violation|0|||
147537194|NCT03669640|532122007|FG000|Overall Study|Physician Decision|0|||
147537195|NCT03669640|532122008|FG001|Overall Study|Physician Decision|2|||
147437007|NCT04667377|531767234|FG004|Maintenance Period|Burden of study procedures|0|||
147437008|NCT04667377|531767230|FG000|Maintenance Period|Change of residence|0|||
147437009|NCT04667377|531767231|FG001|Maintenance Period|Change of residence|1|||
147437010|NCT04667377|531767232|FG002|Maintenance Period|Change of residence|0|||
147437011|NCT04667377|531767233|FG003|Maintenance Period|Change of residence|0|||
147437012|NCT04667377|531767234|FG004|Maintenance Period|Change of residence|1|||
147437013|NCT04667377|531767230|FG000|Maintenance Period|Missing|1|||
147437014|NCT04667377|531767231|FG001|Maintenance Period|Missing|0|||
147306807|NCT01852058|531290776|FG003|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
147437015|NCT04667377|531767232|FG002|Maintenance Period|Missing|0|||
147437016|NCT04667377|531767233|FG003|Maintenance Period|Missing|0|||
147437017|NCT04667377|531767234|FG004|Maintenance Period|Missing|0|||
147537196|NCT03669640|532122009|FG002|Overall Study|Physician Decision|0|||
147537197|NCT03669640|532122010|FG003|Overall Study|Physician Decision|0|||
147537198|NCT03669640|532122011|FG004|Overall Study|Physician Decision|0|||
147537199|NCT03669640|532122012|FG005|Overall Study|Physician Decision|0|||
147537200|NCT03669640|532122007|FG000|Overall Study|Disease Relapse|1|||
147537201|NCT03669640|532122008|FG001|Overall Study|Disease Relapse|0|||
147537202|NCT03669640|532122009|FG002|Overall Study|Disease Relapse|0|||
147537203|NCT03669640|532122010|FG003|Overall Study|Disease Relapse|0|||
147537204|NCT03669640|532122011|FG004|Overall Study|Disease Relapse|0|||
147537205|NCT03669640|532122012|FG005|Overall Study|Disease Relapse|0|||
147537206|NCT03669640|532122007|FG000|Overall Study|Adverse Event|2|||
147537207|NCT03669640|532122008|FG001|Overall Study|Adverse Event|1|||
147537208|NCT03669640|532122009|FG002|Overall Study|Adverse Event|0|||
147537209|NCT03669640|532122010|FG003|Overall Study|Adverse Event|0|||
147537210|NCT03669640|532122011|FG004|Overall Study|Adverse Event|1|||
147537211|NCT03669640|532122012|FG005|Overall Study|Adverse Event|0|||
147537212|NCT00366678|532122013|FG000|Infant Series|Withdrawal by Subject|8|||
147537213|NCT00366678|532122014|FG001|Infant Series|Withdrawal by Subject|6|||
147537214|NCT00366678|532122015|FG002|Infant Series|Withdrawal by Subject|0|||
147537215|NCT00366678|532122013|FG000|Infant Series|Protocol Violation|4|||
147537216|NCT00366678|532122014|FG001|Infant Series|Protocol Violation|3|||
147537217|NCT00366678|532122015|FG002|Infant Series|Protocol Violation|0|||
147537218|NCT00366678|532122013|FG000|Infant Series|Failed to return|1|||
147537219|NCT00366678|532122014|FG001|Infant Series|Failed to return|1|||
147537220|NCT00366678|532122015|FG002|Infant Series|Failed to return|0|||
147537221|NCT00366678|532122013|FG000|Infant Series|Adverse Event|1|||
147537222|NCT00366678|532122014|FG001|Infant Series|Adverse Event|0|||
147537223|NCT00366678|532122015|FG002|Infant Series|Adverse Event|0|||
147537224|NCT00366678|532122013|FG000|After Infant|Withdrawal by Subject|8|||
147537225|NCT00366678|532122014|FG001|After Infant|Withdrawal by Subject|4|||
147537226|NCT00366678|532122015|FG002|After Infant|Withdrawal by Subject|0|||
147537227|NCT00366678|532122013|FG000|After Infant|Lost to Follow-up|2|||
147537228|NCT00366678|532122014|FG001|After Infant|Lost to Follow-up|1|||
147537229|NCT00366678|532122015|FG002|After Infant|Lost to Follow-up|0|||
147537230|NCT00366678|532122013|FG000|After Infant|Failed to return|5|||
147537231|NCT00366678|532122014|FG001|After Infant|Failed to return|5|||
147537232|NCT00366678|532122015|FG002|After Infant|Failed to return|0|||
147537233|NCT00366678|532122013|FG000|After Infant|Adverse Event|1|||
147202253|NCT03486834|530910583|FG000|Overall Study|Randomized but not treated|4|||
147202254|NCT03486834|530910584|FG001|Overall Study|Randomized but not treated|4|||
147202255|NCT03486834|530910585|FG002|Overall Study|Randomized but not treated|1|||
147202256|NCT02745119|530910587|FG000|Overall Study|Adverse Event|1|||
147202257|NCT02745119|530910588|FG001|Overall Study|Adverse Event|0|||
147202258|NCT02745119|530910589|FG002|Overall Study|Adverse Event|1|||
147202259|NCT02745119|530910590|FG003|Overall Study|Adverse Event|3|||
147202260|NCT02745119|530910587|FG000|Overall Study|Death|3|||
147202261|NCT02745119|530910588|FG001|Overall Study|Death|3|||
147202262|NCT02745119|530910589|FG002|Overall Study|Death|0|||
147202263|NCT02745119|530910590|FG003|Overall Study|Death|4|||
147202264|NCT02745119|530910587|FG000|Overall Study|Lost to Follow-up|0|||
147537234|NCT00366678|532122014|FG001|After Infant|Adverse Event|0|||
147537235|NCT00366678|532122015|FG002|After Infant|Adverse Event|0|||
147537236|NCT00366678|532122013|FG000|After Infant|Protocol Violation|1|||
147537237|NCT00366678|532122014|FG001|After Infant|Protocol Violation|0|||
147537238|NCT00366678|532122015|FG002|After Infant|Protocol Violation|0|||
147537239|NCT00366678|532122013|FG000|Toddler Dose|Protocol Violation|2|||
147202265|NCT02745119|530910588|FG001|Overall Study|Lost to Follow-up|0|||
147202266|NCT02745119|530910589|FG002|Overall Study|Lost to Follow-up|0|||
147202267|NCT02745119|530910590|FG003|Overall Study|Lost to Follow-up|1|||
147437018|NCT04667377|531767230|FG000|Maintenance Period|Other than listed above|2|||
147437019|NCT04667377|531767231|FG001|Maintenance Period|Other than listed above|0|||
147437020|NCT04667377|531767232|FG002|Maintenance Period|Other than listed above|3|||
147437021|NCT04667377|531767233|FG003|Maintenance Period|Other than listed above|2|||
147437022|NCT04667377|531767234|FG004|Maintenance Period|Other than listed above|6|||
147437023|NCT04667377|531767230|FG000|Maintenance Period|Withdrawal by Subject|0|||
147437024|NCT04667377|531767231|FG001|Maintenance Period|Withdrawal by Subject|1|||
147437025|NCT04667377|531767232|FG002|Maintenance Period|Withdrawal by Subject|0|||
147437026|NCT04667377|531767233|FG003|Maintenance Period|Withdrawal by Subject|0|||
147437027|NCT04667377|531767234|FG004|Maintenance Period|Withdrawal by Subject|0|||
147437028|NCT04667377|531767230|FG000|Maintenance Period|Lost to Follow-up|1|||
147437029|NCT04667377|531767231|FG001|Maintenance Period|Lost to Follow-up|0|||
147437030|NCT04667377|531767232|FG002|Maintenance Period|Lost to Follow-up|1|||
147437031|NCT04667377|531767233|FG003|Maintenance Period|Lost to Follow-up|0|||
147437032|NCT04667377|531767234|FG004|Maintenance Period|Lost to Follow-up|1|||
147437033|NCT00210184|531767235|FG000|Overall Study|The medical record was lost for these patients: no clinical data is available|2|||
147437034|NCT02316340|531767236|FG000|First Progression|Clinical progression|2|||
147437035|NCT02316340|531767237|FG001|First Progression|Clinical progression|1|||
147202268|NCT02745119|530910587|FG000|Overall Study|Protocol Deviation|0|||
147202269|NCT02745119|530910588|FG001|Overall Study|Protocol Deviation|0|||
147437036|NCT02316340|531767236|FG000|First Progression|Withdrawal by Subject|1|||
147437037|NCT02316340|531767237|FG001|First Progression|Withdrawal by Subject|0|||
147437038|NCT01118325|531767242|FG000|Overall Study|Adverse Event|1|||
147537240|NCT00366678|532122014|FG001|Toddler Dose|Protocol Violation|1|||
147537241|NCT00366678|532122015|FG002|Toddler Dose|Protocol Violation|0|||
147537242|NCT00366678|532122013|FG000|Toddler Dose|Failed to return|1|||
147537243|NCT00366678|532122014|FG001|Toddler Dose|Failed to return|0|||
147537244|NCT00366678|532122015|FG002|Toddler Dose|Failed to return|0|||
147537245|NCT00366678|532122013|FG000|Toddler Dose|Withdrawal by Subject|1|||
147202270|NCT02745119|530910589|FG002|Overall Study|Protocol Deviation|0|||
147202271|NCT02745119|530910590|FG003|Overall Study|Protocol Deviation|1|||
147202272|NCT02745119|530910587|FG000|Overall Study|Withdrawal by Subject|7|||
147537246|NCT00366678|532122014|FG001|Toddler Dose|Withdrawal by Subject|0|||
147537247|NCT00366678|532122015|FG002|Toddler Dose|Withdrawal by Subject|0|||
147537248|NCT00366678|532122013|FG000|Toddler Dose|protocol deviation|1|||
147537249|NCT00366678|532122014|FG001|Toddler Dose|protocol deviation|0|||
147537250|NCT00366678|532122015|FG002|Toddler Dose|protocol deviation|0|||
147537251|NCT00826176|532122018|FG000|Overall Study|Lost to Follow-up|1|||
147537252|NCT00826176|532122019|FG001|Overall Study|Lost to Follow-up|0|||
147537253|NCT00826176|532122018|FG000|Overall Study|Subject Withdrew Consent|3|||
147202273|NCT02745119|530910588|FG001|Overall Study|Withdrawal by Subject|15|||
147537254|NCT00826176|532122019|FG001|Overall Study|Subject Withdrew Consent|0|||
147537255|NCT00826176|532122018|FG000|Overall Study|Administrative|9|||
147537256|NCT00826176|532122019|FG001|Overall Study|Administrative|0|||
147537257|NCT00388674|532122021|FG000|Initial Treatment|Administrative Reason by Sponsor|241|||
147537258|NCT00388674|532122022|FG001|Initial Treatment|Administrative Reason by Sponsor|158|||
147537259|NCT00388674|532122021|FG000|Initial Treatment|Adverse Event|22|||
147537260|NCT00388674|532122022|FG001|Initial Treatment|Adverse Event|87|||
147537261|NCT00388674|532122021|FG000|Initial Treatment|Death|215|||
147537262|NCT00388674|532122022|FG001|Initial Treatment|Death|216|||
147537263|NCT00388674|532122021|FG000|Initial Treatment|Non-HCC HBV Disease Progression|11|||
147537264|NCT00388674|532122022|FG001|Initial Treatment|Non-HCC HBV Disease Progression|17|||
147537265|NCT00388674|532122021|FG000|Initial Treatment|HCC|12|||
147537266|NCT00388674|532122022|FG001|Initial Treatment|HCC|20|||
147537267|NCT00388674|532122021|FG000|Initial Treatment|Lost to Follow-up|526|||
147537268|NCT00388674|532122022|FG001|Initial Treatment|Lost to Follow-up|624|||
147537269|NCT00388674|532122021|FG000|Initial Treatment|Malignancy (Non-HCC)|7|||
147537270|NCT00388674|532122022|FG001|Initial Treatment|Malignancy (Non-HCC)|3|||
147537271|NCT00388674|532122021|FG000|Initial Treatment|Never Treated with Study Medication|1|||
147537272|NCT00388674|532122022|FG001|Initial Treatment|Never Treated with Study Medication|7|||
147537273|NCT00388674|532122021|FG000|Initial Treatment|Non-Study related Comorbidities|3|||
147537274|NCT00388674|532122022|FG001|Initial Treatment|Non-Study related Comorbidities|4|||
147537275|NCT00388674|532122021|FG000|Initial Treatment|Not Defined|125|||
147537276|NCT00388674|532122022|FG001|Initial Treatment|Not Defined|172|||
147537277|NCT00388674|532122021|FG000|Initial Treatment|Partial or inadequate Treatment|112|||
147537278|NCT00388674|532122022|FG001|Initial Treatment|Partial or inadequate Treatment|472|||
147537279|NCT00388674|532122021|FG000|Initial Treatment|Pregnancy|26|||
147537280|NCT00388674|532122022|FG001|Initial Treatment|Pregnancy|16|||
147537281|NCT00388674|532122021|FG000|Initial Treatment|Study Drug Toxicity|5|||
147537282|NCT00388674|532122022|FG001|Initial Treatment|Study Drug Toxicity|92|||
147537283|NCT00388674|532122021|FG000|Initial Treatment|Participant Request|501|||
147537284|NCT00388674|532122022|FG001|Initial Treatment|Participant Request|673|||
147537285|NCT00388674|532122021|FG000|Initial Treatment|No Off-Treatment Status Data|11|||
147537286|NCT00388674|532122022|FG001|Initial Treatment|No Off-Treatment Status Data|13|||
147537287|NCT00388674|532122021|FG000|Initial Treatment|Not Reported|10|||
147537288|NCT00388674|532122022|FG001|Initial Treatment|Not Reported|12|||
147537289|NCT00388674|532122021|FG000|End of Study|Administrative Reason By Sponsor|299|||
147537290|NCT00388674|532122022|FG001|End of Study|Administrative Reason By Sponsor|253|||
147537291|NCT00388674|532122021|FG000|End of Study|Death|239|||
147537292|NCT00388674|532122022|FG001|End of Study|Death|262|||
147537293|NCT00388674|532122021|FG000|End of Study|HBV Disease Progression (Non-HCC)|3|||
147537294|NCT00388674|532122022|FG001|End of Study|HBV Disease Progression (Non-HCC)|9|||
147537295|NCT00388674|532122021|FG000|End of Study|HCC|8|||
147202274|NCT02745119|530910589|FG002|Overall Study|Withdrawal by Subject|8|||
147202275|NCT02745119|530910590|FG003|Overall Study|Withdrawal by Subject|14|||
147202276|NCT02745119|530910587|FG000|Overall Study|Study Terminated by Sponsor|134|||
147202277|NCT02745119|530910588|FG001|Overall Study|Study Terminated by Sponsor|252|||
147202278|NCT02745119|530910589|FG002|Overall Study|Study Terminated by Sponsor|135|||
147202279|NCT02745119|530910590|FG003|Overall Study|Study Terminated by Sponsor|251|||
147202280|NCT02745119|530910587|FG000|Overall Study|Physician Decision|0|||
147202281|NCT02745119|530910588|FG001|Overall Study|Physician Decision|2|||
147202282|NCT02745119|530910589|FG002|Overall Study|Physician Decision|2|||
147202283|NCT02745119|530910590|FG003|Overall Study|Physician Decision|2|||
147202284|NCT02745119|530910587|FG000|Overall Study|Reason Not Specified|0|||
147202285|NCT02745119|530910588|FG001|Overall Study|Reason Not Specified|2|||
147202286|NCT02745119|530910589|FG002|Overall Study|Reason Not Specified|0|||
147537296|NCT00388674|532122022|FG001|End of Study|HCC|7|||
147537297|NCT00388674|532122021|FG000|End of Study|Lost to Follow-up|587|||
147537298|NCT00388674|532122022|FG001|End of Study|Lost to Follow-up|715|||
147537299|NCT00388674|532122021|FG000|End of Study|Malignancy (Non-HCC)|1|||
147537300|NCT00388674|532122022|FG001|End of Study|Malignancy (Non-HCC)|1|||
147537301|NCT00388674|532122021|FG000|End of Study|Non-Study Related Comorbidities|3|||
147537302|NCT00388674|532122022|FG001|End of Study|Non-Study Related Comorbidities|4|||
147537303|NCT00388674|532122021|FG000|End of Study|Not Defined|135|||
147537304|NCT00388674|532122022|FG001|End of Study|Not Defined|214|||
147537305|NCT00388674|532122021|FG000|End of Study|Participant Withdrew Consent|437|||
147537306|NCT00388674|532122022|FG001|End of Study|Participant Withdrew Consent|673|||
147537307|NCT00388674|532122021|FG000|End of Study|No Off-Treatment Status Data|22|||
147202287|NCT02745119|530910590|FG003|Overall Study|Reason Not Specified|1|||
147202288|NCT00687193|530910594|FG000|Overall Study|Adverse Event|0|||
147537308|NCT00388674|532122022|FG001|End of Study|No Off-Treatment Status Data|30|||
147537309|NCT00388674|532122021|FG000|End of Study|Not Reported|0|||
147537310|NCT00388674|532122022|FG001|End of Study|Not Reported|1|||
147537311|NCT03576131|532122023|FG000|Overall Study|Investigator decision|0|||
147537312|NCT03576131|532122024|FG001|Overall Study|Investigator decision|0|||
147537313|NCT03576131|532122025|FG002|Overall Study|Investigator decision|0|||
147537314|NCT03576131|532122026|FG003|Overall Study|Investigator decision|1|||
147537315|NCT03576131|532122027|FG004|Overall Study|Investigator decision|0|||
147537316|NCT03576131|532122028|FG005|Overall Study|Investigator decision|1|||
147537317|NCT03576131|532122029|FG006|Overall Study|Investigator decision|0|||
147537318|NCT03576131|532122030|FG007|Overall Study|Investigator decision|0|||
147537319|NCT03576131|532122023|FG000|Overall Study|Withdrawal by Subject|1|||
147537320|NCT03576131|532122024|FG001|Overall Study|Withdrawal by Subject|1|||
147537321|NCT03576131|532122025|FG002|Overall Study|Withdrawal by Subject|0|||
147537322|NCT03576131|532122026|FG003|Overall Study|Withdrawal by Subject|1|||
147537323|NCT03576131|532122027|FG004|Overall Study|Withdrawal by Subject|2|||
147537324|NCT03576131|532122028|FG005|Overall Study|Withdrawal by Subject|3|||
147537325|NCT03576131|532122029|FG006|Overall Study|Withdrawal by Subject|1|||
147537326|NCT03576131|532122030|FG007|Overall Study|Withdrawal by Subject|0|||
147537327|NCT03576131|532122023|FG000|Overall Study|Death|3|||
147537328|NCT03576131|532122024|FG001|Overall Study|Death|3|||
147537329|NCT03576131|532122025|FG002|Overall Study|Death|1|||
147537330|NCT03576131|532122026|FG003|Overall Study|Death|5|||
147537331|NCT03576131|532122027|FG004|Overall Study|Death|4|||
147537332|NCT03576131|532122028|FG005|Overall Study|Death|1|||
147537333|NCT03576131|532122029|FG006|Overall Study|Death|0|||
147537334|NCT03576131|532122030|FG007|Overall Study|Death|1|||
147537335|NCT03576131|532122023|FG000|Overall Study|New anti-cancer treatment|5|||
147537336|NCT03576131|532122024|FG001|Overall Study|New anti-cancer treatment|1|||
147537337|NCT03576131|532122025|FG002|Overall Study|New anti-cancer treatment|2|||
147537338|NCT03576131|532122026|FG003|Overall Study|New anti-cancer treatment|3|||
147537339|NCT03576131|532122027|FG004|Overall Study|New anti-cancer treatment|0|||
147537340|NCT03576131|532122028|FG005|Overall Study|New anti-cancer treatment|0|||
147537341|NCT03576131|532122029|FG006|Overall Study|New anti-cancer treatment|0|||
147537342|NCT03576131|532122030|FG007|Overall Study|New anti-cancer treatment|0|||
147537343|NCT03576131|532122023|FG000|Overall Study|Unspecified reason|0|||
147537344|NCT03576131|532122024|FG001|Overall Study|Unspecified reason|0|||
147537345|NCT03576131|532122025|FG002|Overall Study|Unspecified reason|1|||
147537346|NCT03576131|532122026|FG003|Overall Study|Unspecified reason|1|||
147537347|NCT03576131|532122027|FG004|Overall Study|Unspecified reason|1|||
147537348|NCT03576131|532122028|FG005|Overall Study|Unspecified reason|1|||
147537349|NCT03576131|532122029|FG006|Overall Study|Unspecified reason|0|||
147537350|NCT03576131|532122030|FG007|Overall Study|Unspecified reason|0|||
147537351|NCT03576131|532122023|FG000|Overall Study|Subject non-compliance|0|||
147537352|NCT03576131|532122024|FG001|Overall Study|Subject non-compliance|0|||
147537353|NCT03576131|532122025|FG002|Overall Study|Subject non-compliance|0|||
147537354|NCT03576131|532122026|FG003|Overall Study|Subject non-compliance|0|||
147537355|NCT03576131|532122027|FG004|Overall Study|Subject non-compliance|0|||
147537356|NCT03576131|532122028|FG005|Overall Study|Subject non-compliance|1|||
147537357|NCT03576131|532122029|FG006|Overall Study|Subject non-compliance|0|||
147537358|NCT03576131|532122030|FG007|Overall Study|Subject non-compliance|0|||
147537359|NCT00996632|532122035|FG000|Overall Study|Physician Decision|0|||
147537360|NCT00996632|532122036|FG001|Overall Study|Physician Decision|0|||
147537361|NCT04484805|532122047|FG000|Overall Study|LTI_H01 piloted the device and was too familiar with the study design to be unblinded/analyzed|1|||
147537362|NCT04484805|532122048|FG001|Overall Study|LTI_H01 piloted the device and was too familiar with the study design to be unblinded/analyzed|0|||
147537363|NCT04484805|532122047|FG000|Overall Study|LTI_H02 had socket fit issues causing discomfort which caused us to withdraw them from the study.|1|||
147537364|NCT04484805|532122048|FG001|Overall Study|LTI_H02 had socket fit issues causing discomfort which caused us to withdraw them from the study.|0|||
147537365|NCT02118896|532122049|FG000|Overall Study|Death|4|||
147537366|NCT02118896|532122050|FG001|Overall Study|Death|0|||
147537367|NCT02118896|532122051|FG002|Overall Study|Death|4|||
147537368|NCT02118896|532122052|FG003|Overall Study|Death|6|||
147537369|NCT02118896|532122053|FG004|Overall Study|Death|3|||
147537370|NCT02118896|532122054|FG005|Overall Study|Death|1|||
147537371|NCT02118896|532122055|FG006|Overall Study|Death|0|||
147537372|NCT02118896|532122056|FG007|Overall Study|Death|0|||
147537373|NCT02118896|532122057|FG008|Overall Study|Death|0|||
147537374|NCT02118896|532122058|FG009|Overall Study|Death|0|||
147537375|NCT02118896|532122049|FG000|Overall Study|Adverse Event|5|||
147537376|NCT02118896|532122050|FG001|Overall Study|Adverse Event|4|||
147537377|NCT02118896|532122051|FG002|Overall Study|Adverse Event|4|||
147537378|NCT02118896|532122052|FG003|Overall Study|Adverse Event|5|||
147537379|NCT02118896|532122053|FG004|Overall Study|Adverse Event|5|||
147537380|NCT02118896|532122054|FG005|Overall Study|Adverse Event|9|||
147537381|NCT02118896|532122055|FG006|Overall Study|Adverse Event|1|||
147537382|NCT02118896|532122056|FG007|Overall Study|Adverse Event|1|||
147537383|NCT02118896|532122057|FG008|Overall Study|Adverse Event|4|||
147537384|NCT02118896|532122058|FG009|Overall Study|Adverse Event|0|||
147537385|NCT02118896|532122049|FG000|Overall Study|Consent withdrawn|2|||
147537386|NCT02118896|532122050|FG001|Overall Study|Consent withdrawn|0|||
147537387|NCT02118896|532122051|FG002|Overall Study|Consent withdrawn|3|||
147537388|NCT02118896|532122052|FG003|Overall Study|Consent withdrawn|4|||
147537389|NCT02118896|532122053|FG004|Overall Study|Consent withdrawn|1|||
147537390|NCT02118896|532122054|FG005|Overall Study|Consent withdrawn|4|||
147537391|NCT02118896|532122055|FG006|Overall Study|Consent withdrawn|0|||
147537392|NCT02118896|532122056|FG007|Overall Study|Consent withdrawn|0|||
147537393|NCT02118896|532122057|FG008|Overall Study|Consent withdrawn|0|||
147537394|NCT02118896|532122058|FG009|Overall Study|Consent withdrawn|0|||
147537395|NCT02118896|532122049|FG000|Overall Study|Non-compliance|2|||
147537396|NCT02118896|532122050|FG001|Overall Study|Non-compliance|1|||
147537397|NCT02118896|532122051|FG002|Overall Study|Non-compliance|1|||
147537398|NCT02118896|532122052|FG003|Overall Study|Non-compliance|5|||
147537399|NCT02118896|532122053|FG004|Overall Study|Non-compliance|0|||
147537400|NCT02118896|532122054|FG005|Overall Study|Non-compliance|1|||
147537401|NCT02118896|532122055|FG006|Overall Study|Non-compliance|0|||
147537402|NCT02118896|532122056|FG007|Overall Study|Non-compliance|1|||
147537403|NCT02118896|532122057|FG008|Overall Study|Non-compliance|0|||
147537404|NCT02118896|532122058|FG009|Overall Study|Non-compliance|0|||
147537405|NCT02118896|532122049|FG000|Overall Study|Pregnancy|1|||
147537406|NCT02118896|532122050|FG001|Overall Study|Pregnancy|1|||
147537407|NCT02118896|532122051|FG002|Overall Study|Pregnancy|0|||
147537408|NCT02118896|532122052|FG003|Overall Study|Pregnancy|0|||
147537409|NCT02118896|532122053|FG004|Overall Study|Pregnancy|1|||
147537410|NCT02118896|532122054|FG005|Overall Study|Pregnancy|3|||
147537411|NCT02118896|532122055|FG006|Overall Study|Pregnancy|1|||
147537412|NCT02118896|532122056|FG007|Overall Study|Pregnancy|0|||
147537413|NCT02118896|532122057|FG008|Overall Study|Pregnancy|0|||
147537414|NCT02118896|532122058|FG009|Overall Study|Pregnancy|0|||
147537415|NCT02118896|532122049|FG000|Overall Study|Lost to Follow-up|1|||
147537416|NCT02118896|532122050|FG001|Overall Study|Lost to Follow-up|2|||
147537417|NCT02118896|532122051|FG002|Overall Study|Lost to Follow-up|1|||
147537418|NCT02118896|532122052|FG003|Overall Study|Lost to Follow-up|0|||
147537419|NCT02118896|532122053|FG004|Overall Study|Lost to Follow-up|2|||
147537420|NCT02118896|532122054|FG005|Overall Study|Lost to Follow-up|1|||
147537421|NCT02118896|532122055|FG006|Overall Study|Lost to Follow-up|0|||
147537422|NCT02118896|532122056|FG007|Overall Study|Lost to Follow-up|0|||
147537423|NCT02118896|532122057|FG008|Overall Study|Lost to Follow-up|0|||
147537424|NCT02118896|532122058|FG009|Overall Study|Lost to Follow-up|0|||
147537425|NCT02118896|532122049|FG000|Overall Study|Immunosuppressive regimen (not MR4)|1|||
147537426|NCT02118896|532122050|FG001|Overall Study|Immunosuppressive regimen (not MR4)|5|||
147537427|NCT02118896|532122051|FG002|Overall Study|Immunosuppressive regimen (not MR4)|1|||
147537428|NCT02118896|532122052|FG003|Overall Study|Immunosuppressive regimen (not MR4)|2|||
147537429|NCT02118896|532122053|FG004|Overall Study|Immunosuppressive regimen (not MR4)|4|||
147537430|NCT02118896|532122054|FG005|Overall Study|Immunosuppressive regimen (not MR4)|2|||
147537431|NCT02118896|532122055|FG006|Overall Study|Immunosuppressive regimen (not MR4)|0|||
147537432|NCT02118896|532122056|FG007|Overall Study|Immunosuppressive regimen (not MR4)|0|||
147537433|NCT02118896|532122057|FG008|Overall Study|Immunosuppressive regimen (not MR4)|0|||
147537434|NCT02118896|532122058|FG009|Overall Study|Immunosuppressive regimen (not MR4)|2|||
147537435|NCT02118896|532122049|FG000|Overall Study|Prohibited medication|0|||
147537436|NCT02118896|532122050|FG001|Overall Study|Prohibited medication|0|||
147537437|NCT02118896|532122051|FG002|Overall Study|Prohibited medication|0|||
147537438|NCT02118896|532122052|FG003|Overall Study|Prohibited medication|0|||
147537439|NCT02118896|532122053|FG004|Overall Study|Prohibited medication|1|||
147537440|NCT02118896|532122054|FG005|Overall Study|Prohibited medication|3|||
147537441|NCT02118896|532122055|FG006|Overall Study|Prohibited medication|0|||
147537442|NCT02118896|532122056|FG007|Overall Study|Prohibited medication|0|||
147537443|NCT02118896|532122057|FG008|Overall Study|Prohibited medication|0|||
147537444|NCT02118896|532122058|FG009|Overall Study|Prohibited medication|0|||
147537445|NCT02118896|532122049|FG000|Overall Study|Miscellaneous|1|||
147537446|NCT02118896|532122050|FG001|Overall Study|Miscellaneous|2|||
147537447|NCT02118896|532122051|FG002|Overall Study|Miscellaneous|0|||
147537448|NCT02118896|532122052|FG003|Overall Study|Miscellaneous|2|||
147537449|NCT02118896|532122053|FG004|Overall Study|Miscellaneous|0|||
147537450|NCT02118896|532122054|FG005|Overall Study|Miscellaneous|4|||
147537451|NCT02118896|532122055|FG006|Overall Study|Miscellaneous|0|||
147537452|NCT02118896|532122056|FG007|Overall Study|Miscellaneous|0|||
147649424|NCT02634801|532537341|FG000|Treatment Period (Weeks 0 to 24)|Withdrawal by Subject|0|||
147202289|NCT00687193|530910595|FG001|Overall Study|Adverse Event|1|||
147537453|NCT02118896|532122057|FG008|Overall Study|Miscellaneous|0|||
147537454|NCT02118896|532122058|FG009|Overall Study|Miscellaneous|0|||
147537455|NCT02116309|532122060|FG000|Overall Study|Lost to Follow-up|0|||
147537456|NCT02116309|532122061|FG001|Overall Study|Lost to Follow-up|1|||
147537457|NCT03292731|532122062|FG000|Overall Study|Protocol Violation|4|||
147537458|NCT03292731|532122063|FG001|Overall Study|Protocol Violation|11|||
147537459|NCT03292731|532122064|FG002|Overall Study|Protocol Violation|1|||
147537460|NCT00471237|532122065|FG000|Overall Study|Adverse Event|6|||
147537461|NCT00471237|532122066|FG001|Overall Study|Adverse Event|5|||
147537462|NCT00471237|532122067|FG002|Overall Study|Adverse Event|4|||
147537463|NCT00471237|532122068|FG003|Overall Study|Adverse Event|8|||
147537464|NCT00471237|532122069|FG004|Overall Study|Adverse Event|7|||
147537465|NCT00471237|532122070|FG005|Overall Study|Adverse Event|5|||
147537466|NCT00471237|532122071|FG006|Overall Study|Adverse Event|0|||
147537467|NCT00471237|532122065|FG000|Overall Study|Lost to Follow-up|1|||
147537468|NCT00471237|532122066|FG001|Overall Study|Lost to Follow-up|1|||
147537469|NCT00471237|532122067|FG002|Overall Study|Lost to Follow-up|0|||
147537470|NCT00471237|532122068|FG003|Overall Study|Lost to Follow-up|2|||
147537471|NCT00471237|532122069|FG004|Overall Study|Lost to Follow-up|3|||
147537472|NCT00471237|532122070|FG005|Overall Study|Lost to Follow-up|0|||
147537473|NCT00471237|532122071|FG006|Overall Study|Lost to Follow-up|0|||
147537474|NCT00471237|532122065|FG000|Overall Study|Protocol Violation|3|||
147537475|NCT00471237|532122066|FG001|Overall Study|Protocol Violation|6|||
147537476|NCT00471237|532122067|FG002|Overall Study|Protocol Violation|3|||
147537477|NCT00471237|532122068|FG003|Overall Study|Protocol Violation|2|||
147537478|NCT00471237|532122069|FG004|Overall Study|Protocol Violation|2|||
147537479|NCT00471237|532122070|FG005|Overall Study|Protocol Violation|4|||
147537480|NCT00471237|532122071|FG006|Overall Study|Protocol Violation|1|||
147537481|NCT00471237|532122065|FG000|Overall Study|Withdrawal by Subject|8|||
147537482|NCT00471237|532122066|FG001|Overall Study|Withdrawal by Subject|6|||
147537483|NCT00471237|532122067|FG002|Overall Study|Withdrawal by Subject|5|||
147537484|NCT00471237|532122068|FG003|Overall Study|Withdrawal by Subject|8|||
147537485|NCT00471237|532122069|FG004|Overall Study|Withdrawal by Subject|7|||
147537486|NCT00471237|532122070|FG005|Overall Study|Withdrawal by Subject|4|||
147537487|NCT00471237|532122071|FG006|Overall Study|Withdrawal by Subject|2|||
147537488|NCT00471237|532122065|FG000|Overall Study|Sponsor terminated study|20|||
147537489|NCT00471237|532122066|FG001|Overall Study|Sponsor terminated study|23|||
147537490|NCT00471237|532122067|FG002|Overall Study|Sponsor terminated study|19|||
147537491|NCT00471237|532122068|FG003|Overall Study|Sponsor terminated study|22|||
147537492|NCT00471237|532122069|FG004|Overall Study|Sponsor terminated study|18|||
147537493|NCT00471237|532122070|FG005|Overall Study|Sponsor terminated study|24|||
147537494|NCT00471237|532122071|FG006|Overall Study|Sponsor terminated study|0|||
147537495|NCT00471237|532122065|FG000|Overall Study|Non-compliance|0|||
147537496|NCT00471237|532122066|FG001|Overall Study|Non-compliance|1|||
147537497|NCT00471237|532122067|FG002|Overall Study|Non-compliance|0|||
147537498|NCT00471237|532122068|FG003|Overall Study|Non-compliance|1|||
147537499|NCT00471237|532122069|FG004|Overall Study|Non-compliance|0|||
147537500|NCT00471237|532122070|FG005|Overall Study|Non-compliance|0|||
147537501|NCT00471237|532122071|FG006|Overall Study|Non-compliance|0|||
147537502|NCT00471237|532122065|FG000|Overall Study|Met serum creatinine withdrawal criteria|1|||
147537503|NCT00471237|532122066|FG001|Overall Study|Met serum creatinine withdrawal criteria|0|||
147537504|NCT00471237|532122067|FG002|Overall Study|Met serum creatinine withdrawal criteria|2|||
147537505|NCT00471237|532122068|FG003|Overall Study|Met serum creatinine withdrawal criteria|2|||
147537506|NCT00471237|532122069|FG004|Overall Study|Met serum creatinine withdrawal criteria|0|||
147537507|NCT00471237|532122070|FG005|Overall Study|Met serum creatinine withdrawal criteria|0|||
147537508|NCT00471237|532122071|FG006|Overall Study|Met serum creatinine withdrawal criteria|0|||
147537509|NCT00471237|532122065|FG000|Overall Study|Early stopping due to non-efficacy|1|||
147537510|NCT00471237|532122066|FG001|Overall Study|Early stopping due to non-efficacy|0|||
147537511|NCT00471237|532122067|FG002|Overall Study|Early stopping due to non-efficacy|0|||
147537512|NCT00471237|532122068|FG003|Overall Study|Early stopping due to non-efficacy|0|||
147537513|NCT00471237|532122069|FG004|Overall Study|Early stopping due to non-efficacy|1|||
147537514|NCT00471237|532122070|FG005|Overall Study|Early stopping due to non-efficacy|0|||
147537515|NCT00471237|532122071|FG006|Overall Study|Early stopping due to non-efficacy|0|||
147537516|NCT00471237|532122065|FG000|Overall Study|Participant planned to travel to abraod|1|||
147537517|NCT00471237|532122066|FG001|Overall Study|Participant planned to travel to abraod|0|||
147537518|NCT00471237|532122067|FG002|Overall Study|Participant planned to travel to abraod|0|||
147537519|NCT00471237|532122068|FG003|Overall Study|Participant planned to travel to abraod|0|||
147537520|NCT00471237|532122069|FG004|Overall Study|Participant planned to travel to abraod|0|||
147537521|NCT00471237|532122070|FG005|Overall Study|Participant planned to travel to abraod|1|||
147537522|NCT00471237|532122071|FG006|Overall Study|Participant planned to travel to abraod|0|||
147202290|NCT00687193|530910596|FG002|Overall Study|Adverse Event|2|||
147649425|NCT02634801|532537342|FG001|Treatment Period (Weeks 0 to 24)|Withdrawal by Subject|8|||
147537523|NCT00471237|532122065|FG000|Overall Study|High parathyroid hormone|0|||
147537524|NCT00471237|532122066|FG001|Overall Study|High parathyroid hormone|0|||
147537525|NCT00471237|532122067|FG002|Overall Study|High parathyroid hormone|1|||
147537526|NCT00471237|532122068|FG003|Overall Study|High parathyroid hormone|0|||
147537527|NCT00471237|532122069|FG004|Overall Study|High parathyroid hormone|0|||
147537528|NCT00471237|532122070|FG005|Overall Study|High parathyroid hormone|0|||
147537529|NCT00471237|532122071|FG006|Overall Study|High parathyroid hormone|0|||
147537530|NCT00471237|532122065|FG000|Overall Study|Participant lost medication|0|||
147537531|NCT00471237|532122066|FG001|Overall Study|Participant lost medication|0|||
147537532|NCT00471237|532122067|FG002|Overall Study|Participant lost medication|0|||
147537533|NCT00471237|532122068|FG003|Overall Study|Participant lost medication|0|||
147537534|NCT00471237|532122069|FG004|Overall Study|Participant lost medication|1|||
147537535|NCT00471237|532122070|FG005|Overall Study|Participant lost medication|0|||
147537536|NCT00471237|532122071|FG006|Overall Study|Participant lost medication|0|||
147537537|NCT00471237|532122065|FG000|Overall Study|Administration of prohibited medicine|0|||
147537538|NCT00471237|532122066|FG001|Overall Study|Administration of prohibited medicine|0|||
147537539|NCT00471237|532122067|FG002|Overall Study|Administration of prohibited medicine|0|||
147537540|NCT00471237|532122068|FG003|Overall Study|Administration of prohibited medicine|0|||
147537541|NCT00471237|532122069|FG004|Overall Study|Administration of prohibited medicine|1|||
147537542|NCT00471237|532122070|FG005|Overall Study|Administration of prohibited medicine|0|||
147537543|NCT00471237|532122071|FG006|Overall Study|Administration of prohibited medicine|0|||
147537544|NCT00471237|532122065|FG000|Overall Study|Participant shifted residence|0|||
147537545|NCT00471237|532122066|FG001|Overall Study|Participant shifted residence|0|||
147537546|NCT00471237|532122067|FG002|Overall Study|Participant shifted residence|0|||
147537547|NCT00471237|532122068|FG003|Overall Study|Participant shifted residence|0|||
147537548|NCT00471237|532122069|FG004|Overall Study|Participant shifted residence|1|||
147537549|NCT00471237|532122070|FG005|Overall Study|Participant shifted residence|0|||
147537550|NCT00471237|532122071|FG006|Overall Study|Participant shifted residence|0|||
147537551|NCT00471237|532122065|FG000|Overall Study|Participant's decision|0|||
147537552|NCT00471237|532122066|FG001|Overall Study|Participant's decision|0|||
147537553|NCT00471237|532122067|FG002|Overall Study|Participant's decision|0|||
147537554|NCT00471237|532122068|FG003|Overall Study|Participant's decision|0|||
147537555|NCT00471237|532122069|FG004|Overall Study|Participant's decision|0|||
147537556|NCT00471237|532122070|FG005|Overall Study|Participant's decision|1|||
147537557|NCT00471237|532122071|FG006|Overall Study|Participant's decision|0|||
147537558|NCT02329834|532122072|FG000|Overall Study|Physician Decision|1|||
147537559|NCT02329834|532122073|FG001|Overall Study|Physician Decision|0|||
147537560|NCT00578448|532122074|FG000|Day 1 up to 3 Years of Planned Study|Death|1|||
147537561|NCT00578448|532122074|FG000|Day 1 up to 3 Years of Planned Study|Adverse Event|1|||
147537562|NCT00578448|532122074|FG000|Day 1 up to 3 Years of Planned Study|started marketed Cellcept and Prograf|1|||
147537563|NCT00578448|532122074|FG000|1 Year Long Term Extension (LTE)|Adverse Event|1|||
147537564|NCT01317199|532122075|FG000|Dose-escalation Phase 1|Physician Decision|5|||
147537565|NCT01317199|532122076|FG001|Dose-escalation Phase 1|Physician Decision|0|||
147537566|NCT01317199|532122077|FG002|Dose-escalation Phase 1|Physician Decision|0|||
147537567|NCT01317199|532122078|FG003|Dose-escalation Phase 1|Physician Decision|0|||
147537568|NCT01317199|532122075|FG000|Dose-escalation Phase 1|Disease progression|1|||
147537569|NCT01317199|532122076|FG001|Dose-escalation Phase 1|Disease progression|0|||
147537570|NCT01317199|532122077|FG002|Dose-escalation Phase 1|Disease progression|0|||
147537571|NCT01317199|532122078|FG003|Dose-escalation Phase 1|Disease progression|0|||
147537572|NCT01317199|532122075|FG000|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|1|||
147537573|NCT01317199|532122076|FG001|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|0|||
147537574|NCT01317199|532122077|FG002|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|0|||
147537575|NCT01317199|532122078|FG003|Dose-escalation Phase 1|Comorbidities, myasthenia gravis|0|||
147537576|NCT01317199|532122075|FG000|Randomized Phase 2|Disease progression|0|||
147537577|NCT01317199|532122076|FG001|Randomized Phase 2|Disease progression|3|||
147537578|NCT01317199|532122077|FG002|Randomized Phase 2|Disease progression|7|||
147537579|NCT01317199|532122078|FG003|Randomized Phase 2|Disease progression|5|||
147537580|NCT01317199|532122075|FG000|Randomized Phase 2|Withdrawal by Subject|0|||
147537581|NCT01317199|532122076|FG001|Randomized Phase 2|Withdrawal by Subject|3|||
147537582|NCT01317199|532122077|FG002|Randomized Phase 2|Withdrawal by Subject|5|||
147537583|NCT01317199|532122078|FG003|Randomized Phase 2|Withdrawal by Subject|4|||
147537584|NCT01317199|532122075|FG000|Randomized Phase 2|Adverse Event|0|||
147537585|NCT01317199|532122076|FG001|Randomized Phase 2|Adverse Event|0|||
147537586|NCT01317199|532122077|FG002|Randomized Phase 2|Adverse Event|0|||
147537587|NCT01317199|532122078|FG003|Randomized Phase 2|Adverse Event|1|||
147537588|NCT01317199|532122075|FG000|Randomized Phase 2|Comorbidities|0|||
147537589|NCT01317199|532122076|FG001|Randomized Phase 2|Comorbidities|2|||
147537590|NCT01317199|532122077|FG002|Randomized Phase 2|Comorbidities|2|||
147537591|NCT01317199|532122078|FG003|Randomized Phase 2|Comorbidities|2|||
147537592|NCT01317199|532122075|FG000|Randomized Phase 2|Rising PSA, not as defined by protocol|0|||
147537593|NCT01317199|532122076|FG001|Randomized Phase 2|Rising PSA, not as defined by protocol|2|||
147537594|NCT01317199|532122077|FG002|Randomized Phase 2|Rising PSA, not as defined by protocol|5|||
147537595|NCT01317199|532122078|FG003|Randomized Phase 2|Rising PSA, not as defined by protocol|2|||
147537596|NCT01317199|532122075|FG000|Randomized Phase 2|Disenrolled before treatment|0|||
147537597|NCT01317199|532122076|FG001|Randomized Phase 2|Disenrolled before treatment|1|||
147537598|NCT01317199|532122077|FG002|Randomized Phase 2|Disenrolled before treatment|1|||
147537599|NCT01317199|532122078|FG003|Randomized Phase 2|Disenrolled before treatment|2|||
147537600|NCT01317199|532122075|FG000|Randomized Phase 2|Patient stopped taking study drug|0|||
147537601|NCT01317199|532122076|FG001|Randomized Phase 2|Patient stopped taking study drug|0|||
147202291|NCT00687193|530910597|FG003|Overall Study|Adverse Event|3|||
147202292|NCT00687193|530910598|FG004|Overall Study|Adverse Event|0|||
147202293|NCT00687193|530910599|FG005|Overall Study|Adverse Event|2|||
147202294|NCT00687193|530910594|FG000|Overall Study|Lack of Efficacy|1|||
147202295|NCT00687193|530910595|FG001|Overall Study|Lack of Efficacy|1|||
147202296|NCT00687193|530910596|FG002|Overall Study|Lack of Efficacy|0|||
147202297|NCT00687193|530910597|FG003|Overall Study|Lack of Efficacy|0|||
147202298|NCT00687193|530910598|FG004|Overall Study|Lack of Efficacy|0|||
147202299|NCT00687193|530910599|FG005|Overall Study|Lack of Efficacy|2|||
147202300|NCT00687193|530910594|FG000|Overall Study|Protocol Violation|1|||
147202301|NCT00687193|530910595|FG001|Overall Study|Protocol Violation|2|||
147202302|NCT00687193|530910596|FG002|Overall Study|Protocol Violation|0|||
147202303|NCT00687193|530910597|FG003|Overall Study|Protocol Violation|1|||
147202304|NCT00687193|530910598|FG004|Overall Study|Protocol Violation|2|||
147202305|NCT00687193|530910599|FG005|Overall Study|Protocol Violation|0|||
147202306|NCT02447003|530910600|FG000|Overall Study|Other|0|||
147202307|NCT02447003|530910601|FG001|Overall Study|Other|4|||
147202308|NCT02447003|530910600|FG000|Overall Study|Site discontinued|0|||
147202309|NCT02447003|530910601|FG001|Overall Study|Site discontinued|2|||
147202310|NCT02447003|530910600|FG000|Overall Study|Physician Decision|0|||
147202311|NCT02447003|530910601|FG001|Overall Study|Physician Decision|1|||
147202312|NCT02447003|530910600|FG000|Overall Study|Withdrawal by Subject|4|||
147202313|NCT02447003|530910601|FG001|Overall Study|Withdrawal by Subject|3|||
147202314|NCT02447003|530910600|FG000|Overall Study|Sponsor Decision|6|||
147202315|NCT02447003|530910601|FG001|Overall Study|Sponsor Decision|11|||
147202316|NCT02447003|530910600|FG000|Overall Study|Progressive Disease|1|||
147202317|NCT02447003|530910601|FG001|Overall Study|Progressive Disease|0|||
147202318|NCT02447003|530910600|FG000|Overall Study|Lost to Follow-up|5|||
147202319|NCT02447003|530910601|FG001|Overall Study|Lost to Follow-up|0|||
147202320|NCT02447003|530910600|FG000|Overall Study|Death|154|||
147202321|NCT02447003|530910601|FG001|Overall Study|Death|63|||
147202322|NCT01394016|530910602|FG000|Overall Study|Progressive Disease|2|||
147202323|NCT01394016|530910603|FG001|Overall Study|Progressive Disease|0|||
147202324|NCT01394016|530910604|FG002|Overall Study|Progressive Disease|0|||
147202325|NCT01394016|530910605|FG003|Overall Study|Progressive Disease|0|||
147202326|NCT01394016|530910606|FG004|Overall Study|Progressive Disease|0|||
147202327|NCT01394016|530910607|FG005|Overall Study|Progressive Disease|0|||
147202328|NCT01394016|530910608|FG006|Overall Study|Progressive Disease|0|||
147202329|NCT01394016|530910609|FG007|Overall Study|Progressive Disease|0|||
147202330|NCT01394016|530910610|FG008|Overall Study|Progressive Disease|0|||
147202331|NCT01394016|530910611|FG009|Overall Study|Progressive Disease|0|||
147202332|NCT01394016|530910612|FG010|Overall Study|Progressive Disease|0|||
147202333|NCT01394016|530910613|FG011|Overall Study|Progressive Disease|0|||
147202334|NCT01394016|530910614|FG012|Overall Study|Progressive Disease|0|||
147202335|NCT01394016|530910615|FG013|Overall Study|Progressive Disease|0|||
147202336|NCT01394016|530910616|FG014|Overall Study|Progressive Disease|0|||
147202337|NCT01394016|530910617|FG015|Overall Study|Progressive Disease|0|||
147202338|NCT01394016|530910618|FG016|Overall Study|Progressive Disease|0|||
147202339|NCT01394016|530910619|FG017|Overall Study|Progressive Disease|0|||
147202340|NCT01394016|530910620|FG018|Overall Study|Progressive Disease|0|||
147202341|NCT01394016|530910602|FG000|Overall Study|Withdrawal by Subject|0|||
147202342|NCT01394016|530910603|FG001|Overall Study|Withdrawal by Subject|0|||
147202343|NCT01394016|530910604|FG002|Overall Study|Withdrawal by Subject|0|||
147202344|NCT01394016|530910605|FG003|Overall Study|Withdrawal by Subject|0|||
147202345|NCT01394016|530910606|FG004|Overall Study|Withdrawal by Subject|0|||
147202346|NCT01394016|530910607|FG005|Overall Study|Withdrawal by Subject|0|||
147202347|NCT01394016|530910608|FG006|Overall Study|Withdrawal by Subject|0|||
147202348|NCT01394016|530910609|FG007|Overall Study|Withdrawal by Subject|1|||
147202349|NCT01394016|530910610|FG008|Overall Study|Withdrawal by Subject|1|||
147202350|NCT01394016|530910611|FG009|Overall Study|Withdrawal by Subject|1|||
147202351|NCT01394016|530910612|FG010|Overall Study|Withdrawal by Subject|4|||
147202352|NCT01394016|530910613|FG011|Overall Study|Withdrawal by Subject|0|||
147202353|NCT01394016|530910614|FG012|Overall Study|Withdrawal by Subject|0|||
147202354|NCT01394016|530910615|FG013|Overall Study|Withdrawal by Subject|3|||
147537602|NCT01317199|532122077|FG002|Randomized Phase 2|Patient stopped taking study drug|0|||
147537603|NCT01317199|532122078|FG003|Randomized Phase 2|Patient stopped taking study drug|1|||
147202355|NCT01394016|530910616|FG014|Overall Study|Withdrawal by Subject|1|||
147202356|NCT01394016|530910617|FG015|Overall Study|Withdrawal by Subject|3|||
147202357|NCT01394016|530910618|FG016|Overall Study|Withdrawal by Subject|1|||
147202358|NCT01394016|530910619|FG017|Overall Study|Withdrawal by Subject|1|||
147202359|NCT01394016|530910620|FG018|Overall Study|Withdrawal by Subject|2|||
147202360|NCT01394016|530910602|FG000|Overall Study|Adverse Event|0|||
147202361|NCT01394016|530910603|FG001|Overall Study|Adverse Event|0|||
147202362|NCT01394016|530910604|FG002|Overall Study|Adverse Event|0|||
147202363|NCT01394016|530910605|FG003|Overall Study|Adverse Event|0|||
147202364|NCT01394016|530910606|FG004|Overall Study|Adverse Event|0|||
147202365|NCT01394016|530910607|FG005|Overall Study|Adverse Event|0|||
147202366|NCT01394016|530910608|FG006|Overall Study|Adverse Event|0|||
147437039|NCT01118325|531767243|FG001|Overall Study|Adverse Event|0|||
147437040|NCT01118325|531767244|FG002|Overall Study|Adverse Event|1|||
147437041|NCT03334409|531767245|FG000|Overall Study|Did not meet inclusion criteria|1|||
147437042|NCT03334409|531767246|FG001|Overall Study|Did not meet inclusion criteria|0|||
147437043|NCT00975715|531767247|FG000|Titration Period|Adverse Event|6|||
147437044|NCT00975715|531767248|FG001|Titration Period|Adverse Event|0|||
147437045|NCT00975715|531767247|FG000|Titration Period|Protocol Violation|1|||
147437046|NCT00975715|531767248|FG001|Titration Period|Protocol Violation|0|||
147437047|NCT00975715|531767247|FG000|Maintenance Period|Adverse Event|2|||
147437048|NCT00975715|531767248|FG001|Maintenance Period|Adverse Event|1|||
147437049|NCT04004429|531767256|FG000|Overall Study|Protocol Violation|1|||
147437050|NCT04004429|531767257|FG001|Overall Study|Protocol Violation|0|||
147437051|NCT04004429|531767258|FG002|Overall Study|Protocol Violation|0|||
147437052|NCT04004429|531767256|FG000|Overall Study|Physician Decision|0|||
147437053|NCT04004429|531767257|FG001|Overall Study|Physician Decision|1|||
147437054|NCT04004429|531767258|FG002|Overall Study|Physician Decision|1|||
147437055|NCT04004429|531767256|FG000|Overall Study|Withdrawal by Subject|1|||
147437056|NCT04004429|531767257|FG001|Overall Study|Withdrawal by Subject|1|||
147437057|NCT04004429|531767258|FG002|Overall Study|Withdrawal by Subject|1|||
147437058|NCT00646906|531767264|FG000|Crossover Period 1|Withdrawal by Subject|1|||
147437059|NCT00646906|531767265|FG001|Crossover Period 1|Withdrawal by Subject|0|||
147437060|NCT00646906|531767266|FG002|Crossover Period 1|Withdrawal by Subject|0|||
147437061|NCT00646906|531767267|FG003|Crossover Period 1|Withdrawal by Subject|0|||
147437062|NCT00646906|531767268|FG004|Crossover Period 1|Withdrawal by Subject|0|||
147437063|NCT00646906|531767269|FG005|Crossover Period 1|Withdrawal by Subject|1|||
147437064|NCT00646906|531767270|FG006|Crossover Period 1|Withdrawal by Subject|0|||
147437065|NCT00646906|531767264|FG000|Crossover Period 2|Withdrawal by Subject|0|||
147437066|NCT00646906|531767265|FG001|Crossover Period 2|Withdrawal by Subject|1|||
147437067|NCT00646906|531767266|FG002|Crossover Period 2|Withdrawal by Subject|2|||
147437068|NCT00646906|531767267|FG003|Crossover Period 2|Withdrawal by Subject|1|||
147437069|NCT00646906|531767268|FG004|Crossover Period 2|Withdrawal by Subject|0|||
147437070|NCT00646906|531767269|FG005|Crossover Period 2|Withdrawal by Subject|0|||
147437071|NCT00646906|531767270|FG006|Crossover Period 2|Withdrawal by Subject|0|||
147437072|NCT00646906|531767264|FG000|Crossover Period 2|Physician Decision|0|||
147437073|NCT00646906|531767265|FG001|Crossover Period 2|Physician Decision|0|||
147437074|NCT00646906|531767266|FG002|Crossover Period 2|Physician Decision|0|||
147437075|NCT00646906|531767267|FG003|Crossover Period 2|Physician Decision|0|||
147437076|NCT00646906|531767268|FG004|Crossover Period 2|Physician Decision|0|||
147437077|NCT00646906|531767269|FG005|Crossover Period 2|Physician Decision|0|||
147437078|NCT00646906|531767270|FG006|Crossover Period 2|Physician Decision|1|||
147437079|NCT02448225|531767272|FG000|Overall Study|Withdrawal by Subject|1|||
147437080|NCT02448225|531767272|FG000|Overall Study|Did not get FSPG scan|18|||
147437081|NCT02448225|531767272|FG000|Overall Study|Treated between the FDG and FSPG scan|1|||
147437082|NCT00851682|531767273|FG000|Overall Study|screen failure|5|||
147437083|NCT00851682|531767274|FG001|Overall Study|screen failure|0|||
147437084|NCT04422990|531767279|FG000|Overall Study|Withdrawal by Subject|0|||
147437085|NCT04422990|531767280|FG001|Overall Study|Withdrawal by Subject|1|||
147437086|NCT04422990|531767279|FG000|Overall Study|Travel|3|||
147437087|NCT04422990|531767280|FG001|Overall Study|Travel|0|||
147437088|NCT02486653|531767285|FG000|Overall Study|Withdrawal by Subject|1|||
147437089|NCT02486653|531767286|FG001|Overall Study|Withdrawal by Subject|3|||
147437090|NCT02486653|531767285|FG000|Overall Study|Protocol Violation|1|||
147437091|NCT02486653|531767286|FG001|Overall Study|Protocol Violation|0|||
147437092|NCT02486653|531767285|FG000|Overall Study|surgery cancelled|4|||
147437093|NCT02486653|531767286|FG001|Overall Study|surgery cancelled|1|||
147202367|NCT01394016|530910609|FG007|Overall Study|Adverse Event|0|||
147202368|NCT01394016|530910610|FG008|Overall Study|Adverse Event|0|||
147437094|NCT01230554|531767293|FG000|Overall Study|Lost to Follow-up|2|||
147437095|NCT01230554|531767293|FG000|Overall Study|Inability to maintain visit schedule|1|||
147437096|NCT00307333|531767294|FG000|Overall Study|Lost to Follow-up|11|||
147437097|NCT00307333|531767295|FG001|Overall Study|Lost to Follow-up|3|||
147437098|NCT01245387|531767296|FG000|Overall Study|Lost to Follow-up|106|||
147437099|NCT01245387|531767296|FG000|Overall Study|Lack of Efficacy|195|||
147437100|NCT01245387|531767296|FG000|Overall Study|Adverse Event|9|||
147437101|NCT01245387|531767296|FG000|Overall Study|Death|3|||
147202369|NCT01394016|530910611|FG009|Overall Study|Adverse Event|1|||
147437102|NCT01245387|531767296|FG000|Overall Study|Other|131|||
147437103|NCT01245387|531767296|FG000|Overall Study|Missing discontinuation status|369|||
147437104|NCT04246801|531767297|FG000|Overall Study|Adverse Event|1|||
147202370|NCT01394016|530910612|FG010|Overall Study|Adverse Event|0|||
147202371|NCT01394016|530910613|FG011|Overall Study|Adverse Event|0|||
147202372|NCT01394016|530910614|FG012|Overall Study|Adverse Event|0|||
147437105|NCT04246801|531767298|FG001|Overall Study|Adverse Event|1|||
147437106|NCT04246801|531767297|FG000|Overall Study|Protocol Violation|1|||
147437107|NCT04246801|531767298|FG001|Overall Study|Protocol Violation|1|||
147437108|NCT04246801|531767297|FG000|Overall Study|Lack of Efficacy|0|||
147437109|NCT04246801|531767298|FG001|Overall Study|Lack of Efficacy|2|||
147437110|NCT04246801|531767297|FG000|Overall Study|Lost to Follow-up|1|||
147437111|NCT04246801|531767298|FG001|Overall Study|Lost to Follow-up|1|||
147437112|NCT04246801|531767297|FG000|Overall Study|Withdrawal by Subject|2|||
147437113|NCT04246801|531767298|FG001|Overall Study|Withdrawal by Subject|1|||
147437114|NCT01368042|531767299|FG000|Overall Study|Death|14|||
147437115|NCT01368042|531767299|FG000|Overall Study|Protocol Violation|11|||
147437116|NCT01368042|531767299|FG000|Overall Study|Lost to Follow-up|4|||
147437117|NCT01368042|531767299|FG000|Overall Study|Transplanted|1|||
147437118|NCT01621542|531767300|FG000|Overall Study|Adverse Event|0|||
147437119|NCT01621542|531767301|FG001|Overall Study|Adverse Event|0|||
147437120|NCT01621542|531767302|FG002|Overall Study|Adverse Event|1|||
147437121|NCT01621542|531767303|FG003|Overall Study|Adverse Event|3|||
147437122|NCT01621542|531767304|FG004|Overall Study|Adverse Event|0|||
147437123|NCT01621542|531767305|FG005|Overall Study|Adverse Event|0|||
147437124|NCT01621542|531767300|FG000|Overall Study|Death|0|||
147437125|NCT01621542|531767301|FG001|Overall Study|Death|1|||
147437126|NCT01621542|531767302|FG002|Overall Study|Death|0|||
147437127|NCT01621542|531767303|FG003|Overall Study|Death|0|||
147437128|NCT01621542|531767304|FG004|Overall Study|Death|0|||
147437129|NCT01621542|531767305|FG005|Overall Study|Death|0|||
147437130|NCT01621542|531767300|FG000|Overall Study|Physician Decision|1|||
147437131|NCT01621542|531767301|FG001|Overall Study|Physician Decision|0|||
147437132|NCT01621542|531767302|FG002|Overall Study|Physician Decision|1|||
147437133|NCT01621542|531767303|FG003|Overall Study|Physician Decision|13|||
147437134|NCT01621542|531767304|FG004|Overall Study|Physician Decision|3|||
147437135|NCT01621542|531767305|FG005|Overall Study|Physician Decision|1|||
147437136|NCT01621542|531767300|FG000|Overall Study|Withdrawal by Subject|2|||
147437137|NCT01621542|531767301|FG001|Overall Study|Withdrawal by Subject|0|||
147437138|NCT01621542|531767302|FG002|Overall Study|Withdrawal by Subject|1|||
147437139|NCT01621542|531767303|FG003|Overall Study|Withdrawal by Subject|3|||
147437140|NCT01621542|531767304|FG004|Overall Study|Withdrawal by Subject|3|||
147437141|NCT01621542|531767305|FG005|Overall Study|Withdrawal by Subject|3|||
147437142|NCT01621542|531767300|FG000|Overall Study|progression/treatment failure|2|||
147437143|NCT01621542|531767301|FG001|Overall Study|progression/treatment failure|4|||
147437144|NCT01621542|531767302|FG002|Overall Study|progression/treatment failure|3|||
147437145|NCT01621542|531767303|FG003|Overall Study|progression/treatment failure|7|||
147437146|NCT01621542|531767304|FG004|Overall Study|progression/treatment failure|3|||
147437147|NCT01621542|531767305|FG005|Overall Study|progression/treatment failure|5|||
147437148|NCT01621542|531767300|FG000|Overall Study|Protocol Violation|0|||
147437149|NCT01621542|531767301|FG001|Overall Study|Protocol Violation|0|||
147437150|NCT01621542|531767302|FG002|Overall Study|Protocol Violation|0|||
147437151|NCT01621542|531767303|FG003|Overall Study|Protocol Violation|1|||
147437152|NCT01621542|531767304|FG004|Overall Study|Protocol Violation|0|||
147437153|NCT01621542|531767305|FG005|Overall Study|Protocol Violation|0|||
147437154|NCT01621542|531767300|FG000|Overall Study|study stopped by sponsor|0|||
147437155|NCT01621542|531767301|FG001|Overall Study|study stopped by sponsor|0|||
147437156|NCT01621542|531767302|FG002|Overall Study|study stopped by sponsor|0|||
147437157|NCT01621542|531767303|FG003|Overall Study|study stopped by sponsor|1|||
147437158|NCT01621542|531767304|FG004|Overall Study|study stopped by sponsor|0|||
147437159|NCT01621542|531767305|FG005|Overall Study|study stopped by sponsor|0|||
147437160|NCT02632721|531767309|FG000|Overall Study|Adverse Event|0|||
147437161|NCT02632721|531767310|FG001|Overall Study|Adverse Event|0|||
147437162|NCT02632721|531767311|FG002|Overall Study|Adverse Event|2|||
147437163|NCT02632721|531767312|FG003|Overall Study|Adverse Event|5|||
147437164|NCT02632721|531767313|FG004|Overall Study|Adverse Event|3|||
147437165|NCT02632721|531767309|FG000|Overall Study|Dose limiting toxicity|0|||
147437166|NCT02632721|531767310|FG001|Overall Study|Dose limiting toxicity|0|||
147202373|NCT01394016|530910615|FG013|Overall Study|Adverse Event|0|||
147437167|NCT02632721|531767311|FG002|Overall Study|Dose limiting toxicity|0|||
147437168|NCT02632721|531767312|FG003|Overall Study|Dose limiting toxicity|1|||
147437169|NCT02632721|531767313|FG004|Overall Study|Dose limiting toxicity|0|||
147437170|NCT02632721|531767309|FG000|Overall Study|Progressive disease|3|||
147437171|NCT02632721|531767310|FG001|Overall Study|Progressive disease|0|||
147437172|NCT02632721|531767311|FG002|Overall Study|Progressive disease|4|||
147437173|NCT02632721|531767312|FG003|Overall Study|Progressive disease|6|||
147202374|NCT01394016|530910616|FG014|Overall Study|Adverse Event|0|||
147437174|NCT02632721|531767313|FG004|Overall Study|Progressive disease|5|||
147437175|NCT02632721|531767309|FG000|Overall Study|Refused to continue taking trial medication|0|||
147437176|NCT02632721|531767310|FG001|Overall Study|Refused to continue taking trial medication|1|||
147437177|NCT02632721|531767311|FG002|Overall Study|Refused to continue taking trial medication|1|||
147537604|NCT01317199|532122075|FG000|Randomized Phase 2|Patient transferred to other facility|0|||
147537605|NCT01317199|532122076|FG001|Randomized Phase 2|Patient transferred to other facility|0|||
147537606|NCT01317199|532122077|FG002|Randomized Phase 2|Patient transferred to other facility|1|||
147537607|NCT01317199|532122078|FG003|Randomized Phase 2|Patient transferred to other facility|0|||
147537608|NCT04221373|532122082|FG000|Overall Study|Physician Decision|4|||
147537609|NCT04221373|532122083|FG001|Overall Study|Physician Decision|0|||
147537610|NCT00627094|532122087|FG000|Overall Study|Adverse Event|8|||
147537611|NCT00627094|532122088|FG001|Overall Study|Adverse Event|7|||
147537612|NCT00627094|532122087|FG000|Overall Study|Lost to Follow-up|1|||
147537613|NCT00627094|532122088|FG001|Overall Study|Lost to Follow-up|0|||
147537614|NCT00627094|532122087|FG000|Overall Study|Withdrawal by Subject|1|||
147537615|NCT00627094|532122088|FG001|Overall Study|Withdrawal by Subject|1|||
147537616|NCT00627094|532122087|FG000|Overall Study|ulcer healed|1|||
147537617|NCT00627094|532122088|FG001|Overall Study|ulcer healed|7|||
147537618|NCT00627094|532122087|FG000|Overall Study|Other reason|1|||
147537619|NCT00627094|532122088|FG001|Overall Study|Other reason|0|||
147537620|NCT00138658|532122096|FG000|Overall Study|Adverse Event|23|||
147537621|NCT00138658|532122096|FG000|Overall Study|Death|1|||
147537622|NCT00138658|532122096|FG000|Overall Study|Disease Progression|21|||
147537623|NCT00138658|532122096|FG000|Overall Study|Physician Decision|11|||
147537624|NCT00138658|532122096|FG000|Overall Study|Withdrawal by Subject|5|||
147537625|NCT01965431|532122099|FG000|Overall Study|Adverse Event|0|||
147537626|NCT01965431|532122100|FG001|Overall Study|Adverse Event|1|||
147537627|NCT01965431|532122101|FG002|Overall Study|Adverse Event|0|||
147537628|NCT01965431|532122102|FG003|Overall Study|Adverse Event|0|||
147537629|NCT01965431|532122103|FG004|Overall Study|Adverse Event|0|||
147537630|NCT01965431|532122104|FG005|Overall Study|Adverse Event|0|||
147537631|NCT01965431|532122099|FG000|Overall Study|Other than stated above|6|||
147537632|NCT01965431|532122100|FG001|Overall Study|Other than stated above|5|||
147537633|NCT01965431|532122101|FG002|Overall Study|Other than stated above|6|||
147537634|NCT01965431|532122102|FG003|Overall Study|Other than stated above|6|||
147537635|NCT01965431|532122103|FG004|Overall Study|Other than stated above|6|||
147537636|NCT01965431|532122104|FG005|Overall Study|Other than stated above|6|||
147537637|NCT00577031|532122105|FG000|Overall Study|Adverse Event|52|||
147537638|NCT00577031|532122105|FG000|Overall Study|Progression of disease|93|||
147537639|NCT00577031|532122105|FG000|Overall Study|Protocol Violation|5|||
147537640|NCT00577031|532122105|FG000|Overall Study|Participant withdrew consent|13|||
147537641|NCT00577031|532122105|FG000|Overall Study|Participant non-compliance|5|||
147537642|NCT00577031|532122105|FG000|Overall Study|Need for surgery|17|||
147537643|NCT00577031|532122105|FG000|Overall Study|Medical decision|14|||
147537644|NCT00577031|532122105|FG000|Overall Study|Death|6|||
147537645|NCT04635631|532122106|FG000|Overall Study|Adverse Event|1|||
147537646|NCT04635631|532122106|FG000|Overall Study|Progressive disease|13|||
147537647|NCT04635631|532122106|FG000|Overall Study|Withdrawal by Subject|1|||
147537648|NCT01067339|532122109|FG000|Overall Study|Withdrawal by Subject|6|||
147537649|NCT01067339|532122110|FG001|Overall Study|Withdrawal by Subject|5|||
147537650|NCT00769132|532122111|FG000|Period 1|Adverse Event|1|||
147537651|NCT00769132|532122112|FG001|Period 1|Adverse Event|0|||
147537652|NCT00769132|532122113|FG002|Period 1|Adverse Event|0|||
147537653|NCT00769132|532122114|FG003|Period 1|Adverse Event|1|||
147537654|NCT00769132|532122111|FG000|Period 2|Withdrawal by Subject|0|||
147537655|NCT00769132|532122112|FG001|Period 2|Withdrawal by Subject|0|||
147537656|NCT00769132|532122113|FG002|Period 2|Withdrawal by Subject|0|||
147537657|NCT00769132|532122114|FG003|Period 2|Withdrawal by Subject|1|||
147537658|NCT00769132|532122111|FG000|Period 3|Withdrawal by Subject|1|||
147537659|NCT00769132|532122112|FG001|Period 3|Withdrawal by Subject|0|||
147537660|NCT00769132|532122113|FG002|Period 3|Withdrawal by Subject|0|||
147537661|NCT00769132|532122114|FG003|Period 3|Withdrawal by Subject|0|||
147537662|NCT00769132|532122111|FG000|Period 4|Withdrawal by Subject|0|||
147537663|NCT00769132|532122112|FG001|Period 4|Withdrawal by Subject|1|||
147537664|NCT00769132|532122113|FG002|Period 4|Withdrawal by Subject|0|||
147537665|NCT00769132|532122114|FG003|Period 4|Withdrawal by Subject|0|||
147537666|NCT00877799|532122116|FG000|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|2|||
147537667|NCT00877799|532122117|FG001|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|1|||
147537668|NCT00877799|532122118|FG002|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|1|||
147537669|NCT00877799|532122119|FG003|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|0|||
147537670|NCT00877799|532122120|FG004|Cohort 1: 24 Hours After Surgery (Day 1)|Adverse Event|0|||
147537671|NCT00877799|532122116|FG000|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|1|||
147537672|NCT00877799|532122117|FG001|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|1|||
147537673|NCT00877799|532122118|FG002|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|2|||
147537674|NCT00877799|532122119|FG003|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|0|||
147537675|NCT00877799|532122120|FG004|Cohort 1: 24 Hours After Surgery (Day 1)|Lost to Follow-up|0|||
147202375|NCT01394016|530910617|FG015|Overall Study|Adverse Event|0|||
147202376|NCT01394016|530910618|FG016|Overall Study|Adverse Event|1|||
147537676|NCT00877799|532122116|FG000|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0|||
147537677|NCT00877799|532122117|FG001|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|3|||
147202377|NCT01394016|530910619|FG017|Overall Study|Adverse Event|1|||
147537678|NCT00877799|532122118|FG002|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0|||
147537679|NCT00877799|532122119|FG003|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0|||
147537680|NCT00877799|532122120|FG004|Cohort 1: 24 Hours After Surgery (Day 1)|Withdrawal by Subject|0|||
147537681|NCT00877799|532122116|FG000|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0|||
147537682|NCT00877799|532122117|FG001|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0|||
147537683|NCT00877799|532122118|FG002|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0|||
147537684|NCT00877799|532122119|FG003|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|1|||
147537685|NCT00877799|532122120|FG004|Cohort 2: Immediately Post-op (Day 0)|Protocol Violation|0|||
147537686|NCT00877799|532122116|FG000|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|0|||
147537687|NCT00877799|532122117|FG001|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|0|||
147537688|NCT00877799|532122118|FG002|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|0|||
147537689|NCT00877799|532122119|FG003|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|1|||
147537690|NCT00877799|532122120|FG004|Cohort 2: Immediately Post-op (Day 0)|Lost to Follow-up|1|||
147537691|NCT00127192|532122121|FG000|Overall Study|Adverse Event|0|||
147202378|NCT01394016|530910620|FG018|Overall Study|Adverse Event|0|||
147537692|NCT00127192|532122122|FG001|Overall Study|Adverse Event|1|||
147537693|NCT00127192|532122123|FG002|Overall Study|Adverse Event|1|||
147537694|NCT00127192|532122124|FG003|Overall Study|Adverse Event|1|||
147537695|NCT00127192|532122125|FG004|Overall Study|Adverse Event|0|||
147202379|NCT01394016|530910602|FG000|Overall Study|Sponsor Decision|0|||
147202380|NCT01394016|530910603|FG001|Overall Study|Sponsor Decision|0|||
147202381|NCT01394016|530910604|FG002|Overall Study|Sponsor Decision|0|||
147202382|NCT01394016|530910605|FG003|Overall Study|Sponsor Decision|0|||
147202383|NCT01394016|530910606|FG004|Overall Study|Sponsor Decision|0|||
147202384|NCT01394016|530910607|FG005|Overall Study|Sponsor Decision|0|||
147202385|NCT01394016|530910608|FG006|Overall Study|Sponsor Decision|0|||
147202386|NCT01394016|530910609|FG007|Overall Study|Sponsor Decision|0|||
147202387|NCT01394016|530910610|FG008|Overall Study|Sponsor Decision|0|||
147202388|NCT01394016|530910611|FG009|Overall Study|Sponsor Decision|0|||
147202389|NCT01394016|530910612|FG010|Overall Study|Sponsor Decision|0|||
147202390|NCT01394016|530910613|FG011|Overall Study|Sponsor Decision|0|||
147202391|NCT01394016|530910614|FG012|Overall Study|Sponsor Decision|1|||
147202392|NCT01394016|530910615|FG013|Overall Study|Sponsor Decision|0|||
147202393|NCT01394016|530910616|FG014|Overall Study|Sponsor Decision|0|||
147202394|NCT01394016|530910617|FG015|Overall Study|Sponsor Decision|0|||
147202395|NCT01394016|530910618|FG016|Overall Study|Sponsor Decision|0|||
147202396|NCT01394016|530910619|FG017|Overall Study|Sponsor Decision|0|||
147202397|NCT01394016|530910620|FG018|Overall Study|Sponsor Decision|0|||
147202398|NCT01394016|530910602|FG000|Overall Study|Lost to Follow-up|0|||
147202399|NCT01394016|530910603|FG001|Overall Study|Lost to Follow-up|0|||
147202400|NCT01394016|530910604|FG002|Overall Study|Lost to Follow-up|0|||
147202401|NCT01394016|530910605|FG003|Overall Study|Lost to Follow-up|0|||
147202402|NCT01394016|530910606|FG004|Overall Study|Lost to Follow-up|0|||
147202403|NCT01394016|530910607|FG005|Overall Study|Lost to Follow-up|0|||
147202404|NCT01394016|530910608|FG006|Overall Study|Lost to Follow-up|0|||
147202405|NCT01394016|530910609|FG007|Overall Study|Lost to Follow-up|0|||
147202406|NCT01394016|530910610|FG008|Overall Study|Lost to Follow-up|0|||
147202407|NCT01394016|530910611|FG009|Overall Study|Lost to Follow-up|0|||
147202408|NCT01394016|530910612|FG010|Overall Study|Lost to Follow-up|0|||
147202409|NCT01394016|530910613|FG011|Overall Study|Lost to Follow-up|0|||
147202410|NCT01394016|530910614|FG012|Overall Study|Lost to Follow-up|0|||
147202411|NCT01394016|530910615|FG013|Overall Study|Lost to Follow-up|0|||
147202412|NCT01394016|530910616|FG014|Overall Study|Lost to Follow-up|0|||
147202413|NCT01394016|530910617|FG015|Overall Study|Lost to Follow-up|0|||
147202414|NCT01394016|530910618|FG016|Overall Study|Lost to Follow-up|0|||
147202415|NCT01394016|530910619|FG017|Overall Study|Lost to Follow-up|0|||
147202416|NCT01394016|530910620|FG018|Overall Study|Lost to Follow-up|1|||
147202417|NCT03534804|530910621|FG000|Overall Study|Withdrawal by Subject|1|||
147202418|NCT04161157|530910622|FG000|Overall Study|Lost to Follow-up|4|||
147202419|NCT04161157|530910622|FG000|Overall Study|Death|3|||
147202420|NCT04161157|530910622|FG000|Overall Study|Ineligible|2|||
147202421|NCT04161157|530910622|FG000|Overall Study|Withdrawal by Subject|4|||
147202422|NCT04922216|530910630|FG000|Overall Study|Withdrawal by Subject|0|||
147202423|NCT04922216|530910631|FG001|Overall Study|Withdrawal by Subject|1|||
147202424|NCT04922216|530910632|FG002|Overall Study|Withdrawal by Subject|0|||
147202425|NCT04922216|530910633|FG003|Overall Study|Withdrawal by Subject|0|||
147202426|NCT04922216|530910634|FG004|Overall Study|Withdrawal by Subject|0|||
147202427|NCT04922216|530910635|FG005|Overall Study|Withdrawal by Subject|0|||
147537696|NCT00127192|532122121|FG000|Overall Study|Lack of Efficacy|2|||
147537697|NCT00127192|532122122|FG001|Overall Study|Lack of Efficacy|0|||
147202428|NCT04922216|530910636|FG006|Overall Study|Withdrawal by Subject|0|||
147202429|NCT04922216|530910637|FG007|Overall Study|Withdrawal by Subject|2|||
147537698|NCT00127192|532122123|FG002|Overall Study|Lack of Efficacy|0|||
147202430|NCT04922216|530910638|FG008|Overall Study|Withdrawal by Subject|0|||
147202431|NCT04922216|530910639|FG009|Overall Study|Withdrawal by Subject|0|||
147202432|NCT04922216|530910640|FG010|Overall Study|Withdrawal by Subject|0|||
147202433|NCT04922216|530910641|FG011|Overall Study|Withdrawal by Subject|0|||
147202434|NCT04922216|530910642|FG012|Overall Study|Withdrawal by Subject|1|||
147202435|NCT04922216|530910643|FG013|Overall Study|Withdrawal by Subject|1|||
147202436|NCT04922216|530910644|FG014|Overall Study|Withdrawal by Subject|1|||
147202437|NCT04922216|530910645|FG015|Overall Study|Withdrawal by Subject|0|||
147202438|NCT04922216|530910646|FG016|Overall Study|Withdrawal by Subject|0|||
147202439|NCT04922216|530910647|FG017|Overall Study|Withdrawal by Subject|1|||
147202440|NCT04922216|530910648|FG018|Overall Study|Withdrawal by Subject|1|||
147202441|NCT04922216|530910649|FG019|Overall Study|Withdrawal by Subject|1|||
147202442|NCT04922216|530910650|FG020|Overall Study|Withdrawal by Subject|1|||
147202443|NCT04922216|530910651|FG021|Overall Study|Withdrawal by Subject|0|||
147202444|NCT04922216|530910652|FG022|Overall Study|Withdrawal by Subject|0|||
147202445|NCT04922216|530910653|FG023|Overall Study|Withdrawal by Subject|2|||
147537699|NCT00127192|532122124|FG003|Overall Study|Lack of Efficacy|0|||
147537700|NCT00127192|532122125|FG004|Overall Study|Lack of Efficacy|2|||
147537701|NCT00127192|532122121|FG000|Overall Study|Withdrawal by Subject|0|||
147537702|NCT00127192|532122122|FG001|Overall Study|Withdrawal by Subject|0|||
147537703|NCT00127192|532122123|FG002|Overall Study|Withdrawal by Subject|1|||
147537704|NCT00127192|532122124|FG003|Overall Study|Withdrawal by Subject|0|||
147537705|NCT00127192|532122125|FG004|Overall Study|Withdrawal by Subject|3|||
147537706|NCT00127192|532122121|FG000|Overall Study|Adverse event in pre-treatment period|1|||
147537707|NCT00127192|532122122|FG001|Overall Study|Adverse event in pre-treatment period|0|||
147537708|NCT00127192|532122123|FG002|Overall Study|Adverse event in pre-treatment period|0|||
147537709|NCT00127192|532122124|FG003|Overall Study|Adverse event in pre-treatment period|0|||
147537710|NCT00127192|532122125|FG004|Overall Study|Adverse event in pre-treatment period|0|||
147537711|NCT00203892|532122126|FG000|Overall Study|Physician Decision|1|||
147537712|NCT00203892|532122127|FG001|Overall Study|Physician Decision|2|||
147537713|NCT00203892|532122128|FG002|Overall Study|Physician Decision|0|||
147537714|NCT00203892|532122126|FG000|Overall Study|Death|1|||
147537715|NCT00203892|532122127|FG001|Overall Study|Death|0|||
147537716|NCT00203892|532122128|FG002|Overall Study|Death|0|||
147537717|NCT00806416|532122131|FG000|Period 1 - Part I|Adverse Event|0|||
147537718|NCT00806416|532122132|FG001|Period 1 - Part I|Adverse Event|1|||
147537719|NCT00806416|532122133|FG002|Period 1 - Part I|Adverse Event|0|||
147537720|NCT00806416|532122134|FG003|Period 1 - Part I|Adverse Event|0|||
147537721|NCT00806416|532122131|FG000|Period 1 - Part I|Lost to Follow-up|0|||
147537722|NCT00806416|532122132|FG001|Period 1 - Part I|Lost to Follow-up|2|||
147537723|NCT00806416|532122133|FG002|Period 1 - Part I|Lost to Follow-up|0|||
147537724|NCT00806416|532122134|FG003|Period 1 - Part I|Lost to Follow-up|0|||
147537725|NCT00806416|532122131|FG000|Period 1 - Part I|Withdrawal by Subject|3|||
147537726|NCT00806416|532122132|FG001|Period 1 - Part I|Withdrawal by Subject|1|||
147537727|NCT00806416|532122133|FG002|Period 1 - Part I|Withdrawal by Subject|0|||
147537728|NCT00806416|532122134|FG003|Period 1 - Part I|Withdrawal by Subject|0|||
147537729|NCT00806416|532122131|FG000|Period 1 - Part II|Withdrawal by Subject|0|||
147537730|NCT00806416|532122132|FG001|Period 1 - Part II|Withdrawal by Subject|0|||
147537731|NCT00806416|532122133|FG002|Period 1 - Part II|Withdrawal by Subject|0|||
147537732|NCT00806416|532122134|FG003|Period 1 - Part II|Withdrawal by Subject|2|||
147537733|NCT01102972|532122138|FG000|Overall Study|Adverse Event|8|||
147537734|NCT01102972|532122139|FG001|Overall Study|Adverse Event|2|||
147537735|NCT01102972|532122138|FG000|Overall Study|Lack of Efficacy|2|||
147537736|NCT01102972|532122139|FG001|Overall Study|Lack of Efficacy|1|||
147537737|NCT01102972|532122138|FG000|Overall Study|Protocol Violation|1|||
147537738|NCT01102972|532122139|FG001|Overall Study|Protocol Violation|0|||
147537739|NCT01102972|532122138|FG000|Overall Study|Lost to Follow-up|10|||
147537740|NCT01102972|532122139|FG001|Overall Study|Lost to Follow-up|5|||
147537741|NCT01102972|532122138|FG000|Overall Study|Investigator Discretion|2|||
147537742|NCT01102972|532122139|FG001|Overall Study|Investigator Discretion|0|||
147537743|NCT01102972|532122138|FG000|Overall Study|Withdrawal by Subject|6|||
147537744|NCT01102972|532122139|FG001|Overall Study|Withdrawal by Subject|6|||
147537745|NCT04935931|532122140|FG000|Overall Study|Withdrawal by Subject|1|||
147202446|NCT04922216|530910654|FG024|Overall Study|Withdrawal by Subject|0|||
147202447|NCT04922216|530910655|FG025|Overall Study|Withdrawal by Subject|0|||
147202448|NCT04922216|530910656|FG026|Overall Study|Withdrawal by Subject|1|||
147202449|NCT04922216|530910657|FG027|Overall Study|Withdrawal by Subject|0|||
147202450|NCT04922216|530910658|FG028|Overall Study|Withdrawal by Subject|0|||
147202451|NCT04922216|530910659|FG029|Overall Study|Withdrawal by Subject|0|||
147202452|NCT04922216|530910660|FG030|Overall Study|Withdrawal by Subject|1|||
147537746|NCT01360021|532122141|FG000|Overall Study|Eligibility criteria + other|2|||
147537747|NCT01360021|532122142|FG001|Overall Study|Eligibility criteria + other|1|||
147537748|NCT01360021|532122143|FG002|Overall Study|Eligibility criteria + other|1|||
147537749|NCT01360021|532122141|FG000|Overall Study|Protocol Violation|0|||
147537750|NCT01360021|532122142|FG001|Overall Study|Protocol Violation|0|||
147202453|NCT04922216|530910661|FG031|Overall Study|Withdrawal by Subject|0|||
147537751|NCT01360021|532122143|FG002|Overall Study|Protocol Violation|1|||
147202454|NCT04922216|530910630|FG000|Overall Study|Lost to Follow-up|1|||
147202455|NCT04922216|530910631|FG001|Overall Study|Lost to Follow-up|0|||
147537752|NCT01360021|532122141|FG000|Overall Study|Withdrawal by Subject|4|||
147537753|NCT01360021|532122142|FG001|Overall Study|Withdrawal by Subject|0|||
147537754|NCT01360021|532122143|FG002|Overall Study|Withdrawal by Subject|2|||
147537755|NCT01360021|532122141|FG000|Overall Study|Adverse Event|2|||
147537756|NCT01360021|532122142|FG001|Overall Study|Adverse Event|3|||
147537757|NCT01360021|532122143|FG002|Overall Study|Adverse Event|3|||
147537758|NCT02596009|532122146|FG000|Overall Study|Administrative problems|0|||
147537759|NCT02596009|532122147|FG001|Overall Study|Administrative problems|1|||
147537760|NCT02596009|532122148|FG002|Overall Study|Administrative problems|0|||
147537761|NCT02596009|532122149|FG003|Overall Study|Administrative problems|0|||
147537762|NCT02596009|532122150|FG004|Overall Study|Administrative problems|0|||
147537763|NCT02596009|532122151|FG005|Overall Study|Administrative problems|0|||
147537764|NCT01071278|532122152|FG000|Overall Study|Premature Discontinuation|254|||
147537765|NCT01071278|532122152|FG000|Overall Study|Completion Status Unknown|459|||
147537766|NCT03539952|532122153|FG000|Penicillamine Baseline Period (Day1-W12)|Baseline run-in failure|24|||
147537767|NCT03539952|532122154|FG001|Penicillamine Baseline Period (Day1-W12)|Baseline run-in failure|0|||
147537768|NCT03539952|532122153|FG000|Post-randomization Period (Week 12-36)|Withdrawal by Subject|1|||
147537769|NCT03539952|532122154|FG001|Post-randomization Period (Week 12-36)|Withdrawal by Subject|0|||
147537770|NCT03539952|532122153|FG000|Extension Post Random. (Week 36-60)|Adverse Event|1|||
147537771|NCT03539952|532122154|FG001|Extension Post Random. (Week 36-60)|Adverse Event|1|||
147537772|NCT03539952|532122153|FG000|Extension Post Random. (Week 36-60)|Withdrawal by Subject|3|||
147537773|NCT03539952|532122154|FG001|Extension Post Random. (Week 36-60)|Withdrawal by Subject|1|||
147537774|NCT03539952|532122153|FG000|Extension Post Random. (Week 36-60)|Not further documented|3|||
147537775|NCT03539952|532122154|FG001|Extension Post Random. (Week 36-60)|Not further documented|1|||
147537776|NCT03539952|532122153|FG000|All on TETA 4HCl, From wk 60 Till 108max|Death|0|||
147537777|NCT03539952|532122154|FG001|All on TETA 4HCl, From wk 60 Till 108max|Death|1|||
147537778|NCT03539952|532122153|FG000|All on TETA 4HCl, From wk 60 Till 108max|Withdrawal by Subject|0|||
147537779|NCT03539952|532122154|FG001|All on TETA 4HCl, From wk 60 Till 108max|Withdrawal by Subject|1|||
147537780|NCT02184988|532122155|FG000|Overall Study|Pregnancy|2|||
147537781|NCT02184988|532122155|FG000|Overall Study|Adverse Event|2|||
147537782|NCT02184988|532122155|FG000|Overall Study|moving away/travelling/unable to complet|6|||
147537783|NCT02184988|532122155|FG000|Overall Study|work scheduling issues|4|||
147537784|NCT02184988|532122155|FG000|Overall Study|various other reasons|9|||
147537785|NCT02184988|532122155|FG000|Overall Study|Lost to Follow-up|32|||
147537786|NCT01821391|532122156|FG000|Overall Study|Adverse Event|1|||
147537787|NCT01821391|532122157|FG001|Overall Study|Adverse Event|0|||
147537788|NCT01843660|532122158|FG000|Overall Study|Other|30|||
147537789|NCT01608321|532122161|FG000|Overall Study|Withdrawal by Subject|1|||
147537790|NCT01608321|532122162|FG001|Overall Study|Withdrawal by Subject|0|||
147537791|NCT03505606|532123788|FG000|Overall Study|Unable to complete testing / poor co-operation|0|||
147537792|NCT03505606|532123789|FG001|Overall Study|Unable to complete testing / poor co-operation|1|||
147537793|NCT03505606|532123790|FG002|Overall Study|Unable to complete testing / poor co-operation|0|||
147537794|NCT03505606|532123788|FG000|Overall Study|Under observation at Orthoptic clinic for high bilateral hypermetropia|1|||
147537795|NCT03505606|532123789|FG001|Overall Study|Under observation at Orthoptic clinic for high bilateral hypermetropia|0|||
147537796|NCT03505606|532123790|FG002|Overall Study|Under observation at Orthoptic clinic for high bilateral hypermetropia|0|||
147537797|NCT03505606|532123788|FG000|Overall Study|Stimulus deprivation / previous haemangioma|0|||
147537798|NCT03505606|532123789|FG001|Overall Study|Stimulus deprivation / previous haemangioma|1|||
147537799|NCT03505606|532123790|FG002|Overall Study|Stimulus deprivation / previous haemangioma|0|||
147537800|NCT03505606|532123788|FG000|Overall Study|Poor compliance with refractive correction|0|||
147537801|NCT03505606|532123789|FG001|Overall Study|Poor compliance with refractive correction|0|||
147537802|NCT03505606|532123790|FG002|Overall Study|Poor compliance with refractive correction|1|||
147537803|NCT03505606|532123788|FG000|Overall Study|Insufficient anisometropia|0|||
147537804|NCT03505606|532123789|FG001|Overall Study|Insufficient anisometropia|0|||
147537805|NCT03505606|532123790|FG002|Overall Study|Insufficient anisometropia|2|||
147537806|NCT03505606|532123788|FG000|Overall Study|Ectopia Lentis|0|||
147537807|NCT03505606|532123789|FG001|Overall Study|Ectopia Lentis|0|||
147537808|NCT03505606|532123790|FG002|Overall Study|Ectopia Lentis|1|||
147537809|NCT03505606|532123788|FG000|Overall Study|alternation of amblyopic eye|0|||
147537810|NCT03505606|532123789|FG001|Overall Study|alternation of amblyopic eye|1|||
147537811|NCT03505606|532123790|FG002|Overall Study|alternation of amblyopic eye|0|||
147537812|NCT02087865|532123792|FG000|Overall Study|Withdrawal by Subject|6|||
147537813|NCT02087865|532123793|FG001|Overall Study|Withdrawal by Subject|0|||
147537814|NCT02087865|532123794|FG002|Overall Study|Withdrawal by Subject|1|||
147537815|NCT02087865|532123792|FG000|Overall Study|Lost to Follow-up|0|||
147537816|NCT02087865|532123793|FG001|Overall Study|Lost to Follow-up|0|||
147537817|NCT02087865|532123794|FG002|Overall Study|Lost to Follow-up|1|||
147537818|NCT02087865|532123792|FG000|Overall Study|Drug Non-compliance|0|||
147537819|NCT02087865|532123793|FG001|Overall Study|Drug Non-compliance|2|||
147537820|NCT02087865|532123794|FG002|Overall Study|Drug Non-compliance|0|||
147537821|NCT02087865|532123792|FG000|Overall Study|Not analyzed due to anatomical abnormalities|0|||
147537822|NCT02087865|532123793|FG001|Overall Study|Not analyzed due to anatomical abnormalities|1|||
147202456|NCT04922216|530910632|FG002|Overall Study|Lost to Follow-up|2|||
147202457|NCT04922216|530910633|FG003|Overall Study|Lost to Follow-up|0|||
147202458|NCT04922216|530910634|FG004|Overall Study|Lost to Follow-up|0|||
147202459|NCT04922216|530910635|FG005|Overall Study|Lost to Follow-up|2|||
147202460|NCT04922216|530910636|FG006|Overall Study|Lost to Follow-up|0|||
147202461|NCT04922216|530910637|FG007|Overall Study|Lost to Follow-up|1|||
147202462|NCT04922216|530910638|FG008|Overall Study|Lost to Follow-up|1|||
147202463|NCT04922216|530910639|FG009|Overall Study|Lost to Follow-up|2|||
147437178|NCT02632721|531767312|FG003|Overall Study|Refused to continue taking trial medication|1|||
147437179|NCT02632721|531767313|FG004|Overall Study|Refused to continue taking trial medication|2|||
147437180|NCT02632721|531767309|FG000|Overall Study|Inadequate clinical condition|0|||
147437181|NCT02632721|531767310|FG001|Overall Study|Inadequate clinical condition|0|||
147437182|NCT02632721|531767311|FG002|Overall Study|Inadequate clinical condition|0|||
147437183|NCT02632721|531767312|FG003|Overall Study|Inadequate clinical condition|0|||
147437184|NCT02632721|531767313|FG004|Overall Study|Inadequate clinical condition|1|||
147437185|NCT02632721|531767309|FG000|Overall Study|No meet eligibility|0|||
147437186|NCT02632721|531767310|FG001|Overall Study|No meet eligibility|0|||
147437187|NCT02632721|531767311|FG002|Overall Study|No meet eligibility|0|||
147437188|NCT02632721|531767312|FG003|Overall Study|No meet eligibility|0|||
147437189|NCT02632721|531767313|FG004|Overall Study|No meet eligibility|1|||
147437190|NCT02632721|531767309|FG000|Overall Study|Allergic reaction|0|||
147437191|NCT02632721|531767310|FG001|Overall Study|Allergic reaction|0|||
147437192|NCT02632721|531767311|FG002|Overall Study|Allergic reaction|0|||
147437193|NCT02632721|531767312|FG003|Overall Study|Allergic reaction|1|||
147437194|NCT02632721|531767313|FG004|Overall Study|Allergic reaction|0|||
147437195|NCT02632721|531767309|FG000|Overall Study|Receiving Decitabine locally|0|||
147437196|NCT02632721|531767310|FG001|Overall Study|Receiving Decitabine locally|0|||
147437197|NCT02632721|531767311|FG002|Overall Study|Receiving Decitabine locally|1|||
147437198|NCT02632721|531767312|FG003|Overall Study|Receiving Decitabine locally|0|||
147437199|NCT02632721|531767313|FG004|Overall Study|Receiving Decitabine locally|0|||
147437200|NCT02632721|531767309|FG000|Overall Study|No benefit from study treatment|1|||
147437201|NCT02632721|531767310|FG001|Overall Study|No benefit from study treatment|1|||
147437202|NCT02632721|531767311|FG002|Overall Study|No benefit from study treatment|0|||
147437203|NCT02632721|531767312|FG003|Overall Study|No benefit from study treatment|0|||
147437204|NCT02632721|531767313|FG004|Overall Study|No benefit from study treatment|1|||
147437205|NCT02632721|531767309|FG000|Overall Study|Patient wish for other treatment|0|||
147437206|NCT02632721|531767310|FG001|Overall Study|Patient wish for other treatment|1|||
147437207|NCT02632721|531767311|FG002|Overall Study|Patient wish for other treatment|0|||
147437208|NCT02632721|531767312|FG003|Overall Study|Patient wish for other treatment|0|||
147437209|NCT02632721|531767313|FG004|Overall Study|Patient wish for other treatment|0|||
147437210|NCT02632721|531767309|FG000|Overall Study|Relapsed Pneumonia|0|||
147437211|NCT02632721|531767310|FG001|Overall Study|Relapsed Pneumonia|0|||
147437212|NCT02632721|531767311|FG002|Overall Study|Relapsed Pneumonia|0|||
147437213|NCT02632721|531767312|FG003|Overall Study|Relapsed Pneumonia|0|||
147437214|NCT02632721|531767313|FG004|Overall Study|Relapsed Pneumonia|1|||
147437215|NCT02632721|531767309|FG000|Overall Study|Therapy refractory AML|0|||
147437216|NCT02632721|531767310|FG001|Overall Study|Therapy refractory AML|0|||
147437217|NCT02632721|531767311|FG002|Overall Study|Therapy refractory AML|0|||
147437218|NCT02632721|531767312|FG003|Overall Study|Therapy refractory AML|0|||
147437219|NCT02632721|531767313|FG004|Overall Study|Therapy refractory AML|1|||
147437220|NCT02632721|531767309|FG000|Overall Study|Increase of white blood cell count|0|||
147437221|NCT02632721|531767310|FG001|Overall Study|Increase of white blood cell count|0|||
147437222|NCT02632721|531767311|FG002|Overall Study|Increase of white blood cell count|0|||
147437223|NCT02632721|531767312|FG003|Overall Study|Increase of white blood cell count|0|||
147437224|NCT02632721|531767313|FG004|Overall Study|Increase of white blood cell count|1|||
147437225|NCT02632721|531767309|FG000|Overall Study|Allogeneic peripheral blood stem cell transplantation|0|||
147437226|NCT02632721|531767310|FG001|Overall Study|Allogeneic peripheral blood stem cell transplantation|0|||
147437227|NCT02632721|531767311|FG002|Overall Study|Allogeneic peripheral blood stem cell transplantation|1|||
147437228|NCT02632721|531767312|FG003|Overall Study|Allogeneic peripheral blood stem cell transplantation|0|||
147437229|NCT02632721|531767313|FG004|Overall Study|Allogeneic peripheral blood stem cell transplantation|0|||
147437230|NCT00544648|531767317|FG000|Overall Study|Withdrawal by Subject|1|||
147437231|NCT00544648|531767318|FG001|Overall Study|Withdrawal by Subject|0|||
147437232|NCT00544648|531767317|FG000|Overall Study|Adverse Event|1|||
147437233|NCT00544648|531767318|FG001|Overall Study|Adverse Event|1|||
147437234|NCT00544648|531767317|FG000|Overall Study|progression of disease|1|||
147437235|NCT00544648|531767318|FG001|Overall Study|progression of disease|0|||
147437236|NCT02663271|531767319|FG000|Overall Study|Withdrawal by Subject|5|||
147437237|NCT02663271|531767319|FG000|Overall Study|Lack of Efficacy|1|||
147437238|NCT01572675|531767320|FG000|Overall Study|End of prescribed treatment|140|||
147437239|NCT01572675|531767321|FG001|Overall Study|End of prescribed treatment|118|||
147437240|NCT01572675|531767320|FG000|Overall Study|Recovery|16|||
147202464|NCT04922216|530910640|FG010|Overall Study|Lost to Follow-up|2|||
147202465|NCT04922216|530910641|FG011|Overall Study|Lost to Follow-up|1|||
147202466|NCT04922216|530910642|FG012|Overall Study|Lost to Follow-up|1|||
147202467|NCT04922216|530910643|FG013|Overall Study|Lost to Follow-up|0|||
147202468|NCT04922216|530910644|FG014|Overall Study|Lost to Follow-up|1|||
147202469|NCT04922216|530910645|FG015|Overall Study|Lost to Follow-up|0|||
147202470|NCT04922216|530910646|FG016|Overall Study|Lost to Follow-up|0|||
147202471|NCT04922216|530910647|FG017|Overall Study|Lost to Follow-up|2|||
147202472|NCT04922216|530910648|FG018|Overall Study|Lost to Follow-up|1|||
147202473|NCT04922216|530910649|FG019|Overall Study|Lost to Follow-up|0|||
147437241|NCT01572675|531767321|FG001|Overall Study|Recovery|23|||
147437242|NCT01572675|531767320|FG000|Overall Study|Lack of Efficacy|31|||
147437243|NCT01572675|531767321|FG001|Overall Study|Lack of Efficacy|31|||
147437244|NCT01572675|531767320|FG000|Overall Study|Intolerance|6|||
147437245|NCT01572675|531767321|FG001|Overall Study|Intolerance|5|||
147437246|NCT01572675|531767320|FG000|Overall Study|Improved symptoms|8|||
147437247|NCT01572675|531767321|FG001|Overall Study|Improved symptoms|2|||
147437248|NCT01572675|531767320|FG000|Overall Study|Surgical intervention|3|||
147437249|NCT01572675|531767321|FG001|Overall Study|Surgical intervention|6|||
147437250|NCT01572675|531767320|FG000|Overall Study|Withdrawal by Subject|5|||
147437251|NCT01572675|531767321|FG001|Overall Study|Withdrawal by Subject|1|||
147437252|NCT01572675|531767320|FG000|Overall Study|Physician Decision|2|||
147437253|NCT01572675|531767321|FG001|Overall Study|Physician Decision|2|||
147437254|NCT01572675|531767320|FG000|Overall Study|Death unrelated to coxibs|1|||
147437255|NCT01572675|531767321|FG001|Overall Study|Death unrelated to coxibs|1|||
147437256|NCT01572675|531767320|FG000|Overall Study|Other disease detected|1|||
147437257|NCT01572675|531767321|FG001|Overall Study|Other disease detected|1|||
147437258|NCT01572675|531767320|FG000|Overall Study|Unknown reason|1|||
147437259|NCT01572675|531767321|FG001|Overall Study|Unknown reason|1|||
147437260|NCT01572675|531767320|FG000|Overall Study|Rheumatologist new evaluation|0|||
147437261|NCT01572675|531767321|FG001|Overall Study|Rheumatologist new evaluation|1|||
147437262|NCT01572675|531767320|FG000|Overall Study|Missing data|1|||
147437263|NCT01572675|531767321|FG001|Overall Study|Missing data|4|||
147437264|NCT01572675|531767320|FG000|Overall Study|Lost to Follow-up|22|||
147437265|NCT01572675|531767321|FG001|Overall Study|Lost to Follow-up|27|||
147437266|NCT04166383|531767322|FG000|Drug Administration|Prior to treatment (tx), had a medical emergency requiring surgery & was unable to have further tx.|1|||
147437267|NCT04166383|531767322|FG000|TAC 1 - Second Biopsy Cycle 2 Day 1|Did not complete 2nd biopsy.|2|||
147437268|NCT04166383|531767322|FG000|TAC 2 - Second Biopsy Cycle 4 Day 1|Did not complete 2nd biopsy.|1|||
147437269|NCT03346057|531767324|FG000|Overall Study|Death|1|||
147437270|NCT03346057|531767325|FG001|Overall Study|Death|2|||
147437271|NCT03346057|531767326|FG002|Overall Study|Death|0|||
147437272|NCT03346057|531767327|FG003|Overall Study|Death|0|||
147437273|NCT03346057|531767324|FG000|Overall Study|Lost to Follow-up|0|||
147437274|NCT03346057|531767325|FG001|Overall Study|Lost to Follow-up|2|||
147437275|NCT03346057|531767326|FG002|Overall Study|Lost to Follow-up|1|||
147437276|NCT03346057|531767327|FG003|Overall Study|Lost to Follow-up|0|||
147437277|NCT03346057|531767324|FG000|Overall Study|Ineligible For Study - Not Treated|0|||
147437278|NCT03346057|531767325|FG001|Overall Study|Ineligible For Study - Not Treated|1|||
147437279|NCT03346057|531767326|FG002|Overall Study|Ineligible For Study - Not Treated|0|||
147437280|NCT03346057|531767327|FG003|Overall Study|Ineligible For Study - Not Treated|0|||
147437281|NCT03346057|531767324|FG000|Overall Study|Renal Insufficiency - Not Treated|1|||
147437282|NCT03346057|531767325|FG001|Overall Study|Renal Insufficiency - Not Treated|0|||
147437283|NCT03346057|531767326|FG002|Overall Study|Renal Insufficiency - Not Treated|0|||
147437284|NCT03346057|531767327|FG003|Overall Study|Renal Insufficiency - Not Treated|0|||
147437285|NCT03346057|531767324|FG000|Overall Study|Physician Decision|3|||
147537823|NCT02087865|532123794|FG002|Overall Study|Not analyzed due to anatomical abnormalities|1|||
147537824|NCT01392469|532123797|FG000|Overall Study|Adverse Event|2|||
147537825|NCT01392469|532123797|FG000|Overall Study|Withdrawal by Subject|1|||
147202474|NCT04922216|530910650|FG020|Overall Study|Lost to Follow-up|1|||
147202475|NCT04922216|530910651|FG021|Overall Study|Lost to Follow-up|0|||
147202476|NCT04922216|530910652|FG022|Overall Study|Lost to Follow-up|2|||
147202477|NCT04922216|530910653|FG023|Overall Study|Lost to Follow-up|1|||
147202478|NCT04922216|530910654|FG024|Overall Study|Lost to Follow-up|0|||
147202479|NCT04922216|530910655|FG025|Overall Study|Lost to Follow-up|2|||
147202480|NCT04922216|530910656|FG026|Overall Study|Lost to Follow-up|0|||
147202481|NCT04922216|530910657|FG027|Overall Study|Lost to Follow-up|0|||
147202482|NCT04922216|530910658|FG028|Overall Study|Lost to Follow-up|1|||
147202483|NCT04922216|530910659|FG029|Overall Study|Lost to Follow-up|0|||
147202484|NCT04922216|530910660|FG030|Overall Study|Lost to Follow-up|2|||
147202485|NCT04922216|530910661|FG031|Overall Study|Lost to Follow-up|1|||
147202486|NCT04721977|530910662|FG000|Overall Study|Death|15|||
147437286|NCT03346057|531767325|FG001|Overall Study|Physician Decision|2|||
147437287|NCT03346057|531767326|FG002|Overall Study|Physician Decision|0|||
147437288|NCT03346057|531767327|FG003|Overall Study|Physician Decision|2|||
147437289|NCT03346057|531767324|FG000|Overall Study|Randomization Mistake - Not Treated|1|||
147537826|NCT01392469|532123797|FG000|Overall Study|Protocol Violation|1|||
147202487|NCT04721977|530910662|FG000|Overall Study|Ongoing|51|||
147202488|NCT03278249|530910663|FG000|Overall Study|Withdrawal by Subject|2|||
147202489|NCT03278249|530910663|FG000|Overall Study|Lost to Follow-up|1|||
147202490|NCT02017405|530910664|FG000|Two-day, Double-blind, Crossover Phase|Withdrawal by Subject|0|||
147437290|NCT03346057|531767325|FG001|Overall Study|Randomization Mistake - Not Treated|1|||
147437291|NCT03346057|531767326|FG002|Overall Study|Randomization Mistake - Not Treated|0|||
147437292|NCT03346057|531767327|FG003|Overall Study|Randomization Mistake - Not Treated|0|||
147437293|NCT03346057|531767324|FG000|Overall Study|Withdrawal by Subject|1|||
147437294|NCT03346057|531767325|FG001|Overall Study|Withdrawal by Subject|0|||
147437295|NCT03346057|531767326|FG002|Overall Study|Withdrawal by Subject|0|||
147437296|NCT03346057|531767327|FG003|Overall Study|Withdrawal by Subject|0|||
147437297|NCT03044886|531767328|FG000|Overall Study|Lost to Follow-up|15|||
147437298|NCT03044886|531767329|FG001|Overall Study|Lost to Follow-up|10|||
147437299|NCT03044886|531767330|FG002|Overall Study|Lost to Follow-up|12|||
147437300|NCT02921269|531767331|FG000|Overall Study|Did not complete DLT period|1|||
147437301|NCT03065023|531767341|FG000|Overall Study|Progressive Disease|0|||
147437302|NCT03065023|531767342|FG001|Overall Study|Progressive Disease|1|||
147437303|NCT03065023|531767343|FG002|Overall Study|Progressive Disease|0|||
147437304|NCT03065023|531767344|FG003|Overall Study|Progressive Disease|0|||
147437305|NCT03065023|531767345|FG004|Overall Study|Progressive Disease|0|||
147437306|NCT03065023|531767341|FG000|Overall Study|Death|2|||
147437307|NCT03065023|531767342|FG001|Overall Study|Death|0|||
147437308|NCT03065023|531767343|FG002|Overall Study|Death|1|||
147437309|NCT03065023|531767344|FG003|Overall Study|Death|1|||
147437310|NCT03065023|531767345|FG004|Overall Study|Death|0|||
147437311|NCT03065023|531767341|FG000|Overall Study|Lost to Follow-up|0|||
147437312|NCT03065023|531767342|FG001|Overall Study|Lost to Follow-up|1|||
147437313|NCT03065023|531767343|FG002|Overall Study|Lost to Follow-up|0|||
147437314|NCT03065023|531767344|FG003|Overall Study|Lost to Follow-up|0|||
147437315|NCT03065023|531767345|FG004|Overall Study|Lost to Follow-up|0|||
147437316|NCT03065023|531767341|FG000|Overall Study|Participant Decision|0|||
147437317|NCT03065023|531767342|FG001|Overall Study|Participant Decision|0|||
147437318|NCT03065023|531767343|FG002|Overall Study|Participant Decision|0|||
147437319|NCT03065023|531767344|FG003|Overall Study|Participant Decision|1|||
147437320|NCT03065023|531767345|FG004|Overall Study|Participant Decision|0|||
147437321|NCT03065023|531767341|FG000|Overall Study|Withdrawal by Subject|0|||
147437322|NCT03065023|531767342|FG001|Overall Study|Withdrawal by Subject|0|||
147437323|NCT03065023|531767343|FG002|Overall Study|Withdrawal by Subject|0|||
147437324|NCT03065023|531767344|FG003|Overall Study|Withdrawal by Subject|1|||
147437325|NCT03065023|531767345|FG004|Overall Study|Withdrawal by Subject|0|||
147437326|NCT00228566|531767346|FG000|Overall Study|Adverse Event|31|||
147437327|NCT00228566|531767346|FG000|Overall Study|Lack of Efficacy|14|||
147437328|NCT00228566|531767346|FG000|Overall Study|Lost to Follow-up|16|||
147437329|NCT00228566|531767346|FG000|Overall Study|Physician Decision|5|||
147437330|NCT00228566|531767346|FG000|Overall Study|Withdrawal by Subject|4|||
147437331|NCT00228566|531767346|FG000|Overall Study|Miscellaneous|1|||
147437332|NCT05975840|531767347|FG000|Overall Study|Other|1|||
147437333|NCT05975840|531767348|FG001|Overall Study|Other|0|||
147437334|NCT05975840|531767349|FG002|Overall Study|Other|0|||
147437335|NCT05975840|531767350|FG003|Overall Study|Other|0|||
147437336|NCT05975840|531767351|FG004|Overall Study|Other|1|||
147437337|NCT05975840|531767352|FG005|Overall Study|Other|0|||
147437338|NCT05975840|531767353|FG006|Overall Study|Other|0|||
147437339|NCT05975840|531767354|FG007|Overall Study|Other|0|||
147437340|NCT05975840|531767347|FG000|Overall Study|Lost to Follow-up|3|||
147437341|NCT05975840|531767348|FG001|Overall Study|Lost to Follow-up|6|||
147437342|NCT05975840|531767349|FG002|Overall Study|Lost to Follow-up|3|||
147437343|NCT05975840|531767350|FG003|Overall Study|Lost to Follow-up|1|||
147437344|NCT05975840|531767351|FG004|Overall Study|Lost to Follow-up|4|||
147437345|NCT05975840|531767352|FG005|Overall Study|Lost to Follow-up|1|||
147437346|NCT05975840|531767353|FG006|Overall Study|Lost to Follow-up|2|||
147437347|NCT05975840|531767354|FG007|Overall Study|Lost to Follow-up|4|||
147437348|NCT05975840|531767347|FG000|Overall Study|Migrated/moved from the study area|1|||
147437349|NCT05975840|531767348|FG001|Overall Study|Migrated/moved from the study area|0|||
147437350|NCT05975840|531767349|FG002|Overall Study|Migrated/moved from the study area|0|||
147437351|NCT05975840|531767350|FG003|Overall Study|Migrated/moved from the study area|0|||
147437352|NCT05975840|531767351|FG004|Overall Study|Migrated/moved from the study area|0|||
147437353|NCT05975840|531767352|FG005|Overall Study|Migrated/moved from the study area|0|||
147437354|NCT05975840|531767353|FG006|Overall Study|Migrated/moved from the study area|0|||
147437355|NCT05975840|531767354|FG007|Overall Study|Migrated/moved from the study area|0|||
147437356|NCT05975840|531767347|FG000|Overall Study|Withdrawal by Subject|0|||
147437357|NCT05975840|531767348|FG001|Overall Study|Withdrawal by Subject|5|||
147437358|NCT05975840|531767349|FG002|Overall Study|Withdrawal by Subject|2|||
147437359|NCT05975840|531767350|FG003|Overall Study|Withdrawal by Subject|2|||
147437360|NCT05975840|531767351|FG004|Overall Study|Withdrawal by Subject|0|||
147437361|NCT05975840|531767352|FG005|Overall Study|Withdrawal by Subject|2|||
147437362|NCT05975840|531767353|FG006|Overall Study|Withdrawal by Subject|2|||
147437363|NCT05975840|531767354|FG007|Overall Study|Withdrawal by Subject|1|||
147437364|NCT05975840|531767347|FG000|Overall Study|Protocol Violation|0|||
147437365|NCT05975840|531767348|FG001|Overall Study|Protocol Violation|1|||
147437366|NCT05975840|531767349|FG002|Overall Study|Protocol Violation|0|||
147537827|NCT01017731|532123799|FG000|Overall Study|Lost to Follow-up|2|||
147437367|NCT05975840|531767350|FG003|Overall Study|Protocol Violation|0|||
147202491|NCT02017405|530910665|FG001|Two-day, Double-blind, Crossover Phase|Withdrawal by Subject|0|||
147202492|NCT02017405|530910666|FG002|Two-day, Double-blind, Crossover Phase|Withdrawal by Subject|0|||
147202493|NCT02017405|530910667|FG003|Two-day, Double-blind, Crossover Phase|Withdrawal by Subject|0|||
147202494|NCT02017405|530910668|FG004|Two-day, Double-blind, Crossover Phase|Withdrawal by Subject|0|||
147202495|NCT02017405|530910669|FG005|Two-day, Double-blind, Crossover Phase|Withdrawal by Subject|1|||
147202496|NCT02017405|530910664|FG000|Open-label Phase|Adverse Event|1|||
147202497|NCT02017405|530910665|FG001|Open-label Phase|Adverse Event|1|||
147202498|NCT02017405|530910666|FG002|Open-label Phase|Adverse Event|0|||
147202499|NCT02017405|530910667|FG003|Open-label Phase|Adverse Event|0|||
147202500|NCT02017405|530910668|FG004|Open-label Phase|Adverse Event|0|||
147202501|NCT02017405|530910669|FG005|Open-label Phase|Adverse Event|0|||
147537828|NCT01017731|532123799|FG000|Overall Study|Withdrawal by Subject|3|||
147537829|NCT01017731|532123799|FG000|Overall Study|Physician Decision|2|||
147537830|NCT01017731|532123799|FG000|Overall Study|Adverse Event|1|||
147537831|NCT00648739|532123801|FG000|Overall Study|Adverse Event|1|||
147537832|NCT00648739|532123802|FG001|Overall Study|Adverse Event|0|||
147537833|NCT00648739|532123803|FG002|Overall Study|Adverse Event|1|||
147537834|NCT00648739|532123804|FG003|Overall Study|Adverse Event|2|||
147537835|NCT00648739|532123805|FG004|Overall Study|Adverse Event|1|||
147537836|NCT00648739|532123806|FG005|Overall Study|Adverse Event|0|||
147537837|NCT00648739|532123807|FG006|Overall Study|Adverse Event|0|||
147537838|NCT00648739|532123801|FG000|Overall Study|Withdrawal by Subject|1|||
147537839|NCT00648739|532123802|FG001|Overall Study|Withdrawal by Subject|0|||
147537840|NCT00648739|532123803|FG002|Overall Study|Withdrawal by Subject|1|||
147537841|NCT00648739|532123804|FG003|Overall Study|Withdrawal by Subject|0|||
147537842|NCT00648739|532123805|FG004|Overall Study|Withdrawal by Subject|0|||
147537843|NCT00648739|532123806|FG005|Overall Study|Withdrawal by Subject|2|||
147537844|NCT00648739|532123807|FG006|Overall Study|Withdrawal by Subject|0|||
147537845|NCT00648739|532123801|FG000|Overall Study|Lack of Efficacy|0|||
147537846|NCT00648739|532123802|FG001|Overall Study|Lack of Efficacy|0|||
147537847|NCT00648739|532123803|FG002|Overall Study|Lack of Efficacy|0|||
147202502|NCT02864394|530910671|FG000|Overall Study|Death|184|||
147202503|NCT02864394|530910672|FG001|Overall Study|Death|189|||
147202504|NCT02864394|530910671|FG000|Overall Study|Lost to Follow-up|0|||
147202505|NCT02864394|530910672|FG001|Overall Study|Lost to Follow-up|2|||
147202506|NCT02864394|530910671|FG000|Overall Study|Sponsor Decision|26|||
147202507|NCT02864394|530910672|FG001|Overall Study|Sponsor Decision|11|||
147202508|NCT02864394|530910671|FG000|Overall Study|Withdrawal by Subject|3|||
147202509|NCT02864394|530910672|FG001|Overall Study|Withdrawal by Subject|10|||
147202510|NCT02374450|530910673|FG000|Overall Study|Protocol Violation|0|||
147202511|NCT02374450|530910674|FG001|Overall Study|Protocol Violation|1|||
147202512|NCT02374450|530910675|FG002|Overall Study|Protocol Violation|0|||
147202513|NCT02374450|530910673|FG000|Overall Study|Withdrawal by Subject|91|||
147202514|NCT02374450|530910674|FG001|Overall Study|Withdrawal by Subject|110|||
147202515|NCT02374450|530910675|FG002|Overall Study|Withdrawal by Subject|4|||
147202516|NCT02374450|530910673|FG000|Overall Study|Lost to Follow-up|168|||
147202517|NCT02374450|530910674|FG001|Overall Study|Lost to Follow-up|194|||
147202518|NCT02374450|530910675|FG002|Overall Study|Lost to Follow-up|138|||
147202519|NCT02374450|530910673|FG000|Overall Study|Death|173|||
147202520|NCT02374450|530910674|FG001|Overall Study|Death|185|||
147202521|NCT02374450|530910675|FG002|Overall Study|Death|81|||
147202522|NCT02374450|530910673|FG000|Overall Study|Migrated from the study area|538|||
147202523|NCT02374450|530910674|FG001|Overall Study|Migrated from the study area|648|||
147202524|NCT02374450|530910675|FG002|Overall Study|Migrated from the study area|181|||
147202525|NCT02374450|530910673|FG000|Overall Study|Enrollment in NCT03855995 study|0|||
147202526|NCT02374450|530910674|FG001|Overall Study|Enrollment in NCT03855995 study|1|||
147202527|NCT02374450|530910675|FG002|Overall Study|Enrollment in NCT03855995 study|0|||
147202528|NCT02374450|530910673|FG000|Overall Study|Vaccination with RTS,S/AS01E vaccine|2|||
147202529|NCT02374450|530910674|FG001|Overall Study|Vaccination with RTS,S/AS01E vaccine|0|||
147537848|NCT00648739|532123804|FG003|Overall Study|Lack of Efficacy|0|||
147537849|NCT00648739|532123805|FG004|Overall Study|Lack of Efficacy|1|||
147537850|NCT00648739|532123806|FG005|Overall Study|Lack of Efficacy|2|||
147537851|NCT00648739|532123807|FG006|Overall Study|Lack of Efficacy|0|||
147537852|NCT00648739|532123801|FG000|Overall Study|Investigator Considered it Advisable|0|||
147537853|NCT00648739|532123802|FG001|Overall Study|Investigator Considered it Advisable|0|||
147537854|NCT00648739|532123803|FG002|Overall Study|Investigator Considered it Advisable|0|||
147537855|NCT00648739|532123804|FG003|Overall Study|Investigator Considered it Advisable|0|||
147202530|NCT02374450|530910675|FG002|Overall Study|Vaccination with RTS,S/AS01E vaccine|0|||
147202531|NCT02374450|530910673|FG000|Overall Study|Other|0|||
147202532|NCT02374450|530910674|FG001|Overall Study|Other|21|||
147202533|NCT02374450|530910675|FG002|Overall Study|Other|79|||
147202534|NCT04730804|530910676|FG000|Overall Study|Physician Decision|0|||
147202535|NCT04730804|530910677|FG001|Overall Study|Physician Decision|0|||
147537856|NCT00648739|532123805|FG004|Overall Study|Investigator Considered it Advisable|0|||
147537857|NCT00648739|532123806|FG005|Overall Study|Investigator Considered it Advisable|1|||
147202536|NCT04730804|530910678|FG002|Overall Study|Physician Decision|0|||
147202537|NCT04730804|530910679|FG003|Overall Study|Physician Decision|0|||
147202538|NCT04730804|530910680|FG004|Overall Study|Physician Decision|0|||
147437368|NCT05975840|531767351|FG004|Overall Study|Protocol Violation|0|||
147437369|NCT05975840|531767352|FG005|Overall Study|Protocol Violation|0|||
147437370|NCT05975840|531767353|FG006|Overall Study|Protocol Violation|0|||
147437371|NCT05975840|531767354|FG007|Overall Study|Protocol Violation|0|||
147437372|NCT05975840|531767347|FG000|Overall Study|Adverse Event|0|||
147437373|NCT05975840|531767348|FG001|Overall Study|Adverse Event|0|||
147437374|NCT05975840|531767349|FG002|Overall Study|Adverse Event|0|||
147437375|NCT05975840|531767350|FG003|Overall Study|Adverse Event|1|||
147437376|NCT05975840|531767351|FG004|Overall Study|Adverse Event|0|||
147437377|NCT05975840|531767352|FG005|Overall Study|Adverse Event|0|||
147437378|NCT05975840|531767353|FG006|Overall Study|Adverse Event|0|||
147437379|NCT05975840|531767354|FG007|Overall Study|Adverse Event|0|||
147437380|NCT05975840|531767347|FG000|Overall Study|Death|0|||
147437381|NCT05975840|531767348|FG001|Overall Study|Death|1|||
147437382|NCT05975840|531767349|FG002|Overall Study|Death|0|||
147437383|NCT05975840|531767350|FG003|Overall Study|Death|0|||
147437384|NCT05975840|531767351|FG004|Overall Study|Death|0|||
147437385|NCT05975840|531767352|FG005|Overall Study|Death|0|||
147437386|NCT05975840|531767353|FG006|Overall Study|Death|0|||
147437387|NCT05975840|531767354|FG007|Overall Study|Death|1|||
147437388|NCT01624259|531767357|FG000|Overall Study|Adverse Event|18|||
147437389|NCT01624259|531767358|FG001|Overall Study|Adverse Event|18|||
147437390|NCT01624259|531767357|FG000|Overall Study|Protocol Violation|1|||
147437391|NCT01624259|531767358|FG001|Overall Study|Protocol Violation|2|||
147437392|NCT01624259|531767357|FG000|Overall Study|Withdrawal by Subject|5|||
147437393|NCT01624259|531767358|FG001|Overall Study|Withdrawal by Subject|7|||
147437394|NCT01624259|531767357|FG000|Overall Study|Physician Decision|1|||
147437395|NCT01624259|531767358|FG001|Overall Study|Physician Decision|1|||
147437396|NCT01624259|531767357|FG000|Overall Study|Lost to Follow-up|2|||
147437397|NCT01624259|531767358|FG001|Overall Study|Lost to Follow-up|3|||
147437398|NCT01624259|531767357|FG000|Overall Study|Abnormal laboratory measure|3|||
147437399|NCT01624259|531767358|FG001|Overall Study|Abnormal laboratory measure|0|||
147437400|NCT02246582|531768612|FG000|Overall Study|Withdrawal by Subject|3|||
147437401|NCT02246582|531768613|FG001|Overall Study|Withdrawal by Subject|4|||
147437402|NCT02229539|531768614|FG000|Cycle 1 (Treatment Per Protocol)|Withdrawal by Subject|0|||
147437403|NCT02229539|531768615|FG001|Cycle 1 (Treatment Per Protocol)|Withdrawal by Subject|1|||
147437404|NCT02229539|531768616|FG002|Cycle 1 (Treatment Per Protocol)|Withdrawal by Subject|0|||
147437405|NCT02229539|531768614|FG000|Cycle 1 (Treatment Per Protocol)|Alternate Therapy|0|||
147437406|NCT02229539|531768615|FG001|Cycle 1 (Treatment Per Protocol)|Alternate Therapy|0|||
147437407|NCT02229539|531768616|FG002|Cycle 1 (Treatment Per Protocol)|Alternate Therapy|1|||
147437408|NCT02229539|531768614|FG000|Cycle 1 (Treatment Per Protocol)|Medical Problems|0|||
147437409|NCT02229539|531768615|FG001|Cycle 1 (Treatment Per Protocol)|Medical Problems|0|||
147437410|NCT02229539|531768616|FG002|Cycle 1 (Treatment Per Protocol)|Medical Problems|1|||
147437411|NCT02229539|531768614|FG000|Cycle 2 (Optional Continuation Phase)|Withdrawal by Subject|5|||
147437412|NCT02229539|531768615|FG001|Cycle 2 (Optional Continuation Phase)|Withdrawal by Subject|6|||
147437413|NCT02229539|531768616|FG002|Cycle 2 (Optional Continuation Phase)|Withdrawal by Subject|8|||
147437414|NCT02229539|531768614|FG000|Cycle 2 (Optional Continuation Phase)|Adverse Event|2|||
147437415|NCT02229539|531768615|FG001|Cycle 2 (Optional Continuation Phase)|Adverse Event|0|||
147437416|NCT02229539|531768616|FG002|Cycle 2 (Optional Continuation Phase)|Adverse Event|0|||
147437417|NCT02229539|531768614|FG000|Cycle 2 (Optional Continuation Phase)|Alternative Therapy|0|||
147437418|NCT02229539|531768615|FG001|Cycle 2 (Optional Continuation Phase)|Alternative Therapy|1|||
147437419|NCT02229539|531768616|FG002|Cycle 2 (Optional Continuation Phase)|Alternative Therapy|2|||
147437420|NCT02060383|531768618|FG000|Core Phase|Unsatisfactory therapeutic effect|1|||
147437421|NCT02060383|531768619|FG001|Core Phase|Unsatisfactory therapeutic effect|5|||
147437422|NCT02060383|531768620|FG002|Core Phase|Unsatisfactory therapeutic effect|0|||
147437423|NCT02060383|531768621|FG003|Core Phase|Unsatisfactory therapeutic effect|0|||
147437424|NCT02060383|531768622|FG004|Core Phase|Unsatisfactory therapeutic effect|0|||
147437425|NCT02060383|531768618|FG000|Core Phase|Adverse Event|2|||
147437426|NCT02060383|531768619|FG001|Core Phase|Adverse Event|0|||
147437427|NCT02060383|531768620|FG002|Core Phase|Adverse Event|0|||
147437428|NCT02060383|531768621|FG003|Core Phase|Adverse Event|2|||
147437429|NCT02060383|531768622|FG004|Core Phase|Adverse Event|6|||
147437430|NCT02060383|531768618|FG000|Core Phase|Administrative problems|0|||
147437431|NCT02060383|531768619|FG001|Core Phase|Administrative problems|1|||
147437432|NCT02060383|531768620|FG002|Core Phase|Administrative problems|0|||
147437433|NCT02060383|531768621|FG003|Core Phase|Administrative problems|0|||
147437434|NCT02060383|531768622|FG004|Core Phase|Administrative problems|0|||
147437435|NCT02060383|531768618|FG000|Core Phase|Protocol Violation|0|||
147437436|NCT02060383|531768619|FG001|Core Phase|Protocol Violation|0|||
147437437|NCT02060383|531768620|FG002|Core Phase|Protocol Violation|0|||
147437438|NCT02060383|531768621|FG003|Core Phase|Protocol Violation|1|||
147437439|NCT02060383|531768622|FG004|Core Phase|Protocol Violation|0|||
147202539|NCT04730804|530910681|FG005|Overall Study|Physician Decision|1|||
147202540|NCT04730804|530910676|FG000|Overall Study|Withdrawal by Subject|0|||
147537858|NCT00648739|532123807|FG006|Overall Study|Investigator Considered it Advisable|1|||
147537859|NCT00648739|532123801|FG000|Overall Study|Death|0|||
147537860|NCT00648739|532123802|FG001|Overall Study|Death|1|||
147537861|NCT00648739|532123803|FG002|Overall Study|Death|0|||
147537862|NCT00648739|532123804|FG003|Overall Study|Death|0|||
147537863|NCT00648739|532123805|FG004|Overall Study|Death|0|||
147537864|NCT00648739|532123806|FG005|Overall Study|Death|0|||
147537865|NCT00648739|532123807|FG006|Overall Study|Death|0|||
147537866|NCT00648739|532123801|FG000|Overall Study|Positive Human Anti-human Antibody|0|||
147537867|NCT00648739|532123802|FG001|Overall Study|Positive Human Anti-human Antibody|0|||
147537868|NCT00648739|532123803|FG002|Overall Study|Positive Human Anti-human Antibody|1|||
147537869|NCT00648739|532123804|FG003|Overall Study|Positive Human Anti-human Antibody|0|||
147537870|NCT00648739|532123805|FG004|Overall Study|Positive Human Anti-human Antibody|0|||
147537871|NCT00648739|532123806|FG005|Overall Study|Positive Human Anti-human Antibody|0|||
147537872|NCT00648739|532123807|FG006|Overall Study|Positive Human Anti-human Antibody|0|||
147537873|NCT00648739|532123801|FG000|Overall Study|Follow-up Visits Not Completed|0|||
147537874|NCT00648739|532123802|FG001|Overall Study|Follow-up Visits Not Completed|1|||
147537875|NCT00648739|532123803|FG002|Overall Study|Follow-up Visits Not Completed|0|||
147537876|NCT00648739|532123804|FG003|Overall Study|Follow-up Visits Not Completed|0|||
147537877|NCT00648739|532123805|FG004|Overall Study|Follow-up Visits Not Completed|0|||
147537878|NCT00648739|532123806|FG005|Overall Study|Follow-up Visits Not Completed|0|||
147537879|NCT00648739|532123807|FG006|Overall Study|Follow-up Visits Not Completed|0|||
147537880|NCT00564486|532123810|FG000|Overall Study|Adverse Event|0|||
147537881|NCT00564486|532123811|FG001|Overall Study|Adverse Event|1|||
147537882|NCT00564486|532123812|FG002|Overall Study|Adverse Event|0|||
147537883|NCT00564486|532123813|FG003|Overall Study|Adverse Event|0|||
147537884|NCT00564486|532123810|FG000|Overall Study|Withdrawal by Subject|4|||
147537885|NCT00564486|532123811|FG001|Overall Study|Withdrawal by Subject|0|||
147537886|NCT00564486|532123812|FG002|Overall Study|Withdrawal by Subject|0|||
147537887|NCT00564486|532123813|FG003|Overall Study|Withdrawal by Subject|5|||
147537888|NCT00564486|532123810|FG000|Overall Study|Subject refused to have blood drawn|0|||
147537889|NCT00564486|532123811|FG001|Overall Study|Subject refused to have blood drawn|0|||
147537890|NCT00564486|532123812|FG002|Overall Study|Subject refused to have blood drawn|1|||
147537891|NCT00564486|532123813|FG003|Overall Study|Subject refused to have blood drawn|0|||
147537892|NCT00564486|532123810|FG000|Overall Study|Lost to Follow-up|3|||
147537893|NCT00564486|532123811|FG001|Overall Study|Lost to Follow-up|0|||
147537894|NCT00564486|532123812|FG002|Overall Study|Lost to Follow-up|2|||
147537895|NCT00564486|532123813|FG003|Overall Study|Lost to Follow-up|2|||
147537896|NCT04362761|532123818|FG000|Part A (48 Weeks)|Adverse Event|2|||
147537897|NCT04362761|532123818|FG000|Part A (48 Weeks)|Withdrawal of consent (not due to AE)|4|||
147537898|NCT04362761|532123818|FG000|Part A (48 Weeks)|Commercial drug is available for participant|2|||
147537899|NCT04362761|532123818|FG000|Part A (48 Weeks)|Other|5|||
147537900|NCT04362761|532123818|FG000|Part B (86 Weeks)|Commercial drug is available for participant|46|||
147537901|NCT04362761|532123818|FG000|Part B (86 Weeks)|Other|4|||
147537902|NCT01819467|532123819|FG000|Overall Study|Physician Decision|20|||
147537903|NCT01819467|532123820|FG001|Overall Study|Physician Decision|9|||
147537904|NCT03926728|532123823|FG000|Overall Study|Withdrawal by Subject|0|||
147537905|NCT03926728|532123824|FG001|Overall Study|Withdrawal by Subject|1|||
147537906|NCT03926728|532123825|FG002|Overall Study|Withdrawal by Subject|1|||
147537907|NCT03926728|532123826|FG003|Overall Study|Withdrawal by Subject|0|||
147537908|NCT03926728|532123827|FG004|Overall Study|Withdrawal by Subject|0|||
147537909|NCT03926728|532123828|FG005|Overall Study|Withdrawal by Subject|1|||
147537910|NCT03926728|532123829|FG006|Overall Study|Withdrawal by Subject|1|||
147537911|NCT03926728|532123830|FG007|Overall Study|Withdrawal by Subject|0|||
147537912|NCT03926728|532123831|FG008|Overall Study|Withdrawal by Subject|0|||
147537913|NCT03926728|532123832|FG009|Overall Study|Withdrawal by Subject|1|||
147537914|NCT03926728|532123833|FG010|Overall Study|Withdrawal by Subject|0|||
147537915|NCT03926728|532123834|FG011|Overall Study|Withdrawal by Subject|0|||
147537916|NCT03993288|532123835|FG000|Overall Study|Lost to Follow-up|2|||
147537917|NCT03993288|532123836|FG001|Overall Study|Lost to Follow-up|1|||
147537918|NCT03993288|532123835|FG000|Overall Study|non-compliance to the inclusion criteria|0|||
147537919|NCT03993288|532123836|FG001|Overall Study|non-compliance to the inclusion criteria|1|||
147537920|NCT03993288|532123835|FG000|Overall Study|wrong randomization|0|||
147537921|NCT03993288|532123836|FG001|Overall Study|wrong randomization|1|||
147649426|NCT02634801|532537343|FG002|Treatment Period (Weeks 0 to 24)|Withdrawal by Subject|3|||
147537922|NCT03993288|532123835|FG000|Overall Study|improper enrollment|0|||
147537923|NCT03993288|532123836|FG001|Overall Study|improper enrollment|1|||
147537924|NCT03993288|532123835|FG000|Overall Study|prescribed with prohibited concomitant therapy|1|||
147537925|NCT03993288|532123836|FG001|Overall Study|prescribed with prohibited concomitant therapy|0|||
147537926|NCT03993288|532123835|FG000|Overall Study|developed SAE|2|||
147537927|NCT03993288|532123836|FG001|Overall Study|developed SAE|0|||
147537928|NCT03993288|532123835|FG000|Overall Study|consent withdrawal|1|||
147537929|NCT03993288|532123836|FG001|Overall Study|consent withdrawal|0|||
147537930|NCT03993288|532123835|FG000|Overall Study|did not follow the treatment schedule|1|||
147537931|NCT03993288|532123836|FG001|Overall Study|did not follow the treatment schedule|0|||
147202541|NCT04730804|530910677|FG001|Overall Study|Withdrawal by Subject|0|||
147202542|NCT04730804|530910678|FG002|Overall Study|Withdrawal by Subject|0|||
147537932|NCT03993288|532123835|FG000|Overall Study|did not follow the treatment regimen|1|||
147537933|NCT03993288|532123836|FG001|Overall Study|did not follow the treatment regimen|0|||
147537934|NCT03993288|532123835|FG000|Overall Study|Adverse Event|1|||
147537935|NCT03993288|532123836|FG001|Overall Study|Adverse Event|0|||
147537936|NCT03993288|532123835|FG000|Overall Study|Withdrawal by Subject|1|||
147537937|NCT03993288|532123836|FG001|Overall Study|Withdrawal by Subject|1|||
147537938|NCT02729545|532123837|FG000|Overall Study|Pregnancy|1|||
147537939|NCT02729545|532123838|FG001|Overall Study|Pregnancy|1|||
147537940|NCT02729545|532123837|FG000|Overall Study|Lost to Follow-up|0|||
147537941|NCT02729545|532123838|FG001|Overall Study|Lost to Follow-up|1|||
147537942|NCT02729545|532123837|FG000|Overall Study|Withdrawal by Subject|2|||
147537943|NCT02729545|532123838|FG001|Overall Study|Withdrawal by Subject|3|||
147537944|NCT00915473|532123839|FG000|Screening|Withdrawal by Subject|1|||
147537945|NCT00915473|532123840|FG001|Screening|Withdrawal by Subject|0|||
147537946|NCT00915473|532123839|FG000|4-week Follow Up|Lost to Follow-up|1|||
147537947|NCT00915473|532123840|FG001|4-week Follow Up|Lost to Follow-up|5|||
147537948|NCT01389024|532123841|FG000|Overall Study|Withdrawal by Subject|0|||
147537949|NCT01389024|532123842|FG001|Overall Study|Withdrawal by Subject|1|||
147537950|NCT01389024|532123841|FG000|Overall Study|Lost to Follow-up|1|||
147537951|NCT01389024|532123842|FG001|Overall Study|Lost to Follow-up|0|||
147537952|NCT00529802|532123846|FG000|Evaluable for Primary Endpoint|Did not complete 2d CT scan|3|||
147537953|NCT00529802|532123846|FG000|Evaluable for Primary Endpoint|Worsening performance status|2|||
147537954|NCT00529802|532123846|FG000|Evaluable for Primary Endpoint|Adverse Event|2|||
147537955|NCT00529802|532123846|FG000|Evaluable for Primary Endpoint|Death|1|||
147537956|NCT00529802|532123846|FG000|Evaluable for Primary Endpoint|Lack of Efficacy|1|||
147537957|NCT00529802|532123846|FG000|Evaluable for Primary Endpoint|Lost to Follow-up|1|||
147537958|NCT00529802|532123846|FG000|Evaluable for Secondary Endpoint|Did not complete 2d FDG-PET scan|2|||
147537959|NCT03286400|532123850|FG000|Overall Study|Death|10|||
147537960|NCT03286400|532123850|FG000|Overall Study|Lost to Follow-up|10|||
147537961|NCT03286400|532123850|FG000|Overall Study|Physician Decision|1|||
147537962|NCT03286400|532123850|FG000|Overall Study|Scheduling difficulty|4|||
147537963|NCT00740480|532123855|FG000|Overall Study|Adverse Event|1|||
147537964|NCT00740480|532123855|FG000|Overall Study|Physician Decision|1|||
147537965|NCT01325701|532123860|FG000|Overall Study|Adverse Event|12|||
147537966|NCT01325701|532123861|FG001|Overall Study|Adverse Event|0|||
147537967|NCT01325701|532123860|FG000|Overall Study|Protocol Violation|1|||
147537968|NCT01325701|532123861|FG001|Overall Study|Protocol Violation|0|||
147537969|NCT01325701|532123860|FG000|Overall Study|Physician Decision|2|||
147537970|NCT01325701|532123861|FG001|Overall Study|Physician Decision|2|||
147537971|NCT01325701|532123860|FG000|Overall Study|Withdrawal by Subject|2|||
147537972|NCT01325701|532123861|FG001|Overall Study|Withdrawal by Subject|1|||
147537973|NCT01325701|532123860|FG000|Overall Study|Rollerover Extension Study|4|||
147537974|NCT01325701|532123861|FG001|Overall Study|Rollerover Extension Study|0|||
147537975|NCT00568776|532123863|FG000|Overall Study|Adverse Event|8|||
147202543|NCT04730804|530910679|FG003|Overall Study|Withdrawal by Subject|0|||
147202544|NCT04730804|530910680|FG004|Overall Study|Withdrawal by Subject|1|||
147202545|NCT04730804|530910681|FG005|Overall Study|Withdrawal by Subject|2|||
147202546|NCT02202759|530911994|FG000|Overall Study|Study Terminated by Sponsor|3|||
147202547|NCT02202759|530911995|FG001|Overall Study|Study Terminated by Sponsor|3|||
147202548|NCT02202759|530911996|FG002|Overall Study|Study Terminated by Sponsor|3|||
147202549|NCT02202759|530911994|FG000|Overall Study|Withdrawal by Subject|2|||
147202550|NCT02202759|530911995|FG001|Overall Study|Withdrawal by Subject|1|||
147202551|NCT02202759|530911996|FG002|Overall Study|Withdrawal by Subject|1|||
147202552|NCT02202759|530911994|FG000|Overall Study|Reason not Specified|4|||
147202553|NCT02202759|530911995|FG001|Overall Study|Reason not Specified|11|||
147202554|NCT02202759|530911996|FG002|Overall Study|Reason not Specified|10|||
147202555|NCT02105662|530911997|FG000|Overall Study|Lost to Follow-up|5|||
147202556|NCT02105662|530911997|FG000|Overall Study|Withdrawal by Subject|1|||
147202557|NCT00990704|530912001|FG000|Overall Study|Adverse Event|1|||
147202558|NCT00990704|530912002|FG001|Overall Study|Adverse Event|1|||
147202559|NCT00990704|530912001|FG000|Overall Study|Physician Decision|0|||
147537976|NCT00568776|532123864|FG001|Overall Study|Adverse Event|8|||
147202560|NCT00990704|530912002|FG001|Overall Study|Physician Decision|1|||
147202561|NCT03722238|530912008|FG000|Overall Study|Protocol Violation|1|||
147202562|NCT03722238|530912009|FG001|Overall Study|Protocol Violation|0|||
147202563|NCT03722238|530912008|FG000|Overall Study|Physician Decision|1|||
147202564|NCT03722238|530912009|FG001|Overall Study|Physician Decision|0|||
147537977|NCT00568776|532123865|FG002|Overall Study|Adverse Event|10|||
147537978|NCT00568776|532123866|FG003|Overall Study|Adverse Event|8|||
147537979|NCT00568776|532123863|FG000|Overall Study|Death|0|||
147537980|NCT00568776|532123864|FG001|Overall Study|Death|1|||
147537981|NCT00568776|532123865|FG002|Overall Study|Death|4|||
147537982|NCT00568776|532123866|FG003|Overall Study|Death|3|||
147537983|NCT00568776|532123863|FG000|Overall Study|Physician Decision|0|||
147537984|NCT00568776|532123864|FG001|Overall Study|Physician Decision|2|||
147537985|NCT00568776|532123865|FG002|Overall Study|Physician Decision|0|||
147202565|NCT03722238|530912008|FG000|Overall Study|Death|1|||
147202566|NCT03722238|530912009|FG001|Overall Study|Death|0|||
147202567|NCT03722238|530912008|FG000|Overall Study|Lost to Follow-up|6|||
147202568|NCT03722238|530912009|FG001|Overall Study|Lost to Follow-up|0|||
147202569|NCT03722238|530912008|FG000|Overall Study|Partial missing data|44|||
147202570|NCT03722238|530912009|FG001|Overall Study|Partial missing data|1|||
147202571|NCT03722238|530912008|FG000|Overall Study|Withdrawal by Subject|2|||
147202572|NCT03722238|530912009|FG001|Overall Study|Withdrawal by Subject|0|||
147202573|NCT03722238|530912008|FG000|Overall Study|Other|4|||
147202574|NCT03722238|530912009|FG001|Overall Study|Other|0|||
147202575|NCT03722238|530912008|FG000|Overall Study|Not returned to sign consent, download electronic diary application or to purchase study medication|2|||
147202576|NCT03722238|530912009|FG001|Overall Study|Not returned to sign consent, download electronic diary application or to purchase study medication|0|||
147202577|NCT03722238|530912008|FG000|Overall Study|Did not meet risk classification group criteria|90|||
147202578|NCT03722238|530912009|FG001|Overall Study|Did not meet risk classification group criteria|0|||
147202579|NCT03722238|530912008|FG000|Overall Study|Did not sign consent|17|||
147202580|NCT03722238|530912009|FG001|Overall Study|Did not sign consent|0|||
147202581|NCT03722238|530912008|FG000|Overall Study|Other eligibility criteria not met pre-consent|22|||
147202582|NCT03722238|530912009|FG001|Overall Study|Other eligibility criteria not met pre-consent|0|||
147202583|NCT03722238|530912008|FG000|Overall Study|Not willing to purchase study medication|142|||
147202584|NCT03722238|530912009|FG001|Overall Study|Not willing to purchase study medication|0|||
147202585|NCT03722238|530912008|FG000|Overall Study|Did not qualify at re-screening and medical conditions|133|||
147202586|NCT03722238|530912009|FG001|Overall Study|Did not qualify at re-screening and medical conditions|0|||
147202587|NCT00561925|530912010|FG000|14 Day Lead-In Period|Adverse Event|38|||
147202588|NCT00561925|530912011|FG001|14 Day Lead-In Period|Adverse Event|0|||
147202589|NCT00561925|530912012|FG002|14 Day Lead-In Period|Adverse Event|0|||
147202590|NCT00561925|530912013|FG003|14 Day Lead-In Period|Adverse Event|0|||
147202591|NCT00561925|530912014|FG004|14 Day Lead-In Period|Adverse Event|0|||
147202592|NCT00561925|530912010|FG000|14 Day Lead-In Period|In/Exclusion criteria|4|||
147202593|NCT00561925|530912011|FG001|14 Day Lead-In Period|In/Exclusion criteria|0|||
147202594|NCT00561925|530912012|FG002|14 Day Lead-In Period|In/Exclusion criteria|0|||
147202595|NCT00561925|530912013|FG003|14 Day Lead-In Period|In/Exclusion criteria|0|||
147202596|NCT00561925|530912014|FG004|14 Day Lead-In Period|In/Exclusion criteria|0|||
147202597|NCT00561925|530912010|FG000|14 Day Lead-In Period|Lost to Follow-up|4|||
147202598|NCT00561925|530912011|FG001|14 Day Lead-In Period|Lost to Follow-up|0|||
147202599|NCT00561925|530912012|FG002|14 Day Lead-In Period|Lost to Follow-up|0|||
147202600|NCT00561925|530912013|FG003|14 Day Lead-In Period|Lost to Follow-up|0|||
147202601|NCT00561925|530912014|FG004|14 Day Lead-In Period|Lost to Follow-up|0|||
147202602|NCT00561925|530912010|FG000|14 Day Lead-In Period|Withdrawal by Subject|4|||
147202603|NCT00561925|530912011|FG001|14 Day Lead-In Period|Withdrawal by Subject|0|||
147202604|NCT00561925|530912012|FG002|14 Day Lead-In Period|Withdrawal by Subject|0|||
147202605|NCT00561925|530912013|FG003|14 Day Lead-In Period|Withdrawal by Subject|0|||
147202606|NCT00561925|530912014|FG004|14 Day Lead-In Period|Withdrawal by Subject|0|||
147202607|NCT00561925|530912010|FG000|14 Day Lead-In Period|Other|5|||
147202608|NCT00561925|530912011|FG001|14 Day Lead-In Period|Other|0|||
147202609|NCT00561925|530912012|FG002|14 Day Lead-In Period|Other|0|||
147202610|NCT00561925|530912013|FG003|14 Day Lead-In Period|Other|0|||
147202611|NCT00561925|530912014|FG004|14 Day Lead-In Period|Other|0|||
147202612|NCT00561925|530912010|FG000|144-week Double-blind, Double-dummy|Adverse Event|0|||
147437440|NCT02060383|531768618|FG000|Core Phase|Withdrawal by Subject|0|||
147437441|NCT02060383|531768619|FG001|Core Phase|Withdrawal by Subject|0|||
147437442|NCT02060383|531768620|FG002|Core Phase|Withdrawal by Subject|0|||
147437443|NCT02060383|531768621|FG003|Core Phase|Withdrawal by Subject|4|||
147437444|NCT02060383|531768622|FG004|Core Phase|Withdrawal by Subject|2|||
147437445|NCT02060383|531768618|FG000|Extension Phase|Unsatisfactory therapeutic effect|1|||
147437446|NCT02060383|531768619|FG001|Extension Phase|Unsatisfactory therapeutic effect|1|||
147437447|NCT02060383|531768620|FG002|Extension Phase|Unsatisfactory therapeutic effect|0|||
147437448|NCT02060383|531768621|FG003|Extension Phase|Unsatisfactory therapeutic effect|2|||
147437449|NCT02060383|531768622|FG004|Extension Phase|Unsatisfactory therapeutic effect|2|||
147437450|NCT02060383|531768618|FG000|Extension Phase|Adverse Event|1|||
147437451|NCT02060383|531768619|FG001|Extension Phase|Adverse Event|1|||
147437452|NCT02060383|531768620|FG002|Extension Phase|Adverse Event|2|||
147437453|NCT02060383|531768621|FG003|Extension Phase|Adverse Event|0|||
147437454|NCT02060383|531768622|FG004|Extension Phase|Adverse Event|1|||
147437455|NCT02060383|531768618|FG000|Extension Phase|Withdrawal by Subject|0|||
147437456|NCT02060383|531768619|FG001|Extension Phase|Withdrawal by Subject|1|||
147437457|NCT02060383|531768620|FG002|Extension Phase|Withdrawal by Subject|0|||
147437458|NCT02060383|531768621|FG003|Extension Phase|Withdrawal by Subject|0|||
147202613|NCT00561925|530912011|FG001|144-week Double-blind, Double-dummy|Adverse Event|48|||
147202614|NCT00561925|530912012|FG002|144-week Double-blind, Double-dummy|Adverse Event|43|||
147437459|NCT02060383|531768622|FG004|Extension Phase|Withdrawal by Subject|2|||
147437460|NCT02060383|531768618|FG000|Extension Phase|Administrative problems|1|||
147202615|NCT00561925|530912013|FG003|144-week Double-blind, Double-dummy|Adverse Event|0|||
147537986|NCT00568776|532123866|FG003|Overall Study|Physician Decision|0|||
147537987|NCT00568776|532123863|FG000|Overall Study|Lack of Efficacy|2|||
147537988|NCT00568776|532123864|FG001|Overall Study|Lack of Efficacy|2|||
147537989|NCT00568776|532123865|FG002|Overall Study|Lack of Efficacy|2|||
147537990|NCT00568776|532123866|FG003|Overall Study|Lack of Efficacy|4|||
147537991|NCT00568776|532123863|FG000|Overall Study|Lost to Follow-up|1|||
147537992|NCT00568776|532123864|FG001|Overall Study|Lost to Follow-up|1|||
147537993|NCT00568776|532123865|FG002|Overall Study|Lost to Follow-up|1|||
147537994|NCT00568776|532123866|FG003|Overall Study|Lost to Follow-up|1|||
147537995|NCT00568776|532123863|FG000|Overall Study|Protocol Violation|1|||
147537996|NCT00568776|532123864|FG001|Overall Study|Protocol Violation|0|||
147537997|NCT00568776|532123865|FG002|Overall Study|Protocol Violation|1|||
147537998|NCT00568776|532123866|FG003|Overall Study|Protocol Violation|1|||
147537999|NCT00568776|532123863|FG000|Overall Study|Withdrawal by Subject|13|||
147538000|NCT00568776|532123864|FG001|Overall Study|Withdrawal by Subject|15|||
147538001|NCT00568776|532123865|FG002|Overall Study|Withdrawal by Subject|13|||
147538002|NCT00568776|532123866|FG003|Overall Study|Withdrawal by Subject|7|||
147538003|NCT00568776|532123863|FG000|Overall Study|Loss of Caregiver|0|||
147538004|NCT00568776|532123864|FG001|Overall Study|Loss of Caregiver|2|||
147538005|NCT00568776|532123865|FG002|Overall Study|Loss of Caregiver|1|||
147538006|NCT00568776|532123866|FG003|Overall Study|Loss of Caregiver|2|||
147538007|NCT00568776|532123863|FG000|Overall Study|Sponsor Decision|2|||
147538008|NCT00568776|532123864|FG001|Overall Study|Sponsor Decision|2|||
147538009|NCT00568776|532123865|FG002|Overall Study|Sponsor Decision|41|||
147538010|NCT00568776|532123866|FG003|Overall Study|Sponsor Decision|42|||
147538011|NCT00568776|532123863|FG000|Overall Study|Miscellaeneous|3|||
147538012|NCT00568776|532123864|FG001|Overall Study|Miscellaeneous|3|||
147538013|NCT00568776|532123865|FG002|Overall Study|Miscellaeneous|1|||
147538014|NCT00568776|532123866|FG003|Overall Study|Miscellaeneous|4|||
147538015|NCT01005680|532123867|FG000|Overall Study|Lost to Follow-up|4|||
147538016|NCT01005680|532123868|FG001|Overall Study|Lost to Follow-up|6|||
147538017|NCT01005680|532123867|FG000|Overall Study|Withdrawal by Subject|1|||
147538018|NCT01005680|532123868|FG001|Overall Study|Withdrawal by Subject|4|||
147538019|NCT01005680|532123867|FG000|Overall Study|Physician Decision|1|||
147538020|NCT01005680|532123868|FG001|Overall Study|Physician Decision|1|||
147538021|NCT00539006|532123881|FG000|Pre-treatment|Other|0|||
147538022|NCT00539006|532123882|FG001|Pre-treatment|Other|1|||
147538023|NCT00539006|532123883|FG002|Pre-treatment|Other|0|||
147538024|NCT00539006|532123884|FG003|Pre-treatment|Other|0|||
147538025|NCT00539006|532123881|FG000|Treatment Period 1|Lost to Follow-up|0|||
147538026|NCT00539006|532123882|FG001|Treatment Period 1|Lost to Follow-up|0|||
147538027|NCT00539006|532123883|FG002|Treatment Period 1|Lost to Follow-up|1|||
147538028|NCT00539006|532123884|FG003|Treatment Period 1|Lost to Follow-up|0|||
147538029|NCT00539006|532123881|FG000|Treatment Period 1|Protocol Violation|0|||
147538030|NCT00539006|532123882|FG001|Treatment Period 1|Protocol Violation|0|||
147538031|NCT00539006|532123883|FG002|Treatment Period 1|Protocol Violation|1|||
147538032|NCT00539006|532123884|FG003|Treatment Period 1|Protocol Violation|0|||
147538033|NCT00539006|532123881|FG000|Treatment Period 1|Lack of Efficacy|0|||
147538034|NCT00539006|532123882|FG001|Treatment Period 1|Lack of Efficacy|0|||
147538035|NCT00539006|532123883|FG002|Treatment Period 1|Lack of Efficacy|0|||
147538036|NCT00539006|532123884|FG003|Treatment Period 1|Lack of Efficacy|1|||
147538037|NCT00539006|532123881|FG000|Washout|Adverse Event|2|||
147538038|NCT00539006|532123882|FG001|Washout|Adverse Event|1|||
147538039|NCT00539006|532123883|FG002|Washout|Adverse Event|0|||
147538040|NCT00539006|532123884|FG003|Washout|Adverse Event|0|||
147538041|NCT00539006|532123881|FG000|Washout|Protocol Violation|1|||
147538042|NCT00539006|532123882|FG001|Washout|Protocol Violation|1|||
147538043|NCT00539006|532123883|FG002|Washout|Protocol Violation|0|||
147538044|NCT00539006|532123884|FG003|Washout|Protocol Violation|0|||
147538045|NCT00539006|532123881|FG000|Washout|Withdrawal by Subject|0|||
147538046|NCT00539006|532123882|FG001|Washout|Withdrawal by Subject|2|||
147538047|NCT00539006|532123883|FG002|Washout|Withdrawal by Subject|0|||
147538048|NCT00539006|532123884|FG003|Washout|Withdrawal by Subject|0|||
147538049|NCT00539006|532123881|FG000|Washout|Failed to meet continuation criteria|16|||
147538050|NCT00539006|532123882|FG001|Washout|Failed to meet continuation criteria|5|||
147538051|NCT00539006|532123883|FG002|Washout|Failed to meet continuation criteria|14|||
147538052|NCT00539006|532123884|FG003|Washout|Failed to meet continuation criteria|6|||
147538053|NCT00539006|532123881|FG000|Washout|Other|1|||
147538054|NCT00539006|532123882|FG001|Washout|Other|1|||
147538055|NCT00539006|532123883|FG002|Washout|Other|2|||
147538056|NCT00539006|532123884|FG003|Washout|Other|3|||
147538057|NCT00539006|532123881|FG000|Treatment Period 2|Protocol Violation|1|||
147538058|NCT00539006|532123882|FG001|Treatment Period 2|Protocol Violation|0|||
147202616|NCT00561925|530912014|FG004|144-week Double-blind, Double-dummy|Adverse Event|0|||
147202617|NCT00561925|530912010|FG000|144-week Double-blind, Double-dummy|Protocol Violation|0|||
147202618|NCT00561925|530912011|FG001|144-week Double-blind, Double-dummy|Protocol Violation|15|||
147202619|NCT00561925|530912012|FG002|144-week Double-blind, Double-dummy|Protocol Violation|9|||
147202620|NCT00561925|530912013|FG003|144-week Double-blind, Double-dummy|Protocol Violation|0|||
147202621|NCT00561925|530912014|FG004|144-week Double-blind, Double-dummy|Protocol Violation|0|||
147202622|NCT00561925|530912010|FG000|144-week Double-blind, Double-dummy|Lost to Follow-up|0|||
147202623|NCT00561925|530912011|FG001|144-week Double-blind, Double-dummy|Lost to Follow-up|15|||
147202624|NCT00561925|530912012|FG002|144-week Double-blind, Double-dummy|Lost to Follow-up|12|||
147202625|NCT00561925|530912013|FG003|144-week Double-blind, Double-dummy|Lost to Follow-up|0|||
147202626|NCT00561925|530912014|FG004|144-week Double-blind, Double-dummy|Lost to Follow-up|0|||
147202627|NCT00561925|530912010|FG000|144-week Double-blind, Double-dummy|Withdrawal by Subject|0|||
147202628|NCT00561925|530912011|FG001|144-week Double-blind, Double-dummy|Withdrawal by Subject|19|||
147202629|NCT00561925|530912012|FG002|144-week Double-blind, Double-dummy|Withdrawal by Subject|7|||
147202630|NCT00561925|530912013|FG003|144-week Double-blind, Double-dummy|Withdrawal by Subject|0|||
147202631|NCT00561925|530912014|FG004|144-week Double-blind, Double-dummy|Withdrawal by Subject|0|||
147306808|NCT01852058|531290777|FG004|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
147437461|NCT02060383|531768619|FG001|Extension Phase|Administrative problems|0|||
147437462|NCT02060383|531768620|FG002|Extension Phase|Administrative problems|0|||
147437463|NCT02060383|531768621|FG003|Extension Phase|Administrative problems|0|||
147437464|NCT02060383|531768622|FG004|Extension Phase|Administrative problems|0|||
147437465|NCT02060383|531768618|FG000|Extension Phase|Death|0|||
147437466|NCT02060383|531768619|FG001|Extension Phase|Death|0|||
147437467|NCT02060383|531768620|FG002|Extension Phase|Death|1|||
147437468|NCT02060383|531768621|FG003|Extension Phase|Death|0|||
147437469|NCT02060383|531768622|FG004|Extension Phase|Death|1|||
147437470|NCT02060383|531768618|FG000|Extension Phase|Protocol Violation|0|||
147437471|NCT02060383|531768619|FG001|Extension Phase|Protocol Violation|0|||
147437472|NCT02060383|531768620|FG002|Extension Phase|Protocol Violation|0|||
147437473|NCT02060383|531768621|FG003|Extension Phase|Protocol Violation|0|||
147437474|NCT02060383|531768622|FG004|Extension Phase|Protocol Violation|1|||
147437475|NCT03441334|531768623|FG000|Overall Study|Withdrawal by Subject|1|||
147437476|NCT03441334|531768624|FG001|Overall Study|Withdrawal by Subject|0|||
147437477|NCT03426787|531768631|FG000|Overall Study|Withdrawal by Subject|6|||
147437478|NCT03426787|531768631|FG000|Overall Study|Lost to Follow-up|7|||
147437479|NCT03426787|531768631|FG000|Overall Study|Unrelated to intervention death|1|||
147437480|NCT03627767|531768638|FG000|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|48|||
147437481|NCT03627767|531768639|FG001|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|0|||
147437482|NCT03627767|531768640|FG002|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|0|||
147437483|NCT03627767|531768641|FG003|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|0|||
147437484|NCT03627767|531768642|FG004|Open-label (OL) Run-in Period (12 Weeks)|Adverse Event|0|||
147437485|NCT03627767|531768638|FG000|Open-label (OL) Run-in Period (12 Weeks)|Death|1|||
147437486|NCT03627767|531768639|FG001|Open-label (OL) Run-in Period (12 Weeks)|Death|0|||
147437487|NCT03627767|531768640|FG002|Open-label (OL) Run-in Period (12 Weeks)|Death|0|||
147437488|NCT03627767|531768641|FG003|Open-label (OL) Run-in Period (12 Weeks)|Death|0|||
147437489|NCT03627767|531768642|FG004|Open-label (OL) Run-in Period (12 Weeks)|Death|0|||
147437490|NCT03627767|531768638|FG000|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|315|||
147437491|NCT03627767|531768639|FG001|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|0|||
147437492|NCT03627767|531768640|FG002|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|0|||
147437493|NCT03627767|531768641|FG003|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|0|||
147437494|NCT03627767|531768642|FG004|Open-label (OL) Run-in Period (12 Weeks)|Lack of Efficacy|0|||
147437495|NCT03627767|531768638|FG000|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|13|||
147437496|NCT03627767|531768639|FG001|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|0|||
147437497|NCT03627767|531768640|FG002|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|0|||
147437498|NCT03627767|531768641|FG003|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|0|||
147437499|NCT03627767|531768642|FG004|Open-label (OL) Run-in Period (12 Weeks)|Lost to Follow-up|0|||
147437500|NCT03627767|531768638|FG000|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|11|||
147437501|NCT03627767|531768639|FG001|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|0|||
147437502|NCT03627767|531768640|FG002|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|0|||
147437503|NCT03627767|531768641|FG003|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|0|||
147437504|NCT03627767|531768642|FG004|Open-label (OL) Run-in Period (12 Weeks)|Protocol Violation|0|||
147437505|NCT03627767|531768638|FG000|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|40|||
147437506|NCT03627767|531768639|FG001|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|0|||
147437507|NCT03627767|531768640|FG002|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|0|||
147437508|NCT03627767|531768641|FG003|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|0|||
147437509|NCT03627767|531768642|FG004|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal by Subject|0|||
147437510|NCT03627767|531768638|FG000|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|1|||
147538059|NCT00539006|532123883|FG002|Treatment Period 2|Protocol Violation|0|||
147538060|NCT00539006|532123884|FG003|Treatment Period 2|Protocol Violation|0|||
147538061|NCT00539006|532123881|FG000|Treatment Period 2|Other|0|||
147538062|NCT00539006|532123882|FG001|Treatment Period 2|Other|1|||
147538063|NCT00539006|532123883|FG002|Treatment Period 2|Other|0|||
147538064|NCT00539006|532123884|FG003|Treatment Period 2|Other|0|||
147538065|NCT01179191|532123885|FG000|Titration Phase (up to 6 Weeks)|Adverse Event|47|||
147538066|NCT01179191|532123885|FG000|Titration Phase (up to 6 Weeks)|Lost to Follow-up|19|||
147538067|NCT01179191|532123885|FG000|Titration Phase (up to 6 Weeks)|Physician Decision|30|||
147538068|NCT01179191|532123885|FG000|Titration Phase (up to 6 Weeks)|Withdrawal by Subject|162|||
147538069|NCT01179191|532123885|FG000|Titration Phase (up to 6 Weeks)|Participant did not reach stable dose|13|||
147538070|NCT01179191|532123885|FG000|Titration Phase (up to 6 Weeks)|Other|62|||
147538071|NCT01179191|532123885|FG000|Maintenance Phase (8 Weeks)|Adverse Event|10|||
147538072|NCT01179191|532123885|FG000|Maintenance Phase (8 Weeks)|Lost to Follow-up|9|||
147538073|NCT01179191|532123885|FG000|Maintenance Phase (8 Weeks)|Physician Decision|3|||
147538074|NCT01179191|532123885|FG000|Maintenance Phase (8 Weeks)|Withdrawal by Subject|29|||
147538075|NCT01179191|532123885|FG000|Maintenance Phase (8 Weeks)|Other|66|||
147538076|NCT00572910|532123886|FG000|Overall Study|Adverse Event|1|||
147538077|NCT00572910|532123887|FG001|Overall Study|Adverse Event|2|||
147538078|NCT00572910|532123888|FG002|Overall Study|Adverse Event|0|||
147538079|NCT00572910|532123889|FG003|Overall Study|Adverse Event|2|||
147538080|NCT00572910|532123890|FG004|Overall Study|Adverse Event|0|||
147538081|NCT00572910|532123891|FG005|Overall Study|Adverse Event|0|||
147538082|NCT00572910|532123892|FG006|Overall Study|Adverse Event|4|||
147538083|NCT00572910|532123893|FG007|Overall Study|Adverse Event|2|||
147538084|NCT00572910|532123894|FG008|Overall Study|Adverse Event|1|||
147538085|NCT00572910|532123895|FG009|Overall Study|Adverse Event|3|||
147538086|NCT00572910|532123896|FG010|Overall Study|Adverse Event|2|||
147538087|NCT00572910|532123886|FG000|Overall Study|Lost to Follow-up|0|||
147538088|NCT00572910|532123887|FG001|Overall Study|Lost to Follow-up|1|||
147538089|NCT00572910|532123888|FG002|Overall Study|Lost to Follow-up|1|||
147538090|NCT00572910|532123889|FG003|Overall Study|Lost to Follow-up|2|||
147538091|NCT00572910|532123890|FG004|Overall Study|Lost to Follow-up|1|||
147538092|NCT00572910|532123891|FG005|Overall Study|Lost to Follow-up|0|||
147202632|NCT00561925|530912010|FG000|144-week Double-blind, Double-dummy|Lack of Efficacy|0|||
147202633|NCT00561925|530912011|FG001|144-week Double-blind, Double-dummy|Lack of Efficacy|36|||
147202634|NCT00561925|530912012|FG002|144-week Double-blind, Double-dummy|Lack of Efficacy|33|||
147202635|NCT00561925|530912013|FG003|144-week Double-blind, Double-dummy|Lack of Efficacy|0|||
147202636|NCT00561925|530912014|FG004|144-week Double-blind, Double-dummy|Lack of Efficacy|0|||
147202637|NCT00561925|530912010|FG000|144-week Double-blind, Double-dummy|Pregnancy|0|||
147202638|NCT00561925|530912011|FG001|144-week Double-blind, Double-dummy|Pregnancy|1|||
147202639|NCT00561925|530912012|FG002|144-week Double-blind, Double-dummy|Pregnancy|9|||
147202640|NCT00561925|530912013|FG003|144-week Double-blind, Double-dummy|Pregnancy|0|||
147202641|NCT00561925|530912014|FG004|144-week Double-blind, Double-dummy|Pregnancy|0|||
147202642|NCT00561925|530912010|FG000|144-week Double-blind, Double-dummy|Death|0|||
147202643|NCT00561925|530912011|FG001|144-week Double-blind, Double-dummy|Death|6|||
147202644|NCT00561925|530912012|FG002|144-week Double-blind, Double-dummy|Death|3|||
147202645|NCT00561925|530912013|FG003|144-week Double-blind, Double-dummy|Death|0|||
147202646|NCT00561925|530912014|FG004|144-week Double-blind, Double-dummy|Death|0|||
147202647|NCT00561925|530912010|FG000|144-week Double-blind, Double-dummy|Not treated with study drug|0|||
147202648|NCT00561925|530912011|FG001|144-week Double-blind, Double-dummy|Not treated with study drug|2|||
147202649|NCT00561925|530912012|FG002|144-week Double-blind, Double-dummy|Not treated with study drug|0|||
147202650|NCT00561925|530912013|FG003|144-week Double-blind, Double-dummy|Not treated with study drug|0|||
147202651|NCT00561925|530912014|FG004|144-week Double-blind, Double-dummy|Not treated with study drug|0|||
147202652|NCT00561925|530912010|FG000|144-week Double-blind, Double-dummy|Other|0|||
147202653|NCT00561925|530912011|FG001|144-week Double-blind, Double-dummy|Other|8|||
147202654|NCT00561925|530912012|FG002|144-week Double-blind, Double-dummy|Other|11|||
147202655|NCT00561925|530912013|FG003|144-week Double-blind, Double-dummy|Other|0|||
147202656|NCT00561925|530912014|FG004|144-week Double-blind, Double-dummy|Other|0|||
147202657|NCT00561925|530912010|FG000|Open-Label Extension Period|Declined entry into extension period|0|||
147202658|NCT00561925|530912011|FG001|Open-Label Extension Period|Declined entry into extension period|0|||
147202659|NCT00561925|530912012|FG002|Open-Label Extension Period|Declined entry into extension period|0|||
147202660|NCT00561925|530912013|FG003|Open-Label Extension Period|Declined entry into extension period|43|||
147538093|NCT00572910|532123892|FG006|Overall Study|Lost to Follow-up|0|||
147202661|NCT00561925|530912014|FG004|Open-Label Extension Period|Declined entry into extension period|50|||
147538094|NCT00572910|532123893|FG007|Overall Study|Lost to Follow-up|0|||
147538095|NCT00572910|532123894|FG008|Overall Study|Lost to Follow-up|0|||
147538096|NCT00572910|532123895|FG009|Overall Study|Lost to Follow-up|1|||
147538097|NCT00572910|532123896|FG010|Overall Study|Lost to Follow-up|0|||
147538098|NCT00572910|532123886|FG000|Overall Study|Withdrawal by Subject|3|||
147538099|NCT00572910|532123887|FG001|Overall Study|Withdrawal by Subject|0|||
147538100|NCT00572910|532123888|FG002|Overall Study|Withdrawal by Subject|1|||
147202662|NCT00684021|530912017|FG000|Overall Study|MRI Contraindicated|1|||
147538101|NCT00572910|532123889|FG003|Overall Study|Withdrawal by Subject|0|||
147538102|NCT00572910|532123890|FG004|Overall Study|Withdrawal by Subject|1|||
147538103|NCT00572910|532123891|FG005|Overall Study|Withdrawal by Subject|3|||
147538104|NCT00572910|532123892|FG006|Overall Study|Withdrawal by Subject|0|||
147538105|NCT00572910|532123893|FG007|Overall Study|Withdrawal by Subject|2|||
147538106|NCT00572910|532123894|FG008|Overall Study|Withdrawal by Subject|2|||
147538107|NCT00572910|532123895|FG009|Overall Study|Withdrawal by Subject|2|||
147538108|NCT00572910|532123896|FG010|Overall Study|Withdrawal by Subject|1|||
147538109|NCT02230332|532123897|FG000|Overall Study|Adverse Event|2|||
147538110|NCT02230332|532123898|FG001|Overall Study|Adverse Event|1|||
147538111|NCT02230332|532123897|FG000|Overall Study|Lost to Follow-up|1|||
147538112|NCT02230332|532123898|FG001|Overall Study|Lost to Follow-up|0|||
147538113|NCT02230332|532123897|FG000|Overall Study|Protocol Violation|1|||
147538114|NCT02230332|532123898|FG001|Overall Study|Protocol Violation|0|||
147538115|NCT01260194|532123899|FG000|Overall Study|Withdrawal of Consent|1|||
147538116|NCT04054011|532123900|FG000|Overall Study|COVID|3|||
147538117|NCT00592007|532123901|FG000|Overall Study|Withdrawal by Subject|1|||
147538118|NCT00592007|532123901|FG000|Overall Study|patient ineligible (out of lab range)|1|||
147538119|NCT00595127|532123902|FG000|Overall Study|Death|6|||
147538120|NCT00595127|532123902|FG000|Overall Study|Relapsed|3|||
147538121|NCT00595127|532123902|FG000|Overall Study|joined another trial|1|||
147538122|NCT00538473|532123903|FG000|Overall Study|Adverse Event|1|||
147538123|NCT00538473|532123904|FG001|Overall Study|Adverse Event|0|||
147538124|NCT01569074|532123905|FG000|Overall Study|Study stopped|6|||
147538125|NCT01569074|532123906|FG001|Overall Study|Study stopped|6|||
147538126|NCT01569074|532123907|FG002|Overall Study|Study stopped|8|||
147538127|NCT01569074|532123908|FG003|Overall Study|Study stopped|7|||
147538128|NCT01569074|532123909|FG004|Overall Study|Study stopped|7|||
147538129|NCT01569074|532123905|FG000|Overall Study|Study-specific discontinuation criteria|0|||
147538130|NCT01569074|532123906|FG001|Overall Study|Study-specific discontinuation criteria|1|||
147538131|NCT01569074|532123907|FG002|Overall Study|Study-specific discontinuation criteria|0|||
147538132|NCT01569074|532123908|FG003|Overall Study|Study-specific discontinuation criteria|0|||
147538133|NCT01569074|532123909|FG004|Overall Study|Study-specific discontinuation criteria|0|||
147538134|NCT01569074|532123905|FG000|Overall Study|Severe non-compliance to protocol|0|||
147538135|NCT01569074|532123906|FG001|Overall Study|Severe non-compliance to protocol|0|||
147538136|NCT01569074|532123907|FG002|Overall Study|Severe non-compliance to protocol|1|||
147538137|NCT01569074|532123908|FG003|Overall Study|Severe non-compliance to protocol|0|||
147538138|NCT01569074|532123909|FG004|Overall Study|Severe non-compliance to protocol|0|||
147538139|NCT01569074|532123905|FG000|Overall Study|eg change in circumstances|0|||
147538140|NCT01569074|532123906|FG001|Overall Study|eg change in circumstances|2|||
147538141|NCT01569074|532123907|FG002|Overall Study|eg change in circumstances|0|||
147538142|NCT01569074|532123908|FG003|Overall Study|eg change in circumstances|1|||
147538143|NCT01569074|532123909|FG004|Overall Study|eg change in circumstances|1|||
147538144|NCT01569074|532123905|FG000|Overall Study|Adverse Event|1|||
147538145|NCT01569074|532123906|FG001|Overall Study|Adverse Event|0|||
147538146|NCT01569074|532123907|FG002|Overall Study|Adverse Event|3|||
147538147|NCT01569074|532123908|FG003|Overall Study|Adverse Event|0|||
147538148|NCT01569074|532123909|FG004|Overall Study|Adverse Event|0|||
147538149|NCT01036594|532123915|FG000|Run-In: Ketoconazole Only (200 mg)|Adverse Event|1|||
147538150|NCT01036594|532123916|FG001|Run-In: Ketoconazole Only (200 mg)|Adverse Event|0|||
147538151|NCT01036594|532123915|FG000|First Treatment Regimen|Withdrawal by Subject|1|||
147538152|NCT01036594|532123916|FG001|First Treatment Regimen|Withdrawal by Subject|0|||
147538153|NCT01036594|532123915|FG000|Week 12 Evaluation|Adverse Event|5|||
147538154|NCT01036594|532123916|FG001|Week 12 Evaluation|Adverse Event|0|||
147538155|NCT01036594|532123915|FG000|Week 12 Evaluation|Physician Decision|1|||
147538156|NCT01036594|532123916|FG001|Week 12 Evaluation|Physician Decision|0|||
147538157|NCT01036594|532123915|FG000|Treatment Regiments Post Week 12|Physician Decision|1|||
147538158|NCT01036594|532123916|FG001|Treatment Regiments Post Week 12|Physician Decision|1|||
147538159|NCT01036594|532123915|FG000|Treatment Regiments Post Week 12|Withdrawal by Subject|1|||
147538160|NCT01036594|532123916|FG001|Treatment Regiments Post Week 12|Withdrawal by Subject|0|||
147538161|NCT01036594|532123915|FG000|Treatment Regiments Post Week 12|Adverse Event|0|||
147538162|NCT01036594|532123916|FG001|Treatment Regiments Post Week 12|Adverse Event|1|||
147538163|NCT01036594|532123915|FG000|Treatment Regiments Post Week 12|Non-Cancer Disease Complications|0|||
147538164|NCT01036594|532123916|FG001|Treatment Regiments Post Week 12|Non-Cancer Disease Complications|1|||
147538165|NCT01036594|532123915|FG000|Treatment Regiments Post Week 12|Lack of Efficacy|0|||
147538166|NCT01036594|532123916|FG001|Treatment Regiments Post Week 12|Lack of Efficacy|1|||
147538167|NCT00244881|532123918|FG000|Overall Study|Withdrawal by Subject|3|||
147538168|NCT03345485|532123919|FG000|Overall Study|Do not have a post-dose tumour assessment|0|||
147538169|NCT03345485|532123920|FG001|Overall Study|Do not have a post-dose tumour assessment|0|||
147538170|NCT03345485|532123921|FG002|Overall Study|Do not have a post-dose tumour assessment|0|||
147538171|NCT03345485|532123922|FG003|Overall Study|Do not have a post-dose tumour assessment|0|||
147538172|NCT03345485|532123923|FG004|Overall Study|Do not have a post-dose tumour assessment|0|||
147538173|NCT03345485|532123924|FG005|Overall Study|Do not have a post-dose tumour assessment|0|||
147538174|NCT03345485|532123925|FG006|Overall Study|Do not have a post-dose tumour assessment|1|||
147538175|NCT03345485|532123926|FG007|Overall Study|Do not have a post-dose tumour assessment|2|||
147538176|NCT03345485|532123927|FG008|Overall Study|Do not have a post-dose tumour assessment|0|||
147538177|NCT03345485|532123928|FG009|Overall Study|Do not have a post-dose tumour assessment|0|||
147538178|NCT03345485|532123929|FG010|Overall Study|Do not have a post-dose tumour assessment|2|||
147538179|NCT03345485|532123930|FG011|Overall Study|Do not have a post-dose tumour assessment|3|||
147538180|NCT03345485|532123931|FG012|Overall Study|Do not have a post-dose tumour assessment|3|||
147538181|NCT01610284|532123932|FG000|Randomization Phase|Adverse Event|1|||
147538182|NCT01610284|532123933|FG001|Randomization Phase|Adverse Event|0|||
147538183|NCT01610284|532123932|FG000|Randomization Phase|Physician Decision|1|||
147538184|NCT01610284|532123933|FG001|Randomization Phase|Physician Decision|1|||
147538185|NCT01610284|532123932|FG000|Randomization Phase|Death|0|||
147538186|NCT01610284|532123933|FG001|Randomization Phase|Death|1|||
147538187|NCT01610284|532123932|FG000|Treatment Phase|Adverse Event|80|||
147538188|NCT01610284|532123933|FG001|Treatment Phase|Adverse Event|12|||
147538189|NCT01610284|532123932|FG000|Treatment Phase|Lost to Follow-up|1|||
147538190|NCT01610284|532123933|FG001|Treatment Phase|Lost to Follow-up|0|||
147538191|NCT01610284|532123932|FG000|Treatment Phase|Non-compliance with Study Treatment|8|||
147538192|NCT01610284|532123933|FG001|Treatment Phase|Non-compliance with Study Treatment|1|||
147538193|NCT01610284|532123932|FG000|Treatment Phase|Physician Decision|27|||
147538194|NCT01610284|532123933|FG001|Treatment Phase|Physician Decision|24|||
147538195|NCT01610284|532123932|FG000|Treatment Phase|Progressive Disease|377|||
147538196|NCT01610284|532123933|FG001|Treatment Phase|Progressive Disease|486|||
147538197|NCT01610284|532123932|FG000|Treatment Phase|Protocol Deviation|2|||
147538198|NCT01610284|532123933|FG001|Treatment Phase|Protocol Deviation|3|||
147538199|NCT01610284|532123932|FG000|Treatment Phase|Study terminated by Sponsor|18|||
147202663|NCT00684021|530912018|FG001|Overall Study|MRI Contraindicated|1|||
147202664|NCT00684021|530912019|FG002|Overall Study|MRI Contraindicated|1|||
147202665|NCT00684021|530912020|FG003|Overall Study|MRI Contraindicated|0|||
147202666|NCT00684021|530912017|FG000|Overall Study|MRI not performed|0|||
147202667|NCT00684021|530912018|FG001|Overall Study|MRI not performed|1|||
147202668|NCT00684021|530912019|FG002|Overall Study|MRI not performed|1|||
147202669|NCT00684021|530912020|FG003|Overall Study|MRI not performed|2|||
147202670|NCT00684021|530912017|FG000|Overall Study|Death|1|||
147202671|NCT00684021|530912018|FG001|Overall Study|Death|0|||
147202672|NCT00684021|530912019|FG002|Overall Study|Death|0|||
147202673|NCT00684021|530912020|FG003|Overall Study|Death|0|||
147202674|NCT00891904|530912021|FG000|Overall Study|Death|1|||
147202675|NCT00891904|530912021|FG000|Overall Study|Adverse Event|1|||
147202676|NCT02976038|530912022|FG000|Overall Study|Physician Decision|22|||
147202677|NCT02976038|530912022|FG000|Overall Study|Withdrawal by Subject|3|||
147202678|NCT02976038|530912022|FG000|Overall Study|Lost to Follow-up|2|||
147202679|NCT02976038|530912022|FG000|Overall Study|Adverse Event|1|||
147202680|NCT01046396|530912023|FG000|Overall Study|Withdrawal by Subject|5|||
147202681|NCT00724698|530912024|FG000|Overall Study|Adverse Event|9|||
147202682|NCT00724698|530912024|FG000|Overall Study|Failure of Therapy|4|||
147538200|NCT01610284|532123933|FG001|Treatment Phase|Study terminated by Sponsor|15|||
147538201|NCT01610284|532123932|FG000|Treatment Phase|Subject/Guardian Decision|55|||
147538202|NCT01610284|532123933|FG001|Treatment Phase|Subject/Guardian Decision|23|||
147538203|NCT01610284|532123932|FG000|Treatment Phase|Death|6|||
147202683|NCT00724698|530912024|FG000|Overall Study|Poor Compliance|16|||
147306809|NCT01852058|531290778|FG005|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
147202684|NCT00724698|530912024|FG000|Overall Study|Lost to Follow-up|36|||
147202685|NCT00724698|530912024|FG000|Overall Study|No Info|25|||
147202686|NCT02177032|530912025|FG000|Overall Study|ADMINISTRATIVE REASON|2|||
147202687|NCT02177032|530912026|FG001|Overall Study|ADMINISTRATIVE REASON|0|||
147202688|NCT02177032|530912027|FG002|Overall Study|ADMINISTRATIVE REASON|1|||
147538204|NCT01610284|532123933|FG001|Treatment Phase|Death|5|||
147538205|NCT01610284|532123932|FG000|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|2|||
147538206|NCT01610284|532123933|FG001|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
147538207|NCT01610284|532123932|FG000|Post-Treatment Efficacy Follow-Up Phase|Physician Decision|10|||
147538208|NCT01610284|532123933|FG001|Post-Treatment Efficacy Follow-Up Phase|Physician Decision|3|||
147538209|NCT01610284|532123932|FG000|Post-Treatment Efficacy Follow-Up Phase|Progressive Disease|24|||
147538210|NCT01610284|532123933|FG001|Post-Treatment Efficacy Follow-Up Phase|Progressive Disease|8|||
147538211|NCT01610284|532123932|FG000|Post-Treatment Efficacy Follow-Up Phase|Subject/Guardian Decision|11|||
147538212|NCT01610284|532123933|FG001|Post-Treatment Efficacy Follow-Up Phase|Subject/Guardian Decision|1|||
147538213|NCT01610284|532123932|FG000|Post-Treatment Efficacy Follow-Up Phase|Death|4|||
147538214|NCT01610284|532123933|FG001|Post-Treatment Efficacy Follow-Up Phase|Death|4|||
147538215|NCT01610284|532123932|FG000|Post-Treatment Efficacy Follow-Up Phase|New therapy for study indication|38|||
147538216|NCT01610284|532123933|FG001|Post-Treatment Efficacy Follow-Up Phase|New therapy for study indication|13|||
147538217|NCT01125358|532123937|FG000|Overall Study|Adverse Event|3|||
147538218|NCT01125358|532123938|FG001|Overall Study|Adverse Event|0|||
147538219|NCT01125358|532123939|FG002|Overall Study|Adverse Event|0|||
147538220|NCT01125358|532123940|FG003|Overall Study|Adverse Event|2|||
147202689|NCT02177032|530912028|FG003|Overall Study|ADMINISTRATIVE REASON|0|||
147202690|NCT02177032|530912025|FG000|Overall Study|Lost to Follow-up|0|||
147202691|NCT02177032|530912026|FG001|Overall Study|Lost to Follow-up|2|||
147202692|NCT02177032|530912027|FG002|Overall Study|Lost to Follow-up|0|||
147202693|NCT02177032|530912028|FG003|Overall Study|Lost to Follow-up|0|||
147202694|NCT02177032|530912025|FG000|Overall Study|OTHER|2|||
147202695|NCT02177032|530912026|FG001|Overall Study|OTHER|0|||
147202696|NCT02177032|530912027|FG002|Overall Study|OTHER|1|||
147202697|NCT02177032|530912028|FG003|Overall Study|OTHER|0|||
147202698|NCT02177032|530912025|FG000|Overall Study|Withdrawal by Subject|1|||
147202699|NCT02177032|530912026|FG001|Overall Study|Withdrawal by Subject|0|||
147538221|NCT01125358|532123937|FG000|Overall Study|Perceived Lack of Efficacy|6|||
147538222|NCT01125358|532123938|FG001|Overall Study|Perceived Lack of Efficacy|3|||
147538223|NCT01125358|532123939|FG002|Overall Study|Perceived Lack of Efficacy|7|||
147538224|NCT01125358|532123940|FG003|Overall Study|Perceived Lack of Efficacy|4|||
147202700|NCT02177032|530912027|FG002|Overall Study|Withdrawal by Subject|1|||
147202701|NCT02177032|530912028|FG003|Overall Study|Withdrawal by Subject|0|||
147202702|NCT02556177|530912030|FG000|Overall Study|Subjects did not complete all 4 visits|283|||
147202703|NCT02556177|530912031|FG001|Overall Study|Subjects did not complete all 4 visits|61|||
147437511|NCT03627767|531768639|FG001|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|0|||
147437512|NCT03627767|531768640|FG002|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|0|||
147437513|NCT03627767|531768641|FG003|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|0|||
147437514|NCT03627767|531768642|FG004|Open-label (OL) Run-in Period (12 Weeks)|Medication Error Without Associated Adverse Event|0|||
147437515|NCT03627767|531768638|FG000|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|2|||
147437516|NCT03627767|531768639|FG001|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|0|||
147437517|NCT03627767|531768640|FG002|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|0|||
147437518|NCT03627767|531768641|FG003|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|0|||
147437519|NCT03627767|531768642|FG004|Open-label (OL) Run-in Period (12 Weeks)|Withdrawal By Parent/Guardian|0|||
147437520|NCT03627767|531768638|FG000|Open-label (OL) Run-in Period (12 Weeks)|Other|4|||
147437521|NCT03627767|531768639|FG001|Open-label (OL) Run-in Period (12 Weeks)|Other|0|||
147437522|NCT03627767|531768640|FG002|Open-label (OL) Run-in Period (12 Weeks)|Other|0|||
147437523|NCT03627767|531768641|FG003|Open-label (OL) Run-in Period (12 Weeks)|Other|0|||
147437524|NCT03627767|531768642|FG004|Open-label (OL) Run-in Period (12 Weeks)|Other|0|||
147437525|NCT03627767|531768638|FG000|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|2|||
147437526|NCT03627767|531768639|FG001|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|0|||
147437527|NCT03627767|531768640|FG002|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|0|||
147437528|NCT03627767|531768641|FG003|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|0|||
147437529|NCT03627767|531768642|FG004|Open-label (OL) Run-in Period (12 Weeks)|Randomized but not treated|0|||
147437530|NCT03627767|531768638|FG000|Double-blind Treatment Period (40 Weeks)|Adverse Event|0|||
147437531|NCT03627767|531768639|FG001|Double-blind Treatment Period (40 Weeks)|Adverse Event|6|||
147437532|NCT03627767|531768640|FG002|Double-blind Treatment Period (40 Weeks)|Adverse Event|7|||
147437533|NCT03627767|531768641|FG003|Double-blind Treatment Period (40 Weeks)|Adverse Event|19|||
147437534|NCT03627767|531768642|FG004|Double-blind Treatment Period (40 Weeks)|Adverse Event|0|||
147437535|NCT03627767|531768638|FG000|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|0|||
147437536|NCT03627767|531768639|FG001|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|0|||
147538225|NCT01125358|532123937|FG000|Overall Study|Protocol Violation|1|||
147538226|NCT01125358|532123938|FG001|Overall Study|Protocol Violation|0|||
147202704|NCT00658359|530912032|FG000|Overall Study|Death|3|||
147202705|NCT00658359|530912033|FG001|Overall Study|Death|1|||
147202706|NCT00658359|530912034|FG002|Overall Study|Death|2|||
147202707|NCT00658359|530912032|FG000|Overall Study|Adverse Event|13|||
147538227|NCT01125358|532123939|FG002|Overall Study|Protocol Violation|0|||
147538228|NCT01125358|532123940|FG003|Overall Study|Protocol Violation|0|||
147538229|NCT01125358|532123937|FG000|Overall Study|Sponsor Decision|0|||
147538230|NCT01125358|532123938|FG001|Overall Study|Sponsor Decision|0|||
147538231|NCT01125358|532123939|FG002|Overall Study|Sponsor Decision|1|||
147538232|NCT01125358|532123940|FG003|Overall Study|Sponsor Decision|1|||
147538233|NCT01125358|532123937|FG000|Overall Study|Withdrawal by Subject|2|||
147538234|NCT01125358|532123938|FG001|Overall Study|Withdrawal by Subject|1|||
147538235|NCT01125358|532123939|FG002|Overall Study|Withdrawal by Subject|1|||
147538236|NCT01125358|532123940|FG003|Overall Study|Withdrawal by Subject|1|||
147538237|NCT01060007|532123941|FG000|Overall Study|Withdrawal by Subject|1|||
147538238|NCT01060007|532123941|FG000|Overall Study|Inevaluable for response at surgery|3|||
147538239|NCT05168657|532123942|FG000|Overall Study|Adverse Event|0|||
147538240|NCT05168657|532123943|FG001|Overall Study|Adverse Event|0|||
147538241|NCT05168657|532123944|FG002|Overall Study|Adverse Event|1|||
147538242|NCT05168657|532123945|FG003|Overall Study|Adverse Event|0|||
147538243|NCT05168657|532123946|FG004|Overall Study|Adverse Event|0|||
147538244|NCT05168657|532123947|FG005|Overall Study|Adverse Event|0|||
147538245|NCT05168657|532123948|FG006|Overall Study|Adverse Event|0|||
147538246|NCT05168657|532123949|FG007|Overall Study|Adverse Event|0|||
147538247|NCT00358670|532123950|FG000|Overall Study|Adverse Event|26|||
147538248|NCT00358670|532123951|FG001|Overall Study|Adverse Event|29|||
147538249|NCT00358670|532123950|FG000|Overall Study|Lack of Efficacy|20|||
147538250|NCT00358670|532123951|FG001|Overall Study|Lack of Efficacy|23|||
147538251|NCT00358670|532123950|FG000|Overall Study|Protocol Violation|6|||
147538252|NCT00358670|532123951|FG001|Overall Study|Protocol Violation|9|||
147538253|NCT00358670|532123950|FG000|Overall Study|Lost to Follow-up|4|||
147538254|NCT00358670|532123951|FG001|Overall Study|Lost to Follow-up|5|||
147538255|NCT00358670|532123950|FG000|Overall Study|Withdrawal by Subject|13|||
147538256|NCT00358670|532123951|FG001|Overall Study|Withdrawal by Subject|24|||
147538257|NCT00358670|532123950|FG000|Overall Study|Protocol Defined Clinical Event|0|||
147538258|NCT00358670|532123951|FG001|Overall Study|Protocol Defined Clinical Event|1|||
147538259|NCT00358670|532123950|FG000|Overall Study|Did Not Meet Protocol Eligibility|0|||
147538260|NCT00358670|532123951|FG001|Overall Study|Did Not Meet Protocol Eligibility|3|||
147538261|NCT00358670|532123950|FG000|Overall Study|Administrative|153|||
147538262|NCT00358670|532123951|FG001|Overall Study|Administrative|125|||
147538263|NCT00903409|532123954|FG000|Overall Study|Adverse Event|11|||
147538264|NCT00903409|532123955|FG001|Overall Study|Adverse Event|9|||
147538265|NCT00903409|532123954|FG000|Overall Study|Non-compliance with Protocol|1|||
147538266|NCT00903409|532123955|FG001|Overall Study|Non-compliance with Protocol|1|||
147538267|NCT00903409|532123954|FG000|Overall Study|Laboratory Abnormality|2|||
147538268|NCT00903409|532123955|FG001|Overall Study|Laboratory Abnormality|0|||
147538269|NCT00903409|532123954|FG000|Overall Study|Withdrawal by Subject|8|||
147538270|NCT00903409|532123955|FG001|Overall Study|Withdrawal by Subject|8|||
147538271|NCT00903409|532123954|FG000|Overall Study|Other|2|||
147538272|NCT00903409|532123955|FG001|Overall Study|Other|3|||
147538273|NCT00903409|532123954|FG000|Overall Study|Lost to Follow-up|2|||
147538274|NCT00903409|532123955|FG001|Overall Study|Lost to Follow-up|6|||
147538275|NCT01977482|532123957|FG000|Overall Study|Adverse Event|0|||
147538276|NCT01977482|532123958|FG001|Overall Study|Adverse Event|1|||
147538277|NCT01977482|532123959|FG002|Overall Study|Adverse Event|1|||
147538278|NCT01977482|532123960|FG003|Overall Study|Adverse Event|0|||
147538279|NCT01977482|532123961|FG004|Overall Study|Adverse Event|2|||
147538280|NCT01977482|532123962|FG005|Overall Study|Adverse Event|0|||
147538281|NCT01977482|532123957|FG000|Overall Study|Lost to Follow-up|1|||
147538282|NCT01977482|532123958|FG001|Overall Study|Lost to Follow-up|0|||
147538283|NCT01977482|532123959|FG002|Overall Study|Lost to Follow-up|0|||
147538284|NCT01977482|532123960|FG003|Overall Study|Lost to Follow-up|0|||
147538285|NCT01977482|532123961|FG004|Overall Study|Lost to Follow-up|0|||
147538286|NCT01977482|532123962|FG005|Overall Study|Lost to Follow-up|0|||
147538287|NCT01977482|532123957|FG000|Overall Study|Physician Decision|0|||
147538288|NCT01977482|532123958|FG001|Overall Study|Physician Decision|1|||
147538289|NCT01977482|532123959|FG002|Overall Study|Physician Decision|0|||
147538290|NCT01977482|532123960|FG003|Overall Study|Physician Decision|0|||
147538291|NCT01977482|532123961|FG004|Overall Study|Physician Decision|0|||
147538292|NCT01977482|532123962|FG005|Overall Study|Physician Decision|0|||
147538293|NCT01977482|532123957|FG000|Overall Study|Protocol Violation|0|||
147538294|NCT01977482|532123958|FG001|Overall Study|Protocol Violation|0|||
147538295|NCT01977482|532123959|FG002|Overall Study|Protocol Violation|1|||
147538296|NCT01977482|532123960|FG003|Overall Study|Protocol Violation|0|||
147538297|NCT01977482|532123961|FG004|Overall Study|Protocol Violation|0|||
147538298|NCT01977482|532123962|FG005|Overall Study|Protocol Violation|0|||
147538299|NCT01977482|532123957|FG000|Overall Study|Other-Protocol-defined Stopping Criteria|0|||
147538300|NCT01977482|532123958|FG001|Overall Study|Other-Protocol-defined Stopping Criteria|3|||
147538301|NCT01977482|532123959|FG002|Overall Study|Other-Protocol-defined Stopping Criteria|2|||
147538302|NCT01977482|532123960|FG003|Overall Study|Other-Protocol-defined Stopping Criteria|1|||
147538303|NCT01977482|532123961|FG004|Overall Study|Other-Protocol-defined Stopping Criteria|0|||
147538304|NCT01977482|532123962|FG005|Overall Study|Other-Protocol-defined Stopping Criteria|0|||
147538305|NCT01977482|532123957|FG000|Overall Study|Withdrawal by Subject|2|||
147538306|NCT01977482|532123958|FG001|Overall Study|Withdrawal by Subject|4|||
147538307|NCT01977482|532123959|FG002|Overall Study|Withdrawal by Subject|1|||
147538308|NCT01977482|532123960|FG003|Overall Study|Withdrawal by Subject|3|||
147538309|NCT01977482|532123961|FG004|Overall Study|Withdrawal by Subject|1|||
147538310|NCT01977482|532123962|FG005|Overall Study|Withdrawal by Subject|5|||
147538311|NCT00209560|532123963|FG000|Overall Study|Lack of Efficacy|1|||
147538312|NCT00209560|532123964|FG001|Overall Study|Lack of Efficacy|0|||
147538313|NCT01525407|532123969|FG000|Overall Study|Change in recipient treatment plan|2|||
147538314|NCT01525407|532123970|FG001|Overall Study|Change in recipient treatment plan|2|||
147538315|NCT01525407|532123969|FG000|Overall Study|Withdrawal by Subject|0|||
147538316|NCT01525407|532123970|FG001|Overall Study|Withdrawal by Subject|1|||
147538317|NCT01525407|532123969|FG000|Overall Study|Transplant was delayed|0|||
147538318|NCT01525407|532123970|FG001|Overall Study|Transplant was delayed|1|||
147538319|NCT01525407|532123969|FG000|Overall Study|Delay in Transplant|1|||
147538320|NCT01525407|532123970|FG001|Overall Study|Delay in Transplant|0|||
147538321|NCT01721369|532123971|FG000|Overall Study|Not initial etiological diagnosis|12|||
147538322|NCT03256526|532125338|FG000|Overall Study|Adverse Event|1|||
147538323|NCT03256526|532125339|FG001|Overall Study|Adverse Event|0|||
147538324|NCT03256526|532125340|FG002|Overall Study|Adverse Event|1|||
147538325|NCT03256526|532125338|FG000|Overall Study|Lost to Follow-up|1|||
147538326|NCT03256526|532125339|FG001|Overall Study|Lost to Follow-up|0|||
147538327|NCT03256526|532125340|FG002|Overall Study|Lost to Follow-up|2|||
147538328|NCT01607398|532125341|FG000|Overall Study|Adverse Event|0|||
147538329|NCT01607398|532125342|FG001|Overall Study|Adverse Event|2|||
147538330|NCT01607398|532125341|FG000|Overall Study|Severe COPD|2|||
147538331|NCT01607398|532125342|FG001|Overall Study|Severe COPD|0|||
147538332|NCT03443973|532125346|FG000|Double-blind Treatment Period|Adverse Event|5|||
147538333|NCT03443973|532125347|FG001|Double-blind Treatment Period|Adverse Event|19|||
147538334|NCT03443973|532125348|FG002|Double-blind Treatment Period|Adverse Event|0|||
147538335|NCT03443973|532125349|FG003|Double-blind Treatment Period|Adverse Event|0|||
147538336|NCT03443973|532125346|FG000|Double-blind Treatment Period|Death|5|||
147538337|NCT03443973|532125347|FG001|Double-blind Treatment Period|Death|7|||
147538338|NCT03443973|532125348|FG002|Double-blind Treatment Period|Death|0|||
147538339|NCT03443973|532125349|FG003|Double-blind Treatment Period|Death|0|||
147538340|NCT03443973|532125346|FG000|Double-blind Treatment Period|Lack of Efficacy|1|||
147538341|NCT03443973|532125347|FG001|Double-blind Treatment Period|Lack of Efficacy|1|||
147538342|NCT03443973|532125348|FG002|Double-blind Treatment Period|Lack of Efficacy|0|||
147538343|NCT03443973|532125349|FG003|Double-blind Treatment Period|Lack of Efficacy|0|||
147538344|NCT03443973|532125346|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
147538345|NCT03443973|532125347|FG001|Double-blind Treatment Period|Lost to Follow-up|1|||
147538346|NCT03443973|532125348|FG002|Double-blind Treatment Period|Lost to Follow-up|0|||
147538347|NCT03443973|532125349|FG003|Double-blind Treatment Period|Lost to Follow-up|0|||
147538348|NCT03443973|532125346|FG000|Double-blind Treatment Period|Reason Not Specified|9|||
147538349|NCT03443973|532125347|FG001|Double-blind Treatment Period|Reason Not Specified|11|||
147538350|NCT03443973|532125348|FG002|Double-blind Treatment Period|Reason Not Specified|0|||
147538351|NCT03443973|532125349|FG003|Double-blind Treatment Period|Reason Not Specified|0|||
147538352|NCT03443973|532125346|FG000|Double-blind Treatment Period|Physician Decision|5|||
147538353|NCT03443973|532125347|FG001|Double-blind Treatment Period|Physician Decision|6|||
147538354|NCT03443973|532125348|FG002|Double-blind Treatment Period|Physician Decision|0|||
147538355|NCT03443973|532125349|FG003|Double-blind Treatment Period|Physician Decision|0|||
147538356|NCT03443973|532125346|FG000|Double-blind Treatment Period|Protocol Deviation|1|||
147538357|NCT03443973|532125347|FG001|Double-blind Treatment Period|Protocol Deviation|2|||
147538358|NCT03443973|532125348|FG002|Double-blind Treatment Period|Protocol Deviation|0|||
147538359|NCT03443973|532125349|FG003|Double-blind Treatment Period|Protocol Deviation|0|||
147538360|NCT03443973|532125346|FG000|Double-blind Treatment Period|Withdrawal by Subject|54|||
147538361|NCT03443973|532125347|FG001|Double-blind Treatment Period|Withdrawal by Subject|79|||
147538362|NCT03443973|532125348|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
147538363|NCT03443973|532125349|FG003|Double-blind Treatment Period|Withdrawal by Subject|0|||
147538364|NCT03443973|532125346|FG000|Open-label Extension Period|Reason Not Specified|0|||
147538365|NCT03443973|532125347|FG001|Open-label Extension Period|Reason Not Specified|0|||
147538366|NCT03443973|532125348|FG002|Open-label Extension Period|Reason Not Specified|3|||
147538367|NCT03443973|532125349|FG003|Open-label Extension Period|Reason Not Specified|0|||
147538368|NCT03443973|532125346|FG000|Open-label Extension Period|Withdrawal by Subject|0|||
147538369|NCT03443973|532125347|FG001|Open-label Extension Period|Withdrawal by Subject|0|||
147538370|NCT03443973|532125348|FG002|Open-label Extension Period|Withdrawal by Subject|2|||
147538371|NCT03443973|532125349|FG003|Open-label Extension Period|Withdrawal by Subject|1|||
147538372|NCT00398632|532125352|FG000|Overall Study|Withdrawal by Subject|1|||
147538373|NCT00398632|532125352|FG000|Overall Study|Lack of Efficacy|1|||
147538374|NCT00267020|532125353|FG000|Overall Study|Adverse Event|22|||
147538375|NCT00267020|532125354|FG001|Overall Study|Adverse Event|5|||
147538376|NCT00267020|532125353|FG000|Overall Study|Death|2|||
147202708|NCT00658359|530912033|FG001|Overall Study|Adverse Event|6|||
147202709|NCT00658359|530912034|FG002|Overall Study|Adverse Event|9|||
147202710|NCT00658359|530912032|FG000|Overall Study|Protocol Violation|1|||
147202711|NCT00658359|530912033|FG001|Overall Study|Protocol Violation|0|||
147202712|NCT00658359|530912034|FG002|Overall Study|Protocol Violation|0|||
147202713|NCT00658359|530912032|FG000|Overall Study|Includes protocol Amendments 3 and 4|2|||
147202714|NCT00658359|530912033|FG001|Overall Study|Includes protocol Amendments 3 and 4|31|||
147202715|NCT00658359|530912034|FG002|Overall Study|Includes protocol Amendments 3 and 4|29|||
147202716|NCT00658359|530912032|FG000|Overall Study|Withdrawal by Subject|7|||
147202717|NCT00658359|530912033|FG001|Overall Study|Withdrawal by Subject|4|||
147202718|NCT00658359|530912034|FG002|Overall Study|Withdrawal by Subject|2|||
147202719|NCT00658359|530912032|FG000|Overall Study|Lost to Follow-up|2|||
147202720|NCT00658359|530912033|FG001|Overall Study|Lost to Follow-up|2|||
147202721|NCT00658359|530912034|FG002|Overall Study|Lost to Follow-up|4|||
147202722|NCT00658359|530912032|FG000|Overall Study|Lack of Efficacy|0|||
147202723|NCT00658359|530912033|FG001|Overall Study|Lack of Efficacy|1|||
147202724|NCT00658359|530912034|FG002|Overall Study|Lack of Efficacy|0|||
147202725|NCT00734539|530912035|FG000|Main Study|Death|33|||
147202726|NCT00734539|530912036|FG001|Main Study|Death|32|||
147202727|NCT00734539|530912035|FG000|Main Study|Physician Decision|2|||
147202728|NCT00734539|530912036|FG001|Main Study|Physician Decision|0|||
147202729|NCT00734539|530912035|FG000|Main Study|Withdrawal by Subject|1|||
147202730|NCT00734539|530912036|FG001|Main Study|Withdrawal by Subject|3|||
147202731|NCT00734539|530912035|FG000|Main Study|Enrolled in error; ineligible|1|||
147202732|NCT00734539|530912036|FG001|Main Study|Enrolled in error; ineligible|0|||
147202733|NCT02504151|530912039|FG000|First Intervention (4 Weeks)|Physician Decision|1|||
147202734|NCT02504151|530912040|FG001|First Intervention (4 Weeks)|Physician Decision|1|||
147202735|NCT02504151|530912039|FG000|Washout (2 Weeks)|Lost to Follow-up|1|||
147202736|NCT02504151|530912040|FG001|Washout (2 Weeks)|Lost to Follow-up|0|||
147202737|NCT02504151|530912039|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
147202738|NCT02504151|530912040|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
147202739|NCT02504151|530912039|FG000|Second Intervention (4 Weeks)|Physician Decision|2|||
147202740|NCT02504151|530912040|FG001|Second Intervention (4 Weeks)|Physician Decision|1|||
147202741|NCT00705016|530912041|FG000|Overall Study|Adverse Event|6|||
147202742|NCT00705016|530912042|FG001|Overall Study|Adverse Event|11|||
147202743|NCT00705016|530912043|FG002|Overall Study|Adverse Event|10|||
147202744|NCT00705016|530912041|FG000|Overall Study|Death|5|||
147202745|NCT00705016|530912042|FG001|Overall Study|Death|7|||
147437537|NCT03627767|531768640|FG002|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|2|||
147437538|NCT03627767|531768641|FG003|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|3|||
147437539|NCT03627767|531768642|FG004|Double-blind Treatment Period (40 Weeks)|Lost to Follow-up|0|||
147437540|NCT03627767|531768638|FG000|Double-blind Treatment Period (40 Weeks)|Protocol Violation|0|||
147437541|NCT03627767|531768639|FG001|Double-blind Treatment Period (40 Weeks)|Protocol Violation|1|||
147437542|NCT03627767|531768640|FG002|Double-blind Treatment Period (40 Weeks)|Protocol Violation|5|||
147437543|NCT03627767|531768641|FG003|Double-blind Treatment Period (40 Weeks)|Protocol Violation|2|||
147437544|NCT03627767|531768642|FG004|Double-blind Treatment Period (40 Weeks)|Protocol Violation|0|||
147437545|NCT03627767|531768638|FG000|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|0|||
147437546|NCT03627767|531768639|FG001|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|9|||
147437547|NCT03627767|531768640|FG002|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|6|||
147437548|NCT03627767|531768641|FG003|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|10|||
147437549|NCT03627767|531768642|FG004|Double-blind Treatment Period (40 Weeks)|Withdrawal by Subject|0|||
147437550|NCT03627767|531768638|FG000|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|0|||
147437551|NCT03627767|531768639|FG001|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|0|||
147437552|NCT03627767|531768640|FG002|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|1|||
147437553|NCT03627767|531768641|FG003|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|0|||
147437554|NCT03627767|531768642|FG004|Double-blind Treatment Period (40 Weeks)|Withdrawal By Parent/Guardian|0|||
147437555|NCT03627767|531768638|FG000|Double-blind Treatment Period (40 Weeks)|Other|0|||
147437556|NCT03627767|531768639|FG001|Double-blind Treatment Period (40 Weeks)|Other|0|||
147437557|NCT03627767|531768640|FG002|Double-blind Treatment Period (40 Weeks)|Other|1|||
147437558|NCT03627767|531768641|FG003|Double-blind Treatment Period (40 Weeks)|Other|1|||
147437559|NCT03627767|531768642|FG004|Double-blind Treatment Period (40 Weeks)|Other|0|||
147437560|NCT03627767|531768638|FG000|Open-label Rescue Period (12 Weeks)|Adverse Event|0|||
147437561|NCT03627767|531768639|FG001|Open-label Rescue Period (12 Weeks)|Adverse Event|0|||
147437562|NCT03627767|531768640|FG002|Open-label Rescue Period (12 Weeks)|Adverse Event|0|||
147437563|NCT03627767|531768641|FG003|Open-label Rescue Period (12 Weeks)|Adverse Event|0|||
147202746|NCT00705016|530912043|FG002|Overall Study|Death|5|||
147202747|NCT00705016|530912041|FG000|Overall Study|Protocol Violation|0|||
147202748|NCT00705016|530912042|FG001|Overall Study|Protocol Violation|1|||
147202749|NCT00705016|530912043|FG002|Overall Study|Protocol Violation|1|||
147202750|NCT00705016|530912041|FG000|Overall Study|Withdrawal by Subject|4|||
147202751|NCT00705016|530912042|FG001|Overall Study|Withdrawal by Subject|3|||
147538377|NCT00267020|532125354|FG001|Overall Study|Death|1|||
147538378|NCT00267020|532125353|FG000|Overall Study|Withdrawal by Subject|17|||
147538379|NCT00267020|532125354|FG001|Overall Study|Withdrawal by Subject|7|||
147538380|NCT00267020|532125353|FG000|Overall Study|Physician Decision|3|||
147538381|NCT00267020|532125354|FG001|Overall Study|Physician Decision|2|||
147538382|NCT00267020|532125353|FG000|Overall Study|Disease Progression|39|||
147538383|NCT00267020|532125354|FG001|Overall Study|Disease Progression|25|||
147538384|NCT00267020|532125353|FG000|Overall Study|Unrelated Complication|1|||
147538385|NCT00267020|532125354|FG001|Overall Study|Unrelated Complication|1|||
147538386|NCT00267020|532125353|FG000|Overall Study|Sponsor Request|1|||
147538387|NCT00267020|532125354|FG001|Overall Study|Sponsor Request|0|||
147538388|NCT00267020|532125353|FG000|Overall Study|Other|1|||
147538389|NCT00267020|532125354|FG001|Overall Study|Other|2|||
147538390|NCT00640614|532125355|FG000|Overall Study|Lost to Follow-up|1|||
147538391|NCT00640614|532125356|FG001|Overall Study|Lost to Follow-up|0|||
147538392|NCT02209454|532125359|FG000|Second Period|Adverse Event|1|||
147538393|NCT02209454|532125360|FG001|Second Period|Adverse Event|0|||
147538394|NCT02545868|532125361|FG000|Overall Study|Lack of Efficacy|1|||
147538395|NCT02545868|532125362|FG001|Overall Study|Lack of Efficacy|1|||
147538396|NCT02545868|532125363|FG002|Overall Study|Lack of Efficacy|0|||
147538397|NCT02545868|532125361|FG000|Overall Study|Lost to Follow-up|1|||
147538398|NCT02545868|532125362|FG001|Overall Study|Lost to Follow-up|5|||
147538399|NCT02545868|532125363|FG002|Overall Study|Lost to Follow-up|1|||
147538400|NCT02545868|532125361|FG000|Overall Study|Non-compliance|1|||
147538401|NCT02545868|532125362|FG001|Overall Study|Non-compliance|1|||
147538402|NCT02545868|532125363|FG002|Overall Study|Non-compliance|1|||
147538403|NCT02545868|532125361|FG000|Overall Study|Treatment change|21|||
147538404|NCT02545868|532125362|FG001|Overall Study|Treatment change|19|||
147538405|NCT02545868|532125363|FG002|Overall Study|Treatment change|22|||
147538406|NCT02545868|532125361|FG000|Overall Study|Physician Decision|1|||
147538407|NCT02545868|532125362|FG001|Overall Study|Physician Decision|1|||
147538408|NCT02545868|532125363|FG002|Overall Study|Physician Decision|1|||
147538409|NCT02545868|532125361|FG000|Overall Study|Withdrawal by Subject|6|||
147538410|NCT02545868|532125362|FG001|Overall Study|Withdrawal by Subject|7|||
147538411|NCT02545868|532125363|FG002|Overall Study|Withdrawal by Subject|9|||
147538412|NCT01777191|532125364|FG000|Treatment Period (Per) (Week 0-Week 12)|Adverse Event|2|||
147538413|NCT01777191|532125365|FG001|Treatment Period (Per) (Week 0-Week 12)|Adverse Event|1|||
147538414|NCT01777191|532125364|FG000|Treatment Period (Per) (Week 0-Week 12)|Entry Criteria Not Met|1|||
147538415|NCT01777191|532125365|FG001|Treatment Period (Per) (Week 0-Week 12)|Entry Criteria Not Met|1|||
147538416|NCT01777191|532125364|FG000|Treatment Period (Per) (Week 0-Week 12)|Protocol Violation|1|||
147538417|NCT01777191|532125365|FG001|Treatment Period (Per) (Week 0-Week 12)|Protocol Violation|2|||
147538418|NCT01777191|532125364|FG000|Treatment Period (Per) (Week 0-Week 12)|Withdrawal by Subject|0|||
147538419|NCT01777191|532125365|FG001|Treatment Period (Per) (Week 0-Week 12)|Withdrawal by Subject|3|||
147538420|NCT01777191|532125364|FG000|Treatment Period (Per) (Week 0-Week 12)|Lack of Efficacy|1|||
147538421|NCT01777191|532125365|FG001|Treatment Period (Per) (Week 0-Week 12)|Lack of Efficacy|1|||
147538422|NCT01777191|532125364|FG000|Treatment Period (Per) (Week 0-Week 12)|Lost to Follow-up|1|||
147538423|NCT01777191|532125365|FG001|Treatment Period (Per) (Week 0-Week 12)|Lost to Follow-up|0|||
147538424|NCT01777191|532125364|FG000|Safety Extension Per (Week 12-Week 48)|Adverse Event|3|||
147538425|NCT01777191|532125365|FG001|Safety Extension Per (Week 12-Week 48)|Adverse Event|3|||
147538426|NCT01777191|532125364|FG000|Safety Extension Per (Week 12-Week 48)|Death|0|||
147538427|NCT01777191|532125365|FG001|Safety Extension Per (Week 12-Week 48)|Death|1|||
147538428|NCT01777191|532125364|FG000|Safety Extension Per (Week 12-Week 48)|Withdrawal by Subject|4|||
147538429|NCT01777191|532125365|FG001|Safety Extension Per (Week 12-Week 48)|Withdrawal by Subject|4|||
147538430|NCT01777191|532125364|FG000|Safety Extension Per (Week 12-Week 48)|Lack of Efficacy|1|||
147538431|NCT01777191|532125365|FG001|Safety Extension Per (Week 12-Week 48)|Lack of Efficacy|2|||
147538432|NCT01777191|532125364|FG000|Safety Extension Per (Week 12-Week 48)|Lost to Follow-up|1|||
147538433|NCT01777191|532125365|FG001|Safety Extension Per (Week 12-Week 48)|Lost to Follow-up|3|||
147538434|NCT04465916|532125370|FG000|Overall Study|Withdrawal by Subject|0|||
147538435|NCT04465916|532125371|FG001|Overall Study|Withdrawal by Subject|1|||
147538436|NCT01856686|532125372|FG000|Overall Study|Lost to Follow-up|5|||
147538437|NCT01856686|532125373|FG001|Overall Study|Lost to Follow-up|11|||
147538438|NCT00602979|532125374|FG000|Overall Study|Lost to Follow-up|3|||
147538439|NCT00602979|532125375|FG001|Overall Study|Lost to Follow-up|2|||
147538440|NCT00602979|532125376|FG002|Overall Study|Lost to Follow-up|3|||
147538441|NCT00602979|532125377|FG003|Overall Study|Lost to Follow-up|2|||
147538442|NCT00602979|532125378|FG004|Overall Study|Lost to Follow-up|3|||
147538443|NCT00602979|532125374|FG000|Overall Study|Failed Intubation|0|||
147538444|NCT00602979|532125375|FG001|Overall Study|Failed Intubation|1|||
147538445|NCT00602979|532125376|FG002|Overall Study|Failed Intubation|0|||
147538446|NCT00602979|532125377|FG003|Overall Study|Failed Intubation|1|||
147538447|NCT00602979|532125378|FG004|Overall Study|Failed Intubation|0|||
147538448|NCT00468312|532125379|FG000|Overall Study|Adverse Event|2|||
147538449|NCT00468312|532125380|FG001|Overall Study|Adverse Event|1|||
147538450|NCT00468312|532125379|FG000|Overall Study|Lack of Efficacy|0|||
147538451|NCT00468312|532125380|FG001|Overall Study|Lack of Efficacy|1|||
147202752|NCT00705016|530912043|FG002|Overall Study|Withdrawal by Subject|2|||
147202753|NCT00705016|530912041|FG000|Overall Study|Progressive Disease|33|||
147202754|NCT00705016|530912042|FG001|Overall Study|Progressive Disease|29|||
147202755|NCT00705016|530912043|FG002|Overall Study|Progressive Disease|33|||
147202756|NCT00705016|530912041|FG000|Overall Study|Symptomatic Deterioration|3|||
147202757|NCT00705016|530912042|FG001|Overall Study|Symptomatic Deterioration|1|||
147202758|NCT00705016|530912043|FG002|Overall Study|Symptomatic Deterioration|1|||
147202759|NCT00705016|530912041|FG000|Overall Study|Other|9|||
147202760|NCT00705016|530912042|FG001|Overall Study|Other|6|||
147202761|NCT00705016|530912043|FG002|Overall Study|Other|6|||
147202762|NCT01188343|530912044|FG000|Overall Study|Not vaccinated|0|||
147202763|NCT01188343|530912045|FG001|Overall Study|Not vaccinated|2|||
147202764|NCT01188343|530912046|FG002|Overall Study|Not vaccinated|1|||
147202765|NCT01188343|530912044|FG000|Overall Study|Withdrawal by Subject|1|||
147202766|NCT01188343|530912045|FG001|Overall Study|Withdrawal by Subject|24|||
147202767|NCT01188343|530912046|FG002|Overall Study|Withdrawal by Subject|0|||
147202768|NCT00363480|530912047|FG000|Overall Study|Criteria for treatment period not fulfil|1|||
147202769|NCT00363480|530912047|FG000|Overall Study|Adverse Event|4|||
147202770|NCT00363480|530912047|FG000|Overall Study|Lost to Follow-up|5|||
147202771|NCT00363480|530912047|FG000|Overall Study|Withdrawal by Subject|5|||
147202772|NCT00363480|530912047|FG000|Overall Study|Non-compliance of subject|1|||
147202773|NCT00363480|530912047|FG000|Overall Study|Participant discontinued on its own|1|||
147202774|NCT04634253|530912050|FG000|Overall Study|Adverse Event|1|||
147202775|NCT04634253|530912051|FG001|Overall Study|Adverse Event|1|||
147202776|NCT04634253|530912052|FG002|Overall Study|Adverse Event|0|||
147202777|NCT04634253|530912050|FG000|Overall Study|Physician Decision|0|||
147202778|NCT04634253|530912051|FG001|Overall Study|Physician Decision|1|||
147202779|NCT04634253|530912052|FG002|Overall Study|Physician Decision|0|||
147202780|NCT04634253|530912050|FG000|Overall Study|Withdrawal by Subject|1|||
147202781|NCT04634253|530912051|FG001|Overall Study|Withdrawal by Subject|0|||
147202782|NCT04634253|530912052|FG002|Overall Study|Withdrawal by Subject|3|||
147202783|NCT01499355|530912053|FG000|Run-In Period|Study Termination|15|||
147202784|NCT01499355|530912054|FG001|Run-In Period|Study Termination|0|||
147437564|NCT03627767|531768642|FG004|Open-label Rescue Period (12 Weeks)|Adverse Event|9|||
147437565|NCT03627767|531768638|FG000|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|0|||
147437566|NCT03627767|531768639|FG001|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|0|||
147437567|NCT03627767|531768640|FG002|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|0|||
147437568|NCT03627767|531768641|FG003|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|0|||
147437569|NCT03627767|531768642|FG004|Open-label Rescue Period (12 Weeks)|Lost to Follow-up|1|||
147437570|NCT03627767|531768638|FG000|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|0|||
147437571|NCT03627767|531768639|FG001|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|0|||
147437572|NCT03627767|531768640|FG002|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|0|||
147437573|NCT03627767|531768641|FG003|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|0|||
147437574|NCT03627767|531768642|FG004|Open-label Rescue Period (12 Weeks)|Withdrawal by Subject|9|||
147437575|NCT03627767|531768638|FG000|Open-label Rescue Period (12 Weeks)|Other|0|||
147437576|NCT03627767|531768639|FG001|Open-label Rescue Period (12 Weeks)|Other|0|||
147437577|NCT03627767|531768640|FG002|Open-label Rescue Period (12 Weeks)|Other|0|||
147437578|NCT03627767|531768641|FG003|Open-label Rescue Period (12 Weeks)|Other|0|||
147437579|NCT03627767|531768642|FG004|Open-label Rescue Period (12 Weeks)|Other|1|||
147437580|NCT00907257|531768643|FG000|Overall Study|Adverse Event|0|||
147437581|NCT00907257|531768644|FG001|Overall Study|Adverse Event|4|||
147437582|NCT00907257|531768643|FG000|Overall Study|Protocol Violation|1|||
147437583|NCT00907257|531768644|FG001|Overall Study|Protocol Violation|2|||
147437584|NCT00907257|531768643|FG000|Overall Study|Lost to Follow-up|3|||
147437585|NCT00907257|531768644|FG001|Overall Study|Lost to Follow-up|3|||
147437586|NCT00907257|531768643|FG000|Overall Study|Withdrawal by Subject|1|||
147437587|NCT00907257|531768644|FG001|Overall Study|Withdrawal by Subject|2|||
147437588|NCT00907257|531768643|FG000|Overall Study|Per IRB-Subject became vulnerable|1|||
147437589|NCT00907257|531768644|FG001|Overall Study|Per IRB-Subject became vulnerable|0|||
147437590|NCT00907257|531768643|FG000|Overall Study|Moved|1|||
147437591|NCT00907257|531768644|FG001|Overall Study|Moved|0|||
147437592|NCT00907257|531768643|FG000|Overall Study|Personal Reasons|6|||
147437593|NCT00907257|531768644|FG001|Overall Study|Personal Reasons|1|||
147437594|NCT04163900|531768645|FG000|Overall Study|Radiological disease progression|112|||
147437595|NCT04163900|531768646|FG001|Overall Study|Radiological disease progression|127|||
147437596|NCT04163900|531768645|FG000|Overall Study|Study closure|98|||
147437597|NCT04163900|531768646|FG001|Overall Study|Study closure|133|||
147437598|NCT04163900|531768645|FG000|Overall Study|Adverse Event|78|||
147437599|NCT04163900|531768646|FG001|Overall Study|Adverse Event|32|||
147437600|NCT04163900|531768645|FG000|Overall Study|Withdrawal by Subject|37|||
147437601|NCT04163900|531768646|FG001|Overall Study|Withdrawal by Subject|34|||
147437602|NCT04163900|531768645|FG000|Overall Study|Death|29|||
147437603|NCT04163900|531768646|FG001|Overall Study|Death|16|||
147437604|NCT04163900|531768645|FG000|Overall Study|Physician Decision|17|||
147202785|NCT01499355|530912055|FG002|Run-In Period|Study Termination|0|||
147202786|NCT01499355|530912056|FG003|Run-In Period|Study Termination|0|||
147202787|NCT01499355|530912053|FG000|Run-In Period|Other|3|||
147202788|NCT01499355|530912054|FG001|Run-In Period|Other|0|||
147202789|NCT01499355|530912055|FG002|Run-In Period|Other|0|||
147202790|NCT01499355|530912056|FG003|Run-In Period|Other|0|||
147202791|NCT01499355|530912053|FG000|Run-In Period|Death|2|||
147202792|NCT01499355|530912054|FG001|Run-In Period|Death|0|||
147202793|NCT01499355|530912055|FG002|Run-In Period|Death|0|||
147202794|NCT01499355|530912056|FG003|Run-In Period|Death|0|||
147202795|NCT01499355|530912053|FG000|Run-In Period|Investigator Decision|2|||
147202796|NCT01499355|530912054|FG001|Run-In Period|Investigator Decision|0|||
147202797|NCT01499355|530912055|FG002|Run-In Period|Investigator Decision|0|||
147202798|NCT01499355|530912056|FG003|Run-In Period|Investigator Decision|0|||
147202799|NCT01499355|530912053|FG000|Run-In Period|Consent Withdrawn|1|||
147202800|NCT01499355|530912054|FG001|Run-In Period|Consent Withdrawn|0|||
147202801|NCT01499355|530912055|FG002|Run-In Period|Consent Withdrawn|0|||
147202802|NCT01499355|530912056|FG003|Run-In Period|Consent Withdrawn|0|||
147202803|NCT01499355|530912053|FG000|Run-In Period|Adverse Event|8|||
147202804|NCT01499355|530912054|FG001|Run-In Period|Adverse Event|0|||
147202805|NCT01499355|530912055|FG002|Run-In Period|Adverse Event|0|||
147202806|NCT01499355|530912056|FG003|Run-In Period|Adverse Event|0|||
147202807|NCT01499355|530912053|FG000|Double-Blind Period|Adverse Event|0|||
147202808|NCT01499355|530912054|FG001|Double-Blind Period|Adverse Event|2|||
147202809|NCT01499355|530912055|FG002|Double-Blind Period|Adverse Event|3|||
147202810|NCT01499355|530912056|FG003|Double-Blind Period|Adverse Event|2|||
147202811|NCT01499355|530912053|FG000|Double-Blind Period|Study Termination|0|||
147202812|NCT01499355|530912054|FG001|Double-Blind Period|Study Termination|18|||
147202813|NCT01499355|530912055|FG002|Double-Blind Period|Study Termination|16|||
147202814|NCT01499355|530912056|FG003|Double-Blind Period|Study Termination|14|||
147202815|NCT01499355|530912053|FG000|Double-Blind Period|Other|0|||
147202816|NCT01499355|530912054|FG001|Double-Blind Period|Other|1|||
147202817|NCT01499355|530912055|FG002|Double-Blind Period|Other|2|||
147202818|NCT01499355|530912056|FG003|Double-Blind Period|Other|2|||
147202819|NCT01499355|530912053|FG000|Double-Blind Period|Death|0|||
147202820|NCT01499355|530912054|FG001|Double-Blind Period|Death|1|||
147202821|NCT01499355|530912055|FG002|Double-Blind Period|Death|0|||
147202822|NCT01499355|530912056|FG003|Double-Blind Period|Death|0|||
147202823|NCT01499355|530912053|FG000|Double-Blind Period|Investigator Decision|0|||
147202824|NCT01499355|530912054|FG001|Double-Blind Period|Investigator Decision|0|||
147202825|NCT01499355|530912055|FG002|Double-Blind Period|Investigator Decision|3|||
147202826|NCT01499355|530912056|FG003|Double-Blind Period|Investigator Decision|3|||
147202827|NCT01499355|530912053|FG000|Double-Blind Period|Consent Withdrawn|0|||
147202828|NCT01499355|530912054|FG001|Double-Blind Period|Consent Withdrawn|0|||
147202829|NCT01499355|530912055|FG002|Double-Blind Period|Consent Withdrawn|1|||
147202830|NCT01499355|530912056|FG003|Double-Blind Period|Consent Withdrawn|2|||
147202831|NCT01499355|530912053|FG000|Double-Blind Period|Lost to Follow-up|0|||
147202832|NCT01499355|530912054|FG001|Double-Blind Period|Lost to Follow-up|1|||
147202833|NCT01499355|530912055|FG002|Double-Blind Period|Lost to Follow-up|0|||
147202834|NCT01499355|530912056|FG003|Double-Blind Period|Lost to Follow-up|0|||
147202835|NCT01457703|530912059|FG000|Overall Study|Screen Failure|5|||
147202836|NCT01457703|530912060|FG001|Overall Study|Screen Failure|7|||
147202837|NCT01457703|530912059|FG000|Overall Study|Withdrawal by Subject|1|||
147202838|NCT01457703|530912060|FG001|Overall Study|Withdrawal by Subject|4|||
147202839|NCT00432172|530912066|FG000|Overall Study|Physician Decision|0|||
147202840|NCT00432172|530912067|FG001|Overall Study|Physician Decision|0|||
147202841|NCT00432172|530912068|FG002|Overall Study|Physician Decision|2|||
147202842|NCT00432172|530912069|FG003|Overall Study|Physician Decision|0|||
147202843|NCT00432172|530912066|FG000|Overall Study|Adverse Event|4|||
147202844|NCT00432172|530912067|FG001|Overall Study|Adverse Event|2|||
147202845|NCT00432172|530912068|FG002|Overall Study|Adverse Event|4|||
147202846|NCT00432172|530912069|FG003|Overall Study|Adverse Event|3|||
147202847|NCT00432172|530912066|FG000|Overall Study|Disease progression|0|||
147202848|NCT00432172|530912067|FG001|Overall Study|Disease progression|2|||
147202849|NCT00432172|530912068|FG002|Overall Study|Disease progression|5|||
147202850|NCT00432172|530912069|FG003|Overall Study|Disease progression|1|||
147202851|NCT00432172|530912066|FG000|Overall Study|Withdrawal by Subject|0|||
147202852|NCT00432172|530912067|FG001|Overall Study|Withdrawal by Subject|1|||
147202853|NCT00432172|530912068|FG002|Overall Study|Withdrawal by Subject|0|||
147202854|NCT00432172|530912069|FG003|Overall Study|Withdrawal by Subject|2|||
147202855|NCT00432172|530912066|FG000|Overall Study|No treatment received|2|||
147202856|NCT00432172|530912067|FG001|Overall Study|No treatment received|2|||
147202857|NCT00432172|530912068|FG002|Overall Study|No treatment received|0|||
147202858|NCT00432172|530912069|FG003|Overall Study|No treatment received|1|||
147202859|NCT02536963|530912070|FG000|Overall Study|Withdrawal by Subject|18|||
147202860|NCT00515619|530912075|FG000|Overall Study|Adverse Event|34|||
147202861|NCT00515619|530912075|FG000|Overall Study|Lack of Efficacy|92|||
147202862|NCT00515619|530912075|FG000|Overall Study|Withdrawal by Subject|66|||
147202863|NCT00515619|530912075|FG000|Overall Study|Protocol Violation|3|||
147202864|NCT00515619|530912075|FG000|Overall Study|Lost to Follow-up|4|||
147202865|NCT00515619|530912075|FG000|Overall Study|Unsatisfactory compliance|6|||
147202866|NCT00515619|530912075|FG000|Overall Study|Other: Site discontinuing trials|2|||
147538452|NCT00468312|532125379|FG000|Overall Study|Withdrawal by Subject|0|||
147538453|NCT00468312|532125380|FG001|Overall Study|Withdrawal by Subject|1|||
147538454|NCT00468312|532125379|FG000|Overall Study|Protocol Violation|2|||
147538455|NCT00468312|532125380|FG001|Overall Study|Protocol Violation|1|||
147538456|NCT00468312|532125379|FG000|Overall Study|Did not meet protocol eligibility|0|||
147538457|NCT00468312|532125380|FG001|Overall Study|Did not meet protocol eligibility|1|||
147538458|NCT00916617|532125387|FG000|Overall Study|Adverse Event|3|||
147538459|NCT00916617|532125388|FG001|Overall Study|Adverse Event|2|||
147538460|NCT00916617|532125389|FG002|Overall Study|Adverse Event|6|||
147538461|NCT00916617|532125390|FG003|Overall Study|Adverse Event|3|||
147538462|NCT00916617|532125387|FG000|Overall Study|Withdrawal by Subject|3|||
147538463|NCT00916617|532125388|FG001|Overall Study|Withdrawal by Subject|2|||
147538464|NCT00916617|532125389|FG002|Overall Study|Withdrawal by Subject|0|||
147538465|NCT00916617|532125390|FG003|Overall Study|Withdrawal by Subject|1|||
147538466|NCT00916617|532125387|FG000|Overall Study|Caregiver Request|3|||
147538467|NCT00916617|532125388|FG001|Overall Study|Caregiver Request|2|||
147538468|NCT00916617|532125389|FG002|Overall Study|Caregiver Request|1|||
147538469|NCT00916617|532125390|FG003|Overall Study|Caregiver Request|0|||
147538470|NCT00916617|532125387|FG000|Overall Study|Physician Decision|1|||
147538471|NCT00916617|532125388|FG001|Overall Study|Physician Decision|1|||
147538472|NCT00916617|532125389|FG002|Overall Study|Physician Decision|0|||
147538473|NCT00916617|532125390|FG003|Overall Study|Physician Decision|0|||
147538474|NCT00916617|532125387|FG000|Overall Study|Discontinuation of Study by Sponsor|8|||
147538475|NCT00916617|532125388|FG001|Overall Study|Discontinuation of Study by Sponsor|13|||
147538476|NCT00916617|532125389|FG002|Overall Study|Discontinuation of Study by Sponsor|3|||
147538477|NCT00916617|532125390|FG003|Overall Study|Discontinuation of Study by Sponsor|1|||
147538478|NCT00916617|532125387|FG000|Overall Study|Lost to Follow-up|2|||
147538479|NCT00916617|532125388|FG001|Overall Study|Lost to Follow-up|1|||
147538480|NCT00916617|532125389|FG002|Overall Study|Lost to Follow-up|0|||
147538481|NCT00916617|532125390|FG003|Overall Study|Lost to Follow-up|0|||
147202867|NCT00515619|530912075|FG000|Overall Study|Other: Subject cannot attend visits|2|||
147202868|NCT00515619|530912075|FG000|Overall Study|Other: Subject required surgery|1|||
147202869|NCT00515619|530912075|FG000|Overall Study|Other: Subject moved to another country|1|||
147202870|NCT00515619|530912075|FG000|Overall Study|Other: Investigator decision|1|||
147202871|NCT00515619|530912075|FG000|Overall Study|Other: Subject became pregnant|1|||
147202872|NCT00515619|530912075|FG000|Overall Study|Other: Request from sponsor|1|||
147202873|NCT00515619|530912075|FG000|Overall Study|Other: Drug available on license|1|||
147202874|NCT00515619|530912075|FG000|Overall Study|Other: Subject interested in other AED|1|||
147202875|NCT02379091|530912076|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
147202876|NCT02379091|530912077|FG001|Overall Study|Pretreatment Event/Adverse Event|2|||
147202877|NCT02379091|530912078|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
147202878|NCT02379091|530912079|FG003|Overall Study|Pretreatment Event/Adverse Event|1|||
147202879|NCT02379091|530912076|FG000|Overall Study|Principal Investigator Discretion|0|||
147202880|NCT02379091|530912077|FG001|Overall Study|Principal Investigator Discretion|1|||
147202881|NCT02379091|530912078|FG002|Overall Study|Principal Investigator Discretion|0|||
147202882|NCT02379091|530912079|FG003|Overall Study|Principal Investigator Discretion|0|||
147202883|NCT02379091|530912076|FG000|Overall Study|Lost to Follow-up|0|||
147202884|NCT02379091|530912077|FG001|Overall Study|Lost to Follow-up|0|||
147202885|NCT02379091|530912078|FG002|Overall Study|Lost to Follow-up|0|||
147202886|NCT02379091|530912079|FG003|Overall Study|Lost to Follow-up|1|||
147202887|NCT02379091|530912076|FG000|Overall Study|Voluntary Withdrawal|2|||
147202888|NCT02379091|530912077|FG001|Overall Study|Voluntary Withdrawal|5|||
147202889|NCT02379091|530912078|FG002|Overall Study|Voluntary Withdrawal|2|||
147202890|NCT02379091|530912079|FG003|Overall Study|Voluntary Withdrawal|4|||
147202891|NCT02379091|530912076|FG000|Overall Study|Study Termination|7|||
147202892|NCT02379091|530912077|FG001|Overall Study|Study Termination|2|||
147202893|NCT02379091|530912078|FG002|Overall Study|Study Termination|5|||
147202894|NCT02379091|530912079|FG003|Overall Study|Study Termination|8|||
147202895|NCT02379091|530912076|FG000|Overall Study|Lack of Efficacy|3|||
147202896|NCT02379091|530912077|FG001|Overall Study|Lack of Efficacy|0|||
147202897|NCT02379091|530912078|FG002|Overall Study|Lack of Efficacy|0|||
147202898|NCT02379091|530912079|FG003|Overall Study|Lack of Efficacy|0|||
147202899|NCT02129699|530912081|FG000|Overall Study|Did not start treatment|3|||
147202900|NCT02129699|530912082|FG001|Overall Study|Did not start treatment|2|||
147202901|NCT00670748|530912087|FG000|Overall Study|Death during treatment|1|||
147202902|NCT00670748|530912088|FG001|Overall Study|Death during treatment|1|||
147202903|NCT00670748|530912089|FG002|Overall Study|Death during treatment|1|||
147202904|NCT00670748|530912090|FG003|Overall Study|Death during treatment|0|||
147202905|NCT00670748|530912087|FG000|Overall Study|Not off study|2|||
147538482|NCT00916617|532125387|FG000|Overall Study|Lack of Efficacy|1|||
147538483|NCT00916617|532125388|FG001|Overall Study|Lack of Efficacy|0|||
147538484|NCT00916617|532125389|FG002|Overall Study|Lack of Efficacy|0|||
147538485|NCT00916617|532125390|FG003|Overall Study|Lack of Efficacy|0|||
147538486|NCT00916617|532125387|FG000|Overall Study|Other|2|||
147538487|NCT00916617|532125388|FG001|Overall Study|Other|0|||
147538488|NCT00916617|532125389|FG002|Overall Study|Other|0|||
147538489|NCT00916617|532125390|FG003|Overall Study|Other|2|||
147306810|NCT01852058|531290779|FG006|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
147437605|NCT04163900|531768646|FG001|Overall Study|Physician Decision|25|||
147437606|NCT04163900|531768645|FG000|Overall Study|Clinical disease progression|14|||
147437607|NCT04163900|531768646|FG001|Overall Study|Clinical disease progression|13|||
147437608|NCT04163900|531768645|FG000|Overall Study|Protocol Violation|3|||
147437609|NCT04163900|531768646|FG001|Overall Study|Protocol Violation|4|||
147437610|NCT04163900|531768645|FG000|Overall Study|Lost to Follow-up|0|||
147437611|NCT04163900|531768646|FG001|Overall Study|Lost to Follow-up|1|||
147437612|NCT01873417|531768647|FG000|Overall Study|Did Not Receive Any Study Drug|4|||
147437613|NCT01873417|531768647|FG000|Overall Study|Adverse Event|24|||
147437614|NCT01873417|531768647|FG000|Overall Study|Lost to Follow-up|2|||
147437615|NCT01873417|531768647|FG000|Overall Study|Withdrawal by Subject|2|||
147437616|NCT01873417|531768647|FG000|Overall Study|Physician Decision|3|||
147437617|NCT00785044|531768648|FG000|Overall Study|Dosed at non-participating sites|152|||
147437618|NCT00785044|531768648|FG000|Overall Study|Death|77|||
147437619|NCT00785044|531768648|FG000|Overall Study|Lost to Follow-up|266|||
147437620|NCT00785044|531768648|FG000|Overall Study|Withdrawal by Subject|1|||
147437621|NCT01628107|531768649|FG000|Overall Study|Withdrawal by Subject|17|||
147437622|NCT01628107|531768649|FG000|Overall Study|Lost to Follow-up|4|||
147437623|NCT01628107|531768649|FG000|Overall Study|Adverse Event|33|||
147437624|NCT01628107|531768649|FG000|Overall Study|Physician Decision|2|||
147437625|NCT01628107|531768649|FG000|Overall Study|Not met Inclusion/Exclusion Criteria|1|||
147437626|NCT01628107|531768649|FG000|Overall Study|Non-compliant with Study Procedures|10|||
147437627|NCT01628107|531768649|FG000|Overall Study|Not Treated|8|||
147437628|NCT01628107|531768649|FG000|Overall Study|Sponsor Decision|11|||
147437629|NCT01628107|531768649|FG000|Overall Study|Missed Study Drug More than 2 Weeks|7|||
147437630|NCT01628107|531768649|FG000|Overall Study|Relocated|8|||
147437631|NCT01628107|531768649|FG000|Overall Study|Kidney Transplant|9|||
147437632|NCT01628107|531768649|FG000|Overall Study|Use of Standard of Care|9|||
147437633|NCT02767323|531768650|FG000|Overall Study|Withdrawal by Subject|17|||
147437634|NCT02767323|531768651|FG001|Overall Study|Withdrawal by Subject|5|||
147437635|NCT02767323|531768652|FG002|Overall Study|Withdrawal by Subject|13|||
147437636|NCT02767323|531768653|FG003|Overall Study|Withdrawal by Subject|0|||
147437637|NCT02767323|531768650|FG000|Overall Study|Contraindication, moving during the scan, low behavior, or Covid-19|17|||
147437638|NCT02767323|531768651|FG001|Overall Study|Contraindication, moving during the scan, low behavior, or Covid-19|20|||
147437639|NCT02767323|531768652|FG002|Overall Study|Contraindication, moving during the scan, low behavior, or Covid-19|17|||
147437640|NCT02767323|531768653|FG003|Overall Study|Contraindication, moving during the scan, low behavior, or Covid-19|0|||
147437641|NCT00930722|531768654|FG000|Overall Study|Lost to Follow-up|16|||
147437642|NCT00930722|531768654|FG000|Overall Study|No longer willing to participate|9|||
147437643|NCT00930722|531768654|FG000|Overall Study|Study terminated by sponsor|2|||
147437644|NCT03523728|531768655|FG000|Stage 1 (24 Months)|Adverse Event|2|||
147437645|NCT03523728|531768656|FG001|Stage 1 (24 Months)|Adverse Event|2|||
147437646|NCT03523728|531768657|FG002|Stage 1 (24 Months)|Adverse Event|4|||
147437647|NCT03523728|531768658|FG003|Stage 1 (24 Months)|Adverse Event|0|||
147437648|NCT03523728|531768659|FG004|Stage 1 (24 Months)|Adverse Event|0|||
147437649|NCT03523728|531768655|FG000|Stage 1 (24 Months)|Progressive disease|0|||
147437650|NCT03523728|531768656|FG001|Stage 1 (24 Months)|Progressive disease|0|||
147437651|NCT03523728|531768657|FG002|Stage 1 (24 Months)|Progressive disease|1|||
147437652|NCT03523728|531768658|FG003|Stage 1 (24 Months)|Progressive disease|0|||
147437653|NCT03523728|531768659|FG004|Stage 1 (24 Months)|Progressive disease|0|||
147437654|NCT03523728|531768655|FG000|Stage 1 (24 Months)|Lack of Efficacy|2|||
147437655|NCT03523728|531768656|FG001|Stage 1 (24 Months)|Lack of Efficacy|0|||
147437656|NCT03523728|531768657|FG002|Stage 1 (24 Months)|Lack of Efficacy|0|||
147437657|NCT03523728|531768658|FG003|Stage 1 (24 Months)|Lack of Efficacy|0|||
147437658|NCT03523728|531768659|FG004|Stage 1 (24 Months)|Lack of Efficacy|0|||
147437659|NCT03523728|531768655|FG000|Stage 1 (24 Months)|Poor compliance to protocol|1|||
147437660|NCT03523728|531768656|FG001|Stage 1 (24 Months)|Poor compliance to protocol|0|||
147437661|NCT03523728|531768657|FG002|Stage 1 (24 Months)|Poor compliance to protocol|0|||
147437662|NCT03523728|531768658|FG003|Stage 1 (24 Months)|Poor compliance to protocol|0|||
147437663|NCT03523728|531768659|FG004|Stage 1 (24 Months)|Poor compliance to protocol|0|||
147437664|NCT03523728|531768655|FG000|Stage 1 (24 Months)|Withdrawal by Subject|6|||
147437665|NCT03523728|531768656|FG001|Stage 1 (24 Months)|Withdrawal by Subject|5|||
147437666|NCT03523728|531768657|FG002|Stage 1 (24 Months)|Withdrawal by Subject|7|||
147437667|NCT03523728|531768658|FG003|Stage 1 (24 Months)|Withdrawal by Subject|0|||
147437668|NCT03523728|531768659|FG004|Stage 1 (24 Months)|Withdrawal by Subject|0|||
147437669|NCT03523728|531768655|FG000|Stage 1 (24 Months)|Study terminated by sponsor|54|||
147437670|NCT03523728|531768656|FG001|Stage 1 (24 Months)|Study terminated by sponsor|59|||
147437671|NCT03523728|531768657|FG002|Stage 1 (24 Months)|Study terminated by sponsor|56|||
147437672|NCT03523728|531768658|FG003|Stage 1 (24 Months)|Study terminated by sponsor|0|||
147437673|NCT03523728|531768659|FG004|Stage 1 (24 Months)|Study terminated by sponsor|0|||
147437674|NCT03523728|531768655|FG000|Stage 1 (24 Months)|Other-Unspecified|1|||
147437675|NCT03523728|531768656|FG001|Stage 1 (24 Months)|Other-Unspecified|2|||
147437676|NCT03523728|531768657|FG002|Stage 1 (24 Months)|Other-Unspecified|0|||
147437677|NCT03523728|531768658|FG003|Stage 1 (24 Months)|Other-Unspecified|0|||
147538490|NCT00566631|532125392|FG000|Part 1: Core Treatment Phase|Lack of Efficacy|18|||
147538491|NCT00566631|532125392|FG000|Part 1: Core Treatment Phase|Physician Decision|1|||
147538492|NCT00566631|532125392|FG000|Part 1: Core Treatment Phase|Adverse Event|9|||
147538493|NCT00566631|532125392|FG000|Part 1: Core Treatment Phase|Lost to Follow-up|4|||
147538494|NCT00566631|532125392|FG000|Part 1: Core Treatment Phase|Withdrawal by Subject|26|||
147538495|NCT00566631|532125392|FG000|Part 1: Core Treatment Phase|Moved to a penitentiary hospital|1|||
147538496|NCT00566631|532125392|FG000|Part 1: Core Treatment Phase|Met exclusion criteria|1|||
147538497|NCT00566631|532125392|FG000|Between Treatment and Extension Phase|Participants not willing to participate|95|||
147538498|NCT00566631|532125392|FG000|Part 2: Extension Phase|Lack of Efficacy|25|||
147538499|NCT00566631|532125392|FG000|Part 2: Extension Phase|Withdrawal by Subject|34|||
147538500|NCT00566631|532125392|FG000|Part 2: Extension Phase|Adverse Event|11|||
147538501|NCT00566631|532125392|FG000|Part 2: Extension Phase|Lost to Follow-up|6|||
147538502|NCT00566631|532125392|FG000|Part 2: Extension Phase|Death|1|||
147538503|NCT00566631|532125392|FG000|Part 2: Extension Phase|Other|5|||
147538504|NCT02723786|532125393|FG000|Overall Study|Lost to Follow-up|1|||
147538505|NCT03170271|532125396|FG000|Overall Study|Adverse Event|7|||
147538506|NCT03170271|532125397|FG001|Overall Study|Adverse Event|2|||
147538507|NCT03170271|532125396|FG000|Overall Study|Lost to Follow-up|0|||
147538508|NCT03170271|532125397|FG001|Overall Study|Lost to Follow-up|1|||
147538509|NCT03170271|532125396|FG000|Overall Study|Physician Decision|1|||
147538510|NCT03170271|532125397|FG001|Overall Study|Physician Decision|0|||
147538511|NCT03170271|532125396|FG000|Overall Study|Protocol-specified withdrawal criterion|2|||
147538512|NCT03170271|532125397|FG001|Overall Study|Protocol-specified withdrawal criterion|1|||
147538513|NCT03170271|532125396|FG000|Overall Study|Withdrawal by Subject|17|||
147538514|NCT03170271|532125397|FG001|Overall Study|Withdrawal by Subject|5|||
147538515|NCT03170271|532125396|FG000|Overall Study|Other|2|||
147538516|NCT03170271|532125397|FG001|Overall Study|Other|2|||
147538517|NCT03170271|532125396|FG000|Overall Study|Randomized in error|4|||
147538518|NCT03170271|532125397|FG001|Overall Study|Randomized in error|0|||
147538519|NCT03466060|532125407|FG000|Period 1|Test Lens Damage|0|||
147538520|NCT03466060|532125408|FG001|Period 1|Test Lens Damage|2|||
147538521|NCT03466060|532125409|FG002|Period 1|Test Lens Damage|0|||
147538522|NCT03466060|532125410|FG003|Period 1|Test Lens Damage|0|||
147538523|NCT03466060|532125411|FG004|Period 1|Test Lens Damage|0|||
147538524|NCT03466060|532125412|FG005|Period 1|Test Lens Damage|0|||
147538525|NCT03466060|532125407|FG000|Period 1|Withdrawal by Subject|0|||
147538526|NCT03466060|532125408|FG001|Period 1|Withdrawal by Subject|0|||
147538527|NCT03466060|532125409|FG002|Period 1|Withdrawal by Subject|2|||
147538528|NCT03466060|532125410|FG003|Period 1|Withdrawal by Subject|0|||
147538529|NCT03466060|532125411|FG004|Period 1|Withdrawal by Subject|0|||
147538530|NCT03466060|532125412|FG005|Period 1|Withdrawal by Subject|0|||
147538531|NCT03466060|532125407|FG000|Period 1|Lost to Follow-up|0|||
147538532|NCT03466060|532125408|FG001|Period 1|Lost to Follow-up|0|||
147538533|NCT03466060|532125409|FG002|Period 1|Lost to Follow-up|0|||
147538534|NCT03466060|532125410|FG003|Period 1|Lost to Follow-up|1|||
147538535|NCT03466060|532125411|FG004|Period 1|Lost to Follow-up|0|||
147538536|NCT03466060|532125412|FG005|Period 1|Lost to Follow-up|0|||
147538537|NCT03466060|532125407|FG000|Period 1|Grade 2 Conjunctivitis|0|||
147538538|NCT03466060|532125408|FG001|Period 1|Grade 2 Conjunctivitis|0|||
147538539|NCT03466060|532125409|FG002|Period 1|Grade 2 Conjunctivitis|1|||
147538540|NCT03466060|532125410|FG003|Period 1|Grade 2 Conjunctivitis|0|||
147538541|NCT03466060|532125411|FG004|Period 1|Grade 2 Conjunctivitis|0|||
147538542|NCT03466060|532125412|FG005|Period 1|Grade 2 Conjunctivitis|0|||
147538543|NCT03466060|532125407|FG000|Period 2|Lens Handling Difficulties|0|||
147538544|NCT03466060|532125408|FG001|Period 2|Lens Handling Difficulties|0|||
147538545|NCT03466060|532125409|FG002|Period 2|Lens Handling Difficulties|1|||
147538546|NCT03466060|532125410|FG003|Period 2|Lens Handling Difficulties|0|||
147538547|NCT03466060|532125411|FG004|Period 2|Lens Handling Difficulties|0|||
147538548|NCT03466060|532125412|FG005|Period 2|Lens Handling Difficulties|0|||
147538549|NCT03159611|532125415|FG000|Overall Study|Did Not Meet Inclusion Criteria|9|||
147538550|NCT03159611|532125416|FG001|Overall Study|Did Not Meet Inclusion Criteria|5|||
147538551|NCT03159611|532125415|FG000|Overall Study|Did Not Meet Exclusion Criteria|1|||
147538552|NCT03159611|532125416|FG001|Overall Study|Did Not Meet Exclusion Criteria|3|||
147538553|NCT03159611|532125415|FG000|Overall Study|Protocol Violation|7|||
147538554|NCT03159611|532125416|FG001|Overall Study|Protocol Violation|4|||
147538555|NCT03159611|532125415|FG000|Overall Study|Adverse Event|1|||
147538556|NCT03159611|532125416|FG001|Overall Study|Adverse Event|0|||
147538557|NCT03159611|532125415|FG000|Overall Study|Withdrawal by Subject|1|||
147538558|NCT03159611|532125416|FG001|Overall Study|Withdrawal by Subject|1|||
147538559|NCT03159611|532125415|FG000|Overall Study|Non-compliance with protocol requirement|3|||
147202906|NCT00670748|530912088|FG001|Overall Study|Not off study|1|||
147538560|NCT03159611|532125416|FG001|Overall Study|Non-compliance with protocol requirement|2|||
147538561|NCT03159611|532125415|FG000|Overall Study|Inability to perform procedures|1|||
147538562|NCT03159611|532125416|FG001|Overall Study|Inability to perform procedures|0|||
147538563|NCT01984229|532125417|FG000|Safety Follow-up Period|Adverse Event|1|||
147538564|NCT01984229|532125418|FG001|Safety Follow-up Period|Adverse Event|1|||
147538565|NCT01984229|532125417|FG000|Safety Follow-up Period|Lost to Follow-up|1|||
147538566|NCT01984229|532125418|FG001|Safety Follow-up Period|Lost to Follow-up|0|||
147538567|NCT02072174|532125419|FG000|Overall Study|Did Not Meet In-/Exclusion Criteria|14|||
147538568|NCT02072174|532125420|FG001|Overall Study|Did Not Meet In-/Exclusion Criteria|15|||
147538569|NCT02072174|532125419|FG000|Overall Study|Protocol Violation|16|||
147538570|NCT02072174|532125420|FG001|Overall Study|Protocol Violation|23|||
147538571|NCT02072174|532125419|FG000|Overall Study|Physician Decision|0|||
147538572|NCT02072174|532125420|FG001|Overall Study|Physician Decision|1|||
147538573|NCT02072174|532125419|FG000|Overall Study|Non-compliance with protocol requirement|2|||
147538574|NCT02072174|532125420|FG001|Overall Study|Non-compliance with protocol requirement|0|||
147538575|NCT01418365|532125425|FG000|First Intervention|Withdrawal by Subject|0|||
147538576|NCT01418365|532125426|FG001|First Intervention|Withdrawal by Subject|1|||
147538577|NCT01418365|532125425|FG000|First Intervention|Non-compliance|1|||
147538578|NCT01418365|532125426|FG001|First Intervention|Non-compliance|0|||
147538579|NCT01418365|532125425|FG000|Second Intervention|Withdrawal by Subject|0|||
147538580|NCT01418365|532125426|FG001|Second Intervention|Withdrawal by Subject|1|||
147538581|NCT03319368|532125431|FG000|Overall Study|Discharge swabs not collected from resident|57|||
147538582|NCT03319368|532125432|FG001|Overall Study|Discharge swabs not collected from resident|46|||
147538583|NCT00824993|532125437|FG000|Overall Study|Withdrawal by Subject|1|||
147538584|NCT00824993|532125438|FG001|Overall Study|Withdrawal by Subject|1|||
147538585|NCT00824993|532125437|FG000|Overall Study|Malignancy Relapse|9|||
147538586|NCT00824993|532125438|FG001|Overall Study|Malignancy Relapse|10|||
147538587|NCT00824993|532125437|FG000|Overall Study|Rapid Bone Loss|0|||
147538588|NCT00824993|532125438|FG001|Overall Study|Rapid Bone Loss|1|||
147538589|NCT00824993|532125437|FG000|Overall Study|Non-Compliant|2|||
147538590|NCT00824993|532125438|FG001|Overall Study|Non-Compliant|1|||
147538591|NCT00824993|532125437|FG000|Overall Study|Insurance Issue|2|||
147538592|NCT00824993|532125438|FG001|Overall Study|Insurance Issue|1|||
147538593|NCT00824993|532125437|FG000|Overall Study|Death|0|||
147538594|NCT00824993|532125438|FG001|Overall Study|Death|3|||
147538595|NCT03409328|532125439|FG000|Overall Study|Lost to Follow-up|6|||
147538596|NCT03409328|532125440|FG001|Overall Study|Lost to Follow-up|3|||
147538597|NCT00518011|532125441|FG000|Overall Study|Death|1|||
147538598|NCT00518011|532125442|FG001|Overall Study|Death|1|||
147538599|NCT00518011|532125441|FG000|Overall Study|Adverse Event|2|||
147538600|NCT00518011|532125442|FG001|Overall Study|Adverse Event|3|||
147538601|NCT00518011|532125441|FG000|Overall Study|Disease Progression|2|||
147538602|NCT00518011|532125442|FG001|Overall Study|Disease Progression|2|||
147538603|NCT00518011|532125441|FG000|Overall Study|Other Reasons|3|||
147538604|NCT00518011|532125442|FG001|Overall Study|Other Reasons|2|||
147538605|NCT00518011|532125441|FG000|Overall Study|Withdrawal by Subject|1|||
147538606|NCT00518011|532125442|FG001|Overall Study|Withdrawal by Subject|0|||
147538607|NCT02998645|532125443|FG000|Treatment Period 1|Adverse Event|6|||
147538608|NCT02998645|532125443|FG000|Treatment Period 1|Death|5|||
147538609|NCT02998645|532125443|FG000|Treatment Period 1|Technical Problems|4|||
147202907|NCT00670748|530912089|FG002|Overall Study|Not off study|1|||
147202908|NCT00670748|530912090|FG003|Overall Study|Not off study|1|||
147202909|NCT03863080|530912095|FG000|Double-Blind Treatment Period (6 Weeks)|Adverse Event|0|||
147202910|NCT03863080|530912096|FG001|Double-Blind Treatment Period (6 Weeks)|Adverse Event|0|||
147202911|NCT03863080|530912097|FG002|Double-Blind Treatment Period (6 Weeks)|Adverse Event|1|||
147202912|NCT03863080|530912098|FG003|Double-Blind Treatment Period (6 Weeks)|Adverse Event|0|||
147202913|NCT03863080|530912095|FG000|Open Label Extension Period (12 Weeks)|Withdrawal by Subject|0|||
147202914|NCT03863080|530912096|FG001|Open Label Extension Period (12 Weeks)|Withdrawal by Subject|0|||
147202915|NCT03863080|530912097|FG002|Open Label Extension Period (12 Weeks)|Withdrawal by Subject|0|||
147202916|NCT03863080|530912098|FG003|Open Label Extension Period (12 Weeks)|Withdrawal by Subject|3|||
147202917|NCT03863080|530912095|FG000|Open Label Extension Period (12 Weeks)|Adverse Event|0|||
147202918|NCT03863080|530912096|FG001|Open Label Extension Period (12 Weeks)|Adverse Event|0|||
147202919|NCT03863080|530912097|FG002|Open Label Extension Period (12 Weeks)|Adverse Event|0|||
147202920|NCT03863080|530912098|FG003|Open Label Extension Period (12 Weeks)|Adverse Event|3|||
147202921|NCT02991768|530912108|FG000|Overall Study|Physician Decision|4|||
147538610|NCT02998645|532125443|FG000|Treatment Period 1|Lack of Efficacy|2|||
147538611|NCT02998645|532125443|FG000|Treatment Period 1|Progressive disease|1|||
147538612|NCT02998645|532125443|FG000|Treatment Period 1|Subject/guardian decision|1|||
147202922|NCT03467750|530912109|FG000|Overall Study|Surgery canceled|1|||
147538613|NCT02998645|532125443|FG000|Treatment Period 2|Lack of Efficacy|5|||
147538614|NCT02998645|532125443|FG000|Treatment Period 2|Adverse Event|2|||
147538615|NCT02998645|532125443|FG000|Treatment Period 2|Progressive disease|2|||
147538616|NCT02998645|532125443|FG000|Treatment Period 2|Physician Decision|1|||
147538617|NCT03701516|532125444|FG000|Period 1|Lost to Follow-up|0|||
147538618|NCT03701516|532125445|FG001|Period 1|Lost to Follow-up|1|||
147538619|NCT03701516|532125444|FG000|Period 1|Adverse Event|0|||
147538620|NCT03701516|532125445|FG001|Period 1|Adverse Event|2|||
147538621|NCT03701516|532125444|FG000|Period 1|Unsatisfactory Lens Fitting due to Test Article|2|||
147538622|NCT03701516|532125445|FG001|Period 1|Unsatisfactory Lens Fitting due to Test Article|0|||
147538623|NCT03701516|532125444|FG000|Period 1|Non Compliance to Protocol|2|||
147538624|NCT03701516|532125445|FG001|Period 1|Non Compliance to Protocol|1|||
147538625|NCT03701516|532125444|FG000|Period 1|Withdrawal by Subject|0|||
147538626|NCT03701516|532125445|FG001|Period 1|Withdrawal by Subject|1|||
147538627|NCT03701516|532125444|FG000|Period 2|failed to meet all eligibility creiteria|1|||
147538628|NCT03701516|532125445|FG001|Period 2|failed to meet all eligibility creiteria|0|||
147538629|NCT03701516|532125444|FG000|Period 2|Unsatisfactory Lens Fitting due to Test Article|0|||
147538630|NCT03701516|532125445|FG001|Period 2|Unsatisfactory Lens Fitting due to Test Article|1|||
147538631|NCT03930615|532125447|FG000|Overall Study|Death|9|||
147538632|NCT03930615|532125448|FG001|Overall Study|Death|3|||
147538633|NCT03930615|532125447|FG000|Overall Study|Lost to Follow-up|1|||
147538634|NCT03930615|532125448|FG001|Overall Study|Lost to Follow-up|2|||
147538635|NCT03930615|532125447|FG000|Overall Study|Physician Decision|3|||
147538636|NCT03930615|532125448|FG001|Overall Study|Physician Decision|4|||
147538637|NCT03930615|532125447|FG000|Overall Study|Withdrawal by Subject|13|||
147538638|NCT03930615|532125448|FG001|Overall Study|Withdrawal by Subject|2|||
147538639|NCT03930615|532125447|FG000|Overall Study|Not treated|1|||
147538640|NCT03930615|532125448|FG001|Overall Study|Not treated|1|||
147538641|NCT03644927|532125451|FG000|Overall Study|The single subject in this arm didn't complete the 12 weeks intervention before study termination.|1|||
147538642|NCT03644927|532125452|FG001|Overall Study|The single subject in this arm didn't complete the 12 weeks intervention before study termination.|0|||
147538643|NCT00956813|532125453|FG000|Flaxseed and Placebo|Withdrawal by Subject|5|||
147538644|NCT00956813|532125454|FG001|Flaxseed and Placebo|Withdrawal by Subject|4|||
147538645|NCT00956813|532125453|FG000|Flaxseed and Placebo|Ineligible|3|||
147538646|NCT00956813|532125454|FG001|Flaxseed and Placebo|Ineligible|1|||
147538647|NCT02864953|532125455|FG000|Overall Study|Adverse Event|22|||
147538648|NCT02864953|532125456|FG001|Overall Study|Adverse Event|19|||
147538649|NCT02864953|532125455|FG000|Overall Study|Withdrawal by Subject|1|||
147538650|NCT02864953|532125456|FG001|Overall Study|Withdrawal by Subject|0|||
147538651|NCT02864953|532125455|FG000|Overall Study|Physician Decision|4|||
147538652|NCT02864953|532125456|FG001|Overall Study|Physician Decision|2|||
147538653|NCT02864953|532125455|FG000|Overall Study|Death|3|||
147538654|NCT02864953|532125456|FG001|Overall Study|Death|13|||
147538655|NCT02864953|532125455|FG000|Overall Study|Reason not specified|14|||
147538656|NCT02864953|532125456|FG001|Overall Study|Reason not specified|12|||
147538657|NCT02864953|532125455|FG000|Overall Study|Withdrew Prior to Dosing|9|||
147538658|NCT02864953|532125456|FG001|Overall Study|Withdrew Prior to Dosing|8|||
147538659|NCT00981019|532125457|FG000|Overall Study|Did not respond|65|||
147538660|NCT00981019|532125457|FG000|Overall Study|Did not match target population|94|||
147538661|NCT00981019|532125457|FG000|Overall Study|Inadvertent exclusion|239|||
147202923|NCT03467750|530912110|FG001|Overall Study|Surgery canceled|0|||
147202924|NCT03467750|530912109|FG000|Overall Study|Protocol Violation|1|||
147202925|NCT03467750|530912110|FG001|Overall Study|Protocol Violation|1|||
147202926|NCT03467750|530912109|FG000|Overall Study|Withdrawal by Subject|0|||
147202927|NCT03467750|530912110|FG001|Overall Study|Withdrawal by Subject|1|||
147202928|NCT05673876|530912111|FG000|Overall Study|Death|3|||
147202929|NCT05673876|530912112|FG001|Overall Study|Death|1|||
147202930|NCT05673876|530912111|FG000|Overall Study|Study Terminated by Sponsor|0|||
147202931|NCT05673876|530912112|FG001|Overall Study|Study Terminated by Sponsor|1|||
147202932|NCT05673876|530912111|FG000|Overall Study|Physician Decision|0|||
147202933|NCT05673876|530912112|FG001|Overall Study|Physician Decision|1|||
147202934|NCT03529422|530912113|FG000|Overall Study|Withdrawal by Subject|1|||
147202935|NCT03529422|530912113|FG000|Overall Study|Protocol Violation|1|||
147202936|NCT03529422|530912113|FG000|Overall Study|Disease progression|2|||
147202937|NCT02000115|530912116|FG000|Overall Study|Death|56|||
147202938|NCT02000115|530912117|FG001|Overall Study|Death|45|||
147202939|NCT02000115|530912118|FG002|Overall Study|Death|0|||
147202940|NCT02000115|530912119|FG003|Overall Study|Death|0|||
147202941|NCT02000115|530912116|FG000|Overall Study|Missed Visit|6|||
147202942|NCT02000115|530912117|FG001|Overall Study|Missed Visit|8|||
147202943|NCT02000115|530912118|FG002|Overall Study|Missed Visit|1|||
147202944|NCT02000115|530912119|FG003|Overall Study|Missed Visit|0|||
147202945|NCT02000115|530912116|FG000|Overall Study|Protocol Violation|2|||
147202946|NCT02000115|530912117|FG001|Overall Study|Protocol Violation|1|||
147202947|NCT02000115|530912118|FG002|Overall Study|Protocol Violation|0|||
147202948|NCT02000115|530912119|FG003|Overall Study|Protocol Violation|0|||
147202949|NCT02000115|530912116|FG000|Overall Study|Physician Decision|2|||
147202950|NCT02000115|530912117|FG001|Overall Study|Physician Decision|0|||
147202951|NCT02000115|530912118|FG002|Overall Study|Physician Decision|0|||
147202952|NCT02000115|530912119|FG003|Overall Study|Physician Decision|0|||
147202953|NCT02000115|530912116|FG000|Overall Study|Withdrawal by Subject|11|||
147202954|NCT02000115|530912117|FG001|Overall Study|Withdrawal by Subject|11|||
147202955|NCT02000115|530912118|FG002|Overall Study|Withdrawal by Subject|0|||
147202956|NCT02000115|530912119|FG003|Overall Study|Withdrawal by Subject|0|||
147202957|NCT02000115|530912116|FG000|Overall Study|Lost to Follow-up|0|||
147202958|NCT02000115|530912117|FG001|Overall Study|Lost to Follow-up|1|||
147202959|NCT02000115|530912118|FG002|Overall Study|Lost to Follow-up|0|||
147202960|NCT02000115|530912119|FG003|Overall Study|Lost to Follow-up|0|||
147202961|NCT02000115|530912116|FG000|Overall Study|Non-compliance|2|||
147202962|NCT02000115|530912117|FG001|Overall Study|Non-compliance|1|||
147202963|NCT02000115|530912118|FG002|Overall Study|Non-compliance|0|||
147202964|NCT02000115|530912119|FG003|Overall Study|Non-compliance|0|||
147202965|NCT02000115|530912116|FG000|Overall Study|Withdrawn on day of randomization|0|||
147437678|NCT03523728|531768659|FG004|Stage 1 (24 Months)|Other-Unspecified|0|||
147437679|NCT03523728|531768655|FG000|Stage 2 (24 Months)|Adverse Event|0|||
147437680|NCT03523728|531768656|FG001|Stage 2 (24 Months)|Adverse Event|0|||
147437681|NCT03523728|531768657|FG002|Stage 2 (24 Months)|Adverse Event|0|||
147437682|NCT03523728|531768658|FG003|Stage 2 (24 Months)|Adverse Event|1|||
147437683|NCT03523728|531768659|FG004|Stage 2 (24 Months)|Adverse Event|2|||
147437684|NCT03523728|531768655|FG000|Stage 2 (24 Months)|Withdrawal by Subject|0|||
147437685|NCT03523728|531768656|FG001|Stage 2 (24 Months)|Withdrawal by Subject|0|||
147437686|NCT03523728|531768657|FG002|Stage 2 (24 Months)|Withdrawal by Subject|0|||
147437687|NCT03523728|531768658|FG003|Stage 2 (24 Months)|Withdrawal by Subject|0|||
147437688|NCT03523728|531768659|FG004|Stage 2 (24 Months)|Withdrawal by Subject|4|||
147437689|NCT03523728|531768655|FG000|Stage 2 (24 Months)|Study terminated by sponsor|0|||
147437690|NCT03523728|531768656|FG001|Stage 2 (24 Months)|Study terminated by sponsor|0|||
147437691|NCT03523728|531768657|FG002|Stage 2 (24 Months)|Study terminated by sponsor|0|||
147437692|NCT03523728|531768658|FG003|Stage 2 (24 Months)|Study terminated by sponsor|119|||
147437693|NCT03523728|531768659|FG004|Stage 2 (24 Months)|Study terminated by sponsor|110|||
147437694|NCT03523728|531768655|FG000|Stage 2 (24 Months)|Other-Unspecified|0|||
147437695|NCT03523728|531768656|FG001|Stage 2 (24 Months)|Other-Unspecified|0|||
147437696|NCT03523728|531768657|FG002|Stage 2 (24 Months)|Other-Unspecified|0|||
147437697|NCT03523728|531768658|FG003|Stage 2 (24 Months)|Other-Unspecified|2|||
147437698|NCT03523728|531768659|FG004|Stage 2 (24 Months)|Other-Unspecified|3|||
147437699|NCT03523728|531768655|FG000|Stage 2 (24 Months)|Randomized and not treated|0|||
147437700|NCT03523728|531768656|FG001|Stage 2 (24 Months)|Randomized and not treated|0|||
147437701|NCT03523728|531768657|FG002|Stage 2 (24 Months)|Randomized and not treated|0|||
147437702|NCT03523728|531768658|FG003|Stage 2 (24 Months)|Randomized and not treated|1|||
147437703|NCT03523728|531768659|FG004|Stage 2 (24 Months)|Randomized and not treated|0|||
147202966|NCT02000115|530912117|FG001|Overall Study|Withdrawn on day of randomization|1|||
147202967|NCT02000115|530912118|FG002|Overall Study|Withdrawn on day of randomization|0|||
147202968|NCT02000115|530912119|FG003|Overall Study|Withdrawn on day of randomization|0|||
147202969|NCT02000115|530912116|FG000|Overall Study|Still on Study|0|||
147202970|NCT02000115|530912117|FG001|Overall Study|Still on Study|0|||
147202971|NCT02000115|530912118|FG002|Overall Study|Still on Study|0|||
147202972|NCT02000115|530912119|FG003|Overall Study|Still on Study|53|||
147202973|NCT05006573|530912122|FG000|Double-blind Treatment Period|Physician Decision|2|||
147202974|NCT05006573|530912123|FG001|Double-blind Treatment Period|Physician Decision|0|||
147202975|NCT05006573|530912122|FG000|Double-blind Treatment Period|Study terminated by sponsor|1|||
147202976|NCT05006573|530912123|FG001|Double-blind Treatment Period|Study terminated by sponsor|0|||
147202977|NCT05006573|530912122|FG000|Double-blind Treatment Period|Withdrawal by Subject|7|||
147202978|NCT05006573|530912123|FG001|Double-blind Treatment Period|Withdrawal by Subject|2|||
147202979|NCT05006573|530912122|FG000|Double-blind Treatment Period|Protocol Violation|2|||
147202980|NCT05006573|530912123|FG001|Double-blind Treatment Period|Protocol Violation|0|||
147202981|NCT05006573|530912122|FG000|Double-blind Treatment Period|Subject decision without consent withdrawn|0|||
147202982|NCT05006573|530912123|FG001|Double-blind Treatment Period|Subject decision without consent withdrawn|1|||
147202983|NCT05006573|530912122|FG000|Open-label Extension Period|Subject decision without consent withdrawn|0|||
147202984|NCT05006573|530912123|FG001|Open-label Extension Period|Subject decision without consent withdrawn|1|||
147202985|NCT04949490|530912124|FG000|Group A and Group B|Non-study SARS-COV-2 vaccination|0|||
147202986|NCT04949490|530912125|FG001|Group A and Group B|Non-study SARS-COV-2 vaccination|0|||
147202987|NCT04949490|530912126|FG002|Group A and Group B|Non-study SARS-COV-2 vaccination|0|||
147202988|NCT04949490|530912127|FG003|Group A and Group B|Non-study SARS-COV-2 vaccination|2|||
147202989|NCT04949490|530912128|FG004|Group A and Group B|Non-study SARS-COV-2 vaccination|0|||
147202990|NCT04949490|530912129|FG005|Group A and Group B|Non-study SARS-COV-2 vaccination|0|||
147202991|NCT04949490|530912124|FG000|Group A and Group B|Withdrawal by Subject|0|||
147202992|NCT04949490|530912125|FG001|Group A and Group B|Withdrawal by Subject|0|||
147202993|NCT04949490|530912126|FG002|Group A and Group B|Withdrawal by Subject|1|||
147202994|NCT04949490|530912127|FG003|Group A and Group B|Withdrawal by Subject|0|||
147202995|NCT04949490|530912128|FG004|Group A and Group B|Withdrawal by Subject|0|||
147202996|NCT04949490|530912129|FG005|Group A and Group B|Withdrawal by Subject|0|||
147202997|NCT04949490|530912124|FG000|Subset Group B Immunogenicity Evaluation|Non-study SARS-COV-2 vaccination|0|||
147202998|NCT04949490|530912125|FG001|Subset Group B Immunogenicity Evaluation|Non-study SARS-COV-2 vaccination|0|||
147202999|NCT04949490|530912126|FG002|Subset Group B Immunogenicity Evaluation|Non-study SARS-COV-2 vaccination|0|||
147203000|NCT04949490|530912127|FG003|Subset Group B Immunogenicity Evaluation|Non-study SARS-COV-2 vaccination|0|||
147203001|NCT04949490|530912128|FG004|Subset Group B Immunogenicity Evaluation|Non-study SARS-COV-2 vaccination|0|||
147203002|NCT04949490|530912129|FG005|Subset Group B Immunogenicity Evaluation|Non-study SARS-COV-2 vaccination|2|||
147203003|NCT04949490|530912124|FG000|Subset Group B Immunogenicity Evaluation|Withdrawal by Subject|0|||
147203004|NCT04949490|530912125|FG001|Subset Group B Immunogenicity Evaluation|Withdrawal by Subject|0|||
147203005|NCT04949490|530912126|FG002|Subset Group B Immunogenicity Evaluation|Withdrawal by Subject|0|||
147203006|NCT04949490|530912127|FG003|Subset Group B Immunogenicity Evaluation|Withdrawal by Subject|0|||
147203007|NCT04949490|530912128|FG004|Subset Group B Immunogenicity Evaluation|Withdrawal by Subject|1|||
147203008|NCT04949490|530912129|FG005|Subset Group B Immunogenicity Evaluation|Withdrawal by Subject|0|||
147203009|NCT04988477|530912132|FG000|Overall Study|Death|1|||
147203010|NCT04988477|530912133|FG001|Overall Study|Death|0|||
147203011|NCT04988477|530912134|FG002|Overall Study|Death|0|||
147203012|NCT04988477|530912132|FG000|Overall Study|Lost to Follow-up|5|||
147203013|NCT04988477|530912133|FG001|Overall Study|Lost to Follow-up|2|||
147203014|NCT04988477|530912134|FG002|Overall Study|Lost to Follow-up|0|||
147203015|NCT04988477|530912132|FG000|Overall Study|Withdrawal by Subject|2|||
147203016|NCT04988477|530912133|FG001|Overall Study|Withdrawal by Subject|0|||
147203017|NCT04988477|530912134|FG002|Overall Study|Withdrawal by Subject|0|||
147203018|NCT01987453|530913682|FG000|Overall Study|Death|0|||
147203019|NCT01987453|530913683|FG001|Overall Study|Death|0|||
147203020|NCT01987453|530913684|FG002|Overall Study|Death|1|||
147203021|NCT01987453|530913682|FG000|Overall Study|Lack of Efficacy|1|||
147203022|NCT01987453|530913683|FG001|Overall Study|Lack of Efficacy|12|||
147203023|NCT01987453|530913684|FG002|Overall Study|Lack of Efficacy|0|||
147203024|NCT01590888|530913685|FG000|Overall Study|Adverse Event|3|||
147437704|NCT02230254|531768660|FG000|Overall Study|Lost to Follow-up|3|||
147437705|NCT00621751|531768661|FG000|Overall Study|Adverse Event|0|||
147437706|NCT00621751|531768662|FG001|Overall Study|Adverse Event|1|||
147437707|NCT02023242|531768663|FG000|Overall Study|Lost to Follow-up|3|||
147437708|NCT02023242|531768664|FG001|Overall Study|Lost to Follow-up|1|||
147437709|NCT02023242|531768663|FG000|Overall Study|Death|0|||
147437710|NCT02023242|531768664|FG001|Overall Study|Death|1|||
147437711|NCT00419120|531768667|FG000|Long Term Follow up Period|study ongoing|10|||
147437712|NCT01069120|531768670|FG000|Overall Study|Study prematurely terminated|27|||
147437713|NCT01809132|531768674|FG000|Overall Study|Withdrawal by Subject|0|||
147437714|NCT01809132|531768675|FG001|Overall Study|Withdrawal by Subject|0|||
147437715|NCT01809132|531768676|FG002|Overall Study|Withdrawal by Subject|1|||
147437716|NCT04854434|531768677|FG000|Overall Study|Death|1|||
147437717|NCT04854434|531768678|FG001|Overall Study|Death|3|||
147437718|NCT04854434|531768679|FG002|Overall Study|Death|4|||
147437719|NCT04854434|531768677|FG000|Overall Study|Study Terminated by Sponsor|2|||
147437720|NCT04854434|531768678|FG001|Overall Study|Study Terminated by Sponsor|0|||
147437721|NCT04854434|531768679|FG002|Overall Study|Study Terminated by Sponsor|0|||
147437722|NCT04854434|531768677|FG000|Overall Study|Other|1|||
147203025|NCT01590888|530913686|FG001|Overall Study|Adverse Event|0|||
147203026|NCT01590888|530913687|FG002|Overall Study|Adverse Event|1|||
147437723|NCT04854434|531768678|FG001|Overall Study|Other|1|||
147437724|NCT04854434|531768679|FG002|Overall Study|Other|0|||
147437725|NCT03349775|531768680|FG000|Overall Study|Side Effects|1|||
147437726|NCT03349775|531768681|FG001|Overall Study|Side Effects|2|||
147437727|NCT03349775|531768680|FG000|Overall Study|Withdrawal by Subject|1|||
147437728|NCT03349775|531768681|FG001|Overall Study|Withdrawal by Subject|1|||
147437729|NCT03349775|531768680|FG000|Overall Study|No primary outcome measurements|0|||
147437730|NCT03349775|531768681|FG001|Overall Study|No primary outcome measurements|1|||
147437731|NCT02667275|531768682|FG000|Overall Study|Protocol Violation|11|||
147437732|NCT02667275|531768683|FG001|Overall Study|Protocol Violation|7|||
147437733|NCT02667275|531768682|FG000|Overall Study|Lost to Follow-up|0|||
147437734|NCT02667275|531768683|FG001|Overall Study|Lost to Follow-up|2|||
147437735|NCT02667275|531768682|FG000|Overall Study|Withdrawal by Subject|0|||
147437736|NCT02667275|531768683|FG001|Overall Study|Withdrawal by Subject|5|||
147437737|NCT02667275|531768682|FG000|Overall Study|Discontinued early without completing|0|||
147437738|NCT02667275|531768683|FG001|Overall Study|Discontinued early without completing|1|||
147437739|NCT03583450|531768685|FG000|Overall Study|hardware malfunction (battery depletion)|1|||
147437740|NCT03583450|531768686|FG001|Overall Study|hardware malfunction (battery depletion)|0|||
147437741|NCT00791258|531768689|FG000|Overall Study|Adverse Event|87|||
147437742|NCT00791258|531768689|FG000|Overall Study|Lost to Follow-up|18|||
147437743|NCT00791258|531768689|FG000|Overall Study|Protocol Violation|109|||
147437744|NCT00791258|531768689|FG000|Overall Study|Withdrawal by Subject|40|||
147437745|NCT00791258|531768689|FG000|Overall Study|Did not take medication for >3 days|1|||
147437746|NCT00791258|531768689|FG000|Overall Study|subject left area|2|||
147437747|NCT00791258|531768689|FG000|Overall Study|non-compliance|3|||
147437748|NCT00791258|531768689|FG000|Overall Study|Subject incarcerated|1|||
147437749|NCT00791258|531768689|FG000|Overall Study|Subject required restricted medication|1|||
147437750|NCT00791258|531768689|FG000|Overall Study|Lack of Efficacy|1|||
147437751|NCT05215262|531768692|FG000|Overall Study|Lost to Follow-up|12|||
147437752|NCT05215262|531768693|FG001|Overall Study|Lost to Follow-up|0|||
147437753|NCT00239226|531768694|FG000|Overall Study|permAF during stabilization period|0|||
147437754|NCT00239226|531768695|FG001|Overall Study|permAF during stabilization period|0|||
147437755|NCT00239226|531768696|FG002|Overall Study|permAF during stabilization period|0|||
147437756|NCT00239226|531768697|FG003|Overall Study|permAF during stabilization period|3|||
147437757|NCT00239226|531768694|FG000|Overall Study|Lost to Follow-up|1|||
147437758|NCT00239226|531768695|FG001|Overall Study|Lost to Follow-up|0|||
147437759|NCT00239226|531768696|FG002|Overall Study|Lost to Follow-up|1|||
147437760|NCT00239226|531768697|FG003|Overall Study|Lost to Follow-up|0|||
147437761|NCT04060563|531768700|FG000|Overall Study|Lost to Follow-up|1|||
147437762|NCT04060563|531768701|FG001|Overall Study|Lost to Follow-up|1|||
147437763|NCT04060563|531768700|FG000|Overall Study|Physician Decision|0|||
147437764|NCT04060563|531768701|FG001|Overall Study|Physician Decision|1|||
147437765|NCT01379573|531768706|FG000|Overall Study|Lost to Follow-up|1|||
147437766|NCT01379573|531768706|FG000|Overall Study|Screen Failure|10|||
147437767|NCT00962390|531768707|FG000|Overall Study|Adverse Event|0|||
147437768|NCT00962390|531768708|FG001|Overall Study|Adverse Event|0|||
147437769|NCT00962390|531768709|FG002|Overall Study|Adverse Event|3|||
147437770|NCT00962390|531768710|FG003|Overall Study|Adverse Event|1|||
147437771|NCT00962390|531768707|FG000|Overall Study|Lost to Follow-up|2|||
147437772|NCT00962390|531768708|FG001|Overall Study|Lost to Follow-up|2|||
147437773|NCT00962390|531768709|FG002|Overall Study|Lost to Follow-up|0|||
147437774|NCT00962390|531768710|FG003|Overall Study|Lost to Follow-up|0|||
147437775|NCT00962390|531768707|FG000|Overall Study|Protocol Violation|1|||
147437776|NCT00962390|531768708|FG001|Overall Study|Protocol Violation|0|||
147437777|NCT00962390|531768709|FG002|Overall Study|Protocol Violation|0|||
147437778|NCT00962390|531768710|FG003|Overall Study|Protocol Violation|0|||
147437779|NCT00962390|531768707|FG000|Overall Study|Withdrawal by Subject|1|||
147437780|NCT00962390|531768708|FG001|Overall Study|Withdrawal by Subject|1|||
147437781|NCT00962390|531768709|FG002|Overall Study|Withdrawal by Subject|1|||
147437782|NCT00962390|531768710|FG003|Overall Study|Withdrawal by Subject|0|||
147437783|NCT02613884|531768711|FG000|Overall Study|Death|1|||
147437784|NCT02613884|531768711|FG000|Overall Study|Lost to Follow-up|1|||
147437785|NCT02844920|531768712|FG000|Overall Study|Lost to Follow-up|2|||
147437786|NCT00131469|531768713|FG000|Overall Study|Withdrawal by Subject|3|||
147437787|NCT00131469|531768714|FG001|Overall Study|Withdrawal by Subject|4|||
147437788|NCT00131469|531768713|FG000|Overall Study|Protocol Violation|3|||
147437789|NCT00131469|531768714|FG001|Overall Study|Protocol Violation|1|||
147437790|NCT00131469|531768713|FG000|Overall Study|Death|0|||
147437791|NCT00131469|531768714|FG001|Overall Study|Death|1|||
147437792|NCT00131469|531768713|FG000|Overall Study|Lost to Follow-up|0|||
147437793|NCT00131469|531768714|FG001|Overall Study|Lost to Follow-up|1|||
147437794|NCT00131469|531768713|FG000|Overall Study|scan not analyzable|3|||
147437795|NCT00131469|531768714|FG001|Overall Study|scan not analyzable|6|||
147437796|NCT02871778|531768715|FG000|Part A: Treatment Period 1|Adverse Event|1|||
147437797|NCT02871778|531768716|FG001|Part A: Treatment Period 1|Adverse Event|1|||
147437798|NCT02871778|531768717|FG002|Part A: Treatment Period 1|Adverse Event|1|||
147437799|NCT02871778|531768718|FG003|Part A: Treatment Period 1|Adverse Event|0|||
147437800|NCT02871778|531768719|FG004|Part A: Treatment Period 1|Adverse Event|0|||
147538662|NCT00981019|532125457|FG000|Overall Study|Hit the survey after closure|79|||
147538663|NCT05083559|532125458|FG000|First Intervention (~8 Hours)|hit stopping rules for hyperglycemia|4|||
147538664|NCT05083559|532125459|FG001|First Intervention (~8 Hours)|hit stopping rules for hyperglycemia|1|||
147538665|NCT05083559|532125458|FG000|Second at Home Period (3-30 Days)|Withdrawal by Subject|2|||
147538666|NCT05083559|532125459|FG001|Second at Home Period (3-30 Days)|Withdrawal by Subject|0|||
147538667|NCT05083559|532125458|FG000|Second Intervention Visit (~8 Hours)|hit stopping rules for hyperglycemia|1|||
147538668|NCT05083559|532125459|FG001|Second Intervention Visit (~8 Hours)|hit stopping rules for hyperglycemia|0|||
147538669|NCT00905437|532125462|FG000|Overall Study|Adverse Event|3|||
147538670|NCT00905437|532125463|FG001|Overall Study|Adverse Event|2|||
147538671|NCT00905437|532125462|FG000|Overall Study|Lost to Follow-up|0|||
147538672|NCT00905437|532125463|FG001|Overall Study|Lost to Follow-up|1|||
147538673|NCT00905437|532125462|FG000|Overall Study|Withdrawal by Subject|0|||
147538674|NCT00905437|532125463|FG001|Overall Study|Withdrawal by Subject|1|||
147538675|NCT00905437|532125462|FG000|Overall Study|Other|5|||
147538676|NCT00905437|532125463|FG001|Overall Study|Other|6|||
147538677|NCT03252015|532125464|FG000|Overall Study|Withdrawal by Subject|0|||
147538678|NCT03252015|532125465|FG001|Overall Study|Withdrawal by Subject|1|||
147538679|NCT03252015|532125466|FG002|Overall Study|Withdrawal by Subject|1|||
147538680|NCT03252015|532125467|FG003|Overall Study|Withdrawal by Subject|0|||
147538681|NCT03252015|532125464|FG000|Overall Study|Adverse Event|1|||
147538682|NCT03252015|532125465|FG001|Overall Study|Adverse Event|0|||
147538683|NCT03252015|532125466|FG002|Overall Study|Adverse Event|0|||
147538684|NCT03252015|532125467|FG003|Overall Study|Adverse Event|1|||
147538685|NCT03128931|532125468|FG000|Overall Study|Physician Decision|1|||
147538686|NCT03128931|532125468|FG000|Overall Study|Equipment Issues|3|||
147538687|NCT04993339|532125469|FG000|Overall Study|Lost to Follow-up|0|||
147538688|NCT04993339|532125470|FG001|Overall Study|Lost to Follow-up|1|||
147538689|NCT04993339|532125469|FG000|Overall Study|no MRI scan|3|||
147538690|NCT04993339|532125470|FG001|Overall Study|no MRI scan|1|||
147538691|NCT03075215|532125473|FG000|12-Month Primary Endpoint|Death|152|||
147538692|NCT03075215|532125473|FG000|12-Month Primary Endpoint|Withdrawal by Subject|267|||
147538693|NCT03075215|532125473|FG000|Post Market Clinical Follow-Up ONLY|Death|15|||
147538694|NCT03075215|532125473|FG000|Post Market Clinical Follow-Up ONLY|Withdrawal by Subject|25|||
147538695|NCT01956123|532126820|FG000|COS Cycle 2|Protocol Violation|8|||
147538696|NCT01956123|532126821|FG001|COS Cycle 2|Protocol Violation|3|||
147538697|NCT01956123|532126822|FG002|COS Cycle 2|Protocol Violation|0|||
147538698|NCT01956123|532126823|FG003|COS Cycle 2|Protocol Violation|0|||
147538699|NCT01956123|532126820|FG000|COS Cycle 2|Adverse Event|3|||
147538700|NCT01956123|532126821|FG001|COS Cycle 2|Adverse Event|4|||
147538701|NCT01956123|532126822|FG002|COS Cycle 2|Adverse Event|0|||
147538702|NCT01956123|532126823|FG003|COS Cycle 2|Adverse Event|0|||
147538703|NCT01956123|532126820|FG000|COS Cycle 2|Personal Reasons|2|||
147538704|NCT01956123|532126821|FG001|COS Cycle 2|Personal Reasons|0|||
147538705|NCT01956123|532126822|FG002|COS Cycle 2|Personal Reasons|0|||
147538706|NCT01956123|532126823|FG003|COS Cycle 2|Personal Reasons|0|||
147538707|NCT01956123|532126820|FG000|COS Cycle 2|Withdrawal by Subject|1|||
147538708|NCT01956123|532126821|FG001|COS Cycle 2|Withdrawal by Subject|0|||
147538709|NCT01956123|532126822|FG002|COS Cycle 2|Withdrawal by Subject|0|||
147538710|NCT01956123|532126823|FG003|COS Cycle 2|Withdrawal by Subject|0|||
147538711|NCT01956123|532126820|FG000|COS Cycle 3|Protocol Violation|0|||
147538712|NCT01956123|532126821|FG001|COS Cycle 3|Protocol Violation|0|||
147538713|NCT01956123|532126822|FG002|COS Cycle 3|Protocol Violation|2|||
147538714|NCT01956123|532126823|FG003|COS Cycle 3|Protocol Violation|1|||
147538715|NCT01956123|532126820|FG000|COS Cycle 3|Adverse Event|0|||
147538716|NCT01956123|532126821|FG001|COS Cycle 3|Adverse Event|0|||
147538717|NCT01956123|532126822|FG002|COS Cycle 3|Adverse Event|3|||
147538718|NCT01956123|532126823|FG003|COS Cycle 3|Adverse Event|0|||
147538719|NCT01956123|532126820|FG000|COS Cycle 3|Personal Reasons|0|||
147538720|NCT01956123|532126821|FG001|COS Cycle 3|Personal Reasons|0|||
147538721|NCT01956123|532126822|FG002|COS Cycle 3|Personal Reasons|1|||
147538722|NCT01956123|532126823|FG003|COS Cycle 3|Personal Reasons|0|||
147538723|NCT01956123|532126820|FG000|COS Cycle 3|Withdrawal by Subject|0|||
147538724|NCT01956123|532126821|FG001|COS Cycle 3|Withdrawal by Subject|0|||
147538725|NCT01956123|532126822|FG002|COS Cycle 3|Withdrawal by Subject|0|||
147203027|NCT01590888|530913685|FG000|Overall Study|Lost to Follow-up|1|||
147203028|NCT01590888|530913686|FG001|Overall Study|Lost to Follow-up|0|||
147538726|NCT01956123|532126823|FG003|COS Cycle 3|Withdrawal by Subject|1|||
147538727|NCT01461369|532126824|FG000|Overall Study|Lack of Efficacy|2|||
147538728|NCT01461369|532126825|FG001|Overall Study|Lack of Efficacy|0|||
147538729|NCT01461369|532126826|FG002|Overall Study|Lack of Efficacy|6|||
147538730|NCT01461369|532126824|FG000|Overall Study|Lost to Follow-up|0|||
147538731|NCT01461369|532126825|FG001|Overall Study|Lost to Follow-up|0|||
147538732|NCT01461369|532126826|FG002|Overall Study|Lost to Follow-up|3|||
147538733|NCT01461369|532126824|FG000|Overall Study|Adverse Event|9|||
147538734|NCT01461369|532126825|FG001|Overall Study|Adverse Event|12|||
147538735|NCT01461369|532126826|FG002|Overall Study|Adverse Event|4|||
147649427|NCT02634801|532537341|FG000|Extension Period (Weeks 24 to 36)|Adverse Event|0|||
147538736|NCT01461369|532126824|FG000|Overall Study|Protocol Violation|1|||
147538737|NCT01461369|532126825|FG001|Overall Study|Protocol Violation|2|||
147203029|NCT01590888|530913687|FG002|Overall Study|Lost to Follow-up|0|||
147203030|NCT04953728|530913688|FG000|Overall Study|Withdrawal by Subject|3|||
147203031|NCT04953728|530913688|FG000|Overall Study|Physician Decision|1|||
147203032|NCT02331277|530913689|FG000|Overall Study|Withdrawal by Subject|1|||
147203033|NCT02331277|530913690|FG001|Overall Study|Withdrawal by Subject|0|||
147203034|NCT01399372|530913692|FG000|Overall Study|Protocol Violation|3|||
147203035|NCT01399372|530913693|FG001|Overall Study|Protocol Violation|1|||
147203036|NCT01376804|530913694|FG000|Treatment Period|Withdrawal by Subject|1|||
147203037|NCT01376804|530913694|FG000|Treatment Period|Adverse Event|6|||
147203038|NCT01376804|530913694|FG000|Treatment Period|Patient did not receive study drug|1|||
147437801|NCT02871778|531768720|FG005|Part A: Treatment Period 1|Adverse Event|0|||
147437802|NCT02871778|531768721|FG006|Part A: Treatment Period 1|Adverse Event|0|||
147437803|NCT02871778|531768722|FG007|Part A: Treatment Period 1|Adverse Event|0|||
147437804|NCT02871778|531768715|FG000|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|2|||
147437805|NCT02871778|531768716|FG001|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|2|||
147437806|NCT02871778|531768717|FG002|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0|||
147437807|NCT02871778|531768718|FG003|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|2|||
147437808|NCT02871778|531768719|FG004|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0|||
147437809|NCT02871778|531768720|FG005|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0|||
147437810|NCT02871778|531768721|FG006|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0|||
147437811|NCT02871778|531768722|FG007|Part A: Treatment Period 1|Withdrawal of consent (not due to adverse event)|0|||
147437812|NCT02871778|531768715|FG000|Part A: Treatment Period 1|Noncompliant with study drug|0|||
147437813|NCT02871778|531768716|FG001|Part A: Treatment Period 1|Noncompliant with study drug|0|||
147437814|NCT02871778|531768717|FG002|Part A: Treatment Period 1|Noncompliant with study drug|1|||
147437815|NCT02871778|531768718|FG003|Part A: Treatment Period 1|Noncompliant with study drug|0|||
147437816|NCT02871778|531768719|FG004|Part A: Treatment Period 1|Noncompliant with study drug|0|||
147437817|NCT02871778|531768720|FG005|Part A: Treatment Period 1|Noncompliant with study drug|0|||
147437818|NCT02871778|531768721|FG006|Part A: Treatment Period 1|Noncompliant with study drug|0|||
147437819|NCT02871778|531768722|FG007|Part A: Treatment Period 1|Noncompliant with study drug|0|||
147437820|NCT02871778|531768715|FG000|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
147437821|NCT02871778|531768716|FG001|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
147437822|NCT02871778|531768717|FG002|Part A: Treatment Period 1|Other withdrawal criteria met|1|||
147437823|NCT02871778|531768718|FG003|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
147437824|NCT02871778|531768719|FG004|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
147437825|NCT02871778|531768720|FG005|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
147437826|NCT02871778|531768721|FG006|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
147437827|NCT02871778|531768722|FG007|Part A: Treatment Period 1|Other withdrawal criteria met|0|||
147437828|NCT02871778|531768715|FG000|Part A: Treatment Period 1|Wrong drug shipment|0|||
147437829|NCT02871778|531768716|FG001|Part A: Treatment Period 1|Wrong drug shipment|1|||
147437830|NCT02871778|531768717|FG002|Part A: Treatment Period 1|Wrong drug shipment|0|||
147437831|NCT02871778|531768718|FG003|Part A: Treatment Period 1|Wrong drug shipment|0|||
147437832|NCT02871778|531768719|FG004|Part A: Treatment Period 1|Wrong drug shipment|0|||
147437833|NCT02871778|531768720|FG005|Part A: Treatment Period 1|Wrong drug shipment|0|||
147437834|NCT02871778|531768721|FG006|Part A: Treatment Period 1|Wrong drug shipment|0|||
147437835|NCT02871778|531768722|FG007|Part A: Treatment Period 1|Wrong drug shipment|0|||
147437836|NCT02871778|531768715|FG000|Part A: Treatment Period 2|Adverse Event|2|||
147437837|NCT02871778|531768716|FG001|Part A: Treatment Period 2|Adverse Event|2|||
147437838|NCT02871778|531768717|FG002|Part A: Treatment Period 2|Adverse Event|0|||
147437839|NCT02871778|531768718|FG003|Part A: Treatment Period 2|Adverse Event|0|||
147437840|NCT02871778|531768719|FG004|Part A: Treatment Period 2|Adverse Event|0|||
147306811|NCT01852058|531290780|FG007|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
147306812|NCT01852058|531290781|FG008|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
147437841|NCT02871778|531768720|FG005|Part A: Treatment Period 2|Adverse Event|0|||
147437842|NCT02871778|531768721|FG006|Part A: Treatment Period 2|Adverse Event|0|||
147437843|NCT02871778|531768722|FG007|Part A: Treatment Period 2|Adverse Event|0|||
147437844|NCT02871778|531768715|FG000|Part A: Treatment Period 2|Lost to Follow-up|0|||
147437845|NCT02871778|531768716|FG001|Part A: Treatment Period 2|Lost to Follow-up|0|||
147437846|NCT02871778|531768717|FG002|Part A: Treatment Period 2|Lost to Follow-up|0|||
147437847|NCT02871778|531768718|FG003|Part A: Treatment Period 2|Lost to Follow-up|1|||
147437848|NCT02871778|531768719|FG004|Part A: Treatment Period 2|Lost to Follow-up|0|||
147437849|NCT02871778|531768720|FG005|Part A: Treatment Period 2|Lost to Follow-up|0|||
147538738|NCT01461369|532126826|FG002|Overall Study|Protocol Violation|2|||
147203039|NCT01071798|530913695|FG000|Participants Who Received One Cycle|Lack of Efficacy|18|||
147437850|NCT02871778|531768721|FG006|Part A: Treatment Period 2|Lost to Follow-up|0|||
147437851|NCT02871778|531768722|FG007|Part A: Treatment Period 2|Lost to Follow-up|0|||
147538739|NCT01461369|532126824|FG000|Overall Study|Withdrawal by Subject|1|||
147203040|NCT01071798|530913695|FG000|Participants Who Received One Cycle|Lack of tolerability|14|||
147203041|NCT01071798|530913695|FG000|Participants Who Received One Cycle|Patient requirement|20|||
147538740|NCT01461369|532126825|FG001|Overall Study|Withdrawal by Subject|3|||
147538741|NCT01461369|532126826|FG002|Overall Study|Withdrawal by Subject|2|||
147538742|NCT02886494|532126835|FG000|Overall Study|Adverse Event|1|||
147538743|NCT02886494|532126836|FG001|Overall Study|Adverse Event|0|||
147203042|NCT01071798|530913695|FG000|Participants Who Received One Cycle|Death|5|||
147203043|NCT01071798|530913695|FG000|Participants Who Received One Cycle|Change of therapy|6|||
147203044|NCT01071798|530913695|FG000|Participants Who Received One Cycle|Severe concomitant disease|2|||
147203045|NCT01071798|530913695|FG000|Subpopulation Who Received Two Cycles|Remission|1|||
147203046|NCT01071798|530913695|FG000|Subpopulation Who Received Two Cycles|Lack of Efficacy|3|||
147538744|NCT02886494|532126835|FG000|Overall Study|Withdrawal by Subject|12|||
147538745|NCT02886494|532126836|FG001|Overall Study|Withdrawal by Subject|3|||
147538746|NCT02886494|532126835|FG000|Overall Study|Protocol Violation|4|||
147538747|NCT02886494|532126836|FG001|Overall Study|Protocol Violation|1|||
147538748|NCT00499252|532126844|FG000|Overall Study|Adverse Event|3|||
147538749|NCT00499252|532126844|FG000|Overall Study|Refused further treatment|2|||
147538750|NCT00499252|532126844|FG000|Overall Study|Ineligible|4|||
147538751|NCT00499252|532126844|FG000|Overall Study|<no further label>|3|||
147538752|NCT01612780|532126860|FG000|Overall Study|Treatment not completed|1|||
147538753|NCT01612780|532126860|FG000|Overall Study|Withdrawal by Subject|5|||
147538754|NCT00556166|532126861|FG000|Overall Study|Withdrawal by Subject|1|||
147538755|NCT02985515|532126864|FG000|Olfaction Testing|Lost to Follow-up|0|||
147538756|NCT02985515|532126865|FG001|Olfaction Testing|Lost to Follow-up|5|||
147538757|NCT02985515|532126864|FG000|Olfaction Testing|Protocol Violation|0|||
147538758|NCT02985515|532126865|FG001|Olfaction Testing|Protocol Violation|3|||
147538759|NCT03359473|532126866|FG000|Overall Study|Adverse Event|0|||
147538760|NCT03359473|532126867|FG001|Overall Study|Adverse Event|2|||
147538761|NCT03359473|532126868|FG002|Overall Study|Adverse Event|5|||
147538762|NCT03359473|532126869|FG003|Overall Study|Adverse Event|3|||
147538763|NCT03359473|532126866|FG000|Overall Study|Lost to Follow-up|0|||
147538764|NCT03359473|532126867|FG001|Overall Study|Lost to Follow-up|1|||
147538765|NCT03359473|532126868|FG002|Overall Study|Lost to Follow-up|0|||
147538766|NCT03359473|532126869|FG003|Overall Study|Lost to Follow-up|0|||
147538767|NCT03359473|532126866|FG000|Overall Study|Physician Decision|0|||
147538768|NCT03359473|532126867|FG001|Overall Study|Physician Decision|1|||
147538769|NCT03359473|532126868|FG002|Overall Study|Physician Decision|0|||
147538770|NCT03359473|532126869|FG003|Overall Study|Physician Decision|1|||
147538771|NCT03359473|532126866|FG000|Overall Study|Withdrawal by Subject|1|||
147538772|NCT03359473|532126867|FG001|Overall Study|Withdrawal by Subject|2|||
147538773|NCT03359473|532126868|FG002|Overall Study|Withdrawal by Subject|1|||
147538774|NCT03359473|532126869|FG003|Overall Study|Withdrawal by Subject|0|||
147538775|NCT03359473|532126866|FG000|Overall Study|Protocol-defined stopping criteria|1|||
147538776|NCT03359473|532126867|FG001|Overall Study|Protocol-defined stopping criteria|0|||
147538777|NCT03359473|532126868|FG002|Overall Study|Protocol-defined stopping criteria|0|||
147538778|NCT03359473|532126869|FG003|Overall Study|Protocol-defined stopping criteria|1|||
147538779|NCT05302414|532126870|FG000|Pretest to Posttest|Lost to Follow-up|12|||
147538780|NCT05302414|532126871|FG001|Pretest to Posttest|Lost to Follow-up|8|||
147538781|NCT05302414|532126872|FG002|Pretest to Posttest|Lost to Follow-up|8|||
147538782|NCT05302414|532126870|FG000|Posttest to Three Months Follow-up|Lost to Follow-up|16|||
147538783|NCT05302414|532126871|FG001|Posttest to Three Months Follow-up|Lost to Follow-up|16|||
147538784|NCT05302414|532126872|FG002|Posttest to Three Months Follow-up|Lost to Follow-up|16|||
147538785|NCT02628418|532126875|FG000|Overall Study|Lost to Follow-up|1|||
147538786|NCT02628418|532126876|FG001|Overall Study|Lost to Follow-up|2|||
147538787|NCT00424632|532126877|FG000|Overall Study|Death|0|||
147538788|NCT00424632|532126878|FG001|Overall Study|Death|0|||
147538789|NCT00424632|532126879|FG002|Overall Study|Death|0|||
147538790|NCT00424632|532126880|FG003|Overall Study|Death|0|||
147538791|NCT00424632|532126881|FG004|Overall Study|Death|0|||
147538792|NCT00424632|532126882|FG005|Overall Study|Death|2|||
147538793|NCT00424632|532126883|FG006|Overall Study|Death|0|||
147538794|NCT00424632|532126884|FG007|Overall Study|Death|0|||
147538795|NCT00424632|532126885|FG008|Overall Study|Death|0|||
147538796|NCT00424632|532126886|FG009|Overall Study|Death|0|||
147538797|NCT00424632|532126877|FG000|Overall Study|Adverse Event|0|||
147538798|NCT00424632|532126878|FG001|Overall Study|Adverse Event|0|||
147538799|NCT00424632|532126879|FG002|Overall Study|Adverse Event|0|||
147538800|NCT00424632|532126880|FG003|Overall Study|Adverse Event|0|||
147538801|NCT00424632|532126881|FG004|Overall Study|Adverse Event|0|||
147538802|NCT00424632|532126882|FG005|Overall Study|Adverse Event|0|||
147538803|NCT00424632|532126883|FG006|Overall Study|Adverse Event|0|||
147538804|NCT00424632|532126884|FG007|Overall Study|Adverse Event|0|||
147538805|NCT00424632|532126885|FG008|Overall Study|Adverse Event|3|||
147538806|NCT00424632|532126886|FG009|Overall Study|Adverse Event|2|||
147538807|NCT00424632|532126877|FG000|Overall Study|Global deterioration of health status|0|||
147538808|NCT00424632|532126878|FG001|Overall Study|Global deterioration of health status|0|||
147538809|NCT00424632|532126879|FG002|Overall Study|Global deterioration of health status|0|||
147538810|NCT00424632|532126880|FG003|Overall Study|Global deterioration of health status|1|||
147538811|NCT00424632|532126881|FG004|Overall Study|Global deterioration of health status|1|||
147203047|NCT01071798|530913695|FG000|Subpopulation Who Received Two Cycles|Lack of Tolerability|4|||
147203048|NCT01071798|530913695|FG000|Subpopulation Who Received Two Cycles|Patient Requirement|7|||
147203049|NCT01705509|530913700|FG000|Inclusion CPET|Screen Failure|5|||
147203050|NCT01705509|530913700|FG000|Inclusion CPET|Withdrawal by Subject|2|||
147203051|NCT01705509|530913700|FG000|CPET w/ Ranexa|Screen Failure|2|||
147203052|NCT02736890|530913701|FG000|Crossover Next 12 Weeks|Lost to Follow-up|1|||
147437852|NCT02871778|531768715|FG000|Part A: Treatment Period 2|Non-Compliant with Study Drug|1|||
147437853|NCT02871778|531768716|FG001|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
147437854|NCT02871778|531768717|FG002|Part A: Treatment Period 2|Non-Compliant with Study Drug|1|||
147437855|NCT02871778|531768718|FG003|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
147437856|NCT02871778|531768719|FG004|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
147437857|NCT02871778|531768720|FG005|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
147437858|NCT02871778|531768721|FG006|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
147437859|NCT02871778|531768722|FG007|Part A: Treatment Period 2|Non-Compliant with Study Drug|0|||
147437860|NCT02871778|531768715|FG000|Part B: Treatment Period 3|Adverse Event|0|||
147437861|NCT02871778|531768716|FG001|Part B: Treatment Period 3|Adverse Event|0|||
147437862|NCT02871778|531768717|FG002|Part B: Treatment Period 3|Adverse Event|0|||
147437863|NCT02871778|531768718|FG003|Part B: Treatment Period 3|Adverse Event|0|||
147437864|NCT02871778|531768719|FG004|Part B: Treatment Period 3|Adverse Event|1|||
147437865|NCT02871778|531768720|FG005|Part B: Treatment Period 3|Adverse Event|1|||
147437866|NCT02871778|531768721|FG006|Part B: Treatment Period 3|Adverse Event|1|||
147437867|NCT02871778|531768722|FG007|Part B: Treatment Period 3|Adverse Event|0|||
147437868|NCT00232141|531768723|FG000|Overall Study|Adverse Event|9|||
147437869|NCT00232141|531768724|FG001|Overall Study|Adverse Event|4|||
147437870|NCT00232141|531768723|FG000|Overall Study|Lack of Efficacy|0|||
147437871|NCT00232141|531768724|FG001|Overall Study|Lack of Efficacy|3|||
147437872|NCT00232141|531768723|FG000|Overall Study|Lost to Follow-up|9|||
147437873|NCT00232141|531768724|FG001|Overall Study|Lost to Follow-up|6|||
147437874|NCT00232141|531768723|FG000|Overall Study|Other|8|||
147437875|NCT00232141|531768724|FG001|Overall Study|Other|10|||
147437876|NCT00232141|531768723|FG000|Overall Study|Withdrawal by Subject|5|||
147437877|NCT00232141|531768724|FG001|Overall Study|Withdrawal by Subject|3|||
147437878|NCT02273726|531768725|FG000|Overall Study|Death|70|||
147437879|NCT02273726|531768726|FG001|Overall Study|Death|62|||
147437880|NCT02273726|531768725|FG000|Overall Study|Withdrawal by Subject|41|||
147437881|NCT02273726|531768726|FG001|Overall Study|Withdrawal by Subject|29|||
147437882|NCT02273726|531768725|FG000|Overall Study|Kidney transplant|31|||
147437883|NCT02273726|531768726|FG001|Overall Study|Kidney transplant|39|||
147437884|NCT02273726|531768725|FG000|Overall Study|Physician Decision|30|||
147437885|NCT02273726|531768726|FG001|Overall Study|Physician Decision|15|||
147437886|NCT02273726|531768725|FG000|Overall Study|Adverse Event|27|||
147437887|NCT02273726|531768726|FG001|Overall Study|Adverse Event|9|||
147437888|NCT02273726|531768725|FG000|Overall Study|Lost to Follow-up|6|||
147437889|NCT02273726|531768726|FG001|Overall Study|Lost to Follow-up|3|||
147437890|NCT02273726|531768725|FG000|Overall Study|Lack of Efficacy|6|||
147437891|NCT02273726|531768726|FG001|Overall Study|Lack of Efficacy|1|||
147437892|NCT02273726|531768725|FG000|Overall Study|Protocol Violation|4|||
147437893|NCT02273726|531768726|FG001|Overall Study|Protocol Violation|0|||
147437894|NCT02273726|531768725|FG000|Overall Study|Other than specified|28|||
147437895|NCT02273726|531768726|FG001|Overall Study|Other than specified|30|||
147437896|NCT01479829|531768727|FG000|Overall Study|Withdrawal by Subject|8|||
147437897|NCT01479829|531768728|FG001|Overall Study|Withdrawal by Subject|10|||
147437898|NCT04263896|531768730|FG000|Overall Study|Withdrawal by Subject|2|||
147437899|NCT04263896|531768731|FG001|Overall Study|Withdrawal by Subject|4|||
147437900|NCT04263896|531768730|FG000|Overall Study|converted to open procedure|0|||
147437901|NCT04263896|531768731|FG001|Overall Study|converted to open procedure|1|||
147437902|NCT04263896|531768730|FG000|Overall Study|Lost to Follow-up|9|||
147437903|NCT04263896|531768731|FG001|Overall Study|Lost to Follow-up|11|||
147437904|NCT04263896|531768730|FG000|Overall Study|surveys lost in mail|5|||
147437905|NCT04263896|531768731|FG001|Overall Study|surveys lost in mail|3|||
147437906|NCT04263896|531768730|FG000|Overall Study|excluded from analysis|1|||
147437907|NCT04263896|531768731|FG001|Overall Study|excluded from analysis|0|||
147437908|NCT00088907|531770303|FG000|Randomized Study (Step 1)|Lack of Efficacy|55|||
147437909|NCT00088907|531770304|FG001|Randomized Study (Step 1)|Lack of Efficacy|62|||
147203053|NCT02736890|530913702|FG001|Crossover Next 12 Weeks|Lost to Follow-up|2|||
147437910|NCT00088907|531770303|FG000|Randomized Study (Step 1)|Adverse Event|14|||
147437911|NCT00088907|531770304|FG001|Randomized Study (Step 1)|Adverse Event|19|||
147437912|NCT00088907|531770303|FG000|Randomized Study (Step 1)|Death|11|||
147437913|NCT00088907|531770304|FG001|Randomized Study (Step 1)|Death|12|||
147437914|NCT00088907|531770303|FG000|Randomized Study (Step 1)|Withdrawal by Subject|10|||
147437915|NCT00088907|531770304|FG001|Randomized Study (Step 1)|Withdrawal by Subject|15|||
147437916|NCT00088907|531770303|FG000|Randomized Study (Step 1)|complicating disease|3|||
147437917|NCT00088907|531770304|FG001|Randomized Study (Step 1)|complicating disease|1|||
147203054|NCT02736890|530913701|FG000|Crossover Next 12 Weeks|Withdrawal by Subject|1|||
147203055|NCT02736890|530913702|FG001|Crossover Next 12 Weeks|Withdrawal by Subject|0|||
147538812|NCT00424632|532126882|FG005|Overall Study|Global deterioration of health status|0|||
147538813|NCT00424632|532126883|FG006|Overall Study|Global deterioration of health status|0|||
147538814|NCT00424632|532126884|FG007|Overall Study|Global deterioration of health status|0|||
147538815|NCT00424632|532126885|FG008|Overall Study|Global deterioration of health status|0|||
147538816|NCT00424632|532126886|FG009|Overall Study|Global deterioration of health status|0|||
147538817|NCT00424632|532126877|FG000|Overall Study|Objective progression or relapse|1|||
147538818|NCT00424632|532126878|FG001|Overall Study|Objective progression or relapse|1|||
147538819|NCT00424632|532126879|FG002|Overall Study|Objective progression or relapse|1|||
147538820|NCT00424632|532126880|FG003|Overall Study|Objective progression or relapse|2|||
147538821|NCT00424632|532126881|FG004|Overall Study|Objective progression or relapse|2|||
147538822|NCT00424632|532126882|FG005|Overall Study|Objective progression or relapse|13|||
147538823|NCT00424632|532126883|FG006|Overall Study|Objective progression or relapse|7|||
147538824|NCT00424632|532126884|FG007|Overall Study|Objective progression or relapse|3|||
147538825|NCT00424632|532126885|FG008|Overall Study|Objective progression or relapse|12|||
147538826|NCT00424632|532126886|FG009|Overall Study|Objective progression or relapse|4|||
147538827|NCT00424632|532126877|FG000|Overall Study|Other|0|||
147538828|NCT00424632|532126878|FG001|Overall Study|Other|0|||
147538829|NCT00424632|532126879|FG002|Overall Study|Other|0|||
147538830|NCT00424632|532126880|FG003|Overall Study|Other|1|||
147538831|NCT00424632|532126881|FG004|Overall Study|Other|0|||
147538832|NCT00424632|532126882|FG005|Overall Study|Other|0|||
147538833|NCT00424632|532126883|FG006|Overall Study|Other|0|||
147538834|NCT00424632|532126884|FG007|Overall Study|Other|0|||
147538835|NCT00424632|532126885|FG008|Overall Study|Other|1|||
147538836|NCT00424632|532126886|FG009|Overall Study|Other|0|||
147538837|NCT01071083|532126890|FG000|Overall Study|Adverse Event|1|||
147538838|NCT01071083|532126891|FG001|Overall Study|Adverse Event|0|||
147538839|NCT01071083|532126892|FG002|Overall Study|Adverse Event|1|||
147538840|NCT01071083|532126893|FG003|Overall Study|Adverse Event|0|||
147538841|NCT01071083|532126894|FG004|Overall Study|Adverse Event|1|||
147538842|NCT01071083|532126890|FG000|Overall Study|Withdrawal by Subject|3|||
147538843|NCT01071083|532126891|FG001|Overall Study|Withdrawal by Subject|0|||
147538844|NCT01071083|532126892|FG002|Overall Study|Withdrawal by Subject|2|||
147538845|NCT01071083|532126893|FG003|Overall Study|Withdrawal by Subject|0|||
147538846|NCT01071083|532126894|FG004|Overall Study|Withdrawal by Subject|3|||
147538847|NCT01071083|532126890|FG000|Overall Study|Physician Decision|1|||
147538848|NCT01071083|532126891|FG001|Overall Study|Physician Decision|0|||
147538849|NCT01071083|532126892|FG002|Overall Study|Physician Decision|0|||
147538850|NCT01071083|532126893|FG003|Overall Study|Physician Decision|1|||
147538851|NCT01071083|532126894|FG004|Overall Study|Physician Decision|1|||
147538852|NCT01071083|532126890|FG000|Overall Study|Early Rescue|1|||
147538853|NCT01071083|532126891|FG001|Overall Study|Early Rescue|0|||
147538854|NCT01071083|532126892|FG002|Overall Study|Early Rescue|0|||
147538855|NCT01071083|532126893|FG003|Overall Study|Early Rescue|0|||
147538856|NCT01071083|532126894|FG004|Overall Study|Early Rescue|1|||
147538857|NCT01071083|532126890|FG000|Overall Study|Subject Moved|0|||
147538858|NCT01071083|532126891|FG001|Overall Study|Subject Moved|1|||
147538859|NCT01071083|532126892|FG002|Overall Study|Subject Moved|0|||
147538860|NCT01071083|532126893|FG003|Overall Study|Subject Moved|0|||
147538861|NCT01071083|532126894|FG004|Overall Study|Subject Moved|0|||
147538862|NCT01071083|532126890|FG000|Overall Study|Images Not Usable (Motion)|0|||
147538863|NCT01071083|532126891|FG001|Overall Study|Images Not Usable (Motion)|1|||
147538864|NCT01071083|532126892|FG002|Overall Study|Images Not Usable (Motion)|0|||
147538865|NCT01071083|532126893|FG003|Overall Study|Images Not Usable (Motion)|0|||
147538866|NCT01071083|532126894|FG004|Overall Study|Images Not Usable (Motion)|0|||
147538867|NCT01071083|532126890|FG000|Overall Study|Did Not Meet Eligibility Criteria|0|||
147538868|NCT01071083|532126891|FG001|Overall Study|Did Not Meet Eligibility Criteria|0|||
147538869|NCT01071083|532126892|FG002|Overall Study|Did Not Meet Eligibility Criteria|1|||
147538870|NCT01071083|532126893|FG003|Overall Study|Did Not Meet Eligibility Criteria|1|||
147538871|NCT01071083|532126894|FG004|Overall Study|Did Not Meet Eligibility Criteria|1|||
147538872|NCT01071083|532126890|FG000|Overall Study|Did Not Want Per Protocol Treatment|0|||
147538873|NCT01071083|532126891|FG001|Overall Study|Did Not Want Per Protocol Treatment|0|||
147538874|NCT01071083|532126892|FG002|Overall Study|Did Not Want Per Protocol Treatment|1|||
147538875|NCT01071083|532126893|FG003|Overall Study|Did Not Want Per Protocol Treatment|0|||
147538876|NCT01071083|532126894|FG004|Overall Study|Did Not Want Per Protocol Treatment|1|||
147538877|NCT01071083|532126890|FG000|Overall Study|Subject Refused to Continue|1|||
147538878|NCT01071083|532126891|FG001|Overall Study|Subject Refused to Continue|0|||
147538879|NCT01071083|532126892|FG002|Overall Study|Subject Refused to Continue|0|||
147538880|NCT01071083|532126893|FG003|Overall Study|Subject Refused to Continue|0|||
147538881|NCT01071083|532126894|FG004|Overall Study|Subject Refused to Continue|0|||
147538882|NCT01523301|532126895|FG000|Overall Study|Adverse Event|25|||
147538883|NCT01523301|532126896|FG001|Overall Study|Adverse Event|16|||
147538884|NCT01523301|532126895|FG000|Overall Study|Lack of Efficacy|0|||
147538885|NCT01523301|532126896|FG001|Overall Study|Lack of Efficacy|2|||
147538886|NCT01523301|532126895|FG000|Overall Study|Protocol Violation|3|||
147538887|NCT01523301|532126896|FG001|Overall Study|Protocol Violation|4|||
147203056|NCT02904954|530913703|FG000|Neoadjuvant (Preoperative) to Surgery|Death|1|||
147203057|NCT02904954|530913704|FG001|Neoadjuvant (Preoperative) to Surgery|Death|1|||
147203058|NCT02904954|530913703|FG000|Neoadjuvant (Preoperative) to Surgery|Withdrawal by Subject|1|||
147203059|NCT02904954|530913704|FG001|Neoadjuvant (Preoperative) to Surgery|Withdrawal by Subject|0|||
147538888|NCT01523301|532126895|FG000|Overall Study|Lost to Follow-up|1|||
147538889|NCT01523301|532126896|FG001|Overall Study|Lost to Follow-up|0|||
147538890|NCT01523301|532126895|FG000|Overall Study|Withdrawal by Subject|6|||
147538891|NCT01523301|532126896|FG001|Overall Study|Withdrawal by Subject|8|||
147538892|NCT01523301|532126895|FG000|Overall Study|Other Reason|0|||
147538893|NCT01523301|532126896|FG001|Overall Study|Other Reason|2|||
147538894|NCT01339000|532126897|FG000|Overall Study|study closed due to lack of drug supply|1|||
147538895|NCT01339000|532126898|FG001|Overall Study|study closed due to lack of drug supply|0|||
147538896|NCT00728988|532126899|FG000|Overall Study|Not Treated|2|||
147538897|NCT00728988|532126900|FG001|Overall Study|Not Treated|2|||
147538898|NCT00728988|532126899|FG000|Overall Study|Death|1|||
147538899|NCT00728988|532126900|FG001|Overall Study|Death|1|||
147538900|NCT00728988|532126899|FG000|Overall Study|Adverse Event|3|||
147538901|NCT00728988|532126900|FG001|Overall Study|Adverse Event|2|||
147538902|NCT00728988|532126899|FG000|Overall Study|Other|85|||
147538903|NCT00728988|532126900|FG001|Overall Study|Other|77|||
147538904|NCT00728988|532126899|FG000|Overall Study|Withdrawal by Subject|2|||
147538905|NCT00728988|532126900|FG001|Overall Study|Withdrawal by Subject|6|||
147538906|NCT05674721|532126903|FG000|Washout Period (Up to 7 Days)|Adverse Event|0|||
147538907|NCT05674721|532126904|FG001|Washout Period (Up to 7 Days)|Adverse Event|1|||
147538908|NCT05674721|532126903|FG000|Washout Period (Up to 7 Days)|Withdrawal by Subject|0|||
147538909|NCT05674721|532126904|FG001|Washout Period (Up to 7 Days)|Withdrawal by Subject|1|||
147538910|NCT05013749|532126910|FG000|Overall Study|Patients without signs of PAS in the intraoperative staging. US false positive|7|||
147538911|NCT05013749|532126911|FG001|Overall Study|Patients without signs of PAS in the intraoperative staging. US false positive|2|||
147538912|NCT05013749|532126910|FG000|Overall Study|Did not meet the requirements for OSCS after intraoperative staging.|0|||
147538913|NCT05013749|532126911|FG001|Overall Study|Did not meet the requirements for OSCS after intraoperative staging.|9|||
147538914|NCT02017535|532126914|FG000|Overall Study|Withdrawal by Subject|1|||
147538915|NCT02017535|532126915|FG001|Overall Study|Withdrawal by Subject|0|||
147538916|NCT02017535|532126916|FG002|Overall Study|Withdrawal by Subject|0|||
147538917|NCT02017535|532126917|FG003|Overall Study|Withdrawal by Subject|0|||
147538918|NCT03506425|532126918|FG000|Overall Study|Adverse Event|1|||
147538919|NCT03506425|532126919|FG001|Overall Study|Adverse Event|3|||
147538920|NCT03506425|532126920|FG002|Overall Study|Adverse Event|0|||
147538921|NCT03506425|532126918|FG000|Overall Study|Death|1|||
147538922|NCT03506425|532126919|FG001|Overall Study|Death|0|||
147538923|NCT03506425|532126920|FG002|Overall Study|Death|0|||
147538924|NCT03506425|532126918|FG000|Overall Study|Withdrawal by Subject|0|||
147538925|NCT03506425|532126919|FG001|Overall Study|Withdrawal by Subject|0|||
147538926|NCT03506425|532126920|FG002|Overall Study|Withdrawal by Subject|1|||
147538927|NCT04797637|532126923|FG000|Overall Study|Lost to Follow-up|23|||
147538928|NCT04797637|532126924|FG001|Overall Study|Lost to Follow-up|32|||
147538929|NCT04797637|532126923|FG000|Overall Study|Withdrawal by Subject|0|||
147538930|NCT04797637|532126924|FG001|Overall Study|Withdrawal by Subject|1|||
147538931|NCT02380248|532126925|FG000|Overall Study|Lost to Follow-up|11|||
147538932|NCT02380248|532126925|FG000|Overall Study|Withdrawal by Subject|3|||
147538933|NCT00690573|532126937|FG000|Overall Study|Lack of Efficacy|8|||
147538934|NCT00690573|532126937|FG000|Overall Study|Withdrawal by Subject|1|||
147538935|NCT01126359|532126940|FG000|First Intervention (20-minutes)|Physician Decision|0|||
147538936|NCT01126359|532126941|FG001|First Intervention (20-minutes)|Physician Decision|1|||
147538937|NCT01298661|532126942|FG000|Overall Study|Withdrawal by Subject|2|||
147538938|NCT01298661|532126943|FG001|Overall Study|Withdrawal by Subject|0|||
147538939|NCT01298661|532126944|FG002|Overall Study|Withdrawal by Subject|2|||
147538940|NCT00526227|532126945|FG000|Overall Study|Device not implanted|1|||
147538941|NCT00526227|532126945|FG000|Overall Study|Death|1|||
147538942|NCT05378269|532128954|FG000|Overall Study|Protocol Violation|1|||
147203060|NCT02904954|530913703|FG000|Neoadjuvant (Preoperative) to Surgery|Disease progression|2|||
147538943|NCT05378269|532128955|FG001|Overall Study|Protocol Violation|0|||
147203061|NCT02904954|530913704|FG001|Neoadjuvant (Preoperative) to Surgery|Disease progression|3|||
147538944|NCT05378269|532128956|FG002|Overall Study|Protocol Violation|2|||
147538945|NCT05378269|532128957|FG003|Overall Study|Protocol Violation|0|||
147538946|NCT05378269|532128958|FG004|Overall Study|Protocol Violation|0|||
147538947|NCT00684645|532128959|FG000|Overall Study|Death|2|||
147538948|NCT00684645|532128959|FG000|Overall Study|Progressive disease|67|||
147203062|NCT02904954|530913703|FG000|Adjuvant Durvalumab|Recurrence|2|||
147538949|NCT00684645|532128959|FG000|Overall Study|Adverse Event|27|||
147538950|NCT00684645|532128959|FG000|Overall Study|Lost to Follow-up|3|||
147203063|NCT02904954|530913704|FG001|Adjuvant Durvalumab|Recurrence|0|||
147538951|NCT00684645|532128959|FG000|Overall Study|Other|15|||
147538952|NCT01186744|532128960|FG000|Overall Study|Lack of Efficacy|156|||
147538953|NCT01186744|532128961|FG001|Overall Study|Lack of Efficacy|99|||
147538954|NCT01186744|532128962|FG002|Overall Study|Lack of Efficacy|0|||
147538955|NCT01186744|532128963|FG003|Overall Study|Lack of Efficacy|2|||
147538956|NCT01186744|532128964|FG004|Overall Study|Lack of Efficacy|2|||
147538957|NCT01186744|532128965|FG005|Overall Study|Lack of Efficacy|5|||
147538958|NCT01186744|532128960|FG000|Overall Study|Protocol Violation|1|||
147538959|NCT01186744|532128961|FG001|Overall Study|Protocol Violation|2|||
147538960|NCT01186744|532128962|FG002|Overall Study|Protocol Violation|0|||
147538961|NCT01186744|532128963|FG003|Overall Study|Protocol Violation|1|||
147538962|NCT01186744|532128964|FG004|Overall Study|Protocol Violation|1|||
147538963|NCT01186744|532128965|FG005|Overall Study|Protocol Violation|2|||
147538964|NCT01186744|532128960|FG000|Overall Study|Lost to Follow-up|15|||
147538965|NCT01186744|532128961|FG001|Overall Study|Lost to Follow-up|16|||
147538966|NCT01186744|532128962|FG002|Overall Study|Lost to Follow-up|2|||
147538967|NCT01186744|532128963|FG003|Overall Study|Lost to Follow-up|1|||
147538968|NCT01186744|532128964|FG004|Overall Study|Lost to Follow-up|1|||
147538969|NCT01186744|532128965|FG005|Overall Study|Lost to Follow-up|4|||
147538970|NCT01186744|532128960|FG000|Overall Study|Screen failure|1|||
147538971|NCT01186744|532128961|FG001|Overall Study|Screen failure|1|||
147538972|NCT01186744|532128962|FG002|Overall Study|Screen failure|0|||
147538973|NCT01186744|532128963|FG003|Overall Study|Screen failure|1|||
147538974|NCT01186744|532128964|FG004|Overall Study|Screen failure|0|||
147538975|NCT01186744|532128965|FG005|Overall Study|Screen failure|0|||
147538976|NCT01186744|532128960|FG000|Overall Study|Withdrawal by Subject|14|||
147538977|NCT01186744|532128961|FG001|Overall Study|Withdrawal by Subject|10|||
147538978|NCT01186744|532128962|FG002|Overall Study|Withdrawal by Subject|2|||
147538979|NCT01186744|532128963|FG003|Overall Study|Withdrawal by Subject|5|||
147538980|NCT01186744|532128964|FG004|Overall Study|Withdrawal by Subject|0|||
147538981|NCT01186744|532128965|FG005|Overall Study|Withdrawal by Subject|6|||
147538982|NCT01186744|532128960|FG000|Overall Study|Study terminated by Sponsor|1|||
147538983|NCT01186744|532128961|FG001|Overall Study|Study terminated by Sponsor|0|||
147538984|NCT01186744|532128962|FG002|Overall Study|Study terminated by Sponsor|0|||
147538985|NCT01186744|532128963|FG003|Overall Study|Study terminated by Sponsor|0|||
147538986|NCT01186744|532128964|FG004|Overall Study|Study terminated by Sponsor|0|||
147538987|NCT01186744|532128965|FG005|Overall Study|Study terminated by Sponsor|0|||
147538988|NCT01186744|532128960|FG000|Overall Study|Other|9|||
147538989|NCT01186744|532128961|FG001|Overall Study|Other|10|||
147538990|NCT01186744|532128962|FG002|Overall Study|Other|1|||
147538991|NCT01186744|532128963|FG003|Overall Study|Other|2|||
147538992|NCT01186744|532128964|FG004|Overall Study|Other|1|||
147538993|NCT01186744|532128965|FG005|Overall Study|Other|5|||
147538994|NCT01186744|532128960|FG000|Overall Study|Adverse Event|10|||
147538995|NCT01186744|532128961|FG001|Overall Study|Adverse Event|14|||
147538996|NCT01186744|532128962|FG002|Overall Study|Adverse Event|1|||
147538997|NCT01186744|532128963|FG003|Overall Study|Adverse Event|0|||
147538998|NCT01186744|532128964|FG004|Overall Study|Adverse Event|1|||
147538999|NCT01186744|532128965|FG005|Overall Study|Adverse Event|4|||
147539000|NCT01186744|532128960|FG000|Overall Study|Death|1|||
147539001|NCT01186744|532128961|FG001|Overall Study|Death|0|||
147539002|NCT01186744|532128962|FG002|Overall Study|Death|0|||
147539003|NCT01186744|532128963|FG003|Overall Study|Death|0|||
147539004|NCT01186744|532128964|FG004|Overall Study|Death|0|||
147539005|NCT01186744|532128965|FG005|Overall Study|Death|0|||
147539006|NCT02325401|532128968|FG000|Overall Study|Withdrawal by Subject|0|||
147539007|NCT02325401|532128969|FG001|Overall Study|Withdrawal by Subject|1|||
147539008|NCT02325401|532128970|FG002|Overall Study|Withdrawal by Subject|1|||
147539009|NCT00734617|532128971|FG000|Overall Study|Adverse Event|4|||
147539010|NCT00734617|532128972|FG001|Overall Study|Adverse Event|7|||
147539011|NCT00734617|532128971|FG000|Overall Study|Withdrawal by Subject|103|||
147539012|NCT00734617|532128972|FG001|Overall Study|Withdrawal by Subject|95|||
147539013|NCT00537056|532128976|FG000|Interim PET/CT|scheduling conflicts and/or exposure|5|||
147539014|NCT01257737|532128977|FG000|Overall Study|Lost to Follow-up|1|||
147539015|NCT01257737|532128978|FG001|Overall Study|Lost to Follow-up|2|||
147539016|NCT01257737|532128977|FG000|Overall Study|Liver transplant|1|||
147539017|NCT01257737|532128978|FG001|Overall Study|Liver transplant|0|||
147539018|NCT01257737|532128977|FG000|Overall Study|Relocation out of the country|0|||
147539019|NCT01257737|532128978|FG001|Overall Study|Relocation out of the country|1|||
147539020|NCT01257737|532128977|FG000|Overall Study|Withdrew from study|0|||
147539021|NCT01257737|532128978|FG001|Overall Study|Withdrew from study|1|||
147539022|NCT03020966|532128981|FG000|Overall Study|Withdrawal by Subject|2|||
147539023|NCT03020966|532128982|FG001|Overall Study|Withdrawal by Subject|0|||
147539024|NCT00962013|532128988|FG000|Overall Study|Did not have surgery|1|||
147539025|NCT00962013|532128988|FG000|Overall Study|Death|8|||
147539026|NCT00962013|532128988|FG000|Overall Study|Lost to Follow-up|12|||
147539027|NCT00962013|532128988|FG000|Overall Study|Unable/Unwilling to return|6|||
147539028|NCT00962013|532128988|FG000|Overall Study|Withdrawal by Subject|8|||
147539029|NCT00962013|532128988|FG000|Overall Study|Removal of study device|3|||
147539030|NCT00962013|532128988|FG000|Overall Study|Site Termination|24|||
147539031|NCT00962013|532128988|FG000|Overall Study|No 5 year evaluation|6|||
147539032|NCT00445458|532128995|FG000|Overall Study|Disease Progression|3|||
147539033|NCT00445458|532128996|FG001|Overall Study|Disease Progression|4|||
147539034|NCT00445458|532128997|FG002|Overall Study|Disease Progression|54|||
147203064|NCT02904954|530913703|FG000|Adjuvant Durvalumab|Adverse Event|2|||
147203065|NCT02904954|530913704|FG001|Adjuvant Durvalumab|Adverse Event|6|||
147203066|NCT02904954|530913703|FG000|Adjuvant Durvalumab|Participant wishes|12|||
147437918|NCT00088907|531770303|FG000|Randomized Study (Step 1)|unknown/not specify|24|||
147437919|NCT00088907|531770304|FG001|Randomized Study (Step 1)|unknown/not specify|13|||
147437920|NCT00088907|531770303|FG000|Randomized Study (Step 1)|ineligible or not start protocol therapy|19|||
147437921|NCT00088907|531770304|FG001|Randomized Study (Step 1)|ineligible or not start protocol therapy|12|||
147437922|NCT00088907|531770303|FG000|Single Gefitinib Treatment (Step 2)|Lack of Efficacy|16|||
147437923|NCT00088907|531770304|FG001|Single Gefitinib Treatment (Step 2)|Lack of Efficacy|0|||
147437924|NCT00088907|531770303|FG000|Single Gefitinib Treatment (Step 2)|Death|1|||
147437925|NCT00088907|531770304|FG001|Single Gefitinib Treatment (Step 2)|Death|0|||
147437926|NCT00088907|531770303|FG000|Single Gefitinib Treatment (Step 2)|unknown/not specify|2|||
147437927|NCT00088907|531770304|FG001|Single Gefitinib Treatment (Step 2)|unknown/not specify|0|||
147437928|NCT00088907|531770303|FG000|Single Gefitinib Treatment (Step 2)|not start protocol therapy|5|||
147437929|NCT00088907|531770304|FG001|Single Gefitinib Treatment (Step 2)|not start protocol therapy|0|||
147437930|NCT04050670|531770305|FG000|Period 3|Physician Decision|0|||
147437931|NCT04050670|531770306|FG001|Period 3|Physician Decision|1|||
147437932|NCT04050670|531770307|FG002|Period 3|Physician Decision|0|||
147437933|NCT00880555|531770309|FG000|Overall Study|Physician Decision|0|||
147437934|NCT00880555|531770310|FG001|Overall Study|Physician Decision|8|||
147437935|NCT00880555|531770311|FG002|Overall Study|Physician Decision|0|||
147437936|NCT00880555|531770312|FG003|Overall Study|Physician Decision|2|||
147437937|NCT00880555|531770313|FG004|Overall Study|Physician Decision|1|||
147437938|NCT00880555|531770314|FG005|Overall Study|Physician Decision|0|||
147437939|NCT00880555|531770309|FG000|Overall Study|Withdrawal by Subject|1|||
147437940|NCT00880555|531770310|FG001|Overall Study|Withdrawal by Subject|1|||
147437941|NCT00880555|531770311|FG002|Overall Study|Withdrawal by Subject|0|||
147437942|NCT00880555|531770312|FG003|Overall Study|Withdrawal by Subject|0|||
147437943|NCT00880555|531770313|FG004|Overall Study|Withdrawal by Subject|0|||
147437944|NCT00880555|531770314|FG005|Overall Study|Withdrawal by Subject|0|||
147437945|NCT00880555|531770309|FG000|Overall Study|Lack of resources (hired rater)|9|||
147437946|NCT00880555|531770310|FG001|Overall Study|Lack of resources (hired rater)|7|||
147437947|NCT00880555|531770311|FG002|Overall Study|Lack of resources (hired rater)|5|||
147437948|NCT00880555|531770312|FG003|Overall Study|Lack of resources (hired rater)|0|||
147437949|NCT00880555|531770313|FG004|Overall Study|Lack of resources (hired rater)|0|||
147437950|NCT00880555|531770314|FG005|Overall Study|Lack of resources (hired rater)|0|||
147437951|NCT00880555|531770309|FG000|Overall Study|Death|0|||
147437952|NCT00880555|531770310|FG001|Overall Study|Death|0|||
147437953|NCT00880555|531770311|FG002|Overall Study|Death|0|||
147437954|NCT00880555|531770312|FG003|Overall Study|Death|0|||
147437955|NCT00880555|531770313|FG004|Overall Study|Death|0|||
147437956|NCT00880555|531770314|FG005|Overall Study|Death|1|||
147437957|NCT00880555|531770309|FG000|Overall Study|Lost to Follow-up|0|||
147437958|NCT00880555|531770310|FG001|Overall Study|Lost to Follow-up|1|||
147437959|NCT00880555|531770311|FG002|Overall Study|Lost to Follow-up|0|||
147437960|NCT00880555|531770312|FG003|Overall Study|Lost to Follow-up|0|||
147437961|NCT00880555|531770313|FG004|Overall Study|Lost to Follow-up|0|||
147437962|NCT00880555|531770314|FG005|Overall Study|Lost to Follow-up|0|||
147437963|NCT01756040|531770316|FG000|IP in Preterm Infants: Cohort 1|Death|1|||
147437964|NCT01756040|531770316|FG000|IP in Preterm Infants: Cohort 2|Death|1|||
147437965|NCT01756040|531770316|FG000|IP in Preterm Infants: Cohort 2|did not receive sugar probe dose|8|||
147437966|NCT01274715|531770317|FG000|Overall Study|Lost to Follow-up|1|||
147437967|NCT01274715|531770317|FG000|Overall Study|After consent, met exclusion criteria.|1|||
147437968|NCT01274715|531770317|FG000|Overall Study|After consent, met exclusion criteria.|1|||
147437969|NCT01274715|531770317|FG000|Overall Study|After consent, met exclusion criteria.|1|||
147437970|NCT04479436|531770318|FG000|Overall Study|Progressive disease|26|||
147437971|NCT04479436|531770319|FG001|Overall Study|Progressive disease|1|||
147437972|NCT04479436|531770318|FG000|Overall Study|Adverse Event|6|||
147437973|NCT04479436|531770319|FG001|Overall Study|Adverse Event|0|||
147437974|NCT04479436|531770318|FG000|Overall Study|Withdrawal by Subject|5|||
147437975|NCT04479436|531770319|FG001|Overall Study|Withdrawal by Subject|0|||
147437976|NCT04479436|531770318|FG000|Overall Study|Clinical progression|1|||
147437977|NCT04479436|531770319|FG001|Overall Study|Clinical progression|0|||
147437978|NCT04479436|531770318|FG000|Overall Study|Physician Decision|1|||
147437979|NCT04479436|531770319|FG001|Overall Study|Physician Decision|0|||
147437980|NCT02713542|531770320|FG000|Overall Study|Use of prohibited medication|14|||
147437981|NCT02713542|531770321|FG001|Overall Study|Use of prohibited medication|5|||
147437982|NCT02713542|531770320|FG000|Overall Study|Withdrawal by Subject|4|||
147437983|NCT02713542|531770321|FG001|Overall Study|Withdrawal by Subject|1|||
147437984|NCT02357134|531770322|FG000|Overall Study|Lost to Follow-up|1|||
147437985|NCT02357134|531770323|FG001|Overall Study|Lost to Follow-up|0|||
147437986|NCT02357134|531770324|FG002|Overall Study|Lost to Follow-up|0|||
147437987|NCT02357134|531770325|FG003|Overall Study|Lost to Follow-up|0|||
147437988|NCT05097716|531770326|FG000|Period 1|Adverse Event|1|||
147203067|NCT02904954|530913704|FG001|Adjuvant Durvalumab|Participant wishes|7|||
147539035|NCT00445458|532128998|FG003|Overall Study|Disease Progression|27|||
147539036|NCT00445458|532128995|FG000|Overall Study|Withdrawal by Subject|0|||
147539037|NCT00445458|532128996|FG001|Overall Study|Withdrawal by Subject|0|||
147539038|NCT00445458|532128997|FG002|Overall Study|Withdrawal by Subject|7|||
147539039|NCT00445458|532128998|FG003|Overall Study|Withdrawal by Subject|0|||
147539040|NCT00445458|532128995|FG000|Overall Study|Adverse Event|0|||
147539041|NCT00445458|532128996|FG001|Overall Study|Adverse Event|0|||
147539042|NCT00445458|532128997|FG002|Overall Study|Adverse Event|3|||
147539043|NCT00445458|532128998|FG003|Overall Study|Adverse Event|0|||
147539044|NCT00445458|532128995|FG000|Overall Study|Death|0|||
147539045|NCT00445458|532128996|FG001|Overall Study|Death|1|||
147539046|NCT00445458|532128997|FG002|Overall Study|Death|2|||
147539047|NCT00445458|532128998|FG003|Overall Study|Death|0|||
147539048|NCT00445458|532128995|FG000|Overall Study|Physician Decision|0|||
147539049|NCT00445458|532128996|FG001|Overall Study|Physician Decision|0|||
147539050|NCT00445458|532128997|FG002|Overall Study|Physician Decision|1|||
147539051|NCT00445458|532128998|FG003|Overall Study|Physician Decision|1|||
147539052|NCT00445458|532128995|FG000|Overall Study|Surgery|0|||
147539053|NCT00445458|532128996|FG001|Overall Study|Surgery|0|||
147539054|NCT00445458|532128997|FG002|Overall Study|Surgery|1|||
147539055|NCT00445458|532128998|FG003|Overall Study|Surgery|0|||
147539056|NCT03972709|532129001|FG000|Overall Study|Withdrawal by Subject|18|||
147539057|NCT03972709|532129002|FG001|Overall Study|Withdrawal by Subject|7|||
147539058|NCT03972709|532129003|FG002|Overall Study|Withdrawal by Subject|14|||
147539059|NCT03972709|532129001|FG000|Overall Study|Study Terminated by Sponsor|48|||
147539060|NCT03972709|532129002|FG001|Overall Study|Study Terminated by Sponsor|25|||
147539061|NCT03972709|532129003|FG002|Overall Study|Study Terminated by Sponsor|50|||
147539062|NCT03972709|532129001|FG000|Overall Study|Physician Decision|1|||
147539063|NCT03972709|532129002|FG001|Overall Study|Physician Decision|0|||
147539064|NCT03972709|532129003|FG002|Overall Study|Physician Decision|0|||
147539065|NCT03972709|532129001|FG000|Overall Study|COVID-19|0|||
147539066|NCT03972709|532129002|FG001|Overall Study|COVID-19|1|||
147539067|NCT03972709|532129003|FG002|Overall Study|COVID-19|1|||
147539068|NCT03972709|532129001|FG000|Overall Study|Lost to Follow-up|6|||
147539069|NCT03972709|532129002|FG001|Overall Study|Lost to Follow-up|1|||
147539070|NCT03972709|532129003|FG002|Overall Study|Lost to Follow-up|2|||
147539071|NCT03972709|532129001|FG000|Overall Study|Death|5|||
147539072|NCT03972709|532129002|FG001|Overall Study|Death|1|||
147539073|NCT03972709|532129003|FG002|Overall Study|Death|4|||
147539074|NCT03972709|532129001|FG000|Overall Study|Adverse Event|3|||
147539075|NCT03972709|532129002|FG001|Overall Study|Adverse Event|1|||
147539076|NCT03972709|532129003|FG002|Overall Study|Adverse Event|4|||
147539077|NCT03972709|532129001|FG000|Overall Study|Subject Expired Due to SAE with Onset Beyond Protocol Reporting Period|0|||
147539078|NCT03972709|532129002|FG001|Overall Study|Subject Expired Due to SAE with Onset Beyond Protocol Reporting Period|1|||
147539079|NCT03972709|532129003|FG002|Overall Study|Subject Expired Due to SAE with Onset Beyond Protocol Reporting Period|0|||
147539080|NCT03972709|532129001|FG000|Overall Study|Subject in Nursing Home, Unable to Attend Visit|0|||
147539081|NCT03972709|532129002|FG001|Overall Study|Subject in Nursing Home, Unable to Attend Visit|0|||
147539082|NCT03972709|532129003|FG002|Overall Study|Subject in Nursing Home, Unable to Attend Visit|1|||
147539083|NCT03972709|532129001|FG000|Overall Study|Subject Unable to be Contacted|0|||
147539084|NCT03972709|532129002|FG001|Overall Study|Subject Unable to be Contacted|1|||
147539085|NCT03972709|532129003|FG002|Overall Study|Subject Unable to be Contacted|0|||
147539086|NCT03972709|532129001|FG000|Overall Study|Subject Discontinuation Due to AEs with Onset Beyond Study Reporting Period|0|||
147539087|NCT03972709|532129002|FG001|Overall Study|Subject Discontinuation Due to AEs with Onset Beyond Study Reporting Period|1|||
147539088|NCT03972709|532129003|FG002|Overall Study|Subject Discontinuation Due to AEs with Onset Beyond Study Reporting Period|0|||
147539089|NCT03972709|532129001|FG000|Overall Study|Subject Moved|0|||
147539090|NCT03972709|532129002|FG001|Overall Study|Subject Moved|1|||
147539091|NCT03972709|532129003|FG002|Overall Study|Subject Moved|0|||
147539092|NCT03972709|532129001|FG000|Overall Study|Missed Study Visits|1|||
147539093|NCT03972709|532129002|FG001|Overall Study|Missed Study Visits|0|||
147539094|NCT03972709|532129003|FG002|Overall Study|Missed Study Visits|0|||
147539095|NCT04732728|532129004|FG000|Overall Study|Death|12|||
147539096|NCT04732728|532129004|FG000|Overall Study|Withdrawn|136|||
147539097|NCT01393626|532129013|FG000|Overall Study|Adverse Event|2|||
147539098|NCT01393626|532129014|FG001|Overall Study|Adverse Event|1|||
147539099|NCT01393626|532129015|FG002|Overall Study|Adverse Event|5|||
147539100|NCT01393626|532129016|FG003|Overall Study|Adverse Event|0|||
147539101|NCT01393626|532129013|FG000|Overall Study|Did not meet entrance criteria|1|||
147539102|NCT01393626|532129014|FG001|Overall Study|Did not meet entrance criteria|0|||
147539103|NCT01393626|532129015|FG002|Overall Study|Did not meet entrance criteria|0|||
147539104|NCT01393626|532129016|FG003|Overall Study|Did not meet entrance criteria|0|||
147539105|NCT01393626|532129013|FG000|Overall Study|Lack of Efficacy|6|||
147539106|NCT01393626|532129014|FG001|Overall Study|Lack of Efficacy|6|||
147539107|NCT01393626|532129015|FG002|Overall Study|Lack of Efficacy|4|||
147539108|NCT01393626|532129016|FG003|Overall Study|Lack of Efficacy|1|||
147539109|NCT01393626|532129013|FG000|Overall Study|Lost to Follow-up|1|||
147539110|NCT01393626|532129014|FG001|Overall Study|Lost to Follow-up|1|||
147203068|NCT02904954|530913703|FG000|Adjuvant Durvalumab|Physician Decision|2|||
147203069|NCT02904954|530913704|FG001|Adjuvant Durvalumab|Physician Decision|1|||
147203070|NCT02904954|530913703|FG000|Adjuvant Durvalumab|Slow recovery after chemotherapy|1|||
147203071|NCT02904954|530913704|FG001|Adjuvant Durvalumab|Slow recovery after chemotherapy|0|||
147203072|NCT02904954|530913703|FG000|Adjuvant Durvalumab|Death|0|||
147203073|NCT02904954|530913704|FG001|Adjuvant Durvalumab|Death|1|||
147203074|NCT02904954|530913703|FG000|Adjuvant Durvalumab|Prostate cancer|1|||
147203075|NCT02904954|530913704|FG001|Adjuvant Durvalumab|Prostate cancer|0|||
147203076|NCT05097963|530913705|FG000|Overall Study|Protocol Violation|13|||
147203077|NCT05097963|530913705|FG000|Overall Study|Withdrawal by Subject|21|||
147203078|NCT03349034|530913708|FG000|Overall Study|catheters dislodged during transport|2|||
147203079|NCT03349034|530913709|FG001|Overall Study|catheters dislodged during transport|0|||
147203080|NCT03349034|530913708|FG000|Overall Study|intubated for >48 hrs following surgery|1|||
147203081|NCT03349034|530913709|FG001|Overall Study|intubated for >48 hrs following surgery|1|||
147203082|NCT03349034|530913708|FG000|Overall Study|soft tissue flap used|1|||
147203083|NCT03349034|530913709|FG001|Overall Study|soft tissue flap used|0|||
147203084|NCT03349034|530913708|FG000|Overall Study|Other|0|||
147203085|NCT03349034|530913709|FG001|Overall Study|Other|1|||
147203086|NCT01039376|530913710|FG000|Overall Study|Lost to Follow-up|5|||
147203087|NCT01039376|530913711|FG001|Overall Study|Lost to Follow-up|12|||
147203088|NCT01039376|530913710|FG000|Overall Study|Physician Decision|15|||
147203089|NCT01039376|530913711|FG001|Overall Study|Physician Decision|10|||
147203090|NCT01039376|530913710|FG000|Overall Study|Withdrawal by Subject|20|||
147203091|NCT01039376|530913711|FG001|Overall Study|Withdrawal by Subject|32|||
147203092|NCT01039376|530913710|FG000|Overall Study|Study terminated by Sponsor|90|||
147203093|NCT01039376|530913711|FG001|Overall Study|Study terminated by Sponsor|72|||
147203094|NCT00123422|530913712|FG000|Overall Study|Physician Decision|2|||
147203095|NCT00123422|530913713|FG001|Overall Study|Physician Decision|2|||
147203096|NCT00123422|530913714|FG002|Overall Study|Physician Decision|6|||
147203097|NCT00123422|530913712|FG000|Overall Study|Withdrawal by Subject|1|||
147203098|NCT00123422|530913713|FG001|Overall Study|Withdrawal by Subject|2|||
147203099|NCT00123422|530913714|FG002|Overall Study|Withdrawal by Subject|2|||
147203100|NCT00123422|530913712|FG000|Overall Study|Lost to Follow-up|1|||
147203101|NCT00123422|530913713|FG001|Overall Study|Lost to Follow-up|2|||
147203102|NCT00123422|530913714|FG002|Overall Study|Lost to Follow-up|2|||
147203103|NCT01554241|530913715|FG000|Overall Study|Death|3|||
147203104|NCT01554241|530913716|FG001|Overall Study|Death|1|||
147203105|NCT01554241|530913717|FG002|Overall Study|Death|1|||
147203106|NCT01554241|530913718|FG003|Overall Study|Death|0|||
147203107|NCT01554241|530913715|FG000|Overall Study|protocol specified renal stone|0|||
147203108|NCT01554241|530913716|FG001|Overall Study|protocol specified renal stone|0|||
147203109|NCT01554241|530913717|FG002|Overall Study|protocol specified renal stone|0|||
147203110|NCT01554241|530913718|FG003|Overall Study|protocol specified renal stone|1|||
147203111|NCT01554241|530913715|FG000|Overall Study|protocol specified change in eGFR|0|||
147203112|NCT01554241|530913716|FG001|Overall Study|protocol specified change in eGFR|0|||
147203113|NCT01554241|530913717|FG002|Overall Study|protocol specified change in eGFR|1|||
147203114|NCT01554241|530913718|FG003|Overall Study|protocol specified change in eGFR|0|||
147203115|NCT01554241|530913715|FG000|Overall Study|Withdrawal by Subject|0|||
147203116|NCT01554241|530913716|FG001|Overall Study|Withdrawal by Subject|0|||
147203117|NCT01554241|530913717|FG002|Overall Study|Withdrawal by Subject|2|||
147203118|NCT01554241|530913718|FG003|Overall Study|Withdrawal by Subject|0|||
147203119|NCT02118961|530913719|FG000|Overall Study|Withdrawal by Subject|1|||
147203120|NCT02118961|530913720|FG001|Overall Study|Withdrawal by Subject|0|||
147203121|NCT03809104|530913723|FG000|Overall Study|Withdrawal by Subject|3|||
147203122|NCT01532986|530913724|FG000|Overall Study|Death|9|||
147203123|NCT01532986|530913725|FG001|Overall Study|Death|9|||
147203124|NCT01532986|530913724|FG000|Overall Study|Withdrawal by Subject|7|||
147203125|NCT01532986|530913725|FG001|Overall Study|Withdrawal by Subject|10|||
147203126|NCT01532986|530913724|FG000|Overall Study|Physician Decision|7|||
147203127|NCT01532986|530913725|FG001|Overall Study|Physician Decision|5|||
147203128|NCT02120898|530913726|FG000|Overall Study|Withdrawal by Subject|4|||
147203129|NCT02120898|530913727|FG001|Overall Study|Withdrawal by Subject|2|||
147203130|NCT02120898|530913728|FG002|Overall Study|Withdrawal by Subject|2|||
147203131|NCT02120898|530913726|FG000|Overall Study|Non-compliance with study drug|3|||
147203132|NCT02120898|530913727|FG001|Overall Study|Non-compliance with study drug|0|||
147203133|NCT02120898|530913728|FG002|Overall Study|Non-compliance with study drug|0|||
147203134|NCT02120898|530913726|FG000|Overall Study|Adverse Event|1|||
147203135|NCT02120898|530913727|FG001|Overall Study|Adverse Event|2|||
147203136|NCT02120898|530913728|FG002|Overall Study|Adverse Event|1|||
147203137|NCT02120898|530913726|FG000|Overall Study|Protocol Violation|1|||
147203138|NCT02120898|530913727|FG001|Overall Study|Protocol Violation|2|||
147203139|NCT02120898|530913728|FG002|Overall Study|Protocol Violation|0|||
147203140|NCT02120898|530913726|FG000|Overall Study|Lost to Follow-up|0|||
147203141|NCT02120898|530913727|FG001|Overall Study|Lost to Follow-up|0|||
147203142|NCT02120898|530913728|FG002|Overall Study|Lost to Follow-up|1|||
147203143|NCT04313244|530913729|FG000|Overall Study|Withdrawal of Consent|3|||
147203144|NCT04313244|530913730|FG001|Overall Study|Withdrawal of Consent|3|||
147203145|NCT04313244|530913729|FG000|Overall Study|Met Exclusion Criteria|1|||
147203146|NCT04313244|530913730|FG001|Overall Study|Met Exclusion Criteria|0|||
147203147|NCT04313244|530913729|FG000|Overall Study|Invalid Informed Consent Form (ICF)|1|||
147203148|NCT04313244|530913730|FG001|Overall Study|Invalid Informed Consent Form (ICF)|0|||
147203149|NCT05021978|530913731|FG000|PART A OLT Phase (Day 1 to Day 21)|Adverse Event|1|||
147203150|NCT05021978|530913732|FG001|PART A OLT Phase (Day 1 to Day 21)|Adverse Event|0|||
147203151|NCT05021978|530913733|FG002|PART A OLT Phase (Day 1 to Day 21)|Adverse Event|0|||
147203152|NCT05021978|530913734|FG003|PART A OLT Phase (Day 1 to Day 21)|Adverse Event|0|||
147203153|NCT05021978|530913731|FG000|PART B OLT Phase (Day 1 to Day 42)|Adverse Event|0|||
147203154|NCT05021978|530913732|FG001|PART B OLT Phase (Day 1 to Day 42)|Adverse Event|6|||
147203155|NCT05021978|530913733|FG002|PART B OLT Phase (Day 1 to Day 42)|Adverse Event|0|||
147203156|NCT05021978|530913734|FG003|PART B OLT Phase (Day 1 to Day 42)|Adverse Event|0|||
147203157|NCT03096288|530913736|FG000|Overall Study|Withdrawal by Subject|0|||
147203158|NCT03096288|530913737|FG001|Overall Study|Withdrawal by Subject|1|||
147203159|NCT03096288|530913738|FG002|Overall Study|Withdrawal by Subject|0|||
147203160|NCT03096288|530913739|FG003|Overall Study|Withdrawal by Subject|1|||
147203161|NCT02004093|530913745|FG000|Overall Study|Death|2|||
147203162|NCT02004093|530913746|FG001|Overall Study|Death|1|||
147203163|NCT02004093|530913745|FG000|Overall Study|Lack of Efficacy|66|||
147203164|NCT02004093|530913746|FG001|Overall Study|Lack of Efficacy|62|||
147203165|NCT02004093|530913745|FG000|Overall Study|Protocol Violation|0|||
147203166|NCT02004093|530913746|FG001|Overall Study|Protocol Violation|1|||
147203167|NCT02004093|530913745|FG000|Overall Study|Lost to Follow-up|0|||
147203168|NCT02004093|530913746|FG001|Overall Study|Lost to Follow-up|1|||
147203169|NCT02004093|530913745|FG000|Overall Study|Withdrawal by Subject|3|||
147203170|NCT02004093|530913746|FG001|Overall Study|Withdrawal by Subject|7|||
147203171|NCT02004093|530913745|FG000|Overall Study|Other|3|||
147203172|NCT02004093|530913746|FG001|Overall Study|Other|1|||
147203173|NCT01411891|530913747|FG000|Overall Study|Catheter dislodgement or loss to follow-|3|||
147203174|NCT01411891|530913748|FG001|Overall Study|Catheter dislodgement or loss to follow-|2|||
147203175|NCT04085289|530913749|FG000|Overall Study|Withdrawal by Subject|0|||
147203176|NCT04085289|530913750|FG001|Overall Study|Withdrawal by Subject|0|||
147203177|NCT04085289|530913751|FG002|Overall Study|Withdrawal by Subject|1|||
147203178|NCT04639258|530913752|FG000|Overall Study|Screen failure|5|||
147203179|NCT04639258|530913752|FG000|Overall Study|Physician Decision|2|||
147203180|NCT04639258|530913752|FG000|Overall Study|Early study termination|3|||
147203181|NCT04639258|530913752|FG000|Overall Study|Withdrawal by Subject|1|||
147203182|NCT00414596|530913753|FG000|Overall Study|Protocol Violation|2|||
147306813|NCT01852058|531290782|FG009|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
147437989|NCT05097716|531770326|FG000|Period 1|Close contact with highly-transmissible infection|1|||
147437990|NCT01303965|531770327|FG000|Overall Study|Adverse Event|1|||
147437991|NCT01303965|531770328|FG001|Overall Study|Adverse Event|1|||
147437992|NCT01303965|531770327|FG000|Overall Study|Death|0|||
147437993|NCT01303965|531770328|FG001|Overall Study|Death|3|||
147437994|NCT01303965|531770327|FG000|Overall Study|Withdrawal by Subject|1|||
147437995|NCT01303965|531770328|FG001|Overall Study|Withdrawal by Subject|0|||
147437996|NCT01303965|531770327|FG000|Overall Study|Disease Progression|1|||
147437997|NCT01303965|531770328|FG001|Overall Study|Disease Progression|6|||
147437998|NCT00433914|531770330|FG000|Overall Study|Withdrawal by Subject|0|||
147437999|NCT00433914|531770331|FG001|Overall Study|Withdrawal by Subject|2|||
147438000|NCT00433914|531770330|FG000|Overall Study|Lost to Follow-up|0|||
147438001|NCT00433914|531770331|FG001|Overall Study|Lost to Follow-up|1|||
147438002|NCT04534491|531770332|FG000|Overall Study|Not completed end-of-study interview|24|||
147438003|NCT04534491|531770332|FG000|Overall Study|Non-users|70|||
147438004|NCT04534491|531770332|FG000|Overall Study|Non-verifiable users|58|||
147438005|NCT00766090|531770335|FG000|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
147438006|NCT00766090|531770336|FG001|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
147438007|NCT00766090|531770337|FG002|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
147438008|NCT00766090|531770338|FG003|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
147438009|NCT00766090|531770339|FG004|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
147438010|NCT00766090|531770340|FG005|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
147438011|NCT00766090|531770341|FG006|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
147438012|NCT00766090|531770342|FG007|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
147438013|NCT00766090|531770343|FG008|Treatment Period 1 (28 Days)|Lost to Follow-up|1|||
147438014|NCT00766090|531770344|FG009|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
147438015|NCT00766090|531770345|FG010|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
147438016|NCT00766090|531770346|FG011|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
147438017|NCT00766090|531770335|FG000|Treatment Period 1 (28 Days)|Lack of Efficacy|2|||
147438018|NCT00766090|531770336|FG001|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
147438019|NCT00766090|531770337|FG002|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
147203183|NCT04614974|530913755|FG000|Overall Study|Lost to Follow-up|14|||
147203184|NCT04614974|530913756|FG001|Overall Study|Lost to Follow-up|11|||
147203185|NCT01635153|530913757|FG000|Overall Study|Lost to Follow-up|40|||
147203186|NCT01635153|530913758|FG001|Overall Study|Lost to Follow-up|43|||
147203187|NCT02558296|530913760|FG000|Completed the Study Through Week 24|Adverse Event|9|||
147539111|NCT01393626|532129015|FG002|Overall Study|Lost to Follow-up|1|||
147539112|NCT01393626|532129016|FG003|Overall Study|Lost to Follow-up|0|||
147539113|NCT01393626|532129013|FG000|Overall Study|Withdrawal by Subject|6|||
147539114|NCT01393626|532129014|FG001|Overall Study|Withdrawal by Subject|4|||
147539115|NCT01393626|532129015|FG002|Overall Study|Withdrawal by Subject|0|||
147539116|NCT01393626|532129016|FG003|Overall Study|Withdrawal by Subject|0|||
147539117|NCT01393626|532129013|FG000|Overall Study|Other|1|||
147539118|NCT01393626|532129014|FG001|Overall Study|Other|0|||
147539119|NCT01393626|532129015|FG002|Overall Study|Other|0|||
147539120|NCT01393626|532129016|FG003|Overall Study|Other|0|||
147539121|NCT01393626|532129013|FG000|Overall Study|Protocol Violation|1|||
147539122|NCT01393626|532129014|FG001|Overall Study|Protocol Violation|0|||
147539123|NCT01393626|532129015|FG002|Overall Study|Protocol Violation|2|||
147539124|NCT01393626|532129016|FG003|Overall Study|Protocol Violation|0|||
147539125|NCT02426125|532129017|FG000|Overall Study|Lost to Follow-up|14|||
147539126|NCT02426125|532129018|FG001|Overall Study|Lost to Follow-up|12|||
147539127|NCT02426125|532129017|FG000|Overall Study|Withdrawal by Subject|13|||
147539128|NCT02426125|532129018|FG001|Overall Study|Withdrawal by Subject|14|||
147539129|NCT02426125|532129017|FG000|Overall Study|Death|185|||
147539130|NCT02426125|532129018|FG001|Overall Study|Death|200|||
147539131|NCT02426125|532129017|FG000|Overall Study|Randomized, But Never Treated|5|||
147539132|NCT02426125|532129018|FG001|Overall Study|Randomized, But Never Treated|2|||
147539133|NCT02858076|532129019|FG000|Overall Study|Death|6|||
147539134|NCT02858076|532129020|FG001|Overall Study|Death|3|||
147539135|NCT02858076|532129019|FG000|Overall Study|Withdrawal by Subject|1|||
147539136|NCT02858076|532129020|FG001|Overall Study|Withdrawal by Subject|5|||
147539137|NCT02858076|532129019|FG000|Overall Study|Lost to Follow-up|2|||
147539138|NCT02858076|532129020|FG001|Overall Study|Lost to Follow-up|7|||
147539139|NCT02858076|532129019|FG000|Overall Study|Completed Out of Window|1|||
147539140|NCT02858076|532129020|FG001|Overall Study|Completed Out of Window|3|||
147539141|NCT00938015|532129025|FG000|Overall Study|Death|2|||
147539142|NCT00938015|532129025|FG000|Overall Study|Lost to Follow-up|32|||
147539143|NCT00938015|532129025|FG000|Overall Study|Adverse Event|32|||
147539144|NCT00938015|532129025|FG000|Overall Study|Non-responder|52|||
147539145|NCT00938015|532129025|FG000|Overall Study|Reason not related to Etanercept|29|||
147539146|NCT02341482|532129026|FG000|Overall Study|Adverse Event|1|||
147539147|NCT03186794|532129027|FG000|Overall Study|Physician Decision|2|||
147539148|NCT03186794|532129027|FG000|Overall Study|Withdrawal due to COVID-19 pandemic closure|2|||
147539149|NCT00664066|532129031|FG000|Overall Study|Study terminated|3|||
147539150|NCT02180659|532129035|FG000|Overall Study|Adverse Event|1|||
147539151|NCT02180659|532129036|FG001|Overall Study|Adverse Event|0|||
147539152|NCT02180659|532129035|FG000|Overall Study|Lost to Follow-up|4|||
147539153|NCT02180659|532129036|FG001|Overall Study|Lost to Follow-up|2|||
147539154|NCT02180659|532129035|FG000|Overall Study|Subject incarcerated during conduct|1|||
147539155|NCT02180659|532129036|FG001|Overall Study|Subject incarcerated during conduct|0|||
147539156|NCT02180659|532129035|FG000|Overall Study|Withdrawal by Subject|0|||
147539157|NCT02180659|532129036|FG001|Overall Study|Withdrawal by Subject|2|||
147539158|NCT02180659|532129035|FG000|Overall Study|AT REQUEST OF THE SPONSOR|0|||
147539159|NCT02180659|532129036|FG001|Overall Study|AT REQUEST OF THE SPONSOR|1|||
147539160|NCT03000075|532129037|FG000|Part A|Adverse Event|4|||
147539161|NCT03000075|532129038|FG001|Part A|Adverse Event|0|||
147539162|NCT03000075|532129039|FG002|Part A|Adverse Event|0|||
147539163|NCT03000075|532129040|FG003|Part A|Adverse Event|0|||
147539164|NCT03000075|532129041|FG004|Part A|Adverse Event|0|||
147539165|NCT03000075|532129042|FG005|Part A|Adverse Event|0|||
147539166|NCT03000075|532129043|FG006|Part A|Adverse Event|0|||
147539167|NCT03000075|532129037|FG000|Part B|Not dosed due to AE|0|||
147539168|NCT03000075|532129038|FG001|Part B|Not dosed due to AE|0|||
147539169|NCT03000075|532129039|FG002|Part B|Not dosed due to AE|0|||
147539170|NCT03000075|532129040|FG003|Part B|Not dosed due to AE|0|||
147539171|NCT03000075|532129041|FG004|Part B|Not dosed due to AE|0|||
147539172|NCT03000075|532129042|FG005|Part B|Not dosed due to AE|2|||
147539173|NCT03000075|532129043|FG006|Part B|Not dosed due to AE|1|||
147539174|NCT03000075|532129037|FG000|Part B|Adverse Event|0|||
147539175|NCT03000075|532129038|FG001|Part B|Adverse Event|0|||
147539176|NCT03000075|532129039|FG002|Part B|Adverse Event|0|||
147539177|NCT03000075|532129040|FG003|Part B|Adverse Event|0|||
147539178|NCT03000075|532129041|FG004|Part B|Adverse Event|1|||
147539179|NCT03000075|532129042|FG005|Part B|Adverse Event|0|||
147539180|NCT03000075|532129043|FG006|Part B|Adverse Event|0|||
147539181|NCT00111007|532129044|FG000|Double-blind (DB) Treatment|Adverse Event|12|||
147539182|NCT00111007|532129045|FG001|Double-blind (DB) Treatment|Adverse Event|4|||
147539183|NCT00111007|532129044|FG000|Double-blind (DB) Treatment|Death|5|||
147539184|NCT00111007|532129045|FG001|Double-blind (DB) Treatment|Death|2|||
147539185|NCT00111007|532129044|FG000|Double-blind (DB) Treatment|Protocol Violation|0|||
147539186|NCT00111007|532129045|FG001|Double-blind (DB) Treatment|Protocol Violation|1|||
147539187|NCT00111007|532129044|FG000|Double-blind (DB) Treatment|Withdrawal by Subject|6|||
147539188|NCT00111007|532129045|FG001|Double-blind (DB) Treatment|Withdrawal by Subject|8|||
147539189|NCT00111007|532129044|FG000|Double-blind (DB) Treatment|Disease progression/recurrence/relapse|1|||
147539190|NCT00111007|532129045|FG001|Double-blind (DB) Treatment|Disease progression/recurrence/relapse|0|||
147539191|NCT00111007|532129044|FG000|Double-blind (DB) Treatment|Relapse|1|||
147539192|NCT00111007|532129045|FG001|Double-blind (DB) Treatment|Relapse|0|||
147539193|NCT00111007|532129044|FG000|Double-blind (DB) Treatment|Progression by clinical judgement|0|||
147539194|NCT00111007|532129045|FG001|Double-blind (DB) Treatment|Progression by clinical judgement|2|||
147539195|NCT00111007|532129044|FG000|Double-blind (DB) Treatment|Radiological and symptomatic progression|83|||
147539196|NCT00111007|532129045|FG001|Double-blind (DB) Treatment|Radiological and symptomatic progression|93|||
147539197|NCT00111007|532129044|FG000|Double-blind (DB) Treatment|Primary reason with other category|0|||
147539198|NCT00111007|532129045|FG001|Double-blind (DB) Treatment|Primary reason with other category|1|||
147539199|NCT00111007|532129044|FG000|Active Follow-up|Adverse Event|1|||
147539200|NCT00111007|532129045|FG001|Active Follow-up|Adverse Event|0|||
147539201|NCT00111007|532129044|FG000|Active Follow-up|Death|2|||
147539202|NCT00111007|532129045|FG001|Active Follow-up|Death|0|||
147539203|NCT00111007|532129044|FG000|Active Follow-up|Disease progression/recurrence/relapse|3|||
147539204|NCT00111007|532129045|FG001|Active Follow-up|Disease progression/recurrence/relapse|2|||
147539205|NCT00111007|532129044|FG000|Long Term Follow-up|Death|34|||
147539206|NCT00111007|532129045|FG001|Long Term Follow-up|Death|39|||
147539207|NCT00111007|532129044|FG000|Long Term Follow-up|Lost to Follow-up|1|||
147539208|NCT00111007|532129045|FG001|Long Term Follow-up|Lost to Follow-up|1|||
147539209|NCT00111007|532129044|FG000|Long Term Follow-up|Withdrawal by Subject|0|||
147539210|NCT00111007|532129045|FG001|Long Term Follow-up|Withdrawal by Subject|1|||
147539211|NCT00111007|532129044|FG000|Long Term Follow-up|Disease progression/recurrence/relapse|2|||
147539212|NCT00111007|532129045|FG001|Long Term Follow-up|Disease progression/recurrence/relapse|1|||
147539213|NCT00111007|532129044|FG000|Long Term Follow-up|Missing|10|||
147539214|NCT00111007|532129045|FG001|Long Term Follow-up|Missing|3|||
147539215|NCT01495793|532129046|FG000|Overall Study|Lost to Follow-up|1|||
147539216|NCT01495793|532129046|FG000|Overall Study|Violation of inclusion criteria|1|||
147539217|NCT00440193|532129047|FG000|Treatment Period|Adverse Event|74|||
147539218|NCT00440193|532129048|FG001|Treatment Period|Adverse Event|67|||
147539219|NCT00440193|532129047|FG000|Treatment Period|Death|19|||
147539220|NCT00440193|532129048|FG001|Treatment Period|Death|22|||
147539221|NCT00440193|532129047|FG000|Treatment Period|Lack of Efficacy|0|||
147539222|NCT00440193|532129048|FG001|Treatment Period|Lack of Efficacy|1|||
147539223|NCT00440193|532129047|FG000|Treatment Period|Lost to Follow-up|12|||
147539224|NCT00440193|532129048|FG001|Treatment Period|Lost to Follow-up|18|||
147203188|NCT02558296|530913761|FG001|Completed the Study Through Week 24|Adverse Event|3|||
147203189|NCT02558296|530913760|FG000|Completed the Study Through Week 24|Death|7|||
147203190|NCT02558296|530913761|FG001|Completed the Study Through Week 24|Death|7|||
147203191|NCT02558296|530913760|FG000|Completed the Study Through Week 24|Lost to Follow-up|8|||
147203192|NCT02558296|530913761|FG001|Completed the Study Through Week 24|Lost to Follow-up|1|||
147203193|NCT02558296|530913760|FG000|Completed the Study Through Week 24|Physician Decision|1|||
147203194|NCT02558296|530913761|FG001|Completed the Study Through Week 24|Physician Decision|0|||
147203195|NCT02558296|530913760|FG000|Completed the Study Through Week 24|Protocol Violation|1|||
147203196|NCT02558296|530913761|FG001|Completed the Study Through Week 24|Protocol Violation|1|||
147203197|NCT02558296|530913760|FG000|Completed the Study Through Week 24|Withdrawal by Subject|17|||
147203198|NCT02558296|530913761|FG001|Completed the Study Through Week 24|Withdrawal by Subject|13|||
147203199|NCT02558296|530913760|FG000|Completed the Study Through Week 24|The subject was randomized, but did not take any investigational product|1|||
147203200|NCT02558296|530913761|FG001|Completed the Study Through Week 24|The subject was randomized, but did not take any investigational product|0|||
147203201|NCT02558296|530913760|FG000|Completed the Study|Adverse Event|14|||
147203202|NCT02558296|530913761|FG001|Completed the Study|Adverse Event|5|||
147203203|NCT02558296|530913760|FG000|Completed the Study|Death|39|||
147203204|NCT02558296|530913761|FG001|Completed the Study|Death|25|||
147203205|NCT02558296|530913760|FG000|Completed the Study|Lost to Follow-up|31|||
147203206|NCT02558296|530913761|FG001|Completed the Study|Lost to Follow-up|23|||
147203207|NCT02558296|530913760|FG000|Completed the Study|Physician Decision|6|||
147203208|NCT02558296|530913761|FG001|Completed the Study|Physician Decision|0|||
147203209|NCT02558296|530913760|FG000|Completed the Study|Protocol Violation|2|||
147203210|NCT02558296|530913761|FG001|Completed the Study|Protocol Violation|1|||
147203211|NCT02558296|530913760|FG000|Completed the Study|Withdrawal by Subject|53|||
147203212|NCT02558296|530913761|FG001|Completed the Study|Withdrawal by Subject|31|||
147203213|NCT02558296|530913760|FG000|Completed the Study|The subject was randomized, but did not take any investigational product|1|||
147203214|NCT02558296|530913761|FG001|Completed the Study|The subject was randomized, but did not take any investigational product|0|||
147539225|NCT00440193|532129047|FG000|Treatment Period|Physician Decision|3|||
147539226|NCT00440193|532129048|FG001|Treatment Period|Physician Decision|6|||
147539227|NCT00440193|532129047|FG000|Treatment Period|Protocol Violation|16|||
147203215|NCT02754440|530913762|FG000|Overall Study|Protocol Violation|3|||
147203216|NCT02754440|530913763|FG001|Overall Study|Protocol Violation|2|||
147203217|NCT02754440|530913764|FG002|Overall Study|Protocol Violation|2|||
147203218|NCT02754440|530913765|FG003|Overall Study|Protocol Violation|6|||
147203219|NCT02754440|530913762|FG000|Overall Study|Adverse Event|3|||
147203220|NCT02754440|530913763|FG001|Overall Study|Adverse Event|1|||
147203221|NCT02754440|530913764|FG002|Overall Study|Adverse Event|0|||
147203222|NCT02754440|530913765|FG003|Overall Study|Adverse Event|9|||
147203223|NCT02754440|530913762|FG000|Overall Study|Withdrawal by Subject|0|||
147203224|NCT02754440|530913763|FG001|Overall Study|Withdrawal by Subject|0|||
147203225|NCT02754440|530913764|FG002|Overall Study|Withdrawal by Subject|0|||
147203226|NCT02754440|530913765|FG003|Overall Study|Withdrawal by Subject|1|||
147203227|NCT02754440|530913762|FG000|Overall Study|Equipment failure|0|||
147203228|NCT02754440|530913763|FG001|Overall Study|Equipment failure|5|||
147203229|NCT02754440|530913764|FG002|Overall Study|Equipment failure|5|||
147203230|NCT02754440|530913765|FG003|Overall Study|Equipment failure|7|||
147203231|NCT02754440|530913762|FG000|Overall Study|Subject issues not resulting in AE|0|||
147438020|NCT00766090|531770338|FG003|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
147438021|NCT00766090|531770339|FG004|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
147438022|NCT00766090|531770340|FG005|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
147438023|NCT00766090|531770341|FG006|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
147438024|NCT00766090|531770342|FG007|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
147438025|NCT00766090|531770343|FG008|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
147438026|NCT00766090|531770344|FG009|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
147438027|NCT00766090|531770345|FG010|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
147438028|NCT00766090|531770346|FG011|Treatment Period 1 (28 Days)|Lack of Efficacy|0|||
147438029|NCT00766090|531770335|FG000|Treatment Period 1 (28 Days)|Withdrawal by Subject|1|||
147438030|NCT00766090|531770336|FG001|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
147438031|NCT00766090|531770337|FG002|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
147438032|NCT00766090|531770338|FG003|Treatment Period 1 (28 Days)|Withdrawal by Subject|1|||
147438033|NCT00766090|531770339|FG004|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
147438034|NCT00766090|531770340|FG005|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
147438035|NCT00766090|531770341|FG006|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
147438036|NCT00766090|531770342|FG007|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
147438037|NCT00766090|531770343|FG008|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
147438038|NCT00766090|531770344|FG009|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
147438039|NCT00766090|531770345|FG010|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
147438040|NCT00766090|531770346|FG011|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
147438041|NCT00766090|531770335|FG000|Washout Period 1 (14 Days)|Protocol Violation|0|||
147438042|NCT00766090|531770336|FG001|Washout Period 1 (14 Days)|Protocol Violation|0|||
147438043|NCT00766090|531770337|FG002|Washout Period 1 (14 Days)|Protocol Violation|1|||
147438044|NCT00766090|531770338|FG003|Washout Period 1 (14 Days)|Protocol Violation|0|||
147438045|NCT00766090|531770339|FG004|Washout Period 1 (14 Days)|Protocol Violation|0|||
147438046|NCT00766090|531770340|FG005|Washout Period 1 (14 Days)|Protocol Violation|0|||
147438047|NCT00766090|531770341|FG006|Washout Period 1 (14 Days)|Protocol Violation|0|||
147438048|NCT00766090|531770342|FG007|Washout Period 1 (14 Days)|Protocol Violation|0|||
147438049|NCT00766090|531770343|FG008|Washout Period 1 (14 Days)|Protocol Violation|0|||
147438050|NCT00766090|531770344|FG009|Washout Period 1 (14 Days)|Protocol Violation|0|||
147438051|NCT00766090|531770345|FG010|Washout Period 1 (14 Days)|Protocol Violation|0|||
147438052|NCT00766090|531770346|FG011|Washout Period 1 (14 Days)|Protocol Violation|0|||
147438053|NCT00766090|531770335|FG000|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
147438054|NCT00766090|531770336|FG001|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
147438055|NCT00766090|531770337|FG002|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
147438056|NCT00766090|531770338|FG003|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
147438057|NCT00766090|531770339|FG004|Treatment Period 2 (28 Days)|Lost to Follow-up|2|||
147438058|NCT00766090|531770340|FG005|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
147438059|NCT00766090|531770341|FG006|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
147438060|NCT00766090|531770342|FG007|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
147438061|NCT00766090|531770343|FG008|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
147438062|NCT00766090|531770344|FG009|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
147438063|NCT00766090|531770345|FG010|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
147438064|NCT00766090|531770346|FG011|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
147438065|NCT00766090|531770335|FG000|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
147438066|NCT00766090|531770336|FG001|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
147438067|NCT00766090|531770337|FG002|Treatment Period 2 (28 Days)|Lack of Efficacy|1|||
147438068|NCT00766090|531770338|FG003|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
147438069|NCT00766090|531770339|FG004|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
147438070|NCT00766090|531770340|FG005|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
147438071|NCT00766090|531770341|FG006|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
147438072|NCT00766090|531770342|FG007|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
147438073|NCT00766090|531770343|FG008|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
147438074|NCT00766090|531770344|FG009|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
147438075|NCT00766090|531770345|FG010|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
147539228|NCT00440193|532129048|FG001|Treatment Period|Protocol Violation|19|||
147203232|NCT02754440|530913763|FG001|Overall Study|Subject issues not resulting in AE|0|||
147203233|NCT02754440|530913764|FG002|Overall Study|Subject issues not resulting in AE|0|||
147539229|NCT00440193|532129047|FG000|Treatment Period|Withdrawal by Subject|36|||
147539230|NCT00440193|532129048|FG001|Treatment Period|Withdrawal by Subject|77|||
147539231|NCT00440193|532129047|FG000|Treatment Period|Clinical endpoint reached|28|||
147539232|NCT00440193|532129048|FG001|Treatment Period|Clinical endpoint reached|25|||
147539233|NCT00440193|532129047|FG000|Treatment Period|Study terminated by sponsor|102|||
147539234|NCT00440193|532129048|FG001|Treatment Period|Study terminated by sponsor|94|||
147539235|NCT00440193|532129047|FG000|Treatment Period|Protocol driven decision point|2|||
147539236|NCT00440193|532129048|FG001|Treatment Period|Protocol driven decision point|2|||
147203234|NCT02754440|530913765|FG003|Overall Study|Subject issues not resulting in AE|12|||
147203235|NCT02919995|530913768|FG000|Overall Study|Adverse Event|0|||
147203236|NCT02919995|530913769|FG001|Overall Study|Adverse Event|0|||
147203237|NCT02919995|530913770|FG002|Overall Study|Adverse Event|0|||
147203238|NCT02919995|530913771|FG003|Overall Study|Adverse Event|0|||
147203239|NCT02919995|530913772|FG004|Overall Study|Adverse Event|0|||
147203240|NCT02919995|530913773|FG005|Overall Study|Adverse Event|1|||
147203241|NCT02560558|530913774|FG000|Overall Study|Adverse Event|1|||
147203242|NCT02560558|530913775|FG001|Overall Study|Adverse Event|0|||
147203243|NCT02560558|530913774|FG000|Overall Study|Death|0|||
147203244|NCT02560558|530913775|FG001|Overall Study|Death|2|||
147203245|NCT02560558|530913774|FG000|Overall Study|Lost to Follow-up|0|||
147203246|NCT02560558|530913775|FG001|Overall Study|Lost to Follow-up|4|||
147203247|NCT02560558|530913774|FG000|Overall Study|Protocol Violation|3|||
147203248|NCT02560558|530913775|FG001|Overall Study|Protocol Violation|0|||
147203249|NCT02560558|530913774|FG000|Overall Study|Withdrawal by Subject|3|||
147203250|NCT02560558|530913775|FG001|Overall Study|Withdrawal by Subject|0|||
147203251|NCT01263197|530913777|FG000|First Intervention (Period 1)|Adverse Event|0|||
147203252|NCT01263197|530913778|FG001|First Intervention (Period 1)|Adverse Event|0|||
147203253|NCT01263197|530913779|FG002|First Intervention (Period 1)|Adverse Event|0|||
147203254|NCT01263197|530913780|FG003|First Intervention (Period 1)|Adverse Event|0|||
147203255|NCT01263197|530913781|FG004|First Intervention (Period 1)|Adverse Event|0|||
147203256|NCT01263197|530913782|FG005|First Intervention (Period 1)|Adverse Event|1|||
147203257|NCT01263197|530913777|FG000|Washout Period 1|Protocol Violation|0|||
147203258|NCT01263197|530913778|FG001|Washout Period 1|Protocol Violation|0|||
147203259|NCT01263197|530913779|FG002|Washout Period 1|Protocol Violation|0|||
147203260|NCT01263197|530913780|FG003|Washout Period 1|Protocol Violation|0|||
147203261|NCT01263197|530913781|FG004|Washout Period 1|Protocol Violation|1|||
147203262|NCT01263197|530913782|FG005|Washout Period 1|Protocol Violation|0|||
147203263|NCT01263197|530913777|FG000|Washout Period 2|Physician Decision|0|||
147203264|NCT01263197|530913778|FG001|Washout Period 2|Physician Decision|0|||
147203265|NCT01263197|530913779|FG002|Washout Period 2|Physician Decision|0|||
147203266|NCT01263197|530913780|FG003|Washout Period 2|Physician Decision|0|||
147203267|NCT01263197|530913781|FG004|Washout Period 2|Physician Decision|0|||
147203268|NCT01263197|530913782|FG005|Washout Period 2|Physician Decision|1|||
147203269|NCT01263197|530913777|FG000|Washout Period 2|Protocol Violation|0|||
147438076|NCT00766090|531770346|FG011|Treatment Period 2 (28 Days)|Lack of Efficacy|0|||
147438077|NCT00766090|531770335|FG000|Washout Period 2 (14 Days)|Physician Decision|0|||
147438078|NCT00766090|531770336|FG001|Washout Period 2 (14 Days)|Physician Decision|0|||
147438079|NCT00766090|531770337|FG002|Washout Period 2 (14 Days)|Physician Decision|1|||
147438080|NCT00766090|531770338|FG003|Washout Period 2 (14 Days)|Physician Decision|0|||
147438081|NCT00766090|531770339|FG004|Washout Period 2 (14 Days)|Physician Decision|0|||
147438082|NCT00766090|531770340|FG005|Washout Period 2 (14 Days)|Physician Decision|0|||
147438083|NCT00766090|531770341|FG006|Washout Period 2 (14 Days)|Physician Decision|0|||
147438084|NCT00766090|531770342|FG007|Washout Period 2 (14 Days)|Physician Decision|0|||
147438085|NCT00766090|531770343|FG008|Washout Period 2 (14 Days)|Physician Decision|0|||
147438086|NCT00766090|531770344|FG009|Washout Period 2 (14 Days)|Physician Decision|0|||
147438087|NCT00766090|531770345|FG010|Washout Period 2 (14 Days)|Physician Decision|0|||
147438088|NCT00766090|531770346|FG011|Washout Period 2 (14 Days)|Physician Decision|0|||
147438089|NCT00766090|531770335|FG000|Treatment Period 3 (28 Days)|Protocol Violation|0|||
147438090|NCT00766090|531770336|FG001|Treatment Period 3 (28 Days)|Protocol Violation|0|||
147438091|NCT00766090|531770337|FG002|Treatment Period 3 (28 Days)|Protocol Violation|0|||
147438092|NCT00766090|531770338|FG003|Treatment Period 3 (28 Days)|Protocol Violation|0|||
147438093|NCT00766090|531770339|FG004|Treatment Period 3 (28 Days)|Protocol Violation|0|||
147438094|NCT00766090|531770340|FG005|Treatment Period 3 (28 Days)|Protocol Violation|1|||
147438095|NCT00766090|531770341|FG006|Treatment Period 3 (28 Days)|Protocol Violation|0|||
147438096|NCT00766090|531770342|FG007|Treatment Period 3 (28 Days)|Protocol Violation|0|||
147438097|NCT00766090|531770343|FG008|Treatment Period 3 (28 Days)|Protocol Violation|0|||
147438098|NCT00766090|531770344|FG009|Treatment Period 3 (28 Days)|Protocol Violation|0|||
147438099|NCT00766090|531770345|FG010|Treatment Period 3 (28 Days)|Protocol Violation|0|||
147438100|NCT00766090|531770346|FG011|Treatment Period 3 (28 Days)|Protocol Violation|0|||
147203270|NCT01263197|530913778|FG001|Washout Period 2|Protocol Violation|0|||
147203271|NCT01263197|530913779|FG002|Washout Period 2|Protocol Violation|0|||
147203272|NCT01263197|530913780|FG003|Washout Period 2|Protocol Violation|1|||
147203273|NCT01263197|530913781|FG004|Washout Period 2|Protocol Violation|0|||
147539237|NCT00440193|532129047|FG000|Treatment Period|Switch to commercial drug|0|||
147539238|NCT00440193|532129048|FG001|Treatment Period|Switch to commercial drug|2|||
147539239|NCT00440193|532129047|FG000|Treatment Period|Technical problems|1|||
147539240|NCT00440193|532129048|FG001|Treatment Period|Technical problems|1|||
147539241|NCT00440193|532129047|FG000|Treatment Period|Participant convenience|5|||
147539242|NCT00440193|532129048|FG001|Treatment Period|Participant convenience|2|||
147539243|NCT00440193|532129047|FG000|Treatment Period|Participant did not receive treatment|7|||
147539244|NCT00440193|532129048|FG001|Treatment Period|Participant did not receive treatment|13|||
147539245|NCT00440193|532129047|FG000|Treatment Period|Site closed by investigator|0|||
147539246|NCT00440193|532129048|FG001|Treatment Period|Site closed by investigator|2|||
147539247|NCT00440193|532129047|FG000|Observational Period|Adverse Event|2|||
147539248|NCT00440193|532129048|FG001|Observational Period|Adverse Event|2|||
147539249|NCT00440193|532129047|FG000|Observational Period|Death|15|||
147539250|NCT00440193|532129048|FG001|Observational Period|Death|20|||
147539251|NCT00440193|532129047|FG000|Observational Period|Lost to Follow-up|12|||
147539252|NCT00440193|532129048|FG001|Observational Period|Lost to Follow-up|8|||
147539253|NCT00440193|532129047|FG000|Observational Period|Protocol Violation|1|||
147539254|NCT00440193|532129048|FG001|Observational Period|Protocol Violation|0|||
147539255|NCT00440193|532129047|FG000|Observational Period|Withdrawal by Subject|11|||
147539256|NCT00440193|532129048|FG001|Observational Period|Withdrawal by Subject|8|||
147539257|NCT00440193|532129047|FG000|Observational Period|Physician Decision|1|||
147539258|NCT00440193|532129048|FG001|Observational Period|Physician Decision|0|||
147539259|NCT00440193|532129047|FG000|Observational Period|Clinical endpoint reached|1|||
147539260|NCT00440193|532129048|FG001|Observational Period|Clinical endpoint reached|0|||
147539261|NCT00440193|532129047|FG000|Observational Period|Participant convenience|2|||
147539262|NCT00440193|532129048|FG001|Observational Period|Participant convenience|0|||
147539263|NCT00834366|532129049|FG000|Treatment Period 1|Adverse Event|1|||
147539264|NCT00834366|532129050|FG001|Treatment Period 1|Adverse Event|1|||
147539265|NCT03014570|532129051|FG000|Overall Study|COVID-19 Restrictions|38|||
147539266|NCT03014570|532129052|FG001|Overall Study|COVID-19 Restrictions|24|||
147539267|NCT03014570|532129051|FG000|Overall Study|Death|70|||
147539268|NCT03014570|532129052|FG001|Overall Study|Death|79|||
147539269|NCT03014570|532129051|FG000|Overall Study|Transfer from facility|11|||
147539270|NCT03014570|532129052|FG001|Overall Study|Transfer from facility|14|||
147539271|NCT03014570|532129051|FG000|Overall Study|Hospitalized|5|||
147539272|NCT03014570|532129052|FG001|Overall Study|Hospitalized|3|||
147539273|NCT03014570|532129051|FG000|Overall Study|Transfer within facility|1|||
147539274|NCT03014570|532129052|FG001|Overall Study|Transfer within facility|0|||
147539275|NCT03014570|532129051|FG000|Overall Study|Site refusal|0|||
147539276|NCT03014570|532129052|FG001|Overall Study|Site refusal|11|||
147539277|NCT01154673|532129053|FG000|Overall Study|Lost to Follow-up|1|||
147539278|NCT01154673|532129054|FG001|Overall Study|Lost to Follow-up|0|||
147539279|NCT01154673|532129053|FG000|Overall Study|moved out of province|1|||
147539280|NCT01154673|532129054|FG001|Overall Study|moved out of province|0|||
147539281|NCT00090259|532129055|FG000|Overall Study|Lost to Follow-up|30|||
147539282|NCT00090259|532129056|FG001|Overall Study|Lost to Follow-up|26|||
147539283|NCT00090259|532129055|FG000|Overall Study|Withdrawal by Subject|21|||
147539284|NCT00090259|532129056|FG001|Overall Study|Withdrawal by Subject|15|||
147539285|NCT00090259|532129055|FG000|Overall Study|Investigator site closed|11|||
147539286|NCT00090259|532129056|FG001|Overall Study|Investigator site closed|7|||
147539287|NCT03083639|532129060|FG000|Washout Period (at Least 6 Days)|Pregnancy|0|||
147539288|NCT03083639|532129061|FG001|Washout Period (at Least 6 Days)|Pregnancy|1|||
147539289|NCT03083639|532129060|FG000|Washout Period (at Least 6 Days)|Lost to Follow-up|1|||
147539290|NCT03083639|532129061|FG001|Washout Period (at Least 6 Days)|Lost to Follow-up|0|||
147539291|NCT01275170|532129062|FG000|Part 1: Period 1|Equipment malfunction before study drug|1|||
147539292|NCT01275170|532129063|FG001|Part 1: Period 1|Equipment malfunction before study drug|0|||
147539293|NCT01275170|532129064|FG002|Part 1: Period 1|Equipment malfunction before study drug|0|||
147539294|NCT01275170|532129065|FG003|Part 1: Period 1|Equipment malfunction before study drug|0|||
147539295|NCT01275170|532129066|FG004|Part 1: Period 1|Equipment malfunction before study drug|0|||
147539296|NCT01275170|532129067|FG005|Part 1: Period 1|Equipment malfunction before study drug|0|||
147539297|NCT01275170|532129068|FG006|Part 1: Period 1|Equipment malfunction before study drug|0|||
147539298|NCT01275170|532129069|FG007|Part 1: Period 1|Equipment malfunction before study drug|0|||
147539299|NCT00960687|532129070|FG000|Washout Period of 7 Days|Adverse Event|3|||
147539300|NCT00960687|532129071|FG001|Washout Period of 7 Days|Adverse Event|2|||
147539301|NCT00960687|532129070|FG000|Washout Period of 7 Days|Withdrawal by Subject|1|||
147539302|NCT00960687|532129071|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
147539303|NCT02362646|532129072|FG000|Overall Study|Death|15|||
147539304|NCT02362646|532129073|FG001|Overall Study|Death|8|||
147539305|NCT02362646|532129072|FG000|Overall Study|Withdrawal by Subject|2|||
147539306|NCT02362646|532129073|FG001|Overall Study|Withdrawal by Subject|2|||
147539307|NCT02362646|532129072|FG000|Overall Study|received transplant|21|||
147539308|NCT02362646|532129073|FG001|Overall Study|received transplant|14|||
147539309|NCT00865306|532129074|FG000|Controlled Trial|Lost to Follow-up|1|||
147539310|NCT00865306|532129075|FG001|Controlled Trial|Lost to Follow-up|1|||
147539311|NCT00865306|532129074|FG000|Controlled Trial|Difficulty commuting|2|||
147539312|NCT00865306|532129075|FG001|Controlled Trial|Difficulty commuting|0|||
147539313|NCT00865306|532129074|FG000|Controlled Trial|Improved btw baseline and first session|1|||
147539314|NCT00865306|532129075|FG001|Controlled Trial|Improved btw baseline and first session|0|||
147539315|NCT00865306|532129074|FG000|Controlled Trial|Sought treatment for conduct disorder|1|||
147539316|NCT00865306|532129075|FG001|Controlled Trial|Sought treatment for conduct disorder|0|||
147539317|NCT00865306|532129074|FG000|Controlled Trial|Withdrawal by Subject|0|||
147539318|NCT00865306|532129075|FG001|Controlled Trial|Withdrawal by Subject|1|||
147539319|NCT02704130|532129079|FG000|Overall Study|Physician Decision|5|||
147539320|NCT02704130|532129080|FG001|Overall Study|Physician Decision|3|||
147539321|NCT01216319|532129084|FG000|Overall Study|Lost to Follow-up|2|||
147539322|NCT01216319|532129084|FG000|Overall Study|Unanticipated chemo for breast cancer|2|||
147539323|NCT03611751|532129088|FG000|Pre-treatment|Randomized but not treated|1|||
147539324|NCT03611751|532129089|FG001|Pre-treatment|Randomized but not treated|1|||
147539325|NCT03611751|532129090|FG002|Pre-treatment|Randomized but not treated|0|||
147539326|NCT03611751|532129088|FG000|Treatment Week 0 - Week 16|Adverse Event|11|||
147539327|NCT03611751|532129089|FG001|Treatment Week 0 - Week 16|Adverse Event|7|||
147539328|NCT03611751|532129090|FG002|Treatment Week 0 - Week 16|Adverse Event|12|||
147539329|NCT03611751|532129088|FG000|Treatment Week 0 - Week 16|Lack of Efficacy|6|||
147539330|NCT03611751|532129089|FG001|Treatment Week 0 - Week 16|Lack of Efficacy|9|||
147539331|NCT03611751|532129090|FG002|Treatment Week 0 - Week 16|Lack of Efficacy|4|||
147539332|NCT03611751|532129088|FG000|Treatment Week 0 - Week 16|Lost to Follow-up|5|||
147539333|NCT03611751|532129089|FG001|Treatment Week 0 - Week 16|Lost to Follow-up|6|||
147539334|NCT03611751|532129090|FG002|Treatment Week 0 - Week 16|Lost to Follow-up|2|||
147539335|NCT03611751|532129088|FG000|Treatment Week 0 - Week 16|Non-compliance with protocol|5|||
147539336|NCT03611751|532129089|FG001|Treatment Week 0 - Week 16|Non-compliance with protocol|2|||
147539337|NCT03611751|532129090|FG002|Treatment Week 0 - Week 16|Non-compliance with protocol|1|||
147539338|NCT03611751|532129088|FG000|Treatment Week 0 - Week 16|Withdrawal by Subject|14|||
147539339|NCT03611751|532129089|FG001|Treatment Week 0 - Week 16|Withdrawal by Subject|9|||
147539340|NCT03611751|532129090|FG002|Treatment Week 0 - Week 16|Withdrawal by Subject|9|||
147539341|NCT03611751|532129088|FG000|Treatment Week 0 - Week 16|Other reasons|13|||
147203274|NCT01263197|530913782|FG005|Washout Period 2|Protocol Violation|0|||
147203275|NCT01263197|530913777|FG000|Third Intervention (Period 3)|Adverse Event|0|||
147203276|NCT01263197|530913778|FG001|Third Intervention (Period 3)|Adverse Event|1|||
147203277|NCT01263197|530913779|FG002|Third Intervention (Period 3)|Adverse Event|0|||
147203278|NCT01263197|530913780|FG003|Third Intervention (Period 3)|Adverse Event|0|||
147203279|NCT01263197|530913781|FG004|Third Intervention (Period 3)|Adverse Event|0|||
147203280|NCT01263197|530913782|FG005|Third Intervention (Period 3)|Adverse Event|0|||
147203281|NCT01967576|530913783|FG000|Overall Study|Withdrawal by Subject|3|||
147203282|NCT01967576|530913783|FG000|Overall Study|Progressed/Removed from treatment|1|||
147203283|NCT01967576|530913783|FG000|Overall Study|Study closing at site|1|||
147203284|NCT01967576|530913783|FG000|Overall Study|Adverse Event|1|||
147203285|NCT01967576|530913783|FG000|Overall Study|Refused further treatment|1|||
147203286|NCT01821118|530913791|FG000|Overall Study|Death|0|||
147203287|NCT01821118|530913792|FG001|Overall Study|Death|1|||
147203288|NCT00345358|530913793|FG000|Primary Vaccination Phase|Other|0|||
147203289|NCT00345358|530913794|FG001|Primary Vaccination Phase|Other|1|||
147203290|NCT00345358|530913795|FG002|Primary Vaccination Phase|Other|1|||
147203291|NCT00345358|530913796|FG003|Primary Vaccination Phase|Other|0|||
147539342|NCT03611751|532129089|FG001|Treatment Week 0 - Week 16|Other reasons|9|||
147539343|NCT03611751|532129090|FG002|Treatment Week 0 - Week 16|Other reasons|7|||
147539344|NCT03611751|532129088|FG000|Treatment Week 0 - Week 16|Pregnancy|0|||
147539345|NCT03611751|532129089|FG001|Treatment Week 0 - Week 16|Pregnancy|0|||
147539346|NCT03611751|532129090|FG002|Treatment Week 0 - Week 16|Pregnancy|1|||
147539347|NCT03611751|532129088|FG000|Treatment Week 0 - Week 16|Death|0|||
147539348|NCT03611751|532129089|FG001|Treatment Week 0 - Week 16|Death|0|||
147539349|NCT03611751|532129090|FG002|Treatment Week 0 - Week 16|Death|1|||
147539350|NCT03611751|532129088|FG000|Treatment Week 16 - Week 24|Adverse Event|7|||
147539351|NCT03611751|532129089|FG001|Treatment Week 16 - Week 24|Adverse Event|0|||
147539352|NCT03611751|532129090|FG002|Treatment Week 16 - Week 24|Adverse Event|2|||
147539353|NCT03611751|532129088|FG000|Treatment Week 16 - Week 24|Lack of Efficacy|8|||
147539354|NCT03611751|532129089|FG001|Treatment Week 16 - Week 24|Lack of Efficacy|0|||
147539355|NCT03611751|532129090|FG002|Treatment Week 16 - Week 24|Lack of Efficacy|1|||
147539356|NCT03611751|532129088|FG000|Treatment Week 16 - Week 24|Lost to Follow-up|2|||
147539357|NCT03611751|532129089|FG001|Treatment Week 16 - Week 24|Lost to Follow-up|0|||
147539358|NCT03611751|532129090|FG002|Treatment Week 16 - Week 24|Lost to Follow-up|0|||
147539359|NCT03611751|532129088|FG000|Treatment Week 16 - Week 24|Non-compliance with protocol|3|||
147203292|NCT00345358|530913793|FG000|Primary Vaccination Phase|Adverse event, non-fatal|3|||
147203293|NCT00345358|530913794|FG001|Primary Vaccination Phase|Adverse event, non-fatal|1|||
147203294|NCT00345358|530913795|FG002|Primary Vaccination Phase|Adverse event, non-fatal|1|||
147203295|NCT00345358|530913796|FG003|Primary Vaccination Phase|Adverse event, non-fatal|0|||
147203296|NCT00345358|530913793|FG000|Primary Vaccination Phase|Withdrawal by Subject|1|||
147203297|NCT00345358|530913794|FG001|Primary Vaccination Phase|Withdrawal by Subject|2|||
147203298|NCT00345358|530913795|FG002|Primary Vaccination Phase|Withdrawal by Subject|4|||
147203299|NCT00345358|530913796|FG003|Primary Vaccination Phase|Withdrawal by Subject|0|||
147203300|NCT00345358|530913793|FG000|Primary Vaccination Phase|Lost to Follow-up|1|||
147203301|NCT00345358|530913794|FG001|Primary Vaccination Phase|Lost to Follow-up|0|||
147203302|NCT00345358|530913795|FG002|Primary Vaccination Phase|Lost to Follow-up|2|||
147438101|NCT00766090|531770335|FG000|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
147438102|NCT00766090|531770336|FG001|Treatment Period 3 (28 Days)|Lack of Efficacy|1|||
147438103|NCT00766090|531770337|FG002|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
147438104|NCT00766090|531770338|FG003|Treatment Period 3 (28 Days)|Lack of Efficacy|1|||
147438105|NCT00766090|531770339|FG004|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
147438106|NCT00766090|531770340|FG005|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
147438107|NCT00766090|531770341|FG006|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
147438108|NCT00766090|531770342|FG007|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
147438109|NCT00766090|531770343|FG008|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
147438110|NCT00766090|531770344|FG009|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
147438111|NCT00766090|531770345|FG010|Treatment Period 3 (28 Days)|Lack of Efficacy|0|||
147438112|NCT00766090|531770346|FG011|Treatment Period 3 (28 Days)|Lack of Efficacy|1|||
147438113|NCT00766090|531770335|FG000|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
147438114|NCT00766090|531770336|FG001|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
147438115|NCT00766090|531770337|FG002|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
147438116|NCT00766090|531770338|FG003|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
147438117|NCT00766090|531770339|FG004|Treatment Period 3 (28 Days)|Lost to Follow-up|1|||
147438118|NCT00766090|531770340|FG005|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
147438119|NCT00766090|531770341|FG006|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
147438120|NCT00766090|531770342|FG007|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
147438121|NCT00766090|531770343|FG008|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
147438122|NCT00766090|531770344|FG009|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
147438123|NCT00766090|531770345|FG010|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
147438124|NCT00766090|531770346|FG011|Treatment Period 3 (28 Days)|Lost to Follow-up|0|||
147438125|NCT03024970|531770351|FG000|First Intervention|Adverse Event|1|||
147438126|NCT03024970|531770352|FG001|First Intervention|Adverse Event|0|||
147438127|NCT03024970|531770351|FG000|Second Intervention|Lost to Follow-up|1|||
147438128|NCT03024970|531770352|FG001|Second Intervention|Lost to Follow-up|0|||
147438129|NCT02653300|531770354|FG000|Overall Study|Withdrawal by Subject|2|||
147438130|NCT01910116|531770363|FG000|Overall Study|Adverse Event|0|||
147438131|NCT01910116|531770364|FG001|Overall Study|Adverse Event|3|||
147438132|NCT01910116|531770363|FG000|Overall Study|Lack of Efficacy|3|||
147438133|NCT01910116|531770364|FG001|Overall Study|Lack of Efficacy|4|||
147438134|NCT01910116|531770363|FG000|Overall Study|Lost to Follow-up|1|||
147438135|NCT01910116|531770364|FG001|Overall Study|Lost to Follow-up|0|||
147438136|NCT01910116|531770363|FG000|Overall Study|Protocol Violation|1|||
147438137|NCT01910116|531770364|FG001|Overall Study|Protocol Violation|2|||
147438138|NCT01910116|531770363|FG000|Overall Study|Withdrawal by Subject|8|||
147438139|NCT01910116|531770364|FG001|Overall Study|Withdrawal by Subject|3|||
147438140|NCT01910116|531770363|FG000|Overall Study|uncertain allocation|1|||
147438141|NCT01910116|531770364|FG001|Overall Study|uncertain allocation|3|||
147438142|NCT01910116|531770363|FG000|Overall Study|incomplete data|0|||
147438143|NCT01910116|531770364|FG001|Overall Study|incomplete data|1|||
147438144|NCT02289352|531770365|FG000|Overall Study|Withdrawal by Subject|1|||
147438145|NCT02289352|531770366|FG001|Overall Study|Withdrawal by Subject|1|||
147438146|NCT02289352|531770367|FG002|Overall Study|Withdrawal by Subject|0|||
147438147|NCT01390272|531770368|FG000|Overall Study|Death|3|||
147438148|NCT01390272|531770369|FG001|Overall Study|Death|2|||
147438149|NCT01390272|531770368|FG000|Overall Study|Withdrawal by Subject|9|||
147438150|NCT01390272|531770369|FG001|Overall Study|Withdrawal by Subject|5|||
147438151|NCT01390272|531770368|FG000|Overall Study|Patient moved, no longer eligible|5|||
147438152|NCT01390272|531770369|FG001|Overall Study|Patient moved, no longer eligible|8|||
147438153|NCT01177384|531770370|FG000|Overall Study|Adverse Event|6|||
147438154|NCT01177384|531770371|FG001|Overall Study|Adverse Event|4|||
147438155|NCT01177384|531770370|FG000|Overall Study|Lack of Efficacy|0|||
147438156|NCT01177384|531770371|FG001|Overall Study|Lack of Efficacy|1|||
147438157|NCT01177384|531770370|FG000|Overall Study|Lost to Follow-up|3|||
147203303|NCT00345358|530913796|FG003|Primary Vaccination Phase|Lost to Follow-up|2|||
147203304|NCT00345358|530913793|FG000|Booster Vaccination Phase|Withdrawal by Subject|1|||
147438158|NCT01177384|531770371|FG001|Overall Study|Lost to Follow-up|4|||
147438159|NCT01177384|531770370|FG000|Overall Study|Physician Decision|0|||
147438160|NCT01177384|531770371|FG001|Overall Study|Physician Decision|3|||
147438161|NCT01177384|531770370|FG000|Overall Study|Protocol Violation|0|||
147438162|NCT01177384|531770371|FG001|Overall Study|Protocol Violation|2|||
147438163|NCT01177384|531770370|FG000|Overall Study|Withdrawal by Subject|5|||
147438164|NCT01177384|531770371|FG001|Overall Study|Withdrawal by Subject|12|||
147438165|NCT01849497|531770372|FG000|Overall Study|Withdrawal by Subject|1|||
147306814|NCT01852058|531290783|FG010|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
147438166|NCT01849497|531770373|FG001|Overall Study|Withdrawal by Subject|2|||
147438167|NCT01849497|531770372|FG000|Overall Study|Sponsor Decision|0|||
147438168|NCT01849497|531770373|FG001|Overall Study|Sponsor Decision|1|||
147438169|NCT01849497|531770372|FG000|Overall Study|Lost to Follow-up|0|||
147438170|NCT01849497|531770373|FG001|Overall Study|Lost to Follow-up|1|||
147438171|NCT00911625|531770400|FG000|Overall Study|Lost to Follow-up|7|||
147438172|NCT00911625|531770401|FG001|Overall Study|Lost to Follow-up|0|||
147438173|NCT01289821|531770402|FG000|Treatment Period|Withdrawal by Subject|1|||
147438174|NCT01289821|531770402|FG000|Treatment Period|Physician Decision|3|||
147438175|NCT01289821|531770402|FG000|Treatment Period|Adverse Event|4|||
147438176|NCT01289821|531770402|FG000|Treatment Period|Radiological Progression|43|||
147438177|NCT01289821|531770402|FG000|Treatment Period|Clinical Progression|2|||
147438178|NCT01289821|531770402|FG000|Treatment Period|Therapeutic procedure required|1|||
147438179|NCT01289821|531770402|FG000|Safety Follow-up Period|Withdrawal by Subject|1|||
147438180|NCT01289821|531770402|FG000|Safety Follow-up Period|Protocol Violation|3|||
147438181|NCT01289821|531770402|FG000|Safety Follow-up Period|Unspecified reason|1|||
147438182|NCT01289821|531770402|FG000|Survival Follow-up Period|Protocol Violation|1|||
147438183|NCT01289821|531770402|FG000|Survival Follow-up Period|Lost to Follow-up|1|||
147438184|NCT01289821|531770402|FG000|Survival Follow-up Period|Clinical endpoint reached|16|||
147438185|NCT00590044|531770406|FG000|Overall Study|Withdrawal by Subject|2|||
147438186|NCT00590044|531770407|FG001|Overall Study|Withdrawal by Subject|2|||
147438187|NCT00590044|531770406|FG000|Overall Study|wrong insulin arm assigned|1|||
147438188|NCT00590044|531770407|FG001|Overall Study|wrong insulin arm assigned|0|||
147438189|NCT00590044|531770406|FG000|Overall Study|Protocol Violation|1|||
147438190|NCT00590044|531770407|FG001|Overall Study|Protocol Violation|0|||
147438191|NCT02729740|531770411|FG000|Overall Study|Early Termination|130|||
147438192|NCT02729740|531770411|FG000|Overall Study|Other|1|||
147438193|NCT00175877|531770430|FG000|Overall Study|Adverse Event|136|||
147438194|NCT00175877|531770430|FG000|Overall Study|Withdrawal by Subject|141|||
147438195|NCT00175877|531770430|FG000|Overall Study|Lost to Follow-up|9|||
147438196|NCT00175877|531770430|FG000|Overall Study|Lack of Efficacy|26|||
147438197|NCT00175877|531770430|FG000|Overall Study|Protocol Violation|15|||
147438198|NCT00175877|531770430|FG000|Overall Study|Other Reason|20|||
147438199|NCT00175877|531770430|FG000|Overall Study|AE & Other|1|||
147438200|NCT00175877|531770430|FG000|Overall Study|Withdrawal by subject & Other|1|||
147438201|NCT03061175|531770431|FG000|Baseline|Participant was deemed ineligible|1|||
147438202|NCT03061175|531770432|FG001|Baseline|Participant was deemed ineligible|0|||
147438203|NCT03061175|531770431|FG000|Followup 1 at 2-4 Weeks Post-surgery|Skipped assessment|6|||
147438204|NCT03061175|531770432|FG001|Followup 1 at 2-4 Weeks Post-surgery|Skipped assessment|2|||
147438205|NCT03061175|531770431|FG000|Followup 1 at 2-4 Weeks Post-surgery|Withdrawal by Subject|0|||
147438206|NCT03061175|531770432|FG001|Followup 1 at 2-4 Weeks Post-surgery|Withdrawal by Subject|1|||
147438207|NCT03061175|531770431|FG000|Followup 2 at 6 Months|Lost to Follow-up|4|||
147438208|NCT03061175|531770432|FG001|Followup 2 at 6 Months|Lost to Follow-up|7|||
147438209|NCT03044249|531770435|FG000|Overall Study|Adverse Event|4|||
147438210|NCT03044249|531770436|FG001|Overall Study|Adverse Event|9|||
147438211|NCT03044249|531770435|FG000|Overall Study|Lost to Follow-up|1|||
147438212|NCT03044249|531770436|FG001|Overall Study|Lost to Follow-up|0|||
147438213|NCT03044249|531770435|FG000|Overall Study|Non-compliance with Study Drug|1|||
147438214|NCT03044249|531770436|FG001|Overall Study|Non-compliance with Study Drug|0|||
147438215|NCT03044249|531770435|FG000|Overall Study|Study Terminated by Sponsor|2|||
147438216|NCT03044249|531770436|FG001|Overall Study|Study Terminated by Sponsor|0|||
147438217|NCT03044249|531770435|FG000|Overall Study|Withdrawal by Subject|2|||
147438218|NCT03044249|531770436|FG001|Overall Study|Withdrawal by Subject|5|||
147438219|NCT00955279|531770437|FG000|Overall Study|Other|0|||
147438220|NCT00955279|531770438|FG001|Overall Study|Other|0|||
147438221|NCT00955279|531770439|FG002|Overall Study|Other|3|||
147438222|NCT00955279|531770437|FG000|Overall Study|Death|1|||
147438223|NCT00955279|531770438|FG001|Overall Study|Death|1|||
147438224|NCT00955279|531770439|FG002|Overall Study|Death|1|||
147438225|NCT00955279|531770437|FG000|Overall Study|Lost to Follow-up|0|||
147438226|NCT00955279|531770438|FG001|Overall Study|Lost to Follow-up|3|||
147438227|NCT00955279|531770439|FG002|Overall Study|Lost to Follow-up|1|||
147438228|NCT00955279|531770437|FG000|Overall Study|Withdrawal by Subject|2|||
147438229|NCT00955279|531770438|FG001|Overall Study|Withdrawal by Subject|0|||
147438230|NCT00955279|531770439|FG002|Overall Study|Withdrawal by Subject|3|||
147438231|NCT00760669|531770440|FG000|Overall Study|Not assessed for overall improvement|18|||
147438232|NCT00760669|531770440|FG000|Overall Study|Participants missing efficacy assessment|6|||
147438233|NCT00760669|531770440|FG000|Overall Study|Participants with overlapping cases|1|||
147438234|NCT00760669|531770440|FG000|Overall Study|Took drug before entering in contract|5|||
147438235|NCT01235793|531770441|FG000|Overall Study|Death|6|||
147438236|NCT01159912|531770443|FG000|Overall Study|Adverse Event|2|||
147438237|NCT01159912|531770444|FG001|Overall Study|Adverse Event|2|||
147438238|NCT01159912|531770445|FG002|Overall Study|Adverse Event|3|||
147438239|NCT01159912|531770443|FG000|Overall Study|Lack of Efficacy|23|||
147649428|NCT02634801|532537342|FG001|Extension Period (Weeks 24 to 36)|Adverse Event|0|||
147203305|NCT00345358|530913794|FG001|Booster Vaccination Phase|Withdrawal by Subject|0|||
147539360|NCT03611751|532129089|FG001|Treatment Week 16 - Week 24|Non-compliance with protocol|0|||
147539361|NCT03611751|532129090|FG002|Treatment Week 16 - Week 24|Non-compliance with protocol|1|||
147539362|NCT03611751|532129088|FG000|Treatment Week 16 - Week 24|Withdrawal by Subject|2|||
147539363|NCT03611751|532129089|FG001|Treatment Week 16 - Week 24|Withdrawal by Subject|0|||
147539364|NCT03611751|532129090|FG002|Treatment Week 16 - Week 24|Withdrawal by Subject|1|||
147539365|NCT03611751|532129088|FG000|Treatment Week 16 - Week 24|Other reasons|2|||
147539366|NCT03611751|532129089|FG001|Treatment Week 16 - Week 24|Other reasons|0|||
147539367|NCT03611751|532129090|FG002|Treatment Week 16 - Week 24|Other reasons|3|||
147539368|NCT03611751|532129088|FG000|Treatment Week 16 - Week 24|Pregnancy|1|||
147539369|NCT03611751|532129089|FG001|Treatment Week 16 - Week 24|Pregnancy|0|||
147539370|NCT03611751|532129090|FG002|Treatment Week 16 - Week 24|Pregnancy|1|||
147539371|NCT03611751|532129088|FG000|Treatment Week 24 - Week 52|Adverse Event|14|||
147539372|NCT03611751|532129089|FG001|Treatment Week 24 - Week 52|Adverse Event|7|||
147539373|NCT03611751|532129090|FG002|Treatment Week 24 - Week 52|Adverse Event|0|||
147539374|NCT03611751|532129088|FG000|Treatment Week 24 - Week 52|Lack of Efficacy|8|||
147539375|NCT03611751|532129089|FG001|Treatment Week 24 - Week 52|Lack of Efficacy|8|||
147539376|NCT03611751|532129090|FG002|Treatment Week 24 - Week 52|Lack of Efficacy|0|||
147539377|NCT03611751|532129088|FG000|Treatment Week 24 - Week 52|Lost to Follow-up|9|||
147539378|NCT03611751|532129089|FG001|Treatment Week 24 - Week 52|Lost to Follow-up|4|||
147539379|NCT03611751|532129090|FG002|Treatment Week 24 - Week 52|Lost to Follow-up|0|||
147539380|NCT03611751|532129088|FG000|Treatment Week 24 - Week 52|Non-compliance with protocol|2|||
147539381|NCT03611751|532129089|FG001|Treatment Week 24 - Week 52|Non-compliance with protocol|0|||
147539382|NCT03611751|532129090|FG002|Treatment Week 24 - Week 52|Non-compliance with protocol|0|||
147539383|NCT03611751|532129088|FG000|Treatment Week 24 - Week 52|Withdrawal by Subject|8|||
147539384|NCT03611751|532129089|FG001|Treatment Week 24 - Week 52|Withdrawal by Subject|6|||
147539385|NCT03611751|532129090|FG002|Treatment Week 24 - Week 52|Withdrawal by Subject|0|||
147539386|NCT03611751|532129088|FG000|Treatment Week 24 - Week 52|Other reasons|28|||
147539387|NCT03611751|532129089|FG001|Treatment Week 24 - Week 52|Other reasons|7|||
147539388|NCT03611751|532129090|FG002|Treatment Week 24 - Week 52|Other reasons|0|||
147539389|NCT03611751|532129088|FG000|Treatment Week 24 - Week 52|Pregnancy|0|||
147539390|NCT03611751|532129089|FG001|Treatment Week 24 - Week 52|Pregnancy|1|||
147539391|NCT03611751|532129090|FG002|Treatment Week 24 - Week 52|Pregnancy|0|||
147539392|NCT00929864|532129091|FG000|Overall Study|Death|1|||
147539393|NCT00929864|532129092|FG001|Overall Study|Death|1|||
147539394|NCT00929864|532129091|FG000|Overall Study|Adverse Event|11|||
147539395|NCT00929864|532129092|FG001|Overall Study|Adverse Event|30|||
147539396|NCT00929864|532129091|FG000|Overall Study|Lack of Efficacy|19|||
147539397|NCT00929864|532129092|FG001|Overall Study|Lack of Efficacy|16|||
147539398|NCT00929864|532129091|FG000|Overall Study|Lost to Follow-up|7|||
147539399|NCT00929864|532129092|FG001|Overall Study|Lost to Follow-up|12|||
147539400|NCT00929864|532129091|FG000|Overall Study|Withdrawal by Subject|20|||
147539401|NCT00929864|532129092|FG001|Overall Study|Withdrawal by Subject|9|||
147539402|NCT00929864|532129091|FG000|Overall Study|No longer met criteria|2|||
147539403|NCT00929864|532129092|FG001|Overall Study|No longer met criteria|1|||
147539404|NCT00929864|532129091|FG000|Overall Study|Poor or non-compliance|3|||
147539405|NCT00929864|532129092|FG001|Overall Study|Poor or non-compliance|3|||
147539406|NCT00929864|532129091|FG000|Overall Study|Pregnancy|0|||
147539407|NCT00929864|532129092|FG001|Overall Study|Pregnancy|3|||
147539408|NCT00929864|532129091|FG000|Overall Study|Administrative reason by Sponsor|1|||
147539409|NCT00929864|532129092|FG001|Overall Study|Administrative reason by Sponsor|1|||
147539410|NCT00929864|532129091|FG000|Overall Study|Non-specified|2|||
147539411|NCT00929864|532129092|FG001|Overall Study|Non-specified|7|||
147539412|NCT02666768|532129093|FG000|Overall Study|Withdrawal by Subject|4|||
147539413|NCT01023022|532129094|FG000|Overall Study|Death|5|||
147539414|NCT01023022|532129094|FG000|Overall Study|Lost to Follow-up|7|||
147539415|NCT01023022|532129094|FG000|Overall Study|due to technical issues|2|||
147539416|NCT03728257|532129095|FG000|Overall Study|Death|3|||
147539417|NCT03728257|532129096|FG001|Overall Study|Death|0|||
147539418|NCT01306968|532129099|FG000|Overall Study|Lost to Follow-up|1|||
147539419|NCT01306968|532129100|FG001|Overall Study|Lost to Follow-up|1|||
147539420|NCT01306968|532129101|FG002|Overall Study|Lost to Follow-up|0|||
147539421|NCT01306968|532129102|FG003|Overall Study|Lost to Follow-up|0|||
147539422|NCT01306968|532129099|FG000|Overall Study|Physician Decision|0|||
147539423|NCT01306968|532129100|FG001|Overall Study|Physician Decision|1|||
147539424|NCT01306968|532129101|FG002|Overall Study|Physician Decision|0|||
147539425|NCT01306968|532129102|FG003|Overall Study|Physician Decision|0|||
147539426|NCT01306968|532129099|FG000|Overall Study|Relocated and left active duty|0|||
147539427|NCT01306968|532129100|FG001|Overall Study|Relocated and left active duty|1|||
147539428|NCT01306968|532129101|FG002|Overall Study|Relocated and left active duty|1|||
147539429|NCT01306968|532129102|FG003|Overall Study|Relocated and left active duty|1|||
147539430|NCT01306968|532129099|FG000|Overall Study|Withdrew - time commitment|0|||
147539431|NCT01306968|532129100|FG001|Overall Study|Withdrew - time commitment|0|||
147539432|NCT01306968|532129101|FG002|Overall Study|Withdrew - time commitment|0|||
147539433|NCT01306968|532129102|FG003|Overall Study|Withdrew - time commitment|2|||
147539434|NCT01306968|532129099|FG000|Overall Study|Withdrew over privacy concerns|0|||
147539435|NCT01306968|532129100|FG001|Overall Study|Withdrew over privacy concerns|0|||
147539436|NCT01306968|532129101|FG002|Overall Study|Withdrew over privacy concerns|0|||
147539437|NCT01306968|532129102|FG003|Overall Study|Withdrew over privacy concerns|1|||
147539438|NCT01381068|532129103|FG000|Overall Study|Death|1|||
147539439|NCT01381068|532129104|FG001|Overall Study|Death|0|||
147539440|NCT00797316|532129105|FG000|Overall Study|Administrative problems|1|||
147539441|NCT00797316|532129106|FG001|Overall Study|Administrative problems|0|||
147539442|NCT00797316|532129105|FG000|Overall Study|Adverse Event|5|||
147539443|NCT00797316|532129106|FG001|Overall Study|Adverse Event|3|||
147539444|NCT00797316|532129105|FG000|Overall Study|Lost to Follow-up|4|||
147539445|NCT00797316|532129106|FG001|Overall Study|Lost to Follow-up|8|||
147539446|NCT00797316|532129105|FG000|Overall Study|Protocol Deviation|1|||
147539447|NCT00797316|532129106|FG001|Overall Study|Protocol Deviation|2|||
147539448|NCT00797316|532129105|FG000|Overall Study|Patient withdrew consent|12|||
147539449|NCT00797316|532129106|FG001|Overall Study|Patient withdrew consent|6|||
147539450|NCT00797316|532129105|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
147539451|NCT00797316|532129106|FG001|Overall Study|Unsatisfactory therapeutic effect|13|||
147539452|NCT03239340|532129109|FG000|Overall Study|Other|26|||
147539453|NCT03239340|532129109|FG000|Overall Study|Patients who are ongoing in the study at DCO|10|||
147539454|NCT03239340|532129109|FG000|Overall Study|Death|40|||
147539455|NCT03239340|532129109|FG000|Overall Study|Lost to Follow-up|2|||
147539456|NCT03239340|532129109|FG000|Overall Study|Physician Decision|16|||
147539457|NCT03239340|532129109|FG000|Overall Study|Withdrawal by Subject|27|||
147539458|NCT02392377|532129112|FG000|Overall Study|Withdrawal by Subject|0|||
147539459|NCT02392377|532129113|FG001|Overall Study|Withdrawal by Subject|1|||
147539460|NCT00902486|532129114|FG000|Treatment Period (Weeks 0 Through 12)|Adverse Event|1|||
147539461|NCT00902486|532129115|FG001|Treatment Period (Weeks 0 Through 12)|Adverse Event|0|||
147539462|NCT00902486|532129116|FG002|Treatment Period (Weeks 0 Through 12)|Adverse Event|0|||
147539463|NCT00902486|532129117|FG003|Treatment Period (Weeks 0 Through 12)|Adverse Event|1|||
147539464|NCT00902486|532129118|FG004|Treatment Period (Weeks 0 Through 12)|Adverse Event|1|||
147539465|NCT00902486|532129119|FG005|Treatment Period (Weeks 0 Through 12)|Adverse Event|2|||
147539466|NCT00902486|532129114|FG000|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|1|||
147539467|NCT00902486|532129115|FG001|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|0|||
147539468|NCT00902486|532129116|FG002|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|0|||
147539469|NCT00902486|532129117|FG003|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|0|||
147539470|NCT00902486|532129118|FG004|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|0|||
147539471|NCT00902486|532129119|FG005|Treatment Period (Weeks 0 Through 12)|Consent Withdrawn|2|||
147539472|NCT00902486|532129114|FG000|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|0|||
147539473|NCT00902486|532129115|FG001|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|0|||
147539474|NCT00902486|532129116|FG002|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|0|||
147539475|NCT00902486|532129117|FG003|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|0|||
147539476|NCT00902486|532129118|FG004|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|1|||
147539477|NCT00902486|532129119|FG005|Treatment Period (Weeks 0 Through 12)|Protocol Deviation|1|||
147539478|NCT00902486|532129114|FG000|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0|||
147539479|NCT00902486|532129115|FG001|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0|||
147539480|NCT00902486|532129116|FG002|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0|||
147539481|NCT00902486|532129117|FG003|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|1|||
147539482|NCT00902486|532129118|FG004|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0|||
147539483|NCT00902486|532129119|FG005|Treatment Period (Weeks 0 Through 12)|Lost to Follow-up|0|||
147539484|NCT00902486|532129114|FG000|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0|||
147539485|NCT00902486|532129115|FG001|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0|||
147539486|NCT00902486|532129116|FG002|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0|||
147539487|NCT00902486|532129117|FG003|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|1|||
147539488|NCT00902486|532129118|FG004|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0|||
147539489|NCT00902486|532129119|FG005|Treatment Period (Weeks 0 Through 12)|corrected QT (QTc) exclusion criteria|0|||
147539490|NCT00902486|532129114|FG000|Extension Period (Weeks 12 Through 24)|Adverse Event|0|||
147539491|NCT00902486|532129115|FG001|Extension Period (Weeks 12 Through 24)|Adverse Event|0|||
147539492|NCT00902486|532129116|FG002|Extension Period (Weeks 12 Through 24)|Adverse Event|0|||
147539493|NCT00902486|532129117|FG003|Extension Period (Weeks 12 Through 24)|Adverse Event|0|||
147539494|NCT00902486|532129118|FG004|Extension Period (Weeks 12 Through 24)|Adverse Event|1|||
147539495|NCT00902486|532129119|FG005|Extension Period (Weeks 12 Through 24)|Adverse Event|2|||
147539496|NCT00902486|532129114|FG000|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|0|||
147539497|NCT00902486|532129115|FG001|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|0|||
147539498|NCT00902486|532129116|FG002|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|1|||
147539499|NCT00902486|532129117|FG003|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|1|||
147539500|NCT00902486|532129118|FG004|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|0|||
147539501|NCT00902486|532129119|FG005|Extension Period (Weeks 12 Through 24)|Consent Withdrawn|0|||
147539502|NCT00902486|532129114|FG000|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0|||
147438240|NCT01159912|531770444|FG001|Overall Study|Lack of Efficacy|15|||
147438241|NCT01159912|531770445|FG002|Overall Study|Lack of Efficacy|14|||
147438242|NCT01159912|531770443|FG000|Overall Study|Protocol Violation|1|||
147438243|NCT01159912|531770444|FG001|Overall Study|Protocol Violation|2|||
147438244|NCT01159912|531770445|FG002|Overall Study|Protocol Violation|3|||
147438245|NCT01159912|531770443|FG000|Overall Study|Lost to Follow-up|4|||
147438246|NCT01159912|531770444|FG001|Overall Study|Lost to Follow-up|0|||
147438247|NCT01159912|531770445|FG002|Overall Study|Lost to Follow-up|0|||
147438248|NCT01159912|531770443|FG000|Overall Study|Physician Decision|0|||
147438249|NCT01159912|531770444|FG001|Overall Study|Physician Decision|0|||
147438250|NCT01159912|531770445|FG002|Overall Study|Physician Decision|3|||
147438251|NCT01159912|531770443|FG000|Overall Study|Withdrawal by Subject|10|||
147438252|NCT01159912|531770444|FG001|Overall Study|Withdrawal by Subject|3|||
147438253|NCT01159912|531770445|FG002|Overall Study|Withdrawal by Subject|3|||
147438254|NCT02456662|531770448|FG000|Overall Study|Lost to Follow-up|2|||
147438255|NCT02456662|531770449|FG001|Overall Study|Lost to Follow-up|1|||
147438256|NCT02374021|531770452|FG000|Overall Study|Adverse Event|1|||
147438257|NCT02374021|531770453|FG001|Overall Study|Adverse Event|0|||
147438258|NCT02374021|531770452|FG000|Overall Study|Lost to Follow-up|3|||
147438259|NCT02374021|531770453|FG001|Overall Study|Lost to Follow-up|2|||
147438260|NCT02374021|531770452|FG000|Overall Study|Physician Decision|0|||
147438261|NCT02374021|531770453|FG001|Overall Study|Physician Decision|3|||
147438262|NCT02374021|531770452|FG000|Overall Study|Withdrawal by Subject|6|||
147438263|NCT02374021|531770453|FG001|Overall Study|Withdrawal by Subject|5|||
147438264|NCT02374021|531770452|FG000|Overall Study|Poor Adherence|0|||
147438265|NCT02374021|531770453|FG001|Overall Study|Poor Adherence|1|||
147438266|NCT02374021|531770452|FG000|Overall Study|Scan protocol not followed|0|||
147438267|NCT02374021|531770453|FG001|Overall Study|Scan protocol not followed|1|||
147438268|NCT02374021|531770452|FG000|Overall Study|Poor quality scan/scan not able to be analyzed|13|||
147438269|NCT02374021|531770453|FG001|Overall Study|Poor quality scan/scan not able to be analyzed|9|||
147438270|NCT00504153|531770458|FG000|Overall Study|Withdrawal by Subject|1|||
147438271|NCT00504153|531770458|FG000|Overall Study|Adverse Event|4|||
147438272|NCT00504153|531770458|FG000|Overall Study|Death|1|||
147438273|NCT00732251|531770461|FG000|Overall Study|Lost to Follow-up|3|||
147438274|NCT00732251|531770461|FG000|Overall Study|Withdrawal by Subject|3|||
147438275|NCT00732251|531770461|FG000|Overall Study|Early Term due to Site Closure|1|||
147438276|NCT00805025|531770462|FG000|Overall Study|Screened but not enrolled/treated|42|||
147438277|NCT00805025|531770462|FG000|Overall Study|Adverse Event|4|||
147438278|NCT00805025|531770462|FG000|Overall Study|Withdrawal by Subject|2|||
147438279|NCT00805025|531770462|FG000|Overall Study|Physician Decision|1|||
147438280|NCT04029961|531770463|FG000|Overall Study|Withdrawal after participant advisal they viewed exact same education intervention prior to visit|1|||
147438281|NCT04029961|531770464|FG001|Overall Study|Withdrawal after participant advisal they viewed exact same education intervention prior to visit|0|||
147438282|NCT04029961|531770463|FG000|Overall Study|Change in Treatment Course|0|||
147438283|NCT04029961|531770464|FG001|Overall Study|Change in Treatment Course|1|||
147438284|NCT03007979|531770468|FG000|Overall Study|Deemed not eligible prior to starting palbociclib|1|||
147438285|NCT00682448|531772084|FG000|Overall Study|Adverse Event|1|||
147438286|NCT00682448|531772085|FG001|Overall Study|Adverse Event|2|||
147438287|NCT00682448|531772084|FG000|Overall Study|Lack of Efficacy|1|||
147438288|NCT00682448|531772085|FG001|Overall Study|Lack of Efficacy|0|||
147438289|NCT00682448|531772084|FG000|Overall Study|Lost to Follow-up|1|||
147438290|NCT00682448|531772085|FG001|Overall Study|Lost to Follow-up|3|||
147438291|NCT00682448|531772084|FG000|Overall Study|Pregnancy|0|||
147438292|NCT00682448|531772085|FG001|Overall Study|Pregnancy|1|||
147438293|NCT00682448|531772084|FG000|Overall Study|Withdrawal by Subject|2|||
147438294|NCT00682448|531772085|FG001|Overall Study|Withdrawal by Subject|0|||
147438295|NCT00761306|531772088|FG000|Overall Study|Adverse Event|5|||
147438296|NCT00761306|531772088|FG000|Overall Study|Lack of Efficacy|4|||
147438297|NCT00761306|531772088|FG000|Overall Study|Protocol Violation|2|||
147438298|NCT00761306|531772088|FG000|Overall Study|Withdrawal of Consent|3|||
147438299|NCT00761306|531772088|FG000|Overall Study|Lost to Follow-up|1|||
147438300|NCT00761306|531772088|FG000|Overall Study|Administrative or Other Reasons|5|||
147438301|NCT00268437|531772089|FG000|Overall Study|Ineligible|1|||
147438302|NCT00525044|531772090|FG000|Overall Study|Lost to Follow-up|0|||
147438303|NCT00525044|531772091|FG001|Overall Study|Lost to Follow-up|1|||
147438304|NCT02982239|531772094|FG000|Overall Study|Lost to Follow-up|3|||
147438305|NCT02982239|531772095|FG001|Overall Study|Lost to Follow-up|2|||
147438306|NCT01383096|531772114|FG000|Second Intervention (8 Days)|Vomited Study Drug within 30min of admin|0|||
147438307|NCT01383096|531772115|FG001|Second Intervention (8 Days)|Vomited Study Drug within 30min of admin|0|||
147438308|NCT01383096|531772116|FG002|Second Intervention (8 Days)|Vomited Study Drug within 30min of admin|1|||
147438309|NCT01383096|531772114|FG000|Second Intervention (8 Days)|Haemoglobin was <13.5 g/dL|0|||
147438310|NCT01383096|531772115|FG001|Second Intervention (8 Days)|Haemoglobin was <13.5 g/dL|1|||
147438311|NCT01383096|531772116|FG002|Second Intervention (8 Days)|Haemoglobin was <13.5 g/dL|1|||
147438312|NCT01383096|531772114|FG000|Third Intervention (8 Days)|Elevated AST|0|||
147438313|NCT01383096|531772115|FG001|Third Intervention (8 Days)|Elevated AST|1|||
147438314|NCT01383096|531772116|FG002|Third Intervention (8 Days)|Elevated AST|0|||
147539503|NCT00902486|532129115|FG001|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0|||
147539504|NCT00902486|532129116|FG002|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0|||
147539505|NCT00902486|532129117|FG003|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0|||
147539506|NCT00902486|532129118|FG004|Extension Period (Weeks 12 Through 24)|Protocol Deviation|0|||
147539507|NCT00902486|532129119|FG005|Extension Period (Weeks 12 Through 24)|Protocol Deviation|1|||
147539508|NCT00902486|532129114|FG000|Extension Period (Weeks 12 Through 24)|Disease Progression|0|||
147539509|NCT00902486|532129115|FG001|Extension Period (Weeks 12 Through 24)|Disease Progression|0|||
147539510|NCT00902486|532129116|FG002|Extension Period (Weeks 12 Through 24)|Disease Progression|0|||
147539511|NCT00902486|532129117|FG003|Extension Period (Weeks 12 Through 24)|Disease Progression|1|||
147539512|NCT00902486|532129118|FG004|Extension Period (Weeks 12 Through 24)|Disease Progression|0|||
147539513|NCT00902486|532129119|FG005|Extension Period (Weeks 12 Through 24)|Disease Progression|0|||
147539514|NCT00902486|532129114|FG000|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0|||
147539515|NCT00902486|532129115|FG001|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0|||
147539516|NCT00902486|532129116|FG002|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|1|||
147539517|NCT00902486|532129117|FG003|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0|||
147539518|NCT00902486|532129118|FG004|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0|||
147539519|NCT00902486|532129119|FG005|Extension Period (Weeks 12 Through 24)|Lost to Follow-up|0|||
147539520|NCT00902486|532129114|FG000|Follow-up (After Week 24)|Lost to Follow-up|0|||
147539521|NCT00902486|532129115|FG001|Follow-up (After Week 24)|Lost to Follow-up|0|||
147539522|NCT00902486|532129116|FG002|Follow-up (After Week 24)|Lost to Follow-up|0|||
147539523|NCT00902486|532129117|FG003|Follow-up (After Week 24)|Lost to Follow-up|1|||
147539524|NCT00902486|532129118|FG004|Follow-up (After Week 24)|Lost to Follow-up|0|||
147539525|NCT00902486|532129119|FG005|Follow-up (After Week 24)|Lost to Follow-up|0|||
147539526|NCT02332655|532129120|FG000|Overall Study|Lack of Efficacy|1|||
147539527|NCT03284424|532130701|FG000|Overall Study|Death|70|||
147539528|NCT03284424|532130702|FG001|Overall Study|Death|24|||
147539529|NCT03284424|532130701|FG000|Overall Study|Lost to Follow-up|3|||
147539530|NCT03284424|532130702|FG001|Overall Study|Lost to Follow-up|1|||
147539531|NCT03284424|532130701|FG000|Overall Study|Physician Decision|1|||
147539532|NCT03284424|532130702|FG001|Overall Study|Physician Decision|2|||
147539533|NCT03284424|532130701|FG000|Overall Study|Withdrawal by Subject|4|||
147539534|NCT03284424|532130702|FG001|Overall Study|Withdrawal by Subject|5|||
147203306|NCT00345358|530913795|FG002|Booster Vaccination Phase|Withdrawal by Subject|0|||
147203307|NCT00345358|530913796|FG003|Booster Vaccination Phase|Withdrawal by Subject|0|||
147203308|NCT00345358|530913793|FG000|Booster Vaccination Phase|Lost to Follow-up|3|||
147203309|NCT00345358|530913794|FG001|Booster Vaccination Phase|Lost to Follow-up|0|||
147203310|NCT00345358|530913795|FG002|Booster Vaccination Phase|Lost to Follow-up|0|||
147203311|NCT00345358|530913796|FG003|Booster Vaccination Phase|Lost to Follow-up|0|||
147203312|NCT02892448|530913798|FG000|Overall Study|Screening failure|2|||
147203313|NCT02892448|530913799|FG001|Overall Study|Screening failure|2|||
147438315|NCT01383096|531772114|FG000|Third Intervention (8 Days)|Vomited Study Drug within 30min of admin|1|||
147438316|NCT01383096|531772115|FG001|Third Intervention (8 Days)|Vomited Study Drug within 30min of admin|3|||
147438317|NCT01383096|531772116|FG002|Third Intervention (8 Days)|Vomited Study Drug within 30min of admin|0|||
147438318|NCT01383096|531772114|FG000|Third Intervention (8 Days)|Adverse Event|1|||
147438319|NCT01383096|531772115|FG001|Third Intervention (8 Days)|Adverse Event|0|||
147438320|NCT01383096|531772116|FG002|Third Intervention (8 Days)|Adverse Event|0|||
147438321|NCT01383096|531772114|FG000|Third Intervention (8 Days)|Withdrawal by Subject|1|||
147438322|NCT01383096|531772115|FG001|Third Intervention (8 Days)|Withdrawal by Subject|0|||
147438323|NCT01383096|531772116|FG002|Third Intervention (8 Days)|Withdrawal by Subject|0|||
147438324|NCT01383096|531772114|FG000|Third Intervention (8 Days)|QTcF was greater than 450 msec|1|||
147438325|NCT01383096|531772115|FG001|Third Intervention (8 Days)|QTcF was greater than 450 msec|0|||
147438326|NCT01383096|531772116|FG002|Third Intervention (8 Days)|QTcF was greater than 450 msec|0|||
147438327|NCT01383096|531772114|FG000|Fourth Intervention (8 Days)|Haemoglobin was <13.5 g/dL|1|||
147438328|NCT01383096|531772115|FG001|Fourth Intervention (8 Days)|Haemoglobin was <13.5 g/dL|0|||
147438329|NCT01383096|531772116|FG002|Fourth Intervention (8 Days)|Haemoglobin was <13.5 g/dL|0|||
147438330|NCT01383096|531772114|FG000|Fourth Intervention (8 Days)|QTcF was greater than 450 msec|1|||
147438331|NCT01383096|531772115|FG001|Fourth Intervention (8 Days)|QTcF was greater than 450 msec|0|||
147438332|NCT01383096|531772116|FG002|Fourth Intervention (8 Days)|QTcF was greater than 450 msec|0|||
147438333|NCT01383096|531772114|FG000|Fifth Intervention (8 Days)|Withdrawal by Subject|1|||
147438334|NCT01383096|531772115|FG001|Fifth Intervention (8 Days)|Withdrawal by Subject|0|||
147438335|NCT01383096|531772116|FG002|Fifth Intervention (8 Days)|Withdrawal by Subject|0|||
147438336|NCT01383096|531772114|FG000|Fifth Intervention (8 Days)|haemoglobin was <13.5 g/dL|1|||
147438337|NCT01383096|531772115|FG001|Fifth Intervention (8 Days)|haemoglobin was <13.5 g/dL|0|||
147539535|NCT03284424|532130701|FG000|Overall Study|Sponsor's decision|27|||
147539536|NCT03284424|532130702|FG001|Overall Study|Sponsor's decision|22|||
147539537|NCT01563029|532130705|FG000|Overall Study|Adverse Event|1|||
147539538|NCT01563029|532130706|FG001|Overall Study|Adverse Event|0|||
147539539|NCT01563029|532130707|FG002|Overall Study|Adverse Event|1|||
147203314|NCT02892448|530913800|FG002|Overall Study|Screening failure|1|||
147539540|NCT01563029|532130708|FG003|Overall Study|Adverse Event|2|||
147539541|NCT01563029|532130709|FG004|Overall Study|Adverse Event|1|||
147539542|NCT01563029|532130705|FG000|Overall Study|Lack of Efficacy|42|||
147539543|NCT01563029|532130706|FG001|Overall Study|Lack of Efficacy|16|||
147539544|NCT01563029|532130707|FG002|Overall Study|Lack of Efficacy|23|||
147539545|NCT01563029|532130708|FG003|Overall Study|Lack of Efficacy|21|||
147539546|NCT01563029|532130709|FG004|Overall Study|Lack of Efficacy|19|||
147539547|NCT01563029|532130705|FG000|Overall Study|Protocol Violation|1|||
147539548|NCT01563029|532130706|FG001|Overall Study|Protocol Violation|2|||
147539549|NCT01563029|532130707|FG002|Overall Study|Protocol Violation|3|||
147539550|NCT01563029|532130708|FG003|Overall Study|Protocol Violation|1|||
147539551|NCT01563029|532130709|FG004|Overall Study|Protocol Violation|3|||
147539552|NCT01563029|532130705|FG000|Overall Study|Protocol defined stopping criteria|1|||
147539553|NCT01563029|532130706|FG001|Overall Study|Protocol defined stopping criteria|0|||
147539554|NCT01563029|532130707|FG002|Overall Study|Protocol defined stopping criteria|0|||
147539555|NCT01563029|532130708|FG003|Overall Study|Protocol defined stopping criteria|0|||
147539556|NCT01563029|532130709|FG004|Overall Study|Protocol defined stopping criteria|0|||
147539557|NCT01563029|532130705|FG000|Overall Study|Lost to Follow-up|1|||
147539558|NCT01563029|532130706|FG001|Overall Study|Lost to Follow-up|0|||
147539559|NCT01563029|532130707|FG002|Overall Study|Lost to Follow-up|1|||
147539560|NCT01563029|532130708|FG003|Overall Study|Lost to Follow-up|1|||
147539561|NCT01563029|532130709|FG004|Overall Study|Lost to Follow-up|1|||
147539562|NCT01563029|532130705|FG000|Overall Study|Physician Decision|3|||
147539563|NCT01563029|532130706|FG001|Overall Study|Physician Decision|5|||
147539564|NCT01563029|532130707|FG002|Overall Study|Physician Decision|2|||
147539565|NCT01563029|532130708|FG003|Overall Study|Physician Decision|4|||
147539566|NCT01563029|532130709|FG004|Overall Study|Physician Decision|2|||
147539567|NCT01563029|532130705|FG000|Overall Study|Withdrawal by Subject|4|||
147539568|NCT01563029|532130706|FG001|Overall Study|Withdrawal by Subject|1|||
147539569|NCT01563029|532130707|FG002|Overall Study|Withdrawal by Subject|3|||
147539570|NCT01563029|532130708|FG003|Overall Study|Withdrawal by Subject|4|||
147539571|NCT01563029|532130709|FG004|Overall Study|Withdrawal by Subject|3|||
147539572|NCT01569594|532130710|FG000|Overall Study|Physician Decision|4|||
147539573|NCT01569594|532130710|FG000|Overall Study|Death|13|||
147539574|NCT01569594|532130710|FG000|Overall Study|Lost to Follow-up|22|||
147539575|NCT01569594|532130710|FG000|Overall Study|Adverse Event|2|||
147539576|NCT01569594|532130710|FG000|Overall Study|Withdrawal by Subject|13|||
147539577|NCT01569594|532130710|FG000|Overall Study|Other|4|||
147539578|NCT01569594|532130710|FG000|Overall Study|No ECM used|9|||
147539579|NCT03069365|532130711|FG000|Overall Study|Adverse Event|1|||
147539580|NCT02861534|532130712|FG000|Overall Study|Death|541|||
147539581|NCT02861534|532130713|FG001|Overall Study|Death|552|||
147539582|NCT02861534|532130712|FG000|Overall Study|Lost to Follow-up|14|||
147539583|NCT02861534|532130713|FG001|Overall Study|Lost to Follow-up|14|||
147539584|NCT02861534|532130712|FG000|Overall Study|Site Terminated by Sponsor|4|||
147539585|NCT02861534|532130713|FG001|Overall Study|Site Terminated by Sponsor|3|||
147539586|NCT02861534|532130712|FG000|Overall Study|Withdrawal by Subject|15|||
147539587|NCT02861534|532130713|FG001|Overall Study|Withdrawal by Subject|18|||
147539588|NCT02780115|532130714|FG000|Overall Study|Withdrawal by Subject|0|||
147539589|NCT02780115|532130715|FG001|Overall Study|Withdrawal by Subject|1|||
147539590|NCT02780115|532130716|FG002|Overall Study|Withdrawal by Subject|1|||
147539591|NCT02780115|532130717|FG003|Overall Study|Withdrawal by Subject|0|||
147539592|NCT02780115|532130718|FG004|Overall Study|Withdrawal by Subject|0|||
147539593|NCT02780115|532130714|FG000|Overall Study|Adverse Event|0|||
147539594|NCT02780115|532130715|FG001|Overall Study|Adverse Event|0|||
147539595|NCT02780115|532130716|FG002|Overall Study|Adverse Event|0|||
147539596|NCT02780115|532130717|FG003|Overall Study|Adverse Event|1|||
147539597|NCT02780115|532130718|FG004|Overall Study|Adverse Event|1|||
147539598|NCT02086968|532130722|FG000|Overall Study|Adverse Event|1|||
147539599|NCT02086968|532130723|FG001|Overall Study|Adverse Event|5|||
147539600|NCT02086968|532130722|FG000|Overall Study|Lost to Follow-up|2|||
147539601|NCT02086968|532130723|FG001|Overall Study|Lost to Follow-up|3|||
147539602|NCT02086968|532130722|FG000|Overall Study|Study drug received outside protocol|0|||
147539603|NCT02086968|532130723|FG001|Overall Study|Study drug received outside protocol|1|||
147539604|NCT02086968|532130722|FG000|Overall Study|Physician Decision|4|||
147539605|NCT02086968|532130723|FG001|Overall Study|Physician Decision|0|||
147539606|NCT02086968|532130722|FG000|Overall Study|Withdrawal by Subject|1|||
147539607|NCT02086968|532130723|FG001|Overall Study|Withdrawal by Subject|4|||
147539608|NCT03387735|532130724|FG000|Overall Study|Lost to Follow-up|4|||
147539609|NCT03387735|532130725|FG001|Overall Study|Lost to Follow-up|8|||
147539610|NCT03387735|532130724|FG000|Overall Study|Death|4|||
147539611|NCT03387735|532130725|FG001|Overall Study|Death|8|||
147539612|NCT00742859|532130728|FG000|Overall Study|Adverse Event|5|||
147539613|NCT00742859|532130729|FG001|Overall Study|Adverse Event|6|||
147539614|NCT00742859|532130730|FG002|Overall Study|Adverse Event|3|||
147539615|NCT00742859|532130731|FG003|Overall Study|Adverse Event|1|||
147539616|NCT00742859|532130728|FG000|Overall Study|Death|1|||
147539617|NCT00742859|532130729|FG001|Overall Study|Death|0|||
147539618|NCT00742859|532130730|FG002|Overall Study|Death|0|||
147539619|NCT00742859|532130731|FG003|Overall Study|Death|1|||
147539620|NCT00742859|532130728|FG000|Overall Study|Physician Decision|1|||
147539621|NCT00742859|532130729|FG001|Overall Study|Physician Decision|2|||
147539622|NCT00742859|532130730|FG002|Overall Study|Physician Decision|0|||
147539623|NCT00742859|532130731|FG003|Overall Study|Physician Decision|0|||
147539624|NCT00742859|532130728|FG000|Overall Study|Withdrawal by Subject|4|||
147539625|NCT00742859|532130729|FG001|Overall Study|Withdrawal by Subject|2|||
147539626|NCT00742859|532130730|FG002|Overall Study|Withdrawal by Subject|4|||
147539627|NCT00742859|532130731|FG003|Overall Study|Withdrawal by Subject|1|||
147539628|NCT00742859|532130728|FG000|Overall Study|Endpoint|0|||
147539629|NCT00742859|532130729|FG001|Overall Study|Endpoint|1|||
147539630|NCT00742859|532130730|FG002|Overall Study|Endpoint|1|||
147539631|NCT00742859|532130731|FG003|Overall Study|Endpoint|2|||
147539632|NCT00742859|532130728|FG000|Overall Study|Amendment 2 patient off study drug >4wks|0|||
147539633|NCT00742859|532130729|FG001|Overall Study|Amendment 2 patient off study drug >4wks|1|||
147539634|NCT00742859|532130730|FG002|Overall Study|Amendment 2 patient off study drug >4wks|1|||
147539635|NCT00742859|532130731|FG003|Overall Study|Amendment 2 patient off study drug >4wks|0|||
147539636|NCT00742859|532130728|FG000|Overall Study|Sponsor req visit schedule noncompliance|0|||
147539637|NCT00742859|532130729|FG001|Overall Study|Sponsor req visit schedule noncompliance|0|||
147539638|NCT00742859|532130730|FG002|Overall Study|Sponsor req visit schedule noncompliance|0|||
147539639|NCT00742859|532130731|FG003|Overall Study|Sponsor req visit schedule noncompliance|1|||
147539640|NCT00742859|532130728|FG000|Overall Study|Sponsor request patient out of town|0|||
147539641|NCT00742859|532130729|FG001|Overall Study|Sponsor request patient out of town|0|||
147539642|NCT00742859|532130730|FG002|Overall Study|Sponsor request patient out of town|1|||
147539643|NCT00742859|532130731|FG003|Overall Study|Sponsor request patient out of town|1|||
147539644|NCT00742859|532130728|FG000|Overall Study|Site error|0|||
147539645|NCT00742859|532130729|FG001|Overall Study|Site error|0|||
147539646|NCT00742859|532130730|FG002|Overall Study|Site error|1|||
147539647|NCT00742859|532130731|FG003|Overall Study|Site error|1|||
147539648|NCT00943384|532130733|FG000|Overall Study|Dispositioned prior to treatment|23|||
147539649|NCT00943384|532130733|FG000|Overall Study|Treated off protocol-protocol violation|5|||
147539650|NCT00943384|532130733|FG000|Overall Study|Lost to Follow-up|16|||
147539651|NCT00943384|532130733|FG000|Overall Study|Withdrawal by Subject|5|||
147539652|NCT02575807|532130737|FG000|Overall Study|Death|8|||
147539653|NCT02575807|532130738|FG001|Overall Study|Death|3|||
147539654|NCT02575807|532130739|FG002|Overall Study|Death|7|||
147539655|NCT02575807|532130740|FG003|Overall Study|Death|0|||
147539656|NCT02575807|532130741|FG004|Overall Study|Death|1|||
147539657|NCT02575807|532130737|FG000|Overall Study|Study terminated by Sponsor|0|||
147539658|NCT02575807|532130738|FG001|Overall Study|Study terminated by Sponsor|1|||
147539659|NCT02575807|532130739|FG002|Overall Study|Study terminated by Sponsor|7|||
147539660|NCT02575807|532130740|FG003|Overall Study|Study terminated by Sponsor|0|||
147539661|NCT02575807|532130741|FG004|Overall Study|Study terminated by Sponsor|1|||
147539662|NCT02575807|532130737|FG000|Overall Study|Terminated due to FDA clinical hold|1|||
147539663|NCT02575807|532130738|FG001|Overall Study|Terminated due to FDA clinical hold|0|||
147539664|NCT02575807|532130739|FG002|Overall Study|Terminated due to FDA clinical hold|0|||
147539665|NCT02575807|532130740|FG003|Overall Study|Terminated due to FDA clinical hold|0|||
147539666|NCT02575807|532130741|FG004|Overall Study|Terminated due to FDA clinical hold|0|||
147539667|NCT02575807|532130737|FG000|Overall Study|Terminated due to physician decision|0|||
147539668|NCT02575807|532130738|FG001|Overall Study|Terminated due to physician decision|0|||
147539669|NCT02575807|532130739|FG002|Overall Study|Terminated due to physician decision|1|||
147539670|NCT02575807|532130740|FG003|Overall Study|Terminated due to physician decision|0|||
147539671|NCT02575807|532130741|FG004|Overall Study|Terminated due to physician decision|0|||
147539672|NCT02575807|532130737|FG000|Overall Study|Subject ineligible - medical implant|0|||
147539673|NCT02575807|532130738|FG001|Overall Study|Subject ineligible - medical implant|0|||
147539674|NCT02575807|532130739|FG002|Overall Study|Subject ineligible - medical implant|0|||
147539675|NCT02575807|532130740|FG003|Overall Study|Subject ineligible - medical implant|1|||
147539676|NCT02575807|532130741|FG004|Overall Study|Subject ineligible - medical implant|0|||
147539677|NCT02575807|532130737|FG000|Overall Study|Withdrawal by Subject|0|||
147203315|NCT00346697|530913801|FG000|Overall Study|Lost to Follow-up|0|||
147203316|NCT00346697|530913802|FG001|Overall Study|Lost to Follow-up|1|||
147539678|NCT02575807|532130738|FG001|Overall Study|Withdrawal by Subject|0|||
147539679|NCT02575807|532130739|FG002|Overall Study|Withdrawal by Subject|1|||
147539680|NCT02575807|532130740|FG003|Overall Study|Withdrawal by Subject|1|||
147539681|NCT02575807|532130741|FG004|Overall Study|Withdrawal by Subject|2|||
147203317|NCT00499083|530913803|FG000|Overall Study|Not evaluable|3|||
147539682|NCT00478673|532130749|FG000|30-Days Post-Procedure|Death|2|||
147539683|NCT00478673|532130749|FG000|30-Days Post-Procedure|Withdrawal by Subject|1|||
147539684|NCT00478673|532130749|FG000|30-Days Post-Procedure|Missed Visit|7|||
147539685|NCT00478673|532130749|FG000|12-Months Post-Procedure|Death|23|||
147539686|NCT00478673|532130749|FG000|12-Months Post-Procedure|Lost to Follow-up|4|||
147539687|NCT00478673|532130749|FG000|12-Months Post-Procedure|Withdrawal by Subject|6|||
147203318|NCT00318643|530913807|FG000|Overall Study|Adverse Event|0|||
147203319|NCT00318643|530913808|FG001|Overall Study|Adverse Event|0|||
147539688|NCT00478673|532130749|FG000|12-Months Post-Procedure|Missed Visit|25|||
147203320|NCT00318643|530913809|FG002|Overall Study|Adverse Event|0|||
147203321|NCT00318643|530913810|FG003|Overall Study|Adverse Event|0|||
147203322|NCT00318643|530913811|FG004|Overall Study|Adverse Event|1|||
147203323|NCT00318643|530913807|FG000|Overall Study|Participant's Decision|0|||
147203324|NCT00318643|530913808|FG001|Overall Study|Participant's Decision|0|||
147203325|NCT00318643|530913809|FG002|Overall Study|Participant's Decision|0|||
147203326|NCT00318643|530913810|FG003|Overall Study|Participant's Decision|0|||
147203327|NCT00318643|530913811|FG004|Overall Study|Participant's Decision|1|||
147203328|NCT00318643|530913807|FG000|Overall Study|Investigator's Decision|0|||
147203329|NCT00318643|530913808|FG001|Overall Study|Investigator's Decision|0|||
147203330|NCT00318643|530913809|FG002|Overall Study|Investigator's Decision|0|||
147203331|NCT00318643|530913810|FG003|Overall Study|Investigator's Decision|0|||
147203332|NCT00318643|530913811|FG004|Overall Study|Investigator's Decision|1|||
147203333|NCT01812252|530913812|FG000|Overall Study|Persistent Disease|1|||
147203334|NCT01812252|530913813|FG001|Overall Study|Persistent Disease|0|||
147203335|NCT01812252|530913812|FG000|Overall Study|Not transplanted|11|||
147539689|NCT00478673|532130749|FG000|12-Months Post-Procedure|Visit Not Required by Protocol|6|||
147539690|NCT03940742|532130755|FG000|Overall Study|Lost to Follow-up|0|||
147539691|NCT03940742|532130756|FG001|Overall Study|Lost to Follow-up|0|||
147539692|NCT03940742|532130757|FG002|Overall Study|Lost to Follow-up|0|||
147539693|NCT03940742|532130758|FG003|Overall Study|Lost to Follow-up|1|||
147539694|NCT03428217|532130759|FG000|Overall Study|Death|89|||
147539695|NCT03428217|532130760|FG001|Overall Study|Death|93|||
147539696|NCT03428217|532130759|FG000|Overall Study|Withdrawal by Subject|8|||
147539697|NCT03428217|532130760|FG001|Overall Study|Withdrawal by Subject|7|||
147539698|NCT03428217|532130759|FG000|Overall Study|Lost to Follow-up|1|||
147539699|NCT03428217|532130760|FG001|Overall Study|Lost to Follow-up|3|||
147539700|NCT03428217|532130759|FG000|Overall Study|Study terminated by sponsor|124|||
147539701|NCT03428217|532130760|FG001|Overall Study|Study terminated by sponsor|118|||
147539702|NCT03428217|532130759|FG000|Overall Study|Other, Not Specified|1|||
147539703|NCT03428217|532130760|FG001|Overall Study|Other, Not Specified|0|||
147539704|NCT03889197|532130761|FG000|Overall Study|Withdrawal by Subject|1|||
147539705|NCT03889197|532130762|FG001|Overall Study|Withdrawal by Subject|0|||
147539706|NCT03889197|532130761|FG000|Overall Study|Physician Decision|0|||
147539707|NCT03889197|532130762|FG001|Overall Study|Physician Decision|1|||
147539708|NCT03889197|532130761|FG000|Overall Study|met exclusion criteria|0|||
147539709|NCT03889197|532130762|FG001|Overall Study|met exclusion criteria|1|||
147539710|NCT03889197|532130761|FG000|Overall Study|Protocol Violation|1|||
147539711|NCT03889197|532130762|FG001|Overall Study|Protocol Violation|0|||
147539712|NCT00621309|532130763|FG000|Overall Study|Withdrawal by Subject|2|||
147539713|NCT00621309|532130764|FG001|Overall Study|Withdrawal by Subject|0|||
147539714|NCT00621309|532130765|FG002|Overall Study|Withdrawal by Subject|1|||
147539715|NCT00621309|532130766|FG003|Overall Study|Withdrawal by Subject|1|||
147539716|NCT00621309|532130767|FG004|Overall Study|Withdrawal by Subject|1|||
147539717|NCT00621309|532130768|FG005|Overall Study|Withdrawal by Subject|1|||
147539718|NCT05246111|532130769|FG000|Period 01|NOT ELIGIBLE IC5|1|||
147539719|NCT05246111|532130770|FG001|Period 01|NOT ELIGIBLE IC5|0|||
147539720|NCT01329562|532130773|FG000|Overall Study|Protocol Violation|5|||
147539721|NCT01329562|532130774|FG001|Overall Study|Protocol Violation|3|||
147539722|NCT01329562|532130773|FG000|Overall Study|Lost to Follow-up|1|||
147539723|NCT01329562|532130774|FG001|Overall Study|Lost to Follow-up|1|||
147539724|NCT01329562|532130773|FG000|Overall Study|Subject withdrew due to personal issues.|3|||
147539725|NCT01329562|532130774|FG001|Overall Study|Subject withdrew due to personal issues.|2|||
147539726|NCT01329562|532130773|FG000|Overall Study|Physician Decision|0|||
147539727|NCT01329562|532130774|FG001|Overall Study|Physician Decision|1|||
147539728|NCT03151226|532130775|FG000|Overall Study|Withdrawal by Subject|2|||
147539729|NCT03151226|532130775|FG000|Overall Study|not wear device correctly|1|||
147539730|NCT00061568|532130776|FG000|Overall Study|Lost to Follow-up|12|||
147539731|NCT00061568|532130777|FG001|Overall Study|Lost to Follow-up|0|||
147539732|NCT00061568|532130776|FG000|Overall Study|Death|6|||
147539733|NCT00061568|532130777|FG001|Overall Study|Death|0|||
147539734|NCT00061568|532130776|FG000|Overall Study|Withdrawal by Subject|1|||
147539735|NCT00061568|532130777|FG001|Overall Study|Withdrawal by Subject|0|||
147539736|NCT00402779|532130778|FG000|Overall Study|Screen Failure|77|||
147203336|NCT01812252|530913813|FG001|Overall Study|Not transplanted|11|||
147539737|NCT00402779|532130779|FG001|Overall Study|Screen Failure|76|||
147539738|NCT05004181|532130789|FG000|Overall Study|Withdrawal of consent|0|||
147203337|NCT01812252|530913812|FG000|Overall Study|Transplanted died prior to 18-months post-transplant follow-up|5|||
147203338|NCT01812252|530913813|FG001|Overall Study|Transplanted died prior to 18-months post-transplant follow-up|3|||
147539739|NCT05004181|532130790|FG001|Overall Study|Withdrawal of consent|0|||
147539740|NCT05004181|532130791|FG002|Overall Study|Withdrawal of consent|1|||
147539741|NCT05004181|532130792|FG003|Overall Study|Withdrawal of consent|3|||
147203339|NCT01812252|530913812|FG000|Overall Study|Withdrawal by Subject|1|||
147203340|NCT01812252|530913813|FG001|Overall Study|Withdrawal by Subject|1|||
147539742|NCT05004181|532130793|FG004|Overall Study|Withdrawal of consent|3|||
147539743|NCT05004181|532130794|FG005|Overall Study|Withdrawal of consent|0|||
147438338|NCT01383096|531772116|FG002|Fifth Intervention (8 Days)|haemoglobin was <13.5 g/dL|0|||
147438339|NCT00616434|531772119|FG000|Overall Study|Adverse Event|5|||
147438340|NCT00616434|531772120|FG001|Overall Study|Adverse Event|2|||
147438341|NCT00616434|531772119|FG000|Overall Study|Physician Decision|0|||
147438342|NCT00616434|531772120|FG001|Overall Study|Physician Decision|4|||
147438343|NCT00616434|531772119|FG000|Overall Study|Withdrawal by Subject|1|||
147438344|NCT00616434|531772120|FG001|Overall Study|Withdrawal by Subject|1|||
147438345|NCT00616434|531772119|FG000|Overall Study|Protocol deviation|0|||
147438346|NCT00616434|531772120|FG001|Overall Study|Protocol deviation|1|||
147438347|NCT00467779|531772123|FG000|Stage 1|Adverse Event|1|||
147438348|NCT00467779|531772124|FG001|Stage 1|Adverse Event|0|||
147438349|NCT00467779|531772125|FG002|Stage 1|Adverse Event|0|||
147438350|NCT00467779|531772126|FG003|Stage 1|Adverse Event|0|||
147438351|NCT00467779|531772127|FG004|Stage 1|Adverse Event|0|||
147438352|NCT00467779|531772128|FG005|Stage 1|Adverse Event|1|||
147438353|NCT00467779|531772129|FG006|Stage 1|Adverse Event|2|||
147438354|NCT00467779|531772130|FG007|Stage 1|Adverse Event|1|||
147438355|NCT00467779|531772131|FG008|Stage 1|Adverse Event|0|||
147438356|NCT00467779|531772132|FG009|Stage 1|Adverse Event|0|||
147438357|NCT00467779|531772133|FG010|Stage 1|Adverse Event|0|||
147438358|NCT00467779|531772134|FG011|Stage 1|Adverse Event|0|||
147438359|NCT00467779|531772135|FG012|Stage 1|Adverse Event|0|||
147438360|NCT00467779|531772136|FG013|Stage 1|Adverse Event|0|||
147438361|NCT00467779|531772137|FG014|Stage 1|Adverse Event|0|||
147438362|NCT00467779|531772123|FG000|Stage 1|Disease Progression|2|||
147438363|NCT00467779|531772124|FG001|Stage 1|Disease Progression|2|||
147438364|NCT00467779|531772125|FG002|Stage 1|Disease Progression|2|||
147438365|NCT00467779|531772126|FG003|Stage 1|Disease Progression|3|||
147438366|NCT00467779|531772127|FG004|Stage 1|Disease Progression|2|||
147438367|NCT00467779|531772128|FG005|Stage 1|Disease Progression|2|||
147438368|NCT00467779|531772129|FG006|Stage 1|Disease Progression|4|||
147438369|NCT00467779|531772130|FG007|Stage 1|Disease Progression|5|||
147438370|NCT00467779|531772131|FG008|Stage 1|Disease Progression|0|||
147438371|NCT00467779|531772132|FG009|Stage 1|Disease Progression|0|||
147438372|NCT00467779|531772133|FG010|Stage 1|Disease Progression|0|||
147438373|NCT00467779|531772134|FG011|Stage 1|Disease Progression|0|||
147438374|NCT00467779|531772135|FG012|Stage 1|Disease Progression|0|||
147438375|NCT00467779|531772136|FG013|Stage 1|Disease Progression|0|||
147438376|NCT00467779|531772137|FG014|Stage 1|Disease Progression|0|||
147438377|NCT00467779|531772123|FG000|Stage 1|Unspecified Reason|1|||
147438378|NCT00467779|531772124|FG001|Stage 1|Unspecified Reason|0|||
147438379|NCT00467779|531772125|FG002|Stage 1|Unspecified Reason|1|||
147438380|NCT00467779|531772126|FG003|Stage 1|Unspecified Reason|0|||
147438381|NCT00467779|531772127|FG004|Stage 1|Unspecified Reason|1|||
147438382|NCT00467779|531772128|FG005|Stage 1|Unspecified Reason|2|||
147438383|NCT00467779|531772129|FG006|Stage 1|Unspecified Reason|0|||
147438384|NCT00467779|531772130|FG007|Stage 1|Unspecified Reason|0|||
147438385|NCT00467779|531772131|FG008|Stage 1|Unspecified Reason|0|||
147438386|NCT00467779|531772132|FG009|Stage 1|Unspecified Reason|0|||
147438387|NCT00467779|531772133|FG010|Stage 1|Unspecified Reason|0|||
147438388|NCT00467779|531772134|FG011|Stage 1|Unspecified Reason|0|||
147438389|NCT00467779|531772135|FG012|Stage 1|Unspecified Reason|0|||
147438390|NCT00467779|531772136|FG013|Stage 1|Unspecified Reason|0|||
147438391|NCT00467779|531772137|FG014|Stage 1|Unspecified Reason|0|||
147438392|NCT00467779|531772123|FG000|Stage 1|Physician Decision|0|||
147438393|NCT00467779|531772124|FG001|Stage 1|Physician Decision|1|||
147438394|NCT00467779|531772125|FG002|Stage 1|Physician Decision|0|||
147438395|NCT00467779|531772126|FG003|Stage 1|Physician Decision|0|||
147438396|NCT00467779|531772127|FG004|Stage 1|Physician Decision|0|||
147438397|NCT00467779|531772128|FG005|Stage 1|Physician Decision|0|||
147438398|NCT00467779|531772129|FG006|Stage 1|Physician Decision|0|||
147438399|NCT00467779|531772130|FG007|Stage 1|Physician Decision|0|||
147438400|NCT00467779|531772131|FG008|Stage 1|Physician Decision|0|||
147438401|NCT00467779|531772132|FG009|Stage 1|Physician Decision|0|||
147438402|NCT00467779|531772133|FG010|Stage 1|Physician Decision|0|||
147438403|NCT00467779|531772134|FG011|Stage 1|Physician Decision|0|||
147438404|NCT00467779|531772135|FG012|Stage 1|Physician Decision|0|||
147438405|NCT00467779|531772136|FG013|Stage 1|Physician Decision|0|||
147438406|NCT00467779|531772137|FG014|Stage 1|Physician Decision|0|||
147438407|NCT00467779|531772123|FG000|Stage 1|Withdrawal by Subject|0|||
147438408|NCT00467779|531772124|FG001|Stage 1|Withdrawal by Subject|0|||
147438409|NCT00467779|531772125|FG002|Stage 1|Withdrawal by Subject|0|||
147438410|NCT00467779|531772126|FG003|Stage 1|Withdrawal by Subject|0|||
147438411|NCT00467779|531772127|FG004|Stage 1|Withdrawal by Subject|0|||
147438412|NCT00467779|531772128|FG005|Stage 1|Withdrawal by Subject|0|||
147438413|NCT00467779|531772129|FG006|Stage 1|Withdrawal by Subject|1|||
147438414|NCT00467779|531772130|FG007|Stage 1|Withdrawal by Subject|1|||
147438415|NCT00467779|531772131|FG008|Stage 1|Withdrawal by Subject|0|||
147438416|NCT00467779|531772132|FG009|Stage 1|Withdrawal by Subject|0|||
147438417|NCT00467779|531772133|FG010|Stage 1|Withdrawal by Subject|0|||
147438418|NCT00467779|531772134|FG011|Stage 1|Withdrawal by Subject|0|||
147438419|NCT00467779|531772135|FG012|Stage 1|Withdrawal by Subject|0|||
147203341|NCT01812252|530913812|FG000|Overall Study|Screen Failure|1|||
147203342|NCT01812252|530913813|FG001|Overall Study|Screen Failure|0|||
147203343|NCT02557139|530913814|FG000|Overall Study|Significant liver elevation|1|||
147203344|NCT02557139|530913815|FG001|Overall Study|Significant liver elevation|0|||
147203345|NCT02557139|530913816|FG002|Overall Study|Significant liver elevation|1|||
147203346|NCT02557139|530913814|FG000|Overall Study|Withdrawal by Subject|1|||
147203347|NCT02557139|530913815|FG001|Overall Study|Withdrawal by Subject|0|||
147203348|NCT02557139|530913816|FG002|Overall Study|Withdrawal by Subject|0|||
147203349|NCT02557139|530913814|FG000|Overall Study|Illness of prohibited medication|0|||
147203350|NCT02557139|530913815|FG001|Overall Study|Illness of prohibited medication|0|||
147203351|NCT02557139|530913816|FG002|Overall Study|Illness of prohibited medication|1|||
147203352|NCT01146795|530913818|FG000|Overall Study|Withdrawal by Subject|4|||
147203353|NCT01146795|530913818|FG000|Overall Study|Adverse Event|6|||
147203354|NCT01146795|530913818|FG000|Overall Study|Still in treatment at study closure|10|||
147203355|NCT05375760|530913819|FG000|Overall Study|Adverse Event|1|||
147203356|NCT05375760|530913820|FG001|Overall Study|Adverse Event|0|||
147203357|NCT05375760|530913819|FG000|Overall Study|Death|0|||
147203358|NCT05375760|530913820|FG001|Overall Study|Death|1|||
147203359|NCT05375760|530913819|FG000|Overall Study|Lost to Follow-up|6|||
147203360|NCT05375760|530913820|FG001|Overall Study|Lost to Follow-up|6|||
147203361|NCT05375760|530913819|FG000|Overall Study|Withdrawal by Subject|17|||
147203362|NCT05375760|530913820|FG001|Overall Study|Withdrawal by Subject|19|||
147203363|NCT05375760|530913819|FG000|Overall Study|Dosing halted by FDA|96|||
147203364|NCT05375760|530913820|FG001|Overall Study|Dosing halted by FDA|100|||
147203365|NCT05375760|530913819|FG000|Overall Study|Not compliant with study visit|2|||
147203366|NCT05375760|530913820|FG001|Overall Study|Not compliant with study visit|0|||
147203367|NCT05375760|530913819|FG000|Overall Study|Physician Decision|1|||
147203368|NCT05375760|530913820|FG001|Overall Study|Physician Decision|0|||
147203369|NCT05375760|530913819|FG000|Overall Study|Signed ICF addendum, however refused procedures|1|||
147203370|NCT05375760|530913820|FG001|Overall Study|Signed ICF addendum, however refused procedures|0|||
147203371|NCT05375760|530913819|FG000|Overall Study|Participant moved|1|||
147203372|NCT05375760|530913820|FG001|Overall Study|Participant moved|0|||
147203373|NCT03853109|530913821|FG000|Overall Study|Withdrawal by Subject|0|||
147203374|NCT03853109|530913822|FG001|Overall Study|Withdrawal by Subject|0|||
147203375|NCT03853109|530913823|FG002|Overall Study|Withdrawal by Subject|1|||
147203376|NCT03853109|530913824|FG003|Overall Study|Withdrawal by Subject|2|||
147203377|NCT03853109|530913825|FG004|Overall Study|Withdrawal by Subject|1|||
147203378|NCT03853109|530913826|FG005|Overall Study|Withdrawal by Subject|4|||
147203379|NCT03853109|530913827|FG006|Overall Study|Withdrawal by Subject|5|||
147203380|NCT03853109|530913828|FG007|Overall Study|Withdrawal by Subject|3|||
147438420|NCT00467779|531772136|FG013|Stage 1|Withdrawal by Subject|0|||
147438421|NCT00467779|531772137|FG014|Stage 1|Withdrawal by Subject|0|||
147438422|NCT00467779|531772123|FG000|Stage 1A|Adverse Event|0|||
147438423|NCT00467779|531772124|FG001|Stage 1A|Adverse Event|0|||
147438424|NCT00467779|531772125|FG002|Stage 1A|Adverse Event|0|||
147438425|NCT00467779|531772126|FG003|Stage 1A|Adverse Event|0|||
147438426|NCT00467779|531772127|FG004|Stage 1A|Adverse Event|0|||
147438427|NCT00467779|531772128|FG005|Stage 1A|Adverse Event|0|||
147438428|NCT00467779|531772129|FG006|Stage 1A|Adverse Event|0|||
147438429|NCT00467779|531772130|FG007|Stage 1A|Adverse Event|0|||
147438430|NCT00467779|531772131|FG008|Stage 1A|Adverse Event|0|||
147438431|NCT00467779|531772132|FG009|Stage 1A|Adverse Event|0|||
147438432|NCT00467779|531772133|FG010|Stage 1A|Adverse Event|0|||
147438433|NCT00467779|531772134|FG011|Stage 1A|Adverse Event|0|||
147438434|NCT00467779|531772135|FG012|Stage 1A|Adverse Event|1|||
147438435|NCT00467779|531772136|FG013|Stage 1A|Adverse Event|0|||
147438436|NCT00467779|531772137|FG014|Stage 1A|Adverse Event|0|||
147438437|NCT00467779|531772123|FG000|Stage 1A|Death|0|||
147438438|NCT00467779|531772124|FG001|Stage 1A|Death|0|||
147438439|NCT00467779|531772125|FG002|Stage 1A|Death|0|||
147438440|NCT00467779|531772126|FG003|Stage 1A|Death|0|||
147438441|NCT00467779|531772127|FG004|Stage 1A|Death|0|||
147438442|NCT00467779|531772128|FG005|Stage 1A|Death|0|||
147203381|NCT03853109|530913821|FG000|Overall Study|Decision by Sponsor|0|||
147203382|NCT03853109|530913822|FG001|Overall Study|Decision by Sponsor|0|||
147203383|NCT03853109|530913823|FG002|Overall Study|Decision by Sponsor|1|||
147438443|NCT00467779|531772129|FG006|Stage 1A|Death|0|||
147203384|NCT03853109|530913824|FG003|Overall Study|Decision by Sponsor|0|||
147203385|NCT03853109|530913825|FG004|Overall Study|Decision by Sponsor|1|||
147203386|NCT03853109|530913826|FG005|Overall Study|Decision by Sponsor|1|||
147203387|NCT03853109|530913827|FG006|Overall Study|Decision by Sponsor|10|||
147203388|NCT03853109|530913828|FG007|Overall Study|Decision by Sponsor|2|||
147203389|NCT03853109|530913821|FG000|Overall Study|Lost to Follow-up|0|||
147438444|NCT00467779|531772130|FG007|Stage 1A|Death|0|||
147438445|NCT00467779|531772131|FG008|Stage 1A|Death|0|||
147438446|NCT00467779|531772132|FG009|Stage 1A|Death|0|||
147438447|NCT00467779|531772133|FG010|Stage 1A|Death|0|||
147438448|NCT00467779|531772134|FG011|Stage 1A|Death|1|||
147438449|NCT00467779|531772135|FG012|Stage 1A|Death|1|||
147438450|NCT00467779|531772136|FG013|Stage 1A|Death|0|||
147438451|NCT00467779|531772137|FG014|Stage 1A|Death|0|||
147203390|NCT03853109|530913822|FG001|Overall Study|Lost to Follow-up|0|||
147203391|NCT03853109|530913823|FG002|Overall Study|Lost to Follow-up|0|||
147203392|NCT03853109|530913824|FG003|Overall Study|Lost to Follow-up|0|||
147203393|NCT03853109|530913825|FG004|Overall Study|Lost to Follow-up|1|||
147203394|NCT03853109|530913826|FG005|Overall Study|Lost to Follow-up|3|||
147203395|NCT03853109|530913827|FG006|Overall Study|Lost to Follow-up|0|||
147203396|NCT03853109|530913828|FG007|Overall Study|Lost to Follow-up|0|||
147203397|NCT03853109|530913821|FG000|Overall Study|Death|2|||
147203398|NCT03853109|530913822|FG001|Overall Study|Death|5|||
147203399|NCT03853109|530913823|FG002|Overall Study|Death|8|||
147203400|NCT03853109|530913824|FG003|Overall Study|Death|10|||
147203401|NCT03853109|530913825|FG004|Overall Study|Death|3|||
147203402|NCT03853109|530913826|FG005|Overall Study|Death|20|||
147203403|NCT03853109|530913827|FG006|Overall Study|Death|10|||
147203404|NCT03853109|530913828|FG007|Overall Study|Death|5|||
147203405|NCT01721044|530913831|FG000|Treatment Period|Adverse Event|7|||
147203406|NCT01721044|530913832|FG001|Treatment Period|Adverse Event|7|||
147438452|NCT00467779|531772123|FG000|Stage 1A|Disease Progression|0|||
147438453|NCT00467779|531772124|FG001|Stage 1A|Disease Progression|0|||
147438454|NCT00467779|531772125|FG002|Stage 1A|Disease Progression|0|||
147438455|NCT00467779|531772126|FG003|Stage 1A|Disease Progression|0|||
147438456|NCT00467779|531772127|FG004|Stage 1A|Disease Progression|0|||
147438457|NCT00467779|531772128|FG005|Stage 1A|Disease Progression|0|||
147438458|NCT00467779|531772129|FG006|Stage 1A|Disease Progression|0|||
147438459|NCT00467779|531772130|FG007|Stage 1A|Disease Progression|0|||
147438460|NCT00467779|531772131|FG008|Stage 1A|Disease Progression|0|||
147438461|NCT00467779|531772132|FG009|Stage 1A|Disease Progression|2|||
147438462|NCT00467779|531772133|FG010|Stage 1A|Disease Progression|2|||
147438463|NCT00467779|531772134|FG011|Stage 1A|Disease Progression|5|||
147438464|NCT00467779|531772135|FG012|Stage 1A|Disease Progression|2|||
147438465|NCT00467779|531772136|FG013|Stage 1A|Disease Progression|0|||
147438466|NCT00467779|531772137|FG014|Stage 1A|Disease Progression|0|||
147438467|NCT00467779|531772123|FG000|Stage 1A|Physician Decision|0|||
147438468|NCT00467779|531772124|FG001|Stage 1A|Physician Decision|0|||
147438469|NCT00467779|531772125|FG002|Stage 1A|Physician Decision|0|||
147438470|NCT00467779|531772126|FG003|Stage 1A|Physician Decision|0|||
147438471|NCT00467779|531772127|FG004|Stage 1A|Physician Decision|0|||
147438472|NCT00467779|531772128|FG005|Stage 1A|Physician Decision|0|||
147438473|NCT00467779|531772129|FG006|Stage 1A|Physician Decision|0|||
147438474|NCT00467779|531772130|FG007|Stage 1A|Physician Decision|0|||
147438475|NCT00467779|531772131|FG008|Stage 1A|Physician Decision|0|||
147438476|NCT00467779|531772132|FG009|Stage 1A|Physician Decision|1|||
147438477|NCT00467779|531772133|FG010|Stage 1A|Physician Decision|0|||
147438478|NCT00467779|531772134|FG011|Stage 1A|Physician Decision|0|||
147438479|NCT00467779|531772135|FG012|Stage 1A|Physician Decision|0|||
147438480|NCT00467779|531772136|FG013|Stage 1A|Physician Decision|0|||
147438481|NCT00467779|531772137|FG014|Stage 1A|Physician Decision|0|||
147438482|NCT00467779|531772123|FG000|Stage 1A|Withdrawal by Subject|0|||
147438483|NCT00467779|531772124|FG001|Stage 1A|Withdrawal by Subject|0|||
147438484|NCT00467779|531772125|FG002|Stage 1A|Withdrawal by Subject|0|||
147438485|NCT00467779|531772126|FG003|Stage 1A|Withdrawal by Subject|0|||
147438486|NCT00467779|531772127|FG004|Stage 1A|Withdrawal by Subject|0|||
147438487|NCT00467779|531772128|FG005|Stage 1A|Withdrawal by Subject|0|||
147438488|NCT00467779|531772129|FG006|Stage 1A|Withdrawal by Subject|0|||
147438489|NCT00467779|531772130|FG007|Stage 1A|Withdrawal by Subject|0|||
147438490|NCT00467779|531772131|FG008|Stage 1A|Withdrawal by Subject|0|||
147438491|NCT00467779|531772132|FG009|Stage 1A|Withdrawal by Subject|0|||
147438492|NCT00467779|531772133|FG010|Stage 1A|Withdrawal by Subject|1|||
147438493|NCT00467779|531772134|FG011|Stage 1A|Withdrawal by Subject|1|||
147438494|NCT00467779|531772135|FG012|Stage 1A|Withdrawal by Subject|1|||
147438495|NCT00467779|531772136|FG013|Stage 1A|Withdrawal by Subject|0|||
147438496|NCT00467779|531772137|FG014|Stage 1A|Withdrawal by Subject|0|||
147438497|NCT00467779|531772123|FG000|Stage 1A|Unspecified Reason|0|||
147438498|NCT00467779|531772124|FG001|Stage 1A|Unspecified Reason|0|||
147438499|NCT00467779|531772125|FG002|Stage 1A|Unspecified Reason|0|||
147438500|NCT00467779|531772126|FG003|Stage 1A|Unspecified Reason|0|||
147438501|NCT00467779|531772127|FG004|Stage 1A|Unspecified Reason|0|||
147438502|NCT00467779|531772128|FG005|Stage 1A|Unspecified Reason|0|||
147438503|NCT00467779|531772129|FG006|Stage 1A|Unspecified Reason|0|||
147203407|NCT01721044|530913833|FG002|Treatment Period|Adverse Event|10|||
147203408|NCT01721044|530913831|FG000|Treatment Period|Death|0|||
147203409|NCT01721044|530913832|FG001|Treatment Period|Death|0|||
147438504|NCT00467779|531772130|FG007|Stage 1A|Unspecified Reason|0|||
147438505|NCT00467779|531772131|FG008|Stage 1A|Unspecified Reason|0|||
147438506|NCT00467779|531772132|FG009|Stage 1A|Unspecified Reason|0|||
147438507|NCT00467779|531772133|FG010|Stage 1A|Unspecified Reason|0|||
147438508|NCT00467779|531772134|FG011|Stage 1A|Unspecified Reason|1|||
147203410|NCT01721044|530913833|FG002|Treatment Period|Death|1|||
147438509|NCT00467779|531772135|FG012|Stage 1A|Unspecified Reason|1|||
147438510|NCT00467779|531772136|FG013|Stage 1A|Unspecified Reason|0|||
147438511|NCT00467779|531772137|FG014|Stage 1A|Unspecified Reason|0|||
147438512|NCT00467779|531772123|FG000|Stage 2|Adverse Event|0|||
147539744|NCT05004181|532130795|FG006|Overall Study|Withdrawal of consent|30|||
147539745|NCT05004181|532130796|FG007|Overall Study|Withdrawal of consent|9|||
147539746|NCT05004181|532130797|FG008|Overall Study|Withdrawal of consent|3|||
147539747|NCT05004181|532130798|FG009|Overall Study|Withdrawal of consent|2|||
147539748|NCT05004181|532130799|FG010|Overall Study|Withdrawal of consent|5|||
147539749|NCT05004181|532130800|FG011|Overall Study|Withdrawal of consent|1|||
147539750|NCT05004181|532130789|FG000|Overall Study|Lost to Follow-up|2|||
147539751|NCT05004181|532130790|FG001|Overall Study|Lost to Follow-up|4|||
147539752|NCT05004181|532130791|FG002|Overall Study|Lost to Follow-up|2|||
147539753|NCT05004181|532130792|FG003|Overall Study|Lost to Follow-up|3|||
147539754|NCT05004181|532130793|FG004|Overall Study|Lost to Follow-up|5|||
147539755|NCT05004181|532130794|FG005|Overall Study|Lost to Follow-up|2|||
147539756|NCT05004181|532130795|FG006|Overall Study|Lost to Follow-up|15|||
147539757|NCT05004181|532130796|FG007|Overall Study|Lost to Follow-up|12|||
147539758|NCT05004181|532130797|FG008|Overall Study|Lost to Follow-up|38|||
147539759|NCT05004181|532130798|FG009|Overall Study|Lost to Follow-up|6|||
147539760|NCT05004181|532130799|FG010|Overall Study|Lost to Follow-up|6|||
147539761|NCT05004181|532130800|FG011|Overall Study|Lost to Follow-up|0|||
147539762|NCT05004181|532130789|FG000|Overall Study|Death|0|||
147539763|NCT05004181|532130790|FG001|Overall Study|Death|0|||
147539764|NCT05004181|532130791|FG002|Overall Study|Death|0|||
147539765|NCT05004181|532130792|FG003|Overall Study|Death|0|||
147539766|NCT05004181|532130793|FG004|Overall Study|Death|0|||
147539767|NCT05004181|532130794|FG005|Overall Study|Death|0|||
147539768|NCT05004181|532130795|FG006|Overall Study|Death|1|||
147539769|NCT05004181|532130796|FG007|Overall Study|Death|0|||
147539770|NCT05004181|532130797|FG008|Overall Study|Death|2|||
147539771|NCT05004181|532130798|FG009|Overall Study|Death|0|||
147539772|NCT05004181|532130799|FG010|Overall Study|Death|0|||
147539773|NCT05004181|532130800|FG011|Overall Study|Death|0|||
147539774|NCT05004181|532130789|FG000|Overall Study|Physician Decision|0|||
147539775|NCT05004181|532130790|FG001|Overall Study|Physician Decision|0|||
147539776|NCT05004181|532130791|FG002|Overall Study|Physician Decision|0|||
147539777|NCT05004181|532130792|FG003|Overall Study|Physician Decision|0|||
147539778|NCT05004181|532130793|FG004|Overall Study|Physician Decision|0|||
147539779|NCT05004181|532130794|FG005|Overall Study|Physician Decision|0|||
147539780|NCT05004181|532130795|FG006|Overall Study|Physician Decision|2|||
147539781|NCT05004181|532130796|FG007|Overall Study|Physician Decision|0|||
147539782|NCT05004181|532130797|FG008|Overall Study|Physician Decision|7|||
147539783|NCT05004181|532130798|FG009|Overall Study|Physician Decision|0|||
147539784|NCT05004181|532130799|FG010|Overall Study|Physician Decision|0|||
147539785|NCT05004181|532130800|FG011|Overall Study|Physician Decision|0|||
147539786|NCT05004181|532130789|FG000|Overall Study|Withdrawal by Subject|2|||
147539787|NCT05004181|532130790|FG001|Overall Study|Withdrawal by Subject|3|||
147539788|NCT05004181|532130791|FG002|Overall Study|Withdrawal by Subject|2|||
147539789|NCT05004181|532130792|FG003|Overall Study|Withdrawal by Subject|2|||
147539790|NCT05004181|532130793|FG004|Overall Study|Withdrawal by Subject|4|||
147539791|NCT05004181|532130794|FG005|Overall Study|Withdrawal by Subject|2|||
147539792|NCT05004181|532130795|FG006|Overall Study|Withdrawal by Subject|4|||
147539793|NCT05004181|532130796|FG007|Overall Study|Withdrawal by Subject|22|||
147539794|NCT05004181|532130797|FG008|Overall Study|Withdrawal by Subject|8|||
147539795|NCT05004181|532130798|FG009|Overall Study|Withdrawal by Subject|1|||
147539796|NCT05004181|532130799|FG010|Overall Study|Withdrawal by Subject|3|||
147539797|NCT05004181|532130800|FG011|Overall Study|Withdrawal by Subject|2|||
147539798|NCT05004181|532130789|FG000|Overall Study|Protocol Violation|2|||
147539799|NCT05004181|532130790|FG001|Overall Study|Protocol Violation|3|||
147539800|NCT05004181|532130791|FG002|Overall Study|Protocol Violation|0|||
147539801|NCT05004181|532130792|FG003|Overall Study|Protocol Violation|0|||
147539802|NCT05004181|532130793|FG004|Overall Study|Protocol Violation|1|||
147539803|NCT05004181|532130794|FG005|Overall Study|Protocol Violation|0|||
147539804|NCT05004181|532130795|FG006|Overall Study|Protocol Violation|16|||
147539805|NCT05004181|532130796|FG007|Overall Study|Protocol Violation|18|||
147539806|NCT05004181|532130797|FG008|Overall Study|Protocol Violation|2|||
147539807|NCT05004181|532130798|FG009|Overall Study|Protocol Violation|2|||
147539808|NCT05004181|532130799|FG010|Overall Study|Protocol Violation|2|||
147203411|NCT01721044|530913831|FG000|Treatment Period|Lack of Efficacy|16|||
147203412|NCT01721044|530913832|FG001|Treatment Period|Lack of Efficacy|4|||
147539809|NCT05004181|532130800|FG011|Overall Study|Protocol Violation|1|||
147539810|NCT05004181|532130789|FG000|Overall Study|Not further specified|1|||
147539811|NCT05004181|532130790|FG001|Overall Study|Not further specified|0|||
147203413|NCT01721044|530913833|FG002|Treatment Period|Lack of Efficacy|4|||
147539812|NCT05004181|532130791|FG002|Overall Study|Not further specified|0|||
147539813|NCT05004181|532130792|FG003|Overall Study|Not further specified|0|||
147539814|NCT05004181|532130793|FG004|Overall Study|Not further specified|0|||
147539815|NCT05004181|532130794|FG005|Overall Study|Not further specified|0|||
147539816|NCT05004181|532130795|FG006|Overall Study|Not further specified|1|||
147203414|NCT01721044|530913831|FG000|Treatment Period|Lost to Follow-up|0|||
147539817|NCT05004181|532130796|FG007|Overall Study|Not further specified|0|||
147539818|NCT05004181|532130797|FG008|Overall Study|Not further specified|2|||
147539819|NCT05004181|532130798|FG009|Overall Study|Not further specified|1|||
147539820|NCT05004181|532130799|FG010|Overall Study|Not further specified|0|||
147539821|NCT05004181|532130800|FG011|Overall Study|Not further specified|1|||
147539822|NCT03868059|532130802|FG000|Overall Study|Adverse Event|3|||
147539823|NCT03868059|532130802|FG000|Overall Study|Lost to Follow-up|3|||
147539824|NCT03868059|532130802|FG000|Overall Study|Withdrawal by Subject|6|||
147539825|NCT02061293|532130803|FG000|Overall Study|Elevated Blood Pressure|1|||
147539826|NCT02061293|532130804|FG001|Overall Study|Elevated Blood Pressure|1|||
147539827|NCT04066894|532130805|FG000|Overall Study|Lack of Efficacy|1|||
147539828|NCT04066894|532130805|FG000|Overall Study|Screen Failure|1|||
147539829|NCT04278872|532130806|FG000|Overall Study|Adverse Event|1|||
147539830|NCT04278872|532130807|FG001|Overall Study|Adverse Event|0|||
147539831|NCT04278872|532130806|FG000|Overall Study|Protocol Violation|0|||
147539832|NCT04278872|532130807|FG001|Overall Study|Protocol Violation|1|||
147539833|NCT04278872|532130806|FG000|Overall Study|Study Termination|2|||
147539834|NCT04278872|532130807|FG001|Overall Study|Study Termination|0|||
147539835|NCT00777920|532130812|FG000|Overall Study|Adverse Event|39|||
147539836|NCT00777920|532130812|FG000|Overall Study|Withdrawal of Consent|4|||
147539837|NCT00777920|532130812|FG000|Overall Study|Lost to Follow-up|1|||
147539838|NCT00777920|532130812|FG000|Overall Study|Investigator's discretion|1|||
147539839|NCT00777920|532130812|FG000|Overall Study|Clinical status did not improve|1|||
147539840|NCT00777920|532130812|FG000|Overall Study|Other, not specified|4|||
147539841|NCT00483717|532130813|FG000|Overall Study|Protocol Violation|5|||
147539842|NCT00483717|532130814|FG001|Overall Study|Protocol Violation|7|||
147539843|NCT00483717|532130813|FG000|Overall Study|Time of dosing missing|1|||
147539844|NCT00483717|532130814|FG001|Overall Study|Time of dosing missing|1|||
147539845|NCT00483717|532130813|FG000|Overall Study|No treatment for migraine|16|||
147539846|NCT00483717|532130814|FG001|Overall Study|No treatment for migraine|13|||
147539847|NCT00483717|532130813|FG000|Overall Study|Lost to Follow-up|1|||
147539848|NCT00483717|532130814|FG001|Overall Study|Lost to Follow-up|0|||
147539849|NCT00483717|532130813|FG000|Overall Study|Withdrawal by Subject|1|||
147539850|NCT00483717|532130814|FG001|Overall Study|Withdrawal by Subject|0|||
147539851|NCT03878108|532130815|FG000|Overall Study|Adverse Event|1|||
147539852|NCT03878108|532130816|FG001|Overall Study|Adverse Event|0|||
147539853|NCT00604175|532130823|FG000|Entry Through Week 28|Death|2|||
147539854|NCT00604175|532130824|FG001|Entry Through Week 28|Death|0|||
147539855|NCT00604175|532130825|FG002|Entry Through Week 28|Death|0|||
147539856|NCT00604175|532130823|FG000|Entry Through Week 28|Withdrawal by Subject|1|||
147539857|NCT00604175|532130824|FG001|Entry Through Week 28|Withdrawal by Subject|0|||
147539858|NCT00604175|532130825|FG002|Entry Through Week 28|Withdrawal by Subject|0|||
147539859|NCT00604175|532130823|FG000|Entry Through Week 28|Lost to Follow-up|4|||
147539860|NCT00604175|532130824|FG001|Entry Through Week 28|Lost to Follow-up|3|||
147539861|NCT00604175|532130825|FG002|Entry Through Week 28|Lost to Follow-up|0|||
147539862|NCT00604175|532130823|FG000|Entry Through Week 28|Ineligible|1|||
147539863|NCT00604175|532130824|FG001|Entry Through Week 28|Ineligible|0|||
147539864|NCT00604175|532130825|FG002|Entry Through Week 28|Ineligible|0|||
147539865|NCT00604175|532130823|FG000|Entry Through Week 28|Did not start intervention|2|||
147539866|NCT00604175|532130824|FG001|Entry Through Week 28|Did not start intervention|0|||
147539867|NCT00604175|532130825|FG002|Entry Through Week 28|Did not start intervention|1|||
147539868|NCT00604175|532130823|FG000|Week 29 Through Week 72|Death|0|||
147539869|NCT00604175|532130824|FG001|Week 29 Through Week 72|Death|0|||
147539870|NCT00604175|532130825|FG002|Week 29 Through Week 72|Death|1|||
147539871|NCT00604175|532130823|FG000|Week 29 Through Week 72|Lost to Follow-up|12|||
147539872|NCT00604175|532130824|FG001|Week 29 Through Week 72|Lost to Follow-up|6|||
147539873|NCT00604175|532130825|FG002|Week 29 Through Week 72|Lost to Follow-up|2|||
147539874|NCT00604175|532130823|FG000|Week 29 Through Week 72|Site closure|0|||
147539875|NCT00604175|532130824|FG001|Week 29 Through Week 72|Site closure|1|||
147539876|NCT00604175|532130825|FG002|Week 29 Through Week 72|Site closure|0|||
147539877|NCT00604175|532130823|FG000|Week 29 Through Week 72|Non-adherence to study requirements|0|||
147539878|NCT00604175|532130824|FG001|Week 29 Through Week 72|Non-adherence to study requirements|0|||
147539879|NCT00604175|532130825|FG002|Week 29 Through Week 72|Non-adherence to study requirements|1|||
147539880|NCT02044094|532130826|FG000|RBP-6000 Injection 1 (Day 1 to Day 28)|Lost to Follow-up|3|||
147539881|NCT02044094|532130826|FG000|RBP-6000 Injection 1 (Day 1 to Day 28)|Physician Decision|3|||
147539882|NCT02044094|532130826|FG000|RBP-6000 Injection 1 (Day 1 to Day 28)|Withdrawal by Subject|3|||
147539883|NCT02044094|532130826|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Adverse Event|4|||
147539884|NCT02044094|532130826|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Lost to Follow-up|5|||
147539885|NCT02044094|532130826|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Withdrawal by Subject|2|||
147539886|NCT02044094|532130826|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Physician Decision|1|||
147539887|NCT02044094|532130826|FG000|RBP-6000 Injection 2 (Day 29 to Week 12)|Noncompliance|1|||
147539888|NCT03353415|532130827|FG000|Masked CGM Wear|Lost to Follow-up|2|||
147539889|NCT03353415|532130827|FG000|Unmasked CGM Wear|Excluded due to missing data.|1|||
147539890|NCT03205163|532130828|FG000|ATP (LDC: 3 Days; HDC: 4 Days)|Sponsor Decision|1|||
147539891|NCT03205163|532130829|FG001|ATP (LDC: 3 Days; HDC: 4 Days)|Sponsor Decision|0|||
147203415|NCT01721044|530913832|FG001|Treatment Period|Lost to Follow-up|0|||
147203416|NCT01721044|530913833|FG002|Treatment Period|Lost to Follow-up|1|||
147203417|NCT01721044|530913831|FG000|Treatment Period|Physician Decision|1|||
147203418|NCT01721044|530913832|FG001|Treatment Period|Physician Decision|0|||
147203419|NCT01721044|530913833|FG002|Treatment Period|Physician Decision|2|||
147203420|NCT01721044|530913831|FG000|Treatment Period|Protocol Violation|1|||
147203421|NCT01721044|530913832|FG001|Treatment Period|Protocol Violation|0|||
147203422|NCT01721044|530913833|FG002|Treatment Period|Protocol Violation|0|||
147203423|NCT01721044|530913831|FG000|Treatment Period|Withdrawal by Subject|7|||
147203424|NCT01721044|530913832|FG001|Treatment Period|Withdrawal by Subject|6|||
147203425|NCT01721044|530913833|FG002|Treatment Period|Withdrawal by Subject|1|||
147203426|NCT04032093|530913834|FG000|Overall Study|Lost to Follow-up|7|||
147203427|NCT04032093|530913835|FG001|Overall Study|Lost to Follow-up|7|||
147203428|NCT04032093|530913836|FG002|Overall Study|Lost to Follow-up|6|||
147203429|NCT04032093|530913837|FG003|Overall Study|Lost to Follow-up|10|||
147203430|NCT04032093|530913838|FG004|Overall Study|Lost to Follow-up|13|||
147203431|NCT04032093|530913839|FG005|Overall Study|Lost to Follow-up|7|||
147203432|NCT04032093|530913840|FG006|Overall Study|Lost to Follow-up|7|||
147203433|NCT04032093|530913841|FG007|Overall Study|Lost to Follow-up|5|||
147203434|NCT04032093|530913842|FG008|Overall Study|Lost to Follow-up|9|||
147203435|NCT04032093|530913843|FG009|Overall Study|Lost to Follow-up|12|||
147203436|NCT04032093|530913834|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
147203437|NCT04032093|530913835|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
147438513|NCT00467779|531772124|FG001|Stage 2|Adverse Event|0|||
147438514|NCT00467779|531772125|FG002|Stage 2|Adverse Event|0|||
147438515|NCT00467779|531772126|FG003|Stage 2|Adverse Event|0|||
147438516|NCT00467779|531772127|FG004|Stage 2|Adverse Event|0|||
147438517|NCT00467779|531772128|FG005|Stage 2|Adverse Event|0|||
147438518|NCT00467779|531772129|FG006|Stage 2|Adverse Event|0|||
147438519|NCT00467779|531772130|FG007|Stage 2|Adverse Event|0|||
147438520|NCT00467779|531772131|FG008|Stage 2|Adverse Event|1|||
147438521|NCT00467779|531772132|FG009|Stage 2|Adverse Event|0|||
147438522|NCT00467779|531772133|FG010|Stage 2|Adverse Event|0|||
147438523|NCT00467779|531772134|FG011|Stage 2|Adverse Event|0|||
147438524|NCT00467779|531772135|FG012|Stage 2|Adverse Event|0|||
147438525|NCT00467779|531772136|FG013|Stage 2|Adverse Event|0|||
147438526|NCT00467779|531772137|FG014|Stage 2|Adverse Event|0|||
147438527|NCT00467779|531772123|FG000|Stage 2|Death|0|||
147438528|NCT00467779|531772124|FG001|Stage 2|Death|0|||
147438529|NCT00467779|531772125|FG002|Stage 2|Death|0|||
147438530|NCT00467779|531772126|FG003|Stage 2|Death|0|||
147438531|NCT00467779|531772127|FG004|Stage 2|Death|0|||
147438532|NCT00467779|531772128|FG005|Stage 2|Death|0|||
147438533|NCT00467779|531772129|FG006|Stage 2|Death|0|||
147438534|NCT00467779|531772130|FG007|Stage 2|Death|0|||
147438535|NCT00467779|531772131|FG008|Stage 2|Death|1|||
147438536|NCT00467779|531772132|FG009|Stage 2|Death|0|||
147438537|NCT00467779|531772133|FG010|Stage 2|Death|0|||
147438538|NCT00467779|531772134|FG011|Stage 2|Death|0|||
147438539|NCT00467779|531772135|FG012|Stage 2|Death|0|||
147438540|NCT00467779|531772136|FG013|Stage 2|Death|0|||
147438541|NCT00467779|531772137|FG014|Stage 2|Death|0|||
147438542|NCT00467779|531772123|FG000|Stage 2|Disease Progression|0|||
147438543|NCT00467779|531772124|FG001|Stage 2|Disease Progression|0|||
147438544|NCT00467779|531772125|FG002|Stage 2|Disease Progression|0|||
147438545|NCT00467779|531772126|FG003|Stage 2|Disease Progression|0|||
147438546|NCT00467779|531772127|FG004|Stage 2|Disease Progression|0|||
147438547|NCT00467779|531772128|FG005|Stage 2|Disease Progression|0|||
147438548|NCT00467779|531772129|FG006|Stage 2|Disease Progression|0|||
147438549|NCT00467779|531772130|FG007|Stage 2|Disease Progression|0|||
147438550|NCT00467779|531772131|FG008|Stage 2|Disease Progression|16|||
147438551|NCT00467779|531772132|FG009|Stage 2|Disease Progression|0|||
147438552|NCT00467779|531772133|FG010|Stage 2|Disease Progression|0|||
147438553|NCT00467779|531772134|FG011|Stage 2|Disease Progression|0|||
147438554|NCT00467779|531772135|FG012|Stage 2|Disease Progression|0|||
147438555|NCT00467779|531772136|FG013|Stage 2|Disease Progression|0|||
147438556|NCT00467779|531772137|FG014|Stage 2|Disease Progression|0|||
147438557|NCT00467779|531772123|FG000|Stage 2|Unspecified Reason|0|||
147438558|NCT00467779|531772124|FG001|Stage 2|Unspecified Reason|0|||
147539892|NCT04502862|532130830|FG000|Overall Study|Not Related to Coronavirus Disease-2019 (COVID-19) pandemic|4|||
147438559|NCT00467779|531772125|FG002|Stage 2|Unspecified Reason|0|||
147438560|NCT00467779|531772126|FG003|Stage 2|Unspecified Reason|0|||
147438561|NCT00467779|531772127|FG004|Stage 2|Unspecified Reason|0|||
147438562|NCT00467779|531772128|FG005|Stage 2|Unspecified Reason|0|||
147203438|NCT04032093|530913836|FG002|Overall Study|No Longer Meets Eligibility Criteria|0|||
147203439|NCT04032093|530913837|FG003|Overall Study|No Longer Meets Eligibility Criteria|2|||
147203440|NCT04032093|530913838|FG004|Overall Study|No Longer Meets Eligibility Criteria|1|||
147438563|NCT00467779|531772129|FG006|Stage 2|Unspecified Reason|0|||
147438564|NCT00467779|531772130|FG007|Stage 2|Unspecified Reason|0|||
147438565|NCT00467779|531772131|FG008|Stage 2|Unspecified Reason|3|||
147438566|NCT00467779|531772132|FG009|Stage 2|Unspecified Reason|0|||
147438567|NCT00467779|531772133|FG010|Stage 2|Unspecified Reason|0|||
147438568|NCT00467779|531772134|FG011|Stage 2|Unspecified Reason|0|||
147438569|NCT00467779|531772135|FG012|Stage 2|Unspecified Reason|0|||
147438570|NCT00467779|531772136|FG013|Stage 2|Unspecified Reason|0|||
147438571|NCT00467779|531772137|FG014|Stage 2|Unspecified Reason|0|||
147438572|NCT00467779|531772123|FG000|Stage 2A|Adverse Event|0|||
147438573|NCT00467779|531772124|FG001|Stage 2A|Adverse Event|0|||
147438574|NCT00467779|531772125|FG002|Stage 2A|Adverse Event|0|||
147438575|NCT00467779|531772126|FG003|Stage 2A|Adverse Event|0|||
147438576|NCT00467779|531772127|FG004|Stage 2A|Adverse Event|0|||
147438577|NCT00467779|531772128|FG005|Stage 2A|Adverse Event|0|||
147438578|NCT00467779|531772129|FG006|Stage 2A|Adverse Event|0|||
147438579|NCT00467779|531772130|FG007|Stage 2A|Adverse Event|0|||
147438580|NCT00467779|531772131|FG008|Stage 2A|Adverse Event|0|||
147438581|NCT00467779|531772132|FG009|Stage 2A|Adverse Event|0|||
147438582|NCT00467779|531772133|FG010|Stage 2A|Adverse Event|0|||
147438583|NCT00467779|531772134|FG011|Stage 2A|Adverse Event|0|||
147438584|NCT00467779|531772135|FG012|Stage 2A|Adverse Event|0|||
147438585|NCT00467779|531772136|FG013|Stage 2A|Adverse Event|2|||
147438586|NCT00467779|531772137|FG014|Stage 2A|Adverse Event|0|||
147438587|NCT00467779|531772123|FG000|Stage 2A|Death|0|||
147438588|NCT00467779|531772124|FG001|Stage 2A|Death|0|||
147438589|NCT00467779|531772125|FG002|Stage 2A|Death|0|||
147438590|NCT00467779|531772126|FG003|Stage 2A|Death|0|||
147438591|NCT00467779|531772127|FG004|Stage 2A|Death|0|||
147438592|NCT00467779|531772128|FG005|Stage 2A|Death|0|||
147438593|NCT00467779|531772129|FG006|Stage 2A|Death|0|||
147438594|NCT00467779|531772130|FG007|Stage 2A|Death|0|||
147438595|NCT00467779|531772131|FG008|Stage 2A|Death|0|||
147438596|NCT00467779|531772132|FG009|Stage 2A|Death|0|||
147438597|NCT00467779|531772133|FG010|Stage 2A|Death|0|||
147438598|NCT00467779|531772134|FG011|Stage 2A|Death|0|||
147438599|NCT00467779|531772135|FG012|Stage 2A|Death|0|||
147438600|NCT00467779|531772136|FG013|Stage 2A|Death|1|||
147438601|NCT00467779|531772137|FG014|Stage 2A|Death|0|||
147438602|NCT00467779|531772123|FG000|Stage 2A|Disease Progression|0|||
147438603|NCT00467779|531772124|FG001|Stage 2A|Disease Progression|0|||
147438604|NCT00467779|531772125|FG002|Stage 2A|Disease Progression|0|||
147438605|NCT00467779|531772126|FG003|Stage 2A|Disease Progression|0|||
147438606|NCT00467779|531772127|FG004|Stage 2A|Disease Progression|0|||
147438607|NCT00467779|531772128|FG005|Stage 2A|Disease Progression|0|||
147438608|NCT00467779|531772129|FG006|Stage 2A|Disease Progression|0|||
147438609|NCT00467779|531772130|FG007|Stage 2A|Disease Progression|0|||
147438610|NCT00467779|531772131|FG008|Stage 2A|Disease Progression|0|||
147438611|NCT00467779|531772132|FG009|Stage 2A|Disease Progression|0|||
147438612|NCT00467779|531772133|FG010|Stage 2A|Disease Progression|0|||
147438613|NCT00467779|531772134|FG011|Stage 2A|Disease Progression|0|||
147438614|NCT00467779|531772135|FG012|Stage 2A|Disease Progression|0|||
147438615|NCT00467779|531772136|FG013|Stage 2A|Disease Progression|10|||
147438616|NCT00467779|531772137|FG014|Stage 2A|Disease Progression|0|||
147438617|NCT00467779|531772123|FG000|Stage 2A|Unspecified Reason|0|||
147438618|NCT00467779|531772124|FG001|Stage 2A|Unspecified Reason|0|||
147438619|NCT00467779|531772125|FG002|Stage 2A|Unspecified Reason|0|||
147438620|NCT00467779|531772126|FG003|Stage 2A|Unspecified Reason|0|||
147438621|NCT00467779|531772127|FG004|Stage 2A|Unspecified Reason|0|||
147438622|NCT00467779|531772128|FG005|Stage 2A|Unspecified Reason|0|||
147438623|NCT00467779|531772129|FG006|Stage 2A|Unspecified Reason|0|||
147438624|NCT00467779|531772130|FG007|Stage 2A|Unspecified Reason|0|||
147438625|NCT00467779|531772131|FG008|Stage 2A|Unspecified Reason|0|||
147438626|NCT00467779|531772132|FG009|Stage 2A|Unspecified Reason|0|||
147438627|NCT00467779|531772133|FG010|Stage 2A|Unspecified Reason|0|||
147438628|NCT00467779|531772134|FG011|Stage 2A|Unspecified Reason|0|||
147438629|NCT00467779|531772135|FG012|Stage 2A|Unspecified Reason|0|||
147438630|NCT00467779|531772136|FG013|Stage 2A|Unspecified Reason|7|||
147438631|NCT00467779|531772137|FG014|Stage 2A|Unspecified Reason|0|||
147438632|NCT00467779|531772123|FG000|Stage 2A|Withdrawal by Subject|0|||
147438633|NCT00467779|531772124|FG001|Stage 2A|Withdrawal by Subject|0|||
147438634|NCT00467779|531772125|FG002|Stage 2A|Withdrawal by Subject|0|||
147438635|NCT00467779|531772126|FG003|Stage 2A|Withdrawal by Subject|0|||
147438636|NCT00467779|531772127|FG004|Stage 2A|Withdrawal by Subject|0|||
147438637|NCT00467779|531772128|FG005|Stage 2A|Withdrawal by Subject|0|||
147438638|NCT00467779|531772129|FG006|Stage 2A|Withdrawal by Subject|0|||
147438639|NCT00467779|531772130|FG007|Stage 2A|Withdrawal by Subject|0|||
147438640|NCT00467779|531772131|FG008|Stage 2A|Withdrawal by Subject|0|||
147438641|NCT00467779|531772132|FG009|Stage 2A|Withdrawal by Subject|0|||
147438642|NCT00467779|531772133|FG010|Stage 2A|Withdrawal by Subject|0|||
147438643|NCT00467779|531772134|FG011|Stage 2A|Withdrawal by Subject|0|||
147438644|NCT00467779|531772135|FG012|Stage 2A|Withdrawal by Subject|0|||
147438645|NCT00467779|531772136|FG013|Stage 2A|Withdrawal by Subject|1|||
147438646|NCT00467779|531772137|FG014|Stage 2A|Withdrawal by Subject|0|||
147438647|NCT00467779|531772123|FG000|Stage 3|Adverse Event|0|||
147539893|NCT04502862|532130831|FG001|Overall Study|Not Related to Coronavirus Disease-2019 (COVID-19) pandemic|6|||
147539894|NCT04502862|532130830|FG000|Overall Study|Withdrawal by Subject|1|||
147539895|NCT04502862|532130831|FG001|Overall Study|Withdrawal by Subject|0|||
147539896|NCT04502862|532130830|FG000|Overall Study|Adverse Event|1|||
147539897|NCT04502862|532130831|FG001|Overall Study|Adverse Event|1|||
147539898|NCT00359073|532132802|FG000|Overall Study|Withdrawal by Subject|1|||
147539899|NCT00359073|532132803|FG001|Overall Study|Withdrawal by Subject|1|||
147539900|NCT00359073|532132802|FG000|Overall Study|Eligibility criteria no longer met|3|||
147539901|NCT00359073|532132803|FG001|Overall Study|Eligibility criteria no longer met|0|||
147539902|NCT00359073|532132802|FG000|Overall Study|developed RV16 antibody|0|||
147539903|NCT00359073|532132803|FG001|Overall Study|developed RV16 antibody|1|||
147539904|NCT01371006|532132804|FG000|Overall Study|Adverse Event|1|||
147539905|NCT01371006|532132805|FG001|Overall Study|Adverse Event|0|||
147539906|NCT00891527|532132806|FG000|Overall Study|Withdrawal by Subject|2|||
147539907|NCT03515837|532132808|FG000|Overall Study|Death|219|||
147539908|NCT03515837|532132809|FG001|Overall Study|Death|227|||
147539909|NCT03515837|532132808|FG000|Overall Study|Lost to Follow-up|0|||
147539910|NCT03515837|532132809|FG001|Overall Study|Lost to Follow-up|1|||
147539911|NCT03515837|532132808|FG000|Overall Study|Withdrawal by Subject|0|||
147539912|NCT03515837|532132809|FG001|Overall Study|Withdrawal by Subject|4|||
147539913|NCT03515837|532132808|FG000|Overall Study|Participation Was Terminated By Sponsor|26|||
147539914|NCT03515837|532132809|FG001|Overall Study|Participation Was Terminated By Sponsor|15|||
147539915|NCT01964898|532132810|FG000|Overall Study|ineligible post-randomization|1|||
147539916|NCT01964898|532132811|FG001|Overall Study|ineligible post-randomization|1|||
147539917|NCT01964898|532132810|FG000|Overall Study|did not receive the allocated interventi|2|||
147539918|NCT01964898|532132811|FG001|Overall Study|did not receive the allocated interventi|1|||
147539919|NCT01964898|532132810|FG000|Overall Study|Lost to Follow-up|3|||
147539920|NCT01964898|532132811|FG001|Overall Study|Lost to Follow-up|5|||
147539921|NCT01964898|532132810|FG000|Overall Study|Withdrawal by Subject|1|||
147539922|NCT01964898|532132811|FG001|Overall Study|Withdrawal by Subject|0|||
147539923|NCT02957682|532132814|FG000|Overall Study|Adverse Event|64|||
147539924|NCT02957682|532132815|FG001|Overall Study|Adverse Event|67|||
147539925|NCT02957682|532132814|FG000|Overall Study|Poor Compliance to Protocol|30|||
147539926|NCT02957682|532132815|FG001|Overall Study|Poor Compliance to Protocol|26|||
147539927|NCT02957682|532132814|FG000|Overall Study|Physician Decision|4|||
147539928|NCT02957682|532132815|FG001|Overall Study|Physician Decision|4|||
147539929|NCT02957682|532132814|FG000|Overall Study|Study Terminated by Sponsor|4|||
147539930|NCT02957682|532132815|FG001|Overall Study|Study Terminated by Sponsor|3|||
147539931|NCT02957682|532132814|FG000|Overall Study|Subject Moved|10|||
147539932|NCT02957682|532132815|FG001|Overall Study|Subject Moved|16|||
147539933|NCT02957682|532132814|FG000|Overall Study|Withdrawal by Subject|64|||
147539934|NCT02957682|532132815|FG001|Overall Study|Withdrawal by Subject|33|||
147539935|NCT02957682|532132814|FG000|Overall Study|Related to IMP Administration|3|||
147539936|NCT02957682|532132815|FG001|Overall Study|Related to IMP Administration|6|||
147539937|NCT02957682|532132814|FG000|Overall Study|Non-disclosed|16|||
147539938|NCT02957682|532132815|FG001|Overall Study|Non-disclosed|12|||
147539939|NCT02957682|532132814|FG000|Overall Study|Discontinued After Randomization and Prior to Any Treatment|3|||
147539940|NCT02957682|532132815|FG001|Overall Study|Discontinued After Randomization and Prior to Any Treatment|2|||
147539941|NCT02953262|532132823|FG000|Overall Study|Used portal during 6 months prior to randomization|3|||
147539942|NCT02953262|532132824|FG001|Overall Study|Used portal during 6 months prior to randomization|6|||
147539943|NCT02953262|532132825|FG002|Overall Study|Used portal during 6 months prior to randomization|3|||
147539944|NCT02953262|532132826|FG003|Overall Study|Used portal during 6 months prior to randomization|3|||
147539945|NCT00934622|532132827|FG000|Overall Study|Lost to Follow-up|7|||
147539946|NCT00934622|532132827|FG000|Overall Study|2nd Intraoperative exclusion criteria|1|||
147539947|NCT03349437|532132828|FG000|Screening|Screen Fail|4|||
147539948|NCT03349437|532132829|FG001|Screening|Screen Fail|0|||
147539949|NCT03349437|532132830|FG002|Screening|Screen Fail|0|||
147539950|NCT03349437|532132828|FG000|Screening|Withdrawn|1|||
147539951|NCT03349437|532132829|FG001|Screening|Withdrawn|0|||
147539952|NCT03349437|532132830|FG002|Screening|Withdrawn|0|||
147539953|NCT02406742|532132831|FG000|Overall Study|Progression of Disease|5|||
147539954|NCT02406742|532132832|FG001|Overall Study|Progression of Disease|1|||
147539955|NCT02406742|532132833|FG002|Overall Study|Progression of Disease|6|||
147539956|NCT02406742|532132831|FG000|Overall Study|Adverse Event|3|||
147539957|NCT02406742|532132832|FG001|Overall Study|Adverse Event|0|||
147539958|NCT02406742|532132833|FG002|Overall Study|Adverse Event|2|||
147539959|NCT02406742|532132831|FG000|Overall Study|Death|1|||
147539960|NCT02406742|532132832|FG001|Overall Study|Death|0|||
147539961|NCT02406742|532132833|FG002|Overall Study|Death|0|||
147539962|NCT02406742|532132831|FG000|Overall Study|Lack of Efficacy|0|||
147539963|NCT02406742|532132832|FG001|Overall Study|Lack of Efficacy|0|||
147539964|NCT02406742|532132833|FG002|Overall Study|Lack of Efficacy|1|||
147539965|NCT02406742|532132831|FG000|Overall Study|Withdrawal by Participant|1|||
147539966|NCT02406742|532132832|FG001|Overall Study|Withdrawal by Participant|2|||
147539967|NCT02406742|532132833|FG002|Overall Study|Withdrawal by Participant|0|||
147203441|NCT04032093|530913839|FG005|Overall Study|No Longer Meets Eligibility Criteria|0|||
147203442|NCT04032093|530913840|FG006|Overall Study|No Longer Meets Eligibility Criteria|0|||
147203443|NCT04032093|530913841|FG007|Overall Study|No Longer Meets Eligibility Criteria|0|||
147203444|NCT04032093|530913842|FG008|Overall Study|No Longer Meets Eligibility Criteria|1|||
147203445|NCT04032093|530913843|FG009|Overall Study|No Longer Meets Eligibility Criteria|1|||
147203446|NCT04032093|530913834|FG000|Overall Study|Other|1|||
147203447|NCT04032093|530913835|FG001|Overall Study|Other|0|||
147203448|NCT04032093|530913836|FG002|Overall Study|Other|0|||
147203449|NCT04032093|530913837|FG003|Overall Study|Other|1|||
147203450|NCT04032093|530913838|FG004|Overall Study|Other|1|||
147203451|NCT04032093|530913839|FG005|Overall Study|Other|0|||
147203452|NCT04032093|530913840|FG006|Overall Study|Other|0|||
147203453|NCT04032093|530913841|FG007|Overall Study|Other|0|||
147203454|NCT04032093|530913842|FG008|Overall Study|Other|0|||
147203455|NCT04032093|530913843|FG009|Overall Study|Other|1|||
147203456|NCT04032093|530913834|FG000|Overall Study|Withdrawal by Subject|1|||
147203457|NCT04032093|530913835|FG001|Overall Study|Withdrawal by Subject|3|||
147203458|NCT04032093|530913836|FG002|Overall Study|Withdrawal by Subject|2|||
147203459|NCT04032093|530913837|FG003|Overall Study|Withdrawal by Subject|2|||
147203460|NCT04032093|530913838|FG004|Overall Study|Withdrawal by Subject|3|||
147203461|NCT04032093|530913839|FG005|Overall Study|Withdrawal by Subject|0|||
147203462|NCT04032093|530913840|FG006|Overall Study|Withdrawal by Subject|0|||
147203463|NCT04032093|530913841|FG007|Overall Study|Withdrawal by Subject|0|||
147203464|NCT04032093|530913842|FG008|Overall Study|Withdrawal by Subject|0|||
147203465|NCT04032093|530913843|FG009|Overall Study|Withdrawal by Subject|0|||
147203466|NCT04032093|530913834|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
147203467|NCT04032093|530913835|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
147203468|NCT04032093|530913836|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
147203469|NCT04032093|530913837|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
147203470|NCT04032093|530913838|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
147203471|NCT04032093|530913839|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
147203472|NCT04032093|530913840|FG006|Overall Study|Withdrawal by Parent/Guardian|3|||
147203473|NCT04032093|530913841|FG007|Overall Study|Withdrawal by Parent/Guardian|0|||
147203474|NCT04032093|530913842|FG008|Overall Study|Withdrawal by Parent/Guardian|2|||
147203475|NCT04032093|530913843|FG009|Overall Study|Withdrawal by Parent/Guardian|3|||
147203476|NCT04032093|530913834|FG000|Overall Study|Adverse Event|0|||
147203477|NCT04032093|530913835|FG001|Overall Study|Adverse Event|0|||
147203478|NCT04032093|530913836|FG002|Overall Study|Adverse Event|0|||
147203479|NCT04032093|530913837|FG003|Overall Study|Adverse Event|0|||
147203480|NCT04032093|530913838|FG004|Overall Study|Adverse Event|0|||
147203481|NCT04032093|530913839|FG005|Overall Study|Adverse Event|0|||
147203482|NCT04032093|530913840|FG006|Overall Study|Adverse Event|0|||
147203483|NCT04032093|530913841|FG007|Overall Study|Adverse Event|0|||
147203484|NCT04032093|530913842|FG008|Overall Study|Adverse Event|0|||
147203485|NCT04032093|530913843|FG009|Overall Study|Adverse Event|1|||
147203486|NCT04032093|530913834|FG000|Overall Study|Physician Decision|0|||
147203487|NCT04032093|530913835|FG001|Overall Study|Physician Decision|0|||
147203488|NCT04032093|530913836|FG002|Overall Study|Physician Decision|0|||
147203489|NCT04032093|530913837|FG003|Overall Study|Physician Decision|0|||
147203490|NCT04032093|530913838|FG004|Overall Study|Physician Decision|0|||
147438648|NCT00467779|531772124|FG001|Stage 3|Adverse Event|0|||
147438649|NCT00467779|531772125|FG002|Stage 3|Adverse Event|0|||
147438650|NCT00467779|531772126|FG003|Stage 3|Adverse Event|0|||
147438651|NCT00467779|531772127|FG004|Stage 3|Adverse Event|0|||
147438652|NCT00467779|531772128|FG005|Stage 3|Adverse Event|0|||
147438653|NCT00467779|531772129|FG006|Stage 3|Adverse Event|0|||
147438654|NCT00467779|531772130|FG007|Stage 3|Adverse Event|0|||
147438655|NCT00467779|531772131|FG008|Stage 3|Adverse Event|0|||
147438656|NCT00467779|531772132|FG009|Stage 3|Adverse Event|0|||
147438657|NCT00467779|531772133|FG010|Stage 3|Adverse Event|0|||
147438658|NCT00467779|531772134|FG011|Stage 3|Adverse Event|0|||
147438659|NCT00467779|531772135|FG012|Stage 3|Adverse Event|0|||
147438660|NCT00467779|531772136|FG013|Stage 3|Adverse Event|0|||
147438661|NCT00467779|531772137|FG014|Stage 3|Adverse Event|2|||
147438662|NCT00467779|531772123|FG000|Stage 3|Death|0|||
147539968|NCT02406742|532132831|FG000|Overall Study|Physician Decision|1|||
147539969|NCT02406742|532132832|FG001|Overall Study|Physician Decision|2|||
147203491|NCT04032093|530913839|FG005|Overall Study|Physician Decision|1|||
147203492|NCT04032093|530913840|FG006|Overall Study|Physician Decision|0|||
147203493|NCT04032093|530913841|FG007|Overall Study|Physician Decision|0|||
147438663|NCT00467779|531772124|FG001|Stage 3|Death|0|||
147438664|NCT00467779|531772125|FG002|Stage 3|Death|0|||
147203494|NCT04032093|530913842|FG008|Overall Study|Physician Decision|0|||
147203495|NCT04032093|530913843|FG009|Overall Study|Physician Decision|0|||
147203496|NCT00960999|530913844|FG000|Overall Study|Withdrawal by Subject|1|||
147438665|NCT00467779|531772126|FG003|Stage 3|Death|0|||
147438666|NCT00467779|531772127|FG004|Stage 3|Death|0|||
147438667|NCT00467779|531772128|FG005|Stage 3|Death|0|||
147438668|NCT00467779|531772129|FG006|Stage 3|Death|0|||
147438669|NCT00467779|531772130|FG007|Stage 3|Death|0|||
147539970|NCT02406742|532132833|FG002|Overall Study|Physician Decision|1|||
147539971|NCT02406742|532132831|FG000|Overall Study|Transition to other treatment|2|||
147539972|NCT02406742|532132832|FG001|Overall Study|Transition to other treatment|0|||
147539973|NCT02406742|532132833|FG002|Overall Study|Transition to other treatment|1|||
147539974|NCT02406742|532132831|FG000|Overall Study|Other Reasons|1|||
147539975|NCT02406742|532132832|FG001|Overall Study|Other Reasons|11|||
147539976|NCT02406742|532132833|FG002|Overall Study|Other Reasons|5|||
147539977|NCT00765999|532132834|FG000|Overall Study|Adverse Event|203|||
147203497|NCT00960999|530913845|FG001|Overall Study|Withdrawal by Subject|0|||
147539978|NCT00765999|532132834|FG000|Overall Study|Insufficient Therapeutic Response|100|||
147539979|NCT00765999|532132834|FG000|Overall Study|Protocol Violation|95|||
147539980|NCT00765999|532132834|FG000|Overall Study|Consent Withdrawn|202|||
147539981|NCT00765999|532132834|FG000|Overall Study|Lost to Follow-up|131|||
147539982|NCT00765999|532132834|FG000|Overall Study|Study Terminated by Sponsor|2|||
147539983|NCT00765999|532132834|FG000|Overall Study|Other Miscellaneous Reasons|51|||
147539984|NCT02367729|532132835|FG000|Overall Study|Organic disorder diagnosed|2|||
147539985|NCT02367729|532132836|FG001|Overall Study|Organic disorder diagnosed|1|||
147539986|NCT02367729|532132835|FG000|Overall Study|Adverse Event|1|||
147539987|NCT02367729|532132836|FG001|Overall Study|Adverse Event|2|||
147539988|NCT02367729|532132835|FG000|Overall Study|Withdrawal by Subject|0|||
147539989|NCT02367729|532132836|FG001|Overall Study|Withdrawal by Subject|5|||
147539990|NCT00759174|532132841|FG000|Overall Study|Other|0|||
147539991|NCT00759174|532132842|FG001|Overall Study|Other|2|||
147539992|NCT01890109|532132843|FG000|Overall Study|Withdrawal by Subject|0|||
147539993|NCT01890109|532132844|FG001|Overall Study|Withdrawal by Subject|3|||
147539994|NCT01890109|532132843|FG000|Overall Study|Lost to Follow-up|1|||
147539995|NCT01890109|532132844|FG001|Overall Study|Lost to Follow-up|2|||
147539996|NCT01643928|532132845|FG000|Overall Study|Lost to Follow-up|1|||
147539997|NCT01643928|532132846|FG001|Overall Study|Lost to Follow-up|0|||
147539998|NCT01643928|532132847|FG002|Overall Study|Lost to Follow-up|2|||
147539999|NCT01643928|532132848|FG003|Overall Study|Lost to Follow-up|0|||
147540000|NCT01643928|532132849|FG004|Overall Study|Lost to Follow-up|0|||
147540001|NCT01643928|532132845|FG000|Overall Study|Withdrawal by Subject|2|||
147540002|NCT01643928|532132846|FG001|Overall Study|Withdrawal by Subject|0|||
147203498|NCT00960999|530913844|FG000|Overall Study|Protocol Violation|5|||
147203499|NCT00960999|530913845|FG001|Overall Study|Protocol Violation|2|||
147203500|NCT00960999|530913844|FG000|Overall Study|RT dose constraints not met|2|||
147203501|NCT00960999|530913845|FG001|Overall Study|RT dose constraints not met|0|||
147203502|NCT02141204|530913846|FG000|Overall Study|Lost to Follow-up|2|||
147203503|NCT02141204|530913847|FG001|Overall Study|Lost to Follow-up|1|||
147203504|NCT02141204|530913846|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO AE|1|||
147203505|NCT02141204|530913847|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO AE|2|||
147203506|NCT02141204|530913846|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|3|||
147203507|NCT02141204|530913847|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|5|||
147203508|NCT02141204|530913846|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|9|||
147203509|NCT02141204|530913847|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|7|||
147203510|NCT01177397|530915675|FG000|Overall Study|Protocol Violation|0|||
147203511|NCT01177397|530915676|FG001|Overall Study|Protocol Violation|0|||
147203512|NCT01177397|530915677|FG002|Overall Study|Protocol Violation|0|||
147203513|NCT01177397|530915678|FG003|Overall Study|Protocol Violation|0|||
147203514|NCT01177397|530915679|FG004|Overall Study|Protocol Violation|0|||
147203515|NCT01177397|530915680|FG005|Overall Study|Protocol Violation|1|||
147203516|NCT01177397|530915681|FG006|Overall Study|Protocol Violation|0|||
147203517|NCT01177397|530915682|FG007|Overall Study|Protocol Violation|0|||
147203518|NCT01177397|530915683|FG008|Overall Study|Protocol Violation|0|||
147203519|NCT01177397|530915684|FG009|Overall Study|Protocol Violation|0|||
147203520|NCT01177397|530915685|FG010|Overall Study|Protocol Violation|0|||
147203521|NCT01177397|530915686|FG011|Overall Study|Protocol Violation|0|||
147203522|NCT01177397|530915675|FG000|Overall Study|Lost to Follow-up|0|||
147203523|NCT01177397|530915676|FG001|Overall Study|Lost to Follow-up|0|||
147203524|NCT01177397|530915677|FG002|Overall Study|Lost to Follow-up|0|||
147203525|NCT01177397|530915678|FG003|Overall Study|Lost to Follow-up|0|||
147203526|NCT01177397|530915679|FG004|Overall Study|Lost to Follow-up|1|||
147203527|NCT01177397|530915680|FG005|Overall Study|Lost to Follow-up|0|||
147203528|NCT01177397|530915681|FG006|Overall Study|Lost to Follow-up|0|||
147540003|NCT01643928|532132847|FG002|Overall Study|Withdrawal by Subject|0|||
147540004|NCT01643928|532132848|FG003|Overall Study|Withdrawal by Subject|1|||
147203529|NCT01177397|530915682|FG007|Overall Study|Lost to Follow-up|2|||
147203530|NCT01177397|530915683|FG008|Overall Study|Lost to Follow-up|0|||
147203531|NCT01177397|530915684|FG009|Overall Study|Lost to Follow-up|0|||
147203532|NCT01177397|530915685|FG010|Overall Study|Lost to Follow-up|0|||
147203533|NCT01177397|530915686|FG011|Overall Study|Lost to Follow-up|0|||
147203534|NCT01177397|530915675|FG000|Overall Study|Death|0|||
147540005|NCT01643928|532132849|FG004|Overall Study|Withdrawal by Subject|0|||
147540006|NCT01643928|532132845|FG000|Overall Study|Pregnancy|0|||
147540007|NCT01643928|532132846|FG001|Overall Study|Pregnancy|0|||
147540008|NCT01643928|532132847|FG002|Overall Study|Pregnancy|0|||
147540009|NCT01643928|532132848|FG003|Overall Study|Pregnancy|1|||
147540010|NCT01643928|532132849|FG004|Overall Study|Pregnancy|0|||
147540011|NCT01643928|532132845|FG000|Overall Study|Other|5|||
147540012|NCT01643928|532132846|FG001|Overall Study|Other|1|||
147540013|NCT01643928|532132847|FG002|Overall Study|Other|1|||
147540014|NCT01643928|532132848|FG003|Overall Study|Other|0|||
147540015|NCT01643928|532132849|FG004|Overall Study|Other|0|||
147540016|NCT01643928|532132845|FG000|Overall Study|Adverse Event|2|||
147540017|NCT01643928|532132846|FG001|Overall Study|Adverse Event|1|||
147540018|NCT01643928|532132847|FG002|Overall Study|Adverse Event|0|||
147540019|NCT01643928|532132848|FG003|Overall Study|Adverse Event|1|||
147540020|NCT01643928|532132849|FG004|Overall Study|Adverse Event|2|||
147540021|NCT03692078|532132851|FG000|Overall Study|Adverse Event|0|||
147540022|NCT03692078|532132852|FG001|Overall Study|Adverse Event|0|||
147540023|NCT03692078|532132853|FG002|Overall Study|Adverse Event|0|||
147540024|NCT03692078|532132854|FG003|Overall Study|Adverse Event|0|||
147540025|NCT03692078|532132855|FG004|Overall Study|Adverse Event|0|||
147540026|NCT03692078|532132856|FG005|Overall Study|Adverse Event|1|||
147540027|NCT03692078|532132857|FG006|Overall Study|Adverse Event|0|||
147540028|NCT03692078|532132851|FG000|Overall Study|Enrollment Closed|5|||
147540029|NCT03692078|532132852|FG001|Overall Study|Enrollment Closed|0|||
147540030|NCT03692078|532132853|FG002|Overall Study|Enrollment Closed|0|||
147540031|NCT03692078|532132854|FG003|Overall Study|Enrollment Closed|0|||
147540032|NCT03692078|532132855|FG004|Overall Study|Enrollment Closed|0|||
147540033|NCT03692078|532132856|FG005|Overall Study|Enrollment Closed|0|||
147540034|NCT03692078|532132857|FG006|Overall Study|Enrollment Closed|0|||
147540035|NCT03692078|532132851|FG000|Overall Study|Failure To Meet Randomization Criteria|13|||
147540036|NCT03692078|532132852|FG001|Overall Study|Failure To Meet Randomization Criteria|0|||
147540037|NCT03692078|532132853|FG002|Overall Study|Failure To Meet Randomization Criteria|0|||
147540038|NCT03692078|532132854|FG003|Overall Study|Failure To Meet Randomization Criteria|0|||
147540039|NCT03692078|532132855|FG004|Overall Study|Failure To Meet Randomization Criteria|0|||
147540040|NCT03692078|532132856|FG005|Overall Study|Failure To Meet Randomization Criteria|0|||
147540041|NCT03692078|532132857|FG006|Overall Study|Failure To Meet Randomization Criteria|0|||
147540042|NCT03692078|532132851|FG000|Overall Study|Withdrawal by Subject|0|||
147540043|NCT03692078|532132852|FG001|Overall Study|Withdrawal by Subject|2|||
147540044|NCT03692078|532132853|FG002|Overall Study|Withdrawal by Subject|0|||
147540045|NCT03692078|532132854|FG003|Overall Study|Withdrawal by Subject|1|||
147540046|NCT03692078|532132855|FG004|Overall Study|Withdrawal by Subject|5|||
147540047|NCT03692078|532132856|FG005|Overall Study|Withdrawal by Subject|3|||
147540048|NCT03692078|532132857|FG006|Overall Study|Withdrawal by Subject|3|||
147540049|NCT05723835|532132860|FG000|Extension I Period: Weeks 39 Upto 156|Study is ongoing, data is reported till data cut-off 24 Nov 2024|4|||
147540050|NCT05723835|532132861|FG001|Extension I Period: Weeks 39 Upto 156|Study is ongoing, data is reported till data cut-off 24 Nov 2024|8|||
147540051|NCT05723835|532132862|FG002|Extension I Period: Weeks 39 Upto 156|Study is ongoing, data is reported till data cut-off 24 Nov 2024|3|||
147540052|NCT05723835|532132863|FG003|Extension I Period: Weeks 39 Upto 156|Study is ongoing, data is reported till data cut-off 24 Nov 2024|8|||
147540053|NCT05723835|532132864|FG004|Extension I Period: Weeks 39 Upto 156|Study is ongoing, data is reported till data cut-off 24 Nov 2024|6|||
147540054|NCT05723835|532132865|FG005|Extension I Period: Weeks 39 Upto 156|Study is ongoing, data is reported till data cut-off 24 Nov 2024|7|||
147540055|NCT05723835|532132866|FG006|Extension I Period: Weeks 39 Upto 156|Study is ongoing, data is reported till data cut-off 24 Nov 2024|2|||
147540056|NCT05723835|532132867|FG007|Extension I Period: Weeks 39 Upto 156|Study is ongoing, data is reported till data cut-off 24 Nov 2024|9|||
147540057|NCT05226286|532132868|FG000|Overall Study|Screen failures prior to implant|62|||
147540058|NCT05226286|532132868|FG000|Overall Study|Withdrawal by Subject|13|||
147540059|NCT05226286|532132868|FG000|Overall Study|Lost to Follow-up|3|||
147540060|NCT05226286|532132868|FG000|Overall Study|Physician Decision|1|||
147540061|NCT05226286|532132868|FG000|Overall Study|Adverse Event|1|||
147540062|NCT05226286|532132868|FG000|Overall Study|Death|1|||
147540063|NCT05226286|532132868|FG000|Overall Study|Device explant with no planned replacement|1|||
147540064|NCT05226286|532132868|FG000|Overall Study|Planned surgery with an implanted metal material closer than allowed in research protocol|1|||
147540065|NCT05226286|532132868|FG000|Overall Study|Transitioned to urethral catheter/suprapubic tube|1|||
147540066|NCT03395197|532132869|FG000|Analysis for Part 1 and Part 2 Cohort 1|Lost to Follow-up|0|||
147540067|NCT03395197|532132870|FG001|Analysis for Part 1 and Part 2 Cohort 1|Lost to Follow-up|0|||
147540068|NCT03395197|532132871|FG002|Analysis for Part 1 and Part 2 Cohort 1|Lost to Follow-up|0|||
147540069|NCT03395197|532132872|FG003|Analysis for Part 1 and Part 2 Cohort 1|Lost to Follow-up|1|||
147540070|NCT03395197|532132873|FG004|Analysis for Part 1 and Part 2 Cohort 1|Lost to Follow-up|0|||
147540071|NCT03395197|532132874|FG005|Analysis for Part 1 and Part 2 Cohort 1|Lost to Follow-up|0|||
147540072|NCT03395197|532132869|FG000|Analysis for Part 1 and Part 2 Cohort 1|Death|0|||
147540073|NCT03395197|532132870|FG001|Analysis for Part 1 and Part 2 Cohort 1|Death|0|||
147540074|NCT03395197|532132871|FG002|Analysis for Part 1 and Part 2 Cohort 1|Death|8|||
147540075|NCT03395197|532132872|FG003|Analysis for Part 1 and Part 2 Cohort 1|Death|10|||
147540076|NCT03395197|532132873|FG004|Analysis for Part 1 and Part 2 Cohort 1|Death|0|||
147540077|NCT03395197|532132874|FG005|Analysis for Part 1 and Part 2 Cohort 1|Death|0|||
147540078|NCT03395197|532132869|FG000|Analysis for Part 1 and Part 2 Cohort 1|No longer meets eligibility ceriteria|0|||
147540079|NCT03395197|532132870|FG001|Analysis for Part 1 and Part 2 Cohort 1|No longer meets eligibility ceriteria|0|||
147203535|NCT01177397|530915676|FG001|Overall Study|Death|0|||
147203536|NCT01177397|530915677|FG002|Overall Study|Death|1|||
147203537|NCT01177397|530915678|FG003|Overall Study|Death|1|||
147203538|NCT01177397|530915679|FG004|Overall Study|Death|0|||
147203539|NCT01177397|530915680|FG005|Overall Study|Death|0|||
147203540|NCT01177397|530915681|FG006|Overall Study|Death|0|||
147203541|NCT01177397|530915682|FG007|Overall Study|Death|5|||
147438670|NCT00467779|531772131|FG008|Stage 3|Death|0|||
147438671|NCT00467779|531772132|FG009|Stage 3|Death|0|||
147438672|NCT00467779|531772133|FG010|Stage 3|Death|0|||
147438673|NCT00467779|531772134|FG011|Stage 3|Death|0|||
147438674|NCT00467779|531772135|FG012|Stage 3|Death|0|||
147438675|NCT00467779|531772136|FG013|Stage 3|Death|0|||
147438676|NCT00467779|531772137|FG014|Stage 3|Death|1|||
147438677|NCT00467779|531772123|FG000|Stage 3|Disease Progression|0|||
147438678|NCT00467779|531772124|FG001|Stage 3|Disease Progression|0|||
147438679|NCT00467779|531772125|FG002|Stage 3|Disease Progression|0|||
147438680|NCT00467779|531772126|FG003|Stage 3|Disease Progression|0|||
147438681|NCT00467779|531772127|FG004|Stage 3|Disease Progression|0|||
147438682|NCT00467779|531772128|FG005|Stage 3|Disease Progression|0|||
147438683|NCT00467779|531772129|FG006|Stage 3|Disease Progression|0|||
147438684|NCT00467779|531772130|FG007|Stage 3|Disease Progression|0|||
147438685|NCT00467779|531772131|FG008|Stage 3|Disease Progression|0|||
147438686|NCT00467779|531772132|FG009|Stage 3|Disease Progression|0|||
147438687|NCT00467779|531772133|FG010|Stage 3|Disease Progression|0|||
147438688|NCT00467779|531772134|FG011|Stage 3|Disease Progression|0|||
147438689|NCT00467779|531772135|FG012|Stage 3|Disease Progression|0|||
147438690|NCT00467779|531772136|FG013|Stage 3|Disease Progression|0|||
147438691|NCT00467779|531772137|FG014|Stage 3|Disease Progression|9|||
147438692|NCT00467779|531772123|FG000|Stage 3|Unspecified Reason|0|||
147438693|NCT00467779|531772124|FG001|Stage 3|Unspecified Reason|0|||
147438694|NCT00467779|531772125|FG002|Stage 3|Unspecified Reason|0|||
147438695|NCT00467779|531772126|FG003|Stage 3|Unspecified Reason|0|||
147438696|NCT00467779|531772127|FG004|Stage 3|Unspecified Reason|0|||
147438697|NCT00467779|531772128|FG005|Stage 3|Unspecified Reason|0|||
147438698|NCT00467779|531772129|FG006|Stage 3|Unspecified Reason|0|||
147438699|NCT00467779|531772130|FG007|Stage 3|Unspecified Reason|0|||
147438700|NCT00467779|531772131|FG008|Stage 3|Unspecified Reason|0|||
147438701|NCT00467779|531772132|FG009|Stage 3|Unspecified Reason|0|||
147438702|NCT00467779|531772133|FG010|Stage 3|Unspecified Reason|0|||
147438703|NCT00467779|531772134|FG011|Stage 3|Unspecified Reason|0|||
147438704|NCT00467779|531772135|FG012|Stage 3|Unspecified Reason|0|||
147438705|NCT00467779|531772136|FG013|Stage 3|Unspecified Reason|0|||
147438706|NCT00467779|531772137|FG014|Stage 3|Unspecified Reason|5|||
147438707|NCT01509079|531772138|FG000|Overall Study|Lack of Efficacy|0|||
147438708|NCT01509079|531772139|FG001|Overall Study|Lack of Efficacy|2|||
147438709|NCT01509079|531772138|FG000|Overall Study|started an excluded medication|0|||
147438710|NCT01509079|531772139|FG001|Overall Study|started an excluded medication|1|||
147438711|NCT05111041|531772140|FG000|Overall Study|Lost to Follow-up|6|||
147438712|NCT05111041|531772141|FG001|Overall Study|Lost to Follow-up|7|||
147438713|NCT05111041|531772140|FG000|Overall Study|Withdrawal by Subject|1|||
147438714|NCT05111041|531772141|FG001|Overall Study|Withdrawal by Subject|0|||
147438715|NCT00041080|531772142|FG000|Overall Study|Adverse Event|21|||
147438716|NCT00041080|531772143|FG001|Overall Study|Adverse Event|1|||
147438717|NCT00041080|531772142|FG000|Overall Study|Withdrawal by Subject|6|||
147438718|NCT00041080|531772143|FG001|Overall Study|Withdrawal by Subject|6|||
147438719|NCT00041080|531772142|FG000|Overall Study|Concommitant Illness/Other|1|||
147438720|NCT00041080|531772143|FG001|Overall Study|Concommitant Illness/Other|2|||
147438721|NCT00041080|531772142|FG000|Overall Study|Did not start therapy|1|||
147438722|NCT00041080|531772143|FG001|Overall Study|Did not start therapy|1|||
147438723|NCT00041080|531772142|FG000|Overall Study|Ineligible|1|||
147438724|NCT00041080|531772143|FG001|Overall Study|Ineligible|0|||
147438725|NCT00436618|531772144|FG000|Overall Study|Withdrawal by Subject|5|||
147438726|NCT00436618|531772145|FG001|Overall Study|Withdrawal by Subject|8|||
147438727|NCT00436618|531772146|FG002|Overall Study|Withdrawal by Subject|11|||
147438728|NCT00436618|531772144|FG000|Overall Study|Adverse Event|8|||
147203542|NCT01177397|530915683|FG008|Overall Study|Death|2|||
147203543|NCT01177397|530915684|FG009|Overall Study|Death|1|||
147306815|NCT01852058|531290784|FG011|Treatment Cycle 1, Occurred in Study 120|Lost to Follow-up|0|||
147438729|NCT00436618|531772145|FG001|Overall Study|Adverse Event|8|||
147438730|NCT00436618|531772146|FG002|Overall Study|Adverse Event|9|||
147438731|NCT00436618|531772144|FG000|Overall Study|Alternate Treatment|3|||
147438732|NCT00436618|531772145|FG001|Overall Study|Alternate Treatment|4|||
147438733|NCT00436618|531772146|FG002|Overall Study|Alternate Treatment|12|||
147438734|NCT00436618|531772144|FG000|Overall Study|Other Medical Problems|3|||
147438735|NCT00436618|531772145|FG001|Overall Study|Other Medical Problems|1|||
147203544|NCT01177397|530915685|FG010|Overall Study|Death|0|||
147203545|NCT01177397|530915686|FG011|Overall Study|Death|0|||
147203546|NCT01177397|530915675|FG000|Overall Study|Withdrawal by Subject|0|||
147438736|NCT00436618|531772146|FG002|Overall Study|Other Medical Problems|7|||
147438737|NCT00436618|531772144|FG000|Overall Study|Death|4|||
147438738|NCT00436618|531772145|FG001|Overall Study|Death|2|||
147438739|NCT00436618|531772146|FG002|Overall Study|Death|3|||
147438740|NCT00436618|531772144|FG000|Overall Study|New Primary or Other Reasons|6|||
147438741|NCT00436618|531772145|FG001|Overall Study|New Primary or Other Reasons|2|||
147438742|NCT00436618|531772146|FG002|Overall Study|New Primary or Other Reasons|12|||
147438743|NCT00436618|531772144|FG000|Overall Study|Still on treatment|1|||
147438744|NCT00436618|531772145|FG001|Overall Study|Still on treatment|2|||
147438745|NCT00436618|531772146|FG002|Overall Study|Still on treatment|7|||
147438746|NCT01994382|531772147|FG000|Overall Study|Informed consent withdrawn|0|||
147438747|NCT01994382|531772148|FG001|Overall Study|Informed consent withdrawn|0|||
147438748|NCT01994382|531772149|FG002|Overall Study|Informed consent withdrawn|0|||
147438749|NCT01994382|531772150|FG003|Overall Study|Informed consent withdrawn|0|||
147438750|NCT01994382|531772151|FG004|Overall Study|Informed consent withdrawn|0|||
147438751|NCT01994382|531772152|FG005|Overall Study|Informed consent withdrawn|0|||
147438752|NCT01994382|531772153|FG006|Overall Study|Informed consent withdrawn|1|||
147438753|NCT01994382|531772154|FG007|Overall Study|Informed consent withdrawn|0|||
147438754|NCT01994382|531772155|FG008|Overall Study|Informed consent withdrawn|0|||
147438755|NCT01994382|531772156|FG009|Overall Study|Informed consent withdrawn|0|||
147438756|NCT01994382|531772157|FG010|Overall Study|Informed consent withdrawn|0|||
147438757|NCT01994382|531772158|FG011|Overall Study|Informed consent withdrawn|0|||
147438758|NCT01994382|531772159|FG012|Overall Study|Informed consent withdrawn|0|||
147438759|NCT01994382|531772160|FG013|Overall Study|Informed consent withdrawn|0|||
147438760|NCT01994382|531772161|FG014|Overall Study|Informed consent withdrawn|0|||
147438761|NCT01994382|531772162|FG015|Overall Study|Informed consent withdrawn|0|||
147438762|NCT01994382|531772163|FG016|Overall Study|Informed consent withdrawn|0|||
147438763|NCT01994382|531772147|FG000|Overall Study|Progressive disease|3|||
147438764|NCT01994382|531772148|FG001|Overall Study|Progressive disease|4|||
147438765|NCT01994382|531772149|FG002|Overall Study|Progressive disease|4|||
147438766|NCT01994382|531772150|FG003|Overall Study|Progressive disease|3|||
147438767|NCT01994382|531772151|FG004|Overall Study|Progressive disease|2|||
147438768|NCT01994382|531772152|FG005|Overall Study|Progressive disease|3|||
147438769|NCT01994382|531772153|FG006|Overall Study|Progressive disease|3|||
147438770|NCT01994382|531772154|FG007|Overall Study|Progressive disease|6|||
147203547|NCT01177397|530915676|FG001|Overall Study|Withdrawal by Subject|0|||
147203548|NCT01177397|530915677|FG002|Overall Study|Withdrawal by Subject|1|||
147203549|NCT01177397|530915678|FG003|Overall Study|Withdrawal by Subject|1|||
147203550|NCT01177397|530915679|FG004|Overall Study|Withdrawal by Subject|1|||
147540080|NCT03395197|532132871|FG002|Analysis for Part 1 and Part 2 Cohort 1|No longer meets eligibility ceriteria|1|||
147540081|NCT03395197|532132872|FG003|Analysis for Part 1 and Part 2 Cohort 1|No longer meets eligibility ceriteria|0|||
147540082|NCT03395197|532132873|FG004|Analysis for Part 1 and Part 2 Cohort 1|No longer meets eligibility ceriteria|0|||
147540083|NCT03395197|532132874|FG005|Analysis for Part 1 and Part 2 Cohort 1|No longer meets eligibility ceriteria|0|||
147540084|NCT03395197|532132869|FG000|Analysis for Part 1 and Part 2 Cohort 1|No longer clinically benefiting|0|||
147540085|NCT03395197|532132870|FG001|Analysis for Part 1 and Part 2 Cohort 1|No longer clinically benefiting|0|||
147540086|NCT03395197|532132871|FG002|Analysis for Part 1 and Part 2 Cohort 1|No longer clinically benefiting|14|||
147540087|NCT03395197|532132872|FG003|Analysis for Part 1 and Part 2 Cohort 1|No longer clinically benefiting|21|||
147540088|NCT03395197|532132873|FG004|Analysis for Part 1 and Part 2 Cohort 1|No longer clinically benefiting|0|||
147540089|NCT03395197|532132874|FG005|Analysis for Part 1 and Part 2 Cohort 1|No longer clinically benefiting|0|||
147540090|NCT03395197|532132869|FG000|Analysis for Part 1 and Part 2 Cohort 1|Not treated with talazoparib|0|||
147540091|NCT03395197|532132870|FG001|Analysis for Part 1 and Part 2 Cohort 1|Not treated with talazoparib|0|||
147540092|NCT03395197|532132871|FG002|Analysis for Part 1 and Part 2 Cohort 1|Not treated with talazoparib|5|||
147540093|NCT03395197|532132872|FG003|Analysis for Part 1 and Part 2 Cohort 1|Not treated with talazoparib|3|||
147540094|NCT03395197|532132873|FG004|Analysis for Part 1 and Part 2 Cohort 1|Not treated with talazoparib|0|||
147540095|NCT03395197|532132874|FG005|Analysis for Part 1 and Part 2 Cohort 1|Not treated with talazoparib|0|||
147540096|NCT03395197|532132869|FG000|Analysis for Part 1 and Part 2 Cohort 1|Adverse Event|9|||
147540097|NCT03395197|532132870|FG001|Analysis for Part 1 and Part 2 Cohort 1|Adverse Event|3|||
147540098|NCT03395197|532132871|FG002|Analysis for Part 1 and Part 2 Cohort 1|Adverse Event|69|||
147540099|NCT03395197|532132872|FG003|Analysis for Part 1 and Part 2 Cohort 1|Adverse Event|43|||
147540100|NCT03395197|532132873|FG004|Analysis for Part 1 and Part 2 Cohort 1|Adverse Event|0|||
147540101|NCT03395197|532132874|FG005|Analysis for Part 1 and Part 2 Cohort 1|Adverse Event|0|||
147540102|NCT03395197|532132869|FG000|Analysis for Part 1 and Part 2 Cohort 1|Progressive Disease|1|||
147540103|NCT03395197|532132870|FG001|Analysis for Part 1 and Part 2 Cohort 1|Progressive Disease|1|||
147540104|NCT03395197|532132871|FG002|Analysis for Part 1 and Part 2 Cohort 1|Progressive Disease|76|||
147540105|NCT03395197|532132872|FG003|Analysis for Part 1 and Part 2 Cohort 1|Progressive Disease|124|||
147540106|NCT03395197|532132873|FG004|Analysis for Part 1 and Part 2 Cohort 1|Progressive Disease|0|||
147540107|NCT03395197|532132874|FG005|Analysis for Part 1 and Part 2 Cohort 1|Progressive Disease|0|||
147540108|NCT03395197|532132869|FG000|Analysis for Part 1 and Part 2 Cohort 1|Withdrawal by Subject|0|||
147540109|NCT03395197|532132870|FG001|Analysis for Part 1 and Part 2 Cohort 1|Withdrawal by Subject|1|||
147540110|NCT03395197|532132871|FG002|Analysis for Part 1 and Part 2 Cohort 1|Withdrawal by Subject|29|||
147540111|NCT03395197|532132872|FG003|Analysis for Part 1 and Part 2 Cohort 1|Withdrawal by Subject|30|||
147540112|NCT03395197|532132873|FG004|Analysis for Part 1 and Part 2 Cohort 1|Withdrawal by Subject|0|||
147540113|NCT03395197|532132874|FG005|Analysis for Part 1 and Part 2 Cohort 1|Withdrawal by Subject|0|||
147540114|NCT03395197|532132869|FG000|Analysis for Part 1 and Part 2 Cohort 1|Global Deterioration Of Health Status|1|||
147540115|NCT03395197|532132870|FG001|Analysis for Part 1 and Part 2 Cohort 1|Global Deterioration Of Health Status|0|||
147540116|NCT03395197|532132871|FG002|Analysis for Part 1 and Part 2 Cohort 1|Global Deterioration Of Health Status|44|||
147540117|NCT03395197|532132872|FG003|Analysis for Part 1 and Part 2 Cohort 1|Global Deterioration Of Health Status|46|||
147540118|NCT03395197|532132873|FG004|Analysis for Part 1 and Part 2 Cohort 1|Global Deterioration Of Health Status|0|||
147540119|NCT03395197|532132874|FG005|Analysis for Part 1 and Part 2 Cohort 1|Global Deterioration Of Health Status|0|||
147540120|NCT03395197|532132869|FG000|Analysis for Part 1 and Part 2 Cohort 1|Other|1|||
147540121|NCT03395197|532132870|FG001|Analysis for Part 1 and Part 2 Cohort 1|Other|1|||
147540122|NCT03395197|532132871|FG002|Analysis for Part 1 and Part 2 Cohort 1|Other|4|||
147540123|NCT03395197|532132872|FG003|Analysis for Part 1 and Part 2 Cohort 1|Other|5|||
147540124|NCT03395197|532132873|FG004|Analysis for Part 1 and Part 2 Cohort 1|Other|0|||
147540125|NCT03395197|532132874|FG005|Analysis for Part 1 and Part 2 Cohort 1|Other|0|||
147540126|NCT03395197|532132869|FG000|Analysis for Part 1 and Part 2 Cohort 1|Ongoing|1|||
147540127|NCT03395197|532132870|FG001|Analysis for Part 1 and Part 2 Cohort 1|Ongoing|0|||
147540128|NCT03395197|532132871|FG002|Analysis for Part 1 and Part 2 Cohort 1|Ongoing|152|||
147540129|NCT03395197|532132872|FG003|Analysis for Part 1 and Part 2 Cohort 1|Ongoing|120|||
147540130|NCT03395197|532132873|FG004|Analysis for Part 1 and Part 2 Cohort 1|Ongoing|0|||
147540131|NCT03395197|532132874|FG005|Analysis for Part 1 and Part 2 Cohort 1|Ongoing|0|||
147540132|NCT03395197|532132869|FG000|Analysis for DDR-Deficient Participants|Death|0|||
147540133|NCT03395197|532132870|FG001|Analysis for DDR-Deficient Participants|Death|0|||
147540134|NCT03395197|532132871|FG002|Analysis for DDR-Deficient Participants|Death|0|||
147540135|NCT03395197|532132872|FG003|Analysis for DDR-Deficient Participants|Death|0|||
147203551|NCT01177397|530915680|FG005|Overall Study|Withdrawal by Subject|2|||
147203552|NCT01177397|530915681|FG006|Overall Study|Withdrawal by Subject|0|||
147203553|NCT01177397|530915682|FG007|Overall Study|Withdrawal by Subject|5|||
147203554|NCT01177397|530915683|FG008|Overall Study|Withdrawal by Subject|9|||
147203555|NCT01177397|530915684|FG009|Overall Study|Withdrawal by Subject|1|||
147203556|NCT01177397|530915685|FG010|Overall Study|Withdrawal by Subject|1|||
147203557|NCT01177397|530915686|FG011|Overall Study|Withdrawal by Subject|0|||
147203558|NCT01177397|530915675|FG000|Overall Study|Adverse Event|0|||
147203559|NCT01177397|530915676|FG001|Overall Study|Adverse Event|0|||
147203560|NCT01177397|530915677|FG002|Overall Study|Adverse Event|1|||
147203561|NCT01177397|530915678|FG003|Overall Study|Adverse Event|2|||
147203562|NCT01177397|530915679|FG004|Overall Study|Adverse Event|0|||
147203563|NCT01177397|530915680|FG005|Overall Study|Adverse Event|12|||
147203564|NCT01177397|530915681|FG006|Overall Study|Adverse Event|1|||
147203565|NCT01177397|530915682|FG007|Overall Study|Adverse Event|14|||
147203566|NCT01177397|530915683|FG008|Overall Study|Adverse Event|8|||
147203567|NCT01177397|530915684|FG009|Overall Study|Adverse Event|6|||
147203568|NCT01177397|530915685|FG010|Overall Study|Adverse Event|3|||
147203569|NCT01177397|530915686|FG011|Overall Study|Adverse Event|7|||
147203570|NCT01177397|530915675|FG000|Overall Study|Disease progression|1|||
147203571|NCT01177397|530915676|FG001|Overall Study|Disease progression|2|||
147203572|NCT01177397|530915677|FG002|Overall Study|Disease progression|5|||
147203573|NCT01177397|530915678|FG003|Overall Study|Disease progression|5|||
147203574|NCT01177397|530915679|FG004|Overall Study|Disease progression|4|||
147203575|NCT01177397|530915680|FG005|Overall Study|Disease progression|10|||
147203576|NCT01177397|530915681|FG006|Overall Study|Disease progression|10|||
147203577|NCT01177397|530915682|FG007|Overall Study|Disease progression|21|||
147203578|NCT01177397|530915683|FG008|Overall Study|Disease progression|18|||
147203579|NCT01177397|530915684|FG009|Overall Study|Disease progression|12|||
147203580|NCT01177397|530915685|FG010|Overall Study|Disease progression|10|||
147203581|NCT01177397|530915686|FG011|Overall Study|Disease progression|8|||
147203582|NCT01177397|530915675|FG000|Overall Study|Other reasons|0|||
147203583|NCT01177397|530915676|FG001|Overall Study|Other reasons|0|||
147203584|NCT01177397|530915677|FG002|Overall Study|Other reasons|1|||
147203585|NCT01177397|530915678|FG003|Overall Study|Other reasons|0|||
147203586|NCT01177397|530915679|FG004|Overall Study|Other reasons|1|||
147203587|NCT01177397|530915680|FG005|Overall Study|Other reasons|1|||
147203588|NCT01177397|530915681|FG006|Overall Study|Other reasons|2|||
147203589|NCT01177397|530915682|FG007|Overall Study|Other reasons|6|||
147203590|NCT01177397|530915683|FG008|Overall Study|Other reasons|10|||
147203591|NCT01177397|530915684|FG009|Overall Study|Other reasons|8|||
147203592|NCT01177397|530915685|FG010|Overall Study|Other reasons|0|||
147203593|NCT01177397|530915686|FG011|Overall Study|Other reasons|2|||
147203594|NCT04555616|530915687|FG000|Overall Study|Death|1|||
147203595|NCT04555616|530915688|FG001|Overall Study|Death|0|||
147203596|NCT04555616|530915689|FG002|Overall Study|Death|1|||
147203597|NCT04555616|530915687|FG000|Overall Study|Withdrawal by Subject|2|||
147203598|NCT04555616|530915688|FG001|Overall Study|Withdrawal by Subject|1|||
147203599|NCT04555616|530915689|FG002|Overall Study|Withdrawal by Subject|0|||
147203600|NCT01106690|530915695|FG000|Core Period: Baseline to Week 26|Adverse Event|6|||
147203601|NCT01106690|530915696|FG001|Core Period: Baseline to Week 26|Adverse Event|1|||
147203602|NCT01106690|530915697|FG002|Core Period: Baseline to Week 26|Adverse Event|4|||
147203603|NCT01106690|530915695|FG000|Core Period: Baseline to Week 26|Lost to Follow-up|1|||
147203604|NCT01106690|530915696|FG001|Core Period: Baseline to Week 26|Lost to Follow-up|1|||
147203605|NCT01106690|530915697|FG002|Core Period: Baseline to Week 26|Lost to Follow-up|2|||
147203606|NCT01106690|530915695|FG000|Core Period: Baseline to Week 26|Protocol Violation|1|||
147438771|NCT01994382|531772155|FG008|Overall Study|Progressive disease|2|||
147438772|NCT01994382|531772156|FG009|Overall Study|Progressive disease|2|||
147438773|NCT01994382|531772157|FG010|Overall Study|Progressive disease|13|||
147438774|NCT01994382|531772158|FG011|Overall Study|Progressive disease|8|||
147438775|NCT01994382|531772159|FG012|Overall Study|Progressive disease|7|||
147438776|NCT01994382|531772160|FG013|Overall Study|Progressive disease|3|||
147438777|NCT01994382|531772161|FG014|Overall Study|Progressive disease|6|||
147438778|NCT01994382|531772162|FG015|Overall Study|Progressive disease|44|||
147438779|NCT01994382|531772163|FG016|Overall Study|Progressive disease|28|||
147438780|NCT01994382|531772147|FG000|Overall Study|Physician Decision|0|||
147203607|NCT01106690|530915696|FG001|Core Period: Baseline to Week 26|Protocol Violation|0|||
147203608|NCT01106690|530915697|FG002|Core Period: Baseline to Week 26|Protocol Violation|0|||
147203609|NCT01106690|530915695|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|4|||
147203610|NCT01106690|530915696|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|1|||
147203611|NCT01106690|530915697|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|0|||
147203612|NCT01106690|530915695|FG000|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|0|||
147203613|NCT01106690|530915696|FG001|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|3|||
147203614|NCT01106690|530915697|FG002|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|1|||
147203615|NCT01106690|530915695|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
147203616|NCT01106690|530915696|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|1|||
147203617|NCT01106690|530915697|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
147203618|NCT01106690|530915695|FG000|Core Period: Baseline to Week 26|Unable to take rescue therapy|1|||
147438781|NCT01994382|531772148|FG001|Overall Study|Physician Decision|1|||
147540136|NCT03395197|532132873|FG004|Analysis for DDR-Deficient Participants|Death|1|||
147540137|NCT03395197|532132874|FG005|Analysis for DDR-Deficient Participants|Death|4|||
147540138|NCT03395197|532132869|FG000|Analysis for DDR-Deficient Participants|No longer clinically benefiting|0|||
147540139|NCT03395197|532132870|FG001|Analysis for DDR-Deficient Participants|No longer clinically benefiting|0|||
147540140|NCT03395197|532132871|FG002|Analysis for DDR-Deficient Participants|No longer clinically benefiting|0|||
147540141|NCT03395197|532132872|FG003|Analysis for DDR-Deficient Participants|No longer clinically benefiting|0|||
147540142|NCT03395197|532132873|FG004|Analysis for DDR-Deficient Participants|No longer clinically benefiting|5|||
147540143|NCT03395197|532132874|FG005|Analysis for DDR-Deficient Participants|No longer clinically benefiting|8|||
147203619|NCT01106690|530915696|FG001|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
147203620|NCT01106690|530915697|FG002|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
147203621|NCT01106690|530915695|FG000|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|1|||
147540144|NCT03395197|532132869|FG000|Analysis for DDR-Deficient Participants|Not treated with talazoparib|0|||
147540145|NCT03395197|532132870|FG001|Analysis for DDR-Deficient Participants|Not treated with talazoparib|0|||
147540146|NCT03395197|532132871|FG002|Analysis for DDR-Deficient Participants|Not treated with talazoparib|0|||
147540147|NCT03395197|532132872|FG003|Analysis for DDR-Deficient Participants|Not treated with talazoparib|0|||
147540148|NCT03395197|532132873|FG004|Analysis for DDR-Deficient Participants|Not treated with talazoparib|3|||
147540149|NCT03395197|532132874|FG005|Analysis for DDR-Deficient Participants|Not treated with talazoparib|0|||
147540150|NCT03395197|532132869|FG000|Analysis for DDR-Deficient Participants|Adverse Event|0|||
147540151|NCT03395197|532132870|FG001|Analysis for DDR-Deficient Participants|Adverse Event|0|||
147540152|NCT03395197|532132871|FG002|Analysis for DDR-Deficient Participants|Adverse Event|0|||
147540153|NCT03395197|532132872|FG003|Analysis for DDR-Deficient Participants|Adverse Event|0|||
147540154|NCT03395197|532132873|FG004|Analysis for DDR-Deficient Participants|Adverse Event|19|||
147540155|NCT03395197|532132874|FG005|Analysis for DDR-Deficient Participants|Adverse Event|11|||
147540156|NCT03395197|532132869|FG000|Analysis for DDR-Deficient Participants|Progressive Disease|0|||
147540157|NCT03395197|532132870|FG001|Analysis for DDR-Deficient Participants|Progressive Disease|0|||
147203622|NCT01106690|530915696|FG001|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0|||
147203623|NCT01106690|530915697|FG002|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0|||
147203624|NCT01106690|530915695|FG000|Core Period: Baseline to Week 26|Other|10|||
147203625|NCT01106690|530915696|FG001|Core Period: Baseline to Week 26|Other|2|||
147203626|NCT01106690|530915697|FG002|Core Period: Baseline to Week 26|Other|6|||
147203627|NCT01106690|530915695|FG000|Extension Period: Week 26 to Week 52|Adverse Event|1|||
147203628|NCT01106690|530915696|FG001|Extension Period: Week 26 to Week 52|Adverse Event|1|||
147203629|NCT01106690|530915697|FG002|Extension Period: Week 26 to Week 52|Adverse Event|0|||
147203630|NCT01106690|530915695|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
147203631|NCT01106690|530915696|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
147203632|NCT01106690|530915697|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
147203633|NCT01106690|530915695|FG000|Extension Period: Week 26 to Week 52|Physician Decision|0|||
147203634|NCT01106690|530915696|FG001|Extension Period: Week 26 to Week 52|Physician Decision|2|||
147203635|NCT01106690|530915697|FG002|Extension Period: Week 26 to Week 52|Physician Decision|2|||
147203636|NCT01106690|530915695|FG000|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0|||
147203637|NCT01106690|530915696|FG001|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0|||
147203638|NCT01106690|530915697|FG002|Extension Period: Week 26 to Week 52|Noncompliance with study drug|1|||
147203639|NCT01106690|530915695|FG000|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1|||
147203640|NCT01106690|530915696|FG001|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1|||
147203641|NCT01106690|530915697|FG002|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
147203642|NCT01106690|530915695|FG000|Extension Period: Week 26 to Week 52|Other|8|||
147203643|NCT01106690|530915696|FG001|Extension Period: Week 26 to Week 52|Other|3|||
147203644|NCT01106690|530915697|FG002|Extension Period: Week 26 to Week 52|Other|4|||
147203645|NCT01106690|530915695|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|1|||
147203646|NCT01106690|530915696|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
147203647|NCT01106690|530915697|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
147203648|NCT00998296|530915698|FG000|Overall Study|Progressive disease|0|||
147203649|NCT00998296|530915699|FG001|Overall Study|Progressive disease|1|||
147203650|NCT00998296|530915700|FG002|Overall Study|Progressive disease|0|||
147203651|NCT00998296|530915701|FG003|Overall Study|Progressive disease|0|||
147203652|NCT00998296|530915702|FG004|Overall Study|Progressive disease|0|||
147203653|NCT00998296|530915703|FG005|Overall Study|Progressive disease|0|||
147203654|NCT00998296|530915704|FG006|Overall Study|Progressive disease|1|||
147203655|NCT00998296|530915705|FG007|Overall Study|Progressive disease|0|||
147203656|NCT00998296|530915706|FG008|Overall Study|Progressive disease|0|||
147203657|NCT00998296|530915707|FG009|Overall Study|Progressive disease|14|||
147203658|NCT00998296|530915708|FG010|Overall Study|Progressive disease|5|||
147203659|NCT00998296|530915698|FG000|Overall Study|Dose limiting or dose reducing toxicity|0|||
147203660|NCT00998296|530915699|FG001|Overall Study|Dose limiting or dose reducing toxicity|0|||
147203661|NCT00998296|530915700|FG002|Overall Study|Dose limiting or dose reducing toxicity|0|||
147203662|NCT00998296|530915701|FG003|Overall Study|Dose limiting or dose reducing toxicity|0|||
147203663|NCT00998296|530915702|FG004|Overall Study|Dose limiting or dose reducing toxicity|1|||
147203664|NCT00998296|530915703|FG005|Overall Study|Dose limiting or dose reducing toxicity|0|||
147203665|NCT00998296|530915704|FG006|Overall Study|Dose limiting or dose reducing toxicity|0|||
147203666|NCT00998296|530915705|FG007|Overall Study|Dose limiting or dose reducing toxicity|2|||
147203667|NCT00998296|530915706|FG008|Overall Study|Dose limiting or dose reducing toxicity|2|||
147203668|NCT00998296|530915707|FG009|Overall Study|Dose limiting or dose reducing toxicity|0|||
147203669|NCT00998296|530915708|FG010|Overall Study|Dose limiting or dose reducing toxicity|0|||
147203670|NCT00998296|530915698|FG000|Overall Study|Other adverse event|0|||
147203671|NCT00998296|530915699|FG001|Overall Study|Other adverse event|0|||
147203672|NCT00998296|530915700|FG002|Overall Study|Other adverse event|0|||
147203673|NCT00998296|530915701|FG003|Overall Study|Other adverse event|0|||
147203674|NCT00998296|530915702|FG004|Overall Study|Other adverse event|1|||
147203675|NCT00998296|530915703|FG005|Overall Study|Other adverse event|0|||
147203676|NCT00998296|530915704|FG006|Overall Study|Other adverse event|0|||
147203677|NCT00998296|530915705|FG007|Overall Study|Other adverse event|0|||
147203678|NCT00998296|530915706|FG008|Overall Study|Other adverse event|0|||
147203679|NCT00998296|530915707|FG009|Overall Study|Other adverse event|1|||
147203680|NCT00998296|530915708|FG010|Overall Study|Other adverse event|2|||
147203681|NCT00998296|530915698|FG000|Overall Study|Refused to continue taking trial med.|0|||
147203682|NCT00998296|530915699|FG001|Overall Study|Refused to continue taking trial med.|0|||
147203683|NCT00998296|530915700|FG002|Overall Study|Refused to continue taking trial med.|0|||
147203684|NCT00998296|530915701|FG003|Overall Study|Refused to continue taking trial med.|0|||
147203685|NCT00998296|530915702|FG004|Overall Study|Refused to continue taking trial med.|0|||
147203686|NCT00998296|530915703|FG005|Overall Study|Refused to continue taking trial med.|0|||
147203687|NCT00998296|530915704|FG006|Overall Study|Refused to continue taking trial med.|0|||
147203688|NCT00998296|530915705|FG007|Overall Study|Refused to continue taking trial med.|0|||
147203689|NCT00998296|530915706|FG008|Overall Study|Refused to continue taking trial med.|0|||
147203690|NCT00998296|530915707|FG009|Overall Study|Refused to continue taking trial med.|2|||
147203691|NCT00998296|530915708|FG010|Overall Study|Refused to continue taking trial med.|0|||
147203692|NCT00998296|530915698|FG000|Overall Study|Reason other than those specified above|0|||
147203693|NCT00998296|530915699|FG001|Overall Study|Reason other than those specified above|0|||
147203694|NCT00998296|530915700|FG002|Overall Study|Reason other than those specified above|0|||
147203695|NCT00998296|530915701|FG003|Overall Study|Reason other than those specified above|0|||
147203696|NCT00998296|530915702|FG004|Overall Study|Reason other than those specified above|0|||
147203697|NCT00998296|530915703|FG005|Overall Study|Reason other than those specified above|0|||
147203698|NCT00998296|530915704|FG006|Overall Study|Reason other than those specified above|0|||
147203699|NCT00998296|530915705|FG007|Overall Study|Reason other than those specified above|0|||
147203700|NCT00998296|530915706|FG008|Overall Study|Reason other than those specified above|0|||
147203701|NCT00998296|530915707|FG009|Overall Study|Reason other than those specified above|1|||
147203702|NCT00998296|530915708|FG010|Overall Study|Reason other than those specified above|0|||
147203703|NCT04396639|530915709|FG000|Overall Study|Withdrawal by Subject|1|||
147203704|NCT04396639|530915709|FG000|Overall Study|Other|1|||
147203705|NCT01544335|530915710|FG000|Overall Study|Lost to Follow-up|27|||
147203706|NCT01544335|530915710|FG000|Overall Study|Death|4|||
147203707|NCT01544335|530915710|FG000|Overall Study|Disease progression|3|||
147203708|NCT01544335|530915710|FG000|Overall Study|Baseline Measurements not Available|19|||
147203709|NCT03219528|530915717|FG000|Overall Study|Lost to Follow-up|5|||
147203710|NCT03219528|530915718|FG001|Overall Study|Lost to Follow-up|4|||
147203711|NCT03219528|530915717|FG000|Overall Study|Withdrawal by Subject|4|||
147203712|NCT03219528|530915718|FG001|Overall Study|Withdrawal by Subject|4|||
147203713|NCT00241839|530915719|FG000|Overall Study|Withdrawal by Subject|18|||
147203714|NCT00241839|530915720|FG001|Overall Study|Withdrawal by Subject|17|||
147203715|NCT00241839|530915719|FG000|Overall Study|Adverse Event|1|||
147203716|NCT00241839|530915720|FG001|Overall Study|Adverse Event|1|||
147203717|NCT00927953|530915723|FG000|Overall Study|Death|2|||
147540158|NCT03395197|532132871|FG002|Analysis for DDR-Deficient Participants|Progressive Disease|0|||
147540159|NCT03395197|532132872|FG003|Analysis for DDR-Deficient Participants|Progressive Disease|0|||
147540160|NCT03395197|532132873|FG004|Analysis for DDR-Deficient Participants|Progressive Disease|39|||
147540161|NCT03395197|532132874|FG005|Analysis for DDR-Deficient Participants|Progressive Disease|60|||
147540162|NCT03395197|532132869|FG000|Analysis for DDR-Deficient Participants|Withdrawal by Subject|0|||
147540163|NCT03395197|532132870|FG001|Analysis for DDR-Deficient Participants|Withdrawal by Subject|0|||
147203718|NCT00927953|530915724|FG001|Overall Study|Death|1|||
147203719|NCT00196313|530915727|FG000|Overall Study|Protocol Violation|2|||
147203720|NCT00196313|530915728|FG001|Overall Study|Protocol Violation|3|||
147540164|NCT03395197|532132871|FG002|Analysis for DDR-Deficient Participants|Withdrawal by Subject|0|||
147203721|NCT00196313|530915727|FG000|Overall Study|Withdrawal by Subject|3|||
147203722|NCT00196313|530915728|FG001|Overall Study|Withdrawal by Subject|1|||
147203723|NCT00196313|530915727|FG000|Overall Study|Adverse Event|3|||
147203724|NCT00196313|530915728|FG001|Overall Study|Adverse Event|1|||
147649429|NCT02634801|532537343|FG002|Extension Period (Weeks 24 to 36)|Adverse Event|1|||
147540165|NCT03395197|532132872|FG003|Analysis for DDR-Deficient Participants|Withdrawal by Subject|0|||
147540166|NCT03395197|532132873|FG004|Analysis for DDR-Deficient Participants|Withdrawal by Subject|11|||
147540167|NCT03395197|532132874|FG005|Analysis for DDR-Deficient Participants|Withdrawal by Subject|13|||
147540168|NCT03395197|532132869|FG000|Analysis for DDR-Deficient Participants|Global Deterioration Of Health Status|0|||
147540169|NCT03395197|532132870|FG001|Analysis for DDR-Deficient Participants|Global Deterioration Of Health Status|0|||
147540170|NCT03395197|532132871|FG002|Analysis for DDR-Deficient Participants|Global Deterioration Of Health Status|0|||
147540171|NCT03395197|532132872|FG003|Analysis for DDR-Deficient Participants|Global Deterioration Of Health Status|0|||
147540172|NCT03395197|532132873|FG004|Analysis for DDR-Deficient Participants|Global Deterioration Of Health Status|24|||
147540173|NCT03395197|532132874|FG005|Analysis for DDR-Deficient Participants|Global Deterioration Of Health Status|40|||
147540174|NCT03395197|532132869|FG000|Analysis for DDR-Deficient Participants|Other|0|||
147540175|NCT03395197|532132870|FG001|Analysis for DDR-Deficient Participants|Other|0|||
147540176|NCT03395197|532132871|FG002|Analysis for DDR-Deficient Participants|Other|0|||
147540177|NCT03395197|532132872|FG003|Analysis for DDR-Deficient Participants|Other|0|||
147540178|NCT03395197|532132873|FG004|Analysis for DDR-Deficient Participants|Other|3|||
147540179|NCT03395197|532132874|FG005|Analysis for DDR-Deficient Participants|Other|3|||
147540180|NCT03395197|532132869|FG000|Analysis for DDR-Deficient Participants|Ongoing|0|||
147540181|NCT03395197|532132870|FG001|Analysis for DDR-Deficient Participants|Ongoing|0|||
147540182|NCT03395197|532132871|FG002|Analysis for DDR-Deficient Participants|Ongoing|0|||
147540183|NCT03395197|532132872|FG003|Analysis for DDR-Deficient Participants|Ongoing|0|||
147540184|NCT03395197|532132873|FG004|Analysis for DDR-Deficient Participants|Ongoing|95|||
147540185|NCT03395197|532132874|FG005|Analysis for DDR-Deficient Participants|Ongoing|60|||
147540186|NCT01988337|532132877|FG000|Overall Study|Study was terminated due to insufficient recruitment before 36 month follow up could be completed|56|||
147540187|NCT02742818|532132878|FG000|Overall Study|Adverse Event|0|||
147540188|NCT02742818|532132879|FG001|Overall Study|Adverse Event|1|||
147540189|NCT02742818|532132878|FG000|Overall Study|Protocol Violation|0|||
147540190|NCT02742818|532132879|FG001|Overall Study|Protocol Violation|1|||
147540191|NCT04701658|532132880|FG000|Overall Study|Lost to Follow-up|6|||
147540192|NCT00457418|532132881|FG000|Pharmacokinetic (PK) Sampling Phase|Adverse Event|2|||
147540193|NCT00457418|532132881|FG000|Pharmacokinetic (PK) Sampling Phase|Progression of Disease|1|||
147540194|NCT00457418|532132881|FG000|Pharmacokinetic (PK) Sampling Phase|Non-compliance with protocol|2|||
147540195|NCT00457418|532132881|FG000|Post PK Maintenance|Adverse Event|10|||
147540196|NCT00457418|532132881|FG000|Post PK Maintenance|Progression of Disease|6|||
147540197|NCT00457418|532132881|FG000|Post PK Maintenance|Withdrawal by Subject|11|||
147540198|NCT00457418|532132881|FG000|Post PK Maintenance|Lost to Follow-up|1|||
147540199|NCT01785472|532132882|FG000|Overall Study|Adverse Event|5|||
147540200|NCT01785472|532132883|FG001|Overall Study|Adverse Event|4|||
147540201|NCT01785472|532132884|FG002|Overall Study|Adverse Event|6|||
147540202|NCT01785472|532132882|FG000|Overall Study|Lack of Efficacy|2|||
147540203|NCT01785472|532132883|FG001|Overall Study|Lack of Efficacy|0|||
147540204|NCT01785472|532132884|FG002|Overall Study|Lack of Efficacy|1|||
147540205|NCT01785472|532132882|FG000|Overall Study|Lost to Follow-up|1|||
147540206|NCT01785472|532132883|FG001|Overall Study|Lost to Follow-up|2|||
147540207|NCT01785472|532132884|FG002|Overall Study|Lost to Follow-up|0|||
147540208|NCT01785472|532132882|FG000|Overall Study|Physician Decision|1|||
147540209|NCT01785472|532132883|FG001|Overall Study|Physician Decision|1|||
147540210|NCT01785472|532132884|FG002|Overall Study|Physician Decision|1|||
147540211|NCT01785472|532132882|FG000|Overall Study|Protocol deviation|0|||
147540212|NCT01785472|532132883|FG001|Overall Study|Protocol deviation|2|||
147540213|NCT01785472|532132884|FG002|Overall Study|Protocol deviation|2|||
147540214|NCT01785472|532132882|FG000|Overall Study|Subject/guardian decision|15|||
147540215|NCT01785472|532132883|FG001|Overall Study|Subject/guardian decision|10|||
147540216|NCT01785472|532132884|FG002|Overall Study|Subject/guardian decision|11|||
147540217|NCT01785472|532132882|FG000|Overall Study|Technical problems|0|||
147540218|NCT01785472|532132883|FG001|Overall Study|Technical problems|0|||
147540219|NCT01785472|532132884|FG002|Overall Study|Technical problems|1|||
147540220|NCT03099161|532132887|FG000|Overall Study|Adverse Event|0|||
147540221|NCT03099161|532132888|FG001|Overall Study|Adverse Event|0|||
147540222|NCT03099161|532132889|FG002|Overall Study|Adverse Event|2|||
147540223|NCT03099161|532132887|FG000|Overall Study|Physician Decision|2|||
147540224|NCT03099161|532132888|FG001|Overall Study|Physician Decision|0|||
147540225|NCT03099161|532132889|FG002|Overall Study|Physician Decision|0|||
147540226|NCT03099161|532132887|FG000|Overall Study|Progressive Disease|1|||
147540227|NCT03099161|532132888|FG001|Overall Study|Progressive Disease|4|||
147540228|NCT03099161|532132889|FG002|Overall Study|Progressive Disease|1|||
147540229|NCT00110084|532132890|FG000|Overall Study|Adverse Event|9|||
147540230|NCT00110084|532132890|FG000|Overall Study|Death|1|||
147540231|NCT00110084|532132890|FG000|Overall Study|Patient Refusal|10|||
147540232|NCT00110084|532132890|FG000|Overall Study|Alternate Therapy|5|||
147540233|NCT00110084|532132890|FG000|Overall Study|Intercurrent Illness|1|||
147540234|NCT00110084|532132890|FG000|Overall Study|Other|2|||
147540235|NCT04854707|532132892|FG000|Overall Study|Lack of Efficacy|78|||
147540236|NCT04854707|532132893|FG001|Overall Study|Lack of Efficacy|59|||
147540237|NCT04854707|532132894|FG002|Overall Study|Lack of Efficacy|30|||
147203725|NCT00196313|530915727|FG000|Overall Study|Subject Pregnant|1|||
147203726|NCT00196313|530915728|FG001|Overall Study|Subject Pregnant|1|||
147203727|NCT00196313|530915727|FG000|Overall Study|Lost to Follow-up|2|||
147203728|NCT00196313|530915728|FG001|Overall Study|Lost to Follow-up|2|||
147540238|NCT01346501|532132899|FG000|Overall Study|Initiated Other Biological Agents|3|||
147540239|NCT01346501|532132900|FG001|Overall Study|Initiated Other Biological Agents|1|||
147540240|NCT01346501|532132899|FG000|Overall Study|Other|8|||
147540241|NCT01346501|532132900|FG001|Overall Study|Other|12|||
147540242|NCT04101721|532132901|FG000|Overall Study|Withdrawal By Parent/Guardian|1|||
147540243|NCT04101721|532132902|FG001|Overall Study|Withdrawal By Parent/Guardian|2|||
147540244|NCT04101721|532132901|FG000|Overall Study|Death|0|||
147540245|NCT04101721|532132902|FG001|Overall Study|Death|1|||
147540246|NCT04101721|532132901|FG000|Overall Study|Lost to Follow-up|0|||
147540247|NCT04101721|532132902|FG001|Overall Study|Lost to Follow-up|3|||
147540248|NCT02564952|532132905|FG000|Overall Study|Adverse Event|6|||
147540249|NCT02564952|532132905|FG000|Overall Study|Lost to Follow-up|1|||
147540250|NCT02564952|532132905|FG000|Overall Study|Participant Withdrawn by Investigator|1|||
147540251|NCT02564952|532132905|FG000|Overall Study|Withdrawal by Subject|1|||
147540252|NCT02564952|532132905|FG000|Overall Study|Low Efficacy|1|||
147540253|NCT02564952|532132905|FG000|Overall Study|Participant Met Withdrawal Criteria|1|||
147540254|NCT00756652|532132906|FG000|Original Phase|Withdrawal by Subject|864|||
147540255|NCT00756652|532132907|FG001|Original Phase|Withdrawal by Subject|23|||
147540256|NCT00756652|532132906|FG000|Original Phase|Lost to Follow-up|601|||
147540257|NCT00756652|532132907|FG001|Original Phase|Lost to Follow-up|0|||
147540258|NCT00756652|532132906|FG000|Original Phase|Other Discontinuation|797|||
147540259|NCT00756652|532132907|FG001|Original Phase|Other Discontinuation|5|||
147540260|NCT00756652|532132906|FG000|Original Phase|Participant Noncompliance|18622|||
147540261|NCT00756652|532132907|FG001|Original Phase|Participant Noncompliance|424|||
147540262|NCT00756652|532132906|FG000|Original Phase|Unknown Discontinuation Reason|2|||
147540263|NCT00756652|532132907|FG001|Original Phase|Unknown Discontinuation Reason|0|||
147540264|NCT00756652|532132906|FG000|Original Phase|Participants without data|3259|||
147540265|NCT00756652|532132907|FG001|Original Phase|Participants without data|466|||
147540266|NCT00756652|532132906|FG000|Original Phase|Death|168|||
147540267|NCT00756652|532132907|FG001|Original Phase|Death|1|||
147540268|NCT00756652|532132906|FG000|Original Phase|Not due for F/U at Phase One closure|11076|||
147540269|NCT00756652|532132907|FG001|Original Phase|Not due for F/U at Phase One closure|2|||
147540270|NCT00756652|532132906|FG000|Re-Op Phase|Withdrawal by Subject|62|||
147540271|NCT00756652|532132907|FG001|Re-Op Phase|Withdrawal by Subject|0|||
147540272|NCT00756652|532132906|FG000|Re-Op Phase|Death|6|||
147540273|NCT00756652|532132907|FG001|Re-Op Phase|Death|0|||
147540274|NCT00756652|532132906|FG000|Re-Op Phase|Lost to Follow-up|340|||
147540275|NCT00756652|532132907|FG001|Re-Op Phase|Lost to Follow-up|0|||
147540276|NCT00756652|532132906|FG000|Re-Op Phase|Site Closed|2454|||
147540277|NCT00756652|532132907|FG001|Re-Op Phase|Site Closed|0|||
147540278|NCT00756652|532132906|FG000|Re-Op Phase|Withdrawn after explant|14|||
147540279|NCT00756652|532132907|FG001|Re-Op Phase|Withdrawn after explant|0|||
147540280|NCT01215955|532132912|FG000|Overall Study|Adverse Event|1|||
147540281|NCT01215955|532132913|FG001|Overall Study|Adverse Event|4|||
147540282|NCT01215955|532132914|FG002|Overall Study|Adverse Event|2|||
147540283|NCT01215955|532132915|FG003|Overall Study|Adverse Event|3|||
147540284|NCT01215955|532132912|FG000|Overall Study|Death|2|||
147540285|NCT01215955|532132913|FG001|Overall Study|Death|0|||
147540286|NCT01215955|532132914|FG002|Overall Study|Death|1|||
147540287|NCT01215955|532132915|FG003|Overall Study|Death|3|||
147540288|NCT01215955|532132912|FG000|Overall Study|Entry Criteria Not Met|1|||
147540289|NCT01215955|532132913|FG001|Overall Study|Entry Criteria Not Met|3|||
147540290|NCT01215955|532132914|FG002|Overall Study|Entry Criteria Not Met|4|||
147540291|NCT01215955|532132915|FG003|Overall Study|Entry Criteria Not Met|7|||
147540292|NCT01215955|532132912|FG000|Overall Study|Lack of Efficacy|1|||
147540293|NCT01215955|532132913|FG001|Overall Study|Lack of Efficacy|2|||
147540294|NCT01215955|532132914|FG002|Overall Study|Lack of Efficacy|1|||
147540295|NCT01215955|532132915|FG003|Overall Study|Lack of Efficacy|0|||
147203729|NCT00043979|530915729|FG000|Period 1|recipient with progressive disease|7|||
147203730|NCT00043979|530915730|FG001|Period 1|recipient with progressive disease|4|||
147540296|NCT01215955|532132912|FG000|Overall Study|Lost to Follow-up|4|||
147540297|NCT01215955|532132913|FG001|Overall Study|Lost to Follow-up|4|||
147540298|NCT01215955|532132914|FG002|Overall Study|Lost to Follow-up|8|||
147540299|NCT01215955|532132915|FG003|Overall Study|Lost to Follow-up|9|||
147540300|NCT01215955|532132912|FG000|Overall Study|Physician Decision|4|||
147540301|NCT01215955|532132913|FG001|Overall Study|Physician Decision|10|||
147540302|NCT01215955|532132914|FG002|Overall Study|Physician Decision|8|||
147540303|NCT01215955|532132915|FG003|Overall Study|Physician Decision|11|||
147203731|NCT00043979|530915731|FG002|Period 1|recipient with progressive disease|3|||
147540304|NCT01215955|532132912|FG000|Overall Study|Protocol Violation|17|||
147540305|NCT01215955|532132913|FG001|Overall Study|Protocol Violation|13|||
147540306|NCT01215955|532132914|FG002|Overall Study|Protocol Violation|8|||
147540307|NCT01215955|532132915|FG003|Overall Study|Protocol Violation|8|||
147540308|NCT01215955|532132912|FG000|Overall Study|Sponsor Decision|1|||
147540309|NCT01215955|532132913|FG001|Overall Study|Sponsor Decision|2|||
147540310|NCT01215955|532132914|FG002|Overall Study|Sponsor Decision|0|||
147540311|NCT01215955|532132915|FG003|Overall Study|Sponsor Decision|1|||
147540312|NCT01215955|532132912|FG000|Overall Study|Withdrawal by Subject|14|||
147540313|NCT01215955|532132913|FG001|Overall Study|Withdrawal by Subject|15|||
147540314|NCT01215955|532132914|FG002|Overall Study|Withdrawal by Subject|13|||
147540315|NCT01215955|532132915|FG003|Overall Study|Withdrawal by Subject|9|||
147540316|NCT01215955|532132912|FG000|Overall Study|Quality Issues|0|||
147540317|NCT01215955|532132913|FG001|Overall Study|Quality Issues|0|||
147540318|NCT01215955|532132914|FG002|Overall Study|Quality Issues|3|||
147540319|NCT01215955|532132915|FG003|Overall Study|Quality Issues|2|||
147540320|NCT00038467|532132916|FG000|Overall Study|Adverse Event|170|||
147540321|NCT00038467|532132917|FG001|Overall Study|Adverse Event|145|||
147540322|NCT00038467|532132916|FG000|Overall Study|Withdrawal by Subject|150|||
147540323|NCT00038467|532132917|FG001|Overall Study|Withdrawal by Subject|107|||
147540324|NCT00038467|532132916|FG000|Overall Study|Protocol Violation|19|||
147540325|NCT00038467|532132917|FG001|Overall Study|Protocol Violation|22|||
147540326|NCT00038467|532132916|FG000|Overall Study|Death|22|||
147540327|NCT00038467|532132917|FG001|Overall Study|Death|16|||
147540328|NCT00038467|532132916|FG000|Overall Study|Lost to Follow-up|15|||
147540329|NCT00038467|532132917|FG001|Overall Study|Lost to Follow-up|10|||
147540330|NCT00038467|532132916|FG000|Overall Study|Recurrence|109|||
147540331|NCT00038467|532132917|FG001|Overall Study|Recurrence|179|||
147540332|NCT00038467|532132916|FG000|Overall Study|Randomized, but not treated|31|||
147540333|NCT00038467|532132917|FG001|Overall Study|Randomized, but not treated|35|||
147540334|NCT00038467|532132916|FG000|Overall Study|Other|26|||
147540335|NCT00038467|532132917|FG001|Overall Study|Other|28|||
147540336|NCT04088734|532132918|FG000|Overall Study|Other, Not Specified|5|||
147540337|NCT00096200|532132919|FG000|Overall Study|Adverse Event|0|||
147540338|NCT00096200|532132920|FG001|Overall Study|Adverse Event|4|||
147540339|NCT00096200|532132921|FG002|Overall Study|Adverse Event|0|||
147540340|NCT00096200|532132919|FG000|Overall Study|Withdrawal by Subject|1|||
147540341|NCT00096200|532132920|FG001|Overall Study|Withdrawal by Subject|2|||
147540342|NCT00096200|532132921|FG002|Overall Study|Withdrawal by Subject|0|||
147540343|NCT00096200|532132919|FG000|Overall Study|Ineligible pathology|0|||
147540344|NCT00096200|532132920|FG001|Overall Study|Ineligible pathology|1|||
147540345|NCT00096200|532132921|FG002|Overall Study|Ineligible pathology|0|||
147540346|NCT00835068|532132922|FG000|Overall Study|Death|1|||
147540347|NCT00835068|532132923|FG001|Overall Study|Death|0|||
147540348|NCT00835068|532132922|FG000|Overall Study|Adverse Event|0|||
147540349|NCT00835068|532132923|FG001|Overall Study|Adverse Event|1|||
147540350|NCT00835068|532132922|FG000|Overall Study|Other|8|||
147540351|NCT00835068|532132923|FG001|Overall Study|Other|0|||
147540352|NCT00835068|532132922|FG000|Overall Study|Withdrawal by Subject|1|||
147540353|NCT00835068|532132923|FG001|Overall Study|Withdrawal by Subject|0|||
147540354|NCT05264506|532132926|FG000|Overall Study|Adverse Event|59|||
147540355|NCT05264506|532132926|FG000|Overall Study|Lost to Follow-up|204|||
147540356|NCT05264506|532132926|FG000|Overall Study|Protocol Violation|185|||
147540357|NCT05264506|532132926|FG000|Overall Study|Pregnancy|60|||
147540358|NCT05264506|532132926|FG000|Overall Study|Physician Decision|6|||
147540359|NCT05264506|532132926|FG000|Overall Study|Non-compliance with Study Drug|29|||
147540360|NCT05264506|532132926|FG000|Overall Study|Study termination|677|||
147540361|NCT05264506|532132926|FG000|Overall Study|Withdrawal by Subject|208|||
147540362|NCT05264506|532132926|FG000|Overall Study|Discontinued prior treatment|89|||
147540363|NCT02032823|532132928|FG000|Overall Study|Death|75|||
147540364|NCT02032823|532132929|FG001|Overall Study|Death|109|||
147540365|NCT02032823|532132928|FG000|Overall Study|Lost to Follow-up|18|||
147540366|NCT02032823|532132929|FG001|Overall Study|Lost to Follow-up|17|||
147540367|NCT02032823|532132928|FG000|Overall Study|Withdrawal by Subject|70|||
147540368|NCT02032823|532132929|FG001|Overall Study|Withdrawal by Subject|53|||
147203732|NCT00297258|530915742|FG000|Overall Study|Disease Progression, Relapse, Death|120|||
147203733|NCT00297258|530915742|FG000|Overall Study|Toxicity (or Toxic Death)|10|||
147203734|NCT00297258|530915742|FG000|Overall Study|Patient Refusal: Not Related to Toxicity|2|||
147203735|NCT00297258|530915742|FG000|Overall Study|Intercurrent Illness|3|||
147203736|NCT00297258|530915742|FG000|Overall Study|Intercurrent Death|2|||
147540369|NCT02032823|532132928|FG000|Overall Study|Ongoing study at data cut-off|755|||
147540370|NCT02032823|532132929|FG001|Overall Study|Ongoing study at data cut-off|731|||
147540371|NCT02032823|532132928|FG000|Overall Study|Other (e.g investigators decision, protocol deviation, randomised by mistake)|3|||
147540372|NCT02032823|532132929|FG001|Overall Study|Other (e.g investigators decision, protocol deviation, randomised by mistake)|5|||
147540373|NCT02949219|532132931|FG000|Overall Study|Withdrawal by Subject|1|||
147540374|NCT01283282|532132932|FG000|First Intervention (6 Weeks)|Physician Decision|0|||
147540375|NCT01283282|532132933|FG001|First Intervention (6 Weeks)|Physician Decision|1|||
147540376|NCT01283282|532132932|FG000|First Intervention (6 Weeks)|Withdrawal by Subject|2|||
147540377|NCT01283282|532132933|FG001|First Intervention (6 Weeks)|Withdrawal by Subject|3|||
147540378|NCT01283282|532132932|FG000|First Intervention (6 Weeks)|Lost to Follow-up|1|||
147540379|NCT01283282|532132933|FG001|First Intervention (6 Weeks)|Lost to Follow-up|0|||
147540380|NCT00096031|532132934|FG000|Overall Study|Adverse Event|3|||
147540381|NCT00096031|532132934|FG000|Overall Study|Lack of Efficacy|42|||
147203737|NCT00297258|530915742|FG000|Overall Study|Deteriorization of General Condition|1|||
147203738|NCT00297258|530915742|FG000|Overall Study|Radiotherapy to Destroy Last Lesion|1|||
147203739|NCT00297258|530915742|FG000|Overall Study|Surgery Performed on Target Lesion|1|||
147203740|NCT00297258|530915742|FG000|Overall Study|Switch to Commercial Treatment|1|||
147203741|NCT00297258|530915742|FG000|Overall Study|Interruption: Cold/Flu-like Symptoms|1|||
147203742|NCT01470326|530915743|FG000|Overall Study|Protocol Violation|32|||
147203743|NCT01470326|530915743|FG000|Overall Study|No Drug Administration Information|2|||
147203744|NCT01470326|530915743|FG000|Overall Study|No Visit After 1st Day of Treatment|119|||
147203745|NCT03967444|530915744|FG000|Overall Study|Lost to Follow-up|1|||
147203746|NCT03967444|530915745|FG001|Overall Study|Lost to Follow-up|2|||
147203747|NCT01519921|530915751|FG000|Overall Study|Adverse Event|10|||
147203748|NCT01519921|530915752|FG001|Overall Study|Adverse Event|9|||
147203749|NCT01519921|530915751|FG000|Overall Study|Lack of Efficacy|4|||
147203750|NCT01519921|530915752|FG001|Overall Study|Lack of Efficacy|3|||
147203751|NCT01519921|530915751|FG000|Overall Study|Withdrawal by Subject|3|||
147203752|NCT01519921|530915752|FG001|Overall Study|Withdrawal by Subject|0|||
147203753|NCT01519921|530915751|FG000|Overall Study|Lost to Follow-up|2|||
147203754|NCT01519921|530915752|FG001|Overall Study|Lost to Follow-up|1|||
147203755|NCT01519921|530915751|FG000|Overall Study|Treatment refusal|2|||
147203756|NCT01519921|530915752|FG001|Overall Study|Treatment refusal|1|||
147203757|NCT01519921|530915751|FG000|Overall Study|High alanine aminotransferase (ALT)|0|||
147203758|NCT01519921|530915752|FG001|Overall Study|High alanine aminotransferase (ALT)|1|||
147203759|NCT01216189|530915754|FG000|Overall Study|Lost to Follow-up|21|||
147203760|NCT01216189|530915755|FG001|Overall Study|Lost to Follow-up|3|||
147203761|NCT01216189|530915754|FG000|Overall Study|Death|4|||
147203762|NCT01216189|530915755|FG001|Overall Study|Death|2|||
147203763|NCT00541385|530915756|FG000|Overall Study|Adverse Event|6|||
147203764|NCT00541385|530915757|FG001|Overall Study|Adverse Event|3|||
147203765|NCT00541385|530915756|FG000|Overall Study|Withdrawal by Subject|2|||
147203766|NCT00541385|530915757|FG001|Overall Study|Withdrawal by Subject|2|||
147203767|NCT00541385|530915756|FG000|Overall Study|Lost to Follow-up|6|||
147203768|NCT00541385|530915757|FG001|Overall Study|Lost to Follow-up|1|||
147203769|NCT00541385|530915756|FG000|Overall Study|Parasite reappearance/malaria|67|||
147203770|NCT00541385|530915757|FG001|Overall Study|Parasite reappearance/malaria|32|||
147203771|NCT01733680|530915758|FG000|Overall Study|Withdrawal by Subject|0|||
147203772|NCT01733680|530915759|FG001|Overall Study|Withdrawal by Subject|1|||
147203773|NCT04269889|530915761|FG000|Initial Phase (Day 0 to Month 6)|Lack of Efficacy|14|||
147203774|NCT03155841|530915762|FG000|Overall Study|Protocol Violation|3|||
147203775|NCT03155841|530915763|FG001|Overall Study|Protocol Violation|4|||
147203776|NCT01526733|530915764|FG000|Phase 1|Protocol Violation|1|||
147203777|NCT01526733|530915765|FG001|Phase 1|Protocol Violation|0|||
147203778|NCT01526733|530915764|FG000|Phase 1|Withdrawal by Subject|1|||
147203779|NCT01526733|530915765|FG001|Phase 1|Withdrawal by Subject|1|||
147203780|NCT00949702|530915771|FG000|Overall Study|Death|40|||
147203781|NCT00949702|530915771|FG000|Overall Study|Disease progression|7|||
147203782|NCT00949702|530915771|FG000|Overall Study|Withdrawal of consent|1|||
147540382|NCT00096031|532132934|FG000|Overall Study|Death|4|||
147540383|NCT00096031|532132934|FG000|Overall Study|Withdrawal by Subject|1|||
147540384|NCT00096031|532132934|FG000|Overall Study|Ineligible|8|||
147540385|NCT00096031|532132934|FG000|Overall Study|Not protocol specified|5|||
147540386|NCT00083226|532132935|FG000|Overall Study|Lack of Efficacy|19|||
147540387|NCT00083226|532132935|FG000|Overall Study|Adverse Event|9|||
147540388|NCT00083226|532132935|FG000|Overall Study|Death|4|||
147540389|NCT00083226|532132935|FG000|Overall Study|Withdrawal by Subject|4|||
147540390|NCT00083226|532132935|FG000|Overall Study|Other|2|||
147540391|NCT00083226|532132935|FG000|Overall Study|ineligible or not receiving treatment|4|||
147540392|NCT00909857|532132936|FG000|Overall Study|Withdrawal by Subject|6|||
147540393|NCT00909857|532132937|FG001|Overall Study|Withdrawal by Subject|10|||
147540394|NCT00909857|532132936|FG000|Overall Study|Adverse Event|5|||
147540395|NCT00909857|532132937|FG001|Overall Study|Adverse Event|5|||
147540396|NCT00909857|532132936|FG000|Overall Study|Lost to Follow-up|2|||
147540397|NCT00909857|532132937|FG001|Overall Study|Lost to Follow-up|5|||
147203783|NCT01654302|530915772|FG000|Second Intervention (Day 7)|Lost to Follow-up|1|||
147203784|NCT01654302|530915773|FG001|Second Intervention (Day 7)|Lost to Follow-up|1|||
147540398|NCT00909857|532132936|FG000|Overall Study|Protocol Violation|2|||
147203785|NCT02699749|530915780|FG000|Overall Study|Other|0|||
147203786|NCT02699749|530915781|FG001|Overall Study|Other|0|||
147203787|NCT02699749|530915782|FG002|Overall Study|Other|2|||
147203788|NCT02699749|530915783|FG003|Overall Study|Other|0|||
147203789|NCT02699749|530915784|FG004|Overall Study|Other|0|||
147540399|NCT00909857|532132937|FG001|Overall Study|Protocol Violation|1|||
147540400|NCT00909857|532132936|FG000|Overall Study|Pregnancy|1|||
147540401|NCT00909857|532132937|FG001|Overall Study|Pregnancy|0|||
147203790|NCT02699749|530915785|FG005|Overall Study|Other|1|||
147203791|NCT02699749|530915786|FG006|Overall Study|Other|1|||
147203792|NCT02699749|530915787|FG007|Overall Study|Other|0|||
147540402|NCT00909857|532132936|FG000|Overall Study|Other|1|||
147540403|NCT00909857|532132937|FG001|Overall Study|Other|0|||
147540404|NCT00909857|532132936|FG000|Overall Study|Did not receive study medication|19|||
147540405|NCT00909857|532132937|FG001|Overall Study|Did not receive study medication|24|||
147540406|NCT01682681|532132938|FG000|Overall Study|Lack of Efficacy|62|||
147540407|NCT01682681|532132938|FG000|Overall Study|Withdrawal by Subject|1|||
147540408|NCT01682681|532132938|FG000|Overall Study|Moved to other hospital|10|||
147540409|NCT01682681|532132938|FG000|Overall Study|Lost to Follow-up|174|||
147540410|NCT01682681|532132938|FG000|Overall Study|Adverse Event|46|||
147540411|NCT01682681|532132938|FG000|Overall Study|tapering of topiramate|5|||
147540412|NCT01682681|532132938|FG000|Overall Study|Other|21|||
147540413|NCT01682681|532132938|FG000|Overall Study|Low compliance|13|||
147540414|NCT00975000|532132939|FG000|Overall Study|Other|1|||
147540415|NCT00975000|532132940|FG001|Overall Study|Other|0|||
147540416|NCT00975000|532132939|FG000|Overall Study|Adverse Event|1|||
147540417|NCT00975000|532132940|FG001|Overall Study|Adverse Event|1|||
147540418|NCT00975000|532132939|FG000|Overall Study|Withdrawal by Subject|2|||
147540419|NCT00975000|532132940|FG001|Overall Study|Withdrawal by Subject|2|||
147540420|NCT00975000|532132939|FG000|Overall Study|Lost to Follow-up|0|||
147540421|NCT00975000|532132940|FG001|Overall Study|Lost to Follow-up|1|||
147540422|NCT00975000|532132939|FG000|Overall Study|Protocol-specified Criteria|1|||
147540423|NCT00975000|532132940|FG001|Overall Study|Protocol-specified Criteria|0|||
147540424|NCT00975000|532132939|FG000|Overall Study|Non-compliance|0|||
147540425|NCT00975000|532132940|FG001|Overall Study|Non-compliance|1|||
147540426|NCT01652573|532133930|FG000|Overall Study|Adverse Event|0|||
147540427|NCT01652573|532133931|FG001|Overall Study|Adverse Event|1|||
147540428|NCT01052038|532133935|FG000|Overall Study|Lost to Follow-up|2|||
147540429|NCT01052038|532133936|FG001|Overall Study|Lost to Follow-up|3|||
147540430|NCT01052038|532133937|FG002|Overall Study|Lost to Follow-up|1|||
147540431|NCT01052038|532133935|FG000|Overall Study|Protocol Violation|2|||
147540432|NCT01052038|532133936|FG001|Overall Study|Protocol Violation|3|||
147540433|NCT01052038|532133937|FG002|Overall Study|Protocol Violation|3|||
147540434|NCT03976076|532133938|FG000|Overall Study|Withdrawal by Subject|2|||
147540435|NCT00602641|532133940|FG000|Overall Study|Never started protocol therapy|6|||
147540436|NCT00602641|532133941|FG001|Overall Study|Never started protocol therapy|2|||
147540437|NCT00602641|532133940|FG000|Overall Study|Still on treatment at time of analysis|8|||
147540438|NCT00602641|532133941|FG001|Overall Study|Still on treatment at time of analysis|15|||
147540439|NCT00602641|532133940|FG000|Overall Study|Adverse Event|62|||
147203793|NCT02699749|530915788|FG008|Overall Study|Other|0|||
147203794|NCT02699749|530915789|FG009|Overall Study|Other|0|||
147203795|NCT02699749|530915790|FG010|Overall Study|Other|1|||
147203796|NCT02699749|530915791|FG011|Overall Study|Other|0|||
147203797|NCT02699749|530915792|FG012|Overall Study|Other|0|||
147203798|NCT02699749|530915793|FG013|Overall Study|Other|0|||
147203799|NCT02699749|530915780|FG000|Overall Study|Progressive Disease|3|||
147203800|NCT02699749|530915781|FG001|Overall Study|Progressive Disease|3|||
147203801|NCT02699749|530915782|FG002|Overall Study|Progressive Disease|14|||
147203802|NCT02699749|530915783|FG003|Overall Study|Progressive Disease|3|||
147203803|NCT02699749|530915784|FG004|Overall Study|Progressive Disease|3|||
147203804|NCT02699749|530915785|FG005|Overall Study|Progressive Disease|7|||
147203805|NCT02699749|530915786|FG006|Overall Study|Progressive Disease|5|||
147203806|NCT02699749|530915787|FG007|Overall Study|Progressive Disease|5|||
147203807|NCT02699749|530915788|FG008|Overall Study|Progressive Disease|6|||
147203808|NCT02699749|530915789|FG009|Overall Study|Progressive Disease|6|||
147203809|NCT02699749|530915790|FG010|Overall Study|Progressive Disease|5|||
147203810|NCT02699749|530915791|FG011|Overall Study|Progressive Disease|4|||
147203811|NCT02699749|530915792|FG012|Overall Study|Progressive Disease|3|||
147203812|NCT02699749|530915793|FG013|Overall Study|Progressive Disease|5|||
147203813|NCT02699749|530915780|FG000|Overall Study|Death|0|||
147203814|NCT02699749|530915781|FG001|Overall Study|Death|0|||
147203815|NCT02699749|530915782|FG002|Overall Study|Death|0|||
147203816|NCT02699749|530915783|FG003|Overall Study|Death|0|||
147203817|NCT02699749|530915784|FG004|Overall Study|Death|0|||
147203818|NCT02699749|530915785|FG005|Overall Study|Death|0|||
147203819|NCT02699749|530915786|FG006|Overall Study|Death|0|||
147203820|NCT02699749|530915787|FG007|Overall Study|Death|0|||
147203821|NCT02699749|530915788|FG008|Overall Study|Death|0|||
147203822|NCT02699749|530915789|FG009|Overall Study|Death|0|||
147203823|NCT02699749|530915790|FG010|Overall Study|Death|0|||
147203824|NCT02699749|530915791|FG011|Overall Study|Death|0|||
147540440|NCT00602641|532133941|FG001|Overall Study|Adverse Event|53|||
147203825|NCT02699749|530915792|FG012|Overall Study|Death|0|||
147203826|NCT02699749|530915793|FG013|Overall Study|Death|1|||
147203827|NCT02699749|530915780|FG000|Overall Study|Lost to Follow-up|0|||
147203828|NCT02699749|530915781|FG001|Overall Study|Lost to Follow-up|0|||
147203829|NCT02699749|530915782|FG002|Overall Study|Lost to Follow-up|0|||
147203830|NCT02699749|530915783|FG003|Overall Study|Lost to Follow-up|0|||
147540441|NCT00602641|532133940|FG000|Overall Study|Disease progression|38|||
147540442|NCT00602641|532133941|FG001|Overall Study|Disease progression|55|||
147540443|NCT00602641|532133940|FG000|Overall Study|Death|6|||
147540444|NCT00602641|532133941|FG001|Overall Study|Death|5|||
147540445|NCT00602641|532133940|FG000|Overall Study|Withdrawal by Subject|15|||
147540446|NCT00602641|532133941|FG001|Overall Study|Withdrawal by Subject|12|||
147540447|NCT00602641|532133940|FG000|Overall Study|Alternative therapy|5|||
147203831|NCT02699749|530915784|FG004|Overall Study|Lost to Follow-up|0|||
147540448|NCT00602641|532133941|FG001|Overall Study|Alternative therapy|2|||
147540449|NCT00602641|532133940|FG000|Overall Study|Other Complicating Disease|5|||
147540450|NCT00602641|532133941|FG001|Overall Study|Other Complicating Disease|2|||
147540451|NCT00602641|532133940|FG000|Overall Study|Physician Decision|5|||
147203832|NCT02699749|530915785|FG005|Overall Study|Lost to Follow-up|1|||
147203833|NCT02699749|530915786|FG006|Overall Study|Lost to Follow-up|0|||
147203834|NCT02699749|530915787|FG007|Overall Study|Lost to Follow-up|1|||
147203835|NCT02699749|530915788|FG008|Overall Study|Lost to Follow-up|0|||
147203836|NCT02699749|530915789|FG009|Overall Study|Lost to Follow-up|0|||
147203837|NCT02699749|530915790|FG010|Overall Study|Lost to Follow-up|0|||
147203838|NCT02699749|530915791|FG011|Overall Study|Lost to Follow-up|0|||
147203839|NCT02699749|530915792|FG012|Overall Study|Lost to Follow-up|0|||
147203840|NCT02699749|530915793|FG013|Overall Study|Lost to Follow-up|0|||
147203841|NCT02377817|530915795|FG000|Overall Study|Transportation/childcare barriers.|2|||
147203842|NCT02377817|530915796|FG001|Overall Study|Transportation/childcare barriers.|0|||
147203843|NCT02377817|530915795|FG000|Overall Study|Unrelated injury prevented lateral sleep|1|||
147203844|NCT02377817|530915796|FG001|Overall Study|Unrelated injury prevented lateral sleep|0|||
147203845|NCT02839200|530915797|FG000|Overall Study|Withdrawal by Subject|2|||
147203846|NCT02839200|530915798|FG001|Overall Study|Withdrawal by Subject|0|||
147203847|NCT02839200|530915799|FG002|Overall Study|Withdrawal by Subject|1|||
147203848|NCT02839200|530915800|FG003|Overall Study|Withdrawal by Subject|0|||
147203849|NCT02839200|530915801|FG004|Overall Study|Withdrawal by Subject|0|||
147203850|NCT02839200|530915802|FG005|Overall Study|Withdrawal by Subject|1|||
147203851|NCT02839200|530915797|FG000|Overall Study|Lost to Follow-up|2|||
147203852|NCT02839200|530915798|FG001|Overall Study|Lost to Follow-up|0|||
147203853|NCT02839200|530915799|FG002|Overall Study|Lost to Follow-up|0|||
147203854|NCT02839200|530915800|FG003|Overall Study|Lost to Follow-up|0|||
147203855|NCT02839200|530915801|FG004|Overall Study|Lost to Follow-up|1|||
147203856|NCT02839200|530915802|FG005|Overall Study|Lost to Follow-up|0|||
147203857|NCT02839200|530915797|FG000|Overall Study|Adverse Event|0|||
147540452|NCT00602641|532133941|FG001|Overall Study|Physician Decision|4|||
147540453|NCT00602641|532133940|FG000|Overall Study|Administrative Closure|1|||
147540454|NCT00602641|532133941|FG001|Overall Study|Administrative Closure|1|||
147540455|NCT00602641|532133940|FG000|Overall Study|Other|3|||
147540456|NCT00602641|532133941|FG001|Overall Study|Other|1|||
147540457|NCT03901352|532133943|FG000|Double-blind Phase|Adverse Event|6|||
147540458|NCT03901352|532133944|FG001|Double-blind Phase|Adverse Event|4|||
147540459|NCT03901352|532133943|FG000|Double-blind Phase|Death|1|||
147540460|NCT03901352|532133944|FG001|Double-blind Phase|Death|0|||
147540461|NCT03901352|532133943|FG000|Double-blind Phase|Lack of Efficacy|0|||
147540462|NCT03901352|532133944|FG001|Double-blind Phase|Lack of Efficacy|1|||
147540463|NCT03901352|532133943|FG000|Double-blind Phase|Protocol Violation|0|||
147540464|NCT03901352|532133944|FG001|Double-blind Phase|Protocol Violation|1|||
147540465|NCT03901352|532133943|FG000|Double-blind Phase|Withdrawal by Subject|10|||
147540466|NCT03901352|532133944|FG001|Double-blind Phase|Withdrawal by Subject|8|||
147540467|NCT03901352|532133943|FG000|Open-label Extension Phase|Adverse Event|24|||
147540468|NCT03901352|532133944|FG001|Open-label Extension Phase|Adverse Event|0|||
147540469|NCT03901352|532133943|FG000|Open-label Extension Phase|Lack of Efficacy|1|||
147540470|NCT03901352|532133944|FG001|Open-label Extension Phase|Lack of Efficacy|0|||
147540471|NCT03901352|532133943|FG000|Open-label Extension Phase|Withdrawal by Subject|14|||
147540472|NCT03901352|532133944|FG001|Open-label Extension Phase|Withdrawal by Subject|0|||
147540473|NCT03901352|532133943|FG000|Open-label Extension Phase|Other|1|||
147540474|NCT03901352|532133944|FG001|Open-label Extension Phase|Other|0|||
147540475|NCT01615822|532133947|FG000|Period 1|Withdrawal by Subject|0|||
147540476|NCT01615822|532133948|FG001|Period 1|Withdrawal by Subject|1|||
147540477|NCT01615822|532133949|FG002|Period 1|Withdrawal by Subject|0|||
147540478|NCT01615822|532133947|FG000|Period 1|Adverse Event|1|||
147540479|NCT01615822|532133948|FG001|Period 1|Adverse Event|1|||
147203858|NCT02839200|530915798|FG001|Overall Study|Adverse Event|0|||
147203859|NCT02839200|530915799|FG002|Overall Study|Adverse Event|0|||
147203860|NCT02839200|530915800|FG003|Overall Study|Adverse Event|0|||
147203861|NCT02839200|530915801|FG004|Overall Study|Adverse Event|1|||
147203862|NCT02839200|530915802|FG005|Overall Study|Adverse Event|0|||
147203863|NCT02839200|530915797|FG000|Overall Study|Randomized in error|0|||
147203864|NCT02839200|530915798|FG001|Overall Study|Randomized in error|1|||
147203865|NCT02839200|530915799|FG002|Overall Study|Randomized in error|0|||
147540480|NCT01615822|532133949|FG002|Period 1|Adverse Event|0|||
147203866|NCT02839200|530915800|FG003|Overall Study|Randomized in error|0|||
147203867|NCT02839200|530915801|FG004|Overall Study|Randomized in error|0|||
147540481|NCT01615822|532133947|FG000|Period 2|Lost to Follow-up|0|||
147540482|NCT01615822|532133948|FG001|Period 2|Lost to Follow-up|1|||
147540483|NCT01615822|532133949|FG002|Period 2|Lost to Follow-up|2|||
147203868|NCT02839200|530915802|FG005|Overall Study|Randomized in error|0|||
147203869|NCT02952820|530915803|FG000|Placebo-Controlled Treatment (6 Months)|Adverse Event|8|||
147203870|NCT02952820|530915804|FG001|Placebo-Controlled Treatment (6 Months)|Adverse Event|9|||
147203871|NCT02952820|530915805|FG002|Placebo-Controlled Treatment (6 Months)|Adverse Event|16|||
147203872|NCT02952820|530915803|FG000|Placebo-Controlled Treatment (6 Months)|Lost to Follow-up|7|||
147540484|NCT03981614|532133950|FG000|Overall Study|Patient withdrawn prior to treatment|5|||
147540485|NCT03981614|532133951|FG001|Overall Study|Patient withdrawn prior to treatment|5|||
147540486|NCT03981614|532133952|FG002|Overall Study|Patient withdrawn prior to treatment|1|||
147540487|NCT03901339|532133953|FG000|Overall Study|Death|220|||
147540488|NCT03901339|532133954|FG001|Overall Study|Death|192|||
147540489|NCT03901339|532133953|FG000|Overall Study|Informed consent withdrawn|13|||
147540490|NCT03901339|532133954|FG001|Overall Study|Informed consent withdrawn|40|||
147540491|NCT03901339|532133953|FG000|Overall Study|Sponsor request|30|||
147540492|NCT03901339|532133954|FG001|Overall Study|Sponsor request|23|||
147540493|NCT03901339|532133953|FG000|Overall Study|Reason not specified|5|||
147540494|NCT03901339|532133954|FG001|Overall Study|Reason not specified|7|||
147203873|NCT02952820|530915804|FG001|Placebo-Controlled Treatment (6 Months)|Lost to Follow-up|7|||
147203874|NCT02952820|530915805|FG002|Placebo-Controlled Treatment (6 Months)|Lost to Follow-up|6|||
147203875|NCT02952820|530915803|FG000|Placebo-Controlled Treatment (6 Months)|Subject choice|15|||
147203876|NCT02952820|530915804|FG001|Placebo-Controlled Treatment (6 Months)|Subject choice|12|||
147203877|NCT02952820|530915805|FG002|Placebo-Controlled Treatment (6 Months)|Subject choice|17|||
147203878|NCT02952820|530915803|FG000|Placebo-Controlled Treatment (6 Months)|Inadequate therapeutic effect|17|||
147203879|NCT02952820|530915804|FG001|Placebo-Controlled Treatment (6 Months)|Inadequate therapeutic effect|12|||
147203880|NCT02952820|530915805|FG002|Placebo-Controlled Treatment (6 Months)|Inadequate therapeutic effect|11|||
147203881|NCT02952820|530915803|FG000|Placebo-Controlled Treatment (6 Months)|Other than specified|0|||
147203882|NCT02952820|530915804|FG001|Placebo-Controlled Treatment (6 Months)|Other than specified|14|||
147203883|NCT02952820|530915805|FG002|Placebo-Controlled Treatment (6 Months)|Other than specified|13|||
147203884|NCT02952820|530915803|FG000|Placebo-Controlled Treatment (6 Months)|Withdrawal of consent|13|||
147203885|NCT02952820|530915804|FG001|Placebo-Controlled Treatment (6 Months)|Withdrawal of consent|11|||
147203886|NCT02952820|530915805|FG002|Placebo-Controlled Treatment (6 Months)|Withdrawal of consent|21|||
147203887|NCT02952820|530915803|FG000|Placebo-Controlled Treatment (6 Months)|Not treated|4|||
147203888|NCT02952820|530915804|FG001|Placebo-Controlled Treatment (6 Months)|Not treated|4|||
147203889|NCT02952820|530915805|FG002|Placebo-Controlled Treatment (6 Months)|Not treated|4|||
147203890|NCT02952820|530915803|FG000|Active Treatment Period (6 Months)|Adverse Event|0|||
147203891|NCT02952820|530915804|FG001|Active Treatment Period (6 Months)|Adverse Event|6|||
147540495|NCT03901339|532133953|FG000|Overall Study|Lost to Follow-up|4|||
147540496|NCT03901339|532133954|FG001|Overall Study|Lost to Follow-up|7|||
147540497|NCT03901339|532133953|FG000|Overall Study|Covid19|0|||
147540498|NCT03901339|532133954|FG001|Overall Study|Covid19|2|||
147540499|NCT01787188|532133955|FG000|Overall Study|Adverse Event|2|||
147540500|NCT01787188|532133956|FG001|Overall Study|Adverse Event|4|||
147540501|NCT01787188|532133957|FG002|Overall Study|Adverse Event|6|||
147540502|NCT01787188|532133955|FG000|Overall Study|Lack of Efficacy|7|||
147540503|NCT01787188|532133956|FG001|Overall Study|Lack of Efficacy|3|||
147540504|NCT01787188|532133957|FG002|Overall Study|Lack of Efficacy|5|||
147540505|NCT01787188|532133955|FG000|Overall Study|Non-compliance with Study Drug|0|||
147540506|NCT01787188|532133956|FG001|Overall Study|Non-compliance with Study Drug|1|||
147540507|NCT01787188|532133957|FG002|Overall Study|Non-compliance with Study Drug|0|||
147540508|NCT01787188|532133955|FG000|Overall Study|Withdrawal by Subject|4|||
147540509|NCT01787188|532133956|FG001|Overall Study|Withdrawal by Subject|3|||
147540510|NCT01787188|532133957|FG002|Overall Study|Withdrawal by Subject|2|||
147540511|NCT01787188|532133955|FG000|Overall Study|Protocol Violation|3|||
147540512|NCT01787188|532133956|FG001|Overall Study|Protocol Violation|2|||
147540513|NCT01787188|532133957|FG002|Overall Study|Protocol Violation|3|||
147540514|NCT01787188|532133955|FG000|Overall Study|Lost to Follow-up|1|||
147540515|NCT01787188|532133956|FG001|Overall Study|Lost to Follow-up|2|||
147540516|NCT01787188|532133957|FG002|Overall Study|Lost to Follow-up|2|||
147540517|NCT01787188|532133955|FG000|Overall Study|Other, including patient moved|0|||
147540518|NCT01787188|532133956|FG001|Overall Study|Other, including patient moved|3|||
147540519|NCT01787188|532133957|FG002|Overall Study|Other, including patient moved|0|||
147540520|NCT05511428|532133958|FG000|Overall Study|Withdrawal by Subject|1|||
147540521|NCT05511428|532133958|FG000|Overall Study|Adverse Event|1|||
147540522|NCT02643394|532133959|FG000|Overall Study|Protocol Violation|4|||
147540523|NCT02643394|532133960|FG001|Overall Study|Protocol Violation|5|||
147203892|NCT02952820|530915805|FG002|Active Treatment Period (6 Months)|Adverse Event|5|||
147203893|NCT02952820|530915803|FG000|Active Treatment Period (6 Months)|Lost to Follow-up|0|||
147540524|NCT04971226|532133963|FG000|Overall Study|Unsatisfactory therapeutic effect|6|||
147203894|NCT02952820|530915804|FG001|Active Treatment Period (6 Months)|Lost to Follow-up|4|||
147203895|NCT02952820|530915805|FG002|Active Treatment Period (6 Months)|Lost to Follow-up|6|||
147203896|NCT02952820|530915803|FG000|Active Treatment Period (6 Months)|Subject choice|0|||
147540525|NCT04971226|532133964|FG001|Overall Study|Unsatisfactory therapeutic effect|6|||
147540526|NCT04971226|532133965|FG002|Overall Study|Unsatisfactory therapeutic effect|21|||
147540527|NCT04971226|532133966|FG003|Overall Study|Unsatisfactory therapeutic effect|10|||
147540528|NCT04971226|532133963|FG000|Overall Study|Adverse Event|6|||
147540529|NCT04971226|532133964|FG001|Overall Study|Adverse Event|5|||
147540530|NCT04971226|532133965|FG002|Overall Study|Adverse Event|11|||
147540531|NCT04971226|532133966|FG003|Overall Study|Adverse Event|10|||
147203897|NCT02952820|530915804|FG001|Active Treatment Period (6 Months)|Subject choice|10|||
147203898|NCT02952820|530915805|FG002|Active Treatment Period (6 Months)|Subject choice|7|||
147203899|NCT02952820|530915803|FG000|Active Treatment Period (6 Months)|Inadequate therapeutic effect|0|||
147203900|NCT02952820|530915804|FG001|Active Treatment Period (6 Months)|Inadequate therapeutic effect|6|||
147203901|NCT02952820|530915805|FG002|Active Treatment Period (6 Months)|Inadequate therapeutic effect|2|||
147203902|NCT02952820|530915803|FG000|Active Treatment Period (6 Months)|Withdrawal of consent|0|||
147540532|NCT04971226|532133963|FG000|Overall Study|Progressive disease|2|||
147540533|NCT04971226|532133964|FG001|Overall Study|Progressive disease|0|||
147203903|NCT02952820|530915804|FG001|Active Treatment Period (6 Months)|Withdrawal of consent|6|||
147203904|NCT02952820|530915805|FG002|Active Treatment Period (6 Months)|Withdrawal of consent|8|||
147203905|NCT02952820|530915803|FG000|Active Treatment Period (6 Months)|Other than specified|0|||
147203906|NCT02952820|530915804|FG001|Active Treatment Period (6 Months)|Other than specified|6|||
147203907|NCT02952820|530915805|FG002|Active Treatment Period (6 Months)|Other than specified|2|||
147540534|NCT04971226|532133965|FG002|Overall Study|Progressive disease|3|||
147540535|NCT04971226|532133966|FG003|Overall Study|Progressive disease|1|||
147540536|NCT04971226|532133963|FG000|Overall Study|Protocol Deviation|1|||
147540537|NCT04971226|532133964|FG001|Overall Study|Protocol Deviation|0|||
147540538|NCT04971226|532133965|FG002|Overall Study|Protocol Deviation|1|||
147540539|NCT04971226|532133966|FG003|Overall Study|Protocol Deviation|1|||
147540540|NCT04971226|532133963|FG000|Overall Study|Subject Decision|0|||
147540541|NCT04971226|532133964|FG001|Overall Study|Subject Decision|1|||
147540542|NCT04971226|532133965|FG002|Overall Study|Subject Decision|1|||
147540543|NCT04971226|532133966|FG003|Overall Study|Subject Decision|1|||
147540544|NCT04971226|532133963|FG000|Overall Study|Pregnancy|0|||
147540545|NCT04971226|532133964|FG001|Overall Study|Pregnancy|0|||
147540546|NCT04971226|532133965|FG002|Overall Study|Pregnancy|0|||
147540547|NCT04971226|532133966|FG003|Overall Study|Pregnancy|1|||
147540548|NCT04971226|532133963|FG000|Overall Study|Participants not treated|1|||
147540549|NCT04971226|532133964|FG001|Overall Study|Participants not treated|0|||
147540550|NCT04971226|532133965|FG002|Overall Study|Participants not treated|2|||
147540551|NCT04971226|532133966|FG003|Overall Study|Participants not treated|1|||
147540552|NCT04439149|532133967|FG000|Overall Study|Ineligible|1|||
147540553|NCT04439149|532133967|FG000|Overall Study|Never start protocol therapy|1|||
147540554|NCT04439149|532133967|FG000|Overall Study|Adverse Event|4|||
147540555|NCT04439149|532133967|FG000|Overall Study|Disease Progression|14|||
147540556|NCT04439149|532133967|FG000|Overall Study|Complicating disease|1|||
147540557|NCT04439149|532133967|FG000|Overall Study|Withdrawal by Subject|3|||
147540558|NCT05919823|532133974|FG000|Pre-Treatment Period|Screen failure|1|||
147540559|NCT05919823|532133975|FG001|Pre-Treatment Period|Screen failure|0|||
147540560|NCT05919823|532133976|FG002|Pre-Treatment Period|Screen failure|0|||
147540561|NCT05919823|532133977|FG003|Pre-Treatment Period|Screen failure|0|||
147540562|NCT05919823|532133974|FG000|Pre-Treatment Period|Protocol Violation|0|||
147540563|NCT05919823|532133975|FG001|Pre-Treatment Period|Protocol Violation|1|||
147540564|NCT05919823|532133976|FG002|Pre-Treatment Period|Protocol Violation|0|||
147540565|NCT05919823|532133977|FG003|Pre-Treatment Period|Protocol Violation|0|||
147540566|NCT05919823|532133974|FG000|Double-Blind Period|Adverse Event|8|||
147540567|NCT05919823|532133975|FG001|Double-Blind Period|Adverse Event|9|||
147540568|NCT05919823|532133976|FG002|Double-Blind Period|Adverse Event|0|||
147540569|NCT05919823|532133977|FG003|Double-Blind Period|Adverse Event|0|||
147203908|NCT02952820|530915803|FG000|Active Treatment Period (6 Months)|Not treated|0|||
147203909|NCT02952820|530915804|FG001|Active Treatment Period (6 Months)|Not treated|0|||
147203910|NCT02952820|530915805|FG002|Active Treatment Period (6 Months)|Not treated|1|||
147203911|NCT04139018|530915806|FG000|Overall Study|Screen fail|1|||
147203912|NCT04139018|530915807|FG001|Overall Study|Screen fail|0|||
147203913|NCT04139018|530915806|FG000|Overall Study|Withdrawal by Subject|2|||
147203914|NCT04139018|530915807|FG001|Overall Study|Withdrawal by Subject|0|||
147203915|NCT04139018|530915806|FG000|Overall Study|Lost to Follow-up|0|||
147203916|NCT04139018|530915807|FG001|Overall Study|Lost to Follow-up|1|||
147203917|NCT02565108|530915808|FG000|Overall Study|Adverse Event|1|||
147203918|NCT02565108|530915809|FG001|Overall Study|Adverse Event|0|||
147203919|NCT02565108|530915808|FG000|Overall Study|Withdrew Consent|1|||
147203920|NCT02565108|530915809|FG001|Overall Study|Withdrew Consent|0|||
147540570|NCT05919823|532133974|FG000|Double-Blind Period|Protocol Violation|2|||
147540571|NCT05919823|532133975|FG001|Double-Blind Period|Protocol Violation|1|||
147540572|NCT05919823|532133976|FG002|Double-Blind Period|Protocol Violation|0|||
147203921|NCT01310075|530915826|FG000|Overall Study|Lost to Follow-up|1|||
147203922|NCT01310075|530915827|FG001|Overall Study|Lost to Follow-up|0|||
147540573|NCT05919823|532133977|FG003|Double-Blind Period|Protocol Violation|0|||
147540574|NCT05919823|532133974|FG000|Double-Blind Period|Participant withdrew consent|11|||
147540575|NCT05919823|532133975|FG001|Double-Blind Period|Participant withdrew consent|7|||
147540576|NCT05919823|532133976|FG002|Double-Blind Period|Participant withdrew consent|0|||
147203923|NCT01310075|530915826|FG000|Overall Study|Physician Decision|10|||
147540577|NCT05919823|532133977|FG003|Double-Blind Period|Participant withdrew consent|0|||
147540578|NCT05919823|532133974|FG000|Double-Blind Period|Other reasons|2|||
147540579|NCT05919823|532133975|FG001|Double-Blind Period|Other reasons|3|||
147540580|NCT05919823|532133976|FG002|Double-Blind Period|Other reasons|0|||
147438782|NCT01994382|531772149|FG002|Overall Study|Physician Decision|0|||
147438783|NCT01994382|531772150|FG003|Overall Study|Physician Decision|0|||
147438784|NCT01994382|531772151|FG004|Overall Study|Physician Decision|0|||
147438785|NCT01994382|531772152|FG005|Overall Study|Physician Decision|0|||
147438786|NCT01994382|531772153|FG006|Overall Study|Physician Decision|0|||
147438787|NCT01994382|531772154|FG007|Overall Study|Physician Decision|0|||
147438788|NCT01994382|531772155|FG008|Overall Study|Physician Decision|0|||
147438789|NCT01994382|531772156|FG009|Overall Study|Physician Decision|0|||
147438790|NCT01994382|531772157|FG010|Overall Study|Physician Decision|3|||
147438791|NCT01994382|531772158|FG011|Overall Study|Physician Decision|1|||
147438792|NCT01994382|531772159|FG012|Overall Study|Physician Decision|1|||
147438793|NCT01994382|531772160|FG013|Overall Study|Physician Decision|0|||
147438794|NCT01994382|531772161|FG014|Overall Study|Physician Decision|1|||
147438795|NCT01994382|531772162|FG015|Overall Study|Physician Decision|4|||
147438796|NCT01994382|531772163|FG016|Overall Study|Physician Decision|2|||
147438797|NCT01994382|531772147|FG000|Overall Study|Death|0|||
147438798|NCT01994382|531772148|FG001|Overall Study|Death|0|||
147438799|NCT01994382|531772149|FG002|Overall Study|Death|0|||
147438800|NCT01994382|531772150|FG003|Overall Study|Death|0|||
147438801|NCT01994382|531772151|FG004|Overall Study|Death|1|||
147438802|NCT01994382|531772152|FG005|Overall Study|Death|0|||
147438803|NCT01994382|531772153|FG006|Overall Study|Death|0|||
147438804|NCT01994382|531772154|FG007|Overall Study|Death|0|||
147438805|NCT01994382|531772155|FG008|Overall Study|Death|1|||
147438806|NCT01994382|531772156|FG009|Overall Study|Death|1|||
147438807|NCT01994382|531772157|FG010|Overall Study|Death|0|||
147438808|NCT01994382|531772158|FG011|Overall Study|Death|0|||
147438809|NCT01994382|531772159|FG012|Overall Study|Death|0|||
147438810|NCT01994382|531772160|FG013|Overall Study|Death|0|||
147438811|NCT01994382|531772161|FG014|Overall Study|Death|0|||
147438812|NCT01994382|531772162|FG015|Overall Study|Death|1|||
147438813|NCT01994382|531772163|FG016|Overall Study|Death|0|||
147438814|NCT01994382|531772147|FG000|Overall Study|Adverse Event|0|||
147438815|NCT01994382|531772148|FG001|Overall Study|Adverse Event|1|||
147438816|NCT01994382|531772149|FG002|Overall Study|Adverse Event|2|||
147438817|NCT01994382|531772150|FG003|Overall Study|Adverse Event|0|||
147438818|NCT01994382|531772151|FG004|Overall Study|Adverse Event|0|||
147438819|NCT01994382|531772152|FG005|Overall Study|Adverse Event|0|||
147438820|NCT01994382|531772153|FG006|Overall Study|Adverse Event|0|||
147438821|NCT01994382|531772154|FG007|Overall Study|Adverse Event|0|||
147438822|NCT01994382|531772155|FG008|Overall Study|Adverse Event|0|||
147438823|NCT01994382|531772156|FG009|Overall Study|Adverse Event|0|||
147438824|NCT01994382|531772157|FG010|Overall Study|Adverse Event|15|||
147438825|NCT01994382|531772158|FG011|Overall Study|Adverse Event|2|||
147438826|NCT01994382|531772159|FG012|Overall Study|Adverse Event|7|||
147438827|NCT01994382|531772160|FG013|Overall Study|Adverse Event|3|||
147438828|NCT01994382|531772161|FG014|Overall Study|Adverse Event|17|||
147438829|NCT01994382|531772162|FG015|Overall Study|Adverse Event|6|||
147438830|NCT01994382|531772163|FG016|Overall Study|Adverse Event|3|||
147438831|NCT01994382|531772147|FG000|Overall Study|Other than specified|0|||
147438832|NCT01994382|531772148|FG001|Overall Study|Other than specified|0|||
147438833|NCT01994382|531772149|FG002|Overall Study|Other than specified|0|||
147438834|NCT01994382|531772150|FG003|Overall Study|Other than specified|0|||
147438835|NCT01994382|531772151|FG004|Overall Study|Other than specified|0|||
147438836|NCT01994382|531772152|FG005|Overall Study|Other than specified|0|||
147438837|NCT01994382|531772153|FG006|Overall Study|Other than specified|0|||
147438838|NCT01994382|531772154|FG007|Overall Study|Other than specified|0|||
147438839|NCT01994382|531772155|FG008|Overall Study|Other than specified|0|||
147438840|NCT01994382|531772156|FG009|Overall Study|Other than specified|0|||
147438841|NCT01994382|531772157|FG010|Overall Study|Other than specified|2|||
147438842|NCT01994382|531772158|FG011|Overall Study|Other than specified|0|||
147438843|NCT01994382|531772159|FG012|Overall Study|Other than specified|2|||
147438844|NCT01994382|531772160|FG013|Overall Study|Other than specified|0|||
147438845|NCT01994382|531772161|FG014|Overall Study|Other than specified|0|||
147438846|NCT01994382|531772162|FG015|Overall Study|Other than specified|4|||
147438847|NCT01994382|531772163|FG016|Overall Study|Other than specified|4|||
147438848|NCT01994382|531772147|FG000|Overall Study|Withdrawal by Subject|0|||
147438849|NCT01994382|531772148|FG001|Overall Study|Withdrawal by Subject|0|||
147438850|NCT01994382|531772149|FG002|Overall Study|Withdrawal by Subject|0|||
147438851|NCT01994382|531772150|FG003|Overall Study|Withdrawal by Subject|0|||
147438852|NCT01994382|531772151|FG004|Overall Study|Withdrawal by Subject|0|||
147438853|NCT01994382|531772152|FG005|Overall Study|Withdrawal by Subject|0|||
147438854|NCT01994382|531772153|FG006|Overall Study|Withdrawal by Subject|0|||
147438855|NCT01994382|531772154|FG007|Overall Study|Withdrawal by Subject|0|||
147438856|NCT01994382|531772155|FG008|Overall Study|Withdrawal by Subject|0|||
147438857|NCT01994382|531772156|FG009|Overall Study|Withdrawal by Subject|0|||
147438858|NCT01994382|531772157|FG010|Overall Study|Withdrawal by Subject|6|||
147438859|NCT01994382|531772158|FG011|Overall Study|Withdrawal by Subject|0|||
147438860|NCT01994382|531772159|FG012|Overall Study|Withdrawal by Subject|2|||
147438861|NCT01994382|531772160|FG013|Overall Study|Withdrawal by Subject|0|||
147203924|NCT01310075|530915827|FG001|Overall Study|Physician Decision|7|||
147203925|NCT01310075|530915826|FG000|Overall Study|Protocol Violation|2|||
147203926|NCT01310075|530915827|FG001|Overall Study|Protocol Violation|2|||
147438862|NCT01994382|531772161|FG014|Overall Study|Withdrawal by Subject|4|||
147438863|NCT01994382|531772162|FG015|Overall Study|Withdrawal by Subject|3|||
147438864|NCT01994382|531772163|FG016|Overall Study|Withdrawal by Subject|0|||
147438865|NCT01994382|531772147|FG000|Overall Study|Lost to Follow-up|0|||
147438866|NCT01994382|531772148|FG001|Overall Study|Lost to Follow-up|0|||
147438867|NCT01994382|531772149|FG002|Overall Study|Lost to Follow-up|0|||
147438868|NCT01994382|531772150|FG003|Overall Study|Lost to Follow-up|0|||
147438869|NCT01994382|531772151|FG004|Overall Study|Lost to Follow-up|0|||
147438870|NCT01994382|531772152|FG005|Overall Study|Lost to Follow-up|0|||
147438871|NCT01994382|531772153|FG006|Overall Study|Lost to Follow-up|0|||
147438872|NCT01994382|531772154|FG007|Overall Study|Lost to Follow-up|0|||
147438873|NCT01994382|531772155|FG008|Overall Study|Lost to Follow-up|0|||
147438874|NCT01994382|531772156|FG009|Overall Study|Lost to Follow-up|0|||
147438875|NCT01994382|531772157|FG010|Overall Study|Lost to Follow-up|1|||
147438876|NCT01994382|531772158|FG011|Overall Study|Lost to Follow-up|0|||
147438877|NCT01994382|531772159|FG012|Overall Study|Lost to Follow-up|0|||
147438878|NCT01994382|531772160|FG013|Overall Study|Lost to Follow-up|0|||
147438879|NCT01994382|531772161|FG014|Overall Study|Lost to Follow-up|0|||
147438880|NCT01994382|531772162|FG015|Overall Study|Lost to Follow-up|0|||
147438881|NCT01994382|531772163|FG016|Overall Study|Lost to Follow-up|0|||
147438882|NCT01994382|531772147|FG000|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
147438883|NCT01994382|531772148|FG001|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
147438884|NCT01994382|531772149|FG002|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
147438885|NCT01994382|531772150|FG003|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
147438886|NCT01994382|531772151|FG004|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
147438887|NCT01994382|531772152|FG005|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
147438888|NCT01994382|531772153|FG006|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
147438889|NCT01994382|531772154|FG007|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
147438890|NCT01994382|531772155|FG008|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
147438891|NCT01994382|531772156|FG009|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
147438892|NCT01994382|531772157|FG010|Overall Study|Participants rolled over into expanded access program (NCT04757259)|2|||
147438893|NCT01994382|531772158|FG011|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
147438894|NCT01994382|531772159|FG012|Overall Study|Participants rolled over into expanded access program (NCT04757259)|7|||
147438895|NCT01994382|531772160|FG013|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
147438896|NCT01994382|531772161|FG014|Overall Study|Participants rolled over into expanded access program (NCT04757259)|0|||
147438897|NCT01994382|531772162|FG015|Overall Study|Participants rolled over into expanded access program (NCT04757259)|3|||
147438898|NCT01994382|531772163|FG016|Overall Study|Participants rolled over into expanded access program (NCT04757259)|2|||
147438899|NCT01994382|531772147|FG000|Overall Study|Protocol violation/noncompliance|0|||
147438900|NCT01994382|531772148|FG001|Overall Study|Protocol violation/noncompliance|0|||
147438901|NCT01994382|531772149|FG002|Overall Study|Protocol violation/noncompliance|0|||
147438902|NCT01994382|531772150|FG003|Overall Study|Protocol violation/noncompliance|0|||
147438903|NCT01994382|531772151|FG004|Overall Study|Protocol violation/noncompliance|0|||
147438904|NCT01994382|531772152|FG005|Overall Study|Protocol violation/noncompliance|0|||
147438905|NCT01994382|531772153|FG006|Overall Study|Protocol violation/noncompliance|0|||
147438906|NCT01994382|531772154|FG007|Overall Study|Protocol violation/noncompliance|0|||
147438907|NCT01994382|531772155|FG008|Overall Study|Protocol violation/noncompliance|0|||
147438908|NCT01994382|531772156|FG009|Overall Study|Protocol violation/noncompliance|0|||
147438909|NCT01994382|531772157|FG010|Overall Study|Protocol violation/noncompliance|0|||
147438910|NCT01994382|531772158|FG011|Overall Study|Protocol violation/noncompliance|1|||
147438911|NCT01994382|531772159|FG012|Overall Study|Protocol violation/noncompliance|0|||
147438912|NCT01994382|531772160|FG013|Overall Study|Protocol violation/noncompliance|0|||
147438913|NCT01994382|531772161|FG014|Overall Study|Protocol violation/noncompliance|0|||
147438914|NCT01994382|531772162|FG015|Overall Study|Protocol violation/noncompliance|0|||
147438915|NCT01994382|531772163|FG016|Overall Study|Protocol violation/noncompliance|2|||
147438916|NCT01994382|531772147|FG000|Overall Study|Rolled over to Phase 2a|0|||
147438917|NCT01994382|531772148|FG001|Overall Study|Rolled over to Phase 2a|0|||
147438918|NCT01994382|531772149|FG002|Overall Study|Rolled over to Phase 2a|1|||
147438919|NCT01994382|531772150|FG003|Overall Study|Rolled over to Phase 2a|0|||
147438920|NCT01994382|531772151|FG004|Overall Study|Rolled over to Phase 2a|0|||
147438921|NCT01994382|531772152|FG005|Overall Study|Rolled over to Phase 2a|0|||
147438922|NCT01994382|531772153|FG006|Overall Study|Rolled over to Phase 2a|0|||
147438923|NCT01994382|531772154|FG007|Overall Study|Rolled over to Phase 2a|0|||
147438924|NCT01994382|531772155|FG008|Overall Study|Rolled over to Phase 2a|0|||
147203927|NCT01310075|530915826|FG000|Overall Study|Withdrawal by Subject|1|||
147438925|NCT01994382|531772156|FG009|Overall Study|Rolled over to Phase 2a|2|||
147203928|NCT01310075|530915827|FG001|Overall Study|Withdrawal by Subject|1|||
147540581|NCT05919823|532133977|FG003|Double-Blind Period|Other reasons|0|||
147540582|NCT05919823|532133974|FG000|Open Label Period|Adverse Event|0|||
147540583|NCT05919823|532133975|FG001|Open Label Period|Adverse Event|0|||
147540584|NCT05919823|532133976|FG002|Open Label Period|Adverse Event|2|||
147540585|NCT05919823|532133977|FG003|Open Label Period|Adverse Event|4|||
147540586|NCT05919823|532133974|FG000|Open Label Period|Lost to Follow-up|0|||
147540587|NCT05919823|532133975|FG001|Open Label Period|Lost to Follow-up|0|||
147540588|NCT05919823|532133976|FG002|Open Label Period|Lost to Follow-up|1|||
147540589|NCT05919823|532133977|FG003|Open Label Period|Lost to Follow-up|0|||
147540590|NCT05919823|532133974|FG000|Open Label Period|Protocol Violation|0|||
147540591|NCT05919823|532133975|FG001|Open Label Period|Protocol Violation|0|||
147540592|NCT05919823|532133976|FG002|Open Label Period|Protocol Violation|0|||
147540593|NCT05919823|532133977|FG003|Open Label Period|Protocol Violation|1|||
147540594|NCT05919823|532133974|FG000|Open Label Period|Participant withdrew consent|0|||
147540595|NCT05919823|532133975|FG001|Open Label Period|Participant withdrew consent|0|||
147540596|NCT05919823|532133976|FG002|Open Label Period|Participant withdrew consent|8|||
147540597|NCT05919823|532133977|FG003|Open Label Period|Participant withdrew consent|6|||
147540598|NCT05919823|532133974|FG000|Open Label Period|Death|0|||
147540599|NCT05919823|532133975|FG001|Open Label Period|Death|0|||
147540600|NCT05919823|532133976|FG002|Open Label Period|Death|0|||
147540601|NCT05919823|532133977|FG003|Open Label Period|Death|1|||
147540602|NCT05919823|532133974|FG000|Open Label Period|Other reasons|0|||
147540603|NCT05919823|532133975|FG001|Open Label Period|Other reasons|0|||
147540604|NCT05919823|532133976|FG002|Open Label Period|Other reasons|9|||
147540605|NCT05919823|532133977|FG003|Open Label Period|Other reasons|5|||
147540606|NCT04521608|532133978|FG000|Overall Study|Death|8|||
147540607|NCT04521608|532133979|FG001|Overall Study|Death|9|||
147540608|NCT04521608|532133978|FG000|Overall Study|Withdrawal by Subject|25|||
147540609|NCT04521608|532133979|FG001|Overall Study|Withdrawal by Subject|18|||
147540610|NCT04521608|532133978|FG000|Overall Study|Disease Progression|3|||
147540611|NCT04521608|532133979|FG001|Overall Study|Disease Progression|10|||
147540612|NCT04521608|532133978|FG000|Overall Study|Complicating Disease|6|||
147540613|NCT04521608|532133979|FG001|Overall Study|Complicating Disease|3|||
147540614|NCT04521608|532133978|FG000|Overall Study|Lost Contact|25|||
147540615|NCT04521608|532133979|FG001|Overall Study|Lost Contact|27|||
147540616|NCT04521608|532133978|FG000|Overall Study|Ineligible|1|||
147540617|NCT04521608|532133979|FG001|Overall Study|Ineligible|0|||
147540618|NCT04521608|532133978|FG000|Overall Study|Refused Further Study Participation|13|||
147540619|NCT04521608|532133979|FG001|Overall Study|Refused Further Study Participation|7|||
147540620|NCT00285012|532133982|FG000|Assigned to Study Treatment (Tx)|Other|2|||
147540621|NCT00285012|532133983|FG001|Assigned to Study Treatment (Tx)|Other|3|||
147540622|NCT00285012|532133982|FG000|Received Study Tx|Death|2|||
147540623|NCT00285012|532133983|FG001|Received Study Tx|Death|1|||
147540624|NCT00285012|532133982|FG000|Received Study Tx|Adverse Event|5|||
147540625|NCT00285012|532133983|FG001|Received Study Tx|Adverse Event|11|||
147540626|NCT00285012|532133982|FG000|Received Study Tx|Lack of Efficacy|0|||
147540627|NCT00285012|532133983|FG001|Received Study Tx|Lack of Efficacy|3|||
147540628|NCT00285012|532133982|FG000|Received Study Tx|Lost to Follow-up|29|||
147540629|NCT00285012|532133983|FG001|Received Study Tx|Lost to Follow-up|31|||
147540630|NCT00285012|532133982|FG000|Received Study Tx|Withdrawal by Subject|31|||
147540631|NCT00285012|532133983|FG001|Received Study Tx|Withdrawal by Subject|43|||
147540632|NCT00285012|532133982|FG000|Received Study Tx|Other|5|||
147540633|NCT00285012|532133983|FG001|Received Study Tx|Other|5|||
147540634|NCT04050293|532133987|FG000|Overall Study|Lost to Follow-up|1|||
147540635|NCT04050293|532133988|FG001|Overall Study|Lost to Follow-up|2|||
147540636|NCT04050293|532133987|FG000|Overall Study|Withdrawal by Subject|2|||
147540637|NCT04050293|532133988|FG001|Overall Study|Withdrawal by Subject|0|||
147540638|NCT05631093|532133991|FG000|Overall Study|Death|0|||
147540639|NCT05631093|532133992|FG001|Overall Study|Death|1|||
147540640|NCT05631093|532133991|FG000|Overall Study|Lost to Follow-up|1|||
147540641|NCT05631093|532133992|FG001|Overall Study|Lost to Follow-up|2|||
147540642|NCT05631093|532133991|FG000|Overall Study|Physician Decision|1|||
147540643|NCT05631093|532133992|FG001|Overall Study|Physician Decision|0|||
147540644|NCT05631093|532133991|FG000|Overall Study|Withdrawal by Subject|4|||
147540645|NCT05631093|532133992|FG001|Overall Study|Withdrawal by Subject|1|||
147540646|NCT05631093|532133991|FG000|Overall Study|Ongoing|353|||
147540647|NCT05631093|532133992|FG001|Overall Study|Ongoing|177|||
147540648|NCT05631093|532133991|FG000|Overall Study|Adverse Event|0|||
147540649|NCT05631093|532133992|FG001|Overall Study|Adverse Event|1|||
147540650|NCT03494816|532134001|FG000|Overall Study|Protocol Violation|2|||
147540651|NCT03494816|532134001|FG000|Overall Study|Physician Decision|2|||
147540652|NCT03494816|532134001|FG000|Overall Study|Did not start trial treatment|1|||
147540653|NCT03494816|532134001|FG000|Overall Study|Adverse Event|1|||
147540654|NCT00005879|532134009|FG000|Overall Study|Withdrawal by Subject|8|||
147540655|NCT00005879|532134010|FG001|Overall Study|Withdrawal by Subject|10|||
147540656|NCT01238172|532134011|FG000|Overall Study|Ineligible: based on Eligibility Review|2|||
147540657|NCT01238172|532134012|FG001|Overall Study|Ineligible: based on Eligibility Review|5|||
147540658|NCT01238172|532134011|FG000|Overall Study|Ineligible: based on Central Path Review|9|||
147203929|NCT03614156|530915828|FG000|Open-Label Treatment Period|Protocol-specified withdrawal met|6|||
147203930|NCT03614156|530915829|FG001|Open-Label Treatment Period|Protocol-specified withdrawal met|0|||
147203931|NCT03614156|530915830|FG002|Open-Label Treatment Period|Protocol-specified withdrawal met|0|||
147203932|NCT03614156|530915831|FG003|Open-Label Treatment Period|Protocol-specified withdrawal met|0|||
147203933|NCT03614156|530915828|FG000|Open-Label Treatment Period|Adverse Event|7|||
147203934|NCT03614156|530915829|FG001|Open-Label Treatment Period|Adverse Event|0|||
147540659|NCT01238172|532134012|FG001|Overall Study|Ineligible: based on Central Path Review|19|||
147540660|NCT05022121|532134013|FG000|Overall Study|Lack of Efficacy|1|||
147540661|NCT05022121|532134014|FG001|Overall Study|Lack of Efficacy|0|||
147540662|NCT05022121|532134013|FG000|Overall Study|Lost to Follow-up|0|||
147540663|NCT05022121|532134014|FG001|Overall Study|Lost to Follow-up|2|||
147540664|NCT00391092|532135199|FG000|Overall Study|Death|78|||
147540665|NCT00391092|532135200|FG001|Overall Study|Death|81|||
147540666|NCT00391092|532135199|FG000|Overall Study|Lost to Follow-up|13|||
147540667|NCT00391092|532135200|FG001|Overall Study|Lost to Follow-up|18|||
147540668|NCT00391092|532135199|FG000|Overall Study|Alive on treatment|29|||
147540669|NCT00391092|532135200|FG001|Overall Study|Alive on treatment|33|||
147540670|NCT00391092|532135199|FG000|Overall Study|Alive in follow-up|88|||
147540671|NCT00391092|532135200|FG001|Overall Study|Alive in follow-up|84|||
147540672|NCT00424515|532135203|FG000|Overall Study|Progressive Disease|10|||
147540673|NCT00424515|532135204|FG001|Overall Study|Progressive Disease|11|||
147540674|NCT00424515|532135203|FG000|Overall Study|Adverse Event|0|||
147540675|NCT00424515|532135204|FG001|Overall Study|Adverse Event|1|||
147540676|NCT00424515|532135203|FG000|Overall Study|Intercurrent Illness|0|||
147540677|NCT00424515|532135204|FG001|Overall Study|Intercurrent Illness|1|||
147540678|NCT00424515|532135203|FG000|Overall Study|Withdrawal by Subject|1|||
147540679|NCT00424515|532135204|FG001|Overall Study|Withdrawal by Subject|0|||
147540680|NCT04071366|532135205|FG000|Part 1: Open-label (29 Days)|Death|4|||
147540681|NCT04071366|532135206|FG001|Part 1: Open-label (29 Days)|Death|2|||
147540682|NCT04071366|532135207|FG002|Part 1: Open-label (29 Days)|Death|8|||
147540683|NCT04071366|532135208|FG003|Part 1: Open-label (29 Days)|Death|0|||
147540684|NCT04071366|532135209|FG004|Part 1: Open-label (29 Days)|Death|0|||
147540685|NCT04071366|532135205|FG000|Part 1: Open-label (29 Days)|Progressive Disease|0|||
147540686|NCT04071366|532135206|FG001|Part 1: Open-label (29 Days)|Progressive Disease|0|||
147540687|NCT04071366|532135207|FG002|Part 1: Open-label (29 Days)|Progressive Disease|4|||
147540688|NCT04071366|532135208|FG003|Part 1: Open-label (29 Days)|Progressive Disease|0|||
147540689|NCT04071366|532135209|FG004|Part 1: Open-label (29 Days)|Progressive Disease|0|||
147540690|NCT04071366|532135205|FG000|Part 1: Open-label (29 Days)|Withdrawal by Subject|1|||
147540691|NCT04071366|532135206|FG001|Part 1: Open-label (29 Days)|Withdrawal by Subject|0|||
147540692|NCT04071366|532135207|FG002|Part 1: Open-label (29 Days)|Withdrawal by Subject|1|||
147540693|NCT04071366|532135208|FG003|Part 1: Open-label (29 Days)|Withdrawal by Subject|0|||
147540694|NCT04071366|532135209|FG004|Part 1: Open-label (29 Days)|Withdrawal by Subject|0|||
147540695|NCT04071366|532135205|FG000|Part 2: Randomized (29 Days)|Death|0|||
147540696|NCT04071366|532135206|FG001|Part 2: Randomized (29 Days)|Death|0|||
147540697|NCT04071366|532135207|FG002|Part 2: Randomized (29 Days)|Death|0|||
147540698|NCT04071366|532135208|FG003|Part 2: Randomized (29 Days)|Death|2|||
147540699|NCT04071366|532135209|FG004|Part 2: Randomized (29 Days)|Death|2|||
147540700|NCT04071366|532135205|FG000|Part 2: Randomized (29 Days)|Lost to Follow-up|0|||
147540701|NCT04071366|532135206|FG001|Part 2: Randomized (29 Days)|Lost to Follow-up|0|||
147540702|NCT04071366|532135207|FG002|Part 2: Randomized (29 Days)|Lost to Follow-up|0|||
147540703|NCT04071366|532135208|FG003|Part 2: Randomized (29 Days)|Lost to Follow-up|0|||
147540704|NCT04071366|532135209|FG004|Part 2: Randomized (29 Days)|Lost to Follow-up|1|||
147540705|NCT04071366|532135205|FG000|Part 2: Randomized (29 Days)|Physician Decision|0|||
147540706|NCT04071366|532135206|FG001|Part 2: Randomized (29 Days)|Physician Decision|0|||
147540707|NCT04071366|532135207|FG002|Part 2: Randomized (29 Days)|Physician Decision|0|||
147540708|NCT04071366|532135208|FG003|Part 2: Randomized (29 Days)|Physician Decision|0|||
147540709|NCT04071366|532135209|FG004|Part 2: Randomized (29 Days)|Physician Decision|1|||
147540710|NCT04071366|532135205|FG000|Part 2: Randomized (29 Days)|Progressive Disease|0|||
147540711|NCT04071366|532135206|FG001|Part 2: Randomized (29 Days)|Progressive Disease|0|||
147540712|NCT04071366|532135207|FG002|Part 2: Randomized (29 Days)|Progressive Disease|0|||
147540713|NCT04071366|532135208|FG003|Part 2: Randomized (29 Days)|Progressive Disease|2|||
147540714|NCT04071366|532135209|FG004|Part 2: Randomized (29 Days)|Progressive Disease|4|||
147540715|NCT04071366|532135205|FG000|Part 2: Randomized (29 Days)|Protocol Violation|0|||
147540716|NCT04071366|532135206|FG001|Part 2: Randomized (29 Days)|Protocol Violation|0|||
147540717|NCT04071366|532135207|FG002|Part 2: Randomized (29 Days)|Protocol Violation|0|||
147540718|NCT04071366|532135208|FG003|Part 2: Randomized (29 Days)|Protocol Violation|0|||
147540719|NCT04071366|532135209|FG004|Part 2: Randomized (29 Days)|Protocol Violation|1|||
147540720|NCT04071366|532135205|FG000|Part 2: Randomized (29 Days)|Withdrawal by Subject|0|||
147540721|NCT04071366|532135206|FG001|Part 2: Randomized (29 Days)|Withdrawal by Subject|0|||
147540722|NCT04071366|532135207|FG002|Part 2: Randomized (29 Days)|Withdrawal by Subject|0|||
147540723|NCT04071366|532135208|FG003|Part 2: Randomized (29 Days)|Withdrawal by Subject|1|||
147540724|NCT04071366|532135209|FG004|Part 2: Randomized (29 Days)|Withdrawal by Subject|0|||
147203935|NCT03614156|530915830|FG002|Open-Label Treatment Period|Adverse Event|0|||
147203936|NCT03614156|530915831|FG003|Open-Label Treatment Period|Adverse Event|0|||
147203937|NCT03614156|530915828|FG000|Open-Label Treatment Period|Lack of Efficacy|18|||
147203938|NCT03614156|530915829|FG001|Open-Label Treatment Period|Lack of Efficacy|0|||
147203939|NCT03614156|530915830|FG002|Open-Label Treatment Period|Lack of Efficacy|0|||
147203940|NCT03614156|530915831|FG003|Open-Label Treatment Period|Lack of Efficacy|0|||
147203941|NCT03614156|530915828|FG000|Open-Label Treatment Period|Withdrawal by Subject|36|||
147203942|NCT03614156|530915829|FG001|Open-Label Treatment Period|Withdrawal by Subject|0|||
147203943|NCT03614156|530915830|FG002|Open-Label Treatment Period|Withdrawal by Subject|0|||
147203944|NCT03614156|530915831|FG003|Open-Label Treatment Period|Withdrawal by Subject|0|||
147203945|NCT03614156|530915828|FG000|Open-Label Treatment Period|Lost to Follow-up|10|||
147203946|NCT03614156|530915829|FG001|Open-Label Treatment Period|Lost to Follow-up|0|||
147203947|NCT03614156|530915830|FG002|Open-Label Treatment Period|Lost to Follow-up|0|||
147203948|NCT03614156|530915831|FG003|Open-Label Treatment Period|Lost to Follow-up|0|||
147203949|NCT03614156|530915828|FG000|Open-Label Treatment Period|Protocol Violation|2|||
147203950|NCT03614156|530915829|FG001|Open-Label Treatment Period|Protocol Violation|0|||
147203951|NCT03614156|530915830|FG002|Open-Label Treatment Period|Protocol Violation|0|||
147203952|NCT03614156|530915831|FG003|Open-Label Treatment Period|Protocol Violation|0|||
147203953|NCT03614156|530915828|FG000|Open-Label Treatment Period|Non-compliance with study drug|1|||
147203954|NCT03614156|530915829|FG001|Open-Label Treatment Period|Non-compliance with study drug|0|||
147203955|NCT03614156|530915830|FG002|Open-Label Treatment Period|Non-compliance with study drug|0|||
147203956|NCT03614156|530915831|FG003|Open-Label Treatment Period|Non-compliance with study drug|0|||
147203957|NCT03614156|530915828|FG000|Open-Label Treatment Period|Study terminated by sponsor|74|||
147203958|NCT03614156|530915829|FG001|Open-Label Treatment Period|Study terminated by sponsor|0|||
147203959|NCT03614156|530915830|FG002|Open-Label Treatment Period|Study terminated by sponsor|0|||
147203960|NCT03614156|530915831|FG003|Open-Label Treatment Period|Study terminated by sponsor|0|||
147203961|NCT03614156|530915828|FG000|Double-Blind Treatment Period (DBTP)|Adverse Event|0|||
147203962|NCT03614156|530915829|FG001|Double-Blind Treatment Period (DBTP)|Adverse Event|2|||
147203963|NCT03614156|530915830|FG002|Double-Blind Treatment Period (DBTP)|Adverse Event|0|||
147203964|NCT03614156|530915831|FG003|Double-Blind Treatment Period (DBTP)|Adverse Event|1|||
147203965|NCT03614156|530915828|FG000|Double-Blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
147203966|NCT03614156|530915829|FG001|Double-Blind Treatment Period (DBTP)|Withdrawal by Subject|4|||
147203967|NCT03614156|530915830|FG002|Double-Blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
147203968|NCT03614156|530915831|FG003|Double-Blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
147203969|NCT03614156|530915828|FG000|Double-Blind Treatment Period (DBTP)|Lost to Follow-up|0|||
147203970|NCT03614156|530915829|FG001|Double-Blind Treatment Period (DBTP)|Lost to Follow-up|0|||
147203971|NCT03614156|530915830|FG002|Double-Blind Treatment Period (DBTP)|Lost to Follow-up|3|||
147203972|NCT03614156|530915831|FG003|Double-Blind Treatment Period (DBTP)|Lost to Follow-up|4|||
147203973|NCT03614156|530915828|FG000|Double-Blind Treatment Period (DBTP)|Protocol Violation|0|||
147203974|NCT03614156|530915829|FG001|Double-Blind Treatment Period (DBTP)|Protocol Violation|1|||
147203975|NCT03614156|530915830|FG002|Double-Blind Treatment Period (DBTP)|Protocol Violation|1|||
147203976|NCT03614156|530915831|FG003|Double-Blind Treatment Period (DBTP)|Protocol Violation|1|||
147203977|NCT03614156|530915828|FG000|Double-Blind Treatment Period (DBTP)|Study terminated by sponsor|0|||
147203978|NCT03614156|530915829|FG001|Double-Blind Treatment Period (DBTP)|Study terminated by sponsor|22|||
147203979|NCT03614156|530915830|FG002|Double-Blind Treatment Period (DBTP)|Study terminated by sponsor|26|||
147203980|NCT03614156|530915831|FG003|Double-Blind Treatment Period (DBTP)|Study terminated by sponsor|38|||
147540725|NCT04071366|532135205|FG000|Part 2: Randomized (29 Days)|Declined Further Treatment; Entered Hospice|0|||
147540726|NCT04071366|532135206|FG001|Part 2: Randomized (29 Days)|Declined Further Treatment; Entered Hospice|0|||
147203981|NCT03614156|530915828|FG000|Double-Blind Treatment Period (DBTP)|Miscellaneous Reasons|0|||
147203982|NCT03614156|530915829|FG001|Double-Blind Treatment Period (DBTP)|Miscellaneous Reasons|1|||
147540727|NCT04071366|532135207|FG002|Part 2: Randomized (29 Days)|Declined Further Treatment; Entered Hospice|0|||
147540728|NCT04071366|532135208|FG003|Part 2: Randomized (29 Days)|Declined Further Treatment; Entered Hospice|1|||
147540729|NCT04071366|532135209|FG004|Part 2: Randomized (29 Days)|Declined Further Treatment; Entered Hospice|0|||
147540730|NCT02239692|532135210|FG000|Overall Study|Incomplete colonoscopy|1|||
147540731|NCT02239692|532135211|FG001|Overall Study|Incomplete colonoscopy|2|||
147540732|NCT02239692|532135210|FG000|Overall Study|Adverse Event|0|||
147540733|NCT02239692|532135211|FG001|Overall Study|Adverse Event|1|||
147540734|NCT02239692|532135210|FG000|Overall Study|Physician Decision|0|||
147540735|NCT02239692|532135211|FG001|Overall Study|Physician Decision|1|||
147540736|NCT02239692|532135210|FG000|Overall Study|Lost to Follow-up|1|||
147540737|NCT02239692|532135211|FG001|Overall Study|Lost to Follow-up|4|||
147203983|NCT03614156|530915830|FG002|Double-Blind Treatment Period (DBTP)|Miscellaneous Reasons|0|||
147203984|NCT03614156|530915831|FG003|Double-Blind Treatment Period (DBTP)|Miscellaneous Reasons|0|||
147540738|NCT02239692|532135210|FG000|Overall Study|Withdrawal by Subject|3|||
147540739|NCT02239692|532135211|FG001|Overall Study|Withdrawal by Subject|5|||
147540740|NCT02239692|532135210|FG000|Overall Study|Other reason|1|||
147540741|NCT02239692|532135211|FG001|Overall Study|Other reason|0|||
147540742|NCT00858234|532135212|FG000|Overall Study|Adverse Event|6|||
147540743|NCT00858234|532135212|FG000|Overall Study|Progressive disease|2|||
147540744|NCT00858234|532135212|FG000|Overall Study|Status unknown|1|||
147540745|NCT01678924|532135213|FG000|Overall Study|Adverse Event|1|||
147540746|NCT01678924|532135214|FG001|Overall Study|Adverse Event|1|||
147540747|NCT01678924|532135215|FG002|Overall Study|Adverse Event|0|||
147540748|NCT01678924|532135216|FG003|Overall Study|Adverse Event|1|||
147540749|NCT01678924|532135213|FG000|Overall Study|Lack of Efficacy|7|||
147540750|NCT01678924|532135214|FG001|Overall Study|Lack of Efficacy|2|||
147540751|NCT01678924|532135215|FG002|Overall Study|Lack of Efficacy|0|||
147540752|NCT01678924|532135216|FG003|Overall Study|Lack of Efficacy|5|||
147540753|NCT01678924|532135213|FG000|Overall Study|Lost to Follow-up|0|||
147540754|NCT01678924|532135214|FG001|Overall Study|Lost to Follow-up|4|||
147540755|NCT01678924|532135215|FG002|Overall Study|Lost to Follow-up|0|||
147540756|NCT01678924|532135216|FG003|Overall Study|Lost to Follow-up|2|||
147540757|NCT01678924|532135213|FG000|Overall Study|Personal Reasons|2|||
147540758|NCT01678924|532135214|FG001|Overall Study|Personal Reasons|2|||
147540759|NCT01678924|532135215|FG002|Overall Study|Personal Reasons|2|||
147540760|NCT01678924|532135216|FG003|Overall Study|Personal Reasons|7|||
147540761|NCT01678924|532135213|FG000|Overall Study|Withdrawal by Subject|0|||
147540762|NCT01678924|532135214|FG001|Overall Study|Withdrawal by Subject|3|||
147540763|NCT01678924|532135215|FG002|Overall Study|Withdrawal by Subject|0|||
147540764|NCT01678924|532135216|FG003|Overall Study|Withdrawal by Subject|2|||
147540765|NCT01678924|532135213|FG000|Overall Study|Unable to attend scheduled visits|0|||
147540766|NCT01678924|532135214|FG001|Overall Study|Unable to attend scheduled visits|0|||
147540767|NCT01678924|532135215|FG002|Overall Study|Unable to attend scheduled visits|0|||
147540768|NCT01678924|532135216|FG003|Overall Study|Unable to attend scheduled visits|1|||
147540769|NCT02428231|532135221|FG000|Overall Study|Other|10|||
147540770|NCT02428231|532135222|FG001|Overall Study|Other|16|||
147540771|NCT02428231|532135221|FG000|Overall Study|Required Symptomatic Therapy|0|||
147540772|NCT02428231|532135222|FG001|Overall Study|Required Symptomatic Therapy|1|||
147540773|NCT02428231|532135221|FG000|Overall Study|Adverse Event|3|||
147540774|NCT02428231|532135222|FG001|Overall Study|Adverse Event|0|||
147540775|NCT03978117|532135223|FG000|Overall Study|self- withdrawal or PI withdrawal|26|||
147540776|NCT03978117|532135224|FG001|Overall Study|self- withdrawal or PI withdrawal|26|||
147540777|NCT03978117|532135223|FG000|Overall Study|Lost to Follow-up|4|||
147540778|NCT03978117|532135224|FG001|Overall Study|Lost to Follow-up|4|||
147540779|NCT00791154|532135225|FG000|Overall Study|Noncompliance|0|||
147540780|NCT00791154|532135226|FG001|Overall Study|Noncompliance|1|||
147540781|NCT00791154|532135227|FG002|Overall Study|Noncompliance|0|||
147540782|NCT00791154|532135228|FG003|Overall Study|Noncompliance|0|||
147540783|NCT00791154|532135229|FG004|Overall Study|Noncompliance|1|||
147540784|NCT00791154|532135230|FG005|Overall Study|Noncompliance|1|||
147540785|NCT00791154|532135231|FG006|Overall Study|Noncompliance|1|||
147540786|NCT00791154|532135225|FG000|Overall Study|Adverse Event|0|||
147540787|NCT00791154|532135226|FG001|Overall Study|Adverse Event|0|||
147540788|NCT00791154|532135227|FG002|Overall Study|Adverse Event|0|||
147540789|NCT00791154|532135228|FG003|Overall Study|Adverse Event|0|||
147540790|NCT00791154|532135229|FG004|Overall Study|Adverse Event|2|||
147540791|NCT00791154|532135230|FG005|Overall Study|Adverse Event|0|||
147540792|NCT00791154|532135231|FG006|Overall Study|Adverse Event|1|||
147540793|NCT00791154|532135225|FG000|Overall Study|Full Consent withdrawn|1|||
147540794|NCT00791154|532135226|FG001|Overall Study|Full Consent withdrawn|3|||
147540795|NCT00791154|532135227|FG002|Overall Study|Full Consent withdrawn|0|||
147540796|NCT00791154|532135228|FG003|Overall Study|Full Consent withdrawn|0|||
147540797|NCT00791154|532135229|FG004|Overall Study|Full Consent withdrawn|1|||
147540798|NCT00791154|532135230|FG005|Overall Study|Full Consent withdrawn|3|||
147540799|NCT00791154|532135231|FG006|Overall Study|Full Consent withdrawn|1|||
147540800|NCT00791154|532135225|FG000|Overall Study|Lost to Follow-up|0|||
147540801|NCT00791154|532135226|FG001|Overall Study|Lost to Follow-up|0|||
147540802|NCT00791154|532135227|FG002|Overall Study|Lost to Follow-up|0|||
147540803|NCT00791154|532135228|FG003|Overall Study|Lost to Follow-up|1|||
147540804|NCT00791154|532135229|FG004|Overall Study|Lost to Follow-up|2|||
147540805|NCT00791154|532135230|FG005|Overall Study|Lost to Follow-up|0|||
147540806|NCT00791154|532135231|FG006|Overall Study|Lost to Follow-up|4|||
147540807|NCT00791154|532135225|FG000|Overall Study|Death|5|||
147540808|NCT00791154|532135226|FG001|Overall Study|Death|4|||
147540809|NCT00791154|532135227|FG002|Overall Study|Death|4|||
147540810|NCT00791154|532135228|FG003|Overall Study|Death|7|||
147540811|NCT00791154|532135229|FG004|Overall Study|Death|54|||
147540812|NCT00791154|532135230|FG005|Overall Study|Death|54|||
147540813|NCT00791154|532135231|FG006|Overall Study|Death|52|||
147540814|NCT00791154|532135225|FG000|Overall Study|Other event|0|||
147540815|NCT00791154|532135226|FG001|Overall Study|Other event|0|||
147540816|NCT00791154|532135227|FG002|Overall Study|Other event|2|||
147540817|NCT00791154|532135228|FG003|Overall Study|Other event|0|||
147540818|NCT00791154|532135229|FG004|Overall Study|Other event|2|||
147540819|NCT00791154|532135230|FG005|Overall Study|Other event|4|||
147540820|NCT00791154|532135231|FG006|Overall Study|Other event|2|||
147540821|NCT00817778|532135233|FG000|Overall Study|Adverse Event|1|||
147203985|NCT03614156|530915828|FG000|Safety Follow-Up Period|Miscellaneous Reasons|2|||
147203986|NCT03614156|530915829|FG001|Safety Follow-Up Period|Miscellaneous Reasons|0|||
147203987|NCT03614156|530915830|FG002|Safety Follow-Up Period|Miscellaneous Reasons|0|||
147203988|NCT03614156|530915831|FG003|Safety Follow-Up Period|Miscellaneous Reasons|0|||
147203989|NCT03614156|530915828|FG000|Safety Follow-Up Period|Withdrawal by Subject|0|||
147203990|NCT03614156|530915829|FG001|Safety Follow-Up Period|Withdrawal by Subject|0|||
147203991|NCT03614156|530915830|FG002|Safety Follow-Up Period|Withdrawal by Subject|1|||
147203992|NCT03614156|530915831|FG003|Safety Follow-Up Period|Withdrawal by Subject|0|||
147203993|NCT03614156|530915828|FG000|Safety Follow-Up Period|Lost to Follow-up|1|||
147203994|NCT03614156|530915829|FG001|Safety Follow-Up Period|Lost to Follow-up|0|||
147203995|NCT03614156|530915830|FG002|Safety Follow-Up Period|Lost to Follow-up|0|||
147203996|NCT03614156|530915831|FG003|Safety Follow-Up Period|Lost to Follow-up|1|||
147203997|NCT01094119|530915833|FG000|Overall Study|Lack of Efficacy|2|||
147203998|NCT01094119|530915834|FG001|Overall Study|Lack of Efficacy|4|||
147203999|NCT01696188|530915835|FG000|Overall Study|Protocol Violation|1|||
147204000|NCT01696188|530915836|FG001|Overall Study|Protocol Violation|1|||
147204001|NCT02668393|530915837|FG000|Overall Study|Progressive disease|6|||
147204002|NCT02668393|530915838|FG001|Overall Study|Progressive disease|3|||
147204003|NCT02668393|530915837|FG000|Overall Study|Adverse Event|0|||
147204004|NCT02668393|530915838|FG001|Overall Study|Adverse Event|2|||
147204005|NCT02668393|530915837|FG000|Overall Study|Withdrawal from the trial|0|||
147204006|NCT02668393|530915838|FG001|Overall Study|Withdrawal from the trial|1|||
147204007|NCT02668393|530915837|FG000|Overall Study|Lack of benefit and side effects|1|||
147204008|NCT02668393|530915838|FG001|Overall Study|Lack of benefit and side effects|0|||
147204009|NCT00606593|530915839|FG000|Overall Study|Adverse Event|0|||
147204010|NCT00606593|530915840|FG001|Overall Study|Adverse Event|0|||
147204011|NCT00606593|530915841|FG002|Overall Study|Adverse Event|0|||
147204012|NCT00606593|530915842|FG003|Overall Study|Adverse Event|1|||
147204013|NCT00606593|530915843|FG004|Overall Study|Adverse Event|1|||
147204014|NCT00606593|530915844|FG005|Overall Study|Adverse Event|0|||
147204015|NCT00606593|530915845|FG006|Overall Study|Adverse Event|1|||
147204016|NCT00606593|530915846|FG007|Overall Study|Adverse Event|2|||
147204017|NCT00606593|530915847|FG008|Overall Study|Adverse Event|1|||
147204018|NCT00606593|530915848|FG009|Overall Study|Adverse Event|0|||
147204019|NCT00606593|530915839|FG000|Overall Study|Withdrawal of consent|1|||
147204020|NCT00606593|530915840|FG001|Overall Study|Withdrawal of consent|0|||
147204021|NCT00606593|530915841|FG002|Overall Study|Withdrawal of consent|1|||
147204022|NCT00606593|530915842|FG003|Overall Study|Withdrawal of consent|0|||
147204023|NCT00606593|530915843|FG004|Overall Study|Withdrawal of consent|0|||
147204024|NCT00606593|530915844|FG005|Overall Study|Withdrawal of consent|0|||
147204025|NCT00606593|530915845|FG006|Overall Study|Withdrawal of consent|0|||
147204026|NCT00606593|530915846|FG007|Overall Study|Withdrawal of consent|0|||
147204027|NCT00606593|530915847|FG008|Overall Study|Withdrawal of consent|0|||
147204028|NCT00606593|530915848|FG009|Overall Study|Withdrawal of consent|0|||
147204029|NCT00606593|530915839|FG000|Overall Study|Administrative/Other|0|||
147204030|NCT00606593|530915840|FG001|Overall Study|Administrative/Other|0|||
147204031|NCT00606593|530915841|FG002|Overall Study|Administrative/Other|1|||
147204032|NCT00606593|530915842|FG003|Overall Study|Administrative/Other|0|||
147204033|NCT00606593|530915843|FG004|Overall Study|Administrative/Other|0|||
147204034|NCT00606593|530915844|FG005|Overall Study|Administrative/Other|0|||
147204035|NCT00606593|530915845|FG006|Overall Study|Administrative/Other|0|||
147204036|NCT00606593|530915846|FG007|Overall Study|Administrative/Other|0|||
147204037|NCT00606593|530915847|FG008|Overall Study|Administrative/Other|0|||
147204038|NCT00606593|530915848|FG009|Overall Study|Administrative/Other|0|||
147204039|NCT03181529|530915849|FG000|Overall Study|Withdrawal by Subject|1|||
147204040|NCT03181529|530915850|FG001|Overall Study|Withdrawal by Subject|1|||
147204041|NCT03181529|530915849|FG000|Overall Study|Dropped out of study due to sleep difficulties. Sleep difficulties were also reported at screening|1|||
147204042|NCT03181529|530915850|FG001|Overall Study|Dropped out of study due to sleep difficulties. Sleep difficulties were also reported at screening|0|||
147204043|NCT00536744|530915851|FG000|Overall Study|Adverse Event|13|||
147204044|NCT00536744|530915852|FG001|Overall Study|Adverse Event|10|||
147204045|NCT00536744|530915851|FG000|Overall Study|Death|2|||
147204046|NCT00536744|530915852|FG001|Overall Study|Death|1|||
147204047|NCT00536744|530915851|FG000|Overall Study|Physician Decision|3|||
147204048|NCT00536744|530915852|FG001|Overall Study|Physician Decision|1|||
147204049|NCT00536744|530915851|FG000|Overall Study|Lost to Follow-up|3|||
147204050|NCT00536744|530915852|FG001|Overall Study|Lost to Follow-up|5|||
147204051|NCT00536744|530915851|FG000|Overall Study|Withdrawal by Subject|7|||
147204052|NCT00536744|530915852|FG001|Overall Study|Withdrawal by Subject|8|||
147204053|NCT00536744|530915851|FG000|Overall Study|PI tried alternative treatment|1|||
147204054|NCT00536744|530915852|FG001|Overall Study|PI tried alternative treatment|3|||
147204055|NCT02581410|530915853|FG000|Vaccination Phase|Adverse Event|2|||
147204056|NCT02581410|530915854|FG001|Vaccination Phase|Adverse Event|1|||
147204057|NCT02581410|530915853|FG000|Vaccination Phase|Withdrawal by Subject|0|||
147204058|NCT02581410|530915854|FG001|Vaccination Phase|Withdrawal by Subject|1|||
147204059|NCT02581410|530915853|FG000|Vaccination Phase|Migrated/moved from study area|0|||
147204060|NCT02581410|530915854|FG001|Vaccination Phase|Migrated/moved from study area|1|||
147204061|NCT02581410|530915853|FG000|End of Study Phase|Adverse Event|4|||
147204062|NCT02581410|530915854|FG001|End of Study Phase|Adverse Event|3|||
147204063|NCT02581410|530915853|FG000|End of Study Phase|Withdrawal by Subject|1|||
147204064|NCT02581410|530915854|FG001|End of Study Phase|Withdrawal by Subject|2|||
147204065|NCT02581410|530915853|FG000|End of Study Phase|Migrated/moved from study area|0|||
147204066|NCT02581410|530915854|FG001|End of Study Phase|Migrated/moved from study area|3|||
147204067|NCT02581410|530915853|FG000|End of Study Phase|Lost to Follow-up|0|||
147204068|NCT02581410|530915854|FG001|End of Study Phase|Lost to Follow-up|2|||
147204069|NCT02581410|530915853|FG000|End of Study Phase|Other-transfer of subject not completed|0|||
147204070|NCT02581410|530915854|FG001|End of Study Phase|Other-transfer of subject not completed|1|||
147204071|NCT02876601|530915855|FG000|Washout (Minimum of 6 Weeks)|unforeseen unavailability|0|||
147204072|NCT02876601|530915856|FG001|Washout (Minimum of 6 Weeks)|unforeseen unavailability|0|||
147204073|NCT02876601|530915857|FG002|Washout (Minimum of 6 Weeks)|unforeseen unavailability|1|||
147204074|NCT02876601|530915858|FG003|Washout (Minimum of 6 Weeks)|unforeseen unavailability|0|||
147204075|NCT04774094|530915859|FG000|Overall Study|Other|2|||
147204076|NCT04774094|530915859|FG000|Overall Study|Withdrawal by Subject|9|||
147204077|NCT04774094|530915859|FG000|Overall Study|Lost to Follow-up|7|||
147204078|NCT04774094|530915859|FG000|Overall Study|Lack of Efficacy|5|||
147204079|NCT04774094|530915859|FG000|Overall Study|Death|17|||
147204080|NCT04774094|530915859|FG000|Overall Study|Adverse Event|4|||
147204081|NCT05232682|530915862|FG000|Overall Study|Lost to Follow-up|2|||
147204082|NCT03207763|530917333|FG000|Overall Study|Lost to Follow-up|1|||
147204083|NCT03207763|530917334|FG001|Overall Study|Lost to Follow-up|0|||
147204084|NCT03751657|530917335|FG000|Overall Study|Physician Decision|0|||
147204085|NCT03751657|530917336|FG001|Overall Study|Physician Decision|1|||
147204086|NCT03751657|530917335|FG000|Overall Study|Withdrawal by Subject|1|||
147204087|NCT03751657|530917336|FG001|Overall Study|Withdrawal by Subject|1|||
147204088|NCT03751657|530917335|FG000|Overall Study|Lost to Follow-up|2|||
147204089|NCT03751657|530917336|FG001|Overall Study|Lost to Follow-up|1|||
147204090|NCT01938716|530917340|FG000|Overall Study|Physician Decision|2|||
147204091|NCT01938716|530917340|FG000|Overall Study|Withdrawal by Subject|2|||
147204092|NCT01358721|530917341|FG000|Overall Study|Withdrawal by Subject|0|||
147204093|NCT01358721|530917342|FG001|Overall Study|Withdrawal by Subject|0|||
147204094|NCT01358721|530917343|FG002|Overall Study|Withdrawal by Subject|0|||
147204095|NCT01358721|530917344|FG003|Overall Study|Withdrawal by Subject|1|||
147204096|NCT01358721|530917341|FG000|Overall Study|Death|0|||
147204097|NCT01358721|530917342|FG001|Overall Study|Death|2|||
147204098|NCT01358721|530917343|FG002|Overall Study|Death|0|||
147204099|NCT01358721|530917344|FG003|Overall Study|Death|0|||
147204100|NCT01358721|530917341|FG000|Overall Study|Study Drug Toxicity|1|||
147204101|NCT01358721|530917342|FG001|Overall Study|Study Drug Toxicity|3|||
147204102|NCT01358721|530917343|FG002|Overall Study|Study Drug Toxicity|4|||
147204103|NCT01358721|530917344|FG003|Overall Study|Study Drug Toxicity|5|||
147204104|NCT01358721|530917341|FG000|Overall Study|SUBJ request to discontinue study TRT|0|||
147204105|NCT01358721|530917342|FG001|Overall Study|SUBJ request to discontinue study TRT|0|||
147204106|NCT01358721|530917343|FG002|Overall Study|SUBJ request to discontinue study TRT|0|||
147204107|NCT01358721|530917344|FG003|Overall Study|SUBJ request to discontinue study TRT|1|||
147204108|NCT01358721|530917341|FG000|Overall Study|Subject No Longer Meets Study Criteria|0|||
147204109|NCT01358721|530917342|FG001|Overall Study|Subject No Longer Meets Study Criteria|2|||
147204110|NCT01358721|530917343|FG002|Overall Study|Subject No Longer Meets Study Criteria|0|||
147204111|NCT01358721|530917344|FG003|Overall Study|Subject No Longer Meets Study Criteria|1|||
147438926|NCT01994382|531772157|FG010|Overall Study|Rolled over to Phase 2a|0|||
147438927|NCT01994382|531772158|FG011|Overall Study|Rolled over to Phase 2a|0|||
147438928|NCT01994382|531772159|FG012|Overall Study|Rolled over to Phase 2a|0|||
147438929|NCT01994382|531772160|FG013|Overall Study|Rolled over to Phase 2a|0|||
147438930|NCT01994382|531772161|FG014|Overall Study|Rolled over to Phase 2a|0|||
147438931|NCT01994382|531772162|FG015|Overall Study|Rolled over to Phase 2a|0|||
147438932|NCT01994382|531772163|FG016|Overall Study|Rolled over to Phase 2a|0|||
147438933|NCT01011439|531772164|FG000|Overall Study|Death|37|||
147438934|NCT01011439|531772164|FG000|Overall Study|Lost to Follow-up|4|||
147438935|NCT01011439|531772164|FG000|Overall Study|Withdrawal by Subject|1|||
147438936|NCT01011439|531772164|FG000|Overall Study|Sponsor's decision|15|||
147438937|NCT02428855|531772165|FG000|Overall Study|Withdrawal by Subject|2|||
147438938|NCT00359021|531772166|FG000|Overall Study|Adverse Event|26|||
147438939|NCT00359021|531772167|FG001|Overall Study|Adverse Event|8|||
147204112|NCT01358721|530917341|FG000|Overall Study|Adverse Event related to study drug|1|||
147204113|NCT01358721|530917342|FG001|Overall Study|Adverse Event related to study drug|0|||
147204114|NCT01358721|530917343|FG002|Overall Study|Adverse Event related to study drug|0|||
147204115|NCT01358721|530917344|FG003|Overall Study|Adverse Event related to study drug|1|||
147204116|NCT01358721|530917341|FG000|Overall Study|Disease Progression|19|||
147204117|NCT01358721|530917342|FG001|Overall Study|Disease Progression|15|||
147204118|NCT01358721|530917343|FG002|Overall Study|Disease Progression|17|||
147204119|NCT01358721|530917344|FG003|Overall Study|Disease Progression|15|||
147204120|NCT01358721|530917341|FG000|Overall Study|Out of State/Unmet Criteria|0|||
147204121|NCT01358721|530917342|FG001|Overall Study|Out of State/Unmet Criteria|0|||
147204122|NCT01358721|530917343|FG002|Overall Study|Out of State/Unmet Criteria|1|||
147204123|NCT01358721|530917344|FG003|Overall Study|Out of State/Unmet Criteria|0|||
147204124|NCT02446899|530917349|FG000|Overall Study|Adverse Event|4|||
147204125|NCT02446899|530917350|FG001|Overall Study|Adverse Event|7|||
147204126|NCT02446899|530917349|FG000|Overall Study|Condition Under Investigation Worsened|1|||
147204127|NCT02446899|530917350|FG001|Overall Study|Condition Under Investigation Worsened|4|||
147204128|NCT02446899|530917349|FG000|Overall Study|Study Specific Withdrawal Criteria|1|||
147204129|NCT02446899|530917350|FG001|Overall Study|Study Specific Withdrawal Criteria|0|||
147204130|NCT02446899|530917349|FG000|Overall Study|Lack of Efficacy|2|||
147204131|NCT02446899|530917350|FG001|Overall Study|Lack of Efficacy|8|||
147204132|NCT02446899|530917349|FG000|Overall Study|Lost to Follow-up|1|||
147204133|NCT02446899|530917350|FG001|Overall Study|Lost to Follow-up|3|||
147204134|NCT02446899|530917349|FG000|Overall Study|Severe Non-Compliance to Protocol|0|||
147204135|NCT02446899|530917350|FG001|Overall Study|Severe Non-Compliance to Protocol|1|||
147204136|NCT02446899|530917349|FG000|Overall Study|Withdrawal by Subject|11|||
147204137|NCT02446899|530917350|FG001|Overall Study|Withdrawal by Subject|19|||
147204138|NCT02446899|530917349|FG000|Overall Study|Miscellaneous|5|||
147204139|NCT02446899|530917350|FG001|Overall Study|Miscellaneous|4|||
147204140|NCT02446899|530917349|FG000|Overall Study|Failure to Meet Randomization Criteria|0|||
147204141|NCT02446899|530917350|FG001|Overall Study|Failure to Meet Randomization Criteria|2|||
147204142|NCT04730271|530917352|FG000|Overall Study|Adverse Event|0|||
147204143|NCT04730271|530917353|FG001|Overall Study|Adverse Event|2|||
147204144|NCT04730271|530917352|FG000|Overall Study|Withdrawal by Subject|1|||
147204145|NCT04730271|530917353|FG001|Overall Study|Withdrawal by Subject|1|||
147204146|NCT04730271|530917352|FG000|Overall Study|Protocol Violation|7|||
147204147|NCT04730271|530917353|FG001|Overall Study|Protocol Violation|13|||
147204148|NCT04730271|530917352|FG000|Overall Study|Lost to Follow-up|3|||
147204149|NCT04730271|530917353|FG001|Overall Study|Lost to Follow-up|3|||
147204150|NCT04730271|530917352|FG000|Overall Study|Death|1|||
147204151|NCT04730271|530917353|FG001|Overall Study|Death|0|||
147204152|NCT02223858|530917356|FG000|Overall Study|Death|1|||
147204153|NCT02223858|530917357|FG001|Overall Study|Death|1|||
147204154|NCT02223858|530917356|FG000|Overall Study|Lost to Follow-up|6|||
147204155|NCT02223858|530917357|FG001|Overall Study|Lost to Follow-up|11|||
147204156|NCT02223858|530917356|FG000|Overall Study|Withdrawal by Subject|8|||
147204157|NCT02223858|530917357|FG001|Overall Study|Withdrawal by Subject|5|||
147204158|NCT02223858|530917356|FG000|Overall Study|Refused|9|||
147204159|NCT02223858|530917357|FG001|Overall Study|Refused|9|||
147204160|NCT04455815|530917360|FG000|Randomisation Phase|Adverse Event|1|||
147204161|NCT04455815|530917361|FG001|Randomisation Phase|Adverse Event|0|||
147204162|NCT04455815|530917360|FG000|Treatment Phase|Adverse Event|0|||
147204163|NCT04455815|530917361|FG001|Treatment Phase|Adverse Event|1|||
147204164|NCT04455815|530917360|FG000|Treatment Phase|Hospital admission and treatment stopped in hospital|1|||
147204165|NCT04455815|530917361|FG001|Treatment Phase|Hospital admission and treatment stopped in hospital|0|||
147204166|NCT04455815|530917360|FG000|Treatment Phase|Withdrawal by Subject|1|||
147204167|NCT04455815|530917361|FG001|Treatment Phase|Withdrawal by Subject|1|||
147204168|NCT02106390|530917362|FG000|Overall Study|Withdrawal by Subject|15|||
147204169|NCT02106390|530917363|FG001|Overall Study|Withdrawal by Subject|16|||
147204170|NCT02106390|530917364|FG002|Overall Study|Withdrawal by Subject|15|||
147204171|NCT02106390|530917362|FG000|Overall Study|Lost to Follow-up|25|||
147204172|NCT02106390|530917363|FG001|Overall Study|Lost to Follow-up|20|||
147204173|NCT02106390|530917364|FG002|Overall Study|Lost to Follow-up|13|||
147204174|NCT02106390|530917362|FG000|Overall Study|Other: Administrative Reason|8|||
147204175|NCT02106390|530917363|FG001|Overall Study|Other: Administrative Reason|5|||
147204176|NCT02106390|530917364|FG002|Overall Study|Other: Administrative Reason|12|||
147204177|NCT02106390|530917362|FG000|Overall Study|Other: Unspecified|1|||
147204178|NCT02106390|530917363|FG001|Overall Study|Other: Unspecified|4|||
147204179|NCT02106390|530917364|FG002|Overall Study|Other: Unspecified|2|||
147204180|NCT02106390|530917362|FG000|Overall Study|Adverse Event|0|||
147204181|NCT02106390|530917363|FG001|Overall Study|Adverse Event|2|||
147204182|NCT02106390|530917364|FG002|Overall Study|Adverse Event|1|||
147204183|NCT02106390|530917362|FG000|Overall Study|Protocol Violation|0|||
147204184|NCT02106390|530917363|FG001|Overall Study|Protocol Violation|1|||
147204185|NCT02106390|530917364|FG002|Overall Study|Protocol Violation|0|||
147204186|NCT00473382|530917365|FG000|Core Study|Adverse Event|3|||
147204187|NCT00473382|530917366|FG001|Core Study|Adverse Event|1|||
147204188|NCT00473382|530917367|FG002|Core Study|Adverse Event|1|||
147204189|NCT00473382|530917365|FG000|Core Study|Death|3|||
147204190|NCT00473382|530917366|FG001|Core Study|Death|5|||
147204191|NCT00473382|530917367|FG002|Core Study|Death|10|||
147204192|NCT00473382|530917365|FG000|Core Study|Lost to Follow-up|3|||
147204193|NCT00473382|530917366|FG001|Core Study|Lost to Follow-up|3|||
147204194|NCT00473382|530917367|FG002|Core Study|Lost to Follow-up|3|||
147204195|NCT00473382|530917365|FG000|Core Study|Physician Decision|1|||
147540822|NCT00817778|532135234|FG001|Overall Study|Adverse Event|0|||
147204196|NCT00473382|530917366|FG001|Core Study|Physician Decision|2|||
147204197|NCT00473382|530917367|FG002|Core Study|Physician Decision|2|||
147204198|NCT00473382|530917365|FG000|Core Study|Subject non-compliance|5|||
147204199|NCT00473382|530917366|FG001|Core Study|Subject non-compliance|2|||
147204200|NCT00473382|530917367|FG002|Core Study|Subject non-compliance|1|||
147204201|NCT00473382|530917365|FG000|Core Study|Subject needed other treatment|1|||
147204202|NCT00473382|530917366|FG001|Core Study|Subject needed other treatment|3|||
147204203|NCT00473382|530917367|FG002|Core Study|Subject needed other treatment|2|||
147204204|NCT00473382|530917365|FG000|Core Study|Subject's decision|12|||
147204205|NCT00473382|530917366|FG001|Core Study|Subject's decision|11|||
147204206|NCT00473382|530917367|FG002|Core Study|Subject's decision|10|||
147204207|NCT00473382|530917365|FG000|Open-label Extension Through Month 48|Adverse Event|0|||
147204208|NCT00473382|530917366|FG001|Open-label Extension Through Month 48|Adverse Event|0|||
147204209|NCT00473382|530917367|FG002|Open-label Extension Through Month 48|Adverse Event|1|||
147204210|NCT00473382|530917365|FG000|Open-label Extension Through Month 48|Death|1|||
147204211|NCT00473382|530917366|FG001|Open-label Extension Through Month 48|Death|3|||
147204212|NCT00473382|530917367|FG002|Open-label Extension Through Month 48|Death|3|||
147204213|NCT00473382|530917365|FG000|Open-label Extension Through Month 48|Lost to Follow-up|1|||
147204214|NCT00473382|530917366|FG001|Open-label Extension Through Month 48|Lost to Follow-up|2|||
147204215|NCT00473382|530917367|FG002|Open-label Extension Through Month 48|Lost to Follow-up|1|||
147204216|NCT00473382|530917365|FG000|Open-label Extension Through Month 48|Subject's Decision|5|||
147204217|NCT00473382|530917366|FG001|Open-label Extension Through Month 48|Subject's Decision|1|||
147204218|NCT00473382|530917367|FG002|Open-label Extension Through Month 48|Subject's Decision|6|||
147204219|NCT00473382|530917365|FG000|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|41|||
147204220|NCT00473382|530917366|FG001|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|34|||
147204221|NCT00473382|530917367|FG002|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|36|||
147204222|NCT00473382|530917365|FG000|Open-label Extension Through Month 48|Subject Required Other Intervention|2|||
147204223|NCT00473382|530917366|FG001|Open-label Extension Through Month 48|Subject Required Other Intervention|1|||
147204224|NCT00473382|530917367|FG002|Open-label Extension Through Month 48|Subject Required Other Intervention|0|||
147204225|NCT00473382|530917365|FG000|Open-label Extension Through Month 60|Adverse Event|0|||
147204226|NCT00473382|530917366|FG001|Open-label Extension Through Month 60|Adverse Event|0|||
147204227|NCT00473382|530917367|FG002|Open-label Extension Through Month 60|Adverse Event|2|||
147204228|NCT00473382|530917365|FG000|Open-label Extension Through Month 60|Death|1|||
147204229|NCT00473382|530917366|FG001|Open-label Extension Through Month 60|Death|7|||
147204230|NCT00473382|530917367|FG002|Open-label Extension Through Month 60|Death|4|||
147204231|NCT00473382|530917365|FG000|Open-label Extension Through Month 60|Lost to Follow-up|1|||
147204232|NCT00473382|530917366|FG001|Open-label Extension Through Month 60|Lost to Follow-up|3|||
147204233|NCT00473382|530917367|FG002|Open-label Extension Through Month 60|Lost to Follow-up|1|||
147204234|NCT00473382|530917365|FG000|Open-label Extension Through Month 60|Subject's Decision|7|||
147204235|NCT00473382|530917366|FG001|Open-label Extension Through Month 60|Subject's Decision|1|||
147204236|NCT00473382|530917367|FG002|Open-label Extension Through Month 60|Subject's Decision|6|||
147204237|NCT00473382|530917365|FG000|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|75|||
147204238|NCT00473382|530917366|FG001|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|70|||
147204239|NCT00473382|530917367|FG002|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|69|||
147204240|NCT00473382|530917365|FG000|Open-label Extension Through Month 60|Subject Required Other Intervention|2|||
147204241|NCT00473382|530917366|FG001|Open-label Extension Through Month 60|Subject Required Other Intervention|1|||
147204242|NCT00473382|530917367|FG002|Open-label Extension Through Month 60|Subject Required Other Intervention|0|||
147204243|NCT01189032|530917368|FG000|Overall Study|Adverse Event|1|||
147204244|NCT01189032|530917369|FG001|Overall Study|Adverse Event|3|||
147204245|NCT01189032|530917370|FG002|Overall Study|Adverse Event|4|||
147204246|NCT01189032|530917368|FG000|Overall Study|Lack of Efficacy|2|||
147204247|NCT01189032|530917369|FG001|Overall Study|Lack of Efficacy|3|||
147204248|NCT01189032|530917370|FG002|Overall Study|Lack of Efficacy|0|||
147204249|NCT01189032|530917368|FG000|Overall Study|Withdrawal by Subject|1|||
147204250|NCT01189032|530917369|FG001|Overall Study|Withdrawal by Subject|0|||
147204251|NCT01189032|530917370|FG002|Overall Study|Withdrawal by Subject|1|||
147204252|NCT01189032|530917368|FG000|Overall Study|Protocol Violation|1|||
147204253|NCT01189032|530917369|FG001|Overall Study|Protocol Violation|1|||
147204254|NCT01189032|530917370|FG002|Overall Study|Protocol Violation|1|||
147204255|NCT01166282|530917371|FG000|Open-label Period|Adverse Event|0|||
147204256|NCT01166282|530917372|FG001|Open-label Period|Adverse Event|0|||
147204257|NCT01166282|530917373|FG002|Open-label Period|Adverse Event|6|||
147204258|NCT01166282|530917371|FG000|Open-label Period|Withdrawal by Subject|0|||
147204259|NCT01166282|530917372|FG001|Open-label Period|Withdrawal by Subject|0|||
147204260|NCT01166282|530917373|FG002|Open-label Period|Withdrawal by Subject|4|||
147204261|NCT01166282|530917371|FG000|Open-label Period|Lack of Efficacy|0|||
147204262|NCT01166282|530917372|FG001|Open-label Period|Lack of Efficacy|0|||
147204263|NCT01166282|530917373|FG002|Open-label Period|Lack of Efficacy|2|||
147204264|NCT01166282|530917371|FG000|Open-label Period|Remission|0|||
147204265|NCT01166282|530917372|FG001|Open-label Period|Remission|0|||
147204266|NCT01166282|530917373|FG002|Open-label Period|Remission|4|||
147204267|NCT01166282|530917371|FG000|Open-label Period|Irregular Compliance|0|||
147204268|NCT01166282|530917372|FG001|Open-label Period|Irregular Compliance|0|||
147204269|NCT01166282|530917373|FG002|Open-label Period|Irregular Compliance|1|||
147204270|NCT02577718|530917374|FG000|Overall Study|Death|6|||
147204271|NCT02577718|530917374|FG000|Overall Study|Withdrawal by Subject|2|||
147204272|NCT01995838|530917379|FG000|Overall Study|Lost to Follow-up|0|||
147204273|NCT01995838|530917380|FG001|Overall Study|Lost to Follow-up|1|||
147204274|NCT01995838|530917381|FG002|Overall Study|Lost to Follow-up|0|||
147204275|NCT01995838|530917382|FG003|Overall Study|Lost to Follow-up|0|||
147204276|NCT01995838|530917383|FG004|Overall Study|Lost to Follow-up|0|||
147204277|NCT01995838|530917384|FG005|Overall Study|Lost to Follow-up|0|||
147204278|NCT01995838|530917385|FG006|Overall Study|Lost to Follow-up|1|||
147204279|NCT01995838|530917379|FG000|Overall Study|Participant choice|2|||
147204280|NCT01995838|530917380|FG001|Overall Study|Participant choice|0|||
147204281|NCT01995838|530917381|FG002|Overall Study|Participant choice|0|||
147204282|NCT01995838|530917382|FG003|Overall Study|Participant choice|0|||
147204283|NCT01995838|530917383|FG004|Overall Study|Participant choice|0|||
147204284|NCT01995838|530917384|FG005|Overall Study|Participant choice|1|||
147204285|NCT01995838|530917385|FG006|Overall Study|Participant choice|1|||
147204286|NCT01995838|530917379|FG000|Overall Study|Adverse Event|0|||
147204287|NCT01995838|530917380|FG001|Overall Study|Adverse Event|0|||
147204288|NCT01995838|530917381|FG002|Overall Study|Adverse Event|0|||
147204289|NCT01995838|530917382|FG003|Overall Study|Adverse Event|0|||
147204290|NCT01995838|530917383|FG004|Overall Study|Adverse Event|0|||
147204291|NCT01995838|530917384|FG005|Overall Study|Adverse Event|0|||
147204292|NCT01995838|530917385|FG006|Overall Study|Adverse Event|1|||
147204293|NCT01995838|530917379|FG000|Overall Study|Withdrawal by Subject|0|||
147204294|NCT01995838|530917380|FG001|Overall Study|Withdrawal by Subject|0|||
147204295|NCT01995838|530917381|FG002|Overall Study|Withdrawal by Subject|0|||
147204296|NCT01995838|530917382|FG003|Overall Study|Withdrawal by Subject|0|||
147204297|NCT01995838|530917383|FG004|Overall Study|Withdrawal by Subject|1|||
147204298|NCT01995838|530917384|FG005|Overall Study|Withdrawal by Subject|0|||
147204299|NCT01995838|530917385|FG006|Overall Study|Withdrawal by Subject|0|||
147204300|NCT01995838|530917379|FG000|Overall Study|Other|3|||
147204301|NCT01995838|530917380|FG001|Overall Study|Other|1|||
147204302|NCT01995838|530917381|FG002|Overall Study|Other|0|||
147204303|NCT01995838|530917382|FG003|Overall Study|Other|2|||
147204304|NCT01995838|530917383|FG004|Overall Study|Other|1|||
147204305|NCT01995838|530917384|FG005|Overall Study|Other|1|||
147204306|NCT01995838|530917385|FG006|Overall Study|Other|2|||
147204307|NCT00275509|530917386|FG000|Overall Study|graft thrombosis, post-operative day #8|0|||
147204308|NCT00275509|530917387|FG001|Overall Study|graft thrombosis, post-operative day #8|1|||
147204309|NCT02819804|530917388|FG000|Complete Cycle 1 (28 Days)|Progressive disease/no response|1|||
147204310|NCT03196349|530917389|FG000|Overall Study|Did not receive study drug|0|||
147204311|NCT03196349|530917390|FG001|Overall Study|Did not receive study drug|1|||
147204312|NCT03196349|530917391|FG002|Overall Study|Did not receive study drug|2|||
147204313|NCT03196349|530917389|FG000|Overall Study|No data entered|2|||
147204314|NCT03196349|530917390|FG001|Overall Study|No data entered|4|||
147204315|NCT03196349|530917391|FG002|Overall Study|No data entered|0|||
147204316|NCT03196349|530917389|FG000|Overall Study|Study Terminated early|15|||
147204317|NCT03196349|530917390|FG001|Overall Study|Study Terminated early|9|||
147204318|NCT03196349|530917391|FG002|Overall Study|Study Terminated early|11|||
147204319|NCT03388164|530917396|FG000|Overall Study|Withdrawal by Subject|3|||
147204320|NCT03388164|530917397|FG001|Overall Study|Withdrawal by Subject|1|||
147204321|NCT00686686|530917399|FG000|Overall Study|Non-compliance|1|||
147204322|NCT00686686|530917399|FG000|Overall Study|Adverse Event|2|||
147204323|NCT00686686|530917399|FG000|Overall Study|Lost to Follow-up|3|||
147204324|NCT01012440|530917400|FG000|Overall Study|Withdrawal by Subject|2|||
147204325|NCT00131248|530917402|FG000|Intervention 1 (3-day Course)|Withdrawal by Subject|1|||
147204326|NCT00131248|530917403|FG001|Intervention 1 (3-day Course)|Withdrawal by Subject|0|||
147204327|NCT00477386|530917411|FG000|Overall Study|Adverse Event|4|||
147204328|NCT00477386|530917412|FG001|Overall Study|Adverse Event|8|||
147204329|NCT00477386|530917411|FG000|Overall Study|Disease progression, relapse|3|||
147204330|NCT00477386|530917412|FG001|Overall Study|Disease progression, relapse|4|||
147204331|NCT00477386|530917411|FG000|Overall Study|Disease progression, refractory|1|||
147204332|NCT00477386|530917412|FG001|Overall Study|Disease progression, refractory|3|||
147204333|NCT00477386|530917411|FG000|Overall Study|Other|1|||
147204334|NCT00477386|530917412|FG001|Overall Study|Other|2|||
147204335|NCT00477386|530917411|FG000|Overall Study|Physician Decision|1|||
147204336|NCT00477386|530917412|FG001|Overall Study|Physician Decision|0|||
147204337|NCT00477386|530917411|FG000|Overall Study|Withdrawal by Subject|1|||
147204338|NCT00477386|530917412|FG001|Overall Study|Withdrawal by Subject|0|||
147204339|NCT01254422|530917413|FG000|Overall Study|Protocol Violation|1|||
147204340|NCT01254422|530917414|FG001|Overall Study|Protocol Violation|0|||
147204341|NCT01254422|530917413|FG000|Overall Study|Adverse Event|1|||
147204342|NCT01254422|530917414|FG001|Overall Study|Adverse Event|0|||
147204343|NCT01254422|530917413|FG000|Overall Study|Serious adverse event|0|||
147204344|NCT01254422|530917414|FG001|Overall Study|Serious adverse event|1|||
147204345|NCT01254422|530917413|FG000|Overall Study|Lost to Follow-up|1|||
147540823|NCT00817778|532135233|FG000|Overall Study|Withdrawal by Subject|1|||
147540824|NCT00817778|532135234|FG001|Overall Study|Withdrawal by Subject|1|||
147540825|NCT00817778|532135233|FG000|Overall Study|Protocol Violation|0|||
147204346|NCT01254422|530917414|FG001|Overall Study|Lost to Follow-up|0|||
147204347|NCT02207088|530917415|FG000|Overall Study|Adverse Event|2|||
147204348|NCT00643162|530917416|FG000|Overall Study|Withdrawal by Subject|1|||
147204349|NCT00643162|530917417|FG001|Overall Study|Withdrawal by Subject|1|||
147204350|NCT02691507|530917418|FG000|Overall Study|Missed Visit 3|0|||
147204351|NCT02691507|530917419|FG001|Overall Study|Missed Visit 3|1|||
147204352|NCT03023397|530917420|FG000|Run-In|Failed screening allergen challenge|1|||
147204353|NCT03023397|530917421|FG001|Run-In|Failed screening allergen challenge|0|||
147204354|NCT03023397|530917422|FG002|Run-In|Failed screening allergen challenge|0|||
147204355|NCT03023397|530917420|FG000|Run-In|Loss of funding after informed consent but before screening allergen challenge|1|||
147204356|NCT03023397|530917421|FG001|Run-In|Loss of funding after informed consent but before screening allergen challenge|0|||
147204357|NCT03023397|530917422|FG002|Run-In|Loss of funding after informed consent but before screening allergen challenge|0|||
147204358|NCT01587924|530917423|FG000|Overall Study|Adverse Event|0|||
147204359|NCT01587924|530917424|FG001|Overall Study|Adverse Event|2|||
147204360|NCT01587924|530917425|FG002|Overall Study|Adverse Event|0|||
147204361|NCT01587924|530917426|FG003|Overall Study|Adverse Event|0|||
147204362|NCT01587924|530917423|FG000|Overall Study|Protocol Violation|2|||
147204363|NCT01587924|530917424|FG001|Overall Study|Protocol Violation|1|||
147204364|NCT01587924|530917425|FG002|Overall Study|Protocol Violation|2|||
147204365|NCT01587924|530917426|FG003|Overall Study|Protocol Violation|1|||
147204366|NCT01587924|530917423|FG000|Overall Study|Met Hemoglobin stopping criteria|2|||
147204367|NCT01587924|530917424|FG001|Overall Study|Met Hemoglobin stopping criteria|0|||
147204368|NCT01587924|530917425|FG002|Overall Study|Met Hemoglobin stopping criteria|1|||
147204369|NCT01587924|530917426|FG003|Overall Study|Met Hemoglobin stopping criteria|0|||
147204370|NCT01587924|530917423|FG000|Overall Study|Withdrawal by Subject|0|||
147204371|NCT01587924|530917424|FG001|Overall Study|Withdrawal by Subject|1|||
147204372|NCT01587924|530917425|FG002|Overall Study|Withdrawal by Subject|1|||
147204373|NCT01587924|530917426|FG003|Overall Study|Withdrawal by Subject|0|||
147204374|NCT03848728|530917427|FG000|Overall Study|Death|16|||
147204375|NCT03848728|530917428|FG001|Overall Study|Death|13|||
147204376|NCT03848728|530917427|FG000|Overall Study|Outmigrated to non-study community|98|||
147204377|NCT03848728|530917428|FG001|Overall Study|Outmigrated to non-study community|106|||
147204378|NCT03848728|530917427|FG000|Overall Study|Transfered to non-study clinic|32|||
147204379|NCT03848728|530917428|FG001|Overall Study|Transfered to non-study clinic|48|||
147204380|NCT03848728|530917427|FG000|Overall Study|Withdrawal by Subject|1|||
147204381|NCT03848728|530917428|FG001|Overall Study|Withdrawal by Subject|0|||
147204382|NCT00787644|530917431|FG000|Overall Study|Lost to Follow-up|1|||
147204383|NCT00787644|530917432|FG001|Overall Study|Lost to Follow-up|1|||
147204384|NCT00787644|530917431|FG000|Overall Study|Withdrawal by Subject|1|||
147204385|NCT00787644|530917432|FG001|Overall Study|Withdrawal by Subject|1|||
147204386|NCT01642589|530917436|FG000|Overall Study|Withdrawal by Subject|1|||
147204387|NCT01642589|530917437|FG001|Overall Study|Withdrawal by Subject|1|||
147204388|NCT01108185|530917438|FG000|Overall Study|Non-compliance|15|||
147204389|NCT01108185|530917438|FG000|Overall Study|Lost to Follow-up|12|||
147204390|NCT02908672|530917445|FG000|Run-in Period|Death|12|||
147204391|NCT02908672|530917446|FG001|Run-in Period|Death|10|||
147204392|NCT02908672|530917447|FG002|Run-in Period|Death|0|||
147204393|NCT02908672|530917448|FG003|Run-in Period|Death|0|||
147204394|NCT02908672|530917445|FG000|Run-in Period|Lost to Follow-up|1|||
147204395|NCT02908672|530917446|FG001|Run-in Period|Lost to Follow-up|1|||
147204396|NCT02908672|530917447|FG002|Run-in Period|Lost to Follow-up|0|||
147204397|NCT02908672|530917448|FG003|Run-in Period|Lost to Follow-up|0|||
147204398|NCT02908672|530917445|FG000|Run-in Period|Reason Not Specified|2|||
147204399|NCT02908672|530917446|FG001|Run-in Period|Reason Not Specified|0|||
147204400|NCT02908672|530917447|FG002|Run-in Period|Reason Not Specified|0|||
147540826|NCT00817778|532135234|FG001|Overall Study|Protocol Violation|1|||
147540827|NCT00817778|532135233|FG000|Overall Study|Study-specific discontinuation criteria|0|||
147540828|NCT00817778|532135234|FG001|Overall Study|Study-specific discontinuation criteria|1|||
147540829|NCT00817778|532135233|FG000|Overall Study|Poor venous access|1|||
147540830|NCT00817778|532135234|FG001|Overall Study|Poor venous access|0|||
147204401|NCT02908672|530917448|FG003|Run-in Period|Reason Not Specified|0|||
147204402|NCT02908672|530917445|FG000|Run-in Period|Protocol Violation|1|||
147204403|NCT02908672|530917446|FG001|Run-in Period|Protocol Violation|1|||
147204404|NCT02908672|530917447|FG002|Run-in Period|Protocol Violation|0|||
147204405|NCT02908672|530917448|FG003|Run-in Period|Protocol Violation|0|||
147204406|NCT02908672|530917445|FG000|Run-in Period|Study Ended by Sponsor|5|||
147204407|NCT02908672|530917446|FG001|Run-in Period|Study Ended by Sponsor|1|||
147204408|NCT02908672|530917447|FG002|Run-in Period|Study Ended by Sponsor|0|||
147204409|NCT02908672|530917448|FG003|Run-in Period|Study Ended by Sponsor|0|||
147204410|NCT02908672|530917445|FG000|Run-in Period|Withdrawal by Subject|3|||
147204411|NCT02908672|530917446|FG001|Run-in Period|Withdrawal by Subject|9|||
147540831|NCT03343054|532135235|FG000|Dose Escalation Period (Up to 286 Days)|Progressive Disease|2|||
147204412|NCT02908672|530917447|FG002|Run-in Period|Withdrawal by Subject|0|||
147204413|NCT02908672|530917448|FG003|Run-in Period|Withdrawal by Subject|0|||
147204414|NCT02908672|530917445|FG000|Triple Combination Period|Death|0|||
147204415|NCT02908672|530917446|FG001|Triple Combination Period|Death|0|||
147204416|NCT02908672|530917447|FG002|Triple Combination Period|Death|150|||
147204417|NCT02908672|530917448|FG003|Triple Combination Period|Death|127|||
147204418|NCT02908672|530917445|FG000|Triple Combination Period|Lost to Follow-up|0|||
147204419|NCT02908672|530917446|FG001|Triple Combination Period|Lost to Follow-up|0|||
147204420|NCT02908672|530917447|FG002|Triple Combination Period|Lost to Follow-up|6|||
147204421|NCT02908672|530917448|FG003|Triple Combination Period|Lost to Follow-up|8|||
147204422|NCT02908672|530917445|FG000|Triple Combination Period|Reason Not Specified|0|||
147204423|NCT02908672|530917446|FG001|Triple Combination Period|Reason Not Specified|0|||
147204424|NCT02908672|530917447|FG002|Triple Combination Period|Reason Not Specified|0|||
147204425|NCT02908672|530917448|FG003|Triple Combination Period|Reason Not Specified|1|||
147204426|NCT02908672|530917445|FG000|Triple Combination Period|Physician Decision|0|||
147204427|NCT02908672|530917446|FG001|Triple Combination Period|Physician Decision|0|||
147204428|NCT02908672|530917447|FG002|Triple Combination Period|Physician Decision|1|||
147204429|NCT02908672|530917448|FG003|Triple Combination Period|Physician Decision|1|||
147204430|NCT02908672|530917445|FG000|Triple Combination Period|Study Ended by Sponsor|0|||
147204431|NCT02908672|530917446|FG001|Triple Combination Period|Study Ended by Sponsor|0|||
147204432|NCT02908672|530917447|FG002|Triple Combination Period|Study Ended by Sponsor|61|||
147204433|NCT02908672|530917448|FG003|Triple Combination Period|Study Ended by Sponsor|77|||
147204434|NCT02908672|530917445|FG000|Triple Combination Period|Withdrawal by Subject|0|||
147204435|NCT02908672|530917446|FG001|Triple Combination Period|Withdrawal by Subject|0|||
147204436|NCT02908672|530917447|FG002|Triple Combination Period|Withdrawal by Subject|13|||
147204437|NCT02908672|530917448|FG003|Triple Combination Period|Withdrawal by Subject|16|||
147204438|NCT01185080|530917452|FG000|Overall Study|Adverse Event|1|||
147204439|NCT01185080|530917453|FG001|Overall Study|Adverse Event|1|||
147204440|NCT01185080|530917454|FG002|Overall Study|Adverse Event|0|||
147540832|NCT03343054|532135236|FG001|Dose Escalation Period (Up to 286 Days)|Progressive Disease|6|||
147204441|NCT01185080|530917452|FG000|Overall Study|Personal reasons|0|||
147540833|NCT03343054|532135237|FG002|Dose Escalation Period (Up to 286 Days)|Progressive Disease|0|||
147540834|NCT03343054|532135235|FG000|Dose Escalation Period (Up to 286 Days)|Global Deterioration of Health Status|1|||
147540835|NCT03343054|532135236|FG001|Dose Escalation Period (Up to 286 Days)|Global Deterioration of Health Status|0|||
147540836|NCT03343054|532135237|FG002|Dose Escalation Period (Up to 286 Days)|Global Deterioration of Health Status|0|||
147540837|NCT03343054|532135235|FG000|Dose Expansion Period (Up to 502 Days)|Progressive Disease|0|||
147540838|NCT03343054|532135236|FG001|Dose Expansion Period (Up to 502 Days)|Progressive Disease|0|||
147540839|NCT03343054|532135237|FG002|Dose Expansion Period (Up to 502 Days)|Progressive Disease|11|||
147540840|NCT03343054|532135235|FG000|Dose Expansion Period (Up to 502 Days)|Ongoing|0|||
147204442|NCT01185080|530917453|FG001|Overall Study|Personal reasons|0|||
147204443|NCT01185080|530917454|FG002|Overall Study|Personal reasons|1|||
147204444|NCT00759941|530917455|FG000|Overall Study|Use of medication|1|||
147204445|NCT00759941|530917456|FG001|Overall Study|Use of medication|0|||
147204446|NCT00759941|530917455|FG000|Overall Study|Adverse Event|1|||
147204447|NCT00759941|530917456|FG001|Overall Study|Adverse Event|0|||
147204448|NCT00759941|530917455|FG000|Overall Study|Exited in error by site|1|||
147204449|NCT00759941|530917456|FG001|Overall Study|Exited in error by site|1|||
147204450|NCT05615922|530917460|FG000|Overall Study|Lost to Follow-up|1|||
147204451|NCT06083506|530917461|FG000|Overall Study|Physician Decision|2|||
147204452|NCT06083506|530917461|FG000|Overall Study|Lack of Efficacy|1|||
147204453|NCT05307692|530917463|FG000|Double-blind (DB) Phase (Day 1- Day 43):|Adverse Event|0|||
147204454|NCT05307692|530917464|FG001|Double-blind (DB) Phase (Day 1- Day 43):|Adverse Event|1|||
147204455|NCT05307692|530917465|FG002|Double-blind (DB) Phase (Day 1- Day 43):|Adverse Event|0|||
147204456|NCT05307692|530917466|FG003|Double-blind (DB) Phase (Day 1- Day 43):|Adverse Event|0|||
147204457|NCT05307692|530917463|FG000|Double-blind (DB) Phase (Day 1- Day 43):|Protocol-specified withdrawal criterion met|0|||
147204458|NCT05307692|530917464|FG001|Double-blind (DB) Phase (Day 1- Day 43):|Protocol-specified withdrawal criterion met|2|||
147204459|NCT05307692|530917465|FG002|Double-blind (DB) Phase (Day 1- Day 43):|Protocol-specified withdrawal criterion met|0|||
147204460|NCT05307692|530917466|FG003|Double-blind (DB) Phase (Day 1- Day 43):|Protocol-specified withdrawal criterion met|0|||
147204461|NCT05307692|530917463|FG000|Double-blind (DB) Phase (Day 1- Day 43):|Protocol Violation|1|||
147204462|NCT05307692|530917464|FG001|Double-blind (DB) Phase (Day 1- Day 43):|Protocol Violation|1|||
147204463|NCT05307692|530917465|FG002|Double-blind (DB) Phase (Day 1- Day 43):|Protocol Violation|0|||
147204464|NCT05307692|530917466|FG003|Double-blind (DB) Phase (Day 1- Day 43):|Protocol Violation|0|||
147204465|NCT05307692|530917463|FG000|Double-blind (DB) Phase (Day 1- Day 43):|Withdrawal by Subject|2|||
147204466|NCT05307692|530917464|FG001|Double-blind (DB) Phase (Day 1- Day 43):|Withdrawal by Subject|3|||
147204467|NCT05307692|530917465|FG002|Double-blind (DB) Phase (Day 1- Day 43):|Withdrawal by Subject|0|||
147540841|NCT03343054|532135236|FG001|Dose Expansion Period (Up to 502 Days)|Ongoing|0|||
147540842|NCT03343054|532135237|FG002|Dose Expansion Period (Up to 502 Days)|Ongoing|8|||
147540843|NCT04256759|532135238|FG000|Overall Study|Physician Decision|1|||
147540844|NCT04256759|532135238|FG000|Overall Study|Lack of Efficacy|1|||
147204468|NCT05307692|530917466|FG003|Double-blind (DB) Phase (Day 1- Day 43):|Withdrawal by Subject|0|||
147204469|NCT05307692|530917463|FG000|Double-blind (DB) Phase (Day 1- Day 43):|Other|0|||
147204470|NCT05307692|530917464|FG001|Double-blind (DB) Phase (Day 1- Day 43):|Other|1|||
147204471|NCT05307692|530917465|FG002|Double-blind (DB) Phase (Day 1- Day 43):|Other|0|||
147204472|NCT05307692|530917466|FG003|Double-blind (DB) Phase (Day 1- Day 43):|Other|0|||
147204473|NCT05307692|530917463|FG000|Double-blind (DB) Phase (Day 1- Day 43):|Randomized but not treated|2|||
147204474|NCT05307692|530917464|FG001|Double-blind (DB) Phase (Day 1- Day 43):|Randomized but not treated|1|||
147204475|NCT05307692|530917465|FG002|Double-blind (DB) Phase (Day 1- Day 43):|Randomized but not treated|0|||
147204476|NCT05307692|530917466|FG003|Double-blind (DB) Phase (Day 1- Day 43):|Randomized but not treated|0|||
147204477|NCT05307692|530917463|FG000|FU Phase (Day 43 to Day 57):|Withdrawal by Subject|0|||
147204478|NCT05307692|530917464|FG001|FU Phase (Day 43 to Day 57):|Withdrawal by Subject|0|||
147204479|NCT05307692|530917465|FG002|FU Phase (Day 43 to Day 57):|Withdrawal by Subject|0|||
147204480|NCT05307692|530917466|FG003|FU Phase (Day 43 to Day 57):|Withdrawal by Subject|1|||
147204481|NCT05307692|530917463|FG000|FU Phase (Day 43 to Day 57):|Protocol Violation|0|||
147204482|NCT05307692|530917464|FG001|FU Phase (Day 43 to Day 57):|Protocol Violation|0|||
147204483|NCT05307692|530917465|FG002|FU Phase (Day 43 to Day 57):|Protocol Violation|0|||
147204484|NCT05307692|530917466|FG003|FU Phase (Day 43 to Day 57):|Protocol Violation|3|||
147204485|NCT04500158|530917467|FG000|Overall Study|Physician Decision|17|||
147204486|NCT04500158|530917468|FG001|Overall Study|Physician Decision|11|||
147204487|NCT01967238|530917469|FG000|Overall Study|Adverse Event|1|||
147204488|NCT01967238|530917470|FG001|Overall Study|Adverse Event|1|||
147204489|NCT01967238|530917471|FG002|Overall Study|Adverse Event|0|||
147204490|NCT01967238|530917469|FG000|Overall Study|Lost to Follow-up|1|||
147204491|NCT01967238|530917470|FG001|Overall Study|Lost to Follow-up|0|||
147204492|NCT01967238|530917471|FG002|Overall Study|Lost to Follow-up|1|||
147204493|NCT01967238|530917469|FG000|Overall Study|Withdrawal by Subject|0|||
147204494|NCT01967238|530917470|FG001|Overall Study|Withdrawal by Subject|0|||
147204495|NCT01967238|530917471|FG002|Overall Study|Withdrawal by Subject|1|||
147204496|NCT03493464|530917480|FG000|Overall Study|Surgery not performed|1|||
147204497|NCT01442103|530918596|FG000|Overall Study|Lost to Follow-up|2|||
147204498|NCT02605122|530918601|FG000|Overall Study|Withdrawal by Subject|4|||
147204499|NCT02605122|530918602|FG001|Overall Study|Withdrawal by Subject|1|||
147204500|NCT02605122|530918601|FG000|Overall Study|Lost to Follow-up|1|||
147204501|NCT02605122|530918602|FG001|Overall Study|Lost to Follow-up|1|||
147204502|NCT03894813|530918609|FG000|Overall Study|Adverse Event|1|||
147204503|NCT03894813|530918610|FG001|Overall Study|Adverse Event|1|||
147204504|NCT03894813|530918609|FG000|Overall Study|Lack of Efficacy|3|||
147204505|NCT03894813|530918610|FG001|Overall Study|Lack of Efficacy|3|||
147204506|NCT03894813|530918609|FG000|Overall Study|Lost to Follow-up|1|||
147204507|NCT03894813|530918610|FG001|Overall Study|Lost to Follow-up|0|||
147204508|NCT03894813|530918609|FG000|Overall Study|Pregnancy|2|||
147204509|NCT03894813|530918610|FG001|Overall Study|Pregnancy|1|||
147204510|NCT03894813|530918609|FG000|Overall Study|Protocol Violation|3|||
147204511|NCT03894813|530918610|FG001|Overall Study|Protocol Violation|7|||
147204512|NCT03894813|530918609|FG000|Overall Study|Withdrawal by Subject|1|||
147204513|NCT03894813|530918610|FG001|Overall Study|Withdrawal by Subject|3|||
147204514|NCT03894813|530918609|FG000|Overall Study|Complain of the research staff and refused to continue the trial|0|||
147204515|NCT03894813|530918610|FG001|Overall Study|Complain of the research staff and refused to continue the trial|1|||
147204516|NCT02139592|530918611|FG000|Overall Study|Case Report Forms Uncollected|8|||
147438940|NCT00359021|531772166|FG000|Overall Study|Subject Non-Compliant|1|||
147438941|NCT00359021|531772167|FG001|Overall Study|Subject Non-Compliant|2|||
147438942|NCT00359021|531772166|FG000|Overall Study|Subject Ineligible To Continue The Trial|1|||
147438943|NCT00359021|531772167|FG001|Overall Study|Subject Ineligible To Continue The Trial|0|||
147438944|NCT00359021|531772166|FG000|Overall Study|Subject Reached A Virologic Endpoint|45|||
147438945|NCT00359021|531772167|FG001|Overall Study|Subject Reached A Virologic Endpoint|32|||
147438946|NCT00359021|531772166|FG000|Overall Study|Withdrawal by Subject|2|||
147438947|NCT00359021|531772167|FG001|Overall Study|Withdrawal by Subject|9|||
147438948|NCT00359021|531772166|FG000|Overall Study|Lost to Follow-up|1|||
147438949|NCT00359021|531772167|FG001|Overall Study|Lost to Follow-up|0|||
147438950|NCT00359021|531772166|FG000|Overall Study|Other|4|||
147438951|NCT00359021|531772167|FG001|Overall Study|Other|1|||
147438952|NCT00359021|531772166|FG000|Overall Study|Pregnancy|1|||
147438953|NCT00359021|531772167|FG001|Overall Study|Pregnancy|0|||
147438954|NCT02066311|531772168|FG000|Overall Study|Adverse Event|4|||
147438955|NCT02066311|531772168|FG000|Overall Study|Withdrawal by Subject|1|||
147438956|NCT04353596|531772171|FG000|Overall Study|Protocol Violation|4|||
147438957|NCT04353596|531772172|FG001|Overall Study|Protocol Violation|4|||
147438958|NCT04353596|531772171|FG000|Overall Study|no evidence of recent SARS-CoV-2|1|||
147438959|NCT04353596|531772172|FG001|Overall Study|no evidence of recent SARS-CoV-2|3|||
147438960|NCT05418673|531772173|FG000|Overall Study|Study Terminated by Sponsor|2|||
147438961|NCT05418673|531772174|FG001|Overall Study|Study Terminated by Sponsor|4|||
147204517|NCT00372593|530918615|FG000|Overall Study|Adverse Event|43|||
147204518|NCT00372593|530918616|FG001|Overall Study|Adverse Event|45|||
147204519|NCT00372593|530918617|FG002|Overall Study|Adverse Event|0|||
147540845|NCT04075292|532135243|FG000|Overall Study|Withdrawal by Subject|1|||
147540846|NCT04075292|532135244|FG001|Overall Study|Withdrawal by Subject|9|||
147540847|NCT04075292|532135243|FG000|Overall Study|Death|2|||
147540848|NCT04075292|532135244|FG001|Overall Study|Death|5|||
147540849|NCT04075292|532135243|FG000|Overall Study|Remained on study at time of DCO|74|||
147540850|NCT04075292|532135244|FG001|Overall Study|Remained on study at time of DCO|64|||
147540851|NCT01826201|532135245|FG000|Overall Study|Non compliance with protocol|4|||
147540852|NCT03829462|532135247|FG000|Overall Study|No tumoral evaluation due to progression disease|6|||
147540853|NCT03829462|532135248|FG001|Overall Study|No tumoral evaluation due to progression disease|3|||
147540854|NCT03829462|532135247|FG000|Overall Study|No treatment due to progression disease|0|||
147540855|NCT03829462|532135248|FG001|Overall Study|No treatment due to progression disease|1|||
147540856|NCT00481871|532135251|FG000|Overall Study|Progressive Disease - pt withdrew|0|||
147540857|NCT00481871|532135252|FG001|Overall Study|Progressive Disease - pt withdrew|0|||
147540858|NCT00481871|532135253|FG002|Overall Study|Progressive Disease - pt withdrew|1|||
147204520|NCT00372593|530918615|FG000|Overall Study|Death|16|||
147204521|NCT00372593|530918616|FG001|Overall Study|Death|20|||
147204522|NCT00372593|530918617|FG002|Overall Study|Death|1|||
147204523|NCT00372593|530918615|FG000|Overall Study|Lack of Efficacy|82|||
147204524|NCT00372593|530918616|FG001|Overall Study|Lack of Efficacy|71|||
147204525|NCT00372593|530918617|FG002|Overall Study|Lack of Efficacy|2|||
147204526|NCT00372593|530918615|FG000|Overall Study|Lost to Follow-up|1|||
147204527|NCT00372593|530918616|FG001|Overall Study|Lost to Follow-up|0|||
147204528|NCT00372593|530918617|FG002|Overall Study|Lost to Follow-up|0|||
147204529|NCT00372593|530918615|FG000|Overall Study|Physician Decision|42|||
147204530|NCT00372593|530918616|FG001|Overall Study|Physician Decision|41|||
147204531|NCT00372593|530918617|FG002|Overall Study|Physician Decision|0|||
147204532|NCT00372593|530918615|FG000|Overall Study|Ineligible|20|||
147204533|NCT00372593|530918616|FG001|Overall Study|Ineligible|21|||
147204534|NCT00372593|530918617|FG002|Overall Study|Ineligible|1|||
147204535|NCT00433004|530918618|FG000|Overall Study|Lost to Follow-up|5|||
147204536|NCT00433004|530918619|FG001|Overall Study|Lost to Follow-up|7|||
147204537|NCT00742235|530918620|FG000|Overall Study|Lost to Follow-up|0|||
147204538|NCT00742235|530918621|FG001|Overall Study|Lost to Follow-up|31|||
147204539|NCT05661409|530918622|FG000|Overall Study|Drug administered, but monitor disconnected|1|||
147204540|NCT05661409|530918623|FG001|Overall Study|Drug administered, but monitor disconnected|0|||
147204541|NCT05661409|530918624|FG002|Overall Study|Drug administered, but monitor disconnected|0|||
147204542|NCT05661409|530918625|FG003|Overall Study|Drug administered, but monitor disconnected|0|||
147204543|NCT05661409|530918626|FG004|Overall Study|Drug administered, but monitor disconnected|0|||
147204544|NCT05661409|530918627|FG005|Overall Study|Drug administered, but monitor disconnected|0|||
147204545|NCT05661409|530918622|FG000|Overall Study|No TOFR data; problem with the monitor|0|||
147204546|NCT05661409|530918623|FG001|Overall Study|No TOFR data; problem with the monitor|1|||
147204547|NCT05661409|530918624|FG002|Overall Study|No TOFR data; problem with the monitor|0|||
147204548|NCT05661409|530918625|FG003|Overall Study|No TOFR data; problem with the monitor|0|||
147204549|NCT05661409|530918626|FG004|Overall Study|No TOFR data; problem with the monitor|0|||
147204550|NCT05661409|530918627|FG005|Overall Study|No TOFR data; problem with the monitor|0|||
147204551|NCT05661409|530918622|FG000|Overall Study|TOFR≥0.9 at time of drug admin.|0|||
147204552|NCT05661409|530918623|FG001|Overall Study|TOFR≥0.9 at time of drug admin.|0|||
147204553|NCT05661409|530918624|FG002|Overall Study|TOFR≥0.9 at time of drug admin.|0|||
147204554|NCT05661409|530918625|FG003|Overall Study|TOFR≥0.9 at time of drug admin.|1|||
147204555|NCT05661409|530918626|FG004|Overall Study|TOFR≥0.9 at time of drug admin.|2|||
147204556|NCT05661409|530918627|FG005|Overall Study|TOFR≥0.9 at time of drug admin.|2|||
147204557|NCT05661409|530918622|FG000|Overall Study|Lost TOFR data prior to time study drug given|0|||
147204558|NCT05661409|530918623|FG001|Overall Study|Lost TOFR data prior to time study drug given|0|||
147204559|NCT05661409|530918624|FG002|Overall Study|Lost TOFR data prior to time study drug given|0|||
147204560|NCT05661409|530918625|FG003|Overall Study|Lost TOFR data prior to time study drug given|0|||
147204561|NCT05661409|530918626|FG004|Overall Study|Lost TOFR data prior to time study drug given|0|||
147204562|NCT05661409|530918627|FG005|Overall Study|Lost TOFR data prior to time study drug given|1|||
147204563|NCT05661409|530918622|FG000|Overall Study|Miscommu-nication about administration|0|||
147204564|NCT05661409|530918623|FG001|Overall Study|Miscommu-nication about administration|0|||
147204565|NCT05661409|530918624|FG002|Overall Study|Miscommu-nication about administration|0|||
147204566|NCT05661409|530918625|FG003|Overall Study|Miscommu-nication about administration|0|||
147204567|NCT05661409|530918626|FG004|Overall Study|Miscommu-nication about administration|0|||
147204568|NCT05661409|530918627|FG005|Overall Study|Miscommu-nication about administration|1|||
147204569|NCT00831181|530918632|FG000|Overall Study|Adverse Event|12|||
147204570|NCT02863419|530918633|FG000|Overall Study|Lost to Follow-up|0|||
147204571|NCT02863419|530918634|FG001|Overall Study|Lost to Follow-up|1|||
147540859|NCT00481871|532135254|FG003|Overall Study|Progressive Disease - pt withdrew|0|||
147204572|NCT02863419|530918635|FG002|Overall Study|Lost to Follow-up|4|||
147204573|NCT02863419|530918633|FG000|Overall Study|Withdrawal by Subject|5|||
147204574|NCT02863419|530918634|FG001|Overall Study|Withdrawal by Subject|5|||
147204575|NCT02863419|530918635|FG002|Overall Study|Withdrawal by Subject|3|||
147204576|NCT02863419|530918633|FG000|Overall Study|Died|3|||
147204577|NCT02863419|530918634|FG001|Overall Study|Died|4|||
147204578|NCT02863419|530918635|FG002|Overall Study|Died|1|||
147204579|NCT02362282|530918636|FG000|Overall Study|Withdrawal by Subject|1|||
147204580|NCT02362282|530918637|FG001|Overall Study|Withdrawal by Subject|0|||
147204581|NCT02284243|530918644|FG000|Overall Study|Lack of Efficacy|3|||
147204582|NCT02284243|530918645|FG001|Overall Study|Lack of Efficacy|3|||
147204583|NCT02284243|530918644|FG000|Overall Study|Adverse Event|1|||
147204584|NCT02284243|530918645|FG001|Overall Study|Adverse Event|0|||
147204585|NCT01932437|530918646|FG000|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0|||
147204586|NCT01932437|530918647|FG001|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0|||
147204587|NCT01932437|530918648|FG002|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0|||
147204588|NCT01932437|530918649|FG003|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0|||
147204589|NCT01932437|530918650|FG004|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|0|||
147204590|NCT01932437|530918651|FG005|Cohort 5 - ETI-204 24 mg/kg or Placebo|Lost to Follow-up|1|||
147204591|NCT00074490|530918652|FG000|Overall Study|Progressive malignancy|0|||
147204592|NCT00074490|530918653|FG001|Overall Study|Progressive malignancy|7|||
147204593|NCT00074490|530918654|FG002|Overall Study|Progressive malignancy|0|||
147204594|NCT00074490|530918655|FG003|Overall Study|Progressive malignancy|0|||
147204595|NCT00074490|530918656|FG004|Overall Study|Progressive malignancy|3|||
147204596|NCT00074490|530918657|FG005|Overall Study|Progressive malignancy|0|||
147204597|NCT04411667|530918662|FG000|Overall Study|Physician Decision|1|||
147204598|NCT04411667|530918663|FG001|Overall Study|Physician Decision|0|||
147204599|NCT01599637|530918666|FG000|Overall Study|administrative problems|0|||
147204600|NCT01599637|530918667|FG001|Overall Study|administrative problems|2|||
147204601|NCT01599637|530918668|FG002|Overall Study|administrative problems|0|||
147204602|NCT01599637|530918666|FG000|Overall Study|Adverse Event|1|||
147204603|NCT01599637|530918667|FG001|Overall Study|Adverse Event|0|||
147204604|NCT01599637|530918668|FG002|Overall Study|Adverse Event|0|||
147204605|NCT00760617|530918669|FG000|Overall Study|Adverse Event|5|||
147204606|NCT00760617|530918670|FG001|Overall Study|Adverse Event|2|||
147204607|NCT00760617|530918671|FG002|Overall Study|Adverse Event|0|||
147204608|NCT00760617|530918669|FG000|Overall Study|Lost to Follow-up|0|||
147204609|NCT00760617|530918670|FG001|Overall Study|Lost to Follow-up|0|||
147204610|NCT00760617|530918671|FG002|Overall Study|Lost to Follow-up|5|||
147204611|NCT04287517|530918674|FG000|Overall Study|Withdrawal by Subject|1|||
147204612|NCT04287517|530918675|FG001|Overall Study|Withdrawal by Subject|1|||
147204613|NCT03857867|530918677|FG000|Overall Study|Physician Decision|1|||
147204614|NCT01869764|530918678|FG000|Overall Study|Withdrawal by Subject|0|||
147204615|NCT01869764|530918679|FG001|Overall Study|Withdrawal by Subject|2|||
147204616|NCT01626872|530918680|FG000|Overall Study|Physician Decision|13|||
147204617|NCT01626872|530918681|FG001|Overall Study|Physician Decision|9|||
147204618|NCT01626872|530918682|FG002|Overall Study|Physician Decision|6|||
147204619|NCT01626872|530918680|FG000|Overall Study|Withdrawal by Subject|19|||
147204620|NCT01626872|530918681|FG001|Overall Study|Withdrawal by Subject|27|||
147204621|NCT01626872|530918682|FG002|Overall Study|Withdrawal by Subject|8|||
147204622|NCT01626872|530918680|FG000|Overall Study|Adverse Event (including Death)|20|||
147204623|NCT01626872|530918681|FG001|Overall Study|Adverse Event (including Death)|28|||
147204624|NCT01626872|530918682|FG002|Overall Study|Adverse Event (including Death)|8|||
147204625|NCT01626872|530918680|FG000|Overall Study|Protocol Violation (including Pregnancy)|0|||
147204626|NCT01626872|530918681|FG001|Overall Study|Protocol Violation (including Pregnancy)|2|||
147204627|NCT01626872|530918682|FG002|Overall Study|Protocol Violation (including Pregnancy)|2|||
147204628|NCT01578486|530918683|FG000|Overall Study|Physician Decision|3|||
147204629|NCT01578486|530918683|FG000|Overall Study|Withdrawal by Subject|2|||
147204630|NCT02425943|530918684|FG000|Overall Study|Adverse Event|3|||
147204631|NCT02425943|530918685|FG001|Overall Study|Adverse Event|1|||
147204632|NCT02425943|530918684|FG000|Overall Study|Lost to Follow-up|59|||
147204633|NCT02425943|530918685|FG001|Overall Study|Lost to Follow-up|37|||
147204634|NCT02425943|530918684|FG000|Overall Study|Protocol Violation|4|||
147204635|NCT02425943|530918685|FG001|Overall Study|Protocol Violation|1|||
147204636|NCT02425943|530918684|FG000|Overall Study|Withdrawal by Subject|64|||
147204637|NCT02425943|530918685|FG001|Overall Study|Withdrawal by Subject|31|||
147540860|NCT00481871|532135255|FG004|Overall Study|Progressive Disease - pt withdrew|0|||
147540861|NCT06065176|532135256|FG000|Overall Study|Lost to Follow-up|11|||
147540862|NCT06065176|532135257|FG001|Overall Study|Lost to Follow-up|11|||
147540863|NCT06065176|532135258|FG002|Overall Study|Lost to Follow-up|10|||
147540864|NCT06065176|532135256|FG000|Overall Study|Withdrawal by Subject|1|||
147540865|NCT06065176|532135257|FG001|Overall Study|Withdrawal by Subject|1|||
147540866|NCT06065176|532135258|FG002|Overall Study|Withdrawal by Subject|2|||
147204638|NCT02425943|530918684|FG000|Overall Study|Other|6|||
147204639|NCT02425943|530918685|FG001|Overall Study|Other|0|||
147204640|NCT01106248|530918688|FG000|Overall Study|Adverse Event|1|||
147204641|NCT01106248|530918688|FG000|Overall Study|Administrative|2|||
147204642|NCT00357903|530918689|FG000|Overall Study|Adverse Event|87|||
147204643|NCT00357903|530918690|FG001|Overall Study|Adverse Event|4|||
147204644|NCT00357903|530918689|FG000|Overall Study|Death|33|||
147204645|NCT00357903|530918690|FG001|Overall Study|Death|0|||
147595946|NCT03096847|532338751|FG000|Overall Study|Non-compliance with study medication|1|||
147204646|NCT00357903|530918689|FG000|Overall Study|Lost to Follow-up|23|||
147204647|NCT00357903|530918690|FG001|Overall Study|Lost to Follow-up|4|||
147204648|NCT00357903|530918689|FG000|Overall Study|Physician Decision|39|||
147204649|NCT00357903|530918690|FG001|Overall Study|Physician Decision|5|||
147204650|NCT00357903|530918689|FG000|Overall Study|Withdrawal by Subject|57|||
147204651|NCT00357903|530918690|FG001|Overall Study|Withdrawal by Subject|7|||
147204652|NCT00357903|530918689|FG000|Overall Study|Completed month 12 only|0|||
147204653|NCT00357903|530918690|FG001|Overall Study|Completed month 12 only|1|||
147438962|NCT05418673|531772173|FG000|Overall Study|Lost to Follow-up|1|||
147438963|NCT05418673|531772174|FG001|Overall Study|Lost to Follow-up|0|||
147438964|NCT01986920|531772175|FG000|A- 101 25%|Withdrawal by Subject|1|||
147438965|NCT01986920|531772176|FG001|A- 101 25%|Withdrawal by Subject|0|||
147438966|NCT01986920|531772177|FG002|A- 101 25%|Withdrawal by Subject|0|||
147438967|NCT01986920|531772178|FG003|A- 101 25%|Withdrawal by Subject|0|||
147438968|NCT01986920|531772175|FG000|A-101 32.5%|Withdrawal by Subject|0|||
147438969|NCT01986920|531772176|FG001|A-101 32.5%|Withdrawal by Subject|1|||
147438970|NCT01986920|531772177|FG002|A-101 32.5%|Withdrawal by Subject|0|||
147438971|NCT01986920|531772178|FG003|A-101 32.5%|Withdrawal by Subject|0|||
147438972|NCT01986920|531772175|FG000|A-101 40%|Withdrawal by Subject|0|||
147438973|NCT01986920|531772176|FG001|A-101 40%|Withdrawal by Subject|0|||
147438974|NCT01986920|531772177|FG002|A-101 40%|Withdrawal by Subject|1|||
147438975|NCT01986920|531772178|FG003|A-101 40%|Withdrawal by Subject|0|||
147438976|NCT01986920|531772175|FG000|Placebo|Withdrawal by Subject|0|||
147438977|NCT01986920|531772176|FG001|Placebo|Withdrawal by Subject|0|||
147438978|NCT01986920|531772177|FG002|Placebo|Withdrawal by Subject|0|||
147438979|NCT01986920|531772178|FG003|Placebo|Withdrawal by Subject|1|||
147438980|NCT03781323|531772179|FG000|Overall Study|Withdrawal by Subject|1|||
147438981|NCT01338415|531772180|FG000|Core + Extension|Adverse Event|8|||
147438982|NCT01338415|531772181|FG001|Core + Extension|Adverse Event|6|||
147438983|NCT01338415|531772182|FG002|Core + Extension|Adverse Event|0|||
147438984|NCT01338415|531772180|FG000|Core + Extension|Withdrawal by Subject|1|||
147438985|NCT01338415|531772181|FG001|Core + Extension|Withdrawal by Subject|1|||
147438986|NCT01338415|531772182|FG002|Core + Extension|Withdrawal by Subject|0|||
147438987|NCT01338415|531772180|FG000|Core + Extension|Other (PAH not the main etiology of PH)|0|||
147438988|NCT01338415|531772181|FG001|Core + Extension|Other (PAH not the main etiology of PH)|2|||
147438989|NCT01338415|531772182|FG002|Core + Extension|Other (PAH not the main etiology of PH)|0|||
147438990|NCT01338415|531772180|FG000|Core + Extension|Other (administrative reason)|1|||
147438991|NCT01338415|531772181|FG001|Core + Extension|Other (administrative reason)|0|||
147438992|NCT01338415|531772182|FG002|Core + Extension|Other (administrative reason)|0|||
147438993|NCT01338415|531772180|FG000|Exceptional Use Treatment Period|Administrative decision|0|||
147438994|NCT01338415|531772181|FG001|Exceptional Use Treatment Period|Administrative decision|0|||
147438995|NCT01338415|531772182|FG002|Exceptional Use Treatment Period|Administrative decision|1|||
147438996|NCT01338415|531772180|FG000|Exceptional Use Treatment Period|Ongoing at the cut-off date of 19 Nov 2019|0|||
147438997|NCT01338415|531772181|FG001|Exceptional Use Treatment Period|Ongoing at the cut-off date of 19 Nov 2019|0|||
147438998|NCT01338415|531772182|FG002|Exceptional Use Treatment Period|Ongoing at the cut-off date of 19 Nov 2019|3|||
147438999|NCT01338415|531772180|FG000|Exceptional Use Treatment Period|Withdrawal by Subject|0|||
147439000|NCT01338415|531772181|FG001|Exceptional Use Treatment Period|Withdrawal by Subject|0|||
147439001|NCT01338415|531772182|FG002|Exceptional Use Treatment Period|Withdrawal by Subject|1|||
147439002|NCT01338415|531772180|FG000|Exceptional Use Treatment Period|Death|0|||
147439003|NCT01338415|531772181|FG001|Exceptional Use Treatment Period|Death|0|||
147439004|NCT01338415|531772182|FG002|Exceptional Use Treatment Period|Death|1|||
147439005|NCT00233363|531772185|FG000|Overall Study|Adverse Event|1|||
147439006|NCT00233363|531772186|FG001|Overall Study|Adverse Event|2|||
147439007|NCT00233363|531772185|FG000|Overall Study|Lack of Efficacy|0|||
147439008|NCT00233363|531772186|FG001|Overall Study|Lack of Efficacy|2|||
147439009|NCT00233363|531772185|FG000|Overall Study|Withdrawal by Subject|1|||
147439010|NCT00233363|531772186|FG001|Overall Study|Withdrawal by Subject|1|||
147439011|NCT00233363|531772185|FG000|Overall Study|Aggravation of complication|1|||
147439012|NCT00233363|531772186|FG001|Overall Study|Aggravation of complication|0|||
147439013|NCT01526551|531772190|FG000|Overall Study|Lack of returned parental consent form|424|||
147439014|NCT00874770|531772191|FG000|Overall Study|Lack of Efficacy|2|||
147439015|NCT00874770|531772192|FG001|Overall Study|Lack of Efficacy|0|||
147439016|NCT00874770|531772193|FG002|Overall Study|Lack of Efficacy|0|||
147439017|NCT00874770|531772194|FG003|Overall Study|Lack of Efficacy|2|||
147439018|NCT00874770|531772191|FG000|Overall Study|Adverse Event|1|||
147439019|NCT00874770|531772192|FG001|Overall Study|Adverse Event|1|||
147540867|NCT06065176|532135256|FG000|Overall Study|No longer met eligibility requirements to continue participation.|3|||
147439020|NCT00874770|531772193|FG002|Overall Study|Adverse Event|4|||
147439021|NCT00874770|531772194|FG003|Overall Study|Adverse Event|2|||
147204654|NCT00357903|530918689|FG000|Overall Study|Protocol issues|14|||
147204655|NCT00357903|530918690|FG001|Overall Study|Protocol issues|3|||
147204656|NCT00357903|530918689|FG000|Overall Study|Response status|61|||
147439022|NCT00874770|531772191|FG000|Overall Study|Lost to Follow-up|1|||
147439023|NCT00874770|531772192|FG001|Overall Study|Lost to Follow-up|0|||
147439024|NCT00874770|531772193|FG002|Overall Study|Lost to Follow-up|0|||
147204657|NCT00357903|530918690|FG001|Overall Study|Response status|9|||
147204658|NCT00357903|530918689|FG000|Overall Study|Other|49|||
147204659|NCT00357903|530918690|FG001|Overall Study|Other|10|||
147204660|NCT02506244|530918693|FG000|Overall Study|Did not undergo active monitoring|458|||
147204661|NCT02506244|530918694|FG001|Overall Study|Did not undergo active monitoring|459|||
147204662|NCT02506244|530918695|FG002|Overall Study|Did not undergo active monitoring|0|||
147204663|NCT00314795|530918697|FG000|Overall Study|Adverse Event|8|||
147204664|NCT00314795|530918697|FG000|Overall Study|Death|4|||
147204665|NCT00314795|530918697|FG000|Overall Study|Reason not Specified|3|||
147204666|NCT00314795|530918697|FG000|Overall Study|Renal Transplant|3|||
147204667|NCT00314795|530918697|FG000|Overall Study|Participants Withdrew Consent|2|||
147204668|NCT04717336|530918698|FG000|Period 1: Baseline to Week 2|Withdrawal by Subject|2|||
147204669|NCT04717336|530918699|FG001|Period 1: Baseline to Week 2|Withdrawal by Subject|2|||
147204670|NCT04717336|530918698|FG000|Washout: Week 2 to Week 5|Withdrawal by Subject|2|||
147204671|NCT04717336|530918699|FG001|Washout: Week 2 to Week 5|Withdrawal by Subject|2|||
147204672|NCT02039843|530918700|FG000|Randomization and Observation Period|Adverse Event|2|||
147204673|NCT02039843|530918701|FG001|Randomization and Observation Period|Adverse Event|0|||
147204674|NCT02039843|530918700|FG000|Randomization and Observation Period|Death|1|||
147204675|NCT02039843|530918701|FG001|Randomization and Observation Period|Death|0|||
147204676|NCT02039843|530918700|FG000|Randomization and Observation Period|Lost to Follow-up|2|||
147204677|NCT02039843|530918701|FG001|Randomization and Observation Period|Lost to Follow-up|3|||
147204678|NCT02039843|530918700|FG000|Randomization and Observation Period|Withdrawal by Subject|2|||
147204679|NCT02039843|530918701|FG001|Randomization and Observation Period|Withdrawal by Subject|3|||
147204680|NCT02039843|530918700|FG000|Randomization and Observation Period|Other reasons not paired with a study dog|22|||
147204681|NCT02039843|530918701|FG001|Randomization and Observation Period|Other reasons not paired with a study dog|11|||
147204682|NCT02039843|530918700|FG000|Pairing With a Study Dog|Death|1|||
147204683|NCT02039843|530918701|FG001|Pairing With a Study Dog|Death|0|||
147204684|NCT02039843|530918700|FG000|Pairing With a Study Dog|Lost to Follow-up|1|||
147204685|NCT02039843|530918701|FG001|Pairing With a Study Dog|Lost to Follow-up|4|||
147204686|NCT02039843|530918700|FG000|Pairing With a Study Dog|Withdrawal by Subject|4|||
147204687|NCT02039843|530918701|FG001|Pairing With a Study Dog|Withdrawal by Subject|1|||
147204688|NCT02039843|530918700|FG000|Pairing With a Study Dog|Other reasons for not completing study|13|||
147204689|NCT02039843|530918701|FG001|Pairing With a Study Dog|Other reasons for not completing study|4|||
147204690|NCT01958164|530918706|FG000|Overall Study|Adverse Event|0|||
147204691|NCT01958164|530918707|FG001|Overall Study|Adverse Event|2|||
147204692|NCT01958164|530918706|FG000|Overall Study|Lost to Follow-up|2|||
147204693|NCT01958164|530918707|FG001|Overall Study|Lost to Follow-up|3|||
147204694|NCT00525161|530918710|FG000|Overall Study|Adverse Event|1|||
147204695|NCT01076361|530918711|FG000|Overall Study|22 leads were excluded from analysis|21|||
147204696|NCT02807402|530918712|FG000|Overall Study|Failure to Return|1|||
147204697|NCT02807402|530918712|FG000|Overall Study|Death|3|||
147204698|NCT02807402|530918712|FG000|Overall Study|Other|2|||
147204699|NCT02873702|530920191|FG000|Healing Period (up to Week 8)|Adverse Event|1|||
147204700|NCT02873702|530920192|FG001|Healing Period (up to Week 8)|Adverse Event|0|||
147204701|NCT02873702|530920193|FG002|Healing Period (up to Week 8)|Adverse Event|0|||
147204702|NCT02873702|530920194|FG003|Healing Period (up to Week 8)|Adverse Event|0|||
147204703|NCT02873702|530920191|FG000|Healing Period (up to Week 8)|Withdrawal by Subject|0|||
147204704|NCT02873702|530920192|FG001|Healing Period (up to Week 8)|Withdrawal by Subject|1|||
147204705|NCT02873702|530920193|FG002|Healing Period (up to Week 8)|Withdrawal by Subject|0|||
147204706|NCT02873702|530920194|FG003|Healing Period (up to Week 8)|Withdrawal by Subject|0|||
147204707|NCT02873702|530920191|FG000|Maintenance Period (up to Month 6)|Adverse Event|0|||
147204708|NCT02873702|530920192|FG001|Maintenance Period (up to Month 6)|Adverse Event|0|||
147204709|NCT02873702|530920193|FG002|Maintenance Period (up to Month 6)|Adverse Event|1|||
147204710|NCT02873702|530920194|FG003|Maintenance Period (up to Month 6)|Adverse Event|0|||
147204711|NCT02873702|530920191|FG000|Maintenance Period (up to Month 6)|Relapse of EE|0|||
147204712|NCT02873702|530920192|FG001|Maintenance Period (up to Month 6)|Relapse of EE|0|||
147204713|NCT02873702|530920193|FG002|Maintenance Period (up to Month 6)|Relapse of EE|4|||
147204714|NCT02873702|530920194|FG003|Maintenance Period (up to Month 6)|Relapse of EE|1|||
147204715|NCT02873702|530920191|FG000|Maintenance Period (up to Month 6)|Withdrawal by Subject|0|||
147204716|NCT02873702|530920192|FG001|Maintenance Period (up to Month 6)|Withdrawal by Subject|0|||
147204717|NCT02873702|530920193|FG002|Maintenance Period (up to Month 6)|Withdrawal by Subject|2|||
147204718|NCT02873702|530920194|FG003|Maintenance Period (up to Month 6)|Withdrawal by Subject|1|||
147204719|NCT01255436|530920204|FG000|Overall Study|Lost to Follow-up|178|||
147204720|NCT01255436|530920205|FG001|Overall Study|Lost to Follow-up|191|||
147204721|NCT01255436|530920204|FG000|Overall Study|Death, stroke, or MI|4|||
147204722|NCT01255436|530920205|FG001|Overall Study|Death, stroke, or MI|3|||
147204723|NCT04816669|530920206|FG000|Part 1|Adverse Event|1|||
147204724|NCT04816669|530920207|FG001|Part 1|Adverse Event|1|||
147204725|NCT04816669|530920208|FG002|Part 1|Adverse Event|0|||
147204726|NCT04816669|530920209|FG003|Part 1|Adverse Event|0|||
147204727|NCT04816669|530920206|FG000|Part 1|Lost to Follow-up|2|||
147204728|NCT04816669|530920207|FG001|Part 1|Lost to Follow-up|2|||
147204729|NCT04816669|530920208|FG002|Part 1|Lost to Follow-up|0|||
147204730|NCT04816669|530920209|FG003|Part 1|Lost to Follow-up|0|||
147204731|NCT04816669|530920206|FG000|Part 1|Protocol Violation|0|||
147204732|NCT04816669|530920207|FG001|Part 1|Protocol Violation|1|||
147204733|NCT04816669|530920208|FG002|Part 1|Protocol Violation|0|||
147204734|NCT04816669|530920209|FG003|Part 1|Protocol Violation|0|||
147204735|NCT04816669|530920206|FG000|Part 1|Withdrawal by Subject|1|||
147204736|NCT04816669|530920207|FG001|Part 1|Withdrawal by Subject|2|||
147204737|NCT04816669|530920208|FG002|Part 1|Withdrawal by Subject|0|||
147204738|NCT04816669|530920209|FG003|Part 1|Withdrawal by Subject|0|||
147204739|NCT04816669|530920206|FG000|Part 2|Other|0|||
147204740|NCT04816669|530920207|FG001|Part 2|Other|0|||
147204741|NCT04816669|530920208|FG002|Part 2|Other|1|||
147204742|NCT04816669|530920209|FG003|Part 2|Other|0|||
147204743|NCT04816669|530920206|FG000|Part 2|Withdrawal by Subject|0|||
147204744|NCT04816669|530920207|FG001|Part 2|Withdrawal by Subject|0|||
147204745|NCT04816669|530920208|FG002|Part 2|Withdrawal by Subject|0|||
147204746|NCT04816669|530920209|FG003|Part 2|Withdrawal by Subject|1|||
147204747|NCT04816669|530920206|FG000|Part 2|Lost to Follow-up|0|||
147204748|NCT04816669|530920207|FG001|Part 2|Lost to Follow-up|0|||
147204749|NCT04816669|530920208|FG002|Part 2|Lost to Follow-up|1|||
147204750|NCT04816669|530920209|FG003|Part 2|Lost to Follow-up|0|||
147204751|NCT01229267|530920210|FG000|Overall Study|Adverse Event|4|||
147204752|NCT01229267|530920211|FG001|Overall Study|Adverse Event|6|||
147204753|NCT01229267|530920212|FG002|Overall Study|Adverse Event|3|||
147204754|NCT01229267|530920213|FG003|Overall Study|Adverse Event|2|||
147204755|NCT01229267|530920214|FG004|Overall Study|Adverse Event|10|||
147204756|NCT01229267|530920210|FG000|Overall Study|Death|40|||
147204757|NCT01229267|530920211|FG001|Overall Study|Death|37|||
147204758|NCT01229267|530920212|FG002|Overall Study|Death|35|||
147204759|NCT01229267|530920213|FG003|Overall Study|Death|13|||
147204760|NCT01229267|530920214|FG004|Overall Study|Death|103|||
147204761|NCT01229267|530920210|FG000|Overall Study|Withdrawal by Subject|23|||
147204762|NCT01229267|530920211|FG001|Overall Study|Withdrawal by Subject|22|||
147204763|NCT01229267|530920212|FG002|Overall Study|Withdrawal by Subject|32|||
147204764|NCT01229267|530920213|FG003|Overall Study|Withdrawal by Subject|14|||
147204765|NCT01229267|530920214|FG004|Overall Study|Withdrawal by Subject|59|||
147204766|NCT01229267|530920210|FG000|Overall Study|Protocol Violation|0|||
147204767|NCT01229267|530920211|FG001|Overall Study|Protocol Violation|1|||
147204768|NCT01229267|530920212|FG002|Overall Study|Protocol Violation|0|||
147204769|NCT01229267|530920213|FG003|Overall Study|Protocol Violation|0|||
147204770|NCT01229267|530920214|FG004|Overall Study|Protocol Violation|0|||
147204771|NCT01229267|530920210|FG000|Overall Study|Progressive disease|0|||
147204772|NCT01229267|530920211|FG001|Overall Study|Progressive disease|0|||
147204773|NCT01229267|530920212|FG002|Overall Study|Progressive disease|0|||
147204774|NCT01229267|530920213|FG003|Overall Study|Progressive disease|0|||
147540868|NCT06065176|532135257|FG001|Overall Study|No longer met eligibility requirements to continue participation.|5|||
147540869|NCT06065176|532135258|FG002|Overall Study|No longer met eligibility requirements to continue participation.|1|||
147540870|NCT02588651|532135259|FG000|Overall Study|Adverse Event|1|||
147540871|NCT02588651|532135259|FG000|Overall Study|Withdrawal by Subject|2|||
147540872|NCT02588651|532135259|FG000|Overall Study|Death|1|||
147540873|NCT02588651|532135259|FG000|Overall Study|Lack of Efficacy|13|||
147540874|NCT02588651|532135259|FG000|Overall Study|Lost to Follow-up|1|||
147540875|NCT02588651|532135259|FG000|Overall Study|Physician Decision|1|||
147540876|NCT02588651|532135259|FG000|Overall Study|Disease progression|2|||
147540877|NCT04083378|532135264|FG000|Overall Study|Death|18|||
147540878|NCT04083378|532135265|FG001|Overall Study|Death|4|||
147540879|NCT04083378|532135264|FG000|Overall Study|Lost to Follow-up|4|||
147540880|NCT04083378|532135265|FG001|Overall Study|Lost to Follow-up|0|||
147540881|NCT04803214|532135266|FG000|Overall Study|Adverse Event|1|||
147204775|NCT01229267|530920214|FG004|Overall Study|Progressive disease|1|||
147204776|NCT01229267|530920210|FG000|Overall Study|Physician Decision|8|||
147204777|NCT01229267|530920211|FG001|Overall Study|Physician Decision|11|||
147204778|NCT01229267|530920212|FG002|Overall Study|Physician Decision|8|||
147204779|NCT01229267|530920213|FG003|Overall Study|Physician Decision|3|||
147204780|NCT01229267|530920214|FG004|Overall Study|Physician Decision|25|||
147204781|NCT01229267|530920210|FG000|Overall Study|Lost to Follow-up|6|||
147204782|NCT01229267|530920211|FG001|Overall Study|Lost to Follow-up|5|||
147204783|NCT01229267|530920212|FG002|Overall Study|Lost to Follow-up|8|||
147204784|NCT01229267|530920213|FG003|Overall Study|Lost to Follow-up|3|||
147204785|NCT01229267|530920214|FG004|Overall Study|Lost to Follow-up|22|||
147204786|NCT00867815|530920220|FG000|Overall Study|Lost to Follow-up|1|||
147204787|NCT04050202|530920221|FG000|Overall Study|Lost to Follow-up|2|||
147204788|NCT00001213|530920222|FG000|Overall Study|Death|18|||
147204789|NCT01499277|530920225|FG000|Overall Study|Adverse Event|3|||
147204790|NCT01499277|530920226|FG001|Overall Study|Adverse Event|6|||
147204791|NCT01499277|530920225|FG000|Overall Study|Death|3|||
147204792|NCT01499277|530920226|FG001|Overall Study|Death|2|||
147204793|NCT01499277|530920225|FG000|Overall Study|Lost to Follow-up|15|||
147540882|NCT04803214|532135267|FG001|Overall Study|Adverse Event|0|||
147540883|NCT04803214|532135266|FG000|Overall Study|Withdrawal by Subject|1|||
147540884|NCT04803214|532135267|FG001|Overall Study|Withdrawal by Subject|2|||
147540885|NCT04803214|532135266|FG000|Overall Study|Lost to Follow-up|2|||
147540886|NCT04803214|532135267|FG001|Overall Study|Lost to Follow-up|4|||
147540887|NCT04803214|532135266|FG000|Overall Study|Physician Decision|1|||
147540888|NCT04803214|532135267|FG001|Overall Study|Physician Decision|1|||
147540889|NCT04803214|532135266|FG000|Overall Study|Missed 12 month visit|0|||
147540890|NCT04803214|532135267|FG001|Overall Study|Missed 12 month visit|3|||
147540891|NCT00644228|532135268|FG000|Randomization & Eligibility|Ineligible|31|||
147540892|NCT00644228|532135269|FG001|Randomization & Eligibility|Ineligible|21|||
147540893|NCT00644228|532135268|FG000|Randomization & Eligibility|Withdrew Consent prior to therapy start|1|||
147540894|NCT00644228|532135269|FG001|Randomization & Eligibility|Withdrew Consent prior to therapy start|0|||
147540895|NCT00644228|532135268|FG000|Randomization & Eligibility|Invalid Consent|0|||
147540896|NCT00644228|532135269|FG001|Randomization & Eligibility|Invalid Consent|1|||
147540897|NCT00644228|532135268|FG000|Induction Therapy|Adverse Event|22|||
147540898|NCT00644228|532135269|FG001|Induction Therapy|Adverse Event|55|||
147540899|NCT00644228|532135268|FG000|Induction Therapy|Withdrawal by Subject|10|||
147540900|NCT00644228|532135269|FG001|Induction Therapy|Withdrawal by Subject|3|||
147540901|NCT00644228|532135268|FG000|Induction Therapy|Progression/Relapse|24|||
147540902|NCT00644228|532135269|FG001|Induction Therapy|Progression/Relapse|12|||
147540903|NCT00644228|532135268|FG000|Induction Therapy|Death|3|||
147540904|NCT00644228|532135269|FG001|Induction Therapy|Death|7|||
147540905|NCT00644228|532135268|FG000|Induction Therapy|Not Protocol-Specified|24|||
147540906|NCT00644228|532135269|FG001|Induction Therapy|Not Protocol-Specified|28|||
147540907|NCT00644228|532135268|FG000|Maintenance|Adverse Event|27|||
147540908|NCT00644228|532135269|FG001|Maintenance|Adverse Event|31|||
147540909|NCT00644228|532135268|FG000|Maintenance|Withdrawal by Subject|6|||
147540910|NCT00644228|532135269|FG001|Maintenance|Withdrawal by Subject|4|||
147540911|NCT00644228|532135268|FG000|Maintenance|Progression/Relapse|67|||
147540912|NCT00644228|532135269|FG001|Maintenance|Progression/Relapse|42|||
147204794|NCT01499277|530920226|FG001|Overall Study|Lost to Follow-up|8|||
147204795|NCT01499277|530920225|FG000|Overall Study|Protocol Violation|2|||
147204796|NCT01499277|530920226|FG001|Overall Study|Protocol Violation|3|||
147204797|NCT01499277|530920225|FG000|Overall Study|Withdrawal by Subject|16|||
147204798|NCT01499277|530920226|FG001|Overall Study|Withdrawal by Subject|6|||
147204799|NCT01499277|530920225|FG000|Overall Study|Lack of therapeutic response and other|8|||
147204800|NCT01499277|530920226|FG001|Overall Study|Lack of therapeutic response and other|7|||
147204801|NCT02974543|530920229|FG000|Overall Study|Withdrawal by Subject|1|||
147204802|NCT02974543|530920230|FG001|Overall Study|Withdrawal by Subject|0|||
147204803|NCT03534180|530920231|FG000|Overall Study|Withdrawal by Subject|1|||
147204804|NCT00220636|530920232|FG000|Overall Study|Withdrawal by Subject|4|||
147204805|NCT01237899|530920235|FG000|Washout Period of at Least 7 Days|Adverse Event|0|||
147204806|NCT01237899|530920236|FG001|Washout Period of at Least 7 Days|Adverse Event|0|||
147204807|NCT01237899|530920237|FG002|Washout Period of at Least 7 Days|Adverse Event|1|||
147204808|NCT01237899|530920238|FG003|Washout Period of at Least 7 Days|Adverse Event|0|||
147204809|NCT01237899|530920239|FG004|Washout Period of at Least 7 Days|Adverse Event|0|||
147204810|NCT01237899|530920240|FG005|Washout Period of at Least 7 Days|Adverse Event|0|||
147204811|NCT01237899|530920241|FG006|Washout Period of at Least 7 Days|Adverse Event|0|||
147204812|NCT01237899|530920242|FG007|Washout Period of at Least 7 Days|Adverse Event|0|||
147204813|NCT01237899|530920243|FG008|Washout Period of at Least 7 Days|Adverse Event|0|||
147204814|NCT01237899|530920244|FG009|Washout Period of at Least 7 Days|Adverse Event|0|||
147204815|NCT01237899|530920245|FG010|Washout Period of at Least 7 Days|Adverse Event|0|||
147204816|NCT00790088|530920246|FG000|Overall Study|Protocol Violation|11|||
147204817|NCT00790088|530920246|FG000|Overall Study|Withdrawal by Subject|17|||
147204818|NCT00790088|530920246|FG000|Overall Study|Lost to Follow-up|7|||
147204819|NCT00790088|530920246|FG000|Overall Study|Physician Decision|4|||
147204820|NCT02636595|530920247|FG000|Overall Study|Lost to Follow-up|1|||
147204821|NCT02636595|530920247|FG000|Overall Study|Other|1|||
147204822|NCT02015637|530920252|FG000|Overall Study|Lost to Follow-up|3|||
147204823|NCT02015637|530920253|FG001|Overall Study|Lost to Follow-up|5|||
147204824|NCT02015637|530920252|FG000|Overall Study|Adverse Event|3|||
147204825|NCT02015637|530920253|FG001|Overall Study|Adverse Event|0|||
147204826|NCT02015637|530920252|FG000|Overall Study|Did not take study drug|2|||
147204827|NCT02015637|530920253|FG001|Overall Study|Did not take study drug|0|||
147439025|NCT00874770|531772194|FG003|Overall Study|Lost to Follow-up|1|||
147439026|NCT00874770|531772191|FG000|Overall Study|Subject no Longer Meets Study Criteria|1|||
147439027|NCT00874770|531772192|FG001|Overall Study|Subject no Longer Meets Study Criteria|0|||
147439028|NCT00874770|531772193|FG002|Overall Study|Subject no Longer Meets Study Criteria|0|||
147439029|NCT00874770|531772194|FG003|Overall Study|Subject no Longer Meets Study Criteria|0|||
147439030|NCT04880447|531772196|FG000|Overall Study|No vaccination information|1|||
147439031|NCT04880447|531772196|FG000|Overall Study|No adverse event information (missing information)|1|||
147439032|NCT04880447|531772196|FG000|Overall Study|Disease not covered in this study|35|||
147439033|NCT00718549|531772197|FG000|Induction Phase|Disease Progression|1|||
147439034|NCT00718549|531772198|FG001|Induction Phase|Disease Progression|0|||
147439035|NCT00718549|531772199|FG002|Induction Phase|Disease Progression|0|||
147439036|NCT00718549|531772197|FG000|Induction Phase|Eligibility Criteria Violation|2|||
147439037|NCT00718549|531772198|FG001|Induction Phase|Eligibility Criteria Violation|0|||
147439038|NCT00718549|531772199|FG002|Induction Phase|Eligibility Criteria Violation|0|||
147439039|NCT00718549|531772197|FG000|Induction Phase|Early Termination - No Additional Info|59|||
147439040|NCT00718549|531772198|FG001|Induction Phase|Early Termination - No Additional Info|0|||
147439041|NCT00718549|531772199|FG002|Induction Phase|Early Termination - No Additional Info|0|||
147439042|NCT00718549|531772197|FG000|Maintenance/ Observation Phase|Early Termination - No Additional Info|0|||
147439043|NCT00718549|531772198|FG001|Maintenance/ Observation Phase|Early Termination - No Additional Info|15|||
147439044|NCT00718549|531772199|FG002|Maintenance/ Observation Phase|Early Termination - No Additional Info|8|||
147439045|NCT00718549|531772197|FG000|Maintenance/ Observation Phase|Death|0|||
147439046|NCT00718549|531772198|FG001|Maintenance/ Observation Phase|Death|1|||
147439047|NCT00718549|531772199|FG002|Maintenance/ Observation Phase|Death|2|||
147439048|NCT00718549|531772197|FG000|Maintenance/ Observation Phase|Lost to Follow-up|0|||
147439049|NCT00718549|531772198|FG001|Maintenance/ Observation Phase|Lost to Follow-up|4|||
147439050|NCT00718549|531772199|FG002|Maintenance/ Observation Phase|Lost to Follow-up|4|||
147439051|NCT00718549|531772197|FG000|Maintenance/ Observation Phase|Progression|0|||
147439052|NCT00718549|531772198|FG001|Maintenance/ Observation Phase|Progression|5|||
147439053|NCT00718549|531772199|FG002|Maintenance/ Observation Phase|Progression|14|||
147439054|NCT00718549|531772197|FG000|Maintenance/ Observation Phase|Relapse|0|||
147439055|NCT00718549|531772198|FG001|Maintenance/ Observation Phase|Relapse|3|||
147439056|NCT00718549|531772199|FG002|Maintenance/ Observation Phase|Relapse|2|||
147439057|NCT01353508|531772200|FG000|Period 1 - First Intervention (7 Days)|Adverse Event|0|||
147540913|NCT00644228|532135268|FG000|Maintenance|Death|3|||
147540914|NCT00644228|532135269|FG001|Maintenance|Death|3|||
147540915|NCT00644228|532135268|FG000|Maintenance|Not Protocol-Specified|14|||
147540916|NCT00644228|532135269|FG001|Maintenance|Not Protocol-Specified|15|||
147540917|NCT00644228|532135268|FG000|Maintenance|On Treatment|26|||
147540918|NCT00644228|532135269|FG001|Maintenance|On Treatment|40|||
147540919|NCT06078124|532135270|FG000|Overall Study|Lost to Follow-up|14|||
147204828|NCT03198507|530920256|FG000|Overall Study|Withdrawal by Subject|1|||
147204829|NCT03198507|530920257|FG001|Overall Study|Withdrawal by Subject|0|||
147204830|NCT02454517|530920258|FG000|Overall Study|Withdrawal by Subject|3|||
147204831|NCT02454517|530920259|FG001|Overall Study|Withdrawal by Subject|0|||
147204832|NCT02454517|530920258|FG000|Overall Study|Lost to Follow-up|4|||
147204833|NCT02454517|530920259|FG001|Overall Study|Lost to Follow-up|7|||
147204834|NCT02454517|530920258|FG000|Overall Study|Discontinued Active surveillance and underwent treatment|1|||
147204835|NCT02454517|530920259|FG001|Overall Study|Discontinued Active surveillance and underwent treatment|2|||
147204836|NCT02194985|530920260|FG000|Overall Study|Adverse Event|1|||
147204837|NCT02194985|530920260|FG000|Overall Study|Met Protocol Defined Stopping Criteria|3|||
147204838|NCT02194985|530920260|FG000|Overall Study|Physician Decision|4|||
147204839|NCT02194985|530920260|FG000|Overall Study|Lost to Follow-up|1|||
147204840|NCT02194985|530920260|FG000|Overall Study|Withdrawal by Subject|2|||
147204841|NCT00594815|530920270|FG000|Overall Study|Never Treated|3|||
147204842|NCT00594815|530920270|FG000|Overall Study|Withdrawal by Subject|2|||
147204843|NCT00594815|530920270|FG000|Overall Study|Toxicity|4|||
147204844|NCT02304367|530920271|FG000|Overall Study|Lack of Response to Bruosumab|1|||
147204845|NCT02304367|530920271|FG000|Overall Study|Sponsor Decision|3|||
147204846|NCT02304367|530920271|FG000|Overall Study|Death|2|||
147204847|NCT02304367|530920271|FG000|Overall Study|Physician Decision|1|||
147204848|NCT02304367|530920271|FG000|Overall Study|Unable to Return Due to Corona Virus Pandemic|1|||
147204849|NCT03599089|530920272|FG000|Overall Study|Lost to Follow-up|1|||
147204850|NCT03599089|530920273|FG001|Overall Study|Lost to Follow-up|0|||
147204851|NCT03599089|530920274|FG002|Overall Study|Lost to Follow-up|0|||
147204852|NCT03599089|530920275|FG003|Overall Study|Lost to Follow-up|0|||
147204853|NCT03599089|530920272|FG000|Overall Study|Withdrawal by Subject|2|||
147204854|NCT03599089|530920273|FG001|Overall Study|Withdrawal by Subject|1|||
147204855|NCT03599089|530920274|FG002|Overall Study|Withdrawal by Subject|0|||
147204856|NCT03599089|530920275|FG003|Overall Study|Withdrawal by Subject|0|||
147204857|NCT03599089|530920272|FG000|Overall Study|Lack of Efficacy|0|||
147204858|NCT03599089|530920273|FG001|Overall Study|Lack of Efficacy|0|||
147204859|NCT03599089|530920274|FG002|Overall Study|Lack of Efficacy|1|||
147204860|NCT03599089|530920275|FG003|Overall Study|Lack of Efficacy|2|||
147204861|NCT03214666|530920276|FG000|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|0|||
147204862|NCT03214666|530920277|FG001|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|0|||
147204863|NCT03214666|530920278|FG002|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|0|||
147204864|NCT03214666|530920279|FG003|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|0|||
147204865|NCT03214666|530920280|FG004|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|1|||
147204866|NCT03214666|530920281|FG005|Cohort 5: Dose Level 5: 100 ug/kg/Day|Adverse Event|0|||
147204867|NCT04139798|530920288|FG000|Overall Study|Withdrawal by Subject|6|||
147204868|NCT04139798|530920289|FG001|Overall Study|Withdrawal by Subject|5|||
147204869|NCT04139798|530920288|FG000|Overall Study|Lost to Follow-up|2|||
147204870|NCT04139798|530920289|FG001|Overall Study|Lost to Follow-up|5|||
147204871|NCT04139798|530920288|FG000|Overall Study|Discontinued|4|||
147204872|NCT04139798|530920289|FG001|Overall Study|Discontinued|2|||
147204873|NCT04139798|530920288|FG000|Overall Study|Adverse Event|1|||
147540920|NCT06078124|532135271|FG001|Overall Study|Lost to Follow-up|14|||
147540921|NCT05824273|532135272|FG000|Overall Study|Lost to Follow-up|16|||
147540922|NCT05824273|532135273|FG001|Overall Study|Lost to Follow-up|13|||
147540923|NCT02736695|532135274|FG000|Overall Study|Ineligible|6|||
147540924|NCT02736695|532135275|FG001|Overall Study|Ineligible|0|||
147540925|NCT04223193|532135276|FG000|Overall Study|Adverse Event|6|||
147540926|NCT04223193|532135277|FG001|Overall Study|Adverse Event|36|||
147540927|NCT04223193|532135276|FG000|Overall Study|Lack of Efficacy|2|||
147540928|NCT04223193|532135277|FG001|Overall Study|Lack of Efficacy|2|||
147540929|NCT04223193|532135276|FG000|Overall Study|Lost to Follow-up|1|||
147540930|NCT04223193|532135277|FG001|Overall Study|Lost to Follow-up|1|||
147540931|NCT04223193|532135276|FG000|Overall Study|Failure to Meet Continuation Criteria|1|||
147204874|NCT04139798|530920289|FG001|Overall Study|Adverse Event|3|||
147204875|NCT04139798|530920288|FG000|Overall Study|Protocol Violation|1|||
147204876|NCT04139798|530920289|FG001|Overall Study|Protocol Violation|0|||
147204877|NCT03895840|530920290|FG000|Overall Study|Withdrawal by Subject|21|||
147204878|NCT01931566|530920291|FG000|Overall Study|Randomized But Not Treated|6|||
147204879|NCT01931566|530920292|FG001|Overall Study|Randomized But Not Treated|9|||
147204880|NCT01931566|530920293|FG002|Overall Study|Randomized But Not Treated|14|||
147204881|NCT01931566|530920291|FG000|Overall Study|Adverse Event|37|||
147204882|NCT01931566|530920292|FG001|Overall Study|Adverse Event|167|||
147204883|NCT01931566|530920293|FG002|Overall Study|Adverse Event|132|||
147204884|NCT01931566|530920291|FG000|Overall Study|Major Protocol Deviation|5|||
147540932|NCT04223193|532135277|FG001|Overall Study|Failure to Meet Continuation Criteria|0|||
147540933|NCT04223193|532135276|FG000|Overall Study|Treatment with Prohibited Concomitant Medications|3|||
147204885|NCT01931566|530920292|FG001|Overall Study|Major Protocol Deviation|14|||
147204886|NCT01931566|530920293|FG002|Overall Study|Major Protocol Deviation|21|||
147204887|NCT01931566|530920291|FG000|Overall Study|Lost to Follow-up|3|||
147204888|NCT01931566|530920292|FG001|Overall Study|Lost to Follow-up|26|||
147649430|NCT02634801|532537341|FG000|Extension Period (Weeks 24 to 36)|Lost to Follow-up|1|||
147204889|NCT01931566|530920293|FG002|Overall Study|Lost to Follow-up|23|||
147540934|NCT04223193|532135277|FG001|Overall Study|Treatment with Prohibited Concomitant Medications|0|||
147204890|NCT01931566|530920291|FG000|Overall Study|Voluntary Withdrawal|78|||
147204891|NCT01931566|530920292|FG001|Overall Study|Voluntary Withdrawal|245|||
147204892|NCT01931566|530920293|FG002|Overall Study|Voluntary Withdrawal|225|||
147204893|NCT01931566|530920291|FG000|Overall Study|Study Termination|289|||
147204894|NCT01931566|530920292|FG001|Overall Study|Study Termination|968|||
147204895|NCT01931566|530920293|FG002|Overall Study|Study Termination|1037|||
147204896|NCT01931566|530920291|FG000|Overall Study|Reason Not Specified|11|||
147204897|NCT01931566|530920292|FG001|Overall Study|Reason Not Specified|47|||
147204898|NCT01931566|530920293|FG002|Overall Study|Reason Not Specified|53|||
147204899|NCT01931566|530920291|FG000|Overall Study|Missing|0|||
147204900|NCT01931566|530920292|FG001|Overall Study|Missing|0|||
147204901|NCT01931566|530920293|FG002|Overall Study|Missing|1|||
147204902|NCT04476797|530920295|FG000|Overall Study|Withdrawal by Subject|1|||
147204903|NCT04476797|530920296|FG001|Overall Study|Withdrawal by Subject|0|||
147204904|NCT04476797|530920297|FG002|Overall Study|Withdrawal by Subject|0|||
147204905|NCT04476797|530920295|FG000|Overall Study|Death|0|||
147204906|NCT04476797|530920296|FG001|Overall Study|Death|1|||
147204907|NCT04476797|530920297|FG002|Overall Study|Death|2|||
147540935|NCT04223193|532135276|FG000|Overall Study|Non-Compliance with Study Drug|0|||
147540936|NCT04223193|532135277|FG001|Overall Study|Non-Compliance with Study Drug|1|||
147540937|NCT04223193|532135276|FG000|Overall Study|Physician Decision|0|||
147204908|NCT04476797|530920295|FG000|Overall Study|Sponsor Terminated Study|0|||
147204909|NCT04476797|530920296|FG001|Overall Study|Sponsor Terminated Study|18|||
147204910|NCT04476797|530920297|FG002|Overall Study|Sponsor Terminated Study|17|||
147204911|NCT02395081|530920298|FG000|Overall Study|Withdrawal by Subject|1|||
147204912|NCT02395081|530920299|FG001|Overall Study|Withdrawal by Subject|1|||
147204913|NCT02395081|530920300|FG002|Overall Study|Withdrawal by Subject|0|||
147204914|NCT02395081|530920298|FG000|Overall Study|Moved where blood couldn't be collected|4|||
147204915|NCT02395081|530920299|FG001|Overall Study|Moved where blood couldn't be collected|1|||
147204916|NCT02395081|530920300|FG002|Overall Study|Moved where blood couldn't be collected|3|||
147204917|NCT02395081|530920298|FG000|Overall Study|Fetal Loss|2|||
147204918|NCT02395081|530920299|FG001|Overall Study|Fetal Loss|3|||
147204919|NCT02395081|530920300|FG002|Overall Study|Fetal Loss|1|||
147204920|NCT04625101|530920301|FG000|Overall Study|Withdrawal by Subject|0|||
147204921|NCT04625101|530920302|FG001|Overall Study|Withdrawal by Subject|1|||
147204922|NCT04625101|530920301|FG000|Overall Study|Protocol Deviation|1|||
147204923|NCT04625101|530920302|FG001|Overall Study|Protocol Deviation|0|||
147204924|NCT02991040|530920303|FG000|Overall Study|Withdrawal by Subject|2|||
147204925|NCT02991040|530920303|FG000|Overall Study|Lost to Follow-up|2|||
147204926|NCT02721966|530920304|FG000|Overall Study|Protocol Violation|1|||
147204927|NCT02721966|530920305|FG001|Overall Study|Protocol Violation|0|||
147204928|NCT02721966|530920306|FG002|Overall Study|Protocol Violation|0|||
147204929|NCT02721966|530920307|FG003|Overall Study|Protocol Violation|0|||
147204930|NCT02721966|530920308|FG004|Overall Study|Protocol Violation|0|||
147204931|NCT02721966|530920304|FG000|Overall Study|Withdrawal by Subject|9|||
147204932|NCT02721966|530920305|FG001|Overall Study|Withdrawal by Subject|2|||
147204933|NCT02721966|530920306|FG002|Overall Study|Withdrawal by Subject|3|||
147204934|NCT02721966|530920307|FG003|Overall Study|Withdrawal by Subject|7|||
147204935|NCT02721966|530920308|FG004|Overall Study|Withdrawal by Subject|0|||
147204936|NCT02721966|530920304|FG000|Overall Study|Adverse Event|4|||
147204937|NCT02721966|530920305|FG001|Overall Study|Adverse Event|4|||
147204938|NCT02721966|530920306|FG002|Overall Study|Adverse Event|3|||
147204939|NCT02721966|530920307|FG003|Overall Study|Adverse Event|0|||
147204940|NCT02721966|530920308|FG004|Overall Study|Adverse Event|0|||
147204941|NCT02721966|530920304|FG000|Overall Study|Death|1|||
147204942|NCT02721966|530920305|FG001|Overall Study|Death|0|||
147204943|NCT02721966|530920306|FG002|Overall Study|Death|0|||
147204944|NCT02721966|530920307|FG003|Overall Study|Death|0|||
147204945|NCT02721966|530920308|FG004|Overall Study|Death|0|||
147204946|NCT02721966|530920304|FG000|Overall Study|Lack of Efficacy|7|||
147204947|NCT02721966|530920305|FG001|Overall Study|Lack of Efficacy|4|||
147204948|NCT02721966|530920306|FG002|Overall Study|Lack of Efficacy|0|||
147204949|NCT02721966|530920307|FG003|Overall Study|Lack of Efficacy|0|||
147204950|NCT02721966|530920308|FG004|Overall Study|Lack of Efficacy|0|||
147204951|NCT02721966|530920304|FG000|Overall Study|Lost to Follow-up|0|||
147204952|NCT02721966|530920305|FG001|Overall Study|Lost to Follow-up|0|||
147204953|NCT02721966|530920306|FG002|Overall Study|Lost to Follow-up|3|||
147204954|NCT02721966|530920307|FG003|Overall Study|Lost to Follow-up|0|||
147540938|NCT04223193|532135277|FG001|Overall Study|Physician Decision|1|||
147204955|NCT02721966|530920308|FG004|Overall Study|Lost to Follow-up|0|||
147204956|NCT02721966|530920304|FG000|Overall Study|Physician Decision|1|||
147204957|NCT02721966|530920305|FG001|Overall Study|Physician Decision|1|||
147204958|NCT02721966|530920306|FG002|Overall Study|Physician Decision|0|||
147204959|NCT02721966|530920307|FG003|Overall Study|Physician Decision|0|||
147204960|NCT02721966|530920308|FG004|Overall Study|Physician Decision|0|||
147204961|NCT02721966|530920304|FG000|Overall Study|Pregnancy|1|||
147204962|NCT02721966|530920305|FG001|Overall Study|Pregnancy|0|||
147540939|NCT04223193|532135276|FG000|Overall Study|Protocol Violation|1|||
147540940|NCT04223193|532135277|FG001|Overall Study|Protocol Violation|1|||
147540941|NCT04223193|532135276|FG000|Overall Study|Site Terminated by Sponsor|1|||
147540942|NCT04223193|532135277|FG001|Overall Study|Site Terminated by Sponsor|3|||
147540943|NCT04223193|532135276|FG000|Overall Study|Withdrawal by Subject|5|||
147540944|NCT04223193|532135277|FG001|Overall Study|Withdrawal by Subject|6|||
147540945|NCT04223193|532135276|FG000|Overall Study|Other|3|||
147540946|NCT04223193|532135277|FG001|Overall Study|Other|6|||
147540947|NCT03193190|532135280|FG000|Stage 1|Arm Terminated by Sponsor|0|||
147540948|NCT03193190|532135281|FG001|Stage 1|Arm Terminated by Sponsor|0|||
147540949|NCT03193190|532135282|FG002|Stage 1|Arm Terminated by Sponsor|0|||
147540950|NCT03193190|532135283|FG003|Stage 1|Arm Terminated by Sponsor|1|||
147540951|NCT03193190|532135284|FG004|Stage 1|Arm Terminated by Sponsor|0|||
147540952|NCT03193190|532135285|FG005|Stage 1|Arm Terminated by Sponsor|2|||
147540953|NCT03193190|532135286|FG006|Stage 1|Arm Terminated by Sponsor|0|||
147540954|NCT03193190|532135287|FG007|Stage 1|Arm Terminated by Sponsor|0|||
147204963|NCT02721966|530920306|FG002|Overall Study|Pregnancy|0|||
147204964|NCT02721966|530920307|FG003|Overall Study|Pregnancy|0|||
147540955|NCT03193190|532135288|FG008|Stage 1|Arm Terminated by Sponsor|0|||
147540956|NCT03193190|532135289|FG009|Stage 1|Arm Terminated by Sponsor|0|||
147540957|NCT03193190|532135290|FG010|Stage 1|Arm Terminated by Sponsor|0|||
147540958|NCT03193190|532135291|FG011|Stage 1|Arm Terminated by Sponsor|0|||
147540959|NCT03193190|532135292|FG012|Stage 1|Arm Terminated by Sponsor|0|||
147540960|NCT03193190|532135293|FG013|Stage 1|Arm Terminated by Sponsor|0|||
147540961|NCT03193190|532135294|FG014|Stage 1|Arm Terminated by Sponsor|0|||
147540962|NCT03193190|532135295|FG015|Stage 1|Arm Terminated by Sponsor|0|||
147540963|NCT03193190|532135280|FG000|Stage 1|Death|22|||
147540964|NCT03193190|532135281|FG001|Stage 1|Death|8|||
147540965|NCT03193190|532135282|FG002|Stage 1|Death|23|||
147204965|NCT02721966|530920308|FG004|Overall Study|Pregnancy|0|||
147204966|NCT02721966|530920304|FG000|Overall Study|Did not continue to period 2|5|||
147204967|NCT02721966|530920305|FG001|Overall Study|Did not continue to period 2|12|||
147204968|NCT02721966|530920306|FG002|Overall Study|Did not continue to period 2|0|||
147204969|NCT02721966|530920307|FG003|Overall Study|Did not continue to period 2|0|||
147204970|NCT02721966|530920308|FG004|Overall Study|Did not continue to period 2|5|||
147204971|NCT03070964|530920309|FG000|Overall Study|Progressive disease|8|||
147204972|NCT03070964|530920309|FG000|Overall Study|Treatment-unrelated adverse event|2|||
147204973|NCT03070964|530920309|FG000|Overall Study|Never treated|1|||
147204974|NCT03070964|530920309|FG000|Overall Study|Physician Decision|1|||
147204975|NCT03070964|530920309|FG000|Overall Study|Withdrawal by Subject|1|||
147204976|NCT03070964|530920309|FG000|Overall Study|Adverse Event|1|||
147204977|NCT01286480|530920310|FG000|Overall Study|Withdrawal by Subject|5|||
147204978|NCT01286480|530920311|FG001|Overall Study|Withdrawal by Subject|3|||
147204979|NCT00834093|530920312|FG000|Overall Study|Progressive Disease|3|||
147204980|NCT00834093|530920312|FG000|Overall Study|Withdrawal by subject or MD Decision|5|||
147204981|NCT01209325|530920313|FG000|Overall Study|Lost to Follow-up|24|||
147204982|NCT01209325|530920313|FG000|Overall Study|Adverse Event|1|||
147204983|NCT01209325|530920313|FG000|Overall Study|Relocated|3|||
147204984|NCT01209325|530920313|FG000|Overall Study|Refusal after starting therapy|8|||
147204985|NCT01209325|530920313|FG000|Overall Study|Protocol Violation|4|||
147204986|NCT01209325|530920313|FG000|Overall Study|Refusal prior to therapy|1|||
147204987|NCT01209325|530920313|FG000|Overall Study|Incarceration|2|||
147204988|NCT00607373|530920314|FG000|Treatment Period|Adverse Event|0|||
147204989|NCT00607373|530920315|FG001|Treatment Period|Adverse Event|4|||
147204990|NCT00607373|530920314|FG000|Treatment Period|Physician Decision|0|||
147204991|NCT00607373|530920315|FG001|Treatment Period|Physician Decision|1|||
147204992|NCT00607373|530920314|FG000|Treatment Period|Withdrawal by Subject|0|||
147204993|NCT00607373|530920315|FG001|Treatment Period|Withdrawal by Subject|1|||
147204994|NCT00607373|530920314|FG000|Follow-up Period|Other|0|||
147204995|NCT00607373|530920315|FG001|Follow-up Period|Other|1|||
147204996|NCT00607373|530920314|FG000|Follow-up Period|Protocol Violation|0|||
147204997|NCT00607373|530920315|FG001|Follow-up Period|Protocol Violation|1|||
147540966|NCT03193190|532135283|FG003|Stage 1|Death|14|||
147540967|NCT03193190|532135284|FG004|Stage 1|Death|34|||
147540968|NCT03193190|532135285|FG005|Stage 1|Death|28|||
147540969|NCT03193190|532135286|FG006|Stage 1|Death|19|||
147540970|NCT03193190|532135287|FG007|Stage 1|Death|21|||
147204998|NCT00607373|530920314|FG000|Follow-up Period|Withdrawal by Subject|1|||
147204999|NCT00607373|530920315|FG001|Follow-up Period|Withdrawal by Subject|3|||
147205000|NCT01918306|530920316|FG000|Overall Study|progresive disease|4|||
147205001|NCT01918306|530920317|FG001|Overall Study|progresive disease|0|||
147205002|NCT01918306|530920318|FG002|Overall Study|progresive disease|1|||
147205003|NCT01918306|530920319|FG003|Overall Study|progresive disease|1|||
147205004|NCT01918306|530920316|FG000|Overall Study|Withdrawal by Subject|0|||
147205005|NCT01918306|530920317|FG001|Overall Study|Withdrawal by Subject|0|||
147540971|NCT03193190|532135288|FG008|Stage 1|Death|14|||
147540972|NCT03193190|532135289|FG009|Stage 1|Death|10|||
147540973|NCT03193190|532135290|FG010|Stage 1|Death|59|||
147540974|NCT03193190|532135291|FG011|Stage 1|Death|14|||
147540975|NCT03193190|532135292|FG012|Stage 1|Death|14|||
147540976|NCT03193190|532135293|FG013|Stage 1|Death|0|||
147205006|NCT01918306|530920318|FG002|Overall Study|Withdrawal by Subject|0|||
147205007|NCT01918306|530920319|FG003|Overall Study|Withdrawal by Subject|2|||
147205008|NCT01918306|530920316|FG000|Overall Study|neutropenia|1|||
147205009|NCT01918306|530920317|FG001|Overall Study|neutropenia|0|||
147205010|NCT01918306|530920318|FG002|Overall Study|neutropenia|0|||
147205011|NCT01918306|530920319|FG003|Overall Study|neutropenia|0|||
147205012|NCT01918306|530920316|FG000|Overall Study|Lack of Efficacy|1|||
147439058|NCT01353508|531772201|FG001|Period 1 - First Intervention (7 Days)|Adverse Event|0|||
147439059|NCT01353508|531772202|FG002|Period 1 - First Intervention (7 Days)|Adverse Event|0|||
147439060|NCT01353508|531772203|FG003|Period 1 - First Intervention (7 Days)|Adverse Event|1|||
147439061|NCT01353508|531772200|FG000|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|1|||
147439062|NCT01353508|531772201|FG001|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|0|||
147439063|NCT01353508|531772202|FG002|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|0|||
147439064|NCT01353508|531772203|FG003|Period 2 - Second Intervention (7 Days)|Withdrawal by Subject|0|||
147439065|NCT01576172|531772204|FG000|Overall Study|Ineligible|2|||
147439066|NCT01576172|531772205|FG001|Overall Study|Ineligible|1|||
147439067|NCT01576172|531772204|FG000|Overall Study|Withdrawal by Subject|2|||
147439068|NCT01576172|531772205|FG001|Overall Study|Withdrawal by Subject|0|||
147439069|NCT01576172|531772204|FG000|Overall Study|Insurance issue|1|||
147439070|NCT01576172|531772205|FG001|Overall Study|Insurance issue|0|||
147439071|NCT01514136|531772210|FG000|Test Period 1; Test A|Protocol Violation|1|||
147439072|NCT01514136|531772211|FG001|Test Period 1; Test A|Protocol Violation|0|||
147439073|NCT01514136|531772212|FG002|Test Period 1; Test A|Protocol Violation|0|||
147439074|NCT01514136|531772213|FG003|Test Period 1; Test A|Protocol Violation|0|||
147439075|NCT01514136|531772214|FG004|Test Period 1; Test A|Protocol Violation|0|||
147439076|NCT01514136|531772215|FG005|Test Period 1; Test A|Protocol Violation|0|||
147439077|NCT01514136|531772216|FG006|Test Period 1; Test A|Protocol Violation|0|||
147439078|NCT01514136|531772217|FG007|Test Period 1; Test A|Protocol Violation|0|||
147439079|NCT01514136|531772210|FG000|Test Period 1; Test A|Break from study holiday|2|||
147439080|NCT01514136|531772211|FG001|Test Period 1; Test A|Break from study holiday|0|||
147439081|NCT01514136|531772212|FG002|Test Period 1; Test A|Break from study holiday|0|||
147439082|NCT01514136|531772213|FG003|Test Period 1; Test A|Break from study holiday|0|||
147439083|NCT01514136|531772214|FG004|Test Period 1; Test A|Break from study holiday|0|||
147439084|NCT01514136|531772215|FG005|Test Period 1; Test A|Break from study holiday|0|||
147439085|NCT01514136|531772216|FG006|Test Period 1; Test A|Break from study holiday|0|||
147439086|NCT01514136|531772217|FG007|Test Period 1; Test A|Break from study holiday|0|||
147439087|NCT01514136|531772210|FG000|Test Period 1; Test B|Withdrawal by Subject|0|||
147439088|NCT01514136|531772211|FG001|Test Period 1; Test B|Withdrawal by Subject|1|||
147439089|NCT01514136|531772212|FG002|Test Period 1; Test B|Withdrawal by Subject|0|||
147439090|NCT01514136|531772213|FG003|Test Period 1; Test B|Withdrawal by Subject|0|||
147439091|NCT01514136|531772214|FG004|Test Period 1; Test B|Withdrawal by Subject|0|||
147439092|NCT01514136|531772215|FG005|Test Period 1; Test B|Withdrawal by Subject|0|||
147439093|NCT01514136|531772216|FG006|Test Period 1; Test B|Withdrawal by Subject|0|||
147439094|NCT01514136|531772217|FG007|Test Period 1; Test B|Withdrawal by Subject|0|||
147439095|NCT01514136|531772210|FG000|Test Period 1; Test D|Subject took a break due to holiday|0|||
147439096|NCT01514136|531772211|FG001|Test Period 1; Test D|Subject took a break due to holiday|0|||
147439097|NCT01514136|531772212|FG002|Test Period 1; Test D|Subject took a break due to holiday|0|||
147439098|NCT01514136|531772213|FG003|Test Period 1; Test D|Subject took a break due to holiday|2|||
147439099|NCT01514136|531772214|FG004|Test Period 1; Test D|Subject took a break due to holiday|0|||
147439100|NCT01514136|531772215|FG005|Test Period 1; Test D|Subject took a break due to holiday|0|||
147439101|NCT01514136|531772216|FG006|Test Period 1; Test D|Subject took a break due to holiday|0|||
147439102|NCT01514136|531772217|FG007|Test Period 1; Test D|Subject took a break due to holiday|0|||
147439103|NCT01514136|531772210|FG000|Test Period 2; Test A*|Adverse Event|0|||
147439104|NCT01514136|531772211|FG001|Test Period 2; Test A*|Adverse Event|0|||
147439105|NCT01514136|531772212|FG002|Test Period 2; Test A*|Adverse Event|0|||
147439106|NCT01514136|531772213|FG003|Test Period 2; Test A*|Adverse Event|0|||
147439107|NCT01514136|531772214|FG004|Test Period 2; Test A*|Adverse Event|1|||
147439108|NCT01514136|531772215|FG005|Test Period 2; Test A*|Adverse Event|0|||
147439109|NCT01514136|531772216|FG006|Test Period 2; Test A*|Adverse Event|0|||
147439110|NCT01514136|531772217|FG007|Test Period 2; Test A*|Adverse Event|0|||
147439111|NCT01514136|531772210|FG000|Test Period 2; Test A*|Holiday|0|||
147439112|NCT01514136|531772211|FG001|Test Period 2; Test A*|Holiday|0|||
147439113|NCT01514136|531772212|FG002|Test Period 2; Test A*|Holiday|0|||
147439114|NCT01514136|531772213|FG003|Test Period 2; Test A*|Holiday|0|||
147439115|NCT01514136|531772214|FG004|Test Period 2; Test A*|Holiday|1|||
147439116|NCT01514136|531772215|FG005|Test Period 2; Test A*|Holiday|0|||
147439117|NCT01514136|531772216|FG006|Test Period 2; Test A*|Holiday|0|||
147439118|NCT01514136|531772217|FG007|Test Period 2; Test A*|Holiday|0|||
147439119|NCT01514136|531772210|FG000|Test Period 2; Test B*|Withdrawal by Subject|0|||
147439120|NCT01514136|531772211|FG001|Test Period 2; Test B*|Withdrawal by Subject|0|||
147439121|NCT01514136|531772212|FG002|Test Period 2; Test B*|Withdrawal by Subject|0|||
147649431|NCT02634801|532537342|FG001|Extension Period (Weeks 24 to 36)|Lost to Follow-up|0|||
147439122|NCT01514136|531772213|FG003|Test Period 2; Test B*|Withdrawal by Subject|0|||
147205013|NCT01918306|530920317|FG001|Overall Study|Lack of Efficacy|0|||
147205014|NCT01918306|530920318|FG002|Overall Study|Lack of Efficacy|0|||
147205015|NCT01918306|530920319|FG003|Overall Study|Lack of Efficacy|0|||
147205016|NCT01918306|530920316|FG000|Overall Study|progress disease, crossover|0|||
147205017|NCT01918306|530920317|FG001|Overall Study|progress disease, crossover|0|||
147205018|NCT01918306|530920318|FG002|Overall Study|progress disease, crossover|1|||
147205019|NCT01918306|530920319|FG003|Overall Study|progress disease, crossover|0|||
147205020|NCT01160822|530920324|FG000|Overall Study|Adverse Event|0|||
147205021|NCT01160822|530920325|FG001|Overall Study|Adverse Event|0|||
147205022|NCT01160822|530920326|FG002|Overall Study|Adverse Event|0|||
147205023|NCT01160822|530920327|FG003|Overall Study|Adverse Event|0|||
147205024|NCT01160822|530920328|FG004|Overall Study|Adverse Event|1|||
147205025|NCT01160822|530920329|FG005|Overall Study|Adverse Event|2|||
147205026|NCT01160822|530920330|FG006|Overall Study|Adverse Event|5|||
147205027|NCT01160822|530920324|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
147205028|NCT01160822|530920325|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
147205029|NCT01160822|530920326|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
147205030|NCT01160822|530920327|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
147205031|NCT01160822|530920328|FG004|Overall Study|Unsatisfactory therapeutic effect|4|||
147205032|NCT01160822|530920329|FG005|Overall Study|Unsatisfactory therapeutic effect|5|||
147205033|NCT01160822|530920330|FG006|Overall Study|Unsatisfactory therapeutic effect|3|||
147205034|NCT01160822|530920324|FG000|Overall Study|Withdrawal by Subject|0|||
147205035|NCT01160822|530920325|FG001|Overall Study|Withdrawal by Subject|0|||
147205036|NCT01160822|530920326|FG002|Overall Study|Withdrawal by Subject|0|||
147205037|NCT01160822|530920327|FG003|Overall Study|Withdrawal by Subject|0|||
147205038|NCT01160822|530920328|FG004|Overall Study|Withdrawal by Subject|0|||
147205039|NCT01160822|530920329|FG005|Overall Study|Withdrawal by Subject|0|||
147205040|NCT01160822|530920330|FG006|Overall Study|Withdrawal by Subject|1|||
147205041|NCT01160822|530920324|FG000|Overall Study|Lost to Follow-up|0|||
147205042|NCT01160822|530920325|FG001|Overall Study|Lost to Follow-up|0|||
147205043|NCT01160822|530920326|FG002|Overall Study|Lost to Follow-up|0|||
147205044|NCT01160822|530920327|FG003|Overall Study|Lost to Follow-up|0|||
147205045|NCT01160822|530920328|FG004|Overall Study|Lost to Follow-up|1|||
147205046|NCT01160822|530920329|FG005|Overall Study|Lost to Follow-up|0|||
147205047|NCT01160822|530920330|FG006|Overall Study|Lost to Follow-up|0|||
147205048|NCT01160822|530920324|FG000|Overall Study|Administrative problems|0|||
147205049|NCT01160822|530920325|FG001|Overall Study|Administrative problems|0|||
147205050|NCT01160822|530920326|FG002|Overall Study|Administrative problems|0|||
147205051|NCT01160822|530920327|FG003|Overall Study|Administrative problems|0|||
147205052|NCT01160822|530920328|FG004|Overall Study|Administrative problems|1|||
147205053|NCT01160822|530920329|FG005|Overall Study|Administrative problems|0|||
147205054|NCT01160822|530920330|FG006|Overall Study|Administrative problems|0|||
147205055|NCT01160822|530920324|FG000|Overall Study|Protocol deviation|0|||
147205056|NCT01160822|530920325|FG001|Overall Study|Protocol deviation|0|||
147205057|NCT01160822|530920326|FG002|Overall Study|Protocol deviation|0|||
147205058|NCT01160822|530920327|FG003|Overall Study|Protocol deviation|0|||
147205059|NCT01160822|530920328|FG004|Overall Study|Protocol deviation|2|||
147205060|NCT01160822|530920329|FG005|Overall Study|Protocol deviation|0|||
147205061|NCT01160822|530920330|FG006|Overall Study|Protocol deviation|0|||
147205062|NCT02170077|530920333|FG000|Overall Study|Withdrawal by Subject|3|||
147205063|NCT02170077|530920334|FG001|Overall Study|Withdrawal by Subject|4|||
147205064|NCT02170077|530920335|FG002|Overall Study|Withdrawal by Subject|2|||
147205065|NCT02170077|530920333|FG000|Overall Study|Adverse Event|4|||
147205066|NCT02170077|530920334|FG001|Overall Study|Adverse Event|4|||
147205067|NCT02170077|530920335|FG002|Overall Study|Adverse Event|4|||
147205068|NCT02170077|530920333|FG000|Overall Study|Lost to Follow-up|0|||
147205069|NCT02170077|530920334|FG001|Overall Study|Lost to Follow-up|1|||
147205070|NCT02170077|530920335|FG002|Overall Study|Lost to Follow-up|0|||
147205071|NCT02170077|530920333|FG000|Overall Study|Exclusion criteria|2|||
147205072|NCT02170077|530920334|FG001|Overall Study|Exclusion criteria|2|||
147205073|NCT02170077|530920335|FG002|Overall Study|Exclusion criteria|5|||
147205074|NCT02170077|530920333|FG000|Overall Study|Exacerbation of seizures|0|||
147205075|NCT02170077|530920334|FG001|Overall Study|Exacerbation of seizures|2|||
147439123|NCT01514136|531772214|FG004|Test Period 2; Test B*|Withdrawal by Subject|0|||
147439124|NCT01514136|531772215|FG005|Test Period 2; Test B*|Withdrawal by Subject|2|||
147439125|NCT01514136|531772216|FG006|Test Period 2; Test B*|Withdrawal by Subject|0|||
147205076|NCT02170077|530920335|FG002|Overall Study|Exacerbation of seizures|1|||
147205077|NCT01780974|530920338|FG000|Overall Study|Death|1|||
147205078|NCT01780974|530920339|FG001|Overall Study|Death|0|||
147205079|NCT01780974|530920338|FG000|Overall Study|Adverse Event|1|||
147205080|NCT01780974|530920339|FG001|Overall Study|Adverse Event|3|||
147205081|NCT01724346|530920340|FG000|Overall Study|Death|42|||
147205082|NCT01724346|530920341|FG001|Overall Study|Death|42|||
147205083|NCT01724346|530920340|FG000|Overall Study|Lost to Follow-up|5|||
147205084|NCT01724346|530920341|FG001|Overall Study|Lost to Follow-up|1|||
147439126|NCT01514136|531772217|FG007|Test Period 2; Test B*|Withdrawal by Subject|0|||
147439127|NCT01514136|531772210|FG000|Test Period 2; Test C*|Withdrawal by Subject|0|||
147205085|NCT01724346|530920340|FG000|Overall Study|Withdrawal by Subject|27|||
147205086|NCT01724346|530920341|FG001|Overall Study|Withdrawal by Subject|19|||
147205087|NCT01724346|530920340|FG000|Overall Study|Did Not Rollover From Parent Study|5|||
147205088|NCT01724346|530920341|FG001|Overall Study|Did Not Rollover From Parent Study|8|||
147205089|NCT00750438|530920348|FG000|Overall Study|Protocol Violation|4|||
147205090|NCT00750438|530920349|FG001|Overall Study|Protocol Violation|1|||
147205091|NCT00750438|530920348|FG000|Overall Study|Physician Decision|2|||
147205092|NCT00750438|530920349|FG001|Overall Study|Physician Decision|2|||
147205093|NCT00750438|530920348|FG000|Overall Study|Withdrawal by Subject|1|||
147205094|NCT00750438|530920349|FG001|Overall Study|Withdrawal by Subject|1|||
147205095|NCT00256997|530920352|FG000|Overall Study|Protocol Violation|1|||
147205096|NCT00256997|530920353|FG001|Overall Study|Protocol Violation|4|||
147205097|NCT00256997|530920352|FG000|Overall Study|Lack of Efficacy|1|||
147205098|NCT00256997|530920353|FG001|Overall Study|Lack of Efficacy|4|||
147205099|NCT00256997|530920352|FG000|Overall Study|Death|2|||
147205100|NCT00256997|530920353|FG001|Overall Study|Death|0|||
147205101|NCT00256997|530920352|FG000|Overall Study|Adverse Event|4|||
147205102|NCT00256997|530920353|FG001|Overall Study|Adverse Event|0|||
147205103|NCT00256997|530920352|FG000|Overall Study|Lost to Follow-up|3|||
147205104|NCT00256997|530920353|FG001|Overall Study|Lost to Follow-up|5|||
147205105|NCT00256997|530920352|FG000|Overall Study|Withdrawal by Subject|13|||
147205106|NCT00256997|530920353|FG001|Overall Study|Withdrawal by Subject|3|||
147205107|NCT00256997|530920352|FG000|Overall Study|Started but not treated|2|||
147439128|NCT01514136|531772211|FG001|Test Period 2; Test C*|Withdrawal by Subject|0|||
147439129|NCT01514136|531772212|FG002|Test Period 2; Test C*|Withdrawal by Subject|0|||
147439130|NCT01514136|531772213|FG003|Test Period 2; Test C*|Withdrawal by Subject|0|||
147439131|NCT01514136|531772214|FG004|Test Period 2; Test C*|Withdrawal by Subject|0|||
147439132|NCT01514136|531772215|FG005|Test Period 2; Test C*|Withdrawal by Subject|0|||
147439133|NCT01514136|531772216|FG006|Test Period 2; Test C*|Withdrawal by Subject|1|||
147439134|NCT01514136|531772217|FG007|Test Period 2; Test C*|Withdrawal by Subject|0|||
147439135|NCT01514136|531772210|FG000|Test Period 2; Test C*|holiday|0|||
147439136|NCT01514136|531772211|FG001|Test Period 2; Test C*|holiday|0|||
147439137|NCT01514136|531772212|FG002|Test Period 2; Test C*|holiday|0|||
147439138|NCT01514136|531772213|FG003|Test Period 2; Test C*|holiday|0|||
147439139|NCT01514136|531772214|FG004|Test Period 2; Test C*|holiday|0|||
147439140|NCT01514136|531772215|FG005|Test Period 2; Test C*|holiday|0|||
147439141|NCT01514136|531772216|FG006|Test Period 2; Test C*|holiday|1|||
147439142|NCT01514136|531772217|FG007|Test Period 2; Test C*|holiday|0|||
147439143|NCT01514136|531772210|FG000|Test Period 2; Test C*|Protocol Violation|0|||
147439144|NCT01514136|531772211|FG001|Test Period 2; Test C*|Protocol Violation|0|||
147439145|NCT01514136|531772212|FG002|Test Period 2; Test C*|Protocol Violation|0|||
147439146|NCT01514136|531772213|FG003|Test Period 2; Test C*|Protocol Violation|0|||
147439147|NCT01514136|531772214|FG004|Test Period 2; Test C*|Protocol Violation|0|||
147205108|NCT00256997|530920353|FG001|Overall Study|Started but not treated|0|||
147205109|NCT00256997|530920352|FG000|Overall Study|Other|5|||
147205110|NCT00256997|530920353|FG001|Overall Study|Other|8|||
147205111|NCT00256997|530920352|FG000|Overall Study|End of Study (As Per Sponsor)|12|||
147439148|NCT01514136|531772215|FG005|Test Period 2; Test C*|Protocol Violation|0|||
147439149|NCT01514136|531772216|FG006|Test Period 2; Test C*|Protocol Violation|1|||
147205112|NCT00256997|530920353|FG001|Overall Study|End of Study (As Per Sponsor)|24|||
147205113|NCT00256997|530920352|FG000|Overall Study|Participant Non-compliant|3|||
147439150|NCT01514136|531772217|FG007|Test Period 2; Test C*|Protocol Violation|0|||
147439151|NCT01010633|531772218|FG000|Overall Study|Adverse Event|1|||
147439152|NCT01010633|531772219|FG001|Overall Study|Adverse Event|1|||
147205114|NCT00256997|530920353|FG001|Overall Study|Participant Non-compliant|6|||
147205115|NCT00256997|530920352|FG000|Overall Study|Investigator Withdrew Participant|2|||
147205116|NCT00256997|530920353|FG001|Overall Study|Investigator Withdrew Participant|1|||
147205117|NCT02736578|530920354|FG000|Overall Study|Adverse Event|1|||
147205118|NCT02736578|530920355|FG001|Overall Study|Adverse Event|0|||
147205119|NCT00354432|530920356|FG000|Overall Study|Adverse Event|3|||
147540977|NCT03193190|532135294|FG014|Stage 1|Death|0|||
147540978|NCT03193190|532135295|FG015|Stage 1|Death|0|||
147540979|NCT03193190|532135280|FG000|Stage 1|Lost to Follow-up|2|||
147540980|NCT03193190|532135281|FG001|Stage 1|Lost to Follow-up|1|||
147540981|NCT03193190|532135282|FG002|Stage 1|Lost to Follow-up|1|||
147540982|NCT03193190|532135283|FG003|Stage 1|Lost to Follow-up|0|||
147540983|NCT03193190|532135284|FG004|Stage 1|Lost to Follow-up|0|||
147540984|NCT03193190|532135285|FG005|Stage 1|Lost to Follow-up|0|||
147540985|NCT03193190|532135286|FG006|Stage 1|Lost to Follow-up|1|||
147540986|NCT03193190|532135287|FG007|Stage 1|Lost to Follow-up|0|||
147540987|NCT03193190|532135288|FG008|Stage 1|Lost to Follow-up|0|||
147540988|NCT03193190|532135289|FG009|Stage 1|Lost to Follow-up|0|||
147540989|NCT03193190|532135290|FG010|Stage 1|Lost to Follow-up|0|||
147540990|NCT03193190|532135291|FG011|Stage 1|Lost to Follow-up|0|||
147540991|NCT03193190|532135292|FG012|Stage 1|Lost to Follow-up|0|||
147540992|NCT03193190|532135293|FG013|Stage 1|Lost to Follow-up|0|||
147540993|NCT03193190|532135294|FG014|Stage 1|Lost to Follow-up|0|||
147540994|NCT03193190|532135295|FG015|Stage 1|Lost to Follow-up|0|||
147540995|NCT03193190|532135280|FG000|Stage 1|Reason not Specified|1|||
147540996|NCT03193190|532135281|FG001|Stage 1|Reason not Specified|0|||
147205120|NCT00354432|530920357|FG001|Overall Study|Adverse Event|1|||
147205121|NCT00354432|530920358|FG002|Overall Study|Adverse Event|5|||
147205122|NCT00354432|530920359|FG003|Overall Study|Adverse Event|5|||
147205123|NCT00354432|530920356|FG000|Overall Study|Off/Toxicity|3|||
147205124|NCT00354432|530920357|FG001|Overall Study|Off/Toxicity|7|||
147205125|NCT00354432|530920358|FG002|Overall Study|Off/Toxicity|5|||
147205126|NCT00354432|530920359|FG003|Overall Study|Off/Toxicity|5|||
147205127|NCT00802945|530920360|FG000|Overall Study|Death|27|||
147205128|NCT00802945|530920361|FG001|Overall Study|Death|23|||
147205129|NCT00802945|530920360|FG000|Overall Study|Terminated by sponsor|8|||
147205130|NCT00802945|530920361|FG001|Overall Study|Terminated by sponsor|12|||
147205131|NCT01104311|530920362|FG000|Overall Study|Withdrawal by Subject|6|||
147205132|NCT01104311|530920363|FG001|Overall Study|Withdrawal by Subject|6|||
147205133|NCT01104311|530920362|FG000|Overall Study|Protocol Violation|0|||
147205134|NCT01104311|530920363|FG001|Overall Study|Protocol Violation|1|||
147205135|NCT01104311|530920362|FG000|Overall Study|Physician Decision|2|||
147205136|NCT01104311|530920363|FG001|Overall Study|Physician Decision|2|||
147205137|NCT01104311|530920362|FG000|Overall Study|low compliance|1|||
147205138|NCT01104311|530920363|FG001|Overall Study|low compliance|1|||
147205139|NCT01104311|530920362|FG000|Overall Study|Adverse Event|1|||
147205140|NCT01104311|530920363|FG001|Overall Study|Adverse Event|2|||
147205141|NCT02102204|530921979|FG000|Overall Study|Withdrawal by Subject|137|||
147205142|NCT02102204|530921979|FG000|Overall Study|Death|92|||
147205143|NCT02102204|530921979|FG000|Overall Study|Lost to Follow-up|65|||
147205144|NCT02102204|530921979|FG000|Overall Study|Sponsor Decision|5|||
147205145|NCT02102204|530921979|FG000|Overall Study|Ongoing|5|||
147205146|NCT00807001|530921981|FG000|Overall Study|Non-compliance|0|||
147205147|NCT00807001|530921982|FG001|Overall Study|Non-compliance|1|||
147205148|NCT00807001|530921983|FG002|Overall Study|Non-compliance|0|||
147205149|NCT00807001|530921984|FG003|Overall Study|Non-compliance|0|||
147205150|NCT00807001|530921985|FG004|Overall Study|Non-compliance|0|||
147205151|NCT02656693|530921986|FG000|Overall Study|Pregnancy|1|||
147205152|NCT02656693|530921987|FG001|Overall Study|Pregnancy|1|||
147205153|NCT02656693|530921988|FG002|Overall Study|Pregnancy|1|||
147205154|NCT02656693|530921986|FG000|Overall Study|Bariatric surgery|0|||
147540997|NCT03193190|532135282|FG002|Stage 1|Reason not Specified|0|||
147205155|NCT02656693|530921987|FG001|Overall Study|Bariatric surgery|1|||
147205156|NCT02656693|530921988|FG002|Overall Study|Bariatric surgery|2|||
147205157|NCT02269267|530921990|FG000|Overall Study|Death|5|||
147205158|NCT03773796|530921991|FG000|Overall Study|Adverse Event|1|||
147205159|NCT03773796|530921991|FG000|Overall Study|Withdrawal by Subject|1|||
147205160|NCT03773796|530921991|FG000|Overall Study|Lack of Efficacy|1|||
147205161|NCT03805659|530921993|FG000|Overall Study|Withdrawal by Subject|0|||
147205162|NCT03805659|530921994|FG001|Overall Study|Withdrawal by Subject|1|||
147205163|NCT02273596|530921996|FG000|24-Week Treatment Period|Adverse Event|3|||
147205164|NCT02273596|530921996|FG000|24-Week Treatment Period|Withdrawal by Participant Prior to First Dose|1|||
147205165|NCT02273596|530921996|FG000|24-Week Treatment Period|Participant was unable to Come|1|||
147205166|NCT02273596|530921996|FG000|24-Week Treatment Period|Physician Decision|1|||
147540998|NCT03193190|532135283|FG003|Stage 1|Reason not Specified|1|||
147540999|NCT03193190|532135284|FG004|Stage 1|Reason not Specified|0|||
147541000|NCT03193190|532135285|FG005|Stage 1|Reason not Specified|1|||
147541001|NCT03193190|532135286|FG006|Stage 1|Reason not Specified|2|||
147541002|NCT03193190|532135287|FG007|Stage 1|Reason not Specified|2|||
147541003|NCT03193190|532135288|FG008|Stage 1|Reason not Specified|0|||
147541004|NCT03193190|532135289|FG009|Stage 1|Reason not Specified|1|||
147541005|NCT03193190|532135290|FG010|Stage 1|Reason not Specified|3|||
147205167|NCT02273596|530921996|FG000|24-Week Treatment Period|Protocol Deviation|1|||
147205168|NCT02273596|530921996|FG000|Extension Period|Continued into Study WTX101-301 extension (NCT03403205).|19|||
147205169|NCT02273596|530921996|FG000|Extension Period|Participant Withdrew for Personal Reasons|1|||
147205170|NCT02273596|530921996|FG000|Extension Period|Lost to Follow-up|1|||
147205171|NCT02273596|530921996|FG000|Extension Period|Protocol Deviation|1|||
147205172|NCT02604160|530921997|FG000|Overall Study|Protocol Violation|0|||
147205173|NCT02604160|530921998|FG001|Overall Study|Protocol Violation|1|||
147205174|NCT02604160|530921997|FG000|Overall Study|Physician Decision|0|||
147205175|NCT02604160|530921998|FG001|Overall Study|Physician Decision|1|||
147205176|NCT01069900|530921999|FG000|Overall Study|Technical problems|0|||
147205177|NCT01069900|530922000|FG001|Overall Study|Technical problems|1|||
147205178|NCT01069900|530921999|FG000|Overall Study|Lost to Follow-up|7|||
147205179|NCT01069900|530922000|FG001|Overall Study|Lost to Follow-up|1|||
147205180|NCT01069900|530921999|FG000|Overall Study|Withdrawal by Subject|6|||
147205181|NCT01069900|530922000|FG001|Overall Study|Withdrawal by Subject|1|||
147205182|NCT01069900|530921999|FG000|Overall Study|Protocol Violation|4|||
147205183|NCT01069900|530922000|FG001|Overall Study|Protocol Violation|1|||
147205184|NCT01069900|530921999|FG000|Overall Study|Insufficient Therapeutic effect|1|||
147205185|NCT01069900|530922000|FG001|Overall Study|Insufficient Therapeutic effect|0|||
147205186|NCT00145158|530922001|FG000|Overall Study|premature withdrawal|2|||
147205187|NCT00145158|530922002|FG001|Overall Study|premature withdrawal|3|||
147205188|NCT03085797|530922005|FG000|Treatment Period (TP) (52 Weeks)|Lost to Follow-up|1|||
147205189|NCT03085797|530922006|FG001|Treatment Period (TP) (52 Weeks)|Lost to Follow-up|0|||
147205190|NCT03085797|530922005|FG000|Treatment Period (TP) (52 Weeks)|Withdrawal by Subject|16|||
147205191|NCT03085797|530922006|FG001|Treatment Period (TP) (52 Weeks)|Withdrawal by Subject|17|||
147205192|NCT03085797|530922005|FG000|No-treatment Follow-up Period (6 Months)|Withdrawal by Subject|0|||
147205193|NCT03085797|530922006|FG001|No-treatment Follow-up Period (6 Months)|Withdrawal by Subject|1|||
147205194|NCT00859456|530922007|FG000|Overall Study|Adverse Event|3|||
147205195|NCT00859456|530922007|FG000|Overall Study|Progressive disease|2|||
147205196|NCT00859456|530922007|FG000|Overall Study|Non-compliance|3|||
147205197|NCT05782179|530922009|FG000|Overall Study|Adverse Event|0|||
147205198|NCT05782179|530922010|FG001|Overall Study|Adverse Event|0|||
147205199|NCT05782179|530922011|FG002|Overall Study|Adverse Event|2|||
147205200|NCT05782179|530922012|FG003|Overall Study|Adverse Event|0|||
147205201|NCT05782179|530922013|FG004|Overall Study|Adverse Event|0|||
147205202|NCT05782179|530922014|FG005|Overall Study|Adverse Event|0|||
147205203|NCT06170242|530922015|FG000|Overall Study|Lost to Follow-up|0|||
147205204|NCT06170242|530922016|FG001|Overall Study|Lost to Follow-up|0|||
147205205|NCT06170242|530922017|FG002|Overall Study|Lost to Follow-up|1|||
147205206|NCT06170242|530922018|FG003|Overall Study|Lost to Follow-up|1|||
147205207|NCT03682770|530922028|FG000|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|0|||
147205208|NCT03682770|530922029|FG001|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|1|||
147205209|NCT03682770|530922030|FG002|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|0|||
147205210|NCT03682770|530922031|FG003|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|0|||
147205211|NCT03682770|530922032|FG004|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|0|||
147205212|NCT03682770|530922033|FG005|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|0|||
147205213|NCT03682770|530922034|FG006|Pre-AR101 Dosing Period (Day 1 - Week 4)|Sponsor decision|0|||
147205214|NCT03682770|530922028|FG000|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|1|||
147205215|NCT03682770|530922029|FG001|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|1|||
147205216|NCT03682770|530922030|FG002|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|0|||
147205217|NCT03682770|530922031|FG003|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|0|||
147205218|NCT03682770|530922032|FG004|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|0|||
147205219|NCT03682770|530922033|FG005|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|0|||
147205220|NCT03682770|530922034|FG006|Pre-AR101 Dosing Period (Day 1 - Week 4)|Withdrawal by Subject|0|||
147205221|NCT03682770|530922028|FG000|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|0|||
147205222|NCT03682770|530922029|FG001|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|0|||
147205223|NCT03682770|530922030|FG002|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|7|||
147205224|NCT03682770|530922031|FG003|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|3|||
147205225|NCT03682770|530922032|FG004|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|0|||
147205226|NCT03682770|530922033|FG005|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|0|||
147205227|NCT03682770|530922034|FG006|AR101 Up-dosing Period (Week 28-40)|Withdrawal by Subject|0|||
147205228|NCT03682770|530922028|FG000|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|0|||
147439153|NCT01010633|531772218|FG000|Overall Study|Protocol Violation|1|||
147439154|NCT01010633|531772219|FG001|Overall Study|Protocol Violation|2|||
147439155|NCT01010633|531772218|FG000|Overall Study|Withdrawal by Subject|2|||
147439156|NCT01010633|531772219|FG001|Overall Study|Withdrawal by Subject|1|||
147439157|NCT01010633|531772218|FG000|Overall Study|Investigator decision|0|||
147439158|NCT01010633|531772219|FG001|Overall Study|Investigator decision|1|||
147439159|NCT00888381|531772221|FG000|Overall Study|Lost to Follow-up|0|||
147439160|NCT00888381|531772222|FG001|Overall Study|Lost to Follow-up|1|||
147439161|NCT04411628|531772231|FG000|Overall Study|Withdrawal by Subject|1|||
147205229|NCT03682770|530922029|FG001|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|0|||
147205230|NCT03682770|530922030|FG002|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|0|||
147205231|NCT03682770|530922031|FG003|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|1|||
147205232|NCT03682770|530922032|FG004|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|0|||
147205233|NCT03682770|530922033|FG005|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|0|||
147205234|NCT03682770|530922034|FG006|AR101 Up-dosing Period (Week 28-40)|Protocol Violation|0|||
147205235|NCT03682770|530922028|FG000|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|0|||
147205236|NCT03682770|530922029|FG001|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|0|||
147205237|NCT03682770|530922030|FG002|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|1|||
147205238|NCT03682770|530922031|FG003|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|2|||
147205239|NCT03682770|530922032|FG004|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|0|||
147205240|NCT03682770|530922033|FG005|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|0|||
147205241|NCT03682770|530922034|FG006|AR101 Up-dosing Period (Week 28-40)|Investigator/Sponsor decision|0|||
147205242|NCT03682770|530922028|FG000|AR101 Up-dosing Period (Week 28-40)|Adverse Event|0|||
147205243|NCT03682770|530922029|FG001|AR101 Up-dosing Period (Week 28-40)|Adverse Event|0|||
147205244|NCT03682770|530922030|FG002|AR101 Up-dosing Period (Week 28-40)|Adverse Event|1|||
147205245|NCT03682770|530922031|FG003|AR101 Up-dosing Period (Week 28-40)|Adverse Event|0|||
147205246|NCT03682770|530922032|FG004|AR101 Up-dosing Period (Week 28-40)|Adverse Event|0|||
147205247|NCT03682770|530922033|FG005|AR101 Up-dosing Period (Week 28-40)|Adverse Event|0|||
147205248|NCT03682770|530922034|FG006|AR101 Up-dosing Period (Week 28-40)|Adverse Event|0|||
147205249|NCT03682770|530922028|FG000|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|0|||
147205250|NCT03682770|530922029|FG001|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|0|||
147205251|NCT03682770|530922030|FG002|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|1|||
147205252|NCT03682770|530922031|FG003|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|0|||
147205253|NCT03682770|530922032|FG004|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|0|||
147205254|NCT03682770|530922033|FG005|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|0|||
147205255|NCT03682770|530922034|FG006|AR101 Up-dosing Period (Week 28-40)|Chronic/recurrent GI AEs/Symptoms|0|||
147205256|NCT03682770|530922028|FG000|AR101 Up-dosing Period (Week 28-40)|Other|0|||
147205257|NCT03682770|530922029|FG001|AR101 Up-dosing Period (Week 28-40)|Other|0|||
147205258|NCT03682770|530922030|FG002|AR101 Up-dosing Period (Week 28-40)|Other|0|||
147205259|NCT03682770|530922031|FG003|AR101 Up-dosing Period (Week 28-40)|Other|2|||
147205260|NCT03682770|530922032|FG004|AR101 Up-dosing Period (Week 28-40)|Other|0|||
147205261|NCT03682770|530922033|FG005|AR101 Up-dosing Period (Week 28-40)|Other|0|||
147205262|NCT03682770|530922034|FG006|AR101 Up-dosing Period (Week 28-40)|Other|0|||
147205263|NCT03682770|530922028|FG000|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|0|||
147205264|NCT03682770|530922029|FG001|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|0|||
147205265|NCT03682770|530922030|FG002|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|0|||
147205266|NCT03682770|530922031|FG003|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|0|||
147205267|NCT03682770|530922032|FG004|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|3|||
147205268|NCT03682770|530922033|FG005|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|1|||
147205269|NCT03682770|530922034|FG006|AR101 Maintenance Period: (Week 52-64)|Withdrawal by Subject|1|||
147205270|NCT03682770|530922028|FG000|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|0|||
147205271|NCT03682770|530922029|FG001|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|0|||
147205272|NCT03682770|530922030|FG002|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|0|||
147205273|NCT03682770|530922031|FG003|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|0|||
147205274|NCT03682770|530922032|FG004|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|1|||
147205275|NCT03682770|530922033|FG005|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|0|||
147205276|NCT03682770|530922034|FG006|AR101 Maintenance Period: (Week 52-64)|Investigator/Sponsor decision|0|||
147205277|NCT03682770|530922028|FG000|AR101 Maintenance Period: (Week 52-64)|Other|0|||
147205278|NCT03682770|530922029|FG001|AR101 Maintenance Period: (Week 52-64)|Other|0|||
147205279|NCT03682770|530922030|FG002|AR101 Maintenance Period: (Week 52-64)|Other|0|||
147205280|NCT03682770|530922031|FG003|AR101 Maintenance Period: (Week 52-64)|Other|0|||
147205281|NCT03682770|530922032|FG004|AR101 Maintenance Period: (Week 52-64)|Other|0|||
147205282|NCT03682770|530922033|FG005|AR101 Maintenance Period: (Week 52-64)|Other|1|||
147439162|NCT04411628|531772232|FG001|Overall Study|Withdrawal by Subject|1|||
147439163|NCT04411628|531772233|FG002|Overall Study|Withdrawal by Subject|2|||
147439164|NCT04411628|531772234|FG003|Overall Study|Withdrawal by Subject|0|||
147439165|NCT04411628|531772231|FG000|Overall Study|Lost to Follow-up|0|||
147439166|NCT04411628|531772232|FG001|Overall Study|Lost to Follow-up|1|||
147439167|NCT04411628|531772233|FG002|Overall Study|Lost to Follow-up|0|||
147439168|NCT04411628|531772234|FG003|Overall Study|Lost to Follow-up|0|||
147439169|NCT03828292|531772235|FG000|Main Study: Part 1 (Up to 141 Weeks)|Death|0|||
147439170|NCT03828292|531772236|FG001|Main Study: Part 1 (Up to 141 Weeks)|Death|1|||
147439171|NCT03828292|531772237|FG002|Main Study: Part 1 (Up to 141 Weeks)|Death|0|||
147439172|NCT03828292|531772238|FG003|Main Study: Part 1 (Up to 141 Weeks)|Death|0|||
147439173|NCT03828292|531772239|FG004|Main Study: Part 1 (Up to 141 Weeks)|Death|0|||
147205283|NCT03682770|530922034|FG006|AR101 Maintenance Period: (Week 52-64)|Other|0|||
147205284|NCT03682770|530922028|FG000|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|0|||
147205285|NCT03682770|530922029|FG001|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|0|||
147205286|NCT03682770|530922030|FG002|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|0|||
147205287|NCT03682770|530922031|FG003|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|0|||
147205288|NCT03682770|530922032|FG004|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|0|||
147205289|NCT03682770|530922033|FG005|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|1|||
147205290|NCT03682770|530922034|FG006|AR101 Maintenance Period: (Week 52-64)|Randomized, but not treated|2|||
147205291|NCT01491607|530922035|FG000|Overall Study|Lost to Follow-up|7|||
147205292|NCT01491607|530922035|FG000|Overall Study|Withdrawal by Subject|3|||
147205293|NCT01317277|530922036|FG000|Overall Study|Lost to Follow-up|3|||
147205294|NCT01317277|530922037|FG001|Overall Study|Lost to Follow-up|1|||
147205295|NCT01317277|530922036|FG000|Overall Study|Lost MEMS|1|||
147205296|NCT01317277|530922037|FG001|Overall Study|Lost MEMS|1|||
147205297|NCT01317277|530922036|FG000|Overall Study|Unable to comply with intervention|1|||
147205298|NCT01317277|530922037|FG001|Overall Study|Unable to comply with intervention|0|||
147205299|NCT01317277|530922036|FG000|Overall Study|Withdrawal by Subject|1|||
147205300|NCT01317277|530922037|FG001|Overall Study|Withdrawal by Subject|0|||
147205301|NCT01317277|530922036|FG000|Overall Study|Adverse Event|1|||
147205302|NCT01317277|530922037|FG001|Overall Study|Adverse Event|0|||
147205303|NCT00774566|530922038|FG000|Overall Study|Protocol Violation|18|||
147205304|NCT00774566|530922039|FG001|Overall Study|Protocol Violation|15|||
147205305|NCT04896073|530922046|FG000|Overall Study|Screen failure|0|||
147205306|NCT04896073|530922047|FG001|Overall Study|Screen failure|2|||
147205307|NCT04896073|530922046|FG000|Overall Study|Participant declined to participate (before treatment started)|0|||
147205308|NCT04896073|530922047|FG001|Overall Study|Participant declined to participate (before treatment started)|2|||
147205309|NCT03565497|530922049|FG000|Overall Study|COVID-19 halt to human subjects research|0|||
147205310|NCT03565497|530922050|FG001|Overall Study|COVID-19 halt to human subjects research|1|||
147205311|NCT03565497|530922051|FG002|Overall Study|COVID-19 halt to human subjects research|1|||
147205312|NCT03565497|530922049|FG000|Overall Study|Lost to Follow-up|1|||
147205313|NCT03565497|530922050|FG001|Overall Study|Lost to Follow-up|1|||
147205314|NCT03565497|530922051|FG002|Overall Study|Lost to Follow-up|2|||
147205315|NCT03565497|530922049|FG000|Overall Study|Withdrawal by Subject|1|||
147439174|NCT03828292|531772240|FG005|Main Study: Part 1 (Up to 141 Weeks)|Death|0|||
147439175|NCT03828292|531772235|FG000|Main Study: Part 2 (Up to 212 Weeks)|Withdrawal by Subject|0|||
147439176|NCT03828292|531772236|FG001|Main Study: Part 2 (Up to 212 Weeks)|Withdrawal by Subject|0|||
147439177|NCT03828292|531772237|FG002|Main Study: Part 2 (Up to 212 Weeks)|Withdrawal by Subject|1|||
147439178|NCT03828292|531772238|FG003|Main Study: Part 2 (Up to 212 Weeks)|Withdrawal by Subject|0|||
147439179|NCT03828292|531772239|FG004|Main Study: Part 2 (Up to 212 Weeks)|Withdrawal by Subject|0|||
147439180|NCT03828292|531772240|FG005|Main Study: Part 2 (Up to 212 Weeks)|Withdrawal by Subject|0|||
147439181|NCT03828292|531772235|FG000|Main Study: Part 2 (Up to 212 Weeks)|Progressive disease|0|||
147439182|NCT03828292|531772236|FG001|Main Study: Part 2 (Up to 212 Weeks)|Progressive disease|0|||
147439183|NCT03828292|531772237|FG002|Main Study: Part 2 (Up to 212 Weeks)|Progressive disease|0|||
147439184|NCT03828292|531772238|FG003|Main Study: Part 2 (Up to 212 Weeks)|Progressive disease|1|||
147439185|NCT03828292|531772239|FG004|Main Study: Part 2 (Up to 212 Weeks)|Progressive disease|0|||
147439186|NCT03828292|531772240|FG005|Main Study: Part 2 (Up to 212 Weeks)|Progressive disease|0|||
147439187|NCT03828292|531772235|FG000|Main Study: Part 2 (Up to 212 Weeks)|Adverse Event|0|||
147439188|NCT03828292|531772236|FG001|Main Study: Part 2 (Up to 212 Weeks)|Adverse Event|0|||
147439189|NCT03828292|531772237|FG002|Main Study: Part 2 (Up to 212 Weeks)|Adverse Event|0|||
147439190|NCT03828292|531772238|FG003|Main Study: Part 2 (Up to 212 Weeks)|Adverse Event|1|||
147439191|NCT03828292|531772239|FG004|Main Study: Part 2 (Up to 212 Weeks)|Adverse Event|0|||
147439192|NCT03828292|531772240|FG005|Main Study: Part 2 (Up to 212 Weeks)|Adverse Event|0|||
147439193|NCT03828292|531772235|FG000|Main Study: Part 2 (Up to 212 Weeks)|Transitioned to PACT|0|||
147439194|NCT03828292|531772236|FG001|Main Study: Part 2 (Up to 212 Weeks)|Transitioned to PACT|0|||
147439195|NCT03828292|531772237|FG002|Main Study: Part 2 (Up to 212 Weeks)|Transitioned to PACT|2|||
147439196|NCT03828292|531772238|FG003|Main Study: Part 2 (Up to 212 Weeks)|Transitioned to PACT|2|||
147439197|NCT03828292|531772239|FG004|Main Study: Part 2 (Up to 212 Weeks)|Transitioned to PACT|0|||
147439198|NCT03828292|531772240|FG005|Main Study: Part 2 (Up to 212 Weeks)|Transitioned to PACT|0|||
147205316|NCT03565497|530922050|FG001|Overall Study|Withdrawal by Subject|1|||
147205317|NCT03565497|530922051|FG002|Overall Study|Withdrawal by Subject|1|||
147205318|NCT02999672|530922052|FG000|Overall Study|Death|0|||
147205319|NCT02999672|530922053|FG001|Overall Study|Death|1|||
147439199|NCT01444456|531772241|FG000|Overall Study|Withdrawal by Subject|21|||
147439200|NCT01444456|531772241|FG000|Overall Study|Physician Decision|9|||
147439201|NCT01444456|531772241|FG000|Overall Study|Lost to Follow-up|37|||
147439202|NCT01444456|531772241|FG000|Overall Study|Death|73|||
147439203|NCT01444456|531772241|FG000|Overall Study|Ineligibility determined|23|||
147439204|NCT01444456|531772241|FG000|Overall Study|Other|18|||
147439205|NCT01444456|531772241|FG000|Overall Study|Not treated|104|||
147541006|NCT03193190|532135291|FG011|Stage 1|Reason not Specified|0|||
147541007|NCT03193190|532135292|FG012|Stage 1|Reason not Specified|1|||
147541008|NCT03193190|532135293|FG013|Stage 1|Reason not Specified|0|||
147541009|NCT03193190|532135294|FG014|Stage 1|Reason not Specified|0|||
147541010|NCT03193190|532135295|FG015|Stage 1|Reason not Specified|0|||
147541011|NCT03193190|532135280|FG000|Stage 1|Physician Decision|0|||
147541012|NCT03193190|532135281|FG001|Stage 1|Physician Decision|0|||
147541013|NCT03193190|532135282|FG002|Stage 1|Physician Decision|0|||
147541014|NCT03193190|532135283|FG003|Stage 1|Physician Decision|0|||
147541015|NCT03193190|532135284|FG004|Stage 1|Physician Decision|0|||
147541016|NCT03193190|532135285|FG005|Stage 1|Physician Decision|0|||
147541017|NCT03193190|532135286|FG006|Stage 1|Physician Decision|0|||
147541018|NCT03193190|532135287|FG007|Stage 1|Physician Decision|0|||
147541019|NCT03193190|532135288|FG008|Stage 1|Physician Decision|0|||
147541020|NCT03193190|532135289|FG009|Stage 1|Physician Decision|0|||
147541021|NCT03193190|532135290|FG010|Stage 1|Physician Decision|0|||
147541022|NCT03193190|532135291|FG011|Stage 1|Physician Decision|1|||
147541023|NCT03193190|532135292|FG012|Stage 1|Physician Decision|0|||
147541024|NCT03193190|532135293|FG013|Stage 1|Physician Decision|0|||
147541025|NCT03193190|532135294|FG014|Stage 1|Physician Decision|0|||
147205320|NCT02999672|530922052|FG000|Overall Study|Study Terminated by Sponsor|0|||
147205321|NCT02999672|530922053|FG001|Overall Study|Study Terminated by Sponsor|1|||
147205322|NCT02999672|530922052|FG000|Overall Study|Progressive Disease|9|||
147205323|NCT02999672|530922053|FG001|Overall Study|Progressive Disease|5|||
147205324|NCT02999672|530922052|FG000|Overall Study|Adverse Event|4|||
147205325|NCT02999672|530922053|FG001|Overall Study|Adverse Event|0|||
147205326|NCT01075685|530922054|FG000|Overall Study|Protocol Violation|9|||
147205327|NCT01075685|530922055|FG001|Overall Study|Protocol Violation|1|||
147205328|NCT01075685|530922054|FG000|Overall Study|Withdrawal by Subject|20|||
147205329|NCT01075685|530922055|FG001|Overall Study|Withdrawal by Subject|5|||
147205330|NCT01075685|530922054|FG000|Overall Study|Lost to Follow-up|563|||
147205331|NCT01075685|530922055|FG001|Overall Study|Lost to Follow-up|220|||
147205332|NCT02858362|530922058|FG000|Overall Study|Protocol Violation|0|||
147205333|NCT02858362|530922059|FG001|Overall Study|Protocol Violation|1|||
147205334|NCT02858362|530922060|FG002|Overall Study|Protocol Violation|0|||
147205335|NCT02858362|530922058|FG000|Overall Study|Withdrawal by Subject|1|||
147205336|NCT02858362|530922059|FG001|Overall Study|Withdrawal by Subject|0|||
147205337|NCT02858362|530922060|FG002|Overall Study|Withdrawal by Subject|0|||
147205338|NCT02858362|530922058|FG000|Overall Study|Early Study Termination|0|||
147205339|NCT02858362|530922059|FG001|Overall Study|Early Study Termination|0|||
147205340|NCT02858362|530922060|FG002|Overall Study|Early Study Termination|3|||
147205341|NCT02858362|530922058|FG000|Overall Study|Lost to Follow-up|1|||
147205342|NCT02858362|530922059|FG001|Overall Study|Lost to Follow-up|0|||
147205343|NCT02858362|530922060|FG002|Overall Study|Lost to Follow-up|0|||
147205344|NCT00392769|530922061|FG000|Overall Study|Clinical Deterioration|9|||
147205345|NCT00392769|530922061|FG000|Overall Study|Adverse Event|1|||
147205346|NCT02561832|530922062|FG000|Overall Study|Withdrawal by Subject|1|||
147205347|NCT02561832|530922063|FG001|Overall Study|Withdrawal by Subject|1|||
147205348|NCT02561832|530922062|FG000|Overall Study|Adverse Event|3|||
147205349|NCT02561832|530922063|FG001|Overall Study|Adverse Event|0|||
147205350|NCT02561832|530922062|FG000|Overall Study|Disease progression|3|||
147205351|NCT02561832|530922063|FG001|Overall Study|Disease progression|3|||
147205352|NCT00439517|530922065|FG000|Overall Study|Subject on treatment|1|||
147205353|NCT00439517|530922066|FG001|Overall Study|Subject on treatment|0|||
147205354|NCT00439517|530922065|FG000|Overall Study|Subject in survival follow-up|1|||
147205355|NCT00439517|530922066|FG001|Overall Study|Subject in survival follow-up|0|||
147205356|NCT03527732|530922069|FG000|Overall Study|Lost to Follow-up|21|||
147205357|NCT03527732|530922070|FG001|Overall Study|Lost to Follow-up|23|||
147205358|NCT03527732|530922071|FG002|Overall Study|Lost to Follow-up|80|||
147205359|NCT03527732|530922072|FG003|Overall Study|Lost to Follow-up|62|||
147205360|NCT03527732|530922073|FG004|Overall Study|Lost to Follow-up|12|||
147541026|NCT03193190|532135295|FG015|Stage 1|Physician Decision|0|||
147541027|NCT03193190|532135280|FG000|Stage 1|Progressive Disease|1|||
147541028|NCT03193190|532135281|FG001|Stage 1|Progressive Disease|0|||
147205361|NCT03527732|530922074|FG005|Overall Study|Lost to Follow-up|20|||
147205362|NCT01262989|530922075|FG000|Period 1|Lost to Follow-up|1|||
147541029|NCT03193190|532135282|FG002|Stage 1|Progressive Disease|0|||
147205363|NCT01262989|530922076|FG001|Period 1|Lost to Follow-up|1|||
147205364|NCT01262989|530922075|FG000|Period 1|Intercurrent disease|0|||
147205365|NCT01262989|530922076|FG001|Period 1|Intercurrent disease|1|||
147205366|NCT01262989|530922075|FG000|Period 1|Positive answer for exclusion criteria|0|||
147205367|NCT01262989|530922076|FG001|Period 1|Positive answer for exclusion criteria|1|||
147205368|NCT01262989|530922075|FG000|Period 2|Intercurrent disease|0|||
147205369|NCT01262989|530922076|FG001|Period 2|Intercurrent disease|1|||
147205370|NCT00470275|530922077|FG000|Overall Study|Death|1|||
147205371|NCT00470275|530922077|FG000|Overall Study|Lack of Efficacy|7|||
147541030|NCT03193190|532135283|FG003|Stage 1|Progressive Disease|0|||
147541031|NCT03193190|532135284|FG004|Stage 1|Progressive Disease|0|||
147541032|NCT03193190|532135285|FG005|Stage 1|Progressive Disease|0|||
147439206|NCT04376827|531772245|FG000|Double Blind Period: Week 0 to Week 52|Withdrawal by Subject|1|||
147439207|NCT04376827|531772246|FG001|Double Blind Period: Week 0 to Week 52|Withdrawal by Subject|1|||
147439208|NCT04376827|531772245|FG000|Double Blind Period: Week 0 to Week 52|Study Terminated by Sponsor|6|||
147439209|NCT04376827|531772246|FG001|Double Blind Period: Week 0 to Week 52|Study Terminated by Sponsor|8|||
147439210|NCT04376827|531772245|FG000|LTE Phase:Week 52 to 96(LTE Termination)|Protocol-specified withdrawal criterion met|1|||
147439211|NCT04376827|531772246|FG001|LTE Phase:Week 52 to 96(LTE Termination)|Protocol-specified withdrawal criterion met|0|||
147439212|NCT04376827|531772245|FG000|LTE Phase:Week 52 to 96(LTE Termination)|Withdrawal by Subject|0|||
147439213|NCT04376827|531772246|FG001|LTE Phase:Week 52 to 96(LTE Termination)|Withdrawal by Subject|1|||
147439214|NCT04376827|531772245|FG000|LTE Phase:Week 52 to 96(LTE Termination)|Study Terminated by Sponsor|3|||
147439215|NCT04376827|531772246|FG001|LTE Phase:Week 52 to 96(LTE Termination)|Study Terminated by Sponsor|0|||
147439216|NCT00257166|531773976|FG000|Overall Study|Adverse Event|18|||
147439217|NCT00257166|531773977|FG001|Overall Study|Adverse Event|13|||
147439218|NCT00257166|531773976|FG000|Overall Study|Laboratory abnormality|1|||
147205372|NCT00470275|530922077|FG000|Overall Study|Withdrawal by Subject|2|||
147205373|NCT02500797|530922078|FG000|Overall Study|Cancel (rapid disease progression)|0|||
147205374|NCT02500797|530922079|FG001|Overall Study|Cancel (rapid disease progression)|0|||
147205375|NCT02500797|530922080|FG002|Overall Study|Cancel (rapid disease progression)|0|||
147205376|NCT02500797|530922081|FG003|Overall Study|Cancel (rapid disease progression)|0|||
147205377|NCT02500797|530922082|FG004|Overall Study|Cancel (rapid disease progression)|1|||
147205378|NCT02500797|530922083|FG005|Overall Study|Cancel (rapid disease progression)|1|||
147205379|NCT02500797|530922084|FG006|Overall Study|Cancel (rapid disease progression)|0|||
147205380|NCT02500797|530922085|FG007|Overall Study|Cancel (rapid disease progression)|0|||
147205381|NCT02500797|530922078|FG000|Overall Study|Withdrawal by Subject|1|||
147205382|NCT02500797|530922079|FG001|Overall Study|Withdrawal by Subject|0|||
147205383|NCT02500797|530922080|FG002|Overall Study|Withdrawal by Subject|0|||
147439219|NCT00257166|531773977|FG001|Overall Study|Laboratory abnormality|0|||
147439220|NCT00257166|531773976|FG000|Overall Study|Lost to Follow-up|8|||
147439221|NCT00257166|531773977|FG001|Overall Study|Lost to Follow-up|1|||
147439222|NCT00257166|531773976|FG000|Overall Study|Withdrawal by Subject|9|||
147439223|NCT00257166|531773977|FG001|Overall Study|Withdrawal by Subject|2|||
147205384|NCT02500797|530922081|FG003|Overall Study|Withdrawal by Subject|0|||
147205385|NCT02500797|530922082|FG004|Overall Study|Withdrawal by Subject|0|||
147439224|NCT00257166|531773976|FG000|Overall Study|Other|16|||
147439225|NCT00257166|531773977|FG001|Overall Study|Other|21|||
147439226|NCT00257166|531773976|FG000|Overall Study|Randomized, but not treated|1|||
147439227|NCT00257166|531773977|FG001|Overall Study|Randomized, but not treated|0|||
147439228|NCT02142738|531773978|FG000|Overall Study|Adverse Event|13|||
147439229|NCT02142738|531773979|FG001|Overall Study|Adverse Event|9|||
147439230|NCT02142738|531773978|FG000|Overall Study|Death|92|||
147439231|NCT02142738|531773979|FG001|Overall Study|Death|112|||
147439232|NCT02142738|531773978|FG000|Overall Study|Lost to Follow-up|0|||
147439233|NCT02142738|531773979|FG001|Overall Study|Lost to Follow-up|3|||
147439234|NCT02142738|531773978|FG000|Overall Study|Withdrawal by Subject|6|||
147439235|NCT02142738|531773979|FG001|Overall Study|Withdrawal by Subject|7|||
147205386|NCT02500797|530922083|FG005|Overall Study|Withdrawal by Subject|0|||
147205387|NCT02500797|530922084|FG006|Overall Study|Withdrawal by Subject|0|||
147205388|NCT02500797|530922085|FG007|Overall Study|Withdrawal by Subject|0|||
147205389|NCT00060840|530922086|FG000|Overall Study|Change in surgical plan|2|||
147205390|NCT00060840|530922087|FG001|Overall Study|Change in surgical plan|6|||
147205391|NCT00060840|530922086|FG000|Overall Study|Death|0|||
147205392|NCT00060840|530922087|FG001|Overall Study|Death|1|||
147205393|NCT00060840|530922086|FG000|Overall Study|Withdrawal by Subject|0|||
147205394|NCT00060840|530922087|FG001|Overall Study|Withdrawal by Subject|1|||
147205395|NCT00060840|530922086|FG000|Overall Study|Subinvestigator unavailable|0|||
147205396|NCT00060840|530922087|FG001|Overall Study|Subinvestigator unavailable|1|||
147205397|NCT00060840|530922086|FG000|Overall Study|Physician Decision|1|||
147205398|NCT00060840|530922087|FG001|Overall Study|Physician Decision|0|||
147205399|NCT00060840|530922086|FG000|Overall Study|Other|1|||
147205400|NCT00060840|530922087|FG001|Overall Study|Other|0|||
147205401|NCT00357006|530922088|FG000|Overall Study|Lost to Follow-up|1|||
147205402|NCT00357006|530922089|FG001|Overall Study|Lost to Follow-up|2|||
147205403|NCT00357006|530922090|FG002|Overall Study|Lost to Follow-up|1|||
147205404|NCT00357006|530922088|FG000|Overall Study|Withdrawal by Subject|1|||
147205405|NCT00357006|530922089|FG001|Overall Study|Withdrawal by Subject|3|||
147205406|NCT00357006|530922090|FG002|Overall Study|Withdrawal by Subject|2|||
147205407|NCT00976560|530922091|FG000|Overall Study|Adverse Event|5|||
147205408|NCT00976560|530922092|FG001|Overall Study|Adverse Event|5|||
147205409|NCT00976560|530922091|FG000|Overall Study|Lack of Efficacy|3|||
147205410|NCT00976560|530922092|FG001|Overall Study|Lack of Efficacy|5|||
147205411|NCT00976560|530922091|FG000|Overall Study|Protocol Violation|1|||
147205412|NCT00976560|530922092|FG001|Overall Study|Protocol Violation|0|||
147205413|NCT00976560|530922091|FG000|Overall Study|Lost to Follow-up|1|||
147205414|NCT00976560|530922092|FG001|Overall Study|Lost to Follow-up|0|||
147205415|NCT00976560|530922091|FG000|Overall Study|Physician Decision|2|||
147205416|NCT00976560|530922092|FG001|Overall Study|Physician Decision|0|||
147205417|NCT00976560|530922091|FG000|Overall Study|Withdrawal by Subject|2|||
147205418|NCT00976560|530922092|FG001|Overall Study|Withdrawal by Subject|3|||
147205419|NCT03710161|530922093|FG000|Overall Study|Study halted due to COVID pandemic|3|||
147205420|NCT03710161|530922094|FG001|Overall Study|Study halted due to COVID pandemic|2|||
147205421|NCT02175030|530922103|FG000|Overall Study|Failed screen after consent|7|||
147205422|NCT02175030|530922104|FG001|Overall Study|Failed screen after consent|6|||
147205423|NCT02175030|530922103|FG000|Overall Study|Failed IUD Insertion|20|||
147205424|NCT02175030|530922104|FG001|Overall Study|Failed IUD Insertion|21|||
147205425|NCT02175030|530922103|FG000|Overall Study|Physician Decision|1|||
147205426|NCT02175030|530922104|FG001|Overall Study|Physician Decision|1|||
147205427|NCT02175030|530922103|FG000|Overall Study|Lost to Follow-up|6|||
147205428|NCT02175030|530922104|FG001|Overall Study|Lost to Follow-up|6|||
147205429|NCT02175030|530922103|FG000|Overall Study|Withdrawal by Subject|1|||
147205430|NCT02175030|530922104|FG001|Overall Study|Withdrawal by Subject|4|||
147205431|NCT02533453|530922105|FG000|Overall Study|Adverse Event|6|||
147205432|NCT02533453|530922105|FG000|Overall Study|Protocol Violation|1|||
147205433|NCT02533453|530922105|FG000|Overall Study|Withdrawal by Subject|2|||
147205434|NCT05340478|530922111|FG000|Overall Study|Scheduling Issues|10|||
147205435|NCT05340478|530922112|FG001|Overall Study|Scheduling Issues|4|||
147205436|NCT05340478|530922111|FG000|Overall Study|Neither member of dyad started treatment|2|||
147205437|NCT05340478|530922112|FG001|Overall Study|Neither member of dyad started treatment|2|||
147205438|NCT05340478|530922111|FG000|Overall Study|Withdrawn from study|2|||
147205439|NCT05340478|530922112|FG001|Overall Study|Withdrawn from study|2|||
147205440|NCT05340478|530922111|FG000|Overall Study|Lost to Follow-up|1|||
147205441|NCT05340478|530922112|FG001|Overall Study|Lost to Follow-up|4|||
147205442|NCT00092443|530922113|FG000|Overall Study|Adverse Event|9|||
147205443|NCT00092443|530922114|FG001|Overall Study|Adverse Event|13|||
147205444|NCT00092443|530922113|FG000|Overall Study|Lost to Follow-up|7|||
147205445|NCT00092443|530922114|FG001|Overall Study|Lost to Follow-up|3|||
147205446|NCT00092443|530922113|FG000|Overall Study|Protocol Violation|11|||
147205447|NCT00092443|530922114|FG001|Overall Study|Protocol Violation|9|||
147205448|NCT00092443|530922113|FG000|Overall Study|Withdrawal by Subject|9|||
147205449|NCT00092443|530922114|FG001|Overall Study|Withdrawal by Subject|11|||
147205450|NCT00092443|530922113|FG000|Overall Study|Moved|5|||
147205451|NCT00092443|530922114|FG001|Overall Study|Moved|5|||
147205452|NCT00092443|530922113|FG000|Overall Study|Other|17|||
147205453|NCT00092443|530922114|FG001|Overall Study|Other|13|||
147205454|NCT02963506|530922116|FG000|Double-Blind Period|Adverse Event|0|||
147205455|NCT02963506|530922117|FG001|Double-Blind Period|Adverse Event|0|||
147205456|NCT02963506|530922118|FG002|Double-Blind Period|Adverse Event|1|||
147205457|NCT02963506|530922119|FG003|Double-Blind Period|Adverse Event|0|||
147205458|NCT02963506|530922120|FG004|Double-Blind Period|Adverse Event|0|||
147205459|NCT02963506|530922121|FG005|Double-Blind Period|Adverse Event|0|||
147205460|NCT02963506|530922122|FG006|Double-Blind Period|Adverse Event|0|||
147205461|NCT02963506|530922123|FG007|Double-Blind Period|Adverse Event|0|||
147205462|NCT02963506|530922124|FG008|Double-Blind Period|Adverse Event|0|||
147205463|NCT02963506|530922125|FG009|Double-Blind Period|Adverse Event|0|||
147205464|NCT02963506|530922126|FG010|Double-Blind Period|Adverse Event|0|||
147205465|NCT02963506|530922127|FG011|Double-Blind Period|Adverse Event|0|||
147205466|NCT02963506|530922128|FG012|Double-Blind Period|Adverse Event|0|||
147205467|NCT02963506|530922116|FG000|Double-Blind Period|Death|0|||
147205468|NCT02963506|530922117|FG001|Double-Blind Period|Death|0|||
147205469|NCT02963506|530922118|FG002|Double-Blind Period|Death|0|||
147205470|NCT02963506|530922119|FG003|Double-Blind Period|Death|1|||
147205471|NCT02963506|530922120|FG004|Double-Blind Period|Death|0|||
147205472|NCT02963506|530922121|FG005|Double-Blind Period|Death|0|||
147205473|NCT02963506|530922122|FG006|Double-Blind Period|Death|0|||
147205474|NCT02963506|530922123|FG007|Double-Blind Period|Death|0|||
147205475|NCT02963506|530922124|FG008|Double-Blind Period|Death|0|||
147205476|NCT02963506|530922125|FG009|Double-Blind Period|Death|0|||
147205477|NCT02963506|530922126|FG010|Double-Blind Period|Death|0|||
147205478|NCT02963506|530922127|FG011|Double-Blind Period|Death|0|||
147205479|NCT02963506|530922128|FG012|Double-Blind Period|Death|0|||
147205480|NCT02963506|530922116|FG000|Double-Blind Period|Lost to Follow-up|0|||
147205481|NCT02963506|530922117|FG001|Double-Blind Period|Lost to Follow-up|1|||
147205482|NCT02963506|530922118|FG002|Double-Blind Period|Lost to Follow-up|0|||
147205483|NCT02963506|530922119|FG003|Double-Blind Period|Lost to Follow-up|0|||
147205484|NCT02963506|530922120|FG004|Double-Blind Period|Lost to Follow-up|0|||
147205485|NCT02963506|530922121|FG005|Double-Blind Period|Lost to Follow-up|0|||
147205486|NCT02963506|530922122|FG006|Double-Blind Period|Lost to Follow-up|0|||
147205487|NCT02963506|530922123|FG007|Double-Blind Period|Lost to Follow-up|0|||
147205488|NCT02963506|530922124|FG008|Double-Blind Period|Lost to Follow-up|0|||
147205489|NCT02963506|530922125|FG009|Double-Blind Period|Lost to Follow-up|0|||
147205490|NCT02963506|530922126|FG010|Double-Blind Period|Lost to Follow-up|0|||
147205491|NCT02963506|530922127|FG011|Double-Blind Period|Lost to Follow-up|0|||
147205492|NCT02963506|530922128|FG012|Double-Blind Period|Lost to Follow-up|0|||
147205493|NCT02963506|530922116|FG000|Double-Blind Period|Withdrawal by Subject|0|||
147205494|NCT02963506|530922117|FG001|Double-Blind Period|Withdrawal by Subject|0|||
147205495|NCT02963506|530922118|FG002|Double-Blind Period|Withdrawal by Subject|1|||
147205496|NCT02963506|530922119|FG003|Double-Blind Period|Withdrawal by Subject|1|||
147205497|NCT02963506|530922120|FG004|Double-Blind Period|Withdrawal by Subject|0|||
147205498|NCT02963506|530922121|FG005|Double-Blind Period|Withdrawal by Subject|0|||
147205499|NCT02963506|530922122|FG006|Double-Blind Period|Withdrawal by Subject|0|||
147205500|NCT02963506|530922123|FG007|Double-Blind Period|Withdrawal by Subject|0|||
147205501|NCT02963506|530922124|FG008|Double-Blind Period|Withdrawal by Subject|0|||
147205502|NCT02963506|530922125|FG009|Double-Blind Period|Withdrawal by Subject|0|||
147205503|NCT02963506|530922126|FG010|Double-Blind Period|Withdrawal by Subject|0|||
147205504|NCT02963506|530922127|FG011|Double-Blind Period|Withdrawal by Subject|0|||
147205505|NCT02963506|530922128|FG012|Double-Blind Period|Withdrawal by Subject|0|||
147205506|NCT02963506|530922116|FG000|Double-Blind Period|No compliance|0|||
147205507|NCT02963506|530922117|FG001|Double-Blind Period|No compliance|1|||
147205508|NCT02963506|530922118|FG002|Double-Blind Period|No compliance|0|||
147205509|NCT02963506|530922119|FG003|Double-Blind Period|No compliance|0|||
147205510|NCT02963506|530922120|FG004|Double-Blind Period|No compliance|0|||
147205511|NCT02963506|530922121|FG005|Double-Blind Period|No compliance|0|||
147205512|NCT02963506|530922122|FG006|Double-Blind Period|No compliance|0|||
147205513|NCT02963506|530922123|FG007|Double-Blind Period|No compliance|0|||
147205514|NCT02963506|530922124|FG008|Double-Blind Period|No compliance|0|||
147205515|NCT02963506|530922125|FG009|Double-Blind Period|No compliance|0|||
147205516|NCT02963506|530922126|FG010|Double-Blind Period|No compliance|0|||
147205517|NCT02963506|530922127|FG011|Double-Blind Period|No compliance|0|||
147205518|NCT02963506|530922128|FG012|Double-Blind Period|No compliance|0|||
147205519|NCT02963506|530922116|FG000|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
147205520|NCT02963506|530922117|FG001|Double-Blind Period|Adverse event, non fatal after Wk12|1|||
147205521|NCT02963506|530922118|FG002|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
147205522|NCT02963506|530922119|FG003|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
147205523|NCT02963506|530922120|FG004|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
147205524|NCT02963506|530922121|FG005|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
147205525|NCT02963506|530922122|FG006|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
147205526|NCT02963506|530922123|FG007|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
147205527|NCT02963506|530922124|FG008|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
147205528|NCT02963506|530922125|FG009|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
147205529|NCT02963506|530922126|FG010|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
147205530|NCT02963506|530922127|FG011|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
147205531|NCT02963506|530922128|FG012|Double-Blind Period|Adverse event, non fatal after Wk12|0|||
147205532|NCT02963506|530922116|FG000|Dose-Blind Period|Adverse Event|0|||
147205533|NCT02963506|530922117|FG001|Dose-Blind Period|Adverse Event|0|||
147205534|NCT02963506|530922118|FG002|Dose-Blind Period|Adverse Event|0|||
147205535|NCT02963506|530922119|FG003|Dose-Blind Period|Adverse Event|0|||
147205536|NCT02963506|530922120|FG004|Dose-Blind Period|Adverse Event|0|||
147205537|NCT02963506|530922121|FG005|Dose-Blind Period|Adverse Event|1|||
147205538|NCT02963506|530922122|FG006|Dose-Blind Period|Adverse Event|3|||
147205539|NCT02963506|530922123|FG007|Dose-Blind Period|Adverse Event|2|||
147205540|NCT02963506|530922124|FG008|Dose-Blind Period|Adverse Event|2|||
147205541|NCT02963506|530922125|FG009|Dose-Blind Period|Adverse Event|2|||
147205542|NCT02963506|530922126|FG010|Dose-Blind Period|Adverse Event|1|||
147205543|NCT02963506|530922127|FG011|Dose-Blind Period|Adverse Event|1|||
147205544|NCT02963506|530922128|FG012|Dose-Blind Period|Adverse Event|6|||
147205545|NCT02963506|530922116|FG000|Dose-Blind Period|Lack of Efficacy|0|||
147205546|NCT02963506|530922117|FG001|Dose-Blind Period|Lack of Efficacy|0|||
147205547|NCT02963506|530922118|FG002|Dose-Blind Period|Lack of Efficacy|0|||
147205548|NCT02963506|530922119|FG003|Dose-Blind Period|Lack of Efficacy|0|||
147205549|NCT02963506|530922120|FG004|Dose-Blind Period|Lack of Efficacy|0|||
147205550|NCT02963506|530922121|FG005|Dose-Blind Period|Lack of Efficacy|0|||
147205551|NCT02963506|530922122|FG006|Dose-Blind Period|Lack of Efficacy|0|||
147205552|NCT02963506|530922123|FG007|Dose-Blind Period|Lack of Efficacy|1|||
147205553|NCT02963506|530922124|FG008|Dose-Blind Period|Lack of Efficacy|0|||
147205554|NCT02963506|530922125|FG009|Dose-Blind Period|Lack of Efficacy|1|||
147205555|NCT02963506|530922126|FG010|Dose-Blind Period|Lack of Efficacy|0|||
147205556|NCT02963506|530922127|FG011|Dose-Blind Period|Lack of Efficacy|0|||
147205557|NCT02963506|530922128|FG012|Dose-Blind Period|Lack of Efficacy|0|||
147205558|NCT02963506|530922116|FG000|Dose-Blind Period|Lost to Follow-up|0|||
147205559|NCT02963506|530922117|FG001|Dose-Blind Period|Lost to Follow-up|0|||
147205560|NCT02963506|530922118|FG002|Dose-Blind Period|Lost to Follow-up|0|||
147205561|NCT02963506|530922119|FG003|Dose-Blind Period|Lost to Follow-up|0|||
147205562|NCT02963506|530922120|FG004|Dose-Blind Period|Lost to Follow-up|0|||
147205563|NCT02963506|530922121|FG005|Dose-Blind Period|Lost to Follow-up|1|||
147205564|NCT02963506|530922122|FG006|Dose-Blind Period|Lost to Follow-up|0|||
147205565|NCT02963506|530922123|FG007|Dose-Blind Period|Lost to Follow-up|0|||
147205566|NCT02963506|530922124|FG008|Dose-Blind Period|Lost to Follow-up|1|||
147205567|NCT02963506|530922125|FG009|Dose-Blind Period|Lost to Follow-up|0|||
147205568|NCT02963506|530922126|FG010|Dose-Blind Period|Lost to Follow-up|0|||
147205569|NCT02963506|530922127|FG011|Dose-Blind Period|Lost to Follow-up|1|||
147205570|NCT02963506|530922128|FG012|Dose-Blind Period|Lost to Follow-up|0|||
147205571|NCT02963506|530922116|FG000|Dose-Blind Period|Withdrawal by Subject|0|||
147205572|NCT02963506|530922117|FG001|Dose-Blind Period|Withdrawal by Subject|0|||
147205573|NCT02963506|530922118|FG002|Dose-Blind Period|Withdrawal by Subject|0|||
147205574|NCT02963506|530922119|FG003|Dose-Blind Period|Withdrawal by Subject|0|||
147205575|NCT02963506|530922120|FG004|Dose-Blind Period|Withdrawal by Subject|0|||
147205576|NCT02963506|530922121|FG005|Dose-Blind Period|Withdrawal by Subject|1|||
147205577|NCT02963506|530922122|FG006|Dose-Blind Period|Withdrawal by Subject|2|||
147205578|NCT02963506|530922123|FG007|Dose-Blind Period|Withdrawal by Subject|2|||
147205579|NCT02963506|530922124|FG008|Dose-Blind Period|Withdrawal by Subject|0|||
147205580|NCT02963506|530922125|FG009|Dose-Blind Period|Withdrawal by Subject|1|||
147205581|NCT02963506|530922126|FG010|Dose-Blind Period|Withdrawal by Subject|0|||
147205582|NCT02963506|530922127|FG011|Dose-Blind Period|Withdrawal by Subject|0|||
147205583|NCT02963506|530922128|FG012|Dose-Blind Period|Withdrawal by Subject|0|||
147205584|NCT02963506|530922116|FG000|Dose-Blind Period|Sponsor decision|0|||
147205585|NCT02963506|530922117|FG001|Dose-Blind Period|Sponsor decision|0|||
147205586|NCT02963506|530922118|FG002|Dose-Blind Period|Sponsor decision|0|||
147205587|NCT02963506|530922119|FG003|Dose-Blind Period|Sponsor decision|0|||
147205588|NCT02963506|530922120|FG004|Dose-Blind Period|Sponsor decision|0|||
147205589|NCT02963506|530922121|FG005|Dose-Blind Period|Sponsor decision|1|||
147205590|NCT02963506|530922122|FG006|Dose-Blind Period|Sponsor decision|0|||
147205591|NCT02963506|530922123|FG007|Dose-Blind Period|Sponsor decision|0|||
147205592|NCT02963506|530922124|FG008|Dose-Blind Period|Sponsor decision|0|||
147205593|NCT02963506|530922125|FG009|Dose-Blind Period|Sponsor decision|0|||
147439236|NCT02142738|531773978|FG000|Overall Study|Follow up ended by sponsor|43|||
147439237|NCT02142738|531773979|FG001|Overall Study|Follow up ended by sponsor|20|||
147439238|NCT03688880|531773980|FG000|Overall Study|Withdrawal by Subject|0|||
147439239|NCT03688880|531773981|FG001|Overall Study|Withdrawal by Subject|2|||
147439240|NCT03688880|531773980|FG000|Overall Study|Use of non-permitted concurrent therapy|0|||
147439241|NCT03688880|531773981|FG001|Overall Study|Use of non-permitted concurrent therapy|2|||
147439242|NCT03688880|531773980|FG000|Overall Study|Lost to Follow-up|4|||
147439243|NCT03688880|531773981|FG001|Overall Study|Lost to Follow-up|7|||
147439244|NCT03688880|531773980|FG000|Overall Study|Adverse Event|0|||
147439245|NCT03688880|531773981|FG001|Overall Study|Adverse Event|2|||
147439246|NCT03688880|531773980|FG000|Overall Study|Device deficiencies|0|||
147205594|NCT02963506|530922126|FG010|Dose-Blind Period|Sponsor decision|0|||
147205595|NCT02963506|530922127|FG011|Dose-Blind Period|Sponsor decision|0|||
147205596|NCT02963506|530922128|FG012|Dose-Blind Period|Sponsor decision|0|||
147205597|NCT02963506|530922116|FG000|Dose-Blind Period|Meeting exclusion criteria 9|0|||
147205598|NCT02963506|530922117|FG001|Dose-Blind Period|Meeting exclusion criteria 9|0|||
147205599|NCT02963506|530922118|FG002|Dose-Blind Period|Meeting exclusion criteria 9|0|||
147205600|NCT02963506|530922119|FG003|Dose-Blind Period|Meeting exclusion criteria 9|0|||
147205601|NCT02963506|530922120|FG004|Dose-Blind Period|Meeting exclusion criteria 9|0|||
147205602|NCT02963506|530922121|FG005|Dose-Blind Period|Meeting exclusion criteria 9|0|||
147205603|NCT02963506|530922122|FG006|Dose-Blind Period|Meeting exclusion criteria 9|0|||
147205604|NCT02963506|530922123|FG007|Dose-Blind Period|Meeting exclusion criteria 9|0|||
147205605|NCT02963506|530922124|FG008|Dose-Blind Period|Meeting exclusion criteria 9|0|||
147205606|NCT02963506|530922125|FG009|Dose-Blind Period|Meeting exclusion criteria 9|0|||
147205607|NCT02963506|530922126|FG010|Dose-Blind Period|Meeting exclusion criteria 9|0|||
147205608|NCT02963506|530922127|FG011|Dose-Blind Period|Meeting exclusion criteria 9|0|||
147205609|NCT02963506|530922128|FG012|Dose-Blind Period|Meeting exclusion criteria 9|1|||
147205610|NCT00630838|530922131|FG000|Overall Study|Death|0|||
147541033|NCT03193190|532135286|FG006|Stage 1|Progressive Disease|0|||
147541034|NCT03193190|532135287|FG007|Stage 1|Progressive Disease|0|||
147541035|NCT03193190|532135288|FG008|Stage 1|Progressive Disease|0|||
147541036|NCT03193190|532135289|FG009|Stage 1|Progressive Disease|0|||
147541037|NCT03193190|532135290|FG010|Stage 1|Progressive Disease|0|||
147541038|NCT03193190|532135291|FG011|Stage 1|Progressive Disease|0|||
147541039|NCT03193190|532135292|FG012|Stage 1|Progressive Disease|0|||
147541040|NCT03193190|532135293|FG013|Stage 1|Progressive Disease|0|||
147541041|NCT03193190|532135294|FG014|Stage 1|Progressive Disease|0|||
147541042|NCT03193190|532135295|FG015|Stage 1|Progressive Disease|0|||
147541043|NCT03193190|532135280|FG000|Stage 1|Study Terminated By Sponsor|3|||
147541044|NCT03193190|532135281|FG001|Stage 1|Study Terminated By Sponsor|0|||
147541045|NCT03193190|532135282|FG002|Stage 1|Study Terminated By Sponsor|0|||
147541046|NCT03193190|532135283|FG003|Stage 1|Study Terminated By Sponsor|0|||
147541047|NCT03193190|532135284|FG004|Stage 1|Study Terminated By Sponsor|6|||
147541048|NCT03193190|532135285|FG005|Stage 1|Study Terminated By Sponsor|0|||
147541049|NCT03193190|532135286|FG006|Stage 1|Study Terminated By Sponsor|0|||
147541050|NCT03193190|532135287|FG007|Stage 1|Study Terminated By Sponsor|0|||
147541051|NCT03193190|532135288|FG008|Stage 1|Study Terminated By Sponsor|0|||
147541052|NCT03193190|532135289|FG009|Stage 1|Study Terminated By Sponsor|0|||
147541053|NCT03193190|532135290|FG010|Stage 1|Study Terminated By Sponsor|0|||
147541054|NCT03193190|532135291|FG011|Stage 1|Study Terminated By Sponsor|0|||
147541055|NCT03193190|532135292|FG012|Stage 1|Study Terminated By Sponsor|0|||
147541056|NCT03193190|532135293|FG013|Stage 1|Study Terminated By Sponsor|0|||
147541057|NCT03193190|532135294|FG014|Stage 1|Study Terminated By Sponsor|0|||
147541058|NCT03193190|532135295|FG015|Stage 1|Study Terminated By Sponsor|0|||
147541059|NCT03193190|532135280|FG000|Stage 1|Withdrawal by Subject|6|||
147541060|NCT03193190|532135281|FG001|Stage 1|Withdrawal by Subject|0|||
147541061|NCT03193190|532135282|FG002|Stage 1|Withdrawal by Subject|1|||
147541062|NCT03193190|532135283|FG003|Stage 1|Withdrawal by Subject|0|||
147205611|NCT00630838|530922132|FG001|Overall Study|Death|1|||
147205612|NCT00630838|530922131|FG000|Overall Study|Lost to Follow-up|0|||
147205613|NCT00630838|530922132|FG001|Overall Study|Lost to Follow-up|1|||
147205614|NCT00928408|530922133|FG000|Overall Study|Other|2|||
147205615|NCT00928408|530922133|FG000|Overall Study|Withdrawal by Subject|4|||
147205616|NCT00928408|530922133|FG000|Overall Study|Death|5|||
147205617|NCT00928408|530922133|FG000|Overall Study|Lost to Follow-up|12|||
147205618|NCT03843541|530922134|FG000|Overall Study|Adverse Event|4|||
147205619|NCT03843541|530922135|FG001|Overall Study|Adverse Event|2|||
147205620|NCT03843541|530922136|FG002|Overall Study|Adverse Event|3|||
147205621|NCT03843541|530922134|FG000|Overall Study|Death|1|||
147205622|NCT03843541|530922135|FG001|Overall Study|Death|0|||
147205623|NCT03843541|530922136|FG002|Overall Study|Death|0|||
147205624|NCT03843541|530922134|FG000|Overall Study|Lack of adherence to study medication|0|||
147205625|NCT03843541|530922135|FG001|Overall Study|Lack of adherence to study medication|0|||
147205626|NCT03843541|530922136|FG002|Overall Study|Lack of adherence to study medication|1|||
147205627|NCT03843541|530922134|FG000|Overall Study|Physician Decision|1|||
147205628|NCT03843541|530922135|FG001|Overall Study|Physician Decision|2|||
147205629|NCT03843541|530922136|FG002|Overall Study|Physician Decision|2|||
147205630|NCT03843541|530922134|FG000|Overall Study|Study subject withdrawal by parent or guardian|1|||
147205631|NCT03843541|530922135|FG001|Overall Study|Study subject withdrawal by parent or guardian|0|||
147205632|NCT03843541|530922136|FG002|Overall Study|Study subject withdrawal by parent or guardian|0|||
147205633|NCT03843541|530922134|FG000|Overall Study|Withdrawal by Subject|6|||
147205634|NCT03843541|530922135|FG001|Overall Study|Withdrawal by Subject|9|||
147205635|NCT03843541|530922136|FG002|Overall Study|Withdrawal by Subject|7|||
147205636|NCT03843541|530922134|FG000|Overall Study|Administration of rescue mucolytic|0|||
147205637|NCT03843541|530922135|FG001|Overall Study|Administration of rescue mucolytic|0|||
147205638|NCT03843541|530922136|FG002|Overall Study|Administration of rescue mucolytic|1|||
147205639|NCT03843541|530922134|FG000|Overall Study|Reporting drug over temperature, patients plan to transfer to hospital, and discharge from hospital.|2|||
147205640|NCT03843541|530922135|FG001|Overall Study|Reporting drug over temperature, patients plan to transfer to hospital, and discharge from hospital.|3|||
147205641|NCT03843541|530922136|FG002|Overall Study|Reporting drug over temperature, patients plan to transfer to hospital, and discharge from hospital.|0|||
147205642|NCT04163016|530922138|FG000|Enrollment|Adverse Event|1|||
147205643|NCT04163016|530922139|FG001|Enrollment|Adverse Event|0|||
147205644|NCT04163016|530922140|FG002|Enrollment|Adverse Event|0|||
147205645|NCT04163016|530922141|FG003|Enrollment|Adverse Event|0|||
147205646|NCT04163016|530922138|FG000|Treatment|Adverse Event|0|||
147205647|NCT04163016|530922139|FG001|Treatment|Adverse Event|1|||
147541063|NCT03193190|532135284|FG004|Stage 1|Withdrawal by Subject|2|||
147649432|NCT02634801|532537343|FG002|Extension Period (Weeks 24 to 36)|Lost to Follow-up|0|||
147649433|NCT02634801|532537341|FG000|Extension Period (Weeks 24 to 36)|Withdrawal by Subject|1|||
147205648|NCT04163016|530922140|FG002|Treatment|Adverse Event|0|||
147205649|NCT04163016|530922141|FG003|Treatment|Adverse Event|0|||
147205650|NCT04163016|530922138|FG000|Treatment|Withdrawal by Subject|0|||
147205651|NCT04163016|530922139|FG001|Treatment|Withdrawal by Subject|2|||
147205652|NCT04163016|530922140|FG002|Treatment|Withdrawal by Subject|0|||
147205653|NCT04163016|530922141|FG003|Treatment|Withdrawal by Subject|0|||
147205654|NCT04163016|530922138|FG000|Treatment|Indeterminate TB-test|0|||
147205655|NCT04163016|530922139|FG001|Treatment|Indeterminate TB-test|0|||
147205656|NCT04163016|530922140|FG002|Treatment|Indeterminate TB-test|0|||
147205657|NCT04163016|530922141|FG003|Treatment|Indeterminate TB-test|1|||
147205658|NCT04163016|530922138|FG000|Treatment|Participant did not want to continue in study|0|||
147205659|NCT04163016|530922139|FG001|Treatment|Participant did not want to continue in study|0|||
147205660|NCT04163016|530922140|FG002|Treatment|Participant did not want to continue in study|0|||
147205661|NCT04163016|530922141|FG003|Treatment|Participant did not want to continue in study|1|||
147205662|NCT02930018|530922145|FG000|Overall Study|Lost to Follow-up|1|||
147205663|NCT02930018|530922146|FG001|Overall Study|Lost to Follow-up|1|||
147205664|NCT02930018|530922145|FG000|Overall Study|Withdrawal by Subject|5|||
147205665|NCT02930018|530922146|FG001|Overall Study|Withdrawal by Subject|2|||
147205666|NCT01596062|530923643|FG000|Overall Study|Adverse Event|1|||
147205667|NCT01596062|530923644|FG001|Overall Study|Adverse Event|0|||
147205668|NCT01596062|530923645|FG002|Overall Study|Adverse Event|2|||
147205669|NCT01596062|530923643|FG000|Overall Study|Lack of Efficacy|0|||
147205670|NCT01596062|530923644|FG001|Overall Study|Lack of Efficacy|0|||
147205671|NCT01596062|530923645|FG002|Overall Study|Lack of Efficacy|1|||
147205672|NCT02255435|530923646|FG000|Overall Study|Patient's Limited Time Availability|0|||
147205673|NCT02255435|530923647|FG001|Overall Study|Patient's Limited Time Availability|0|||
147205674|NCT02255435|530923648|FG002|Overall Study|Patient's Limited Time Availability|0|||
147205675|NCT02255435|530923649|FG003|Overall Study|Patient's Limited Time Availability|0|||
147205676|NCT02255435|530923650|FG004|Overall Study|Patient's Limited Time Availability|0|||
147205677|NCT02255435|530923651|FG005|Overall Study|Patient's Limited Time Availability|0|||
147205678|NCT02255435|530923652|FG006|Overall Study|Patient's Limited Time Availability|0|||
147205679|NCT02255435|530923653|FG007|Overall Study|Patient's Limited Time Availability|1|||
147205680|NCT02255435|530923654|FG008|Overall Study|Patient's Limited Time Availability|0|||
147205681|NCT02255435|530923655|FG009|Overall Study|Patient's Limited Time Availability|0|||
147205682|NCT02255435|530923646|FG000|Overall Study|Withdrawal by Subject|0|||
147205683|NCT02255435|530923647|FG001|Overall Study|Withdrawal by Subject|0|||
147205684|NCT02255435|530923648|FG002|Overall Study|Withdrawal by Subject|0|||
147205685|NCT02255435|530923649|FG003|Overall Study|Withdrawal by Subject|0|||
147205686|NCT02255435|530923650|FG004|Overall Study|Withdrawal by Subject|0|||
147205687|NCT02255435|530923651|FG005|Overall Study|Withdrawal by Subject|0|||
147205688|NCT02255435|530923652|FG006|Overall Study|Withdrawal by Subject|0|||
147205689|NCT02255435|530923653|FG007|Overall Study|Withdrawal by Subject|0|||
147205690|NCT02255435|530923654|FG008|Overall Study|Withdrawal by Subject|1|||
147439247|NCT03688880|531773981|FG001|Overall Study|Device deficiencies|2|||
147439248|NCT03688880|531773980|FG000|Overall Study|Other|10|||
147439249|NCT03688880|531773981|FG001|Overall Study|Other|16|||
147439250|NCT01704287|531773982|FG000|Initial Treatment Period|Death|139|||
147439251|NCT01704287|531773983|FG001|Initial Treatment Period|Death|129|||
147439252|NCT01704287|531773984|FG002|Initial Treatment Period|Death|71|||
147439253|NCT01704287|531773985|FG003|Initial Treatment Period|Death|0|||
147439254|NCT01704287|531773986|FG004|Initial Treatment Period|Death|0|||
147439255|NCT01704287|531773982|FG000|Initial Treatment Period|Withdrawal by Subject|3|||
147439256|NCT01704287|531773983|FG001|Initial Treatment Period|Withdrawal by Subject|2|||
147439257|NCT01704287|531773984|FG002|Initial Treatment Period|Withdrawal by Subject|4|||
147439258|NCT01704287|531773985|FG003|Initial Treatment Period|Withdrawal by Subject|0|||
147439259|NCT01704287|531773986|FG004|Initial Treatment Period|Withdrawal by Subject|0|||
147439260|NCT01704287|531773982|FG000|Initial Treatment Period|Lost to Follow-up|5|||
147439261|NCT01704287|531773983|FG001|Initial Treatment Period|Lost to Follow-up|3|||
147439262|NCT01704287|531773984|FG002|Initial Treatment Period|Lost to Follow-up|0|||
147439263|NCT01704287|531773985|FG003|Initial Treatment Period|Lost to Follow-up|0|||
147439264|NCT01704287|531773986|FG004|Initial Treatment Period|Lost to Follow-up|0|||
147439265|NCT01704287|531773982|FG000|Initial Treatment Period|Switched to Pembrolizumab|0|||
147439266|NCT01704287|531773983|FG001|Initial Treatment Period|Switched to Pembrolizumab|0|||
147439267|NCT01704287|531773984|FG002|Initial Treatment Period|Switched to Pembrolizumab|98|||
147439268|NCT01704287|531773985|FG003|Initial Treatment Period|Switched to Pembrolizumab|0|||
147439269|NCT01704287|531773986|FG004|Initial Treatment Period|Switched to Pembrolizumab|0|||
147439270|NCT01704287|531773982|FG000|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|0|||
147439271|NCT01704287|531773983|FG001|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|0|||
147439272|NCT01704287|531773984|FG002|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|0|||
147439273|NCT01704287|531773985|FG003|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|2|||
147439274|NCT01704287|531773986|FG004|Switch to Pembrolizumab Treatment Period|Lost to Follow-up|1|||
147439275|NCT01704287|531773982|FG000|Switch to Pembrolizumab Treatment Period|Death|0|||
147439276|NCT01704287|531773983|FG001|Switch to Pembrolizumab Treatment Period|Death|0|||
147439277|NCT01704287|531773984|FG002|Switch to Pembrolizumab Treatment Period|Death|0|||
147439278|NCT01704287|531773985|FG003|Switch to Pembrolizumab Treatment Period|Death|35|||
147439279|NCT01704287|531773986|FG004|Switch to Pembrolizumab Treatment Period|Death|37|||
147439280|NCT01704287|531773982|FG000|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0|||
147439281|NCT01704287|531773983|FG001|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0|||
147439282|NCT01704287|531773984|FG002|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0|||
147439283|NCT01704287|531773985|FG003|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|1|||
147439284|NCT01704287|531773986|FG004|Switch to Pembrolizumab Treatment Period|Withdrawal by Subject|0|||
147439285|NCT02615470|531773987|FG000|Overall Study|Lost to Follow-up|21|||
147439286|NCT02615470|531773988|FG001|Overall Study|Lost to Follow-up|32|||
147439287|NCT03713034|531773989|FG000|Overall Study|Withdrawn by staff for incomplete consent forms|5|||
147439288|NCT03713034|531773990|FG001|Overall Study|Withdrawn by staff for incomplete consent forms|4|||
147439289|NCT04024228|531773995|FG000|Overall Study|Adverse Event|1|||
147439290|NCT04024228|531773996|FG001|Overall Study|Adverse Event|0|||
147439291|NCT04024228|531773995|FG000|Overall Study|Protocol Deviation|0|||
147439292|NCT04024228|531773996|FG001|Overall Study|Protocol Deviation|2|||
147439293|NCT04024228|531773995|FG000|Overall Study|Withdrawal by Subject|3|||
147439294|NCT04024228|531773996|FG001|Overall Study|Withdrawal by Subject|4|||
147439295|NCT02982590|531773999|FG000|Overall Study|Lost to Follow-up|0|||
147439296|NCT02982590|531774000|FG001|Overall Study|Lost to Follow-up|1|||
147439297|NCT02982590|531773999|FG000|Overall Study|Death|4|||
147439298|NCT02982590|531774000|FG001|Overall Study|Death|0|||
147439299|NCT01168973|531774002|FG000|Overall Study|Progressive Disease|341|||
147439300|NCT01168973|531774003|FG001|Overall Study|Progressive Disease|429|||
147439301|NCT01168973|531774002|FG000|Overall Study|Adverse Event|94|||
147439302|NCT01168973|531774003|FG001|Overall Study|Adverse Event|55|||
147439303|NCT01168973|531774002|FG000|Overall Study|Withdrawal by Subject|90|||
147439304|NCT01168973|531774003|FG001|Overall Study|Withdrawal by Subject|53|||
147439305|NCT01168973|531774002|FG000|Overall Study|Death|42|||
147439306|NCT01168973|531774003|FG001|Overall Study|Death|45|||
147439307|NCT01168973|531774002|FG000|Overall Study|Physician Decision|37|||
147439308|NCT01168973|531774003|FG001|Overall Study|Physician Decision|19|||
147439309|NCT01168973|531774002|FG000|Overall Study|Sponsor Decision|2|||
147439310|NCT01168973|531774003|FG001|Overall Study|Sponsor Decision|1|||
147439311|NCT01168973|531774002|FG000|Overall Study|Protocol Criterion Not Met and Deviation|7|||
147439312|NCT01168973|531774003|FG001|Overall Study|Protocol Criterion Not Met and Deviation|9|||
147439313|NCT02163187|531774009|FG000|Overall Study|Device removed|1|||
147439314|NCT02163187|531774010|FG001|Overall Study|Device removed|0|||
147439315|NCT02163187|531774009|FG000|Overall Study|Progressive disease|1|||
147439316|NCT02163187|531774010|FG001|Overall Study|Progressive disease|0|||
147439317|NCT03281668|531774012|FG000|Overall Study|Physician Decision|1|||
147439318|NCT03281668|531774012|FG000|Overall Study|scheduling conflict, family circumstance|2|||
147439319|NCT03281668|531774012|FG000|Overall Study|Withdrawal by Subject|4|||
147439320|NCT03281668|531774012|FG000|Overall Study|Lost to Follow-up|1|||
147439321|NCT01641237|531774024|FG000|Period II|Withdrawal by Subject|1|||
147439322|NCT01641237|531774025|FG001|Period II|Withdrawal by Subject|0|||
147439323|NCT01641237|531774026|FG002|Period II|Withdrawal by Subject|0|||
147439324|NCT01641237|531774027|FG003|Period II|Withdrawal by Subject|0|||
147439325|NCT01641237|531774024|FG000|Period III|Lost to Follow-up|1|||
147439326|NCT01641237|531774025|FG001|Period III|Lost to Follow-up|0|||
147439327|NCT01641237|531774026|FG002|Period III|Lost to Follow-up|0|||
147439328|NCT01641237|531774027|FG003|Period III|Lost to Follow-up|0|||
147439329|NCT00709111|531774028|FG000|Overall Study|Withdrawal by Subject|1|||
147439330|NCT00709111|531774028|FG000|Overall Study|Unable to attend clinic visits|1|||
147439331|NCT02716675|531774029|FG000|Overall Study|Death|2|||
147439332|NCT02716675|531774030|FG001|Overall Study|Death|3|||
147439333|NCT02716675|531774031|FG002|Overall Study|Death|0|||
147439334|NCT02716675|531774029|FG000|Overall Study|Physician Decision|2|||
147439335|NCT02716675|531774030|FG001|Overall Study|Physician Decision|1|||
147439336|NCT02716675|531774031|FG002|Overall Study|Physician Decision|1|||
147439337|NCT02716675|531774029|FG000|Overall Study|Lost to Follow-up|100|||
147439338|NCT02716675|531774030|FG001|Overall Study|Lost to Follow-up|87|||
147439339|NCT02716675|531774031|FG002|Overall Study|Lost to Follow-up|99|||
147439340|NCT02716675|531774029|FG000|Overall Study|Withdrawal by Subject|22|||
147439341|NCT02716675|531774030|FG001|Overall Study|Withdrawal by Subject|25|||
147439342|NCT02716675|531774031|FG002|Overall Study|Withdrawal by Subject|20|||
147439343|NCT02716675|531774029|FG000|Overall Study|Protocol Violation|0|||
147439344|NCT02716675|531774030|FG001|Overall Study|Protocol Violation|3|||
147439345|NCT02716675|531774031|FG002|Overall Study|Protocol Violation|1|||
147439346|NCT02716675|531774029|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|36|||
147439347|NCT02716675|531774030|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|31|||
147439348|NCT02716675|531774031|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|42|||
147439349|NCT02716675|531774029|FG000|Overall Study|Other|38|||
147439350|NCT02716675|531774030|FG001|Overall Study|Other|47|||
147439351|NCT02716675|531774031|FG002|Overall Study|Other|48|||
147439352|NCT01301456|531774036|FG000|Stage 1|Withdrawal by Subject|0|||
147205691|NCT02255435|530923655|FG009|Overall Study|Withdrawal by Subject|4|||
147205692|NCT02255435|530923646|FG000|Overall Study|Administrative reasons|0|||
147205693|NCT02255435|530923647|FG001|Overall Study|Administrative reasons|0|||
147205694|NCT02255435|530923648|FG002|Overall Study|Administrative reasons|0|||
147205695|NCT02255435|530923649|FG003|Overall Study|Administrative reasons|0|||
147205696|NCT02255435|530923650|FG004|Overall Study|Administrative reasons|0|||
147205697|NCT02255435|530923651|FG005|Overall Study|Administrative reasons|0|||
147205698|NCT02255435|530923652|FG006|Overall Study|Administrative reasons|0|||
147205699|NCT02255435|530923653|FG007|Overall Study|Administrative reasons|0|||
147205700|NCT02255435|530923654|FG008|Overall Study|Administrative reasons|0|||
147205701|NCT02255435|530923655|FG009|Overall Study|Administrative reasons|2|||
147205702|NCT02741518|530923658|FG000|Overall Study|Withdrawal by Subject|1|||
147205703|NCT02741518|530923659|FG001|Overall Study|Withdrawal by Subject|1|||
147205704|NCT00476008|530923660|FG000|Overall Study|Adverse Event|4|||
147205705|NCT00476008|530923661|FG001|Overall Study|Adverse Event|4|||
147205706|NCT00476008|530923660|FG000|Overall Study|Placebo concerns|2|||
147205707|NCT00476008|530923661|FG001|Overall Study|Placebo concerns|2|||
147205708|NCT00476008|530923660|FG000|Overall Study|Physician Decision: Medication Noncompli|2|||
147205709|NCT00476008|530923661|FG001|Overall Study|Physician Decision: Medication Noncompli|1|||
147205710|NCT00476008|530923660|FG000|Overall Study|Withdrawal by Subject|0|||
147205711|NCT00476008|530923661|FG001|Overall Study|Withdrawal by Subject|1|||
147205712|NCT00476008|530923660|FG000|Overall Study|Death|1|||
147205713|NCT00476008|530923661|FG001|Overall Study|Death|0|||
147205714|NCT01788358|530923662|FG000|Overall Study|Other|11|||
147205715|NCT01788358|530923662|FG000|Overall Study|Logistical difficulties|1|||
147205716|NCT01788358|530923662|FG000|Overall Study|Lost to Follow-up|5|||
147205717|NCT01788358|530923662|FG000|Overall Study|Protocol Violation|3|||
147205718|NCT01788358|530923662|FG000|Overall Study|Withdrawal by Subject|26|||
147205719|NCT01788358|530923662|FG000|Overall Study|Lack of Efficacy|1|||
147205720|NCT01788358|530923662|FG000|Overall Study|Adverse Event|51|||
147205721|NCT01168219|530923663|FG000|Overall Study|off study before starting treatment|2|||
147205722|NCT01168219|530923663|FG000|Overall Study|withdrew before transplant|1|||
147205723|NCT01168219|530923663|FG000|Overall Study|ineligible due to CML|2|||
147205724|NCT01227018|530923664|FG000|Overall Study|Disease progression|9|||
147205725|NCT01227018|530923664|FG000|Overall Study|Toxicity|2|||
147205726|NCT01227018|530923664|FG000|Overall Study|Withdrew after beginning treatment|4|||
147205727|NCT02948634|530923665|FG000|Overall Study|Lack of efficacy and study suspended|10|||
147205728|NCT02948634|530923666|FG001|Overall Study|Lack of efficacy and study suspended|2|||
147205729|NCT01413204|530923669|FG000|Overall Study|Adverse Event|1|||
147205730|NCT01413204|530923670|FG001|Overall Study|Adverse Event|2|||
147205731|NCT01413204|530923671|FG002|Overall Study|Adverse Event|2|||
147205732|NCT01413204|530923669|FG000|Overall Study|Physician Decision|3|||
147205733|NCT01413204|530923670|FG001|Overall Study|Physician Decision|0|||
147205734|NCT01413204|530923671|FG002|Overall Study|Physician Decision|2|||
147205735|NCT01413204|530923669|FG000|Overall Study|Withdrawal by Subject|1|||
147205736|NCT01413204|530923670|FG001|Overall Study|Withdrawal by Subject|4|||
147205737|NCT01413204|530923671|FG002|Overall Study|Withdrawal by Subject|4|||
147205738|NCT01413204|530923669|FG000|Overall Study|Clearly not eligible for the study|0|||
147205739|NCT01413204|530923670|FG001|Overall Study|Clearly not eligible for the study|0|||
147205740|NCT01413204|530923671|FG002|Overall Study|Clearly not eligible for the study|1|||
147205741|NCT01413204|530923669|FG000|Overall Study|Fasting plasma glucose level increased|1|||
147205742|NCT01413204|530923670|FG001|Overall Study|Fasting plasma glucose level increased|0|||
147205743|NCT01413204|530923671|FG002|Overall Study|Fasting plasma glucose level increased|10|||
147205744|NCT00753649|530923672|FG000|Overall Study|Migrated/moved from study area|1|||
147205745|NCT00753649|530923673|FG001|Overall Study|Migrated/moved from study area|0|||
147205746|NCT00753649|530923672|FG000|Overall Study|Lost to follow-up-incomplete vaccination|3|||
147541064|NCT03193190|532135285|FG005|Stage 1|Withdrawal by Subject|0|||
147541065|NCT03193190|532135286|FG006|Stage 1|Withdrawal by Subject|3|||
147541066|NCT03193190|532135287|FG007|Stage 1|Withdrawal by Subject|2|||
147541067|NCT03193190|532135288|FG008|Stage 1|Withdrawal by Subject|2|||
147205747|NCT00753649|530923673|FG001|Overall Study|Lost to follow-up-incomplete vaccination|0|||
147205748|NCT00753649|530923672|FG000|Overall Study|Lost to follow-up-complete vaccination|1|||
147205749|NCT00753649|530923673|FG001|Overall Study|Lost to follow-up-complete vaccination|0|||
147205750|NCT00753649|530923672|FG000|Overall Study|Protocol Violation|2|||
147205751|NCT00753649|530923673|FG001|Overall Study|Protocol Violation|0|||
147205752|NCT00499616|530923674|FG000|Overall Study|Death|1|||
147205753|NCT00499616|530923675|FG001|Overall Study|Death|5|||
147205754|NCT00499616|530923676|FG002|Overall Study|Death|3|||
147205755|NCT00499616|530923677|FG003|Overall Study|Death|1|||
147205756|NCT00499616|530923674|FG000|Overall Study|Lack of Efficacy|5|||
147205757|NCT00499616|530923675|FG001|Overall Study|Lack of Efficacy|0|||
147205758|NCT00499616|530923676|FG002|Overall Study|Lack of Efficacy|19|||
147205759|NCT00499616|530923677|FG003|Overall Study|Lack of Efficacy|0|||
147205760|NCT00499616|530923674|FG000|Overall Study|Lost to Follow-up|0|||
147541068|NCT03193190|532135289|FG009|Stage 1|Withdrawal by Subject|4|||
147541069|NCT03193190|532135290|FG010|Stage 1|Withdrawal by Subject|9|||
147205761|NCT00499616|530923675|FG001|Overall Study|Lost to Follow-up|0|||
147205762|NCT00499616|530923676|FG002|Overall Study|Lost to Follow-up|1|||
147205763|NCT00499616|530923677|FG003|Overall Study|Lost to Follow-up|0|||
147205764|NCT00499616|530923674|FG000|Overall Study|Physician Decision|6|||
147205765|NCT00499616|530923675|FG001|Overall Study|Physician Decision|16|||
147205766|NCT00499616|530923676|FG002|Overall Study|Physician Decision|9|||
147205767|NCT00499616|530923677|FG003|Overall Study|Physician Decision|0|||
147205768|NCT00499616|530923674|FG000|Overall Study|Withdrawal by Subject|1|||
147205769|NCT00499616|530923675|FG001|Overall Study|Withdrawal by Subject|0|||
147205770|NCT00499616|530923676|FG002|Overall Study|Withdrawal by Subject|1|||
147205771|NCT00499616|530923677|FG003|Overall Study|Withdrawal by Subject|0|||
147205772|NCT00499616|530923674|FG000|Overall Study|Ineligible|1|||
147205773|NCT00499616|530923675|FG001|Overall Study|Ineligible|2|||
147205774|NCT00499616|530923676|FG002|Overall Study|Ineligible|0|||
147205775|NCT00499616|530923677|FG003|Overall Study|Ineligible|15|||
147205776|NCT00499616|530923674|FG000|Overall Study|Not evaluable|0|||
147205777|NCT00499616|530923675|FG001|Overall Study|Not evaluable|0|||
147205778|NCT00499616|530923676|FG002|Overall Study|Not evaluable|0|||
147205779|NCT00499616|530923677|FG003|Overall Study|Not evaluable|41|||
147205780|NCT00499616|530923674|FG000|Overall Study|Patient/Parent Refusal|1|||
147205781|NCT00499616|530923675|FG001|Overall Study|Patient/Parent Refusal|5|||
147205782|NCT00499616|530923676|FG002|Overall Study|Patient/Parent Refusal|3|||
147205783|NCT00499616|530923677|FG003|Overall Study|Patient/Parent Refusal|0|||
147205784|NCT01837823|530923679|FG000|Overall Study|Lost to Follow-up|6|||
147205785|NCT01864603|530923680|FG000|Stage 2|DSMB design modification|86056|||
147205786|NCT01864603|530923681|FG001|Stage 2|DSMB design modification|92558|||
147205787|NCT03830892|530923685|FG000|Overall Study|Physician Decision|2|||
147205788|NCT03830892|530923686|FG001|Overall Study|Physician Decision|3|||
147205789|NCT03830892|530923685|FG000|Overall Study|Study terminated due to COVID|4|||
147205790|NCT03830892|530923686|FG001|Overall Study|Study terminated due to COVID|0|||
147205791|NCT03830892|530923685|FG000|Overall Study|Protocol Violation|0|||
147205792|NCT03830892|530923686|FG001|Overall Study|Protocol Violation|1|||
147205793|NCT03830892|530923685|FG000|Overall Study|Withdrawal by Subject|0|||
147205794|NCT03830892|530923686|FG001|Overall Study|Withdrawal by Subject|2|||
147205795|NCT00330967|530923687|FG000|Overall Study|Withdrawal by Subject|0|||
147205796|NCT00330967|530923688|FG001|Overall Study|Withdrawal by Subject|5|||
147205797|NCT00330967|530923687|FG000|Overall Study|Physician Decision|0|||
147205798|NCT00330967|530923688|FG001|Overall Study|Physician Decision|9|||
147205799|NCT04269265|530923689|FG000|Overall Study|Physician Decision|1|||
147205800|NCT04269265|530923689|FG000|Overall Study|Withdrawal by Subject|1|||
147205801|NCT04269265|530923689|FG000|Overall Study|Overenrolled (sample size reached)|4|||
147205802|NCT04439136|530923690|FG000|Overall Study|Ineligible|1|||
147205803|NCT04439136|530923690|FG000|Overall Study|Never Started Treatment|2|||
147205804|NCT04439136|530923690|FG000|Overall Study|Adverse Event|4|||
147205805|NCT04439136|530923690|FG000|Overall Study|Death|3|||
147205806|NCT04439136|530923690|FG000|Overall Study|Disease Progression|27|||
147205807|NCT04439136|530923690|FG000|Overall Study|Alternative Therapy|1|||
147205808|NCT04439136|530923690|FG000|Overall Study|Increased Tumor Burden|1|||
147205809|NCT04439136|530923690|FG000|Overall Study|Symptomatic Detrioration|1|||
147205810|NCT02578706|530923693|FG000|Overall Study|Withdrawal by Subject|1|||
147205811|NCT02578706|530923694|FG001|Overall Study|Withdrawal by Subject|0|||
147205812|NCT02578706|530923695|FG002|Overall Study|Withdrawal by Subject|0|||
147205813|NCT02578706|530923693|FG000|Overall Study|Lost to Follow-up|0|||
147205814|NCT02578706|530923694|FG001|Overall Study|Lost to Follow-up|4|||
147205815|NCT02578706|530923695|FG002|Overall Study|Lost to Follow-up|0|||
147205816|NCT02578706|530923693|FG000|Overall Study|Physician Decision|0|||
147205817|NCT02578706|530923694|FG001|Overall Study|Physician Decision|1|||
147205818|NCT02578706|530923695|FG002|Overall Study|Physician Decision|0|||
147439353|NCT01301456|531774037|FG001|Stage 1|Withdrawal by Subject|0|||
147439354|NCT01301456|531774038|FG002|Stage 1|Withdrawal by Subject|1|||
147439355|NCT01301456|531774039|FG003|Stage 1|Withdrawal by Subject|0|||
147205819|NCT04849559|530923698|FG000|Overall Study|Withdrawal by Subject|2|||
147205820|NCT04849559|530923699|FG001|Overall Study|Withdrawal by Subject|1|||
147205821|NCT02910986|530923702|FG000|Overall Study|non-Latina|14|||
147205822|NCT02910986|530923703|FG001|Overall Study|non-Latina|13|||
147205823|NCT02910986|530923704|FG002|Overall Study|non-Latina|12|||
147205824|NCT02910986|530923702|FG000|Overall Study|Failure to return T! survey|72|||
147439356|NCT01301456|531774040|FG004|Stage 1|Withdrawal by Subject|1|||
147205825|NCT02910986|530923703|FG001|Overall Study|Failure to return T! survey|84|||
147205826|NCT02910986|530923704|FG002|Overall Study|Failure to return T! survey|72|||
147205827|NCT02910986|530923702|FG000|Overall Study|T1 Survey not 14-180 post education|25|||
147205828|NCT02910986|530923703|FG001|Overall Study|T1 Survey not 14-180 post education|25|||
147205829|NCT02910986|530923704|FG002|Overall Study|T1 Survey not 14-180 post education|115|||
147205830|NCT02910986|530923702|FG000|Overall Study|Withdrew after randomization prior to start of intervention|0|||
147205831|NCT02910986|530923703|FG001|Overall Study|Withdrew after randomization prior to start of intervention|0|||
147205832|NCT02910986|530923704|FG002|Overall Study|Withdrew after randomization prior to start of intervention|2|||
147205833|NCT01662102|530923711|FG000|Overall Study|Sponsor's decision|1|||
147205834|NCT01662102|530923712|FG001|Overall Study|Sponsor's decision|0|||
147205835|NCT02586207|530923713|FG000|Overall Study|Physician Decision|1|||
147205836|NCT02586207|530923713|FG000|Overall Study|Withdrawal by Subject|1|||
147205837|NCT03048578|530923714|FG000|Overall Study|Withdrawal by Subject|5|||
147205838|NCT03048578|530923715|FG001|Overall Study|Withdrawal by Subject|6|||
147205839|NCT03048578|530923714|FG000|Overall Study|Lost to Follow-up|22|||
147205840|NCT03048578|530923715|FG001|Overall Study|Lost to Follow-up|10|||
147205841|NCT03048578|530923714|FG000|Overall Study|Adverse Event|1|||
147205842|NCT03048578|530923715|FG001|Overall Study|Adverse Event|2|||
147439357|NCT01301456|531774041|FG005|Stage 1|Withdrawal by Subject|0|||
147439358|NCT01301456|531774042|FG006|Stage 1|Withdrawal by Subject|0|||
147439359|NCT01301456|531774043|FG007|Stage 1|Withdrawal by Subject|0|||
147439360|NCT01301456|531774044|FG008|Stage 1|Withdrawal by Subject|0|||
147439361|NCT01301456|531774045|FG009|Stage 1|Withdrawal by Subject|0|||
147439362|NCT01301456|531774046|FG010|Stage 1|Withdrawal by Subject|0|||
147439363|NCT01301456|531774047|FG011|Stage 1|Withdrawal by Subject|0|||
147439364|NCT01301456|531774036|FG000|Stage 1|Randomized but not treated|0|||
147439365|NCT01301456|531774037|FG001|Stage 1|Randomized but not treated|0|||
147439366|NCT01301456|531774038|FG002|Stage 1|Randomized but not treated|0|||
147439367|NCT01301456|531774039|FG003|Stage 1|Randomized but not treated|0|||
147439368|NCT01301456|531774040|FG004|Stage 1|Randomized but not treated|0|||
147439369|NCT01301456|531774041|FG005|Stage 1|Randomized but not treated|0|||
147439370|NCT01301456|531774042|FG006|Stage 1|Randomized but not treated|1|||
147439371|NCT01301456|531774043|FG007|Stage 1|Randomized but not treated|0|||
147439372|NCT01301456|531774044|FG008|Stage 1|Randomized but not treated|0|||
147439373|NCT01301456|531774045|FG009|Stage 1|Randomized but not treated|0|||
147439374|NCT01301456|531774046|FG010|Stage 1|Randomized but not treated|0|||
147439375|NCT01301456|531774047|FG011|Stage 1|Randomized but not treated|0|||
147439376|NCT01301456|531774036|FG000|Stage 2|Adverse Event|0|||
147439377|NCT01301456|531774037|FG001|Stage 2|Adverse Event|0|||
147439378|NCT01301456|531774038|FG002|Stage 2|Adverse Event|0|||
147439379|NCT01301456|531774039|FG003|Stage 2|Adverse Event|0|||
147439380|NCT01301456|531774040|FG004|Stage 2|Adverse Event|0|||
147439381|NCT01301456|531774041|FG005|Stage 2|Adverse Event|0|||
147439382|NCT01301456|531774042|FG006|Stage 2|Adverse Event|0|||
147439383|NCT01301456|531774043|FG007|Stage 2|Adverse Event|0|||
147439384|NCT01301456|531774044|FG008|Stage 2|Adverse Event|0|||
147439385|NCT01301456|531774045|FG009|Stage 2|Adverse Event|0|||
147439386|NCT01301456|531774046|FG010|Stage 2|Adverse Event|1|||
147439387|NCT01301456|531774047|FG011|Stage 2|Adverse Event|0|||
147439388|NCT00290290|531774050|FG000|Overall Study|Death|3|||
147439389|NCT00290290|531774051|FG001|Overall Study|Death|4|||
147439390|NCT00290290|531774050|FG000|Overall Study|Withdrawal by Subject|2|||
147439391|NCT00290290|531774051|FG001|Overall Study|Withdrawal by Subject|2|||
147439392|NCT00290290|531774050|FG000|Overall Study|Underwent clean surgical procedure|13|||
147439393|NCT00290290|531774051|FG001|Overall Study|Underwent clean surgical procedure|12|||
147439394|NCT00915772|531774052|FG000|Overall Study|Adverse Event|12|||
147439395|NCT00915772|531774053|FG001|Overall Study|Adverse Event|13|||
147439396|NCT00915772|531774054|FG002|Overall Study|Adverse Event|11|||
147439397|NCT00915772|531774052|FG000|Overall Study|Protocol Violation|4|||
147439398|NCT00915772|531774053|FG001|Overall Study|Protocol Violation|1|||
147439399|NCT00915772|531774054|FG002|Overall Study|Protocol Violation|2|||
147439400|NCT00915772|531774052|FG000|Overall Study|Lost to Follow-up|1|||
147439401|NCT00915772|531774053|FG001|Overall Study|Lost to Follow-up|2|||
147439402|NCT00915772|531774054|FG002|Overall Study|Lost to Follow-up|2|||
147439403|NCT00915772|531774052|FG000|Overall Study|Lack of Efficacy|9|||
147439404|NCT00915772|531774053|FG001|Overall Study|Lack of Efficacy|15|||
147439405|NCT00915772|531774054|FG002|Overall Study|Lack of Efficacy|3|||
147439406|NCT00915772|531774052|FG000|Overall Study|Refused to continue trial medication|6|||
147439407|NCT00915772|531774053|FG001|Overall Study|Refused to continue trial medication|8|||
147439408|NCT00915772|531774054|FG002|Overall Study|Refused to continue trial medication|4|||
147439409|NCT00915772|531774052|FG000|Overall Study|Any other reason|4|||
147439410|NCT00915772|531774053|FG001|Overall Study|Any other reason|7|||
147439411|NCT00915772|531774054|FG002|Overall Study|Any other reason|7|||
147205843|NCT03048578|530923714|FG000|Overall Study|Terminated|3|||
147205844|NCT03048578|530923715|FG001|Overall Study|Terminated|2|||
147439412|NCT03374995|531774055|FG000|Overall Study|Withdrawal by Subject|0|||
147439413|NCT03374995|531774056|FG001|Overall Study|Withdrawal by Subject|1|||
147439414|NCT03023059|531774071|FG000|Overall Study|Withdrawal by Subject|5|||
147439415|NCT01106027|531774087|FG000|Overall Study|Lost graft early, discontinued|1|||
147439416|NCT02170779|531774088|FG000|Overall Study|Withdrawal by Subject|1|||
147439417|NCT02170779|531774089|FG001|Overall Study|Withdrawal by Subject|0|||
147439418|NCT02170779|531774088|FG000|Overall Study|Lost to Follow-up|0|||
147439419|NCT02170779|531774089|FG001|Overall Study|Lost to Follow-up|1|||
147439420|NCT00369785|531774090|FG000|Overall Study|Physician Decision|3|||
147439421|NCT00369785|531774091|FG001|Overall Study|Physician Decision|2|||
147439422|NCT00369785|531774090|FG000|Overall Study|Death|1|||
147439423|NCT00369785|531774091|FG001|Overall Study|Death|2|||
147439424|NCT00369785|531774090|FG000|Overall Study|Withdrawal by Subject|7|||
147439425|NCT00369785|531774091|FG001|Overall Study|Withdrawal by Subject|6|||
147439426|NCT00369785|531774090|FG000|Overall Study|Toxicity|6|||
147205845|NCT00526071|530923716|FG000|Overall Study|Adverse Event|1|||
147205846|NCT00526071|530923716|FG000|Overall Study|Withdrawal by Subject|1|||
147205847|NCT00526071|530923716|FG000|Overall Study|Lack of Response to Study Drug|4|||
147205848|NCT03306173|530923717|FG000|Overall Study|Lost to Follow-up|16|||
147205849|NCT03306173|530923718|FG001|Overall Study|Lost to Follow-up|23|||
147205850|NCT03306173|530923717|FG000|Overall Study|Withdrawal by Subject|4|||
147205851|NCT03306173|530923718|FG001|Overall Study|Withdrawal by Subject|3|||
147205852|NCT03306173|530923717|FG000|Overall Study|Discontinued|4|||
147205853|NCT03306173|530923718|FG001|Overall Study|Discontinued|4|||
147205854|NCT00573144|530923719|FG000|Overall Study|Withdrawal by Subject|2|||
147205855|NCT00573144|530923720|FG001|Overall Study|Withdrawal by Subject|3|||
147205856|NCT00125164|530923727|FG000|Overall Study|Adverse Event|0|||
147205857|NCT00125164|530923728|FG001|Overall Study|Adverse Event|0|||
147205858|NCT00125164|530923729|FG002|Overall Study|Adverse Event|2|||
147205859|NCT00125164|530923730|FG003|Overall Study|Adverse Event|4|||
147205860|NCT00125164|530923727|FG000|Overall Study|Lost to Follow-up|0|||
147205861|NCT00125164|530923728|FG001|Overall Study|Lost to Follow-up|0|||
147205862|NCT00125164|530923729|FG002|Overall Study|Lost to Follow-up|1|||
147205863|NCT00125164|530923730|FG003|Overall Study|Lost to Follow-up|1|||
147205864|NCT00125164|530923727|FG000|Overall Study|Withdrawal by Subject|2|||
147205865|NCT00125164|530923728|FG001|Overall Study|Withdrawal by Subject|0|||
147205866|NCT00125164|530923729|FG002|Overall Study|Withdrawal by Subject|1|||
147205867|NCT00125164|530923730|FG003|Overall Study|Withdrawal by Subject|1|||
147205868|NCT01339052|530923731|FG000|Overall Study|Disease progression|13|||
147205869|NCT01339052|530923732|FG001|Overall Study|Disease progression|46|||
147205870|NCT01339052|530923731|FG000|Overall Study|Adverse Event|1|||
147205871|NCT01339052|530923732|FG001|Overall Study|Adverse Event|1|||
147205872|NCT01339052|530923731|FG000|Overall Study|Withdrawal by Subject|0|||
147205873|NCT01339052|530923732|FG001|Overall Study|Withdrawal by Subject|3|||
147205874|NCT01339052|530923731|FG000|Overall Study|Physician Decision|1|||
147205875|NCT01339052|530923732|FG001|Overall Study|Physician Decision|0|||
147205876|NCT02637037|530923733|FG000|Overall Study|Positive drug screen at admission|1|||
147205877|NCT02637037|530923734|FG001|Overall Study|Positive drug screen at admission|0|||
147205878|NCT02637037|530923733|FG000|Overall Study|Withdrawal by Subject|2|||
147205879|NCT02637037|530923734|FG001|Overall Study|Withdrawal by Subject|1|||
147205880|NCT02637037|530923733|FG000|Overall Study|Adverse Event|1|||
147205881|NCT02637037|530923734|FG001|Overall Study|Adverse Event|0|||
147205882|NCT02023697|530923736|FG000|Treatment Period|Radiological progression|13|||
147205883|NCT02023697|530923737|FG001|Treatment Period|Radiological progression|17|||
147205884|NCT02023697|530923738|FG002|Treatment Period|Radiological progression|26|||
147205885|NCT02023697|530923736|FG000|Treatment Period|Never Treated|5|||
147205886|NCT02023697|530923737|FG001|Treatment Period|Never Treated|6|||
147205887|NCT02023697|530923738|FG002|Treatment Period|Never Treated|10|||
147205888|NCT02023697|530923736|FG000|Treatment Period|Adverse Event|13|||
147205889|NCT02023697|530923737|FG001|Treatment Period|Adverse Event|25|||
147205890|NCT02023697|530923738|FG002|Treatment Period|Adverse Event|23|||
147205891|NCT02023697|530923736|FG000|Treatment Period|Logistical difficulties|1|||
147205892|NCT02023697|530923737|FG001|Treatment Period|Logistical difficulties|1|||
147205893|NCT02023697|530923738|FG002|Treatment Period|Logistical difficulties|1|||
147205894|NCT02023697|530923736|FG000|Treatment Period|Clinical progression|10|||
147205895|NCT02023697|530923737|FG001|Treatment Period|Clinical progression|8|||
147205896|NCT02023697|530923738|FG002|Treatment Period|Clinical progression|28|||
147205897|NCT02023697|530923736|FG000|Treatment Period|Withdrawal by Subject|4|||
147205898|NCT02023697|530923737|FG001|Treatment Period|Withdrawal by Subject|5|||
147205899|NCT02023697|530923738|FG002|Treatment Period|Withdrawal by Subject|13|||
147205900|NCT02023697|530923736|FG000|Treatment Period|Safety outcome reached|0|||
147205901|NCT02023697|530923737|FG001|Treatment Period|Safety outcome reached|1|||
147205902|NCT02023697|530923738|FG002|Treatment Period|Safety outcome reached|0|||
147205903|NCT02023697|530923736|FG000|Treatment Period|Physician Decision|0|||
147205904|NCT02023697|530923737|FG001|Treatment Period|Physician Decision|0|||
147205905|NCT02023697|530923738|FG002|Treatment Period|Physician Decision|1|||
147205906|NCT02023697|530923736|FG000|Active Follow-up Period|Withdrawal by Subject|5|||
147205907|NCT02023697|530923737|FG001|Active Follow-up Period|Withdrawal by Subject|13|||
147205908|NCT02023697|530923738|FG002|Active Follow-up Period|Withdrawal by Subject|7|||
147205909|NCT02023697|530923736|FG000|Active Follow-up Period|Lost to Follow-up|1|||
147205910|NCT02023697|530923737|FG001|Active Follow-up Period|Lost to Follow-up|1|||
147205911|NCT02023697|530923738|FG002|Active Follow-up Period|Lost to Follow-up|1|||
147205912|NCT02023697|530923736|FG000|Active Follow-up Period|Deterioration of general condition|1|||
147205913|NCT02023697|530923737|FG001|Active Follow-up Period|Deterioration of general condition|1|||
147205914|NCT02023697|530923738|FG002|Active Follow-up Period|Deterioration of general condition|1|||
147205915|NCT02023697|530923736|FG000|Active Follow-up Period|Other unspecified|2|||
147205916|NCT02023697|530923737|FG001|Active Follow-up Period|Other unspecified|0|||
147205917|NCT02023697|530923738|FG002|Active Follow-up Period|Other unspecified|1|||
147205918|NCT02023697|530923736|FG000|Active Follow-up Period|Clinical progression|0|||
147205919|NCT02023697|530923737|FG001|Active Follow-up Period|Clinical progression|2|||
147205920|NCT02023697|530923738|FG002|Active Follow-up Period|Clinical progression|1|||
147205921|NCT02023697|530923736|FG000|Active Follow-up Period|Radiological progression|0|||
147205922|NCT02023697|530923737|FG001|Active Follow-up Period|Radiological progression|0|||
147205923|NCT02023697|530923738|FG002|Active Follow-up Period|Radiological progression|1|||
147205924|NCT02023697|530923736|FG000|Active Follow-up Period|Death|83|||
147205925|NCT02023697|530923737|FG001|Active Follow-up Period|Death|82|||
147205926|NCT02023697|530923738|FG002|Active Follow-up Period|Death|87|||
147541070|NCT03193190|532135291|FG011|Stage 1|Withdrawal by Subject|1|||
147541071|NCT03193190|532135292|FG012|Stage 1|Withdrawal by Subject|0|||
147541072|NCT03193190|532135293|FG013|Stage 1|Withdrawal by Subject|0|||
147541073|NCT03193190|532135294|FG014|Stage 1|Withdrawal by Subject|0|||
147541074|NCT03193190|532135295|FG015|Stage 1|Withdrawal by Subject|0|||
147541075|NCT03193190|532135280|FG000|Stage 2|Death|0|||
147541076|NCT03193190|532135281|FG001|Stage 2|Death|0|||
147541077|NCT03193190|532135282|FG002|Stage 2|Death|0|||
147541078|NCT03193190|532135283|FG003|Stage 2|Death|0|||
147541079|NCT03193190|532135284|FG004|Stage 2|Death|0|||
147541080|NCT03193190|532135285|FG005|Stage 2|Death|0|||
147541081|NCT03193190|532135286|FG006|Stage 2|Death|0|||
147541082|NCT03193190|532135287|FG007|Stage 2|Death|0|||
147541083|NCT03193190|532135288|FG008|Stage 2|Death|0|||
147541084|NCT03193190|532135289|FG009|Stage 2|Death|0|||
147541085|NCT03193190|532135290|FG010|Stage 2|Death|0|||
147541086|NCT03193190|532135291|FG011|Stage 2|Death|0|||
147541087|NCT03193190|532135292|FG012|Stage 2|Death|0|||
147541088|NCT03193190|532135293|FG013|Stage 2|Death|14|||
147541089|NCT03193190|532135294|FG014|Stage 2|Death|4|||
147541090|NCT03193190|532135295|FG015|Stage 2|Death|1|||
147541091|NCT03193190|532135280|FG000|Stage 2|Lost to Follow-up|0|||
147541092|NCT03193190|532135281|FG001|Stage 2|Lost to Follow-up|0|||
147541093|NCT03193190|532135282|FG002|Stage 2|Lost to Follow-up|0|||
147541094|NCT03193190|532135283|FG003|Stage 2|Lost to Follow-up|0|||
147541095|NCT03193190|532135284|FG004|Stage 2|Lost to Follow-up|0|||
147541096|NCT03193190|532135285|FG005|Stage 2|Lost to Follow-up|0|||
147541097|NCT03193190|532135286|FG006|Stage 2|Lost to Follow-up|0|||
147541098|NCT03193190|532135287|FG007|Stage 2|Lost to Follow-up|0|||
147541099|NCT03193190|532135288|FG008|Stage 2|Lost to Follow-up|0|||
147541100|NCT03193190|532135289|FG009|Stage 2|Lost to Follow-up|0|||
147541101|NCT03193190|532135290|FG010|Stage 2|Lost to Follow-up|0|||
147541102|NCT03193190|532135291|FG011|Stage 2|Lost to Follow-up|0|||
147541103|NCT03193190|532135292|FG012|Stage 2|Lost to Follow-up|0|||
147541104|NCT03193190|532135293|FG013|Stage 2|Lost to Follow-up|0|||
147541105|NCT03193190|532135294|FG014|Stage 2|Lost to Follow-up|1|||
147205927|NCT02023697|530923736|FG000|Long-term Follow-up Period|Death|9|||
147541106|NCT03193190|532135295|FG015|Stage 2|Lost to Follow-up|0|||
147541107|NCT03193190|532135280|FG000|Stage 2|Withdrawal by Subject|0|||
147541108|NCT03193190|532135281|FG001|Stage 2|Withdrawal by Subject|0|||
147541109|NCT03193190|532135282|FG002|Stage 2|Withdrawal by Subject|0|||
147541110|NCT03193190|532135283|FG003|Stage 2|Withdrawal by Subject|0|||
147541111|NCT03193190|532135284|FG004|Stage 2|Withdrawal by Subject|0|||
147541112|NCT03193190|532135285|FG005|Stage 2|Withdrawal by Subject|0|||
147541113|NCT03193190|532135286|FG006|Stage 2|Withdrawal by Subject|0|||
147541114|NCT03193190|532135287|FG007|Stage 2|Withdrawal by Subject|0|||
147541115|NCT03193190|532135288|FG008|Stage 2|Withdrawal by Subject|0|||
147541116|NCT03193190|532135289|FG009|Stage 2|Withdrawal by Subject|0|||
147541117|NCT03193190|532135290|FG010|Stage 2|Withdrawal by Subject|0|||
147541118|NCT03193190|532135291|FG011|Stage 2|Withdrawal by Subject|0|||
147541119|NCT03193190|532135292|FG012|Stage 2|Withdrawal by Subject|0|||
147541120|NCT03193190|532135293|FG013|Stage 2|Withdrawal by Subject|1|||
147541121|NCT03193190|532135294|FG014|Stage 2|Withdrawal by Subject|1|||
147541122|NCT03193190|532135295|FG015|Stage 2|Withdrawal by Subject|0|||
147541123|NCT03532295|532135296|FG000|Overall Study|Did not start treatment|0|||
147541124|NCT03532295|532135297|FG001|Overall Study|Did not start treatment|2|||
147541125|NCT03732677|532135301|FG000|Overall Study|Terminated the study|154|||
147541126|NCT03732677|532135302|FG001|Overall Study|Terminated the study|197|||
147205928|NCT02023697|530923737|FG001|Long-term Follow-up Period|Death|6|||
147205929|NCT02023697|530923738|FG002|Long-term Follow-up Period|Death|4|||
147205930|NCT02023697|530923736|FG000|Long-term Follow-up Period|Withdrawal by Subject|6|||
147205931|NCT02023697|530923737|FG001|Long-term Follow-up Period|Withdrawal by Subject|3|||
147205932|NCT02023697|530923738|FG002|Long-term Follow-up Period|Withdrawal by Subject|0|||
147541127|NCT03732677|532135301|FG000|Overall Study|Continuing study off treatment|379|||
147541128|NCT03732677|532135302|FG001|Overall Study|Continuing study off treatment|333|||
147541129|NCT04644237|532135303|FG000|Overall Study|Death|4|||
147205933|NCT02023697|530923736|FG000|Long-term Follow-up Period|Lost to Follow-up|1|||
147541130|NCT04644237|532135304|FG001|Overall Study|Death|2|||
147541131|NCT04644237|532135303|FG000|Overall Study|Adverse Event|18|||
147541132|NCT04644237|532135304|FG001|Overall Study|Adverse Event|19|||
147541133|NCT04644237|532135303|FG000|Overall Study|Progressive Disease|61|||
147541134|NCT04644237|532135304|FG001|Overall Study|Progressive Disease|23|||
147541135|NCT04644237|532135303|FG000|Overall Study|Clinical Progression|4|||
147541136|NCT04644237|532135304|FG001|Overall Study|Clinical Progression|1|||
147541137|NCT04644237|532135303|FG000|Overall Study|Withdrawal by Subject|4|||
147541138|NCT04644237|532135304|FG001|Overall Study|Withdrawal by Subject|2|||
147541139|NCT04644237|532135303|FG000|Overall Study|Physician Decision|4|||
147541140|NCT04644237|532135304|FG001|Overall Study|Physician Decision|0|||
147205934|NCT02023697|530923737|FG001|Long-term Follow-up Period|Lost to Follow-up|0|||
147205935|NCT02023697|530923738|FG002|Long-term Follow-up Period|Lost to Follow-up|1|||
147205936|NCT02023697|530923736|FG000|Long-term Follow-up Period|Entered the long-term follow-up study|6|||
147205937|NCT02023697|530923737|FG001|Long-term Follow-up Period|Entered the long-term follow-up study|9|||
147205938|NCT02023697|530923738|FG002|Long-term Follow-up Period|Entered the long-term follow-up study|6|||
147205939|NCT02023697|530923736|FG000|Long-term Follow-up Period|Technical problems|0|||
147205940|NCT02023697|530923737|FG001|Long-term Follow-up Period|Technical problems|0|||
147205941|NCT02023697|530923738|FG002|Long-term Follow-up Period|Technical problems|1|||
147205942|NCT02023697|530923736|FG000|Long-term Follow-up Period|Other unspecified|6|||
147205943|NCT02023697|530923737|FG001|Long-term Follow-up Period|Other unspecified|3|||
147205944|NCT02023697|530923738|FG002|Long-term Follow-up Period|Other unspecified|5|||
147205945|NCT01469377|530923744|FG000|Overall Study|Protocol Deviation|7|||
147205946|NCT01469377|530923745|FG001|Overall Study|Protocol Deviation|10|||
147205947|NCT01469377|530923746|FG002|Overall Study|Protocol Deviation|10|||
147205948|NCT01469377|530923744|FG000|Overall Study|Lost to Follow-up|3|||
147205949|NCT01469377|530923745|FG001|Overall Study|Lost to Follow-up|2|||
147205950|NCT01469377|530923746|FG002|Overall Study|Lost to Follow-up|5|||
147205951|NCT01469377|530923744|FG000|Overall Study|Withdrawal of Consent|12|||
147205952|NCT01469377|530923745|FG001|Overall Study|Withdrawal of Consent|14|||
147205953|NCT01469377|530923746|FG002|Overall Study|Withdrawal of Consent|15|||
147205954|NCT01469377|530923744|FG000|Overall Study|Adverse Event|8|||
147205955|NCT01469377|530923745|FG001|Overall Study|Adverse Event|18|||
147205956|NCT01469377|530923746|FG002|Overall Study|Adverse Event|36|||
147205957|NCT01469377|530923744|FG000|Overall Study|Insufficient Therapeutic Response|3|||
147205958|NCT01469377|530923745|FG001|Overall Study|Insufficient Therapeutic Response|4|||
147205959|NCT01469377|530923746|FG002|Overall Study|Insufficient Therapeutic Response|0|||
147205960|NCT01469377|530923744|FG000|Overall Study|Other Miscellaneous Reasons|2|||
147205961|NCT01469377|530923745|FG001|Overall Study|Other Miscellaneous Reasons|0|||
147205962|NCT01469377|530923746|FG002|Overall Study|Other Miscellaneous Reasons|0|||
147205963|NCT04939415|530923747|FG000|Overall Study|Withdrawal by Subject|1|||
147205964|NCT04939415|530923748|FG001|Overall Study|Withdrawal by Subject|3|||
147205965|NCT04939415|530923747|FG000|Overall Study|Lost to Follow-up|0|||
147205966|NCT04939415|530923748|FG001|Overall Study|Lost to Follow-up|2|||
147205967|NCT04308291|530923749|FG000|Run-In Phase|Withdrawal by Subject|4|||
147205968|NCT04308291|530923749|FG000|Study Phase 6-M|Withdrawal by Subject|13|||
147205969|NCT04308291|530923749|FG000|Study Phase 6-M|Physician Decision|2|||
147205970|NCT04308291|530923749|FG000|Study Phase 6-M|Carelink uploading issues (Linux user)|1|||
147205971|NCT04308291|530923749|FG000|Study Phase 12-M|Withdrawal by Subject|11|||
147205972|NCT04308291|530923749|FG000|Study Phase 12-M|Physician Decision|2|||
147205973|NCT04308291|530923749|FG000|Study Phase 12-M|Hospitalization for cause not related to the study (Pancytopenia)|1|||
147205974|NCT03610269|530923751|FG000|Overall Study|Physician Decision|10|||
147205975|NCT03610269|530923751|FG000|Overall Study|Protocol Violation|1|||
147205976|NCT03610269|530923751|FG000|Overall Study|Unable to draw blood|1|||
147205977|NCT03610269|530923751|FG000|Overall Study|Screen fail|4|||
147205978|NCT00714870|530923754|FG000|Overall Study|Lost to Follow-up|22|||
147205979|NCT00714870|530923755|FG001|Overall Study|Lost to Follow-up|5|||
147205980|NCT00714870|530923754|FG000|Overall Study|patient unable to come b/c back pain|1|||
147205981|NCT00714870|530923755|FG001|Overall Study|patient unable to come b/c back pain|0|||
147205982|NCT00714870|530923754|FG000|Overall Study|did not attend minimum of 4 sessions|4|||
147205983|NCT00714870|530923755|FG001|Overall Study|did not attend minimum of 4 sessions|0|||
147205984|NCT03399552|530923756|FG000|Overall Study|No evidence of disease|1|||
147205985|NCT03399552|530923756|FG000|Overall Study|Unevaluable|1|||
147205986|NCT02357368|530923757|FG000|Overall Study|Lost to Follow-up|0|||
147205987|NCT02357368|530923758|FG001|Overall Study|Lost to Follow-up|0|||
147205988|NCT02357368|530923759|FG002|Overall Study|Lost to Follow-up|0|||
147205989|NCT02357368|530923760|FG003|Overall Study|Lost to Follow-up|1|||
147205990|NCT02357368|530923757|FG000|Overall Study|Pregnancy|3|||
147205991|NCT02357368|530923758|FG001|Overall Study|Pregnancy|2|||
147205992|NCT02357368|530923759|FG002|Overall Study|Pregnancy|0|||
147205993|NCT02357368|530923760|FG003|Overall Study|Pregnancy|0|||
147439427|NCT00369785|531774091|FG001|Overall Study|Toxicity|4|||
147439428|NCT00369785|531774090|FG000|Overall Study|Never started|0|||
147439429|NCT00369785|531774091|FG001|Overall Study|Never started|2|||
147439430|NCT00369785|531774090|FG000|Overall Study|Progression|4|||
147439431|NCT00369785|531774091|FG001|Overall Study|Progression|4|||
147439432|NCT00369785|531774090|FG000|Overall Study|Multiple reasons|6|||
147541141|NCT04644237|532135303|FG000|Overall Study|Other|6|||
147205994|NCT02357368|530923757|FG000|Overall Study|Withdrawal by Subject|3|||
147205995|NCT02357368|530923758|FG001|Overall Study|Withdrawal by Subject|1|||
147439433|NCT00369785|531774091|FG001|Overall Study|Multiple reasons|5|||
147439434|NCT00800683|531774092|FG000|Overall Study|Adverse Event|11|||
147439435|NCT00800683|531774093|FG001|Overall Study|Adverse Event|8|||
147439436|NCT00800683|531774092|FG000|Overall Study|Lost to Follow-up|3|||
147541142|NCT04644237|532135304|FG001|Overall Study|Other|3|||
147205996|NCT02357368|530923759|FG002|Overall Study|Withdrawal by Subject|1|||
147205997|NCT02357368|530923760|FG003|Overall Study|Withdrawal by Subject|2|||
147205998|NCT00611026|530923763|FG000|Randomized to Double-blind Treatment|Not treated|2|||
147205999|NCT00611026|530923764|FG001|Randomized to Double-blind Treatment|Not treated|1|||
147206000|NCT00611026|530923765|FG002|Randomized to Double-blind Treatment|Not treated|3|||
147206001|NCT00611026|530923763|FG000|Double-blind Treatment Period|Death|1|||
147206002|NCT00611026|530923764|FG001|Double-blind Treatment Period|Death|0|||
147206003|NCT00611026|530923765|FG002|Double-blind Treatment Period|Death|0|||
147206004|NCT00611026|530923763|FG000|Double-blind Treatment Period|Adverse Event|9|||
147206005|NCT00611026|530923764|FG001|Double-blind Treatment Period|Adverse Event|28|||
147206006|NCT00611026|530923765|FG002|Double-blind Treatment Period|Adverse Event|46|||
147206007|NCT00611026|530923763|FG000|Double-blind Treatment Period|Lack of Efficacy|11|||
147206008|NCT00611026|530923764|FG001|Double-blind Treatment Period|Lack of Efficacy|10|||
147206009|NCT00611026|530923765|FG002|Double-blind Treatment Period|Lack of Efficacy|4|||
147206010|NCT00611026|530923763|FG000|Double-blind Treatment Period|Lost to Follow-up|6|||
147206011|NCT00611026|530923764|FG001|Double-blind Treatment Period|Lost to Follow-up|11|||
147206012|NCT00611026|530923765|FG002|Double-blind Treatment Period|Lost to Follow-up|14|||
147206013|NCT00611026|530923763|FG000|Double-blind Treatment Period|Withdrawal by Subject|7|||
147206014|NCT00611026|530923764|FG001|Double-blind Treatment Period|Withdrawal by Subject|19|||
147206015|NCT00611026|530923765|FG002|Double-blind Treatment Period|Withdrawal by Subject|16|||
147206016|NCT00611026|530923763|FG000|Double-blind Treatment Period|Other|13|||
147206017|NCT00611026|530923764|FG001|Double-blind Treatment Period|Other|20|||
147206018|NCT00611026|530923765|FG002|Double-blind Treatment Period|Other|18|||
147206019|NCT01147874|530923767|FG000|Overall Study|Adverse Event|5|||
147206020|NCT01147874|530923767|FG000|Overall Study|Investigator's Request|1|||
147206021|NCT01147874|530923767|FG000|Overall Study|Lost to Follow-up|25|||
147206022|NCT01147874|530923767|FG000|Overall Study|Other|5|||
147206023|NCT01147874|530923767|FG000|Overall Study|Protocol Violation|5|||
147206024|NCT01147874|530923767|FG000|Overall Study|Sponsor's Decision|2|||
147206025|NCT01147874|530923767|FG000|Overall Study|Withdrawal by Subject|24|||
147206026|NCT03892967|530923773|FG000|Step 1: 4/1/2019-9/30/2019|Participants did not answer at least two surveys and were not included in the analytic cohort|1283|||
147206027|NCT03892967|530923774|FG001|Step 1: 4/1/2019-9/30/2019|Participants did not answer at least two surveys and were not included in the analytic cohort|1728|||
147206028|NCT03892967|530923775|FG002|Step 1: 4/1/2019-9/30/2019|Participants did not answer at least two surveys and were not included in the analytic cohort|1823|||
147206029|NCT03892967|530923776|FG003|Step 1: 4/1/2019-9/30/2019|Participants did not answer at least two surveys and were not included in the analytic cohort|1443|||
147206030|NCT03892967|530923777|FG004|Step 1: 4/1/2019-9/30/2019|Participants did not answer at least two surveys and were not included in the analytic cohort|728|||
147206031|NCT03892967|530923773|FG000|Step 2: 10/1/2019-5/31/2020|Participants did not answer at least two surveys and were not included in the analytic cohort|474|||
147206032|NCT03892967|530923774|FG001|Step 2: 10/1/2019-5/31/2020|Participants did not answer at least two surveys and were not included in the analytic cohort|726|||
147206033|NCT03892967|530923775|FG002|Step 2: 10/1/2019-5/31/2020|Participants did not answer at least two surveys and were not included in the analytic cohort|774|||
147206034|NCT03892967|530923776|FG003|Step 2: 10/1/2019-5/31/2020|Participants did not answer at least two surveys and were not included in the analytic cohort|552|||
147206035|NCT03892967|530923777|FG004|Step 2: 10/1/2019-5/31/2020|Participants did not answer at least two surveys and were not included in the analytic cohort|366|||
147206036|NCT03892967|530923773|FG000|Step 3: 6/1/2020-1/31/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|710|||
147206037|NCT03892967|530923774|FG001|Step 3: 6/1/2020-1/31/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|993|||
147206038|NCT03892967|530923775|FG002|Step 3: 6/1/2020-1/31/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|910|||
147206039|NCT03892967|530923776|FG003|Step 3: 6/1/2020-1/31/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|739|||
147206040|NCT03892967|530923777|FG004|Step 3: 6/1/2020-1/31/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|280|||
147206041|NCT03892967|530923773|FG000|Step 4: 2/1/2021-9/30/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|585|||
147206042|NCT03892967|530923774|FG001|Step 4: 2/1/2021-9/30/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|893|||
147206043|NCT03892967|530923775|FG002|Step 4: 2/1/2021-9/30/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|962|||
147206044|NCT03892967|530923776|FG003|Step 4: 2/1/2021-9/30/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|830|||
147206045|NCT03892967|530923777|FG004|Step 4: 2/1/2021-9/30/2021|Participants did not answer at least two surveys and were not included in the analytic cohort|315|||
147206046|NCT03892967|530923773|FG000|Step 5: 10/1/2021-5/31/2022|Participants did not answer at least two surveys and were not included in the analytic cohort|508|||
147206047|NCT03892967|530923774|FG001|Step 5: 10/1/2021-5/31/2022|Participants did not answer at least two surveys and were not included in the analytic cohort|845|||
147206048|NCT03892967|530923775|FG002|Step 5: 10/1/2021-5/31/2022|Participants did not answer at least two surveys and were not included in the analytic cohort|1025|||
147206049|NCT03892967|530923776|FG003|Step 5: 10/1/2021-5/31/2022|Participants did not answer at least two surveys and were not included in the analytic cohort|751|||
147206050|NCT03892967|530923777|FG004|Step 5: 10/1/2021-5/31/2022|Participants did not answer at least two surveys and were not included in the analytic cohort|302|||
147306816|NCT01852058|531290773|FG000|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
147439437|NCT00800683|531774093|FG001|Overall Study|Lost to Follow-up|1|||
147439438|NCT00800683|531774092|FG000|Overall Study|Withdrawal by Subject|1|||
147439439|NCT00800683|531774093|FG001|Overall Study|Withdrawal by Subject|7|||
147439440|NCT00800683|531774092|FG000|Overall Study|Lack of Efficacy|1|||
147439441|NCT00800683|531774093|FG001|Overall Study|Lack of Efficacy|1|||
147439442|NCT00800683|531774092|FG000|Overall Study|Other|1|||
147439443|NCT00800683|531774093|FG001|Overall Study|Other|2|||
147439444|NCT00356889|531774094|FG000|Overall Study|Protocol Violation|2|||
147439445|NCT00356889|531774094|FG000|Overall Study|Adverse Event|1|||
147439446|NCT02678416|531774095|FG000|Part 1|Withdrawal by Subject|1|||
147439447|NCT02678416|531774095|FG000|Part 2|Adverse Event|2|||
147439448|NCT02678416|531774095|FG000|Part 2|Withdrawal by Subject|1|||
147439449|NCT01848353|531774096|FG000|Phase 1|Withdrawal by Subject|3|||
147439450|NCT01848353|531774097|FG001|Phase 1|Withdrawal by Subject|1|||
147439451|NCT01848353|531774098|FG002|Phase 1|Withdrawal by Subject|0|||
147439452|NCT01848353|531774099|FG003|Phase 1|Withdrawal by Subject|0|||
147439453|NCT01848353|531774096|FG000|Phase 2|Withdrawal by Subject|3|||
147439454|NCT01848353|531774097|FG001|Phase 2|Withdrawal by Subject|2|||
147439455|NCT01848353|531774098|FG002|Phase 2|Withdrawal by Subject|0|||
147439456|NCT01848353|531774099|FG003|Phase 2|Withdrawal by Subject|0|||
147439457|NCT01848353|531774096|FG000|Phase 3|Withdrawal by Subject|1|||
147439458|NCT01848353|531774097|FG001|Phase 3|Withdrawal by Subject|1|||
147439459|NCT01848353|531774098|FG002|Phase 3|Withdrawal by Subject|0|||
147439460|NCT01848353|531774099|FG003|Phase 3|Withdrawal by Subject|0|||
147439461|NCT00935272|531774100|FG000|Overall Study|Lost to Follow-up|10|||
147439462|NCT00935272|531774101|FG001|Overall Study|Lost to Follow-up|3|||
147439463|NCT00935272|531774100|FG000|Overall Study|Withdrawal by Subject|8|||
147439464|NCT00935272|531774101|FG001|Overall Study|Withdrawal by Subject|2|||
147439465|NCT00935272|531774100|FG000|Overall Study|Physician Decision|1|||
147439466|NCT00935272|531774101|FG001|Overall Study|Physician Decision|0|||
147439467|NCT00935272|531774100|FG000|Overall Study|Protocol Violation|0|||
147439468|NCT00935272|531774101|FG001|Overall Study|Protocol Violation|1|||
147439469|NCT03492554|531774111|FG000|Overall Study|Protocol Violation|0|||
147439470|NCT03492554|531774112|FG001|Overall Study|Protocol Violation|14|||
147439471|NCT00736034|531774115|FG000|Overall Study|Adverse Event|2|||
147439472|NCT01478360|531774116|FG000|Overall Study|Lost to Follow-up|1|||
147439473|NCT01478360|531774117|FG001|Overall Study|Lost to Follow-up|0|||
147439474|NCT01478360|531774116|FG000|Overall Study|Adverse Event|0|||
147439475|NCT01478360|531774117|FG001|Overall Study|Adverse Event|1|||
147439476|NCT01478360|531774116|FG000|Overall Study|Administrative problems|1|||
147439477|NCT01478360|531774117|FG001|Overall Study|Administrative problems|2|||
147439478|NCT05293743|531774125|FG000|Overall Study|Withdrawal by Subject|1|||
147439479|NCT05293743|531774126|FG001|Overall Study|Withdrawal by Subject|0|||
147439480|NCT02064920|531774127|FG000|Overall Study|Adverse Event|0|||
147439481|NCT02064920|531774128|FG001|Overall Study|Adverse Event|4|||
147439482|NCT02064920|531774127|FG000|Overall Study|Physician Decision|0|||
147439483|NCT02064920|531774128|FG001|Overall Study|Physician Decision|1|||
147439484|NCT02064920|531774127|FG000|Overall Study|Technical Problems|0|||
147439485|NCT02064920|531774128|FG001|Overall Study|Technical Problems|1|||
147439486|NCT02064920|531774127|FG000|Overall Study|Withdrawal by Subject|1|||
147439487|NCT02064920|531774128|FG001|Overall Study|Withdrawal by Subject|3|||
147439488|NCT03734016|531774137|FG000|Overall Study|Sponsor Ended Study|225|||
147439489|NCT03734016|531774138|FG001|Overall Study|Sponsor Ended Study|200|||
147439490|NCT03734016|531774137|FG000|Overall Study|Death|69|||
147439491|NCT03734016|531774138|FG001|Overall Study|Death|83|||
147439492|NCT03734016|531774137|FG000|Overall Study|Withdrawal by Subject|21|||
147439493|NCT03734016|531774138|FG001|Overall Study|Withdrawal by Subject|27|||
147439494|NCT03734016|531774137|FG000|Overall Study|Physician Decision|1|||
147439495|NCT03734016|531774138|FG001|Overall Study|Physician Decision|12|||
147439496|NCT03734016|531774137|FG000|Overall Study|Lost to Follow-up|6|||
147439497|NCT03734016|531774138|FG001|Overall Study|Lost to Follow-up|2|||
147439498|NCT03734016|531774137|FG000|Overall Study|Miscellaneous|5|||
147439499|NCT03734016|531774138|FG001|Overall Study|Miscellaneous|1|||
147439500|NCT01979835|531774139|FG000|Primary Outcome SA Measurment|failed insertion|18|||
147541143|NCT04644237|532135303|FG000|Overall Study|Randomized but not Treated|1|||
147439501|NCT01979835|531774139|FG000|Follow-up|Lost to Follow-up|32|||
147439502|NCT01428661|531774142|FG000|Double-Masked Phase|Protocol Violation|9|||
147439503|NCT01428661|531774143|FG001|Double-Masked Phase|Protocol Violation|4|||
147439504|NCT01428661|531774144|FG002|Double-Masked Phase|Protocol Violation|0|||
147439505|NCT01428661|531774142|FG000|Double-Masked Phase|Adverse Event|13|||
147439506|NCT01428661|531774143|FG001|Double-Masked Phase|Adverse Event|4|||
147439507|NCT01428661|531774144|FG002|Double-Masked Phase|Adverse Event|0|||
147439508|NCT01428661|531774142|FG000|Double-Masked Phase|Lost to Follow-up|14|||
147439509|NCT01428661|531774143|FG001|Double-Masked Phase|Lost to Follow-up|14|||
147439510|NCT01428661|531774144|FG002|Double-Masked Phase|Lost to Follow-up|0|||
147439511|NCT01428661|531774142|FG000|Double-Masked Phase|Withdrawal by Subject|18|||
147439512|NCT01428661|531774143|FG001|Double-Masked Phase|Withdrawal by Subject|20|||
147439513|NCT01428661|531774144|FG002|Double-Masked Phase|Withdrawal by Subject|0|||
147439514|NCT01428661|531774142|FG000|Double-Masked Phase|Lack of Efficacy|2|||
147439515|NCT01428661|531774143|FG001|Double-Masked Phase|Lack of Efficacy|1|||
147206051|NCT03892967|530923773|FG000|Step 6: 6/1/2022-1/31/2023|Participants did not answer at least two surveys and were not included in the analytic cohort|797|||
147206052|NCT03892967|530923774|FG001|Step 6: 6/1/2022-1/31/2023|Participants did not answer at least two surveys and were not included in the analytic cohort|1177|||
147206053|NCT03892967|530923775|FG002|Step 6: 6/1/2022-1/31/2023|Participants did not answer at least two surveys and were not included in the analytic cohort|1398|||
147206054|NCT03892967|530923776|FG003|Step 6: 6/1/2022-1/31/2023|Participants did not answer at least two surveys and were not included in the analytic cohort|1069|||
147206055|NCT03892967|530923777|FG004|Step 6: 6/1/2022-1/31/2023|Participants did not answer at least two surveys and were not included in the analytic cohort|486|||
147206056|NCT04434937|530923778|FG000|Overall Study|Death|4|||
147206057|NCT04434937|530923778|FG000|Overall Study|Withdrawal by Subject|1|||
147206058|NCT04434937|530923778|FG000|Overall Study|Transitioned to Rollover Study|19|||
147206059|NCT04434937|530923778|FG000|Overall Study|Progressive Disease|18|||
147206060|NCT03387085|530923783|FG000|Overall Study|Reason for Treatment Discontinuation|7|||
147206061|NCT04193189|530923784|FG000|Overall Study|Lost to Follow-up|9|||
147206062|NCT04193189|530923785|FG001|Overall Study|Lost to Follow-up|7|||
147206063|NCT04193189|530923786|FG002|Overall Study|Lost to Follow-up|9|||
147206064|NCT04193189|530923787|FG003|Overall Study|Lost to Follow-up|0|||
147206065|NCT04193189|530923784|FG000|Overall Study|Withdrawal by Subject|1|||
147206066|NCT04193189|530923785|FG001|Overall Study|Withdrawal by Subject|2|||
147206067|NCT04193189|530923786|FG002|Overall Study|Withdrawal by Subject|2|||
147206068|NCT04193189|530923787|FG003|Overall Study|Withdrawal by Subject|0|||
147206069|NCT04193189|530923784|FG000|Overall Study|Death|1|||
147206070|NCT04193189|530923785|FG001|Overall Study|Death|1|||
147206071|NCT04193189|530923786|FG002|Overall Study|Death|0|||
147206072|NCT04193189|530923787|FG003|Overall Study|Death|0|||
147206073|NCT04193189|530923784|FG000|Overall Study|Protocol Violation|0|||
147206074|NCT04193189|530923785|FG001|Overall Study|Protocol Violation|0|||
147206075|NCT04193189|530923786|FG002|Overall Study|Protocol Violation|0|||
147206076|NCT04193189|530923787|FG003|Overall Study|Protocol Violation|1|||
147206077|NCT01077050|530925551|FG000|Overall Study|Subjects signed ICF could not be located|1|||
147206078|NCT01077050|530925551|FG000|Overall Study|Screen failure|8|||
147206079|NCT01006291|530925557|FG000|Overall Study|Adverse Event|2|||
147206080|NCT01006291|530925558|FG001|Overall Study|Adverse Event|1|||
147206081|NCT01006291|530925559|FG002|Overall Study|Adverse Event|2|||
147206082|NCT01006291|530925557|FG000|Overall Study|Lack of Efficacy|2|||
147206083|NCT01006291|530925558|FG001|Overall Study|Lack of Efficacy|2|||
147206084|NCT01006291|530925559|FG002|Overall Study|Lack of Efficacy|1|||
147206085|NCT01006291|530925557|FG000|Overall Study|Protocol Violation|3|||
147206086|NCT01006291|530925558|FG001|Overall Study|Protocol Violation|3|||
147206087|NCT01006291|530925559|FG002|Overall Study|Protocol Violation|3|||
147206088|NCT01006291|530925557|FG000|Overall Study|Withdrawal criteria|5|||
147206089|NCT01006291|530925558|FG001|Overall Study|Withdrawal criteria|4|||
147206090|NCT01006291|530925559|FG002|Overall Study|Withdrawal criteria|4|||
147206091|NCT01006291|530925557|FG000|Overall Study|Other|14|||
147206092|NCT01006291|530925558|FG001|Overall Study|Other|14|||
147206093|NCT01006291|530925559|FG002|Overall Study|Other|17|||
147206094|NCT00684060|530925560|FG000|Overall Study|Lost to Follow-up|1|||
147206095|NCT00684060|530925561|FG001|Overall Study|Lost to Follow-up|0|||
147206096|NCT00684060|530925560|FG000|Overall Study|New stenosis identified|1|||
147206097|NCT00684060|530925561|FG001|Overall Study|New stenosis identified|0|||
147206098|NCT00684060|530925560|FG000|Overall Study|Unable to collect MRI|1|||
147206099|NCT00684060|530925561|FG001|Overall Study|Unable to collect MRI|2|||
147206100|NCT00684060|530925560|FG000|Overall Study|Death|0|||
147206101|NCT00684060|530925561|FG001|Overall Study|Death|1|||
147206102|NCT00702715|530925562|FG000|Overall Study|Lost to Follow-up|1|||
147206103|NCT00702715|530925563|FG001|Overall Study|Lost to Follow-up|0|||
147206104|NCT01865552|530925564|FG000|Period 1|Adverse Event|1|||
147206105|NCT01865552|530925565|FG001|Period 1|Adverse Event|0|||
147206106|NCT01865552|530925566|FG002|Period 1|Adverse Event|0|||
147206107|NCT01865552|530925567|FG003|Period 1|Adverse Event|1|||
147206108|NCT01865552|530925568|FG004|Period 1|Adverse Event|1|||
147206109|NCT01865552|530925569|FG005|Period 1|Adverse Event|1|||
147206110|NCT01865552|530925564|FG000|Period 1|Pathological lab|0|||
147206111|NCT01865552|530925565|FG001|Period 1|Pathological lab|0|||
147206112|NCT01865552|530925566|FG002|Period 1|Pathological lab|0|||
147206113|NCT01865552|530925567|FG003|Period 1|Pathological lab|0|||
147206114|NCT01865552|530925568|FG004|Period 1|Pathological lab|1|||
147206115|NCT01865552|530925569|FG005|Period 1|Pathological lab|0|||
147206116|NCT01865552|530925564|FG000|Period 1|Other|0|||
147206117|NCT01865552|530925565|FG001|Period 1|Other|0|||
147206118|NCT01865552|530925566|FG002|Period 1|Other|0|||
147206119|NCT01865552|530925567|FG003|Period 1|Other|0|||
147206120|NCT01865552|530925568|FG004|Period 1|Other|1|||
147439516|NCT01428661|531774144|FG002|Double-Masked Phase|Lack of Efficacy|0|||
147206121|NCT01865552|530925569|FG005|Period 1|Other|0|||
147206122|NCT03079102|530925570|FG000|Overall Study|Physician Decision|0|||
147206123|NCT03079102|530925571|FG001|Overall Study|Physician Decision|1|||
147206124|NCT02923921|530925572|FG000|Overall Study|Sponsor Decision|39|||
147206125|NCT02923921|530925573|FG001|Overall Study|Sponsor Decision|38|||
147206126|NCT02923921|530925572|FG000|Overall Study|Lost to Follow-up|1|||
147206127|NCT02923921|530925573|FG001|Overall Study|Lost to Follow-up|0|||
147541144|NCT04644237|532135304|FG001|Overall Study|Randomized but not Treated|0|||
147541145|NCT03131817|532135305|FG000|Overall Study|Participant developed cognitive decline and was unable to provide regular symptom assessments|1|||
147541146|NCT05838755|532135306|FG000|Overall Study|Adverse Event|1|||
147541147|NCT05838755|532135307|FG001|Overall Study|Adverse Event|0|||
147541148|NCT05838755|532135308|FG002|Overall Study|Adverse Event|0|||
147541149|NCT05838755|532135306|FG000|Overall Study|Lack of Efficacy|1|||
147541150|NCT05838755|532135307|FG001|Overall Study|Lack of Efficacy|0|||
147541151|NCT05838755|532135308|FG002|Overall Study|Lack of Efficacy|1|||
147541152|NCT05838755|532135306|FG000|Overall Study|Lost to Follow-up|0|||
147541153|NCT05838755|532135307|FG001|Overall Study|Lost to Follow-up|1|||
147541154|NCT05838755|532135308|FG002|Overall Study|Lost to Follow-up|4|||
147541155|NCT05838755|532135306|FG000|Overall Study|Withdrawal by Subject|0|||
147541156|NCT05838755|532135307|FG001|Overall Study|Withdrawal by Subject|2|||
147541157|NCT05838755|532135308|FG002|Overall Study|Withdrawal by Subject|0|||
147541158|NCT05838755|532135306|FG000|Overall Study|Study terminated by sponsor|26|||
147649434|NCT02634801|532537342|FG001|Extension Period (Weeks 24 to 36)|Withdrawal by Subject|1|||
147439517|NCT01428661|531774142|FG000|Double-Masked Phase|*Various|1|||
147439518|NCT01428661|531774143|FG001|Double-Masked Phase|*Various|6|||
147439519|NCT01428661|531774144|FG002|Double-Masked Phase|*Various|0|||
147439520|NCT01428661|531774142|FG000|Open Label Extension|Protocol Violation|0|||
147439521|NCT01428661|531774143|FG001|Open Label Extension|Protocol Violation|0|||
147439522|NCT01428661|531774144|FG002|Open Label Extension|Protocol Violation|9|||
147439523|NCT01428661|531774142|FG000|Open Label Extension|Adverse Event|0|||
147439524|NCT01428661|531774143|FG001|Open Label Extension|Adverse Event|0|||
147439525|NCT01428661|531774144|FG002|Open Label Extension|Adverse Event|15|||
147439526|NCT01428661|531774142|FG000|Open Label Extension|Lost to Follow-up|0|||
147439527|NCT01428661|531774143|FG001|Open Label Extension|Lost to Follow-up|0|||
147439528|NCT01428661|531774144|FG002|Open Label Extension|Lost to Follow-up|38|||
147439529|NCT01428661|531774142|FG000|Open Label Extension|Withdrawal by Subject|0|||
147439530|NCT01428661|531774143|FG001|Open Label Extension|Withdrawal by Subject|0|||
147439531|NCT01428661|531774144|FG002|Open Label Extension|Withdrawal by Subject|49|||
147439532|NCT01428661|531774142|FG000|Open Label Extension|Lack of Efficacy|0|||
147439533|NCT01428661|531774143|FG001|Open Label Extension|Lack of Efficacy|0|||
147439534|NCT01428661|531774144|FG002|Open Label Extension|Lack of Efficacy|24|||
147439535|NCT01428661|531774142|FG000|Open Label Extension|**Various|0|||
147439536|NCT01428661|531774143|FG001|Open Label Extension|**Various|0|||
147439537|NCT01428661|531774144|FG002|Open Label Extension|**Various|185|||
147439538|NCT00388505|531775744|FG000|Overall Study|Adverse Event or Death|43|||
147439539|NCT00388505|531775745|FG001|Overall Study|Adverse Event or Death|17|||
147439540|NCT00388505|531775744|FG000|Overall Study|Withdrawal by Subject|24|||
147439541|NCT00388505|531775745|FG001|Overall Study|Withdrawal by Subject|9|||
147439542|NCT00388505|531775744|FG000|Overall Study|Lost to Follow-up|5|||
147439543|NCT00388505|531775745|FG001|Overall Study|Lost to Follow-up|3|||
147439544|NCT00388505|531775744|FG000|Overall Study|Inappropriate Enrollment|0|||
147439545|NCT00388505|531775745|FG001|Overall Study|Inappropriate Enrollment|1|||
147439546|NCT00388505|531775744|FG000|Overall Study|Administrative Reason|1|||
147439547|NCT00388505|531775745|FG001|Overall Study|Administrative Reason|0|||
147439548|NCT00388505|531775744|FG000|Overall Study|Protocol Violation|6|||
147439549|NCT00388505|531775745|FG001|Overall Study|Protocol Violation|5|||
147439550|NCT00388505|531775744|FG000|Overall Study|Unable to classify|4|||
147439551|NCT00388505|531775745|FG001|Overall Study|Unable to classify|3|||
147439552|NCT03785925|531775749|FG000|Overall Study|Withdrawal by Subject|15|||
147439553|NCT03785925|531775749|FG000|Overall Study|Lost to Follow-up|1|||
147439554|NCT00957528|531775753|FG000|Overall Study|Protocol Violation|0|||
147439555|NCT00957528|531775754|FG001|Overall Study|Protocol Violation|1|||
147439556|NCT00957528|531775755|FG002|Overall Study|Protocol Violation|0|||
147439557|NCT00957528|531775753|FG000|Overall Study|Withdrawal by Subject|0|||
147439558|NCT00957528|531775754|FG001|Overall Study|Withdrawal by Subject|0|||
147439559|NCT00957528|531775755|FG002|Overall Study|Withdrawal by Subject|1|||
147439560|NCT00762892|531775756|FG000|Overall Study|Lost to Follow-up|2|||
147439561|NCT00762892|531775757|FG001|Overall Study|Lost to Follow-up|5|||
147439562|NCT00762892|531775756|FG000|Overall Study|Withdrawal by Subject|0|||
147439563|NCT00762892|531775757|FG001|Overall Study|Withdrawal by Subject|1|||
147439564|NCT00762892|531775756|FG000|Overall Study|Death|1|||
147439565|NCT00762892|531775757|FG001|Overall Study|Death|0|||
147439566|NCT00762892|531775756|FG000|Overall Study|Pregnancy|1|||
147439567|NCT00762892|531775757|FG001|Overall Study|Pregnancy|0|||
147439568|NCT00762892|531775756|FG000|Overall Study|Incarceration|1|||
147439569|NCT00762892|531775757|FG001|Overall Study|Incarceration|0|||
147439570|NCT01841749|531775762|FG000|Overall Study|Protocol Violation|1|||
147439571|NCT00677820|531775763|FG000|Overall Study|Lost to Follow-up|1|||
147541159|NCT05838755|532135307|FG001|Overall Study|Study terminated by sponsor|27|||
147541160|NCT05838755|532135308|FG002|Overall Study|Study terminated by sponsor|26|||
147541161|NCT05838755|532135306|FG000|Overall Study|Randomized, not treated|2|||
147541162|NCT05838755|532135307|FG001|Overall Study|Randomized, not treated|0|||
147541163|NCT05838755|532135308|FG002|Overall Study|Randomized, not treated|1|||
147541164|NCT05838755|532135306|FG000|Overall Study|Pregnancy|0|||
147541165|NCT05838755|532135307|FG001|Overall Study|Pregnancy|1|||
147541166|NCT05838755|532135308|FG002|Overall Study|Pregnancy|0|||
147541167|NCT04439110|532135309|FG000|Overall Study|Ineligible|2|||
147541168|NCT04439110|532135309|FG000|Overall Study|Adverse Event|4|||
147541169|NCT04439110|532135309|FG000|Overall Study|Death|2|||
147541170|NCT04439110|532135309|FG000|Overall Study|Disease proression|25|||
147541171|NCT04439110|532135309|FG000|Overall Study|Withdrawal by Subject|1|||
147541172|NCT04439110|532135309|FG000|Overall Study|Alternative therapy|1|||
147541173|NCT04439110|532135309|FG000|Overall Study|Other complicating disease|1|||
147541174|NCT04439110|532135309|FG000|Overall Study|Personal reasons|1|||
147541175|NCT04439110|532135309|FG000|Overall Study|Still on treatment|1|||
147541176|NCT04647253|532135316|FG000|Overall Study|Death ≤ 365 Days|16|||
147541177|NCT04647253|532135317|FG001|Overall Study|Death ≤ 365 Days|7|||
147541178|NCT04647253|532135316|FG000|Overall Study|Physician Decision|0|||
147541179|NCT04647253|532135317|FG001|Overall Study|Physician Decision|1|||
147541180|NCT04647253|532135316|FG000|Overall Study|Withdrawal by Subject|7|||
147541181|NCT04647253|532135317|FG001|Overall Study|Withdrawal by Subject|2|||
147541182|NCT04647253|532135316|FG000|Overall Study|Missed 12-Month Visit|9|||
147541183|NCT04647253|532135317|FG001|Overall Study|Missed 12-Month Visit|7|||
147541184|NCT04647253|532135316|FG000|Overall Study|Death > 365 days and ≤ 395 days with no 12-month clinical follow-up performed|1|||
147541185|NCT04647253|532135317|FG001|Overall Study|Death > 365 days and ≤ 395 days with no 12-month clinical follow-up performed|1|||
147541186|NCT02706353|532135318|FG000|Dose Level 1|Disease Progression|1|||
147541187|NCT02706353|532135319|FG001|Dose Level 1|Disease Progression|0|||
147541188|NCT02706353|532135320|FG002|Dose Level 1|Disease Progression|0|||
147541189|NCT02706353|532135321|FG003|Dose Level 1|Disease Progression|0|||
147541190|NCT02706353|532135322|FG004|Dose Level 1|Disease Progression|0|||
147541191|NCT02706353|532135323|FG005|Dose Level 1|Disease Progression|0|||
147541192|NCT02706353|532135318|FG000|Dose Level 3|Disease Progression|0|||
147541193|NCT02706353|532135319|FG001|Dose Level 3|Disease Progression|0|||
147541194|NCT02706353|532135320|FG002|Dose Level 3|Disease Progression|2|||
147541195|NCT02706353|532135321|FG003|Dose Level 3|Disease Progression|0|||
147541196|NCT02706353|532135322|FG004|Dose Level 3|Disease Progression|0|||
147541197|NCT02706353|532135323|FG005|Dose Level 3|Disease Progression|0|||
147541198|NCT02706353|532135318|FG000|Dose Level 4|Disease Progression|0|||
147541199|NCT02706353|532135319|FG001|Dose Level 4|Disease Progression|0|||
147541200|NCT02706353|532135320|FG002|Dose Level 4|Disease Progression|0|||
147541201|NCT02706353|532135321|FG003|Dose Level 4|Disease Progression|1|||
147541202|NCT02706353|532135322|FG004|Dose Level 4|Disease Progression|0|||
147541203|NCT02706353|532135323|FG005|Dose Level 4|Disease Progression|0|||
147541204|NCT02706353|532135318|FG000|Dose Level 4|Toxicity|0|||
147541205|NCT02706353|532135319|FG001|Dose Level 4|Toxicity|0|||
147541206|NCT02706353|532135320|FG002|Dose Level 4|Toxicity|0|||
147541207|NCT02706353|532135321|FG003|Dose Level 4|Toxicity|1|||
147541208|NCT02706353|532135322|FG004|Dose Level 4|Toxicity|0|||
147541209|NCT02706353|532135323|FG005|Dose Level 4|Toxicity|0|||
147541210|NCT02706353|532135318|FG000|Dose Level 4|Death|0|||
147541211|NCT02706353|532135319|FG001|Dose Level 4|Death|0|||
147541212|NCT02706353|532135320|FG002|Dose Level 4|Death|0|||
147541213|NCT02706353|532135321|FG003|Dose Level 4|Death|1|||
147541214|NCT02706353|532135322|FG004|Dose Level 4|Death|0|||
147649435|NCT02634801|532537343|FG002|Extension Period (Weeks 24 to 36)|Withdrawal by Subject|1|||
147541215|NCT02706353|532135323|FG005|Dose Level 4|Death|0|||
147541216|NCT02706353|532135318|FG000|Dose Level 5|Toxicity|0|||
147541217|NCT02706353|532135319|FG001|Dose Level 5|Toxicity|0|||
147541218|NCT02706353|532135320|FG002|Dose Level 5|Toxicity|0|||
147541219|NCT02706353|532135321|FG003|Dose Level 5|Toxicity|0|||
147541220|NCT02706353|532135322|FG004|Dose Level 5|Toxicity|1|||
147541221|NCT02706353|532135323|FG005|Dose Level 5|Toxicity|0|||
147541222|NCT02706353|532135318|FG000|Dose Level 5|Disease Progression|0|||
147541223|NCT02706353|532135319|FG001|Dose Level 5|Disease Progression|0|||
147541224|NCT02706353|532135320|FG002|Dose Level 5|Disease Progression|0|||
147541225|NCT02706353|532135321|FG003|Dose Level 5|Disease Progression|0|||
147541226|NCT02706353|532135322|FG004|Dose Level 5|Disease Progression|3|||
147541227|NCT02706353|532135323|FG005|Dose Level 5|Disease Progression|2|||
147541228|NCT02706353|532135318|FG000|Dose Level 5|Death|0|||
147541229|NCT02706353|532135319|FG001|Dose Level 5|Death|0|||
147541230|NCT02706353|532135320|FG002|Dose Level 5|Death|0|||
147541231|NCT02706353|532135321|FG003|Dose Level 5|Death|0|||
147541232|NCT02706353|532135322|FG004|Dose Level 5|Death|1|||
147206128|NCT02923921|530925572|FG000|Overall Study|Withdrawal by Subject|6|||
147206129|NCT02923921|530925573|FG001|Overall Study|Withdrawal by Subject|13|||
147206130|NCT02923921|530925572|FG000|Overall Study|Unknown, Not Collected|7|||
147206131|NCT02923921|530925573|FG001|Overall Study|Unknown, Not Collected|6|||
147206132|NCT00854113|530925574|FG000|Overall Study|Adverse Event|0|||
147206133|NCT00854113|530925575|FG001|Overall Study|Adverse Event|0|||
147206134|NCT00854113|530925576|FG002|Overall Study|Adverse Event|0|||
147206135|NCT00854113|530925577|FG003|Overall Study|Adverse Event|0|||
147206136|NCT00854113|530925578|FG004|Overall Study|Adverse Event|0|||
147206137|NCT00854113|530925579|FG005|Overall Study|Adverse Event|0|||
147541233|NCT02706353|532135323|FG005|Dose Level 5|Death|6|||
147541234|NCT02706353|532135318|FG000|Dose Level 5|Withdrawal by Subject|0|||
147541235|NCT02706353|532135319|FG001|Dose Level 5|Withdrawal by Subject|0|||
147541236|NCT02706353|532135320|FG002|Dose Level 5|Withdrawal by Subject|0|||
147541237|NCT02706353|532135321|FG003|Dose Level 5|Withdrawal by Subject|0|||
147541238|NCT02706353|532135322|FG004|Dose Level 5|Withdrawal by Subject|0|||
147541239|NCT02706353|532135323|FG005|Dose Level 5|Withdrawal by Subject|2|||
147541240|NCT03560466|532135324|FG000|Overall Study|Adverse Event|1|||
147541241|NCT03560466|532135325|FG001|Overall Study|Adverse Event|2|||
147541242|NCT03560466|532135326|FG002|Overall Study|Adverse Event|0|||
147541243|NCT03560466|532135324|FG000|Overall Study|Poor Compliance to Protocol|0|||
147541244|NCT03560466|532135325|FG001|Overall Study|Poor Compliance to Protocol|2|||
147541245|NCT03560466|532135326|FG002|Overall Study|Poor Compliance to Protocol|0|||
147541246|NCT03560466|532135324|FG000|Overall Study|Other|6|||
147541247|NCT03560466|532135325|FG001|Overall Study|Other|8|||
147541248|NCT03560466|532135326|FG002|Overall Study|Other|1|||
147541249|NCT05257109|532135327|FG000|Overall Study|Withdrawal by Subject|1|||
147541250|NCT05257109|532135328|FG001|Overall Study|Withdrawal by Subject|0|||
147541251|NCT05257109|532135329|FG002|Overall Study|Withdrawal by Subject|0|||
147541252|NCT05257109|532135330|FG003|Overall Study|Withdrawal by Subject|0|||
147541253|NCT02038959|532136343|FG000|Overall Study|Withdrawal by Subject|6|||
147541254|NCT02038959|532136344|FG001|Overall Study|Withdrawal by Subject|8|||
147541255|NCT00819091|532136350|FG000|Overall Study|Adverse Event|3|||
147541256|NCT00819091|532136351|FG001|Overall Study|Adverse Event|5|||
147541257|NCT00819091|532136350|FG000|Overall Study|Protocol Violation|0|||
147541258|NCT00819091|532136351|FG001|Overall Study|Protocol Violation|1|||
147541259|NCT00819091|532136350|FG000|Overall Study|Lost to Follow-up|2|||
147541260|NCT00819091|532136351|FG001|Overall Study|Lost to Follow-up|0|||
147541261|NCT00819091|532136350|FG000|Overall Study|Withdrawal by Subject|1|||
147541262|NCT00819091|532136351|FG001|Overall Study|Withdrawal by Subject|2|||
147541263|NCT00819091|532136350|FG000|Overall Study|Other|1|||
147541264|NCT00819091|532136351|FG001|Overall Study|Other|2|||
147541265|NCT03911960|532136353|FG000|Overall Study|Lost to Follow-up|5|||
147541266|NCT03911960|532136354|FG001|Overall Study|Lost to Follow-up|3|||
147541267|NCT04318535|532136355|FG000|Period2washout(Atleast 7 Days Post-dose)|Lost to Follow-up|0|||
147541268|NCT04318535|532136356|FG001|Period2washout(Atleast 7 Days Post-dose)|Lost to Follow-up|1|||
147541269|NCT04318535|532136357|FG002|Period2washout(Atleast 7 Days Post-dose)|Lost to Follow-up|0|||
147541270|NCT02675426|532136360|FG000|Period 1: Week 1 to Week 12|Adverse Event|3|||
147541271|NCT02675426|532136361|FG001|Period 1: Week 1 to Week 12|Adverse Event|3|||
147541272|NCT02675426|532136362|FG002|Period 1: Week 1 to Week 12|Adverse Event|3|||
147541273|NCT02675426|532136363|FG003|Period 1: Week 1 to Week 12|Adverse Event|9|||
147541274|NCT02675426|532136360|FG000|Period 1: Week 1 to Week 12|Withdrawal by Subject|1|||
147541275|NCT02675426|532136361|FG001|Period 1: Week 1 to Week 12|Withdrawal by Subject|2|||
147541276|NCT02675426|532136362|FG002|Period 1: Week 1 to Week 12|Withdrawal by Subject|5|||
147541277|NCT02675426|532136363|FG003|Period 1: Week 1 to Week 12|Withdrawal by Subject|5|||
147206138|NCT00854113|530925580|FG006|Overall Study|Adverse Event|0|||
147206139|NCT00854113|530925581|FG007|Overall Study|Adverse Event|2|||
147541278|NCT02675426|532136360|FG000|Period 1: Week 1 to Week 12|Lost to Follow-up|0|||
147541279|NCT02675426|532136361|FG001|Period 1: Week 1 to Week 12|Lost to Follow-up|1|||
147541280|NCT02675426|532136362|FG002|Period 1: Week 1 to Week 12|Lost to Follow-up|0|||
147541281|NCT02675426|532136363|FG003|Period 1: Week 1 to Week 12|Lost to Follow-up|2|||
147541282|NCT02675426|532136360|FG000|Period 1: Week 1 to Week 12|Other|2|||
147541283|NCT02675426|532136361|FG001|Period 1: Week 1 to Week 12|Other|1|||
147206140|NCT00854113|530925582|FG008|Overall Study|Adverse Event|0|||
147206141|NCT00854113|530925583|FG009|Overall Study|Adverse Event|0|||
147206142|NCT00854113|530925584|FG010|Overall Study|Adverse Event|0|||
147206143|NCT00854113|530925574|FG000|Overall Study|Withdrawal by Subject|0|||
147541284|NCT02675426|532136362|FG002|Period 1: Week 1 to Week 12|Other|0|||
147206144|NCT00854113|530925575|FG001|Overall Study|Withdrawal by Subject|0|||
147206145|NCT00854113|530925576|FG002|Overall Study|Withdrawal by Subject|0|||
147206146|NCT00854113|530925577|FG003|Overall Study|Withdrawal by Subject|0|||
147206147|NCT00854113|530925578|FG004|Overall Study|Withdrawal by Subject|0|||
147206148|NCT00854113|530925579|FG005|Overall Study|Withdrawal by Subject|0|||
147206149|NCT00854113|530925580|FG006|Overall Study|Withdrawal by Subject|0|||
147541285|NCT02675426|532136363|FG003|Period 1: Week 1 to Week 12|Other|2|||
147541286|NCT02675426|532136360|FG000|Period 2: Week 12 to Week 260|Adverse Event|13|||
147541287|NCT02675426|532136361|FG001|Period 2: Week 12 to Week 260|Adverse Event|16|||
147541288|NCT02675426|532136362|FG002|Period 2: Week 12 to Week 260|Adverse Event|17|||
147206150|NCT00854113|530925581|FG007|Overall Study|Withdrawal by Subject|1|||
147206151|NCT00854113|530925582|FG008|Overall Study|Withdrawal by Subject|1|||
147206152|NCT00854113|530925583|FG009|Overall Study|Withdrawal by Subject|0|||
147206153|NCT00854113|530925584|FG010|Overall Study|Withdrawal by Subject|0|||
147206154|NCT01250145|530925587|FG000|Overall Study|Adverse Event|2|||
147206155|NCT01250145|530925588|FG001|Overall Study|Adverse Event|1|||
147206156|NCT01250145|530925587|FG000|Overall Study|Withdrawal by Subject|0|||
147206157|NCT01250145|530925588|FG001|Overall Study|Withdrawal by Subject|4|||
147206158|NCT02687191|530925589|FG000|Overall Study|Death|0|||
147206159|NCT02687191|530925590|FG001|Overall Study|Death|1|||
147206160|NCT02687191|530925591|FG002|Overall Study|Death|1|||
147206161|NCT02687191|530925592|FG003|Overall Study|Death|0|||
147206162|NCT02687191|530925593|FG004|Overall Study|Death|1|||
147206163|NCT02687191|530925594|FG005|Overall Study|Death|1|||
147206164|NCT02687191|530925589|FG000|Overall Study|Withdrawal by Subject|0|||
147206165|NCT02687191|530925590|FG001|Overall Study|Withdrawal by Subject|0|||
147206166|NCT02687191|530925591|FG002|Overall Study|Withdrawal by Subject|0|||
147206167|NCT02687191|530925592|FG003|Overall Study|Withdrawal by Subject|1|||
147206168|NCT02687191|530925593|FG004|Overall Study|Withdrawal by Subject|0|||
147206169|NCT02687191|530925594|FG005|Overall Study|Withdrawal by Subject|0|||
147206170|NCT03180840|530925595|FG000|Overall Study|Withdrawal by Subject|1|||
147206171|NCT02563067|530925603|FG000|Overall Study|Subject/guardian decision|14|||
147206172|NCT02563067|530925604|FG001|Overall Study|Subject/guardian decision|20|||
147206173|NCT02563067|530925605|FG002|Overall Study|Subject/guardian decision|16|||
147206174|NCT02563067|530925603|FG000|Overall Study|Physician Decision|0|||
147206175|NCT02563067|530925604|FG001|Overall Study|Physician Decision|1|||
147206176|NCT02563067|530925605|FG002|Overall Study|Physician Decision|3|||
147206177|NCT02563067|530925603|FG000|Overall Study|Lost to Follow-up|1|||
147439572|NCT00677820|531775764|FG001|Overall Study|Lost to Follow-up|0|||
147439573|NCT01211535|531775765|FG000|Overall Study|Adverse Event|0|||
147439574|NCT01211535|531775766|FG001|Overall Study|Adverse Event|1|||
147439575|NCT00549939|531775767|FG000|12-week Double Blind Treatment Period|Adverse Event|1|||
147439576|NCT00549939|531775768|FG001|12-week Double Blind Treatment Period|Adverse Event|1|||
147439577|NCT00549939|531775769|FG002|12-week Double Blind Treatment Period|Adverse Event|2|||
147439578|NCT00549939|531775767|FG000|12-week Double Blind Treatment Period|Too many blood draws|0|||
147439579|NCT00549939|531775768|FG001|12-week Double Blind Treatment Period|Too many blood draws|1|||
147439580|NCT00549939|531775769|FG002|12-week Double Blind Treatment Period|Too many blood draws|0|||
147439581|NCT00549939|531775767|FG000|40-week Open Label Treatment Period|Adverse Event|0|||
147439582|NCT00549939|531775768|FG001|40-week Open Label Treatment Period|Adverse Event|2|||
147439583|NCT00549939|531775769|FG002|40-week Open Label Treatment Period|Adverse Event|1|||
147439584|NCT00549939|531775767|FG000|40-week Open Label Treatment Period|Lack of Efficacy|0|||
147439585|NCT00549939|531775768|FG001|40-week Open Label Treatment Period|Lack of Efficacy|1|||
147439586|NCT00549939|531775769|FG002|40-week Open Label Treatment Period|Lack of Efficacy|0|||
147439587|NCT00549939|531775767|FG000|40-week Open Label Treatment Period|Protocol Violation|0|||
147439588|NCT00549939|531775768|FG001|40-week Open Label Treatment Period|Protocol Violation|1|||
147439589|NCT00549939|531775769|FG002|40-week Open Label Treatment Period|Protocol Violation|0|||
147439590|NCT00549939|531775767|FG000|40-week Open Label Treatment Period|Other|0|||
147439591|NCT00549939|531775768|FG001|40-week Open Label Treatment Period|Other|1|||
147439592|NCT00549939|531775769|FG002|40-week Open Label Treatment Period|Other|4|||
147439593|NCT03593850|531775770|FG000|3-6 Hours Post Intervention Outcomes|Did not returned or filled wrongly the outcome questionnaire|2|||
147439594|NCT03593850|531775771|FG001|3-6 Hours Post Intervention Outcomes|Did not returned or filled wrongly the outcome questionnaire|3|||
147439595|NCT00003895|531775772|FG000|Overall Study|Adverse Event|4|||
147439596|NCT00003895|531775773|FG001|Overall Study|Adverse Event|0|||
147439597|NCT00003895|531775772|FG000|Overall Study|Lack of Efficacy|1|||
147439598|NCT00003895|531775773|FG001|Overall Study|Lack of Efficacy|1|||
147439599|NCT00003895|531775772|FG000|Overall Study|Patient Vacation|2|||
147439600|NCT00003895|531775773|FG001|Overall Study|Patient Vacation|0|||
147439601|NCT00003895|531775772|FG000|Overall Study|Withdrawal by Subject|0|||
147439602|NCT00003895|531775773|FG001|Overall Study|Withdrawal by Subject|3|||
147439603|NCT01735279|531775774|FG000|Overall Study|Lost to Follow-up|11|||
147439604|NCT01735279|531775775|FG001|Overall Study|Lost to Follow-up|8|||
147439605|NCT02490475|531775776|FG000|Period 1: First 6 Cycles|Adverse Event|2|||
147439606|NCT02490475|531775777|FG001|Period 1: First 6 Cycles|Adverse Event|1|||
147439607|NCT02490475|531775778|FG002|Period 1: First 6 Cycles|Adverse Event|0|||
147206178|NCT02563067|530925604|FG001|Overall Study|Lost to Follow-up|2|||
147206179|NCT02563067|530925605|FG002|Overall Study|Lost to Follow-up|0|||
147439608|NCT02490475|531775779|FG003|Period 1: First 6 Cycles|Adverse Event|1|||
147206180|NCT02563067|530925603|FG000|Overall Study|Technical problems|0|||
147206181|NCT02563067|530925604|FG001|Overall Study|Technical problems|1|||
147439609|NCT02490475|531775776|FG000|Period 1: First 6 Cycles|Insufficient Therapeutic Response|2|||
147206182|NCT02563067|530925605|FG002|Overall Study|Technical problems|0|||
147206183|NCT02563067|530925603|FG000|Overall Study|Lack of Efficacy|1|||
147206184|NCT02563067|530925604|FG001|Overall Study|Lack of Efficacy|0|||
147206185|NCT02563067|530925605|FG002|Overall Study|Lack of Efficacy|0|||
147541289|NCT02675426|532136363|FG003|Period 2: Week 12 to Week 260|Adverse Event|30|||
147541290|NCT02675426|532136360|FG000|Period 2: Week 12 to Week 260|Withdrawal by Subject|14|||
147541291|NCT02675426|532136361|FG001|Period 2: Week 12 to Week 260|Withdrawal by Subject|21|||
147541292|NCT02675426|532136362|FG002|Period 2: Week 12 to Week 260|Withdrawal by Subject|31|||
147541293|NCT02675426|532136363|FG003|Period 2: Week 12 to Week 260|Withdrawal by Subject|30|||
147541294|NCT02675426|532136360|FG000|Period 2: Week 12 to Week 260|Lost to Follow-up|5|||
147541295|NCT02675426|532136361|FG001|Period 2: Week 12 to Week 260|Lost to Follow-up|5|||
147541296|NCT02675426|532136362|FG002|Period 2: Week 12 to Week 260|Lost to Follow-up|10|||
147541297|NCT02675426|532136363|FG003|Period 2: Week 12 to Week 260|Lost to Follow-up|4|||
147541298|NCT02675426|532136360|FG000|Period 2: Week 12 to Week 260|Coronavirus Disease - 2019 (COVID-19) Infection|1|||
147541299|NCT02675426|532136361|FG001|Period 2: Week 12 to Week 260|Coronavirus Disease - 2019 (COVID-19) Infection|0|||
147541300|NCT02675426|532136362|FG002|Period 2: Week 12 to Week 260|Coronavirus Disease - 2019 (COVID-19) Infection|0|||
147541301|NCT02675426|532136363|FG003|Period 2: Week 12 to Week 260|Coronavirus Disease - 2019 (COVID-19) Infection|1|||
147541302|NCT02675426|532136360|FG000|Period 2: Week 12 to Week 260|COVID-19 Logistic Restrictions|1|||
147541303|NCT02675426|532136361|FG001|Period 2: Week 12 to Week 260|COVID-19 Logistic Restrictions|0|||
147541304|NCT02675426|532136362|FG002|Period 2: Week 12 to Week 260|COVID-19 Logistic Restrictions|1|||
147541305|NCT02675426|532136363|FG003|Period 2: Week 12 to Week 260|COVID-19 Logistic Restrictions|0|||
147541306|NCT02675426|532136360|FG000|Period 2: Week 12 to Week 260|Other|8|||
147541307|NCT02675426|532136361|FG001|Period 2: Week 12 to Week 260|Other|12|||
147541308|NCT02675426|532136362|FG002|Period 2: Week 12 to Week 260|Other|23|||
147541309|NCT02675426|532136363|FG003|Period 2: Week 12 to Week 260|Other|15|||
147541310|NCT02156466|532136366|FG000|Overall Study|Adverse Event|0|||
147541311|NCT02156466|532136367|FG001|Overall Study|Adverse Event|0|||
147541312|NCT02156466|532136368|FG002|Overall Study|Adverse Event|1|||
147541313|NCT02156466|532136369|FG003|Overall Study|Adverse Event|1|||
147541314|NCT02156466|532136370|FG004|Overall Study|Adverse Event|0|||
147541315|NCT02156466|532136366|FG000|Overall Study|Quantiferon Positivity|0|||
147541316|NCT02156466|532136367|FG001|Overall Study|Quantiferon Positivity|0|||
147541317|NCT02156466|532136368|FG002|Overall Study|Quantiferon Positivity|0|||
147541318|NCT02156466|532136369|FG003|Overall Study|Quantiferon Positivity|1|||
147541319|NCT02156466|532136370|FG004|Overall Study|Quantiferon Positivity|0|||
147541320|NCT02237118|532136371|FG000|Overall Study|Protocol Violation|0|||
147541321|NCT02237118|532136372|FG001|Overall Study|Protocol Violation|1|||
147541322|NCT02237118|532136371|FG000|Overall Study|consent withdrawn|1|||
147541323|NCT02237118|532136372|FG001|Overall Study|consent withdrawn|0|||
147541324|NCT00080288|532136373|FG000|Overall Study|Adverse Event|7|||
147541325|NCT00080288|532136374|FG001|Overall Study|Adverse Event|4|||
147541326|NCT00080288|532136373|FG000|Overall Study|Lost to Follow-up|3|||
147541327|NCT00080288|532136374|FG001|Overall Study|Lost to Follow-up|5|||
147541328|NCT00080288|532136373|FG000|Overall Study|Physician Decision|6|||
147541329|NCT00080288|532136374|FG001|Overall Study|Physician Decision|2|||
147541330|NCT00080288|532136373|FG000|Overall Study|Withdrawal by Subject|3|||
147541331|NCT00080288|532136374|FG001|Overall Study|Withdrawal by Subject|16|||
147541332|NCT00080288|532136373|FG000|Overall Study|Miscellaneous|11|||
147541333|NCT00080288|532136374|FG001|Overall Study|Miscellaneous|11|||
147541334|NCT02253654|532136375|FG000|Overall Study|Withdrawal by Subject|12|||
147541335|NCT02253654|532136376|FG001|Overall Study|Withdrawal by Subject|4|||
147541336|NCT02253654|532136375|FG000|Overall Study|Decision by Sponsor|1|||
147541337|NCT02253654|532136376|FG001|Overall Study|Decision by Sponsor|1|||
147541338|NCT02253654|532136375|FG000|Overall Study|Lost to Follow-up|2|||
147541339|NCT02253654|532136376|FG001|Overall Study|Lost to Follow-up|5|||
147541340|NCT02253654|532136375|FG000|Overall Study|Death|4|||
147541341|NCT02253654|532136376|FG001|Overall Study|Death|7|||
147541342|NCT02253654|532136375|FG000|Overall Study|Did Not Receive Study Treatment|4|||
147541343|NCT02253654|532136376|FG001|Overall Study|Did Not Receive Study Treatment|1|||
147541344|NCT03044431|532136379|FG000|Overall Study|Lost to Follow-up|59|||
147541345|NCT03456726|532136380|FG000|Overall Study|Disease Progression|6|||
147541346|NCT03456726|532136381|FG001|Overall Study|Disease Progression|1|||
147541347|NCT03456726|532136380|FG000|Overall Study|Adverse Event|4|||
147541348|NCT03456726|532136381|FG001|Overall Study|Adverse Event|2|||
147541349|NCT03456726|532136380|FG000|Overall Study|Withdrawal by Subject|1|||
147206186|NCT02563067|530925603|FG000|Overall Study|Death|0|||
147206187|NCT02563067|530925604|FG001|Overall Study|Death|1|||
147541350|NCT03456726|532136381|FG001|Overall Study|Withdrawal by Subject|0|||
147541351|NCT03456726|532136380|FG000|Overall Study|Discontinued from study due to switch to commercial tazemetostat|6|||
147541352|NCT03456726|532136381|FG001|Overall Study|Discontinued from study due to switch to commercial tazemetostat|0|||
147541353|NCT04470622|532136382|FG000|Overall Study|Withdrawal by Subject|0|||
147541354|NCT04470622|532136383|FG001|Overall Study|Withdrawal by Subject|1|||
147541355|NCT04470622|532136382|FG000|Overall Study|Screen Failure|0|||
147541356|NCT04470622|532136383|FG001|Overall Study|Screen Failure|1|||
147541357|NCT04470622|532136382|FG000|Overall Study|Death|0|||
147541358|NCT04470622|532136383|FG001|Overall Study|Death|1|||
147541359|NCT00399490|532136384|FG000|Overall Study|Adverse Event|19|||
147541360|NCT00399490|532136384|FG000|Overall Study|Lack of Efficacy|31|||
147206188|NCT02563067|530925605|FG002|Overall Study|Death|1|||
147541361|NCT00399490|532136384|FG000|Overall Study|Lost to Follow-up|5|||
147206189|NCT02563067|530925603|FG000|Overall Study|Adverse Event|2|||
147541362|NCT00399490|532136384|FG000|Overall Study|Withdrawal by Subject|18|||
147541363|NCT00399490|532136384|FG000|Overall Study|Other|25|||
147541364|NCT02328547|532136385|FG000|First Intervention (12 Weeks)|Lost to Follow-up|1|||
147541365|NCT02328547|532136386|FG001|First Intervention (12 Weeks)|Lost to Follow-up|0|||
147541366|NCT02328547|532136385|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|2|||
147206190|NCT02563067|530925604|FG001|Overall Study|Adverse Event|1|||
147206191|NCT02563067|530925605|FG002|Overall Study|Adverse Event|0|||
147206192|NCT02563067|530925603|FG000|Overall Study|Death post Treatment/safety period|1|||
147541367|NCT02328547|532136386|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|0|||
147541368|NCT02576054|532136387|FG000|Overall Study|Withdrawal by Subject|1|||
147541369|NCT01586624|532136392|FG000|Overall Study|Adverse Event|3|||
147541370|NCT01586624|532136393|FG001|Overall Study|Adverse Event|0|||
147206193|NCT02563067|530925604|FG001|Overall Study|Death post Treatment/safety period|0|||
147206194|NCT02563067|530925605|FG002|Overall Study|Death post Treatment/safety period|0|||
147206195|NCT01039519|530925610|FG000|Treatment|Progressive disease|20|||
147206196|NCT01039519|530925610|FG000|Treatment|Treatment failure|2|||
147206197|NCT01039519|530925610|FG000|Treatment|Adverse Event|3|||
147206198|NCT01039519|530925610|FG000|Treatment|Physician Decision|2|||
147206199|NCT01039519|530925610|FG000|Survival Follow-up|Death|23|||
147206200|NCT01039519|530925610|FG000|Survival Follow-up|Sponsor decision|4|||
147206201|NCT00808080|530925614|FG000|Overall Study|Patients Became Ineligible for infusion|6|||
147206202|NCT00423917|530925615|FG000|Overall Study|Cancel|2|||
147206203|NCT00423917|530925615|FG000|Overall Study|Ineligible|1|||
147206204|NCT00243269|530925616|FG000|Overall Study|Protocol Violation|2|||
147206205|NCT00243269|530925617|FG001|Overall Study|Protocol Violation|1|||
147206206|NCT00243269|530925618|FG002|Overall Study|Protocol Violation|0|||
147206207|NCT00243269|530925619|FG003|Overall Study|Protocol Violation|1|||
147206208|NCT00243269|530925616|FG000|Overall Study|Lost to Follow-up|1|||
147206209|NCT00243269|530925617|FG001|Overall Study|Lost to Follow-up|0|||
147206210|NCT00243269|530925618|FG002|Overall Study|Lost to Follow-up|1|||
147206211|NCT00243269|530925619|FG003|Overall Study|Lost to Follow-up|3|||
147206212|NCT03052400|530925620|FG000|Overall Study|Lost to Follow-up|1|||
147206213|NCT03052400|530925621|FG001|Overall Study|Lost to Follow-up|0|||
147206214|NCT03052400|530925620|FG000|Overall Study|Withdrawal by Subject|0|||
147206215|NCT03052400|530925621|FG001|Overall Study|Withdrawal by Subject|1|||
147206216|NCT00555061|530925622|FG000|Overall Study|Adverse Event|3|||
147206217|NCT00555061|530925622|FG000|Overall Study|Protocol Violation|1|||
147206218|NCT00555061|530925622|FG000|Overall Study|Lost to Follow-up|2|||
147206219|NCT00555061|530925622|FG000|Overall Study|Withdrawal by Subject|2|||
147206220|NCT00555061|530925622|FG000|Overall Study|Participant enrolled, but never treated|1|||
147206221|NCT00337675|530925623|FG000|Overall Study|Adverse Event|10|||
147206222|NCT00337675|530925624|FG001|Overall Study|Adverse Event|9|||
147206223|NCT00337675|530925625|FG002|Overall Study|Adverse Event|19|||
147206224|NCT00337675|530925623|FG000|Overall Study|Lack of Efficacy|10|||
147206225|NCT00337675|530925624|FG001|Overall Study|Lack of Efficacy|7|||
147206226|NCT00337675|530925625|FG002|Overall Study|Lack of Efficacy|9|||
147206227|NCT00337675|530925623|FG000|Overall Study|Lost to Follow-up|22|||
147206228|NCT00337675|530925624|FG001|Overall Study|Lost to Follow-up|19|||
147541371|NCT01586624|532136394|FG002|Overall Study|Adverse Event|2|||
147541372|NCT01586624|532136395|FG003|Overall Study|Adverse Event|1|||
147541373|NCT01586624|532136396|FG004|Overall Study|Adverse Event|3|||
147206229|NCT00337675|530925625|FG002|Overall Study|Lost to Follow-up|17|||
147206230|NCT00337675|530925623|FG000|Overall Study|Physician Decision|9|||
147206231|NCT00337675|530925624|FG001|Overall Study|Physician Decision|17|||
147206232|NCT00337675|530925625|FG002|Overall Study|Physician Decision|14|||
147206233|NCT00337675|530925623|FG000|Overall Study|Protocol Violation|21|||
147206234|NCT00337675|530925624|FG001|Overall Study|Protocol Violation|24|||
147206235|NCT00337675|530925625|FG002|Overall Study|Protocol Violation|19|||
147206236|NCT00337675|530925623|FG000|Overall Study|Withdrawal by Subject|25|||
147206237|NCT00337675|530925624|FG001|Overall Study|Withdrawal by Subject|25|||
147206238|NCT00337675|530925625|FG002|Overall Study|Withdrawal by Subject|19|||
147206239|NCT00337675|530925623|FG000|Overall Study|Progressive Disease|0|||
147206240|NCT00337675|530925624|FG001|Overall Study|Progressive Disease|2|||
147206241|NCT00337675|530925625|FG002|Overall Study|Progressive Disease|0|||
147206242|NCT00337675|530925623|FG000|Overall Study|Trial Terminated|0|||
147206243|NCT00337675|530925624|FG001|Overall Study|Trial Terminated|0|||
147206244|NCT00337675|530925625|FG002|Overall Study|Trial Terminated|2|||
147206245|NCT00441064|530925628|FG000|Overall Study|Adverse Event|1|||
147206246|NCT00441064|530925629|FG001|Overall Study|Adverse Event|0|||
147206247|NCT00441064|530925628|FG000|Overall Study|Abnormal laboratory values|0|||
147206248|NCT00441064|530925629|FG001|Overall Study|Abnormal laboratory values|2|||
147206249|NCT00441064|530925628|FG000|Overall Study|Abnormal test procedure results|0|||
147541374|NCT01586624|532136397|FG005|Overall Study|Adverse Event|3|||
147541375|NCT01586624|532136398|FG006|Overall Study|Adverse Event|2|||
147541376|NCT01586624|532136399|FG007|Overall Study|Adverse Event|3|||
147541377|NCT01586624|532136392|FG000|Overall Study|Physician Decision|0|||
147206250|NCT00441064|530925629|FG001|Overall Study|Abnormal test procedure results|1|||
147206251|NCT00441064|530925628|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
147206252|NCT00441064|530925629|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
147206253|NCT00441064|530925628|FG000|Overall Study|Protocol Deviation|3|||
147206254|NCT00441064|530925629|FG001|Overall Study|Protocol Deviation|2|||
147206255|NCT00441064|530925628|FG000|Overall Study|Patient withdrew consent|5|||
147206256|NCT00441064|530925629|FG001|Overall Study|Patient withdrew consent|2|||
147206257|NCT03962504|530925630|FG000|Overall Study|Other|11|||
147206258|NCT03962504|530925631|FG001|Overall Study|Other|32|||
147206259|NCT00067002|530925641|FG000|Overall Study|Early Death|1|||
147206260|NCT00067002|530925642|FG001|Overall Study|Early Death|2|||
147206261|NCT00067002|530925641|FG000|Overall Study|Delayed|1|||
147206262|NCT00067002|530925642|FG001|Overall Study|Delayed|1|||
147206263|NCT00067002|530925641|FG000|Overall Study|Graft Failure|5|||
147206264|NCT00067002|530925642|FG001|Overall Study|Graft Failure|6|||
147206265|NCT01354314|530925643|FG000|Overall Study|Lost to Follow-up|1|||
147206266|NCT01354314|530925644|FG001|Overall Study|Lost to Follow-up|0|||
147206267|NCT01354314|530925645|FG002|Overall Study|Lost to Follow-up|1|||
147206268|NCT01354314|530925646|FG003|Overall Study|Lost to Follow-up|1|||
147206269|NCT01354314|530925643|FG000|Overall Study|Withdrawal by Subject|0|||
147206270|NCT01354314|530925644|FG001|Overall Study|Withdrawal by Subject|0|||
147206271|NCT01354314|530925645|FG002|Overall Study|Withdrawal by Subject|1|||
147206272|NCT01354314|530925646|FG003|Overall Study|Withdrawal by Subject|0|||
147206273|NCT01354314|530925643|FG000|Overall Study|Adverse Event|0|||
147206274|NCT01354314|530925644|FG001|Overall Study|Adverse Event|0|||
147206275|NCT01354314|530925645|FG002|Overall Study|Adverse Event|0|||
147206276|NCT01354314|530925646|FG003|Overall Study|Adverse Event|1|||
147206277|NCT01354314|530925643|FG000|Overall Study|Protocol Violation|1|||
147206278|NCT01354314|530925644|FG001|Overall Study|Protocol Violation|1|||
147206279|NCT01354314|530925645|FG002|Overall Study|Protocol Violation|0|||
147206280|NCT01354314|530925646|FG003|Overall Study|Protocol Violation|0|||
147206281|NCT01354314|530925643|FG000|Overall Study|Less than 90% Adherence|4|||
147206282|NCT01354314|530925644|FG001|Overall Study|Less than 90% Adherence|2|||
147206283|NCT01354314|530925645|FG002|Overall Study|Less than 90% Adherence|6|||
147206284|NCT01354314|530925646|FG003|Overall Study|Less than 90% Adherence|4|||
147206285|NCT00478023|530925647|FG000|Overall Study|Adverse Event|11|||
147206286|NCT00478023|530925648|FG001|Overall Study|Adverse Event|7|||
147206287|NCT00478023|530925649|FG002|Overall Study|Adverse Event|8|||
147206288|NCT00478023|530925650|FG003|Overall Study|Adverse Event|14|||
147206289|NCT00478023|530925651|FG004|Overall Study|Adverse Event|6|||
147206290|NCT00478023|530925647|FG000|Overall Study|Death|1|||
147206291|NCT00478023|530925648|FG001|Overall Study|Death|0|||
147206292|NCT00478023|530925649|FG002|Overall Study|Death|0|||
147206293|NCT00478023|530925650|FG003|Overall Study|Death|0|||
147206294|NCT00478023|530925651|FG004|Overall Study|Death|0|||
147206295|NCT00478023|530925647|FG000|Overall Study|Lack of Efficacy|11|||
147206296|NCT00478023|530925648|FG001|Overall Study|Lack of Efficacy|10|||
147206297|NCT00478023|530925649|FG002|Overall Study|Lack of Efficacy|4|||
147206298|NCT00478023|530925650|FG003|Overall Study|Lack of Efficacy|5|||
147206299|NCT00478023|530925651|FG004|Overall Study|Lack of Efficacy|41|||
147206300|NCT00478023|530925647|FG000|Overall Study|Lost to Follow-up|3|||
147206301|NCT00478023|530925648|FG001|Overall Study|Lost to Follow-up|1|||
147206302|NCT00478023|530925649|FG002|Overall Study|Lost to Follow-up|1|||
147206303|NCT00478023|530925650|FG003|Overall Study|Lost to Follow-up|1|||
147206304|NCT00478023|530925651|FG004|Overall Study|Lost to Follow-up|0|||
147206305|NCT00478023|530925647|FG000|Overall Study|Withdrawal by Subject|2|||
147206306|NCT00478023|530925648|FG001|Overall Study|Withdrawal by Subject|3|||
147206307|NCT00478023|530925649|FG002|Overall Study|Withdrawal by Subject|2|||
147206308|NCT00478023|530925650|FG003|Overall Study|Withdrawal by Subject|4|||
147206309|NCT00478023|530925651|FG004|Overall Study|Withdrawal by Subject|5|||
147206310|NCT00478023|530925647|FG000|Overall Study|Lack of pain, Technical difficulties|7|||
147206311|NCT00478023|530925648|FG001|Overall Study|Lack of pain, Technical difficulties|3|||
147206312|NCT00478023|530925649|FG002|Overall Study|Lack of pain, Technical difficulties|5|||
147206313|NCT00478023|530925650|FG003|Overall Study|Lack of pain, Technical difficulties|6|||
147206314|NCT00478023|530925651|FG004|Overall Study|Lack of pain, Technical difficulties|3|||
147206315|NCT05019521|530925655|FG000|Primary Evaluation Period (52 Weeks)|Adverse Event|7|||
147206316|NCT05019521|530925656|FG001|Primary Evaluation Period (52 Weeks)|Adverse Event|9|||
147206317|NCT05019521|530925657|FG002|Primary Evaluation Period (52 Weeks)|Adverse Event|8|||
147206318|NCT05019521|530925658|FG003|Primary Evaluation Period (52 Weeks)|Adverse Event|4|||
147206319|NCT05019521|530925659|FG004|Primary Evaluation Period (52 Weeks)|Adverse Event|0|||
147206320|NCT05019521|530925660|FG005|Primary Evaluation Period (52 Weeks)|Adverse Event|0|||
147206321|NCT05019521|530925661|FG006|Primary Evaluation Period (52 Weeks)|Adverse Event|0|||
147206322|NCT05019521|530925655|FG000|Primary Evaluation Period (52 Weeks)|Investigator's Discretion|1|||
147206323|NCT05019521|530925656|FG001|Primary Evaluation Period (52 Weeks)|Investigator's Discretion|1|||
147206324|NCT05019521|530925657|FG002|Primary Evaluation Period (52 Weeks)|Investigator's Discretion|0|||
147206325|NCT05019521|530925658|FG003|Primary Evaluation Period (52 Weeks)|Investigator's Discretion|2|||
147206326|NCT05019521|530925659|FG004|Primary Evaluation Period (52 Weeks)|Investigator's Discretion|0|||
147206327|NCT05019521|530925660|FG005|Primary Evaluation Period (52 Weeks)|Investigator's Discretion|0|||
147206328|NCT05019521|530925661|FG006|Primary Evaluation Period (52 Weeks)|Investigator's Discretion|0|||
147541378|NCT01586624|532136393|FG001|Overall Study|Physician Decision|1|||
147541379|NCT01586624|532136394|FG002|Overall Study|Physician Decision|1|||
147541380|NCT01586624|532136395|FG003|Overall Study|Physician Decision|0|||
147541381|NCT01586624|532136396|FG004|Overall Study|Physician Decision|2|||
147541382|NCT01586624|532136397|FG005|Overall Study|Physician Decision|0|||
147541383|NCT01586624|532136398|FG006|Overall Study|Physician Decision|1|||
147541384|NCT01586624|532136399|FG007|Overall Study|Physician Decision|1|||
147541385|NCT01586624|532136392|FG000|Overall Study|Withdrawal by Subject|0|||
147541386|NCT01586624|532136393|FG001|Overall Study|Withdrawal by Subject|0|||
147541387|NCT01586624|532136394|FG002|Overall Study|Withdrawal by Subject|0|||
147541388|NCT01586624|532136395|FG003|Overall Study|Withdrawal by Subject|1|||
147541389|NCT01586624|532136396|FG004|Overall Study|Withdrawal by Subject|0|||
147541390|NCT01586624|532136397|FG005|Overall Study|Withdrawal by Subject|0|||
147541391|NCT01586624|532136398|FG006|Overall Study|Withdrawal by Subject|0|||
147541392|NCT01586624|532136399|FG007|Overall Study|Withdrawal by Subject|0|||
147541393|NCT01586624|532136392|FG000|Overall Study|Evidence of disease progression|1|||
147541394|NCT01586624|532136393|FG001|Overall Study|Evidence of disease progression|3|||
147541395|NCT01586624|532136394|FG002|Overall Study|Evidence of disease progression|2|||
147541396|NCT01586624|532136395|FG003|Overall Study|Evidence of disease progression|5|||
147541397|NCT01586624|532136396|FG004|Overall Study|Evidence of disease progression|3|||
147541398|NCT01586624|532136397|FG005|Overall Study|Evidence of disease progression|5|||
147541399|NCT01586624|532136398|FG006|Overall Study|Evidence of disease progression|4|||
147541400|NCT01586624|532136399|FG007|Overall Study|Evidence of disease progression|6|||
147541401|NCT01586624|532136392|FG000|Overall Study|Screen failure (no treatment received)|0|||
147541402|NCT01586624|532136393|FG001|Overall Study|Screen failure (no treatment received)|0|||
147541403|NCT01586624|532136394|FG002|Overall Study|Screen failure (no treatment received)|0|||
147541404|NCT01586624|532136395|FG003|Overall Study|Screen failure (no treatment received)|0|||
147541405|NCT01586624|532136396|FG004|Overall Study|Screen failure (no treatment received)|0|||
147541406|NCT01586624|532136397|FG005|Overall Study|Screen failure (no treatment received)|0|||
147541407|NCT01586624|532136398|FG006|Overall Study|Screen failure (no treatment received)|1|||
147541408|NCT01586624|532136399|FG007|Overall Study|Screen failure (no treatment received)|0|||
147541409|NCT00953927|532136400|FG000|Overall Study|Lost to Follow-up|61|||
147541410|NCT00953927|532136401|FG001|Overall Study|Lost to Follow-up|65|||
147541411|NCT00953927|532136400|FG000|Overall Study|Withdrawal by Subject|36|||
147541412|NCT00953927|532136401|FG001|Overall Study|Withdrawal by Subject|25|||
147541413|NCT00953927|532136400|FG000|Overall Study|Death|7|||
147206329|NCT05019521|530925655|FG000|Primary Evaluation Period (52 Weeks)|Withdrawal by Subject|7|||
147206330|NCT05019521|530925656|FG001|Primary Evaluation Period (52 Weeks)|Withdrawal by Subject|13|||
147206331|NCT05019521|530925657|FG002|Primary Evaluation Period (52 Weeks)|Withdrawal by Subject|6|||
147206332|NCT05019521|530925658|FG003|Primary Evaluation Period (52 Weeks)|Withdrawal by Subject|9|||
147206333|NCT05019521|530925659|FG004|Primary Evaluation Period (52 Weeks)|Withdrawal by Subject|0|||
147206334|NCT05019521|530925660|FG005|Primary Evaluation Period (52 Weeks)|Withdrawal by Subject|0|||
147206335|NCT05019521|530925661|FG006|Primary Evaluation Period (52 Weeks)|Withdrawal by Subject|0|||
147206336|NCT05019521|530925655|FG000|Primary Evaluation Period (52 Weeks)|Lost to Follow-up|1|||
147206337|NCT05019521|530925656|FG001|Primary Evaluation Period (52 Weeks)|Lost to Follow-up|0|||
147206338|NCT05019521|530925657|FG002|Primary Evaluation Period (52 Weeks)|Lost to Follow-up|1|||
147206339|NCT05019521|530925658|FG003|Primary Evaluation Period (52 Weeks)|Lost to Follow-up|0|||
147206340|NCT05019521|530925659|FG004|Primary Evaluation Period (52 Weeks)|Lost to Follow-up|0|||
147206341|NCT05019521|530925660|FG005|Primary Evaluation Period (52 Weeks)|Lost to Follow-up|0|||
147206342|NCT05019521|530925661|FG006|Primary Evaluation Period (52 Weeks)|Lost to Follow-up|0|||
147206343|NCT05019521|530925655|FG000|Primary Evaluation Period (52 Weeks)|Death|0|||
147206344|NCT05019521|530925656|FG001|Primary Evaluation Period (52 Weeks)|Death|1|||
147206345|NCT05019521|530925657|FG002|Primary Evaluation Period (52 Weeks)|Death|0|||
147206346|NCT05019521|530925658|FG003|Primary Evaluation Period (52 Weeks)|Death|3|||
147206347|NCT05019521|530925659|FG004|Primary Evaluation Period (52 Weeks)|Death|0|||
147206348|NCT05019521|530925660|FG005|Primary Evaluation Period (52 Weeks)|Death|0|||
147206349|NCT05019521|530925661|FG006|Primary Evaluation Period (52 Weeks)|Death|0|||
147206350|NCT05019521|530925655|FG000|Primary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|1|||
147206351|NCT05019521|530925656|FG001|Primary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
147541414|NCT00953927|532136401|FG001|Overall Study|Death|4|||
147541415|NCT00953927|532136400|FG000|Overall Study|Other study discontinuation|1|||
147541416|NCT00953927|532136401|FG001|Overall Study|Other study discontinuation|1|||
147541417|NCT01396161|532136402|FG000|Overall Study|Withdrawal by Subject|0|||
147541418|NCT01396161|532136403|FG001|Overall Study|Withdrawal by Subject|0|||
147541419|NCT01396161|532136404|FG002|Overall Study|Withdrawal by Subject|0|||
147541420|NCT01396161|532136405|FG003|Overall Study|Withdrawal by Subject|0|||
147206352|NCT05019521|530925657|FG002|Primary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
147206353|NCT05019521|530925658|FG003|Primary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
147206354|NCT05019521|530925659|FG004|Primary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
147206355|NCT05019521|530925660|FG005|Primary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
147206356|NCT05019521|530925661|FG006|Primary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
147206357|NCT05019521|530925655|FG000|Primary Evaluation Period (52 Weeks)|Other Than Specified|3|||
147206358|NCT05019521|530925656|FG001|Primary Evaluation Period (52 Weeks)|Other Than Specified|0|||
147206359|NCT05019521|530925657|FG002|Primary Evaluation Period (52 Weeks)|Other Than Specified|3|||
147206360|NCT05019521|530925658|FG003|Primary Evaluation Period (52 Weeks)|Other Than Specified|2|||
147206361|NCT05019521|530925659|FG004|Primary Evaluation Period (52 Weeks)|Other Than Specified|0|||
147206362|NCT05019521|530925660|FG005|Primary Evaluation Period (52 Weeks)|Other Than Specified|0|||
147206363|NCT05019521|530925661|FG006|Primary Evaluation Period (52 Weeks)|Other Than Specified|0|||
147206364|NCT05019521|530925655|FG000|Secondary Evaluation Period (52 Weeks)|Adverse Event|2|||
147206365|NCT05019521|530925656|FG001|Secondary Evaluation Period (52 Weeks)|Adverse Event|3|||
147206366|NCT05019521|530925657|FG002|Secondary Evaluation Period (52 Weeks)|Adverse Event|2|||
147206367|NCT05019521|530925658|FG003|Secondary Evaluation Period (52 Weeks)|Adverse Event|0|||
147206368|NCT05019521|530925659|FG004|Secondary Evaluation Period (52 Weeks)|Adverse Event|0|||
147206369|NCT05019521|530925660|FG005|Secondary Evaluation Period (52 Weeks)|Adverse Event|0|||
147206370|NCT05019521|530925661|FG006|Secondary Evaluation Period (52 Weeks)|Adverse Event|3|||
147206371|NCT05019521|530925655|FG000|Secondary Evaluation Period (52 Weeks)|Investigator's Discretion|1|||
147206372|NCT05019521|530925656|FG001|Secondary Evaluation Period (52 Weeks)|Investigator's Discretion|2|||
147206373|NCT05019521|530925657|FG002|Secondary Evaluation Period (52 Weeks)|Investigator's Discretion|1|||
147206374|NCT05019521|530925658|FG003|Secondary Evaluation Period (52 Weeks)|Investigator's Discretion|0|||
147206375|NCT05019521|530925659|FG004|Secondary Evaluation Period (52 Weeks)|Investigator's Discretion|0|||
147206376|NCT05019521|530925660|FG005|Secondary Evaluation Period (52 Weeks)|Investigator's Discretion|0|||
147206377|NCT05019521|530925661|FG006|Secondary Evaluation Period (52 Weeks)|Investigator's Discretion|1|||
147206378|NCT05019521|530925655|FG000|Secondary Evaluation Period (52 Weeks)|Withdrawal by Subject|3|||
147206379|NCT05019521|530925656|FG001|Secondary Evaluation Period (52 Weeks)|Withdrawal by Subject|0|||
147206380|NCT05019521|530925657|FG002|Secondary Evaluation Period (52 Weeks)|Withdrawal by Subject|0|||
147206381|NCT05019521|530925658|FG003|Secondary Evaluation Period (52 Weeks)|Withdrawal by Subject|0|||
147206382|NCT05019521|530925659|FG004|Secondary Evaluation Period (52 Weeks)|Withdrawal by Subject|5|||
147206383|NCT05019521|530925660|FG005|Secondary Evaluation Period (52 Weeks)|Withdrawal by Subject|2|||
147206384|NCT05019521|530925661|FG006|Secondary Evaluation Period (52 Weeks)|Withdrawal by Subject|2|||
147206385|NCT05019521|530925655|FG000|Secondary Evaluation Period (52 Weeks)|Lack of Efficacy|0|||
147206386|NCT05019521|530925656|FG001|Secondary Evaluation Period (52 Weeks)|Lack of Efficacy|1|||
147206387|NCT05019521|530925657|FG002|Secondary Evaluation Period (52 Weeks)|Lack of Efficacy|2|||
147206388|NCT05019521|530925658|FG003|Secondary Evaluation Period (52 Weeks)|Lack of Efficacy|0|||
147206389|NCT05019521|530925659|FG004|Secondary Evaluation Period (52 Weeks)|Lack of Efficacy|0|||
147206390|NCT05019521|530925660|FG005|Secondary Evaluation Period (52 Weeks)|Lack of Efficacy|0|||
147206391|NCT05019521|530925661|FG006|Secondary Evaluation Period (52 Weeks)|Lack of Efficacy|0|||
147206392|NCT05019521|530925655|FG000|Secondary Evaluation Period (52 Weeks)|Death|0|||
147206393|NCT05019521|530925656|FG001|Secondary Evaluation Period (52 Weeks)|Death|1|||
147206394|NCT05019521|530925657|FG002|Secondary Evaluation Period (52 Weeks)|Death|1|||
147206395|NCT05019521|530925658|FG003|Secondary Evaluation Period (52 Weeks)|Death|0|||
147206396|NCT05019521|530925659|FG004|Secondary Evaluation Period (52 Weeks)|Death|1|||
147206397|NCT05019521|530925660|FG005|Secondary Evaluation Period (52 Weeks)|Death|0|||
147206398|NCT05019521|530925661|FG006|Secondary Evaluation Period (52 Weeks)|Death|0|||
147206399|NCT05019521|530925655|FG000|Secondary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
147206400|NCT05019521|530925656|FG001|Secondary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
147206401|NCT05019521|530925657|FG002|Secondary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
147206402|NCT05019521|530925658|FG003|Secondary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
147206403|NCT05019521|530925659|FG004|Secondary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
147206404|NCT05019521|530925660|FG005|Secondary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|1|||
147439610|NCT02490475|531775777|FG001|Period 1: First 6 Cycles|Insufficient Therapeutic Response|0|||
147439611|NCT02490475|531775778|FG002|Period 1: First 6 Cycles|Insufficient Therapeutic Response|2|||
147439612|NCT02490475|531775779|FG003|Period 1: First 6 Cycles|Insufficient Therapeutic Response|2|||
147439613|NCT02490475|531775776|FG000|Period 1: First 6 Cycles|Refused Treatment|1|||
147439614|NCT02490475|531775777|FG001|Period 1: First 6 Cycles|Refused Treatment|0|||
147439615|NCT02490475|531775778|FG002|Period 1: First 6 Cycles|Refused Treatment|0|||
147439616|NCT02490475|531775779|FG003|Period 1: First 6 Cycles|Refused Treatment|0|||
147439617|NCT02490475|531775776|FG000|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|1|||
147439618|NCT02490475|531775777|FG001|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|1|||
147206405|NCT05019521|530925661|FG006|Secondary Evaluation Period (52 Weeks)|Liver abnormalities meeting Hy's Law criteria|0|||
147206406|NCT05019521|530925655|FG000|Secondary Evaluation Period (52 Weeks)|Other Than Specified|3|||
147206407|NCT05019521|530925656|FG001|Secondary Evaluation Period (52 Weeks)|Other Than Specified|1|||
147206408|NCT05019521|530925657|FG002|Secondary Evaluation Period (52 Weeks)|Other Than Specified|3|||
147206409|NCT05019521|530925658|FG003|Secondary Evaluation Period (52 Weeks)|Other Than Specified|0|||
147206410|NCT05019521|530925659|FG004|Secondary Evaluation Period (52 Weeks)|Other Than Specified|0|||
147206411|NCT05019521|530925660|FG005|Secondary Evaluation Period (52 Weeks)|Other Than Specified|1|||
147206412|NCT05019521|530925661|FG006|Secondary Evaluation Period (52 Weeks)|Other Than Specified|0|||
147206413|NCT05019521|530925655|FG000|Secondary Evaluation Period (52 Weeks)|Study Terminated by Sponsor|49|||
147206414|NCT05019521|530925656|FG001|Secondary Evaluation Period (52 Weeks)|Study Terminated by Sponsor|45|||
147206415|NCT05019521|530925657|FG002|Secondary Evaluation Period (52 Weeks)|Study Terminated by Sponsor|53|||
147206416|NCT05019521|530925658|FG003|Secondary Evaluation Period (52 Weeks)|Study Terminated by Sponsor|0|||
147206417|NCT05019521|530925659|FG004|Secondary Evaluation Period (52 Weeks)|Study Terminated by Sponsor|13|||
147206418|NCT05019521|530925660|FG005|Secondary Evaluation Period (52 Weeks)|Study Terminated by Sponsor|17|||
147206419|NCT05019521|530925661|FG006|Secondary Evaluation Period (52 Weeks)|Study Terminated by Sponsor|14|||
147206420|NCT02453711|530925662|FG000|Overall Study|Withdrawal by Subject|5|||
147206421|NCT02453711|530925663|FG001|Overall Study|Withdrawal by Subject|4|||
147206422|NCT02453711|530925664|FG002|Overall Study|Withdrawal by Subject|6|||
147206423|NCT02453711|530925665|FG003|Overall Study|Withdrawal by Subject|4|||
147206424|NCT02453711|530925666|FG004|Overall Study|Withdrawal by Subject|1|||
147206425|NCT02453711|530925667|FG005|Overall Study|Withdrawal by Subject|1|||
147206426|NCT02453711|530925668|FG006|Overall Study|Withdrawal by Subject|0|||
147206427|NCT02453711|530925669|FG007|Overall Study|Withdrawal by Subject|1|||
147206428|NCT02453711|530925670|FG008|Overall Study|Withdrawal by Subject|7|||
147206429|NCT02453711|530925662|FG000|Overall Study|Lost to Follow-up|5|||
147206430|NCT02453711|530925663|FG001|Overall Study|Lost to Follow-up|3|||
147206431|NCT02453711|530925664|FG002|Overall Study|Lost to Follow-up|2|||
147206432|NCT02453711|530925665|FG003|Overall Study|Lost to Follow-up|3|||
147206433|NCT02453711|530925666|FG004|Overall Study|Lost to Follow-up|1|||
147206434|NCT02453711|530925667|FG005|Overall Study|Lost to Follow-up|5|||
147206435|NCT02453711|530925668|FG006|Overall Study|Lost to Follow-up|2|||
147206436|NCT02453711|530925669|FG007|Overall Study|Lost to Follow-up|6|||
147206437|NCT02453711|530925670|FG008|Overall Study|Lost to Follow-up|6|||
147206438|NCT02453711|530925662|FG000|Overall Study|Death|0|||
147206439|NCT02453711|530925663|FG001|Overall Study|Death|0|||
147206440|NCT02453711|530925664|FG002|Overall Study|Death|0|||
147206441|NCT02453711|530925665|FG003|Overall Study|Death|0|||
147206442|NCT02453711|530925666|FG004|Overall Study|Death|0|||
147206443|NCT02453711|530925667|FG005|Overall Study|Death|0|||
147206444|NCT02453711|530925668|FG006|Overall Study|Death|1|||
147206445|NCT02453711|530925669|FG007|Overall Study|Death|0|||
147206446|NCT02453711|530925670|FG008|Overall Study|Death|0|||
147206447|NCT02453711|530925662|FG000|Overall Study|Unclassified|1|||
147206448|NCT02453711|530925663|FG001|Overall Study|Unclassified|0|||
147206449|NCT02453711|530925664|FG002|Overall Study|Unclassified|1|||
147206450|NCT02453711|530925665|FG003|Overall Study|Unclassified|0|||
147206451|NCT02453711|530925666|FG004|Overall Study|Unclassified|0|||
147206452|NCT02453711|530925667|FG005|Overall Study|Unclassified|0|||
147206453|NCT02453711|530925668|FG006|Overall Study|Unclassified|0|||
147206454|NCT02453711|530925669|FG007|Overall Study|Unclassified|0|||
147206455|NCT02453711|530925670|FG008|Overall Study|Unclassified|0|||
147206456|NCT03695367|530925672|FG000|Overall Study|Missed the Day 28 visit.|1|||
147206457|NCT03695367|530925673|FG001|Overall Study|Missed the Day 28 visit.|0|||
147206458|NCT03695367|530925672|FG000|Overall Study|Lost to Follow-up|0|||
147206459|NCT03695367|530925673|FG001|Overall Study|Lost to Follow-up|1|||
147206460|NCT03695367|530925672|FG000|Overall Study|Withdrawal by Subject|0|||
147206461|NCT03695367|530925673|FG001|Overall Study|Withdrawal by Subject|1|||
147206462|NCT03695367|530925672|FG000|Overall Study|One subject missed the Day 28 visit and one subject missed the Day 10 and Day 28 visits.|0|||
147206463|NCT03695367|530925673|FG001|Overall Study|One subject missed the Day 28 visit and one subject missed the Day 10 and Day 28 visits.|2|||
147439619|NCT02490475|531775778|FG002|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|4|||
147439620|NCT02490475|531775779|FG003|Period 1: First 6 Cycles|Completed 6 Cycles of Therapy|2|||
147439621|NCT02490475|531775776|FG000|Period 2: Extension Phase|Insufficient Therapeutic Response|1|||
147439622|NCT02490475|531775777|FG001|Period 2: Extension Phase|Insufficient Therapeutic Response|0|||
147439623|NCT02490475|531775778|FG002|Period 2: Extension Phase|Insufficient Therapeutic Response|2|||
147439624|NCT02490475|531775779|FG003|Period 2: Extension Phase|Insufficient Therapeutic Response|0|||
147439625|NCT02490475|531775776|FG000|Period 2: Extension Phase|Refused Treatment|0|||
147439626|NCT02490475|531775777|FG001|Period 2: Extension Phase|Refused Treatment|0|||
147206464|NCT00068419|530925674|FG000|Overall Study|Adverse Event|3|||
147206465|NCT00068419|530925674|FG000|Overall Study|Lack of Efficacy|24|||
147206466|NCT00068419|530925674|FG000|Overall Study|Lost to Follow-up|1|||
147206467|NCT00068419|530925674|FG000|Overall Study|Physician Decision|7|||
147439627|NCT02490475|531775778|FG002|Period 2: Extension Phase|Refused Treatment|0|||
147206468|NCT00068419|530925674|FG000|Overall Study|Withdrawal by Subject|14|||
147206469|NCT00068419|530925674|FG000|Overall Study|Ineligible|11|||
147206470|NCT00396253|530925683|FG000|Overall Study|Protocol Violation|1|||
147206471|NCT00396253|530925683|FG000|Overall Study|Withdrawal by Subject|7|||
147206472|NCT00396253|530925683|FG000|Overall Study|Death|3|||
147206473|NCT00396253|530925683|FG000|Overall Study|Physician Decision|1|||
147206474|NCT00396253|530925683|FG000|Overall Study|Change in eligibility status|1|||
147206475|NCT04672655|530925694|FG000|Overall Study|Lost to Follow-up|12|||
147206476|NCT04672655|530925695|FG001|Overall Study|Lost to Follow-up|17|||
147206477|NCT04672655|530925694|FG000|Overall Study|Withdrawal by Subject|1|||
147206478|NCT04672655|530925695|FG001|Overall Study|Withdrawal by Subject|0|||
147206479|NCT04672655|530925694|FG000|Overall Study|Withdrawal by Study|1|||
147206480|NCT04672655|530925695|FG001|Overall Study|Withdrawal by Study|0|||
147206481|NCT01677377|530927739|FG000|Overall Study|Protocol Violation|1|||
147206482|NCT01677377|530927740|FG001|Overall Study|Protocol Violation|0|||
147206483|NCT01677377|530927741|FG002|Overall Study|Protocol Violation|0|||
147206484|NCT01677377|530927739|FG000|Overall Study|Lost to Follow-up|0|||
147206485|NCT01677377|530927740|FG001|Overall Study|Lost to Follow-up|1|||
147206486|NCT01677377|530927741|FG002|Overall Study|Lost to Follow-up|1|||
147206487|NCT01677377|530927739|FG000|Overall Study|Withdrawal by Subject|0|||
147206488|NCT01677377|530927740|FG001|Overall Study|Withdrawal by Subject|0|||
147206489|NCT01677377|530927741|FG002|Overall Study|Withdrawal by Subject|3|||
147206490|NCT01677377|530927739|FG000|Overall Study|Lack of Efficacy|0|||
147206491|NCT01677377|530927740|FG001|Overall Study|Lack of Efficacy|0|||
147206492|NCT01677377|530927741|FG002|Overall Study|Lack of Efficacy|1|||
147206493|NCT01677377|530927739|FG000|Overall Study|Pregnancy|0|||
147206494|NCT01677377|530927740|FG001|Overall Study|Pregnancy|0|||
147206495|NCT01677377|530927741|FG002|Overall Study|Pregnancy|1|||
147206496|NCT00479687|530927742|FG000|Ph 1: Blinded, Randomized, Controlled|Adverse Event|0|||
147206497|NCT00479687|530927743|FG001|Ph 1: Blinded, Randomized, Controlled|Adverse Event|2|||
147206498|NCT00479687|530927744|FG002|Ph 1: Blinded, Randomized, Controlled|Adverse Event|0|||
147206499|NCT00479687|530927742|FG000|Ph 1: Blinded, Randomized, Controlled|Death|0|||
147206500|NCT00479687|530927743|FG001|Ph 1: Blinded, Randomized, Controlled|Death|1|||
147206501|NCT00479687|530927744|FG002|Ph 1: Blinded, Randomized, Controlled|Death|0|||
147206502|NCT00479687|530927742|FG000|Ph 1: Blinded, Randomized, Controlled|Lost to Follow-up|4|||
147206503|NCT00479687|530927743|FG001|Ph 1: Blinded, Randomized, Controlled|Lost to Follow-up|5|||
147206504|NCT00479687|530927744|FG002|Ph 1: Blinded, Randomized, Controlled|Lost to Follow-up|0|||
147206505|NCT00479687|530927742|FG000|Ph 1: Blinded, Randomized, Controlled|Physician Decision|2|||
147206506|NCT00479687|530927743|FG001|Ph 1: Blinded, Randomized, Controlled|Physician Decision|0|||
147206507|NCT00479687|530927744|FG002|Ph 1: Blinded, Randomized, Controlled|Physician Decision|0|||
147206508|NCT00479687|530927742|FG000|Ph 1: Blinded, Randomized, Controlled|Withdrawal by Subject|19|||
147206509|NCT00479687|530927743|FG001|Ph 1: Blinded, Randomized, Controlled|Withdrawal by Subject|11|||
147206510|NCT00479687|530927744|FG002|Ph 1: Blinded, Randomized, Controlled|Withdrawal by Subject|0|||
147206511|NCT00479687|530927742|FG000|Ph 2: Open Label, Single (Supartz) Arm|Adverse Event|0|||
147206512|NCT00479687|530927743|FG001|Ph 2: Open Label, Single (Supartz) Arm|Adverse Event|0|||
147206513|NCT00479687|530927744|FG002|Ph 2: Open Label, Single (Supartz) Arm|Adverse Event|4|||
147206514|NCT00479687|530927742|FG000|Ph 2: Open Label, Single (Supartz) Arm|Withdrawal by Subject|0|||
147206515|NCT00479687|530927743|FG001|Ph 2: Open Label, Single (Supartz) Arm|Withdrawal by Subject|0|||
147206516|NCT00479687|530927744|FG002|Ph 2: Open Label, Single (Supartz) Arm|Withdrawal by Subject|3|||
147206517|NCT00479687|530927742|FG000|Ph 2: Open Label, Single (Supartz) Arm|Lost to Follow-up|0|||
147206518|NCT00479687|530927743|FG001|Ph 2: Open Label, Single (Supartz) Arm|Lost to Follow-up|0|||
147206519|NCT00479687|530927744|FG002|Ph 2: Open Label, Single (Supartz) Arm|Lost to Follow-up|1|||
147206520|NCT00479687|530927742|FG000|Ph 2: Open Label, Single (Supartz) Arm|Death|0|||
147206521|NCT00479687|530927743|FG001|Ph 2: Open Label, Single (Supartz) Arm|Death|0|||
147206522|NCT00479687|530927744|FG002|Ph 2: Open Label, Single (Supartz) Arm|Death|1|||
147206523|NCT00295880|530927745|FG000|Overall Study|IBMI unit could not be volume reduced|1|||
147206524|NCT00295880|530927745|FG000|Overall Study|Unit randomization did not occur|1|||
147206525|NCT01474239|530927746|FG000|Overall Study|Disease Progression|37|||
147206526|NCT01474239|530927747|FG001|Overall Study|Disease Progression|25|||
147439628|NCT02490475|531775779|FG003|Period 2: Extension Phase|Refused Treatment|1|||
147439629|NCT02490475|531775776|FG000|Period 2: Extension Phase|Adverse Event|0|||
147439630|NCT02490475|531775777|FG001|Period 2: Extension Phase|Adverse Event|0|||
147439631|NCT02490475|531775778|FG002|Period 2: Extension Phase|Adverse Event|1|||
147439632|NCT02490475|531775779|FG003|Period 2: Extension Phase|Adverse Event|0|||
147439633|NCT01195090|531775784|FG000|Overall Study|Adverse Event|1|||
147439634|NCT01195090|531775785|FG001|Overall Study|Adverse Event|2|||
147439635|NCT01195090|531775784|FG000|Overall Study|Lost to Follow-up|2|||
147206527|NCT01474239|530927746|FG000|Overall Study|Adverse Event|12|||
147206528|NCT01474239|530927747|FG001|Overall Study|Adverse Event|3|||
147206529|NCT01474239|530927746|FG000|Overall Study|Withdrawal by Subject|1|||
147206530|NCT01474239|530927747|FG001|Overall Study|Withdrawal by Subject|2|||
147206531|NCT01474239|530927746|FG000|Overall Study|Death|1|||
147439636|NCT01195090|531775785|FG001|Overall Study|Lost to Follow-up|2|||
147541421|NCT01396161|532136406|FG004|Overall Study|Withdrawal by Subject|1|||
147541422|NCT01396161|532136407|FG005|Overall Study|Withdrawal by Subject|0|||
147541423|NCT01396161|532136408|FG006|Overall Study|Withdrawal by Subject|0|||
147541424|NCT01396161|532136402|FG000|Overall Study|Other|0|||
147541425|NCT01396161|532136403|FG001|Overall Study|Other|0|||
147541426|NCT01396161|532136404|FG002|Overall Study|Other|0|||
147541427|NCT01396161|532136405|FG003|Overall Study|Other|0|||
147541428|NCT01396161|532136406|FG004|Overall Study|Other|0|||
147206532|NCT01474239|530927747|FG001|Overall Study|Death|1|||
147206533|NCT01474239|530927746|FG000|Overall Study|Clinical Disease Progression|7|||
147206534|NCT01474239|530927747|FG001|Overall Study|Clinical Disease Progression|1|||
147206535|NCT01474239|530927746|FG000|Overall Study|Withdrawal for Economic Reason|1|||
147206536|NCT01474239|530927747|FG001|Overall Study|Withdrawal for Economic Reason|0|||
147206537|NCT00796419|530927749|FG000|Overall Study|Death|0|||
147206538|NCT00796419|530927750|FG001|Overall Study|Death|1|||
147206539|NCT02840799|530927751|FG000|Phase 1|Physician Decision|1|||
147206540|NCT02840799|530927752|FG001|Phase 1|Physician Decision|3|||
147206541|NCT02840799|530927751|FG000|Phase 1|Withdrawal by Subject|4|||
147206542|NCT02840799|530927752|FG001|Phase 1|Withdrawal by Subject|0|||
147206543|NCT02840799|530927751|FG000|Phase 2 (Crossover)|Adverse Event|0|||
147206544|NCT02840799|530927752|FG001|Phase 2 (Crossover)|Adverse Event|1|||
147206545|NCT02840799|530927751|FG000|Phase 2 (Crossover)|Withdrawal by Subject|0|||
147206546|NCT02840799|530927752|FG001|Phase 2 (Crossover)|Withdrawal by Subject|1|||
147206547|NCT02565784|530927753|FG000|First Treatment|Adverse Event|1|||
147206548|NCT02565784|530927753|FG000|First Treatment|Withdrawal by Subject|1|||
147206549|NCT02565784|530927753|FG000|Second Treatment|Withdrawal by Subject|2|||
147206550|NCT01349049|530927757|FG000|Overall Study|Disease progression|3|||
147206551|NCT01349049|530927758|FG001|Overall Study|Disease progression|5|||
147206552|NCT01349049|530927759|FG002|Overall Study|Disease progression|3|||
147206553|NCT01349049|530927760|FG003|Overall Study|Disease progression|2|||
147206554|NCT01349049|530927761|FG004|Overall Study|Disease progression|2|||
147206555|NCT01349049|530927762|FG005|Overall Study|Disease progression|2|||
147206556|NCT01349049|530927763|FG006|Overall Study|Disease progression|3|||
147206557|NCT01349049|530927764|FG007|Overall Study|Disease progression|2|||
147206558|NCT01349049|530927765|FG008|Overall Study|Disease progression|33|||
147206559|NCT01349049|530927757|FG000|Overall Study|Adverse Event|0|||
147206560|NCT01349049|530927758|FG001|Overall Study|Adverse Event|1|||
147206561|NCT01349049|530927759|FG002|Overall Study|Adverse Event|0|||
147206562|NCT01349049|530927760|FG003|Overall Study|Adverse Event|0|||
147206563|NCT01349049|530927761|FG004|Overall Study|Adverse Event|0|||
147206564|NCT01349049|530927762|FG005|Overall Study|Adverse Event|3|||
147206565|NCT01349049|530927763|FG006|Overall Study|Adverse Event|1|||
147206566|NCT01349049|530927764|FG007|Overall Study|Adverse Event|0|||
147206567|NCT01349049|530927765|FG008|Overall Study|Adverse Event|4|||
147206568|NCT01349049|530927757|FG000|Overall Study|Physician Decision|0|||
147206569|NCT01349049|530927758|FG001|Overall Study|Physician Decision|1|||
147206570|NCT01349049|530927759|FG002|Overall Study|Physician Decision|0|||
147206571|NCT01349049|530927760|FG003|Overall Study|Physician Decision|0|||
147206572|NCT01349049|530927761|FG004|Overall Study|Physician Decision|0|||
147206573|NCT01349049|530927762|FG005|Overall Study|Physician Decision|0|||
147206574|NCT01349049|530927763|FG006|Overall Study|Physician Decision|0|||
147206575|NCT01349049|530927764|FG007|Overall Study|Physician Decision|0|||
147206576|NCT01349049|530927765|FG008|Overall Study|Physician Decision|2|||
147206577|NCT01349049|530927757|FG000|Overall Study|Protocol Violation|0|||
147206578|NCT01349049|530927758|FG001|Overall Study|Protocol Violation|0|||
147206579|NCT01349049|530927759|FG002|Overall Study|Protocol Violation|0|||
147206580|NCT01349049|530927760|FG003|Overall Study|Protocol Violation|0|||
147206581|NCT01349049|530927761|FG004|Overall Study|Protocol Violation|0|||
147206582|NCT01349049|530927762|FG005|Overall Study|Protocol Violation|0|||
147206583|NCT01349049|530927763|FG006|Overall Study|Protocol Violation|0|||
147206584|NCT01349049|530927764|FG007|Overall Study|Protocol Violation|0|||
147206585|NCT01349049|530927765|FG008|Overall Study|Protocol Violation|1|||
147206586|NCT01349049|530927757|FG000|Overall Study|Hematopoietic stem cell transplant|0|||
147206587|NCT01349049|530927758|FG001|Overall Study|Hematopoietic stem cell transplant|0|||
147206588|NCT01349049|530927759|FG002|Overall Study|Hematopoietic stem cell transplant|0|||
147206589|NCT01349049|530927760|FG003|Overall Study|Hematopoietic stem cell transplant|0|||
147541429|NCT01396161|532136407|FG005|Overall Study|Other|0|||
147541430|NCT01396161|532136408|FG006|Overall Study|Other|1|||
147541431|NCT02962739|532136413|FG000|Overall Study|Withdrawal by Subject|0|||
147206590|NCT01349049|530927761|FG004|Overall Study|Hematopoietic stem cell transplant|1|||
147206591|NCT01349049|530927762|FG005|Overall Study|Hematopoietic stem cell transplant|0|||
147206592|NCT01349049|530927763|FG006|Overall Study|Hematopoietic stem cell transplant|1|||
147206593|NCT01349049|530927764|FG007|Overall Study|Hematopoietic stem cell transplant|1|||
147541432|NCT02962739|532136414|FG001|Overall Study|Withdrawal by Subject|1|||
147541433|NCT02962739|532136415|FG002|Overall Study|Withdrawal by Subject|0|||
147541434|NCT02962739|532136416|FG003|Overall Study|Withdrawal by Subject|0|||
147541435|NCT02962739|532136417|FG004|Overall Study|Withdrawal by Subject|0|||
147206594|NCT01349049|530927765|FG008|Overall Study|Hematopoietic stem cell transplant|0|||
147206595|NCT01349049|530927757|FG000|Overall Study|Other|0|||
147206596|NCT01349049|530927758|FG001|Overall Study|Other|0|||
147206597|NCT01349049|530927759|FG002|Overall Study|Other|0|||
147206598|NCT01349049|530927760|FG003|Overall Study|Other|0|||
147206599|NCT01349049|530927761|FG004|Overall Study|Other|0|||
147206600|NCT01349049|530927762|FG005|Overall Study|Other|1|||
147206601|NCT01349049|530927763|FG006|Overall Study|Other|0|||
147206602|NCT01349049|530927764|FG007|Overall Study|Other|0|||
147206603|NCT01349049|530927765|FG008|Overall Study|Other|4|||
147206604|NCT01349049|530927757|FG000|Overall Study|Death|0|||
147206605|NCT01349049|530927758|FG001|Overall Study|Death|0|||
147206606|NCT01349049|530927759|FG002|Overall Study|Death|0|||
147206607|NCT01349049|530927760|FG003|Overall Study|Death|0|||
147206608|NCT01349049|530927761|FG004|Overall Study|Death|0|||
147206609|NCT01349049|530927762|FG005|Overall Study|Death|0|||
147206610|NCT01349049|530927763|FG006|Overall Study|Death|0|||
147206611|NCT01349049|530927764|FG007|Overall Study|Death|1|||
147206612|NCT01349049|530927765|FG008|Overall Study|Death|5|||
147206613|NCT01349049|530927757|FG000|Overall Study|Non-compliance|0|||
147206614|NCT01349049|530927758|FG001|Overall Study|Non-compliance|0|||
147206615|NCT01349049|530927759|FG002|Overall Study|Non-compliance|0|||
147206616|NCT01349049|530927760|FG003|Overall Study|Non-compliance|1|||
147206617|NCT01349049|530927761|FG004|Overall Study|Non-compliance|0|||
147206618|NCT01349049|530927762|FG005|Overall Study|Non-compliance|0|||
147206619|NCT01349049|530927763|FG006|Overall Study|Non-compliance|0|||
147206620|NCT01349049|530927764|FG007|Overall Study|Non-compliance|0|||
147206621|NCT01349049|530927765|FG008|Overall Study|Non-compliance|0|||
147206622|NCT01349049|530927757|FG000|Overall Study|Withdrawal by Subject|0|||
147206623|NCT01349049|530927758|FG001|Overall Study|Withdrawal by Subject|0|||
147206624|NCT01349049|530927759|FG002|Overall Study|Withdrawal by Subject|0|||
147206625|NCT01349049|530927760|FG003|Overall Study|Withdrawal by Subject|0|||
147206626|NCT01349049|530927761|FG004|Overall Study|Withdrawal by Subject|0|||
147206627|NCT01349049|530927762|FG005|Overall Study|Withdrawal by Subject|0|||
147206628|NCT01349049|530927763|FG006|Overall Study|Withdrawal by Subject|0|||
147206629|NCT01349049|530927764|FG007|Overall Study|Withdrawal by Subject|0|||
147206630|NCT01349049|530927765|FG008|Overall Study|Withdrawal by Subject|6|||
147206631|NCT00552188|530927768|FG000|Overall Study|Adverse Event|0|||
147206632|NCT00552188|530927769|FG001|Overall Study|Adverse Event|2|||
147206633|NCT00552188|530927768|FG000|Overall Study|Lost to Follow-up|2|||
147206634|NCT00552188|530927769|FG001|Overall Study|Lost to Follow-up|1|||
147206635|NCT00552188|530927768|FG000|Overall Study|Withdrawal of consent|0|||
147206636|NCT00552188|530927769|FG001|Overall Study|Withdrawal of consent|1|||
147206637|NCT00552188|530927768|FG000|Overall Study|Subject returned to home country|0|||
147206638|NCT00552188|530927769|FG001|Overall Study|Subject returned to home country|1|||
147206639|NCT03887702|530927770|FG000|Overall Study|Study terminated|0|||
147206640|NCT03887702|530927771|FG001|Overall Study|Study terminated|0|||
147206641|NCT03887702|530927772|FG002|Overall Study|Study terminated|2|||
147206642|NCT03887702|530927773|FG003|Overall Study|Study terminated|2|||
147206643|NCT01193257|530927779|FG000|Overall Study|Death|202|||
147206644|NCT01193257|530927780|FG001|Overall Study|Death|391|||
147206645|NCT01193257|530927779|FG000|Overall Study|Study termination by sponsor|0|||
147206646|NCT01193257|530927780|FG001|Overall Study|Study termination by sponsor|3|||
147206647|NCT01193257|530927779|FG000|Overall Study|Withdrawal by Subject|26|||
147206648|NCT01193257|530927780|FG001|Overall Study|Withdrawal by Subject|86|||
147206649|NCT01193257|530927779|FG000|Overall Study|Lost to Follow-up|2|||
147206650|NCT01193257|530927780|FG001|Overall Study|Lost to Follow-up|3|||
147206651|NCT01193257|530927779|FG000|Overall Study|Unblinded due to futility|135|||
147206652|NCT01193257|530927780|FG001|Overall Study|Unblinded due to futility|251|||
147206653|NCT01675544|530927788|FG000|Overall Study|Withdrawal by Subject|2|||
147206654|NCT03544333|530927789|FG000|Overall Study|Withdrawal by Subject|1|||
147206655|NCT03544333|530927790|FG001|Overall Study|Withdrawal by Subject|0|||
147439637|NCT01195090|531775784|FG000|Overall Study|Protocol Violation|3|||
147439638|NCT01195090|531775785|FG001|Overall Study|Protocol Violation|4|||
147439639|NCT04912245|531775786|FG000|Overall Study|Withdrawal by Subject|21|||
147439640|NCT04912245|531775787|FG001|Overall Study|Withdrawal by Subject|4|||
147439641|NCT04912245|531775786|FG000|Overall Study|Lost to Follow-up|5|||
147439642|NCT04912245|531775787|FG001|Overall Study|Lost to Follow-up|11|||
147439643|NCT01205230|531775788|FG000|Overall Study|Adverse Event|4|||
147439644|NCT01205230|531775789|FG001|Overall Study|Adverse Event|0|||
147206656|NCT03656562|530927794|FG000|Overall Study|Ongoing at the time of Interim Analysis Cut-off date|19|||
147206657|NCT03656562|530927795|FG001|Overall Study|Ongoing at the time of Interim Analysis Cut-off date|13|||
147206658|NCT03656562|530927796|FG002|Overall Study|Ongoing at the time of Interim Analysis Cut-off date|5|||
147206659|NCT03656562|530927797|FG003|Overall Study|Ongoing at the time of Interim Analysis Cut-off date|4|||
147206660|NCT03656562|530927794|FG000|Overall Study|Physician Decision|1|||
147206661|NCT03656562|530927795|FG001|Overall Study|Physician Decision|2|||
147206662|NCT03656562|530927796|FG002|Overall Study|Physician Decision|0|||
147206663|NCT03656562|530927797|FG003|Overall Study|Physician Decision|0|||
147206664|NCT03656562|530927794|FG000|Overall Study|Subject Decision|3|||
147206665|NCT03656562|530927795|FG001|Overall Study|Subject Decision|5|||
147439645|NCT01205230|531775788|FG000|Overall Study|Physician Decision|1|||
147206666|NCT03656562|530927796|FG002|Overall Study|Subject Decision|0|||
147206667|NCT03656562|530927797|FG003|Overall Study|Subject Decision|2|||
147206668|NCT02136069|530927798|FG000|Overall Study|UC flare-up|1|||
147206669|NCT02136069|530927799|FG001|Overall Study|UC flare-up|0|||
147206670|NCT02136069|530927798|FG000|Overall Study|Adverse Event|6|||
147206671|NCT02136069|530927799|FG001|Overall Study|Adverse Event|8|||
147206672|NCT02136069|530927798|FG000|Overall Study|Death|0|||
147206673|NCT02136069|530927799|FG001|Overall Study|Death|1|||
147206674|NCT02136069|530927798|FG000|Overall Study|Lack of Efficacy|10|||
147206675|NCT02136069|530927799|FG001|Overall Study|Lack of Efficacy|4|||
147206676|NCT02136069|530927798|FG000|Overall Study|Lost to Follow-up|1|||
147206677|NCT02136069|530927799|FG001|Overall Study|Lost to Follow-up|0|||
147206678|NCT02136069|530927798|FG000|Overall Study|Non-Compliance|1|||
147206679|NCT02136069|530927799|FG001|Overall Study|Non-Compliance|0|||
147206680|NCT02136069|530927798|FG000|Overall Study|Physician Decision|5|||
147206681|NCT02136069|530927799|FG001|Overall Study|Physician Decision|4|||
147206682|NCT02136069|530927798|FG000|Overall Study|Withdrawal by Subject|10|||
147206683|NCT02136069|530927799|FG001|Overall Study|Withdrawal by Subject|11|||
147206684|NCT04693234|530927800|FG000|Overall Study|Death|79|||
147206685|NCT04693234|530927801|FG001|Overall Study|Death|19|||
147206686|NCT04693234|530927800|FG000|Overall Study|Sponsor Ended Study|47|||
147206687|NCT04693234|530927801|FG001|Overall Study|Sponsor Ended Study|18|||
147206688|NCT04693234|530927800|FG000|Overall Study|Withdrawal by Subject|10|||
147206689|NCT04693234|530927801|FG001|Overall Study|Withdrawal by Subject|2|||
147206690|NCT04693234|530927800|FG000|Overall Study|Lost to Follow-up|2|||
147206691|NCT04693234|530927801|FG001|Overall Study|Lost to Follow-up|1|||
147206692|NCT00459186|530927802|FG000|Single Agent RAD001|Withdrawal by Subject|1|||
147206693|NCT00459186|530927802|FG000|PET Imaging and Assessment|Adverse Event|3|||
147206694|NCT02920242|530927803|FG000|Overall Study|Withdrawal by Subject|1|||
147206695|NCT02920242|530927804|FG001|Overall Study|Withdrawal by Subject|0|||
147206696|NCT02920242|530927805|FG002|Overall Study|Withdrawal by Subject|1|||
147206697|NCT02920242|530927803|FG000|Overall Study|Did not meet inc./exc. criteria|1|||
147206698|NCT02920242|530927804|FG001|Overall Study|Did not meet inc./exc. criteria|0|||
147206699|NCT02920242|530927805|FG002|Overall Study|Did not meet inc./exc. criteria|0|||
147206700|NCT04995419|530927806|FG000|Overall Study|Withdrawal by Subject|3|||
147206701|NCT04995419|530927806|FG000|Overall Study|Progressive Disease|19|||
147206702|NCT04995419|530927806|FG000|Overall Study|Adverse Event|2|||
147206703|NCT04995419|530927806|FG000|Overall Study|Ongoing|16|||
147206704|NCT01409811|530927807|FG000|Overall Study|Insurance denial|1|||
147206705|NCT00634101|530927808|FG000|Overall Study|Study Terminated|3|||
147206706|NCT00634101|530927809|FG001|Overall Study|Study Terminated|3|||
147206707|NCT00634101|530927808|FG000|Overall Study|Lost to Follow-up|2|||
147206708|NCT00634101|530927809|FG001|Overall Study|Lost to Follow-up|0|||
147206709|NCT00838513|530927811|FG000|Screening Period|Screen Failure|3|||
147206710|NCT00838513|530927811|FG000|Extension Treatment Period|Death|1|||
147206711|NCT00838513|530927811|FG000|Post Treatment Period (Patients Who Disc|Death|1|||
147206712|NCT03051178|530927814|FG000|Overall Study|Withdrawal by Subject|5|||
147206713|NCT00953056|530927815|FG000|Overall Study|Withdrew Consent|0|||
147206714|NCT00953056|530927816|FG001|Overall Study|Withdrew Consent|0|||
147206715|NCT00953056|530927817|FG002|Overall Study|Withdrew Consent|0|||
147206716|NCT00953056|530927818|FG003|Overall Study|Withdrew Consent|0|||
147206717|NCT00953056|530927819|FG004|Overall Study|Withdrew Consent|2|||
147206718|NCT00953056|530927820|FG005|Overall Study|Withdrew Consent|3|||
147206719|NCT00953056|530927815|FG000|Overall Study|Serious Adverse Event|0|||
147206720|NCT00953056|530927816|FG001|Overall Study|Serious Adverse Event|0|||
147206721|NCT00953056|530927817|FG002|Overall Study|Serious Adverse Event|0|||
147206722|NCT00953056|530927818|FG003|Overall Study|Serious Adverse Event|0|||
147206723|NCT00953056|530927819|FG004|Overall Study|Serious Adverse Event|0|||
147206724|NCT00953056|530927820|FG005|Overall Study|Serious Adverse Event|1|||
147206725|NCT02813577|530927821|FG000|Overall Study|Study terminated|4|||
147206726|NCT01388335|530927822|FG000|Period 1|Progressive Disease|1|||
147206727|NCT01388335|530927822|FG000|Period 2|Progressive Disease|2|||
147206728|NCT01388335|530927822|FG000|Period 2|Sponsor Decision|1|||
147206729|NCT01388335|530927822|FG000|Safety Extension|Progressive Disease|7|||
147206730|NCT03339219|530927823|FG000|Overall Study|Death|12|||
147206731|NCT03339219|530927823|FG000|Overall Study|Site Terminated by Sponsor|22|||
147206732|NCT03339219|530927823|FG000|Overall Study|Withdrawal by Subject|1|||
147206733|NCT00885534|530927825|FG000|Overall Study|Patient deemed ineligible|1|||
147206734|NCT01273519|530927827|FG000|Overall Study|Adverse Event|3|||
147206735|NCT01273519|530927828|FG001|Overall Study|Adverse Event|0|||
147206736|NCT01273519|530927829|FG002|Overall Study|Adverse Event|0|||
147206737|NCT01273519|530927827|FG000|Overall Study|Lost to Follow-up|2|||
147206738|NCT01273519|530927828|FG001|Overall Study|Lost to Follow-up|1|||
147206739|NCT01273519|530927829|FG002|Overall Study|Lost to Follow-up|3|||
147206740|NCT01273519|530927827|FG000|Overall Study|Lack of Efficacy|8|||
147206741|NCT01273519|530927828|FG001|Overall Study|Lack of Efficacy|3|||
147206742|NCT01273519|530927829|FG002|Overall Study|Lack of Efficacy|4|||
147206743|NCT01273519|530927827|FG000|Overall Study|Other|6|||
147206744|NCT01273519|530927828|FG001|Overall Study|Other|1|||
147206745|NCT01273519|530927829|FG002|Overall Study|Other|1|||
147206746|NCT04292899|530927830|FG000|Overall Study|Death|21|||
147206747|NCT04292899|530927831|FG001|Overall Study|Death|28|||
147206748|NCT04292899|530927832|FG002|Overall Study|Death|188|||
147206749|NCT04292899|530927833|FG003|Overall Study|Death|371|||
147206750|NCT04292899|530927830|FG000|Overall Study|Lost to Follow-up|8|||
147206751|NCT04292899|530927831|FG001|Overall Study|Lost to Follow-up|4|||
147206752|NCT04292899|530927832|FG002|Overall Study|Lost to Follow-up|22|||
147206753|NCT04292899|530927833|FG003|Overall Study|Lost to Follow-up|235|||
147206754|NCT04292899|530927830|FG000|Overall Study|Withdrew consent|1|||
147206755|NCT04292899|530927831|FG001|Overall Study|Withdrew consent|0|||
147206756|NCT04292899|530927832|FG002|Overall Study|Withdrew consent|11|||
147206757|NCT04292899|530927833|FG003|Overall Study|Withdrew consent|32|||
147206758|NCT04292899|530927830|FG000|Overall Study|Adverse Event|2|||
147206759|NCT04292899|530927831|FG001|Overall Study|Adverse Event|1|||
147206760|NCT04292899|530927832|FG002|Overall Study|Adverse Event|2|||
147206761|NCT04292899|530927833|FG003|Overall Study|Adverse Event|2|||
147206762|NCT04292899|530927830|FG000|Overall Study|Investigator's Discretion|0|||
147206763|NCT04292899|530927831|FG001|Overall Study|Investigator's Discretion|0|||
147206764|NCT04292899|530927832|FG002|Overall Study|Investigator's Discretion|0|||
147206765|NCT04292899|530927833|FG003|Overall Study|Investigator's Discretion|3|||
147206766|NCT04292899|530927830|FG000|Overall Study|Non-compliance With Study Drug|0|||
147206767|NCT04292899|530927831|FG001|Overall Study|Non-compliance With Study Drug|0|||
147206768|NCT04292899|530927832|FG002|Overall Study|Non-compliance With Study Drug|0|||
147206769|NCT04292899|530927833|FG003|Overall Study|Non-compliance With Study Drug|1|||
147206770|NCT04292899|530927830|FG000|Overall Study|Protocol Violation|0|||
147206771|NCT04292899|530927831|FG001|Overall Study|Protocol Violation|0|||
147206772|NCT04292899|530927832|FG002|Overall Study|Protocol Violation|0|||
147206773|NCT04292899|530927833|FG003|Overall Study|Protocol Violation|1|||
147206774|NCT01032889|530927834|FG000|Overall Study|Adverse Event|2|||
147206775|NCT01032889|530927835|FG001|Overall Study|Adverse Event|2|||
147206776|NCT01032889|530927836|FG002|Overall Study|Adverse Event|0|||
147206777|NCT01032889|530927834|FG000|Overall Study|Withdrawal of Consent|1|||
147206778|NCT01032889|530927835|FG001|Overall Study|Withdrawal of Consent|2|||
147206779|NCT01032889|530927836|FG002|Overall Study|Withdrawal of Consent|1|||
147206780|NCT01032889|530927834|FG000|Overall Study|Patient Request|0|||
147206781|NCT01032889|530927835|FG001|Overall Study|Patient Request|1|||
147206782|NCT01032889|530927836|FG002|Overall Study|Patient Request|0|||
147206783|NCT01032889|530927834|FG000|Overall Study|Lost to Follow-up|1|||
147206784|NCT01032889|530927835|FG001|Overall Study|Lost to Follow-up|1|||
147206785|NCT01032889|530927836|FG002|Overall Study|Lost to Follow-up|0|||
147206786|NCT01032889|530927834|FG000|Overall Study|Lack of Submental Fat|2|||
147206787|NCT01032889|530927835|FG001|Overall Study|Lack of Submental Fat|8|||
147206788|NCT01032889|530927836|FG002|Overall Study|Lack of Submental Fat|1|||
147206789|NCT01032889|530927834|FG000|Overall Study|Miscellaneous Reasons|2|||
147206790|NCT01032889|530927835|FG001|Overall Study|Miscellaneous Reasons|1|||
147206791|NCT01032889|530927836|FG002|Overall Study|Miscellaneous Reasons|1|||
147206792|NCT01500720|530927838|FG000|Overall Study|Randomized But Not Treated|1|||
147206793|NCT01500720|530927839|FG001|Overall Study|Randomized But Not Treated|1|||
147206794|NCT01500720|530927838|FG000|Overall Study|Other|4|||
147206795|NCT01500720|530927839|FG001|Overall Study|Other|8|||
147206796|NCT00740857|530927841|FG000|Overall Study|Withdrawal by Subject|1|||
147206797|NCT00740857|530927842|FG001|Overall Study|Withdrawal by Subject|0|||
147206798|NCT00740857|530927843|FG002|Overall Study|Withdrawal by Subject|0|||
147206799|NCT03532451|530927847|FG000|Overall Study|Withdrawal by Subject|0|||
147206800|NCT03532451|530927848|FG001|Overall Study|Withdrawal by Subject|1|||
147206801|NCT03532451|530927847|FG000|Overall Study|Did not undergo surgery|1|||
147206802|NCT03532451|530927848|FG001|Overall Study|Did not undergo surgery|1|||
147206803|NCT02527421|530927849|FG000|Overall Study|Withdrawal by Subject|1|||
147206804|NCT02527421|530927850|FG001|Overall Study|Withdrawal by Subject|0|||
147206805|NCT02541604|530927851|FG000|Overall Study|Death|6|||
147206806|NCT02541604|530927852|FG001|Overall Study|Death|5|||
147206807|NCT02541604|530927853|FG002|Overall Study|Death|7|||
147439646|NCT01205230|531775789|FG001|Overall Study|Physician Decision|0|||
147439647|NCT00058552|531775790|FG000|Overall Study|Died prior to receiving treatment|4|||
147439648|NCT00058552|531775791|FG001|Overall Study|Died prior to receiving treatment|2|||
147439649|NCT00058552|531775790|FG000|Overall Study|Disease progression|52|||
147439650|NCT00058552|531775791|FG001|Overall Study|Disease progression|44|||
147206808|NCT02541604|530927854|FG003|Overall Study|Death|2|||
147206809|NCT02541604|530927855|FG004|Overall Study|Death|9|||
147206810|NCT02541604|530927856|FG005|Overall Study|Death|8|||
147206811|NCT02541604|530927857|FG006|Overall Study|Death|9|||
147206812|NCT02541604|530927858|FG007|Overall Study|Death|9|||
147206813|NCT02541604|530927859|FG008|Overall Study|Death|3|||
147206814|NCT02541604|530927860|FG009|Overall Study|Death|4|||
147206815|NCT02541604|530927861|FG010|Overall Study|Death|2|||
147206816|NCT02541604|530927862|FG011|Overall Study|Death|3|||
147206817|NCT02541604|530927851|FG000|Overall Study|Lost to Follow-up|2|||
147206818|NCT02541604|530927852|FG001|Overall Study|Lost to Follow-up|0|||
147206819|NCT02541604|530927853|FG002|Overall Study|Lost to Follow-up|1|||
147206820|NCT02541604|530927854|FG003|Overall Study|Lost to Follow-up|0|||
147206821|NCT02541604|530927855|FG004|Overall Study|Lost to Follow-up|0|||
147206822|NCT02541604|530927856|FG005|Overall Study|Lost to Follow-up|1|||
147206823|NCT02541604|530927857|FG006|Overall Study|Lost to Follow-up|1|||
147206824|NCT02541604|530927858|FG007|Overall Study|Lost to Follow-up|0|||
147206825|NCT02541604|530927859|FG008|Overall Study|Lost to Follow-up|0|||
147206826|NCT02541604|530927860|FG009|Overall Study|Lost to Follow-up|0|||
147206827|NCT02541604|530927861|FG010|Overall Study|Lost to Follow-up|0|||
147206828|NCT02541604|530927862|FG011|Overall Study|Lost to Follow-up|0|||
147206829|NCT02541604|530927851|FG000|Overall Study|Withdrawal by Subject|2|||
147206830|NCT02541604|530927852|FG001|Overall Study|Withdrawal by Subject|0|||
147206831|NCT02541604|530927853|FG002|Overall Study|Withdrawal by Subject|1|||
147206832|NCT02541604|530927854|FG003|Overall Study|Withdrawal by Subject|0|||
147206833|NCT02541604|530927855|FG004|Overall Study|Withdrawal by Subject|1|||
147206834|NCT02541604|530927856|FG005|Overall Study|Withdrawal by Subject|1|||
147206835|NCT02541604|530927857|FG006|Overall Study|Withdrawal by Subject|0|||
147206836|NCT02541604|530927858|FG007|Overall Study|Withdrawal by Subject|0|||
147206837|NCT02541604|530927859|FG008|Overall Study|Withdrawal by Subject|1|||
147206838|NCT02541604|530927860|FG009|Overall Study|Withdrawal by Subject|0|||
147206839|NCT02541604|530927861|FG010|Overall Study|Withdrawal by Subject|0|||
147206840|NCT02541604|530927862|FG011|Overall Study|Withdrawal by Subject|0|||
147206841|NCT02541604|530927851|FG000|Overall Study|Study Terminated by Sponsor|1|||
147206842|NCT02541604|530927852|FG001|Overall Study|Study Terminated by Sponsor|4|||
147206843|NCT02541604|530927853|FG002|Overall Study|Study Terminated by Sponsor|2|||
147206844|NCT02541604|530927854|FG003|Overall Study|Study Terminated by Sponsor|1|||
147206845|NCT02541604|530927855|FG004|Overall Study|Study Terminated by Sponsor|0|||
147206846|NCT02541604|530927856|FG005|Overall Study|Study Terminated by Sponsor|0|||
147206847|NCT02541604|530927857|FG006|Overall Study|Study Terminated by Sponsor|0|||
147206848|NCT02541604|530927858|FG007|Overall Study|Study Terminated by Sponsor|0|||
147206849|NCT02541604|530927859|FG008|Overall Study|Study Terminated by Sponsor|0|||
147206850|NCT02541604|530927860|FG009|Overall Study|Study Terminated by Sponsor|0|||
147206851|NCT02541604|530927861|FG010|Overall Study|Study Terminated by Sponsor|0|||
147206852|NCT02541604|530927862|FG011|Overall Study|Study Terminated by Sponsor|0|||
147206853|NCT02541604|530927851|FG000|Overall Study|Medical condition may jeopardize safety|0|||
147206854|NCT02541604|530927852|FG001|Overall Study|Medical condition may jeopardize safety|0|||
147206855|NCT02541604|530927853|FG002|Overall Study|Medical condition may jeopardize safety|0|||
147206856|NCT02541604|530927854|FG003|Overall Study|Medical condition may jeopardize safety|0|||
147206857|NCT02541604|530927855|FG004|Overall Study|Medical condition may jeopardize safety|0|||
147206858|NCT02541604|530927856|FG005|Overall Study|Medical condition may jeopardize safety|0|||
147206859|NCT02541604|530927857|FG006|Overall Study|Medical condition may jeopardize safety|0|||
147206860|NCT02541604|530927858|FG007|Overall Study|Medical condition may jeopardize safety|1|||
147206861|NCT02541604|530927859|FG008|Overall Study|Medical condition may jeopardize safety|0|||
147206862|NCT02541604|530927860|FG009|Overall Study|Medical condition may jeopardize safety|0|||
147206863|NCT02541604|530927861|FG010|Overall Study|Medical condition may jeopardize safety|0|||
147206864|NCT02541604|530927862|FG011|Overall Study|Medical condition may jeopardize safety|0|||
147206865|NCT00828204|530927863|FG000|Main Study: Prior to Study Suspension|Adverse Event|1|||
147206866|NCT00828204|530927864|FG001|Main Study: Prior to Study Suspension|Adverse Event|0|||
147206867|NCT00828204|530927863|FG000|Main Study: Prior to Study Suspension|Subject Was Withdrawn|2|||
147206868|NCT00828204|530927864|FG001|Main Study: Prior to Study Suspension|Subject Was Withdrawn|0|||
147206869|NCT00828204|530927863|FG000|Main Study: Prior to Study Suspension|Study Suspension|11|||
147206870|NCT00828204|530927864|FG001|Main Study: Prior to Study Suspension|Study Suspension|0|||
147206871|NCT00828204|530927863|FG000|Main Study: After Study Restart|Adverse Event|0|||
147206872|NCT00828204|530927864|FG001|Main Study: After Study Restart|Adverse Event|2|||
147206873|NCT00828204|530927863|FG000|Main Study: After Study Restart|Noncompliance|0|||
147206874|NCT00828204|530927864|FG001|Main Study: After Study Restart|Noncompliance|1|||
147206875|NCT00828204|530927863|FG000|Extension Study|Lost to Follow-up|0|||
147206876|NCT00828204|530927864|FG001|Extension Study|Lost to Follow-up|1|||
147206877|NCT00828204|530927863|FG000|Extension Study|Physician Decision|0|||
147206878|NCT00828204|530927864|FG001|Extension Study|Physician Decision|2|||
147206879|NCT01615029|530927865|FG000|Overall Study|Adverse Event|0|||
147206880|NCT01615029|530927866|FG001|Overall Study|Adverse Event|0|||
147206881|NCT01615029|530927867|FG002|Overall Study|Adverse Event|0|||
147206882|NCT01615029|530927868|FG003|Overall Study|Adverse Event|0|||
147206883|NCT01615029|530927869|FG004|Overall Study|Adverse Event|1|||
147206884|NCT01615029|530927865|FG000|Overall Study|Death|0|||
147206885|NCT01615029|530927866|FG001|Overall Study|Death|0|||
147206886|NCT01615029|530927867|FG002|Overall Study|Death|0|||
147206887|NCT01615029|530927868|FG003|Overall Study|Death|0|||
147206888|NCT01615029|530927869|FG004|Overall Study|Death|1|||
147206889|NCT01615029|530927865|FG000|Overall Study|Lost to Follow-up|0|||
147206890|NCT01615029|530927866|FG001|Overall Study|Lost to Follow-up|0|||
147206891|NCT01615029|530927867|FG002|Overall Study|Lost to Follow-up|0|||
147206892|NCT01615029|530927868|FG003|Overall Study|Lost to Follow-up|0|||
147206893|NCT01615029|530927869|FG004|Overall Study|Lost to Follow-up|1|||
147206894|NCT01615029|530927865|FG000|Overall Study|Progressive disease|2|||
147206895|NCT01615029|530927866|FG001|Overall Study|Progressive disease|1|||
147206896|NCT01615029|530927867|FG002|Overall Study|Progressive disease|1|||
147206897|NCT01615029|530927868|FG003|Overall Study|Progressive disease|1|||
147206898|NCT01615029|530927869|FG004|Overall Study|Progressive disease|5|||
147206899|NCT01615029|530927865|FG000|Overall Study|Physician Decision|0|||
147206900|NCT01615029|530927866|FG001|Overall Study|Physician Decision|0|||
147206901|NCT01615029|530927867|FG002|Overall Study|Physician Decision|0|||
147206902|NCT01615029|530927868|FG003|Overall Study|Physician Decision|0|||
147206903|NCT01615029|530927869|FG004|Overall Study|Physician Decision|1|||
147206904|NCT01615029|530927865|FG000|Overall Study|Ongoing|1|||
147206905|NCT01615029|530927866|FG001|Overall Study|Ongoing|2|||
147206906|NCT01615029|530927867|FG002|Overall Study|Ongoing|3|||
147206907|NCT01615029|530927868|FG003|Overall Study|Ongoing|2|||
147206908|NCT01615029|530927869|FG004|Overall Study|Ongoing|23|||
147206909|NCT05064358|530927870|FG000|Overall Study|Death|23|||
147206910|NCT05064358|530927871|FG001|Overall Study|Death|23|||
147206911|NCT05064358|530927872|FG002|Overall Study|Death|25|||
147206912|NCT05064358|530927873|FG003|Overall Study|Death|21|||
147206913|NCT05064358|530927874|FG004|Overall Study|Death|5|||
147206914|NCT05064358|530927870|FG000|Overall Study|Lost to Follow-up|1|||
147206915|NCT05064358|530927871|FG001|Overall Study|Lost to Follow-up|2|||
147206916|NCT05064358|530927872|FG002|Overall Study|Lost to Follow-up|0|||
147206917|NCT05064358|530927873|FG003|Overall Study|Lost to Follow-up|2|||
147206918|NCT05064358|530927874|FG004|Overall Study|Lost to Follow-up|0|||
147206919|NCT05064358|530927870|FG000|Overall Study|Physician Decision|1|||
147541436|NCT02962739|532136418|FG005|Overall Study|Withdrawal by Subject|0|||
147541437|NCT02962739|532136413|FG000|Overall Study|Protocol Violation|0|||
147541438|NCT02962739|532136414|FG001|Overall Study|Protocol Violation|0|||
147541439|NCT02962739|532136415|FG002|Overall Study|Protocol Violation|1|||
147541440|NCT02962739|532136416|FG003|Overall Study|Protocol Violation|0|||
147541441|NCT02962739|532136417|FG004|Overall Study|Protocol Violation|1|||
147541442|NCT02962739|532136418|FG005|Overall Study|Protocol Violation|0|||
147206920|NCT05064358|530927871|FG001|Overall Study|Physician Decision|1|||
147541443|NCT00414011|532136419|FG000|Overall Study|Physician Decision|3|||
147541444|NCT00414011|532136419|FG000|Overall Study|Withdrawal by Subject|2|||
147541445|NCT02360397|532136426|FG000|Overall Study|Incomplete screening|3|||
147541446|NCT02360397|532136426|FG000|Overall Study|Adverse Event|1|||
147541447|NCT01537549|532136427|FG000|Overall Study|Lost to Follow-up|1|||
147541448|NCT01537549|532136427|FG000|Overall Study|Withdrawal by Subject|2|||
147541449|NCT05349188|532136434|FG000|Overall Study|Withdrawal by Subject|1|||
147541450|NCT05349188|532136435|FG001|Overall Study|Withdrawal by Subject|0|||
147541451|NCT00131937|532136436|FG000|Overall Study|Adverse Event|3|||
147541452|NCT00131937|532136436|FG000|Overall Study|Withdrawal by Subject|2|||
147541453|NCT00131937|532136436|FG000|Overall Study|Physician Decision|1|||
147541454|NCT00131937|532136436|FG000|Overall Study|Disease Progression|7|||
147541455|NCT00131937|532136436|FG000|Overall Study|Alternative therapy|1|||
147206921|NCT05064358|530927872|FG002|Overall Study|Physician Decision|2|||
147206922|NCT05064358|530927873|FG003|Overall Study|Physician Decision|0|||
147206923|NCT05064358|530927874|FG004|Overall Study|Physician Decision|0|||
147206924|NCT05064358|530927870|FG000|Overall Study|Withdrawal by Subject|4|||
147206925|NCT05064358|530927871|FG001|Overall Study|Withdrawal by Subject|5|||
147206926|NCT05064358|530927872|FG002|Overall Study|Withdrawal by Subject|3|||
147206927|NCT05064358|530927873|FG003|Overall Study|Withdrawal by Subject|6|||
147206928|NCT05064358|530927874|FG004|Overall Study|Withdrawal by Subject|3|||
147206929|NCT05064358|530927870|FG000|Overall Study|Ongoing at the time of analysis|1|||
147206930|NCT05064358|530927871|FG001|Overall Study|Ongoing at the time of analysis|2|||
147206931|NCT05064358|530927872|FG002|Overall Study|Ongoing at the time of analysis|2|||
147206932|NCT05064358|530927873|FG003|Overall Study|Ongoing at the time of analysis|2|||
147206933|NCT05064358|530927874|FG004|Overall Study|Ongoing at the time of analysis|2|||
147206934|NCT01287741|530927875|FG000|Overall Study|Withdrawal by Subject|35|||
147541456|NCT03703297|532136437|FG000|Overall Study|Death|115|||
147541457|NCT03703297|532136438|FG001|Overall Study|Death|0|||
147541458|NCT03703297|532136439|FG002|Overall Study|Death|144|||
147541459|NCT03703297|532136437|FG000|Overall Study|Withdrawal by Subject|9|||
147541460|NCT03703297|532136438|FG001|Overall Study|Withdrawal by Subject|0|||
147541461|NCT03703297|532136439|FG002|Overall Study|Withdrawal by Subject|11|||
147541462|NCT03703297|532136437|FG000|Overall Study|Ongoing at the time of DCO|140|||
147649436|NCT02634801|532537341|FG000|Extension Period (Weeks 24 to 36)|Missing|1|||
147206935|NCT01287741|530927876|FG001|Overall Study|Withdrawal by Subject|38|||
147206936|NCT01287741|530927875|FG000|Overall Study|Protocol Violation|2|||
147206937|NCT01287741|530927876|FG001|Overall Study|Protocol Violation|0|||
147206938|NCT01287741|530927875|FG000|Overall Study|Physician Decision|15|||
147206939|NCT01287741|530927876|FG001|Overall Study|Physician Decision|23|||
147206940|NCT01287741|530927875|FG000|Overall Study|Non-compliance|8|||
147206941|NCT01287741|530927876|FG001|Overall Study|Non-compliance|6|||
147206942|NCT01287741|530927875|FG000|Overall Study|Lost to Follow-up|10|||
147206943|NCT01287741|530927876|FG001|Overall Study|Lost to Follow-up|8|||
147206944|NCT01287741|530927875|FG000|Overall Study|Death|32|||
147206945|NCT01287741|530927876|FG001|Overall Study|Death|44|||
147541463|NCT03703297|532136438|FG001|Overall Study|Ongoing at the time of DCO|200|||
147206946|NCT01287741|530927875|FG000|Overall Study|Adverse Event|4|||
147206947|NCT01287741|530927876|FG001|Overall Study|Adverse Event|6|||
147206948|NCT01287741|530927875|FG000|Overall Study|Study terminated by Sponsor|307|||
147206949|NCT01287741|530927876|FG001|Overall Study|Study terminated by Sponsor|315|||
147206950|NCT01287741|530927875|FG000|Overall Study|Progressive disease|190|||
147206951|NCT01287741|530927876|FG001|Overall Study|Progressive disease|166|||
147206952|NCT01287741|530927875|FG000|Overall Study|Reason not specified|23|||
147206953|NCT01287741|530927876|FG001|Overall Study|Reason not specified|9|||
147206954|NCT04421027|530927877|FG000|Treatment Period|Adverse Event|5|||
147439651|NCT00058552|531775790|FG000|Overall Study|Adverse Event|4|||
147439652|NCT00058552|531775791|FG001|Overall Study|Adverse Event|2|||
147439653|NCT00058552|531775790|FG000|Overall Study|Withdrawal by Subject|3|||
147439654|NCT00058552|531775791|FG001|Overall Study|Withdrawal by Subject|5|||
147439655|NCT00058552|531775790|FG000|Overall Study|Physician Decision|2|||
147439656|NCT00058552|531775791|FG001|Overall Study|Physician Decision|5|||
147439657|NCT00058552|531775790|FG000|Overall Study|Clinical disease progression|0|||
147439658|NCT00058552|531775791|FG001|Overall Study|Clinical disease progression|4|||
147439659|NCT03861936|531775792|FG000|Overall Study|Withdrawal by Subject|4|||
147439660|NCT03861936|531775793|FG001|Overall Study|Withdrawal by Subject|1|||
147439661|NCT03861936|531775794|FG002|Overall Study|Withdrawal by Subject|3|||
147439662|NCT03861936|531775792|FG000|Overall Study|Lost to Follow-up|5|||
147439663|NCT03861936|531775793|FG001|Overall Study|Lost to Follow-up|3|||
147439664|NCT03861936|531775794|FG002|Overall Study|Lost to Follow-up|3|||
147439665|NCT03861936|531775792|FG000|Overall Study|Physician Decision|0|||
147439666|NCT03861936|531775793|FG001|Overall Study|Physician Decision|1|||
147439667|NCT03861936|531775794|FG002|Overall Study|Physician Decision|0|||
147439668|NCT03861936|531775792|FG000|Overall Study|Protocol Deviation|0|||
147439669|NCT03861936|531775793|FG001|Overall Study|Protocol Deviation|0|||
147439670|NCT03861936|531775794|FG002|Overall Study|Protocol Deviation|1|||
147439671|NCT03861936|531775792|FG000|Overall Study|Reason not Specified|5|||
147439672|NCT03861936|531775793|FG001|Overall Study|Reason not Specified|5|||
147439673|NCT03861936|531775794|FG002|Overall Study|Reason not Specified|3|||
147439674|NCT02319668|531775795|FG000|Overall Study|Other (Not specified)|0|||
147439675|NCT02319668|531775796|FG001|Overall Study|Other (Not specified)|2|||
147439676|NCT01372150|531775801|FG000|Overall Study|Lack of Efficacy|3|||
147439677|NCT01372150|531775802|FG001|Overall Study|Lack of Efficacy|0|||
147439678|NCT01372150|531775803|FG002|Overall Study|Lack of Efficacy|1|||
147439679|NCT01372150|531775801|FG000|Overall Study|Lost to Follow-up|4|||
147439680|NCT01372150|531775802|FG001|Overall Study|Lost to Follow-up|5|||
147439681|NCT01372150|531775803|FG002|Overall Study|Lost to Follow-up|6|||
147439682|NCT01372150|531775801|FG000|Overall Study|Protocol Violation|1|||
147439683|NCT01372150|531775802|FG001|Overall Study|Protocol Violation|0|||
147439684|NCT01372150|531775803|FG002|Overall Study|Protocol Violation|3|||
147439685|NCT01372150|531775801|FG000|Overall Study|Withdrawal by Subject|2|||
147439686|NCT01372150|531775802|FG001|Overall Study|Withdrawal by Subject|7|||
147439687|NCT01372150|531775803|FG002|Overall Study|Withdrawal by Subject|2|||
147439688|NCT01372150|531775801|FG000|Overall Study|Other|1|||
147439689|NCT01372150|531775802|FG001|Overall Study|Other|0|||
147439690|NCT01372150|531775803|FG002|Overall Study|Other|2|||
147439691|NCT01372150|531775801|FG000|Overall Study|Adverse Event|2|||
147439692|NCT01372150|531775802|FG001|Overall Study|Adverse Event|1|||
147439693|NCT01372150|531775803|FG002|Overall Study|Adverse Event|2|||
147439694|NCT01372150|531775801|FG000|Overall Study|Randomized but not treated|0|||
147439695|NCT01372150|531775802|FG001|Overall Study|Randomized but not treated|1|||
147439696|NCT01372150|531775803|FG002|Overall Study|Randomized but not treated|0|||
147439697|NCT03198520|531775804|FG000|Overall Study|Physician Decision|2|||
147439698|NCT03198520|531775804|FG000|Overall Study|Protocol Violation|2|||
147439699|NCT03198520|531775804|FG000|Overall Study|Withdrawal by Subject|1|||
147439700|NCT03198520|531775804|FG000|Overall Study|Study Ended|1|||
147439701|NCT01670539|531775805|FG000|Overall Study|Death|3|||
147439702|NCT01670539|531775806|FG001|Overall Study|Death|5|||
147439703|NCT01670539|531775805|FG000|Overall Study|Withdrawal by Subject|3|||
147439704|NCT01670539|531775806|FG001|Overall Study|Withdrawal by Subject|0|||
147439705|NCT01236573|531775807|FG000|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
147439706|NCT01236573|531775808|FG001|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
147439707|NCT01236573|531775809|FG002|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
147439708|NCT01236573|531775810|FG003|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
147439709|NCT01236573|531775811|FG004|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
147439710|NCT01236573|531775812|FG005|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
147439711|NCT01236573|531775813|FG006|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|1|||
147439712|NCT01236573|531775814|FG007|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
147439713|NCT01236573|531775815|FG008|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|1|||
147206955|NCT04421027|530927878|FG001|Treatment Period|Adverse Event|3|||
147206956|NCT04421027|530927879|FG002|Treatment Period|Adverse Event|0|||
147206957|NCT04421027|530927880|FG003|Treatment Period|Adverse Event|0|||
147206958|NCT04421027|530927877|FG000|Treatment Period|Death|98|||
147206959|NCT04421027|530927878|FG001|Treatment Period|Death|61|||
147206960|NCT04421027|530927879|FG002|Treatment Period|Death|0|||
147206961|NCT04421027|530927880|FG003|Treatment Period|Death|0|||
147206962|NCT04421027|530927877|FG000|Treatment Period|Lost to Follow-up|22|||
147206963|NCT04421027|530927878|FG001|Treatment Period|Lost to Follow-up|20|||
147206964|NCT04421027|530927879|FG002|Treatment Period|Lost to Follow-up|0|||
147206965|NCT04421027|530927880|FG003|Treatment Period|Lost to Follow-up|0|||
147206966|NCT04421027|530927877|FG000|Treatment Period|Other-Unknown|15|||
147206967|NCT04421027|530927878|FG001|Treatment Period|Other-Unknown|9|||
147206968|NCT04421027|530927879|FG002|Treatment Period|Other-Unknown|0|||
147206969|NCT04421027|530927880|FG003|Treatment Period|Other-Unknown|0|||
147206970|NCT04421027|530927877|FG000|Treatment Period|Physician Decision|1|||
147206971|NCT04421027|530927878|FG001|Treatment Period|Physician Decision|1|||
147206972|NCT04421027|530927879|FG002|Treatment Period|Physician Decision|0|||
147206973|NCT04421027|530927880|FG003|Treatment Period|Physician Decision|0|||
147206974|NCT04421027|530927877|FG000|Treatment Period|Withdrawal by Subject|7|||
147206975|NCT04421027|530927878|FG001|Treatment Period|Withdrawal by Subject|12|||
147206976|NCT04421027|530927879|FG002|Treatment Period|Withdrawal by Subject|0|||
147206977|NCT04421027|530927880|FG003|Treatment Period|Withdrawal by Subject|0|||
147206978|NCT04421027|530927877|FG000|Treatment Period|Randomized Not Dosed|9|||
147206979|NCT04421027|530927878|FG001|Treatment Period|Randomized Not Dosed|14|||
147206980|NCT04421027|530927879|FG002|Treatment Period|Randomized Not Dosed|0|||
147206981|NCT04421027|530927880|FG003|Treatment Period|Randomized Not Dosed|0|||
147206982|NCT04421027|530927877|FG000|Follow-Up Period|Adverse Event|0|||
147206983|NCT04421027|530927878|FG001|Follow-Up Period|Adverse Event|0|||
147206984|NCT04421027|530927879|FG002|Follow-Up Period|Adverse Event|0|||
147206985|NCT04421027|530927880|FG003|Follow-Up Period|Adverse Event|3|||
147206986|NCT04421027|530927877|FG000|Follow-Up Period|Death|0|||
147206987|NCT04421027|530927878|FG001|Follow-Up Period|Death|0|||
147206988|NCT04421027|530927879|FG002|Follow-Up Period|Death|16|||
147206989|NCT04421027|530927880|FG003|Follow-Up Period|Death|17|||
147206990|NCT04421027|530927877|FG000|Follow-Up Period|Lost to Follow-up|0|||
147206991|NCT04421027|530927878|FG001|Follow-Up Period|Lost to Follow-up|0|||
147206992|NCT04421027|530927879|FG002|Follow-Up Period|Lost to Follow-up|7|||
147206993|NCT04421027|530927880|FG003|Follow-Up Period|Lost to Follow-up|7|||
147206994|NCT04421027|530927877|FG000|Follow-Up Period|Protocol Deviation|0|||
147206995|NCT04421027|530927878|FG001|Follow-Up Period|Protocol Deviation|0|||
147206996|NCT04421027|530927879|FG002|Follow-Up Period|Protocol Deviation|1|||
147206997|NCT04421027|530927880|FG003|Follow-Up Period|Protocol Deviation|0|||
147206998|NCT04421027|530927877|FG000|Follow-Up Period|Still in hospital on ventilator at end of study|0|||
147439714|NCT01236573|531775816|FG009|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|1|||
147439715|NCT01236573|531775817|FG010|Phase 1-Dose Escalation-Cohorts 5-10|Death during treatment|0|||
147439716|NCT01236573|531775807|FG000|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
147439717|NCT01236573|531775808|FG001|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
147439718|NCT01236573|531775809|FG002|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
147439719|NCT01236573|531775810|FG003|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
147439720|NCT01236573|531775811|FG004|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
147439721|NCT01236573|531775812|FG005|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
147439722|NCT01236573|531775813|FG006|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
147439723|NCT01236573|531775814|FG007|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
147439724|NCT01236573|531775815|FG008|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|1|||
147439725|NCT01236573|531775816|FG009|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
147439726|NCT01236573|531775817|FG010|Phase 1-Dose Escalation-Cohorts 5-10|Not treated|0|||
147439727|NCT01236573|531775807|FG000|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
147439728|NCT01236573|531775808|FG001|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
147439729|NCT01236573|531775809|FG002|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
147439730|NCT01236573|531775810|FG003|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
147439731|NCT01236573|531775811|FG004|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
147439732|NCT01236573|531775812|FG005|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
147439733|NCT01236573|531775813|FG006|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
147439734|NCT01236573|531775814|FG007|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
147206999|NCT04421027|530927878|FG001|Follow-Up Period|Still in hospital on ventilator at end of study|0|||
147207000|NCT04421027|530927879|FG002|Follow-Up Period|Still in hospital on ventilator at end of study|1|||
147207001|NCT04421027|530927880|FG003|Follow-Up Period|Still in hospital on ventilator at end of study|0|||
147207002|NCT04421027|530927877|FG000|Follow-Up Period|Left message, participant did not call back|0|||
147207003|NCT04421027|530927878|FG001|Follow-Up Period|Left message, participant did not call back|0|||
147207004|NCT04421027|530927879|FG002|Follow-Up Period|Left message, participant did not call back|0|||
147207005|NCT04421027|530927880|FG003|Follow-Up Period|Left message, participant did not call back|1|||
147207006|NCT04421027|530927877|FG000|Follow-Up Period|Participant died|0|||
147207007|NCT04421027|530927878|FG001|Follow-Up Period|Participant died|0|||
147207008|NCT04421027|530927879|FG002|Follow-Up Period|Participant died|0|||
147207009|NCT04421027|530927880|FG003|Follow-Up Period|Participant died|1|||
147207010|NCT04421027|530927877|FG000|Follow-Up Period|Participant was alive but did not respond to calls|0|||
147207011|NCT04421027|530927878|FG001|Follow-Up Period|Participant was alive but did not respond to calls|0|||
147207012|NCT04421027|530927879|FG002|Follow-Up Period|Participant was alive but did not respond to calls|0|||
147207013|NCT04421027|530927880|FG003|Follow-Up Period|Participant was alive but did not respond to calls|1|||
147207014|NCT05767749|530927890|FG000|Overall Study|Withdrawal by Subject|0|||
147207015|NCT05767749|530927891|FG001|Overall Study|Withdrawal by Subject|0|||
147207016|NCT05767749|530927892|FG002|Overall Study|Withdrawal by Subject|2|||
147207017|NCT05767749|530927893|FG003|Overall Study|Withdrawal by Subject|2|||
147207018|NCT05767749|530927894|FG004|Overall Study|Withdrawal by Subject|2|||
147207019|NCT05767749|530927895|FG005|Overall Study|Withdrawal by Subject|2|||
147207020|NCT03083873|530929503|FG000|Overall Study|Death|6|||
147207021|NCT03083873|530929504|FG001|Overall Study|Death|15|||
147207022|NCT03083873|530929505|FG002|Overall Study|Death|13|||
147207023|NCT03083873|530929506|FG003|Overall Study|Death|9|||
147207024|NCT03083873|530929507|FG004|Overall Study|Death|0|||
147207025|NCT03083873|530929503|FG000|Overall Study|Sponsor Terminated Study|0|||
147207026|NCT03083873|530929504|FG001|Overall Study|Sponsor Terminated Study|1|||
147207027|NCT03083873|530929505|FG002|Overall Study|Sponsor Terminated Study|2|||
147207028|NCT03083873|530929506|FG003|Overall Study|Sponsor Terminated Study|3|||
147207029|NCT03083873|530929507|FG004|Overall Study|Sponsor Terminated Study|0|||
147207030|NCT03083873|530929503|FG000|Overall Study|Lost to Follow-up|0|||
147207031|NCT03083873|530929504|FG001|Overall Study|Lost to Follow-up|1|||
147207032|NCT03083873|530929505|FG002|Overall Study|Lost to Follow-up|1|||
147207033|NCT03083873|530929506|FG003|Overall Study|Lost to Follow-up|0|||
147207034|NCT03083873|530929507|FG004|Overall Study|Lost to Follow-up|0|||
147207035|NCT03083873|530929503|FG000|Overall Study|Withdrawal by Subject|2|||
147207036|NCT03083873|530929504|FG001|Overall Study|Withdrawal by Subject|0|||
147207037|NCT03083873|530929505|FG002|Overall Study|Withdrawal by Subject|0|||
147207038|NCT03083873|530929506|FG003|Overall Study|Withdrawal by Subject|0|||
147207039|NCT03083873|530929507|FG004|Overall Study|Withdrawal by Subject|0|||
147207040|NCT03083873|530929503|FG000|Overall Study|Did Not Receive TIL|2|||
147207041|NCT03083873|530929504|FG001|Overall Study|Did Not Receive TIL|5|||
147207042|NCT03083873|530929505|FG002|Overall Study|Did Not Receive TIL|3|||
147207043|NCT03083873|530929506|FG003|Overall Study|Did Not Receive TIL|1|||
147207044|NCT03083873|530929507|FG004|Overall Study|Did Not Receive TIL|0|||
147207045|NCT02260180|530929511|FG000|Overall Study|Adverse Event|2|||
147207046|NCT02260180|530929512|FG001|Overall Study|Adverse Event|0|||
147207047|NCT02260180|530929513|FG002|Overall Study|Adverse Event|1|||
147207048|NCT03126344|530929520|FG000|Overall Study|Lost to Follow-up|0|||
147207049|NCT03126344|530929521|FG001|Overall Study|Lost to Follow-up|0|||
147207050|NCT03126344|530929522|FG002|Overall Study|Lost to Follow-up|5|||
147207051|NCT01027273|530929523|FG000|Overall Study|Lost to Follow-up|57|||
147207052|NCT01027273|530929524|FG001|Overall Study|Lost to Follow-up|31|||
147207053|NCT01027273|530929523|FG000|Overall Study|Death|2|||
147207054|NCT01027273|530929524|FG001|Overall Study|Death|2|||
147207055|NCT01330108|530929531|FG000|Overall Study|Withdrawal by Subject|4|||
147207056|NCT00485134|530929532|FG000|Overall Study|Lost to Follow-up|1|||
147207057|NCT00485134|530929533|FG001|Overall Study|Lost to Follow-up|0|||
147207058|NCT00485134|530929534|FG002|Overall Study|Lost to Follow-up|0|||
147207059|NCT00485134|530929535|FG003|Overall Study|Lost to Follow-up|0|||
147207060|NCT00485134|530929536|FG004|Overall Study|Lost to Follow-up|0|||
147207061|NCT00485134|530929537|FG005|Overall Study|Lost to Follow-up|0|||
147207062|NCT00485134|530929538|FG006|Overall Study|Lost to Follow-up|0|||
147207063|NCT00485134|530929539|FG007|Overall Study|Lost to Follow-up|0|||
147207064|NCT00485134|530929532|FG000|Overall Study|Withdrawal by Subject|0|||
147439735|NCT01236573|531775815|FG008|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
147439736|NCT01236573|531775816|FG009|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|0|||
147439737|NCT01236573|531775817|FG010|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11|Did not receive cells|1|||
147439738|NCT02665052|531775818|FG000|Overall Study|Lost to Follow-up|1|||
147439739|NCT02665052|531775819|FG001|Overall Study|Lost to Follow-up|0|||
147439740|NCT02665052|531775820|FG002|Overall Study|Lost to Follow-up|0|||
147439741|NCT02665052|531775821|FG003|Overall Study|Lost to Follow-up|0|||
147439742|NCT02665052|531775818|FG000|Overall Study|Withdrawal by Subject|1|||
147439743|NCT02665052|531775819|FG001|Overall Study|Withdrawal by Subject|1|||
147207065|NCT00485134|530929533|FG001|Overall Study|Withdrawal by Subject|1|||
147207066|NCT00485134|530929534|FG002|Overall Study|Withdrawal by Subject|0|||
147207067|NCT00485134|530929535|FG003|Overall Study|Withdrawal by Subject|0|||
147207068|NCT00485134|530929536|FG004|Overall Study|Withdrawal by Subject|0|||
147207069|NCT00485134|530929537|FG005|Overall Study|Withdrawal by Subject|0|||
147207070|NCT00485134|530929538|FG006|Overall Study|Withdrawal by Subject|0|||
147207071|NCT00485134|530929539|FG007|Overall Study|Withdrawal by Subject|0|||
147207072|NCT00485134|530929532|FG000|Overall Study|Change in health status|0|||
147207073|NCT00485134|530929533|FG001|Overall Study|Change in health status|1|||
147207074|NCT00485134|530929534|FG002|Overall Study|Change in health status|2|||
147207075|NCT00485134|530929535|FG003|Overall Study|Change in health status|1|||
147207076|NCT00485134|530929536|FG004|Overall Study|Change in health status|0|||
147207077|NCT00485134|530929537|FG005|Overall Study|Change in health status|1|||
147207078|NCT00485134|530929538|FG006|Overall Study|Change in health status|0|||
147207079|NCT00485134|530929539|FG007|Overall Study|Change in health status|0|||
147207080|NCT00485134|530929532|FG000|Overall Study|Withdrew for adverse event|0|||
147207081|NCT00485134|530929533|FG001|Overall Study|Withdrew for adverse event|0|||
147207082|NCT00485134|530929534|FG002|Overall Study|Withdrew for adverse event|1|||
147207083|NCT00485134|530929535|FG003|Overall Study|Withdrew for adverse event|0|||
147207084|NCT00485134|530929536|FG004|Overall Study|Withdrew for adverse event|0|||
147207085|NCT00485134|530929537|FG005|Overall Study|Withdrew for adverse event|0|||
147541464|NCT03703297|532136439|FG002|Overall Study|Ongoing at the time of DCO|111|||
147541465|NCT01211613|532137970|FG000|Overall Study|Lost to Follow-up|2|||
147541466|NCT01211613|532137971|FG001|Overall Study|Lost to Follow-up|2|||
147541467|NCT01211613|532137972|FG002|Overall Study|Lost to Follow-up|2|||
147541468|NCT01211613|532137970|FG000|Overall Study|Withdrawal by Subject|1|||
147541469|NCT01211613|532137971|FG001|Overall Study|Withdrawal by Subject|0|||
147541470|NCT01211613|532137972|FG002|Overall Study|Withdrawal by Subject|0|||
147541471|NCT01020773|532137973|FG000|Overall Study|Withdrawal by Subject|4|||
147541472|NCT01020773|532137974|FG001|Overall Study|Withdrawal by Subject|3|||
147541473|NCT03853213|532137975|FG000|Overall Study|Extenuating Circumstances (COVID-19 pandemic)|1|||
147541474|NCT03853213|532137976|FG001|Overall Study|Extenuating Circumstances (COVID-19 pandemic)|0|||
147541475|NCT03853213|532137975|FG000|Overall Study|Other (e.g., too busy)|0|||
147439744|NCT02665052|531775820|FG002|Overall Study|Withdrawal by Subject|0|||
147439745|NCT02665052|531775821|FG003|Overall Study|Withdrawal by Subject|5|||
147439746|NCT02665052|531775818|FG000|Overall Study|Adverse Event|1|||
147439747|NCT02665052|531775819|FG001|Overall Study|Adverse Event|1|||
147439748|NCT02665052|531775820|FG002|Overall Study|Adverse Event|0|||
147439749|NCT02665052|531775821|FG003|Overall Study|Adverse Event|0|||
147439750|NCT00823823|531775822|FG000|Overall Study|Lost to Follow-up|3|||
147439751|NCT00823823|531775823|FG001|Overall Study|Lost to Follow-up|1|||
147541476|NCT03853213|532137976|FG001|Overall Study|Other (e.g., too busy)|2|||
147541477|NCT03302299|532137977|FG000|Overall Study|Protocol Violation|1|||
147541478|NCT01458132|532137978|FG000|Overall Study|Other|15|||
147541479|NCT01458132|532137979|FG001|Overall Study|Other|3|||
147541480|NCT01788163|532137980|FG000|Overall Study|Other|53|||
147541481|NCT01788163|532137981|FG001|Overall Study|Other|0|||
147541482|NCT01788163|532137982|FG002|Overall Study|Other|0|||
147541483|NCT01788163|532137983|FG003|Overall Study|Other|0|||
147207086|NCT00485134|530929538|FG006|Overall Study|Withdrew for adverse event|0|||
147207087|NCT00485134|530929539|FG007|Overall Study|Withdrew for adverse event|0|||
147207088|NCT00485134|530929532|FG000|Overall Study|Positive drug test|0|||
147207089|NCT00485134|530929533|FG001|Overall Study|Positive drug test|0|||
147207090|NCT00485134|530929534|FG002|Overall Study|Positive drug test|0|||
147207091|NCT00485134|530929535|FG003|Overall Study|Positive drug test|0|||
147207092|NCT00485134|530929536|FG004|Overall Study|Positive drug test|2|||
147207093|NCT00485134|530929537|FG005|Overall Study|Positive drug test|1|||
147207094|NCT00485134|530929538|FG006|Overall Study|Positive drug test|0|||
147207095|NCT00485134|530929539|FG007|Overall Study|Positive drug test|0|||
147207096|NCT00485134|530929532|FG000|Overall Study|Non-compliance|0|||
147207097|NCT00485134|530929533|FG001|Overall Study|Non-compliance|0|||
147207098|NCT00485134|530929534|FG002|Overall Study|Non-compliance|0|||
147207099|NCT00485134|530929535|FG003|Overall Study|Non-compliance|0|||
147207100|NCT00485134|530929536|FG004|Overall Study|Non-compliance|1|||
147207101|NCT00485134|530929537|FG005|Overall Study|Non-compliance|2|||
147207102|NCT00485134|530929538|FG006|Overall Study|Non-compliance|2|||
147207103|NCT00485134|530929539|FG007|Overall Study|Non-compliance|0|||
147207104|NCT00485134|530929532|FG000|Overall Study|Unable to comply with study schedule|0|||
147207105|NCT00485134|530929533|FG001|Overall Study|Unable to comply with study schedule|0|||
147207106|NCT00485134|530929534|FG002|Overall Study|Unable to comply with study schedule|0|||
147207107|NCT00485134|530929535|FG003|Overall Study|Unable to comply with study schedule|0|||
147439752|NCT00823823|531775822|FG000|Overall Study|Protocol Violation|5|||
147439753|NCT00823823|531775823|FG001|Overall Study|Protocol Violation|5|||
147439754|NCT02234284|531775824|FG000|Overall Study|Death|4|||
147439755|NCT02234284|531775825|FG001|Overall Study|Death|2|||
147439756|NCT02234284|531775824|FG000|Overall Study|Withdrawal by Subject|1|||
147207108|NCT00485134|530929536|FG004|Overall Study|Unable to comply with study schedule|0|||
147207109|NCT00485134|530929537|FG005|Overall Study|Unable to comply with study schedule|0|||
147439757|NCT02234284|531775825|FG001|Overall Study|Withdrawal by Subject|0|||
147439758|NCT02234284|531775824|FG000|Overall Study|Lost to Follow-up|20|||
147541484|NCT01788163|532137984|FG004|Overall Study|Other|0|||
147541485|NCT01788163|532137985|FG005|Overall Study|Other|7|||
147541486|NCT01788163|532137986|FG006|Overall Study|Other|1|||
147541487|NCT01788163|532137987|FG007|Overall Study|Other|48|||
147541488|NCT01788163|532137988|FG008|Overall Study|Other|15|||
147207110|NCT00485134|530929538|FG006|Overall Study|Unable to comply with study schedule|0|||
147439759|NCT02234284|531775825|FG001|Overall Study|Lost to Follow-up|7|||
147207111|NCT00485134|530929539|FG007|Overall Study|Unable to comply with study schedule|1|||
147207112|NCT00485134|530929532|FG000|Overall Study|Pregnancy|0|||
147207113|NCT00485134|530929533|FG001|Overall Study|Pregnancy|0|||
147541489|NCT01788163|532137980|FG000|Overall Study|Withdrawal by Subject|2|||
147541490|NCT01788163|532137981|FG001|Overall Study|Withdrawal by Subject|0|||
147541491|NCT01788163|532137982|FG002|Overall Study|Withdrawal by Subject|0|||
147541492|NCT01788163|532137983|FG003|Overall Study|Withdrawal by Subject|0|||
147541493|NCT01788163|532137984|FG004|Overall Study|Withdrawal by Subject|0|||
147541494|NCT01788163|532137985|FG005|Overall Study|Withdrawal by Subject|0|||
147541495|NCT01788163|532137986|FG006|Overall Study|Withdrawal by Subject|0|||
147541496|NCT01788163|532137987|FG007|Overall Study|Withdrawal by Subject|0|||
147541497|NCT01788163|532137988|FG008|Overall Study|Withdrawal by Subject|1|||
147541498|NCT00545441|532137989|FG000|Overall Study|Fistula draining at 6 months|2|||
147541499|NCT00545441|532137990|FG001|Overall Study|Fistula draining at 6 months|4|||
147541500|NCT00545441|532137989|FG000|Overall Study|Lost to Follow-up|9|||
147541501|NCT00545441|532137990|FG001|Overall Study|Lost to Follow-up|5|||
147541502|NCT00545441|532137989|FG000|Overall Study|Technical failure|0|||
147541503|NCT00545441|532137990|FG001|Overall Study|Technical failure|1|||
147541504|NCT00545441|532137989|FG000|Overall Study|Withdrawal by Subject|1|||
147541505|NCT00545441|532137990|FG001|Overall Study|Withdrawal by Subject|1|||
147541506|NCT00545441|532137989|FG000|Overall Study|Persistence or recurrence of fistula|5|||
147207114|NCT00485134|530929534|FG002|Overall Study|Pregnancy|0|||
147207115|NCT00485134|530929535|FG003|Overall Study|Pregnancy|0|||
147207116|NCT00485134|530929536|FG004|Overall Study|Pregnancy|0|||
147207117|NCT00485134|530929537|FG005|Overall Study|Pregnancy|0|||
147207118|NCT00485134|530929538|FG006|Overall Study|Pregnancy|1|||
147207119|NCT00485134|530929539|FG007|Overall Study|Pregnancy|0|||
147207120|NCT00970684|530929540|FG000|Overall Study|Lack of Efficacy|5|||
147207121|NCT00970684|530929540|FG000|Overall Study|Adverse Event|4|||
147207122|NCT00970684|530929540|FG000|Overall Study|Withdrawal by Subject|1|||
147207123|NCT04294680|530929541|FG000|Overall Study|Withdrawal by Subject|2|||
147207124|NCT04294680|530929542|FG001|Overall Study|Withdrawal by Subject|1|||
147207125|NCT04294680|530929541|FG000|Overall Study|Follow-up visits completed outside of window|1|||
147207126|NCT04294680|530929542|FG001|Overall Study|Follow-up visits completed outside of window|0|||
147207127|NCT00475306|530929543|FG000|Overall Study|Protocol Violation|1|||
147207128|NCT00475306|530929544|FG001|Overall Study|Protocol Violation|1|||
147207129|NCT00475306|530929545|FG002|Overall Study|Protocol Violation|0|||
147207130|NCT00475306|530929546|FG003|Overall Study|Protocol Violation|1|||
147207131|NCT00905645|530929548|FG000|Overall Study|Death (not device related)|10|||
147207132|NCT00905645|530929549|FG001|Overall Study|Death (not device related)|4|||
147207133|NCT00905645|530929550|FG002|Overall Study|Death (not device related)|15|||
147207134|NCT00905645|530929551|FG003|Overall Study|Death (not device related)|8|||
147207135|NCT00905645|530929548|FG000|Overall Study|Explantation of study device(s)|78|||
147207136|NCT00905645|530929549|FG001|Overall Study|Explantation of study device(s)|47|||
147207137|NCT00905645|530929550|FG002|Overall Study|Explantation of study device(s)|28|||
147207138|NCT00905645|530929551|FG003|Overall Study|Explantation of study device(s)|21|||
147207139|NCT00905645|530929548|FG000|Overall Study|Subject Request|41|||
147207140|NCT00905645|530929549|FG001|Overall Study|Subject Request|17|||
147207141|NCT00905645|530929550|FG002|Overall Study|Subject Request|13|||
147207142|NCT00905645|530929551|FG003|Overall Study|Subject Request|11|||
147207143|NCT00905645|530929548|FG000|Overall Study|Lost to Follow-up|299|||
147207144|NCT00905645|530929549|FG001|Overall Study|Lost to Follow-up|103|||
147207145|NCT00905645|530929550|FG002|Overall Study|Lost to Follow-up|51|||
147207146|NCT00905645|530929551|FG003|Overall Study|Lost to Follow-up|12|||
147207147|NCT04881942|530929552|FG000|Overall Study|Adverse Event|0|||
147207148|NCT04881942|530929553|FG001|Overall Study|Adverse Event|0|||
147207149|NCT04881942|530929554|FG002|Overall Study|Adverse Event|0|||
147207150|NCT04881942|530929555|FG003|Overall Study|Adverse Event|0|||
147207151|NCT04881942|530929556|FG004|Overall Study|Adverse Event|1|||
147207152|NCT04881942|530929552|FG000|Overall Study|Alternates|0|||
147207153|NCT04881942|530929553|FG001|Overall Study|Alternates|0|||
147207154|NCT04881942|530929554|FG002|Overall Study|Alternates|0|||
147207155|NCT04881942|530929555|FG003|Overall Study|Alternates|0|||
147207156|NCT04881942|530929556|FG004|Overall Study|Alternates|2|||
147541507|NCT00545441|532137990|FG001|Overall Study|Persistence or recurrence of fistula|2|||
147541508|NCT00545441|532137989|FG000|Overall Study|Patients were not treated|1|||
147541509|NCT00545441|532137990|FG001|Overall Study|Patients were not treated|3|||
147207157|NCT00578292|530929557|FG000|Overall Study|Death|1|||
147207158|NCT00578292|530929557|FG000|Overall Study|Graft failure|2|||
147207159|NCT01485172|530929558|FG000|Overall Study|Adverse Event|2|||
147207160|NCT01485172|530929559|FG001|Overall Study|Adverse Event|1|||
147207161|NCT01485172|530929560|FG002|Overall Study|Adverse Event|2|||
147207162|NCT01485172|530929561|FG003|Overall Study|Adverse Event|2|||
147207163|NCT01485172|530929562|FG004|Overall Study|Adverse Event|1|||
147207164|NCT01485172|530929563|FG005|Overall Study|Adverse Event|2|||
147207165|NCT01485172|530929558|FG000|Overall Study|Lack of Efficacy|2|||
147207166|NCT01485172|530929559|FG001|Overall Study|Lack of Efficacy|0|||
147207167|NCT01485172|530929560|FG002|Overall Study|Lack of Efficacy|0|||
147207168|NCT01485172|530929561|FG003|Overall Study|Lack of Efficacy|0|||
147207169|NCT01485172|530929562|FG004|Overall Study|Lack of Efficacy|0|||
147207170|NCT01485172|530929563|FG005|Overall Study|Lack of Efficacy|0|||
147207171|NCT01485172|530929558|FG000|Overall Study|Protocol Violation|0|||
147207172|NCT01485172|530929559|FG001|Overall Study|Protocol Violation|0|||
147207173|NCT01485172|530929560|FG002|Overall Study|Protocol Violation|4|||
147207174|NCT01485172|530929561|FG003|Overall Study|Protocol Violation|5|||
147207175|NCT01485172|530929562|FG004|Overall Study|Protocol Violation|1|||
147207176|NCT01485172|530929563|FG005|Overall Study|Protocol Violation|0|||
147207177|NCT01485172|530929558|FG000|Overall Study|Protocol defined stopping criteria|1|||
147207178|NCT01485172|530929559|FG001|Overall Study|Protocol defined stopping criteria|0|||
147207179|NCT01485172|530929560|FG002|Overall Study|Protocol defined stopping criteria|0|||
147207180|NCT01485172|530929561|FG003|Overall Study|Protocol defined stopping criteria|0|||
147207181|NCT01485172|530929562|FG004|Overall Study|Protocol defined stopping criteria|1|||
147207182|NCT01485172|530929563|FG005|Overall Study|Protocol defined stopping criteria|0|||
147207183|NCT01485172|530929558|FG000|Overall Study|Lost to Follow-up|0|||
147207184|NCT01485172|530929559|FG001|Overall Study|Lost to Follow-up|0|||
147207185|NCT01485172|530929560|FG002|Overall Study|Lost to Follow-up|1|||
147207186|NCT01485172|530929561|FG003|Overall Study|Lost to Follow-up|0|||
147207187|NCT01485172|530929562|FG004|Overall Study|Lost to Follow-up|0|||
147207188|NCT01485172|530929563|FG005|Overall Study|Lost to Follow-up|1|||
147207189|NCT01485172|530929558|FG000|Overall Study|Physician Decision|0|||
147207190|NCT01485172|530929559|FG001|Overall Study|Physician Decision|0|||
147207191|NCT01485172|530929560|FG002|Overall Study|Physician Decision|0|||
147207192|NCT01485172|530929561|FG003|Overall Study|Physician Decision|0|||
147207193|NCT01485172|530929562|FG004|Overall Study|Physician Decision|1|||
147207194|NCT01485172|530929563|FG005|Overall Study|Physician Decision|0|||
147207195|NCT01485172|530929558|FG000|Overall Study|Withdrawal by Subject|2|||
147207196|NCT01485172|530929559|FG001|Overall Study|Withdrawal by Subject|0|||
147207197|NCT01485172|530929560|FG002|Overall Study|Withdrawal by Subject|0|||
147207198|NCT01485172|530929561|FG003|Overall Study|Withdrawal by Subject|1|||
147207199|NCT01485172|530929562|FG004|Overall Study|Withdrawal by Subject|1|||
147207200|NCT01485172|530929563|FG005|Overall Study|Withdrawal by Subject|1|||
147207201|NCT01587014|530929564|FG000|Overall Study|Death|2|||
147207202|NCT02948088|530929568|FG000|Overall Study|Lost to Follow-up|8|||
147207203|NCT02948088|530929568|FG000|Overall Study|Death|1|||
147207204|NCT02948088|530929568|FG000|Overall Study|Withdrawal by Subject|4|||
147207205|NCT02948088|530929568|FG000|Overall Study|Other|2|||
147207206|NCT00139477|530929572|FG000|First Intervention -Baseline to 6Months|No Longer Interested|6|||
147207207|NCT00139477|530929573|FG001|First Intervention -Baseline to 6Months|No Longer Interested|7|||
147207208|NCT00139477|530929572|FG000|First Intervention -Baseline to 6Months|Relocation|1|||
147207209|NCT00139477|530929573|FG001|First Intervention -Baseline to 6Months|Relocation|2|||
147207210|NCT00139477|530929572|FG000|First Intervention -Baseline to 6Months|Lost to Follow-up|3|||
147207211|NCT00139477|530929573|FG001|First Intervention -Baseline to 6Months|Lost to Follow-up|3|||
147207212|NCT00139477|530929572|FG000|First Intervention -Baseline to 6Months|Impaired Glucose Tolerance at Screening|2|||
147207213|NCT00139477|530929573|FG001|First Intervention -Baseline to 6Months|Impaired Glucose Tolerance at Screening|0|||
147207214|NCT00139477|530929572|FG000|Second Intervention -6Months to 12Months|No Longer Interested|0|||
147207215|NCT00139477|530929573|FG001|Second Intervention -6Months to 12Months|No Longer Interested|2|||
147207216|NCT00139477|530929572|FG000|Second Intervention -6Months to 12Months|Relocation|1|||
147207217|NCT00139477|530929573|FG001|Second Intervention -6Months to 12Months|Relocation|0|||
147207218|NCT00139477|530929572|FG000|Second Intervention -6Months to 12Months|Lost to Follow-up|4|||
147207219|NCT00139477|530929573|FG001|Second Intervention -6Months to 12Months|Lost to Follow-up|3|||
147207220|NCT00975780|530929574|FG000|Follow Up|Death|88|||
147207221|NCT00975780|530929575|FG001|Follow Up|Death|122|||
147207222|NCT00975780|530929574|FG000|Follow Up|Facility Withdrawal|7|||
147207223|NCT00975780|530929575|FG001|Follow Up|Facility Withdrawal|23|||
147207224|NCT00975780|530929574|FG000|Follow Up|Discharged from Facility|7|||
147207225|NCT00975780|530929575|FG001|Follow Up|Discharged from Facility|12|||
147207226|NCT01077076|530929578|FG000|First Intervention|Withdrawal by Subject|1|||
147207227|NCT01077076|530929579|FG001|First Intervention|Withdrawal by Subject|0|||
147207228|NCT01077076|530929580|FG002|First Intervention|Withdrawal by Subject|0|||
147207229|NCT01077076|530929581|FG003|First Intervention|Withdrawal by Subject|0|||
147207230|NCT01077076|530929582|FG004|First Intervention|Withdrawal by Subject|0|||
147207231|NCT01077076|530929583|FG005|First Intervention|Withdrawal by Subject|0|||
147207232|NCT01077076|530929578|FG000|Third Intervention|Death in the participant's family|0|||
147207233|NCT01077076|530929579|FG001|Third Intervention|Death in the participant's family|0|||
147207234|NCT01077076|530929580|FG002|Third Intervention|Death in the participant's family|0|||
147207235|NCT01077076|530929581|FG003|Third Intervention|Death in the participant's family|0|||
147439760|NCT00536809|531775826|FG000|Phase II|Adverse Event|1|||
147439761|NCT00536809|531775826|FG000|Phase II|Referred for surgical resection|1|||
147439762|NCT04569032|531775827|FG000|Overall Study|Death|10|||
147207236|NCT01077076|530929582|FG004|Third Intervention|Death in the participant's family|0|||
147207237|NCT01077076|530929583|FG005|Third Intervention|Death in the participant's family|1|||
147207238|NCT01976741|530929586|FG000|Overall Study|Withdrawal by Subject|1|||
147207239|NCT01976741|530929587|FG001|Overall Study|Withdrawal by Subject|0|||
147207240|NCT01976741|530929588|FG002|Overall Study|Withdrawal by Subject|1|||
147207241|NCT01976741|530929589|FG003|Overall Study|Withdrawal by Subject|1|||
147207242|NCT01976741|530929590|FG004|Overall Study|Withdrawal by Subject|0|||
147439763|NCT04569032|531775828|FG001|Overall Study|Death|13|||
147207243|NCT01976741|530929591|FG005|Overall Study|Withdrawal by Subject|0|||
147207244|NCT01976741|530929592|FG006|Overall Study|Withdrawal by Subject|1|||
147207245|NCT01976741|530929593|FG007|Overall Study|Withdrawal by Subject|4|||
147207246|NCT01976741|530929594|FG008|Overall Study|Withdrawal by Subject|0|||
147207247|NCT01976741|530929595|FG009|Overall Study|Withdrawal by Subject|0|||
147207248|NCT01976741|530929586|FG000|Overall Study|Adverse Event|0|||
147207249|NCT01976741|530929587|FG001|Overall Study|Adverse Event|0|||
147207250|NCT01976741|530929588|FG002|Overall Study|Adverse Event|2|||
147207251|NCT01976741|530929589|FG003|Overall Study|Adverse Event|0|||
147207252|NCT01976741|530929590|FG004|Overall Study|Adverse Event|0|||
147207253|NCT01976741|530929591|FG005|Overall Study|Adverse Event|0|||
147207254|NCT01976741|530929592|FG006|Overall Study|Adverse Event|3|||
147207255|NCT01976741|530929593|FG007|Overall Study|Adverse Event|8|||
147207256|NCT01976741|530929594|FG008|Overall Study|Adverse Event|1|||
147207257|NCT01976741|530929595|FG009|Overall Study|Adverse Event|4|||
147207258|NCT01415882|530929596|FG000|Overall Study|Ineligible|1|||
147207259|NCT01415882|530929597|FG001|Overall Study|Ineligible|0|||
147207260|NCT01415882|530929598|FG002|Overall Study|Ineligible|0|||
147207261|NCT01415882|530929599|FG003|Overall Study|Ineligible|3|||
147207262|NCT01415882|530929600|FG004|Overall Study|Ineligible|0|||
147207263|NCT01415882|530929596|FG000|Overall Study|Withdrawal by Subject|0|||
147207264|NCT01415882|530929597|FG001|Overall Study|Withdrawal by Subject|1|||
147207265|NCT01415882|530929598|FG002|Overall Study|Withdrawal by Subject|0|||
147207266|NCT01415882|530929599|FG003|Overall Study|Withdrawal by Subject|1|||
147207267|NCT01415882|530929600|FG004|Overall Study|Withdrawal by Subject|0|||
147207268|NCT00670306|530929601|FG000|Overall Study|Adverse Event|8|||
147207269|NCT00670306|530929601|FG000|Overall Study|Lack of Efficacy|10|||
147207270|NCT00670306|530929601|FG000|Overall Study|Withdrawal by Subject|9|||
147207271|NCT00670306|530929601|FG000|Overall Study|Physician Decision|1|||
147207272|NCT00670306|530929601|FG000|Overall Study|Lost to Follow-up|8|||
147207273|NCT00670306|530929601|FG000|Overall Study|incl/excl criterias did not meet|19|||
147207274|NCT01301027|530929602|FG000|Overall Study|Physician Decision|2|||
147207275|NCT01301027|530929603|FG001|Overall Study|Physician Decision|0|||
147207276|NCT01301027|530929602|FG000|Overall Study|Withdrawal by Subject|2|||
147207277|NCT01301027|530929603|FG001|Overall Study|Withdrawal by Subject|3|||
147207278|NCT01301027|530929602|FG000|Overall Study|Adverse Event|0|||
147207279|NCT01301027|530929603|FG001|Overall Study|Adverse Event|2|||
147207280|NCT01301027|530929602|FG000|Overall Study|Fracture|1|||
147207281|NCT01301027|530929603|FG001|Overall Study|Fracture|3|||
147207282|NCT01301027|530929602|FG000|Overall Study|Transplant|0|||
147207283|NCT01301027|530929603|FG001|Overall Study|Transplant|2|||
147207284|NCT01301027|530929602|FG000|Overall Study|Volume Overload|3|||
147207285|NCT01301027|530929603|FG001|Overall Study|Volume Overload|0|||
147207286|NCT00845897|530929604|FG000|Overall Study|Lost to Follow-up|1|||
147207287|NCT00845897|530929605|FG001|Overall Study|Lost to Follow-up|1|||
147207288|NCT00845897|530929606|FG002|Overall Study|Lost to Follow-up|0|||
147207289|NCT00845897|530929604|FG000|Overall Study|Withdrawal by Subject|0|||
147207290|NCT00845897|530929605|FG001|Overall Study|Withdrawal by Subject|3|||
147207291|NCT00845897|530929606|FG002|Overall Study|Withdrawal by Subject|2|||
147207292|NCT00845897|530929604|FG000|Overall Study|Ulcer did not heal|1|||
147207293|NCT00845897|530929605|FG001|Overall Study|Ulcer did not heal|0|||
147207294|NCT00845897|530929606|FG002|Overall Study|Ulcer did not heal|1|||
147207295|NCT00845897|530929604|FG000|Overall Study|Too ill to participate|0|||
147207296|NCT00845897|530929605|FG001|Overall Study|Too ill to participate|1|||
147207297|NCT00845897|530929606|FG002|Overall Study|Too ill to participate|0|||
147207298|NCT02722499|530929607|FG000|Overall Study|Lost to Follow-up|2|||
147207299|NCT02722499|530929608|FG001|Overall Study|Lost to Follow-up|0|||
147207300|NCT02722499|530929609|FG002|Overall Study|Lost to Follow-up|1|||
147207301|NCT03566485|530929619|FG000|Overall Study|Disease progression|5|||
147207302|NCT03566485|530929620|FG001|Overall Study|Disease progression|4|||
147207303|NCT03566485|530929619|FG000|Overall Study|Clinical progression|0|||
147207304|NCT03566485|530929620|FG001|Overall Study|Clinical progression|1|||
147207305|NCT03566485|530929619|FG000|Overall Study|Toxicity|0|||
147207306|NCT03566485|530929620|FG001|Overall Study|Toxicity|2|||
147207307|NCT00369265|530929621|FG000|Overall Study|Study terminated|4|||
147207308|NCT00369265|530929622|FG001|Overall Study|Study terminated|7|||
147207309|NCT01192191|530929623|FG000|Overall Study|Adverse Event|7|||
147207310|NCT01192191|530929624|FG001|Overall Study|Adverse Event|12|||
147207311|NCT01192191|530929623|FG000|Overall Study|Participants Reached Stopping Criteria|3|||
147207312|NCT01192191|530929624|FG001|Overall Study|Participants Reached Stopping Criteria|2|||
147207313|NCT01192191|530929623|FG000|Overall Study|Lost to Follow-up|0|||
147207314|NCT01192191|530929624|FG001|Overall Study|Lost to Follow-up|1|||
147207315|NCT01192191|530929623|FG000|Overall Study|Withdrawal by Subject|1|||
147207316|NCT01192191|530929624|FG001|Overall Study|Withdrawal by Subject|6|||
147207317|NCT00467753|530929625|FG000|Overall Study|Lost to Follow-up|1|||
147207318|NCT00467753|530929626|FG001|Overall Study|Lost to Follow-up|2|||
147207319|NCT00467753|530929625|FG000|Overall Study|Adverse Event|2|||
147207320|NCT00467753|530929626|FG001|Overall Study|Adverse Event|0|||
147207321|NCT02817464|530929632|FG000|Overall Study|Lost to Follow-up|1|||
147207322|NCT02817464|530929633|FG001|Overall Study|Lost to Follow-up|0|||
147207323|NCT02817464|530929632|FG000|Overall Study|Discontinued early due to personal decision|1|||
147207324|NCT02817464|530929633|FG001|Overall Study|Discontinued early due to personal decision|1|||
147541510|NCT00265239|532137991|FG000|Overall Study|Adverse Event|2|||
147207325|NCT01704599|530929640|FG000|Overall Study|Adverse Event|1|||
147207326|NCT02840461|530929641|FG000|Overall Study|Adverse Event|1|||
147207327|NCT02840461|530929642|FG001|Overall Study|Adverse Event|5|||
147207328|NCT02840461|530929643|FG002|Overall Study|Adverse Event|3|||
147207329|NCT02840461|530929641|FG000|Overall Study|Lost to Follow-up|10|||
147207330|NCT02840461|530929642|FG001|Overall Study|Lost to Follow-up|7|||
147207331|NCT02840461|530929643|FG002|Overall Study|Lost to Follow-up|6|||
147207332|NCT02840461|530929641|FG000|Overall Study|Non-Comliance with Dosing Requirements|0|||
147207333|NCT02840461|530929642|FG001|Overall Study|Non-Comliance with Dosing Requirements|1|||
147207334|NCT02840461|530929643|FG002|Overall Study|Non-Comliance with Dosing Requirements|0|||
147207335|NCT02840461|530929641|FG000|Overall Study|Protocol Violation|2|||
147207336|NCT02840461|530929642|FG001|Overall Study|Protocol Violation|3|||
147207337|NCT02840461|530929643|FG002|Overall Study|Protocol Violation|1|||
147207338|NCT02840461|530929641|FG000|Overall Study|Withdrawal by Subject|10|||
147207339|NCT02840461|530929642|FG001|Overall Study|Withdrawal by Subject|6|||
147207340|NCT02840461|530929643|FG002|Overall Study|Withdrawal by Subject|2|||
147207341|NCT02840461|530929641|FG000|Overall Study|Worsening of Symptom & Kit Error|0|||
147207342|NCT02840461|530929642|FG001|Overall Study|Worsening of Symptom & Kit Error|0|||
147207343|NCT02840461|530929643|FG002|Overall Study|Worsening of Symptom & Kit Error|2|||
147207344|NCT01737502|530929646|FG000|Phase I|Disease progression|2|||
147207345|NCT01737502|530929647|FG001|Phase I|Disease progression|3|||
147207346|NCT01737502|530929646|FG000|Phase I|Complicating disease|1|||
147207347|NCT01737502|530929647|FG001|Phase I|Complicating disease|0|||
147207348|NCT01737502|530929646|FG000|Phase II|Adverse Event|0|||
147207349|NCT01737502|530929647|FG001|Phase II|Adverse Event|3|||
147207350|NCT01737502|530929646|FG000|Phase II|Disease progression|0|||
147207351|NCT01737502|530929647|FG001|Phase II|Disease progression|18|||
147207352|NCT01737502|530929646|FG000|Phase II|Death|0|||
147207353|NCT01737502|530929647|FG001|Phase II|Death|1|||
147207354|NCT01737502|530929646|FG000|Phase II|Transition to hospice care|0|||
147207355|NCT01737502|530929647|FG001|Phase II|Transition to hospice care|1|||
147207356|NCT02003924|530929658|FG000|Double-blind Phase|Lost to Follow-up|2|||
147207357|NCT02003924|530929659|FG001|Double-blind Phase|Lost to Follow-up|1|||
147207358|NCT02003924|530929660|FG002|Double-blind Phase|Lost to Follow-up|0|||
147207359|NCT02003924|530929658|FG000|Double-blind Phase|Protocol Violation|1|||
147207360|NCT02003924|530929659|FG001|Double-blind Phase|Protocol Violation|2|||
147207361|NCT02003924|530929660|FG002|Double-blind Phase|Protocol Violation|0|||
147207362|NCT02003924|530929658|FG000|Double-blind Phase|Withdrawal Consent to Continue Treatment|71|||
147207363|NCT02003924|530929659|FG001|Double-blind Phase|Withdrawal Consent to Continue Treatment|47|||
147207364|NCT02003924|530929660|FG002|Double-blind Phase|Withdrawal Consent to Continue Treatment|0|||
147207365|NCT02003924|530929658|FG000|Double-blind Phase|Disease Progression|229|||
147207366|NCT02003924|530929659|FG001|Double-blind Phase|Disease Progression|247|||
147207367|NCT02003924|530929660|FG002|Double-blind Phase|Disease Progression|0|||
147207368|NCT02003924|530929658|FG000|Double-blind Phase|Adverse Event|120|||
147207369|NCT02003924|530929659|FG001|Double-blind Phase|Adverse Event|31|||
147207370|NCT02003924|530929660|FG002|Double-blind Phase|Adverse Event|0|||
147207371|NCT02003924|530929658|FG000|Double-blind Phase|Randomized But not Treated|3|||
147207372|NCT02003924|530929659|FG001|Double-blind Phase|Randomized But not Treated|3|||
147207373|NCT02003924|530929660|FG002|Double-blind Phase|Randomized But not Treated|0|||
147207374|NCT02003924|530929658|FG000|Double-blind Phase|Other|29|||
147207375|NCT02003924|530929659|FG001|Double-blind Phase|Other|50|||
147207376|NCT02003924|530929660|FG002|Double-blind Phase|Other|0|||
147207377|NCT02003924|530929658|FG000|Open-label Phase|Lost to Follow-up|0|||
147207378|NCT02003924|530929659|FG001|Open-label Phase|Lost to Follow-up|0|||
147207379|NCT02003924|530929660|FG002|Open-label Phase|Lost to Follow-up|1|||
147207380|NCT02003924|530929658|FG000|Open-label Phase|Withdrawal Consent to Continue Treatment|9|||
147207381|NCT02003924|530929659|FG001|Open-label Phase|Withdrawal Consent to Continue Treatment|0|||
147207382|NCT02003924|530929660|FG002|Open-label Phase|Withdrawal Consent to Continue Treatment|1|||
147207383|NCT02003924|530929658|FG000|Open-label Phase|Disease Progression|59|||
147207384|NCT02003924|530929659|FG001|Open-label Phase|Disease Progression|0|||
147207385|NCT02003924|530929660|FG002|Open-label Phase|Disease Progression|5|||
147207386|NCT02003924|530929658|FG000|Open-label Phase|Adverse Event|25|||
147207387|NCT02003924|530929659|FG001|Open-label Phase|Adverse Event|0|||
147207388|NCT02003924|530929660|FG002|Open-label Phase|Adverse Event|10|||
147207389|NCT02003924|530929658|FG000|Open-label Phase|Other|7|||
147207390|NCT02003924|530929659|FG001|Open-label Phase|Other|0|||
147207391|NCT02003924|530929660|FG002|Open-label Phase|Other|0|||
147207392|NCT02003924|530929658|FG000|Long-term Follow-up Phase|Death|288|||
147207393|NCT02003924|530929659|FG001|Long-term Follow-up Phase|Death|174|||
147207394|NCT02003924|530929660|FG002|Long-term Follow-up Phase|Death|4|||
147207395|NCT02003924|530929658|FG000|Long-term Follow-up Phase|Lost to Follow-up|8|||
147207396|NCT02003924|530929659|FG001|Long-term Follow-up Phase|Lost to Follow-up|6|||
147207397|NCT02003924|530929660|FG002|Long-term Follow-up Phase|Lost to Follow-up|1|||
147207398|NCT02003924|530929658|FG000|Long-term Follow-up Phase|Withdrew Consent to Be Followed|66|||
147207399|NCT02003924|530929659|FG001|Long-term Follow-up Phase|Withdrew Consent to Be Followed|55|||
147207400|NCT02003924|530929660|FG002|Long-term Follow-up Phase|Withdrew Consent to Be Followed|1|||
147207401|NCT02003924|530929658|FG000|Long-term Follow-up Phase|Other|5|||
147207402|NCT02003924|530929659|FG001|Long-term Follow-up Phase|Other|2|||
147207403|NCT02003924|530929660|FG002|Long-term Follow-up Phase|Other|1|||
147207404|NCT00124306|530929664|FG000|Overall Study|Adverse Event|7|||
147207405|NCT00124306|530929665|FG001|Overall Study|Adverse Event|2|||
147207406|NCT00124306|530929664|FG000|Overall Study|Lost to Follow-up|10|||
147207407|NCT00124306|530929665|FG001|Overall Study|Lost to Follow-up|6|||
147207408|NCT00124306|530929664|FG000|Overall Study|Lack of Efficacy|3|||
147207409|NCT00124306|530929665|FG001|Overall Study|Lack of Efficacy|6|||
147207410|NCT00124306|530929664|FG000|Overall Study|Personal constraints|0|||
147207411|NCT00124306|530929665|FG001|Overall Study|Personal constraints|2|||
147207412|NCT00124306|530929664|FG000|Overall Study|Use of unacceptable medication|1|||
147207413|NCT00124306|530929665|FG001|Overall Study|Use of unacceptable medication|0|||
147207414|NCT00124306|530929664|FG000|Overall Study|Abnormal lab result|0|||
147207415|NCT00124306|530929665|FG001|Overall Study|Abnormal lab result|1|||
147207416|NCT00124306|530929664|FG000|Overall Study|Other|2|||
147207417|NCT00124306|530929665|FG001|Overall Study|Other|0|||
147207418|NCT00560352|530929667|FG000|Overall Study|Adverse event unrelated to study drug|2|||
147207419|NCT00560352|530929668|FG001|Overall Study|Adverse event unrelated to study drug|1|||
147207420|NCT00560352|530929669|FG002|Overall Study|Adverse event unrelated to study drug|1|||
147541511|NCT00265239|532137992|FG001|Overall Study|Adverse Event|1|||
147541512|NCT02803138|532137993|FG000|Overall Study|Failure to return|38|||
147541513|NCT02803138|532137993|FG000|Overall Study|Insufficient virological response|2|||
147541514|NCT02803138|532137993|FG000|Overall Study|Withdrawn consent|1|||
147541515|NCT02803138|532137993|FG000|Overall Study|Death|1|||
147541516|NCT02803138|532137993|FG000|Overall Study|Other, not specified|28|||
147541517|NCT00021229|532137994|FG000|Overall Study|Adverse Event|10|||
147541518|NCT00021229|532137995|FG001|Overall Study|Adverse Event|5|||
147541519|NCT00021229|532137996|FG002|Overall Study|Adverse Event|2|||
147541520|NCT00021229|532137994|FG000|Overall Study|Death|0|||
147541521|NCT00021229|532137995|FG001|Overall Study|Death|1|||
147541522|NCT00021229|532137996|FG002|Overall Study|Death|0|||
147541523|NCT00021229|532137994|FG000|Overall Study|Withdrawal by Subject|7|||
147541524|NCT00021229|532137995|FG001|Overall Study|Withdrawal by Subject|7|||
147541525|NCT00021229|532137996|FG002|Overall Study|Withdrawal by Subject|1|||
147541526|NCT00021229|532137994|FG000|Overall Study|Progressive Disease|15|||
147541527|NCT00021229|532137995|FG001|Overall Study|Progressive Disease|19|||
147541528|NCT00021229|532137996|FG002|Overall Study|Progressive Disease|12|||
147541529|NCT00021229|532137994|FG000|Overall Study|Protocol Violation|1|||
147541530|NCT00021229|532137995|FG001|Overall Study|Protocol Violation|1|||
147541531|NCT00021229|532137996|FG002|Overall Study|Protocol Violation|0|||
147541532|NCT00021229|532137994|FG000|Overall Study|Physician Decision|0|||
147541533|NCT00021229|532137995|FG001|Overall Study|Physician Decision|0|||
147541534|NCT00021229|532137996|FG002|Overall Study|Physician Decision|1|||
147207421|NCT00560352|530929667|FG000|Overall Study|Study drug toxicity|3|||
147207422|NCT00560352|530929668|FG001|Overall Study|Study drug toxicity|0|||
147207423|NCT00560352|530929669|FG002|Overall Study|Study drug toxicity|1|||
147207424|NCT00560352|530929667|FG000|Overall Study|Disease progression|0|||
147207425|NCT00560352|530929668|FG001|Overall Study|Disease progression|1|||
147207426|NCT00560352|530929669|FG002|Overall Study|Disease progression|1|||
147207427|NCT00560352|530929667|FG000|Overall Study|Withdrawal by Subject|1|||
147207428|NCT00560352|530929668|FG001|Overall Study|Withdrawal by Subject|1|||
147207429|NCT00560352|530929669|FG002|Overall Study|Withdrawal by Subject|1|||
147207430|NCT00560352|530929667|FG000|Overall Study|Maximum clinical benefit|1|||
147207431|NCT00560352|530929668|FG001|Overall Study|Maximum clinical benefit|0|||
147207432|NCT00560352|530929669|FG002|Overall Study|Maximum clinical benefit|0|||
147207433|NCT00114517|530929670|FG000|Overall Study|Adverse Event|6|||
147207434|NCT00114517|530929671|FG001|Overall Study|Adverse Event|1|||
147207435|NCT00114517|530929672|FG002|Overall Study|Adverse Event|6|||
147207436|NCT00114517|530929673|FG003|Overall Study|Adverse Event|3|||
147207437|NCT00114517|530929670|FG000|Overall Study|Lost to Follow-up|2|||
147207438|NCT00114517|530929671|FG001|Overall Study|Lost to Follow-up|2|||
147207439|NCT00114517|530929672|FG002|Overall Study|Lost to Follow-up|2|||
147207440|NCT00114517|530929673|FG003|Overall Study|Lost to Follow-up|1|||
147207441|NCT00114517|530929670|FG000|Overall Study|Too busy|3|||
147541535|NCT00021229|532137994|FG000|Overall Study|Punctate hemmorrhage post RT|2|||
147541536|NCT00021229|532137995|FG001|Overall Study|Punctate hemmorrhage post RT|0|||
147541537|NCT00021229|532137996|FG002|Overall Study|Punctate hemmorrhage post RT|0|||
147541538|NCT01858558|532138000|FG000|Overall Study|Death|1|||
147541539|NCT01858558|532138001|FG001|Overall Study|Death|1|||
147207442|NCT00114517|530929671|FG001|Overall Study|Too busy|1|||
147207443|NCT00114517|530929672|FG002|Overall Study|Too busy|1|||
147207444|NCT00114517|530929673|FG003|Overall Study|Too busy|2|||
147541540|NCT01858558|532138000|FG000|Overall Study|Lost to Follow-up|1|||
147541541|NCT01858558|532138001|FG001|Overall Study|Lost to Follow-up|0|||
147207445|NCT00114517|530929670|FG000|Overall Study|Moved from area|0|||
147207446|NCT00114517|530929671|FG001|Overall Study|Moved from area|3|||
147207447|NCT00114517|530929672|FG002|Overall Study|Moved from area|2|||
147207448|NCT00114517|530929673|FG003|Overall Study|Moved from area|1|||
147207449|NCT00114517|530929670|FG000|Overall Study|Did not want estradiol|1|||
147207450|NCT00114517|530929671|FG001|Overall Study|Did not want estradiol|1|||
147207451|NCT00114517|530929672|FG002|Overall Study|Did not want estradiol|0|||
147207452|NCT00114517|530929673|FG003|Overall Study|Did not want estradiol|0|||
147207453|NCT00114517|530929670|FG000|Overall Study|Armed-services duty|0|||
147207454|NCT00114517|530929671|FG001|Overall Study|Armed-services duty|1|||
147207455|NCT00114517|530929672|FG002|Overall Study|Armed-services duty|0|||
147207456|NCT00114517|530929673|FG003|Overall Study|Armed-services duty|1|||
147207457|NCT00114517|530929670|FG000|Overall Study|Competing family issue|0|||
147207458|NCT00114517|530929671|FG001|Overall Study|Competing family issue|1|||
147207459|NCT00114517|530929672|FG002|Overall Study|Competing family issue|0|||
147207460|NCT00114517|530929673|FG003|Overall Study|Competing family issue|1|||
147207461|NCT00114517|530929670|FG000|Overall Study|Physician Decision|0|||
147207462|NCT00114517|530929671|FG001|Overall Study|Physician Decision|1|||
147207463|NCT00114517|530929672|FG002|Overall Study|Physician Decision|0|||
147207464|NCT00114517|530929673|FG003|Overall Study|Physician Decision|0|||
147207465|NCT00114517|530929670|FG000|Overall Study|Lost interest|0|||
147207466|NCT00114517|530929671|FG001|Overall Study|Lost interest|0|||
147207467|NCT00114517|530929672|FG002|Overall Study|Lost interest|1|||
147207468|NCT00114517|530929673|FG003|Overall Study|Lost interest|0|||
147207469|NCT00114517|530929670|FG000|Overall Study|Weight increase|0|||
147207470|NCT00114517|530929671|FG001|Overall Study|Weight increase|0|||
147207471|NCT00114517|530929672|FG002|Overall Study|Weight increase|1|||
147207472|NCT00114517|530929673|FG003|Overall Study|Weight increase|0|||
147207473|NCT00114517|530929670|FG000|Overall Study|Concern about blood clots|0|||
147207474|NCT00114517|530929671|FG001|Overall Study|Concern about blood clots|0|||
147207475|NCT00114517|530929672|FG002|Overall Study|Concern about blood clots|1|||
147207476|NCT00114517|530929673|FG003|Overall Study|Concern about blood clots|0|||
147207477|NCT00114517|530929670|FG000|Overall Study|Breast cancer diagnosis on baseline mammogram|0|||
147207478|NCT00114517|530929671|FG001|Overall Study|Breast cancer diagnosis on baseline mammogram|0|||
147207479|NCT00114517|530929672|FG002|Overall Study|Breast cancer diagnosis on baseline mammogram|0|||
147207480|NCT00114517|530929673|FG003|Overall Study|Breast cancer diagnosis on baseline mammogram|1|||
147207481|NCT00539864|530931128|FG000|Overall Study|Lost to Follow-up|0|||
147207482|NCT00539864|530931129|FG001|Overall Study|Lost to Follow-up|1|||
147207483|NCT00539864|530931128|FG000|Overall Study|Withdrawal by Subject|1|||
147207484|NCT00539864|530931129|FG001|Overall Study|Withdrawal by Subject|1|||
147207485|NCT00943072|530931135|FG000|Overall Study|Adverse Event|0|||
147207486|NCT00943072|530931136|FG001|Overall Study|Adverse Event|3|||
147207487|NCT00943072|530931135|FG000|Overall Study|Death|0|||
147207488|NCT00943072|530931136|FG001|Overall Study|Death|2|||
147207489|NCT00943072|530931135|FG000|Overall Study|Withdrawal by Subject|3|||
147207490|NCT00943072|530931136|FG001|Overall Study|Withdrawal by Subject|1|||
147207491|NCT00943072|530931135|FG000|Overall Study|Protocol Violation|0|||
147207492|NCT00943072|530931136|FG001|Overall Study|Protocol Violation|1|||
147207493|NCT00943072|530931135|FG000|Overall Study|Lost to Follow-up|1|||
147207494|NCT00943072|530931136|FG001|Overall Study|Lost to Follow-up|2|||
147207495|NCT00943072|530931135|FG000|Overall Study|Lack of Efficacy|0|||
147439764|NCT04569032|531775827|FG000|Overall Study|Withdrawal by Subject|2|||
147439765|NCT04569032|531775828|FG001|Overall Study|Withdrawal by Subject|0|||
147439766|NCT04569032|531775827|FG000|Overall Study|Lost to Follow-up|0|||
147439767|NCT04569032|531775828|FG001|Overall Study|Lost to Follow-up|1|||
147439768|NCT04569032|531775827|FG000|Overall Study|In long term follow up|22|||
147439769|NCT04569032|531775828|FG001|Overall Study|In long term follow up|34|||
147439770|NCT00873366|531775829|FG000|Overall Study|Off tamoxifen for reconstructive surgery|1|||
147439771|NCT00873366|531775829|FG000|Overall Study|Off tamoxifen due to side effects|2|||
147439772|NCT00873366|531775829|FG000|Overall Study|Refused to continue DM-BT testing|3|||
147439773|NCT00496730|531775843|FG000|Overall Study|Lost to Follow-up|4|||
147439774|NCT00496730|531775844|FG001|Overall Study|Lost to Follow-up|3|||
147439775|NCT00496730|531775843|FG000|Overall Study|Withdrawal by Subject|2|||
147439776|NCT00496730|531775844|FG001|Overall Study|Withdrawal by Subject|2|||
147439777|NCT00113074|531775847|FG000|Overall Study|Lost to Follow-up|10|||
147439778|NCT00113074|531775848|FG001|Overall Study|Lost to Follow-up|10|||
147439779|NCT00113074|531775849|FG002|Overall Study|Lost to Follow-up|14|||
147439780|NCT03123250|531775851|FG000|60 Months Follow Up|Withdrawal by Subject|2|||
147207496|NCT00943072|530931136|FG001|Overall Study|Lack of Efficacy|4|||
147207497|NCT00943072|530931135|FG000|Overall Study|Other|1|||
147439781|NCT04340557|531775852|FG000|Overall Study|Transferred to ICU and/or death|1|||
147207498|NCT00943072|530931136|FG001|Overall Study|Other|1|||
147207499|NCT03860818|530931142|FG000|Overall Study|Death|144|||
147207500|NCT03860818|530931143|FG001|Overall Study|Death|195|||
147439782|NCT04340557|531775853|FG001|Overall Study|Transferred to ICU and/or death|2|||
147439783|NCT00773136|531775854|FG000|Overall Study|Physician Decision|2|||
147439784|NCT02463071|531775857|FG000|Overall Study|Adverse Event|3|||
147207501|NCT03860818|530931142|FG000|Overall Study|Graft Loss|32|||
147207502|NCT03860818|530931143|FG001|Overall Study|Graft Loss|45|||
147439785|NCT02463071|531775858|FG001|Overall Study|Adverse Event|5|||
147439786|NCT02463071|531775859|FG002|Overall Study|Adverse Event|1|||
147439787|NCT02463071|531775857|FG000|Overall Study|Death|1|||
147439788|NCT02463071|531775858|FG001|Overall Study|Death|0|||
147439789|NCT02463071|531775859|FG002|Overall Study|Death|0|||
147439790|NCT02463071|531775857|FG000|Overall Study|Eligibility criteria not fulfilled|1|||
147439791|NCT02463071|531775858|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
147439792|NCT02463071|531775859|FG002|Overall Study|Eligibility criteria not fulfilled|0|||
147439793|NCT02463071|531775857|FG000|Overall Study|Reason not specified|7|||
147439794|NCT02463071|531775858|FG001|Overall Study|Reason not specified|9|||
147439795|NCT02463071|531775859|FG002|Overall Study|Reason not specified|4|||
147439796|NCT02463071|531775857|FG000|Overall Study|Protocol Violation|0|||
147439797|NCT02463071|531775858|FG001|Overall Study|Protocol Violation|2|||
147439798|NCT02463071|531775859|FG002|Overall Study|Protocol Violation|0|||
147439799|NCT02463071|531775857|FG000|Overall Study|Lost to Follow-up|0|||
147439800|NCT02463071|531775858|FG001|Overall Study|Lost to Follow-up|0|||
147439801|NCT02463071|531775859|FG002|Overall Study|Lost to Follow-up|1|||
147439802|NCT02941926|531775860|FG000|Core Phase|Progressive disease|1109|||
147439803|NCT02941926|531775860|FG000|Core Phase|Adverse Event|504|||
147207503|NCT00792571|530931144|FG000|Overall Study|Death|1|||
147207504|NCT00792571|530931144|FG000|Overall Study|Adverse Event|4|||
147207505|NCT00792571|530931144|FG000|Overall Study|Withdrawal by Subject|1|||
147207506|NCT00792571|530931144|FG000|Overall Study|Other|4|||
147207507|NCT02600819|530931145|FG000|GEN Phase|Adverse Event|2|||
147207508|NCT02600819|530931146|FG001|GEN Phase|Adverse Event|0|||
147207509|NCT02600819|530931145|FG000|GEN Phase|Death|2|||
147207510|NCT02600819|530931146|FG001|GEN Phase|Death|0|||
147207511|NCT02600819|530931145|FG000|GEN Phase|Investigator's Discretion|4|||
147207512|NCT02600819|530931146|FG001|GEN Phase|Investigator's Discretion|0|||
147207513|NCT02600819|530931145|FG000|GEN Phase|Non-Compliance with Study Drug|1|||
147207514|NCT02600819|530931146|FG001|GEN Phase|Non-Compliance with Study Drug|0|||
147207515|NCT02600819|530931145|FG000|GEN Phase|Withdrew Consent|5|||
147207516|NCT02600819|530931146|FG001|GEN Phase|Withdrew Consent|0|||
147207517|NCT02600819|530931145|FG000|GEN Phase|Lost to Follow-up|2|||
147207518|NCT02600819|530931146|FG001|GEN Phase|Lost to Follow-up|0|||
147207519|NCT01715857|530931147|FG000|Overall Study|Did Not Meet Eligibility Criteria|96|||
147207520|NCT00505778|530931148|FG000|Overall Study|Adverse Event|2|||
147207521|NCT00505778|530931149|FG001|Overall Study|Adverse Event|7|||
147207522|NCT00505778|530931148|FG000|Overall Study|Physician Decision|8|||
147207523|NCT00505778|530931149|FG001|Overall Study|Physician Decision|14|||
147207524|NCT00505778|530931148|FG000|Overall Study|Lost to Follow-up|17|||
147207525|NCT00505778|530931149|FG001|Overall Study|Lost to Follow-up|23|||
147207526|NCT00505778|530931148|FG000|Overall Study|Unable to Meet Protocol Criteria|4|||
147207527|NCT00505778|530931149|FG001|Overall Study|Unable to Meet Protocol Criteria|1|||
147207528|NCT00505778|530931148|FG000|Overall Study|Protocol Violation|7|||
147207529|NCT00505778|530931149|FG001|Overall Study|Protocol Violation|9|||
147207530|NCT00505778|530931148|FG000|Overall Study|Withdrawal by Subject|29|||
147207531|NCT00505778|530931149|FG001|Overall Study|Withdrawal by Subject|14|||
147207532|NCT00505778|530931148|FG000|Overall Study|Relapse|65|||
147207533|NCT00505778|530931149|FG001|Overall Study|Relapse|65|||
147207534|NCT00505778|530931148|FG000|Overall Study|Took No Study Drug|2|||
147207535|NCT00505778|530931149|FG001|Overall Study|Took No Study Drug|2|||
147207536|NCT03790696|530931152|FG000|Overall Study|Cognitive training task was too difficult for child to complete.|0|||
147207537|NCT03790696|530931153|FG001|Overall Study|Cognitive training task was too difficult for child to complete.|1|||
147207538|NCT00481091|530931160|FG000|Overall Study|Withdrawal by Subject|0|||
147207539|NCT00481091|530931161|FG001|Overall Study|Withdrawal by Subject|1|||
147207540|NCT00481091|530931162|FG002|Overall Study|Withdrawal by Subject|1|||
147207541|NCT00481091|530931163|FG003|Overall Study|Withdrawal by Subject|0|||
147207542|NCT00481091|530931164|FG004|Overall Study|Withdrawal by Subject|0|||
147207543|NCT00481091|530931165|FG005|Overall Study|Withdrawal by Subject|0|||
147207544|NCT00481091|530931166|FG006|Overall Study|Withdrawal by Subject|0|||
147207545|NCT00481091|530931167|FG007|Overall Study|Withdrawal by Subject|0|||
147207546|NCT00481091|530931168|FG008|Overall Study|Withdrawal by Subject|1|||
147207547|NCT00481091|530931169|FG009|Overall Study|Withdrawal by Subject|6|||
147207548|NCT00481091|530931160|FG000|Overall Study|Other, Not Specified|0|||
147207549|NCT00481091|530931161|FG001|Overall Study|Other, Not Specified|1|||
147207550|NCT00481091|530931162|FG002|Overall Study|Other, Not Specified|1|||
147207551|NCT00481091|530931163|FG003|Overall Study|Other, Not Specified|0|||
147207552|NCT00481091|530931164|FG004|Overall Study|Other, Not Specified|0|||
147207553|NCT00481091|530931165|FG005|Overall Study|Other, Not Specified|1|||
147207554|NCT00481091|530931166|FG006|Overall Study|Other, Not Specified|0|||
147207555|NCT00481091|530931167|FG007|Overall Study|Other, Not Specified|0|||
147207556|NCT00481091|530931168|FG008|Overall Study|Other, Not Specified|0|||
147439804|NCT02941926|531775860|FG000|Core Phase|Subject/guardian decision|127|||
147439805|NCT02941926|531775860|FG000|Core Phase|Physician Decision|112|||
147439806|NCT02941926|531775860|FG000|Core Phase|Death|46|||
147439807|NCT02941926|531775860|FG000|Core Phase|Protocol deviation|34|||
147439808|NCT02941926|531775860|FG000|Core Phase|Lost to Follow-up|8|||
147439809|NCT02941926|531775860|FG000|Core Phase|Technical problems|5|||
147439810|NCT02941926|531775860|FG000|Extension Phase|Physician Decision|155|||
147439811|NCT02941926|531775860|FG000|Extension Phase|Progressive disease|115|||
147439812|NCT02941926|531775860|FG000|Extension Phase|Adverse Event|13|||
147439813|NCT02941926|531775860|FG000|Extension Phase|Subject/Guardian decision|12|||
147439814|NCT02941926|531775860|FG000|Extension Phase|Death|6|||
147439815|NCT00097773|531775861|FG000|Overall Study|Lost to Follow-up|2|||
147439816|NCT00097773|531775862|FG001|Overall Study|Lost to Follow-up|2|||
147439817|NCT00097773|531775863|FG002|Overall Study|Lost to Follow-up|0|||
147439818|NCT00097773|531775864|FG003|Overall Study|Lost to Follow-up|1|||
147439819|NCT00097773|531775861|FG000|Overall Study|Physician Decision|2|||
147439820|NCT00097773|531775862|FG001|Overall Study|Physician Decision|2|||
147439821|NCT00097773|531775863|FG002|Overall Study|Physician Decision|3|||
147439822|NCT00097773|531775864|FG003|Overall Study|Physician Decision|1|||
147207557|NCT00481091|530931169|FG009|Overall Study|Other, Not Specified|4|||
147207558|NCT00481091|530931160|FG000|Overall Study|Adverse Event|1|||
147439823|NCT00097773|531775861|FG000|Overall Study|Withdrawal by Subject|3|||
147439824|NCT00097773|531775862|FG001|Overall Study|Withdrawal by Subject|3|||
147439825|NCT00097773|531775863|FG002|Overall Study|Withdrawal by Subject|3|||
147541542|NCT01858558|532138000|FG000|Overall Study|Disease progression|3|||
147207559|NCT00481091|530931161|FG001|Overall Study|Adverse Event|2|||
147207560|NCT00481091|530931162|FG002|Overall Study|Adverse Event|0|||
147207561|NCT00481091|530931163|FG003|Overall Study|Adverse Event|1|||
147207562|NCT00481091|530931164|FG004|Overall Study|Adverse Event|1|||
147207563|NCT00481091|530931165|FG005|Overall Study|Adverse Event|1|||
147207564|NCT00481091|530931166|FG006|Overall Study|Adverse Event|2|||
147207565|NCT00481091|530931167|FG007|Overall Study|Adverse Event|1|||
147207566|NCT00481091|530931168|FG008|Overall Study|Adverse Event|1|||
147207567|NCT00481091|530931169|FG009|Overall Study|Adverse Event|6|||
147207568|NCT00481091|530931160|FG000|Overall Study|Progressive disease clinical|0|||
147207569|NCT00481091|530931161|FG001|Overall Study|Progressive disease clinical|0|||
147207570|NCT00481091|530931162|FG002|Overall Study|Progressive disease clinical|0|||
147207571|NCT00481091|530931163|FG003|Overall Study|Progressive disease clinical|0|||
147207572|NCT00481091|530931164|FG004|Overall Study|Progressive disease clinical|0|||
147207573|NCT00481091|530931165|FG005|Overall Study|Progressive disease clinical|0|||
147207574|NCT00481091|530931166|FG006|Overall Study|Progressive disease clinical|0|||
147207575|NCT00481091|530931167|FG007|Overall Study|Progressive disease clinical|0|||
147207576|NCT00481091|530931168|FG008|Overall Study|Progressive disease clinical|1|||
147207577|NCT00481091|530931169|FG009|Overall Study|Progressive disease clinical|7|||
147207578|NCT00481091|530931160|FG000|Overall Study|Progressive disease clinical National Cancer Institute|1|||
147207579|NCT00481091|530931161|FG001|Overall Study|Progressive disease clinical National Cancer Institute|1|||
147207580|NCT00481091|530931162|FG002|Overall Study|Progressive disease clinical National Cancer Institute|0|||
147207581|NCT00481091|530931163|FG003|Overall Study|Progressive disease clinical National Cancer Institute|0|||
147207582|NCT00481091|530931164|FG004|Overall Study|Progressive disease clinical National Cancer Institute|0|||
147207583|NCT00481091|530931165|FG005|Overall Study|Progressive disease clinical National Cancer Institute|1|||
147207584|NCT00481091|530931166|FG006|Overall Study|Progressive disease clinical National Cancer Institute|0|||
147207585|NCT00481091|530931167|FG007|Overall Study|Progressive disease clinical National Cancer Institute|0|||
147207586|NCT00481091|530931168|FG008|Overall Study|Progressive disease clinical National Cancer Institute|0|||
147207587|NCT00481091|530931169|FG009|Overall Study|Progressive disease clinical National Cancer Institute|0|||
147207588|NCT00481091|530931160|FG000|Overall Study|Progressive disease other|1|||
147207589|NCT00481091|530931161|FG001|Overall Study|Progressive disease other|1|||
147207590|NCT00481091|530931162|FG002|Overall Study|Progressive disease other|0|||
147207591|NCT00481091|530931163|FG003|Overall Study|Progressive disease other|1|||
147207592|NCT00481091|530931164|FG004|Overall Study|Progressive disease other|1|||
147207593|NCT00481091|530931165|FG005|Overall Study|Progressive disease other|1|||
147207594|NCT00481091|530931166|FG006|Overall Study|Progressive disease other|0|||
147207595|NCT00481091|530931167|FG007|Overall Study|Progressive disease other|2|||
147207596|NCT00481091|530931168|FG008|Overall Study|Progressive disease other|0|||
147207597|NCT00481091|530931169|FG009|Overall Study|Progressive disease other|0|||
147207598|NCT00481091|530931160|FG000|Overall Study|No reason given|0|||
147207599|NCT00481091|530931161|FG001|Overall Study|No reason given|0|||
147207600|NCT00481091|530931162|FG002|Overall Study|No reason given|1|||
147207601|NCT00481091|530931163|FG003|Overall Study|No reason given|1|||
147207602|NCT00481091|530931164|FG004|Overall Study|No reason given|1|||
147207603|NCT00481091|530931165|FG005|Overall Study|No reason given|0|||
147207604|NCT00481091|530931166|FG006|Overall Study|No reason given|1|||
147207605|NCT00481091|530931167|FG007|Overall Study|No reason given|1|||
147439826|NCT00097773|531775864|FG003|Overall Study|Withdrawal by Subject|1|||
147439827|NCT00097773|531775861|FG000|Overall Study|Adverse Event|0|||
147439828|NCT00097773|531775862|FG001|Overall Study|Adverse Event|1|||
147439829|NCT00097773|531775863|FG002|Overall Study|Adverse Event|0|||
147439830|NCT00097773|531775864|FG003|Overall Study|Adverse Event|0|||
147439831|NCT00097773|531775861|FG000|Overall Study|Other|1|||
147439832|NCT00097773|531775862|FG001|Overall Study|Other|0|||
147439833|NCT00097773|531775863|FG002|Overall Study|Other|2|||
147439834|NCT00097773|531775864|FG003|Overall Study|Other|0|||
147439835|NCT01009034|531775865|FG000|Overall Study|Lost to Follow-up|2|||
147439836|NCT01009034|531775865|FG000|Overall Study|Withdrawal by Subject|2|||
147439837|NCT04305275|531775866|FG000|Overall Study|Adverse Event|4|||
147439838|NCT04305275|531775867|FG001|Overall Study|Adverse Event|0|||
147439839|NCT04305275|531775866|FG000|Overall Study|Lost to Follow-up|1|||
147439840|NCT04305275|531775867|FG001|Overall Study|Lost to Follow-up|1|||
147439841|NCT04305275|531775866|FG000|Overall Study|Withdrawal by Participant|8|||
147439842|NCT04305275|531775867|FG001|Overall Study|Withdrawal by Participant|1|||
147439843|NCT00199836|531775869|FG000|Overall Study|Progressive Disease|5|||
147541543|NCT01858558|532138001|FG001|Overall Study|Disease progression|1|||
147207606|NCT00481091|530931168|FG008|Overall Study|No reason given|1|||
147207607|NCT00481091|530931169|FG009|Overall Study|No reason given|4|||
147207608|NCT02881567|530931170|FG000|Overall Study|Adverse Event|1|||
147439844|NCT00199836|531775869|FG000|Overall Study|Death|1|||
147439845|NCT02243865|531775870|FG000|Overall Study|Protocol Violation|1|||
147541544|NCT01858558|532138000|FG000|Overall Study|Product contamination|2|||
147439846|NCT02243865|531775871|FG001|Overall Study|Protocol Violation|3|||
147439847|NCT02243865|531775870|FG000|Overall Study|Lost to Follow-up|1|||
147207609|NCT02881567|530931170|FG000|Overall Study|Lost to Follow-up|3|||
147207610|NCT02881567|530931170|FG000|Overall Study|Consent withdrawn|1|||
147207611|NCT02881567|530931170|FG000|Overall Study|Investigator decision|1|||
147207612|NCT02881567|530931170|FG000|Overall Study|Study terminated by sponsor|9|||
147207613|NCT02881567|530931170|FG000|Overall Study|Reason not Specified|3|||
147207614|NCT02405442|530931171|FG000|Double-Blind Phase (up to Week 8)|Adverse Event|0|||
147207615|NCT02405442|530931172|FG001|Double-Blind Phase (up to Week 8)|Adverse Event|2|||
147207616|NCT02405442|530931173|FG002|Double-Blind Phase (up to Week 8)|Adverse Event|4|||
147207617|NCT02405442|530931174|FG003|Double-Blind Phase (up to Week 8)|Adverse Event|1|||
147207618|NCT02405442|530931171|FG000|Double-Blind Phase (up to Week 8)|Withdrew Consent|0|||
147207619|NCT02405442|530931172|FG001|Double-Blind Phase (up to Week 8)|Withdrew Consent|1|||
147207620|NCT02405442|530931173|FG002|Double-Blind Phase (up to Week 8)|Withdrew Consent|2|||
147207621|NCT02405442|530931174|FG003|Double-Blind Phase (up to Week 8)|Withdrew Consent|0|||
147207622|NCT02405442|530931171|FG000|Double-Blind Phase (up to Week 8)|Study Disease-Related Symptoms|1|||
147207623|NCT02405442|530931172|FG001|Double-Blind Phase (up to Week 8)|Study Disease-Related Symptoms|1|||
147207624|NCT02405442|530931173|FG002|Double-Blind Phase (up to Week 8)|Study Disease-Related Symptoms|0|||
147207625|NCT02405442|530931174|FG003|Double-Blind Phase (up to Week 8)|Study Disease-Related Symptoms|0|||
147541545|NCT01858558|532138001|FG001|Overall Study|Product contamination|0|||
147207626|NCT02405442|530931171|FG000|Double-Blind Phase (up to Week 8)|Investigator's Discretion|0|||
147207627|NCT02405442|530931172|FG001|Double-Blind Phase (up to Week 8)|Investigator's Discretion|1|||
147207628|NCT02405442|530931173|FG002|Double-Blind Phase (up to Week 8)|Investigator's Discretion|0|||
147207629|NCT02405442|530931174|FG003|Double-Blind Phase (up to Week 8)|Investigator's Discretion|0|||
147207630|NCT02405442|530931171|FG000|Open-Label Phase (up to Week 52)|Study Terminated by Sponsor|27|||
147207631|NCT02405442|530931172|FG001|Open-Label Phase (up to Week 52)|Study Terminated by Sponsor|28|||
147207632|NCT02405442|530931173|FG002|Open-Label Phase (up to Week 52)|Study Terminated by Sponsor|28|||
147207633|NCT02405442|530931174|FG003|Open-Label Phase (up to Week 52)|Study Terminated by Sponsor|13|||
147207634|NCT02405442|530931171|FG000|Open-Label Phase (up to Week 52)|Investigator's Discretion|14|||
147207635|NCT02405442|530931172|FG001|Open-Label Phase (up to Week 52)|Investigator's Discretion|11|||
147207636|NCT02405442|530931173|FG002|Open-Label Phase (up to Week 52)|Investigator's Discretion|11|||
147207637|NCT02405442|530931174|FG003|Open-Label Phase (up to Week 52)|Investigator's Discretion|2|||
147207638|NCT02405442|530931171|FG000|Open-Label Phase (up to Week 52)|Adverse Event|6|||
147207639|NCT02405442|530931172|FG001|Open-Label Phase (up to Week 52)|Adverse Event|1|||
147207640|NCT02405442|530931173|FG002|Open-Label Phase (up to Week 52)|Adverse Event|2|||
147207641|NCT02405442|530931174|FG003|Open-Label Phase (up to Week 52)|Adverse Event|6|||
147207642|NCT02405442|530931171|FG000|Open-Label Phase (up to Week 52)|Study Disease-Related Symptoms|0|||
147207643|NCT02405442|530931172|FG001|Open-Label Phase (up to Week 52)|Study Disease-Related Symptoms|1|||
147207644|NCT02405442|530931173|FG002|Open-Label Phase (up to Week 52)|Study Disease-Related Symptoms|3|||
147207645|NCT02405442|530931174|FG003|Open-Label Phase (up to Week 52)|Study Disease-Related Symptoms|2|||
147207646|NCT02405442|530931171|FG000|Open-Label Phase (up to Week 52)|Withdrew Consent|1|||
147207647|NCT02405442|530931172|FG001|Open-Label Phase (up to Week 52)|Withdrew Consent|2|||
147207648|NCT02405442|530931173|FG002|Open-Label Phase (up to Week 52)|Withdrew Consent|1|||
147207649|NCT02405442|530931174|FG003|Open-Label Phase (up to Week 52)|Withdrew Consent|1|||
147207650|NCT02405442|530931171|FG000|Open-Label Phase (up to Week 52)|Lack of Efficacy|0|||
147207651|NCT02405442|530931172|FG001|Open-Label Phase (up to Week 52)|Lack of Efficacy|1|||
147207652|NCT02405442|530931173|FG002|Open-Label Phase (up to Week 52)|Lack of Efficacy|0|||
147207653|NCT02405442|530931174|FG003|Open-Label Phase (up to Week 52)|Lack of Efficacy|0|||
147207654|NCT02405442|530931171|FG000|Open-Label Phase (up to Week 52)|Lost to Follow-up|0|||
147207655|NCT02405442|530931172|FG001|Open-Label Phase (up to Week 52)|Lost to Follow-up|1|||
147207656|NCT02405442|530931173|FG002|Open-Label Phase (up to Week 52)|Lost to Follow-up|0|||
147207657|NCT02405442|530931174|FG003|Open-Label Phase (up to Week 52)|Lost to Follow-up|0|||
147207658|NCT02405442|530931171|FG000|Extended Treatment Phase(up to Week 208)|Study Terminated by Sponsor|2|||
147207659|NCT02405442|530931172|FG001|Extended Treatment Phase(up to Week 208)|Study Terminated by Sponsor|1|||
147207660|NCT02405442|530931173|FG002|Extended Treatment Phase(up to Week 208)|Study Terminated by Sponsor|2|||
147207661|NCT02405442|530931174|FG003|Extended Treatment Phase(up to Week 208)|Study Terminated by Sponsor|2|||
147207662|NCT02405442|530931171|FG000|Extended Treatment Phase(up to Week 208)|Investigator's Discretion|0|||
147207663|NCT02405442|530931172|FG001|Extended Treatment Phase(up to Week 208)|Investigator's Discretion|1|||
147207664|NCT02405442|530931173|FG002|Extended Treatment Phase(up to Week 208)|Investigator's Discretion|0|||
147207665|NCT02405442|530931174|FG003|Extended Treatment Phase(up to Week 208)|Investigator's Discretion|0|||
147207666|NCT02405442|530931171|FG000|Extended Treatment Phase(up to Week 208)|Study Disease-Related Symptoms|1|||
147207667|NCT02405442|530931172|FG001|Extended Treatment Phase(up to Week 208)|Study Disease-Related Symptoms|0|||
147306817|NCT01852058|531290774|FG001|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
147541546|NCT01858558|532138000|FG000|Overall Study|Failed expansion of cell product|2|||
147541547|NCT01858558|532138001|FG001|Overall Study|Failed expansion of cell product|0|||
147541548|NCT01784419|532138002|FG000|Overall Study|Adverse Event|3|||
147541549|NCT00306852|532138003|FG000|Overall Study|Death|14|||
147541550|NCT00306852|532138004|FG001|Overall Study|Death|14|||
147207668|NCT02405442|530931173|FG002|Extended Treatment Phase(up to Week 208)|Study Disease-Related Symptoms|0|||
147207669|NCT02405442|530931174|FG003|Extended Treatment Phase(up to Week 208)|Study Disease-Related Symptoms|0|||
147207670|NCT00373113|530931175|FG000|Overall Study|Death|1|||
147207671|NCT00373113|530931176|FG001|Overall Study|Death|7|||
147207672|NCT00373113|530931175|FG000|Overall Study|Adverse Event|38|||
147207673|NCT00373113|530931176|FG001|Overall Study|Adverse Event|24|||
147207674|NCT00373113|530931175|FG000|Overall Study|Study terminated by sponsor|9|||
147207675|NCT00373113|530931176|FG001|Overall Study|Study terminated by sponsor|1|||
147207676|NCT00373113|530931175|FG000|Overall Study|Global deterioration of health status|10|||
147207677|NCT00373113|530931176|FG001|Overall Study|Global deterioration of health status|7|||
147207678|NCT00373113|530931175|FG000|Overall Study|Lost to Follow-up|1|||
147207679|NCT00373113|530931176|FG001|Overall Study|Lost to Follow-up|3|||
147207680|NCT00373113|530931175|FG000|Overall Study|Objective progression or relapse|150|||
147207681|NCT00373113|530931176|FG001|Overall Study|Objective progression or relapse|169|||
147207682|NCT00373113|530931175|FG000|Overall Study|Other|14|||
147207683|NCT00373113|530931176|FG001|Overall Study|Other|17|||
147207684|NCT00373113|530931175|FG000|Overall Study|Protocol Violation|5|||
147207685|NCT00373113|530931176|FG001|Overall Study|Protocol Violation|1|||
147207686|NCT00373113|530931175|FG000|Overall Study|Withdrawal by Subject|10|||
147207687|NCT00373113|530931176|FG001|Overall Study|Withdrawal by Subject|15|||
147207688|NCT02078960|530931177|FG000|Treatment Period|Other|0|||
147207689|NCT02078960|530931178|FG001|Treatment Period|Other|0|||
147207690|NCT02078960|530931179|FG002|Treatment Period|Other|1|||
147207691|NCT02078960|530931177|FG000|Treatment Period|Lack of Efficacy|0|||
147207692|NCT02078960|530931178|FG001|Treatment Period|Lack of Efficacy|1|||
147207693|NCT02078960|530931179|FG002|Treatment Period|Lack of Efficacy|0|||
147541551|NCT00306852|532138003|FG000|Overall Study|Lost to Follow-up|15|||
147541552|NCT00306852|532138004|FG001|Overall Study|Lost to Follow-up|24|||
147207694|NCT02078960|530931177|FG000|Treatment Period|Disease progression - accelerated phase|0|||
147207695|NCT02078960|530931178|FG001|Treatment Period|Disease progression - accelerated phase|1|||
147207696|NCT02078960|530931179|FG002|Treatment Period|Disease progression - accelerated phase|0|||
147207697|NCT02078960|530931177|FG000|Treatment Period|Disease progression - blast phase|1|||
147207698|NCT02078960|530931178|FG001|Treatment Period|Disease progression - blast phase|0|||
147207699|NCT02078960|530931179|FG002|Treatment Period|Disease progression - blast phase|0|||
147207700|NCT02078960|530931177|FG000|Treatment Period|Withdrawal by Subject|0|||
147207701|NCT02078960|530931178|FG001|Treatment Period|Withdrawal by Subject|1|||
147207702|NCT02078960|530931179|FG002|Treatment Period|Withdrawal by Subject|1|||
147207703|NCT02078960|530931177|FG000|Treatment Period|Adverse Event|1|||
147207704|NCT02078960|530931178|FG001|Treatment Period|Adverse Event|0|||
147207705|NCT02078960|530931179|FG002|Treatment Period|Adverse Event|0|||
147541553|NCT03578276|532138005|FG000|Overall Study|Subjects did not comply with study protocol instructions.|2|||
147541554|NCT03578276|532138006|FG001|Overall Study|Subjects did not comply with study protocol instructions.|2|||
147541555|NCT00883740|532138007|FG000|First Intervention|Lost to Follow-up|1|||
147541556|NCT00883740|532138008|FG001|First Intervention|Lost to Follow-up|0|||
147541557|NCT00883740|532138007|FG000|First Intervention|No longer willing to participate|2|||
147541558|NCT00883740|532138008|FG001|First Intervention|No longer willing to participate|0|||
147541559|NCT00883740|532138007|FG000|First Intervention|Protocol Violation|3|||
147541560|NCT00883740|532138008|FG001|First Intervention|Protocol Violation|6|||
147207706|NCT02078960|530931177|FG000|Treatment Period|Death|0|||
147207707|NCT02078960|530931178|FG001|Treatment Period|Death|0|||
147207708|NCT02078960|530931179|FG002|Treatment Period|Death|1|||
147207709|NCT02078960|530931177|FG000|Follow-up Period|Death|2|||
147207710|NCT02078960|530931178|FG001|Follow-up Period|Death|0|||
147207711|NCT02078960|530931179|FG002|Follow-up Period|Death|0|||
147207712|NCT02078960|530931177|FG000|Follow-up Period|Lost to Follow-up|0|||
147207713|NCT02078960|530931178|FG001|Follow-up Period|Lost to Follow-up|1|||
147207714|NCT02078960|530931179|FG002|Follow-up Period|Lost to Follow-up|0|||
147207715|NCT03275350|530931180|FG000|Overall Study|Lost to Follow-up|4|||
147207716|NCT03275350|530931181|FG001|Overall Study|Lost to Follow-up|6|||
147207717|NCT03275350|530931180|FG000|Overall Study|Death|2|||
147207718|NCT03275350|530931181|FG001|Overall Study|Death|1|||
147207719|NCT03275350|530931180|FG000|Overall Study|Physician Decision|1|||
147207720|NCT03275350|530931181|FG001|Overall Study|Physician Decision|0|||
147207721|NCT03275350|530931180|FG000|Overall Study|Incarcerated|1|||
147207722|NCT03275350|530931181|FG001|Overall Study|Incarcerated|1|||
147207723|NCT04661579|530931184|FG000|Overall Study|Lost to Follow-up|19|||
147207724|NCT04661579|530931185|FG001|Overall Study|Lost to Follow-up|10|||
147207725|NCT04661579|530931186|FG002|Overall Study|Lost to Follow-up|2|||
147207726|NCT04661579|530931187|FG003|Overall Study|Lost to Follow-up|7|||
147207727|NCT04661579|530931188|FG004|Overall Study|Lost to Follow-up|11|||
147207728|NCT04661579|530931184|FG000|Overall Study|Physician Decision|2|||
147207729|NCT04661579|530931185|FG001|Overall Study|Physician Decision|0|||
147207730|NCT04661579|530931186|FG002|Overall Study|Physician Decision|0|||
147207731|NCT04661579|530931187|FG003|Overall Study|Physician Decision|1|||
147207732|NCT04661579|530931188|FG004|Overall Study|Physician Decision|0|||
147207733|NCT04661579|530931184|FG000|Overall Study|Withdrawal by Subject|1|||
147541561|NCT00883740|532138007|FG000|First Intervention|Adverse Event|1|||
147207734|NCT04661579|530931185|FG001|Overall Study|Withdrawal by Subject|4|||
147207735|NCT04661579|530931186|FG002|Overall Study|Withdrawal by Subject|0|||
147207736|NCT04661579|530931187|FG003|Overall Study|Withdrawal by Subject|2|||
147207737|NCT04661579|530931188|FG004|Overall Study|Withdrawal by Subject|0|||
147207738|NCT04661579|530931184|FG000|Overall Study|Death|1|||
147207739|NCT04661579|530931185|FG001|Overall Study|Death|0|||
147207740|NCT04661579|530931186|FG002|Overall Study|Death|0|||
147207741|NCT04661579|530931187|FG003|Overall Study|Death|0|||
147207742|NCT04661579|530931188|FG004|Overall Study|Death|0|||
147207743|NCT04661579|530931184|FG000|Overall Study|Other|1|||
147207744|NCT04661579|530931185|FG001|Overall Study|Other|2|||
147207745|NCT04661579|530931186|FG002|Overall Study|Other|1|||
147207746|NCT04661579|530931187|FG003|Overall Study|Other|1|||
147207747|NCT04661579|530931188|FG004|Overall Study|Other|1|||
147207748|NCT04661579|530931184|FG000|Overall Study|Randomized but Did Not Receive Study Product|4|||
147207749|NCT04661579|530931185|FG001|Overall Study|Randomized but Did Not Receive Study Product|4|||
147207750|NCT04661579|530931186|FG002|Overall Study|Randomized but Did Not Receive Study Product|1|||
147207751|NCT04661579|530931187|FG003|Overall Study|Randomized but Did Not Receive Study Product|5|||
147207752|NCT04661579|530931188|FG004|Overall Study|Randomized but Did Not Receive Study Product|1|||
147207753|NCT01396447|530931189|FG000|Overall Study|Did Not Receive Treatment|3|||
147207754|NCT01396447|530931190|FG001|Overall Study|Did Not Receive Treatment|2|||
147207755|NCT01396447|530931191|FG002|Overall Study|Did Not Receive Treatment|1|||
147207756|NCT01396447|530931192|FG003|Overall Study|Did Not Receive Treatment|0|||
147207757|NCT01396447|530931189|FG000|Overall Study|Adverse Event|15|||
147207758|NCT01396447|530931190|FG001|Overall Study|Adverse Event|12|||
147207759|NCT01396447|530931191|FG002|Overall Study|Adverse Event|12|||
147207760|NCT01396447|530931192|FG003|Overall Study|Adverse Event|17|||
147207761|NCT01396447|530931189|FG000|Overall Study|Insufficient Therapeutic Response|5|||
147207762|NCT01396447|530931190|FG001|Overall Study|Insufficient Therapeutic Response|5|||
147207763|NCT01396447|530931191|FG002|Overall Study|Insufficient Therapeutic Response|2|||
147207764|NCT01396447|530931192|FG003|Overall Study|Insufficient Therapeutic Response|4|||
147207765|NCT01396447|530931189|FG000|Overall Study|Protocol Violation|5|||
147207766|NCT01396447|530931190|FG001|Overall Study|Protocol Violation|2|||
147207767|NCT01396447|530931191|FG002|Overall Study|Protocol Violation|3|||
147207768|NCT01396447|530931192|FG003|Overall Study|Protocol Violation|7|||
147207769|NCT01396447|530931189|FG000|Overall Study|Withdrawal of Consent|11|||
147207770|NCT01396447|530931190|FG001|Overall Study|Withdrawal of Consent|9|||
147207771|NCT01396447|530931191|FG002|Overall Study|Withdrawal of Consent|4|||
147207772|NCT01396447|530931192|FG003|Overall Study|Withdrawal of Consent|15|||
147207773|NCT01396447|530931189|FG000|Overall Study|Lost to Follow-up|4|||
147207774|NCT01396447|530931190|FG001|Overall Study|Lost to Follow-up|8|||
147207775|NCT01396447|530931191|FG002|Overall Study|Lost to Follow-up|7|||
147207776|NCT01396447|530931192|FG003|Overall Study|Lost to Follow-up|9|||
147207777|NCT01396447|530931189|FG000|Overall Study|Other Miscellaneous Reasons|0|||
147207778|NCT01396447|530931190|FG001|Overall Study|Other Miscellaneous Reasons|2|||
147207779|NCT01396447|530931191|FG002|Overall Study|Other Miscellaneous Reasons|1|||
147207780|NCT01396447|530931192|FG003|Overall Study|Other Miscellaneous Reasons|0|||
147207781|NCT01402102|530931194|FG000|Overall Study|Protocol Violation|1|||
147207782|NCT01402102|530931195|FG001|Overall Study|Protocol Violation|0|||
147207783|NCT01402102|530931194|FG000|Overall Study|Insufficiency of compliance|1|||
147207784|NCT01402102|530931195|FG001|Overall Study|Insufficiency of compliance|1|||
147207785|NCT01402102|530931194|FG000|Overall Study|Withdrawal by Subject|0|||
147207786|NCT01402102|530931195|FG001|Overall Study|Withdrawal by Subject|2|||
147207787|NCT01386970|530931196|FG000|Overall Study|Withdrawal by Subject|0|||
147207788|NCT01386970|530931197|FG001|Overall Study|Withdrawal by Subject|1|||
147207789|NCT01386970|530931196|FG000|Overall Study|Adverse Event|4|||
147207790|NCT01386970|530931197|FG001|Overall Study|Adverse Event|1|||
147207791|NCT02423902|530931199|FG000|Overall Study|Disease progression|1|||
147207792|NCT02423902|530931200|FG001|Overall Study|Disease progression|4|||
147207793|NCT04329806|530931201|FG000|Overall Study|Physician Decision|3|||
147207794|NCT04329806|530931202|FG001|Overall Study|Physician Decision|4|||
147207795|NCT04838626|530931203|FG000|Overall Study|Adverse Event|2|||
147207796|NCT04838626|530931203|FG000|Overall Study|Physician Decision|6|||
147207797|NCT04838626|530931203|FG000|Overall Study|Protocol Violation|3|||
147207798|NCT04838626|530931203|FG000|Overall Study|Withdrawal by Subject|9|||
147207799|NCT04838626|530931203|FG000|Overall Study|Technical Problems|2|||
147207800|NCT02867384|530931204|FG000|Overall Study|GVHD requiring change in Treatment Medication|14|||
147207801|NCT02867384|530931205|FG001|Overall Study|GVHD requiring change in Treatment Medication|30|||
147207802|NCT02867384|530931206|FG002|Overall Study|GVHD requiring change in Treatment Medication|0|||
147207803|NCT02867384|530931204|FG000|Overall Study|Progression/ Relapse|15|||
147207804|NCT02867384|530931205|FG001|Overall Study|Progression/ Relapse|19|||
147207805|NCT02867384|530931206|FG002|Overall Study|Progression/ Relapse|0|||
147207806|NCT02867384|530931204|FG000|Overall Study|Adverse Event|13|||
147207807|NCT02867384|530931205|FG001|Overall Study|Adverse Event|1|||
147207808|NCT02867384|530931206|FG002|Overall Study|Adverse Event|0|||
147207809|NCT02867384|530931204|FG000|Overall Study|Withdrawal by Subject|6|||
147207810|NCT02867384|530931205|FG001|Overall Study|Withdrawal by Subject|5|||
147207811|NCT02867384|530931206|FG002|Overall Study|Withdrawal by Subject|0|||
147207812|NCT02867384|530931204|FG000|Overall Study|Physician Decision|1|||
147207813|NCT02867384|530931205|FG001|Overall Study|Physician Decision|2|||
147207814|NCT02867384|530931206|FG002|Overall Study|Physician Decision|0|||
147207815|NCT02867384|530931204|FG000|Overall Study|Patient compliance|1|||
147207816|NCT02867384|530931205|FG001|Overall Study|Patient compliance|0|||
147207817|NCT02867384|530931206|FG002|Overall Study|Patient compliance|0|||
147207818|NCT02867384|530931204|FG000|Overall Study|Intercurrent illness or uncontrolled infection|1|||
147207819|NCT02867384|530931205|FG001|Overall Study|Intercurrent illness or uncontrolled infection|1|||
147207820|NCT02867384|530931206|FG002|Overall Study|Intercurrent illness or uncontrolled infection|0|||
147207821|NCT02867384|530931204|FG000|Overall Study|Never start treatment|3|||
147207822|NCT02867384|530931205|FG001|Overall Study|Never start treatment|0|||
147207823|NCT02867384|530931206|FG002|Overall Study|Never start treatment|0|||
147207824|NCT03901469|530931207|FG000|Overall Study|Radiographic Progression|4|||
147207825|NCT03901469|530931208|FG001|Overall Study|Radiographic Progression|6|||
147207826|NCT03901469|530931209|FG002|Overall Study|Radiographic Progression|3|||
147207827|NCT03901469|530931210|FG003|Overall Study|Radiographic Progression|30|||
147207828|NCT03901469|530931211|FG004|Overall Study|Radiographic Progression|7|||
147207829|NCT03901469|530931212|FG005|Overall Study|Radiographic Progression|2|||
147207830|NCT03901469|530931213|FG006|Overall Study|Radiographic Progression|11|||
147207831|NCT03901469|530931207|FG000|Overall Study|Clinical Progression|0|||
147207832|NCT03901469|530931208|FG001|Overall Study|Clinical Progression|2|||
147207833|NCT03901469|530931209|FG002|Overall Study|Clinical Progression|0|||
147207834|NCT03901469|530931210|FG003|Overall Study|Clinical Progression|7|||
147207835|NCT03901469|530931211|FG004|Overall Study|Clinical Progression|6|||
147207836|NCT03901469|530931212|FG005|Overall Study|Clinical Progression|0|||
147207837|NCT03901469|530931213|FG006|Overall Study|Clinical Progression|2|||
147207838|NCT03901469|530931207|FG000|Overall Study|Adverse Event|1|||
147207839|NCT03901469|530931208|FG001|Overall Study|Adverse Event|0|||
147207840|NCT03901469|530931209|FG002|Overall Study|Adverse Event|0|||
147207841|NCT03901469|530931210|FG003|Overall Study|Adverse Event|0|||
147207842|NCT03901469|530931211|FG004|Overall Study|Adverse Event|0|||
147207843|NCT03901469|530931212|FG005|Overall Study|Adverse Event|0|||
147207844|NCT03901469|530931213|FG006|Overall Study|Adverse Event|9|||
147207845|NCT03901469|530931207|FG000|Overall Study|Physician Decision|0|||
147207846|NCT03901469|530931208|FG001|Overall Study|Physician Decision|0|||
147207847|NCT03901469|530931209|FG002|Overall Study|Physician Decision|0|||
147207848|NCT03901469|530931210|FG003|Overall Study|Physician Decision|1|||
147207849|NCT03901469|530931211|FG004|Overall Study|Physician Decision|0|||
147207850|NCT03901469|530931212|FG005|Overall Study|Physician Decision|0|||
147207851|NCT03901469|530931213|FG006|Overall Study|Physician Decision|0|||
147207852|NCT03901469|530931207|FG000|Overall Study|Withdrawal by Subject|0|||
147207853|NCT03901469|530931208|FG001|Overall Study|Withdrawal by Subject|0|||
147207854|NCT03901469|530931209|FG002|Overall Study|Withdrawal by Subject|0|||
147207855|NCT03901469|530931210|FG003|Overall Study|Withdrawal by Subject|0|||
147207856|NCT03901469|530931211|FG004|Overall Study|Withdrawal by Subject|2|||
147207857|NCT03901469|530931212|FG005|Overall Study|Withdrawal by Subject|0|||
147207858|NCT03901469|530931213|FG006|Overall Study|Withdrawal by Subject|8|||
147207859|NCT03901469|530931207|FG000|Overall Study|Death|0|||
147207860|NCT03901469|530931208|FG001|Overall Study|Death|0|||
147541562|NCT00883740|532138008|FG001|First Intervention|Adverse Event|2|||
147541563|NCT00883740|532138007|FG000|Second Intervention|Protocol Violation|1|||
147541564|NCT00883740|532138008|FG001|Second Intervention|Protocol Violation|0|||
147541565|NCT00883740|532138007|FG000|Second Intervention|No longer willing to participate|0|||
147541566|NCT00883740|532138008|FG001|Second Intervention|No longer willing to participate|1|||
147541567|NCT01286207|532138011|FG000|Overall Study|Adverse Event|27|||
147541568|NCT01286207|532138012|FG001|Overall Study|Adverse Event|41|||
147541569|NCT01286207|532138013|FG002|Overall Study|Adverse Event|8|||
147541570|NCT01286207|532138011|FG000|Overall Study|Lost to Follow-up|49|||
147541571|NCT01286207|532138012|FG001|Overall Study|Lost to Follow-up|43|||
147541572|NCT01286207|532138013|FG002|Overall Study|Lost to Follow-up|20|||
147541573|NCT01286207|532138011|FG000|Overall Study|Withdrawal by Subject|93|||
147207861|NCT03901469|530931209|FG002|Overall Study|Death|0|||
147207862|NCT03901469|530931210|FG003|Overall Study|Death|3|||
147207863|NCT03901469|530931211|FG004|Overall Study|Death|5|||
147207864|NCT03901469|530931212|FG005|Overall Study|Death|0|||
147207865|NCT03901469|530931213|FG006|Overall Study|Death|1|||
147207866|NCT03901469|530931207|FG000|Overall Study|Termination of study by sponsor|0|||
147207867|NCT03901469|530931208|FG001|Overall Study|Termination of study by sponsor|0|||
147207868|NCT03901469|530931209|FG002|Overall Study|Termination of study by sponsor|0|||
147207869|NCT03901469|530931210|FG003|Overall Study|Termination of study by sponsor|0|||
147541574|NCT01286207|532138012|FG001|Overall Study|Withdrawal by Subject|79|||
147207870|NCT03901469|530931211|FG004|Overall Study|Termination of study by sponsor|1|||
147207871|NCT03901469|530931212|FG005|Overall Study|Termination of study by sponsor|1|||
147207872|NCT03901469|530931213|FG006|Overall Study|Termination of study by sponsor|0|||
147541575|NCT01286207|532138013|FG002|Overall Study|Withdrawal by Subject|41|||
147207873|NCT03901469|530931207|FG000|Overall Study|Not Reported|1|||
147207874|NCT03901469|530931208|FG001|Overall Study|Not Reported|0|||
147207875|NCT03901469|530931209|FG002|Overall Study|Not Reported|0|||
147207876|NCT03901469|530931210|FG003|Overall Study|Not Reported|1|||
147207877|NCT03901469|530931211|FG004|Overall Study|Not Reported|0|||
147207878|NCT03901469|530931212|FG005|Overall Study|Not Reported|0|||
147207879|NCT03901469|530931213|FG006|Overall Study|Not Reported|1|||
147207880|NCT03710083|530931214|FG000|Overall Study|Withdrawal by Subject|2|||
147207881|NCT03710083|530931214|FG000|Overall Study|Unsuccessful Procedure|1|||
147207882|NCT01727024|530931215|FG000|Period 1|Lost to Follow-up|1|||
147207883|NCT01727024|530931216|FG001|Period 1|Lost to Follow-up|1|||
147207884|NCT01727024|530931215|FG000|Period 1|Withdrawal by Subject|2|||
147207885|NCT01727024|530931216|FG001|Period 1|Withdrawal by Subject|3|||
147207886|NCT01047553|530931217|FG000|Overall Study|Adverse Event|10|||
147207887|NCT01047553|530931218|FG001|Overall Study|Adverse Event|5|||
147207888|NCT01047553|530931217|FG000|Overall Study|Withdrawal by Subject|4|||
147207889|NCT01047553|530931218|FG001|Overall Study|Withdrawal by Subject|2|||
147207890|NCT01047553|530931217|FG000|Overall Study|Development of Study-Specific Withdrawal|1|||
147207891|NCT01047553|530931218|FG001|Overall Study|Development of Study-Specific Withdrawal|1|||
147207892|NCT01047553|530931217|FG000|Overall Study|Lost to Follow-up|1|||
147207893|NCT01047553|530931218|FG001|Overall Study|Lost to Follow-up|0|||
147207894|NCT01047553|530931217|FG000|Overall Study|Sever Non-Compliance to Protocol|1|||
147207895|NCT01047553|530931218|FG001|Overall Study|Sever Non-Compliance to Protocol|0|||
147207896|NCT01047553|530931217|FG000|Overall Study|PI's decision|0|||
147207897|NCT01047553|530931218|FG001|Overall Study|PI's decision|1|||
147207898|NCT00948441|530931219|FG000|Overall Study|no longer meet inclusion criteria|1|||
147207899|NCT00948441|530931220|FG001|Overall Study|no longer meet inclusion criteria|4|||
147207900|NCT00104520|530931222|FG000|Overall Study|Unrelated adverse event|34|||
147207901|NCT00104520|530931223|FG001|Overall Study|Unrelated adverse event|47|||
147207902|NCT00104520|530931222|FG000|Overall Study|Study drug intolerance|0|||
147207903|NCT00104520|530931223|FG001|Overall Study|Study drug intolerance|1|||
147207904|NCT00104520|530931222|FG000|Overall Study|Related adverse event|13|||
147207905|NCT00104520|530931223|FG001|Overall Study|Related adverse event|15|||
147207906|NCT00104520|530931222|FG000|Overall Study|Lost to Follow-up|1|||
147207907|NCT00104520|530931223|FG001|Overall Study|Lost to Follow-up|0|||
147207908|NCT00104520|530931222|FG000|Overall Study|Noncompliance|0|||
147207909|NCT00104520|530931223|FG001|Overall Study|Noncompliance|2|||
147207910|NCT00104520|530931222|FG000|Overall Study|Personal/administrative|1|||
147207911|NCT00104520|530931223|FG001|Overall Study|Personal/administrative|1|||
147207912|NCT00104520|530931222|FG000|Overall Study|Other|1|||
147207913|NCT00104520|530931223|FG001|Overall Study|Other|5|||
147207914|NCT01026324|530931224|FG000|Follow up/Survival|Withdrawal by Subject|1|||
147207915|NCT01026324|530931225|FG001|Follow up/Survival|Withdrawal by Subject|0|||
147207916|NCT01026324|530931226|FG002|Follow up/Survival|Withdrawal by Subject|0|||
147207917|NCT02442804|530931227|FG000|Overall Study|Withdrawal by Subject|0|||
147207918|NCT02442804|530931228|FG001|Overall Study|Withdrawal by Subject|1|||
147207919|NCT02442804|530931227|FG000|Overall Study|Adverse Event|1|||
147207920|NCT02442804|530931228|FG001|Overall Study|Adverse Event|0|||
147207921|NCT02624986|530931232|FG000|Overall Study|Death|0|||
147207922|NCT02624986|530931233|FG001|Overall Study|Death|1|||
147207923|NCT02624986|530931234|FG002|Overall Study|Death|2|||
147207924|NCT02624986|530931235|FG003|Overall Study|Death|2|||
147207925|NCT02624986|530931236|FG004|Overall Study|Death|2|||
147207926|NCT02624986|530931237|FG005|Overall Study|Death|0|||
147207927|NCT02624986|530931238|FG006|Overall Study|Death|0|||
147207928|NCT02624986|530931239|FG007|Overall Study|Death|1|||
147207929|NCT02624986|530931232|FG000|Overall Study|Study Terminated by Sponsor|1|||
147207930|NCT02624986|530931233|FG001|Overall Study|Study Terminated by Sponsor|1|||
147207931|NCT02624986|530931234|FG002|Overall Study|Study Terminated by Sponsor|0|||
147207932|NCT02624986|530931235|FG003|Overall Study|Study Terminated by Sponsor|1|||
147207933|NCT02624986|530931236|FG004|Overall Study|Study Terminated by Sponsor|2|||
147207934|NCT02624986|530931237|FG005|Overall Study|Study Terminated by Sponsor|2|||
147207935|NCT02624986|530931238|FG006|Overall Study|Study Terminated by Sponsor|4|||
147207936|NCT02624986|530931239|FG007|Overall Study|Study Terminated by Sponsor|3|||
147207937|NCT02624986|530931232|FG000|Overall Study|Progressive Disease|0|||
147207938|NCT02624986|530931233|FG001|Overall Study|Progressive Disease|1|||
147207939|NCT02624986|530931234|FG002|Overall Study|Progressive Disease|0|||
147207940|NCT02624986|530931235|FG003|Overall Study|Progressive Disease|0|||
147207941|NCT02624986|530931236|FG004|Overall Study|Progressive Disease|0|||
147207942|NCT02624986|530931237|FG005|Overall Study|Progressive Disease|0|||
147207943|NCT02624986|530931238|FG006|Overall Study|Progressive Disease|0|||
147207944|NCT02624986|530931239|FG007|Overall Study|Progressive Disease|0|||
147207945|NCT02624986|530931232|FG000|Overall Study|Protocol Violation|1|||
147207946|NCT02624986|530931233|FG001|Overall Study|Protocol Violation|0|||
147207947|NCT02624986|530931234|FG002|Overall Study|Protocol Violation|0|||
147207948|NCT02624986|530931235|FG003|Overall Study|Protocol Violation|0|||
147207949|NCT02624986|530931236|FG004|Overall Study|Protocol Violation|0|||
147207950|NCT02624986|530931237|FG005|Overall Study|Protocol Violation|0|||
147207951|NCT02624986|530931238|FG006|Overall Study|Protocol Violation|0|||
147207952|NCT02624986|530931239|FG007|Overall Study|Protocol Violation|0|||
147207953|NCT02624986|530931232|FG000|Overall Study|Withdrawal by Subject|0|||
147207954|NCT02624986|530931233|FG001|Overall Study|Withdrawal by Subject|0|||
147207955|NCT02624986|530931234|FG002|Overall Study|Withdrawal by Subject|0|||
147207956|NCT02624986|530931235|FG003|Overall Study|Withdrawal by Subject|0|||
147207957|NCT02624986|530931236|FG004|Overall Study|Withdrawal by Subject|0|||
147207958|NCT02624986|530931237|FG005|Overall Study|Withdrawal by Subject|0|||
147207959|NCT02624986|530931238|FG006|Overall Study|Withdrawal by Subject|0|||
147207960|NCT02624986|530931239|FG007|Overall Study|Withdrawal by Subject|1|||
147207961|NCT02116205|530931240|FG000|Overall Study|Withdrawal by Subject|2|||
147207962|NCT02116205|530931241|FG001|Overall Study|Withdrawal by Subject|4|||
147207963|NCT02116205|530931242|FG002|Overall Study|Withdrawal by Subject|1|||
147439848|NCT02243865|531775871|FG001|Overall Study|Lost to Follow-up|1|||
147439849|NCT02243865|531775870|FG000|Overall Study|Withdrawal by Subject|1|||
147439850|NCT02243865|531775871|FG001|Overall Study|Withdrawal by Subject|0|||
147439851|NCT02243865|531775870|FG000|Overall Study|Adverse Event|1|||
147439852|NCT02243865|531775871|FG001|Overall Study|Adverse Event|1|||
147541576|NCT01286207|532138011|FG000|Overall Study|Lack of Response|92|||
147541577|NCT01286207|532138012|FG001|Overall Study|Lack of Response|38|||
147439853|NCT02003014|531775877|FG000|Overall Study|Case report forms uncollected|9|||
147439854|NCT02003014|531775877|FG000|Overall Study|Treatment started after contract period|1|||
147439855|NCT02003014|531775877|FG000|Overall Study|Patient did not visit the study site|5|||
147439856|NCT02003014|531775877|FG000|Overall Study|Investigator's transfer|4|||
147541578|NCT01286207|532138013|FG002|Overall Study|Lack of Response|8|||
147541579|NCT01286207|532138011|FG000|Overall Study|Other|37|||
147541580|NCT01286207|532138012|FG001|Overall Study|Other|47|||
147207964|NCT02116205|530931243|FG003|Overall Study|Withdrawal by Subject|3|||
147207965|NCT02116205|530931240|FG000|Overall Study|Lost to Follow-up|0|||
147207966|NCT02116205|530931241|FG001|Overall Study|Lost to Follow-up|2|||
147207967|NCT02116205|530931242|FG002|Overall Study|Lost to Follow-up|1|||
147207968|NCT02116205|530931243|FG003|Overall Study|Lost to Follow-up|2|||
147207969|NCT02116205|530931240|FG000|Overall Study|Physician Decision|0|||
147207970|NCT02116205|530931241|FG001|Overall Study|Physician Decision|1|||
147207971|NCT02116205|530931242|FG002|Overall Study|Physician Decision|1|||
147207972|NCT02116205|530931243|FG003|Overall Study|Physician Decision|1|||
147207973|NCT02116205|530931240|FG000|Overall Study|Exclusion criteria|0|||
147541581|NCT01286207|532138013|FG002|Overall Study|Other|13|||
147541582|NCT00981409|532138014|FG000|Overall Study|Adverse Event|4|||
147541583|NCT00981409|532138015|FG001|Overall Study|Adverse Event|0|||
147207974|NCT02116205|530931241|FG001|Overall Study|Exclusion criteria|0|||
147207975|NCT02116205|530931242|FG002|Overall Study|Exclusion criteria|1|||
147207976|NCT02116205|530931243|FG003|Overall Study|Exclusion criteria|0|||
147207977|NCT04200352|530931249|FG000|Overall Study|Death|1|||
147207978|NCT04200352|530931249|FG000|Overall Study|Adverse Event|6|||
147207979|NCT04200352|530931249|FG000|Overall Study|Withdrawal by parent/guardian|6|||
147207980|NCT04200352|530931249|FG000|Overall Study|Lack of Efficacy|1|||
147207981|NCT04200352|530931249|FG000|Overall Study|Other than specified|6|||
147207982|NCT00806819|530931250|FG000|Overall Study|progressive disease (modified RECIST )|217|||
147207983|NCT00806819|530931251|FG001|Overall Study|progressive disease (modified RECIST )|216|||
147207984|NCT00806819|530931250|FG000|Overall Study|Worsening or AE of underlying disease|18|||
147207985|NCT00806819|530931251|FG001|Overall Study|Worsening or AE of underlying disease|25|||
147207986|NCT00806819|530931250|FG000|Overall Study|Other AE|38|||
147207987|NCT00806819|530931251|FG001|Overall Study|Other AE|40|||
147207988|NCT00806819|530931250|FG000|Overall Study|Protocol Violation|9|||
147207989|NCT00806819|530931251|FG001|Overall Study|Protocol Violation|4|||
147207990|NCT00806819|530931250|FG000|Overall Study|Lost to Follow-up|1|||
147207991|NCT00806819|530931251|FG001|Overall Study|Lost to Follow-up|0|||
147207992|NCT00806819|530931250|FG000|Overall Study|Withdrawal by Subject|32|||
147207993|NCT00806819|530931251|FG001|Overall Study|Withdrawal by Subject|29|||
147207994|NCT00806819|530931250|FG000|Overall Study|Not treated|6|||
147207995|NCT00806819|530931251|FG001|Overall Study|Not treated|3|||
147207996|NCT00806819|530931250|FG000|Overall Study|Reasons other than stated above|25|||
147207997|NCT00806819|530931251|FG001|Overall Study|Reasons other than stated above|41|||
147207998|NCT00912197|530931256|FG000|Overall Study|Withdrawal by Subject|3|||
147207999|NCT00912197|530931257|FG001|Overall Study|Withdrawal by Subject|3|||
147439857|NCT01660451|531775878|FG000|Overall Study|Protocol Violation|0|||
147541584|NCT00981409|532138014|FG000|Overall Study|Protocol Violation|0|||
147541585|NCT00981409|532138015|FG001|Overall Study|Protocol Violation|1|||
147541586|NCT00981409|532138014|FG000|Overall Study|Prostate Cancer Treatment before Trial|2|||
147541587|NCT00981409|532138015|FG001|Overall Study|Prostate Cancer Treatment before Trial|0|||
147208000|NCT01326104|530931265|FG000|Overall Study|progressed prior to vaccine|0|||
147208001|NCT01326104|530931266|FG001|Overall Study|progressed prior to vaccine|2|||
147208002|NCT01326104|530931265|FG000|Overall Study|unable to make vaccine|0|||
147208003|NCT01326104|530931266|FG001|Overall Study|unable to make vaccine|2|||
147208004|NCT00494676|530931269|FG000|Allocation|Withdrawal by Subject|2|||
147208005|NCT00494676|530931270|FG001|Allocation|Withdrawal by Subject|4|||
147208006|NCT00494676|530931269|FG000|First Intervention|Withdrawal by Subject|1|||
147208007|NCT00494676|530931270|FG001|First Intervention|Withdrawal by Subject|3|||
147208008|NCT00494676|530931269|FG000|Second Intervention|Withdrawal by Subject|1|||
147208009|NCT00494676|530931270|FG001|Second Intervention|Withdrawal by Subject|1|||
147208010|NCT04073225|530931271|FG000|Overall Study|Lost to Follow-up|4|||
147208011|NCT04073225|530931272|FG001|Overall Study|Lost to Follow-up|3|||
147208012|NCT04681352|530932541|FG000|Overall Study|Lost to Follow-up|2|||
147208013|NCT04681352|530932541|FG000|Overall Study|Withdrawal by Subject|22|||
147208014|NCT00975689|530932544|FG000|Overall Study|Adverse Event|0|||
147208015|NCT00975689|530932545|FG001|Overall Study|Adverse Event|3|||
147208016|NCT00975689|530932544|FG000|Overall Study|Withdrawal by Subject|1|||
147208017|NCT00975689|530932545|FG001|Overall Study|Withdrawal by Subject|0|||
147208018|NCT00975689|530932544|FG000|Overall Study|Physician Decision|1|||
147208019|NCT00975689|530932545|FG001|Overall Study|Physician Decision|0|||
147208020|NCT04335136|530932546|FG000|Overall Study|Death|8|||
147208021|NCT04335136|530932547|FG001|Overall Study|Death|4|||
147208022|NCT04335136|530932546|FG000|Overall Study|Lost to Follow-up|2|||
147208023|NCT04335136|530932547|FG001|Overall Study|Lost to Follow-up|0|||
147208024|NCT04335136|530932546|FG000|Overall Study|Protocol Violation|1|||
147208025|NCT04335136|530932547|FG001|Overall Study|Protocol Violation|0|||
147208026|NCT04335136|530932546|FG000|Overall Study|Withdrawal by Subject|1|||
147208027|NCT04335136|530932547|FG001|Overall Study|Withdrawal by Subject|1|||
147208028|NCT04335136|530932546|FG000|Overall Study|Health-threatening condition|0|||
147208029|NCT04335136|530932547|FG001|Overall Study|Health-threatening condition|1|||
147208030|NCT04335136|530932546|FG000|Overall Study|Adverse Event|0|||
147208031|NCT04335136|530932547|FG001|Overall Study|Adverse Event|1|||
147439858|NCT01660451|531775879|FG001|Overall Study|Protocol Violation|1|||
147439859|NCT01660451|531775880|FG002|Overall Study|Protocol Violation|1|||
147439860|NCT01660451|531775878|FG000|Overall Study|AE not associated with clinical disease progression|13|||
147439861|NCT01660451|531775879|FG001|Overall Study|AE not associated with clinical disease progression|10|||
147439862|NCT01660451|531775880|FG002|Overall Study|AE not associated with clinical disease progression|40|||
147439863|NCT01660451|531775878|FG000|Overall Study|AE associated with clinical disease progression|1|||
147439864|NCT01660451|531775879|FG001|Overall Study|AE associated with clinical disease progression|3|||
147439865|NCT01660451|531775880|FG002|Overall Study|AE associated with clinical disease progression|11|||
147439866|NCT01660451|531775878|FG000|Overall Study|Sponsor Decision|0|||
147439867|NCT01660451|531775879|FG001|Overall Study|Sponsor Decision|0|||
147439868|NCT01660451|531775880|FG002|Overall Study|Sponsor Decision|1|||
147439869|NCT01660451|531775878|FG000|Overall Study|Protocol Deviation|0|||
147439870|NCT01660451|531775879|FG001|Overall Study|Protocol Deviation|0|||
147439871|NCT01660451|531775880|FG002|Overall Study|Protocol Deviation|1|||
147439872|NCT01660451|531775878|FG000|Overall Study|Physician Decision|1|||
147439873|NCT01660451|531775879|FG001|Overall Study|Physician Decision|2|||
147439874|NCT01660451|531775880|FG002|Overall Study|Physician Decision|5|||
147439875|NCT01660451|531775878|FG000|Overall Study|Withdrawal by Subject|1|||
147439876|NCT01660451|531775879|FG001|Overall Study|Withdrawal by Subject|1|||
147439877|NCT01660451|531775880|FG002|Overall Study|Withdrawal by Subject|20|||
147439878|NCT01660451|531775878|FG000|Overall Study|Trial closure.|0|||
147439879|NCT01660451|531775879|FG001|Overall Study|Trial closure.|0|||
147439880|NCT01660451|531775880|FG002|Overall Study|Trial closure.|1|||
147439881|NCT01660451|531775878|FG000|Overall Study|Switching to other therapy|0|||
147439882|NCT01660451|531775879|FG001|Overall Study|Switching to other therapy|1|||
147439883|NCT01660451|531775880|FG002|Overall Study|Switching to other therapy|1|||
147439884|NCT01660451|531775878|FG000|Overall Study|Progressive disease - clinical progression|4|||
147439885|NCT01660451|531775879|FG001|Overall Study|Progressive disease - clinical progression|10|||
147439886|NCT01660451|531775880|FG002|Overall Study|Progressive disease - clinical progression|9|||
147439887|NCT01660451|531775878|FG000|Overall Study|Progressive disease - radiological progression|12|||
147439888|NCT01660451|531775879|FG001|Overall Study|Progressive disease - radiological progression|23|||
147439889|NCT01660451|531775880|FG002|Overall Study|Progressive disease - radiological progression|50|||
147439890|NCT01660451|531775878|FG000|Overall Study|Death|1|||
147439891|NCT01660451|531775879|FG001|Overall Study|Death|0|||
147439892|NCT01660451|531775880|FG002|Overall Study|Death|1|||
147439893|NCT01660451|531775878|FG000|Overall Study|Other|0|||
147439894|NCT01660451|531775879|FG001|Overall Study|Other|0|||
147439895|NCT01660451|531775880|FG002|Overall Study|Other|1|||
147439896|NCT05093322|531775881|FG000|Overall Study|Death|6|||
147439897|NCT05093322|531775882|FG001|Overall Study|Death|2|||
147439898|NCT05093322|531775881|FG000|Overall Study|Other|4|||
147439899|NCT05093322|531775882|FG001|Overall Study|Other|1|||
147439900|NCT00074581|531775884|FG000|Overall Study|Death|15|||
147439901|NCT00074581|531775885|FG001|Overall Study|Death|16|||
147541588|NCT00450177|532138016|FG000|Overall Study|Adverse Event|7|||
147208032|NCT04335136|530932546|FG000|Overall Study|Erroneously randomized|2|||
147208033|NCT04335136|530932547|FG001|Overall Study|Erroneously randomized|0|||
147208034|NCT01598506|530932548|FG000|Overall Study|Withdrawal by Subject|2|||
147208035|NCT02367833|530932549|FG000|Overall Study|Withdrawal by Subject|1|||
147208036|NCT02367833|530932550|FG001|Overall Study|Withdrawal by Subject|1|||
147208037|NCT02367833|530932551|FG002|Overall Study|Withdrawal by Subject|0|||
147208038|NCT00775593|530932554|FG000|Overall Study|Unmet eligibility criteria|6|||
147208039|NCT00775593|530932554|FG000|Overall Study|Death|1|||
147208040|NCT02067676|530932555|FG000|Overall Study|Withdrawal by Subject|1|||
147208041|NCT02067676|530932556|FG001|Overall Study|Withdrawal by Subject|0|||
147208042|NCT02067676|530932557|FG002|Overall Study|Withdrawal by Subject|0|||
147208043|NCT02067676|530932558|FG003|Overall Study|Withdrawal by Subject|0|||
147208044|NCT02067676|530932559|FG004|Overall Study|Withdrawal by Subject|0|||
147208045|NCT02067676|530932560|FG005|Overall Study|Withdrawal by Subject|0|||
147208046|NCT00996333|530932561|FG000|Overall Study|Screen failure|1|||
147208047|NCT00996333|530932561|FG000|Overall Study|Withdrawal by Subject|1|||
147208048|NCT00996333|530932561|FG000|Overall Study|Death|4|||
147208049|NCT00996333|530932561|FG000|Overall Study|Adverse Event|1|||
147208050|NCT00996333|530932561|FG000|Overall Study|Physician Decision|1|||
147208051|NCT00996333|530932561|FG000|Overall Study|Other|5|||
147208052|NCT01327482|530932562|FG000|Overall Study|Adverse Event|1|||
147208053|NCT00476229|530932563|FG000|Overall Study|Progressive shortness of breath|1|||
147208054|NCT02164461|530932564|FG000|Overall Study|Adverse Event|0|||
147208055|NCT02164461|530932565|FG001|Overall Study|Adverse Event|0|||
147208056|NCT02164461|530932566|FG002|Overall Study|Adverse Event|1|||
147208057|NCT02164461|530932564|FG000|Overall Study|Disease Progression|1|||
147208058|NCT02164461|530932565|FG001|Overall Study|Disease Progression|3|||
147208059|NCT02164461|530932566|FG002|Overall Study|Disease Progression|4|||
147208060|NCT02164461|530932564|FG000|Overall Study|Withdrawal by Subject|0|||
147208061|NCT02164461|530932565|FG001|Overall Study|Withdrawal by Subject|3|||
147208062|NCT02164461|530932566|FG002|Overall Study|Withdrawal by Subject|0|||
147208063|NCT02100696|530932568|FG000|Induction Phase|Adverse Event|0|||
147208064|NCT02100696|530932569|FG001|Induction Phase|Adverse Event|0|||
147208065|NCT02100696|530932570|FG002|Induction Phase|Adverse Event|1|||
147208066|NCT02100696|530932571|FG003|Induction Phase|Adverse Event|0|||
147208067|NCT02100696|530932572|FG004|Induction Phase|Adverse Event|0|||
147208068|NCT02100696|530932573|FG005|Induction Phase|Adverse Event|0|||
147208069|NCT02100696|530932568|FG000|Induction Phase|Lost to Follow-up|1|||
147208070|NCT02100696|530932569|FG001|Induction Phase|Lost to Follow-up|0|||
147208071|NCT02100696|530932570|FG002|Induction Phase|Lost to Follow-up|1|||
147208072|NCT02100696|530932571|FG003|Induction Phase|Lost to Follow-up|0|||
147439902|NCT00074581|531775884|FG000|Overall Study|Withdrawal by Subject|50|||
147439903|NCT00074581|531775885|FG001|Overall Study|Withdrawal by Subject|49|||
147439904|NCT00074581|531775884|FG000|Overall Study|Unable to adhere to visit schedule|13|||
147439905|NCT00074581|531775885|FG001|Overall Study|Unable to adhere to visit schedule|14|||
147439906|NCT00074581|531775884|FG000|Overall Study|Relocated|14|||
147439907|NCT00074581|531775885|FG001|Overall Study|Relocated|9|||
147439908|NCT00074581|531775884|FG000|Overall Study|Were withdrawn by investigator|5|||
147439909|NCT00074581|531775885|FG001|Overall Study|Were withdrawn by investigator|2|||
147439910|NCT00074581|531775884|FG000|Overall Study|Lost to Follow-up|16|||
147439911|NCT00074581|531775885|FG001|Overall Study|Lost to Follow-up|11|||
147439912|NCT00074581|531775884|FG000|Overall Study|Ended relationship w. index participant|117|||
147439913|NCT00074581|531775885|FG001|Overall Study|Ended relationship w. index participant|106|||
147439914|NCT00074581|531775884|FG000|Overall Study|Other|14|||
147439915|NCT00074581|531775885|FG001|Overall Study|Other|19|||
147439916|NCT00617604|531775887|FG000|Overall Study|Death|2|||
147439917|NCT00617604|531775888|FG001|Overall Study|Death|1|||
147439918|NCT00617604|531775887|FG000|Overall Study|Lost to Follow-up|1|||
147439919|NCT00617604|531775888|FG001|Overall Study|Lost to Follow-up|0|||
147439920|NCT00617604|531775887|FG000|Overall Study|Miscellaneous Reasons|8|||
147439921|NCT00617604|531775888|FG001|Overall Study|Miscellaneous Reasons|10|||
147439922|NCT00617604|531775887|FG000|Overall Study|Withdrawal by Subject|4|||
147439923|NCT00617604|531775888|FG001|Overall Study|Withdrawal by Subject|6|||
147439924|NCT00617604|531775887|FG000|Overall Study|Randomized but Never Received Study Drug|3|||
147439925|NCT00617604|531775888|FG001|Overall Study|Randomized but Never Received Study Drug|3|||
147439926|NCT03250832|531775889|FG000|Part 1 (Up to Approximately 51 Months)|Death|1|||
147439927|NCT03250832|531775890|FG001|Part 1 (Up to Approximately 51 Months)|Death|6|||
147439928|NCT03250832|531775891|FG002|Part 1 (Up to Approximately 51 Months)|Death|5|||
147439929|NCT03250832|531775892|FG003|Part 1 (Up to Approximately 51 Months)|Death|5|||
147439930|NCT03250832|531775893|FG004|Part 1 (Up to Approximately 51 Months)|Death|3|||
147439931|NCT03250832|531775894|FG005|Part 1 (Up to Approximately 51 Months)|Death|6|||
147208073|NCT02100696|530932572|FG004|Induction Phase|Lost to Follow-up|0|||
147208074|NCT02100696|530932573|FG005|Induction Phase|Lost to Follow-up|0|||
147208075|NCT02100696|530932568|FG000|Induction Phase|Protocol Violation|0|||
147208076|NCT02100696|530932569|FG001|Induction Phase|Protocol Violation|1|||
147208077|NCT02100696|530932570|FG002|Induction Phase|Protocol Violation|1|||
147439932|NCT03250832|531775895|FG006|Part 1 (Up to Approximately 51 Months)|Death|3|||
147439933|NCT03250832|531775896|FG007|Part 1 (Up to Approximately 51 Months)|Death|0|||
147439934|NCT03250832|531775897|FG008|Part 1 (Up to Approximately 51 Months)|Death|0|||
147439935|NCT03250832|531775898|FG009|Part 1 (Up to Approximately 51 Months)|Death|0|||
147208078|NCT02100696|530932571|FG003|Induction Phase|Protocol Violation|0|||
147208079|NCT02100696|530932572|FG004|Induction Phase|Protocol Violation|0|||
147208080|NCT02100696|530932573|FG005|Induction Phase|Protocol Violation|0|||
147208081|NCT02100696|530932568|FG000|Induction Phase|Withdrawal by Subject|8|||
147208082|NCT02100696|530932569|FG001|Induction Phase|Withdrawal by Subject|2|||
147208083|NCT02100696|530932570|FG002|Induction Phase|Withdrawal by Subject|13|||
147208084|NCT02100696|530932571|FG003|Induction Phase|Withdrawal by Subject|0|||
147208085|NCT02100696|530932572|FG004|Induction Phase|Withdrawal by Subject|0|||
147208086|NCT02100696|530932573|FG005|Induction Phase|Withdrawal by Subject|0|||
147208087|NCT02100696|530932568|FG000|Induction Phase|Physician Decision|1|||
147208088|NCT02100696|530932569|FG001|Induction Phase|Physician Decision|0|||
147208089|NCT02100696|530932570|FG002|Induction Phase|Physician Decision|2|||
147208090|NCT02100696|530932571|FG003|Induction Phase|Physician Decision|0|||
147208091|NCT02100696|530932572|FG004|Induction Phase|Physician Decision|0|||
147208092|NCT02100696|530932573|FG005|Induction Phase|Physician Decision|0|||
147208093|NCT02100696|530932568|FG000|Induction Phase|Multiple Reasons|5|||
147208094|NCT02100696|530932569|FG001|Induction Phase|Multiple Reasons|2|||
147208095|NCT02100696|530932570|FG002|Induction Phase|Multiple Reasons|8|||
147208096|NCT02100696|530932571|FG003|Induction Phase|Multiple Reasons|0|||
147208097|NCT02100696|530932572|FG004|Induction Phase|Multiple Reasons|0|||
147208098|NCT02100696|530932573|FG005|Induction Phase|Multiple Reasons|0|||
147208099|NCT02100696|530932568|FG000|Maintenance Phase|Adverse Event|0|||
147208100|NCT02100696|530932569|FG001|Maintenance Phase|Adverse Event|0|||
147208101|NCT02100696|530932570|FG002|Maintenance Phase|Adverse Event|0|||
147208102|NCT02100696|530932571|FG003|Maintenance Phase|Adverse Event|0|||
147208103|NCT02100696|530932572|FG004|Maintenance Phase|Adverse Event|0|||
147208104|NCT02100696|530932573|FG005|Maintenance Phase|Adverse Event|2|||
147208105|NCT02100696|530932568|FG000|Maintenance Phase|Lost to Follow-up|0|||
147208106|NCT02100696|530932569|FG001|Maintenance Phase|Lost to Follow-up|0|||
147208107|NCT02100696|530932570|FG002|Maintenance Phase|Lost to Follow-up|0|||
147208108|NCT02100696|530932571|FG003|Maintenance Phase|Lost to Follow-up|0|||
147208109|NCT02100696|530932572|FG004|Maintenance Phase|Lost to Follow-up|1|||
147208110|NCT02100696|530932573|FG005|Maintenance Phase|Lost to Follow-up|0|||
147208111|NCT02100696|530932568|FG000|Maintenance Phase|Protocol Violation|0|||
147208112|NCT02100696|530932569|FG001|Maintenance Phase|Protocol Violation|0|||
147208113|NCT02100696|530932570|FG002|Maintenance Phase|Protocol Violation|0|||
147208114|NCT02100696|530932571|FG003|Maintenance Phase|Protocol Violation|0|||
147208115|NCT02100696|530932572|FG004|Maintenance Phase|Protocol Violation|1|||
147208116|NCT02100696|530932573|FG005|Maintenance Phase|Protocol Violation|0|||
147208117|NCT02100696|530932568|FG000|Maintenance Phase|Withdrawal by Subject|0|||
147208118|NCT02100696|530932569|FG001|Maintenance Phase|Withdrawal by Subject|0|||
147208119|NCT02100696|530932570|FG002|Maintenance Phase|Withdrawal by Subject|0|||
147208120|NCT02100696|530932571|FG003|Maintenance Phase|Withdrawal by Subject|1|||
147208121|NCT02100696|530932572|FG004|Maintenance Phase|Withdrawal by Subject|4|||
147208122|NCT02100696|530932573|FG005|Maintenance Phase|Withdrawal by Subject|2|||
147208123|NCT02100696|530932568|FG000|Maintenance Phase|Physician Decision|0|||
147208124|NCT02100696|530932569|FG001|Maintenance Phase|Physician Decision|0|||
147208125|NCT02100696|530932570|FG002|Maintenance Phase|Physician Decision|0|||
147208126|NCT02100696|530932571|FG003|Maintenance Phase|Physician Decision|0|||
147208127|NCT02100696|530932572|FG004|Maintenance Phase|Physician Decision|1|||
147208128|NCT02100696|530932573|FG005|Maintenance Phase|Physician Decision|0|||
147208129|NCT02100696|530932568|FG000|Maintenance Phase|Multiple Reasons|0|||
147208130|NCT02100696|530932569|FG001|Maintenance Phase|Multiple Reasons|0|||
147208131|NCT02100696|530932570|FG002|Maintenance Phase|Multiple Reasons|0|||
147208132|NCT02100696|530932571|FG003|Maintenance Phase|Multiple Reasons|0|||
147208133|NCT02100696|530932572|FG004|Maintenance Phase|Multiple Reasons|2|||
147208134|NCT02100696|530932573|FG005|Maintenance Phase|Multiple Reasons|1|||
147208135|NCT03865381|530932577|FG000|Overall Study|Protocol Violation/Non-Compliance|3|||
147208136|NCT03865381|530932577|FG000|Overall Study|Withdrawal by Subject|2|||
147208137|NCT04999852|530932578|FG000|Overall Study|Withdrawal by Subject|11|||
147208138|NCT04999852|530932579|FG001|Overall Study|Withdrawal by Subject|1|||
147208139|NCT04999852|530932578|FG000|Overall Study|Switched to different psychotherapy that was ineligible for study|2|||
147208140|NCT04999852|530932579|FG001|Overall Study|Switched to different psychotherapy that was ineligible for study|0|||
147208141|NCT05626322|530932580|FG000|Overall Study|Death|2|||
147208142|NCT05626322|530932581|FG001|Overall Study|Death|0|||
147208143|NCT05626322|530932582|FG002|Overall Study|Death|0|||
147208144|NCT05626322|530932580|FG000|Overall Study|Physician Decision|1|||
147208145|NCT05626322|530932581|FG001|Overall Study|Physician Decision|0|||
147208146|NCT05626322|530932582|FG002|Overall Study|Physician Decision|0|||
147208147|NCT05626322|530932580|FG000|Overall Study|Progressive Disease|0|||
147208148|NCT05626322|530932581|FG001|Overall Study|Progressive Disease|1|||
147208149|NCT05626322|530932582|FG002|Overall Study|Progressive Disease|1|||
147208150|NCT05626322|530932580|FG000|Overall Study|Study terminated by sponsor|0|||
147208151|NCT05626322|530932581|FG001|Overall Study|Study terminated by sponsor|1|||
147208152|NCT05626322|530932582|FG002|Overall Study|Study terminated by sponsor|0|||
147208153|NCT03776812|530932583|FG000|Overall Study|Death|53|||
147541589|NCT00450177|532138017|FG001|Overall Study|Adverse Event|4|||
147208154|NCT03776812|530932584|FG001|Overall Study|Death|49|||
147208155|NCT03776812|530932585|FG002|Overall Study|Death|56|||
147208156|NCT03776812|530932583|FG000|Overall Study|Withdrawal by Subject|1|||
147208157|NCT03776812|530932584|FG001|Overall Study|Withdrawal by Subject|7|||
147208158|NCT03776812|530932585|FG002|Overall Study|Withdrawal by Subject|2|||
147208159|NCT03776812|530932583|FG000|Overall Study|Lost to Follow-up|1|||
147208160|NCT03776812|530932584|FG001|Overall Study|Lost to Follow-up|1|||
147208161|NCT03776812|530932585|FG002|Overall Study|Lost to Follow-up|0|||
147208162|NCT03776812|530932583|FG000|Overall Study|Did not enter long-term follow-up|3|||
147208163|NCT03776812|530932584|FG001|Overall Study|Did not enter long-term follow-up|3|||
147208164|NCT03776812|530932585|FG002|Overall Study|Did not enter long-term follow-up|2|||
147208165|NCT04758637|530932588|FG000|Overall Study|Lost to Follow-up|0|||
147208166|NCT04758637|530932589|FG001|Overall Study|Lost to Follow-up|1|||
147208167|NCT04758637|530932590|FG002|Overall Study|Lost to Follow-up|0|||
147208168|NCT04758637|530932591|FG003|Overall Study|Lost to Follow-up|0|||
147208169|NCT03350672|530932597|FG000|Overall Study|Withdrawal by Subject|7|||
147208170|NCT03350672|530932598|FG001|Overall Study|Withdrawal by Subject|0|||
147208171|NCT03350672|530932599|FG002|Overall Study|Withdrawal by Subject|0|||
147208172|NCT00048074|530932602|FG000|Overall Study|Adverse Event|46|||
147208173|NCT00048074|530932603|FG001|Overall Study|Adverse Event|41|||
147208174|NCT00048074|530932604|FG002|Overall Study|Adverse Event|53|||
147208175|NCT00048074|530932602|FG000|Overall Study|Death|3|||
147208176|NCT00048074|530932603|FG001|Overall Study|Death|3|||
147208177|NCT00048074|530932604|FG002|Overall Study|Death|2|||
147208178|NCT00048074|530932602|FG000|Overall Study|Lost to Follow-up|2|||
147208179|NCT00048074|530932603|FG001|Overall Study|Lost to Follow-up|6|||
147208180|NCT00048074|530932604|FG002|Overall Study|Lost to Follow-up|6|||
147208181|NCT00048074|530932602|FG000|Overall Study|Withdrawal by Subject|28|||
147208182|NCT00048074|530932603|FG001|Overall Study|Withdrawal by Subject|30|||
147208183|NCT00048074|530932604|FG002|Overall Study|Withdrawal by Subject|35|||
147208184|NCT00048074|530932602|FG000|Overall Study|Protocol Violation|1|||
147208185|NCT00048074|530932603|FG001|Overall Study|Protocol Violation|3|||
147208186|NCT00048074|530932604|FG002|Overall Study|Protocol Violation|0|||
147208187|NCT00048074|530932602|FG000|Overall Study|Study participation was terminated|0|||
147208188|NCT00048074|530932603|FG001|Overall Study|Study participation was terminated|1|||
147208189|NCT00048074|530932604|FG002|Overall Study|Study participation was terminated|0|||
147208190|NCT00048074|530932602|FG000|Overall Study|Husband ill|0|||
147208191|NCT00048074|530932603|FG001|Overall Study|Husband ill|1|||
147208192|NCT00048074|530932604|FG002|Overall Study|Husband ill|0|||
147208193|NCT00048074|530932602|FG000|Overall Study|Poor compliance|0|||
147208194|NCT00048074|530932603|FG001|Overall Study|Poor compliance|1|||
147208195|NCT00048074|530932604|FG002|Overall Study|Poor compliance|0|||
147208196|NCT00048074|530932602|FG000|Overall Study|Out of station|0|||
147208197|NCT00048074|530932603|FG001|Overall Study|Out of station|1|||
147208198|NCT00048074|530932604|FG002|Overall Study|Out of station|1|||
147208199|NCT00048074|530932602|FG000|Overall Study|Social reasons|1|||
147208200|NCT00048074|530932603|FG001|Overall Study|Social reasons|0|||
147208201|NCT00048074|530932604|FG002|Overall Study|Social reasons|0|||
147208202|NCT02873377|530932605|FG000|Period Title 2: 3 Months Follow up|Lost to Follow-up|22|||
147208203|NCT02873377|530932606|FG001|Period Title 2: 3 Months Follow up|Lost to Follow-up|22|||
147208204|NCT02873377|530932605|FG000|Period Title 3: 6 Months Follow up|Lost to Follow-up|15|||
147208205|NCT02873377|530932606|FG001|Period Title 3: 6 Months Follow up|Lost to Follow-up|23|||
147208206|NCT01583296|530932609|FG000|Overall Study|Withdrawal by Subject|11|||
147208207|NCT01583296|530932610|FG001|Overall Study|Withdrawal by Subject|10|||
147208208|NCT01063283|530932611|FG000|Cycle 1|Adverse Event|2|||
147208209|NCT01063283|530932612|FG001|Cycle 1|Adverse Event|0|||
147208210|NCT01063283|530932613|FG002|Cycle 1|Adverse Event|0|||
147208211|NCT01063283|530932611|FG000|Cycle 1|Technical failure in data collection|1|||
147208212|NCT01063283|530932612|FG001|Cycle 1|Technical failure in data collection|0|||
147208213|NCT01063283|530932613|FG002|Cycle 1|Technical failure in data collection|0|||
147439936|NCT03250832|531775899|FG010|Part 1 (Up to Approximately 51 Months)|Death|0|||
147439937|NCT03250832|531775900|FG011|Part 1 (Up to Approximately 51 Months)|Death|0|||
147439938|NCT03250832|531775889|FG000|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|2|||
147439939|NCT03250832|531775890|FG001|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|4|||
147208214|NCT02504216|530932616|FG000|Overall Study|Lost to Follow-up|3|||
147208215|NCT02504216|530932617|FG001|Overall Study|Lost to Follow-up|3|||
147208216|NCT02504216|530932616|FG000|Overall Study|Withdrawal by Subject|8|||
147208217|NCT02504216|530932617|FG001|Overall Study|Withdrawal by Subject|12|||
147208218|NCT02598583|530932618|FG000|Extension Period|Withdrawal by Subject|1|||
147208219|NCT02598583|530932619|FG001|Extension Period|Withdrawal by Subject|0|||
147208220|NCT03237286|530932620|FG000|Overall Study|Withdrawal by Subject|1|||
147208221|NCT03237286|530932621|FG001|Overall Study|Withdrawal by Subject|0|||
147208222|NCT03237286|530932622|FG002|Overall Study|Withdrawal by Subject|2|||
147208223|NCT03237286|530932620|FG000|Overall Study|Study withdrew participant due to repeated non-compliance|0|||
147439940|NCT03250832|531775891|FG002|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|5|||
147208224|NCT03237286|530932621|FG001|Overall Study|Study withdrew participant due to repeated non-compliance|0|||
147208225|NCT03237286|530932622|FG002|Overall Study|Study withdrew participant due to repeated non-compliance|1|||
147208226|NCT02792829|530932623|FG000|Treatment Period 2|Non compliance with alcohol prohibition|0|||
147208227|NCT02792829|530932624|FG001|Treatment Period 2|Non compliance with alcohol prohibition|1|||
147208228|NCT02792829|530932625|FG002|Treatment Period 2|Non compliance with alcohol prohibition|0|||
147208229|NCT02792829|530932626|FG003|Treatment Period 2|Non compliance with alcohol prohibition|0|||
147208230|NCT02792829|530932627|FG004|Treatment Period 2|Non compliance with alcohol prohibition|0|||
147208231|NCT02792829|530932628|FG005|Treatment Period 2|Non compliance with alcohol prohibition|0|||
147208232|NCT02792829|530932629|FG006|Treatment Period 2|Non compliance with alcohol prohibition|0|||
147208233|NCT02792829|530932630|FG007|Treatment Period 2|Non compliance with alcohol prohibition|0|||
147208234|NCT02792829|530932623|FG000|Treatment Period 2|Adverse Event|0|||
147208235|NCT02792829|530932624|FG001|Treatment Period 2|Adverse Event|0|||
147208236|NCT02792829|530932625|FG002|Treatment Period 2|Adverse Event|0|||
147208237|NCT02792829|530932626|FG003|Treatment Period 2|Adverse Event|0|||
147208238|NCT02792829|530932627|FG004|Treatment Period 2|Adverse Event|1|||
147208239|NCT02792829|530932628|FG005|Treatment Period 2|Adverse Event|0|||
147208240|NCT02792829|530932629|FG006|Treatment Period 2|Adverse Event|1|||
147208241|NCT02792829|530932630|FG007|Treatment Period 2|Adverse Event|1|||
147208242|NCT02792829|530932623|FG000|Treatment Period 2|Use of proscribed medications|0|||
147208243|NCT02792829|530932624|FG001|Treatment Period 2|Use of proscribed medications|0|||
147208244|NCT02792829|530932625|FG002|Treatment Period 2|Use of proscribed medications|0|||
147208245|NCT02792829|530932626|FG003|Treatment Period 2|Use of proscribed medications|0|||
147208246|NCT02792829|530932627|FG004|Treatment Period 2|Use of proscribed medications|0|||
147208247|NCT02792829|530932628|FG005|Treatment Period 2|Use of proscribed medications|0|||
147208248|NCT02792829|530932629|FG006|Treatment Period 2|Use of proscribed medications|0|||
147208249|NCT02792829|530932630|FG007|Treatment Period 2|Use of proscribed medications|1|||
147208250|NCT01668589|530932636|FG000|Overall Study|Lost to Follow-up|29|||
147208251|NCT01668589|530932637|FG001|Overall Study|Lost to Follow-up|37|||
147208252|NCT01668589|530932638|FG002|Overall Study|Lost to Follow-up|15|||
147208253|NCT01668589|530932639|FG003|Overall Study|Lost to Follow-up|5|||
147208254|NCT01668589|530932636|FG000|Overall Study|Full Consent/Agreement Withdrawn|54|||
147208255|NCT01668589|530932637|FG001|Overall Study|Full Consent/Agreement Withdrawn|8|||
147208256|NCT01668589|530932638|FG002|Overall Study|Full Consent/Agreement Withdrawn|11|||
147208257|NCT01668589|530932639|FG003|Overall Study|Full Consent/Agreement Withdrawn|4|||
147208258|NCT01668589|530932636|FG000|Overall Study|Death|12|||
147208259|NCT01668589|530932637|FG001|Overall Study|Death|3|||
147208260|NCT01668589|530932638|FG002|Overall Study|Death|2|||
147208261|NCT01668589|530932639|FG003|Overall Study|Death|11|||
147208262|NCT01668589|530932636|FG000|Overall Study|Other|44|||
147208263|NCT01668589|530932637|FG001|Overall Study|Other|10|||
147208264|NCT01668589|530932638|FG002|Overall Study|Other|7|||
147208265|NCT01668589|530932639|FG003|Overall Study|Other|15|||
147208266|NCT00993148|530932640|FG000|Overall Study|Lost to Follow-up|2|||
147208267|NCT00993148|530932640|FG000|Overall Study|never initiated treatment|1|||
147208268|NCT02302339|530932641|FG000|Overall Study|Lost to Follow-up|1|||
147208269|NCT02302339|530932642|FG001|Overall Study|Lost to Follow-up|0|||
147208270|NCT02302339|530932643|FG002|Overall Study|Lost to Follow-up|0|||
147208271|NCT02302339|530932644|FG003|Overall Study|Lost to Follow-up|0|||
147208272|NCT02302339|530932641|FG000|Overall Study|Withdrawal by Subject|0|||
147208273|NCT02302339|530932642|FG001|Overall Study|Withdrawal by Subject|2|||
147208274|NCT02302339|530932643|FG002|Overall Study|Withdrawal by Subject|1|||
147208275|NCT02302339|530932644|FG003|Overall Study|Withdrawal by Subject|0|||
147208276|NCT02752165|530932645|FG000|Overall Study|Withdrawal by Subject|6|||
147208277|NCT02752165|530932646|FG001|Overall Study|Withdrawal by Subject|6|||
147208278|NCT02752165|530932645|FG000|Overall Study|Protocol Violation|6|||
147208279|NCT02752165|530932646|FG001|Overall Study|Protocol Violation|5|||
147208280|NCT02752165|530932645|FG000|Overall Study|Lost to Follow-up|33|||
147208281|NCT02752165|530932646|FG001|Overall Study|Lost to Follow-up|38|||
147208282|NCT03568461|530932653|FG000|Overall Study|Death|7|||
147208283|NCT03568461|530932653|FG000|Overall Study|Physician Decision|5|||
147208284|NCT03568461|530932653|FG000|Overall Study|Subject decision|5|||
147208285|NCT03568461|530932653|FG000|Overall Study|Lost to Follow-up|1|||
147439941|NCT03250832|531775892|FG003|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|5|||
147439942|NCT03250832|531775893|FG004|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|2|||
147439943|NCT03250832|531775894|FG005|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|1|||
147439944|NCT03250832|531775895|FG006|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|3|||
147439945|NCT03250832|531775896|FG007|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|0|||
147439946|NCT03250832|531775897|FG008|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|0|||
147439947|NCT03250832|531775898|FG009|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|0|||
147649437|NCT02634801|532537342|FG001|Extension Period (Weeks 24 to 36)|Missing|0|||
147208286|NCT04695977|530932654|FG000|Overall Study|Sponsor Decision|9|||
147208287|NCT04695977|530932655|FG001|Overall Study|Sponsor Decision|4|||
147439948|NCT03250832|531775899|FG010|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|0|||
147208288|NCT04695977|530932654|FG000|Overall Study|Death|2|||
147208289|NCT04695977|530932655|FG001|Overall Study|Death|5|||
147439949|NCT03250832|531775900|FG011|Part 1 (Up to Approximately 51 Months)|Withdrawal by Subject|0|||
147439950|NCT03250832|531775889|FG000|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
147439951|NCT03250832|531775890|FG001|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
147439952|NCT03250832|531775891|FG002|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|1|||
147439953|NCT03250832|531775892|FG003|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
147439954|NCT03250832|531775893|FG004|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
147208290|NCT02175199|530933989|FG000|Overall Study|Withdrawal by Subject|1|||
147208291|NCT02175199|530933990|FG001|Overall Study|Withdrawal by Subject|5|||
147208292|NCT02175199|530933989|FG000|Overall Study|Randomized in Error|1|||
147208293|NCT02175199|530933990|FG001|Overall Study|Randomized in Error|0|||
147208294|NCT02175199|530933989|FG000|Overall Study|Sponsor Decision|1|||
147208295|NCT02175199|530933990|FG001|Overall Study|Sponsor Decision|0|||
147208296|NCT03983317|530933993|FG000|Overall Study|Physician Decision|5|||
147208297|NCT01761162|530933994|FG000|Overall Study|Withdrawal by Subject|3|||
147208298|NCT01643772|530933995|FG000|Overall Study|Protocol Violation|0|||
147208299|NCT01643772|530933996|FG001|Overall Study|Protocol Violation|0|||
147208300|NCT01643772|530933997|FG002|Overall Study|Protocol Violation|0|||
147208301|NCT01643772|530933998|FG003|Overall Study|Protocol Violation|1|||
147208302|NCT01643772|530933995|FG000|Overall Study|Adverse Event|0|||
147208303|NCT01643772|530933996|FG001|Overall Study|Adverse Event|0|||
147208304|NCT01643772|530933997|FG002|Overall Study|Adverse Event|0|||
147208305|NCT01643772|530933998|FG003|Overall Study|Adverse Event|1|||
147208306|NCT01621802|530933999|FG000|Overall Study|Protocol Violation|0|||
147208307|NCT01621802|530934000|FG001|Overall Study|Protocol Violation|0|||
147208308|NCT01621802|530934001|FG002|Overall Study|Protocol Violation|0|||
147208309|NCT01621802|530934002|FG003|Overall Study|Protocol Violation|0|||
147208310|NCT01621802|530934003|FG004|Overall Study|Protocol Violation|0|||
147208311|NCT01621802|530934004|FG005|Overall Study|Protocol Violation|1|||
147208312|NCT01621802|530933999|FG000|Overall Study|Withdrawal by Subject|8|||
147208313|NCT01621802|530934000|FG001|Overall Study|Withdrawal by Subject|4|||
147208314|NCT01621802|530934001|FG002|Overall Study|Withdrawal by Subject|4|||
147208315|NCT01621802|530934002|FG003|Overall Study|Withdrawal by Subject|2|||
147208316|NCT01621802|530934003|FG004|Overall Study|Withdrawal by Subject|2|||
147208317|NCT01621802|530934004|FG005|Overall Study|Withdrawal by Subject|0|||
147208318|NCT01621802|530933999|FG000|Overall Study|Migrated/moved from study area|0|||
147208319|NCT01621802|530934000|FG001|Overall Study|Migrated/moved from study area|0|||
147208320|NCT01621802|530934001|FG002|Overall Study|Migrated/moved from study area|2|||
147208321|NCT01621802|530934002|FG003|Overall Study|Migrated/moved from study area|0|||
147208322|NCT01621802|530934003|FG004|Overall Study|Migrated/moved from study area|1|||
147208323|NCT01621802|530934004|FG005|Overall Study|Migrated/moved from study area|0|||
147208324|NCT01621802|530933999|FG000|Overall Study|Others|3|||
147208325|NCT01621802|530934000|FG001|Overall Study|Others|3|||
147208326|NCT01621802|530934001|FG002|Overall Study|Others|3|||
147208327|NCT01621802|530934002|FG003|Overall Study|Others|2|||
147208328|NCT01621802|530934003|FG004|Overall Study|Others|1|||
147208329|NCT01621802|530934004|FG005|Overall Study|Others|0|||
147208330|NCT01621802|530933999|FG000|Overall Study|Lost to Follow-up|36|||
147208331|NCT01621802|530934000|FG001|Overall Study|Lost to Follow-up|16|||
147208332|NCT01621802|530934001|FG002|Overall Study|Lost to Follow-up|24|||
147208333|NCT01621802|530934002|FG003|Overall Study|Lost to Follow-up|7|||
147208334|NCT01621802|530934003|FG004|Overall Study|Lost to Follow-up|31|||
147208335|NCT01621802|530934004|FG005|Overall Study|Lost to Follow-up|11|||
147208336|NCT03436082|530934005|FG000|Overall Study|Did not undergo procedure|1|||
147208337|NCT03436082|530934006|FG001|Overall Study|Did not undergo procedure|0|||
147208338|NCT01296672|530934007|FG000|Overall Study|Lost to Follow-up|73|||
147208339|NCT01296672|530934008|FG001|Overall Study|Lost to Follow-up|18|||
147208340|NCT01716052|530934009|FG000|Overall Study|Withdrawal of funding|1|||
147208341|NCT01716052|530934010|FG001|Overall Study|Withdrawal of funding|1|||
147208342|NCT04027608|530934011|FG000|Overall Study|Withdrawal by Subject|13|||
147208343|NCT04027608|530934012|FG001|Overall Study|Withdrawal by Subject|2|||
147208344|NCT04027608|530934011|FG000|Overall Study|Protocol Violation|2|||
147208345|NCT04027608|530934012|FG001|Overall Study|Protocol Violation|1|||
147439955|NCT03250832|531775894|FG005|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
147208346|NCT04027608|530934011|FG000|Overall Study|Physician Decision|1|||
147208347|NCT04027608|530934012|FG001|Overall Study|Physician Decision|0|||
147208348|NCT04027608|530934011|FG000|Overall Study|Lost to Follow-up|20|||
147208349|NCT04027608|530934012|FG001|Overall Study|Lost to Follow-up|4|||
147208350|NCT01305577|530934016|FG000|Overall Study|Adverse Event|2|||
147208351|NCT01305577|530934017|FG001|Overall Study|Adverse Event|2|||
147208352|NCT01305577|530934018|FG002|Overall Study|Adverse Event|1|||
147208353|NCT01305577|530934016|FG000|Overall Study|Withdrawal by Subject|7|||
147208354|NCT01305577|530934017|FG001|Overall Study|Withdrawal by Subject|5|||
147208355|NCT01305577|530934018|FG002|Overall Study|Withdrawal by Subject|6|||
147208356|NCT01305577|530934016|FG000|Overall Study|Lost to Follow-up|4|||
147208357|NCT01305577|530934017|FG001|Overall Study|Lost to Follow-up|3|||
147208358|NCT01305577|530934018|FG002|Overall Study|Lost to Follow-up|2|||
147208359|NCT01305577|530934016|FG000|Overall Study|Protocol Deviation|0|||
147208360|NCT01305577|530934017|FG001|Overall Study|Protocol Deviation|1|||
147208361|NCT01305577|530934018|FG002|Overall Study|Protocol Deviation|1|||
147208362|NCT00796978|530934019|FG000|Overall Study|Cardiac adverse event|5|||
147208363|NCT00796978|530934019|FG000|Overall Study|Adverse Event|4|||
147208364|NCT00796978|530934019|FG000|Overall Study|Withdrawal by Subject|3|||
147208365|NCT01092546|530934023|FG000|Overall Study|Subjects withdrawn prior to dosing|4|||
147208366|NCT00622440|530934036|FG000|Baseline - Week 12 (Treatment)|Received cream but did not return|4|||
147208367|NCT00622440|530934037|FG001|Baseline - Week 12 (Treatment)|Received cream but did not return|1|||
147208368|NCT00622440|530934036|FG000|Week 12 - Week 48 (Treatment)|Lost to Follow-up|3|||
147208369|NCT00622440|530934037|FG001|Week 12 - Week 48 (Treatment)|Lost to Follow-up|5|||
147208370|NCT00622440|530934036|FG000|Week 12 - Week 48 (Treatment)|Not evaluable - censored from dataset|0|||
147208371|NCT00622440|530934037|FG001|Week 12 - Week 48 (Treatment)|Not evaluable - censored from dataset|1|||
147208372|NCT00622440|530934036|FG000|Week 60 (Post-treatment Follow-up Visit)|Lost to Follow-up|0|||
147208373|NCT00622440|530934037|FG001|Week 60 (Post-treatment Follow-up Visit)|Lost to Follow-up|1|||
147208374|NCT00771953|530934040|FG000|Overall Study|Adverse Event|5|||
147208375|NCT00771953|530934041|FG001|Overall Study|Adverse Event|3|||
147208376|NCT00771953|530934040|FG000|Overall Study|Death|2|||
147208377|NCT00771953|530934041|FG001|Overall Study|Death|2|||
147208378|NCT00771953|530934040|FG000|Overall Study|Progression before active Tx|1|||
147208379|NCT00771953|530934041|FG001|Overall Study|Progression before active Tx|2|||
147208380|NCT00771953|530934040|FG000|Overall Study|Sponsor decision|1|||
147208381|NCT00771953|530934041|FG001|Overall Study|Sponsor decision|0|||
147208382|NCT00771953|530934040|FG000|Overall Study|Other complicating disease|1|||
147208383|NCT00771953|530934041|FG001|Overall Study|Other complicating disease|0|||
147208384|NCT00771953|530934040|FG000|Overall Study|Withdrawal by Subject|0|||
147208385|NCT00771953|530934041|FG001|Overall Study|Withdrawal by Subject|3|||
147208386|NCT00947193|530934044|FG000|Overall Study|Lost to Follow-up|1|||
147208387|NCT00947193|530934045|FG001|Overall Study|Lost to Follow-up|0|||
147208388|NCT00947193|530934044|FG000|Overall Study|Withdrawal by Subject|1|||
147208389|NCT00947193|530934045|FG001|Overall Study|Withdrawal by Subject|0|||
147208390|NCT00947193|530934044|FG000|Overall Study|Factor VIII >1%|1|||
147208391|NCT00947193|530934045|FG001|Overall Study|Factor VIII >1%|0|||
147208392|NCT04364984|530934046|FG000|Overall Study|Death|2|||
147208393|NCT04364984|530934047|FG001|Overall Study|Death|2|||
147208394|NCT04364984|530934048|FG002|Overall Study|Death|0|||
147208395|NCT01349959|530934049|FG000|Overall Study|Adverse Event|7|||
147208396|NCT02675634|530934050|FG000|Test Period 1|Adverse Event|0|||
147208397|NCT02675634|530934051|FG001|Test Period 1|Adverse Event|1|||
147208398|NCT02675634|530934052|FG002|Test Period 1|Adverse Event|0|||
147208399|NCT02675634|530934053|FG003|Test Period 1|Adverse Event|1|||
147208400|NCT02675634|530934054|FG004|Test Period 1|Adverse Event|0|||
147208401|NCT02675634|530934055|FG005|Test Period 1|Adverse Event|0|||
147208402|NCT02675634|530934050|FG000|Test Period 1|Device deficiency that did not lead to A|0|||
147208403|NCT02675634|530934051|FG001|Test Period 1|Device deficiency that did not lead to A|0|||
147208404|NCT02675634|530934052|FG002|Test Period 1|Device deficiency that did not lead to A|1|||
147208405|NCT02675634|530934053|FG003|Test Period 1|Device deficiency that did not lead to A|0|||
147208406|NCT02675634|530934054|FG004|Test Period 1|Device deficiency that did not lead to A|0|||
147208407|NCT02675634|530934055|FG005|Test Period 1|Device deficiency that did not lead to A|0|||
147208408|NCT02675634|530934050|FG000|Test Period 2|Lack of Efficacy|1|||
147208409|NCT02675634|530934051|FG001|Test Period 2|Lack of Efficacy|0|||
147208410|NCT02675634|530934052|FG002|Test Period 2|Lack of Efficacy|0|||
147208411|NCT02675634|530934053|FG003|Test Period 2|Lack of Efficacy|0|||
147208412|NCT02675634|530934054|FG004|Test Period 2|Lack of Efficacy|0|||
147208413|NCT02675634|530934055|FG005|Test Period 2|Lack of Efficacy|0|||
147208414|NCT02675634|530934050|FG000|Test Period 2|Adverse Event|0|||
147208415|NCT02675634|530934051|FG001|Test Period 2|Adverse Event|0|||
147208416|NCT02675634|530934052|FG002|Test Period 2|Adverse Event|0|||
147208417|NCT02675634|530934053|FG003|Test Period 2|Adverse Event|0|||
147208418|NCT02675634|530934054|FG004|Test Period 2|Adverse Event|0|||
147208419|NCT02675634|530934055|FG005|Test Period 2|Adverse Event|1|||
147208420|NCT01652534|530934056|FG000|Overall Study|Lack of Efficacy|1|||
147208421|NCT01652534|530934057|FG001|Overall Study|Lack of Efficacy|0|||
147208422|NCT01941186|530934058|FG000|Follow-up|Lost to Follow-up|1|||
147208423|NCT01941186|530934059|FG001|Follow-up|Lost to Follow-up|0|||
147208424|NCT03860259|530934060|FG000|Overall Study|Lost to Follow-up|5|||
147208425|NCT03860259|530934061|FG001|Overall Study|Lost to Follow-up|5|||
147208426|NCT03860259|530934060|FG000|Overall Study|Protocol Violation|1|||
147208427|NCT03860259|530934061|FG001|Overall Study|Protocol Violation|0|||
147208428|NCT00811018|530934062|FG000|Overall Study|Additional Chronic Treatment|31|||
147208429|NCT00811018|530934062|FG000|Overall Study|Adverse Event|79|||
147208430|NCT00811018|530934062|FG000|Overall Study|Death|147|||
147208431|NCT00811018|530934062|FG000|Overall Study|ALT/AST >3x UNL, Bilirubin >2xUNL|4|||
147208432|NCT00811018|530934062|FG000|Overall Study|ALT/AST >5x Upper Limit of Normal (ULN)|70|||
147208433|NCT00811018|530934062|FG000|Overall Study|Investigator Decision|57|||
147208434|NCT00811018|530934062|FG000|Overall Study|Lost to Follow-up|19|||
147208435|NCT00811018|530934062|FG000|Overall Study|Pregnancy|6|||
147208436|NCT00811018|530934062|FG000|Overall Study|Sponsor Decision|450|||
147208437|NCT00811018|530934062|FG000|Overall Study|Withdrawal by Subject|70|||
147208438|NCT00811018|530934062|FG000|Overall Study|WHO FC deterioration and 6MWD decrease|9|||
147208439|NCT00811018|530934062|FG000|Overall Study|Other|26|||
147208440|NCT02722304|530934066|FG000|Overall Study|Study Terminated by Sponsor|1|||
147208441|NCT02722304|530934067|FG001|Overall Study|Study Terminated by Sponsor|0|||
147208442|NCT02722304|530934068|FG002|Overall Study|Study Terminated by Sponsor|2|||
147208443|NCT02722304|530934069|FG003|Overall Study|Study Terminated by Sponsor|1|||
147208444|NCT02722304|530934070|FG004|Overall Study|Study Terminated by Sponsor|1|||
147208445|NCT02722304|530934066|FG000|Overall Study|Other|0|||
147208446|NCT02722304|530934067|FG001|Overall Study|Other|0|||
147208447|NCT02722304|530934068|FG002|Overall Study|Other|0|||
147208448|NCT02722304|530934069|FG003|Overall Study|Other|1|||
147208449|NCT02722304|530934070|FG004|Overall Study|Other|1|||
147208450|NCT00934362|530934071|FG000|Overall Study|Adverse Event|1|||
147208451|NCT00934362|530934072|FG001|Overall Study|Adverse Event|0|||
147208452|NCT01092117|530934075|FG000|Index Procedure to 1 Month|Death|1|||
147208453|NCT01092117|530934075|FG000|1 Month|Death|1|||
147208454|NCT01092117|530934075|FG000|1 Month|Withdrawal by Subject|1|||
147208455|NCT01092117|530934075|FG000|1 Month|Lost to Follow-up|1|||
147208456|NCT01092117|530934075|FG000|6 Months|Death|2|||
147208457|NCT01092117|530934075|FG000|6 Months|Withdrawal by Subject|3|||
147208458|NCT01092117|530934075|FG000|12 Month|Death|11|||
147208459|NCT01092117|530934075|FG000|12 Month|Withdrawal by Subject|2|||
147208460|NCT01092117|530934075|FG000|12 Month|Lost to Follow-up|1|||
147208461|NCT01092117|530934075|FG000|Year 2|Death|5|||
147208462|NCT01092117|530934075|FG000|Year 2|Withdrawal by Subject|4|||
147208463|NCT01092117|530934075|FG000|Year 2|Lost to Follow-up|1|||
147208464|NCT01092117|530934075|FG000|Year 3|Death|7|||
147208465|NCT01092117|530934075|FG000|Year 3|Withdrawal by Subject|9|||
147208466|NCT01092117|530934075|FG000|Year 3|Lost to Follow-up|3|||
147208467|NCT01092117|530934075|FG000|Year 4|Death|8|||
147208468|NCT01092117|530934075|FG000|Year 4|Withdrawal by Subject|4|||
147208469|NCT01092117|530934075|FG000|Year 4|Lost to Follow-up|4|||
147208470|NCT04380519|530934076|FG000|Overall Study|Withdrawal by Subject|4|||
147208471|NCT04380519|530934077|FG001|Overall Study|Withdrawal by Subject|0|||
147208472|NCT04380519|530934078|FG002|Overall Study|Withdrawal by Subject|1|||
147208473|NCT04380519|530934076|FG000|Overall Study|Death|14|||
147208474|NCT04380519|530934077|FG001|Overall Study|Death|9|||
147208475|NCT04380519|530934078|FG002|Overall Study|Death|6|||
147208476|NCT04380519|530934076|FG000|Overall Study|Adverse Event|0|||
147208477|NCT04380519|530934077|FG001|Overall Study|Adverse Event|1|||
147208478|NCT04380519|530934078|FG002|Overall Study|Adverse Event|0|||
147208479|NCT04380519|530934076|FG000|Overall Study|relatives' decision|0|||
147208480|NCT04380519|530934077|FG001|Overall Study|relatives' decision|1|||
147208481|NCT04380519|530934078|FG002|Overall Study|relatives' decision|0|||
147208482|NCT02147561|530934083|FG000|Overall Study|Lost to Follow-up|3|||
147208483|NCT02147561|530934083|FG000|Overall Study|Subjects who didn't receive BOTOX|1|||
147208484|NCT00393861|530934084|FG000|Overall Study|Adverse Event|2|||
147208485|NCT00393861|530934084|FG000|Overall Study|Disease Progression|24|||
147208486|NCT05300763|530934085|FG000|Overall Study|Adverse Event|0|||
147208487|NCT05300763|530934086|FG001|Overall Study|Adverse Event|1|||
147208488|NCT05300763|530934085|FG000|Overall Study|Major Protocol Deviation|1|||
147208489|NCT05300763|530934086|FG001|Overall Study|Major Protocol Deviation|0|||
147208490|NCT05300763|530934085|FG000|Overall Study|Subject No Longer Meets Eligibility Criteria|1|||
147208491|NCT05300763|530934086|FG001|Overall Study|Subject No Longer Meets Eligibility Criteria|0|||
147208492|NCT02283762|530934087|FG000|Main Treatment Phase (MT)|Adverse Event|9|||
147208493|NCT02283762|530934088|FG001|Main Treatment Phase (MT)|Adverse Event|9|||
147208494|NCT02283762|530934087|FG000|Main Treatment Phase (MT)|Lack of Efficacy|1|||
147208495|NCT02283762|530934088|FG001|Main Treatment Phase (MT)|Lack of Efficacy|0|||
147208496|NCT02283762|530934087|FG000|Main Treatment Phase (MT)|Physician Decision|1|||
147208497|NCT02283762|530934088|FG001|Main Treatment Phase (MT)|Physician Decision|1|||
147208498|NCT02283762|530934087|FG000|Main Treatment Phase (MT)|Pregnancy|0|||
147208499|NCT02283762|530934088|FG001|Main Treatment Phase (MT)|Pregnancy|1|||
147208500|NCT02283762|530934087|FG000|Main Treatment Phase (MT)|Withdrawal by Subject|7|||
147208501|NCT02283762|530934088|FG001|Main Treatment Phase (MT)|Withdrawal by Subject|4|||
147208502|NCT02283762|530934087|FG000|Long-term Extension Phase (LTE)|Adverse Event|2|||
147208503|NCT02283762|530934088|FG001|Long-term Extension Phase (LTE)|Adverse Event|6|||
147208504|NCT02283762|530934087|FG000|Long-term Extension Phase (LTE)|Lack of Efficacy|1|||
147208505|NCT02283762|530934088|FG001|Long-term Extension Phase (LTE)|Lack of Efficacy|1|||
147208506|NCT02283762|530934087|FG000|Long-term Extension Phase (LTE)|Study terminated at site|1|||
147208507|NCT02283762|530934088|FG001|Long-term Extension Phase (LTE)|Study terminated at site|0|||
147208508|NCT02283762|530934087|FG000|Long-term Extension Phase (LTE)|Withdrawal by Subject|4|||
147208509|NCT02283762|530934088|FG001|Long-term Extension Phase (LTE)|Withdrawal by Subject|3|||
147208510|NCT02283762|530934087|FG000|Long-term Extension Phase (LTE)|Protocol Violation|1|||
147208511|NCT02283762|530934088|FG001|Long-term Extension Phase (LTE)|Protocol Violation|1|||
147208512|NCT02283762|530934087|FG000|Long-term Extension Phase (LTE)|Lost to Follow-up|0|||
147208513|NCT02283762|530934088|FG001|Long-term Extension Phase (LTE)|Lost to Follow-up|1|||
147208514|NCT02283762|530934087|FG000|Long-term Extension Phase (LTE)|Physician Decision|1|||
147208515|NCT02283762|530934088|FG001|Long-term Extension Phase (LTE)|Physician Decision|2|||
147208516|NCT00889720|530934094|FG000|Overall Study|Withdrawal by Subject|4|||
147208517|NCT00889720|530934094|FG000|Overall Study|Other|4|||
147208518|NCT00223080|530934095|FG000|Overall Study|Withdrawal by Subject|253|||
147208519|NCT00223080|530934096|FG001|Overall Study|Withdrawal by Subject|232|||
147208520|NCT00223080|530934095|FG000|Overall Study|Required contraindicated med|0|||
147208521|NCT00223080|530934096|FG001|Overall Study|Required contraindicated med|1|||
147208522|NCT00223080|530934095|FG000|Overall Study|Non-compliant|7|||
147208523|NCT00223080|530934096|FG001|Overall Study|Non-compliant|7|||
147208524|NCT00223080|530934095|FG000|Overall Study|Moved from study area|37|||
147208525|NCT00223080|530934096|FG001|Overall Study|Moved from study area|47|||
147208526|NCT00223080|530934095|FG000|Overall Study|Lost to Follow-up|259|||
147208527|NCT00223080|530934096|FG001|Overall Study|Lost to Follow-up|284|||
147208528|NCT00223080|530934095|FG000|Overall Study|Death|85|||
147208529|NCT00223080|530934096|FG001|Overall Study|Death|74|||
147208530|NCT00223080|530934095|FG000|Overall Study|Other|14|||
147208531|NCT00223080|530934096|FG001|Overall Study|Other|11|||
147208532|NCT00223080|530934095|FG000|Overall Study|Reason not provided|141|||
147208533|NCT00223080|530934096|FG001|Overall Study|Reason not provided|140|||
147208534|NCT00223080|530934095|FG000|Overall Study|Adverse Event|0|||
147208535|NCT00223080|530934096|FG001|Overall Study|Adverse Event|1|||
147208536|NCT00947882|530934104|FG000|Overall Study|Adverse Event|0|||
147208537|NCT00947882|530934105|FG001|Overall Study|Adverse Event|1|||
147208538|NCT00947882|530934106|FG002|Overall Study|Adverse Event|4|||
147208539|NCT00947882|530934107|FG003|Overall Study|Adverse Event|4|||
147208540|NCT00947882|530934104|FG000|Overall Study|Withdrawal by Subject|2|||
147208541|NCT00947882|530934105|FG001|Overall Study|Withdrawal by Subject|0|||
147208542|NCT00947882|530934106|FG002|Overall Study|Withdrawal by Subject|8|||
147208543|NCT00947882|530934107|FG003|Overall Study|Withdrawal by Subject|2|||
147208544|NCT00947882|530934104|FG000|Overall Study|Protocol Violation|0|||
147208545|NCT00947882|530934105|FG001|Overall Study|Protocol Violation|0|||
147208546|NCT00947882|530934106|FG002|Overall Study|Protocol Violation|1|||
147208547|NCT00947882|530934107|FG003|Overall Study|Protocol Violation|0|||
147208548|NCT00947882|530934104|FG000|Overall Study|Lost to Follow-up|0|||
147208549|NCT00947882|530934105|FG001|Overall Study|Lost to Follow-up|2|||
147208550|NCT00947882|530934106|FG002|Overall Study|Lost to Follow-up|1|||
147208551|NCT00947882|530934107|FG003|Overall Study|Lost to Follow-up|0|||
147208552|NCT00947882|530934104|FG000|Overall Study|Other/Unknown|10|||
147208553|NCT00947882|530934105|FG001|Overall Study|Other/Unknown|13|||
147208554|NCT00947882|530934106|FG002|Overall Study|Other/Unknown|3|||
147208555|NCT00947882|530934107|FG003|Overall Study|Other/Unknown|6|||
147208556|NCT00947882|530934104|FG000|Overall Study|Trial Terminated by Sponsor|62|||
147208557|NCT00947882|530934105|FG001|Overall Study|Trial Terminated by Sponsor|61|||
147208558|NCT00947882|530934106|FG002|Overall Study|Trial Terminated by Sponsor|62|||
147208559|NCT00947882|530934107|FG003|Overall Study|Trial Terminated by Sponsor|70|||
147208560|NCT01262820|530934108|FG000|Overall Study|Adverse Event|5|||
147208561|NCT01262820|530934108|FG000|Overall Study|Lack of Efficacy|9|||
147208562|NCT01262820|530934108|FG000|Overall Study|Drug held for 21+ days|1|||
147208563|NCT00452361|530934109|FG000|Overall Study|Adverse Event|8|||
147208564|NCT00452361|530934110|FG001|Overall Study|Adverse Event|0|||
147208565|NCT00452361|530934109|FG000|Overall Study|Withdrawal by Subject|0|||
147208566|NCT00452361|530934110|FG001|Overall Study|Withdrawal by Subject|1|||
147208567|NCT00452361|530934109|FG000|Overall Study|Premature termination|13|||
147208568|NCT00452361|530934110|FG001|Overall Study|Premature termination|9|||
147208569|NCT05188053|530934111|FG000|Overall Study|Lost to Follow-up|23|||
147208570|NCT05188053|530934112|FG001|Overall Study|Lost to Follow-up|30|||
147208571|NCT05188053|530934111|FG000|Overall Study|Protocol Violation|16|||
147208572|NCT05188053|530934112|FG001|Overall Study|Protocol Violation|16|||
147208573|NCT05188053|530934111|FG000|Overall Study|Physician Decision|3|||
147208574|NCT05188053|530934112|FG001|Overall Study|Physician Decision|0|||
147208575|NCT05188053|530934111|FG000|Overall Study|Withdrawal by Subject|0|||
147208576|NCT05188053|530934112|FG001|Overall Study|Withdrawal by Subject|1|||
147208577|NCT01010867|530934116|FG000|Overall Study|< 50% adherence to probiotic|1|||
147208578|NCT01120964|530934120|FG000|Overall Study|Did not receive full treatment|1|||
147208579|NCT01120964|530934121|FG001|Overall Study|Did not receive full treatment|0|||
147208580|NCT02621151|530934122|FG000|Overall Study|Not eligible for trial|6|||
147208581|NCT04198714|530934123|FG000|Overall Study|Physician Decision|0|||
147208582|NCT04198714|530934124|FG001|Overall Study|Physician Decision|1|||
147208583|NCT04238819|530934125|FG000|Overall Study|Ongoing Treatment|0|||
147208584|NCT04238819|530934126|FG001|Overall Study|Ongoing Treatment|0|||
147208585|NCT04238819|530934127|FG002|Overall Study|Ongoing Treatment|0|||
147208586|NCT04238819|530934128|FG003|Overall Study|Ongoing Treatment|0|||
147208587|NCT04238819|530934129|FG004|Overall Study|Ongoing Treatment|1|||
147208588|NCT04238819|530934130|FG005|Overall Study|Ongoing Treatment|4|||
147208589|NCT04238819|530934131|FG006|Overall Study|Ongoing Treatment|0|||
147208590|NCT04238819|530934125|FG000|Overall Study|Withdrawal by Parent/Subject|0|||
147208591|NCT04238819|530934126|FG001|Overall Study|Withdrawal by Parent/Subject|0|||
147208592|NCT04238819|530934127|FG002|Overall Study|Withdrawal by Parent/Subject|0|||
147208593|NCT04238819|530934128|FG003|Overall Study|Withdrawal by Parent/Subject|1|||
147208594|NCT04238819|530934129|FG004|Overall Study|Withdrawal by Parent/Subject|0|||
147208595|NCT04238819|530934130|FG005|Overall Study|Withdrawal by Parent/Subject|0|||
147208596|NCT04238819|530934131|FG006|Overall Study|Withdrawal by Parent/Subject|1|||
147208597|NCT02529553|530934132|FG000|Overall Study|Progressive Disease|1|||
147208598|NCT02529553|530934133|FG001|Overall Study|Progressive Disease|0|||
147208599|NCT02529553|530934134|FG002|Overall Study|Progressive Disease|1|||
147208600|NCT02529553|530934135|FG003|Overall Study|Progressive Disease|3|||
147208601|NCT02529553|530934136|FG004|Overall Study|Progressive Disease|2|||
147208602|NCT02529553|530934137|FG005|Overall Study|Progressive Disease|3|||
147208603|NCT02529553|530934138|FG006|Overall Study|Progressive Disease|3|||
147208604|NCT02529553|530934139|FG007|Overall Study|Progressive Disease|5|||
147208605|NCT02529553|530934140|FG008|Overall Study|Progressive Disease|3|||
147208606|NCT02529553|530934132|FG000|Overall Study|Physician Decision|0|||
147208607|NCT02529553|530934133|FG001|Overall Study|Physician Decision|1|||
147208608|NCT02529553|530934134|FG002|Overall Study|Physician Decision|0|||
147208609|NCT02529553|530934135|FG003|Overall Study|Physician Decision|0|||
147208610|NCT02529553|530934136|FG004|Overall Study|Physician Decision|1|||
147208611|NCT02529553|530934137|FG005|Overall Study|Physician Decision|0|||
147208612|NCT02529553|530934138|FG006|Overall Study|Physician Decision|0|||
147208613|NCT02529553|530934139|FG007|Overall Study|Physician Decision|0|||
147208614|NCT02529553|530934140|FG008|Overall Study|Physician Decision|0|||
147208615|NCT02529553|530934132|FG000|Overall Study|Withdrawal by Subject|0|||
147208616|NCT02529553|530934133|FG001|Overall Study|Withdrawal by Subject|0|||
147208617|NCT02529553|530934134|FG002|Overall Study|Withdrawal by Subject|0|||
147208618|NCT02529553|530934135|FG003|Overall Study|Withdrawal by Subject|0|||
147208619|NCT02529553|530934136|FG004|Overall Study|Withdrawal by Subject|0|||
147208620|NCT02529553|530934137|FG005|Overall Study|Withdrawal by Subject|1|||
147208621|NCT02529553|530934138|FG006|Overall Study|Withdrawal by Subject|0|||
147208622|NCT02529553|530934139|FG007|Overall Study|Withdrawal by Subject|1|||
147208623|NCT02529553|530934140|FG008|Overall Study|Withdrawal by Subject|0|||
147208624|NCT02355184|530934142|FG000|Overall Study|Lost to Follow-up|2|||
147208625|NCT02355184|530934142|FG000|Overall Study|Study Terminated|10|||
147208626|NCT01124864|530935797|FG000|Overall Study|Follow up phase competed as per protocol|18|||
147208627|NCT01124864|530935798|FG001|Overall Study|Follow up phase competed as per protocol|22|||
147208628|NCT01124864|530935799|FG002|Overall Study|Follow up phase competed as per protocol|24|||
147208629|NCT01124864|530935800|FG003|Overall Study|Follow up phase competed as per protocol|18|||
147208630|NCT01124864|530935801|FG004|Overall Study|Follow up phase competed as per protocol|26|||
147208631|NCT01124864|530935802|FG005|Overall Study|Follow up phase competed as per protocol|2|||
147208632|NCT01124864|530935797|FG000|Overall Study|Death|6|||
147208633|NCT01124864|530935798|FG001|Overall Study|Death|9|||
147208634|NCT01124864|530935799|FG002|Overall Study|Death|6|||
147208635|NCT01124864|530935800|FG003|Overall Study|Death|2|||
147208636|NCT01124864|530935801|FG004|Overall Study|Death|1|||
147208637|NCT01124864|530935802|FG005|Overall Study|Death|0|||
147208638|NCT01124864|530935797|FG000|Overall Study|Withdrawal by Subject|2|||
147208639|NCT01124864|530935798|FG001|Overall Study|Withdrawal by Subject|3|||
147208640|NCT01124864|530935799|FG002|Overall Study|Withdrawal by Subject|4|||
147208641|NCT01124864|530935800|FG003|Overall Study|Withdrawal by Subject|0|||
147208642|NCT01124864|530935801|FG004|Overall Study|Withdrawal by Subject|2|||
147208643|NCT01124864|530935802|FG005|Overall Study|Withdrawal by Subject|1|||
147208644|NCT01124864|530935797|FG000|Overall Study|Lost to Follow-up|1|||
147208645|NCT01124864|530935798|FG001|Overall Study|Lost to Follow-up|1|||
147208646|NCT01124864|530935799|FG002|Overall Study|Lost to Follow-up|0|||
147208647|NCT01124864|530935800|FG003|Overall Study|Lost to Follow-up|1|||
147208648|NCT01124864|530935801|FG004|Overall Study|Lost to Follow-up|0|||
147208649|NCT01124864|530935802|FG005|Overall Study|Lost to Follow-up|0|||
147208650|NCT01124864|530935797|FG000|Overall Study|Protocol Violation|1|||
147208651|NCT01124864|530935798|FG001|Overall Study|Protocol Violation|0|||
147208652|NCT01124864|530935799|FG002|Overall Study|Protocol Violation|0|||
147208653|NCT01124864|530935800|FG003|Overall Study|Protocol Violation|0|||
147208654|NCT01124864|530935801|FG004|Overall Study|Protocol Violation|1|||
147208655|NCT01124864|530935802|FG005|Overall Study|Protocol Violation|0|||
147208656|NCT01243242|530935803|FG000|Overall Study|Adverse Event|1|||
147208657|NCT01243242|530935804|FG001|Overall Study|Adverse Event|1|||
147208658|NCT01243242|530935803|FG000|Overall Study|Withdrawal by Subject|1|||
147208659|NCT01243242|530935804|FG001|Overall Study|Withdrawal by Subject|1|||
147208660|NCT01243242|530935803|FG000|Overall Study|Physician Decision|0|||
147208661|NCT01243242|530935804|FG001|Overall Study|Physician Decision|1|||
147208662|NCT01243242|530935803|FG000|Overall Study|sponsor decision|0|||
147208663|NCT01243242|530935804|FG001|Overall Study|sponsor decision|1|||
147541590|NCT00450177|532138016|FG000|Overall Study|Withdrawal by Subject|1|||
147208664|NCT01243242|530935803|FG000|Overall Study|non compliance|1|||
147208665|NCT01243242|530935804|FG001|Overall Study|non compliance|0|||
147208666|NCT02160899|530935813|FG000|Overall Study|Adverse Event or Serious Adverse Event|0|||
147208667|NCT02160899|530935814|FG001|Overall Study|Adverse Event or Serious Adverse Event|1|||
147208668|NCT02160899|530935815|FG002|Overall Study|Adverse Event or Serious Adverse Event|0|||
147208669|NCT02160899|530935816|FG003|Overall Study|Adverse Event or Serious Adverse Event|1|||
147208670|NCT02160899|530935817|FG004|Overall Study|Adverse Event or Serious Adverse Event|2|||
147208671|NCT02160899|530935818|FG005|Overall Study|Adverse Event or Serious Adverse Event|0|||
147208672|NCT01256294|530935819|FG000|Overall Study|Adverse Event|1|||
147208673|NCT01256294|530935820|FG001|Overall Study|Adverse Event|0|||
147208674|NCT01256294|530935819|FG000|Overall Study|Withdrawal by Subject|1|||
147208675|NCT01256294|530935820|FG001|Overall Study|Withdrawal by Subject|1|||
147208676|NCT01256294|530935819|FG000|Overall Study|Protocol deviation|2|||
147208677|NCT01256294|530935820|FG001|Overall Study|Protocol deviation|1|||
147208678|NCT04129151|530935821|FG000|Overall Study|Adverse Event|1|||
147208679|NCT04129151|530935821|FG000|Overall Study|Disease Progression|7|||
147208680|NCT04129151|530935821|FG000|Overall Study|Study closure|1|||
147208681|NCT00724711|530935823|FG000|Overall Study|Adverse Event|7|||
147208682|NCT00724711|530935824|FG001|Overall Study|Adverse Event|3|||
147208683|NCT00724711|530935823|FG000|Overall Study|Pregnancy|0|||
147208684|NCT00724711|530935824|FG001|Overall Study|Pregnancy|1|||
147208685|NCT00724711|530935823|FG000|Overall Study|Lack of Efficacy|0|||
147208686|NCT00724711|530935824|FG001|Overall Study|Lack of Efficacy|1|||
147208687|NCT00724711|530935823|FG000|Overall Study|Physician Decision|0|||
147208688|NCT00724711|530935824|FG001|Overall Study|Physician Decision|3|||
147208689|NCT00724711|530935823|FG000|Overall Study|Withdrawal by Subject|5|||
147208690|NCT00724711|530935824|FG001|Overall Study|Withdrawal by Subject|4|||
147208691|NCT00724711|530935823|FG000|Overall Study|Lost to Follow-up|4|||
147208692|NCT00724711|530935824|FG001|Overall Study|Lost to Follow-up|5|||
147208693|NCT00724711|530935823|FG000|Overall Study|Protocol Violation|1|||
147208694|NCT00724711|530935824|FG001|Overall Study|Protocol Violation|0|||
147208695|NCT01088048|530935826|FG000|Overall Study|Adverse Event|7|||
147208696|NCT01088048|530935827|FG001|Overall Study|Adverse Event|9|||
147208697|NCT01088048|530935828|FG002|Overall Study|Adverse Event|7|||
147208698|NCT01088048|530935829|FG003|Overall Study|Adverse Event|5|||
147208699|NCT01088048|530935830|FG004|Overall Study|Adverse Event|6|||
147208700|NCT01088048|530935831|FG005|Overall Study|Adverse Event|3|||
147208701|NCT01088048|530935832|FG006|Overall Study|Adverse Event|3|||
147208702|NCT01088048|530935833|FG007|Overall Study|Adverse Event|0|||
147208703|NCT01088048|530935834|FG008|Overall Study|Adverse Event|2|||
147208704|NCT01088048|530935835|FG009|Overall Study|Adverse Event|2|||
147208705|NCT01088048|530935826|FG000|Overall Study|Withdrew Consent|1|||
147208706|NCT01088048|530935827|FG001|Overall Study|Withdrew Consent|1|||
147208707|NCT01088048|530935828|FG002|Overall Study|Withdrew Consent|1|||
147208708|NCT01088048|530935829|FG003|Overall Study|Withdrew Consent|1|||
147208709|NCT01088048|530935830|FG004|Overall Study|Withdrew Consent|2|||
147208710|NCT01088048|530935831|FG005|Overall Study|Withdrew Consent|1|||
147208711|NCT01088048|530935832|FG006|Overall Study|Withdrew Consent|0|||
147208712|NCT01088048|530935833|FG007|Overall Study|Withdrew Consent|2|||
147208713|NCT01088048|530935834|FG008|Overall Study|Withdrew Consent|2|||
147208714|NCT01088048|530935835|FG009|Overall Study|Withdrew Consent|1|||
147208715|NCT01088048|530935826|FG000|Overall Study|Concomitant Medication Prohibited|1|||
147208716|NCT01088048|530935827|FG001|Overall Study|Concomitant Medication Prohibited|0|||
147208717|NCT01088048|530935828|FG002|Overall Study|Concomitant Medication Prohibited|0|||
147208718|NCT01088048|530935829|FG003|Overall Study|Concomitant Medication Prohibited|0|||
147208719|NCT01088048|530935830|FG004|Overall Study|Concomitant Medication Prohibited|0|||
147208720|NCT01088048|530935831|FG005|Overall Study|Concomitant Medication Prohibited|0|||
147208721|NCT01088048|530935832|FG006|Overall Study|Concomitant Medication Prohibited|0|||
147208722|NCT01088048|530935833|FG007|Overall Study|Concomitant Medication Prohibited|0|||
147208723|NCT01088048|530935834|FG008|Overall Study|Concomitant Medication Prohibited|0|||
147208724|NCT01088048|530935835|FG009|Overall Study|Concomitant Medication Prohibited|0|||
147208725|NCT01088048|530935826|FG000|Overall Study|Investigator Request|2|||
147208726|NCT01088048|530935827|FG001|Overall Study|Investigator Request|2|||
147208727|NCT01088048|530935828|FG002|Overall Study|Investigator Request|0|||
147208728|NCT01088048|530935829|FG003|Overall Study|Investigator Request|0|||
147208729|NCT01088048|530935830|FG004|Overall Study|Investigator Request|3|||
147208730|NCT01088048|530935831|FG005|Overall Study|Investigator Request|1|||
147208731|NCT01088048|530935832|FG006|Overall Study|Investigator Request|1|||
147208732|NCT01088048|530935833|FG007|Overall Study|Investigator Request|0|||
147208733|NCT01088048|530935834|FG008|Overall Study|Investigator Request|0|||
147208734|NCT01088048|530935835|FG009|Overall Study|Investigator Request|0|||
147208735|NCT01088048|530935826|FG000|Overall Study|Patient Non-compliance|0|||
147208736|NCT01088048|530935827|FG001|Overall Study|Patient Non-compliance|1|||
147208737|NCT01088048|530935828|FG002|Overall Study|Patient Non-compliance|0|||
147208738|NCT01088048|530935829|FG003|Overall Study|Patient Non-compliance|0|||
147208739|NCT01088048|530935830|FG004|Overall Study|Patient Non-compliance|0|||
147208740|NCT01088048|530935831|FG005|Overall Study|Patient Non-compliance|0|||
147208741|NCT01088048|530935832|FG006|Overall Study|Patient Non-compliance|0|||
147208742|NCT01088048|530935833|FG007|Overall Study|Patient Non-compliance|0|||
147208743|NCT01088048|530935834|FG008|Overall Study|Patient Non-compliance|0|||
147208744|NCT01088048|530935835|FG009|Overall Study|Patient Non-compliance|0|||
147208745|NCT01088048|530935826|FG000|Overall Study|Disease Progression|7|||
147208746|NCT01088048|530935827|FG001|Overall Study|Disease Progression|4|||
147208747|NCT01088048|530935828|FG002|Overall Study|Disease Progression|3|||
147208748|NCT01088048|530935829|FG003|Overall Study|Disease Progression|5|||
147208749|NCT01088048|530935830|FG004|Overall Study|Disease Progression|3|||
147208750|NCT01088048|530935831|FG005|Overall Study|Disease Progression|3|||
147208751|NCT01088048|530935832|FG006|Overall Study|Disease Progression|2|||
147208752|NCT01088048|530935833|FG007|Overall Study|Disease Progression|1|||
147208753|NCT01088048|530935834|FG008|Overall Study|Disease Progression|0|||
147208754|NCT01088048|530935835|FG009|Overall Study|Disease Progression|0|||
147208755|NCT01088048|530935826|FG000|Overall Study|Death|1|||
147208756|NCT01088048|530935827|FG001|Overall Study|Death|5|||
147208757|NCT01088048|530935828|FG002|Overall Study|Death|3|||
147208758|NCT01088048|530935829|FG003|Overall Study|Death|3|||
147208759|NCT01088048|530935830|FG004|Overall Study|Death|1|||
147208760|NCT01088048|530935831|FG005|Overall Study|Death|3|||
147208761|NCT01088048|530935832|FG006|Overall Study|Death|0|||
147208762|NCT01088048|530935833|FG007|Overall Study|Death|0|||
147208763|NCT01088048|530935834|FG008|Overall Study|Death|3|||
147208764|NCT01088048|530935835|FG009|Overall Study|Death|1|||
147208765|NCT01088048|530935826|FG000|Overall Study|Other|3|||
147208766|NCT01088048|530935827|FG001|Overall Study|Other|5|||
147208767|NCT01088048|530935828|FG002|Overall Study|Other|0|||
147208768|NCT01088048|530935829|FG003|Overall Study|Other|0|||
147208769|NCT01088048|530935830|FG004|Overall Study|Other|2|||
147208770|NCT01088048|530935831|FG005|Overall Study|Other|0|||
147208771|NCT01088048|530935832|FG006|Overall Study|Other|0|||
147208772|NCT01088048|530935833|FG007|Overall Study|Other|2|||
147208773|NCT01088048|530935834|FG008|Overall Study|Other|0|||
147208774|NCT01088048|530935835|FG009|Overall Study|Other|0|||
147208775|NCT01149148|530935836|FG000|Overall Study|Lost to Follow-up|1|||
147208776|NCT01149148|530935837|FG001|Overall Study|Lost to Follow-up|2|||
147208777|NCT01149148|530935836|FG000|Overall Study|Death|1|||
147208778|NCT01149148|530935837|FG001|Overall Study|Death|0|||
147208779|NCT00950859|530935838|FG000|Overall Study|Adverse Event|3|||
147208780|NCT00950859|530935839|FG001|Overall Study|Adverse Event|3|||
147208781|NCT00950859|530935838|FG000|Overall Study|Insufficient Viral Load Response|12|||
147208782|NCT00950859|530935839|FG001|Overall Study|Insufficient Viral Load Response|3|||
147208783|NCT00950859|530935838|FG000|Overall Study|Protocol Violation|1|||
147208784|NCT00950859|530935839|FG001|Overall Study|Protocol Violation|1|||
147208785|NCT00950859|530935838|FG000|Overall Study|Lost to Follow-up|0|||
147208786|NCT00950859|530935839|FG001|Overall Study|Lost to Follow-up|3|||
147208787|NCT04896086|530935840|FG000|Overall Study|Lost to Follow-up|0|||
147208788|NCT04896086|530935841|FG001|Overall Study|Lost to Follow-up|2|||
147208789|NCT04896086|530935842|FG002|Overall Study|Lost to Follow-up|1|||
147208790|NCT04896086|530935843|FG003|Overall Study|Lost to Follow-up|0|||
147208791|NCT04896086|530935844|FG004|Overall Study|Lost to Follow-up|0|||
147208792|NCT04896086|530935840|FG000|Overall Study|Physician Decision|0|||
147208793|NCT04896086|530935841|FG001|Overall Study|Physician Decision|1|||
147208794|NCT04896086|530935842|FG002|Overall Study|Physician Decision|0|||
147208795|NCT04896086|530935843|FG003|Overall Study|Physician Decision|0|||
147208796|NCT04896086|530935844|FG004|Overall Study|Physician Decision|0|||
147208797|NCT04896086|530935840|FG000|Overall Study|Difficulties were experienced with vein access for blood sample collection|0|||
147208798|NCT04896086|530935841|FG001|Overall Study|Difficulties were experienced with vein access for blood sample collection|0|||
147208799|NCT04896086|530935842|FG002|Overall Study|Difficulties were experienced with vein access for blood sample collection|0|||
147208800|NCT04896086|530935843|FG003|Overall Study|Difficulties were experienced with vein access for blood sample collection|1|||
147208801|NCT04896086|530935844|FG004|Overall Study|Difficulties were experienced with vein access for blood sample collection|0|||
147208802|NCT04896086|530935840|FG000|Overall Study|Participant had a syncopal event during a blood draw|0|||
147208803|NCT04896086|530935841|FG001|Overall Study|Participant had a syncopal event during a blood draw|0|||
147208804|NCT04896086|530935842|FG002|Overall Study|Participant had a syncopal event during a blood draw|0|||
147208805|NCT04896086|530935843|FG003|Overall Study|Participant had a syncopal event during a blood draw|1|||
147208806|NCT04896086|530935844|FG004|Overall Study|Participant had a syncopal event during a blood draw|0|||
147208807|NCT02249832|530935847|FG000|Overall Study|Withdrawal by Subject|3|||
147208808|NCT02249832|530935847|FG000|Overall Study|Lost to Follow-up|10|||
147208809|NCT00724867|530935852|FG000|Overall Study|Adverse Event|25|||
147208810|NCT00724867|530935852|FG000|Overall Study|Lack of Efficacy|14|||
147208811|NCT00724867|530935852|FG000|Overall Study|Lost to Follow-up|12|||
147208812|NCT00724867|530935852|FG000|Overall Study|Non-compliance with study drug|6|||
147208813|NCT00724867|530935852|FG000|Overall Study|Physician Decision|17|||
147208814|NCT00724867|530935852|FG000|Overall Study|Protocol Violation|1|||
147208815|NCT00724867|530935852|FG000|Overall Study|Withdrawal by Subject|31|||
147208816|NCT00724867|530935852|FG000|Overall Study|Sponsor decision to end study|14|||
147208817|NCT00724867|530935852|FG000|Overall Study|Subject incarcerated|1|||
147208818|NCT00724867|530935852|FG000|Overall Study|Developed withdrawal criteria- pregnancy|4|||
147208819|NCT00724867|530935852|FG000|Overall Study|Subject moved out of state|1|||
147208820|NCT00724867|530935852|FG000|Overall Study|Elected to exit due to site closure|2|||
147208821|NCT00436345|530935853|FG000|Overall Study|ICU resident beyond follow-up period|3|||
147208822|NCT00436345|530935854|FG001|Overall Study|ICU resident beyond follow-up period|0|||
147208823|NCT01175083|530935855|FG000|Primary Epoch|Withdrawal by Subject|0|||
147208824|NCT01175083|530935856|FG001|Primary Epoch|Withdrawal by Subject|0|||
147208825|NCT01175083|530935857|FG002|Primary Epoch|Withdrawal by Subject|0|||
147208826|NCT01175083|530935858|FG003|Primary Epoch|Withdrawal by Subject|0|||
147208827|NCT01175083|530935859|FG004|Primary Epoch|Withdrawal by Subject|0|||
147208828|NCT01175083|530935860|FG005|Primary Epoch|Withdrawal by Subject|2|||
147208829|NCT01175083|530935855|FG000|Primary Epoch|Lost to Follow-up|0|||
147208830|NCT01175083|530935856|FG001|Primary Epoch|Lost to Follow-up|0|||
147208831|NCT01175083|530935857|FG002|Primary Epoch|Lost to Follow-up|0|||
147208832|NCT01175083|530935858|FG003|Primary Epoch|Lost to Follow-up|0|||
147208833|NCT01175083|530935859|FG004|Primary Epoch|Lost to Follow-up|0|||
147208834|NCT01175083|530935860|FG005|Primary Epoch|Lost to Follow-up|1|||
147208835|NCT01175083|530935855|FG000|Booster Epoch|Death|0|||
147208836|NCT01175083|530935856|FG001|Booster Epoch|Death|0|||
147208837|NCT01175083|530935857|FG002|Booster Epoch|Death|1|||
147208838|NCT01175083|530935858|FG003|Booster Epoch|Death|0|||
147208839|NCT01175083|530935859|FG004|Booster Epoch|Death|0|||
147208840|NCT01175083|530935860|FG005|Booster Epoch|Death|0|||
147208841|NCT01175083|530935855|FG000|Booster Epoch|Withdrawal by Subject|0|||
147208842|NCT01175083|530935856|FG001|Booster Epoch|Withdrawal by Subject|0|||
147208843|NCT01175083|530935857|FG002|Booster Epoch|Withdrawal by Subject|0|||
147208844|NCT01175083|530935858|FG003|Booster Epoch|Withdrawal by Subject|1|||
147208845|NCT01175083|530935859|FG004|Booster Epoch|Withdrawal by Subject|0|||
147208846|NCT01175083|530935860|FG005|Booster Epoch|Withdrawal by Subject|0|||
147208847|NCT02105961|530935865|FG000|Overall Study|Adverse Event|18|||
147208848|NCT02105961|530935866|FG001|Overall Study|Adverse Event|7|||
147208849|NCT02105961|530935867|FG002|Overall Study|Adverse Event|13|||
147208850|NCT02105961|530935865|FG000|Overall Study|Lack of Efficacy|3|||
147208851|NCT02105961|530935866|FG001|Overall Study|Lack of Efficacy|0|||
147541591|NCT00450177|532138017|FG001|Overall Study|Withdrawal by Subject|6|||
147541592|NCT00450177|532138016|FG000|Overall Study|Withdrawal by Primary Team|1|||
147541593|NCT00450177|532138017|FG001|Overall Study|Withdrawal by Primary Team|1|||
147541594|NCT02923115|532138018|FG000|Overall Study|Lost to Follow-up|0|||
147541595|NCT02923115|532138019|FG001|Overall Study|Lost to Follow-up|0|||
147541596|NCT02923115|532138020|FG002|Overall Study|Lost to Follow-up|0|||
147541597|NCT02923115|532138021|FG003|Overall Study|Lost to Follow-up|1|||
147541598|NCT02923115|532138022|FG004|Overall Study|Lost to Follow-up|0|||
147541599|NCT02923115|532138023|FG005|Overall Study|Lost to Follow-up|0|||
147208852|NCT02105961|530935867|FG002|Overall Study|Lack of Efficacy|3|||
147208853|NCT02105961|530935865|FG000|Overall Study|Lost to Follow-up|2|||
147208854|NCT02105961|530935866|FG001|Overall Study|Lost to Follow-up|0|||
147208855|NCT02105961|530935867|FG002|Overall Study|Lost to Follow-up|1|||
147208856|NCT02105961|530935865|FG000|Overall Study|Physician Decision|3|||
147208857|NCT02105961|530935866|FG001|Overall Study|Physician Decision|3|||
147208858|NCT02105961|530935867|FG002|Overall Study|Physician Decision|2|||
147208859|NCT02105961|530935865|FG000|Overall Study|Withdrawal by Subject|15|||
147208860|NCT02105961|530935866|FG001|Overall Study|Withdrawal by Subject|7|||
147208861|NCT02105961|530935867|FG002|Overall Study|Withdrawal by Subject|11|||
147208862|NCT04154189|530935868|FG000|Overall Study|Withdrawal by Subject|4|||
147208863|NCT04154189|530935869|FG001|Overall Study|Withdrawal by Subject|6|||
147208864|NCT04154189|530935868|FG000|Overall Study|Survival follow-up discontinued by sponsor|8|||
147208865|NCT04154189|530935869|FG001|Overall Study|Survival follow-up discontinued by sponsor|10|||
147208866|NCT04154189|530935868|FG000|Overall Study|Participants transitioned to patient access program (PAP)|1|||
147541600|NCT02923115|532138018|FG000|Overall Study|Withdrawal by Subject|0|||
147208867|NCT04154189|530935869|FG001|Overall Study|Participants transitioned to patient access program (PAP)|0|||
147208868|NCT04154189|530935868|FG000|Overall Study|Participants transitioned to managed access program (MAP)|2|||
147208869|NCT04154189|530935869|FG001|Overall Study|Participants transitioned to managed access program (MAP)|0|||
147208870|NCT04154189|530935868|FG000|Overall Study|Death|25|||
147208871|NCT04154189|530935869|FG001|Overall Study|Death|25|||
147208872|NCT02280408|530935870|FG000|Overall Study|Lost to Follow-up|0|||
147208873|NCT02280408|530935871|FG001|Overall Study|Lost to Follow-up|2|||
147208874|NCT02280408|530935872|FG002|Overall Study|Lost to Follow-up|0|||
147208875|NCT02280408|530935873|FG003|Overall Study|Lost to Follow-up|0|||
147208876|NCT02474069|530935874|FG000|Selection Phase (SP)|Adverse Event|8|||
147208877|NCT02474069|530935875|FG001|Selection Phase (SP)|Adverse Event|0|||
147208878|NCT02474069|530935876|FG002|Selection Phase (SP)|Adverse Event|0|||
147208879|NCT02474069|530935874|FG000|Selection Phase (SP)|Lack of Efficacy|1|||
147208880|NCT02474069|530935875|FG001|Selection Phase (SP)|Lack of Efficacy|0|||
147208881|NCT02474069|530935876|FG002|Selection Phase (SP)|Lack of Efficacy|0|||
147541601|NCT02923115|532138019|FG001|Overall Study|Withdrawal by Subject|1|||
147541602|NCT02923115|532138020|FG002|Overall Study|Withdrawal by Subject|0|||
147208882|NCT02474069|530935874|FG000|Selection Phase (SP)|Lost to Follow-up|4|||
147208883|NCT02474069|530935875|FG001|Selection Phase (SP)|Lost to Follow-up|0|||
147208884|NCT02474069|530935876|FG002|Selection Phase (SP)|Lost to Follow-up|0|||
147208885|NCT02474069|530935874|FG000|Selection Phase (SP)|Physician Decision|1|||
147541603|NCT02923115|532138021|FG003|Overall Study|Withdrawal by Subject|0|||
147208886|NCT02474069|530935875|FG001|Selection Phase (SP)|Physician Decision|0|||
147208887|NCT02474069|530935876|FG002|Selection Phase (SP)|Physician Decision|0|||
147208888|NCT02474069|530935874|FG000|Selection Phase (SP)|Protocol Violation|1|||
147208889|NCT02474069|530935875|FG001|Selection Phase (SP)|Protocol Violation|0|||
147208890|NCT02474069|530935876|FG002|Selection Phase (SP)|Protocol Violation|0|||
147208891|NCT02474069|530935874|FG000|Selection Phase (SP)|No longer requires treatment|1|||
147208892|NCT02474069|530935875|FG001|Selection Phase (SP)|No longer requires treatment|0|||
147208893|NCT02474069|530935876|FG002|Selection Phase (SP)|No longer requires treatment|0|||
147208894|NCT02474069|530935874|FG000|Selection Phase (SP)|Technical Problem|1|||
147208895|NCT02474069|530935875|FG001|Selection Phase (SP)|Technical Problem|0|||
147208896|NCT02474069|530935876|FG002|Selection Phase (SP)|Technical Problem|0|||
147208897|NCT02474069|530935874|FG000|Selection Phase (SP)|Withdrawal by Subject|3|||
147208898|NCT02474069|530935875|FG001|Selection Phase (SP)|Withdrawal by Subject|0|||
147208899|NCT02474069|530935876|FG002|Selection Phase (SP)|Withdrawal by Subject|0|||
147208900|NCT02474069|530935874|FG000|Selection Phase (SP)|Withdrawal of Informed Consent|3|||
147208901|NCT02474069|530935875|FG001|Selection Phase (SP)|Withdrawal of Informed Consent|0|||
147208902|NCT02474069|530935876|FG002|Selection Phase (SP)|Withdrawal of Informed Consent|0|||
147208903|NCT02474069|530935874|FG000|Comparative Dosing Phase (CDP)|Adverse Event|0|||
147208904|NCT02474069|530935875|FG001|Comparative Dosing Phase (CDP)|Adverse Event|3|||
147208905|NCT02474069|530935876|FG002|Comparative Dosing Phase (CDP)|Adverse Event|2|||
147208906|NCT02474069|530935874|FG000|Comparative Dosing Phase (CDP)|Lost to Follow-up|0|||
147208907|NCT02474069|530935875|FG001|Comparative Dosing Phase (CDP)|Lost to Follow-up|4|||
147208908|NCT02474069|530935876|FG002|Comparative Dosing Phase (CDP)|Lost to Follow-up|1|||
147208909|NCT02474069|530935874|FG000|Comparative Dosing Phase (CDP)|Withdrawal by Subject|0|||
147208910|NCT02474069|530935875|FG001|Comparative Dosing Phase (CDP)|Withdrawal by Subject|0|||
147208911|NCT02474069|530935876|FG002|Comparative Dosing Phase (CDP)|Withdrawal by Subject|1|||
147208912|NCT02474069|530935874|FG000|Comparative Dosing Phase (CDP)|Withdrawal of informed Consent|0|||
147208913|NCT02474069|530935875|FG001|Comparative Dosing Phase (CDP)|Withdrawal of informed Consent|2|||
147208914|NCT02474069|530935876|FG002|Comparative Dosing Phase (CDP)|Withdrawal of informed Consent|2|||
147208915|NCT04173494|530935877|FG000|Randomized DB TP (Up to Week 24)|Adverse Event|16|||
147208916|NCT04173494|530935878|FG001|Randomized DB TP (Up to Week 24)|Adverse Event|11|||
147208917|NCT04173494|530935877|FG000|Randomized DB TP (Up to Week 24)|Withdrawal by Subject|6|||
147208918|NCT04173494|530935878|FG001|Randomized DB TP (Up to Week 24)|Withdrawal by Subject|5|||
147208919|NCT04173494|530935877|FG000|Randomized DB TP (Up to Week 24)|Lack of Efficacy|6|||
147208920|NCT04173494|530935878|FG001|Randomized DB TP (Up to Week 24)|Lack of Efficacy|3|||
147208921|NCT04173494|530935877|FG000|Randomized DB TP (Up to Week 24)|Death|4|||
147208922|NCT04173494|530935878|FG001|Randomized DB TP (Up to Week 24)|Death|3|||
147208923|NCT04173494|530935877|FG000|Randomized DB TP (Up to Week 24)|Leukemic Transformation|2|||
147208924|NCT04173494|530935878|FG001|Randomized DB TP (Up to Week 24)|Leukemic Transformation|2|||
147208925|NCT04173494|530935877|FG000|Randomized DB TP (Up to Week 24)|Disease Progression|1|||
147208926|NCT04173494|530935878|FG001|Randomized DB TP (Up to Week 24)|Disease Progression|2|||
147208927|NCT04173494|530935877|FG000|Randomized DB TP (Up to Week 24)|Lost to Follow-up|1|||
147208928|NCT04173494|530935878|FG001|Randomized DB TP (Up to Week 24)|Lost to Follow-up|0|||
147208929|NCT04173494|530935877|FG000|Randomized DB TP (Up to Week 24)|Physician Decision|0|||
147208930|NCT04173494|530935878|FG001|Randomized DB TP (Up to Week 24)|Physician Decision|1|||
147208931|NCT04173494|530935877|FG000|Open-Label Extended TP(Weeks 24 to 151)|Adverse Event|11|||
147208932|NCT04173494|530935878|FG001|Open-Label Extended TP(Weeks 24 to 151)|Adverse Event|1|||
147208933|NCT04173494|530935877|FG000|Open-Label Extended TP(Weeks 24 to 151)|Death|6|||
147208934|NCT04173494|530935878|FG001|Open-Label Extended TP(Weeks 24 to 151)|Death|3|||
147208935|NCT04173494|530935877|FG000|Open-Label Extended TP(Weeks 24 to 151)|Lack of Efficacy|6|||
147208936|NCT04173494|530935878|FG001|Open-Label Extended TP(Weeks 24 to 151)|Lack of Efficacy|2|||
147208937|NCT04173494|530935877|FG000|Open-Label Extended TP(Weeks 24 to 151)|Physician Decision|4|||
147208938|NCT04173494|530935878|FG001|Open-Label Extended TP(Weeks 24 to 151)|Physician Decision|3|||
147208939|NCT04173494|530935877|FG000|Open-Label Extended TP(Weeks 24 to 151)|Withdrawal by Subject|4|||
147208940|NCT04173494|530935878|FG001|Open-Label Extended TP(Weeks 24 to 151)|Withdrawal by Subject|3|||
147208941|NCT04173494|530935877|FG000|Open-Label Extended TP(Weeks 24 to 151)|Leukemic transformation|0|||
147208942|NCT04173494|530935878|FG001|Open-Label Extended TP(Weeks 24 to 151)|Leukemic transformation|1|||
147208943|NCT04173494|530935877|FG000|Open-Label Extended TP(Weeks 24 to 151)|Disease progression|1|||
147208944|NCT04173494|530935878|FG001|Open-Label Extended TP(Weeks 24 to 151)|Disease progression|1|||
147208945|NCT04173494|530935877|FG000|Open-Label Extended TP(Weeks 24 to 151)|Continuing in MMB extension study|61|||
147439956|NCT03250832|531775895|FG006|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
147439957|NCT03250832|531775896|FG007|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
147439958|NCT03250832|531775897|FG008|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
147439959|NCT03250832|531775898|FG009|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
147439960|NCT03250832|531775899|FG010|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
147439961|NCT03250832|531775900|FG011|Part 1 (Up to Approximately 51 Months)|Sponsor Decision|0|||
147439962|NCT03250832|531775889|FG000|Part 2A (Up to Approximately 30 Months)|Death|0|||
147208946|NCT04173494|530935878|FG001|Open-Label Extended TP(Weeks 24 to 151)|Continuing in MMB extension study|27|||
147208947|NCT01623050|530935879|FG000|Overall Study|Lost to Follow-up|9|||
147208948|NCT01191762|530935880|FG000|Overall Study|Adverse Event|1|||
147208949|NCT01191762|530935881|FG001|Overall Study|Adverse Event|0|||
147208950|NCT01519869|530935884|FG000|Overall Study|Lost to Follow-up|1|||
147208951|NCT03023813|530935885|FG000|Overall Study|Lost to Follow-up|1|||
147208952|NCT03023813|530935886|FG001|Overall Study|Lost to Follow-up|2|||
147208953|NCT03023813|530935887|FG002|Overall Study|Lost to Follow-up|0|||
147208954|NCT00202878|530935888|FG000|Overall Study|Death|964|||
147208955|NCT00202878|530935889|FG001|Overall Study|Death|968|||
147208956|NCT00202878|530935888|FG000|Overall Study|Only Vital Status Known|357|||
147208957|NCT00202878|530935889|FG001|Overall Study|Only Vital Status Known|356|||
147208958|NCT00202878|530935888|FG000|Overall Study|Lost to Follow-up|44|||
147208959|NCT00202878|530935889|FG001|Overall Study|Lost to Follow-up|49|||
147208960|NCT00202878|530935888|FG000|Overall Study|Site Closure|39|||
147208961|NCT00202878|530935889|FG001|Overall Study|Site Closure|36|||
147208962|NCT00202878|530935888|FG000|Overall Study|Withdrawal by Subject|795|||
147208963|NCT00202878|530935889|FG001|Overall Study|Withdrawal by Subject|808|||
147208964|NCT02123472|530935891|FG000|Period 2 (7 Days)|Withdrawal by Subject|0|||
147208965|NCT02123472|530935892|FG001|Period 2 (7 Days)|Withdrawal by Subject|1|||
147208966|NCT02433080|530935894|FG000|Overall Study|Lost to Follow-up|1|||
147208967|NCT02433080|530935895|FG001|Overall Study|Lost to Follow-up|2|||
147208968|NCT02433080|530935894|FG000|Overall Study|Withdrawal by Subject|0|||
147208969|NCT02433080|530935895|FG001|Overall Study|Withdrawal by Subject|2|||
147208970|NCT03801031|530935896|FG000|Overall Study|Lost to Follow-up|1|||
147208971|NCT03801031|530935897|FG001|Overall Study|Lost to Follow-up|0|||
147208972|NCT03801031|530935896|FG000|Overall Study|Unable to comply|1|||
147208973|NCT03801031|530935897|FG001|Overall Study|Unable to comply|0|||
147208974|NCT03801031|530935896|FG000|Overall Study|Withdrawal by Subject|0|||
147208975|NCT03801031|530935897|FG001|Overall Study|Withdrawal by Subject|1|||
147208976|NCT00126490|530935902|FG000|Overall Study|Stopped after 1 infusion (fall/injury)|1|||
147208977|NCT01459497|530935907|FG000|Overall Study|Inability to meet trial constraints.|1|||
147208978|NCT01459497|530935908|FG001|Overall Study|Inability to meet trial constraints.|0|||
147439963|NCT03250832|531775890|FG001|Part 2A (Up to Approximately 30 Months)|Death|0|||
147439964|NCT03250832|531775891|FG002|Part 2A (Up to Approximately 30 Months)|Death|0|||
147439965|NCT03250832|531775892|FG003|Part 2A (Up to Approximately 30 Months)|Death|0|||
147439966|NCT03250832|531775893|FG004|Part 2A (Up to Approximately 30 Months)|Death|0|||
147439967|NCT03250832|531775894|FG005|Part 2A (Up to Approximately 30 Months)|Death|0|||
147439968|NCT03250832|531775895|FG006|Part 2A (Up to Approximately 30 Months)|Death|0|||
147439969|NCT03250832|531775896|FG007|Part 2A (Up to Approximately 30 Months)|Death|18|||
147439970|NCT03250832|531775897|FG008|Part 2A (Up to Approximately 30 Months)|Death|0|||
147439971|NCT03250832|531775898|FG009|Part 2A (Up to Approximately 30 Months)|Death|0|||
147439972|NCT03250832|531775899|FG010|Part 2A (Up to Approximately 30 Months)|Death|0|||
147439973|NCT03250832|531775900|FG011|Part 2A (Up to Approximately 30 Months)|Death|0|||
147439974|NCT03250832|531775889|FG000|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
147439975|NCT03250832|531775890|FG001|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
147439976|NCT03250832|531775891|FG002|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
147439977|NCT03250832|531775892|FG003|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
147439978|NCT03250832|531775893|FG004|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
147439979|NCT03250832|531775894|FG005|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
147439980|NCT03250832|531775895|FG006|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
147439981|NCT03250832|531775896|FG007|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|3|||
147439982|NCT03250832|531775897|FG008|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
147439983|NCT03250832|531775898|FG009|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
147439984|NCT03250832|531775899|FG010|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
147439985|NCT03250832|531775900|FG011|Part 2A (Up to Approximately 30 Months)|Lost to Follow-up|0|||
147439986|NCT03250832|531775889|FG000|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
147439987|NCT03250832|531775890|FG001|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
147439988|NCT03250832|531775891|FG002|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
147439989|NCT03250832|531775892|FG003|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
147439990|NCT03250832|531775893|FG004|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
147439991|NCT03250832|531775894|FG005|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
147439992|NCT03250832|531775895|FG006|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
147439993|NCT03250832|531775896|FG007|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|8|||
147439994|NCT03250832|531775897|FG008|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
147439995|NCT03250832|531775898|FG009|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
147208979|NCT01459497|530935907|FG000|Overall Study|Physician Decision|1|||
147208980|NCT01459497|530935908|FG001|Overall Study|Physician Decision|1|||
147208981|NCT01459497|530935907|FG000|Overall Study|Hospitalization.|0|||
147208982|NCT01459497|530935908|FG001|Overall Study|Hospitalization.|3|||
147208983|NCT01459497|530935907|FG000|Overall Study|Disease progression.|0|||
147439996|NCT03250832|531775899|FG010|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
147208984|NCT01459497|530935908|FG001|Overall Study|Disease progression.|1|||
147208985|NCT01120717|530935909|FG000|Overall Study|Withdrawal by Subject|11|||
147208986|NCT01120717|530935910|FG001|Overall Study|Withdrawal by Subject|6|||
147208987|NCT01120717|530935909|FG000|Overall Study|Adverse Event|10|||
147208988|NCT01120717|530935910|FG001|Overall Study|Adverse Event|6|||
147208989|NCT01120717|530935909|FG000|Overall Study|Protocol Deviation|2|||
147208990|NCT01120717|530935910|FG001|Overall Study|Protocol Deviation|5|||
147208991|NCT01120717|530935909|FG000|Overall Study|Unsatisfactory Therapeutic Effect|3|||
147208992|NCT01120717|530935910|FG001|Overall Study|Unsatisfactory Therapeutic Effect|3|||
147208993|NCT01120717|530935909|FG000|Overall Study|Lost to Follow-up|2|||
147208994|NCT01120717|530935910|FG001|Overall Study|Lost to Follow-up|3|||
147208995|NCT01120717|530935909|FG000|Overall Study|Death|3|||
147208996|NCT01120717|530935910|FG001|Overall Study|Death|1|||
147208997|NCT01120717|530935909|FG000|Overall Study|Abnormal Test Procedure Result(s)|1|||
147208998|NCT01120717|530935910|FG001|Overall Study|Abnormal Test Procedure Result(s)|0|||
147208999|NCT02379637|530935915|FG000|Overall Study|Protocol Violation|0|||
147209000|NCT02379637|530935916|FG001|Overall Study|Protocol Violation|1|||
147209001|NCT02379637|530935915|FG000|Overall Study|Adverse Event|1|||
147209002|NCT02379637|530935916|FG001|Overall Study|Adverse Event|0|||
147209003|NCT02379637|530935915|FG000|Overall Study|Withdrawal by Subject|1|||
147209004|NCT02379637|530935916|FG001|Overall Study|Withdrawal by Subject|0|||
147209005|NCT01309282|530935917|FG000|Overall Study|Lost to Follow-up|1|||
147209006|NCT02087423|530935918|FG000|Overall Study|Withdrawal by Subject|20|||
147209007|NCT02087423|530935919|FG001|Overall Study|Withdrawal by Subject|20|||
147209008|NCT02087423|530935920|FG002|Overall Study|Withdrawal by Subject|3|||
147209009|NCT02087423|530935918|FG000|Overall Study|Death|68|||
147209010|NCT02087423|530935919|FG001|Overall Study|Death|207|||
147209011|NCT02087423|530935920|FG002|Overall Study|Death|40|||
147209012|NCT02087423|530935918|FG000|Overall Study|Lost to Follow-up|0|||
147209013|NCT02087423|530935919|FG001|Overall Study|Lost to Follow-up|2|||
147209014|NCT02087423|530935920|FG002|Overall Study|Lost to Follow-up|0|||
147209015|NCT02087423|530935918|FG000|Overall Study|Terminated from study at final DCO|23|||
147209016|NCT02087423|530935919|FG001|Overall Study|Terminated from study at final DCO|36|||
147209017|NCT02087423|530935920|FG002|Overall Study|Terminated from study at final DCO|25|||
147209018|NCT02762370|530935923|FG000|Overall Study|Protocol Violation|1|||
147209019|NCT02762370|530935924|FG001|Overall Study|Protocol Violation|0|||
147209020|NCT02445794|530935925|FG000|Overall Study|Adverse Event|0|||
147209021|NCT02445794|530935926|FG001|Overall Study|Adverse Event|0|||
147209022|NCT02445794|530935927|FG002|Overall Study|Adverse Event|2|||
147209023|NCT02445794|530935928|FG003|Overall Study|Adverse Event|0|||
147209024|NCT01136785|530935929|FG000|Overall Study|Protocol Violation|2|||
147209025|NCT01136785|530935930|FG001|Overall Study|Protocol Violation|1|||
147209026|NCT00233064|530935934|FG000|Overall Study|Lost to Follow-up|7|||
147209027|NCT00233064|530935935|FG001|Overall Study|Lost to Follow-up|7|||
147209028|NCT00233064|530935934|FG000|Overall Study|Withdrawal by Subject|5|||
147209029|NCT00233064|530935935|FG001|Overall Study|Withdrawal by Subject|3|||
147209030|NCT00233064|530935934|FG000|Overall Study|Death|0|||
147209031|NCT00233064|530935935|FG001|Overall Study|Death|1|||
147209032|NCT00233064|530935934|FG000|Overall Study|Relocation|0|||
147209033|NCT00233064|530935935|FG001|Overall Study|Relocation|1|||
147209034|NCT00233064|530935934|FG000|Overall Study|Protocol Violation|1|||
147209035|NCT00233064|530935935|FG001|Overall Study|Protocol Violation|0|||
147209036|NCT00233064|530935934|FG000|Overall Study|Moved to Dom. Republic|1|||
147209037|NCT00233064|530935935|FG001|Overall Study|Moved to Dom. Republic|0|||
147209038|NCT04393454|530935936|FG000|Overall Study|Death|1|||
147209039|NCT04393454|530935936|FG000|Overall Study|Lost to Follow-up|1|||
147209040|NCT03304249|530935938|FG000|Overall Study|Lost to Follow-up|8|||
147209041|NCT03304249|530935939|FG001|Overall Study|Lost to Follow-up|10|||
147209042|NCT03304249|530935938|FG000|Overall Study|Withdrawal by Subject|12|||
147209043|NCT03304249|530935939|FG001|Overall Study|Withdrawal by Subject|2|||
147209044|NCT03304249|530935938|FG000|Overall Study|Moved Out of District|4|||
147209045|NCT03304249|530935939|FG001|Overall Study|Moved Out of District|2|||
147209046|NCT04976192|530935940|FG000|Main Treatment Period (12 Weeks)|Adverse Event|0|||
147209047|NCT04976192|530935941|FG001|Main Treatment Period (12 Weeks)|Adverse Event|1|||
147209048|NCT04976192|530935942|FG002|Main Treatment Period (12 Weeks)|Adverse Event|0|||
147209049|NCT04976192|530935943|FG003|Main Treatment Period (12 Weeks)|Adverse Event|0|||
147209050|NCT04976192|530935944|FG004|Main Treatment Period (12 Weeks)|Adverse Event|0|||
147209051|NCT04976192|530935945|FG005|Main Treatment Period (12 Weeks)|Adverse Event|0|||
147209052|NCT04976192|530935946|FG006|Main Treatment Period (12 Weeks)|Adverse Event|0|||
147209053|NCT04976192|530935947|FG007|Main Treatment Period (12 Weeks)|Adverse Event|0|||
147209054|NCT04976192|530935948|FG008|Main Treatment Period (12 Weeks)|Adverse Event|0|||
147209055|NCT04976192|530935949|FG009|Main Treatment Period (12 Weeks)|Adverse Event|0|||
147209056|NCT04976192|530935940|FG000|Main Treatment Period (12 Weeks)|Withdrawal by Subject|12|||
147439997|NCT03250832|531775900|FG011|Part 2A (Up to Approximately 30 Months)|Withdrawal by Subject|0|||
147209057|NCT04976192|530935941|FG001|Main Treatment Period (12 Weeks)|Withdrawal by Subject|3|||
147209058|NCT04976192|530935942|FG002|Main Treatment Period (12 Weeks)|Withdrawal by Subject|8|||
147209059|NCT04976192|530935943|FG003|Main Treatment Period (12 Weeks)|Withdrawal by Subject|1|||
147209060|NCT04976192|530935944|FG004|Main Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
147209061|NCT04976192|530935945|FG005|Main Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
147209062|NCT04976192|530935946|FG006|Main Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
147209063|NCT04976192|530935947|FG007|Main Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
147209064|NCT04976192|530935948|FG008|Main Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
147209065|NCT04976192|530935949|FG009|Main Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
147209066|NCT04976192|530935940|FG000|Main Treatment Period (12 Weeks)|Other Than Specified|1|||
147209067|NCT04976192|530935941|FG001|Main Treatment Period (12 Weeks)|Other Than Specified|0|||
147209068|NCT04976192|530935942|FG002|Main Treatment Period (12 Weeks)|Other Than Specified|1|||
147209069|NCT04976192|530935943|FG003|Main Treatment Period (12 Weeks)|Other Than Specified|0|||
147209070|NCT04976192|530935944|FG004|Main Treatment Period (12 Weeks)|Other Than Specified|0|||
147209071|NCT04976192|530935945|FG005|Main Treatment Period (12 Weeks)|Other Than Specified|0|||
147209072|NCT04976192|530935946|FG006|Main Treatment Period (12 Weeks)|Other Than Specified|0|||
147209073|NCT04976192|530935947|FG007|Main Treatment Period (12 Weeks)|Other Than Specified|0|||
147209074|NCT04976192|530935948|FG008|Main Treatment Period (12 Weeks)|Other Than Specified|0|||
147209075|NCT04976192|530935949|FG009|Main Treatment Period (12 Weeks)|Other Than Specified|0|||
147209076|NCT04976192|530935940|FG000|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
147209077|NCT04976192|530935941|FG001|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
147209078|NCT04976192|530935942|FG002|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
147209079|NCT04976192|530935943|FG003|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
147209080|NCT04976192|530935944|FG004|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|9|||
147209081|NCT04976192|530935945|FG005|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|7|||
147209082|NCT04976192|530935946|FG006|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|4|||
147209083|NCT04976192|530935947|FG007|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|2|||
147209084|NCT04976192|530935948|FG008|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|2|||
147209085|NCT04976192|530935949|FG009|Transition Treatment Period (12 Weeks)|Withdrawal by Subject|3|||
147209086|NCT04976192|530935940|FG000|Transition Treatment Period (12 Weeks)|Other Than Specified|0|||
147209087|NCT04976192|530935941|FG001|Transition Treatment Period (12 Weeks)|Other Than Specified|0|||
147209088|NCT04976192|530935942|FG002|Transition Treatment Period (12 Weeks)|Other Than Specified|0|||
147209089|NCT04976192|530935943|FG003|Transition Treatment Period (12 Weeks)|Other Than Specified|0|||
147209090|NCT04976192|530935944|FG004|Transition Treatment Period (12 Weeks)|Other Than Specified|1|||
147209091|NCT04976192|530935945|FG005|Transition Treatment Period (12 Weeks)|Other Than Specified|0|||
147209092|NCT04976192|530935946|FG006|Transition Treatment Period (12 Weeks)|Other Than Specified|0|||
147209093|NCT04976192|530935947|FG007|Transition Treatment Period (12 Weeks)|Other Than Specified|0|||
147209094|NCT04976192|530935948|FG008|Transition Treatment Period (12 Weeks)|Other Than Specified|0|||
147209095|NCT04976192|530935949|FG009|Transition Treatment Period (12 Weeks)|Other Than Specified|0|||
147209096|NCT04976192|530935940|FG000|Transition Treatment Period (12 Weeks)|Lost to Follow-up|0|||
147209097|NCT04976192|530935941|FG001|Transition Treatment Period (12 Weeks)|Lost to Follow-up|0|||
147209098|NCT04976192|530935942|FG002|Transition Treatment Period (12 Weeks)|Lost to Follow-up|0|||
147209099|NCT04976192|530935943|FG003|Transition Treatment Period (12 Weeks)|Lost to Follow-up|0|||
147209100|NCT04976192|530935944|FG004|Transition Treatment Period (12 Weeks)|Lost to Follow-up|0|||
147209101|NCT04976192|530935945|FG005|Transition Treatment Period (12 Weeks)|Lost to Follow-up|1|||
147209102|NCT04976192|530935946|FG006|Transition Treatment Period (12 Weeks)|Lost to Follow-up|0|||
147209103|NCT04976192|530935947|FG007|Transition Treatment Period (12 Weeks)|Lost to Follow-up|0|||
147209104|NCT04976192|530935948|FG008|Transition Treatment Period (12 Weeks)|Lost to Follow-up|0|||
147209105|NCT04976192|530935949|FG009|Transition Treatment Period (12 Weeks)|Lost to Follow-up|0|||
147209106|NCT00924027|530935950|FG000|Overall Study|Lost to Further Follow-Up|4|||
147209107|NCT00924027|530935951|FG001|Overall Study|Lost to Further Follow-Up|0|||
147209108|NCT00924027|530935952|FG002|Overall Study|Lost to Further Follow-Up|0|||
147209109|NCT00924027|530935953|FG003|Overall Study|Lost to Further Follow-Up|0|||
147209110|NCT00924027|530935950|FG000|Overall Study|Physician Decision|1|||
147209111|NCT00924027|530935951|FG001|Overall Study|Physician Decision|0|||
147209112|NCT00924027|530935952|FG002|Overall Study|Physician Decision|0|||
147209113|NCT00924027|530935953|FG003|Overall Study|Physician Decision|1|||
147209114|NCT00924027|530935950|FG000|Overall Study|Withdrawal: Refused further treatment|1|||
147209115|NCT00924027|530935951|FG001|Overall Study|Withdrawal: Refused further treatment|0|||
147209116|NCT00924027|530935952|FG002|Overall Study|Withdrawal: Refused further treatment|0|||
147209117|NCT00924027|530935953|FG003|Overall Study|Withdrawal: Refused further treatment|0|||
147209118|NCT00924027|530935950|FG000|Overall Study|Withdrawal: Refused to start treatment|1|||
147209119|NCT00924027|530935951|FG001|Overall Study|Withdrawal: Refused to start treatment|0|||
147209120|NCT00924027|530935952|FG002|Overall Study|Withdrawal: Refused to start treatment|0|||
147209121|NCT00924027|530935953|FG003|Overall Study|Withdrawal: Refused to start treatment|0|||
147209122|NCT00924027|530935950|FG000|Overall Study|Withdrawal: Refused further follow-up|1|||
147209123|NCT00924027|530935951|FG001|Overall Study|Withdrawal: Refused further follow-up|0|||
147209124|NCT00924027|530935952|FG002|Overall Study|Withdrawal: Refused further follow-up|0|||
147209125|NCT00924027|530935953|FG003|Overall Study|Withdrawal: Refused further follow-up|0|||
147209126|NCT04549545|530938217|FG000|Initial Period|Withdrawal by Subject|4|||
147209127|NCT04549545|530938218|FG001|Initial Period|Withdrawal by Subject|0|||
147209128|NCT04549545|530938217|FG000|Initial Period|Additional ENT Procedure|3|||
147209129|NCT04549545|530938218|FG001|Initial Period|Additional ENT Procedure|0|||
147209130|NCT04549545|530938217|FG000|Initial Period|Lost to Follow-up|3|||
147209131|NCT04549545|530938218|FG001|Initial Period|Lost to Follow-up|1|||
147209132|NCT04549545|530938217|FG000|Initial Period|Ineligible for Crossover and Exited as study complete|0|||
147209133|NCT04549545|530938218|FG001|Initial Period|Ineligible for Crossover and Exited as study complete|9|||
147209134|NCT04549545|530938217|FG000|Crossover Period|Additional ENT Procedure|0|||
147209135|NCT04549545|530938218|FG001|Crossover Period|Additional ENT Procedure|6|||
147209136|NCT04549545|530938217|FG000|Crossover Period|Lost to Follow-up|0|||
147209137|NCT04549545|530938218|FG001|Crossover Period|Lost to Follow-up|1|||
147209138|NCT04549545|530938217|FG000|Crossover Period|Withdrawal by Subject|0|||
147209139|NCT04549545|530938218|FG001|Crossover Period|Withdrawal by Subject|4|||
147209140|NCT01395524|530938223|FG000|Overall Study|Non-compliance with study schedule|1|||
147209141|NCT01395524|530938224|FG001|Overall Study|Non-compliance with study schedule|0|||
147209142|NCT01395524|530938225|FG002|Overall Study|Non-compliance with study schedule|1|||
147209143|NCT01395524|530938223|FG000|Overall Study|Lost to Follow-up|3|||
147209144|NCT01395524|530938224|FG001|Overall Study|Lost to Follow-up|1|||
147209145|NCT01395524|530938225|FG002|Overall Study|Lost to Follow-up|1|||
147209146|NCT01395524|530938223|FG000|Overall Study|Study-Specific Withdrawal Criteria|1|||
147209147|NCT01395524|530938224|FG001|Overall Study|Study-Specific Withdrawal Criteria|2|||
147209148|NCT01395524|530938225|FG002|Overall Study|Study-Specific Withdrawal Criteria|0|||
147209149|NCT01395524|530938223|FG000|Overall Study|Severe noncompliance with protocol|1|||
147209150|NCT01395524|530938224|FG001|Overall Study|Severe noncompliance with protocol|0|||
147209151|NCT01395524|530938225|FG002|Overall Study|Severe noncompliance with protocol|0|||
147209152|NCT01395524|530938223|FG000|Overall Study|Adverse Event|4|||
147209153|NCT01395524|530938224|FG001|Overall Study|Adverse Event|4|||
147209154|NCT01395524|530938225|FG002|Overall Study|Adverse Event|3|||
147209155|NCT01395524|530938223|FG000|Overall Study|Death|1|||
147209156|NCT01395524|530938224|FG001|Overall Study|Death|0|||
147209157|NCT01395524|530938225|FG002|Overall Study|Death|0|||
147209158|NCT01395524|530938223|FG000|Overall Study|Eligibility Criteria Not Fulfilled|2|||
147209159|NCT01395524|530938224|FG001|Overall Study|Eligibility Criteria Not Fulfilled|0|||
147209160|NCT01395524|530938225|FG002|Overall Study|Eligibility Criteria Not Fulfilled|0|||
147209161|NCT01395524|530938223|FG000|Overall Study|Withdrawal by Subject|4|||
147209162|NCT01395524|530938224|FG001|Overall Study|Withdrawal by Subject|8|||
147209163|NCT01395524|530938225|FG002|Overall Study|Withdrawal by Subject|8|||
147209164|NCT01395524|530938223|FG000|Overall Study|Did not receive treatment|1|||
147209165|NCT01395524|530938224|FG001|Overall Study|Did not receive treatment|1|||
147209166|NCT01395524|530938225|FG002|Overall Study|Did not receive treatment|3|||
147209167|NCT01395524|530938223|FG000|Overall Study|Subject had spinal surgery|0|||
147209168|NCT01395524|530938224|FG001|Overall Study|Subject had spinal surgery|0|||
147209169|NCT01395524|530938225|FG002|Overall Study|Subject had spinal surgery|1|||
147209170|NCT01657461|530938226|FG000|Overall Study|Death|9|||
147209171|NCT01657461|530938227|FG001|Overall Study|Death|12|||
147209172|NCT01657461|530938226|FG000|Overall Study|Lost to Follow-up|0|||
147209173|NCT01657461|530938227|FG001|Overall Study|Lost to Follow-up|3|||
147209174|NCT01657461|530938226|FG000|Overall Study|Physician Decision|0|||
147209175|NCT01657461|530938227|FG001|Overall Study|Physician Decision|2|||
147209176|NCT01657461|530938226|FG000|Overall Study|Withdrawal by Subject|1|||
147209177|NCT01657461|530938227|FG001|Overall Study|Withdrawal by Subject|3|||
147209178|NCT01868542|530938228|FG000|Overall Study|Protocol Violation|0|||
147209179|NCT01868542|530938229|FG001|Overall Study|Protocol Violation|1|||
147209180|NCT01868542|530938228|FG000|Overall Study|Unclassified|0|||
147209181|NCT01868542|530938229|FG001|Overall Study|Unclassified|1|||
147209182|NCT00130247|530938230|FG000|Overall Study|Pregnancy|1|||
147209183|NCT00130247|530938231|FG001|Overall Study|Pregnancy|0|||
147209184|NCT00130247|530938230|FG000|Overall Study|Post-randomization exclusion|1|||
147209185|NCT00130247|530938231|FG001|Overall Study|Post-randomization exclusion|2|||
147209186|NCT00130247|530938230|FG000|Overall Study|Not compliant with DOT|0|||
147209187|NCT00130247|530938231|FG001|Overall Study|Not compliant with DOT|2|||
147209188|NCT00843284|530938236|FG000|Overall Study|Adverse Event|39|||
147209189|NCT00843284|530938236|FG000|Overall Study|Lack of Efficacy|5|||
147209190|NCT00843284|530938236|FG000|Overall Study|Lost to Follow-up|11|||
147209191|NCT00843284|530938236|FG000|Overall Study|Other|10|||
147209192|NCT00843284|530938236|FG000|Overall Study|Withdrawal by Subject|4|||
147209193|NCT00843284|530938236|FG000|Overall Study|Death|3|||
147439998|NCT03250832|531775889|FG000|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
147209194|NCT00122980|530938237|FG000|Overall Study|Death|0|||
147209195|NCT00122980|530938238|FG001|Overall Study|Death|1|||
147209196|NCT00122980|530938237|FG000|Overall Study|Physician Decision|2|||
147209197|NCT00122980|530938238|FG001|Overall Study|Physician Decision|0|||
147439999|NCT03250832|531775890|FG001|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
147209198|NCT00122980|530938237|FG000|Overall Study|Protocol Violation|5|||
147209199|NCT00122980|530938238|FG001|Overall Study|Protocol Violation|1|||
147209200|NCT00122980|530938237|FG000|Overall Study|Withdrawal by Subject|2|||
147209201|NCT00122980|530938238|FG001|Overall Study|Withdrawal by Subject|3|||
147209202|NCT00122980|530938237|FG000|Overall Study|Adjudicated stroke (study endpoint)|7|||
147209203|NCT00122980|530938238|FG001|Overall Study|Adjudicated stroke (study endpoint)|0|||
147209204|NCT00122980|530938237|FG000|Overall Study|Study termination|27|||
147209205|NCT00122980|530938238|FG001|Overall Study|Study termination|35|||
147209206|NCT03844945|530938239|FG000|Overall Study|Adverse Event|1|||
147209207|NCT03844945|530938240|FG001|Overall Study|Adverse Event|1|||
147209208|NCT03844945|530938241|FG002|Overall Study|Adverse Event|4|||
147209209|NCT03844945|530938242|FG003|Overall Study|Adverse Event|0|||
147209210|NCT03844945|530938239|FG000|Overall Study|Withdrawal by Subject|0|||
147209211|NCT03844945|530938240|FG001|Overall Study|Withdrawal by Subject|0|||
147209212|NCT03844945|530938241|FG002|Overall Study|Withdrawal by Subject|1|||
147209213|NCT03844945|530938242|FG003|Overall Study|Withdrawal by Subject|0|||
147209214|NCT03844945|530938239|FG000|Overall Study|Lack of Efficacy|0|||
147209215|NCT03844945|530938240|FG001|Overall Study|Lack of Efficacy|0|||
147209216|NCT03844945|530938241|FG002|Overall Study|Lack of Efficacy|0|||
147209217|NCT03844945|530938242|FG003|Overall Study|Lack of Efficacy|1|||
147209218|NCT01139008|530938252|FG000|Overall Study|Withdrawal by Subject|5|||
147209219|NCT01139008|530938252|FG000|Overall Study|Non-compliant, lost product|1|||
147209220|NCT00545272|530938258|FG000|Overall Study|Protocol deviation|0|||
147209221|NCT00545272|530938259|FG001|Overall Study|Protocol deviation|1|||
147209222|NCT00545272|530938260|FG002|Overall Study|Protocol deviation|0|||
147209223|NCT00545272|530938261|FG003|Overall Study|Protocol deviation|1|||
147209224|NCT00545272|530938262|FG004|Overall Study|Protocol deviation|0|||
147209225|NCT00545272|530938263|FG005|Overall Study|Protocol deviation|1|||
147209226|NCT00545272|530938258|FG000|Overall Study|Adverse Event|0|||
147209227|NCT00545272|530938259|FG001|Overall Study|Adverse Event|0|||
147209228|NCT00545272|530938260|FG002|Overall Study|Adverse Event|1|||
147209229|NCT00545272|530938261|FG003|Overall Study|Adverse Event|0|||
147209230|NCT00545272|530938262|FG004|Overall Study|Adverse Event|0|||
147209231|NCT00545272|530938263|FG005|Overall Study|Adverse Event|1|||
147209232|NCT00545272|530938258|FG000|Overall Study|Abnormal laboratory value(s)|0|||
147209233|NCT00545272|530938259|FG001|Overall Study|Abnormal laboratory value(s)|0|||
147209234|NCT00545272|530938260|FG002|Overall Study|Abnormal laboratory value(s)|0|||
147209235|NCT00545272|530938261|FG003|Overall Study|Abnormal laboratory value(s)|0|||
147209236|NCT00545272|530938262|FG004|Overall Study|Abnormal laboratory value(s)|0|||
147209237|NCT00545272|530938263|FG005|Overall Study|Abnormal laboratory value(s)|1|||
147209238|NCT00545272|530938258|FG000|Overall Study|Abnormal test procedure result(s)|0|||
147209239|NCT00545272|530938259|FG001|Overall Study|Abnormal test procedure result(s)|0|||
147209240|NCT00545272|530938260|FG002|Overall Study|Abnormal test procedure result(s)|0|||
147209241|NCT00545272|530938261|FG003|Overall Study|Abnormal test procedure result(s)|0|||
147209242|NCT00545272|530938262|FG004|Overall Study|Abnormal test procedure result(s)|1|||
147209243|NCT00545272|530938263|FG005|Overall Study|Abnormal test procedure result(s)|0|||
147209244|NCT00545272|530938258|FG000|Overall Study|Lost to Follow-up|0|||
147209245|NCT00545272|530938259|FG001|Overall Study|Lost to Follow-up|0|||
147209246|NCT00545272|530938260|FG002|Overall Study|Lost to Follow-up|0|||
147209247|NCT00545272|530938261|FG003|Overall Study|Lost to Follow-up|0|||
147209248|NCT00545272|530938262|FG004|Overall Study|Lost to Follow-up|1|||
147209249|NCT00545272|530938263|FG005|Overall Study|Lost to Follow-up|0|||
147209250|NCT02934503|530938264|FG000|Overall Study|progression of disease|3|||
147209251|NCT02934503|530938264|FG000|Overall Study|Withdrawal by Subject|1|||
147209252|NCT04248491|530938265|FG000|Overall Study|Lost to Follow-up|1|||
147209253|NCT04248491|530938266|FG001|Overall Study|Lost to Follow-up|0|||
147209254|NCT01311024|530938269|FG000|Overall Study|Protocol Violation|35|||
147209255|NCT01311024|530938270|FG001|Overall Study|Protocol Violation|22|||
147209256|NCT01652469|530938271|FG000|Overall Study|Withdrawal by Subject|1|||
147209257|NCT01652469|530938272|FG001|Overall Study|Withdrawal by Subject|4|||
147209258|NCT01652469|530938271|FG000|Overall Study|Lost to Follow-up|0|||
147209259|NCT01652469|530938272|FG001|Overall Study|Lost to Follow-up|2|||
147209260|NCT02834793|530938273|FG000|Core Study (Up to 18 Weeks)|Withdrawal by Subject|2|||
147209261|NCT02834793|530938274|FG001|Core Study (Up to 18 Weeks)|Withdrawal by Subject|1|||
147209262|NCT02834793|530938275|FG002|Core Study (Up to 18 Weeks)|Withdrawal by Subject|0|||
147209263|NCT02834793|530938276|FG003|Core Study (Up to 18 Weeks)|Withdrawal by Subject|0|||
147209264|NCT02834793|530938273|FG000|Core Study (Up to 18 Weeks)|Lack of Efficacy|1|||
147209265|NCT02834793|530938274|FG001|Core Study (Up to 18 Weeks)|Lack of Efficacy|0|||
147209266|NCT02834793|530938275|FG002|Core Study (Up to 18 Weeks)|Lack of Efficacy|0|||
147209267|NCT02834793|530938276|FG003|Core Study (Up to 18 Weeks)|Lack of Efficacy|0|||
147209268|NCT02834793|530938273|FG000|Core Study (Up to 18 Weeks)|Lost to Follow-up|1|||
147209269|NCT02834793|530938274|FG001|Core Study (Up to 18 Weeks)|Lost to Follow-up|0|||
147209270|NCT02834793|530938275|FG002|Core Study (Up to 18 Weeks)|Lost to Follow-up|0|||
147209271|NCT02834793|530938276|FG003|Core Study (Up to 18 Weeks)|Lost to Follow-up|0|||
147209272|NCT02834793|530938273|FG000|Core Study (Up to 18 Weeks)|Adverse Event|0|||
147209273|NCT02834793|530938274|FG001|Core Study (Up to 18 Weeks)|Adverse Event|3|||
147209274|NCT02834793|530938275|FG002|Core Study (Up to 18 Weeks)|Adverse Event|0|||
147209275|NCT02834793|530938276|FG003|Core Study (Up to 18 Weeks)|Adverse Event|0|||
147209276|NCT02834793|530938273|FG000|Core Study (Up to 18 Weeks)|Study terminated by sponsor|0|||
147209277|NCT02834793|530938274|FG001|Core Study (Up to 18 Weeks)|Study terminated by sponsor|1|||
147209278|NCT02834793|530938275|FG002|Core Study (Up to 18 Weeks)|Study terminated by sponsor|0|||
147209279|NCT02834793|530938276|FG003|Core Study (Up to 18 Weeks)|Study terminated by sponsor|0|||
147209280|NCT02834793|530938273|FG000|Extension Phase A (up to 52 Weeks)|Withdrawal by Subject|0|||
147209281|NCT02834793|530938274|FG001|Extension Phase A (up to 52 Weeks)|Withdrawal by Subject|0|||
147209282|NCT02834793|530938275|FG002|Extension Phase A (up to 52 Weeks)|Withdrawal by Subject|7|||
147209283|NCT02834793|530938276|FG003|Extension Phase A (up to 52 Weeks)|Withdrawal by Subject|0|||
147209284|NCT02834793|530938273|FG000|Extension Phase A (up to 52 Weeks)|Lack of Efficacy|0|||
147209285|NCT02834793|530938274|FG001|Extension Phase A (up to 52 Weeks)|Lack of Efficacy|0|||
147209286|NCT02834793|530938275|FG002|Extension Phase A (up to 52 Weeks)|Lack of Efficacy|4|||
147209287|NCT02834793|530938276|FG003|Extension Phase A (up to 52 Weeks)|Lack of Efficacy|0|||
147209288|NCT02834793|530938273|FG000|Extension Phase A (up to 52 Weeks)|Adverse Event|0|||
147209289|NCT02834793|530938274|FG001|Extension Phase A (up to 52 Weeks)|Adverse Event|0|||
147209290|NCT02834793|530938275|FG002|Extension Phase A (up to 52 Weeks)|Adverse Event|5|||
147209291|NCT02834793|530938276|FG003|Extension Phase A (up to 52 Weeks)|Adverse Event|0|||
147209292|NCT02834793|530938273|FG000|Extension Phase A (up to 52 Weeks)|Study terminated by sponsor|0|||
147209293|NCT02834793|530938274|FG001|Extension Phase A (up to 52 Weeks)|Study terminated by sponsor|0|||
147209294|NCT02834793|530938275|FG002|Extension Phase A (up to 52 Weeks)|Study terminated by sponsor|9|||
147209295|NCT02834793|530938276|FG003|Extension Phase A (up to 52 Weeks)|Study terminated by sponsor|0|||
147209296|NCT02834793|530938273|FG000|Extension Phase A (up to 52 Weeks)|Other|0|||
147209297|NCT02834793|530938274|FG001|Extension Phase A (up to 52 Weeks)|Other|0|||
147209298|NCT02834793|530938275|FG002|Extension Phase A (up to 52 Weeks)|Other|1|||
147209299|NCT02834793|530938276|FG003|Extension Phase A (up to 52 Weeks)|Other|0|||
147209300|NCT02834793|530938273|FG000|Extension Phase B (up to 188 Weeks)|Lack of Efficacy|0|||
147209301|NCT02834793|530938274|FG001|Extension Phase B (up to 188 Weeks)|Lack of Efficacy|0|||
147209302|NCT02834793|530938275|FG002|Extension Phase B (up to 188 Weeks)|Lack of Efficacy|0|||
147209303|NCT02834793|530938276|FG003|Extension Phase B (up to 188 Weeks)|Lack of Efficacy|1|||
147209304|NCT02834793|530938273|FG000|Extension Phase B (up to 188 Weeks)|Adverse Event|0|||
147209305|NCT02834793|530938274|FG001|Extension Phase B (up to 188 Weeks)|Adverse Event|0|||
147209306|NCT02834793|530938275|FG002|Extension Phase B (up to 188 Weeks)|Adverse Event|0|||
147209307|NCT02834793|530938276|FG003|Extension Phase B (up to 188 Weeks)|Adverse Event|1|||
147209308|NCT02834793|530938273|FG000|Extension Phase B (up to 188 Weeks)|Study terminated by sponsor|0|||
147209309|NCT02834793|530938274|FG001|Extension Phase B (up to 188 Weeks)|Study terminated by sponsor|0|||
147209310|NCT02834793|530938275|FG002|Extension Phase B (up to 188 Weeks)|Study terminated by sponsor|0|||
147209311|NCT02834793|530938276|FG003|Extension Phase B (up to 188 Weeks)|Study terminated by sponsor|8|||
147209312|NCT02834793|530938273|FG000|Extension Phase B (up to 188 Weeks)|Other|0|||
147209313|NCT02834793|530938274|FG001|Extension Phase B (up to 188 Weeks)|Other|0|||
147209314|NCT02834793|530938275|FG002|Extension Phase B (up to 188 Weeks)|Other|0|||
147209315|NCT02834793|530938276|FG003|Extension Phase B (up to 188 Weeks)|Other|1|||
147209316|NCT02834793|530938273|FG000|Extension Phase B (up to 188 Weeks)|Withdrawal by Subject|0|||
147209317|NCT02834793|530938274|FG001|Extension Phase B (up to 188 Weeks)|Withdrawal by Subject|0|||
147209318|NCT02834793|530938275|FG002|Extension Phase B (up to 188 Weeks)|Withdrawal by Subject|0|||
147209319|NCT02834793|530938276|FG003|Extension Phase B (up to 188 Weeks)|Withdrawal by Subject|1|||
147209320|NCT02364336|530938277|FG000|Overall Study|Adverse Event|0|||
147209321|NCT02364336|530938278|FG001|Overall Study|Adverse Event|1|||
147209322|NCT01731938|530938279|FG000|Preliminary Part I|Withdrawal by Subject|2|||
147209323|NCT01731938|530938280|FG001|Preliminary Part I|Withdrawal by Subject|2|||
147209324|NCT01731938|530938279|FG000|Preliminary Part I|Physician Decision|1|||
147209325|NCT01731938|530938280|FG001|Preliminary Part I|Physician Decision|0|||
147209326|NCT01731938|530938279|FG000|Preliminary Part I|Lost to Follow-up|0|||
147209327|NCT01731938|530938280|FG001|Preliminary Part I|Lost to Follow-up|3|||
147209328|NCT01731938|530938279|FG000|Preliminary Part I|Missed Week 6 visit|0|||
147209329|NCT01731938|530938280|FG001|Preliminary Part I|Missed Week 6 visit|3|||
147209330|NCT01731938|530938279|FG000|Primary Part II|Withdrawal by Subject|5|||
147209331|NCT01731938|530938280|FG001|Primary Part II|Withdrawal by Subject|4|||
147209332|NCT01731938|530938279|FG000|Primary Part II|Lost to Follow-up|4|||
147209333|NCT01731938|530938280|FG001|Primary Part II|Lost to Follow-up|5|||
147209334|NCT01731938|530938279|FG000|Primary Part II|Death|2|||
147209335|NCT01731938|530938280|FG001|Primary Part II|Death|1|||
147209336|NCT01731938|530938279|FG000|Primary Part II|Missed Week 6 visit|2|||
147209337|NCT01731938|530938280|FG001|Primary Part II|Missed Week 6 visit|3|||
147209338|NCT04931888|530938281|FG000|Overall Study|Excluded families participated in EMPOWER previously|4|||
147209339|NCT04931888|530938282|FG001|Overall Study|Excluded families participated in EMPOWER previously|2|||
147209340|NCT04931888|530938283|FG002|Overall Study|Excluded families participated in EMPOWER previously|0|||
147209341|NCT04931888|530938284|FG003|Overall Study|Excluded families participated in EMPOWER previously|0|||
147209342|NCT01049009|530938285|FG000|Treatment Period 1 (12 Weeks)|Protocol Violation|2|||
147209343|NCT01049009|530938286|FG001|Treatment Period 1 (12 Weeks)|Protocol Violation|2|||
147209344|NCT01049009|530938285|FG000|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
147209345|NCT01049009|530938286|FG001|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
147209346|NCT01049009|530938285|FG000|Treatment Period 2 (12 Weeks)|Lost to Follow-up|2|||
147209347|NCT01049009|530938286|FG001|Treatment Period 2 (12 Weeks)|Lost to Follow-up|3|||
147209348|NCT01049009|530938285|FG000|Treatment Period 2 (12 Weeks)|Protocol Violation|8|||
147209349|NCT01049009|530938286|FG001|Treatment Period 2 (12 Weeks)|Protocol Violation|7|||
147209350|NCT03179202|530938287|FG000|Overall Study|Screen Failure|67|||
147209351|NCT03179202|530938287|FG000|Overall Study|Subject Lost to Follow Up|12|||
147209352|NCT03179202|530938287|FG000|Overall Study|Withdrawal by Subject|7|||
147209353|NCT03179202|530938287|FG000|Overall Study|Adverse Event|3|||
147209354|NCT03179202|530938287|FG000|Overall Study|Unrelated Death Reported in All-Cause Mortality|1|||
147209355|NCT03179202|530938287|FG000|Overall Study|Other Reason: Incarceration after Enrollment|1|||
147209356|NCT00859638|530938288|FG000|Overall Study|Lost to Follow-up|6|||
147209357|NCT00859638|530938289|FG001|Overall Study|Lost to Follow-up|1|||
147209358|NCT00859638|530938288|FG000|Overall Study|Withdrawal by Subject|3|||
147209359|NCT00859638|530938289|FG001|Overall Study|Withdrawal by Subject|2|||
147209360|NCT00859638|530938288|FG000|Overall Study|Ill health|1|||
147209361|NCT00859638|530938289|FG001|Overall Study|Ill health|1|||
147209362|NCT02969408|530938291|FG000|Overall Study|Adverse Event|2|||
147209363|NCT02969408|530938291|FG000|Overall Study|Withdrawal by Subject|8|||
147209364|NCT02969408|530938291|FG000|Overall Study|Lost to Follow-up|4|||
147209365|NCT02969408|530938291|FG000|Overall Study|Protocol Violation|1|||
147209366|NCT02969408|530938291|FG000|Overall Study|Other than specified|1|||
147209367|NCT04643158|530938292|FG000|Overall Study|Study terminated by sponsor|0|||
147209368|NCT04643158|530938293|FG001|Overall Study|Study terminated by sponsor|0|||
147209369|NCT04643158|530938294|FG002|Overall Study|Study terminated by sponsor|1|||
147209370|NCT04643158|530938295|FG003|Overall Study|Study terminated by sponsor|0|||
147209371|NCT04643158|530938296|FG004|Overall Study|Study terminated by sponsor|0|||
147209372|NCT04643158|530938297|FG005|Overall Study|Study terminated by sponsor|1|||
147209373|NCT04643158|530938298|FG006|Overall Study|Study terminated by sponsor|0|||
147209374|NCT04643158|530938292|FG000|Overall Study|Global/country situation|0|||
147209375|NCT04643158|530938293|FG001|Overall Study|Global/country situation|0|||
147209376|NCT04643158|530938294|FG002|Overall Study|Global/country situation|1|||
147209377|NCT04643158|530938295|FG003|Overall Study|Global/country situation|0|||
147209378|NCT04643158|530938296|FG004|Overall Study|Global/country situation|0|||
147209379|NCT04643158|530938297|FG005|Overall Study|Global/country situation|0|||
147209380|NCT04643158|530938298|FG006|Overall Study|Global/country situation|0|||
147209381|NCT04643158|530938292|FG000|Overall Study|Withdrawal by Subject|0|||
147209382|NCT04643158|530938293|FG001|Overall Study|Withdrawal by Subject|0|||
147209383|NCT04643158|530938294|FG002|Overall Study|Withdrawal by Subject|0|||
147209384|NCT04643158|530938295|FG003|Overall Study|Withdrawal by Subject|0|||
147209385|NCT04643158|530938296|FG004|Overall Study|Withdrawal by Subject|0|||
147209386|NCT04643158|530938297|FG005|Overall Study|Withdrawal by Subject|1|||
147209387|NCT04643158|530938298|FG006|Overall Study|Withdrawal by Subject|0|||
147209388|NCT01068600|530938299|FG000|Overall Study|Withdrawal by Subject|5|||
147209389|NCT01068600|530938300|FG001|Overall Study|Withdrawal by Subject|6|||
147209390|NCT01068600|530938299|FG000|Overall Study|Adverse Event|3|||
147209391|NCT01068600|530938300|FG001|Overall Study|Adverse Event|3|||
147209392|NCT01068600|530938299|FG000|Overall Study|Abnormal laboratory value(s)|1|||
147209393|NCT01068600|530938300|FG001|Overall Study|Abnormal laboratory value(s)|0|||
147209394|NCT01068600|530938299|FG000|Overall Study|Lost to Follow-up|1|||
147209395|NCT01068600|530938300|FG001|Overall Study|Lost to Follow-up|2|||
147209396|NCT01068600|530938299|FG000|Overall Study|Protocol deviation|1|||
147209397|NCT01068600|530938300|FG001|Overall Study|Protocol deviation|1|||
147209398|NCT01068600|530938299|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
147209399|NCT01068600|530938300|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
147209400|NCT01068600|530938299|FG000|Overall Study|Administrative problems|0|||
147209401|NCT01068600|530938300|FG001|Overall Study|Administrative problems|1|||
147209402|NCT01474018|530938301|FG000|Overall Study|Lost to Follow-up|0|||
147209403|NCT01474018|530938302|FG001|Overall Study|Lost to Follow-up|1|||
147440000|NCT03250832|531775891|FG002|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
147209404|NCT01474018|530938301|FG000|Overall Study|Withdrawal by Subject|0|||
147209405|NCT01474018|530938302|FG001|Overall Study|Withdrawal by Subject|2|||
147209406|NCT00486291|530938307|FG000|Overall Study|Adverse Event|3|||
147209407|NCT00486291|530938308|FG001|Overall Study|Adverse Event|4|||
147209408|NCT00486291|530938307|FG000|Overall Study|Lost to Follow-up|3|||
147209409|NCT00486291|530938308|FG001|Overall Study|Lost to Follow-up|7|||
147209410|NCT00486291|530938307|FG000|Overall Study|protocol non-compliance|10|||
147209411|NCT00486291|530938308|FG001|Overall Study|protocol non-compliance|15|||
147209412|NCT00486291|530938307|FG000|Overall Study|requirement for restricted medication|0|||
147209413|NCT00486291|530938308|FG001|Overall Study|requirement for restricted medication|3|||
147209414|NCT03462511|530938312|FG000|Overall Study|Withdrawal by Subject|2|||
147209415|NCT03462511|530938313|FG001|Overall Study|Withdrawal by Subject|3|||
147209416|NCT02925416|530938314|FG000|Overall Study|Adverse Event|2|||
147209417|NCT02925416|530938315|FG001|Overall Study|Adverse Event|0|||
147209418|NCT02625909|530938316|FG000|Overall Study|Death|2|||
147209419|NCT02625909|530938317|FG001|Overall Study|Death|0|||
147209420|NCT02625909|530938316|FG000|Overall Study|Lost to Follow-up|3|||
147209421|NCT02625909|530938317|FG001|Overall Study|Lost to Follow-up|5|||
147209422|NCT02625909|530938316|FG000|Overall Study|Lack of Efficacy|9|||
147209423|NCT02625909|530938317|FG001|Overall Study|Lack of Efficacy|2|||
147209424|NCT02625909|530938316|FG000|Overall Study|Reinfection|3|||
147209425|NCT02625909|530938317|FG001|Overall Study|Reinfection|2|||
147209426|NCT00200356|530938318|FG000|Overall Study|Lack of Efficacy|3|||
147209427|NCT00200356|530938319|FG001|Overall Study|Lack of Efficacy|3|||
147209428|NCT00200356|530938318|FG000|Overall Study|Protocol Violation|4|||
147209429|NCT00200356|530938319|FG001|Overall Study|Protocol Violation|4|||
147209430|NCT00200356|530938318|FG000|Overall Study|Nontreatment|1|||
147209431|NCT00200356|530938319|FG001|Overall Study|Nontreatment|0|||
147209432|NCT00035932|530938326|FG000|Overall Study|Adverse Event|10|||
147209433|NCT00035932|530938327|FG001|Overall Study|Adverse Event|9|||
147209434|NCT00035932|530938328|FG002|Overall Study|Adverse Event|9|||
147209435|NCT00035932|530938326|FG000|Overall Study|Death|0|||
147209436|NCT00035932|530938327|FG001|Overall Study|Death|0|||
147209437|NCT00035932|530938328|FG002|Overall Study|Death|1|||
147440001|NCT03250832|531775892|FG003|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
147209438|NCT00035932|530938326|FG000|Overall Study|Disease Progression / Relapse|1|||
147209439|NCT00035932|530938327|FG001|Overall Study|Disease Progression / Relapse|1|||
147209440|NCT00035932|530938328|FG002|Overall Study|Disease Progression / Relapse|0|||
147209441|NCT00035932|530938326|FG000|Overall Study|Lost to Follow-up|4|||
147209442|NCT00035932|530938327|FG001|Overall Study|Lost to Follow-up|4|||
147209443|NCT00035932|530938328|FG002|Overall Study|Lost to Follow-up|3|||
147209444|NCT00035932|530938326|FG000|Overall Study|Noncompliance|6|||
147209445|NCT00035932|530938327|FG001|Overall Study|Noncompliance|7|||
147209446|NCT00035932|530938328|FG002|Overall Study|Noncompliance|6|||
147209447|NCT00035932|530938326|FG000|Overall Study|Protocol Violation While on Study|0|||
147209448|NCT00035932|530938327|FG001|Overall Study|Protocol Violation While on Study|1|||
147209449|NCT00035932|530938328|FG002|Overall Study|Protocol Violation While on Study|2|||
147209450|NCT00035932|530938326|FG000|Overall Study|Withdrawal by Subject|1|||
147209451|NCT00035932|530938327|FG001|Overall Study|Withdrawal by Subject|5|||
147209452|NCT00035932|530938328|FG002|Overall Study|Withdrawal by Subject|0|||
147209453|NCT00035932|530938326|FG000|Overall Study|Study Termination by Sponsor|1|||
147209454|NCT00035932|530938327|FG001|Overall Study|Study Termination by Sponsor|0|||
147209455|NCT00035932|530938328|FG002|Overall Study|Study Termination by Sponsor|0|||
147209456|NCT00035932|530938326|FG000|Overall Study|Lack of Efficacy|33|||
147209457|NCT00035932|530938327|FG001|Overall Study|Lack of Efficacy|33|||
147209458|NCT00035932|530938328|FG002|Overall Study|Lack of Efficacy|28|||
147209459|NCT01297491|530938329|FG000|Overall Study|Adverse Event|11|||
147209460|NCT01297491|530938330|FG001|Overall Study|Adverse Event|6|||
147209461|NCT01297491|530938329|FG000|Overall Study|Physician Decision|3|||
147209462|NCT01297491|530938330|FG001|Overall Study|Physician Decision|2|||
147209463|NCT01297491|530938329|FG000|Overall Study|Progressive disease|11|||
147209464|NCT01297491|530938330|FG001|Overall Study|Progressive disease|20|||
147209465|NCT01297491|530938329|FG000|Overall Study|Patient/Guardian decision|3|||
147209466|NCT01297491|530938330|FG001|Overall Study|Patient/Guardian decision|4|||
147209467|NCT01297491|530938329|FG000|Overall Study|Death|2|||
147209468|NCT01297491|530938330|FG001|Overall Study|Death|1|||
147209469|NCT04413617|530938334|FG000|Overall Study|Refused to come for FU visit and was contacted by phone|0|||
147209470|NCT04413617|530938335|FG001|Overall Study|Refused to come for FU visit and was contacted by phone|0|||
147209471|NCT04413617|530938336|FG002|Overall Study|Refused to come for FU visit and was contacted by phone|0|||
147209472|NCT04413617|530938337|FG003|Overall Study|Refused to come for FU visit and was contacted by phone|1|||
147440002|NCT03250832|531775893|FG004|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
147440003|NCT03250832|531775894|FG005|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
147440004|NCT03250832|531775895|FG006|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
147440005|NCT03250832|531775896|FG007|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|3|||
147440006|NCT03250832|531775897|FG008|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
147440007|NCT03250832|531775898|FG009|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
147440008|NCT03250832|531775899|FG010|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
147440009|NCT03250832|531775900|FG011|Part 2A (Up to Approximately 30 Months)|Sponsor Decision|0|||
147209473|NCT04413617|530938338|FG004|Overall Study|Refused to come for FU visit and was contacted by phone|0|||
147440010|NCT03250832|531775889|FG000|Part 2A (Up to Approximately 30 Months)|Other|0|||
147209474|NCT04413617|530938334|FG000|Overall Study|Protocol Violation|0|||
147209475|NCT04413617|530938335|FG001|Overall Study|Protocol Violation|1|||
147209476|NCT04413617|530938336|FG002|Overall Study|Protocol Violation|0|||
147209477|NCT04413617|530938337|FG003|Overall Study|Protocol Violation|0|||
147209478|NCT04413617|530938338|FG004|Overall Study|Protocol Violation|1|||
147209479|NCT04413617|530938334|FG000|Overall Study|Lack of Efficacy|2|||
147209480|NCT04413617|530938335|FG001|Overall Study|Lack of Efficacy|0|||
147209481|NCT04413617|530938336|FG002|Overall Study|Lack of Efficacy|2|||
147209482|NCT04413617|530938337|FG003|Overall Study|Lack of Efficacy|1|||
147209483|NCT04413617|530938338|FG004|Overall Study|Lack of Efficacy|0|||
147209484|NCT04413617|530938334|FG000|Overall Study|Withdrawal by Subject|3|||
147209485|NCT04413617|530938335|FG001|Overall Study|Withdrawal by Subject|4|||
147209486|NCT04413617|530938336|FG002|Overall Study|Withdrawal by Subject|2|||
147209487|NCT04413617|530938337|FG003|Overall Study|Withdrawal by Subject|5|||
147209488|NCT04413617|530938338|FG004|Overall Study|Withdrawal by Subject|3|||
147209489|NCT04413617|530938334|FG000|Overall Study|Death|1|||
147209490|NCT04413617|530938335|FG001|Overall Study|Death|0|||
147541604|NCT02923115|532138022|FG004|Overall Study|Withdrawal by Subject|0|||
147541605|NCT02923115|532138023|FG005|Overall Study|Withdrawal by Subject|0|||
147209491|NCT04413617|530938336|FG002|Overall Study|Death|0|||
147209492|NCT04413617|530938337|FG003|Overall Study|Death|0|||
147209493|NCT04413617|530938338|FG004|Overall Study|Death|0|||
147209494|NCT04413617|530938334|FG000|Overall Study|Adverse Event|1|||
147209495|NCT04413617|530938335|FG001|Overall Study|Adverse Event|0|||
147209496|NCT04413617|530938336|FG002|Overall Study|Adverse Event|0|||
147209497|NCT04413617|530938337|FG003|Overall Study|Adverse Event|1|||
147209498|NCT04413617|530938338|FG004|Overall Study|Adverse Event|1|||
147209499|NCT04413617|530938334|FG000|Overall Study|COVID-19|0|||
147209500|NCT04413617|530938335|FG001|Overall Study|COVID-19|1|||
147209501|NCT04413617|530938336|FG002|Overall Study|COVID-19|0|||
147209502|NCT04413617|530938337|FG003|Overall Study|COVID-19|0|||
147541606|NCT02923115|532138018|FG000|Overall Study|Randomized, but not dosed|0|||
147541607|NCT02923115|532138019|FG001|Overall Study|Randomized, but not dosed|0|||
147541608|NCT02923115|532138020|FG002|Overall Study|Randomized, but not dosed|3|||
147541609|NCT02923115|532138021|FG003|Overall Study|Randomized, but not dosed|1|||
147541610|NCT02923115|532138022|FG004|Overall Study|Randomized, but not dosed|5|||
147541611|NCT02923115|532138023|FG005|Overall Study|Randomized, but not dosed|0|||
147541612|NCT03869684|532138026|FG000|Overall Study|Adverse Event|0|||
147541613|NCT03869684|532138027|FG001|Overall Study|Adverse Event|3|||
147541614|NCT03869684|532138028|FG002|Overall Study|Adverse Event|1|||
147541615|NCT03869684|532138026|FG000|Overall Study|Withdrawal by Subject|1|||
147541616|NCT03869684|532138027|FG001|Overall Study|Withdrawal by Subject|0|||
147541617|NCT03869684|532138028|FG002|Overall Study|Withdrawal by Subject|0|||
147541618|NCT03869684|532138026|FG000|Overall Study|Lost to Follow-up|1|||
147541619|NCT03869684|532138027|FG001|Overall Study|Lost to Follow-up|0|||
147541620|NCT03869684|532138028|FG002|Overall Study|Lost to Follow-up|0|||
147541621|NCT03869684|532138026|FG000|Overall Study|Study prematurely terminated by sponsor|0|||
147541622|NCT03869684|532138027|FG001|Overall Study|Study prematurely terminated by sponsor|0|||
147541623|NCT03869684|532138028|FG002|Overall Study|Study prematurely terminated by sponsor|2|||
147541624|NCT04056299|532138029|FG000|Overall Study|Sponsor discontinued study|3|||
147209503|NCT04413617|530938338|FG004|Overall Study|COVID-19|0|||
147209504|NCT00312195|530938339|FG000|Overall Study|Adverse Event|4|||
147209505|NCT00312195|530938340|FG001|Overall Study|Adverse Event|6|||
147209506|NCT00312195|530938339|FG000|Overall Study|Lost to Follow-up|1|||
147209507|NCT00312195|530938340|FG001|Overall Study|Lost to Follow-up|0|||
147209508|NCT00312195|530938339|FG000|Overall Study|Protocol Violation|1|||
147209509|NCT00312195|530938340|FG001|Overall Study|Protocol Violation|0|||
147209510|NCT02511106|530938343|FG000|Overall Study|Lost to Follow-up|6|||
147209511|NCT02511106|530938344|FG001|Overall Study|Lost to Follow-up|4|||
147209512|NCT02511106|530938343|FG000|Overall Study|Withdrawal by Subject|24|||
147209513|NCT02511106|530938344|FG001|Overall Study|Withdrawal by Subject|21|||
147209514|NCT02511106|530938343|FG000|Overall Study|Death|42|||
147209515|NCT02511106|530938344|FG001|Overall Study|Death|82|||
147209516|NCT02511106|530938343|FG000|Overall Study|Ongoing study at data cut-off|3|||
147209517|NCT02511106|530938344|FG001|Overall Study|Ongoing study at data cut-off|2|||
147209518|NCT02511106|530938343|FG000|Overall Study|Without specified reason|3|||
147209519|NCT02511106|530938344|FG001|Overall Study|Without specified reason|0|||
147209520|NCT01015638|530938345|FG000|Overall Study|Withdrawal by Subject|1|||
147209521|NCT01015638|530938346|FG001|Overall Study|Withdrawal by Subject|0|||
147209522|NCT01703754|530938348|FG000|Overall Study|Clinically significant disease progression|2|||
147209523|NCT01703754|530938349|FG001|Overall Study|Clinically significant disease progression|2|||
147209524|NCT01703754|530938350|FG002|Overall Study|Clinically significant disease progression|1|||
147209525|NCT01703754|530938348|FG000|Overall Study|Adverse Event|1|||
147209526|NCT01703754|530938349|FG001|Overall Study|Adverse Event|1|||
147541625|NCT04056299|532138030|FG001|Overall Study|Sponsor discontinued study|3|||
147209527|NCT01703754|530938350|FG002|Overall Study|Adverse Event|0|||
147209528|NCT01703754|530938348|FG000|Overall Study|Withdrawal by Subject|2|||
147541626|NCT01296152|532138037|FG000|Overall Study|Unwilling to adhere to study requirement|1|||
147541627|NCT04840901|532138038|FG000|Overall Study|Lost to Follow-up|3|||
147541628|NCT04840901|532138039|FG001|Overall Study|Lost to Follow-up|1|||
147209529|NCT01703754|530938349|FG001|Overall Study|Withdrawal by Subject|0|||
147209530|NCT01703754|530938350|FG002|Overall Study|Withdrawal by Subject|0|||
147209531|NCT03530124|530938351|FG000|Overall Study|Withdrawal by Subject|0|||
147209532|NCT03530124|530938352|FG001|Overall Study|Withdrawal by Subject|1|||
147209533|NCT03530124|530938351|FG000|Overall Study|Protocol Violation|1|||
147541629|NCT04840901|532138038|FG000|Overall Study|Moved|1|||
147209534|NCT03530124|530938352|FG001|Overall Study|Protocol Violation|0|||
147209535|NCT03530124|530938351|FG000|Overall Study|Discharged prior to study completion|1|||
147209536|NCT03530124|530938352|FG001|Overall Study|Discharged prior to study completion|0|||
147209537|NCT03179319|530938353|FG000|Overall Study|Lost to Follow-up|6|||
147209538|NCT03179319|530938354|FG001|Overall Study|Lost to Follow-up|0|||
147209539|NCT01561313|530938361|FG000|Overall Study|Withdrawal by Subject|1|||
147209540|NCT01561313|530938362|FG001|Overall Study|Withdrawal by Subject|0|||
147209541|NCT01561313|530938361|FG000|Overall Study|Adverse event and withdrawal by subject|1|||
147209542|NCT01561313|530938362|FG001|Overall Study|Adverse event and withdrawal by subject|0|||
147209543|NCT04535453|530938363|FG000|Overall Study|Death|0|||
147209544|NCT04535453|530938364|FG001|Overall Study|Death|1|||
147209545|NCT04535453|530938365|FG002|Overall Study|Death|0|||
147209546|NCT04535453|530938366|FG003|Overall Study|Death|0|||
147209547|NCT04535453|530938367|FG004|Overall Study|Death|0|||
147209548|NCT04535453|530938368|FG005|Overall Study|Death|0|||
147209549|NCT04535453|530938369|FG006|Overall Study|Death|0|||
147209550|NCT04535453|530938370|FG007|Overall Study|Death|0|||
147209551|NCT04535453|530938371|FG008|Overall Study|Death|0|||
147209552|NCT04535453|530938372|FG009|Overall Study|Death|0|||
147209553|NCT04535453|530938373|FG010|Overall Study|Death|0|||
147209554|NCT04535453|530938374|FG011|Overall Study|Death|0|||
147209555|NCT04535453|530938363|FG000|Overall Study|Lost to Follow-up|1|||
147209556|NCT04535453|530938364|FG001|Overall Study|Lost to Follow-up|1|||
147209557|NCT04535453|530938365|FG002|Overall Study|Lost to Follow-up|1|||
147209558|NCT04535453|530938366|FG003|Overall Study|Lost to Follow-up|0|||
147209559|NCT04535453|530938367|FG004|Overall Study|Lost to Follow-up|3|||
147209560|NCT04535453|530938368|FG005|Overall Study|Lost to Follow-up|1|||
147209561|NCT04535453|530938369|FG006|Overall Study|Lost to Follow-up|0|||
147209562|NCT04535453|530938370|FG007|Overall Study|Lost to Follow-up|0|||
147209563|NCT04535453|530938371|FG008|Overall Study|Lost to Follow-up|1|||
147209564|NCT04535453|530938372|FG009|Overall Study|Lost to Follow-up|1|||
147209565|NCT04535453|530938373|FG010|Overall Study|Lost to Follow-up|0|||
147209566|NCT04535453|530938374|FG011|Overall Study|Lost to Follow-up|0|||
147209567|NCT04535453|530938363|FG000|Overall Study|Physician Decision|0|||
147209568|NCT04535453|530938364|FG001|Overall Study|Physician Decision|0|||
147209569|NCT04535453|530938365|FG002|Overall Study|Physician Decision|0|||
147440011|NCT03250832|531775890|FG001|Part 2A (Up to Approximately 30 Months)|Other|0|||
147440012|NCT03250832|531775891|FG002|Part 2A (Up to Approximately 30 Months)|Other|0|||
147440013|NCT03250832|531775892|FG003|Part 2A (Up to Approximately 30 Months)|Other|0|||
147440014|NCT03250832|531775893|FG004|Part 2A (Up to Approximately 30 Months)|Other|0|||
147440015|NCT03250832|531775894|FG005|Part 2A (Up to Approximately 30 Months)|Other|0|||
147440016|NCT03250832|531775895|FG006|Part 2A (Up to Approximately 30 Months)|Other|0|||
147440017|NCT03250832|531775896|FG007|Part 2A (Up to Approximately 30 Months)|Other|1|||
147440018|NCT03250832|531775897|FG008|Part 2A (Up to Approximately 30 Months)|Other|0|||
147440019|NCT03250832|531775898|FG009|Part 2A (Up to Approximately 30 Months)|Other|0|||
147440020|NCT03250832|531775899|FG010|Part 2A (Up to Approximately 30 Months)|Other|0|||
147440021|NCT03250832|531775900|FG011|Part 2A (Up to Approximately 30 Months)|Other|0|||
147440022|NCT03250832|531775889|FG000|Part 2B (Up to Approximately 29 Months)|Death|0|||
147440023|NCT03250832|531775890|FG001|Part 2B (Up to Approximately 29 Months)|Death|0|||
147440024|NCT03250832|531775891|FG002|Part 2B (Up to Approximately 29 Months)|Death|0|||
147440025|NCT03250832|531775892|FG003|Part 2B (Up to Approximately 29 Months)|Death|0|||
147440026|NCT03250832|531775893|FG004|Part 2B (Up to Approximately 29 Months)|Death|0|||
147440027|NCT03250832|531775894|FG005|Part 2B (Up to Approximately 29 Months)|Death|0|||
147440028|NCT03250832|531775895|FG006|Part 2B (Up to Approximately 29 Months)|Death|0|||
147440029|NCT03250832|531775896|FG007|Part 2B (Up to Approximately 29 Months)|Death|0|||
147440030|NCT03250832|531775897|FG008|Part 2B (Up to Approximately 29 Months)|Death|1|||
147440031|NCT03250832|531775898|FG009|Part 2B (Up to Approximately 29 Months)|Death|7|||
147440032|NCT03250832|531775899|FG010|Part 2B (Up to Approximately 29 Months)|Death|0|||
147440033|NCT03250832|531775900|FG011|Part 2B (Up to Approximately 29 Months)|Death|0|||
147440034|NCT03250832|531775889|FG000|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
147440035|NCT03250832|531775890|FG001|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
147440036|NCT03250832|531775891|FG002|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
147440037|NCT03250832|531775892|FG003|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
147440038|NCT03250832|531775893|FG004|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
147440039|NCT03250832|531775894|FG005|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
147440040|NCT03250832|531775895|FG006|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
147440041|NCT03250832|531775896|FG007|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
147541630|NCT04840901|532138039|FG001|Overall Study|Moved|0|||
147209570|NCT04535453|530938366|FG003|Overall Study|Physician Decision|1|||
147209571|NCT04535453|530938367|FG004|Overall Study|Physician Decision|0|||
147209572|NCT04535453|530938368|FG005|Overall Study|Physician Decision|0|||
147209573|NCT04535453|530938369|FG006|Overall Study|Physician Decision|0|||
147209574|NCT04535453|530938370|FG007|Overall Study|Physician Decision|0|||
147209575|NCT04535453|530938371|FG008|Overall Study|Physician Decision|0|||
147209576|NCT04535453|530938372|FG009|Overall Study|Physician Decision|0|||
147209577|NCT04535453|530938373|FG010|Overall Study|Physician Decision|0|||
147209578|NCT04535453|530938374|FG011|Overall Study|Physician Decision|0|||
147209579|NCT04535453|530938363|FG000|Overall Study|Withdrawal by Subject|3|||
147209580|NCT04535453|530938364|FG001|Overall Study|Withdrawal by Subject|6|||
147209581|NCT04535453|530938365|FG002|Overall Study|Withdrawal by Subject|3|||
147209582|NCT04535453|530938366|FG003|Overall Study|Withdrawal by Subject|3|||
147209583|NCT04535453|530938367|FG004|Overall Study|Withdrawal by Subject|2|||
147209584|NCT04535453|530938368|FG005|Overall Study|Withdrawal by Subject|1|||
147209585|NCT04535453|530938369|FG006|Overall Study|Withdrawal by Subject|1|||
147209586|NCT04535453|530938370|FG007|Overall Study|Withdrawal by Subject|1|||
147209587|NCT04535453|530938371|FG008|Overall Study|Withdrawal by Subject|1|||
147209588|NCT04535453|530938372|FG009|Overall Study|Withdrawal by Subject|1|||
147209589|NCT04535453|530938373|FG010|Overall Study|Withdrawal by Subject|0|||
147209590|NCT04535453|530938374|FG011|Overall Study|Withdrawal by Subject|1|||
147209591|NCT04535453|530938363|FG000|Overall Study|Other|0|||
147209592|NCT04535453|530938364|FG001|Overall Study|Other|0|||
147209593|NCT04535453|530938365|FG002|Overall Study|Other|1|||
147209594|NCT04535453|530938366|FG003|Overall Study|Other|0|||
147209595|NCT04535453|530938367|FG004|Overall Study|Other|1|||
147209596|NCT04535453|530938368|FG005|Overall Study|Other|0|||
147209597|NCT04535453|530938369|FG006|Overall Study|Other|1|||
147209598|NCT04535453|530938370|FG007|Overall Study|Other|1|||
147209599|NCT04535453|530938371|FG008|Overall Study|Other|1|||
147209600|NCT04535453|530938372|FG009|Overall Study|Other|0|||
147209601|NCT04535453|530938373|FG010|Overall Study|Other|0|||
147209602|NCT04535453|530938374|FG011|Overall Study|Other|0|||
147209603|NCT01387542|530938375|FG000|Overall Study|Adverse Event|3|||
147209604|NCT01387542|530938375|FG000|Overall Study|Withdrawal by Subject|1|||
147209605|NCT01387542|530938375|FG000|Overall Study|Changed diagnosis|1|||
147209606|NCT01387542|530938375|FG000|Overall Study|Insufficient response|1|||
147209607|NCT01387542|530938375|FG000|Overall Study|Non-compliant|1|||
147209608|NCT01387542|530938375|FG000|Overall Study|Lost to Follow-up|1|||
147209609|NCT01233232|530938376|FG000|Overall Study|Voluntary Discontinuation by Subject|1|||
147209610|NCT01233232|530938377|FG001|Overall Study|Voluntary Discontinuation by Subject|0|||
147209611|NCT01233232|530938378|FG002|Overall Study|Voluntary Discontinuation by Subject|0|||
147209612|NCT02633020|530938384|FG000|Overall Study|Adverse Event|1|||
147209613|NCT02633020|530938385|FG001|Overall Study|Adverse Event|0|||
147209614|NCT00934440|530938386|FG000|Overall Study|Lost to Follow-up|1|||
147209615|NCT02152956|530938387|FG000|Overall Study|Adverse Event|0|||
147209616|NCT02152956|530938388|FG001|Overall Study|Adverse Event|0|||
147209617|NCT02152956|530938389|FG002|Overall Study|Adverse Event|0|||
147209618|NCT02152956|530938390|FG003|Overall Study|Adverse Event|0|||
147209619|NCT02152956|530938391|FG004|Overall Study|Adverse Event|0|||
147209620|NCT02152956|530938392|FG005|Overall Study|Adverse Event|0|||
147209621|NCT02152956|530938393|FG006|Overall Study|Adverse Event|0|||
147209622|NCT02152956|530938394|FG007|Overall Study|Adverse Event|0|||
147209623|NCT02152956|530938395|FG008|Overall Study|Adverse Event|0|||
147209624|NCT02152956|530938396|FG009|Overall Study|Adverse Event|0|||
147209625|NCT02152956|530938397|FG010|Overall Study|Adverse Event|0|||
147209626|NCT02152956|530938398|FG011|Overall Study|Adverse Event|4|||
147209627|NCT02152956|530938399|FG012|Overall Study|Adverse Event|0|||
147209628|NCT02152956|530938387|FG000|Overall Study|Death|0|||
147209629|NCT02152956|530938388|FG001|Overall Study|Death|3|||
147209630|NCT02152956|530938389|FG002|Overall Study|Death|3|||
147209631|NCT02152956|530938390|FG003|Overall Study|Death|4|||
147209632|NCT02152956|530938391|FG004|Overall Study|Death|1|||
147209633|NCT02152956|530938392|FG005|Overall Study|Death|2|||
147209634|NCT02152956|530938393|FG006|Overall Study|Death|6|||
147209635|NCT02152956|530938394|FG007|Overall Study|Death|6|||
147209636|NCT02152956|530938395|FG008|Overall Study|Death|4|||
147209637|NCT02152956|530938396|FG009|Overall Study|Death|5|||
147209638|NCT02152956|530938397|FG010|Overall Study|Death|3|||
147209639|NCT02152956|530938398|FG011|Overall Study|Death|143|||
147209640|NCT02152956|530938399|FG012|Overall Study|Death|12|||
147209641|NCT02152956|530938387|FG000|Overall Study|Lost to Follow-up|0|||
147440042|NCT03250832|531775897|FG008|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|2|||
147440043|NCT03250832|531775898|FG009|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|7|||
147440044|NCT03250832|531775899|FG010|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
147440045|NCT03250832|531775900|FG011|Part 2B (Up to Approximately 29 Months)|Withdrawal by Subject|0|||
147209642|NCT02152956|530938388|FG001|Overall Study|Lost to Follow-up|1|||
147209643|NCT02152956|530938389|FG002|Overall Study|Lost to Follow-up|0|||
147209644|NCT02152956|530938390|FG003|Overall Study|Lost to Follow-up|0|||
147209645|NCT02152956|530938391|FG004|Overall Study|Lost to Follow-up|0|||
147209646|NCT02152956|530938392|FG005|Overall Study|Lost to Follow-up|0|||
147209647|NCT02152956|530938393|FG006|Overall Study|Lost to Follow-up|0|||
147209648|NCT02152956|530938394|FG007|Overall Study|Lost to Follow-up|0|||
147209649|NCT02152956|530938395|FG008|Overall Study|Lost to Follow-up|0|||
147209650|NCT02152956|530938396|FG009|Overall Study|Lost to Follow-up|0|||
147209651|NCT02152956|530938397|FG010|Overall Study|Lost to Follow-up|0|||
147209652|NCT02152956|530938398|FG011|Overall Study|Lost to Follow-up|3|||
147209653|NCT02152956|530938399|FG012|Overall Study|Lost to Follow-up|0|||
147209654|NCT02152956|530938387|FG000|Overall Study|Withdrawal by Subject|1|||
147209655|NCT02152956|530938388|FG001|Overall Study|Withdrawal by Subject|0|||
147209656|NCT02152956|530938389|FG002|Overall Study|Withdrawal by Subject|1|||
147440046|NCT03250832|531775889|FG000|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
147440047|NCT03250832|531775890|FG001|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
147440048|NCT03250832|531775891|FG002|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
147440049|NCT03250832|531775892|FG003|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
147440050|NCT03250832|531775893|FG004|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
147440051|NCT03250832|531775894|FG005|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
147440052|NCT03250832|531775895|FG006|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
147440053|NCT03250832|531775896|FG007|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
147440054|NCT03250832|531775897|FG008|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|1|||
147440055|NCT03250832|531775898|FG009|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|6|||
147440056|NCT03250832|531775899|FG010|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
147440057|NCT03250832|531775900|FG011|Part 2B (Up to Approximately 29 Months)|Sponsor Decision|0|||
147440058|NCT03250832|531775889|FG000|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
147440059|NCT03250832|531775890|FG001|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
147440060|NCT03250832|531775891|FG002|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
147440061|NCT03250832|531775892|FG003|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
147440062|NCT03250832|531775893|FG004|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
147440063|NCT03250832|531775894|FG005|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
147440064|NCT03250832|531775895|FG006|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
147440065|NCT03250832|531775896|FG007|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
147440066|NCT03250832|531775897|FG008|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
147440067|NCT03250832|531775898|FG009|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
147440068|NCT03250832|531775899|FG010|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|0|||
147440069|NCT03250832|531775900|FG011|PACT Phase (up to Approximately 36weeks)|Lost to Follow-up|1|||
147440070|NCT00916279|531775901|FG000|Overall Study|Death|2|||
147440071|NCT00916279|531775901|FG000|Overall Study|Lost to Follow-up|2|||
147440072|NCT00310804|531775902|FG000|Overall Study|Lost to Follow-up|2|||
147440073|NCT00310804|531775903|FG001|Overall Study|Lost to Follow-up|0|||
147440074|NCT00310804|531775902|FG000|Overall Study|Withdrawal by Subject|3|||
147440075|NCT00310804|531775903|FG001|Overall Study|Withdrawal by Subject|0|||
147440076|NCT00688155|531775904|FG000|Overall Study|Withdrawal by Subject|2|||
147440077|NCT00688155|531775905|FG001|Overall Study|Withdrawal by Subject|2|||
147440078|NCT00688155|531775906|FG002|Overall Study|Withdrawal by Subject|1|||
147440079|NCT00688155|531775907|FG003|Overall Study|Withdrawal by Subject|1|||
147440080|NCT00382720|531777512|FG000|Overall Study|Adverse Event|21|||
147440081|NCT00382720|531777513|FG001|Overall Study|Adverse Event|23|||
147440082|NCT00382720|531777514|FG002|Overall Study|Adverse Event|15|||
147440083|NCT00382720|531777512|FG000|Overall Study|Protocol Violation|2|||
147440084|NCT00382720|531777513|FG001|Overall Study|Protocol Violation|5|||
147440085|NCT00382720|531777514|FG002|Overall Study|Protocol Violation|1|||
147440086|NCT00382720|531777512|FG000|Overall Study|Death|0|||
147440087|NCT00382720|531777513|FG001|Overall Study|Death|1|||
147440088|NCT00382720|531777514|FG002|Overall Study|Death|2|||
147440089|NCT00382720|531777512|FG000|Overall Study|Progressive disease|37|||
147440090|NCT00382720|531777513|FG001|Overall Study|Progressive disease|28|||
147440091|NCT00382720|531777514|FG002|Overall Study|Progressive disease|38|||
147440092|NCT00382720|531777512|FG000|Overall Study|Withdrew consent|1|||
147440093|NCT00382720|531777513|FG001|Overall Study|Withdrew consent|1|||
147440094|NCT00382720|531777514|FG002|Overall Study|Withdrew consent|2|||
147440095|NCT00382720|531777512|FG000|Overall Study|Withdrawal by Subject|11|||
147440096|NCT00382720|531777513|FG001|Overall Study|Withdrawal by Subject|20|||
147440097|NCT00382720|531777514|FG002|Overall Study|Withdrawal by Subject|12|||
147440098|NCT00382720|531777512|FG000|Overall Study|Surgery|1|||
147440099|NCT00382720|531777513|FG001|Overall Study|Surgery|1|||
147440100|NCT00382720|531777514|FG002|Overall Study|Surgery|4|||
147440101|NCT00382720|531777512|FG000|Overall Study|Patient did not receive study medication|1|||
147440102|NCT00382720|531777513|FG001|Overall Study|Patient did not receive study medication|1|||
147440103|NCT00382720|531777514|FG002|Overall Study|Patient did not receive study medication|4|||
147440104|NCT00382720|531777512|FG000|Overall Study|Clinically progressive disease|0|||
147440105|NCT00382720|531777513|FG001|Overall Study|Clinically progressive disease|1|||
147440106|NCT00382720|531777514|FG002|Overall Study|Clinically progressive disease|0|||
147440107|NCT00382720|531777512|FG000|Overall Study|Good prognosis|0|||
147209657|NCT02152956|530938390|FG003|Overall Study|Withdrawal by Subject|0|||
147440108|NCT00382720|531777513|FG001|Overall Study|Good prognosis|1|||
147440109|NCT00382720|531777514|FG002|Overall Study|Good prognosis|0|||
147209658|NCT02152956|530938391|FG004|Overall Study|Withdrawal by Subject|2|||
147541631|NCT04840901|532138038|FG000|Overall Study|Unable to comply with study schedule|0|||
147541632|NCT04840901|532138039|FG001|Overall Study|Unable to comply with study schedule|1|||
147541633|NCT04840901|532138038|FG000|Overall Study|Screen Failure - Randomized but Did Not Receive Study Drug|1|||
147541634|NCT04840901|532138039|FG001|Overall Study|Screen Failure - Randomized but Did Not Receive Study Drug|0|||
147541635|NCT01268683|532138040|FG000|Overall Study|Lost to Follow-up|1|||
147541636|NCT01268683|532138040|FG000|Overall Study|Death|1|||
147541637|NCT00103259|532138043|FG000|Overall Study|Death|3|||
147541638|NCT00103259|532138044|FG001|Overall Study|Death|2|||
147541639|NCT00103259|532138043|FG000|Overall Study|Withdrawal by Subject|2|||
147541640|NCT00103259|532138044|FG001|Overall Study|Withdrawal by Subject|3|||
147541641|NCT00103259|532138043|FG000|Overall Study|alternative therapy|1|||
147541642|NCT00103259|532138044|FG001|Overall Study|alternative therapy|0|||
147541643|NCT00103259|532138043|FG000|Overall Study|other (reasons were not specified)|2|||
147541644|NCT00103259|532138044|FG001|Overall Study|other (reasons were not specified)|1|||
147541645|NCT00103259|532138043|FG000|Overall Study|ineligible/no protocol therapy|4|||
147541646|NCT00103259|532138044|FG001|Overall Study|ineligible/no protocol therapy|6|||
147541647|NCT03224234|532138047|FG000|Main Study|Lost to Follow-up|5|||
147541648|NCT03224234|532138048|FG001|Main Study|Lost to Follow-up|5|||
147541649|NCT02610842|532138049|FG000|Overall Study|Lost to Follow-up|5|||
147541650|NCT01988493|532138050|FG000|Overall Study|Randomized but not treated|0|||
147541651|NCT01988493|532138051|FG001|Overall Study|Randomized but not treated|0|||
147541652|NCT01988493|532138052|FG002|Overall Study|Randomized but not treated|0|||
147209659|NCT02152956|530938392|FG005|Overall Study|Withdrawal by Subject|2|||
147209660|NCT02152956|530938393|FG006|Overall Study|Withdrawal by Subject|0|||
147209661|NCT02152956|530938394|FG007|Overall Study|Withdrawal by Subject|0|||
147209662|NCT02152956|530938395|FG008|Overall Study|Withdrawal by Subject|1|||
147209663|NCT02152956|530938396|FG009|Overall Study|Withdrawal by Subject|0|||
147209664|NCT02152956|530938397|FG010|Overall Study|Withdrawal by Subject|0|||
147209665|NCT02152956|530938398|FG011|Overall Study|Withdrawal by Subject|4|||
147209666|NCT02152956|530938399|FG012|Overall Study|Withdrawal by Subject|0|||
147209667|NCT02152956|530938387|FG000|Overall Study|Physician Decision|0|||
147209668|NCT02152956|530938388|FG001|Overall Study|Physician Decision|0|||
147209669|NCT02152956|530938389|FG002|Overall Study|Physician Decision|0|||
147209670|NCT02152956|530938390|FG003|Overall Study|Physician Decision|0|||
147209671|NCT02152956|530938391|FG004|Overall Study|Physician Decision|0|||
147209672|NCT02152956|530938392|FG005|Overall Study|Physician Decision|0|||
147209673|NCT02152956|530938393|FG006|Overall Study|Physician Decision|0|||
147209674|NCT02152956|530938394|FG007|Overall Study|Physician Decision|0|||
147209675|NCT02152956|530938395|FG008|Overall Study|Physician Decision|0|||
147209676|NCT02152956|530938396|FG009|Overall Study|Physician Decision|0|||
147209677|NCT02152956|530938397|FG010|Overall Study|Physician Decision|0|||
147209678|NCT02152956|530938398|FG011|Overall Study|Physician Decision|1|||
147209679|NCT02152956|530938399|FG012|Overall Study|Physician Decision|0|||
147209680|NCT02152956|530938387|FG000|Overall Study|Study terminated by sponsor|0|||
147209681|NCT02152956|530938388|FG001|Overall Study|Study terminated by sponsor|0|||
147209682|NCT02152956|530938389|FG002|Overall Study|Study terminated by sponsor|0|||
147209683|NCT02152956|530938390|FG003|Overall Study|Study terminated by sponsor|0|||
147209684|NCT02152956|530938391|FG004|Overall Study|Study terminated by sponsor|0|||
147209685|NCT02152956|530938392|FG005|Overall Study|Study terminated by sponsor|0|||
147209686|NCT02152956|530938393|FG006|Overall Study|Study terminated by sponsor|0|||
147209687|NCT02152956|530938394|FG007|Overall Study|Study terminated by sponsor|0|||
147209688|NCT02152956|530938395|FG008|Overall Study|Study terminated by sponsor|0|||
147209689|NCT02152956|530938396|FG009|Overall Study|Study terminated by sponsor|0|||
147209690|NCT02152956|530938397|FG010|Overall Study|Study terminated by sponsor|0|||
147209691|NCT02152956|530938398|FG011|Overall Study|Study terminated by sponsor|29|||
147209692|NCT02152956|530938399|FG012|Overall Study|Study terminated by sponsor|0|||
147209693|NCT02152956|530938387|FG000|Overall Study|progressive disease|0|||
147209694|NCT02152956|530938388|FG001|Overall Study|progressive disease|0|||
147209695|NCT02152956|530938389|FG002|Overall Study|progressive disease|0|||
147209696|NCT02152956|530938390|FG003|Overall Study|progressive disease|0|||
147209697|NCT02152956|530938391|FG004|Overall Study|progressive disease|0|||
147209698|NCT02152956|530938392|FG005|Overall Study|progressive disease|0|||
147209699|NCT02152956|530938393|FG006|Overall Study|progressive disease|0|||
147209700|NCT02152956|530938394|FG007|Overall Study|progressive disease|0|||
147209701|NCT02152956|530938395|FG008|Overall Study|progressive disease|1|||
147209702|NCT02152956|530938396|FG009|Overall Study|progressive disease|0|||
147209703|NCT02152956|530938397|FG010|Overall Study|progressive disease|0|||
147209704|NCT02152956|530938398|FG011|Overall Study|progressive disease|1|||
147209705|NCT02152956|530938399|FG012|Overall Study|progressive disease|0|||
147209706|NCT00530816|530938400|FG000|Overall Study|Progressive Disease|16|||
147209707|NCT00530816|530938401|FG001|Overall Study|Progressive Disease|24|||
147209708|NCT00530816|530938402|FG002|Overall Study|Progressive Disease|24|||
147541653|NCT01988493|532138053|FG003|Overall Study|Randomized but not treated|0|||
147649438|NCT02634801|532537343|FG002|Extension Period (Weeks 24 to 36)|Missing|0|||
147209709|NCT00530816|530938400|FG000|Overall Study|Adverse Event|6|||
147209710|NCT00530816|530938401|FG001|Overall Study|Adverse Event|13|||
147209711|NCT00530816|530938402|FG002|Overall Study|Adverse Event|7|||
147541654|NCT01988493|532138054|FG004|Overall Study|Randomized but not treated|1|||
147541655|NCT02494583|532138055|FG000|Overall Study|Death|224|||
147209712|NCT00530816|530938400|FG000|Overall Study|Other|3|||
147209713|NCT00530816|530938401|FG001|Overall Study|Other|3|||
147209714|NCT00530816|530938402|FG002|Overall Study|Other|4|||
147209715|NCT00530816|530938400|FG000|Overall Study|Withdrawal by Subject|1|||
147209716|NCT00530816|530938401|FG001|Overall Study|Withdrawal by Subject|2|||
147209717|NCT00530816|530938402|FG002|Overall Study|Withdrawal by Subject|6|||
147209718|NCT01014910|530938403|FG000|Overall Study|Withdrawal by Subject|0|||
147209719|NCT01014910|530938404|FG001|Overall Study|Withdrawal by Subject|2|||
147209720|NCT01388985|530938405|FG000|Overall Study|Death|0|||
147209721|NCT01388985|530938406|FG001|Overall Study|Death|1|||
147209722|NCT01388985|530938405|FG000|Overall Study|Lost to Follow-up|30|||
147209723|NCT01388985|530938406|FG001|Overall Study|Lost to Follow-up|30|||
147209724|NCT01388985|530938405|FG000|Overall Study|Withdrawal by Subject|13|||
147209725|NCT01388985|530938406|FG001|Overall Study|Withdrawal by Subject|4|||
147209726|NCT01388985|530938405|FG000|Overall Study|Subject unavailable|1|||
147209727|NCT01388985|530938406|FG001|Overall Study|Subject unavailable|1|||
147209728|NCT01388985|530938405|FG000|Overall Study|Other (no reason)|0|||
147209729|NCT01388985|530938406|FG001|Overall Study|Other (no reason)|1|||
147209730|NCT01388985|530938405|FG000|Overall Study|Error of nurse|5|||
147209731|NCT01388985|530938406|FG001|Overall Study|Error of nurse|1|||
147209732|NCT02954172|530938409|FG000|Overall Study|Protocol Violation|3|||
147209733|NCT02954172|530938410|FG001|Overall Study|Protocol Violation|0|||
147209734|NCT02954172|530938409|FG000|Overall Study|allergic reaction|2|||
147209735|NCT02954172|530938410|FG001|Overall Study|allergic reaction|1|||
147209736|NCT02954172|530938409|FG000|Overall Study|non-measurable lesions at baseline|1|||
147209737|NCT02954172|530938410|FG001|Overall Study|non-measurable lesions at baseline|2|||
147209738|NCT01519167|530938411|FG000|Overall Study|Diagnostic/TherapeuticProcedureCompleted|0|||
147209739|NCT01519167|530938412|FG001|Overall Study|Diagnostic/TherapeuticProcedureCompleted|3|||
147209740|NCT01519167|530938411|FG000|Overall Study|Adverse Event|0|||
147209741|NCT01519167|530938412|FG001|Overall Study|Adverse Event|1|||
147209742|NCT01519167|530938411|FG000|Overall Study|Lack of Efficacy|0|||
147209743|NCT01519167|530938412|FG001|Overall Study|Lack of Efficacy|1|||
147209744|NCT01519167|530938411|FG000|Overall Study|Medical condition changes&deep sedation|0|||
147209745|NCT01519167|530938412|FG001|Overall Study|Medical condition changes&deep sedation|2|||
147209746|NCT01519167|530938411|FG000|Overall Study|Physician Decision|0|||
147209747|NCT01519167|530938412|FG001|Overall Study|Physician Decision|1|||
147209748|NCT01925131|530939887|FG000|Overall Study|Death|0|||
147209749|NCT01925131|530939888|FG001|Overall Study|Death|0|||
147209750|NCT01925131|530939889|FG002|Overall Study|Death|1|||
147209751|NCT01925131|530939890|FG003|Overall Study|Death|0|||
147209752|NCT01925131|530939891|FG004|Overall Study|Death|0|||
147209753|NCT01925131|530939892|FG005|Overall Study|Death|0|||
147209754|NCT01925131|530939887|FG000|Overall Study|Progression/Relapse|1|||
147209755|NCT01925131|530939888|FG001|Overall Study|Progression/Relapse|1|||
147209756|NCT01925131|530939889|FG002|Overall Study|Progression/Relapse|4|||
147209757|NCT01925131|530939890|FG003|Overall Study|Progression/Relapse|0|||
147209758|NCT01925131|530939891|FG004|Overall Study|Progression/Relapse|0|||
147209759|NCT01925131|530939892|FG005|Overall Study|Progression/Relapse|1|||
147209760|NCT01925131|530939887|FG000|Overall Study|Patient Refusal|1|||
147209761|NCT01925131|530939888|FG001|Overall Study|Patient Refusal|0|||
147209762|NCT01925131|530939889|FG002|Overall Study|Patient Refusal|0|||
147209763|NCT01925131|530939890|FG003|Overall Study|Patient Refusal|0|||
147209764|NCT01925131|530939891|FG004|Overall Study|Patient Refusal|0|||
147209765|NCT01925131|530939892|FG005|Overall Study|Patient Refusal|0|||
147209766|NCT01925131|530939887|FG000|Overall Study|Adverse Event|0|||
147209767|NCT01925131|530939888|FG001|Overall Study|Adverse Event|0|||
147209768|NCT01925131|530939889|FG002|Overall Study|Adverse Event|2|||
147209769|NCT01925131|530939890|FG003|Overall Study|Adverse Event|0|||
147209770|NCT01925131|530939891|FG004|Overall Study|Adverse Event|1|||
147541656|NCT02494583|532138056|FG001|Overall Study|Death|214|||
147209771|NCT01925131|530939892|FG005|Overall Study|Adverse Event|3|||
147541657|NCT02494583|532138057|FG002|Overall Study|Death|225|||
147541658|NCT02494583|532138055|FG000|Overall Study|Lost to Follow-up|1|||
147209772|NCT01925131|530939887|FG000|Overall Study|Other - Not Protocol Specified|3|||
147209773|NCT01925131|530939888|FG001|Overall Study|Other - Not Protocol Specified|1|||
147209774|NCT01925131|530939889|FG002|Overall Study|Other - Not Protocol Specified|2|||
147209775|NCT01925131|530939890|FG003|Overall Study|Other - Not Protocol Specified|5|||
147209776|NCT01925131|530939891|FG004|Overall Study|Other - Not Protocol Specified|10|||
147209777|NCT01925131|530939892|FG005|Overall Study|Other - Not Protocol Specified|6|||
147209778|NCT00745849|530939893|FG000|First Intervention|Withdrawal by Subject|0|||
147209779|NCT00745849|530939894|FG001|First Intervention|Withdrawal by Subject|1|||
147209780|NCT00745849|530939893|FG000|First Intervention|Lost to Follow-up|1|||
147209781|NCT00745849|530939894|FG001|First Intervention|Lost to Follow-up|1|||
147209782|NCT00745849|530939893|FG000|Second Intervention|Lost to Follow-up|2|||
147209783|NCT00745849|530939894|FG001|Second Intervention|Lost to Follow-up|1|||
147209784|NCT01754727|530939895|FG000|Overall Study|Adalimumab Treatment was not Documented|2|||
147541659|NCT02494583|532138056|FG001|Overall Study|Lost to Follow-up|0|||
147209785|NCT02338882|530939896|FG000|Overall Study|Death|1|||
147209786|NCT02338882|530939897|FG001|Overall Study|Death|0|||
147209787|NCT02338882|530939896|FG000|Overall Study|Lost to Follow-up|6|||
147209788|NCT02338882|530939897|FG001|Overall Study|Lost to Follow-up|3|||
147209789|NCT04838977|530939898|FG000|Overall Study|Lost to Follow-up|2|||
147209790|NCT04838977|530939899|FG001|Overall Study|Lost to Follow-up|3|||
147209791|NCT04838977|530939898|FG000|Overall Study|Withdrawal by Subject|1|||
147209792|NCT04838977|530939899|FG001|Overall Study|Withdrawal by Subject|1|||
147209793|NCT00265148|530939900|FG000|Overall Study|Adverse Event|2|||
147209794|NCT00265148|530939901|FG001|Overall Study|Adverse Event|2|||
147209795|NCT00265148|530939900|FG000|Overall Study|Lack of Efficacy|0|||
147209796|NCT00265148|530939901|FG001|Overall Study|Lack of Efficacy|2|||
147209797|NCT00265148|530939900|FG000|Overall Study|Protocol Violation|3|||
147209798|NCT00265148|530939901|FG001|Overall Study|Protocol Violation|2|||
147209799|NCT00265148|530939900|FG000|Overall Study|Lost to Follow-up|0|||
147209800|NCT00265148|530939901|FG001|Overall Study|Lost to Follow-up|1|||
147209801|NCT00265148|530939900|FG000|Overall Study|Withdrawal by Subject|2|||
147209802|NCT00265148|530939901|FG001|Overall Study|Withdrawal by Subject|1|||
147209803|NCT00265148|530939900|FG000|Overall Study|Physician Decision|1|||
147209804|NCT00265148|530939901|FG001|Overall Study|Physician Decision|0|||
147209805|NCT00265148|530939900|FG000|Overall Study|Increasing frailty|0|||
147209806|NCT00265148|530939901|FG001|Overall Study|Increasing frailty|1|||
147209807|NCT00265148|530939900|FG000|Overall Study|Subject chose to change of the dose|1|||
147209808|NCT00265148|530939901|FG001|Overall Study|Subject chose to change of the dose|0|||
147209809|NCT01463007|530939902|FG000|Overall Study|Physician Decision|1|||
147209810|NCT00942994|530939903|FG000|Overall Study|Adverse Event|7|||
147209811|NCT00942994|530939904|FG001|Overall Study|Adverse Event|4|||
147209812|NCT00942994|530939903|FG000|Overall Study|Abnormal laboratory value(s)|1|||
147209813|NCT00942994|530939904|FG001|Overall Study|Abnormal laboratory value(s)|0|||
147209814|NCT00942994|530939903|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
147209815|NCT00942994|530939904|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
147209816|NCT00942994|530939903|FG000|Overall Study|Patient withdrew consent|5|||
147209817|NCT00942994|530939904|FG001|Overall Study|Patient withdrew consent|8|||
147209818|NCT00942994|530939903|FG000|Overall Study|Lost to Follow-up|1|||
147209819|NCT00942994|530939904|FG001|Overall Study|Lost to Follow-up|4|||
147209820|NCT00942994|530939903|FG000|Overall Study|Protocol deviation|1|||
147209821|NCT00942994|530939904|FG001|Overall Study|Protocol deviation|2|||
147209822|NCT03583385|530939905|FG000|Treatment Period 1|Withdrawal by Subject|1|||
147209823|NCT03583385|530939906|FG001|Treatment Period 1|Withdrawal by Subject|1|||
147209824|NCT03583385|530939905|FG000|Treatment Period 2|Adverse Event|1|||
147209825|NCT03583385|530939906|FG001|Treatment Period 2|Adverse Event|0|||
147209826|NCT00095940|530939909|FG000|Lapatinib Continuation/Phase II|Disease Progression|1|||
147209827|NCT00095940|530939910|FG001|Lapatinib Continuation/Phase II|Disease Progression|1|||
147209828|NCT00095940|530939911|FG002|Lapatinib Continuation/Phase II|Disease Progression|15|||
147209829|NCT00095940|530939912|FG003|Lapatinib Continuation/Phase II|Disease Progression|0|||
147209830|NCT00095940|530939913|FG004|Lapatinib Continuation/Phase II|Disease Progression|0|||
147209831|NCT00095940|530939914|FG005|Lapatinib Continuation/Phase II|Disease Progression|13|||
147209832|NCT00095940|530939915|FG006|Lapatinib Continuation/Phase II|Disease Progression|2|||
147209833|NCT00095940|530939916|FG007|Lapatinib Continuation/Phase II|Disease Progression|1|||
147209834|NCT00095940|530939917|FG008|Lapatinib Continuation/Phase II|Disease Progression|12|||
147209835|NCT00095940|530939909|FG000|Lapatinib Continuation/Phase II|Withdrawal by Subject|1|||
147209836|NCT00095940|530939910|FG001|Lapatinib Continuation/Phase II|Withdrawal by Subject|1|||
147209837|NCT00095940|530939911|FG002|Lapatinib Continuation/Phase II|Withdrawal by Subject|1|||
147209838|NCT00095940|530939912|FG003|Lapatinib Continuation/Phase II|Withdrawal by Subject|0|||
147209839|NCT00095940|530939913|FG004|Lapatinib Continuation/Phase II|Withdrawal by Subject|0|||
147209840|NCT00095940|530939914|FG005|Lapatinib Continuation/Phase II|Withdrawal by Subject|0|||
147209841|NCT00095940|530939915|FG006|Lapatinib Continuation/Phase II|Withdrawal by Subject|0|||
147209842|NCT00095940|530939916|FG007|Lapatinib Continuation/Phase II|Withdrawal by Subject|0|||
147209843|NCT00095940|530939917|FG008|Lapatinib Continuation/Phase II|Withdrawal by Subject|1|||
147209844|NCT00095940|530939909|FG000|Lapatinib Continuation/Phase II|Adverse Event|0|||
147209845|NCT00095940|530939910|FG001|Lapatinib Continuation/Phase II|Adverse Event|0|||
147209846|NCT00095940|530939911|FG002|Lapatinib Continuation/Phase II|Adverse Event|0|||
147209847|NCT00095940|530939912|FG003|Lapatinib Continuation/Phase II|Adverse Event|0|||
147209848|NCT00095940|530939913|FG004|Lapatinib Continuation/Phase II|Adverse Event|0|||
147209849|NCT00095940|530939914|FG005|Lapatinib Continuation/Phase II|Adverse Event|0|||
147209850|NCT00095940|530939915|FG006|Lapatinib Continuation/Phase II|Adverse Event|0|||
147209851|NCT00095940|530939916|FG007|Lapatinib Continuation/Phase II|Adverse Event|1|||
147209852|NCT00095940|530939917|FG008|Lapatinib Continuation/Phase II|Adverse Event|0|||
147209853|NCT02314637|530939920|FG000|Overall Study|Adverse Event|4|||
147209854|NCT02314637|530939921|FG001|Overall Study|Adverse Event|8|||
147209855|NCT02314637|530939920|FG000|Overall Study|Lack of Efficacy|1|||
147209856|NCT02314637|530939921|FG001|Overall Study|Lack of Efficacy|0|||
147209857|NCT02314637|530939920|FG000|Overall Study|Physician Decision|5|||
147541660|NCT02494583|532138057|FG002|Overall Study|Lost to Follow-up|0|||
147541661|NCT02494583|532138055|FG000|Overall Study|Protocol Violation|1|||
147541662|NCT02494583|532138056|FG001|Overall Study|Protocol Violation|2|||
147541663|NCT02494583|532138057|FG002|Overall Study|Protocol Violation|0|||
147541664|NCT02494583|532138055|FG000|Overall Study|Screen Failure|0|||
147541665|NCT02494583|532138056|FG001|Overall Study|Screen Failure|1|||
147541666|NCT02494583|532138057|FG002|Overall Study|Screen Failure|0|||
147541667|NCT02494583|532138055|FG000|Overall Study|Transferred to Extension Study|15|||
147541668|NCT02494583|532138056|FG001|Overall Study|Transferred to Extension Study|15|||
147541669|NCT02494583|532138057|FG002|Overall Study|Transferred to Extension Study|6|||
147541670|NCT02494583|532138055|FG000|Overall Study|Did Not Continue on Extension Study|8|||
147541671|NCT02494583|532138056|FG001|Overall Study|Did Not Continue on Extension Study|10|||
147541672|NCT02494583|532138057|FG002|Overall Study|Did Not Continue on Extension Study|4|||
147541673|NCT02494583|532138055|FG000|Overall Study|Withdrawal by Subject|7|||
147541674|NCT02494583|532138056|FG001|Overall Study|Withdrawal by Subject|15|||
147541675|NCT02494583|532138057|FG002|Overall Study|Withdrawal by Subject|15|||
147541676|NCT02756078|532138062|FG000|Period 1|Unsatisfactory Lens Fitting|0|||
147541677|NCT02756078|532138063|FG001|Period 1|Unsatisfactory Lens Fitting|1|||
147541678|NCT02756078|532138062|FG000|Period 1|Lost to Follow-up|0|||
147541679|NCT02756078|532138063|FG001|Period 1|Lost to Follow-up|2|||
147541680|NCT02756078|532138062|FG000|Period 1|Protocol Violation|0|||
147541681|NCT02756078|532138063|FG001|Period 1|Protocol Violation|1|||
147541682|NCT02756078|532138062|FG000|Period 1|Adverse Event|1|||
147541683|NCT02756078|532138063|FG001|Period 1|Adverse Event|10|||
147541684|NCT02756078|532138062|FG000|Period 1|Withdrawal by Subject|6|||
147541685|NCT02756078|532138063|FG001|Period 1|Withdrawal by Subject|6|||
147541686|NCT02756078|532138062|FG000|Period 1|Lens Discomfort|2|||
147541687|NCT02756078|532138063|FG001|Period 1|Lens Discomfort|2|||
147541688|NCT02756078|532138062|FG000|Period 2|Adverse Event|3|||
147541689|NCT02756078|532138063|FG001|Period 2|Adverse Event|5|||
147209858|NCT02314637|530939921|FG001|Overall Study|Physician Decision|2|||
147209859|NCT02314637|530939920|FG000|Overall Study|Withdrawal by Subject|5|||
147209860|NCT02314637|530939921|FG001|Overall Study|Withdrawal by Subject|4|||
147209861|NCT02314637|530939920|FG000|Overall Study|Other Reason|1|||
147209862|NCT02314637|530939921|FG001|Overall Study|Other Reason|0|||
147209863|NCT02597478|530939938|FG000|Overall Study|Withdrawal by Subject|2|||
147209864|NCT02597478|530939939|FG001|Overall Study|Withdrawal by Subject|0|||
147209865|NCT02597478|530939938|FG000|Overall Study|Change of opioid dose|1|||
147209866|NCT02597478|530939939|FG001|Overall Study|Change of opioid dose|0|||
147209867|NCT02597478|530939938|FG000|Overall Study|Insufficient exertional dyspnea|0|||
147209868|NCT02597478|530939939|FG001|Overall Study|Insufficient exertional dyspnea|1|||
147209869|NCT01256190|530939941|FG000|Overall Study|Lost to Follow-up|2|||
147209870|NCT01256190|530939942|FG001|Overall Study|Lost to Follow-up|0|||
147209871|NCT02350478|530939943|FG000|Overall Study|Lost to Follow-up|5|||
147209872|NCT02350478|530939944|FG001|Overall Study|Lost to Follow-up|1|||
147209873|NCT02779556|530939945|FG000|Baseline|Partial baseline interview completed|1|||
147209874|NCT02779556|530939946|FG001|Baseline|Partial baseline interview completed|0|||
147209875|NCT02779556|530939945|FG000|3 Months|Lost to Follow-up|40|||
147209876|NCT02779556|530939946|FG001|3 Months|Lost to Follow-up|29|||
147209877|NCT02779556|530939945|FG000|3 Months|Missed 3 month clinic visit|27|||
147209878|NCT02779556|530939946|FG001|3 Months|Missed 3 month clinic visit|19|||
147209879|NCT02779556|530939945|FG000|6 Month|Lost to Follow-up|33|||
147209880|NCT02779556|530939946|FG001|6 Month|Lost to Follow-up|39|||
147209881|NCT02779556|530939945|FG000|6 Month HbA1c|No value collected during window|69|||
147209882|NCT02779556|530939946|FG001|6 Month HbA1c|No value collected during window|50|||
147209883|NCT02779556|530939945|FG000|12 Month HbA1c|No value collected during window|138|||
147209884|NCT02779556|530939946|FG001|12 Month HbA1c|No value collected during window|102|||
147209885|NCT03110770|530939948|FG000|Overall Study|Death|1|||
147209886|NCT03110770|530939949|FG001|Overall Study|Death|0|||
147209887|NCT03110770|530939950|FG002|Overall Study|Death|0|||
147209888|NCT03110770|530939951|FG003|Overall Study|Death|1|||
147209889|NCT03110770|530939952|FG004|Overall Study|Death|0|||
147209890|NCT03110770|530939948|FG000|Overall Study|Enrolled but did not receive product|0|||
147209891|NCT03110770|530939949|FG001|Overall Study|Enrolled but did not receive product|0|||
147209892|NCT03110770|530939950|FG002|Overall Study|Enrolled but did not receive product|0|||
147209893|NCT03110770|530939951|FG003|Overall Study|Enrolled but did not receive product|8|||
147209894|NCT03110770|530939952|FG004|Overall Study|Enrolled but did not receive product|7|||
147209895|NCT03110770|530939948|FG000|Overall Study|Lost to Follow-up|0|||
147541690|NCT02756078|532138062|FG000|Period 2|Unsatisfactory Lens Fitting|0|||
147541691|NCT02756078|532138063|FG001|Period 2|Unsatisfactory Lens Fitting|1|||
147541692|NCT02756078|532138062|FG000|Period 2|Withdrawal by Subject|3|||
147541693|NCT02756078|532138063|FG001|Period 2|Withdrawal by Subject|1|||
147541694|NCT02268045|532138064|FG000|Overall Study|Death|4|||
147541695|NCT02268045|532138065|FG001|Overall Study|Death|4|||
147541696|NCT02268045|532138064|FG000|Overall Study|Disease Progression|2|||
147541697|NCT02268045|532138065|FG001|Overall Study|Disease Progression|1|||
147541698|NCT02268045|532138064|FG000|Overall Study|Adverse Event|7|||
147541699|NCT02268045|532138065|FG001|Overall Study|Adverse Event|7|||
147209896|NCT03110770|530939949|FG001|Overall Study|Lost to Follow-up|0|||
147209897|NCT03110770|530939950|FG002|Overall Study|Lost to Follow-up|0|||
147209898|NCT03110770|530939951|FG003|Overall Study|Lost to Follow-up|53|||
147209899|NCT03110770|530939952|FG004|Overall Study|Lost to Follow-up|45|||
147541700|NCT02268045|532138064|FG000|Overall Study|Withdrawal by Subject|2|||
147541701|NCT02268045|532138065|FG001|Overall Study|Withdrawal by Subject|6|||
147541702|NCT02268045|532138064|FG000|Overall Study|Physician Decision|0|||
147541703|NCT02268045|532138065|FG001|Overall Study|Physician Decision|1|||
147541704|NCT02268045|532138064|FG000|Overall Study|Protocol Violation|1|||
147541705|NCT02268045|532138065|FG001|Overall Study|Protocol Violation|1|||
147541706|NCT03332212|532138068|FG000|Overall Study|Not treated|0|||
147541707|NCT03332212|532138069|FG001|Overall Study|Not treated|1|||
147541708|NCT03332212|532138070|FG002|Overall Study|Not treated|0|||
147541709|NCT03332212|532138071|FG003|Overall Study|Not treated|0|||
147541710|NCT03332212|532138068|FG000|Overall Study|Adverse Event|0|||
147541711|NCT03332212|532138069|FG001|Overall Study|Adverse Event|0|||
147541712|NCT03332212|532138070|FG002|Overall Study|Adverse Event|0|||
147541713|NCT03332212|532138071|FG003|Overall Study|Adverse Event|1|||
147541714|NCT03332212|532138068|FG000|Overall Study|worsening of disease under study|1|||
147541715|NCT03332212|532138069|FG001|Overall Study|worsening of disease under study|1|||
147541716|NCT03332212|532138070|FG002|Overall Study|worsening of disease under study|0|||
147541717|NCT03332212|532138071|FG003|Overall Study|worsening of disease under study|0|||
147541718|NCT02125734|532138075|FG000|Period 2|Adverse Event|0|||
147541719|NCT02125734|532138076|FG001|Period 2|Adverse Event|1|||
147541720|NCT01308762|532138077|FG000|Overall Study|Protocol Violation|0|||
147541721|NCT01308762|532138078|FG001|Overall Study|Protocol Violation|1|||
147541722|NCT01308762|532138079|FG002|Overall Study|Protocol Violation|0|||
147541723|NCT02617446|532138080|FG000|Overall Study|Withdrawal by Subject|0|||
147541724|NCT02617446|532138081|FG001|Overall Study|Withdrawal by Subject|2|||
147541725|NCT02617446|532138082|FG002|Overall Study|Withdrawal by Subject|0|||
147541726|NCT02617446|532138080|FG000|Overall Study|Adverse Event|1|||
147541727|NCT02617446|532138081|FG001|Overall Study|Adverse Event|0|||
147541728|NCT02617446|532138082|FG002|Overall Study|Adverse Event|5|||
147541729|NCT02617446|532138080|FG000|Overall Study|Lost to Follow-up|3|||
147541730|NCT02617446|532138081|FG001|Overall Study|Lost to Follow-up|0|||
147541731|NCT02617446|532138082|FG002|Overall Study|Lost to Follow-up|0|||
147541732|NCT02617446|532138080|FG000|Overall Study|Death|0|||
147541733|NCT02617446|532138081|FG001|Overall Study|Death|0|||
147541734|NCT02617446|532138082|FG002|Overall Study|Death|2|||
147541735|NCT01556490|532138091|FG000|Randomized Patients Summary|Protocol Violation|22|||
147541736|NCT01556490|532138092|FG001|Randomized Patients Summary|Protocol Violation|23|||
147541737|NCT01556490|532138091|FG000|Overall Survival (OS)|Untreated Patients who Discontinued/Completed from Study|12|||
147541738|NCT01556490|532138092|FG001|Overall Survival (OS)|Untreated Patients who Discontinued/Completed from Study|18|||
147541739|NCT02058368|532138093|FG000|Overall Study|Adverse Event|15|||
147541740|NCT02058368|532138094|FG001|Overall Study|Adverse Event|20|||
147541741|NCT02058368|532138093|FG000|Overall Study|Lack of Efficacy|0|||
147541742|NCT02058368|532138094|FG001|Overall Study|Lack of Efficacy|1|||
147541743|NCT02058368|532138093|FG000|Overall Study|Protocol Violation|0|||
147541744|NCT02058368|532138094|FG001|Overall Study|Protocol Violation|4|||
147541745|NCT02058368|532138093|FG000|Overall Study|Lost to Follow-up|2|||
147541746|NCT02058368|532138094|FG001|Overall Study|Lost to Follow-up|0|||
147541747|NCT02058368|532138093|FG000|Overall Study|Physician Decision|2|||
147541748|NCT02058368|532138094|FG001|Overall Study|Physician Decision|3|||
147541749|NCT02058368|532138093|FG000|Overall Study|Withdrawal by Subject|22|||
147541750|NCT02058368|532138094|FG001|Overall Study|Withdrawal by Subject|26|||
147541751|NCT01652872|532138095|FG000|Overall Study|Death|36|||
147541752|NCT01652872|532138096|FG001|Overall Study|Death|39|||
147541753|NCT01652872|532138095|FG000|Overall Study|Lost to Follow-up|28|||
147541754|NCT01652872|532138096|FG001|Overall Study|Lost to Follow-up|23|||
147541755|NCT01652872|532138095|FG000|Overall Study|Decision by sponsor|5|||
147541756|NCT01652872|532138096|FG001|Overall Study|Decision by sponsor|7|||
147541757|NCT01652872|532138095|FG000|Overall Study|Withdrawal by Subject|76|||
147541758|NCT01652872|532138096|FG001|Overall Study|Withdrawal by Subject|84|||
147541759|NCT03985293|532138099|FG000|DOUBLE-BLIND TREATMENT|Adverse Event|5|||
147541760|NCT03985293|532138100|FG001|DOUBLE-BLIND TREATMENT|Adverse Event|2|||
147541761|NCT03985293|532138101|FG002|DOUBLE-BLIND TREATMENT|Adverse Event|3|||
147541762|NCT03985293|532138102|FG003|DOUBLE-BLIND TREATMENT|Adverse Event|8|||
147541763|NCT03985293|532138103|FG004|DOUBLE-BLIND TREATMENT|Adverse Event|15|||
147541764|NCT03985293|532138104|FG005|DOUBLE-BLIND TREATMENT|Adverse Event|24|||
147541765|NCT03985293|532138099|FG000|DOUBLE-BLIND TREATMENT|Lost to Follow-up|1|||
147541766|NCT03985293|532138100|FG001|DOUBLE-BLIND TREATMENT|Lost to Follow-up|3|||
147541767|NCT03985293|532138101|FG002|DOUBLE-BLIND TREATMENT|Lost to Follow-up|0|||
147541768|NCT03985293|532138102|FG003|DOUBLE-BLIND TREATMENT|Lost to Follow-up|3|||
147541769|NCT03985293|532138103|FG004|DOUBLE-BLIND TREATMENT|Lost to Follow-up|3|||
147541770|NCT03985293|532138104|FG005|DOUBLE-BLIND TREATMENT|Lost to Follow-up|1|||
147541771|NCT03985293|532138099|FG000|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|1|||
147541772|NCT03985293|532138100|FG001|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|1|||
147541773|NCT03985293|532138101|FG002|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|0|||
147541774|NCT03985293|532138102|FG003|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|1|||
147541775|NCT03985293|532138103|FG004|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|0|||
147541776|NCT03985293|532138104|FG005|DOUBLE-BLIND TREATMENT|No Longer Meets Eligibility Criteria|0|||
147541777|NCT03985293|532138099|FG000|DOUBLE-BLIND TREATMENT|Other|1|||
147541778|NCT03985293|532138100|FG001|DOUBLE-BLIND TREATMENT|Other|2|||
147541779|NCT03985293|532138101|FG002|DOUBLE-BLIND TREATMENT|Other|0|||
147541780|NCT03985293|532138102|FG003|DOUBLE-BLIND TREATMENT|Other|2|||
147541781|NCT03985293|532138103|FG004|DOUBLE-BLIND TREATMENT|Other|1|||
147541782|NCT03985293|532138104|FG005|DOUBLE-BLIND TREATMENT|Other|0|||
147541783|NCT03985293|532138099|FG000|DOUBLE-BLIND TREATMENT|Protocol Violation|1|||
147541784|NCT03985293|532138100|FG001|DOUBLE-BLIND TREATMENT|Protocol Violation|2|||
147541785|NCT03985293|532138101|FG002|DOUBLE-BLIND TREATMENT|Protocol Violation|0|||
147541786|NCT03985293|532138102|FG003|DOUBLE-BLIND TREATMENT|Protocol Violation|0|||
147541787|NCT03985293|532138103|FG004|DOUBLE-BLIND TREATMENT|Protocol Violation|0|||
147541788|NCT03985293|532138104|FG005|DOUBLE-BLIND TREATMENT|Protocol Violation|1|||
147541789|NCT03985293|532138099|FG000|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|0|||
147541790|NCT03985293|532138100|FG001|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|4|||
147541791|NCT03985293|532138101|FG002|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|2|||
147541792|NCT03985293|532138102|FG003|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|0|||
147541793|NCT03985293|532138103|FG004|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|1|||
147541794|NCT03985293|532138104|FG005|DOUBLE-BLIND TREATMENT|Withdrawal by Subject|7|||
147541795|NCT03985293|532138099|FG000|FOLLOW-UP|Lost to Follow-up|0|||
147541796|NCT03985293|532138100|FG001|FOLLOW-UP|Lost to Follow-up|0|||
147541797|NCT03985293|532138101|FG002|FOLLOW-UP|Lost to Follow-up|1|||
147541798|NCT03985293|532138102|FG003|FOLLOW-UP|Lost to Follow-up|0|||
147541799|NCT03985293|532138103|FG004|FOLLOW-UP|Lost to Follow-up|0|||
147541800|NCT03985293|532138104|FG005|FOLLOW-UP|Lost to Follow-up|0|||
147541801|NCT03107715|532138105|FG000|Overall Study|did not deliver at the home hospital|4|||
147541802|NCT03107715|532138106|FG001|Overall Study|did not deliver at the home hospital|6|||
147541803|NCT03107715|532138105|FG000|Overall Study|infant stillborn|0|||
147541804|NCT03107715|532138106|FG001|Overall Study|infant stillborn|1|||
147209900|NCT03110770|530939948|FG000|Overall Study|Investigator Decision|0|||
147209901|NCT03110770|530939949|FG001|Overall Study|Investigator Decision|0|||
147209902|NCT03110770|530939950|FG002|Overall Study|Investigator Decision|0|||
147209903|NCT03110770|530939951|FG003|Overall Study|Investigator Decision|5|||
147209904|NCT03110770|530939952|FG004|Overall Study|Investigator Decision|3|||
147209905|NCT03110770|530939948|FG000|Overall Study|Withdrawal by Subject|0|||
147209906|NCT03110770|530939949|FG001|Overall Study|Withdrawal by Subject|0|||
147209907|NCT03110770|530939950|FG002|Overall Study|Withdrawal by Subject|0|||
147209908|NCT03110770|530939951|FG003|Overall Study|Withdrawal by Subject|24|||
147209909|NCT03110770|530939952|FG004|Overall Study|Withdrawal by Subject|24|||
147209910|NCT03110770|530939948|FG000|Overall Study|Moved from area|5|||
147209911|NCT03110770|530939949|FG001|Overall Study|Moved from area|0|||
147209912|NCT03110770|530939950|FG002|Overall Study|Moved from area|2|||
147209913|NCT03110770|530939951|FG003|Overall Study|Moved from area|42|||
147209914|NCT03110770|530939952|FG004|Overall Study|Moved from area|43|||
147209915|NCT03110770|530939948|FG000|Overall Study|Illness/Injury unrelated to product|0|||
147209916|NCT03110770|530939949|FG001|Overall Study|Illness/Injury unrelated to product|0|||
147209917|NCT03110770|530939950|FG002|Overall Study|Illness/Injury unrelated to product|0|||
147209918|NCT03110770|530939951|FG003|Overall Study|Illness/Injury unrelated to product|0|||
147209919|NCT03110770|530939952|FG004|Overall Study|Illness/Injury unrelated to product|1|||
147209920|NCT01667419|530939953|FG000|Overall Study|Reason Not Specified|1|||
147209921|NCT01667419|530939954|FG001|Overall Study|Reason Not Specified|0|||
147209922|NCT01667419|530939955|FG002|Overall Study|Reason Not Specified|0|||
147209923|NCT01667419|530939956|FG003|Overall Study|Reason Not Specified|0|||
147209924|NCT01667419|530939953|FG000|Overall Study|Withdrawal by Subject|16|||
147209925|NCT01667419|530939954|FG001|Overall Study|Withdrawal by Subject|8|||
147209926|NCT01667419|530939955|FG002|Overall Study|Withdrawal by Subject|9|||
147209927|NCT01667419|530939956|FG003|Overall Study|Withdrawal by Subject|8|||
147209928|NCT01667419|530939953|FG000|Overall Study|Non-compliance|0|||
147209929|NCT01667419|530939954|FG001|Overall Study|Non-compliance|0|||
147209930|NCT01667419|530939955|FG002|Overall Study|Non-compliance|0|||
147209931|NCT01667419|530939956|FG003|Overall Study|Non-compliance|1|||
147209932|NCT01667419|530939953|FG000|Overall Study|Protocol Violation|1|||
147209933|NCT01667419|530939954|FG001|Overall Study|Protocol Violation|0|||
147209934|NCT01667419|530939955|FG002|Overall Study|Protocol Violation|0|||
147209935|NCT01667419|530939956|FG003|Overall Study|Protocol Violation|0|||
147209936|NCT01667419|530939953|FG000|Overall Study|Lost to Follow-up|7|||
147209937|NCT01667419|530939954|FG001|Overall Study|Lost to Follow-up|6|||
147209938|NCT01667419|530939955|FG002|Overall Study|Lost to Follow-up|2|||
147209939|NCT01667419|530939956|FG003|Overall Study|Lost to Follow-up|4|||
147209940|NCT01667419|530939953|FG000|Overall Study|Death|18|||
147209941|NCT01667419|530939954|FG001|Overall Study|Death|33|||
147209942|NCT01667419|530939955|FG002|Overall Study|Death|25|||
147541805|NCT01907516|532138107|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|5|||
147541806|NCT01907516|532138108|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|9|||
147209943|NCT01667419|530939956|FG003|Overall Study|Death|26|||
147209944|NCT00856518|530939957|FG000|Overall Study|Lost to Follow-up|4|||
147209945|NCT00856518|530939958|FG001|Overall Study|Lost to Follow-up|2|||
147209946|NCT02082340|530939960|FG000|Overall Study|Lost to Follow-up|1|||
147209947|NCT02082340|530939961|FG001|Overall Study|Lost to Follow-up|1|||
147209948|NCT02644109|530939968|FG000|Overall Study|Adverse Event|0|||
147209949|NCT02644109|530939969|FG001|Overall Study|Adverse Event|4|||
147209950|NCT04195893|530939972|FG000|Second Intervention|Withdrawal by Subject|1|||
147209951|NCT04195893|530939973|FG001|Second Intervention|Withdrawal by Subject|0|||
147209952|NCT00918736|530939976|FG000|Overall Study|Withdrawal by Subject|4|||
147209953|NCT01942733|530939977|FG000|Overall Study|Lost to Follow-up|1|||
147209954|NCT01942733|530939977|FG000|Overall Study|Non-compliance with IMP|1|||
147209955|NCT01942733|530939977|FG000|Overall Study|Administrative|1|||
147209956|NCT04080167|530939981|FG000|Overall Study|Lost to Follow-up-Patients|7|||
147209957|NCT04080167|530939982|FG001|Overall Study|Lost to Follow-up-Patients|14|||
147541807|NCT01907516|532138107|FG000|First Intervention (3 Weeks)|Lost to Follow-up|1|||
147541808|NCT01907516|532138108|FG001|First Intervention (3 Weeks)|Lost to Follow-up|3|||
147541809|NCT01907516|532138107|FG000|First Intervention (3 Weeks)|Delivered before second arm|3|||
147541810|NCT01907516|532138108|FG001|First Intervention (3 Weeks)|Delivered before second arm|4|||
147209958|NCT04080167|530939983|FG002|Overall Study|Lost to Follow-up-Patients|0|||
147209959|NCT04080167|530939981|FG000|Overall Study|Lost to Follow-up-Providers|2|||
147209960|NCT04080167|530939982|FG001|Overall Study|Lost to Follow-up-Providers|2|||
147209961|NCT04080167|530939983|FG002|Overall Study|Lost to Follow-up-Providers|0|||
147209962|NCT04080167|530939981|FG000|Overall Study|Withdrawal by Subject|1|||
147209963|NCT04080167|530939982|FG001|Overall Study|Withdrawal by Subject|2|||
147209964|NCT04080167|530939983|FG002|Overall Study|Withdrawal by Subject|0|||
147209965|NCT04080167|530939981|FG000|Overall Study|Withdrawal by Provider|0|||
147209966|NCT04080167|530939982|FG001|Overall Study|Withdrawal by Provider|0|||
147209967|NCT04080167|530939983|FG002|Overall Study|Withdrawal by Provider|4|||
147209968|NCT04080167|530939981|FG000|Overall Study|Death-Patient|2|||
147209969|NCT04080167|530939982|FG001|Overall Study|Death-Patient|1|||
147209970|NCT04080167|530939983|FG002|Overall Study|Death-Patient|0|||
147209971|NCT04080167|530939981|FG000|Overall Study|Hydroxyurea New Starts|0|||
147209972|NCT04080167|530939982|FG001|Overall Study|Hydroxyurea New Starts|0|||
147209973|NCT04080167|530939983|FG002|Overall Study|Hydroxyurea New Starts|1|||
147209974|NCT04080167|530939981|FG000|Overall Study|Did not complete the baseline survey/activities|0|||
147209975|NCT04080167|530939982|FG001|Overall Study|Did not complete the baseline survey/activities|4|||
147209976|NCT04080167|530939983|FG002|Overall Study|Did not complete the baseline survey/activities|0|||
147209977|NCT02167139|530939984|FG000|Randomised, Double-blind|Withdrawal by Subject|11|||
147209978|NCT02167139|530939985|FG001|Randomised, Double-blind|Withdrawal by Subject|8|||
147209979|NCT02167139|530939986|FG002|Randomised, Double-blind|Withdrawal by Subject|0|||
147209980|NCT02167139|530939987|FG003|Randomised, Double-blind|Withdrawal by Subject|0|||
147209981|NCT02167139|530939984|FG000|Randomised, Double-blind|Adverse Event|2|||
147209982|NCT02167139|530939985|FG001|Randomised, Double-blind|Adverse Event|9|||
147209983|NCT02167139|530939986|FG002|Randomised, Double-blind|Adverse Event|0|||
147209984|NCT02167139|530939987|FG003|Randomised, Double-blind|Adverse Event|0|||
147209985|NCT02167139|530939984|FG000|Randomised, Double-blind|Lack of Efficacy|1|||
147209986|NCT02167139|530939985|FG001|Randomised, Double-blind|Lack of Efficacy|2|||
147209987|NCT02167139|530939986|FG002|Randomised, Double-blind|Lack of Efficacy|0|||
147209988|NCT02167139|530939987|FG003|Randomised, Double-blind|Lack of Efficacy|0|||
147209989|NCT02167139|530939984|FG000|Randomised, Double-blind|Other|3|||
147209990|NCT02167139|530939985|FG001|Randomised, Double-blind|Other|0|||
147209991|NCT02167139|530939986|FG002|Randomised, Double-blind|Other|0|||
147209992|NCT02167139|530939987|FG003|Randomised, Double-blind|Other|0|||
147209993|NCT02167139|530939984|FG000|Transition-extension|Adverse Event|2|||
147209994|NCT02167139|530939985|FG001|Transition-extension|Adverse Event|0|||
147209995|NCT02167139|530939986|FG002|Transition-extension|Adverse Event|2|||
147209996|NCT02167139|530939987|FG003|Transition-extension|Adverse Event|3|||
147209997|NCT02167139|530939984|FG000|Transition-extension|Withdrawal by Subject|2|||
147209998|NCT02167139|530939985|FG001|Transition-extension|Withdrawal by Subject|0|||
147209999|NCT02167139|530939986|FG002|Transition-extension|Withdrawal by Subject|4|||
147210000|NCT02167139|530939987|FG003|Transition-extension|Withdrawal by Subject|1|||
147210001|NCT02167139|530939984|FG000|Transition-extension|Lack of Efficacy|0|||
147210002|NCT02167139|530939985|FG001|Transition-extension|Lack of Efficacy|0|||
147541811|NCT01907516|532138107|FG000|First Intervention (3 Weeks)|Developed DKA during study|1|||
147541812|NCT01907516|532138108|FG001|First Intervention (3 Weeks)|Developed DKA during study|0|||
147210003|NCT02167139|530939986|FG002|Transition-extension|Lack of Efficacy|1|||
147210004|NCT02167139|530939987|FG003|Transition-extension|Lack of Efficacy|1|||
147210005|NCT02167139|530939984|FG000|Transition-extension|Other|1|||
147210006|NCT02167139|530939985|FG001|Transition-extension|Other|0|||
147210007|NCT02167139|530939986|FG002|Transition-extension|Other|1|||
147210008|NCT02167139|530939987|FG003|Transition-extension|Other|0|||
147210009|NCT02167139|530939984|FG000|Transition-extension|Lost to Follow-up|1|||
147210010|NCT02167139|530939985|FG001|Transition-extension|Lost to Follow-up|0|||
147541813|NCT01901146|532140481|FG000|Neoadjuvant Phase|Death|1|||
147210011|NCT02167139|530939986|FG002|Transition-extension|Lost to Follow-up|0|||
147210012|NCT02167139|530939987|FG003|Transition-extension|Lost to Follow-up|0|||
147210013|NCT00984620|530939990|FG000|Overall Study|Adverse Event|5|||
147210014|NCT00984620|530939991|FG001|Overall Study|Adverse Event|5|||
147210015|NCT00984620|530939990|FG000|Overall Study|Lost to Follow-up|1|||
147210016|NCT00984620|530939991|FG001|Overall Study|Lost to Follow-up|1|||
147210017|NCT00984620|530939990|FG000|Overall Study|Withdrawal by Subject|0|||
147210018|NCT00984620|530939991|FG001|Overall Study|Withdrawal by Subject|2|||
147210019|NCT00984620|530939990|FG000|Overall Study|reason other than listed above|0|||
147210020|NCT00984620|530939991|FG001|Overall Study|reason other than listed above|4|||
147210021|NCT00324961|530939995|FG000|Overall Study|Adverse Event|5|||
147210022|NCT00324961|530939995|FG000|Overall Study|Consent Withdrawn|11|||
147210023|NCT00324961|530939995|FG000|Overall Study|Lost to Follow-up|22|||
147210024|NCT00324961|530939995|FG000|Overall Study|Protocol Violation|3|||
147210025|NCT00324961|530939995|FG000|Overall Study|Other|2|||
147210026|NCT00344487|530939996|FG000|Overall Study|immunologic failure|1|||
147210027|NCT02791763|530940000|FG000|Overall Study|Protocol Violation|0|||
147210028|NCT02791763|530940001|FG001|Overall Study|Protocol Violation|0|||
147210029|NCT02791763|530940002|FG002|Overall Study|Protocol Violation|1|||
147210030|NCT02791763|530940000|FG000|Overall Study|Withdrawal by Subject|5|||
147210031|NCT02791763|530940001|FG001|Overall Study|Withdrawal by Subject|1|||
147210032|NCT02791763|530940002|FG002|Overall Study|Withdrawal by Subject|0|||
147210033|NCT02791763|530940000|FG000|Overall Study|Physician Decision|0|||
147210034|NCT02791763|530940001|FG001|Overall Study|Physician Decision|1|||
147210035|NCT02791763|530940002|FG002|Overall Study|Physician Decision|0|||
147210036|NCT02791763|530940000|FG000|Overall Study|Needs maintenance/changes in dialysis|16|||
147210037|NCT02791763|530940001|FG001|Overall Study|Needs maintenance/changes in dialysis|19|||
147210038|NCT02791763|530940002|FG002|Overall Study|Needs maintenance/changes in dialysis|5|||
147210039|NCT02791763|530940000|FG000|Overall Study|Cancer event|1|||
147210040|NCT02791763|530940001|FG001|Overall Study|Cancer event|3|||
147210041|NCT02791763|530940002|FG002|Overall Study|Cancer event|0|||
147210042|NCT02791763|530940000|FG000|Overall Study|Participant had renal transplant|3|||
147440110|NCT00382720|531777512|FG000|Overall Study|Investigator/Clinical decision|5|||
147210043|NCT02791763|530940001|FG001|Overall Study|Participant had renal transplant|0|||
147210044|NCT02791763|530940002|FG002|Overall Study|Participant had renal transplant|0|||
147210045|NCT02791763|530940000|FG000|Overall Study|Met hemoglobin stopping criteria|1|||
147210046|NCT02791763|530940001|FG001|Overall Study|Met hemoglobin stopping criteria|0|||
147210047|NCT02791763|530940002|FG002|Overall Study|Met hemoglobin stopping criteria|0|||
147210048|NCT02791763|530940000|FG000|Overall Study|Adverse Event|12|||
147210049|NCT02791763|530940001|FG001|Overall Study|Adverse Event|13|||
147210050|NCT02791763|530940002|FG002|Overall Study|Adverse Event|7|||
147210051|NCT01456897|530940005|FG000|Overall Study|Adverse Event|19|||
147210052|NCT01456897|530940006|FG001|Overall Study|Adverse Event|22|||
147210053|NCT01456897|530940005|FG000|Overall Study|Protocol Violation|3|||
147210054|NCT01456897|530940006|FG001|Overall Study|Protocol Violation|4|||
147210055|NCT01456897|530940005|FG000|Overall Study|Physician Decision|5|||
147210056|NCT01456897|530940006|FG001|Overall Study|Physician Decision|3|||
147210057|NCT01456897|530940005|FG000|Overall Study|Withdrawal by Subject|44|||
147210058|NCT01456897|530940006|FG001|Overall Study|Withdrawal by Subject|17|||
147210059|NCT01456897|530940005|FG000|Overall Study|Lack of Efficacy|4|||
147440111|NCT00382720|531777513|FG001|Overall Study|Investigator/Clinical decision|6|||
147440112|NCT00382720|531777514|FG002|Overall Study|Investigator/Clinical decision|6|||
147440113|NCT00382720|531777512|FG000|Overall Study|Discontinued at end of study|0|||
147440114|NCT00382720|531777513|FG001|Overall Study|Discontinued at end of study|1|||
147440115|NCT00382720|531777514|FG002|Overall Study|Discontinued at end of study|2|||
147440116|NCT02737852|531777517|FG000|Overall Study|Withdrawal by Subject|2|||
147440117|NCT01183143|531777518|FG000|Overall Study|Protocol Violation|115|||
147440118|NCT01183143|531777518|FG000|Overall Study|Withdrawal by Subject|19|||
147440119|NCT01183143|531777518|FG000|Overall Study|Subject Questionnaires not returned|5|||
147440120|NCT01183143|531777518|FG000|Overall Study|Subjects enrolled, but not treated|11|||
147440121|NCT04042740|531777520|FG000|Step 1 (4-week G/P + 24-week Follow-up)|Lost to Follow-up|2|||
147440122|NCT04042740|531777520|FG000|Step 1 (4-week G/P + 24-week Follow-up)|Withdrawal by Subject|1|||
147440123|NCT01717287|531777521|FG000|Overall Study|Lost to Follow-up|0|||
147210060|NCT01456897|530940006|FG001|Overall Study|Lack of Efficacy|11|||
147210061|NCT01396070|530940008|FG000|Overall Study|Withdrawal by Subject|2|||
147210062|NCT01396070|530940008|FG000|Overall Study|Death|2|||
147210063|NCT01396070|530940008|FG000|Overall Study|Adverse Event|8|||
147210064|NCT01396070|530940008|FG000|Overall Study|Physician Decision|3|||
147210065|NCT01396070|530940008|FG000|Overall Study|Lack of Efficacy|4|||
147210066|NCT04254913|530940009|FG000|Overall Study|Adverse Event|1|||
147210067|NCT01396057|530940010|FG000|Overall Study|Adverse Event|2|||
147210068|NCT01396057|530940011|FG001|Overall Study|Adverse Event|6|||
147440124|NCT01717287|531777522|FG001|Overall Study|Lost to Follow-up|2|||
147440125|NCT01717287|531777521|FG000|Overall Study|Protocol Violation|0|||
147440126|NCT01717287|531777522|FG001|Overall Study|Protocol Violation|1|||
147210069|NCT01396057|530940010|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
147210070|NCT01396057|530940011|FG001|Overall Study|Unsatisfactory therapeutic effect|6|||
147210071|NCT01396057|530940010|FG000|Overall Study|Protocol deviation|4|||
147210072|NCT01396057|530940011|FG001|Overall Study|Protocol deviation|4|||
147210073|NCT01396057|530940010|FG000|Overall Study|Consent withdrawn|3|||
147210074|NCT01396057|530940011|FG001|Overall Study|Consent withdrawn|2|||
147210075|NCT01742286|530940012|FG000|Escalation Phase|Administrative problems|1|||
147210076|NCT01742286|530940013|FG001|Escalation Phase|Administrative problems|1|||
147210077|NCT01742286|530940014|FG002|Escalation Phase|Administrative problems|0|||
147210078|NCT01742286|530940015|FG003|Escalation Phase|Administrative problems|0|||
147210079|NCT01742286|530940016|FG004|Escalation Phase|Administrative problems|0|||
147210080|NCT01742286|530940017|FG005|Escalation Phase|Administrative problems|0|||
147210081|NCT01742286|530940018|FG006|Escalation Phase|Administrative problems|2|||
147210082|NCT01742286|530940012|FG000|Escalation Phase|Adverse Event|0|||
147210083|NCT01742286|530940013|FG001|Escalation Phase|Adverse Event|1|||
147210084|NCT01742286|530940014|FG002|Escalation Phase|Adverse Event|2|||
147210085|NCT01742286|530940015|FG003|Escalation Phase|Adverse Event|0|||
147210086|NCT01742286|530940016|FG004|Escalation Phase|Adverse Event|0|||
147210087|NCT01742286|530940017|FG005|Escalation Phase|Adverse Event|1|||
147210088|NCT01742286|530940018|FG006|Escalation Phase|Adverse Event|0|||
147210089|NCT01742286|530940012|FG000|Escalation Phase|Disease progression|3|||
147210090|NCT01742286|530940013|FG001|Escalation Phase|Disease progression|7|||
147210091|NCT01742286|530940014|FG002|Escalation Phase|Disease progression|4|||
147210092|NCT01742286|530940015|FG003|Escalation Phase|Disease progression|1|||
147210093|NCT01742286|530940016|FG004|Escalation Phase|Disease progression|4|||
147210094|NCT01742286|530940017|FG005|Escalation Phase|Disease progression|3|||
147210095|NCT01742286|530940018|FG006|Escalation Phase|Disease progression|2|||
147210096|NCT01742286|530940012|FG000|Escalation Phase|Death|0|||
147210097|NCT01742286|530940013|FG001|Escalation Phase|Death|0|||
147210098|NCT01742286|530940014|FG002|Escalation Phase|Death|0|||
147210099|NCT01742286|530940015|FG003|Escalation Phase|Death|0|||
147210100|NCT01742286|530940016|FG004|Escalation Phase|Death|0|||
147210101|NCT01742286|530940017|FG005|Escalation Phase|Death|1|||
147210102|NCT01742286|530940018|FG006|Escalation Phase|Death|0|||
147210103|NCT01742286|530940012|FG000|Escalation Phase|Physician Decision|0|||
147210104|NCT01742286|530940013|FG001|Escalation Phase|Physician Decision|3|||
147210105|NCT01742286|530940014|FG002|Escalation Phase|Physician Decision|0|||
147210106|NCT01742286|530940015|FG003|Escalation Phase|Physician Decision|1|||
147210107|NCT01742286|530940016|FG004|Escalation Phase|Physician Decision|0|||
147210108|NCT01742286|530940017|FG005|Escalation Phase|Physician Decision|0|||
147210109|NCT01742286|530940018|FG006|Escalation Phase|Physician Decision|2|||
147210110|NCT01742286|530940012|FG000|Escalation Phase|Subject/guardian decision|1|||
147210111|NCT01742286|530940013|FG001|Escalation Phase|Subject/guardian decision|0|||
147210112|NCT01742286|530940014|FG002|Escalation Phase|Subject/guardian decision|0|||
147210113|NCT01742286|530940015|FG003|Escalation Phase|Subject/guardian decision|0|||
147210114|NCT01742286|530940016|FG004|Escalation Phase|Subject/guardian decision|0|||
147210115|NCT01742286|530940017|FG005|Escalation Phase|Subject/guardian decision|0|||
147210116|NCT01742286|530940018|FG006|Escalation Phase|Subject/guardian decision|0|||
147210117|NCT01742286|530940012|FG000|Expansion Phase|Administrative problems|0|||
147210118|NCT01742286|530940013|FG001|Expansion Phase|Administrative problems|0|||
147210119|NCT01742286|530940014|FG002|Expansion Phase|Administrative problems|0|||
147210120|NCT01742286|530940015|FG003|Expansion Phase|Administrative problems|0|||
147210121|NCT01742286|530940016|FG004|Expansion Phase|Administrative problems|0|||
147210122|NCT01742286|530940017|FG005|Expansion Phase|Administrative problems|0|||
147210123|NCT01742286|530940018|FG006|Expansion Phase|Administrative problems|5|||
147210124|NCT01742286|530940012|FG000|Expansion Phase|Physician Decision|0|||
147210125|NCT01742286|530940013|FG001|Expansion Phase|Physician Decision|0|||
147210126|NCT01742286|530940014|FG002|Expansion Phase|Physician Decision|4|||
147210127|NCT01742286|530940015|FG003|Expansion Phase|Physician Decision|0|||
147440127|NCT04490395|531777523|FG000|Overall Study|Lost to Follow-up|0|||
147440128|NCT04490395|531777524|FG001|Overall Study|Lost to Follow-up|1|||
147440129|NCT05092919|531777527|FG000|Overall Study|Lost to Follow-up|7|||
147440130|NCT05092919|531777527|FG000|Overall Study|Withdrawal by Subject|2|||
147210128|NCT01742286|530940016|FG004|Expansion Phase|Physician Decision|0|||
147210129|NCT01742286|530940017|FG005|Expansion Phase|Physician Decision|0|||
147210130|NCT01742286|530940018|FG006|Expansion Phase|Physician Decision|9|||
147210131|NCT01742286|530940012|FG000|Expansion Phase|Adverse Event|0|||
147210132|NCT01742286|530940013|FG001|Expansion Phase|Adverse Event|0|||
147210133|NCT01742286|530940014|FG002|Expansion Phase|Adverse Event|0|||
147210134|NCT01742286|530940015|FG003|Expansion Phase|Adverse Event|0|||
147210135|NCT01742286|530940016|FG004|Expansion Phase|Adverse Event|0|||
147210136|NCT01742286|530940017|FG005|Expansion Phase|Adverse Event|0|||
147210137|NCT01742286|530940018|FG006|Expansion Phase|Adverse Event|6|||
147210138|NCT01742286|530940012|FG000|Expansion Phase|Disease progression|0|||
147210139|NCT01742286|530940013|FG001|Expansion Phase|Disease progression|0|||
147210140|NCT01742286|530940014|FG002|Expansion Phase|Disease progression|3|||
147440131|NCT01942148|531777528|FG000|Overall Study|Adverse Event|4|||
147210141|NCT01742286|530940015|FG003|Expansion Phase|Disease progression|0|||
147210142|NCT01742286|530940016|FG004|Expansion Phase|Disease progression|0|||
147210143|NCT01742286|530940017|FG005|Expansion Phase|Disease progression|0|||
147210144|NCT01742286|530940018|FG006|Expansion Phase|Disease progression|15|||
147210145|NCT01742286|530940012|FG000|Expansion Phase|Withdrawal by Subject|0|||
147210146|NCT01742286|530940013|FG001|Expansion Phase|Withdrawal by Subject|0|||
147210147|NCT01742286|530940014|FG002|Expansion Phase|Withdrawal by Subject|0|||
147210148|NCT01742286|530940015|FG003|Expansion Phase|Withdrawal by Subject|0|||
147210149|NCT01742286|530940016|FG004|Expansion Phase|Withdrawal by Subject|0|||
147210150|NCT01742286|530940017|FG005|Expansion Phase|Withdrawal by Subject|0|||
147210151|NCT01742286|530940018|FG006|Expansion Phase|Withdrawal by Subject|1|||
147440132|NCT01942148|531777528|FG000|Overall Study|Lack of Efficacy|2|||
147440133|NCT01942148|531777528|FG000|Overall Study|Physician Decision|11|||
147440134|NCT01942148|531777528|FG000|Overall Study|Protocol Violation|1|||
147440135|NCT01942148|531777528|FG000|Overall Study|Withdrawal by Subject|8|||
147440136|NCT01942148|531777528|FG000|Overall Study|Use of the prohibition medicine|1|||
147440137|NCT02248259|531777529|FG000|Treatment Period 1|Adverse Event|0|||
147440138|NCT02248259|531777530|FG001|Treatment Period 1|Adverse Event|0|||
147440139|NCT02248259|531777531|FG002|Treatment Period 1|Adverse Event|1|||
147440140|NCT02248259|531777532|FG003|Treatment Period 1|Adverse Event|0|||
147440141|NCT02807480|531777535|FG000|Overall Study|Withdrawal by Subject|14|||
147440142|NCT02807480|531777536|FG001|Overall Study|Withdrawal by Subject|10|||
147440143|NCT02369848|531777537|FG000|Overall Study|Death|1|||
147440144|NCT02369848|531777537|FG000|Overall Study|Withdrawal by Subject|2|||
147440145|NCT02369848|531777537|FG000|Overall Study|Lost to Follow-up|1|||
147440146|NCT00096785|531777541|FG000|Overall Study|Lost to Follow-up|1|||
147440147|NCT00096785|531777542|FG001|Overall Study|Lost to Follow-up|0|||
147440148|NCT00096785|531777541|FG000|Overall Study|Withdrawal by Subject|0|||
147440149|NCT00096785|531777542|FG001|Overall Study|Withdrawal by Subject|1|||
147440150|NCT00096785|531777541|FG000|Overall Study|Relocated|1|||
147440151|NCT00096785|531777542|FG001|Overall Study|Relocated|0|||
147440152|NCT02573870|531777543|FG000|Overall Study|Adverse Event|0|||
147440153|NCT02573870|531777544|FG001|Overall Study|Adverse Event|2|||
147440154|NCT02573870|531777543|FG000|Overall Study|Lack of Efficacy|0|||
147440155|NCT02573870|531777544|FG001|Overall Study|Lack of Efficacy|1|||
147440156|NCT02573870|531777543|FG000|Overall Study|Other: Reached defined stopping criteria|0|||
147440157|NCT02573870|531777544|FG001|Overall Study|Other: Reached defined stopping criteria|1|||
147440158|NCT02573870|531777543|FG000|Overall Study|Lost to Follow-up|0|||
147440159|NCT02573870|531777544|FG001|Overall Study|Lost to Follow-up|1|||
147440160|NCT02573870|531777543|FG000|Overall Study|Other: Fail to Meet Visit|0|||
147440161|NCT02573870|531777544|FG001|Overall Study|Other: Fail to Meet Visit|2|||
147440162|NCT02081534|531777545|FG000|Overall Study|Adverse Event|5|||
147440163|NCT02081534|531777546|FG001|Overall Study|Adverse Event|4|||
147440164|NCT02081534|531777547|FG002|Overall Study|Adverse Event|3|||
147440165|NCT02081534|531777548|FG003|Overall Study|Adverse Event|10|||
147440166|NCT02081534|531777549|FG004|Overall Study|Adverse Event|2|||
147440167|NCT02081534|531777550|FG005|Overall Study|Adverse Event|8|||
147440168|NCT02081534|531777551|FG006|Overall Study|Adverse Event|2|||
147440169|NCT02081534|531777545|FG000|Overall Study|Withdrawal by Subject|0|||
147440170|NCT02081534|531777546|FG001|Overall Study|Withdrawal by Subject|1|||
147440171|NCT02081534|531777547|FG002|Overall Study|Withdrawal by Subject|1|||
147440172|NCT02081534|531777548|FG003|Overall Study|Withdrawal by Subject|1|||
147440173|NCT02081534|531777549|FG004|Overall Study|Withdrawal by Subject|1|||
147440174|NCT02081534|531777550|FG005|Overall Study|Withdrawal by Subject|0|||
147440175|NCT02081534|531777551|FG006|Overall Study|Withdrawal by Subject|1|||
147440176|NCT02081534|531777545|FG000|Overall Study|Protocol Violation|0|||
147440177|NCT02081534|531777546|FG001|Overall Study|Protocol Violation|3|||
147440178|NCT02081534|531777547|FG002|Overall Study|Protocol Violation|0|||
147440179|NCT02081534|531777548|FG003|Overall Study|Protocol Violation|0|||
147440180|NCT02081534|531777549|FG004|Overall Study|Protocol Violation|0|||
147440181|NCT02081534|531777550|FG005|Overall Study|Protocol Violation|0|||
147440182|NCT02081534|531777551|FG006|Overall Study|Protocol Violation|1|||
147440183|NCT02081534|531777545|FG000|Overall Study|Lost to Follow-up|0|||
147440184|NCT02081534|531777546|FG001|Overall Study|Lost to Follow-up|0|||
147440185|NCT02081534|531777547|FG002|Overall Study|Lost to Follow-up|0|||
147440186|NCT02081534|531777548|FG003|Overall Study|Lost to Follow-up|2|||
147440187|NCT02081534|531777549|FG004|Overall Study|Lost to Follow-up|1|||
147440188|NCT02081534|531777550|FG005|Overall Study|Lost to Follow-up|1|||
147440189|NCT02081534|531777551|FG006|Overall Study|Lost to Follow-up|0|||
147440190|NCT02234479|531777552|FG000|Overall Study|Withdrawal by Subject|1|||
147440191|NCT02234479|531777553|FG001|Overall Study|Withdrawal by Subject|3|||
147440192|NCT02285920|531777554|FG000|Overall Study|Kidney transplantation|2|||
147440193|NCT02285920|531777555|FG001|Overall Study|Kidney transplantation|2|||
147440194|NCT02285920|531777556|FG002|Overall Study|Kidney transplantation|2|||
147440195|NCT02285920|531777557|FG003|Overall Study|Kidney transplantation|0|||
147440196|NCT02285920|531777554|FG000|Overall Study|Change to peritoneal dialysis|0|||
147210152|NCT04530136|530940019|FG000|Overall Study|Lost to Follow-up|2|||
147210153|NCT04530136|530940020|FG001|Overall Study|Lost to Follow-up|3|||
147541814|NCT01901146|532140482|FG001|Neoadjuvant Phase|Death|2|||
147210154|NCT04530136|530940019|FG000|Overall Study|Withdrawal by Subject|1|||
147210155|NCT04530136|530940020|FG001|Overall Study|Withdrawal by Subject|0|||
147210156|NCT04530136|530940019|FG000|Overall Study|Death|0|||
147210157|NCT04530136|530940020|FG001|Overall Study|Death|1|||
147541815|NCT01901146|532140483|FG002|Neoadjuvant Phase|Death|0|||
147541816|NCT01901146|532140484|FG003|Neoadjuvant Phase|Death|0|||
147541817|NCT01901146|532140485|FG004|Neoadjuvant Phase|Death|0|||
147541818|NCT01901146|532140481|FG000|Neoadjuvant Phase|Disease Progression or Recurrence|2|||
147541819|NCT01901146|532140482|FG001|Neoadjuvant Phase|Disease Progression or Recurrence|3|||
147541820|NCT01901146|532140483|FG002|Neoadjuvant Phase|Disease Progression or Recurrence|0|||
147541821|NCT01901146|532140484|FG003|Neoadjuvant Phase|Disease Progression or Recurrence|0|||
147541822|NCT01901146|532140485|FG004|Neoadjuvant Phase|Disease Progression or Recurrence|0|||
147541823|NCT01901146|532140481|FG000|Neoadjuvant Phase|Lost to Follow-up|0|||
147541824|NCT01901146|532140482|FG001|Neoadjuvant Phase|Lost to Follow-up|1|||
147541825|NCT01901146|532140483|FG002|Neoadjuvant Phase|Lost to Follow-up|0|||
147541826|NCT01901146|532140484|FG003|Neoadjuvant Phase|Lost to Follow-up|0|||
147541827|NCT01901146|532140485|FG004|Neoadjuvant Phase|Lost to Follow-up|0|||
147541828|NCT01901146|532140481|FG000|Neoadjuvant Phase|Physician Decision|1|||
147541829|NCT01901146|532140482|FG001|Neoadjuvant Phase|Physician Decision|2|||
147541830|NCT01901146|532140483|FG002|Neoadjuvant Phase|Physician Decision|0|||
147541831|NCT01901146|532140484|FG003|Neoadjuvant Phase|Physician Decision|0|||
147210158|NCT05661851|530940021|FG000|Overall Study|Protocol Violation|1|||
147210159|NCT05661851|530940022|FG001|Overall Study|Protocol Violation|1|||
147210160|NCT05661851|530940021|FG000|Overall Study|Covid-19 Related|3|||
147210161|NCT05661851|530940022|FG001|Overall Study|Covid-19 Related|4|||
147210162|NCT05661851|530940021|FG000|Overall Study|investigational product Was Dispensed Incorrectly At Visit 2|1|||
147210163|NCT05661851|530940022|FG001|Overall Study|investigational product Was Dispensed Incorrectly At Visit 2|0|||
147210164|NCT05661851|530940021|FG000|Overall Study|The Patient Was Dispensed The Incorrect investigational product At Visit 2|0|||
147210165|NCT05661851|530940022|FG001|Overall Study|The Patient Was Dispensed The Incorrect investigational product At Visit 2|1|||
147210166|NCT01057589|530940023|FG000|Overall Study|Disease Progression|35|||
147210167|NCT01057589|530940023|FG000|Overall Study|Adverse Event|10|||
147210168|NCT01057589|530940023|FG000|Overall Study|Physician Decision|8|||
147210169|NCT01057589|530940023|FG000|Overall Study|Withdrawal by Subject|3|||
147210170|NCT01057589|530940023|FG000|Overall Study|Sponsor Decision|1|||
147210171|NCT01057589|530940023|FG000|Overall Study|Death|8|||
147210172|NCT01057589|530940023|FG000|Overall Study|Lost to Follow-up|1|||
147210173|NCT00870584|530940024|FG000|Overall Study|Adverse Event|3|||
147210174|NCT00870584|530940025|FG001|Overall Study|Adverse Event|3|||
147210175|NCT00870584|530940024|FG000|Overall Study|Withdrawal by Subject|6|||
147210176|NCT00870584|530940025|FG001|Overall Study|Withdrawal by Subject|7|||
147210177|NCT00870584|530940024|FG000|Overall Study|Lost to Follow-up|5|||
147210178|NCT00870584|530940025|FG001|Overall Study|Lost to Follow-up|1|||
147210179|NCT00870584|530940024|FG000|Overall Study|Protocol Deviation|2|||
147210180|NCT00870584|530940025|FG001|Overall Study|Protocol Deviation|2|||
147210181|NCT01497366|530940026|FG000|Overall Study|Virologic failure|2|||
147210182|NCT01497366|530940027|FG001|Overall Study|Virologic failure|50|||
147210183|NCT01497366|530940026|FG000|Overall Study|Lost to Follow-up|11|||
147210184|NCT01497366|530940027|FG001|Overall Study|Lost to Follow-up|10|||
147210185|NCT01497366|530940026|FG000|Overall Study|Withdrawal by Subject|6|||
147210186|NCT01497366|530940027|FG001|Overall Study|Withdrawal by Subject|6|||
147210187|NCT01497366|530940026|FG000|Overall Study|Initiated Non-protocol HCV Treatment|7|||
147210188|NCT01497366|530940027|FG001|Overall Study|Initiated Non-protocol HCV Treatment|0|||
147210189|NCT01497366|530940026|FG000|Overall Study|Other|5|||
147210190|NCT01497366|530940027|FG001|Overall Study|Other|0|||
147210191|NCT01497366|530940026|FG000|Overall Study|Death|1|||
147210192|NCT01497366|530940027|FG001|Overall Study|Death|1|||
147541832|NCT01901146|532140485|FG004|Neoadjuvant Phase|Physician Decision|0|||
147541833|NCT01901146|532140481|FG000|Neoadjuvant Phase|Withdrawal by Subject|2|||
147541834|NCT01901146|532140482|FG001|Neoadjuvant Phase|Withdrawal by Subject|5|||
147210193|NCT01497366|530940026|FG000|Overall Study|Randomized but not treated|7|||
147210194|NCT01497366|530940027|FG001|Overall Study|Randomized but not treated|21|||
147541835|NCT01901146|532140483|FG002|Neoadjuvant Phase|Withdrawal by Subject|0|||
147541836|NCT01901146|532140484|FG003|Neoadjuvant Phase|Withdrawal by Subject|0|||
147541837|NCT01901146|532140485|FG004|Neoadjuvant Phase|Withdrawal by Subject|0|||
147541838|NCT01901146|532140481|FG000|Neoadjuvant Phase|Requirement for Alternative Therapy|0|||
147541839|NCT01901146|532140482|FG001|Neoadjuvant Phase|Requirement for Alternative Therapy|1|||
147210195|NCT00472030|530940039|FG000|Overall Study|Physician Decision|1|||
147210196|NCT00472030|530940040|FG001|Overall Study|Physician Decision|0|||
147210197|NCT00829504|530940041|FG000|First Intervention|Adverse Event|1|||
147210198|NCT00829504|530940042|FG001|First Intervention|Adverse Event|0|||
147210199|NCT00829504|530940041|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
147210200|NCT00829504|530940042|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
147210201|NCT00829504|530940041|FG000|Second Intervention|Physician Decision|1|||
147210202|NCT00829504|530940042|FG001|Second Intervention|Physician Decision|0|||
147210203|NCT04189224|530940043|FG000|Period 2|Adverse Event|0|||
147541840|NCT01901146|532140483|FG002|Neoadjuvant Phase|Requirement for Alternative Therapy|0|||
147541841|NCT01901146|532140484|FG003|Neoadjuvant Phase|Requirement for Alternative Therapy|0|||
147541842|NCT01901146|532140485|FG004|Neoadjuvant Phase|Requirement for Alternative Therapy|0|||
147541843|NCT01901146|532140481|FG000|Adjuvant Phase|Other|0|||
147541844|NCT01901146|532140482|FG001|Adjuvant Phase|Other|0|||
147541845|NCT01901146|532140483|FG002|Adjuvant Phase|Other|1|||
147541846|NCT01901146|532140484|FG003|Adjuvant Phase|Other|0|||
147541847|NCT01901146|532140485|FG004|Adjuvant Phase|Other|0|||
147541848|NCT01901146|532140481|FG000|Adjuvant Phase|Death|0|||
147541849|NCT01901146|532140482|FG001|Adjuvant Phase|Death|0|||
147541850|NCT01901146|532140483|FG002|Adjuvant Phase|Death|0|||
147541851|NCT01901146|532140484|FG003|Adjuvant Phase|Death|0|||
147541852|NCT01901146|532140485|FG004|Adjuvant Phase|Death|3|||
147541853|NCT01901146|532140481|FG000|Adjuvant Phase|Disease Progression or Recurrence|0|||
147210204|NCT04189224|530940044|FG001|Period 2|Adverse Event|1|||
147541854|NCT01901146|532140482|FG001|Adjuvant Phase|Disease Progression or Recurrence|0|||
147541855|NCT01901146|532140483|FG002|Adjuvant Phase|Disease Progression or Recurrence|12|||
147541856|NCT01901146|532140484|FG003|Adjuvant Phase|Disease Progression or Recurrence|4|||
147541857|NCT01901146|532140485|FG004|Adjuvant Phase|Disease Progression or Recurrence|3|||
147541858|NCT01901146|532140481|FG000|Adjuvant Phase|Physician Decision|0|||
147541859|NCT01901146|532140482|FG001|Adjuvant Phase|Physician Decision|0|||
147541860|NCT01901146|532140483|FG002|Adjuvant Phase|Physician Decision|9|||
147541861|NCT01901146|532140484|FG003|Adjuvant Phase|Physician Decision|2|||
147541862|NCT01901146|532140485|FG004|Adjuvant Phase|Physician Decision|4|||
147541863|NCT01901146|532140481|FG000|Adjuvant Phase|Withdrawal by Subject|0|||
147541864|NCT01901146|532140482|FG001|Adjuvant Phase|Withdrawal by Subject|0|||
147541865|NCT01901146|532140483|FG002|Adjuvant Phase|Withdrawal by Subject|4|||
147541866|NCT01901146|532140484|FG003|Adjuvant Phase|Withdrawal by Subject|1|||
147541867|NCT01901146|532140485|FG004|Adjuvant Phase|Withdrawal by Subject|4|||
147541868|NCT00297492|532140486|FG000|Set Quit Date|Lost to Follow-up|7|||
147541869|NCT00297492|532140487|FG001|Set Quit Date|Lost to Follow-up|13|||
147541870|NCT00297492|532140488|FG002|Set Quit Date|Lost to Follow-up|5|||
147541871|NCT00297492|532140486|FG000|6 Month Follow-up|Lost to Follow-up|63|||
147541872|NCT00297492|532140487|FG001|6 Month Follow-up|Lost to Follow-up|49|||
147541873|NCT00297492|532140488|FG002|6 Month Follow-up|Lost to Follow-up|27|||
147541874|NCT03724968|532140489|FG000|Overall Study|Insurance issues|0|||
147541875|NCT03724968|532140490|FG001|Overall Study|Insurance issues|1|||
147541876|NCT03724968|532140489|FG000|Overall Study|Study closed|0|||
147541877|NCT03724968|532140490|FG001|Overall Study|Study closed|1|||
147541878|NCT00569231|532140493|FG000|Overall Study|Study unrelated surgery|1|||
147541879|NCT00569231|532140493|FG000|Overall Study|Airfare expense|2|||
147541880|NCT00569231|532140493|FG000|Overall Study|Withdrawal by Subject|1|||
147541881|NCT00569231|532140493|FG000|Overall Study|Car accident injury|1|||
147541882|NCT00569231|532140493|FG000|Overall Study|Non-compliance|2|||
147541883|NCT01614925|532140494|FG000|Overall Study|Withdrawal by Subject|1|||
147541884|NCT01614925|532140495|FG001|Overall Study|Withdrawal by Subject|0|||
147541885|NCT01614925|532140494|FG000|Overall Study|Protocol Violation|3|||
147541886|NCT01614925|532140495|FG001|Overall Study|Protocol Violation|2|||
147541887|NCT02437890|532140500|FG000|Overall Study|Non-compliance to study drug|0|||
147541888|NCT02437890|532140501|FG001|Overall Study|Non-compliance to study drug|1|||
147541889|NCT02437890|532140502|FG002|Overall Study|Non-compliance to study drug|0|||
147210205|NCT04236141|530942650|FG000|Overall Study|Death|18|||
147210206|NCT04236141|530942651|FG001|Overall Study|Death|10|||
147210207|NCT04236141|530942650|FG000|Overall Study|Withdrawal by Participant|1|||
147210208|NCT04236141|530942651|FG001|Overall Study|Withdrawal by Participant|0|||
147210209|NCT04236141|530942650|FG000|Overall Study|Reason not Specified|1|||
147210210|NCT04236141|530942651|FG001|Overall Study|Reason not Specified|0|||
147210211|NCT04236141|530942650|FG000|Overall Study|Study terminated by Sponsor|8|||
147210212|NCT04236141|530942651|FG001|Overall Study|Study terminated by Sponsor|4|||
147210213|NCT01217307|530942655|FG000|Overall Study|Withdrawal by Subject|0|||
147210214|NCT01217307|530942656|FG001|Overall Study|Withdrawal by Subject|1|||
147210215|NCT01888432|530942661|FG000|12-month Analysis (FAS)|Lost to Follow-up|0|||
147210216|NCT01888432|530942662|FG001|12-month Analysis (FAS)|Lost to Follow-up|2|||
147210217|NCT01888432|530942661|FG000|12-month Analysis (FAS)|Physician Decision|1|||
147210218|NCT01888432|530942662|FG001|12-month Analysis (FAS)|Physician Decision|1|||
147210219|NCT01888432|530942661|FG000|12-month Analysis (FAS)|Withdrawal by Subject|6|||
147210220|NCT01888432|530942662|FG001|12-month Analysis (FAS)|Withdrawal by Subject|3|||
147210221|NCT01888432|530942661|FG000|12-month Analysis (FAS)|Death|4|||
147541890|NCT02437890|532140503|FG003|Overall Study|Non-compliance to study drug|0|||
147541891|NCT02437890|532140504|FG004|Overall Study|Non-compliance to study drug|1|||
147541892|NCT02437890|532140500|FG000|Overall Study|Sponsor's decision|1|||
147541893|NCT02437890|532140501|FG001|Overall Study|Sponsor's decision|1|||
147541894|NCT02437890|532140502|FG002|Overall Study|Sponsor's decision|4|||
147541895|NCT02437890|532140503|FG003|Overall Study|Sponsor's decision|0|||
147541896|NCT02437890|532140504|FG004|Overall Study|Sponsor's decision|2|||
147541897|NCT02437890|532140500|FG000|Overall Study|Physician Decision|0|||
147541898|NCT02437890|532140501|FG001|Overall Study|Physician Decision|0|||
147440197|NCT02285920|531777555|FG001|Overall Study|Change to peritoneal dialysis|0|||
147440198|NCT02285920|531777556|FG002|Overall Study|Change to peritoneal dialysis|1|||
147440199|NCT02285920|531777557|FG003|Overall Study|Change to peritoneal dialysis|0|||
147440200|NCT02285920|531777554|FG000|Overall Study|Transfer to non-participating unit|0|||
147440201|NCT02285920|531777555|FG001|Overall Study|Transfer to non-participating unit|1|||
147440202|NCT02285920|531777556|FG002|Overall Study|Transfer to non-participating unit|0|||
147440203|NCT02285920|531777557|FG003|Overall Study|Transfer to non-participating unit|0|||
147440204|NCT02285920|531777554|FG000|Overall Study|Dialysis discontinuation|0|||
147440205|NCT02285920|531777555|FG001|Overall Study|Dialysis discontinuation|1|||
147440206|NCT02285920|531777556|FG002|Overall Study|Dialysis discontinuation|0|||
147440207|NCT02285920|531777557|FG003|Overall Study|Dialysis discontinuation|0|||
147440208|NCT02285920|531777554|FG000|Overall Study|Death|2|||
147440209|NCT02285920|531777555|FG001|Overall Study|Death|0|||
147440210|NCT02285920|531777556|FG002|Overall Study|Death|2|||
147440211|NCT02285920|531777557|FG003|Overall Study|Death|1|||
147440212|NCT01480284|531777563|FG000|Overall Study|Withdrawal by Subject|2|||
147440213|NCT01480284|531777564|FG001|Overall Study|Withdrawal by Subject|0|||
147440214|NCT01480284|531777563|FG000|Overall Study|Adverse Event|1|||
147440215|NCT01480284|531777564|FG001|Overall Study|Adverse Event|0|||
147440216|NCT01480284|531777563|FG000|Overall Study|Study closed/terminated|3|||
147440217|NCT01480284|531777564|FG001|Overall Study|Study closed/terminated|0|||
147440218|NCT01480284|531777563|FG000|Overall Study|Lost to Follow-up|1|||
147440219|NCT01480284|531777564|FG001|Overall Study|Lost to Follow-up|0|||
147440220|NCT01480284|531777563|FG000|Overall Study|Physician Decision|1|||
147440221|NCT01480284|531777564|FG001|Overall Study|Physician Decision|0|||
147440222|NCT00066742|531777565|FG000|Induction Chemoradiotherapy|Did not receive any protocol treatment|1|||
147440223|NCT00066742|531777565|FG000|Induction Chemoradiotherapy|Adverse Event|21|||
147440224|NCT00066742|531777565|FG000|Induction Chemoradiotherapy|Withdrawal by Subject|2|||
147440225|NCT00066742|531777565|FG000|Induction Chemoradiotherapy|not protocol specified|2|||
147440226|NCT00066742|531777565|FG000|Induction Chemoradiotherapy|Ineligible|3|||
147440227|NCT00066742|531777565|FG000|Consolidation Chemotherapy|not protocol specified|1|||
147440228|NCT00066742|531777565|FG000|Consolidation Chemotherapy|Ineligible|2|||
147440229|NCT01380730|531777572|FG000|Overall Study|Death|0|||
147440230|NCT01380730|531777573|FG001|Overall Study|Death|0|||
147440231|NCT01380730|531777574|FG002|Overall Study|Death|0|||
147440232|NCT01380730|531777575|FG003|Overall Study|Death|0|||
147440233|NCT01380730|531777576|FG004|Overall Study|Death|1|||
147440234|NCT01380730|531777577|FG005|Overall Study|Death|0|||
147440235|NCT01380730|531777578|FG006|Overall Study|Death|0|||
147440236|NCT01380730|531777579|FG007|Overall Study|Death|0|||
147440237|NCT00922480|531777581|FG000|Main Study|Protocol Violation|3|||
147440238|NCT00922480|531777582|FG001|Main Study|Protocol Violation|6|||
147440239|NCT00922480|531777581|FG000|Main Study|Adverse Event|6|||
147440240|NCT00922480|531777582|FG001|Main Study|Adverse Event|7|||
147440241|NCT00922480|531777581|FG000|Main Study|Lack of Efficacy|3|||
147440242|NCT00922480|531777582|FG001|Main Study|Lack of Efficacy|0|||
147440243|NCT00922480|531777581|FG000|Main Study|Withdrawal by Subject|20|||
147440244|NCT00922480|531777582|FG001|Main Study|Withdrawal by Subject|15|||
147440245|NCT00922480|531777581|FG000|Main Study|Lost to Follow-up|5|||
147440246|NCT00922480|531777582|FG001|Main Study|Lost to Follow-up|0|||
147440247|NCT00922480|531777581|FG000|Main Study|Physician Decision|0|||
147440248|NCT00922480|531777582|FG001|Main Study|Physician Decision|1|||
147440249|NCT00922480|531777581|FG000|Extension Study|Protocol Violation|3|||
147440250|NCT00922480|531777582|FG001|Extension Study|Protocol Violation|0|||
147440251|NCT00922480|531777581|FG000|Extension Study|Adverse Event|1|||
147440252|NCT00922480|531777582|FG001|Extension Study|Adverse Event|1|||
147440253|NCT00922480|531777581|FG000|Extension Study|Withdrawal by Subject|1|||
147440254|NCT00922480|531777582|FG001|Extension Study|Withdrawal by Subject|1|||
147440255|NCT00922480|531777581|FG000|Extension Study|Others|0|||
147440256|NCT00922480|531777582|FG001|Extension Study|Others|1|||
147440257|NCT04784897|531777583|FG000|Overall Study|Death|4|||
147440258|NCT04784897|531777584|FG001|Overall Study|Death|2|||
147440259|NCT04784897|531777585|FG002|Overall Study|Death|1|||
147440260|NCT04784897|531777583|FG000|Overall Study|Withdrawal by Subject|0|||
147440261|NCT04784897|531777584|FG001|Overall Study|Withdrawal by Subject|0|||
147440262|NCT04784897|531777585|FG002|Overall Study|Withdrawal by Subject|1|||
147440263|NCT04754802|531777587|FG000|Overall Study|Lost to Follow-up|0|||
147440264|NCT04754802|531777588|FG001|Overall Study|Lost to Follow-up|2|||
147440265|NCT04754802|531777587|FG000|Overall Study|Withdrawal by Subject|2|||
147440266|NCT04754802|531777588|FG001|Overall Study|Withdrawal by Subject|0|||
147440267|NCT01970488|531777589|FG000|Part 1: Through Week 16|Protocol-specified Criteria|1|||
147440268|NCT01970488|531777590|FG001|Part 1: Through Week 16|Protocol-specified Criteria|2|||
147440269|NCT01970488|531777591|FG002|Part 1: Through Week 16|Protocol-specified Criteria|0|||
147440270|NCT01970488|531777592|FG003|Part 1: Through Week 16|Protocol-specified Criteria|0|||
147440271|NCT01970488|531777593|FG004|Part 1: Through Week 16|Protocol-specified Criteria|0|||
147440272|NCT01970488|531777589|FG000|Part 1: Through Week 16|Protocol Violation|1|||
147440273|NCT01970488|531777590|FG001|Part 1: Through Week 16|Protocol Violation|2|||
147541899|NCT02437890|532140502|FG002|Overall Study|Physician Decision|0|||
147541900|NCT02437890|532140503|FG003|Overall Study|Physician Decision|1|||
147210222|NCT01888432|530942662|FG001|12-month Analysis (FAS)|Death|3|||
147210223|NCT01888432|530942661|FG000|24-month Analysis (FAS)|Graft loss|0|||
147210224|NCT01888432|530942662|FG001|24-month Analysis (FAS)|Graft loss|1|||
147210225|NCT01888432|530942661|FG000|24-month Analysis (FAS)|Lost to Follow-up|0|||
147210226|NCT01888432|530942662|FG001|24-month Analysis (FAS)|Lost to Follow-up|2|||
147210227|NCT01888432|530942661|FG000|24-month Analysis (FAS)|Physician Decision|2|||
147210228|NCT01888432|530942662|FG001|24-month Analysis (FAS)|Physician Decision|4|||
147210229|NCT01888432|530942661|FG000|24-month Analysis (FAS)|Withdrawal by Subject|7|||
147210230|NCT01888432|530942662|FG001|24-month Analysis (FAS)|Withdrawal by Subject|6|||
147210231|NCT01888432|530942661|FG000|24-month Analysis (FAS)|Death|8|||
147210232|NCT01888432|530942662|FG001|24-month Analysis (FAS)|Death|4|||
147541901|NCT02437890|532140504|FG004|Overall Study|Physician Decision|0|||
147541902|NCT02437890|532140500|FG000|Overall Study|Unable to attend visit(s)|1|||
147541903|NCT02437890|532140501|FG001|Overall Study|Unable to attend visit(s)|0|||
147541904|NCT02437890|532140502|FG002|Overall Study|Unable to attend visit(s)|0|||
147541905|NCT02437890|532140503|FG003|Overall Study|Unable to attend visit(s)|0|||
147210233|NCT01888432|530942661|FG000|36-month Analysis (Extension)|Death|1|||
147210234|NCT01888432|530942662|FG001|36-month Analysis (Extension)|Death|0|||
147210235|NCT01696929|530942665|FG000|Overall Study|Physician Decision|1|||
147210236|NCT04473235|530942668|FG000|Overall Study|Lost to Follow-up|6|||
147210237|NCT04473235|530942669|FG001|Overall Study|Lost to Follow-up|5|||
147210238|NCT04473235|530942668|FG000|Overall Study|Declined continuation|2|||
147210239|NCT04473235|530942669|FG001|Overall Study|Declined continuation|0|||
147210240|NCT04473235|530942668|FG000|Overall Study|Physician Decision|1|||
147210241|NCT04473235|530942669|FG001|Overall Study|Physician Decision|1|||
147210242|NCT04473235|530942668|FG000|Overall Study|Protocol Violation|10|||
147210243|NCT04473235|530942669|FG001|Overall Study|Protocol Violation|6|||
147210244|NCT00798759|530942672|FG000|Overall Study|Adverse Event|3|||
147210245|NCT00798759|530942673|FG001|Overall Study|Adverse Event|3|||
147210246|NCT00798759|530942672|FG000|Overall Study|Lost to Follow-up|1|||
147210247|NCT00798759|530942673|FG001|Overall Study|Lost to Follow-up|1|||
147210248|NCT00798759|530942672|FG000|Overall Study|Protocol Violation|4|||
147210249|NCT00798759|530942673|FG001|Overall Study|Protocol Violation|8|||
147210250|NCT00798759|530942672|FG000|Overall Study|Other|0|||
147210251|NCT00798759|530942673|FG001|Overall Study|Other|1|||
147210252|NCT02156271|530942674|FG000|Overall Study|Physician Decision|4|||
147210253|NCT02156271|530942675|FG001|Overall Study|Physician Decision|3|||
147210254|NCT00955305|530942676|FG000|Overall Study|Disease progression|39|||
147210255|NCT00955305|530942677|FG001|Overall Study|Disease progression|41|||
147210256|NCT00955305|530942676|FG000|Overall Study|Adverse Event|22|||
147210257|NCT00955305|530942677|FG001|Overall Study|Adverse Event|22|||
147210258|NCT00955305|530942676|FG000|Overall Study|Death|2|||
147210259|NCT00955305|530942677|FG001|Overall Study|Death|1|||
147210260|NCT00955305|530942676|FG000|Overall Study|Withdrawal by Subject|5|||
147210261|NCT00955305|530942677|FG001|Overall Study|Withdrawal by Subject|4|||
147210262|NCT00955305|530942676|FG000|Overall Study|Alternative therapy|4|||
147210263|NCT00955305|530942677|FG001|Overall Study|Alternative therapy|0|||
147210264|NCT00955305|530942676|FG000|Overall Study|Other complicating disease|2|||
147210265|NCT00955305|530942677|FG001|Overall Study|Other complicating disease|4|||
147210266|NCT00955305|530942676|FG000|Overall Study|Physician Decision|1|||
147210267|NCT00955305|530942677|FG001|Overall Study|Physician Decision|0|||
147210268|NCT00955305|530942676|FG000|Overall Study|Continued presence of residual disease|0|||
147210269|NCT00955305|530942677|FG001|Overall Study|Continued presence of residual disease|1|||
147210270|NCT00955305|530942676|FG000|Overall Study|Functional decline|2|||
147210271|NCT00955305|530942677|FG001|Overall Study|Functional decline|0|||
147210272|NCT00955305|530942676|FG000|Overall Study|Maximum response achieved|0|||
147210273|NCT00955305|530942677|FG001|Overall Study|Maximum response achieved|1|||
147306818|NCT01852058|531290775|FG002|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
147440274|NCT01970488|531777591|FG002|Part 1: Through Week 16|Protocol Violation|0|||
147440275|NCT01970488|531777592|FG003|Part 1: Through Week 16|Protocol Violation|0|||
147440276|NCT01970488|531777593|FG004|Part 1: Through Week 16|Protocol Violation|0|||
147440277|NCT01970488|531777589|FG000|Part 1: Through Week 16|Adverse Event|6|||
147440278|NCT01970488|531777590|FG001|Part 1: Through Week 16|Adverse Event|5|||
147440279|NCT01970488|531777591|FG002|Part 1: Through Week 16|Adverse Event|0|||
147440280|NCT01970488|531777592|FG003|Part 1: Through Week 16|Adverse Event|0|||
147440281|NCT01970488|531777593|FG004|Part 1: Through Week 16|Adverse Event|0|||
147440282|NCT01970488|531777589|FG000|Part 1: Through Week 16|Withdrawal by Subject|3|||
147440283|NCT01970488|531777590|FG001|Part 1: Through Week 16|Withdrawal by Subject|2|||
147440284|NCT01970488|531777591|FG002|Part 1: Through Week 16|Withdrawal by Subject|0|||
147440285|NCT01970488|531777592|FG003|Part 1: Through Week 16|Withdrawal by Subject|0|||
147541906|NCT02437890|532140504|FG004|Overall Study|Unable to attend visit(s)|0|||
147541907|NCT02437890|532140500|FG000|Overall Study|Lack of Efficacy|1|||
147210274|NCT00955305|530942676|FG000|Overall Study|Lost to Follow-up|0|||
147210275|NCT00955305|530942677|FG001|Overall Study|Lost to Follow-up|1|||
147306819|NCT01852058|531290776|FG003|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
147541908|NCT02437890|532140501|FG001|Overall Study|Lack of Efficacy|3|||
147210276|NCT00955305|530942676|FG000|Overall Study|No off-treatment reason submitted|1|||
147210277|NCT00955305|530942677|FG001|Overall Study|No off-treatment reason submitted|0|||
147210278|NCT00955305|530942676|FG000|Overall Study|Never started protocol treatment|5|||
147210279|NCT00955305|530942677|FG001|Overall Study|Never started protocol treatment|5|||
147210280|NCT00955305|530942676|FG000|Overall Study|Ineligible|5|||
147210281|NCT00955305|530942677|FG001|Overall Study|Ineligible|7|||
147210282|NCT03387111|530942678|FG000|Overall Study|Progressive Disease|3|||
147210283|NCT03387111|530942678|FG000|Overall Study|Other|1|||
147210284|NCT01945710|530942682|FG000|Overall Study|Progressive Disease|5|||
147210285|NCT01945710|530942683|FG001|Overall Study|Progressive Disease|4|||
147210286|NCT01945710|530942684|FG002|Overall Study|Progressive Disease|3|||
147210287|NCT01945710|530942685|FG003|Overall Study|Progressive Disease|2|||
147210288|NCT01945710|530942686|FG004|Overall Study|Progressive Disease|7|||
147210289|NCT01945710|530942687|FG005|Overall Study|Progressive Disease|3|||
147210290|NCT01945710|530942688|FG006|Overall Study|Progressive Disease|19|||
147210291|NCT01945710|530942682|FG000|Overall Study|Adverse Event|0|||
147210292|NCT01945710|530942683|FG001|Overall Study|Adverse Event|1|||
147210293|NCT01945710|530942684|FG002|Overall Study|Adverse Event|0|||
147210294|NCT01945710|530942685|FG003|Overall Study|Adverse Event|0|||
147210295|NCT01945710|530942686|FG004|Overall Study|Adverse Event|0|||
147210296|NCT01945710|530942687|FG005|Overall Study|Adverse Event|0|||
147210297|NCT01945710|530942688|FG006|Overall Study|Adverse Event|0|||
147210298|NCT01945710|530942682|FG000|Overall Study|Other|2|||
147210299|NCT01945710|530942683|FG001|Overall Study|Other|0|||
147210300|NCT01945710|530942684|FG002|Overall Study|Other|3|||
147541909|NCT02437890|532140502|FG002|Overall Study|Lack of Efficacy|0|||
147541910|NCT02437890|532140503|FG003|Overall Study|Lack of Efficacy|3|||
147541911|NCT02437890|532140504|FG004|Overall Study|Lack of Efficacy|1|||
147541912|NCT02437890|532140500|FG000|Overall Study|Adverse Event|4|||
147541913|NCT02437890|532140501|FG001|Overall Study|Adverse Event|9|||
147541914|NCT02437890|532140502|FG002|Overall Study|Adverse Event|5|||
147541915|NCT02437890|532140503|FG003|Overall Study|Adverse Event|11|||
147541916|NCT02437890|532140504|FG004|Overall Study|Adverse Event|7|||
147541917|NCT02437890|532140500|FG000|Overall Study|Withdrawal by Subject|1|||
147541918|NCT02437890|532140501|FG001|Overall Study|Withdrawal by Subject|2|||
147541919|NCT02437890|532140502|FG002|Overall Study|Withdrawal by Subject|6|||
147541920|NCT02437890|532140503|FG003|Overall Study|Withdrawal by Subject|5|||
147541921|NCT02437890|532140504|FG004|Overall Study|Withdrawal by Subject|5|||
147541922|NCT02437890|532140500|FG000|Overall Study|Death|0|||
147541923|NCT02437890|532140501|FG001|Overall Study|Death|0|||
147541924|NCT02437890|532140502|FG002|Overall Study|Death|0|||
147541925|NCT02437890|532140503|FG003|Overall Study|Death|2|||
147541926|NCT02437890|532140504|FG004|Overall Study|Death|0|||
147210301|NCT01945710|530942685|FG003|Overall Study|Other|1|||
147210302|NCT01945710|530942686|FG004|Overall Study|Other|1|||
147210303|NCT01945710|530942687|FG005|Overall Study|Other|0|||
147210304|NCT01945710|530942688|FG006|Overall Study|Other|4|||
147210305|NCT01945710|530942682|FG000|Overall Study|Withdrawal by Subject|0|||
147210306|NCT01945710|530942683|FG001|Overall Study|Withdrawal by Subject|1|||
147210307|NCT01945710|530942684|FG002|Overall Study|Withdrawal by Subject|1|||
147210308|NCT01945710|530942685|FG003|Overall Study|Withdrawal by Subject|0|||
147210309|NCT01945710|530942686|FG004|Overall Study|Withdrawal by Subject|1|||
147210310|NCT01945710|530942687|FG005|Overall Study|Withdrawal by Subject|0|||
147210311|NCT01945710|530942688|FG006|Overall Study|Withdrawal by Subject|0|||
147210312|NCT02730195|530942689|FG000|Overall Study|Withdrawal by Subject|1|||
147210313|NCT00375609|530942690|FG000|Overall Study|Did not receive treatment|1|||
147210314|NCT00375609|530942691|FG001|Overall Study|Did not receive treatment|0|||
147210315|NCT00375609|530942692|FG002|Overall Study|Did not receive treatment|0|||
147210316|NCT00375609|530942690|FG000|Overall Study|Adverse Event|0|||
147210317|NCT00375609|530942691|FG001|Overall Study|Adverse Event|3|||
147210318|NCT00375609|530942692|FG002|Overall Study|Adverse Event|0|||
147210319|NCT00375609|530942690|FG000|Overall Study|Lost to Follow-up|1|||
147210320|NCT00375609|530942691|FG001|Overall Study|Lost to Follow-up|0|||
147210321|NCT00375609|530942692|FG002|Overall Study|Lost to Follow-up|0|||
147210322|NCT00375609|530942690|FG000|Overall Study|Physician Decision|0|||
147210323|NCT00375609|530942691|FG001|Overall Study|Physician Decision|0|||
147210324|NCT00375609|530942692|FG002|Overall Study|Physician Decision|1|||
147541927|NCT01190098|532140505|FG000|Overall Study|Adverse Event|2|||
147541928|NCT01190098|532140506|FG001|Overall Study|Adverse Event|0|||
147541929|NCT01190098|532140505|FG000|Overall Study|Patient coomorbidity|0|||
147541930|NCT01190098|532140506|FG001|Overall Study|Patient coomorbidity|1|||
147210325|NCT00375609|530942690|FG000|Overall Study|Withdrawal by Subject|1|||
147210326|NCT00375609|530942691|FG001|Overall Study|Withdrawal by Subject|4|||
147210327|NCT00375609|530942692|FG002|Overall Study|Withdrawal by Subject|0|||
147210328|NCT00375609|530942690|FG000|Overall Study|Neurologist Wanted Pt to start Plavix|1|||
147210329|NCT00375609|530942691|FG001|Overall Study|Neurologist Wanted Pt to start Plavix|0|||
147210330|NCT00375609|530942692|FG002|Overall Study|Neurologist Wanted Pt to start Plavix|0|||
147541931|NCT01190098|532140505|FG000|Overall Study|Lack of transportation|1|||
147541932|NCT01190098|532140506|FG001|Overall Study|Lack of transportation|0|||
147210331|NCT01368562|530942693|FG000|Overall Study|Adverse Event|1|||
147210332|NCT01368562|530942693|FG000|Overall Study|Disease progression|1|||
147210333|NCT01368562|530942693|FG000|Overall Study|Lost to Follow-up|1|||
147210334|NCT01368562|530942693|FG000|Overall Study|Death|6|||
147210335|NCT01368562|530942693|FG000|Overall Study|Unresponsive to treatment|5|||
147210336|NCT01368562|530942693|FG000|Overall Study|Other|3|||
147210337|NCT01368562|530942693|FG000|Overall Study|Other than specified|2|||
147210338|NCT02810444|530942695|FG000|Overall Study|Screen Failures|14|||
147210339|NCT02810444|530942695|FG000|Overall Study|Withdrawal by Subject|4|||
147210340|NCT02810444|530942695|FG000|Overall Study|Adverse Event|3|||
147210341|NCT02785770|530942698|FG000|Intervention Period 2 (1 Day)|Adverse Event|0|||
147210342|NCT02785770|530942699|FG001|Intervention Period 2 (1 Day)|Adverse Event|1|||
147210343|NCT02785770|530942700|FG002|Intervention Period 2 (1 Day)|Adverse Event|0|||
147210344|NCT02785770|530942701|FG003|Intervention Period 2 (1 Day)|Adverse Event|0|||
147210345|NCT02785770|530942698|FG000|Intervention Period 2 (1 Day)|Family related obligations|0|||
147210346|NCT02785770|530942699|FG001|Intervention Period 2 (1 Day)|Family related obligations|0|||
147210347|NCT02785770|530942700|FG002|Intervention Period 2 (1 Day)|Family related obligations|1|||
147210348|NCT02785770|530942701|FG003|Intervention Period 2 (1 Day)|Family related obligations|0|||
147210349|NCT02785770|530942698|FG000|Intervention Period 3 (1 Day)|Adverse Event|0|||
147210350|NCT02785770|530942699|FG001|Intervention Period 3 (1 Day)|Adverse Event|0|||
147210351|NCT02785770|530942700|FG002|Intervention Period 3 (1 Day)|Adverse Event|0|||
147210352|NCT02785770|530942701|FG003|Intervention Period 3 (1 Day)|Adverse Event|1|||
147210353|NCT01129583|530942707|FG000|Overall Study|Death|1|||
147210354|NCT01129583|530942708|FG001|Overall Study|Death|0|||
147210355|NCT01129583|530942707|FG000|Overall Study|Lost to Follow-up|1|||
147210356|NCT01129583|530942708|FG001|Overall Study|Lost to Follow-up|1|||
147210357|NCT01129583|530942707|FG000|Overall Study|Ipsilateral Upper Extremity Injury|1|||
147210358|NCT01129583|530942708|FG001|Overall Study|Ipsilateral Upper Extremity Injury|1|||
147210359|NCT01904773|530942711|FG000|Screen|Screen failure|3|||
147210360|NCT01904773|530942712|FG001|Screen|Screen failure|0|||
147210361|NCT01904773|530942713|FG002|Screen|Screen failure|0|||
147210362|NCT01904773|530942714|FG003|Screen|Screen failure|0|||
147210363|NCT01904773|530942715|FG004|Screen|Screen failure|0|||
147210364|NCT01904773|530942716|FG005|Screen|Screen failure|0|||
147210365|NCT01904773|530942717|FG006|Screen|Screen failure|0|||
147440286|NCT01970488|531777593|FG004|Part 1: Through Week 16|Withdrawal by Subject|0|||
147440287|NCT01970488|531777589|FG000|Part 1: Through Week 16|Lost to Follow-up|0|||
147440288|NCT01970488|531777590|FG001|Part 1: Through Week 16|Lost to Follow-up|2|||
147440289|NCT01970488|531777591|FG002|Part 1: Through Week 16|Lost to Follow-up|0|||
147440290|NCT01970488|531777592|FG003|Part 1: Through Week 16|Lost to Follow-up|0|||
147440291|NCT01970488|531777593|FG004|Part 1: Through Week 16|Lost to Follow-up|0|||
147440292|NCT01970488|531777589|FG000|Part 2: Post Week 16|Physician Decision|0|||
147440293|NCT01970488|531777590|FG001|Part 2: Post Week 16|Physician Decision|0|||
147440294|NCT01970488|531777591|FG002|Part 2: Post Week 16|Physician Decision|0|||
147440295|NCT01970488|531777592|FG003|Part 2: Post Week 16|Physician Decision|0|||
147440296|NCT01970488|531777593|FG004|Part 2: Post Week 16|Physician Decision|1|||
147440297|NCT01970488|531777589|FG000|Part 2: Post Week 16|Non-compliance|0|||
147440298|NCT01970488|531777590|FG001|Part 2: Post Week 16|Non-compliance|0|||
147440299|NCT01970488|531777591|FG002|Part 2: Post Week 16|Non-compliance|1|||
147440300|NCT01970488|531777592|FG003|Part 2: Post Week 16|Non-compliance|0|||
147440301|NCT01970488|531777593|FG004|Part 2: Post Week 16|Non-compliance|0|||
147440302|NCT01970488|531777589|FG000|Part 2: Post Week 16|Lack of Efficacy|0|||
147440303|NCT01970488|531777590|FG001|Part 2: Post Week 16|Lack of Efficacy|0|||
147440304|NCT01970488|531777591|FG002|Part 2: Post Week 16|Lack of Efficacy|2|||
147440305|NCT01970488|531777592|FG003|Part 2: Post Week 16|Lack of Efficacy|3|||
147440306|NCT01970488|531777593|FG004|Part 2: Post Week 16|Lack of Efficacy|1|||
147440307|NCT01970488|531777589|FG000|Part 2: Post Week 16|Adverse Event|0|||
147440308|NCT01970488|531777590|FG001|Part 2: Post Week 16|Adverse Event|0|||
147440309|NCT01970488|531777591|FG002|Part 2: Post Week 16|Adverse Event|5|||
147440310|NCT01970488|531777592|FG003|Part 2: Post Week 16|Adverse Event|1|||
147440311|NCT01970488|531777593|FG004|Part 2: Post Week 16|Adverse Event|1|||
147440312|NCT01970488|531777589|FG000|Part 2: Post Week 16|Withdrawal by Subject|0|||
147440313|NCT01970488|531777590|FG001|Part 2: Post Week 16|Withdrawal by Subject|0|||
147440314|NCT01970488|531777591|FG002|Part 2: Post Week 16|Withdrawal by Subject|8|||
147440315|NCT01970488|531777592|FG003|Part 2: Post Week 16|Withdrawal by Subject|3|||
147440316|NCT01970488|531777593|FG004|Part 2: Post Week 16|Withdrawal by Subject|3|||
147440317|NCT01970488|531777589|FG000|Part 2: Post Week 16|Lost to Follow-up|0|||
147440318|NCT01970488|531777590|FG001|Part 2: Post Week 16|Lost to Follow-up|0|||
147210366|NCT01904773|530942718|FG007|Screen|Screen failure|0|||
147210367|NCT01904773|530942719|FG008|Screen|Screen failure|0|||
147210368|NCT01904773|530942711|FG000|Screen|Withdrawal by Subject|1|||
147210369|NCT01904773|530942712|FG001|Screen|Withdrawal by Subject|0|||
147210370|NCT01904773|530942713|FG002|Screen|Withdrawal by Subject|0|||
147210371|NCT01904773|530942714|FG003|Screen|Withdrawal by Subject|0|||
147210372|NCT01904773|530942715|FG004|Screen|Withdrawal by Subject|0|||
147440319|NCT01970488|531777591|FG002|Part 2: Post Week 16|Lost to Follow-up|1|||
147210373|NCT01904773|530942716|FG005|Screen|Withdrawal by Subject|0|||
147210374|NCT01904773|530942717|FG006|Screen|Withdrawal by Subject|0|||
147210375|NCT01904773|530942718|FG007|Screen|Withdrawal by Subject|0|||
147210376|NCT01904773|530942719|FG008|Screen|Withdrawal by Subject|0|||
147210377|NCT01904773|530942711|FG000|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|1|||
147210378|NCT01904773|530942712|FG001|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
147210379|NCT01904773|530942713|FG002|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
147210380|NCT01904773|530942714|FG003|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
147210381|NCT01904773|530942715|FG004|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
147210382|NCT01904773|530942716|FG005|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
147210383|NCT01904773|530942717|FG006|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
147210384|NCT01904773|530942718|FG007|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
147210385|NCT01904773|530942719|FG008|Part 1 - Multiple Dose AZD5213 2.0 mg|Adverse Event|0|||
147210386|NCT01904773|530942711|FG000|First Intervention|Adverse Event|0|||
147210387|NCT01904773|530942712|FG001|First Intervention|Adverse Event|0|||
147210388|NCT01904773|530942713|FG002|First Intervention|Adverse Event|0|||
147210389|NCT01904773|530942714|FG003|First Intervention|Adverse Event|0|||
147210390|NCT01904773|530942715|FG004|First Intervention|Adverse Event|0|||
147210391|NCT01904773|530942716|FG005|First Intervention|Adverse Event|0|||
147210392|NCT01904773|530942717|FG006|First Intervention|Adverse Event|1|||
147210393|NCT01904773|530942718|FG007|First Intervention|Adverse Event|0|||
147210394|NCT01904773|530942719|FG008|First Intervention|Adverse Event|0|||
147210395|NCT01904773|530942711|FG000|Placebo Washout First Intervention|Condition worsened|0|||
147210396|NCT01904773|530942712|FG001|Placebo Washout First Intervention|Condition worsened|1|||
147210397|NCT01904773|530942713|FG002|Placebo Washout First Intervention|Condition worsened|0|||
147210398|NCT01904773|530942714|FG003|Placebo Washout First Intervention|Condition worsened|0|||
147210399|NCT01904773|530942715|FG004|Placebo Washout First Intervention|Condition worsened|0|||
147210400|NCT01904773|530942716|FG005|Placebo Washout First Intervention|Condition worsened|0|||
147210401|NCT01904773|530942717|FG006|Placebo Washout First Intervention|Condition worsened|0|||
147210402|NCT01904773|530942718|FG007|Placebo Washout First Intervention|Condition worsened|0|||
147210403|NCT01904773|530942719|FG008|Placebo Washout First Intervention|Condition worsened|0|||
147210404|NCT01904773|530942711|FG000|Fifth Intervention|Adverse Event|0|||
147210405|NCT01904773|530942712|FG001|Fifth Intervention|Adverse Event|0|||
147210406|NCT01904773|530942713|FG002|Fifth Intervention|Adverse Event|0|||
147210407|NCT01904773|530942714|FG003|Fifth Intervention|Adverse Event|0|||
147210408|NCT01904773|530942715|FG004|Fifth Intervention|Adverse Event|0|||
147210409|NCT01904773|530942716|FG005|Fifth Intervention|Adverse Event|0|||
147210410|NCT01904773|530942717|FG006|Fifth Intervention|Adverse Event|0|||
147210411|NCT01904773|530942718|FG007|Fifth Intervention|Adverse Event|1|||
147210412|NCT01904773|530942719|FG008|Fifth Intervention|Adverse Event|0|||
147210413|NCT01904773|530942711|FG000|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
147210414|NCT01904773|530942712|FG001|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|1|||
147210415|NCT01904773|530942713|FG002|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
147210416|NCT01904773|530942714|FG003|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
147210417|NCT01904773|530942715|FG004|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
147210418|NCT01904773|530942716|FG005|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
147210419|NCT01904773|530942717|FG006|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
147210420|NCT01904773|530942718|FG007|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
147210421|NCT01904773|530942719|FG008|Placebo Washout Fifth Intervention|Study specific withdrawal criteria|0|||
147210422|NCT04518995|530942720|FG000|Overall Study|Treatment Emergent or Worsening Adverse Event|2|||
147210423|NCT04518995|530942721|FG001|Overall Study|Treatment Emergent or Worsening Adverse Event|8|||
147541933|NCT01190098|532140505|FG000|Overall Study|Other|0|||
147541934|NCT01190098|532140506|FG001|Overall Study|Other|1|||
147541935|NCT00344305|532140507|FG000|Overall Study|Lost to Follow-up|2|||
147541936|NCT00344305|532140508|FG001|Overall Study|Lost to Follow-up|0|||
147541937|NCT00344305|532140507|FG000|Overall Study|Participant was not contacted in window|0|||
147541938|NCT00344305|532140508|FG001|Overall Study|Participant was not contacted in window|1|||
147541939|NCT01227954|532140522|FG000|Overall Study|Protocol Violation|6|||
147210424|NCT04518995|530942722|FG002|Overall Study|Treatment Emergent or Worsening Adverse Event|4|||
147210425|NCT04518995|530942720|FG000|Overall Study|Lack of Efficacy|2|||
147541940|NCT01227954|532140522|FG000|Overall Study|No protocol treatment|7|||
147541941|NCT00078312|532140528|FG000|Overall Study|Adverse Event|43|||
147541942|NCT00078312|532140528|FG000|Overall Study|Lack of Efficacy|15|||
147541943|NCT00078312|532140528|FG000|Overall Study|Lost to Follow-up|41|||
147541944|NCT00078312|532140528|FG000|Overall Study|Physician Decision|9|||
147541945|NCT00078312|532140528|FG000|Overall Study|Protocol Violation|3|||
147541946|NCT00078312|532140528|FG000|Overall Study|Withdrawal by Subject|33|||
147541947|NCT00078312|532140528|FG000|Overall Study|Miscellaneous|33|||
147541948|NCT01875991|532140532|FG000|Overall Study|Withdrawal by Subject|6|||
147541949|NCT01875991|532140533|FG001|Overall Study|Withdrawal by Subject|6|||
147649439|NCT02634801|532537341|FG000|Follow-up Period|Lost to Follow-up|3|||
147649440|NCT02634801|532537342|FG001|Follow-up Period|Lost to Follow-up|1|||
147210426|NCT04518995|530942721|FG001|Overall Study|Lack of Efficacy|1|||
147210427|NCT04518995|530942722|FG002|Overall Study|Lack of Efficacy|0|||
147210428|NCT04518995|530942720|FG000|Overall Study|Non-compliance With Study Drug|0|||
147210429|NCT04518995|530942721|FG001|Overall Study|Non-compliance With Study Drug|3|||
147210430|NCT04518995|530942722|FG002|Overall Study|Non-compliance With Study Drug|2|||
147210431|NCT04518995|530942720|FG000|Overall Study|Pregnancy|0|||
147210432|NCT04518995|530942721|FG001|Overall Study|Pregnancy|0|||
147210433|NCT04518995|530942722|FG002|Overall Study|Pregnancy|1|||
147210434|NCT04518995|530942720|FG000|Overall Study|Protocol Violation|2|||
147440320|NCT01970488|531777592|FG003|Part 2: Post Week 16|Lost to Follow-up|1|||
147440321|NCT01970488|531777593|FG004|Part 2: Post Week 16|Lost to Follow-up|2|||
147440322|NCT01490814|531777595|FG000|Overall Study|Inclusion/Exclusion Criteria Violation|3|||
147440323|NCT01490814|531777596|FG001|Overall Study|Inclusion/Exclusion Criteria Violation|3|||
147440324|NCT01490814|531777595|FG000|Overall Study|Physician Decision|1|||
147440325|NCT01490814|531777596|FG001|Overall Study|Physician Decision|0|||
147440326|NCT01490814|531777595|FG000|Overall Study|Withdrawal by Subject|0|||
147440327|NCT01490814|531777596|FG001|Overall Study|Withdrawal by Subject|5|||
147440328|NCT01537198|531777597|FG000|Overall Study|RSV infection|2|||
147440329|NCT01537198|531777597|FG000|Overall Study|Adverse Event|4|||
147440330|NCT01537198|531777597|FG000|Overall Study|No Further Visits to the Clinic|37|||
147440331|NCT01537198|531777597|FG000|Overall Study|Other|111|||
147440332|NCT00574288|531777598|FG000|Overall Study|Adverse Event|2|||
147440333|NCT00574288|531777599|FG001|Overall Study|Adverse Event|0|||
147440334|NCT00574288|531777600|FG002|Overall Study|Adverse Event|0|||
147440335|NCT00574288|531777601|FG003|Overall Study|Adverse Event|0|||
147440336|NCT00574288|531777602|FG004|Overall Study|Adverse Event|1|||
147440337|NCT00574288|531777603|FG005|Overall Study|Adverse Event|0|||
147440338|NCT00574288|531777604|FG006|Overall Study|Adverse Event|0|||
147440339|NCT00574288|531777598|FG000|Overall Study|Death|0|||
147440340|NCT00574288|531777599|FG001|Overall Study|Death|0|||
147440341|NCT00574288|531777600|FG002|Overall Study|Death|0|||
147440342|NCT00574288|531777601|FG003|Overall Study|Death|0|||
147440343|NCT00574288|531777602|FG004|Overall Study|Death|0|||
147440344|NCT00574288|531777603|FG005|Overall Study|Death|25|||
147440345|NCT00574288|531777604|FG006|Overall Study|Death|21|||
147440346|NCT00574288|531777598|FG000|Overall Study|Lost to Follow-up|0|||
147440347|NCT00574288|531777599|FG001|Overall Study|Lost to Follow-up|0|||
147440348|NCT00574288|531777600|FG002|Overall Study|Lost to Follow-up|0|||
147440349|NCT00574288|531777601|FG003|Overall Study|Lost to Follow-up|0|||
147440350|NCT00574288|531777602|FG004|Overall Study|Lost to Follow-up|0|||
147440351|NCT00574288|531777603|FG005|Overall Study|Lost to Follow-up|1|||
147440352|NCT00574288|531777604|FG006|Overall Study|Lost to Follow-up|2|||
147440353|NCT00574288|531777598|FG000|Overall Study|Study Terminated By Sponsor|0|||
147440354|NCT00574288|531777599|FG001|Overall Study|Study Terminated By Sponsor|0|||
147440355|NCT00574288|531777600|FG002|Overall Study|Study Terminated By Sponsor|0|||
147440356|NCT00574288|531777601|FG003|Overall Study|Study Terminated By Sponsor|0|||
147440357|NCT00574288|531777602|FG004|Overall Study|Study Terminated By Sponsor|0|||
147440358|NCT00574288|531777603|FG005|Overall Study|Study Terminated By Sponsor|0|||
147440359|NCT00574288|531777604|FG006|Overall Study|Study Terminated By Sponsor|5|||
147440360|NCT00574288|531777598|FG000|Overall Study|Progressive Disease|17|||
147440361|NCT00574288|531777599|FG001|Overall Study|Progressive Disease|2|||
147440362|NCT00574288|531777600|FG002|Overall Study|Progressive Disease|3|||
147440363|NCT00574288|531777601|FG003|Overall Study|Progressive Disease|2|||
147440364|NCT00574288|531777602|FG004|Overall Study|Progressive Disease|1|||
147440365|NCT00574288|531777603|FG005|Overall Study|Progressive Disease|0|||
147440366|NCT00574288|531777604|FG006|Overall Study|Progressive Disease|0|||
147440367|NCT00574288|531777598|FG000|Overall Study|Other|1|||
147440368|NCT00574288|531777599|FG001|Overall Study|Other|1|||
147440369|NCT00574288|531777600|FG002|Overall Study|Other|0|||
147440370|NCT00574288|531777601|FG003|Overall Study|Other|0|||
147440371|NCT00574288|531777602|FG004|Overall Study|Other|0|||
147440372|NCT00574288|531777603|FG005|Overall Study|Other|0|||
147440373|NCT00574288|531777604|FG006|Overall Study|Other|0|||
147440374|NCT02247960|531777607|FG000|Patient Consent and Randomization|Physician Decision|2|||
147440375|NCT02247960|531777608|FG001|Patient Consent and Randomization|Physician Decision|2|||
147440376|NCT02247960|531777607|FG000|Patient Consent and Randomization|Withdrawal by Subject|0|||
147440377|NCT02247960|531777608|FG001|Patient Consent and Randomization|Withdrawal by Subject|4|||
147440378|NCT02247960|531777607|FG000|Catheter Removed|Lost to Follow-up|7|||
147440379|NCT02247960|531777608|FG001|Catheter Removed|Lost to Follow-up|10|||
147440380|NCT03716050|531777614|FG000|Overall Study|Lost to Follow-up|0|||
147210435|NCT04518995|530942721|FG001|Overall Study|Protocol Violation|0|||
147440381|NCT03716050|531777615|FG001|Overall Study|Lost to Follow-up|0|||
147440382|NCT03716050|531777616|FG002|Overall Study|Lost to Follow-up|1|||
147440383|NCT03716050|531777617|FG003|Overall Study|Lost to Follow-up|0|||
147210436|NCT04518995|530942722|FG002|Overall Study|Protocol Violation|1|||
147440384|NCT03716050|531777618|FG004|Overall Study|Lost to Follow-up|0|||
147440385|NCT03716050|531777619|FG005|Overall Study|Lost to Follow-up|0|||
147440386|NCT03716050|531777620|FG006|Overall Study|Lost to Follow-up|0|||
147440387|NCT03716050|531777621|FG007|Overall Study|Lost to Follow-up|0|||
147541950|NCT01875991|532140532|FG000|Overall Study|Sponsor Decision|1|||
147541951|NCT01875991|532140533|FG001|Overall Study|Sponsor Decision|0|||
147541952|NCT02216214|532140534|FG000|Overall Study|Randomized Never Received Study Drug|1|||
147541953|NCT02216214|532140535|FG001|Overall Study|Randomized Never Received Study Drug|0|||
147541954|NCT02216214|532140534|FG000|Overall Study|Adverse Event|10|||
147541955|NCT02216214|532140535|FG001|Overall Study|Adverse Event|8|||
147541956|NCT02216214|532140534|FG000|Overall Study|Lack of Efficacy|2|||
147541957|NCT02216214|532140535|FG001|Overall Study|Lack of Efficacy|2|||
147541958|NCT02216214|532140534|FG000|Overall Study|Lost to Follow-up|3|||
147541959|NCT02216214|532140535|FG001|Overall Study|Lost to Follow-up|2|||
147541960|NCT02216214|532140534|FG000|Overall Study|Protocol Violation|4|||
147541961|NCT02216214|532140535|FG001|Overall Study|Protocol Violation|2|||
147541962|NCT02216214|532140534|FG000|Overall Study|Withdrawal by Subject|22|||
147541963|NCT02216214|532140535|FG001|Overall Study|Withdrawal by Subject|20|||
147541964|NCT02216214|532140534|FG000|Overall Study|Study Terminated By Sponsor|0|||
147541965|NCT02216214|532140535|FG001|Overall Study|Study Terminated By Sponsor|1|||
147541966|NCT02216214|532140534|FG000|Overall Study|Miscellaneous|1|||
147541967|NCT02216214|532140535|FG001|Overall Study|Miscellaneous|1|||
147541968|NCT05354206|532140536|FG000|Overall Study|Withdrawal by Subject|1|||
147541969|NCT05354206|532140537|FG001|Overall Study|Withdrawal by Subject|0|||
147541970|NCT01414062|532140538|FG000|Overall Study|Lost to Follow-up|3|||
147541971|NCT01414062|532140539|FG001|Overall Study|Lost to Follow-up|2|||
147541972|NCT01414062|532140538|FG000|Overall Study|Left Country|1|||
147541973|NCT01414062|532140539|FG001|Overall Study|Left Country|1|||
147541974|NCT01414062|532140538|FG000|Overall Study|Family Disapproval|1|||
147541975|NCT01414062|532140539|FG001|Overall Study|Family Disapproval|0|||
147541976|NCT01414062|532140538|FG000|Overall Study|Withdrawal by Subject|0|||
147541977|NCT01414062|532140539|FG001|Overall Study|Withdrawal by Subject|1|||
147541978|NCT04285983|532140540|FG000|Overall Study|Protocol Violation|6|||
147541979|NCT04936334|532140541|FG000|Overall Study|Metastatic disease found on PSMA-PET, surgery cancelled|1|||
147541980|NCT00902265|532140544|FG000|Overall Study|Lost to Follow-up Prior to First Visit|1|||
147541981|NCT00902265|532140544|FG000|Overall Study|Adverse Event|2|||
147541982|NCT00902265|532140544|FG000|Overall Study|Lack of Efficacy|2|||
147541983|NCT00902265|532140544|FG000|Overall Study|Protocol Violation|1|||
147541984|NCT02866695|532140547|FG000|Overall Study|Adverse Event|1|||
147541985|NCT02866695|532140547|FG000|Overall Study|Lost to Follow-up|1|||
147541986|NCT05016765|532140548|FG000|Overall Study|Lost to Follow-up|4|||
147541987|NCT03747939|532140549|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Death|0|||
147541988|NCT03747939|532140550|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Death|1|||
147541989|NCT03747939|532140551|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Death|0|||
147541990|NCT03747939|532140552|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Death|0|||
147541991|NCT03747939|532140549|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Adverse Event|8|||
147541992|NCT03747939|532140550|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Adverse Event|19|||
147541993|NCT03747939|532140551|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Adverse Event|0|||
147541994|NCT03747939|532140552|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Adverse Event|0|||
147541995|NCT03747939|532140549|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Pregnancy|0|||
147541996|NCT03747939|532140550|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Pregnancy|1|||
147541997|NCT03747939|532140551|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Pregnancy|0|||
147541998|NCT03747939|532140552|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Pregnancy|0|||
147541999|NCT03747939|532140549|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Lack of Efficacy|4|||
147542000|NCT03747939|532140550|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Lack of Efficacy|7|||
147542001|NCT03747939|532140551|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Lack of Efficacy|0|||
147542002|NCT03747939|532140552|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Lack of Efficacy|0|||
147542003|NCT03747939|532140549|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Non-compliance with study drug|1|||
147542004|NCT03747939|532140550|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Non-compliance with study drug|1|||
147542005|NCT03747939|532140551|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Non-compliance with study drug|0|||
147542006|NCT03747939|532140552|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Non-compliance with study drug|0|||
147542007|NCT03747939|532140549|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Lost to Follow-up|0|||
147542008|NCT03747939|532140550|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Lost to Follow-up|3|||
147542009|NCT03747939|532140551|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Lost to Follow-up|0|||
147542010|NCT03747939|532140552|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Lost to Follow-up|0|||
147542011|NCT03747939|532140549|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Protocol Violation|1|||
147542012|NCT03747939|532140550|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Protocol Violation|0|||
147542013|NCT03747939|532140551|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Protocol Violation|0|||
147542014|NCT03747939|532140552|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Protocol Violation|0|||
147542015|NCT03747939|532140549|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Withdrawal by Subject|4|||
147542016|NCT03747939|532140550|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Withdrawal by Subject|7|||
147542017|NCT03747939|532140551|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Withdrawal by Subject|0|||
147542018|NCT03747939|532140552|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Withdrawal by Subject|0|||
147542019|NCT03747939|532140549|FG000|Placebo-controlled Phase (Weeks 0 - 24)|Miscellaneous|0|||
147542020|NCT03747939|532140550|FG001|Placebo-controlled Phase (Weeks 0 - 24)|Miscellaneous|2|||
147542021|NCT03747939|532140551|FG002|Placebo-controlled Phase (Weeks 0 - 24)|Miscellaneous|0|||
147542022|NCT03747939|532140552|FG003|Placebo-controlled Phase (Weeks 0 - 24)|Miscellaneous|0|||
147542023|NCT03747939|532140549|FG000|Apremilast Extension (Weeks 24 - 48)|Adverse Event|0|||
147542024|NCT03747939|532140550|FG001|Apremilast Extension (Weeks 24 - 48)|Adverse Event|0|||
147542025|NCT03747939|532140551|FG002|Apremilast Extension (Weeks 24 - 48)|Adverse Event|2|||
147542026|NCT03747939|532140552|FG003|Apremilast Extension (Weeks 24 - 48)|Adverse Event|6|||
147542027|NCT03747939|532140549|FG000|Apremilast Extension (Weeks 24 - 48)|Lack of Efficacy|0|||
147542028|NCT03747939|532140550|FG001|Apremilast Extension (Weeks 24 - 48)|Lack of Efficacy|0|||
147542029|NCT03747939|532140551|FG002|Apremilast Extension (Weeks 24 - 48)|Lack of Efficacy|3|||
147542030|NCT03747939|532140552|FG003|Apremilast Extension (Weeks 24 - 48)|Lack of Efficacy|8|||
147542031|NCT03747939|532140549|FG000|Apremilast Extension (Weeks 24 - 48)|Lost to Follow-up|0|||
147210437|NCT04518995|530942720|FG000|Overall Study|Reason not Specified|4|||
147542032|NCT03747939|532140550|FG001|Apremilast Extension (Weeks 24 - 48)|Lost to Follow-up|0|||
147542033|NCT03747939|532140551|FG002|Apremilast Extension (Weeks 24 - 48)|Lost to Follow-up|4|||
147542034|NCT03747939|532140552|FG003|Apremilast Extension (Weeks 24 - 48)|Lost to Follow-up|1|||
147542035|NCT03747939|532140549|FG000|Apremilast Extension (Weeks 24 - 48)|Withdrawal by Subject|0|||
147542036|NCT03747939|532140550|FG001|Apremilast Extension (Weeks 24 - 48)|Withdrawal by Subject|0|||
147542037|NCT03747939|532140551|FG002|Apremilast Extension (Weeks 24 - 48)|Withdrawal by Subject|1|||
147542038|NCT03747939|532140552|FG003|Apremilast Extension (Weeks 24 - 48)|Withdrawal by Subject|7|||
147542039|NCT03747939|532140549|FG000|Apremilast Extension (Weeks 24 - 48)|Other|0|||
147542040|NCT03747939|532140550|FG001|Apremilast Extension (Weeks 24 - 48)|Other|0|||
147542041|NCT03747939|532140551|FG002|Apremilast Extension (Weeks 24 - 48)|Other|0|||
147542042|NCT03747939|532140552|FG003|Apremilast Extension (Weeks 24 - 48)|Other|7|||
147542043|NCT01447628|532140555|FG000|Week 0 to Week 12 (1st Intervention)|Adverse Event|0|||
147542044|NCT01447628|532140556|FG001|Week 0 to Week 12 (1st Intervention)|Adverse Event|0|||
147542045|NCT01447628|532140557|FG002|Week 0 to Week 12 (1st Intervention)|Adverse Event|0|||
147542046|NCT01447628|532140558|FG003|Week 0 to Week 12 (1st Intervention)|Adverse Event|1|||
147542047|NCT00185731|532140559|FG000|Overall Study|Withdrawal by Subject|1|||
147542048|NCT00185731|532140559|FG000|Overall Study|Not Eligible|1|||
147542049|NCT03087773|532140560|FG000|Overall Study|Withdrawal by Subject|8|||
147542050|NCT03087773|532140561|FG001|Overall Study|Withdrawal by Subject|4|||
147542051|NCT03087773|532140560|FG000|Overall Study|Lost to Follow-up|12|||
147542052|NCT03087773|532140561|FG001|Overall Study|Lost to Follow-up|8|||
147542053|NCT05144477|532140564|FG000|Overall Study|Withdrawal by Subject|1|||
147542054|NCT05144477|532140565|FG001|Overall Study|Withdrawal by Subject|1|||
147542055|NCT00627458|532140568|FG000|Overall Study|Migrated from study area|1|||
147542056|NCT00627458|532140569|FG001|Overall Study|Migrated from study area|0|||
147542057|NCT00627458|532140570|FG002|Overall Study|Migrated from study area|1|||
147542058|NCT00627458|532140568|FG000|Overall Study|Withdrawal by Subject|2|||
147542059|NCT00627458|532140569|FG001|Overall Study|Withdrawal by Subject|6|||
147542060|NCT00627458|532140570|FG002|Overall Study|Withdrawal by Subject|5|||
147542061|NCT00627458|532140568|FG000|Overall Study|Lost to Follow-up|1|||
147542062|NCT00627458|532140569|FG001|Overall Study|Lost to Follow-up|1|||
147542063|NCT00627458|532140570|FG002|Overall Study|Lost to Follow-up|0|||
147542064|NCT03891875|532140571|FG000|Overall Study|Withdrawal by Subject|20|||
147542065|NCT03891875|532140572|FG001|Overall Study|Withdrawal by Subject|3|||
147542066|NCT03891875|532140571|FG000|Overall Study|Adverse Event|10|||
147542067|NCT03891875|532140572|FG001|Overall Study|Adverse Event|4|||
147542068|NCT03891875|532140571|FG000|Overall Study|Physician Decision|1|||
147542069|NCT03891875|532140572|FG001|Overall Study|Physician Decision|1|||
147542070|NCT03891875|532140571|FG000|Overall Study|Protocol Violation|1|||
147542071|NCT03891875|532140572|FG001|Overall Study|Protocol Violation|0|||
147542072|NCT03891875|532140571|FG000|Overall Study|Lost to Follow-up|1|||
147542073|NCT03891875|532140572|FG001|Overall Study|Lost to Follow-up|0|||
147542074|NCT03891875|532140571|FG000|Overall Study|COVID-19 infection|1|||
147542075|NCT03891875|532140572|FG001|Overall Study|COVID-19 infection|0|||
147542076|NCT02181842|532140573|FG000|Overall Study|Case Report Forms Uncollected|2|||
147542077|NCT04529096|532140574|FG000|Overall Study|Adverse Event|6|||
147542078|NCT04529096|532140575|FG001|Overall Study|Adverse Event|1|||
147542079|NCT04529096|532140574|FG000|Overall Study|Lack of Efficacy|1|||
147542080|NCT04529096|532140575|FG001|Overall Study|Lack of Efficacy|0|||
147542081|NCT04529096|532140574|FG000|Overall Study|Lost to Follow-up|1|||
147210438|NCT04518995|530942721|FG001|Overall Study|Reason not Specified|11|||
147210439|NCT04518995|530942722|FG002|Overall Study|Reason not Specified|2|||
147542082|NCT04529096|532140575|FG001|Overall Study|Lost to Follow-up|1|||
147210440|NCT04518995|530942720|FG000|Overall Study|Lost to Follow-up|1|||
147542083|NCT04529096|532140574|FG000|Overall Study|Non-Compliance With Study Drug|0|||
147542084|NCT04529096|532140575|FG001|Overall Study|Non-Compliance With Study Drug|1|||
147542085|NCT04529096|532140574|FG000|Overall Study|Physician Decision|1|||
147542086|NCT04529096|532140575|FG001|Overall Study|Physician Decision|3|||
147542087|NCT04529096|532140574|FG000|Overall Study|Withdrawal by Subject|5|||
147542088|NCT04529096|532140575|FG001|Overall Study|Withdrawal by Subject|0|||
147542089|NCT00758706|532140576|FG000|Overall Study|Adverse Event|4|||
147542090|NCT00758706|532140577|FG001|Overall Study|Adverse Event|4|||
147542091|NCT03454672|532140587|FG000|Overall Study|Adverse Event|1|||
147542092|NCT03454672|532140588|FG001|Overall Study|Adverse Event|1|||
147542093|NCT03454672|532140587|FG000|Overall Study|Lost to Follow-up|1|||
147542094|NCT03454672|532140588|FG001|Overall Study|Lost to Follow-up|3|||
147542095|NCT03454672|532140587|FG000|Overall Study|painful|1|||
147542096|NCT03454672|532140588|FG001|Overall Study|painful|2|||
147542097|NCT03454672|532140587|FG000|Overall Study|Non-compliance|2|||
147542098|NCT03454672|532140588|FG001|Overall Study|Non-compliance|4|||
147542099|NCT03454672|532140587|FG000|Overall Study|personal reasons|3|||
147542100|NCT03454672|532140588|FG001|Overall Study|personal reasons|2|||
147542101|NCT03454672|532140587|FG000|Overall Study|Withdrawal by Subject|1|||
147542102|NCT03454672|532140588|FG001|Overall Study|Withdrawal by Subject|0|||
147542103|NCT01488071|532140592|FG000|Overall Study|Adverse Event|15|||
147542104|NCT01488071|532140593|FG001|Overall Study|Adverse Event|23|||
147542105|NCT01488071|532140592|FG000|Overall Study|Lack of Efficacy|11|||
147542106|NCT01488071|532140593|FG001|Overall Study|Lack of Efficacy|17|||
147542107|NCT01488071|532140592|FG000|Overall Study|Non-compliance with study drug|2|||
147542108|NCT01488071|532140593|FG001|Overall Study|Non-compliance with study drug|0|||
147542109|NCT01488071|532140592|FG000|Overall Study|Protocol Violation|5|||
147542110|NCT01488071|532140593|FG001|Overall Study|Protocol Violation|7|||
147542111|NCT01488071|532140592|FG000|Overall Study|Withdrawal of Consent|14|||
147542112|NCT01488071|532140593|FG001|Overall Study|Withdrawal of Consent|12|||
147542113|NCT01488071|532140592|FG000|Overall Study|Lost to Follow-up|1|||
147542114|NCT01488071|532140593|FG001|Overall Study|Lost to Follow-up|0|||
147542115|NCT01488071|532140592|FG000|Overall Study|Administrative or Other Reason(s)|5|||
147542116|NCT01488071|532140593|FG001|Overall Study|Administrative or Other Reason(s)|4|||
147542117|NCT02139306|532140594|FG000|Overall Study|Withdrawal by Subject|4|||
147210441|NCT04518995|530942721|FG001|Overall Study|Lost to Follow-up|10|||
147210442|NCT04518995|530942722|FG002|Overall Study|Lost to Follow-up|6|||
147210443|NCT00669409|530942725|FG000|Part 2|Withdrawal by Subject|0|||
147210444|NCT00669409|530942726|FG001|Part 2|Withdrawal by Subject|0|||
147210445|NCT00669409|530942727|FG002|Part 2|Withdrawal by Subject|0|||
147210446|NCT00669409|530942728|FG003|Part 2|Withdrawal by Subject|0|||
147210447|NCT00669409|530942729|FG004|Part 2|Withdrawal by Subject|0|||
147210448|NCT00669409|530942730|FG005|Part 2|Withdrawal by Subject|0|||
147210449|NCT00669409|530942731|FG006|Part 2|Withdrawal by Subject|0|||
147210450|NCT00669409|530942732|FG007|Part 2|Withdrawal by Subject|0|||
147440388|NCT03716050|531777614|FG000|Overall Study|Physician Decision|0|||
147440389|NCT03716050|531777615|FG001|Overall Study|Physician Decision|0|||
147440390|NCT03716050|531777616|FG002|Overall Study|Physician Decision|0|||
147440391|NCT03716050|531777617|FG003|Overall Study|Physician Decision|1|||
147440392|NCT03716050|531777618|FG004|Overall Study|Physician Decision|0|||
147440393|NCT03716050|531777619|FG005|Overall Study|Physician Decision|0|||
147440394|NCT03716050|531777620|FG006|Overall Study|Physician Decision|0|||
147440395|NCT03716050|531777621|FG007|Overall Study|Physician Decision|0|||
147440396|NCT03716050|531777614|FG000|Overall Study|Protocol Violation|0|||
147440397|NCT03716050|531777615|FG001|Overall Study|Protocol Violation|0|||
147440398|NCT03716050|531777616|FG002|Overall Study|Protocol Violation|0|||
147440399|NCT03716050|531777617|FG003|Overall Study|Protocol Violation|1|||
147440400|NCT03716050|531777618|FG004|Overall Study|Protocol Violation|0|||
147440401|NCT03716050|531777619|FG005|Overall Study|Protocol Violation|0|||
147440402|NCT03716050|531777620|FG006|Overall Study|Protocol Violation|0|||
147440403|NCT03716050|531777621|FG007|Overall Study|Protocol Violation|2|||
147440404|NCT02361944|531777622|FG000|Overall Study|surgery cancellation|0|||
147440405|NCT02361944|531777623|FG001|Overall Study|surgery cancellation|1|||
147440406|NCT01221727|531777624|FG000|Overall Study|Physician Decision|2|||
147440407|NCT01221727|531777625|FG001|Overall Study|Physician Decision|0|||
147440408|NCT01221727|531777624|FG000|Overall Study|Withdrawal by Subject|1|||
147440409|NCT01221727|531777625|FG001|Overall Study|Withdrawal by Subject|1|||
147440410|NCT00529451|531777626|FG000|Overall Study|Subject withdrew consent|16|||
147542118|NCT02139306|532140595|FG001|Overall Study|Withdrawal by Subject|6|||
147542119|NCT02139306|532140594|FG000|Overall Study|Adverse Event|3|||
147542120|NCT02139306|532140595|FG001|Overall Study|Adverse Event|4|||
147210451|NCT00669409|530942733|FG008|Part 2|Withdrawal by Subject|0|||
147440411|NCT00529451|531777627|FG001|Overall Study|Subject withdrew consent|21|||
147440412|NCT00529451|531777628|FG002|Overall Study|Subject withdrew consent|13|||
147440413|NCT00529451|531777629|FG003|Overall Study|Subject withdrew consent|12|||
147440414|NCT00529451|531777626|FG000|Overall Study|Adverse Event|9|||
147440415|NCT00529451|531777627|FG001|Overall Study|Adverse Event|16|||
147440416|NCT00529451|531777628|FG002|Overall Study|Adverse Event|14|||
147542121|NCT02139306|532140594|FG000|Overall Study|Physician Decision|0|||
147542122|NCT02139306|532140595|FG001|Overall Study|Physician Decision|1|||
147542123|NCT02139306|532140594|FG000|Overall Study|Other Unspecified|2|||
147542124|NCT02139306|532140595|FG001|Overall Study|Other Unspecified|3|||
147210452|NCT00669409|530942734|FG009|Part 2|Withdrawal by Subject|1|||
147210453|NCT00669409|530942735|FG010|Part 2|Withdrawal by Subject|0|||
147210454|NCT00813943|530942736|FG000|Overall Study|Ongoing at cut-off date|5|||
147210455|NCT00813943|530942737|FG001|Overall Study|Ongoing at cut-off date|5|||
147210456|NCT00813943|530942738|FG002|Overall Study|Ongoing at cut-off date|3|||
147210457|NCT05367492|530942739|FG000|Study Intervention (Week 12)|Withdrawal by Subject|0|||
147210458|NCT05367492|530942740|FG001|Study Intervention (Week 12)|Withdrawal by Subject|2|||
147210459|NCT05367492|530942741|FG002|Study Intervention (Week 12)|Withdrawal by Subject|0|||
147210460|NCT05367492|530942739|FG000|Study Intervention (Week 12)|Lost to Follow-up|0|||
147210461|NCT05367492|530942740|FG001|Study Intervention (Week 12)|Lost to Follow-up|2|||
147210462|NCT05367492|530942741|FG002|Study Intervention (Week 12)|Lost to Follow-up|1|||
147210463|NCT05367492|530942739|FG000|Study Follow Up (Week 24)|Withdrawal by Subject|0|||
147210464|NCT05367492|530942740|FG001|Study Follow Up (Week 24)|Withdrawal by Subject|1|||
147210465|NCT05367492|530942741|FG002|Study Follow Up (Week 24)|Withdrawal by Subject|0|||
147210466|NCT05367492|530942739|FG000|Study Follow Up (Week 24)|Lost to Follow-up|0|||
147210467|NCT05367492|530942740|FG001|Study Follow Up (Week 24)|Lost to Follow-up|1|||
147210468|NCT05367492|530942741|FG002|Study Follow Up (Week 24)|Lost to Follow-up|0|||
147210469|NCT02891070|530942750|FG000|Overall Study|Adverse Event|1|||
147440417|NCT00529451|531777629|FG003|Overall Study|Adverse Event|8|||
147440418|NCT00529451|531777626|FG000|Overall Study|Unsatisfactory therapeutic response|6|||
147440419|NCT00529451|531777627|FG001|Overall Study|Unsatisfactory therapeutic response|2|||
147440420|NCT00529451|531777628|FG002|Overall Study|Unsatisfactory therapeutic response|5|||
147440421|NCT00529451|531777629|FG003|Overall Study|Unsatisfactory therapeutic response|4|||
147440422|NCT00529451|531777626|FG000|Overall Study|Lost to Follow-up|4|||
147440423|NCT00529451|531777627|FG001|Overall Study|Lost to Follow-up|7|||
147440424|NCT00529451|531777628|FG002|Overall Study|Lost to Follow-up|4|||
147440425|NCT00529451|531777629|FG003|Overall Study|Lost to Follow-up|4|||
147440426|NCT00529451|531777626|FG000|Overall Study|Protocol deviation|1|||
147440427|NCT00529451|531777627|FG001|Overall Study|Protocol deviation|1|||
147440428|NCT00529451|531777628|FG002|Overall Study|Protocol deviation|4|||
147440429|NCT00529451|531777629|FG003|Overall Study|Protocol deviation|1|||
147440430|NCT00529451|531777626|FG000|Overall Study|Administrative problems|1|||
147440431|NCT00529451|531777627|FG001|Overall Study|Administrative problems|1|||
147440432|NCT00529451|531777628|FG002|Overall Study|Administrative problems|0|||
147440433|NCT00529451|531777629|FG003|Overall Study|Administrative problems|2|||
147440434|NCT03086057|531777631|FG000|Stage 1: PrEP Uptake|Incarcerated|3|||
147440435|NCT03086057|531777632|FG001|Stage 1: PrEP Uptake|Incarcerated|1|||
147440436|NCT03086057|531777633|FG002|Stage 1: PrEP Uptake|Incarcerated|0|||
147440437|NCT03086057|531777634|FG003|Stage 1: PrEP Uptake|Incarcerated|0|||
147440438|NCT03086057|531777631|FG000|Stage 1: PrEP Uptake|Withdrawal by Subject|1|||
147440439|NCT03086057|531777632|FG001|Stage 1: PrEP Uptake|Withdrawal by Subject|4|||
147440440|NCT03086057|531777633|FG002|Stage 1: PrEP Uptake|Withdrawal by Subject|0|||
147440441|NCT03086057|531777634|FG003|Stage 1: PrEP Uptake|Withdrawal by Subject|0|||
147440442|NCT03086057|531777631|FG000|Stage 1: PrEP Uptake|Lost to Follow-up|6|||
147440443|NCT03086057|531777632|FG001|Stage 1: PrEP Uptake|Lost to Follow-up|5|||
147440444|NCT03086057|531777633|FG002|Stage 1: PrEP Uptake|Lost to Follow-up|0|||
147440445|NCT03086057|531777634|FG003|Stage 1: PrEP Uptake|Lost to Follow-up|0|||
147440446|NCT03086057|531777631|FG000|Stage 1: PrEP Uptake|Death|1|||
147440447|NCT03086057|531777632|FG001|Stage 1: PrEP Uptake|Death|0|||
147440448|NCT03086057|531777633|FG002|Stage 1: PrEP Uptake|Death|0|||
147440449|NCT03086057|531777634|FG003|Stage 1: PrEP Uptake|Death|0|||
147440450|NCT03086057|531777631|FG000|Stage 2: PrEP Adherence|Incarcerated|0|||
147440451|NCT03086057|531777632|FG001|Stage 2: PrEP Adherence|Incarcerated|0|||
147440452|NCT03086057|531777633|FG002|Stage 2: PrEP Adherence|Incarcerated|2|||
147440453|NCT03086057|531777634|FG003|Stage 2: PrEP Adherence|Incarcerated|0|||
147440454|NCT03086057|531777631|FG000|Stage 2: PrEP Adherence|Withdrawal by Subject|0|||
147440455|NCT03086057|531777632|FG001|Stage 2: PrEP Adherence|Withdrawal by Subject|0|||
147440456|NCT03086057|531777633|FG002|Stage 2: PrEP Adherence|Withdrawal by Subject|1|||
147440457|NCT03086057|531777634|FG003|Stage 2: PrEP Adherence|Withdrawal by Subject|0|||
147440458|NCT03086057|531777631|FG000|Stage 2: PrEP Adherence|Lost to Follow-up|0|||
147440459|NCT03086057|531777632|FG001|Stage 2: PrEP Adherence|Lost to Follow-up|0|||
147440460|NCT03086057|531777633|FG002|Stage 2: PrEP Adherence|Lost to Follow-up|3|||
147440461|NCT03086057|531777634|FG003|Stage 2: PrEP Adherence|Lost to Follow-up|2|||
147440462|NCT01494350|531777635|FG000|Overall Study|Worsening of lesion|1|||
147440463|NCT03098836|531777641|FG000|Overall Study|Adverse Event|1|||
147440464|NCT03098836|531777642|FG001|Overall Study|Adverse Event|3|||
147440465|NCT03098836|531777641|FG000|Overall Study|Lack of Efficacy|30|||
147440466|NCT03098836|531777642|FG001|Overall Study|Lack of Efficacy|15|||
147440467|NCT03098836|531777641|FG000|Overall Study|Physician Decision|2|||
147440468|NCT03098836|531777642|FG001|Overall Study|Physician Decision|1|||
147440469|NCT03098836|531777641|FG000|Overall Study|Withdrawal by Subject|3|||
147649441|NCT02634801|532537343|FG002|Follow-up Period|Lost to Follow-up|2|||
147440470|NCT03098836|531777642|FG001|Overall Study|Withdrawal by Subject|2|||
147440471|NCT03986866|531777643|FG000|Overall Study|Withdrawal by Subject|0|||
147440472|NCT03986866|531777644|FG001|Overall Study|Withdrawal by Subject|3|||
147210470|NCT02891070|530942751|FG001|Overall Study|Adverse Event|0|||
147210471|NCT02891070|530942750|FG000|Overall Study|Physician Decision|0|||
147210472|NCT02891070|530942751|FG001|Overall Study|Physician Decision|1|||
147542125|NCT02139306|532140594|FG000|Overall Study|Protocol Violation|4|||
147542126|NCT02139306|532140595|FG001|Overall Study|Protocol Violation|0|||
147542127|NCT04449354|532140596|FG000|Overall Study|Withdrawal by Subject|1|||
147542128|NCT05899218|532140597|FG000|Overall Study|Lost to Follow-up|2|||
147542129|NCT05899218|532140598|FG001|Overall Study|Lost to Follow-up|2|||
147542130|NCT05899218|532140597|FG000|Overall Study|deemed ineligible out of country|1|||
147542131|NCT05899218|532140598|FG001|Overall Study|deemed ineligible out of country|0|||
147542132|NCT02587325|532140599|FG000|16-Week Dose-finding Safety Part|Adverse Event|1|||
147542133|NCT02587325|532140600|FG001|16-Week Dose-finding Safety Part|Adverse Event|0|||
147542134|NCT02587325|532140601|FG002|16-Week Dose-finding Safety Part|Adverse Event|0|||
147542135|NCT02587325|532140602|FG003|16-Week Dose-finding Safety Part|Adverse Event|0|||
147542136|NCT02587325|532140603|FG004|16-Week Dose-finding Safety Part|Adverse Event|0|||
147542137|NCT02587325|532140599|FG000|16-Week Dose-finding Safety Part|COVID-19 risk|0|||
147542138|NCT02587325|532140600|FG001|16-Week Dose-finding Safety Part|COVID-19 risk|0|||
147542139|NCT02587325|532140601|FG002|16-Week Dose-finding Safety Part|COVID-19 risk|0|||
147542140|NCT02587325|532140602|FG003|16-Week Dose-finding Safety Part|COVID-19 risk|1|||
147542141|NCT02587325|532140603|FG004|16-Week Dose-finding Safety Part|COVID-19 risk|0|||
147542142|NCT02587325|532140599|FG000|32-Week Optional Extension Part|Adverse Event|0|||
147542143|NCT02587325|532140600|FG001|32-Week Optional Extension Part|Adverse Event|0|||
147542144|NCT02587325|532140601|FG002|32-Week Optional Extension Part|Adverse Event|1|||
147542145|NCT02587325|532140602|FG003|32-Week Optional Extension Part|Adverse Event|0|||
147542146|NCT02587325|532140603|FG004|32-Week Optional Extension Part|Adverse Event|0|||
147542147|NCT02587325|532140599|FG000|32-Week Optional Extension Part|Lost to Follow-up|0|||
147542148|NCT02587325|532140600|FG001|32-Week Optional Extension Part|Lost to Follow-up|0|||
147542149|NCT02587325|532140601|FG002|32-Week Optional Extension Part|Lost to Follow-up|1|||
147542150|NCT02587325|532140602|FG003|32-Week Optional Extension Part|Lost to Follow-up|0|||
147542151|NCT02587325|532140603|FG004|32-Week Optional Extension Part|Lost to Follow-up|1|||
147542152|NCT00390572|532140604|FG000|Overall Study|Lost to Follow-up|8|||
147542153|NCT00390572|532140605|FG001|Overall Study|Lost to Follow-up|4|||
147542154|NCT00390572|532140604|FG000|Overall Study|health condition|0|||
147542155|NCT00390572|532140605|FG001|Overall Study|health condition|1|||
147542156|NCT02913261|532140612|FG000|Overall Study|Technical problems|0|||
147542157|NCT02913261|532140613|FG001|Overall Study|Technical problems|1|||
147542158|NCT02913261|532140612|FG000|Overall Study|Lack of Efficacy|32|||
147542159|NCT02913261|532140613|FG001|Overall Study|Lack of Efficacy|69|||
147542160|NCT02913261|532140612|FG000|Overall Study|Adverse Event|27|||
147440473|NCT03986866|531777643|FG000|Overall Study|patient required admission so no longer fit study exclusion criteria of ambulatory surgery|2|||
147440474|NCT03986866|531777644|FG001|Overall Study|patient required admission so no longer fit study exclusion criteria of ambulatory surgery|2|||
147440475|NCT00898443|531777645|FG000|Overall Study|Withdrawal by Subject|1|||
147440476|NCT00898443|531777646|FG001|Overall Study|Withdrawal by Subject|0|||
147440477|NCT02303704|531777647|FG000|Overall Study|Protocol Violation|5|||
147440478|NCT02303704|531777648|FG001|Overall Study|Protocol Violation|9|||
147440479|NCT01034540|531777651|FG000|Overall Study|Adverse Event|0|||
147440480|NCT01034540|531777652|FG001|Overall Study|Adverse Event|1|||
147440481|NCT00932425|531777653|FG000|Overall Study|Lost to Follow-up|0|||
147440482|NCT00932425|531777654|FG001|Overall Study|Lost to Follow-up|1|||
147440483|NCT00932425|531777653|FG000|Overall Study|Withdrawal by Subject|0|||
147440484|NCT00932425|531777654|FG001|Overall Study|Withdrawal by Subject|1|||
147440485|NCT01721876|531777658|FG000|Overall Study|Not treated|1|||
147440486|NCT01721876|531777659|FG001|Overall Study|Not treated|4|||
147440487|NCT01721876|531777658|FG000|Overall Study|Disease progression / relapse|123|||
147440488|NCT01721876|531777659|FG001|Overall Study|Disease progression / relapse|156|||
147440489|NCT01721876|531777658|FG000|Overall Study|Death|6|||
147440490|NCT01721876|531777659|FG001|Overall Study|Death|13|||
147440491|NCT01721876|531777658|FG000|Overall Study|Adverse Event|41|||
147440492|NCT01721876|531777659|FG001|Overall Study|Adverse Event|165|||
147440493|NCT01721876|531777658|FG000|Overall Study|Protocol Violation|2|||
147440494|NCT01721876|531777659|FG001|Overall Study|Protocol Violation|1|||
147440495|NCT01721876|531777658|FG000|Overall Study|Withdrawal by Subject|15|||
147440496|NCT01721876|531777659|FG001|Overall Study|Withdrawal by Subject|38|||
147440497|NCT01721876|531777658|FG000|Overall Study|Reason not listed|34|||
147440498|NCT01721876|531777659|FG001|Overall Study|Reason not listed|63|||
147440499|NCT01721876|531777658|FG000|Overall Study|Sponsor terminated trial|0|||
147542161|NCT02913261|532140613|FG001|Overall Study|Adverse Event|5|||
147542162|NCT02913261|532140612|FG000|Overall Study|Death|25|||
147542163|NCT02913261|532140613|FG001|Overall Study|Death|22|||
147210473|NCT02891070|530942750|FG000|Overall Study|Lost to Follow-up|4|||
147440500|NCT01721876|531777659|FG001|Overall Study|Sponsor terminated trial|4|||
147440501|NCT00493220|531777660|FG000|Third Intervention|Withdrawal by Subject|1|||
147440502|NCT00493220|531777661|FG001|Third Intervention|Withdrawal by Subject|0|||
147440503|NCT00493220|531777662|FG002|Third Intervention|Withdrawal by Subject|0|||
147440504|NCT00493220|531777663|FG003|Third Intervention|Withdrawal by Subject|0|||
147542164|NCT02913261|532140612|FG000|Overall Study|Failure to meet protocol continuation criteria|13|||
147542165|NCT02913261|532140613|FG001|Overall Study|Failure to meet protocol continuation criteria|10|||
147542166|NCT02913261|532140612|FG000|Overall Study|Disease relapse|8|||
147542167|NCT02913261|532140613|FG001|Overall Study|Disease relapse|13|||
147542168|NCT02913261|532140612|FG000|Overall Study|Physician Decision|8|||
147542169|NCT02913261|532140613|FG001|Overall Study|Physician Decision|9|||
147542170|NCT02913261|532140612|FG000|Overall Study|Subject/guardian decision|4|||
147542171|NCT02913261|532140613|FG001|Overall Study|Subject/guardian decision|6|||
147542172|NCT02913261|532140612|FG000|Overall Study|Graft loss|2|||
147542173|NCT02913261|532140613|FG001|Overall Study|Graft loss|0|||
147542174|NCT02304302|532140614|FG000|Overall Study|Adverse Event|2|||
147542175|NCT02304302|532140615|FG001|Overall Study|Adverse Event|3|||
147542176|NCT02304302|532140614|FG000|Overall Study|Lost to Follow-up|1|||
147542177|NCT02304302|532140615|FG001|Overall Study|Lost to Follow-up|4|||
147542178|NCT02304302|532140614|FG000|Overall Study|Removed from analysis due to low medication compliance|0|||
147542179|NCT02304302|532140615|FG001|Overall Study|Removed from analysis due to low medication compliance|1|||
147542180|NCT00391118|532140616|FG000|Overall Study|Adverse Event|3|||
147542181|NCT00391118|532140617|FG001|Overall Study|Adverse Event|10|||
147542182|NCT00391118|532140618|FG002|Overall Study|Adverse Event|7|||
147542183|NCT00391118|532140616|FG000|Overall Study|Lost to Follow-up|0|||
147542184|NCT00391118|532140617|FG001|Overall Study|Lost to Follow-up|2|||
147542185|NCT00391118|532140618|FG002|Overall Study|Lost to Follow-up|3|||
147542186|NCT00391118|532140616|FG000|Overall Study|Withdrawal by Subject|0|||
147542187|NCT00391118|532140617|FG001|Overall Study|Withdrawal by Subject|9|||
147542188|NCT00391118|532140618|FG002|Overall Study|Withdrawal by Subject|1|||
147542189|NCT00391118|532140616|FG000|Overall Study|Death|0|||
147542190|NCT00391118|532140617|FG001|Overall Study|Death|1|||
147542191|NCT00391118|532140618|FG002|Overall Study|Death|0|||
147542192|NCT00391118|532140616|FG000|Overall Study|Physician Decision|0|||
147542193|NCT00391118|532140617|FG001|Overall Study|Physician Decision|3|||
147542194|NCT00391118|532140618|FG002|Overall Study|Physician Decision|0|||
147542195|NCT00391118|532140616|FG000|Overall Study|Protocol Entry Criteria Not Met|0|||
147542196|NCT00391118|532140617|FG001|Overall Study|Protocol Entry Criteria Not Met|3|||
147542197|NCT00391118|532140618|FG002|Overall Study|Protocol Entry Criteria Not Met|1|||
147542198|NCT00391118|532140616|FG000|Overall Study|Progressive Disease|7|||
147542199|NCT00391118|532140617|FG001|Overall Study|Progressive Disease|26|||
147542200|NCT00391118|532140618|FG002|Overall Study|Progressive Disease|43|||
147542201|NCT00391118|532140616|FG000|Overall Study|Sponsor Decision|0|||
147542202|NCT00391118|532140617|FG001|Overall Study|Sponsor Decision|1|||
147542203|NCT00391118|532140618|FG002|Overall Study|Sponsor Decision|3|||
147542204|NCT00391118|532140616|FG000|Overall Study|Protocol Violation|1|||
147542205|NCT00391118|532140617|FG001|Overall Study|Protocol Violation|0|||
147542206|NCT00391118|532140618|FG002|Overall Study|Protocol Violation|0|||
147542207|NCT01892020|532140619|FG000|Period 1|Adverse Event|1|||
147210474|NCT02891070|530942751|FG001|Overall Study|Lost to Follow-up|4|||
147210475|NCT02891070|530942750|FG000|Overall Study|Other|1|||
147210476|NCT02891070|530942751|FG001|Overall Study|Other|0|||
147210477|NCT02891070|530942750|FG000|Overall Study|Protocol Violation|0|||
147210478|NCT02891070|530942751|FG001|Overall Study|Protocol Violation|1|||
147210479|NCT02891070|530942750|FG000|Overall Study|Withdrawal by Subject|1|||
147210480|NCT02891070|530942751|FG001|Overall Study|Withdrawal by Subject|2|||
147210481|NCT02891070|530942750|FG000|Overall Study|Death|3|||
147210482|NCT02891070|530942751|FG001|Overall Study|Death|0|||
147210483|NCT02704143|530942752|FG000|Overall Study|disease progression|10|||
147210484|NCT01235598|530942753|FG000|Overall Study|Adverse Event|0|||
147210485|NCT01235598|530942754|FG001|Overall Study|Adverse Event|3|||
147210486|NCT01235598|530942753|FG000|Overall Study|Lack of Efficacy|0|||
147210487|NCT01235598|530942754|FG001|Overall Study|Lack of Efficacy|1|||
147210488|NCT01235598|530942753|FG000|Overall Study|Withdrawal by Subject|1|||
147210489|NCT01235598|530942754|FG001|Overall Study|Withdrawal by Subject|0|||
147210490|NCT04491604|530942759|FG000|Overall Study|Withdrawal by Subject|3|||
147210491|NCT01523275|530942764|FG000|Overall Study|Lost to Follow-up|1|||
147210492|NCT01523275|530942765|FG001|Overall Study|Lost to Follow-up|2|||
147210493|NCT01523275|530942764|FG000|Overall Study|Withdrawal by Subject|1|||
147210494|NCT01523275|530942765|FG001|Overall Study|Withdrawal by Subject|0|||
147210495|NCT01206322|530942766|FG000|Overall Study|Adverse Event|0|||
147210496|NCT01206322|530942767|FG001|Overall Study|Adverse Event|0|||
147210497|NCT01206322|530942768|FG002|Overall Study|Adverse Event|0|||
147210498|NCT01206322|530942769|FG003|Overall Study|Adverse Event|1|||
147210499|NCT02888119|530942774|FG000|Overall Study|Lost to Follow-up|5|||
147210500|NCT02888119|530942775|FG001|Overall Study|Lost to Follow-up|4|||
147542208|NCT01892020|532140620|FG001|Period 1|Adverse Event|1|||
147542209|NCT01892020|532140619|FG000|Period 1|Protocol Violation|2|||
147542210|NCT01892020|532140620|FG001|Period 1|Protocol Violation|4|||
147210501|NCT02888119|530942776|FG002|Overall Study|Lost to Follow-up|0|||
147210502|NCT01767142|530942777|FG000|Overall Study|Lost to Follow-up|3|||
147210503|NCT00926029|530942783|FG000|Overall Study|Lost to Follow-up|2|||
147210504|NCT00926029|530942784|FG001|Overall Study|Lost to Follow-up|1|||
147210505|NCT00926029|530942785|FG002|Overall Study|Lost to Follow-up|1|||
147542211|NCT01892020|532140619|FG000|Period 1|Unclassified|0|||
147542212|NCT01892020|532140620|FG001|Period 1|Unclassified|1|||
147542213|NCT01892020|532140619|FG000|Period 2|Protocol Violation|1|||
147542214|NCT01892020|532140620|FG001|Period 2|Protocol Violation|0|||
147542215|NCT03078192|532140625|FG000|Overall Study|Withdrawal by Subject|2|||
147542216|NCT03078192|532140626|FG001|Overall Study|Withdrawal by Subject|1|||
147542217|NCT03078192|532140625|FG000|Overall Study|screen failure|0|||
147542218|NCT03078192|532140626|FG001|Overall Study|screen failure|3|||
147542219|NCT03252756|532140629|FG000|Overall Study|Protocol Violation|2|||
147542220|NCT03252756|532140630|FG001|Overall Study|Protocol Violation|4|||
147542221|NCT03252756|532140629|FG000|Overall Study|COVID-19 Pandemic|1|||
147542222|NCT03252756|532140630|FG001|Overall Study|COVID-19 Pandemic|1|||
147542223|NCT03252756|532140629|FG000|Overall Study|Study Drug Expiration|0|||
147542224|NCT03252756|532140630|FG001|Overall Study|Study Drug Expiration|1|||
147542225|NCT03594175|532140631|FG000|Overall Study|Not treated|8|||
147542226|NCT03594175|532140632|FG001|Overall Study|Not treated|1|||
147542227|NCT03594175|532140633|FG002|Overall Study|Not treated|5|||
147542228|NCT03594175|532140631|FG000|Overall Study|Adverse Event|3|||
147542229|NCT03594175|532140632|FG001|Overall Study|Adverse Event|0|||
147542230|NCT03594175|532140633|FG002|Overall Study|Adverse Event|0|||
147542231|NCT03594175|532140631|FG000|Overall Study|Withdrawal by Subject|3|||
147542232|NCT03594175|532140632|FG001|Overall Study|Withdrawal by Subject|0|||
147542233|NCT03594175|532140633|FG002|Overall Study|Withdrawal by Subject|0|||
147542234|NCT03594175|532140631|FG000|Overall Study|Protocol Violation|2|||
147542235|NCT03594175|532140632|FG001|Overall Study|Protocol Violation|2|||
147542236|NCT03594175|532140633|FG002|Overall Study|Protocol Violation|2|||
147542237|NCT01915498|532140634|FG000|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
147542238|NCT01915498|532140635|FG001|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
147542239|NCT01915498|532140636|FG002|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
147542240|NCT01915498|532140637|FG003|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1|||
147542241|NCT01915498|532140638|FG004|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1|||
147542242|NCT01915498|532140639|FG005|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
147542243|NCT01915498|532140640|FG006|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
147542244|NCT01915498|532140641|FG007|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
147542245|NCT01915498|532140642|FG008|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
147542246|NCT01915498|532140643|FG009|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1|||
147542247|NCT01915498|532140644|FG010|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
147542248|NCT01915498|532140645|FG011|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
147542249|NCT01915498|532140646|FG012|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1|||
147542250|NCT01915498|532140647|FG013|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|5|||
147542251|NCT01915498|532140648|FG014|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|1|||
147542252|NCT01915498|532140649|FG015|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|2|||
147542253|NCT01915498|532140650|FG016|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|2|||
147542254|NCT01915498|532140651|FG017|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|5|||
147542255|NCT01915498|532140652|FG018|Main Analysis (Sept 2013 - Sept 2017)|Withdrawal by Subject|0|||
147542256|NCT01915498|532140634|FG000|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
147542257|NCT01915498|532140635|FG001|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
147542258|NCT01915498|532140636|FG002|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
147542259|NCT01915498|532140637|FG003|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
147542260|NCT01915498|532140638|FG004|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
147542261|NCT01915498|532140639|FG005|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|1|||
147542262|NCT01915498|532140640|FG006|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
147542263|NCT01915498|532140641|FG007|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
147542264|NCT01915498|532140642|FG008|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
147542265|NCT01915498|532140643|FG009|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|2|||
147542266|NCT01915498|532140644|FG010|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
147542267|NCT01915498|532140645|FG011|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
147542268|NCT01915498|532140646|FG012|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
147542269|NCT01915498|532140647|FG013|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|1|||
147542270|NCT01915498|532140648|FG014|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|2|||
147210506|NCT03206788|530942786|FG000|Overall Study|Withdrawal by Subject|0|||
147210507|NCT03206788|530942787|FG001|Overall Study|Withdrawal by Subject|1|||
147542271|NCT01915498|532140649|FG015|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|1|||
147542272|NCT01915498|532140650|FG016|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|2|||
147542273|NCT01915498|532140651|FG017|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|2|||
147542274|NCT01915498|532140652|FG018|Main Analysis (Sept 2013 - Sept 2017)|Physician Decision|0|||
147210508|NCT03206788|530942786|FG000|Overall Study|Adverse Event|0|||
147542275|NCT01915498|532140634|FG000|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|1|||
147542276|NCT01915498|532140635|FG001|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
147542277|NCT01915498|532140636|FG002|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
147542278|NCT01915498|532140637|FG003|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
147542279|NCT01915498|532140638|FG004|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
147542280|NCT01915498|532140639|FG005|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|1|||
147542281|NCT01915498|532140640|FG006|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
147542282|NCT01915498|532140641|FG007|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
147542283|NCT01915498|532140642|FG008|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
147542284|NCT01915498|532140643|FG009|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
147542285|NCT01915498|532140644|FG010|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
147542286|NCT01915498|532140645|FG011|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
147542287|NCT01915498|532140646|FG012|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
147542288|NCT01915498|532140647|FG013|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
147542289|NCT01915498|532140648|FG014|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|1|||
147542290|NCT01915498|532140649|FG015|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
147542291|NCT01915498|532140650|FG016|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
147542292|NCT01915498|532140651|FG017|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|2|||
147542293|NCT01915498|532140652|FG018|Main Analysis (Sept 2013 - Sept 2017)|Medical Condition|0|||
147542294|NCT01915498|532140634|FG000|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
147542295|NCT01915498|532140635|FG001|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
147542296|NCT01915498|532140636|FG002|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
147542297|NCT01915498|532140637|FG003|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
147542298|NCT01915498|532140638|FG004|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
147542299|NCT01915498|532140639|FG005|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
147542300|NCT01915498|532140640|FG006|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
147542301|NCT01915498|532140641|FG007|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
147542302|NCT01915498|532140642|FG008|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
147542303|NCT01915498|532140643|FG009|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
147542304|NCT01915498|532140644|FG010|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|1|||
147542305|NCT01915498|532140645|FG011|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
147542306|NCT01915498|532140646|FG012|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
147542307|NCT01915498|532140647|FG013|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|1|||
147542308|NCT01915498|532140648|FG014|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
147542309|NCT01915498|532140649|FG015|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
147542310|NCT01915498|532140650|FG016|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|1|||
147542311|NCT01915498|532140651|FG017|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|1|||
147542312|NCT01915498|532140652|FG018|Main Analysis (Sept 2013 - Sept 2017)|Development of Intercurrent Condition|0|||
147542313|NCT01915498|532140634|FG000|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1|||
147542314|NCT01915498|532140635|FG001|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|2|||
147542315|NCT01915498|532140636|FG002|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
147542316|NCT01915498|532140637|FG003|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1|||
147542317|NCT01915498|532140638|FG004|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
147542318|NCT01915498|532140639|FG005|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
147542319|NCT01915498|532140640|FG006|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1|||
147542320|NCT01915498|532140641|FG007|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
147542321|NCT01915498|532140642|FG008|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
147542322|NCT01915498|532140643|FG009|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
147542323|NCT01915498|532140644|FG010|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1|||
147542324|NCT01915498|532140645|FG011|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
147542325|NCT01915498|532140646|FG012|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|1|||
147542326|NCT01915498|532140647|FG013|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|6|||
147542327|NCT01915498|532140648|FG014|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|5|||
147542328|NCT01915498|532140649|FG015|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|2|||
147210509|NCT03206788|530942787|FG001|Overall Study|Adverse Event|1|||
147210510|NCT03206788|530942786|FG000|Overall Study|Physician Decision|0|||
147210511|NCT03206788|530942787|FG001|Overall Study|Physician Decision|1|||
147210512|NCT02471612|530942788|FG000|Overall Study|Lost to Follow-up|2|||
147210513|NCT05573386|530942789|FG000|Overall Study|Withdrawal by Subject|3|||
147542329|NCT01915498|532140650|FG016|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|2|||
147542330|NCT01915498|532140651|FG017|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|9|||
147542331|NCT01915498|532140652|FG018|Main Analysis (Sept 2013 - Sept 2017)|Bone Marrow Transplant (BMT)|0|||
147542332|NCT01915498|532140634|FG000|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
147542333|NCT01915498|532140635|FG001|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
147542334|NCT01915498|532140636|FG002|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|2|||
147542335|NCT01915498|532140637|FG003|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
147542336|NCT01915498|532140638|FG004|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
147542337|NCT01915498|532140639|FG005|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
147542338|NCT01915498|532140640|FG006|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
147542339|NCT01915498|532140641|FG007|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
147542340|NCT01915498|532140642|FG008|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
147542341|NCT01915498|532140643|FG009|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
147542342|NCT01915498|532140644|FG010|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
147542343|NCT01915498|532140645|FG011|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
147210514|NCT05573386|530942790|FG001|Overall Study|Withdrawal by Subject|2|||
147210515|NCT05246514|530942791|FG000|Overall Study|Ongoing in the study at data cut-off date|58|||
147210516|NCT05246514|530942791|FG000|Overall Study|Withdrawal by Subject|1|||
147210517|NCT05246514|530942791|FG000|Overall Study|Death|13|||
147542344|NCT01915498|532140646|FG012|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
147542345|NCT01915498|532140647|FG013|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
147542346|NCT01915498|532140648|FG014|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
147542347|NCT01915498|532140649|FG015|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|1|||
147542348|NCT01915498|532140650|FG016|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|4|||
147542349|NCT01915498|532140651|FG017|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|8|||
147542350|NCT01915498|532140652|FG018|Main Analysis (Sept 2013 - Sept 2017)|Miscellaneous|0|||
147542351|NCT01915498|532140634|FG000|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
147542352|NCT01915498|532140635|FG001|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
147542353|NCT01915498|532140636|FG002|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
147542354|NCT01915498|532140637|FG003|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
147542355|NCT01915498|532140638|FG004|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|1|||
147542356|NCT01915498|532140639|FG005|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
147542357|NCT01915498|532140640|FG006|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
147542358|NCT01915498|532140641|FG007|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
147542359|NCT01915498|532140642|FG008|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
147542360|NCT01915498|532140643|FG009|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|1|||
147542361|NCT01915498|532140644|FG010|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
147542362|NCT01915498|532140645|FG011|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
147542363|NCT01915498|532140646|FG012|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
147542364|NCT01915498|532140647|FG013|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
147542365|NCT01915498|532140648|FG014|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
147542366|NCT01915498|532140649|FG015|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
147542367|NCT01915498|532140650|FG016|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
147542368|NCT01915498|532140651|FG017|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
147542369|NCT01915498|532140652|FG018|Main Analysis (Sept 2013 - Sept 2017)|Protocol Violation|0|||
147542370|NCT01915498|532140634|FG000|Main Analysis (Sept 2013 - Sept 2017)|Death|2|||
147542371|NCT01915498|532140635|FG001|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
147542372|NCT01915498|532140636|FG002|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
147542373|NCT01915498|532140637|FG003|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
147542374|NCT01915498|532140638|FG004|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
147542375|NCT01915498|532140639|FG005|Main Analysis (Sept 2013 - Sept 2017)|Death|2|||
147542376|NCT01915498|532140640|FG006|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
147542377|NCT01915498|532140641|FG007|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
147542378|NCT01915498|532140642|FG008|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
147542379|NCT01915498|532140643|FG009|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
147542380|NCT01915498|532140644|FG010|Main Analysis (Sept 2013 - Sept 2017)|Death|2|||
147542381|NCT01915498|532140645|FG011|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
147210518|NCT03646123|530942792|FG000|Overall Study|Withdrawal by Subject|2|||
147210519|NCT03646123|530942793|FG001|Overall Study|Withdrawal by Subject|2|||
147210520|NCT03646123|530942794|FG002|Overall Study|Withdrawal by Subject|3|||
147210521|NCT03646123|530942792|FG000|Overall Study|Study termination by sponsor|0|||
147210522|NCT03646123|530942793|FG001|Overall Study|Study termination by sponsor|45|||
147210523|NCT03646123|530942794|FG002|Overall Study|Study termination by sponsor|139|||
147210524|NCT03646123|530942792|FG000|Overall Study|Lost to Follow-up|4|||
147210525|NCT03646123|530942793|FG001|Overall Study|Lost to Follow-up|10|||
147210526|NCT03646123|530942794|FG002|Overall Study|Lost to Follow-up|10|||
147210527|NCT03646123|530942792|FG000|Overall Study|Death|2|||
147210528|NCT03646123|530942793|FG001|Overall Study|Death|1|||
147542382|NCT01915498|532140646|FG012|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
147542383|NCT01915498|532140647|FG013|Main Analysis (Sept 2013 - Sept 2017)|Death|4|||
147542384|NCT01915498|532140648|FG014|Main Analysis (Sept 2013 - Sept 2017)|Death|1|||
147542385|NCT01915498|532140649|FG015|Main Analysis (Sept 2013 - Sept 2017)|Death|4|||
147542386|NCT01915498|532140650|FG016|Main Analysis (Sept 2013 - Sept 2017)|Death|3|||
147542387|NCT01915498|532140651|FG017|Main Analysis (Sept 2013 - Sept 2017)|Death|16|||
147542388|NCT01915498|532140652|FG018|Main Analysis (Sept 2013 - Sept 2017)|Death|0|||
147542389|NCT01915498|532140634|FG000|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
147542390|NCT01915498|532140635|FG001|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
147542391|NCT01915498|532140636|FG002|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
147542392|NCT01915498|532140637|FG003|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
147542393|NCT01915498|532140638|FG004|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
147542394|NCT01915498|532140639|FG005|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
147542395|NCT01915498|532140640|FG006|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
147542396|NCT01915498|532140641|FG007|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
147542397|NCT01915498|532140642|FG008|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
147542398|NCT01915498|532140643|FG009|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
147542399|NCT01915498|532140644|FG010|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|1|||
147542400|NCT01915498|532140645|FG011|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
147542401|NCT01915498|532140646|FG012|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
147542402|NCT01915498|532140647|FG013|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
147542403|NCT01915498|532140648|FG014|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
147542404|NCT01915498|532140649|FG015|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
147542405|NCT01915498|532140650|FG016|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
147542406|NCT01915498|532140651|FG017|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
147542407|NCT01915498|532140652|FG018|Main Analysis (Sept 2013 - Sept 2017)|Lost to Follow-up|0|||
147542408|NCT01915498|532140634|FG000|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|2|||
147542409|NCT01915498|532140635|FG001|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|0|||
147542410|NCT01915498|532140636|FG002|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
147542411|NCT01915498|532140637|FG003|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
147542412|NCT01915498|532140638|FG004|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|0|||
147542413|NCT01915498|532140639|FG005|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|0|||
147542414|NCT01915498|532140640|FG006|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
147542415|NCT01915498|532140641|FG007|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|4|||
147542416|NCT01915498|532140642|FG008|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
147542417|NCT01915498|532140643|FG009|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|2|||
147542418|NCT01915498|532140644|FG010|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
147542419|NCT01915498|532140645|FG011|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
147542420|NCT01915498|532140646|FG012|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|2|||
147542421|NCT01915498|532140647|FG013|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|4|||
147542422|NCT01915498|532140648|FG014|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|1|||
147542423|NCT01915498|532140649|FG015|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|4|||
147542424|NCT01915498|532140650|FG016|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|2|||
147542425|NCT01915498|532140651|FG017|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|16|||
147542426|NCT01915498|532140652|FG018|Main Analysis (Sept 2013 - Sept 2017)|Adverse Event|0|||
147542427|NCT01915498|532140634|FG000|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|1|||
147542428|NCT01915498|532140635|FG001|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|3|||
147542429|NCT01915498|532140636|FG002|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|3|||
147542430|NCT01915498|532140637|FG003|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|4|||
147542431|NCT01915498|532140638|FG004|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|2|||
147542432|NCT01915498|532140639|FG005|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|5|||
147542433|NCT01915498|532140640|FG006|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|5|||
147542434|NCT01915498|532140641|FG007|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|15|||
147542435|NCT01915498|532140642|FG008|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|4|||
147542436|NCT01915498|532140643|FG009|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|7|||
147542437|NCT01915498|532140644|FG010|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|3|||
147542438|NCT01915498|532140645|FG011|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|2|||
147210529|NCT03646123|530942794|FG002|Overall Study|Death|1|||
147210530|NCT03646123|530942792|FG000|Overall Study|Other|2|||
147210531|NCT03646123|530942793|FG001|Overall Study|Other|0|||
147210532|NCT03646123|530942794|FG002|Overall Study|Other|2|||
147210533|NCT01802073|530942797|FG000|Overall Study|Lost to Follow-up|0|||
147210534|NCT01802073|530942798|FG001|Overall Study|Lost to Follow-up|1|||
147210535|NCT01802073|530942797|FG000|Overall Study|Non-compliant|4|||
147210536|NCT01802073|530942798|FG001|Overall Study|Non-compliant|2|||
147542439|NCT01915498|532140646|FG012|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|3|||
147542440|NCT01915498|532140647|FG013|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|24|||
147542441|NCT01915498|532140648|FG014|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|14|||
147542442|NCT01915498|532140649|FG015|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|9|||
147542443|NCT01915498|532140650|FG016|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|8|||
147542444|NCT01915498|532140651|FG017|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|41|||
147542445|NCT01915498|532140652|FG018|Main Analysis (Sept 2013 - Sept 2017)|Disease Progression|0|||
147542446|NCT01915498|532140634|FG000|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
147542447|NCT01915498|532140635|FG001|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
147542448|NCT01915498|532140636|FG002|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
147542449|NCT01915498|532140637|FG003|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
147542450|NCT01915498|532140638|FG004|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
147210537|NCT01802073|530942797|FG000|Overall Study|Withdrawal by Subject|1|||
147210538|NCT01802073|530942798|FG001|Overall Study|Withdrawal by Subject|1|||
147210539|NCT01802073|530942797|FG000|Overall Study|Physician Decision|0|||
147210540|NCT01802073|530942798|FG001|Overall Study|Physician Decision|7|||
147210541|NCT02657408|530942801|FG000|Overall Study|Adverse Event|3|||
147210542|NCT02657408|530942802|FG001|Overall Study|Adverse Event|7|||
147210543|NCT05343624|530942803|FG000|Overall Study|Chart review not completed|1|||
147440505|NCT00493220|531777664|FG004|Third Intervention|Withdrawal by Subject|0|||
147440506|NCT00493220|531777665|FG005|Third Intervention|Withdrawal by Subject|0|||
147440507|NCT02109562|531777666|FG000|Overall Study|Insufficient clinical response|2|||
147440508|NCT02109562|531777667|FG001|Overall Study|Insufficient clinical response|0|||
147440509|NCT02109562|531777668|FG002|Overall Study|Insufficient clinical response|4|||
147440510|NCT02109562|531777666|FG000|Overall Study|Adverse Event|0|||
147440511|NCT02109562|531777667|FG001|Overall Study|Adverse Event|2|||
147440512|NCT02109562|531777668|FG002|Overall Study|Adverse Event|3|||
147440513|NCT02109562|531777666|FG000|Overall Study|Lost to Follow-up|1|||
147440514|NCT02109562|531777667|FG001|Overall Study|Lost to Follow-up|0|||
147440515|NCT02109562|531777668|FG002|Overall Study|Lost to Follow-up|1|||
147440516|NCT02109562|531777666|FG000|Overall Study|Protocol Violation|0|||
147440517|NCT02109562|531777667|FG001|Overall Study|Protocol Violation|3|||
147440518|NCT02109562|531777668|FG002|Overall Study|Protocol Violation|1|||
147440519|NCT02109562|531777666|FG000|Overall Study|Withdrawal by Subject|20|||
147440520|NCT02109562|531777667|FG001|Overall Study|Withdrawal by Subject|25|||
147440521|NCT02109562|531777668|FG002|Overall Study|Withdrawal by Subject|21|||
147440522|NCT02109562|531777666|FG000|Overall Study|Physician Decision|3|||
147440523|NCT02109562|531777667|FG001|Overall Study|Physician Decision|4|||
147440524|NCT02109562|531777668|FG002|Overall Study|Physician Decision|5|||
147440525|NCT01889238|531777671|FG000|Overall Study|Death|1|||
147440526|NCT01889238|531777671|FG000|Overall Study|Withdrawal by Subject|1|||
147440527|NCT01889238|531777671|FG000|Overall Study|Adverse Event|6|||
147440528|NCT01889238|531777671|FG000|Overall Study|Disease Progression|104|||
147440529|NCT01889238|531777671|FG000|Overall Study|Other|6|||
147440530|NCT04136184|531777672|FG000|Overall Study|Lost to Follow-up|0|||
147440531|NCT04136184|531777673|FG001|Overall Study|Lost to Follow-up|3|||
147440532|NCT04136184|531777672|FG000|Overall Study|Voluntary Withdrawal (including enrolled OLE)|23|||
147440533|NCT04136184|531777673|FG001|Overall Study|Voluntary Withdrawal (including enrolled OLE)|119|||
147440534|NCT03318978|531777677|FG000|Overall Study|Withdrawal by Subject|1|||
147440535|NCT02844816|531777678|FG000|Overall Study|No protocol treatment received|5|||
147440536|NCT02844816|531777679|FG001|Overall Study|No protocol treatment received|1|||
147440537|NCT02844816|531777678|FG000|Overall Study|Ineligible|22|||
147440538|NCT02844816|531777679|FG001|Overall Study|Ineligible|15|||
147440539|NCT02844816|531777678|FG000|Overall Study|Participant refusal|5|||
147440540|NCT02844816|531777679|FG001|Overall Study|Participant refusal|5|||
147440541|NCT02844816|531777678|FG000|Overall Study|Adverse Event|5|||
147440542|NCT02844816|531777679|FG001|Overall Study|Adverse Event|4|||
147440543|NCT02844816|531777678|FG000|Overall Study|Death|0|||
147440544|NCT02844816|531777679|FG001|Overall Study|Death|1|||
147440545|NCT02844816|531777678|FG000|Overall Study|Disease progression/recurrence|50|||
147440546|NCT02844816|531777679|FG001|Overall Study|Disease progression/recurrence|24|||
147440547|NCT02844816|531777678|FG000|Overall Study|Physician Decision|1|||
147440548|NCT02844816|531777679|FG001|Overall Study|Physician Decision|1|||
147440549|NCT02717754|531777683|FG000|Overall Study|Incorrect Infusion Duration|0|||
147210544|NCT02447302|530942812|FG000|Overall Study|Physician Decision|1|||
147440550|NCT02717754|531777684|FG001|Overall Study|Incorrect Infusion Duration|0|||
147440551|NCT02717754|531777685|FG002|Overall Study|Incorrect Infusion Duration|0|||
147440552|NCT02717754|531777686|FG003|Overall Study|Incorrect Infusion Duration|10|||
147440553|NCT02717754|531777687|FG004|Overall Study|Incorrect Infusion Duration|20|||
147440554|NCT02717754|531777688|FG005|Overall Study|Incorrect Infusion Duration|20|||
147440555|NCT01200238|531777689|FG000|Overall Study|Adverse Event|2|||
147440556|NCT01200238|531777690|FG001|Overall Study|Adverse Event|1|||
147440557|NCT01200238|531777689|FG000|Overall Study|Progressive Disease|5|||
147440558|NCT01200238|531777690|FG001|Overall Study|Progressive Disease|8|||
147440559|NCT01200238|531777689|FG000|Overall Study|Withdrawal by Subject|0|||
147210545|NCT02447302|530942813|FG001|Overall Study|Physician Decision|0|||
147210546|NCT02447302|530942814|FG002|Overall Study|Physician Decision|0|||
147210547|NCT02447302|530942812|FG000|Overall Study|Adverse Event|4|||
147210548|NCT02447302|530942813|FG001|Overall Study|Adverse Event|3|||
147210549|NCT02447302|530942814|FG002|Overall Study|Adverse Event|0|||
147210550|NCT02447302|530942812|FG000|Overall Study|Withdrawal by Subject|0|||
147210551|NCT02447302|530942813|FG001|Overall Study|Withdrawal by Subject|1|||
147210552|NCT02447302|530942814|FG002|Overall Study|Withdrawal by Subject|5|||
147210553|NCT02447302|530942812|FG000|Overall Study|Sponsor Decision|0|||
147210554|NCT02447302|530942813|FG001|Overall Study|Sponsor Decision|0|||
147210555|NCT02447302|530942814|FG002|Overall Study|Sponsor Decision|1|||
147210556|NCT05334212|530942817|FG000|Overall Study|Study terminated prematurely|7|||
147210557|NCT00910299|530942818|FG000|Overall Study|Withdrawal by Subject|16|||
147210558|NCT00910299|530942819|FG001|Overall Study|Withdrawal by Subject|13|||
147210559|NCT00910299|530942818|FG000|Overall Study|Sponsor Decision|58|||
147210560|NCT00910299|530942819|FG001|Overall Study|Sponsor Decision|60|||
147210561|NCT00910299|530942818|FG000|Overall Study|Didn't receive any study drug|2|||
147210562|NCT00910299|530942819|FG001|Overall Study|Didn't receive any study drug|1|||
147210563|NCT02695420|530942820|FG000|Overall Study|Death|0|||
147440560|NCT01200238|531777690|FG001|Overall Study|Withdrawal by Subject|1|||
147440561|NCT00482703|531777691|FG000|Overall Study|Poor compliance|1|||
147440562|NCT00482703|531777692|FG001|Overall Study|Poor compliance|0|||
147440563|NCT00667823|531777694|FG000|Overall Study|Lost to Follow-up|5|||
147440564|NCT00667823|531777694|FG000|Overall Study|Adverse Event|7|||
147440565|NCT00667823|531777694|FG000|Overall Study|Death|182|||
147440566|NCT00667823|531777694|FG000|Overall Study|Withdrawal by Subject|12|||
147440567|NCT00667823|531777694|FG000|Overall Study|Other|8|||
147440568|NCT00667823|531777694|FG000|Overall Study|Missing (completion page missing)|2|||
147440569|NCT03697720|531778953|FG000|Overall Study|Lost to Follow-up|7|||
147440570|NCT04096274|531778954|FG000|Phase I|Lost to Follow-up|5|||
147440571|NCT04096274|531778955|FG001|Phase I|Lost to Follow-up|5|||
147440572|NCT04096274|531778954|FG000|Phase II|Lost to Follow-up|11|||
147440573|NCT04096274|531778955|FG001|Phase II|Lost to Follow-up|11|||
147440574|NCT00257725|531778956|FG000|Overall Study|Adverse Event|3|||
147440575|NCT01858532|531778957|FG000|Overall Study|Adverse Event|58|||
147440576|NCT01858532|531778958|FG001|Overall Study|Adverse Event|50|||
147440577|NCT01858532|531778959|FG002|Overall Study|Adverse Event|23|||
147440578|NCT01858532|531778960|FG003|Overall Study|Adverse Event|28|||
147440579|NCT01858532|531778957|FG000|Overall Study|Withdrew consent|71|||
147440580|NCT01858532|531778958|FG001|Overall Study|Withdrew consent|93|||
147440581|NCT01858532|531778959|FG002|Overall Study|Withdrew consent|46|||
147440582|NCT01858532|531778960|FG003|Overall Study|Withdrew consent|27|||
147440583|NCT01858532|531778957|FG000|Overall Study|Lost to Follow-up|17|||
147440584|NCT01858532|531778958|FG001|Overall Study|Lost to Follow-up|26|||
147440585|NCT01858532|531778959|FG002|Overall Study|Lost to Follow-up|11|||
147440586|NCT01858532|531778960|FG003|Overall Study|Lost to Follow-up|14|||
147440587|NCT01858532|531778957|FG000|Overall Study|Deterioration of medical status|3|||
147440588|NCT01858532|531778958|FG001|Overall Study|Deterioration of medical status|4|||
147440589|NCT01858532|531778959|FG002|Overall Study|Deterioration of medical status|3|||
147440590|NCT01858532|531778960|FG003|Overall Study|Deterioration of medical status|7|||
147440591|NCT01858532|531778957|FG000|Overall Study|Investigator request|3|||
147440592|NCT01858532|531778958|FG001|Overall Study|Investigator request|4|||
147440593|NCT01858532|531778959|FG002|Overall Study|Investigator request|2|||
147440594|NCT01858532|531778960|FG003|Overall Study|Investigator request|6|||
147440595|NCT01858532|531778957|FG000|Overall Study|Other, not specified|29|||
147440596|NCT01858532|531778958|FG001|Overall Study|Other, not specified|15|||
147440597|NCT01858532|531778959|FG002|Overall Study|Other, not specified|13|||
147440598|NCT01858532|531778960|FG003|Overall Study|Other, not specified|11|||
147440599|NCT00514514|531778961|FG000|Pre-phase|Death|10|||
147440600|NCT00514514|531778962|FG001|Pre-phase|Death|0|||
147440601|NCT00514514|531778963|FG002|Pre-phase|Death|0|||
147440602|NCT00514514|531778961|FG000|Pre-phase|administrative problems|2|||
147440603|NCT00514514|531778962|FG001|Pre-phase|administrative problems|0|||
147440604|NCT00514514|531778963|FG002|Pre-phase|administrative problems|0|||
147440605|NCT00514514|531778961|FG000|Pre-phase|Protocol Violation|6|||
147440606|NCT00514514|531778962|FG001|Pre-phase|Protocol Violation|0|||
147440607|NCT00514514|531778963|FG002|Pre-phase|Protocol Violation|0|||
147440608|NCT00514514|531778961|FG000|Pre-phase|condition no longer requires study drug|7|||
147440609|NCT00514514|531778962|FG001|Pre-phase|condition no longer requires study drug|0|||
147440610|NCT00514514|531778963|FG002|Pre-phase|condition no longer requires study drug|0|||
147440611|NCT00514514|531778961|FG000|Pre-phase|abnormal test procedure results|15|||
147440612|NCT00514514|531778962|FG001|Pre-phase|abnormal test procedure results|0|||
147440613|NCT00514514|531778963|FG002|Pre-phase|abnormal test procedure results|0|||
147210564|NCT02695420|530942821|FG001|Overall Study|Death|1|||
147210565|NCT02695420|530942822|FG002|Overall Study|Death|0|||
147210566|NCT02695420|530942823|FG003|Overall Study|Death|0|||
147210567|NCT00916929|530942826|FG000|Overall Study|Lost to Follow-up|1|||
147440614|NCT00514514|531778961|FG000|Pre-phase|Lost to Follow-up|2|||
147542451|NCT01915498|532140639|FG005|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
147542452|NCT01915498|532140640|FG006|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
147542453|NCT01915498|532140641|FG007|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
147542454|NCT01915498|532140642|FG008|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
147542455|NCT01915498|532140643|FG009|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
147542456|NCT01915498|532140644|FG010|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
147542457|NCT01915498|532140645|FG011|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
147542458|NCT01915498|532140646|FG012|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
147542459|NCT01915498|532140647|FG013|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
147542460|NCT01915498|532140648|FG014|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
147542461|NCT01915498|532140649|FG015|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
147542462|NCT01915498|532140650|FG016|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
147542463|NCT01915498|532140651|FG017|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|0|||
147210568|NCT00916929|530942827|FG001|Overall Study|Lost to Follow-up|3|||
147210569|NCT00916929|530942826|FG000|Overall Study|Death|5|||
147210570|NCT00916929|530942827|FG001|Overall Study|Death|10|||
147210571|NCT00916929|530942826|FG000|Overall Study|Withdrawal by Subject|1|||
147210572|NCT00916929|530942827|FG001|Overall Study|Withdrawal by Subject|5|||
147210573|NCT00916929|530942826|FG000|Overall Study|Left ventricular epicardial lead|1|||
147210574|NCT00916929|530942827|FG001|Overall Study|Left ventricular epicardial lead|2|||
147210575|NCT00916929|530942826|FG000|Overall Study|Transferred to hospice care|1|||
147210576|NCT00916929|530942827|FG001|Overall Study|Transferred to hospice care|1|||
147210577|NCT00916929|530942826|FG000|Overall Study|System explant|1|||
147210578|NCT00916929|530942827|FG001|Overall Study|System explant|0|||
147210579|NCT00916929|530942826|FG000|Overall Study|Moved to another state|0|||
147210580|NCT00916929|530942827|FG001|Overall Study|Moved to another state|1|||
147210581|NCT00916929|530942826|FG000|Overall Study|Device unable to process impedance data|0|||
147210582|NCT00916929|530942827|FG001|Overall Study|Device unable to process impedance data|7|||
147210583|NCT02929407|530942828|FG000|Overall Study|Adverse Event|1|||
147210584|NCT02878798|530942831|FG000|Overall Study|Withdrawal by Subject|5|||
147210585|NCT02878798|530942832|FG001|Overall Study|Withdrawal by Subject|4|||
147210586|NCT02878798|530942831|FG000|Overall Study|Lost to Follow-up|2|||
147210587|NCT02878798|530942832|FG001|Overall Study|Lost to Follow-up|2|||
147210588|NCT02878798|530942831|FG000|Overall Study|Protocol Violation|0|||
147210589|NCT02878798|530942832|FG001|Overall Study|Protocol Violation|1|||
147210590|NCT01761240|530942833|FG000|Overall Study|Progressive disease:radiology assessment|3|||
147210591|NCT01761240|530942834|FG001|Overall Study|Progressive disease:radiology assessment|3|||
147210592|NCT01761240|530942835|FG002|Overall Study|Progressive disease:radiology assessment|0|||
147210593|NCT01761240|530942836|FG003|Overall Study|Progressive disease:radiology assessment|0|||
147210594|NCT01761240|530942837|FG004|Overall Study|Progressive disease:radiology assessment|0|||
147210595|NCT01761240|530942833|FG000|Overall Study|Progressive disease:clinical assessment|0|||
147210596|NCT01761240|530942834|FG001|Overall Study|Progressive disease:clinical assessment|0|||
147210597|NCT01761240|530942835|FG002|Overall Study|Progressive disease:clinical assessment|3|||
147210598|NCT01761240|530942836|FG003|Overall Study|Progressive disease:clinical assessment|1|||
147210599|NCT01761240|530942837|FG004|Overall Study|Progressive disease:clinical assessment|0|||
147210600|NCT01761240|530942833|FG000|Overall Study|Withdrawal by Subject|0|||
147210601|NCT01761240|530942834|FG001|Overall Study|Withdrawal by Subject|0|||
147210602|NCT01761240|530942835|FG002|Overall Study|Withdrawal by Subject|0|||
147210603|NCT01761240|530942836|FG003|Overall Study|Withdrawal by Subject|3|||
147210604|NCT01761240|530942837|FG004|Overall Study|Withdrawal by Subject|1|||
147210605|NCT01761240|530942833|FG000|Overall Study|Adverse Event|0|||
147210606|NCT01761240|530942834|FG001|Overall Study|Adverse Event|0|||
147210607|NCT01761240|530942835|FG002|Overall Study|Adverse Event|0|||
147210608|NCT01761240|530942836|FG003|Overall Study|Adverse Event|1|||
147210609|NCT01761240|530942837|FG004|Overall Study|Adverse Event|6|||
147210610|NCT01761240|530942833|FG000|Overall Study|Death|0|||
147210611|NCT01761240|530942834|FG001|Overall Study|Death|1|||
147210612|NCT01761240|530942835|FG002|Overall Study|Death|1|||
147210613|NCT01761240|530942836|FG003|Overall Study|Death|2|||
147210614|NCT01761240|530942837|FG004|Overall Study|Death|1|||
147210615|NCT01761240|530942833|FG000|Overall Study|Non-compliance|0|||
147210616|NCT01761240|530942834|FG001|Overall Study|Non-compliance|0|||
147210617|NCT01761240|530942835|FG002|Overall Study|Non-compliance|1|||
147210618|NCT01761240|530942836|FG003|Overall Study|Non-compliance|0|||
147210619|NCT01761240|530942837|FG004|Overall Study|Non-compliance|0|||
147542464|NCT01915498|532140652|FG018|Safety Follow-up (Sep 2017 to July 2019)|Ongoing Treatment|2|||
147210620|NCT03500224|530942838|FG000|Overall Study|Withdrawal by Subject|2|||
147210621|NCT01324401|530942839|FG000|Overall Study|Withdrawn before any treatment|0|||
147210622|NCT01324401|530942840|FG001|Overall Study|Withdrawn before any treatment|3|||
147210623|NCT01324401|530942839|FG000|Overall Study|Adverse Event|1|||
147210624|NCT01324401|530942840|FG001|Overall Study|Adverse Event|3|||
147210625|NCT01708902|530942842|FG000|Overall Study|Adverse Event|3|||
147542465|NCT01915498|532140634|FG000|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
147542466|NCT01915498|532140635|FG001|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
147542467|NCT01915498|532140636|FG002|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
147542468|NCT01915498|532140637|FG003|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
147542469|NCT01915498|532140638|FG004|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
147542470|NCT01915498|532140639|FG005|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
147542471|NCT01915498|532140640|FG006|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
147542472|NCT01915498|532140641|FG007|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
147542473|NCT01915498|532140642|FG008|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
147542474|NCT01915498|532140643|FG009|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
147542475|NCT01915498|532140644|FG010|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
147542476|NCT01915498|532140645|FG011|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
147542477|NCT01915498|532140646|FG012|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
147542478|NCT01915498|532140647|FG013|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
147542479|NCT01915498|532140648|FG014|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
147542480|NCT01915498|532140649|FG015|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
147542481|NCT01915498|532140650|FG016|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
147542482|NCT01915498|532140651|FG017|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|0|||
147542483|NCT01915498|532140652|FG018|Safety Follow up (Aug 2019 to Sep 2023)|Adverse Event|1|||
147542484|NCT01915498|532140634|FG000|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
147210626|NCT01708902|530942843|FG001|Overall Study|Adverse Event|4|||
147210627|NCT01708902|530942844|FG002|Overall Study|Adverse Event|9|||
147210628|NCT01708902|530942845|FG003|Overall Study|Adverse Event|2|||
147210629|NCT01708902|530942846|FG004|Overall Study|Adverse Event|7|||
147210630|NCT01708902|530942847|FG005|Overall Study|Adverse Event|3|||
147542485|NCT01915498|532140635|FG001|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
147542486|NCT01915498|532140636|FG002|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
147542487|NCT01915498|532140637|FG003|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
147542488|NCT01915498|532140638|FG004|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
147542489|NCT01915498|532140639|FG005|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
147542490|NCT01915498|532140640|FG006|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
147542491|NCT01915498|532140641|FG007|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
147542492|NCT01915498|532140642|FG008|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
147542493|NCT01915498|532140643|FG009|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
147542494|NCT01915498|532140644|FG010|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
147542495|NCT01915498|532140645|FG011|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
147542496|NCT01915498|532140646|FG012|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
147542497|NCT01915498|532140647|FG013|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
147542498|NCT01915498|532140648|FG014|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
147542499|NCT01915498|532140649|FG015|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
147542500|NCT01915498|532140650|FG016|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
147542501|NCT01915498|532140651|FG017|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|0|||
147542502|NCT01915498|532140652|FG018|Safety Follow up (Aug 2019 to Sep 2023)|Withdrawal by Subject|1|||
147210631|NCT01708902|530942848|FG006|Overall Study|Adverse Event|5|||
147210632|NCT01708902|530942842|FG000|Overall Study|Lack of Efficacy|3|||
147210633|NCT01708902|530942843|FG001|Overall Study|Lack of Efficacy|1|||
147210634|NCT01708902|530942844|FG002|Overall Study|Lack of Efficacy|0|||
147210635|NCT01708902|530942845|FG003|Overall Study|Lack of Efficacy|0|||
147210636|NCT01708902|530942846|FG004|Overall Study|Lack of Efficacy|0|||
147210637|NCT01708902|530942847|FG005|Overall Study|Lack of Efficacy|1|||
147210638|NCT01708902|530942848|FG006|Overall Study|Lack of Efficacy|0|||
147210639|NCT01708902|530942842|FG000|Overall Study|Non compliance with protocol|0|||
147210640|NCT01708902|530942843|FG001|Overall Study|Non compliance with protocol|2|||
147210641|NCT01708902|530942844|FG002|Overall Study|Non compliance with protocol|1|||
147210642|NCT01708902|530942845|FG003|Overall Study|Non compliance with protocol|3|||
147210643|NCT01708902|530942846|FG004|Overall Study|Non compliance with protocol|0|||
147210644|NCT01708902|530942847|FG005|Overall Study|Non compliance with protocol|0|||
147210645|NCT01708902|530942848|FG006|Overall Study|Non compliance with protocol|0|||
147210646|NCT01708902|530942842|FG000|Overall Study|Lost to Follow-up|2|||
147210647|NCT01708902|530942843|FG001|Overall Study|Lost to Follow-up|1|||
147210648|NCT01708902|530942844|FG002|Overall Study|Lost to Follow-up|2|||
147210649|NCT01708902|530942845|FG003|Overall Study|Lost to Follow-up|2|||
147210650|NCT01708902|530942846|FG004|Overall Study|Lost to Follow-up|0|||
147210651|NCT01708902|530942847|FG005|Overall Study|Lost to Follow-up|0|||
147210652|NCT01708902|530942848|FG006|Overall Study|Lost to Follow-up|1|||
147210653|NCT01708902|530942842|FG000|Overall Study|Refused to continue trial medication|8|||
147210654|NCT01708902|530942843|FG001|Overall Study|Refused to continue trial medication|0|||
147210655|NCT01708902|530942844|FG002|Overall Study|Refused to continue trial medication|4|||
147542503|NCT01336608|532142132|FG000|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|102|||
147542504|NCT01336608|532142133|FG001|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
147542505|NCT01336608|532142134|FG002|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
147542506|NCT01336608|532142135|FG003|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
147542507|NCT01336608|532142132|FG000|2-week, Single-blind Run-In Period|Withdrawal by Subject|9|||
147542508|NCT01336608|532142133|FG001|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
147542509|NCT01336608|532142134|FG002|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
147542510|NCT01336608|532142135|FG003|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
147542511|NCT01336608|532142132|FG000|2-week, Single-blind Run-In Period|Adverse Event|1|||
147542512|NCT01336608|532142133|FG001|2-week, Single-blind Run-In Period|Adverse Event|0|||
147542513|NCT01336608|532142134|FG002|2-week, Single-blind Run-In Period|Adverse Event|0|||
147542514|NCT01336608|532142135|FG003|2-week, Single-blind Run-In Period|Adverse Event|0|||
147542515|NCT01336608|532142132|FG000|2-week, Single-blind Run-In Period|Physician Decision|1|||
147542516|NCT01336608|532142133|FG001|2-week, Single-blind Run-In Period|Physician Decision|0|||
147542517|NCT01336608|532142134|FG002|2-week, Single-blind Run-In Period|Physician Decision|0|||
147542518|NCT01336608|532142135|FG003|2-week, Single-blind Run-In Period|Physician Decision|0|||
147542519|NCT01336608|532142132|FG000|2-week, Single-blind Run-In Period|Lost to Follow-up|2|||
147542520|NCT01336608|532142133|FG001|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
147542521|NCT01336608|532142134|FG002|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
147542522|NCT01336608|532142135|FG003|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
147542523|NCT01336608|532142132|FG000|24-week, Double-blind Treatment Period|Adverse Event|0|||
147542524|NCT01336608|532142133|FG001|24-week, Double-blind Treatment Period|Adverse Event|8|||
147542525|NCT01336608|532142134|FG002|24-week, Double-blind Treatment Period|Adverse Event|6|||
147542526|NCT01336608|532142135|FG003|24-week, Double-blind Treatment Period|Adverse Event|7|||
147542527|NCT01336608|532142132|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
147542528|NCT01336608|532142133|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|2|||
147542529|NCT01336608|532142134|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
147542530|NCT01336608|532142135|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
147542531|NCT01336608|532142132|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|0|||
147542532|NCT01336608|532142133|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|13|||
147542533|NCT01336608|532142134|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|13|||
147542534|NCT01336608|532142135|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|6|||
147542535|NCT01336608|532142132|FG000|24-week, Double-blind Treatment Period|Protocol Violation|0|||
147542536|NCT01336608|532142133|FG001|24-week, Double-blind Treatment Period|Protocol Violation|4|||
147542537|NCT01336608|532142134|FG002|24-week, Double-blind Treatment Period|Protocol Violation|3|||
147542538|NCT01336608|532142135|FG003|24-week, Double-blind Treatment Period|Protocol Violation|3|||
147542539|NCT01336608|532142132|FG000|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|0|||
147542540|NCT01336608|532142133|FG001|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|4|||
147542541|NCT01336608|532142134|FG002|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|3|||
147542542|NCT01336608|532142135|FG003|24-week, Double-blind Treatment Period|Protocol-defined Stopping Criteria|6|||
147542543|NCT01336608|532142132|FG000|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
147542544|NCT01336608|532142133|FG001|24-week, Double-blind Treatment Period|Lost to Follow-up|3|||
147542545|NCT01336608|532142134|FG002|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
147542546|NCT01336608|532142135|FG003|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
147542547|NCT01336608|532142132|FG000|24-week, Double-blind Treatment Period|Physician Decision|0|||
147542548|NCT01336608|532142133|FG001|24-week, Double-blind Treatment Period|Physician Decision|3|||
147542549|NCT01336608|532142134|FG002|24-week, Double-blind Treatment Period|Physician Decision|1|||
147542550|NCT01336608|532142135|FG003|24-week, Double-blind Treatment Period|Physician Decision|1|||
147542551|NCT01336608|532142132|FG000|24-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
147542552|NCT01336608|532142133|FG001|24-week, Double-blind Treatment Period|Withdrawal by Subject|7|||
147542553|NCT01336608|532142134|FG002|24-week, Double-blind Treatment Period|Withdrawal by Subject|4|||
147542554|NCT01336608|532142135|FG003|24-week, Double-blind Treatment Period|Withdrawal by Subject|1|||
147542555|NCT04723173|532142138|FG000|Subjective Listening Effort Scaling|One participant was not able to perform the test as required by the study protocol.|1|||
147542556|NCT02996448|532142139|FG000|Overall Study|Study terminated due to adverse effects|3|||
147542557|NCT00303316|532142142|FG000|Overall Study|Protocol Violation|1|||
147542558|NCT00303316|532142143|FG001|Overall Study|Protocol Violation|0|||
147542559|NCT00303316|532142142|FG000|Overall Study|Lost to Follow-up|0|||
147542560|NCT00303316|532142143|FG001|Overall Study|Lost to Follow-up|1|||
147542561|NCT00303316|532142142|FG000|Overall Study|Withdrawal by Subject|1|||
147542562|NCT00303316|532142143|FG001|Overall Study|Withdrawal by Subject|2|||
147542563|NCT01160198|532142147|FG000|Overall Study|Withdrawal by Subject|2|||
147542564|NCT01160198|532142148|FG001|Overall Study|Withdrawal by Subject|1|||
147542565|NCT01160198|532142149|FG002|Overall Study|Withdrawal by Subject|0|||
147542566|NCT01160198|532142147|FG000|Overall Study|Adverse Event|0|||
147210656|NCT01708902|530942845|FG003|Overall Study|Refused to continue trial medication|2|||
147210657|NCT01708902|530942846|FG004|Overall Study|Refused to continue trial medication|8|||
147210658|NCT01708902|530942847|FG005|Overall Study|Refused to continue trial medication|1|||
147210659|NCT01708902|530942848|FG006|Overall Study|Refused to continue trial medication|1|||
147210660|NCT01708902|530942842|FG000|Overall Study|Other Reason|1|||
147210661|NCT01708902|530942843|FG001|Overall Study|Other Reason|0|||
147440615|NCT00514514|531778962|FG001|Pre-phase|Lost to Follow-up|0|||
147440616|NCT00514514|531778963|FG002|Pre-phase|Lost to Follow-up|0|||
147440617|NCT00514514|531778961|FG000|Pre-phase|abnormal lab values|23|||
147440618|NCT00514514|531778962|FG001|Pre-phase|abnormal lab values|0|||
147440619|NCT00514514|531778963|FG002|Pre-phase|abnormal lab values|0|||
147440620|NCT00514514|531778961|FG000|Pre-phase|Lack of Efficacy|35|||
147440621|NCT00514514|531778962|FG001|Pre-phase|Lack of Efficacy|0|||
147440622|NCT00514514|531778963|FG002|Pre-phase|Lack of Efficacy|0|||
147440623|NCT00514514|531778961|FG000|Pre-phase|Adverse Event|137|||
147440624|NCT00514514|531778962|FG001|Pre-phase|Adverse Event|0|||
147440625|NCT00514514|531778963|FG002|Pre-phase|Adverse Event|0|||
147440626|NCT00514514|531778961|FG000|Pre-phase|Withdrawal by Subject|66|||
147440627|NCT00514514|531778962|FG001|Pre-phase|Withdrawal by Subject|0|||
147440628|NCT00514514|531778963|FG002|Pre-phase|Withdrawal by Subject|0|||
147440629|NCT00514514|531778961|FG000|Randomized - 9 Month|Death|3|||
147440630|NCT00514514|531778962|FG001|Randomized - 9 Month|Death|2|||
147440631|NCT00514514|531778963|FG002|Randomized - 9 Month|Death|2|||
147440632|NCT00514514|531778961|FG000|Randomized - 9 Month|Administrative problems|1|||
147440633|NCT00514514|531778962|FG001|Randomized - 9 Month|Administrative problems|1|||
147440634|NCT00514514|531778963|FG002|Randomized - 9 Month|Administrative problems|2|||
147440635|NCT00514514|531778961|FG000|Randomized - 9 Month|Withdrawal by Subject|7|||
147440636|NCT00514514|531778962|FG001|Randomized - 9 Month|Withdrawal by Subject|7|||
147440637|NCT00514514|531778963|FG002|Randomized - 9 Month|Withdrawal by Subject|5|||
147440638|NCT00514514|531778961|FG000|Randomized - 9 Month|Protocol Violation|1|||
147440639|NCT00514514|531778962|FG001|Randomized - 9 Month|Protocol Violation|1|||
147440640|NCT00514514|531778963|FG002|Randomized - 9 Month|Protocol Violation|0|||
147440641|NCT00514514|531778961|FG000|Randomized - 9 Month|Lack of Efficacy|2|||
147440642|NCT00514514|531778962|FG001|Randomized - 9 Month|Lack of Efficacy|3|||
147440643|NCT00514514|531778963|FG002|Randomized - 9 Month|Lack of Efficacy|1|||
147440644|NCT00514514|531778961|FG000|Randomized - 9 Month|Abnormal laboratory values|0|||
147440645|NCT00514514|531778962|FG001|Randomized - 9 Month|Abnormal laboratory values|3|||
147440646|NCT00514514|531778963|FG002|Randomized - 9 Month|Abnormal laboratory values|1|||
147440647|NCT00514514|531778961|FG000|Randomized - 9 Month|Adverse Event|25|||
147440648|NCT00514514|531778962|FG001|Randomized - 9 Month|Adverse Event|44|||
147440649|NCT00514514|531778963|FG002|Randomized - 9 Month|Adverse Event|27|||
147440650|NCT00514514|531778961|FG000|Extension - 4 Years|Withdrawal by Subject|5|||
147440651|NCT00514514|531778962|FG001|Extension - 4 Years|Withdrawal by Subject|2|||
147440652|NCT00514514|531778963|FG002|Extension - 4 Years|Withdrawal by Subject|2|||
147440653|NCT00514514|531778961|FG000|Extension - 4 Years|Lost to Follow-up|12|||
147440654|NCT00514514|531778962|FG001|Extension - 4 Years|Lost to Follow-up|10|||
147440655|NCT00514514|531778963|FG002|Extension - 4 Years|Lost to Follow-up|9|||
147440656|NCT00514514|531778961|FG000|Extension - 4 Years|Administrative problems|3|||
147440657|NCT00514514|531778962|FG001|Extension - 4 Years|Administrative problems|1|||
147440658|NCT00514514|531778963|FG002|Extension - 4 Years|Administrative problems|1|||
147440659|NCT00514514|531778961|FG000|Extension - 4 Years|Death|8|||
147440660|NCT00514514|531778962|FG001|Extension - 4 Years|Death|3|||
147440661|NCT00514514|531778963|FG002|Extension - 4 Years|Death|6|||
147440662|NCT00514514|531778961|FG000|Extension - 4 Years|Adverse Event|9|||
147440663|NCT00514514|531778962|FG001|Extension - 4 Years|Adverse Event|6|||
147440664|NCT00514514|531778963|FG002|Extension - 4 Years|Adverse Event|3|||
147440665|NCT01848288|531778971|FG000|Overall Study|Death|1|||
147440666|NCT01848288|531778971|FG000|Overall Study|Protocol Violation|1|||
147440667|NCT01848288|531778971|FG000|Overall Study|Withdrawal by Subject|1|||
147440668|NCT03677596|531778972|FG000|Overall Study|Adverse Event|0|||
147440669|NCT03677596|531778973|FG001|Overall Study|Adverse Event|1|||
147440670|NCT03677596|531778972|FG000|Overall Study|Death|10|||
147440671|NCT03677596|531778973|FG001|Overall Study|Death|6|||
147440672|NCT03677596|531778972|FG000|Overall Study|Lost to Follow-up|0|||
147440673|NCT03677596|531778973|FG001|Overall Study|Lost to Follow-up|1|||
147440674|NCT03677596|531778972|FG000|Overall Study|Progressive Disease|8|||
147440675|NCT03677596|531778973|FG001|Overall Study|Progressive Disease|8|||
147440676|NCT03677596|531778972|FG000|Overall Study|Withdrawal by Subject|3|||
147440677|NCT03677596|531778973|FG001|Overall Study|Withdrawal by Subject|0|||
147542567|NCT01160198|532142148|FG001|Overall Study|Adverse Event|1|||
147440678|NCT03677596|531778972|FG000|Overall Study|Disease Relapse|2|||
147440679|NCT03677596|531778973|FG001|Overall Study|Disease Relapse|2|||
147440680|NCT03677596|531778972|FG000|Overall Study|Other|0|||
147440681|NCT03677596|531778973|FG001|Overall Study|Other|1|||
147440682|NCT03794583|531778974|FG000|Overall Study|Death|8|||
147542568|NCT01160198|532142149|FG002|Overall Study|Adverse Event|0|||
147542569|NCT01160198|532142147|FG000|Overall Study|Lost to Follow-up|0|||
147542570|NCT01160198|532142148|FG001|Overall Study|Lost to Follow-up|1|||
147210662|NCT01708902|530942844|FG002|Overall Study|Other Reason|1|||
147210663|NCT01708902|530942845|FG003|Overall Study|Other Reason|1|||
147210664|NCT01708902|530942846|FG004|Overall Study|Other Reason|1|||
147210665|NCT01708902|530942847|FG005|Overall Study|Other Reason|2|||
147210666|NCT01708902|530942848|FG006|Overall Study|Other Reason|0|||
147210667|NCT00499590|530942851|FG000|Overall Study|Study Terminated|112|||
147210668|NCT00499590|530942852|FG001|Overall Study|Study Terminated|112|||
147210669|NCT00499590|530942853|FG002|Overall Study|Study Terminated|112|||
147210670|NCT00499590|530942851|FG000|Overall Study|Not treated|1|||
147210671|NCT00499590|530942852|FG001|Overall Study|Not treated|0|||
147210672|NCT00499590|530942853|FG002|Overall Study|Not treated|1|||
147210673|NCT02281383|530942858|FG000|Overall Study|Progressive Disease|1|||
147210674|NCT02281383|530942858|FG000|Overall Study|Withdrawal by Subject|6|||
147210675|NCT02281383|530942858|FG000|Overall Study|Protocol Violation|2|||
147210676|NCT02281383|530942858|FG000|Overall Study|Death|1|||
147440683|NCT03794583|531778974|FG000|Overall Study|Study Terminated by Sponsor|24|||
147210677|NCT02281383|530942858|FG000|Overall Study|Adverse Event|2|||
147210678|NCT01215097|530942859|FG000|Overall Study|Adverse Event|1|||
147210679|NCT01215097|530942860|FG001|Overall Study|Adverse Event|3|||
147210680|NCT01215097|530942859|FG000|Overall Study|Protocol Violation|0|||
147210681|NCT01215097|530942860|FG001|Overall Study|Protocol Violation|2|||
147440684|NCT03794583|531778974|FG000|Overall Study|Withdrawal by Subject|9|||
147440685|NCT02752035|531778977|FG000|Safety Cohort: Approximately 5 Years|Miscellaneous|2|||
147440686|NCT02752035|531778978|FG001|Safety Cohort: Approximately 5 Years|Miscellaneous|0|||
147440687|NCT02752035|531778979|FG002|Safety Cohort: Approximately 5 Years|Miscellaneous|0|||
147440688|NCT02752035|531778980|FG003|Safety Cohort: Approximately 5 Years|Miscellaneous|0|||
147440689|NCT02752035|531778977|FG000|Safety Cohort: Approximately 5 Years|Disease relapse|5|||
147440690|NCT02752035|531778978|FG001|Safety Cohort: Approximately 5 Years|Disease relapse|0|||
147440691|NCT02752035|531778979|FG002|Safety Cohort: Approximately 5 Years|Disease relapse|0|||
147440692|NCT02752035|531778980|FG003|Safety Cohort: Approximately 5 Years|Disease relapse|0|||
147440693|NCT02752035|531778977|FG000|Safety Cohort: Approximately 5 Years|Withdrawal by Subject|1|||
147440694|NCT02752035|531778978|FG001|Safety Cohort: Approximately 5 Years|Withdrawal by Subject|0|||
147440695|NCT02752035|531778979|FG002|Safety Cohort: Approximately 5 Years|Withdrawal by Subject|0|||
147440696|NCT02752035|531778980|FG003|Safety Cohort: Approximately 5 Years|Withdrawal by Subject|0|||
147440697|NCT02752035|531778977|FG000|Safety Cohort: Approximately 5 Years|Lack of Efficacy|1|||
147440698|NCT02752035|531778978|FG001|Safety Cohort: Approximately 5 Years|Lack of Efficacy|0|||
147440699|NCT02752035|531778979|FG002|Safety Cohort: Approximately 5 Years|Lack of Efficacy|0|||
147440700|NCT02752035|531778980|FG003|Safety Cohort: Approximately 5 Years|Lack of Efficacy|0|||
147440701|NCT02752035|531778977|FG000|Safety Cohort: Approximately 5 Years|Death|5|||
147440702|NCT02752035|531778978|FG001|Safety Cohort: Approximately 5 Years|Death|0|||
147440703|NCT02752035|531778979|FG002|Safety Cohort: Approximately 5 Years|Death|0|||
147440704|NCT02752035|531778980|FG003|Safety Cohort: Approximately 5 Years|Death|0|||
147440705|NCT02752035|531778977|FG000|Safety Cohort: Approximately 5 Years|Adverse Event|1|||
147440706|NCT02752035|531778978|FG001|Safety Cohort: Approximately 5 Years|Adverse Event|0|||
147440707|NCT02752035|531778979|FG002|Safety Cohort: Approximately 5 Years|Adverse Event|0|||
147440708|NCT02752035|531778980|FG003|Safety Cohort: Approximately 5 Years|Adverse Event|0|||
147440709|NCT02752035|531778977|FG000|Randomization: Approximately 3 Years|Miscellaneous|0|||
147440710|NCT02752035|531778978|FG001|Randomization: Approximately 3 Years|Miscellaneous|7|||
147440711|NCT02752035|531778979|FG002|Randomization: Approximately 3 Years|Miscellaneous|4|||
147440712|NCT02752035|531778980|FG003|Randomization: Approximately 3 Years|Miscellaneous|1|||
147440713|NCT02752035|531778977|FG000|Randomization: Approximately 3 Years|Disease Relapse|0|||
147440714|NCT02752035|531778978|FG001|Randomization: Approximately 3 Years|Disease Relapse|22|||
147440715|NCT02752035|531778979|FG002|Randomization: Approximately 3 Years|Disease Relapse|16|||
147440716|NCT02752035|531778980|FG003|Randomization: Approximately 3 Years|Disease Relapse|6|||
147440717|NCT02752035|531778977|FG000|Randomization: Approximately 3 Years|Physician Decision|0|||
147440718|NCT02752035|531778978|FG001|Randomization: Approximately 3 Years|Physician Decision|3|||
147440719|NCT02752035|531778979|FG002|Randomization: Approximately 3 Years|Physician Decision|1|||
147440720|NCT02752035|531778980|FG003|Randomization: Approximately 3 Years|Physician Decision|1|||
147440721|NCT02752035|531778977|FG000|Randomization: Approximately 3 Years|Withdrawal by Subject|0|||
147440722|NCT02752035|531778978|FG001|Randomization: Approximately 3 Years|Withdrawal by Subject|14|||
147440723|NCT02752035|531778979|FG002|Randomization: Approximately 3 Years|Withdrawal by Subject|7|||
147440724|NCT02752035|531778980|FG003|Randomization: Approximately 3 Years|Withdrawal by Subject|4|||
147440725|NCT02752035|531778977|FG000|Randomization: Approximately 3 Years|Lack of Efficacy|0|||
147440726|NCT02752035|531778978|FG001|Randomization: Approximately 3 Years|Lack of Efficacy|4|||
147440727|NCT02752035|531778979|FG002|Randomization: Approximately 3 Years|Lack of Efficacy|14|||
147440728|NCT02752035|531778980|FG003|Randomization: Approximately 3 Years|Lack of Efficacy|0|||
147440729|NCT02752035|531778977|FG000|Randomization: Approximately 3 Years|Death|0|||
147210682|NCT01215097|530942859|FG000|Overall Study|Lost to Follow-up|2|||
147210683|NCT01215097|530942860|FG001|Overall Study|Lost to Follow-up|0|||
147210684|NCT01215097|530942859|FG000|Overall Study|Withdrawal by Subject|6|||
147542571|NCT01160198|532142149|FG002|Overall Study|Lost to Follow-up|0|||
147542572|NCT01160198|532142147|FG000|Overall Study|Participant lost drug; withdrew consent|0|||
147542573|NCT01160198|532142148|FG001|Overall Study|Participant lost drug; withdrew consent|0|||
147542574|NCT01160198|532142149|FG002|Overall Study|Participant lost drug; withdrew consent|1|||
147542575|NCT01796860|532142151|FG000|Overall Study|Withdrawal by Subject|3|||
147542576|NCT02016755|532142152|FG000|Overall Study|Major amputation of index limb|2|||
147542577|NCT02016755|532142152|FG000|Overall Study|Adverse Event|2|||
147542578|NCT02016755|532142152|FG000|Overall Study|Physician Decision|1|||
147542579|NCT02016755|532142152|FG000|Overall Study|Death|2|||
147542580|NCT00563524|532142162|FG000|Overall Study|Adverse Event|0|||
147542581|NCT00563524|532142163|FG001|Overall Study|Adverse Event|1|||
147542582|NCT00563524|532142164|FG002|Overall Study|Adverse Event|0|||
147542583|NCT00563524|532142165|FG003|Overall Study|Adverse Event|0|||
147542584|NCT00563524|532142166|FG004|Overall Study|Adverse Event|2|||
147542585|NCT00563524|532142167|FG005|Overall Study|Adverse Event|0|||
147440730|NCT02752035|531778978|FG001|Randomization: Approximately 3 Years|Death|25|||
147440731|NCT02752035|531778979|FG002|Randomization: Approximately 3 Years|Death|13|||
147440732|NCT02752035|531778980|FG003|Randomization: Approximately 3 Years|Death|4|||
147440733|NCT02752035|531778977|FG000|Randomization: Approximately 3 Years|Adverse Event|0|||
147440734|NCT02752035|531778978|FG001|Randomization: Approximately 3 Years|Adverse Event|14|||
147440735|NCT02752035|531778979|FG002|Randomization: Approximately 3 Years|Adverse Event|2|||
147440736|NCT02752035|531778980|FG003|Randomization: Approximately 3 Years|Adverse Event|6|||
147440737|NCT02752035|531778977|FG000|Long-term Follow-up: up to 3 Years|Withdrawal by Subject|0|||
147440738|NCT02752035|531778978|FG001|Long-term Follow-up: up to 3 Years|Withdrawal by Subject|3|||
147440739|NCT02752035|531778979|FG002|Long-term Follow-up: up to 3 Years|Withdrawal by Subject|3|||
147440740|NCT02752035|531778980|FG003|Long-term Follow-up: up to 3 Years|Withdrawal by Subject|0|||
147440741|NCT02752035|531778977|FG000|Long-term Follow-up: up to 3 Years|Lost to Follow-up|0|||
147440742|NCT02752035|531778978|FG001|Long-term Follow-up: up to 3 Years|Lost to Follow-up|1|||
147440743|NCT02752035|531778979|FG002|Long-term Follow-up: up to 3 Years|Lost to Follow-up|1|||
147440744|NCT02752035|531778980|FG003|Long-term Follow-up: up to 3 Years|Lost to Follow-up|0|||
147440745|NCT02752035|531778977|FG000|Long-term Follow-up: up to 3 Years|Death|5|||
147440746|NCT02752035|531778978|FG001|Long-term Follow-up: up to 3 Years|Death|26|||
147440747|NCT02752035|531778979|FG002|Long-term Follow-up: up to 3 Years|Death|30|||
147440748|NCT02752035|531778980|FG003|Long-term Follow-up: up to 3 Years|Death|10|||
147440749|NCT02752035|531778977|FG000|Long-term Follow-up: up to 3 Years|Miscellaneous|0|||
147440750|NCT02752035|531778978|FG001|Long-term Follow-up: up to 3 Years|Miscellaneous|3|||
147440751|NCT02752035|531778979|FG002|Long-term Follow-up: up to 3 Years|Miscellaneous|0|||
147440752|NCT02752035|531778980|FG003|Long-term Follow-up: up to 3 Years|Miscellaneous|0|||
147440753|NCT01519934|531778981|FG000|Overall Study|Lost to Follow-up|3|||
147440754|NCT01161043|531778982|FG000|Overall Study|Withdrawal by Subject|3|||
147440755|NCT02161575|531778984|FG000|Overall Study|Protocol Violation|8|||
147440756|NCT02161575|531778984|FG000|Overall Study|Lack of Efficacy|1|||
147440757|NCT02161575|531778984|FG000|Overall Study|Adverse Event|2|||
147440758|NCT00701090|531778993|FG000|Overall Study|Adverse Event|11|||
147440759|NCT00701090|531778994|FG001|Overall Study|Adverse Event|2|||
147440760|NCT00701090|531778993|FG000|Overall Study|Death|0|||
147440761|NCT00701090|531778994|FG001|Overall Study|Death|1|||
147440762|NCT00701090|531778993|FG000|Overall Study|Lack of Efficacy|5|||
147440763|NCT00701090|531778994|FG001|Overall Study|Lack of Efficacy|4|||
147440764|NCT00701090|531778993|FG000|Overall Study|Lost to Follow-up|9|||
147440765|NCT00701090|531778994|FG001|Overall Study|Lost to Follow-up|9|||
147440766|NCT00701090|531778993|FG000|Overall Study|Physician Decision|3|||
147440767|NCT00701090|531778994|FG001|Overall Study|Physician Decision|4|||
147440768|NCT00701090|531778993|FG000|Overall Study|Protocol Violation|2|||
147440769|NCT00701090|531778994|FG001|Overall Study|Protocol Violation|3|||
147440770|NCT00701090|531778993|FG000|Overall Study|Withdrawal by Subject|11|||
147440771|NCT00701090|531778994|FG001|Overall Study|Withdrawal by Subject|16|||
147440772|NCT00701090|531778993|FG000|Overall Study|Other|7|||
147440773|NCT00701090|531778994|FG001|Overall Study|Other|12|||
147440774|NCT01299376|531778998|FG000|Double-blind Treatment (Weeks 1 to 8)|Adverse Event|1|||
147440775|NCT01299376|531778999|FG001|Double-blind Treatment (Weeks 1 to 8)|Adverse Event|2|||
147440776|NCT01299376|531778998|FG000|Double-blind Treatment (Weeks 1 to 8)|Lack of Efficacy|0|||
147440777|NCT01299376|531778999|FG001|Double-blind Treatment (Weeks 1 to 8)|Lack of Efficacy|1|||
147440778|NCT01299376|531778998|FG000|Double-blind Treatment (Weeks 1 to 8)|Lost to Follow-up|0|||
147440779|NCT01299376|531778999|FG001|Double-blind Treatment (Weeks 1 to 8)|Lost to Follow-up|1|||
147440780|NCT01299376|531778998|FG000|Double-blind Treatment (Weeks 1 to 8)|Blood Pressure/Potassium Criteria Met|4|||
147440781|NCT01299376|531778999|FG001|Double-blind Treatment (Weeks 1 to 8)|Blood Pressure/Potassium Criteria Met|7|||
147440782|NCT01299376|531778998|FG000|Double-blind Treatment (Weeks 1 to 8)|Protocol Violation|1|||
147440783|NCT01299376|531778999|FG001|Double-blind Treatment (Weeks 1 to 8)|Protocol Violation|0|||
147440784|NCT01299376|531778998|FG000|Double-blind Treatment (Weeks 1 to 8)|Withdrawal by Subject|1|||
147542586|NCT00563524|532142162|FG000|Overall Study|Lost to Follow-up|1|||
147210685|NCT01215097|530942860|FG001|Overall Study|Withdrawal by Subject|3|||
147542587|NCT00563524|532142163|FG001|Overall Study|Lost to Follow-up|0|||
147542588|NCT00563524|532142164|FG002|Overall Study|Lost to Follow-up|0|||
147542589|NCT00563524|532142165|FG003|Overall Study|Lost to Follow-up|0|||
147542590|NCT00563524|532142166|FG004|Overall Study|Lost to Follow-up|0|||
147542591|NCT00563524|532142167|FG005|Overall Study|Lost to Follow-up|0|||
147542592|NCT00563524|532142162|FG000|Overall Study|Protocol Violation|0|||
147542593|NCT00563524|532142163|FG001|Overall Study|Protocol Violation|1|||
147542594|NCT00563524|532142164|FG002|Overall Study|Protocol Violation|0|||
147542595|NCT00563524|532142165|FG003|Overall Study|Protocol Violation|0|||
147542596|NCT00563524|532142166|FG004|Overall Study|Protocol Violation|0|||
147542597|NCT00563524|532142167|FG005|Overall Study|Protocol Violation|0|||
147542598|NCT00563524|532142162|FG000|Overall Study|Withdrawal by Subject|1|||
147542599|NCT00563524|532142163|FG001|Overall Study|Withdrawal by Subject|1|||
147542600|NCT00563524|532142164|FG002|Overall Study|Withdrawal by Subject|3|||
147542601|NCT00563524|532142165|FG003|Overall Study|Withdrawal by Subject|0|||
147542602|NCT00563524|532142166|FG004|Overall Study|Withdrawal by Subject|0|||
147542603|NCT00563524|532142167|FG005|Overall Study|Withdrawal by Subject|1|||
147542604|NCT03543046|532142173|FG000|Overall Study|Adverse Event|1|||
147542605|NCT03543046|532142174|FG001|Overall Study|Adverse Event|1|||
147542606|NCT03543046|532142173|FG000|Overall Study|Physician Decision|1|||
147542607|NCT03543046|532142174|FG001|Overall Study|Physician Decision|1|||
147542608|NCT03543046|532142173|FG000|Overall Study|Protocol Violation|1|||
147542609|NCT03543046|532142174|FG001|Overall Study|Protocol Violation|0|||
147542610|NCT00520494|532142184|FG000|Overall Study|Withdrawal by Subject|1|||
147542611|NCT04247594|532142185|FG000|Overall Study|Withdrawal by Subject|4|||
147542612|NCT02748616|532142186|FG000|Overall Study|Lost to Follow-up|1|||
147542613|NCT02748616|532142186|FG000|Overall Study|Withdrawal by Subject|2|||
147542614|NCT02748616|532142186|FG000|Overall Study|Physician Decision|2|||
147542615|NCT02748616|532142186|FG000|Overall Study|Did Not Complete Ursodial Course|2|||
147542616|NCT00713830|532142187|FG000|Overall Study|Adverse Event|23|||
147542617|NCT00713830|532142188|FG001|Overall Study|Adverse Event|71|||
147542618|NCT00713830|532142187|FG000|Overall Study|Lack of Efficacy|24|||
147542619|NCT00713830|532142188|FG001|Overall Study|Lack of Efficacy|16|||
147542620|NCT00713830|532142187|FG000|Overall Study|Lost to Follow-up|2|||
147542621|NCT00713830|532142188|FG001|Overall Study|Lost to Follow-up|9|||
147542622|NCT00713830|532142187|FG000|Overall Study|Withdrawal by Subject|13|||
147542623|NCT00713830|532142188|FG001|Overall Study|Withdrawal by Subject|23|||
147542624|NCT00713830|532142187|FG000|Overall Study|Poor Compliance to Protocol|7|||
147542625|NCT00713830|532142188|FG001|Overall Study|Poor Compliance to Protocol|14|||
147542626|NCT00713830|532142187|FG000|Overall Study|Familial and Personal Reasons|9|||
147542627|NCT00713830|532142188|FG001|Overall Study|Familial and Personal Reasons|34|||
147542628|NCT00713830|532142187|FG000|Overall Study|Sponsor Decision|4|||
147542629|NCT00713830|532142188|FG001|Overall Study|Sponsor Decision|10|||
147542630|NCT00422058|532142189|FG000|Double-Blind, Week 0-20|Adverse Event|3|||
147542631|NCT00422058|532142190|FG001|Double-Blind, Week 0-20|Adverse Event|4|||
147542632|NCT00422058|532142191|FG002|Double-Blind, Week 0-20|Adverse Event|5|||
147542633|NCT00422058|532142192|FG003|Double-Blind, Week 0-20|Adverse Event|9|||
147542634|NCT00422058|532142193|FG004|Double-Blind, Week 0-20|Adverse Event|5|||
147542635|NCT00422058|532142194|FG005|Double-Blind, Week 0-20|Adverse Event|3|||
147542636|NCT00422058|532142189|FG000|Double-Blind, Week 0-20|Protocol Violation|3|||
147542637|NCT00422058|532142190|FG001|Double-Blind, Week 0-20|Protocol Violation|2|||
147542638|NCT00422058|532142191|FG002|Double-Blind, Week 0-20|Protocol Violation|2|||
147542639|NCT00422058|532142192|FG003|Double-Blind, Week 0-20|Protocol Violation|3|||
147542640|NCT00422058|532142193|FG004|Double-Blind, Week 0-20|Protocol Violation|2|||
147542641|NCT00422058|532142194|FG005|Double-Blind, Week 0-20|Protocol Violation|2|||
147542642|NCT00422058|532142189|FG000|Double-Blind, Week 0-20|Lack of Efficacy|2|||
147542643|NCT00422058|532142190|FG001|Double-Blind, Week 0-20|Lack of Efficacy|1|||
147542644|NCT00422058|532142191|FG002|Double-Blind, Week 0-20|Lack of Efficacy|1|||
147542645|NCT00422058|532142192|FG003|Double-Blind, Week 0-20|Lack of Efficacy|0|||
147542646|NCT00422058|532142193|FG004|Double-Blind, Week 0-20|Lack of Efficacy|0|||
147542647|NCT00422058|532142194|FG005|Double-Blind, Week 0-20|Lack of Efficacy|1|||
147542648|NCT00422058|532142189|FG000|Double-Blind, Week 0-20|Other|11|||
147542649|NCT00422058|532142190|FG001|Double-Blind, Week 0-20|Other|3|||
147542650|NCT00422058|532142191|FG002|Double-Blind, Week 0-20|Other|8|||
147542651|NCT00422058|532142192|FG003|Double-Blind, Week 0-20|Other|8|||
147542652|NCT00422058|532142193|FG004|Double-Blind, Week 0-20|Other|4|||
147542653|NCT00422058|532142194|FG005|Double-Blind, Week 0-20|Other|10|||
147542654|NCT00422058|532142189|FG000|Open-Label Extension, Week 20-104|Not giving consent for extension|12|||
147542655|NCT00422058|532142190|FG001|Open-Label Extension, Week 20-104|Not giving consent for extension|17|||
147542656|NCT00422058|532142191|FG002|Open-Label Extension, Week 20-104|Not giving consent for extension|15|||
147542657|NCT00422058|532142192|FG003|Open-Label Extension, Week 20-104|Not giving consent for extension|8|||
147542658|NCT00422058|532142193|FG004|Open-Label Extension, Week 20-104|Not giving consent for extension|10|||
147542659|NCT00422058|532142194|FG005|Open-Label Extension, Week 20-104|Not giving consent for extension|12|||
147542660|NCT00422058|532142189|FG000|Open-Label Extension, Week 20-104|Adverse Event|3|||
147542661|NCT00422058|532142190|FG001|Open-Label Extension, Week 20-104|Adverse Event|4|||
147440785|NCT01299376|531778999|FG001|Double-blind Treatment (Weeks 1 to 8)|Withdrawal by Subject|1|||
147440786|NCT01299376|531778998|FG000|Extension (Weeks 9 to 52)|Withdrawal by Subject|2|||
147440787|NCT01299376|531778999|FG001|Extension (Weeks 9 to 52)|Withdrawal by Subject|1|||
147440788|NCT01299376|531778998|FG000|Extension (Weeks 9 to 52)|Adverse Event|2|||
147440789|NCT01299376|531778999|FG001|Extension (Weeks 9 to 52)|Adverse Event|3|||
147440790|NCT01299376|531778998|FG000|Extension (Weeks 9 to 52)|Lost to Follow-up|1|||
147440791|NCT01299376|531778999|FG001|Extension (Weeks 9 to 52)|Lost to Follow-up|2|||
147440792|NCT01299376|531778998|FG000|Extension (Weeks 9 to 52)|Blood Pressure/Potassium Criteria Met|4|||
147440793|NCT01299376|531778999|FG001|Extension (Weeks 9 to 52)|Blood Pressure/Potassium Criteria Met|9|||
147440794|NCT01299376|531778998|FG000|Extension (Weeks 9 to 52)|Physician Decision|1|||
147440795|NCT01299376|531778999|FG001|Extension (Weeks 9 to 52)|Physician Decision|0|||
147440796|NCT03680911|531779000|FG000|At Home Treatment|Study Termination|3|||
147440797|NCT03680911|531779001|FG001|At Home Treatment|Study Termination|0|||
147440798|NCT03680911|531779000|FG000|At Home Treatment|Lost to Follow-up|0|||
147440799|NCT03680911|531779001|FG001|At Home Treatment|Lost to Follow-up|1|||
147440800|NCT03680911|531779000|FG000|At Home Treatment|Withdrawal by Subject|0|||
147440801|NCT03680911|531779001|FG001|At Home Treatment|Withdrawal by Subject|2|||
147440802|NCT03680911|531779000|FG000|Visit 3 (4 Month Follow up)|Study Termination|0|||
147440803|NCT03680911|531779001|FG001|Visit 3 (4 Month Follow up)|Study Termination|1|||
147440804|NCT01786603|531779002|FG000|Overall Study|Death|5|||
147440805|NCT01786603|531779003|FG001|Overall Study|Death|1|||
147440806|NCT01786603|531779002|FG000|Overall Study|Adverse Event|6|||
147440807|NCT01786603|531779003|FG001|Overall Study|Adverse Event|2|||
147440808|NCT01786603|531779002|FG000|Overall Study|Physician decision to withdraw|6|||
147440809|NCT01786603|531779003|FG001|Overall Study|Physician decision to withdraw|7|||
147440810|NCT01786603|531779002|FG000|Overall Study|Lost to Follow-up|1|||
147440811|NCT01786603|531779003|FG001|Overall Study|Lost to Follow-up|2|||
147440812|NCT03700320|531779004|FG000|Overall Study|Adverse Event|5|||
147440813|NCT03700320|531779005|FG001|Overall Study|Adverse Event|31|||
147440814|NCT03700320|531779004|FG000|Overall Study|Lack of Efficacy|2|||
147440815|NCT03700320|531779005|FG001|Overall Study|Lack of Efficacy|5|||
147440816|NCT03700320|531779004|FG000|Overall Study|Withdrawal by Subject|29|||
147440817|NCT03700320|531779005|FG001|Overall Study|Withdrawal by Subject|75|||
147440818|NCT03700320|531779004|FG000|Overall Study|Lost to Follow-up|16|||
147440819|NCT03700320|531779005|FG001|Overall Study|Lost to Follow-up|23|||
147440820|NCT03700320|531779004|FG000|Overall Study|Pregnancy|2|||
147440821|NCT03700320|531779005|FG001|Overall Study|Pregnancy|4|||
147440822|NCT03700320|531779004|FG000|Overall Study|Protocol Deviation|7|||
147440823|NCT03700320|531779005|FG001|Overall Study|Protocol Deviation|31|||
147440824|NCT03700320|531779004|FG000|Overall Study|Non-compliance with Study Drug|1|||
147440825|NCT03700320|531779005|FG001|Overall Study|Non-compliance with Study Drug|3|||
147440826|NCT03700320|531779004|FG000|Overall Study|Reason not Specified|0|||
147210686|NCT01215097|530942859|FG000|Overall Study|Lack of Efficacy|0|||
147210687|NCT01215097|530942860|FG001|Overall Study|Lack of Efficacy|3|||
147210688|NCT01215097|530942859|FG000|Overall Study|patient's refusal to come|2|||
147210689|NCT01215097|530942860|FG001|Overall Study|patient's refusal to come|2|||
147210690|NCT01215097|530942859|FG000|Overall Study|patient's private reason|1|||
147210691|NCT01215097|530942860|FG001|Overall Study|patient's private reason|1|||
147440827|NCT03700320|531779005|FG001|Overall Study|Reason not Specified|1|||
147440828|NCT02054325|531779013|FG000|Overall Study|Lost to Follow-up|8|||
147440829|NCT02054325|531779014|FG001|Overall Study|Lost to Follow-up|5|||
147440830|NCT01770912|531779017|FG000|Overall Study|Lost to Follow-up|2|||
147440831|NCT01770912|531779018|FG001|Overall Study|Lost to Follow-up|0|||
147440832|NCT01708291|531779019|FG000|Overall Study|fighting|2|||
147440833|NCT01708291|531779020|FG001|Overall Study|fighting|1|||
147440834|NCT01536951|531779022|FG000|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
147440835|NCT01536951|531779023|FG001|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
147440836|NCT01536951|531779024|FG002|First Intervention and Washout Period 1|Withdrawal by Subject|1|||
147440837|NCT01536951|531779025|FG003|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
147440838|NCT01536951|531779026|FG004|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
147440839|NCT01536951|531779027|FG005|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
147440840|NCT01536951|531779028|FG006|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
147440841|NCT01536951|531779029|FG007|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
147440842|NCT01536951|531779030|FG008|First Intervention and Washout Period 1|Withdrawal by Subject|0|||
147210692|NCT02252939|530942861|FG000|Overall Study|Lost to Follow-up|3|||
147440843|NCT01536951|531779022|FG000|Second Intervention and Washout Period 2|Adverse Event|0|||
147440844|NCT01536951|531779023|FG001|Second Intervention and Washout Period 2|Adverse Event|0|||
147440845|NCT01536951|531779024|FG002|Second Intervention and Washout Period 2|Adverse Event|0|||
147210693|NCT01516034|530942863|FG000|Overall Study|Physician Decision|1|||
147210694|NCT01516034|530942863|FG000|Overall Study|Lack of Efficacy|7|||
147440846|NCT01536951|531779025|FG003|Second Intervention and Washout Period 2|Adverse Event|0|||
147440847|NCT01536951|531779026|FG004|Second Intervention and Washout Period 2|Adverse Event|0|||
147440848|NCT01536951|531779027|FG005|Second Intervention and Washout Period 2|Adverse Event|0|||
147542662|NCT00422058|532142191|FG002|Open-Label Extension, Week 20-104|Adverse Event|7|||
147542663|NCT00422058|532142192|FG003|Open-Label Extension, Week 20-104|Adverse Event|4|||
147542664|NCT00422058|532142193|FG004|Open-Label Extension, Week 20-104|Adverse Event|4|||
147542665|NCT00422058|532142194|FG005|Open-Label Extension, Week 20-104|Adverse Event|0|||
147542666|NCT00422058|532142189|FG000|Open-Label Extension, Week 20-104|Protocol Violation|1|||
147542667|NCT00422058|532142190|FG001|Open-Label Extension, Week 20-104|Protocol Violation|2|||
147542668|NCT00422058|532142191|FG002|Open-Label Extension, Week 20-104|Protocol Violation|3|||
147542669|NCT00422058|532142192|FG003|Open-Label Extension, Week 20-104|Protocol Violation|1|||
147542670|NCT00422058|532142193|FG004|Open-Label Extension, Week 20-104|Protocol Violation|5|||
147542671|NCT00422058|532142194|FG005|Open-Label Extension, Week 20-104|Protocol Violation|3|||
147542672|NCT00422058|532142189|FG000|Open-Label Extension, Week 20-104|Lack of Efficacy|3|||
147542673|NCT00422058|532142190|FG001|Open-Label Extension, Week 20-104|Lack of Efficacy|2|||
147542674|NCT00422058|532142191|FG002|Open-Label Extension, Week 20-104|Lack of Efficacy|5|||
147542675|NCT00422058|532142192|FG003|Open-Label Extension, Week 20-104|Lack of Efficacy|2|||
147542676|NCT00422058|532142193|FG004|Open-Label Extension, Week 20-104|Lack of Efficacy|0|||
147542677|NCT00422058|532142194|FG005|Open-Label Extension, Week 20-104|Lack of Efficacy|1|||
147542678|NCT00422058|532142189|FG000|Open-Label Extension, Week 20-104|Other|13|||
147542679|NCT00422058|532142190|FG001|Open-Label Extension, Week 20-104|Other|14|||
147542680|NCT00422058|532142191|FG002|Open-Label Extension, Week 20-104|Other|6|||
147542681|NCT00422058|532142192|FG003|Open-Label Extension, Week 20-104|Other|13|||
147542682|NCT00422058|532142193|FG004|Open-Label Extension, Week 20-104|Other|16|||
147542683|NCT00422058|532142194|FG005|Open-Label Extension, Week 20-104|Other|18|||
147542684|NCT02787785|532142197|FG000|Overall Study|Death|3|||
147542685|NCT02787785|532142198|FG001|Overall Study|Death|4|||
147542686|NCT02787785|532142197|FG000|Overall Study|Lost to Follow-up|1|||
147542687|NCT02787785|532142198|FG001|Overall Study|Lost to Follow-up|1|||
147542688|NCT02787785|532142197|FG000|Overall Study|Withdrawal by Subject|0|||
147542689|NCT02787785|532142198|FG001|Overall Study|Withdrawal by Subject|5|||
147542690|NCT02030834|532142199|FG000|Overall Study|Death|4|||
147542691|NCT02030834|532142200|FG001|Overall Study|Death|0|||
147542692|NCT02030834|532142201|FG002|Overall Study|Death|0|||
147542693|NCT02030834|532142199|FG000|Overall Study|Manufacturing failure|2|||
147542694|NCT02030834|532142200|FG001|Overall Study|Manufacturing failure|0|||
147542695|NCT02030834|532142201|FG002|Overall Study|Manufacturing failure|1|||
147542696|NCT02030834|532142199|FG000|Overall Study|Disease progression|2|||
147542697|NCT02030834|532142200|FG001|Overall Study|Disease progression|0|||
147542698|NCT02030834|532142201|FG002|Overall Study|Disease progression|2|||
147542699|NCT02030834|532142199|FG000|Overall Study|Lost to Follow-up|1|||
147542700|NCT02030834|532142200|FG001|Overall Study|Lost to Follow-up|0|||
147542701|NCT02030834|532142201|FG002|Overall Study|Lost to Follow-up|0|||
147542702|NCT02030834|532142199|FG000|Overall Study|Withdrawal by Subject|1|||
147542703|NCT02030834|532142200|FG001|Overall Study|Withdrawal by Subject|0|||
147542704|NCT02030834|532142201|FG002|Overall Study|Withdrawal by Subject|0|||
147542705|NCT02030834|532142199|FG000|Overall Study|Lack of funding|1|||
147542706|NCT02030834|532142200|FG001|Overall Study|Lack of funding|0|||
147542707|NCT02030834|532142201|FG002|Overall Study|Lack of funding|0|||
147542708|NCT00854607|532142205|FG000|2 Weeks After Start Anti-fungal Therapy|Diagnosed with Possible IA|65|||
147542709|NCT00965263|532142213|FG000|Overall Study|Physician Decision|2|||
147542710|NCT00965263|532142214|FG001|Overall Study|Physician Decision|0|||
147542711|NCT00965263|532142213|FG000|Overall Study|Family emergency|0|||
147542712|NCT00965263|532142214|FG001|Overall Study|Family emergency|1|||
147542713|NCT00965263|532142213|FG000|Overall Study|Protocol Violation|0|||
147542714|NCT00965263|532142214|FG001|Overall Study|Protocol Violation|2|||
147542715|NCT01766310|532142215|FG000|Overall Study|Lost to Follow-up|1|||
147542716|NCT01766310|532142216|FG001|Overall Study|Lost to Follow-up|3|||
147542717|NCT03151707|532142217|FG000|Overall Study|Lost to Follow-up|6|||
147542718|NCT00646282|532142219|FG000|Overall Study|Protocol terminated|4|||
147542719|NCT00646282|532142220|FG001|Overall Study|Protocol terminated|4|||
147542720|NCT00530088|532142221|FG000|Overall Study|Disease Progression|4|||
147542721|NCT00530088|532142221|FG000|Overall Study|Physician Decision|4|||
147542722|NCT00530088|532142221|FG000|Overall Study|Other Not Specified|2|||
147542723|NCT00902278|532142222|FG000|Overall Study|Physician Decision|1|||
147542724|NCT00902278|532142223|FG001|Overall Study|Physician Decision|0|||
147542725|NCT00902278|532142224|FG002|Overall Study|Physician Decision|2|||
147542726|NCT00902278|532142225|FG003|Overall Study|Physician Decision|0|||
147542727|NCT00902278|532142226|FG004|Overall Study|Physician Decision|1|||
147542728|NCT00902278|532142222|FG000|Overall Study|Lost to Follow-up|3|||
147542729|NCT00902278|532142223|FG001|Overall Study|Lost to Follow-up|2|||
147542730|NCT00902278|532142224|FG002|Overall Study|Lost to Follow-up|3|||
147542731|NCT00902278|532142225|FG003|Overall Study|Lost to Follow-up|0|||
147542732|NCT00902278|532142226|FG004|Overall Study|Lost to Follow-up|1|||
147542733|NCT02873195|532142258|FG000|Overall Study|Ineligible|5|||
147542734|NCT02873195|532142259|FG001|Overall Study|Ineligible|0|||
147542735|NCT02508649|532142260|FG000|Overall Study|Withdrawal by Subject|4|||
147542736|NCT02508649|532142261|FG001|Overall Study|Withdrawal by Subject|6|||
147542737|NCT02508649|532142262|FG002|Overall Study|Withdrawal by Subject|5|||
147542738|NCT02508649|532142263|FG003|Overall Study|Withdrawal by Subject|6|||
147542739|NCT02508649|532142260|FG000|Overall Study|Investigator withdrew the subject|1|||
147542740|NCT02508649|532142261|FG001|Overall Study|Investigator withdrew the subject|2|||
147542741|NCT02508649|532142262|FG002|Overall Study|Investigator withdrew the subject|1|||
147542742|NCT02508649|532142263|FG003|Overall Study|Investigator withdrew the subject|0|||
147542743|NCT02508649|532142260|FG000|Overall Study|Post randomization screening failure|12|||
147542744|NCT02508649|532142261|FG001|Overall Study|Post randomization screening failure|4|||
147542745|NCT02508649|532142262|FG002|Overall Study|Post randomization screening failure|9|||
147542746|NCT02508649|532142263|FG003|Overall Study|Post randomization screening failure|3|||
147542747|NCT02508649|532142260|FG000|Overall Study|Lost to Follow-up|1|||
147542748|NCT02508649|532142261|FG001|Overall Study|Lost to Follow-up|1|||
147542749|NCT02508649|532142262|FG002|Overall Study|Lost to Follow-up|0|||
147542750|NCT02508649|532142263|FG003|Overall Study|Lost to Follow-up|1|||
147542751|NCT02149199|532142267|FG000|Overall Study|Study specific withdrawal criteria|4|||
147542752|NCT02149199|532142268|FG001|Overall Study|Study specific withdrawal criteria|21|||
147542753|NCT02149199|532142269|FG002|Overall Study|Study specific withdrawal criteria|6|||
147542754|NCT02149199|532142267|FG000|Overall Study|Other|20|||
147542755|NCT02149199|532142268|FG001|Overall Study|Other|25|||
147542756|NCT02149199|532142269|FG002|Overall Study|Other|20|||
147542757|NCT02149199|532142267|FG000|Overall Study|Eligibility criteria not fulfilled|9|||
147542758|NCT02149199|532142268|FG001|Overall Study|Eligibility criteria not fulfilled|14|||
147542759|NCT02149199|532142269|FG002|Overall Study|Eligibility criteria not fulfilled|8|||
147440849|NCT01536951|531779028|FG006|Second Intervention and Washout Period 2|Adverse Event|0|||
147440850|NCT01536951|531779029|FG007|Second Intervention and Washout Period 2|Adverse Event|1|||
147440851|NCT01536951|531779030|FG008|Second Intervention and Washout Period 2|Adverse Event|0|||
147440852|NCT00430482|531779037|FG000|Completed Treatment|Insufficient Treatment|7|||
147440853|NCT00430482|531779038|FG001|Completed Treatment|Insufficient Treatment|11|||
147440854|NCT00555477|531779039|FG000|Overall Study|Adverse Event|0|||
147440855|NCT00555477|531779040|FG001|Overall Study|Adverse Event|9|||
147440856|NCT00555477|531779039|FG000|Overall Study|Withdrawal by Subject|1|||
147440857|NCT00555477|531779040|FG001|Overall Study|Withdrawal by Subject|2|||
147440858|NCT00555477|531779039|FG000|Overall Study|Physician Decision|1|||
147440859|NCT00555477|531779040|FG001|Overall Study|Physician Decision|2|||
147440860|NCT00545402|531779041|FG000|Overall Study|Discontinuation of treatment|17|||
147440861|NCT00545402|531779042|FG001|Overall Study|Discontinuation of treatment|9|||
147440862|NCT00545402|531779041|FG000|Overall Study|Use of unauthorized immunosuppressant|8|||
147440863|NCT00545402|531779042|FG001|Overall Study|Use of unauthorized immunosuppressant|7|||
147440864|NCT00545402|531779041|FG000|Overall Study|Death|5|||
147440865|NCT00545402|531779042|FG001|Overall Study|Death|7|||
147440866|NCT00545402|531779041|FG000|Overall Study|Graft loss|2|||
147440867|NCT00545402|531779042|FG001|Overall Study|Graft loss|4|||
147440868|NCT00545402|531779041|FG000|Overall Study|Withdrawal by Subject|0|||
147440869|NCT00545402|531779042|FG001|Overall Study|Withdrawal by Subject|1|||
147440870|NCT00545402|531779041|FG000|Overall Study|Protocol Violation|1|||
147440871|NCT00545402|531779042|FG001|Overall Study|Protocol Violation|0|||
147440872|NCT00545402|531779041|FG000|Overall Study|Reason not specified|1|||
147440873|NCT00545402|531779042|FG001|Overall Study|Reason not specified|1|||
147440874|NCT01817751|531779043|FG000|Overall Study|Physician Decision|1|||
147440875|NCT00397033|531779044|FG000|Overall Study|Adverse Event|7|||
147440876|NCT00397033|531779045|FG001|Overall Study|Adverse Event|10|||
147440877|NCT00397033|531779046|FG002|Overall Study|Adverse Event|4|||
147440878|NCT00397033|531779044|FG000|Overall Study|Lack of Efficacy|22|||
147440879|NCT00397033|531779045|FG001|Overall Study|Lack of Efficacy|12|||
147440880|NCT00397033|531779046|FG002|Overall Study|Lack of Efficacy|9|||
147440881|NCT00397033|531779044|FG000|Overall Study|Lost to Follow-up|3|||
147440882|NCT00397033|531779045|FG001|Overall Study|Lost to Follow-up|3|||
147440883|NCT00397033|531779046|FG002|Overall Study|Lost to Follow-up|3|||
147440884|NCT00397033|531779044|FG000|Overall Study|Withdrawal by Subject|12|||
147440885|NCT00397033|531779045|FG001|Overall Study|Withdrawal by Subject|7|||
147440886|NCT00397033|531779046|FG002|Overall Study|Withdrawal by Subject|5|||
147440887|NCT00397033|531779044|FG000|Overall Study|Other|0|||
147440888|NCT00397033|531779045|FG001|Overall Study|Other|5|||
147440889|NCT00397033|531779046|FG002|Overall Study|Other|2|||
147440890|NCT03519867|531779047|FG000|Overall Study|Adverse Event|1|||
147440891|NCT03519867|531779048|FG001|Overall Study|Adverse Event|1|||
147440892|NCT03519867|531779049|FG002|Overall Study|Adverse Event|0|||
147440893|NCT03519867|531779050|FG003|Overall Study|Adverse Event|0|||
147440894|NCT03519867|531779051|FG004|Overall Study|Adverse Event|0|||
147542760|NCT02149199|532142267|FG000|Overall Study|Withdrawal by Subject|75|||
147440895|NCT03519867|531779052|FG005|Overall Study|Adverse Event|0|||
147440896|NCT03519867|531779053|FG006|Overall Study|Adverse Event|0|||
147440897|NCT03519867|531779054|FG007|Overall Study|Adverse Event|0|||
147440898|NCT03519867|531779055|FG008|Overall Study|Adverse Event|0|||
147440899|NCT03519867|531779056|FG009|Overall Study|Adverse Event|0|||
147440900|NCT03519867|531779047|FG000|Overall Study|Protocol Violation|0|||
147440901|NCT03519867|531779048|FG001|Overall Study|Protocol Violation|0|||
147440902|NCT03519867|531779049|FG002|Overall Study|Protocol Violation|0|||
147542761|NCT02149199|532142268|FG001|Overall Study|Withdrawal by Subject|93|||
147542762|NCT02149199|532142269|FG002|Overall Study|Withdrawal by Subject|77|||
147542763|NCT02149199|532142267|FG000|Overall Study|Protocol Violation|16|||
147542764|NCT02149199|532142268|FG001|Overall Study|Protocol Violation|13|||
147542765|NCT02149199|532142269|FG002|Overall Study|Protocol Violation|15|||
147542766|NCT02149199|532142267|FG000|Overall Study|Lost to Follow-up|3|||
147542767|NCT02149199|532142268|FG001|Overall Study|Lost to Follow-up|12|||
147542768|NCT02149199|532142269|FG002|Overall Study|Lost to Follow-up|11|||
147210695|NCT01033448|530942864|FG000|Overall Study|Withdrawal by Subject|4|||
147210696|NCT01033448|530942864|FG000|Overall Study|Positive HCV-RNA at week 48|1|||
147210697|NCT01033448|530942864|FG000|Overall Study|Lost to Follow-up|3|||
147210698|NCT01033448|530942864|FG000|Overall Study|Withdrew due to other reasons|3|||
147210699|NCT01033448|530942864|FG000|Overall Study|Unknown disposition|1|||
147440903|NCT03519867|531779050|FG003|Overall Study|Protocol Violation|0|||
147440904|NCT03519867|531779051|FG004|Overall Study|Protocol Violation|0|||
147440905|NCT03519867|531779052|FG005|Overall Study|Protocol Violation|1|||
147440906|NCT03519867|531779053|FG006|Overall Study|Protocol Violation|0|||
147440907|NCT03519867|531779054|FG007|Overall Study|Protocol Violation|0|||
147440908|NCT03519867|531779055|FG008|Overall Study|Protocol Violation|0|||
147440909|NCT03519867|531779056|FG009|Overall Study|Protocol Violation|0|||
147440910|NCT03519867|531779047|FG000|Overall Study|Admin. of relaxant other than Zemuron®|0|||
147440911|NCT03519867|531779048|FG001|Overall Study|Admin. of relaxant other than Zemuron®|0|||
147440912|NCT03519867|531779049|FG002|Overall Study|Admin. of relaxant other than Zemuron®|0|||
147440913|NCT03519867|531779050|FG003|Overall Study|Admin. of relaxant other than Zemuron®|0|||
147440914|NCT03519867|531779051|FG004|Overall Study|Admin. of relaxant other than Zemuron®|0|||
147440915|NCT03519867|531779052|FG005|Overall Study|Admin. of relaxant other than Zemuron®|0|||
147440916|NCT03519867|531779053|FG006|Overall Study|Admin. of relaxant other than Zemuron®|1|||
147440917|NCT03519867|531779054|FG007|Overall Study|Admin. of relaxant other than Zemuron®|0|||
147440918|NCT03519867|531779055|FG008|Overall Study|Admin. of relaxant other than Zemuron®|0|||
147440919|NCT03519867|531779056|FG009|Overall Study|Admin. of relaxant other than Zemuron®|0|||
147440920|NCT03519867|531779047|FG000|Overall Study|Admin. of other reversal agent|1|||
147440921|NCT03519867|531779048|FG001|Overall Study|Admin. of other reversal agent|1|||
147440922|NCT03519867|531779049|FG002|Overall Study|Admin. of other reversal agent|0|||
147440923|NCT03519867|531779050|FG003|Overall Study|Admin. of other reversal agent|0|||
147440924|NCT03519867|531779051|FG004|Overall Study|Admin. of other reversal agent|0|||
147440925|NCT03519867|531779052|FG005|Overall Study|Admin. of other reversal agent|1|||
147440926|NCT03519867|531779053|FG006|Overall Study|Admin. of other reversal agent|0|||
147440927|NCT03519867|531779054|FG007|Overall Study|Admin. of other reversal agent|0|||
147440928|NCT03519867|531779055|FG008|Overall Study|Admin. of other reversal agent|0|||
147440929|NCT03519867|531779056|FG009|Overall Study|Admin. of other reversal agent|0|||
147440930|NCT03519867|531779047|FG000|Overall Study|Reason not provided|1|||
147440931|NCT03519867|531779048|FG001|Overall Study|Reason not provided|1|||
147440932|NCT03519867|531779049|FG002|Overall Study|Reason not provided|1|||
147440933|NCT03519867|531779050|FG003|Overall Study|Reason not provided|1|||
147440934|NCT03519867|531779051|FG004|Overall Study|Reason not provided|0|||
147440935|NCT03519867|531779052|FG005|Overall Study|Reason not provided|1|||
147440936|NCT03519867|531779053|FG006|Overall Study|Reason not provided|0|||
147440937|NCT03519867|531779054|FG007|Overall Study|Reason not provided|1|||
147440938|NCT03519867|531779055|FG008|Overall Study|Reason not provided|1|||
147440939|NCT03519867|531779056|FG009|Overall Study|Reason not provided|0|||
147440940|NCT00382018|531779057|FG000|Overall Study|Progression|0|||
147440941|NCT00382018|531779058|FG001|Overall Study|Progression|136|||
147440942|NCT00382018|531779059|FG002|Overall Study|Progression|51|||
147440943|NCT00382018|531779060|FG003|Overall Study|Progression|43|||
147440944|NCT00382018|531779057|FG000|Overall Study|Death|0|||
147440945|NCT00382018|531779058|FG001|Overall Study|Death|9|||
147440946|NCT00382018|531779059|FG002|Overall Study|Death|7|||
147440947|NCT00382018|531779060|FG003|Overall Study|Death|11|||
147440948|NCT00382018|531779057|FG000|Overall Study|Withdrawal by Subject|0|||
147440949|NCT00382018|531779058|FG001|Overall Study|Withdrawal by Subject|4|||
147440950|NCT00382018|531779059|FG002|Overall Study|Withdrawal by Subject|3|||
147440951|NCT00382018|531779060|FG003|Overall Study|Withdrawal by Subject|4|||
147440952|NCT00382018|531779057|FG000|Overall Study|Other, not protocol specified|0|||
147440953|NCT00382018|531779058|FG001|Overall Study|Other, not protocol specified|16|||
147440954|NCT00382018|531779059|FG002|Overall Study|Other, not protocol specified|3|||
147440955|NCT00382018|531779060|FG003|Overall Study|Other, not protocol specified|1|||
147440956|NCT01252810|531779061|FG000|Overall Study|Withdrawal by Subject|4|||
147440957|NCT01252810|531779062|FG001|Overall Study|Withdrawal by Subject|1|||
147440958|NCT01252810|531779061|FG000|Overall Study|Lost to Follow-up|0|||
147440959|NCT01252810|531779062|FG001|Overall Study|Lost to Follow-up|1|||
147440960|NCT01252810|531779061|FG000|Overall Study|Physician Decision|2|||
147440961|NCT01252810|531779062|FG001|Overall Study|Physician Decision|1|||
147440962|NCT01252810|531779061|FG000|Overall Study|Various reasons|8|||
147440963|NCT01252810|531779062|FG001|Overall Study|Various reasons|0|||
147542769|NCT02149199|532142267|FG000|Overall Study|Death|0|||
147542770|NCT02149199|532142268|FG001|Overall Study|Death|0|||
147542771|NCT02149199|532142269|FG002|Overall Study|Death|1|||
147542772|NCT02149199|532142267|FG000|Overall Study|Adverse Event|6|||
147542773|NCT02149199|532142268|FG001|Overall Study|Adverse Event|15|||
147542774|NCT02149199|532142269|FG002|Overall Study|Adverse Event|9|||
147542775|NCT01500434|532142272|FG000|Overall Study|Death|1|||
147542776|NCT01500434|532142272|FG000|Overall Study|Withdrawal by Subject|1|||
147542777|NCT01500434|532142272|FG000|Overall Study|Missed 12-month follow-up|5|||
147542778|NCT00633217|532142273|FG000|Overall Study|Adverse Event|5|||
147542779|NCT00633217|532142274|FG001|Overall Study|Adverse Event|9|||
147542780|NCT00633217|532142273|FG000|Overall Study|Lack of Efficacy|0|||
147542781|NCT00633217|532142274|FG001|Overall Study|Lack of Efficacy|2|||
147542782|NCT00633217|532142273|FG000|Overall Study|Protocol Violation|3|||
147542783|NCT00633217|532142274|FG001|Overall Study|Protocol Violation|7|||
147542784|NCT00633217|532142273|FG000|Overall Study|Lost to Follow-up|2|||
147542785|NCT00633217|532142274|FG001|Overall Study|Lost to Follow-up|2|||
147542786|NCT00633217|532142273|FG000|Overall Study|Investigator Discretion|2|||
147542787|NCT00633217|532142274|FG001|Overall Study|Investigator Discretion|0|||
147542788|NCT00633217|532142273|FG000|Overall Study|Withdrew Consent|3|||
147542789|NCT00633217|532142274|FG001|Overall Study|Withdrew Consent|3|||
147542790|NCT04881448|532142275|FG000|Overall Study|Study cancelled by sponsor|220|||
147542791|NCT04881448|532142275|FG000|Overall Study|Withdrawal by Subject|2|||
147542792|NCT04881448|532142275|FG000|Overall Study|Exhausted all attempts to contact subject|1|||
147542793|NCT01966107|532142276|FG000|Overall Study|excluded from FAS|21|||
147542794|NCT01966107|532142277|FG001|Overall Study|excluded from FAS|20|||
147542795|NCT01966107|532142276|FG000|Overall Study|discontinued treatment|345|||
147542796|NCT01966107|532142277|FG001|Overall Study|discontinued treatment|372|||
147542797|NCT01966107|532142276|FG000|Overall Study|due to study closure|164|||
147542798|NCT01966107|532142277|FG001|Overall Study|due to study closure|186|||
147542799|NCT01966107|532142276|FG000|Overall Study|withdrew from the study|272|||
147542800|NCT01966107|532142277|FG001|Overall Study|withdrew from the study|303|||
147542801|NCT00689273|532142280|FG000|Overall Study|Adverse Event|3|||
147542802|NCT00689273|532142281|FG001|Overall Study|Adverse Event|1|||
147542803|NCT00689273|532142280|FG000|Overall Study|Lack of Efficacy|3|||
147542804|NCT00689273|532142281|FG001|Overall Study|Lack of Efficacy|0|||
147542805|NCT00689273|532142280|FG000|Overall Study|Lost to Follow-up|0|||
147542806|NCT00689273|532142281|FG001|Overall Study|Lost to Follow-up|2|||
147542807|NCT00689273|532142280|FG000|Overall Study|Other|6|||
147542808|NCT00689273|532142281|FG001|Overall Study|Other|2|||
147542809|NCT00689273|532142280|FG000|Overall Study|Randomized but not Treated|1|||
147542810|NCT00689273|532142281|FG001|Overall Study|Randomized but not Treated|0|||
147542811|NCT00700310|532144084|FG000|Overall Study|Adverse Event|6|||
147542812|NCT00700310|532144085|FG001|Overall Study|Adverse Event|10|||
147542813|NCT00700310|532144086|FG002|Overall Study|Adverse Event|5|||
147542814|NCT00700310|532144087|FG003|Overall Study|Adverse Event|11|||
147210700|NCT01282463|530945334|FG000|Overall Study|Lost to Follow-up|1|||
147210701|NCT01282463|530945335|FG001|Overall Study|Lost to Follow-up|0|||
147210702|NCT01282463|530945336|FG002|Overall Study|Lost to Follow-up|0|||
147210703|NCT01282463|530945334|FG000|Overall Study|Withdrawal by Subject|6|||
147210704|NCT01282463|530945335|FG001|Overall Study|Withdrawal by Subject|2|||
147210705|NCT01282463|530945336|FG002|Overall Study|Withdrawal by Subject|3|||
147210706|NCT01282463|530945334|FG000|Overall Study|"Never Treated Death"|0|||
147210707|NCT01282463|530945335|FG001|Overall Study|"Never Treated Death"|1|||
147210708|NCT01282463|530945336|FG002|Overall Study|"Never Treated Death"|0|||
147210709|NCT01282463|530945334|FG000|Overall Study|"Never Treated PD"|0|||
147210710|NCT01282463|530945335|FG001|Overall Study|"Never Treated PD"|1|||
147210711|NCT01282463|530945336|FG002|Overall Study|"Never Treated PD"|0|||
147210712|NCT01282463|530945334|FG000|Overall Study|Protocol Violation|0|||
147542815|NCT00700310|532144084|FG000|Overall Study|Lost to Follow-up|4|||
147542816|NCT00700310|532144085|FG001|Overall Study|Lost to Follow-up|1|||
147542817|NCT00700310|532144086|FG002|Overall Study|Lost to Follow-up|0|||
147210713|NCT01282463|530945335|FG001|Overall Study|Protocol Violation|0|||
147210714|NCT01282463|530945336|FG002|Overall Study|Protocol Violation|1|||
147210715|NCT01282463|530945334|FG000|Overall Study|Physician Decision|1|||
147210716|NCT01282463|530945335|FG001|Overall Study|Physician Decision|0|||
147210717|NCT01282463|530945336|FG002|Overall Study|Physician Decision|0|||
147210718|NCT01954927|530945337|FG000|Overall Study|Withdrawal by Subject|3|||
147542818|NCT00700310|532144087|FG003|Overall Study|Lost to Follow-up|1|||
147542819|NCT00700310|532144084|FG000|Overall Study|Withdrawal by Subject|8|||
147210719|NCT01954927|530945338|FG001|Overall Study|Withdrawal by Subject|1|||
147542820|NCT00700310|532144085|FG001|Overall Study|Withdrawal by Subject|9|||
147542821|NCT00700310|532144086|FG002|Overall Study|Withdrawal by Subject|8|||
147542822|NCT00700310|532144087|FG003|Overall Study|Withdrawal by Subject|8|||
147542823|NCT00700310|532144084|FG000|Overall Study|Lack of Efficacy|0|||
147542824|NCT00700310|532144085|FG001|Overall Study|Lack of Efficacy|3|||
147542825|NCT00700310|532144086|FG002|Overall Study|Lack of Efficacy|0|||
147542826|NCT00700310|532144087|FG003|Overall Study|Lack of Efficacy|1|||
147542827|NCT00700310|532144084|FG000|Overall Study|Administrative/Other|1|||
147542828|NCT00700310|532144085|FG001|Overall Study|Administrative/Other|3|||
147542829|NCT00700310|532144086|FG002|Overall Study|Administrative/Other|1|||
147542830|NCT00700310|532144087|FG003|Overall Study|Administrative/Other|3|||
147542831|NCT00700310|532144084|FG000|Overall Study|Randomized, Not Treated|2|||
147542832|NCT00700310|532144085|FG001|Overall Study|Randomized, Not Treated|0|||
147542833|NCT00700310|532144086|FG002|Overall Study|Randomized, Not Treated|2|||
147542834|NCT00700310|532144087|FG003|Overall Study|Randomized, Not Treated|2|||
147542835|NCT01422720|532144088|FG000|Overall Study|Adverse Event|16|||
147542836|NCT01422720|532144088|FG000|Overall Study|Lack of Efficacy|1|||
147542837|NCT01422720|532144088|FG000|Overall Study|Withdrawal by Subject|4|||
147542838|NCT01422720|532144088|FG000|Overall Study|Ineligibility|1|||
147542839|NCT00606801|532144089|FG000|Intervention|Protocol Violation|3|||
147542840|NCT00606801|532144090|FG001|Intervention|Protocol Violation|3|||
147542841|NCT02082262|532144091|FG000|Overall Study|Withdrawal by Subject|3|||
147542842|NCT02082262|532144091|FG000|Overall Study|Adverse Event|48|||
147542843|NCT01726335|532144094|FG000|Overall Study|Lost to Follow-up|2|||
147542844|NCT01726335|532144094|FG000|Overall Study|Withdrawal by Subject|15|||
147542845|NCT01726335|532144094|FG000|Overall Study|Adverse Event|4|||
147542846|NCT01726335|532144094|FG000|Overall Study|Lost to Follow-up|2|||
147542847|NCT01726335|532144094|FG000|Overall Study|Exacerbation of psychotic symptoms|1|||
147542848|NCT01074307|532144096|FG000|Overall Study|No primary endpoint evaluation|14|||
147542849|NCT01074307|532144097|FG001|Overall Study|No primary endpoint evaluation|6|||
147542850|NCT01074307|532144096|FG000|Overall Study|Exclusion criterion|0|||
147542851|NCT01074307|532144097|FG001|Overall Study|Exclusion criterion|1|||
147542852|NCT01074307|532144096|FG000|Overall Study|Protocol Violation|8|||
147542853|NCT01074307|532144097|FG001|Overall Study|Protocol Violation|5|||
147542854|NCT02162511|532144103|FG000|Overall Study|Lack of Efficacy|0|||
147542855|NCT02162511|532144104|FG001|Overall Study|Lack of Efficacy|0|||
147542856|NCT02162511|532144105|FG002|Overall Study|Lack of Efficacy|2|||
147542857|NCT02703454|532144110|FG000|Overall Study|Not treated|1|||
147542858|NCT02703454|532144111|FG001|Overall Study|Not treated|3|||
147542859|NCT02703454|532144110|FG000|Overall Study|Withdrawal by Subject|4|||
147542860|NCT02703454|532144111|FG001|Overall Study|Withdrawal by Subject|3|||
147542861|NCT02703454|532144110|FG000|Overall Study|Lost to Follow-up|1|||
147542862|NCT02703454|532144111|FG001|Overall Study|Lost to Follow-up|2|||
147542863|NCT02703454|532144110|FG000|Overall Study|Study discontinuation|5|||
147542864|NCT02703454|532144111|FG001|Overall Study|Study discontinuation|8|||
147542865|NCT02284373|532144112|FG000|Overall Study|Withdrawal by Subject|0|||
147542866|NCT02284373|532144113|FG001|Overall Study|Withdrawal by Subject|1|||
147542867|NCT02284373|532144114|FG002|Overall Study|Withdrawal by Subject|0|||
147542868|NCT02284373|532144112|FG000|Overall Study|Other|0|||
147542869|NCT02284373|532144113|FG001|Overall Study|Other|1|||
147542870|NCT02284373|532144114|FG002|Overall Study|Other|0|||
147542871|NCT02284373|532144112|FG000|Overall Study|Lost to Follow-up|0|||
147542872|NCT02284373|532144113|FG001|Overall Study|Lost to Follow-up|1|||
147542873|NCT02284373|532144114|FG002|Overall Study|Lost to Follow-up|0|||
147542874|NCT02499406|532144117|FG000|Overall Study|missed 3 treatment sessions|4|||
147542875|NCT00552617|532144121|FG000|Overall Study|Not Treated|0|||
147542876|NCT00552617|532144122|FG001|Overall Study|Not Treated|0|||
147542877|NCT00552617|532144123|FG002|Overall Study|Not Treated|1|||
147542878|NCT00552617|532144124|FG003|Overall Study|Not Treated|0|||
147542879|NCT00552617|532144125|FG004|Overall Study|Not Treated|0|||
147542880|NCT00552617|532144126|FG005|Overall Study|Not Treated|0|||
147542881|NCT00552617|532144127|FG006|Overall Study|Not Treated|0|||
147542882|NCT00552617|532144128|FG007|Overall Study|Not Treated|0|||
147542883|NCT00552617|532144129|FG008|Overall Study|Not Treated|0|||
147542884|NCT00552617|532144130|FG009|Overall Study|Not Treated|1|||
147542885|NCT00552617|532144121|FG000|Overall Study|Lost to Follow-up|0|||
147542886|NCT00552617|532144122|FG001|Overall Study|Lost to Follow-up|0|||
147210720|NCT03320824|530945339|FG000|Overall Study|Withdrawal by Subject|8|||
147210721|NCT03320824|530945340|FG001|Overall Study|Withdrawal by Subject|1|||
147210722|NCT03320824|530945339|FG000|Overall Study|Lost to Follow-up|10|||
147542887|NCT00552617|532144123|FG002|Overall Study|Lost to Follow-up|0|||
147542888|NCT00552617|532144124|FG003|Overall Study|Lost to Follow-up|1|||
147542889|NCT00552617|532144125|FG004|Overall Study|Lost to Follow-up|0|||
147542890|NCT00552617|532144126|FG005|Overall Study|Lost to Follow-up|2|||
147542891|NCT00552617|532144127|FG006|Overall Study|Lost to Follow-up|0|||
147542892|NCT00552617|532144128|FG007|Overall Study|Lost to Follow-up|0|||
147542893|NCT00552617|532144129|FG008|Overall Study|Lost to Follow-up|2|||
147542894|NCT00552617|532144130|FG009|Overall Study|Lost to Follow-up|0|||
147542895|NCT04651218|532144131|FG000|Overall Study|Withdrawal by Subject|0|||
147542896|NCT04651218|532144132|FG001|Overall Study|Withdrawal by Subject|2|||
147542897|NCT01399125|532144135|FG000|Overall Study|Adverse Event|32|||
147542898|NCT01399125|532144136|FG001|Overall Study|Adverse Event|30|||
147542899|NCT01399125|532144135|FG000|Overall Study|Abnormal Lab values|0|||
147542900|NCT01399125|532144136|FG001|Overall Study|Abnormal Lab values|1|||
147542901|NCT01399125|532144135|FG000|Overall Study|Unsatisfactory Therapeutic Effect|0|||
147542902|NCT01399125|532144136|FG001|Overall Study|Unsatisfactory Therapeutic Effect|4|||
147542903|NCT01399125|532144135|FG000|Overall Study|Withdrawal by Subject|5|||
147542904|NCT01399125|532144136|FG001|Overall Study|Withdrawal by Subject|8|||
147542905|NCT01399125|532144135|FG000|Overall Study|Lost to Follow-up|2|||
147542906|NCT01399125|532144136|FG001|Overall Study|Lost to Follow-up|3|||
147542907|NCT01399125|532144135|FG000|Overall Study|Administrative Problems|7|||
147542908|NCT01399125|532144136|FG001|Overall Study|Administrative Problems|11|||
147542909|NCT01399125|532144135|FG000|Overall Study|Death|0|||
147542910|NCT01399125|532144136|FG001|Overall Study|Death|1|||
147542911|NCT01399125|532144135|FG000|Overall Study|Protocol Deviation|5|||
147542912|NCT01399125|532144136|FG001|Overall Study|Protocol Deviation|2|||
147542913|NCT00948025|532144145|FG000|Phase 1 (Pilot Phase)|Adverse Event|1|||
147542914|NCT00948025|532144146|FG001|Phase 1 (Pilot Phase)|Adverse Event|1|||
147542915|NCT00948025|532144145|FG000|Phase 1 (Pilot Phase)|Lost to Follow-up|7|||
147542916|NCT00948025|532144146|FG001|Phase 1 (Pilot Phase)|Lost to Follow-up|1|||
147542917|NCT00948025|532144145|FG000|Phase 1 (Pilot Phase)|Withdrawal by Subject|1|||
147542918|NCT00948025|532144146|FG001|Phase 1 (Pilot Phase)|Withdrawal by Subject|1|||
147542919|NCT01591499|532144151|FG000|Baseline Visit|Withdrawal by Subject|0|||
147542920|NCT01591499|532144152|FG001|Baseline Visit|Withdrawal by Subject|2|||
147542921|NCT01591499|532144153|FG002|Baseline Visit|Withdrawal by Subject|0|||
147542922|NCT01591499|532144154|FG003|Baseline Visit|Withdrawal by Subject|2|||
147542923|NCT01591499|532144151|FG000|Second Intervention (up to 24 Days)|Withdrawal by Subject|2|||
147542924|NCT01591499|532144152|FG001|Second Intervention (up to 24 Days)|Withdrawal by Subject|0|||
147542925|NCT01591499|532144153|FG002|Second Intervention (up to 24 Days)|Withdrawal by Subject|2|||
147542926|NCT01591499|532144154|FG003|Second Intervention (up to 24 Days)|Withdrawal by Subject|0|||
147542927|NCT01591499|532144151|FG000|Second Intervention (up to 24 Days)|Lost to Follow-up|4|||
147542928|NCT01591499|532144152|FG001|Second Intervention (up to 24 Days)|Lost to Follow-up|3|||
147542929|NCT01591499|532144153|FG002|Second Intervention (up to 24 Days)|Lost to Follow-up|1|||
147542930|NCT01591499|532144154|FG003|Second Intervention (up to 24 Days)|Lost to Follow-up|3|||
147542931|NCT01289990|532144155|FG000|Overall Study|Death|0|||
147542932|NCT01289990|532144156|FG001|Overall Study|Death|0|||
147542933|NCT01289990|532144157|FG002|Overall Study|Death|0|||
147542934|NCT01289990|532144158|FG003|Overall Study|Death|1|||
147542935|NCT01289990|532144159|FG004|Overall Study|Death|2|||
147542936|NCT01289990|532144160|FG005|Overall Study|Death|1|||
147542937|NCT01289990|532144161|FG006|Overall Study|Death|0|||
147542938|NCT01289990|532144162|FG007|Overall Study|Death|0|||
147542939|NCT01289990|532144163|FG008|Overall Study|Death|0|||
147542940|NCT01289990|532144164|FG009|Overall Study|Death|0|||
147542941|NCT01289990|532144165|FG010|Overall Study|Death|0|||
147210723|NCT03320824|530945340|FG001|Overall Study|Lost to Follow-up|1|||
147210724|NCT03320824|530945339|FG000|Overall Study|moved out of state|0|||
147210725|NCT03320824|530945340|FG001|Overall Study|moved out of state|1|||
147210726|NCT03320824|530945339|FG000|Overall Study|could not complete final visit|0|||
147210727|NCT03320824|530945340|FG001|Overall Study|could not complete final visit|1|||
147210728|NCT00109590|530945341|FG000|Overall Study|Lost to Follow-up|1|||
147210729|NCT00109590|530945342|FG001|Overall Study|Lost to Follow-up|0|||
147210730|NCT00109590|530945343|FG002|Overall Study|Lost to Follow-up|1|||
147542942|NCT01289990|532144166|FG011|Overall Study|Death|1|||
147542943|NCT01289990|532144167|FG012|Overall Study|Death|0|||
147542944|NCT01289990|532144155|FG000|Overall Study|Lost to Follow-up|3|||
147542945|NCT01289990|532144156|FG001|Overall Study|Lost to Follow-up|2|||
147542946|NCT01289990|532144157|FG002|Overall Study|Lost to Follow-up|5|||
147542947|NCT01289990|532144158|FG003|Overall Study|Lost to Follow-up|5|||
147542948|NCT01289990|532144159|FG004|Overall Study|Lost to Follow-up|3|||
147542949|NCT01289990|532144160|FG005|Overall Study|Lost to Follow-up|4|||
147542950|NCT01289990|532144161|FG006|Overall Study|Lost to Follow-up|2|||
147542951|NCT01289990|532144162|FG007|Overall Study|Lost to Follow-up|2|||
147542952|NCT01289990|532144163|FG008|Overall Study|Lost to Follow-up|1|||
147542953|NCT01289990|532144164|FG009|Overall Study|Lost to Follow-up|4|||
147542954|NCT01289990|532144165|FG010|Overall Study|Lost to Follow-up|2|||
147542955|NCT01289990|532144166|FG011|Overall Study|Lost to Follow-up|1|||
147542956|NCT01289990|532144167|FG012|Overall Study|Lost to Follow-up|2|||
147542957|NCT01289990|532144155|FG000|Overall Study|Withdrawal by Subject|15|||
147542958|NCT01289990|532144156|FG001|Overall Study|Withdrawal by Subject|14|||
147542959|NCT01289990|532144157|FG002|Overall Study|Withdrawal by Subject|12|||
147542960|NCT01289990|532144158|FG003|Overall Study|Withdrawal by Subject|13|||
147210731|NCT00109590|530945341|FG000|Overall Study|Never Started Treatment|1|||
147210732|NCT00109590|530945342|FG001|Overall Study|Never Started Treatment|2|||
147542961|NCT01289990|532144159|FG004|Overall Study|Withdrawal by Subject|8|||
147542962|NCT01289990|532144160|FG005|Overall Study|Withdrawal by Subject|7|||
147542963|NCT01289990|532144161|FG006|Overall Study|Withdrawal by Subject|13|||
147542964|NCT01289990|532144162|FG007|Overall Study|Withdrawal by Subject|9|||
147542965|NCT01289990|532144163|FG008|Overall Study|Withdrawal by Subject|12|||
147542966|NCT01289990|532144164|FG009|Overall Study|Withdrawal by Subject|13|||
147542967|NCT01289990|532144165|FG010|Overall Study|Withdrawal by Subject|11|||
147542968|NCT01289990|532144166|FG011|Overall Study|Withdrawal by Subject|13|||
147542969|NCT01289990|532144167|FG012|Overall Study|Withdrawal by Subject|16|||
147542970|NCT01289990|532144155|FG000|Overall Study|discontinued in preceding trial|18|||
147542971|NCT01289990|532144156|FG001|Overall Study|discontinued in preceding trial|20|||
147210733|NCT00109590|530945343|FG002|Overall Study|Never Started Treatment|3|||
147542972|NCT01289990|532144157|FG002|Overall Study|discontinued in preceding trial|41|||
147542973|NCT01289990|532144158|FG003|Overall Study|discontinued in preceding trial|17|||
147542974|NCT01289990|532144159|FG004|Overall Study|discontinued in preceding trial|11|||
147542975|NCT01289990|532144160|FG005|Overall Study|discontinued in preceding trial|12|||
147542976|NCT01289990|532144161|FG006|Overall Study|discontinued in preceding trial|18|||
147542977|NCT01289990|532144162|FG007|Overall Study|discontinued in preceding trial|8|||
147542978|NCT01289990|532144163|FG008|Overall Study|discontinued in preceding trial|17|||
147542979|NCT01289990|532144164|FG009|Overall Study|discontinued in preceding trial|21|||
147542980|NCT01289990|532144165|FG010|Overall Study|discontinued in preceding trial|17|||
147542981|NCT01289990|532144166|FG011|Overall Study|discontinued in preceding trial|17|||
147542982|NCT01289990|532144167|FG012|Overall Study|discontinued in preceding trial|24|||
147542983|NCT01289990|532144155|FG000|Overall Study|did not continue in extension|41|||
147542984|NCT01289990|532144156|FG001|Overall Study|did not continue in extension|45|||
147542985|NCT01289990|532144157|FG002|Overall Study|did not continue in extension|51|||
147542986|NCT01289990|532144158|FG003|Overall Study|did not continue in extension|51|||
147542987|NCT01289990|532144159|FG004|Overall Study|did not continue in extension|48|||
147542988|NCT01289990|532144160|FG005|Overall Study|did not continue in extension|50|||
147542989|NCT01289990|532144161|FG006|Overall Study|did not continue in extension|54|||
147542990|NCT01289990|532144162|FG007|Overall Study|did not continue in extension|36|||
147542991|NCT01289990|532144163|FG008|Overall Study|did not continue in extension|44|||
147542992|NCT01289990|532144164|FG009|Overall Study|did not continue in extension|48|||
147542993|NCT01289990|532144165|FG010|Overall Study|did not continue in extension|45|||
147542994|NCT01289990|532144166|FG011|Overall Study|did not continue in extension|34|||
147542995|NCT01289990|532144167|FG012|Overall Study|did not continue in extension|56|||
147542996|NCT01289990|532144155|FG000|Overall Study|Not treated|0|||
147542997|NCT01289990|532144156|FG001|Overall Study|Not treated|0|||
147542998|NCT01289990|532144157|FG002|Overall Study|Not treated|0|||
147542999|NCT01289990|532144158|FG003|Overall Study|Not treated|0|||
147543000|NCT01289990|532144159|FG004|Overall Study|Not treated|0|||
147543001|NCT01289990|532144160|FG005|Overall Study|Not treated|0|||
147543002|NCT01289990|532144161|FG006|Overall Study|Not treated|1|||
147543003|NCT01289990|532144162|FG007|Overall Study|Not treated|0|||
147543004|NCT01289990|532144163|FG008|Overall Study|Not treated|1|||
147543005|NCT01289990|532144164|FG009|Overall Study|Not treated|0|||
147543006|NCT01289990|532144165|FG010|Overall Study|Not treated|1|||
147543007|NCT01289990|532144166|FG011|Overall Study|Not treated|2|||
147543008|NCT01289990|532144167|FG012|Overall Study|Not treated|0|||
147543009|NCT00683904|532144168|FG000|Dose Level 1|Disease progression|2|||
147543010|NCT00683904|532144169|FG001|Dose Level 1|Disease progression|0|||
147543011|NCT00683904|532144168|FG000|Dose Level 1|Adverse Event|1|||
147543012|NCT00683904|532144169|FG001|Dose Level 1|Adverse Event|0|||
147543013|NCT00683904|532144168|FG000|Dose Level 2|Adverse Event|0|||
147543014|NCT00683904|532144169|FG001|Dose Level 2|Adverse Event|2|||
147543015|NCT01220128|532144170|FG000|Overall Study|Progressive disease|0|||
147543016|NCT01220128|532144171|FG001|Overall Study|Progressive disease|0|||
147543017|NCT01220128|532144172|FG002|Overall Study|Progressive disease|2|||
147543018|NCT01220128|532144173|FG003|Overall Study|Progressive disease|0|||
147543019|NCT01220128|532144174|FG004|Overall Study|Progressive disease|0|||
147543020|NCT01220128|532144175|FG005|Overall Study|Progressive disease|0|||
147543021|NCT01220128|532144176|FG006|Overall Study|Progressive disease|0|||
147543022|NCT01220128|532144170|FG000|Overall Study|Sponsor study termination|0|||
147543023|NCT01220128|532144171|FG001|Overall Study|Sponsor study termination|1|||
147543024|NCT01220128|532144172|FG002|Overall Study|Sponsor study termination|0|||
147543025|NCT01220128|532144173|FG003|Overall Study|Sponsor study termination|0|||
147543026|NCT01220128|532144174|FG004|Overall Study|Sponsor study termination|0|||
147543027|NCT01220128|532144175|FG005|Overall Study|Sponsor study termination|0|||
147543028|NCT01220128|532144176|FG006|Overall Study|Sponsor study termination|1|||
147543029|NCT01220128|532144170|FG000|Overall Study|Adverse event, serious fatal|2|||
147543030|NCT01220128|532144171|FG001|Overall Study|Adverse event, serious fatal|0|||
147543031|NCT01220128|532144172|FG002|Overall Study|Adverse event, serious fatal|0|||
147543032|NCT01220128|532144173|FG003|Overall Study|Adverse event, serious fatal|0|||
147543033|NCT01220128|532144174|FG004|Overall Study|Adverse event, serious fatal|0|||
147543034|NCT01220128|532144175|FG005|Overall Study|Adverse event, serious fatal|0|||
147543035|NCT01220128|532144176|FG006|Overall Study|Adverse event, serious fatal|1|||
147543036|NCT01220128|532144170|FG000|Overall Study|Adverse event, non-fatal|1|||
147543037|NCT01220128|532144171|FG001|Overall Study|Adverse event, non-fatal|0|||
147543038|NCT01220128|532144172|FG002|Overall Study|Adverse event, non-fatal|0|||
147543039|NCT01220128|532144173|FG003|Overall Study|Adverse event, non-fatal|0|||
147543040|NCT01220128|532144174|FG004|Overall Study|Adverse event, non-fatal|0|||
147543041|NCT01220128|532144175|FG005|Overall Study|Adverse event, non-fatal|0|||
147543042|NCT01220128|532144176|FG006|Overall Study|Adverse event, non-fatal|3|||
147543043|NCT01220128|532144170|FG000|Overall Study|Other|0|||
147543044|NCT01220128|532144171|FG001|Overall Study|Other|0|||
147543045|NCT01220128|532144172|FG002|Overall Study|Other|1|||
147543046|NCT01220128|532144173|FG003|Overall Study|Other|0|||
147543047|NCT01220128|532144174|FG004|Overall Study|Other|0|||
147543048|NCT01220128|532144175|FG005|Overall Study|Other|0|||
147543049|NCT01220128|532144176|FG006|Overall Study|Other|0|||
147210734|NCT02123251|530945344|FG000|Overall Study|Death|1|||
147210735|NCT02123251|530945345|FG001|Overall Study|Death|1|||
147543050|NCT01220128|532144170|FG000|Overall Study|Consent withdrawn by subject|1|||
147543051|NCT01220128|532144171|FG001|Overall Study|Consent withdrawn by subject|0|||
147543052|NCT01220128|532144172|FG002|Overall Study|Consent withdrawn by subject|0|||
147543053|NCT01220128|532144173|FG003|Overall Study|Consent withdrawn by subject|0|||
147543054|NCT01220128|532144174|FG004|Overall Study|Consent withdrawn by subject|0|||
147543055|NCT01220128|532144175|FG005|Overall Study|Consent withdrawn by subject|0|||
147543056|NCT01220128|532144176|FG006|Overall Study|Consent withdrawn by subject|0|||
147543057|NCT00752895|532144181|FG000|Overall Study|Withdrawal by Subject|8|||
147543058|NCT00752895|532144182|FG001|Overall Study|Withdrawal by Subject|3|||
147543059|NCT00314262|532144183|FG000|Overall Study|Adverse Event|2|||
147543060|NCT00314262|532144183|FG000|Overall Study|Withdrawal by Subject|2|||
147543061|NCT00314262|532144183|FG000|Overall Study|Physician Decision|1|||
147543062|NCT00532779|532144184|FG000|Overall Study|Adverse Event|122|||
147543063|NCT00532779|532144185|FG001|Overall Study|Adverse Event|112|||
147543064|NCT00532779|532144186|FG002|Overall Study|Adverse Event|56|||
147543065|NCT00532779|532144184|FG000|Overall Study|Lost to Follow-up|76|||
147543066|NCT00532779|532144185|FG001|Overall Study|Lost to Follow-up|65|||
147543067|NCT00532779|532144186|FG002|Overall Study|Lost to Follow-up|66|||
147543068|NCT00532779|532144184|FG000|Overall Study|Withdrawal by Subject|63|||
147543069|NCT00532779|532144185|FG001|Overall Study|Withdrawal by Subject|60|||
147543070|NCT00532779|532144186|FG002|Overall Study|Withdrawal by Subject|90|||
147543071|NCT00532779|532144184|FG000|Overall Study|Lack of Efficacy|12|||
147543072|NCT00532779|532144185|FG001|Overall Study|Lack of Efficacy|12|||
147543073|NCT00532779|532144186|FG002|Overall Study|Lack of Efficacy|40|||
147543074|NCT00532779|532144184|FG000|Overall Study|Protocol Violation|5|||
147543075|NCT00532779|532144185|FG001|Overall Study|Protocol Violation|9|||
147543076|NCT00532779|532144186|FG002|Overall Study|Protocol Violation|7|||
147543077|NCT00532779|532144184|FG000|Overall Study|Pregnancy|2|||
147543078|NCT00532779|532144185|FG001|Overall Study|Pregnancy|5|||
147543079|NCT00532779|532144186|FG002|Overall Study|Pregnancy|3|||
147543080|NCT00532779|532144184|FG000|Overall Study|Death|0|||
147543081|NCT00532779|532144185|FG001|Overall Study|Death|1|||
147543082|NCT00532779|532144186|FG002|Overall Study|Death|0|||
147543083|NCT00532779|532144184|FG000|Overall Study|Drug noncompliance, moved, other|14|||
147543084|NCT00532779|532144185|FG001|Overall Study|Drug noncompliance, moved, other|23|||
147543085|NCT00532779|532144186|FG002|Overall Study|Drug noncompliance, moved, other|29|||
147543086|NCT02662556|532144187|FG000|Overall Study|Adverse Event|4|||
147543087|NCT02662556|532144187|FG000|Overall Study|Lack of Efficacy|4|||
147543088|NCT00828516|532144196|FG000|Clinical Phase: Series 1|Withdrawal by Subject|2|||
147543089|NCT01556165|532144197|FG000|Overall Study|Adverse Event|5|||
147543090|NCT01556165|532144198|FG001|Overall Study|Adverse Event|3|||
147543091|NCT01556165|532144197|FG000|Overall Study|Protocol Violation|0|||
147543092|NCT01556165|532144198|FG001|Overall Study|Protocol Violation|3|||
147543093|NCT01556165|532144197|FG000|Overall Study|Withdrawal of Consent|7|||
147543094|NCT01556165|532144198|FG001|Overall Study|Withdrawal of Consent|1|||
147543095|NCT02531698|532144201|FG000|Overall Study|Adverse Event|2|||
147543096|NCT02531698|532144202|FG001|Overall Study|Adverse Event|1|||
147543097|NCT02531698|532144201|FG000|Overall Study|Withdrawal by Subject|6|||
147543098|NCT02531698|532144202|FG001|Overall Study|Withdrawal by Subject|1|||
147543099|NCT02531698|532144201|FG000|Overall Study|Protocol Violation|2|||
147543100|NCT02531698|532144202|FG001|Overall Study|Protocol Violation|0|||
147543101|NCT02531698|532144201|FG000|Overall Study|Lost to Follow-up|1|||
147543102|NCT02531698|532144202|FG001|Overall Study|Lost to Follow-up|0|||
147543103|NCT02395536|532144208|FG000|Overall Study|Lost to Follow-up|4|||
147210736|NCT02123251|530945344|FG000|Overall Study|Withdrawal by Subject|0|||
147210737|NCT02123251|530945345|FG001|Overall Study|Withdrawal by Subject|3|||
147210738|NCT02123251|530945344|FG000|Overall Study|Lost Medicaid eligibility|29|||
147210739|NCT02123251|530945345|FG001|Overall Study|Lost Medicaid eligibility|22|||
147210740|NCT02123251|530945344|FG000|Overall Study|Switched Managed Care Organization (MCO)|4|||
147210741|NCT02123251|530945345|FG001|Overall Study|Switched Managed Care Organization (MCO)|4|||
147210742|NCT01221285|530945346|FG000|Overall Study|Withdrawal by Subject|1|||
147543104|NCT02395536|532144209|FG001|Overall Study|Lost to Follow-up|4|||
147543105|NCT02395536|532144208|FG000|Overall Study|Death|2|||
147543106|NCT02395536|532144209|FG001|Overall Study|Death|0|||
147543107|NCT02395536|532144208|FG000|Overall Study|Physician Decision|4|||
147543108|NCT02395536|532144209|FG001|Overall Study|Physician Decision|6|||
147543109|NCT02395536|532144208|FG000|Overall Study|Withdrawal by Subject|9|||
147543110|NCT02395536|532144209|FG001|Overall Study|Withdrawal by Subject|17|||
147543111|NCT02395536|532144208|FG000|Overall Study|Inclusion/Excusion Criteria Violation|1|||
147543112|NCT02395536|532144209|FG001|Overall Study|Inclusion/Excusion Criteria Violation|2|||
147543113|NCT02395536|532144208|FG000|Overall Study|Insurance issue|0|||
147543114|NCT02395536|532144209|FG001|Overall Study|Insurance issue|1|||
147543115|NCT00701558|532144210|FG000|Overall Study|Death|7|||
147543116|NCT00701558|532144210|FG000|Overall Study|Lost to Follow-up|8|||
147210743|NCT00727441|530945349|FG000|Overall Study|Disease Progression|11|||
147210744|NCT00727441|530945350|FG001|Overall Study|Disease Progression|14|||
147210745|NCT00727441|530945351|FG002|Overall Study|Disease Progression|17|||
147210746|NCT00727441|530945349|FG000|Overall Study|Eligibility|7|||
147210747|NCT00727441|530945350|FG001|Overall Study|Eligibility|5|||
147210748|NCT00727441|530945351|FG002|Overall Study|Eligibility|7|||
147440964|NCT01721057|531779063|FG000|Treatment Period|Withdrawal by Subject|11|||
147440965|NCT01721057|531779064|FG001|Treatment Period|Withdrawal by Subject|5|||
147440966|NCT01721057|531779065|FG002|Treatment Period|Withdrawal by Subject|8|||
147440967|NCT01721057|531779066|FG003|Treatment Period|Withdrawal by Subject|0|||
147440968|NCT01721057|531779067|FG004|Treatment Period|Withdrawal by Subject|0|||
147440969|NCT01721057|531779068|FG005|Treatment Period|Withdrawal by Subject|0|||
147440970|NCT01721057|531779069|FG006|Treatment Period|Withdrawal by Subject|0|||
147440971|NCT01721057|531779063|FG000|Treatment Period|Adverse Event|7|||
147440972|NCT01721057|531779064|FG001|Treatment Period|Adverse Event|10|||
147440973|NCT01721057|531779065|FG002|Treatment Period|Adverse Event|12|||
147440974|NCT01721057|531779066|FG003|Treatment Period|Adverse Event|0|||
147440975|NCT01721057|531779067|FG004|Treatment Period|Adverse Event|0|||
147440976|NCT01721057|531779068|FG005|Treatment Period|Adverse Event|0|||
147440977|NCT01721057|531779069|FG006|Treatment Period|Adverse Event|0|||
147440978|NCT01721057|531779063|FG000|Treatment Period|Lack of Efficacy|7|||
147440979|NCT01721057|531779064|FG001|Treatment Period|Lack of Efficacy|3|||
147440980|NCT01721057|531779065|FG002|Treatment Period|Lack of Efficacy|0|||
147440981|NCT01721057|531779066|FG003|Treatment Period|Lack of Efficacy|0|||
147440982|NCT01721057|531779067|FG004|Treatment Period|Lack of Efficacy|0|||
147440983|NCT01721057|531779068|FG005|Treatment Period|Lack of Efficacy|0|||
147440984|NCT01721057|531779069|FG006|Treatment Period|Lack of Efficacy|0|||
147440985|NCT01721057|531779063|FG000|Treatment Period|Lost to Follow-up|1|||
147440986|NCT01721057|531779064|FG001|Treatment Period|Lost to Follow-up|0|||
147440987|NCT01721057|531779065|FG002|Treatment Period|Lost to Follow-up|0|||
147440988|NCT01721057|531779066|FG003|Treatment Period|Lost to Follow-up|0|||
147440989|NCT01721057|531779067|FG004|Treatment Period|Lost to Follow-up|0|||
147440990|NCT01721057|531779068|FG005|Treatment Period|Lost to Follow-up|0|||
147440991|NCT01721057|531779069|FG006|Treatment Period|Lost to Follow-up|0|||
147440992|NCT01721057|531779063|FG000|Treatment Period|Physician Decision|0|||
147440993|NCT01721057|531779064|FG001|Treatment Period|Physician Decision|1|||
147440994|NCT01721057|531779065|FG002|Treatment Period|Physician Decision|3|||
147440995|NCT01721057|531779066|FG003|Treatment Period|Physician Decision|0|||
147440996|NCT01721057|531779067|FG004|Treatment Period|Physician Decision|0|||
147440997|NCT01721057|531779068|FG005|Treatment Period|Physician Decision|0|||
147440998|NCT01721057|531779069|FG006|Treatment Period|Physician Decision|0|||
147440999|NCT01721057|531779063|FG000|Treatment Period|Death|2|||
147441000|NCT01721057|531779064|FG001|Treatment Period|Death|0|||
147441001|NCT01721057|531779065|FG002|Treatment Period|Death|0|||
147441002|NCT01721057|531779066|FG003|Treatment Period|Death|0|||
147441003|NCT01721057|531779067|FG004|Treatment Period|Death|0|||
147441004|NCT01721057|531779068|FG005|Treatment Period|Death|0|||
147441005|NCT01721057|531779069|FG006|Treatment Period|Death|0|||
147441006|NCT01721057|531779063|FG000|Rescue Period|Adverse Event|0|||
147441007|NCT01721057|531779064|FG001|Rescue Period|Adverse Event|0|||
147441008|NCT01721057|531779065|FG002|Rescue Period|Adverse Event|0|||
147441009|NCT01721057|531779066|FG003|Rescue Period|Adverse Event|1|||
147441010|NCT01721057|531779067|FG004|Rescue Period|Adverse Event|0|||
147441011|NCT01721057|531779068|FG005|Rescue Period|Adverse Event|0|||
147441012|NCT01721057|531779069|FG006|Rescue Period|Adverse Event|0|||
147441013|NCT01721057|531779063|FG000|Rescue Period|Lack of Efficacy|0|||
147441014|NCT01721057|531779064|FG001|Rescue Period|Lack of Efficacy|0|||
147441015|NCT01721057|531779065|FG002|Rescue Period|Lack of Efficacy|0|||
147441016|NCT01721057|531779066|FG003|Rescue Period|Lack of Efficacy|2|||
147441017|NCT01721057|531779067|FG004|Rescue Period|Lack of Efficacy|0|||
147441018|NCT01721057|531779068|FG005|Rescue Period|Lack of Efficacy|0|||
147441019|NCT01721057|531779069|FG006|Rescue Period|Lack of Efficacy|0|||
147441020|NCT01202279|531779072|FG000|Overall Study|Adverse Event|8|||
147441021|NCT01202279|531779073|FG001|Overall Study|Adverse Event|6|||
147441022|NCT01202279|531779072|FG000|Overall Study|Withdrawal by Subject|13|||
147441023|NCT01202279|531779073|FG001|Overall Study|Withdrawal by Subject|10|||
147441024|NCT01202279|531779072|FG000|Overall Study|Physician Decision|0|||
147441025|NCT01202279|531779073|FG001|Overall Study|Physician Decision|1|||
147441026|NCT01202279|531779072|FG000|Overall Study|Lost to Follow-up|10|||
147441027|NCT01202279|531779073|FG001|Overall Study|Lost to Follow-up|7|||
147441028|NCT01202279|531779072|FG000|Overall Study|Protocol Violation|1|||
147441029|NCT01202279|531779073|FG001|Overall Study|Protocol Violation|1|||
147441030|NCT01202279|531779072|FG000|Overall Study|study compliance|5|||
147441031|NCT01202279|531779073|FG001|Overall Study|study compliance|2|||
147441032|NCT03805750|531779074|FG000|Second Intervention - 4 Weeks|Adverse Event|0|||
147441033|NCT03805750|531779075|FG001|Second Intervention - 4 Weeks|Adverse Event|2|||
147441034|NCT01984164|531779076|FG000|Overall Study|Withdrawal by Subject|4|||
147441035|NCT01984164|531779077|FG001|Overall Study|Withdrawal by Subject|3|||
147441036|NCT01984164|531779076|FG000|Overall Study|Adverse Event|5|||
147441037|NCT01984164|531779077|FG001|Overall Study|Adverse Event|19|||
147210749|NCT00727441|530945349|FG000|Overall Study|Death|0|||
147210750|NCT00727441|530945350|FG001|Overall Study|Death|1|||
147210751|NCT00727441|530945351|FG002|Overall Study|Death|1|||
147441038|NCT01984164|531779076|FG000|Overall Study|Lost to Follow-up|1|||
147441039|NCT01984164|531779077|FG001|Overall Study|Lost to Follow-up|3|||
147441040|NCT02811549|531779078|FG000|Overall Study|Lost to Follow-up|1|||
147441041|NCT02811549|531779078|FG000|Overall Study|Withdrawal by Subject|3|||
147441042|NCT02811549|531779078|FG000|Overall Study|Subject screen failed|4|||
147441043|NCT02811549|531779078|FG000|Overall Study|Surgery denied by subject's insurance carrier|2|||
147441044|NCT03472924|531779079|FG000|Overall Study|Adverse Event|1|||
147441045|NCT03472924|531779080|FG001|Overall Study|Adverse Event|0|||
147441046|NCT02546765|531779084|FG000|Overall Study|Withdrawal by Subject|0|||
147441047|NCT02546765|531779085|FG001|Overall Study|Withdrawal by Subject|1|||
147441048|NCT02546765|531779086|FG002|Overall Study|Withdrawal by Subject|0|||
147441049|NCT02546765|531779087|FG003|Overall Study|Withdrawal by Subject|0|||
147441050|NCT00475722|531779088|FG000|Overall Study|Withdrawal by Subject|12|||
147441051|NCT00475722|531779089|FG001|Overall Study|Withdrawal by Subject|12|||
147441052|NCT00475722|531779088|FG000|Overall Study|Protocol Violation|3|||
147441053|NCT00475722|531779089|FG001|Overall Study|Protocol Violation|0|||
147441054|NCT00698997|531779090|FG000|Overall Study|Lost to Follow-up|3|||
147441055|NCT00698997|531779091|FG001|Overall Study|Lost to Follow-up|0|||
147441056|NCT00698997|531779090|FG000|Overall Study|Withdrawal by Subject|7|||
147441057|NCT00698997|531779091|FG001|Overall Study|Withdrawal by Subject|27|||
147441058|NCT02592018|531779093|FG000|Overall Study|Adverse Event|1|||
147441059|NCT02592018|531779093|FG000|Overall Study|Lost to Follow-up|1|||
147441060|NCT06156215|531779094|FG000|Overall Study|Withdrawal by Subject|2|||
147441061|NCT06156215|531779095|FG001|Overall Study|Withdrawal by Subject|4|||
147441062|NCT06156215|531779096|FG002|Overall Study|Withdrawal by Subject|4|||
147441063|NCT06156215|531779097|FG003|Overall Study|Withdrawal by Subject|0|||
147441064|NCT06156215|531779098|FG004|Overall Study|Withdrawal by Subject|2|||
147441065|NCT06156215|531779099|FG005|Overall Study|Withdrawal by Subject|2|||
147441066|NCT06156215|531779094|FG000|Overall Study|Left ED without completing study|9|||
147441067|NCT06156215|531779095|FG001|Overall Study|Left ED without completing study|3|||
147441068|NCT06156215|531779096|FG002|Overall Study|Left ED without completing study|9|||
147441069|NCT06156215|531779097|FG003|Overall Study|Left ED without completing study|0|||
147441070|NCT06156215|531779098|FG004|Overall Study|Left ED without completing study|8|||
147441071|NCT06156215|531779099|FG005|Overall Study|Left ED without completing study|16|||
147441072|NCT06156215|531779094|FG000|Overall Study|Physician Decision|1|||
147441073|NCT06156215|531779095|FG001|Overall Study|Physician Decision|0|||
147441074|NCT06156215|531779096|FG002|Overall Study|Physician Decision|0|||
147441075|NCT06156215|531779097|FG003|Overall Study|Physician Decision|0|||
147441076|NCT06156215|531779098|FG004|Overall Study|Physician Decision|0|||
147441077|NCT06156215|531779099|FG005|Overall Study|Physician Decision|0|||
147441078|NCT06156215|531779094|FG000|Overall Study|Became or found ineligible|2|||
147441079|NCT06156215|531779095|FG001|Overall Study|Became or found ineligible|0|||
147441080|NCT06156215|531779096|FG002|Overall Study|Became or found ineligible|2|||
147441081|NCT06156215|531779097|FG003|Overall Study|Became or found ineligible|0|||
147441082|NCT06156215|531779098|FG004|Overall Study|Became or found ineligible|1|||
147441083|NCT06156215|531779099|FG005|Overall Study|Became or found ineligible|2|||
147441084|NCT05050318|531780752|FG000|Overall Study|Protocol Deviation|1|||
147441085|NCT05050318|531780753|FG001|Overall Study|Protocol Deviation|0|||
147441086|NCT05050318|531780754|FG002|Overall Study|Protocol Deviation|0|||
147441087|NCT00574145|531780760|FG000|Overall Study|Withdrawal by Subject|2|||
147441088|NCT00574145|531780761|FG001|Overall Study|Withdrawal by Subject|1|||
147441089|NCT03227471|531780762|FG000|Overall Study|Withdrawal by Subject|0|||
147441090|NCT03227471|531780763|FG001|Overall Study|Withdrawal by Subject|0|||
147441091|NCT03227471|531780764|FG002|Overall Study|Withdrawal by Subject|0|||
147441092|NCT03227471|531780765|FG003|Overall Study|Withdrawal by Subject|0|||
147441093|NCT03227471|531780766|FG004|Overall Study|Withdrawal by Subject|1|||
147441094|NCT03227471|531780767|FG005|Overall Study|Withdrawal by Subject|0|||
147441095|NCT03227471|531780768|FG006|Overall Study|Withdrawal by Subject|0|||
147441096|NCT03227471|531780769|FG007|Overall Study|Withdrawal by Subject|0|||
147441097|NCT03227471|531780770|FG008|Overall Study|Withdrawal by Subject|0|||
147441098|NCT03227471|531780771|FG009|Overall Study|Withdrawal by Subject|0|||
147441099|NCT03227471|531780772|FG010|Overall Study|Withdrawal by Subject|0|||
147441100|NCT03227471|531780773|FG011|Overall Study|Withdrawal by Subject|0|||
147441101|NCT03227471|531780774|FG012|Overall Study|Withdrawal by Subject|1|||
147441102|NCT03227471|531780775|FG013|Overall Study|Withdrawal by Subject|0|||
147441103|NCT03227471|531780776|FG014|Overall Study|Withdrawal by Subject|0|||
147441104|NCT03227471|531780762|FG000|Overall Study|Randomized, Never Dosed|0|||
147441105|NCT03227471|531780763|FG001|Overall Study|Randomized, Never Dosed|0|||
147441106|NCT03227471|531780764|FG002|Overall Study|Randomized, Never Dosed|0|||
147441107|NCT03227471|531780765|FG003|Overall Study|Randomized, Never Dosed|0|||
147441108|NCT03227471|531780766|FG004|Overall Study|Randomized, Never Dosed|0|||
147441109|NCT03227471|531780767|FG005|Overall Study|Randomized, Never Dosed|0|||
147441110|NCT03227471|531780768|FG006|Overall Study|Randomized, Never Dosed|0|||
147543117|NCT01640964|532144211|FG000|Overall Study|Lost to Follow-up|0|||
147543118|NCT01640964|532144212|FG001|Overall Study|Lost to Follow-up|0|||
147543119|NCT01640964|532144213|FG002|Overall Study|Lost to Follow-up|1|||
147543120|NCT01640964|532144211|FG000|Overall Study|Protocol Deviation|1|||
147543121|NCT01640964|532144212|FG001|Overall Study|Protocol Deviation|1|||
147543122|NCT01640964|532144213|FG002|Overall Study|Protocol Deviation|2|||
147543123|NCT02787746|532144214|FG000|Overall Study|Adverse Event|42|||
147543124|NCT02787746|532144214|FG000|Overall Study|Withdrawal by Subject|65|||
147543125|NCT02787746|532144214|FG000|Overall Study|Failure to up-titrate to 10mg/day: 12 patients; Other reasons: 30 patients|41|||
147543126|NCT04822701|532144217|FG000|Overall Study|Not treated|2|||
147543127|NCT04822701|532144218|FG001|Overall Study|Not treated|0|||
147543128|NCT04822701|532144217|FG000|Overall Study|Lost to Follow-up|1|||
147543129|NCT04822701|532144218|FG001|Overall Study|Lost to Follow-up|0|||
147543130|NCT04822701|532144217|FG000|Overall Study|Withdrawal by Subject|1|||
147543131|NCT04822701|532144218|FG001|Overall Study|Withdrawal by Subject|0|||
147543132|NCT01408576|532146161|FG000|Overall Study|Lack of Efficacy|17|||
147543133|NCT01408576|532146162|FG001|Overall Study|Lack of Efficacy|30|||
147543134|NCT01408576|532146163|FG002|Overall Study|Lack of Efficacy|48|||
147543135|NCT01408576|532146161|FG000|Overall Study|Protocol Violation|1|||
147543136|NCT01408576|532146162|FG001|Overall Study|Protocol Violation|2|||
147543137|NCT01408576|532146163|FG002|Overall Study|Protocol Violation|2|||
147543138|NCT01408576|532146161|FG000|Overall Study|Lost to Follow-up|10|||
147543139|NCT01408576|532146162|FG001|Overall Study|Lost to Follow-up|9|||
147543140|NCT01408576|532146163|FG002|Overall Study|Lost to Follow-up|17|||
147543141|NCT01408576|532146161|FG000|Overall Study|Withdrawal by Subject|34|||
147543142|NCT01408576|532146162|FG001|Overall Study|Withdrawal by Subject|60|||
147543143|NCT01408576|532146163|FG002|Overall Study|Withdrawal by Subject|66|||
147543144|NCT01408576|532146161|FG000|Overall Study|Sponsor terminated study|89|||
147543145|NCT01408576|532146162|FG001|Overall Study|Sponsor terminated study|333|||
147543146|NCT01408576|532146163|FG002|Overall Study|Sponsor terminated study|330|||
147543147|NCT01408576|532146161|FG000|Overall Study|AE, serious fatal|4|||
147543148|NCT01408576|532146162|FG001|Overall Study|AE, serious fatal|4|||
147543149|NCT01408576|532146163|FG002|Overall Study|AE, serious fatal|1|||
147543150|NCT01408576|532146161|FG000|Overall Study|SAE, non-fatal|11|||
147543151|NCT01408576|532146162|FG001|Overall Study|SAE, non-fatal|23|||
147543152|NCT01408576|532146163|FG002|Overall Study|SAE, non-fatal|14|||
147543153|NCT01408576|532146161|FG000|Overall Study|AE, non-serious non-fatal|12|||
147543154|NCT01408576|532146162|FG001|Overall Study|AE, non-serious non-fatal|19|||
147543155|NCT01408576|532146163|FG002|Overall Study|AE, non-serious non-fatal|11|||
147543156|NCT01408576|532146161|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
147543157|NCT01408576|532146162|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
147543158|NCT01408576|532146163|FG002|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
147543159|NCT01408576|532146161|FG000|Overall Study|AE, unknown type|0|||
147543160|NCT01408576|532146162|FG001|Overall Study|AE, unknown type|1|||
147543161|NCT01408576|532146163|FG002|Overall Study|AE, unknown type|0|||
147543162|NCT01408576|532146161|FG000|Overall Study|Other|10|||
147543163|NCT01408576|532146162|FG001|Overall Study|Other|16|||
147543164|NCT01408576|532146163|FG002|Overall Study|Other|18|||
147543165|NCT00802529|532146164|FG000|Overall Study|Lost to Follow-up|0|||
147543166|NCT00802529|532146165|FG001|Overall Study|Lost to Follow-up|1|||
147543167|NCT02476851|532146166|FG000|Overall Study|Protocol Violation|1|||
147543168|NCT02476851|532146167|FG001|Overall Study|Protocol Violation|1|||
147543169|NCT00337129|532146168|FG000|Overall Study|Adverse Event|4|||
147543170|NCT00337129|532146168|FG000|Overall Study|Withdrawal by Subject|1|||
147543171|NCT00337129|532146168|FG000|Overall Study|Lack of Efficacy|32|||
147543172|NCT00337129|532146168|FG000|Overall Study|Death|2|||
147543173|NCT00337129|532146168|FG000|Overall Study|not protocol specified|1|||
147543174|NCT00647426|532146169|FG000|Overall Study|Withdrawal by Subject|2|||
147543175|NCT01467570|532146173|FG000|Overall Study|Lost to Follow-up|8|||
147543176|NCT01467570|532146174|FG001|Overall Study|Lost to Follow-up|9|||
147543177|NCT02626182|532146177|FG000|Overall Study|Adverse Event|2|||
147543178|NCT02626182|532146178|FG001|Overall Study|Adverse Event|0|||
147543179|NCT01084603|532146181|FG000|Baseline|Withdrawal by Subject|2|||
147543180|NCT01084603|532146181|FG000|NiQuitinTM Lozenge|Withdrawal by Subject|1|||
147543181|NCT01084603|532146181|FG000|Nicorette® Gum|Withdrawal by Subject|1|||
147543182|NCT01084603|532146181|FG000|Oral Nicotine 1|Withdrawal by Subject|1|||
147210752|NCT00727441|530945349|FG000|Overall Study|Physician Decision|0|||
147543183|NCT01084603|532146181|FG000|Washout Period 4|Adverse Event|1|||
147543184|NCT03836729|532146183|FG000|Treatment Period 2 (Up to Day 7)|Adverse Event|1|||
147543185|NCT02239601|532146187|FG000|Overall Study|Withdrawal by Subject|3|||
147543186|NCT02239601|532146188|FG001|Overall Study|Withdrawal by Subject|4|||
147543187|NCT02239601|532146187|FG000|Overall Study|Protocol Violation|4|||
147543188|NCT02239601|532146188|FG001|Overall Study|Protocol Violation|2|||
147543189|NCT01508325|532146189|FG000|Overall Study|Withdrawal by Subject|8|||
147543190|NCT01508325|532146190|FG001|Overall Study|Withdrawal by Subject|9|||
147543191|NCT01508325|532146189|FG000|Overall Study|Protocol Violation|0|||
147543192|NCT01508325|532146190|FG001|Overall Study|Protocol Violation|3|||
147543193|NCT01508325|532146189|FG000|Overall Study|Physician Decision|2|||
147543194|NCT01508325|532146190|FG001|Overall Study|Physician Decision|1|||
147543195|NCT01508325|532146189|FG000|Overall Study|Adverse Event|1|||
147543196|NCT01508325|532146190|FG001|Overall Study|Adverse Event|0|||
147543197|NCT01508325|532146189|FG000|Overall Study|Lost to Follow-up|5|||
147543198|NCT01508325|532146190|FG001|Overall Study|Lost to Follow-up|6|||
147543199|NCT01508325|532146189|FG000|Overall Study|Other|2|||
147543200|NCT01508325|532146190|FG001|Overall Study|Other|2|||
147543201|NCT01392170|532146191|FG000|Overall Study|Withdrawal by Subject|1|||
147543202|NCT01392170|532146191|FG000|Overall Study|Ineligible|1|||
147543203|NCT03174925|532146201|FG000|Overall Study|Elastographic images not retrievable|2|||
147543204|NCT03174925|532146201|FG000|Overall Study|Elastography image not interpretable|1|||
147543205|NCT01791127|532146202|FG000|Overall Study|Death|356|||
147543206|NCT01791127|532146202|FG000|Overall Study|Patient has withdrawn from study|293|||
147543207|NCT01791127|532146202|FG000|Overall Study|Lost to Follow-up|42|||
147543208|NCT01791127|532146202|FG000|Overall Study|All Siello leads are explanted|31|||
147543209|NCT01791127|532146202|FG000|Overall Study|Completion of 30 day safety registry|1|||
147543210|NCT01791127|532146202|FG000|Overall Study|Study terminated for EP Passion|749|||
147543211|NCT00589693|532146208|FG000|Overall Study|randomized in error|12|||
147543212|NCT00589693|532146209|FG001|Overall Study|randomized in error|6|||
147543213|NCT00589693|532146208|FG000|Overall Study|Adverse Event|4|||
147543214|NCT00589693|532146209|FG001|Overall Study|Adverse Event|4|||
147543215|NCT00589693|532146208|FG000|Overall Study|Death|26|||
147543216|NCT00589693|532146209|FG001|Overall Study|Death|16|||
147543217|NCT00589693|532146208|FG000|Overall Study|Lack of Efficacy|0|||
147543218|NCT00589693|532146209|FG001|Overall Study|Lack of Efficacy|1|||
147543219|NCT00589693|532146208|FG000|Overall Study|Lost to Follow-up|1|||
147543220|NCT00589693|532146209|FG001|Overall Study|Lost to Follow-up|0|||
147543221|NCT00589693|532146208|FG000|Overall Study|Physician Decision|0|||
147543222|NCT00589693|532146209|FG001|Overall Study|Physician Decision|1|||
147543223|NCT00589693|532146208|FG000|Overall Study|Protocol Violation|1|||
147543224|NCT00589693|532146209|FG001|Overall Study|Protocol Violation|1|||
147543225|NCT03231709|532146210|FG000|Treatment Period 1|Reason not Specified|0|||
147543226|NCT03231709|532146211|FG001|Treatment Period 1|Reason not Specified|1|||
147543227|NCT03231709|532146210|FG000|Treatment Period 2|Pretreatment Event/Adverse Event|0|||
147543228|NCT03231709|532146211|FG001|Treatment Period 2|Pretreatment Event/Adverse Event|1|||
147543229|NCT02609178|532146212|FG000|First Crown|Withdrawal by Subject|0|||
147543230|NCT02609178|532146213|FG001|First Crown|Withdrawal by Subject|0|||
147543231|NCT02609178|532146214|FG002|First Crown|Withdrawal by Subject|1|||
147543232|NCT02609178|532146215|FG003|First Crown|Withdrawal by Subject|1|||
147543233|NCT02609178|532146216|FG004|First Crown|Withdrawal by Subject|0|||
147543234|NCT02609178|532146217|FG005|First Crown|Withdrawal by Subject|0|||
147543235|NCT01128153|532146218|FG000|Overall Study|Adverse Event|1|||
147543236|NCT01128153|532146219|FG001|Overall Study|Adverse Event|3|||
147543237|NCT01128153|532146218|FG000|Overall Study|Condition under investigation worsened|8|||
147543238|NCT01128153|532146219|FG001|Overall Study|Condition under investigation worsened|7|||
147543239|NCT01128153|532146218|FG000|Overall Study|Withdrawal by Subject|2|||
147543240|NCT01128153|532146219|FG001|Overall Study|Withdrawal by Subject|3|||
147543241|NCT01128153|532146218|FG000|Overall Study|Incorrect enrolment to study|2|||
147543242|NCT01128153|532146219|FG001|Overall Study|Incorrect enrolment to study|1|||
147543243|NCT01128153|532146218|FG000|Overall Study|Protocol Violation|2|||
147543244|NCT01128153|532146219|FG001|Overall Study|Protocol Violation|0|||
147543245|NCT01128153|532146218|FG000|Overall Study|Developed discontinuation criteria|1|||
147543246|NCT01128153|532146219|FG001|Overall Study|Developed discontinuation criteria|1|||
147543247|NCT01954082|532146220|FG000|Overall Study|Study Suspension|42|||
147543248|NCT01954082|532146221|FG001|Overall Study|Study Suspension|36|||
147543249|NCT01954082|532146220|FG000|Overall Study|Adverse Event|10|||
147543250|NCT01954082|532146221|FG001|Overall Study|Adverse Event|4|||
147543251|NCT01954082|532146220|FG000|Overall Study|Intolerance|0|||
147543252|NCT01954082|532146221|FG001|Overall Study|Intolerance|1|||
147543253|NCT01954082|532146220|FG000|Overall Study|Non-compliance|6|||
147543254|NCT01954082|532146221|FG001|Overall Study|Non-compliance|4|||
147543255|NCT01954082|532146220|FG000|Overall Study|Physician Decision|2|||
147543256|NCT01954082|532146221|FG001|Overall Study|Physician Decision|0|||
147543257|NCT01954082|532146220|FG000|Overall Study|Parent Decision|1|||
147543258|NCT01954082|532146221|FG001|Overall Study|Parent Decision|0|||
147543259|NCT01954082|532146220|FG000|Overall Study|Withdrawal by Subject|0|||
147543260|NCT01954082|532146221|FG001|Overall Study|Withdrawal by Subject|1|||
147543261|NCT01954082|532146220|FG000|Overall Study|Discontinued Early Prior to Transfer|3|||
147543262|NCT01954082|532146221|FG001|Overall Study|Discontinued Early Prior to Transfer|2|||
147543263|NCT01954082|532146220|FG000|Overall Study|Redirection of Care|0|||
147543264|NCT01954082|532146221|FG001|Overall Study|Redirection of Care|2|||
147543265|NCT01954082|532146220|FG000|Overall Study|Miscalculation of Final Dose Day|0|||
147543266|NCT01954082|532146221|FG001|Overall Study|Miscalculation of Final Dose Day|3|||
147543267|NCT01954082|532146220|FG000|Overall Study|Comfort Care|0|||
147543268|NCT01954082|532146221|FG001|Overall Study|Comfort Care|1|||
147543269|NCT01954082|532146220|FG000|Overall Study|Infant Moved|0|||
147543270|NCT01954082|532146221|FG001|Overall Study|Infant Moved|1|||
147543271|NCT01954082|532146220|FG000|Overall Study|Randomized not Treated|4|||
147543272|NCT01954082|532146221|FG001|Overall Study|Randomized not Treated|2|||
147543273|NCT02419469|532146222|FG000|Overall Study|Withdrawal by Subject|1|||
147543274|NCT01682512|532146223|FG000|Overall Study|Adverse Event|6|||
147543275|NCT01682512|532146224|FG001|Overall Study|Adverse Event|5|||
147543276|NCT01682512|532146225|FG002|Overall Study|Adverse Event|2|||
147543277|NCT01682512|532146223|FG000|Overall Study|Withdrawal by Subject|2|||
147543278|NCT01682512|532146224|FG001|Overall Study|Withdrawal by Subject|6|||
147543279|NCT01682512|532146225|FG002|Overall Study|Withdrawal by Subject|3|||
147543280|NCT01682512|532146223|FG000|Overall Study|Physician Decision|0|||
147543281|NCT01682512|532146224|FG001|Overall Study|Physician Decision|2|||
147543282|NCT01682512|532146225|FG002|Overall Study|Physician Decision|0|||
147543283|NCT01682512|532146223|FG000|Overall Study|Study terminated by sponsor|46|||
147543284|NCT01682512|532146224|FG001|Overall Study|Study terminated by sponsor|43|||
147543285|NCT01682512|532146225|FG002|Overall Study|Study terminated by sponsor|0|||
147543286|NCT01682512|532146223|FG000|Overall Study|Lost to Follow-up|3|||
147543287|NCT01682512|532146224|FG001|Overall Study|Lost to Follow-up|0|||
147543288|NCT01682512|532146225|FG002|Overall Study|Lost to Follow-up|2|||
147543289|NCT01682512|532146223|FG000|Overall Study|Protocol Violation|2|||
147543290|NCT01682512|532146224|FG001|Overall Study|Protocol Violation|3|||
147543291|NCT01682512|532146225|FG002|Overall Study|Protocol Violation|2|||
147543292|NCT01682512|532146223|FG000|Overall Study|Primary lack of efficacy|10|||
147543293|NCT01682512|532146224|FG001|Overall Study|Primary lack of efficacy|7|||
147543294|NCT01682512|532146225|FG002|Overall Study|Primary lack of efficacy|7|||
147543295|NCT01682512|532146223|FG000|Overall Study|Secondary lack of efficacy|1|||
147543296|NCT01682512|532146224|FG001|Overall Study|Secondary lack of efficacy|1|||
147543297|NCT01682512|532146225|FG002|Overall Study|Secondary lack of efficacy|0|||
147543298|NCT01682512|532146223|FG000|Overall Study|Other than stated above|2|||
147543299|NCT01682512|532146224|FG001|Overall Study|Other than stated above|4|||
147543300|NCT01682512|532146225|FG002|Overall Study|Other than stated above|2|||
147543301|NCT01377233|532146226|FG000|Open-label|Adverse Event|1|||
147543302|NCT01377233|532146227|FG001|Open-label|Adverse Event|0|||
147543303|NCT01377233|532146228|FG002|Open-label|Adverse Event|0|||
147543304|NCT01377233|532146229|FG003|Open-label|Adverse Event|0|||
147543305|NCT01377233|532146230|FG004|Open-label|Adverse Event|0|||
147543306|NCT01377233|532146226|FG000|Open-label|Withdrawal by Subject|3|||
147543307|NCT01377233|532146227|FG001|Open-label|Withdrawal by Subject|0|||
147543308|NCT01377233|532146228|FG002|Open-label|Withdrawal by Subject|0|||
147543309|NCT01377233|532146229|FG003|Open-label|Withdrawal by Subject|0|||
147543310|NCT01377233|532146230|FG004|Open-label|Withdrawal by Subject|0|||
147543311|NCT01377233|532146226|FG000|Double-blind|Adverse Event|0|||
147543312|NCT01377233|532146227|FG001|Double-blind|Adverse Event|1|||
147543313|NCT01377233|532146228|FG002|Double-blind|Adverse Event|2|||
147543314|NCT01377233|532146229|FG003|Double-blind|Adverse Event|2|||
147543315|NCT01377233|532146230|FG004|Double-blind|Adverse Event|0|||
147543316|NCT01377233|532146226|FG000|Double-blind|Protocol Violation|0|||
147543317|NCT01377233|532146227|FG001|Double-blind|Protocol Violation|0|||
147543318|NCT01377233|532146228|FG002|Double-blind|Protocol Violation|0|||
147543319|NCT01377233|532146229|FG003|Double-blind|Protocol Violation|0|||
147543320|NCT01377233|532146230|FG004|Double-blind|Protocol Violation|1|||
147543321|NCT01377233|532146226|FG000|Double-blind|Withdrawal by Subject|0|||
147543322|NCT01377233|532146227|FG001|Double-blind|Withdrawal by Subject|0|||
147543323|NCT01377233|532146228|FG002|Double-blind|Withdrawal by Subject|0|||
147543324|NCT01377233|532146229|FG003|Double-blind|Withdrawal by Subject|1|||
147543325|NCT01377233|532146230|FG004|Double-blind|Withdrawal by Subject|0|||
147543326|NCT01377233|532146226|FG000|Double-blind|Administrative or other|0|||
147543327|NCT01377233|532146227|FG001|Double-blind|Administrative or other|0|||
147543328|NCT01377233|532146228|FG002|Double-blind|Administrative or other|0|||
147543329|NCT01377233|532146229|FG003|Double-blind|Administrative or other|1|||
147543330|NCT01377233|532146230|FG004|Double-blind|Administrative or other|1|||
147543331|NCT01785875|532146231|FG000|Overall Study|Withdrawal by Subject|41|||
147543332|NCT01785875|532146232|FG001|Overall Study|Withdrawal by Subject|34|||
147543333|NCT01785875|532146233|FG002|Overall Study|Withdrawal by Subject|36|||
147543334|NCT01785875|532146231|FG000|Overall Study|Lost to Follow-up|19|||
147543335|NCT01785875|532146232|FG001|Overall Study|Lost to Follow-up|22|||
147543336|NCT01785875|532146233|FG002|Overall Study|Lost to Follow-up|6|||
147543337|NCT01785875|532146231|FG000|Overall Study|Death|27|||
147543338|NCT01785875|532146232|FG001|Overall Study|Death|16|||
147543339|NCT01785875|532146233|FG002|Overall Study|Death|7|||
147543340|NCT01785875|532146231|FG000|Overall Study|Sponsor Decision|0|||
147543341|NCT01785875|532146232|FG001|Overall Study|Sponsor Decision|2|||
147543342|NCT01785875|532146233|FG002|Overall Study|Sponsor Decision|0|||
147543343|NCT01785875|532146231|FG000|Overall Study|Protocol Specified Criteria|207|||
147543344|NCT01785875|532146232|FG001|Overall Study|Protocol Specified Criteria|214|||
147543345|NCT01785875|532146233|FG002|Overall Study|Protocol Specified Criteria|55|||
147543346|NCT01785875|532146231|FG000|Overall Study|Missing|0|||
147543347|NCT01785875|532146232|FG001|Overall Study|Missing|1|||
147543348|NCT01785875|532146233|FG002|Overall Study|Missing|3|||
147543349|NCT00417027|532146236|FG000|Overall Study|Protocol Violation|0|||
147543350|NCT00417027|532146237|FG001|Overall Study|Protocol Violation|5|||
147543351|NCT00417027|532146238|FG002|Overall Study|Protocol Violation|5|||
147543352|NCT03137082|532146239|FG000|Overall Study|Withdrawal by Subject|1|||
147543353|NCT03137082|532146240|FG001|Overall Study|Withdrawal by Subject|1|||
147543354|NCT03137082|532146239|FG000|Overall Study|Lost to Follow-up|1|||
147543355|NCT03137082|532146240|FG001|Overall Study|Lost to Follow-up|0|||
147543356|NCT00707174|532146241|FG000|Overall Study|Adverse Event|1|||
147543357|NCT00707174|532146242|FG001|Overall Study|Adverse Event|6|||
147543358|NCT00707174|532146241|FG000|Overall Study|Withdrawal by Subject|4|||
147543359|NCT00707174|532146242|FG001|Overall Study|Withdrawal by Subject|1|||
147543360|NCT00544557|532146243|FG000|Overall Study|Adverse Event|140|||
147543361|NCT00544557|532146243|FG000|Overall Study|Lack of Efficacy|196|||
147543362|NCT00544557|532146243|FG000|Overall Study|Other|98|||
147543363|NCT04057118|532146244|FG000|Overall Study|Adverse Event|1|||
147543364|NCT04057118|532146245|FG001|Overall Study|Adverse Event|0|||
147543365|NCT04057118|532146246|FG002|Overall Study|Adverse Event|1|||
147543366|NCT04057118|532146247|FG003|Overall Study|Adverse Event|1|||
147543367|NCT04057118|532146244|FG000|Overall Study|Physician Decision|0|||
147543368|NCT04057118|532146245|FG001|Overall Study|Physician Decision|0|||
147543369|NCT04057118|532146246|FG002|Overall Study|Physician Decision|1|||
147543370|NCT04057118|532146247|FG003|Overall Study|Physician Decision|1|||
147543371|NCT04057118|532146244|FG000|Overall Study|Withdrawal by Subject|2|||
147543372|NCT04057118|532146245|FG001|Overall Study|Withdrawal by Subject|2|||
147543373|NCT04057118|532146246|FG002|Overall Study|Withdrawal by Subject|0|||
147543374|NCT04057118|532146247|FG003|Overall Study|Withdrawal by Subject|2|||
147543375|NCT04057118|532146244|FG000|Overall Study|Not Specific|0|||
147543376|NCT04057118|532146245|FG001|Overall Study|Not Specific|0|||
147543377|NCT04057118|532146246|FG002|Overall Study|Not Specific|1|||
147543378|NCT04057118|532146247|FG003|Overall Study|Not Specific|1|||
147543379|NCT04333199|532146255|FG000|Evaluated Patients|Lost to Follow-up|0|||
147543380|NCT04333199|532146256|FG001|Evaluated Patients|Lost to Follow-up|1|||
147543381|NCT04333199|532146257|FG002|Evaluated Patients|Lost to Follow-up|2|||
147543382|NCT03959137|532146258|FG000|Overall Study|Protocol Violation|6|||
147543383|NCT00810615|532146264|FG000|Overall Study|Withdrawal by Subject|1|||
147543384|NCT00810615|532146265|FG001|Overall Study|Withdrawal by Subject|1|||
147543385|NCT02567266|532146266|FG000|Overall Study|Withdrawal by Subject|10|||
147543386|NCT02567266|532146267|FG001|Overall Study|Withdrawal by Subject|7|||
147543387|NCT02567266|532146268|FG002|Overall Study|Withdrawal by Subject|6|||
147543388|NCT02567266|532146266|FG000|Overall Study|Lost to Follow-up|13|||
147543389|NCT02567266|532146267|FG001|Overall Study|Lost to Follow-up|8|||
147543390|NCT02567266|532146268|FG002|Overall Study|Lost to Follow-up|10|||
147543391|NCT00995488|532146272|FG000|Overall Study|Withdrawal by Subject|1|||
147543392|NCT02702271|532146273|FG000|Overall Study|Death|36|||
147543393|NCT02702271|532146274|FG001|Overall Study|Death|7|||
147543394|NCT02702271|532146273|FG000|Overall Study|Lost to Follow-up|12|||
147543395|NCT02702271|532146274|FG001|Overall Study|Lost to Follow-up|0|||
147543396|NCT02702271|532146273|FG000|Overall Study|Withdrawal by Subject|8|||
147543397|NCT02702271|532146274|FG001|Overall Study|Withdrawal by Subject|1|||
147543398|NCT02702271|532146273|FG000|Overall Study|Physician Decision|2|||
147543399|NCT02702271|532146274|FG001|Overall Study|Physician Decision|0|||
147543400|NCT02702271|532146273|FG000|Overall Study|Unsuccessful Implant Attempt|5|||
147543401|NCT02702271|532146274|FG001|Overall Study|Unsuccessful Implant Attempt|1|||
147543402|NCT03091400|532146275|FG000|Washout - 2 Weeks|Withdrawal by Subject|1|||
147543403|NCT03091400|532146276|FG001|Washout - 2 Weeks|Withdrawal by Subject|0|||
147543404|NCT05789420|532146277|FG000|Screening and Safety Assessments|Completed Alternate Status|1|||
147543405|NCT05789420|532146277|FG000|Randomization to Product Assessments|Failed alcohol breath test and urine test on day -1|1|||
147543406|NCT05473247|532146278|FG000|Overall Study|One participant ceased contact with the research study team after the initial, pre-testing appt.|1|||
147543407|NCT02392559|532146279|FG000|Overall Study|Withdrawal by Subject|0|||
147543408|NCT02392559|532146280|FG001|Overall Study|Withdrawal by Subject|1|||
147543409|NCT02340078|532146286|FG000|Overall Study|Protocol Violation|1|||
147543410|NCT01831596|532146287|FG000|Overall Study|Other|8|||
147543411|NCT01311505|532146288|FG000|First Intervention Period|Protocol Violation|0|||
147543412|NCT01311505|532146289|FG001|First Intervention Period|Protocol Violation|1|||
147543413|NCT00446134|532146290|FG000|Overall Study|Adverse Event|7|||
147543414|NCT00446134|532146291|FG001|Overall Study|Adverse Event|17|||
147543415|NCT00446134|532146292|FG002|Overall Study|Adverse Event|13|||
147543416|NCT00446134|532146293|FG003|Overall Study|Adverse Event|18|||
147543417|NCT00446134|532146290|FG000|Overall Study|Lack of Efficacy|19|||
147543418|NCT00446134|532146291|FG001|Overall Study|Lack of Efficacy|19|||
147543419|NCT00446134|532146292|FG002|Overall Study|Lack of Efficacy|24|||
147543420|NCT00446134|532146293|FG003|Overall Study|Lack of Efficacy|19|||
147543421|NCT00446134|532146290|FG000|Overall Study|Protocol Violation|0|||
147543422|NCT00446134|532146291|FG001|Overall Study|Protocol Violation|2|||
147543423|NCT00446134|532146292|FG002|Overall Study|Protocol Violation|1|||
147543424|NCT00446134|532146293|FG003|Overall Study|Protocol Violation|0|||
147543425|NCT00446134|532146290|FG000|Overall Study|Lost to Follow-up|1|||
147543426|NCT00446134|532146291|FG001|Overall Study|Lost to Follow-up|3|||
147543427|NCT00446134|532146292|FG002|Overall Study|Lost to Follow-up|1|||
147543428|NCT00446134|532146293|FG003|Overall Study|Lost to Follow-up|1|||
147543429|NCT00446134|532146290|FG000|Overall Study|Withdrawal by Subject|3|||
147543430|NCT00446134|532146291|FG001|Overall Study|Withdrawal by Subject|3|||
147543431|NCT00446134|532146292|FG002|Overall Study|Withdrawal by Subject|1|||
147543432|NCT00446134|532146293|FG003|Overall Study|Withdrawal by Subject|3|||
147543433|NCT00446134|532146290|FG000|Overall Study|Physician Decision|0|||
147543434|NCT00446134|532146291|FG001|Overall Study|Physician Decision|0|||
147543435|NCT00446134|532146292|FG002|Overall Study|Physician Decision|0|||
147543436|NCT00446134|532146293|FG003|Overall Study|Physician Decision|2|||
147543437|NCT00446134|532146290|FG000|Overall Study|Adverse Event-Diarrhea|1|||
147543438|NCT00446134|532146291|FG001|Overall Study|Adverse Event-Diarrhea|1|||
147543439|NCT00446134|532146292|FG002|Overall Study|Adverse Event-Diarrhea|2|||
147543440|NCT00446134|532146293|FG003|Overall Study|Adverse Event-Diarrhea|0|||
147543441|NCT00446134|532146290|FG000|Overall Study|Reason Not Completed|3|||
147543442|NCT00446134|532146291|FG001|Overall Study|Reason Not Completed|0|||
147543443|NCT00446134|532146292|FG002|Overall Study|Reason Not Completed|1|||
147543444|NCT00446134|532146293|FG003|Overall Study|Reason Not Completed|2|||
147543445|NCT00567996|532146297|FG000|Overall Study|Adverse Event|18|||
147543446|NCT00567996|532146298|FG001|Overall Study|Adverse Event|16|||
147543447|NCT00567996|532146299|FG002|Overall Study|Adverse Event|13|||
147543448|NCT00567996|532146297|FG000|Overall Study|Protocol Deviation|9|||
147543449|NCT00567996|532146298|FG001|Overall Study|Protocol Deviation|11|||
147543450|NCT00567996|532146299|FG002|Overall Study|Protocol Deviation|13|||
147543451|NCT00567996|532146297|FG000|Overall Study|Withdrawal by Subject|8|||
147543452|NCT00567996|532146298|FG001|Overall Study|Withdrawal by Subject|12|||
147543453|NCT00567996|532146299|FG002|Overall Study|Withdrawal by Subject|22|||
147543454|NCT00567996|532146297|FG000|Overall Study|Abnormal Lab value(s)|2|||
147543455|NCT00567996|532146298|FG001|Overall Study|Abnormal Lab value(s)|1|||
147543456|NCT00567996|532146299|FG002|Overall Study|Abnormal Lab value(s)|2|||
147543457|NCT00567996|532146297|FG000|Overall Study|Abnormal test procedure result(s)|2|||
147543458|NCT00567996|532146298|FG001|Overall Study|Abnormal test procedure result(s)|1|||
147543459|NCT00567996|532146299|FG002|Overall Study|Abnormal test procedure result(s)|1|||
147543460|NCT00567996|532146297|FG000|Overall Study|Lost to Follow-up|2|||
147543461|NCT00567996|532146298|FG001|Overall Study|Lost to Follow-up|5|||
147543462|NCT00567996|532146299|FG002|Overall Study|Lost to Follow-up|2|||
147543463|NCT00567996|532146297|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
147543464|NCT00567996|532146298|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
147543465|NCT00567996|532146299|FG002|Overall Study|Unsatisfactory therapeutic effect|15|||
147543466|NCT00567996|532146297|FG000|Overall Study|Administrative problems|1|||
147543467|NCT00567996|532146298|FG001|Overall Study|Administrative problems|1|||
147543468|NCT00567996|532146299|FG002|Overall Study|Administrative problems|0|||
147543469|NCT00567996|532146297|FG000|Overall Study|Death|1|||
147543470|NCT00567996|532146298|FG001|Overall Study|Death|0|||
147543471|NCT00567996|532146299|FG002|Overall Study|Death|2|||
147543472|NCT00567996|532146297|FG000|Overall Study|Patient's inability to use the device|0|||
147543473|NCT00567996|532146298|FG001|Overall Study|Patient's inability to use the device|1|||
147543474|NCT00567996|532146299|FG002|Overall Study|Patient's inability to use the device|0|||
147543475|NCT02956005|532146300|FG000|Overall Study|Not eligible|1|||
147543476|NCT02956005|532146300|FG000|Overall Study|Withdrawal by Subject|3|||
147543477|NCT02956005|532146300|FG000|Overall Study|Physician Decision|12|||
147543478|NCT02524665|532146303|FG000|Overall Study|Lost to Follow-up|1|||
147543479|NCT02602080|532146306|FG000|Overall Study|Protocol Violation|6|||
147543480|NCT02602080|532146307|FG001|Overall Study|Protocol Violation|1|||
147543481|NCT02602080|532146308|FG002|Overall Study|Protocol Violation|3|||
147543482|NCT01066039|532146311|FG000|Overall Study|Adverse Event|6|||
147543483|NCT01066039|532146311|FG000|Overall Study|Withdrawal by Subject|17|||
147543484|NCT01066039|532146311|FG000|Overall Study|Protocol Violation|2|||
147543485|NCT01066039|532146311|FG000|Overall Study|Inclusion/Exclusion Criteria Violation|9|||
147543486|NCT01066039|532146311|FG000|Overall Study|Investigator's Request|1|||
147543487|NCT01066039|532146311|FG000|Overall Study|Dropout due to Insulin Administration|1|||
147543488|NCT01066039|532146311|FG000|Overall Study|Additional Antihypertensive Required|4|||
147543489|NCT01066039|532146311|FG000|Overall Study|Volunteer Failed to Make the Next Visit|2|||
147543490|NCT01066039|532146311|FG000|Overall Study|Failure to Control Blood Pressure|1|||
147543491|NCT01066039|532146311|FG000|Overall Study|Drug/Dose Adjustment Required|1|||
147543492|NCT02574260|532146316|FG000|Overall Study|Disease Progression|1|||
147543493|NCT03022799|532146319|FG000|Overall Study|Adverse Event|0|||
147543494|NCT03022799|532146320|FG001|Overall Study|Adverse Event|0|||
147543495|NCT03022799|532146321|FG002|Overall Study|Adverse Event|0|||
147543496|NCT03022799|532146322|FG003|Overall Study|Adverse Event|0|||
147543497|NCT03022799|532146323|FG004|Overall Study|Adverse Event|0|||
147543498|NCT03022799|532146324|FG005|Overall Study|Adverse Event|0|||
147543499|NCT03022799|532146325|FG006|Overall Study|Adverse Event|0|||
147543500|NCT03022799|532146326|FG007|Overall Study|Adverse Event|0|||
147543501|NCT03022799|532146327|FG008|Overall Study|Adverse Event|0|||
147543502|NCT03022799|532146328|FG009|Overall Study|Adverse Event|1|||
147543503|NCT03022799|532146329|FG010|Overall Study|Adverse Event|1|||
147543504|NCT03022799|532146330|FG011|Overall Study|Adverse Event|0|||
147543505|NCT03022799|532146331|FG012|Overall Study|Adverse Event|0|||
147543506|NCT00883129|532146334|FG000|Overall Study|Adverse Event|7|||
147543507|NCT00883129|532146335|FG001|Overall Study|Adverse Event|15|||
147543508|NCT00883129|532146334|FG000|Overall Study|Withdrawal by Subject|8|||
147543509|NCT00883129|532146335|FG001|Overall Study|Withdrawal by Subject|9|||
147543510|NCT00883129|532146334|FG000|Overall Study|Non-compliance|3|||
147543511|NCT00883129|532146335|FG001|Overall Study|Non-compliance|6|||
147543512|NCT00883129|532146334|FG000|Overall Study|Lost to Follow-up|1|||
147543513|NCT00883129|532146335|FG001|Overall Study|Lost to Follow-up|2|||
147543514|NCT00883129|532146334|FG000|Overall Study|Death|1|||
147543515|NCT00883129|532146335|FG001|Overall Study|Death|2|||
147543516|NCT00883129|532146334|FG000|Overall Study|Defined Treatment Failure|0|||
147543517|NCT00883129|532146335|FG001|Overall Study|Defined Treatment Failure|2|||
147543518|NCT03273257|532146337|FG000|Overall Study|Death|0|||
147543519|NCT03273257|532146338|FG001|Overall Study|Death|1|||
147543520|NCT03273257|532146337|FG000|Overall Study|Inability to schedule PEA according to the protocol due to the COVID pandemic|1|||
147543521|NCT03273257|532146338|FG001|Overall Study|Inability to schedule PEA according to the protocol due to the COVID pandemic|1|||
147543522|NCT03273257|532146337|FG000|Overall Study|Study terminated|3|||
147543523|NCT03273257|532146338|FG001|Overall Study|Study terminated|2|||
147543524|NCT01185639|532146340|FG000|Overall Study|Progressed and didn't receive therapy|2|||
147543525|NCT02200614|532146341|FG000|Double Blind Treatment|Adverse Event|86|||
147543526|NCT02200614|532146342|FG001|Double Blind Treatment|Adverse Event|48|||
147543527|NCT02200614|532146341|FG000|Double Blind Treatment|Confirmed metastasis|120|||
147543528|NCT02200614|532146342|FG001|Double Blind Treatment|Confirmed metastasis|140|||
147543529|NCT02200614|532146341|FG000|Double Blind Treatment|Judgment of the investigator|59|||
147543530|NCT02200614|532146342|FG001|Double Blind Treatment|Judgment of the investigator|99|||
147543531|NCT02200614|532146341|FG000|Double Blind Treatment|Metastasis by local reading|1|||
147543532|NCT02200614|532146342|FG001|Double Blind Treatment|Metastasis by local reading|3|||
147543533|NCT02200614|532146341|FG000|Double Blind Treatment|Other reason|6|||
147543534|NCT02200614|532146342|FG001|Double Blind Treatment|Other reason|2|||
147543535|NCT02200614|532146341|FG000|Double Blind Treatment|Personal reason|77|||
147543536|NCT02200614|532146342|FG001|Double Blind Treatment|Personal reason|85|||
147543537|NCT02200614|532146341|FG000|Double Blind Treatment|Protocol deviation|14|||
147543538|NCT02200614|532146342|FG001|Double Blind Treatment|Protocol deviation|7|||
147543539|NCT02200614|532146341|FG000|Double Blind Treatment|Not treated|1|||
147543540|NCT02200614|532146342|FG001|Double Blind Treatment|Not treated|0|||
147543541|NCT02200614|532146341|FG000|Open Label|Adverse Event|41|||
147543542|NCT02200614|532146342|FG001|Open Label|Adverse Event|11|||
147543543|NCT02200614|532146341|FG000|Open Label|Confirmed metastasis|1|||
147543544|NCT02200614|532146342|FG001|Open Label|Confirmed metastasis|0|||
147543545|NCT02200614|532146341|FG000|Open Label|Judgment of the investigator|29|||
147543546|NCT02200614|532146342|FG001|Open Label|Judgment of the investigator|2|||
147543547|NCT02200614|532146341|FG000|Open Label|Metastasis by local reading|138|||
147543548|NCT02200614|532146342|FG001|Open Label|Metastasis by local reading|27|||
147543549|NCT02200614|532146341|FG000|Open Label|Other reason|22|||
147543550|NCT02200614|532146342|FG001|Open Label|Other reason|4|||
147543551|NCT02200614|532146341|FG000|Open Label|Personal reason|60|||
147543552|NCT02200614|532146342|FG001|Open Label|Personal reason|8|||
147543553|NCT02200614|532146341|FG000|Open Label|Protocol deviation|3|||
147543554|NCT02200614|532146342|FG001|Open Label|Protocol deviation|2|||
147543555|NCT02200614|532146341|FG000|Open Label|Missing|2|||
147543556|NCT02200614|532146342|FG001|Open Label|Missing|2|||
147543557|NCT01898884|532146343|FG000|Multiple Dose Period|Adverse Event|0|||
147543558|NCT01898884|532146344|FG001|Multiple Dose Period|Adverse Event|0|||
147543559|NCT01898884|532146345|FG002|Multiple Dose Period|Adverse Event|0|||
147543560|NCT01898884|532146346|FG003|Multiple Dose Period|Adverse Event|0|||
147543561|NCT01898884|532146347|FG004|Multiple Dose Period|Adverse Event|0|||
147543562|NCT01898884|532146348|FG005|Multiple Dose Period|Adverse Event|0|||
147543563|NCT01898884|532146349|FG006|Multiple Dose Period|Adverse Event|1|||
147543564|NCT01898884|532146350|FG007|Multiple Dose Period|Adverse Event|0|||
147543565|NCT01898884|532146351|FG008|Multiple Dose Period|Adverse Event|0|||
147543566|NCT01898884|532146343|FG000|Multiple Dose Period|Randomized Not Treated|0|||
147543567|NCT01898884|532146344|FG001|Multiple Dose Period|Randomized Not Treated|0|||
147543568|NCT01898884|532146345|FG002|Multiple Dose Period|Randomized Not Treated|0|||
147543569|NCT01898884|532146346|FG003|Multiple Dose Period|Randomized Not Treated|0|||
147543570|NCT01898884|532146347|FG004|Multiple Dose Period|Randomized Not Treated|0|||
147543571|NCT01898884|532146348|FG005|Multiple Dose Period|Randomized Not Treated|0|||
147543572|NCT01898884|532146349|FG006|Multiple Dose Period|Randomized Not Treated|0|||
147543573|NCT01898884|532146350|FG007|Multiple Dose Period|Randomized Not Treated|0|||
147543574|NCT01898884|532146351|FG008|Multiple Dose Period|Randomized Not Treated|1|||
147543575|NCT00434148|532146352|FG000|Overall Study|Adverse Event|18|||
147543576|NCT00434148|532146353|FG001|Overall Study|Adverse Event|18|||
147543577|NCT00434148|532146352|FG000|Overall Study|Lack of Efficacy|25|||
147543578|NCT00434148|532146353|FG001|Overall Study|Lack of Efficacy|28|||
147543579|NCT00434148|532146352|FG000|Overall Study|Withdrawal by Subject|15|||
147543580|NCT00434148|532146353|FG001|Overall Study|Withdrawal by Subject|15|||
147543581|NCT00434148|532146352|FG000|Overall Study|Protocol Violation|4|||
147543582|NCT00434148|532146353|FG001|Overall Study|Protocol Violation|0|||
147543583|NCT00434148|532146352|FG000|Overall Study|Administrative problems|6|||
147543584|NCT00434148|532146353|FG001|Overall Study|Administrative problems|10|||
147543585|NCT00434148|532146352|FG000|Overall Study|Lost to Follow-up|0|||
147543586|NCT00434148|532146353|FG001|Overall Study|Lost to Follow-up|1|||
147543587|NCT00434148|532146352|FG000|Overall Study|Condition no longer requires study drug|1|||
147543588|NCT00434148|532146353|FG001|Overall Study|Condition no longer requires study drug|0|||
147543589|NCT00434148|532146352|FG000|Overall Study|Abnormal test procedure result|0|||
147543590|NCT00434148|532146353|FG001|Overall Study|Abnormal test procedure result|1|||
147543591|NCT01142466|532148226|FG000|Overall Study|Adverse Event|2|||
147543592|NCT01142466|532148227|FG001|Overall Study|Adverse Event|1|||
147543593|NCT01142466|532148226|FG000|Overall Study|Withdrawal by Subject|1|||
147543594|NCT01142466|532148227|FG001|Overall Study|Withdrawal by Subject|1|||
147543595|NCT02414854|532148232|FG000|Overall Study|Adverse Event|9|||
147543596|NCT02414854|532148233|FG001|Overall Study|Adverse Event|7|||
147543597|NCT02414854|532148234|FG002|Overall Study|Adverse Event|1|||
147543598|NCT02414854|532148235|FG003|Overall Study|Adverse Event|12|||
147543599|NCT02414854|532148232|FG000|Overall Study|Poor compliance to protocol|1|||
147543600|NCT02414854|532148233|FG001|Overall Study|Poor compliance to protocol|1|||
147543601|NCT02414854|532148234|FG002|Overall Study|Poor compliance to protocol|2|||
147543602|NCT02414854|532148235|FG003|Overall Study|Poor compliance to protocol|2|||
147543603|NCT02414854|532148232|FG000|Overall Study|Other than specified above|12|||
147543604|NCT02414854|532148233|FG001|Overall Study|Other than specified above|37|||
147543605|NCT02414854|532148234|FG002|Overall Study|Other than specified above|17|||
147543606|NCT02414854|532148235|FG003|Overall Study|Other than specified above|37|||
147543607|NCT01355523|532148236|FG000|Overall Study|Withdrawal by Subject|1|||
147543608|NCT01355523|532148237|FG001|Overall Study|Withdrawal by Subject|4|||
147543609|NCT01355523|532148236|FG000|Overall Study|Lost to Follow-up|0|||
147543610|NCT01355523|532148237|FG001|Overall Study|Lost to Follow-up|2|||
147543611|NCT01355523|532148236|FG000|Overall Study|Protocol Violation|0|||
147543612|NCT01355523|532148237|FG001|Overall Study|Protocol Violation|2|||
147543613|NCT01355523|532148236|FG000|Overall Study|Adverse Event|0|||
147543614|NCT01355523|532148237|FG001|Overall Study|Adverse Event|2|||
147543615|NCT04575038|532148238|FG000|Overall Study|Withdrawal by Subject|1|||
147543616|NCT04575038|532148239|FG001|Overall Study|Withdrawal by Subject|1|||
147543617|NCT02766088|532148242|FG000|Overall Study|Sponsor study termination|498|||
147543618|NCT02766088|532148242|FG000|Overall Study|Migrated/moved from the study area|1|||
147543619|NCT02766088|532148242|FG000|Overall Study|Lost to Follow-up|5|||
147543620|NCT02766088|532148242|FG000|Overall Study|Other|1|||
147543621|NCT02766088|532148242|FG000|Overall Study|Death|1|||
147543622|NCT01222715|532148243|FG000|Overall Study|Adverse Event|0|||
147543623|NCT01222715|532148244|FG001|Overall Study|Adverse Event|4|||
147543624|NCT01222715|532148243|FG000|Overall Study|Death|0|||
147543625|NCT01222715|532148244|FG001|Overall Study|Death|1|||
147543626|NCT01222715|532148243|FG000|Overall Study|Lack of Efficacy|22|||
147543627|NCT01222715|532148244|FG001|Overall Study|Lack of Efficacy|14|||
147543628|NCT01222715|532148243|FG000|Overall Study|Physician Decision|12|||
147543629|NCT01222715|532148244|FG001|Overall Study|Physician Decision|2|||
147543630|NCT01222715|532148243|FG000|Overall Study|Refusal of further protocol therapy|0|||
147543631|NCT01222715|532148244|FG001|Overall Study|Refusal of further protocol therapy|4|||
147543632|NCT01222715|532148243|FG000|Overall Study|Pt cannot receive treatment for >9 wks|1|||
147543633|NCT01222715|532148244|FG001|Overall Study|Pt cannot receive treatment for >9 wks|1|||
147543634|NCT01222715|532148243|FG000|Overall Study|Ineligible|0|||
147543635|NCT01222715|532148244|FG001|Overall Study|Ineligible|1|||
147543636|NCT01222715|532148243|FG000|Overall Study|Surgery or radiation therapy in 1st 6 wk|1|||
147543637|NCT01222715|532148244|FG001|Overall Study|Surgery or radiation therapy in 1st 6 wk|0|||
147543638|NCT03555890|532148253|FG000|Part 2:Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
147543639|NCT03555890|532148254|FG001|Part 2:Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
147543640|NCT03555890|532148255|FG002|Part 2:Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
147543641|NCT03555890|532148256|FG003|Part 2:Washout Period (at Least 5 Days)|Withdrawal by Subject|1|||
147543642|NCT03372369|532148257|FG000|Qualification Period|Withdrawal by Subject|16|||
147543643|NCT03372369|532148258|FG001|Qualification Period|Withdrawal by Subject|13|||
147543644|NCT03372369|532148257|FG000|Qualification Period|Inconsistent Eligibility Results|10|||
147543645|NCT03372369|532148258|FG001|Qualification Period|Inconsistent Eligibility Results|9|||
147543646|NCT03372369|532148257|FG000|Intervention and Follow-Up Period|Withdrawal by Subject|3|||
147543647|NCT03372369|532148258|FG001|Intervention and Follow-Up Period|Withdrawal by Subject|3|||
147543648|NCT04682639|532148259|FG000|Double-Blind Treatment Period (24 Weeks)|Adverse Event|1|||
147543649|NCT04682639|532148260|FG001|Double-Blind Treatment Period (24 Weeks)|Adverse Event|0|||
147543650|NCT04682639|532148261|FG002|Double-Blind Treatment Period (24 Weeks)|Adverse Event|1|||
147543651|NCT04682639|532148262|FG003|Double-Blind Treatment Period (24 Weeks)|Adverse Event|0|||
147543652|NCT04682639|532148263|FG004|Double-Blind Treatment Period (24 Weeks)|Adverse Event|0|||
147543653|NCT04682639|532148259|FG000|Double-Blind Treatment Period (24 Weeks)|Withdrawal by Subject|5|||
147543654|NCT04682639|532148260|FG001|Double-Blind Treatment Period (24 Weeks)|Withdrawal by Subject|5|||
147543655|NCT04682639|532148261|FG002|Double-Blind Treatment Period (24 Weeks)|Withdrawal by Subject|2|||
147543656|NCT04682639|532148262|FG003|Double-Blind Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
147543657|NCT04682639|532148263|FG004|Double-Blind Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
147543658|NCT04682639|532148259|FG000|Double-Blind Treatment Period (24 Weeks)|Lost to Follow-up|2|||
147543659|NCT04682639|532148260|FG001|Double-Blind Treatment Period (24 Weeks)|Lost to Follow-up|1|||
147543660|NCT04682639|532148261|FG002|Double-Blind Treatment Period (24 Weeks)|Lost to Follow-up|0|||
147543661|NCT04682639|532148262|FG003|Double-Blind Treatment Period (24 Weeks)|Lost to Follow-up|0|||
147543662|NCT04682639|532148263|FG004|Double-Blind Treatment Period (24 Weeks)|Lost to Follow-up|0|||
147543663|NCT04682639|532148259|FG000|Double-Blind Treatment Period (24 Weeks)|Pregnancy|0|||
147543664|NCT04682639|532148260|FG001|Double-Blind Treatment Period (24 Weeks)|Pregnancy|1|||
147543665|NCT04682639|532148261|FG002|Double-Blind Treatment Period (24 Weeks)|Pregnancy|0|||
147543666|NCT04682639|532148262|FG003|Double-Blind Treatment Period (24 Weeks)|Pregnancy|0|||
147543667|NCT04682639|532148263|FG004|Double-Blind Treatment Period (24 Weeks)|Pregnancy|0|||
147543668|NCT04682639|532148259|FG000|Double-Blind Treatment Period (24 Weeks)|Non-compliance|2|||
147543669|NCT04682639|532148260|FG001|Double-Blind Treatment Period (24 Weeks)|Non-compliance|0|||
147543670|NCT04682639|532148261|FG002|Double-Blind Treatment Period (24 Weeks)|Non-compliance|0|||
147543671|NCT04682639|532148262|FG003|Double-Blind Treatment Period (24 Weeks)|Non-compliance|0|||
147543672|NCT04682639|532148263|FG004|Double-Blind Treatment Period (24 Weeks)|Non-compliance|0|||
147543673|NCT04682639|532148259|FG000|Double-Blind Treatment Period (24 Weeks)|Lack of Efficacy|1|||
147543674|NCT04682639|532148260|FG001|Double-Blind Treatment Period (24 Weeks)|Lack of Efficacy|1|||
147543675|NCT04682639|532148261|FG002|Double-Blind Treatment Period (24 Weeks)|Lack of Efficacy|1|||
147543676|NCT04682639|532148262|FG003|Double-Blind Treatment Period (24 Weeks)|Lack of Efficacy|0|||
147543677|NCT04682639|532148263|FG004|Double-Blind Treatment Period (24 Weeks)|Lack of Efficacy|0|||
147543678|NCT04682639|532148259|FG000|OLE Period (28 Weeks)|Non-compliance|1|||
147543679|NCT04682639|532148260|FG001|OLE Period (28 Weeks)|Non-compliance|0|||
147543680|NCT04682639|532148261|FG002|OLE Period (28 Weeks)|Non-compliance|0|||
147543681|NCT04682639|532148262|FG003|OLE Period (28 Weeks)|Non-compliance|0|||
147543682|NCT04682639|532148263|FG004|OLE Period (28 Weeks)|Non-compliance|1|||
147543683|NCT04682639|532148259|FG000|OLE Period (28 Weeks)|Other|1|||
147543684|NCT04682639|532148260|FG001|OLE Period (28 Weeks)|Other|2|||
147543685|NCT04682639|532148261|FG002|OLE Period (28 Weeks)|Other|0|||
147543686|NCT04682639|532148262|FG003|OLE Period (28 Weeks)|Other|0|||
147543687|NCT04682639|532148263|FG004|OLE Period (28 Weeks)|Other|1|||
147543688|NCT04682639|532148259|FG000|OLE Period (28 Weeks)|Lack of Efficacy|2|||
147543689|NCT04682639|532148260|FG001|OLE Period (28 Weeks)|Lack of Efficacy|1|||
147543690|NCT04682639|532148261|FG002|OLE Period (28 Weeks)|Lack of Efficacy|0|||
147543691|NCT04682639|532148262|FG003|OLE Period (28 Weeks)|Lack of Efficacy|0|||
147543692|NCT04682639|532148263|FG004|OLE Period (28 Weeks)|Lack of Efficacy|0|||
147543693|NCT04682639|532148259|FG000|OLE Period (28 Weeks)|Lost to Follow-up|1|||
147543694|NCT04682639|532148260|FG001|OLE Period (28 Weeks)|Lost to Follow-up|1|||
147543695|NCT04682639|532148261|FG002|OLE Period (28 Weeks)|Lost to Follow-up|0|||
147543696|NCT04682639|532148262|FG003|OLE Period (28 Weeks)|Lost to Follow-up|0|||
147543697|NCT04682639|532148263|FG004|OLE Period (28 Weeks)|Lost to Follow-up|0|||
147543698|NCT04682639|532148259|FG000|OLE Period (28 Weeks)|Withdrawal by Subject|1|||
147543699|NCT04682639|532148260|FG001|OLE Period (28 Weeks)|Withdrawal by Subject|3|||
147543700|NCT04682639|532148261|FG002|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
147543701|NCT04682639|532148262|FG003|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
147543702|NCT04682639|532148263|FG004|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
147543703|NCT04682639|532148259|FG000|OLE Period (28 Weeks)|Adverse Event|3|||
147543704|NCT04682639|532148260|FG001|OLE Period (28 Weeks)|Adverse Event|0|||
147543705|NCT04682639|532148261|FG002|OLE Period (28 Weeks)|Adverse Event|0|||
147543706|NCT04682639|532148262|FG003|OLE Period (28 Weeks)|Adverse Event|1|||
147543707|NCT04682639|532148263|FG004|OLE Period (28 Weeks)|Adverse Event|0|||
147543708|NCT01383954|532148264|FG000|Overall Study|Lack of Efficacy|2|||
147543709|NCT01383954|532148264|FG000|Overall Study|Electronic Diary Too Cumbersome to Use|2|||
147543710|NCT01383954|532148264|FG000|Overall Study|Adverse Event|1|||
147543711|NCT01383954|532148264|FG000|Overall Study|Reason Not Specified|9|||
147543712|NCT00763269|532148265|FG000|Overall Study|Lost to Follow-up|12|||
147543713|NCT00763269|532148266|FG001|Overall Study|Lost to Follow-up|13|||
147543714|NCT03471182|532148267|FG000|Overall Study|Withdrawal by Subject|1|||
147543715|NCT03471182|532148268|FG001|Overall Study|Withdrawal by Subject|1|||
147543716|NCT03471182|532148269|FG002|Overall Study|Withdrawal by Subject|0|||
147543717|NCT03471182|532148267|FG000|Overall Study|Technical failure|2|||
147543718|NCT03471182|532148268|FG001|Overall Study|Technical failure|0|||
147543719|NCT03471182|532148269|FG002|Overall Study|Technical failure|0|||
147543720|NCT04440163|532148272|FG000|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|26|||
147543721|NCT04440163|532148273|FG001|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|15|||
147543722|NCT04440163|532148274|FG002|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|42|||
147543723|NCT04440163|532148275|FG003|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|22|||
147543724|NCT04440163|532148276|FG004|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|30|||
147543725|NCT04440163|532148277|FG005|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|3|||
147543726|NCT04440163|532148278|FG006|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|18|||
147543727|NCT04440163|532148279|FG007|Vaccination Phase (Approx. 7 Months)|Lost to Follow-up|5|||
147543728|NCT04440163|532148272|FG000|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
147543729|NCT04440163|532148273|FG001|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
147543730|NCT04440163|532148274|FG002|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
147543731|NCT04440163|532148275|FG003|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|1|||
147543732|NCT04440163|532148276|FG004|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|1|||
147543733|NCT04440163|532148277|FG005|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
147543734|NCT04440163|532148278|FG006|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
147543735|NCT04440163|532148279|FG007|Vaccination Phase (Approx. 7 Months)|Medication error without associated adverse event|0|||
147543736|NCT04440163|532148272|FG000|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|5|||
147543737|NCT04440163|532148273|FG001|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|1|||
147543738|NCT04440163|532148274|FG002|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|5|||
147543739|NCT04440163|532148275|FG003|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|2|||
147543740|NCT04440163|532148276|FG004|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|3|||
147543741|NCT04440163|532148277|FG005|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|0|||
147543742|NCT04440163|532148278|FG006|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|2|||
147543743|NCT04440163|532148279|FG007|Vaccination Phase (Approx. 7 Months)|No longer met eligibility criteria|3|||
147543744|NCT04440163|532148272|FG000|Vaccination Phase (Approx. 7 Months)|Pregnancy|1|||
147543745|NCT04440163|532148273|FG001|Vaccination Phase (Approx. 7 Months)|Pregnancy|0|||
147543746|NCT04440163|532148274|FG002|Vaccination Phase (Approx. 7 Months)|Pregnancy|2|||
147543747|NCT04440163|532148275|FG003|Vaccination Phase (Approx. 7 Months)|Pregnancy|0|||
147543748|NCT04440163|532148276|FG004|Vaccination Phase (Approx. 7 Months)|Pregnancy|1|||
147543749|NCT04440163|532148277|FG005|Vaccination Phase (Approx. 7 Months)|Pregnancy|0|||
147543750|NCT04440163|532148278|FG006|Vaccination Phase (Approx. 7 Months)|Pregnancy|0|||
147543751|NCT04440163|532148279|FG007|Vaccination Phase (Approx. 7 Months)|Pregnancy|0|||
147543752|NCT04440163|532148272|FG000|Vaccination Phase (Approx. 7 Months)|Protocol Violation|1|||
147543753|NCT04440163|532148273|FG001|Vaccination Phase (Approx. 7 Months)|Protocol Violation|0|||
147543754|NCT04440163|532148274|FG002|Vaccination Phase (Approx. 7 Months)|Protocol Violation|5|||
147543755|NCT04440163|532148275|FG003|Vaccination Phase (Approx. 7 Months)|Protocol Violation|3|||
147543756|NCT04440163|532148276|FG004|Vaccination Phase (Approx. 7 Months)|Protocol Violation|0|||
147543757|NCT04440163|532148277|FG005|Vaccination Phase (Approx. 7 Months)|Protocol Violation|0|||
147543758|NCT04440163|532148278|FG006|Vaccination Phase (Approx. 7 Months)|Protocol Violation|3|||
147543759|NCT04440163|532148279|FG007|Vaccination Phase (Approx. 7 Months)|Protocol Violation|0|||
147543760|NCT04440163|532148272|FG000|Vaccination Phase (Approx. 7 Months)|Other|0|||
147543761|NCT04440163|532148273|FG001|Vaccination Phase (Approx. 7 Months)|Other|0|||
147543762|NCT04440163|532148274|FG002|Vaccination Phase (Approx. 7 Months)|Other|3|||
147543763|NCT04440163|532148275|FG003|Vaccination Phase (Approx. 7 Months)|Other|2|||
147543764|NCT04440163|532148276|FG004|Vaccination Phase (Approx. 7 Months)|Other|0|||
147543765|NCT04440163|532148277|FG005|Vaccination Phase (Approx. 7 Months)|Other|1|||
147543766|NCT04440163|532148278|FG006|Vaccination Phase (Approx. 7 Months)|Other|0|||
147543767|NCT04440163|532148279|FG007|Vaccination Phase (Approx. 7 Months)|Other|1|||
147543768|NCT04440163|532148272|FG000|Vaccination Phase (Approx. 7 Months)|Adverse Event|3|||
147543769|NCT04440163|532148273|FG001|Vaccination Phase (Approx. 7 Months)|Adverse Event|1|||
147543770|NCT04440163|532148274|FG002|Vaccination Phase (Approx. 7 Months)|Adverse Event|0|||
147543771|NCT04440163|532148275|FG003|Vaccination Phase (Approx. 7 Months)|Adverse Event|1|||
147543772|NCT04440163|532148276|FG004|Vaccination Phase (Approx. 7 Months)|Adverse Event|0|||
147543773|NCT04440163|532148277|FG005|Vaccination Phase (Approx. 7 Months)|Adverse Event|0|||
147543774|NCT04440163|532148278|FG006|Vaccination Phase (Approx. 7 Months)|Adverse Event|0|||
147543775|NCT04440163|532148279|FG007|Vaccination Phase (Approx. 7 Months)|Adverse Event|0|||
147543776|NCT04440163|532148272|FG000|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|11|||
147543777|NCT04440163|532148273|FG001|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|5|||
147543778|NCT04440163|532148274|FG002|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|18|||
147543779|NCT04440163|532148275|FG003|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|14|||
147543780|NCT04440163|532148276|FG004|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|10|||
147543781|NCT04440163|532148277|FG005|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|3|||
147543782|NCT04440163|532148278|FG006|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|5|||
147543783|NCT04440163|532148279|FG007|Vaccination Phase (Approx. 7 Months)|Withdrawal by Subject|4|||
147543784|NCT04440163|532148272|FG000|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|10|||
147543785|NCT04440163|532148273|FG001|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|4|||
147543786|NCT04440163|532148274|FG002|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|11|||
147543787|NCT04440163|532148275|FG003|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|7|||
147543788|NCT04440163|532148276|FG004|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|16|||
147543789|NCT04440163|532148277|FG005|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|4|||
147543790|NCT04440163|532148278|FG006|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|3|||
147543791|NCT04440163|532148279|FG007|Vaccination Phase (Approx. 7 Months)|Withdrawal by parent/guardian|2|||
147543792|NCT04440163|532148272|FG000|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|5|||
147543793|NCT04440163|532148273|FG001|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|2|||
147543794|NCT04440163|532148274|FG002|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|2|||
147543795|NCT04440163|532148275|FG003|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|0|||
147543796|NCT04440163|532148276|FG004|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|7|||
147543797|NCT04440163|532148277|FG005|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|1|||
147543798|NCT04440163|532148278|FG006|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|1|||
147543799|NCT04440163|532148279|FG007|Vaccination Phase (Approx. 7 Months)|Withdrawn before vaccination|0|||
147543800|NCT04440163|532148272|FG000|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|3|||
147543801|NCT04440163|532148273|FG001|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|5|||
147543802|NCT04440163|532148274|FG002|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|0|||
147543803|NCT04440163|532148275|FG003|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|0|||
147543804|NCT04440163|532148276|FG004|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|1|||
147543805|NCT04440163|532148277|FG005|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|0|||
147543806|NCT04440163|532148278|FG006|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|2|||
147543807|NCT04440163|532148279|FG007|Follow-up Phase (Approx. 5 Months)|Lost to Follow-up|1|||
147543808|NCT04440163|532148272|FG000|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
147543809|NCT04440163|532148273|FG001|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
147543810|NCT04440163|532148274|FG002|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
147543811|NCT04440163|532148275|FG003|Follow-up Phase (Approx. 5 Months)|Protocol Violation|1|||
147543812|NCT04440163|532148276|FG004|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
147543813|NCT04440163|532148277|FG005|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
147543814|NCT04440163|532148278|FG006|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
147543815|NCT04440163|532148279|FG007|Follow-up Phase (Approx. 5 Months)|Protocol Violation|0|||
147543816|NCT00068406|532148282|FG000|Overall Study|Ineligible-improper pre-protocol treatm|1|||
147543817|NCT00068406|532148282|FG000|Overall Study|Ineligible-Inadequate Pathology|2|||
147543818|NCT02018042|532148283|FG000|Overall Study|Withdrawal by Subject|1|||
147543819|NCT01850108|532148287|FG000|Overall Study|Lost to Follow-up|4|||
147543820|NCT01850108|532148287|FG000|Overall Study|Not eligible|1|||
147543821|NCT01850108|532148287|FG000|Overall Study|Failed engraftment|2|||
147543822|NCT01850108|532148287|FG000|Overall Study|Physician Decision|1|||
147543823|NCT03273712|532148291|FG000|Overall Study|Death|5|||
147543824|NCT03273712|532148291|FG000|Overall Study|Adverse Event|1|||
147543825|NCT03273712|532148291|FG000|Overall Study|Disease Progression|1|||
147543826|NCT00666718|532148293|FG000|Overall Study|Adverse Event|0|||
147543827|NCT00666718|532148294|FG001|Overall Study|Adverse Event|1|||
147543828|NCT00666718|532148293|FG000|Overall Study|Death|1|||
147543829|NCT00666718|532148294|FG001|Overall Study|Death|0|||
147543830|NCT00666718|532148293|FG000|Overall Study|Lost to Follow-up|1|||
147543831|NCT00666718|532148294|FG001|Overall Study|Lost to Follow-up|0|||
147543832|NCT00666718|532148293|FG000|Overall Study|Entry Criteria Not Met|2|||
147543833|NCT00666718|532148294|FG001|Overall Study|Entry Criteria Not Met|0|||
147543834|NCT00666718|532148293|FG000|Overall Study|Protocol Violation|1|||
147543835|NCT00666718|532148294|FG001|Overall Study|Protocol Violation|3|||
147543836|NCT00666718|532148293|FG000|Overall Study|Withdrawal by Subject|7|||
147543837|NCT00666718|532148294|FG001|Overall Study|Withdrawal by Subject|12|||
147543838|NCT00666718|532148293|FG000|Overall Study|Physician Decision|0|||
147543839|NCT00666718|532148294|FG001|Overall Study|Physician Decision|2|||
147543840|NCT00963599|532148295|FG000|Overall Study|Adverse Event|2|||
147543841|NCT00963599|532148296|FG001|Overall Study|Adverse Event|0|||
147543842|NCT00963599|532148297|FG002|Overall Study|Adverse Event|1|||
147543843|NCT00963599|532148298|FG003|Overall Study|Adverse Event|2|||
147543844|NCT00963599|532148295|FG000|Overall Study|Lack of Efficacy|0|||
147543845|NCT00963599|532148296|FG001|Overall Study|Lack of Efficacy|2|||
147543846|NCT00963599|532148297|FG002|Overall Study|Lack of Efficacy|1|||
147543847|NCT00963599|532148298|FG003|Overall Study|Lack of Efficacy|4|||
147543848|NCT00963599|532148295|FG000|Overall Study|Lost to Follow-up|0|||
147543849|NCT00963599|532148296|FG001|Overall Study|Lost to Follow-up|1|||
147543850|NCT00963599|532148297|FG002|Overall Study|Lost to Follow-up|1|||
147543851|NCT00963599|532148298|FG003|Overall Study|Lost to Follow-up|1|||
147543852|NCT00963599|532148295|FG000|Overall Study|Protocol Violation|2|||
147543853|NCT00963599|532148296|FG001|Overall Study|Protocol Violation|2|||
147543854|NCT00963599|532148297|FG002|Overall Study|Protocol Violation|3|||
147543855|NCT00963599|532148298|FG003|Overall Study|Protocol Violation|4|||
147543856|NCT00963599|532148295|FG000|Overall Study|Withdrawal by Subject|2|||
147543857|NCT00963599|532148296|FG001|Overall Study|Withdrawal by Subject|1|||
147543858|NCT00963599|532148297|FG002|Overall Study|Withdrawal by Subject|3|||
147543859|NCT00963599|532148298|FG003|Overall Study|Withdrawal by Subject|3|||
147543860|NCT00190684|532148306|FG000|Overall Study|Adverse Event|86|||
147543861|NCT00190684|532148306|FG000|Overall Study|Satisfactory response|80|||
147543862|NCT00190684|532148306|FG000|Overall Study|Lack of efficacy|204|||
147543863|NCT00190684|532148306|FG000|Overall Study|Lost to Follow-up|232|||
147543864|NCT00190684|532148306|FG000|Overall Study|Patient moved|60|||
147543865|NCT00190684|532148306|FG000|Overall Study|Patient Decision|432|||
147543866|NCT00190684|532148306|FG000|Overall Study|Clinical relapse|67|||
147543867|NCT00190684|532148306|FG000|Overall Study|Sponsor's decision|17|||
147543868|NCT00190684|532148306|FG000|Overall Study|Physician Decision|84|||
147543869|NCT00190684|532148306|FG000|Overall Study|Protocol Violation|123|||
147543870|NCT00190684|532148306|FG000|Overall Study|Study Period III Completed|103|||
147543871|NCT00190684|532148306|FG000|Overall Study|Study Period V Completed|1|||
147543872|NCT03496207|532148307|FG000|Base Study|Adverse Event|0|||
147543873|NCT03496207|532148308|FG001|Base Study|Adverse Event|0|||
147543874|NCT03496207|532148309|FG002|Base Study|Adverse Event|1|||
147543875|NCT03496207|532148310|FG003|Base Study|Adverse Event|1|||
147543876|NCT03496207|532148311|FG004|Base Study|Adverse Event|4|||
147543877|NCT03496207|532148307|FG000|Base Study|Death|0|||
147543878|NCT03496207|532148308|FG001|Base Study|Death|0|||
147543879|NCT03496207|532148309|FG002|Base Study|Death|0|||
147543880|NCT03496207|532148310|FG003|Base Study|Death|0|||
147543881|NCT03496207|532148311|FG004|Base Study|Death|1|||
147543882|NCT03496207|532148307|FG000|Base Study|Withdrawal by Subject|0|||
147543883|NCT03496207|532148308|FG001|Base Study|Withdrawal by Subject|0|||
147543884|NCT03496207|532148309|FG002|Base Study|Withdrawal by Subject|1|||
147543885|NCT03496207|532148310|FG003|Base Study|Withdrawal by Subject|0|||
147543886|NCT03496207|532148311|FG004|Base Study|Withdrawal by Subject|1|||
147543887|NCT03496207|532148307|FG000|Extension Period|Adverse Event|0|||
147543888|NCT03496207|532148308|FG001|Extension Period|Adverse Event|0|||
147543889|NCT03496207|532148309|FG002|Extension Period|Adverse Event|0|||
147543890|NCT03496207|532148310|FG003|Extension Period|Adverse Event|1|||
147543891|NCT03496207|532148311|FG004|Extension Period|Adverse Event|1|||
147543892|NCT03496207|532148307|FG000|Extension Period|Death|1|||
147543893|NCT03496207|532148308|FG001|Extension Period|Death|0|||
147543894|NCT03496207|532148309|FG002|Extension Period|Death|0|||
147543895|NCT03496207|532148310|FG003|Extension Period|Death|1|||
147543896|NCT03496207|532148311|FG004|Extension Period|Death|2|||
147543897|NCT03496207|532148307|FG000|Extension Period|Withdrawal by Subject|1|||
147543898|NCT03496207|532148308|FG001|Extension Period|Withdrawal by Subject|0|||
147543899|NCT03496207|532148309|FG002|Extension Period|Withdrawal by Subject|0|||
147543900|NCT03496207|532148310|FG003|Extension Period|Withdrawal by Subject|1|||
147543901|NCT03496207|532148311|FG004|Extension Period|Withdrawal by Subject|1|||
147543902|NCT03496207|532148307|FG000|Extension Period|Elevated hemoglobin levels|0|||
147543903|NCT03496207|532148308|FG001|Extension Period|Elevated hemoglobin levels|0|||
147543904|NCT03496207|532148309|FG002|Extension Period|Elevated hemoglobin levels|0|||
147543905|NCT03496207|532148310|FG003|Extension Period|Elevated hemoglobin levels|0|||
147543906|NCT03496207|532148311|FG004|Extension Period|Elevated hemoglobin levels|1|||
147543907|NCT00068445|532148312|FG000|Randomization|Cancel|1|||
147543908|NCT00068445|532148313|FG001|Randomization|Cancel|3|||
147543909|NCT00068445|532148312|FG000|Randomization|Ineligible|1|||
147543910|NCT00068445|532148313|FG001|Randomization|Ineligible|1|||
147543911|NCT00068445|532148312|FG000|Treatment|Refused Further Treatment|13|||
147543912|NCT00068445|532148313|FG001|Treatment|Refused Further Treatment|10|||
147543913|NCT00068445|532148312|FG000|Treatment|Adverse Event|7|||
147543914|NCT00068445|532148313|FG001|Treatment|Adverse Event|1|||
147543915|NCT00068445|532148312|FG000|Treatment|Other (Specifics not available)|9|||
147543916|NCT00068445|532148313|FG001|Treatment|Other (Specifics not available)|5|||
147543917|NCT01155284|532148314|FG000|Overall Study|Withdrawal by Subject|4|||
147543918|NCT01155284|532148315|FG001|Overall Study|Withdrawal by Subject|3|||
147543919|NCT01155284|532148314|FG000|Overall Study|Lost to Follow-up|1|||
147543920|NCT01155284|532148315|FG001|Overall Study|Lost to Follow-up|2|||
147543921|NCT01155284|532148314|FG000|Overall Study|Physician Decision|1|||
147543922|NCT01155284|532148315|FG001|Overall Study|Physician Decision|0|||
147543923|NCT01155284|532148314|FG000|Overall Study|Adverse Event|1|||
147543924|NCT01155284|532148315|FG001|Overall Study|Adverse Event|0|||
147543925|NCT01896700|532148316|FG000|Overall Study|Adverse Event|4|||
147543926|NCT01896700|532148317|FG001|Overall Study|Adverse Event|5|||
147543927|NCT01896700|532148316|FG000|Overall Study|Withdrawal by Subject|0|||
147543928|NCT01896700|532148317|FG001|Overall Study|Withdrawal by Subject|1|||
147543929|NCT00123487|532148318|FG000|Randomized|Death prior to starting treatment|0|||
147543930|NCT00123487|532148319|FG001|Randomized|Death prior to starting treatment|1|||
147543931|NCT00123487|532148318|FG000|Randomized|SAE prior to starting treatment|1|||
147543932|NCT00123487|532148319|FG001|Randomized|SAE prior to starting treatment|0|||
147543933|NCT00123487|532148318|FG000|Treated With Study Drug|Adverse Event|23|||
147543934|NCT00123487|532148319|FG001|Treated With Study Drug|Adverse Event|22|||
147543935|NCT00123487|532148318|FG000|Treated With Study Drug|Disease Progression|141|||
147543936|NCT00123487|532148319|FG001|Treated With Study Drug|Disease Progression|122|||
147543937|NCT00123487|532148318|FG000|Treated With Study Drug|Physician Decision|8|||
147543938|NCT00123487|532148319|FG001|Treated With Study Drug|Physician Decision|9|||
147543939|NCT00123487|532148318|FG000|Treated With Study Drug|Other|59|||
147543940|NCT00123487|532148319|FG001|Treated With Study Drug|Other|58|||
147543941|NCT00123487|532148318|FG000|Treated With Study Drug|Study Drug Toxicity|62|||
147543942|NCT00123487|532148319|FG001|Treated With Study Drug|Study Drug Toxicity|80|||
147543943|NCT00123487|532148318|FG000|Treated With Study Drug|Withdrawal by Subject|11|||
147543944|NCT00123487|532148319|FG001|Treated With Study Drug|Withdrawal by Subject|13|||
147543945|NCT00123487|532148318|FG000|Treated With Study Drug|Unknown (case report form lost)|0|||
147543946|NCT00123487|532148319|FG001|Treated With Study Drug|Unknown (case report form lost)|1|||
147543947|NCT00423488|532148320|FG000|Overall Study|No evidence of study drug intake|2|||
147543948|NCT00423488|532148321|FG001|Overall Study|No evidence of study drug intake|1|||
147543949|NCT00423488|532148320|FG000|Overall Study|No post baseline data|3|||
147543950|NCT00423488|532148321|FG001|Overall Study|No post baseline data|0|||
147543951|NCT00886782|532148322|FG000|Overall Study|Disease progression|3|||
147543952|NCT00886782|532148323|FG001|Overall Study|Disease progression|3|||
147543953|NCT00886782|532148324|FG002|Overall Study|Disease progression|3|||
147543954|NCT00886782|532148322|FG000|Overall Study|Study drug toxicity|0|||
147543955|NCT00886782|532148323|FG001|Overall Study|Study drug toxicity|0|||
147543956|NCT00886782|532148324|FG002|Overall Study|Study drug toxicity|1|||
147543957|NCT00886782|532148322|FG000|Overall Study|Adverse event unrelated to Study drug|0|||
147543958|NCT00886782|532148323|FG001|Overall Study|Adverse event unrelated to Study drug|0|||
147543959|NCT00886782|532148324|FG002|Overall Study|Adverse event unrelated to Study drug|1|||
147543960|NCT01255722|532148325|FG000|Overall Study|Adverse Event|0|||
147210753|NCT00727441|530945350|FG001|Overall Study|Physician Decision|1|||
147210754|NCT00727441|530945351|FG002|Overall Study|Physician Decision|0|||
147441111|NCT03227471|531780769|FG007|Overall Study|Randomized, Never Dosed|0|||
147441112|NCT03227471|531780770|FG008|Overall Study|Randomized, Never Dosed|0|||
147441113|NCT03227471|531780771|FG009|Overall Study|Randomized, Never Dosed|0|||
147441114|NCT03227471|531780772|FG010|Overall Study|Randomized, Never Dosed|0|||
147441115|NCT03227471|531780773|FG011|Overall Study|Randomized, Never Dosed|0|||
147441116|NCT03227471|531780774|FG012|Overall Study|Randomized, Never Dosed|0|||
147441117|NCT03227471|531780775|FG013|Overall Study|Randomized, Never Dosed|0|||
147441118|NCT03227471|531780776|FG014|Overall Study|Randomized, Never Dosed|1|||
147441119|NCT02322125|531780777|FG000|Overall Study|Withdrawal by Subject|2|||
147441120|NCT00766038|531780783|FG000|Overall Study|Lost to Follow-up|15|||
147441121|NCT00766038|531780784|FG001|Overall Study|Lost to Follow-up|14|||
147441122|NCT04183790|531780785|FG000|Overall Study|Participants did not rollover to Part B|12|||
147441123|NCT04183790|531780786|FG001|Overall Study|Participants did not rollover to Part B|0|||
147441124|NCT04183790|531780785|FG000|Overall Study|Withdrawal of consent (not due to AE)|6|||
147441125|NCT04183790|531780786|FG001|Overall Study|Withdrawal of consent (not due to AE)|0|||
147441126|NCT04183790|531780785|FG000|Overall Study|Commercial drug is available for participant|6|||
147441127|NCT04183790|531780786|FG001|Overall Study|Commercial drug is available for participant|0|||
147441128|NCT04183790|531780785|FG000|Overall Study|Adverse Event|1|||
147441129|NCT04183790|531780786|FG001|Overall Study|Adverse Event|0|||
147441130|NCT04183790|531780785|FG000|Overall Study|Not enrolled in 107 study|0|||
147441131|NCT04183790|531780786|FG001|Overall Study|Not enrolled in 107 study|2|||
147441132|NCT01524198|531780787|FG000|Overall Study|Protocol Violation|8|||
147441133|NCT01524198|531780788|FG001|Overall Study|Protocol Violation|6|||
147441134|NCT01524198|531780787|FG000|Overall Study|Withdrawal by Subject|15|||
147441135|NCT01524198|531780788|FG001|Overall Study|Withdrawal by Subject|10|||
147441136|NCT01462435|531780790|FG000|Overall Study|Lack of Efficacy|1|||
147441137|NCT01462435|531780791|FG001|Overall Study|Lack of Efficacy|0|||
147441138|NCT01462435|531780792|FG002|Overall Study|Lack of Efficacy|0|||
147441139|NCT01462435|531780793|FG003|Overall Study|Lack of Efficacy|3|||
147441140|NCT01462435|531780790|FG000|Overall Study|Physician Decision|0|||
147441141|NCT01462435|531780791|FG001|Overall Study|Physician Decision|0|||
147441142|NCT01462435|531780792|FG002|Overall Study|Physician Decision|1|||
147441143|NCT01462435|531780793|FG003|Overall Study|Physician Decision|0|||
147441144|NCT01462435|531780790|FG000|Overall Study|Withdrawal by Subject|0|||
147441145|NCT01462435|531780791|FG001|Overall Study|Withdrawal by Subject|0|||
147441146|NCT01462435|531780792|FG002|Overall Study|Withdrawal by Subject|0|||
147441147|NCT01462435|531780793|FG003|Overall Study|Withdrawal by Subject|1|||
147441148|NCT01462435|531780790|FG000|Overall Study|Lost to Follow-up|0|||
147441149|NCT01462435|531780791|FG001|Overall Study|Lost to Follow-up|0|||
147441150|NCT01462435|531780792|FG002|Overall Study|Lost to Follow-up|0|||
147441151|NCT01462435|531780793|FG003|Overall Study|Lost to Follow-up|1|||
147441152|NCT01543152|531780796|FG000|Overall Study|Withdrawal by Subject|0|||
147441153|NCT01543152|531780797|FG001|Overall Study|Withdrawal by Subject|2|||
147441154|NCT01543152|531780798|FG002|Overall Study|Withdrawal by Subject|0|||
147441155|NCT01543152|531780799|FG003|Overall Study|Withdrawal by Subject|0|||
147441156|NCT01543152|531780800|FG004|Overall Study|Withdrawal by Subject|0|||
147441157|NCT02053168|531780803|FG000|Overall Study|Withdrawal by Subject|1|||
147441158|NCT02053168|531780803|FG000|Overall Study|Physician Decision|1|||
147441159|NCT02053168|531780803|FG000|Overall Study|Lost to Follow-up|1|||
147441160|NCT02687542|531780805|FG000|Overall Study|Medication error without associated AEs|0|||
147441161|NCT02687542|531780806|FG001|Overall Study|Medication error without associated AEs|0|||
147441162|NCT02687542|531780807|FG002|Overall Study|Medication error without associated AEs|0|||
147441163|NCT02687542|531780808|FG003|Overall Study|Medication error without associated AEs|0|||
147441164|NCT02687542|531780809|FG004|Overall Study|Medication error without associated AEs|1|||
147441165|NCT02687542|531780805|FG000|Overall Study|Lost to Follow-up|0|||
147441166|NCT02687542|531780806|FG001|Overall Study|Lost to Follow-up|0|||
147441167|NCT02687542|531780807|FG002|Overall Study|Lost to Follow-up|0|||
147441168|NCT02687542|531780808|FG003|Overall Study|Lost to Follow-up|0|||
147441169|NCT02687542|531780809|FG004|Overall Study|Lost to Follow-up|1|||
147441170|NCT02687542|531780805|FG000|Overall Study|Protocol Violation|0|||
147441171|NCT02687542|531780806|FG001|Overall Study|Protocol Violation|1|||
147441172|NCT02687542|531780807|FG002|Overall Study|Protocol Violation|0|||
147441173|NCT02687542|531780808|FG003|Overall Study|Protocol Violation|0|||
147441174|NCT02687542|531780809|FG004|Overall Study|Protocol Violation|0|||
147441175|NCT02687542|531780805|FG000|Overall Study|Other|5|||
147441176|NCT02687542|531780806|FG001|Overall Study|Other|9|||
147441177|NCT02687542|531780807|FG002|Overall Study|Other|10|||
147441178|NCT02687542|531780808|FG003|Overall Study|Other|6|||
147441179|NCT02687542|531780809|FG004|Overall Study|Other|5|||
147441180|NCT02687542|531780805|FG000|Overall Study|Adverse Event|3|||
147441181|NCT02687542|531780806|FG001|Overall Study|Adverse Event|1|||
147441182|NCT02687542|531780807|FG002|Overall Study|Adverse Event|3|||
147441183|NCT02687542|531780808|FG003|Overall Study|Adverse Event|2|||
147441184|NCT02687542|531780809|FG004|Overall Study|Adverse Event|9|||
147441185|NCT02687542|531780805|FG000|Overall Study|Withdrawal by Subject|0|||
147441186|NCT02687542|531780806|FG001|Overall Study|Withdrawal by Subject|1|||
147441187|NCT02687542|531780807|FG002|Overall Study|Withdrawal by Subject|1|||
147441188|NCT02687542|531780808|FG003|Overall Study|Withdrawal by Subject|2|||
147441189|NCT02687542|531780809|FG004|Overall Study|Withdrawal by Subject|4|||
147441190|NCT00636675|531780810|FG000|Overall Study|Lost to Follow-up|121|||
147441191|NCT00636675|531780811|FG001|Overall Study|Lost to Follow-up|31|||
147441192|NCT00636675|531780810|FG000|Overall Study|Withdrawal by Subject|19|||
147441193|NCT00636675|531780811|FG001|Overall Study|Withdrawal by Subject|10|||
147441194|NCT01838616|531780812|FG000|Titration Period|Adverse Event|18|||
147441195|NCT01838616|531780813|FG001|Titration Period|Adverse Event|48|||
147441196|NCT01838616|531780812|FG000|Titration Period|Lack of Efficacy|5|||
147441197|NCT01838616|531780813|FG001|Titration Period|Lack of Efficacy|12|||
147441198|NCT01838616|531780812|FG000|Titration Period|Withdrawal by Subject|5|||
147441199|NCT01838616|531780813|FG001|Titration Period|Withdrawal by Subject|5|||
147441200|NCT01838616|531780812|FG000|Titration Period|Technical problems|1|||
147441201|NCT01838616|531780813|FG001|Titration Period|Technical problems|0|||
147441202|NCT01838616|531780812|FG000|Titration Period|Other|1|||
147441203|NCT01838616|531780813|FG001|Titration Period|Other|0|||
147441204|NCT01838616|531780812|FG000|Titration Period|Protocol Violation|0|||
147441205|NCT01838616|531780813|FG001|Titration Period|Protocol Violation|1|||
147441206|NCT01838616|531780812|FG000|Continuation Period|Lack of Efficacy|3|||
147441207|NCT01838616|531780813|FG001|Continuation Period|Lack of Efficacy|5|||
147441208|NCT01838616|531780812|FG000|Continuation Period|Adverse Event|8|||
147441209|NCT01838616|531780813|FG001|Continuation Period|Adverse Event|4|||
147441210|NCT01838616|531780812|FG000|Continuation Period|Protocol Violation|2|||
147441211|NCT01838616|531780813|FG001|Continuation Period|Protocol Violation|0|||
147441212|NCT01838616|531780812|FG000|Continuation Period|Lost to Follow-up|1|||
147441213|NCT01838616|531780813|FG001|Continuation Period|Lost to Follow-up|0|||
147441214|NCT01838616|531780812|FG000|Continuation Period|Withdrawal by Subject|0|||
147441215|NCT01838616|531780813|FG001|Continuation Period|Withdrawal by Subject|4|||
147441216|NCT01838616|531780812|FG000|Continuation Period|Technical problems|0|||
147441217|NCT01838616|531780813|FG001|Continuation Period|Technical problems|1|||
147543961|NCT01255722|532148326|FG001|Overall Study|Adverse Event|1|||
147543962|NCT01255722|532148327|FG002|Overall Study|Adverse Event|1|||
147543963|NCT01255722|532148325|FG000|Overall Study|asymptomatic patient|1|||
147543964|NCT01255722|532148326|FG001|Overall Study|asymptomatic patient|0|||
147543965|NCT01255722|532148327|FG002|Overall Study|asymptomatic patient|0|||
147543966|NCT01255722|532148325|FG000|Overall Study|beta-blocker contraindicated|2|||
147543967|NCT01255722|532148326|FG001|Overall Study|beta-blocker contraindicated|0|||
147543968|NCT01255722|532148327|FG002|Overall Study|beta-blocker contraindicated|0|||
147543969|NCT03835975|532148330|FG000|Overall Study|Lost to Follow-up|1|||
147543970|NCT03835975|532148331|FG001|Overall Study|Lost to Follow-up|1|||
147543971|NCT03835975|532148332|FG002|Overall Study|Lost to Follow-up|0|||
147441218|NCT01838616|531780812|FG000|Pick-up Arm|Lack of Efficacy|4|||
147441219|NCT01838616|531780813|FG001|Pick-up Arm|Lack of Efficacy|0|||
147441220|NCT01838616|531780812|FG000|Pick-up Arm|Adverse Event|9|||
147441221|NCT01838616|531780813|FG001|Pick-up Arm|Adverse Event|0|||
147441222|NCT01838616|531780812|FG000|Pick-up Arm|Withdrawal by Subject|1|||
147441223|NCT01838616|531780813|FG001|Pick-up Arm|Withdrawal by Subject|0|||
147441224|NCT01838616|531780812|FG000|Pick-up Arm|Technical problems|1|||
147441225|NCT01838616|531780813|FG001|Pick-up Arm|Technical problems|0|||
147441226|NCT01007032|531780814|FG000|Overall Study|On Study Treatment at Cut-off Date|0|||
147543972|NCT03835975|532148333|FG003|Overall Study|Lost to Follow-up|0|||
147543973|NCT03835975|532148334|FG004|Overall Study|Lost to Follow-up|0|||
147543974|NCT03835975|532148330|FG000|Overall Study|No longer met eligibility criteria|0|||
147543975|NCT03835975|532148331|FG001|Overall Study|No longer met eligibility criteria|1|||
147543976|NCT03835975|532148332|FG002|Overall Study|No longer met eligibility criteria|0|||
147543977|NCT03835975|532148333|FG003|Overall Study|No longer met eligibility criteria|0|||
147543978|NCT03835975|532148334|FG004|Overall Study|No longer met eligibility criteria|0|||
147543979|NCT03835975|532148330|FG000|Overall Study|Protocol Violation|1|||
147543980|NCT03835975|532148331|FG001|Overall Study|Protocol Violation|1|||
147543981|NCT03835975|532148332|FG002|Overall Study|Protocol Violation|2|||
147543982|NCT03835975|532148333|FG003|Overall Study|Protocol Violation|0|||
147543983|NCT03835975|532148334|FG004|Overall Study|Protocol Violation|0|||
147543984|NCT03835975|532148330|FG000|Overall Study|Withdrawal by Subject|1|||
147543985|NCT03835975|532148331|FG001|Overall Study|Withdrawal by Subject|0|||
147543986|NCT03835975|532148332|FG002|Overall Study|Withdrawal by Subject|1|||
147543987|NCT03835975|532148333|FG003|Overall Study|Withdrawal by Subject|1|||
147543988|NCT03835975|532148334|FG004|Overall Study|Withdrawal by Subject|0|||
147543989|NCT00370396|532148340|FG000|Overall Study|Withdrawal by Subject|0|||
147543990|NCT00370396|532148341|FG001|Overall Study|Withdrawal by Subject|0|||
147543991|NCT00370396|532148342|FG002|Overall Study|Withdrawal by Subject|1|||
147543992|NCT00370396|532148340|FG000|Overall Study|Lost to Follow-up|11|||
147543993|NCT00370396|532148341|FG001|Overall Study|Lost to Follow-up|1|||
147543994|NCT00370396|532148342|FG002|Overall Study|Lost to Follow-up|0|||
147543995|NCT04529499|532148345|FG000|Overall Study|Withdrawal by Subject|9|||
147543996|NCT04529499|532148346|FG001|Overall Study|Withdrawal by Subject|11|||
147543997|NCT04529499|532148345|FG000|Overall Study|Physician Decision|1|||
147543998|NCT04529499|532148346|FG001|Overall Study|Physician Decision|2|||
147543999|NCT04529499|532148345|FG000|Overall Study|Adverse Event|4|||
147544000|NCT04529499|532148346|FG001|Overall Study|Adverse Event|4|||
147544001|NCT04529499|532148345|FG000|Overall Study|Death|14|||
147544002|NCT04529499|532148346|FG001|Overall Study|Death|11|||
147544003|NCT04529499|532148345|FG000|Overall Study|Lost to Follow-up|1|||
147544004|NCT04529499|532148346|FG001|Overall Study|Lost to Follow-up|1|||
147544005|NCT04529499|532148345|FG000|Overall Study|Others|7|||
147544006|NCT04529499|532148346|FG001|Overall Study|Others|11|||
147544007|NCT02441179|532148348|FG000|Overall Study|Withdrawal by Subject|1|||
147544008|NCT02441179|532148349|FG001|Overall Study|Withdrawal by Subject|1|||
147544009|NCT01494649|532148350|FG000|Overall Study|Lost to Follow-up|0|||
147544010|NCT01494649|532148351|FG001|Overall Study|Lost to Follow-up|1|||
147544011|NCT03467971|532148352|FG000|Treatment Period 2|Withdrawal by Subject|0|||
147544012|NCT03467971|532148353|FG001|Treatment Period 2|Withdrawal by Subject|1|||
147544013|NCT01656967|532148354|FG000|Overall Study|faulty monitor|1|||
147544014|NCT01656967|532148355|FG001|Overall Study|faulty monitor|0|||
147544015|NCT01656967|532148354|FG000|Overall Study|unsuccessful ETT insertion|3|||
147544016|NCT01656967|532148355|FG001|Overall Study|unsuccessful ETT insertion|2|||
147544017|NCT00479765|532148356|FG000|Overall Study|study terminated|4|||
147544018|NCT05166512|532148357|FG000|Randomized|Lost to Follow-up|2|||
147544019|NCT05166512|532148358|FG001|Randomized|Lost to Follow-up|0|||
147544020|NCT05166512|532148357|FG000|Randomized|Withdrawal by Subject|1|||
147544021|NCT05166512|532148358|FG001|Randomized|Withdrawal by Subject|0|||
147544022|NCT05166512|532148357|FG000|Baseline Data Collection|Lost to Follow-up|0|||
147544023|NCT05166512|532148358|FG001|Baseline Data Collection|Lost to Follow-up|3|||
147544024|NCT05166512|532148357|FG000|Baseline Data Collection|Withdrawal by Subject|1|||
147544025|NCT05166512|532148358|FG001|Baseline Data Collection|Withdrawal by Subject|0|||
147544026|NCT05166512|532148357|FG000|Baseline Data Collection|Protocol Violation|2|||
147544027|NCT05166512|532148358|FG001|Baseline Data Collection|Protocol Violation|0|||
147544028|NCT05166512|532148357|FG000|4 Month Data Collection|Lost to Follow-up|1|||
147544029|NCT05166512|532148358|FG001|4 Month Data Collection|Lost to Follow-up|0|||
147544030|NCT05166512|532148357|FG000|4 Month Data Collection|Withdrawal by Subject|1|||
147544031|NCT05166512|532148358|FG001|4 Month Data Collection|Withdrawal by Subject|5|||
147544032|NCT05166512|532148357|FG000|12 Month Data Collection|Lost to Follow-up|3|||
147544033|NCT05166512|532148358|FG001|12 Month Data Collection|Lost to Follow-up|1|||
147544034|NCT05166512|532148357|FG000|12 Month Data Collection|Withdrawal by Subject|1|||
147544035|NCT05166512|532148358|FG001|12 Month Data Collection|Withdrawal by Subject|0|||
147544036|NCT00420849|532148359|FG000|Overall Study|Lack of Efficacy|154|||
147544037|NCT00420849|532148359|FG000|Overall Study|Adverse Event|107|||
147544038|NCT00420849|532148359|FG000|Overall Study|Withdrawal by Subject|28|||
147544039|NCT00420849|532148359|FG000|Overall Study|Death|18|||
147544040|NCT00420849|532148359|FG000|Overall Study|Other|14|||
147544041|NCT00420849|532148359|FG000|Overall Study|Transplant|8|||
147544042|NCT00420849|532148359|FG000|Overall Study|Protocol Violation|1|||
147544043|NCT00420849|532148359|FG000|Overall Study|Lost to Follow-up|1|||
147544044|NCT00725725|532148360|FG000|Overall Study|Adverse Event|1|||
147544045|NCT00725725|532148361|FG001|Overall Study|Adverse Event|3|||
147544046|NCT00725725|532148362|FG002|Overall Study|Adverse Event|2|||
147544047|NCT00725725|532148360|FG000|Overall Study|Lost to Follow-up|2|||
147544048|NCT00725725|532148361|FG001|Overall Study|Lost to Follow-up|0|||
147544049|NCT00725725|532148362|FG002|Overall Study|Lost to Follow-up|2|||
147441227|NCT01007032|531780815|FG001|Overall Study|On Study Treatment at Cut-off Date|1|||
147441228|NCT01007032|531780816|FG002|Overall Study|On Study Treatment at Cut-off Date|1|||
147441229|NCT01007032|531780817|FG003|Overall Study|On Study Treatment at Cut-off Date|0|||
147441230|NCT01007032|531780814|FG000|Overall Study|Withdrawal by Subject|0|||
147441231|NCT01007032|531780815|FG001|Overall Study|Withdrawal by Subject|0|||
147441232|NCT01007032|531780816|FG002|Overall Study|Withdrawal by Subject|0|||
147441233|NCT01007032|531780817|FG003|Overall Study|Withdrawal by Subject|1|||
147441234|NCT01101438|531780818|FG000|Overall Study|Withdrawal by Subject|8|||
147441235|NCT01101438|531780819|FG001|Overall Study|Withdrawal by Subject|9|||
147441236|NCT00806195|531780824|FG000|Overall Study|Death|6|||
147441237|NCT00806195|531780825|FG001|Overall Study|Death|0|||
147441238|NCT00806195|531780826|FG002|Overall Study|Death|1|||
147441239|NCT00806195|531780827|FG003|Overall Study|Death|0|||
147441240|NCT00806195|531780824|FG000|Overall Study|Adverse Event|25|||
147441241|NCT00806195|531780825|FG001|Overall Study|Adverse Event|5|||
147441242|NCT00806195|531780826|FG002|Overall Study|Adverse Event|11|||
147441243|NCT00806195|531780827|FG003|Overall Study|Adverse Event|2|||
147441244|NCT00806195|531780824|FG000|Overall Study|Withdrawal by Subject|119|||
147441245|NCT00806195|531780825|FG001|Overall Study|Withdrawal by Subject|31|||
147441246|NCT00806195|531780826|FG002|Overall Study|Withdrawal by Subject|76|||
147441247|NCT00806195|531780827|FG003|Overall Study|Withdrawal by Subject|35|||
147441248|NCT00806195|531780824|FG000|Overall Study|Lost to Follow-up|217|||
147441249|NCT00806195|531780825|FG001|Overall Study|Lost to Follow-up|66|||
147441250|NCT00806195|531780826|FG002|Overall Study|Lost to Follow-up|90|||
147441251|NCT00806195|531780827|FG003|Overall Study|Lost to Follow-up|34|||
147441252|NCT00806195|531780824|FG000|Overall Study|Inappropriate Enrollment|0|||
147441253|NCT00806195|531780825|FG001|Overall Study|Inappropriate Enrollment|1|||
147441254|NCT00806195|531780826|FG002|Overall Study|Inappropriate Enrollment|0|||
147441255|NCT00806195|531780827|FG003|Overall Study|Inappropriate Enrollment|0|||
147441256|NCT00806195|531780824|FG000|Overall Study|Administrative Reason|113|||
147441257|NCT00806195|531780825|FG001|Overall Study|Administrative Reason|35|||
147441258|NCT00806195|531780826|FG002|Overall Study|Administrative Reason|66|||
147441259|NCT00806195|531780827|FG003|Overall Study|Administrative Reason|26|||
147441260|NCT00806195|531780824|FG000|Overall Study|Protocol Violation|34|||
147441261|NCT00806195|531780825|FG001|Overall Study|Protocol Violation|24|||
147441262|NCT00806195|531780826|FG002|Overall Study|Protocol Violation|26|||
147441263|NCT00806195|531780827|FG003|Overall Study|Protocol Violation|9|||
147441264|NCT01231659|531780829|FG000|Overall Study|Adverse Event|9|||
147441265|NCT01231659|531780829|FG000|Overall Study|Disease Progression|48|||
147441266|NCT01231659|531780829|FG000|Overall Study|Death|2|||
147441267|NCT01231659|531780829|FG000|Overall Study|Patient refused to complete study visit|1|||
147441268|NCT01231659|531780829|FG000|Overall Study|Other protocol defined criteria|12|||
147441269|NCT03962738|531780830|FG000|Overall Study|Protocol Deviation|3|||
147441270|NCT03962738|531780831|FG001|Overall Study|Protocol Deviation|0|||
147441271|NCT03962738|531780832|FG002|Overall Study|Protocol Deviation|1|||
147441272|NCT03962738|531780833|FG003|Overall Study|Protocol Deviation|1|||
147441273|NCT03962738|531780830|FG000|Overall Study|Withdrawal by Subject|4|||
147441274|NCT03962738|531780831|FG001|Overall Study|Withdrawal by Subject|0|||
147441275|NCT03962738|531780832|FG002|Overall Study|Withdrawal by Subject|0|||
147441276|NCT03962738|531780833|FG003|Overall Study|Withdrawal by Subject|0|||
147441277|NCT03962738|531780830|FG000|Overall Study|Lost to Follow-up|0|||
147441278|NCT03962738|531780831|FG001|Overall Study|Lost to Follow-up|0|||
147441279|NCT03962738|531780832|FG002|Overall Study|Lost to Follow-up|1|||
147441280|NCT03962738|531780833|FG003|Overall Study|Lost to Follow-up|0|||
147441281|NCT00702325|531780845|FG000|Overall Study|Adverse Event|1|||
147441282|NCT00702325|531780846|FG001|Overall Study|Adverse Event|0|||
147441283|NCT00702325|531780845|FG000|Overall Study|Withdrawal by Subject|7|||
147441284|NCT00702325|531780846|FG001|Overall Study|Withdrawal by Subject|7|||
147441285|NCT00702325|531780845|FG000|Overall Study|Lost to Follow-up|3|||
147441286|NCT00702325|531780846|FG001|Overall Study|Lost to Follow-up|4|||
147441287|NCT00702325|531780845|FG000|Overall Study|Incorrect enrollment|5|||
147441288|NCT00702325|531780846|FG001|Overall Study|Incorrect enrollment|7|||
147441289|NCT00702325|531780845|FG000|Overall Study|Developed study discontinuation criteria|18|||
147441290|NCT00702325|531780846|FG001|Overall Study|Developed study discontinuation criteria|28|||
147210755|NCT00727441|530945349|FG000|Overall Study|Withdrawal by Subject|0|||
147441291|NCT00702325|531780845|FG000|Overall Study|Severe noncompliance to protocol|3|||
147441292|NCT00702325|531780846|FG001|Overall Study|Severe noncompliance to protocol|3|||
147441293|NCT00702325|531780845|FG000|Overall Study|Termination due to lab results|1|||
147441294|NCT00702325|531780846|FG001|Overall Study|Termination due to lab results|0|||
147441295|NCT00702325|531780845|FG000|Overall Study|Didn't follow study medication dosage|0|||
147441296|NCT00702325|531780846|FG001|Overall Study|Didn't follow study medication dosage|2|||
147441297|NCT00702325|531780845|FG000|Overall Study|Withdrew consent|0|||
147441298|NCT00702325|531780846|FG001|Overall Study|Withdrew consent|1|||
147441299|NCT00702325|531780845|FG000|Overall Study|Incorrectly Discontinued|0|||
147441300|NCT00702325|531780846|FG001|Overall Study|Incorrectly Discontinued|1|||
147441301|NCT04556136|531780850|FG000|Overall Study|Lost to Follow-up|6|||
147441302|NCT04556136|531780851|FG001|Overall Study|Lost to Follow-up|6|||
147544050|NCT00725725|532148360|FG000|Overall Study|Withdrawal by Subject|1|||
147544051|NCT00725725|532148361|FG001|Overall Study|Withdrawal by Subject|0|||
147544052|NCT00725725|532148362|FG002|Overall Study|Withdrawal by Subject|1|||
147544053|NCT00725725|532148360|FG000|Overall Study|Protocol Violation|0|||
147544054|NCT00725725|532148361|FG001|Overall Study|Protocol Violation|1|||
147544055|NCT00725725|532148362|FG002|Overall Study|Protocol Violation|0|||
147544056|NCT01619085|532148363|FG000|Overall Study|Adverse Event|231|||
147544057|NCT01619085|532148363|FG000|Overall Study|Protocol Violation|4|||
147544058|NCT01619085|532148363|FG000|Overall Study|Lost to Follow-up|3|||
147544059|NCT01619085|532148363|FG000|Overall Study|Withdrawal by Subject|45|||
147544060|NCT01619085|532148363|FG000|Overall Study|Other than specified|96|||
147544061|NCT01619085|532148363|FG000|Overall Study|Not treated|1|||
147544062|NCT01619085|532148363|FG000|Overall Study|Death|145|||
147544063|NCT01345058|532148364|FG000|Overall Study|Withdrawal by Subject|1|||
147544064|NCT01345058|532148365|FG001|Overall Study|Withdrawal by Subject|0|||
147544065|NCT01345058|532148364|FG000|Overall Study|Participant Reported Increase in Events|1|||
147544066|NCT01345058|532148365|FG001|Overall Study|Participant Reported Increase in Events|0|||
147544067|NCT01345058|532148364|FG000|Overall Study|Side Effects of Hair Loss and Itchiness|1|||
147544068|NCT01345058|532148365|FG001|Overall Study|Side Effects of Hair Loss and Itchiness|0|||
147544069|NCT01345058|532148364|FG000|Overall Study|Participant Stopped Taking Study Drug|1|||
147544070|NCT01345058|532148365|FG001|Overall Study|Participant Stopped Taking Study Drug|0|||
147544071|NCT01345058|532148364|FG000|Overall Study|Participant No-Show at Multiple Visits|1|||
147544072|NCT01345058|532148365|FG001|Overall Study|Participant No-Show at Multiple Visits|0|||
147544073|NCT00000135|532148366|FG000|Overall Study|Death|27|||
147544074|NCT00000135|532148367|FG001|Overall Study|Death|14|||
147544075|NCT03125629|532148370|FG000|Overall Study|Withdrawal by Subject|2|||
147544076|NCT03125629|532148370|FG000|Overall Study|Equipment malfunction|1|||
147544077|NCT00743119|532148371|FG000|Overall Study|unreliable|3|||
147544078|NCT00743119|532148371|FG000|Overall Study|Withdrawal by Subject|1|||
147544079|NCT04816877|532148372|FG000|Overall Study|Withdrawal by Subject|1|||
147544080|NCT04816877|532148373|FG001|Overall Study|Withdrawal by Subject|0|||
147544081|NCT00759759|532148374|FG000|Overall Study|didn't return for period 2|1|||
147544082|NCT00759759|532148375|FG001|Overall Study|didn't return for period 2|0|||
147544083|NCT00759759|532148374|FG000|Overall Study|Didn't receive drug in period 2|1|||
147544084|NCT00759759|532148375|FG001|Overall Study|Didn't receive drug in period 2|0|||
147544085|NCT00759759|532148374|FG000|Overall Study|Withdrawal by Subject|2|||
147544086|NCT00759759|532148375|FG001|Overall Study|Withdrawal by Subject|1|||
147544087|NCT01861717|532148376|FG000|Overall Study|Lost to Follow-up|1|||
147544088|NCT01861717|532148376|FG000|Overall Study|Withdrawal by Subject|1|||
147544089|NCT00833976|532150168|FG000|Overall Study|Withdrawal by Subject|5|||
147544090|NCT00833976|532150168|FG000|Overall Study|Lost to Follow-up|4|||
147544091|NCT00833976|532150168|FG000|Overall Study|Did not meet eligibility criteria|41|||
147544092|NCT00833976|532150168|FG000|Overall Study|Physician Decision|1|||
147544093|NCT03724916|532150171|FG000|Overall Study|Withdrawal by Subject|0|||
147544094|NCT03724916|532150172|FG001|Overall Study|Withdrawal by Subject|1|||
147544095|NCT03724916|532150173|FG002|Overall Study|Withdrawal by Subject|1|||
147544096|NCT03724916|532150174|FG003|Overall Study|Withdrawal by Subject|2|||
147544097|NCT03724916|532150171|FG000|Overall Study|Randomized but not Treated|1|||
147544098|NCT03724916|532150172|FG001|Overall Study|Randomized but not Treated|0|||
147544099|NCT03724916|532150173|FG002|Overall Study|Randomized but not Treated|0|||
147544100|NCT03724916|532150174|FG003|Overall Study|Randomized but not Treated|0|||
147544101|NCT02464059|532150179|FG000|Overall Study|Lost to Follow-up|6|||
147544102|NCT01272193|532150180|FG000|Overall Study|Adverse Event|1|||
147544103|NCT01272193|532150181|FG001|Overall Study|Adverse Event|1|||
147544104|NCT01272193|532150180|FG000|Overall Study|Lack of Efficacy|0|||
147544105|NCT01272193|532150181|FG001|Overall Study|Lack of Efficacy|3|||
147544106|NCT01272193|532150180|FG000|Overall Study|Withdrawal Criteria|1|||
147544107|NCT01272193|532150181|FG001|Overall Study|Withdrawal Criteria|1|||
147544108|NCT01272193|532150180|FG000|Overall Study|Unclassified|8|||
147544109|NCT01272193|532150181|FG001|Overall Study|Unclassified|7|||
147544110|NCT00350519|532150190|FG000|Overall Study|Death|0|||
147544111|NCT00350519|532150191|FG001|Overall Study|Death|1|||
147544112|NCT00350519|532150190|FG000|Overall Study|Physician Decision|0|||
147544113|NCT00350519|532150191|FG001|Overall Study|Physician Decision|1|||
147544114|NCT00350519|532150190|FG000|Overall Study|Protocol Violation|1|||
147544115|NCT00350519|532150191|FG001|Overall Study|Protocol Violation|2|||
147544116|NCT00350519|532150190|FG000|Overall Study|Withdrawal by Subject|3|||
147544117|NCT00350519|532150191|FG001|Overall Study|Withdrawal by Subject|2|||
147544118|NCT04388527|532150192|FG000|Overall Study|Death|14|||
147544119|NCT04388527|532150192|FG000|Overall Study|Withdrawal by Subject|2|||
147544120|NCT04388527|532150192|FG000|Overall Study|Lost to Follow-up|1|||
147544121|NCT00289731|532150196|FG000|Overall Study|Adverse Event|1|||
147544122|NCT00289731|532150197|FG001|Overall Study|Adverse Event|2|||
147544123|NCT00289731|532150198|FG002|Overall Study|Adverse Event|2|||
147544124|NCT00289731|532150196|FG000|Overall Study|Other|1|||
147544125|NCT00289731|532150197|FG001|Overall Study|Other|0|||
147544126|NCT00289731|532150198|FG002|Overall Study|Other|0|||
147544127|NCT01830920|532150201|FG000|Overall Study|Adverse Event|1|||
147544128|NCT01830920|532150202|FG001|Overall Study|Adverse Event|0|||
147544129|NCT01830920|532150203|FG002|Overall Study|Adverse Event|1|||
147544130|NCT01830920|532150204|FG003|Overall Study|Adverse Event|0|||
147544131|NCT01830920|532150205|FG004|Overall Study|Adverse Event|0|||
147544132|NCT01830920|532150201|FG000|Overall Study|Withdrawal by Subject|2|||
147544133|NCT01830920|532150202|FG001|Overall Study|Withdrawal by Subject|2|||
147544134|NCT01830920|532150203|FG002|Overall Study|Withdrawal by Subject|1|||
147544135|NCT01830920|532150204|FG003|Overall Study|Withdrawal by Subject|7|||
147544136|NCT01830920|532150205|FG004|Overall Study|Withdrawal by Subject|1|||
147544137|NCT01830920|532150201|FG000|Overall Study|Death|3|||
147544138|NCT01830920|532150202|FG001|Overall Study|Death|3|||
147544139|NCT01830920|532150203|FG002|Overall Study|Death|5|||
147544140|NCT01830920|532150204|FG003|Overall Study|Death|4|||
147544141|NCT01830920|532150205|FG004|Overall Study|Death|4|||
147544142|NCT01830920|532150201|FG000|Overall Study|Other|15|||
147544143|NCT01830920|532150202|FG001|Overall Study|Other|1|||
147544144|NCT01830920|532150203|FG002|Overall Study|Other|1|||
147544145|NCT01830920|532150204|FG003|Overall Study|Other|5|||
147544146|NCT01830920|532150205|FG004|Overall Study|Other|3|||
147544147|NCT01313728|532150206|FG000|Informed Consent to Baseline|Withdrawal by Subject|1|||
147544148|NCT00736333|532150207|FG000|Overall Study|Did Not Receive Drug or Not Documented|7|||
147544149|NCT00736333|532150207|FG000|Overall Study|Data Missing|2|||
147544150|NCT00736333|532150207|FG000|Overall Study|Tumor Progression|75|||
147544151|NCT00736333|532150207|FG000|Overall Study|Toxicity|6|||
147544152|NCT00736333|532150207|FG000|Overall Study|Withdrawal by Subject|10|||
147544153|NCT00736333|532150207|FG000|Overall Study|Death|7|||
147544154|NCT00736333|532150207|FG000|Overall Study|Other|4|||
147544155|NCT00572156|532150215|FG000|Overall Study|Adverse Event|3|||
147544156|NCT00572156|532150216|FG001|Overall Study|Adverse Event|1|||
147544157|NCT00572156|532150217|FG002|Overall Study|Adverse Event|5|||
147544158|NCT00572156|532150218|FG003|Overall Study|Adverse Event|1|||
147544159|NCT00572156|532150215|FG000|Overall Study|Lost to Follow-up|1|||
147544160|NCT00572156|532150216|FG001|Overall Study|Lost to Follow-up|1|||
147544161|NCT00572156|532150217|FG002|Overall Study|Lost to Follow-up|1|||
147544162|NCT00572156|532150218|FG003|Overall Study|Lost to Follow-up|0|||
147544163|NCT00572156|532150215|FG000|Overall Study|Protocol Violation|1|||
147544164|NCT00572156|532150216|FG001|Overall Study|Protocol Violation|2|||
147544165|NCT00572156|532150217|FG002|Overall Study|Protocol Violation|0|||
147544166|NCT00572156|532150218|FG003|Overall Study|Protocol Violation|2|||
147544167|NCT00572156|532150215|FG000|Overall Study|Patient/Parent Decision|1|||
147544168|NCT00572156|532150216|FG001|Overall Study|Patient/Parent Decision|6|||
147544169|NCT00572156|532150217|FG002|Overall Study|Patient/Parent Decision|4|||
147544170|NCT00572156|532150218|FG003|Overall Study|Patient/Parent Decision|3|||
147544171|NCT00572156|532150215|FG000|Overall Study|Sponsor Decision|20|||
147544172|NCT00572156|532150216|FG001|Overall Study|Sponsor Decision|16|||
147544173|NCT00572156|532150217|FG002|Overall Study|Sponsor Decision|17|||
147544174|NCT00572156|532150218|FG003|Overall Study|Sponsor Decision|19|||
147544175|NCT02261974|532150219|FG000|Overall Study|Withdrawal by Subject|3|||
147544176|NCT02261974|532150220|FG001|Overall Study|Withdrawal by Subject|2|||
147544177|NCT02261974|532150219|FG000|Overall Study|Pregnancy|0|||
147544178|NCT02261974|532150220|FG001|Overall Study|Pregnancy|1|||
147544179|NCT02261974|532150219|FG000|Overall Study|Missed treatment cut-off date|6|||
147544180|NCT02261974|532150220|FG001|Overall Study|Missed treatment cut-off date|3|||
147544181|NCT02261974|532150219|FG000|Overall Study|Received partial treatment; FU to 1 mo|3|||
147544182|NCT02261974|532150220|FG001|Overall Study|Received partial treatment; FU to 1 mo|1|||
147544183|NCT02261974|532150219|FG000|Overall Study|Lost to Follow-up|2|||
147544184|NCT02261974|532150220|FG001|Overall Study|Lost to Follow-up|0|||
147544185|NCT02261974|532150219|FG000|Overall Study|Adverse Event|1|||
147544186|NCT02261974|532150220|FG001|Overall Study|Adverse Event|0|||
147544187|NCT01440595|532150221|FG000|Overall Study|Lost to Follow-up|0|||
147544188|NCT01440595|532150222|FG001|Overall Study|Lost to Follow-up|1|||
147544189|NCT01440595|532150223|FG002|Overall Study|Lost to Follow-up|0|||
147544190|NCT01440595|532150221|FG000|Overall Study|Study terminated by sponsor.|1|||
147544191|NCT01440595|532150222|FG001|Overall Study|Study terminated by sponsor.|2|||
147544192|NCT01440595|532150223|FG002|Overall Study|Study terminated by sponsor.|1|||
147544193|NCT01347879|532150224|FG000|Overall Study|Adverse Event|0|||
147544194|NCT01347879|532150225|FG001|Overall Study|Adverse Event|12|||
147544195|NCT01347879|532150224|FG000|Overall Study|Lost to Follow-up|2|||
147544196|NCT01347879|532150225|FG001|Overall Study|Lost to Follow-up|0|||
147544197|NCT01347879|532150224|FG000|Overall Study|Withdrawal by Subject|3|||
147544198|NCT01347879|532150225|FG001|Overall Study|Withdrawal by Subject|2|||
147544199|NCT01347879|532150224|FG000|Overall Study|Other|2|||
147544200|NCT01347879|532150225|FG001|Overall Study|Other|3|||
147544201|NCT04736576|532150228|FG000|Overall Study|Progressive disease|3|||
147544202|NCT04736576|532150229|FG001|Overall Study|Progressive disease|1|||
147544203|NCT04736576|532150228|FG000|Overall Study|Death|1|||
147544204|NCT04736576|532150229|FG001|Overall Study|Death|0|||
147544205|NCT00720304|532150232|FG000|Overall Study|Withdrawal by Subject|14|||
147544206|NCT00720304|532150233|FG001|Overall Study|Withdrawal by Subject|1|||
147544207|NCT00720304|532150232|FG000|Overall Study|Death|1|||
147544208|NCT00720304|532150233|FG001|Overall Study|Death|0|||
147544209|NCT00720304|532150232|FG000|Overall Study|Physician Decision|5|||
147544210|NCT00720304|532150233|FG001|Overall Study|Physician Decision|2|||
147544211|NCT00720304|532150232|FG000|Overall Study|Adverse Event|3|||
147544212|NCT00720304|532150233|FG001|Overall Study|Adverse Event|1|||
147544213|NCT00720304|532150232|FG000|Overall Study|Disease progression|6|||
147544214|NCT00720304|532150233|FG001|Overall Study|Disease progression|1|||
147544215|NCT04330482|532150236|FG000|Overall Study|Lost to Follow-up|2|||
147544216|NCT04330482|532150237|FG001|Overall Study|Lost to Follow-up|1|||
147544217|NCT04330482|532150236|FG000|Overall Study|Withdrawal by Subject|0|||
147544218|NCT04330482|532150237|FG001|Overall Study|Withdrawal by Subject|3|||
147544219|NCT00996918|532150238|FG000|Overall Study|Lack of Efficacy|1|||
147544220|NCT00996918|532150239|FG001|Overall Study|Lack of Efficacy|1|||
147544221|NCT00996918|532150240|FG002|Overall Study|Lack of Efficacy|2|||
147544222|NCT00996918|532150241|FG003|Overall Study|Lack of Efficacy|2|||
147544223|NCT00996918|532150242|FG004|Overall Study|Lack of Efficacy|0|||
147544224|NCT00996918|532150238|FG000|Overall Study|Adverse Event|2|||
147544225|NCT00996918|532150239|FG001|Overall Study|Adverse Event|5|||
147544226|NCT00996918|532150240|FG002|Overall Study|Adverse Event|2|||
147544227|NCT00996918|532150241|FG003|Overall Study|Adverse Event|6|||
147544228|NCT00996918|532150242|FG004|Overall Study|Adverse Event|0|||
147544229|NCT00996918|532150238|FG000|Overall Study|Withdrawal by Subject|1|||
147210756|NCT00727441|530945350|FG001|Overall Study|Withdrawal by Subject|1|||
147441303|NCT04556136|531780850|FG000|Overall Study|Physician Decision|2|||
147441304|NCT04556136|531780851|FG001|Overall Study|Physician Decision|1|||
147441305|NCT04556136|531780850|FG000|Overall Study|Withdrawal by Subject|2|||
147441306|NCT04556136|531780851|FG001|Overall Study|Withdrawal by Subject|1|||
147441307|NCT01022502|531780854|FG000|Overall Study|Adverse Event|1|||
147441308|NCT01022502|531780854|FG000|Overall Study|employment related reasons|1|||
147441309|NCT01022502|531780854|FG000|Overall Study|Withdrawal by Subject|1|||
147441310|NCT02566577|531780855|FG000|Overall Study|Withdrawal by Subject|1|||
147441311|NCT02566577|531780856|FG001|Overall Study|Withdrawal by Subject|1|||
147441312|NCT02566577|531780855|FG000|Overall Study|Equipment failure|1|||
147441313|NCT02566577|531780856|FG001|Overall Study|Equipment failure|1|||
147441314|NCT02566577|531780855|FG000|Overall Study|Physical limitation|1|||
147441315|NCT02566577|531780856|FG001|Overall Study|Physical limitation|0|||
147441316|NCT00073528|531780866|FG000|Overall Study|Death|488|||
147441317|NCT00073528|531780867|FG001|Overall Study|Death|473|||
147441318|NCT00073528|531780866|FG000|Overall Study|Lost to Follow-up|52|||
147441319|NCT00073528|531780867|FG001|Overall Study|Lost to Follow-up|45|||
147441320|NCT00073528|531780866|FG000|Overall Study|Withdrawal by Subject|50|||
147441321|NCT00073528|531780867|FG001|Overall Study|Withdrawal by Subject|45|||
147441322|NCT00073528|531780866|FG000|Overall Study|Study terminated by Sponsor|10|||
147441323|NCT00073528|531780867|FG001|Overall Study|Study terminated by Sponsor|29|||
147441324|NCT00073528|531780866|FG000|Overall Study|Other|18|||
147441325|NCT00073528|531780867|FG001|Overall Study|Other|19|||
147441326|NCT00073528|531780866|FG000|Overall Study|Other|9|||
147441327|NCT00073528|531780867|FG001|Overall Study|Other|12|||
147441328|NCT00073528|531780866|FG000|Overall Study|Protocol Violation|3|||
147441329|NCT00073528|531780867|FG001|Overall Study|Protocol Violation|5|||
147441330|NCT00003702|531780870|FG000|Overall Study|Ineligible cell types|2|||
147441331|NCT00003702|531780871|FG001|Overall Study|Ineligible cell types|2|||
147441332|NCT00003702|531780870|FG000|Overall Study|Did not meet criteria for persistence|8|||
147441333|NCT00003702|531780871|FG001|Overall Study|Did not meet criteria for persistence|5|||
147441334|NCT00003702|531780870|FG000|Overall Study|WHO score > 6|2|||
147441335|NCT00003702|531780871|FG001|Overall Study|WHO score > 6|1|||
147441336|NCT00003702|531780870|FG000|Overall Study|Inadequate documentation of disease|1|||
147441337|NCT00003702|531780871|FG001|Overall Study|Inadequate documentation of disease|3|||
147441338|NCT02790138|531780874|FG000|Overall Study|Adverse Event|5|||
147441339|NCT02790138|531780875|FG001|Overall Study|Adverse Event|2|||
147441340|NCT02790138|531780874|FG000|Overall Study|Significant Protocol Deviation|0|||
147441341|NCT02790138|531780875|FG001|Overall Study|Significant Protocol Deviation|1|||
147441342|NCT02790138|531780874|FG000|Overall Study|Lost to Follow-up|1|||
147441343|NCT02790138|531780875|FG001|Overall Study|Lost to Follow-up|0|||
147544230|NCT00996918|532150239|FG001|Overall Study|Withdrawal by Subject|4|||
147544231|NCT00996918|532150240|FG002|Overall Study|Withdrawal by Subject|3|||
147544232|NCT00996918|532150241|FG003|Overall Study|Withdrawal by Subject|3|||
147544233|NCT00996918|532150242|FG004|Overall Study|Withdrawal by Subject|2|||
147441344|NCT02790138|531780874|FG000|Overall Study|Voluntary Withdrawal|8|||
147441345|NCT02790138|531780875|FG001|Overall Study|Voluntary Withdrawal|9|||
147441346|NCT02790138|531780874|FG000|Overall Study|Lack of Efficacy|6|||
147441347|NCT02790138|531780875|FG001|Overall Study|Lack of Efficacy|7|||
147441348|NCT02790138|531780874|FG000|Overall Study|Reason not Specified|1|||
147544234|NCT00996918|532150238|FG000|Overall Study|Physician Decision|1|||
147544235|NCT00996918|532150239|FG001|Overall Study|Physician Decision|0|||
147544236|NCT00996918|532150240|FG002|Overall Study|Physician Decision|0|||
147544237|NCT00996918|532150241|FG003|Overall Study|Physician Decision|0|||
147544238|NCT00996918|532150242|FG004|Overall Study|Physician Decision|0|||
147544239|NCT00996918|532150238|FG000|Overall Study|Discontinuation of Study by Sponsor|31|||
147544240|NCT00996918|532150239|FG001|Overall Study|Discontinuation of Study by Sponsor|54|||
147544241|NCT00996918|532150240|FG002|Overall Study|Discontinuation of Study by Sponsor|30|||
147544242|NCT00996918|532150241|FG003|Overall Study|Discontinuation of Study by Sponsor|45|||
147544243|NCT00996918|532150242|FG004|Overall Study|Discontinuation of Study by Sponsor|2|||
147544244|NCT00996918|532150238|FG000|Overall Study|Loss of Caregiver|0|||
147544245|NCT00996918|532150239|FG001|Overall Study|Loss of Caregiver|1|||
147544246|NCT00996918|532150240|FG002|Overall Study|Loss of Caregiver|0|||
147544247|NCT00996918|532150241|FG003|Overall Study|Loss of Caregiver|0|||
147544248|NCT00996918|532150242|FG004|Overall Study|Loss of Caregiver|0|||
147544249|NCT00996918|532150238|FG000|Overall Study|Other|3|||
147544250|NCT00996918|532150239|FG001|Overall Study|Other|1|||
147544251|NCT00996918|532150240|FG002|Overall Study|Other|0|||
147544252|NCT00996918|532150241|FG003|Overall Study|Other|0|||
147441349|NCT02790138|531780875|FG001|Overall Study|Reason not Specified|0|||
147441350|NCT03199040|531780876|FG000|Overall Study|Lack of Efficacy|2|||
147441351|NCT03199040|531780877|FG001|Overall Study|Lack of Efficacy|0|||
147441352|NCT03199040|531780876|FG000|Overall Study|Withdrawal by Subject|2|||
147441353|NCT03199040|531780877|FG001|Overall Study|Withdrawal by Subject|0|||
147441354|NCT03199040|531780876|FG000|Overall Study|Adverse Event|0|||
147441355|NCT03199040|531780877|FG001|Overall Study|Adverse Event|1|||
147441356|NCT03199040|531780876|FG000|Overall Study|Only completed 5 out of 6 vaccines|0|||
147441357|NCT03199040|531780877|FG001|Overall Study|Only completed 5 out of 6 vaccines|1|||
147441358|NCT01226459|531780878|FG000|Overall Study|Adverse Event|2|||
147441359|NCT01226459|531780879|FG001|Overall Study|Adverse Event|8|||
147441360|NCT01226459|531780878|FG000|Overall Study|Protocol Violation|4|||
147441361|NCT01226459|531780879|FG001|Overall Study|Protocol Violation|3|||
147441362|NCT01226459|531780878|FG000|Overall Study|Withdrawal by Subject|10|||
147441363|NCT01226459|531780879|FG001|Overall Study|Withdrawal by Subject|13|||
147441364|NCT01226459|531780878|FG000|Overall Study|Lost to Follow-up|4|||
147441365|NCT01226459|531780879|FG001|Overall Study|Lost to Follow-up|8|||
147441366|NCT01226459|531780878|FG000|Overall Study|Pregnancy|1|||
147441367|NCT01226459|531780879|FG001|Overall Study|Pregnancy|0|||
147441368|NCT00474708|531780880|FG000|Overall Study|Lack of Efficacy|11|||
147441369|NCT00474708|531780881|FG001|Overall Study|Lack of Efficacy|5|||
147544253|NCT00996918|532150242|FG004|Overall Study|Other|0|||
147544254|NCT01333475|532150245|FG000|Overall Study|pt withdrew-need emergent radiation trmt|1|||
147544255|NCT01333475|532150246|FG001|Overall Study|pt withdrew-need emergent radiation trmt|0|||
147544256|NCT01333475|532150245|FG000|Overall Study|Toxicity|1|||
147544257|NCT01333475|532150246|FG001|Overall Study|Toxicity|3|||
147544258|NCT04440007|532150247|FG000|Overall Study|Adverse Event|0|||
147544259|NCT04440007|532150248|FG001|Overall Study|Adverse Event|1|||
147544260|NCT04440007|532150247|FG000|Overall Study|Lost to Follow-up|1|||
147544261|NCT04440007|532150248|FG001|Overall Study|Lost to Follow-up|3|||
147544262|NCT04440007|532150247|FG000|Overall Study|Death|7|||
147544263|NCT04440007|532150248|FG001|Overall Study|Death|2|||
147544264|NCT04440007|532150247|FG000|Overall Study|Physician Decision|1|||
147544265|NCT04440007|532150248|FG001|Overall Study|Physician Decision|1|||
147544266|NCT04440007|532150247|FG000|Overall Study|Withdrawal by Subject|2|||
147544267|NCT04440007|532150248|FG001|Overall Study|Withdrawal by Subject|1|||
147544268|NCT04440007|532150247|FG000|Overall Study|Inability to draw blood for labs and being transferred to a nursing facility with no transportation|1|||
147544269|NCT04440007|532150248|FG001|Overall Study|Inability to draw blood for labs and being transferred to a nursing facility with no transportation|2|||
147544270|NCT04440007|532150247|FG000|Overall Study|Discontinued prior to dosing|0|||
147544271|NCT04440007|532150248|FG001|Overall Study|Discontinued prior to dosing|2|||
147544272|NCT01466673|532150249|FG000|Overall Study|Non-compliance with study treatment|2|||
147544273|NCT01466673|532150250|FG001|Overall Study|Non-compliance with study treatment|0|||
147544274|NCT01466673|532150249|FG000|Overall Study|Lost to Follow-up|3|||
147544275|NCT01466673|532150250|FG001|Overall Study|Lost to Follow-up|5|||
147544276|NCT01466673|532150249|FG000|Overall Study|Adverse Event|2|||
147544277|NCT01466673|532150250|FG001|Overall Study|Adverse Event|1|||
147544278|NCT02725671|532150251|FG000|Overall Study|Lost to Follow-up|1|||
147544279|NCT02981602|532150252|FG000|Overall Study|Adverse Event|0|||
147441370|NCT00474708|531780880|FG000|Overall Study|Suicide ideation/behavior|0|||
147441371|NCT00474708|531780881|FG001|Overall Study|Suicide ideation/behavior|1|||
147544280|NCT02981602|532150253|FG001|Overall Study|Adverse Event|0|||
147441372|NCT00474708|531780880|FG000|Overall Study|Withdrawal by Subject|7|||
147441373|NCT00474708|531780881|FG001|Overall Study|Withdrawal by Subject|0|||
147544281|NCT02981602|532150254|FG002|Overall Study|Adverse Event|0|||
147544282|NCT02981602|532150255|FG003|Overall Study|Adverse Event|1|||
147544283|NCT02981602|532150256|FG004|Overall Study|Adverse Event|0|||
147544284|NCT02525562|532150258|FG000|Overall Study|Death|9|||
147544285|NCT02525562|532150259|FG001|Overall Study|Death|0|||
147544286|NCT02525562|532150260|FG002|Overall Study|Death|0|||
147544287|NCT02525562|532150258|FG000|Overall Study|Lost to Follow-up|19|||
147544288|NCT02525562|532150259|FG001|Overall Study|Lost to Follow-up|0|||
147441374|NCT00474708|531780880|FG000|Overall Study|Lack of compliance|12|||
147441375|NCT00474708|531780881|FG001|Overall Study|Lack of compliance|4|||
147544289|NCT02525562|532150260|FG002|Overall Study|Lost to Follow-up|0|||
147544290|NCT02525562|532150258|FG000|Overall Study|Withdrawal by Subject|37|||
147544291|NCT02525562|532150259|FG001|Overall Study|Withdrawal by Subject|0|||
147544292|NCT02525562|532150260|FG002|Overall Study|Withdrawal by Subject|0|||
147544293|NCT02525562|532150258|FG000|Overall Study|Revision/Removal of Study Device|4|||
147544294|NCT02525562|532150259|FG001|Overall Study|Revision/Removal of Study Device|0|||
147544295|NCT02525562|532150260|FG002|Overall Study|Revision/Removal of Study Device|0|||
147544296|NCT02525562|532150258|FG000|Overall Study|Study Closed by Sponsor|154|||
147544297|NCT02525562|532150259|FG001|Overall Study|Study Closed by Sponsor|0|||
147544298|NCT02525562|532150260|FG002|Overall Study|Study Closed by Sponsor|0|||
147544299|NCT02983227|532150261|FG000|Overall Study|Adverse Event|21|||
147544300|NCT02983227|532150262|FG001|Overall Study|Adverse Event|3|||
147544301|NCT02983227|532150261|FG000|Overall Study|Death|3|||
147544302|NCT02983227|532150262|FG001|Overall Study|Death|0|||
147544303|NCT02983227|532150261|FG000|Overall Study|Lack of Efficacy|8|||
147544304|NCT02983227|532150262|FG001|Overall Study|Lack of Efficacy|1|||
147544305|NCT02983227|532150261|FG000|Overall Study|Lost to Follow-up|3|||
147544306|NCT02983227|532150262|FG001|Overall Study|Lost to Follow-up|0|||
147544307|NCT02983227|532150261|FG000|Overall Study|Multiple Reasons|2|||
147544308|NCT02983227|532150262|FG001|Overall Study|Multiple Reasons|1|||
147544309|NCT02983227|532150261|FG000|Overall Study|Physician Decision|3|||
147544310|NCT02983227|532150262|FG001|Overall Study|Physician Decision|1|||
147544311|NCT02983227|532150261|FG000|Overall Study|Withdrawal by Subject|19|||
147544312|NCT02983227|532150262|FG001|Overall Study|Withdrawal by Subject|8|||
147544313|NCT01706770|532150263|FG000|Overall Study|Lost to Follow-up|1|||
147544314|NCT01706770|532150264|FG001|Overall Study|Lost to Follow-up|0|||
147544315|NCT01706770|532150263|FG000|Overall Study|Physician Decision|1|||
147544316|NCT01706770|532150264|FG001|Overall Study|Physician Decision|0|||
147544317|NCT02164539|532150265|FG000|Treatment Phase A (4 Weeks)|Withdrawal by Subject|2|||
147441376|NCT00474708|531780880|FG000|Overall Study|Lost to Follow-up|18|||
147441377|NCT00474708|531780881|FG001|Overall Study|Lost to Follow-up|9|||
147441378|NCT00474708|531780880|FG000|Overall Study|Physician Decision|9|||
147441379|NCT00474708|531780881|FG001|Overall Study|Physician Decision|6|||
147441380|NCT01092143|531780887|FG000|Overall Study|Adverse Event|10|||
147441381|NCT01092143|531780888|FG001|Overall Study|Adverse Event|5|||
147441382|NCT01092143|531780889|FG002|Overall Study|Adverse Event|1|||
147441383|NCT01092143|531780890|FG003|Overall Study|Adverse Event|4|||
147441384|NCT01092143|531780891|FG004|Overall Study|Adverse Event|3|||
147441385|NCT01092143|531780887|FG000|Overall Study|Lost to Follow-up|1|||
147441386|NCT01092143|531780888|FG001|Overall Study|Lost to Follow-up|0|||
147441387|NCT01092143|531780889|FG002|Overall Study|Lost to Follow-up|1|||
147441388|NCT01092143|531780890|FG003|Overall Study|Lost to Follow-up|0|||
147441389|NCT01092143|531780891|FG004|Overall Study|Lost to Follow-up|0|||
147441390|NCT01092143|531780887|FG000|Overall Study|Consent withdrawn|2|||
147441391|NCT01092143|531780888|FG001|Overall Study|Consent withdrawn|1|||
147441392|NCT01092143|531780889|FG002|Overall Study|Consent withdrawn|0|||
147441393|NCT01092143|531780890|FG003|Overall Study|Consent withdrawn|1|||
147441394|NCT01092143|531780891|FG004|Overall Study|Consent withdrawn|3|||
147441395|NCT01092143|531780887|FG000|Overall Study|Not treated|0|||
147441396|NCT01092143|531780888|FG001|Overall Study|Not treated|0|||
147441397|NCT01092143|531780889|FG002|Overall Study|Not treated|1|||
147441398|NCT01092143|531780890|FG003|Overall Study|Not treated|0|||
147441399|NCT01092143|531780891|FG004|Overall Study|Not treated|0|||
147441400|NCT01092143|531780887|FG000|Overall Study|did not reversibility criteria|0|||
147441401|NCT01092143|531780888|FG001|Overall Study|did not reversibility criteria|0|||
147441402|NCT01092143|531780889|FG002|Overall Study|did not reversibility criteria|1|||
147441403|NCT01092143|531780890|FG003|Overall Study|did not reversibility criteria|0|||
147441404|NCT01092143|531780891|FG004|Overall Study|did not reversibility criteria|0|||
147441405|NCT01092143|531780887|FG000|Overall Study|Increased Albuterol use for >2 days|0|||
147441406|NCT01092143|531780888|FG001|Overall Study|Increased Albuterol use for >2 days|1|||
147441407|NCT01092143|531780889|FG002|Overall Study|Increased Albuterol use for >2 days|0|||
147441408|NCT01092143|531780890|FG003|Overall Study|Increased Albuterol use for >2 days|0|||
147441409|NCT01092143|531780891|FG004|Overall Study|Increased Albuterol use for >2 days|0|||
147441410|NCT01092143|531780887|FG000|Overall Study|Ineligible patient|1|||
147441411|NCT01092143|531780888|FG001|Overall Study|Ineligible patient|0|||
147441412|NCT01092143|531780889|FG002|Overall Study|Ineligible patient|0|||
147441413|NCT01092143|531780890|FG003|Overall Study|Ineligible patient|0|||
147441414|NCT01092143|531780891|FG004|Overall Study|Ineligible patient|0|||
147441415|NCT01092143|531780887|FG000|Overall Study|Drop in FEV1 at visit 9|1|||
147544318|NCT02164539|532150266|FG001|Treatment Phase A (4 Weeks)|Withdrawal by Subject|0|||
147544319|NCT02164539|532150267|FG002|Treatment Phase A (4 Weeks)|Withdrawal by Subject|1|||
147441416|NCT01092143|531780888|FG001|Overall Study|Drop in FEV1 at visit 9|0|||
147441417|NCT01092143|531780889|FG002|Overall Study|Drop in FEV1 at visit 9|0|||
147441418|NCT01092143|531780890|FG003|Overall Study|Drop in FEV1 at visit 9|0|||
147544320|NCT02164539|532150268|FG003|Treatment Phase A (4 Weeks)|Withdrawal by Subject|2|||
147544321|NCT02164539|532150269|FG004|Treatment Phase A (4 Weeks)|Withdrawal by Subject|3|||
147544322|NCT02164539|532150270|FG005|Treatment Phase A (4 Weeks)|Withdrawal by Subject|1|||
147544323|NCT02164539|532150271|FG006|Treatment Phase A (4 Weeks)|Withdrawal by Subject|0|||
147544324|NCT02164539|532150265|FG000|Treatment Phase B (1 Week)|Adverse Event|0|||
147544325|NCT02164539|532150266|FG001|Treatment Phase B (1 Week)|Adverse Event|0|||
147544326|NCT02164539|532150267|FG002|Treatment Phase B (1 Week)|Adverse Event|0|||
147544327|NCT02164539|532150268|FG003|Treatment Phase B (1 Week)|Adverse Event|0|||
147544328|NCT02164539|532150269|FG004|Treatment Phase B (1 Week)|Adverse Event|2|||
147544329|NCT02164539|532150270|FG005|Treatment Phase B (1 Week)|Adverse Event|0|||
147544330|NCT02164539|532150271|FG006|Treatment Phase B (1 Week)|Adverse Event|0|||
147544331|NCT02164539|532150265|FG000|Treatment Phase B (1 Week)|Physician Decision|0|||
147544332|NCT02164539|532150266|FG001|Treatment Phase B (1 Week)|Physician Decision|0|||
147544333|NCT02164539|532150267|FG002|Treatment Phase B (1 Week)|Physician Decision|0|||
147544334|NCT02164539|532150268|FG003|Treatment Phase B (1 Week)|Physician Decision|0|||
147544335|NCT02164539|532150269|FG004|Treatment Phase B (1 Week)|Physician Decision|1|||
147544336|NCT02164539|532150270|FG005|Treatment Phase B (1 Week)|Physician Decision|0|||
147544337|NCT02164539|532150271|FG006|Treatment Phase B (1 Week)|Physician Decision|1|||
147544338|NCT02164539|532150265|FG000|Treatment Phase C (1 Week)|Withdrawal by Subject|1|||
147544339|NCT02164539|532150266|FG001|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
147544340|NCT02164539|532150267|FG002|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
147544341|NCT02164539|532150268|FG003|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
147544342|NCT02164539|532150269|FG004|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
147544343|NCT02164539|532150270|FG005|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
147544344|NCT02164539|532150271|FG006|Treatment Phase C (1 Week)|Withdrawal by Subject|0|||
147544345|NCT02164539|532150265|FG000|Treatment Phase C (1 Week)|Adverse Event|0|||
147544346|NCT02164539|532150266|FG001|Treatment Phase C (1 Week)|Adverse Event|0|||
147544347|NCT02164539|532150267|FG002|Treatment Phase C (1 Week)|Adverse Event|0|||
147544348|NCT02164539|532150268|FG003|Treatment Phase C (1 Week)|Adverse Event|0|||
147544349|NCT02164539|532150269|FG004|Treatment Phase C (1 Week)|Adverse Event|0|||
147544350|NCT02164539|532150270|FG005|Treatment Phase C (1 Week)|Adverse Event|0|||
147544351|NCT02164539|532150271|FG006|Treatment Phase C (1 Week)|Adverse Event|1|||
147544352|NCT02164539|532150265|FG000|Treatment Phase C (1 Week)|Physician Decision|0|||
147544353|NCT02164539|532150266|FG001|Treatment Phase C (1 Week)|Physician Decision|0|||
147544354|NCT02164539|532150267|FG002|Treatment Phase C (1 Week)|Physician Decision|0|||
147544355|NCT02164539|532150268|FG003|Treatment Phase C (1 Week)|Physician Decision|0|||
147544356|NCT02164539|532150269|FG004|Treatment Phase C (1 Week)|Physician Decision|0|||
147544357|NCT02164539|532150270|FG005|Treatment Phase C (1 Week)|Physician Decision|0|||
147544358|NCT02164539|532150271|FG006|Treatment Phase C (1 Week)|Physician Decision|1|||
147544359|NCT02643966|532150272|FG000|First Screening Round|ineligible|1|||
147544360|NCT02643966|532150272|FG000|First Screening Round|excluded from analysis|2|||
147544361|NCT02643966|532150272|FG000|First Screening Round|Lost to Follow-up|56|||
147544362|NCT02643966|532150272|FG000|First Screening Round|Withdrawal by Subject|28|||
147544363|NCT02643966|532150272|FG000|First Screening Round|Death|1|||
147544364|NCT02643966|532150272|FG000|Between First and Second Screening|Lost to Follow-up|65|||
147544365|NCT02643966|532150272|FG000|Between First and Second Screening|Withdrawal by Subject|82|||
147210757|NCT00727441|530945351|FG002|Overall Study|Withdrawal by Subject|0|||
147210758|NCT01239992|530945352|FG000|Overall Study|Withdrawal by Subject|2|||
147210759|NCT00535288|530945353|FG000|Overall Study|Adverse Event|20|||
147210760|NCT00535288|530945354|FG001|Overall Study|Adverse Event|19|||
147210761|NCT00535288|530945355|FG002|Overall Study|Adverse Event|25|||
147210762|NCT00535288|530945356|FG003|Overall Study|Adverse Event|20|||
147441419|NCT01092143|531780891|FG004|Overall Study|Drop in FEV1 at visit 9|0|||
147441420|NCT01092143|531780887|FG000|Overall Study|Patient travel|0|||
147441421|NCT01092143|531780888|FG001|Overall Study|Patient travel|0|||
147441422|NCT01092143|531780889|FG002|Overall Study|Patient travel|0|||
147441423|NCT01092143|531780890|FG003|Overall Study|Patient travel|0|||
147441424|NCT01092143|531780891|FG004|Overall Study|Patient travel|1|||
147441425|NCT01092143|531780887|FG000|Overall Study|Non compliance with study medication|0|||
147441426|NCT01092143|531780888|FG001|Overall Study|Non compliance with study medication|0|||
147441427|NCT01092143|531780889|FG002|Overall Study|Non compliance with study medication|0|||
147441428|NCT01092143|531780890|FG003|Overall Study|Non compliance with study medication|0|||
147441429|NCT01092143|531780891|FG004|Overall Study|Non compliance with study medication|1|||
147441430|NCT01092143|531780887|FG000|Overall Study|Randomized by mistake|0|||
147441431|NCT01092143|531780888|FG001|Overall Study|Randomized by mistake|0|||
147441432|NCT01092143|531780889|FG002|Overall Study|Randomized by mistake|0|||
147441433|NCT01092143|531780890|FG003|Overall Study|Randomized by mistake|1|||
147441434|NCT01092143|531780891|FG004|Overall Study|Randomized by mistake|0|||
147441435|NCT01092143|531780887|FG000|Overall Study|Pregnancy|0|||
147441436|NCT01092143|531780888|FG001|Overall Study|Pregnancy|0|||
147441437|NCT01092143|531780889|FG002|Overall Study|Pregnancy|0|||
147441438|NCT01092143|531780890|FG003|Overall Study|Pregnancy|1|||
147441439|NCT01092143|531780891|FG004|Overall Study|Pregnancy|0|||
147441440|NCT03654976|531780892|FG000|Overall Study|Withdrawal by Subject|12|||
147441441|NCT03654976|531780893|FG001|Overall Study|Withdrawal by Subject|11|||
147544366|NCT02643966|532150272|FG000|Between First and Second Screening|women who skipped year 2 exam|11|||
147544367|NCT02643966|532150272|FG000|Second Screening Round|Withdrawal by Subject|20|||
147544368|NCT02643966|532150272|FG000|Second Screening Round|Lost to Follow-up|57|||
147544369|NCT02643966|532150272|FG000|Second Screening Round|Physician Decision|2|||
147544370|NCT02643966|532150272|FG000|Second Screening Round|Death|4|||
147544371|NCT02643966|532150272|FG000|Between Second and Third Screening|Lost to Follow-up|75|||
147544372|NCT02643966|532150272|FG000|Between Second and Third Screening|Death|1|||
147544373|NCT02643966|532150272|FG000|Between Second and Third Screening|Withdrawal by Subject|181|||
147544374|NCT02643966|532150272|FG000|Third Screening Round|PI excluded|2|||
147544375|NCT02643966|532150272|FG000|Third Screening Round|Lost to Follow-up|241|||
147544376|NCT03070431|532150275|FG000|Overall Study|Withdrawal by Subject|2|||
147544377|NCT03070431|532150275|FG000|Overall Study|Lost to Follow-up|2|||
147544378|NCT01542736|532150278|FG000|Overall Study|Death|1|||
147544379|NCT01783483|532150279|FG000|Overall Study|Death|3|||
147544380|NCT01783483|532150280|FG001|Overall Study|Death|3|||
147544381|NCT01783483|532150279|FG000|Overall Study|Lost to Follow-up|14|||
147544382|NCT01783483|532150280|FG001|Overall Study|Lost to Follow-up|10|||
147544383|NCT01783483|532150279|FG000|Overall Study|Withdrawal by Subject|2|||
147544384|NCT01783483|532150280|FG001|Overall Study|Withdrawal by Subject|1|||
147544385|NCT01783483|532150279|FG000|Overall Study|Physician Decision|1|||
147544386|NCT01783483|532150280|FG001|Overall Study|Physician Decision|1|||
147544387|NCT02065791|532150281|FG000|Overall Study|Closed Site|1|||
147544388|NCT02065791|532150282|FG001|Overall Study|Closed Site|1|||
147544389|NCT02065791|532150281|FG000|Overall Study|Withdrawal by Subject|11|||
147544390|NCT02065791|532150282|FG001|Overall Study|Withdrawal by Subject|5|||
147544391|NCT02065791|532150281|FG000|Overall Study|Lost to Follow-up|13|||
147544392|NCT02065791|532150282|FG001|Overall Study|Lost to Follow-up|9|||
147544393|NCT00051636|532150283|FG000|Period 1 - Core|Adverse Event|2|||
147544394|NCT00051636|532150284|FG001|Period 1 - Core|Adverse Event|2|||
147544395|NCT00051636|532150283|FG000|Period 1 - Core|Protocol Violation|1|||
147544396|NCT00051636|532150284|FG001|Period 1 - Core|Protocol Violation|0|||
147544397|NCT00051636|532150283|FG000|Period 1 - Core|Withdrawal by Subject|1|||
147544398|NCT00051636|532150284|FG001|Period 1 - Core|Withdrawal by Subject|2|||
147544399|NCT00051636|532150283|FG000|Period 1 - Core|Lost to Follow-up|0|||
147544400|NCT00051636|532150284|FG001|Period 1 - Core|Lost to Follow-up|2|||
147544401|NCT00051636|532150283|FG000|Period 2- Extended Observation Period|Lost to Follow-up|5|||
147544402|NCT00051636|532150284|FG001|Period 2- Extended Observation Period|Lost to Follow-up|4|||
147544403|NCT00051636|532150283|FG000|Period 2- Extended Observation Period|withdrew for nonclinical reason|12|||
147544404|NCT00051636|532150284|FG001|Period 2- Extended Observation Period|withdrew for nonclinical reason|7|||
147544405|NCT00051636|532150283|FG000|Period 2- Extended Observation Period|Clinical reasons other than Paget's|9|||
147544406|NCT00051636|532150284|FG001|Period 2- Extended Observation Period|Clinical reasons other than Paget's|2|||
147544407|NCT00051636|532150283|FG000|Period 2- Extended Observation Period|Death|4|||
147544408|NCT00051636|532150284|FG001|Period 2- Extended Observation Period|Death|5|||
147544409|NCT00051636|532150283|FG000|Period 2- Extended Observation Period|Amendment 6 Informed Consent Not Signed|40|||
147544410|NCT00051636|532150284|FG001|Period 2- Extended Observation Period|Amendment 6 Informed Consent Not Signed|12|||
147544411|NCT00975884|532150285|FG000|Overall Study|Adverse Event|1|||
147544412|NCT00975884|532150286|FG001|Overall Study|Adverse Event|0|||
147544413|NCT00975884|532150285|FG000|Overall Study|Lost to Follow-up|5|||
147544414|NCT00975884|532150286|FG001|Overall Study|Lost to Follow-up|3|||
147544415|NCT00975884|532150285|FG000|Overall Study|Withdrawal by Subject|9|||
147544416|NCT00975884|532150286|FG001|Overall Study|Withdrawal by Subject|9|||
147544417|NCT00975884|532150285|FG000|Overall Study|Other|1|||
147544418|NCT00975884|532150286|FG001|Overall Study|Other|3|||
147544419|NCT01174368|532150287|FG000|Overall Study|Withdrawal by Subject|1|||
147544420|NCT00363129|532150292|FG000|Overall Study|Withdrawal by Subject|11|||
147544421|NCT00363129|532150293|FG001|Overall Study|Withdrawal by Subject|18|||
147544422|NCT00363129|532150292|FG000|Overall Study|Adverse Event|8|||
147544423|NCT00363129|532150293|FG001|Overall Study|Adverse Event|3|||
147544424|NCT00363129|532150292|FG000|Overall Study|Alternate Treatment|2|||
147544425|NCT00363129|532150293|FG001|Overall Study|Alternate Treatment|4|||
147544426|NCT00363129|532150292|FG000|Overall Study|Other Medical Problems|2|||
147544427|NCT00363129|532150293|FG001|Overall Study|Other Medical Problems|4|||
147544428|NCT00363129|532150292|FG000|Overall Study|Death|0|||
147544429|NCT00363129|532150293|FG001|Overall Study|Death|1|||
147544430|NCT00363129|532150292|FG000|Overall Study|Other Reasons|6|||
147544431|NCT00363129|532150293|FG001|Overall Study|Other Reasons|3|||
147544432|NCT03707522|532150294|FG000|Overall Study|Lost to Follow-up|24|||
147544433|NCT03707522|532150295|FG001|Overall Study|Lost to Follow-up|27|||
147544434|NCT03707522|532150296|FG002|Overall Study|Lost to Follow-up|41|||
147544435|NCT03707522|532150297|FG003|Overall Study|Lost to Follow-up|36|||
147544436|NCT00383019|532150298|FG000|Overall Study|Adverse Event|5|||
147544437|NCT00383019|532150299|FG001|Overall Study|Adverse Event|1|||
147544438|NCT00383019|532150298|FG000|Overall Study|Withdrawal by Subject|0|||
147544439|NCT00383019|532150299|FG001|Overall Study|Withdrawal by Subject|1|||
147544440|NCT02278952|532150300|FG000|Overall Study|Insufficient Sample|6|||
147544441|NCT00659581|532150301|FG000|Overall Study|Adverse Event|1006|||
147544442|NCT00659581|532150301|FG000|Overall Study|Lack of Efficacy|1183|||
147544443|NCT00659581|532150301|FG000|Overall Study|Other|6393|||
147544444|NCT00944125|532150305|FG000|3 to 6 Months|Withdrawal by Subject|0|||
147544445|NCT00944125|532150306|FG001|3 to 6 Months|Withdrawal by Subject|2|||
147544446|NCT00944125|532150305|FG000|6 Months to Study Completion|Withdrawal by Subject|0|||
147544447|NCT00944125|532150306|FG001|6 Months to Study Completion|Withdrawal by Subject|2|||
147544448|NCT02989610|532150307|FG000|Overall Study|Withdrawal by Subject|20|||
147544449|NCT02989610|532150307|FG000|Overall Study|Departure of PI from Site|8|||
147544450|NCT02989610|532150307|FG000|Overall Study|Subject Participation Terminated by Investigator|6|||
147544451|NCT02989610|532150307|FG000|Overall Study|Lost to Follow-up|3|||
147544452|NCT02989610|532150307|FG000|Overall Study|Death|3|||
147544453|NCT02989610|532150307|FG000|Overall Study|System Explant|3|||
147544454|NCT02989610|532150307|FG000|Overall Study|Subject Non-Compliance|2|||
147544455|NCT02989610|532150307|FG000|Overall Study|System Revision|2|||
147544456|NCT02989610|532150307|FG000|Overall Study|PI Left, Study Closing|1|||
147544457|NCT02989610|532150307|FG000|Overall Study|Site Discontinued Participation in the Study|1|||
147544458|NCT02989610|532150307|FG000|Overall Study|Unable to Complete Visit Due to PI Leaving University|1|||
147544459|NCT04508621|532150310|FG000|Overall Study|Adverse Event|39|||
147544460|NCT04508621|532150311|FG001|Overall Study|Adverse Event|16|||
147544461|NCT04508621|532150310|FG000|Overall Study|Lack of Efficacy|2|||
147544462|NCT04508621|532150311|FG001|Overall Study|Lack of Efficacy|8|||
147544463|NCT04508621|532150310|FG000|Overall Study|Physician Decision|0|||
147544464|NCT04508621|532150311|FG001|Overall Study|Physician Decision|1|||
147544465|NCT04508621|532150310|FG000|Overall Study|Withdrawal by Subject|10|||
147544466|NCT04508621|532150311|FG001|Overall Study|Withdrawal by Subject|14|||
147544467|NCT04508621|532150310|FG000|Overall Study|Lost to Follow-up|12|||
147544468|NCT04508621|532150311|FG001|Overall Study|Lost to Follow-up|9|||
147544469|NCT04508621|532150310|FG000|Overall Study|COVID-19 related crisis|3|||
147544470|NCT04508621|532150311|FG001|Overall Study|COVID-19 related crisis|0|||
147544471|NCT04508621|532150310|FG000|Overall Study|Subject non-compliance|1|||
147544472|NCT04508621|532150311|FG001|Overall Study|Subject non-compliance|0|||
147544473|NCT03053622|532152142|FG000|Overall Study|Lost to Follow-up|0|||
147544474|NCT03053622|532152143|FG001|Overall Study|Lost to Follow-up|0|||
147544475|NCT03053622|532152144|FG002|Overall Study|Lost to Follow-up|0|||
147544476|NCT03053622|532152145|FG003|Overall Study|Lost to Follow-up|1|||
147544477|NCT02598622|532152146|FG000|Overall Study|Withdrawal by Subject|3|||
147544478|NCT02598622|532152147|FG001|Overall Study|Withdrawal by Subject|0|||
147544479|NCT02598622|532152146|FG000|Overall Study|Physician Decision|3|||
147544480|NCT02598622|532152147|FG001|Overall Study|Physician Decision|0|||
147544481|NCT00681824|532152151|FG000|Overall Study|withdrawn by investigator|0|||
147544482|NCT00681824|532152152|FG001|Overall Study|withdrawn by investigator|0|||
147544483|NCT00681824|532152153|FG002|Overall Study|withdrawn by investigator|1|||
147544484|NCT00681824|532152151|FG000|Overall Study|scheduling conflict|1|||
147544485|NCT00681824|532152152|FG001|Overall Study|scheduling conflict|0|||
147544486|NCT00681824|532152153|FG002|Overall Study|scheduling conflict|0|||
147544487|NCT00681824|532152151|FG000|Overall Study|Death|0|||
147544488|NCT00681824|532152152|FG001|Overall Study|Death|1|||
147544489|NCT00681824|532152153|FG002|Overall Study|Death|0|||
147544490|NCT03591107|532152156|FG000|Overall Study|Same patient in both arms|1|||
147544491|NCT03591107|532152157|FG001|Overall Study|Same patient in both arms|1|||
147544492|NCT03591107|532152156|FG000|Overall Study|Sought care at other clinics|0|||
147544493|NCT03591107|532152157|FG001|Overall Study|Sought care at other clinics|2|||
147544494|NCT03591107|532152156|FG000|Overall Study|Discharged from clinic|0|||
147544495|NCT03591107|532152157|FG001|Overall Study|Discharged from clinic|1|||
147544496|NCT03591107|532152156|FG000|Overall Study|Withdrawal by Subject|0|||
147544497|NCT03591107|532152157|FG001|Overall Study|Withdrawal by Subject|1|||
147544498|NCT01902134|532152158|FG000|Overall Study|Adverse Event|3|||
147544499|NCT01902134|532152159|FG001|Overall Study|Adverse Event|1|||
147544500|NCT01902134|532152160|FG002|Overall Study|Adverse Event|2|||
147544501|NCT01902134|532152161|FG003|Overall Study|Adverse Event|1|||
147544502|NCT01902134|532152162|FG004|Overall Study|Adverse Event|1|||
147544503|NCT01902134|532152163|FG005|Overall Study|Adverse Event|3|||
147544504|NCT01902134|532152158|FG000|Overall Study|Lack of Efficacy|0|||
147544505|NCT01902134|532152159|FG001|Overall Study|Lack of Efficacy|0|||
147544506|NCT01902134|532152160|FG002|Overall Study|Lack of Efficacy|2|||
147544507|NCT01902134|532152161|FG003|Overall Study|Lack of Efficacy|0|||
147544508|NCT01902134|532152162|FG004|Overall Study|Lack of Efficacy|0|||
147544509|NCT01902134|532152163|FG005|Overall Study|Lack of Efficacy|1|||
147544510|NCT01902134|532152158|FG000|Overall Study|Physician Decision|0|||
147544511|NCT01902134|532152159|FG001|Overall Study|Physician Decision|1|||
147544512|NCT01902134|532152160|FG002|Overall Study|Physician Decision|0|||
147544513|NCT01902134|532152161|FG003|Overall Study|Physician Decision|0|||
147544514|NCT01902134|532152162|FG004|Overall Study|Physician Decision|0|||
147544515|NCT01902134|532152163|FG005|Overall Study|Physician Decision|0|||
147544516|NCT01902134|532152158|FG000|Overall Study|Protocol Violation|0|||
147544517|NCT01902134|532152159|FG001|Overall Study|Protocol Violation|0|||
147544518|NCT01902134|532152160|FG002|Overall Study|Protocol Violation|0|||
147544519|NCT01902134|532152161|FG003|Overall Study|Protocol Violation|0|||
147544520|NCT01902134|532152162|FG004|Overall Study|Protocol Violation|0|||
147544521|NCT01902134|532152163|FG005|Overall Study|Protocol Violation|1|||
147544522|NCT01902134|532152158|FG000|Overall Study|Withdrawal by Subject|4|||
147544523|NCT01902134|532152159|FG001|Overall Study|Withdrawal by Subject|8|||
147544524|NCT01902134|532152160|FG002|Overall Study|Withdrawal by Subject|9|||
147544525|NCT01902134|532152161|FG003|Overall Study|Withdrawal by Subject|1|||
147544526|NCT01902134|532152162|FG004|Overall Study|Withdrawal by Subject|5|||
147544527|NCT01902134|532152163|FG005|Overall Study|Withdrawal by Subject|4|||
147544528|NCT01902134|532152158|FG000|Overall Study|no compliance|1|||
147544529|NCT01902134|532152159|FG001|Overall Study|no compliance|0|||
147544530|NCT01902134|532152160|FG002|Overall Study|no compliance|0|||
147544531|NCT01902134|532152161|FG003|Overall Study|no compliance|0|||
147544532|NCT01902134|532152162|FG004|Overall Study|no compliance|0|||
147544533|NCT01902134|532152163|FG005|Overall Study|no compliance|0|||
147544534|NCT01902134|532152158|FG000|Overall Study|Other|0|||
147544535|NCT01902134|532152159|FG001|Overall Study|Other|1|||
147544536|NCT01902134|532152160|FG002|Overall Study|Other|2|||
147544537|NCT01902134|532152161|FG003|Overall Study|Other|0|||
147544538|NCT01902134|532152162|FG004|Overall Study|Other|1|||
147544539|NCT01902134|532152163|FG005|Overall Study|Other|0|||
147544540|NCT00305110|532152164|FG000|Overall Study|Missing data|29|||
147544541|NCT00736099|532152169|FG000|Overall Study|Adverse Event|61|||
147544542|NCT00736099|532152170|FG001|Overall Study|Adverse Event|18|||
147544543|NCT00736099|532152169|FG000|Overall Study|Protocol Violation|10|||
147544544|NCT00736099|532152170|FG001|Overall Study|Protocol Violation|4|||
147544545|NCT00736099|532152169|FG000|Overall Study|Lost to Follow-up|12|||
147544546|NCT00736099|532152170|FG001|Overall Study|Lost to Follow-up|5|||
147544547|NCT00736099|532152169|FG000|Overall Study|Withdrawal by Subject|42|||
147544548|NCT00736099|532152170|FG001|Overall Study|Withdrawal by Subject|13|||
147544549|NCT00736099|532152169|FG000|Overall Study|Lack of Efficacy|15|||
147544550|NCT00736099|532152170|FG001|Overall Study|Lack of Efficacy|8|||
147544551|NCT00736099|532152169|FG000|Overall Study|Other reason|43|||
147544552|NCT00736099|532152170|FG001|Overall Study|Other reason|10|||
147544553|NCT01637961|532152171|FG000|Overall Study|Ineligible: wrong primary|1|||
147544554|NCT01637961|532152171|FG000|Overall Study|Ineligible: inadequate pathology|1|||
147544555|NCT03101293|532152172|FG000|Washout Period (at Least 7 Days)|Positive drug urine screen|1|||
147544556|NCT03101293|532152173|FG001|Washout Period (at Least 7 Days)|Positive drug urine screen|0|||
147544557|NCT03451331|532152182|FG000|Overall Study|Withdrawal by Subject|1|||
147544558|NCT03451331|532152183|FG001|Overall Study|Withdrawal by Subject|0|||
147544559|NCT03451331|532152182|FG000|Overall Study|Unable to start treatment.|1|||
147544560|NCT03451331|532152183|FG001|Overall Study|Unable to start treatment.|1|||
147544561|NCT02773446|532152184|FG000|First Admission|Withdrawal by Subject|0|||
147544562|NCT02773446|532152185|FG001|First Admission|Withdrawal by Subject|0|||
147544563|NCT02773446|532152186|FG002|First Admission|Withdrawal by Subject|0|||
147544564|NCT02773446|532152187|FG003|First Admission|Withdrawal by Subject|1|||
147544565|NCT02773446|532152188|FG004|First Admission|Withdrawal by Subject|0|||
147544566|NCT02773446|532152189|FG005|First Admission|Withdrawal by Subject|0|||
147544567|NCT02773446|532152184|FG000|First Admission|Lost to Follow-up|1|||
147544568|NCT02773446|532152185|FG001|First Admission|Lost to Follow-up|0|||
147544569|NCT02773446|532152186|FG002|First Admission|Lost to Follow-up|0|||
147544570|NCT02773446|532152187|FG003|First Admission|Lost to Follow-up|0|||
147544571|NCT02773446|532152188|FG004|First Admission|Lost to Follow-up|0|||
147544572|NCT02773446|532152189|FG005|First Admission|Lost to Follow-up|0|||
147544573|NCT04023994|532152190|FG000|Overall Study|Lost to Follow-up|0|||
147544574|NCT04023994|532152191|FG001|Overall Study|Lost to Follow-up|1|||
147544575|NCT04023994|532152192|FG002|Overall Study|Lost to Follow-up|2|||
147544576|NCT04023994|532152193|FG003|Overall Study|Lost to Follow-up|0|||
147544577|NCT04023994|532152194|FG004|Overall Study|Lost to Follow-up|0|||
147544578|NCT04023994|532152195|FG005|Overall Study|Lost to Follow-up|0|||
147544579|NCT04023994|532152190|FG000|Overall Study|Withdrawal by Subject|0|||
147544580|NCT04023994|532152191|FG001|Overall Study|Withdrawal by Subject|0|||
147544581|NCT04023994|532152192|FG002|Overall Study|Withdrawal by Subject|0|||
147544582|NCT04023994|532152193|FG003|Overall Study|Withdrawal by Subject|1|||
147544583|NCT04023994|532152194|FG004|Overall Study|Withdrawal by Subject|0|||
147544584|NCT04023994|532152195|FG005|Overall Study|Withdrawal by Subject|0|||
147544585|NCT01613131|532152196|FG000|Overall Study|Withdrawal by Subject|3|||
147544586|NCT01613131|532152197|FG001|Overall Study|Withdrawal by Subject|5|||
147544587|NCT01020305|532152198|FG000|Overall Study|Adverse Event|2|||
147544588|NCT00467818|532152199|FG000|Overall Study|Adverse Event|1|||
147544589|NCT00467818|532152200|FG001|Overall Study|Adverse Event|0|||
147544590|NCT00467818|532152199|FG000|Overall Study|Lost to Follow-up|2|||
147544591|NCT00467818|532152200|FG001|Overall Study|Lost to Follow-up|2|||
147544592|NCT01017029|532152201|FG000|Overall Study|Lost to Follow-up|1|||
147544593|NCT01017029|532152202|FG001|Overall Study|Lost to Follow-up|0|||
147544594|NCT01017029|532152201|FG000|Overall Study|Administrative problem|0|||
147544595|NCT01017029|532152202|FG001|Overall Study|Administrative problem|1|||
147544596|NCT01017029|532152201|FG000|Overall Study|Death|3|||
147544597|NCT01017029|532152202|FG001|Overall Study|Death|1|||
147544598|NCT02770716|532152205|FG000|Overall Study|Death|101|||
147544599|NCT02770716|532152206|FG001|Overall Study|Death|45|||
147544600|NCT02770716|532152205|FG000|Overall Study|Withdrawal by Subject|4|||
147544601|NCT02770716|532152206|FG001|Overall Study|Withdrawal by Subject|2|||
147544602|NCT02770716|532152205|FG000|Overall Study|Lost to Follow-up|1|||
147544603|NCT02770716|532152206|FG001|Overall Study|Lost to Follow-up|0|||
147544604|NCT02770716|532152205|FG000|Overall Study|Various reasons|6|||
147544605|NCT02770716|532152206|FG001|Overall Study|Various reasons|2|||
147544606|NCT02753400|532152208|FG000|Overall Study|Adverse Event|3|||
147544607|NCT02753400|532152209|FG001|Overall Study|Adverse Event|0|||
147544608|NCT02753400|532152208|FG000|Overall Study|Withdrawal by Subject|2|||
147544609|NCT02753400|532152209|FG001|Overall Study|Withdrawal by Subject|1|||
147544610|NCT03989115|532152210|FG000|Overall Study|Withdrawal by Subject|2|||
147544611|NCT03989115|532152211|FG001|Overall Study|Withdrawal by Subject|1|||
147544612|NCT03989115|532152212|FG002|Overall Study|Withdrawal by Subject|3|||
147544613|NCT03989115|532152213|FG003|Overall Study|Withdrawal by Subject|0|||
147544614|NCT03989115|532152214|FG004|Overall Study|Withdrawal by Subject|17|||
147544615|NCT03989115|532152215|FG005|Overall Study|Withdrawal by Subject|1|||
147544616|NCT03989115|532152216|FG006|Overall Study|Withdrawal by Subject|0|||
147544617|NCT03989115|532152217|FG007|Overall Study|Withdrawal by Subject|0|||
147544618|NCT03989115|532152210|FG000|Overall Study|Sponsor decision to terminate the study|1|||
147544619|NCT03989115|532152211|FG001|Overall Study|Sponsor decision to terminate the study|1|||
147544620|NCT03989115|532152212|FG002|Overall Study|Sponsor decision to terminate the study|0|||
147544621|NCT03989115|532152213|FG003|Overall Study|Sponsor decision to terminate the study|1|||
147544622|NCT03989115|532152214|FG004|Overall Study|Sponsor decision to terminate the study|11|||
147544623|NCT03989115|532152215|FG005|Overall Study|Sponsor decision to terminate the study|0|||
147544624|NCT03989115|532152216|FG006|Overall Study|Sponsor decision to terminate the study|2|||
147544625|NCT03989115|532152217|FG007|Overall Study|Sponsor decision to terminate the study|1|||
147544626|NCT03989115|532152210|FG000|Overall Study|Lost to Follow-up|2|||
147544627|NCT03989115|532152211|FG001|Overall Study|Lost to Follow-up|0|||
147544628|NCT03989115|532152212|FG002|Overall Study|Lost to Follow-up|0|||
147544629|NCT03989115|532152213|FG003|Overall Study|Lost to Follow-up|0|||
147544630|NCT03989115|532152214|FG004|Overall Study|Lost to Follow-up|1|||
147544631|NCT03989115|532152215|FG005|Overall Study|Lost to Follow-up|0|||
147544632|NCT03989115|532152216|FG006|Overall Study|Lost to Follow-up|0|||
147544633|NCT03989115|532152217|FG007|Overall Study|Lost to Follow-up|0|||
147544634|NCT03989115|532152210|FG000|Overall Study|Death|2|||
147544635|NCT03989115|532152211|FG001|Overall Study|Death|2|||
147544636|NCT03989115|532152212|FG002|Overall Study|Death|9|||
147544637|NCT03989115|532152213|FG003|Overall Study|Death|6|||
147544638|NCT03989115|532152214|FG004|Overall Study|Death|31|||
147544639|NCT03989115|532152215|FG005|Overall Study|Death|6|||
147544640|NCT03989115|532152216|FG006|Overall Study|Death|2|||
147544641|NCT03989115|532152217|FG007|Overall Study|Death|3|||
147544642|NCT03989115|532152210|FG000|Overall Study|Other|1|||
147544643|NCT03989115|532152211|FG001|Overall Study|Other|2|||
147544644|NCT03989115|532152212|FG002|Overall Study|Other|0|||
147544645|NCT03989115|532152213|FG003|Overall Study|Other|0|||
147544646|NCT03989115|532152214|FG004|Overall Study|Other|5|||
147544647|NCT03989115|532152215|FG005|Overall Study|Other|0|||
147544648|NCT03989115|532152216|FG006|Overall Study|Other|0|||
147544649|NCT03989115|532152217|FG007|Overall Study|Other|0|||
147544650|NCT02354976|532152226|FG000|Overall Study|Other - reason not specified|1|||
147544651|NCT02354976|532152227|FG001|Overall Study|Other - reason not specified|0|||
147544652|NCT02354976|532152228|FG002|Overall Study|Other - reason not specified|1|||
147544653|NCT02354976|532152226|FG000|Overall Study|Study-specifc withdrawal criteria|0|||
147544654|NCT02354976|532152227|FG001|Overall Study|Study-specifc withdrawal criteria|1|||
147544655|NCT02354976|532152228|FG002|Overall Study|Study-specifc withdrawal criteria|0|||
147544656|NCT02354976|532152226|FG000|Overall Study|Adverse Event|1|||
147544657|NCT02354976|532152227|FG001|Overall Study|Adverse Event|0|||
147544658|NCT02354976|532152228|FG002|Overall Study|Adverse Event|2|||
147544659|NCT03118765|532152229|FG000|Overall Study|Withdrawal by Subject|0|||
147544660|NCT03118765|532152230|FG001|Overall Study|Withdrawal by Subject|0|||
147544661|NCT03118765|532152231|FG002|Overall Study|Withdrawal by Subject|1|||
147544662|NCT03118765|532152232|FG003|Overall Study|Withdrawal by Subject|0|||
147544663|NCT03118765|532152233|FG004|Overall Study|Withdrawal by Subject|0|||
147544664|NCT03118765|532152229|FG000|Overall Study|Adverse Event|1|||
147544665|NCT03118765|532152230|FG001|Overall Study|Adverse Event|1|||
147544666|NCT03118765|532152231|FG002|Overall Study|Adverse Event|1|||
147544667|NCT03118765|532152232|FG003|Overall Study|Adverse Event|1|||
147544668|NCT03118765|532152233|FG004|Overall Study|Adverse Event|1|||
147544669|NCT03118765|532152229|FG000|Overall Study|Non compliance with Study Procedures|0|||
147544670|NCT03118765|532152230|FG001|Overall Study|Non compliance with Study Procedures|0|||
147544671|NCT03118765|532152231|FG002|Overall Study|Non compliance with Study Procedures|0|||
147544672|NCT03118765|532152232|FG003|Overall Study|Non compliance with Study Procedures|1|||
147544673|NCT03118765|532152233|FG004|Overall Study|Non compliance with Study Procedures|0|||
147544674|NCT03118765|532152229|FG000|Overall Study|Violation of Inclusion/ExclusionCriteria|0|||
147544675|NCT03118765|532152230|FG001|Overall Study|Violation of Inclusion/ExclusionCriteria|1|||
147441442|NCT03654976|531780892|FG000|Overall Study|Reason stated as 'Other' in CRF|10|||
147441443|NCT03654976|531780893|FG001|Overall Study|Reason stated as 'Other' in CRF|6|||
147441444|NCT03654976|531780892|FG000|Overall Study|Adverse Event|5|||
147441445|NCT03654976|531780893|FG001|Overall Study|Adverse Event|0|||
147441446|NCT03654976|531780892|FG000|Overall Study|Lost to Follow-up|2|||
147441447|NCT03654976|531780893|FG001|Overall Study|Lost to Follow-up|0|||
147441448|NCT03654976|531780892|FG000|Overall Study|Lack of Efficacy|0|||
147441449|NCT03654976|531780893|FG001|Overall Study|Lack of Efficacy|1|||
147441450|NCT00117598|531780894|FG000|Prior to Treatment Cross Over|Death|40|||
147441451|NCT00117598|531780895|FG001|Prior to Treatment Cross Over|Death|41|||
147441452|NCT00117598|531780896|FG002|Prior to Treatment Cross Over|Death|37|||
147441453|NCT00117598|531780897|FG003|Prior to Treatment Cross Over|Death|0|||
147441454|NCT00117598|531780898|FG004|Prior to Treatment Cross Over|Death|0|||
147441455|NCT00117598|531780894|FG000|Prior to Treatment Cross Over|Lost to Follow-up|0|||
147441456|NCT00117598|531780895|FG001|Prior to Treatment Cross Over|Lost to Follow-up|2|||
147441457|NCT00117598|531780896|FG002|Prior to Treatment Cross Over|Lost to Follow-up|2|||
147441458|NCT00117598|531780897|FG003|Prior to Treatment Cross Over|Lost to Follow-up|0|||
147441459|NCT00117598|531780898|FG004|Prior to Treatment Cross Over|Lost to Follow-up|0|||
147441460|NCT00117598|531780894|FG000|Prior to Treatment Cross Over|Withdrawal by Subject|2|||
147441461|NCT00117598|531780895|FG001|Prior to Treatment Cross Over|Withdrawal by Subject|1|||
147441462|NCT00117598|531780896|FG002|Prior to Treatment Cross Over|Withdrawal by Subject|4|||
147441463|NCT00117598|531780897|FG003|Prior to Treatment Cross Over|Withdrawal by Subject|0|||
147441464|NCT00117598|531780898|FG004|Prior to Treatment Cross Over|Withdrawal by Subject|0|||
147441465|NCT00117598|531780894|FG000|Prior to Treatment Cross Over|Other|15|||
147441466|NCT00117598|531780895|FG001|Prior to Treatment Cross Over|Other|9|||
147441467|NCT00117598|531780896|FG002|Prior to Treatment Cross Over|Other|9|||
147441468|NCT00117598|531780897|FG003|Prior to Treatment Cross Over|Other|0|||
147441469|NCT00117598|531780898|FG004|Prior to Treatment Cross Over|Other|0|||
147441470|NCT00117598|531780894|FG000|After Treament Cross Over|Death|0|||
147441471|NCT00117598|531780895|FG001|After Treament Cross Over|Death|0|||
147441472|NCT00117598|531780896|FG002|After Treament Cross Over|Death|0|||
147441473|NCT00117598|531780897|FG003|After Treament Cross Over|Death|1|||
147441474|NCT00117598|531780898|FG004|After Treament Cross Over|Death|2|||
147441475|NCT00117598|531780894|FG000|After Treament Cross Over|Withdrawal by Subject|0|||
147441476|NCT00117598|531780895|FG001|After Treament Cross Over|Withdrawal by Subject|0|||
147441477|NCT00117598|531780896|FG002|After Treament Cross Over|Withdrawal by Subject|0|||
147441478|NCT00117598|531780897|FG003|After Treament Cross Over|Withdrawal by Subject|1|||
147441479|NCT00117598|531780898|FG004|After Treament Cross Over|Withdrawal by Subject|0|||
147441480|NCT00117598|531780894|FG000|After Treament Cross Over|Other|0|||
147441481|NCT00117598|531780895|FG001|After Treament Cross Over|Other|0|||
147441482|NCT00117598|531780896|FG002|After Treament Cross Over|Other|0|||
147441483|NCT00117598|531780897|FG003|After Treament Cross Over|Other|1|||
147441484|NCT00117598|531780898|FG004|After Treament Cross Over|Other|2|||
147441485|NCT00545064|531780899|FG000|Overall Study|Lost to Follow-up|3|||
147441486|NCT00545064|531780899|FG000|Overall Study|Withdrawal by Subject|2|||
147441487|NCT00545064|531780899|FG000|Overall Study|did not complete course of treatment|1|||
147441488|NCT00545064|531780899|FG000|Overall Study|cancel all appointments, no rebooking|1|||
147441489|NCT00545064|531780899|FG000|Overall Study|inclement weather|1|||
147441490|NCT04688775|531780902|FG000|Placebo-controlled Period|Randomized, not treated|1|||
147441491|NCT04688775|531780903|FG001|Placebo-controlled Period|Randomized, not treated|1|||
147441492|NCT04688775|531780904|FG002|Placebo-controlled Period|Randomized, not treated|0|||
147441493|NCT04688775|531780905|FG003|Placebo-controlled Period|Randomized, not treated|0|||
147441494|NCT04688775|531780902|FG000|Placebo-controlled Period|Adverse Event|2|||
147441495|NCT04688775|531780903|FG001|Placebo-controlled Period|Adverse Event|0|||
147441496|NCT04688775|531780904|FG002|Placebo-controlled Period|Adverse Event|0|||
147441497|NCT04688775|531780905|FG003|Placebo-controlled Period|Adverse Event|0|||
147441498|NCT04688775|531780902|FG000|Placebo-controlled Period|Lack of Efficacy|1|||
147441499|NCT04688775|531780903|FG001|Placebo-controlled Period|Lack of Efficacy|2|||
147441500|NCT04688775|531780904|FG002|Placebo-controlled Period|Lack of Efficacy|0|||
147441501|NCT04688775|531780905|FG003|Placebo-controlled Period|Lack of Efficacy|0|||
147441502|NCT04688775|531780902|FG000|Placebo-controlled Period|Protocol Violation|0|||
147441503|NCT04688775|531780903|FG001|Placebo-controlled Period|Protocol Violation|1|||
147441504|NCT04688775|531780904|FG002|Placebo-controlled Period|Protocol Violation|0|||
147441505|NCT04688775|531780905|FG003|Placebo-controlled Period|Protocol Violation|0|||
147441506|NCT04688775|531780902|FG000|Placebo-controlled Period|Withdrawal by Subject|1|||
147441507|NCT04688775|531780903|FG001|Placebo-controlled Period|Withdrawal by Subject|6|||
147441508|NCT04688775|531780904|FG002|Placebo-controlled Period|Withdrawal by Subject|0|||
147441509|NCT04688775|531780905|FG003|Placebo-controlled Period|Withdrawal by Subject|0|||
147441510|NCT04688775|531780902|FG000|Placebo-controlled Period|Other reasons|0|||
147441511|NCT04688775|531780903|FG001|Placebo-controlled Period|Other reasons|1|||
147441512|NCT04688775|531780904|FG002|Placebo-controlled Period|Other reasons|0|||
147441513|NCT04688775|531780905|FG003|Placebo-controlled Period|Other reasons|0|||
147441514|NCT04688775|531780902|FG000|Delayed Start Period|Adverse Event|0|||
147544676|NCT03118765|532152231|FG002|Overall Study|Violation of Inclusion/ExclusionCriteria|1|||
147544677|NCT03118765|532152232|FG003|Overall Study|Violation of Inclusion/ExclusionCriteria|0|||
147544678|NCT03118765|532152233|FG004|Overall Study|Violation of Inclusion/ExclusionCriteria|0|||
147544679|NCT03118765|532152229|FG000|Overall Study|COPD Exacerbation|1|||
147544680|NCT03118765|532152230|FG001|Overall Study|COPD Exacerbation|0|||
147544681|NCT03118765|532152231|FG002|Overall Study|COPD Exacerbation|0|||
147544682|NCT03118765|532152232|FG003|Overall Study|COPD Exacerbation|1|||
147544683|NCT03118765|532152233|FG004|Overall Study|COPD Exacerbation|0|||
147544684|NCT03118765|532152229|FG000|Overall Study|Lost to Follow-up|1|||
147544685|NCT03118765|532152230|FG001|Overall Study|Lost to Follow-up|0|||
147544686|NCT03118765|532152231|FG002|Overall Study|Lost to Follow-up|1|||
147544687|NCT03118765|532152232|FG003|Overall Study|Lost to Follow-up|0|||
147544688|NCT03118765|532152233|FG004|Overall Study|Lost to Follow-up|0|||
147544689|NCT03118765|532152229|FG000|Overall Study|Sponsor Decision|1|||
147544690|NCT03118765|532152230|FG001|Overall Study|Sponsor Decision|0|||
147544691|NCT03118765|532152231|FG002|Overall Study|Sponsor Decision|1|||
147544692|NCT03118765|532152232|FG003|Overall Study|Sponsor Decision|0|||
147544693|NCT03118765|532152233|FG004|Overall Study|Sponsor Decision|1|||
147544694|NCT01612702|532152234|FG000|Overall Study|Protocol Violation|11|||
147544695|NCT01612702|532152235|FG001|Overall Study|Protocol Violation|11|||
147544696|NCT03674827|532152236|FG000|Treatment Phase|Adverse Event|0|||
147544697|NCT03674827|532152237|FG001|Treatment Phase|Adverse Event|0|||
147544698|NCT03674827|532152238|FG002|Treatment Phase|Adverse Event|0|||
147544699|NCT03674827|532152239|FG003|Treatment Phase|Adverse Event|0|||
147544700|NCT03674827|532152240|FG004|Treatment Phase|Adverse Event|0|||
147544701|NCT03674827|532152241|FG005|Treatment Phase|Adverse Event|2|||
147544702|NCT03674827|532152236|FG000|Treatment Phase|Death|2|||
147544703|NCT03674827|532152237|FG001|Treatment Phase|Death|0|||
147544704|NCT03674827|532152238|FG002|Treatment Phase|Death|0|||
147544705|NCT03674827|532152239|FG003|Treatment Phase|Death|0|||
147544706|NCT03674827|532152240|FG004|Treatment Phase|Death|1|||
147544707|NCT03674827|532152241|FG005|Treatment Phase|Death|0|||
147544708|NCT03674827|532152236|FG000|Treatment Phase|Progressive Disease|0|||
147544709|NCT03674827|532152237|FG001|Treatment Phase|Progressive Disease|4|||
147544710|NCT03674827|532152238|FG002|Treatment Phase|Progressive Disease|3|||
147544711|NCT03674827|532152239|FG003|Treatment Phase|Progressive Disease|4|||
147544712|NCT03674827|532152240|FG004|Treatment Phase|Progressive Disease|4|||
147544713|NCT03674827|532152241|FG005|Treatment Phase|Progressive Disease|9|||
147544714|NCT03674827|532152236|FG000|Treatment Phase|Study Terminated by Sponsor|0|||
147544715|NCT03674827|532152237|FG001|Treatment Phase|Study Terminated by Sponsor|0|||
147544716|NCT03674827|532152238|FG002|Treatment Phase|Study Terminated by Sponsor|0|||
147544717|NCT03674827|532152239|FG003|Treatment Phase|Study Terminated by Sponsor|0|||
147544718|NCT03674827|532152240|FG004|Treatment Phase|Study Terminated by Sponsor|0|||
147544719|NCT03674827|532152241|FG005|Treatment Phase|Study Terminated by Sponsor|1|||
147544720|NCT03674827|532152236|FG000|Treatment Phase|Withdrawal by Subject|0|||
147544721|NCT03674827|532152237|FG001|Treatment Phase|Withdrawal by Subject|0|||
147544722|NCT03674827|532152238|FG002|Treatment Phase|Withdrawal by Subject|0|||
147544723|NCT03674827|532152239|FG003|Treatment Phase|Withdrawal by Subject|0|||
147544724|NCT03674827|532152240|FG004|Treatment Phase|Withdrawal by Subject|0|||
147544725|NCT03674827|532152241|FG005|Treatment Phase|Withdrawal by Subject|1|||
147544726|NCT03674827|532152236|FG000|Treatment Phase|Global Deterioration of Health Status|1|||
147544727|NCT03674827|532152237|FG001|Treatment Phase|Global Deterioration of Health Status|0|||
147544728|NCT03674827|532152238|FG002|Treatment Phase|Global Deterioration of Health Status|0|||
147544729|NCT03674827|532152239|FG003|Treatment Phase|Global Deterioration of Health Status|0|||
147544730|NCT03674827|532152240|FG004|Treatment Phase|Global Deterioration of Health Status|0|||
147544731|NCT03674827|532152241|FG005|Treatment Phase|Global Deterioration of Health Status|2|||
147544732|NCT03674827|532152236|FG000|Treatment Phase|Other|0|||
147544733|NCT03674827|532152237|FG001|Treatment Phase|Other|1|||
147544734|NCT03674827|532152238|FG002|Treatment Phase|Other|0|||
147544735|NCT03674827|532152239|FG003|Treatment Phase|Other|0|||
147544736|NCT03674827|532152240|FG004|Treatment Phase|Other|0|||
147544737|NCT03674827|532152241|FG005|Treatment Phase|Other|1|||
147544738|NCT03674827|532152236|FG000|Long-Term Follow-up Phase|Death|2|||
147544739|NCT03674827|532152237|FG001|Long-Term Follow-up Phase|Death|4|||
147544740|NCT03674827|532152238|FG002|Long-Term Follow-up Phase|Death|2|||
147544741|NCT03674827|532152239|FG003|Long-Term Follow-up Phase|Death|3|||
147544742|NCT03674827|532152240|FG004|Long-Term Follow-up Phase|Death|2|||
147544743|NCT03674827|532152241|FG005|Long-Term Follow-up Phase|Death|6|||
147544744|NCT03674827|532152236|FG000|Long-Term Follow-up Phase|Study Terminated by Sponsor|0|||
147544745|NCT03674827|532152237|FG001|Long-Term Follow-up Phase|Study Terminated by Sponsor|0|||
147544746|NCT03674827|532152238|FG002|Long-Term Follow-up Phase|Study Terminated by Sponsor|1|||
147544747|NCT03674827|532152239|FG003|Long-Term Follow-up Phase|Study Terminated by Sponsor|1|||
147544748|NCT03674827|532152240|FG004|Long-Term Follow-up Phase|Study Terminated by Sponsor|2|||
147544749|NCT03674827|532152241|FG005|Long-Term Follow-up Phase|Study Terminated by Sponsor|8|||
147544750|NCT03674827|532152236|FG000|Long-Term Follow-up Phase|Withdrawal by Subject|1|||
147544751|NCT03674827|532152237|FG001|Long-Term Follow-up Phase|Withdrawal by Subject|1|||
147544752|NCT03674827|532152238|FG002|Long-Term Follow-up Phase|Withdrawal by Subject|0|||
147544753|NCT03674827|532152239|FG003|Long-Term Follow-up Phase|Withdrawal by Subject|0|||
147544754|NCT03674827|532152240|FG004|Long-Term Follow-up Phase|Withdrawal by Subject|1|||
147544755|NCT03674827|532152241|FG005|Long-Term Follow-up Phase|Withdrawal by Subject|2|||
147544756|NCT00527397|532152242|FG000|Overall Study|Adverse Event|3|||
147544757|NCT00527397|532152242|FG000|Overall Study|Lack of Efficacy|1|||
147544758|NCT00527397|532152242|FG000|Overall Study|Protocol Violation|1|||
147544759|NCT00527397|532152242|FG000|Overall Study|Withdrawal by Subject|6|||
147544760|NCT00527397|532152242|FG000|Overall Study|Study terminated by sponsor|13|||
147544761|NCT00061945|532152246|FG000|Registration Through Course 3|Not Alemtuzumab Eligible|18|||
147544762|NCT00061945|532152247|FG001|Registration Through Course 3|Not Alemtuzumab Eligible|25|||
147544763|NCT00061945|532152246|FG000|Registration Through Course 3|Early discontinuation during course I-IV|76|||
147544764|NCT00061945|532152247|FG001|Registration Through Course 3|Early discontinuation during course I-IV|90|||
147544765|NCT00061945|532152246|FG000|Course IV: Alemtuzumab|Declined Alemtuzumab|1|||
147544766|NCT00061945|532152247|FG001|Course IV: Alemtuzumab|Declined Alemtuzumab|1|||
147544767|NCT00061945|532152246|FG000|Course IV: Alemtuzumab|Early exits|6|||
147544768|NCT00061945|532152247|FG001|Course IV: Alemtuzumab|Early exits|15|||
147544769|NCT01039584|532152248|FG000|Overall Study|Withdrawal by Subject|4|||
147544770|NCT01039584|532152249|FG001|Overall Study|Withdrawal by Subject|2|||
147544771|NCT01039584|532152250|FG002|Overall Study|Withdrawal by Subject|1|||
147544772|NCT01039584|532152248|FG000|Overall Study|Protocol Violation|10|||
147544773|NCT01039584|532152249|FG001|Overall Study|Protocol Violation|4|||
147544774|NCT01039584|532152250|FG002|Overall Study|Protocol Violation|6|||
147544775|NCT01039584|532152248|FG000|Overall Study|Lost to Follow-up|5|||
147544776|NCT01039584|532152249|FG001|Overall Study|Lost to Follow-up|3|||
147544777|NCT01039584|532152250|FG002|Overall Study|Lost to Follow-up|4|||
147544778|NCT01039584|532152248|FG000|Overall Study|Negative Baseline culture for Candida|59|||
147544779|NCT01039584|532152249|FG001|Overall Study|Negative Baseline culture for Candida|59|||
147544780|NCT01039584|532152250|FG002|Overall Study|Negative Baseline culture for Candida|24|||
147544781|NCT01039584|532152248|FG000|Overall Study|Lack of Efficacy|7|||
147544782|NCT01039584|532152249|FG001|Overall Study|Lack of Efficacy|6|||
147544783|NCT01039584|532152250|FG002|Overall Study|Lack of Efficacy|10|||
147544784|NCT01039584|532152248|FG000|Overall Study|other|1|||
147544785|NCT01039584|532152249|FG001|Overall Study|other|3|||
147544786|NCT01039584|532152250|FG002|Overall Study|other|1|||
147544787|NCT01039584|532152248|FG000|Overall Study|Pap smear with significant pathology|10|||
147544788|NCT01039584|532152249|FG001|Overall Study|Pap smear with significant pathology|10|||
147544789|NCT01039584|532152250|FG002|Overall Study|Pap smear with significant pathology|3|||
147544790|NCT01039584|532152248|FG000|Overall Study|Positive for Chlamydia or gonorrhea|7|||
147544791|NCT01039584|532152249|FG001|Overall Study|Positive for Chlamydia or gonorrhea|10|||
147544792|NCT01039584|532152250|FG002|Overall Study|Positive for Chlamydia or gonorrhea|8|||
147544793|NCT03672396|532152253|FG000|Overall Study|Withdrawal by Subject|4|||
147544794|NCT03672396|532152253|FG000|Overall Study|Physician Decision|1|||
147544795|NCT03672396|532152253|FG000|Overall Study|Adverse Event|1|||
147544796|NCT04380701|532152256|FG000|Overall Study|Pregnancy|0|||
147544797|NCT04380701|532152257|FG001|Overall Study|Pregnancy|0|||
147544798|NCT04380701|532152258|FG002|Overall Study|Pregnancy|0|||
147544799|NCT04380701|532152259|FG003|Overall Study|Pregnancy|0|||
147544800|NCT04380701|532152260|FG004|Overall Study|Pregnancy|0|||
147544801|NCT04380701|532152261|FG005|Overall Study|Pregnancy|0|||
147544802|NCT04380701|532152262|FG006|Overall Study|Pregnancy|0|||
147544803|NCT04380701|532152263|FG007|Overall Study|Pregnancy|0|||
147544804|NCT04380701|532152264|FG008|Overall Study|Pregnancy|0|||
147544805|NCT04380701|532152265|FG009|Overall Study|Pregnancy|0|||
147544806|NCT04380701|532152266|FG010|Overall Study|Pregnancy|0|||
147544807|NCT04380701|532152267|FG011|Overall Study|Pregnancy|0|||
147544808|NCT04380701|532152268|FG012|Overall Study|Pregnancy|0|||
147544809|NCT04380701|532152269|FG013|Overall Study|Pregnancy|0|||
147544810|NCT04380701|532152270|FG014|Overall Study|Pregnancy|0|||
147544811|NCT04380701|532152271|FG015|Overall Study|Pregnancy|0|||
147544812|NCT04380701|532152272|FG016|Overall Study|Pregnancy|0|||
147544813|NCT04380701|532152273|FG017|Overall Study|Pregnancy|0|||
147544814|NCT04380701|532152274|FG018|Overall Study|Pregnancy|0|||
147544815|NCT04380701|532152275|FG019|Overall Study|Pregnancy|0|||
147544816|NCT04380701|532152276|FG020|Overall Study|Pregnancy|0|||
147544817|NCT04380701|532152277|FG021|Overall Study|Pregnancy|0|||
147544818|NCT04380701|532152278|FG022|Overall Study|Pregnancy|0|||
147544819|NCT04380701|532152279|FG023|Overall Study|Pregnancy|0|||
147544820|NCT04380701|532152280|FG024|Overall Study|Pregnancy|0|||
147544821|NCT04380701|532152281|FG025|Overall Study|Pregnancy|0|||
147544822|NCT04380701|532152282|FG026|Overall Study|Pregnancy|0|||
147544823|NCT04380701|532152283|FG027|Overall Study|Pregnancy|0|||
147544824|NCT04380701|532152284|FG028|Overall Study|Pregnancy|0|||
147544825|NCT04380701|532152285|FG029|Overall Study|Pregnancy|0|||
147544826|NCT04380701|532152286|FG030|Overall Study|Pregnancy|0|||
147544827|NCT04380701|532152287|FG031|Overall Study|Pregnancy|0|||
147544828|NCT04380701|532152288|FG032|Overall Study|Pregnancy|1|||
147544829|NCT04380701|532152289|FG033|Overall Study|Pregnancy|0|||
147544830|NCT04380701|532152256|FG000|Overall Study|Lost to Follow-up|0|||
147544831|NCT04380701|532152257|FG001|Overall Study|Lost to Follow-up|0|||
147544832|NCT04380701|532152258|FG002|Overall Study|Lost to Follow-up|0|||
147544833|NCT04380701|532152259|FG003|Overall Study|Lost to Follow-up|0|||
147544834|NCT04380701|532152260|FG004|Overall Study|Lost to Follow-up|0|||
147544835|NCT04380701|532152261|FG005|Overall Study|Lost to Follow-up|0|||
147544836|NCT04380701|532152262|FG006|Overall Study|Lost to Follow-up|0|||
147544837|NCT04380701|532152263|FG007|Overall Study|Lost to Follow-up|0|||
147544838|NCT04380701|532152264|FG008|Overall Study|Lost to Follow-up|0|||
147544839|NCT04380701|532152265|FG009|Overall Study|Lost to Follow-up|0|||
147544840|NCT04380701|532152266|FG010|Overall Study|Lost to Follow-up|0|||
147544841|NCT04380701|532152267|FG011|Overall Study|Lost to Follow-up|0|||
147544842|NCT04380701|532152268|FG012|Overall Study|Lost to Follow-up|0|||
147544843|NCT04380701|532152269|FG013|Overall Study|Lost to Follow-up|0|||
147544844|NCT04380701|532152270|FG014|Overall Study|Lost to Follow-up|0|||
147544845|NCT04380701|532152271|FG015|Overall Study|Lost to Follow-up|0|||
147544846|NCT04380701|532152272|FG016|Overall Study|Lost to Follow-up|0|||
147544847|NCT04380701|532152273|FG017|Overall Study|Lost to Follow-up|0|||
147544848|NCT04380701|532152274|FG018|Overall Study|Lost to Follow-up|0|||
147544849|NCT04380701|532152275|FG019|Overall Study|Lost to Follow-up|0|||
147544850|NCT04380701|532152276|FG020|Overall Study|Lost to Follow-up|1|||
147544851|NCT04380701|532152277|FG021|Overall Study|Lost to Follow-up|0|||
147544852|NCT04380701|532152278|FG022|Overall Study|Lost to Follow-up|0|||
147544853|NCT04380701|532152279|FG023|Overall Study|Lost to Follow-up|1|||
147544854|NCT04380701|532152280|FG024|Overall Study|Lost to Follow-up|0|||
147544855|NCT04380701|532152281|FG025|Overall Study|Lost to Follow-up|0|||
147544856|NCT04380701|532152282|FG026|Overall Study|Lost to Follow-up|0|||
147544857|NCT04380701|532152283|FG027|Overall Study|Lost to Follow-up|0|||
147544858|NCT04380701|532152284|FG028|Overall Study|Lost to Follow-up|0|||
147544859|NCT04380701|532152285|FG029|Overall Study|Lost to Follow-up|1|||
147544860|NCT04380701|532152286|FG030|Overall Study|Lost to Follow-up|0|||
147544861|NCT04380701|532152287|FG031|Overall Study|Lost to Follow-up|0|||
147544862|NCT04380701|532152288|FG032|Overall Study|Lost to Follow-up|0|||
147544863|NCT04380701|532152289|FG033|Overall Study|Lost to Follow-up|1|||
147544864|NCT04380701|532152256|FG000|Overall Study|Private reason(s)|0|||
147544865|NCT04380701|532152257|FG001|Overall Study|Private reason(s)|0|||
147544866|NCT04380701|532152258|FG002|Overall Study|Private reason(s)|0|||
147544867|NCT04380701|532152259|FG003|Overall Study|Private reason(s)|0|||
147544868|NCT04380701|532152260|FG004|Overall Study|Private reason(s)|0|||
147544869|NCT04380701|532152261|FG005|Overall Study|Private reason(s)|0|||
147544870|NCT04380701|532152262|FG006|Overall Study|Private reason(s)|1|||
147544871|NCT04380701|532152263|FG007|Overall Study|Private reason(s)|0|||
147544872|NCT04380701|532152264|FG008|Overall Study|Private reason(s)|1|||
147544873|NCT04380701|532152265|FG009|Overall Study|Private reason(s)|1|||
147544874|NCT04380701|532152266|FG010|Overall Study|Private reason(s)|0|||
147544875|NCT04380701|532152267|FG011|Overall Study|Private reason(s)|0|||
147544876|NCT04380701|532152268|FG012|Overall Study|Private reason(s)|0|||
147544877|NCT04380701|532152269|FG013|Overall Study|Private reason(s)|0|||
147544878|NCT04380701|532152270|FG014|Overall Study|Private reason(s)|0|||
147544879|NCT04380701|532152271|FG015|Overall Study|Private reason(s)|0|||
147544880|NCT04380701|532152272|FG016|Overall Study|Private reason(s)|0|||
147544881|NCT04380701|532152273|FG017|Overall Study|Private reason(s)|0|||
147544882|NCT04380701|532152274|FG018|Overall Study|Private reason(s)|0|||
147544883|NCT04380701|532152275|FG019|Overall Study|Private reason(s)|0|||
147544884|NCT04380701|532152276|FG020|Overall Study|Private reason(s)|0|||
147544885|NCT04380701|532152277|FG021|Overall Study|Private reason(s)|0|||
147544886|NCT04380701|532152278|FG022|Overall Study|Private reason(s)|0|||
147544887|NCT04380701|532152279|FG023|Overall Study|Private reason(s)|1|||
147544888|NCT04380701|532152280|FG024|Overall Study|Private reason(s)|0|||
147544889|NCT04380701|532152281|FG025|Overall Study|Private reason(s)|0|||
147544890|NCT04380701|532152282|FG026|Overall Study|Private reason(s)|0|||
147544891|NCT04380701|532152283|FG027|Overall Study|Private reason(s)|0|||
147544892|NCT04380701|532152284|FG028|Overall Study|Private reason(s)|0|||
147544893|NCT04380701|532152285|FG029|Overall Study|Private reason(s)|1|||
147544894|NCT04380701|532152286|FG030|Overall Study|Private reason(s)|0|||
147544895|NCT04380701|532152287|FG031|Overall Study|Private reason(s)|0|||
147544896|NCT04380701|532152288|FG032|Overall Study|Private reason(s)|0|||
147544897|NCT04380701|532152289|FG033|Overall Study|Private reason(s)|0|||
147544898|NCT04380701|532152256|FG000|Overall Study|Withdrawal by Subject|0|||
147544899|NCT04380701|532152257|FG001|Overall Study|Withdrawal by Subject|0|||
147544900|NCT04380701|532152258|FG002|Overall Study|Withdrawal by Subject|0|||
147544901|NCT04380701|532152259|FG003|Overall Study|Withdrawal by Subject|0|||
147544902|NCT04380701|532152260|FG004|Overall Study|Withdrawal by Subject|0|||
147544903|NCT04380701|532152261|FG005|Overall Study|Withdrawal by Subject|0|||
147544904|NCT04380701|532152262|FG006|Overall Study|Withdrawal by Subject|1|||
147544905|NCT04380701|532152263|FG007|Overall Study|Withdrawal by Subject|1|||
147544906|NCT04380701|532152264|FG008|Overall Study|Withdrawal by Subject|0|||
147544907|NCT04380701|532152265|FG009|Overall Study|Withdrawal by Subject|0|||
147544908|NCT04380701|532152266|FG010|Overall Study|Withdrawal by Subject|0|||
147544909|NCT04380701|532152267|FG011|Overall Study|Withdrawal by Subject|1|||
147544910|NCT04380701|532152268|FG012|Overall Study|Withdrawal by Subject|0|||
147544911|NCT04380701|532152269|FG013|Overall Study|Withdrawal by Subject|1|||
147544912|NCT04380701|532152270|FG014|Overall Study|Withdrawal by Subject|0|||
147544913|NCT04380701|532152271|FG015|Overall Study|Withdrawal by Subject|0|||
147544914|NCT04380701|532152272|FG016|Overall Study|Withdrawal by Subject|1|||
147544915|NCT04380701|532152273|FG017|Overall Study|Withdrawal by Subject|0|||
147544916|NCT04380701|532152274|FG018|Overall Study|Withdrawal by Subject|0|||
147544917|NCT04380701|532152275|FG019|Overall Study|Withdrawal by Subject|0|||
147544918|NCT04380701|532152276|FG020|Overall Study|Withdrawal by Subject|0|||
147544919|NCT04380701|532152277|FG021|Overall Study|Withdrawal by Subject|0|||
147544920|NCT04380701|532152278|FG022|Overall Study|Withdrawal by Subject|2|||
147544921|NCT04380701|532152279|FG023|Overall Study|Withdrawal by Subject|2|||
147544922|NCT04380701|532152280|FG024|Overall Study|Withdrawal by Subject|1|||
147544923|NCT04380701|532152281|FG025|Overall Study|Withdrawal by Subject|1|||
147544924|NCT04380701|532152282|FG026|Overall Study|Withdrawal by Subject|0|||
147544925|NCT04380701|532152283|FG027|Overall Study|Withdrawal by Subject|0|||
147544926|NCT04380701|532152284|FG028|Overall Study|Withdrawal by Subject|0|||
147544927|NCT04380701|532152285|FG029|Overall Study|Withdrawal by Subject|0|||
147544928|NCT04380701|532152286|FG030|Overall Study|Withdrawal by Subject|0|||
147544929|NCT04380701|532152287|FG031|Overall Study|Withdrawal by Subject|0|||
147544930|NCT04380701|532152288|FG032|Overall Study|Withdrawal by Subject|0|||
147544931|NCT04380701|532152289|FG033|Overall Study|Withdrawal by Subject|0|||
147544932|NCT04380701|532152256|FG000|Overall Study|Adverse Event|0|||
147544933|NCT04380701|532152257|FG001|Overall Study|Adverse Event|0|||
147544934|NCT04380701|532152258|FG002|Overall Study|Adverse Event|0|||
147544935|NCT04380701|532152259|FG003|Overall Study|Adverse Event|0|||
147544936|NCT04380701|532152260|FG004|Overall Study|Adverse Event|0|||
147544937|NCT04380701|532152261|FG005|Overall Study|Adverse Event|1|||
147544938|NCT04380701|532152262|FG006|Overall Study|Adverse Event|0|||
147544939|NCT04380701|532152263|FG007|Overall Study|Adverse Event|0|||
147544940|NCT04380701|532152264|FG008|Overall Study|Adverse Event|0|||
147544941|NCT04380701|532152265|FG009|Overall Study|Adverse Event|0|||
147544942|NCT04380701|532152266|FG010|Overall Study|Adverse Event|0|||
147544943|NCT04380701|532152267|FG011|Overall Study|Adverse Event|0|||
147544944|NCT04380701|532152268|FG012|Overall Study|Adverse Event|0|||
147544945|NCT04380701|532152269|FG013|Overall Study|Adverse Event|0|||
147544946|NCT04380701|532152270|FG014|Overall Study|Adverse Event|0|||
147544947|NCT04380701|532152271|FG015|Overall Study|Adverse Event|1|||
147544948|NCT04380701|532152272|FG016|Overall Study|Adverse Event|0|||
147544949|NCT04380701|532152273|FG017|Overall Study|Adverse Event|0|||
147544950|NCT04380701|532152274|FG018|Overall Study|Adverse Event|0|||
147544951|NCT04380701|532152275|FG019|Overall Study|Adverse Event|1|||
147544952|NCT04380701|532152276|FG020|Overall Study|Adverse Event|0|||
147544953|NCT04380701|532152277|FG021|Overall Study|Adverse Event|0|||
147544954|NCT04380701|532152278|FG022|Overall Study|Adverse Event|0|||
147544955|NCT04380701|532152279|FG023|Overall Study|Adverse Event|0|||
147544956|NCT04380701|532152280|FG024|Overall Study|Adverse Event|0|||
147544957|NCT04380701|532152281|FG025|Overall Study|Adverse Event|0|||
147544958|NCT04380701|532152282|FG026|Overall Study|Adverse Event|0|||
147544959|NCT04380701|532152283|FG027|Overall Study|Adverse Event|0|||
147544960|NCT04380701|532152284|FG028|Overall Study|Adverse Event|0|||
147544961|NCT04380701|532152285|FG029|Overall Study|Adverse Event|0|||
147544962|NCT04380701|532152286|FG030|Overall Study|Adverse Event|0|||
147544963|NCT04380701|532152287|FG031|Overall Study|Adverse Event|0|||
147544964|NCT04380701|532152288|FG032|Overall Study|Adverse Event|0|||
147544965|NCT04380701|532152289|FG033|Overall Study|Adverse Event|0|||
147544966|NCT04380701|532152256|FG000|Overall Study|Roll-over into trial BNT162-14|0|||
147544967|NCT04380701|532152257|FG001|Overall Study|Roll-over into trial BNT162-14|0|||
147544968|NCT04380701|532152258|FG002|Overall Study|Roll-over into trial BNT162-14|0|||
147544969|NCT04380701|532152259|FG003|Overall Study|Roll-over into trial BNT162-14|0|||
147544970|NCT04380701|532152260|FG004|Overall Study|Roll-over into trial BNT162-14|0|||
147544971|NCT04380701|532152261|FG005|Overall Study|Roll-over into trial BNT162-14|0|||
147544972|NCT04380701|532152262|FG006|Overall Study|Roll-over into trial BNT162-14|0|||
147544973|NCT04380701|532152263|FG007|Overall Study|Roll-over into trial BNT162-14|0|||
147544974|NCT04380701|532152264|FG008|Overall Study|Roll-over into trial BNT162-14|0|||
147544975|NCT04380701|532152265|FG009|Overall Study|Roll-over into trial BNT162-14|0|||
147544976|NCT04380701|532152266|FG010|Overall Study|Roll-over into trial BNT162-14|0|||
147544977|NCT04380701|532152267|FG011|Overall Study|Roll-over into trial BNT162-14|0|||
147544978|NCT04380701|532152268|FG012|Overall Study|Roll-over into trial BNT162-14|0|||
147544979|NCT04380701|532152269|FG013|Overall Study|Roll-over into trial BNT162-14|0|||
147544980|NCT04380701|532152270|FG014|Overall Study|Roll-over into trial BNT162-14|0|||
147544981|NCT04380701|532152271|FG015|Overall Study|Roll-over into trial BNT162-14|0|||
147544982|NCT04380701|532152272|FG016|Overall Study|Roll-over into trial BNT162-14|0|||
147544983|NCT04380701|532152273|FG017|Overall Study|Roll-over into trial BNT162-14|0|||
147544984|NCT04380701|532152274|FG018|Overall Study|Roll-over into trial BNT162-14|0|||
147544985|NCT04380701|532152275|FG019|Overall Study|Roll-over into trial BNT162-14|0|||
147544986|NCT04380701|532152276|FG020|Overall Study|Roll-over into trial BNT162-14|0|||
147544987|NCT04380701|532152277|FG021|Overall Study|Roll-over into trial BNT162-14|11|||
147544988|NCT04380701|532152278|FG022|Overall Study|Roll-over into trial BNT162-14|11|||
147544989|NCT04380701|532152279|FG023|Overall Study|Roll-over into trial BNT162-14|10|||
147544990|NCT04380701|532152280|FG024|Overall Study|Roll-over into trial BNT162-14|31|||
147544991|NCT04380701|532152281|FG025|Overall Study|Roll-over into trial BNT162-14|0|||
147544992|NCT04380701|532152282|FG026|Overall Study|Roll-over into trial BNT162-14|0|||
147544993|NCT04380701|532152283|FG027|Overall Study|Roll-over into trial BNT162-14|0|||
147544994|NCT04380701|532152284|FG028|Overall Study|Roll-over into trial BNT162-14|0|||
147544995|NCT04380701|532152285|FG029|Overall Study|Roll-over into trial BNT162-14|0|||
147544996|NCT04380701|532152286|FG030|Overall Study|Roll-over into trial BNT162-14|0|||
147544997|NCT04380701|532152287|FG031|Overall Study|Roll-over into trial BNT162-14|0|||
147544998|NCT04380701|532152288|FG032|Overall Study|Roll-over into trial BNT162-14|0|||
147544999|NCT04380701|532152289|FG033|Overall Study|Roll-over into trial BNT162-14|0|||
147545000|NCT04380701|532152256|FG000|Overall Study|Physician Decision|0|||
147545001|NCT04380701|532152257|FG001|Overall Study|Physician Decision|0|||
147545002|NCT04380701|532152258|FG002|Overall Study|Physician Decision|0|||
147545003|NCT04380701|532152259|FG003|Overall Study|Physician Decision|0|||
147545004|NCT04380701|532152260|FG004|Overall Study|Physician Decision|0|||
147545005|NCT04380701|532152261|FG005|Overall Study|Physician Decision|0|||
147545006|NCT04380701|532152262|FG006|Overall Study|Physician Decision|0|||
147545007|NCT04380701|532152263|FG007|Overall Study|Physician Decision|0|||
147545008|NCT04380701|532152264|FG008|Overall Study|Physician Decision|0|||
147545009|NCT04380701|532152265|FG009|Overall Study|Physician Decision|0|||
147545010|NCT04380701|532152266|FG010|Overall Study|Physician Decision|0|||
147545011|NCT04380701|532152267|FG011|Overall Study|Physician Decision|0|||
147545012|NCT04380701|532152268|FG012|Overall Study|Physician Decision|0|||
147545013|NCT04380701|532152269|FG013|Overall Study|Physician Decision|0|||
147545014|NCT04380701|532152270|FG014|Overall Study|Physician Decision|0|||
147545015|NCT04380701|532152271|FG015|Overall Study|Physician Decision|0|||
147545016|NCT04380701|532152272|FG016|Overall Study|Physician Decision|0|||
147545017|NCT04380701|532152273|FG017|Overall Study|Physician Decision|0|||
147545018|NCT04380701|532152274|FG018|Overall Study|Physician Decision|0|||
147545019|NCT04380701|532152275|FG019|Overall Study|Physician Decision|0|||
147545020|NCT04380701|532152276|FG020|Overall Study|Physician Decision|0|||
147545021|NCT04380701|532152277|FG021|Overall Study|Physician Decision|0|||
147545022|NCT04380701|532152278|FG022|Overall Study|Physician Decision|0|||
147545023|NCT04380701|532152279|FG023|Overall Study|Physician Decision|0|||
147545024|NCT04380701|532152280|FG024|Overall Study|Physician Decision|2|||
147545025|NCT04380701|532152281|FG025|Overall Study|Physician Decision|0|||
147545026|NCT04380701|532152282|FG026|Overall Study|Physician Decision|0|||
147545027|NCT04380701|532152283|FG027|Overall Study|Physician Decision|0|||
147545028|NCT04380701|532152284|FG028|Overall Study|Physician Decision|0|||
147545029|NCT04380701|532152285|FG029|Overall Study|Physician Decision|0|||
147545030|NCT04380701|532152286|FG030|Overall Study|Physician Decision|0|||
147545031|NCT04380701|532152287|FG031|Overall Study|Physician Decision|0|||
147545032|NCT04380701|532152288|FG032|Overall Study|Physician Decision|0|||
147545033|NCT04380701|532152289|FG033|Overall Study|Physician Decision|0|||
147545034|NCT04380701|532152256|FG000|Overall Study|Death|0|||
147545035|NCT04380701|532152257|FG001|Overall Study|Death|0|||
147545036|NCT04380701|532152258|FG002|Overall Study|Death|0|||
147545037|NCT04380701|532152259|FG003|Overall Study|Death|0|||
147545038|NCT04380701|532152260|FG004|Overall Study|Death|0|||
147545039|NCT04380701|532152261|FG005|Overall Study|Death|0|||
147545040|NCT04380701|532152262|FG006|Overall Study|Death|0|||
147545041|NCT04380701|532152263|FG007|Overall Study|Death|0|||
147545042|NCT04380701|532152264|FG008|Overall Study|Death|0|||
147545043|NCT04380701|532152265|FG009|Overall Study|Death|0|||
147545044|NCT04380701|532152266|FG010|Overall Study|Death|0|||
147545045|NCT04380701|532152267|FG011|Overall Study|Death|0|||
147545046|NCT04380701|532152268|FG012|Overall Study|Death|0|||
147545047|NCT04380701|532152269|FG013|Overall Study|Death|0|||
147545048|NCT04380701|532152270|FG014|Overall Study|Death|0|||
147545049|NCT04380701|532152271|FG015|Overall Study|Death|0|||
147545050|NCT04380701|532152272|FG016|Overall Study|Death|0|||
147545051|NCT04380701|532152273|FG017|Overall Study|Death|0|||
147545052|NCT04380701|532152274|FG018|Overall Study|Death|0|||
147545053|NCT04380701|532152275|FG019|Overall Study|Death|0|||
147545054|NCT04380701|532152276|FG020|Overall Study|Death|0|||
147545055|NCT04380701|532152277|FG021|Overall Study|Death|0|||
147545056|NCT04380701|532152278|FG022|Overall Study|Death|0|||
147545057|NCT04380701|532152279|FG023|Overall Study|Death|0|||
147545058|NCT04380701|532152280|FG024|Overall Study|Death|1|||
147545059|NCT04380701|532152281|FG025|Overall Study|Death|0|||
147545060|NCT04380701|532152282|FG026|Overall Study|Death|0|||
147545061|NCT04380701|532152283|FG027|Overall Study|Death|0|||
147545062|NCT04380701|532152284|FG028|Overall Study|Death|0|||
147545063|NCT04380701|532152285|FG029|Overall Study|Death|0|||
147545064|NCT04380701|532152286|FG030|Overall Study|Death|0|||
147545065|NCT04380701|532152287|FG031|Overall Study|Death|0|||
147545066|NCT04380701|532152288|FG032|Overall Study|Death|0|||
147545067|NCT04380701|532152289|FG033|Overall Study|Death|0|||
147545068|NCT04380701|532152256|FG000|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
147210763|NCT00535288|530945357|FG004|Overall Study|Adverse Event|30|||
147210764|NCT00535288|530945353|FG000|Overall Study|Lost to Follow-up|0|||
147210765|NCT00535288|530945354|FG001|Overall Study|Lost to Follow-up|3|||
147210766|NCT00535288|530945355|FG002|Overall Study|Lost to Follow-up|0|||
147210767|NCT00535288|530945356|FG003|Overall Study|Lost to Follow-up|0|||
147210768|NCT00535288|530945357|FG004|Overall Study|Lost to Follow-up|0|||
147210769|NCT00535288|530945353|FG000|Overall Study|Lack of Efficacy|26|||
147210770|NCT00535288|530945354|FG001|Overall Study|Lack of Efficacy|3|||
147210771|NCT00535288|530945355|FG002|Overall Study|Lack of Efficacy|4|||
147210772|NCT00535288|530945356|FG003|Overall Study|Lack of Efficacy|4|||
147210773|NCT00535288|530945357|FG004|Overall Study|Lack of Efficacy|7|||
147210774|NCT00535288|530945353|FG000|Overall Study|Unwilling to cooperate|6|||
147210775|NCT00535288|530945354|FG001|Overall Study|Unwilling to cooperate|6|||
147210776|NCT00535288|530945355|FG002|Overall Study|Unwilling to cooperate|3|||
147210777|NCT00535288|530945356|FG003|Overall Study|Unwilling to cooperate|3|||
147210778|NCT00535288|530945357|FG004|Overall Study|Unwilling to cooperate|4|||
147210779|NCT00535288|530945353|FG000|Overall Study|Other|2|||
147210780|NCT00535288|530945354|FG001|Overall Study|Other|1|||
147210781|NCT00535288|530945355|FG002|Overall Study|Other|1|||
147210782|NCT00535288|530945356|FG003|Overall Study|Other|2|||
147210783|NCT00535288|530945357|FG004|Overall Study|Other|1|||
147545069|NCT04380701|532152257|FG001|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
147545070|NCT04380701|532152258|FG002|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
147545071|NCT04380701|532152259|FG003|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
147545072|NCT04380701|532152260|FG004|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
147545073|NCT04380701|532152261|FG005|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
147545074|NCT04380701|532152262|FG006|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
147545075|NCT04380701|532152263|FG007|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
147545076|NCT04380701|532152264|FG008|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
147545077|NCT04380701|532152265|FG009|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
147545078|NCT04380701|532152266|FG010|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
147545079|NCT04380701|532152267|FG011|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
147545080|NCT04380701|532152268|FG012|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
147545081|NCT04380701|532152269|FG013|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
147545082|NCT04380701|532152270|FG014|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
147545083|NCT04380701|532152271|FG015|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
147545084|NCT04380701|532152272|FG016|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
147545085|NCT04380701|532152273|FG017|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
147545086|NCT04380701|532152274|FG018|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
147545087|NCT04380701|532152275|FG019|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
147545088|NCT04380701|532152276|FG020|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
147545089|NCT04380701|532152277|FG021|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|4|||
147545090|NCT04380701|532152278|FG022|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|2|||
147545091|NCT04380701|532152279|FG023|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|16|||
147545092|NCT04380701|532152280|FG024|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|55|||
147545093|NCT04380701|532152281|FG025|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
147545094|NCT04380701|532152282|FG026|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
147545095|NCT04380701|532152283|FG027|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
147545096|NCT04380701|532152284|FG028|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
147545097|NCT04380701|532152285|FG029|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
147545098|NCT04380701|532152286|FG030|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
147545099|NCT04380701|532152287|FG031|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
147545100|NCT04380701|532152288|FG032|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
147545101|NCT04380701|532152289|FG033|Overall Study|non-trial SARS-COV-2 vaccination due to COVID-19|0|||
147545102|NCT03001011|532152290|FG000|Overall Study|Adverse Event|9|||
147545103|NCT03001011|532152291|FG001|Overall Study|Adverse Event|3|||
147545104|NCT03001011|532152290|FG000|Overall Study|Chronic kidney disease lead to dialysis|15|||
147545105|NCT03001011|532152291|FG001|Overall Study|Chronic kidney disease lead to dialysis|10|||
147545106|NCT03001011|532152290|FG000|Overall Study|Other than specified above|3|||
147545107|NCT03001011|532152291|FG001|Overall Study|Other than specified above|8|||
147545108|NCT03125915|532152298|FG000|1 Month Follow up|Lost to Follow-up|3|||
147545109|NCT03125915|532152299|FG001|1 Month Follow up|Lost to Follow-up|3|||
147545110|NCT03125915|532152300|FG002|1 Month Follow up|Lost to Follow-up|2|||
147545111|NCT03125915|532152301|FG003|1 Month Follow up|Lost to Follow-up|3|||
147545112|NCT03125915|532152298|FG000|3 Month Follow-up|Lost to Follow-up|6|||
147210784|NCT02248675|530945363|FG000|Overall Study|Lost to Follow-up|3|||
147210785|NCT02248675|530945364|FG001|Overall Study|Lost to Follow-up|1|||
147210786|NCT03390101|530945367|FG000|Weeks 0-12|Withdrawal by Subject|0|||
147210787|NCT03390101|530945368|FG001|Weeks 0-12|Withdrawal by Subject|1|||
147545113|NCT03125915|532152299|FG001|3 Month Follow-up|Lost to Follow-up|4|||
147210788|NCT03390101|530945369|FG002|Weeks 0-12|Withdrawal by Subject|1|||
147210789|NCT03390101|530945367|FG000|Weeks 0-12|Lost to Follow-up|0|||
147210790|NCT03390101|530945368|FG001|Weeks 0-12|Lost to Follow-up|1|||
147210791|NCT03390101|530945369|FG002|Weeks 0-12|Lost to Follow-up|0|||
147210792|NCT03390101|530945367|FG000|Weeks 12-54|Withdrawal by Subject|0|||
147210793|NCT03390101|530945368|FG001|Weeks 12-54|Withdrawal by Subject|3|||
147210794|NCT03390101|530945369|FG002|Weeks 12-54|Withdrawal by Subject|1|||
147210795|NCT03390101|530945367|FG000|Weeks 12-54|Pregnancy|1|||
147210796|NCT03390101|530945368|FG001|Weeks 12-54|Pregnancy|0|||
147210797|NCT03390101|530945369|FG002|Weeks 12-54|Pregnancy|0|||
147210798|NCT03390101|530945367|FG000|Weeks 12-54|Adverse Event|2|||
147210799|NCT03390101|530945368|FG001|Weeks 12-54|Adverse Event|1|||
147210800|NCT03390101|530945369|FG002|Weeks 12-54|Adverse Event|1|||
147210801|NCT01511055|530945370|FG000|Overall Study|Withdrawal by Subject|6|||
147210802|NCT00830869|530945371|FG000|Period 1: Part 1|Symptomatic deterioration|0|||
147210803|NCT00830869|530945372|FG001|Period 1: Part 1|Symptomatic deterioration|0|||
147210804|NCT00830869|530945373|FG002|Period 1: Part 1|Symptomatic deterioration|0|||
147210805|NCT00830869|530945374|FG003|Period 1: Part 1|Symptomatic deterioration|1|||
147210806|NCT00830869|530945375|FG004|Period 1: Part 1|Symptomatic deterioration|0|||
147210807|NCT00830869|530945376|FG005|Period 1: Part 1|Symptomatic deterioration|1|||
147210808|NCT00830869|530945377|FG006|Period 1: Part 1|Symptomatic deterioration|1|||
147210809|NCT00830869|530945378|FG007|Period 1: Part 1|Symptomatic deterioration|0|||
147210810|NCT00830869|530945379|FG008|Period 1: Part 1|Symptomatic deterioration|0|||
147210811|NCT00830869|530945380|FG009|Period 1: Part 1|Symptomatic deterioration|0|||
147210812|NCT00830869|530945381|FG010|Period 1: Part 1|Symptomatic deterioration|0|||
147210813|NCT00830869|530945382|FG011|Period 1: Part 1|Symptomatic deterioration|0|||
147210814|NCT00830869|530945371|FG000|Period 1: Part 1|Withdrawal by Subject|0|||
147210815|NCT00830869|530945372|FG001|Period 1: Part 1|Withdrawal by Subject|1|||
147210816|NCT00830869|530945373|FG002|Period 1: Part 1|Withdrawal by Subject|0|||
147210817|NCT00830869|530945374|FG003|Period 1: Part 1|Withdrawal by Subject|0|||
147210818|NCT00830869|530945375|FG004|Period 1: Part 1|Withdrawal by Subject|0|||
147210819|NCT00830869|530945376|FG005|Period 1: Part 1|Withdrawal by Subject|0|||
147210820|NCT00830869|530945377|FG006|Period 1: Part 1|Withdrawal by Subject|0|||
147210821|NCT00830869|530945378|FG007|Period 1: Part 1|Withdrawal by Subject|0|||
147210822|NCT00830869|530945379|FG008|Period 1: Part 1|Withdrawal by Subject|0|||
147210823|NCT00830869|530945380|FG009|Period 1: Part 1|Withdrawal by Subject|0|||
147210824|NCT00830869|530945381|FG010|Period 1: Part 1|Withdrawal by Subject|0|||
147210825|NCT00830869|530945382|FG011|Period 1: Part 1|Withdrawal by Subject|0|||
147210826|NCT00830869|530945371|FG000|Period 1: Part 1|Adverse Event|0|||
147210827|NCT00830869|530945372|FG001|Period 1: Part 1|Adverse Event|0|||
147210828|NCT00830869|530945373|FG002|Period 1: Part 1|Adverse Event|0|||
147210829|NCT00830869|530945374|FG003|Period 1: Part 1|Adverse Event|0|||
147210830|NCT00830869|530945375|FG004|Period 1: Part 1|Adverse Event|0|||
147210831|NCT00830869|530945376|FG005|Period 1: Part 1|Adverse Event|1|||
147210832|NCT00830869|530945377|FG006|Period 1: Part 1|Adverse Event|1|||
147210833|NCT00830869|530945378|FG007|Period 1: Part 1|Adverse Event|0|||
147210834|NCT00830869|530945379|FG008|Period 1: Part 1|Adverse Event|0|||
147210835|NCT00830869|530945380|FG009|Period 1: Part 1|Adverse Event|0|||
147210836|NCT00830869|530945381|FG010|Period 1: Part 1|Adverse Event|0|||
147210837|NCT00830869|530945382|FG011|Period 1: Part 1|Adverse Event|0|||
147210838|NCT00830869|530945371|FG000|Period 1: Part 1|Progressive disease|1|||
147210839|NCT00830869|530945372|FG001|Period 1: Part 1|Progressive disease|0|||
147210840|NCT00830869|530945373|FG002|Period 1: Part 1|Progressive disease|1|||
147210841|NCT00830869|530945374|FG003|Period 1: Part 1|Progressive disease|6|||
147210842|NCT00830869|530945375|FG004|Period 1: Part 1|Progressive disease|4|||
147210843|NCT00830869|530945376|FG005|Period 1: Part 1|Progressive disease|4|||
147210844|NCT00830869|530945377|FG006|Period 1: Part 1|Progressive disease|1|||
147210845|NCT00830869|530945378|FG007|Period 1: Part 1|Progressive disease|0|||
147210846|NCT00830869|530945379|FG008|Period 1: Part 1|Progressive disease|0|||
147210847|NCT00830869|530945380|FG009|Period 1: Part 1|Progressive disease|0|||
147210848|NCT00830869|530945381|FG010|Period 1: Part 1|Progressive disease|0|||
147210849|NCT00830869|530945382|FG011|Period 1: Part 1|Progressive disease|0|||
147210850|NCT00830869|530945371|FG000|Period 2: Part 2|Protocol Violation|0|||
147210851|NCT00830869|530945372|FG001|Period 2: Part 2|Protocol Violation|0|||
147210852|NCT00830869|530945373|FG002|Period 2: Part 2|Protocol Violation|0|||
147210853|NCT00830869|530945374|FG003|Period 2: Part 2|Protocol Violation|0|||
147210854|NCT00830869|530945375|FG004|Period 2: Part 2|Protocol Violation|0|||
147210855|NCT00830869|530945376|FG005|Period 2: Part 2|Protocol Violation|0|||
147210856|NCT00830869|530945377|FG006|Period 2: Part 2|Protocol Violation|0|||
147210857|NCT00830869|530945378|FG007|Period 2: Part 2|Protocol Violation|1|||
147210858|NCT00830869|530945379|FG008|Period 2: Part 2|Protocol Violation|0|||
147210859|NCT00830869|530945380|FG009|Period 2: Part 2|Protocol Violation|1|||
147210860|NCT00830869|530945381|FG010|Period 2: Part 2|Protocol Violation|0|||
147210861|NCT00830869|530945382|FG011|Period 2: Part 2|Protocol Violation|0|||
147210862|NCT00830869|530945371|FG000|Period 2: Part 2|Withdrawal by Subject|0|||
147210863|NCT00830869|530945372|FG001|Period 2: Part 2|Withdrawal by Subject|0|||
147210864|NCT00830869|530945373|FG002|Period 2: Part 2|Withdrawal by Subject|0|||
147210865|NCT00830869|530945374|FG003|Period 2: Part 2|Withdrawal by Subject|0|||
147210866|NCT00830869|530945375|FG004|Period 2: Part 2|Withdrawal by Subject|0|||
147210867|NCT00830869|530945376|FG005|Period 2: Part 2|Withdrawal by Subject|0|||
147210868|NCT00830869|530945377|FG006|Period 2: Part 2|Withdrawal by Subject|0|||
147210869|NCT00830869|530945378|FG007|Period 2: Part 2|Withdrawal by Subject|1|||
147210870|NCT00830869|530945379|FG008|Period 2: Part 2|Withdrawal by Subject|2|||
147210871|NCT00830869|530945380|FG009|Period 2: Part 2|Withdrawal by Subject|1|||
147210872|NCT00830869|530945381|FG010|Period 2: Part 2|Withdrawal by Subject|0|||
147210873|NCT00830869|530945382|FG011|Period 2: Part 2|Withdrawal by Subject|1|||
147210874|NCT00830869|530945371|FG000|Period 2: Part 2|Adverse Event|0|||
147210875|NCT00830869|530945372|FG001|Period 2: Part 2|Adverse Event|0|||
147210876|NCT00830869|530945373|FG002|Period 2: Part 2|Adverse Event|0|||
147210877|NCT00830869|530945374|FG003|Period 2: Part 2|Adverse Event|0|||
147210878|NCT00830869|530945375|FG004|Period 2: Part 2|Adverse Event|0|||
147210879|NCT00830869|530945376|FG005|Period 2: Part 2|Adverse Event|0|||
147210880|NCT00830869|530945377|FG006|Period 2: Part 2|Adverse Event|0|||
147210881|NCT00830869|530945378|FG007|Period 2: Part 2|Adverse Event|4|||
147210882|NCT00830869|530945379|FG008|Period 2: Part 2|Adverse Event|3|||
147210883|NCT00830869|530945380|FG009|Period 2: Part 2|Adverse Event|2|||
147210884|NCT00830869|530945381|FG010|Period 2: Part 2|Adverse Event|2|||
147210885|NCT00830869|530945382|FG011|Period 2: Part 2|Adverse Event|0|||
147210886|NCT00830869|530945371|FG000|Period 2: Part 2|Symptomatic Deterioration|0|||
147210887|NCT00830869|530945372|FG001|Period 2: Part 2|Symptomatic Deterioration|0|||
147210888|NCT00830869|530945373|FG002|Period 2: Part 2|Symptomatic Deterioration|0|||
147210889|NCT00830869|530945374|FG003|Period 2: Part 2|Symptomatic Deterioration|0|||
147210890|NCT00830869|530945375|FG004|Period 2: Part 2|Symptomatic Deterioration|0|||
147210891|NCT00830869|530945376|FG005|Period 2: Part 2|Symptomatic Deterioration|0|||
147210892|NCT00830869|530945377|FG006|Period 2: Part 2|Symptomatic Deterioration|0|||
147210893|NCT00830869|530945378|FG007|Period 2: Part 2|Symptomatic Deterioration|0|||
147210894|NCT00830869|530945379|FG008|Period 2: Part 2|Symptomatic Deterioration|6|||
147210895|NCT00830869|530945380|FG009|Period 2: Part 2|Symptomatic Deterioration|3|||
147210896|NCT00830869|530945381|FG010|Period 2: Part 2|Symptomatic Deterioration|1|||
147210897|NCT00830869|530945382|FG011|Period 2: Part 2|Symptomatic Deterioration|4|||
147210898|NCT00830869|530945371|FG000|Period 2: Part 2|Progressive disease|0|||
147210899|NCT00830869|530945372|FG001|Period 2: Part 2|Progressive disease|0|||
147210900|NCT00830869|530945373|FG002|Period 2: Part 2|Progressive disease|0|||
147210901|NCT00830869|530945374|FG003|Period 2: Part 2|Progressive disease|0|||
147210902|NCT00830869|530945375|FG004|Period 2: Part 2|Progressive disease|0|||
147210903|NCT00830869|530945376|FG005|Period 2: Part 2|Progressive disease|0|||
147210904|NCT00830869|530945377|FG006|Period 2: Part 2|Progressive disease|0|||
147210905|NCT00830869|530945378|FG007|Period 2: Part 2|Progressive disease|14|||
147210906|NCT00830869|530945379|FG008|Period 2: Part 2|Progressive disease|11|||
147210907|NCT00830869|530945380|FG009|Period 2: Part 2|Progressive disease|12|||
147210908|NCT00830869|530945381|FG010|Period 2: Part 2|Progressive disease|8|||
147210909|NCT00830869|530945382|FG011|Period 2: Part 2|Progressive disease|15|||
147210910|NCT00830869|530945371|FG000|Period 2: Part 2|Other|0|||
147210911|NCT00830869|530945372|FG001|Period 2: Part 2|Other|0|||
147210912|NCT00830869|530945373|FG002|Period 2: Part 2|Other|0|||
147210913|NCT00830869|530945374|FG003|Period 2: Part 2|Other|0|||
147210914|NCT00830869|530945375|FG004|Period 2: Part 2|Other|0|||
147210915|NCT00830869|530945376|FG005|Period 2: Part 2|Other|0|||
147210916|NCT00830869|530945377|FG006|Period 2: Part 2|Other|0|||
147210917|NCT00830869|530945378|FG007|Period 2: Part 2|Other|0|||
147210918|NCT00830869|530945379|FG008|Period 2: Part 2|Other|0|||
147210919|NCT00830869|530945380|FG009|Period 2: Part 2|Other|1|||
147210920|NCT00830869|530945381|FG010|Period 2: Part 2|Other|0|||
147210921|NCT00830869|530945382|FG011|Period 2: Part 2|Other|0|||
147210922|NCT00281658|530945388|FG000|Randomized Phase|Adverse Event|0|||
147210923|NCT00281658|530945389|FG001|Randomized Phase|Adverse Event|2|||
147210924|NCT00281658|530945390|FG002|Randomized Phase|Adverse Event|0|||
147210925|NCT00281658|530945391|FG003|Randomized Phase|Adverse Event|0|||
147210926|NCT00281658|530945388|FG000|Randomized Phase|Lost to Follow-up|34|||
147210927|NCT00281658|530945389|FG001|Randomized Phase|Lost to Follow-up|27|||
147210928|NCT00281658|530945390|FG002|Randomized Phase|Lost to Follow-up|0|||
147210929|NCT00281658|530945391|FG003|Randomized Phase|Lost to Follow-up|0|||
147210930|NCT00281658|530945388|FG000|Randomized Phase|Withdrawal by Subject|8|||
147210931|NCT00281658|530945389|FG001|Randomized Phase|Withdrawal by Subject|7|||
147545114|NCT03125915|532152300|FG002|3 Month Follow-up|Lost to Follow-up|4|||
147210932|NCT00281658|530945390|FG002|Randomized Phase|Withdrawal by Subject|0|||
147210933|NCT00281658|530945391|FG003|Randomized Phase|Withdrawal by Subject|0|||
147210934|NCT00281658|530945388|FG000|Randomized Phase|Study closed/terminated|1|||
147210935|NCT00281658|530945389|FG001|Randomized Phase|Study closed/terminated|1|||
147210936|NCT00281658|530945390|FG002|Randomized Phase|Study closed/terminated|0|||
147210937|NCT00281658|530945391|FG003|Randomized Phase|Study closed/terminated|0|||
147210938|NCT00281658|530945388|FG000|Randomized Phase|Disease progression|36|||
147210939|NCT00281658|530945389|FG001|Randomized Phase|Disease progression|27|||
147210940|NCT00281658|530945390|FG002|Randomized Phase|Disease progression|0|||
147210941|NCT00281658|530945391|FG003|Randomized Phase|Disease progression|0|||
147210942|NCT00281658|530945388|FG000|Randomized Phase|Physician Decision|1|||
147210943|NCT00281658|530945389|FG001|Randomized Phase|Physician Decision|1|||
147210944|NCT00281658|530945390|FG002|Randomized Phase|Physician Decision|0|||
147210945|NCT00281658|530945391|FG003|Randomized Phase|Physician Decision|0|||
147210946|NCT00281658|530945388|FG000|Randomized Phase|Other reasons as defined per protocol|4|||
147210947|NCT00281658|530945389|FG001|Randomized Phase|Other reasons as defined per protocol|3|||
147210948|NCT00281658|530945390|FG002|Randomized Phase|Other reasons as defined per protocol|0|||
147210949|NCT00281658|530945391|FG003|Randomized Phase|Other reasons as defined per protocol|0|||
147210950|NCT00281658|530945388|FG000|Randomized Phase|Reason for withdrawal unspecified|4|||
147210951|NCT00281658|530945389|FG001|Randomized Phase|Reason for withdrawal unspecified|5|||
147210952|NCT00281658|530945390|FG002|Randomized Phase|Reason for withdrawal unspecified|0|||
147210953|NCT00281658|530945391|FG003|Randomized Phase|Reason for withdrawal unspecified|0|||
147210954|NCT00281658|530945388|FG000|Randomized Phase|Treatment ongoing|1|||
147210955|NCT00281658|530945389|FG001|Randomized Phase|Treatment ongoing|0|||
147210956|NCT00281658|530945390|FG002|Randomized Phase|Treatment ongoing|0|||
147210957|NCT00281658|530945391|FG003|Randomized Phase|Treatment ongoing|0|||
147210958|NCT00281658|530945388|FG000|Open Label Phase|Adverse Event|0|||
147210959|NCT00281658|530945389|FG001|Open Label Phase|Adverse Event|0|||
147210960|NCT00281658|530945390|FG002|Open Label Phase|Adverse Event|1|||
147210961|NCT00281658|530945391|FG003|Open Label Phase|Adverse Event|0|||
147210962|NCT00281658|530945388|FG000|Open Label Phase|Lost to Follow-up|0|||
147210963|NCT00281658|530945389|FG001|Open Label Phase|Lost to Follow-up|0|||
147210964|NCT00281658|530945390|FG002|Open Label Phase|Lost to Follow-up|16|||
147210965|NCT00281658|530945391|FG003|Open Label Phase|Lost to Follow-up|2|||
147210966|NCT00281658|530945388|FG000|Open Label Phase|Withdrawal by Subject|0|||
147545115|NCT03125915|532152301|FG003|3 Month Follow-up|Lost to Follow-up|2|||
147545116|NCT03125915|532152298|FG000|6 Month Follow-up|Lost to Follow-up|7|||
147545117|NCT03125915|532152299|FG001|6 Month Follow-up|Lost to Follow-up|3|||
147545118|NCT03125915|532152300|FG002|6 Month Follow-up|Lost to Follow-up|6|||
147545119|NCT03125915|532152301|FG003|6 Month Follow-up|Lost to Follow-up|3|||
147545120|NCT02176642|532152306|FG000|Overall Study|Withdrawal by Subject|0|||
147545121|NCT02176642|532152307|FG001|Overall Study|Withdrawal by Subject|1|||
147545122|NCT01309828|532152309|FG000|Overall Study|Adverse Event|10|||
147545123|NCT01309828|532152310|FG001|Overall Study|Adverse Event|11|||
147545124|NCT01309828|532152309|FG000|Overall Study|Voluntary Withdrawal|5|||
147545125|NCT01309828|532152310|FG001|Overall Study|Voluntary Withdrawal|4|||
147545126|NCT01309828|532152309|FG000|Overall Study|Major Protocol Deviation|0|||
147545127|NCT01309828|532152310|FG001|Overall Study|Major Protocol Deviation|1|||
147545128|NCT01309828|532152309|FG000|Overall Study|Other|1|||
147545129|NCT01309828|532152310|FG001|Overall Study|Other|0|||
147545130|NCT00295620|532152311|FG000|Overall Study|Lost to Follow-up|9|||
147545131|NCT00295620|532152312|FG001|Overall Study|Lost to Follow-up|5|||
147545132|NCT00295620|532152311|FG000|Overall Study|Withdrawal by Subject|37|||
147545133|NCT00295620|532152312|FG001|Overall Study|Withdrawal by Subject|50|||
147545134|NCT00295620|532152311|FG000|Overall Study|Death|206|||
147545135|NCT00295620|532152312|FG001|Overall Study|Death|207|||
147545136|NCT00295620|532152311|FG000|Overall Study|Other reasons|10|||
147545137|NCT00295620|532152312|FG001|Overall Study|Other reasons|9|||
147545138|NCT00295620|532152311|FG000|Overall Study|Discontinuation by sponsor|580|||
147545139|NCT00295620|532152312|FG001|Overall Study|Discontinuation by sponsor|593|||
147545140|NCT00295620|532152311|FG000|Overall Study|Protocol Violation|30|||
147545141|NCT00295620|532152312|FG001|Overall Study|Protocol Violation|32|||
147545142|NCT00217971|532152313|FG000|Overall Study|Adverse Event|1|||
147545143|NCT00217971|532152314|FG001|Overall Study|Adverse Event|1|||
147545144|NCT00217971|532152313|FG000|Overall Study|Lost to Follow-up|15|||
147545145|NCT00217971|532152314|FG001|Overall Study|Lost to Follow-up|19|||
147545146|NCT00217971|532152313|FG000|Overall Study|Physician Decision|0|||
147545147|NCT00217971|532152314|FG001|Overall Study|Physician Decision|1|||
147545148|NCT00217971|532152313|FG000|Overall Study|Withdrawal by Subject|7|||
147545149|NCT00217971|532152314|FG001|Overall Study|Withdrawal by Subject|12|||
147210967|NCT00281658|530945389|FG001|Open Label Phase|Withdrawal by Subject|0|||
147210968|NCT00281658|530945390|FG002|Open Label Phase|Withdrawal by Subject|3|||
147210969|NCT00281658|530945391|FG003|Open Label Phase|Withdrawal by Subject|2|||
147210970|NCT00281658|530945388|FG000|Open Label Phase|Disease progression|0|||
147210971|NCT00281658|530945389|FG001|Open Label Phase|Disease progression|0|||
147210972|NCT00281658|530945390|FG002|Open Label Phase|Disease progression|18|||
147210973|NCT00281658|530945391|FG003|Open Label Phase|Disease progression|0|||
147210974|NCT00281658|530945388|FG000|Open Label Phase|Physician Decision|0|||
147210975|NCT00281658|530945389|FG001|Open Label Phase|Physician Decision|0|||
147545150|NCT00217971|532152313|FG000|Overall Study|non compliant|1|||
147545151|NCT00217971|532152314|FG001|Overall Study|non compliant|0|||
147545152|NCT00084617|532152326|FG000|Overall Study|Withdrawal by Subject|7|||
147545153|NCT00084617|532152326|FG000|Overall Study|Lack of Efficacy|1|||
147545154|NCT00084617|532152326|FG000|Overall Study|Protocol Violation|1|||
147545155|NCT01625286|532152327|FG000|Overall Study|Adverse Event|0|||
147545156|NCT01625286|532152328|FG001|Overall Study|Adverse Event|0|||
147545157|NCT01625286|532152329|FG002|Overall Study|Adverse Event|0|||
147545158|NCT01625286|532152330|FG003|Overall Study|Adverse Event|0|||
147545159|NCT01625286|532152331|FG004|Overall Study|Adverse Event|1|||
147545160|NCT01625286|532152332|FG005|Overall Study|Adverse Event|2|||
147545161|NCT01625286|532152333|FG006|Overall Study|Adverse Event|1|||
147545162|NCT01625286|532152327|FG000|Overall Study|Death|0|||
147545163|NCT01625286|532152328|FG001|Overall Study|Death|0|||
147545164|NCT01625286|532152329|FG002|Overall Study|Death|1|||
147545165|NCT01625286|532152330|FG003|Overall Study|Death|1|||
147545166|NCT01625286|532152331|FG004|Overall Study|Death|0|||
147545167|NCT01625286|532152332|FG005|Overall Study|Death|11|||
147545168|NCT01625286|532152333|FG006|Overall Study|Death|16|||
147545169|NCT01625286|532152327|FG000|Overall Study|Withdrawal by Subject|0|||
147545170|NCT01625286|532152328|FG001|Overall Study|Withdrawal by Subject|1|||
147545171|NCT01625286|532152329|FG002|Overall Study|Withdrawal by Subject|0|||
147545172|NCT01625286|532152330|FG003|Overall Study|Withdrawal by Subject|1|||
147545173|NCT01625286|532152331|FG004|Overall Study|Withdrawal by Subject|0|||
147545174|NCT01625286|532152332|FG005|Overall Study|Withdrawal by Subject|0|||
147545175|NCT01625286|532152333|FG006|Overall Study|Withdrawal by Subject|1|||
147545176|NCT01625286|532152327|FG000|Overall Study|Any reason not specifically recorded|0|||
147545177|NCT01625286|532152328|FG001|Overall Study|Any reason not specifically recorded|0|||
147545178|NCT01625286|532152329|FG002|Overall Study|Any reason not specifically recorded|0|||
147545179|NCT01625286|532152330|FG003|Overall Study|Any reason not specifically recorded|0|||
147545180|NCT01625286|532152331|FG004|Overall Study|Any reason not specifically recorded|0|||
147545181|NCT01625286|532152332|FG005|Overall Study|Any reason not specifically recorded|1|||
147545182|NCT01625286|532152333|FG006|Overall Study|Any reason not specifically recorded|0|||
147545183|NCT01625286|532152327|FG000|Overall Study|Progressive disease|6|||
147545184|NCT01625286|532152328|FG001|Overall Study|Progressive disease|3|||
147545185|NCT01625286|532152329|FG002|Overall Study|Progressive disease|4|||
147545186|NCT01625286|532152330|FG003|Overall Study|Progressive disease|5|||
147545187|NCT01625286|532152331|FG004|Overall Study|Progressive disease|5|||
147545188|NCT01625286|532152332|FG005|Overall Study|Progressive disease|0|||
147545189|NCT01625286|532152333|FG006|Overall Study|Progressive disease|0|||
147545190|NCT01625286|532152327|FG000|Overall Study|Lost to Follow-up|0|||
147545191|NCT01625286|532152328|FG001|Overall Study|Lost to Follow-up|0|||
147545192|NCT01625286|532152329|FG002|Overall Study|Lost to Follow-up|0|||
147545193|NCT01625286|532152330|FG003|Overall Study|Lost to Follow-up|0|||
147545194|NCT01625286|532152331|FG004|Overall Study|Lost to Follow-up|0|||
147545195|NCT01625286|532152332|FG005|Overall Study|Lost to Follow-up|0|||
147545196|NCT01625286|532152333|FG006|Overall Study|Lost to Follow-up|1|||
147545197|NCT00928135|532152334|FG000|Overall Study|Withdrawal by Subject|1|||
147545198|NCT00928135|532152335|FG001|Overall Study|Withdrawal by Subject|0|||
147545199|NCT04355767|532152336|FG000|Overall Study|Withdrawal by Subject|2|||
147545200|NCT04355767|532152337|FG001|Overall Study|Withdrawal by Subject|2|||
147545201|NCT04355767|532152336|FG000|Overall Study|Death|5|||
147545202|NCT04355767|532152337|FG001|Overall Study|Death|1|||
147545203|NCT01999322|532152338|FG000|Overall Study|Adverse Event|1|||
147545204|NCT01999322|532152339|FG001|Overall Study|Adverse Event|0|||
147545205|NCT03338673|532152342|FG000|Overall Study|Lost to Follow-up|1|||
147545206|NCT03338673|532152343|FG001|Overall Study|Lost to Follow-up|1|||
147545207|NCT00678379|532153778|FG000|Overall Study|Injection performed after tonsillectomy|2|||
147545208|NCT00678379|532153779|FG001|Overall Study|Injection performed after tonsillectomy|0|||
147545209|NCT00678379|532153780|FG002|Overall Study|Injection performed after tonsillectomy|1|||
147545210|NCT00678379|532153778|FG000|Overall Study|Incomplete Data|4|||
147545211|NCT00678379|532153779|FG001|Overall Study|Incomplete Data|3|||
147545212|NCT00678379|532153780|FG002|Overall Study|Incomplete Data|3|||
147545213|NCT01440647|532153783|FG000|Overall Study|Death|2|||
147545214|NCT01440647|532153784|FG001|Overall Study|Death|3|||
147545215|NCT04335110|532153796|FG000|Overall Study|Withdrawal by Subject|1|||
147545216|NCT04335110|532153797|FG001|Overall Study|Withdrawal by Subject|1|||
147545217|NCT04335110|532153796|FG000|Overall Study|Death|0|||
147545218|NCT04335110|532153797|FG001|Overall Study|Death|1|||
147545219|NCT04006847|532153800|FG000|Overall Study|Product issue|1|||
147545220|NCT03333382|532153809|FG000|Overall Study|Lost to Follow-up|1|||
147545221|NCT03333382|532153810|FG001|Overall Study|Lost to Follow-up|0|||
147545222|NCT02454972|532153813|FG000|Overall Study|Progressive disease|17|||
147545223|NCT02454972|532153814|FG001|Overall Study|Progressive disease|16|||
147545224|NCT02454972|532153815|FG002|Overall Study|Progressive disease|59|||
147545225|NCT02454972|532153816|FG003|Overall Study|Progressive disease|23|||
147545226|NCT02454972|532153817|FG004|Overall Study|Progressive disease|16|||
147545227|NCT02454972|532153818|FG005|Overall Study|Progressive disease|12|||
147545228|NCT02454972|532153819|FG006|Overall Study|Progressive disease|19|||
147545229|NCT02454972|532153820|FG007|Overall Study|Progressive disease|27|||
147545230|NCT02454972|532153821|FG008|Overall Study|Progressive disease|0|||
147545231|NCT02454972|532153813|FG000|Overall Study|Death|0|||
147545232|NCT02454972|532153814|FG001|Overall Study|Death|0|||
147545233|NCT02454972|532153815|FG002|Overall Study|Death|5|||
147210976|NCT00281658|530945390|FG002|Open Label Phase|Physician Decision|1|||
147210977|NCT00281658|530945391|FG003|Open Label Phase|Physician Decision|0|||
147210978|NCT00281658|530945388|FG000|Open Label Phase|Relocation of patient|0|||
147210979|NCT00281658|530945389|FG001|Open Label Phase|Relocation of patient|0|||
147210980|NCT00281658|530945390|FG002|Open Label Phase|Relocation of patient|1|||
147210981|NCT00281658|530945391|FG003|Open Label Phase|Relocation of patient|0|||
147210982|NCT00281658|530945388|FG000|Open Label Phase|Reason for withdrawal unspecified|0|||
147210983|NCT00281658|530945389|FG001|Open Label Phase|Reason for withdrawal unspecified|0|||
147210984|NCT00281658|530945390|FG002|Open Label Phase|Reason for withdrawal unspecified|5|||
147210985|NCT00281658|530945391|FG003|Open Label Phase|Reason for withdrawal unspecified|0|||
147210986|NCT04590248|530945392|FG000|Overall Study|Lost to Follow-up|1|||
147210987|NCT04590248|530945392|FG000|Overall Study|Withdrawal by Subject|16|||
147441515|NCT04688775|531780903|FG001|Delayed Start Period|Adverse Event|0|||
147441516|NCT04688775|531780904|FG002|Delayed Start Period|Adverse Event|1|||
147441517|NCT04688775|531780905|FG003|Delayed Start Period|Adverse Event|0|||
147441518|NCT04688775|531780902|FG000|Delayed Start Period|Lack of Efficacy|0|||
147441519|NCT04688775|531780903|FG001|Delayed Start Period|Lack of Efficacy|0|||
147441520|NCT04688775|531780904|FG002|Delayed Start Period|Lack of Efficacy|0|||
147441521|NCT04688775|531780905|FG003|Delayed Start Period|Lack of Efficacy|3|||
147441522|NCT04688775|531780902|FG000|Delayed Start Period|Withdrawal by Subject|0|||
147441523|NCT04688775|531780903|FG001|Delayed Start Period|Withdrawal by Subject|0|||
147441524|NCT04688775|531780904|FG002|Delayed Start Period|Withdrawal by Subject|2|||
147441525|NCT04688775|531780905|FG003|Delayed Start Period|Withdrawal by Subject|4|||
147441526|NCT04688775|531780902|FG000|Delayed Start Period|Lost to Follow-up|0|||
147441527|NCT04688775|531780903|FG001|Delayed Start Period|Lost to Follow-up|0|||
147441528|NCT04688775|531780904|FG002|Delayed Start Period|Lost to Follow-up|2|||
147441529|NCT04688775|531780905|FG003|Delayed Start Period|Lost to Follow-up|1|||
147441530|NCT04688775|531780902|FG000|Delayed Start Period|other reasons|0|||
147441531|NCT04688775|531780903|FG001|Delayed Start Period|other reasons|0|||
147441532|NCT04688775|531780904|FG002|Delayed Start Period|other reasons|1|||
147441533|NCT04688775|531780905|FG003|Delayed Start Period|other reasons|0|||
147441534|NCT01843972|531780906|FG000|Overall Study|Withdrawal by Subject|0|||
147441535|NCT01843972|531780907|FG001|Overall Study|Withdrawal by Subject|0|||
147441536|NCT01843972|531780908|FG002|Overall Study|Withdrawal by Subject|0|||
147441537|NCT01843972|531780909|FG003|Overall Study|Withdrawal by Subject|0|||
147441538|NCT01843972|531780910|FG004|Overall Study|Withdrawal by Subject|1|||
147441539|NCT01843972|531780911|FG005|Overall Study|Withdrawal by Subject|0|||
147441540|NCT01843972|531780912|FG006|Overall Study|Withdrawal by Subject|0|||
147441541|NCT01843972|531780913|FG007|Overall Study|Withdrawal by Subject|0|||
147441542|NCT01843972|531780914|FG008|Overall Study|Withdrawal by Subject|0|||
147441543|NCT01843972|531780915|FG009|Overall Study|Withdrawal by Subject|0|||
147441544|NCT01854645|531780916|FG000|Overall Study|Protocol-Specified Criteria|13|||
147441545|NCT01854645|531780917|FG001|Overall Study|Protocol-Specified Criteria|10|||
147441546|NCT01854645|531780918|FG002|Overall Study|Protocol-Specified Criteria|8|||
147441547|NCT01854645|531780919|FG003|Overall Study|Protocol-Specified Criteria|5|||
147441548|NCT01854645|531780920|FG004|Overall Study|Protocol-Specified Criteria|7|||
147441549|NCT01854645|531780916|FG000|Overall Study|Administrative Reasons / Missing|0|||
147441550|NCT01854645|531780917|FG001|Overall Study|Administrative Reasons / Missing|0|||
147441551|NCT01854645|531780918|FG002|Overall Study|Administrative Reasons / Missing|0|||
147441552|NCT01854645|531780919|FG003|Overall Study|Administrative Reasons / Missing|1|||
147441553|NCT01854645|531780920|FG004|Overall Study|Administrative Reasons / Missing|1|||
147441554|NCT01854645|531780916|FG000|Overall Study|Protocol Violation|3|||
147441555|NCT01854645|531780917|FG001|Overall Study|Protocol Violation|0|||
147441556|NCT01854645|531780918|FG002|Overall Study|Protocol Violation|5|||
147441557|NCT01854645|531780919|FG003|Overall Study|Protocol Violation|4|||
147441558|NCT01854645|531780920|FG004|Overall Study|Protocol Violation|1|||
147441559|NCT01854645|531780916|FG000|Overall Study|Lost to Follow-up|10|||
147441560|NCT01854645|531780917|FG001|Overall Study|Lost to Follow-up|7|||
147441561|NCT01854645|531780918|FG002|Overall Study|Lost to Follow-up|8|||
147441562|NCT01854645|531780919|FG003|Overall Study|Lost to Follow-up|5|||
147441563|NCT01854645|531780920|FG004|Overall Study|Lost to Follow-up|0|||
147441564|NCT01854645|531780916|FG000|Overall Study|Physician Decision|1|||
147441565|NCT01854645|531780917|FG001|Overall Study|Physician Decision|5|||
147441566|NCT01854645|531780918|FG002|Overall Study|Physician Decision|3|||
147441567|NCT01854645|531780919|FG003|Overall Study|Physician Decision|3|||
147441568|NCT01854645|531780920|FG004|Overall Study|Physician Decision|7|||
147441569|NCT01854645|531780916|FG000|Overall Study|Withdrawal by Subject|31|||
147210988|NCT04590248|530945392|FG000|Overall Study|Other|2|||
147210989|NCT02052414|530945395|FG000|Overall Study|Adverse Event|12|||
147441570|NCT01854645|531780917|FG001|Overall Study|Withdrawal by Subject|41|||
147441571|NCT01854645|531780918|FG002|Overall Study|Withdrawal by Subject|30|||
147441572|NCT01854645|531780919|FG003|Overall Study|Withdrawal by Subject|21|||
147441573|NCT01854645|531780920|FG004|Overall Study|Withdrawal by Subject|24|||
147441574|NCT01854645|531780916|FG000|Overall Study|Lack of Efficacy|7|||
147441575|NCT01854645|531780917|FG001|Overall Study|Lack of Efficacy|12|||
147545234|NCT02454972|532153816|FG003|Overall Study|Death|1|||
147545235|NCT02454972|532153817|FG004|Overall Study|Death|0|||
147545236|NCT02454972|532153818|FG005|Overall Study|Death|0|||
147545237|NCT02454972|532153819|FG006|Overall Study|Death|0|||
147545238|NCT02454972|532153820|FG007|Overall Study|Death|0|||
147545239|NCT02454972|532153821|FG008|Overall Study|Death|95|||
147545240|NCT02454972|532153813|FG000|Overall Study|Physician Decision|0|||
147545241|NCT02454972|532153814|FG001|Overall Study|Physician Decision|1|||
147545242|NCT02454972|532153815|FG002|Overall Study|Physician Decision|2|||
147545243|NCT02454972|532153816|FG003|Overall Study|Physician Decision|1|||
147545244|NCT02454972|532153817|FG004|Overall Study|Physician Decision|2|||
147545245|NCT02454972|532153818|FG005|Overall Study|Physician Decision|0|||
147545246|NCT02454972|532153819|FG006|Overall Study|Physician Decision|0|||
147545247|NCT02454972|532153820|FG007|Overall Study|Physician Decision|1|||
147545248|NCT02454972|532153821|FG008|Overall Study|Physician Decision|0|||
147545249|NCT02454972|532153813|FG000|Overall Study|Non treatment-related adverse event|2|||
147545250|NCT02454972|532153814|FG001|Overall Study|Non treatment-related adverse event|0|||
147545251|NCT02454972|532153815|FG002|Overall Study|Non treatment-related adverse event|1|||
147545252|NCT02454972|532153816|FG003|Overall Study|Non treatment-related adverse event|0|||
147210990|NCT02052414|530945395|FG000|Overall Study|Lack of Efficacy|2|||
147210991|NCT02052414|530945395|FG000|Overall Study|Withdrawal by Subject|3|||
147545253|NCT02454972|532153817|FG004|Overall Study|Non treatment-related adverse event|0|||
147545254|NCT02454972|532153818|FG005|Overall Study|Non treatment-related adverse event|1|||
147545255|NCT02454972|532153819|FG006|Overall Study|Non treatment-related adverse event|0|||
147545256|NCT02454972|532153820|FG007|Overall Study|Non treatment-related adverse event|1|||
147545257|NCT02454972|532153821|FG008|Overall Study|Non treatment-related adverse event|0|||
147545258|NCT02454972|532153813|FG000|Overall Study|Treatment-related adverse events|0|||
147545259|NCT02454972|532153814|FG001|Overall Study|Treatment-related adverse events|1|||
147545260|NCT02454972|532153815|FG002|Overall Study|Treatment-related adverse events|1|||
147545261|NCT02454972|532153816|FG003|Overall Study|Treatment-related adverse events|0|||
147545262|NCT02454972|532153817|FG004|Overall Study|Treatment-related adverse events|2|||
147545263|NCT02454972|532153818|FG005|Overall Study|Treatment-related adverse events|0|||
147545264|NCT02454972|532153819|FG006|Overall Study|Treatment-related adverse events|0|||
147545265|NCT02454972|532153820|FG007|Overall Study|Treatment-related adverse events|2|||
147545266|NCT02454972|532153821|FG008|Overall Study|Treatment-related adverse events|0|||
147545267|NCT02454972|532153813|FG000|Overall Study|Patient moves to compassionate use|0|||
147545268|NCT02454972|532153814|FG001|Overall Study|Patient moves to compassionate use|0|||
147545269|NCT02454972|532153815|FG002|Overall Study|Patient moves to compassionate use|0|||
147545270|NCT02454972|532153816|FG003|Overall Study|Patient moves to compassionate use|0|||
147545271|NCT02454972|532153817|FG004|Overall Study|Patient moves to compassionate use|0|||
147545272|NCT02454972|532153818|FG005|Overall Study|Patient moves to compassionate use|0|||
147545273|NCT02454972|532153819|FG006|Overall Study|Patient moves to compassionate use|2|||
147545274|NCT02454972|532153820|FG007|Overall Study|Patient moves to compassionate use|0|||
147545275|NCT02454972|532153821|FG008|Overall Study|Patient moves to compassionate use|0|||
147545276|NCT02454972|532153813|FG000|Overall Study|Withdrawal by Subject|0|||
147545277|NCT02454972|532153814|FG001|Overall Study|Withdrawal by Subject|1|||
147545278|NCT02454972|532153815|FG002|Overall Study|Withdrawal by Subject|5|||
147545279|NCT02454972|532153816|FG003|Overall Study|Withdrawal by Subject|2|||
147545280|NCT02454972|532153817|FG004|Overall Study|Withdrawal by Subject|3|||
147545281|NCT02454972|532153818|FG005|Overall Study|Withdrawal by Subject|2|||
147545282|NCT02454972|532153819|FG006|Overall Study|Withdrawal by Subject|0|||
147210992|NCT01343693|530945401|FG000|Overall Study|Lost to Follow-up|9|||
147210993|NCT02151773|530945402|FG000|Overall Study|Protocol Deviation|64|||
147210994|NCT02551991|530945403|FG000|Overall Study|Death|5|||
147210995|NCT02551991|530945404|FG001|Overall Study|Death|7|||
147210996|NCT02551991|530945405|FG002|Overall Study|Death|8|||
147210997|NCT02551991|530945406|FG003|Overall Study|Death|7|||
147210998|NCT02551991|530945407|FG004|Overall Study|Death|17|||
147210999|NCT02551991|530945403|FG000|Overall Study|Withdrawal by Subject|1|||
147211000|NCT02551991|530945404|FG001|Overall Study|Withdrawal by Subject|0|||
147211001|NCT02551991|530945405|FG002|Overall Study|Withdrawal by Subject|0|||
147211002|NCT02551991|530945406|FG003|Overall Study|Withdrawal by Subject|0|||
147211003|NCT02551991|530945407|FG004|Overall Study|Withdrawal by Subject|2|||
147211004|NCT02551991|530945403|FG000|Overall Study|Lost to Follow-up|0|||
147211005|NCT02551991|530945404|FG001|Overall Study|Lost to Follow-up|0|||
147545283|NCT02454972|532153820|FG007|Overall Study|Withdrawal by Subject|1|||
147545284|NCT02454972|532153821|FG008|Overall Study|Withdrawal by Subject|2|||
147545285|NCT02454972|532153813|FG000|Overall Study|Multiple delay/holds on treatment|0|||
147545286|NCT02454972|532153814|FG001|Overall Study|Multiple delay/holds on treatment|0|||
147545287|NCT02454972|532153815|FG002|Overall Study|Multiple delay/holds on treatment|0|||
147545288|NCT02454972|532153816|FG003|Overall Study|Multiple delay/holds on treatment|1|||
147545289|NCT02454972|532153817|FG004|Overall Study|Multiple delay/holds on treatment|0|||
147211006|NCT02551991|530945405|FG002|Overall Study|Lost to Follow-up|1|||
147211007|NCT02551991|530945406|FG003|Overall Study|Lost to Follow-up|0|||
147211008|NCT02551991|530945407|FG004|Overall Study|Lost to Follow-up|0|||
147211009|NCT02551991|530945403|FG000|Overall Study|Sponsor Decision|1|||
147211010|NCT02551991|530945404|FG001|Overall Study|Sponsor Decision|0|||
147211011|NCT02551991|530945405|FG002|Overall Study|Sponsor Decision|1|||
147211012|NCT02551991|530945406|FG003|Overall Study|Sponsor Decision|0|||
147211013|NCT02551991|530945407|FG004|Overall Study|Sponsor Decision|5|||
147211014|NCT02551991|530945403|FG000|Overall Study|Other|0|||
147211015|NCT02551991|530945404|FG001|Overall Study|Other|0|||
147211016|NCT02551991|530945405|FG002|Overall Study|Other|0|||
147211017|NCT02551991|530945406|FG003|Overall Study|Other|0|||
147211018|NCT02551991|530945407|FG004|Overall Study|Other|1|||
147211019|NCT00395343|530945408|FG000|Overall Study|Adverse Event|13|||
147211020|NCT00395343|530945409|FG001|Overall Study|Adverse Event|5|||
147211021|NCT00395343|530945408|FG000|Overall Study|Lack of Efficacy|0|||
147211022|NCT00395343|530945409|FG001|Overall Study|Lack of Efficacy|1|||
147211023|NCT00395343|530945408|FG000|Overall Study|Lost to Follow-up|4|||
147211024|NCT00395343|530945409|FG001|Overall Study|Lost to Follow-up|4|||
147211025|NCT00395343|530945408|FG000|Overall Study|Physician Decision|2|||
147545290|NCT02454972|532153818|FG005|Overall Study|Multiple delay/holds on treatment|0|||
147545291|NCT02454972|532153819|FG006|Overall Study|Multiple delay/holds on treatment|0|||
147545292|NCT02454972|532153820|FG007|Overall Study|Multiple delay/holds on treatment|0|||
147545293|NCT02454972|532153821|FG008|Overall Study|Multiple delay/holds on treatment|0|||
147545294|NCT02454972|532153813|FG000|Overall Study|Never treated|0|||
147211026|NCT00395343|530945409|FG001|Overall Study|Physician Decision|4|||
147211027|NCT00395343|530945408|FG000|Overall Study|Protocol Violation|6|||
147211028|NCT00395343|530945409|FG001|Overall Study|Protocol Violation|8|||
147441576|NCT01854645|531780918|FG002|Overall Study|Lack of Efficacy|9|||
147441577|NCT01854645|531780919|FG003|Overall Study|Lack of Efficacy|3|||
147441578|NCT01854645|531780920|FG004|Overall Study|Lack of Efficacy|9|||
147441579|NCT01854645|531780916|FG000|Overall Study|Adverse Event|33|||
147441580|NCT01854645|531780917|FG001|Overall Study|Adverse Event|31|||
147441581|NCT01854645|531780918|FG002|Overall Study|Adverse Event|19|||
147441582|NCT01854645|531780919|FG003|Overall Study|Adverse Event|20|||
147441583|NCT01854645|531780920|FG004|Overall Study|Adverse Event|11|||
147441584|NCT00427349|531780925|FG000|Overall Study|Lack of Efficacy|23|||
147441585|NCT00427349|531780925|FG000|Overall Study|Adverse Event|14|||
147441586|NCT00427349|531780925|FG000|Overall Study|Death|1|||
147441587|NCT00427349|531780925|FG000|Overall Study|Withdrawal by Subject|3|||
147441588|NCT00427349|531780925|FG000|Overall Study|Alternative therapy|1|||
147441589|NCT00427349|531780925|FG000|Overall Study|Other|2|||
147441590|NCT00427349|531780925|FG000|Overall Study|Ineligible|1|||
147441591|NCT00427349|531780925|FG000|Overall Study|Never started therapy|1|||
147441592|NCT05082376|531780926|FG000|Overall Study|Lost to Follow-up|2|||
147441593|NCT00445224|531780927|FG000|Specific Exercises|Withdrawal by Subject|3|||
147441594|NCT00445224|531780928|FG001|Specific Exercises|Withdrawal by Subject|3|||
147441595|NCT00445224|531780927|FG000|Specific Exercises|Withdrawal by Subject|1|||
147441596|NCT00445224|531780928|FG001|Specific Exercises|Withdrawal by Subject|0|||
147441597|NCT04360551|531782563|FG000|Overall Study|Withdrawal by Subject|1|||
147441598|NCT04360551|531782564|FG001|Overall Study|Withdrawal by Subject|0|||
147441599|NCT03496012|531782565|FG000|Overall Study|Withdrawal by Subject|2|||
147441600|NCT03496012|531782566|FG001|Overall Study|Withdrawal by Subject|0|||
147441601|NCT03496012|531782567|FG002|Overall Study|Withdrawal by Subject|2|||
147441602|NCT03496012|531782565|FG000|Overall Study|Adverse Event|0|||
147441603|NCT03496012|531782566|FG001|Overall Study|Adverse Event|0|||
147441604|NCT03496012|531782567|FG002|Overall Study|Adverse Event|1|||
147441605|NCT03496012|531782565|FG000|Overall Study|Reason Not Specified|2|||
147441606|NCT03496012|531782566|FG001|Overall Study|Reason Not Specified|0|||
147441607|NCT03496012|531782567|FG002|Overall Study|Reason Not Specified|1|||
147441608|NCT00449670|531782573|FG000|Primary Phase (Study no.109630)|Serious Adverse Event|1|||
147441609|NCT00449670|531782574|FG001|Primary Phase (Study no.109630)|Serious Adverse Event|0|||
147441610|NCT00449670|531782573|FG000|Primary Phase (Study no.109630)|Non-serious adverse event|4|||
147441611|NCT00449670|531782574|FG001|Primary Phase (Study no.109630)|Non-serious adverse event|0|||
147441612|NCT00449670|531782573|FG000|Primary Phase (Study no.109630)|Withdrawal by Subject|4|||
147441613|NCT00449670|531782574|FG001|Primary Phase (Study no.109630)|Withdrawal by Subject|1|||
147441614|NCT00449670|531782573|FG000|Primary Phase (Study no.109630)|Lost to Follow-up|5|||
147441615|NCT00449670|531782574|FG001|Primary Phase (Study no.109630)|Lost to Follow-up|1|||
147441616|NCT00449670|531782573|FG000|Booster Phase (Study no.109873)|Migrated/moved from study area|0|||
147441617|NCT00449670|531782574|FG001|Booster Phase (Study no.109873)|Migrated/moved from study area|1|||
147211029|NCT00395343|530945408|FG000|Overall Study|Withdrawal by Subject|11|||
147211030|NCT00395343|530945409|FG001|Overall Study|Withdrawal by Subject|12|||
147211031|NCT00395343|530945408|FG000|Overall Study|Other|5|||
147211032|NCT00395343|530945409|FG001|Overall Study|Other|2|||
147211033|NCT00387790|530945413|FG000|Overall Study|Adverse Event|5|||
147211034|NCT00387790|530945413|FG000|Overall Study|Lack of Efficacy|2|||
147441618|NCT00449670|531782573|FG000|Booster Phase (Study no.109873)|Other|0|||
147441619|NCT00449670|531782574|FG001|Booster Phase (Study no.109873)|Other|2|||
147441620|NCT01251653|531782575|FG000|Overall Study|Progressive Disease|1|||
147441621|NCT01251653|531782576|FG001|Overall Study|Progressive Disease|7|||
147545295|NCT02454972|532153814|FG001|Overall Study|Never treated|0|||
147545296|NCT02454972|532153815|FG002|Overall Study|Never treated|3|||
147545297|NCT02454972|532153816|FG003|Overall Study|Never treated|1|||
147545298|NCT02454972|532153817|FG004|Overall Study|Never treated|1|||
147545299|NCT02454972|532153818|FG005|Overall Study|Never treated|0|||
147545300|NCT02454972|532153819|FG006|Overall Study|Never treated|0|||
147545301|NCT02454972|532153820|FG007|Overall Study|Never treated|0|||
147545302|NCT02454972|532153821|FG008|Overall Study|Never treated|5|||
147211035|NCT00387790|530945413|FG000|Overall Study|Physician Decision|2|||
147211036|NCT00387790|530945413|FG000|Overall Study|Withdrawal by Subject|3|||
147211037|NCT00387790|530945413|FG000|Overall Study|Ineligible for study|2|||
147211038|NCT01874340|530945414|FG000|Overall Study|Study terminated by Sponsor|6|||
147211039|NCT01874340|530945415|FG001|Overall Study|Study terminated by Sponsor|8|||
147211040|NCT01874340|530945416|FG002|Overall Study|Study terminated by Sponsor|8|||
147211041|NCT01874340|530945417|FG003|Overall Study|Study terminated by Sponsor|4|||
147211042|NCT01874340|530945414|FG000|Overall Study|Withdrawal by Subject|0|||
147211043|NCT01874340|530945415|FG001|Overall Study|Withdrawal by Subject|0|||
147211044|NCT01874340|530945416|FG002|Overall Study|Withdrawal by Subject|0|||
147211045|NCT01874340|530945417|FG003|Overall Study|Withdrawal by Subject|1|||
147211046|NCT03539549|530945418|FG000|Overall Study|Adverse Event|12|||
147211047|NCT03539549|530945418|FG000|Overall Study|Lost to Follow-up|1|||
147211048|NCT03539549|530945418|FG000|Overall Study|Death|2|||
147211049|NCT03539549|530945418|FG000|Overall Study|Progressive Disease|1|||
147211050|NCT03539549|530945418|FG000|Overall Study|Reason not Specified|1|||
147211051|NCT02864862|530945420|FG000|Overall Study|Lost to Follow-up|1|||
147211052|NCT02864862|530945421|FG001|Overall Study|Lost to Follow-up|0|||
147211053|NCT02864862|530945422|FG002|Overall Study|Lost to Follow-up|1|||
147211054|NCT02864862|530945420|FG000|Overall Study|Protocol Violation|0|||
147211055|NCT02864862|530945421|FG001|Overall Study|Protocol Violation|0|||
147211056|NCT02864862|530945422|FG002|Overall Study|Protocol Violation|1|||
147211057|NCT04605991|530945423|FG000|Overall Study|Adverse Event|5|||
147211058|NCT04605991|530945423|FG000|Overall Study|Lack of Efficacy|1|||
147211059|NCT04605991|530945423|FG000|Overall Study|Lost to Follow-up|8|||
147211060|NCT04605991|530945423|FG000|Overall Study|Physician Decision|4|||
147211061|NCT04605991|530945423|FG000|Overall Study|Withdrawal by Subject|14|||
147211062|NCT04605991|530945423|FG000|Overall Study|Non-compliance with study|1|||
147211063|NCT03263702|530945424|FG000|Overall Study|Lost to Follow-up|2|||
147211064|NCT03263702|530945425|FG001|Overall Study|Lost to Follow-up|2|||
147211065|NCT03263702|530945424|FG000|Overall Study|Withdrawal by Subject|1|||
147211066|NCT03263702|530945425|FG001|Overall Study|Withdrawal by Subject|2|||
147211067|NCT03598114|530945426|FG000|Overall Study|Staff turnover/left the program|3|||
147211068|NCT03598114|530945427|FG001|Overall Study|Staff turnover/left the program|39|||
147211069|NCT02527200|530945428|FG000|Overall Study|Withdrawal by Subject|3|||
147211070|NCT02527200|530945429|FG001|Overall Study|Withdrawal by Subject|2|||
147211071|NCT02527200|530945430|FG002|Overall Study|Withdrawal by Subject|1|||
147211072|NCT02527200|530945431|FG003|Overall Study|Withdrawal by Subject|0|||
147211073|NCT02527200|530945428|FG000|Overall Study|Unclassified|0|||
147211074|NCT02527200|530945429|FG001|Overall Study|Unclassified|1|||
147211075|NCT02527200|530945430|FG002|Overall Study|Unclassified|0|||
147211076|NCT02527200|530945431|FG003|Overall Study|Unclassified|0|||
147211077|NCT02527200|530945428|FG000|Overall Study|Lost to Follow-up|0|||
147211078|NCT02527200|530945429|FG001|Overall Study|Lost to Follow-up|0|||
147211079|NCT02527200|530945430|FG002|Overall Study|Lost to Follow-up|1|||
147211080|NCT02527200|530945431|FG003|Overall Study|Lost to Follow-up|0|||
147211081|NCT00689117|530945432|FG000|Overall Study|Adverse Event|6|||
147211082|NCT00689117|530945433|FG001|Overall Study|Adverse Event|0|||
147211083|NCT00689117|530945434|FG002|Overall Study|Adverse Event|5|||
147211084|NCT00689117|530945435|FG003|Overall Study|Adverse Event|0|||
147211085|NCT00689117|530945432|FG000|Overall Study|Lost to Follow-up|26|||
147211086|NCT00689117|530945433|FG001|Overall Study|Lost to Follow-up|19|||
147211087|NCT00689117|530945434|FG002|Overall Study|Lost to Follow-up|17|||
147211088|NCT00689117|530945435|FG003|Overall Study|Lost to Follow-up|11|||
147211089|NCT00689117|530945432|FG000|Overall Study|Lack of Efficacy|1|||
147211090|NCT00689117|530945433|FG001|Overall Study|Lack of Efficacy|2|||
147211091|NCT00689117|530945434|FG002|Overall Study|Lack of Efficacy|2|||
147211092|NCT00689117|530945435|FG003|Overall Study|Lack of Efficacy|2|||
147211093|NCT00689117|530945432|FG000|Overall Study|Non-Compliance with Study Treatment|3|||
147211094|NCT00689117|530945433|FG001|Overall Study|Non-Compliance with Study Treatment|3|||
147211095|NCT00689117|530945434|FG002|Overall Study|Non-Compliance with Study Treatment|3|||
147211096|NCT00689117|530945435|FG003|Overall Study|Non-Compliance with Study Treatment|1|||
147211097|NCT00689117|530945432|FG000|Overall Study|Withdrawal by Subject|19|||
147211098|NCT00689117|530945433|FG001|Overall Study|Withdrawal by Subject|18|||
147211099|NCT00689117|530945434|FG002|Overall Study|Withdrawal by Subject|26|||
147211100|NCT00689117|530945435|FG003|Overall Study|Withdrawal by Subject|13|||
147211101|NCT00689117|530945432|FG000|Overall Study|Unable to Comply with Visit Schedule|0|||
147211102|NCT00689117|530945433|FG001|Overall Study|Unable to Comply with Visit Schedule|0|||
147211103|NCT00689117|530945434|FG002|Overall Study|Unable to Comply with Visit Schedule|1|||
147545303|NCT02454972|532153813|FG000|Overall Study|Lost to Follow-up|0|||
147545304|NCT02454972|532153814|FG001|Overall Study|Lost to Follow-up|0|||
147211104|NCT00689117|530945435|FG003|Overall Study|Unable to Comply with Visit Schedule|1|||
147211105|NCT00689117|530945432|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
147211106|NCT00689117|530945433|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|2|||
147211107|NCT00689117|530945434|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
147441622|NCT01251653|531782577|FG002|Overall Study|Progressive Disease|16|||
147441623|NCT01251653|531782578|FG003|Overall Study|Progressive Disease|4|||
147441624|NCT01251653|531782579|FG004|Overall Study|Progressive Disease|0|||
147441625|NCT01251653|531782580|FG005|Overall Study|Progressive Disease|17|||
147441626|NCT01251653|531782581|FG006|Overall Study|Progressive Disease|14|||
147441627|NCT01251653|531782582|FG007|Overall Study|Progressive Disease|7|||
147441628|NCT01251653|531782583|FG008|Overall Study|Progressive Disease|5|||
147441629|NCT01251653|531782575|FG000|Overall Study|Dose-limiting toxicity|0|||
147441630|NCT01251653|531782576|FG001|Overall Study|Dose-limiting toxicity|1|||
147441631|NCT01251653|531782577|FG002|Overall Study|Dose-limiting toxicity|1|||
147441632|NCT01251653|531782578|FG003|Overall Study|Dose-limiting toxicity|1|||
147441633|NCT01251653|531782579|FG004|Overall Study|Dose-limiting toxicity|0|||
147441634|NCT01251653|531782580|FG005|Overall Study|Dose-limiting toxicity|0|||
147441635|NCT01251653|531782581|FG006|Overall Study|Dose-limiting toxicity|2|||
147441636|NCT01251653|531782582|FG007|Overall Study|Dose-limiting toxicity|0|||
147441637|NCT01251653|531782583|FG008|Overall Study|Dose-limiting toxicity|0|||
147441638|NCT01251653|531782575|FG000|Overall Study|Adverse Event|1|||
147441639|NCT01251653|531782576|FG001|Overall Study|Adverse Event|0|||
147441640|NCT01251653|531782577|FG002|Overall Study|Adverse Event|2|||
147441641|NCT01251653|531782578|FG003|Overall Study|Adverse Event|1|||
147441642|NCT01251653|531782579|FG004|Overall Study|Adverse Event|1|||
147441643|NCT01251653|531782580|FG005|Overall Study|Adverse Event|0|||
147441644|NCT01251653|531782581|FG006|Overall Study|Adverse Event|2|||
147441645|NCT01251653|531782582|FG007|Overall Study|Adverse Event|2|||
147441646|NCT01251653|531782583|FG008|Overall Study|Adverse Event|1|||
147441647|NCT01251653|531782575|FG000|Overall Study|Withdrawal by Subject|1|||
147441648|NCT01251653|531782576|FG001|Overall Study|Withdrawal by Subject|0|||
147441649|NCT01251653|531782577|FG002|Overall Study|Withdrawal by Subject|1|||
147441650|NCT01251653|531782578|FG003|Overall Study|Withdrawal by Subject|0|||
147441651|NCT01251653|531782579|FG004|Overall Study|Withdrawal by Subject|1|||
147441652|NCT01251653|531782580|FG005|Overall Study|Withdrawal by Subject|1|||
147441653|NCT01251653|531782581|FG006|Overall Study|Withdrawal by Subject|0|||
147441654|NCT01251653|531782582|FG007|Overall Study|Withdrawal by Subject|1|||
147441655|NCT01251653|531782583|FG008|Overall Study|Withdrawal by Subject|0|||
147441656|NCT01251653|531782575|FG000|Overall Study|Other reason not mentioned above|0|||
147441657|NCT01251653|531782576|FG001|Overall Study|Other reason not mentioned above|0|||
147441658|NCT01251653|531782577|FG002|Overall Study|Other reason not mentioned above|0|||
147441659|NCT01251653|531782578|FG003|Overall Study|Other reason not mentioned above|0|||
147441660|NCT01251653|531782579|FG004|Overall Study|Other reason not mentioned above|0|||
147441661|NCT01251653|531782580|FG005|Overall Study|Other reason not mentioned above|0|||
147441662|NCT01251653|531782581|FG006|Overall Study|Other reason not mentioned above|0|||
147441663|NCT01251653|531782582|FG007|Overall Study|Other reason not mentioned above|2|||
147441664|NCT01251653|531782583|FG008|Overall Study|Other reason not mentioned above|0|||
147441665|NCT02232802|531782592|FG000|Period 1|Sponsor request|1|||
147441666|NCT02232802|531782593|FG001|Period 1|Sponsor request|0|||
147441667|NCT02232802|531782592|FG000|Period 1|Adverse Event|1|||
147441668|NCT02232802|531782593|FG001|Period 1|Adverse Event|1|||
147441669|NCT00885703|531782598|FG000|Overall Study|Death|9|||
147441670|NCT00885703|531782599|FG001|Overall Study|Death|7|||
147441671|NCT00885703|531782600|FG002|Overall Study|Death|8|||
147441672|NCT00885703|531782601|FG003|Overall Study|Death|7|||
147441673|NCT00885703|531782602|FG004|Overall Study|Death|7|||
147441674|NCT00885703|531782603|FG005|Overall Study|Death|8|||
147441675|NCT00885703|531782604|FG006|Overall Study|Death|4|||
147441676|NCT00885703|531782598|FG000|Overall Study|Lost to Follow-up|0|||
147441677|NCT00885703|531782599|FG001|Overall Study|Lost to Follow-up|0|||
147441678|NCT00885703|531782600|FG002|Overall Study|Lost to Follow-up|1|||
147441679|NCT00885703|531782601|FG003|Overall Study|Lost to Follow-up|0|||
147441680|NCT00885703|531782602|FG004|Overall Study|Lost to Follow-up|0|||
147441681|NCT00885703|531782603|FG005|Overall Study|Lost to Follow-up|1|||
147441682|NCT00885703|531782604|FG006|Overall Study|Lost to Follow-up|0|||
147441683|NCT00885703|531782598|FG000|Overall Study|Withdrawal by Subject|0|||
147441684|NCT00885703|531782599|FG001|Overall Study|Withdrawal by Subject|0|||
147441685|NCT00885703|531782600|FG002|Overall Study|Withdrawal by Subject|0|||
147441686|NCT00885703|531782601|FG003|Overall Study|Withdrawal by Subject|1|||
147441687|NCT00885703|531782602|FG004|Overall Study|Withdrawal by Subject|3|||
147441688|NCT00885703|531782603|FG005|Overall Study|Withdrawal by Subject|1|||
147441689|NCT00885703|531782604|FG006|Overall Study|Withdrawal by Subject|1|||
147441690|NCT00885703|531782598|FG000|Overall Study|Ineligible (no CM)|1|||
147441691|NCT00885703|531782599|FG001|Overall Study|Ineligible (no CM)|3|||
147441692|NCT00885703|531782600|FG002|Overall Study|Ineligible (no CM)|2|||
147441693|NCT00885703|531782601|FG003|Overall Study|Ineligible (no CM)|1|||
147211108|NCT00689117|530945435|FG003|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
147545305|NCT02454972|532153815|FG002|Overall Study|Lost to Follow-up|0|||
147545306|NCT02454972|532153816|FG003|Overall Study|Lost to Follow-up|0|||
147545307|NCT02454972|532153817|FG004|Overall Study|Lost to Follow-up|0|||
147545308|NCT02454972|532153818|FG005|Overall Study|Lost to Follow-up|0|||
147545309|NCT02454972|532153819|FG006|Overall Study|Lost to Follow-up|0|||
147545310|NCT02454972|532153820|FG007|Overall Study|Lost to Follow-up|0|||
147545311|NCT02454972|532153821|FG008|Overall Study|Lost to Follow-up|2|||
147545312|NCT02454972|532153813|FG000|Overall Study|Study termination|0|||
147545313|NCT02454972|532153814|FG001|Overall Study|Study termination|0|||
147545314|NCT02454972|532153815|FG002|Overall Study|Study termination|0|||
147545315|NCT02454972|532153816|FG003|Overall Study|Study termination|0|||
147545316|NCT02454972|532153817|FG004|Overall Study|Study termination|0|||
147545317|NCT02454972|532153818|FG005|Overall Study|Study termination|0|||
147545318|NCT02454972|532153819|FG006|Overall Study|Study termination|0|||
147545319|NCT02454972|532153820|FG007|Overall Study|Study termination|0|||
147545320|NCT02454972|532153821|FG008|Overall Study|Study termination|6|||
147545321|NCT00787566|532153822|FG000|Overall Study|AE related to chemotherapy|0|||
147545322|NCT00787566|532153823|FG001|Overall Study|AE related to chemotherapy|1|||
147545323|NCT00787566|532153824|FG002|Overall Study|AE related to chemotherapy|0|||
147545324|NCT01070966|532153832|FG000|Participants for Safety Evaluation|Violation of inclusion criteria|59|||
147545325|NCT01070966|532153832|FG000|Participants for Safety Evaluation|Off-label use|9|||
147545326|NCT01070966|532153832|FG000|Participants for Safety Evaluation|Duplicate Participants|4|||
147545327|NCT01070966|532153832|FG000|Participants for Safety Evaluation|Violation inclusion criteria/off label|3|||
147545328|NCT01070966|532153832|FG000|Participants for Safety Evaluation|TMT given before date of contract|3|||
147545329|NCT01070966|532153832|FG000|Participants for Efficacy Evaluation|Lack of tmt period (<28 days)|61|||
147545330|NCT01070966|532153832|FG000|Participants for Efficacy Evaluation|No efficacy evaluation|19|||
147545331|NCT01070966|532153832|FG000|Participants for Efficacy Evaluation|Efficacy evaluation window violation|2|||
147545332|NCT00618774|532153833|FG000|Overall Study|Adverse Event|5|||
147545333|NCT00618774|532153834|FG001|Overall Study|Adverse Event|3|||
147545334|NCT00618774|532153833|FG000|Overall Study|Withdrawal by Subject|1|||
147545335|NCT00618774|532153834|FG001|Overall Study|Withdrawal by Subject|0|||
147545336|NCT01725113|532153836|FG000|Overall Study|Kidney Transplant|1|||
147545337|NCT01725113|532153837|FG001|Overall Study|Kidney Transplant|1|||
147545338|NCT01725113|532153836|FG000|Overall Study|Withdrawal by Subject|0|||
147545339|NCT01725113|532153837|FG001|Overall Study|Withdrawal by Subject|1|||
147545340|NCT01415921|532153839|FG000|Overall Study|Adverse Event|0|||
147545341|NCT01415921|532153840|FG001|Overall Study|Adverse Event|1|||
147545342|NCT01415921|532153839|FG000|Overall Study|Physician Decision|1|||
147545343|NCT01415921|532153840|FG001|Overall Study|Physician Decision|1|||
147545344|NCT01415921|532153839|FG000|Overall Study|Withdrawal by Subject|0|||
147545345|NCT01415921|532153840|FG001|Overall Study|Withdrawal by Subject|1|||
147545346|NCT01415921|532153839|FG000|Overall Study|Other|2|||
147545347|NCT01415921|532153840|FG001|Overall Study|Other|0|||
147545348|NCT02117479|532153846|FG000|Overall Study|Death|13|||
147545349|NCT02117479|532153847|FG001|Overall Study|Death|8|||
147545350|NCT02117479|532153846|FG000|Overall Study|Adverse Event|8|||
147545351|NCT02117479|532153847|FG001|Overall Study|Adverse Event|16|||
147545352|NCT02117479|532153846|FG000|Overall Study|Subject decision|8|||
147545353|NCT02117479|532153847|FG001|Overall Study|Subject decision|9|||
147545354|NCT02117479|532153846|FG000|Overall Study|Disease progression|104|||
147545355|NCT02117479|532153847|FG001|Overall Study|Disease progression|108|||
147545356|NCT02117479|532153846|FG000|Overall Study|Noncompliance with study treatment|1|||
147545357|NCT02117479|532153847|FG001|Overall Study|Noncompliance with study treatment|0|||
147545358|NCT02117479|532153846|FG000|Overall Study|Study terminated by the sponsor|4|||
147545359|NCT02117479|532153847|FG001|Overall Study|Study terminated by the sponsor|6|||
147545360|NCT02117479|532153846|FG000|Overall Study|Physician Decision|7|||
147545361|NCT02117479|532153847|FG001|Overall Study|Physician Decision|2|||
147545362|NCT02117479|532153846|FG000|Overall Study|Other unspecified|11|||
147545363|NCT02117479|532153847|FG001|Overall Study|Other unspecified|7|||
147545364|NCT01453374|532153848|FG000|Overall Study|Adverse Event|7|||
147545365|NCT01453374|532153848|FG000|Overall Study|Lack of Efficacy|1|||
147211109|NCT00689117|530945432|FG000|Overall Study|Non-compliance with Treatment Regimen|0|||
147211110|NCT00689117|530945433|FG001|Overall Study|Non-compliance with Treatment Regimen|1|||
147211111|NCT00689117|530945434|FG002|Overall Study|Non-compliance with Treatment Regimen|0|||
147211112|NCT00689117|530945435|FG003|Overall Study|Non-compliance with Treatment Regimen|0|||
147545366|NCT01453374|532153848|FG000|Overall Study|Lost to Follow-up|3|||
147545367|NCT01453374|532153848|FG000|Overall Study|Withdrawal by Subject|5|||
147649442|NCT02634801|532537341|FG000|Follow-up Period|Physician Decision|0|||
147545368|NCT01453374|532153848|FG000|Overall Study|Incarcerated|2|||
147545369|NCT02629133|532153850|FG000|Overall Study|Lost to Follow-up|3|||
147545370|NCT02629133|532153851|FG001|Overall Study|Lost to Follow-up|1|||
147545371|NCT02629133|532153850|FG000|Overall Study|Withdrawal by Subject|1|||
147545372|NCT02629133|532153851|FG001|Overall Study|Withdrawal by Subject|1|||
147545373|NCT03216954|532153852|FG000|Overall Study|Adverse Event|0|||
147545374|NCT03216954|532153853|FG001|Overall Study|Adverse Event|0|||
147545375|NCT03216954|532153854|FG002|Overall Study|Adverse Event|1|||
147211113|NCT00689117|530945432|FG000|Overall Study|Change/Discontinuation of Birth Control|1|||
147211114|NCT00689117|530945433|FG001|Overall Study|Change/Discontinuation of Birth Control|1|||
147211115|NCT00689117|530945434|FG002|Overall Study|Change/Discontinuation of Birth Control|1|||
147211116|NCT00689117|530945435|FG003|Overall Study|Change/Discontinuation of Birth Control|0|||
147211117|NCT00689117|530945432|FG000|Overall Study|Use of Prohibitive Medication|2|||
147211118|NCT00689117|530945433|FG001|Overall Study|Use of Prohibitive Medication|1|||
147211119|NCT00689117|530945434|FG002|Overall Study|Use of Prohibitive Medication|3|||
147211120|NCT00689117|530945435|FG003|Overall Study|Use of Prohibitive Medication|0|||
147211121|NCT00689117|530945432|FG000|Overall Study|Pregnancy|0|||
147211122|NCT00689117|530945433|FG001|Overall Study|Pregnancy|2|||
147211123|NCT00689117|530945434|FG002|Overall Study|Pregnancy|0|||
147211124|NCT00689117|530945435|FG003|Overall Study|Pregnancy|2|||
147211125|NCT00689117|530945432|FG000|Overall Study|Incarceration|2|||
147211126|NCT00689117|530945433|FG001|Overall Study|Incarceration|0|||
147211127|NCT00689117|530945434|FG002|Overall Study|Incarceration|0|||
147211128|NCT00689117|530945435|FG003|Overall Study|Incarceration|0|||
147211129|NCT00689117|530945432|FG000|Overall Study|Fear of Birth Defects|0|||
147211130|NCT00689117|530945433|FG001|Overall Study|Fear of Birth Defects|0|||
147211131|NCT00689117|530945434|FG002|Overall Study|Fear of Birth Defects|1|||
147211132|NCT00689117|530945435|FG003|Overall Study|Fear of Birth Defects|0|||
147211133|NCT00689117|530945432|FG000|Overall Study|Transportation|1|||
147211134|NCT00689117|530945433|FG001|Overall Study|Transportation|0|||
147211135|NCT00689117|530945434|FG002|Overall Study|Transportation|0|||
147211136|NCT00689117|530945435|FG003|Overall Study|Transportation|0|||
147211137|NCT00689117|530945432|FG000|Overall Study|Patient Withdrew from Study|0|||
147211138|NCT00689117|530945433|FG001|Overall Study|Patient Withdrew from Study|0|||
147211139|NCT00689117|530945434|FG002|Overall Study|Patient Withdrew from Study|0|||
147211140|NCT00689117|530945435|FG003|Overall Study|Patient Withdrew from Study|1|||
147211141|NCT00689117|530945432|FG000|Overall Study|Personal Reason|0|||
147211142|NCT00689117|530945433|FG001|Overall Study|Personal Reason|1|||
147211143|NCT00689117|530945434|FG002|Overall Study|Personal Reason|0|||
147211144|NCT00689117|530945435|FG003|Overall Study|Personal Reason|0|||
147211145|NCT00689117|530945432|FG000|Overall Study|Dispensing Error|0|||
147211146|NCT00689117|530945433|FG001|Overall Study|Dispensing Error|1|||
147211147|NCT00689117|530945434|FG002|Overall Study|Dispensing Error|0|||
147211148|NCT00689117|530945435|FG003|Overall Study|Dispensing Error|0|||
147211149|NCT00444678|530945436|FG000|Overall Study|Toxicity|11|||
147211150|NCT00444678|530945436|FG000|Overall Study|Disease Progression|12|||
147211151|NCT00444678|530945436|FG000|Overall Study|Death|3|||
147211152|NCT00444678|530945436|FG000|Overall Study|Physician Decision|3|||
147211153|NCT00444678|530945436|FG000|Overall Study|Withdrawal by Subject|2|||
147211154|NCT00329797|530945440|FG000|Overall Study|Protocol Violation|1|||
147211155|NCT00329797|530945441|FG001|Overall Study|Protocol Violation|0|||
147211156|NCT00329797|530945440|FG000|Overall Study|Withdrawal by Subject|6|||
147441694|NCT00885703|531782602|FG004|Overall Study|Ineligible (no CM)|2|||
147441695|NCT00885703|531782603|FG005|Overall Study|Ineligible (no CM)|3|||
147441696|NCT00885703|531782604|FG006|Overall Study|Ineligible (no CM)|1|||
147441697|NCT01490450|531782607|FG000|Period 1|Lack of Efficacy|2|||
147441698|NCT01490450|531782608|FG001|Period 1|Lack of Efficacy|0|||
147441699|NCT01490450|531782609|FG002|Period 1|Lack of Efficacy|3|||
147441700|NCT01490450|531782610|FG003|Period 1|Lack of Efficacy|0|||
147441701|NCT01490450|531782607|FG000|Period 1|Adverse Event|0|||
147441702|NCT01490450|531782608|FG001|Period 1|Adverse Event|0|||
147441703|NCT01490450|531782609|FG002|Period 1|Adverse Event|0|||
147441704|NCT01490450|531782610|FG003|Period 1|Adverse Event|5|||
147441705|NCT01490450|531782607|FG000|Period 1|Request to discontinue treatment|1|||
147441706|NCT01490450|531782608|FG001|Period 1|Request to discontinue treatment|0|||
147441707|NCT01490450|531782609|FG002|Period 1|Request to discontinue treatment|0|||
147441708|NCT01490450|531782610|FG003|Period 1|Request to discontinue treatment|0|||
147441709|NCT01490450|531782607|FG000|Period 1|Withdrawal by Subject|0|||
147441710|NCT01490450|531782608|FG001|Period 1|Withdrawal by Subject|0|||
147441711|NCT01490450|531782609|FG002|Period 1|Withdrawal by Subject|0|||
147441712|NCT01490450|531782610|FG003|Period 1|Withdrawal by Subject|3|||
147441713|NCT01490450|531782607|FG000|Period 1|No longer met study criteria|0|||
147441714|NCT01490450|531782608|FG001|Period 1|No longer met study criteria|1|||
147441715|NCT01490450|531782609|FG002|Period 1|No longer met study criteria|1|||
147441716|NCT01490450|531782610|FG003|Period 1|No longer met study criteria|0|||
147441717|NCT01490450|531782607|FG000|Period 2|Lack of Efficacy|0|||
147441718|NCT01490450|531782608|FG001|Period 2|Lack of Efficacy|0|||
147441719|NCT01490450|531782609|FG002|Period 2|Lack of Efficacy|0|||
147441720|NCT01490450|531782610|FG003|Period 2|Lack of Efficacy|1|||
147441721|NCT01490450|531782607|FG000|Period 2|Adverse Event|1|||
147441722|NCT01490450|531782608|FG001|Period 2|Adverse Event|1|||
147441723|NCT01490450|531782609|FG002|Period 2|Adverse Event|0|||
147441724|NCT01490450|531782610|FG003|Period 2|Adverse Event|1|||
147211157|NCT00329797|530945441|FG001|Overall Study|Withdrawal by Subject|6|||
147441725|NCT01490450|531782607|FG000|Period 2|Withdrawal by Subject|1|||
147441726|NCT01490450|531782608|FG001|Period 2|Withdrawal by Subject|0|||
147441727|NCT01490450|531782609|FG002|Period 2|Withdrawal by Subject|0|||
147441728|NCT01490450|531782610|FG003|Period 2|Withdrawal by Subject|0|||
147545376|NCT03216954|532153855|FG003|Overall Study|Adverse Event|0|||
147545377|NCT03216954|532153856|FG004|Overall Study|Adverse Event|1|||
147545378|NCT03216954|532153852|FG000|Overall Study|Withdrawal by Subject|2|||
147545379|NCT03216954|532153853|FG001|Overall Study|Withdrawal by Subject|0|||
147545380|NCT03216954|532153854|FG002|Overall Study|Withdrawal by Subject|0|||
147545381|NCT03216954|532153855|FG003|Overall Study|Withdrawal by Subject|0|||
147545382|NCT03216954|532153856|FG004|Overall Study|Withdrawal by Subject|0|||
147545383|NCT03216954|532153852|FG000|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|0|||
147545384|NCT03216954|532153853|FG001|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|1|||
147545385|NCT03216954|532153854|FG002|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|0|||
147545386|NCT03216954|532153855|FG003|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|0|||
147545387|NCT03216954|532153856|FG004|Overall Study|Subject used cocaine during participation, which is an exclusion criterion.|0|||
147545388|NCT01238822|532153859|FG000|Overall Study|COULD NOT SWALLOW PILLS|3|||
147545389|NCT05180630|532153860|FG000|First Intervention|Physician Decision|0|||
147545390|NCT05180630|532153861|FG001|First Intervention|Physician Decision|0|||
147545391|NCT05180630|532153862|FG002|First Intervention|Physician Decision|3|||
147545392|NCT00709735|532153865|FG000|Overall Study|Lost to Follow-up|1|||
147545393|NCT00709735|532153866|FG001|Overall Study|Lost to Follow-up|1|||
147545394|NCT00709735|532153865|FG000|Overall Study|Relapse into Opioid Abuse|0|||
147545395|NCT00709735|532153866|FG001|Overall Study|Relapse into Opioid Abuse|1|||
147545396|NCT00709735|532153865|FG000|Overall Study|Did not meet PTSD Diagnostic Criteria|2|||
147545397|NCT00709735|532153866|FG001|Overall Study|Did not meet PTSD Diagnostic Criteria|0|||
147545398|NCT00849524|532153869|FG000|Overall Study|Lack of Efficacy|3|||
147545399|NCT01027884|532153872|FG000|Overall Study|Adverse Event|2|||
147545400|NCT01027884|532153873|FG001|Overall Study|Adverse Event|1|||
147545401|NCT01027884|532153872|FG000|Overall Study|Protocol Violation|1|||
147545402|NCT01027884|532153873|FG001|Overall Study|Protocol Violation|0|||
147545403|NCT01027884|532153872|FG000|Overall Study|Non-compliance|1|||
147545404|NCT01027884|532153873|FG001|Overall Study|Non-compliance|1|||
147545405|NCT01027884|532153872|FG000|Overall Study|Withdrawal by Subject|0|||
147545406|NCT01027884|532153873|FG001|Overall Study|Withdrawal by Subject|1|||
147545407|NCT01027884|532153872|FG000|Overall Study|Lost to Follow-up|0|||
147545408|NCT01027884|532153873|FG001|Overall Study|Lost to Follow-up|1|||
147545409|NCT01027884|532153872|FG000|Overall Study|Spinal fixation surgery|0|||
147545410|NCT01027884|532153873|FG001|Overall Study|Spinal fixation surgery|3|||
147545411|NCT03636542|532153874|FG000|Overall Study|Lost to Follow-up|1|||
147545412|NCT03636542|532153875|FG001|Overall Study|Lost to Follow-up|1|||
147545413|NCT03636542|532153874|FG000|Overall Study|Physician Decision|0|||
147545414|NCT03636542|532153875|FG001|Overall Study|Physician Decision|1|||
147545415|NCT03636542|532153874|FG000|Overall Study|Withdrawal by Subject|1|||
147545416|NCT03636542|532153875|FG001|Overall Study|Withdrawal by Subject|0|||
147545417|NCT02059187|532153876|FG000|Overall Study|Adverse Event|0|||
147545418|NCT02059187|532153877|FG001|Overall Study|Adverse Event|3|||
147545419|NCT02059187|532153876|FG000|Overall Study|Death|1|||
147545420|NCT02059187|532153877|FG001|Overall Study|Death|1|||
147545421|NCT02059187|532153876|FG000|Overall Study|Lost to Follow-up|9|||
147545422|NCT02059187|532153877|FG001|Overall Study|Lost to Follow-up|8|||
147545423|NCT02059187|532153876|FG000|Overall Study|Non-compliance with study drug|1|||
147545424|NCT02059187|532153877|FG001|Overall Study|Non-compliance with study drug|0|||
147545425|NCT02059187|532153876|FG000|Overall Study|Physician Decision|1|||
147545426|NCT02059187|532153877|FG001|Overall Study|Physician Decision|2|||
147545427|NCT02059187|532153876|FG000|Overall Study|Protocol Violation|1|||
147545428|NCT02059187|532153877|FG001|Overall Study|Protocol Violation|0|||
147545429|NCT02059187|532153876|FG000|Overall Study|Withdrawal by Subject|12|||
147545430|NCT02059187|532153877|FG001|Overall Study|Withdrawal by Subject|8|||
147545431|NCT04130919|532153878|FG000|Blinded Treatment Phase|Study terminated by sponsor|1|||
147211158|NCT02055118|530945447|FG000|Overall Study|Withdrawal by Subject|0|||
147545432|NCT04130919|532153879|FG001|Blinded Treatment Phase|Study terminated by sponsor|1|||
147545433|NCT04130919|532153880|FG002|Blinded Treatment Phase|Study terminated by sponsor|1|||
147211159|NCT02055118|530945448|FG001|Overall Study|Withdrawal by Subject|2|||
147211160|NCT02055118|530945449|FG002|Overall Study|Withdrawal by Subject|0|||
147211161|NCT02560025|530945453|FG000|Overall Study|Ineligible after consent/ registration|3|||
147211162|NCT02703337|530945456|FG000|Period One (Part A)|Withdrawal by Subject|0|||
147211163|NCT02703337|530945457|FG001|Period One (Part A)|Withdrawal by Subject|0|||
147545434|NCT04130919|532153881|FG003|Blinded Treatment Phase|Study terminated by sponsor|0|||
147545435|NCT04130919|532153882|FG004|Blinded Treatment Phase|Study terminated by sponsor|0|||
147545436|NCT04130919|532153883|FG005|Blinded Treatment Phase|Study terminated by sponsor|0|||
147545437|NCT04130919|532153878|FG000|Blinded Treatment Phase|Adverse Event|0|||
147545438|NCT04130919|532153879|FG001|Blinded Treatment Phase|Adverse Event|0|||
147545439|NCT04130919|532153880|FG002|Blinded Treatment Phase|Adverse Event|1|||
147545440|NCT04130919|532153881|FG003|Blinded Treatment Phase|Adverse Event|0|||
147545441|NCT04130919|532153882|FG004|Blinded Treatment Phase|Adverse Event|0|||
147545442|NCT04130919|532153883|FG005|Blinded Treatment Phase|Adverse Event|0|||
147211164|NCT02703337|530945458|FG002|Period One (Part A)|Withdrawal by Subject|0|||
147211165|NCT02703337|530945459|FG003|Period One (Part A)|Withdrawal by Subject|0|||
147211166|NCT02703337|530945460|FG004|Period One (Part A)|Withdrawal by Subject|1|||
147211167|NCT02703337|530945461|FG005|Period One (Part A)|Withdrawal by Subject|0|||
147211168|NCT02703337|530945462|FG006|Period One (Part A)|Withdrawal by Subject|0|||
147211169|NCT02703337|530945463|FG007|Period One (Part A)|Withdrawal by Subject|0|||
147211170|NCT00282308|530945464|FG000|Treatment Period|Lost to Follow-up|1|||
147211171|NCT00282308|530945465|FG001|Treatment Period|Lost to Follow-up|0|||
147211172|NCT00282308|530945466|FG002|Treatment Period|Lost to Follow-up|0|||
147211173|NCT00282308|530945464|FG000|Treatment Period|Subject/Guardian Decision to Withdraw|2|||
147545443|NCT04130919|532153878|FG000|Blinded Treatment Phase|Disease worsening|0|||
147545444|NCT04130919|532153879|FG001|Blinded Treatment Phase|Disease worsening|0|||
147545445|NCT04130919|532153880|FG002|Blinded Treatment Phase|Disease worsening|1|||
147545446|NCT04130919|532153881|FG003|Blinded Treatment Phase|Disease worsening|0|||
147545447|NCT04130919|532153882|FG004|Blinded Treatment Phase|Disease worsening|0|||
147545448|NCT04130919|532153883|FG005|Blinded Treatment Phase|Disease worsening|0|||
147545449|NCT04130919|532153878|FG000|Blinded Treatment Phase|Investigator's decision|0|||
147545450|NCT04130919|532153879|FG001|Blinded Treatment Phase|Investigator's decision|1|||
147545451|NCT04130919|532153880|FG002|Blinded Treatment Phase|Investigator's decision|0|||
147545452|NCT04130919|532153881|FG003|Blinded Treatment Phase|Investigator's decision|0|||
147545453|NCT04130919|532153882|FG004|Blinded Treatment Phase|Investigator's decision|0|||
147545454|NCT04130919|532153883|FG005|Blinded Treatment Phase|Investigator's decision|0|||
147545455|NCT04130919|532153878|FG000|Blinded Treatment Phase|Withdrew consent|1|||
147545456|NCT04130919|532153879|FG001|Blinded Treatment Phase|Withdrew consent|0|||
147545457|NCT04130919|532153880|FG002|Blinded Treatment Phase|Withdrew consent|0|||
147545458|NCT04130919|532153881|FG003|Blinded Treatment Phase|Withdrew consent|0|||
147545459|NCT04130919|532153882|FG004|Blinded Treatment Phase|Withdrew consent|0|||
147545460|NCT04130919|532153883|FG005|Blinded Treatment Phase|Withdrew consent|0|||
147545461|NCT04130919|532153878|FG000|Open-label Treatment Phase|Withdrew consent|0|||
147545462|NCT04130919|532153879|FG001|Open-label Treatment Phase|Withdrew consent|0|||
147545463|NCT04130919|532153880|FG002|Open-label Treatment Phase|Withdrew consent|0|||
147545464|NCT04130919|532153881|FG003|Open-label Treatment Phase|Withdrew consent|1|||
147545465|NCT04130919|532153882|FG004|Open-label Treatment Phase|Withdrew consent|1|||
147545466|NCT04130919|532153883|FG005|Open-label Treatment Phase|Withdrew consent|1|||
147545467|NCT04130919|532153878|FG000|Open-label Treatment Phase|Disease worsening|0|||
147545468|NCT04130919|532153879|FG001|Open-label Treatment Phase|Disease worsening|0|||
147545469|NCT04130919|532153880|FG002|Open-label Treatment Phase|Disease worsening|0|||
147545470|NCT04130919|532153881|FG003|Open-label Treatment Phase|Disease worsening|1|||
147545471|NCT04130919|532153882|FG004|Open-label Treatment Phase|Disease worsening|0|||
147545472|NCT04130919|532153883|FG005|Open-label Treatment Phase|Disease worsening|1|||
147545473|NCT04130919|532153878|FG000|Open-label Treatment Phase|Investigator's decision|0|||
147545474|NCT04130919|532153879|FG001|Open-label Treatment Phase|Investigator's decision|0|||
147545475|NCT04130919|532153880|FG002|Open-label Treatment Phase|Investigator's decision|0|||
147545476|NCT04130919|532153881|FG003|Open-label Treatment Phase|Investigator's decision|1|||
147545477|NCT04130919|532153882|FG004|Open-label Treatment Phase|Investigator's decision|0|||
147545478|NCT04130919|532153883|FG005|Open-label Treatment Phase|Investigator's decision|0|||
147545479|NCT04130919|532153878|FG000|Open-label Treatment Phase|Lost to Follow-up|0|||
147545480|NCT04130919|532153879|FG001|Open-label Treatment Phase|Lost to Follow-up|0|||
147545481|NCT04130919|532153880|FG002|Open-label Treatment Phase|Lost to Follow-up|0|||
147545482|NCT04130919|532153881|FG003|Open-label Treatment Phase|Lost to Follow-up|0|||
147545483|NCT04130919|532153882|FG004|Open-label Treatment Phase|Lost to Follow-up|0|||
147545484|NCT04130919|532153883|FG005|Open-label Treatment Phase|Lost to Follow-up|1|||
147545485|NCT04130919|532153878|FG000|Open-label Treatment Phase|MCS response not achieved at open-label week 10|0|||
147545486|NCT04130919|532153879|FG001|Open-label Treatment Phase|MCS response not achieved at open-label week 10|0|||
147545487|NCT04130919|532153880|FG002|Open-label Treatment Phase|MCS response not achieved at open-label week 10|0|||
147545488|NCT04130919|532153881|FG003|Open-label Treatment Phase|MCS response not achieved at open-label week 10|0|||
147545489|NCT04130919|532153882|FG004|Open-label Treatment Phase|MCS response not achieved at open-label week 10|1|||
147545490|NCT04130919|532153883|FG005|Open-label Treatment Phase|MCS response not achieved at open-label week 10|0|||
147545491|NCT02624518|532153884|FG000|Overall Study|Physician Decision|1|||
147211174|NCT00282308|530945465|FG001|Treatment Period|Subject/Guardian Decision to Withdraw|4|||
147211175|NCT00282308|530945466|FG002|Treatment Period|Subject/Guardian Decision to Withdraw|0|||
147211176|NCT00282308|530945464|FG000|Treatment Period|Adverse Event|0|||
147211177|NCT00282308|530945465|FG001|Treatment Period|Adverse Event|2|||
147545492|NCT02729194|532153885|FG000|Overall Study|Withdrawal by Subject|3|||
147545493|NCT00845026|532153886|FG000|Study Period III|Adverse Event|23|||
147545494|NCT00845026|532153887|FG001|Study Period III|Adverse Event|19|||
147545495|NCT00845026|532153886|FG000|Study Period III|Perceived lack of efficacy|27|||
147545496|NCT00845026|532153887|FG001|Study Period III|Perceived lack of efficacy|15|||
147545497|NCT00845026|532153886|FG000|Study Period III|Withdrawal by Subject|19|||
147545498|NCT00845026|532153887|FG001|Study Period III|Withdrawal by Subject|15|||
147211178|NCT00282308|530945466|FG002|Treatment Period|Adverse Event|0|||
147211179|NCT00282308|530945464|FG000|Treatment Period|Not Treated with Study Drug|1|||
147211180|NCT00282308|530945465|FG001|Treatment Period|Not Treated with Study Drug|0|||
147211181|NCT00282308|530945466|FG002|Treatment Period|Not Treated with Study Drug|0|||
147211182|NCT00282308|530945464|FG000|Optional Extension Re-treatment Period|Adverse Event|0|||
147211183|NCT00282308|530945465|FG001|Optional Extension Re-treatment Period|Adverse Event|0|||
147211184|NCT00282308|530945466|FG002|Optional Extension Re-treatment Period|Adverse Event|4|||
147211185|NCT00282308|530945464|FG000|Optional Extension Re-treatment Period|Physician's Decision to Withdraw|0|||
147211186|NCT00282308|530945465|FG001|Optional Extension Re-treatment Period|Physician's Decision to Withdraw|0|||
147211187|NCT00282308|530945466|FG002|Optional Extension Re-treatment Period|Physician's Decision to Withdraw|1|||
147211188|NCT00282308|530945464|FG000|Optional Extension Re-treatment Period|Subject/Guardian Decision to Withdraw|0|||
147441729|NCT01490450|531782607|FG000|Period 2|Lost to Follow-up|0|||
147441730|NCT01490450|531782608|FG001|Period 2|Lost to Follow-up|0|||
147441731|NCT01490450|531782609|FG002|Period 2|Lost to Follow-up|0|||
147441732|NCT01490450|531782610|FG003|Period 2|Lost to Follow-up|2|||
147441733|NCT03197493|531782611|FG000|Overall Study|Withdrawal by Subject|5|||
147441734|NCT00938717|531782612|FG000|Overall Study|Adverse Event|10|||
147441735|NCT00938717|531782613|FG001|Overall Study|Adverse Event|41|||
147441736|NCT00938717|531782612|FG000|Overall Study|Protocol Violation|11|||
147441737|NCT00938717|531782613|FG001|Overall Study|Protocol Violation|8|||
147441738|NCT00938717|531782612|FG000|Overall Study|Withdrawal by Subject|26|||
147441739|NCT00938717|531782613|FG001|Overall Study|Withdrawal by Subject|24|||
147441740|NCT00938717|531782612|FG000|Overall Study|Lost to Follow-up|13|||
147441741|NCT00938717|531782613|FG001|Overall Study|Lost to Follow-up|18|||
147441742|NCT00938717|531782612|FG000|Overall Study|Lack of Efficacy|33|||
147441743|NCT00938717|531782613|FG001|Overall Study|Lack of Efficacy|15|||
147441744|NCT00938717|531782612|FG000|Overall Study|Other reason|5|||
147441745|NCT00938717|531782613|FG001|Overall Study|Other reason|2|||
147441746|NCT00139776|531782619|FG000|Period I|Did not enter Period II|575|||
147441747|NCT00139776|531782620|FG001|Period I|Did not enter Period II|0|||
147441748|NCT00139776|531782621|FG002|Period I|Did not enter Period II|0|||
147441749|NCT00139776|531782622|FG003|Period I|Did not enter Period II|0|||
147441750|NCT00139776|531782619|FG000|Period II|Not Randomized into Period III|0|||
147441751|NCT00139776|531782620|FG001|Period II|Not Randomized into Period III|322|||
147441752|NCT00139776|531782621|FG002|Period II|Not Randomized into Period III|0|||
147441753|NCT00139776|531782622|FG003|Period II|Not Randomized into Period III|0|||
147441754|NCT00139776|531782619|FG000|Period III|Adverse Event|0|||
147441755|NCT00139776|531782620|FG001|Period III|Adverse Event|0|||
147441756|NCT00139776|531782621|FG002|Period III|Adverse Event|22|||
147441757|NCT00139776|531782622|FG003|Period III|Adverse Event|23|||
147441758|NCT00139776|531782619|FG000|Period III|Other|0|||
147441759|NCT00139776|531782620|FG001|Period III|Other|0|||
147441760|NCT00139776|531782621|FG002|Period III|Other|23|||
147441761|NCT00139776|531782622|FG003|Period III|Other|34|||
147441762|NCT00139776|531782619|FG000|Period III|Lack of Efficacy|0|||
147441763|NCT00139776|531782620|FG001|Period III|Lack of Efficacy|0|||
147441764|NCT00139776|531782621|FG002|Period III|Lack of Efficacy|10|||
147441765|NCT00139776|531782622|FG003|Period III|Lack of Efficacy|24|||
147441766|NCT00139776|531782619|FG000|Period III|Lost to Follow-up|0|||
147441767|NCT00139776|531782620|FG001|Period III|Lost to Follow-up|0|||
147441768|NCT00139776|531782621|FG002|Period III|Lost to Follow-up|5|||
147441769|NCT00139776|531782622|FG003|Period III|Lost to Follow-up|4|||
147441770|NCT00139776|531782619|FG000|Period III|Withdrawal by Subject|0|||
147441771|NCT00139776|531782620|FG001|Period III|Withdrawal by Subject|0|||
147441772|NCT00139776|531782621|FG002|Period III|Withdrawal by Subject|16|||
147441773|NCT00139776|531782622|FG003|Period III|Withdrawal by Subject|21|||
147441774|NCT00914927|531782631|FG000|Overall Study|Adverse Event|0|||
147441775|NCT00914927|531782632|FG001|Overall Study|Adverse Event|0|||
147441776|NCT00914927|531782633|FG002|Overall Study|Adverse Event|0|||
147441777|NCT00914927|531782634|FG003|Overall Study|Adverse Event|0|||
147441778|NCT00914927|531782635|FG004|Overall Study|Adverse Event|1|||
147441779|NCT00914927|531782636|FG005|Overall Study|Adverse Event|0|||
147441780|NCT00914927|531782637|FG006|Overall Study|Adverse Event|0|||
147441781|NCT00914927|531782631|FG000|Overall Study|Withdrawal by Subject|0|||
147441782|NCT00914927|531782632|FG001|Overall Study|Withdrawal by Subject|1|||
147441783|NCT00914927|531782633|FG002|Overall Study|Withdrawal by Subject|0|||
147441784|NCT00914927|531782634|FG003|Overall Study|Withdrawal by Subject|1|||
147441785|NCT00914927|531782635|FG004|Overall Study|Withdrawal by Subject|0|||
147441786|NCT00914927|531782636|FG005|Overall Study|Withdrawal by Subject|0|||
147441787|NCT00914927|531782637|FG006|Overall Study|Withdrawal by Subject|0|||
147441788|NCT00914927|531782631|FG000|Overall Study|Lost to Follow-up|0|||
147441789|NCT00914927|531782632|FG001|Overall Study|Lost to Follow-up|0|||
147441790|NCT00914927|531782633|FG002|Overall Study|Lost to Follow-up|0|||
147441791|NCT00914927|531782634|FG003|Overall Study|Lost to Follow-up|1|||
147441792|NCT00914927|531782635|FG004|Overall Study|Lost to Follow-up|0|||
147441793|NCT00914927|531782636|FG005|Overall Study|Lost to Follow-up|0|||
147441794|NCT00914927|531782637|FG006|Overall Study|Lost to Follow-up|0|||
147441795|NCT00914927|531782631|FG000|Overall Study|Administrative/Other|2|||
147545499|NCT00845026|532153886|FG000|Study Period III|Entry Criteria not met|8|||
147545500|NCT00845026|532153887|FG001|Study Period III|Entry Criteria not met|11|||
147545501|NCT00845026|532153886|FG000|Study Period III|Lost to Follow-up|4|||
147545502|NCT00845026|532153887|FG001|Study Period III|Lost to Follow-up|5|||
147545503|NCT00845026|532153886|FG000|Study Period III|Protocol Violation|8|||
147545504|NCT00845026|532153887|FG001|Study Period III|Protocol Violation|1|||
147545505|NCT00845026|532153886|FG000|Study Period III|Scheduled conflict|3|||
147545506|NCT00845026|532153887|FG001|Study Period III|Scheduled conflict|1|||
147545507|NCT00845026|532153886|FG000|Study Period III|Subject is moving or has moved|2|||
147545508|NCT00845026|532153887|FG001|Study Period III|Subject is moving or has moved|4|||
147545509|NCT00845026|532153886|FG000|Study Period III|Transportation issues|1|||
147545510|NCT00845026|532153887|FG001|Study Period III|Transportation issues|1|||
147545511|NCT00845026|532153886|FG000|Study Period IV|Adverse Event|4|||
147545512|NCT00845026|532153887|FG001|Study Period IV|Adverse Event|0|||
147545513|NCT00845026|532153886|FG000|Study Period IV|Perceived lack of efficacy|2|||
147545514|NCT00845026|532153887|FG001|Study Period IV|Perceived lack of efficacy|1|||
147545515|NCT00845026|532153886|FG000|Study Period IV|Protocol Violation|3|||
147545516|NCT00845026|532153887|FG001|Study Period IV|Protocol Violation|1|||
147545517|NCT00845026|532153886|FG000|Study Period IV|Lost to Follow-up|1|||
147545518|NCT00845026|532153887|FG001|Study Period IV|Lost to Follow-up|0|||
147545519|NCT00845026|532153886|FG000|Study Period IV|Withdrawal by Subject|4|||
147545520|NCT00845026|532153887|FG001|Study Period IV|Withdrawal by Subject|1|||
147545521|NCT00845026|532153886|FG000|Study Period IV|Entry Criteria Not Met|1|||
147545522|NCT00845026|532153887|FG001|Study Period IV|Entry Criteria Not Met|0|||
147545523|NCT00845026|532153886|FG000|Study Period IV|Subject is moving or has moved|0|||
147545524|NCT00845026|532153887|FG001|Study Period IV|Subject is moving or has moved|1|||
147545525|NCT00845026|532153886|FG000|Study Period IV|Scheduling conflict|1|||
147545526|NCT00845026|532153887|FG001|Study Period IV|Scheduling conflict|0|||
147545527|NCT03012815|532153888|FG000|Overall Study|Lost to Follow-up|1|||
147545528|NCT03012815|532153889|FG001|Overall Study|Lost to Follow-up|0|||
147545529|NCT03012815|532153888|FG000|Overall Study|Physician Decision|3|||
147545530|NCT03012815|532153889|FG001|Overall Study|Physician Decision|2|||
147545531|NCT03012815|532153888|FG000|Overall Study|Adverse Event|1|||
147211189|NCT00282308|530945465|FG001|Optional Extension Re-treatment Period|Subject/Guardian Decision to Withdraw|0|||
147545532|NCT03012815|532153889|FG001|Overall Study|Adverse Event|0|||
147545533|NCT01462695|532153890|FG000|Overall Study|Adverse Event|1|||
147545534|NCT01462695|532153891|FG001|Overall Study|Adverse Event|1|||
147545535|NCT01462695|532153890|FG000|Overall Study|Death|2|||
147545536|NCT01462695|532153891|FG001|Overall Study|Death|0|||
147545537|NCT01462695|532153890|FG000|Overall Study|Lack of Efficacy|6|||
147545538|NCT01462695|532153891|FG001|Overall Study|Lack of Efficacy|12|||
147545539|NCT01462695|532153890|FG000|Overall Study|Physician Decision|5|||
147545540|NCT01462695|532153891|FG001|Overall Study|Physician Decision|0|||
147545541|NCT01462695|532153890|FG000|Overall Study|Withdrawal by Subject|2|||
147545542|NCT01462695|532153891|FG001|Overall Study|Withdrawal by Subject|0|||
147545543|NCT01462695|532153890|FG000|Overall Study|Inevaluable (did not receive study drug)|1|||
147545544|NCT01462695|532153891|FG001|Overall Study|Inevaluable (did not receive study drug)|0|||
147545545|NCT02400905|532153892|FG000|Overall Study|Death|24|||
147545546|NCT02400905|532153892|FG000|Overall Study|Lost to Follow-up|18|||
147545547|NCT02400905|532153892|FG000|Overall Study|Withdrawal by Subject|16|||
147545548|NCT02400905|532153892|FG000|Overall Study|Physician Decision|4|||
147545549|NCT02400905|532153892|FG000|Overall Study|Other|1|||
147545550|NCT00879970|532153893|FG000|Period 1 TZD Randomization|Refused to Attend Final Visit|3|||
147545551|NCT00879970|532153894|FG001|Period 1 TZD Randomization|Refused to Attend Final Visit|3|||
147545552|NCT00879970|532153895|FG002|Period 1 TZD Randomization|Refused to Attend Final Visit|4|||
147545553|NCT00879970|532153896|FG003|Period 1 TZD Randomization|Refused to Attend Final Visit|0|||
147211190|NCT00282308|530945466|FG002|Optional Extension Re-treatment Period|Subject/Guardian Decision to Withdraw|1|||
147211191|NCT00282308|530945464|FG000|Safety Follow-up Period|Adverse Event|0|||
147211192|NCT00282308|530945465|FG001|Safety Follow-up Period|Adverse Event|0|||
147545554|NCT00879970|532153897|FG004|Period 1 TZD Randomization|Refused to Attend Final Visit|0|||
147545555|NCT00879970|532153893|FG000|Period 1 TZD Randomization|Lost to Follow-up|1|||
147545556|NCT00879970|532153894|FG001|Period 1 TZD Randomization|Lost to Follow-up|0|||
147545557|NCT00879970|532153895|FG002|Period 1 TZD Randomization|Lost to Follow-up|1|||
147545558|NCT00879970|532153896|FG003|Period 1 TZD Randomization|Lost to Follow-up|0|||
147545559|NCT00879970|532153897|FG004|Period 1 TZD Randomization|Lost to Follow-up|0|||
147545560|NCT00879970|532153893|FG000|Period 1 TZD Randomization|Death|2|||
147545561|NCT00879970|532153894|FG001|Period 1 TZD Randomization|Death|1|||
147545562|NCT00879970|532153895|FG002|Period 1 TZD Randomization|Death|0|||
147545563|NCT00879970|532153896|FG003|Period 1 TZD Randomization|Death|0|||
147545564|NCT00879970|532153897|FG004|Period 1 TZD Randomization|Death|0|||
147545565|NCT00879970|532153893|FG000|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|2|||
147545566|NCT00879970|532153894|FG001|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|0|||
147545567|NCT00879970|532153895|FG002|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|1|||
147649443|NCT02634801|532537342|FG001|Follow-up Period|Physician Decision|0|||
147545568|NCT00879970|532153896|FG003|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|0|||
147545569|NCT00879970|532153897|FG004|Period 1 TZD Randomization|Final or Study Hold Visits Not Completed|0|||
147545570|NCT00879970|532153893|FG000|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|0|||
147545571|NCT00879970|532153894|FG001|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|0|||
147545572|NCT00879970|532153895|FG002|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|0|||
147545573|NCT00879970|532153896|FG003|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|2|||
147545574|NCT00879970|532153897|FG004|Period 2 Vitamin D Randomization|Refused to Attend Final Visit|6|||
147545575|NCT00879970|532153893|FG000|Period 2 Vitamin D Randomization|Lost to Follow-up|0|||
147545576|NCT00879970|532153894|FG001|Period 2 Vitamin D Randomization|Lost to Follow-up|0|||
147545577|NCT00879970|532153895|FG002|Period 2 Vitamin D Randomization|Lost to Follow-up|0|||
147545578|NCT00879970|532153896|FG003|Period 2 Vitamin D Randomization|Lost to Follow-up|0|||
147545579|NCT00879970|532153897|FG004|Period 2 Vitamin D Randomization|Lost to Follow-up|1|||
147545580|NCT00879970|532153893|FG000|Period 2 Vitamin D Randomization|Death|0|||
147545581|NCT00879970|532153894|FG001|Period 2 Vitamin D Randomization|Death|0|||
147545582|NCT00879970|532153895|FG002|Period 2 Vitamin D Randomization|Death|0|||
147545583|NCT00879970|532153896|FG003|Period 2 Vitamin D Randomization|Death|2|||
147545584|NCT00879970|532153897|FG004|Period 2 Vitamin D Randomization|Death|0|||
147545585|NCT00558519|532153899|FG000|Overall Study|Ph+|20|||
147545586|NCT00558519|532153899|FG000|Overall Study|Ineligible|1|||
147545587|NCT00558519|532153899|FG000|Overall Study|Insufficient data|1|||
147545588|NCT00558519|532153899|FG000|Overall Study|Never received treatment|1|||
147545589|NCT01021137|532153901|FG000|Overall Study|Lost to Follow-up|9|||
147545590|NCT01021137|532153902|FG001|Overall Study|Lost to Follow-up|4|||
147545591|NCT01021137|532153903|FG002|Overall Study|Lost to Follow-up|2|||
147545592|NCT01021137|532153904|FG003|Overall Study|Lost to Follow-up|6|||
147545593|NCT01021137|532153901|FG000|Overall Study|Withdrawal by Subject|1|||
147545594|NCT01021137|532153902|FG001|Overall Study|Withdrawal by Subject|0|||
147545595|NCT01021137|532153903|FG002|Overall Study|Withdrawal by Subject|0|||
147545596|NCT01021137|532153904|FG003|Overall Study|Withdrawal by Subject|3|||
147545597|NCT02556632|532153908|FG000|Overall Study|Lost to Follow-up|1|||
147545598|NCT02556632|532153909|FG001|Overall Study|Lost to Follow-up|0|||
147545599|NCT02556632|532153910|FG002|Overall Study|Lost to Follow-up|0|||
147545600|NCT02556632|532153908|FG000|Overall Study|Disliked Intervention|1|||
147545601|NCT02556632|532153909|FG001|Overall Study|Disliked Intervention|1|||
147545602|NCT02556632|532153910|FG002|Overall Study|Disliked Intervention|1|||
147545603|NCT02556632|532153908|FG000|Overall Study|No Reason|1|||
147545604|NCT02556632|532153909|FG001|Overall Study|No Reason|0|||
147545605|NCT02556632|532153910|FG002|Overall Study|No Reason|1|||
147545606|NCT02556632|532153908|FG000|Overall Study|Personal Issues|0|||
147545607|NCT02556632|532153909|FG001|Overall Study|Personal Issues|1|||
147545608|NCT02556632|532153910|FG002|Overall Study|Personal Issues|1|||
147545609|NCT02556632|532153908|FG000|Overall Study|Changed Mind|0|||
147545610|NCT02556632|532153909|FG001|Overall Study|Changed Mind|1|||
147545611|NCT02556632|532153910|FG002|Overall Study|Changed Mind|0|||
147545612|NCT02556632|532153908|FG000|Overall Study|Withdrew (Unrelated Medical)|1|||
147545613|NCT02556632|532153909|FG001|Overall Study|Withdrew (Unrelated Medical)|0|||
147545614|NCT02556632|532153910|FG002|Overall Study|Withdrew (Unrelated Medical)|0|||
147545615|NCT02556632|532153908|FG000|Overall Study|Unrelated Adverse Event|1|||
147545616|NCT02556632|532153909|FG001|Overall Study|Unrelated Adverse Event|0|||
147545617|NCT02556632|532153910|FG002|Overall Study|Unrelated Adverse Event|3|||
147545618|NCT02556632|532153908|FG000|Overall Study|Related Adverse Event|0|||
147545619|NCT02556632|532153909|FG001|Overall Study|Related Adverse Event|1|||
147545620|NCT02556632|532153910|FG002|Overall Study|Related Adverse Event|0|||
147545621|NCT02556632|532153908|FG000|Overall Study|Possibly Related Adverse Event|0|||
147545622|NCT02556632|532153909|FG001|Overall Study|Possibly Related Adverse Event|0|||
147545623|NCT02556632|532153910|FG002|Overall Study|Possibly Related Adverse Event|1|||
147545624|NCT02556632|532153908|FG000|Overall Study|Did Not Start RT|0|||
147545625|NCT02556632|532153909|FG001|Overall Study|Did Not Start RT|1|||
147545626|NCT02556632|532153910|FG002|Overall Study|Did Not Start RT|0|||
147545627|NCT02556632|532153908|FG000|Overall Study|Ineligible|0|||
147545628|NCT02556632|532153909|FG001|Overall Study|Ineligible|1|||
147545629|NCT02556632|532153910|FG002|Overall Study|Ineligible|0|||
147545630|NCT02556632|532153908|FG000|Overall Study|Disliked Study Procedures|0|||
147545631|NCT02556632|532153909|FG001|Overall Study|Disliked Study Procedures|0|||
147545632|NCT02556632|532153910|FG002|Overall Study|Disliked Study Procedures|1|||
147545633|NCT02556632|532153908|FG000|Overall Study|Treatment or Change Delay|0|||
147545634|NCT02556632|532153909|FG001|Overall Study|Treatment or Change Delay|0|||
147545635|NCT02556632|532153910|FG002|Overall Study|Treatment or Change Delay|1|||
147545636|NCT00808015|532153911|FG000|Overall Study|Death|1|||
147545637|NCT00808015|532153911|FG000|Overall Study|Lack of Efficacy|58|||
147545638|NCT00808015|532153911|FG000|Overall Study|Lost to Follow-up|76|||
147545639|NCT00808015|532153911|FG000|Overall Study|Participants not willing to participate|158|||
147545640|NCT00808015|532153911|FG000|Overall Study|Adverse Event|22|||
147545641|NCT00808015|532153911|FG000|Overall Study|Other|25|||
147545642|NCT00808015|532153911|FG000|Overall Study|Enrolled but not treated|4|||
147211193|NCT00282308|530945466|FG002|Safety Follow-up Period|Adverse Event|1|||
147211194|NCT00282308|530945464|FG000|Safety Follow-up Period|Lost to Follow-up|0|||
147211195|NCT00282308|530945465|FG001|Safety Follow-up Period|Lost to Follow-up|0|||
147211196|NCT00282308|530945466|FG002|Safety Follow-up Period|Lost to Follow-up|5|||
147211197|NCT00282308|530945464|FG000|Safety Follow-up Period|Physician Decision to Withdraw|0|||
147211198|NCT00282308|530945465|FG001|Safety Follow-up Period|Physician Decision to Withdraw|0|||
147211199|NCT00282308|530945466|FG002|Safety Follow-up Period|Physician Decision to Withdraw|1|||
147211200|NCT00282308|530945464|FG000|Safety Follow-up Period|Subject/Guardian Decision to Withdraw|0|||
147211201|NCT00282308|530945465|FG001|Safety Follow-up Period|Subject/Guardian Decision to Withdraw|0|||
147441796|NCT00914927|531782632|FG001|Overall Study|Administrative/Other|1|||
147545643|NCT04523831|532153917|FG000|Overall Study|Lost to Follow-up|15|||
147545644|NCT04523831|532153918|FG001|Overall Study|Lost to Follow-up|17|||
147545645|NCT04523831|532153917|FG000|Overall Study|Death|0|||
147545646|NCT04523831|532153918|FG001|Overall Study|Death|3|||
147545647|NCT04523831|532153917|FG000|Overall Study|Adverse Event|2|||
147545648|NCT04523831|532153918|FG001|Overall Study|Adverse Event|0|||
147545649|NCT04556838|532153919|FG000|Overall Study|Withdrawal by Subject|3|||
147545650|NCT04556838|532153920|FG001|Overall Study|Withdrawal by Subject|1|||
147545651|NCT04556838|532153921|FG002|Overall Study|Withdrawal by Subject|2|||
147545652|NCT04556838|532153919|FG000|Overall Study|Adverse Event|0|||
147545653|NCT04556838|532153920|FG001|Overall Study|Adverse Event|1|||
147545654|NCT04556838|532153921|FG002|Overall Study|Adverse Event|1|||
147545655|NCT04556838|532153919|FG000|Overall Study|Lost to Follow-up|0|||
147545656|NCT04556838|532153920|FG001|Overall Study|Lost to Follow-up|0|||
147545657|NCT04556838|532153921|FG002|Overall Study|Lost to Follow-up|2|||
147545658|NCT04556838|532153919|FG000|Overall Study|Subject travel|0|||
147545659|NCT04556838|532153920|FG001|Overall Study|Subject travel|1|||
147545660|NCT04556838|532153921|FG002|Overall Study|Subject travel|0|||
147545661|NCT04556838|532153919|FG000|Overall Study|Physician Decision|1|||
147545662|NCT04556838|532153920|FG001|Overall Study|Physician Decision|0|||
147545663|NCT04556838|532153921|FG002|Overall Study|Physician Decision|0|||
147545664|NCT00995930|532153922|FG000|Overall Study|Protocol deviation|2|||
147545665|NCT00995930|532153923|FG001|Overall Study|Protocol deviation|5|||
147545666|NCT00995930|532153922|FG000|Overall Study|Death|0|||
147545667|NCT00995930|532153923|FG001|Overall Study|Death|1|||
147441797|NCT00914927|531782633|FG002|Overall Study|Administrative/Other|0|||
147441798|NCT00914927|531782634|FG003|Overall Study|Administrative/Other|0|||
147441799|NCT00914927|531782635|FG004|Overall Study|Administrative/Other|1|||
147441800|NCT00914927|531782636|FG005|Overall Study|Administrative/Other|0|||
147441801|NCT00914927|531782637|FG006|Overall Study|Administrative/Other|0|||
147441802|NCT02164929|531782648|FG000|Overall Study|Converted to open procedure|1|||
147441803|NCT02164929|531782649|FG001|Overall Study|Converted to open procedure|0|||
147441804|NCT02164929|531782650|FG002|Overall Study|Converted to open procedure|0|||
147441805|NCT02164929|531782651|FG003|Overall Study|Converted to open procedure|2|||
147441806|NCT02164929|531782648|FG000|Overall Study|Failed regional block|0|||
147441807|NCT02164929|531782649|FG001|Overall Study|Failed regional block|0|||
147441808|NCT02164929|531782650|FG002|Overall Study|Failed regional block|1|||
147441809|NCT02164929|531782651|FG003|Overall Study|Failed regional block|0|||
147441810|NCT00971178|531782655|FG000|Overall Study|Lost to Follow-up|2|||
147441811|NCT00971178|531782656|FG001|Overall Study|Lost to Follow-up|2|||
147441812|NCT00971178|531782657|FG002|Overall Study|Lost to Follow-up|2|||
147441813|NCT00365456|531782658|FG000|Trial Period I (12 Months)|Adverse Event|84|||
147441814|NCT00365456|531782659|FG001|Trial Period I (12 Months)|Adverse Event|0|||
147441815|NCT00365456|531782658|FG000|Trial Period I (12 Months)|Non-compliance|3|||
147441816|NCT00365456|531782659|FG001|Trial Period I (12 Months)|Non-compliance|0|||
147441817|NCT00365456|531782658|FG000|Trial Period I (12 Months)|Withdrawal by Subject|27|||
147441818|NCT00365456|531782659|FG001|Trial Period I (12 Months)|Withdrawal by Subject|0|||
147441819|NCT00365456|531782658|FG000|Trial Period I (12 Months)|Other|11|||
147441820|NCT00365456|531782659|FG001|Trial Period I (12 Months)|Other|0|||
147441821|NCT00365456|531782658|FG000|Trial Period II (12 Months)|Adverse Event|0|||
147441822|NCT00365456|531782659|FG001|Trial Period II (12 Months)|Adverse Event|6|||
147441823|NCT00365456|531782658|FG000|Trial Period II (12 Months)|Non-compliance|0|||
147441824|NCT00365456|531782659|FG001|Trial Period II (12 Months)|Non-compliance|2|||
147441825|NCT00365456|531782658|FG000|Trial Period II (12 Months)|Withdrawal by Subject|0|||
147441826|NCT00365456|531782659|FG001|Trial Period II (12 Months)|Withdrawal by Subject|5|||
147441827|NCT00365456|531782658|FG000|Trial Period II (12 Months)|Other|0|||
147441828|NCT00365456|531782659|FG001|Trial Period II (12 Months)|Other|1|||
147441829|NCT00365456|531782658|FG000|Trial Period III (12 Months)|Adverse Event|13|||
147441830|NCT00365456|531782659|FG001|Trial Period III (12 Months)|Adverse Event|3|||
147441831|NCT00365456|531782658|FG000|Trial Period III (12 Months)|Withdrawal by Subject|4|||
147441832|NCT00365456|531782659|FG001|Trial Period III (12 Months)|Withdrawal by Subject|1|||
147441833|NCT00365456|531782658|FG000|Trial Period III (12 Months)|Other|1|||
147441834|NCT00365456|531782659|FG001|Trial Period III (12 Months)|Other|1|||
147441835|NCT00714285|531782662|FG000|Overall Study|Lost to Follow-up|0|||
147545668|NCT00995930|532153922|FG000|Overall Study|Administrative problems|4|||
147545669|NCT00995930|532153923|FG001|Overall Study|Administrative problems|2|||
147545670|NCT00995930|532153922|FG000|Overall Study|Lost to Follow-up|1|||
147545671|NCT00995930|532153923|FG001|Overall Study|Lost to Follow-up|2|||
147545672|NCT00995930|532153922|FG000|Overall Study|Withdrawal by Subject|3|||
147211202|NCT00282308|530945466|FG002|Safety Follow-up Period|Subject/Guardian Decision to Withdraw|12|||
147211203|NCT01584440|530945468|FG000|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|1|||
147211204|NCT01584440|530945469|FG001|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|0|||
147211205|NCT01584440|530945470|FG002|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|0|||
147545673|NCT00995930|532153923|FG001|Overall Study|Withdrawal by Subject|4|||
147545674|NCT00995930|532153922|FG000|Overall Study|Adverse Event|11|||
147545675|NCT00995930|532153923|FG001|Overall Study|Adverse Event|14|||
147545676|NCT01458119|532153924|FG000|Overall Study|Physician Decision|4|||
147211206|NCT01584440|530945471|FG003|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|0|||
147211207|NCT01584440|530945472|FG004|Stage 1 (5 Weeks)|Advised Not to Take Study Medication|0|||
147211208|NCT01584440|530945468|FG000|Stage 1 (5 Weeks)|Adverse Event|5|||
147211209|NCT01584440|530945469|FG001|Stage 1 (5 Weeks)|Adverse Event|3|||
147211210|NCT01584440|530945470|FG002|Stage 1 (5 Weeks)|Adverse Event|0|||
147211211|NCT01584440|530945471|FG003|Stage 1 (5 Weeks)|Adverse Event|0|||
147211212|NCT01584440|530945472|FG004|Stage 1 (5 Weeks)|Adverse Event|0|||
147211213|NCT01584440|530945468|FG000|Stage 1 (5 Weeks)|Lost to Follow-up|1|||
147211214|NCT01584440|530945469|FG001|Stage 1 (5 Weeks)|Lost to Follow-up|0|||
147211215|NCT01584440|530945470|FG002|Stage 1 (5 Weeks)|Lost to Follow-up|0|||
147211216|NCT01584440|530945471|FG003|Stage 1 (5 Weeks)|Lost to Follow-up|0|||
147211217|NCT01584440|530945472|FG004|Stage 1 (5 Weeks)|Lost to Follow-up|0|||
147211218|NCT01584440|530945468|FG000|Stage 1 (5 Weeks)|Protocol Violation|2|||
147211219|NCT01584440|530945469|FG001|Stage 1 (5 Weeks)|Protocol Violation|3|||
147211220|NCT01584440|530945470|FG002|Stage 1 (5 Weeks)|Protocol Violation|0|||
147211221|NCT01584440|530945471|FG003|Stage 1 (5 Weeks)|Protocol Violation|0|||
147211222|NCT01584440|530945472|FG004|Stage 1 (5 Weeks)|Protocol Violation|0|||
147211223|NCT01584440|530945468|FG000|Stage 1 (5 Weeks)|Withdrawal by Subject|1|||
147211224|NCT01584440|530945469|FG001|Stage 1 (5 Weeks)|Withdrawal by Subject|0|||
147211225|NCT01584440|530945470|FG002|Stage 1 (5 Weeks)|Withdrawal by Subject|0|||
147211226|NCT01584440|530945471|FG003|Stage 1 (5 Weeks)|Withdrawal by Subject|0|||
147211227|NCT01584440|530945472|FG004|Stage 1 (5 Weeks)|Withdrawal by Subject|0|||
147211228|NCT01584440|530945468|FG000|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|0|||
147211229|NCT01584440|530945469|FG001|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|2|||
147211230|NCT01584440|530945470|FG002|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|0|||
147211231|NCT01584440|530945471|FG003|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|0|||
147211232|NCT01584440|530945472|FG004|Stage 1 (5 Weeks)|Withdrawal by Parent/Guardian|0|||
147211233|NCT01584440|530945468|FG000|Stage 2 (5 Weeks)|Withdrawal by Subject|0|||
147211234|NCT01584440|530945469|FG001|Stage 2 (5 Weeks)|Withdrawal by Subject|0|||
147211235|NCT01584440|530945470|FG002|Stage 2 (5 Weeks)|Withdrawal by Subject|1|||
147211236|NCT01584440|530945471|FG003|Stage 2 (5 Weeks)|Withdrawal by Subject|2|||
147211237|NCT01584440|530945472|FG004|Stage 2 (5 Weeks)|Withdrawal by Subject|0|||
147211238|NCT01584440|530945468|FG000|Stage 2 (5 Weeks)|Adverse Event|0|||
147211239|NCT01584440|530945469|FG001|Stage 2 (5 Weeks)|Adverse Event|0|||
147211240|NCT01584440|530945470|FG002|Stage 2 (5 Weeks)|Adverse Event|1|||
147211241|NCT01584440|530945471|FG003|Stage 2 (5 Weeks)|Adverse Event|2|||
147211242|NCT01584440|530945472|FG004|Stage 2 (5 Weeks)|Adverse Event|1|||
147211243|NCT01584440|530945468|FG000|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|0|||
147211244|NCT01584440|530945469|FG001|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|0|||
147211245|NCT01584440|530945470|FG002|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|1|||
147211246|NCT01584440|530945471|FG003|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|0|||
147211247|NCT01584440|530945472|FG004|Stage 2 (5 Weeks)|Unable to Return to Site: Rehabilitation|0|||
147211248|NCT04237116|530945473|FG000|Overall Study|Adverse Event|0|||
147211249|NCT04237116|530945474|FG001|Overall Study|Adverse Event|1|||
147211250|NCT04237116|530945473|FG000|Overall Study|Study terminated by Sponsor|4|||
147211251|NCT04237116|530945474|FG001|Overall Study|Study terminated by Sponsor|1|||
147211252|NCT00899431|530945475|FG000|Overall Study|Physician Decision|1|||
147211253|NCT00899431|530945476|FG001|Overall Study|Physician Decision|0|||
147211254|NCT00899431|530945477|FG002|Overall Study|Physician Decision|0|||
147545677|NCT01458119|532153924|FG000|Overall Study|Withdrawal Due to Nonamenable Mutation|1|||
147545678|NCT01458119|532153924|FG000|Overall Study|Pregnancy|1|||
147211255|NCT03212144|530945478|FG000|First Sequence (4 Weeks)|Lost to Follow-up|1|||
147211256|NCT03212144|530945479|FG001|First Sequence (4 Weeks)|Lost to Follow-up|0|||
147211257|NCT03212144|530945478|FG000|Second Sequence (4 Weeks)|Lost to Follow-up|1|||
147211258|NCT03212144|530945479|FG001|Second Sequence (4 Weeks)|Lost to Follow-up|1|||
147545679|NCT01458119|532153924|FG000|Overall Study|Death|2|||
147545680|NCT01458119|532153924|FG000|Overall Study|Adverse Event|1|||
147545681|NCT01458119|532153924|FG000|Overall Study|Consent Withdrawn by Participant|8|||
147211259|NCT00661427|530945480|FG000|Overall Study|Adverse Event|5|||
147545682|NCT01458119|532153924|FG000|Overall Study|Non-compliance With Study Drug|3|||
147545683|NCT03033069|532153925|FG000|Overall Study|Adverse Event|6|||
147211260|NCT00661427|530945481|FG001|Overall Study|Adverse Event|5|||
147211261|NCT00661427|530945480|FG000|Overall Study|Patient not treated|0|||
147211262|NCT00661427|530945481|FG001|Overall Study|Patient not treated|2|||
147211263|NCT00599339|530945482|FG000|Overall Study|Adverse Event|79|||
147211264|NCT00599339|530945482|FG000|Overall Study|Withdrawal by Subject|137|||
147211265|NCT00599339|530945482|FG000|Overall Study|Other Reason|179|||
147211266|NCT00599339|530945482|FG000|Overall Study|Lost to Follow-up|221|||
147211267|NCT00599339|530945482|FG000|Overall Study|No valid data consent|36|||
147211268|NCT00599339|530945482|FG000|Overall Study|Study Termination Status Unknown|12|||
147211269|NCT05564052|530945483|FG000|Overall Study|Withdrawal by Subject|0|||
147211270|NCT05564052|530945484|FG001|Overall Study|Withdrawal by Subject|0|||
147211271|NCT05564052|530945485|FG002|Overall Study|Withdrawal by Subject|0|||
147211272|NCT05564052|530945486|FG003|Overall Study|Withdrawal by Subject|1|||
147211273|NCT01821560|530945487|FG000|Overall Study|Lost to Follow-up|5|||
147211274|NCT01821560|530945488|FG001|Overall Study|Lost to Follow-up|5|||
147211275|NCT01821560|530945487|FG000|Overall Study|Withdrawal by Subject|1|||
147211276|NCT01821560|530945488|FG001|Overall Study|Withdrawal by Subject|1|||
147211277|NCT01821560|530945487|FG000|Overall Study|Protocol Violation|0|||
147211278|NCT01821560|530945488|FG001|Overall Study|Protocol Violation|1|||
147211279|NCT00531427|530945489|FG000|Overall Study|Withdrawal by Subject|7|||
147211280|NCT00531427|530945490|FG001|Overall Study|Withdrawal by Subject|13|||
147211281|NCT00531427|530945489|FG000|Overall Study|Adverse Event|44|||
147211282|NCT00531427|530945490|FG001|Overall Study|Adverse Event|30|||
147211283|NCT00531427|530945489|FG000|Overall Study|Lost to Follow-up|4|||
147211284|NCT00531427|530945490|FG001|Overall Study|Lost to Follow-up|3|||
147211285|NCT00531427|530945489|FG000|Overall Study|Lack of Efficacy|14|||
147211286|NCT00531427|530945490|FG001|Overall Study|Lack of Efficacy|39|||
147211287|NCT00531427|530945489|FG000|Overall Study|Administrative|4|||
147211288|NCT00531427|530945490|FG001|Overall Study|Administrative|9|||
147211289|NCT01338298|530945491|FG000|Overall Study|Withdrawal by Subject|1|||
147211290|NCT01338298|530945492|FG001|Overall Study|Withdrawal by Subject|1|||
147211291|NCT01338298|530945491|FG000|Overall Study|Abdominal Pain and scheduled surgery|0|||
147211292|NCT01338298|530945492|FG001|Overall Study|Abdominal Pain and scheduled surgery|1|||
147211293|NCT01338298|530945491|FG000|Overall Study|Administrative error|0|||
147211294|NCT01338298|530945492|FG001|Overall Study|Administrative error|1|||
147211295|NCT01338298|530945491|FG000|Overall Study|Positive symptom worsening|1|||
147211296|NCT01338298|530945492|FG001|Overall Study|Positive symptom worsening|0|||
147211297|NCT01338298|530945491|FG000|Overall Study|Depressive symptoms and nausea|1|||
147211298|NCT01338298|530945492|FG001|Overall Study|Depressive symptoms and nausea|0|||
147211299|NCT01338298|530945491|FG000|Overall Study|Non-adherence|1|||
147211300|NCT01338298|530945492|FG001|Overall Study|Non-adherence|0|||
147211301|NCT02872285|530945493|FG000|Overall Study|Withdrawal by Subject|2|||
147211302|NCT02872285|530945494|FG001|Overall Study|Withdrawal by Subject|0|||
147211303|NCT02872285|530945493|FG000|Overall Study|Lost to Follow-up|2|||
147211304|NCT02872285|530945494|FG001|Overall Study|Lost to Follow-up|2|||
147211305|NCT02872285|530945493|FG000|Overall Study|Discontinued due to back surgery|1|||
147211306|NCT02872285|530945494|FG001|Overall Study|Discontinued due to back surgery|0|||
147211307|NCT02660983|530945496|FG000|Double-blind (DB) Phase (24 Weeks)|Protocol Violation|1|||
147211308|NCT02660983|530945497|FG001|Double-blind (DB) Phase (24 Weeks)|Protocol Violation|5|||
147211309|NCT02660983|530945496|FG000|Double-blind (DB) Phase (24 Weeks)|Withdrawal by Subject|15|||
147211310|NCT02660983|530945497|FG001|Double-blind (DB) Phase (24 Weeks)|Withdrawal by Subject|12|||
147211311|NCT02660983|530945496|FG000|Double-blind (DB) Phase (24 Weeks)|Adverse Event|8|||
147211312|NCT02660983|530945497|FG001|Double-blind (DB) Phase (24 Weeks)|Adverse Event|9|||
147211313|NCT02660983|530945496|FG000|Open Label Extension Phase (24 Weeks)|Protocol Violation|1|||
147211314|NCT02660983|530945497|FG001|Open Label Extension Phase (24 Weeks)|Protocol Violation|1|||
147211315|NCT02660983|530945496|FG000|Open Label Extension Phase (24 Weeks)|Withdrawal by Subject|1|||
147211316|NCT02660983|530945497|FG001|Open Label Extension Phase (24 Weeks)|Withdrawal by Subject|4|||
147211317|NCT02660983|530945496|FG000|Open Label Extension Phase (24 Weeks)|Adverse Event|1|||
147211318|NCT02660983|530945497|FG001|Open Label Extension Phase (24 Weeks)|Adverse Event|3|||
147211319|NCT02660983|530945496|FG000|Open Label Extension Phase (24 Weeks)|Other|0|||
147211320|NCT02660983|530945497|FG001|Open Label Extension Phase (24 Weeks)|Other|1|||
147211321|NCT01253577|530945501|FG000|Overall Study|Lost to Follow-up|3|||
147211322|NCT00721968|530945502|FG000|Overall Study|Lost to Follow-up|2|||
147211323|NCT00721968|530945503|FG001|Overall Study|Lost to Follow-up|0|||
147211324|NCT05601544|530945504|FG000|Phase 2 Period 1|Adverse Event|0|||
147211325|NCT05601544|530945505|FG001|Phase 2 Period 1|Adverse Event|1|||
147211326|NCT05601544|530945506|FG002|Phase 2 Period 1|Adverse Event|0|||
147211327|NCT05601544|530945507|FG003|Phase 2 Period 1|Adverse Event|0|||
147211328|NCT05601544|530945508|FG004|Phase 2 Period 1|Adverse Event|0|||
147211329|NCT05601544|530945509|FG005|Phase 2 Period 1|Adverse Event|0|||
147211330|NCT01064947|530945510|FG000|Overall Study|negative culture|41|||
147211331|NCT06457204|530945511|FG000|Washout|Adverse Event|0|||
147211332|NCT06457204|530945512|FG001|Washout|Adverse Event|2|||
147211333|NCT01601652|530945514|FG000|Overall Study|Death|1|||
147211334|NCT00488683|530945521|FG000|Overall Study|Withdrawal by Subject|1|||
147211335|NCT00488683|530945522|FG001|Overall Study|Withdrawal by Subject|2|||
147649444|NCT02634801|532537343|FG002|Follow-up Period|Physician Decision|1|||
147545684|NCT03033069|532153926|FG001|Overall Study|Adverse Event|7|||
147545685|NCT03033069|532153927|FG002|Overall Study|Adverse Event|4|||
147545686|NCT03033069|532153928|FG003|Overall Study|Adverse Event|6|||
147545687|NCT03033069|532153925|FG000|Overall Study|Lack of Efficacy|0|||
147545688|NCT03033069|532153926|FG001|Overall Study|Lack of Efficacy|0|||
147545689|NCT03033069|532153927|FG002|Overall Study|Lack of Efficacy|1|||
147545690|NCT03033069|532153928|FG003|Overall Study|Lack of Efficacy|0|||
147545691|NCT03033069|532153925|FG000|Overall Study|Lost to Follow-up|6|||
147545692|NCT03033069|532153926|FG001|Overall Study|Lost to Follow-up|5|||
147545693|NCT03033069|532153927|FG002|Overall Study|Lost to Follow-up|5|||
147545694|NCT03033069|532153928|FG003|Overall Study|Lost to Follow-up|6|||
147545695|NCT03033069|532153925|FG000|Overall Study|Non-Compliance With Study Drug|1|||
147545696|NCT03033069|532153926|FG001|Overall Study|Non-Compliance With Study Drug|1|||
147545697|NCT03033069|532153927|FG002|Overall Study|Non-Compliance With Study Drug|1|||
147545698|NCT03033069|532153928|FG003|Overall Study|Non-Compliance With Study Drug|0|||
147545699|NCT03033069|532153925|FG000|Overall Study|Protocol Deviation|0|||
147211336|NCT00488683|530945523|FG002|Overall Study|Withdrawal by Subject|2|||
147211337|NCT00488683|530945521|FG000|Overall Study|Lost to Follow-up|5|||
147211338|NCT00488683|530945522|FG001|Overall Study|Lost to Follow-up|3|||
147211339|NCT00488683|530945523|FG002|Overall Study|Lost to Follow-up|0|||
147211340|NCT00488683|530945521|FG000|Overall Study|Protocol Violation|5|||
147211341|NCT00488683|530945522|FG001|Overall Study|Protocol Violation|1|||
147211342|NCT00488683|530945523|FG002|Overall Study|Protocol Violation|0|||
147211343|NCT00488683|530945521|FG000|Overall Study|Unable to Classify|1|||
147211344|NCT00488683|530945522|FG001|Overall Study|Unable to Classify|0|||
147211345|NCT00488683|530945523|FG002|Overall Study|Unable to Classify|0|||
147211346|NCT03818035|530945525|FG000|Part 1 (Up to 28 Weeks)|Death|1|||
147211347|NCT03818035|530945526|FG001|Part 1 (Up to 28 Weeks)|Death|0|||
147211348|NCT03818035|530945527|FG002|Part 1 (Up to 28 Weeks)|Death|0|||
147211349|NCT03818035|530945528|FG003|Part 1 (Up to 28 Weeks)|Death|0|||
147211350|NCT03818035|530945525|FG000|Part 1 (Up to 28 Weeks)|Lack of Efficacy|3|||
147211351|NCT03818035|530945526|FG001|Part 1 (Up to 28 Weeks)|Lack of Efficacy|0|||
147211352|NCT03818035|530945527|FG002|Part 1 (Up to 28 Weeks)|Lack of Efficacy|0|||
147211353|NCT03818035|530945528|FG003|Part 1 (Up to 28 Weeks)|Lack of Efficacy|0|||
147211354|NCT03818035|530945525|FG000|Part 1 (Up to 28 Weeks)|Lost to Follow-up|10|||
147211355|NCT03818035|530945526|FG001|Part 1 (Up to 28 Weeks)|Lost to Follow-up|0|||
147211356|NCT03818035|530945527|FG002|Part 1 (Up to 28 Weeks)|Lost to Follow-up|0|||
147211357|NCT03818035|530945528|FG003|Part 1 (Up to 28 Weeks)|Lost to Follow-up|0|||
147211358|NCT03818035|530945525|FG000|Part 1 (Up to 28 Weeks)|Protocol Violation|10|||
147211359|NCT03818035|530945526|FG001|Part 1 (Up to 28 Weeks)|Protocol Violation|0|||
147211360|NCT03818035|530945527|FG002|Part 1 (Up to 28 Weeks)|Protocol Violation|0|||
147211361|NCT03818035|530945528|FG003|Part 1 (Up to 28 Weeks)|Protocol Violation|0|||
147211362|NCT03818035|530945525|FG000|Part 1 (Up to 28 Weeks)|Withdrawal by Subject|8|||
147211363|NCT03818035|530945526|FG001|Part 1 (Up to 28 Weeks)|Withdrawal by Subject|0|||
147211364|NCT03818035|530945527|FG002|Part 1 (Up to 28 Weeks)|Withdrawal by Subject|0|||
147211365|NCT03818035|530945528|FG003|Part 1 (Up to 28 Weeks)|Withdrawal by Subject|0|||
147211366|NCT03818035|530945525|FG000|Part 1 (Up to 28 Weeks)|Adverse Event - Worsening of Psoriasis|1|||
147211367|NCT03818035|530945526|FG001|Part 1 (Up to 28 Weeks)|Adverse Event - Worsening of Psoriasis|0|||
147211368|NCT03818035|530945527|FG002|Part 1 (Up to 28 Weeks)|Adverse Event - Worsening of Psoriasis|0|||
147211369|NCT03818035|530945528|FG003|Part 1 (Up to 28 Weeks)|Adverse Event - Worsening of Psoriasis|0|||
147211370|NCT03818035|530945525|FG000|Part 1 (Up to 28 Weeks)|Adverse Event - Other|16|||
147211371|NCT03818035|530945526|FG001|Part 1 (Up to 28 Weeks)|Adverse Event - Other|0|||
147211372|NCT03818035|530945527|FG002|Part 1 (Up to 28 Weeks)|Adverse Event - Other|0|||
147211373|NCT03818035|530945528|FG003|Part 1 (Up to 28 Weeks)|Adverse Event - Other|0|||
147211374|NCT03818035|530945525|FG000|Part 1 (Up to 28 Weeks)|Non-Compliance with Study Drug|1|||
147211375|NCT03818035|530945526|FG001|Part 1 (Up to 28 Weeks)|Non-Compliance with Study Drug|0|||
147211376|NCT03818035|530945527|FG002|Part 1 (Up to 28 Weeks)|Non-Compliance with Study Drug|0|||
147211377|NCT03818035|530945528|FG003|Part 1 (Up to 28 Weeks)|Non-Compliance with Study Drug|0|||
147211378|NCT03818035|530945525|FG000|Part 1 (Up to 28 Weeks)|Other|7|||
147211379|NCT03818035|530945526|FG001|Part 1 (Up to 28 Weeks)|Other|0|||
147211380|NCT03818035|530945527|FG002|Part 1 (Up to 28 Weeks)|Other|0|||
147211381|NCT03818035|530945528|FG003|Part 1 (Up to 28 Weeks)|Other|0|||
147211382|NCT03818035|530945525|FG000|Part 2 (Week 28 to Week 68)|Lack of Efficacy|0|||
147211383|NCT03818035|530945526|FG001|Part 2 (Week 28 to Week 68)|Lack of Efficacy|0|||
147211384|NCT03818035|530945527|FG002|Part 2 (Week 28 to Week 68)|Lack of Efficacy|0|||
147211385|NCT03818035|530945528|FG003|Part 2 (Week 28 to Week 68)|Lack of Efficacy|4|||
147545700|NCT03033069|532153926|FG001|Overall Study|Protocol Deviation|1|||
147545701|NCT03033069|532153927|FG002|Overall Study|Protocol Deviation|0|||
147545702|NCT03033069|532153928|FG003|Overall Study|Protocol Deviation|0|||
147545703|NCT03033069|532153925|FG000|Overall Study|Withdrawal by Subject|10|||
147545704|NCT03033069|532153926|FG001|Overall Study|Withdrawal by Subject|10|||
147211386|NCT03818035|530945525|FG000|Part 2 (Week 28 to Week 68)|Lost to Follow-up|0|||
147545705|NCT03033069|532153927|FG002|Overall Study|Withdrawal by Subject|11|||
147545706|NCT03033069|532153928|FG003|Overall Study|Withdrawal by Subject|6|||
147211387|NCT03818035|530945526|FG001|Part 2 (Week 28 to Week 68)|Lost to Follow-up|6|||
147211388|NCT03818035|530945527|FG002|Part 2 (Week 28 to Week 68)|Lost to Follow-up|1|||
147211389|NCT03818035|530945528|FG003|Part 2 (Week 28 to Week 68)|Lost to Follow-up|9|||
147211390|NCT03818035|530945525|FG000|Part 2 (Week 28 to Week 68)|Withdrawal by Subject|0|||
147211391|NCT03818035|530945526|FG001|Part 2 (Week 28 to Week 68)|Withdrawal by Subject|0|||
147211392|NCT03818035|530945527|FG002|Part 2 (Week 28 to Week 68)|Withdrawal by Subject|0|||
147211393|NCT03818035|530945528|FG003|Part 2 (Week 28 to Week 68)|Withdrawal by Subject|8|||
147211394|NCT03818035|530945525|FG000|Part 2 (Week 28 to Week 68)|Other Adverse Events|0|||
147211395|NCT03818035|530945526|FG001|Part 2 (Week 28 to Week 68)|Other Adverse Events|3|||
147211396|NCT03818035|530945527|FG002|Part 2 (Week 28 to Week 68)|Other Adverse Events|4|||
147211397|NCT03818035|530945528|FG003|Part 2 (Week 28 to Week 68)|Other Adverse Events|7|||
147211398|NCT03818035|530945525|FG000|Part 2 (Week 28 to Week 68)|Subject Started Retreatment Phase Within Study Part 2|0|||
147211399|NCT03818035|530945526|FG001|Part 2 (Week 28 to Week 68)|Subject Started Retreatment Phase Within Study Part 2|1|||
147211400|NCT03818035|530945527|FG002|Part 2 (Week 28 to Week 68)|Subject Started Retreatment Phase Within Study Part 2|2|||
147211401|NCT03818035|530945528|FG003|Part 2 (Week 28 to Week 68)|Subject Started Retreatment Phase Within Study Part 2|0|||
147211402|NCT03818035|530945525|FG000|Part 2 (Week 28 to Week 68)|Other|0|||
147211403|NCT03818035|530945526|FG001|Part 2 (Week 28 to Week 68)|Other|1|||
147211404|NCT03818035|530945527|FG002|Part 2 (Week 28 to Week 68)|Other|1|||
147211405|NCT03818035|530945528|FG003|Part 2 (Week 28 to Week 68)|Other|1|||
147211406|NCT03374202|530945531|FG000|Five Year Long Term Follow Up|Long Term Follow Up Ongoing|1|||
147211407|NCT03374202|530945532|FG001|Five Year Long Term Follow Up|Long Term Follow Up Ongoing|2|||
147211408|NCT03374202|530945533|FG002|Five Year Long Term Follow Up|Long Term Follow Up Ongoing|4|||
147211409|NCT03374202|530945531|FG000|Five Year Long Term Follow Up|Death|0|||
147211410|NCT03374202|530945532|FG001|Five Year Long Term Follow Up|Death|1|||
147211411|NCT03374202|530945533|FG002|Five Year Long Term Follow Up|Death|0|||
147211412|NCT01794338|530947122|FG000|Overall Study|Death|2|||
147211413|NCT01794338|530947123|FG001|Overall Study|Death|0|||
147211414|NCT01794338|530947122|FG000|Overall Study|Lost to Follow-up|6|||
147211415|NCT01794338|530947123|FG001|Overall Study|Lost to Follow-up|9|||
147211416|NCT01754402|530947124|FG000|Overall Study|Death|0|||
147211417|NCT01754402|530947125|FG001|Overall Study|Death|0|||
147211418|NCT01754402|530947126|FG002|Overall Study|Death|1|||
147211419|NCT01754402|530947124|FG000|Overall Study|Adverse Event|2|||
147211420|NCT01754402|530947125|FG001|Overall Study|Adverse Event|2|||
147211421|NCT01754402|530947126|FG002|Overall Study|Adverse Event|1|||
147211422|NCT01754402|530947124|FG000|Overall Study|Withdrawal by Subject|0|||
147211423|NCT01754402|530947125|FG001|Overall Study|Withdrawal by Subject|0|||
147211424|NCT01754402|530947126|FG002|Overall Study|Withdrawal by Subject|1|||
147211425|NCT01754402|530947124|FG000|Overall Study|Lack of Efficacy|0|||
147211426|NCT01754402|530947125|FG001|Overall Study|Lack of Efficacy|0|||
147211427|NCT01754402|530947126|FG002|Overall Study|Lack of Efficacy|1|||
147211428|NCT02848729|530947129|FG000|Overall Study|Withdrawal by Subject|1|||
147211429|NCT02848729|530947130|FG001|Overall Study|Withdrawal by Subject|0|||
147211430|NCT02848729|530947129|FG000|Overall Study|Emesis|15|||
147211431|NCT02848729|530947130|FG001|Overall Study|Emesis|11|||
147211432|NCT02617485|530947131|FG000|Treatment and Observation Period|Adverse Event|9|||
147211433|NCT02617485|530947132|FG001|Treatment and Observation Period|Adverse Event|1|||
147211434|NCT02617485|530947131|FG000|Treatment and Observation Period|Withdrawal by Subject|4|||
147211435|NCT02617485|530947132|FG001|Treatment and Observation Period|Withdrawal by Subject|1|||
147211436|NCT02617485|530947131|FG000|Treatment and Observation Period|Patient needed radiotherapy|1|||
147211437|NCT02617485|530947132|FG001|Treatment and Observation Period|Patient needed radiotherapy|0|||
147211438|NCT02617485|530947131|FG000|Treatment and Observation Period|Lack of Efficacy|1|||
147211439|NCT02617485|530947132|FG001|Treatment and Observation Period|Lack of Efficacy|2|||
147211440|NCT02617485|530947131|FG000|Treatment and Observation Period|Physician Decision|0|||
147211441|NCT02617485|530947132|FG001|Treatment and Observation Period|Physician Decision|1|||
147211442|NCT02617485|530947131|FG000|Follow-up Period|Adverse Event|1|||
147211443|NCT02617485|530947132|FG001|Follow-up Period|Adverse Event|0|||
147211444|NCT02617485|530947131|FG000|Follow-up Period|Withdrawal by Subject|1|||
147211445|NCT02617485|530947132|FG001|Follow-up Period|Withdrawal by Subject|0|||
147211446|NCT02617485|530947131|FG000|Follow-up Period|Disease progression|2|||
147441836|NCT00714285|531782663|FG001|Overall Study|Lost to Follow-up|2|||
147441837|NCT00714285|531782664|FG002|Overall Study|Lost to Follow-up|0|||
147441838|NCT00714285|531782665|FG003|Overall Study|Lost to Follow-up|1|||
147441839|NCT00714285|531782662|FG000|Overall Study|Migrated/moved from study area|0|||
147441840|NCT00714285|531782663|FG001|Overall Study|Migrated/moved from study area|1|||
147441841|NCT00714285|531782664|FG002|Overall Study|Migrated/moved from study area|0|||
147441842|NCT00714285|531782665|FG003|Overall Study|Migrated/moved from study area|0|||
147441843|NCT01131676|531782666|FG000|Discontinuation From Treatment|Study drug stopped, reason missing|5|||
147441844|NCT01131676|531782667|FG001|Discontinuation From Treatment|Study drug stopped, reason missing|3|||
147441845|NCT01131676|531782668|FG002|Discontinuation From Treatment|Study drug stopped, reason missing|4|||
147441846|NCT01131676|531782666|FG000|Discontinuation From Treatment|Not treated|4|||
147441847|NCT01131676|531782667|FG001|Discontinuation From Treatment|Not treated|2|||
147545707|NCT03033069|532153925|FG000|Overall Study|Withdrawal By Caregiver|1|||
147545708|NCT03033069|532153926|FG001|Overall Study|Withdrawal By Caregiver|0|||
147545709|NCT03033069|532153927|FG002|Overall Study|Withdrawal By Caregiver|0|||
147545710|NCT03033069|532153928|FG003|Overall Study|Withdrawal By Caregiver|0|||
147545711|NCT03033069|532153925|FG000|Overall Study|Reason not Specified|0|||
147545712|NCT03033069|532153926|FG001|Overall Study|Reason not Specified|1|||
147545713|NCT03033069|532153927|FG002|Overall Study|Reason not Specified|0|||
147545714|NCT03033069|532153928|FG003|Overall Study|Reason not Specified|1|||
147545715|NCT01246973|532155918|FG000|Overall Study|Other|38|||
147545716|NCT01246973|532155919|FG001|Overall Study|Other|25|||
147545717|NCT01246973|532155918|FG000|Overall Study|Adverse Event|16|||
147545718|NCT01246973|532155919|FG001|Overall Study|Adverse Event|9|||
147545719|NCT01246973|532155918|FG000|Overall Study|Withdrawal by Subject|7|||
147545720|NCT01246973|532155919|FG001|Overall Study|Withdrawal by Subject|13|||
147545721|NCT01416142|532155920|FG000|PureVision2 HD|Inability to maintain lens wear|0|||
147545722|NCT01416142|532155921|FG001|PureVision2 HD|Inability to maintain lens wear|0|||
147545723|NCT01416142|532155922|FG002|PureVision2 HD|Inability to maintain lens wear|1|||
147545724|NCT01326702|532155924|FG000|Overall Study|Other|1|||
147545725|NCT01326702|532155925|FG001|Overall Study|Other|0|||
147545726|NCT01326702|532155926|FG002|Overall Study|Other|0|||
147545727|NCT01326702|532155927|FG003|Overall Study|Other|0|||
147545728|NCT01326702|532155928|FG004|Overall Study|Other|0|||
147545729|NCT01326702|532155929|FG005|Overall Study|Other|1|||
147211447|NCT02617485|530947132|FG001|Follow-up Period|Disease progression|1|||
147211448|NCT02617485|530947131|FG000|Follow-up Period|Need for CNS prophylaxis|1|||
147211449|NCT02617485|530947132|FG001|Follow-up Period|Need for CNS prophylaxis|0|||
147211450|NCT02617485|530947131|FG000|Follow-up Period|Patient needed radiotherapy|9|||
147211451|NCT02617485|530947132|FG001|Follow-up Period|Patient needed radiotherapy|5|||
147211452|NCT02617485|530947131|FG000|Follow-up Period|Patient needed bone marrow transplantation|1|||
147211453|NCT02617485|530947132|FG001|Follow-up Period|Patient needed bone marrow transplantation|0|||
147211454|NCT00220779|530947136|FG000|Overall Study|Adverse Event|1|||
147211455|NCT00220779|530947137|FG001|Overall Study|Adverse Event|0|||
147211456|NCT00220779|530947138|FG002|Overall Study|Adverse Event|0|||
147211457|NCT00220779|530947136|FG000|Overall Study|Withdrawal by Subject|1|||
147211458|NCT00220779|530947137|FG001|Overall Study|Withdrawal by Subject|4|||
147211459|NCT00220779|530947138|FG002|Overall Study|Withdrawal by Subject|1|||
147211460|NCT00220779|530947136|FG000|Overall Study|Non-compliance|1|||
147211461|NCT00220779|530947137|FG001|Overall Study|Non-compliance|0|||
147211462|NCT00220779|530947138|FG002|Overall Study|Non-compliance|0|||
147211463|NCT00220779|530947136|FG000|Overall Study|Too time consuming|1|||
147211464|NCT00220779|530947137|FG001|Overall Study|Too time consuming|0|||
147211465|NCT00220779|530947138|FG002|Overall Study|Too time consuming|0|||
147211466|NCT00220779|530947136|FG000|Overall Study|Pregnancy|0|||
147211467|NCT00220779|530947137|FG001|Overall Study|Pregnancy|0|||
147211468|NCT00220779|530947138|FG002|Overall Study|Pregnancy|2|||
147211469|NCT00220779|530947136|FG000|Overall Study|Lack of Efficacy|3|||
147211470|NCT00220779|530947137|FG001|Overall Study|Lack of Efficacy|0|||
147211471|NCT00220779|530947138|FG002|Overall Study|Lack of Efficacy|1|||
147211472|NCT00791076|530947139|FG000|Overall Study|Study was terminated,PI left institution|8|||
147211473|NCT00507728|530947146|FG000|Randomization to Month 3|Lost to Follow-up|15|||
147211474|NCT00507728|530947147|FG001|Randomization to Month 3|Lost to Follow-up|14|||
147211475|NCT00507728|530947148|FG002|Randomization to Month 3|Lost to Follow-up|20|||
147211476|NCT00507728|530947146|FG000|From 3 Months to 6 Months|Lost to Follow-up|6|||
147211477|NCT00507728|530947147|FG001|From 3 Months to 6 Months|Lost to Follow-up|10|||
147211478|NCT00507728|530947148|FG002|From 3 Months to 6 Months|Lost to Follow-up|9|||
147211479|NCT00966875|530947151|FG000|Part A|Adverse Event|2|||
147211480|NCT00966875|530947152|FG001|Part A|Adverse Event|1|||
147211481|NCT00966875|530947153|FG002|Part A|Adverse Event|0|||
147211482|NCT00966875|530947154|FG003|Part A|Adverse Event|1|||
147211483|NCT00966875|530947155|FG004|Part A|Adverse Event|0|||
147545730|NCT01326702|532155930|FG006|Overall Study|Other|0|||
147545731|NCT01326702|532155924|FG000|Overall Study|progressive disease|1|||
147545732|NCT01326702|532155925|FG001|Overall Study|progressive disease|1|||
147211484|NCT00966875|530947156|FG005|Part A|Adverse Event|1|||
147211485|NCT00966875|530947157|FG006|Part A|Adverse Event|0|||
147211486|NCT00966875|530947158|FG007|Part A|Adverse Event|3|||
147211487|NCT00966875|530947159|FG008|Part A|Adverse Event|3|||
147211488|NCT00966875|530947151|FG000|Part A|Entry Criteria|0|||
147211489|NCT00966875|530947152|FG001|Part A|Entry Criteria|0|||
147211490|NCT00966875|530947153|FG002|Part A|Entry Criteria|0|||
147211491|NCT00966875|530947154|FG003|Part A|Entry Criteria|0|||
147211492|NCT00966875|530947155|FG004|Part A|Entry Criteria|0|||
147211493|NCT00966875|530947156|FG005|Part A|Entry Criteria|2|||
147211494|NCT00966875|530947157|FG006|Part A|Entry Criteria|0|||
147211495|NCT00966875|530947158|FG007|Part A|Entry Criteria|0|||
147211496|NCT00966875|530947159|FG008|Part A|Entry Criteria|0|||
147545733|NCT01326702|532155926|FG002|Overall Study|progressive disease|3|||
147545734|NCT01326702|532155927|FG003|Overall Study|progressive disease|1|||
147545735|NCT01326702|532155928|FG004|Overall Study|progressive disease|3|||
147545736|NCT01326702|532155929|FG005|Overall Study|progressive disease|2|||
147545737|NCT01326702|532155930|FG006|Overall Study|progressive disease|3|||
147545738|NCT01326702|532155924|FG000|Overall Study|Death|0|||
147545739|NCT01326702|532155925|FG001|Overall Study|Death|1|||
147545740|NCT01326702|532155926|FG002|Overall Study|Death|0|||
147545741|NCT01326702|532155927|FG003|Overall Study|Death|0|||
147545742|NCT01326702|532155928|FG004|Overall Study|Death|0|||
147545743|NCT01326702|532155929|FG005|Overall Study|Death|0|||
147545744|NCT01326702|532155930|FG006|Overall Study|Death|0|||
147545745|NCT01326702|532155924|FG000|Overall Study|Adverse Event|0|||
147545746|NCT01326702|532155925|FG001|Overall Study|Adverse Event|0|||
147545747|NCT01326702|532155926|FG002|Overall Study|Adverse Event|1|||
147545748|NCT01326702|532155927|FG003|Overall Study|Adverse Event|1|||
147545749|NCT01326702|532155928|FG004|Overall Study|Adverse Event|0|||
147545750|NCT01326702|532155929|FG005|Overall Study|Adverse Event|3|||
147545751|NCT01326702|532155930|FG006|Overall Study|Adverse Event|1|||
147545752|NCT01326702|532155924|FG000|Overall Study|Withdrawal by Subject|0|||
147545753|NCT01326702|532155925|FG001|Overall Study|Withdrawal by Subject|0|||
147545754|NCT01326702|532155926|FG002|Overall Study|Withdrawal by Subject|1|||
147545755|NCT01326702|532155927|FG003|Overall Study|Withdrawal by Subject|0|||
147545756|NCT01326702|532155928|FG004|Overall Study|Withdrawal by Subject|1|||
147545757|NCT01326702|532155929|FG005|Overall Study|Withdrawal by Subject|1|||
147545758|NCT01326702|532155930|FG006|Overall Study|Withdrawal by Subject|3|||
147545759|NCT01326702|532155924|FG000|Overall Study|Not Treated|0|||
147545760|NCT01326702|532155925|FG001|Overall Study|Not Treated|0|||
147545761|NCT01326702|532155926|FG002|Overall Study|Not Treated|0|||
147545762|NCT01326702|532155927|FG003|Overall Study|Not Treated|1|||
147545763|NCT01326702|532155928|FG004|Overall Study|Not Treated|0|||
147545764|NCT01326702|532155929|FG005|Overall Study|Not Treated|1|||
147545765|NCT01326702|532155930|FG006|Overall Study|Not Treated|0|||
147545766|NCT02082912|532155931|FG000|Overall Study|Physician Decision|0|||
147545767|NCT02082912|532155932|FG001|Overall Study|Physician Decision|1|||
147545768|NCT01835132|532155938|FG000|Initial Phase|Insufficient Therapeutic Response|2|||
147545769|NCT00265083|532155939|FG000|Overall Study|Adverse Event|5|||
147545770|NCT00265083|532155940|FG001|Overall Study|Adverse Event|13|||
147545771|NCT00265083|532155941|FG002|Overall Study|Adverse Event|15|||
147545772|NCT00265083|532155939|FG000|Overall Study|Lost to Follow-up|3|||
147545773|NCT00265083|532155940|FG001|Overall Study|Lost to Follow-up|4|||
147545774|NCT00265083|532155941|FG002|Overall Study|Lost to Follow-up|4|||
147545775|NCT00265083|532155939|FG000|Overall Study|Unsatisfactory therapeutic effect|8|||
147545776|NCT00265083|532155940|FG001|Overall Study|Unsatisfactory therapeutic effect|13|||
147545777|NCT00265083|532155941|FG002|Overall Study|Unsatisfactory therapeutic effect|14|||
147545778|NCT00265083|532155939|FG000|Overall Study|Other|1|||
147545779|NCT00265083|532155940|FG001|Overall Study|Other|12|||
147545780|NCT00265083|532155941|FG002|Overall Study|Other|9|||
147545781|NCT03208933|532155942|FG000|Overall Study|Death|3|||
147545782|NCT03208933|532155942|FG000|Overall Study|Withdrawal by Subject|3|||
147211497|NCT00966875|530947151|FG000|Part A|Lack of Efficacy|0|||
147211498|NCT00966875|530947152|FG001|Part A|Lack of Efficacy|1|||
147211499|NCT00966875|530947153|FG002|Part A|Lack of Efficacy|0|||
147211500|NCT00966875|530947154|FG003|Part A|Lack of Efficacy|0|||
147211501|NCT00966875|530947155|FG004|Part A|Lack of Efficacy|0|||
147211502|NCT00966875|530947156|FG005|Part A|Lack of Efficacy|0|||
147211503|NCT00966875|530947157|FG006|Part A|Lack of Efficacy|4|||
147211504|NCT00966875|530947158|FG007|Part A|Lack of Efficacy|0|||
147211505|NCT00966875|530947159|FG008|Part A|Lack of Efficacy|0|||
147211506|NCT00966875|530947151|FG000|Part A|Lost to Follow-up|2|||
147211507|NCT00966875|530947152|FG001|Part A|Lost to Follow-up|0|||
147211508|NCT00966875|530947153|FG002|Part A|Lost to Follow-up|0|||
147211509|NCT00966875|530947154|FG003|Part A|Lost to Follow-up|0|||
147211510|NCT00966875|530947155|FG004|Part A|Lost to Follow-up|0|||
147211511|NCT00966875|530947156|FG005|Part A|Lost to Follow-up|1|||
147211512|NCT00966875|530947157|FG006|Part A|Lost to Follow-up|0|||
147545783|NCT03208933|532155942|FG000|Overall Study|Adverse Event|1|||
147545784|NCT03208933|532155942|FG000|Overall Study|Lost to Follow-up|2|||
147545785|NCT03208933|532155942|FG000|Overall Study|Physician Decision|3|||
147545786|NCT03208933|532155942|FG000|Overall Study|Protocol Violation|1|||
147545787|NCT00782275|532155945|FG000|Overall Study|Adverse Event|11|||
147545788|NCT00782275|532155945|FG000|Overall Study|Withdrawal by Subject|1|||
147545789|NCT00782275|532155945|FG000|Overall Study|Progressive Disease|21|||
147545790|NCT00782275|532155945|FG000|Overall Study|Physician Decision|4|||
147545791|NCT00782275|532155945|FG000|Overall Study|Not started treatment|1|||
147211513|NCT00966875|530947158|FG007|Part A|Lost to Follow-up|0|||
147211514|NCT00966875|530947159|FG008|Part A|Lost to Follow-up|0|||
147211515|NCT00966875|530947151|FG000|Part A|Parent/Caregiver Decision|0|||
147211516|NCT00966875|530947152|FG001|Part A|Parent/Caregiver Decision|0|||
147211517|NCT00966875|530947153|FG002|Part A|Parent/Caregiver Decision|0|||
147545792|NCT00782275|532155945|FG000|Overall Study|Other|3|||
147545793|NCT04378010|532155946|FG000|Overall Study|Adverse Event|8|||
147545794|NCT04378010|532155947|FG001|Overall Study|Adverse Event|14|||
147545795|NCT04378010|532155948|FG002|Overall Study|Adverse Event|4|||
147545796|NCT04378010|532155946|FG000|Overall Study|Withdrawal by Subject|0|||
147545797|NCT04378010|532155947|FG001|Overall Study|Withdrawal by Subject|2|||
147545798|NCT04378010|532155948|FG002|Overall Study|Withdrawal by Subject|1|||
147545799|NCT04378010|532155946|FG000|Overall Study|Protocol Violation|2|||
147545800|NCT04378010|532155947|FG001|Overall Study|Protocol Violation|1|||
147545801|NCT04378010|532155948|FG002|Overall Study|Protocol Violation|4|||
147545802|NCT04378010|532155946|FG000|Overall Study|Study terminated by Sponsor|22|||
147545803|NCT04378010|532155947|FG001|Overall Study|Study terminated by Sponsor|16|||
147545804|NCT04378010|532155948|FG002|Overall Study|Study terminated by Sponsor|22|||
147545805|NCT04378010|532155946|FG000|Overall Study|Subject inability to complete study visit|0|||
147545806|NCT04378010|532155947|FG001|Overall Study|Subject inability to complete study visit|0|||
147545807|NCT04378010|532155948|FG002|Overall Study|Subject inability to complete study visit|1|||
147545808|NCT04378010|532155946|FG000|Overall Study|Subject never dosed|0|||
147545809|NCT04378010|532155947|FG001|Overall Study|Subject never dosed|1|||
147545810|NCT04378010|532155948|FG002|Overall Study|Subject never dosed|0|||
147545811|NCT02019979|532155949|FG000|Overall Study|study terminated|14|||
147545812|NCT02513459|532155950|FG000|Overall Study|Adverse Event|7|||
147545813|NCT02513459|532155950|FG000|Overall Study|Withdrew consent|5|||
147545814|NCT02513459|532155950|FG000|Overall Study|Loss of efficacy|2|||
147545815|NCT02513459|532155950|FG000|Overall Study|Pregnancy|2|||
147545816|NCT02513459|532155950|FG000|Overall Study|Subject decision|2|||
147545817|NCT02513459|532155950|FG000|Overall Study|Lack of response|1|||
147545818|NCT02513459|532155950|FG000|Overall Study|Reproductive plans|1|||
147545819|NCT02513459|532155950|FG000|Overall Study|Surgery planned-- not done|1|||
147545820|NCT03237611|532155951|FG000|Overall Study|Withdrawal by Subject|1|||
147545821|NCT03237611|532155951|FG000|Overall Study|Ineligible|1|||
147545822|NCT00923195|532155955|FG000|Overall Study|Death|0|||
147545823|NCT00923195|532155956|FG001|Overall Study|Death|1|||
147545824|NCT00525031|532155957|FG000|Overall Study|Disease Progression|1|||
147545825|NCT00525031|532155958|FG001|Overall Study|Disease Progression|1|||
147545826|NCT00830063|532155961|FG000|Overall Study|Adverse Event|7|||
147545827|NCT00830063|532155962|FG001|Overall Study|Adverse Event|13|||
147545828|NCT00830063|532155963|FG002|Overall Study|Adverse Event|16|||
147545829|NCT00830063|532155964|FG003|Overall Study|Adverse Event|13|||
147545830|NCT00830063|532155961|FG000|Overall Study|Death|1|||
147545831|NCT00830063|532155962|FG001|Overall Study|Death|0|||
147545832|NCT00830063|532155963|FG002|Overall Study|Death|0|||
147545833|NCT00830063|532155964|FG003|Overall Study|Death|0|||
147545834|NCT00830063|532155961|FG000|Overall Study|Lost to Follow-up|0|||
147545835|NCT00830063|532155962|FG001|Overall Study|Lost to Follow-up|0|||
147545836|NCT00830063|532155963|FG002|Overall Study|Lost to Follow-up|3|||
147545837|NCT00830063|532155964|FG003|Overall Study|Lost to Follow-up|1|||
147211518|NCT00966875|530947154|FG003|Part A|Parent/Caregiver Decision|1|||
147211519|NCT00966875|530947155|FG004|Part A|Parent/Caregiver Decision|0|||
147211520|NCT00966875|530947156|FG005|Part A|Parent/Caregiver Decision|0|||
147211521|NCT00966875|530947157|FG006|Part A|Parent/Caregiver Decision|0|||
147211522|NCT00966875|530947158|FG007|Part A|Parent/Caregiver Decision|0|||
147211523|NCT00966875|530947159|FG008|Part A|Parent/Caregiver Decision|0|||
147211524|NCT00966875|530947151|FG000|Part A|Physician Decision|0|||
147211525|NCT00966875|530947152|FG001|Part A|Physician Decision|0|||
147211526|NCT00966875|530947153|FG002|Part A|Physician Decision|0|||
147211527|NCT00966875|530947154|FG003|Part A|Physician Decision|0|||
147211528|NCT00966875|530947155|FG004|Part A|Physician Decision|1|||
147211529|NCT00966875|530947156|FG005|Part A|Physician Decision|0|||
147211530|NCT00966875|530947157|FG006|Part A|Physician Decision|1|||
147211531|NCT00966875|530947158|FG007|Part A|Physician Decision|0|||
147211532|NCT00966875|530947159|FG008|Part A|Physician Decision|2|||
147211533|NCT00966875|530947151|FG000|Part A|Sponsor Decision|0|||
147211534|NCT00966875|530947152|FG001|Part A|Sponsor Decision|0|||
147545838|NCT00830063|532155961|FG000|Overall Study|Preferred Time Entry in Extension Study|119|||
147211535|NCT00966875|530947153|FG002|Part A|Sponsor Decision|1|||
147545839|NCT00830063|532155962|FG001|Overall Study|Preferred Time Entry in Extension Study|139|||
147545840|NCT00830063|532155963|FG002|Overall Study|Preferred Time Entry in Extension Study|127|||
147545841|NCT00830063|532155964|FG003|Overall Study|Preferred Time Entry in Extension Study|126|||
147545842|NCT00830063|532155961|FG000|Overall Study|Lack of Efficacy|51|||
147545843|NCT00830063|532155962|FG001|Overall Study|Lack of Efficacy|23|||
147211536|NCT00966875|530947154|FG003|Part A|Sponsor Decision|0|||
147211537|NCT00966875|530947155|FG004|Part A|Sponsor Decision|1|||
147211538|NCT00966875|530947156|FG005|Part A|Sponsor Decision|0|||
147211539|NCT00966875|530947157|FG006|Part A|Sponsor Decision|0|||
147211540|NCT00966875|530947158|FG007|Part A|Sponsor Decision|2|||
147211541|NCT00966875|530947159|FG008|Part A|Sponsor Decision|1|||
147211542|NCT00966875|530947151|FG000|Part A|Withdrawal by Subject|2|||
147545844|NCT00830063|532155963|FG002|Overall Study|Lack of Efficacy|25|||
147545845|NCT00830063|532155964|FG003|Overall Study|Lack of Efficacy|32|||
147545846|NCT00830063|532155961|FG000|Overall Study|Other|5|||
147545847|NCT00830063|532155962|FG001|Overall Study|Other|5|||
147545848|NCT00830063|532155963|FG002|Overall Study|Other|8|||
147545849|NCT00830063|532155964|FG003|Overall Study|Other|6|||
147545850|NCT00830063|532155961|FG000|Overall Study|Withdrawal by Subject|16|||
147545851|NCT00830063|532155962|FG001|Overall Study|Withdrawal by Subject|10|||
147545852|NCT00830063|532155963|FG002|Overall Study|Withdrawal by Subject|16|||
147545853|NCT00830063|532155964|FG003|Overall Study|Withdrawal by Subject|13|||
147545854|NCT00830063|532155961|FG000|Overall Study|Protocol Violation|1|||
147545855|NCT00830063|532155962|FG001|Overall Study|Protocol Violation|0|||
147545856|NCT00830063|532155963|FG002|Overall Study|Protocol Violation|3|||
147545857|NCT00830063|532155964|FG003|Overall Study|Protocol Violation|2|||
147545858|NCT00830063|532155961|FG000|Overall Study|Randomized But Not Treated|0|||
147545859|NCT00830063|532155962|FG001|Overall Study|Randomized But Not Treated|2|||
147545860|NCT00830063|532155963|FG002|Overall Study|Randomized But Not Treated|0|||
147545861|NCT00830063|532155964|FG003|Overall Study|Randomized But Not Treated|2|||
147545862|NCT02140164|532155967|FG000|Overall Study|Cystoid Macular Edema (CME) resolved|2|||
147545863|NCT01814761|532155968|FG000|Overall Study|Other Reasons|1|||
147545864|NCT01814761|532155969|FG001|Overall Study|Other Reasons|10|||
147545865|NCT01814761|532155968|FG000|Overall Study|Ocular Adverse Event|6|||
147545866|NCT01814761|532155969|FG001|Overall Study|Ocular Adverse Event|15|||
147545867|NCT01814761|532155968|FG000|Overall Study|Lost to Follow-up|1|||
147545868|NCT01814761|532155969|FG001|Overall Study|Lost to Follow-up|5|||
147545869|NCT01872689|532155984|FG000|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|0|||
147545870|NCT01872689|532155985|FG001|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|1|||
147545871|NCT01872689|532155986|FG002|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|0|||
147545872|NCT01872689|532155987|FG003|Double-Blind/Placebo-Controlled Period|Lack of Efficacy|0|||
147545873|NCT01872689|532155984|FG000|Double-Blind/Placebo-Controlled Period|Other|1|||
147545874|NCT01872689|532155985|FG001|Double-Blind/Placebo-Controlled Period|Other|1|||
147545875|NCT01872689|532155986|FG002|Double-Blind/Placebo-Controlled Period|Other|6|||
147545876|NCT01872689|532155987|FG003|Double-Blind/Placebo-Controlled Period|Other|3|||
147545877|NCT01872689|532155984|FG000|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|9|||
147545878|NCT01872689|532155985|FG001|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|8|||
147545879|NCT01872689|532155986|FG002|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|14|||
147545880|NCT01872689|532155987|FG003|Double-Blind/Placebo-Controlled Period|Withdrawal by Subject|16|||
147545881|NCT01872689|532155984|FG000|Double-Blind/Placebo-Controlled Period|Protocol Violation|0|||
147545882|NCT01872689|532155985|FG001|Double-Blind/Placebo-Controlled Period|Protocol Violation|0|||
147545883|NCT01872689|532155986|FG002|Double-Blind/Placebo-Controlled Period|Protocol Violation|1|||
147545884|NCT01872689|532155987|FG003|Double-Blind/Placebo-Controlled Period|Protocol Violation|1|||
147545885|NCT01872689|532155984|FG000|Double-Blind/Placebo-Controlled Period|Physician Decision|0|||
147545886|NCT01872689|532155985|FG001|Double-Blind/Placebo-Controlled Period|Physician Decision|3|||
147545887|NCT01872689|532155986|FG002|Double-Blind/Placebo-Controlled Period|Physician Decision|3|||
147545888|NCT01872689|532155987|FG003|Double-Blind/Placebo-Controlled Period|Physician Decision|1|||
147545889|NCT01872689|532155984|FG000|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|1|||
147211543|NCT00966875|530947152|FG001|Part A|Withdrawal by Subject|2|||
147211544|NCT00966875|530947153|FG002|Part A|Withdrawal by Subject|1|||
147211545|NCT00966875|530947154|FG003|Part A|Withdrawal by Subject|1|||
147211546|NCT00966875|530947155|FG004|Part A|Withdrawal by Subject|3|||
147211547|NCT00966875|530947156|FG005|Part A|Withdrawal by Subject|0|||
147211548|NCT00966875|530947157|FG006|Part A|Withdrawal by Subject|5|||
147211549|NCT00966875|530947158|FG007|Part A|Withdrawal by Subject|1|||
147211550|NCT00966875|530947159|FG008|Part A|Withdrawal by Subject|1|||
147211551|NCT00966875|530947151|FG000|Part A|Protocol Violation|0|||
147211552|NCT00966875|530947152|FG001|Part A|Protocol Violation|0|||
147211553|NCT00966875|530947153|FG002|Part A|Protocol Violation|0|||
147211554|NCT00966875|530947154|FG003|Part A|Protocol Violation|0|||
147211555|NCT00966875|530947155|FG004|Part A|Protocol Violation|0|||
147211556|NCT00966875|530947156|FG005|Part A|Protocol Violation|0|||
147211557|NCT00966875|530947157|FG006|Part A|Protocol Violation|2|||
147211558|NCT00966875|530947158|FG007|Part A|Protocol Violation|1|||
147211559|NCT00966875|530947159|FG008|Part A|Protocol Violation|1|||
147211560|NCT00966875|530947151|FG000|Part B|Adverse Event|0|||
147211561|NCT00966875|530947152|FG001|Part B|Adverse Event|1|||
147211562|NCT00966875|530947153|FG002|Part B|Adverse Event|1|||
147211563|NCT00966875|530947154|FG003|Part B|Adverse Event|0|||
147545890|NCT01872689|532155985|FG001|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|0|||
147545891|NCT01872689|532155986|FG002|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|0|||
147545892|NCT01872689|532155987|FG003|Double-Blind/Placebo-Controlled Period|Lost to Follow-up|1|||
147211564|NCT00966875|530947155|FG004|Part B|Adverse Event|1|||
147211565|NCT00966875|530947156|FG005|Part B|Adverse Event|0|||
147211566|NCT00966875|530947157|FG006|Part B|Adverse Event|5|||
147211567|NCT00966875|530947158|FG007|Part B|Adverse Event|2|||
147211568|NCT00966875|530947159|FG008|Part B|Adverse Event|2|||
147211569|NCT00966875|530947151|FG000|Part B|Death|0|||
147211570|NCT00966875|530947152|FG001|Part B|Death|0|||
147211571|NCT00966875|530947153|FG002|Part B|Death|1|||
147211572|NCT00966875|530947154|FG003|Part B|Death|0|||
147545893|NCT01872689|532155984|FG000|Double-Blind/Placebo-Controlled Period|Death|3|||
147545894|NCT01872689|532155985|FG001|Double-Blind/Placebo-Controlled Period|Death|4|||
147211573|NCT00966875|530947155|FG004|Part B|Death|0|||
147211574|NCT00966875|530947156|FG005|Part B|Death|0|||
147211575|NCT00966875|530947157|FG006|Part B|Death|0|||
147211576|NCT00966875|530947158|FG007|Part B|Death|1|||
147211577|NCT00966875|530947159|FG008|Part B|Death|0|||
147545895|NCT01872689|532155986|FG002|Double-Blind/Placebo-Controlled Period|Death|14|||
147545896|NCT01872689|532155987|FG003|Double-Blind/Placebo-Controlled Period|Death|9|||
147545897|NCT01872689|532155984|FG000|Double-Blind/Placebo-Controlled Period|Adverse Event|6|||
147545898|NCT01872689|532155985|FG001|Double-Blind/Placebo-Controlled Period|Adverse Event|3|||
147545899|NCT01872689|532155986|FG002|Double-Blind/Placebo-Controlled Period|Adverse Event|10|||
147545900|NCT01872689|532155987|FG003|Double-Blind/Placebo-Controlled Period|Adverse Event|7|||
147545901|NCT01872689|532155984|FG000|Open-Label Period (Only For Monotherapy)|Other|2|||
147545902|NCT01872689|532155985|FG001|Open-Label Period (Only For Monotherapy)|Other|3|||
147545903|NCT01872689|532155986|FG002|Open-Label Period (Only For Monotherapy)|Other|0|||
147545904|NCT01872689|532155987|FG003|Open-Label Period (Only For Monotherapy)|Other|0|||
147545905|NCT01872689|532155984|FG000|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|11|||
147545906|NCT01872689|532155985|FG001|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|12|||
147211578|NCT00966875|530947151|FG000|Part B|Lack of Efficacy|2|||
147211579|NCT00966875|530947152|FG001|Part B|Lack of Efficacy|1|||
147211580|NCT00966875|530947153|FG002|Part B|Lack of Efficacy|1|||
147211581|NCT00966875|530947154|FG003|Part B|Lack of Efficacy|1|||
147211582|NCT00966875|530947155|FG004|Part B|Lack of Efficacy|2|||
147211583|NCT00966875|530947156|FG005|Part B|Lack of Efficacy|3|||
147211584|NCT00966875|530947157|FG006|Part B|Lack of Efficacy|12|||
147211585|NCT00966875|530947158|FG007|Part B|Lack of Efficacy|9|||
147211586|NCT00966875|530947159|FG008|Part B|Lack of Efficacy|6|||
147211587|NCT00966875|530947151|FG000|Part B|Lost to Follow-up|0|||
147211588|NCT00966875|530947152|FG001|Part B|Lost to Follow-up|0|||
147211589|NCT00966875|530947153|FG002|Part B|Lost to Follow-up|0|||
147211590|NCT00966875|530947154|FG003|Part B|Lost to Follow-up|1|||
147211591|NCT00966875|530947155|FG004|Part B|Lost to Follow-up|0|||
147211592|NCT00966875|530947156|FG005|Part B|Lost to Follow-up|0|||
147211593|NCT00966875|530947157|FG006|Part B|Lost to Follow-up|0|||
147211594|NCT00966875|530947158|FG007|Part B|Lost to Follow-up|0|||
147211595|NCT00966875|530947159|FG008|Part B|Lost to Follow-up|1|||
147211596|NCT00966875|530947151|FG000|Part B|Physician Decision|0|||
147211597|NCT00966875|530947152|FG001|Part B|Physician Decision|0|||
147211598|NCT00966875|530947153|FG002|Part B|Physician Decision|1|||
147211599|NCT00966875|530947154|FG003|Part B|Physician Decision|0|||
147211600|NCT00966875|530947155|FG004|Part B|Physician Decision|2|||
147211601|NCT00966875|530947156|FG005|Part B|Physician Decision|1|||
147211602|NCT00966875|530947157|FG006|Part B|Physician Decision|0|||
147211603|NCT00966875|530947158|FG007|Part B|Physician Decision|0|||
147211604|NCT00966875|530947159|FG008|Part B|Physician Decision|2|||
147211605|NCT00966875|530947151|FG000|Part B|Sponsor Decision|1|||
147211606|NCT00966875|530947152|FG001|Part B|Sponsor Decision|0|||
147211607|NCT00966875|530947153|FG002|Part B|Sponsor Decision|0|||
147211608|NCT00966875|530947154|FG003|Part B|Sponsor Decision|0|||
147211609|NCT00966875|530947155|FG004|Part B|Sponsor Decision|0|||
147211610|NCT00966875|530947156|FG005|Part B|Sponsor Decision|1|||
147211611|NCT00966875|530947157|FG006|Part B|Sponsor Decision|0|||
147211612|NCT00966875|530947158|FG007|Part B|Sponsor Decision|2|||
147211613|NCT00966875|530947159|FG008|Part B|Sponsor Decision|1|||
147211614|NCT00966875|530947151|FG000|Part B|Withdrawal by Subject|2|||
147211615|NCT00966875|530947152|FG001|Part B|Withdrawal by Subject|1|||
147211616|NCT00966875|530947153|FG002|Part B|Withdrawal by Subject|2|||
147211617|NCT00966875|530947154|FG003|Part B|Withdrawal by Subject|1|||
147211618|NCT00966875|530947155|FG004|Part B|Withdrawal by Subject|2|||
147211619|NCT00966875|530947156|FG005|Part B|Withdrawal by Subject|1|||
147211620|NCT00966875|530947157|FG006|Part B|Withdrawal by Subject|4|||
147211621|NCT00966875|530947158|FG007|Part B|Withdrawal by Subject|5|||
147211622|NCT00966875|530947159|FG008|Part B|Withdrawal by Subject|5|||
147211623|NCT00966875|530947151|FG000|Part B|Entry Criteria|0|||
147211624|NCT00966875|530947152|FG001|Part B|Entry Criteria|0|||
147211625|NCT00966875|530947153|FG002|Part B|Entry Criteria|0|||
147211626|NCT00966875|530947154|FG003|Part B|Entry Criteria|0|||
147211627|NCT00966875|530947155|FG004|Part B|Entry Criteria|0|||
147545907|NCT01872689|532155986|FG002|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|0|||
147545908|NCT01872689|532155987|FG003|Open-Label Period (Only For Monotherapy)|Withdrawal by Subject|0|||
147545909|NCT01872689|532155984|FG000|Open-Label Period (Only For Monotherapy)|Physician Decision|0|||
147211628|NCT00966875|530947156|FG005|Part B|Entry Criteria|0|||
147211629|NCT00966875|530947157|FG006|Part B|Entry Criteria|1|||
147211630|NCT00966875|530947158|FG007|Part B|Entry Criteria|0|||
147211631|NCT00966875|530947159|FG008|Part B|Entry Criteria|1|||
147211632|NCT01589653|530947162|FG000|Overall Study|Protocol Violation|3|||
147211633|NCT01589653|530947163|FG001|Overall Study|Protocol Violation|1|||
147211634|NCT01589653|530947162|FG000|Overall Study|Withdrawal criteria|4|||
147211635|NCT01589653|530947163|FG001|Overall Study|Withdrawal criteria|7|||
147211636|NCT01589653|530947162|FG000|Overall Study|Unclassified|0|||
147211637|NCT01589653|530947163|FG001|Overall Study|Unclassified|3|||
147211638|NCT01536067|530947164|FG000|Overall Study|Disease Progression|1|||
147211639|NCT00606905|530947167|FG000|Overall Study|No Pregnancy|9|||
147211640|NCT00606905|530947168|FG001|Overall Study|No Pregnancy|6|||
147211641|NCT00606905|530947167|FG000|Overall Study|Non-Index Pregnancy|1|||
147211642|NCT00606905|530947168|FG001|Overall Study|Non-Index Pregnancy|4|||
147211643|NCT00606905|530947167|FG000|Overall Study|Withdrew|5|||
147211644|NCT00606905|530947168|FG001|Overall Study|Withdrew|5|||
147211645|NCT02386189|530947169|FG000|Overall Study|Lost to Follow-up|2|||
147211646|NCT02386189|530947170|FG001|Overall Study|Lost to Follow-up|3|||
147211647|NCT02386189|530947169|FG000|Overall Study|Withdrawal by Subject|1|||
147211648|NCT02386189|530947170|FG001|Overall Study|Withdrawal by Subject|0|||
147211649|NCT02386189|530947169|FG000|Overall Study|Death|1|||
147211650|NCT02386189|530947170|FG001|Overall Study|Death|0|||
147211651|NCT04657666|530947171|FG000|Period 1|Withdrawal of participant consent|2|||
147211652|NCT04657666|530947172|FG001|Period 1|Withdrawal of participant consent|1|||
147211653|NCT04657666|530947171|FG000|Period 1|Withdrawn/discontinued due to AE|1|||
147211654|NCT04657666|530947172|FG001|Period 1|Withdrawn/discontinued due to AE|0|||
147211655|NCT04657666|530947171|FG000|Period 1|Administrative decision by investigator, GW, or a regulatory authority|0|||
147211656|NCT04657666|530947172|FG001|Period 1|Administrative decision by investigator, GW, or a regulatory authority|1|||
147211657|NCT04657666|530947171|FG000|Period 2|Other|2|||
147211658|NCT04657666|530947172|FG001|Period 2|Other|0|||
147211659|NCT04657666|530947171|FG000|Period 2|Withdrawn/discontinued due to AE|0|||
147211660|NCT04657666|530947172|FG001|Period 2|Withdrawn/discontinued due to AE|3|||
147211661|NCT03120351|530947173|FG000|Overall Study|Physician Decision|1|||
147211662|NCT03120351|530947174|FG001|Overall Study|Physician Decision|1|||
147211663|NCT04250077|530947183|FG000|Overall Study|Withdrawal by Subject|0|||
147211664|NCT04250077|530947184|FG001|Overall Study|Withdrawal by Subject|1|||
147211665|NCT04250077|530947185|FG002|Overall Study|Withdrawal by Subject|0|||
147211666|NCT04250077|530947183|FG000|Overall Study|Lost to Follow-up|2|||
147211667|NCT04250077|530947184|FG001|Overall Study|Lost to Follow-up|3|||
147211668|NCT04250077|530947185|FG002|Overall Study|Lost to Follow-up|0|||
147211669|NCT01022398|530947186|FG000|Overall Study|Study terminated|2|||
147211670|NCT01022398|530947187|FG001|Overall Study|Study terminated|2|||
147211671|NCT03319745|530947189|FG000|Overall Study|Death|1|||
147211672|NCT03319745|530947189|FG000|Overall Study|Toxicity Precluding Surgery|1|||
147211673|NCT00870103|530947190|FG000|Overall Study|Physician Decision|2|||
147211674|NCT00870103|530947190|FG000|Overall Study|Lost to Follow-up|2|||
147211675|NCT01317550|530947191|FG000|Overall Study|Withdrawal by Subject|1|||
147211676|NCT01317550|530947192|FG001|Overall Study|Withdrawal by Subject|0|||
147211677|NCT01317550|530947193|FG002|Overall Study|Withdrawal by Subject|0|||
147211678|NCT01317550|530947194|FG003|Overall Study|Withdrawal by Subject|0|||
147211679|NCT01317550|530947191|FG000|Overall Study|Lack of compliance study med|1|||
147211680|NCT01317550|530947192|FG001|Overall Study|Lack of compliance study med|0|||
147211681|NCT01317550|530947193|FG002|Overall Study|Lack of compliance study med|0|||
147211682|NCT01317550|530947194|FG003|Overall Study|Lack of compliance study med|0|||
147211683|NCT03255629|530947195|FG000|Overall Study|Adverse Event|1|||
147211684|NCT03255629|530947196|FG001|Overall Study|Adverse Event|0|||
147211685|NCT03255629|530947195|FG000|Overall Study|did not experience hypoglycemia|2|||
147211686|NCT03255629|530947196|FG001|Overall Study|did not experience hypoglycemia|1|||
147211687|NCT04540198|530947197|FG000|Overall Study|Lost to Follow-up|25|||
147211688|NCT04540198|530947198|FG001|Overall Study|Lost to Follow-up|23|||
147211689|NCT04540198|530947197|FG000|Overall Study|Withdrawal by Subject|15|||
147211690|NCT04540198|530947198|FG001|Overall Study|Withdrawal by Subject|9|||
147211691|NCT04540198|530947197|FG000|Overall Study|Discontinued|1|||
147211692|NCT04540198|530947198|FG001|Overall Study|Discontinued|0|||
147211693|NCT01086358|530947199|FG000|First Intervention|Lost to Follow-up|9|||
147211694|NCT01086358|530947200|FG001|First Intervention|Lost to Follow-up|4|||
147211695|NCT01086358|530947199|FG000|First Intervention|Withdrawal by Subject|0|||
147211696|NCT01086358|530947200|FG001|First Intervention|Withdrawal by Subject|1|||
147211697|NCT01086358|530947199|FG000|Second Intervention|Lost to Follow-up|4|||
147211698|NCT01086358|530947200|FG001|Second Intervention|Lost to Follow-up|4|||
147211699|NCT03330002|530947204|FG000|Overall Study|Lost to Follow-up|15|||
147211700|NCT03330002|530947204|FG000|Overall Study|Death|7|||
147211701|NCT00833417|530947205|FG000|Overall Study|Adverse Event|5|||
147211702|NCT00833417|530947206|FG001|Overall Study|Adverse Event|16|||
147211703|NCT00833417|530947205|FG000|Overall Study|Death|1|||
147211704|NCT00833417|530947206|FG001|Overall Study|Death|3|||
147211705|NCT00833417|530947205|FG000|Overall Study|Lost to Follow-up|1|||
147211706|NCT00833417|530947206|FG001|Overall Study|Lost to Follow-up|2|||
147211707|NCT00833417|530947205|FG000|Overall Study|Physician Decision to Withdraw Patient|3|||
147211708|NCT00833417|530947206|FG001|Overall Study|Physician Decision to Withdraw Patient|7|||
147211709|NCT00833417|530947205|FG000|Overall Study|Patient Decision to Withdraw|4|||
147211710|NCT00833417|530947206|FG001|Overall Study|Patient Decision to Withdraw|23|||
147211711|NCT00833417|530947205|FG000|Overall Study|Sponsor Decision to Terminate Study|1|||
147211712|NCT00833417|530947206|FG001|Overall Study|Sponsor Decision to Terminate Study|2|||
147211713|NCT00833417|530947205|FG000|Overall Study|Disease Progression|18|||
147211714|NCT00833417|530947206|FG001|Overall Study|Disease Progression|17|||
147211715|NCT00833417|530947205|FG000|Overall Study|Reason Not Specified|0|||
147211716|NCT00833417|530947206|FG001|Overall Study|Reason Not Specified|1|||
147211717|NCT01625260|530947207|FG000|Overall Study|Adverse Event|3|||
147545910|NCT01872689|532155985|FG001|Open-Label Period (Only For Monotherapy)|Physician Decision|1|||
147211718|NCT01625260|530947208|FG001|Overall Study|Adverse Event|0|||
147211719|NCT01625260|530947207|FG000|Overall Study|Study Terminated by Investigator|2|||
147211720|NCT01625260|530947208|FG001|Overall Study|Study Terminated by Investigator|0|||
147211721|NCT01625260|530947207|FG000|Overall Study|Disease Progression|2|||
147211722|NCT01625260|530947208|FG001|Overall Study|Disease Progression|0|||
147211723|NCT01625260|530947207|FG000|Overall Study|PI and subject decided to terminate treatment|0|||
147211724|NCT01625260|530947208|FG001|Overall Study|PI and subject decided to terminate treatment|1|||
147211725|NCT03899805|530947209|FG000|Overall Study|Physician Decision|3|||
147211726|NCT03899805|530947210|FG001|Overall Study|Physician Decision|0|||
147211727|NCT03899805|530947211|FG002|Overall Study|Physician Decision|2|||
147211728|NCT03899805|530947209|FG000|Overall Study|Withdrawal by Subject|1|||
147211729|NCT03899805|530947210|FG001|Overall Study|Withdrawal by Subject|0|||
147211730|NCT03899805|530947211|FG002|Overall Study|Withdrawal by Subject|2|||
147211731|NCT03899805|530947209|FG000|Overall Study|Progressive Disease|10|||
147211732|NCT03899805|530947210|FG001|Overall Study|Progressive Disease|18|||
147211733|NCT03899805|530947211|FG002|Overall Study|Progressive Disease|12|||
147211734|NCT03899805|530947209|FG000|Overall Study|Adverse Event|3|||
147211735|NCT03899805|530947210|FG001|Overall Study|Adverse Event|1|||
147211736|NCT03899805|530947211|FG002|Overall Study|Adverse Event|0|||
147211737|NCT03899805|530947209|FG000|Overall Study|Death|2|||
147211738|NCT03899805|530947210|FG001|Overall Study|Death|0|||
147211739|NCT03899805|530947211|FG002|Overall Study|Death|0|||
147211740|NCT03899805|530947209|FG000|Overall Study|Came off for surgery|0|||
147211741|NCT03899805|530947210|FG001|Overall Study|Came off for surgery|0|||
147211742|NCT03899805|530947211|FG002|Overall Study|Came off for surgery|1|||
147211743|NCT01776307|530947216|FG000|Overall Study|Not dosed|0|||
147211744|NCT01776307|530947217|FG001|Overall Study|Not dosed|0|||
147211745|NCT01776307|530947218|FG002|Overall Study|Not dosed|1|||
147211746|NCT03679754|530947222|FG000|Overall Study|Investigator request|1|||
147211747|NCT00964171|530947223|FG000|Overall Study|Death|5|||
147211748|NCT02872935|530947226|FG000|Overall Study|Other|0|||
147211749|NCT02872935|530947227|FG001|Overall Study|Other|1|||
147211750|NCT02640508|530947228|FG000|Overall Study|Death|19|||
147211751|NCT02640508|530947228|FG000|Overall Study|Withdrawal by Subject|8|||
147211752|NCT02640508|530947228|FG000|Overall Study|Physician Decision|1|||
147211753|NCT02640508|530947228|FG000|Overall Study|Lost to Follow-up|1|||
147211754|NCT00862082|530947229|FG000|Overall Study|Sponsor decision to terminate the study|5|||
147211755|NCT00862082|530947230|FG001|Overall Study|Sponsor decision to terminate the study|0|||
147211756|NCT00862082|530947229|FG000|Overall Study|Withdrawal by Subject|0|||
147211757|NCT00862082|530947230|FG001|Overall Study|Withdrawal by Subject|1|||
147211758|NCT05405257|530947231|FG000|Overall Study|Withdrawal by Subject|1|||
147211759|NCT00862641|530947235|FG000|Overall Study|Randomized, but drug not received|1|||
147211760|NCT00862641|530947236|FG001|Overall Study|Randomized, but drug not received|4|||
147211761|NCT00862641|530947237|FG002|Overall Study|Randomized, but drug not received|1|||
147211762|NCT00862641|530947238|FG003|Overall Study|Randomized, but drug not received|4|||
147211763|NCT03179605|530947239|FG000|Overall Study|Withdrawal by Subject|1|||
147211764|NCT00635999|530947240|FG000|Overall Study|Withdrawal by Subject|4|||
147211765|NCT00635999|530947241|FG001|Overall Study|Withdrawal by Subject|2|||
147211766|NCT00635999|530947242|FG002|Overall Study|Withdrawal by Subject|1|||
147211767|NCT00711477|530947243|FG000|Overall Study|Adverse Event|3|||
147211768|NCT00711477|530947244|FG001|Overall Study|Adverse Event|1|||
147211769|NCT00711477|530947243|FG000|Overall Study|Lost to Follow-up|0|||
147211770|NCT00711477|530947244|FG001|Overall Study|Lost to Follow-up|1|||
147211771|NCT00711477|530947243|FG000|Overall Study|Noncompliance|0|||
147211772|NCT00711477|530947244|FG001|Overall Study|Noncompliance|1|||
147211773|NCT03037580|530947245|FG000|Overall Study|Withdrawal by Subject|3|||
147211774|NCT03037580|530947246|FG001|Overall Study|Withdrawal by Subject|0|||
147211775|NCT03037580|530947245|FG000|Overall Study|Adverse Event|1|||
147211776|NCT03037580|530947246|FG001|Overall Study|Adverse Event|0|||
147211777|NCT03037580|530947245|FG000|Overall Study|Study Terminated by Sponsor|12|||
147211778|NCT03037580|530947246|FG001|Overall Study|Study Terminated by Sponsor|15|||
147211779|NCT03037580|530947245|FG000|Overall Study|Death|0|||
147211780|NCT03037580|530947246|FG001|Overall Study|Death|1|||
147211781|NCT02873429|530947247|FG000|6-8 Weeks|Missed 6-8 week, eligible for 16 week|10|||
147211782|NCT02873429|530947248|FG001|6-8 Weeks|Missed 6-8 week, eligible for 16 week|1|||
147211783|NCT02873429|530947247|FG000|16 Weeks|Completed 6-8 week, missed 16 week|2|||
147211784|NCT02873429|530947248|FG001|16 Weeks|Completed 6-8 week, missed 16 week|2|||
147211785|NCT02873429|530947247|FG000|16 Weeks|Lost to Follow-up|3|||
147211786|NCT02873429|530947248|FG001|16 Weeks|Lost to Follow-up|0|||
147211787|NCT00853567|530947250|FG000|Overall Study|Study prematurely terminated|71|||
147211788|NCT00782834|530947251|FG000|Treatment Phase|fibrous tumor not GIST|1|||
147211789|NCT02259088|530947252|FG000|Overall Study|Adverse Event|6|||
147211790|NCT02259088|530947253|FG001|Overall Study|Adverse Event|4|||
147211791|NCT02259088|530947252|FG000|Overall Study|Lost to Follow-up|2|||
147211792|NCT02259088|530947253|FG001|Overall Study|Lost to Follow-up|0|||
147211793|NCT02259088|530947252|FG000|Overall Study|Death|2|||
147211794|NCT02259088|530947253|FG001|Overall Study|Death|0|||
147211795|NCT02259088|530947252|FG000|Overall Study|Physician Decision|5|||
147211796|NCT02259088|530947253|FG001|Overall Study|Physician Decision|2|||
147211797|NCT02259088|530947252|FG000|Overall Study|Protocol deviation|5|||
147211798|NCT02259088|530947253|FG001|Overall Study|Protocol deviation|0|||
147211799|NCT02259088|530947252|FG000|Overall Study|Subject/guardian decision|8|||
147211800|NCT02259088|530947253|FG001|Overall Study|Subject/guardian decision|8|||
147211801|NCT01818752|530947254|FG000|Overall Study|Adverse Event|64|||
147211802|NCT01818752|530947255|FG001|Overall Study|Adverse Event|74|||
147211803|NCT01818752|530947254|FG000|Overall Study|Death|14|||
147211804|NCT01818752|530947255|FG001|Overall Study|Death|18|||
147211805|NCT01818752|530947254|FG000|Overall Study|Non-compliance|16|||
147211806|NCT01818752|530947255|FG001|Overall Study|Non-compliance|20|||
147211807|NCT01818752|530947254|FG000|Overall Study|Withdrawal by Subject|15|||
147211808|NCT01818752|530947255|FG001|Overall Study|Withdrawal by Subject|14|||
147211809|NCT01818752|530947254|FG000|Overall Study|Physician Decision|9|||
147211810|NCT01818752|530947255|FG001|Overall Study|Physician Decision|8|||
147211811|NCT01818752|530947254|FG000|Overall Study|Disease Progression|54|||
147211812|NCT01818752|530947255|FG001|Overall Study|Disease Progression|48|||
147211813|NCT01818752|530947254|FG000|Overall Study|Other|7|||
147211814|NCT01818752|530947255|FG001|Overall Study|Other|8|||
147211815|NCT01818752|530947254|FG000|Overall Study|Continuing Treatment|1|||
147211816|NCT01818752|530947255|FG001|Overall Study|Continuing Treatment|4|||
147211817|NCT01818752|530947254|FG000|Overall Study|Randomized but not Dosed|7|||
147211818|NCT01818752|530947255|FG001|Overall Study|Randomized but not Dosed|4|||
147211819|NCT04270370|530947256|FG000|Overall Study|Lost to Follow-up|1|||
147211820|NCT04270370|530947257|FG001|Overall Study|Lost to Follow-up|0|||
147211821|NCT04270370|530947258|FG002|Overall Study|Lost to Follow-up|0|||
147211822|NCT04270370|530947259|FG003|Overall Study|Lost to Follow-up|0|||
147211823|NCT04270370|530947260|FG004|Overall Study|Lost to Follow-up|0|||
147211824|NCT04270370|530947261|FG005|Overall Study|Lost to Follow-up|0|||
147211825|NCT04270370|530947262|FG006|Overall Study|Lost to Follow-up|0|||
147211826|NCT04270370|530947263|FG007|Overall Study|Lost to Follow-up|0|||
147211827|NCT04270370|530947264|FG008|Overall Study|Lost to Follow-up|1|||
147211828|NCT04270370|530947265|FG009|Overall Study|Lost to Follow-up|0|||
147211829|NCT04270370|530947266|FG010|Overall Study|Lost to Follow-up|0|||
147211830|NCT04270370|530947267|FG011|Overall Study|Lost to Follow-up|0|||
147211831|NCT01324141|530947268|FG000|Overall Study|Declined to participate before treatment started|1|||
147211832|NCT01324141|530947268|FG000|Overall Study|Disease progression on study|1|||
147211833|NCT02745080|530947269|FG000|Overall Study|Adverse Event|13|||
147211834|NCT02745080|530947270|FG001|Overall Study|Adverse Event|21|||
147211835|NCT02745080|530947269|FG000|Overall Study|Lack of Efficacy|11|||
147211836|NCT02745080|530947270|FG001|Overall Study|Lack of Efficacy|23|||
147211837|NCT02745080|530947269|FG000|Overall Study|Lost to Follow-up|3|||
147211838|NCT02745080|530947270|FG001|Overall Study|Lost to Follow-up|3|||
147211839|NCT02745080|530947269|FG000|Overall Study|Physician Decision|3|||
147545911|NCT01872689|532155986|FG002|Open-Label Period (Only For Monotherapy)|Physician Decision|0|||
147545912|NCT01872689|532155987|FG003|Open-Label Period (Only For Monotherapy)|Physician Decision|0|||
147545913|NCT01872689|532155984|FG000|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|1|||
147545914|NCT01872689|532155985|FG001|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|3|||
147545915|NCT01872689|532155986|FG002|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|0|||
147545916|NCT01872689|532155987|FG003|Open-Label Period (Only For Monotherapy)|Lost to Follow-up|0|||
147545917|NCT01872689|532155984|FG000|Open-Label Period (Only For Monotherapy)|Death|5|||
147545918|NCT01872689|532155985|FG001|Open-Label Period (Only For Monotherapy)|Death|3|||
147545919|NCT01872689|532155986|FG002|Open-Label Period (Only For Monotherapy)|Death|0|||
147545920|NCT01872689|532155987|FG003|Open-Label Period (Only For Monotherapy)|Death|0|||
147545921|NCT01872689|532155984|FG000|Open-Label Period (Only For Monotherapy)|Adverse Event|2|||
147545922|NCT01872689|532155985|FG001|Open-Label Period (Only For Monotherapy)|Adverse Event|1|||
147545923|NCT01872689|532155986|FG002|Open-Label Period (Only For Monotherapy)|Adverse Event|0|||
147545924|NCT01872689|532155987|FG003|Open-Label Period (Only For Monotherapy)|Adverse Event|0|||
147545925|NCT00660790|532155990|FG000|Baseline to 3 Months|Death|1|||
147211840|NCT02745080|530947270|FG001|Overall Study|Physician Decision|0|||
147211841|NCT02745080|530947269|FG000|Overall Study|Protocol Violation|3|||
147211842|NCT02745080|530947270|FG001|Overall Study|Protocol Violation|1|||
147211843|NCT02745080|530947269|FG000|Overall Study|Withdrawal by Subject|22|||
147211844|NCT02745080|530947270|FG001|Overall Study|Withdrawal by Subject|41|||
147211845|NCT01001325|530947272|FG000|Overall Study|Lost to Follow-up|16|||
147211846|NCT01001325|530947273|FG001|Overall Study|Lost to Follow-up|10|||
147211847|NCT01001325|530947272|FG000|Overall Study|Protocol Violation|2|||
147211848|NCT01001325|530947273|FG001|Overall Study|Protocol Violation|0|||
147211849|NCT02051933|530948954|FG000|Overall Study|Physician Decision|0|||
147211850|NCT02051933|530948955|FG001|Overall Study|Physician Decision|1|||
147211851|NCT00588861|530948959|FG000|Pre-Operative|Patients Did Not Complete Preop Data|95|||
147211852|NCT00588861|530948960|FG001|Pre-Operative|Patients Did Not Complete Preop Data|86|||
147211853|NCT00588861|530948959|FG000|6 Months|Patients did not return for follow-up|98|||
147211854|NCT00588861|530948960|FG001|6 Months|Patients did not return for follow-up|73|||
147545926|NCT00660790|532155990|FG000|Baseline to 3 Months|Withdrawal by Subject|2|||
147545927|NCT00660790|532155990|FG000|3 Months to 2 Years|Withdrawal by Subject|17|||
147545928|NCT00686374|532155995|FG000|Overall Study|Lack of Efficacy|10|||
147545929|NCT00686374|532155995|FG000|Overall Study|Adverse Event|8|||
147545930|NCT00686374|532155995|FG000|Overall Study|Withdrew consent|5|||
147545931|NCT00686374|532155995|FG000|Overall Study|Lost to Follow-up|1|||
147545932|NCT00686374|532155995|FG000|Overall Study|Missing reason|33|||
147545933|NCT00686374|532155995|FG000|Overall Study|Other, not specified|4|||
147545934|NCT02143947|532155996|FG000|Overall Study|Lost to Follow-up|4|||
147545935|NCT02143947|532155997|FG001|Overall Study|Lost to Follow-up|2|||
147545936|NCT01244815|532156000|FG000|Overall Study|Not Treated|0|||
147545937|NCT01244815|532156001|FG001|Overall Study|Not Treated|1|||
147545938|NCT01244815|532156002|FG002|Overall Study|Not Treated|0|||
147545939|NCT01244815|532156003|FG003|Overall Study|Not Treated|0|||
147545940|NCT01244815|532156000|FG000|Overall Study|Adverse Event|4|||
147545941|NCT01244815|532156001|FG001|Overall Study|Adverse Event|7|||
147545942|NCT01244815|532156002|FG002|Overall Study|Adverse Event|5|||
147545943|NCT01244815|532156003|FG003|Overall Study|Adverse Event|5|||
147545944|NCT01244815|532156000|FG000|Overall Study|Treatment Failure|0|||
147545945|NCT01244815|532156001|FG001|Overall Study|Treatment Failure|0|||
147545946|NCT01244815|532156002|FG002|Overall Study|Treatment Failure|0|||
147545947|NCT01244815|532156003|FG003|Overall Study|Treatment Failure|1|||
147211855|NCT00588861|530948959|FG000|1 Year|Patients did not return for follow-up|89|||
147211856|NCT00588861|530948960|FG001|1 Year|Patients did not return for follow-up|82|||
147211857|NCT00588861|530948959|FG000|2 Years|Patients did not return for follow-up|92|||
147211858|NCT00588861|530948960|FG001|2 Years|Patients did not return for follow-up|87|||
147211859|NCT00588861|530948959|FG000|4 Years|Patients did not return for follow-up|91|||
147211860|NCT00588861|530948960|FG001|4 Years|Patients did not return for follow-up|103|||
147211861|NCT00588861|530948959|FG000|6 Years|Patients did not return for follow-up|104|||
147211862|NCT00588861|530948960|FG001|6 Years|Patients did not return for follow-up|109|||
147211863|NCT00588861|530948959|FG000|8 Years|Patients did not return for follow-up|105|||
147211864|NCT00588861|530948960|FG001|8 Years|Patients did not return for follow-up|114|||
147211865|NCT00588861|530948959|FG000|10 Years|Incomplete due to study termination|107|||
147211866|NCT00588861|530948960|FG001|10 Years|Incomplete due to study termination|114|||
147211867|NCT03254459|530948966|FG000|Overall Study|Adverse Event|7|||
147211868|NCT03254459|530948967|FG001|Overall Study|Adverse Event|20|||
147211869|NCT03254459|530948966|FG000|Overall Study|Withdrawal by Subject Consent|3|||
147211870|NCT03254459|530948967|FG001|Overall Study|Withdrawal by Subject Consent|1|||
147211871|NCT03254459|530948966|FG000|Overall Study|Lost to Follow-up|0|||
147211872|NCT03254459|530948967|FG001|Overall Study|Lost to Follow-up|1|||
147211873|NCT03254459|530948966|FG000|Overall Study|Miscellaneous|0|||
147211874|NCT03254459|530948967|FG001|Overall Study|Miscellaneous|1|||
147211875|NCT03745820|530948969|FG000|Overall Study|Adverse Event|0|||
147211876|NCT03745820|530948970|FG001|Overall Study|Adverse Event|3|||
147211877|NCT03745820|530948971|FG002|Overall Study|Adverse Event|2|||
147211878|NCT03745820|530948969|FG000|Overall Study|Non-Compliance with Study Drug|4|||
147211879|NCT03745820|530948970|FG001|Overall Study|Non-Compliance with Study Drug|3|||
147211880|NCT03745820|530948971|FG002|Overall Study|Non-Compliance with Study Drug|0|||
147211881|NCT03745820|530948969|FG000|Overall Study|Withdrawal by Subject|4|||
147211882|NCT03745820|530948970|FG001|Overall Study|Withdrawal by Subject|4|||
147211883|NCT03745820|530948971|FG002|Overall Study|Withdrawal by Subject|4|||
147211884|NCT03745820|530948969|FG000|Overall Study|Physician decision unrelated to safety/efficacy|0|||
147211885|NCT03745820|530948970|FG001|Overall Study|Physician decision unrelated to safety/efficacy|0|||
147211886|NCT03745820|530948971|FG002|Overall Study|Physician decision unrelated to safety/efficacy|4|||
147211887|NCT03745820|530948969|FG000|Overall Study|Lost to Follow-up|2|||
147211888|NCT03745820|530948970|FG001|Overall Study|Lost to Follow-up|0|||
147211889|NCT03745820|530948971|FG002|Overall Study|Lost to Follow-up|3|||
147211890|NCT03745820|530948969|FG000|Overall Study|Reason not Specified|2|||
147211891|NCT03745820|530948970|FG001|Overall Study|Reason not Specified|4|||
147211892|NCT03745820|530948971|FG002|Overall Study|Reason not Specified|1|||
147211893|NCT03317405|530948972|FG000|Overall Study|Withdrawal by Subject|1|||
147211894|NCT03317405|530948973|FG001|Overall Study|Withdrawal by Subject|0|||
147211895|NCT03317405|530948974|FG002|Overall Study|Withdrawal by Subject|0|||
147211896|NCT03317405|530948972|FG000|Overall Study|Physician Decision|0|||
147211897|NCT03317405|530948973|FG001|Overall Study|Physician Decision|0|||
147211898|NCT03317405|530948974|FG002|Overall Study|Physician Decision|1|||
147211899|NCT03317405|530948972|FG000|Overall Study|Surgery Rescheduled|0|||
147545948|NCT01244815|532156000|FG000|Overall Study|Lost to Follow-up|3|||
147545949|NCT01244815|532156001|FG001|Overall Study|Lost to Follow-up|2|||
147545950|NCT01244815|532156002|FG002|Overall Study|Lost to Follow-up|3|||
147545951|NCT01244815|532156003|FG003|Overall Study|Lost to Follow-up|2|||
147545952|NCT01244815|532156000|FG000|Overall Study|Withdrawal by Subject|0|||
147211900|NCT03317405|530948973|FG001|Overall Study|Surgery Rescheduled|1|||
147211901|NCT03317405|530948974|FG002|Overall Study|Surgery Rescheduled|0|||
147211902|NCT04075734|530948975|FG000|Overall Study|Lost to Follow-up|1|||
147211903|NCT04075734|530948976|FG001|Overall Study|Lost to Follow-up|1|||
147211904|NCT04075734|530948977|FG002|Overall Study|Lost to Follow-up|0|||
147545953|NCT01244815|532156001|FG001|Overall Study|Withdrawal by Subject|2|||
147545954|NCT01244815|532156002|FG002|Overall Study|Withdrawal by Subject|0|||
147545955|NCT01244815|532156003|FG003|Overall Study|Withdrawal by Subject|3|||
147545956|NCT01244815|532156000|FG000|Overall Study|Protocol Violation|7|||
147545957|NCT01244815|532156001|FG001|Overall Study|Protocol Violation|4|||
147545958|NCT01244815|532156002|FG002|Overall Study|Protocol Violation|3|||
147545959|NCT01244815|532156003|FG003|Overall Study|Protocol Violation|1|||
147545960|NCT01244815|532156000|FG000|Overall Study|Did Not Meet Protocol Eligibility|0|||
147211905|NCT04075734|530948975|FG000|Overall Study|Withdrawal by Subject|3|||
147211906|NCT04075734|530948976|FG001|Overall Study|Withdrawal by Subject|0|||
147211907|NCT04075734|530948977|FG002|Overall Study|Withdrawal by Subject|0|||
147211908|NCT01137604|530948978|FG000|Overall Study|Adverse Event|3|||
147211909|NCT01137604|530948979|FG001|Overall Study|Adverse Event|6|||
147211910|NCT01137604|530948980|FG002|Overall Study|Adverse Event|9|||
147211911|NCT01137604|530948981|FG003|Overall Study|Adverse Event|9|||
147211912|NCT01137604|530948978|FG000|Overall Study|Participant Choice|0|||
147211913|NCT01137604|530948979|FG001|Overall Study|Participant Choice|2|||
147211914|NCT01137604|530948980|FG002|Overall Study|Participant Choice|2|||
147211915|NCT01137604|530948981|FG003|Overall Study|Participant Choice|0|||
147211916|NCT01137604|530948978|FG000|Overall Study|Withdrawal of consent|0|||
147211917|NCT01137604|530948979|FG001|Overall Study|Withdrawal of consent|0|||
147211918|NCT01137604|530948980|FG002|Overall Study|Withdrawal of consent|0|||
147211919|NCT01137604|530948981|FG003|Overall Study|Withdrawal of consent|2|||
147211920|NCT01137604|530948978|FG000|Overall Study|Clinical progression/deterioration|1|||
147211921|NCT01137604|530948979|FG001|Overall Study|Clinical progression/deterioration|2|||
147211922|NCT01137604|530948980|FG002|Overall Study|Clinical progression/deterioration|2|||
147211923|NCT01137604|530948981|FG003|Overall Study|Clinical progression/deterioration|0|||
147211924|NCT00591318|530948982|FG000|Overall Study|Lack of Efficacy|2|||
147211925|NCT00591318|530948983|FG001|Overall Study|Lack of Efficacy|0|||
147211926|NCT00591318|530948982|FG000|Overall Study|Adverse Event|2|||
147211927|NCT00591318|530948983|FG001|Overall Study|Adverse Event|0|||
147211928|NCT01024309|530948989|FG000|Overall Study|Physician Decision|4|||
147211929|NCT01024309|530948990|FG001|Overall Study|Physician Decision|0|||
147211930|NCT01024309|530948989|FG000|Overall Study|Withdrawal by Subject|4|||
147211931|NCT01024309|530948990|FG001|Overall Study|Withdrawal by Subject|4|||
147211932|NCT02745145|530948993|FG000|Overall Study|Adverse Event|1|||
147211933|NCT02745145|530948994|FG001|Overall Study|Adverse Event|0|||
147211934|NCT02745145|530948995|FG002|Overall Study|Adverse Event|0|||
147211935|NCT02745145|530948993|FG000|Overall Study|Death|0|||
147211936|NCT02745145|530948994|FG001|Overall Study|Death|1|||
147211937|NCT02745145|530948995|FG002|Overall Study|Death|0|||
147211938|NCT02745145|530948993|FG000|Overall Study|Progressive disease|0|||
147211939|NCT02745145|530948994|FG001|Overall Study|Progressive disease|0|||
147211940|NCT02745145|530948995|FG002|Overall Study|Progressive disease|1|||
147211941|NCT02745145|530948993|FG000|Overall Study|Withdrew consent|1|||
147211942|NCT02745145|530948994|FG001|Overall Study|Withdrew consent|1|||
147211943|NCT02745145|530948995|FG002|Overall Study|Withdrew consent|1|||
147211944|NCT02745145|530948993|FG000|Overall Study|Study Termination|8|||
147211945|NCT02745145|530948994|FG001|Overall Study|Study Termination|3|||
147211946|NCT02745145|530948995|FG002|Overall Study|Study Termination|7|||
147211947|NCT03083990|530948996|FG000|Overall Study|Adverse Event|1|||
147211948|NCT03083990|530948997|FG001|Overall Study|Adverse Event|0|||
147211949|NCT01018810|530948998|FG000|Overall Study|Withdrawal by Subject|0|||
147211950|NCT01018810|530948999|FG001|Overall Study|Withdrawal by Subject|1|||
147211951|NCT01018810|530949000|FG002|Overall Study|Withdrawal by Subject|0|||
147211952|NCT01018810|530949001|FG003|Overall Study|Withdrawal by Subject|0|||
147211953|NCT01018810|530949002|FG004|Overall Study|Withdrawal by Subject|0|||
147211954|NCT01018810|530948998|FG000|Overall Study|Sponsor Decision|2|||
147211955|NCT01018810|530948999|FG001|Overall Study|Sponsor Decision|0|||
147211956|NCT01018810|530949000|FG002|Overall Study|Sponsor Decision|1|||
147211957|NCT01018810|530949001|FG003|Overall Study|Sponsor Decision|1|||
147211958|NCT01018810|530949002|FG004|Overall Study|Sponsor Decision|1|||
147211959|NCT02424578|530949003|FG000|Overall Study|Withdrawal by Subject|0|||
147545961|NCT01244815|532156001|FG001|Overall Study|Did Not Meet Protocol Eligibility|1|||
147211960|NCT02424578|530949004|FG001|Overall Study|Withdrawal by Subject|1|||
147211961|NCT00776919|530949005|FG000|Overall Study|Withdrawal by Subject|16|||
147211962|NCT00776919|530949006|FG001|Overall Study|Withdrawal by Subject|14|||
147211963|NCT00776919|530949007|FG002|Overall Study|Withdrawal by Subject|15|||
147211964|NCT00776919|530949008|FG003|Overall Study|Withdrawal by Subject|26|||
147211965|NCT00776919|530949005|FG000|Overall Study|Lost to Follow-up|8|||
147211966|NCT00776919|530949006|FG001|Overall Study|Lost to Follow-up|12|||
147211967|NCT00776919|530949007|FG002|Overall Study|Lost to Follow-up|11|||
147545962|NCT01244815|532156002|FG002|Overall Study|Did Not Meet Protocol Eligibility|0|||
147211968|NCT00776919|530949008|FG003|Overall Study|Lost to Follow-up|8|||
147211969|NCT00776919|530949005|FG000|Overall Study|Adverse Event|1|||
147211970|NCT00776919|530949006|FG001|Overall Study|Adverse Event|0|||
147211971|NCT00776919|530949007|FG002|Overall Study|Adverse Event|2|||
147211972|NCT00776919|530949008|FG003|Overall Study|Adverse Event|2|||
147211973|NCT00776919|530949005|FG000|Overall Study|Protocol Violation|1|||
147211974|NCT00776919|530949006|FG001|Overall Study|Protocol Violation|2|||
147211975|NCT00776919|530949007|FG002|Overall Study|Protocol Violation|0|||
147211976|NCT00776919|530949008|FG003|Overall Study|Protocol Violation|1|||
147211977|NCT00776919|530949005|FG000|Overall Study|Other: Lack of Efficacy/Lost Medication|1|||
147211978|NCT00776919|530949006|FG001|Overall Study|Other: Lack of Efficacy/Lost Medication|5|||
147211979|NCT00776919|530949007|FG002|Overall Study|Other: Lack of Efficacy/Lost Medication|4|||
147211980|NCT00776919|530949008|FG003|Overall Study|Other: Lack of Efficacy/Lost Medication|2|||
147211981|NCT03116152|530949009|FG000|Overall Study|Disease Progression|49|||
147211982|NCT03116152|530949010|FG001|Overall Study|Disease Progression|47|||
147211983|NCT03116152|530949009|FG000|Overall Study|Death|5|||
147211984|NCT03116152|530949010|FG001|Overall Study|Death|2|||
147211985|NCT03116152|530949009|FG000|Overall Study|Adverse Event|21|||
147211986|NCT03116152|530949010|FG001|Overall Study|Adverse Event|7|||
147211987|NCT03116152|530949009|FG000|Overall Study|Protocol Violation|2|||
147211988|NCT03116152|530949010|FG001|Overall Study|Protocol Violation|2|||
147211989|NCT03116152|530949009|FG000|Overall Study|Withdrawal by Subject|0|||
147211990|NCT03116152|530949010|FG001|Overall Study|Withdrawal by Subject|1|||
147211991|NCT03116152|530949009|FG000|Overall Study|Physician Decision|3|||
147211992|NCT03116152|530949010|FG001|Overall Study|Physician Decision|2|||
147211993|NCT03116152|530949009|FG000|Overall Study|other|11|||
147211994|NCT03116152|530949010|FG001|Overall Study|other|34|||
147545963|NCT01244815|532156003|FG003|Overall Study|Did Not Meet Protocol Eligibility|0|||
147545964|NCT01808209|532156005|FG000|Overall Study|Lost to Follow-up|0|||
147545965|NCT01808209|532156006|FG001|Overall Study|Lost to Follow-up|1|||
147211995|NCT01798849|530949012|FG000|Overall Study|Physician Decision|0|||
147211996|NCT01798849|530949013|FG001|Overall Study|Physician Decision|0|||
147211997|NCT01798849|530949014|FG002|Overall Study|Physician Decision|1|||
147211998|NCT02636361|530949015|FG000|Period 4|Physician Decision|0|||
147211999|NCT02636361|530949016|FG001|Period 4|Physician Decision|0|||
147212000|NCT02636361|530949017|FG002|Period 4|Physician Decision|0|||
147212001|NCT02636361|530949018|FG003|Period 4|Physician Decision|1|||
147212002|NCT02636361|530949019|FG004|Period 4|Physician Decision|0|||
147212003|NCT02410343|530949025|FG000|Core Period (24 Weeks)|Adverse Event|1|||
147212004|NCT02410343|530949026|FG001|Core Period (24 Weeks)|Adverse Event|0|||
147212005|NCT02410343|530949025|FG000|Core Period (24 Weeks)|Early termination of study by sponsor|4|||
147212006|NCT02410343|530949026|FG001|Core Period (24 Weeks)|Early termination of study by sponsor|7|||
147212007|NCT02410343|530949025|FG000|Extension Period (12 Months)|Adverse Event|1|||
147212008|NCT02410343|530949026|FG001|Extension Period (12 Months)|Adverse Event|0|||
147212009|NCT02410343|530949025|FG000|Extension Period (12 Months)|Early termination of study by sponsor|0|||
147212010|NCT02410343|530949026|FG001|Extension Period (12 Months)|Early termination of study by sponsor|1|||
147212011|NCT02036853|530949027|FG000|Overall Study|Adverse Event|0|||
147212012|NCT02036853|530949028|FG001|Overall Study|Adverse Event|2|||
147212013|NCT02036853|530949027|FG000|Overall Study|Lack of Efficacy|0|||
147212014|NCT02036853|530949028|FG001|Overall Study|Lack of Efficacy|2|||
147212015|NCT02036853|530949027|FG000|Overall Study|Physician Decision|0|||
147212016|NCT02036853|530949028|FG001|Overall Study|Physician Decision|1|||
147212017|NCT02036853|530949027|FG000|Overall Study|Withdrawal by Subject|0|||
147212018|NCT02036853|530949028|FG001|Overall Study|Withdrawal by Subject|1|||
147212019|NCT00228553|530949029|FG000|Overall Study|Adverse Event|112|||
147212020|NCT00228553|530949029|FG000|Overall Study|Lack of Efficacy|34|||
147212021|NCT00228553|530949029|FG000|Overall Study|Lost to Follow-up|67|||
147212022|NCT00228553|530949029|FG000|Overall Study|Physician Decision|48|||
147212023|NCT00228553|530949029|FG000|Overall Study|Protocol Violation|6|||
147212024|NCT00228553|530949029|FG000|Overall Study|Withdrawal by Subject|115|||
147212025|NCT00228553|530949029|FG000|Overall Study|Pregnancy|2|||
147212026|NCT00228553|530949029|FG000|Overall Study|Miscellaneous|46|||
147212027|NCT04556383|530949032|FG000|PCP|Lack of Efficacy|28|||
147212028|NCT04556383|530949033|FG001|PCP|Lack of Efficacy|23|||
147212029|NCT04556383|530949034|FG002|PCP|Lack of Efficacy|23|||
147212030|NCT04556383|530949035|FG003|PCP|Lack of Efficacy|0|||
147212031|NCT04556383|530949032|FG000|PCP|Study terminated by sponsor|15|||
147212032|NCT04556383|530949033|FG001|PCP|Study terminated by sponsor|13|||
147545966|NCT00697112|532156007|FG000|Overall Study|Adverse Event|8|||
147545967|NCT00697112|532156007|FG000|Overall Study|Lost to Follow-up|1|||
147212033|NCT04556383|530949034|FG002|PCP|Study terminated by sponsor|16|||
147212034|NCT04556383|530949035|FG003|PCP|Study terminated by sponsor|0|||
147212035|NCT04556383|530949032|FG000|PCP|Withdrawal by Subject|8|||
147545968|NCT00697112|532156007|FG000|Overall Study|Did not meet inclusion criteria|1|||
147212036|NCT04556383|530949033|FG001|PCP|Withdrawal by Subject|6|||
147212037|NCT04556383|530949034|FG002|PCP|Withdrawal by Subject|6|||
147212038|NCT04556383|530949035|FG003|PCP|Withdrawal by Subject|0|||
147212039|NCT04556383|530949032|FG000|PCP|Adverse Event|1|||
147212040|NCT04556383|530949033|FG001|PCP|Adverse Event|7|||
147212041|NCT04556383|530949034|FG002|PCP|Adverse Event|7|||
147212042|NCT04556383|530949035|FG003|PCP|Adverse Event|0|||
147212043|NCT04556383|530949032|FG000|PCP|Other, Not Specified|1|||
147212044|NCT04556383|530949033|FG001|PCP|Other, Not Specified|2|||
147212045|NCT04556383|530949034|FG002|PCP|Other, Not Specified|1|||
147212046|NCT04556383|530949035|FG003|PCP|Other, Not Specified|0|||
147212047|NCT04556383|530949032|FG000|PCP|Protocol Violation|1|||
147212048|NCT04556383|530949033|FG001|PCP|Protocol Violation|0|||
147212049|NCT04556383|530949034|FG002|PCP|Protocol Violation|1|||
147212050|NCT04556383|530949035|FG003|PCP|Protocol Violation|0|||
147212051|NCT04556383|530949032|FG000|PCP|Lost to Follow-up|1|||
147212052|NCT04556383|530949033|FG001|PCP|Lost to Follow-up|0|||
147212053|NCT04556383|530949034|FG002|PCP|Lost to Follow-up|0|||
147212054|NCT04556383|530949035|FG003|PCP|Lost to Follow-up|0|||
147212055|NCT04556383|530949032|FG000|PCP|Physician Decision|0|||
147212056|NCT04556383|530949033|FG001|PCP|Physician Decision|1|||
147212057|NCT04556383|530949034|FG002|PCP|Physician Decision|0|||
147212058|NCT04556383|530949035|FG003|PCP|Physician Decision|0|||
147212059|NCT04556383|530949032|FG000|PCP|Site terminated by sponsor|0|||
147212060|NCT04556383|530949033|FG001|PCP|Site terminated by sponsor|1|||
147212061|NCT04556383|530949034|FG002|PCP|Site terminated by sponsor|0|||
147212062|NCT04556383|530949035|FG003|PCP|Site terminated by sponsor|0|||
147212063|NCT04556383|530949032|FG000|OLE|Study terminated by sponsor|0|||
147212064|NCT04556383|530949033|FG001|OLE|Study terminated by sponsor|0|||
147212065|NCT04556383|530949034|FG002|OLE|Study terminated by sponsor|0|||
147212066|NCT04556383|530949035|FG003|OLE|Study terminated by sponsor|68|||
147212067|NCT04556383|530949032|FG000|OLE|Withdrawal by Subject|0|||
147212068|NCT04556383|530949033|FG001|OLE|Withdrawal by Subject|0|||
147212069|NCT04556383|530949034|FG002|OLE|Withdrawal by Subject|0|||
147212070|NCT04556383|530949035|FG003|OLE|Withdrawal by Subject|10|||
147212071|NCT04556383|530949032|FG000|OLE|Lack of Efficacy|0|||
147212072|NCT04556383|530949033|FG001|OLE|Lack of Efficacy|0|||
147212073|NCT04556383|530949034|FG002|OLE|Lack of Efficacy|0|||
147212074|NCT04556383|530949035|FG003|OLE|Lack of Efficacy|7|||
147212075|NCT04556383|530949032|FG000|OLE|Adverse Event|0|||
147212076|NCT04556383|530949033|FG001|OLE|Adverse Event|0|||
147212077|NCT04556383|530949034|FG002|OLE|Adverse Event|0|||
147212078|NCT04556383|530949035|FG003|OLE|Adverse Event|2|||
147212079|NCT04556383|530949032|FG000|OLE|Other, Not Specified|0|||
147212080|NCT04556383|530949033|FG001|OLE|Other, Not Specified|0|||
147212081|NCT04556383|530949034|FG002|OLE|Other, Not Specified|0|||
147212082|NCT04556383|530949035|FG003|OLE|Other, Not Specified|2|||
147212083|NCT04556383|530949032|FG000|OLE|Death|0|||
147212084|NCT04556383|530949033|FG001|OLE|Death|0|||
147212085|NCT04556383|530949034|FG002|OLE|Death|0|||
147212086|NCT04556383|530949035|FG003|OLE|Death|1|||
147212087|NCT04556383|530949032|FG000|OLE|Lost to Follow-up|0|||
147212088|NCT04556383|530949033|FG001|OLE|Lost to Follow-up|0|||
147212089|NCT04556383|530949034|FG002|OLE|Lost to Follow-up|0|||
147212090|NCT04556383|530949035|FG003|OLE|Lost to Follow-up|1|||
147212091|NCT00884741|530949043|FG000|Step 1 Registration: Tissue Screening|Protocol Violation|157|||
147212092|NCT00884741|530949044|FG001|Step 1 Registration: Tissue Screening|Protocol Violation|0|||
147212093|NCT00884741|530949045|FG002|Step 1 Registration: Tissue Screening|Protocol Violation|0|||
147212094|NCT00884741|530949046|FG003|Step 1 Registration: Tissue Screening|Protocol Violation|0|||
147212095|NCT00884741|530949043|FG000|Step 1 Registration: Tissue Screening|Death|3|||
147212096|NCT00884741|530949044|FG001|Step 1 Registration: Tissue Screening|Death|0|||
147212097|NCT00884741|530949045|FG002|Step 1 Registration: Tissue Screening|Death|0|||
147212098|NCT00884741|530949046|FG003|Step 1 Registration: Tissue Screening|Death|0|||
147212099|NCT00884741|530949043|FG000|Step 1 Registration: Tissue Screening|Physician Decision|3|||
147212100|NCT00884741|530949044|FG001|Step 1 Registration: Tissue Screening|Physician Decision|0|||
147212101|NCT00884741|530949045|FG002|Step 1 Registration: Tissue Screening|Physician Decision|0|||
147212102|NCT00884741|530949046|FG003|Step 1 Registration: Tissue Screening|Physician Decision|0|||
147212103|NCT00884741|530949043|FG000|Step 1 Registration: Tissue Screening|Insufficient tissue|105|||
147212104|NCT00884741|530949044|FG001|Step 1 Registration: Tissue Screening|Insufficient tissue|0|||
147212105|NCT00884741|530949045|FG002|Step 1 Registration: Tissue Screening|Insufficient tissue|0|||
147212106|NCT00884741|530949046|FG003|Step 1 Registration: Tissue Screening|Insufficient tissue|0|||
147212107|NCT00884741|530949043|FG000|Step 1 Registration: Tissue Screening|Disease progression|12|||
147212108|NCT00884741|530949044|FG001|Step 1 Registration: Tissue Screening|Disease progression|0|||
147212109|NCT00884741|530949045|FG002|Step 1 Registration: Tissue Screening|Disease progression|0|||
147212110|NCT00884741|530949046|FG003|Step 1 Registration: Tissue Screening|Disease progression|0|||
147212111|NCT00884741|530949043|FG000|Step 1 Registration: Tissue Screening|Patient refusal|32|||
147212112|NCT00884741|530949044|FG001|Step 1 Registration: Tissue Screening|Patient refusal|0|||
147212113|NCT00884741|530949045|FG002|Step 1 Registration: Tissue Screening|Patient refusal|0|||
147212114|NCT00884741|530949046|FG003|Step 1 Registration: Tissue Screening|Patient refusal|0|||
147212115|NCT00884741|530949043|FG000|Step 2 Registration: Tissue Analysis|Protocol Violation|0|||
147212116|NCT00884741|530949044|FG001|Step 2 Registration: Tissue Analysis|Protocol Violation|15|||
147212117|NCT00884741|530949045|FG002|Step 2 Registration: Tissue Analysis|Protocol Violation|0|||
147212118|NCT00884741|530949046|FG003|Step 2 Registration: Tissue Analysis|Protocol Violation|0|||
147545969|NCT01427920|532156012|FG000|Overall Study|Adverse Event|1|||
147545970|NCT01427920|532156013|FG001|Overall Study|Adverse Event|2|||
147545971|NCT01427920|532156012|FG000|Overall Study|Lack of Efficacy|1|||
147545972|NCT01427920|532156013|FG001|Overall Study|Lack of Efficacy|0|||
147545973|NCT01427920|532156012|FG000|Overall Study|Protocol Violation|1|||
147545974|NCT01427920|532156013|FG001|Overall Study|Protocol Violation|3|||
147545975|NCT01427920|532156012|FG000|Overall Study|Withdrawal Criteria|4|||
147545976|NCT01427920|532156013|FG001|Overall Study|Withdrawal Criteria|4|||
147545977|NCT01427920|532156012|FG000|Overall Study|Unclassified|2|||
147545978|NCT01427920|532156013|FG001|Overall Study|Unclassified|8|||
147649445|NCT02634801|532537341|FG000|Follow-up Period|Withdrawal by Subject|1|||
147649446|NCT02634801|532537342|FG001|Follow-up Period|Withdrawal by Subject|2|||
147649447|NCT02634801|532537343|FG002|Follow-up Period|Withdrawal by Subject|5|||
147649448|NCT02634801|532537341|FG000|Follow-up Period|Adverse Event|1|||
147649449|NCT02634801|532537342|FG001|Follow-up Period|Adverse Event|5|||
147649450|NCT02634801|532537343|FG002|Follow-up Period|Adverse Event|0|||
147649451|NCT02335346|532537346|FG000|Overall Study|Adverse Event|11|||
147649452|NCT02335346|532537346|FG000|Overall Study|Withdrawal by Subject|1|||
147649453|NCT01548768|532537347|FG000|Overall Study|Withdrawal by Subject|0|||
147649454|NCT01548768|532537348|FG001|Overall Study|Withdrawal by Subject|2|||
147649455|NCT01548768|532537349|FG002|Overall Study|Withdrawal by Subject|1|||
147649456|NCT01548768|532537350|FG003|Overall Study|Withdrawal by Subject|0|||
147649457|NCT01548768|532537347|FG000|Overall Study|Physician Decision|1|||
147649458|NCT01548768|532537348|FG001|Overall Study|Physician Decision|0|||
147649459|NCT01548768|532537349|FG002|Overall Study|Physician Decision|0|||
147649460|NCT01548768|532537350|FG003|Overall Study|Physician Decision|0|||
147649461|NCT01548768|532537347|FG000|Overall Study|Adverse Event|0|||
147649462|NCT01548768|532537348|FG001|Overall Study|Adverse Event|0|||
147649463|NCT01548768|532537349|FG002|Overall Study|Adverse Event|0|||
147649464|NCT01548768|532537350|FG003|Overall Study|Adverse Event|1|||
147649465|NCT01548768|532537347|FG000|Overall Study|Non-Compliance|0|||
147649466|NCT01548768|532537348|FG001|Overall Study|Non-Compliance|0|||
147649467|NCT01548768|532537349|FG002|Overall Study|Non-Compliance|0|||
147649468|NCT01548768|532537350|FG003|Overall Study|Non-Compliance|3|||
147649469|NCT02907619|532537351|FG000|Overall Study|Study terminated by sponsor|18|||
147649470|NCT02907619|532537352|FG001|Overall Study|Study terminated by sponsor|18|||
147649471|NCT02907619|532537353|FG002|Overall Study|Study terminated by sponsor|19|||
147649472|NCT02907619|532537351|FG000|Overall Study|Death|0|||
147649473|NCT02907619|532537352|FG001|Overall Study|Death|0|||
147649474|NCT02907619|532537353|FG002|Overall Study|Death|1|||
147649475|NCT02907619|532537351|FG000|Overall Study|Withdrawal by Subject|1|||
147649476|NCT02907619|532537352|FG001|Overall Study|Withdrawal by Subject|1|||
147649477|NCT02907619|532537353|FG002|Overall Study|Withdrawal by Subject|0|||
147649478|NCT02907619|532537351|FG000|Overall Study|Other|0|||
147649479|NCT02907619|532537352|FG001|Overall Study|Other|1|||
147649480|NCT02907619|532537353|FG002|Overall Study|Other|0|||
147649481|NCT03326518|532537354|FG000|Overall Study|Protocol Violation|1|||
147649482|NCT03326518|532537355|FG001|Overall Study|Protocol Violation|0|||
147649483|NCT03326518|532537356|FG002|Overall Study|Protocol Violation|0|||
147649484|NCT03326518|532537354|FG000|Overall Study|Withdrawal by Subject|1|||
147649485|NCT03326518|532537355|FG001|Overall Study|Withdrawal by Subject|0|||
147649486|NCT03326518|532537356|FG002|Overall Study|Withdrawal by Subject|0|||
147649487|NCT03326518|532537354|FG000|Overall Study|Lost to Follow-up|1|||
147649488|NCT03326518|532537355|FG001|Overall Study|Lost to Follow-up|0|||
147649489|NCT03326518|532537356|FG002|Overall Study|Lost to Follow-up|1|||
147649490|NCT01375374|532537357|FG000|Overall Study|Adverse Event|1|||
147649491|NCT01908582|532537358|FG000|Period 2|Physician Decision|1|||
147649492|NCT01908582|532537358|FG000|Period 2|Withdrawal by Subject|1|||
147649493|NCT02065518|532537360|FG000|Overall Study|Lost to Follow-up|3|||
147649494|NCT02065518|532537361|FG001|Overall Study|Lost to Follow-up|4|||
147649495|NCT02065518|532537362|FG002|Overall Study|Lost to Follow-up|0|||
147649496|NCT02065518|532537363|FG003|Overall Study|Lost to Follow-up|3|||
147649497|NCT02065518|532537360|FG000|Overall Study|Withdrawal by Subject|3|||
147212119|NCT00884741|530949043|FG000|Step 2 Registration: Tissue Analysis|Death|0|||
147212120|NCT00884741|530949044|FG001|Step 2 Registration: Tissue Analysis|Death|1|||
147212121|NCT00884741|530949045|FG002|Step 2 Registration: Tissue Analysis|Death|0|||
147441848|NCT01131676|531782668|FG002|Discontinuation From Treatment|Not treated|2|||
147441849|NCT01131676|531782666|FG000|Discontinuation From Treatment|Lack of Efficacy|11|||
147441850|NCT01131676|531782667|FG001|Discontinuation From Treatment|Lack of Efficacy|1|||
147441851|NCT01131676|531782668|FG002|Discontinuation From Treatment|Lack of Efficacy|0|||
147441852|NCT01131676|531782666|FG000|Discontinuation From Treatment|Non compliant with protocol|15|||
147441853|NCT01131676|531782667|FG001|Discontinuation From Treatment|Non compliant with protocol|15|||
147441854|NCT01131676|531782668|FG002|Discontinuation From Treatment|Non compliant with protocol|12|||
147441855|NCT01131676|531782666|FG000|Discontinuation From Treatment|Lost to Follow-up|15|||
147649498|NCT02065518|532537361|FG001|Overall Study|Withdrawal by Subject|4|||
147649499|NCT02065518|532537362|FG002|Overall Study|Withdrawal by Subject|9|||
147649500|NCT02065518|532537363|FG003|Overall Study|Withdrawal by Subject|2|||
147649501|NCT00564278|532537365|FG000|Overall Study|Lost to Follow-up|35|||
147649502|NCT00564278|532537366|FG001|Overall Study|Lost to Follow-up|33|||
147649503|NCT00564278|532537365|FG000|Overall Study|Physician Decision|1|||
147649504|NCT00564278|532537366|FG001|Overall Study|Physician Decision|2|||
147649505|NCT00564278|532537365|FG000|Overall Study|Withdrawal by Subject|11|||
147649506|NCT00564278|532537366|FG001|Overall Study|Withdrawal by Subject|7|||
147649507|NCT00560703|532537367|FG000|Overall Study|Adverse Event|0|||
147649508|NCT00560703|532537368|FG001|Overall Study|Adverse Event|2|||
147649509|NCT00560703|532537367|FG000|Overall Study|Protocol Violation|0|||
147649510|NCT00560703|532537368|FG001|Overall Study|Protocol Violation|2|||
147649511|NCT00560703|532537367|FG000|Overall Study|Withdrawal by Subject|0|||
147649512|NCT00560703|532537368|FG001|Overall Study|Withdrawal by Subject|1|||
147649513|NCT00560703|532537367|FG000|Overall Study|non-compliance|0|||
147649514|NCT00560703|532537368|FG001|Overall Study|non-compliance|1|||
147649515|NCT06439095|532537369|FG000|Overall Study|Lost to Follow-up|2|||
147545979|NCT04228302|532156014|FG000|Overall Study|Adverse Event|0|||
147545980|NCT04228302|532156015|FG001|Overall Study|Adverse Event|0|||
147545981|NCT04228302|532156016|FG002|Overall Study|Adverse Event|0|||
147545982|NCT04228302|532156017|FG003|Overall Study|Adverse Event|0|||
147545983|NCT04228302|532156018|FG004|Overall Study|Adverse Event|1|||
147545984|NCT04228302|532156019|FG005|Overall Study|Adverse Event|0|||
147545985|NCT03066440|532156022|FG000|Overall Study|Physician Decision|1|||
147545986|NCT03066440|532156023|FG001|Overall Study|Physician Decision|1|||
147545987|NCT03066440|532156022|FG000|Overall Study|Protocol Violation|0|||
147545988|NCT03066440|532156023|FG001|Overall Study|Protocol Violation|2|||
147649516|NCT03484403|532537371|FG000|Overall Study|Withdrawal by Subject|6|||
147649517|NCT03484403|532537372|FG001|Overall Study|Withdrawal by Subject|4|||
147649518|NCT04278924|532537373|FG000|Double Blind Period (Main Study)|Withdrawal by Subject|1|||
147649519|NCT04278924|532537374|FG001|Double Blind Period (Main Study)|Withdrawal by Subject|1|||
147649520|NCT04278924|532537375|FG002|Double Blind Period (Main Study)|Withdrawal by Subject|0|||
147649521|NCT04278924|532537376|FG003|Double Blind Period (Main Study)|Withdrawal by Subject|2|||
147649522|NCT04278924|532537377|FG004|Double Blind Period (Main Study)|Withdrawal by Subject|0|||
147649523|NCT04278924|532537378|FG005|Double Blind Period (Main Study)|Withdrawal by Subject|0|||
147649524|NCT04278924|532537379|FG006|Double Blind Period (Main Study)|Withdrawal by Subject|0|||
147649525|NCT04278924|532537373|FG000|Double Blind Period (Main Study)|Reason Not Specified|0|||
147649526|NCT04278924|532537374|FG001|Double Blind Period (Main Study)|Reason Not Specified|1|||
147649527|NCT04278924|532537375|FG002|Double Blind Period (Main Study)|Reason Not Specified|0|||
147649528|NCT04278924|532537376|FG003|Double Blind Period (Main Study)|Reason Not Specified|0|||
147649529|NCT04278924|532537377|FG004|Double Blind Period (Main Study)|Reason Not Specified|0|||
147649530|NCT04278924|532537378|FG005|Double Blind Period (Main Study)|Reason Not Specified|0|||
147649531|NCT04278924|532537379|FG006|Double Blind Period (Main Study)|Reason Not Specified|0|||
147649532|NCT04847232|532537380|FG000|Overall Study|Death|123|||
147649533|NCT04847232|532537381|FG001|Overall Study|Death|115|||
147649534|NCT04847232|532537380|FG000|Overall Study|Lost to Follow-up|3|||
147649535|NCT04847232|532537381|FG001|Overall Study|Lost to Follow-up|10|||
147649536|NCT04847232|532537380|FG000|Overall Study|Withdrawal by Subject|73|||
147649537|NCT04847232|532537381|FG001|Overall Study|Withdrawal by Subject|101|||
147649538|NCT04847232|532537380|FG000|Overall Study|"Subcategories under Other not reported."|1150|||
147649539|NCT04847232|532537381|FG001|Overall Study|"Subcategories under Other not reported."|1115|||
147649540|NCT02476916|532537386|FG000|Core Period|Adverse Event|2|||
147649541|NCT02476916|532537387|FG001|Core Period|Adverse Event|2|||
147649542|NCT02476916|532537386|FG000|Core Period|Investigator decision|1|||
147649543|NCT02476916|532537387|FG001|Core Period|Investigator decision|1|||
147649544|NCT02476916|532537386|FG000|Core Period|Withdrawal by Subject|3|||
147649545|NCT02476916|532537387|FG001|Core Period|Withdrawal by Subject|0|||
147649546|NCT02476916|532537386|FG000|Extension Period|Prematurely Discontinued Treatment|6|||
147649547|NCT02476916|532537387|FG001|Extension Period|Prematurely Discontinued Treatment|1|||
147649548|NCT02476916|532537386|FG000|Extension Period|On Treatment|12|||
147649549|NCT02476916|532537387|FG001|Extension Period|On Treatment|17|||
147649550|NCT05600036|532537388|FG000|Overall Study|Adverse Event|0|||
147649551|NCT05600036|532537389|FG001|Overall Study|Adverse Event|2|||
147649552|NCT05600036|532537390|FG002|Overall Study|Adverse Event|1|||
147649553|NCT05600036|532537391|FG003|Overall Study|Adverse Event|0|||
147649554|NCT05600036|532537392|FG004|Overall Study|Adverse Event|1|||
147649555|NCT05600036|532537393|FG005|Overall Study|Adverse Event|0|||
147649556|NCT05600036|532537388|FG000|Overall Study|Lost to Follow-up|0|||
147649557|NCT05600036|532537389|FG001|Overall Study|Lost to Follow-up|2|||
147649558|NCT05600036|532537390|FG002|Overall Study|Lost to Follow-up|1|||
147649559|NCT05600036|532537391|FG003|Overall Study|Lost to Follow-up|1|||
147545989|NCT04991311|532156024|FG000|Overall Study|Adverse Event|1|||
147545990|NCT01223196|532156027|FG000|Overall Study|Lost to Follow-up|2|||
147545991|NCT01223196|532156028|FG001|Overall Study|Lost to Follow-up|0|||
147649560|NCT05600036|532537392|FG004|Overall Study|Lost to Follow-up|0|||
147649561|NCT05600036|532537393|FG005|Overall Study|Lost to Follow-up|0|||
147649562|NCT05600036|532537388|FG000|Overall Study|Protocol Violation|0|||
147649563|NCT05600036|532537389|FG001|Overall Study|Protocol Violation|0|||
147649564|NCT05600036|532537390|FG002|Overall Study|Protocol Violation|2|||
147545992|NCT01223196|532156027|FG000|Overall Study|Physician Decision|1|||
147545993|NCT01223196|532156028|FG001|Overall Study|Physician Decision|0|||
147649565|NCT05600036|532537391|FG003|Overall Study|Protocol Violation|0|||
147649566|NCT05600036|532537392|FG004|Overall Study|Protocol Violation|0|||
147545994|NCT01223196|532156027|FG000|Overall Study|Withdrawal by Subject|1|||
147545995|NCT01223196|532156028|FG001|Overall Study|Withdrawal by Subject|0|||
147545996|NCT02598193|532156029|FG000|Overall Study|Adverse Event|13|||
147649567|NCT05600036|532537393|FG005|Overall Study|Protocol Violation|0|||
147649568|NCT05600036|532537388|FG000|Overall Study|Withdrawal by Subject|0|||
147649569|NCT05600036|532537389|FG001|Overall Study|Withdrawal by Subject|1|||
147212122|NCT00884741|530949046|FG003|Step 2 Registration: Tissue Analysis|Death|0|||
147441856|NCT01131676|531782667|FG001|Discontinuation From Treatment|Lost to Follow-up|9|||
147441857|NCT01131676|531782668|FG002|Discontinuation From Treatment|Lost to Follow-up|6|||
147441858|NCT01131676|531782666|FG000|Discontinuation From Treatment|Refusal to continue, not due to AE|172|||
147441859|NCT01131676|531782667|FG001|Discontinuation From Treatment|Refusal to continue, not due to AE|118|||
147441860|NCT01131676|531782668|FG002|Discontinuation From Treatment|Refusal to continue, not due to AE|122|||
147441861|NCT01131676|531782666|FG000|Discontinuation From Treatment|Other than those specified|162|||
147441862|NCT01131676|531782667|FG001|Discontinuation From Treatment|Other than those specified|142|||
147441863|NCT01131676|531782668|FG002|Discontinuation From Treatment|Other than those specified|125|||
147441864|NCT01131676|531782666|FG000|Discontinuation From Treatment|Adverse Event|303|||
147441865|NCT01131676|531782667|FG001|Discontinuation From Treatment|Adverse Event|267|||
147441866|NCT01131676|531782668|FG002|Discontinuation From Treatment|Adverse Event|273|||
147441867|NCT01131676|531782666|FG000|Discontinuation From Study (Treated Set)|Consent withdrawn: Final VS available|23|||
147441868|NCT01131676|531782667|FG001|Discontinuation From Study (Treated Set)|Consent withdrawn: Final VS available|35|||
147441869|NCT01131676|531782668|FG002|Discontinuation From Study (Treated Set)|Consent withdrawn: Final VS available|25|||
147441870|NCT01131676|531782666|FG000|Discontinuation From Study (Treated Set)|Consent withdrawn:Final VS not available|8|||
147441871|NCT01131676|531782667|FG001|Discontinuation From Study (Treated Set)|Consent withdrawn:Final VS not available|6|||
147441872|NCT01131676|531782668|FG002|Discontinuation From Study (Treated Set)|Consent withdrawn:Final VS not available|5|||
147441873|NCT01131676|531782666|FG000|Discontinuation From Study (Treated Set)|Site closure: Final VS available|20|||
147441874|NCT01131676|531782667|FG001|Discontinuation From Study (Treated Set)|Site closure: Final VS available|21|||
147441875|NCT01131676|531782668|FG002|Discontinuation From Study (Treated Set)|Site closure: Final VS available|19|||
147441876|NCT01131676|531782666|FG000|Discontinuation From Study (Treated Set)|Site closure:Final VS not available (NA)|5|||
147441877|NCT01131676|531782667|FG001|Discontinuation From Study (Treated Set)|Site closure:Final VS not available (NA)|9|||
147441878|NCT01131676|531782668|FG002|Discontinuation From Study (Treated Set)|Site closure:Final VS not available (NA)|7|||
147441879|NCT01131676|531782666|FG000|Discontinuation From Study (Treated Set)|Lost to FU for 3PMACE:Final VS available|7|||
147441880|NCT01131676|531782667|FG001|Discontinuation From Study (Treated Set)|Lost to FU for 3PMACE:Final VS available|6|||
147441881|NCT01131676|531782668|FG002|Discontinuation From Study (Treated Set)|Lost to FU for 3PMACE:Final VS available|5|||
147441882|NCT01131676|531782666|FG000|Discontinuation From Study (Treated Set)|Lost to FU for 3P-MACE:Final VS NA|4|||
147441883|NCT01131676|531782667|FG001|Discontinuation From Study (Treated Set)|Lost to FU for 3P-MACE:Final VS NA|4|||
147441884|NCT01131676|531782668|FG002|Discontinuation From Study (Treated Set)|Lost to FU for 3P-MACE:Final VS NA|2|||
147441885|NCT04109222|531782669|FG000|Overall Study|Adverse Event|1|||
147441886|NCT04109222|531782670|FG001|Overall Study|Adverse Event|0|||
147441887|NCT04109222|531782671|FG002|Overall Study|Adverse Event|0|||
147441888|NCT02138617|531782672|FG000|Overall Study|Death|1|||
147441889|NCT02138617|531782673|FG001|Overall Study|Death|2|||
147441890|NCT02138617|531782674|FG002|Overall Study|Death|2|||
147441891|NCT02138617|531782672|FG000|Overall Study|Adverse Event|8|||
147441892|NCT02138617|531782673|FG001|Overall Study|Adverse Event|5|||
147441893|NCT02138617|531782674|FG002|Overall Study|Adverse Event|2|||
147441894|NCT02138617|531782672|FG000|Overall Study|Disease Progression|20|||
147441895|NCT02138617|531782673|FG001|Overall Study|Disease Progression|13|||
147441896|NCT02138617|531782674|FG002|Overall Study|Disease Progression|4|||
147441897|NCT02138617|531782672|FG000|Overall Study|Withdrawal by Subject|7|||
147441898|NCT02138617|531782673|FG001|Overall Study|Withdrawal by Subject|10|||
147441899|NCT02138617|531782674|FG002|Overall Study|Withdrawal by Subject|2|||
147441900|NCT02138617|531782672|FG000|Overall Study|other complicating disease|0|||
147441901|NCT02138617|531782673|FG001|Overall Study|other complicating disease|2|||
147441902|NCT02138617|531782674|FG002|Overall Study|other complicating disease|0|||
147441903|NCT02138617|531782672|FG000|Overall Study|Protocol Violation|1|||
147441904|NCT02138617|531782673|FG001|Overall Study|Protocol Violation|0|||
147441905|NCT02138617|531782674|FG002|Overall Study|Protocol Violation|0|||
147441906|NCT02138617|531782672|FG000|Overall Study|Physician Decision|7|||
147441907|NCT02138617|531782673|FG001|Overall Study|Physician Decision|6|||
147545997|NCT02598193|532156029|FG000|Overall Study|Withdrawal by Subject|1|||
147545998|NCT02598193|532156029|FG000|Overall Study|Listed in active lung transplant list|1|||
147545999|NCT02598193|532156029|FG000|Overall Study|Does not want to take Nintedanib|1|||
147546000|NCT02487979|532156030|FG000|Overall Study|Physician Decision|2|||
147546001|NCT02487979|532156030|FG000|Overall Study|Withdrawal by Subject|2|||
147546002|NCT02487979|532156030|FG000|Overall Study|Progressive Disease|17|||
147546003|NCT00447694|532156031|FG000|Overall Study|Adverse Event|2|||
147546004|NCT00447694|532156031|FG000|Overall Study|Abnormal laboratory value|1|||
147546005|NCT00447694|532156031|FG000|Overall Study|Abnormal test procedure result|1|||
147546006|NCT00447694|532156031|FG000|Overall Study|Withdrawal by Subject|2|||
147546007|NCT01169987|532156032|FG000|Overall Study|Withdrawal by Subject|3|||
147546008|NCT01169987|532156032|FG000|Overall Study|Lost to Follow-up|24|||
147546009|NCT01169987|532156032|FG000|Overall Study|Other|4|||
147546010|NCT00829439|532156033|FG000|Overall Study|Adverse Event|0|||
147546011|NCT00829439|532156034|FG001|Overall Study|Adverse Event|0|||
147546012|NCT00829439|532156035|FG002|Overall Study|Adverse Event|1|||
147546013|NCT00829439|532156036|FG003|Overall Study|Adverse Event|0|||
147546014|NCT00386100|532156037|FG000|Overall Study|Did not receive study medication|6|||
147212123|NCT00884741|530949043|FG000|Step 2 Registration: Tissue Analysis|Adverse Event|0|||
147546015|NCT00386100|532156038|FG001|Overall Study|Did not receive study medication|4|||
147546016|NCT00386100|532156037|FG000|Overall Study|Adverse Event|15|||
147546017|NCT00386100|532156038|FG001|Overall Study|Adverse Event|25|||
147546018|NCT00386100|532156037|FG000|Overall Study|Death|0|||
147546019|NCT00386100|532156038|FG001|Overall Study|Death|1|||
147546020|NCT00386100|532156037|FG000|Overall Study|Insufficient therapeutic effect|30|||
147546021|NCT00386100|532156038|FG001|Overall Study|Insufficient therapeutic effect|6|||
147546022|NCT00386100|532156037|FG000|Overall Study|Lost to Follow-up|29|||
147546023|NCT00386100|532156038|FG001|Overall Study|Lost to Follow-up|29|||
147546024|NCT00386100|532156037|FG000|Overall Study|Non-compliance|18|||
147546025|NCT00386100|532156038|FG001|Overall Study|Non-compliance|19|||
147546026|NCT00386100|532156037|FG000|Overall Study|Protocol Violation|5|||
147546027|NCT00386100|532156038|FG001|Overall Study|Protocol Violation|3|||
147546028|NCT00386100|532156037|FG000|Overall Study|Withdrawal by Subject|32|||
147546029|NCT00386100|532156038|FG001|Overall Study|Withdrawal by Subject|31|||
147546030|NCT00386100|532156037|FG000|Overall Study|Bone mass density (BMD) loss >6%|4|||
147546031|NCT00386100|532156038|FG001|Overall Study|Bone mass density (BMD) loss >6%|4|||
147546032|NCT00386100|532156037|FG000|Overall Study|BMD <2.5|1|||
147546033|NCT00386100|532156038|FG001|Overall Study|BMD <2.5|0|||
147546034|NCT00386100|532156037|FG000|Overall Study|Consecutive elevated Hba1C|1|||
147546035|NCT00386100|532156038|FG001|Overall Study|Consecutive elevated Hba1C|0|||
147546036|NCT00386100|532156037|FG000|Overall Study|Visit 11 DXA showed excessive bone loss|0|||
147546037|NCT00386100|532156038|FG001|Overall Study|Visit 11 DXA showed excessive bone loss|1|||
147546038|NCT00386100|532156037|FG000|Overall Study|Laboratory findings|1|||
147546039|NCT00386100|532156038|FG001|Overall Study|Laboratory findings|0|||
147546040|NCT00386100|532156037|FG000|Overall Study|Participant's concern due to CPK levels|1|||
147546041|NCT00386100|532156038|FG001|Overall Study|Participant's concern due to CPK levels|0|||
147546042|NCT00386100|532156037|FG000|Overall Study|Participant moving out of state|2|||
147546043|NCT00386100|532156038|FG001|Overall Study|Participant moving out of state|0|||
147546044|NCT00386100|532156037|FG000|Overall Study|Excessive bone loss vs. baseline value|0|||
147546045|NCT00386100|532156038|FG001|Overall Study|Excessive bone loss vs. baseline value|1|||
147546046|NCT00386100|532156037|FG000|Overall Study|Didn't meet entry criteria|1|||
147546047|NCT00386100|532156038|FG001|Overall Study|Didn't meet entry criteria|1|||
147546048|NCT00386100|532156037|FG000|Overall Study|Participant's PCP wanted to stop drug|1|||
147546049|NCT00386100|532156038|FG001|Overall Study|Participant's PCP wanted to stop drug|0|||
147546050|NCT00386100|532156037|FG000|Overall Study|Osteoporosis findings on Visit 2 DXA|0|||
147546051|NCT00386100|532156038|FG001|Overall Study|Osteoporosis findings on Visit 2 DXA|1|||
147546052|NCT00386100|532156037|FG000|Overall Study|Bad metabolic control & patient security|1|||
147546053|NCT00386100|532156038|FG001|Overall Study|Bad metabolic control & patient security|0|||
147546054|NCT00386100|532156037|FG000|Overall Study|Bone loss by DXA bone scan|1|||
147546055|NCT00386100|532156038|FG001|Overall Study|Bone loss by DXA bone scan|0|||
147546056|NCT00386100|532156037|FG000|Overall Study|DBP 93 mmHg at randomization|1|||
147546057|NCT00386100|532156038|FG001|Overall Study|DBP 93 mmHg at randomization|0|||
147546058|NCT00386100|532156037|FG000|Overall Study|7.6% bone loss|1|||
147546059|NCT00386100|532156038|FG001|Overall Study|7.6% bone loss|0|||
147546060|NCT00386100|532156037|FG000|Overall Study|Osteoporosis|0|||
147546061|NCT00386100|532156038|FG001|Overall Study|Osteoporosis|1|||
147546062|NCT00386100|532156037|FG000|Overall Study|Positive pregnancy test|1|||
147546063|NCT00386100|532156038|FG001|Overall Study|Positive pregnancy test|3|||
147546064|NCT00386100|532156037|FG000|Overall Study|Out of country for 5 months|1|||
147546065|NCT00386100|532156038|FG001|Overall Study|Out of country for 5 months|0|||
147546066|NCT00386100|532156037|FG000|Overall Study|Hb1Ac >8%|0|||
147546067|NCT00386100|532156038|FG001|Overall Study|Hb1Ac >8%|1|||
147546068|NCT00386100|532156037|FG000|Overall Study|Participant randomized in error|1|||
147546069|NCT00386100|532156038|FG001|Overall Study|Participant randomized in error|0|||
147546070|NCT01493531|532156048|FG000|Overall Study|Adverse Event|4|||
147546071|NCT01493531|532156049|FG001|Overall Study|Adverse Event|12|||
147546072|NCT01493531|532156050|FG002|Overall Study|Adverse Event|9|||
147546073|NCT01493531|532156048|FG000|Overall Study|Gout flare|3|||
147546074|NCT01493531|532156049|FG001|Overall Study|Gout flare|0|||
147546075|NCT01493531|532156050|FG002|Overall Study|Gout flare|2|||
147546076|NCT01493531|532156048|FG000|Overall Study|Protocol Violation|8|||
147546077|NCT01493531|532156049|FG001|Overall Study|Protocol Violation|15|||
147546078|NCT01493531|532156050|FG002|Overall Study|Protocol Violation|12|||
147546079|NCT01493531|532156048|FG000|Overall Study|Sponsor terminated study|5|||
147546080|NCT01493531|532156049|FG001|Overall Study|Sponsor terminated study|2|||
147546081|NCT01493531|532156050|FG002|Overall Study|Sponsor terminated study|3|||
147546082|NCT01493531|532156048|FG000|Overall Study|Lost to Follow-up|5|||
147546083|NCT01493531|532156049|FG001|Overall Study|Lost to Follow-up|7|||
147546084|NCT01493531|532156050|FG002|Overall Study|Lost to Follow-up|11|||
147546085|NCT01493531|532156048|FG000|Overall Study|Withdrawal by Subject|16|||
147649570|NCT05600036|532537390|FG002|Overall Study|Withdrawal by Subject|2|||
147649571|NCT05600036|532537391|FG003|Overall Study|Withdrawal by Subject|0|||
147649572|NCT05600036|532537392|FG004|Overall Study|Withdrawal by Subject|3|||
147649573|NCT05600036|532537393|FG005|Overall Study|Withdrawal by Subject|5|||
147649574|NCT05600036|532537388|FG000|Overall Study|Discontinued Prior to Dosing Due to the Blood Sample Logistics|0|||
147649575|NCT05600036|532537389|FG001|Overall Study|Discontinued Prior to Dosing Due to the Blood Sample Logistics|0|||
147649576|NCT05600036|532537390|FG002|Overall Study|Discontinued Prior to Dosing Due to the Blood Sample Logistics|0|||
147649577|NCT05600036|532537391|FG003|Overall Study|Discontinued Prior to Dosing Due to the Blood Sample Logistics|1|||
147649578|NCT05600036|532537392|FG004|Overall Study|Discontinued Prior to Dosing Due to the Blood Sample Logistics|0|||
147649579|NCT05600036|532537393|FG005|Overall Study|Discontinued Prior to Dosing Due to the Blood Sample Logistics|0|||
147649580|NCT05600036|532537388|FG000|Overall Study|Subject Can't Continue With Week 16 Visit|0|||
147649581|NCT05600036|532537389|FG001|Overall Study|Subject Can't Continue With Week 16 Visit|1|||
147649582|NCT05600036|532537390|FG002|Overall Study|Subject Can't Continue With Week 16 Visit|0|||
147649583|NCT05600036|532537391|FG003|Overall Study|Subject Can't Continue With Week 16 Visit|0|||
147649584|NCT05600036|532537392|FG004|Overall Study|Subject Can't Continue With Week 16 Visit|0|||
147649585|NCT05600036|532537393|FG005|Overall Study|Subject Can't Continue With Week 16 Visit|0|||
147659414|NCT01064414|532576181|FG000|Core Period: Baseline to Week 26|Death|0|||
147212124|NCT00884741|530949044|FG001|Step 2 Registration: Tissue Analysis|Adverse Event|2|||
147212125|NCT00884741|530949045|FG002|Step 2 Registration: Tissue Analysis|Adverse Event|0|||
147212126|NCT00884741|530949046|FG003|Step 2 Registration: Tissue Analysis|Adverse Event|0|||
147212127|NCT00884741|530949043|FG000|Step 2 Registration: Tissue Analysis|Patient refusal|0|||
147212128|NCT00884741|530949044|FG001|Step 2 Registration: Tissue Analysis|Patient refusal|7|||
147212129|NCT00884741|530949045|FG002|Step 2 Registration: Tissue Analysis|Patient refusal|0|||
147212130|NCT00884741|530949046|FG003|Step 2 Registration: Tissue Analysis|Patient refusal|0|||
147212131|NCT00884741|530949043|FG000|Step 2 Registration: Tissue Analysis|Disease Progression|0|||
147212132|NCT00884741|530949044|FG001|Step 2 Registration: Tissue Analysis|Disease Progression|4|||
147212133|NCT00884741|530949045|FG002|Step 2 Registration: Tissue Analysis|Disease Progression|0|||
147546086|NCT01493531|532156049|FG001|Overall Study|Withdrawal by Subject|13|||
147546087|NCT01493531|532156050|FG002|Overall Study|Withdrawal by Subject|11|||
147212134|NCT00884741|530949046|FG003|Step 2 Registration: Tissue Analysis|Disease Progression|0|||
147212135|NCT00884741|530949043|FG000|Randomization|Protocol Violation|0|||
147212136|NCT00884741|530949044|FG001|Randomization|Protocol Violation|0|||
147212137|NCT00884741|530949045|FG002|Randomization|Protocol Violation|8|||
147212138|NCT00884741|530949046|FG003|Randomization|Protocol Violation|8|||
147212139|NCT00335764|530949047|FG000|Overall Study|wrong histology|1|||
147212140|NCT00335764|530949048|FG001|Overall Study|wrong histology|0|||
147212141|NCT00335764|530949049|FG002|Overall Study|wrong histology|0|||
147212142|NCT00335764|530949050|FG003|Overall Study|wrong histology|0|||
147212143|NCT00335764|530949051|FG004|Overall Study|wrong histology|1|||
147212144|NCT00612807|530949052|FG000|Overall Study|Withdrawal by Subject|2|||
147212145|NCT00612807|530949053|FG001|Overall Study|Withdrawal by Subject|0|||
147212146|NCT00744042|530949056|FG000|Overall Study|Withdrawal by Subject|1|||
147212147|NCT04303195|530949059|FG000|Overall Study|Adverse Event|1|||
147212148|NCT04303195|530949060|FG001|Overall Study|Adverse Event|3|||
147212149|NCT04303195|530949061|FG002|Overall Study|Adverse Event|7|||
147212150|NCT04303195|530949062|FG003|Overall Study|Adverse Event|0|||
147212151|NCT04303195|530949059|FG000|Overall Study|Lost to Follow-up|1|||
147212152|NCT04303195|530949060|FG001|Overall Study|Lost to Follow-up|0|||
147212153|NCT04303195|530949061|FG002|Overall Study|Lost to Follow-up|1|||
147212154|NCT04303195|530949062|FG003|Overall Study|Lost to Follow-up|4|||
147212155|NCT04303195|530949059|FG000|Overall Study|Withdrawal by Subject|3|||
147212156|NCT04303195|530949060|FG001|Overall Study|Withdrawal by Subject|1|||
147212157|NCT04303195|530949061|FG002|Overall Study|Withdrawal by Subject|1|||
147546088|NCT01493531|532156048|FG000|Overall Study|Death|0|||
147546089|NCT01493531|532156049|FG001|Overall Study|Death|1|||
147546090|NCT01493531|532156050|FG002|Overall Study|Death|0|||
147546091|NCT01946282|532156051|FG000|Year 1|Did not return FIT kit|4186|||
147546092|NCT01946282|532156052|FG001|Year 1|Did not return FIT kit|608|||
147546093|NCT01946282|532156053|FG002|Year 1|Did not return FIT kit|654|||
147546094|NCT01946282|532156051|FG000|Year 2|Did not return FIT kit|803|||
147546095|NCT01946282|532156052|FG001|Year 2|Did not return FIT kit|131|||
147212158|NCT04303195|530949062|FG003|Overall Study|Withdrawal by Subject|1|||
147212159|NCT04303195|530949059|FG000|Overall Study|No study drug administered or protocol deviation|0|||
147212160|NCT04303195|530949060|FG001|Overall Study|No study drug administered or protocol deviation|2|||
147546096|NCT01946282|532156053|FG002|Year 2|Did not return FIT kit|115|||
147212161|NCT04303195|530949061|FG002|Overall Study|No study drug administered or protocol deviation|0|||
147212162|NCT04303195|530949062|FG003|Overall Study|No study drug administered or protocol deviation|2|||
147212163|NCT02970942|530949063|FG000|Overall Study|Death|0|||
147546097|NCT01946282|532156051|FG000|Year 3|Did not return FIT kit|288|||
147546098|NCT01946282|532156052|FG001|Year 3|Did not return FIT kit|43|||
147546099|NCT01946282|532156053|FG002|Year 3|Did not return FIT kit|30|||
147546100|NCT03031431|532156054|FG000|Overall Study|Infant removed by maternal request|1|||
147212164|NCT02970942|530949064|FG001|Overall Study|Death|1|||
147212165|NCT02970942|530949065|FG002|Overall Study|Death|0|||
147212166|NCT02970942|530949066|FG003|Overall Study|Death|0|||
147212167|NCT02970942|530949063|FG000|Overall Study|Lost to Follow-up|1|||
147212168|NCT02970942|530949064|FG001|Overall Study|Lost to Follow-up|0|||
147212169|NCT02970942|530949065|FG002|Overall Study|Lost to Follow-up|2|||
147212170|NCT02970942|530949066|FG003|Overall Study|Lost to Follow-up|1|||
147212171|NCT02970942|530949063|FG000|Overall Study|Withdrawal by Subject|3|||
147212172|NCT02970942|530949064|FG001|Overall Study|Withdrawal by Subject|5|||
147212173|NCT02970942|530949065|FG002|Overall Study|Withdrawal by Subject|3|||
147212174|NCT02970942|530949066|FG003|Overall Study|Withdrawal by Subject|2|||
147212175|NCT01065454|530949069|FG000|Treatment|Adverse Event|7|||
147212176|NCT01065454|530949070|FG001|Treatment|Adverse Event|4|||
147212177|NCT01065454|530949071|FG002|Treatment|Adverse Event|3|||
147212178|NCT01065454|530949072|FG003|Treatment|Adverse Event|6|||
147212179|NCT01065454|530949069|FG000|Treatment|Death|1|||
147212180|NCT01065454|530949070|FG001|Treatment|Death|0|||
147649586|NCT05600036|532537388|FG000|Overall Study|The Patient was Terminated From The Study Due to Sponsor Requirements|0|||
147649587|NCT05600036|532537389|FG001|Overall Study|The Patient was Terminated From The Study Due to Sponsor Requirements|0|||
147649588|NCT05600036|532537390|FG002|Overall Study|The Patient was Terminated From The Study Due to Sponsor Requirements|0|||
147649589|NCT05600036|532537391|FG003|Overall Study|The Patient was Terminated From The Study Due to Sponsor Requirements|1|||
147649590|NCT05600036|532537392|FG004|Overall Study|The Patient was Terminated From The Study Due to Sponsor Requirements|0|||
147649591|NCT05600036|532537393|FG005|Overall Study|The Patient was Terminated From The Study Due to Sponsor Requirements|0|||
147649592|NCT00715520|532537394|FG000|Overall Study|Screen failure|8|||
147649593|NCT00715520|532537395|FG001|Overall Study|Screen failure|1|||
147649594|NCT00715520|532537396|FG002|Overall Study|Screen failure|1|||
147649595|NCT00715520|532537394|FG000|Overall Study|Withdrawal by Subject|2|||
147649596|NCT00715520|532537395|FG001|Overall Study|Withdrawal by Subject|0|||
147649597|NCT00715520|532537396|FG002|Overall Study|Withdrawal by Subject|1|||
147649598|NCT02570750|532537397|FG000|Overall Study|Inclusion/exclusion criteria deviation|1|||
147649599|NCT02570750|532537398|FG001|Overall Study|Inclusion/exclusion criteria deviation|0|||
147649600|NCT02570750|532537397|FG000|Overall Study|Protocol deviation|4|||
147649601|NCT02570750|532537398|FG001|Overall Study|Protocol deviation|2|||
147649602|NCT02570750|532537397|FG000|Overall Study|Withdrawal by Subject|5|||
147649603|NCT02570750|532537398|FG001|Overall Study|Withdrawal by Subject|0|||
147212181|NCT01065454|530949071|FG002|Treatment|Death|0|||
147212182|NCT01065454|530949072|FG003|Treatment|Death|0|||
147212183|NCT01065454|530949069|FG000|Treatment|Non-compliance|1|||
147212184|NCT01065454|530949070|FG001|Treatment|Non-compliance|0|||
147212185|NCT01065454|530949071|FG002|Treatment|Non-compliance|0|||
147212186|NCT01065454|530949072|FG003|Treatment|Non-compliance|1|||
147212187|NCT01065454|530949069|FG000|Treatment|Protocol Decision|0|||
147212188|NCT01065454|530949070|FG001|Treatment|Protocol Decision|0|||
147212189|NCT01065454|530949071|FG002|Treatment|Protocol Decision|3|||
147212190|NCT01065454|530949072|FG003|Treatment|Protocol Decision|2|||
147212191|NCT01065454|530949069|FG000|Treatment|Protocol Violation|1|||
147546101|NCT03670537|532156059|FG000|Overall Study|Protocol Violation|1|||
147546102|NCT04133519|532156060|FG000|Overall Study|Withdrawal by Subject|5|||
147649604|NCT02570750|532537397|FG000|Overall Study|Lost to Follow-up|2|||
147649605|NCT02570750|532537398|FG001|Overall Study|Lost to Follow-up|2|||
147649606|NCT02570750|532537397|FG000|Overall Study|Adverse Event|2|||
147649607|NCT02570750|532537398|FG001|Overall Study|Adverse Event|1|||
147649608|NCT04122625|532537399|FG000|Part A (up to 2.92 Years)|Death|2|||
147649609|NCT04122625|532537400|FG001|Part A (up to 2.92 Years)|Death|4|||
147546103|NCT04133519|532156061|FG001|Overall Study|Withdrawal by Subject|4|||
147546104|NCT04133519|532156060|FG000|Overall Study|Protocol Violation|0|||
147546105|NCT04133519|532156061|FG001|Overall Study|Protocol Violation|1|||
147546106|NCT04133519|532156060|FG000|Overall Study|Never started treatment|1|||
147546107|NCT04133519|532156061|FG001|Overall Study|Never started treatment|1|||
147546108|NCT02217345|532156062|FG000|Overall Study|Lost to Follow-up|2|||
147546109|NCT02217345|532156063|FG001|Overall Study|Lost to Follow-up|1|||
147546110|NCT02217345|532156062|FG000|Overall Study|Withdrawal by Subject|3|||
147649610|NCT04122625|532537401|FG002|Part A (up to 2.92 Years)|Death|0|||
147649611|NCT04122625|532537402|FG003|Part A (up to 2.92 Years)|Death|0|||
147649612|NCT04122625|532537403|FG004|Part A (up to 2.92 Years)|Death|0|||
147649613|NCT04122625|532537404|FG005|Part A (up to 2.92 Years)|Death|0|||
147649614|NCT04122625|532537399|FG000|Part B (up to 2.33 Years)|Patient lost to follow-up|0|||
147649615|NCT04122625|532537400|FG001|Part B (up to 2.33 Years)|Patient lost to follow-up|0|||
147212192|NCT01065454|530949070|FG001|Treatment|Protocol Violation|0|||
147212193|NCT01065454|530949071|FG002|Treatment|Protocol Violation|1|||
147212194|NCT01065454|530949072|FG003|Treatment|Protocol Violation|0|||
147212195|NCT01065454|530949069|FG000|Treatment|Withdrawal by Subject|3|||
147212196|NCT01065454|530949070|FG001|Treatment|Withdrawal by Subject|1|||
147212197|NCT01065454|530949071|FG002|Treatment|Withdrawal by Subject|2|||
147212198|NCT01065454|530949072|FG003|Treatment|Withdrawal by Subject|3|||
147546111|NCT02217345|532156063|FG001|Overall Study|Withdrawal by Subject|2|||
147546112|NCT02217345|532156062|FG000|Overall Study|Adverse Event|2|||
147649616|NCT04122625|532537401|FG002|Part B (up to 2.33 Years)|Patient lost to follow-up|1|||
147649617|NCT04122625|532537402|FG003|Part B (up to 2.33 Years)|Patient lost to follow-up|1|||
147212199|NCT01065454|530949069|FG000|Follow up|Adverse Event|1|||
147212200|NCT01065454|530949070|FG001|Follow up|Adverse Event|0|||
147212201|NCT01065454|530949071|FG002|Follow up|Adverse Event|0|||
147212202|NCT01065454|530949072|FG003|Follow up|Adverse Event|1|||
147212203|NCT01065454|530949069|FG000|Follow up|Death|0|||
147212204|NCT01065454|530949070|FG001|Follow up|Death|1|||
147212205|NCT01065454|530949071|FG002|Follow up|Death|1|||
147212206|NCT01065454|530949072|FG003|Follow up|Death|0|||
147212207|NCT01065454|530949069|FG000|Follow up|Lost to Follow-up|0|||
147212208|NCT01065454|530949070|FG001|Follow up|Lost to Follow-up|0|||
147212209|NCT01065454|530949071|FG002|Follow up|Lost to Follow-up|0|||
147212210|NCT01065454|530949072|FG003|Follow up|Lost to Follow-up|1|||
147212211|NCT01065454|530949069|FG000|Follow up|Progressive disease|0|||
147212212|NCT01065454|530949070|FG001|Follow up|Progressive disease|0|||
147212213|NCT01065454|530949071|FG002|Follow up|Progressive disease|0|||
147212214|NCT01065454|530949072|FG003|Follow up|Progressive disease|1|||
147212215|NCT01065454|530949069|FG000|Follow up|Withdrawal by Subject|1|||
147212216|NCT01065454|530949070|FG001|Follow up|Withdrawal by Subject|1|||
147212217|NCT01065454|530949071|FG002|Follow up|Withdrawal by Subject|1|||
147212218|NCT01065454|530949072|FG003|Follow up|Withdrawal by Subject|0|||
147212219|NCT01065454|530949069|FG000|Follow up|study ongoing|37|||
147212220|NCT01065454|530949070|FG001|Follow up|study ongoing|22|||
147212221|NCT01065454|530949071|FG002|Follow up|study ongoing|15|||
147212222|NCT01065454|530949072|FG003|Follow up|study ongoing|41|||
147212223|NCT05688670|530949073|FG000|Overall Study|Change in surgery plan|1|||
147212224|NCT05688670|530949074|FG001|Overall Study|Change in surgery plan|4|||
147212225|NCT05688670|530949073|FG000|Overall Study|Inability to extubate|1|||
147212226|NCT05688670|530949074|FG001|Overall Study|Inability to extubate|2|||
147212227|NCT05688670|530949073|FG000|Overall Study|Day of surgery cancellation|0|||
147212228|NCT05688670|530949074|FG001|Overall Study|Day of surgery cancellation|1|||
147212229|NCT05688670|530949073|FG000|Overall Study|Reintubated on PCICU arrival|0|||
147212230|NCT05688670|530949074|FG001|Overall Study|Reintubated on PCICU arrival|1|||
147212231|NCT02537015|530949081|FG000|Overall Study|Adverse Event|3|||
147212232|NCT02537015|530949081|FG000|Overall Study|Withdrawal by Subject|2|||
147212233|NCT02537015|530949081|FG000|Overall Study|Other Miscellaneous Reasons|1|||
147649618|NCT04122625|532537403|FG004|Part B (up to 2.33 Years)|Patient lost to follow-up|2|||
147649619|NCT04122625|532537404|FG005|Part B (up to 2.33 Years)|Patient lost to follow-up|0|||
147649620|NCT04122625|532537399|FG000|Part B (up to 2.33 Years)|Death|0|||
147649621|NCT04122625|532537400|FG001|Part B (up to 2.33 Years)|Death|0|||
147649622|NCT04122625|532537401|FG002|Part B (up to 2.33 Years)|Death|5|||
147649623|NCT04122625|532537402|FG003|Part B (up to 2.33 Years)|Death|7|||
147649624|NCT04122625|532537403|FG004|Part B (up to 2.33 Years)|Death|6|||
147649625|NCT04122625|532537404|FG005|Part B (up to 2.33 Years)|Death|7|||
147649626|NCT02697591|532537405|FG000|Overall Study|Lost to Follow-up|0|||
147649627|NCT02697591|532537406|FG001|Overall Study|Lost to Follow-up|0|||
147649628|NCT02697591|532537407|FG002|Overall Study|Lost to Follow-up|0|||
147649629|NCT02697591|532537408|FG003|Overall Study|Lost to Follow-up|0|||
147649630|NCT02697591|532537409|FG004|Overall Study|Lost to Follow-up|0|||
147649631|NCT02697591|532537410|FG005|Overall Study|Lost to Follow-up|1|||
147649632|NCT02697591|532537411|FG006|Overall Study|Lost to Follow-up|1|||
147649633|NCT02697591|532537412|FG007|Overall Study|Lost to Follow-up|0|||
147649634|NCT02697591|532537413|FG008|Overall Study|Lost to Follow-up|0|||
147649635|NCT02697591|532537414|FG009|Overall Study|Lost to Follow-up|1|||
147649636|NCT02697591|532537405|FG000|Overall Study|Withdrawal by Subject|1|||
147649637|NCT02697591|532537406|FG001|Overall Study|Withdrawal by Subject|1|||
147649638|NCT02697591|532537407|FG002|Overall Study|Withdrawal by Subject|2|||
147649639|NCT02697591|532537408|FG003|Overall Study|Withdrawal by Subject|1|||
147649640|NCT02697591|532537409|FG004|Overall Study|Withdrawal by Subject|7|||
147649641|NCT02697591|532537410|FG005|Overall Study|Withdrawal by Subject|6|||
147649642|NCT02697591|532537411|FG006|Overall Study|Withdrawal by Subject|9|||
147649643|NCT02697591|532537412|FG007|Overall Study|Withdrawal by Subject|1|||
147649644|NCT02697591|532537413|FG008|Overall Study|Withdrawal by Subject|6|||
147649645|NCT02697591|532537414|FG009|Overall Study|Withdrawal by Subject|10|||
147649646|NCT02697591|532537405|FG000|Overall Study|Physician Decision|1|||
147212234|NCT01097005|530949085|FG000|Overall Study|Case Report Form not collected|18|||
147212235|NCT01097005|530949085|FG000|Overall Study|Subjects cannot visit the hospital|1|||
147212236|NCT01097005|530949085|FG000|Overall Study|Poor medication compliance|1|||
147212237|NCT01097005|530949085|FG000|Overall Study|No examination data available|244|||
147212238|NCT01097005|530949085|FG000|Overall Study|Deviation from exclusion criteria|37|||
147212239|NCT01097005|530949085|FG000|Overall Study|Adverse Event|14|||
147212240|NCT01097005|530949085|FG000|Overall Study|Discontinuance by complication|50|||
147649647|NCT02697591|532537406|FG001|Overall Study|Physician Decision|0|||
147649648|NCT02697591|532537407|FG002|Overall Study|Physician Decision|0|||
147649649|NCT02697591|532537408|FG003|Overall Study|Physician Decision|0|||
147212241|NCT04627285|530949086|FG000|Overall Study|Adverse Event|0|||
147212242|NCT04627285|530949087|FG001|Overall Study|Adverse Event|2|||
147649650|NCT02697591|532537409|FG004|Overall Study|Physician Decision|1|||
147212243|NCT04627285|530949086|FG000|Overall Study|Lost to Follow-up|1|||
147212244|NCT04627285|530949087|FG001|Overall Study|Lost to Follow-up|0|||
147212245|NCT04627285|530949086|FG000|Overall Study|Withdrawal by Subject|1|||
147212246|NCT04627285|530949087|FG001|Overall Study|Withdrawal by Subject|1|||
147212247|NCT04627285|530949086|FG000|Overall Study|Sponsor decision|5|||
147212248|NCT04627285|530949087|FG001|Overall Study|Sponsor decision|0|||
147212249|NCT04627285|530949086|FG000|Overall Study|Participant left country; aunt informed the site|0|||
147212250|NCT04627285|530949087|FG001|Overall Study|Participant left country; aunt informed the site|1|||
147212251|NCT00617669|530950406|FG000|Overall Study|Withdrawal by Subject|71|||
147212252|NCT00617669|530950407|FG001|Overall Study|Withdrawal by Subject|77|||
147212253|NCT00617669|530950406|FG000|Overall Study|Lost to Follow-up|3|||
147212254|NCT00617669|530950407|FG001|Overall Study|Lost to Follow-up|2|||
147212255|NCT00617669|530950406|FG000|Overall Study|Adverse Event|87|||
147212256|NCT00617669|530950407|FG001|Overall Study|Adverse Event|76|||
147441908|NCT02138617|531782674|FG002|Overall Study|Physician Decision|0|||
147441909|NCT02138617|531782672|FG000|Overall Study|financial reason|0|||
147441910|NCT02138617|531782673|FG001|Overall Study|financial reason|1|||
147441911|NCT02138617|531782674|FG002|Overall Study|financial reason|0|||
147441912|NCT02138617|531782672|FG000|Overall Study|other therapy|3|||
147441913|NCT02138617|531782673|FG001|Overall Study|other therapy|4|||
147441914|NCT02138617|531782674|FG002|Overall Study|other therapy|0|||
147441915|NCT01961349|531782678|FG000|Overall Study|Withdrawal by Subject|1|||
147441916|NCT01961349|531782679|FG001|Overall Study|Withdrawal by Subject|4|||
147441917|NCT01961349|531782680|FG002|Overall Study|Withdrawal by Subject|0|||
147441918|NCT01961349|531782678|FG000|Overall Study|Adverse Event|0|||
147441919|NCT01961349|531782679|FG001|Overall Study|Adverse Event|0|||
147441920|NCT01961349|531782680|FG002|Overall Study|Adverse Event|1|||
147441921|NCT01961349|531782678|FG000|Overall Study|registration error, personal reason etc|2|||
147441922|NCT01961349|531782679|FG001|Overall Study|registration error, personal reason etc|2|||
147441923|NCT01961349|531782680|FG002|Overall Study|registration error, personal reason etc|1|||
147441924|NCT05525689|531782681|FG000|Overall Study|Lost to Follow-up|1|||
147441925|NCT05525689|531782682|FG001|Overall Study|Lost to Follow-up|0|||
147441926|NCT02343159|531782685|FG000|Overall Study|Early Study Termination|16|||
147441927|NCT02343159|531782686|FG001|Overall Study|Early Study Termination|19|||
147441928|NCT02343159|531782687|FG002|Overall Study|Early Study Termination|23|||
147441929|NCT02343159|531782685|FG000|Overall Study|Physician Decision|2|||
147441930|NCT02343159|531782686|FG001|Overall Study|Physician Decision|0|||
147441931|NCT02343159|531782687|FG002|Overall Study|Physician Decision|1|||
147441932|NCT02343159|531782685|FG000|Overall Study|Withdrawal by Subject|3|||
147441933|NCT02343159|531782686|FG001|Overall Study|Withdrawal by Subject|0|||
147441934|NCT02343159|531782687|FG002|Overall Study|Withdrawal by Subject|2|||
147441935|NCT02343159|531782685|FG000|Overall Study|Lost to Follow-up|0|||
147441936|NCT02343159|531782686|FG001|Overall Study|Lost to Follow-up|2|||
147441937|NCT02343159|531782687|FG002|Overall Study|Lost to Follow-up|2|||
147441938|NCT02343159|531782685|FG000|Overall Study|Adverse Event|4|||
147441939|NCT02343159|531782686|FG001|Overall Study|Adverse Event|4|||
147441940|NCT02343159|531782687|FG002|Overall Study|Adverse Event|2|||
147441941|NCT02343159|531782685|FG000|Overall Study|Sponsor Decision|0|||
147441942|NCT02343159|531782686|FG001|Overall Study|Sponsor Decision|1|||
147441943|NCT02343159|531782687|FG002|Overall Study|Sponsor Decision|0|||
147441944|NCT02343159|531782685|FG000|Overall Study|Enrollment Error|1|||
147441945|NCT02343159|531782686|FG001|Overall Study|Enrollment Error|0|||
147441946|NCT02343159|531782687|FG002|Overall Study|Enrollment Error|0|||
147441947|NCT00509067|531782690|FG000|Overall Study|Lost to Follow-up|1|||
147441948|NCT00509067|531782691|FG001|Overall Study|Lost to Follow-up|1|||
147441949|NCT00509067|531782690|FG000|Overall Study|Adverse Event|3|||
147441950|NCT00509067|531782691|FG001|Overall Study|Adverse Event|1|||
147441951|NCT00509067|531782690|FG000|Overall Study|Protocol Violation|0|||
147441952|NCT00509067|531782691|FG001|Overall Study|Protocol Violation|3|||
147441953|NCT01846624|531782692|FG000|Overall Study|Died during induction, no midostaurin|1|||
147441954|NCT04702737|531782693|FG000|Overall Study|Decision by Sponsor|1|||
147441955|NCT04702737|531782693|FG000|Overall Study|Withdrawal of Consent from Study|3|||
147441956|NCT04702737|531782693|FG000|Overall Study|Lost to Follow-up|1|||
147441957|NCT04702737|531782693|FG000|Overall Study|Death|35|||
147441958|NCT01177683|531782694|FG000|Study Treatment|Disease Progressions during treatment|2|||
147441959|NCT01177683|531782695|FG001|Study Treatment|Disease Progressions during treatment|0|||
147441960|NCT01177683|531782696|FG002|Study Treatment|Disease Progressions during treatment|3|||
147441961|NCT01177683|531782694|FG000|Study Treatment|Adverse Event|0|||
147441962|NCT01177683|531782695|FG001|Study Treatment|Adverse Event|1|||
147441963|NCT01177683|531782696|FG002|Study Treatment|Adverse Event|12|||
147441964|NCT01177683|531782694|FG000|Study Treatment|Patient Withdrawal After Therapy Start|0|||
147441965|NCT01177683|531782695|FG001|Study Treatment|Patient Withdrawal After Therapy Start|2|||
147441966|NCT01177683|531782696|FG002|Study Treatment|Patient Withdrawal After Therapy Start|1|||
147441967|NCT01177683|531782694|FG000|Study Treatment|Alternative therapy|0|||
147441968|NCT01177683|531782695|FG001|Study Treatment|Alternative therapy|0|||
147441969|NCT01177683|531782696|FG002|Study Treatment|Alternative therapy|4|||
147441970|NCT01177683|531782694|FG000|Study Treatment|Physician Decision|1|||
147546113|NCT02217345|532156063|FG001|Overall Study|Adverse Event|1|||
147546114|NCT02217345|532156062|FG000|Overall Study|Physician Decision|0|||
147546115|NCT02217345|532156063|FG001|Overall Study|Physician Decision|1|||
147546116|NCT00789828|532156068|FG000|Core Period (48 Weeks)|Administrative problems|0|||
147546117|NCT00789828|532156069|FG001|Core Period (48 Weeks)|Administrative problems|1|||
147546118|NCT00789828|532156068|FG000|Core Period (48 Weeks)|Withdrawal by Subject|0|||
147546119|NCT00789828|532156069|FG001|Core Period (48 Weeks)|Withdrawal by Subject|4|||
147546120|NCT00789828|532156068|FG000|Core Period (48 Weeks)|Lost to Follow-up|0|||
147546121|NCT00789828|532156069|FG001|Core Period (48 Weeks)|Lost to Follow-up|1|||
147546122|NCT00789828|532156068|FG000|Open-label Extension Period (4 Years)|Adverse Event|10|||
147546123|NCT00789828|532156069|FG001|Open-label Extension Period (4 Years)|Adverse Event|0|||
147546124|NCT00789828|532156068|FG000|Open-label Extension Period (4 Years)|Withdrawal by Subject|6|||
147546125|NCT00789828|532156069|FG001|Open-label Extension Period (4 Years)|Withdrawal by Subject|0|||
147546126|NCT00789828|532156068|FG000|Open-label Extension Period (4 Years)|Lost to Follow-up|3|||
147546127|NCT00789828|532156069|FG001|Open-label Extension Period (4 Years)|Lost to Follow-up|0|||
147546128|NCT00789828|532156068|FG000|Open-label Extension Period (4 Years)|Administrative problems|7|||
147546129|NCT00789828|532156069|FG001|Open-label Extension Period (4 Years)|Administrative problems|0|||
147546130|NCT00789828|532156068|FG000|Open-label Extension Period (4 Years)|Death|1|||
147546131|NCT00789828|532156069|FG001|Open-label Extension Period (4 Years)|Death|0|||
147546132|NCT00789828|532156068|FG000|Open-label Extension Period (4 Years)|Disease progression|1|||
147546133|NCT00789828|532156069|FG001|Open-label Extension Period (4 Years)|Disease progression|0|||
147546134|NCT00789828|532156068|FG000|Open-label Extension Period (4 Years)|New treatment for indication under study|1|||
147546135|NCT00789828|532156069|FG001|Open-label Extension Period (4 Years)|New treatment for indication under study|0|||
147546136|NCT02623426|532156070|FG000|Overall Study|Lost to Follow-up|0|||
147546137|NCT02623426|532156071|FG001|Overall Study|Lost to Follow-up|0|||
147546138|NCT02623426|532156072|FG002|Overall Study|Lost to Follow-up|1|||
147546139|NCT02623426|532156070|FG000|Overall Study|Withdrawal by Subject|1|||
147546140|NCT02623426|532156071|FG001|Overall Study|Withdrawal by Subject|2|||
147546141|NCT02623426|532156072|FG002|Overall Study|Withdrawal by Subject|2|||
147546142|NCT02094937|532156073|FG000|8 Weeks in Period 1|Adverse Event|9|||
147546143|NCT02094937|532156074|FG001|8 Weeks in Period 1|Adverse Event|0|||
147546144|NCT02094937|532156075|FG002|8 Weeks in Period 1|Adverse Event|0|||
147546145|NCT02094937|532156076|FG003|8 Weeks in Period 1|Adverse Event|0|||
147546146|NCT02094937|532156073|FG000|8 Weeks in Period 1|Lack of Efficacy|3|||
147546147|NCT02094937|532156074|FG001|8 Weeks in Period 1|Lack of Efficacy|0|||
147546148|NCT02094937|532156075|FG002|8 Weeks in Period 1|Lack of Efficacy|0|||
147546149|NCT02094937|532156076|FG003|8 Weeks in Period 1|Lack of Efficacy|0|||
147546150|NCT02094937|532156073|FG000|8 Weeks in Period 1|Protocol Violation|2|||
147546151|NCT02094937|532156074|FG001|8 Weeks in Period 1|Protocol Violation|0|||
147546152|NCT02094937|532156075|FG002|8 Weeks in Period 1|Protocol Violation|0|||
147546153|NCT02094937|532156076|FG003|8 Weeks in Period 1|Protocol Violation|0|||
147546154|NCT02094937|532156073|FG000|8 Weeks in Period 1|Protocol defined stopping criteria|41|||
147546155|NCT02094937|532156074|FG001|8 Weeks in Period 1|Protocol defined stopping criteria|0|||
147546156|NCT02094937|532156075|FG002|8 Weeks in Period 1|Protocol defined stopping criteria|0|||
147546157|NCT02094937|532156076|FG003|8 Weeks in Period 1|Protocol defined stopping criteria|0|||
147546158|NCT02094937|532156073|FG000|8 Weeks in Period 1|Physician Decision|1|||
147546159|NCT02094937|532156074|FG001|8 Weeks in Period 1|Physician Decision|0|||
147546160|NCT02094937|532156075|FG002|8 Weeks in Period 1|Physician Decision|0|||
147546161|NCT02094937|532156076|FG003|8 Weeks in Period 1|Physician Decision|0|||
147546162|NCT02094937|532156073|FG000|8 Weeks in Period 1|Withdrawal by Subject|4|||
147546163|NCT02094937|532156074|FG001|8 Weeks in Period 1|Withdrawal by Subject|0|||
147546164|NCT02094937|532156075|FG002|8 Weeks in Period 1|Withdrawal by Subject|0|||
147546165|NCT02094937|532156076|FG003|8 Weeks in Period 1|Withdrawal by Subject|0|||
147546166|NCT02094937|532156073|FG000|12 Weeks in Period 2|Adverse Event|0|||
147546167|NCT02094937|532156074|FG001|12 Weeks in Period 2|Adverse Event|2|||
147546168|NCT02094937|532156075|FG002|12 Weeks in Period 2|Adverse Event|4|||
147546169|NCT02094937|532156076|FG003|12 Weeks in Period 2|Adverse Event|1|||
147546170|NCT02094937|532156073|FG000|12 Weeks in Period 2|Lack of Efficacy|0|||
147546171|NCT02094937|532156074|FG001|12 Weeks in Period 2|Lack of Efficacy|1|||
147546172|NCT02094937|532156075|FG002|12 Weeks in Period 2|Lack of Efficacy|0|||
147546173|NCT02094937|532156076|FG003|12 Weeks in Period 2|Lack of Efficacy|0|||
147546174|NCT02094937|532156073|FG000|12 Weeks in Period 2|Protocol defined stopping criteria|0|||
147546175|NCT02094937|532156074|FG001|12 Weeks in Period 2|Protocol defined stopping criteria|5|||
147212257|NCT00617669|530950406|FG000|Overall Study|Protocol Violation|2|||
147212258|NCT00617669|530950407|FG001|Overall Study|Protocol Violation|3|||
147212259|NCT00617669|530950406|FG000|Overall Study|Reason not otherwise captured, eg; death|265|||
147212260|NCT00617669|530950407|FG001|Overall Study|Reason not otherwise captured, eg; death|290|||
147212261|NCT00617669|530950406|FG000|Overall Study|Patients randomized but not treated|2|||
147212262|NCT00617669|530950407|FG001|Overall Study|Patients randomized but not treated|3|||
147546176|NCT02094937|532156075|FG002|12 Weeks in Period 2|Protocol defined stopping criteria|6|||
147546177|NCT02094937|532156076|FG003|12 Weeks in Period 2|Protocol defined stopping criteria|11|||
147546178|NCT02094937|532156073|FG000|12 Weeks in Period 2|Withdrawal by Subject|0|||
147546179|NCT02094937|532156074|FG001|12 Weeks in Period 2|Withdrawal by Subject|2|||
147546180|NCT02094937|532156075|FG002|12 Weeks in Period 2|Withdrawal by Subject|2|||
147546181|NCT02094937|532156076|FG003|12 Weeks in Period 2|Withdrawal by Subject|0|||
147546182|NCT02094937|532156073|FG000|12 Weeks in Period 2|Randomized incorrectly|0|||
147546183|NCT02094937|532156074|FG001|12 Weeks in Period 2|Randomized incorrectly|1|||
147546184|NCT02094937|532156075|FG002|12 Weeks in Period 2|Randomized incorrectly|0|||
147546185|NCT02094937|532156076|FG003|12 Weeks in Period 2|Randomized incorrectly|0|||
147546186|NCT01133392|532156077|FG000|Interval Between Dosing (4-7 Days)|Withdrawal by Subject|0|||
147546187|NCT01133392|532156078|FG001|Interval Between Dosing (4-7 Days)|Withdrawal by Subject|1|||
147546188|NCT01133392|532156077|FG000|Interval Between Dosing (4-7 Days)|Protocol Violation|0|||
147546189|NCT01133392|532156078|FG001|Interval Between Dosing (4-7 Days)|Protocol Violation|1|||
147546190|NCT03185949|532156079|FG000|ITT Analysis|Withdrawal by Subject|4|||
147546191|NCT03185949|532156080|FG001|ITT Analysis|Withdrawal by Subject|3|||
147546192|NCT03185949|532156079|FG000|PP Analysis|Protocol Violation|2|||
147546193|NCT03185949|532156080|FG001|PP Analysis|Protocol Violation|2|||
147546194|NCT03185949|532156079|FG000|PP Analysis|Failed/Incomplete LGA embolization|0|||
147546195|NCT03185949|532156080|FG001|PP Analysis|Failed/Incomplete LGA embolization|2|||
147546196|NCT05788237|532156086|FG000|SSA (Approximately 2 Months)|No longer met eligibility criteria|0|||
147546197|NCT05788237|532156087|FG001|SSA (Approximately 2 Months)|No longer met eligibility criteria|1|||
147546198|NCT05788237|532156088|FG002|SSA (Approximately 2 Months)|No longer met eligibility criteria|0|||
147546199|NCT05788237|532156089|FG003|SSA (Approximately 2 Months)|No longer met eligibility criteria|0|||
147546200|NCT05788237|532156086|FG000|SSA (Approximately 2 Months)|Lost to Follow-up|0|||
147546201|NCT05788237|532156087|FG001|SSA (Approximately 2 Months)|Lost to Follow-up|1|||
147546202|NCT05788237|532156088|FG002|SSA (Approximately 2 Months)|Lost to Follow-up|0|||
147546203|NCT05788237|532156089|FG003|SSA (Approximately 2 Months)|Lost to Follow-up|0|||
147546204|NCT05788237|532156086|FG000|SSA (Approximately 2 Months)|Withdrawal by Subject|4|||
147546205|NCT05788237|532156087|FG001|SSA (Approximately 2 Months)|Withdrawal by Subject|8|||
147546206|NCT05788237|532156088|FG002|SSA (Approximately 2 Months)|Withdrawal by Subject|0|||
147546207|NCT05788237|532156089|FG003|SSA (Approximately 2 Months)|Withdrawal by Subject|0|||
147546208|NCT05788237|532156086|FG000|SSA (Approximately 2 Months)|Adverse Event|1|||
147546209|NCT05788237|532156087|FG001|SSA (Approximately 2 Months)|Adverse Event|2|||
147546210|NCT05788237|532156088|FG002|SSA (Approximately 2 Months)|Adverse Event|0|||
147546211|NCT05788237|532156089|FG003|SSA (Approximately 2 Months)|Adverse Event|0|||
147546212|NCT05788237|532156086|FG000|SSA (Approximately 2 Months)|Death|0|||
147546213|NCT05788237|532156087|FG001|SSA (Approximately 2 Months)|Death|1|||
147546214|NCT05788237|532156088|FG002|SSA (Approximately 2 Months)|Death|0|||
147546215|NCT05788237|532156089|FG003|SSA (Approximately 2 Months)|Death|0|||
147546216|NCT05788237|532156086|FG000|SSB (Approximately 1 Month)|Not Vaccinated|0|||
147546217|NCT05788237|532156087|FG001|SSB (Approximately 1 Month)|Not Vaccinated|0|||
147546218|NCT05788237|532156088|FG002|SSB (Approximately 1 Month)|Not Vaccinated|1|||
147546219|NCT05788237|532156089|FG003|SSB (Approximately 1 Month)|Not Vaccinated|0|||
147546220|NCT05788237|532156086|FG000|SSB (Approximately 1 Month)|Refused further study procedures|0|||
147546221|NCT05788237|532156087|FG001|SSB (Approximately 1 Month)|Refused further study procedures|0|||
147546222|NCT05788237|532156088|FG002|SSB (Approximately 1 Month)|Refused further study procedures|0|||
147546223|NCT05788237|532156089|FG003|SSB (Approximately 1 Month)|Refused further study procedures|1|||
147546224|NCT05788237|532156086|FG000|SSB (Approximately 1 Month)|Other|0|||
147546225|NCT05788237|532156087|FG001|SSB (Approximately 1 Month)|Other|0|||
147546226|NCT05788237|532156088|FG002|SSB (Approximately 1 Month)|Other|0|||
147546227|NCT05788237|532156089|FG003|SSB (Approximately 1 Month)|Other|1|||
147546228|NCT03751124|532156090|FG000|Overall Study|Adverse Event|4|||
147546229|NCT03751124|532156091|FG001|Overall Study|Adverse Event|3|||
147546230|NCT03751124|532156090|FG000|Overall Study|Protocol Deviation|0|||
147546231|NCT03751124|532156091|FG001|Overall Study|Protocol Deviation|1|||
147546232|NCT03751124|532156090|FG000|Overall Study|Lost to Follow-up|6|||
147212263|NCT03680742|530950408|FG000|Overall Study|Unsuccessful Implant Attempt|2|||
147546233|NCT03751124|532156091|FG001|Overall Study|Lost to Follow-up|4|||
147546234|NCT03751124|532156090|FG000|Overall Study|Withdrawal by Subject|6|||
147546235|NCT03751124|532156091|FG001|Overall Study|Withdrawal by Subject|8|||
147546236|NCT03751124|532156090|FG000|Overall Study|Lack of Efficacy|1|||
147546237|NCT03751124|532156091|FG001|Overall Study|Lack of Efficacy|1|||
147546238|NCT03751124|532156090|FG000|Overall Study|Pregnancy|0|||
147546239|NCT03751124|532156091|FG001|Overall Study|Pregnancy|1|||
147546240|NCT03751124|532156090|FG000|Overall Study|Other|9|||
147546241|NCT03751124|532156091|FG001|Overall Study|Other|9|||
147546242|NCT03751124|532156090|FG000|Overall Study|Participants who did not receive any study drug|0|||
147546243|NCT03751124|532156091|FG001|Overall Study|Participants who did not receive any study drug|1|||
147546244|NCT00555399|532156102|FG000|Overall Study|Withdrawal by Subject|0|||
147546245|NCT00555399|532156103|FG001|Overall Study|Withdrawal by Subject|0|||
147649651|NCT02697591|532537410|FG005|Overall Study|Physician Decision|2|||
147649652|NCT02697591|532537411|FG006|Overall Study|Physician Decision|0|||
147649653|NCT02697591|532537412|FG007|Overall Study|Physician Decision|0|||
147649654|NCT02697591|532537413|FG008|Overall Study|Physician Decision|1|||
147649655|NCT02697591|532537414|FG009|Overall Study|Physician Decision|1|||
147649656|NCT02697591|532537405|FG000|Overall Study|Death|2|||
147649657|NCT02697591|532537406|FG001|Overall Study|Death|3|||
147649658|NCT02697591|532537407|FG002|Overall Study|Death|1|||
147649659|NCT02697591|532537408|FG003|Overall Study|Death|1|||
147649660|NCT02697591|532537409|FG004|Overall Study|Death|4|||
147649661|NCT02697591|532537410|FG005|Overall Study|Death|5|||
147649662|NCT02697591|532537411|FG006|Overall Study|Death|3|||
147649663|NCT02697591|532537412|FG007|Overall Study|Death|1|||
147649664|NCT02697591|532537413|FG008|Overall Study|Death|1|||
147649665|NCT02697591|532537414|FG009|Overall Study|Death|5|||
147649666|NCT02697591|532537405|FG000|Overall Study|Reason not Specified|0|||
147649667|NCT02697591|532537406|FG001|Overall Study|Reason not Specified|0|||
147649668|NCT02697591|532537407|FG002|Overall Study|Reason not Specified|0|||
147649669|NCT02697591|532537408|FG003|Overall Study|Reason not Specified|1|||
147649670|NCT02697591|532537409|FG004|Overall Study|Reason not Specified|1|||
147649671|NCT02697591|532537410|FG005|Overall Study|Reason not Specified|2|||
147649672|NCT02697591|532537411|FG006|Overall Study|Reason not Specified|3|||
147649673|NCT02697591|532537412|FG007|Overall Study|Reason not Specified|1|||
147649674|NCT02697591|532537413|FG008|Overall Study|Reason not Specified|1|||
147649675|NCT02697591|532537414|FG009|Overall Study|Reason not Specified|3|||
147649676|NCT01939223|532537415|FG000|Overall Study|AE not assoc. with disease recurrence|1|||
147649677|NCT01939223|532537416|FG001|Overall Study|AE not assoc. with disease recurrence|1|||
147649678|NCT01939223|532537415|FG000|Overall Study|Disease recurrence (radiological)|1|||
147649679|NCT01939223|532537416|FG001|Overall Study|Disease recurrence (radiological)|3|||
147649680|NCT01939223|532537415|FG000|Overall Study|Study stopped by Sponsor|5|||
147649681|NCT01939223|532537416|FG001|Overall Study|Study stopped by Sponsor|7|||
147649682|NCT01939223|532537415|FG000|Overall Study|Withdrawal by Subject|6|||
147649683|NCT01939223|532537416|FG001|Overall Study|Withdrawal by Subject|0|||
147649684|NCT01853696|532537419|FG000|Overall Study|Withdrawal by Subject|1|||
147649685|NCT01853696|532537420|FG001|Overall Study|Withdrawal by Subject|1|||
147649686|NCT01853696|532537419|FG000|Overall Study|Lost to Follow-up|5|||
147649687|NCT01853696|532537420|FG001|Overall Study|Lost to Follow-up|4|||
147649688|NCT00438256|532537423|FG000|Overall Study|Ineligible for Resection|2|||
147649689|NCT00438256|532537424|FG001|Overall Study|Ineligible for Resection|1|||
147649690|NCT00438256|532537425|FG002|Overall Study|Ineligible for Resection|1|||
147649691|NCT00438256|532537426|FG003|Overall Study|Ineligible for Resection|7|||
147649692|NCT00438256|532537423|FG000|Overall Study|Excluded final Diagnosis|0|||
147649693|NCT00438256|532537424|FG001|Overall Study|Excluded final Diagnosis|0|||
147649694|NCT00438256|532537425|FG002|Overall Study|Excluded final Diagnosis|0|||
147649695|NCT00438256|532537426|FG003|Overall Study|Excluded final Diagnosis|2|||
147649696|NCT01964716|532537440|FG000|Overall Study|Withdrawal by Subject|2|||
147546246|NCT00555399|532156104|FG002|Overall Study|Withdrawal by Subject|1|||
147546247|NCT00555399|532156105|FG003|Overall Study|Withdrawal by Subject|0|||
147546248|NCT00555399|532156106|FG004|Overall Study|Withdrawal by Subject|0|||
147649697|NCT01964716|532537441|FG001|Overall Study|Withdrawal by Subject|3|||
147649698|NCT01964716|532537440|FG000|Overall Study|Lost to Follow-up|1|||
147212264|NCT02894502|530950409|FG000|Baseline|Withdrawal by Subject|24|||
147649699|NCT01964716|532537441|FG001|Overall Study|Lost to Follow-up|2|||
147649700|NCT01964716|532537440|FG000|Overall Study|No longer met eligibility criteria|1|||
147649701|NCT01964716|532537441|FG001|Overall Study|No longer met eligibility criteria|1|||
147649702|NCT01964716|532537440|FG000|Overall Study|Death|1|||
147649703|NCT01964716|532537441|FG001|Overall Study|Death|0|||
147649704|NCT03913104|532537446|FG000|Overall Study|Lost to Follow-up|20|||
147649705|NCT03913104|532537446|FG000|Overall Study|Did Not Take Mifepristone or Misoprostol|8|||
147649706|NCT03913104|532537446|FG000|Overall Study|Withdrawal by Subject|2|||
147546249|NCT00555399|532156107|FG005|Overall Study|Withdrawal by Subject|0|||
147546250|NCT00555399|532156108|FG006|Overall Study|Withdrawal by Subject|0|||
147546251|NCT00555399|532156109|FG007|Overall Study|Withdrawal by Subject|0|||
147546252|NCT00555399|532156110|FG008|Overall Study|Withdrawal by Subject|0|||
147649707|NCT01370616|532537447|FG000|Overall Study|Adverse Event|11|||
147649708|NCT01370616|532537448|FG001|Overall Study|Adverse Event|16|||
147649709|NCT01370616|532537447|FG000|Overall Study|Death|1|||
147649710|NCT01370616|532537448|FG001|Overall Study|Death|0|||
147649711|NCT01370616|532537447|FG000|Overall Study|Lack of Efficacy|6|||
147649712|NCT01370616|532537448|FG001|Overall Study|Lack of Efficacy|2|||
147649713|NCT01370616|532537447|FG000|Overall Study|Lost to Follow-up|0|||
147649714|NCT01370616|532537448|FG001|Overall Study|Lost to Follow-up|3|||
147649715|NCT01370616|532537447|FG000|Overall Study|Physician Decision|6|||
147649716|NCT01370616|532537448|FG001|Overall Study|Physician Decision|6|||
147649717|NCT01370616|532537447|FG000|Overall Study|Progressive Disease|0|||
147649718|NCT01370616|532537448|FG001|Overall Study|Progressive Disease|1|||
147649719|NCT01370616|532537447|FG000|Overall Study|Recovery|1|||
147649720|NCT01370616|532537448|FG001|Overall Study|Recovery|0|||
147649721|NCT01370616|532537447|FG000|Overall Study|Technical Problems|3|||
147649722|NCT01370616|532537448|FG001|Overall Study|Technical Problems|5|||
147649723|NCT01370616|532537447|FG000|Overall Study|Withdrawal by Subject|34|||
147649724|NCT01370616|532537448|FG001|Overall Study|Withdrawal by Subject|34|||
147649725|NCT01693185|532537451|FG000|Overall Study|diagnostic procedure after colonoscopy|0|||
147649726|NCT01693185|532537452|FG001|Overall Study|diagnostic procedure after colonoscopy|6|||
147649727|NCT03742258|532537462|FG000|Continued Treatment After 1st Response|Adverse Event|0|||
147649728|NCT03742258|532537463|FG001|Continued Treatment After 1st Response|Adverse Event|1|||
147649729|NCT03742258|532537464|FG002|Continued Treatment After 1st Response|Adverse Event|1|||
147649730|NCT03742258|532537462|FG000|Continued Treatment After 1st Response|Withdrawal by Subject|0|||
147649731|NCT03742258|532537463|FG001|Continued Treatment After 1st Response|Withdrawal by Subject|0|||
147649732|NCT03742258|532537464|FG002|Continued Treatment After 1st Response|Withdrawal by Subject|1|||
147649733|NCT03742258|532537462|FG000|Survival Follow-Up|Still in Follow-up|0|||
147649734|NCT03742258|532537463|FG001|Survival Follow-Up|Still in Follow-up|0|||
147649735|NCT03742258|532537464|FG002|Survival Follow-Up|Still in Follow-up|2|||
147649736|NCT01380691|532537469|FG000|Washout (7 Days)|Protocol Violation|0|||
147649737|NCT01380691|532537470|FG001|Washout (7 Days)|Protocol Violation|0|||
147649738|NCT01380691|532537471|FG002|Washout (7 Days)|Protocol Violation|0|||
147649739|NCT01380691|532537472|FG003|Washout (7 Days)|Protocol Violation|1|||
147441971|NCT01177683|531782695|FG001|Study Treatment|Physician Decision|0|||
147441972|NCT01177683|531782696|FG002|Study Treatment|Physician Decision|1|||
147441973|NCT01177683|531782694|FG000|Study Treatment|Patient withdrawal before therapy start|0|||
147441974|NCT01177683|531782695|FG001|Study Treatment|Patient withdrawal before therapy start|0|||
147441975|NCT01177683|531782696|FG002|Study Treatment|Patient withdrawal before therapy start|1|||
147441976|NCT01177683|531782694|FG000|Study Treatment|Symptomatic Deterioration|0|||
147441977|NCT01177683|531782695|FG001|Study Treatment|Symptomatic Deterioration|0|||
147441978|NCT01177683|531782696|FG002|Study Treatment|Symptomatic Deterioration|1|||
147441979|NCT01177683|531782694|FG000|Study Treatment|Subject came off study without receiving any treatment.|0|||
147441980|NCT01177683|531782695|FG001|Study Treatment|Subject came off study without receiving any treatment.|0|||
147441981|NCT01177683|531782696|FG002|Study Treatment|Subject came off study without receiving any treatment.|1|||
147441982|NCT01177683|531782694|FG000|Follow up|Patient lost to follow up|0|||
147441983|NCT01177683|531782695|FG001|Follow up|Patient lost to follow up|0|||
147441984|NCT01177683|531782696|FG002|Follow up|Patient lost to follow up|2|||
147441985|NCT01177683|531782694|FG000|Follow up|Death|2|||
147441986|NCT01177683|531782695|FG001|Follow up|Death|1|||
147441987|NCT01177683|531782696|FG002|Follow up|Death|7|||
147441988|NCT01177683|531782694|FG000|Follow up|Study closed by Sponsor due slow enrollment.|1|||
147441989|NCT01177683|531782695|FG001|Follow up|Study closed by Sponsor due slow enrollment.|2|||
147441990|NCT01177683|531782696|FG002|Follow up|Study closed by Sponsor due slow enrollment.|15|||
147441991|NCT01977820|531782700|FG000|Overall Study|Sponsor terminated the study|1|||
147441992|NCT01977820|531782701|FG001|Overall Study|Sponsor terminated the study|1|||
147441993|NCT02568475|531782705|FG000|Overall Study|Lost to Follow-up|40|||
147441994|NCT02568475|531782706|FG001|Overall Study|Lost to Follow-up|39|||
147441995|NCT02568475|531782705|FG000|Overall Study|Withdrawal by Subject|2|||
147441996|NCT02568475|531782706|FG001|Overall Study|Withdrawal by Subject|0|||
147441997|NCT02568475|531782705|FG000|Overall Study|Discharged home|4|||
147441998|NCT02568475|531782706|FG001|Overall Study|Discharged home|4|||
147441999|NCT02568475|531782705|FG000|Overall Study|Short-term: Discharge location unknown|4|||
147442000|NCT02568475|531782706|FG001|Overall Study|Short-term: Discharge location unknown|0|||
147442001|NCT02568475|531782705|FG000|Overall Study|Transferred to another facility|1|||
147442002|NCT02568475|531782706|FG001|Overall Study|Transferred to another facility|0|||
147442003|NCT02625233|531782707|FG000|Overall Study|Adverse Event|2|||
147442004|NCT02625233|531782708|FG001|Overall Study|Adverse Event|0|||
147442005|NCT04425720|531782718|FG000|Overall Study|Withdrawal by Subject|0|||
147442006|NCT04425720|531782719|FG001|Overall Study|Withdrawal by Subject|20|||
147442007|NCT00290186|531782720|FG000|Overall Study|Adverse Event|1|||
147442008|NCT00290186|531782721|FG001|Overall Study|Adverse Event|1|||
147442009|NCT00290186|531782720|FG000|Overall Study|Lost to Follow-up|3|||
147442010|NCT00290186|531782721|FG001|Overall Study|Lost to Follow-up|2|||
147212265|NCT02894502|530950410|FG001|Baseline|Withdrawal by Subject|31|||
147546253|NCT00555399|532156111|FG009|Overall Study|Withdrawal by Subject|0|||
147546254|NCT00555399|532156112|FG010|Overall Study|Withdrawal by Subject|0|||
147546255|NCT00555399|532156113|FG011|Overall Study|Withdrawal by Subject|1|||
147546256|NCT00555399|532156102|FG000|Overall Study|Patient decided not to proceed with treatment|0|||
147546257|NCT00555399|532156103|FG001|Overall Study|Patient decided not to proceed with treatment|0|||
147546258|NCT00555399|532156104|FG002|Overall Study|Patient decided not to proceed with treatment|1|||
147546259|NCT00555399|532156105|FG003|Overall Study|Patient decided not to proceed with treatment|0|||
147546260|NCT00555399|532156106|FG004|Overall Study|Patient decided not to proceed with treatment|0|||
147546261|NCT00555399|532156107|FG005|Overall Study|Patient decided not to proceed with treatment|0|||
147212266|NCT02894502|530950411|FG002|Baseline|Withdrawal by Subject|36|||
147212267|NCT02894502|530950409|FG000|Baseline|Death|3|||
147212268|NCT02894502|530950410|FG001|Baseline|Death|1|||
147212269|NCT02894502|530950411|FG002|Baseline|Death|9|||
147212270|NCT02894502|530950409|FG000|First Follow up|Withdrawal by Subject|32|||
147212271|NCT02894502|530950410|FG001|First Follow up|Withdrawal by Subject|29|||
147212272|NCT02894502|530950411|FG002|First Follow up|Withdrawal by Subject|37|||
147212273|NCT02894502|530950409|FG000|First Follow up|Death|2|||
147212274|NCT02894502|530950410|FG001|First Follow up|Death|2|||
147212275|NCT02894502|530950411|FG002|First Follow up|Death|3|||
147212276|NCT02894502|530950409|FG000|Second Follow up|Withdrawal by Subject|13|||
147212277|NCT02894502|530950410|FG001|Second Follow up|Withdrawal by Subject|15|||
147212278|NCT02894502|530950411|FG002|Second Follow up|Withdrawal by Subject|13|||
147212279|NCT02894502|530950409|FG000|Second Follow up|Death|2|||
147212280|NCT02894502|530950410|FG001|Second Follow up|Death|3|||
147212281|NCT02894502|530950411|FG002|Second Follow up|Death|1|||
147212282|NCT02894502|530950409|FG000|Third Follow up|Withdrawal by Subject|5|||
147212283|NCT02894502|530950410|FG001|Third Follow up|Withdrawal by Subject|6|||
147212284|NCT02894502|530950411|FG002|Third Follow up|Withdrawal by Subject|3|||
147212285|NCT02894502|530950409|FG000|Third Follow up|Death|1|||
147212286|NCT02894502|530950410|FG001|Third Follow up|Death|1|||
147212287|NCT02894502|530950411|FG002|Third Follow up|Death|0|||
147212288|NCT00615901|530950412|FG000|Overall Study|Withdrawal by Subject|2|||
147212289|NCT00615901|530950412|FG000|Overall Study|Adverse Event|7|||
147212290|NCT00796445|530950417|FG000|Overall Study|Protocol Violation|5|||
147212291|NCT00796445|530950418|FG001|Overall Study|Protocol Violation|3|||
147212292|NCT00796445|530950417|FG000|Overall Study|Adverse event, serious fatal|10|||
147212293|NCT00796445|530950418|FG001|Overall Study|Adverse event, serious fatal|5|||
147212294|NCT00796445|530950417|FG000|Overall Study|Adverse event, non-fatal|4|||
147212295|NCT00796445|530950418|FG001|Overall Study|Adverse event, non-fatal|0|||
147212296|NCT00796445|530950417|FG000|Overall Study|Disease progression/recurrence|537|||
147212297|NCT00796445|530950418|FG001|Overall Study|Disease progression/recurrence|268|||
147546262|NCT00555399|532156108|FG006|Overall Study|Patient decided not to proceed with treatment|0|||
147546263|NCT00555399|532156109|FG007|Overall Study|Patient decided not to proceed with treatment|0|||
147546264|NCT00555399|532156110|FG008|Overall Study|Patient decided not to proceed with treatment|0|||
147546265|NCT00555399|532156111|FG009|Overall Study|Patient decided not to proceed with treatment|0|||
147546266|NCT00555399|532156112|FG010|Overall Study|Patient decided not to proceed with treatment|0|||
147546267|NCT00555399|532156113|FG011|Overall Study|Patient decided not to proceed with treatment|0|||
147546268|NCT05458895|532156114|FG000|Overall Study|Withdrawal by Subject|8|||
147546269|NCT05458895|532156114|FG000|Overall Study|Lost to Follow-up|17|||
147546270|NCT05458895|532156114|FG000|Overall Study|Pregnancy|2|||
147546271|NCT05458895|532156114|FG000|Overall Study|Withdrawal by Study Team|1|||
147546272|NCT04639310|532156115|FG000|Overall Study|Subject qualified to rollover to open label extension due to meeting disease worsening criteria|0|||
147546273|NCT04639310|532156116|FG001|Overall Study|Subject qualified to rollover to open label extension due to meeting disease worsening criteria|1|||
147546274|NCT01835470|532157645|FG000|Long Term Treatment Period|Subject Request to Discontinue|1|||
147546275|NCT01835470|532157645|FG000|Long Term Treatment Period|Lack of Efficacy|3|||
147546276|NCT01011907|532157646|FG000|Overall Study|Withdrawal by Subject|13|||
147546277|NCT01011907|532157647|FG001|Overall Study|Withdrawal by Subject|11|||
147546278|NCT01011907|532157646|FG000|Overall Study|Adverse Event|1|||
147546279|NCT01011907|532157647|FG001|Overall Study|Adverse Event|4|||
147546280|NCT00304954|532157648|FG000|Overall Study|Withdrawal by Subject|0|||
147546281|NCT00304954|532157649|FG001|Overall Study|Withdrawal by Subject|0|||
147546282|NCT00304954|532157650|FG002|Overall Study|Withdrawal by Subject|1|||
147546283|NCT00304954|532157651|FG003|Overall Study|Withdrawal by Subject|0|||
147546284|NCT00304954|532157648|FG000|Overall Study|Adverse Event|1|||
147546285|NCT00304954|532157649|FG001|Overall Study|Adverse Event|0|||
147546286|NCT00304954|532157650|FG002|Overall Study|Adverse Event|0|||
147546287|NCT00304954|532157651|FG003|Overall Study|Adverse Event|0|||
147546288|NCT01406873|532157656|FG000|Overall Study|Withdrawal by Subject|1|||
147546289|NCT01406873|532157657|FG001|Overall Study|Withdrawal by Subject|1|||
147546290|NCT00207714|532157658|FG000|Overall Study|Adverse Event|6|||
147546291|NCT00207714|532157659|FG001|Overall Study|Adverse Event|2|||
147212298|NCT00796445|530950417|FG000|Overall Study|Other|10|||
147212299|NCT00796445|530950418|FG001|Overall Study|Other|7|||
147546292|NCT00207714|532157660|FG002|Overall Study|Adverse Event|4|||
147546293|NCT00207714|532157661|FG003|Overall Study|Adverse Event|3|||
147546294|NCT00207714|532157662|FG004|Overall Study|Adverse Event|1|||
147546295|NCT00207714|532157658|FG000|Overall Study|Unsatisfactory therapeutic effect|5|||
147546296|NCT00207714|532157659|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
147546297|NCT00207714|532157660|FG002|Overall Study|Unsatisfactory therapeutic effect|1|||
147546298|NCT00207714|532157661|FG003|Overall Study|Unsatisfactory therapeutic effect|4|||
147546299|NCT00207714|532157662|FG004|Overall Study|Unsatisfactory therapeutic effect|4|||
147546300|NCT00207714|532157658|FG000|Overall Study|Other|3|||
147546301|NCT00207714|532157659|FG001|Overall Study|Other|2|||
147546302|NCT00207714|532157660|FG002|Overall Study|Other|5|||
147546303|NCT00207714|532157661|FG003|Overall Study|Other|1|||
147546304|NCT00207714|532157662|FG004|Overall Study|Other|0|||
147546305|NCT03627195|532157663|FG000|Overall Study|OTHER (LACK OF EFFICACY)|1|||
147546306|NCT03627195|532157664|FG001|Overall Study|OTHER (LACK OF EFFICACY)|0|||
147546307|NCT03627195|532157665|FG002|Overall Study|OTHER (LACK OF EFFICACY)|0|||
147546308|NCT03627195|532157666|FG003|Overall Study|OTHER (LACK OF EFFICACY)|0|||
147546309|NCT03627195|532157667|FG004|Overall Study|OTHER (LACK OF EFFICACY)|0|||
147546310|NCT03627195|532157668|FG005|Overall Study|OTHER (LACK OF EFFICACY)|0|||
147546311|NCT02290028|532157671|FG000|Overall Study|Death|217|||
147546312|NCT02290028|532157671|FG000|Overall Study|Sentus lead or required CRT-D was not implanted|186|||
147546313|NCT02290028|532157671|FG000|Overall Study|No longer under care of study physician|76|||
147546314|NCT02290028|532157671|FG000|Overall Study|Sentus lead or required CRT-D explanted|55|||
147546315|NCT02290028|532157671|FG000|Overall Study|Withdrawal by Subject|52|||
147546316|NCT02290028|532157671|FG000|Overall Study|Study site closure|44|||
147546317|NCT02290028|532157671|FG000|Overall Study|Lost to Follow-up|34|||
147546318|NCT02290028|532157671|FG000|Overall Study|Miscellaneous|10|||
147546319|NCT02290028|532157671|FG000|Overall Study|Transition to EP PASSION|1295|||
147546320|NCT02290028|532157671|FG000|Overall Study|Planned study completion at 12 months|257|||
147546321|NCT03862625|532157672|FG000|Overall Study|Lost to Follow-up|0|||
147212300|NCT00796445|530950417|FG000|Overall Study|Withdrawal by Subject|18|||
147649740|NCT01380691|532537469|FG000|Washout (7 Days)|Withdrawal by Subject|0|||
147546322|NCT03862625|532157673|FG001|Overall Study|Lost to Follow-up|1|||
147546323|NCT00856778|532157675|FG000|Overall Study|Adverse Event|7|||
147546324|NCT00856778|532157675|FG000|Overall Study|Withdrawal by Subject|10|||
147649741|NCT01380691|532537470|FG001|Washout (7 Days)|Withdrawal by Subject|0|||
147649742|NCT01380691|532537471|FG002|Washout (7 Days)|Withdrawal by Subject|1|||
147649743|NCT01380691|532537472|FG003|Washout (7 Days)|Withdrawal by Subject|0|||
147649744|NCT01048099|532537473|FG000|Patients Enrolled and Blood Collected|Patients without circulating tumor cells|57|||
147649745|NCT01048099|532537473|FG000|Patients Evaluated by PRO Onc Assay|Patients with no HER2 abnormality|202|||
147649746|NCT01731470|532537474|FG000|Overall Study|Withdrawal by Subject|1|||
147649747|NCT01731470|532537474|FG000|Overall Study|Did not meet study criteria|1|||
147649748|NCT00358956|532537475|FG000|Overall Study|Adverse Event|3|||
147649749|NCT00358956|532537475|FG000|Overall Study|condition under investigation worsened|4|||
147649750|NCT00358956|532537475|FG000|Overall Study|Withdrawal by Subject|1|||
147649751|NCT03300050|532539680|FG000|Overall Study|Lost to Follow-up|2|||
147649752|NCT03300050|532539681|FG001|Overall Study|Lost to Follow-up|1|||
147649753|NCT03300050|532539682|FG002|Overall Study|Lost to Follow-up|0|||
147649754|NCT03300050|532539683|FG003|Overall Study|Lost to Follow-up|0|||
147649755|NCT03300050|532539684|FG004|Overall Study|Lost to Follow-up|1|||
147649756|NCT03300050|532539680|FG000|Overall Study|Withdrawal by Subject|1|||
147649757|NCT03300050|532539681|FG001|Overall Study|Withdrawal by Subject|1|||
147649758|NCT03300050|532539682|FG002|Overall Study|Withdrawal by Subject|1|||
147649759|NCT03300050|532539683|FG003|Overall Study|Withdrawal by Subject|0|||
147649760|NCT03300050|532539684|FG004|Overall Study|Withdrawal by Subject|0|||
147649761|NCT03300050|532539680|FG000|Overall Study|Death|0|||
147649762|NCT03300050|532539681|FG001|Overall Study|Death|0|||
147649763|NCT03300050|532539682|FG002|Overall Study|Death|1|||
147212301|NCT00796445|530950418|FG001|Overall Study|Withdrawal by Subject|9|||
147212302|NCT00796445|530950417|FG000|Overall Study|Invalid Informed Consent Form|1|||
147212303|NCT00796445|530950418|FG001|Overall Study|Invalid Informed Consent Form|0|||
147212304|NCT00388583|530950419|FG000|Overall Study|Protocol Violation|1|||
147649764|NCT03300050|532539683|FG003|Overall Study|Death|0|||
147649765|NCT03300050|532539684|FG004|Overall Study|Death|0|||
147649766|NCT03300050|532539680|FG000|Overall Study|Not Eligible at Randomization|0|||
147649767|NCT03300050|532539681|FG001|Overall Study|Not Eligible at Randomization|0|||
147649768|NCT03300050|532539682|FG002|Overall Study|Not Eligible at Randomization|1|||
147546325|NCT00856778|532157675|FG000|Overall Study|Study deviation|2|||
147546326|NCT00856778|532157675|FG000|Overall Study|Lost to Follow-up|5|||
147546327|NCT01681771|532157676|FG000|Overall Study|Lost to Follow-up|4|||
147546328|NCT01681771|532157677|FG001|Overall Study|Lost to Follow-up|2|||
147546329|NCT04242186|532157680|FG000|Overall Study|Death|5|||
147212305|NCT00388583|530950420|FG001|Overall Study|Protocol Violation|0|||
147546330|NCT00550420|532157681|FG000|Overall Study|Adverse Event|28|||
147546331|NCT00550420|532157681|FG000|Overall Study|Lost to Follow-up|8|||
147546332|NCT00550420|532157681|FG000|Overall Study|Protocol Violation|11|||
147649769|NCT03300050|532539683|FG003|Overall Study|Not Eligible at Randomization|1|||
147649770|NCT03300050|532539684|FG004|Overall Study|Not Eligible at Randomization|0|||
147546333|NCT00550420|532157681|FG000|Overall Study|Withdrawal by Subject|30|||
147649771|NCT03594955|532539685|FG000|Overall Study|Adverse Event|1|||
147649772|NCT03594955|532539685|FG000|Overall Study|Progressive disease|5|||
147649773|NCT03594955|532539685|FG000|Overall Study|Sponsor's decision|1|||
147649774|NCT01066663|532539687|FG000|Overall Study|Adverse Event|0|||
147649775|NCT01066663|532539688|FG001|Overall Study|Adverse Event|0|||
147649776|NCT01066663|532539689|FG002|Overall Study|Adverse Event|1|||
147649777|NCT01090050|532539690|FG000|Overall Study|Lost to Follow-up|0|||
147649778|NCT01090050|532539691|FG001|Overall Study|Lost to Follow-up|1|||
147649779|NCT01090050|532539690|FG000|Overall Study|Lack of Efficacy|1|||
147649780|NCT01090050|532539691|FG001|Overall Study|Lack of Efficacy|5|||
147649781|NCT01090050|532539690|FG000|Overall Study|Physician Decision|0|||
147649782|NCT01090050|532539691|FG001|Overall Study|Physician Decision|1|||
147649783|NCT03539484|532539692|FG000|Overall Study|Death|1|||
147649784|NCT03539484|532539693|FG001|Overall Study|Death|0|||
147649785|NCT03539484|532539694|FG002|Overall Study|Death|0|||
147649786|NCT03539484|532539695|FG003|Overall Study|Death|2|||
147649787|NCT03539484|532539696|FG004|Overall Study|Death|8|||
147649788|NCT03539484|532539697|FG005|Overall Study|Death|3|||
147649789|NCT03539484|532539698|FG006|Overall Study|Death|0|||
147649790|NCT03539484|532539692|FG000|Overall Study|Lost to Follow-up|0|||
147649791|NCT03539484|532539693|FG001|Overall Study|Lost to Follow-up|1|||
147649792|NCT03539484|532539694|FG002|Overall Study|Lost to Follow-up|0|||
147649793|NCT03539484|532539695|FG003|Overall Study|Lost to Follow-up|0|||
147649794|NCT03539484|532539696|FG004|Overall Study|Lost to Follow-up|1|||
147649795|NCT03539484|532539697|FG005|Overall Study|Lost to Follow-up|0|||
147649796|NCT03539484|532539698|FG006|Overall Study|Lost to Follow-up|0|||
147649797|NCT03539484|532539692|FG000|Overall Study|Withdrawal by Subject|0|||
147546334|NCT00550420|532157681|FG000|Overall Study|Still in study at termination|206|||
147546335|NCT00550420|532157681|FG000|Overall Study|Missing|2|||
147546336|NCT00550420|532157681|FG000|Overall Study|Prolonged QT Interval Electrocardiogram|12|||
147546337|NCT00550420|532157681|FG000|Overall Study|Investigators opinion|1|||
147546338|NCT00550420|532157681|FG000|Overall Study|Lack of curative effect|1|||
147546339|NCT00550420|532157681|FG000|Overall Study|Unethical stop of enrollment|2|||
147546340|NCT00550420|532157681|FG000|Overall Study|Caregiver's decision to withdraw|1|||
147649798|NCT03539484|532539693|FG001|Overall Study|Withdrawal by Subject|0|||
147649799|NCT03539484|532539694|FG002|Overall Study|Withdrawal by Subject|0|||
147649800|NCT03539484|532539695|FG003|Overall Study|Withdrawal by Subject|0|||
147649801|NCT03539484|532539696|FG004|Overall Study|Withdrawal by Subject|2|||
147649802|NCT03539484|532539697|FG005|Overall Study|Withdrawal by Subject|0|||
147649803|NCT03539484|532539698|FG006|Overall Study|Withdrawal by Subject|1|||
147649804|NCT03539484|532539692|FG000|Overall Study|Study Terminated by Sponsor|0|||
147649805|NCT03539484|532539693|FG001|Overall Study|Study Terminated by Sponsor|0|||
147649806|NCT03539484|532539694|FG002|Overall Study|Study Terminated by Sponsor|1|||
147649807|NCT03539484|532539695|FG003|Overall Study|Study Terminated by Sponsor|1|||
147649808|NCT03539484|532539696|FG004|Overall Study|Study Terminated by Sponsor|2|||
147649809|NCT03539484|532539697|FG005|Overall Study|Study Terminated by Sponsor|2|||
147649810|NCT03539484|532539698|FG006|Overall Study|Study Terminated by Sponsor|1|||
147649811|NCT02232061|532539699|FG000|Overall Study|Administrative problems|1|||
147649812|NCT02232061|532539699|FG000|Overall Study|Withdrawal by Subject|1|||
147649813|NCT00571103|532539700|FG000|Overall Study|Withdrawal by Subject|1|||
147649814|NCT00571103|532539700|FG000|Overall Study|Lost to Follow-up|1|||
147649815|NCT06010732|532539703|FG000|Crossover Period 1|Protocol Violation|0|||
147649816|NCT06010732|532539704|FG001|Crossover Period 1|Protocol Violation|0|||
147649817|NCT06010732|532539705|FG002|Crossover Period 1|Protocol Violation|1|||
147649818|NCT06010732|532539706|FG003|Crossover Period 1|Protocol Violation|0|||
147649819|NCT06010732|532539707|FG004|Crossover Period 1|Protocol Violation|1|||
147649820|NCT06010732|532539708|FG005|Crossover Period 1|Protocol Violation|0|||
147649821|NCT06010732|532539703|FG000|Washout Between Periods 1 and 2|Withdrawal by Subject|0|||
147649822|NCT06010732|532539704|FG001|Washout Between Periods 1 and 2|Withdrawal by Subject|1|||
147649823|NCT06010732|532539705|FG002|Washout Between Periods 1 and 2|Withdrawal by Subject|0|||
147546341|NCT00550420|532157681|FG000|Overall Study|Out of Electrocardiogram criteria|1|||
147546342|NCT00550420|532157681|FG000|Overall Study|Exclusion criteria|1|||
147546343|NCT00550420|532157681|FG000|Overall Study|Prohibited medicine|1|||
147649824|NCT06010732|532539706|FG003|Washout Between Periods 1 and 2|Withdrawal by Subject|0|||
147649825|NCT06010732|532539707|FG004|Washout Between Periods 1 and 2|Withdrawal by Subject|0|||
147649826|NCT06010732|532539708|FG005|Washout Between Periods 1 and 2|Withdrawal by Subject|0|||
147649827|NCT06010732|532539703|FG000|Crossover Period 2|Adverse Event|0|||
147649828|NCT06010732|532539704|FG001|Crossover Period 2|Adverse Event|1|||
147649829|NCT06010732|532539705|FG002|Crossover Period 2|Adverse Event|0|||
147649830|NCT06010732|532539706|FG003|Crossover Period 2|Adverse Event|0|||
147649831|NCT06010732|532539707|FG004|Crossover Period 2|Adverse Event|0|||
147649832|NCT06010732|532539708|FG005|Crossover Period 2|Adverse Event|0|||
147649833|NCT06010732|532539703|FG000|Crossover Period 2|broken denture|0|||
147546344|NCT00331773|532157682|FG000|Overall Study|Withdrawal by Subject|6|||
147546345|NCT00331773|532157683|FG001|Overall Study|Withdrawal by Subject|4|||
147546346|NCT00331773|532157682|FG000|Overall Study|Protocol Violation|10|||
147546347|NCT00331773|532157683|FG001|Overall Study|Protocol Violation|3|||
147546348|NCT01792284|532157684|FG000|Lead-in Period|Adverse Event|15|||
147546349|NCT01792284|532157685|FG001|Lead-in Period|Adverse Event|0|||
147546350|NCT01792284|532157686|FG002|Lead-in Period|Adverse Event|0|||
147546351|NCT01792284|532157684|FG000|Lead-in Period|Lost to Follow-up|2|||
147546352|NCT01792284|532157685|FG001|Lead-in Period|Lost to Follow-up|0|||
147546353|NCT01792284|532157686|FG002|Lead-in Period|Lost to Follow-up|0|||
147546354|NCT01792284|532157684|FG000|Lead-in Period|Protocol Violation|1|||
147546355|NCT01792284|532157685|FG001|Lead-in Period|Protocol Violation|0|||
147546356|NCT01792284|532157686|FG002|Lead-in Period|Protocol Violation|0|||
147546357|NCT01792284|532157684|FG000|Lead-in Period|Withdrawal by Subject|10|||
147546358|NCT01792284|532157685|FG001|Lead-in Period|Withdrawal by Subject|0|||
147546359|NCT01792284|532157686|FG002|Lead-in Period|Withdrawal by Subject|0|||
147546360|NCT01792284|532157684|FG000|Lead-in Period|Physician Decision|1|||
147546361|NCT01792284|532157685|FG001|Lead-in Period|Physician Decision|0|||
147546362|NCT01792284|532157686|FG002|Lead-in Period|Physician Decision|0|||
147546363|NCT01792284|532157684|FG000|Lead-in Period|Protocol Required Discontinuation|1|||
147546364|NCT01792284|532157685|FG001|Lead-in Period|Protocol Required Discontinuation|0|||
147546365|NCT01792284|532157686|FG002|Lead-in Period|Protocol Required Discontinuation|0|||
147546366|NCT01792284|532157684|FG000|Randomization Period 1|Withdrawal by Subject|0|||
147546367|NCT01792284|532157685|FG001|Randomization Period 1|Withdrawal by Subject|1|||
147546368|NCT01792284|532157686|FG002|Randomization Period 1|Withdrawal by Subject|1|||
147546369|NCT01792284|532157684|FG000|Randomization Period 1|Physician Decision|0|||
147546370|NCT01792284|532157685|FG001|Randomization Period 1|Physician Decision|1|||
147546371|NCT01792284|532157686|FG002|Randomization Period 1|Physician Decision|1|||
147546372|NCT01792284|532157684|FG000|Randomization Period 1|Adverse Event|0|||
147546373|NCT01792284|532157685|FG001|Randomization Period 1|Adverse Event|0|||
147546374|NCT01792284|532157686|FG002|Randomization Period 1|Adverse Event|2|||
147546375|NCT01792284|532157684|FG000|Randomization Period 1|Lost to Follow-up|0|||
147546376|NCT01792284|532157685|FG001|Randomization Period 1|Lost to Follow-up|0|||
147546377|NCT01792284|532157686|FG002|Randomization Period 1|Lost to Follow-up|1|||
147546378|NCT01792284|532157684|FG000|Randomization Period 2|Protocol Violation|0|||
147546379|NCT01792284|532157685|FG001|Randomization Period 2|Protocol Violation|1|||
147546380|NCT01792284|532157686|FG002|Randomization Period 2|Protocol Violation|0|||
147546381|NCT01792284|532157684|FG000|Randomization Period 2|Withdrawal by Subject|0|||
147546382|NCT01792284|532157685|FG001|Randomization Period 2|Withdrawal by Subject|2|||
147546383|NCT01792284|532157686|FG002|Randomization Period 2|Withdrawal by Subject|0|||
147546384|NCT00379587|532157692|FG000|Overall Study|Lost to Follow-up|2|||
147546385|NCT00054275|532157695|FG000|Overall Study|Withdrawal by Subject|4|||
147546386|NCT00054275|532157695|FG000|Overall Study|Adverse Event|5|||
147546387|NCT00054275|532157695|FG000|Overall Study|Progressive disease in cycle 1|1|||
147546388|NCT00054275|532157695|FG000|Overall Study|Physician Decision|1|||
147546389|NCT00755937|532157696|FG000|Recruitment|Unknown if infliximab received|164|||
147546390|NCT00755937|532157696|FG000|Observational Follow-up|Lost to Follow-up|148|||
147546391|NCT01106352|532157697|FG000|Overall Study|Subjects untreated|0|||
147546392|NCT01106352|532157698|FG001|Overall Study|Subjects untreated|0|||
147546393|NCT01106352|532157699|FG002|Overall Study|Subjects untreated|0|||
147546394|NCT01106352|532157700|FG003|Overall Study|Subjects untreated|3|||
147546395|NCT01106352|532157701|FG004|Overall Study|Subjects untreated|4|||
147546396|NCT01106352|532157697|FG000|Overall Study|Sponsor Decision|1|||
147546397|NCT01106352|532157698|FG001|Overall Study|Sponsor Decision|0|||
147546398|NCT01106352|532157699|FG002|Overall Study|Sponsor Decision|0|||
147546399|NCT01106352|532157700|FG003|Overall Study|Sponsor Decision|0|||
147546400|NCT01106352|532157701|FG004|Overall Study|Sponsor Decision|0|||
147546401|NCT01106352|532157697|FG000|Overall Study|Too ill to come in for the visit|0|||
147546402|NCT01106352|532157698|FG001|Overall Study|Too ill to come in for the visit|0|||
147546403|NCT01106352|532157699|FG002|Overall Study|Too ill to come in for the visit|1|||
147546404|NCT01106352|532157700|FG003|Overall Study|Too ill to come in for the visit|0|||
147546405|NCT01106352|532157701|FG004|Overall Study|Too ill to come in for the visit|0|||
147546406|NCT01106352|532157697|FG000|Overall Study|Lost to Follow-up|0|||
147546407|NCT01106352|532157698|FG001|Overall Study|Lost to Follow-up|0|||
147546408|NCT01106352|532157699|FG002|Overall Study|Lost to Follow-up|0|||
147546409|NCT01106352|532157700|FG003|Overall Study|Lost to Follow-up|0|||
147546410|NCT01106352|532157701|FG004|Overall Study|Lost to Follow-up|1|||
147546411|NCT01106352|532157697|FG000|Overall Study|Death|0|||
147546412|NCT01106352|532157698|FG001|Overall Study|Death|0|||
147546413|NCT01106352|532157699|FG002|Overall Study|Death|1|||
147546414|NCT01106352|532157700|FG003|Overall Study|Death|3|||
147546415|NCT01106352|532157701|FG004|Overall Study|Death|1|||
147546416|NCT01106352|532157697|FG000|Overall Study|Disease progression|0|||
147546417|NCT01106352|532157698|FG001|Overall Study|Disease progression|0|||
147546418|NCT01106352|532157699|FG002|Overall Study|Disease progression|0|||
147546419|NCT01106352|532157700|FG003|Overall Study|Disease progression|1|||
147546420|NCT01106352|532157701|FG004|Overall Study|Disease progression|0|||
147649834|NCT06010732|532539704|FG001|Crossover Period 2|broken denture|0|||
147546421|NCT01106352|532157697|FG000|Overall Study|Withdrawal by Subject|0|||
147546422|NCT01106352|532157698|FG001|Overall Study|Withdrawal by Subject|0|||
147546423|NCT01106352|532157699|FG002|Overall Study|Withdrawal by Subject|0|||
147442011|NCT00290186|531782720|FG000|Overall Study|Study was terminated prior to 3-month te|1|||
147442012|NCT00290186|531782721|FG001|Overall Study|Study was terminated prior to 3-month te|1|||
147442013|NCT00290186|531782720|FG000|Overall Study|Withdrawal by Subject|0|||
147442014|NCT00290186|531782721|FG001|Overall Study|Withdrawal by Subject|1|||
147442015|NCT03184077|531782724|FG000|Overall Study|Lost to Follow-up|21|||
147442016|NCT03184077|531782725|FG001|Overall Study|Lost to Follow-up|21|||
147442017|NCT00262522|531782728|FG000|Study Start Through 8 Weeks|Adverse Event|1|||
147442018|NCT00262522|531782729|FG001|Study Start Through 8 Weeks|Adverse Event|2|||
147442019|NCT00262522|531782730|FG002|Study Start Through 8 Weeks|Adverse Event|3|||
147442020|NCT00262522|531782731|FG003|Study Start Through 8 Weeks|Adverse Event|1|||
147442021|NCT00262522|531782728|FG000|Study Start Through 8 Weeks|Withdrawal by Subject|1|||
147442022|NCT00262522|531782729|FG001|Study Start Through 8 Weeks|Withdrawal by Subject|1|||
147442023|NCT00262522|531782730|FG002|Study Start Through 8 Weeks|Withdrawal by Subject|3|||
147442024|NCT00262522|531782731|FG003|Study Start Through 8 Weeks|Withdrawal by Subject|0|||
147442025|NCT00262522|531782728|FG000|Study Start Through 8 Weeks|Lost to Follow-up|1|||
147442026|NCT00262522|531782729|FG001|Study Start Through 8 Weeks|Lost to Follow-up|2|||
147442027|NCT00262522|531782730|FG002|Study Start Through 8 Weeks|Lost to Follow-up|3|||
147442028|NCT00262522|531782731|FG003|Study Start Through 8 Weeks|Lost to Follow-up|2|||
147442029|NCT00262522|531782728|FG000|Study Start Through 8 Weeks|Noncompliance|0|||
147442030|NCT00262522|531782729|FG001|Study Start Through 8 Weeks|Noncompliance|0|||
147442031|NCT00262522|531782730|FG002|Study Start Through 8 Weeks|Noncompliance|2|||
147442032|NCT00262522|531782731|FG003|Study Start Through 8 Weeks|Noncompliance|2|||
147442033|NCT00262522|531782728|FG000|Study Start Through 8 Weeks|Death|1|||
147442034|NCT00262522|531782729|FG001|Study Start Through 8 Weeks|Death|0|||
147442035|NCT00262522|531782730|FG002|Study Start Through 8 Weeks|Death|0|||
147442036|NCT00262522|531782731|FG003|Study Start Through 8 Weeks|Death|0|||
147442037|NCT00262522|531782728|FG000|Study Start Through 48 Weeks|Adverse Event|16|||
147442038|NCT00262522|531782729|FG001|Study Start Through 48 Weeks|Adverse Event|0|||
147442039|NCT00262522|531782730|FG002|Study Start Through 48 Weeks|Adverse Event|10|||
147442040|NCT00262522|531782731|FG003|Study Start Through 48 Weeks|Adverse Event|0|||
147546424|NCT01106352|532157700|FG003|Overall Study|Withdrawal by Subject|3|||
147546425|NCT01106352|532157701|FG004|Overall Study|Withdrawal by Subject|2|||
147546426|NCT01106352|532157697|FG000|Overall Study|Went on hospice|0|||
147546427|NCT01106352|532157698|FG001|Overall Study|Went on hospice|0|||
147546428|NCT01106352|532157699|FG002|Overall Study|Went on hospice|0|||
147546429|NCT01106352|532157700|FG003|Overall Study|Went on hospice|1|||
147546430|NCT01106352|532157701|FG004|Overall Study|Went on hospice|0|||
147546431|NCT01106352|532157697|FG000|Overall Study|Subject entered hospice|0|||
147546432|NCT01106352|532157698|FG001|Overall Study|Subject entered hospice|0|||
147546433|NCT01106352|532157699|FG002|Overall Study|Subject entered hospice|0|||
147546434|NCT01106352|532157700|FG003|Overall Study|Subject entered hospice|1|||
147546435|NCT01106352|532157701|FG004|Overall Study|Subject entered hospice|0|||
147546436|NCT01106352|532157697|FG000|Overall Study|Home hospice since July 2013|0|||
147546437|NCT01106352|532157698|FG001|Overall Study|Home hospice since July 2013|0|||
147546438|NCT01106352|532157699|FG002|Overall Study|Home hospice since July 2013|0|||
147546439|NCT01106352|532157700|FG003|Overall Study|Home hospice since July 2013|1|||
147546440|NCT01106352|532157701|FG004|Overall Study|Home hospice since July 2013|0|||
147546441|NCT03876873|532157702|FG000|Overall Study|Physician Decision|0|||
147546442|NCT03876873|532157703|FG001|Overall Study|Physician Decision|1|||
147546443|NCT03547531|532157704|FG000|Overall Study|not coming in data collection : sick|2|||
147546444|NCT03547531|532157705|FG001|Overall Study|not coming in data collection : sick|2|||
147546445|NCT03547531|532157704|FG000|Overall Study|having family occasion|0|||
147546446|NCT03547531|532157705|FG001|Overall Study|having family occasion|2|||
147546447|NCT03944707|532157706|FG000|Overall Study|Adverse Event|0|||
147546448|NCT03944707|532157707|FG001|Overall Study|Adverse Event|2|||
147546449|NCT03944707|532157706|FG000|Overall Study|Study terminated by sponsor|12|||
147546450|NCT03944707|532157707|FG001|Overall Study|Study terminated by sponsor|7|||
147546451|NCT03944707|532157706|FG000|Overall Study|Subject decision|0|||
147546452|NCT03944707|532157707|FG001|Overall Study|Subject decision|1|||
147546453|NCT03402126|532157715|FG000|Overall Study|Lost to Follow-up|6|||
147546454|NCT03402126|532157715|FG000|Overall Study|Protocol Violation|10|||
147546455|NCT03402126|532157715|FG000|Overall Study|Sponsor request/Study termination|29|||
147546456|NCT03402126|532157715|FG000|Overall Study|Study product no longer in use|1|||
147546457|NCT03402126|532157715|FG000|Overall Study|Technical problems|1|||
147442041|NCT00262522|531782728|FG000|Study Start Through 48 Weeks|Withdrawal by Subject|10|||
147442042|NCT00262522|531782729|FG001|Study Start Through 48 Weeks|Withdrawal by Subject|0|||
147442043|NCT00262522|531782730|FG002|Study Start Through 48 Weeks|Withdrawal by Subject|11|||
147546458|NCT03402126|532157715|FG000|Overall Study|Withdrawal by Subject|6|||
147546459|NCT03402126|532157715|FG000|Overall Study|Physician Decision|2|||
147546460|NCT03402126|532157715|FG000|Overall Study|upgrade to Cardiac Resynchronization Therapy-Defibrillator/stage IV cancer|3|||
147546461|NCT03402126|532157715|FG000|Overall Study|Death|4|||
147546462|NCT02444182|532157716|FG000|Overall Study|non-compliance|2|||
147546463|NCT02444182|532157717|FG001|Overall Study|non-compliance|1|||
147546464|NCT02444182|532157716|FG000|Overall Study|Lost to Follow-up|0|||
147546465|NCT02444182|532157717|FG001|Overall Study|Lost to Follow-up|4|||
147546466|NCT01959230|532157720|FG000|Overall Study|Failure to follow study procedures|0|||
147546467|NCT01959230|532157721|FG001|Overall Study|Failure to follow study procedures|1|||
147546468|NCT01959230|532157720|FG000|Overall Study|Administrative reasons|2|||
147546469|NCT01959230|532157721|FG001|Overall Study|Administrative reasons|0|||
147546470|NCT01959230|532157720|FG000|Overall Study|Withdrawal by Subject|2|||
147546471|NCT01959230|532157721|FG001|Overall Study|Withdrawal by Subject|0|||
147546472|NCT01965535|532157722|FG000|Overall Study|Lack of Efficacy|2|||
147546473|NCT01965535|532157723|FG001|Overall Study|Lack of Efficacy|1|||
147546474|NCT01825876|532157724|FG000|Period 2|Withdrawal by Subject|0|||
147546475|NCT01825876|532157725|FG001|Period 2|Withdrawal by Subject|1|||
147546476|NCT03751020|532157728|FG000|Overall Study|Withdrawal by Subject|2|||
147546477|NCT03751020|532157729|FG001|Overall Study|Withdrawal by Subject|0|||
147546478|NCT03751020|532157730|FG002|Overall Study|Withdrawal by Subject|0|||
147546479|NCT03751020|532157728|FG000|Overall Study|Lost to Follow-up|7|||
147546480|NCT03751020|532157729|FG001|Overall Study|Lost to Follow-up|4|||
147546481|NCT03751020|532157730|FG002|Overall Study|Lost to Follow-up|10|||
147546482|NCT01889862|532157731|FG000|Part 1 (Up to 13 Weeks)|Adverse Event|4|||
147546483|NCT01889862|532157732|FG001|Part 1 (Up to 13 Weeks)|Adverse Event|0|||
147546484|NCT01889862|532157733|FG002|Part 1 (Up to 13 Weeks)|Adverse Event|0|||
147546485|NCT01889862|532157734|FG003|Part 1 (Up to 13 Weeks)|Adverse Event|0|||
147546486|NCT01889862|532157735|FG004|Part 1 (Up to 13 Weeks)|Adverse Event|0|||
147546487|NCT01889862|532157731|FG000|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|2|||
147546488|NCT01889862|532157732|FG001|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|0|||
147546489|NCT01889862|532157733|FG002|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|0|||
147546490|NCT01889862|532157734|FG003|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|0|||
147546491|NCT01889862|532157735|FG004|Part 1 (Up to 13 Weeks)|Withdrawal by Subject|0|||
147546492|NCT01889862|532157731|FG000|Part 1 (Up to 13 Weeks)|Lost to Follow-up|4|||
147546493|NCT01889862|532157732|FG001|Part 1 (Up to 13 Weeks)|Lost to Follow-up|0|||
147546494|NCT01889862|532157733|FG002|Part 1 (Up to 13 Weeks)|Lost to Follow-up|0|||
147546495|NCT01889862|532157734|FG003|Part 1 (Up to 13 Weeks)|Lost to Follow-up|0|||
147546496|NCT01889862|532157735|FG004|Part 1 (Up to 13 Weeks)|Lost to Follow-up|0|||
147546497|NCT01889862|532157731|FG000|Part 1 (Up to 13 Weeks)|Physician Decision|2|||
147546498|NCT01889862|532157732|FG001|Part 1 (Up to 13 Weeks)|Physician Decision|0|||
147546499|NCT01889862|532157733|FG002|Part 1 (Up to 13 Weeks)|Physician Decision|0|||
147546500|NCT01889862|532157734|FG003|Part 1 (Up to 13 Weeks)|Physician Decision|0|||
147546501|NCT01889862|532157735|FG004|Part 1 (Up to 13 Weeks)|Physician Decision|0|||
147546502|NCT01889862|532157731|FG000|Part 2 (8 Weeks)|Withdrawal by Subject|0|||
147546503|NCT01889862|532157732|FG001|Part 2 (8 Weeks)|Withdrawal by Subject|0|||
147546504|NCT01889862|532157733|FG002|Part 2 (8 Weeks)|Withdrawal by Subject|1|||
147546505|NCT01889862|532157734|FG003|Part 2 (8 Weeks)|Withdrawal by Subject|0|||
147546506|NCT01889862|532157735|FG004|Part 2 (8 Weeks)|Withdrawal by Subject|0|||
147546507|NCT01889862|532157731|FG000|Part 4 (Up to 274 Weeks)|Adverse Event|0|||
147546508|NCT01889862|532157732|FG001|Part 4 (Up to 274 Weeks)|Adverse Event|0|||
147546509|NCT01889862|532157733|FG002|Part 4 (Up to 274 Weeks)|Adverse Event|0|||
147546510|NCT01889862|532157734|FG003|Part 4 (Up to 274 Weeks)|Adverse Event|0|||
147546511|NCT01889862|532157735|FG004|Part 4 (Up to 274 Weeks)|Adverse Event|5|||
147546512|NCT01889862|532157731|FG000|Part 4 (Up to 274 Weeks)|Subject withdrew consent|0|||
147546513|NCT01889862|532157732|FG001|Part 4 (Up to 274 Weeks)|Subject withdrew consent|0|||
147649835|NCT06010732|532539705|FG002|Crossover Period 2|broken denture|1|||
147649836|NCT06010732|532539706|FG003|Crossover Period 2|broken denture|0|||
147649837|NCT06010732|532539707|FG004|Crossover Period 2|broken denture|0|||
147649838|NCT06010732|532539708|FG005|Crossover Period 2|broken denture|0|||
147649839|NCT04401202|532539709|FG000|Overall Study|Lost to Follow-up|2|||
147649840|NCT04401202|532539710|FG001|Overall Study|Lost to Follow-up|2|||
147649841|NCT04401202|532539709|FG000|Overall Study|Adverse Event|0|||
147649842|NCT04401202|532539710|FG001|Overall Study|Adverse Event|1|||
147649843|NCT04401202|532539709|FG000|Overall Study|Hospitalized|4|||
147649844|NCT04401202|532539710|FG001|Overall Study|Hospitalized|1|||
147649845|NCT02714036|532539712|FG000|Overall Study|Adverse Event|9|||
147649846|NCT02714036|532539713|FG001|Overall Study|Adverse Event|2|||
147649847|NCT02714036|532539712|FG000|Overall Study|Withdrawal by Subject|3|||
147649848|NCT02714036|532539713|FG001|Overall Study|Withdrawal by Subject|2|||
147649849|NCT01006590|532539715|FG000|Overall Study|Adverse Event|2|||
147649850|NCT01006590|532539716|FG001|Overall Study|Adverse Event|3|||
147649851|NCT01006590|532539715|FG000|Overall Study|Death|1|||
147649852|NCT01006590|532539716|FG001|Overall Study|Death|1|||
147649853|NCT01006590|532539715|FG000|Overall Study|Lost to Follow-up|1|||
147649854|NCT01006590|532539716|FG001|Overall Study|Lost to Follow-up|1|||
147649855|NCT01006590|532539715|FG000|Overall Study|Protocol Violation|1|||
147649856|NCT01006590|532539716|FG001|Overall Study|Protocol Violation|0|||
147649857|NCT01006590|532539715|FG000|Overall Study|Withdrawal by Subject|4|||
147649858|NCT01006590|532539716|FG001|Overall Study|Withdrawal by Subject|2|||
147649859|NCT01006590|532539715|FG000|Overall Study|Study specific discontinuation criteria|16|||
147649860|NCT01006590|532539716|FG001|Overall Study|Study specific discontinuation criteria|23|||
147649861|NCT01006590|532539715|FG000|Overall Study|Other|3|||
147649862|NCT01006590|532539716|FG001|Overall Study|Other|2|||
147212306|NCT00388583|530950419|FG000|Overall Study|Withdrawal by Subject|3|||
147212307|NCT00388583|530950420|FG001|Overall Study|Withdrawal by Subject|3|||
147212308|NCT00388583|530950419|FG000|Overall Study|Serious Adverse Event|2|||
147212309|NCT00388583|530950420|FG001|Overall Study|Serious Adverse Event|0|||
147212310|NCT00388583|530950419|FG000|Overall Study|Did not receive vaccine|0|||
147212311|NCT00388583|530950420|FG001|Overall Study|Did not receive vaccine|1|||
147212312|NCT05194579|530950423|FG000|Overall Study|Lost to Follow-up|2|||
147212313|NCT05194579|530950424|FG001|Overall Study|Lost to Follow-up|3|||
147212314|NCT05194579|530950423|FG000|Overall Study|Withdrawal by Subject|3|||
147212315|NCT05194579|530950424|FG001|Overall Study|Withdrawal by Subject|4|||
147212316|NCT05194579|530950423|FG000|Overall Study|Refused further study procedures|0|||
147212317|NCT05194579|530950424|FG001|Overall Study|Refused further study procedures|1|||
147212318|NCT05194579|530950423|FG000|Overall Study|Protocol deviation|1|||
147212319|NCT05194579|530950424|FG001|Overall Study|Protocol deviation|0|||
147212320|NCT03595228|530950429|FG000|Overall Study|Death|2|||
147212321|NCT03595228|530950429|FG000|Overall Study|Lack of Efficacy|13|||
147212322|NCT03595228|530950429|FG000|Overall Study|Withdrawal by Subject|3|||
147212323|NCT03595228|530950429|FG000|Overall Study|Withdrawal by Sponsor|1|||
147212324|NCT03232333|530950430|FG000|Overall Study|Infection or Osteomyelitis|9|||
147212325|NCT03232333|530950430|FG000|Overall Study|Lost to Follow-up|4|||
147212326|NCT03232333|530950430|FG000|Overall Study|Withdrawal by Subject|2|||
147212327|NCT01087736|530950431|FG000|Overall Study|Lost to Follow-up|1|||
147212328|NCT01087736|530950432|FG001|Overall Study|Lost to Follow-up|0|||
147212329|NCT01087736|530950431|FG000|Overall Study|Death|0|||
147649863|NCT03332095|532539717|FG000|Overall Study|Lost to Follow-up|1|||
147649864|NCT03332095|532539718|FG001|Overall Study|Lost to Follow-up|0|||
147649865|NCT03332095|532539717|FG000|Overall Study|Pregnancy|0|||
147649866|NCT03332095|532539718|FG001|Overall Study|Pregnancy|1|||
147649867|NCT04942210|532539722|FG000|Overall Study|Adverse Event|0|||
147649868|NCT04942210|532539723|FG001|Overall Study|Adverse Event|1|||
147649869|NCT04942210|532539722|FG000|Overall Study|Protocol Deviation|4|||
147649870|NCT04942210|532539723|FG001|Overall Study|Protocol Deviation|1|||
147649871|NCT04942210|532539722|FG000|Overall Study|Withdrawal by Subject|5|||
147649872|NCT04942210|532539723|FG001|Overall Study|Withdrawal by Subject|2|||
147649873|NCT04942210|532539722|FG000|Overall Study|Lost to Follow-up|16|||
147649874|NCT04942210|532539723|FG001|Overall Study|Lost to Follow-up|7|||
147649875|NCT04942210|532539722|FG000|Overall Study|Ongoing at the time of DBL date|60|||
147649876|NCT04942210|532539723|FG001|Overall Study|Ongoing at the time of DBL date|25|||
147649877|NCT04942210|532539722|FG000|Overall Study|Randomized but did not receive vaccination|3|||
147649878|NCT04942210|532539723|FG001|Overall Study|Randomized but did not receive vaccination|0|||
147649879|NCT05697627|532539726|FG000|Overall Study|Adverse Event|1|||
147649880|NCT01410240|532539727|FG000|Overall Study|Physician Decision|0|||
147649881|NCT01410240|532539728|FG001|Overall Study|Physician Decision|0|||
147649882|NCT01410240|532539729|FG002|Overall Study|Physician Decision|1|||
147649883|NCT01410240|532539727|FG000|Overall Study|Missed week 6 assessments|1|||
147212330|NCT01087736|530950432|FG001|Overall Study|Death|1|||
147649884|NCT01410240|532539728|FG001|Overall Study|Missed week 6 assessments|1|||
147649885|NCT01410240|532539729|FG002|Overall Study|Missed week 6 assessments|1|||
147649886|NCT04348500|532539730|FG000|Overall Study|Death|2|||
147649887|NCT04348500|532539731|FG001|Overall Study|Death|2|||
147649888|NCT04348500|532539730|FG000|Overall Study|Withdrawn by subject due to dementia|0|||
147649889|NCT04348500|532539731|FG001|Overall Study|Withdrawn by subject due to dementia|1|||
147649890|NCT02776670|532539732|FG000|Overall Study|Adverse Event|0|||
147649891|NCT02776670|532539733|FG001|Overall Study|Adverse Event|2|||
147649892|NCT02776670|532539732|FG000|Overall Study|Protocol Violation|0|||
147649893|NCT02776670|532539733|FG001|Overall Study|Protocol Violation|2|||
147649894|NCT02776670|532539732|FG000|Overall Study|Withdrawal by Subject|0|||
147649895|NCT02776670|532539733|FG001|Overall Study|Withdrawal by Subject|1|||
147649896|NCT02776670|532539732|FG000|Overall Study|Other - Reason not given|0|||
147649897|NCT02776670|532539733|FG001|Overall Study|Other - Reason not given|1|||
147649898|NCT03699540|532539734|FG000|Overall Study|Lost to Follow-up|1|||
147649899|NCT02722746|532539739|FG000|Overall Study|Withdrawal by Subject|0|||
147649900|NCT02722746|532539740|FG001|Overall Study|Withdrawal by Subject|1|||
147649901|NCT02722746|532539741|FG002|Overall Study|Withdrawal by Subject|0|||
147649902|NCT02722746|532539739|FG000|Overall Study|Protocol Violation|8|||
147649903|NCT02722746|532539740|FG001|Overall Study|Protocol Violation|4|||
147649904|NCT02722746|532539741|FG002|Overall Study|Protocol Violation|6|||
147649905|NCT02636699|532539746|FG000|Screening Period|Inclusion/Exclusion Failure|0|||
147649906|NCT02636699|532539747|FG001|Screening Period|Inclusion/Exclusion Failure|0|||
147649907|NCT02636699|532539748|FG002|Screening Period|Inclusion/Exclusion Failure|117|||
147649908|NCT02636699|532539746|FG000|Screening Period|Withdrawal by Subject|0|||
147649909|NCT02636699|532539747|FG001|Screening Period|Withdrawal by Subject|0|||
147649910|NCT02636699|532539748|FG002|Screening Period|Withdrawal by Subject|23|||
147649911|NCT02636699|532539746|FG000|Screening Period|Adverse Event|0|||
147649912|NCT02636699|532539747|FG001|Screening Period|Adverse Event|0|||
147649913|NCT02636699|532539748|FG002|Screening Period|Adverse Event|1|||
147649914|NCT02636699|532539746|FG000|Screening Period|Other not specified|0|||
147546514|NCT01889862|532157733|FG002|Part 4 (Up to 274 Weeks)|Subject withdrew consent|0|||
147546515|NCT01889862|532157734|FG003|Part 4 (Up to 274 Weeks)|Subject withdrew consent|0|||
147649915|NCT02636699|532539747|FG001|Screening Period|Other not specified|0|||
147649916|NCT02636699|532539748|FG002|Screening Period|Other not specified|3|||
147649917|NCT02636699|532539746|FG000|Treatment and Follow-up Periods|Adverse Event|4|||
147649918|NCT02636699|532539747|FG001|Treatment and Follow-up Periods|Adverse Event|0|||
147649919|NCT02636699|532539748|FG002|Treatment and Follow-up Periods|Adverse Event|0|||
147649920|NCT02636699|532539746|FG000|Treatment and Follow-up Periods|Lost to Follow-up|3|||
147649921|NCT02636699|532539747|FG001|Treatment and Follow-up Periods|Lost to Follow-up|3|||
147649922|NCT02636699|532539748|FG002|Treatment and Follow-up Periods|Lost to Follow-up|0|||
147649923|NCT02636699|532539746|FG000|Treatment and Follow-up Periods|Non-compliance with the investigational product (IP)|2|||
147649924|NCT02636699|532539747|FG001|Treatment and Follow-up Periods|Non-compliance with the investigational product (IP)|0|||
147649925|NCT02636699|532539748|FG002|Treatment and Follow-up Periods|Non-compliance with the investigational product (IP)|0|||
147649926|NCT02636699|532539746|FG000|Treatment and Follow-up Periods|Physician Decision|0|||
147649927|NCT02636699|532539747|FG001|Treatment and Follow-up Periods|Physician Decision|1|||
147649928|NCT02636699|532539748|FG002|Treatment and Follow-up Periods|Physician Decision|0|||
147649929|NCT02636699|532539746|FG000|Treatment and Follow-up Periods|Withdrawal by Subject|13|||
147649930|NCT02636699|532539747|FG001|Treatment and Follow-up Periods|Withdrawal by Subject|6|||
147649931|NCT02636699|532539748|FG002|Treatment and Follow-up Periods|Withdrawal by Subject|0|||
147649932|NCT02636699|532539746|FG000|Treatment and Follow-up Periods|Other|3|||
147212331|NCT01087736|530950431|FG000|Overall Study|Withdrawal by Subject|0|||
147212332|NCT01087736|530950432|FG001|Overall Study|Withdrawal by Subject|1|||
147212333|NCT01253811|530950433|FG000|Overall Study|Withdrawal criteria|1|||
147212334|NCT00435045|530950435|FG000|Weeks 1-8 / 10 mg Dose Level|Adverse Event|1|||
147212335|NCT00435045|530950436|FG001|Weeks 1-8 / 10 mg Dose Level|Adverse Event|1|||
147546516|NCT01889862|532157735|FG004|Part 4 (Up to 274 Weeks)|Subject withdrew consent|14|||
147546517|NCT01889862|532157731|FG000|Part 4 (Up to 274 Weeks)|Lost to Follow-up|0|||
147546518|NCT01889862|532157732|FG001|Part 4 (Up to 274 Weeks)|Lost to Follow-up|0|||
147546519|NCT01889862|532157733|FG002|Part 4 (Up to 274 Weeks)|Lost to Follow-up|0|||
147546520|NCT01889862|532157734|FG003|Part 4 (Up to 274 Weeks)|Lost to Follow-up|0|||
147546521|NCT01889862|532157735|FG004|Part 4 (Up to 274 Weeks)|Lost to Follow-up|4|||
147546522|NCT01889862|532157731|FG000|Part 4 (Up to 274 Weeks)|Physician Decision|0|||
147212336|NCT00435045|530950435|FG000|Weeks 1-8 / 10 mg Dose Level|Lost to Follow-up|1|||
147212337|NCT00435045|530950436|FG001|Weeks 1-8 / 10 mg Dose Level|Lost to Follow-up|1|||
147212338|NCT00435045|530950435|FG000|Weeks 1-8 / 10 mg Dose Level|Withdrawal by Subject|2|||
147212339|NCT00435045|530950436|FG001|Weeks 1-8 / 10 mg Dose Level|Withdrawal by Subject|1|||
147546523|NCT01889862|532157732|FG001|Part 4 (Up to 274 Weeks)|Physician Decision|0|||
147212340|NCT00435045|530950435|FG000|Weeks 1-8 / 10 mg Dose Level|Family Crisis - could not participate|1|||
147212341|NCT00435045|530950436|FG001|Weeks 1-8 / 10 mg Dose Level|Family Crisis - could not participate|0|||
147546524|NCT01889862|532157733|FG002|Part 4 (Up to 274 Weeks)|Physician Decision|0|||
147546525|NCT01889862|532157734|FG003|Part 4 (Up to 274 Weeks)|Physician Decision|0|||
147546526|NCT01889862|532157735|FG004|Part 4 (Up to 274 Weeks)|Physician Decision|5|||
147649933|NCT02636699|532539747|FG001|Treatment and Follow-up Periods|Other|1|||
147649934|NCT02636699|532539748|FG002|Treatment and Follow-up Periods|Other|0|||
147649935|NCT00624832|532539749|FG000|Overall Study|Adverse Event|0|||
147546527|NCT01889862|532157731|FG000|Part 4 (Up to 274 Weeks)|Protocol deviations|0|||
147546528|NCT01889862|532157732|FG001|Part 4 (Up to 274 Weeks)|Protocol deviations|0|||
147546529|NCT01889862|532157733|FG002|Part 4 (Up to 274 Weeks)|Protocol deviations|0|||
147546530|NCT01889862|532157734|FG003|Part 4 (Up to 274 Weeks)|Protocol deviations|0|||
147212342|NCT00435045|530950435|FG000|Weeks 1-8 / 10 mg Dose Level|Requirement for Excluded Medications|0|||
147212343|NCT00435045|530950436|FG001|Weeks 1-8 / 10 mg Dose Level|Requirement for Excluded Medications|1|||
147649936|NCT00624832|532539750|FG001|Overall Study|Adverse Event|1|||
147649937|NCT00624832|532539751|FG002|Overall Study|Adverse Event|0|||
147649938|NCT00624832|532539752|FG003|Overall Study|Adverse Event|1|||
147649939|NCT00624832|532539749|FG000|Overall Study|Abnormal Laboratory Value|2|||
147649940|NCT00624832|532539750|FG001|Overall Study|Abnormal Laboratory Value|0|||
147649941|NCT00624832|532539751|FG002|Overall Study|Abnormal Laboratory Value|0|||
147649942|NCT00624832|532539752|FG003|Overall Study|Abnormal Laboratory Value|0|||
147649943|NCT04379700|532539753|FG000|Overall Study|Withdrawal by Subject|10|||
147649944|NCT04379700|532539753|FG000|Overall Study|Screen Fail|4|||
147649945|NCT04379700|532539753|FG000|Overall Study|Lost to Follow-up|3|||
147212344|NCT00435045|530950435|FG000|Weeks 9-12 / 20mg Dose Level|Adverse Event|4|||
147212345|NCT00435045|530950436|FG001|Weeks 9-12 / 20mg Dose Level|Adverse Event|3|||
147212346|NCT00435045|530950435|FG000|Weeks 9-12 / 20mg Dose Level|Lost to Follow-up|1|||
147212347|NCT00435045|530950436|FG001|Weeks 9-12 / 20mg Dose Level|Lost to Follow-up|1|||
147212348|NCT00435045|530950435|FG000|Weeks 9-12 / 20mg Dose Level|Withdrawal by Subject|0|||
147212349|NCT00435045|530950436|FG001|Weeks 9-12 / 20mg Dose Level|Withdrawal by Subject|1|||
147212350|NCT00435045|530950435|FG000|Weeks 13-16 / 40mg Dose Level|Adverse Event|3|||
147212351|NCT00435045|530950436|FG001|Weeks 13-16 / 40mg Dose Level|Adverse Event|2|||
147212352|NCT00435045|530950435|FG000|Weeks 13-16 / 40mg Dose Level|Withdrawal by Subject|1|||
147212353|NCT00435045|530950436|FG001|Weeks 13-16 / 40mg Dose Level|Withdrawal by Subject|0|||
147212354|NCT00435045|530950435|FG000|Weeks 13-16 / 40mg Dose Level|Per Sponsors Request|1|||
147212355|NCT00435045|530950436|FG001|Weeks 13-16 / 40mg Dose Level|Per Sponsors Request|0|||
147212356|NCT00567255|530950437|FG000|Overall Study|Adverse Event|241|||
147212357|NCT00567255|530950438|FG001|Overall Study|Adverse Event|68|||
147212358|NCT00567255|530950437|FG000|Overall Study|Lost to Follow-up|77|||
147212359|NCT00567255|530950438|FG001|Overall Study|Lost to Follow-up|48|||
147212360|NCT00567255|530950437|FG000|Overall Study|Withdrawal by Subject|75|||
147212361|NCT00567255|530950438|FG001|Overall Study|Withdrawal by Subject|56|||
147212362|NCT00567255|530950437|FG000|Overall Study|Lack of Efficacy|19|||
147212363|NCT00567255|530950438|FG001|Overall Study|Lack of Efficacy|33|||
147212364|NCT00567255|530950437|FG000|Overall Study|Protocol Violation|20|||
147212365|NCT00567255|530950438|FG001|Overall Study|Protocol Violation|8|||
147212366|NCT00567255|530950437|FG000|Overall Study|Pregnancy|6|||
147212367|NCT00567255|530950438|FG001|Overall Study|Pregnancy|0|||
147212368|NCT00567255|530950437|FG000|Overall Study|Drug noncompliance,moved,other|25|||
147212369|NCT00567255|530950438|FG001|Overall Study|Drug noncompliance,moved,other|15|||
147212370|NCT01743001|530950441|FG000|Overall Study|Physician Decision|1|||
147212371|NCT01743001|530950442|FG001|Overall Study|Physician Decision|0|||
147212372|NCT01743001|530950441|FG000|Overall Study|Pregnancy|1|||
147212373|NCT01743001|530950442|FG001|Overall Study|Pregnancy|0|||
147212374|NCT01743001|530950441|FG000|Overall Study|Death|1|||
147212375|NCT01743001|530950442|FG001|Overall Study|Death|0|||
147212376|NCT03052426|530950445|FG000|Overall Study|Withdrawal by Subject|0|||
147212377|NCT03052426|530950446|FG001|Overall Study|Withdrawal by Subject|1|||
147212378|NCT03052426|530950447|FG002|Overall Study|Withdrawal by Subject|0|||
147212379|NCT03052426|530950445|FG000|Overall Study|Lost to Follow-up|2|||
147212380|NCT03052426|530950446|FG001|Overall Study|Lost to Follow-up|0|||
147212381|NCT03052426|530950447|FG002|Overall Study|Lost to Follow-up|1|||
147212382|NCT01565343|530950450|FG000|Overall Study|Administrative decision/technical issues|1|||
147212383|NCT01565343|530950451|FG001|Overall Study|Administrative decision/technical issues|0|||
147212384|NCT01565343|530950452|FG002|Overall Study|Administrative decision/technical issues|0|||
147212385|NCT01853839|530950458|FG000|Overall Study|Violated inclusion criteria|2|||
147212386|NCT01853839|530950458|FG000|Overall Study|Not meet ITT population definition|58|||
147546531|NCT01889862|532157735|FG004|Part 4 (Up to 274 Weeks)|Protocol deviations|2|||
147649946|NCT03624569|532539755|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
147649947|NCT03624569|532539756|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|2|||
147546532|NCT00528879|532157736|FG000|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|3|||
147546533|NCT00528879|532157737|FG001|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|0|||
147546534|NCT00528879|532157738|FG002|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|1|||
147649948|NCT03624569|532539755|FG000|Second Intervention (2 Weeks)|Protocol Violation|1|||
147649949|NCT03624569|532539756|FG001|Second Intervention (2 Weeks)|Protocol Violation|1|||
147649950|NCT00957424|532539757|FG000|Overall Study|Lost to Follow-up|19|||
147649951|NCT00957424|532539757|FG000|Overall Study|Protocol Violation|3|||
147649952|NCT00957424|532539757|FG000|Overall Study|Withdrawal by Subject|1|||
147212387|NCT01853839|530950458|FG000|Overall Study|End of treatment visit too early|33|||
147212388|NCT01853839|530950458|FG000|Overall Study|Lost to follow-up or no valid BP measure|336|||
147649953|NCT01038752|532539758|FG000|Overall Study|Tumor Progression|2|||
147649954|NCT01038752|532539759|FG001|Overall Study|Tumor Progression|2|||
147649955|NCT01038752|532539758|FG000|Overall Study|Lost to Follow-up|3|||
147649956|NCT01038752|532539759|FG001|Overall Study|Lost to Follow-up|3|||
147649957|NCT02700698|532539766|FG000|Overall Study|Withdrawal by Subject|1|||
147546535|NCT00528879|532157739|FG003|Short-term Period (Day 1 to Week 24)|Lack of Efficacy|0|||
147546536|NCT00528879|532157736|FG000|Short-term Period (Day 1 to Week 24)|Adverse Event|4|||
147546537|NCT00528879|532157737|FG001|Short-term Period (Day 1 to Week 24)|Adverse Event|4|||
147546538|NCT00528879|532157738|FG002|Short-term Period (Day 1 to Week 24)|Adverse Event|2|||
147546539|NCT00528879|532157739|FG003|Short-term Period (Day 1 to Week 24)|Adverse Event|4|||
147546540|NCT00528879|532157736|FG000|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|7|||
147546541|NCT00528879|532157737|FG001|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|5|||
147546542|NCT00528879|532157738|FG002|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|5|||
147546543|NCT00528879|532157739|FG003|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|3|||
147546544|NCT00528879|532157736|FG000|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|5|||
147546545|NCT00528879|532157737|FG001|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4|||
147546546|NCT00528879|532157738|FG002|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4|||
147546547|NCT00528879|532157739|FG003|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|5|||
147546548|NCT00528879|532157736|FG000|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|0|||
147546549|NCT00528879|532157737|FG001|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|0|||
147546550|NCT00528879|532157738|FG002|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|2|||
147546551|NCT00528879|532157739|FG003|Short-term Period (Day 1 to Week 24)|Poor compliance/noncompliance|0|||
147546552|NCT00528879|532157736|FG000|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|2|||
147546553|NCT00528879|532157737|FG001|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|3|||
147546554|NCT00528879|532157738|FG002|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|0|||
147546555|NCT00528879|532157739|FG003|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|2|||
147546556|NCT00528879|532157736|FG000|Short-term Period (Day 1 to Week 24)|Administrative reason by author|1|||
147546557|NCT00528879|532157737|FG001|Short-term Period (Day 1 to Week 24)|Administrative reason by author|1|||
147546558|NCT00528879|532157738|FG002|Short-term Period (Day 1 to Week 24)|Administrative reason by author|0|||
147546559|NCT00528879|532157739|FG003|Short-term Period (Day 1 to Week 24)|Administrative reason by author|1|||
147546560|NCT00528879|532157736|FG000|Short-term Period (Day 1 to Week 24)|Other|0|||
147546561|NCT00528879|532157737|FG001|Short-term Period (Day 1 to Week 24)|Other|0|||
147546562|NCT00528879|532157738|FG002|Short-term Period (Day 1 to Week 24)|Other|1|||
147546563|NCT00528879|532157739|FG003|Short-term Period (Day 1 to Week 24)|Other|1|||
147546564|NCT00528879|532157736|FG000|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|27|||
147546565|NCT00528879|532157737|FG001|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|16|||
147546566|NCT00528879|532157738|FG002|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|17|||
147546567|NCT00528879|532157739|FG003|Long-term Period (Weeks 24 to 102)|Lack of Efficacy|9|||
147546568|NCT00528879|532157736|FG000|Long-term Period (Weeks 24 to 102)|Adverse Event|5|||
147546569|NCT00528879|532157737|FG001|Long-term Period (Weeks 24 to 102)|Adverse Event|4|||
147546570|NCT00528879|532157738|FG002|Long-term Period (Weeks 24 to 102)|Adverse Event|3|||
147546571|NCT00528879|532157739|FG003|Long-term Period (Weeks 24 to 102)|Adverse Event|2|||
147546572|NCT00528879|532157736|FG000|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|4|||
147546573|NCT00528879|532157737|FG001|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|6|||
147546574|NCT00528879|532157738|FG002|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|8|||
147546575|NCT00528879|532157739|FG003|Long-term Period (Weeks 24 to 102)|Withdrawal by Subject|4|||
147546576|NCT00528879|532157736|FG000|Long-term Period (Weeks 24 to 102)|Death|0|||
147546577|NCT00528879|532157737|FG001|Long-term Period (Weeks 24 to 102)|Death|1|||
147546578|NCT00528879|532157738|FG002|Long-term Period (Weeks 24 to 102)|Death|0|||
147546579|NCT00528879|532157739|FG003|Long-term Period (Weeks 24 to 102)|Death|0|||
147546580|NCT00528879|532157736|FG000|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|4|||
147546581|NCT00528879|532157737|FG001|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|5|||
147546582|NCT00528879|532157738|FG002|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|3|||
147546583|NCT00528879|532157739|FG003|Long-term Period (Weeks 24 to 102)|Lost to Follow-up|7|||
147546584|NCT00528879|532157736|FG000|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|0|||
147546585|NCT00528879|532157737|FG001|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|5|||
147546586|NCT00528879|532157738|FG002|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|1|||
147546587|NCT00528879|532157739|FG003|Long-term Period (Weeks 24 to 102)|Poor compliance/noncompliance|2|||
147546588|NCT00528879|532157736|FG000|Long-term Period (Weeks 24 to 102)|Pregnancy|1|||
147546589|NCT00528879|532157737|FG001|Long-term Period (Weeks 24 to 102)|Pregnancy|0|||
147546590|NCT00528879|532157738|FG002|Long-term Period (Weeks 24 to 102)|Pregnancy|0|||
147546591|NCT00528879|532157739|FG003|Long-term Period (Weeks 24 to 102)|Pregnancy|0|||
147546592|NCT00528879|532157736|FG000|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|1|||
147546593|NCT00528879|532157737|FG001|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|1|||
147546594|NCT00528879|532157738|FG002|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|1|||
147212389|NCT03672097|530950459|FG000|Period 1|Withdrawal by Subject|2|||
147212390|NCT03672097|530950459|FG000|Period 1|Adverse Event|1|||
147212391|NCT03672097|530950459|FG000|Period 1|Did not receive treatment|1|||
147212392|NCT03672097|530950459|FG000|Period 2|Withdrawal by Subject|3|||
147212393|NCT03672097|530950459|FG000|Period 2|Other|1|||
147212394|NCT03087617|530950461|FG000|Overall Study|Lost to Follow-up|32|||
147212395|NCT03087617|530950462|FG001|Overall Study|Lost to Follow-up|30|||
147212396|NCT03087617|530950463|FG002|Overall Study|Lost to Follow-up|30|||
147212397|NCT03087617|530950464|FG003|Overall Study|Lost to Follow-up|39|||
147212398|NCT04450381|530950466|FG000|Overall Study|Protocol Violation|4|||
147212399|NCT04450381|530950466|FG000|Overall Study|Wrong device setting|2|||
147212400|NCT02059291|530950469|FG000|Epoch 2|Lack of Efficacy|0|||
147212401|NCT02059291|530950470|FG001|Epoch 2|Lack of Efficacy|0|||
147212402|NCT02059291|530950471|FG002|Epoch 2|Lack of Efficacy|0|||
147212403|NCT02059291|530950472|FG003|Epoch 2|Lack of Efficacy|1|||
147212404|NCT02059291|530950473|FG004|Epoch 2|Lack of Efficacy|0|||
147212405|NCT02059291|530950474|FG005|Epoch 2|Lack of Efficacy|1|||
147212406|NCT02059291|530950475|FG006|Epoch 2|Lack of Efficacy|0|||
147212407|NCT02059291|530950476|FG007|Epoch 2|Lack of Efficacy|0|||
147212408|NCT02059291|530950477|FG008|Epoch 2|Lack of Efficacy|0|||
147212409|NCT02059291|530950478|FG009|Epoch 2|Lack of Efficacy|0|||
147212410|NCT02059291|530950479|FG010|Epoch 2|Lack of Efficacy|0|||
147212411|NCT02059291|530950480|FG011|Epoch 2|Lack of Efficacy|0|||
147212412|NCT02059291|530950481|FG012|Epoch 2|Lack of Efficacy|0|||
147212413|NCT02059291|530950482|FG013|Epoch 2|Lack of Efficacy|0|||
147212414|NCT02059291|530950483|FG014|Epoch 2|Lack of Efficacy|0|||
147212415|NCT02059291|530950484|FG015|Epoch 2|Lack of Efficacy|0|||
147212416|NCT02059291|530950485|FG016|Epoch 2|Lack of Efficacy|0|||
147212417|NCT02059291|530950486|FG017|Epoch 2|Lack of Efficacy|0|||
147212418|NCT02059291|530950487|FG018|Epoch 2|Lack of Efficacy|0|||
147212419|NCT02059291|530950488|FG019|Epoch 2|Lack of Efficacy|0|||
147212420|NCT02059291|530950489|FG020|Epoch 2|Lack of Efficacy|0|||
147212421|NCT02059291|530950490|FG021|Epoch 2|Lack of Efficacy|0|||
147212422|NCT02059291|530950491|FG022|Epoch 2|Lack of Efficacy|0|||
147212423|NCT02059291|530950492|FG023|Epoch 2|Lack of Efficacy|0|||
147212424|NCT02059291|530950493|FG024|Epoch 2|Lack of Efficacy|0|||
147212425|NCT02059291|530950469|FG000|Epoch 2|Adverse Event|0|||
147212426|NCT02059291|530950470|FG001|Epoch 2|Adverse Event|0|||
147212427|NCT02059291|530950471|FG002|Epoch 2|Adverse Event|1|||
147212428|NCT02059291|530950472|FG003|Epoch 2|Adverse Event|1|||
147212429|NCT02059291|530950473|FG004|Epoch 2|Adverse Event|0|||
147212430|NCT02059291|530950474|FG005|Epoch 2|Adverse Event|0|||
147212431|NCT02059291|530950475|FG006|Epoch 2|Adverse Event|0|||
147212432|NCT02059291|530950476|FG007|Epoch 2|Adverse Event|1|||
147212433|NCT02059291|530950477|FG008|Epoch 2|Adverse Event|1|||
147212434|NCT02059291|530950478|FG009|Epoch 2|Adverse Event|0|||
147212435|NCT02059291|530950479|FG010|Epoch 2|Adverse Event|0|||
147212436|NCT02059291|530950480|FG011|Epoch 2|Adverse Event|0|||
147212437|NCT02059291|530950481|FG012|Epoch 2|Adverse Event|0|||
147212438|NCT02059291|530950482|FG013|Epoch 2|Adverse Event|0|||
147212439|NCT02059291|530950483|FG014|Epoch 2|Adverse Event|0|||
147212440|NCT02059291|530950484|FG015|Epoch 2|Adverse Event|0|||
147212441|NCT02059291|530950485|FG016|Epoch 2|Adverse Event|0|||
147212442|NCT02059291|530950486|FG017|Epoch 2|Adverse Event|0|||
147212443|NCT02059291|530950487|FG018|Epoch 2|Adverse Event|0|||
147212444|NCT02059291|530950488|FG019|Epoch 2|Adverse Event|0|||
147212445|NCT02059291|530950489|FG020|Epoch 2|Adverse Event|0|||
147442044|NCT00262522|531782731|FG003|Study Start Through 48 Weeks|Withdrawal by Subject|0|||
147442045|NCT00262522|531782728|FG000|Study Start Through 48 Weeks|Lost to Follow-up|8|||
147442046|NCT00262522|531782729|FG001|Study Start Through 48 Weeks|Lost to Follow-up|0|||
147442047|NCT00262522|531782730|FG002|Study Start Through 48 Weeks|Lost to Follow-up|14|||
147442048|NCT00262522|531782731|FG003|Study Start Through 48 Weeks|Lost to Follow-up|0|||
147442049|NCT00262522|531782728|FG000|Study Start Through 48 Weeks|Noncompliance|3|||
147442050|NCT00262522|531782729|FG001|Study Start Through 48 Weeks|Noncompliance|0|||
147442051|NCT00262522|531782730|FG002|Study Start Through 48 Weeks|Noncompliance|8|||
147212446|NCT02059291|530950490|FG021|Epoch 2|Adverse Event|0|||
147212447|NCT02059291|530950491|FG022|Epoch 2|Adverse Event|0|||
147212448|NCT02059291|530950492|FG023|Epoch 2|Adverse Event|0|||
147212449|NCT02059291|530950493|FG024|Epoch 2|Adverse Event|0|||
147212450|NCT02059291|530950469|FG000|Epoch 2|Withdrawal by Subject|0|||
147212451|NCT02059291|530950470|FG001|Epoch 2|Withdrawal by Subject|1|||
147212452|NCT02059291|530950471|FG002|Epoch 2|Withdrawal by Subject|0|||
147212453|NCT02059291|530950472|FG003|Epoch 2|Withdrawal by Subject|0|||
147546595|NCT00528879|532157739|FG003|Long-term Period (Weeks 24 to 102)|No longer meets study criteria|0|||
147212454|NCT02059291|530950473|FG004|Epoch 2|Withdrawal by Subject|0|||
147212455|NCT02059291|530950474|FG005|Epoch 2|Withdrawal by Subject|1|||
147212456|NCT02059291|530950475|FG006|Epoch 2|Withdrawal by Subject|0|||
147212457|NCT02059291|530950476|FG007|Epoch 2|Withdrawal by Subject|0|||
147212458|NCT02059291|530950477|FG008|Epoch 2|Withdrawal by Subject|1|||
147212459|NCT02059291|530950478|FG009|Epoch 2|Withdrawal by Subject|0|||
147212460|NCT02059291|530950479|FG010|Epoch 2|Withdrawal by Subject|0|||
147212461|NCT02059291|530950480|FG011|Epoch 2|Withdrawal by Subject|0|||
147212462|NCT02059291|530950481|FG012|Epoch 2|Withdrawal by Subject|0|||
147546596|NCT00971204|532157740|FG000|Overall Study|Did not meet all criteria-not treated|14|||
147546597|NCT00971204|532157740|FG000|Overall Study|Lost to Follow-up|10|||
147546598|NCT01256398|532157741|FG000|Overall Study|Withdrawal by Subject|1|||
147212463|NCT02059291|530950482|FG013|Epoch 2|Withdrawal by Subject|0|||
147212464|NCT02059291|530950483|FG014|Epoch 2|Withdrawal by Subject|0|||
147212465|NCT02059291|530950484|FG015|Epoch 2|Withdrawal by Subject|0|||
147212466|NCT02059291|530950485|FG016|Epoch 2|Withdrawal by Subject|0|||
147212467|NCT02059291|530950486|FG017|Epoch 2|Withdrawal by Subject|0|||
147212468|NCT02059291|530950487|FG018|Epoch 2|Withdrawal by Subject|0|||
147212469|NCT02059291|530950488|FG019|Epoch 2|Withdrawal by Subject|0|||
147212470|NCT02059291|530950489|FG020|Epoch 2|Withdrawal by Subject|0|||
147212471|NCT02059291|530950490|FG021|Epoch 2|Withdrawal by Subject|0|||
147212472|NCT02059291|530950491|FG022|Epoch 2|Withdrawal by Subject|0|||
147212473|NCT02059291|530950492|FG023|Epoch 2|Withdrawal by Subject|0|||
147212474|NCT02059291|530950493|FG024|Epoch 2|Withdrawal by Subject|0|||
147212475|NCT02059291|530950469|FG000|Epoch 3|Physician Decision|0|||
147212476|NCT02059291|530950470|FG001|Epoch 3|Physician Decision|0|||
147212477|NCT02059291|530950471|FG002|Epoch 3|Physician Decision|0|||
147212478|NCT02059291|530950472|FG003|Epoch 3|Physician Decision|0|||
147212479|NCT02059291|530950473|FG004|Epoch 3|Physician Decision|0|||
147212480|NCT02059291|530950474|FG005|Epoch 3|Physician Decision|0|||
147212481|NCT02059291|530950475|FG006|Epoch 3|Physician Decision|0|||
147212482|NCT02059291|530950476|FG007|Epoch 3|Physician Decision|0|||
147212483|NCT02059291|530950477|FG008|Epoch 3|Physician Decision|0|||
147212484|NCT02059291|530950478|FG009|Epoch 3|Physician Decision|0|||
147212485|NCT02059291|530950479|FG010|Epoch 3|Physician Decision|0|||
147212486|NCT02059291|530950480|FG011|Epoch 3|Physician Decision|0|||
147212487|NCT02059291|530950481|FG012|Epoch 3|Physician Decision|0|||
147212488|NCT02059291|530950482|FG013|Epoch 3|Physician Decision|1|||
147212489|NCT02059291|530950483|FG014|Epoch 3|Physician Decision|0|||
147212490|NCT02059291|530950484|FG015|Epoch 3|Physician Decision|1|||
147212491|NCT02059291|530950485|FG016|Epoch 3|Physician Decision|0|||
147212492|NCT02059291|530950486|FG017|Epoch 3|Physician Decision|0|||
147212493|NCT02059291|530950487|FG018|Epoch 3|Physician Decision|0|||
147212494|NCT02059291|530950488|FG019|Epoch 3|Physician Decision|0|||
147212495|NCT02059291|530950489|FG020|Epoch 3|Physician Decision|0|||
147212496|NCT02059291|530950490|FG021|Epoch 3|Physician Decision|0|||
147212497|NCT02059291|530950491|FG022|Epoch 3|Physician Decision|0|||
147212498|NCT02059291|530950492|FG023|Epoch 3|Physician Decision|0|||
147212499|NCT02059291|530950493|FG024|Epoch 3|Physician Decision|0|||
147212500|NCT02059291|530950469|FG000|Epoch 3|Adverse Event|0|||
147212501|NCT02059291|530950470|FG001|Epoch 3|Adverse Event|0|||
147212502|NCT02059291|530950471|FG002|Epoch 3|Adverse Event|0|||
147212503|NCT02059291|530950472|FG003|Epoch 3|Adverse Event|0|||
147212504|NCT02059291|530950473|FG004|Epoch 3|Adverse Event|0|||
147212505|NCT02059291|530950474|FG005|Epoch 3|Adverse Event|0|||
147212506|NCT02059291|530950475|FG006|Epoch 3|Adverse Event|0|||
147212507|NCT02059291|530950476|FG007|Epoch 3|Adverse Event|0|||
147212508|NCT02059291|530950477|FG008|Epoch 3|Adverse Event|0|||
147212509|NCT02059291|530950478|FG009|Epoch 3|Adverse Event|0|||
147212510|NCT02059291|530950479|FG010|Epoch 3|Adverse Event|0|||
147212511|NCT02059291|530950480|FG011|Epoch 3|Adverse Event|0|||
147212512|NCT02059291|530950481|FG012|Epoch 3|Adverse Event|0|||
147212513|NCT02059291|530950482|FG013|Epoch 3|Adverse Event|0|||
147212514|NCT02059291|530950483|FG014|Epoch 3|Adverse Event|0|||
147212515|NCT02059291|530950484|FG015|Epoch 3|Adverse Event|1|||
147212516|NCT02059291|530950485|FG016|Epoch 3|Adverse Event|0|||
147546599|NCT01364298|532157742|FG000|Overall Study|Adverse Event|3|||
147546600|NCT01364298|532157743|FG001|Overall Study|Adverse Event|4|||
147546601|NCT01364298|532157742|FG000|Overall Study|Lack of adherence to treatment|1|||
147212517|NCT02059291|530950486|FG017|Epoch 3|Adverse Event|0|||
147212518|NCT02059291|530950487|FG018|Epoch 3|Adverse Event|0|||
147212519|NCT02059291|530950488|FG019|Epoch 3|Adverse Event|0|||
147212520|NCT02059291|530950489|FG020|Epoch 3|Adverse Event|0|||
147212521|NCT02059291|530950490|FG021|Epoch 3|Adverse Event|0|||
147212522|NCT02059291|530950491|FG022|Epoch 3|Adverse Event|0|||
147212523|NCT02059291|530950492|FG023|Epoch 3|Adverse Event|0|||
147212524|NCT02059291|530950493|FG024|Epoch 3|Adverse Event|0|||
147212525|NCT02059291|530950469|FG000|Epoch 3|Lack of Efficacy|0|||
147212526|NCT02059291|530950470|FG001|Epoch 3|Lack of Efficacy|0|||
147212527|NCT02059291|530950471|FG002|Epoch 3|Lack of Efficacy|0|||
147212528|NCT02059291|530950472|FG003|Epoch 3|Lack of Efficacy|0|||
147212529|NCT02059291|530950473|FG004|Epoch 3|Lack of Efficacy|0|||
147212530|NCT02059291|530950474|FG005|Epoch 3|Lack of Efficacy|0|||
147212531|NCT02059291|530950475|FG006|Epoch 3|Lack of Efficacy|0|||
147212532|NCT02059291|530950476|FG007|Epoch 3|Lack of Efficacy|0|||
147212533|NCT02059291|530950477|FG008|Epoch 3|Lack of Efficacy|0|||
147212534|NCT02059291|530950478|FG009|Epoch 3|Lack of Efficacy|0|||
147212535|NCT02059291|530950479|FG010|Epoch 3|Lack of Efficacy|0|||
147212536|NCT02059291|530950480|FG011|Epoch 3|Lack of Efficacy|0|||
147212537|NCT02059291|530950481|FG012|Epoch 3|Lack of Efficacy|0|||
147212538|NCT02059291|530950482|FG013|Epoch 3|Lack of Efficacy|0|||
147212539|NCT02059291|530950483|FG014|Epoch 3|Lack of Efficacy|0|||
147212540|NCT02059291|530950484|FG015|Epoch 3|Lack of Efficacy|3|||
147546602|NCT01364298|532157743|FG001|Overall Study|Lack of adherence to treatment|3|||
147546603|NCT01364298|532157742|FG000|Overall Study|Lack of Efficacy|1|||
147546604|NCT01364298|532157743|FG001|Overall Study|Lack of Efficacy|0|||
147546605|NCT01364298|532157742|FG000|Overall Study|Lost to Follow-up|5|||
147546606|NCT01364298|532157743|FG001|Overall Study|Lost to Follow-up|10|||
147546607|NCT01364298|532157742|FG000|Overall Study|Withdrawal by Subject|3|||
147546608|NCT01364298|532157743|FG001|Overall Study|Withdrawal by Subject|3|||
147546609|NCT01364298|532157742|FG000|Overall Study|Other|1|||
147212541|NCT02059291|530950485|FG016|Epoch 3|Lack of Efficacy|0|||
147212542|NCT02059291|530950486|FG017|Epoch 3|Lack of Efficacy|0|||
147212543|NCT02059291|530950487|FG018|Epoch 3|Lack of Efficacy|0|||
147212544|NCT02059291|530950488|FG019|Epoch 3|Lack of Efficacy|0|||
147212545|NCT02059291|530950489|FG020|Epoch 3|Lack of Efficacy|0|||
147212546|NCT02059291|530950490|FG021|Epoch 3|Lack of Efficacy|0|||
147212547|NCT02059291|530950491|FG022|Epoch 3|Lack of Efficacy|0|||
147212548|NCT02059291|530950492|FG023|Epoch 3|Lack of Efficacy|0|||
147212549|NCT02059291|530950493|FG024|Epoch 3|Lack of Efficacy|0|||
147212550|NCT02059291|530950469|FG000|Epoch 3|Withdrawal by Subject|0|||
147212551|NCT02059291|530950470|FG001|Epoch 3|Withdrawal by Subject|0|||
147212552|NCT02059291|530950471|FG002|Epoch 3|Withdrawal by Subject|0|||
147212553|NCT02059291|530950472|FG003|Epoch 3|Withdrawal by Subject|0|||
147212554|NCT02059291|530950473|FG004|Epoch 3|Withdrawal by Subject|0|||
147212555|NCT02059291|530950474|FG005|Epoch 3|Withdrawal by Subject|0|||
147212556|NCT02059291|530950475|FG006|Epoch 3|Withdrawal by Subject|0|||
147212557|NCT02059291|530950476|FG007|Epoch 3|Withdrawal by Subject|0|||
147212558|NCT02059291|530950477|FG008|Epoch 3|Withdrawal by Subject|0|||
147212559|NCT02059291|530950478|FG009|Epoch 3|Withdrawal by Subject|0|||
147212560|NCT02059291|530950479|FG010|Epoch 3|Withdrawal by Subject|0|||
147212561|NCT02059291|530950480|FG011|Epoch 3|Withdrawal by Subject|0|||
147212562|NCT02059291|530950481|FG012|Epoch 3|Withdrawal by Subject|0|||
147212563|NCT02059291|530950482|FG013|Epoch 3|Withdrawal by Subject|0|||
147212564|NCT02059291|530950483|FG014|Epoch 3|Withdrawal by Subject|0|||
147212565|NCT02059291|530950484|FG015|Epoch 3|Withdrawal by Subject|1|||
147212566|NCT02059291|530950485|FG016|Epoch 3|Withdrawal by Subject|0|||
147212567|NCT02059291|530950486|FG017|Epoch 3|Withdrawal by Subject|0|||
147212568|NCT02059291|530950487|FG018|Epoch 3|Withdrawal by Subject|0|||
147212569|NCT02059291|530950488|FG019|Epoch 3|Withdrawal by Subject|0|||
147212570|NCT02059291|530950489|FG020|Epoch 3|Withdrawal by Subject|0|||
147212571|NCT02059291|530950490|FG021|Epoch 3|Withdrawal by Subject|0|||
147212572|NCT02059291|530950491|FG022|Epoch 3|Withdrawal by Subject|0|||
147212573|NCT02059291|530950492|FG023|Epoch 3|Withdrawal by Subject|0|||
147212574|NCT02059291|530950493|FG024|Epoch 3|Withdrawal by Subject|0|||
147212575|NCT02059291|530950469|FG000|Epoch 4|Adverse Event|0|||
147212576|NCT02059291|530950470|FG001|Epoch 4|Adverse Event|0|||
147212577|NCT02059291|530950471|FG002|Epoch 4|Adverse Event|0|||
147212578|NCT02059291|530950472|FG003|Epoch 4|Adverse Event|0|||
147212579|NCT02059291|530950473|FG004|Epoch 4|Adverse Event|0|||
147212580|NCT02059291|530950474|FG005|Epoch 4|Adverse Event|0|||
147212581|NCT02059291|530950475|FG006|Epoch 4|Adverse Event|0|||
147212582|NCT02059291|530950476|FG007|Epoch 4|Adverse Event|0|||
147212583|NCT02059291|530950477|FG008|Epoch 4|Adverse Event|0|||
147212584|NCT02059291|530950478|FG009|Epoch 4|Adverse Event|0|||
147212585|NCT02059291|530950479|FG010|Epoch 4|Adverse Event|0|||
147212586|NCT02059291|530950480|FG011|Epoch 4|Adverse Event|0|||
147212587|NCT02059291|530950481|FG012|Epoch 4|Adverse Event|0|||
147212588|NCT02059291|530950482|FG013|Epoch 4|Adverse Event|0|||
147212589|NCT02059291|530950483|FG014|Epoch 4|Adverse Event|0|||
147212590|NCT02059291|530950484|FG015|Epoch 4|Adverse Event|0|||
147212591|NCT02059291|530950485|FG016|Epoch 4|Adverse Event|1|||
147212592|NCT02059291|530950486|FG017|Epoch 4|Adverse Event|0|||
147546610|NCT01364298|532157743|FG001|Overall Study|Other|3|||
147546611|NCT03550794|532157748|FG000|Overall Study|No longer met inclusion criteria|1|||
147212593|NCT02059291|530950487|FG018|Epoch 4|Adverse Event|0|||
147212594|NCT02059291|530950488|FG019|Epoch 4|Adverse Event|0|||
147212595|NCT02059291|530950489|FG020|Epoch 4|Adverse Event|0|||
147212596|NCT02059291|530950490|FG021|Epoch 4|Adverse Event|0|||
147212597|NCT02059291|530950491|FG022|Epoch 4|Adverse Event|1|||
147212598|NCT02059291|530950492|FG023|Epoch 4|Adverse Event|0|||
147212599|NCT02059291|530950493|FG024|Epoch 4|Adverse Event|0|||
147212600|NCT02059291|530950469|FG000|Epoch 4|Pregnancy|0|||
147212601|NCT02059291|530950470|FG001|Epoch 4|Pregnancy|0|||
147212602|NCT02059291|530950471|FG002|Epoch 4|Pregnancy|0|||
147212603|NCT02059291|530950472|FG003|Epoch 4|Pregnancy|0|||
147212604|NCT02059291|530950473|FG004|Epoch 4|Pregnancy|0|||
147212605|NCT02059291|530950474|FG005|Epoch 4|Pregnancy|0|||
147212606|NCT02059291|530950475|FG006|Epoch 4|Pregnancy|0|||
147212607|NCT02059291|530950476|FG007|Epoch 4|Pregnancy|0|||
147212608|NCT02059291|530950477|FG008|Epoch 4|Pregnancy|0|||
147212609|NCT02059291|530950478|FG009|Epoch 4|Pregnancy|0|||
147212610|NCT02059291|530950479|FG010|Epoch 4|Pregnancy|0|||
147212611|NCT02059291|530950480|FG011|Epoch 4|Pregnancy|0|||
147212612|NCT02059291|530950481|FG012|Epoch 4|Pregnancy|0|||
147212613|NCT02059291|530950482|FG013|Epoch 4|Pregnancy|0|||
147212614|NCT02059291|530950483|FG014|Epoch 4|Pregnancy|0|||
147212615|NCT02059291|530950484|FG015|Epoch 4|Pregnancy|0|||
147212616|NCT02059291|530950485|FG016|Epoch 4|Pregnancy|1|||
147546612|NCT03550794|532157749|FG001|Overall Study|No longer met inclusion criteria|2|||
147546613|NCT03550794|532157748|FG000|Overall Study|Goals of care changed|1|||
147546614|NCT03550794|532157749|FG001|Overall Study|Goals of care changed|0|||
147546615|NCT03550794|532157748|FG000|Overall Study|Withdrawal by Subject|2|||
147546616|NCT03550794|532157749|FG001|Overall Study|Withdrawal by Subject|0|||
147546617|NCT03550794|532157748|FG000|Overall Study|Death|0|||
147546618|NCT03550794|532157749|FG001|Overall Study|Death|1|||
147546619|NCT01864525|532157750|FG000|Overall Study|Adverse Event|1|||
147546620|NCT01864525|532157751|FG001|Overall Study|Adverse Event|0|||
147546621|NCT01890785|532157752|FG000|Third Intervention|Withdrawal by Subject|0|||
147546622|NCT01890785|532157753|FG001|Third Intervention|Withdrawal by Subject|1|||
147546623|NCT01890785|532157754|FG002|Third Intervention|Withdrawal by Subject|0|||
147546624|NCT01890785|532157755|FG003|Third Intervention|Withdrawal by Subject|0|||
147546625|NCT01890785|532157756|FG004|Third Intervention|Withdrawal by Subject|0|||
147546626|NCT01890785|532157757|FG005|Third Intervention|Withdrawal by Subject|0|||
147546627|NCT03296553|532157758|FG000|Overall Study|Withdrawal by Subject|1|||
147546628|NCT03296553|532157759|FG001|Overall Study|Withdrawal by Subject|1|||
147546629|NCT03296553|532157758|FG000|Overall Study|Death|1|||
147546630|NCT03296553|532157759|FG001|Overall Study|Death|0|||
147546631|NCT00065065|532157760|FG000|Overall Study|Adverse Event|3|||
147546632|NCT00065065|532157761|FG001|Overall Study|Adverse Event|2|||
147546633|NCT00065065|532157760|FG000|Overall Study|Withdrawal by Subject|1|||
147546634|NCT00065065|532157761|FG001|Overall Study|Withdrawal by Subject|5|||
147546635|NCT00065065|532157760|FG000|Overall Study|Lack of Efficacy|4|||
147546636|NCT00065065|532157761|FG001|Overall Study|Lack of Efficacy|11|||
147546637|NCT00065065|532157760|FG000|Overall Study|Other|2|||
147546638|NCT00065065|532157761|FG001|Overall Study|Other|2|||
147546639|NCT01050673|532157762|FG000|Overall Study|Physician Decision|4|||
147546640|NCT01050673|532157763|FG001|Overall Study|Physician Decision|5|||
147546641|NCT04363736|532157764|FG000|Overall Study|Withdrawal by Subject|1|||
147546642|NCT04363736|532157765|FG001|Overall Study|Withdrawal by Subject|0|||
147546643|NCT04363736|532157764|FG000|Overall Study|Lost to Follow-up|10|||
147546644|NCT04363736|532157765|FG001|Overall Study|Lost to Follow-up|7|||
147546645|NCT04363736|532157764|FG000|Overall Study|Death|8|||
147546646|NCT04363736|532157765|FG001|Overall Study|Death|6|||
147546647|NCT01254045|532157766|FG000|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|1|||
147546648|NCT01254045|532157767|FG001|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0|||
147546649|NCT01254045|532157768|FG002|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0|||
147546650|NCT01254045|532157769|FG003|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0|||
147546651|NCT01254045|532157770|FG004|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0|||
147546652|NCT01254045|532157771|FG005|First/Baseline (1 Day at Week 1 )|Lost to Follow-up|0|||
147546653|NCT00520351|532157772|FG000|First Intervention|Withdrawal by Subject|1|||
147546654|NCT00520351|532157773|FG001|First Intervention|Withdrawal by Subject|1|||
147546655|NCT03797222|532157775|FG000|Overall Study|Withdrawal by Subject|1|||
147212617|NCT02059291|530950486|FG017|Epoch 4|Pregnancy|0|||
147212618|NCT02059291|530950487|FG018|Epoch 4|Pregnancy|0|||
147212619|NCT02059291|530950488|FG019|Epoch 4|Pregnancy|0|||
147212620|NCT02059291|530950489|FG020|Epoch 4|Pregnancy|0|||
147212621|NCT02059291|530950490|FG021|Epoch 4|Pregnancy|0|||
147212622|NCT02059291|530950491|FG022|Epoch 4|Pregnancy|0|||
147212623|NCT02059291|530950492|FG023|Epoch 4|Pregnancy|0|||
147212624|NCT02059291|530950493|FG024|Epoch 4|Pregnancy|0|||
147212625|NCT02059291|530950469|FG000|Epoch 4|Withdrawal by Subject|0|||
147212626|NCT02059291|530950470|FG001|Epoch 4|Withdrawal by Subject|0|||
147212627|NCT02059291|530950471|FG002|Epoch 4|Withdrawal by Subject|0|||
147212628|NCT02059291|530950472|FG003|Epoch 4|Withdrawal by Subject|0|||
147212629|NCT02059291|530950473|FG004|Epoch 4|Withdrawal by Subject|0|||
147212630|NCT02059291|530950474|FG005|Epoch 4|Withdrawal by Subject|0|||
147212631|NCT02059291|530950475|FG006|Epoch 4|Withdrawal by Subject|0|||
147212632|NCT02059291|530950476|FG007|Epoch 4|Withdrawal by Subject|0|||
147212633|NCT02059291|530950477|FG008|Epoch 4|Withdrawal by Subject|0|||
147212634|NCT02059291|530950478|FG009|Epoch 4|Withdrawal by Subject|0|||
147546656|NCT04288115|532157781|FG000|Overall Study|Withdrawal by Subject|0|||
147546657|NCT04288115|532157782|FG001|Overall Study|Withdrawal by Subject|1|||
147546658|NCT04288115|532157781|FG000|Overall Study|Pre-study SCH diagnosis could not be confirmed per study entry criteria|3|||
147546659|NCT04288115|532157782|FG001|Overall Study|Pre-study SCH diagnosis could not be confirmed per study entry criteria|2|||
147546660|NCT00729365|532157783|FG000|Overall Study|Physician Decision|33|||
147546661|NCT00729365|532157784|FG001|Overall Study|Physician Decision|6|||
147212635|NCT02059291|530950479|FG010|Epoch 4|Withdrawal by Subject|0|||
147212636|NCT02059291|530950480|FG011|Epoch 4|Withdrawal by Subject|0|||
147212637|NCT02059291|530950481|FG012|Epoch 4|Withdrawal by Subject|0|||
147212638|NCT02059291|530950482|FG013|Epoch 4|Withdrawal by Subject|0|||
147546662|NCT00729365|532157785|FG002|Overall Study|Physician Decision|7|||
147546663|NCT00869089|532157789|FG000|Overall Study|Lost to Follow-up|1|||
147546664|NCT00869089|532157789|FG000|Overall Study|Withdrawal by Subject|1|||
147212639|NCT02059291|530950483|FG014|Epoch 4|Withdrawal by Subject|0|||
147212640|NCT02059291|530950484|FG015|Epoch 4|Withdrawal by Subject|0|||
147212641|NCT02059291|530950485|FG016|Epoch 4|Withdrawal by Subject|0|||
147212642|NCT02059291|530950486|FG017|Epoch 4|Withdrawal by Subject|0|||
147212643|NCT02059291|530950487|FG018|Epoch 4|Withdrawal by Subject|0|||
147212644|NCT02059291|530950488|FG019|Epoch 4|Withdrawal by Subject|0|||
147212645|NCT02059291|530950489|FG020|Epoch 4|Withdrawal by Subject|1|||
147212646|NCT02059291|530950490|FG021|Epoch 4|Withdrawal by Subject|0|||
147546665|NCT00869089|532157789|FG000|Overall Study|Screen Fail|1|||
147546666|NCT02766400|532157790|FG000|Overall Study|Death|1|||
147546667|NCT02766400|532157791|FG001|Overall Study|Death|2|||
147546668|NCT02766400|532157790|FG000|Overall Study|Withdrawal by Subject|1|||
147546669|NCT02766400|532157791|FG001|Overall Study|Withdrawal by Subject|0|||
147546670|NCT01374906|532157792|FG000|Overall Study|Abnormal laboratory value(s)|0|||
147546671|NCT01374906|532157793|FG001|Overall Study|Abnormal laboratory value(s)|3|||
147546672|NCT01374906|532157792|FG000|Overall Study|Administrative problems|2|||
147546673|NCT01374906|532157793|FG001|Overall Study|Administrative problems|2|||
147546674|NCT01374906|532157792|FG000|Overall Study|Adverse Event|10|||
147546675|NCT01374906|532157793|FG001|Overall Study|Adverse Event|11|||
147546676|NCT01374906|532157792|FG000|Overall Study|Death|0|||
147546677|NCT01374906|532157793|FG001|Overall Study|Death|2|||
147546678|NCT01374906|532157792|FG000|Overall Study|Protocol Violation|2|||
147546679|NCT01374906|532157793|FG001|Overall Study|Protocol Violation|2|||
147546680|NCT01374906|532157792|FG000|Overall Study|Withdrawal by Subject|15|||
147546681|NCT01374906|532157793|FG001|Overall Study|Withdrawal by Subject|9|||
147546682|NCT01374906|532157792|FG000|Overall Study|Unsatisfactory therapeutic effect|11|||
147546683|NCT01374906|532157793|FG001|Overall Study|Unsatisfactory therapeutic effect|19|||
147546684|NCT00430638|532157798|FG000|Overall Study|Adverse Event|15|||
147212647|NCT02059291|530950491|FG022|Epoch 4|Withdrawal by Subject|0|||
147212648|NCT02059291|530950492|FG023|Epoch 4|Withdrawal by Subject|0|||
147212649|NCT02059291|530950493|FG024|Epoch 4|Withdrawal by Subject|0|||
147212650|NCT02059291|530950469|FG000|Epoch 4|Lack of Efficacy|0|||
147212651|NCT02059291|530950470|FG001|Epoch 4|Lack of Efficacy|0|||
147212652|NCT02059291|530950471|FG002|Epoch 4|Lack of Efficacy|0|||
147212653|NCT02059291|530950472|FG003|Epoch 4|Lack of Efficacy|0|||
147212654|NCT02059291|530950473|FG004|Epoch 4|Lack of Efficacy|0|||
147212655|NCT02059291|530950474|FG005|Epoch 4|Lack of Efficacy|0|||
147212656|NCT02059291|530950475|FG006|Epoch 4|Lack of Efficacy|0|||
147212657|NCT02059291|530950476|FG007|Epoch 4|Lack of Efficacy|0|||
147212658|NCT02059291|530950477|FG008|Epoch 4|Lack of Efficacy|0|||
147212659|NCT02059291|530950478|FG009|Epoch 4|Lack of Efficacy|0|||
147212660|NCT02059291|530950479|FG010|Epoch 4|Lack of Efficacy|0|||
147212661|NCT02059291|530950480|FG011|Epoch 4|Lack of Efficacy|0|||
147212662|NCT02059291|530950481|FG012|Epoch 4|Lack of Efficacy|0|||
147212663|NCT02059291|530950482|FG013|Epoch 4|Lack of Efficacy|0|||
147212664|NCT02059291|530950483|FG014|Epoch 4|Lack of Efficacy|0|||
147212665|NCT02059291|530950484|FG015|Epoch 4|Lack of Efficacy|0|||
147212666|NCT02059291|530950485|FG016|Epoch 4|Lack of Efficacy|0|||
147212667|NCT02059291|530950486|FG017|Epoch 4|Lack of Efficacy|0|||
147212668|NCT02059291|530950487|FG018|Epoch 4|Lack of Efficacy|0|||
147212669|NCT02059291|530950488|FG019|Epoch 4|Lack of Efficacy|0|||
147212670|NCT02059291|530950489|FG020|Epoch 4|Lack of Efficacy|0|||
147212671|NCT02059291|530950490|FG021|Epoch 4|Lack of Efficacy|0|||
147212672|NCT02059291|530950491|FG022|Epoch 4|Lack of Efficacy|0|||
147212673|NCT02059291|530950492|FG023|Epoch 4|Lack of Efficacy|1|||
147212674|NCT02059291|530950493|FG024|Epoch 4|Lack of Efficacy|0|||
147212675|NCT00470834|530950494|FG000|Treatment Period (18 Months)|Protocol-defined Stopping Criteria|16|||
147212676|NCT00470834|530950495|FG001|Treatment Period (18 Months)|Protocol-defined Stopping Criteria|14|||
147212677|NCT00470834|530950494|FG000|Treatment Period (18 Months)|Adverse Event|7|||
147212678|NCT00470834|530950495|FG001|Treatment Period (18 Months)|Adverse Event|6|||
147212679|NCT00470834|530950494|FG000|Treatment Period (18 Months)|Withdrawal by Subject|4|||
147546685|NCT00430638|532157799|FG001|Overall Study|Adverse Event|15|||
147546686|NCT00430638|532157798|FG000|Overall Study|Uncontrolled blood pressure|48|||
147212680|NCT00470834|530950495|FG001|Treatment Period (18 Months)|Withdrawal by Subject|5|||
147212681|NCT00470834|530950494|FG000|Treatment Period (18 Months)|Physician Decision|4|||
147212682|NCT00470834|530950495|FG001|Treatment Period (18 Months)|Physician Decision|4|||
147212683|NCT00470834|530950494|FG000|Treatment Period (18 Months)|Protocol Violation|3|||
147212684|NCT00470834|530950495|FG001|Treatment Period (18 Months)|Protocol Violation|1|||
147212685|NCT00470834|530950494|FG000|Treatment Period (18 Months)|Sponsor Terminated Study|1|||
147212686|NCT00470834|530950495|FG001|Treatment Period (18 Months)|Sponsor Terminated Study|1|||
147212687|NCT00470834|530950494|FG000|Treatment Period (18 Months)|Lost to Follow-up|1|||
147212688|NCT00470834|530950495|FG001|Treatment Period (18 Months)|Lost to Follow-up|0|||
147546687|NCT00430638|532157799|FG001|Overall Study|Uncontrolled blood pressure|13|||
147546688|NCT00430638|532157798|FG000|Overall Study|Lost to Follow-up|1|||
147546689|NCT00430638|532157799|FG001|Overall Study|Lost to Follow-up|7|||
147546690|NCT00430638|532157798|FG000|Overall Study|Protocol Violation|6|||
147546691|NCT00430638|532157799|FG001|Overall Study|Protocol Violation|4|||
147546692|NCT00430638|532157798|FG000|Overall Study|Withdrawal by Subject|4|||
147212689|NCT00470834|530950494|FG000|Treatment Period (18 Months)|Non-compliance|1|||
147212690|NCT00470834|530950495|FG001|Treatment Period (18 Months)|Non-compliance|0|||
147212691|NCT00470834|530950494|FG000|Treatment Period (18 Months)|Lack of Efficacy|1|||
147546693|NCT00430638|532157799|FG001|Overall Study|Withdrawal by Subject|6|||
147546694|NCT00430638|532157798|FG000|Overall Study|Non-compliant|2|||
147212692|NCT00470834|530950495|FG001|Treatment Period (18 Months)|Lack of Efficacy|0|||
147212693|NCT00470834|530950494|FG000|Extension Period (24 Months)|Protocol-defined Stopping Criteria|6|||
147212694|NCT00470834|530950495|FG001|Extension Period (24 Months)|Protocol-defined Stopping Criteria|7|||
147212695|NCT00470834|530950494|FG000|Extension Period (24 Months)|Adverse Event|3|||
147212696|NCT00470834|530950495|FG001|Extension Period (24 Months)|Adverse Event|4|||
147212697|NCT00470834|530950494|FG000|Extension Period (24 Months)|Withdrawal by Subject|2|||
147212698|NCT00470834|530950495|FG001|Extension Period (24 Months)|Withdrawal by Subject|5|||
147212699|NCT00470834|530950494|FG000|Extension Period (24 Months)|Physician Decision|4|||
147212700|NCT00470834|530950495|FG001|Extension Period (24 Months)|Physician Decision|3|||
147212701|NCT00470834|530950494|FG000|Extension Period (24 Months)|Sponsor Terminated Study|0|||
147212702|NCT00470834|530950495|FG001|Extension Period (24 Months)|Sponsor Terminated Study|1|||
147212703|NCT00470834|530950494|FG000|Extension Period (24 Months)|Lost to Follow-up|0|||
147212704|NCT00470834|530950495|FG001|Extension Period (24 Months)|Lost to Follow-up|1|||
147212705|NCT00470834|530950494|FG000|Extension Period (24 Months)|Non-compliance|0|||
147212706|NCT00470834|530950495|FG001|Extension Period (24 Months)|Non-compliance|1|||
147212707|NCT00470834|530950494|FG000|Extension Period (24 Months)|Disease Progression|0|||
147212708|NCT00470834|530950495|FG001|Extension Period (24 Months)|Disease Progression|1|||
147212709|NCT01989208|530950498|FG000|200 mg (7 Days)|Protocol Violation|0|||
147212710|NCT01989208|530950499|FG001|200 mg (7 Days)|Protocol Violation|1|||
147212711|NCT00080899|530950503|FG000|Overall Study|Adverse Event|1|||
147212712|NCT01276054|530950506|FG000|Overall Study|No one to oversee trial after P.I. left|2|||
147212713|NCT01276054|530950507|FG001|Overall Study|No one to oversee trial after P.I. left|2|||
147212714|NCT04343235|530950508|FG000|Overall Study|Lost to Follow-up|3|||
147212715|NCT04343235|530950509|FG001|Overall Study|Lost to Follow-up|2|||
147212716|NCT00787267|530950510|FG000|Overall Study|Screen failure/Ineligible|10|||
147212717|NCT00787267|530950510|FG000|Overall Study|No Reason Provided|1|||
147212718|NCT00787267|530950510|FG000|Overall Study|Withdrawal by Subject|1|||
147212719|NCT01763996|530950511|FG000|Treatment Period 2|Adverse Event|0|||
147212720|NCT01763996|530950512|FG001|Treatment Period 2|Adverse Event|1|||
147212721|NCT00865280|530950513|FG000|Overall Study|Withdrawal by Subject|4|||
147212722|NCT00865280|530950514|FG001|Overall Study|Withdrawal by Subject|1|||
147212723|NCT00865280|530950513|FG000|Overall Study|End of Treatment/Lost to Follow-up|0|||
147212724|NCT00865280|530950514|FG001|Overall Study|End of Treatment/Lost to Follow-up|1|||
147212725|NCT00865280|530950513|FG000|Overall Study|Adverse Event/Lost to Follow-up|1|||
147212726|NCT00865280|530950514|FG001|Overall Study|Adverse Event/Lost to Follow-up|0|||
147212727|NCT00865280|530950513|FG000|Overall Study|Exclusion Condition|1|||
147212728|NCT00865280|530950514|FG001|Overall Study|Exclusion Condition|0|||
147212729|NCT00865280|530950513|FG000|Overall Study|Adverse Event|0|||
147212730|NCT00865280|530950514|FG001|Overall Study|Adverse Event|1|||
147212731|NCT01419197|530950515|FG000|Overall Study|Death|247|||
147212732|NCT01419197|530950516|FG001|Overall Study|Death|122|||
147212733|NCT01419197|530950515|FG000|Overall Study|Physician Decision|4|||
147212734|NCT01419197|530950516|FG001|Overall Study|Physician Decision|4|||
147212735|NCT01419197|530950515|FG000|Overall Study|Non-compliance|3|||
147212736|NCT01419197|530950516|FG001|Overall Study|Non-compliance|1|||
147212737|NCT01419197|530950515|FG000|Overall Study|Withdrawal by Subject|33|||
147212738|NCT01419197|530950516|FG001|Overall Study|Withdrawal by Subject|32|||
147212739|NCT01419197|530950515|FG000|Overall Study|Study Completed by Sponsor|103|||
147212740|NCT01419197|530950516|FG001|Overall Study|Study Completed by Sponsor|34|||
147212741|NCT01419197|530950515|FG000|Overall Study|Reason Not Specified|0|||
147212742|NCT01419197|530950516|FG001|Overall Study|Reason Not Specified|1|||
147212743|NCT01419197|530950515|FG000|Overall Study|Lost to Follow-up|14|||
147212744|NCT01419197|530950516|FG001|Overall Study|Lost to Follow-up|4|||
147212745|NCT00743106|530950517|FG000|Overall Study|Met intraoperative exclusion criterion|8|||
147442052|NCT00262522|531782731|FG003|Study Start Through 48 Weeks|Noncompliance|0|||
147442053|NCT00262522|531782728|FG000|Study Start Through 48 Weeks|Death|2|||
147442054|NCT00262522|531782729|FG001|Study Start Through 48 Weeks|Death|0|||
147442055|NCT00262522|531782730|FG002|Study Start Through 48 Weeks|Death|1|||
147442056|NCT00262522|531782731|FG003|Study Start Through 48 Weeks|Death|0|||
147442057|NCT00262522|531782728|FG000|Study Start Through 48 Weeks|Virologic failure|2|||
147442058|NCT00262522|531782729|FG001|Study Start Through 48 Weeks|Virologic failure|0|||
147442059|NCT00262522|531782730|FG002|Study Start Through 48 Weeks|Virologic failure|4|||
147442060|NCT00262522|531782731|FG003|Study Start Through 48 Weeks|Virologic failure|0|||
147442061|NCT00262522|531782728|FG000|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|8|||
147442062|NCT00262522|531782729|FG001|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|0|||
147442063|NCT00262522|531782730|FG002|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|7|||
147442064|NCT00262522|531782731|FG003|Study Start Through 48 Weeks|Relocated, Needed to take twice daily|0|||
147442065|NCT00262522|531782728|FG000|Study Start Through 96 Weeks|Adverse Event|20|||
147442066|NCT00262522|531782729|FG001|Study Start Through 96 Weeks|Adverse Event|0|||
147442067|NCT00262522|531782730|FG002|Study Start Through 96 Weeks|Adverse Event|16|||
147442068|NCT00262522|531782731|FG003|Study Start Through 96 Weeks|Adverse Event|0|||
147442069|NCT00262522|531782728|FG000|Study Start Through 96 Weeks|Withdrawal by Subject|15|||
147212746|NCT00743106|530950518|FG001|Overall Study|Met intraoperative exclusion criterion|5|||
147212747|NCT00145977|530950520|FG000|Overall Study|Lack of Efficacy|0|||
147212748|NCT00145977|530950521|FG001|Overall Study|Lack of Efficacy|4|||
147212749|NCT00145977|530950520|FG000|Overall Study|Lost to Follow-up|1|||
147212750|NCT00145977|530950521|FG001|Overall Study|Lost to Follow-up|0|||
147546695|NCT00430638|532157799|FG001|Overall Study|Non-compliant|1|||
147546696|NCT00430638|532157798|FG000|Overall Study|Other|2|||
147546697|NCT00430638|532157799|FG001|Overall Study|Other|2|||
147212751|NCT00145977|530950520|FG000|Overall Study|Withdrawal by Subject|1|||
147212752|NCT00145977|530950521|FG001|Overall Study|Withdrawal by Subject|0|||
147212753|NCT03060551|530950522|FG000|Overall Study|Withdrawal by Subject|1|||
147212754|NCT03060551|530950522|FG000|Overall Study|Adverse Event|1|||
147212755|NCT04629066|530950523|FG000|Overall Study|Lost to Follow-up|3|||
147212756|NCT04629066|530950524|FG001|Overall Study|Lost to Follow-up|2|||
147212757|NCT04359901|530950531|FG000|Overall Study|Withdrawal by Subject|0|||
147212758|NCT04359901|530950532|FG001|Overall Study|Withdrawal by Subject|1|||
147212759|NCT04359901|530950531|FG000|Overall Study|Death|6|||
147212760|NCT04359901|530950532|FG001|Overall Study|Death|2|||
147212761|NCT01808092|530950540|FG000|Overall Study|Death|39|||
147212762|NCT01808092|530950541|FG001|Overall Study|Death|29|||
147212763|NCT01808092|530950540|FG000|Overall Study|Lost to Follow-up|3|||
147212764|NCT01808092|530950541|FG001|Overall Study|Lost to Follow-up|7|||
147212765|NCT01808092|530950540|FG000|Overall Study|Withdrawal by Subject|9|||
147212766|NCT01808092|530950541|FG001|Overall Study|Withdrawal by Subject|4|||
147212767|NCT01808092|530950540|FG000|Overall Study|Other Eligibility criteria|3|||
147212768|NCT01808092|530950541|FG001|Overall Study|Other Eligibility criteria|5|||
147212769|NCT03425253|530950544|FG000|Overall Study|Adverse Event|2|||
147212770|NCT03425253|530950544|FG000|Overall Study|Lost to Follow-up|3|||
147212771|NCT03425253|530950544|FG000|Overall Study|Withdrew Consent|6|||
147212772|NCT03425253|530950544|FG000|Overall Study|Did not Meet all Eligibility Criteria Defined in the Protocol|5|||
147212773|NCT04614324|530950545|FG000|Overall Study|Lost to Follow-up|3|||
147212774|NCT04614324|530950545|FG000|Overall Study|Physician Decision|1|||
147212775|NCT04614324|530950545|FG000|Overall Study|Withdrawal by Subject|2|||
147212776|NCT04614324|530950545|FG000|Overall Study|Remaining in Follow up|123|||
147212777|NCT01031836|530952342|FG000|Stage I|Adverse Event|1|||
147212778|NCT01031836|530952343|FG001|Stage I|Adverse Event|1|||
147212779|NCT01031836|530952344|FG002|Stage I|Adverse Event|0|||
147212780|NCT01031836|530952345|FG003|Stage I|Adverse Event|0|||
147212781|NCT01031836|530952346|FG004|Stage I|Adverse Event|0|||
147212782|NCT01031836|530952347|FG005|Stage I|Adverse Event|0|||
147212783|NCT01031836|530952342|FG000|Stage I|Other|0|||
147212784|NCT01031836|530952343|FG001|Stage I|Other|1|||
147212785|NCT01031836|530952344|FG002|Stage I|Other|0|||
147212786|NCT01031836|530952345|FG003|Stage I|Other|0|||
147212787|NCT01031836|530952346|FG004|Stage I|Other|0|||
147212788|NCT01031836|530952347|FG005|Stage I|Other|1|||
147212789|NCT01031836|530952342|FG000|Stage II|Adverse Event|0|||
147212790|NCT01031836|530952343|FG001|Stage II|Adverse Event|0|||
147212791|NCT01031836|530952344|FG002|Stage II|Adverse Event|2|||
147212792|NCT01031836|530952345|FG003|Stage II|Adverse Event|2|||
147212793|NCT01031836|530952346|FG004|Stage II|Adverse Event|1|||
147212794|NCT01031836|530952347|FG005|Stage II|Adverse Event|1|||
147546698|NCT02367781|532157800|FG000|Overall Study|Withdrawal by Subject|20|||
147546699|NCT02367781|532157801|FG001|Overall Study|Withdrawal by Subject|13|||
147546700|NCT02367781|532157800|FG000|Overall Study|Protocol Violation|0|||
147546701|NCT02367781|532157801|FG001|Overall Study|Protocol Violation|1|||
147546702|NCT02367781|532157800|FG000|Overall Study|Physician Decision|7|||
147546703|NCT02367781|532157801|FG001|Overall Study|Physician Decision|0|||
147546704|NCT02367781|532157800|FG000|Overall Study|Randomized in Error|5|||
147546705|NCT02367781|532157801|FG001|Overall Study|Randomized in Error|4|||
147546706|NCT02367781|532157800|FG000|Overall Study|Non-Compliance|1|||
147546707|NCT02367781|532157801|FG001|Overall Study|Non-Compliance|0|||
147546708|NCT02367781|532157800|FG000|Overall Study|Lost to Follow-up|1|||
147212795|NCT01031836|530952342|FG000|Stage II|Other|2|||
147546709|NCT02367781|532157801|FG001|Overall Study|Lost to Follow-up|2|||
147212796|NCT01031836|530952343|FG001|Stage II|Other|0|||
147212797|NCT01031836|530952344|FG002|Stage II|Other|0|||
147212798|NCT01031836|530952345|FG003|Stage II|Other|1|||
147212799|NCT01031836|530952346|FG004|Stage II|Other|1|||
147212800|NCT01031836|530952347|FG005|Stage II|Other|0|||
147212801|NCT00490529|530952348|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Death|4|||
147212802|NCT00490529|530952348|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Withdrawal by Subject|4|||
147212803|NCT00490529|530952348|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Withdrawn, AHCT not suitable treatment|1|||
147212804|NCT00490529|530952348|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Withdrawn, chemo not suitable treatment|1|||
147212805|NCT00490529|530952348|FG000|Completed Pre-CpG-MCL Vaccine Procedures|Withdrawal due to insurance refusal|1|||
147212806|NCT00490529|530952348|FG000|Treatment With CpG-MCL Vaccine|Received vaccine, did not receive AHCT|1|||
147212807|NCT01410357|530952351|FG000|Overall Study|Death|2|||
147212808|NCT01410357|530952352|FG001|Overall Study|Death|1|||
147212809|NCT01410357|530952351|FG000|Overall Study|Withdrawal by Subject|1|||
147212810|NCT01410357|530952352|FG001|Overall Study|Withdrawal by Subject|2|||
147546710|NCT02367781|532157800|FG000|Overall Study|Death|330|||
147546711|NCT02367781|532157801|FG001|Overall Study|Death|176|||
147546712|NCT02367781|532157800|FG000|Overall Study|Patient Moving to Roll-Over Study|17|||
147546713|NCT02367781|532157801|FG001|Overall Study|Patient Moving to Roll-Over Study|5|||
147546714|NCT02367781|532157800|FG000|Overall Study|Prolonged Hospitalization|1|||
147546715|NCT02367781|532157801|FG001|Overall Study|Prolonged Hospitalization|0|||
147546716|NCT02367781|532157800|FG000|Overall Study|Death Prior First Dose|1|||
147546717|NCT02367781|532157801|FG001|Overall Study|Death Prior First Dose|0|||
147546718|NCT02367781|532157800|FG000|Overall Study|Administrative-Change Facility|1|||
147546719|NCT02367781|532157801|FG001|Overall Study|Administrative-Change Facility|0|||
147212811|NCT01410357|530952351|FG000|Overall Study|Lost to Follow-up|23|||
147212812|NCT01410357|530952352|FG001|Overall Study|Lost to Follow-up|21|||
147212813|NCT03467152|530952357|FG000|Overall Study|Adverse Event|4|||
147212814|NCT03467152|530952358|FG001|Overall Study|Adverse Event|5|||
147212815|NCT03467152|530952359|FG002|Overall Study|Adverse Event|0|||
147212816|NCT03467152|530952357|FG000|Overall Study|Subject Choice|1|||
147212817|NCT03467152|530952358|FG001|Overall Study|Subject Choice|3|||
147212818|NCT03467152|530952359|FG002|Overall Study|Subject Choice|0|||
147212819|NCT03467152|530952357|FG000|Overall Study|Lost to Follow-up|1|||
147212820|NCT03467152|530952358|FG001|Overall Study|Lost to Follow-up|0|||
147212821|NCT03467152|530952359|FG002|Overall Study|Lost to Follow-up|0|||
147212822|NCT03467152|530952357|FG000|Overall Study|Withdrawal by Subject|4|||
147212823|NCT03467152|530952358|FG001|Overall Study|Withdrawal by Subject|2|||
147212824|NCT03467152|530952359|FG002|Overall Study|Withdrawal by Subject|0|||
147212825|NCT03467152|530952357|FG000|Overall Study|Others|3|||
147212826|NCT03467152|530952358|FG001|Overall Study|Others|0|||
147212827|NCT03467152|530952359|FG002|Overall Study|Others|0|||
147212828|NCT03467152|530952357|FG000|Overall Study|Not treated|3|||
147212829|NCT03467152|530952358|FG001|Overall Study|Not treated|1|||
147212830|NCT03467152|530952359|FG002|Overall Study|Not treated|6|||
147212831|NCT00945906|530952360|FG000|Overall Study|Withdrawal by Subject|1|||
147212832|NCT00945906|530952360|FG000|Overall Study|Did not want to return for last visit|2|||
147212833|NCT00945906|530952360|FG000|Overall Study|Unable to return for last visit|2|||
147212834|NCT00945906|530952360|FG000|Overall Study|Moved to another country|2|||
147212835|NCT03700684|530952362|FG000|Overall Study|COVID-19|0|||
147212836|NCT03700684|530952363|FG001|Overall Study|COVID-19|0|||
147212837|NCT03700684|530952364|FG002|Overall Study|COVID-19|2|||
147212838|NCT01120782|530952365|FG000|Overall Study|Test article shipping error|11|||
147212839|NCT04140227|530952366|FG000|Overall Study|Withdrawal by Subject|26|||
147212840|NCT04140227|530952366|FG000|Overall Study|Lost to Follow-up|8|||
147212841|NCT04140227|530952366|FG000|Overall Study|Adverse Event|8|||
147212842|NCT04140227|530952366|FG000|Overall Study|Death|1|||
147212843|NCT04140227|530952366|FG000|Overall Study|Other|3|||
147212844|NCT04140227|530952366|FG000|Overall Study|Protocol Violation|2|||
147212845|NCT00635219|530952367|FG000|Overall Study|Adverse Event|12|||
147212846|NCT00635219|530952368|FG001|Overall Study|Adverse Event|10|||
147212847|NCT00635219|530952369|FG002|Overall Study|Adverse Event|18|||
147212848|NCT00635219|530952370|FG003|Overall Study|Adverse Event|15|||
147212849|NCT00635219|530952371|FG004|Overall Study|Adverse Event|19|||
147212850|NCT00635219|530952367|FG000|Overall Study|Lack of Efficacy|5|||
147212851|NCT00635219|530952368|FG001|Overall Study|Lack of Efficacy|6|||
147212852|NCT00635219|530952369|FG002|Overall Study|Lack of Efficacy|3|||
147212853|NCT00635219|530952370|FG003|Overall Study|Lack of Efficacy|4|||
147212854|NCT00635219|530952371|FG004|Overall Study|Lack of Efficacy|6|||
147212855|NCT00635219|530952367|FG000|Overall Study|Non-compliance With Study Product|0|||
147212856|NCT00635219|530952368|FG001|Overall Study|Non-compliance With Study Product|0|||
147212857|NCT00635219|530952369|FG002|Overall Study|Non-compliance With Study Product|0|||
147212858|NCT00635219|530952370|FG003|Overall Study|Non-compliance With Study Product|2|||
147212859|NCT00635219|530952371|FG004|Overall Study|Non-compliance With Study Product|1|||
147212860|NCT00635219|530952367|FG000|Overall Study|Protocol Violation|0|||
147212861|NCT00635219|530952368|FG001|Overall Study|Protocol Violation|2|||
147212862|NCT00635219|530952369|FG002|Overall Study|Protocol Violation|3|||
147212863|NCT00635219|530952370|FG003|Overall Study|Protocol Violation|2|||
147212864|NCT00635219|530952371|FG004|Overall Study|Protocol Violation|4|||
147212865|NCT00635219|530952367|FG000|Overall Study|Withdrawal of Consent|8|||
147212866|NCT00635219|530952368|FG001|Overall Study|Withdrawal of Consent|6|||
147212867|NCT00635219|530952369|FG002|Overall Study|Withdrawal of Consent|8|||
147546720|NCT02367781|532157800|FG000|Overall Study|Request From Sponsor to Withdraw Patient in Survival Follow-Up|78|||
147546721|NCT02367781|532157801|FG001|Overall Study|Request From Sponsor to Withdraw Patient in Survival Follow-Up|29|||
147212868|NCT00635219|530952370|FG003|Overall Study|Withdrawal of Consent|11|||
147212869|NCT00635219|530952371|FG004|Overall Study|Withdrawal of Consent|8|||
147212870|NCT00635219|530952367|FG000|Overall Study|Lost to Follow-up|0|||
147212871|NCT00635219|530952368|FG001|Overall Study|Lost to Follow-up|0|||
147212872|NCT00635219|530952369|FG002|Overall Study|Lost to Follow-up|2|||
147212873|NCT00635219|530952370|FG003|Overall Study|Lost to Follow-up|0|||
147212874|NCT00635219|530952371|FG004|Overall Study|Lost to Follow-up|3|||
147212875|NCT00635219|530952367|FG000|Overall Study|Administrative or Other Reasons|0|||
147212876|NCT00635219|530952368|FG001|Overall Study|Administrative or Other Reasons|1|||
147212877|NCT00635219|530952369|FG002|Overall Study|Administrative or Other Reasons|1|||
147546722|NCT02367781|532157800|FG000|Overall Study|Patient Moved to Commercial Atezolizumab Use|14|||
147546723|NCT02367781|532157801|FG001|Overall Study|Patient Moved to Commercial Atezolizumab Use|9|||
147546724|NCT02367781|532157800|FG000|Overall Study|Study Terminated by Sponsor|3|||
147546725|NCT02367781|532157801|FG001|Overall Study|Study Terminated by Sponsor|1|||
147546726|NCT02367781|532157800|FG000|Overall Study|Patient Admitted to Hospital & Couldn't be Dosed for Randomization|1|||
147546727|NCT02367781|532157801|FG001|Overall Study|Patient Admitted to Hospital & Couldn't be Dosed for Randomization|0|||
147546728|NCT02367781|532157800|FG000|Overall Study|Sponsor Decision|2|||
147546729|NCT02367781|532157801|FG001|Overall Study|Sponsor Decision|0|||
147546730|NCT02367781|532157800|FG000|Overall Study|3 Year Treatment Completed, Immunotherapy Paused, Continuing Follow-Up Planned|1|||
147546731|NCT02367781|532157801|FG001|Overall Study|3 Year Treatment Completed, Immunotherapy Paused, Continuing Follow-Up Planned|0|||
147546732|NCT01529749|532157802|FG000|Overall Study|Lost to Follow-up|0|||
147212878|NCT00635219|530952370|FG003|Overall Study|Administrative or Other Reasons|0|||
147212879|NCT00635219|530952371|FG004|Overall Study|Administrative or Other Reasons|1|||
147212880|NCT01639729|530952372|FG000|Overall Study|Withdrawal by Subject|1|||
147212881|NCT01639729|530952373|FG001|Overall Study|Withdrawal by Subject|0|||
147212882|NCT01639729|530952374|FG002|Overall Study|Withdrawal by Subject|1|||
147212883|NCT01639729|530952375|FG003|Overall Study|Withdrawal by Subject|1|||
147212884|NCT01639729|530952376|FG004|Overall Study|Withdrawal by Subject|0|||
147212885|NCT01639729|530952377|FG005|Overall Study|Withdrawal by Subject|0|||
147212886|NCT00759564|530952378|FG000|Washout Period (at Least 14 Days)|Adverse Event|0|||
147212887|NCT00759564|530952379|FG001|Washout Period (at Least 14 Days)|Adverse Event|0|||
147212888|NCT00759564|530952380|FG002|Washout Period (at Least 14 Days)|Adverse Event|0|||
147212889|NCT00759564|530952381|FG003|Washout Period (at Least 14 Days)|Adverse Event|0|||
147212890|NCT00759564|530952382|FG004|Washout Period (at Least 14 Days)|Adverse Event|1|||
147212891|NCT04145219|530952383|FG000|Overall Study|Adverse Event|18|||
147212892|NCT04145219|530952384|FG001|Overall Study|Adverse Event|6|||
147212893|NCT04145219|530952383|FG000|Overall Study|Lost to Follow-up|2|||
147212894|NCT04145219|530952384|FG001|Overall Study|Lost to Follow-up|3|||
147212895|NCT04145219|530952383|FG000|Overall Study|Physician Decision|0|||
147212896|NCT04145219|530952384|FG001|Overall Study|Physician Decision|2|||
147212897|NCT04145219|530952383|FG000|Overall Study|Withdrawal by Subject|12|||
147212898|NCT04145219|530952384|FG001|Overall Study|Withdrawal by Subject|8|||
147212899|NCT04145219|530952383|FG000|Overall Study|Reason stated as 'Other' in the case report form (CRF)|7|||
147212900|NCT04145219|530952384|FG001|Overall Study|Reason stated as 'Other' in the case report form (CRF)|7|||
147212901|NCT01640314|530952385|FG000|Overall Study|Protocol Violation|0|||
147212902|NCT01640314|530952386|FG001|Overall Study|Protocol Violation|1|||
147212903|NCT01290796|530952387|FG000|Overall Study|Lost to Follow-up|21|||
147212904|NCT01290796|530952387|FG000|Overall Study|Withdrawal by Subject|4|||
147212905|NCT01290796|530952387|FG000|Overall Study|Physician Decision|2|||
147212906|NCT01290796|530952387|FG000|Overall Study|Secondary Surgical Intervention|2|||
147212907|NCT01290796|530952387|FG000|Overall Study|Withdrawal by Sponsor|1|||
147212908|NCT02709538|530952389|FG000|Overall Study|Adverse Event|13|||
147212909|NCT02709538|530952390|FG001|Overall Study|Adverse Event|2|||
147212910|NCT02709538|530952391|FG002|Overall Study|Adverse Event|3|||
147212911|NCT02709538|530952389|FG000|Overall Study|Lack of Efficacy|1|||
147212912|NCT02709538|530952390|FG001|Overall Study|Lack of Efficacy|0|||
147212913|NCT02709538|530952391|FG002|Overall Study|Lack of Efficacy|0|||
147212914|NCT02709538|530952389|FG000|Overall Study|Lost to Follow-up|24|||
147212915|NCT02709538|530952390|FG001|Overall Study|Lost to Follow-up|8|||
147212916|NCT02709538|530952391|FG002|Overall Study|Lost to Follow-up|4|||
147212917|NCT02709538|530952389|FG000|Overall Study|Physician Decision|1|||
147212918|NCT02709538|530952390|FG001|Overall Study|Physician Decision|0|||
147212919|NCT02709538|530952391|FG002|Overall Study|Physician Decision|0|||
147212920|NCT02709538|530952389|FG000|Overall Study|Withdrawal by Subject|40|||
147212921|NCT02709538|530952390|FG001|Overall Study|Withdrawal by Subject|7|||
147212922|NCT02709538|530952391|FG002|Overall Study|Withdrawal by Subject|4|||
147212923|NCT02709538|530952389|FG000|Overall Study|Non-compliance with study procedures|5|||
147212924|NCT02709538|530952390|FG001|Overall Study|Non-compliance with study procedures|0|||
147212925|NCT02709538|530952391|FG002|Overall Study|Non-compliance with study procedures|0|||
147212926|NCT02709538|530952389|FG000|Overall Study|Non-compliance with study drug|2|||
147212927|NCT02709538|530952390|FG001|Overall Study|Non-compliance with study drug|0|||
147212928|NCT02709538|530952391|FG002|Overall Study|Non-compliance with study drug|0|||
147212929|NCT02709538|530952389|FG000|Overall Study|Protocol deviation|10|||
147212930|NCT02709538|530952390|FG001|Overall Study|Protocol deviation|4|||
147212931|NCT02709538|530952391|FG002|Overall Study|Protocol deviation|4|||
147212932|NCT02709538|530952389|FG000|Overall Study|Withdrawal by Parent or Legal Guardian|1|||
147212933|NCT02709538|530952390|FG001|Overall Study|Withdrawal by Parent or Legal Guardian|0|||
147212934|NCT02709538|530952391|FG002|Overall Study|Withdrawal by Parent or Legal Guardian|0|||
147212935|NCT02709538|530952389|FG000|Overall Study|Other|16|||
147212936|NCT02709538|530952390|FG001|Overall Study|Other|7|||
147212937|NCT02709538|530952391|FG002|Overall Study|Other|5|||
147212938|NCT00835211|530952392|FG000|First Intervention|Withdrawal by Subject|0|||
147212939|NCT00835211|530952393|FG001|First Intervention|Withdrawal by Subject|1|||
147212940|NCT00835211|530952392|FG000|Washout: 7 Days|Adverse Event|2|||
147212941|NCT00835211|530952393|FG001|Washout: 7 Days|Adverse Event|1|||
147212942|NCT00835211|530952392|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
147212943|NCT00835211|530952393|FG001|Washout: 7 Days|Withdrawal by Subject|0|||
147212944|NCT02343549|530952394|FG000|Overall Study|Death|11|||
147212945|NCT02343549|530952394|FG000|Overall Study|Withdrawal by Subject|2|||
147212946|NCT02160041|530952396|FG000|Overall Study|Adverse Event|11|||
147212947|NCT02160041|530952396|FG000|Overall Study|Death|2|||
147212948|NCT02160041|530952396|FG000|Overall Study|disease progression|57|||
147212949|NCT02160041|530952396|FG000|Overall Study|Protocol Violation|1|||
147212950|NCT02160041|530952396|FG000|Overall Study|non-compliance with study|1|||
147212951|NCT02160041|530952396|FG000|Overall Study|Physician Decision|3|||
147212952|NCT02160041|530952396|FG000|Overall Study|Withdrawal by Subject|8|||
147212953|NCT02160041|530952396|FG000|Overall Study|study terminated by by sponsor|1|||
147212954|NCT01403948|530952397|FG000|Overall Study|Progressive disease|0|||
147212955|NCT01403948|530952398|FG001|Overall Study|Progressive disease|2|||
147212956|NCT01403948|530952399|FG002|Overall Study|Progressive disease|2|||
147212957|NCT01403948|530952400|FG003|Overall Study|Progressive disease|4|||
147212958|NCT01403948|530952401|FG004|Overall Study|Progressive disease|2|||
147212959|NCT01403948|530952402|FG005|Overall Study|Progressive disease|6|||
147212960|NCT01403948|530952403|FG006|Overall Study|Progressive disease|2|||
147212961|NCT01403948|530952404|FG007|Overall Study|Progressive disease|4|||
147212962|NCT01403948|530952405|FG008|Overall Study|Progressive disease|5|||
147212963|NCT01403948|530952406|FG009|Overall Study|Progressive disease|5|||
147212964|NCT01403948|530952397|FG000|Overall Study|Other Adverse Event (Other than DLT)|0|||
147212965|NCT01403948|530952398|FG001|Overall Study|Other Adverse Event (Other than DLT)|0|||
147212966|NCT01403948|530952399|FG002|Overall Study|Other Adverse Event (Other than DLT)|0|||
147212967|NCT01403948|530952400|FG003|Overall Study|Other Adverse Event (Other than DLT)|0|||
147212968|NCT01403948|530952401|FG004|Overall Study|Other Adverse Event (Other than DLT)|2|||
147212969|NCT01403948|530952402|FG005|Overall Study|Other Adverse Event (Other than DLT)|0|||
147212970|NCT01403948|530952403|FG006|Overall Study|Other Adverse Event (Other than DLT)|2|||
147546733|NCT01529749|532157803|FG001|Overall Study|Lost to Follow-up|1|||
147212971|NCT01403948|530952404|FG007|Overall Study|Other Adverse Event (Other than DLT)|0|||
147212972|NCT01403948|530952405|FG008|Overall Study|Other Adverse Event (Other than DLT)|1|||
147212973|NCT01403948|530952406|FG009|Overall Study|Other Adverse Event (Other than DLT)|0|||
147212974|NCT01403948|530952397|FG000|Overall Study|Lost to Follow-up|0|||
147546734|NCT01529749|532157804|FG002|Overall Study|Lost to Follow-up|1|||
147546735|NCT01529749|532157805|FG003|Overall Study|Lost to Follow-up|0|||
147546736|NCT01529749|532157802|FG000|Overall Study|Physician Decision|0|||
147546737|NCT01529749|532157803|FG001|Overall Study|Physician Decision|0|||
147546738|NCT01529749|532157804|FG002|Overall Study|Physician Decision|0|||
147546739|NCT01529749|532157805|FG003|Overall Study|Physician Decision|1|||
147212975|NCT01403948|530952398|FG001|Overall Study|Lost to Follow-up|0|||
147212976|NCT01403948|530952399|FG002|Overall Study|Lost to Follow-up|0|||
147212977|NCT01403948|530952400|FG003|Overall Study|Lost to Follow-up|0|||
147212978|NCT01403948|530952401|FG004|Overall Study|Lost to Follow-up|0|||
147212979|NCT01403948|530952402|FG005|Overall Study|Lost to Follow-up|0|||
147212980|NCT01403948|530952403|FG006|Overall Study|Lost to Follow-up|0|||
147212981|NCT01403948|530952404|FG007|Overall Study|Lost to Follow-up|0|||
147212982|NCT01403948|530952405|FG008|Overall Study|Lost to Follow-up|0|||
147212983|NCT01403948|530952406|FG009|Overall Study|Lost to Follow-up|1|||
147212984|NCT01403948|530952397|FG000|Overall Study|Refused cont. medication|0|||
147212985|NCT01403948|530952398|FG001|Overall Study|Refused cont. medication|0|||
147212986|NCT01403948|530952399|FG002|Overall Study|Refused cont. medication|0|||
147212987|NCT01403948|530952400|FG003|Overall Study|Refused cont. medication|0|||
147546740|NCT01529749|532157802|FG000|Overall Study|Withdrawal by Subject|0|||
147546741|NCT01529749|532157803|FG001|Overall Study|Withdrawal by Subject|1|||
147546742|NCT01529749|532157804|FG002|Overall Study|Withdrawal by Subject|1|||
147546743|NCT01529749|532157805|FG003|Overall Study|Withdrawal by Subject|0|||
147546744|NCT01529749|532157802|FG000|Overall Study|Protocol Violation|0|||
147546745|NCT01529749|532157803|FG001|Overall Study|Protocol Violation|0|||
147546746|NCT01529749|532157804|FG002|Overall Study|Protocol Violation|0|||
147546747|NCT01529749|532157805|FG003|Overall Study|Protocol Violation|1|||
147546748|NCT00378482|532157806|FG000|Overall Study|Lost to Follow-up|1|||
147546749|NCT00378482|532157806|FG000|Overall Study|Lack of Efficacy|8|||
147546750|NCT00378482|532157806|FG000|Overall Study|Subject or physician decision, or subject relocation to another city or region.|9|||
147546751|NCT00378482|532157806|FG000|Overall Study|Withdrawal by Subject|4|||
147546752|NCT00378482|532157806|FG000|Overall Study|Adverse Event|9|||
147546753|NCT05166421|532157807|FG000|Overall Study|Other|3|||
147546754|NCT05166421|532157808|FG001|Overall Study|Other|1|||
147546755|NCT05166421|532157809|FG002|Overall Study|Other|1|||
147212988|NCT01403948|530952401|FG004|Overall Study|Refused cont. medication|1|||
147212989|NCT01403948|530952402|FG005|Overall Study|Refused cont. medication|0|||
147212990|NCT01403948|530952403|FG006|Overall Study|Refused cont. medication|0|||
147212991|NCT01403948|530952404|FG007|Overall Study|Refused cont. medication|0|||
147212992|NCT01403948|530952405|FG008|Overall Study|Refused cont. medication|0|||
147212993|NCT01403948|530952406|FG009|Overall Study|Refused cont. medication|1|||
147212994|NCT01403948|530952397|FG000|Overall Study|other than above|1|||
147212995|NCT01403948|530952398|FG001|Overall Study|other than above|2|||
147212996|NCT01403948|530952399|FG002|Overall Study|other than above|1|||
147212997|NCT01403948|530952400|FG003|Overall Study|other than above|0|||
147212998|NCT01403948|530952401|FG004|Overall Study|other than above|1|||
147212999|NCT01403948|530952402|FG005|Overall Study|other than above|1|||
147213000|NCT01403948|530952403|FG006|Overall Study|other than above|2|||
147213001|NCT01403948|530952404|FG007|Overall Study|other than above|0|||
147213002|NCT01403948|530952405|FG008|Overall Study|other than above|0|||
147213003|NCT01403948|530952406|FG009|Overall Study|other than above|0|||
147213004|NCT01090323|530952407|FG000|Overall Study|Adverse Event|12|||
147213005|NCT01090323|530952408|FG001|Overall Study|Adverse Event|2|||
147213006|NCT01090323|530952407|FG000|Overall Study|Abnormal Lab Values|3|||
147213007|NCT01090323|530952408|FG001|Overall Study|Abnormal Lab Values|1|||
147213008|NCT01090323|530952407|FG000|Overall Study|Abnormal Test Procedure Results|2|||
147213009|NCT01090323|530952408|FG001|Overall Study|Abnormal Test Procedure Results|0|||
147213010|NCT01090323|530952407|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
147213011|NCT01090323|530952408|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
147213012|NCT01090323|530952407|FG000|Overall Study|Condition no longer requires drug|5|||
147213013|NCT01090323|530952408|FG001|Overall Study|Condition no longer requires drug|4|||
147213014|NCT01090323|530952407|FG000|Overall Study|Protocol Violation|2|||
147213015|NCT01090323|530952408|FG001|Overall Study|Protocol Violation|1|||
147213016|NCT01090323|530952407|FG000|Overall Study|Withdrew consent|33|||
147213017|NCT01090323|530952408|FG001|Overall Study|Withdrew consent|11|||
147213018|NCT01090323|530952407|FG000|Overall Study|Lost to Follow-up|11|||
147213019|NCT01090323|530952408|FG001|Overall Study|Lost to Follow-up|6|||
147213020|NCT01090323|530952407|FG000|Overall Study|Administrative problems|6|||
147213021|NCT01090323|530952408|FG001|Overall Study|Administrative problems|4|||
147213022|NCT01090323|530952407|FG000|Overall Study|Death|1|||
147213023|NCT01090323|530952408|FG001|Overall Study|Death|2|||
147213024|NCT01090323|530952407|FG000|Overall Study|Stopped end of core|7|||
147213025|NCT01090323|530952408|FG001|Overall Study|Stopped end of core|0|||
147213026|NCT01090323|530952407|FG000|Overall Study|Stopped end of extension 1#|3|||
147213027|NCT01090323|530952408|FG001|Overall Study|Stopped end of extension 1#|1|||
147213028|NCT05498701|530952409|FG000|Period 3|Adverse Event|1|||
147213029|NCT05498701|530952410|FG001|Period 3|Adverse Event|0|||
147213030|NCT01864005|530952411|FG000|Overall Study|Protocol Violation|0|||
147213031|NCT01864005|530952412|FG001|Overall Study|Protocol Violation|1|||
147213032|NCT01864005|530952411|FG000|Overall Study|Withdrawal by Subject|0|||
147213033|NCT01864005|530952412|FG001|Overall Study|Withdrawal by Subject|1|||
147213034|NCT01864005|530952411|FG000|Overall Study|Incorrect enrolment|1|||
147213035|NCT01864005|530952412|FG001|Overall Study|Incorrect enrolment|0|||
147213036|NCT01864005|530952411|FG000|Overall Study|Disease need|1|||
147213037|NCT01864005|530952412|FG001|Overall Study|Disease need|1|||
147213038|NCT01864005|530952411|FG000|Overall Study|Need GP IIb/IIIa|1|||
147213039|NCT01864005|530952412|FG001|Overall Study|Need GP IIb/IIIa|3|||
147213040|NCT02184572|530952418|FG000|Overall Study|Lost to Follow-up|29|||
147213041|NCT02184572|530952419|FG001|Overall Study|Lost to Follow-up|21|||
147213042|NCT02184572|530952418|FG000|Overall Study|Family Out Of Country Until 9/29/2015|1|||
147213043|NCT02184572|530952419|FG001|Overall Study|Family Out Of Country Until 9/29/2015|0|||
147213044|NCT02184572|530952418|FG000|Overall Study|Loss Of Kaiser Insurance|1|||
147213045|NCT02184572|530952419|FG001|Overall Study|Loss Of Kaiser Insurance|0|||
147213046|NCT02184572|530952418|FG000|Overall Study|2nd blooddraw & diary card incomplete|1|||
147213047|NCT02184572|530952419|FG001|Overall Study|2nd blooddraw & diary card incomplete|0|||
147213048|NCT02184572|530952418|FG000|Overall Study|Traveling Outside The Country|1|||
147213049|NCT02184572|530952419|FG001|Overall Study|Traveling Outside The Country|0|||
147213050|NCT02184572|530952418|FG000|Overall Study|Withdrawal by Subject|14|||
147213051|NCT02184572|530952419|FG001|Overall Study|Withdrawal by Subject|9|||
147213052|NCT00763698|530952420|FG000|Overall Study|Unsuccessful Implant|5|||
147213053|NCT00763698|530952420|FG000|Overall Study|Death|4|||
147213054|NCT00763698|530952420|FG000|Overall Study|Withdrawal by Subject|1|||
147213055|NCT00638183|530952424|FG000|Overall Study|Adverse Event|23|||
147213056|NCT00638183|530952424|FG000|Overall Study|Lack of Efficacy|14|||
147213057|NCT00638183|530952424|FG000|Overall Study|Physician Decision|9|||
147213058|NCT00638183|530952424|FG000|Overall Study|Lost to Follow-up|46|||
147213059|NCT00638183|530952424|FG000|Overall Study|Other reason not defined above|27|||
147213060|NCT00006409|530952425|FG000|Baseline|Protocol Violation|48|||
147213061|NCT00006409|530952426|FG001|Baseline|Protocol Violation|70|||
147213062|NCT00006409|530952427|FG002|Baseline|Protocol Violation|0|||
147213063|NCT00006409|530952428|FG003|Baseline|Protocol Violation|0|||
147213064|NCT00006409|530952429|FG004|Baseline|Protocol Violation|0|||
147213065|NCT00006409|530952430|FG005|Baseline|Protocol Violation|0|||
147213066|NCT00006409|530952425|FG000|Post-2 Year Intervention|Protocol Violation|0|||
147213067|NCT00006409|530952426|FG001|Post-2 Year Intervention|Protocol Violation|0|||
147213068|NCT00006409|530952427|FG002|Post-2 Year Intervention|Protocol Violation|251|||
147213069|NCT00006409|530952428|FG003|Post-2 Year Intervention|Protocol Violation|168|||
147213070|NCT00006409|530952429|FG004|Post-2 Year Intervention|Protocol Violation|0|||
147546756|NCT05166421|532157807|FG000|Overall Study|Withdrawal by Subject|5|||
147546757|NCT05166421|532157808|FG001|Overall Study|Withdrawal by Subject|3|||
147546758|NCT05166421|532157809|FG002|Overall Study|Withdrawal by Subject|6|||
147546759|NCT05166421|532157807|FG000|Overall Study|Lost to Follow-up|4|||
147546760|NCT05166421|532157808|FG001|Overall Study|Lost to Follow-up|1|||
147546761|NCT05166421|532157809|FG002|Overall Study|Lost to Follow-up|7|||
147546762|NCT01335399|532158829|FG000|Pre-treatment Period|No longer meeting study criteria|0|||
147546763|NCT01335399|532158830|FG001|Pre-treatment Period|No longer meeting study criteria|1|||
147546764|NCT01335399|532158829|FG000|Pre-treatment Period|Participant request to discontinue|0|||
147546765|NCT01335399|532158830|FG001|Pre-treatment Period|Participant request to discontinue|1|||
147546766|NCT01335399|532158829|FG000|Pre-treatment Period|Adverse event unrelated to study drug|0|||
147213071|NCT00006409|530952430|FG005|Post-2 Year Intervention|Protocol Violation|0|||
147213072|NCT00006409|530952425|FG000|Post-3 Year Intervention|Protocol Violation|0|||
147213073|NCT00006409|530952426|FG001|Post-3 Year Intervention|Protocol Violation|0|||
147213074|NCT00006409|530952427|FG002|Post-3 Year Intervention|Protocol Violation|0|||
147213075|NCT00006409|530952428|FG003|Post-3 Year Intervention|Protocol Violation|0|||
147213076|NCT00006409|530952429|FG004|Post-3 Year Intervention|Protocol Violation|62|||
147213077|NCT00006409|530952430|FG005|Post-3 Year Intervention|Protocol Violation|62|||
147213078|NCT01433289|530952431|FG000|Overall Study|Pregnancy|0|||
147213079|NCT01433289|530952432|FG001|Overall Study|Pregnancy|1|||
147213080|NCT01433289|530952433|FG002|Overall Study|Pregnancy|0|||
147213081|NCT01433289|530952434|FG003|Overall Study|Pregnancy|0|||
147213082|NCT04973436|530952438|FG000|Overall Study|Lost to Follow-up|3|||
147213083|NCT04973436|530952438|FG000|Overall Study|Withdrawal by Subject|1|||
147213084|NCT04973436|530952438|FG000|Overall Study|Death|2|||
147213085|NCT01788215|530952442|FG000|Overall Study|Withdrawal by Subject|0|||
147213086|NCT01788215|530952443|FG001|Overall Study|Withdrawal by Subject|1|||
147213087|NCT01788215|530952442|FG000|Overall Study|Lost to Follow-up|2|||
147213088|NCT01788215|530952443|FG001|Overall Study|Lost to Follow-up|0|||
147213089|NCT02365480|530952448|FG000|Overall Study|Withdrawal by Subject|2|||
147213090|NCT02365480|530952449|FG001|Overall Study|Withdrawal by Subject|0|||
147213091|NCT03091348|530952450|FG000|Overall Study|Lost to Follow-up|2|||
147213092|NCT03091348|530952451|FG001|Overall Study|Lost to Follow-up|1|||
147213093|NCT00706342|530952452|FG000|Overall Study|Adverse Event|3|||
147213094|NCT00706342|530952452|FG000|Overall Study|Not responding to treatment|2|||
147213095|NCT00706342|530952452|FG000|Overall Study|Withdrawn due to failure to respond|1|||
147213096|NCT00706342|530952452|FG000|Overall Study|Death|1|||
147213097|NCT00706342|530952452|FG000|Overall Study|Withdrew from the study on his own.|1|||
147213098|NCT00706342|530952452|FG000|Overall Study|Investigator discretion|2|||
147213099|NCT00706342|530952452|FG000|Overall Study|Non-responder Week 12|1|||
147213100|NCT00706342|530952452|FG000|Overall Study|Ongoing|6|||
147213101|NCT00706342|530952452|FG000|Overall Study|WIthdrawal of consent|1|||
147213102|NCT04534686|530952453|FG000|Baseline Measurement|Lost to Follow-up|4|||
147213103|NCT04534686|530952454|FG001|Baseline Measurement|Lost to Follow-up|6|||
147213104|NCT04534686|530952453|FG000|Baseline Measurement|Withdrawal by Subject|3|||
147213105|NCT04534686|530952454|FG001|Baseline Measurement|Withdrawal by Subject|1|||
147213106|NCT04534686|530952453|FG000|Intervention|Withdrawal by Subject|2|||
147213107|NCT04534686|530952454|FG001|Intervention|Withdrawal by Subject|2|||
147213108|NCT01781299|530952459|FG000|Overall Study|Withdrawal by Subject|0|||
147213109|NCT01781299|530952460|FG001|Overall Study|Withdrawal by Subject|1|||
147213110|NCT00146848|530952464|FG000|Pre-randomization|Death|19|||
147213111|NCT00146848|530952465|FG001|Pre-randomization|Death|0|||
147213112|NCT00146848|530952466|FG002|Pre-randomization|Death|0|||
147213113|NCT00146848|530952464|FG000|Pre-randomization|Lost to Follow-up|70|||
147213114|NCT00146848|530952465|FG001|Pre-randomization|Lost to Follow-up|0|||
147213115|NCT00146848|530952466|FG002|Pre-randomization|Lost to Follow-up|0|||
147213116|NCT00146848|530952464|FG000|Pre-randomization|Physician Decision|8|||
147213117|NCT00146848|530952465|FG001|Pre-randomization|Physician Decision|0|||
147213118|NCT00146848|530952466|FG002|Pre-randomization|Physician Decision|0|||
147213119|NCT00146848|530952464|FG000|Pre-randomization|Protocol Violation|172|||
147213120|NCT00146848|530952465|FG001|Pre-randomization|Protocol Violation|0|||
147213121|NCT00146848|530952466|FG002|Pre-randomization|Protocol Violation|0|||
147213122|NCT00146848|530952464|FG000|Pre-randomization|Withdrawal by Subject|40|||
147213123|NCT00146848|530952465|FG001|Pre-randomization|Withdrawal by Subject|0|||
147213124|NCT00146848|530952466|FG002|Pre-randomization|Withdrawal by Subject|0|||
147213125|NCT00146848|530952464|FG000|Post-randomization|Lost to Follow-up|12|||
147213126|NCT00146848|530952465|FG001|Post-randomization|Lost to Follow-up|15|||
147213127|NCT00146848|530952466|FG002|Post-randomization|Lost to Follow-up|12|||
147213128|NCT00146848|530952464|FG000|Post-randomization|Withdrawn|26|||
147213129|NCT00146848|530952465|FG001|Post-randomization|Withdrawn|32|||
147213130|NCT00146848|530952466|FG002|Post-randomization|Withdrawn|27|||
147213131|NCT00119678|530952469|FG000|Double-blind Treatment Period|Death|1|||
147213132|NCT00119678|530952470|FG001|Double-blind Treatment Period|Death|0|||
147213133|NCT00119678|530952469|FG000|Double-blind Treatment Period|Adverse Event|7|||
147213134|NCT00119678|530952470|FG001|Double-blind Treatment Period|Adverse Event|1|||
147213135|NCT00119678|530952469|FG000|Double-blind Treatment Period|Lack of Efficacy|21|||
147213136|NCT00119678|530952470|FG001|Double-blind Treatment Period|Lack of Efficacy|12|||
147213137|NCT00119678|530952469|FG000|Double-blind Treatment Period|Lost to Follow-up|1|||
147213138|NCT00119678|530952470|FG001|Double-blind Treatment Period|Lost to Follow-up|2|||
147213139|NCT00119678|530952469|FG000|Double-blind Treatment Period|Participant withdrew consent|4|||
147213140|NCT00119678|530952470|FG001|Double-blind Treatment Period|Participant withdrew consent|4|||
147213141|NCT00119678|530952469|FG000|Double-blind Treatment Period|Participants not meeting study criteria|0|||
147213142|NCT00119678|530952470|FG001|Double-blind Treatment Period|Participants not meeting study criteria|1|||
147213143|NCT00119678|530952469|FG000|Double-blind Treatment Period|Poor/Non-compliance|3|||
147213144|NCT00119678|530952470|FG001|Double-blind Treatment Period|Poor/Non-compliance|0|||
147213145|NCT00119678|530952469|FG000|Double-blind Treatment Period|Pregnancy|0|||
147213146|NCT00119678|530952470|FG001|Double-blind Treatment Period|Pregnancy|2|||
147213147|NCT00119678|530952469|FG000|Double-blind Treatment Period|Not treated|1|||
147213148|NCT00119678|530952470|FG001|Double-blind Treatment Period|Not treated|2|||
147213149|NCT00119678|530952469|FG000|Double-blind Treatment Period|Site closed due to non-compliance|3|||
147213150|NCT00119678|530952470|FG001|Double-blind Treatment Period|Site closed due to non-compliance|2|||
147213151|NCT00119678|530952469|FG000|Open-label Treatment Period|Death|1|||
147213152|NCT00119678|530952470|FG001|Open-label Treatment Period|Death|0|||
147213153|NCT00119678|530952469|FG000|Open-label Treatment Period|Adverse Event|3|||
147213154|NCT00119678|530952470|FG001|Open-label Treatment Period|Adverse Event|0|||
147213155|NCT00119678|530952469|FG000|Open-label Treatment Period|Lack of Efficacy|9|||
147213156|NCT00119678|530952470|FG001|Open-label Treatment Period|Lack of Efficacy|0|||
147213157|NCT00119678|530952469|FG000|Open-label Treatment Period|Lost to Follow-up|3|||
147213158|NCT00119678|530952470|FG001|Open-label Treatment Period|Lost to Follow-up|0|||
147213159|NCT00119678|530952469|FG000|Open-label Treatment Period|Participant withdrew consent|4|||
147213160|NCT00119678|530952470|FG001|Open-label Treatment Period|Participant withdrew consent|0|||
147213161|NCT00119678|530952469|FG000|Open-label Treatment Period|Participants not meeting study criteria|2|||
147213162|NCT00119678|530952470|FG001|Open-label Treatment Period|Participants not meeting study criteria|0|||
147213163|NCT00119678|530952469|FG000|Open-label Treatment Period|Pregnancy|1|||
147213164|NCT00119678|530952470|FG001|Open-label Treatment Period|Pregnancy|0|||
147213165|NCT00119678|530952469|FG000|Open-label Treatment Period|Administrative reasons by sponsor|87|||
147213166|NCT00119678|530952470|FG001|Open-label Treatment Period|Administrative reasons by sponsor|0|||
147213167|NCT03704636|530952471|FG000|Overall Study|Inadequate Venous Flow|3|||
147213168|NCT02720042|530952472|FG000|Overall Study|Death|3|||
147213169|NCT02720042|530952472|FG000|Overall Study|Lost to Follow-up|4|||
147213170|NCT02720042|530952472|FG000|Overall Study|Withdrawal by Subject|1|||
147213171|NCT02720042|530952472|FG000|Overall Study|Physician Decision|3|||
147213172|NCT02720042|530952472|FG000|Overall Study|Phasix Mesh explanted|1|||
147213173|NCT02720042|530952472|FG000|Overall Study|unable due to non-study-related illness|3|||
147213174|NCT01134705|530952477|FG000|Overall Study|Adverse Event|1|||
147213175|NCT01134705|530952478|FG001|Overall Study|Adverse Event|7|||
147213176|NCT01134705|530952477|FG000|Overall Study|Withdrawal by Subject|6|||
147213177|NCT01134705|530952478|FG001|Overall Study|Withdrawal by Subject|6|||
147213178|NCT01134705|530952477|FG000|Overall Study|Pregnancy|1|||
147213179|NCT01134705|530952478|FG001|Overall Study|Pregnancy|0|||
147213180|NCT01134705|530952477|FG000|Overall Study|Lost to Follow-up|5|||
147213181|NCT01134705|530952478|FG001|Overall Study|Lost to Follow-up|2|||
147213182|NCT01134705|530952477|FG000|Overall Study|Protocol Violation|1|||
147213183|NCT01134705|530952478|FG001|Overall Study|Protocol Violation|1|||
147213184|NCT01134705|530952477|FG000|Overall Study|Other|1|||
147213185|NCT01134705|530952478|FG001|Overall Study|Other|6|||
147213186|NCT00509145|530952479|FG000|Overall Study|Death|0|||
147213187|NCT00509145|530952480|FG001|Overall Study|Death|2|||
147213188|NCT00509145|530952479|FG000|Overall Study|Adverse Event|42|||
147213189|NCT00509145|530952480|FG001|Overall Study|Adverse Event|28|||
147213190|NCT00509145|530952479|FG000|Overall Study|Withdrawal by Subject|32|||
147213191|NCT00509145|530952480|FG001|Overall Study|Withdrawal by Subject|38|||
147213192|NCT00509145|530952479|FG000|Overall Study|Physician Decision|11|||
147442070|NCT00262522|531782729|FG001|Study Start Through 96 Weeks|Withdrawal by Subject|0|||
147442071|NCT00262522|531782730|FG002|Study Start Through 96 Weeks|Withdrawal by Subject|13|||
147442072|NCT00262522|531782731|FG003|Study Start Through 96 Weeks|Withdrawal by Subject|0|||
147442073|NCT00262522|531782728|FG000|Study Start Through 96 Weeks|Lost to Follow-up|19|||
147442074|NCT00262522|531782729|FG001|Study Start Through 96 Weeks|Lost to Follow-up|0|||
147442075|NCT00262522|531782730|FG002|Study Start Through 96 Weeks|Lost to Follow-up|18|||
147442076|NCT00262522|531782731|FG003|Study Start Through 96 Weeks|Lost to Follow-up|0|||
147442077|NCT00262522|531782728|FG000|Study Start Through 96 Weeks|Noncompliance|6|||
147546767|NCT01335399|532158830|FG001|Pre-treatment Period|Adverse event unrelated to study drug|1|||
147213193|NCT00509145|530952480|FG001|Overall Study|Physician Decision|14|||
147213194|NCT00509145|530952479|FG000|Overall Study|Protocol Violation|1|||
147213195|NCT00509145|530952480|FG001|Overall Study|Protocol Violation|6|||
147213196|NCT00509145|530952479|FG000|Overall Study|Pregnancy|3|||
147213197|NCT00509145|530952480|FG001|Overall Study|Pregnancy|8|||
147213198|NCT00509145|530952479|FG000|Overall Study|Lost to Follow-up|6|||
147213199|NCT00509145|530952480|FG001|Overall Study|Lost to Follow-up|5|||
147546768|NCT01335399|532158829|FG000|Pre-treatment Period|Consent withdrawal|3|||
147546769|NCT01335399|532158830|FG001|Pre-treatment Period|Consent withdrawal|0|||
147546770|NCT01335399|532158829|FG000|Treatment Period|Disease progression|117|||
147546771|NCT01335399|532158830|FG001|Treatment Period|Disease progression|145|||
147546772|NCT01335399|532158829|FG000|Treatment Period|Adverse event unrelated to study drug|110|||
147546773|NCT01335399|532158830|FG001|Treatment Period|Adverse event unrelated to study drug|73|||
147546774|NCT01335399|532158829|FG000|Treatment Period|Study drug toxicity|52|||
147546775|NCT01335399|532158830|FG001|Treatment Period|Study drug toxicity|64|||
147546776|NCT01335399|532158829|FG000|Treatment Period|Participant request to discontinue|30|||
147546777|NCT01335399|532158830|FG001|Treatment Period|Participant request to discontinue|22|||
147546778|NCT01335399|532158829|FG000|Treatment Period|Other reasons|30|||
147546779|NCT01335399|532158830|FG001|Treatment Period|Other reasons|30|||
147546780|NCT01335399|532158829|FG000|Treatment Period|Consent withdrawal|10|||
147546781|NCT01335399|532158830|FG001|Treatment Period|Consent withdrawal|7|||
147546782|NCT01335399|532158829|FG000|Treatment Period|Death|7|||
147546783|NCT01335399|532158830|FG001|Treatment Period|Death|6|||
147546784|NCT01335399|532158829|FG000|Treatment Period|Poor/Non-compliance|3|||
147546785|NCT01335399|532158830|FG001|Treatment Period|Poor/Non-compliance|4|||
147546786|NCT01335399|532158829|FG000|Treatment Period|Lost to Follow-up|2|||
147546787|NCT01335399|532158830|FG001|Treatment Period|Lost to Follow-up|2|||
147546788|NCT01335399|532158829|FG000|Treatment Period|Maximum clinical benefit|1|||
147546789|NCT01335399|532158830|FG001|Treatment Period|Maximum clinical benefit|1|||
147546790|NCT01335399|532158829|FG000|Treatment Period|No longer meet study criteria|1|||
147546791|NCT01335399|532158830|FG001|Treatment Period|No longer meet study criteria|1|||
147546792|NCT01335399|532158829|FG000|Treatment Period|Administrative reasons by Sponsor|8|||
147546793|NCT01335399|532158830|FG001|Treatment Period|Administrative reasons by Sponsor|16|||
147546794|NCT03202511|532158832|FG000|Overall Study|Withdrawal by Subject|1|||
147546795|NCT03202511|532158833|FG001|Overall Study|Withdrawal by Subject|0|||
147546796|NCT00096382|532158834|FG000|Overall Study|Not treated|1|||
147546797|NCT00096382|532158835|FG001|Overall Study|Not treated|0|||
147546798|NCT00096382|532158834|FG000|Overall Study|Death during treatment|1|||
147546799|NCT00096382|532158835|FG001|Overall Study|Death during treatment|0|||
147546800|NCT01270841|532158836|FG000|Overall Study|Adverse Event|0|||
147546801|NCT01270841|532158837|FG001|Overall Study|Adverse Event|1|||
147546802|NCT01270841|532158838|FG002|Overall Study|Adverse Event|0|||
147546803|NCT01270841|532158839|FG003|Overall Study|Adverse Event|3|||
147546804|NCT01270841|532158836|FG000|Overall Study|Withdrawal by Subject|3|||
147546805|NCT01270841|532158837|FG001|Overall Study|Withdrawal by Subject|2|||
147546806|NCT01270841|532158838|FG002|Overall Study|Withdrawal by Subject|3|||
147546807|NCT01270841|532158839|FG003|Overall Study|Withdrawal by Subject|3|||
147546808|NCT01270841|532158836|FG000|Overall Study|Lost to Follow-up|3|||
147546809|NCT01270841|532158837|FG001|Overall Study|Lost to Follow-up|1|||
147546810|NCT01270841|532158838|FG002|Overall Study|Lost to Follow-up|4|||
147546811|NCT01270841|532158839|FG003|Overall Study|Lost to Follow-up|2|||
147546812|NCT01270841|532158836|FG000|Overall Study|Physician Decision|0|||
147546813|NCT01270841|532158837|FG001|Overall Study|Physician Decision|1|||
147546814|NCT01270841|532158838|FG002|Overall Study|Physician Decision|0|||
147546815|NCT01270841|532158839|FG003|Overall Study|Physician Decision|0|||
147546816|NCT01270841|532158836|FG000|Overall Study|Did not qualify|6|||
147546817|NCT01270841|532158837|FG001|Overall Study|Did not qualify|3|||
147546818|NCT01270841|532158838|FG002|Overall Study|Did not qualify|4|||
147546819|NCT01270841|532158839|FG003|Overall Study|Did not qualify|5|||
147546820|NCT01270841|532158836|FG000|Overall Study|Protocol Violation|1|||
147546821|NCT01270841|532158837|FG001|Overall Study|Protocol Violation|5|||
147546822|NCT01270841|532158838|FG002|Overall Study|Protocol Violation|0|||
147546823|NCT01270841|532158839|FG003|Overall Study|Protocol Violation|0|||
147546824|NCT01270841|532158836|FG000|Overall Study|Enrolled in error|0|||
147546825|NCT01270841|532158837|FG001|Overall Study|Enrolled in error|1|||
147546826|NCT01270841|532158838|FG002|Overall Study|Enrolled in error|0|||
147546827|NCT01270841|532158839|FG003|Overall Study|Enrolled in error|0|||
147546828|NCT01375010|532158840|FG000|Overall Study|Lost to Follow-up|8|||
147546829|NCT01375010|532158841|FG001|Overall Study|Lost to Follow-up|2|||
147546830|NCT01375010|532158840|FG000|Overall Study|Withdrawal by Subject|4|||
147546831|NCT01375010|532158841|FG001|Overall Study|Withdrawal by Subject|2|||
147546832|NCT02614703|532158842|FG000|Overall Study|Withdrawal by Subject|7|||
147546833|NCT02614703|532158843|FG001|Overall Study|Withdrawal by Subject|1|||
147546834|NCT02402933|532158844|FG000|Overall Study|Withdrawal by Subject|4|||
147546835|NCT02402933|532158844|FG000|Overall Study|Discontinued; Site Termination|10|||
147546836|NCT00854620|532158853|FG000|Overall Study|Adverse Event|1|||
147546837|NCT02962882|532158857|FG000|Overall Study|Adverse Event|2|||
147546838|NCT02962882|532158857|FG000|Overall Study|Withdrawal by Subject|2|||
147546839|NCT02962882|532158857|FG000|Overall Study|Transfer from ICU|32|||
147546840|NCT03763331|532158860|FG000|Overall Study|Lost to Follow-up|1|||
147546841|NCT03763331|532158861|FG001|Overall Study|Lost to Follow-up|0|||
147546842|NCT03763331|532158860|FG000|Overall Study|Withdrawal by Subject|1|||
147546843|NCT03763331|532158861|FG001|Overall Study|Withdrawal by Subject|0|||
147546844|NCT03763331|532158860|FG000|Overall Study|Non-compliance|0|||
147213200|NCT00509145|530952479|FG000|Overall Study|Withdrawal by participant after confirmed relapse|12|||
147213201|NCT00509145|530952480|FG001|Overall Study|Withdrawal by participant after confirmed relapse|22|||
147213202|NCT00509145|530952479|FG000|Overall Study|Other|6|||
147213203|NCT00509145|530952480|FG001|Overall Study|Other|6|||
147213204|NCT00246740|530952481|FG000|Initial Enrollment|Death|1|||
147213205|NCT00246740|530952482|FG001|Initial Enrollment|Death|0|||
147213206|NCT00246740|530952481|FG000|Initial Enrollment|Additional surgery scheduled|0|||
147213207|NCT00246740|530952482|FG001|Initial Enrollment|Additional surgery scheduled|2|||
147213208|NCT00246740|530952481|FG000|Initial Enrollment|Surgery schedule change|4|||
147442078|NCT00262522|531782729|FG001|Study Start Through 96 Weeks|Noncompliance|0|||
147442079|NCT00262522|531782730|FG002|Study Start Through 96 Weeks|Noncompliance|11|||
147442080|NCT00262522|531782731|FG003|Study Start Through 96 Weeks|Noncompliance|0|||
147442081|NCT00262522|531782728|FG000|Study Start Through 96 Weeks|Death|2|||
147442082|NCT00262522|531782729|FG001|Study Start Through 96 Weeks|Death|0|||
147442083|NCT00262522|531782730|FG002|Study Start Through 96 Weeks|Death|2|||
147442084|NCT00262522|531782731|FG003|Study Start Through 96 Weeks|Death|0|||
147442085|NCT00262522|531782728|FG000|Study Start Through 96 Weeks|Virologic failure|5|||
147442086|NCT00262522|531782729|FG001|Study Start Through 96 Weeks|Virologic failure|0|||
147442087|NCT00262522|531782730|FG002|Study Start Through 96 Weeks|Virologic failure|8|||
147442088|NCT00262522|531782731|FG003|Study Start Through 96 Weeks|Virologic failure|0|||
147442089|NCT00262522|531782728|FG000|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|10|||
147442090|NCT00262522|531782729|FG001|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|0|||
147442091|NCT00262522|531782730|FG002|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|9|||
147442092|NCT00262522|531782731|FG003|Study Start Through 96 Weeks|Relocated, Needed to take twice daily|0|||
147442093|NCT02710136|531782740|FG000|Phase 1a[Refer to Arm/Group Description]|Adverse Event|1|||
147442094|NCT02710136|531782741|FG001|Phase 1a[Refer to Arm/Group Description]|Adverse Event|0|||
147442095|NCT02269787|531782745|FG000|Overall Study|Lost to Follow-up|20|||
147442096|NCT02269787|531782746|FG001|Overall Study|Lost to Follow-up|6|||
147442097|NCT02269787|531782745|FG000|Overall Study|Death|2|||
147442098|NCT02269787|531782746|FG001|Overall Study|Death|3|||
147442099|NCT02269787|531782745|FG000|Overall Study|Incapacitated|0|||
147442100|NCT02269787|531782746|FG001|Overall Study|Incapacitated|1|||
147442101|NCT00798135|531782747|FG000|Overall Study|Disease progression, relapse|11|||
147442102|NCT00798135|531782747|FG000|Overall Study|Disease progression, refractory|1|||
147442103|NCT00798135|531782747|FG000|Overall Study|Physician Decision|1|||
147442104|NCT00687440|531782748|FG000|Overall Study|Adverse Event|3|||
147442105|NCT00687440|531782748|FG000|Overall Study|Lost to Follow-up|3|||
147442106|NCT00687440|531782748|FG000|Overall Study|Lack of Efficacy|2|||
147442107|NCT00687440|531782748|FG000|Overall Study|Death|2|||
147442108|NCT00687440|531782748|FG000|Overall Study|Other|1|||
147442109|NCT00687440|531782748|FG000|Overall Study|Missing|1|||
147442110|NCT00404820|531784260|FG000|Overall Study|Adverse Event|4|||
147442111|NCT00404820|531784261|FG001|Overall Study|Adverse Event|16|||
147442112|NCT00404820|531784260|FG000|Overall Study|Withdrawal by Subject|5|||
147442113|NCT00404820|531784261|FG001|Overall Study|Withdrawal by Subject|3|||
147442114|NCT00404820|531784260|FG000|Overall Study|Lost to Follow-up|7|||
147442115|NCT00404820|531784261|FG001|Overall Study|Lost to Follow-up|3|||
147442116|NCT00404820|531784260|FG000|Overall Study|Administrative problems|2|||
147442117|NCT00404820|531784261|FG001|Overall Study|Administrative problems|0|||
147442118|NCT00404820|531784260|FG000|Overall Study|Death|1|||
147442119|NCT00404820|531784261|FG001|Overall Study|Death|0|||
147442120|NCT00404820|531784260|FG000|Overall Study|Other|0|||
147442121|NCT00404820|531784261|FG001|Overall Study|Other|2|||
147442122|NCT00176605|531784263|FG000|Overall Study|Withdrawal by Subject|2|||
147442123|NCT01321710|531784264|FG000|Overall Study|Lost to Follow-up|4|||
147442124|NCT01321710|531784265|FG001|Overall Study|Lost to Follow-up|5|||
147442125|NCT01321710|531784266|FG002|Overall Study|Lost to Follow-up|0|||
147442126|NCT01566773|531784268|FG000|Overall Study|Protocol specified criteria|4|||
147442127|NCT01566773|531784268|FG000|Overall Study|Protocol Violation|4|||
147442128|NCT01566773|531784268|FG000|Overall Study|Withdrawal by Subject|9|||
147442129|NCT01566773|531784268|FG000|Overall Study|Administrative reason|1|||
147442130|NCT01566773|531784268|FG000|Overall Study|Adverse Event|10|||
147442131|NCT01566773|531784268|FG000|Overall Study|Physician Decision|2|||
147442132|NCT00833053|531784269|FG000|Overall Study|Adverse Event|4|||
147442133|NCT00833053|531784270|FG001|Overall Study|Adverse Event|0|||
147442134|NCT00833053|531784269|FG000|Overall Study|Treatment Failure|3|||
147442135|NCT00833053|531784270|FG001|Overall Study|Treatment Failure|1|||
147442136|NCT00833053|531784269|FG000|Overall Study|Withdrawal by Subject|0|||
147442137|NCT00833053|531784270|FG001|Overall Study|Withdrawal by Subject|1|||
147442138|NCT00833053|531784269|FG000|Overall Study|Protocol Violation|2|||
147442139|NCT00833053|531784270|FG001|Overall Study|Protocol Violation|1|||
147442140|NCT02187471|531784271|FG000|Overall Study|Protocol Violation|4|||
147442141|NCT02187471|531784272|FG001|Overall Study|Protocol Violation|5|||
147442142|NCT02187471|531784273|FG002|Overall Study|Protocol Violation|4|||
147442143|NCT02187471|531784274|FG003|Overall Study|Protocol Violation|4|||
147213209|NCT00246740|530952482|FG001|Initial Enrollment|Surgery schedule change|4|||
147546845|NCT03763331|532158861|FG001|Overall Study|Non-compliance|3|||
147546846|NCT01155063|532158862|FG000|Overall Study|Adverse Event|1|||
147546847|NCT01155063|532158862|FG000|Overall Study|Withdrawal by Subject|1|||
147546848|NCT01155063|532158862|FG000|Overall Study|Study terminated by sponsor|87|||
147546849|NCT00936884|532158863|FG000|Double-blind|Withdrawal by Subject|6|||
147546850|NCT00936884|532158864|FG001|Double-blind|Withdrawal by Subject|4|||
147546851|NCT00936884|532158865|FG002|Double-blind|Withdrawal by Subject|0|||
147546852|NCT00936884|532158863|FG000|Double-blind|Death|2|||
147546853|NCT00936884|532158864|FG001|Double-blind|Death|1|||
147546854|NCT00936884|532158865|FG002|Double-blind|Death|0|||
147546855|NCT00936884|532158863|FG000|Double-blind|Lack of Efficacy|1|||
147546856|NCT00936884|532158864|FG001|Double-blind|Lack of Efficacy|1|||
147546857|NCT00936884|532158865|FG002|Double-blind|Lack of Efficacy|0|||
147546858|NCT00936884|532158863|FG000|Double-blind|Adverse Event|1|||
147546859|NCT00936884|532158864|FG001|Double-blind|Adverse Event|0|||
147546860|NCT00936884|532158865|FG002|Double-blind|Adverse Event|0|||
147546861|NCT00936884|532158863|FG000|Double-blind|Physician Decision|1|||
147546862|NCT00936884|532158864|FG001|Double-blind|Physician Decision|0|||
147546863|NCT00936884|532158865|FG002|Double-blind|Physician Decision|0|||
147546864|NCT00936884|532158863|FG000|Double-blind|No post baseline diary entry|1|||
147546865|NCT00936884|532158864|FG001|Double-blind|No post baseline diary entry|0|||
147546866|NCT00936884|532158865|FG002|Double-blind|No post baseline diary entry|0|||
147546867|NCT00936884|532158863|FG000|Double-blind|Did not receive study drug|0|||
147546868|NCT00936884|532158864|FG001|Double-blind|Did not receive study drug|1|||
147546869|NCT00936884|532158865|FG002|Double-blind|Did not receive study drug|0|||
147546870|NCT01314703|532158866|FG000|Overall Study|screen failure and closed enrollment|8|||
147546871|NCT00597584|532158867|FG000|Overall Study|Adverse Event|4|||
147546872|NCT00597584|532158868|FG001|Overall Study|Adverse Event|2|||
147546873|NCT00597584|532158867|FG000|Overall Study|Death|53|||
147546874|NCT00597584|532158868|FG001|Overall Study|Death|30|||
147546875|NCT00597584|532158867|FG000|Overall Study|Lack of Efficacy|1|||
147546876|NCT00597584|532158868|FG001|Overall Study|Lack of Efficacy|0|||
147546877|NCT00597584|532158867|FG000|Overall Study|Lost to Follow-up|2|||
147546878|NCT00597584|532158868|FG001|Overall Study|Lost to Follow-up|4|||
147546879|NCT00597584|532158867|FG000|Overall Study|Physician Decision|3|||
147546880|NCT00597584|532158868|FG001|Overall Study|Physician Decision|0|||
147546881|NCT00597584|532158867|FG000|Overall Study|Pregnancy|2|||
147546882|NCT00597584|532158868|FG001|Overall Study|Pregnancy|0|||
147546883|NCT00597584|532158867|FG000|Overall Study|Withdrawal by Subject|44|||
147546884|NCT00597584|532158868|FG001|Overall Study|Withdrawal by Subject|12|||
147546885|NCT00597584|532158867|FG000|Overall Study|Discontinued Dialysis|0|||
147546886|NCT00597584|532158868|FG001|Overall Study|Discontinued Dialysis|1|||
147546887|NCT00597584|532158867|FG000|Overall Study|Lost ability to consent|1|||
147546888|NCT00597584|532158868|FG001|Overall Study|Lost ability to consent|1|||
147546889|NCT00597584|532158867|FG000|Overall Study|Never dosed|1|||
147546890|NCT00597584|532158868|FG001|Overall Study|Never dosed|0|||
147546891|NCT00597584|532158867|FG000|Overall Study|Relocation|8|||
147546892|NCT00597584|532158868|FG001|Overall Study|Relocation|6|||
147546893|NCT00597584|532158867|FG000|Overall Study|Renal transplant|9|||
147546894|NCT00597584|532158868|FG001|Overall Study|Renal transplant|7|||
147546895|NCT02791659|532158875|FG000|Overall Study|Protocol Violation|0|||
147546896|NCT02791659|532158876|FG001|Overall Study|Protocol Violation|1|||
147546897|NCT00881959|532158877|FG000|Overall Study|Lost to Follow-up|2|||
147442144|NCT02187471|531784271|FG000|Overall Study|Missing|0|||
147442145|NCT02187471|531784272|FG001|Overall Study|Missing|0|||
147442146|NCT02187471|531784273|FG002|Overall Study|Missing|0|||
147442147|NCT02187471|531784274|FG003|Overall Study|Missing|1|||
147442148|NCT02187471|531784271|FG000|Overall Study|Lack of Efficacy|18|||
147442149|NCT02187471|531784272|FG001|Overall Study|Lack of Efficacy|9|||
147442150|NCT02187471|531784273|FG002|Overall Study|Lack of Efficacy|13|||
147442151|NCT02187471|531784274|FG003|Overall Study|Lack of Efficacy|11|||
147442152|NCT02187471|531784271|FG000|Overall Study|Adverse Event|24|||
147442153|NCT02187471|531784272|FG001|Overall Study|Adverse Event|34|||
147442154|NCT02187471|531784273|FG002|Overall Study|Adverse Event|44|||
147442155|NCT02187471|531784274|FG003|Overall Study|Adverse Event|36|||
147442156|NCT02187471|531784271|FG000|Overall Study|Withdrawal by Subject|23|||
147442157|NCT02187471|531784272|FG001|Overall Study|Withdrawal by Subject|29|||
147442158|NCT02187471|531784273|FG002|Overall Study|Withdrawal by Subject|22|||
147546898|NCT00881959|532158878|FG001|Overall Study|Lost to Follow-up|4|||
147546899|NCT01456052|532158879|FG000|Overall Study|Adverse Event|1|||
147546900|NCT01456052|532158880|FG001|Overall Study|Adverse Event|1|||
147546901|NCT01456052|532158881|FG002|Overall Study|Adverse Event|2|||
147546902|NCT01456052|532158879|FG000|Overall Study|Consent withdrawn|0|||
147546903|NCT01456052|532158880|FG001|Overall Study|Consent withdrawn|2|||
147546904|NCT01456052|532158881|FG002|Overall Study|Consent withdrawn|1|||
147546905|NCT01456052|532158879|FG000|Overall Study|Protocol Violation|0|||
147546906|NCT01456052|532158880|FG001|Overall Study|Protocol Violation|1|||
147546907|NCT01456052|532158881|FG002|Overall Study|Protocol Violation|0|||
147546908|NCT01456052|532158879|FG000|Overall Study|Physician Decision|1|||
147546909|NCT01456052|532158880|FG001|Overall Study|Physician Decision|0|||
147546910|NCT01456052|532158881|FG002|Overall Study|Physician Decision|1|||
147546911|NCT01456052|532158879|FG000|Overall Study|Treatment Failure|0|||
147546912|NCT01456052|532158880|FG001|Overall Study|Treatment Failure|1|||
147546913|NCT01456052|532158881|FG002|Overall Study|Treatment Failure|1|||
147546914|NCT00623623|532158882|FG000|Overall Study|Previous enrolment into this study|1|||
147546915|NCT00623623|532158883|FG001|Overall Study|Previous enrolment into this study|1|||
147546916|NCT02265952|532158885|FG000|Open Label Extension (OLE) Period|Physician Decision|0|||
147546917|NCT02265952|532158886|FG001|Open Label Extension (OLE) Period|Physician Decision|7|||
147546918|NCT02265952|532158885|FG000|Open Label Extension (OLE) Period|Withdrawal by Subject|0|||
147546919|NCT02265952|532158886|FG001|Open Label Extension (OLE) Period|Withdrawal by Subject|1|||
147546920|NCT01042977|532158887|FG000|Overall Study|Adverse Event|4|||
147546921|NCT01042977|532158888|FG001|Overall Study|Adverse Event|12|||
147546922|NCT01042977|532158887|FG000|Overall Study|Death|2|||
147546923|NCT01042977|532158888|FG001|Overall Study|Death|1|||
147546924|NCT01042977|532158887|FG000|Overall Study|Withdrawal by Subject|8|||
147546925|NCT01042977|532158888|FG001|Overall Study|Withdrawal by Subject|16|||
147546926|NCT01042977|532158887|FG000|Overall Study|Lost to Follow-up|0|||
147546927|NCT01042977|532158888|FG001|Overall Study|Lost to Follow-up|2|||
147546928|NCT01042977|532158887|FG000|Overall Study|Poor/non-compliance|3|||
147546929|NCT01042977|532158888|FG001|Overall Study|Poor/non-compliance|4|||
147546930|NCT01042977|532158887|FG000|Overall Study|Subject no longer meets study criteria|15|||
147546931|NCT01042977|532158888|FG001|Overall Study|Subject no longer meets study criteria|13|||
147546932|NCT01042977|532158887|FG000|Overall Study|Incorrect enrollment|6|||
147546933|NCT01042977|532158888|FG001|Overall Study|Incorrect enrollment|4|||
147546934|NCT01042977|532158887|FG000|Overall Study|Safety|0|||
147546935|NCT01042977|532158888|FG001|Overall Study|Safety|2|||
147546936|NCT01042977|532158887|FG000|Overall Study|Administrative reason by sponsor|0|||
147546937|NCT01042977|532158888|FG001|Overall Study|Administrative reason by sponsor|1|||
147546938|NCT01042977|532158887|FG000|Overall Study|Various|3|||
147546939|NCT01042977|532158888|FG001|Overall Study|Various|0|||
147546940|NCT02499354|532158889|FG000|Overall Study|Withdrawal by Subject|1|||
147546941|NCT02499354|532158890|FG001|Overall Study|Withdrawal by Subject|0|||
147546942|NCT04356573|532158892|FG000|Overall Study|Didn't Qualify|1|||
147546943|NCT04356573|532158893|FG001|Overall Study|Didn't Qualify|0|||
147546944|NCT02424565|532158894|FG000|Period 1 (D0)|Protocol Violation|0|||
147546945|NCT02424565|532158895|FG001|Period 1 (D0)|Protocol Violation|1|||
147546946|NCT01677910|532158896|FG000|Double-Blind Treatment Period|Adverse Event|6|||
147546947|NCT01677910|532158897|FG001|Double-Blind Treatment Period|Adverse Event|2|||
147546948|NCT01677910|532158898|FG002|Double-Blind Treatment Period|Adverse Event|3|||
147546949|NCT01677910|532158899|FG003|Double-Blind Treatment Period|Adverse Event|0|||
147546950|NCT01677910|532158896|FG000|Double-Blind Treatment Period|Physician Decision|0|||
147546951|NCT01677910|532158897|FG001|Double-Blind Treatment Period|Physician Decision|0|||
147546952|NCT01677910|532158898|FG002|Double-Blind Treatment Period|Physician Decision|1|||
147546953|NCT01677910|532158899|FG003|Double-Blind Treatment Period|Physician Decision|0|||
147546954|NCT01677910|532158896|FG000|Double-Blind Treatment Period|Withdrawal of consent|1|||
147546955|NCT01677910|532158897|FG001|Double-Blind Treatment Period|Withdrawal of consent|0|||
147546956|NCT01677910|532158898|FG002|Double-Blind Treatment Period|Withdrawal of consent|3|||
147546957|NCT01677910|532158899|FG003|Double-Blind Treatment Period|Withdrawal of consent|0|||
147546958|NCT01677910|532158896|FG000|Double-Blind Treatment Period|Reason Not Specified|0|||
147546959|NCT01677910|532158897|FG001|Double-Blind Treatment Period|Reason Not Specified|1|||
147546960|NCT01677910|532158898|FG002|Double-Blind Treatment Period|Reason Not Specified|0|||
147546961|NCT01677910|532158899|FG003|Double-Blind Treatment Period|Reason Not Specified|0|||
147546962|NCT01677910|532158896|FG000|Open-Label Extension Period (OLE)|Physician Decision|0|||
147546963|NCT01677910|532158897|FG001|Open-Label Extension Period (OLE)|Physician Decision|0|||
147546964|NCT01677910|532158898|FG002|Open-Label Extension Period (OLE)|Physician Decision|0|||
147546965|NCT01677910|532158899|FG003|Open-Label Extension Period (OLE)|Physician Decision|4|||
147546966|NCT01677910|532158896|FG000|Open-Label Extension Period (OLE)|Reason not Specified|0|||
147546967|NCT01677910|532158897|FG001|Open-Label Extension Period (OLE)|Reason not Specified|0|||
147546968|NCT01677910|532158898|FG002|Open-Label Extension Period (OLE)|Reason not Specified|0|||
147546969|NCT01677910|532158899|FG003|Open-Label Extension Period (OLE)|Reason not Specified|2|||
147546970|NCT01677910|532158896|FG000|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
147546971|NCT01677910|532158897|FG001|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
147546972|NCT01677910|532158898|FG002|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
147546973|NCT01677910|532158899|FG003|Open-Label Extension Period (OLE)|Withdrawal of Consent|9|||
147546974|NCT01677910|532158896|FG000|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
147546975|NCT01677910|532158897|FG001|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
147546976|NCT01677910|532158898|FG002|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
147546977|NCT01677910|532158899|FG003|Open-Label Extension Period (OLE)|Lack of Efficacy|5|||
147546978|NCT01677910|532158896|FG000|Open-Label Extension Period (OLE)|Adverse Event|0|||
147546979|NCT01677910|532158897|FG001|Open-Label Extension Period (OLE)|Adverse Event|0|||
147546980|NCT01677910|532158898|FG002|Open-Label Extension Period (OLE)|Adverse Event|0|||
147546981|NCT01677910|532158899|FG003|Open-Label Extension Period (OLE)|Adverse Event|15|||
147546982|NCT01677910|532158896|FG000|Open-Label Extension Period (OLE)|Lost to Follow-up|0|||
147546983|NCT01677910|532158897|FG001|Open-Label Extension Period (OLE)|Lost to Follow-up|0|||
147546984|NCT01677910|532158898|FG002|Open-Label Extension Period (OLE)|Lost to Follow-up|0|||
147546985|NCT01677910|532158899|FG003|Open-Label Extension Period (OLE)|Lost to Follow-up|1|||
147546986|NCT03650400|532158900|FG000|Overall Study|Study terminated by sponsor|0|||
147546987|NCT03650400|532158901|FG001|Overall Study|Study terminated by sponsor|5|||
147546988|NCT00751998|532158908|FG000|Overall Study|Lost to Follow-up|7|||
147546989|NCT00751998|532158908|FG000|Overall Study|Death|11|||
147546990|NCT00751998|532158908|FG000|Overall Study|Withdrawal by Subject|2|||
147546991|NCT04126733|532158909|FG000|Treatment Period|Progressive Disease - Radiological Progression|47|||
147546992|NCT04126733|532158909|FG000|Treatment Period|Adverse Event|8|||
147546993|NCT04126733|532158909|FG000|Treatment Period|Progressive Disease - Clinical Assessment|7|||
147546994|NCT04126733|532158909|FG000|Treatment Period|Physician Decision|5|||
147546995|NCT04126733|532158909|FG000|Treatment Period|Death|1|||
147546996|NCT04126733|532158909|FG000|Treatment Period|Other Reasons|2|||
147546997|NCT04126733|532158909|FG000|Active Follow-up Period|Death|13|||
147546998|NCT04126733|532158909|FG000|Active Follow-up Period|Progressive Disease - Clinical Assessment|4|||
147546999|NCT04126733|532158909|FG000|Active Follow-up Period|Withdrawal by Subject|2|||
147547000|NCT04126733|532158909|FG000|Active Follow-up Period|Other Reasons|1|||
147547001|NCT04126733|532158909|FG000|Long-term Follow-up Period|Death|22|||
147213210|NCT00246740|530952481|FG000|Initial Enrollment|Other|1|||
147547002|NCT04126733|532158909|FG000|Long-term Follow-up Period|Withdrawal by Subject|1|||
147547003|NCT04126733|532158909|FG000|Long-term Follow-up Period|Ongoing with Long Term Follow-up|6|||
147547004|NCT02410837|532158910|FG000|Overall Study|Death|387|||
147547005|NCT02410837|532158910|FG000|Overall Study|Lost to Follow-up|50|||
147547006|NCT02410837|532158910|FG000|Overall Study|Withdrawal by Subject|44|||
147547007|NCT02410837|532158910|FG000|Overall Study|Physician Decision|6|||
147547008|NCT02410837|532158910|FG000|Overall Study|Moved to nursing home, cannot communicat|1|||
147547009|NCT00078819|532158915|FG000|Double-blind Treatment Period: Week 1-12|Adverse Event|0|||
147547010|NCT00078819|532158916|FG001|Double-blind Treatment Period: Week 1-12|Adverse Event|1|||
147547011|NCT00078819|532158917|FG002|Double-blind Treatment Period: Week 1-12|Adverse Event|0|||
147547012|NCT00078819|532158918|FG003|Double-blind Treatment Period: Week 1-12|Adverse Event|0|||
147547013|NCT00078819|532158915|FG000|Double-blind Treatment Period: Week 1-12|Withdrawal by Subject|1|||
147547014|NCT00078819|532158916|FG001|Double-blind Treatment Period: Week 1-12|Withdrawal by Subject|0|||
147547015|NCT00078819|532158917|FG002|Double-blind Treatment Period: Week 1-12|Withdrawal by Subject|0|||
147547016|NCT00078819|532158918|FG003|Double-blind Treatment Period: Week 1-12|Withdrawal by Subject|0|||
147547017|NCT00078819|532158915|FG000|Open-label Treatment Period: Weeks 13-36|Lost to Follow-up|1|||
147547018|NCT00078819|532158916|FG001|Open-label Treatment Period: Weeks 13-36|Lost to Follow-up|1|||
147547019|NCT00078819|532158917|FG002|Open-label Treatment Period: Weeks 13-36|Lost to Follow-up|0|||
147547020|NCT00078819|532158918|FG003|Open-label Treatment Period: Weeks 13-36|Lost to Follow-up|0|||
147547021|NCT00078819|532158915|FG000|Open-label Treatment Period: Weeks 13-36|Adverse Event|3|||
147547022|NCT00078819|532158916|FG001|Open-label Treatment Period: Weeks 13-36|Adverse Event|2|||
147547023|NCT00078819|532158917|FG002|Open-label Treatment Period: Weeks 13-36|Adverse Event|0|||
147547024|NCT00078819|532158918|FG003|Open-label Treatment Period: Weeks 13-36|Adverse Event|0|||
147547025|NCT00078819|532158915|FG000|Open-label Treatment Period: Weeks 13-36|Withdrawal by Subject|2|||
147547026|NCT00078819|532158916|FG001|Open-label Treatment Period: Weeks 13-36|Withdrawal by Subject|2|||
147547027|NCT00078819|532158917|FG002|Open-label Treatment Period: Weeks 13-36|Withdrawal by Subject|0|||
147547028|NCT00078819|532158918|FG003|Open-label Treatment Period: Weeks 13-36|Withdrawal by Subject|0|||
147547029|NCT00078819|532158915|FG000|Open-label Treatment Period: Weeks 13-36|Incomplete Responders|34|||
147547030|NCT00078819|532158916|FG001|Open-label Treatment Period: Weeks 13-36|Incomplete Responders|25|||
147547031|NCT00078819|532158917|FG002|Open-label Treatment Period: Weeks 13-36|Incomplete Responders|0|||
147547032|NCT00078819|532158918|FG003|Open-label Treatment Period: Weeks 13-36|Incomplete Responders|0|||
147547033|NCT00078819|532158915|FG000|Withdrawal Period: Weeks 37-48|Entered Retreatment|0|||
147547034|NCT00078819|532158916|FG001|Withdrawal Period: Weeks 37-48|Entered Retreatment|0|||
147547035|NCT00078819|532158917|FG002|Withdrawal Period: Weeks 37-48|Entered Retreatment|29|||
147547036|NCT00078819|532158918|FG003|Withdrawal Period: Weeks 37-48|Entered Retreatment|13|||
147547037|NCT00078819|532158915|FG000|Withdrawal Period: Weeks 37-48|Lost to Follow-up|0|||
147547038|NCT00078819|532158916|FG001|Withdrawal Period: Weeks 37-48|Lost to Follow-up|0|||
147547039|NCT00078819|532158917|FG002|Withdrawal Period: Weeks 37-48|Lost to Follow-up|0|||
147213211|NCT00246740|530952482|FG001|Initial Enrollment|Other|2|||
147213212|NCT00101452|530952485|FG000|Overall Study|Adverse Event|2|||
147213213|NCT00101452|530952486|FG001|Overall Study|Adverse Event|0|||
147213214|NCT00101452|530952487|FG002|Overall Study|Adverse Event|1|||
147213215|NCT00101452|530952485|FG000|Overall Study|Lost to Follow-up|13|||
147547040|NCT00078819|532158918|FG003|Withdrawal Period: Weeks 37-48|Lost to Follow-up|1|||
147547041|NCT02555618|532158919|FG000|Overall Study|Sponsor's Circumstances|1|||
147547042|NCT02555618|532158920|FG001|Overall Study|Sponsor's Circumstances|0|||
147213216|NCT00101452|530952486|FG001|Overall Study|Lost to Follow-up|8|||
147213217|NCT00101452|530952487|FG002|Overall Study|Lost to Follow-up|14|||
147213218|NCT00101452|530952485|FG000|Overall Study|Withdrawal by Subject|10|||
147213219|NCT00101452|530952486|FG001|Overall Study|Withdrawal by Subject|14|||
147213220|NCT00101452|530952487|FG002|Overall Study|Withdrawal by Subject|9|||
147213221|NCT00101452|530952485|FG000|Overall Study|Baseline Fail|2|||
147213222|NCT00101452|530952486|FG001|Overall Study|Baseline Fail|1|||
147213223|NCT00101452|530952487|FG002|Overall Study|Baseline Fail|2|||
147213224|NCT00101452|530952485|FG000|Overall Study|Physician Decision|0|||
147213225|NCT00101452|530952486|FG001|Overall Study|Physician Decision|3|||
147213226|NCT00101452|530952487|FG002|Overall Study|Physician Decision|2|||
147213227|NCT00101452|530952485|FG000|Overall Study|Protocol Violation|2|||
147547043|NCT01325532|532158923|FG000|Overall Study|Withdrawal by Subject|2|||
147547044|NCT01325532|532158924|FG001|Overall Study|Withdrawal by Subject|0|||
147547045|NCT03196791|532158927|FG000|Overall Study|Protocol Violation|7|||
147547046|NCT03196791|532158928|FG001|Overall Study|Protocol Violation|3|||
147547047|NCT03196791|532158927|FG000|Overall Study|Withdrawal by Subject|3|||
147547048|NCT03196791|532158928|FG001|Overall Study|Withdrawal by Subject|2|||
147547049|NCT01280981|532158934|FG000|Overall Study|Withdrawal by Subject|11|||
147547050|NCT01280981|532158934|FG000|Overall Study|Protocol Violation|2|||
147547051|NCT01280981|532158934|FG000|Overall Study|Lack of Efficacy|13|||
147547052|NCT01280981|532158934|FG000|Overall Study|Lost to Follow-up|3|||
147547053|NCT01280981|532158934|FG000|Overall Study|Adverse Event|6|||
147213228|NCT00101452|530952486|FG001|Overall Study|Protocol Violation|1|||
147442159|NCT02187471|531784274|FG003|Overall Study|Withdrawal by Subject|24|||
147442160|NCT02187471|531784271|FG000|Overall Study|Other|7|||
147442161|NCT02187471|531784272|FG001|Overall Study|Other|5|||
147442162|NCT02187471|531784273|FG002|Overall Study|Other|3|||
147442163|NCT02187471|531784274|FG003|Overall Study|Other|4|||
147442164|NCT02236520|531784275|FG000|Overall Study|Physician Decision|0|||
147442165|NCT02236520|531784276|FG001|Overall Study|Physician Decision|5|||
147442166|NCT02236520|531784277|FG002|Overall Study|Physician Decision|0|||
147442167|NCT02236520|531784278|FG003|Overall Study|Physician Decision|0|||
147442168|NCT02236520|531784275|FG000|Overall Study|Withdrawal by Subject|1|||
147442169|NCT02236520|531784276|FG001|Overall Study|Withdrawal by Subject|0|||
147442170|NCT02236520|531784277|FG002|Overall Study|Withdrawal by Subject|0|||
147442171|NCT02236520|531784278|FG003|Overall Study|Withdrawal by Subject|1|||
147442172|NCT02236520|531784275|FG000|Overall Study|Pregnancy|1|||
147442173|NCT02236520|531784276|FG001|Overall Study|Pregnancy|0|||
147442174|NCT02236520|531784277|FG002|Overall Study|Pregnancy|0|||
147442175|NCT02236520|531784278|FG003|Overall Study|Pregnancy|0|||
147442176|NCT01785160|531784279|FG000|Treatment Period 1: Raltegravir|Not treated|1|||
147442177|NCT01785160|531784279|FG000|Washout Period of at Least 7 Days|Consent withdrawn|1|||
147442178|NCT02318667|531784280|FG000|Overall Study|Adverse Event|1|||
147442179|NCT02318667|531784280|FG000|Overall Study|Lack of Efficacy|6|||
147442180|NCT02318667|531784280|FG000|Overall Study|Protocol Violation|2|||
147442181|NCT01033734|531784281|FG000|Overall Study|Withdrawal by Subject|1|||
147442182|NCT02865018|531784290|FG000|Overall Study|Withdrawal by Subject|1|||
147442183|NCT00111800|531784291|FG000|Period 1: Main Phase (12 Weeks)|Adverse Event|5|||
147442184|NCT00111800|531784292|FG001|Period 1: Main Phase (12 Weeks)|Adverse Event|4|||
147442185|NCT00111800|531784293|FG002|Period 1: Main Phase (12 Weeks)|Adverse Event|0|||
147442186|NCT00111800|531784294|FG003|Period 1: Main Phase (12 Weeks)|Adverse Event|0|||
147442187|NCT00111800|531784295|FG004|Period 1: Main Phase (12 Weeks)|Adverse Event|1|||
147442188|NCT00111800|531784296|FG005|Period 1: Main Phase (12 Weeks)|Adverse Event|0|||
147442189|NCT00111800|531784291|FG000|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|1|||
147442190|NCT00111800|531784292|FG001|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|0|||
147442191|NCT00111800|531784293|FG002|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|2|||
147442192|NCT00111800|531784294|FG003|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|0|||
147442193|NCT00111800|531784295|FG004|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|0|||
147442194|NCT00111800|531784296|FG005|Period 1: Main Phase (12 Weeks)|Lost to Follow-up|2|||
147442195|NCT00111800|531784291|FG000|Period 1: Main Phase (12 Weeks)|Protocol Violation|0|||
147442196|NCT00111800|531784292|FG001|Period 1: Main Phase (12 Weeks)|Protocol Violation|2|||
147442197|NCT00111800|531784293|FG002|Period 1: Main Phase (12 Weeks)|Protocol Violation|4|||
147442198|NCT00111800|531784294|FG003|Period 1: Main Phase (12 Weeks)|Protocol Violation|2|||
147442199|NCT00111800|531784295|FG004|Period 1: Main Phase (12 Weeks)|Protocol Violation|1|||
147442200|NCT00111800|531784296|FG005|Period 1: Main Phase (12 Weeks)|Protocol Violation|1|||
147442201|NCT00111800|531784291|FG000|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|2|||
147442202|NCT00111800|531784292|FG001|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|2|||
147442203|NCT00111800|531784293|FG002|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|3|||
147442204|NCT00111800|531784294|FG003|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|0|||
147547054|NCT01280981|532158934|FG000|Overall Study|Irregular or discontinued menses|3|||
147213229|NCT00101452|530952487|FG002|Overall Study|Protocol Violation|3|||
147213230|NCT00101452|530952485|FG000|Overall Study|Other|15|||
147213231|NCT00101452|530952486|FG001|Overall Study|Other|16|||
147213232|NCT00101452|530952487|FG002|Overall Study|Other|12|||
147442205|NCT00111800|531784295|FG004|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|0|||
147442206|NCT00111800|531784296|FG005|Period 1: Main Phase (12 Weeks)|Withdrawal by Subject|1|||
147547055|NCT01280981|532158934|FG000|Overall Study|Failed to return|45|||
147213233|NCT01994889|530952488|FG000|Overall Study|Adverse Event|5|||
147213234|NCT01994889|530952489|FG001|Overall Study|Adverse Event|12|||
147213235|NCT01994889|530952490|FG002|Overall Study|Adverse Event|11|||
147213236|NCT01994889|530952488|FG000|Overall Study|Cardiac Device Implantation|0|||
147213237|NCT01994889|530952489|FG001|Overall Study|Cardiac Device Implantation|2|||
147213238|NCT01994889|530952490|FG002|Overall Study|Cardiac Device Implantation|0|||
147213239|NCT01994889|530952488|FG000|Overall Study|Organ Transplantation|1|||
147213240|NCT01994889|530952489|FG001|Overall Study|Organ Transplantation|5|||
147213241|NCT01994889|530952490|FG002|Overall Study|Organ Transplantation|5|||
147213242|NCT01994889|530952488|FG000|Overall Study|No longer willing to participate|8|||
147213243|NCT01994889|530952489|FG001|Overall Study|No longer willing to participate|17|||
147213244|NCT01994889|530952490|FG002|Overall Study|No longer willing to participate|37|||
147213245|NCT01994889|530952488|FG000|Overall Study|Lost to Follow-up|0|||
147213246|NCT01994889|530952489|FG001|Overall Study|Lost to Follow-up|1|||
147442207|NCT00111800|531784291|FG000|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|3|||
147442208|NCT00111800|531784292|FG001|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0|||
147213247|NCT01994889|530952490|FG002|Overall Study|Lost to Follow-up|0|||
147213248|NCT01994889|530952488|FG000|Overall Study|Protocol Violation|0|||
147213249|NCT01994889|530952489|FG001|Overall Study|Protocol Violation|1|||
147213250|NCT01994889|530952490|FG002|Overall Study|Protocol Violation|1|||
147213251|NCT01994889|530952488|FG000|Overall Study|Death|14|||
147213252|NCT01994889|530952489|FG001|Overall Study|Death|25|||
147213253|NCT01994889|530952490|FG002|Overall Study|Death|38|||
147213254|NCT02969655|530952491|FG000|Overall Study|Withdrawal by Subject|3|||
147213255|NCT02969655|530952492|FG001|Overall Study|Withdrawal by Subject|2|||
147213256|NCT02969655|530952491|FG000|Overall Study|Physician Decision|4|||
147213257|NCT02969655|530952492|FG001|Overall Study|Physician Decision|3|||
147213258|NCT02969655|530952491|FG000|Overall Study|Protocol-specified withdrawal criteria|4|||
147213259|NCT02969655|530952492|FG001|Overall Study|Protocol-specified withdrawal criteria|2|||
147213260|NCT02969655|530952491|FG000|Overall Study|Adverse Event|10|||
147213261|NCT02969655|530952492|FG001|Overall Study|Adverse Event|8|||
147213262|NCT02674204|530952493|FG000|Overall Study|Adverse Event|1|||
147213263|NCT02674204|530952494|FG001|Overall Study|Adverse Event|0|||
147213264|NCT02466659|530952497|FG000|Overall Study|Lost to Follow-up|5|||
147213265|NCT02466659|530952498|FG001|Overall Study|Lost to Follow-up|2|||
147213266|NCT01536392|530952499|FG000|Overall Study|Adverse Event|2|||
147213267|NCT01536392|530952500|FG001|Overall Study|Adverse Event|2|||
147213268|NCT01536392|530952499|FG000|Overall Study|Physician Decision|2|||
147213269|NCT01536392|530952500|FG001|Overall Study|Physician Decision|3|||
147213270|NCT01536392|530952499|FG000|Overall Study|Withdrawal by Subject|3|||
147213271|NCT01536392|530952500|FG001|Overall Study|Withdrawal by Subject|6|||
147213272|NCT01536392|530952499|FG000|Overall Study|Non Compliance|3|||
147213273|NCT01536392|530952500|FG001|Overall Study|Non Compliance|4|||
147213274|NCT01536392|530952499|FG000|Overall Study|Completed therapy early|3|||
147213275|NCT01536392|530952500|FG001|Overall Study|Completed therapy early|0|||
147213276|NCT03753789|530952501|FG000|Overall Study|Withdrawal by Subject|2|||
147213277|NCT01030666|530952506|FG000|Overall Study|Lost to Follow-up|3|||
147213278|NCT01030666|530952507|FG001|Overall Study|Lost to Follow-up|2|||
147213279|NCT04002908|530952508|FG000|Overall Study|Death|41|||
147213280|NCT04002908|530952509|FG001|Overall Study|Death|0|||
147213281|NCT04002908|530952510|FG002|Overall Study|Death|0|||
147442209|NCT00111800|531784293|FG002|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0|||
147213282|NCT04002908|530952511|FG003|Overall Study|Death|0|||
147213283|NCT04002908|530952508|FG000|Overall Study|Withdrawal by Subject|112|||
147213284|NCT04002908|530952509|FG001|Overall Study|Withdrawal by Subject|0|||
147213285|NCT04002908|530952510|FG002|Overall Study|Withdrawal by Subject|0|||
147213286|NCT04002908|530952511|FG003|Overall Study|Withdrawal by Subject|0|||
147213287|NCT04002908|530952508|FG000|Overall Study|Lost to Follow-up|72|||
147213288|NCT04002908|530952509|FG001|Overall Study|Lost to Follow-up|0|||
147213289|NCT04002908|530952510|FG002|Overall Study|Lost to Follow-up|0|||
147213290|NCT04002908|530952511|FG003|Overall Study|Lost to Follow-up|0|||
147213291|NCT04002908|530952508|FG000|Overall Study|Infant died, so mother withdrawn|34|||
147213292|NCT04002908|530952509|FG001|Overall Study|Infant died, so mother withdrawn|0|||
147213293|NCT04002908|530952510|FG002|Overall Study|Infant died, so mother withdrawn|0|||
147213294|NCT04002908|530952511|FG003|Overall Study|Infant died, so mother withdrawn|0|||
147213295|NCT05477108|530952515|FG000|Overall Study|Participants randomized, not treated|1|||
147213296|NCT05477108|530952516|FG001|Overall Study|Participants randomized, not treated|1|||
147213297|NCT05477108|530952517|FG002|Overall Study|Participants randomized, not treated|1|||
147213298|NCT05477108|530952515|FG000|Overall Study|Physician Decision|0|||
147213299|NCT05477108|530952516|FG001|Overall Study|Physician Decision|0|||
147213300|NCT05477108|530952517|FG002|Overall Study|Physician Decision|1|||
147213301|NCT05477108|530952515|FG000|Overall Study|withdrawn from study|0|||
147213302|NCT05477108|530952516|FG001|Overall Study|withdrawn from study|0|||
147442210|NCT00111800|531784294|FG003|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|1|||
147213303|NCT05477108|530952517|FG002|Overall Study|withdrawn from study|1|||
147213304|NCT00334113|530952518|FG000|Overall Study|Lost to Follow-up|2|||
147213305|NCT00334113|530952519|FG001|Overall Study|Lost to Follow-up|2|||
147213306|NCT00334113|530952518|FG000|Overall Study|Withdrawal by Subject|0|||
147213307|NCT00334113|530952519|FG001|Overall Study|Withdrawal by Subject|1|||
147213308|NCT02509026|530952524|FG000|Induction Period (24 Weeks)|Adverse Event|5|||
147213309|NCT02509026|530952524|FG000|Induction Period (24 Weeks)|Eligibility Criteria|5|||
147213310|NCT02509026|530952524|FG000|Induction Period (24 Weeks)|Lack of Efficacy|6|||
147213311|NCT02509026|530952524|FG000|Induction Period (24 Weeks)|Lost to Follow-up|1|||
147213312|NCT02509026|530952524|FG000|Induction Period (24 Weeks)|Other|2|||
147213313|NCT02509026|530952524|FG000|Induction Period (24 Weeks)|Protocol Violation|1|||
147213314|NCT02509026|530952524|FG000|Induction Period (24 Weeks)|Withdrawal by Subject|1|||
147213315|NCT02509026|530952524|FG000|Induction Period (24 Weeks)|Enrolled but not treated|1|||
147213316|NCT02509026|530952524|FG000|Withdrawal Period (40 Weeks)|Protocol Violation|2|||
147213317|NCT02509026|530952524|FG000|Withdrawal Period (40 Weeks)|Withdrawal by Subject|5|||
147213318|NCT02509026|530952524|FG000|Retreatment Period (12 Weeks)|Lost to Follow-up|1|||
147213319|NCT02509026|530952524|FG000|Retreatment Period (12 Weeks)|Withdrawal by Subject|2|||
147213320|NCT02509026|530952524|FG000|Retreatment Period (12 Weeks)|Enrolled but not treated|1|||
147213321|NCT00243841|530952525|FG000|Overall Study|Physician Decision|0|||
147213322|NCT00243841|530952526|FG001|Overall Study|Physician Decision|0|||
147213323|NCT00243841|530952527|FG002|Overall Study|Physician Decision|1|||
147213324|NCT00243841|530952528|FG003|Overall Study|Physician Decision|0|||
147213325|NCT00243841|530952529|FG004|Overall Study|Physician Decision|0|||
147213326|NCT00243841|530952530|FG005|Overall Study|Physician Decision|2|||
147213327|NCT01948193|530954135|FG000|Overall Study|Serious event|2|||
147213328|NCT01948193|530954135|FG000|Overall Study|Lost to Follow-up|7|||
147213329|NCT01964755|530954137|FG000|Overall Study|Death|2|||
147213330|NCT00361634|530954148|FG000|Overall Study|Lost to Follow-up|1|||
147213331|NCT00361634|530954148|FG000|Overall Study|Withdrawal by Subject|1|||
147213332|NCT05315908|530954149|FG000|Overall Study|Lost to Follow-up|4477|||
147213333|NCT05315908|530954150|FG001|Overall Study|Lost to Follow-up|4606|||
147213334|NCT00294762|530954151|FG000|Overall Study|Did not receive study treatment|3|||
147213335|NCT00294762|530954152|FG001|Overall Study|Did not receive study treatment|3|||
147213336|NCT02937584|530954153|FG000|Period 1|Adverse Event|1|||
147213337|NCT02937584|530954154|FG001|Period 1|Adverse Event|2|||
147213338|NCT02937584|530954153|FG000|Washout|Adverse Event|0|||
147213339|NCT02937584|530954154|FG001|Washout|Adverse Event|1|||
147213340|NCT02238080|530954163|FG000|Overall Study|Death|13|||
147213341|NCT02238080|530954163|FG000|Overall Study|Treatment interrupted|6|||
147213342|NCT02238080|530954163|FG000|Overall Study|Withdrawal by Subject|2|||
147213343|NCT02238080|530954163|FG000|Overall Study|Other|4|||
147213344|NCT01738646|530954164|FG000|Overall Study|Still Receiving Treatment|2|||
147213345|NCT01598129|530954165|FG000|Overall Study|Disease progression|6|||
147213346|NCT01598129|530954165|FG000|Overall Study|Deterioration of WHO status to WHO 4|2|||
147213347|NCT01598129|530954165|FG000|Overall Study|Withdrawal by Subject|1|||
147213348|NCT00505076|530954166|FG000|Overall Study|Adverse Event|1|||
147213349|NCT00505076|530954167|FG001|Overall Study|Adverse Event|0|||
147213350|NCT00505076|530954168|FG002|Overall Study|Adverse Event|1|||
147213351|NCT00505076|530954166|FG000|Overall Study|Protocol Violation|2|||
147213352|NCT00505076|530954167|FG001|Overall Study|Protocol Violation|1|||
147213353|NCT00505076|530954168|FG002|Overall Study|Protocol Violation|2|||
147213354|NCT00505076|530954166|FG000|Overall Study|Withdrawal by Subject|0|||
147213355|NCT00505076|530954167|FG001|Overall Study|Withdrawal by Subject|1|||
147213356|NCT00505076|530954168|FG002|Overall Study|Withdrawal by Subject|2|||
147213357|NCT04093024|530954171|FG000|Double-blind Period|Completed prematurely due to administrative end of trial and did not continue with OLNP|2|||
147213358|NCT04093024|530954172|FG001|Double-blind Period|Completed prematurely due to administrative end of trial and did not continue with OLNP|2|||
147213359|NCT04093024|530954171|FG000|Double-blind Period|Discontinued treatment due to adverse event|0|||
147213360|NCT04093024|530954172|FG001|Double-blind Period|Discontinued treatment due to adverse event|2|||
147213361|NCT04093024|530954171|FG000|Double-blind Period|Discontinued treatment due to other reason|0|||
147213362|NCT04093024|530954172|FG001|Double-blind Period|Discontinued treatment due to other reason|1|||
147213363|NCT04093024|530954171|FG000|Open-label Nintedanib Period (OLNP)|Discontinuation of trial medication due to other reason|0|||
147213364|NCT04093024|530954172|FG001|Open-label Nintedanib Period (OLNP)|Discontinuation of trial medication due to other reason|1|||
147213365|NCT03180619|530954177|FG000|Overall Study|Withdrew Consent|5|||
147213366|NCT03180619|530954178|FG001|Overall Study|Withdrew Consent|0|||
147213367|NCT03180619|530954179|FG002|Overall Study|Withdrew Consent|2|||
147213368|NCT03180619|530954177|FG000|Overall Study|Death|2|||
147213369|NCT03180619|530954178|FG001|Overall Study|Death|1|||
147213370|NCT03180619|530954179|FG002|Overall Study|Death|2|||
147213371|NCT03180619|530954177|FG000|Overall Study|Adverse Event|2|||
147213372|NCT03180619|530954178|FG001|Overall Study|Adverse Event|0|||
147213373|NCT03180619|530954179|FG002|Overall Study|Adverse Event|1|||
147213374|NCT03180619|530954177|FG000|Overall Study|Investigator's discretion|2|||
147213375|NCT03180619|530954178|FG001|Overall Study|Investigator's discretion|0|||
147213376|NCT03180619|530954179|FG002|Overall Study|Investigator's discretion|1|||
147213377|NCT00729469|530954180|FG000|Overall Study|Adverse Event|14|||
147213378|NCT00729469|530954181|FG001|Overall Study|Adverse Event|25|||
147213379|NCT00729469|530954180|FG000|Overall Study|Lost to Follow-up|9|||
147213380|NCT00729469|530954181|FG001|Overall Study|Lost to Follow-up|9|||
147213381|NCT00729469|530954180|FG000|Overall Study|Protocol Violation|2|||
147213382|NCT00729469|530954181|FG001|Overall Study|Protocol Violation|1|||
147213383|NCT00729469|530954180|FG000|Overall Study|Withdrawal by Subject|19|||
147213384|NCT00729469|530954181|FG001|Overall Study|Withdrawal by Subject|8|||
147213385|NCT00729469|530954180|FG000|Overall Study|Other-Not mentioned|9|||
147547056|NCT01280981|532158934|FG000|Overall Study|Non-compliance with protocol|3|||
147547057|NCT01280981|532158934|FG000|Overall Study|Withdrawal of consent|3|||
147213386|NCT00729469|530954181|FG001|Overall Study|Other-Not mentioned|4|||
147213387|NCT00561977|530954184|FG000|Overall Study|Withdrawal by Subject|0|||
147213388|NCT00561977|530954185|FG001|Overall Study|Withdrawal by Subject|2|||
147213389|NCT00561977|530954186|FG002|Overall Study|Withdrawal by Subject|1|||
147213390|NCT00561977|530954184|FG000|Overall Study|Pregnancy|0|||
147213391|NCT00561977|530954185|FG001|Overall Study|Pregnancy|1|||
147213392|NCT00561977|530954186|FG002|Overall Study|Pregnancy|1|||
147213393|NCT04975438|530954187|FG000|Overall Study|Lost to Follow-up|1|||
147213394|NCT04975438|530954188|FG001|Overall Study|Lost to Follow-up|0|||
147213395|NCT04975438|530954189|FG002|Overall Study|Lost to Follow-up|1|||
147213396|NCT04975438|530954190|FG003|Overall Study|Lost to Follow-up|0|||
147213397|NCT04975438|530954187|FG000|Overall Study|Withdrawal by Subject|1|||
147213398|NCT04975438|530954188|FG001|Overall Study|Withdrawal by Subject|0|||
147213399|NCT04975438|530954189|FG002|Overall Study|Withdrawal by Subject|0|||
147213400|NCT04975438|530954190|FG003|Overall Study|Withdrawal by Subject|0|||
147213401|NCT00977080|530954191|FG000|Overall Study|Adverse Event|2|||
147213402|NCT00977080|530954192|FG001|Overall Study|Adverse Event|7|||
147213403|NCT00977080|530954193|FG002|Overall Study|Adverse Event|7|||
147213404|NCT00977080|530954194|FG003|Overall Study|Adverse Event|7|||
147213405|NCT00977080|530954191|FG000|Overall Study|Withdrawal by Subject|1|||
147213406|NCT00977080|530954192|FG001|Overall Study|Withdrawal by Subject|5|||
147213407|NCT00977080|530954193|FG002|Overall Study|Withdrawal by Subject|1|||
147213408|NCT00977080|530954194|FG003|Overall Study|Withdrawal by Subject|5|||
147213409|NCT00977080|530954191|FG000|Overall Study|Protocol Violation|7|||
147213410|NCT00977080|530954192|FG001|Overall Study|Protocol Violation|3|||
147213411|NCT00977080|530954193|FG002|Overall Study|Protocol Violation|4|||
147213412|NCT00977080|530954194|FG003|Overall Study|Protocol Violation|3|||
147213413|NCT00977080|530954191|FG000|Overall Study|Noncompliance|0|||
147213414|NCT00977080|530954192|FG001|Overall Study|Noncompliance|2|||
147213415|NCT00977080|530954193|FG002|Overall Study|Noncompliance|1|||
147213416|NCT00977080|530954194|FG003|Overall Study|Noncompliance|0|||
147213417|NCT00977080|530954191|FG000|Overall Study|Calcium < 7.5 mg/dL on 3 draws|0|||
147213418|NCT00977080|530954192|FG001|Overall Study|Calcium < 7.5 mg/dL on 3 draws|0|||
147213419|NCT00977080|530954193|FG002|Overall Study|Calcium < 7.5 mg/dL on 3 draws|0|||
147213420|NCT00977080|530954194|FG003|Overall Study|Calcium < 7.5 mg/dL on 3 draws|1|||
147213421|NCT00977080|530954191|FG000|Overall Study|Required kidney transplantation|1|||
147213422|NCT00977080|530954192|FG001|Overall Study|Required kidney transplantation|3|||
147213423|NCT00977080|530954193|FG002|Overall Study|Required kidney transplantation|3|||
147213424|NCT00977080|530954194|FG003|Overall Study|Required kidney transplantation|1|||
147213425|NCT00977080|530954191|FG000|Overall Study|Travel for family reasons|1|||
147213426|NCT00977080|530954192|FG001|Overall Study|Travel for family reasons|0|||
147213427|NCT00977080|530954193|FG002|Overall Study|Travel for family reasons|0|||
147213428|NCT00977080|530954194|FG003|Overall Study|Travel for family reasons|0|||
147213429|NCT00566696|530954195|FG000|Overall Study|Met Exclusion Criteria|2|||
147213430|NCT00566696|530954195|FG000|Overall Study|Muromonab not available|1|||
147213431|NCT00566696|530954195|FG000|Overall Study|Health Status Change|1|||
147213432|NCT00566696|530954195|FG000|Overall Study|Physician Decision|1|||
147213433|NCT00566696|530954195|FG000|Overall Study|Non-Patient Donors|37|||
147213434|NCT00275340|530954203|FG000|Overall Study|Lost to Follow-up|2|||
147213435|NCT00275340|530954204|FG001|Overall Study|Lost to Follow-up|4|||
147213436|NCT00653939|530954206|FG000|Overall Study|Adverse Event|1|||
147213437|NCT00653939|530954207|FG001|Overall Study|Adverse Event|3|||
147213438|NCT00653939|530954206|FG000|Overall Study|Withdrawal by Subject|3|||
147213439|NCT00653939|530954207|FG001|Overall Study|Withdrawal by Subject|3|||
147213440|NCT00653939|530954206|FG000|Overall Study|Physician Decision|4|||
147213441|NCT00653939|530954207|FG001|Overall Study|Physician Decision|0|||
147213442|NCT00653939|530954206|FG000|Overall Study|Disease Progression|2|||
147213443|NCT00653939|530954207|FG001|Overall Study|Disease Progression|3|||
147213444|NCT00653939|530954206|FG000|Overall Study|Other|2|||
147213445|NCT00653939|530954207|FG001|Overall Study|Other|6|||
147213446|NCT02032238|530954208|FG000|Overall Study|Lost to Follow-up|2|||
147213447|NCT02032238|530954209|FG001|Overall Study|Lost to Follow-up|0|||
147213448|NCT00612105|530954210|FG000|Period Title 1: 6-Week Titration Phase|Adverse Event|18|||
147213449|NCT00612105|530954211|FG001|Period Title 1: 6-Week Titration Phase|Adverse Event|1|||
147213450|NCT00612105|530954210|FG000|Period Title 1: 6-Week Titration Phase|Withdrawal by Subject|6|||
147213451|NCT00612105|530954211|FG001|Period Title 1: 6-Week Titration Phase|Withdrawal by Subject|1|||
147213452|NCT00612105|530954210|FG000|Period Title 1: 6-Week Titration Phase|Lost to Follow-up|2|||
147213453|NCT00612105|530954211|FG001|Period Title 1: 6-Week Titration Phase|Lost to Follow-up|0|||
147213454|NCT00612105|530954210|FG000|Period Title 1: 6-Week Titration Phase|Physician Decision|1|||
147213455|NCT00612105|530954211|FG001|Period Title 1: 6-Week Titration Phase|Physician Decision|1|||
147213456|NCT00612105|530954210|FG000|Period Title 1: 6-Week Titration Phase|Protocol Violation|1|||
147213457|NCT00612105|530954211|FG001|Period Title 1: 6-Week Titration Phase|Protocol Violation|0|||
147442211|NCT00111800|531784295|FG004|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0|||
147442212|NCT00111800|531784296|FG005|Period 1: Main Phase (12 Weeks)|Lack of Efficacy|0|||
147442213|NCT00111800|531784291|FG000|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|1|||
147442214|NCT00111800|531784292|FG001|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0|||
147442215|NCT00111800|531784293|FG002|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0|||
147442216|NCT00111800|531784294|FG003|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0|||
147442217|NCT00111800|531784295|FG004|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|1|||
147442218|NCT00111800|531784296|FG005|Period 1: Main Phase (12 Weeks)|Insufficient therapeutic effect|0|||
147442219|NCT00111800|531784291|FG000|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|1|||
147442220|NCT00111800|531784292|FG001|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|1|||
147442221|NCT00111800|531784293|FG002|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|0|||
147442222|NCT00111800|531784294|FG003|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|1|||
147442223|NCT00111800|531784295|FG004|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|0|||
147442224|NCT00111800|531784296|FG005|Period 1: Main Phase (12 Weeks)|Not meet treatment eligibility criteria|0|||
147442225|NCT00111800|531784291|FG000|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|1|||
147213458|NCT00612105|530954210|FG000|Period Title 1: 6-Week Titration Phase|Missed study drug for more than two days|3|||
147547058|NCT01280981|532158934|FG000|Overall Study|Elective surgery|2|||
147547059|NCT01280981|532158934|FG000|Overall Study|Study site closure|1|||
147547060|NCT01749033|532158936|FG000|Overall Study|Did not receive allocated intervention|3|||
147547061|NCT01749033|532158937|FG001|Overall Study|Did not receive allocated intervention|3|||
147547062|NCT01749033|532158938|FG002|Overall Study|Did not receive allocated intervention|0|||
147547063|NCT01749033|532158936|FG000|Overall Study|Lost to Follow-up|0|||
147547064|NCT01749033|532158937|FG001|Overall Study|Lost to Follow-up|2|||
147547065|NCT01749033|532158938|FG002|Overall Study|Lost to Follow-up|1|||
147547066|NCT03056001|532158942|FG000|Overall Study|Death|24|||
147547067|NCT02295280|532158944|FG000|Overall Study|Adverse Event|0|||
147547068|NCT02295280|532158945|FG001|Overall Study|Adverse Event|1|||
147547069|NCT02875067|532158946|FG000|Overall Study|Withdrawal by Subject|1|||
147547070|NCT02875067|532158946|FG000|Overall Study|Withdrawal by Termination of Study|5|||
147547071|NCT02713243|532158948|FG000|Overall Study|Abnormal laboratory value(s)#|1|||
147547072|NCT02713243|532158949|FG001|Overall Study|Abnormal laboratory value(s)#|0|||
147547073|NCT02713243|532158948|FG000|Overall Study|Administrative problems|0|||
147547074|NCT02713243|532158949|FG001|Overall Study|Administrative problems|1|||
147547075|NCT02713243|532158948|FG000|Overall Study|Protocol deviation|0|||
147547076|NCT02713243|532158949|FG001|Overall Study|Protocol deviation|1|||
147547077|NCT03056352|532158950|FG000|Overall Study|Lost to Follow-up|1|||
147547078|NCT02971605|532158951|FG000|Overall Study|Withdrawal by Subject|1|||
147547079|NCT00597207|532158952|FG000|Overall Study|Lost to Follow-up|5|||
147547080|NCT00597207|532158953|FG001|Overall Study|Lost to Follow-up|7|||
147547081|NCT03439293|532158956|FG000|Overall Study|Death|22|||
147547082|NCT03439293|532158956|FG000|Overall Study|Withdrawal by Subject|8|||
147547083|NCT03439293|532158956|FG000|Overall Study|Lost to Follow-up|2|||
147547084|NCT03439293|532158956|FG000|Overall Study|Reason Not Specified|28|||
147547085|NCT03439293|532158956|FG000|Overall Study|Missing|1|||
147547086|NCT03077828|532158959|FG000|Treatment Cycles|Death|1|||
147547087|NCT03077828|532158959|FG000|Treatment Cycles|Withdrawal by Subject|1|||
147547088|NCT03077828|532158959|FG000|Treatment Cycles|Screen Fail|2|||
147547089|NCT03077828|532158959|FG000|Autologous Stem Cell Transplant|Adverse Event|1|||
147547090|NCT03077828|532158959|FG000|Autologous Stem Cell Transplant|Withdrawal by Subject|2|||
147547091|NCT03077828|532158959|FG000|Autologous Stem Cell Transplant|Physician Decision|1|||
147547092|NCT03077828|532158959|FG000|Follow-up|Patients still in follow-up|15|||
147547093|NCT05037409|532158961|FG000|Blinded Treatment (1 Day)|Failure to comply with site instruction|0|||
147547094|NCT05037409|532158962|FG001|Blinded Treatment (1 Day)|Failure to comply with site instruction|1|||
147547095|NCT05037409|532158963|FG002|Blinded Treatment (1 Day)|Failure to comply with site instruction|0|||
147547096|NCT03499249|532158964|FG000|Overall Study|Physician Decision|1|||
147547097|NCT01963676|532160688|FG000|Overall Study|Withdrawal by Subject|1|||
147547098|NCT01963676|532160689|FG001|Overall Study|Withdrawal by Subject|0|||
147547099|NCT01120600|532160692|FG000|Overall Study|Adverse Event|7|||
147547100|NCT01120600|532160693|FG001|Overall Study|Adverse Event|7|||
147547101|NCT01120600|532160692|FG000|Overall Study|Excessive Bone Loss|0|||
147213459|NCT00612105|530954211|FG001|Period Title 1: 6-Week Titration Phase|Missed study drug for more than two days|1|||
147213460|NCT00612105|530954210|FG000|Period Title 1: 6-Week Titration Phase|Lack of Efficacy|5|||
147213461|NCT00612105|530954211|FG001|Period Title 1: 6-Week Titration Phase|Lack of Efficacy|0|||
147213462|NCT00612105|530954210|FG000|Period Title 1: 6-Week Titration Phase|Other|0|||
147213463|NCT00612105|530954211|FG001|Period Title 1: 6-Week Titration Phase|Other|1|||
147213464|NCT00612105|530954210|FG000|Period Title 2: 4-Week Maintenance Phase|Adverse Event|9|||
147213465|NCT00612105|530954211|FG001|Period Title 2: 4-Week Maintenance Phase|Adverse Event|1|||
147213466|NCT00612105|530954210|FG000|Period Title 2: 4-Week Maintenance Phase|Missed study drug for more than two days|1|||
147213467|NCT00612105|530954211|FG001|Period Title 2: 4-Week Maintenance Phase|Missed study drug for more than two days|1|||
147213468|NCT00612105|530954210|FG000|Period Title 2: 4-Week Maintenance Phase|Lost to Follow-up|1|||
147547102|NCT01120600|532160693|FG001|Overall Study|Excessive Bone Loss|4|||
147547103|NCT01120600|532160692|FG000|Overall Study|Lost to Follow-up|1|||
147547104|NCT01120600|532160693|FG001|Overall Study|Lost to Follow-up|3|||
147547105|NCT01120600|532160692|FG000|Overall Study|Physician Decision|1|||
147547106|NCT01120600|532160693|FG001|Overall Study|Physician Decision|3|||
147547107|NCT01120600|532160692|FG000|Overall Study|Protocol Violation|0|||
147547108|NCT01120600|532160693|FG001|Overall Study|Protocol Violation|4|||
147213469|NCT00612105|530954211|FG001|Period Title 2: 4-Week Maintenance Phase|Lost to Follow-up|0|||
147213470|NCT00612105|530954210|FG000|Period Title 3: 3-Week Taper Phase|Other|1|||
147213471|NCT00612105|530954211|FG001|Period Title 3: 3-Week Taper Phase|Other|0|||
147213472|NCT00717236|530954212|FG000|Double-Blind Period|Adverse Event|33|||
147213473|NCT00717236|530954213|FG001|Double-Blind Period|Adverse Event|6|||
147213474|NCT00717236|530954212|FG000|Double-Blind Period|Lack of Efficacy|6|||
147547109|NCT01120600|532160692|FG000|Overall Study|Withdrawal by Subject|10|||
147547110|NCT01120600|532160693|FG001|Overall Study|Withdrawal by Subject|11|||
147547111|NCT00686790|532160694|FG000|Overall Study|Adverse Event|2|||
147547112|NCT00686790|532160694|FG000|Overall Study|Withdrawal by Subject|1|||
147547113|NCT00686790|532160694|FG000|Overall Study|Death|1|||
147547114|NCT00686790|532160694|FG000|Overall Study|Lost to Follow-up|12|||
147547115|NCT00382291|532160695|FG000|Overall Study|Adverse Event|1|||
147547116|NCT00382291|532160696|FG001|Overall Study|Adverse Event|2|||
147547117|NCT00382291|532160697|FG002|Overall Study|Adverse Event|2|||
147547118|NCT00382291|532160695|FG000|Overall Study|Protocol Violation|1|||
147547119|NCT00382291|532160696|FG001|Overall Study|Protocol Violation|0|||
147547120|NCT00382291|532160697|FG002|Overall Study|Protocol Violation|0|||
147547121|NCT00382291|532160695|FG000|Overall Study|Temporary study suspension|2|||
147547122|NCT00382291|532160696|FG001|Overall Study|Temporary study suspension|2|||
147547123|NCT00382291|532160697|FG002|Overall Study|Temporary study suspension|5|||
147547124|NCT00382291|532160695|FG000|Overall Study|Withdrawal by Subject|0|||
147213475|NCT00717236|530954213|FG001|Double-Blind Period|Lack of Efficacy|6|||
147213476|NCT00717236|530954212|FG000|Double-Blind Period|Lost to Follow-up|3|||
147213477|NCT00717236|530954213|FG001|Double-Blind Period|Lost to Follow-up|5|||
147213478|NCT00717236|530954212|FG000|Double-Blind Period|Withdrawal by Subject|10|||
147213479|NCT00717236|530954213|FG001|Double-Blind Period|Withdrawal by Subject|2|||
147213480|NCT00717236|530954212|FG000|Double-Blind Period|Loss of efficacy|3|||
147213481|NCT00717236|530954213|FG001|Double-Blind Period|Loss of efficacy|0|||
147213482|NCT00717236|530954212|FG000|Double-Blind Period|Other: Death|1|||
147213483|NCT00717236|530954213|FG001|Double-Blind Period|Other: Death|0|||
147213484|NCT00717236|530954212|FG000|Double-Blind Period|Other: Pregnancy|1|||
147213485|NCT00717236|530954213|FG001|Double-Blind Period|Other: Pregnancy|0|||
147213486|NCT00717236|530954212|FG000|Double-Blind Period|Other: Protocol Violation|2|||
147213487|NCT00717236|530954213|FG001|Double-Blind Period|Other: Protocol Violation|0|||
147213488|NCT00717236|530954212|FG000|Double-Blind Period|Other: Inclusion/Exclusion criteria|6|||
147213489|NCT00717236|530954213|FG001|Double-Blind Period|Other: Inclusion/Exclusion criteria|2|||
147213490|NCT00717236|530954212|FG000|Double-Blind Period|Other: Site withdrew|2|||
147213491|NCT00717236|530954213|FG001|Double-Blind Period|Other: Site withdrew|0|||
147213492|NCT00717236|530954212|FG000|Double-Blind Period|Other: Screening failure|1|||
147213493|NCT00717236|530954213|FG001|Double-Blind Period|Other: Screening failure|0|||
147213494|NCT00717236|530954212|FG000|Double-Blind Period|Other: subject withdrew consent|1|||
147213495|NCT00717236|530954213|FG001|Double-Blind Period|Other: subject withdrew consent|1|||
147213496|NCT00717236|530954212|FG000|Double-Blind Period|Other: Abnormal chest X-ray|2|||
147213497|NCT00717236|530954213|FG001|Double-Blind Period|Other: Abnormal chest X-ray|1|||
147213498|NCT00717236|530954212|FG000|Double-Blind Period|Other: History of adenoid grown|1|||
147213499|NCT00717236|530954213|FG001|Double-Blind Period|Other: History of adenoid grown|0|||
147213500|NCT00717236|530954212|FG000|Double-Blind Period|Other: History of cancer|1|||
147213501|NCT00717236|530954213|FG001|Double-Blind Period|Other: History of cancer|0|||
147213502|NCT00717236|530954212|FG000|Double-Blind Period|Other: Sponsor request|1|||
147213503|NCT00717236|530954213|FG001|Double-Blind Period|Other: Sponsor request|0|||
147213504|NCT00717236|530954212|FG000|Double-Blind Period|Other: Inappropriate randomization|1|||
147213505|NCT00717236|530954213|FG001|Double-Blind Period|Other: Inappropriate randomization|0|||
147213506|NCT00717236|530954212|FG000|Double-Blind Period|Other: Detection of Hepatitis C Virus|1|||
147213507|NCT00717236|530954213|FG001|Double-Blind Period|Other: Detection of Hepatitis C Virus|0|||
147213508|NCT00717236|530954212|FG000|Double-Blind Period|Other: Subject moved|1|||
147213509|NCT00717236|530954213|FG001|Double-Blind Period|Other: Subject moved|1|||
147213510|NCT00717236|530954212|FG000|Double-Blind Period|Other: Stopped taking DMARD|1|||
147213511|NCT00717236|530954213|FG001|Double-Blind Period|Other: Stopped taking DMARD|0|||
147213512|NCT00717236|530954212|FG000|Double-Blind Period|Other: Prohibited medication taken|2|||
147213513|NCT00717236|530954213|FG001|Double-Blind Period|Other: Prohibited medication taken|2|||
147213514|NCT00717236|530954212|FG000|Double-Blind Period|Other: Transportation problems|0|||
147213515|NCT00717236|530954213|FG001|Double-Blind Period|Other: Transportation problems|1|||
147213516|NCT00717236|530954212|FG000|Double-Blind Period|Other: Investigator Decision|0|||
147213517|NCT00717236|530954213|FG001|Double-Blind Period|Other: Investigator Decision|1|||
147213518|NCT00717236|530954212|FG000|Open-Label Period|Adverse Event|29|||
147213519|NCT00717236|530954213|FG001|Open-Label Period|Adverse Event|4|||
147213520|NCT00717236|530954212|FG000|Open-Label Period|Lack of Efficacy|30|||
147213521|NCT00717236|530954213|FG001|Open-Label Period|Lack of Efficacy|8|||
147213522|NCT00717236|530954212|FG000|Open-Label Period|Lost to Follow-up|28|||
147213523|NCT00717236|530954213|FG001|Open-Label Period|Lost to Follow-up|4|||
147213524|NCT00717236|530954212|FG000|Open-Label Period|Withdrawal by Subject|20|||
147213525|NCT00717236|530954213|FG001|Open-Label Period|Withdrawal by Subject|2|||
147213526|NCT00717236|530954212|FG000|Open-Label Period|Loss of Efficacy|6|||
147213527|NCT00717236|530954213|FG001|Open-Label Period|Loss of Efficacy|1|||
147213528|NCT00717236|530954212|FG000|Open-Label Period|Other: Peripheral Neuropathy|0|||
147213529|NCT00717236|530954213|FG001|Open-Label Period|Other: Peripheral Neuropathy|1|||
147213530|NCT00717236|530954212|FG000|Open-Label Period|Other: Lack of Compliance|1|||
147213531|NCT00717236|530954213|FG001|Open-Label Period|Other: Lack of Compliance|1|||
147547125|NCT00382291|532160696|FG001|Overall Study|Withdrawal by Subject|2|||
147213532|NCT00717236|530954212|FG000|Open-Label Period|Other: History of Basal Cell Carcinoma|1|||
147213533|NCT00717236|530954213|FG001|Open-Label Period|Other: History of Basal Cell Carcinoma|0|||
147547126|NCT00382291|532160697|FG002|Overall Study|Withdrawal by Subject|0|||
147547127|NCT00382291|532160695|FG000|Overall Study|Physician Decision|0|||
147547128|NCT00382291|532160696|FG001|Overall Study|Physician Decision|1|||
147213534|NCT00717236|530954212|FG000|Open-Label Period|Other: Moved|1|||
147213535|NCT00717236|530954213|FG001|Open-Label Period|Other: Moved|0|||
147213536|NCT00717236|530954212|FG000|Open-Label Period|Other: Investigator Decision|1|||
147213537|NCT00717236|530954213|FG001|Open-Label Period|Other: Investigator Decision|0|||
147213538|NCT00717236|530954212|FG000|Open-Label Period|Other: Loss of Staff (unblinded)|1|||
147213539|NCT00717236|530954213|FG001|Open-Label Period|Other: Loss of Staff (unblinded)|0|||
147213540|NCT00717236|530954212|FG000|Open-Label Period|Other: Sponsor Request|3|||
147213541|NCT00717236|530954213|FG001|Open-Label Period|Other: Sponsor Request|0|||
147213542|NCT00717236|530954212|FG000|Open-Label Period|Other: Cataract Surgery|1|||
147213543|NCT00717236|530954213|FG001|Open-Label Period|Other: Cataract Surgery|0|||
147213544|NCT00717236|530954212|FG000|Open-Label Period|Other: Administration of Golimumab|1|||
147213545|NCT00717236|530954213|FG001|Open-Label Period|Other: Administration of Golimumab|0|||
147213546|NCT00717236|530954212|FG000|Open-Label Period|Other: Completion Accidently Performed|1|||
147213547|NCT00717236|530954213|FG001|Open-Label Period|Other: Completion Accidently Performed|0|||
147213548|NCT00717236|530954212|FG000|Open-Label Period|Other: Medical Monitor Recommendation|1|||
147213549|NCT00717236|530954213|FG001|Open-Label Period|Other: Medical Monitor Recommendation|0|||
147213550|NCT01105767|530954214|FG000|Overall Study|Lost to Follow-up|1160|||
147213551|NCT01105767|530954215|FG001|Overall Study|Lost to Follow-up|1614|||
147213552|NCT01105767|530954216|FG002|Overall Study|Lost to Follow-up|1184|||
147213553|NCT00475982|530954217|FG000|Overall Study|surgery rescheduled|7|||
147213554|NCT00475982|530954218|FG001|Overall Study|surgery rescheduled|3|||
147213555|NCT00783198|530954224|FG000|Overall Study|Adverse Event|15|||
147213556|NCT00783198|530954225|FG001|Overall Study|Adverse Event|19|||
147213557|NCT00783198|530954226|FG002|Overall Study|Adverse Event|3|||
147213558|NCT00783198|530954224|FG000|Overall Study|Lost to Follow-up|11|||
147213559|NCT00783198|530954225|FG001|Overall Study|Lost to Follow-up|1|||
147213560|NCT00783198|530954226|FG002|Overall Study|Lost to Follow-up|7|||
147213561|NCT00783198|530954224|FG000|Overall Study|Withdrawal by Subject|22|||
147213562|NCT00783198|530954225|FG001|Overall Study|Withdrawal by Subject|14|||
147213563|NCT00783198|530954226|FG002|Overall Study|Withdrawal by Subject|20|||
147213564|NCT00783198|530954224|FG000|Overall Study|Noncompliance with protocol|7|||
147213565|NCT00783198|530954225|FG001|Overall Study|Noncompliance with protocol|7|||
147213566|NCT00783198|530954226|FG002|Overall Study|Noncompliance with protocol|10|||
147213567|NCT00783198|530954224|FG000|Overall Study|Did not meet protocol eligibility|0|||
147213568|NCT00783198|530954225|FG001|Overall Study|Did not meet protocol eligibility|1|||
147213569|NCT00783198|530954226|FG002|Overall Study|Did not meet protocol eligibility|0|||
147213570|NCT00783198|530954224|FG000|Overall Study|Administrative|2|||
147213571|NCT00783198|530954225|FG001|Overall Study|Administrative|1|||
147213572|NCT00783198|530954226|FG002|Overall Study|Administrative|2|||
147213573|NCT01510769|530954227|FG000|Overall Study|Adverse Event|7|||
147213574|NCT01510769|530954228|FG001|Overall Study|Adverse Event|6|||
147213575|NCT01510769|530954229|FG002|Overall Study|Adverse Event|4|||
147213576|NCT01510769|530954227|FG000|Overall Study|Gout Flare|0|||
147213577|NCT01510769|530954228|FG001|Overall Study|Gout Flare|3|||
147213578|NCT01510769|530954229|FG002|Overall Study|Gout Flare|1|||
147213579|NCT01510769|530954227|FG000|Overall Study|Protocol Violation|11|||
147213580|NCT01510769|530954228|FG001|Overall Study|Protocol Violation|10|||
147213581|NCT01510769|530954229|FG002|Overall Study|Protocol Violation|9|||
147213582|NCT01510769|530954227|FG000|Overall Study|Lost to Follow-up|5|||
147213583|NCT01510769|530954228|FG001|Overall Study|Lost to Follow-up|1|||
147213584|NCT01510769|530954229|FG002|Overall Study|Lost to Follow-up|5|||
147213585|NCT01510769|530954227|FG000|Overall Study|Withdrawal by Subject|3|||
147442226|NCT00111800|531784292|FG001|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|1|||
147442227|NCT00111800|531784293|FG002|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0|||
147442228|NCT00111800|531784294|FG003|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0|||
147442229|NCT00111800|531784295|FG004|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0|||
147442230|NCT00111800|531784296|FG005|Period 1: Main Phase (12 Weeks)|Lack of glycaemic control|0|||
147442231|NCT00111800|531784291|FG000|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|1|||
147442232|NCT00111800|531784292|FG001|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0|||
147442233|NCT00111800|531784293|FG002|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0|||
147442234|NCT00111800|531784294|FG003|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0|||
147442235|NCT00111800|531784295|FG004|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0|||
147442236|NCT00111800|531784296|FG005|Period 1: Main Phase (12 Weeks)|Discontinued for not receiving incentive|0|||
147442237|NCT00111800|531784291|FG000|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0|||
147442238|NCT00111800|531784292|FG001|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|1|||
147442239|NCT00111800|531784293|FG002|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0|||
147547129|NCT00382291|532160697|FG002|Overall Study|Physician Decision|0|||
147213586|NCT01510769|530954228|FG001|Overall Study|Withdrawal by Subject|4|||
147213587|NCT01510769|530954229|FG002|Overall Study|Withdrawal by Subject|3|||
147213588|NCT01510769|530954227|FG000|Overall Study|Death|1|||
147213589|NCT01510769|530954228|FG001|Overall Study|Death|1|||
147213590|NCT01510769|530954229|FG002|Overall Study|Death|0|||
147213591|NCT00929643|530954230|FG000|Overall Study|Protocol Violation|2|||
147213592|NCT02874144|530954231|FG000|Overall Study|Lost to Follow-up|3|||
147213593|NCT02874144|530954232|FG001|Overall Study|Lost to Follow-up|5|||
147213594|NCT01578850|530954236|FG000|Period 1|Insufficient Clinical Response|1|||
147213595|NCT01578850|530954237|FG001|Period 1|Insufficient Clinical Response|0|||
147213596|NCT01578850|530954238|FG002|Period 1|Insufficient Clinical Response|0|||
147442240|NCT00111800|531784294|FG003|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0|||
147442241|NCT00111800|531784295|FG004|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0|||
147442242|NCT00111800|531784296|FG005|Period 1: Main Phase (12 Weeks)|Would have been a drop out at Visit 4|0|||
147442243|NCT00111800|531784291|FG000|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0|||
147442244|NCT00111800|531784292|FG001|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|1|||
147442245|NCT00111800|531784293|FG002|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0|||
147442246|NCT00111800|531784294|FG003|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0|||
147442247|NCT00111800|531784295|FG004|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0|||
147442248|NCT00111800|531784296|FG005|Period 1: Main Phase (12 Weeks)|Fasting plasma glucose (FPG) below 140|0|||
147442249|NCT00111800|531784291|FG000|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0|||
147442250|NCT00111800|531784292|FG001|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|1|||
147442251|NCT00111800|531784293|FG002|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0|||
147442252|NCT00111800|531784294|FG003|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0|||
147442253|NCT00111800|531784295|FG004|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0|||
147442254|NCT00111800|531784296|FG005|Period 1: Main Phase (12 Weeks)|Elevated triglycerides|0|||
147442255|NCT00111800|531784291|FG000|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0|||
147442256|NCT00111800|531784292|FG001|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|1|||
147442257|NCT00111800|531784293|FG002|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0|||
147442258|NCT00111800|531784294|FG003|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0|||
147442259|NCT00111800|531784295|FG004|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0|||
147442260|NCT00111800|531784296|FG005|Period 1: Main Phase (12 Weeks)|Decrease in hemoglobin and hematocrit|0|||
147442261|NCT00111800|531784291|FG000|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0|||
147442262|NCT00111800|531784292|FG001|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0|||
147442263|NCT00111800|531784293|FG002|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0|||
147442264|NCT00111800|531784294|FG003|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|1|||
147442265|NCT00111800|531784295|FG004|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0|||
147442266|NCT00111800|531784296|FG005|Period 1: Main Phase (12 Weeks)|Other-Protocol violator|0|||
147442267|NCT00111800|531784291|FG000|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0|||
147442268|NCT00111800|531784292|FG001|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0|||
147442269|NCT00111800|531784293|FG002|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0|||
147442270|NCT00111800|531784294|FG003|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|1|||
147442271|NCT00111800|531784295|FG004|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0|||
147442272|NCT00111800|531784296|FG005|Period 1: Main Phase (12 Weeks)|Participant went on extended holiday|0|||
147442273|NCT00111800|531784291|FG000|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0|||
147442274|NCT00111800|531784292|FG001|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0|||
147442275|NCT00111800|531784293|FG002|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0|||
147442276|NCT00111800|531784294|FG003|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0|||
147442277|NCT00111800|531784295|FG004|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|1|||
147442278|NCT00111800|531784296|FG005|Period 1: Main Phase (12 Weeks)|Participant's study medication stolen|0|||
147442279|NCT00111800|531784291|FG000|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0|||
147442280|NCT00111800|531784292|FG001|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0|||
147442281|NCT00111800|531784293|FG002|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0|||
147442282|NCT00111800|531784294|FG003|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0|||
147442283|NCT00111800|531784295|FG004|Period 1: Main Phase (12 Weeks)|Participant moved out of area|1|||
147442284|NCT00111800|531784296|FG005|Period 1: Main Phase (12 Weeks)|Participant moved out of area|0|||
147442285|NCT00111800|531784291|FG000|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0|||
147442286|NCT00111800|531784292|FG001|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0|||
147442287|NCT00111800|531784293|FG002|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0|||
147442288|NCT00111800|531784294|FG003|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0|||
147442289|NCT00111800|531784295|FG004|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|0|||
147442290|NCT00111800|531784296|FG005|Period 1: Main Phase (12 Weeks)|Sponsor requested withdrawal|1|||
147442291|NCT00111800|531784291|FG000|Period 2: Extension Phase (12 Weeks)|Adverse Event|0|||
147442292|NCT00111800|531784292|FG001|Period 2: Extension Phase (12 Weeks)|Adverse Event|2|||
147442293|NCT00111800|531784293|FG002|Period 2: Extension Phase (12 Weeks)|Adverse Event|1|||
147442294|NCT00111800|531784294|FG003|Period 2: Extension Phase (12 Weeks)|Adverse Event|3|||
147442295|NCT00111800|531784295|FG004|Period 2: Extension Phase (12 Weeks)|Adverse Event|0|||
147213597|NCT01578850|530954236|FG000|Period 1|Adverse Event|11|||
147213598|NCT01578850|530954237|FG001|Period 1|Adverse Event|0|||
147213599|NCT01578850|530954238|FG002|Period 1|Adverse Event|0|||
147213600|NCT01578850|530954236|FG000|Period 1|Death|1|||
147213601|NCT01578850|530954237|FG001|Period 1|Death|0|||
147213602|NCT01578850|530954238|FG002|Period 1|Death|0|||
147213603|NCT01578850|530954236|FG000|Period 1|Does Not Meet Entrance Criteria|12|||
147213604|NCT01578850|530954237|FG001|Period 1|Does Not Meet Entrance Criteria|0|||
147213605|NCT01578850|530954238|FG002|Period 1|Does Not Meet Entrance Criteria|0|||
147213606|NCT01578850|530954236|FG000|Period 1|Withdrawal by Subject|9|||
147213607|NCT01578850|530954237|FG001|Period 1|Withdrawal by Subject|0|||
147213608|NCT01578850|530954238|FG002|Period 1|Withdrawal by Subject|0|||
147213609|NCT01578850|530954236|FG000|Period 1|Study Terminated by Sponsor|3|||
147213610|NCT01578850|530954237|FG001|Period 1|Study Terminated by Sponsor|0|||
147213611|NCT01578850|530954238|FG002|Period 1|Study Terminated by Sponsor|0|||
147213612|NCT01578850|530954236|FG000|Period 2|Insufficient Clinical Response|0|||
147213613|NCT01578850|530954237|FG001|Period 2|Insufficient Clinical Response|1|||
147213614|NCT01578850|530954238|FG002|Period 2|Insufficient Clinical Response|0|||
147213615|NCT01578850|530954236|FG000|Period 2|Adverse Event|0|||
147213616|NCT01578850|530954237|FG001|Period 2|Adverse Event|3|||
147213617|NCT01578850|530954238|FG002|Period 2|Adverse Event|6|||
147213618|NCT01578850|530954236|FG000|Period 2|Lost to Follow-up|0|||
147213619|NCT01578850|530954237|FG001|Period 2|Lost to Follow-up|1|||
147213620|NCT01578850|530954238|FG002|Period 2|Lost to Follow-up|2|||
147213621|NCT01578850|530954236|FG000|Period 2|Withdrawal by Subject|0|||
147213622|NCT01578850|530954237|FG001|Period 2|Withdrawal by Subject|2|||
147213623|NCT01578850|530954238|FG002|Period 2|Withdrawal by Subject|2|||
147213624|NCT01578850|530954236|FG000|Period 2|Study Terminated by Sponsor|0|||
147213625|NCT01578850|530954237|FG001|Period 2|Study Terminated by Sponsor|5|||
147213626|NCT01578850|530954238|FG002|Period 2|Study Terminated by Sponsor|4|||
147213627|NCT01578850|530954236|FG000|Period 2|Unspecified Reasons|0|||
147213628|NCT01578850|530954237|FG001|Period 2|Unspecified Reasons|1|||
147213629|NCT01578850|530954238|FG002|Period 2|Unspecified Reasons|0|||
147213630|NCT01711216|530954239|FG000|Overall Study|Adverse Event|4|||
147213631|NCT01711216|530954239|FG000|Overall Study|Pregnancy|56|||
147213632|NCT01711216|530954239|FG000|Overall Study|Withdrawal by Subject|6|||
147213633|NCT01711216|530954239|FG000|Overall Study|Lost to Follow-up|46|||
147213634|NCT01711216|530954239|FG000|Overall Study|variety of other minor reasons|83|||
147213635|NCT01711216|530954239|FG000|Overall Study|no reason specified|22|||
147213636|NCT02228980|530954240|FG000|Overall Study|Adverse Event|14|||
147213637|NCT02228980|530954241|FG001|Overall Study|Adverse Event|0|||
147213638|NCT02228980|530954242|FG002|Overall Study|Adverse Event|0|||
147213639|NCT02228980|530954243|FG003|Overall Study|Adverse Event|0|||
147213640|NCT02228980|530954240|FG000|Overall Study|Protocol Violation|7|||
147213641|NCT02228980|530954241|FG001|Overall Study|Protocol Violation|0|||
147213642|NCT02228980|530954242|FG002|Overall Study|Protocol Violation|0|||
147213643|NCT02228980|530954243|FG003|Overall Study|Protocol Violation|0|||
147213644|NCT02228980|530954240|FG000|Overall Study|Withdrawal by Subject|3|||
147213645|NCT02228980|530954241|FG001|Overall Study|Withdrawal by Subject|3|||
147213646|NCT02228980|530954242|FG002|Overall Study|Withdrawal by Subject|2|||
147213647|NCT02228980|530954243|FG003|Overall Study|Withdrawal by Subject|3|||
147213648|NCT02929498|530954244|FG000|Part 1: Dose Confirmation (Upto 2 Years)|Study terminated by sponsor|3|||
147213649|NCT02929498|530954245|FG001|Part 1: Dose Confirmation (Upto 2 Years)|Study terminated by sponsor|0|||
147213650|NCT02929498|530954246|FG002|Part 1: Dose Confirmation (Upto 2 Years)|Study terminated by sponsor|0|||
147213651|NCT02929498|530954244|FG000|Part 1: Dose Confirmation (Upto 2 Years)|Death|2|||
147213652|NCT02929498|530954245|FG001|Part 1: Dose Confirmation (Upto 2 Years)|Death|0|||
147213653|NCT02929498|530954246|FG002|Part 1: Dose Confirmation (Upto 2 Years)|Death|0|||
147213654|NCT00750152|530954249|FG000|Overall Study|Adverse Event|2|||
147213655|NCT00750152|530954250|FG001|Overall Study|Adverse Event|1|||
147213656|NCT00750152|530954249|FG000|Overall Study|Lost to Follow-up|8|||
147213657|NCT00750152|530954250|FG001|Overall Study|Lost to Follow-up|13|||
147213658|NCT00750152|530954249|FG000|Overall Study|Withdrawal by Subject|3|||
147442296|NCT00111800|531784296|FG005|Period 2: Extension Phase (12 Weeks)|Adverse Event|0|||
147213659|NCT00750152|530954250|FG001|Overall Study|Withdrawal by Subject|3|||
147213660|NCT00750152|530954249|FG000|Overall Study|Physician Decision|1|||
147213661|NCT00750152|530954250|FG001|Overall Study|Physician Decision|1|||
147213662|NCT00750152|530954249|FG000|Overall Study|Non-compliance|0|||
147213663|NCT00750152|530954250|FG001|Overall Study|Non-compliance|1|||
147213664|NCT00750152|530954249|FG000|Overall Study|Termination by sponsor|1|||
147213665|NCT00750152|530954250|FG001|Overall Study|Termination by sponsor|0|||
147213666|NCT00750152|530954249|FG000|Overall Study|Other|7|||
147442297|NCT00111800|531784291|FG000|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0|||
147442298|NCT00111800|531784292|FG001|Period 2: Extension Phase (12 Weeks)|Protocol Violation|1|||
147213667|NCT00750152|530954250|FG001|Overall Study|Other|8|||
147213668|NCT01028300|530954251|FG000|Overall Study|Study Terminated|4|||
147213669|NCT00715910|530954252|FG000|Booster and ESFU Phase|Lost to Follow-up|0|||
147213670|NCT00715910|530954253|FG001|Booster and ESFU Phase|Lost to Follow-up|0|||
147213671|NCT00715910|530954254|FG002|Booster and ESFU Phase|Lost to Follow-up|0|||
147213672|NCT00715910|530954255|FG003|Booster and ESFU Phase|Lost to Follow-up|6|||
147547130|NCT00382291|532160695|FG000|Overall Study|Lack of Efficacy|0|||
147547131|NCT00382291|532160696|FG001|Overall Study|Lack of Efficacy|0|||
147547132|NCT00382291|532160697|FG002|Overall Study|Lack of Efficacy|1|||
147547133|NCT02266706|532160698|FG000|Overall Study|Withdrawal by Subject|0|||
147547134|NCT02266706|532160699|FG001|Overall Study|Withdrawal by Subject|1|||
147547135|NCT02266706|532160700|FG002|Overall Study|Withdrawal by Subject|1|||
147547136|NCT02266706|532160701|FG003|Overall Study|Withdrawal by Subject|0|||
147547137|NCT02266706|532160702|FG004|Overall Study|Withdrawal by Subject|0|||
147547138|NCT02266706|532160703|FG005|Overall Study|Withdrawal by Subject|1|||
147547139|NCT02266706|532160704|FG006|Overall Study|Withdrawal by Subject|0|||
147547140|NCT02266706|532160705|FG007|Overall Study|Withdrawal by Subject|0|||
147547141|NCT02266706|532160706|FG008|Overall Study|Withdrawal by Subject|0|||
147547142|NCT02266706|532160698|FG000|Overall Study|Screen failure|0|||
147547143|NCT02266706|532160699|FG001|Overall Study|Screen failure|0|||
147547144|NCT02266706|532160700|FG002|Overall Study|Screen failure|0|||
147547145|NCT02266706|532160701|FG003|Overall Study|Screen failure|0|||
147547146|NCT02266706|532160702|FG004|Overall Study|Screen failure|0|||
147547147|NCT02266706|532160703|FG005|Overall Study|Screen failure|1|||
147547148|NCT02266706|532160704|FG006|Overall Study|Screen failure|1|||
147547149|NCT02266706|532160705|FG007|Overall Study|Screen failure|0|||
147547150|NCT02266706|532160706|FG008|Overall Study|Screen failure|0|||
147547151|NCT02266706|532160698|FG000|Overall Study|Enrollment in another study|0|||
147547152|NCT02266706|532160699|FG001|Overall Study|Enrollment in another study|0|||
147547153|NCT02266706|532160700|FG002|Overall Study|Enrollment in another study|0|||
147547154|NCT02266706|532160701|FG003|Overall Study|Enrollment in another study|1|||
147547155|NCT02266706|532160702|FG004|Overall Study|Enrollment in another study|0|||
147547156|NCT02266706|532160703|FG005|Overall Study|Enrollment in another study|0|||
147547157|NCT02266706|532160704|FG006|Overall Study|Enrollment in another study|0|||
147547158|NCT02266706|532160705|FG007|Overall Study|Enrollment in another study|0|||
147547159|NCT02266706|532160706|FG008|Overall Study|Enrollment in another study|0|||
147547160|NCT01977352|532160707|FG000|Overall Study|Lost to Follow-up|1|||
147547161|NCT01977352|532160708|FG001|Overall Study|Lost to Follow-up|2|||
147547162|NCT00409188|532160709|FG000|Overall Study|Ongoing at data cut-off|383|||
147213673|NCT00715910|530954256|FG004|Booster and ESFU Phase|Lost to Follow-up|1|||
147213674|NCT00715910|530954257|FG005|Booster and ESFU Phase|Lost to Follow-up|13|||
147213675|NCT00715910|530954252|FG000|Booster and ESFU Phase|Other|0|||
147213676|NCT00715910|530954253|FG001|Booster and ESFU Phase|Other|0|||
147213677|NCT00715910|530954254|FG002|Booster and ESFU Phase|Other|0|||
147213678|NCT00715910|530954255|FG003|Booster and ESFU Phase|Other|5|||
147213679|NCT00715910|530954256|FG004|Booster and ESFU Phase|Other|1|||
147213680|NCT00715910|530954257|FG005|Booster and ESFU Phase|Other|0|||
147213681|NCT03698591|530954258|FG000|Overall Study|Withdrawal by Subject|2|||
147213682|NCT03698591|530954259|FG001|Overall Study|Withdrawal by Subject|2|||
147213683|NCT03698591|530954258|FG000|Overall Study|Failed drug screen|1|||
147213684|NCT03698591|530954259|FG001|Overall Study|Failed drug screen|1|||
147213685|NCT03698591|530954258|FG000|Overall Study|Failed health screen|0|||
147547163|NCT00409188|532160710|FG001|Overall Study|Ongoing at data cut-off|175|||
147547164|NCT01169649|532160720|FG000|Overall Study|Patient Not Treated|3|||
147547165|NCT00534092|532160721|FG000|Overall Study|Lost to Follow-up|1|||
147547166|NCT00534092|532160722|FG001|Overall Study|Lost to Follow-up|0|||
147547167|NCT00534092|532160721|FG000|Overall Study|personal reasons/family concerns|1|||
147547168|NCT00534092|532160722|FG001|Overall Study|personal reasons/family concerns|0|||
147547169|NCT02919475|532160723|FG000|Overall Study|Adverse Event|3|||
147547170|NCT02919475|532160724|FG001|Overall Study|Adverse Event|3|||
147547171|NCT02919475|532160725|FG002|Overall Study|Adverse Event|3|||
147547172|NCT02919475|532160726|FG003|Overall Study|Adverse Event|9|||
147547173|NCT02919475|532160727|FG004|Overall Study|Adverse Event|2|||
147547174|NCT02919475|532160723|FG000|Overall Study|Death|0|||
147547175|NCT02919475|532160724|FG001|Overall Study|Death|1|||
147547176|NCT02919475|532160725|FG002|Overall Study|Death|0|||
147547177|NCT02919475|532160726|FG003|Overall Study|Death|0|||
147547178|NCT02919475|532160727|FG004|Overall Study|Death|0|||
147547179|NCT02919475|532160723|FG000|Overall Study|Lost to Follow-up|0|||
147547180|NCT02919475|532160724|FG001|Overall Study|Lost to Follow-up|0|||
147547181|NCT02919475|532160725|FG002|Overall Study|Lost to Follow-up|0|||
147547182|NCT02919475|532160726|FG003|Overall Study|Lost to Follow-up|1|||
147547183|NCT02919475|532160727|FG004|Overall Study|Lost to Follow-up|0|||
147547184|NCT02919475|532160723|FG000|Overall Study|Withdrawal by Subject|2|||
147547185|NCT02919475|532160724|FG001|Overall Study|Withdrawal by Subject|3|||
147213686|NCT03698591|530954259|FG001|Overall Study|Failed health screen|1|||
147213687|NCT03698591|530954258|FG000|Overall Study|Ineligible for financial compensation|1|||
147547186|NCT02919475|532160725|FG002|Overall Study|Withdrawal by Subject|1|||
147547187|NCT02919475|532160726|FG003|Overall Study|Withdrawal by Subject|2|||
147547188|NCT02919475|532160727|FG004|Overall Study|Withdrawal by Subject|2|||
147547189|NCT02919475|532160723|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
147547190|NCT02919475|532160724|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
147547191|NCT02919475|532160725|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
147547192|NCT02919475|532160726|FG003|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
147547193|NCT02919475|532160727|FG004|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
147547194|NCT02323295|532160734|FG000|Overall Study|Adverse Event|0|||
147547195|NCT02323295|532160735|FG001|Overall Study|Adverse Event|1|||
147547196|NCT02323295|532160734|FG000|Overall Study|Withdrawal by Subject|0|||
147547197|NCT02323295|532160735|FG001|Overall Study|Withdrawal by Subject|1|||
147547198|NCT02323295|532160734|FG000|Overall Study|Patient did not have surgery as planned.|0|||
147547199|NCT02323295|532160735|FG001|Overall Study|Patient did not have surgery as planned.|1|||
147547200|NCT02370784|532160736|FG000|Overall Study|Patient started prohibited medication|0|||
147547201|NCT02370784|532160737|FG001|Overall Study|Patient started prohibited medication|1|||
147547202|NCT00775983|532160739|FG000|Overall Study|Protocol Violation|1|||
147547203|NCT00775983|532160740|FG001|Overall Study|Protocol Violation|2|||
147547204|NCT01059071|532160741|FG000|Overall Study|Lack of Efficacy|1|||
147547205|NCT01059071|532160742|FG001|Overall Study|Lack of Efficacy|4|||
147547206|NCT01059071|532160743|FG002|Overall Study|Lack of Efficacy|2|||
147547207|NCT01059071|532160744|FG003|Overall Study|Lack of Efficacy|3|||
147547208|NCT01059071|532160741|FG000|Overall Study|Withdrawal by Subject|1|||
147547209|NCT01059071|532160742|FG001|Overall Study|Withdrawal by Subject|0|||
147547210|NCT01059071|532160743|FG002|Overall Study|Withdrawal by Subject|0|||
147547211|NCT01059071|532160744|FG003|Overall Study|Withdrawal by Subject|2|||
147547212|NCT01059071|532160741|FG000|Overall Study|Physician Decision|0|||
147547213|NCT01059071|532160742|FG001|Overall Study|Physician Decision|0|||
147547214|NCT01059071|532160743|FG002|Overall Study|Physician Decision|0|||
147547215|NCT01059071|532160744|FG003|Overall Study|Physician Decision|1|||
147547216|NCT04741503|532160747|FG000|Initial Enrollment|Failed to meet screening criteria|0|||
147547217|NCT04741503|532160748|FG001|Initial Enrollment|Failed to meet screening criteria|0|||
147547218|NCT04741503|532160749|FG002|Initial Enrollment|Failed to meet screening criteria|767|||
147547219|NCT04741503|532160747|FG000|Initial Enrollment|Overquotas removed|0|||
147547220|NCT04741503|532160748|FG001|Initial Enrollment|Overquotas removed|0|||
147547221|NCT04741503|532160749|FG002|Initial Enrollment|Overquotas removed|186|||
147547222|NCT04741503|532160747|FG000|Met Protocol Criteria for Data Inclusion|Removed from study for not meeting protocol criteria for free responses to knowledge questions|23|||
147547223|NCT04741503|532160748|FG001|Met Protocol Criteria for Data Inclusion|Removed from study for not meeting protocol criteria for free responses to knowledge questions|17|||
147547224|NCT04741503|532160749|FG002|Met Protocol Criteria for Data Inclusion|Removed from study for not meeting protocol criteria for free responses to knowledge questions|0|||
147547225|NCT01663714|532160750|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|3|||
147547226|NCT01663714|532160750|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|11|||
147547227|NCT01663714|532160750|FG000|Dosimetric and Therapeutic Treatment|Rolled Over to Study BEX104528|16|||
147547228|NCT01663714|532160750|FG000|Long-Term Follow-Up|Lost to Follow-up|1|||
147547229|NCT01663714|532160750|FG000|Long-Term Follow-Up|Death|4|||
147547230|NCT01663714|532160750|FG000|Long-Term Follow-Up|Non-compliance|1|||
147547231|NCT02280421|532160753|FG000|Washout (2 Weeks)|Adverse Event|0|||
147547232|NCT02280421|532160754|FG001|Washout (2 Weeks)|Adverse Event|1|||
147547233|NCT02280421|532160753|FG000|Washout (2 Weeks)|Withdrawal by Subject|1|||
147547234|NCT02280421|532160754|FG001|Washout (2 Weeks)|Withdrawal by Subject|0|||
147547235|NCT00515073|532160755|FG000|Overall Study|Withdrawal by Subject|1|||
147547236|NCT00515073|532160755|FG000|Overall Study|Physician Decision|1|||
147547237|NCT02764489|532160756|FG000|Part 1: Day 1 up to Day 16|Adverse Event|2|||
147547238|NCT02764489|532160757|FG001|Part 1: Day 1 up to Day 16|Adverse Event|0|||
147547239|NCT02764489|532160756|FG000|Part 1: Day 1 up to Day 16|Withdrawal by Subject|1|||
147547240|NCT02764489|532160757|FG001|Part 1: Day 1 up to Day 16|Withdrawal by Subject|0|||
147547241|NCT02764489|532160756|FG000|Part 2: Day 19 up to Day 41|Adverse Event|1|||
147547242|NCT02764489|532160757|FG001|Part 2: Day 19 up to Day 41|Adverse Event|0|||
147547243|NCT02764489|532160756|FG000|Part 2: Day 19 up to Day 41|Physician Decision|1|||
147547244|NCT02764489|532160757|FG001|Part 2: Day 19 up to Day 41|Physician Decision|0|||
147547245|NCT03840811|532160758|FG000|Overall Study|Lost to Follow-up|0|||
147547246|NCT03840811|532160759|FG001|Overall Study|Lost to Follow-up|0|||
147547247|NCT03840811|532160760|FG002|Overall Study|Lost to Follow-up|1|||
147547248|NCT01904383|532160761|FG000|Overall Study|CRF not collected|117|||
147547249|NCT01904383|532160761|FG000|Overall Study|Reason not listed|147|||
147547250|NCT01904383|532160761|FG000|Overall Study|Lost to Follow-up|674|||
147547251|NCT01904383|532160761|FG000|Overall Study|Lack of Efficacy|370|||
147547252|NCT01904383|532160761|FG000|Overall Study|Improvement|141|||
147547253|NCT01904383|532160761|FG000|Overall Study|Adverse Event|271|||
147547254|NCT01904383|532160761|FG000|Overall Study|No patient visit after entry|54|||
147547255|NCT01625845|532160762|FG000|Overall Study|Adverse Event|1|||
147547256|NCT01625845|532160763|FG001|Overall Study|Adverse Event|2|||
147547257|NCT01625845|532160762|FG000|Overall Study|Lost to Follow-up|2|||
147547258|NCT01625845|532160763|FG001|Overall Study|Lost to Follow-up|1|||
147547259|NCT01625845|532160762|FG000|Overall Study|Withdrawal by Subject|2|||
147547260|NCT01625845|532160763|FG001|Overall Study|Withdrawal by Subject|0|||
147547261|NCT02853929|532160764|FG000|Overall Study|Lost to Follow-up|3|||
147547262|NCT02853929|532160765|FG001|Overall Study|Lost to Follow-up|0|||
147547263|NCT02853929|532160764|FG000|Overall Study|Withdrawal by Subject|1|||
147547264|NCT02853929|532160765|FG001|Overall Study|Withdrawal by Subject|0|||
147547265|NCT02853929|532160764|FG000|Overall Study|Subjects enrolled but not vaccinated|7|||
147547266|NCT02853929|532160765|FG001|Overall Study|Subjects enrolled but not vaccinated|4|||
147547267|NCT01294592|532160766|FG000|Overall Study|Adverse Event|28|||
147547268|NCT01294592|532160767|FG001|Overall Study|Adverse Event|13|||
147547269|NCT01294592|532160766|FG000|Overall Study|Lack of Efficacy|7|||
147547270|NCT01294592|532160767|FG001|Overall Study|Lack of Efficacy|5|||
147547271|NCT01294592|532160766|FG000|Overall Study|Protocol Violation|1|||
147547272|NCT01294592|532160767|FG001|Overall Study|Protocol Violation|7|||
147547273|NCT01294592|532160766|FG000|Overall Study|Lost to Follow-up|7|||
147547274|NCT01294592|532160767|FG001|Overall Study|Lost to Follow-up|9|||
147547275|NCT01294592|532160766|FG000|Overall Study|Physician Decision|6|||
147547276|NCT01294592|532160767|FG001|Overall Study|Physician Decision|11|||
147547277|NCT01294592|532160766|FG000|Overall Study|Withdrawal by Subject|28|||
147547278|NCT01294592|532160767|FG001|Overall Study|Withdrawal by Subject|28|||
147547279|NCT00693784|532160768|FG000|Overall Study|Lost to Follow-up|2|||
147547280|NCT00693784|532160768|FG000|Overall Study|Withdrawal by Subject|2|||
147547281|NCT00326885|532160772|FG000|Overall Study|Adverse Event|1|||
147547282|NCT00326885|532160772|FG000|Overall Study|Withdrawal by Subject|3|||
147547283|NCT00326885|532160772|FG000|Overall Study|Physician Decision|1|||
147547284|NCT00326885|532160772|FG000|Overall Study|Hospice withdrew consent|2|||
147547285|NCT01703741|532160776|FG000|Overall Study|Withdrawal by Subject|6|||
147547286|NCT01703741|532160776|FG000|Overall Study|Adverse Event|2|||
147547287|NCT01703741|532160776|FG000|Overall Study|Physician Decision|2|||
147547288|NCT01703741|532160776|FG000|Overall Study|Protocol Violation|1|||
147547289|NCT01703741|532160776|FG000|Overall Study|Lost to Follow-up|3|||
147547290|NCT01703741|532160776|FG000|Overall Study|Subject did not want to continue|2|||
147547291|NCT01703741|532160776|FG000|Overall Study|Subject cannot comply with study visits|1|||
147547292|NCT01703741|532160776|FG000|Overall Study|Subject started testosterone injections|1|||
147547293|NCT01717456|532160777|FG000|End of Treatment|Physician Decision|0|||
147547294|NCT01717456|532160778|FG001|End of Treatment|Physician Decision|1|||
147547295|NCT01717456|532160777|FG000|End of Treatment|Lost to Follow-up|0|||
147547296|NCT01717456|532160778|FG001|End of Treatment|Lost to Follow-up|1|||
147547297|NCT01717456|532160777|FG000|Follow-Up 6 Months After End of Tx|Lost to Follow-up|4|||
147547298|NCT01717456|532160778|FG001|Follow-Up 6 Months After End of Tx|Lost to Follow-up|4|||
147547299|NCT00837577|532160779|FG000|Double-blind Period|Clinical Adverse Event|1|||
147547300|NCT00837577|532160780|FG001|Double-blind Period|Clinical Adverse Event|0|||
147547301|NCT00837577|532160779|FG000|Double-blind Period|Withdrawal by Subject|1|||
147547302|NCT00837577|532160780|FG001|Double-blind Period|Withdrawal by Subject|0|||
147547303|NCT00837577|532160779|FG000|Open-label Period|Clinical Adverse Event|2|||
147547304|NCT00837577|532160780|FG001|Open-label Period|Clinical Adverse Event|2|||
147547305|NCT00837577|532160779|FG000|Open-label Period|Laboratory Adverse Event|0|||
147547306|NCT00837577|532160780|FG001|Open-label Period|Laboratory Adverse Event|1|||
147547307|NCT00837577|532160779|FG000|Open-label Period|Lack of Efficacy|4|||
147547308|NCT00837577|532160780|FG001|Open-label Period|Lack of Efficacy|3|||
147547309|NCT00837577|532160779|FG000|Open-label Period|Withdrawal by Subject|1|||
147547310|NCT00837577|532160780|FG001|Open-label Period|Withdrawal by Subject|2|||
147547311|NCT00837577|532160779|FG000|Open-label Period|Other Reason|1|||
147547312|NCT00837577|532160780|FG001|Open-label Period|Other Reason|1|||
147547313|NCT00986154|532160781|FG000|Overall Study|Death|136|||
147547314|NCT00986154|532160782|FG001|Overall Study|Death|127|||
147547315|NCT00986154|532160781|FG000|Overall Study|Lost to Follow-up|7|||
147547316|NCT00986154|532160782|FG001|Overall Study|Lost to Follow-up|4|||
147547317|NCT00986154|532160781|FG000|Overall Study|Withdrawal by Subject|32|||
147547318|NCT00986154|532160782|FG001|Overall Study|Withdrawal by Subject|33|||
147547319|NCT00986154|532160781|FG000|Overall Study|investigator/subject decide not continue|6|||
147547320|NCT00986154|532160782|FG001|Overall Study|investigator/subject decide not continue|3|||
147547321|NCT00986154|532160781|FG000|Overall Study|never received study drug|25|||
147547322|NCT00986154|532160782|FG001|Overall Study|never received study drug|27|||
147547323|NCT00033631|532160784|FG000|Overall Study|Protocol Violation|14|||
147547324|NCT00033631|532160785|FG001|Overall Study|Protocol Violation|11|||
147547325|NCT00033631|532160784|FG000|Overall Study|Withdrawal by Subject|4|||
147547326|NCT00033631|532160785|FG001|Overall Study|Withdrawal by Subject|4|||
147547327|NCT00272961|532160788|FG000|Placebo Run-in Phase: Up to Week 2|Physician Decision|1|||
147547328|NCT00272961|532160789|FG001|Placebo Run-in Phase: Up to Week 2|Physician Decision|0|||
147547329|NCT00272961|532160790|FG002|Placebo Run-in Phase: Up to Week 2|Physician Decision|0|||
147547330|NCT00272961|532160791|FG003|Placebo Run-in Phase: Up to Week 2|Physician Decision|0|||
147547331|NCT00272961|532160792|FG004|Placebo Run-in Phase: Up to Week 2|Physician Decision|0|||
147547332|NCT00272961|532160788|FG000|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|1|||
147547333|NCT00272961|532160789|FG001|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0|||
147547334|NCT00272961|532160790|FG002|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0|||
147547335|NCT00272961|532160791|FG003|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0|||
147547336|NCT00272961|532160792|FG004|Placebo Run-in Phase: Up to Week 2|Sponsor Decision|0|||
147547337|NCT00272961|532160788|FG000|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|5|||
147547338|NCT00272961|532160789|FG001|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0|||
147547339|NCT00272961|532160790|FG002|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0|||
147213688|NCT03698591|530954259|FG001|Overall Study|Ineligible for financial compensation|0|||
147213689|NCT03698591|530954258|FG000|Overall Study|Equipment Error|1|||
147213690|NCT03698591|530954259|FG001|Overall Study|Equipment Error|0|||
147213691|NCT03698591|530954258|FG000|Overall Study|Could not establish TMS dosage|0|||
147213692|NCT03698591|530954259|FG001|Overall Study|Could not establish TMS dosage|1|||
147213693|NCT01165216|530954260|FG000|Overall Study|Adverse Event|6|||
147213694|NCT01165216|530954261|FG001|Overall Study|Adverse Event|3|||
147213695|NCT01165216|530954260|FG000|Overall Study|Withdrawal by Subject|1|||
147213696|NCT01165216|530954261|FG001|Overall Study|Withdrawal by Subject|1|||
147213697|NCT01165216|530954260|FG000|Overall Study|Disease progression|1|||
147213698|NCT01165216|530954261|FG001|Overall Study|Disease progression|3|||
147213699|NCT01379508|530954264|FG000|Treatment to Week 104|Adverse Event|2|||
147213700|NCT01379508|530954265|FG001|Treatment to Week 104|Adverse Event|0|||
147213701|NCT01379508|530954266|FG002|Treatment to Week 104|Adverse Event|5|||
147213702|NCT01379508|530954267|FG003|Treatment to Week 104|Adverse Event|0|||
147213703|NCT01379508|530954264|FG000|Treatment to Week 104|Abnormal lab value|1|||
147213704|NCT01379508|530954265|FG001|Treatment to Week 104|Abnormal lab value|0|||
147213705|NCT01379508|530954266|FG002|Treatment to Week 104|Abnormal lab value|0|||
147213706|NCT01379508|530954267|FG003|Treatment to Week 104|Abnormal lab value|0|||
147213707|NCT01379508|530954264|FG000|Treatment to Week 104|Abnormal test procedure result(s)|1|||
147213708|NCT01379508|530954265|FG001|Treatment to Week 104|Abnormal test procedure result(s)|0|||
147213709|NCT01379508|530954266|FG002|Treatment to Week 104|Abnormal test procedure result(s)|0|||
147213710|NCT01379508|530954267|FG003|Treatment to Week 104|Abnormal test procedure result(s)|0|||
147213711|NCT01379508|530954264|FG000|Treatment to Week 104|Withdrawal by Subject|6|||
147213712|NCT01379508|530954265|FG001|Treatment to Week 104|Withdrawal by Subject|1|||
147213713|NCT01379508|530954266|FG002|Treatment to Week 104|Withdrawal by Subject|4|||
147213714|NCT01379508|530954267|FG003|Treatment to Week 104|Withdrawal by Subject|0|||
147213715|NCT01379508|530954264|FG000|Treatment to Week 104|Lost to Follow-up|5|||
147213716|NCT01379508|530954265|FG001|Treatment to Week 104|Lost to Follow-up|0|||
147213717|NCT01379508|530954266|FG002|Treatment to Week 104|Lost to Follow-up|3|||
147213718|NCT01379508|530954267|FG003|Treatment to Week 104|Lost to Follow-up|0|||
147213719|NCT01379508|530954264|FG000|Treatment to Week 104|Administrative problems|3|||
147213720|NCT01379508|530954265|FG001|Treatment to Week 104|Administrative problems|1|||
147213721|NCT01379508|530954266|FG002|Treatment to Week 104|Administrative problems|0|||
147213722|NCT01379508|530954267|FG003|Treatment to Week 104|Administrative problems|0|||
147213723|NCT01379508|530954264|FG000|Treatment to Week 104|Protocol Violation|1|||
147213724|NCT01379508|530954265|FG001|Treatment to Week 104|Protocol Violation|1|||
147213725|NCT01379508|530954266|FG002|Treatment to Week 104|Protocol Violation|1|||
147213726|NCT01379508|530954267|FG003|Treatment to Week 104|Protocol Violation|0|||
147213727|NCT01379508|530954264|FG000|Extension Period Weeks 109-156|Withdrawal by Subject|8|||
147213728|NCT01379508|530954265|FG001|Extension Period Weeks 109-156|Withdrawal by Subject|1|||
147213729|NCT01379508|530954266|FG002|Extension Period Weeks 109-156|Withdrawal by Subject|8|||
147213730|NCT01379508|530954267|FG003|Extension Period Weeks 109-156|Withdrawal by Subject|0|||
147213731|NCT01379508|530954264|FG000|Extension Period Weeks 109-156|Lost to Follow-up|6|||
147213732|NCT01379508|530954265|FG001|Extension Period Weeks 109-156|Lost to Follow-up|1|||
147213733|NCT01379508|530954266|FG002|Extension Period Weeks 109-156|Lost to Follow-up|5|||
147213734|NCT01379508|530954267|FG003|Extension Period Weeks 109-156|Lost to Follow-up|0|||
147213735|NCT01379508|530954264|FG000|Extension Period Weeks 109-156|Administrative problems|3|||
147213736|NCT01379508|530954265|FG001|Extension Period Weeks 109-156|Administrative problems|0|||
147213737|NCT01379508|530954266|FG002|Extension Period Weeks 109-156|Administrative problems|1|||
147213738|NCT01379508|530954267|FG003|Extension Period Weeks 109-156|Administrative problems|0|||
147213739|NCT01379508|530954264|FG000|Extension Period Weeks 109-156|Protocol Violation|2|||
147213740|NCT01379508|530954265|FG001|Extension Period Weeks 109-156|Protocol Violation|1|||
147213741|NCT01379508|530954266|FG002|Extension Period Weeks 109-156|Protocol Violation|0|||
147213742|NCT01379508|530954267|FG003|Extension Period Weeks 109-156|Protocol Violation|0|||
147213743|NCT02626624|530954270|FG000|Overall Study|Adverse Event|1|||
147213744|NCT02626624|530954270|FG000|Overall Study|Lost to Follow-up|3|||
147213745|NCT02626624|530954270|FG000|Overall Study|Protocol Violation|4|||
147213746|NCT02626624|530954270|FG000|Overall Study|Death|2|||
147213747|NCT03338959|530956404|FG000|Overall Study|Patients remain in Long-Term Follow-Up|17|||
147213748|NCT03338959|530956404|FG000|Overall Study|Physician Decision|1|||
147213749|NCT00409331|530956409|FG000|Overall Study|Physician Decision|1|||
147213750|NCT02184455|530956410|FG000|Overall Study|Lost to Follow-up|1|||
147442299|NCT00111800|531784293|FG002|Period 2: Extension Phase (12 Weeks)|Protocol Violation|1|||
147442300|NCT00111800|531784294|FG003|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0|||
147442301|NCT00111800|531784295|FG004|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0|||
147442302|NCT00111800|531784296|FG005|Period 2: Extension Phase (12 Weeks)|Protocol Violation|0|||
147442303|NCT00111800|531784291|FG000|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|0|||
147442304|NCT00111800|531784292|FG001|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|2|||
147442305|NCT00111800|531784293|FG002|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|2|||
147442306|NCT00111800|531784294|FG003|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|0|||
147213751|NCT00730028|530956413|FG000|Overall Study|Adverse Event|23|||
147213752|NCT00730028|530956414|FG001|Overall Study|Adverse Event|26|||
147547340|NCT00272961|532160791|FG003|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0|||
147547341|NCT00272961|532160792|FG004|Placebo Run-in Phase: Up to Week 2|Subject Defaulted|0|||
147547342|NCT00272961|532160788|FG000|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|2|||
147547343|NCT00272961|532160789|FG001|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0|||
147547344|NCT00272961|532160790|FG002|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0|||
147547345|NCT00272961|532160791|FG003|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0|||
147547346|NCT00272961|532160792|FG004|Placebo Run-in Phase: Up to Week 2|Participant Needed Prohibited Medication|0|||
147547347|NCT00272961|532160788|FG000|Placebo Run-in Phase: Up to Week 2|Other|2|||
147547348|NCT00272961|532160789|FG001|Placebo Run-in Phase: Up to Week 2|Other|0|||
147547349|NCT00272961|532160790|FG002|Placebo Run-in Phase: Up to Week 2|Other|0|||
147547350|NCT00272961|532160791|FG003|Placebo Run-in Phase: Up to Week 2|Other|0|||
147547351|NCT00272961|532160792|FG004|Placebo Run-in Phase: Up to Week 2|Other|0|||
147547352|NCT00272961|532160788|FG000|Treatment Phase: Week 3 Up to Week 12|Adverse Event|0|||
147547353|NCT00272961|532160789|FG001|Treatment Phase: Week 3 Up to Week 12|Adverse Event|1|||
147547354|NCT00272961|532160790|FG002|Treatment Phase: Week 3 Up to Week 12|Adverse Event|0|||
147547355|NCT00272961|532160791|FG003|Treatment Phase: Week 3 Up to Week 12|Adverse Event|1|||
147547356|NCT00272961|532160792|FG004|Treatment Phase: Week 3 Up to Week 12|Adverse Event|2|||
147547357|NCT00272961|532160788|FG000|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|1|||
147547358|NCT00272961|532160789|FG001|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|0|||
147547359|NCT00272961|532160790|FG002|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|1|||
147547360|NCT00272961|532160791|FG003|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|0|||
147547361|NCT00272961|532160792|FG004|Treatment Phase: Week 3 Up to Week 12|Participant Defaulted|0|||
147547362|NCT00272961|532160788|FG000|Treatment Phase: Week 3 Up to Week 12|Other|1|||
147547363|NCT00272961|532160789|FG001|Treatment Phase: Week 3 Up to Week 12|Other|3|||
147547364|NCT00272961|532160790|FG002|Treatment Phase: Week 3 Up to Week 12|Other|3|||
147547365|NCT00272961|532160791|FG003|Treatment Phase: Week 3 Up to Week 12|Other|2|||
147547366|NCT00272961|532160792|FG004|Treatment Phase: Week 3 Up to Week 12|Other|2|||
147547367|NCT01507831|532160794|FG000|Overall Study|Randomized but not treated|0|||
147547368|NCT01507831|532160795|FG001|Overall Study|Randomized but not treated|3|||
147547369|NCT01507831|532160794|FG000|Overall Study|Adverse Event|48|||
147547370|NCT01507831|532160795|FG001|Overall Study|Adverse Event|113|||
147547371|NCT01507831|532160794|FG000|Overall Study|Death|6|||
147547372|NCT01507831|532160795|FG001|Overall Study|Death|2|||
147547373|NCT01507831|532160794|FG000|Overall Study|Poor compliance to protocol|38|||
147547374|NCT01507831|532160795|FG001|Overall Study|Poor compliance to protocol|60|||
147547375|NCT01507831|532160794|FG000|Overall Study|Physician Decision|0|||
147547376|NCT01507831|532160795|FG001|Overall Study|Physician Decision|4|||
147547377|NCT01507831|532160794|FG000|Overall Study|Participant moved|5|||
147547378|NCT01507831|532160795|FG001|Overall Study|Participant moved|19|||
147547379|NCT01507831|532160794|FG000|Overall Study|Consent withdrawn by participant|34|||
147547380|NCT01507831|532160795|FG001|Overall Study|Consent withdrawn by participant|72|||
147547381|NCT01507831|532160794|FG000|Overall Study|Related to study drug administration|5|||
147547382|NCT01507831|532160795|FG001|Overall Study|Related to study drug administration|14|||
147547383|NCT01507831|532160794|FG000|Overall Study|Last visit outside protocol visit window|51|||
147547384|NCT01507831|532160795|FG001|Overall Study|Last visit outside protocol visit window|143|||
147547385|NCT01507831|532160794|FG000|Overall Study|Selection criteria finally not met|0|||
147547386|NCT01507831|532160795|FG001|Overall Study|Selection criteria finally not met|1|||
147547387|NCT01507831|532160794|FG000|Overall Study|Site closure|0|||
147547388|NCT01507831|532160795|FG001|Overall Study|Site closure|3|||
147547389|NCT01507831|532160794|FG000|Overall Study|Potential lost to follow-up|3|||
147547390|NCT01507831|532160795|FG001|Overall Study|Potential lost to follow-up|0|||
147547391|NCT01507831|532160794|FG000|Overall Study|Other|3|||
147547392|NCT01507831|532160795|FG001|Overall Study|Other|6|||
147547393|NCT01252238|532160796|FG000|Overall Study|Sponsor terminated study|4|||
147547394|NCT01252238|532160797|FG001|Overall Study|Sponsor terminated study|4|||
147547395|NCT01252238|532160798|FG002|Overall Study|Sponsor terminated study|4|||
147547396|NCT00068237|532160799|FG000|Overall Study|Ineligible|3|||
147547397|NCT00068237|532160799|FG000|Overall Study|No protocol treatment received|2|||
147547398|NCT03276962|532160805|FG000|Overall Study|Serious Adverse Event And/Or Pimd|2|||
147547399|NCT03276962|532160806|FG001|Overall Study|Serious Adverse Event And/Or Pimd|1|||
147547400|NCT03276962|532160807|FG002|Overall Study|Serious Adverse Event And/Or Pimd|0|||
147547401|NCT03276962|532160808|FG003|Overall Study|Serious Adverse Event And/Or Pimd|4|||
147547402|NCT03276962|532160809|FG004|Overall Study|Serious Adverse Event And/Or Pimd|1|||
147547403|NCT03276962|532160805|FG000|Overall Study|Protocol Deviation|2|||
147547404|NCT03276962|532160806|FG001|Overall Study|Protocol Deviation|0|||
147547405|NCT03276962|532160807|FG002|Overall Study|Protocol Deviation|1|||
147547406|NCT03276962|532160808|FG003|Overall Study|Protocol Deviation|2|||
147213753|NCT00730028|530956415|FG002|Overall Study|Adverse Event|16|||
147213754|NCT00730028|530956416|FG003|Overall Study|Adverse Event|20|||
147547407|NCT03276962|532160809|FG004|Overall Study|Protocol Deviation|1|||
147547408|NCT03276962|532160805|FG000|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|29|||
147547409|NCT03276962|532160806|FG001|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|21|||
147547410|NCT03276962|532160807|FG002|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|13|||
147547411|NCT03276962|532160808|FG003|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|21|||
147547412|NCT03276962|532160809|FG004|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|16|||
147547413|NCT03276962|532160805|FG000|Overall Study|Migrated / Moved From The Study Area|26|||
147547414|NCT03276962|532160806|FG001|Overall Study|Migrated / Moved From The Study Area|28|||
147547415|NCT03276962|532160807|FG002|Overall Study|Migrated / Moved From The Study Area|44|||
147547416|NCT03276962|532160808|FG003|Overall Study|Migrated / Moved From The Study Area|29|||
147547417|NCT03276962|532160809|FG004|Overall Study|Migrated / Moved From The Study Area|27|||
147547418|NCT03276962|532160805|FG000|Overall Study|Lost to Follow-up|10|||
147547419|NCT03276962|532160806|FG001|Overall Study|Lost to Follow-up|10|||
147547420|NCT03276962|532160807|FG002|Overall Study|Lost to Follow-up|4|||
147547421|NCT03276962|532160808|FG003|Overall Study|Lost to Follow-up|6|||
147547422|NCT03276962|532160809|FG004|Overall Study|Lost to Follow-up|10|||
147547423|NCT03276962|532160805|FG000|Overall Study|Other|0|||
147547424|NCT03276962|532160806|FG001|Overall Study|Other|2|||
147547425|NCT03276962|532160807|FG002|Overall Study|Other|0|||
147547426|NCT03276962|532160808|FG003|Overall Study|Other|2|||
147547427|NCT03276962|532160809|FG004|Overall Study|Other|1|||
147547428|NCT01238211|532160810|FG000|Overall Study|Continues active treatment|31|||
147547429|NCT01238211|532160810|FG000|Overall Study|Adverse Event|7|||
147547430|NCT01238211|532160810|FG000|Overall Study|Death|4|||
147547431|NCT01238211|532160810|FG000|Overall Study|Relapse/Progression|2|||
147547432|NCT01238211|532160810|FG000|Overall Study|Withdrawal by Subject|7|||
147547433|NCT01238211|532160810|FG000|Overall Study|Non-protocol treatment|4|||
147547434|NCT01238211|532160810|FG000|Overall Study|Investigator/Patient Decision|3|||
147547435|NCT01358708|532160811|FG000|Double-Blind Treatment Phase|Lost to Follow-up|2|||
147547436|NCT01358708|532160812|FG001|Double-Blind Treatment Phase|Lost to Follow-up|0|||
147547437|NCT01358708|532160811|FG000|Double-Blind Treatment Phase|Protocol Violation|1|||
147547438|NCT01358708|532160812|FG001|Double-Blind Treatment Phase|Protocol Violation|0|||
147547439|NCT02475980|532160817|FG000|Overall Study|Lost to Follow-up|4|||
147547440|NCT02475980|532160817|FG000|Overall Study|Withdrawal by Subject|1|||
147547441|NCT00990093|532160818|FG000|Test Period 1 (1-14 Days)|Adverse Event|1|||
147547442|NCT00990093|532160819|FG001|Test Period 1 (1-14 Days)|Adverse Event|0|||
147547443|NCT00990093|532160818|FG000|Test Period 1 (1-14 Days)|Withdrawal by Subject|2|||
147547444|NCT00990093|532160819|FG001|Test Period 1 (1-14 Days)|Withdrawal by Subject|0|||
147547445|NCT00990093|532160818|FG000|Test Period 1 (1-14 Days)|Other|1|||
147547446|NCT00990093|532160819|FG001|Test Period 1 (1-14 Days)|Other|0|||
147547447|NCT00990093|532160818|FG000|Test Period 1 (1-14 Days)|Lack of Efficacy|0|||
147547448|NCT00990093|532160819|FG001|Test Period 1 (1-14 Days)|Lack of Efficacy|2|||
147547449|NCT00990093|532160818|FG000|Test Period 2 (15-28 Days)|Adverse Event|1|||
147547450|NCT00990093|532160819|FG001|Test Period 2 (15-28 Days)|Adverse Event|0|||
147547451|NCT00990093|532160818|FG000|Test Period 2 (15-28 Days)|Lack of Efficacy|1|||
147547452|NCT00990093|532160819|FG001|Test Period 2 (15-28 Days)|Lack of Efficacy|0|||
147547453|NCT00990093|532160818|FG000|Test Period 2 (15-28 Days)|Other|0|||
147547454|NCT00990093|532160819|FG001|Test Period 2 (15-28 Days)|Other|1|||
147547455|NCT00435825|532160821|FG000|Overall Study|Abnormality of Laboratory Test|0|||
147547456|NCT00435825|532160822|FG001|Overall Study|Abnormality of Laboratory Test|1|||
147547457|NCT00435825|532160823|FG002|Overall Study|Abnormality of Laboratory Test|0|||
147547458|NCT00435825|532160824|FG003|Overall Study|Abnormality of Laboratory Test|0|||
147547459|NCT00435825|532160821|FG000|Overall Study|Insufficient Therapeutic Response|3|||
147547460|NCT00435825|532160822|FG001|Overall Study|Insufficient Therapeutic Response|1|||
147547461|NCT00435825|532160823|FG002|Overall Study|Insufficient Therapeutic Response|0|||
147547462|NCT00435825|532160824|FG003|Overall Study|Insufficient Therapeutic Response|3|||
147547463|NCT00435825|532160821|FG000|Overall Study|Other Protocol Violation|1|||
147547464|NCT00435825|532160822|FG001|Overall Study|Other Protocol Violation|0|||
147547465|NCT00435825|532160823|FG002|Overall Study|Other Protocol Violation|0|||
147547466|NCT00435825|532160824|FG003|Overall Study|Other Protocol Violation|0|||
147547467|NCT00435825|532160821|FG000|Overall Study|Refused treatment|2|||
147547468|NCT00435825|532160822|FG001|Overall Study|Refused treatment|0|||
147547469|NCT00435825|532160823|FG002|Overall Study|Refused treatment|0|||
147547470|NCT00435825|532160824|FG003|Overall Study|Refused treatment|5|||
147547471|NCT00435825|532160821|FG000|Overall Study|Failure to return|5|||
147547472|NCT00435825|532160822|FG001|Overall Study|Failure to return|0|||
147547473|NCT00435825|532160823|FG002|Overall Study|Failure to return|4|||
147547474|NCT00435825|532160824|FG003|Overall Study|Failure to return|0|||
147547475|NCT00435825|532160821|FG000|Overall Study|Did not receive study drug|1|||
147547476|NCT00435825|532160822|FG001|Overall Study|Did not receive study drug|0|||
147547477|NCT00435825|532160823|FG002|Overall Study|Did not receive study drug|2|||
147547478|NCT00435825|532160824|FG003|Overall Study|Did not receive study drug|0|||
147547479|NCT00435825|532160821|FG000|Overall Study|Did not enter follow-up|0|||
147213755|NCT00730028|530956417|FG004|Overall Study|Adverse Event|43|||
147213756|NCT00730028|530956413|FG000|Overall Study|Lost to Follow-up|13|||
147213757|NCT00730028|530956414|FG001|Overall Study|Lost to Follow-up|26|||
147213758|NCT00730028|530956415|FG002|Overall Study|Lost to Follow-up|22|||
147213759|NCT00730028|530956416|FG003|Overall Study|Lost to Follow-up|26|||
147213760|NCT00730028|530956417|FG004|Overall Study|Lost to Follow-up|25|||
147213761|NCT00730028|530956413|FG000|Overall Study|Protocol Violation|6|||
147213762|NCT00730028|530956414|FG001|Overall Study|Protocol Violation|1|||
147213763|NCT00730028|530956415|FG002|Overall Study|Protocol Violation|1|||
147213764|NCT00730028|530956416|FG003|Overall Study|Protocol Violation|2|||
147213765|NCT00730028|530956417|FG004|Overall Study|Protocol Violation|0|||
147213766|NCT00730028|530956413|FG000|Overall Study|Withdrawal by Subject|9|||
147213767|NCT00730028|530956414|FG001|Overall Study|Withdrawal by Subject|5|||
147213768|NCT00730028|530956415|FG002|Overall Study|Withdrawal by Subject|4|||
147213769|NCT00730028|530956416|FG003|Overall Study|Withdrawal by Subject|5|||
147213770|NCT00730028|530956417|FG004|Overall Study|Withdrawal by Subject|9|||
147213771|NCT00730028|530956413|FG000|Overall Study|Physician Decision|3|||
147213772|NCT00730028|530956414|FG001|Overall Study|Physician Decision|3|||
147213773|NCT00730028|530956415|FG002|Overall Study|Physician Decision|2|||
147213774|NCT00730028|530956416|FG003|Overall Study|Physician Decision|3|||
147213775|NCT00730028|530956417|FG004|Overall Study|Physician Decision|2|||
147213776|NCT00730028|530956413|FG000|Overall Study|Treatment Failure|5|||
147213777|NCT00730028|530956414|FG001|Overall Study|Treatment Failure|5|||
147213778|NCT00730028|530956415|FG002|Overall Study|Treatment Failure|0|||
147213779|NCT00730028|530956416|FG003|Overall Study|Treatment Failure|0|||
147213780|NCT00730028|530956417|FG004|Overall Study|Treatment Failure|1|||
147213781|NCT00730028|530956413|FG000|Overall Study|Randomization Error|1|||
147213782|NCT00730028|530956414|FG001|Overall Study|Randomization Error|0|||
147213783|NCT00730028|530956415|FG002|Overall Study|Randomization Error|0|||
147213784|NCT00730028|530956416|FG003|Overall Study|Randomization Error|0|||
147213785|NCT00730028|530956417|FG004|Overall Study|Randomization Error|2|||
147213786|NCT02870933|530956418|FG000|Overall Study|Death|2|||
147213787|NCT02870933|530956419|FG001|Overall Study|Death|1|||
147213788|NCT02870933|530956418|FG000|Overall Study|Withdrawal by Subject|0|||
147213789|NCT02870933|530956419|FG001|Overall Study|Withdrawal by Subject|1|||
147213790|NCT01250496|530956422|FG000|Overall Study|Study terminated|124|||
147213791|NCT01250496|530956423|FG001|Overall Study|Study terminated|124|||
147213792|NCT00003590|530956424|FG000|Overall Study|Ineligible Patient|1|||
147213793|NCT00003590|530956424|FG000|Overall Study|Adverse Event|7|||
147547480|NCT00435825|532160822|FG001|Overall Study|Did not enter follow-up|4|||
147547481|NCT00435825|532160823|FG002|Overall Study|Did not enter follow-up|1|||
147213794|NCT00003590|530956424|FG000|Overall Study|Withdrawal by Subject|1|||
147213795|NCT00003590|530956424|FG000|Overall Study|Lack of Efficacy|11|||
147213796|NCT00003590|530956424|FG000|Overall Study|Death|1|||
147213797|NCT00003590|530956424|FG000|Overall Study|Physician Decision|1|||
147213798|NCT01425463|530956430|FG000|Overall Study|Adverse Event|5|||
147213799|NCT01425463|530956431|FG001|Overall Study|Adverse Event|7|||
147213800|NCT01425463|530956430|FG000|Overall Study|Lack of Efficacy|1|||
147213801|NCT01425463|530956431|FG001|Overall Study|Lack of Efficacy|1|||
147213802|NCT01425463|530956430|FG000|Overall Study|Protocol Violation|2|||
147213803|NCT01425463|530956431|FG001|Overall Study|Protocol Violation|2|||
147213804|NCT01425463|530956430|FG000|Overall Study|Lost to Follow-up|5|||
147213805|NCT01425463|530956431|FG001|Overall Study|Lost to Follow-up|2|||
147213806|NCT01425463|530956430|FG000|Overall Study|Withdrawal by Subject|7|||
147213807|NCT01425463|530956431|FG001|Overall Study|Withdrawal by Subject|5|||
147213808|NCT01425463|530956430|FG000|Overall Study|Unknown Reason|4|||
147213809|NCT01425463|530956431|FG001|Overall Study|Unknown Reason|7|||
147213810|NCT01332799|530956432|FG000|Overall Study|Insufficient funding|10|||
147213811|NCT01332799|530956433|FG001|Overall Study|Insufficient funding|10|||
147213812|NCT00668733|530956434|FG000|Overall Study|Lost to Follow-up|2|||
147213813|NCT00668733|530956435|FG001|Overall Study|Lost to Follow-up|3|||
147213814|NCT00668733|530956434|FG000|Overall Study|Withdrawal by Subject|0|||
147213815|NCT00668733|530956435|FG001|Overall Study|Withdrawal by Subject|4|||
147213816|NCT00538785|530956437|FG000|Overall Study|Death|9|||
147213817|NCT00538785|530956438|FG001|Overall Study|Death|10|||
147213818|NCT00538785|530956437|FG000|Overall Study|Withdrawal of consent|9|||
147547482|NCT00435825|532160824|FG003|Overall Study|Did not enter follow-up|3|||
147213819|NCT00538785|530956438|FG001|Overall Study|Withdrawal of consent|7|||
147213820|NCT00538785|530956437|FG000|Overall Study|Lost to Follow-up|1|||
147213821|NCT00538785|530956438|FG001|Overall Study|Lost to Follow-up|0|||
147213822|NCT00647270|530956439|FG000|Period 1, Placebo-control (12 Weeks)|Adverse Event|2|||
147213823|NCT00647270|530956440|FG001|Period 1, Placebo-control (12 Weeks)|Adverse Event|7|||
147213824|NCT00647270|530956441|FG002|Period 1, Placebo-control (12 Weeks)|Adverse Event|7|||
147213825|NCT00647270|530956439|FG000|Period 1, Placebo-control (12 Weeks)|Lost to Follow-up|0|||
147213826|NCT00647270|530956440|FG001|Period 1, Placebo-control (12 Weeks)|Lost to Follow-up|1|||
147213827|NCT00647270|530956441|FG002|Period 1, Placebo-control (12 Weeks)|Lost to Follow-up|1|||
147213828|NCT00647270|530956439|FG000|Period 1, Placebo-control (12 Weeks)|Withdrawal by Subject|2|||
147547483|NCT00435825|532160821|FG000|Overall Study|Did not complete full follow-up period|6|||
147547484|NCT00435825|532160822|FG001|Overall Study|Did not complete full follow-up period|6|||
147547485|NCT00435825|532160823|FG002|Overall Study|Did not complete full follow-up period|4|||
147547486|NCT00435825|532160824|FG003|Overall Study|Did not complete full follow-up period|5|||
147547487|NCT01246986|532162104|FG000|Overall Study|Lost to Follow-up|0|||
147547488|NCT01246986|532162105|FG001|Overall Study|Lost to Follow-up|1|||
147547489|NCT01246986|532162106|FG002|Overall Study|Lost to Follow-up|3|||
147547490|NCT01246986|532162107|FG003|Overall Study|Lost to Follow-up|0|||
147547491|NCT01246986|532162108|FG004|Overall Study|Lost to Follow-up|0|||
147547492|NCT01246986|532162109|FG005|Overall Study|Lost to Follow-up|1|||
147547493|NCT01246986|532162110|FG006|Overall Study|Lost to Follow-up|0|||
147547494|NCT01246986|532162104|FG000|Overall Study|Withdrawal by Subject|3|||
147547495|NCT01246986|532162105|FG001|Overall Study|Withdrawal by Subject|4|||
147547496|NCT01246986|532162106|FG002|Overall Study|Withdrawal by Subject|3|||
147547497|NCT01246986|532162107|FG003|Overall Study|Withdrawal by Subject|0|||
147547498|NCT01246986|532162108|FG004|Overall Study|Withdrawal by Subject|4|||
147547499|NCT01246986|532162109|FG005|Overall Study|Withdrawal by Subject|0|||
147547500|NCT01246986|532162110|FG006|Overall Study|Withdrawal by Subject|0|||
147547501|NCT02496221|532162111|FG000|Treatment Period 2 - 4 Days|Adverse Event|0|||
147547502|NCT02496221|532162112|FG001|Treatment Period 2 - 4 Days|Adverse Event|1|||
147547503|NCT02496221|532162111|FG000|Treatment Period 2 - 4 Days|Protocol Violation|1|||
147547504|NCT02496221|532162112|FG001|Treatment Period 2 - 4 Days|Protocol Violation|0|||
147547505|NCT02496221|532162111|FG000|Treatment Period 2 - 4 Days|Physician Decision|1|||
147547506|NCT02496221|532162112|FG001|Treatment Period 2 - 4 Days|Physician Decision|0|||
147547507|NCT03990389|532162113|FG000|Overall Study|Lost to Follow-up|3|||
147547508|NCT03990389|532162114|FG001|Overall Study|Lost to Follow-up|0|||
147547509|NCT03770000|532162115|FG000|Overall Study|Premature discontinuation due to PD|0|||
147547510|NCT03770000|532162116|FG001|Overall Study|Premature discontinuation due to PD|0|||
147547511|NCT03770000|532162117|FG002|Overall Study|Premature discontinuation due to PD|1|||
147547512|NCT03770000|532162118|FG003|Overall Study|Premature discontinuation due to PD|3|||
147547513|NCT03770000|532162119|FG004|Overall Study|Premature discontinuation due to PD|2|||
147547514|NCT02595528|532162121|FG000|Overall Study|Withdrawal by Subject|1|||
147547515|NCT02595528|532162122|FG001|Overall Study|Withdrawal by Subject|2|||
147547516|NCT02595528|532162123|FG002|Overall Study|Withdrawal by Subject|1|||
147547517|NCT02595528|532162124|FG003|Overall Study|Withdrawal by Subject|3|||
147547518|NCT02595528|532162121|FG000|Overall Study|Lost to Follow-up|1|||
147547519|NCT02595528|532162122|FG001|Overall Study|Lost to Follow-up|1|||
147547520|NCT02595528|532162123|FG002|Overall Study|Lost to Follow-up|0|||
147547521|NCT02595528|532162124|FG003|Overall Study|Lost to Follow-up|1|||
147547522|NCT00833547|532162125|FG000|Overall Study|Withdrawal by Subject|2|||
147547523|NCT00833547|532162126|FG001|Overall Study|Withdrawal by Subject|2|||
147547524|NCT00566098|532162128|FG000|Collection of MILs|Withdrawal by Subject|1|||
147547525|NCT00566098|532162128|FG000|Collection of MILs|Relapsed|1|||
147547526|NCT00566098|532162128|FG000|Generation of MILs Product|Relapsed|1|||
147547527|NCT00566098|532162128|FG000|Administration of ASCT+MILs|Death|10|||
147547528|NCT00566098|532162128|FG000|Administration of ASCT+MILs|Lack of Efficacy|8|||
147547529|NCT01690520|532162131|FG000|Overall Study|Death|25|||
147547530|NCT01690520|532162132|FG001|Overall Study|Death|21|||
147547531|NCT01690520|532162131|FG000|Overall Study|Lost to Follow-up|2|||
147547532|NCT01690520|532162132|FG001|Overall Study|Lost to Follow-up|3|||
147547533|NCT01690520|532162131|FG000|Overall Study|Withdrawal by Subject|2|||
147547534|NCT01690520|532162132|FG001|Overall Study|Withdrawal by Subject|0|||
147547535|NCT01690520|532162131|FG000|Overall Study|Relapse|0|||
147547536|NCT01690520|532162132|FG001|Overall Study|Relapse|1|||
147547537|NCT01690520|532162131|FG000|Overall Study|Other|0|||
147547538|NCT01690520|532162132|FG001|Overall Study|Other|1|||
147547539|NCT01690520|532162131|FG000|Overall Study|Ongoing Follow-Up at time of Analysis|22|||
147547540|NCT01690520|532162132|FG001|Overall Study|Ongoing Follow-Up at time of Analysis|21|||
147547541|NCT00275028|532162133|FG000|Overall Study|Withdrew consent before treatment began|1|||
147547542|NCT00275028|532162133|FG000|Overall Study|Withdrawal by Subject|5|||
147547543|NCT00275028|532162133|FG000|Overall Study|Adverse Event|9|||
147547544|NCT00275028|532162133|FG000|Overall Study|Progressive Disease|30|||
147547545|NCT00275028|532162133|FG000|Overall Study|Physician Decision|2|||
147547546|NCT01847313|532162136|FG000|Overall Study|Death|0|||
147547547|NCT01847313|532162137|FG001|Overall Study|Death|1|||
147547548|NCT01847313|532162136|FG000|Overall Study|Withdrawal by Subject|0|||
147547549|NCT01847313|532162137|FG001|Overall Study|Withdrawal by Subject|1|||
147547550|NCT00598559|532162139|FG000|Overall Study|Adverse Event|11|||
147547551|NCT00598559|532162140|FG001|Overall Study|Adverse Event|7|||
147547552|NCT00598559|532162141|FG002|Overall Study|Adverse Event|0|||
147547553|NCT00598559|532162139|FG000|Overall Study|Withdrawal by Subject|2|||
147547554|NCT00598559|532162140|FG001|Overall Study|Withdrawal by Subject|2|||
147547555|NCT00598559|532162141|FG002|Overall Study|Withdrawal by Subject|0|||
147547556|NCT00598559|532162139|FG000|Overall Study|Protocol Non-compliance|1|||
147547557|NCT00598559|532162140|FG001|Overall Study|Protocol Non-compliance|0|||
147547558|NCT00598559|532162141|FG002|Overall Study|Protocol Non-compliance|0|||
147547559|NCT00598559|532162139|FG000|Overall Study|Early discharge from hospital|9|||
147213829|NCT00647270|530956440|FG001|Period 1, Placebo-control (12 Weeks)|Withdrawal by Subject|1|||
147213830|NCT00647270|530956441|FG002|Period 1, Placebo-control (12 Weeks)|Withdrawal by Subject|7|||
147213831|NCT00647270|530956439|FG000|Period 1, Placebo-control (12 Weeks)|Other|4|||
147213832|NCT00647270|530956440|FG001|Period 1, Placebo-control (12 Weeks)|Other|4|||
147213833|NCT00647270|530956441|FG002|Period 1, Placebo-control (12 Weeks)|Other|8|||
147213834|NCT00647270|530956439|FG000|Period 2, Placebo Switched to Adalimumab|Adverse Event|1|||
147213835|NCT00647270|530956440|FG001|Period 2, Placebo Switched to Adalimumab|Adverse Event|3|||
147213836|NCT00647270|530956441|FG002|Period 2, Placebo Switched to Adalimumab|Adverse Event|3|||
147213837|NCT00647270|530956439|FG000|Period 2, Placebo Switched to Adalimumab|Withdrawal by Subject|0|||
147213838|NCT00647270|530956440|FG001|Period 2, Placebo Switched to Adalimumab|Withdrawal by Subject|0|||
147213839|NCT00647270|530956441|FG002|Period 2, Placebo Switched to Adalimumab|Withdrawal by Subject|4|||
147213840|NCT00647270|530956439|FG000|Period 2, Placebo Switched to Adalimumab|Other|2|||
147213841|NCT00647270|530956440|FG001|Period 2, Placebo Switched to Adalimumab|Other|6|||
147213842|NCT00647270|530956441|FG002|Period 2, Placebo Switched to Adalimumab|Other|0|||
147213843|NCT03615040|530956444|FG000|Overall Study|Withdrawal by Subject|2|||
147213844|NCT03615040|530956445|FG001|Overall Study|Withdrawal by Subject|1|||
147213845|NCT03615040|530956444|FG000|Overall Study|Physician Decision|2|||
147213846|NCT03615040|530956445|FG001|Overall Study|Physician Decision|2|||
147213847|NCT03615040|530956444|FG000|Overall Study|Clinical diagnosis of lung cancer|1|||
147213848|NCT03615040|530956445|FG001|Overall Study|Clinical diagnosis of lung cancer|0|||
147213849|NCT03615040|530956444|FG000|Overall Study|Clinical diagnosis of oesophageal cancer|1|||
147213850|NCT03615040|530956445|FG001|Overall Study|Clinical diagnosis of oesophageal cancer|0|||
147213851|NCT03615040|530956444|FG000|Overall Study|Death|0|||
147213852|NCT03615040|530956445|FG001|Overall Study|Death|2|||
147213853|NCT01541397|530956448|FG000|Overall Study|Study ended prior to data collection|4|||
147213854|NCT01541397|530956449|FG001|Overall Study|Study ended prior to data collection|2|||
147213855|NCT02267317|530956450|FG000|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|1|||
147213856|NCT02267317|530956451|FG001|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0|||
147213857|NCT02267317|530956452|FG002|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0|||
147213858|NCT02267317|530956453|FG003|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0|||
147213859|NCT02267317|530956454|FG004|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0|||
147213860|NCT02267317|530956455|FG005|Washout (3-4weeks Between Infusions)|Withdrawal by Subject|0|||
147213861|NCT02267317|530956450|FG000|Washout (3-4weeks Between Infusions)|Lost to Follow-up|1|||
147213862|NCT02267317|530956451|FG001|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0|||
147213863|NCT02267317|530956452|FG002|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0|||
147213864|NCT02267317|530956453|FG003|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0|||
147213865|NCT02267317|530956454|FG004|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0|||
147213866|NCT02267317|530956455|FG005|Washout (3-4weeks Between Infusions)|Lost to Follow-up|0|||
147213867|NCT01128621|530956456|FG000|Part B: GSK1292263 75 mg/300 mg/ 600 mg|Reached defined stopping criteria|0|||
147213868|NCT01128621|530956457|FG001|Part B: GSK1292263 75 mg/300 mg/ 600 mg|Reached defined stopping criteria|2|||
147213869|NCT00233454|530956463|FG000|Overall Study|Death|6|||
147213870|NCT04224688|530956464|FG000|Overall Study|Withdrawal by Subject|1|||
147213871|NCT04224688|530956465|FG001|Overall Study|Withdrawal by Subject|3|||
147213872|NCT04224688|530956464|FG000|Overall Study|Lack of Efficacy|1|||
147213873|NCT04224688|530956465|FG001|Overall Study|Lack of Efficacy|1|||
147213874|NCT04224688|530956464|FG000|Overall Study|Adverse event, not fatal|0|||
147213875|NCT04224688|530956465|FG001|Overall Study|Adverse event, not fatal|2|||
147213876|NCT04224688|530956464|FG000|Overall Study|COVID-19|0|||
147213877|NCT04224688|530956465|FG001|Overall Study|COVID-19|1|||
147213878|NCT04074161|530956466|FG000|Overall Study|Withdrawal by Subject|2|||
147213879|NCT04074161|530956467|FG001|Overall Study|Withdrawal by Subject|4|||
147213880|NCT04074161|530956468|FG002|Overall Study|Withdrawal by Subject|1|||
147213881|NCT04074161|530956466|FG000|Overall Study|Lost to Follow-up|4|||
147213882|NCT04074161|530956467|FG001|Overall Study|Lost to Follow-up|5|||
147213883|NCT04074161|530956468|FG002|Overall Study|Lost to Follow-up|3|||
147213884|NCT00329849|530956471|FG000|Overall Study|Withdrawal by Subject|6|||
147213885|NCT00329849|530956472|FG001|Overall Study|Withdrawal by Subject|4|||
147213886|NCT00322621|530956473|FG000|Period II - Acute Therapy Phase|Adverse Event|20|||
147213887|NCT00322621|530956474|FG001|Period II - Acute Therapy Phase|Adverse Event|0|||
147213888|NCT00322621|530956475|FG002|Period II - Acute Therapy Phase|Adverse Event|0|||
147213889|NCT00322621|530956473|FG000|Period II - Acute Therapy Phase|Lack of Efficacy|1|||
147442307|NCT00111800|531784295|FG004|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|3|||
147213890|NCT00322621|530956474|FG001|Period II - Acute Therapy Phase|Lack of Efficacy|0|||
147442308|NCT00111800|531784296|FG005|Period 2: Extension Phase (12 Weeks)|Withdrawal by Subject|0|||
147442309|NCT00111800|531784291|FG000|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1|||
147442310|NCT00111800|531784292|FG001|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|0|||
147442311|NCT00111800|531784293|FG002|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1|||
147442312|NCT00111800|531784294|FG003|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1|||
147547560|NCT00598559|532162140|FG001|Overall Study|Early discharge from hospital|12|||
147547561|NCT00598559|532162141|FG002|Overall Study|Early discharge from hospital|3|||
147547562|NCT00598559|532162139|FG000|Overall Study|Subject unable/unwilling to attend visit|4|||
147547563|NCT00598559|532162140|FG001|Overall Study|Subject unable/unwilling to attend visit|7|||
147547564|NCT00598559|532162141|FG002|Overall Study|Subject unable/unwilling to attend visit|0|||
147547565|NCT02762565|532162142|FG000|Overall Study|Missing iBE data: a result of incomplete data transfer from the iBE|11|||
147547566|NCT01113710|532162143|FG000|Overall Study|Adverse Event|64|||
147547567|NCT01113710|532162143|FG000|Overall Study|Lack of Efficacy|41|||
147547568|NCT01113710|532162143|FG000|Overall Study|No Information Available|40|||
147213891|NCT00322621|530956475|FG002|Period II - Acute Therapy Phase|Lack of Efficacy|0|||
147213892|NCT00322621|530956473|FG000|Period II - Acute Therapy Phase|Withdrawal by Subject|8|||
147213893|NCT00322621|530956474|FG001|Period II - Acute Therapy Phase|Withdrawal by Subject|0|||
147213894|NCT00322621|530956475|FG002|Period II - Acute Therapy Phase|Withdrawal by Subject|0|||
147213895|NCT00322621|530956473|FG000|Period II - Acute Therapy Phase|Protocol Violation|2|||
147213896|NCT00322621|530956474|FG001|Period II - Acute Therapy Phase|Protocol Violation|0|||
147213897|NCT00322621|530956475|FG002|Period II - Acute Therapy Phase|Protocol Violation|0|||
147213898|NCT00322621|530956473|FG000|Period II - Acute Therapy Phase|Physician Decision|1|||
147213899|NCT00322621|530956474|FG001|Period II - Acute Therapy Phase|Physician Decision|0|||
147213900|NCT00322621|530956475|FG002|Period II - Acute Therapy Phase|Physician Decision|0|||
147213901|NCT00322621|530956473|FG000|Period III - Maintenance / Rescue Phase|Adverse Event|0|||
147213902|NCT00322621|530956474|FG001|Period III - Maintenance / Rescue Phase|Adverse Event|14|||
147213903|NCT00322621|530956475|FG002|Period III - Maintenance / Rescue Phase|Adverse Event|5|||
147213904|NCT00322621|530956473|FG000|Period III - Maintenance / Rescue Phase|Lack of Efficacy|0|||
147213905|NCT00322621|530956474|FG001|Period III - Maintenance / Rescue Phase|Lack of Efficacy|4|||
147213906|NCT00322621|530956475|FG002|Period III - Maintenance / Rescue Phase|Lack of Efficacy|24|||
147213907|NCT00322621|530956473|FG000|Period III - Maintenance / Rescue Phase|Withdrawal by Subject|0|||
147213908|NCT00322621|530956474|FG001|Period III - Maintenance / Rescue Phase|Withdrawal by Subject|7|||
147213909|NCT00322621|530956475|FG002|Period III - Maintenance / Rescue Phase|Withdrawal by Subject|1|||
147213910|NCT00322621|530956473|FG000|Period III - Maintenance / Rescue Phase|Protocol Violation|0|||
147213911|NCT00322621|530956474|FG001|Period III - Maintenance / Rescue Phase|Protocol Violation|2|||
147213912|NCT00322621|530956475|FG002|Period III - Maintenance / Rescue Phase|Protocol Violation|5|||
147213913|NCT00322621|530956473|FG000|Period III - Maintenance / Rescue Phase|Death|0|||
147213914|NCT00322621|530956474|FG001|Period III - Maintenance / Rescue Phase|Death|1|||
147213915|NCT00322621|530956475|FG002|Period III - Maintenance / Rescue Phase|Death|0|||
147213916|NCT00322621|530956473|FG000|Period III - Maintenance / Rescue Phase|Lost to Follow-up|0|||
147213917|NCT00322621|530956474|FG001|Period III - Maintenance / Rescue Phase|Lost to Follow-up|1|||
147213918|NCT00322621|530956475|FG002|Period III - Maintenance / Rescue Phase|Lost to Follow-up|1|||
147213919|NCT01038869|530956478|FG000|Overall Study|Withdrawal by Subject|1|||
147213920|NCT01038869|530956478|FG000|Overall Study|Lost to Follow-up|6|||
147213921|NCT02238067|530956479|FG000|Overall Study|Not completed survey at Month 6|45|||
147213922|NCT03726996|530956483|FG000|Overall Study|Parent's decision|2|||
147213923|NCT03726996|530956483|FG000|Overall Study|Study early termination|2|||
147213924|NCT01328444|530956484|FG000|Treatment Period 1 (12 Weeks)|Adverse Event|3|||
147213925|NCT01328444|530956485|FG001|Treatment Period 1 (12 Weeks)|Adverse Event|1|||
147213926|NCT01328444|530956486|FG002|Treatment Period 1 (12 Weeks)|Adverse Event|1|||
147213927|NCT01328444|530956487|FG003|Treatment Period 1 (12 Weeks)|Adverse Event|3|||
147213928|NCT01328444|530956488|FG004|Treatment Period 1 (12 Weeks)|Adverse Event|5|||
147213929|NCT01328444|530956489|FG005|Treatment Period 1 (12 Weeks)|Adverse Event|2|||
147213930|NCT01328444|530956484|FG000|Treatment Period 1 (12 Weeks)|Lack of Efficacy|6|||
147213931|NCT01328444|530956485|FG001|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1|||
147213932|NCT01328444|530956486|FG002|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1|||
147213933|NCT01328444|530956487|FG003|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1|||
147213934|NCT01328444|530956488|FG004|Treatment Period 1 (12 Weeks)|Lack of Efficacy|6|||
147213935|NCT01328444|530956489|FG005|Treatment Period 1 (12 Weeks)|Lack of Efficacy|2|||
147213936|NCT01328444|530956484|FG000|Treatment Period 1 (12 Weeks)|Protocol Violation|0|||
147213937|NCT01328444|530956485|FG001|Treatment Period 1 (12 Weeks)|Protocol Violation|0|||
147213938|NCT01328444|530956486|FG002|Treatment Period 1 (12 Weeks)|Protocol Violation|0|||
147213939|NCT01328444|530956487|FG003|Treatment Period 1 (12 Weeks)|Protocol Violation|1|||
147213940|NCT01328444|530956488|FG004|Treatment Period 1 (12 Weeks)|Protocol Violation|0|||
147213941|NCT01328444|530956489|FG005|Treatment Period 1 (12 Weeks)|Protocol Violation|1|||
147213942|NCT01328444|530956484|FG000|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0|||
147213943|NCT01328444|530956485|FG001|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|1|||
147213944|NCT01328444|530956486|FG002|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0|||
147547569|NCT01113710|532162143|FG000|Overall Study|Withdrawal by Subject|28|||
147547570|NCT01113710|532162143|FG000|Overall Study|Lost to Follow-up|20|||
147547571|NCT01113710|532162143|FG000|Overall Study|Lack of Efficacy/Withdrawal by Subject|13|||
147547572|NCT01113710|532162143|FG000|Overall Study|Withdrawal by Subject/Adverse Event|11|||
147547573|NCT01113710|532162143|FG000|Overall Study|Lack of Patient's Compliance|8|||
147547574|NCT01113710|532162143|FG000|Overall Study|Other|7|||
147547575|NCT01113710|532162143|FG000|Overall Study|Adverse Event/Other|5|||
147547576|NCT01113710|532162143|FG000|Overall Study|Patient's Compliance/Lost to Follow up|5|||
147547577|NCT01113710|532162143|FG000|Overall Study|Lack of Efficacy/Other|4|||
147547578|NCT01113710|532162143|FG000|Overall Study|Patient Compliance/Withdrawal by Subject|4|||
147547579|NCT01113710|532162143|FG000|Overall Study|Lack of Efficacy/Adverse Event|3|||
147547580|NCT01113710|532162143|FG000|Overall Study|Efficacy/Subject Withdrawal/AE|2|||
147547581|NCT01113710|532162143|FG000|Overall Study|Compliance/Lost to Follow up/Pt Withdraw|2|||
147547582|NCT01113710|532162143|FG000|Overall Study|Lost to Follow up/Withdrawal by Subject|2|||
147547583|NCT01113710|532162143|FG000|Overall Study|Efficacy/Withdrawal by Subject/Other|1|||
147547584|NCT01113710|532162143|FG000|Overall Study|Compliance/Efficacy/Adverse Event|1|||
147547585|NCT01113710|532162143|FG000|Overall Study|Compliance/Efficacy/AE/Other|1|||
147547586|NCT01113710|532162143|FG000|Overall Study|Compliance/Efficacy/Subject Withdrawal|1|||
147547587|NCT01113710|532162143|FG000|Overall Study|Compliance/Lost to Follow up/Efficacy/AE|1|||
147547588|NCT01113710|532162143|FG000|Overall Study|Lack of Patient's Compliance/Other|1|||
147547589|NCT01113710|532162143|FG000|Overall Study|Compliance/Subject Withdrawal/AE|1|||
147547590|NCT01113710|532162143|FG000|Overall Study|Subject Did Not Receive Neupro|3|||
147547591|NCT01078623|532162145|FG000|Treatment Period 1|Adverse Event|1|||
147547592|NCT01078623|532162146|FG001|Treatment Period 1|Adverse Event|1|||
147547593|NCT01078623|532162147|FG002|Treatment Period 1|Adverse Event|1|||
147547594|NCT01078623|532162148|FG003|Treatment Period 1|Adverse Event|0|||
147547595|NCT01078623|532162149|FG004|Treatment Period 1|Adverse Event|0|||
147547596|NCT01078623|532162150|FG005|Treatment Period 1|Adverse Event|0|||
147547597|NCT01078623|532162151|FG006|Treatment Period 1|Adverse Event|1|||
147547598|NCT01078623|532162152|FG007|Treatment Period 1|Adverse Event|0|||
147547599|NCT01078623|532162153|FG008|Treatment Period 1|Adverse Event|1|||
147547600|NCT01078623|532162154|FG009|Treatment Period 1|Adverse Event|1|||
147547601|NCT01078623|532162155|FG010|Treatment Period 1|Adverse Event|0|||
147547602|NCT01078623|532162156|FG011|Treatment Period 1|Adverse Event|0|||
147547603|NCT01078623|532162157|FG012|Treatment Period 1|Adverse Event|0|||
147547604|NCT01078623|532162158|FG013|Treatment Period 1|Adverse Event|0|||
147547605|NCT01078623|532162159|FG014|Treatment Period 1|Adverse Event|0|||
147547606|NCT01078623|532162160|FG015|Treatment Period 1|Adverse Event|0|||
147547607|NCT01078623|532162161|FG016|Treatment Period 1|Adverse Event|0|||
147547608|NCT01078623|532162162|FG017|Treatment Period 1|Adverse Event|0|||
147547609|NCT01078623|532162163|FG018|Treatment Period 1|Adverse Event|0|||
147547610|NCT01078623|532162164|FG019|Treatment Period 1|Adverse Event|0|||
147547611|NCT01078623|532162145|FG000|Treatment Period 1|Withdrawal by Subject|0|||
147547612|NCT01078623|532162146|FG001|Treatment Period 1|Withdrawal by Subject|0|||
147547613|NCT01078623|532162147|FG002|Treatment Period 1|Withdrawal by Subject|0|||
147547614|NCT01078623|532162148|FG003|Treatment Period 1|Withdrawal by Subject|0|||
147547615|NCT01078623|532162149|FG004|Treatment Period 1|Withdrawal by Subject|0|||
147547616|NCT01078623|532162150|FG005|Treatment Period 1|Withdrawal by Subject|0|||
147213945|NCT01328444|530956487|FG003|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0|||
147213946|NCT01328444|530956488|FG004|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|2|||
147213947|NCT01328444|530956489|FG005|Treatment Period 1 (12 Weeks)|Met Protocol- Defined Stopping Criteria|0|||
147213948|NCT01328444|530956484|FG000|Treatment Period 1 (12 Weeks)|Lost to Follow-up|2|||
147547617|NCT01078623|532162151|FG006|Treatment Period 1|Withdrawal by Subject|0|||
147547618|NCT01078623|532162152|FG007|Treatment Period 1|Withdrawal by Subject|1|||
147547619|NCT01078623|532162153|FG008|Treatment Period 1|Withdrawal by Subject|0|||
147547620|NCT01078623|532162154|FG009|Treatment Period 1|Withdrawal by Subject|0|||
147547621|NCT01078623|532162155|FG010|Treatment Period 1|Withdrawal by Subject|1|||
147547622|NCT01078623|532162156|FG011|Treatment Period 1|Withdrawal by Subject|0|||
147213949|NCT01328444|530956485|FG001|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
147213950|NCT01328444|530956486|FG002|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
147213951|NCT01328444|530956487|FG003|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
147213952|NCT01328444|530956488|FG004|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
147213953|NCT01328444|530956489|FG005|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
147213954|NCT01328444|530956484|FG000|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
147547623|NCT01078623|532162157|FG012|Treatment Period 1|Withdrawal by Subject|0|||
147547624|NCT01078623|532162158|FG013|Treatment Period 1|Withdrawal by Subject|0|||
147547625|NCT01078623|532162159|FG014|Treatment Period 1|Withdrawal by Subject|0|||
147547626|NCT01078623|532162160|FG015|Treatment Period 1|Withdrawal by Subject|0|||
147547627|NCT01078623|532162161|FG016|Treatment Period 1|Withdrawal by Subject|0|||
147547628|NCT01078623|532162162|FG017|Treatment Period 1|Withdrawal by Subject|0|||
147547629|NCT01078623|532162163|FG018|Treatment Period 1|Withdrawal by Subject|0|||
147547630|NCT01078623|532162164|FG019|Treatment Period 1|Withdrawal by Subject|0|||
147547631|NCT01078623|532162145|FG000|Treatment Period 1|Protocol Violation|0|||
147547632|NCT01078623|532162146|FG001|Treatment Period 1|Protocol Violation|0|||
147547633|NCT01078623|532162147|FG002|Treatment Period 1|Protocol Violation|0|||
147547634|NCT01078623|532162148|FG003|Treatment Period 1|Protocol Violation|0|||
147547635|NCT01078623|532162149|FG004|Treatment Period 1|Protocol Violation|0|||
147547636|NCT01078623|532162150|FG005|Treatment Period 1|Protocol Violation|1|||
147547637|NCT01078623|532162151|FG006|Treatment Period 1|Protocol Violation|0|||
147547638|NCT01078623|532162152|FG007|Treatment Period 1|Protocol Violation|0|||
147547639|NCT01078623|532162153|FG008|Treatment Period 1|Protocol Violation|0|||
147547640|NCT01078623|532162154|FG009|Treatment Period 1|Protocol Violation|0|||
147547641|NCT01078623|532162155|FG010|Treatment Period 1|Protocol Violation|0|||
147547642|NCT01078623|532162156|FG011|Treatment Period 1|Protocol Violation|0|||
147213955|NCT01328444|530956485|FG001|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|2|||
147213956|NCT01328444|530956486|FG002|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1|||
147213957|NCT01328444|530956487|FG003|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|2|||
147213958|NCT01328444|530956488|FG004|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1|||
147213959|NCT01328444|530956489|FG005|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
147213960|NCT01328444|530956484|FG000|Washout Period (14 Days)|Adverse Event|1|||
147213961|NCT01328444|530956485|FG001|Washout Period (14 Days)|Adverse Event|1|||
147213962|NCT01328444|530956486|FG002|Washout Period (14 Days)|Adverse Event|0|||
147213963|NCT01328444|530956487|FG003|Washout Period (14 Days)|Adverse Event|1|||
147213964|NCT01328444|530956488|FG004|Washout Period (14 Days)|Adverse Event|1|||
147213965|NCT01328444|530956489|FG005|Washout Period (14 Days)|Adverse Event|2|||
147213966|NCT01328444|530956484|FG000|Washout Period (14 Days)|Lack of Efficacy|0|||
147213967|NCT01328444|530956485|FG001|Washout Period (14 Days)|Lack of Efficacy|0|||
147213968|NCT01328444|530956486|FG002|Washout Period (14 Days)|Lack of Efficacy|0|||
147213969|NCT01328444|530956487|FG003|Washout Period (14 Days)|Lack of Efficacy|0|||
147213970|NCT01328444|530956488|FG004|Washout Period (14 Days)|Lack of Efficacy|0|||
147213971|NCT01328444|530956489|FG005|Washout Period (14 Days)|Lack of Efficacy|1|||
147213972|NCT01328444|530956484|FG000|Washout Period (14 Days)|Withdrawal by Subject|0|||
147213973|NCT01328444|530956485|FG001|Washout Period (14 Days)|Withdrawal by Subject|0|||
147213974|NCT01328444|530956486|FG002|Washout Period (14 Days)|Withdrawal by Subject|0|||
147213975|NCT01328444|530956487|FG003|Washout Period (14 Days)|Withdrawal by Subject|0|||
147213976|NCT01328444|530956488|FG004|Washout Period (14 Days)|Withdrawal by Subject|0|||
147213977|NCT01328444|530956489|FG005|Washout Period (14 Days)|Withdrawal by Subject|1|||
147213978|NCT01328444|530956484|FG000|Treatment Period 2 (12 Weeks)|Adverse Event|5|||
147213979|NCT01328444|530956485|FG001|Treatment Period 2 (12 Weeks)|Adverse Event|0|||
147213980|NCT01328444|530956486|FG002|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
147213981|NCT01328444|530956487|FG003|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
147213982|NCT01328444|530956488|FG004|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
147213983|NCT01328444|530956489|FG005|Treatment Period 2 (12 Weeks)|Adverse Event|0|||
147213984|NCT01328444|530956484|FG000|Treatment Period 2 (12 Weeks)|Lack of Efficacy|5|||
147213985|NCT01328444|530956485|FG001|Treatment Period 2 (12 Weeks)|Lack of Efficacy|1|||
147213986|NCT01328444|530956486|FG002|Treatment Period 2 (12 Weeks)|Lack of Efficacy|1|||
147213987|NCT01328444|530956487|FG003|Treatment Period 2 (12 Weeks)|Lack of Efficacy|2|||
147213988|NCT01328444|530956488|FG004|Treatment Period 2 (12 Weeks)|Lack of Efficacy|3|||
147213989|NCT01328444|530956489|FG005|Treatment Period 2 (12 Weeks)|Lack of Efficacy|4|||
147213990|NCT01328444|530956484|FG000|Treatment Period 2 (12 Weeks)|Protocol Violation|1|||
147213991|NCT01328444|530956485|FG001|Treatment Period 2 (12 Weeks)|Protocol Violation|0|||
147213992|NCT01328444|530956486|FG002|Treatment Period 2 (12 Weeks)|Protocol Violation|0|||
147213993|NCT01328444|530956487|FG003|Treatment Period 2 (12 Weeks)|Protocol Violation|0|||
147213994|NCT01328444|530956488|FG004|Treatment Period 2 (12 Weeks)|Protocol Violation|1|||
147213995|NCT01328444|530956489|FG005|Treatment Period 2 (12 Weeks)|Protocol Violation|0|||
147213996|NCT01328444|530956484|FG000|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0|||
147213997|NCT01328444|530956485|FG001|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0|||
147213998|NCT01328444|530956486|FG002|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0|||
147213999|NCT01328444|530956487|FG003|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|1|||
147214000|NCT01328444|530956488|FG004|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|1|||
147214001|NCT01328444|530956489|FG005|Treatment Period 2 (12 Weeks)|Met Protocol Defined Stopping Criteria|0|||
147214002|NCT01328444|530956484|FG000|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
147214003|NCT01328444|530956485|FG001|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
147214004|NCT01328444|530956486|FG002|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1|||
147214005|NCT01328444|530956487|FG003|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1|||
147214006|NCT01328444|530956488|FG004|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1|||
147214007|NCT01328444|530956489|FG005|Treatment Period 2 (12 Weeks)|Lost to Follow-up|2|||
147214008|NCT01328444|530956484|FG000|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
147214009|NCT01328444|530956485|FG001|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
147214010|NCT01328444|530956486|FG002|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
147214011|NCT01328444|530956487|FG003|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
147214012|NCT01328444|530956488|FG004|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
147547643|NCT01078623|532162157|FG012|Treatment Period 1|Protocol Violation|0|||
147214013|NCT01328444|530956489|FG005|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
147214014|NCT03531632|530956490|FG000|Overall Study|Adverse Event|0|||
147214015|NCT03531632|530956491|FG001|Overall Study|Adverse Event|0|||
147214016|NCT03531632|530956492|FG002|Overall Study|Adverse Event|1|||
147214017|NCT03531632|530956490|FG000|Overall Study|Death|4|||
147547644|NCT01078623|532162158|FG013|Treatment Period 1|Protocol Violation|0|||
147547645|NCT01078623|532162159|FG014|Treatment Period 1|Protocol Violation|0|||
147547646|NCT01078623|532162160|FG015|Treatment Period 1|Protocol Violation|0|||
147547647|NCT01078623|532162161|FG016|Treatment Period 1|Protocol Violation|0|||
147547648|NCT01078623|532162162|FG017|Treatment Period 1|Protocol Violation|0|||
147547649|NCT01078623|532162163|FG018|Treatment Period 1|Protocol Violation|0|||
147547650|NCT01078623|532162164|FG019|Treatment Period 1|Protocol Violation|0|||
147547651|NCT01078623|532162145|FG000|Treatment Period 2|Adverse Event|0|||
147547652|NCT01078623|532162146|FG001|Treatment Period 2|Adverse Event|0|||
147547653|NCT01078623|532162147|FG002|Treatment Period 2|Adverse Event|0|||
147547654|NCT01078623|532162148|FG003|Treatment Period 2|Adverse Event|0|||
147547655|NCT01078623|532162149|FG004|Treatment Period 2|Adverse Event|0|||
147547656|NCT01078623|532162150|FG005|Treatment Period 2|Adverse Event|0|||
147547657|NCT01078623|532162151|FG006|Treatment Period 2|Adverse Event|1|||
147547658|NCT01078623|532162152|FG007|Treatment Period 2|Adverse Event|0|||
147214018|NCT03531632|530956491|FG001|Overall Study|Death|0|||
147214019|NCT03531632|530956492|FG002|Overall Study|Death|14|||
147547659|NCT01078623|532162153|FG008|Treatment Period 2|Adverse Event|0|||
147547660|NCT01078623|532162154|FG009|Treatment Period 2|Adverse Event|0|||
147547661|NCT01078623|532162155|FG010|Treatment Period 2|Adverse Event|0|||
147214020|NCT03531632|530956490|FG000|Overall Study|Study Terminated|1|||
147214021|NCT03531632|530956491|FG001|Overall Study|Study Terminated|3|||
147214022|NCT03531632|530956492|FG002|Overall Study|Study Terminated|11|||
147214023|NCT02743611|530956493|FG000|Overall Study|Early study termination due to Sponsor discretion|4|||
147214024|NCT02743611|530956494|FG001|Overall Study|Early study termination due to Sponsor discretion|0|||
147214025|NCT02743611|530956495|FG002|Overall Study|Early study termination due to Sponsor discretion|0|||
147214026|NCT02743611|530956496|FG003|Overall Study|Early study termination due to Sponsor discretion|0|||
147214027|NCT00600119|530956497|FG000|Single-blind Placebo run-in Period|Other - Not specified|1|||
147214028|NCT00600119|530956498|FG001|Single-blind Placebo run-in Period|Other - Not specified|0|||
147214029|NCT00600119|530956499|FG002|Single-blind Placebo run-in Period|Other - Not specified|0|||
147214030|NCT00600119|530956500|FG003|Single-blind Placebo run-in Period|Other - Not specified|0|||
147214031|NCT00600119|530956501|FG004|Single-blind Placebo run-in Period|Other - Not specified|1|||
147214032|NCT00600119|530956502|FG005|Single-blind Placebo run-in Period|Other - Not specified|1|||
147214033|NCT00600119|530956497|FG000|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
147214034|NCT00600119|530956498|FG001|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|1|||
147214035|NCT00600119|530956499|FG002|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|1|||
147214036|NCT00600119|530956500|FG003|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
147214037|NCT00600119|530956501|FG004|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
147214038|NCT00600119|530956502|FG005|Single-blind Placebo run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
147214039|NCT00600119|530956497|FG000|Single-blind Placebo run-in Period|Sponsor Decision|0|||
147214040|NCT00600119|530956498|FG001|Single-blind Placebo run-in Period|Sponsor Decision|0|||
147214041|NCT00600119|530956499|FG002|Single-blind Placebo run-in Period|Sponsor Decision|1|||
147214042|NCT00600119|530956500|FG003|Single-blind Placebo run-in Period|Sponsor Decision|0|||
147214043|NCT00600119|530956501|FG004|Single-blind Placebo run-in Period|Sponsor Decision|1|||
147214044|NCT00600119|530956502|FG005|Single-blind Placebo run-in Period|Sponsor Decision|0|||
147214045|NCT00600119|530956497|FG000|Single-blind Placebo run-in Period|Lost to Follow-up|1|||
147214046|NCT00600119|530956498|FG001|Single-blind Placebo run-in Period|Lost to Follow-up|0|||
147214047|NCT00600119|530956499|FG002|Single-blind Placebo run-in Period|Lost to Follow-up|0|||
147214048|NCT00600119|530956500|FG003|Single-blind Placebo run-in Period|Lost to Follow-up|0|||
147214049|NCT00600119|530956501|FG004|Single-blind Placebo run-in Period|Lost to Follow-up|0|||
147214050|NCT00600119|530956502|FG005|Single-blind Placebo run-in Period|Lost to Follow-up|0|||
147214051|NCT00600119|530956497|FG000|Single-blind Placebo run-in Period|Adverse Event|0|||
147214052|NCT00600119|530956498|FG001|Single-blind Placebo run-in Period|Adverse Event|0|||
147214053|NCT00600119|530956499|FG002|Single-blind Placebo run-in Period|Adverse Event|0|||
147214054|NCT00600119|530956500|FG003|Single-blind Placebo run-in Period|Adverse Event|1|||
147214055|NCT00600119|530956501|FG004|Single-blind Placebo run-in Period|Adverse Event|0|||
147214056|NCT00600119|530956502|FG005|Single-blind Placebo run-in Period|Adverse Event|1|||
147214057|NCT00600119|530956497|FG000|Single-blind Placebo run-in Period|Withdrawal by Subject|2|||
147214058|NCT00600119|530956498|FG001|Single-blind Placebo run-in Period|Withdrawal by Subject|1|||
147214059|NCT00600119|530956499|FG002|Single-blind Placebo run-in Period|Withdrawal by Subject|0|||
147547662|NCT01078623|532162156|FG011|Treatment Period 2|Adverse Event|0|||
147547663|NCT01078623|532162157|FG012|Treatment Period 2|Adverse Event|0|||
147547664|NCT01078623|532162158|FG013|Treatment Period 2|Adverse Event|0|||
147547665|NCT01078623|532162159|FG014|Treatment Period 2|Adverse Event|0|||
147547666|NCT01078623|532162160|FG015|Treatment Period 2|Adverse Event|0|||
147547667|NCT01078623|532162161|FG016|Treatment Period 2|Adverse Event|0|||
147547668|NCT01078623|532162162|FG017|Treatment Period 2|Adverse Event|0|||
147547669|NCT01078623|532162163|FG018|Treatment Period 2|Adverse Event|1|||
147547670|NCT01078623|532162164|FG019|Treatment Period 2|Adverse Event|0|||
147547671|NCT01078623|532162145|FG000|Treatment Period 2|Withdrawal by Subject|0|||
147547672|NCT01078623|532162146|FG001|Treatment Period 2|Withdrawal by Subject|0|||
147547673|NCT01078623|532162147|FG002|Treatment Period 2|Withdrawal by Subject|0|||
147547674|NCT01078623|532162148|FG003|Treatment Period 2|Withdrawal by Subject|0|||
147547675|NCT01078623|532162149|FG004|Treatment Period 2|Withdrawal by Subject|0|||
147547676|NCT01078623|532162150|FG005|Treatment Period 2|Withdrawal by Subject|1|||
147547677|NCT01078623|532162151|FG006|Treatment Period 2|Withdrawal by Subject|0|||
147547678|NCT01078623|532162152|FG007|Treatment Period 2|Withdrawal by Subject|0|||
147547679|NCT01078623|532162153|FG008|Treatment Period 2|Withdrawal by Subject|0|||
147547680|NCT01078623|532162154|FG009|Treatment Period 2|Withdrawal by Subject|0|||
147547681|NCT01078623|532162155|FG010|Treatment Period 2|Withdrawal by Subject|0|||
147547682|NCT01078623|532162156|FG011|Treatment Period 2|Withdrawal by Subject|0|||
147547683|NCT01078623|532162157|FG012|Treatment Period 2|Withdrawal by Subject|0|||
147547684|NCT01078623|532162158|FG013|Treatment Period 2|Withdrawal by Subject|0|||
147547685|NCT01078623|532162159|FG014|Treatment Period 2|Withdrawal by Subject|0|||
147547686|NCT01078623|532162160|FG015|Treatment Period 2|Withdrawal by Subject|0|||
147547687|NCT01078623|532162161|FG016|Treatment Period 2|Withdrawal by Subject|0|||
147547688|NCT01078623|532162162|FG017|Treatment Period 2|Withdrawal by Subject|0|||
147547689|NCT01078623|532162163|FG018|Treatment Period 2|Withdrawal by Subject|0|||
147547690|NCT01078623|532162164|FG019|Treatment Period 2|Withdrawal by Subject|0|||
147547691|NCT01078623|532162145|FG000|Treatment Period 3|Adverse Event|0|||
147547692|NCT01078623|532162146|FG001|Treatment Period 3|Adverse Event|0|||
147547693|NCT01078623|532162147|FG002|Treatment Period 3|Adverse Event|0|||
147547694|NCT01078623|532162148|FG003|Treatment Period 3|Adverse Event|0|||
147547695|NCT01078623|532162149|FG004|Treatment Period 3|Adverse Event|1|||
147547696|NCT01078623|532162150|FG005|Treatment Period 3|Adverse Event|0|||
147547697|NCT01078623|532162151|FG006|Treatment Period 3|Adverse Event|0|||
147547698|NCT01078623|532162152|FG007|Treatment Period 3|Adverse Event|0|||
147547699|NCT01078623|532162153|FG008|Treatment Period 3|Adverse Event|0|||
147547700|NCT01078623|532162154|FG009|Treatment Period 3|Adverse Event|0|||
147547701|NCT01078623|532162155|FG010|Treatment Period 3|Adverse Event|0|||
147547702|NCT01078623|532162156|FG011|Treatment Period 3|Adverse Event|0|||
147547703|NCT01078623|532162157|FG012|Treatment Period 3|Adverse Event|0|||
147547704|NCT01078623|532162158|FG013|Treatment Period 3|Adverse Event|1|||
147547705|NCT01078623|532162159|FG014|Treatment Period 3|Adverse Event|0|||
147547706|NCT01078623|532162160|FG015|Treatment Period 3|Adverse Event|0|||
147547707|NCT01078623|532162161|FG016|Treatment Period 3|Adverse Event|0|||
147547708|NCT01078623|532162162|FG017|Treatment Period 3|Adverse Event|0|||
147547709|NCT01078623|532162163|FG018|Treatment Period 3|Adverse Event|0|||
147547710|NCT01078623|532162164|FG019|Treatment Period 3|Adverse Event|0|||
147547711|NCT01078623|532162145|FG000|Treatment Period 4|Adverse Event|0|||
147547712|NCT01078623|532162146|FG001|Treatment Period 4|Adverse Event|0|||
147547713|NCT01078623|532162147|FG002|Treatment Period 4|Adverse Event|1|||
147547714|NCT01078623|532162148|FG003|Treatment Period 4|Adverse Event|0|||
147547715|NCT01078623|532162149|FG004|Treatment Period 4|Adverse Event|0|||
147547716|NCT01078623|532162150|FG005|Treatment Period 4|Adverse Event|0|||
147547717|NCT01078623|532162151|FG006|Treatment Period 4|Adverse Event|0|||
147547718|NCT01078623|532162152|FG007|Treatment Period 4|Adverse Event|0|||
147547719|NCT01078623|532162153|FG008|Treatment Period 4|Adverse Event|0|||
147547720|NCT01078623|532162154|FG009|Treatment Period 4|Adverse Event|0|||
147547721|NCT01078623|532162155|FG010|Treatment Period 4|Adverse Event|0|||
147547722|NCT01078623|532162156|FG011|Treatment Period 4|Adverse Event|0|||
147547723|NCT01078623|532162157|FG012|Treatment Period 4|Adverse Event|0|||
147547724|NCT01078623|532162158|FG013|Treatment Period 4|Adverse Event|0|||
147214060|NCT00600119|530956500|FG003|Single-blind Placebo run-in Period|Withdrawal by Subject|0|||
147214061|NCT00600119|530956501|FG004|Single-blind Placebo run-in Period|Withdrawal by Subject|0|||
147214062|NCT00600119|530956502|FG005|Single-blind Placebo run-in Period|Withdrawal by Subject|0|||
147214063|NCT00600119|530956497|FG000|Double-blind Treatment Period|Withdrawal by Subject|2|||
147214064|NCT00600119|530956498|FG001|Double-blind Treatment Period|Withdrawal by Subject|0|||
147214065|NCT00600119|530956499|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
147214066|NCT00600119|530956500|FG003|Double-blind Treatment Period|Withdrawal by Subject|1|||
147214067|NCT00600119|530956501|FG004|Double-blind Treatment Period|Withdrawal by Subject|0|||
147214068|NCT00600119|530956502|FG005|Double-blind Treatment Period|Withdrawal by Subject|3|||
147214069|NCT00600119|530956497|FG000|Double-blind Treatment Period|Other|0|||
147214070|NCT00600119|530956498|FG001|Double-blind Treatment Period|Other|0|||
147547725|NCT01078623|532162159|FG014|Treatment Period 4|Adverse Event|0|||
147547726|NCT01078623|532162160|FG015|Treatment Period 4|Adverse Event|0|||
147547727|NCT01078623|532162161|FG016|Treatment Period 4|Adverse Event|0|||
147547728|NCT01078623|532162162|FG017|Treatment Period 4|Adverse Event|0|||
147547729|NCT01078623|532162163|FG018|Treatment Period 4|Adverse Event|0|||
147547730|NCT01078623|532162164|FG019|Treatment Period 4|Adverse Event|0|||
147547731|NCT01078623|532162145|FG000|Treatment Period 4|Withdrawal by Subject|0|||
147547732|NCT01078623|532162146|FG001|Treatment Period 4|Withdrawal by Subject|0|||
147214071|NCT00600119|530956499|FG002|Double-blind Treatment Period|Other|0|||
147547733|NCT01078623|532162147|FG002|Treatment Period 4|Withdrawal by Subject|0|||
147547734|NCT01078623|532162148|FG003|Treatment Period 4|Withdrawal by Subject|0|||
147547735|NCT01078623|532162149|FG004|Treatment Period 4|Withdrawal by Subject|0|||
147547736|NCT01078623|532162150|FG005|Treatment Period 4|Withdrawal by Subject|0|||
147547737|NCT01078623|532162151|FG006|Treatment Period 4|Withdrawal by Subject|0|||
147547738|NCT01078623|532162152|FG007|Treatment Period 4|Withdrawal by Subject|0|||
147547739|NCT01078623|532162153|FG008|Treatment Period 4|Withdrawal by Subject|0|||
147214072|NCT00600119|530956500|FG003|Double-blind Treatment Period|Other|0|||
147214073|NCT00600119|530956501|FG004|Double-blind Treatment Period|Other|2|||
147214074|NCT00600119|530956502|FG005|Double-blind Treatment Period|Other|1|||
147214075|NCT00600119|530956497|FG000|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0|||
147214076|NCT00600119|530956498|FG001|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|1|||
147214077|NCT00600119|530956499|FG002|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0|||
147214078|NCT00600119|530956500|FG003|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0|||
147214079|NCT00600119|530956501|FG004|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|1|||
147214080|NCT00600119|530956502|FG005|Double-blind Treatment Period|Inclusion/Exclusion Criteria Not Met|0|||
147214081|NCT00600119|530956497|FG000|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0|||
147214082|NCT00600119|530956498|FG001|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|1|||
147214083|NCT00600119|530956499|FG002|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0|||
147214084|NCT00600119|530956500|FG003|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0|||
147214085|NCT00600119|530956501|FG004|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0|||
147214086|NCT00600119|530956502|FG005|Double-blind Treatment Period|Moderate to Severe Opioid Withdrawal|0|||
147214087|NCT00600119|530956497|FG000|Double-blind Treatment Period|Sponsor Decision|0|||
147214088|NCT00600119|530956498|FG001|Double-blind Treatment Period|Sponsor Decision|1|||
147214089|NCT00600119|530956499|FG002|Double-blind Treatment Period|Sponsor Decision|0|||
147214090|NCT00600119|530956500|FG003|Double-blind Treatment Period|Sponsor Decision|0|||
147214091|NCT00600119|530956501|FG004|Double-blind Treatment Period|Sponsor Decision|1|||
147214092|NCT00600119|530956502|FG005|Double-blind Treatment Period|Sponsor Decision|0|||
147214093|NCT00600119|530956497|FG000|Double-blind Treatment Period|Physician Decision|2|||
147214094|NCT00600119|530956498|FG001|Double-blind Treatment Period|Physician Decision|0|||
147214095|NCT00600119|530956499|FG002|Double-blind Treatment Period|Physician Decision|0|||
147214096|NCT00600119|530956500|FG003|Double-blind Treatment Period|Physician Decision|0|||
147214097|NCT00600119|530956501|FG004|Double-blind Treatment Period|Physician Decision|0|||
147214098|NCT00600119|530956502|FG005|Double-blind Treatment Period|Physician Decision|0|||
147214099|NCT00600119|530956497|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
147214100|NCT00600119|530956498|FG001|Double-blind Treatment Period|Lost to Follow-up|1|||
147214101|NCT00600119|530956499|FG002|Double-blind Treatment Period|Lost to Follow-up|0|||
147214102|NCT00600119|530956500|FG003|Double-blind Treatment Period|Lost to Follow-up|0|||
147214103|NCT00600119|530956501|FG004|Double-blind Treatment Period|Lost to Follow-up|0|||
147214104|NCT00600119|530956502|FG005|Double-blind Treatment Period|Lost to Follow-up|0|||
147214105|NCT00600119|530956497|FG000|Double-blind Treatment Period|Adverse Event|1|||
147214106|NCT00600119|530956498|FG001|Double-blind Treatment Period|Adverse Event|1|||
147214107|NCT00600119|530956499|FG002|Double-blind Treatment Period|Adverse Event|0|||
147214108|NCT00600119|530956500|FG003|Double-blind Treatment Period|Adverse Event|1|||
147214109|NCT00600119|530956501|FG004|Double-blind Treatment Period|Adverse Event|2|||
147214110|NCT00600119|530956502|FG005|Double-blind Treatment Period|Adverse Event|10|||
147214111|NCT00600119|530956497|FG000|Follow-up Period|Adverse Event|0|||
147214112|NCT00600119|530956498|FG001|Follow-up Period|Adverse Event|0|||
147214113|NCT00600119|530956499|FG002|Follow-up Period|Adverse Event|0|||
147214114|NCT00600119|530956500|FG003|Follow-up Period|Adverse Event|0|||
147214115|NCT00600119|530956501|FG004|Follow-up Period|Adverse Event|0|||
147214116|NCT00600119|530956502|FG005|Follow-up Period|Adverse Event|1|||
147214117|NCT00600119|530956497|FG000|Follow-up Period|Other|1|||
147214118|NCT00600119|530956498|FG001|Follow-up Period|Other|0|||
147214119|NCT00600119|530956499|FG002|Follow-up Period|Other|0|||
147214120|NCT00600119|530956500|FG003|Follow-up Period|Other|0|||
147214121|NCT00600119|530956501|FG004|Follow-up Period|Other|0|||
147214122|NCT00600119|530956502|FG005|Follow-up Period|Other|0|||
147214123|NCT01616693|530956503|FG000|Evaluated for Safety|Physician Decision|1|||
147214124|NCT01616693|530956504|FG001|Evaluated for Safety|Physician Decision|0|||
147214125|NCT01616693|530956505|FG002|Evaluated for Safety|Physician Decision|1|||
147214126|NCT01616693|530956506|FG003|Evaluated for Safety|Physician Decision|0|||
147214127|NCT01616693|530956503|FG000|Received Both Vaccines|Adverse Event|2|||
147214128|NCT01616693|530956504|FG001|Received Both Vaccines|Adverse Event|0|||
147214129|NCT01616693|530956505|FG002|Received Both Vaccines|Adverse Event|0|||
147214130|NCT01616693|530956506|FG003|Received Both Vaccines|Adverse Event|0|||
147214131|NCT01616693|530956503|FG000|Received Both Vaccines|Withdrawal by Subject|7|||
147214132|NCT01616693|530956504|FG001|Received Both Vaccines|Withdrawal by Subject|7|||
147214133|NCT01616693|530956505|FG002|Received Both Vaccines|Withdrawal by Subject|8|||
147214134|NCT01616693|530956506|FG003|Received Both Vaccines|Withdrawal by Subject|15|||
147214135|NCT01616693|530956503|FG000|Received Both Vaccines|Lost to Follow-up|4|||
147214136|NCT01616693|530956504|FG001|Received Both Vaccines|Lost to Follow-up|3|||
147214137|NCT01616693|530956505|FG002|Received Both Vaccines|Lost to Follow-up|4|||
147214138|NCT01616693|530956506|FG003|Received Both Vaccines|Lost to Follow-up|4|||
147214139|NCT01616693|530956503|FG000|Blood Analyzed for Immunogenicity|Protocol Violation|4|||
147214140|NCT01616693|530956504|FG001|Blood Analyzed for Immunogenicity|Protocol Violation|2|||
147214141|NCT01616693|530956505|FG002|Blood Analyzed for Immunogenicity|Protocol Violation|6|||
147547740|NCT01078623|532162154|FG009|Treatment Period 4|Withdrawal by Subject|0|||
147547741|NCT01078623|532162155|FG010|Treatment Period 4|Withdrawal by Subject|0|||
147547742|NCT01078623|532162156|FG011|Treatment Period 4|Withdrawal by Subject|0|||
147547743|NCT01078623|532162157|FG012|Treatment Period 4|Withdrawal by Subject|0|||
147547744|NCT01078623|532162158|FG013|Treatment Period 4|Withdrawal by Subject|0|||
147547745|NCT01078623|532162159|FG014|Treatment Period 4|Withdrawal by Subject|0|||
147547746|NCT01078623|532162160|FG015|Treatment Period 4|Withdrawal by Subject|1|||
147547747|NCT01078623|532162161|FG016|Treatment Period 4|Withdrawal by Subject|0|||
147547748|NCT01078623|532162162|FG017|Treatment Period 4|Withdrawal by Subject|0|||
147547749|NCT01078623|532162163|FG018|Treatment Period 4|Withdrawal by Subject|0|||
147547750|NCT01078623|532162164|FG019|Treatment Period 4|Withdrawal by Subject|0|||
147547751|NCT00463866|532162165|FG000|Overall Study|Adverse Event|70|||
147547752|NCT00463866|532162166|FG001|Overall Study|Adverse Event|93|||
147547753|NCT00463866|532162165|FG000|Overall Study|Withdrawal by Subject|81|||
147547754|NCT00463866|532162166|FG001|Overall Study|Withdrawal by Subject|79|||
147547755|NCT00463866|532162165|FG000|Overall Study|Lost to Follow-up|46|||
147547756|NCT00463866|532162166|FG001|Overall Study|Lost to Follow-up|55|||
147547757|NCT00463866|532162165|FG000|Overall Study|Incorrect Enrolment|64|||
147547758|NCT00463866|532162166|FG001|Overall Study|Incorrect Enrolment|66|||
147547759|NCT00463866|532162165|FG000|Overall Study|Severe Non-Compliance to Protocol|25|||
147547760|NCT00463866|532162166|FG001|Overall Study|Severe Non-Compliance to Protocol|21|||
147547761|NCT00463866|532162165|FG000|Overall Study|Safety Reason|1|||
147547762|NCT00463866|532162166|FG001|Overall Study|Safety Reason|3|||
147547763|NCT00463866|532162165|FG000|Overall Study|Mis-Randomization of subject|0|||
147547764|NCT00463866|532162166|FG001|Overall Study|Mis-Randomization of subject|1|||
147214142|NCT01616693|530956506|FG003|Blood Analyzed for Immunogenicity|Protocol Violation|1|||
147214143|NCT01950013|530956507|FG000|Overall Study|Withdrawal by Subject|0|||
147214144|NCT01950013|530956508|FG001|Overall Study|Withdrawal by Subject|2|||
147214145|NCT01950013|530956509|FG002|Overall Study|Withdrawal by Subject|0|||
147214146|NCT00271505|530956513|FG000|Overall Study|Screen Failure|3|||
147214147|NCT00271505|530956513|FG000|Overall Study|Adverse Event|1|||
147214148|NCT00271505|530956513|FG000|Overall Study|Death|1|||
147214149|NCT00539188|530956514|FG000|Overall Study|Withdrawal by Subject|1|||
147547765|NCT00463866|532162165|FG000|Overall Study|Other|22|||
147547766|NCT00463866|532162166|FG001|Overall Study|Other|22|||
147547767|NCT03568500|532162169|FG000|Overall Study|Lost to Follow-up|1|||
147547768|NCT03568500|532162170|FG001|Overall Study|Lost to Follow-up|1|||
147547769|NCT03568500|532162171|FG002|Overall Study|Lost to Follow-up|2|||
147547770|NCT03568500|532162169|FG000|Overall Study|Adverse Event|1|||
147547771|NCT03568500|532162170|FG001|Overall Study|Adverse Event|1|||
147547772|NCT03568500|532162171|FG002|Overall Study|Adverse Event|2|||
147547773|NCT03568500|532162169|FG000|Overall Study|Physician Decision|1|||
147547774|NCT03568500|532162170|FG001|Overall Study|Physician Decision|0|||
147547775|NCT03568500|532162171|FG002|Overall Study|Physician Decision|0|||
147547776|NCT03568500|532162169|FG000|Overall Study|Withdrawal by Subject|4|||
147547777|NCT03568500|532162170|FG001|Overall Study|Withdrawal by Subject|2|||
147547778|NCT03568500|532162171|FG002|Overall Study|Withdrawal by Subject|0|||
147547779|NCT03568500|532162169|FG000|Overall Study|Technical Problems|2|||
147547780|NCT03568500|532162170|FG001|Overall Study|Technical Problems|1|||
147547781|NCT03568500|532162171|FG002|Overall Study|Technical Problems|0|||
147547782|NCT03568500|532162169|FG000|Overall Study|Participant Noncompliance|1|||
147214150|NCT00539188|530956515|FG001|Overall Study|Withdrawal by Subject|0|||
147214151|NCT00539188|530956514|FG000|Overall Study|Lost to Follow-up|2|||
147547783|NCT03568500|532162170|FG001|Overall Study|Participant Noncompliance|1|||
147547784|NCT03568500|532162171|FG002|Overall Study|Participant Noncompliance|0|||
147547785|NCT01170364|532162186|FG000|Overall Study|Protocol Violation|4|||
147547786|NCT01170364|532162187|FG001|Overall Study|Protocol Violation|1|||
147547787|NCT01368276|532162188|FG000|Overall Study|Death|1|||
147547788|NCT01368276|532162189|FG001|Overall Study|Death|10|||
147547789|NCT02041494|532162190|FG000|Overall Study|Death|1|||
147547790|NCT02041494|532162191|FG001|Overall Study|Death|3|||
147547791|NCT02041494|532162190|FG000|Overall Study|Lost to Follow-up|2|||
147547792|NCT02041494|532162191|FG001|Overall Study|Lost to Follow-up|6|||
147547793|NCT02041494|532162190|FG000|Overall Study|study terminated|16|||
147214152|NCT00539188|530956515|FG001|Overall Study|Lost to Follow-up|1|||
147547794|NCT02041494|532162191|FG001|Overall Study|study terminated|11|||
147547795|NCT03341273|532162192|FG000|Overall Study|Lost to Follow-up|7|||
147547796|NCT03341273|532162193|FG001|Overall Study|Lost to Follow-up|7|||
147547797|NCT03341273|532162192|FG000|Overall Study|Withdrawal by Subject|4|||
147547798|NCT03341273|532162193|FG001|Overall Study|Withdrawal by Subject|2|||
147547799|NCT03341273|532162192|FG000|Overall Study|Physician Decision|1|||
147214153|NCT04784442|530956516|FG000|Overall Study|Adverse Event|1|||
147214154|NCT04784442|530956517|FG001|Overall Study|Adverse Event|0|||
147214155|NCT04784442|530956518|FG002|Overall Study|Adverse Event|2|||
147547800|NCT03341273|532162193|FG001|Overall Study|Physician Decision|0|||
147547801|NCT03341273|532162192|FG000|Overall Study|Protocol Violation|0|||
147547802|NCT03341273|532162193|FG001|Overall Study|Protocol Violation|1|||
147547803|NCT03341273|532162192|FG000|Overall Study|Enrolled but Treatment Not Administered|6|||
147547804|NCT03341273|532162193|FG001|Overall Study|Enrolled but Treatment Not Administered|1|||
147547805|NCT03341273|532162192|FG000|Overall Study|Became ineligible after enrollment|1|||
147547806|NCT03341273|532162193|FG001|Overall Study|Became ineligible after enrollment|0|||
147547807|NCT03341273|532162192|FG000|Overall Study|Not Eligible at Enrollment|0|||
147547808|NCT03341273|532162193|FG001|Overall Study|Not Eligible at Enrollment|1|||
147547809|NCT03341273|532162192|FG000|Overall Study|Participant incarcerated|1|||
147547810|NCT03341273|532162193|FG001|Overall Study|Participant incarcerated|0|||
147547811|NCT00685919|532162194|FG000|Overall Study|Withdrawal by Subject|0|||
147547812|NCT00685919|532162195|FG001|Overall Study|Withdrawal by Subject|0|||
147547813|NCT00685919|532162196|FG002|Overall Study|Withdrawal by Subject|1|||
147547814|NCT00685919|532162197|FG003|Overall Study|Withdrawal by Subject|0|||
147547815|NCT00685919|532162194|FG000|Overall Study|Physician Decision|1|||
147547816|NCT00685919|532162195|FG001|Overall Study|Physician Decision|0|||
147547817|NCT00685919|532162196|FG002|Overall Study|Physician Decision|0|||
147547818|NCT00685919|532162197|FG003|Overall Study|Physician Decision|0|||
147547819|NCT02622074|532162198|FG000|Overall Study|Death|4|||
147547820|NCT02622074|532162199|FG001|Overall Study|Death|0|||
147547821|NCT02622074|532162200|FG002|Overall Study|Death|0|||
147547822|NCT02622074|532162201|FG003|Overall Study|Death|1|||
147547823|NCT02622074|532162202|FG004|Overall Study|Death|1|||
147547824|NCT02622074|532162203|FG005|Overall Study|Death|0|||
147547825|NCT02622074|532162198|FG000|Overall Study|Withdrawal by Subject|0|||
147547826|NCT02622074|532162199|FG001|Overall Study|Withdrawal by Subject|1|||
147547827|NCT02622074|532162200|FG002|Overall Study|Withdrawal by Subject|0|||
147547828|NCT02622074|532162201|FG003|Overall Study|Withdrawal by Subject|0|||
147547829|NCT02622074|532162202|FG004|Overall Study|Withdrawal by Subject|0|||
147547830|NCT02622074|532162203|FG005|Overall Study|Withdrawal by Subject|0|||
147547831|NCT02114931|532162204|FG000|Overall Study|Withdrawal by Subject|15|||
147547832|NCT02114931|532162205|FG001|Overall Study|Withdrawal by Subject|18|||
147547833|NCT02114931|532162204|FG000|Overall Study|Adverse Event|4|||
147547834|NCT02114931|532162205|FG001|Overall Study|Adverse Event|6|||
147547835|NCT02114931|532162204|FG000|Overall Study|Lost to Follow-up|3|||
147547836|NCT02114931|532162205|FG001|Overall Study|Lost to Follow-up|3|||
147547837|NCT02114931|532162204|FG000|Overall Study|Physician Decision|1|||
147547838|NCT02114931|532162205|FG001|Overall Study|Physician Decision|2|||
147547839|NCT02114931|532162204|FG000|Overall Study|Other|2|||
147547840|NCT02114931|532162205|FG001|Overall Study|Other|1|||
147547841|NCT03726437|532162206|FG000|Overall Study|Lost to Follow-up|85|||
147547842|NCT03726437|532162207|FG001|Overall Study|Lost to Follow-up|76|||
147547843|NCT00267007|532162208|FG000|Overall Study|Withdrawal by Subject|6|||
147547844|NCT00267007|532162209|FG001|Overall Study|Withdrawal by Subject|0|||
147547845|NCT00267007|532162208|FG000|Overall Study|Lost to Follow-up|1|||
147547846|NCT00267007|532162209|FG001|Overall Study|Lost to Follow-up|0|||
147547847|NCT00267007|532162208|FG000|Overall Study|Non-compliance|0|||
147547848|NCT00267007|532162209|FG001|Overall Study|Non-compliance|1|||
147547849|NCT00267007|532162208|FG000|Overall Study|Adverse Event|1|||
147547850|NCT00267007|532162209|FG001|Overall Study|Adverse Event|0|||
147547851|NCT01205529|532162216|FG000|Overall Study|Procedure Cancelled|4|||
147547852|NCT01205529|532162216|FG000|Overall Study|Withdrawal by Subject|2|||
147547853|NCT01205529|532162216|FG000|Overall Study|Physician Decision|4|||
147547854|NCT01205529|532162216|FG000|Overall Study|Unstable post op|15|||
147547855|NCT01205529|532162216|FG000|Overall Study|No longer met criteria|30|||
147547856|NCT03840135|532162217|FG000|Overall Study|Protocol Violation|6|||
147547857|NCT03840135|532162218|FG001|Overall Study|Protocol Violation|1|||
147547858|NCT03840135|532162217|FG000|Overall Study|Withdrawal by Subject|1|||
147547859|NCT03840135|532162218|FG001|Overall Study|Withdrawal by Subject|0|||
147547860|NCT00667719|532162219|FG000|Overall Study|Adverse Event|39|||
147547861|NCT00667719|532162219|FG000|Overall Study|Abnormal Test Procedure|1|||
147547862|NCT00667719|532162219|FG000|Overall Study|Unsatisfactory Therapeutic Effect|3|||
147547863|NCT00667719|532162219|FG000|Overall Study|Protocol Violation|3|||
147547864|NCT00667719|532162219|FG000|Overall Study|Withdrawal by Subject|17|||
147547865|NCT00667719|532162219|FG000|Overall Study|Lost to Follow-up|8|||
147547866|NCT01159769|532162220|FG000|Overall Study|Adverse Event|1|||
147547867|NCT01827371|532162221|FG000|Overall Study|Adverse Event|0|||
147547868|NCT01827371|532162222|FG001|Overall Study|Adverse Event|0|||
147547869|NCT01827371|532162223|FG002|Overall Study|Adverse Event|4|||
147547870|NCT01827371|532162224|FG003|Overall Study|Adverse Event|2|||
147547871|NCT01827371|532162221|FG000|Overall Study|Lost to Follow-up|0|||
147547872|NCT01827371|532162222|FG001|Overall Study|Lost to Follow-up|2|||
147547873|NCT01827371|532162223|FG002|Overall Study|Lost to Follow-up|0|||
147547874|NCT01827371|532162224|FG003|Overall Study|Lost to Follow-up|4|||
147547875|NCT01827371|532162221|FG000|Overall Study|Protocol Violation|1|||
147547876|NCT01827371|532162222|FG001|Overall Study|Protocol Violation|0|||
147547877|NCT01827371|532162223|FG002|Overall Study|Protocol Violation|0|||
147547878|NCT01827371|532162224|FG003|Overall Study|Protocol Violation|0|||
147547879|NCT01827371|532162221|FG000|Overall Study|Withdrawal by Subject|1|||
147547880|NCT01827371|532162222|FG001|Overall Study|Withdrawal by Subject|2|||
147547881|NCT01827371|532162223|FG002|Overall Study|Withdrawal by Subject|2|||
147547882|NCT01827371|532162224|FG003|Overall Study|Withdrawal by Subject|3|||
147547883|NCT01827371|532162221|FG000|Overall Study|Physician Decision|0|||
147214156|NCT04784442|530956519|FG003|Overall Study|Adverse Event|1|||
147214157|NCT04784442|530956516|FG000|Overall Study|Protocol Violation|1|||
147214158|NCT04784442|530956517|FG001|Overall Study|Protocol Violation|0|||
147214159|NCT04784442|530956518|FG002|Overall Study|Protocol Violation|0|||
147214160|NCT04784442|530956519|FG003|Overall Study|Protocol Violation|0|||
147214161|NCT04784442|530956516|FG000|Overall Study|Non-compliance with study drug|1|||
147214162|NCT04784442|530956517|FG001|Overall Study|Non-compliance with study drug|0|||
147214163|NCT04784442|530956518|FG002|Overall Study|Non-compliance with study drug|0|||
147214164|NCT04784442|530956519|FG003|Overall Study|Non-compliance with study drug|0|||
147214165|NCT00486811|530956522|FG000|Overall Study|Adverse Event|28|||
147214166|NCT00486811|530956523|FG001|Overall Study|Adverse Event|60|||
147214167|NCT00486811|530956524|FG002|Overall Study|Adverse Event|135|||
147214168|NCT00486811|530956522|FG000|Overall Study|Lack of Efficacy|34|||
147214169|NCT00486811|530956523|FG001|Overall Study|Lack of Efficacy|14|||
147214170|NCT00486811|530956524|FG002|Overall Study|Lack of Efficacy|7|||
147214171|NCT00486811|530956522|FG000|Overall Study|Lost to Follow-up|4|||
147214172|NCT00486811|530956523|FG001|Overall Study|Lost to Follow-up|6|||
147214173|NCT00486811|530956524|FG002|Overall Study|Lost to Follow-up|4|||
147214174|NCT00486811|530956522|FG000|Overall Study|Withdrawal by Subject|33|||
147214175|NCT00486811|530956523|FG001|Overall Study|Withdrawal by Subject|44|||
147214176|NCT00486811|530956524|FG002|Overall Study|Withdrawal by Subject|58|||
147214177|NCT00486811|530956522|FG000|Overall Study|Study drug non-compliant|5|||
147214178|NCT00486811|530956523|FG001|Overall Study|Study drug non-compliant|6|||
147214179|NCT00486811|530956524|FG002|Overall Study|Study drug non-compliant|3|||
147214180|NCT00486811|530956522|FG000|Overall Study|All other|18|||
147214181|NCT00486811|530956523|FG001|Overall Study|All other|11|||
147214182|NCT00486811|530956524|FG002|Overall Study|All other|7|||
147214183|NCT00852371|530956528|FG000|Overall Study|Lost to Follow-up|2|||
147214184|NCT00852371|530956529|FG001|Overall Study|Lost to Follow-up|3|||
147214185|NCT00852371|530956530|FG002|Overall Study|Lost to Follow-up|4|||
147214186|NCT00852371|530956531|FG003|Overall Study|Lost to Follow-up|2|||
147214187|NCT02756806|530956532|FG000|Overall Study|Study terminated early|5|||
147214188|NCT03158285|530956533|FG000|Placebo-controlled Period: Week 0 - 24|Adverse Event|4|||
147214189|NCT03158285|530956534|FG001|Placebo-controlled Period: Week 0 - 24|Adverse Event|2|||
147214190|NCT03158285|530956535|FG002|Placebo-controlled Period: Week 0 - 24|Adverse Event|6|||
147214191|NCT03158285|530956533|FG000|Placebo-controlled Period: Week 0 - 24|Lack of Efficacy|0|||
147214192|NCT03158285|530956534|FG001|Placebo-controlled Period: Week 0 - 24|Lack of Efficacy|3|||
147214193|NCT03158285|530956535|FG002|Placebo-controlled Period: Week 0 - 24|Lack of Efficacy|3|||
147214194|NCT03158285|530956533|FG000|Placebo-controlled Period: Week 0 - 24|Withdrawal by Subject|1|||
147214195|NCT03158285|530956534|FG001|Placebo-controlled Period: Week 0 - 24|Withdrawal by Subject|1|||
147214196|NCT03158285|530956535|FG002|Placebo-controlled Period: Week 0 - 24|Withdrawal by Subject|0|||
147214197|NCT03158285|530956533|FG000|Placebo-controlled Period: Week 0 - 24|Lost to Follow-up|0|||
147214198|NCT03158285|530956534|FG001|Placebo-controlled Period: Week 0 - 24|Lost to Follow-up|1|||
147214199|NCT03158285|530956535|FG002|Placebo-controlled Period: Week 0 - 24|Lost to Follow-up|0|||
147214200|NCT03158285|530956533|FG000|Placebo-controlled Period: Week 0 - 24|Other|1|||
147214201|NCT03158285|530956534|FG001|Placebo-controlled Period: Week 0 - 24|Other|1|||
147214202|NCT03158285|530956535|FG002|Placebo-controlled Period: Week 0 - 24|Other|0|||
147214203|NCT03158285|530956533|FG000|Active Treatment Period: Week 24 - 52|Adverse Event|3|||
147214204|NCT03158285|530956534|FG001|Active Treatment Period: Week 24 - 52|Adverse Event|0|||
147214205|NCT03158285|530956535|FG002|Active Treatment Period: Week 24 - 52|Adverse Event|1|||
147214206|NCT03158285|530956533|FG000|Active Treatment Period: Week 24 - 52|Lack of Efficacy|5|||
147214207|NCT03158285|530956534|FG001|Active Treatment Period: Week 24 - 52|Lack of Efficacy|3|||
147214208|NCT03158285|530956535|FG002|Active Treatment Period: Week 24 - 52|Lack of Efficacy|4|||
147214209|NCT03158285|530956533|FG000|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|1|||
147214210|NCT03158285|530956534|FG001|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|2|||
147214211|NCT03158285|530956535|FG002|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|1|||
147214212|NCT03158285|530956533|FG000|Active Treatment Period: Week 24 - 52|Pregnancy|0|||
147547884|NCT01827371|532162222|FG001|Overall Study|Physician Decision|1|||
147547885|NCT01827371|532162223|FG002|Overall Study|Physician Decision|0|||
147547886|NCT01827371|532162224|FG003|Overall Study|Physician Decision|1|||
147547887|NCT01827371|532162221|FG000|Overall Study|Temporary study halt to vaccinations|11|||
147547888|NCT01827371|532162222|FG001|Overall Study|Temporary study halt to vaccinations|2|||
147547889|NCT01827371|532162223|FG002|Overall Study|Temporary study halt to vaccinations|5|||
147214213|NCT03158285|530956534|FG001|Active Treatment Period: Week 24 - 52|Pregnancy|0|||
147214214|NCT03158285|530956535|FG002|Active Treatment Period: Week 24 - 52|Pregnancy|1|||
147214215|NCT03158285|530956533|FG000|Active Treatment Period: Week 24 - 52|Other|1|||
147214216|NCT03158285|530956534|FG001|Active Treatment Period: Week 24 - 52|Other|1|||
147214217|NCT03158285|530956535|FG002|Active Treatment Period: Week 24 - 52|Other|0|||
147214218|NCT03158285|530956533|FG000|Active Treatment Period: Week 52-100|Adverse Event|7|||
147214219|NCT03158285|530956534|FG001|Active Treatment Period: Week 52-100|Adverse Event|5|||
147547890|NCT01827371|532162224|FG003|Overall Study|Temporary study halt to vaccinations|13|||
147547891|NCT01361607|532162225|FG000|Overall Study|Adverse Event|38|||
147547892|NCT01361607|532162226|FG001|Overall Study|Adverse Event|29|||
147547893|NCT01361607|532162225|FG000|Overall Study|Withdrawal by Subject|19|||
147547894|NCT01361607|532162226|FG001|Overall Study|Withdrawal by Subject|8|||
147214220|NCT03158285|530956535|FG002|Active Treatment Period: Week 52-100|Adverse Event|3|||
147214221|NCT03158285|530956533|FG000|Active Treatment Period: Week 52-100|Lack of Efficacy|1|||
147214222|NCT03158285|530956534|FG001|Active Treatment Period: Week 52-100|Lack of Efficacy|1|||
147214223|NCT03158285|530956535|FG002|Active Treatment Period: Week 52-100|Lack of Efficacy|3|||
147214224|NCT03158285|530956533|FG000|Active Treatment Period: Week 52-100|Withdrawal by Subject|5|||
147214225|NCT03158285|530956534|FG001|Active Treatment Period: Week 52-100|Withdrawal by Subject|2|||
147214226|NCT03158285|530956535|FG002|Active Treatment Period: Week 52-100|Withdrawal by Subject|1|||
147214227|NCT03158285|530956533|FG000|Active Treatment Period: Week 52-100|Pregnancy|0|||
147214228|NCT03158285|530956534|FG001|Active Treatment Period: Week 52-100|Pregnancy|0|||
147214229|NCT03158285|530956535|FG002|Active Treatment Period: Week 52-100|Pregnancy|1|||
147214230|NCT03158285|530956533|FG000|Active Treatment Period: Week 52-100|Death|1|||
147214231|NCT03158285|530956534|FG001|Active Treatment Period: Week 52-100|Death|0|||
147214232|NCT03158285|530956535|FG002|Active Treatment Period: Week 52-100|Death|0|||
147214233|NCT03158285|530956533|FG000|Active Treatment Period: Week 52-100|Other|4|||
147214234|NCT03158285|530956534|FG001|Active Treatment Period: Week 52-100|Other|1|||
147214235|NCT03158285|530956535|FG002|Active Treatment Period: Week 52-100|Other|0|||
147214236|NCT01008423|530956538|FG000|Overall Study|Adverse Event|13|||
147214237|NCT01008423|530956539|FG001|Overall Study|Adverse Event|6|||
147214238|NCT01008423|530956538|FG000|Overall Study|Withdrawal by Subject|4|||
147214239|NCT01008423|530956539|FG001|Overall Study|Withdrawal by Subject|7|||
147214240|NCT01008423|530956538|FG000|Overall Study|Lost to Follow-up|0|||
147214241|NCT01008423|530956539|FG001|Overall Study|Lost to Follow-up|2|||
147214242|NCT01008423|530956538|FG000|Overall Study|Low Cortisol|0|||
147214243|NCT01008423|530956539|FG001|Overall Study|Low Cortisol|1|||
147214244|NCT01008423|530956538|FG000|Overall Study|Lack of Efficacy|0|||
147214245|NCT01008423|530956539|FG001|Overall Study|Lack of Efficacy|5|||
147214246|NCT01008423|530956538|FG000|Overall Study|Disease Extent 70 centimeters (cm)|1|||
147214247|NCT01008423|530956539|FG001|Overall Study|Disease Extent 70 centimeters (cm)|0|||
147214248|NCT01008423|530956538|FG000|Overall Study|Personal Conflict|1|||
147214249|NCT01008423|530956539|FG001|Overall Study|Personal Conflict|0|||
147214250|NCT01008423|530956538|FG000|Overall Study|Other|0|||
147214251|NCT01008423|530956539|FG001|Overall Study|Other|1|||
147214252|NCT00946153|530956545|FG000|Phase 2|Adverse Event|0|||
147214253|NCT00946153|530956546|FG001|Phase 2|Adverse Event|0|||
147214254|NCT00946153|530956547|FG002|Phase 2|Adverse Event|0|||
147214255|NCT00946153|530956548|FG003|Phase 2|Adverse Event|0|||
147214256|NCT00946153|530956549|FG004|Phase 2|Adverse Event|6|||
147214257|NCT00946153|530956545|FG000|Phase 2|Need more reduction of dose|0|||
147214258|NCT00946153|530956546|FG001|Phase 2|Need more reduction of dose|0|||
147214259|NCT00946153|530956547|FG002|Phase 2|Need more reduction of dose|0|||
147214260|NCT00946153|530956548|FG003|Phase 2|Need more reduction of dose|0|||
147214261|NCT00946153|530956549|FG004|Phase 2|Need more reduction of dose|2|||
147214262|NCT00946153|530956545|FG000|Phase 2|Physician Decision|0|||
147214263|NCT00946153|530956546|FG001|Phase 2|Physician Decision|0|||
147214264|NCT00946153|530956547|FG002|Phase 2|Physician Decision|0|||
147214265|NCT00946153|530956548|FG003|Phase 2|Physician Decision|0|||
147214266|NCT00946153|530956549|FG004|Phase 2|Physician Decision|1|||
147214267|NCT00946153|530956545|FG000|Phase 2|14 days washout for recovery due to AE|0|||
147214268|NCT00946153|530956546|FG001|Phase 2|14 days washout for recovery due to AE|0|||
147214269|NCT00946153|530956547|FG002|Phase 2|14 days washout for recovery due to AE|0|||
147214270|NCT00946153|530956548|FG003|Phase 2|14 days washout for recovery due to AE|0|||
147214271|NCT00946153|530956549|FG004|Phase 2|14 days washout for recovery due to AE|4|||
147214272|NCT00530504|530956552|FG000|Overall Study|Death|54|||
147214273|NCT00530504|530956552|FG000|Overall Study|Lost to Follow-up|26|||
147214274|NCT00530504|530956552|FG000|Overall Study|Withdrawal by Subject|39|||
147214275|NCT00530504|530956552|FG000|Overall Study|Exited study due to other reasons|33|||
147214276|NCT00006289|530956553|FG000|First Intervention (5 Weeks)|Adverse Event|1|||
147214277|NCT00006289|530956554|FG001|First Intervention (5 Weeks)|Adverse Event|0|||
147214278|NCT00006289|530956553|FG000|Second Intervention (5 Weeks)|Protocol Violation|1|||
147214279|NCT00006289|530956554|FG001|Second Intervention (5 Weeks)|Protocol Violation|1|||
147214280|NCT05141448|530956564|FG000|Period 1|Unsatisfactory Visual Response due to Test Article|0|||
147214281|NCT05141448|530956565|FG001|Period 1|Unsatisfactory Visual Response due to Test Article|1|||
147214282|NCT05141448|530956566|FG002|Period 1|Unsatisfactory Visual Response due to Test Article|0|||
147214283|NCT05141448|530956567|FG003|Period 1|Unsatisfactory Visual Response due to Test Article|0|||
147214284|NCT05141448|530956568|FG004|Period 1|Unsatisfactory Visual Response due to Test Article|0|||
147214285|NCT05141448|530956569|FG005|Period 1|Unsatisfactory Visual Response due to Test Article|0|||
147214286|NCT05141448|530956564|FG000|Period 1|Subject No Longer Meets Eligibility Criteria|0|||
147214287|NCT05141448|530956565|FG001|Period 1|Subject No Longer Meets Eligibility Criteria|0|||
147547895|NCT01361607|532162225|FG000|Overall Study|Withdrawal by Investigator|5|||
147214288|NCT05141448|530956566|FG002|Period 1|Subject No Longer Meets Eligibility Criteria|0|||
147214289|NCT05141448|530956567|FG003|Period 1|Subject No Longer Meets Eligibility Criteria|0|||
147214290|NCT05141448|530956568|FG004|Period 1|Subject No Longer Meets Eligibility Criteria|1|||
147214291|NCT05141448|530956569|FG005|Period 1|Subject No Longer Meets Eligibility Criteria|0|||
147214292|NCT05141448|530956564|FG000|Period 2|Unsatisfactory Visual Response due to Test Article|0|||
147214293|NCT05141448|530956565|FG001|Period 2|Unsatisfactory Visual Response due to Test Article|1|||
147214294|NCT05141448|530956566|FG002|Period 2|Unsatisfactory Visual Response due to Test Article|0|||
147214295|NCT05141448|530956567|FG003|Period 2|Unsatisfactory Visual Response due to Test Article|0|||
147214296|NCT05141448|530956568|FG004|Period 2|Unsatisfactory Visual Response due to Test Article|0|||
147214297|NCT05141448|530956569|FG005|Period 2|Unsatisfactory Visual Response due to Test Article|0|||
147214298|NCT05141448|530956564|FG000|Period 2|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
147214299|NCT05141448|530956565|FG001|Period 2|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
147214300|NCT05141448|530956566|FG002|Period 2|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
147214301|NCT05141448|530956567|FG003|Period 2|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
147214302|NCT05141448|530956568|FG004|Period 2|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
147214303|NCT05141448|530956569|FG005|Period 2|Subject Withdrawn by PI due to Non Compliance to Protocol|1|||
147214304|NCT05141448|530956564|FG000|Period 2|COVID-19 Related|0|||
147214305|NCT05141448|530956565|FG001|Period 2|COVID-19 Related|0|||
147214306|NCT05141448|530956566|FG002|Period 2|COVID-19 Related|0|||
147214307|NCT05141448|530956567|FG003|Period 2|COVID-19 Related|1|||
147214308|NCT05141448|530956568|FG004|Period 2|COVID-19 Related|0|||
147214309|NCT05141448|530956569|FG005|Period 2|COVID-19 Related|1|||
147214310|NCT05141448|530956564|FG000|3|Covid-19 related|2|||
147214311|NCT05141448|530956565|FG001|3|Covid-19 related|0|||
147214312|NCT05141448|530956566|FG002|3|Covid-19 related|0|||
147214313|NCT05141448|530956567|FG003|3|Covid-19 related|0|||
147214314|NCT05141448|530956568|FG004|3|Covid-19 related|0|||
147214315|NCT05141448|530956569|FG005|3|Covid-19 related|1|||
147214316|NCT05141448|530956564|FG000|4|Unsatisfactory Visual Response due to Test Article|1|||
147214317|NCT05141448|530956565|FG001|4|Unsatisfactory Visual Response due to Test Article|0|||
147214318|NCT05141448|530956566|FG002|4|Unsatisfactory Visual Response due to Test Article|0|||
147214319|NCT05141448|530956567|FG003|4|Unsatisfactory Visual Response due to Test Article|0|||
147214320|NCT05141448|530956568|FG004|4|Unsatisfactory Visual Response due to Test Article|0|||
147214321|NCT05141448|530956569|FG005|4|Unsatisfactory Visual Response due to Test Article|0|||
147214322|NCT03865316|530957726|FG000|Overall Study|Procedure Cancelled|4|||
147214323|NCT03865316|530957726|FG000|Overall Study|Equipment failure|4|||
147214324|NCT03137069|530957732|FG000|Overall Study|Withdrawal by Subject|1|||
147214325|NCT03137069|530957733|FG001|Overall Study|Withdrawal by Subject|2|||
147214326|NCT03137069|530957734|FG002|Overall Study|Withdrawal by Subject|2|||
147214327|NCT03137069|530957735|FG003|Overall Study|Withdrawal by Subject|2|||
147214328|NCT03137069|530957736|FG004|Overall Study|Withdrawal by Subject|0|||
147214329|NCT03137069|530957737|FG005|Overall Study|Withdrawal by Subject|0|||
147214330|NCT03137069|530957732|FG000|Overall Study|Adverse Event|0|||
147214331|NCT03137069|530957733|FG001|Overall Study|Adverse Event|3|||
147214332|NCT03137069|530957734|FG002|Overall Study|Adverse Event|1|||
147214333|NCT03137069|530957735|FG003|Overall Study|Adverse Event|1|||
147214334|NCT03137069|530957736|FG004|Overall Study|Adverse Event|0|||
147214335|NCT03137069|530957737|FG005|Overall Study|Adverse Event|1|||
147214336|NCT03137069|530957732|FG000|Overall Study|Protocol Violation|0|||
147214337|NCT03137069|530957733|FG001|Overall Study|Protocol Violation|1|||
147214338|NCT03137069|530957734|FG002|Overall Study|Protocol Violation|0|||
147214339|NCT03137069|530957735|FG003|Overall Study|Protocol Violation|1|||
147214340|NCT03137069|530957736|FG004|Overall Study|Protocol Violation|1|||
147214341|NCT03137069|530957737|FG005|Overall Study|Protocol Violation|1|||
147214342|NCT03137069|530957732|FG000|Overall Study|Physician Decision|0|||
147214343|NCT03137069|530957733|FG001|Overall Study|Physician Decision|0|||
147214344|NCT03137069|530957734|FG002|Overall Study|Physician Decision|0|||
147214345|NCT03137069|530957735|FG003|Overall Study|Physician Decision|1|||
147214346|NCT03137069|530957736|FG004|Overall Study|Physician Decision|0|||
147214347|NCT03137069|530957737|FG005|Overall Study|Physician Decision|0|||
147214348|NCT03137069|530957732|FG000|Overall Study|Study Terminated by Sponsor|0|||
147214349|NCT03137069|530957733|FG001|Overall Study|Study Terminated by Sponsor|0|||
147214350|NCT03137069|530957734|FG002|Overall Study|Study Terminated by Sponsor|0|||
147214351|NCT03137069|530957735|FG003|Overall Study|Study Terminated by Sponsor|0|||
147214352|NCT03137069|530957736|FG004|Overall Study|Study Terminated by Sponsor|1|||
147214353|NCT03137069|530957737|FG005|Overall Study|Study Terminated by Sponsor|0|||
147214354|NCT03137069|530957732|FG000|Overall Study|Data Entry Error|0|||
147214355|NCT03137069|530957733|FG001|Overall Study|Data Entry Error|0|||
147214356|NCT03137069|530957734|FG002|Overall Study|Data Entry Error|0|||
147214357|NCT03137069|530957735|FG003|Overall Study|Data Entry Error|1|||
147214358|NCT03137069|530957736|FG004|Overall Study|Data Entry Error|0|||
147214359|NCT03137069|530957737|FG005|Overall Study|Data Entry Error|0|||
147214360|NCT00336856|530957738|FG000|Overall Study|Withdrawal by Subject|3|||
147547896|NCT01361607|532162226|FG001|Overall Study|Withdrawal by Investigator|3|||
147547897|NCT01361607|532162225|FG000|Overall Study|Lost to Follow-up|1|||
147547898|NCT01361607|532162226|FG001|Overall Study|Lost to Follow-up|0|||
147547899|NCT01361607|532162225|FG000|Overall Study|Met Withdrawal Criteria|1|||
147547900|NCT01361607|532162226|FG001|Overall Study|Met Withdrawal Criteria|1|||
147547901|NCT00373685|532162227|FG000|Overall Study|Death|2|||
147547902|NCT00373685|532162228|FG001|Overall Study|Death|1|||
147547903|NCT00373685|532162227|FG000|Overall Study|Adverse Event|278|||
147547904|NCT00373685|532162228|FG001|Overall Study|Adverse Event|253|||
147547905|NCT00373685|532162227|FG000|Overall Study|Insufficient clinical response|169|||
147547906|NCT00373685|532162228|FG001|Overall Study|Insufficient clinical response|119|||
147547907|NCT00373685|532162227|FG000|Overall Study|Did not meet entrance criteria|167|||
147547908|NCT00373685|532162228|FG001|Overall Study|Did not meet entrance criteria|184|||
147547909|NCT00373685|532162227|FG000|Overall Study|Lost to follow up|83|||
147547910|NCT00373685|532162228|FG001|Overall Study|Lost to follow up|103|||
147547911|NCT00373685|532162227|FG000|Overall Study|No longer willing to participate|337|||
147547912|NCT00373685|532162228|FG001|Overall Study|No longer willing to participate|352|||
147547913|NCT00373685|532162227|FG000|Overall Study|Other|149|||
147547914|NCT00373685|532162228|FG001|Overall Study|Other|146|||
147547915|NCT00373685|532162227|FG000|Overall Study|Protocol Violation|191|||
147547916|NCT00373685|532162228|FG001|Overall Study|Protocol Violation|182|||
147547917|NCT00373685|532162227|FG000|Overall Study|Final Status Unknown|12|||
147547918|NCT00373685|532162228|FG001|Overall Study|Final Status Unknown|4|||
147547919|NCT00373685|532162227|FG000|Overall Study|Randomized, not treated|51|||
147547920|NCT00373685|532162228|FG001|Overall Study|Randomized, not treated|77|||
147547921|NCT02570165|532162229|FG000|Overall Study|Adverse Event|1|||
147547922|NCT02570165|532162230|FG001|Overall Study|Adverse Event|0|||
147547923|NCT02570165|532162231|FG002|Overall Study|Adverse Event|2|||
147547924|NCT02570165|532162232|FG003|Overall Study|Adverse Event|0|||
147547925|NCT02570165|532162233|FG004|Overall Study|Adverse Event|0|||
147547926|NCT02570165|532162234|FG005|Overall Study|Adverse Event|0|||
147547927|NCT02570165|532162235|FG006|Overall Study|Adverse Event|0|||
147547928|NCT02570165|532162229|FG000|Overall Study|Lack of Efficacy|0|||
147547929|NCT02570165|532162230|FG001|Overall Study|Lack of Efficacy|1|||
147547930|NCT02570165|532162231|FG002|Overall Study|Lack of Efficacy|0|||
147547931|NCT02570165|532162232|FG003|Overall Study|Lack of Efficacy|0|||
147547932|NCT02570165|532162233|FG004|Overall Study|Lack of Efficacy|4|||
147547933|NCT02570165|532162234|FG005|Overall Study|Lack of Efficacy|0|||
147547934|NCT02570165|532162235|FG006|Overall Study|Lack of Efficacy|0|||
147547935|NCT02570165|532162229|FG000|Overall Study|Par. Reached Stopping Criteria|1|||
147547936|NCT02570165|532162230|FG001|Overall Study|Par. Reached Stopping Criteria|1|||
147547937|NCT02570165|532162231|FG002|Overall Study|Par. Reached Stopping Criteria|0|||
147547938|NCT02570165|532162232|FG003|Overall Study|Par. Reached Stopping Criteria|2|||
147547939|NCT02570165|532162233|FG004|Overall Study|Par. Reached Stopping Criteria|1|||
147547940|NCT02570165|532162234|FG005|Overall Study|Par. Reached Stopping Criteria|1|||
147547941|NCT02570165|532162235|FG006|Overall Study|Par. Reached Stopping Criteria|0|||
147547942|NCT02570165|532162229|FG000|Overall Study|Lost to Follow-up|0|||
147547943|NCT02570165|532162230|FG001|Overall Study|Lost to Follow-up|0|||
147547944|NCT02570165|532162231|FG002|Overall Study|Lost to Follow-up|1|||
147547945|NCT02570165|532162232|FG003|Overall Study|Lost to Follow-up|1|||
147547946|NCT02570165|532162233|FG004|Overall Study|Lost to Follow-up|0|||
147547947|NCT02570165|532162234|FG005|Overall Study|Lost to Follow-up|0|||
147547948|NCT02570165|532162235|FG006|Overall Study|Lost to Follow-up|0|||
147547949|NCT02570165|532162229|FG000|Overall Study|Physician Decision|0|||
147547950|NCT02570165|532162230|FG001|Overall Study|Physician Decision|1|||
147547951|NCT02570165|532162231|FG002|Overall Study|Physician Decision|0|||
147547952|NCT02570165|532162232|FG003|Overall Study|Physician Decision|0|||
147214361|NCT00336856|530957738|FG000|Overall Study|Found ineligible at time of analysis|1|||
147547953|NCT02570165|532162233|FG004|Overall Study|Physician Decision|0|||
147547954|NCT02570165|532162234|FG005|Overall Study|Physician Decision|0|||
147547955|NCT02570165|532162235|FG006|Overall Study|Physician Decision|0|||
147547956|NCT02570165|532162229|FG000|Overall Study|Withdrawal by Subject|0|||
147547957|NCT02570165|532162230|FG001|Overall Study|Withdrawal by Subject|0|||
147547958|NCT02570165|532162231|FG002|Overall Study|Withdrawal by Subject|0|||
147547959|NCT02570165|532162232|FG003|Overall Study|Withdrawal by Subject|2|||
147547960|NCT02570165|532162233|FG004|Overall Study|Withdrawal by Subject|1|||
147547961|NCT02570165|532162234|FG005|Overall Study|Withdrawal by Subject|0|||
147547962|NCT02570165|532162235|FG006|Overall Study|Withdrawal by Subject|0|||
147547963|NCT02570165|532162229|FG000|Overall Study|Par. did not Meet Continuation Criteria|0|||
147547964|NCT02570165|532162230|FG001|Overall Study|Par. did not Meet Continuation Criteria|0|||
147547965|NCT02570165|532162231|FG002|Overall Study|Par. did not Meet Continuation Criteria|0|||
147214362|NCT02522624|530957740|FG000|Overall Study|Technical failure|1|||
147547966|NCT02570165|532162232|FG003|Overall Study|Par. did not Meet Continuation Criteria|0|||
147547967|NCT02570165|532162233|FG004|Overall Study|Par. did not Meet Continuation Criteria|0|||
147547968|NCT02570165|532162234|FG005|Overall Study|Par. did not Meet Continuation Criteria|1|||
147547969|NCT02570165|532162235|FG006|Overall Study|Par. did not Meet Continuation Criteria|0|||
147547970|NCT02570165|532162229|FG000|Overall Study|Withdrawal Request by GSK|0|||
147547971|NCT02570165|532162230|FG001|Overall Study|Withdrawal Request by GSK|0|||
147547972|NCT02570165|532162231|FG002|Overall Study|Withdrawal Request by GSK|2|||
147547973|NCT02570165|532162232|FG003|Overall Study|Withdrawal Request by GSK|0|||
147547974|NCT02570165|532162233|FG004|Overall Study|Withdrawal Request by GSK|0|||
147547975|NCT02570165|532162234|FG005|Overall Study|Withdrawal Request by GSK|0|||
147547976|NCT02570165|532162235|FG006|Overall Study|Withdrawal Request by GSK|0|||
147547977|NCT00411762|532162238|FG000|Overall Study|Withdrawal by Subject|5|||
147547978|NCT04428502|532162239|FG000|Overall Study|Did not meet entrance criteria|14|||
147547979|NCT03712228|532162243|FG000|Treatment Period 1|Lack of Efficacy|0|||
147547980|NCT03712228|532162244|FG001|Treatment Period 1|Lack of Efficacy|0|||
147547981|NCT03712228|532162245|FG002|Treatment Period 1|Lack of Efficacy|0|||
147547982|NCT03712228|532162246|FG003|Treatment Period 1|Lack of Efficacy|0|||
147547983|NCT03712228|532162247|FG004|Treatment Period 1|Lack of Efficacy|0|||
147547984|NCT03712228|532162248|FG005|Treatment Period 1|Lack of Efficacy|1|||
147547985|NCT03712228|532162243|FG000|Treatment Period 2|Pregnancy|0|||
147547986|NCT03712228|532162244|FG001|Treatment Period 2|Pregnancy|0|||
147547987|NCT03712228|532162245|FG002|Treatment Period 2|Pregnancy|0|||
147547988|NCT03712228|532162246|FG003|Treatment Period 2|Pregnancy|1|||
147547989|NCT03712228|532162247|FG004|Treatment Period 2|Pregnancy|0|||
147547990|NCT03712228|532162248|FG005|Treatment Period 2|Pregnancy|0|||
147547991|NCT03712228|532162243|FG000|Treatment Period 2|Withdrawal by Subject|0|||
147547992|NCT03712228|532162244|FG001|Treatment Period 2|Withdrawal by Subject|0|||
147547993|NCT03712228|532162245|FG002|Treatment Period 2|Withdrawal by Subject|0|||
147547994|NCT03712228|532162246|FG003|Treatment Period 2|Withdrawal by Subject|1|||
147547995|NCT03712228|532162247|FG004|Treatment Period 2|Withdrawal by Subject|0|||
147547996|NCT03712228|532162248|FG005|Treatment Period 2|Withdrawal by Subject|0|||
147547997|NCT01430104|532162249|FG000|28-Day Teriparatide Treatment Period|Adverse Event|1|||
147547998|NCT05288673|532162250|FG000|Overall Study|Consent withdrawn by subject|0|||
147547999|NCT05288673|532162251|FG001|Overall Study|Consent withdrawn by subject|0|||
147548000|NCT05288673|532162252|FG002|Overall Study|Consent withdrawn by subject|1|||
147548001|NCT04147611|532162260|FG000|Overall Study|Physician Decision|0|||
147548002|NCT04147611|532162261|FG001|Overall Study|Physician Decision|1|||
147548003|NCT05003167|532162262|FG000|Overall Study|Withdrawal by Subject|1|||
147548004|NCT01010230|532162263|FG000|Overall Study|Withdrawal by Subject|6|||
147548005|NCT01010230|532162264|FG001|Overall Study|Withdrawal by Subject|5|||
147548006|NCT01010230|532162263|FG000|Overall Study|Lost to Follow-up|4|||
147548007|NCT01010230|532162264|FG001|Overall Study|Lost to Follow-up|2|||
147548008|NCT01585831|532162265|FG000|Overall Study|Physician Decision|0|||
147548009|NCT01585831|532162266|FG001|Overall Study|Physician Decision|1|||
147548010|NCT01585831|532162265|FG000|Overall Study|Withdrawal by Subject|2|||
147548011|NCT01585831|532162266|FG001|Overall Study|Withdrawal by Subject|1|||
147548012|NCT01123980|532162267|FG000|Overall Study|Adverse Event|1|||
147548013|NCT01123980|532162268|FG001|Overall Study|Adverse Event|1|||
147548014|NCT01123980|532162267|FG000|Overall Study|Lack of Efficacy|1|||
147548015|NCT01123980|532162268|FG001|Overall Study|Lack of Efficacy|0|||
147548016|NCT01123980|532162267|FG000|Overall Study|Physician Decision|0|||
147548017|NCT01123980|532162268|FG001|Overall Study|Physician Decision|1|||
147548018|NCT01123980|532162267|FG000|Overall Study|Lost to Follow-up|0|||
147548019|NCT01123980|532162268|FG001|Overall Study|Lost to Follow-up|6|||
147548020|NCT01123980|532162267|FG000|Overall Study|Protocol Violation|6|||
147548021|NCT01123980|532162268|FG001|Overall Study|Protocol Violation|6|||
147548022|NCT01123980|532162267|FG000|Overall Study|Withdrawal by Subject|5|||
147548023|NCT01123980|532162268|FG001|Overall Study|Withdrawal by Subject|3|||
147548024|NCT01123980|532162267|FG000|Overall Study|Unclassified|6|||
147548025|NCT01123980|532162268|FG001|Overall Study|Unclassified|7|||
147548026|NCT01225991|532162269|FG000|Overall Study|Withdrawal by Subject|6|||
147548027|NCT04444752|532162270|FG000|Overall Study|Adverse Event|1|||
147548028|NCT04444752|532162271|FG001|Overall Study|Adverse Event|0|||
147548029|NCT04444752|532162272|FG002|Overall Study|Adverse Event|0|||
147548030|NCT04444752|532162273|FG003|Overall Study|Adverse Event|2|||
147548031|NCT04444752|532162270|FG000|Overall Study|Lost to Follow-up|2|||
147548032|NCT04444752|532162271|FG001|Overall Study|Lost to Follow-up|6|||
147548033|NCT04444752|532162272|FG002|Overall Study|Lost to Follow-up|2|||
147548034|NCT04444752|532162273|FG003|Overall Study|Lost to Follow-up|5|||
147548035|NCT04444752|532162270|FG000|Overall Study|Physician Decision|0|||
147548036|NCT04444752|532162271|FG001|Overall Study|Physician Decision|0|||
147548037|NCT04444752|532162272|FG002|Overall Study|Physician Decision|0|||
147548038|NCT04444752|532162273|FG003|Overall Study|Physician Decision|2|||
147548039|NCT04444752|532162270|FG000|Overall Study|Pregnancy|0|||
147548040|NCT04444752|532162271|FG001|Overall Study|Pregnancy|0|||
147548041|NCT04444752|532162272|FG002|Overall Study|Pregnancy|0|||
147548042|NCT04444752|532162273|FG003|Overall Study|Pregnancy|1|||
147548043|NCT04444752|532162270|FG000|Overall Study|Withdrawal by Subject|6|||
147548044|NCT04444752|532162271|FG001|Overall Study|Withdrawal by Subject|5|||
147548045|NCT04444752|532162272|FG002|Overall Study|Withdrawal by Subject|3|||
147548046|NCT04444752|532162273|FG003|Overall Study|Withdrawal by Subject|4|||
147548047|NCT04444752|532162270|FG000|Overall Study|Protocol Violation|1|||
147548048|NCT04444752|532162271|FG001|Overall Study|Protocol Violation|1|||
147548049|NCT04444752|532162272|FG002|Overall Study|Protocol Violation|0|||
147548050|NCT04444752|532162273|FG003|Overall Study|Protocol Violation|0|||
147548051|NCT04444752|532162270|FG000|Overall Study|Patient moving out of town|1|||
147548052|NCT04444752|532162271|FG001|Overall Study|Patient moving out of town|0|||
147548053|NCT04444752|532162272|FG002|Overall Study|Patient moving out of town|0|||
147548054|NCT04444752|532162273|FG003|Overall Study|Patient moving out of town|1|||
147548055|NCT04444752|532162270|FG000|Overall Study|Lack of Efficacy|0|||
147548056|NCT04444752|532162271|FG001|Overall Study|Lack of Efficacy|0|||
147548057|NCT04444752|532162272|FG002|Overall Study|Lack of Efficacy|0|||
147548058|NCT04444752|532162273|FG003|Overall Study|Lack of Efficacy|1|||
147548059|NCT04444752|532162270|FG000|Overall Study|Death|0|||
147548060|NCT04444752|532162271|FG001|Overall Study|Death|0|||
147548061|NCT04444752|532162272|FG002|Overall Study|Death|1|||
147548062|NCT04444752|532162273|FG003|Overall Study|Death|0|||
147548063|NCT00579254|532162274|FG000|Overall Study|Lost to Follow-up|39|||
147548064|NCT00579254|532162274|FG000|Overall Study|Discontinued when study terminated|73|||
147548065|NCT02557672|532162275|FG000|Overall Study|Withdrawal by Subject|4|||
147548066|NCT02557672|532162276|FG001|Overall Study|Withdrawal by Subject|2|||
147548067|NCT00343642|532163678|FG000|Overall Study|Lost to Follow-up|0|||
147548068|NCT00343642|532163679|FG001|Overall Study|Lost to Follow-up|1|||
147548069|NCT00343642|532163680|FG002|Overall Study|Lost to Follow-up|0|||
147548070|NCT00343642|532163678|FG000|Overall Study|Pregnancy|1|||
147548071|NCT00343642|532163679|FG001|Overall Study|Pregnancy|0|||
147548072|NCT00343642|532163680|FG002|Overall Study|Pregnancy|2|||
147548073|NCT00343642|532163678|FG000|Overall Study|Withdrawal by Subject|2|||
147548074|NCT00343642|532163679|FG001|Overall Study|Withdrawal by Subject|3|||
147548075|NCT00343642|532163680|FG002|Overall Study|Withdrawal by Subject|4|||
147548076|NCT00343642|532163678|FG000|Overall Study|Adverse Event|0|||
147548077|NCT00343642|532163679|FG001|Overall Study|Adverse Event|0|||
147548078|NCT00343642|532163680|FG002|Overall Study|Adverse Event|1|||
147548079|NCT00343642|532163678|FG000|Overall Study|Flare up|6|||
147548080|NCT00343642|532163679|FG001|Overall Study|Flare up|4|||
147548081|NCT00343642|532163680|FG002|Overall Study|Flare up|0|||
147548082|NCT00766506|532163683|FG000|Overall Study|Use rescue medication after 3 hours|3|||
147548083|NCT00766506|532163684|FG001|Overall Study|Use rescue medication after 3 hours|0|||
147548084|NCT00766506|532163683|FG000|Overall Study|Other|2|||
147548085|NCT00766506|532163684|FG001|Overall Study|Other|2|||
147548086|NCT03262233|532163686|FG000|Overall Study|Withdrawal by Subject|12|||
147548087|NCT03262233|532163687|FG001|Overall Study|Withdrawal by Subject|8|||
147548088|NCT03262233|532163688|FG002|Overall Study|Withdrawal by Subject|21|||
147548089|NCT03262233|532163689|FG003|Overall Study|Withdrawal by Subject|13|||
147548090|NCT03262233|532163686|FG000|Overall Study|Declined due to shock|1|||
147548091|NCT03262233|532163687|FG001|Overall Study|Declined due to shock|2|||
147548092|NCT03262233|532163688|FG002|Overall Study|Declined due to shock|2|||
147548093|NCT03262233|532163689|FG003|Overall Study|Declined due to shock|3|||
147548094|NCT03262233|532163686|FG000|Overall Study|Protocol Violation|5|||
147548095|NCT03262233|532163687|FG001|Overall Study|Protocol Violation|10|||
147548096|NCT03262233|532163688|FG002|Overall Study|Protocol Violation|2|||
147548097|NCT03262233|532163689|FG003|Overall Study|Protocol Violation|13|||
147548098|NCT03262233|532163686|FG000|Overall Study|data collection artifact|0|||
147548099|NCT03262233|532163687|FG001|Overall Study|data collection artifact|1|||
147548100|NCT03262233|532163688|FG002|Overall Study|data collection artifact|0|||
147548101|NCT03262233|532163689|FG003|Overall Study|data collection artifact|0|||
147548102|NCT03877237|532163690|FG000|Overall Study|Adverse Event|1|||
147548103|NCT03877237|532163691|FG001|Overall Study|Adverse Event|2|||
147548104|NCT03877237|532163690|FG000|Overall Study|Death|3|||
147548105|NCT03877237|532163691|FG001|Overall Study|Death|2|||
147548106|NCT03877237|532163690|FG000|Overall Study|Physician Decision|1|||
147548107|NCT03877237|532163691|FG001|Overall Study|Physician Decision|0|||
147548108|NCT03877237|532163690|FG000|Overall Study|Withdrawal by Subject|0|||
147548109|NCT03877237|532163691|FG001|Overall Study|Withdrawal by Subject|2|||
147548110|NCT03372083|532163692|FG000|Overall Study|Adverse Event|3|||
147548111|NCT03372083|532163692|FG000|Overall Study|Physician Decision|1|||
147548112|NCT03372083|532163692|FG000|Overall Study|Withdrawal by Subject|1|||
147548113|NCT02236754|532163693|FG000|Overall Study|Withdrawal by Subject|1|||
147548114|NCT02236754|532163694|FG001|Overall Study|Withdrawal by Subject|0|||
147548115|NCT02544633|532163695|FG000|Treatment Period|Patient Still on Treatment/Study|0|||
147548116|NCT02544633|532163696|FG001|Treatment Period|Patient Still on Treatment/Study|1|||
147548117|NCT02544633|532163697|FG002|Treatment Period|Patient Still on Treatment/Study|1|||
147548118|NCT02544633|532163698|FG003|Treatment Period|Patient Still on Treatment/Study|0|||
147548119|NCT02544633|532163695|FG000|Treatment Period|Adverse Event|7|||
147548120|NCT02544633|532163696|FG001|Treatment Period|Adverse Event|4|||
147548121|NCT02544633|532163697|FG002|Treatment Period|Adverse Event|0|||
147548122|NCT02544633|532163698|FG003|Treatment Period|Adverse Event|5|||
147548123|NCT02544633|532163695|FG000|Treatment Period|Lack of Efficacy|17|||
147548124|NCT02544633|532163696|FG001|Treatment Period|Lack of Efficacy|11|||
147548125|NCT02544633|532163697|FG002|Treatment Period|Lack of Efficacy|5|||
147548126|NCT02544633|532163698|FG003|Treatment Period|Lack of Efficacy|5|||
147548127|NCT02544633|532163695|FG000|Treatment Period|Global Deterioration of Health|3|||
147548128|NCT02544633|532163696|FG001|Treatment Period|Global Deterioration of Health|3|||
147548129|NCT02544633|532163697|FG002|Treatment Period|Global Deterioration of Health|0|||
147548130|NCT02544633|532163698|FG003|Treatment Period|Global Deterioration of Health|1|||
147548131|NCT02544633|532163695|FG000|Treatment Period|Withdrawal by Subject|1|||
147548132|NCT02544633|532163696|FG001|Treatment Period|Withdrawal by Subject|0|||
147548133|NCT02544633|532163697|FG002|Treatment Period|Withdrawal by Subject|0|||
147548134|NCT02544633|532163698|FG003|Treatment Period|Withdrawal by Subject|0|||
147548135|NCT02544633|532163695|FG000|Treatment Period|Lost to Follow-up|0|||
147548136|NCT02544633|532163696|FG001|Treatment Period|Lost to Follow-up|1|||
147548137|NCT02544633|532163697|FG002|Treatment Period|Lost to Follow-up|0|||
147548138|NCT02544633|532163698|FG003|Treatment Period|Lost to Follow-up|0|||
147548139|NCT02544633|532163695|FG000|Treatment Period|Death|0|||
147548140|NCT02544633|532163696|FG001|Treatment Period|Death|0|||
147548141|NCT02544633|532163697|FG002|Treatment Period|Death|1|||
147548142|NCT02544633|532163698|FG003|Treatment Period|Death|0|||
147548143|NCT02544633|532163695|FG000|Treatment Period|Non-compliance|0|||
147548144|NCT02544633|532163696|FG001|Treatment Period|Non-compliance|0|||
147548145|NCT02544633|532163697|FG002|Treatment Period|Non-compliance|1|||
147548146|NCT02544633|532163698|FG003|Treatment Period|Non-compliance|0|||
147214363|NCT02522624|530957741|FG001|Overall Study|Technical failure|0|||
147214364|NCT01325337|530957742|FG000|Overall Study|Adverse Event|0|||
147214365|NCT01325337|530957743|FG001|Overall Study|Adverse Event|2|||
147214366|NCT01325337|530957744|FG002|Overall Study|Adverse Event|2|||
147214367|NCT01325337|530957745|FG003|Overall Study|Adverse Event|1|||
147214368|NCT01325337|530957746|FG004|Overall Study|Adverse Event|2|||
147214369|NCT01325337|530957742|FG000|Overall Study|Lost to Follow-up|2|||
147214370|NCT01325337|530957743|FG001|Overall Study|Lost to Follow-up|2|||
147214371|NCT01325337|530957744|FG002|Overall Study|Lost to Follow-up|2|||
147214372|NCT01325337|530957745|FG003|Overall Study|Lost to Follow-up|1|||
147214373|NCT01325337|530957746|FG004|Overall Study|Lost to Follow-up|2|||
147214374|NCT01325337|530957742|FG000|Overall Study|Personal Reasons|2|||
147214375|NCT01325337|530957743|FG001|Overall Study|Personal Reasons|5|||
147214376|NCT01325337|530957744|FG002|Overall Study|Personal Reasons|4|||
147214377|NCT01325337|530957745|FG003|Overall Study|Personal Reasons|8|||
147214378|NCT01325337|530957746|FG004|Overall Study|Personal Reasons|3|||
147214379|NCT01325337|530957742|FG000|Overall Study|Withdrawal by Subject|1|||
147214380|NCT01325337|530957743|FG001|Overall Study|Withdrawal by Subject|0|||
147214381|NCT01325337|530957744|FG002|Overall Study|Withdrawal by Subject|1|||
147214382|NCT01325337|530957745|FG003|Overall Study|Withdrawal by Subject|0|||
147214383|NCT01325337|530957746|FG004|Overall Study|Withdrawal by Subject|1|||
147214384|NCT00843778|530957759|FG000|Overall Study|Adverse Event|15|||
147214385|NCT00843778|530957759|FG000|Overall Study|Lack of Efficacy|14|||
147214386|NCT00843778|530957759|FG000|Overall Study|Loss of efficacy|2|||
147214387|NCT00843778|530957759|FG000|Overall Study|Withdrawal by Subject|4|||
147214388|NCT00369629|530957760|FG000|Treated 2 Cycles/Reached First Response|Physician Decision|0|||
147214389|NCT00369629|530957761|FG001|Treated 2 Cycles/Reached First Response|Physician Decision|1|||
147214390|NCT00369629|530957762|FG002|Treated 2 Cycles/Reached First Response|Physician Decision|1|||
147214391|NCT00369629|530957763|FG003|Treated 2 Cycles/Reached First Response|Physician Decision|0|||
147214392|NCT00369629|530957760|FG000|Treated 2 Cycles/Reached First Response|Adverse Event|0|||
147214393|NCT00369629|530957761|FG001|Treated 2 Cycles/Reached First Response|Adverse Event|0|||
147214394|NCT00369629|530957762|FG002|Treated 2 Cycles/Reached First Response|Adverse Event|1|||
147214395|NCT00369629|530957763|FG003|Treated 2 Cycles/Reached First Response|Adverse Event|0|||
147214396|NCT00369629|530957760|FG000|Treated 2 Cycles/Reached First Response|Progressive disease|2|||
147214397|NCT00369629|530957761|FG001|Treated 2 Cycles/Reached First Response|Progressive disease|0|||
147214398|NCT00369629|530957762|FG002|Treated 2 Cycles/Reached First Response|Progressive disease|0|||
147214399|NCT00369629|530957763|FG003|Treated 2 Cycles/Reached First Response|Progressive disease|0|||
147214400|NCT00369629|530957760|FG000|Moved on to 4 More Cycles|Progressive Disease|0|||
147214401|NCT00369629|530957761|FG001|Moved on to 4 More Cycles|Progressive Disease|0|||
147214402|NCT00369629|530957762|FG002|Moved on to 4 More Cycles|Progressive Disease|1|||
147214403|NCT00369629|530957763|FG003|Moved on to 4 More Cycles|Progressive Disease|0|||
147214404|NCT00369629|530957760|FG000|Completed 4 More Cycles|Withdrawal by Subject|2|||
147214405|NCT00369629|530957761|FG001|Completed 4 More Cycles|Withdrawal by Subject|1|||
147214406|NCT00369629|530957762|FG002|Completed 4 More Cycles|Withdrawal by Subject|0|||
147214407|NCT00369629|530957763|FG003|Completed 4 More Cycles|Withdrawal by Subject|0|||
147548147|NCT02544633|532163695|FG000|Treatment Period|Clinical Disease Progression|0|||
147548148|NCT02544633|532163696|FG001|Treatment Period|Clinical Disease Progression|0|||
147214408|NCT00369629|530957760|FG000|Completed 4 More Cycles|Progressive disease|2|||
147214409|NCT00369629|530957761|FG001|Completed 4 More Cycles|Progressive disease|1|||
147548149|NCT02544633|532163697|FG002|Treatment Period|Clinical Disease Progression|0|||
147548150|NCT02544633|532163698|FG003|Treatment Period|Clinical Disease Progression|1|||
147548151|NCT02544633|532163695|FG000|Survival Follow-up Period|Death|12|||
147548152|NCT02544633|532163696|FG001|Survival Follow-up Period|Death|14|||
147548153|NCT02544633|532163697|FG002|Survival Follow-up Period|Death|3|||
147548154|NCT02544633|532163698|FG003|Survival Follow-up Period|Death|9|||
147214410|NCT00369629|530957762|FG002|Completed 4 More Cycles|Progressive disease|2|||
147214411|NCT00369629|530957763|FG003|Completed 4 More Cycles|Progressive disease|0|||
147214412|NCT00369629|530957760|FG000|Follow up for 1 Year|Death|2|||
147214413|NCT00369629|530957761|FG001|Follow up for 1 Year|Death|1|||
147214414|NCT00369629|530957762|FG002|Follow up for 1 Year|Death|1|||
147214415|NCT00369629|530957763|FG003|Follow up for 1 Year|Death|0|||
147214416|NCT00369629|530957760|FG000|Follow up for 1 Year|Lost to Follow-up|0|||
147214417|NCT00369629|530957761|FG001|Follow up for 1 Year|Lost to Follow-up|1|||
147214418|NCT00369629|530957762|FG002|Follow up for 1 Year|Lost to Follow-up|0|||
147214419|NCT00369629|530957763|FG003|Follow up for 1 Year|Lost to Follow-up|0|||
147214420|NCT00369629|530957760|FG000|Follow up for 1 Year|stopped being followed as study closed|0|||
147214421|NCT00369629|530957761|FG001|Follow up for 1 Year|stopped being followed as study closed|0|||
147214422|NCT00369629|530957762|FG002|Follow up for 1 Year|stopped being followed as study closed|2|||
147214423|NCT00369629|530957763|FG003|Follow up for 1 Year|stopped being followed as study closed|0|||
147214424|NCT02600871|530957764|FG000|Overall Study|Lost to Follow-up|13|||
147214425|NCT02600871|530957765|FG001|Overall Study|Lost to Follow-up|10|||
147214426|NCT01604278|530957766|FG000|Overall Study|Lack of Efficacy|0|||
147214427|NCT01604278|530957767|FG001|Overall Study|Lack of Efficacy|1|||
147214428|NCT01604278|530957766|FG000|Overall Study|Lost to Follow-up|1|||
147214429|NCT01604278|530957767|FG001|Overall Study|Lost to Follow-up|0|||
147214430|NCT01604278|530957766|FG000|Overall Study|Administrative problems|2|||
147214431|NCT01604278|530957767|FG001|Overall Study|Administrative problems|1|||
147214432|NCT01604278|530957766|FG000|Overall Study|Withdrawal by Subject|3|||
147214433|NCT01604278|530957767|FG001|Overall Study|Withdrawal by Subject|3|||
147214434|NCT01604278|530957766|FG000|Overall Study|Adverse Event|3|||
147214435|NCT01604278|530957767|FG001|Overall Study|Adverse Event|5|||
147214436|NCT01604278|530957766|FG000|Overall Study|Protocol Deviation|5|||
147214437|NCT01604278|530957767|FG001|Overall Study|Protocol Deviation|3|||
147214438|NCT01347580|530957770|FG000|Overall Study|Withdrawal by Subject|13|||
147214439|NCT01347580|530957771|FG001|Overall Study|Withdrawal by Subject|23|||
147214440|NCT01347580|530957770|FG000|Overall Study|Death|30|||
147214441|NCT01347580|530957771|FG001|Overall Study|Death|19|||
147214442|NCT01347580|530957770|FG000|Overall Study|Protocol Violation|10|||
147214443|NCT01347580|530957771|FG001|Overall Study|Protocol Violation|7|||
147214444|NCT01347580|530957770|FG000|Overall Study|Lost to Follow-up|3|||
147214445|NCT01347580|530957771|FG001|Overall Study|Lost to Follow-up|1|||
147214446|NCT01347580|530957770|FG000|Overall Study|Had other reason|9|||
147214447|NCT01347580|530957771|FG001|Overall Study|Had other reason|6|||
147214448|NCT00874939|530957772|FG000|Overall Study|Study terminated|4|||
147214449|NCT01909791|530957773|FG000|Overall Study|Death|9|||
147214450|NCT01909791|530957774|FG001|Overall Study|Death|8|||
147214451|NCT01909791|530957775|FG002|Overall Study|Death|4|||
147214452|NCT01909791|530957773|FG000|Overall Study|Withdrawal by Subject|5|||
147214453|NCT01909791|530957774|FG001|Overall Study|Withdrawal by Subject|9|||
147214454|NCT01909791|530957775|FG002|Overall Study|Withdrawal by Subject|13|||
147214455|NCT01909791|530957773|FG000|Overall Study|Lost to Follow-up|5|||
147214456|NCT01909791|530957774|FG001|Overall Study|Lost to Follow-up|11|||
147214457|NCT01909791|530957775|FG002|Overall Study|Lost to Follow-up|10|||
147214458|NCT01909791|530957773|FG000|Overall Study|Missed Visit|2|||
147214459|NCT01909791|530957774|FG001|Overall Study|Missed Visit|0|||
147214460|NCT01909791|530957775|FG002|Overall Study|Missed Visit|1|||
147214461|NCT01659554|530957778|FG000|Overall Study|Study Termination|4|||
147214462|NCT01236547|530957779|FG000|Overall Study|Protocol Violation|0|||
147214463|NCT01236547|530957780|FG001|Overall Study|Protocol Violation|1|||
147214464|NCT01236547|530957781|FG002|Overall Study|Protocol Violation|1|||
147214465|NCT01236547|530957782|FG003|Overall Study|Protocol Violation|6|||
147214466|NCT01236547|530957783|FG004|Overall Study|Protocol Violation|12|||
147214467|NCT04022733|530957784|FG000|Overall Study|conversion to open surgery|3|||
147214468|NCT04022733|530957785|FG001|Overall Study|conversion to open surgery|2|||
147214469|NCT04022733|530957784|FG000|Overall Study|bradycardia|0|||
147214470|NCT04022733|530957785|FG001|Overall Study|bradycardia|1|||
147214471|NCT02208063|530957792|FG000|Overall Study|Death|3|||
147214472|NCT02208063|530957793|FG001|Overall Study|Death|5|||
147214473|NCT02208063|530957792|FG000|Overall Study|Not Specified in report|3|||
147214474|NCT02208063|530957793|FG001|Overall Study|Not Specified in report|4|||
147214475|NCT02208063|530957792|FG000|Overall Study|Withdrawal by Subject|5|||
147214476|NCT02208063|530957793|FG001|Overall Study|Withdrawal by Subject|2|||
147214477|NCT02208063|530957792|FG000|Overall Study|Lost to Follow-up|1|||
147214478|NCT02208063|530957793|FG001|Overall Study|Lost to Follow-up|0|||
147214479|NCT02279407|530957794|FG000|Overall Study|Couldn't swallow IP; noncompliance|0|||
147214480|NCT02279407|530957795|FG001|Overall Study|Couldn't swallow IP; noncompliance|0|||
147214481|NCT02279407|530957796|FG002|Overall Study|Couldn't swallow IP; noncompliance|2|||
147214482|NCT02279407|530957797|FG003|Overall Study|Couldn't swallow IP; noncompliance|0|||
147214483|NCT02279407|530957794|FG000|Overall Study|Withdrawal by Subject|1|||
147214484|NCT02279407|530957795|FG001|Overall Study|Withdrawal by Subject|0|||
147214485|NCT02279407|530957796|FG002|Overall Study|Withdrawal by Subject|1|||
147214486|NCT02279407|530957797|FG003|Overall Study|Withdrawal by Subject|1|||
147214487|NCT02279407|530957794|FG000|Overall Study|Adverse Event|1|||
147548155|NCT02544633|532163695|FG000|Survival Follow-up Period|Lost to Follow-up|0|||
147548156|NCT02544633|532163696|FG001|Survival Follow-up Period|Lost to Follow-up|1|||
147548157|NCT02544633|532163697|FG002|Survival Follow-up Period|Lost to Follow-up|1|||
147548158|NCT02544633|532163698|FG003|Survival Follow-up Period|Lost to Follow-up|0|||
147548159|NCT02544633|532163695|FG000|Survival Follow-up Period|Withdrawal by Subject|4|||
147548160|NCT02544633|532163696|FG001|Survival Follow-up Period|Withdrawal by Subject|0|||
147548161|NCT02544633|532163697|FG002|Survival Follow-up Period|Withdrawal by Subject|1|||
147548162|NCT02544633|532163698|FG003|Survival Follow-up Period|Withdrawal by Subject|0|||
147548163|NCT02544633|532163695|FG000|Survival Follow-up Period|Study Terminated by Sponsor|12|||
147548164|NCT02544633|532163696|FG001|Survival Follow-up Period|Study Terminated by Sponsor|4|||
147548165|NCT02544633|532163697|FG002|Survival Follow-up Period|Study Terminated by Sponsor|2|||
147548166|NCT02544633|532163698|FG003|Survival Follow-up Period|Study Terminated by Sponsor|3|||
147548167|NCT02092961|532163699|FG000|Overall Study|Not reported|1|||
147214488|NCT02279407|530957795|FG001|Overall Study|Adverse Event|1|||
147214489|NCT02279407|530957796|FG002|Overall Study|Adverse Event|2|||
147214490|NCT02279407|530957797|FG003|Overall Study|Adverse Event|0|||
147214491|NCT02500056|530957798|FG000|Overall Study|Lost to Follow-up|3|||
147214492|NCT02500056|530957799|FG001|Overall Study|Lost to Follow-up|7|||
147214493|NCT02500056|530957798|FG000|Overall Study|Recurrence|1|||
147214494|NCT02500056|530957799|FG001|Overall Study|Recurrence|0|||
147214495|NCT02500056|530957798|FG000|Overall Study|Death|3|||
147214496|NCT02500056|530957799|FG001|Overall Study|Death|1|||
147214497|NCT00864916|530957800|FG000|Overall Study|Lost to Follow-up|4|||
147214498|NCT00864916|530957801|FG001|Overall Study|Lost to Follow-up|4|||
147214499|NCT00864916|530957800|FG000|Overall Study|Protocol Violation|1|||
147214500|NCT00864916|530957801|FG001|Overall Study|Protocol Violation|0|||
147214501|NCT00864916|530957800|FG000|Overall Study|Withdrawal by Subject|1|||
147214502|NCT00864916|530957801|FG001|Overall Study|Withdrawal by Subject|0|||
147214503|NCT01155011|530957807|FG000|Baseline to 6 Months|Withdrawal by Subject|18|||
147214504|NCT01155011|530957808|FG001|Baseline to 6 Months|Withdrawal by Subject|19|||
147214505|NCT01155011|530957807|FG000|Baseline to 6 Months|investigator decision, moved|4|||
147214506|NCT01155011|530957808|FG001|Baseline to 6 Months|investigator decision, moved|5|||
147214507|NCT01155011|530957807|FG000|Baseline to 6 Months|Death|0|||
147214508|NCT01155011|530957808|FG001|Baseline to 6 Months|Death|1|||
147214509|NCT01155011|530957807|FG000|6 to 12 Months|Withdrawal by Subject|8|||
147214510|NCT01155011|530957808|FG001|6 to 12 Months|Withdrawal by Subject|5|||
147214511|NCT01155011|530957807|FG000|6 to 12 Months|Death|1|||
147214512|NCT01155011|530957808|FG001|6 to 12 Months|Death|5|||
147214513|NCT02122783|530957814|FG000|Overall Study|Adverse Event|0|||
147214514|NCT02122783|530957815|FG001|Overall Study|Adverse Event|1|||
147214515|NCT02213133|530957822|FG000|Overall Study|Participant discontinued study therapy|2|||
147214516|NCT02213133|530957823|FG001|Overall Study|Participant discontinued study therapy|0|||
147214517|NCT02213133|530957824|FG002|Overall Study|Participant discontinued study therapy|0|||
147214518|NCT02213133|530957822|FG000|Overall Study|Participant withdrew informed consent|2|||
147214519|NCT02213133|530957823|FG001|Overall Study|Participant withdrew informed consent|1|||
147214520|NCT02213133|530957824|FG002|Overall Study|Participant withdrew informed consent|2|||
147214521|NCT02213133|530957822|FG000|Overall Study|Disease progression|11|||
147214522|NCT02213133|530957823|FG001|Overall Study|Disease progression|2|||
147214523|NCT02213133|530957824|FG002|Overall Study|Disease progression|0|||
147214524|NCT02213133|530957822|FG000|Overall Study|Adverse Event (AE)|1|||
147214525|NCT02213133|530957823|FG001|Overall Study|Adverse Event (AE)|0|||
147214526|NCT02213133|530957824|FG002|Overall Study|Adverse Event (AE)|0|||
147214527|NCT02213133|530957822|FG000|Overall Study|Death|16|||
147214528|NCT02213133|530957823|FG001|Overall Study|Death|2|||
147214529|NCT02213133|530957824|FG002|Overall Study|Death|1|||
147214530|NCT02213133|530957822|FG000|Overall Study|Other|5|||
147214531|NCT02213133|530957823|FG001|Overall Study|Other|0|||
147214532|NCT02213133|530957824|FG002|Overall Study|Other|0|||
147214533|NCT02744040|530957827|FG000|Overall Study|Withdrawal by Subject|3|||
147214534|NCT02744040|530957828|FG001|Overall Study|Withdrawal by Subject|2|||
147214535|NCT02744040|530957829|FG002|Overall Study|Withdrawal by Subject|2|||
147214536|NCT02744040|530957827|FG000|Overall Study|Physician Decision|0|||
147214537|NCT02744040|530957828|FG001|Overall Study|Physician Decision|8|||
147214538|NCT02744040|530957829|FG002|Overall Study|Physician Decision|13|||
147214539|NCT02744040|530957827|FG000|Overall Study|Lost to Follow-up|3|||
147214540|NCT02744040|530957828|FG001|Overall Study|Lost to Follow-up|1|||
147214541|NCT02744040|530957829|FG002|Overall Study|Lost to Follow-up|7|||
147214542|NCT01642615|530957830|FG000|Open Label Maintenance Phase|Pretreatment Event/Adverse Event|1|||
147214543|NCT01642615|530957831|FG001|Open Label Maintenance Phase|Pretreatment Event/Adverse Event|0|||
147214544|NCT01642615|530957832|FG002|Open Label Maintenance Phase|Pretreatment Event/Adverse Event|0|||
147214545|NCT01642615|530957830|FG000|Open Label Maintenance Phase|Major Protocol Deviation|1|||
147214546|NCT01642615|530957831|FG001|Open Label Maintenance Phase|Major Protocol Deviation|0|||
147214547|NCT01642615|530957832|FG002|Open Label Maintenance Phase|Major Protocol Deviation|0|||
147214548|NCT01642615|530957830|FG000|Open Label Maintenance Phase|Lost to Follow-up|1|||
147214549|NCT01642615|530957831|FG001|Open Label Maintenance Phase|Lost to Follow-up|0|||
147548168|NCT02092961|532163700|FG001|Overall Study|Not reported|0|||
147548169|NCT02092961|532163701|FG002|Overall Study|Not reported|1|||
147548170|NCT02092961|532163699|FG000|Overall Study|Study stopped|13|||
147548171|NCT02092961|532163700|FG001|Overall Study|Study stopped|9|||
147548172|NCT02092961|532163701|FG002|Overall Study|Study stopped|12|||
147548173|NCT02092961|532163699|FG000|Overall Study|Lack of therapeutic response|2|||
147548174|NCT02092961|532163700|FG001|Overall Study|Lack of therapeutic response|1|||
147548175|NCT02092961|532163701|FG002|Overall Study|Lack of therapeutic response|3|||
147548176|NCT02092961|532163699|FG000|Overall Study|Dev. of study specific discont. criteria|3|||
147548177|NCT02092961|532163700|FG001|Overall Study|Dev. of study specific discont. criteria|0|||
147548178|NCT02092961|532163701|FG002|Overall Study|Dev. of study specific discont. criteria|0|||
147548179|NCT02092961|532163699|FG000|Overall Study|Adverse Event|2|||
147548180|NCT02092961|532163700|FG001|Overall Study|Adverse Event|4|||
147548181|NCT02092961|532163701|FG002|Overall Study|Adverse Event|0|||
147548182|NCT02270983|532163702|FG000|Overall Study|Adverse Event|3|||
147548183|NCT02270983|532163703|FG001|Overall Study|Adverse Event|2|||
147548184|NCT02270983|532163704|FG002|Overall Study|Adverse Event|6|||
147548185|NCT02270983|532163702|FG000|Overall Study|Lack of Efficacy|2|||
147548186|NCT02270983|532163703|FG001|Overall Study|Lack of Efficacy|1|||
147548187|NCT02270983|532163704|FG002|Overall Study|Lack of Efficacy|1|||
147548188|NCT02270983|532163702|FG000|Overall Study|Withdrawal by Subject|1|||
147548189|NCT02270983|532163703|FG001|Overall Study|Withdrawal by Subject|0|||
147548190|NCT02270983|532163704|FG002|Overall Study|Withdrawal by Subject|2|||
147548191|NCT02270983|532163702|FG000|Overall Study|Lost to Follow-up|1|||
147548192|NCT02270983|532163703|FG001|Overall Study|Lost to Follow-up|1|||
147548193|NCT02270983|532163704|FG002|Overall Study|Lost to Follow-up|2|||
147548194|NCT02270983|532163702|FG000|Overall Study|Protocol Violation|1|||
147548195|NCT02270983|532163703|FG001|Overall Study|Protocol Violation|1|||
147548196|NCT02270983|532163704|FG002|Overall Study|Protocol Violation|1|||
147548197|NCT02270983|532163702|FG000|Overall Study|family emergency|0|||
147548198|NCT02270983|532163703|FG001|Overall Study|family emergency|1|||
147548199|NCT02270983|532163704|FG002|Overall Study|family emergency|0|||
147548200|NCT02270983|532163702|FG000|Overall Study|study procedure non-compliance|1|||
147548201|NCT02270983|532163703|FG001|Overall Study|study procedure non-compliance|0|||
147548202|NCT02270983|532163704|FG002|Overall Study|study procedure non-compliance|0|||
147548203|NCT02270983|532163702|FG000|Overall Study|moved away from study site|0|||
147548204|NCT02270983|532163703|FG001|Overall Study|moved away from study site|1|||
147548205|NCT02270983|532163704|FG002|Overall Study|moved away from study site|0|||
147548206|NCT01623830|532163707|FG000|Overall Study|Withdrawal by Subject|6|||
147548207|NCT01623830|532163708|FG001|Overall Study|Withdrawal by Subject|7|||
147548208|NCT01623830|532163707|FG000|Overall Study|Exclusion from Study|1|||
147548209|NCT01623830|532163708|FG001|Overall Study|Exclusion from Study|2|||
147548210|NCT00928252|532163709|FG000|Overall Study|Physician Decision|3|||
147548211|NCT01605461|532163710|FG000|Overall Study|Lost to Follow-up|3|||
147548212|NCT01605461|532163710|FG000|Overall Study|Withdrawal by Subject|1|||
147548213|NCT02024698|532163711|FG000|First Intervention (7 Days)|Withdrawal by Subject|0|||
147548214|NCT02024698|532163712|FG001|First Intervention (7 Days)|Withdrawal by Subject|1|||
147548215|NCT03549130|532163713|FG000|Overall Study|Adverse Event|0|||
147548216|NCT03549130|532163714|FG001|Overall Study|Adverse Event|1|||
147548217|NCT03549130|532163713|FG000|Overall Study|Lost to Follow-up|0|||
147548218|NCT03549130|532163714|FG001|Overall Study|Lost to Follow-up|1|||
147548219|NCT04313283|532163715|FG000|Overall Study|did not complete intervention|4|||
147548220|NCT04132232|532163717|FG000|Overall Study|Randomized but met exclusion criteria.|1|||
147548221|NCT04132232|532163718|FG001|Overall Study|Randomized but met exclusion criteria.|1|||
147548222|NCT04132232|532163717|FG000|Overall Study|Lost to Follow-up|6|||
147548223|NCT04132232|532163718|FG001|Overall Study|Lost to Follow-up|7|||
147548224|NCT00368537|532163720|FG000|Randomization|No study drug dosed|13|||
147214550|NCT01642615|530957832|FG002|Open Label Maintenance Phase|Lost to Follow-up|0|||
147214551|NCT01642615|530957830|FG000|Open Label Maintenance Phase|Voluntary Withdrawal|1|||
147214552|NCT01642615|530957831|FG001|Open Label Maintenance Phase|Voluntary Withdrawal|0|||
147214553|NCT01642615|530957832|FG002|Open Label Maintenance Phase|Voluntary Withdrawal|0|||
147214554|NCT01642615|530957830|FG000|Open Label Maintenance Phase|Did not receive treatment|1|||
147214555|NCT01642615|530957831|FG001|Open Label Maintenance Phase|Did not receive treatment|0|||
147548225|NCT00368537|532163721|FG001|Randomization|No study drug dosed|6|||
147214556|NCT01642615|530957832|FG002|Open Label Maintenance Phase|Did not receive treatment|0|||
147548226|NCT00368537|532163720|FG000|Baseline Participants|Lost to Follow-up|16|||
147548227|NCT00368537|532163721|FG001|Baseline Participants|Lost to Follow-up|17|||
147548228|NCT00368537|532163720|FG000|Baseline Participants|Withdrawal by Subject|6|||
147548229|NCT00368537|532163721|FG001|Baseline Participants|Withdrawal by Subject|4|||
147548230|NCT00368537|532163720|FG000|Baseline Participants|Death|1|||
147548231|NCT00368537|532163721|FG001|Baseline Participants|Death|2|||
147548232|NCT00368537|532163720|FG000|Baseline Participants|No susceptibility|1|||
147548233|NCT00368537|532163721|FG001|Baseline Participants|No susceptibility|0|||
147214557|NCT01642615|530957830|FG000|Double Blind Maintenance Phase|Lack of Efficacy|0|||
147214558|NCT01642615|530957831|FG001|Double Blind Maintenance Phase|Lack of Efficacy|1|||
147548234|NCT00368537|532163720|FG000|Baseline Participants|Patient uncompliant|0|||
147548235|NCT00368537|532163721|FG001|Baseline Participants|Patient uncompliant|1|||
147548236|NCT02732561|532163741|FG000|Overall Study|Lost to Follow-up|1|||
147548237|NCT02732561|532163742|FG001|Overall Study|Lost to Follow-up|1|||
147548238|NCT02732561|532163741|FG000|Overall Study|Withdrawal by Subject|1|||
147548239|NCT02732561|532163742|FG001|Overall Study|Withdrawal by Subject|0|||
147548240|NCT01886300|532163743|FG000|Overall Study|Trial terminated by sponsor|16|||
147548241|NCT01797120|532163746|FG000|Overall Study|Disesae progression|37|||
147548242|NCT01797120|532163747|FG001|Overall Study|Disesae progression|49|||
147548243|NCT01797120|532163746|FG000|Overall Study|Adverse Event|13|||
147548244|NCT01797120|532163747|FG001|Overall Study|Adverse Event|5|||
147548245|NCT01797120|532163746|FG000|Overall Study|Withdrawal by Subject|6|||
147548246|NCT01797120|532163747|FG001|Overall Study|Withdrawal by Subject|6|||
147548247|NCT01797120|532163746|FG000|Overall Study|Symptomatic progression|2|||
147548248|NCT01797120|532163747|FG001|Overall Study|Symptomatic progression|1|||
147548249|NCT01797120|532163746|FG000|Overall Study|Non-compliance|1|||
147548250|NCT01797120|532163747|FG001|Overall Study|Non-compliance|0|||
147548251|NCT01797120|532163746|FG000|Overall Study|Physician Decision|3|||
147548252|NCT01797120|532163747|FG001|Overall Study|Physician Decision|0|||
147548253|NCT01797120|532163746|FG000|Overall Study|still on treatment|2|||
147548254|NCT01797120|532163747|FG001|Overall Study|still on treatment|4|||
147548255|NCT01797120|532163746|FG000|Overall Study|never start protocol therapy|2|||
147548256|NCT01797120|532163747|FG001|Overall Study|never start protocol therapy|0|||
147548257|NCT00295854|532163748|FG000|Overall Study|Adverse Event|7|||
147548258|NCT00295854|532163749|FG001|Overall Study|Adverse Event|7|||
147548259|NCT00295854|532163750|FG002|Overall Study|Adverse Event|6|||
147548260|NCT00295854|532163748|FG000|Overall Study|Protocol Violation|1|||
147548261|NCT00295854|532163749|FG001|Overall Study|Protocol Violation|1|||
147548262|NCT00295854|532163750|FG002|Overall Study|Protocol Violation|1|||
147214559|NCT01642615|530957832|FG002|Double Blind Maintenance Phase|Lack of Efficacy|3|||
147214560|NCT01642615|530957830|FG000|Double Blind Maintenance Phase|Voluntary Withdrawal|0|||
147214561|NCT01642615|530957831|FG001|Double Blind Maintenance Phase|Voluntary Withdrawal|5|||
147214562|NCT01642615|530957832|FG002|Double Blind Maintenance Phase|Voluntary Withdrawal|2|||
147214563|NCT01642615|530957830|FG000|Double Blind Maintenance Phase|Pretreatment Event/Adverse Event|0|||
147214564|NCT01642615|530957831|FG001|Double Blind Maintenance Phase|Pretreatment Event/Adverse Event|1|||
147214565|NCT01642615|530957832|FG002|Double Blind Maintenance Phase|Pretreatment Event/Adverse Event|0|||
147214566|NCT01642615|530957830|FG000|Double Blind Maintenance Phase|Requires Treatment with Another Drug|0|||
147214567|NCT01642615|530957831|FG001|Double Blind Maintenance Phase|Requires Treatment with Another Drug|0|||
147214568|NCT01642615|530957832|FG002|Double Blind Maintenance Phase|Requires Treatment with Another Drug|1|||
147214569|NCT00096356|530957833|FG000|Overall Study|Adverse Event|11|||
147214570|NCT00096356|530957834|FG001|Overall Study|Adverse Event|9|||
147214571|NCT00096356|530957833|FG000|Overall Study|Physician Decision|5|||
147214572|NCT00096356|530957834|FG001|Overall Study|Physician Decision|3|||
147214573|NCT00096356|530957833|FG000|Overall Study|Withdrawal by Subject|17|||
147214574|NCT00096356|530957834|FG001|Overall Study|Withdrawal by Subject|23|||
147214575|NCT00096356|530957833|FG000|Overall Study|Lack of Efficacy|1|||
147214576|NCT00096356|530957834|FG001|Overall Study|Lack of Efficacy|0|||
147214577|NCT00096356|530957833|FG000|Overall Study|multiple reasons|10|||
147214578|NCT00096356|530957834|FG001|Overall Study|multiple reasons|18|||
147214579|NCT00402740|530957838|FG000|Overall Study|Withdrawal by Subject|18|||
147214580|NCT00402740|530957838|FG000|Overall Study|Death|50|||
147214581|NCT00402740|530957838|FG000|Overall Study|Lost to Follow-up|6|||
147214582|NCT00402740|530957838|FG000|Overall Study|No stent. Completed FU at 30 days.|5|||
147214583|NCT00402740|530957838|FG000|Overall Study|Subject disposition unknown.|1|||
147214584|NCT01699867|530957841|FG000|Overall Study|Screening Failure|3|||
147214585|NCT01675167|530957854|FG000|Open-label Titration Phase|Adverse Event|81|||
147214586|NCT01675167|530957855|FG001|Open-label Titration Phase|Adverse Event|0|||
147214587|NCT01675167|530957856|FG002|Open-label Titration Phase|Adverse Event|0|||
147214588|NCT01675167|530957854|FG000|Open-label Titration Phase|Lack of Efficacy|63|||
147214589|NCT01675167|530957855|FG001|Open-label Titration Phase|Lack of Efficacy|0|||
147214590|NCT01675167|530957856|FG002|Open-label Titration Phase|Lack of Efficacy|0|||
147214591|NCT01675167|530957854|FG000|Open-label Titration Phase|Withdrawal by Subject|46|||
147214592|NCT01675167|530957855|FG001|Open-label Titration Phase|Withdrawal by Subject|0|||
147214593|NCT01675167|530957856|FG002|Open-label Titration Phase|Withdrawal by Subject|0|||
147214594|NCT01675167|530957854|FG000|Open-label Titration Phase|Protocol Violation|43|||
147214595|NCT01675167|530957855|FG001|Open-label Titration Phase|Protocol Violation|0|||
147214596|NCT01675167|530957856|FG002|Open-label Titration Phase|Protocol Violation|0|||
147214597|NCT01675167|530957854|FG000|Open-label Titration Phase|Lost to Follow-up|15|||
147548263|NCT00295854|532163748|FG000|Overall Study|Lost to Follow-up|2|||
147548264|NCT00295854|532163749|FG001|Overall Study|Lost to Follow-up|0|||
147548265|NCT00295854|532163750|FG002|Overall Study|Lost to Follow-up|1|||
147548266|NCT00295854|532163748|FG000|Overall Study|Withdrawal by Subject|3|||
147548267|NCT00295854|532163749|FG001|Overall Study|Withdrawal by Subject|7|||
147548268|NCT00295854|532163750|FG002|Overall Study|Withdrawal by Subject|4|||
147548269|NCT00295854|532163748|FG000|Overall Study|did not continue to meet criteria|1|||
147548270|NCT00295854|532163749|FG001|Overall Study|did not continue to meet criteria|1|||
147548271|NCT00295854|532163750|FG002|Overall Study|did not continue to meet criteria|2|||
147548272|NCT00295854|532163748|FG000|Overall Study|required a prohibited medication|1|||
147548273|NCT00295854|532163749|FG001|Overall Study|required a prohibited medication|0|||
147548274|NCT00295854|532163750|FG002|Overall Study|required a prohibited medication|0|||
147548275|NCT00295854|532163748|FG000|Overall Study|Other|3|||
147548276|NCT00295854|532163749|FG001|Overall Study|Other|5|||
147214598|NCT01675167|530957855|FG001|Open-label Titration Phase|Lost to Follow-up|0|||
147214599|NCT01675167|530957856|FG002|Open-label Titration Phase|Lost to Follow-up|0|||
147214600|NCT01675167|530957854|FG000|Open-label Titration Phase|Withdrawal due to opioid withdrawal|1|||
147214601|NCT01675167|530957855|FG001|Open-label Titration Phase|Withdrawal due to opioid withdrawal|0|||
147214602|NCT01675167|530957856|FG002|Open-label Titration Phase|Withdrawal due to opioid withdrawal|0|||
147214603|NCT01675167|530957854|FG000|Open-label Titration Phase|Other|55|||
147214604|NCT01675167|530957855|FG001|Open-label Titration Phase|Other|0|||
147214605|NCT01675167|530957856|FG002|Open-label Titration Phase|Other|0|||
147214606|NCT01675167|530957854|FG000|Double-blind Treatment Phase|Lack of Efficacy|0|||
147214607|NCT01675167|530957855|FG001|Double-blind Treatment Phase|Lack of Efficacy|19|||
147214608|NCT01675167|530957856|FG002|Double-blind Treatment Phase|Lack of Efficacy|61|||
147214609|NCT01675167|530957854|FG000|Double-blind Treatment Phase|Withdrawal by Subject|0|||
147214610|NCT01675167|530957855|FG001|Double-blind Treatment Phase|Withdrawal by Subject|11|||
147214611|NCT01675167|530957856|FG002|Double-blind Treatment Phase|Withdrawal by Subject|6|||
147548277|NCT00295854|532163750|FG002|Overall Study|Other|1|||
147548278|NCT00672620|532163751|FG000|Overall Study|Adverse Event|7|||
147548279|NCT00672620|532163752|FG001|Overall Study|Adverse Event|7|||
147548280|NCT00672620|532163753|FG002|Overall Study|Adverse Event|12|||
147548281|NCT00672620|532163754|FG003|Overall Study|Adverse Event|17|||
147548282|NCT00672620|532163751|FG000|Overall Study|Lack of Efficacy|1|||
147548283|NCT00672620|532163752|FG001|Overall Study|Lack of Efficacy|2|||
147548284|NCT00672620|532163753|FG002|Overall Study|Lack of Efficacy|2|||
147548285|NCT00672620|532163754|FG003|Overall Study|Lack of Efficacy|0|||
147548286|NCT00672620|532163751|FG000|Overall Study|Noncompliance with Study Drug|3|||
147548287|NCT00672620|532163752|FG001|Overall Study|Noncompliance with Study Drug|4|||
147548288|NCT00672620|532163753|FG002|Overall Study|Noncompliance with Study Drug|0|||
147548289|NCT00672620|532163754|FG003|Overall Study|Noncompliance with Study Drug|2|||
147548290|NCT00672620|532163751|FG000|Overall Study|Protocol Deviations|5|||
147548291|NCT00672620|532163752|FG001|Overall Study|Protocol Deviations|7|||
147548292|NCT00672620|532163753|FG002|Overall Study|Protocol Deviations|2|||
147548293|NCT00672620|532163754|FG003|Overall Study|Protocol Deviations|5|||
147548294|NCT00672620|532163751|FG000|Overall Study|Withdrawal of Consent|6|||
147548295|NCT00672620|532163752|FG001|Overall Study|Withdrawal of Consent|12|||
147548296|NCT00672620|532163753|FG002|Overall Study|Withdrawal of Consent|5|||
147548297|NCT00672620|532163754|FG003|Overall Study|Withdrawal of Consent|6|||
147548298|NCT00672620|532163751|FG000|Overall Study|Lost to Follow-up|8|||
147548299|NCT00672620|532163752|FG001|Overall Study|Lost to Follow-up|19|||
147548300|NCT00672620|532163753|FG002|Overall Study|Lost to Follow-up|8|||
147548301|NCT00672620|532163754|FG003|Overall Study|Lost to Follow-up|11|||
147548302|NCT00672620|532163751|FG000|Overall Study|Reason not Specified|3|||
147548303|NCT00672620|532163752|FG001|Overall Study|Reason not Specified|3|||
147548304|NCT00672620|532163753|FG002|Overall Study|Reason not Specified|2|||
147548305|NCT00672620|532163754|FG003|Overall Study|Reason not Specified|1|||
147548306|NCT02736227|532163758|FG000|Overall Study|Withdrawal by Subject|0|||
147548307|NCT02736227|532163759|FG001|Overall Study|Withdrawal by Subject|0|||
147548308|NCT02736227|532163760|FG002|Overall Study|Withdrawal by Subject|1|||
147548309|NCT02736227|532163758|FG000|Overall Study|Physician Decision|0|||
147548310|NCT02736227|532163759|FG001|Overall Study|Physician Decision|0|||
147548311|NCT02736227|532163760|FG002|Overall Study|Physician Decision|5|||
147548312|NCT02736227|532163758|FG000|Overall Study|Non Compliant|0|||
147548313|NCT02736227|532163759|FG001|Overall Study|Non Compliant|0|||
147548314|NCT02736227|532163760|FG002|Overall Study|Non Compliant|2|||
147548315|NCT04120194|532163761|FG000|Overall Study|Lost to Follow-up|11|||
147548316|NCT04120194|532163762|FG001|Overall Study|Lost to Follow-up|8|||
147548317|NCT04120194|532163761|FG000|Overall Study|Adverse Event|4|||
147548318|NCT04120194|532163762|FG001|Overall Study|Adverse Event|5|||
147548319|NCT04120194|532163761|FG000|Overall Study|Voluntary withdrawal unrelated to adverse event|1|||
147548320|NCT04120194|532163762|FG001|Overall Study|Voluntary withdrawal unrelated to adverse event|2|||
147548321|NCT04120194|532163761|FG000|Overall Study|Miscellaneous|4|||
147548322|NCT04120194|532163762|FG001|Overall Study|Miscellaneous|5|||
147548323|NCT03870997|532163769|FG000|Overall Study|Did not complete mid-study/final survey|10544|||
147548324|NCT03870997|532163770|FG001|Overall Study|Did not complete mid-study/final survey|10431|||
147548325|NCT03870997|532163771|FG002|Overall Study|Did not complete mid-study/final survey|10978|||
147548326|NCT03870997|532163772|FG003|Overall Study|Did not complete mid-study/final survey|10947|||
147214612|NCT01675167|530957854|FG000|Double-blind Treatment Phase|Adverse Event|0|||
147548327|NCT03870997|532163773|FG004|Overall Study|Did not complete mid-study/final survey|10588|||
147214613|NCT01675167|530957855|FG001|Double-blind Treatment Phase|Adverse Event|5|||
147214614|NCT01675167|530957856|FG002|Double-blind Treatment Phase|Adverse Event|13|||
147214615|NCT01675167|530957854|FG000|Double-blind Treatment Phase|Protocol Violation|0|||
147214616|NCT01675167|530957855|FG001|Double-blind Treatment Phase|Protocol Violation|4|||
147214617|NCT01675167|530957856|FG002|Double-blind Treatment Phase|Protocol Violation|11|||
147214618|NCT01675167|530957854|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
147214619|NCT01675167|530957855|FG001|Double-blind Treatment Phase|Lost to Follow-up|1|||
147214620|NCT01675167|530957856|FG002|Double-blind Treatment Phase|Lost to Follow-up|5|||
147214621|NCT01675167|530957854|FG000|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|0|||
147214622|NCT01675167|530957855|FG001|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|1|||
147214623|NCT01675167|530957856|FG002|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|9|||
147214624|NCT01675167|530957854|FG000|Double-blind Treatment Phase|Other|0|||
147214625|NCT01675167|530957855|FG001|Double-blind Treatment Phase|Other|7|||
147214626|NCT01675167|530957856|FG002|Double-blind Treatment Phase|Other|5|||
147214627|NCT03255083|530957857|FG000|Overall Study|Clinical progression|1|||
147214628|NCT03255083|530957858|FG001|Overall Study|Clinical progression|0|||
147214629|NCT03255083|530957859|FG002|Overall Study|Clinical progression|0|||
147214630|NCT03255083|530957860|FG003|Overall Study|Clinical progression|0|||
147214631|NCT03255083|530957857|FG000|Overall Study|Adverse Event|0|||
147214632|NCT03255083|530957858|FG001|Overall Study|Adverse Event|1|||
147214633|NCT03255083|530957859|FG002|Overall Study|Adverse Event|0|||
147214634|NCT03255083|530957860|FG003|Overall Study|Adverse Event|0|||
147214635|NCT03255083|530957857|FG000|Overall Study|Progressive disease by RECIST version 1.1|4|||
147214636|NCT03255083|530957858|FG001|Overall Study|Progressive disease by RECIST version 1.1|1|||
147214637|NCT03255083|530957859|FG002|Overall Study|Progressive disease by RECIST version 1.1|2|||
147214638|NCT03255083|530957860|FG003|Overall Study|Progressive disease by RECIST version 1.1|1|||
147214639|NCT03255083|530957857|FG000|Overall Study|Withdrawal by Subject|1|||
147214640|NCT03255083|530957858|FG001|Overall Study|Withdrawal by Subject|1|||
147214641|NCT03255083|530957859|FG002|Overall Study|Withdrawal by Subject|1|||
147214642|NCT03255083|530957860|FG003|Overall Study|Withdrawal by Subject|0|||
147214643|NCT00363545|530957861|FG000|Overall Study|Serious Adverse Event|0|||
147214644|NCT00363545|530957862|FG001|Overall Study|Serious Adverse Event|1|||
147214645|NCT00363545|530957861|FG000|Overall Study|Withdrawal by Subject|12|||
147214646|NCT00363545|530957862|FG001|Overall Study|Withdrawal by Subject|15|||
147214647|NCT00363545|530957861|FG000|Overall Study|Migrated/moved from study area|3|||
147214648|NCT00363545|530957862|FG001|Overall Study|Migrated/moved from study area|6|||
147214649|NCT00363545|530957861|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|14|||
147214650|NCT00363545|530957862|FG001|Overall Study|Lost to follow-up (incompl. vaccination)|18|||
147214651|NCT00363545|530957861|FG000|Overall Study|Lost to follow-up (complete vaccination)|14|||
147214652|NCT00363545|530957862|FG001|Overall Study|Lost to follow-up (complete vaccination)|17|||
147214653|NCT00363545|530957861|FG000|Overall Study|Others|1|||
147214654|NCT00363545|530957862|FG001|Overall Study|Others|0|||
147214655|NCT01457352|530957863|FG000|Period 1|Adverse Event|2|||
147214656|NCT01457352|530957864|FG001|Period 1|Adverse Event|0|||
147214657|NCT01457352|530957863|FG000|Period 1|Withdrawal by Subject|2|||
147442313|NCT00111800|531784295|FG004|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|0|||
147442314|NCT00111800|531784296|FG005|Period 2: Extension Phase (12 Weeks)|Lack of Efficacy|1|||
147442315|NCT00111800|531784291|FG000|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1|||
147442316|NCT00111800|531784292|FG001|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1|||
147442317|NCT00111800|531784293|FG002|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|0|||
147442318|NCT00111800|531784294|FG003|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1|||
147442319|NCT00111800|531784295|FG004|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1|||
147442320|NCT00111800|531784296|FG005|Period 2: Extension Phase (12 Weeks)|Insufficient therapeutic effect|1|||
147442321|NCT00111800|531784291|FG000|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0|||
147442322|NCT00111800|531784292|FG001|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|1|||
147442323|NCT00111800|531784293|FG002|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0|||
147442324|NCT00111800|531784294|FG003|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0|||
147442325|NCT00111800|531784295|FG004|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0|||
147442326|NCT00111800|531784296|FG005|Period 2: Extension Phase (12 Weeks)|Lack of Glycaemic Control|0|||
147442327|NCT00111800|531784291|FG000|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0|||
147442328|NCT00111800|531784292|FG001|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0|||
147442329|NCT00111800|531784293|FG002|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|1|||
147442330|NCT00111800|531784294|FG003|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0|||
147442331|NCT00111800|531784295|FG004|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0|||
147442332|NCT00111800|531784296|FG005|Period 2: Extension Phase (12 Weeks)|Electrocardiogram (ECG) results|0|||
147442333|NCT00111800|531784291|FG000|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0|||
147442334|NCT00111800|531784292|FG001|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0|||
147449487|NCT00440947|531809508|FG003|36-Week Induction Phase|Took Exclusionary Medications|0|||
147548328|NCT03870997|532163774|FG005|Overall Study|Did not complete mid-study/final survey|10531|||
147442335|NCT00111800|531784293|FG002|Period 2: Extension Phase (12 Weeks)|Participant received metformin|1|||
147442336|NCT00111800|531784294|FG003|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0|||
147442337|NCT00111800|531784295|FG004|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0|||
147442338|NCT00111800|531784296|FG005|Period 2: Extension Phase (12 Weeks)|Participant received metformin|0|||
147442339|NCT00326209|531784297|FG000|Overall Study|Adverse Event|28|||
147442340|NCT00326209|531784297|FG000|Overall Study|Withdrawal by Subject|22|||
147442341|NCT00326209|531784297|FG000|Overall Study|Lack of Efficacy|31|||
147442342|NCT00326209|531784297|FG000|Overall Study|Lost to Follow-up|18|||
147442343|NCT00326209|531784297|FG000|Overall Study|Participant non-compliant|6|||
147442344|NCT00326209|531784297|FG000|Overall Study|Sponsor closed study|173|||
147442345|NCT00326209|531784297|FG000|Overall Study|Prohibited medication use|1|||
147442346|NCT00326209|531784297|FG000|Overall Study|Violation of entry criteria|1|||
147442347|NCT00326209|531784297|FG000|Overall Study|Withdrawn in error|1|||
147442348|NCT00326209|531784297|FG000|Overall Study|Pregnancy|1|||
147442349|NCT02577406|531784298|FG000|Randomized Period|Death|1|||
147442350|NCT02577406|531784299|FG001|Randomized Period|Death|0|||
147442351|NCT02577406|531784298|FG000|Randomized Period|Other reasons|0|||
147442352|NCT02577406|531784299|FG001|Randomized Period|Other reasons|20|||
147442353|NCT02577406|531784298|FG000|Treatment Period|Death|38|||
147442354|NCT02577406|531784299|FG001|Treatment Period|Death|23|||
147442355|NCT02577406|531784298|FG000|Treatment Period|Adverse Event|17|||
147442356|NCT02577406|531784299|FG001|Treatment Period|Adverse Event|12|||
147442357|NCT02577406|531784298|FG000|Treatment Period|Progressive Disease|53|||
147442358|NCT02577406|531784299|FG001|Treatment Period|Progressive Disease|37|||
147442359|NCT02577406|531784298|FG000|Treatment Period|Withdrawal by Subject|10|||
147442360|NCT02577406|531784299|FG001|Treatment Period|Withdrawal by Subject|24|||
147442361|NCT02577406|531784298|FG000|Treatment Period|Lost to Follow-up|0|||
147442362|NCT02577406|531784299|FG001|Treatment Period|Lost to Follow-up|1|||
147442363|NCT02577406|531784298|FG000|Treatment Period|Transition to commercially available treatment|1|||
147442364|NCT02577406|531784299|FG001|Treatment Period|Transition to commercially available treatment|1|||
147442365|NCT02577406|531784298|FG000|Treatment Period|Physician Decision|1|||
147442366|NCT02577406|531784299|FG001|Treatment Period|Physician Decision|0|||
147442367|NCT02577406|531784298|FG000|Treatment Period|Disease Relapse|28|||
147442368|NCT02577406|531784299|FG001|Treatment Period|Disease Relapse|1|||
147442369|NCT02577406|531784298|FG000|Treatment Period|Protocol Violation|0|||
147442370|NCT02577406|531784299|FG001|Treatment Period|Protocol Violation|1|||
147442371|NCT02577406|531784298|FG000|Treatment Period|Other Reasons|3|||
147442372|NCT02577406|531784299|FG001|Treatment Period|Other Reasons|39|||
147442373|NCT02577406|531784298|FG000|Treatment Period|Hematopoietic Stem Cell Transplantation|6|||
147442374|NCT02577406|531784299|FG001|Treatment Period|Hematopoietic Stem Cell Transplantation|2|||
147442375|NCT01111851|531784302|FG000|Overall Study|All planned PET scans were not obtained.|2|||
147442376|NCT01111851|531784303|FG001|Overall Study|All planned PET scans were not obtained.|0|||
147442377|NCT05500274|531784304|FG000|Overall Study|Not able to complete the session and follow-up visits.|7|||
147442378|NCT05500274|531784305|FG001|Overall Study|Not able to complete the session and follow-up visits.|15|||
147442379|NCT05500274|531784304|FG000|Overall Study|Lost to Follow-up|76|||
147442380|NCT05500274|531784305|FG001|Overall Study|Lost to Follow-up|51|||
147442381|NCT05807464|531784308|FG000|Overall Study|Adverse Event|1|||
147442382|NCT01555151|531784310|FG000|Overall Study|Withdrawal by Subject|6|||
147442383|NCT01555151|531784311|FG001|Overall Study|Withdrawal by Subject|2|||
147442384|NCT01555151|531784312|FG002|Overall Study|Withdrawal by Subject|0|||
147442385|NCT01555151|531784313|FG003|Overall Study|Withdrawal by Subject|2|||
147442386|NCT01555151|531784310|FG000|Overall Study|Administrative|3|||
147442387|NCT01555151|531784311|FG001|Overall Study|Administrative|1|||
147442388|NCT01555151|531784312|FG002|Overall Study|Administrative|2|||
147442389|NCT01555151|531784313|FG003|Overall Study|Administrative|0|||
147442390|NCT01555151|531784310|FG000|Overall Study|Protocol Violation|3|||
147442391|NCT01555151|531784311|FG001|Overall Study|Protocol Violation|3|||
147442392|NCT01555151|531784312|FG002|Overall Study|Protocol Violation|3|||
147442393|NCT01555151|531784313|FG003|Overall Study|Protocol Violation|5|||
147442394|NCT01555151|531784310|FG000|Overall Study|Adverse Event|1|||
147442395|NCT01555151|531784311|FG001|Overall Study|Adverse Event|2|||
147442396|NCT01555151|531784312|FG002|Overall Study|Adverse Event|1|||
147442397|NCT01555151|531784313|FG003|Overall Study|Adverse Event|2|||
147442398|NCT01555151|531784310|FG000|Overall Study|Lost to Follow-up|0|||
147442399|NCT01555151|531784311|FG001|Overall Study|Lost to Follow-up|0|||
147442400|NCT01555151|531784312|FG002|Overall Study|Lost to Follow-up|0|||
147442401|NCT01555151|531784313|FG003|Overall Study|Lost to Follow-up|1|||
147442402|NCT03596866|531784314|FG000|Overall Study|Site terminated by Sponsor|64|||
147442403|NCT03596866|531784315|FG001|Overall Study|Site terminated by Sponsor|65|||
147442404|NCT03596866|531784314|FG000|Overall Study|Death|37|||
147442405|NCT03596866|531784315|FG001|Overall Study|Death|24|||
147442406|NCT03596866|531784314|FG000|Overall Study|Withdrawal by Subject|4|||
147442407|NCT03596866|531784315|FG001|Overall Study|Withdrawal by Subject|6|||
147442408|NCT03596866|531784314|FG000|Overall Study|Missing|0|||
147442409|NCT03596866|531784315|FG001|Overall Study|Missing|6|||
147548329|NCT00219557|532163775|FG000|Phase 1|Lack of Efficacy|3|||
147548330|NCT00219557|532163776|FG001|Phase 1|Lack of Efficacy|0|||
147214658|NCT01457352|530957864|FG001|Period 1|Withdrawal by Subject|0|||
147214659|NCT01457352|530957863|FG000|Period 1|Physician Decision|2|||
147214660|NCT01457352|530957864|FG001|Period 1|Physician Decision|0|||
147214661|NCT01457352|530957863|FG000|Period 1|MS related disease progression|1|||
147214662|NCT01457352|530957864|FG001|Period 1|MS related disease progression|0|||
147214663|NCT01457352|530957863|FG000|Period 1|Withdrawn|1|||
147214664|NCT01457352|530957864|FG001|Period 1|Withdrawn|0|||
147214665|NCT01457352|530957863|FG000|Period 1|withdrew per sponsor|1|||
147214666|NCT01457352|530957864|FG001|Period 1|withdrew per sponsor|0|||
147214667|NCT01457352|530957863|FG000|Period 1|Protocol Violation|4|||
147214668|NCT01457352|530957864|FG001|Period 1|Protocol Violation|0|||
147214669|NCT01457352|530957863|FG000|Period 1|Did not meet eligibility criteria|3|||
147214670|NCT01457352|530957864|FG001|Period 1|Did not meet eligibility criteria|0|||
147214671|NCT01457352|530957863|FG000|Period 2|Withdrawal by Subject|23|||
147214672|NCT01457352|530957864|FG001|Period 2|Withdrawal by Subject|0|||
147214673|NCT01457352|530957863|FG000|Period 2|Adverse Event|22|||
147214674|NCT01457352|530957864|FG001|Period 2|Adverse Event|0|||
147214675|NCT01457352|530957863|FG000|Period 2|no analysis|10|||
147214676|NCT01457352|530957864|FG001|Period 2|no analysis|0|||
147214677|NCT01457352|530957863|FG000|Period 2|Lack of Efficacy|8|||
147214678|NCT01457352|530957864|FG001|Period 2|Lack of Efficacy|0|||
147214679|NCT01457352|530957863|FG000|Period 2|Protocol Violation|4|||
147214680|NCT01457352|530957864|FG001|Period 2|Protocol Violation|0|||
147214681|NCT01457352|530957863|FG000|Period 2|Sponsor's withdrawal|7|||
147214682|NCT01457352|530957864|FG001|Period 2|Sponsor's withdrawal|0|||
147214683|NCT01457352|530957863|FG000|Period 2|Lost to Follow-up|1|||
147214684|NCT01457352|530957864|FG001|Period 2|Lost to Follow-up|0|||
147214685|NCT01457352|530957863|FG000|Period 2|dose change|1|||
147214686|NCT01457352|530957864|FG001|Period 2|dose change|0|||
147214687|NCT01457352|530957863|FG000|Period 2|Physician Decision|1|||
147214688|NCT01457352|530957864|FG001|Period 2|Physician Decision|0|||
147214689|NCT01457352|530957863|FG000|Period 2|Did not meet eligibility criteria|3|||
147214690|NCT01457352|530957864|FG001|Period 2|Did not meet eligibility criteria|0|||
147214691|NCT01457352|530957863|FG000|Period 3|Adverse Event|1|||
147214692|NCT01457352|530957864|FG001|Period 3|Adverse Event|1|||
147214693|NCT01457352|530957863|FG000|Period 3|Withdrawal by Subject|0|||
147214694|NCT01457352|530957864|FG001|Period 3|Withdrawal by Subject|2|||
147214695|NCT01457352|530957863|FG000|Period 3|incorrect treatment|0|||
147214696|NCT01457352|530957864|FG001|Period 3|incorrect treatment|1|||
147214697|NCT01457352|530957863|FG000|Period 3|Sponsor's withdrawal|0|||
147214698|NCT01457352|530957864|FG001|Period 3|Sponsor's withdrawal|1|||
147214699|NCT03952039|530957865|FG000|Overall Study|Adverse Event|22|||
147214700|NCT03952039|530957866|FG001|Overall Study|Adverse Event|8|||
147214701|NCT03952039|530957865|FG000|Overall Study|Withdrawal by Participant|17|||
147214702|NCT03952039|530957866|FG001|Overall Study|Withdrawal by Participant|12|||
147214703|NCT03952039|530957865|FG000|Overall Study|Death|13|||
147214704|NCT03952039|530957866|FG001|Overall Study|Death|6|||
147214705|NCT03952039|530957865|FG000|Overall Study|Lack of Efficacy|12|||
147214706|NCT03952039|530957866|FG001|Overall Study|Lack of Efficacy|2|||
147214707|NCT03952039|530957865|FG000|Overall Study|Physician Decision|9|||
147214708|NCT03952039|530957866|FG001|Overall Study|Physician Decision|3|||
147214709|NCT03952039|530957865|FG000|Overall Study|Progressive Disease|6|||
147214710|NCT03952039|530957866|FG001|Overall Study|Progressive Disease|4|||
147214711|NCT03952039|530957865|FG000|Overall Study|Other Reasons|12|||
147214712|NCT03952039|530957866|FG001|Overall Study|Other Reasons|4|||
147214713|NCT05009979|530957867|FG000|Overall Study|Withdrawal by Subject|1|||
147214714|NCT04174365|530957868|FG000|Overall Study|Lost to Follow-up|1|||
147214715|NCT04174365|530957869|FG001|Overall Study|Lost to Follow-up|2|||
147214716|NCT04174365|530957868|FG000|Overall Study|Adverse Event|2|||
147214717|NCT04174365|530957869|FG001|Overall Study|Adverse Event|1|||
147214718|NCT04174365|530957868|FG000|Overall Study|Subject Withdrew Consent To Participate|1|||
147214719|NCT04174365|530957869|FG001|Overall Study|Subject Withdrew Consent To Participate|0|||
147214720|NCT04174365|530957868|FG000|Overall Study|Subject Was Withdrawn From Participation By Parent/Guardian|2|||
147214721|NCT04174365|530957869|FG001|Overall Study|Subject Was Withdrawn From Participation By Parent/Guardian|1|||
147214722|NCT04174365|530957868|FG000|Overall Study|Protocol Deviation|1|||
147548331|NCT00219557|532163777|FG002|Phase 1|Lack of Efficacy|0|||
147548332|NCT00219557|532163775|FG000|Phase 1|Adverse Event|2|||
147548333|NCT00219557|532163776|FG001|Phase 1|Adverse Event|0|||
147548334|NCT00219557|532163777|FG002|Phase 1|Adverse Event|0|||
147548335|NCT00219557|532163775|FG000|Phase 1|Withdrawal by Subject|1|||
147214723|NCT04174365|530957869|FG001|Overall Study|Protocol Deviation|0|||
147214724|NCT04174365|530957868|FG000|Overall Study|Lack of Efficacy|0|||
147214725|NCT04174365|530957869|FG001|Overall Study|Lack of Efficacy|2|||
147214726|NCT04174365|530957868|FG000|Overall Study|Disease Relapse|1|||
147214727|NCT04174365|530957869|FG001|Overall Study|Disease Relapse|0|||
147214728|NCT04174365|530957868|FG000|Overall Study|Reason Not Specified|0|||
147214729|NCT04174365|530957869|FG001|Overall Study|Reason Not Specified|1|||
147214730|NCT03472547|530957870|FG000|Overall Study|Withdrawal by Subject|30|||
147548336|NCT00219557|532163776|FG001|Phase 1|Withdrawal by Subject|0|||
147548337|NCT00219557|532163777|FG002|Phase 1|Withdrawal by Subject|0|||
147548338|NCT00219557|532163775|FG000|Phase 1|Started chemotherapy at other institute|1|||
147548339|NCT00219557|532163776|FG001|Phase 1|Started chemotherapy at other institute|0|||
147548340|NCT00219557|532163777|FG002|Phase 1|Started chemotherapy at other institute|0|||
147548341|NCT00219557|532163775|FG000|Phase 2|Lack of Efficacy|0|||
147548342|NCT00219557|532163776|FG001|Phase 2|Lack of Efficacy|21|||
147548343|NCT00219557|532163777|FG002|Phase 2|Lack of Efficacy|15|||
147548344|NCT00219557|532163775|FG000|Phase 2|Adverse Event|0|||
147548345|NCT00219557|532163776|FG001|Phase 2|Adverse Event|22|||
147548346|NCT00219557|532163777|FG002|Phase 2|Adverse Event|2|||
147548347|NCT00219557|532163775|FG000|Phase 2|Death|0|||
147548348|NCT00219557|532163776|FG001|Phase 2|Death|8|||
147548349|NCT00219557|532163777|FG002|Phase 2|Death|2|||
147548350|NCT00219557|532163775|FG000|Phase 2|Other|0|||
147548351|NCT00219557|532163776|FG001|Phase 2|Other|8|||
147548352|NCT00219557|532163777|FG002|Phase 2|Other|6|||
147548353|NCT00219557|532163775|FG000|Phase 2|Withdrawal by Subject|0|||
147548354|NCT00219557|532163776|FG001|Phase 2|Withdrawal by Subject|9|||
147548355|NCT00219557|532163777|FG002|Phase 2|Withdrawal by Subject|5|||
147548356|NCT00219557|532163775|FG000|Phase 2|Treatment not received|0|||
147548357|NCT00219557|532163776|FG001|Phase 2|Treatment not received|1|||
147548358|NCT00219557|532163777|FG002|Phase 2|Treatment not received|3|||
147548359|NCT03063632|532163778|FG000|Overall Study|Death|4|||
147548360|NCT03063632|532163779|FG001|Overall Study|Death|6|||
147548361|NCT03063632|532163778|FG000|Overall Study|Lost to Follow-up|0|||
147548362|NCT03063632|532163779|FG001|Overall Study|Lost to Follow-up|1|||
147548363|NCT03063632|532163778|FG000|Overall Study|Withdrawal by Subject|0|||
147548364|NCT03063632|532163779|FG001|Overall Study|Withdrawal by Subject|2|||
147548365|NCT03063632|532163778|FG000|Overall Study|Physician Decision|2|||
147548366|NCT03063632|532163779|FG001|Overall Study|Physician Decision|0|||
147548367|NCT03063632|532163778|FG000|Overall Study|Other: Disease progression; starting another treatment|1|||
147548368|NCT03063632|532163779|FG001|Overall Study|Other: Disease progression; starting another treatment|1|||
147548369|NCT00106028|532163780|FG000|Overall Study|Adverse Event|3|||
147548370|NCT00106028|532163781|FG001|Overall Study|Adverse Event|2|||
147548371|NCT00106028|532163780|FG000|Overall Study|Protocol Violation|1|||
147548372|NCT00106028|532163781|FG001|Overall Study|Protocol Violation|1|||
147548373|NCT00106028|532163780|FG000|Overall Study|Withdrawal by Subject|2|||
147548374|NCT00106028|532163781|FG001|Overall Study|Withdrawal by Subject|8|||
147548375|NCT00106028|532163780|FG000|Overall Study|Lost to Follow-up|0|||
147548376|NCT00106028|532163781|FG001|Overall Study|Lost to Follow-up|1|||
147548377|NCT00947011|532163783|FG000|Overall Study|Study was terminated,PI left institution|12|||
147548378|NCT00814658|532163784|FG000|Overall Study|Lost to Follow-up|0|||
147548379|NCT00814658|532163785|FG001|Overall Study|Lost to Follow-up|1|||
147548380|NCT00814658|532163784|FG000|Overall Study|Physician Decision|1|||
147548381|NCT00814658|532163785|FG001|Overall Study|Physician Decision|0|||
147548382|NCT00814658|532163784|FG000|Overall Study|Adverse Event|3|||
147548383|NCT00814658|532163785|FG001|Overall Study|Adverse Event|3|||
147548384|NCT05266456|532163786|FG000|Phase 1, Adults 18-49 Years of Age|Lost to Follow-up|1|||
147548385|NCT05266456|532163787|FG001|Phase 1, Adults 18-49 Years of Age|Lost to Follow-up|1|||
147548386|NCT05266456|532163788|FG002|Phase 1, Adults 18-49 Years of Age|Lost to Follow-up|0|||
147548387|NCT05266456|532163789|FG003|Phase 1, Adults 18-49 Years of Age|Lost to Follow-up|0|||
147548388|NCT05266456|532163786|FG000|Phase 1, Adults 18-49 Years of Age|Withdrawal by Subject|0|||
147548389|NCT05266456|532163787|FG001|Phase 1, Adults 18-49 Years of Age|Withdrawal by Subject|0|||
147548390|NCT05266456|532163788|FG002|Phase 1, Adults 18-49 Years of Age|Withdrawal by Subject|0|||
147548391|NCT05266456|532163789|FG003|Phase 1, Adults 18-49 Years of Age|Withdrawal by Subject|1|||
147548392|NCT05266456|532163786|FG000|Phase 2, Adults 50-64 Years|Lost to Follow-up|6|||
147548393|NCT05266456|532163787|FG001|Phase 2, Adults 50-64 Years|Lost to Follow-up|6|||
147548394|NCT05266456|532163788|FG002|Phase 2, Adults 50-64 Years|Lost to Follow-up|3|||
147548395|NCT05266456|532163789|FG003|Phase 2, Adults 50-64 Years|Lost to Follow-up|1|||
147548396|NCT05266456|532163786|FG000|Phase 2, Adults 50-64 Years|Withdrawal by Subject|0|||
147548397|NCT05266456|532163787|FG001|Phase 2, Adults 50-64 Years|Withdrawal by Subject|0|||
147548398|NCT05266456|532163788|FG002|Phase 2, Adults 50-64 Years|Withdrawal by Subject|2|||
147548399|NCT05266456|532163789|FG003|Phase 2, Adults 50-64 Years|Withdrawal by Subject|0|||
147548400|NCT05266456|532163786|FG000|Phase 2, Adults 50-64 Years|Unavailable for follow up|1|||
147548401|NCT05266456|532163787|FG001|Phase 2, Adults 50-64 Years|Unavailable for follow up|0|||
147548402|NCT05266456|532163788|FG002|Phase 2, Adults 50-64 Years|Unavailable for follow up|0|||
147548403|NCT05266456|532163789|FG003|Phase 2, Adults 50-64 Years|Unavailable for follow up|1|||
147548404|NCT01610167|532163791|FG000|Overall Study|Scheduling conflict.|0|||
147548405|NCT01610167|532163792|FG001|Overall Study|Scheduling conflict.|0|||
147548406|NCT01610167|532163793|FG002|Overall Study|Scheduling conflict.|2|||
147548407|NCT06371079|532163795|FG000|Overall Study|Missing data|88|||
147548408|NCT06371079|532163796|FG001|Overall Study|Missing data|247|||
147548409|NCT02746705|532163797|FG000|Overall Study|Physician Decision|1|||
147548410|NCT02746705|532163798|FG001|Overall Study|Physician Decision|1|||
147548411|NCT02746705|532163797|FG000|Overall Study|Lost to Follow-up|1|||
147548412|NCT02746705|532163798|FG001|Overall Study|Lost to Follow-up|0|||
147548413|NCT02746705|532163797|FG000|Overall Study|outlier scores deemed not valid|0|||
147548414|NCT02746705|532163798|FG001|Overall Study|outlier scores deemed not valid|1|||
147548415|NCT01964105|532163799|FG000|Overall Study|Lost to Follow-up|2|||
147548416|NCT01964105|532163800|FG001|Overall Study|Lost to Follow-up|13|||
147548417|NCT01964105|532163801|FG002|Overall Study|Lost to Follow-up|0|||
147548418|NCT00575328|532163802|FG000|Overall Study|Adverse Event|1|||
147548419|NCT00575328|532163803|FG001|Overall Study|Adverse Event|1|||
147548420|NCT00575328|532163802|FG000|Overall Study|Lost to Follow-up|2|||
147548421|NCT00575328|532163803|FG001|Overall Study|Lost to Follow-up|1|||
147548422|NCT00124449|532163808|FG000|6-month Double-Blind Treatment Period|Adverse Event|1|||
147548423|NCT00124449|532163809|FG001|6-month Double-Blind Treatment Period|Adverse Event|0|||
147548424|NCT00124449|532163808|FG000|6-month Double-Blind Treatment Period|Lack of Efficacy|3|||
147548425|NCT00124449|532163809|FG001|6-month Double-Blind Treatment Period|Lack of Efficacy|8|||
147548426|NCT00124449|532163808|FG000|6-month Double-Blind Treatment Period|Withdrawal by Subject|1|||
147548427|NCT00124449|532163809|FG001|6-month Double-Blind Treatment Period|Withdrawal by Subject|1|||
147548428|NCT00124449|532163808|FG000|6-month Double-Blind Treatment Period|Poor/Noncompliance|1|||
147548429|NCT00124449|532163809|FG001|6-month Double-Blind Treatment Period|Poor/Noncompliance|0|||
147548430|NCT00124449|532163808|FG000|6-month Double-Blind Treatment Period|Sponsor request|0|||
147548431|NCT00124449|532163809|FG001|6-month Double-Blind Treatment Period|Sponsor request|1|||
147548432|NCT00124449|532163808|FG000|6-month Double-Blind Treatment Period|Exposure to mycobacterium tuberculosis|0|||
147548433|NCT00124449|532163809|FG001|6-month Double-Blind Treatment Period|Exposure to mycobacterium tuberculosis|1|||
147548434|NCT00124449|532163808|FG000|18-Month Untreated Observation Period|Adverse Event|0|||
147548435|NCT00124449|532163809|FG001|18-Month Untreated Observation Period|Adverse Event|1|||
147548436|NCT00124449|532163808|FG000|18-Month Untreated Observation Period|Lack of Efficacy|11|||
147548437|NCT00124449|532163809|FG001|18-Month Untreated Observation Period|Lack of Efficacy|12|||
147548438|NCT00124449|532163808|FG000|18-Month Untreated Observation Period|Lost to Follow-up|1|||
147548439|NCT00124449|532163809|FG001|18-Month Untreated Observation Period|Lost to Follow-up|0|||
147548440|NCT00124449|532163808|FG000|18-Month Untreated Observation Period|Pregnancy|1|||
147548441|NCT00124449|532163809|FG001|18-Month Untreated Observation Period|Pregnancy|0|||
147548442|NCT00124449|532163808|FG000|18-Month Untreated Observation Period|Poor/Noncompliance|1|||
147548443|NCT00124449|532163809|FG001|18-Month Untreated Observation Period|Poor/Noncompliance|0|||
147548444|NCT00124449|532163808|FG000|18-Month Untreated Observation Period|Relocated|1|||
147548445|NCT00124449|532163809|FG001|18-Month Untreated Observation Period|Relocated|0|||
147548446|NCT03940586|532163810|FG000|Overall Study|Death|3|||
147548447|NCT03940586|532163811|FG001|Overall Study|Death|2|||
147548448|NCT03940586|532163812|FG002|Overall Study|Death|0|||
147548449|NCT03940586|532163810|FG000|Overall Study|Physician Decision|1|||
147548450|NCT03940586|532163811|FG001|Overall Study|Physician Decision|0|||
147548451|NCT03940586|532163812|FG002|Overall Study|Physician Decision|1|||
147548452|NCT03940586|532163810|FG000|Overall Study|Withdrawal By Parent/Guardian|3|||
147548453|NCT03940586|532163811|FG001|Overall Study|Withdrawal By Parent/Guardian|4|||
147548454|NCT03940586|532163812|FG002|Overall Study|Withdrawal By Parent/Guardian|1|||
147548455|NCT03940586|532163810|FG000|Overall Study|Not Treated|0|||
147548456|NCT03940586|532163811|FG001|Overall Study|Not Treated|2|||
147548457|NCT03940586|532163812|FG002|Overall Study|Not Treated|0|||
147548458|NCT02006147|532163813|FG000|Overall Study|Protocol Violation|1|||
147548459|NCT02006147|532163814|FG001|Overall Study|Protocol Violation|1|||
147548460|NCT02006147|532163815|FG002|Overall Study|Protocol Violation|0|||
147548461|NCT02006147|532163816|FG003|Overall Study|Protocol Violation|0|||
147548462|NCT02006147|532163813|FG000|Overall Study|Withdrawal by Subject|0|||
147548463|NCT02006147|532163814|FG001|Overall Study|Withdrawal by Subject|1|||
147548464|NCT02006147|532163815|FG002|Overall Study|Withdrawal by Subject|0|||
147548465|NCT02006147|532163816|FG003|Overall Study|Withdrawal by Subject|0|||
147548466|NCT02006147|532163813|FG000|Overall Study|Withdrawal by Sponsor|1|||
147548467|NCT02006147|532163814|FG001|Overall Study|Withdrawal by Sponsor|0|||
147548468|NCT02006147|532163815|FG002|Overall Study|Withdrawal by Sponsor|0|||
147548469|NCT02006147|532163816|FG003|Overall Study|Withdrawal by Sponsor|0|||
147548470|NCT00811070|532163820|FG000|Overall Study|Death|0|||
147548471|NCT00811070|532163821|FG001|Overall Study|Death|0|||
147548472|NCT00811070|532163822|FG002|Overall Study|Death|0|||
147548473|NCT00811070|532163823|FG003|Overall Study|Death|2|||
147548474|NCT00811070|532163824|FG004|Overall Study|Death|5|||
147548475|NCT00811070|532163825|FG005|Overall Study|Death|0|||
147548476|NCT00811070|532163820|FG000|Overall Study|Other|1|||
147548477|NCT00811070|532163821|FG001|Overall Study|Other|0|||
147548478|NCT00811070|532163822|FG002|Overall Study|Other|0|||
147548479|NCT00811070|532163823|FG003|Overall Study|Other|0|||
147548480|NCT00811070|532163824|FG004|Overall Study|Other|0|||
147548481|NCT00811070|532163825|FG005|Overall Study|Other|0|||
147548482|NCT00811070|532163820|FG000|Overall Study|Withdrawal by Subject|0|||
147548483|NCT00811070|532163821|FG001|Overall Study|Withdrawal by Subject|1|||
147548484|NCT00811070|532163822|FG002|Overall Study|Withdrawal by Subject|0|||
147548485|NCT00811070|532163823|FG003|Overall Study|Withdrawal by Subject|0|||
147548486|NCT00811070|532163824|FG004|Overall Study|Withdrawal by Subject|0|||
147548487|NCT00811070|532163825|FG005|Overall Study|Withdrawal by Subject|0|||
147548488|NCT00811070|532163820|FG000|Overall Study|Physician Decision|0|||
147548489|NCT00811070|532163821|FG001|Overall Study|Physician Decision|0|||
147548490|NCT00811070|532163822|FG002|Overall Study|Physician Decision|0|||
147548491|NCT00811070|532163823|FG003|Overall Study|Physician Decision|0|||
147548492|NCT00811070|532163824|FG004|Overall Study|Physician Decision|0|||
147548493|NCT00811070|532163825|FG005|Overall Study|Physician Decision|1|||
147548494|NCT00585039|532163827|FG000|Overall Study|medication spilled|2|||
147548495|NCT00585039|532163828|FG001|Overall Study|medication spilled|0|||
147548496|NCT00860574|532166085|FG000|Overall Study|Death|2|||
147548497|NCT00860574|532166085|FG000|Overall Study|Relapse|1|||
147548498|NCT01165242|532166088|FG000|Overall Study|Unreachable Subjects|1|||
147548499|NCT01165242|532166089|FG001|Overall Study|Unreachable Subjects|0|||
147548500|NCT01165242|532166090|FG002|Overall Study|Unreachable Subjects|0|||
147548501|NCT01165242|532166088|FG000|Overall Study|Incarcerated Subjects|0|||
147548502|NCT01165242|532166089|FG001|Overall Study|Incarcerated Subjects|1|||
147548503|NCT01165242|532166090|FG002|Overall Study|Incarcerated Subjects|0|||
147548504|NCT01165242|532166088|FG000|Overall Study|Visit 2 Declined by Subject|0|||
147548505|NCT01165242|532166089|FG001|Overall Study|Visit 2 Declined by Subject|0|||
147548506|NCT01165242|532166090|FG002|Overall Study|Visit 2 Declined by Subject|1|||
147548507|NCT01165242|532166088|FG000|Overall Study|Withdrawal by Subject|0|||
147548508|NCT01165242|532166089|FG001|Overall Study|Withdrawal by Subject|2|||
147548509|NCT01165242|532166090|FG002|Overall Study|Withdrawal by Subject|2|||
147548510|NCT01165242|532166088|FG000|Overall Study|Extended Holiday|0|||
147548511|NCT01165242|532166089|FG001|Overall Study|Extended Holiday|0|||
147548512|NCT01165242|532166090|FG002|Overall Study|Extended Holiday|1|||
147548513|NCT01165242|532166088|FG000|Overall Study|Lost to Follow-up|9|||
147548514|NCT01165242|532166089|FG001|Overall Study|Lost to Follow-up|7|||
147548515|NCT01165242|532166090|FG002|Overall Study|Lost to Follow-up|10|||
147214731|NCT02168387|530959883|FG000|Overall Study|Planned exubation|6|||
147214732|NCT02168387|530959884|FG001|Overall Study|Planned exubation|3|||
147214733|NCT02168387|530959883|FG000|Overall Study|Death|1|||
147214734|NCT02168387|530959884|FG001|Overall Study|Death|0|||
147214735|NCT00640224|530959890|FG000|Overall Study|Lost to Follow-up|5|||
147214736|NCT00640224|530959891|FG001|Overall Study|Lost to Follow-up|2|||
147214737|NCT00640224|530959892|FG002|Overall Study|Lost to Follow-up|0|||
147214738|NCT00640224|530959893|FG003|Overall Study|Lost to Follow-up|0|||
147214739|NCT00640224|530959890|FG000|Overall Study|Withdrawal by Subject|1|||
147214740|NCT00640224|530959891|FG001|Overall Study|Withdrawal by Subject|0|||
147214741|NCT00640224|530959892|FG002|Overall Study|Withdrawal by Subject|0|||
147214742|NCT00640224|530959893|FG003|Overall Study|Withdrawal by Subject|0|||
147214743|NCT00640224|530959890|FG000|Overall Study|Headaches|0|||
147214744|NCT00640224|530959891|FG001|Overall Study|Headaches|1|||
147214745|NCT00640224|530959892|FG002|Overall Study|Headaches|0|||
147214746|NCT00640224|530959893|FG003|Overall Study|Headaches|0|||
147214747|NCT00422513|530959894|FG000|Overall Study|Lack of Efficacy|4|||
147214748|NCT00422513|530959895|FG001|Overall Study|Lack of Efficacy|5|||
147214749|NCT00422513|530959894|FG000|Overall Study|Protocol Violation|23|||
147214750|NCT00422513|530959895|FG001|Overall Study|Protocol Violation|7|||
147214751|NCT00422513|530959894|FG000|Overall Study|Refused Treatment|4|||
147214752|NCT00422513|530959895|FG001|Overall Study|Refused Treatment|2|||
147214753|NCT00422513|530959894|FG000|Overall Study|Withdrawal by Subject|2|||
147214754|NCT00422513|530959895|FG001|Overall Study|Withdrawal by Subject|1|||
147214755|NCT00422513|530959894|FG000|Overall Study|early termination of the study|67|||
147214756|NCT00422513|530959895|FG001|Overall Study|early termination of the study|80|||
147214757|NCT00422513|530959894|FG000|Overall Study|Adverse Event|4|||
147214758|NCT00422513|530959895|FG001|Overall Study|Adverse Event|4|||
147214759|NCT00422513|530959894|FG000|Overall Study|Death|3|||
147214760|NCT00422513|530959895|FG001|Overall Study|Death|7|||
147214761|NCT03135119|530959896|FG000|Overall Study|Lost to Follow-up|2|||
147214762|NCT03135119|530959897|FG001|Overall Study|Lost to Follow-up|0|||
147214763|NCT03135119|530959896|FG000|Overall Study|Physician Decision|1|||
147214764|NCT03135119|530959897|FG001|Overall Study|Physician Decision|1|||
147214765|NCT03135119|530959896|FG000|Overall Study|COVID-19 Shutdown|2|||
147214766|NCT03135119|530959897|FG001|Overall Study|COVID-19 Shutdown|2|||
147214767|NCT01478048|530959898|FG000|Overall Study|Disease Progression|52|||
147214768|NCT01478048|530959899|FG001|Overall Study|Disease Progression|35|||
147214769|NCT01478048|530959898|FG000|Overall Study|study drug toxicity|11|||
147214770|NCT01478048|530959899|FG001|Overall Study|study drug toxicity|14|||
147214771|NCT01478048|530959898|FG000|Overall Study|Adverse Event|2|||
147214772|NCT01478048|530959899|FG001|Overall Study|Adverse Event|11|||
147442410|NCT03596866|531784314|FG000|Overall Study|Lost to Follow-up|2|||
147442411|NCT03596866|531784315|FG001|Overall Study|Lost to Follow-up|3|||
147442412|NCT03596866|531784314|FG000|Overall Study|Protocol Violation|1|||
147442413|NCT03596866|531784315|FG001|Overall Study|Protocol Violation|0|||
147442414|NCT03596866|531784314|FG000|Overall Study|Reason Not Specified|14|||
147442415|NCT03596866|531784315|FG001|Overall Study|Reason Not Specified|13|||
147442416|NCT01816061|531784316|FG000|Overall Study|Lost to Follow-up|13|||
147442417|NCT01816061|531784317|FG001|Overall Study|Lost to Follow-up|24|||
147442418|NCT01671111|531784319|FG000|Overall Study|Adverse Event|2|||
147442419|NCT01671111|531784319|FG000|Overall Study|Lack of Efficacy|1|||
147214773|NCT01478048|530959898|FG000|Overall Study|subject request to discontinue treatment|3|||
147214774|NCT01478048|530959899|FG001|Overall Study|subject request to discontinue treatment|5|||
147214775|NCT01478048|530959898|FG000|Overall Study|Withdrawal by Subject|2|||
147214776|NCT01478048|530959899|FG001|Overall Study|Withdrawal by Subject|5|||
147214777|NCT01478048|530959898|FG000|Overall Study|non-specified|6|||
147214778|NCT01478048|530959899|FG001|Overall Study|non-specified|4|||
147214779|NCT01478048|530959898|FG000|Overall Study|poor/non-compliance|0|||
147214780|NCT01478048|530959899|FG001|Overall Study|poor/non-compliance|1|||
147214781|NCT01478048|530959898|FG000|Overall Study|no longer meets study criteria|1|||
147214782|NCT01478048|530959899|FG001|Overall Study|no longer meets study criteria|0|||
147214783|NCT01252667|530959904|FG000|Overall Study|Transplant aborted post-conditioning|0|||
147214784|NCT01252667|530959905|FG001|Overall Study|Transplant aborted post-conditioning|0|||
147214785|NCT01252667|530959906|FG002|Overall Study|Transplant aborted post-conditioning|0|||
147214786|NCT01252667|530959907|FG003|Overall Study|Transplant aborted post-conditioning|0|||
147214787|NCT01252667|530959908|FG004|Overall Study|Transplant aborted post-conditioning|0|||
147214788|NCT01252667|530959909|FG005|Overall Study|Transplant aborted post-conditioning|1|||
147214789|NCT04644315|530959910|FG000|Overall Study|Subject withdrawal of consent|1|||
147214790|NCT03032380|530959911|FG000|Overall Study|Adverse Event|0|||
147214791|NCT03032380|530959912|FG001|Overall Study|Adverse Event|1|||
147214792|NCT03032380|530959911|FG000|Overall Study|Lack of Efficacy|1|||
147214793|NCT03032380|530959912|FG001|Overall Study|Lack of Efficacy|0|||
147214794|NCT03032380|530959911|FG000|Overall Study|Withdrawal by Subject|2|||
147214795|NCT03032380|530959912|FG001|Overall Study|Withdrawal by Subject|3|||
147214796|NCT03032380|530959911|FG000|Overall Study|Recovery|0|||
147214797|NCT03032380|530959912|FG001|Overall Study|Recovery|1|||
147214798|NCT03032380|530959911|FG000|Overall Study|Death|39|||
147214799|NCT03032380|530959912|FG001|Overall Study|Death|34|||
147214800|NCT03032380|530959911|FG000|Overall Study|Other - Miscellaneous|0|||
147214801|NCT03032380|530959912|FG001|Overall Study|Other - Miscellaneous|1|||
147214802|NCT01836276|530959913|FG000|Overall Study|Lost to Follow-up|28|||
147214803|NCT01836276|530959914|FG001|Overall Study|Lost to Follow-up|51|||
147214804|NCT01561898|530959915|FG000|Overall Study|Withdrawal by Subject|0|||
147214805|NCT01561898|530959916|FG001|Overall Study|Withdrawal by Subject|8|||
147214806|NCT01561898|530959917|FG002|Overall Study|Withdrawal by Subject|12|||
147214807|NCT01561898|530959918|FG003|Overall Study|Withdrawal by Subject|5|||
147214808|NCT01561898|530959915|FG000|Overall Study|Lack of Efficacy|0|||
147214809|NCT01561898|530959916|FG001|Overall Study|Lack of Efficacy|8|||
147214810|NCT01561898|530959917|FG002|Overall Study|Lack of Efficacy|10|||
147214811|NCT01561898|530959918|FG003|Overall Study|Lack of Efficacy|5|||
147214812|NCT01561898|530959915|FG000|Overall Study|Worsening of complications|0|||
147214813|NCT01561898|530959916|FG001|Overall Study|Worsening of complications|1|||
147214814|NCT01561898|530959917|FG002|Overall Study|Worsening of complications|0|||
147214815|NCT01561898|530959918|FG003|Overall Study|Worsening of complications|0|||
147214816|NCT01561898|530959915|FG000|Overall Study|Lost to Follow-up|0|||
147214817|NCT01561898|530959916|FG001|Overall Study|Lost to Follow-up|0|||
147214818|NCT01561898|530959917|FG002|Overall Study|Lost to Follow-up|1|||
147214819|NCT01561898|530959918|FG003|Overall Study|Lost to Follow-up|0|||
147214820|NCT01561898|530959915|FG000|Overall Study|Adverse Event|1|||
147214821|NCT01561898|530959916|FG001|Overall Study|Adverse Event|19|||
147548516|NCT01859390|532166095|FG000|Overall Study|Insufficient Sputum Collected|1|||
147548517|NCT01859390|532166096|FG001|Overall Study|Insufficient Sputum Collected|3|||
147548518|NCT01859390|532166095|FG000|Overall Study|Sample Missing Collection Date|0|||
147548519|NCT01859390|532166096|FG001|Overall Study|Sample Missing Collection Date|1|||
147548520|NCT01859390|532166095|FG000|Overall Study|Tube Cracked|0|||
147548521|NCT01859390|532166096|FG001|Overall Study|Tube Cracked|2|||
147548522|NCT01859390|532166095|FG000|Overall Study|Shipment Error|0|||
147548523|NCT01859390|532166096|FG001|Overall Study|Shipment Error|1|||
147548524|NCT01706198|532166098|FG000|Overall Study|Adverse Event|12|||
147548525|NCT01706198|532166099|FG001|Overall Study|Adverse Event|15|||
147548526|NCT01706198|532166098|FG000|Overall Study|Protocol Violation|7|||
147548527|NCT01706198|532166099|FG001|Overall Study|Protocol Violation|5|||
147548528|NCT01706198|532166098|FG000|Overall Study|Other: Subject reached stopping criteria|11|||
147548529|NCT01706198|532166099|FG001|Overall Study|Other: Subject reached stopping criteria|13|||
147214822|NCT01561898|530959917|FG002|Overall Study|Adverse Event|14|||
147214823|NCT01561898|530959918|FG003|Overall Study|Adverse Event|9|||
147214824|NCT01561898|530959915|FG000|Overall Study|Physician Decision|1|||
147214825|NCT01561898|530959916|FG001|Overall Study|Physician Decision|5|||
147548530|NCT01706198|532166098|FG000|Overall Study|Lost to Follow-up|97|||
147548531|NCT01706198|532166099|FG001|Overall Study|Lost to Follow-up|93|||
147548532|NCT01706198|532166098|FG000|Overall Study|Physician Decision|23|||
147214826|NCT01561898|530959917|FG002|Overall Study|Physician Decision|7|||
147214827|NCT01561898|530959918|FG003|Overall Study|Physician Decision|1|||
147214828|NCT00331552|530959921|FG000|Period 3: Phase II|Neurological Symptoms|1|||
147214829|NCT00331552|530959922|FG001|Period 3: Phase II|Neurological Symptoms|0|||
147214830|NCT00331552|530959921|FG000|Period 3: Phase II|Severe Nausea|1|||
147214831|NCT00331552|530959922|FG001|Period 3: Phase II|Severe Nausea|0|||
147214832|NCT01445548|530959923|FG000|Overall Study|Adverse Event|1|||
147548533|NCT01706198|532166099|FG001|Overall Study|Physician Decision|37|||
147548534|NCT01706198|532166098|FG000|Overall Study|Withdrawal by Subject|23|||
147548535|NCT01706198|532166099|FG001|Overall Study|Withdrawal by Subject|31|||
147548536|NCT01084005|532166100|FG000|Overall Study|Adverse Event|1|||
147548537|NCT01084005|532166101|FG001|Overall Study|Adverse Event|8|||
147548538|NCT01084005|532166100|FG000|Overall Study|Protocol Violation|3|||
147548539|NCT01084005|532166101|FG001|Overall Study|Protocol Violation|7|||
147548540|NCT01084005|532166100|FG000|Overall Study|Withdrawal by Subject|1|||
147548541|NCT01084005|532166101|FG001|Overall Study|Withdrawal by Subject|1|||
147548542|NCT03377556|532166106|FG000|Overall Study|Adverse Event|5|||
147548543|NCT03377556|532166106|FG000|Overall Study|Refusal unrelated to adverse events|1|||
147548544|NCT03377556|532166106|FG000|Overall Study|Progression/relapse|38|||
147548545|NCT03377556|532166106|FG000|Overall Study|Death|3|||
147548546|NCT00472446|532166107|FG000|Overall Study|Protocol Violation|0|||
147548547|NCT00472446|532166108|FG001|Overall Study|Protocol Violation|0|||
147548548|NCT00472446|532166109|FG002|Overall Study|Protocol Violation|0|||
147548549|NCT00472446|532166110|FG003|Overall Study|Protocol Violation|1|||
147548550|NCT00472446|532166107|FG000|Overall Study|Reintervention|0|||
147548551|NCT00472446|532166108|FG001|Overall Study|Reintervention|0|||
147548552|NCT00472446|532166109|FG002|Overall Study|Reintervention|1|||
147548553|NCT00472446|532166110|FG003|Overall Study|Reintervention|1|||
147548554|NCT00472446|532166107|FG000|Overall Study|Questionnaires not returned|5|||
147548555|NCT00472446|532166108|FG001|Overall Study|Questionnaires not returned|6|||
147548556|NCT00472446|532166109|FG002|Overall Study|Questionnaires not returned|6|||
147548557|NCT00472446|532166110|FG003|Overall Study|Questionnaires not returned|4|||
147548558|NCT02008721|532166113|FG000|Overall Study|Withdrawal by Subject|5|||
147548559|NCT02008721|532166114|FG001|Overall Study|Withdrawal by Subject|1|||
147548560|NCT02008721|532166113|FG000|Overall Study|Death|4|||
147548561|NCT02008721|532166114|FG001|Overall Study|Death|2|||
147548562|NCT02008721|532166113|FG000|Overall Study|Adverse Event|3|||
147548563|NCT02008721|532166114|FG001|Overall Study|Adverse Event|5|||
147214833|NCT01883453|530959924|FG000|Overall Study|No episode of common cold|25|||
147214834|NCT01883453|530959925|FG001|Overall Study|No episode of common cold|23|||
147214835|NCT03642132|530959928|FG000|Chemotherapy Period|Adverse Event|1|||
147214836|NCT03642132|530959929|FG001|Chemotherapy Period|Adverse Event|1|||
147214837|NCT03642132|530959930|FG002|Chemotherapy Period|Adverse Event|0|||
147214838|NCT03642132|530959928|FG000|Chemotherapy Period|Physician's decision|4|||
147214839|NCT03642132|530959929|FG001|Chemotherapy Period|Physician's decision|1|||
147214840|NCT03642132|530959930|FG002|Chemotherapy Period|Physician's decision|0|||
147214841|NCT03642132|530959928|FG000|Chemotherapy Period|Progressive disease|0|||
147214842|NCT03642132|530959929|FG001|Chemotherapy Period|Progressive disease|0|||
147214843|NCT03642132|530959930|FG002|Chemotherapy Period|Progressive disease|1|||
147214844|NCT03642132|530959928|FG000|Chemotherapy Period|Study terminated by sponsor|0|||
147548564|NCT02008721|532166113|FG000|Overall Study|Protocol Violation|3|||
147548565|NCT02008721|532166114|FG001|Overall Study|Protocol Violation|2|||
147548566|NCT00772577|532166120|FG000|Overall Study|Adverse Event|6|||
147548567|NCT00772577|532166121|FG001|Overall Study|Adverse Event|3|||
147548568|NCT00772577|532166120|FG000|Overall Study|Abnormal laboratory values|0|||
147548569|NCT00772577|532166121|FG001|Overall Study|Abnormal laboratory values|1|||
147548570|NCT00772577|532166120|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
147548571|NCT00772577|532166121|FG001|Overall Study|Unsatisfactory therapeutic effect|8|||
147548572|NCT00772577|532166120|FG000|Overall Study|Patient withdrew consent|8|||
147548573|NCT00772577|532166121|FG001|Overall Study|Patient withdrew consent|5|||
147548574|NCT00772577|532166120|FG000|Overall Study|Lost to Follow-up|4|||
147548575|NCT00772577|532166121|FG001|Overall Study|Lost to Follow-up|3|||
147548576|NCT00772577|532166120|FG000|Overall Study|Administrative problems|2|||
147548577|NCT00772577|532166121|FG001|Overall Study|Administrative problems|1|||
147548578|NCT00772577|532166120|FG000|Overall Study|Protocol Deviation|3|||
147548579|NCT00772577|532166121|FG001|Overall Study|Protocol Deviation|2|||
147548580|NCT03211156|532166122|FG000|Overall Study|Withdrawal by Subject|0|||
147548581|NCT03211156|532166123|FG001|Overall Study|Withdrawal by Subject|2|||
147548582|NCT03211156|532166122|FG000|Overall Study|Lost to Follow-up|1|||
147548583|NCT03211156|532166123|FG001|Overall Study|Lost to Follow-up|1|||
147548584|NCT03211156|532166122|FG000|Overall Study|Adverse Event|1|||
147548585|NCT03211156|532166123|FG001|Overall Study|Adverse Event|0|||
147548586|NCT00553540|532166134|FG000|Overall Study|discharged after first visit|2|||
147548587|NCT00553540|532166135|FG001|Overall Study|discharged after first visit|5|||
147548588|NCT03565211|532166142|FG000|Overall Study|Withdrawal by Subject|2|||
147548589|NCT03565211|532166142|FG000|Overall Study|Lost to Follow-up|1|||
147548590|NCT03565211|532166142|FG000|Overall Study|Adverse Event|44|||
147548591|NCT03565211|532166142|FG000|Overall Study|Personal issues|1|||
147548592|NCT00950599|532166144|FG000|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
147548593|NCT00950599|532166145|FG001|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
147548594|NCT00950599|532166146|FG002|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
147548595|NCT00950599|532166147|FG003|Double-Blind Treatment Period|Administrative reason by sponsor|1|||
147548596|NCT00950599|532166148|FG004|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
147548597|NCT00950599|532166149|FG005|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
147548598|NCT00950599|532166150|FG006|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
147548599|NCT00950599|532166151|FG007|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
147548600|NCT00950599|532166152|FG008|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
147548601|NCT00950599|532166153|FG009|Double-Blind Treatment Period|Administrative reason by sponsor|0|||
147548602|NCT00950599|532166144|FG000|Double-Blind Treatment Period|Adverse Event|0|||
147548603|NCT00950599|532166145|FG001|Double-Blind Treatment Period|Adverse Event|1|||
147548604|NCT00950599|532166146|FG002|Double-Blind Treatment Period|Adverse Event|1|||
147548605|NCT00950599|532166147|FG003|Double-Blind Treatment Period|Adverse Event|1|||
147548606|NCT00950599|532166148|FG004|Double-Blind Treatment Period|Adverse Event|1|||
147548607|NCT00950599|532166149|FG005|Double-Blind Treatment Period|Adverse Event|1|||
147548608|NCT00950599|532166150|FG006|Double-Blind Treatment Period|Adverse Event|0|||
147548609|NCT00950599|532166151|FG007|Double-Blind Treatment Period|Adverse Event|0|||
147548610|NCT00950599|532166152|FG008|Double-Blind Treatment Period|Adverse Event|0|||
147548611|NCT00950599|532166153|FG009|Double-Blind Treatment Period|Adverse Event|0|||
147548612|NCT00950599|532166144|FG000|Double-Blind Treatment Period|Lack of Efficacy|2|||
147548613|NCT00950599|532166145|FG001|Double-Blind Treatment Period|Lack of Efficacy|5|||
147548614|NCT00950599|532166146|FG002|Double-Blind Treatment Period|Lack of Efficacy|5|||
147548615|NCT00950599|532166147|FG003|Double-Blind Treatment Period|Lack of Efficacy|7|||
147548616|NCT00950599|532166148|FG004|Double-Blind Treatment Period|Lack of Efficacy|3|||
147548617|NCT00950599|532166149|FG005|Double-Blind Treatment Period|Lack of Efficacy|6|||
147548618|NCT00950599|532166150|FG006|Double-Blind Treatment Period|Lack of Efficacy|0|||
147548619|NCT00950599|532166151|FG007|Double-Blind Treatment Period|Lack of Efficacy|1|||
147548620|NCT00950599|532166152|FG008|Double-Blind Treatment Period|Lack of Efficacy|0|||
147548621|NCT00950599|532166153|FG009|Double-Blind Treatment Period|Lack of Efficacy|0|||
147548622|NCT00950599|532166144|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
147548623|NCT00950599|532166145|FG001|Double-Blind Treatment Period|Lost to Follow-up|0|||
147548624|NCT00950599|532166146|FG002|Double-Blind Treatment Period|Lost to Follow-up|0|||
147548625|NCT00950599|532166147|FG003|Double-Blind Treatment Period|Lost to Follow-up|1|||
147548626|NCT00950599|532166148|FG004|Double-Blind Treatment Period|Lost to Follow-up|1|||
147548627|NCT00950599|532166149|FG005|Double-Blind Treatment Period|Lost to Follow-up|2|||
147548628|NCT00950599|532166150|FG006|Double-Blind Treatment Period|Lost to Follow-up|0|||
147548629|NCT00950599|532166151|FG007|Double-Blind Treatment Period|Lost to Follow-up|1|||
147548630|NCT00950599|532166152|FG008|Double-Blind Treatment Period|Lost to Follow-up|0|||
147548631|NCT00950599|532166153|FG009|Double-Blind Treatment Period|Lost to Follow-up|0|||
147548632|NCT00950599|532166144|FG000|Double-Blind Treatment Period|Poor/Noncompliance|1|||
147548633|NCT00950599|532166145|FG001|Double-Blind Treatment Period|Poor/Noncompliance|1|||
147548634|NCT00950599|532166146|FG002|Double-Blind Treatment Period|Poor/Noncompliance|0|||
147548635|NCT00950599|532166147|FG003|Double-Blind Treatment Period|Poor/Noncompliance|0|||
147548636|NCT00950599|532166148|FG004|Double-Blind Treatment Period|Poor/Noncompliance|0|||
147548637|NCT00950599|532166149|FG005|Double-Blind Treatment Period|Poor/Noncompliance|0|||
147548638|NCT00950599|532166150|FG006|Double-Blind Treatment Period|Poor/Noncompliance|0|||
147548639|NCT00950599|532166151|FG007|Double-Blind Treatment Period|Poor/Noncompliance|1|||
147548640|NCT00950599|532166152|FG008|Double-Blind Treatment Period|Poor/Noncompliance|0|||
147548641|NCT00950599|532166153|FG009|Double-Blind Treatment Period|Poor/Noncompliance|0|||
147548642|NCT00950599|532166144|FG000|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
147548643|NCT00950599|532166145|FG001|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
147548644|NCT00950599|532166146|FG002|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
147548645|NCT00950599|532166147|FG003|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
147548646|NCT00950599|532166148|FG004|Double-Blind Treatment Period|Subject no longer meets study criteria|1|||
147548647|NCT00950599|532166149|FG005|Double-Blind Treatment Period|Subject no longer meets study criteria|1|||
147548648|NCT00950599|532166150|FG006|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
147548649|NCT00950599|532166151|FG007|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
147548650|NCT00950599|532166152|FG008|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
147548651|NCT00950599|532166153|FG009|Double-Blind Treatment Period|Subject no longer meets study criteria|0|||
147548652|NCT00950599|532166144|FG000|Double-Blind Treatment Period|Subject Withdrew consent|4|||
147548653|NCT00950599|532166145|FG001|Double-Blind Treatment Period|Subject Withdrew consent|3|||
147548654|NCT00950599|532166146|FG002|Double-Blind Treatment Period|Subject Withdrew consent|3|||
147548655|NCT00950599|532166147|FG003|Double-Blind Treatment Period|Subject Withdrew consent|1|||
147548656|NCT00950599|532166148|FG004|Double-Blind Treatment Period|Subject Withdrew consent|1|||
147548657|NCT00950599|532166149|FG005|Double-Blind Treatment Period|Subject Withdrew consent|2|||
147548658|NCT00950599|532166150|FG006|Double-Blind Treatment Period|Subject Withdrew consent|0|||
147548659|NCT00950599|532166151|FG007|Double-Blind Treatment Period|Subject Withdrew consent|3|||
147548660|NCT00950599|532166152|FG008|Double-Blind Treatment Period|Subject Withdrew consent|0|||
147548661|NCT00950599|532166153|FG009|Double-Blind Treatment Period|Subject Withdrew consent|0|||
147548662|NCT00950599|532166144|FG000|Follow-Up Period|Adverse Event|0|||
147548663|NCT00950599|532166145|FG001|Follow-Up Period|Adverse Event|0|||
147548664|NCT00950599|532166146|FG002|Follow-Up Period|Adverse Event|0|||
147548665|NCT00950599|532166147|FG003|Follow-Up Period|Adverse Event|0|||
147548666|NCT00950599|532166148|FG004|Follow-Up Period|Adverse Event|0|||
147548667|NCT00950599|532166149|FG005|Follow-Up Period|Adverse Event|0|||
147548668|NCT00950599|532166150|FG006|Follow-Up Period|Adverse Event|0|||
147548669|NCT00950599|532166151|FG007|Follow-Up Period|Adverse Event|0|||
147548670|NCT00950599|532166152|FG008|Follow-Up Period|Adverse Event|1|||
147548671|NCT00950599|532166153|FG009|Follow-Up Period|Adverse Event|0|||
147548672|NCT00950599|532166144|FG000|Follow-Up Period|Lack of Efficacy|0|||
147548673|NCT00950599|532166145|FG001|Follow-Up Period|Lack of Efficacy|0|||
147548674|NCT00950599|532166146|FG002|Follow-Up Period|Lack of Efficacy|0|||
147548675|NCT00950599|532166147|FG003|Follow-Up Period|Lack of Efficacy|0|||
147548676|NCT00950599|532166148|FG004|Follow-Up Period|Lack of Efficacy|0|||
147548677|NCT00950599|532166149|FG005|Follow-Up Period|Lack of Efficacy|0|||
147548678|NCT00950599|532166150|FG006|Follow-Up Period|Lack of Efficacy|0|||
147548679|NCT00950599|532166151|FG007|Follow-Up Period|Lack of Efficacy|0|||
147548680|NCT00950599|532166152|FG008|Follow-Up Period|Lack of Efficacy|3|||
147548681|NCT00950599|532166153|FG009|Follow-Up Period|Lack of Efficacy|0|||
147548682|NCT00950599|532166144|FG000|Follow-Up Period|Lost to Follow-up|0|||
147548683|NCT00950599|532166145|FG001|Follow-Up Period|Lost to Follow-up|0|||
147548684|NCT00950599|532166146|FG002|Follow-Up Period|Lost to Follow-up|0|||
147548685|NCT00950599|532166147|FG003|Follow-Up Period|Lost to Follow-up|0|||
147548686|NCT00950599|532166148|FG004|Follow-Up Period|Lost to Follow-up|0|||
147548687|NCT00950599|532166149|FG005|Follow-Up Period|Lost to Follow-up|0|||
147548688|NCT00950599|532166150|FG006|Follow-Up Period|Lost to Follow-up|0|||
147548689|NCT00950599|532166151|FG007|Follow-Up Period|Lost to Follow-up|0|||
147548690|NCT00950599|532166152|FG008|Follow-Up Period|Lost to Follow-up|5|||
147548691|NCT00950599|532166153|FG009|Follow-Up Period|Lost to Follow-up|1|||
147548692|NCT00950599|532166144|FG000|Follow-Up Period|Physician Decision|0|||
147548693|NCT00950599|532166145|FG001|Follow-Up Period|Physician Decision|0|||
147548694|NCT00950599|532166146|FG002|Follow-Up Period|Physician Decision|0|||
147548695|NCT00950599|532166147|FG003|Follow-Up Period|Physician Decision|0|||
147548696|NCT00950599|532166148|FG004|Follow-Up Period|Physician Decision|0|||
147548697|NCT00950599|532166149|FG005|Follow-Up Period|Physician Decision|0|||
147548698|NCT00950599|532166150|FG006|Follow-Up Period|Physician Decision|0|||
147548699|NCT00950599|532166151|FG007|Follow-Up Period|Physician Decision|0|||
147214845|NCT03642132|530959929|FG001|Chemotherapy Period|Study terminated by sponsor|0|||
147214846|NCT03642132|530959930|FG002|Chemotherapy Period|Study terminated by sponsor|3|||
147214847|NCT03642132|530959928|FG000|Chemotherapy Period|Other|1|||
147214848|NCT03642132|530959929|FG001|Chemotherapy Period|Other|0|||
147214849|NCT03642132|530959930|FG002|Chemotherapy Period|Other|2|||
147214850|NCT03642132|530959928|FG000|Chemotherapy Period|Withdrawal by Subject|7|||
147214851|NCT03642132|530959929|FG001|Chemotherapy Period|Withdrawal by Subject|3|||
147214852|NCT03642132|530959930|FG002|Chemotherapy Period|Withdrawal by Subject|1|||
147214853|NCT03642132|530959928|FG000|Maintenance Period|Adverse Event|1|||
147214854|NCT03642132|530959929|FG001|Maintenance Period|Adverse Event|2|||
147214855|NCT03642132|530959930|FG002|Maintenance Period|Adverse Event|0|||
147214856|NCT03642132|530959928|FG000|Maintenance Period|Non-compliance with study drug|0|||
147548700|NCT00950599|532166152|FG008|Follow-Up Period|Physician Decision|1|||
147548701|NCT00950599|532166153|FG009|Follow-Up Period|Physician Decision|0|||
147548702|NCT00950599|532166144|FG000|Follow-Up Period|Poor/Noncompliance|0|||
147548703|NCT00950599|532166145|FG001|Follow-Up Period|Poor/Noncompliance|0|||
147548704|NCT00950599|532166146|FG002|Follow-Up Period|Poor/Noncompliance|0|||
147548705|NCT00950599|532166147|FG003|Follow-Up Period|Poor/Noncompliance|0|||
147214857|NCT03642132|530959929|FG001|Maintenance Period|Non-compliance with study drug|0|||
147548706|NCT00950599|532166148|FG004|Follow-Up Period|Poor/Noncompliance|0|||
147548707|NCT00950599|532166149|FG005|Follow-Up Period|Poor/Noncompliance|0|||
147548708|NCT00950599|532166150|FG006|Follow-Up Period|Poor/Noncompliance|0|||
147548709|NCT00950599|532166151|FG007|Follow-Up Period|Poor/Noncompliance|0|||
147548710|NCT00950599|532166152|FG008|Follow-Up Period|Poor/Noncompliance|1|||
147548711|NCT00950599|532166153|FG009|Follow-Up Period|Poor/Noncompliance|0|||
147548712|NCT00950599|532166144|FG000|Follow-Up Period|Subject withdrew Consent|0|||
147548713|NCT00950599|532166145|FG001|Follow-Up Period|Subject withdrew Consent|0|||
147214858|NCT03642132|530959930|FG002|Maintenance Period|Non-compliance with study drug|1|||
147214859|NCT03642132|530959928|FG000|Maintenance Period|Physician's decision|2|||
147214860|NCT03642132|530959929|FG001|Maintenance Period|Physician's decision|2|||
147214861|NCT03642132|530959930|FG002|Maintenance Period|Physician's decision|2|||
147214862|NCT03642132|530959928|FG000|Maintenance Period|Progressive disease|9|||
147214863|NCT03642132|530959929|FG001|Maintenance Period|Progressive disease|3|||
147214864|NCT03642132|530959930|FG002|Maintenance Period|Progressive disease|6|||
147214865|NCT03642132|530959928|FG000|Maintenance Period|Other|0|||
147214866|NCT03642132|530959929|FG001|Maintenance Period|Other|0|||
147214867|NCT03642132|530959930|FG002|Maintenance Period|Other|3|||
147214868|NCT03642132|530959928|FG000|Maintenance Period|Withdrawal by Subject|1|||
147214869|NCT03642132|530959929|FG001|Maintenance Period|Withdrawal by Subject|1|||
147214870|NCT03642132|530959930|FG002|Maintenance Period|Withdrawal by Subject|2|||
147214871|NCT03642132|530959928|FG000|Follow-up Period|Other|0|||
147214872|NCT03642132|530959929|FG001|Follow-up Period|Other|0|||
147214873|NCT03642132|530959930|FG002|Follow-up Period|Other|1|||
147214874|NCT03642132|530959928|FG000|Follow-up Period|Withdrawal by Subject|1|||
147214875|NCT03642132|530959929|FG001|Follow-up Period|Withdrawal by Subject|2|||
147214876|NCT03642132|530959930|FG002|Follow-up Period|Withdrawal by Subject|0|||
147214877|NCT03642132|530959928|FG000|Follow-up Period|Study terminated by sponsor|1|||
147214878|NCT03642132|530959929|FG001|Follow-up Period|Study terminated by sponsor|0|||
147214879|NCT03642132|530959930|FG002|Follow-up Period|Study terminated by sponsor|1|||
147214880|NCT03642132|530959928|FG000|Follow-up Period|Lack of Efficacy|1|||
147214881|NCT03642132|530959929|FG001|Follow-up Period|Lack of Efficacy|0|||
147214882|NCT03642132|530959930|FG002|Follow-up Period|Lack of Efficacy|0|||
147214883|NCT03642132|530959928|FG000|Follow-up Period|Death|1|||
147214884|NCT03642132|530959929|FG001|Follow-up Period|Death|0|||
147214885|NCT03642132|530959930|FG002|Follow-up Period|Death|2|||
147214886|NCT03642132|530959928|FG000|Follow-up Period|Adverse Event|1|||
147214887|NCT03642132|530959929|FG001|Follow-up Period|Adverse Event|0|||
147214888|NCT03642132|530959930|FG002|Follow-up Period|Adverse Event|0|||
147214889|NCT02577887|530959932|FG000|Overall Study|Death|93|||
147214890|NCT02577887|530959932|FG000|Overall Study|Protocol Violation|125|||
147214891|NCT02577887|530959932|FG000|Overall Study|Withdrawal by Subject|80|||
147214892|NCT00913458|530959933|FG000|Phase 1|Non-Responder|54|||
147214893|NCT00913458|530959934|FG001|Phase 1|Non-Responder|0|||
147214894|NCT00913458|530959935|FG002|Phase 1|Non-Responder|0|||
147214895|NCT00913458|530959936|FG003|Phase 1|Non-Responder|0|||
147214896|NCT00913458|530959937|FG004|Phase 1|Non-Responder|0|||
147214897|NCT00913458|530959938|FG005|Phase 1|Non-Responder|0|||
147214898|NCT00913458|530959939|FG006|Phase 1|Non-Responder|0|||
147214899|NCT00913458|530959933|FG000|Phase 1|Subject Request|17|||
147214900|NCT00913458|530959934|FG001|Phase 1|Subject Request|0|||
147214901|NCT00913458|530959935|FG002|Phase 1|Subject Request|0|||
147214902|NCT00913458|530959936|FG003|Phase 1|Subject Request|0|||
147214903|NCT00913458|530959937|FG004|Phase 1|Subject Request|0|||
147214904|NCT00913458|530959938|FG005|Phase 1|Subject Request|0|||
147214905|NCT00913458|530959939|FG006|Phase 1|Subject Request|0|||
147214906|NCT00913458|530959933|FG000|Phase 1|Adverse Event|20|||
147214907|NCT00913458|530959934|FG001|Phase 1|Adverse Event|0|||
147214908|NCT00913458|530959935|FG002|Phase 1|Adverse Event|0|||
147214909|NCT00913458|530959936|FG003|Phase 1|Adverse Event|0|||
147214910|NCT00913458|530959937|FG004|Phase 1|Adverse Event|0|||
147214911|NCT00913458|530959938|FG005|Phase 1|Adverse Event|0|||
147214912|NCT00913458|530959939|FG006|Phase 1|Adverse Event|0|||
147214913|NCT00913458|530959933|FG000|Phase 1|Lost to Follow-up|2|||
147214914|NCT00913458|530959934|FG001|Phase 1|Lost to Follow-up|0|||
147214915|NCT00913458|530959935|FG002|Phase 1|Lost to Follow-up|0|||
147548714|NCT00950599|532166146|FG002|Follow-Up Period|Subject withdrew Consent|0|||
147214916|NCT00913458|530959936|FG003|Phase 1|Lost to Follow-up|0|||
147214917|NCT00913458|530959937|FG004|Phase 1|Lost to Follow-up|0|||
147214918|NCT00913458|530959938|FG005|Phase 1|Lost to Follow-up|0|||
147214919|NCT00913458|530959939|FG006|Phase 1|Lost to Follow-up|0|||
147548715|NCT00950599|532166147|FG003|Follow-Up Period|Subject withdrew Consent|0|||
147214920|NCT00913458|530959933|FG000|Phase 1|Protocol Violation|10|||
147214921|NCT00913458|530959934|FG001|Phase 1|Protocol Violation|0|||
147214922|NCT00913458|530959935|FG002|Phase 1|Protocol Violation|0|||
147214923|NCT00913458|530959936|FG003|Phase 1|Protocol Violation|0|||
147214924|NCT00913458|530959937|FG004|Phase 1|Protocol Violation|0|||
147214925|NCT00913458|530959938|FG005|Phase 1|Protocol Violation|0|||
147214926|NCT00913458|530959939|FG006|Phase 1|Protocol Violation|0|||
147214927|NCT00913458|530959933|FG000|Phase 1|Sponsor|2|||
147214928|NCT00913458|530959934|FG001|Phase 1|Sponsor|0|||
147214929|NCT00913458|530959935|FG002|Phase 1|Sponsor|0|||
147214930|NCT00913458|530959936|FG003|Phase 1|Sponsor|0|||
147548716|NCT00950599|532166148|FG004|Follow-Up Period|Subject withdrew Consent|0|||
147548717|NCT00950599|532166149|FG005|Follow-Up Period|Subject withdrew Consent|0|||
147548718|NCT00950599|532166150|FG006|Follow-Up Period|Subject withdrew Consent|0|||
147548719|NCT00950599|532166151|FG007|Follow-Up Period|Subject withdrew Consent|0|||
147548720|NCT00950599|532166152|FG008|Follow-Up Period|Subject withdrew Consent|2|||
147548721|NCT00950599|532166153|FG009|Follow-Up Period|Subject withdrew Consent|1|||
147548722|NCT01684722|532166154|FG000|Overall Study|Lost to Follow-up|78|||
147548723|NCT01684722|532166155|FG001|Overall Study|Lost to Follow-up|56|||
147548724|NCT01684722|532166156|FG002|Overall Study|Lost to Follow-up|75|||
147548725|NCT01684722|532166157|FG003|Overall Study|Lost to Follow-up|89|||
147548726|NCT01684722|532166154|FG000|Overall Study|Death|19|||
147548727|NCT01684722|532166155|FG001|Overall Study|Death|21|||
147548728|NCT01684722|532166156|FG002|Overall Study|Death|19|||
147548729|NCT01684722|532166157|FG003|Overall Study|Death|21|||
147548730|NCT02741271|532166166|FG000|Overall Study|Lost to Follow-up|2|||
147548731|NCT02741271|532166167|FG001|Overall Study|Lost to Follow-up|0|||
147548732|NCT02741271|532166166|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
147548733|NCT02741271|532166167|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
147548734|NCT03652961|532166168|FG000|Overall Study|Lost to Follow-up|3|||
147548735|NCT03652961|532166168|FG000|Overall Study|Screen Failure|1|||
147548736|NCT00410410|532166169|FG000|Induction Period (IP)|Death|1|||
147548737|NCT00410410|532166170|FG001|Induction Period (IP)|Death|0|||
147548738|NCT00410410|532166171|FG002|Induction Period (IP)|Death|0|||
147548739|NCT00410410|532166172|FG003|Induction Period (IP)|Death|0|||
147548740|NCT00410410|532166173|FG004|Induction Period (IP)|Death|0|||
147548741|NCT00410410|532166174|FG005|Induction Period (IP)|Death|0|||
147548742|NCT00410410|532166175|FG006|Induction Period (IP)|Death|0|||
147548743|NCT00410410|532166176|FG007|Induction Period (IP)|Death|0|||
147548744|NCT00410410|532166177|FG008|Induction Period (IP)|Death|0|||
147548745|NCT00410410|532166169|FG000|Induction Period (IP)|Adverse Event|3|||
147548746|NCT00410410|532166170|FG001|Induction Period (IP)|Adverse Event|4|||
147548747|NCT00410410|532166171|FG002|Induction Period (IP)|Adverse Event|2|||
147548748|NCT00410410|532166172|FG003|Induction Period (IP)|Adverse Event|4|||
147548749|NCT00410410|532166173|FG004|Induction Period (IP)|Adverse Event|1|||
147548750|NCT00410410|532166174|FG005|Induction Period (IP)|Adverse Event|0|||
147548751|NCT00410410|532166175|FG006|Induction Period (IP)|Adverse Event|0|||
147548752|NCT00410410|532166176|FG007|Induction Period (IP)|Adverse Event|0|||
147548753|NCT00410410|532166177|FG008|Induction Period (IP)|Adverse Event|0|||
147548754|NCT00410410|532166169|FG000|Induction Period (IP)|Lack of Efficacy|26|||
147548755|NCT00410410|532166170|FG001|Induction Period (IP)|Lack of Efficacy|24|||
147548756|NCT00410410|532166171|FG002|Induction Period (IP)|Lack of Efficacy|8|||
147548757|NCT00410410|532166172|FG003|Induction Period (IP)|Lack of Efficacy|8|||
147548758|NCT00410410|532166173|FG004|Induction Period (IP)|Lack of Efficacy|7|||
147548759|NCT00410410|532166174|FG005|Induction Period (IP)|Lack of Efficacy|7|||
147548760|NCT00410410|532166175|FG006|Induction Period (IP)|Lack of Efficacy|0|||
147548761|NCT00410410|532166176|FG007|Induction Period (IP)|Lack of Efficacy|0|||
147548762|NCT00410410|532166177|FG008|Induction Period (IP)|Lack of Efficacy|0|||
147548763|NCT00410410|532166169|FG000|Induction Period (IP)|Lost to Follow-up|2|||
147548764|NCT00410410|532166170|FG001|Induction Period (IP)|Lost to Follow-up|2|||
147548765|NCT00410410|532166171|FG002|Induction Period (IP)|Lost to Follow-up|2|||
147548766|NCT00410410|532166172|FG003|Induction Period (IP)|Lost to Follow-up|3|||
147548767|NCT00410410|532166173|FG004|Induction Period (IP)|Lost to Follow-up|0|||
147548768|NCT00410410|532166174|FG005|Induction Period (IP)|Lost to Follow-up|1|||
147214931|NCT00913458|530959937|FG004|Phase 1|Sponsor|0|||
147548769|NCT00410410|532166175|FG006|Induction Period (IP)|Lost to Follow-up|0|||
147548770|NCT00410410|532166176|FG007|Induction Period (IP)|Lost to Follow-up|0|||
147548771|NCT00410410|532166177|FG008|Induction Period (IP)|Lost to Follow-up|0|||
147548772|NCT00410410|532166169|FG000|Induction Period (IP)|Withdrawal by Subject|3|||
147548773|NCT00410410|532166170|FG001|Induction Period (IP)|Withdrawal by Subject|5|||
147548774|NCT00410410|532166171|FG002|Induction Period (IP)|Withdrawal by Subject|3|||
147548775|NCT00410410|532166172|FG003|Induction Period (IP)|Withdrawal by Subject|5|||
147548776|NCT00410410|532166173|FG004|Induction Period (IP)|Withdrawal by Subject|2|||
147548777|NCT00410410|532166174|FG005|Induction Period (IP)|Withdrawal by Subject|0|||
147548778|NCT00410410|532166175|FG006|Induction Period (IP)|Withdrawal by Subject|0|||
147548779|NCT00410410|532166176|FG007|Induction Period (IP)|Withdrawal by Subject|0|||
147548780|NCT00410410|532166177|FG008|Induction Period (IP)|Withdrawal by Subject|0|||
147214932|NCT00913458|530959938|FG005|Phase 1|Sponsor|0|||
147548781|NCT00410410|532166169|FG000|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
147548782|NCT00410410|532166170|FG001|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
147548783|NCT00410410|532166171|FG002|Induction Period (IP)|Subject No Longer Meets Study Criteria|1|||
147548784|NCT00410410|532166172|FG003|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
147548785|NCT00410410|532166173|FG004|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
147548786|NCT00410410|532166174|FG005|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
147548787|NCT00410410|532166175|FG006|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
147548788|NCT00410410|532166176|FG007|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
147548789|NCT00410410|532166177|FG008|Induction Period (IP)|Subject No Longer Meets Study Criteria|0|||
147548790|NCT00410410|532166169|FG000|Induction Period (IP)|Administrative Reason By Sponsor|0|||
147548791|NCT00410410|532166170|FG001|Induction Period (IP)|Administrative Reason By Sponsor|0|||
147548792|NCT00410410|532166171|FG002|Induction Period (IP)|Administrative Reason By Sponsor|0|||
147548793|NCT00410410|532166172|FG003|Induction Period (IP)|Administrative Reason By Sponsor|0|||
147548794|NCT00410410|532166173|FG004|Induction Period (IP)|Administrative Reason By Sponsor|22|||
147214933|NCT00913458|530959939|FG006|Phase 1|Sponsor|0|||
147214934|NCT00913458|530959933|FG000|Phase 1|Unsatisfactory Response per Investigator|7|||
147214935|NCT00913458|530959934|FG001|Phase 1|Unsatisfactory Response per Investigator|0|||
147214936|NCT00913458|530959935|FG002|Phase 1|Unsatisfactory Response per Investigator|0|||
147214937|NCT00913458|530959936|FG003|Phase 1|Unsatisfactory Response per Investigator|0|||
147214938|NCT00913458|530959937|FG004|Phase 1|Unsatisfactory Response per Investigator|0|||
147214939|NCT00913458|530959938|FG005|Phase 1|Unsatisfactory Response per Investigator|0|||
147214940|NCT00913458|530959939|FG006|Phase 1|Unsatisfactory Response per Investigator|0|||
147214941|NCT00913458|530959933|FG000|Phase 2|Non-Responder|0|||
147214942|NCT00913458|530959934|FG001|Phase 2|Non-Responder|5|||
147214943|NCT00913458|530959935|FG002|Phase 2|Non-Responder|7|||
147214944|NCT00913458|530959936|FG003|Phase 2|Non-Responder|12|||
147214945|NCT00913458|530959937|FG004|Phase 2|Non-Responder|0|||
147214946|NCT00913458|530959938|FG005|Phase 2|Non-Responder|0|||
147214947|NCT00913458|530959939|FG006|Phase 2|Non-Responder|0|||
147214948|NCT00913458|530959933|FG000|Phase 2|Subject Request|0|||
147214949|NCT00913458|530959934|FG001|Phase 2|Subject Request|0|||
147214950|NCT00913458|530959935|FG002|Phase 2|Subject Request|1|||
147214951|NCT00913458|530959936|FG003|Phase 2|Subject Request|2|||
147214952|NCT00913458|530959937|FG004|Phase 2|Subject Request|0|||
147214953|NCT00913458|530959938|FG005|Phase 2|Subject Request|0|||
147214954|NCT00913458|530959939|FG006|Phase 2|Subject Request|0|||
147214955|NCT00913458|530959933|FG000|Phase 2|Adverse Event|0|||
147214956|NCT00913458|530959934|FG001|Phase 2|Adverse Event|3|||
147214957|NCT00913458|530959935|FG002|Phase 2|Adverse Event|0|||
147214958|NCT00913458|530959936|FG003|Phase 2|Adverse Event|1|||
147214959|NCT00913458|530959937|FG004|Phase 2|Adverse Event|0|||
147214960|NCT00913458|530959938|FG005|Phase 2|Adverse Event|0|||
147214961|NCT00913458|530959939|FG006|Phase 2|Adverse Event|0|||
147214962|NCT00913458|530959933|FG000|Phase 2|Lost to Follow-up|0|||
147214963|NCT00913458|530959934|FG001|Phase 2|Lost to Follow-up|0|||
147214964|NCT00913458|530959935|FG002|Phase 2|Lost to Follow-up|0|||
147214965|NCT00913458|530959936|FG003|Phase 2|Lost to Follow-up|1|||
147214966|NCT00913458|530959937|FG004|Phase 2|Lost to Follow-up|0|||
147214967|NCT00913458|530959938|FG005|Phase 2|Lost to Follow-up|0|||
147214968|NCT00913458|530959939|FG006|Phase 2|Lost to Follow-up|0|||
147214969|NCT00913458|530959933|FG000|Phase 2|Protocol Violation|0|||
147214970|NCT00913458|530959934|FG001|Phase 2|Protocol Violation|2|||
147214971|NCT00913458|530959935|FG002|Phase 2|Protocol Violation|0|||
147214972|NCT00913458|530959936|FG003|Phase 2|Protocol Violation|0|||
147214973|NCT00913458|530959937|FG004|Phase 2|Protocol Violation|0|||
147214974|NCT00913458|530959938|FG005|Phase 2|Protocol Violation|0|||
147214975|NCT00913458|530959939|FG006|Phase 2|Protocol Violation|0|||
147214976|NCT00913458|530959933|FG000|Phase 2|Unsatisfactory Response per Investigator|0|||
147214977|NCT00913458|530959934|FG001|Phase 2|Unsatisfactory Response per Investigator|0|||
147214978|NCT00913458|530959935|FG002|Phase 2|Unsatisfactory Response per Investigator|11|||
147214979|NCT00913458|530959936|FG003|Phase 2|Unsatisfactory Response per Investigator|17|||
147214980|NCT00913458|530959937|FG004|Phase 2|Unsatisfactory Response per Investigator|0|||
147214981|NCT00913458|530959938|FG005|Phase 2|Unsatisfactory Response per Investigator|0|||
147214982|NCT00913458|530959939|FG006|Phase 2|Unsatisfactory Response per Investigator|0|||
147214983|NCT00913458|530959933|FG000|Phase 3|Adverse Event|0|||
147214984|NCT00913458|530959934|FG001|Phase 3|Adverse Event|0|||
147214985|NCT00913458|530959935|FG002|Phase 3|Adverse Event|0|||
147214986|NCT00913458|530959936|FG003|Phase 3|Adverse Event|0|||
147214987|NCT00913458|530959937|FG004|Phase 3|Adverse Event|5|||
147214988|NCT00913458|530959938|FG005|Phase 3|Adverse Event|4|||
147214989|NCT00913458|530959939|FG006|Phase 3|Adverse Event|1|||
147214990|NCT00913458|530959933|FG000|Phase 3|Lost to Follow-up|0|||
147214991|NCT00913458|530959934|FG001|Phase 3|Lost to Follow-up|0|||
147214992|NCT00913458|530959935|FG002|Phase 3|Lost to Follow-up|0|||
147214993|NCT00913458|530959936|FG003|Phase 3|Lost to Follow-up|0|||
147214994|NCT00913458|530959937|FG004|Phase 3|Lost to Follow-up|2|||
147548795|NCT00410410|532166174|FG005|Induction Period (IP)|Administrative Reason By Sponsor|21|||
147214995|NCT00913458|530959938|FG005|Phase 3|Lost to Follow-up|0|||
147214996|NCT00913458|530959939|FG006|Phase 3|Lost to Follow-up|0|||
147548796|NCT00410410|532166175|FG006|Induction Period (IP)|Administrative Reason By Sponsor|0|||
147548797|NCT00410410|532166176|FG007|Induction Period (IP)|Administrative Reason By Sponsor|0|||
147214997|NCT00913458|530959933|FG000|Phase 3|Non-Responder|0|||
147214998|NCT00913458|530959934|FG001|Phase 3|Non-Responder|0|||
147214999|NCT00913458|530959935|FG002|Phase 3|Non-Responder|0|||
147215000|NCT00913458|530959936|FG003|Phase 3|Non-Responder|0|||
147215001|NCT00913458|530959937|FG004|Phase 3|Non-Responder|0|||
147215002|NCT00913458|530959938|FG005|Phase 3|Non-Responder|1|||
147215003|NCT00913458|530959939|FG006|Phase 3|Non-Responder|3|||
147215004|NCT00913458|530959933|FG000|Phase 3|Withdrawal by Subject|0|||
147215005|NCT00913458|530959934|FG001|Phase 3|Withdrawal by Subject|0|||
147215006|NCT00913458|530959935|FG002|Phase 3|Withdrawal by Subject|0|||
147215007|NCT00913458|530959936|FG003|Phase 3|Withdrawal by Subject|0|||
147215008|NCT00913458|530959937|FG004|Phase 3|Withdrawal by Subject|1|||
147215009|NCT00913458|530959938|FG005|Phase 3|Withdrawal by Subject|2|||
147215010|NCT00913458|530959939|FG006|Phase 3|Withdrawal by Subject|0|||
147215011|NCT00913458|530959933|FG000|Phase 3|Unsatisfactory Response per Investigator|0|||
147215012|NCT00913458|530959934|FG001|Phase 3|Unsatisfactory Response per Investigator|0|||
147215013|NCT00913458|530959935|FG002|Phase 3|Unsatisfactory Response per Investigator|0|||
147215014|NCT00913458|530959936|FG003|Phase 3|Unsatisfactory Response per Investigator|0|||
147215015|NCT00913458|530959937|FG004|Phase 3|Unsatisfactory Response per Investigator|14|||
147215016|NCT00913458|530959938|FG005|Phase 3|Unsatisfactory Response per Investigator|11|||
147215017|NCT00913458|530959939|FG006|Phase 3|Unsatisfactory Response per Investigator|4|||
147215018|NCT02366091|530959940|FG000|Overall Study|Withdrawal by Subject|3|||
147215019|NCT02366091|530959941|FG001|Overall Study|Withdrawal by Subject|7|||
147215020|NCT02366091|530959942|FG002|Overall Study|Withdrawal by Subject|3|||
147215021|NCT02366091|530959943|FG003|Overall Study|Withdrawal by Subject|1|||
147215022|NCT03595618|530959944|FG000|Overall Study|Adverse Event|16|||
147215023|NCT03595618|530959945|FG001|Overall Study|Adverse Event|17|||
147215024|NCT03595618|530959946|FG002|Overall Study|Adverse Event|20|||
147548798|NCT00410410|532166177|FG008|Induction Period (IP)|Administrative Reason By Sponsor|0|||
147548799|NCT00410410|532166169|FG000|Induction Period (IP)|Other|0|||
147548800|NCT00410410|532166170|FG001|Induction Period (IP)|Other|0|||
147548801|NCT00410410|532166171|FG002|Induction Period (IP)|Other|1|||
147548802|NCT00410410|532166172|FG003|Induction Period (IP)|Other|0|||
147548803|NCT00410410|532166173|FG004|Induction Period (IP)|Other|0|||
147548804|NCT00410410|532166174|FG005|Induction Period (IP)|Other|0|||
147548805|NCT00410410|532166175|FG006|Induction Period (IP)|Other|0|||
147548806|NCT00410410|532166176|FG007|Induction Period (IP)|Other|0|||
147548807|NCT00410410|532166177|FG008|Induction Period (IP)|Other|0|||
147548808|NCT00410410|532166169|FG000|Maintenance Period (MP)|Death|0|||
147548809|NCT00410410|532166170|FG001|Maintenance Period (MP)|Death|0|||
147548810|NCT00410410|532166171|FG002|Maintenance Period (MP)|Death|0|||
147548811|NCT00410410|532166172|FG003|Maintenance Period (MP)|Death|0|||
147548812|NCT00410410|532166173|FG004|Maintenance Period (MP)|Death|0|||
147548813|NCT00410410|532166174|FG005|Maintenance Period (MP)|Death|0|||
147548814|NCT00410410|532166175|FG006|Maintenance Period (MP)|Death|1|||
147548815|NCT00410410|532166176|FG007|Maintenance Period (MP)|Death|0|||
147548816|NCT00410410|532166177|FG008|Maintenance Period (MP)|Death|0|||
147548817|NCT00410410|532166169|FG000|Maintenance Period (MP)|Adverse Event|0|||
147548818|NCT00410410|532166170|FG001|Maintenance Period (MP)|Adverse Event|0|||
147548819|NCT00410410|532166171|FG002|Maintenance Period (MP)|Adverse Event|0|||
147548820|NCT00410410|532166172|FG003|Maintenance Period (MP)|Adverse Event|0|||
147548821|NCT00410410|532166173|FG004|Maintenance Period (MP)|Adverse Event|0|||
147548822|NCT00410410|532166174|FG005|Maintenance Period (MP)|Adverse Event|0|||
147548823|NCT00410410|532166175|FG006|Maintenance Period (MP)|Adverse Event|1|||
147548824|NCT00410410|532166176|FG007|Maintenance Period (MP)|Adverse Event|3|||
147548825|NCT00410410|532166177|FG008|Maintenance Period (MP)|Adverse Event|0|||
147548826|NCT00410410|532166169|FG000|Maintenance Period (MP)|Lack of Efficacy|0|||
147548827|NCT00410410|532166170|FG001|Maintenance Period (MP)|Lack of Efficacy|0|||
147548828|NCT00410410|532166171|FG002|Maintenance Period (MP)|Lack of Efficacy|0|||
147548829|NCT00410410|532166172|FG003|Maintenance Period (MP)|Lack of Efficacy|0|||
147548830|NCT00410410|532166173|FG004|Maintenance Period (MP)|Lack of Efficacy|0|||
147548831|NCT00410410|532166174|FG005|Maintenance Period (MP)|Lack of Efficacy|0|||
147548832|NCT00410410|532166175|FG006|Maintenance Period (MP)|Lack of Efficacy|25|||
147548833|NCT00410410|532166176|FG007|Maintenance Period (MP)|Lack of Efficacy|24|||
147548834|NCT00410410|532166177|FG008|Maintenance Period (MP)|Lack of Efficacy|0|||
147548835|NCT00410410|532166169|FG000|Maintenance Period (MP)|Lost to Follow-up|0|||
147548836|NCT00410410|532166170|FG001|Maintenance Period (MP)|Lost to Follow-up|0|||
147215025|NCT03595618|530959947|FG003|Overall Study|Adverse Event|8|||
147215026|NCT03595618|530959944|FG000|Overall Study|Withdrawal by Subject|12|||
147215027|NCT03595618|530959945|FG001|Overall Study|Withdrawal by Subject|14|||
147215028|NCT03595618|530959946|FG002|Overall Study|Withdrawal by Subject|14|||
147215029|NCT03595618|530959947|FG003|Overall Study|Withdrawal by Subject|10|||
147215030|NCT03595618|530959944|FG000|Overall Study|Lost to Follow-up|6|||
147215031|NCT03595618|530959945|FG001|Overall Study|Lost to Follow-up|4|||
147215032|NCT03595618|530959946|FG002|Overall Study|Lost to Follow-up|5|||
147548837|NCT00410410|532166171|FG002|Maintenance Period (MP)|Lost to Follow-up|0|||
147548838|NCT00410410|532166172|FG003|Maintenance Period (MP)|Lost to Follow-up|0|||
147548839|NCT00410410|532166173|FG004|Maintenance Period (MP)|Lost to Follow-up|0|||
147548840|NCT00410410|532166174|FG005|Maintenance Period (MP)|Lost to Follow-up|0|||
147548841|NCT00410410|532166175|FG006|Maintenance Period (MP)|Lost to Follow-up|1|||
147548842|NCT00410410|532166176|FG007|Maintenance Period (MP)|Lost to Follow-up|2|||
147548843|NCT00410410|532166177|FG008|Maintenance Period (MP)|Lost to Follow-up|0|||
147548844|NCT00410410|532166169|FG000|Maintenance Period (MP)|Withdrawal by Subject|0|||
147548845|NCT00410410|532166170|FG001|Maintenance Period (MP)|Withdrawal by Subject|0|||
147548846|NCT00410410|532166171|FG002|Maintenance Period (MP)|Withdrawal by Subject|0|||
147548847|NCT00410410|532166172|FG003|Maintenance Period (MP)|Withdrawal by Subject|0|||
147548848|NCT00410410|532166173|FG004|Maintenance Period (MP)|Withdrawal by Subject|0|||
147548849|NCT00410410|532166174|FG005|Maintenance Period (MP)|Withdrawal by Subject|0|||
147548850|NCT00410410|532166175|FG006|Maintenance Period (MP)|Withdrawal by Subject|1|||
147548851|NCT00410410|532166176|FG007|Maintenance Period (MP)|Withdrawal by Subject|1|||
147548852|NCT00410410|532166177|FG008|Maintenance Period (MP)|Withdrawal by Subject|0|||
147548853|NCT00410410|532166169|FG000|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
147548854|NCT00410410|532166170|FG001|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
147548855|NCT00410410|532166171|FG002|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
147548856|NCT00410410|532166172|FG003|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
147548857|NCT00410410|532166173|FG004|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
147548858|NCT00410410|532166174|FG005|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
147548859|NCT00410410|532166175|FG006|Maintenance Period (MP)|Administrative Reason By Sponsor|21|||
147215033|NCT03595618|530959947|FG003|Overall Study|Lost to Follow-up|6|||
147215034|NCT03595618|530959944|FG000|Overall Study|Protocol Violation|2|||
147215035|NCT03595618|530959945|FG001|Overall Study|Protocol Violation|0|||
147215036|NCT03595618|530959946|FG002|Overall Study|Protocol Violation|6|||
147215037|NCT03595618|530959947|FG003|Overall Study|Protocol Violation|2|||
147215038|NCT03595618|530959944|FG000|Overall Study|Physician Decision|0|||
147215039|NCT03595618|530959945|FG001|Overall Study|Physician Decision|0|||
147215040|NCT03595618|530959946|FG002|Overall Study|Physician Decision|1|||
147215041|NCT03595618|530959947|FG003|Overall Study|Physician Decision|2|||
147215042|NCT03595618|530959944|FG000|Overall Study|Miscellaneous|7|||
147215043|NCT03595618|530959945|FG001|Overall Study|Miscellaneous|5|||
147215044|NCT03595618|530959946|FG002|Overall Study|Miscellaneous|10|||
147215045|NCT03595618|530959947|FG003|Overall Study|Miscellaneous|6|||
147215046|NCT02338232|530959948|FG000|Overall Study|Screen Failure|3|||
147215047|NCT02338232|530959948|FG000|Overall Study|Withdrawal by Subject|6|||
147215048|NCT02338232|530959948|FG000|Overall Study|Adverse Event|2|||
147215049|NCT03890666|530959949|FG000|Overall Study|Withdrawal by Subject|0|||
147215050|NCT03890666|530959950|FG001|Overall Study|Withdrawal by Subject|1|||
147215051|NCT03890666|530959949|FG000|Overall Study|Protocol deviation|1|||
147215052|NCT03890666|530959950|FG001|Overall Study|Protocol deviation|4|||
147215053|NCT03890666|530959949|FG000|Overall Study|Lost to Follow-up|2|||
147215054|NCT03890666|530959950|FG001|Overall Study|Lost to Follow-up|5|||
147215055|NCT03890666|530959949|FG000|Overall Study|Other than specified|1|||
147215056|NCT03890666|530959950|FG001|Overall Study|Other than specified|8|||
147215057|NCT01105065|530959951|FG000|Overall Study|Adverse Event|5|||
147215058|NCT01105065|530959951|FG000|Overall Study|Technical Problems|1|||
147215059|NCT03996369|530959952|FG000|Overall Study|Protocol deviation|1|||
147215060|NCT03996369|530959953|FG001|Overall Study|Protocol deviation|1|||
147215061|NCT03996369|530959952|FG000|Overall Study|Physician Decision|4|||
147215062|NCT03996369|530959953|FG001|Overall Study|Physician Decision|2|||
147215063|NCT03996369|530959952|FG000|Overall Study|Participant decision|0|||
147215064|NCT03996369|530959953|FG001|Overall Study|Participant decision|1|||
147215065|NCT03996369|530959952|FG000|Overall Study|Lack of Efficacy|4|||
147215066|NCT03996369|530959953|FG001|Overall Study|Lack of Efficacy|0|||
147215067|NCT03996369|530959952|FG000|Overall Study|Adverse Event|9|||
147215068|NCT03996369|530959953|FG001|Overall Study|Adverse Event|0|||
147215069|NCT03996369|530959952|FG000|Overall Study|Withdrawal by Subject|6|||
147215070|NCT03996369|530959953|FG001|Overall Study|Withdrawal by Subject|8|||
147215071|NCT03996369|530959952|FG000|Overall Study|Didn't meet Inclusion/Exclusion criteria|1|||
147215072|NCT03996369|530959953|FG001|Overall Study|Didn't meet Inclusion/Exclusion criteria|0|||
147215073|NCT03996369|530959952|FG000|Overall Study|Lost to Follow-up|0|||
147215074|NCT03996369|530959953|FG001|Overall Study|Lost to Follow-up|1|||
147215075|NCT00653432|530959954|FG000|Overall Study|Adverse Event|4|||
147215076|NCT00653432|530959955|FG001|Overall Study|Adverse Event|1|||
147215077|NCT00653432|530959954|FG000|Overall Study|Withdrawal by Subject|4|||
147215078|NCT00653432|530959955|FG001|Overall Study|Withdrawal by Subject|5|||
147215079|NCT00653432|530959954|FG000|Overall Study|Lost to Follow-up|7|||
147215080|NCT00653432|530959955|FG001|Overall Study|Lost to Follow-up|6|||
147215081|NCT00653432|530959954|FG000|Overall Study|Use/Need of Con Therapy|2|||
147215082|NCT00653432|530959955|FG001|Overall Study|Use/Need of Con Therapy|1|||
147548860|NCT00410410|532166176|FG007|Maintenance Period (MP)|Administrative Reason By Sponsor|25|||
147215083|NCT00653432|530959954|FG000|Overall Study|Other - Reason Not Provided|5|||
147215084|NCT00653432|530959955|FG001|Overall Study|Other - Reason Not Provided|3|||
147215085|NCT05277337|530959956|FG000|Overall Study|Lost to Follow-up|2|||
147215086|NCT05277337|530959957|FG001|Overall Study|Lost to Follow-up|0|||
147215087|NCT05277337|530959956|FG000|Overall Study|Withdrawal by Subject|1|||
147215088|NCT05277337|530959957|FG001|Overall Study|Withdrawal by Subject|0|||
147215089|NCT00357760|530959958|FG000|Overall Study|Disease progression|44|||
147215090|NCT00357760|530959959|FG001|Overall Study|Disease progression|17|||
147215091|NCT00357760|530959958|FG000|Overall Study|Adverse Event|10|||
147215092|NCT00357760|530959959|FG001|Overall Study|Adverse Event|7|||
147215093|NCT00357760|530959958|FG000|Overall Study|Death|0|||
147215094|NCT00357760|530959959|FG001|Overall Study|Death|3|||
147215095|NCT00357760|530959958|FG000|Overall Study|Alternative therapy|1|||
147215096|NCT00357760|530959959|FG001|Overall Study|Alternative therapy|0|||
147215097|NCT00357760|530959958|FG000|Overall Study|Withdrawal by Subject|0|||
147215098|NCT00357760|530959959|FG001|Overall Study|Withdrawal by Subject|2|||
147215099|NCT00357760|530959958|FG000|Overall Study|Never started treatment|2|||
147215100|NCT00357760|530959959|FG001|Overall Study|Never started treatment|1|||
147215101|NCT00357760|530959958|FG000|Overall Study|Ineligible|0|||
147215102|NCT00357760|530959959|FG001|Overall Study|Ineligible|2|||
147215103|NCT00357760|530959958|FG000|Overall Study|Physician Decision|2|||
147548861|NCT00410410|532166177|FG008|Maintenance Period (MP)|Administrative Reason By Sponsor|0|||
147548862|NCT00410410|532166169|FG000|Open-Label Period (OL)|Death|0|||
147548863|NCT00410410|532166170|FG001|Open-Label Period (OL)|Death|0|||
147548864|NCT00410410|532166171|FG002|Open-Label Period (OL)|Death|0|||
147215104|NCT00357760|530959959|FG001|Overall Study|Physician Decision|1|||
147215105|NCT00357760|530959958|FG000|Overall Study|Protocol Violation|0|||
147215106|NCT00357760|530959959|FG001|Overall Study|Protocol Violation|1|||
147215107|NCT00357760|530959958|FG000|Overall Study|To receive hospice care|0|||
147215108|NCT00357760|530959959|FG001|Overall Study|To receive hospice care|1|||
147215109|NCT02350764|530959960|FG000|Overall Study|Adverse Event|4|||
147215110|NCT02350764|530959960|FG000|Overall Study|Death|3|||
147215111|NCT02350764|530959960|FG000|Overall Study|Physician Decision|2|||
147215112|NCT02350764|530959960|FG000|Overall Study|Withdrawal by Subject|2|||
147215113|NCT04620798|530959963|FG000|Overall Study|Lost to Follow-up|126|||
147215114|NCT04620798|530959964|FG001|Overall Study|Lost to Follow-up|138|||
147215115|NCT01224782|530959965|FG000|Overall Study|Lost to Follow-up|177|||
147215116|NCT01224782|530959965|FG000|Overall Study|Withdrawal by Subject|16|||
147215117|NCT01224782|530959965|FG000|Overall Study|Death|14|||
147215118|NCT01224782|530959965|FG000|Overall Study|Improvement|13|||
147215119|NCT01224782|530959965|FG000|Overall Study|Adverse Event|12|||
147215120|NCT01224782|530959965|FG000|Overall Study|Adverse Reaction|11|||
147215121|NCT01224782|530959965|FG000|Overall Study|Noncompliance|10|||
147215122|NCT01224782|530959965|FG000|Overall Study|Other|4|||
147215123|NCT01224782|530959965|FG000|Overall Study|Start of Dialysis|3|||
147215124|NCT01224782|530959965|FG000|Overall Study|Change of Treatment|1|||
147215125|NCT01224782|530959965|FG000|Overall Study|Financial Reasons|1|||
147215126|NCT01224782|530959965|FG000|Overall Study|Deterioration|1|||
147215127|NCT01224782|530959965|FG000|Overall Study|Transplantation|1|||
147215128|NCT01960907|530959966|FG000|Overall Study|Death|4|||
147215129|NCT01960907|530959967|FG001|Overall Study|Death|3|||
147215130|NCT01960907|530959966|FG000|Overall Study|Withdrawal by Subject|32|||
147215131|NCT01960907|530959967|FG001|Overall Study|Withdrawal by Subject|42|||
147215132|NCT00441116|530959970|FG000|Overall Study|Adverse Event|1|||
147215133|NCT00441116|530959971|FG001|Overall Study|Adverse Event|1|||
147215134|NCT00441116|530959970|FG000|Overall Study|Withdrawal by Subject|1|||
147215135|NCT00441116|530959971|FG001|Overall Study|Withdrawal by Subject|0|||
147215136|NCT00441116|530959970|FG000|Overall Study|Did not meet Eligibility Criteria|1|||
147215137|NCT00441116|530959971|FG001|Overall Study|Did not meet Eligibility Criteria|1|||
147215138|NCT02925338|530959972|FG000|Overall Study|Death|0|||
147548865|NCT00410410|532166172|FG003|Open-Label Period (OL)|Death|0|||
147548866|NCT00410410|532166173|FG004|Open-Label Period (OL)|Death|0|||
147548867|NCT00410410|532166174|FG005|Open-Label Period (OL)|Death|0|||
147548868|NCT00410410|532166175|FG006|Open-Label Period (OL)|Death|0|||
147548869|NCT00410410|532166176|FG007|Open-Label Period (OL)|Death|0|||
147548870|NCT00410410|532166177|FG008|Open-Label Period (OL)|Death|1|||
147215139|NCT02925338|530959973|FG001|Overall Study|Death|2|||
147215140|NCT02925338|530959974|FG002|Overall Study|Death|1|||
147215141|NCT02925338|530959975|FG003|Overall Study|Death|0|||
147215142|NCT02925338|530959976|FG004|Overall Study|Death|0|||
147215143|NCT02925338|530959972|FG000|Overall Study|Lost to Follow-up|30|||
147215144|NCT02925338|530959973|FG001|Overall Study|Lost to Follow-up|10|||
147215145|NCT02925338|530959974|FG002|Overall Study|Lost to Follow-up|1|||
147215146|NCT02925338|530959975|FG003|Overall Study|Lost to Follow-up|16|||
147215147|NCT02925338|530959976|FG004|Overall Study|Lost to Follow-up|3|||
147215148|NCT02925338|530959972|FG000|Overall Study|Withdrawal by Subject|3|||
147215149|NCT02925338|530959973|FG001|Overall Study|Withdrawal by Subject|0|||
147215150|NCT02925338|530959974|FG002|Overall Study|Withdrawal by Subject|3|||
147215151|NCT02925338|530959975|FG003|Overall Study|Withdrawal by Subject|2|||
147215152|NCT02925338|530959976|FG004|Overall Study|Withdrawal by Subject|2|||
147215153|NCT02925338|530959972|FG000|Overall Study|Missing|38|||
147215154|NCT02925338|530959973|FG001|Overall Study|Missing|27|||
147215155|NCT02925338|530959974|FG002|Overall Study|Missing|0|||
147215156|NCT02925338|530959975|FG003|Overall Study|Missing|3|||
147215157|NCT02925338|530959976|FG004|Overall Study|Missing|2|||
147215158|NCT02925338|530959972|FG000|Overall Study|Participant's Decision|11|||
147215159|NCT02925338|530959973|FG001|Overall Study|Participant's Decision|7|||
147215160|NCT02925338|530959974|FG002|Overall Study|Participant's Decision|3|||
147215161|NCT02925338|530959975|FG003|Overall Study|Participant's Decision|8|||
147215162|NCT02925338|530959976|FG004|Overall Study|Participant's Decision|1|||
147548871|NCT00410410|532166169|FG000|Open-Label Period (OL)|Adverse Event|0|||
147548872|NCT00410410|532166170|FG001|Open-Label Period (OL)|Adverse Event|0|||
147548873|NCT00410410|532166171|FG002|Open-Label Period (OL)|Adverse Event|0|||
147215163|NCT02925338|530959972|FG000|Overall Study|Treatment Discontinuation|144|||
147215164|NCT02925338|530959973|FG001|Overall Study|Treatment Discontinuation|65|||
147215165|NCT02925338|530959974|FG002|Overall Study|Treatment Discontinuation|56|||
147215166|NCT02925338|530959975|FG003|Overall Study|Treatment Discontinuation|131|||
147215167|NCT02925338|530959976|FG004|Overall Study|Treatment Discontinuation|22|||
147215168|NCT02395172|530959977|FG000|Overall Study|Participants randomized but not treated|3|||
147215169|NCT02395172|530959978|FG001|Overall Study|Participants randomized but not treated|31|||
147215170|NCT02717832|530959983|FG000|Overall Study|Inability to place IV|3|||
147215171|NCT00978757|530959987|FG000|Overall Study|Physician Decision|1|||
147215172|NCT00978757|530959988|FG001|Overall Study|Physician Decision|3|||
147215173|NCT03288142|530959989|FG000|Overall Study|Lost to Follow-up|22|||
147215174|NCT03288142|530959990|FG001|Overall Study|Lost to Follow-up|15|||
147215175|NCT01214395|530959993|FG000|Overall Study|All patients had infection|5|||
147215176|NCT02034409|530959994|FG000|Sham Run-in Period|Participants withdrawn per protocol because less than 80% treatment compliance|4|||
147215177|NCT02034409|530959995|FG001|Sham Run-in Period|Participants withdrawn per protocol because less than 80% treatment compliance|0|||
147215178|NCT02034409|530959994|FG000|Sham-Controlled Treatment Period|Adverse Event|1|||
147215179|NCT02034409|530959995|FG001|Sham-Controlled Treatment Period|Adverse Event|1|||
147215180|NCT02034409|530959994|FG000|Sham-Controlled Treatment Period|Lost to Follow-up|0|||
147215181|NCT02034409|530959995|FG001|Sham-Controlled Treatment Period|Lost to Follow-up|1|||
147215182|NCT02034409|530959994|FG000|Sham-Controlled Treatment Period|Withdrawal by Subject|8|||
147215183|NCT02034409|530959995|FG001|Sham-Controlled Treatment Period|Withdrawal by Subject|8|||
147215184|NCT02034409|530959994|FG000|Sham-Controlled Treatment Period|Physician Decision|1|||
147215185|NCT02034409|530959995|FG001|Sham-Controlled Treatment Period|Physician Decision|3|||
147215186|NCT02034409|530959994|FG000|Sham-Controlled Treatment Period|misrandomized|2|||
147215187|NCT02034409|530959995|FG001|Sham-Controlled Treatment Period|misrandomized|2|||
147215188|NCT00934843|530959996|FG000|Overall Study|Protocol Violation|0|||
147215189|NCT00934843|530959997|FG001|Overall Study|Protocol Violation|1|||
147215190|NCT03612856|530959999|FG000|Pre-dose Period|Physician Decision|0|||
147215191|NCT03612856|530960000|FG001|Pre-dose Period|Physician Decision|1|||
147215192|NCT03612856|530960001|FG002|Pre-dose Period|Physician Decision|1|||
147215193|NCT03612856|530959999|FG000|Pre-dose Period|Withdrawal by Subject|0|||
147215194|NCT03612856|530960000|FG001|Pre-dose Period|Withdrawal by Subject|1|||
147215195|NCT03612856|530960001|FG002|Pre-dose Period|Withdrawal by Subject|0|||
147215196|NCT01576159|530960002|FG000|Overall Study|Withdrawal by Subject|0|||
147215197|NCT01576159|530960003|FG001|Overall Study|Withdrawal by Subject|1|||
147215198|NCT01576159|530960004|FG002|Overall Study|Withdrawal by Subject|0|||
147215199|NCT01576159|530960005|FG003|Overall Study|Withdrawal by Subject|0|||
147215200|NCT01576159|530960002|FG000|Overall Study|Physician Decision|0|||
147215201|NCT01576159|530960003|FG001|Overall Study|Physician Decision|0|||
147215202|NCT01576159|530960004|FG002|Overall Study|Physician Decision|1|||
147215203|NCT01576159|530960005|FG003|Overall Study|Physician Decision|0|||
147215204|NCT01576159|530960002|FG000|Overall Study|Lost to Follow-up|0|||
147215205|NCT01576159|530960003|FG001|Overall Study|Lost to Follow-up|0|||
147215206|NCT01576159|530960004|FG002|Overall Study|Lost to Follow-up|0|||
147215207|NCT01576159|530960005|FG003|Overall Study|Lost to Follow-up|1|||
147215208|NCT01576159|530960002|FG000|Overall Study|Protocol Violation|1|||
147215209|NCT01576159|530960003|FG001|Overall Study|Protocol Violation|0|||
147215210|NCT01576159|530960004|FG002|Overall Study|Protocol Violation|0|||
147215211|NCT01576159|530960005|FG003|Overall Study|Protocol Violation|0|||
147215212|NCT01011309|530960006|FG000|Overall Study|Adverse Event|2|||
147215213|NCT01011309|530960007|FG001|Overall Study|Adverse Event|1|||
147215214|NCT01011309|530960008|FG002|Overall Study|Adverse Event|2|||
147215215|NCT01011309|530960006|FG000|Overall Study|Lack of Efficacy|0|||
147215216|NCT01011309|530960007|FG001|Overall Study|Lack of Efficacy|1|||
147215217|NCT01011309|530960008|FG002|Overall Study|Lack of Efficacy|0|||
147215218|NCT01011309|530960006|FG000|Overall Study|Protocol Violation|0|||
147215219|NCT01011309|530960007|FG001|Overall Study|Protocol Violation|1|||
147215220|NCT01011309|530960008|FG002|Overall Study|Protocol Violation|3|||
147548874|NCT00410410|532166172|FG003|Open-Label Period (OL)|Adverse Event|0|||
147548875|NCT00410410|532166173|FG004|Open-Label Period (OL)|Adverse Event|0|||
147548876|NCT00410410|532166174|FG005|Open-Label Period (OL)|Adverse Event|0|||
147548877|NCT00410410|532166175|FG006|Open-Label Period (OL)|Adverse Event|0|||
147215221|NCT00831493|530960011|FG000|Overall Study|Intractable nausea and vomiting|1|||
147215222|NCT00557856|530960014|FG000|Part 1: Dose Escalation Phase|objective progression or relapse|3|||
147215223|NCT00557856|530960015|FG001|Part 1: Dose Escalation Phase|objective progression or relapse|5|||
147215224|NCT00557856|530960016|FG002|Part 1: Dose Escalation Phase|objective progression or relapse|3|||
147215225|NCT00557856|530960017|FG003|Part 1: Dose Escalation Phase|objective progression or relapse|1|||
147548878|NCT00410410|532166176|FG007|Open-Label Period (OL)|Adverse Event|0|||
147215226|NCT00557856|530960018|FG004|Part 1: Dose Escalation Phase|objective progression or relapse|3|||
147215227|NCT00557856|530960019|FG005|Part 1: Dose Escalation Phase|objective progression or relapse|2|||
147548879|NCT00410410|532166177|FG008|Open-Label Period (OL)|Adverse Event|10|||
147548880|NCT00410410|532166169|FG000|Open-Label Period (OL)|Lack of Efficacy|0|||
147548881|NCT00410410|532166170|FG001|Open-Label Period (OL)|Lack of Efficacy|0|||
147548882|NCT00410410|532166171|FG002|Open-Label Period (OL)|Lack of Efficacy|0|||
147548883|NCT00410410|532166172|FG003|Open-Label Period (OL)|Lack of Efficacy|0|||
147548884|NCT00410410|532166173|FG004|Open-Label Period (OL)|Lack of Efficacy|0|||
147548885|NCT00410410|532166174|FG005|Open-Label Period (OL)|Lack of Efficacy|0|||
147548886|NCT00410410|532166175|FG006|Open-Label Period (OL)|Lack of Efficacy|0|||
147548887|NCT00410410|532166176|FG007|Open-Label Period (OL)|Lack of Efficacy|0|||
147548888|NCT00410410|532166177|FG008|Open-Label Period (OL)|Lack of Efficacy|161|||
147548889|NCT00410410|532166169|FG000|Open-Label Period (OL)|Lost to Follow-up|0|||
147548890|NCT00410410|532166170|FG001|Open-Label Period (OL)|Lost to Follow-up|0|||
147548891|NCT00410410|532166171|FG002|Open-Label Period (OL)|Lost to Follow-up|0|||
147548892|NCT00410410|532166172|FG003|Open-Label Period (OL)|Lost to Follow-up|0|||
147548893|NCT00410410|532166173|FG004|Open-Label Period (OL)|Lost to Follow-up|0|||
147548894|NCT00410410|532166174|FG005|Open-Label Period (OL)|Lost to Follow-up|0|||
147548895|NCT00410410|532166175|FG006|Open-Label Period (OL)|Lost to Follow-up|0|||
147548896|NCT00410410|532166176|FG007|Open-Label Period (OL)|Lost to Follow-up|0|||
147548897|NCT00410410|532166177|FG008|Open-Label Period (OL)|Lost to Follow-up|4|||
147548898|NCT00410410|532166169|FG000|Open-Label Period (OL)|Withdrawal by Subject|0|||
147548899|NCT00410410|532166170|FG001|Open-Label Period (OL)|Withdrawal by Subject|0|||
147548900|NCT00410410|532166171|FG002|Open-Label Period (OL)|Withdrawal by Subject|0|||
147548901|NCT00410410|532166172|FG003|Open-Label Period (OL)|Withdrawal by Subject|0|||
147548902|NCT00410410|532166173|FG004|Open-Label Period (OL)|Withdrawal by Subject|0|||
147548903|NCT00410410|532166174|FG005|Open-Label Period (OL)|Withdrawal by Subject|0|||
147548904|NCT00410410|532166175|FG006|Open-Label Period (OL)|Withdrawal by Subject|0|||
147548905|NCT00410410|532166176|FG007|Open-Label Period (OL)|Withdrawal by Subject|0|||
147548906|NCT00410410|532166177|FG008|Open-Label Period (OL)|Withdrawal by Subject|20|||
147548907|NCT00410410|532166169|FG000|Open-Label Period (OL)|Pregnancy|0|||
147548908|NCT00410410|532166170|FG001|Open-Label Period (OL)|Pregnancy|0|||
147548909|NCT00410410|532166171|FG002|Open-Label Period (OL)|Pregnancy|0|||
147548910|NCT00410410|532166172|FG003|Open-Label Period (OL)|Pregnancy|0|||
147548911|NCT00410410|532166173|FG004|Open-Label Period (OL)|Pregnancy|0|||
147548912|NCT00410410|532166174|FG005|Open-Label Period (OL)|Pregnancy|0|||
147548913|NCT00410410|532166175|FG006|Open-Label Period (OL)|Pregnancy|0|||
147548914|NCT00410410|532166176|FG007|Open-Label Period (OL)|Pregnancy|0|||
147548915|NCT00410410|532166177|FG008|Open-Label Period (OL)|Pregnancy|1|||
147548916|NCT00410410|532166169|FG000|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
147548917|NCT00410410|532166170|FG001|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
147548918|NCT00410410|532166171|FG002|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
147548919|NCT00410410|532166172|FG003|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
147548920|NCT00410410|532166173|FG004|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
147548921|NCT00410410|532166174|FG005|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
147548922|NCT00410410|532166175|FG006|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
147548923|NCT00410410|532166176|FG007|Open-Label Period (OL)|Administrative Reason By Sponsor|0|||
147548924|NCT00410410|532166177|FG008|Open-Label Period (OL)|Administrative Reason By Sponsor|145|||
147548925|NCT00410410|532166169|FG000|Open-Label Period (OL)|Other|0|||
147548926|NCT00410410|532166170|FG001|Open-Label Period (OL)|Other|0|||
147548927|NCT00410410|532166171|FG002|Open-Label Period (OL)|Other|0|||
147548928|NCT00410410|532166172|FG003|Open-Label Period (OL)|Other|0|||
147548929|NCT00410410|532166173|FG004|Open-Label Period (OL)|Other|0|||
147548930|NCT00410410|532166174|FG005|Open-Label Period (OL)|Other|0|||
147548931|NCT00410410|532166175|FG006|Open-Label Period (OL)|Other|0|||
147548932|NCT00410410|532166176|FG007|Open-Label Period (OL)|Other|0|||
147548933|NCT00410410|532166177|FG008|Open-Label Period (OL)|Other|7|||
147548934|NCT01783496|532166178|FG000|Overall Study|Lost to Follow-up|0|||
147548935|NCT01783496|532166179|FG001|Overall Study|Lost to Follow-up|0|||
147548936|NCT01783496|532166180|FG002|Overall Study|Lost to Follow-up|0|||
147548937|NCT01783496|532166181|FG003|Overall Study|Lost to Follow-up|2|||
147548938|NCT01783496|532166182|FG004|Overall Study|Lost to Follow-up|0|||
147548939|NCT01783496|532166183|FG005|Overall Study|Lost to Follow-up|1|||
147548940|NCT01783496|532166178|FG000|Overall Study|Withdrawal by Subject|1|||
147548941|NCT01783496|532166179|FG001|Overall Study|Withdrawal by Subject|0|||
147548942|NCT01783496|532166180|FG002|Overall Study|Withdrawal by Subject|0|||
147548943|NCT01783496|532166181|FG003|Overall Study|Withdrawal by Subject|0|||
147548944|NCT01783496|532166182|FG004|Overall Study|Withdrawal by Subject|0|||
147548945|NCT01783496|532166183|FG005|Overall Study|Withdrawal by Subject|0|||
147548946|NCT01023269|532166184|FG000|Overall Study|early termination of the study|2|||
147548947|NCT01023269|532166185|FG001|Overall Study|early termination of the study|0|||
147548948|NCT01953783|532166186|FG000|Overall Study|Progressive disease|2|||
147548949|NCT01789281|532166187|FG000|Overall Study|Disease progression|15|||
147548950|NCT01789281|532166188|FG001|Overall Study|Disease progression|4|||
147548951|NCT01789281|532166187|FG000|Overall Study|Adverse Event|5|||
147548952|NCT01789281|532166188|FG001|Overall Study|Adverse Event|5|||
147548953|NCT01789281|532166187|FG000|Overall Study|Withdrawal by Subject|1|||
147548954|NCT01789281|532166188|FG001|Overall Study|Withdrawal by Subject|0|||
147548955|NCT01789281|532166187|FG000|Overall Study|Lost to Follow-up|1|||
147215228|NCT00557856|530960020|FG006|Part 1: Dose Escalation Phase|objective progression or relapse|5|||
147215229|NCT00557856|530960021|FG007|Part 1: Dose Escalation Phase|objective progression or relapse|3|||
147215230|NCT00557856|530960022|FG008|Part 1: Dose Escalation Phase|objective progression or relapse|0|||
147215231|NCT00557856|530960014|FG000|Part 1: Dose Escalation Phase|Withdrawal by Subject|1|||
147215232|NCT00557856|530960015|FG001|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
147215233|NCT00557856|530960016|FG002|Part 1: Dose Escalation Phase|Withdrawal by Subject|1|||
147215234|NCT00557856|530960017|FG003|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
147215235|NCT00557856|530960018|FG004|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
147215236|NCT00557856|530960019|FG005|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
147215237|NCT00557856|530960020|FG006|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
147215238|NCT00557856|530960021|FG007|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
147215239|NCT00557856|530960022|FG008|Part 1: Dose Escalation Phase|Withdrawal by Subject|0|||
147215240|NCT00557856|530960014|FG000|Part 1: Dose Escalation Phase|Adverse Event|1|||
147215241|NCT00557856|530960015|FG001|Part 1: Dose Escalation Phase|Adverse Event|0|||
147215242|NCT00557856|530960016|FG002|Part 1: Dose Escalation Phase|Adverse Event|1|||
147215243|NCT00557856|530960017|FG003|Part 1: Dose Escalation Phase|Adverse Event|1|||
147215244|NCT00557856|530960018|FG004|Part 1: Dose Escalation Phase|Adverse Event|1|||
147215245|NCT00557856|530960019|FG005|Part 1: Dose Escalation Phase|Adverse Event|3|||
147215246|NCT00557856|530960020|FG006|Part 1: Dose Escalation Phase|Adverse Event|1|||
147215247|NCT00557856|530960021|FG007|Part 1: Dose Escalation Phase|Adverse Event|2|||
147215248|NCT00557856|530960022|FG008|Part 1: Dose Escalation Phase|Adverse Event|0|||
147215249|NCT00557856|530960014|FG000|Part 1: Dose Escalation Phase|Other|0|||
147215250|NCT00557856|530960015|FG001|Part 1: Dose Escalation Phase|Other|0|||
147215251|NCT00557856|530960016|FG002|Part 1: Dose Escalation Phase|Other|1|||
147215252|NCT00557856|530960017|FG003|Part 1: Dose Escalation Phase|Other|1|||
147215253|NCT00557856|530960018|FG004|Part 1: Dose Escalation Phase|Other|0|||
147215254|NCT00557856|530960019|FG005|Part 1: Dose Escalation Phase|Other|0|||
147215255|NCT00557856|530960020|FG006|Part 1: Dose Escalation Phase|Other|0|||
147215256|NCT00557856|530960021|FG007|Part 1: Dose Escalation Phase|Other|1|||
147215257|NCT00557856|530960022|FG008|Part 1: Dose Escalation Phase|Other|0|||
147215258|NCT00557856|530960014|FG000|Part 1: Dose Escalation Phase|Death|0|||
147215259|NCT00557856|530960015|FG001|Part 1: Dose Escalation Phase|Death|0|||
147215260|NCT00557856|530960016|FG002|Part 1: Dose Escalation Phase|Death|0|||
147215261|NCT00557856|530960017|FG003|Part 1: Dose Escalation Phase|Death|0|||
147215262|NCT00557856|530960018|FG004|Part 1: Dose Escalation Phase|Death|0|||
147215263|NCT00557856|530960019|FG005|Part 1: Dose Escalation Phase|Death|1|||
147215264|NCT00557856|530960020|FG006|Part 1: Dose Escalation Phase|Death|0|||
147215265|NCT00557856|530960021|FG007|Part 1: Dose Escalation Phase|Death|0|||
147215266|NCT00557856|530960022|FG008|Part 1: Dose Escalation Phase|Death|0|||
147215267|NCT00557856|530960014|FG000|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
147215268|NCT00557856|530960015|FG001|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
147215269|NCT00557856|530960016|FG002|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
147215270|NCT00557856|530960017|FG003|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
147548956|NCT01789281|532166188|FG001|Overall Study|Lost to Follow-up|0|||
147215271|NCT00557856|530960018|FG004|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
147215272|NCT00557856|530960019|FG005|Part 1: Dose Escalation Phase|global deterioration of health status|2|||
147215273|NCT00557856|530960020|FG006|Part 1: Dose Escalation Phase|global deterioration of health status|1|||
147215274|NCT00557856|530960021|FG007|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
147215275|NCT00557856|530960022|FG008|Part 1: Dose Escalation Phase|global deterioration of health status|0|||
147215276|NCT00557856|530960014|FG000|Part 1: Dose Escalation Phase|randomized but not treated|2|||
147548957|NCT01789281|532166187|FG000|Overall Study|Administrative problems|0|||
147548958|NCT01789281|532166188|FG001|Overall Study|Administrative problems|1|||
147548959|NCT00686920|532166189|FG000|Overall Study|Death|45|||
147215277|NCT00557856|530960015|FG001|Part 1: Dose Escalation Phase|randomized but not treated|0|||
147548960|NCT00686920|532166190|FG001|Overall Study|Death|14|||
147215278|NCT00557856|530960016|FG002|Part 1: Dose Escalation Phase|randomized but not treated|0|||
147215279|NCT00557856|530960017|FG003|Part 1: Dose Escalation Phase|randomized but not treated|0|||
147215280|NCT00557856|530960018|FG004|Part 1: Dose Escalation Phase|randomized but not treated|0|||
147548961|NCT00686920|532166189|FG000|Overall Study|Liver Transplant|23|||
147548962|NCT00686920|532166190|FG001|Overall Study|Liver Transplant|8|||
147548963|NCT00686920|532166189|FG000|Overall Study|Recurrent Hepatic Encephalopathy Episode|1|||
147548964|NCT00686920|532166190|FG001|Overall Study|Recurrent Hepatic Encephalopathy Episode|2|||
147548965|NCT00686920|532166189|FG000|Overall Study|Withdrawal by Subject|23|||
147548966|NCT00686920|532166190|FG001|Overall Study|Withdrawal by Subject|5|||
147548967|NCT00686920|532166189|FG000|Overall Study|Protocol Violation|2|||
147548968|NCT00686920|532166190|FG001|Overall Study|Protocol Violation|1|||
147548969|NCT00686920|532166189|FG000|Overall Study|Adverse Event|10|||
147548970|NCT00686920|532166190|FG001|Overall Study|Adverse Event|2|||
147548971|NCT00686920|532166189|FG000|Overall Study|Personal Reason|0|||
147548972|NCT00686920|532166190|FG001|Overall Study|Personal Reason|1|||
147548973|NCT00686920|532166189|FG000|Overall Study|Lost to Follow-up|15|||
147548974|NCT00686920|532166190|FG001|Overall Study|Lost to Follow-up|3|||
147548975|NCT00686920|532166189|FG000|Overall Study|Moved to Another State|1|||
147548976|NCT00686920|532166190|FG001|Overall Study|Moved to Another State|0|||
147548977|NCT00686920|532166189|FG000|Overall Study|Transferred to Nursing Home|1|||
147548978|NCT00686920|532166190|FG001|Overall Study|Transferred to Nursing Home|0|||
147548979|NCT00686920|532166189|FG000|Overall Study|Noncompliance|9|||
147215281|NCT00557856|530960019|FG005|Part 1: Dose Escalation Phase|randomized but not treated|0|||
147215282|NCT00557856|530960020|FG006|Part 1: Dose Escalation Phase|randomized but not treated|0|||
147215283|NCT00557856|530960021|FG007|Part 1: Dose Escalation Phase|randomized but not treated|0|||
147215284|NCT00557856|530960022|FG008|Part 1: Dose Escalation Phase|randomized but not treated|0|||
147215285|NCT00557856|530960014|FG000|Part 2: Exploratory Phase|objective progression or relapse|0|||
147215286|NCT00557856|530960015|FG001|Part 2: Exploratory Phase|objective progression or relapse|0|||
147215287|NCT00557856|530960016|FG002|Part 2: Exploratory Phase|objective progression or relapse|0|||
147215288|NCT00557856|530960017|FG003|Part 2: Exploratory Phase|objective progression or relapse|0|||
147215289|NCT00557856|530960018|FG004|Part 2: Exploratory Phase|objective progression or relapse|0|||
147215290|NCT00557856|530960019|FG005|Part 2: Exploratory Phase|objective progression or relapse|0|||
147215291|NCT00557856|530960020|FG006|Part 2: Exploratory Phase|objective progression or relapse|0|||
147215292|NCT00557856|530960021|FG007|Part 2: Exploratory Phase|objective progression or relapse|0|||
147215293|NCT00557856|530960022|FG008|Part 2: Exploratory Phase|objective progression or relapse|15|||
147215294|NCT00557856|530960014|FG000|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
147215295|NCT00557856|530960015|FG001|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
147215296|NCT00557856|530960016|FG002|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
147215297|NCT00557856|530960017|FG003|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
147215298|NCT00557856|530960018|FG004|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
147215299|NCT00557856|530960019|FG005|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
147215300|NCT00557856|530960020|FG006|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
147215301|NCT00557856|530960021|FG007|Part 2: Exploratory Phase|Withdrawal by Subject|0|||
147215302|NCT00557856|530960022|FG008|Part 2: Exploratory Phase|Withdrawal by Subject|1|||
147215303|NCT00557856|530960014|FG000|Part 2: Exploratory Phase|Adverse Event|0|||
147215304|NCT00557856|530960015|FG001|Part 2: Exploratory Phase|Adverse Event|0|||
147215305|NCT00557856|530960016|FG002|Part 2: Exploratory Phase|Adverse Event|0|||
147215306|NCT00557856|530960017|FG003|Part 2: Exploratory Phase|Adverse Event|0|||
147215307|NCT00557856|530960018|FG004|Part 2: Exploratory Phase|Adverse Event|0|||
147215308|NCT00557856|530960019|FG005|Part 2: Exploratory Phase|Adverse Event|0|||
147215309|NCT00557856|530960020|FG006|Part 2: Exploratory Phase|Adverse Event|0|||
147215310|NCT00557856|530960021|FG007|Part 2: Exploratory Phase|Adverse Event|0|||
147215311|NCT00557856|530960022|FG008|Part 2: Exploratory Phase|Adverse Event|4|||
147215312|NCT00557856|530960014|FG000|Part 2: Exploratory Phase|Other|0|||
147215313|NCT00557856|530960015|FG001|Part 2: Exploratory Phase|Other|0|||
147215314|NCT00557856|530960016|FG002|Part 2: Exploratory Phase|Other|0|||
147215315|NCT00557856|530960017|FG003|Part 2: Exploratory Phase|Other|0|||
147215316|NCT00557856|530960018|FG004|Part 2: Exploratory Phase|Other|0|||
147215317|NCT00557856|530960019|FG005|Part 2: Exploratory Phase|Other|0|||
147215318|NCT00557856|530960020|FG006|Part 2: Exploratory Phase|Other|0|||
147215319|NCT00557856|530960021|FG007|Part 2: Exploratory Phase|Other|0|||
147215320|NCT00557856|530960022|FG008|Part 2: Exploratory Phase|Other|1|||
147215321|NCT00557856|530960014|FG000|Part 2: Exploratory Phase|Death|0|||
147215322|NCT00557856|530960015|FG001|Part 2: Exploratory Phase|Death|0|||
147215323|NCT00557856|530960016|FG002|Part 2: Exploratory Phase|Death|0|||
147215324|NCT00557856|530960017|FG003|Part 2: Exploratory Phase|Death|0|||
147215325|NCT00557856|530960018|FG004|Part 2: Exploratory Phase|Death|0|||
147215326|NCT00557856|530960019|FG005|Part 2: Exploratory Phase|Death|0|||
147215327|NCT00557856|530960020|FG006|Part 2: Exploratory Phase|Death|0|||
147215328|NCT00557856|530960021|FG007|Part 2: Exploratory Phase|Death|0|||
147215329|NCT00557856|530960022|FG008|Part 2: Exploratory Phase|Death|2|||
147215330|NCT00557856|530960014|FG000|Part 2: Exploratory Phase|global deterioration of health status|0|||
147215331|NCT00557856|530960015|FG001|Part 2: Exploratory Phase|global deterioration of health status|0|||
147215332|NCT00557856|530960016|FG002|Part 2: Exploratory Phase|global deterioration of health status|0|||
147215333|NCT00557856|530960017|FG003|Part 2: Exploratory Phase|global deterioration of health status|0|||
147548980|NCT00686920|532166190|FG001|Overall Study|Noncompliance|0|||
147215334|NCT00557856|530960018|FG004|Part 2: Exploratory Phase|global deterioration of health status|0|||
147548981|NCT00686920|532166189|FG000|Overall Study|Principal Investigator Decision|2|||
147548982|NCT00686920|532166190|FG001|Overall Study|Principal Investigator Decision|0|||
147548983|NCT00449930|532166193|FG000|Overall Study|Adverse Event|9|||
147548984|NCT00449930|532166194|FG001|Overall Study|Adverse Event|19|||
147548985|NCT00449930|532166193|FG000|Overall Study|Trial Terminated ( Site Closed)|1|||
147548986|NCT00449930|532166194|FG001|Overall Study|Trial Terminated ( Site Closed)|0|||
147548987|NCT00449930|532166193|FG000|Overall Study|Lack of Efficacy|10|||
147548988|NCT00449930|532166194|FG001|Overall Study|Lack of Efficacy|1|||
147548989|NCT00449930|532166193|FG000|Overall Study|Lost to Follow-up|9|||
147548990|NCT00449930|532166194|FG001|Overall Study|Lost to Follow-up|14|||
147548991|NCT00449930|532166193|FG000|Overall Study|Physician Decision|1|||
147548992|NCT00449930|532166194|FG001|Overall Study|Physician Decision|2|||
147548993|NCT00449930|532166193|FG000|Overall Study|Protocol Violation|14|||
147548994|NCT00449930|532166194|FG001|Overall Study|Protocol Violation|15|||
147548995|NCT00449930|532166193|FG000|Overall Study|Withdrawal by Subject|16|||
147548996|NCT00449930|532166194|FG001|Overall Study|Withdrawal by Subject|23|||
147548997|NCT00449930|532166193|FG000|Overall Study|Glycemic discontinuation criteria|1|||
147548998|NCT00449930|532166194|FG001|Overall Study|Glycemic discontinuation criteria|1|||
147548999|NCT03124381|532166200|FG000|Overall Study|Lost to Follow-up|1|||
147549000|NCT03124381|532166201|FG001|Overall Study|Lost to Follow-up|1|||
147549001|NCT03124381|532166200|FG000|Overall Study|Withdrawal by Subject|6|||
147549002|NCT03124381|532166201|FG001|Overall Study|Withdrawal by Subject|3|||
147549003|NCT03124381|532166200|FG000|Overall Study|Protocol Violation|0|||
147549004|NCT03124381|532166201|FG001|Overall Study|Protocol Violation|1|||
147549005|NCT03124381|532166200|FG000|Overall Study|Adverse Event|1|||
147549006|NCT03124381|532166201|FG001|Overall Study|Adverse Event|1|||
147549007|NCT03124381|532166200|FG000|Overall Study|Non-Compliance with Study Treatment|1|||
147549008|NCT03124381|532166201|FG001|Overall Study|Non-Compliance with Study Treatment|0|||
147549009|NCT05017493|532166207|FG000|Overall Study|Withdrawal by Subject|26|||
147549010|NCT05017493|532166208|FG001|Overall Study|Withdrawal by Subject|0|||
147549011|NCT05017493|532166207|FG000|Overall Study|Physician Decision|15|||
147549012|NCT05017493|532166208|FG001|Overall Study|Physician Decision|0|||
147549013|NCT05017493|532166207|FG000|Overall Study|Protocol Violation|81|||
147549014|NCT05017493|532166208|FG001|Overall Study|Protocol Violation|0|||
147549015|NCT02473510|532166209|FG000|Overall Study|Lost to Follow-up|1|||
147549016|NCT02473510|532166210|FG001|Overall Study|Lost to Follow-up|2|||
147549017|NCT00345683|532166218|FG000|Overall Study|Lost to Follow-up|19|||
147549018|NCT00345683|532166219|FG001|Overall Study|Lost to Follow-up|7|||
147549019|NCT00345683|532166218|FG000|Overall Study|Other|6|||
147549020|NCT00345683|532166219|FG001|Overall Study|Other|2|||
147549021|NCT03182686|532166222|FG000|Overall Study|Lost to Follow-up|2|||
147549022|NCT03182686|532166223|FG001|Overall Study|Lost to Follow-up|0|||
147549023|NCT03182686|532166222|FG000|Overall Study|Adverse Event|2|||
147549024|NCT03182686|532166223|FG001|Overall Study|Adverse Event|0|||
147549025|NCT03182686|532166222|FG000|Overall Study|Withdrawal by Subject|3|||
147549026|NCT03182686|532166223|FG001|Overall Study|Withdrawal by Subject|0|||
147549027|NCT01154127|532166230|FG000|Period 1 (21 Days)|Adverse Event|3|||
147215335|NCT00557856|530960019|FG005|Part 2: Exploratory Phase|global deterioration of health status|0|||
147215336|NCT00557856|530960020|FG006|Part 2: Exploratory Phase|global deterioration of health status|0|||
147215337|NCT00557856|530960021|FG007|Part 2: Exploratory Phase|global deterioration of health status|0|||
147215338|NCT00557856|530960022|FG008|Part 2: Exploratory Phase|global deterioration of health status|1|||
147215339|NCT05092360|530960023|FG000|Overall Study|Withdrawal by Subject|21|||
147215340|NCT05092360|530960024|FG001|Overall Study|Withdrawal by Subject|4|||
147215341|NCT05092360|530960025|FG002|Overall Study|Withdrawal by Subject|9|||
147215342|NCT05092360|530960026|FG003|Overall Study|Withdrawal by Subject|26|||
147215343|NCT05092360|530960023|FG000|Overall Study|Death|97|||
147215344|NCT05092360|530960024|FG001|Overall Study|Death|14|||
147215345|NCT05092360|530960025|FG002|Overall Study|Death|31|||
147215346|NCT05092360|530960026|FG003|Overall Study|Death|101|||
147215347|NCT05092360|530960023|FG000|Overall Study|Lost to Follow-up|1|||
147215348|NCT05092360|530960024|FG001|Overall Study|Lost to Follow-up|2|||
147215349|NCT05092360|530960025|FG002|Overall Study|Lost to Follow-up|2|||
147215350|NCT05092360|530960026|FG003|Overall Study|Lost to Follow-up|2|||
147215351|NCT05092360|530960023|FG000|Overall Study|Study terminated by sponsor|65|||
147215352|NCT05092360|530960024|FG001|Overall Study|Study terminated by sponsor|7|||
147215353|NCT05092360|530960025|FG002|Overall Study|Study terminated by sponsor|13|||
147215354|NCT05092360|530960026|FG003|Overall Study|Study terminated by sponsor|61|||
147549028|NCT01154127|532166231|FG001|Period 1 (21 Days)|Adverse Event|4|||
147549029|NCT01154127|532166230|FG000|Period 1 (21 Days)|Withdrawal by Subject|0|||
147549030|NCT01154127|532166231|FG001|Period 1 (21 Days)|Withdrawal by Subject|2|||
147549031|NCT01154127|532166230|FG000|Washout (14 - 28 Days)|Adverse Event|2|||
147549032|NCT01154127|532166231|FG001|Washout (14 - 28 Days)|Adverse Event|0|||
147549033|NCT01154127|532166230|FG000|Washout (14 - 28 Days)|Abnormal Test Procedure|1|||
147549034|NCT01154127|532166231|FG001|Washout (14 - 28 Days)|Abnormal Test Procedure|0|||
147549035|NCT01154127|532166230|FG000|Period 2 (21 Days)|Protocol Deviation|0|||
147549036|NCT01154127|532166231|FG001|Period 2 (21 Days)|Protocol Deviation|1|||
147549037|NCT01697449|532166232|FG000|Overall Study|Disease progression|47|||
147549038|NCT01697449|532166232|FG000|Overall Study|Adverse Event|7|||
147549039|NCT01697449|532166232|FG000|Overall Study|Lost to Follow-up|5|||
147549040|NCT01697449|532166232|FG000|Overall Study|Withdrawal by Subject|2|||
147549041|NCT01697449|532166232|FG000|Overall Study|Physician Decision|1|||
147549042|NCT01697449|532166232|FG000|Overall Study|Death|2|||
147549043|NCT01697449|532166232|FG000|Overall Study|Other|1|||
147549044|NCT01697449|532166232|FG000|Overall Study|Missing|25|||
147549045|NCT01169844|532166233|FG000|Overall Study|Adverse Event|0|||
147549046|NCT01169844|532166234|FG001|Overall Study|Adverse Event|1|||
147549047|NCT01169844|532166233|FG000|Overall Study|Patient withdrew consent|4|||
147549048|NCT01169844|532166234|FG001|Overall Study|Patient withdrew consent|0|||
147549049|NCT01169844|532166233|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
147549050|NCT01169844|532166234|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
147549051|NCT01337050|532166235|FG000|Overall Study|Death|0|||
147549052|NCT01337050|532166236|FG001|Overall Study|Death|0|||
147549053|NCT01337050|532166237|FG002|Overall Study|Death|4|||
147549054|NCT01337050|532166235|FG000|Overall Study|Other|4|||
147549055|NCT01337050|532166236|FG001|Overall Study|Other|6|||
147549056|NCT01337050|532166237|FG002|Overall Study|Other|8|||
147549057|NCT01337050|532166235|FG000|Overall Study|Participants refused further follow-up|0|||
147549058|NCT01337050|532166236|FG001|Overall Study|Participants refused further follow-up|7|||
147549059|NCT01337050|532166237|FG002|Overall Study|Participants refused further follow-up|7|||
147549060|NCT00003102|532166238|FG000|Overall Study|Physician Decision|1|||
147549061|NCT00003102|532166239|FG001|Overall Study|Physician Decision|1|||
147549062|NCT00003102|532166240|FG002|Overall Study|Physician Decision|0|||
147549063|NCT00003102|532166238|FG000|Overall Study|Progressive Disease|0|||
147215355|NCT01525225|530960027|FG000|Enrollment|No longer met study criteria|1|||
147215356|NCT01525225|530960027|FG000|Enrollment|Other|1|||
147215357|NCT01182844|530960028|FG000|Overall Study|Withdrawal by Subject|0|||
147215358|NCT01182844|530960029|FG001|Overall Study|Withdrawal by Subject|2|||
147549064|NCT00003102|532166239|FG001|Overall Study|Progressive Disease|1|||
147549065|NCT00003102|532166240|FG002|Overall Study|Progressive Disease|0|||
147549066|NCT00003102|532166238|FG000|Overall Study|Adverse Event|0|||
147549067|NCT00003102|532166239|FG001|Overall Study|Adverse Event|1|||
147549068|NCT00003102|532166240|FG002|Overall Study|Adverse Event|1|||
147549069|NCT00003102|532166238|FG000|Overall Study|Death|0|||
147549070|NCT00003102|532166239|FG001|Overall Study|Death|0|||
147549071|NCT00003102|532166240|FG002|Overall Study|Death|1|||
147549072|NCT01559818|532166241|FG000|Overall Study|Physician Decision|1|||
147549073|NCT01559818|532166241|FG000|Overall Study|Pregnancy|1|||
147549074|NCT01559818|532166241|FG000|Overall Study|Study terminated by Sponsor|4|||
147549075|NCT01559818|532166241|FG000|Overall Study|Withdrawal by Subject|1|||
147549076|NCT04071626|532166242|FG000|Overall Study|Withdrawal by Subject|1|||
147549077|NCT04071626|532166243|FG001|Overall Study|Withdrawal by Subject|1|||
147549078|NCT04071626|532166242|FG000|Overall Study|Protocol Violation|0|||
147549079|NCT04071626|532166243|FG001|Overall Study|Protocol Violation|1|||
147549080|NCT00931385|532166244|FG000|Overall Study|Adverse Event|2|||
147549081|NCT00931385|532166245|FG001|Overall Study|Adverse Event|1|||
147549082|NCT00931385|532166246|FG002|Overall Study|Adverse Event|0|||
147549083|NCT00931385|532166247|FG003|Overall Study|Adverse Event|3|||
147549084|NCT00931385|532166244|FG000|Overall Study|Protocol Violation|0|||
147549085|NCT00931385|532166245|FG001|Overall Study|Protocol Violation|0|||
147549086|NCT00931385|532166246|FG002|Overall Study|Protocol Violation|1|||
147549087|NCT00931385|532166247|FG003|Overall Study|Protocol Violation|0|||
147549088|NCT00931385|532166244|FG000|Overall Study|Withdrawal by Subject|0|||
147549089|NCT00931385|532166245|FG001|Overall Study|Withdrawal by Subject|1|||
147549090|NCT00931385|532166246|FG002|Overall Study|Withdrawal by Subject|0|||
147549091|NCT00931385|532166247|FG003|Overall Study|Withdrawal by Subject|1|||
147549092|NCT00931385|532166244|FG000|Overall Study|Lost to Follow-up|0|||
147549093|NCT00931385|532166245|FG001|Overall Study|Lost to Follow-up|0|||
147549094|NCT00931385|532166246|FG002|Overall Study|Lost to Follow-up|0|||
147549095|NCT00931385|532166247|FG003|Overall Study|Lost to Follow-up|1|||
147549096|NCT00665626|532166252|FG000|Overall Study|Lack of Efficacy|8|||
147549097|NCT00665626|532166253|FG001|Overall Study|Lack of Efficacy|5|||
147549098|NCT00665626|532166252|FG000|Overall Study|Lost to Follow-up|0|||
147215359|NCT00910624|530961596|FG000|Treatment Phase|Adverse Event|2|||
147215360|NCT00910624|530961597|FG001|Treatment Phase|Adverse Event|6|||
147549099|NCT00665626|532166253|FG001|Overall Study|Lost to Follow-up|2|||
147549100|NCT00665626|532166252|FG000|Overall Study|Withdrawal by Subject|0|||
147549101|NCT00665626|532166253|FG001|Overall Study|Withdrawal by Subject|1|||
147549102|NCT00665626|532166252|FG000|Overall Study|Protocol Violation|0|||
147549103|NCT00665626|532166253|FG001|Overall Study|Protocol Violation|2|||
147549104|NCT00665626|532166252|FG000|Overall Study|Adverse Event|1|||
147549105|NCT00665626|532166253|FG001|Overall Study|Adverse Event|9|||
147549106|NCT00665626|532166252|FG000|Overall Study|Due to exclusion criteria|0|||
147549107|NCT00665626|532166253|FG001|Overall Study|Due to exclusion criteria|1|||
147549108|NCT00665626|532166252|FG000|Overall Study|Did not fulfil inclusion criteria|0|||
147549109|NCT00665626|532166253|FG001|Overall Study|Did not fulfil inclusion criteria|1|||
147549110|NCT00665626|532166252|FG000|Overall Study|Unably to comply with dosing regimen|0|||
147549111|NCT00665626|532166253|FG001|Overall Study|Unably to comply with dosing regimen|1|||
147215361|NCT00910624|530961598|FG002|Treatment Phase|Adverse Event|6|||
147549112|NCT00665626|532166252|FG000|Overall Study|Death|1|||
147549113|NCT00665626|532166253|FG001|Overall Study|Death|0|||
147549114|NCT01629693|532166256|FG000|Overall Study|Lost to Follow-up|2|||
147549115|NCT01629693|532166257|FG001|Overall Study|Lost to Follow-up|4|||
147549116|NCT01629693|532166256|FG000|Overall Study|Withdrawal by Subject|2|||
147549117|NCT01629693|532166257|FG001|Overall Study|Withdrawal by Subject|2|||
147549118|NCT01629693|532166256|FG000|Overall Study|Adverse Event|1|||
147549119|NCT01629693|532166257|FG001|Overall Study|Adverse Event|0|||
147549120|NCT01629693|532166256|FG000|Overall Study|Investigator decision|0|||
147549121|NCT01629693|532166257|FG001|Overall Study|Investigator decision|1|||
147549122|NCT01629693|532166256|FG000|Overall Study|Poor comfort of study lenses|0|||
147549123|NCT01629693|532166257|FG001|Overall Study|Poor comfort of study lenses|2|||
147549124|NCT01629693|532166256|FG000|Overall Study|Subject decision unrelated to AE|0|||
147549125|NCT01629693|532166257|FG001|Overall Study|Subject decision unrelated to AE|1|||
147549126|NCT04385199|532166258|FG000|Overall Study|Withdrawal by Subject|1|||
147549127|NCT04385199|532166259|FG001|Overall Study|Withdrawal by Subject|0|||
147549128|NCT04079842|532166261|FG000|Overall Study|Request of subject|2|||
147549129|NCT04079842|532166261|FG000|Overall Study|Unable to draw Arterial samples|1|||
147549130|NCT01025193|532166262|FG000|Overall Study|Protocol Violation|1|||
147549131|NCT01025193|532166262|FG000|Overall Study|Adverse Event|3|||
147549132|NCT02904200|532166263|FG000|Overall Study|Withdrawal by Subject|1|||
147549133|NCT02904200|532166264|FG001|Overall Study|Withdrawal by Subject|0|||
147549134|NCT02133352|532166267|FG000|Longer Term Extension|4 of the initial 10 subjects agreed/cons|6|||
147549135|NCT03705169|532166268|FG000|Overall Study|Lost to Follow-up|0|||
147549136|NCT03705169|532166269|FG001|Overall Study|Lost to Follow-up|0|||
147549137|NCT03705169|532166270|FG002|Overall Study|Lost to Follow-up|0|||
147549138|NCT03705169|532166271|FG003|Overall Study|Lost to Follow-up|2|||
147549139|NCT03705169|532166272|FG004|Overall Study|Lost to Follow-up|0|||
147549140|NCT03705169|532166273|FG005|Overall Study|Lost to Follow-up|2|||
147549141|NCT03705169|532166274|FG006|Overall Study|Lost to Follow-up|1|||
147549142|NCT03705169|532166275|FG007|Overall Study|Lost to Follow-up|0|||
147549143|NCT03705169|532166276|FG008|Overall Study|Lost to Follow-up|0|||
147549144|NCT03705169|532166277|FG009|Overall Study|Lost to Follow-up|1|||
147549145|NCT03705169|532166268|FG000|Overall Study|Adverse Event|0|||
147549146|NCT03705169|532166269|FG001|Overall Study|Adverse Event|0|||
147549147|NCT03705169|532166270|FG002|Overall Study|Adverse Event|0|||
147549148|NCT03705169|532166271|FG003|Overall Study|Adverse Event|1|||
147549149|NCT03705169|532166272|FG004|Overall Study|Adverse Event|0|||
147549150|NCT03705169|532166273|FG005|Overall Study|Adverse Event|0|||
147549151|NCT03705169|532166274|FG006|Overall Study|Adverse Event|0|||
147549152|NCT03705169|532166275|FG007|Overall Study|Adverse Event|0|||
147549153|NCT03705169|532166276|FG008|Overall Study|Adverse Event|0|||
147549154|NCT03705169|532166277|FG009|Overall Study|Adverse Event|0|||
147549155|NCT03705169|532166268|FG000|Overall Study|Site Closure|0|||
147549156|NCT03705169|532166269|FG001|Overall Study|Site Closure|0|||
147549157|NCT03705169|532166270|FG002|Overall Study|Site Closure|0|||
147549158|NCT03705169|532166271|FG003|Overall Study|Site Closure|1|||
147549159|NCT03705169|532166272|FG004|Overall Study|Site Closure|0|||
147549160|NCT03705169|532166273|FG005|Overall Study|Site Closure|0|||
147549161|NCT03705169|532166274|FG006|Overall Study|Site Closure|0|||
147549162|NCT03705169|532166275|FG007|Overall Study|Site Closure|0|||
147549163|NCT03705169|532166276|FG008|Overall Study|Site Closure|0|||
147549164|NCT03705169|532166277|FG009|Overall Study|Site Closure|0|||
147549165|NCT03705169|532166268|FG000|Overall Study|Did not receive study treatment|0|||
147549166|NCT03705169|532166269|FG001|Overall Study|Did not receive study treatment|0|||
147549167|NCT03705169|532166270|FG002|Overall Study|Did not receive study treatment|0|||
147549168|NCT03705169|532166271|FG003|Overall Study|Did not receive study treatment|1|||
147549169|NCT03705169|532166272|FG004|Overall Study|Did not receive study treatment|0|||
147549170|NCT03705169|532166273|FG005|Overall Study|Did not receive study treatment|0|||
147549171|NCT03705169|532166274|FG006|Overall Study|Did not receive study treatment|0|||
147549172|NCT03705169|532166275|FG007|Overall Study|Did not receive study treatment|0|||
147549173|NCT03705169|532166276|FG008|Overall Study|Did not receive study treatment|0|||
147549174|NCT03705169|532166277|FG009|Overall Study|Did not receive study treatment|0|||
147549175|NCT03705169|532166268|FG000|Overall Study|Concerns about study visit compliance|0|||
147549176|NCT03705169|532166269|FG001|Overall Study|Concerns about study visit compliance|0|||
147549177|NCT03705169|532166270|FG002|Overall Study|Concerns about study visit compliance|0|||
147549178|NCT03705169|532166271|FG003|Overall Study|Concerns about study visit compliance|1|||
147549179|NCT03705169|532166272|FG004|Overall Study|Concerns about study visit compliance|0|||
147549180|NCT03705169|532166273|FG005|Overall Study|Concerns about study visit compliance|0|||
147549181|NCT03705169|532166274|FG006|Overall Study|Concerns about study visit compliance|0|||
147549182|NCT03705169|532166275|FG007|Overall Study|Concerns about study visit compliance|0|||
147549183|NCT03705169|532166276|FG008|Overall Study|Concerns about study visit compliance|0|||
147549184|NCT03705169|532166277|FG009|Overall Study|Concerns about study visit compliance|0|||
147549185|NCT00185211|532166278|FG000|Placebo-controlled Study (92012)|Adverse Event|8|||
147549186|NCT00185211|532166279|FG001|Placebo-controlled Study (92012)|Adverse Event|0|||
147549187|NCT00185211|532166278|FG000|Placebo-controlled Study (92012)|Lost to Follow-up|3|||
147549188|NCT00185211|532166279|FG001|Placebo-controlled Study (92012)|Lost to Follow-up|2|||
147549189|NCT00185211|532166278|FG000|Placebo-controlled Study (92012)|Withdrawal by Subject|9|||
147549190|NCT00185211|532166279|FG001|Placebo-controlled Study (92012)|Withdrawal by Subject|7|||
147549191|NCT00185211|532166278|FG000|Placebo-controlled Study (92012)|fulfilled local def. and McDonald crit.|0|||
147549192|NCT00185211|532166279|FG001|Placebo-controlled Study (92012)|fulfilled local def. and McDonald crit.|1|||
147549193|NCT00185211|532166278|FG000|Placebo-controlled Study (92012)|Adverse event, then subject's withdrawal|1|||
147549194|NCT00185211|532166279|FG001|Placebo-controlled Study (92012)|Adverse event, then subject's withdrawal|0|||
147549195|NCT00185211|532166278|FG000|Follow-up Study (91031 - This Study)|Adverse Event|5|||
147549196|NCT00185211|532166279|FG001|Follow-up Study (91031 - This Study)|Adverse Event|6|||
147549197|NCT00185211|532166278|FG000|Follow-up Study (91031 - This Study)|Lack of Efficacy|1|||
147549198|NCT00185211|532166279|FG001|Follow-up Study (91031 - This Study)|Lack of Efficacy|0|||
147549199|NCT00185211|532166278|FG000|Follow-up Study (91031 - This Study)|Lost to Follow-up|6|||
147549200|NCT00185211|532166279|FG001|Follow-up Study (91031 - This Study)|Lost to Follow-up|4|||
147549201|NCT00185211|532166278|FG000|Follow-up Study (91031 - This Study)|Physician Decision|1|||
147549202|NCT00185211|532166279|FG001|Follow-up Study (91031 - This Study)|Physician Decision|0|||
147549203|NCT00185211|532166278|FG000|Follow-up Study (91031 - This Study)|Pregnancy|0|||
147549204|NCT00185211|532166279|FG001|Follow-up Study (91031 - This Study)|Pregnancy|1|||
147215362|NCT00910624|530961599|FG003|Treatment Phase|Adverse Event|0|||
147549205|NCT00185211|532166278|FG000|Follow-up Study (91031 - This Study)|Withdrawal by Subject|13|||
147549206|NCT00185211|532166279|FG001|Follow-up Study (91031 - This Study)|Withdrawal by Subject|21|||
147549207|NCT00185211|532166278|FG000|Follow-up Study (91031 - This Study)|other disease modif. treatment|0|||
147549208|NCT00185211|532166279|FG001|Follow-up Study (91031 - This Study)|other disease modif. treatment|2|||
147549209|NCT01759537|532166280|FG000|Overall Study|Death|1|||
147549210|NCT01759537|532166281|FG001|Overall Study|Death|1|||
147549211|NCT01759537|532166280|FG000|Overall Study|Pregnancy|1|||
147549212|NCT01759537|532166281|FG001|Overall Study|Pregnancy|1|||
147549213|NCT01759537|532166280|FG000|Overall Study|Lost to Follow-up|9|||
147549214|NCT01759537|532166281|FG001|Overall Study|Lost to Follow-up|9|||
147549215|NCT01759537|532166280|FG000|Overall Study|Accident involving jaw fracture|1|||
147549216|NCT01759537|532166281|FG001|Overall Study|Accident involving jaw fracture|1|||
147549217|NCT01759537|532166280|FG000|Overall Study|Subcrestal implant too coronal|1|||
147549218|NCT01759537|532166281|FG001|Overall Study|Subcrestal implant too coronal|1|||
147549219|NCT00606684|532167864|FG000|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|173|||
147549220|NCT00606684|532167865|FG001|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
147549221|NCT00606684|532167866|FG002|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
147549222|NCT00606684|532167867|FG003|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
147549223|NCT00606684|532167868|FG004|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
147549224|NCT00606684|532167869|FG005|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
147549225|NCT00606684|532167870|FG006|2-week Single-Blind Run-in Period|Did Not Meet Continuation Criteria|0|||
147549226|NCT00606684|532167864|FG000|2-week Single-Blind Run-in Period|Study Closed/Terminated|32|||
147549227|NCT00606684|532167865|FG001|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
147549228|NCT00606684|532167866|FG002|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
147549229|NCT00606684|532167867|FG003|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
147549230|NCT00606684|532167868|FG004|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
147549231|NCT00606684|532167869|FG005|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
147549232|NCT00606684|532167870|FG006|2-week Single-Blind Run-in Period|Study Closed/Terminated|0|||
147549233|NCT00606684|532167864|FG000|2-week Single-Blind Run-in Period|Physician Decision|18|||
147549234|NCT00606684|532167865|FG001|2-week Single-Blind Run-in Period|Physician Decision|0|||
147215363|NCT00910624|530961596|FG000|Treatment Phase|Treatment Failure|23|||
147215364|NCT00910624|530961597|FG001|Treatment Phase|Treatment Failure|10|||
147215365|NCT00910624|530961598|FG002|Treatment Phase|Treatment Failure|0|||
147215366|NCT00910624|530961599|FG003|Treatment Phase|Treatment Failure|0|||
147215367|NCT00910624|530961596|FG000|Treatment Phase|Lost to Follow-up|0|||
147215368|NCT00910624|530961597|FG001|Treatment Phase|Lost to Follow-up|0|||
147215369|NCT00910624|530961598|FG002|Treatment Phase|Lost to Follow-up|1|||
147215370|NCT00910624|530961599|FG003|Treatment Phase|Lost to Follow-up|0|||
147215371|NCT00910624|530961596|FG000|Treatment Phase|Reasons Unrelated To Assigned Treatment|3|||
147215372|NCT00910624|530961597|FG001|Treatment Phase|Reasons Unrelated To Assigned Treatment|3|||
147215373|NCT00910624|530961598|FG002|Treatment Phase|Reasons Unrelated To Assigned Treatment|1|||
147215374|NCT00910624|530961599|FG003|Treatment Phase|Reasons Unrelated To Assigned Treatment|0|||
147549235|NCT00606684|532167866|FG002|2-week Single-Blind Run-in Period|Physician Decision|0|||
147549236|NCT00606684|532167867|FG003|2-week Single-Blind Run-in Period|Physician Decision|0|||
147549237|NCT00606684|532167868|FG004|2-week Single-Blind Run-in Period|Physician Decision|0|||
147549238|NCT00606684|532167869|FG005|2-week Single-Blind Run-in Period|Physician Decision|0|||
147549239|NCT00606684|532167870|FG006|2-week Single-Blind Run-in Period|Physician Decision|0|||
147215375|NCT00910624|530961596|FG000|Treatment Phase|Withdrawal by Subject|2|||
147549240|NCT00606684|532167864|FG000|2-week Single-Blind Run-in Period|Withdrawal by Subject|15|||
147549241|NCT00606684|532167865|FG001|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
147549242|NCT00606684|532167866|FG002|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
147549243|NCT00606684|532167867|FG003|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
147549244|NCT00606684|532167868|FG004|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
147549245|NCT00606684|532167869|FG005|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
147549246|NCT00606684|532167870|FG006|2-week Single-Blind Run-in Period|Withdrawal by Subject|0|||
147549247|NCT00606684|532167864|FG000|2-week Single-Blind Run-in Period|Lost to Follow-up|5|||
147549248|NCT00606684|532167865|FG001|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
147549249|NCT00606684|532167866|FG002|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
147549250|NCT00606684|532167867|FG003|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
147549251|NCT00606684|532167868|FG004|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
147549252|NCT00606684|532167869|FG005|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
147549253|NCT00606684|532167870|FG006|2-week Single-Blind Run-in Period|Lost to Follow-up|0|||
147549254|NCT00606684|532167864|FG000|2-week Single-Blind Run-in Period|Adverse Event|2|||
147549255|NCT00606684|532167865|FG001|2-week Single-Blind Run-in Period|Adverse Event|0|||
147549256|NCT00606684|532167866|FG002|2-week Single-Blind Run-in Period|Adverse Event|0|||
147549257|NCT00606684|532167867|FG003|2-week Single-Blind Run-in Period|Adverse Event|0|||
147549258|NCT00606684|532167868|FG004|2-week Single-Blind Run-in Period|Adverse Event|0|||
147549259|NCT00606684|532167869|FG005|2-week Single-Blind Run-in Period|Adverse Event|0|||
147549260|NCT00606684|532167870|FG006|2-week Single-Blind Run-in Period|Adverse Event|0|||
147549261|NCT00606684|532167864|FG000|2-week Single-Blind Run-in Period|Received Study Medication in Error|1|||
147549262|NCT00606684|532167865|FG001|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
147549263|NCT00606684|532167866|FG002|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
147549264|NCT00606684|532167867|FG003|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
147549265|NCT00606684|532167868|FG004|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
147549266|NCT00606684|532167869|FG005|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
147549267|NCT00606684|532167870|FG006|2-week Single-Blind Run-in Period|Received Study Medication in Error|0|||
147549268|NCT00606684|532167864|FG000|Double-Blind Treatment Period|Adverse Event|0|||
147549269|NCT00606684|532167865|FG001|Double-Blind Treatment Period|Adverse Event|3|||
147549270|NCT00606684|532167866|FG002|Double-Blind Treatment Period|Adverse Event|2|||
147549271|NCT00606684|532167867|FG003|Double-Blind Treatment Period|Adverse Event|4|||
147549272|NCT00606684|532167868|FG004|Double-Blind Treatment Period|Adverse Event|2|||
147549273|NCT00606684|532167869|FG005|Double-Blind Treatment Period|Adverse Event|0|||
147215376|NCT00910624|530961597|FG001|Treatment Phase|Withdrawal by Subject|1|||
147215377|NCT00910624|530961598|FG002|Treatment Phase|Withdrawal by Subject|0|||
147215378|NCT00910624|530961599|FG003|Treatment Phase|Withdrawal by Subject|0|||
147549274|NCT00606684|532167870|FG006|Double-Blind Treatment Period|Adverse Event|1|||
147549275|NCT00606684|532167864|FG000|Double-Blind Treatment Period|Lack of Efficacy|0|||
147549276|NCT00606684|532167865|FG001|Double-Blind Treatment Period|Lack of Efficacy|1|||
147549277|NCT00606684|532167866|FG002|Double-Blind Treatment Period|Lack of Efficacy|0|||
147549278|NCT00606684|532167867|FG003|Double-Blind Treatment Period|Lack of Efficacy|0|||
147549279|NCT00606684|532167868|FG004|Double-Blind Treatment Period|Lack of Efficacy|1|||
147549280|NCT00606684|532167869|FG005|Double-Blind Treatment Period|Lack of Efficacy|0|||
147549281|NCT00606684|532167870|FG006|Double-Blind Treatment Period|Lack of Efficacy|0|||
147549282|NCT00606684|532167864|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
147549283|NCT00606684|532167865|FG001|Double-Blind Treatment Period|Protocol Violation|5|||
147549284|NCT00606684|532167866|FG002|Double-Blind Treatment Period|Protocol Violation|5|||
147549285|NCT00606684|532167867|FG003|Double-Blind Treatment Period|Protocol Violation|3|||
147549286|NCT00606684|532167868|FG004|Double-Blind Treatment Period|Protocol Violation|0|||
147549287|NCT00606684|532167869|FG005|Double-Blind Treatment Period|Protocol Violation|3|||
147549288|NCT00606684|532167870|FG006|Double-Blind Treatment Period|Protocol Violation|4|||
147549289|NCT00606684|532167864|FG000|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|0|||
147549290|NCT00606684|532167865|FG001|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|1|||
147549291|NCT00606684|532167866|FG002|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|2|||
147549292|NCT00606684|532167867|FG003|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|1|||
147549293|NCT00606684|532167868|FG004|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|2|||
147549294|NCT00606684|532167869|FG005|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|3|||
147549295|NCT00606684|532167870|FG006|Double-Blind Treatment Period|Met Protocol Defined Stopping Criteria|1|||
147549296|NCT00606684|532167864|FG000|Double-Blind Treatment Period|Physician Decision|0|||
147549297|NCT00606684|532167865|FG001|Double-Blind Treatment Period|Physician Decision|5|||
147549298|NCT00606684|532167866|FG002|Double-Blind Treatment Period|Physician Decision|1|||
147549299|NCT00606684|532167867|FG003|Double-Blind Treatment Period|Physician Decision|0|||
147549300|NCT00606684|532167868|FG004|Double-Blind Treatment Period|Physician Decision|3|||
147549301|NCT00606684|532167869|FG005|Double-Blind Treatment Period|Physician Decision|1|||
147549302|NCT00606684|532167870|FG006|Double-Blind Treatment Period|Physician Decision|2|||
147549303|NCT00606684|532167864|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
147549304|NCT00606684|532167865|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
147549305|NCT00606684|532167866|FG002|Double-Blind Treatment Period|Withdrawal by Subject|1|||
147549306|NCT00606684|532167867|FG003|Double-Blind Treatment Period|Withdrawal by Subject|2|||
147549307|NCT00606684|532167868|FG004|Double-Blind Treatment Period|Withdrawal by Subject|1|||
147549308|NCT00606684|532167869|FG005|Double-Blind Treatment Period|Withdrawal by Subject|2|||
147549309|NCT00606684|532167870|FG006|Double-Blind Treatment Period|Withdrawal by Subject|0|||
147549310|NCT01759381|532167873|FG000|Overall Study|Death|1|||
147549311|NCT01759381|532167874|FG001|Overall Study|Death|0|||
147549312|NCT01907737|532167882|FG000|Overall Study|Withdrawal by Subject|1|||
147549313|NCT00909727|532167887|FG000|Overall Study|Adverse Event|1|||
147549314|NCT00909727|532167888|FG001|Overall Study|Adverse Event|0|||
147549315|NCT00909727|532167887|FG000|Overall Study|Wrong Genotype|1|||
147549316|NCT00909727|532167888|FG001|Overall Study|Wrong Genotype|0|||
147549317|NCT00909727|532167887|FG000|Overall Study|Withdrawal of Consent|1|||
147549318|NCT00909727|532167888|FG001|Overall Study|Withdrawal of Consent|0|||
147549319|NCT00909727|532167887|FG000|Overall Study|Prohibited Medication|1|||
147549320|NCT00909727|532167888|FG001|Overall Study|Prohibited Medication|0|||
147549321|NCT00829413|532167893|FG000|Overall Study|No study drug admimnistered|13|||
147549322|NCT00829413|532167893|FG000|Overall Study|Training Patients|67|||
147549323|NCT00829413|532167893|FG000|Overall Study|No truth standard procedure available|9|||
147549324|NCT00829413|532167893|FG000|Overall Study|Technically inadequate truth standard|2|||
147549325|NCT00829413|532167893|FG000|Overall Study|Indeterminate diagnosis from truth stand|3|||
147549326|NCT04272775|532167895|FG000|Overall Study|Study Terminated by Sponsor|1|||
147549327|NCT04272775|532167896|FG001|Overall Study|Study Terminated by Sponsor|0|||
147549328|NCT04272775|532167895|FG000|Overall Study|Protocol Violation|0|||
147549329|NCT04272775|532167896|FG001|Overall Study|Protocol Violation|1|||
147549330|NCT04272775|532167895|FG000|Overall Study|Symptomatic Deterioration|1|||
147549331|NCT04272775|532167896|FG001|Overall Study|Symptomatic Deterioration|1|||
147549332|NCT04272775|532167895|FG000|Overall Study|Withdrawal by Subject|1|||
147549333|NCT04272775|532167896|FG001|Overall Study|Withdrawal by Subject|2|||
147549334|NCT04272775|532167895|FG000|Overall Study|Adverse Event|1|||
147549335|NCT04272775|532167896|FG001|Overall Study|Adverse Event|2|||
147549336|NCT04272775|532167895|FG000|Overall Study|Progressive Disease|3|||
147549337|NCT04272775|532167896|FG001|Overall Study|Progressive Disease|1|||
147549338|NCT01967888|532167897|FG000|Overall Study|Lost to Follow-up|6|||
147549339|NCT01967888|532167898|FG001|Overall Study|Lost to Follow-up|4|||
147549340|NCT01967888|532167897|FG000|Overall Study|Withdrawal by Subject|1|||
147549341|NCT01967888|532167898|FG001|Overall Study|Withdrawal by Subject|1|||
147549342|NCT01967888|532167897|FG000|Overall Study|Did Not Have Transplant|1|||
147549343|NCT01967888|532167898|FG001|Overall Study|Did Not Have Transplant|0|||
147549344|NCT01967888|532167897|FG000|Overall Study|Research visit not done, data recorded|1|||
147549345|NCT01967888|532167898|FG001|Overall Study|Research visit not done, data recorded|0|||
147549346|NCT01967888|532167897|FG000|Overall Study|Subject excluded after randomization|1|||
147549347|NCT01967888|532167898|FG001|Overall Study|Subject excluded after randomization|0|||
147549348|NCT01967888|532167897|FG000|Overall Study|Patient didn't proceed to pancreatectomy|0|||
147549349|NCT01967888|532167898|FG001|Overall Study|Patient didn't proceed to pancreatectomy|1|||
147549350|NCT01967888|532167897|FG000|Overall Study|Subject Unable To Comply With Final Day|0|||
147549351|NCT01967888|532167898|FG001|Overall Study|Subject Unable To Comply With Final Day|1|||
147549352|NCT00891774|532167899|FG000|Overall Study|Lost to Follow-up|5|||
147549353|NCT00891774|532167899|FG000|Overall Study|Illness (Self/Mother)|3|||
147549354|NCT00891774|532167899|FG000|Overall Study|Withdrawal by Subject|2|||
147549355|NCT00891774|532167899|FG000|Overall Study|Protocol Violation|4|||
147549356|NCT03175120|532167901|FG000|Overall Study|Adverse Event|2|||
147549357|NCT03175120|532167902|FG001|Overall Study|Adverse Event|2|||
147549358|NCT03175120|532167901|FG000|Overall Study|Protocol Violation|5|||
147549359|NCT03175120|532167902|FG001|Overall Study|Protocol Violation|2|||
147549360|NCT03175120|532167901|FG000|Overall Study|Lost to Follow-up|1|||
147549361|NCT03175120|532167902|FG001|Overall Study|Lost to Follow-up|0|||
147549362|NCT03175120|532167901|FG000|Overall Study|Withdrawal by Subject|2|||
147549363|NCT03175120|532167902|FG001|Overall Study|Withdrawal by Subject|5|||
147549364|NCT03175120|532167901|FG000|Overall Study|Other|2|||
147549365|NCT03175120|532167902|FG001|Overall Study|Other|3|||
147549366|NCT01894984|532167906|FG000|Overall Study|Other|314|||
147549367|NCT01894984|532167907|FG001|Overall Study|Other|175|||
147549368|NCT00827359|532167908|FG000|Overall Study|Progressive Diseas|19|||
147549369|NCT00827359|532167908|FG000|Overall Study|Unacceptable Toxicity|5|||
147549370|NCT00827359|532167908|FG000|Overall Study|Ineligible|1|||
147549371|NCT00323609|532167909|FG000|Overall Study|Death|16|||
147549372|NCT00323609|532167910|FG001|Overall Study|Death|21|||
147549373|NCT00323609|532167911|FG002|Overall Study|Death|0|||
147549374|NCT00323609|532167912|FG003|Overall Study|Death|0|||
147549375|NCT00323609|532167909|FG000|Overall Study|Lost to Follow-up|9|||
147549376|NCT00323609|532167910|FG001|Overall Study|Lost to Follow-up|10|||
147549377|NCT00323609|532167911|FG002|Overall Study|Lost to Follow-up|0|||
147549378|NCT00323609|532167912|FG003|Overall Study|Lost to Follow-up|0|||
147549379|NCT00323609|532167909|FG000|Overall Study|Physician Decision|2|||
147549380|NCT00323609|532167910|FG001|Overall Study|Physician Decision|0|||
147549381|NCT00323609|532167911|FG002|Overall Study|Physician Decision|0|||
147549382|NCT00323609|532167912|FG003|Overall Study|Physician Decision|1|||
147549383|NCT00323609|532167909|FG000|Overall Study|Withdrawal by Subject|11|||
147549384|NCT00323609|532167910|FG001|Overall Study|Withdrawal by Subject|23|||
147549385|NCT00323609|532167911|FG002|Overall Study|Withdrawal by Subject|4|||
147549386|NCT00323609|532167912|FG003|Overall Study|Withdrawal by Subject|4|||
147549387|NCT00323609|532167909|FG000|Overall Study|Other non-VCF-related medical condition|3|||
147549388|NCT00323609|532167910|FG001|Overall Study|Other non-VCF-related medical condition|2|||
147549389|NCT00323609|532167911|FG002|Overall Study|Other non-VCF-related medical condition|0|||
147549390|NCT00323609|532167912|FG003|Overall Study|Other non-VCF-related medical condition|0|||
147549391|NCT00323609|532167909|FG000|Overall Study|Sponsor discontinued trial|29|||
147549392|NCT00323609|532167910|FG001|Overall Study|Sponsor discontinued trial|29|||
147549393|NCT00323609|532167911|FG002|Overall Study|Sponsor discontinued trial|0|||
147549394|NCT00323609|532167912|FG003|Overall Study|Sponsor discontinued trial|0|||
147549395|NCT00323609|532167909|FG000|Overall Study|Unrelenting or severe back pain|1|||
147549396|NCT00323609|532167910|FG001|Overall Study|Unrelenting or severe back pain|1|||
147549397|NCT00323609|532167911|FG002|Overall Study|Unrelenting or severe back pain|0|||
147549398|NCT00323609|532167912|FG003|Overall Study|Unrelenting or severe back pain|0|||
147549399|NCT00323609|532167909|FG000|Overall Study|Logistical withdrawal|9|||
147549400|NCT00323609|532167910|FG001|Overall Study|Logistical withdrawal|5|||
147549401|NCT00323609|532167911|FG002|Overall Study|Logistical withdrawal|0|||
147549402|NCT00323609|532167912|FG003|Overall Study|Logistical withdrawal|1|||
147549403|NCT00323609|532167909|FG000|Overall Study|Other reason|11|||
147549404|NCT00323609|532167910|FG001|Overall Study|Other reason|8|||
147549405|NCT00323609|532167911|FG002|Overall Study|Other reason|4|||
147549406|NCT00323609|532167912|FG003|Overall Study|Other reason|9|||
147549407|NCT01612156|532167919|FG000|Overall Study|Protocol Violation|2|||
147549408|NCT01612156|532167920|FG001|Overall Study|Protocol Violation|0|||
147549409|NCT01141283|532167921|FG000|Overall Study|Adverse Event|56|||
147549410|NCT01141283|532167921|FG000|Overall Study|Lost to Follow-up|4|||
147549411|NCT01141283|532167921|FG000|Overall Study|Withdrawal by Subject|14|||
147549412|NCT01141283|532167921|FG000|Overall Study|Administrative|4|||
147549413|NCT01141283|532167921|FG000|Overall Study|Lack of Efficacy|10|||
147549414|NCT02124746|532167924|FG000|Overall Study|Adverse Event|2|||
147549415|NCT02124746|532167925|FG001|Overall Study|Adverse Event|1|||
147549416|NCT02124746|532167926|FG002|Overall Study|Adverse Event|2|||
147549417|NCT02124746|532167924|FG000|Overall Study|Death|2|||
147549418|NCT02124746|532167925|FG001|Overall Study|Death|1|||
147215379|NCT00910624|530961596|FG000|Treatment Phase|Non-Compliance With Protocol|0|||
147215380|NCT00910624|530961597|FG001|Treatment Phase|Non-Compliance With Protocol|1|||
147215381|NCT00910624|530961598|FG002|Treatment Phase|Non-Compliance With Protocol|1|||
147215382|NCT00910624|530961599|FG003|Treatment Phase|Non-Compliance With Protocol|0|||
147215383|NCT00910624|530961596|FG000|Follow-Up Phase|Adverse Event|0|||
147215384|NCT00910624|530961597|FG001|Follow-Up Phase|Adverse Event|0|||
147215385|NCT00910624|530961598|FG002|Follow-Up Phase|Adverse Event|1|||
147215386|NCT00910624|530961599|FG003|Follow-Up Phase|Adverse Event|0|||
147549419|NCT02124746|532167926|FG002|Overall Study|Death|3|||
147549420|NCT02124746|532167924|FG000|Overall Study|Lack of Efficacy|3|||
147549421|NCT02124746|532167925|FG001|Overall Study|Lack of Efficacy|2|||
147215387|NCT00910624|530961596|FG000|Follow-Up Phase|Lost to Follow-up|3|||
147215388|NCT00910624|530961597|FG001|Follow-Up Phase|Lost to Follow-up|1|||
147215389|NCT00910624|530961598|FG002|Follow-Up Phase|Lost to Follow-up|2|||
147549422|NCT02124746|532167926|FG002|Overall Study|Lack of Efficacy|2|||
147549423|NCT02124746|532167924|FG000|Overall Study|Physician Decision|6|||
147549424|NCT02124746|532167925|FG001|Overall Study|Physician Decision|4|||
147549425|NCT02124746|532167926|FG002|Overall Study|Physician Decision|5|||
147549426|NCT02124746|532167924|FG000|Overall Study|Non-Compliance with Study Drug|0|||
147549427|NCT02124746|532167925|FG001|Overall Study|Non-Compliance with Study Drug|1|||
147215390|NCT00910624|530961599|FG003|Follow-Up Phase|Lost to Follow-up|0|||
147549428|NCT02124746|532167926|FG002|Overall Study|Non-Compliance with Study Drug|0|||
147549429|NCT02124746|532167924|FG000|Overall Study|Withdrawal by Subject|3|||
147549430|NCT02124746|532167925|FG001|Overall Study|Withdrawal by Subject|3|||
147549431|NCT02124746|532167926|FG002|Overall Study|Withdrawal by Subject|0|||
147549432|NCT02124746|532167924|FG000|Overall Study|Study Terminated by Sponsor|0|||
147549433|NCT02124746|532167925|FG001|Overall Study|Study Terminated by Sponsor|0|||
147549434|NCT02124746|532167926|FG002|Overall Study|Study Terminated by Sponsor|6|||
147549435|NCT02124746|532167924|FG000|Overall Study|Disease Progression|3|||
147549436|NCT02124746|532167925|FG001|Overall Study|Disease Progression|6|||
147549437|NCT02124746|532167926|FG002|Overall Study|Disease Progression|4|||
147215391|NCT00910624|530961596|FG000|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|1|||
147215392|NCT00910624|530961597|FG001|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|2|||
147215393|NCT00910624|530961598|FG002|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|0|||
147215394|NCT00910624|530961599|FG003|Follow-Up Phase|Reasons Unrelated To Assigned Treatment|0|||
147215395|NCT00910624|530961596|FG000|Follow-Up Phase|Withdrawal by Subject|1|||
147215396|NCT00910624|530961597|FG001|Follow-Up Phase|Withdrawal by Subject|0|||
147215397|NCT00910624|530961598|FG002|Follow-Up Phase|Withdrawal by Subject|0|||
147215398|NCT00910624|530961599|FG003|Follow-Up Phase|Withdrawal by Subject|0|||
147215399|NCT00910624|530961596|FG000|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|1|||
147215400|NCT00910624|530961597|FG001|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|0|||
147215401|NCT00910624|530961598|FG002|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|0|||
147215402|NCT00910624|530961599|FG003|Follow-Up Phase|Withdrew Due To Retreatment Opportunity|0|||
147215403|NCT00910624|530961596|FG000|Follow-Up Phase|Administrative|0|||
147215404|NCT00910624|530961597|FG001|Follow-Up Phase|Administrative|1|||
147215405|NCT00910624|530961598|FG002|Follow-Up Phase|Administrative|1|||
147215406|NCT00910624|530961599|FG003|Follow-Up Phase|Administrative|0|||
147442420|NCT01671111|531784319|FG000|Overall Study|Withdrawal by Subject|2|||
147442421|NCT01671111|531784319|FG000|Overall Study|Physician Decision|1|||
147549438|NCT02868281|532167929|FG000|Overall Study|Adverse Event|2|||
147549439|NCT02868281|532167930|FG001|Overall Study|Adverse Event|2|||
147549440|NCT02868281|532167929|FG000|Overall Study|Protocol Violation|13|||
147549441|NCT02868281|532167930|FG001|Overall Study|Protocol Violation|10|||
147549442|NCT02868281|532167929|FG000|Overall Study|Lost to Follow-up|3|||
147549443|NCT02868281|532167930|FG001|Overall Study|Lost to Follow-up|6|||
147549444|NCT02868281|532167929|FG000|Overall Study|Withdrawal by Subject|11|||
147549445|NCT02868281|532167930|FG001|Overall Study|Withdrawal by Subject|15|||
147549446|NCT02868281|532167929|FG000|Overall Study|Physician Decision|2|||
147549447|NCT02868281|532167930|FG001|Overall Study|Physician Decision|0|||
147549448|NCT02868281|532167929|FG000|Overall Study|Had protocol-defined asthma exacerbation|8|||
147549449|NCT02868281|532167930|FG001|Overall Study|Had protocol-defined asthma exacerbation|8|||
147549450|NCT02868281|532167929|FG000|Overall Study|Inclusion/exclusion criteria violation|3|||
147549451|NCT02868281|532167930|FG001|Overall Study|Inclusion/exclusion criteria violation|2|||
147549452|NCT02868281|532167929|FG000|Overall Study|Long journey/moving away|1|||
147549453|NCT02868281|532167930|FG001|Overall Study|Long journey/moving away|1|||
147549454|NCT01722266|532167931|FG000|Overall Study|Withdrawal by Subject|1|||
147549455|NCT01722266|532167932|FG001|Overall Study|Withdrawal by Subject|2|||
147549456|NCT01722266|532167933|FG002|Overall Study|Withdrawal by Subject|0|||
147549457|NCT01722266|532167934|FG003|Overall Study|Withdrawal by Subject|0|||
147549458|NCT01722266|532167931|FG000|Overall Study|Tolerated only 0.6 mg liraglutide|0|||
147549459|NCT01722266|532167932|FG001|Overall Study|Tolerated only 0.6 mg liraglutide|1|||
147215407|NCT01122264|530961600|FG000|Overall Study|Adverse Event|6|||
147215408|NCT01122264|530961601|FG001|Overall Study|Adverse Event|5|||
147215409|NCT01122264|530961602|FG002|Overall Study|Adverse Event|7|||
147442422|NCT01671111|531784319|FG000|Overall Study|Other|24|||
147442423|NCT00829179|531784320|FG000|Overall Study|Withdrawal by Subject|1|||
147442424|NCT00596947|531784321|FG000|Overall Study|study halted due to low enrollment|5|||
147442425|NCT00596947|531784322|FG001|Overall Study|study halted due to low enrollment|3|||
147442426|NCT00596947|531784321|FG000|Overall Study|Lost to Follow-up|1|||
147442427|NCT00596947|531784322|FG001|Overall Study|Lost to Follow-up|0|||
147442428|NCT03000179|531784323|FG000|Overall Study|Lost to Follow-up|2|||
147442429|NCT02114268|531784326|FG000|Overall Study|Lost to Follow-up|4|||
147442430|NCT02114268|531784327|FG001|Overall Study|Lost to Follow-up|1|||
147442431|NCT02114268|531784328|FG002|Overall Study|Lost to Follow-up|1|||
147442432|NCT02114268|531784329|FG003|Overall Study|Lost to Follow-up|0|||
147442433|NCT02114268|531784330|FG004|Overall Study|Lost to Follow-up|0|||
147442434|NCT02114268|531784331|FG005|Overall Study|Lost to Follow-up|2|||
147442435|NCT02114268|531784326|FG000|Overall Study|Withdrawal by Subject|1|||
147442436|NCT02114268|531784327|FG001|Overall Study|Withdrawal by Subject|0|||
147442437|NCT02114268|531784328|FG002|Overall Study|Withdrawal by Subject|0|||
147442438|NCT02114268|531784329|FG003|Overall Study|Withdrawal by Subject|0|||
147442439|NCT02114268|531784330|FG004|Overall Study|Withdrawal by Subject|0|||
147442440|NCT02114268|531784331|FG005|Overall Study|Withdrawal by Subject|1|||
147442441|NCT02114268|531784326|FG000|Overall Study|Withdrawn by site due to noncompliance|1|||
147442442|NCT02114268|531784327|FG001|Overall Study|Withdrawn by site due to noncompliance|0|||
147442443|NCT02114268|531784328|FG002|Overall Study|Withdrawn by site due to noncompliance|0|||
147549460|NCT01722266|532167933|FG002|Overall Study|Tolerated only 0.6 mg liraglutide|3|||
147549461|NCT01722266|532167934|FG003|Overall Study|Tolerated only 0.6 mg liraglutide|0|||
147549462|NCT01722266|532167931|FG000|Overall Study|Dropped out due to Nausea|0|||
147549463|NCT01722266|532167932|FG001|Overall Study|Dropped out due to Nausea|0|||
147549464|NCT01722266|532167933|FG002|Overall Study|Dropped out due to Nausea|2|||
147549465|NCT01722266|532167934|FG003|Overall Study|Dropped out due to Nausea|0|||
147549466|NCT03811249|532167935|FG000|Overall Study|Withdrawal by Subject|44|||
147215410|NCT01122264|530961600|FG000|Overall Study|Death|1|||
147215411|NCT01122264|530961601|FG001|Overall Study|Death|0|||
147215412|NCT01122264|530961602|FG002|Overall Study|Death|0|||
147215413|NCT01122264|530961600|FG000|Overall Study|Lost to Follow-up|5|||
147215414|NCT01122264|530961601|FG001|Overall Study|Lost to Follow-up|9|||
147215415|NCT01122264|530961602|FG002|Overall Study|Lost to Follow-up|13|||
147215416|NCT01122264|530961600|FG000|Overall Study|Entry Criteria Not Met|1|||
147215417|NCT01122264|530961601|FG001|Overall Study|Entry Criteria Not Met|0|||
147215418|NCT01122264|530961602|FG002|Overall Study|Entry Criteria Not Met|0|||
147549467|NCT03811249|532167935|FG000|Overall Study|Missed Visit|24|||
147549468|NCT01504867|532167939|FG000|Overall Study|Inclusion criteria not met|2|||
147549469|NCT01504867|532167940|FG001|Overall Study|Inclusion criteria not met|2|||
147549470|NCT01504867|532167939|FG000|Overall Study|Consent revoked|5|||
147549471|NCT01504867|532167940|FG001|Overall Study|Consent revoked|1|||
147549472|NCT00571922|532167941|FG000|Overall Study|Completion unknown|36|||
147215419|NCT01122264|530961600|FG000|Overall Study|Protocol Violation|7|||
147215420|NCT01122264|530961601|FG001|Overall Study|Protocol Violation|7|||
147215421|NCT01122264|530961602|FG002|Overall Study|Protocol Violation|9|||
147215422|NCT01122264|530961600|FG000|Overall Study|Withdrawal by Subject|6|||
147215423|NCT01122264|530961601|FG001|Overall Study|Withdrawal by Subject|6|||
147215424|NCT01122264|530961602|FG002|Overall Study|Withdrawal by Subject|16|||
147215425|NCT01122264|530961600|FG000|Overall Study|Physician Decision|3|||
147215426|NCT01122264|530961601|FG001|Overall Study|Physician Decision|1|||
147549473|NCT00571922|532167942|FG001|Overall Study|Completion unknown|36|||
147549474|NCT01783730|532167949|FG000|Overall Study|Failed to meet inclusion criteria|6|||
147549475|NCT02533999|532167950|FG000|Overall Study|Lost to Follow-up|3|||
147549476|NCT02533999|532167951|FG001|Overall Study|Lost to Follow-up|5|||
147549477|NCT02533999|532167950|FG000|Overall Study|Protocol Violation|3|||
147549478|NCT02533999|532167951|FG001|Overall Study|Protocol Violation|0|||
147549479|NCT02533999|532167950|FG000|Overall Study|Adverse Event|0|||
147549480|NCT02533999|532167951|FG001|Overall Study|Adverse Event|1|||
147549481|NCT02533999|532167950|FG000|Overall Study|Randomized but intervention not received|0|||
147549482|NCT02533999|532167951|FG001|Overall Study|Randomized but intervention not received|1|||
147549483|NCT03210259|532167952|FG000|12-Week Run-in Period|Adverse Event|1|||
147549484|NCT03210259|532167953|FG001|12-Week Run-in Period|Adverse Event|0|||
147549485|NCT03210259|532167954|FG002|12-Week Run-in Period|Adverse Event|0|||
147549486|NCT03210259|532167952|FG000|12-Week Run-in Period|Death|1|||
147549487|NCT03210259|532167953|FG001|12-Week Run-in Period|Death|0|||
147549488|NCT03210259|532167954|FG002|12-Week Run-in Period|Death|0|||
147549489|NCT03210259|532167952|FG000|12-Week Run-in Period|Withdrawal by Subject|9|||
147549490|NCT03210259|532167953|FG001|12-Week Run-in Period|Withdrawal by Subject|0|||
147549491|NCT03210259|532167954|FG002|12-Week Run-in Period|Withdrawal by Subject|0|||
147549492|NCT03210259|532167952|FG000|12-Week Run-in Period|Lost to Follow-up|4|||
147549493|NCT03210259|532167953|FG001|12-Week Run-in Period|Lost to Follow-up|0|||
147549494|NCT03210259|532167954|FG002|12-Week Run-in Period|Lost to Follow-up|0|||
147215427|NCT01122264|530961602|FG002|Overall Study|Physician Decision|1|||
147215428|NCT01122264|530961600|FG000|Overall Study|Lack of Efficacy|3|||
147549495|NCT03210259|532167952|FG000|12-Week Run-in Period|Lack of Efficacy|6|||
147549496|NCT03210259|532167953|FG001|12-Week Run-in Period|Lack of Efficacy|0|||
147549497|NCT03210259|532167954|FG002|12-Week Run-in Period|Lack of Efficacy|0|||
147549498|NCT03210259|532167952|FG000|48-Week Randomized Responder Period|Missed study visit|0|||
147549499|NCT03210259|532167953|FG001|48-Week Randomized Responder Period|Missed study visit|1|||
147549500|NCT03210259|532167954|FG002|48-Week Randomized Responder Period|Missed study visit|2|||
147549501|NCT03210259|532167952|FG000|48-Week Randomized Responder Period|Lost to Follow-up|0|||
147549502|NCT03210259|532167953|FG001|48-Week Randomized Responder Period|Lost to Follow-up|3|||
147549503|NCT03210259|532167954|FG002|48-Week Randomized Responder Period|Lost to Follow-up|8|||
147215429|NCT01122264|530961601|FG001|Overall Study|Lack of Efficacy|1|||
147215430|NCT01122264|530961602|FG002|Overall Study|Lack of Efficacy|1|||
147549504|NCT03210259|532167952|FG000|48-Week Randomized Responder Period|Pregnancy|0|||
147549505|NCT03210259|532167953|FG001|48-Week Randomized Responder Period|Pregnancy|1|||
147549506|NCT03210259|532167954|FG002|48-Week Randomized Responder Period|Pregnancy|0|||
147215431|NCT00097981|530961611|FG000|Overall Study|Adverse Event|31|||
147215432|NCT00097981|530961612|FG001|Overall Study|Adverse Event|44|||
147215433|NCT00097981|530961611|FG000|Overall Study|Withdrawal by Subject|10|||
147215434|NCT00097981|530961612|FG001|Overall Study|Withdrawal by Subject|8|||
147215435|NCT00097981|530961611|FG000|Overall Study|Protocol Violation|1|||
147215436|NCT00097981|530961612|FG001|Overall Study|Protocol Violation|1|||
147215437|NCT00097981|530961611|FG000|Overall Study|Death|2|||
147549507|NCT03210259|532167952|FG000|48-Week Randomized Responder Period|Physician Decision|0|||
147549508|NCT03210259|532167953|FG001|48-Week Randomized Responder Period|Physician Decision|0|||
147549509|NCT03210259|532167954|FG002|48-Week Randomized Responder Period|Physician Decision|1|||
147549510|NCT03210259|532167952|FG000|48-Week Randomized Responder Period|Withdrawal by Subject|0|||
147549511|NCT03210259|532167953|FG001|48-Week Randomized Responder Period|Withdrawal by Subject|5|||
147549512|NCT03210259|532167954|FG002|48-Week Randomized Responder Period|Withdrawal by Subject|17|||
147549513|NCT03210259|532167952|FG000|48-Week Randomized Responder Period|Adverse Event|0|||
147549514|NCT03210259|532167953|FG001|48-Week Randomized Responder Period|Adverse Event|1|||
147549515|NCT03210259|532167954|FG002|48-Week Randomized Responder Period|Adverse Event|1|||
147549516|NCT01154153|532167957|FG000|Overall Study|Poor compliance to protocol|2|||
147549517|NCT01154153|532167958|FG001|Overall Study|Poor compliance to protocol|0|||
147549518|NCT01154153|532167957|FG000|Overall Study|Unable to use labs|2|||
147549519|NCT01154153|532167958|FG001|Overall Study|Unable to use labs|3|||
147549520|NCT01154153|532167957|FG000|Overall Study|Withdrew consent|1|||
147549521|NCT01154153|532167958|FG001|Overall Study|Withdrew consent|0|||
147549522|NCT00964223|532167965|FG000|Full Face Treatment (Weeks 5 and 8)|Lost to Follow-up|1|||
147549523|NCT04304950|532167966|FG000|Overall Study|Lost to Follow-up|1|||
147549524|NCT04304950|532167967|FG001|Overall Study|Lost to Follow-up|1|||
147549525|NCT00408876|532167968|FG000|Overall Study|Adverse Event|9|||
147549526|NCT00408876|532167969|FG001|Overall Study|Adverse Event|17|||
147549527|NCT00408876|532167970|FG002|Overall Study|Adverse Event|27|||
147549528|NCT00408876|532167971|FG003|Overall Study|Adverse Event|10|||
147549529|NCT00408876|532167968|FG000|Overall Study|Withdrawal by Subject|3|||
147549530|NCT00408876|532167969|FG001|Overall Study|Withdrawal by Subject|6|||
147549531|NCT00408876|532167970|FG002|Overall Study|Withdrawal by Subject|6|||
147549532|NCT00408876|532167971|FG003|Overall Study|Withdrawal by Subject|14|||
147549533|NCT00408876|532167968|FG000|Overall Study|Lack of Efficacy|2|||
147549534|NCT00408876|532167969|FG001|Overall Study|Lack of Efficacy|4|||
147549535|NCT00408876|532167970|FG002|Overall Study|Lack of Efficacy|5|||
147549536|NCT00408876|532167971|FG003|Overall Study|Lack of Efficacy|6|||
147215438|NCT00097981|530961612|FG001|Overall Study|Death|4|||
147215439|NCT00097981|530961611|FG000|Overall Study|Physician Decision|7|||
147549537|NCT00408876|532167968|FG000|Overall Study|Lost to Follow-up|1|||
147549538|NCT00408876|532167969|FG001|Overall Study|Lost to Follow-up|6|||
147549539|NCT00408876|532167970|FG002|Overall Study|Lost to Follow-up|5|||
147549540|NCT00408876|532167971|FG003|Overall Study|Lost to Follow-up|2|||
147549541|NCT00408876|532167968|FG000|Overall Study|Protocol Violation|0|||
147549542|NCT00408876|532167969|FG001|Overall Study|Protocol Violation|3|||
147549543|NCT00408876|532167970|FG002|Overall Study|Protocol Violation|4|||
147549544|NCT00408876|532167971|FG003|Overall Study|Protocol Violation|3|||
147215440|NCT00097981|530961612|FG001|Overall Study|Physician Decision|1|||
147215441|NCT00097981|530961611|FG000|Overall Study|Disease Progression|8|||
147215442|NCT00097981|530961612|FG001|Overall Study|Disease Progression|2|||
147215443|NCT00097981|530961611|FG000|Overall Study|Transplant planned|28|||
147549545|NCT00408876|532167968|FG000|Overall Study|Physician Decision|1|||
147549546|NCT00408876|532167969|FG001|Overall Study|Physician Decision|0|||
147549547|NCT00408876|532167970|FG002|Overall Study|Physician Decision|3|||
147549548|NCT00408876|532167971|FG003|Overall Study|Physician Decision|0|||
147549549|NCT03404206|532167974|FG000|Overall Study|Withdrawal by Subject|1|||
147549550|NCT03404206|532167975|FG001|Overall Study|Withdrawal by Subject|1|||
147549551|NCT03404206|532167976|FG002|Overall Study|Withdrawal by Subject|0|||
147549552|NCT03404206|532167974|FG000|Overall Study|Lost to Follow-up|3|||
147549553|NCT03404206|532167975|FG001|Overall Study|Lost to Follow-up|1|||
147549554|NCT03404206|532167976|FG002|Overall Study|Lost to Follow-up|0|||
147549555|NCT05478603|532167977|FG000|Overall Study|Withdrawal by Subject|0|||
147549556|NCT05478603|532167978|FG001|Overall Study|Withdrawal by Subject|1|||
147549557|NCT05478603|532167979|FG002|Overall Study|Withdrawal by Subject|0|||
147549558|NCT05478603|532167980|FG003|Overall Study|Withdrawal by Subject|0|||
147549559|NCT03634488|532167981|FG000|Overall Study|Death|1|||
147215444|NCT00097981|530961612|FG001|Overall Study|Transplant planned|27|||
147215445|NCT00097981|530961611|FG000|Overall Study|Other|19|||
147549560|NCT03634488|532167982|FG001|Overall Study|Death|0|||
147549561|NCT03634488|532167983|FG002|Overall Study|Death|0|||
147549562|NCT03634488|532167981|FG000|Overall Study|A participant was administratively withdrawn due to a calculated BMI z-score >-3.0.|1|||
147215446|NCT00097981|530961612|FG001|Overall Study|Other|13|||
147215447|NCT00412373|530961613|FG000|Overall Study|Adverse Event|8|||
147215448|NCT00412373|530961614|FG001|Overall Study|Adverse Event|13|||
147215449|NCT00412373|530961613|FG000|Overall Study|Lack of Efficacy|16|||
147215450|NCT00412373|530961614|FG001|Overall Study|Lack of Efficacy|22|||
147215451|NCT00412373|530961613|FG000|Overall Study|Lost to Follow-up|7|||
147215452|NCT00412373|530961614|FG001|Overall Study|Lost to Follow-up|13|||
147549563|NCT03634488|532167982|FG001|Overall Study|A participant was administratively withdrawn due to a calculated BMI z-score >-3.0.|0|||
147549564|NCT03634488|532167983|FG002|Overall Study|A participant was administratively withdrawn due to a calculated BMI z-score >-3.0.|0|||
147549565|NCT00096486|532167987|FG000|Overall Study|Withdrawal by Subject|0|||
147549566|NCT00096486|532167988|FG001|Overall Study|Withdrawal by Subject|0|||
147549567|NCT00096486|532167989|FG002|Overall Study|Withdrawal by Subject|1|||
147215453|NCT00412373|530961613|FG000|Overall Study|Withdrawal by Subject|8|||
147215454|NCT00412373|530961614|FG001|Overall Study|Withdrawal by Subject|27|||
147215455|NCT00412373|530961613|FG000|Overall Study|Other|2|||
147215456|NCT00412373|530961614|FG001|Overall Study|Other|2|||
147549568|NCT00096486|532167990|FG003|Overall Study|Withdrawal by Subject|1|||
147549569|NCT00096486|532167987|FG000|Overall Study|Not Treated|0|||
147549570|NCT00096486|532167988|FG001|Overall Study|Not Treated|0|||
147549571|NCT00096486|532167989|FG002|Overall Study|Not Treated|1|||
147549572|NCT00096486|532167990|FG003|Overall Study|Not Treated|1|||
147549573|NCT01512979|532167991|FG000|Overall Study|Adverse Event|2|||
147549574|NCT01512979|532167992|FG001|Overall Study|Adverse Event|2|||
147549575|NCT01512979|532167991|FG000|Overall Study|Protocol Violation|1|||
147549576|NCT01512979|532167992|FG001|Overall Study|Protocol Violation|4|||
147549577|NCT01512979|532167991|FG000|Overall Study|Lost to Follow-up|2|||
147549578|NCT01512979|532167992|FG001|Overall Study|Lost to Follow-up|5|||
147549579|NCT01512979|532167991|FG000|Overall Study|Withdrawal by Subject|1|||
147549580|NCT01512979|532167992|FG001|Overall Study|Withdrawal by Subject|2|||
147549581|NCT01512979|532167991|FG000|Overall Study|Reason other than stated above|13|||
147215457|NCT01009840|530961615|FG000|Overall Study|Lost to Follow-up|1|||
147549582|NCT01512979|532167992|FG001|Overall Study|Reason other than stated above|9|||
147549583|NCT00529568|532167993|FG000|Open-label Pre-Antiviral Treatment Phase|Adverse Event|5|||
147549584|NCT00529568|532167994|FG001|Open-label Pre-Antiviral Treatment Phase|Adverse Event|0|||
147549585|NCT00529568|532167995|FG002|Open-label Pre-Antiviral Treatment Phase|Adverse Event|0|||
147549586|NCT00529568|532167993|FG000|Open-label Pre-Antiviral Treatment Phase|Lost to Follow-up|12|||
147549587|NCT00529568|532167994|FG001|Open-label Pre-Antiviral Treatment Phase|Lost to Follow-up|0|||
147549588|NCT00529568|532167995|FG002|Open-label Pre-Antiviral Treatment Phase|Lost to Follow-up|0|||
147549589|NCT00529568|532167993|FG000|Open-label Pre-Antiviral Treatment Phase|Protocol Violation|5|||
147549590|NCT00529568|532167994|FG001|Open-label Pre-Antiviral Treatment Phase|Protocol Violation|0|||
147549591|NCT00529568|532167995|FG002|Open-label Pre-Antiviral Treatment Phase|Protocol Violation|0|||
147549592|NCT00529568|532167993|FG000|Open-label Pre-Antiviral Treatment Phase|Physician Decision|8|||
147549593|NCT00529568|532167994|FG001|Open-label Pre-Antiviral Treatment Phase|Physician Decision|0|||
147549594|NCT00529568|532167995|FG002|Open-label Pre-Antiviral Treatment Phase|Physician Decision|0|||
147549595|NCT00529568|532167993|FG000|Open-label Pre-Antiviral Treatment Phase|Insufficient Platelet Response|13|||
147549596|NCT00529568|532167994|FG001|Open-label Pre-Antiviral Treatment Phase|Insufficient Platelet Response|0|||
147549597|NCT00529568|532167995|FG002|Open-label Pre-Antiviral Treatment Phase|Insufficient Platelet Response|0|||
147549598|NCT00529568|532167993|FG000|Open-label Pre-Antiviral Treatment Phase|Withdrawal by Subject|3|||
147549599|NCT00529568|532167994|FG001|Open-label Pre-Antiviral Treatment Phase|Withdrawal by Subject|0|||
147549600|NCT00529568|532167995|FG002|Open-label Pre-Antiviral Treatment Phase|Withdrawal by Subject|0|||
147549601|NCT00529568|532167993|FG000|Double-bilnd Antiviral Treatment Phase|Adverse Event|0|||
147549602|NCT00529568|532167994|FG001|Double-bilnd Antiviral Treatment Phase|Adverse Event|10|||
147549603|NCT00529568|532167995|FG002|Double-bilnd Antiviral Treatment Phase|Adverse Event|27|||
147549604|NCT00529568|532167993|FG000|Double-bilnd Antiviral Treatment Phase|Protocol Violation|0|||
147549605|NCT00529568|532167994|FG001|Double-bilnd Antiviral Treatment Phase|Protocol Violation|1|||
147549606|NCT00529568|532167995|FG002|Double-bilnd Antiviral Treatment Phase|Protocol Violation|0|||
147549607|NCT00529568|532167993|FG000|Double-bilnd Antiviral Treatment Phase|Lost to Follow-up|0|||
147549608|NCT00529568|532167994|FG001|Double-bilnd Antiviral Treatment Phase|Lost to Follow-up|15|||
147549609|NCT00529568|532167995|FG002|Double-bilnd Antiviral Treatment Phase|Lost to Follow-up|48|||
147549610|NCT00529568|532167993|FG000|Double-bilnd Antiviral Treatment Phase|Physician Decision|0|||
147549611|NCT00529568|532167994|FG001|Double-bilnd Antiviral Treatment Phase|Physician Decision|5|||
147549612|NCT00529568|532167995|FG002|Double-bilnd Antiviral Treatment Phase|Physician Decision|8|||
147549613|NCT00529568|532167993|FG000|Double-bilnd Antiviral Treatment Phase|Withdrawal by Subject|0|||
147549614|NCT00529568|532167994|FG001|Double-bilnd Antiviral Treatment Phase|Withdrawal by Subject|17|||
147549615|NCT00529568|532167995|FG002|Double-bilnd Antiviral Treatment Phase|Withdrawal by Subject|19|||
147549616|NCT04049552|532167996|FG000|Overall Study|Lost to Follow-up|1|||
147549617|NCT01201356|532167997|FG000|Overall Study|Adverse Event|170|||
147549618|NCT01201356|532167997|FG000|Overall Study|Abnormal laboratory value(s)|51|||
147549619|NCT01201356|532167997|FG000|Overall Study|Abnormal test procedure result(s)|3|||
147549620|NCT01201356|532167997|FG000|Overall Study|Unsatisfactory therapeutic effect|112|||
147549621|NCT01201356|532167997|FG000|Overall Study|Condition no longer requires study drug|12|||
147549622|NCT01201356|532167997|FG000|Overall Study|Withdrawal by Subject|144|||
147549623|NCT01201356|532167997|FG000|Overall Study|Lost to Follow-up|50|||
147549624|NCT01201356|532167997|FG000|Overall Study|administrative problems|74|||
147215458|NCT01009840|530961615|FG000|Overall Study|Adverse Event|4|||
147215459|NCT01009840|530961615|FG000|Overall Study|Subject Met Withdrawal Criteria|7|||
147549625|NCT01201356|532167997|FG000|Overall Study|Death|16|||
147549626|NCT01201356|532167997|FG000|Overall Study|Protocol Violation|12|||
147549627|NCT00738920|532168000|FG000|Baseline to 2-Week Follow-Up|Lost to Follow-up|8|||
147549628|NCT00738920|532168001|FG001|Baseline to 2-Week Follow-Up|Lost to Follow-up|9|||
147549629|NCT00738920|532168002|FG002|Baseline to 2-Week Follow-Up|Lost to Follow-up|8|||
147549630|NCT00738920|532168000|FG000|Baseline to 2-Week Follow-Up|Withdrawal by Subject|8|||
147549631|NCT00738920|532168001|FG001|Baseline to 2-Week Follow-Up|Withdrawal by Subject|14|||
147549632|NCT00738920|532168002|FG002|Baseline to 2-Week Follow-Up|Withdrawal by Subject|7|||
147549633|NCT00738920|532168000|FG000|2-Week Follow-Up to 3-Month Follow-Up|Withdrawal by Subject|3|||
147549634|NCT00738920|532168001|FG001|2-Week Follow-Up to 3-Month Follow-Up|Withdrawal by Subject|5|||
147549635|NCT00738920|532168002|FG002|2-Week Follow-Up to 3-Month Follow-Up|Withdrawal by Subject|6|||
147549636|NCT00738920|532168000|FG000|2-Week Follow-Up to 3-Month Follow-Up|Lost to Follow-up|5|||
147549637|NCT00738920|532168001|FG001|2-Week Follow-Up to 3-Month Follow-Up|Lost to Follow-up|7|||
147549638|NCT00738920|532168002|FG002|2-Week Follow-Up to 3-Month Follow-Up|Lost to Follow-up|6|||
147549639|NCT00738920|532168000|FG000|3-Month Follow-Up to 6-Month Follow-Up|Lost to Follow-up|3|||
147549640|NCT00738920|532168001|FG001|3-Month Follow-Up to 6-Month Follow-Up|Lost to Follow-up|0|||
147549641|NCT00738920|532168002|FG002|3-Month Follow-Up to 6-Month Follow-Up|Lost to Follow-up|2|||
147549642|NCT00738920|532168000|FG000|3-Month Follow-Up to 6-Month Follow-Up|Withdrawal by Subject|1|||
147549643|NCT00738920|532168001|FG001|3-Month Follow-Up to 6-Month Follow-Up|Withdrawal by Subject|0|||
147549644|NCT00738920|532168002|FG002|3-Month Follow-Up to 6-Month Follow-Up|Withdrawal by Subject|1|||
147549645|NCT00738920|532168000|FG000|6-Month Follow-Up to 9-Month Follow-Up|Lost to Follow-up|2|||
147549646|NCT00738920|532168001|FG001|6-Month Follow-Up to 9-Month Follow-Up|Lost to Follow-up|4|||
147549647|NCT00738920|532168002|FG002|6-Month Follow-Up to 9-Month Follow-Up|Lost to Follow-up|7|||
147549648|NCT00738920|532168000|FG000|6-Month Follow-Up to 9-Month Follow-Up|Withdrawal by Subject|2|||
147549649|NCT00738920|532168001|FG001|6-Month Follow-Up to 9-Month Follow-Up|Withdrawal by Subject|3|||
147549650|NCT00738920|532168002|FG002|6-Month Follow-Up to 9-Month Follow-Up|Withdrawal by Subject|5|||
147549651|NCT00738920|532168000|FG000|9-Month Follow-Up to 12-Month Follow-Up|Lost to Follow-up|1|||
147549652|NCT00738920|532168001|FG001|9-Month Follow-Up to 12-Month Follow-Up|Lost to Follow-up|0|||
147549653|NCT00738920|532168002|FG002|9-Month Follow-Up to 12-Month Follow-Up|Lost to Follow-up|1|||
147549654|NCT00738920|532168000|FG000|9-Month Follow-Up to 12-Month Follow-Up|Withdrawal by Subject|0|||
147549655|NCT00738920|532168001|FG001|9-Month Follow-Up to 12-Month Follow-Up|Withdrawal by Subject|1|||
147549656|NCT00738920|532168002|FG002|9-Month Follow-Up to 12-Month Follow-Up|Withdrawal by Subject|0|||
147549657|NCT00530439|532168003|FG000|Overall Study|GDM|9|||
147549658|NCT00530439|532168004|FG001|Overall Study|GDM|3|||
147549659|NCT00530439|532168003|FG000|Overall Study|Withdraw|18|||
147549660|NCT00530439|532168004|FG001|Overall Study|Withdraw|14|||
147549661|NCT00530439|532168003|FG000|Overall Study|Missed abortion|1|||
147549662|NCT00530439|532168004|FG001|Overall Study|Missed abortion|4|||
147549663|NCT00530439|532168003|FG000|Overall Study|Misclassification|2|||
147549664|NCT00530439|532168004|FG001|Overall Study|Misclassification|0|||
147549665|NCT00530439|532168003|FG000|Overall Study|Twin pregnancy|0|||
147549666|NCT00530439|532168004|FG001|Overall Study|Twin pregnancy|2|||
147549667|NCT00530439|532168003|FG000|Overall Study|Severe malformation/abortion|0|||
147549668|NCT00530439|532168004|FG001|Overall Study|Severe malformation/abortion|3|||
147549669|NCT00420290|532168005|FG000|Overall Study|Adverse Event|3|||
147549670|NCT00420290|532168006|FG001|Overall Study|Adverse Event|1|||
147549671|NCT00420290|532168005|FG000|Overall Study|Withdrawal by Subject|0|||
147549672|NCT00420290|532168006|FG001|Overall Study|Withdrawal by Subject|2|||
147549673|NCT00420290|532168005|FG000|Overall Study|did not meet inclusion/exclusion|1|||
147549674|NCT00420290|532168006|FG001|Overall Study|did not meet inclusion/exclusion|1|||
147549675|NCT02257632|532170251|FG000|Overall Study|Withdrawal by Subject|0|||
147549676|NCT02257632|532170252|FG001|Overall Study|Withdrawal by Subject|1|||
147549677|NCT02257632|532170251|FG000|Overall Study|Adverse Event|1|||
147549678|NCT02257632|532170252|FG001|Overall Study|Adverse Event|2|||
147549679|NCT02468557|532170253|FG000|Overall Study|Adverse Event|1|||
147549680|NCT02468557|532170253|FG000|Overall Study|Death|1|||
147549681|NCT02468557|532170253|FG000|Overall Study|Study Terminated by Sponsor, Regulatory Agency or Institutional Review Board/ Ethics Committee|10|||
147549682|NCT02468557|532170253|FG000|Overall Study|All Enrolled but Never Dosed|4|||
147549683|NCT03322462|532170257|FG000|Overall Study|Technical difficulties|2|||
147549684|NCT03322462|532170257|FG000|Overall Study|Other|1|||
147549685|NCT01393990|532170258|FG000|Overall Study|Adverse Event|0|||
147549686|NCT01393990|532170259|FG001|Overall Study|Adverse Event|0|||
147549687|NCT01393990|532170260|FG002|Overall Study|Adverse Event|0|||
147549688|NCT01393990|532170261|FG003|Overall Study|Adverse Event|0|||
147549689|NCT01393990|532170262|FG004|Overall Study|Adverse Event|0|||
147549690|NCT01393990|532170263|FG005|Overall Study|Adverse Event|0|||
147549691|NCT01393990|532170264|FG006|Overall Study|Adverse Event|0|||
147549692|NCT01393990|532170265|FG007|Overall Study|Adverse Event|0|||
147549693|NCT01393990|532170266|FG008|Overall Study|Adverse Event|0|||
147549694|NCT01393990|532170267|FG009|Overall Study|Adverse Event|0|||
147549695|NCT01393990|532170268|FG010|Overall Study|Adverse Event|0|||
147549696|NCT01393990|532170269|FG011|Overall Study|Adverse Event|0|||
147549697|NCT01393990|532170270|FG012|Overall Study|Adverse Event|0|||
147549698|NCT01393990|532170271|FG013|Overall Study|Adverse Event|0|||
147549699|NCT01393990|532170272|FG014|Overall Study|Adverse Event|1|||
147549700|NCT01393990|532170273|FG015|Overall Study|Adverse Event|1|||
147549701|NCT01393990|532170274|FG016|Overall Study|Adverse Event|0|||
147549702|NCT01393990|532170275|FG017|Overall Study|Adverse Event|0|||
147549703|NCT01393990|532170258|FG000|Overall Study|Progressive Disease|1|||
147549704|NCT01393990|532170259|FG001|Overall Study|Progressive Disease|0|||
147549705|NCT01393990|532170260|FG002|Overall Study|Progressive Disease|0|||
147549706|NCT01393990|532170261|FG003|Overall Study|Progressive Disease|1|||
147549707|NCT01393990|532170262|FG004|Overall Study|Progressive Disease|1|||
147549708|NCT01393990|532170263|FG005|Overall Study|Progressive Disease|1|||
147549709|NCT01393990|532170264|FG006|Overall Study|Progressive Disease|1|||
147549710|NCT01393990|532170265|FG007|Overall Study|Progressive Disease|1|||
147549711|NCT01393990|532170266|FG008|Overall Study|Progressive Disease|3|||
147549712|NCT01393990|532170267|FG009|Overall Study|Progressive Disease|1|||
147549713|NCT01393990|532170268|FG010|Overall Study|Progressive Disease|0|||
147549714|NCT01393990|532170269|FG011|Overall Study|Progressive Disease|0|||
147549715|NCT01393990|532170270|FG012|Overall Study|Progressive Disease|0|||
147549716|NCT01393990|532170271|FG013|Overall Study|Progressive Disease|1|||
147549717|NCT01393990|532170272|FG014|Overall Study|Progressive Disease|6|||
147549718|NCT01393990|532170273|FG015|Overall Study|Progressive Disease|1|||
147549719|NCT01393990|532170274|FG016|Overall Study|Progressive Disease|0|||
147549720|NCT01393990|532170275|FG017|Overall Study|Progressive Disease|0|||
147549721|NCT01393990|532170258|FG000|Overall Study|Death|0|||
147549722|NCT01393990|532170259|FG001|Overall Study|Death|0|||
147549723|NCT01393990|532170260|FG002|Overall Study|Death|0|||
147549724|NCT01393990|532170261|FG003|Overall Study|Death|0|||
147215460|NCT01009840|530961615|FG000|Overall Study|Subject was Withdrawn by Investigator|1|||
147215461|NCT01009840|530961615|FG000|Overall Study|Subject Withdrew Consent to Participate|1|||
147215462|NCT01002820|530961623|FG000|Overall Study|Adverse Event|1|||
147215463|NCT01002820|530961623|FG000|Overall Study|Withdrawal by Subject|2|||
147549725|NCT01393990|532170262|FG004|Overall Study|Death|1|||
147215464|NCT01002820|530961623|FG000|Overall Study|Lack of Efficacy|1|||
147215465|NCT01673347|530961624|FG000|Overall Study|failure of allograft|7|||
147215466|NCT00895011|530961630|FG000|Overall Study|Withdrawal by Subject|14|||
147549726|NCT01393990|532170263|FG005|Overall Study|Death|0|||
147549727|NCT01393990|532170264|FG006|Overall Study|Death|0|||
147549728|NCT01393990|532170265|FG007|Overall Study|Death|0|||
147549729|NCT01393990|532170266|FG008|Overall Study|Death|0|||
147549730|NCT01393990|532170267|FG009|Overall Study|Death|0|||
147549731|NCT01393990|532170268|FG010|Overall Study|Death|0|||
147549732|NCT01393990|532170269|FG011|Overall Study|Death|0|||
147549733|NCT01393990|532170270|FG012|Overall Study|Death|0|||
147215467|NCT00895011|530961631|FG001|Overall Study|Withdrawal by Subject|7|||
147215468|NCT00895011|530961632|FG002|Overall Study|Withdrawal by Subject|2|||
147215469|NCT00895011|530961630|FG000|Overall Study|Lost to Follow-up|5|||
147215470|NCT00895011|530961631|FG001|Overall Study|Lost to Follow-up|4|||
147215471|NCT00895011|530961632|FG002|Overall Study|Lost to Follow-up|1|||
147549734|NCT01393990|532170271|FG013|Overall Study|Death|1|||
147549735|NCT01393990|532170272|FG014|Overall Study|Death|1|||
147549736|NCT01393990|532170273|FG015|Overall Study|Death|0|||
147549737|NCT01393990|532170274|FG016|Overall Study|Death|0|||
147549738|NCT01393990|532170275|FG017|Overall Study|Death|0|||
147549739|NCT01393990|532170258|FG000|Overall Study|Withdrawal by Subject|0|||
147549740|NCT01393990|532170259|FG001|Overall Study|Withdrawal by Subject|0|||
147549741|NCT01393990|532170260|FG002|Overall Study|Withdrawal by Subject|0|||
147549742|NCT01393990|532170261|FG003|Overall Study|Withdrawal by Subject|0|||
147549743|NCT01393990|532170262|FG004|Overall Study|Withdrawal by Subject|0|||
147549744|NCT01393990|532170263|FG005|Overall Study|Withdrawal by Subject|0|||
147549745|NCT01393990|532170264|FG006|Overall Study|Withdrawal by Subject|0|||
147549746|NCT01393990|532170265|FG007|Overall Study|Withdrawal by Subject|0|||
147549747|NCT01393990|532170266|FG008|Overall Study|Withdrawal by Subject|0|||
147549748|NCT01393990|532170267|FG009|Overall Study|Withdrawal by Subject|0|||
147549749|NCT01393990|532170268|FG010|Overall Study|Withdrawal by Subject|0|||
147549750|NCT01393990|532170269|FG011|Overall Study|Withdrawal by Subject|0|||
147549751|NCT01393990|532170270|FG012|Overall Study|Withdrawal by Subject|0|||
147549752|NCT01393990|532170271|FG013|Overall Study|Withdrawal by Subject|0|||
147549753|NCT01393990|532170272|FG014|Overall Study|Withdrawal by Subject|1|||
147549754|NCT01393990|532170273|FG015|Overall Study|Withdrawal by Subject|1|||
147549755|NCT01393990|532170274|FG016|Overall Study|Withdrawal by Subject|0|||
147549756|NCT01393990|532170275|FG017|Overall Study|Withdrawal by Subject|0|||
147549757|NCT00720798|532170282|FG000|Overall Study|Adverse Event|304|||
147549758|NCT00720798|532170282|FG000|Overall Study|Death|39|||
147549759|NCT00720798|532170282|FG000|Overall Study|Insufficient Therapeutic Response|129|||
147549760|NCT00720798|532170282|FG000|Overall Study|Protocol Violation|4|||
147549761|NCT00720798|532170282|FG000|Overall Study|Refused Treatment|151|||
147549762|NCT00720798|532170282|FG000|Overall Study|Failure to Return|46|||
147549763|NCT00720798|532170282|FG000|Overall Study|Reason not Specified|83|||
147549764|NCT00433381|532170283|FG000|Overall Study|Ineligible / no protocol treatment|3|||
147549765|NCT00433381|532170284|FG001|Overall Study|Ineligible / no protocol treatment|3|||
147549766|NCT00434161|532170285|FG000|Overall Study|Adverse Event|5|||
147549767|NCT00434161|532170286|FG001|Overall Study|Adverse Event|1|||
147549768|NCT00434161|532170287|FG002|Overall Study|Adverse Event|4|||
147549769|NCT00434161|532170285|FG000|Overall Study|Lost to Follow-up|0|||
147549770|NCT00434161|532170286|FG001|Overall Study|Lost to Follow-up|1|||
147549771|NCT00434161|532170287|FG002|Overall Study|Lost to Follow-up|0|||
147549772|NCT00434161|532170285|FG000|Overall Study|Death|1|||
147549773|NCT00434161|532170286|FG001|Overall Study|Death|0|||
147549774|NCT00434161|532170287|FG002|Overall Study|Death|1|||
147549775|NCT00434161|532170285|FG000|Overall Study|Non-Compliance|1|||
147549776|NCT00434161|532170286|FG001|Overall Study|Non-Compliance|1|||
147549777|NCT00434161|532170287|FG002|Overall Study|Non-Compliance|0|||
147549778|NCT00434161|532170285|FG000|Overall Study|Withdrawal by Subject|2|||
147549779|NCT00434161|532170286|FG001|Overall Study|Withdrawal by Subject|0|||
147549780|NCT00434161|532170287|FG002|Overall Study|Withdrawal by Subject|3|||
147549781|NCT00434161|532170285|FG000|Overall Study|Logistical error study assessments|1|||
147549782|NCT00434161|532170286|FG001|Overall Study|Logistical error study assessments|0|||
147549783|NCT00434161|532170287|FG002|Overall Study|Logistical error study assessments|3|||
147549784|NCT00549198|532170291|FG000|Overall Study|Adverse Event|28|||
147549785|NCT00549198|532170292|FG001|Overall Study|Adverse Event|26|||
147549786|NCT00549198|532170291|FG000|Overall Study|Insufficient Viral Load Response|4|||
147549787|NCT00549198|532170292|FG001|Overall Study|Insufficient Viral Load Response|2|||
147549788|NCT00549198|532170291|FG000|Overall Study|Protocol-defined Virological Failure|7|||
147549789|NCT00549198|532170292|FG001|Overall Study|Protocol-defined Virological Failure|0|||
147549790|NCT00549198|532170291|FG000|Overall Study|Non-compliance|2|||
147549791|NCT00549198|532170292|FG001|Overall Study|Non-compliance|4|||
147549792|NCT00549198|532170291|FG000|Overall Study|Lost to Follow-up|7|||
147549793|NCT00549198|532170292|FG001|Overall Study|Lost to Follow-up|8|||
147549794|NCT00549198|532170291|FG000|Overall Study|Treatment Eligibility Criteria Not Met|3|||
147549795|NCT00549198|532170292|FG001|Overall Study|Treatment Eligibility Criteria Not Met|0|||
147549796|NCT00549198|532170291|FG000|Overall Study|Protocol Violation|7|||
147215472|NCT00895011|530961630|FG000|Overall Study|Protocol Violation|3|||
147549797|NCT00549198|532170292|FG001|Overall Study|Protocol Violation|2|||
147549798|NCT00549198|532170291|FG000|Overall Study|Investigator Decision|4|||
147549799|NCT00549198|532170292|FG001|Overall Study|Investigator Decision|3|||
147549800|NCT00549198|532170291|FG000|Overall Study|Withdrawal by Subject|7|||
147215473|NCT00895011|530961631|FG001|Overall Study|Protocol Violation|1|||
147549801|NCT00549198|532170292|FG001|Overall Study|Withdrawal by Subject|7|||
147549802|NCT00549198|532170291|FG000|Overall Study|Disease Progression|1|||
147549803|NCT00549198|532170292|FG001|Overall Study|Disease Progression|0|||
147549804|NCT00549198|532170291|FG000|Overall Study|Participant Moved|2|||
147549805|NCT00549198|532170292|FG001|Overall Study|Participant Moved|0|||
147549806|NCT00549198|532170291|FG000|Overall Study|Participant not able to perform Week 96|1|||
147549807|NCT00549198|532170292|FG001|Overall Study|Participant not able to perform Week 96|0|||
147549808|NCT00549198|532170291|FG000|Overall Study|Participant moved.Week 96 visit, no scan|1|||
147549809|NCT00549198|532170292|FG001|Overall Study|Participant moved.Week 96 visit, no scan|0|||
147549810|NCT00549198|532170291|FG000|Overall Study|Prohibited Medication|1|||
147549811|NCT00549198|532170292|FG001|Overall Study|Prohibited Medication|2|||
147549812|NCT00549198|532170291|FG000|Overall Study|Participant planning pregnancy|1|||
147549813|NCT00549198|532170292|FG001|Overall Study|Participant planning pregnancy|0|||
147549814|NCT00549198|532170291|FG000|Overall Study|Participant overweight, no scan possible|1|||
147549815|NCT00549198|532170292|FG001|Overall Study|Participant overweight, no scan possible|0|||
147549816|NCT00549198|532170291|FG000|Overall Study|No scan facilities|0|||
147549817|NCT00549198|532170292|FG001|Overall Study|No scan facilities|2|||
147549818|NCT00549198|532170291|FG000|Overall Study|Pregnancy|0|||
147549819|NCT00549198|532170292|FG001|Overall Study|Pregnancy|3|||
147549820|NCT00549198|532170291|FG000|Overall Study|Not Exposed to Study Drug|3|||
147549821|NCT00549198|532170292|FG001|Overall Study|Not Exposed to Study Drug|4|||
147549822|NCT01473758|532170293|FG000|Cycle 1|Adverse Event|10|||
147549823|NCT01473758|532170294|FG001|Cycle 1|Adverse Event|2|||
147549824|NCT01473758|532170295|FG002|Cycle 1|Adverse Event|0|||
147549825|NCT01473758|532170296|FG003|Cycle 1|Adverse Event|0|||
147549826|NCT01473758|532170293|FG000|Cycle 1|Withdrawal by Subject|1|||
147549827|NCT01473758|532170294|FG001|Cycle 1|Withdrawal by Subject|1|||
147549828|NCT01473758|532170295|FG002|Cycle 1|Withdrawal by Subject|0|||
147549829|NCT01473758|532170296|FG003|Cycle 1|Withdrawal by Subject|0|||
147549830|NCT01473758|532170293|FG000|Cycle 2|Adverse Event|0|||
147549831|NCT01473758|532170294|FG001|Cycle 2|Adverse Event|0|||
147549832|NCT01473758|532170295|FG002|Cycle 2|Adverse Event|5|||
147549833|NCT01473758|532170296|FG003|Cycle 2|Adverse Event|0|||
147549834|NCT02480010|532170297|FG000|Overall Study|Adverse Event|3|||
147549835|NCT02480010|532170298|FG001|Overall Study|Adverse Event|1|||
147549836|NCT02480010|532170297|FG000|Overall Study|Death|1|||
147549837|NCT02480010|532170298|FG001|Overall Study|Death|0|||
147549838|NCT02480010|532170297|FG000|Overall Study|Insufficient therapeutic response|31|||
147549839|NCT02480010|532170298|FG001|Overall Study|Insufficient therapeutic response|29|||
147549840|NCT02480010|532170297|FG000|Overall Study|Refused Treatment|0|||
147549841|NCT02480010|532170298|FG001|Overall Study|Refused Treatment|3|||
147549842|NCT01764854|532170308|FG000|Overall Study|Adverse Event|0|||
147549843|NCT01764854|532170309|FG001|Overall Study|Adverse Event|0|||
147549844|NCT01764854|532170310|FG002|Overall Study|Adverse Event|2|||
147549845|NCT01764854|532170311|FG003|Overall Study|Adverse Event|0|||
147549846|NCT01764854|532170308|FG000|Overall Study|Withdrawal by Subject|0|||
147549847|NCT01764854|532170309|FG001|Overall Study|Withdrawal by Subject|0|||
147549848|NCT01764854|532170310|FG002|Overall Study|Withdrawal by Subject|1|||
147549849|NCT01764854|532170311|FG003|Overall Study|Withdrawal by Subject|0|||
147549850|NCT01764854|532170308|FG000|Overall Study|relocation|0|||
147549851|NCT01764854|532170309|FG001|Overall Study|relocation|0|||
147549852|NCT01764854|532170310|FG002|Overall Study|relocation|2|||
147549853|NCT01764854|532170311|FG003|Overall Study|relocation|0|||
147549854|NCT01764854|532170308|FG000|Overall Study|Protocol Violation|0|||
147549855|NCT01764854|532170309|FG001|Overall Study|Protocol Violation|0|||
147549856|NCT01764854|532170310|FG002|Overall Study|Protocol Violation|1|||
147549857|NCT01764854|532170311|FG003|Overall Study|Protocol Violation|2|||
147549858|NCT00910858|532170320|FG000|Pharmacokinetic Phase|Adverse Event|1|||
147549859|NCT00910858|532170321|FG001|Pharmacokinetic Phase|Adverse Event|0|||
147549860|NCT00910858|532170322|FG002|Pharmacokinetic Phase|Adverse Event|0|||
147549861|NCT00910858|532170320|FG000|Monotherapy Phase|Adverse Event|3|||
147549862|NCT00910858|532170321|FG001|Monotherapy Phase|Adverse Event|2|||
147549863|NCT00910858|532170322|FG002|Monotherapy Phase|Adverse Event|0|||
147549864|NCT00910858|532170320|FG000|Monotherapy Phase|Lack of therapeutic effect|9|||
147549865|NCT00910858|532170321|FG001|Monotherapy Phase|Lack of therapeutic effect|6|||
147549866|NCT00910858|532170322|FG002|Monotherapy Phase|Lack of therapeutic effect|4|||
147549867|NCT00910858|532170320|FG000|Monotherapy Phase|Withdrawal by Subject|1|||
147549868|NCT00910858|532170321|FG001|Monotherapy Phase|Withdrawal by Subject|3|||
147549869|NCT00910858|532170322|FG002|Monotherapy Phase|Withdrawal by Subject|1|||
147549870|NCT00910858|532170320|FG000|Monotherapy Phase|Protocol Violation|1|||
147549871|NCT00910858|532170321|FG001|Monotherapy Phase|Protocol Violation|0|||
147549872|NCT00910858|532170322|FG002|Monotherapy Phase|Protocol Violation|0|||
147549873|NCT00910858|532170320|FG000|Monotherapy Phase|Other|3|||
147549874|NCT00910858|532170321|FG001|Monotherapy Phase|Other|4|||
147549875|NCT00910858|532170322|FG002|Monotherapy Phase|Other|2|||
147549876|NCT00910858|532170320|FG000|Combined Treatment Phase|Lack of therapeutic effect|8|||
147549877|NCT00910858|532170321|FG001|Combined Treatment Phase|Lack of therapeutic effect|6|||
147549878|NCT00910858|532170322|FG002|Combined Treatment Phase|Lack of therapeutic effect|3|||
147549879|NCT00910858|532170320|FG000|Combined Treatment Phase|Withdrawal by Subject|0|||
147549880|NCT00910858|532170321|FG001|Combined Treatment Phase|Withdrawal by Subject|2|||
147549881|NCT00910858|532170322|FG002|Combined Treatment Phase|Withdrawal by Subject|0|||
147549882|NCT00910858|532170320|FG000|Combined Treatment Phase|Protocol Violation|1|||
147549883|NCT00910858|532170321|FG001|Combined Treatment Phase|Protocol Violation|0|||
147549884|NCT00910858|532170322|FG002|Combined Treatment Phase|Protocol Violation|0|||
147549885|NCT00910858|532170320|FG000|Combined Treatment Phase|Other|0|||
147549886|NCT00910858|532170321|FG001|Combined Treatment Phase|Other|2|||
147549887|NCT00910858|532170322|FG002|Combined Treatment Phase|Other|1|||
147549888|NCT00827827|532170323|FG000|Overall Study|Lost to Follow-up|3|||
147549889|NCT00827827|532170324|FG001|Overall Study|Lost to Follow-up|0|||
147549890|NCT00827827|532170323|FG000|Overall Study|Fall at home- hospitalization|1|||
147549891|NCT00827827|532170324|FG001|Overall Study|Fall at home- hospitalization|0|||
147549892|NCT00827827|532170323|FG000|Overall Study|Another cerebrovascular accident (CVA)|1|||
147549893|NCT00827827|532170324|FG001|Overall Study|Another cerebrovascular accident (CVA)|0|||
147549894|NCT00827827|532170323|FG000|Overall Study|Gout|1|||
147549895|NCT00827827|532170324|FG001|Overall Study|Gout|0|||
147549896|NCT00827827|532170323|FG000|Overall Study|Transportation issues|1|||
147549897|NCT00827827|532170324|FG001|Overall Study|Transportation issues|0|||
147549898|NCT00827827|532170323|FG000|Overall Study|Burned with water at home|1|||
147549899|NCT00827827|532170324|FG001|Overall Study|Burned with water at home|0|||
147549900|NCT00447603|532170326|FG000|Screening|Withdrawal by Subject|1|||
147549901|NCT00447603|532170327|FG001|Screening|Withdrawal by Subject|0|||
147549902|NCT00447603|532170328|FG002|Screening|Withdrawal by Subject|0|||
147549903|NCT00447603|532170326|FG000|Screening|Protocol Violation|1|||
147549904|NCT00447603|532170327|FG001|Screening|Protocol Violation|0|||
147549905|NCT00447603|532170328|FG002|Screening|Protocol Violation|0|||
147549906|NCT00447603|532170326|FG000|Screening|Screen Failure|4|||
147549907|NCT00447603|532170327|FG001|Screening|Screen Failure|0|||
147549908|NCT00447603|532170328|FG002|Screening|Screen Failure|0|||
147549909|NCT00447603|532170326|FG000|Screening|Study Terminated by Sponsor|15|||
147549910|NCT00447603|532170327|FG001|Screening|Study Terminated by Sponsor|0|||
147549911|NCT00447603|532170328|FG002|Screening|Study Terminated by Sponsor|0|||
147549912|NCT00447603|532170326|FG000|Filter Period|Adverse Event|0|||
147549913|NCT00447603|532170327|FG001|Filter Period|Adverse Event|0|||
147549914|NCT00447603|532170328|FG002|Filter Period|Adverse Event|1|||
147549915|NCT00447603|532170326|FG000|Filter Period|Screen Failure|0|||
147549916|NCT00447603|532170327|FG001|Filter Period|Screen Failure|3|||
147549917|NCT00447603|532170328|FG002|Filter Period|Screen Failure|4|||
147549918|NCT00447603|532170326|FG000|Filter Period|Study terminated by Sponsor|0|||
147549919|NCT00447603|532170327|FG001|Filter Period|Study terminated by Sponsor|1|||
147549920|NCT00447603|532170328|FG002|Filter Period|Study terminated by Sponsor|10|||
147549921|NCT01165684|532170335|FG000|Overall Study|Adverse Event|1|||
147549922|NCT01165684|532170336|FG001|Overall Study|Adverse Event|1|||
147549923|NCT01165684|532170335|FG000|Overall Study|Lack of Efficacy|2|||
147549924|NCT01165684|532170336|FG001|Overall Study|Lack of Efficacy|1|||
147549925|NCT01165684|532170335|FG000|Overall Study|Protocol Violation|7|||
147549926|NCT01165684|532170336|FG001|Overall Study|Protocol Violation|15|||
147549927|NCT01165684|532170335|FG000|Overall Study|Withdrawal Criteria|2|||
147549928|NCT01165684|532170336|FG001|Overall Study|Withdrawal Criteria|13|||
147549929|NCT01165684|532170335|FG000|Overall Study|Unclassified|16|||
147442444|NCT02114268|531784329|FG003|Overall Study|Withdrawn by site due to noncompliance|0|||
147442445|NCT02114268|531784330|FG004|Overall Study|Withdrawn by site due to noncompliance|0|||
147442446|NCT02114268|531784331|FG005|Overall Study|Withdrawn by site due to noncompliance|0|||
147442447|NCT01075412|531784338|FG000|Overall Study|Withdrawal by Subject|0|||
147442448|NCT01075412|531784339|FG001|Overall Study|Withdrawal by Subject|1|||
147442449|NCT00865904|531784341|FG000|Overall Study|Randomized but not Treated|2|||
147442450|NCT00865904|531784342|FG001|Overall Study|Randomized but not Treated|0|||
147442451|NCT00865904|531784343|FG002|Overall Study|Randomized but not Treated|0|||
147442452|NCT00865904|531784344|FG003|Overall Study|Randomized but not Treated|1|||
147442453|NCT00865904|531784345|FG004|Overall Study|Randomized but not Treated|1|||
147442454|NCT02228720|531784346|FG000|Open Label - Day 30|Lost to Follow-up|1|||
147442455|NCT00282295|531784347|FG000|Overall Study|Adverse Event|0|||
147442456|NCT00282295|531784348|FG001|Overall Study|Adverse Event|1|||
147442457|NCT00282295|531784349|FG002|Overall Study|Adverse Event|0|||
147442458|NCT00282295|531784347|FG000|Overall Study|Serious Adverse Events|0|||
147442459|NCT00282295|531784348|FG001|Overall Study|Serious Adverse Events|0|||
147549930|NCT01165684|532170336|FG001|Overall Study|Unclassified|22|||
147549931|NCT00901628|532170353|FG000|Overall Study|disconnection of catheter|4|||
147549932|NCT00901628|532170354|FG001|Overall Study|disconnection of catheter|8|||
147549933|NCT00901628|532170353|FG000|Overall Study|disconnection of drain|0|||
147549934|NCT00901628|532170354|FG001|Overall Study|disconnection of drain|1|||
147442460|NCT00282295|531784349|FG002|Overall Study|Serious Adverse Events|1|||
147549935|NCT00901628|532170353|FG000|Overall Study|peroneal nerve palsy|0|||
147549936|NCT00901628|532170354|FG001|Overall Study|peroneal nerve palsy|1|||
147549937|NCT00608205|532170357|FG000|Overall Study|Adverse Event|3|||
147549938|NCT00608205|532170358|FG001|Overall Study|Adverse Event|2|||
147549939|NCT00608205|532170357|FG000|Overall Study|Patient non-compliant|0|||
147549940|NCT00608205|532170358|FG001|Overall Study|Patient non-compliant|1|||
147549941|NCT01003886|532170359|FG000|Overall Study|Lack of Efficacy|5|||
147549942|NCT01003886|532170359|FG000|Overall Study|Lost to Follow-up|169|||
147549943|NCT01003886|532170359|FG000|Overall Study|Withdrawal by Subject|39|||
147549944|NCT01003886|532170359|FG000|Overall Study|Other|14|||
147549945|NCT01003886|532170359|FG000|Overall Study|Adverse Event|3|||
147549946|NCT01339910|532170381|FG000|Overall Study|Withdrawal by Subject|1|||
147549947|NCT01339910|532170382|FG001|Overall Study|Withdrawal by Subject|0|||
147549948|NCT01339910|532170381|FG000|Overall Study|Physician Decision|1|||
147549949|NCT01339910|532170382|FG001|Overall Study|Physician Decision|0|||
147549950|NCT01339910|532170381|FG000|Overall Study|Disease relapse|1|||
147549951|NCT01339910|532170382|FG001|Overall Study|Disease relapse|4|||
147549952|NCT02965820|532170384|FG000|Period 2, Second 30 Days|Adverse Event|1|||
147549953|NCT02965820|532170385|FG001|Period 2, Second 30 Days|Adverse Event|1|||
147549954|NCT01567306|532170386|FG000|Overall Study|Protocol Violation|2|||
147549955|NCT01567306|532170387|FG001|Overall Study|Protocol Violation|2|||
147549956|NCT01567306|532170388|FG002|Overall Study|Protocol Violation|0|||
147549957|NCT01567306|532170389|FG003|Overall Study|Protocol Violation|3|||
147549958|NCT01567306|532170390|FG004|Overall Study|Protocol Violation|1|||
147549959|NCT01567306|532170391|FG005|Overall Study|Protocol Violation|1|||
147549960|NCT01567306|532170386|FG000|Overall Study|Change site living|1|||
147549961|NCT01567306|532170387|FG001|Overall Study|Change site living|0|||
147549962|NCT01567306|532170388|FG002|Overall Study|Change site living|0|||
147549963|NCT01567306|532170389|FG003|Overall Study|Change site living|0|||
147549964|NCT01567306|532170390|FG004|Overall Study|Change site living|0|||
147549965|NCT01567306|532170391|FG005|Overall Study|Change site living|0|||
147549966|NCT01567306|532170386|FG000|Overall Study|Adverse Event|0|||
147549967|NCT01567306|532170387|FG001|Overall Study|Adverse Event|0|||
147549968|NCT01567306|532170388|FG002|Overall Study|Adverse Event|0|||
147549969|NCT01567306|532170389|FG003|Overall Study|Adverse Event|2|||
147549970|NCT01567306|532170390|FG004|Overall Study|Adverse Event|4|||
147549971|NCT01567306|532170391|FG005|Overall Study|Adverse Event|1|||
147549972|NCT01567306|532170386|FG000|Overall Study|Lost to Follow-up|0|||
147549973|NCT01567306|532170387|FG001|Overall Study|Lost to Follow-up|0|||
147549974|NCT01567306|532170388|FG002|Overall Study|Lost to Follow-up|0|||
147549975|NCT01567306|532170389|FG003|Overall Study|Lost to Follow-up|0|||
147549976|NCT01567306|532170390|FG004|Overall Study|Lost to Follow-up|2|||
147549977|NCT01567306|532170391|FG005|Overall Study|Lost to Follow-up|0|||
147549978|NCT01567306|532170386|FG000|Overall Study|Withdrawal by Subject|0|||
147549979|NCT01567306|532170387|FG001|Overall Study|Withdrawal by Subject|0|||
147549980|NCT01567306|532170388|FG002|Overall Study|Withdrawal by Subject|0|||
147549981|NCT01567306|532170389|FG003|Overall Study|Withdrawal by Subject|0|||
147549982|NCT01567306|532170390|FG004|Overall Study|Withdrawal by Subject|0|||
147549983|NCT01567306|532170391|FG005|Overall Study|Withdrawal by Subject|1|||
147549984|NCT00738673|532170392|FG000|Overall Study|Adverse Event|1|||
147549985|NCT00738673|532170393|FG001|Overall Study|Adverse Event|0|||
147549986|NCT00738673|532170392|FG000|Overall Study|Lack of Efficacy|19|||
147549987|NCT00738673|532170393|FG001|Overall Study|Lack of Efficacy|8|||
147549988|NCT00738673|532170392|FG000|Overall Study|Protocol Violation|1|||
147549989|NCT00738673|532170393|FG001|Overall Study|Protocol Violation|2|||
147549990|NCT00738673|532170392|FG000|Overall Study|Withdrawal by Subject|3|||
147549991|NCT00738673|532170393|FG001|Overall Study|Withdrawal by Subject|1|||
147549992|NCT03882047|532170394|FG000|Overall Study|Adverse Event|0|||
147549993|NCT03882047|532170395|FG001|Overall Study|Adverse Event|2|||
147549994|NCT03882047|532170396|FG002|Overall Study|Adverse Event|2|||
147549995|NCT03882047|532170394|FG000|Overall Study|Treatment Failure|3|||
147549996|NCT03882047|532170395|FG001|Overall Study|Treatment Failure|3|||
147549997|NCT03882047|532170396|FG002|Overall Study|Treatment Failure|12|||
147549998|NCT03882047|532170394|FG000|Overall Study|Lost to Follow-up|0|||
147549999|NCT03882047|532170395|FG001|Overall Study|Lost to Follow-up|1|||
147550000|NCT03882047|532170396|FG002|Overall Study|Lost to Follow-up|0|||
147550001|NCT03882047|532170394|FG000|Overall Study|Did Not Wish to Continue|1|||
147550002|NCT03882047|532170395|FG001|Overall Study|Did Not Wish to Continue|4|||
147550003|NCT03882047|532170396|FG002|Overall Study|Did Not Wish to Continue|1|||
147550004|NCT03882047|532170394|FG000|Overall Study|Noncompliance With Protocol|2|||
147550005|NCT03882047|532170395|FG001|Overall Study|Noncompliance With Protocol|0|||
147550006|NCT03882047|532170396|FG002|Overall Study|Noncompliance With Protocol|0|||
147550007|NCT03882047|532170394|FG000|Overall Study|Did Not Meet Eligibility|0|||
147550008|NCT03882047|532170395|FG001|Overall Study|Did Not Meet Eligibility|0|||
147550009|NCT03882047|532170396|FG002|Overall Study|Did Not Meet Eligibility|1|||
147215474|NCT00895011|530961632|FG002|Overall Study|Protocol Violation|3|||
147215475|NCT00895011|530961630|FG000|Overall Study|Adverse Event|1|||
147215476|NCT00895011|530961631|FG001|Overall Study|Adverse Event|2|||
147215477|NCT00895011|530961632|FG002|Overall Study|Adverse Event|2|||
147442461|NCT00282295|531784347|FG000|Overall Study|Protocol Violation|0|||
147442462|NCT00282295|531784348|FG001|Overall Study|Protocol Violation|2|||
147442463|NCT00282295|531784349|FG002|Overall Study|Protocol Violation|1|||
147442464|NCT00282295|531784347|FG000|Overall Study|Withdrawal by Subject|2|||
147442465|NCT00282295|531784348|FG001|Overall Study|Withdrawal by Subject|6|||
147442466|NCT00282295|531784349|FG002|Overall Study|Withdrawal by Subject|4|||
147442467|NCT00282295|531784347|FG000|Overall Study|Lost to Follow-up|1|||
147442468|NCT00282295|531784348|FG001|Overall Study|Lost to Follow-up|7|||
147442469|NCT00282295|531784349|FG002|Overall Study|Lost to Follow-up|2|||
147442470|NCT00282295|531784347|FG000|Overall Study|Other|0|||
147442471|NCT00282295|531784348|FG001|Overall Study|Other|1|||
147442472|NCT00282295|531784349|FG002|Overall Study|Other|0|||
147442473|NCT03337542|531784352|FG000|Overall Study|Withdrew Consent|17|||
147215478|NCT00895011|530961630|FG000|Overall Study|schedule conflict|1|||
147215479|NCT00895011|530961631|FG001|Overall Study|schedule conflict|0|||
147215480|NCT00895011|530961632|FG002|Overall Study|schedule conflict|0|||
147215481|NCT02661178|530961640|FG000|Part 1|Protocol Violation|1|||
147215482|NCT02661178|530961641|FG001|Part 1|Protocol Violation|0|||
147215483|NCT02661178|530961642|FG002|Part 1|Protocol Violation|0|||
147215484|NCT02661178|530961643|FG003|Part 1|Protocol Violation|0|||
147215485|NCT02661178|530961644|FG004|Part 1|Protocol Violation|0|||
147215486|NCT02661178|530961645|FG005|Part 1|Protocol Violation|0|||
147215487|NCT02661178|530961646|FG006|Part 1|Protocol Violation|0|||
147215488|NCT02661178|530961647|FG007|Part 1|Protocol Violation|0|||
147215489|NCT02661178|530961648|FG008|Part 1|Protocol Violation|0|||
147215490|NCT02661178|530961649|FG009|Part 1|Protocol Violation|0|||
147550010|NCT00723554|532170397|FG000|Overall Study|Adverse Event|12|||
147550011|NCT00723554|532170397|FG000|Overall Study|Investigator's judgement|5|||
147550012|NCT00723554|532170397|FG000|Overall Study|Inhaled medication other than iloprost|4|||
147550013|NCT00723554|532170397|FG000|Overall Study|Withdrawal of consent|3|||
147550014|NCT00723554|532170397|FG000|Overall Study|Other|3|||
147550015|NCT00723554|532170397|FG000|Overall Study|Lost to Follow-up|1|||
147550016|NCT00723554|532170397|FG000|Overall Study|Non-compliance|1|||
147550017|NCT02436135|532170399|FG000|Overall Study|Progressive Disease|3|||
147550018|NCT02436135|532170400|FG001|Overall Study|Progressive Disease|1|||
147550019|NCT02436135|532170399|FG000|Overall Study|Investigator Discretion|1|||
147550020|NCT02436135|532170400|FG001|Overall Study|Investigator Discretion|2|||
147550021|NCT02436135|532170399|FG000|Overall Study|Adverse Event|1|||
147550022|NCT02436135|532170400|FG001|Overall Study|Adverse Event|0|||
147550023|NCT02436135|532170399|FG000|Overall Study|Withdrawal by Participant|1|||
147550024|NCT02436135|532170400|FG001|Overall Study|Withdrawal by Participant|0|||
147550025|NCT02436135|532170399|FG000|Overall Study|Study Terminated By Sponsor|0|||
147550026|NCT02436135|532170400|FG001|Overall Study|Study Terminated By Sponsor|1|||
147550027|NCT00475852|532170401|FG000|Overall Study|Death|444|||
147550028|NCT00475852|532170402|FG001|Overall Study|Death|456|||
147550029|NCT00475852|532170401|FG000|Overall Study|Withdrawal by Subject|19|||
147550030|NCT00475852|532170402|FG001|Overall Study|Withdrawal by Subject|24|||
147550031|NCT00475852|532170401|FG000|Overall Study|Lost to Follow-up|54|||
147550032|NCT00475852|532170402|FG001|Overall Study|Lost to Follow-up|68|||
147550033|NCT02063698|532170403|FG000|Overall Study|did not complete booklet for days 2-8|1|||
147550034|NCT02063698|532170404|FG001|Overall Study|did not complete booklet for days 2-8|2|||
147550035|NCT00297479|532170405|FG000|Overall Study|Lost to Follow-up|37|||
147550036|NCT00297479|532170406|FG001|Overall Study|Lost to Follow-up|54|||
147550037|NCT00297479|532170407|FG002|Overall Study|Lost to Follow-up|51|||
147550038|NCT01664494|532170408|FG000|Overall Study|Withdrawal by Subject|27|||
147550039|NCT01664494|532170408|FG000|Overall Study|Death|18|||
147550040|NCT01664494|532170408|FG000|Overall Study|Other|49|||
147550041|NCT01664494|532170408|FG000|Overall Study|Lost to Follow-up|99|||
147550042|NCT03263819|532170409|FG000|Overall Study|1 subject was excluded from analysis because she was using GLP-1 agonist for weight contro|1|||
147550043|NCT03263819|532170410|FG001|Overall Study|1 subject was excluded from analysis because she was using GLP-1 agonist for weight contro|0|||
147550044|NCT01427803|532170412|FG000|Overall Study|Lost to Follow-up|32|||
147550045|NCT01427803|532170413|FG001|Overall Study|Lost to Follow-up|26|||
147550046|NCT01427803|532170412|FG000|Overall Study|Withdrawal by Subject|20|||
147550047|NCT01427803|532170413|FG001|Overall Study|Withdrawal by Subject|0|||
147550048|NCT01427803|532170412|FG000|Overall Study|Unable to complete full treatment period|6|||
147550049|NCT01427803|532170413|FG001|Overall Study|Unable to complete full treatment period|0|||
147550050|NCT01427803|532170412|FG000|Overall Study|Protocol Violation|1|||
147550051|NCT01427803|532170413|FG001|Overall Study|Protocol Violation|0|||
147550052|NCT01427803|532170412|FG000|Overall Study|Physician Decision|3|||
147550053|NCT01427803|532170413|FG001|Overall Study|Physician Decision|0|||
147550054|NCT01427803|532170412|FG000|Overall Study|did not take product|1|||
147550055|NCT01427803|532170413|FG001|Overall Study|did not take product|0|||
147550056|NCT00863057|532170414|FG000|Milestones Period 1 (Weeks 0-5)|Adverse Event|1|||
147550057|NCT00863057|532170415|FG001|Milestones Period 1 (Weeks 0-5)|Adverse Event|1|||
147550058|NCT00863057|532170416|FG002|Milestones Period 1 (Weeks 0-5)|Adverse Event|0|||
147550059|NCT00863057|532170417|FG003|Milestones Period 1 (Weeks 0-5)|Adverse Event|1|||
147550060|NCT00863057|532170414|FG000|Milestones Period 1 (Weeks 0-5)|Physician Decision|0|||
147550061|NCT00863057|532170415|FG001|Milestones Period 1 (Weeks 0-5)|Physician Decision|1|||
147550062|NCT00863057|532170416|FG002|Milestones Period 1 (Weeks 0-5)|Physician Decision|0|||
147550063|NCT00863057|532170417|FG003|Milestones Period 1 (Weeks 0-5)|Physician Decision|0|||
147550064|NCT00863057|532170414|FG000|Period 2 (Weeks 6-10)|Adverse Event|0|||
147550065|NCT00863057|532170415|FG001|Period 2 (Weeks 6-10)|Adverse Event|1|||
147550066|NCT00863057|532170416|FG002|Period 2 (Weeks 6-10)|Adverse Event|1|||
147215491|NCT02661178|530961650|FG010|Part 1|Protocol Violation|0|||
147215492|NCT02661178|530961651|FG011|Part 1|Protocol Violation|0|||
147215493|NCT02661178|530961652|FG012|Part 1|Protocol Violation|0|||
147550067|NCT00863057|532170417|FG003|Period 2 (Weeks 6-10)|Adverse Event|0|||
147550068|NCT00863057|532170414|FG000|Period 2 (Weeks 6-10)|Physician Decision|0|||
147550069|NCT00863057|532170415|FG001|Period 2 (Weeks 6-10)|Physician Decision|0|||
147550070|NCT00863057|532170416|FG002|Period 2 (Weeks 6-10)|Physician Decision|0|||
147550071|NCT00863057|532170417|FG003|Period 2 (Weeks 6-10)|Physician Decision|1|||
147550072|NCT03412019|532170420|FG000|Overall Study|Withdrawal by Subject|1|||
147550073|NCT03412019|532170421|FG001|Overall Study|Withdrawal by Subject|1|||
147550074|NCT02974114|532170432|FG000|Overall Study|Other (Not specified)|0|||
147550075|NCT02974114|532170433|FG001|Overall Study|Other (Not specified)|1|||
147550076|NCT02974114|532170434|FG002|Overall Study|Other (Not specified)|2|||
147550077|NCT01138150|532170437|FG000|Overall Study|blood unable to be processed|0|||
147550078|NCT01138150|532170438|FG001|Overall Study|blood unable to be processed|1|||
147550079|NCT01138150|532170437|FG000|Overall Study|Physician Decision|1|||
147550080|NCT01138150|532170438|FG001|Overall Study|Physician Decision|0|||
147550081|NCT00545233|532170439|FG000|Overall Study|Adverse Event|10|||
147550082|NCT00545233|532170440|FG001|Overall Study|Adverse Event|5|||
147550083|NCT00545233|532170439|FG000|Overall Study|Violation of Selection Criteria at Entry|5|||
147550084|NCT00545233|532170440|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
147550085|NCT00545233|532170439|FG000|Overall Study|Protocol Violation|2|||
147550086|NCT00545233|532170440|FG001|Overall Study|Protocol Violation|0|||
147550087|NCT00545233|532170439|FG000|Overall Study|Refused Treatment|9|||
147550088|NCT00545233|532170440|FG001|Overall Study|Refused Treatment|7|||
147550089|NCT00545233|532170439|FG000|Overall Study|Failure to Return|4|||
147550090|NCT00545233|532170440|FG001|Overall Study|Failure to Return|6|||
147550091|NCT00545233|532170439|FG000|Overall Study|Insufficient response|14|||
147550092|NCT00545233|532170440|FG001|Overall Study|Insufficient response|15|||
147550093|NCT00545233|532170439|FG000|Overall Study|Physician Decision|2|||
147550094|NCT00545233|532170440|FG001|Overall Study|Physician Decision|1|||
147550095|NCT00479401|532170444|FG000|Overall Study|Adverse Event|24|||
147550096|NCT00479401|532170445|FG001|Overall Study|Adverse Event|20|||
147550097|NCT00479401|532170446|FG002|Overall Study|Adverse Event|4|||
147550098|NCT00479401|532170444|FG000|Overall Study|Lack of Efficacy|2|||
147550099|NCT00479401|532170445|FG001|Overall Study|Lack of Efficacy|2|||
147550100|NCT00479401|532170446|FG002|Overall Study|Lack of Efficacy|4|||
147550101|NCT00479401|532170444|FG000|Overall Study|Protocol Violation|2|||
147550102|NCT00479401|532170445|FG001|Overall Study|Protocol Violation|1|||
147550103|NCT00479401|532170446|FG002|Overall Study|Protocol Violation|1|||
147550104|NCT00479401|532170444|FG000|Overall Study|Lost to Follow-up|1|||
147550105|NCT00479401|532170445|FG001|Overall Study|Lost to Follow-up|1|||
147550106|NCT00479401|532170446|FG002|Overall Study|Lost to Follow-up|1|||
147550107|NCT00479401|532170444|FG000|Overall Study|Withdrawal by Subject|16|||
147550108|NCT00479401|532170445|FG001|Overall Study|Withdrawal by Subject|10|||
147550109|NCT00479401|532170446|FG002|Overall Study|Withdrawal by Subject|2|||
147550110|NCT00479401|532170444|FG000|Overall Study|Exclusion criteria, relocation|4|||
147550111|NCT00479401|532170445|FG001|Overall Study|Exclusion criteria, relocation|3|||
147550112|NCT00479401|532170446|FG002|Overall Study|Exclusion criteria, relocation|0|||
147550113|NCT01208402|532170449|FG000|Overall Study|Withdrawal by Subject|1|||
147550114|NCT01208402|532170450|FG001|Overall Study|Withdrawal by Subject|0|||
147550115|NCT01571635|532170451|FG000|Overall Study|Adverse Event|3|||
147550116|NCT01571635|532170452|FG001|Overall Study|Adverse Event|0|||
147550117|NCT01571635|532170453|FG002|Overall Study|Adverse Event|2|||
147550118|NCT01571635|532170454|FG003|Overall Study|Adverse Event|3|||
147550119|NCT01571635|532170455|FG004|Overall Study|Adverse Event|5|||
147550120|NCT01571635|532170451|FG000|Overall Study|Other reasons|2|||
147550121|NCT01571635|532170452|FG001|Overall Study|Other reasons|1|||
147550122|NCT01571635|532170453|FG002|Overall Study|Other reasons|2|||
147550123|NCT01571635|532170454|FG003|Overall Study|Other reasons|2|||
147550124|NCT01571635|532170455|FG004|Overall Study|Other reasons|1|||
147550125|NCT01571635|532170451|FG000|Overall Study|Study terminated by sponsor|0|||
147550126|NCT01571635|532170452|FG001|Overall Study|Study terminated by sponsor|4|||
147550127|NCT01571635|532170453|FG002|Overall Study|Study terminated by sponsor|1|||
147550128|NCT01571635|532170454|FG003|Overall Study|Study terminated by sponsor|3|||
147550129|NCT01571635|532170455|FG004|Overall Study|Study terminated by sponsor|1|||
147550130|NCT01571635|532170451|FG000|Overall Study|Withdrew consent|1|||
147550131|NCT01571635|532170452|FG001|Overall Study|Withdrew consent|1|||
147550132|NCT01571635|532170453|FG002|Overall Study|Withdrew consent|2|||
147550133|NCT01571635|532170454|FG003|Overall Study|Withdrew consent|3|||
147550134|NCT01571635|532170455|FG004|Overall Study|Withdrew consent|0|||
147550135|NCT01571635|532170451|FG000|Overall Study|Lack of Efficacy|0|||
147550136|NCT01571635|532170452|FG001|Overall Study|Lack of Efficacy|2|||
147550137|NCT01571635|532170453|FG002|Overall Study|Lack of Efficacy|0|||
147550138|NCT01571635|532170454|FG003|Overall Study|Lack of Efficacy|1|||
147550139|NCT01571635|532170455|FG004|Overall Study|Lack of Efficacy|2|||
147550140|NCT02151461|532170458|FG000|Overall Study|Adverse Event|5|||
147550141|NCT02151461|532170459|FG001|Overall Study|Adverse Event|1|||
147550142|NCT02151461|532170460|FG002|Overall Study|Adverse Event|0|||
147550143|NCT02151461|532170461|FG003|Overall Study|Adverse Event|2|||
147550144|NCT02151461|532170458|FG000|Overall Study|Lost to Follow-up|0|||
147550145|NCT02151461|532170459|FG001|Overall Study|Lost to Follow-up|0|||
147550146|NCT02151461|532170460|FG002|Overall Study|Lost to Follow-up|1|||
147550147|NCT02151461|532170461|FG003|Overall Study|Lost to Follow-up|1|||
147550148|NCT02151461|532170458|FG000|Overall Study|Withdrawal by Subject|1|||
147550149|NCT02151461|532170459|FG001|Overall Study|Withdrawal by Subject|0|||
147550150|NCT02151461|532170460|FG002|Overall Study|Withdrawal by Subject|1|||
147550151|NCT02151461|532170461|FG003|Overall Study|Withdrawal by Subject|1|||
147550152|NCT02151461|532170458|FG000|Overall Study|Treatment discontinuation|0|||
147550153|NCT02151461|532170459|FG001|Overall Study|Treatment discontinuation|0|||
147550154|NCT02151461|532170460|FG002|Overall Study|Treatment discontinuation|1|||
147550155|NCT02151461|532170461|FG003|Overall Study|Treatment discontinuation|0|||
147550156|NCT00706706|532170462|FG000|Overall Study|Death|53|||
147550157|NCT00706706|532170462|FG000|Overall Study|Lost to Follow-up|7|||
147550158|NCT00706706|532170462|FG000|Overall Study|Study endpoint had reached|45|||
147550159|NCT02191579|532170463|FG000|Treatment 1|Multiple Reasons Specified|27|||
147550160|NCT02191579|532170464|FG001|Treatment 1|Multiple Reasons Specified|58|||
147550161|NCT02191579|532170463|FG000|Treatment 2|Multiple Reasons Specified|0|||
147550162|NCT02191579|532170464|FG001|Treatment 2|Multiple Reasons Specified|25|||
147550163|NCT02046369|532170465|FG000|Overall Study|Adverse Event|3|||
147550164|NCT02046369|532170466|FG001|Overall Study|Adverse Event|3|||
147550165|NCT02046369|532170465|FG000|Overall Study|Lack of Efficacy|3|||
147550166|NCT02046369|532170466|FG001|Overall Study|Lack of Efficacy|3|||
147550167|NCT02046369|532170465|FG000|Overall Study|Lost to Follow-up|3|||
147550168|NCT02046369|532170466|FG001|Overall Study|Lost to Follow-up|3|||
147550169|NCT02046369|532170465|FG000|Overall Study|Protocol Violation|1|||
147550170|NCT02046369|532170466|FG001|Overall Study|Protocol Violation|2|||
147550171|NCT02046369|532170465|FG000|Overall Study|Withdrawal by Subject|3|||
147550172|NCT02046369|532170466|FG001|Overall Study|Withdrawal by Subject|6|||
147550173|NCT02046369|532170465|FG000|Overall Study|never received study drug|0|||
147550174|NCT02046369|532170466|FG001|Overall Study|never received study drug|1|||
147550175|NCT02046369|532170465|FG000|Overall Study|non compliance|1|||
147550176|NCT02046369|532170466|FG001|Overall Study|non compliance|0|||
147550177|NCT02196506|532170471|FG000|Phase A|Participant Met Withdrawal Criteria|34|||
147550178|NCT02196506|532170472|FG001|Phase A|Participant Met Withdrawal Criteria|0|||
147550179|NCT02196506|532170473|FG002|Phase A|Participant Met Withdrawal Criteria|0|||
147550180|NCT02196506|532170474|FG003|Phase A|Participant Met Withdrawal Criteria|0|||
147550181|NCT02196506|532170471|FG000|Phase A|Withdrawal by Subject|34|||
147550182|NCT02196506|532170472|FG001|Phase A|Withdrawal by Subject|0|||
147550183|NCT02196506|532170473|FG002|Phase A|Withdrawal by Subject|0|||
147550184|NCT02196506|532170474|FG003|Phase A|Withdrawal by Subject|0|||
147550185|NCT02196506|532170471|FG000|Phase A|Adverse Event|22|||
147550186|NCT02196506|532170472|FG001|Phase A|Adverse Event|0|||
147550187|NCT02196506|532170473|FG002|Phase A|Adverse Event|0|||
147550188|NCT02196506|532170474|FG003|Phase A|Adverse Event|0|||
147550189|NCT02196506|532170471|FG000|Phase A|Lost to Follow-up|9|||
147215494|NCT02661178|530961653|FG013|Part 1|Protocol Violation|0|||
147550190|NCT02196506|532170472|FG001|Phase A|Lost to Follow-up|0|||
147550191|NCT02196506|532170473|FG002|Phase A|Lost to Follow-up|0|||
147550192|NCT02196506|532170474|FG003|Phase A|Lost to Follow-up|0|||
147550193|NCT02196506|532170471|FG000|Phase A|Protocol deviation|12|||
147550194|NCT02196506|532170472|FG001|Phase A|Protocol deviation|0|||
147550195|NCT02196506|532170473|FG002|Phase A|Protocol deviation|0|||
147550196|NCT02196506|532170474|FG003|Phase A|Protocol deviation|0|||
147550197|NCT02196506|532170471|FG000|Phase A|Participant withdrawn by investigator|10|||
147550198|NCT02196506|532170472|FG001|Phase A|Participant withdrawn by investigator|0|||
147550199|NCT02196506|532170473|FG002|Phase A|Participant withdrawn by investigator|0|||
147550200|NCT02196506|532170474|FG003|Phase A|Participant withdrawn by investigator|0|||
147550201|NCT02196506|532170471|FG000|Phase B|Participant Met Withdrawal Criteria|0|||
147550202|NCT02196506|532170472|FG001|Phase B|Participant Met Withdrawal Criteria|0|||
147550203|NCT02196506|532170473|FG002|Phase B|Participant Met Withdrawal Criteria|1|||
147550204|NCT02196506|532170474|FG003|Phase B|Participant Met Withdrawal Criteria|0|||
147550205|NCT02196506|532170471|FG000|Phase B|Lack of Efficacy|0|||
147550206|NCT02196506|532170472|FG001|Phase B|Lack of Efficacy|1|||
147550207|NCT02196506|532170473|FG002|Phase B|Lack of Efficacy|2|||
147550208|NCT02196506|532170474|FG003|Phase B|Lack of Efficacy|0|||
147550209|NCT02196506|532170471|FG000|Phase B|Withdrawal by Participant|0|||
147550210|NCT02196506|532170472|FG001|Phase B|Withdrawal by Participant|8|||
147550211|NCT02196506|532170473|FG002|Phase B|Withdrawal by Participant|1|||
147550212|NCT02196506|532170474|FG003|Phase B|Withdrawal by Participant|0|||
147550213|NCT02196506|532170471|FG000|Phase B|Adverse Event|0|||
147550214|NCT02196506|532170472|FG001|Phase B|Adverse Event|4|||
147550215|NCT02196506|532170473|FG002|Phase B|Adverse Event|1|||
147550216|NCT02196506|532170474|FG003|Phase B|Adverse Event|0|||
147550217|NCT02196506|532170471|FG000|Phase B|Lost to Follow-up|0|||
147550218|NCT02196506|532170472|FG001|Phase B|Lost to Follow-up|2|||
147550219|NCT02196506|532170473|FG002|Phase B|Lost to Follow-up|1|||
147550220|NCT02196506|532170474|FG003|Phase B|Lost to Follow-up|0|||
147550221|NCT02196506|532170471|FG000|Phase A+|Participant Met Withdrawal Criteria|0|||
147550222|NCT02196506|532170472|FG001|Phase A+|Participant Met Withdrawal Criteria|0|||
147550223|NCT02196506|532170473|FG002|Phase A+|Participant Met Withdrawal Criteria|0|||
147550224|NCT02196506|532170474|FG003|Phase A+|Participant Met Withdrawal Criteria|1|||
147550225|NCT02196506|532170471|FG000|Phase A+|Withdrawal by Participant|0|||
147550226|NCT02196506|532170472|FG001|Phase A+|Withdrawal by Participant|0|||
147550227|NCT02196506|532170473|FG002|Phase A+|Withdrawal by Participant|0|||
147550228|NCT02196506|532170474|FG003|Phase A+|Withdrawal by Participant|5|||
147550229|NCT02196506|532170471|FG000|Phase A+|Adverse Event|0|||
147550230|NCT02196506|532170472|FG001|Phase A+|Adverse Event|0|||
147550231|NCT02196506|532170473|FG002|Phase A+|Adverse Event|0|||
147550232|NCT02196506|532170474|FG003|Phase A+|Adverse Event|1|||
147550233|NCT02196506|532170471|FG000|Phase A+|Lost to Follow-up|0|||
147550234|NCT02196506|532170472|FG001|Phase A+|Lost to Follow-up|0|||
147550235|NCT02196506|532170473|FG002|Phase A+|Lost to Follow-up|0|||
147550236|NCT02196506|532170474|FG003|Phase A+|Lost to Follow-up|6|||
147550237|NCT02196506|532170471|FG000|Phase A+|Participant withdrawn by investigator|0|||
147550238|NCT02196506|532170472|FG001|Phase A+|Participant withdrawn by investigator|0|||
147550239|NCT02196506|532170473|FG002|Phase A+|Participant withdrawn by investigator|0|||
147550240|NCT02196506|532170474|FG003|Phase A+|Participant withdrawn by investigator|1|||
147550241|NCT01606137|532170475|FG000|Overall Study|Adverse Event|85|||
147550242|NCT01606137|532170475|FG000|Overall Study|Withdrawal by Subject|74|||
147550243|NCT01606137|532170475|FG000|Overall Study|Lack of Efficacy|56|||
147550244|NCT01606137|532170475|FG000|Overall Study|Lost to Follow-up|15|||
147550245|NCT01606137|532170475|FG000|Overall Study|Protocol Violation|1|||
147550246|NCT01606137|532170475|FG000|Overall Study|Patient non-compliance|9|||
147550247|NCT01606137|532170475|FG000|Overall Study|Death|1|||
147550248|NCT01606137|532170475|FG000|Overall Study|Decreased/no pain|4|||
147550249|NCT01606137|532170475|FG000|Overall Study|Issues with driving|4|||
147550250|NCT01606137|532170475|FG000|Overall Study|multiple sclerosis less stable|1|||
147550251|NCT01606137|532170475|FG000|Overall Study|Increased bilirubin|1|||
147550252|NCT01606137|532170475|FG000|Overall Study|Spray causes nausea|1|||
147550253|NCT01606137|532170475|FG000|Overall Study|Not enough improvement|4|||
147550254|NCT01606137|532170475|FG000|Overall Study|Wanted to try another treatment|1|||
147550255|NCT01606137|532170475|FG000|Overall Study|Patient leaving country|1|||
147550256|NCT01606137|532170475|FG000|Overall Study|Personal reasons|1|||
147550257|NCT01606137|532170475|FG000|Overall Study|Unable to tolerate study med. taste|1|||
147550258|NCT01606137|532170475|FG000|Overall Study|Patient moving|1|||
147550259|NCT01606137|532170475|FG000|Overall Study|Unable to collect consistent data|1|||
147550260|NCT00066807|532170476|FG000|Overall Study|Study was terminated early|14|||
147550261|NCT00066807|532170477|FG001|Overall Study|Study was terminated early|15|||
147550262|NCT05028751|532170478|FG000|Overall Study|Study Terminated by Sponsor|3|||
147550263|NCT05028751|532170479|FG001|Overall Study|Study Terminated by Sponsor|0|||
147550264|NCT05028751|532170480|FG002|Overall Study|Study Terminated by Sponsor|0|||
147550265|NCT05028751|532170481|FG003|Overall Study|Study Terminated by Sponsor|0|||
147550266|NCT05028751|532170478|FG000|Overall Study|Death|9|||
147550267|NCT05028751|532170479|FG001|Overall Study|Death|3|||
147550268|NCT05028751|532170480|FG002|Overall Study|Death|2|||
147550269|NCT05028751|532170481|FG003|Overall Study|Death|4|||
147550270|NCT05028751|532170478|FG000|Overall Study|Withdrawal by Subject|0|||
147550271|NCT05028751|532170479|FG001|Overall Study|Withdrawal by Subject|0|||
147550272|NCT05028751|532170480|FG002|Overall Study|Withdrawal by Subject|1|||
147550273|NCT05028751|532170481|FG003|Overall Study|Withdrawal by Subject|0|||
147550274|NCT05028751|532170478|FG000|Overall Study|Miscellaneous|2|||
147550275|NCT05028751|532170479|FG001|Overall Study|Miscellaneous|0|||
147550276|NCT05028751|532170480|FG002|Overall Study|Miscellaneous|0|||
147550277|NCT05028751|532170481|FG003|Overall Study|Miscellaneous|0|||
147550278|NCT04578548|532170482|FG000|Double-blind Treatment Period (52 Weeks)|Lost to Follow-up|1|||
147550279|NCT04578548|532170483|FG001|Double-blind Treatment Period (52 Weeks)|Lost to Follow-up|1|||
147550280|NCT04578548|532170482|FG000|Double-blind Treatment Period (52 Weeks)|Non Compliance with study drug|1|||
147550281|NCT04578548|532170483|FG001|Double-blind Treatment Period (52 Weeks)|Non Compliance with study drug|1|||
147550282|NCT04578548|532170482|FG000|Double-blind Treatment Period (52 Weeks)|Withdrawal by Subject|1|||
147550283|NCT04578548|532170483|FG001|Double-blind Treatment Period (52 Weeks)|Withdrawal by Subject|0|||
147550284|NCT04578548|532170482|FG000|Open-Label Treatment Period (52 Weeks)|Adverse Event|1|||
147550285|NCT04578548|532170483|FG001|Open-Label Treatment Period (52 Weeks)|Adverse Event|1|||
147550286|NCT04578548|532170482|FG000|Open-Label Treatment Period (52 Weeks)|Withdrawal by Subject|1|||
147550287|NCT04578548|532170483|FG001|Open-Label Treatment Period (52 Weeks)|Withdrawal by Subject|0|||
147550288|NCT04578548|532170482|FG000|Open-Label Treatment Period (52 Weeks)|Study terminated by sponsor|34|||
147550289|NCT04578548|532170483|FG001|Open-Label Treatment Period (52 Weeks)|Study terminated by sponsor|15|||
147550290|NCT00331630|532172736|FG000|Evaluated for and Completed SOC Surgery|Progressive Disease|1|||
147550291|NCT00331630|532172736|FG000|Evaluated for and Completed SOC Surgery|Lost to Follow-up|1|||
147550292|NCT00331630|532172736|FG000|Follow up for 5 Years|Death|5|||
147550293|NCT00331630|532172736|FG000|Follow up for 5 Years|Data collection was stopped|24|||
147550294|NCT03342898|532172739|FG000|Overall Study|Adverse Event|3|||
147550295|NCT03342898|532172740|FG001|Overall Study|Adverse Event|1|||
147550296|NCT03342898|532172741|FG002|Overall Study|Adverse Event|0|||
147550297|NCT03342898|532172739|FG000|Overall Study|Lost to Follow-up|44|||
147550298|NCT03342898|532172740|FG001|Overall Study|Lost to Follow-up|40|||
147550299|NCT03342898|532172741|FG002|Overall Study|Lost to Follow-up|42|||
147550300|NCT03342898|532172739|FG000|Overall Study|Withdrawal of Consent|5|||
147550301|NCT03342898|532172740|FG001|Overall Study|Withdrawal of Consent|9|||
147550302|NCT03342898|532172741|FG002|Overall Study|Withdrawal of Consent|11|||
147550303|NCT03342898|532172739|FG000|Overall Study|Death|0|||
147550304|NCT03342898|532172740|FG001|Overall Study|Death|1|||
147550305|NCT03342898|532172741|FG002|Overall Study|Death|1|||
147550306|NCT03342898|532172739|FG000|Overall Study|Reason not Specified|2|||
147550307|NCT03342898|532172740|FG001|Overall Study|Reason not Specified|2|||
147550308|NCT03342898|532172741|FG002|Overall Study|Reason not Specified|0|||
147550309|NCT01387282|532172742|FG000|Overall Study|Death|47|||
147550310|NCT01387282|532172743|FG001|Overall Study|Death|16|||
147550311|NCT01387282|532172742|FG000|Overall Study|Other|5|||
147550312|NCT01387282|532172743|FG001|Overall Study|Other|1|||
147550313|NCT01387282|532172742|FG000|Overall Study|Unrelated AE|6|||
147550314|NCT01387282|532172743|FG001|Overall Study|Unrelated AE|4|||
147550315|NCT01387282|532172742|FG000|Overall Study|Withdrawal by patient|33|||
147550316|NCT01387282|532172743|FG001|Overall Study|Withdrawal by patient|23|||
147550317|NCT01387282|532172742|FG000|Overall Study|Study drug-related AE|2|||
147550318|NCT01387282|532172743|FG001|Overall Study|Study drug-related AE|2|||
147550319|NCT01387282|532172742|FG000|Overall Study|Lost to Follow-up|4|||
147550320|NCT01387282|532172743|FG001|Overall Study|Lost to Follow-up|1|||
147550321|NCT03997448|532172744|FG000|Study Treatment|Disease Progression|1|||
147550322|NCT03997448|532172744|FG000|Study Treatment|Symptomatic Deterioration|1|||
147550323|NCT03997448|532172744|FG000|Follow up|Death|2|||
147550324|NCT03997448|532172744|FG000|Follow up|study terminated|1|||
147550325|NCT01312779|532172747|FG000|Overall Study|Withdrawal by Subject|2|||
147550326|NCT01312779|532172747|FG000|Overall Study|Death|3|||
147550327|NCT01312779|532172747|FG000|Overall Study|Not Implanted with Device|27|||
147550328|NCT01621490|532172748|FG000|Overall Study|Subject no longer meets study criteria|0|||
147550329|NCT01621490|532172749|FG001|Overall Study|Subject no longer meets study criteria|0|||
147550330|NCT01621490|532172750|FG002|Overall Study|Subject no longer meets study criteria|0|||
147550331|NCT01621490|532172751|FG003|Overall Study|Subject no longer meets study criteria|0|||
147550332|NCT01621490|532172752|FG004|Overall Study|Subject no longer meets study criteria|1|||
147550333|NCT01621490|532172753|FG005|Overall Study|Subject no longer meets study criteria|0|||
147550334|NCT01621490|532172754|FG006|Overall Study|Subject no longer meets study criteria|0|||
147550335|NCT01621490|532172755|FG007|Overall Study|Subject no longer meets study criteria|0|||
147550336|NCT01621490|532172756|FG008|Overall Study|Subject no longer meets study criteria|0|||
147550337|NCT01621490|532172757|FG009|Overall Study|Subject no longer meets study criteria|0|||
147550338|NCT01621490|532172758|FG010|Overall Study|Subject no longer meets study criteria|0|||
147550339|NCT01621490|532172748|FG000|Overall Study|Maximum clinical benefit|3|||
147550340|NCT01621490|532172749|FG001|Overall Study|Maximum clinical benefit|2|||
147550341|NCT01621490|532172750|FG002|Overall Study|Maximum clinical benefit|0|||
147550342|NCT01621490|532172751|FG003|Overall Study|Maximum clinical benefit|0|||
147550343|NCT01621490|532172752|FG004|Overall Study|Maximum clinical benefit|0|||
147442474|NCT03337542|531784352|FG000|Overall Study|Allergic Adverse Event|1|||
147215495|NCT02661178|530961654|FG014|Part 1|Protocol Violation|0|||
147215496|NCT03859973|530961655|FG000|Overall Study|Other reason than listed|3|||
147215497|NCT03859973|530961656|FG001|Overall Study|Other reason than listed|2|||
147215498|NCT03859973|530961655|FG000|Overall Study|COVID-19 related, not due to AE|3|||
147215499|NCT03859973|530961656|FG001|Overall Study|COVID-19 related, not due to AE|4|||
147215500|NCT03859973|530961655|FG000|Overall Study|Withdrawal by Subject|8|||
147215501|NCT03859973|530961656|FG001|Overall Study|Withdrawal by Subject|9|||
147442475|NCT03337542|531784352|FG000|Overall Study|Chronic /Recurrent GI Adverse Event/Symptoms|1|||
147442476|NCT03337542|531784352|FG000|Overall Study|Lost to Follow-up|1|||
147442477|NCT03337542|531784352|FG000|Overall Study|Unable to Participate in Study Due to Relocation|1|||
147442478|NCT01401842|531784353|FG000|Overall Study|Withdrawal by Subject|3|||
147442479|NCT01401842|531784354|FG001|Overall Study|Withdrawal by Subject|2|||
147442480|NCT01401842|531784353|FG000|Overall Study|academic reason|4|||
147442481|NCT01401842|531784354|FG001|Overall Study|academic reason|1|||
147442482|NCT01401842|531784353|FG000|Overall Study|changed companies|20|||
147442483|NCT01401842|531784354|FG001|Overall Study|changed companies|34|||
147442484|NCT01401842|531784353|FG000|Overall Study|discharged from US Army|3|||
147442485|NCT01401842|531784354|FG001|Overall Study|discharged from US Army|4|||
147442486|NCT01401842|531784353|FG000|Overall Study|invalid follow-up strength data|1|||
147442487|NCT01401842|531784354|FG001|Overall Study|invalid follow-up strength data|4|||
147442488|NCT01401842|531784353|FG000|Overall Study|on profile|9|||
147442489|NCT01401842|531784354|FG001|Overall Study|on profile|5|||
147442490|NCT01401842|531784353|FG000|Overall Study|other/unknown|28|||
147442491|NCT01401842|531784354|FG001|Overall Study|other/unknown|17|||
147442492|NCT00583024|531784369|FG000|Overall Study|Lost to Follow-up|4|||
147442493|NCT03977974|531784372|FG000|Period 2|Adverse Event|0|||
147442494|NCT03977974|531784373|FG001|Period 2|Adverse Event|0|||
147442495|NCT03977974|531784374|FG002|Period 2|Adverse Event|0|||
147442496|NCT03977974|531784375|FG003|Period 2|Adverse Event|0|||
147442497|NCT03977974|531784376|FG004|Period 2|Adverse Event|1|||
147442498|NCT03977974|531784377|FG005|Period 2|Adverse Event|0|||
147442499|NCT03977974|531784378|FG006|Period 2|Adverse Event|0|||
147442500|NCT03977974|531784379|FG007|Period 2|Adverse Event|0|||
147442501|NCT03977974|531784380|FG008|Period 2|Adverse Event|0|||
147442502|NCT03977974|531784381|FG009|Period 2|Adverse Event|0|||
147442503|NCT03977974|531784382|FG010|Period 2|Adverse Event|0|||
147442504|NCT03977974|531784383|FG011|Period 2|Adverse Event|0|||
147442505|NCT03977974|531784384|FG012|Period 2|Adverse Event|0|||
147442506|NCT00736255|531785999|FG000|Overall Study|Adverse Event|1|||
147442507|NCT00736255|531786000|FG001|Overall Study|Adverse Event|0|||
147442508|NCT00736255|531785999|FG000|Overall Study|Physician Decision|1|||
147442509|NCT00736255|531786000|FG001|Overall Study|Physician Decision|0|||
147442510|NCT00736255|531785999|FG000|Overall Study|Non-compliance|1|||
147442511|NCT00736255|531786000|FG001|Overall Study|Non-compliance|1|||
147442512|NCT02833974|531786003|FG000|Overall Study|Lost to Follow-up|1|||
147442513|NCT02833974|531786004|FG001|Overall Study|Lost to Follow-up|0|||
147442514|NCT02833974|531786003|FG000|Overall Study|Adverse Event|0|||
147442515|NCT02833974|531786004|FG001|Overall Study|Adverse Event|3|||
147442516|NCT01439282|531786005|FG000|Overall Study|Adverse Event|5|||
147442517|NCT01439282|531786006|FG001|Overall Study|Adverse Event|0|||
147215502|NCT03859973|530961655|FG000|Overall Study|Lost to Follow-up|2|||
147442518|NCT01439282|531786005|FG000|Overall Study|Withdrawal by Subject|2|||
147442519|NCT01439282|531786006|FG001|Overall Study|Withdrawal by Subject|0|||
147442520|NCT01439282|531786005|FG000|Overall Study|Other|1|||
147442521|NCT01439282|531786006|FG001|Overall Study|Other|1|||
147442522|NCT04419610|531786007|FG000|Overall Study|Withdrawal by Subject|3|||
147442523|NCT04419610|531786008|FG001|Overall Study|Withdrawal by Subject|1|||
147442524|NCT04419610|531786007|FG000|Overall Study|Adverse Event|1|||
147550344|NCT01621490|532172753|FG005|Overall Study|Maximum clinical benefit|0|||
147550345|NCT01621490|532172754|FG006|Overall Study|Maximum clinical benefit|1|||
147550346|NCT01621490|532172755|FG007|Overall Study|Maximum clinical benefit|2|||
147550347|NCT01621490|532172756|FG008|Overall Study|Maximum clinical benefit|2|||
147550348|NCT01621490|532172757|FG009|Overall Study|Maximum clinical benefit|0|||
147550349|NCT01621490|532172758|FG010|Overall Study|Maximum clinical benefit|0|||
147550350|NCT01621490|532172748|FG000|Overall Study|Withdrawal by Subject|1|||
147550351|NCT01621490|532172749|FG001|Overall Study|Withdrawal by Subject|0|||
147550352|NCT01621490|532172750|FG002|Overall Study|Withdrawal by Subject|0|||
147550353|NCT01621490|532172751|FG003|Overall Study|Withdrawal by Subject|0|||
147550354|NCT01621490|532172752|FG004|Overall Study|Withdrawal by Subject|0|||
147550355|NCT01621490|532172753|FG005|Overall Study|Withdrawal by Subject|1|||
147550356|NCT01621490|532172754|FG006|Overall Study|Withdrawal by Subject|0|||
147550357|NCT01621490|532172755|FG007|Overall Study|Withdrawal by Subject|0|||
147550358|NCT01621490|532172756|FG008|Overall Study|Withdrawal by Subject|0|||
147550359|NCT01621490|532172757|FG009|Overall Study|Withdrawal by Subject|0|||
147550360|NCT01621490|532172758|FG010|Overall Study|Withdrawal by Subject|0|||
147550361|NCT01621490|532172748|FG000|Overall Study|Subject request to discontinue study|1|||
147550362|NCT01621490|532172749|FG001|Overall Study|Subject request to discontinue study|3|||
147550363|NCT01621490|532172750|FG002|Overall Study|Subject request to discontinue study|1|||
147550364|NCT01621490|532172751|FG003|Overall Study|Subject request to discontinue study|1|||
147550365|NCT01621490|532172752|FG004|Overall Study|Subject request to discontinue study|0|||
147550366|NCT01621490|532172753|FG005|Overall Study|Subject request to discontinue study|2|||
147550367|NCT01621490|532172754|FG006|Overall Study|Subject request to discontinue study|1|||
147550368|NCT01621490|532172755|FG007|Overall Study|Subject request to discontinue study|0|||
147550369|NCT01621490|532172756|FG008|Overall Study|Subject request to discontinue study|1|||
147550370|NCT01621490|532172757|FG009|Overall Study|Subject request to discontinue study|0|||
147550371|NCT01621490|532172758|FG010|Overall Study|Subject request to discontinue study|0|||
147550372|NCT01621490|532172748|FG000|Overall Study|Adverse event unrelated to study drug|1|||
147550373|NCT01621490|532172749|FG001|Overall Study|Adverse event unrelated to study drug|1|||
147550374|NCT01621490|532172750|FG002|Overall Study|Adverse event unrelated to study drug|0|||
147550375|NCT01621490|532172751|FG003|Overall Study|Adverse event unrelated to study drug|0|||
147550376|NCT01621490|532172752|FG004|Overall Study|Adverse event unrelated to study drug|0|||
147550377|NCT01621490|532172753|FG005|Overall Study|Adverse event unrelated to study drug|0|||
147550378|NCT01621490|532172754|FG006|Overall Study|Adverse event unrelated to study drug|0|||
147550379|NCT01621490|532172755|FG007|Overall Study|Adverse event unrelated to study drug|2|||
147550380|NCT01621490|532172756|FG008|Overall Study|Adverse event unrelated to study drug|0|||
147550381|NCT01621490|532172757|FG009|Overall Study|Adverse event unrelated to study drug|0|||
147550382|NCT01621490|532172758|FG010|Overall Study|Adverse event unrelated to study drug|0|||
147550383|NCT01621490|532172748|FG000|Overall Study|Disease progression|27|||
147550384|NCT01621490|532172749|FG001|Overall Study|Disease progression|28|||
147550385|NCT01621490|532172750|FG002|Overall Study|Disease progression|1|||
147550386|NCT01621490|532172751|FG003|Overall Study|Disease progression|5|||
147550387|NCT01621490|532172752|FG004|Overall Study|Disease progression|3|||
147550388|NCT01621490|532172753|FG005|Overall Study|Disease progression|8|||
147550389|NCT01621490|532172754|FG006|Overall Study|Disease progression|7|||
147550390|NCT01621490|532172755|FG007|Overall Study|Disease progression|1|||
147550391|NCT01621490|532172756|FG008|Overall Study|Disease progression|4|||
147215503|NCT03859973|530961656|FG001|Overall Study|Lost to Follow-up|3|||
147550392|NCT01621490|532172757|FG009|Overall Study|Disease progression|1|||
147550393|NCT01621490|532172758|FG010|Overall Study|Disease progression|1|||
147550394|NCT01621490|532172748|FG000|Overall Study|Study drug toxicity|1|||
147550395|NCT01621490|532172749|FG001|Overall Study|Study drug toxicity|4|||
147550396|NCT01621490|532172750|FG002|Overall Study|Study drug toxicity|5|||
147550397|NCT01621490|532172751|FG003|Overall Study|Study drug toxicity|3|||
147550398|NCT01621490|532172752|FG004|Overall Study|Study drug toxicity|1|||
147550399|NCT01621490|532172753|FG005|Overall Study|Study drug toxicity|10|||
147550400|NCT01621490|532172754|FG006|Overall Study|Study drug toxicity|1|||
147550401|NCT01621490|532172755|FG007|Overall Study|Study drug toxicity|4|||
147215504|NCT03859973|530961655|FG000|Overall Study|Protocol Violation|1|||
147215505|NCT03859973|530961656|FG001|Overall Study|Protocol Violation|3|||
147550402|NCT01621490|532172756|FG008|Overall Study|Study drug toxicity|1|||
147550403|NCT01621490|532172757|FG009|Overall Study|Study drug toxicity|0|||
147550404|NCT01621490|532172758|FG010|Overall Study|Study drug toxicity|0|||
147550405|NCT01621490|532172748|FG000|Overall Study|Death|0|||
147215506|NCT03859973|530961655|FG000|Overall Study|Adverse Event|3|||
147550406|NCT01621490|532172749|FG001|Overall Study|Death|0|||
147550407|NCT01621490|532172750|FG002|Overall Study|Death|0|||
147215507|NCT03859973|530961656|FG001|Overall Study|Adverse Event|5|||
147215508|NCT02855541|530961657|FG000|Overall Study|Change in health status|2|||
147215509|NCT02855541|530961657|FG000|Overall Study|Withdrawal by Subject|2|||
147215510|NCT04493892|530961663|FG000|Overall Study|Withdrawal by Subject|15|||
147215511|NCT01689532|530961664|FG000|Overall Study|Adverse Event|9|||
147215512|NCT01689532|530961665|FG001|Overall Study|Adverse Event|5|||
147215513|NCT01689532|530961664|FG000|Overall Study|Lack of Efficacy|2|||
147215514|NCT01689532|530961665|FG001|Overall Study|Lack of Efficacy|2|||
147215515|NCT01689532|530961664|FG000|Overall Study|Withdrawal by Subject|1|||
147215516|NCT01689532|530961665|FG001|Overall Study|Withdrawal by Subject|2|||
147215517|NCT01689532|530961664|FG000|Overall Study|Physician Decision|2|||
147215518|NCT01689532|530961665|FG001|Overall Study|Physician Decision|0|||
147215519|NCT01363349|530961666|FG000|Overall Study|Adverse Event|6|||
147442525|NCT04419610|531786008|FG001|Overall Study|Adverse Event|0|||
147442526|NCT04419610|531786007|FG000|Overall Study|discharged early|1|||
147550408|NCT01621490|532172751|FG003|Overall Study|Death|0|||
147442527|NCT04419610|531786008|FG001|Overall Study|discharged early|1|||
147442528|NCT01502709|531786012|FG000|Overall Study|Lost to Follow-up|4|||
147442529|NCT01502709|531786013|FG001|Overall Study|Lost to Follow-up|0|||
147442530|NCT00307151|531786014|FG000|Overall Study|Death|4|||
147442531|NCT00307151|531786015|FG001|Overall Study|Death|3|||
147442532|NCT00307151|531786016|FG002|Overall Study|Death|10|||
147442533|NCT00307151|531786017|FG003|Overall Study|Death|3|||
147442534|NCT00307151|531786014|FG000|Overall Study|Severe debilitation, unable to continue|1|||
147442535|NCT00307151|531786015|FG001|Overall Study|Severe debilitation, unable to continue|0|||
147442536|NCT00307151|531786016|FG002|Overall Study|Severe debilitation, unable to continue|0|||
147442537|NCT00307151|531786017|FG003|Overall Study|Severe debilitation, unable to continue|0|||
147442538|NCT00307151|531786014|FG000|Overall Study|Subject unable to get to clinic|1|||
147442539|NCT00307151|531786015|FG001|Overall Study|Subject unable to get to clinic|0|||
147442540|NCT00307151|531786016|FG002|Overall Study|Subject unable to get to clinic|6|||
147442541|NCT00307151|531786017|FG003|Overall Study|Subject unable to get to clinic|2|||
147442542|NCT00307151|531786014|FG000|Overall Study|Withdrew consent|0|||
147442543|NCT00307151|531786015|FG001|Overall Study|Withdrew consent|1|||
147442544|NCT00307151|531786016|FG002|Overall Study|Withdrew consent|1|||
147442545|NCT00307151|531786017|FG003|Overall Study|Withdrew consent|3|||
147442546|NCT00307151|531786014|FG000|Overall Study|Not willing to adhere to study reqs|2|||
147442547|NCT00307151|531786015|FG001|Overall Study|Not willing to adhere to study reqs|0|||
147442548|NCT00307151|531786016|FG002|Overall Study|Not willing to adhere to study reqs|2|||
147442549|NCT00307151|531786017|FG003|Overall Study|Not willing to adhere to study reqs|2|||
147442550|NCT00307151|531786014|FG000|Overall Study|Clinic unable to contact subject|3|||
147442551|NCT00307151|531786015|FG001|Overall Study|Clinic unable to contact subject|3|||
147442552|NCT00307151|531786016|FG002|Overall Study|Clinic unable to contact subject|1|||
147442553|NCT00307151|531786017|FG003|Overall Study|Clinic unable to contact subject|1|||
147442554|NCT00346073|531786018|FG000|Overall Study|Serious Adverse Event|2|||
147442555|NCT00346073|531786019|FG001|Overall Study|Serious Adverse Event|0|||
147442556|NCT00346073|531786018|FG000|Overall Study|Lost to Follow-up|39|||
147442557|NCT00346073|531786019|FG001|Overall Study|Lost to Follow-up|24|||
147442558|NCT04179734|531786024|FG000|Group 1 Placebo, Group 2 Bremelanotide|Withdrawal by Subject|4|||
147442559|NCT04179734|531786025|FG001|Group 1 Placebo, Group 2 Bremelanotide|Withdrawal by Subject|3|||
147442560|NCT04179734|531786024|FG000|Group 1 Placebo, Group 2 Bremelanotide|Abnormal structural findings on MRI|0|||
147442561|NCT04179734|531786025|FG001|Group 1 Placebo, Group 2 Bremelanotide|Abnormal structural findings on MRI|2|||
147442562|NCT00937937|531786026|FG000|Overall Study|Adverse Event|6|||
147442563|NCT00937937|531786026|FG000|Overall Study|Withdrawal by Subject|2|||
147442564|NCT00937937|531786026|FG000|Overall Study|Progression/relapse|61|||
147442565|NCT00937937|531786026|FG000|Overall Study|Death|1|||
147442566|NCT00937937|531786026|FG000|Overall Study|Other|2|||
147442567|NCT02966509|531786027|FG000|Baseline Satisfaction Survey|Withdrawal by Subject|2|||
147442568|NCT02966509|531786028|FG001|Baseline Satisfaction Survey|Withdrawal by Subject|3|||
147442569|NCT02966509|531786027|FG000|Baseline Satisfaction Survey|Death|0|||
147442570|NCT02966509|531786028|FG001|Baseline Satisfaction Survey|Death|1|||
147442571|NCT02966509|531786027|FG000|Baseline Satisfaction Survey|Lost to Follow-up|1|||
147442572|NCT02966509|531786028|FG001|Baseline Satisfaction Survey|Lost to Follow-up|1|||
147442573|NCT02966509|531786027|FG000|Baseline Satisfaction Survey|Refused to Answer|1|||
147442574|NCT02966509|531786028|FG001|Baseline Satisfaction Survey|Refused to Answer|2|||
147442575|NCT02966509|531786027|FG000|6 Month Satisfaction Decision Survey|Death|22|||
147442576|NCT02966509|531786028|FG001|6 Month Satisfaction Decision Survey|Death|25|||
147442577|NCT02966509|531786027|FG000|6 Month Satisfaction Decision Survey|Withdrawal by Subject|2|||
147442578|NCT02966509|531786028|FG001|6 Month Satisfaction Decision Survey|Withdrawal by Subject|3|||
147442579|NCT02966509|531786027|FG000|6 Month Satisfaction Decision Survey|Lost to Follow-up|1|||
147442580|NCT02966509|531786028|FG001|6 Month Satisfaction Decision Survey|Lost to Follow-up|1|||
147442581|NCT02966509|531786027|FG000|6 Month Satisfaction Decision Survey|Refused to Answer|0|||
147550409|NCT01621490|532172752|FG004|Overall Study|Death|0|||
147215520|NCT01363349|530961667|FG001|Overall Study|Adverse Event|7|||
147215521|NCT01363349|530961666|FG000|Overall Study|Lack of Efficacy|3|||
147215522|NCT01363349|530961667|FG001|Overall Study|Lack of Efficacy|10|||
147550410|NCT01621490|532172753|FG005|Overall Study|Death|0|||
147550411|NCT01621490|532172754|FG006|Overall Study|Death|0|||
147550412|NCT01621490|532172755|FG007|Overall Study|Death|0|||
147550413|NCT01621490|532172756|FG008|Overall Study|Death|1|||
147550414|NCT01621490|532172757|FG009|Overall Study|Death|0|||
147550415|NCT01621490|532172758|FG010|Overall Study|Death|0|||
147550416|NCT01621490|532172748|FG000|Overall Study|Other reasons|7|||
147550417|NCT01621490|532172749|FG001|Overall Study|Other reasons|6|||
147550418|NCT01621490|532172750|FG002|Overall Study|Other reasons|4|||
147550419|NCT01621490|532172751|FG003|Overall Study|Other reasons|1|||
147550420|NCT01621490|532172752|FG004|Overall Study|Other reasons|1|||
147550421|NCT01621490|532172753|FG005|Overall Study|Other reasons|3|||
147550422|NCT01621490|532172754|FG006|Overall Study|Other reasons|1|||
147550423|NCT01621490|532172755|FG007|Overall Study|Other reasons|1|||
147550424|NCT01621490|532172756|FG008|Overall Study|Other reasons|1|||
147442582|NCT02966509|531786028|FG001|6 Month Satisfaction Decision Survey|Refused to Answer|2|||
147442583|NCT02966509|531786027|FG000|6 Month Satisfaction Survey|Death|36|||
147442584|NCT02966509|531786028|FG001|6 Month Satisfaction Survey|Death|33|||
147442585|NCT02966509|531786027|FG000|6 Month Satisfaction Survey|Withdrawal by Subject|2|||
147442586|NCT02966509|531786028|FG001|6 Month Satisfaction Survey|Withdrawal by Subject|3|||
147442587|NCT02966509|531786027|FG000|6 Month Satisfaction Survey|Lost to Follow-up|1|||
147442588|NCT02966509|531786028|FG001|6 Month Satisfaction Survey|Lost to Follow-up|1|||
147442589|NCT02966509|531786027|FG000|6 Month Satisfaction Survey|Refused to Answer|8|||
147442590|NCT02966509|531786028|FG001|6 Month Satisfaction Survey|Refused to Answer|11|||
147442591|NCT02966509|531786027|FG000|End of Life Utilization and Cost 6 Month|Patient Still Alive|69|||
147442592|NCT02966509|531786028|FG001|End of Life Utilization and Cost 6 Month|Patient Still Alive|75|||
147442593|NCT02966509|531786027|FG000|End of Life Utilization and Cost 15month|Patient Still Alive|45|||
147442594|NCT02966509|531786028|FG001|End of Life Utilization and Cost 15month|Patient Still Alive|48|||
147442595|NCT00054704|531786030|FG000|Overall Study|Lack of Efficacy|2|||
147442596|NCT00054704|531786031|FG001|Overall Study|Lack of Efficacy|3|||
147442597|NCT00054704|531786030|FG000|Overall Study|Adverse Event|3|||
147442598|NCT00054704|531786031|FG001|Overall Study|Adverse Event|1|||
147442599|NCT00054704|531786030|FG000|Overall Study|Lost to Follow-up|0|||
147442600|NCT00054704|531786031|FG001|Overall Study|Lost to Follow-up|1|||
147442601|NCT00003535|531786034|FG000|Overall Study|Not evaluable|5|||
147442602|NCT02289742|531786039|FG000|First Wear Period|Adverse event prior to treatment|0|||
147442603|NCT02289742|531786040|FG001|First Wear Period|Adverse event prior to treatment|1|||
147442604|NCT02289742|531786041|FG002|First Wear Period|Adverse event prior to treatment|0|||
147550425|NCT01621490|532172757|FG009|Overall Study|Other reasons|0|||
147550426|NCT01621490|532172758|FG010|Overall Study|Other reasons|0|||
147550427|NCT00506753|532172759|FG000|Overall Study|Lost to Follow-up|21|||
147550428|NCT00506753|532172760|FG001|Overall Study|Lost to Follow-up|15|||
147550429|NCT00125359|532172761|FG000|Overall Study|Death|4|||
147550430|NCT00125359|532172761|FG000|Overall Study|Adverse Event|5|||
147550431|NCT00125359|532172761|FG000|Overall Study|Physician Decision|14|||
147550432|NCT02451670|532172762|FG000|Overall Study|Did not have qualifying follow-up visit.|714|||
147550433|NCT02451670|532172763|FG001|Overall Study|Did not have qualifying follow-up visit.|696|||
147550434|NCT00461500|532172764|FG000|Overall Study|Adverse Event|1|||
147550435|NCT00461500|532172765|FG001|Overall Study|Adverse Event|0|||
147550436|NCT00461500|532172764|FG000|Overall Study|Lack of Efficacy|0|||
147550437|NCT00461500|532172765|FG001|Overall Study|Lack of Efficacy|1|||
147550438|NCT00461500|532172764|FG000|Overall Study|Expired Drug Treatment|1|||
147550439|NCT00461500|532172765|FG001|Overall Study|Expired Drug Treatment|1|||
147550440|NCT00461500|532172764|FG000|Overall Study|Study Stopped|1|||
147550441|NCT00461500|532172765|FG001|Overall Study|Study Stopped|2|||
147550442|NCT00461500|532172764|FG000|Overall Study|Drug Treatment Misuse|1|||
147550443|NCT00461500|532172765|FG001|Overall Study|Drug Treatment Misuse|0|||
147550444|NCT00461500|532172764|FG000|Overall Study|No Longer Willing to Take Part in Study|1|||
147550445|NCT00461500|532172765|FG001|Overall Study|No Longer Willing to Take Part in Study|0|||
147550446|NCT00461500|532172764|FG000|Overall Study|Lost to Follow-up|2|||
147550447|NCT00461500|532172765|FG001|Overall Study|Lost to Follow-up|2|||
147550448|NCT01513551|532172770|FG000|Overall Study|Death|0|||
147550449|NCT01513551|532172771|FG001|Overall Study|Death|1|||
147550450|NCT01513551|532172772|FG002|Overall Study|Death|0|||
147550451|NCT01513551|532172770|FG000|Overall Study|Lost to Follow-up|3|||
147550452|NCT01513551|532172771|FG001|Overall Study|Lost to Follow-up|5|||
147550453|NCT01513551|532172772|FG002|Overall Study|Lost to Follow-up|2|||
147550454|NCT01513551|532172770|FG000|Overall Study|Withdrawal by Subject|1|||
147550455|NCT01513551|532172771|FG001|Overall Study|Withdrawal by Subject|0|||
147550456|NCT01513551|532172772|FG002|Overall Study|Withdrawal by Subject|2|||
147550457|NCT01513551|532172770|FG000|Overall Study|Randomized but not vaccinated|0|||
147550458|NCT01513551|532172771|FG001|Overall Study|Randomized but not vaccinated|0|||
147550459|NCT01513551|532172772|FG002|Overall Study|Randomized but not vaccinated|1|||
147550460|NCT02763579|532172773|FG000|Global Period|Death|167|||
147550461|NCT02763579|532172774|FG001|Global Period|Death|151|||
147550462|NCT02763579|532172775|FG002|Global Period|Death|0|||
147550463|NCT02763579|532172776|FG003|Global Period|Death|0|||
147550464|NCT02763579|532172773|FG000|Global Period|Lost to Follow-up|2|||
147550465|NCT02763579|532172774|FG001|Global Period|Lost to Follow-up|4|||
147550466|NCT02763579|532172775|FG002|Global Period|Lost to Follow-up|0|||
147550467|NCT02763579|532172776|FG003|Global Period|Lost to Follow-up|0|||
147550468|NCT02763579|532172773|FG000|Global Period|Physician Decision|0|||
147550469|NCT02763579|532172774|FG001|Global Period|Physician Decision|2|||
147550470|NCT02763579|532172775|FG002|Global Period|Physician Decision|0|||
147550471|NCT02763579|532172776|FG003|Global Period|Physician Decision|0|||
147550472|NCT02763579|532172773|FG000|Global Period|Study Terminated By Sponsor|21|||
147550473|NCT02763579|532172774|FG001|Global Period|Study Terminated By Sponsor|26|||
147215523|NCT01363349|530961666|FG000|Overall Study|Non compliance/Protocol deviations|2|||
147550474|NCT02763579|532172775|FG002|Global Period|Study Terminated By Sponsor|0|||
147550475|NCT02763579|532172776|FG003|Global Period|Study Terminated By Sponsor|0|||
147550476|NCT02763579|532172773|FG000|Global Period|Withdrawal by Subject|12|||
147550477|NCT02763579|532172774|FG001|Global Period|Withdrawal by Subject|18|||
147215524|NCT01363349|530961667|FG001|Overall Study|Non compliance/Protocol deviations|2|||
147215525|NCT01363349|530961666|FG000|Overall Study|Withdrawal by Subject|14|||
147550478|NCT02763579|532172775|FG002|Global Period|Withdrawal by Subject|0|||
147550479|NCT02763579|532172776|FG003|Global Period|Withdrawal by Subject|0|||
147550480|NCT02763579|532172773|FG000|China Period|Death|0|||
147550481|NCT02763579|532172774|FG001|China Period|Death|0|||
147550482|NCT02763579|532172775|FG002|China Period|Death|46|||
147550483|NCT02763579|532172776|FG003|China Period|Death|48|||
147550484|NCT02763579|532172773|FG000|China Period|Lost to Follow-up|0|||
147550485|NCT02763579|532172774|FG001|China Period|Lost to Follow-up|0|||
147550486|NCT02763579|532172775|FG002|China Period|Lost to Follow-up|1|||
147215526|NCT01363349|530961667|FG001|Overall Study|Withdrawal by Subject|6|||
147550487|NCT02763579|532172776|FG003|China Period|Lost to Follow-up|1|||
147550488|NCT02763579|532172773|FG000|China Period|Physician Decision|0|||
147550489|NCT02763579|532172774|FG001|China Period|Physician Decision|0|||
147550490|NCT02763579|532172775|FG002|China Period|Physician Decision|0|||
147550491|NCT02763579|532172776|FG003|China Period|Physician Decision|1|||
147550492|NCT02763579|532172773|FG000|China Period|Study Terminated By Sponsor|0|||
147550493|NCT02763579|532172774|FG001|China Period|Study Terminated By Sponsor|0|||
147550494|NCT02763579|532172775|FG002|China Period|Study Terminated By Sponsor|3|||
147550495|NCT02763579|532172776|FG003|China Period|Study Terminated By Sponsor|4|||
147550496|NCT02763579|532172773|FG000|China Period|Withdrawal by Subject|0|||
147550497|NCT02763579|532172774|FG001|China Period|Withdrawal by Subject|0|||
147550498|NCT02763579|532172775|FG002|China Period|Withdrawal by Subject|3|||
147550499|NCT02763579|532172776|FG003|China Period|Withdrawal by Subject|3|||
147550500|NCT04467697|532172780|FG000|Overall Study|Adverse Event|2|||
147550501|NCT04467697|532172780|FG000|Overall Study|Lost to Follow-up|6|||
147550502|NCT04467697|532172780|FG000|Overall Study|Withdrawal by Subject|9|||
147550503|NCT04467697|532172780|FG000|Overall Study|Protocol Violation|3|||
147550504|NCT05751629|532172781|FG000|Overall Study|Withdrawal by Subject|6|||
147550505|NCT05751629|532172781|FG000|Overall Study|Death|25|||
147550506|NCT05751629|532172781|FG000|Overall Study|Study Site Closed|9|||
147550507|NCT05751629|532172781|FG000|Overall Study|Physician Decision|1|||
147550508|NCT01909466|532172782|FG000|Overall Study|Lost to Follow-up|5|||
147550509|NCT01909466|532172783|FG001|Overall Study|Lost to Follow-up|7|||
147550510|NCT01909466|532172782|FG000|Overall Study|Adverse Event|3|||
147550511|NCT01909466|532172783|FG001|Overall Study|Adverse Event|4|||
147215527|NCT01363349|530961666|FG000|Overall Study|Lost to Follow-up|5|||
147215528|NCT01363349|530961667|FG001|Overall Study|Lost to Follow-up|6|||
147215529|NCT01363349|530961666|FG000|Overall Study|Not reported|36|||
147215530|NCT01363349|530961667|FG001|Overall Study|Not reported|37|||
147550512|NCT01909466|532172782|FG000|Overall Study|Met Withdrawal Criteria|0|||
147550513|NCT01909466|532172783|FG001|Overall Study|Met Withdrawal Criteria|3|||
147550514|NCT01909466|532172782|FG000|Overall Study|Physician Decision|2|||
147550515|NCT01909466|532172783|FG001|Overall Study|Physician Decision|0|||
147550516|NCT01909466|532172782|FG000|Overall Study|Withdrawal by Subject|11|||
147550517|NCT01909466|532172783|FG001|Overall Study|Withdrawal by Subject|9|||
147550518|NCT01909466|532172782|FG000|Overall Study|Lack of Efficacy|1|||
147550519|NCT01909466|532172783|FG001|Overall Study|Lack of Efficacy|0|||
147550520|NCT00673361|532172787|FG000|Overall Study|Screen Failure|2|||
147550521|NCT03038113|532172792|FG000|Overall Study|Withdrawal by Subject|0|||
147550522|NCT03038113|532172793|FG001|Overall Study|Withdrawal by Subject|0|||
147215531|NCT01363349|530961666|FG000|Overall Study|missing|1|||
147215532|NCT01363349|530961667|FG001|Overall Study|missing|2|||
147550523|NCT03038113|532172794|FG002|Overall Study|Withdrawal by Subject|1|||
147215533|NCT01958489|530961668|FG000|Period 2|Adverse Event|0|||
147215534|NCT01958489|530961669|FG001|Period 2|Adverse Event|1|||
147550524|NCT03038113|532172795|FG003|Overall Study|Withdrawal by Subject|0|||
147550525|NCT03038113|532172796|FG004|Overall Study|Withdrawal by Subject|0|||
147550526|NCT03038113|532172797|FG005|Overall Study|Withdrawal by Subject|0|||
147550527|NCT03038113|532172798|FG006|Overall Study|Withdrawal by Subject|0|||
147550528|NCT03038113|532172799|FG007|Overall Study|Withdrawal by Subject|0|||
147550529|NCT03038113|532172800|FG008|Overall Study|Withdrawal by Subject|0|||
147550530|NCT03038113|532172801|FG009|Overall Study|Withdrawal by Subject|0|||
147550531|NCT03038113|532172802|FG010|Overall Study|Withdrawal by Subject|0|||
147550532|NCT03038113|532172803|FG011|Overall Study|Withdrawal by Subject|0|||
147550533|NCT03038113|532172804|FG012|Overall Study|Withdrawal by Subject|0|||
147550534|NCT03038113|532172805|FG013|Overall Study|Withdrawal by Subject|1|||
147550535|NCT03038113|532172792|FG000|Overall Study|Lost to Follow-up|0|||
147550536|NCT03038113|532172793|FG001|Overall Study|Lost to Follow-up|0|||
147550537|NCT03038113|532172794|FG002|Overall Study|Lost to Follow-up|0|||
147550538|NCT03038113|532172795|FG003|Overall Study|Lost to Follow-up|0|||
147550539|NCT03038113|532172796|FG004|Overall Study|Lost to Follow-up|0|||
147550540|NCT03038113|532172797|FG005|Overall Study|Lost to Follow-up|0|||
147550541|NCT03038113|532172798|FG006|Overall Study|Lost to Follow-up|1|||
147550542|NCT03038113|532172799|FG007|Overall Study|Lost to Follow-up|0|||
147550543|NCT03038113|532172800|FG008|Overall Study|Lost to Follow-up|0|||
147550544|NCT03038113|532172801|FG009|Overall Study|Lost to Follow-up|0|||
147550545|NCT03038113|532172802|FG010|Overall Study|Lost to Follow-up|0|||
147550546|NCT03038113|532172803|FG011|Overall Study|Lost to Follow-up|0|||
147550547|NCT03038113|532172804|FG012|Overall Study|Lost to Follow-up|0|||
147550548|NCT03038113|532172805|FG013|Overall Study|Lost to Follow-up|0|||
147550549|NCT01698320|532172814|FG000|Run-In Period (Week -1 to Day 0)|Inclusion/exclusion criteria|24|||
147550550|NCT01698320|532172815|FG001|Run-In Period (Week -1 to Day 0)|Inclusion/exclusion criteria|0|||
147550551|NCT01698320|532172816|FG002|Run-In Period (Week -1 to Day 0)|Inclusion/exclusion criteria|0|||
147550552|NCT01698320|532172814|FG000|Run-In Period (Week -1 to Day 0)|Withdrawal by Subject|1|||
147550553|NCT01698320|532172815|FG001|Run-In Period (Week -1 to Day 0)|Withdrawal by Subject|0|||
147550554|NCT01698320|532172816|FG002|Run-In Period (Week -1 to Day 0)|Withdrawal by Subject|0|||
147550555|NCT01698320|532172814|FG000|Run-In Period (Week -1 to Day 0)|Lost to Follow-up|1|||
147550556|NCT01698320|532172815|FG001|Run-In Period (Week -1 to Day 0)|Lost to Follow-up|0|||
147550557|NCT01698320|532172816|FG002|Run-In Period (Week -1 to Day 0)|Lost to Follow-up|0|||
147550558|NCT01698320|532172814|FG000|Run-In Period (Week -1 to Day 0)|Other|1|||
147550559|NCT01698320|532172815|FG001|Run-In Period (Week -1 to Day 0)|Other|0|||
147550560|NCT01698320|532172816|FG002|Run-In Period (Week -1 to Day 0)|Other|0|||
147550561|NCT01698320|532172814|FG000|12-Week Double-Blind Period|Adverse Event|0|||
147550562|NCT01698320|532172815|FG001|12-Week Double-Blind Period|Adverse Event|1|||
147550563|NCT01698320|532172816|FG002|12-Week Double-Blind Period|Adverse Event|1|||
147550564|NCT01698320|532172814|FG000|12-Week Double-Blind Period|Withdrawal by Subject|0|||
147550565|NCT01698320|532172815|FG001|12-Week Double-Blind Period|Withdrawal by Subject|2|||
147550566|NCT01698320|532172816|FG002|12-Week Double-Blind Period|Withdrawal by Subject|2|||
147550567|NCT01698320|532172814|FG000|12-Week Double-Blind Period|Protocol Violation|0|||
147550568|NCT01698320|532172815|FG001|12-Week Double-Blind Period|Protocol Violation|0|||
147550569|NCT01698320|532172816|FG002|12-Week Double-Blind Period|Protocol Violation|2|||
147550570|NCT01698320|532172814|FG000|12-Week Double-Blind Period|Pregnancy|0|||
147550571|NCT01698320|532172815|FG001|12-Week Double-Blind Period|Pregnancy|1|||
147550572|NCT01698320|532172816|FG002|12-Week Double-Blind Period|Pregnancy|1|||
147550573|NCT01698320|532172814|FG000|12-Week Double-Blind Period|Sponsor requested subject withdrawal|0|||
147550574|NCT01698320|532172815|FG001|12-Week Double-Blind Period|Sponsor requested subject withdrawal|0|||
147550575|NCT01698320|532172816|FG002|12-Week Double-Blind Period|Sponsor requested subject withdrawal|2|||
147550576|NCT01698320|532172814|FG000|12-Week Double-Blind Period|Lost to Follow-up|0|||
147550577|NCT01698320|532172815|FG001|12-Week Double-Blind Period|Lost to Follow-up|0|||
147550578|NCT01698320|532172816|FG002|12-Week Double-Blind Period|Lost to Follow-up|4|||
147550579|NCT01698320|532172814|FG000|40-Week Open-Label Period|Adverse Event|0|||
147550580|NCT01698320|532172815|FG001|40-Week Open-Label Period|Adverse Event|3|||
147550581|NCT01698320|532172816|FG002|40-Week Open-Label Period|Adverse Event|2|||
147550582|NCT01698320|532172814|FG000|40-Week Open-Label Period|Withdrawal by Subject|0|||
147550583|NCT01698320|532172815|FG001|40-Week Open-Label Period|Withdrawal by Subject|11|||
147550584|NCT01698320|532172816|FG002|40-Week Open-Label Period|Withdrawal by Subject|7|||
147550585|NCT01698320|532172814|FG000|40-Week Open-Label Period|Pregnancy|0|||
147550586|NCT01698320|532172815|FG001|40-Week Open-Label Period|Pregnancy|2|||
147550587|NCT01698320|532172816|FG002|40-Week Open-Label Period|Pregnancy|1|||
147550588|NCT01698320|532172814|FG000|40-Week Open-Label Period|Sponsor requested subject withdrawal|0|||
147550589|NCT01698320|532172815|FG001|40-Week Open-Label Period|Sponsor requested subject withdrawal|1|||
147550590|NCT01698320|532172816|FG002|40-Week Open-Label Period|Sponsor requested subject withdrawal|0|||
147550591|NCT01698320|532172814|FG000|40-Week Open-Label Period|Lost to Follow-up|0|||
147550592|NCT01698320|532172815|FG001|40-Week Open-Label Period|Lost to Follow-up|2|||
147550593|NCT01698320|532172816|FG002|40-Week Open-Label Period|Lost to Follow-up|0|||
147550594|NCT02040766|532172820|FG000|Overall Study|Adverse Event|1|||
147550595|NCT02040766|532172821|FG001|Overall Study|Adverse Event|1|||
147215535|NCT00422084|530961672|FG000|Overall Study|Adverse Event|21|||
147215536|NCT00422084|530961673|FG001|Overall Study|Adverse Event|7|||
147215537|NCT00422084|530961672|FG000|Overall Study|Withdrawal by Subject|12|||
147215538|NCT00422084|530961673|FG001|Overall Study|Withdrawal by Subject|9|||
147215539|NCT00422084|530961672|FG000|Overall Study|Lost to Follow-up|14|||
147215540|NCT00422084|530961673|FG001|Overall Study|Lost to Follow-up|9|||
147215541|NCT00422084|530961672|FG000|Overall Study|Protocol Violation|4|||
147215542|NCT00422084|530961673|FG001|Overall Study|Protocol Violation|1|||
147215543|NCT00422084|530961672|FG000|Overall Study|Lack of Efficacy|40|||
147215544|NCT00422084|530961673|FG001|Overall Study|Lack of Efficacy|42|||
147215545|NCT00422084|530961672|FG000|Overall Study|P. vivax infection|3|||
147215546|NCT00422084|530961673|FG001|Overall Study|P. vivax infection|6|||
147215547|NCT00422084|530961672|FG000|Overall Study|Cyesis|1|||
147215548|NCT00422084|530961673|FG001|Overall Study|Cyesis|0|||
147215549|NCT00422084|530961672|FG000|Overall Study|Withdrawn from study accidentally|1|||
147215550|NCT00422084|530961673|FG001|Overall Study|Withdrawn from study accidentally|0|||
147215551|NCT00422084|530961672|FG000|Overall Study|Non-compliance|1|||
147215552|NCT00422084|530961673|FG001|Overall Study|Non-compliance|0|||
147215553|NCT00422084|530961672|FG000|Overall Study|Re-location|0|||
147215554|NCT00422084|530961673|FG001|Overall Study|Re-location|1|||
147215555|NCT00422084|530961672|FG000|Overall Study|Not defined|1|||
147215556|NCT00422084|530961673|FG001|Overall Study|Not defined|1|||
147215557|NCT03774823|530961674|FG000|Overall Study|Withdrawal by Subject|1|||
147215558|NCT03774823|530961675|FG001|Overall Study|Withdrawal by Subject|1|||
147442605|NCT02289742|531786042|FG003|First Wear Period|Adverse event prior to treatment|0|||
147442606|NCT02289742|531786039|FG000|First Wear Period|Adverse Event|0|||
147442607|NCT02289742|531786040|FG001|First Wear Period|Adverse Event|0|||
147442608|NCT02289742|531786041|FG002|First Wear Period|Adverse Event|1|||
147442609|NCT02289742|531786042|FG003|First Wear Period|Adverse Event|0|||
147442610|NCT02289742|531786039|FG000|First Wear Period|Other prior to treatment|0|||
147442611|NCT02289742|531786040|FG001|First Wear Period|Other prior to treatment|0|||
147442612|NCT02289742|531786041|FG002|First Wear Period|Other prior to treatment|0|||
147442613|NCT02289742|531786042|FG003|First Wear Period|Other prior to treatment|1|||
147442614|NCT02289742|531786039|FG000|Third Wear Period|Adverse Event|0|||
147442615|NCT02289742|531786040|FG001|Third Wear Period|Adverse Event|1|||
147442616|NCT02289742|531786041|FG002|Third Wear Period|Adverse Event|0|||
147442617|NCT02289742|531786042|FG003|Third Wear Period|Adverse Event|0|||
147442618|NCT02289742|531786039|FG000|Third Wear Period|Reason not given|0|||
147442619|NCT02289742|531786040|FG001|Third Wear Period|Reason not given|0|||
147442620|NCT02289742|531786041|FG002|Third Wear Period|Reason not given|0|||
147442621|NCT02289742|531786042|FG003|Third Wear Period|Reason not given|1|||
147442622|NCT01365039|531786043|FG000|Overall Study|Study related symptoms and complaints|1|||
147442623|NCT01365039|531786044|FG001|Overall Study|Study related symptoms and complaints|0|||
147442624|NCT03807349|531786047|FG000|Overall Study|Early Study Termination|9|||
147442625|NCT00294060|531786048|FG000|Overall Study|Death|225|||
147442626|NCT00294060|531786048|FG000|Overall Study|Other|59|||
147442627|NCT00294060|531786048|FG000|Overall Study|Lost to Follow-up|55|||
147442628|NCT00294060|531786048|FG000|Overall Study|Withdrawal by Subject|11|||
147442629|NCT00294060|531786048|FG000|Overall Study|Physician Decision|797|||
147442630|NCT00294060|531786048|FG000|Overall Study|Medical condition|3|||
147442631|NCT00294060|531786048|FG000|Overall Study|Device explanted/not replaced|23|||
147442632|NCT01360554|531786049|FG000|Overall Study|Death|359|||
147442633|NCT01360554|531786050|FG001|Overall Study|Death|371|||
147442634|NCT01360554|531786049|FG000|Overall Study|Lost to Follow-up|4|||
147442635|NCT01360554|531786050|FG001|Overall Study|Lost to Follow-up|4|||
147442636|NCT01360554|531786049|FG000|Overall Study|Withdrawal by Subject|23|||
147550596|NCT02040766|532172822|FG002|Overall Study|Adverse Event|1|||
147550597|NCT02040766|532172823|FG003|Overall Study|Adverse Event|0|||
147550598|NCT02040766|532172824|FG004|Overall Study|Adverse Event|2|||
147550599|NCT02040766|532172820|FG000|Overall Study|Withdrawal by Subject|4|||
147550600|NCT02040766|532172821|FG001|Overall Study|Withdrawal by Subject|3|||
147550601|NCT02040766|532172822|FG002|Overall Study|Withdrawal by Subject|2|||
147550602|NCT02040766|532172823|FG003|Overall Study|Withdrawal by Subject|3|||
147550603|NCT02040766|532172824|FG004|Overall Study|Withdrawal by Subject|2|||
147550604|NCT02040766|532172820|FG000|Overall Study|Non-compliance|0|||
147550605|NCT02040766|532172821|FG001|Overall Study|Non-compliance|1|||
147550606|NCT02040766|532172822|FG002|Overall Study|Non-compliance|0|||
147550607|NCT02040766|532172823|FG003|Overall Study|Non-compliance|0|||
147550608|NCT02040766|532172824|FG004|Overall Study|Non-compliance|0|||
147550609|NCT02040766|532172820|FG000|Overall Study|Protocol Violation|2|||
147550610|NCT02040766|532172821|FG001|Overall Study|Protocol Violation|1|||
147550611|NCT02040766|532172822|FG002|Overall Study|Protocol Violation|2|||
147550612|NCT02040766|532172823|FG003|Overall Study|Protocol Violation|3|||
147550613|NCT02040766|532172824|FG004|Overall Study|Protocol Violation|0|||
147550614|NCT02040766|532172820|FG000|Overall Study|Lost to Follow-up|4|||
147550615|NCT02040766|532172821|FG001|Overall Study|Lost to Follow-up|1|||
147550616|NCT02040766|532172822|FG002|Overall Study|Lost to Follow-up|3|||
147550617|NCT02040766|532172823|FG003|Overall Study|Lost to Follow-up|1|||
147550618|NCT02040766|532172824|FG004|Overall Study|Lost to Follow-up|4|||
147550619|NCT02040766|532172820|FG000|Overall Study|Not reported|1|||
147550620|NCT02040766|532172821|FG001|Overall Study|Not reported|0|||
147550621|NCT02040766|532172822|FG002|Overall Study|Not reported|0|||
147550622|NCT02040766|532172823|FG003|Overall Study|Not reported|0|||
147550623|NCT02040766|532172824|FG004|Overall Study|Not reported|0|||
147550624|NCT02040766|532172820|FG000|Overall Study|Lack of Efficacy|6|||
147550625|NCT02040766|532172821|FG001|Overall Study|Lack of Efficacy|3|||
147550626|NCT02040766|532172822|FG002|Overall Study|Lack of Efficacy|4|||
147550627|NCT02040766|532172823|FG003|Overall Study|Lack of Efficacy|6|||
147550628|NCT02040766|532172824|FG004|Overall Study|Lack of Efficacy|5|||
147550629|NCT01271933|532172825|FG000|Single-Blind Phase|Lack of Efficacy|37|||
147550630|NCT01271933|532172826|FG001|Single-Blind Phase|Lack of Efficacy|0|||
147550631|NCT01271933|532172827|FG002|Single-Blind Phase|Lack of Efficacy|0|||
147550632|NCT01271933|532172825|FG000|Single-Blind Phase|Lost to Follow-up|10|||
147550633|NCT01271933|532172826|FG001|Single-Blind Phase|Lost to Follow-up|0|||
147550634|NCT01271933|532172827|FG002|Single-Blind Phase|Lost to Follow-up|0|||
147550635|NCT01271933|532172825|FG000|Single-Blind Phase|Withdrawal by Subject|15|||
147550636|NCT01271933|532172826|FG001|Single-Blind Phase|Withdrawal by Subject|0|||
147550637|NCT01271933|532172827|FG002|Single-Blind Phase|Withdrawal by Subject|0|||
147550638|NCT01271933|532172825|FG000|Single-Blind Phase|Protocol Violation|3|||
147550639|NCT01271933|532172826|FG001|Single-Blind Phase|Protocol Violation|0|||
147550640|NCT01271933|532172827|FG002|Single-Blind Phase|Protocol Violation|0|||
147550641|NCT01271933|532172825|FG000|Single-Blind Phase|Adverse Event|52|||
147550642|NCT01271933|532172826|FG001|Single-Blind Phase|Adverse Event|0|||
147550643|NCT01271933|532172827|FG002|Single-Blind Phase|Adverse Event|0|||
147550644|NCT01271933|532172825|FG000|Single-Blind Phase|(Failed to meet dosing requirement)|1|||
147550645|NCT01271933|532172826|FG001|Single-Blind Phase|(Failed to meet dosing requirement)|0|||
147550646|NCT01271933|532172827|FG002|Single-Blind Phase|(Failed to meet dosing requirement)|0|||
147550647|NCT01271933|532172825|FG000|Single-Blind Phase|(Protocol non-compliance)|2|||
147550648|NCT01271933|532172826|FG001|Single-Blind Phase|(Protocol non-compliance)|0|||
147550649|NCT01271933|532172827|FG002|Single-Blind Phase|(Protocol non-compliance)|0|||
147550650|NCT01271933|532172825|FG000|Single-Blind Phase|(Participant request-personal reason)|1|||
147550651|NCT01271933|532172826|FG001|Single-Blind Phase|(Participant request-personal reason)|0|||
147550652|NCT01271933|532172827|FG002|Single-Blind Phase|(Participant request-personal reason)|0|||
147550653|NCT01271933|532172825|FG000|Double-Blind Phase|Randomized but not treated|0|||
147550654|NCT01271933|532172826|FG001|Double-Blind Phase|Randomized but not treated|0|||
147550655|NCT01271933|532172827|FG002|Double-Blind Phase|Randomized but not treated|1|||
147550656|NCT01271933|532172825|FG000|Double-Blind Phase|Lack of Efficacy|0|||
147550657|NCT01271933|532172826|FG001|Double-Blind Phase|Lack of Efficacy|6|||
147550658|NCT01271933|532172827|FG002|Double-Blind Phase|Lack of Efficacy|9|||
147550659|NCT01271933|532172825|FG000|Double-Blind Phase|Lost to Follow-up|0|||
147550660|NCT01271933|532172826|FG001|Double-Blind Phase|Lost to Follow-up|1|||
147550661|NCT01271933|532172827|FG002|Double-Blind Phase|Lost to Follow-up|1|||
147550662|NCT01271933|532172825|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
147215559|NCT01782469|530961681|FG000|Overall Study|Lost to Follow-up|1|||
147215560|NCT03241368|530961694|FG000|Overall Study|MRE Stricture or Patency Capsule Failure|25|||
147215561|NCT03241368|530961694|FG000|Overall Study|Lost to Follow-up|1|||
147215562|NCT03241368|530961694|FG000|Overall Study|Physician Decision|6|||
147215563|NCT03241368|530961694|FG000|Overall Study|Withdrawal by Subject|6|||
147442637|NCT01360554|531786050|FG001|Overall Study|Withdrawal by Subject|24|||
147442638|NCT01360554|531786049|FG000|Overall Study|Study terminated by sponsor|49|||
147550663|NCT01271933|532172826|FG001|Double-Blind Phase|Withdrawal by Subject|6|||
147550664|NCT01271933|532172827|FG002|Double-Blind Phase|Withdrawal by Subject|1|||
147550665|NCT01271933|532172825|FG000|Double-Blind Phase|Adverse Event|0|||
147550666|NCT01271933|532172826|FG001|Double-Blind Phase|Adverse Event|3|||
147550667|NCT01271933|532172827|FG002|Double-Blind Phase|Adverse Event|0|||
147550668|NCT01271933|532172825|FG000|Double-Blind Phase|Participant request-personal reason|0|||
147550669|NCT01271933|532172826|FG001|Double-Blind Phase|Participant request-personal reason|1|||
147550670|NCT01271933|532172827|FG002|Double-Blind Phase|Participant request-personal reason|0|||
147550671|NCT01620983|532172828|FG000|Overall Study|Lost to Follow-up|8|||
147649958|NCT02700698|532539767|FG001|Overall Study|Withdrawal by Subject|0|||
147442639|NCT01360554|531786050|FG001|Overall Study|Study terminated by sponsor|37|||
147442640|NCT01360554|531786049|FG000|Overall Study|Other, not specified|1|||
147442641|NCT01360554|531786050|FG001|Overall Study|Other, not specified|0|||
147442642|NCT01360554|531786049|FG000|Overall Study|Randomized but not treated.|3|||
147442643|NCT01360554|531786050|FG001|Overall Study|Randomized but not treated.|3|||
147442644|NCT00187096|531786051|FG000|Overall Study|unacceptable toxicity|0|||
147442645|NCT00187096|531786052|FG001|Overall Study|unacceptable toxicity|0|||
147442646|NCT00187096|531786053|FG002|Overall Study|unacceptable toxicity|1|||
147442647|NCT01911442|531786054|FG000|Overall Study|Adverse Event|2|||
147442648|NCT01911442|531786055|FG001|Overall Study|Adverse Event|2|||
147442649|NCT01911442|531786056|FG002|Overall Study|Adverse Event|4|||
147442650|NCT01911442|531786054|FG000|Overall Study|Lack of Efficacy|1|||
147442651|NCT01911442|531786055|FG001|Overall Study|Lack of Efficacy|1|||
147442652|NCT01911442|531786056|FG002|Overall Study|Lack of Efficacy|1|||
147215564|NCT03241368|530961694|FG000|Overall Study|Protocol Violation|1|||
147442653|NCT01911442|531786054|FG000|Overall Study|Lost to Follow-up|2|||
147550672|NCT01620983|532172829|FG001|Overall Study|Lost to Follow-up|4|||
147550673|NCT01620983|532172830|FG002|Overall Study|Lost to Follow-up|9|||
147550674|NCT01620983|532172828|FG000|Overall Study|Withdrawal by Subject|6|||
147550675|NCT01620983|532172829|FG001|Overall Study|Withdrawal by Subject|8|||
147550676|NCT01620983|532172830|FG002|Overall Study|Withdrawal by Subject|1|||
147550677|NCT01620983|532172828|FG000|Overall Study|Death|2|||
147550678|NCT01620983|532172829|FG001|Overall Study|Death|0|||
147550679|NCT01620983|532172830|FG002|Overall Study|Death|0|||
147550680|NCT01620983|532172828|FG000|Overall Study|Physician Decision|3|||
147550681|NCT01620983|532172829|FG001|Overall Study|Physician Decision|10|||
147550682|NCT01620983|532172830|FG002|Overall Study|Physician Decision|5|||
147550683|NCT01724359|532172831|FG000|Overall Study|Adverse Event|10|||
147550684|NCT01724359|532172831|FG000|Overall Study|Death|1|||
147550685|NCT01724359|532172831|FG000|Overall Study|Other|20|||
147550686|NCT01335464|532172832|FG000|Overall Study|Adverse Event|15|||
147550687|NCT01335464|532172833|FG001|Overall Study|Adverse Event|25|||
147550688|NCT01335464|532172832|FG000|Overall Study|Non compliant with protocol|2|||
147550689|NCT01335464|532172833|FG001|Overall Study|Non compliant with protocol|0|||
147550690|NCT01335464|532172832|FG000|Overall Study|Consent withdrawn, not due to AE|12|||
147550691|NCT01335464|532172833|FG001|Overall Study|Consent withdrawn, not due to AE|23|||
147550692|NCT01335464|532172832|FG000|Overall Study|Not treated|2|||
147550693|NCT01335464|532172833|FG001|Overall Study|Not treated|0|||
147550694|NCT01335464|532172832|FG000|Overall Study|Reason other than those stated above|1|||
147550695|NCT01335464|532172833|FG001|Overall Study|Reason other than those stated above|1|||
147550696|NCT00871169|532172834|FG000|Overall Study|Protocol Violation|1|||
147550697|NCT00871169|532172834|FG000|Overall Study|Patient did not receive study treatment|2|||
147550698|NCT00252187|532172835|FG000|Overall Study|Adverse Event|3|||
147550699|NCT00252187|532172836|FG001|Overall Study|Adverse Event|1|||
147550700|NCT00252187|532172835|FG000|Overall Study|Withdrawal by Subject|1|||
147550701|NCT00252187|532172836|FG001|Overall Study|Withdrawal by Subject|0|||
147550702|NCT02280356|532172848|FG000|Overall Study|Not Treated|2|||
147550703|NCT02280356|532172848|FG000|Overall Study|Withdrawal by Subject|1|||
147550704|NCT02280356|532172848|FG000|Overall Study|Not evaluable|2|||
147550705|NCT03493698|532172849|FG000|Treatment Period C|Adverse Event|1|||
147550706|NCT03493698|532172849|FG000|Treatment Period C|Withdrawal by Subject|1|||
147550707|NCT03361956|532172850|FG000|Overall Study|Adverse Event|1|||
147550708|NCT03361956|532172851|FG001|Overall Study|Adverse Event|0|||
147550709|NCT03361956|532172852|FG002|Overall Study|Adverse Event|1|||
147550710|NCT03361956|532172853|FG003|Overall Study|Adverse Event|1|||
147550711|NCT03361956|532172854|FG004|Overall Study|Adverse Event|0|||
147550712|NCT03361956|532172850|FG000|Overall Study|Other|0|||
147550713|NCT03361956|532172851|FG001|Overall Study|Other|0|||
147550714|NCT03361956|532172852|FG002|Overall Study|Other|0|||
147550715|NCT03361956|532172853|FG003|Overall Study|Other|1|||
147550716|NCT03361956|532172854|FG004|Overall Study|Other|0|||
147550717|NCT03361956|532172850|FG000|Overall Study|Withdrawal by Subject|2|||
147550718|NCT03361956|532172851|FG001|Overall Study|Withdrawal by Subject|2|||
147550719|NCT03361956|532172852|FG002|Overall Study|Withdrawal by Subject|2|||
147550720|NCT03361956|532172853|FG003|Overall Study|Withdrawal by Subject|0|||
147550721|NCT03361956|532172854|FG004|Overall Study|Withdrawal by Subject|3|||
147550722|NCT03361956|532172850|FG000|Overall Study|Disease Relapse|0|||
147550723|NCT03361956|532172851|FG001|Overall Study|Disease Relapse|0|||
147550724|NCT03361956|532172852|FG002|Overall Study|Disease Relapse|1|||
147550725|NCT03361956|532172853|FG003|Overall Study|Disease Relapse|0|||
147550726|NCT03361956|532172854|FG004|Overall Study|Disease Relapse|0|||
147550727|NCT03361956|532172850|FG000|Overall Study|Physician Decision|0|||
147550728|NCT03361956|532172851|FG001|Overall Study|Physician Decision|2|||
147550729|NCT03361956|532172852|FG002|Overall Study|Physician Decision|0|||
147550730|NCT03361956|532172853|FG003|Overall Study|Physician Decision|1|||
147550731|NCT03361956|532172854|FG004|Overall Study|Physician Decision|0|||
147550732|NCT03361956|532172850|FG000|Overall Study|Lost to Follow-up|0|||
147550733|NCT03361956|532172851|FG001|Overall Study|Lost to Follow-up|0|||
147550734|NCT03361956|532172852|FG002|Overall Study|Lost to Follow-up|1|||
147550735|NCT03361956|532172853|FG003|Overall Study|Lost to Follow-up|1|||
147550736|NCT03361956|532172854|FG004|Overall Study|Lost to Follow-up|2|||
147550737|NCT00291330|532172856|FG000|Overall Study|Adverse Event|47|||
147550738|NCT00291330|532172857|FG001|Overall Study|Adverse Event|40|||
147550739|NCT00291330|532172856|FG000|Overall Study|Protocol Violation|13|||
147550740|NCT00291330|532172857|FG001|Overall Study|Protocol Violation|20|||
147550741|NCT00291330|532172856|FG000|Overall Study|Lost to Follow-up|16|||
147550742|NCT00291330|532172857|FG001|Overall Study|Lost to Follow-up|11|||
147550743|NCT00291330|532172856|FG000|Overall Study|Withdrawal by Subject|22|||
147550744|NCT00291330|532172857|FG001|Overall Study|Withdrawal by Subject|25|||
147550745|NCT00291330|532172856|FG000|Overall Study|Other|3|||
147550746|NCT00291330|532172857|FG001|Overall Study|Other|1|||
147550747|NCT01829295|532172858|FG000|6-12 Months|Did not want to switch antimetabolites|0|||
147550748|NCT01829295|532172859|FG001|6-12 Months|Did not want to switch antimetabolites|0|||
147550749|NCT01829295|532172860|FG002|6-12 Months|Did not want to switch antimetabolites|9|||
147550750|NCT01829295|532172861|FG003|6-12 Months|Did not want to switch antimetabolites|11|||
147215565|NCT00548184|530961698|FG000|Overall Study|Adverse Event|3|||
147215566|NCT00548184|530961698|FG000|Overall Study|took other drug|1|||
147215567|NCT00548184|530961698|FG000|Overall Study|Found Her2 negative|1|||
147215568|NCT00280748|530961699|FG000|Overall Study|Decline in performance|3|||
147215569|NCT00280748|530961699|FG000|Overall Study|Extra-cranial disease progression|1|||
147215570|NCT00029146|530961700|FG000|Overall Study|Lost to Follow-up|2|||
147215571|NCT00029146|530961701|FG001|Overall Study|Lost to Follow-up|1|||
147215572|NCT01765218|530961702|FG000|Overall Study|Protocol Violation|1|||
147215573|NCT01765218|530961703|FG001|Overall Study|Protocol Violation|2|||
147215574|NCT00946985|530961704|FG000|Stabilization Phase (25 Weeks)|Adverse Event|4|||
147215575|NCT00946985|530961704|FG000|Stabilization Phase (25 Weeks)|Lack of Efficacy|3|||
147215576|NCT00946985|530961704|FG000|Stabilization Phase (25 Weeks)|Lost to Follow-up|5|||
147215577|NCT00946985|530961704|FG000|Stabilization Phase (25 Weeks)|Withdrawal by Subject|4|||
147215578|NCT00946985|530961704|FG000|Stabilization Phase (25 Weeks)|Study Closed by Sponsor|139|||
147215579|NCT00946985|530961704|FG000|Stabilization Phase (25 Weeks)|Failed to Meet Stability Criteria|2|||
147215580|NCT00946985|530961704|FG000|Stabilization Phase (25 Weeks)|Prohibited Medication During Study|1|||
147442654|NCT01911442|531786055|FG001|Overall Study|Lost to Follow-up|0|||
147442655|NCT01911442|531786056|FG002|Overall Study|Lost to Follow-up|1|||
147442656|NCT01911442|531786054|FG000|Overall Study|Withdrawal by Subject|1|||
147442657|NCT01911442|531786055|FG001|Overall Study|Withdrawal by Subject|0|||
147442658|NCT01911442|531786056|FG002|Overall Study|Withdrawal by Subject|6|||
147442659|NCT01911442|531786054|FG000|Overall Study|Mother's Work Schedule|0|||
147442660|NCT01911442|531786055|FG001|Overall Study|Mother's Work Schedule|1|||
147442661|NCT01911442|531786056|FG002|Overall Study|Mother's Work Schedule|0|||
147442662|NCT03668600|531786065|FG000|Overall Study|Study Terminated by the Sponsor|157|||
147442663|NCT03668600|531786065|FG000|Overall Study|Protocol Violation|1|||
147442664|NCT03668600|531786065|FG000|Overall Study|Pregnancy|1|||
147442665|NCT03668600|531786065|FG000|Overall Study|Lost to Follow-up|7|||
147442666|NCT03668600|531786065|FG000|Overall Study|Withdrawal by Subject|56|||
147442667|NCT03668600|531786065|FG000|Overall Study|Lack of Efficacy|7|||
147442668|NCT03668600|531786065|FG000|Overall Study|Adverse Event|1|||
147442669|NCT00424749|531786067|FG000|Overall Study|Withdrawal by Subject|1|||
147215581|NCT00946985|530961704|FG000|Stabilization Phase (25 Weeks)|Patient Moved Away|2|||
147215582|NCT00946985|530961704|FG000|Relapse Prevention Phase (24 Months)|Study Closed by Sponsor|2|||
147215583|NCT00313781|530961705|FG000|Before Crossover|Death|22|||
147215584|NCT00313781|530961706|FG001|Before Crossover|Death|8|||
147215585|NCT00313781|530961707|FG002|Before Crossover|Death|0|||
147215586|NCT00313781|530961705|FG000|Before Crossover|Lost to Follow-up|0|||
147215587|NCT00313781|530961706|FG001|Before Crossover|Lost to Follow-up|3|||
147215588|NCT00313781|530961707|FG002|Before Crossover|Lost to Follow-up|0|||
147215589|NCT00313781|530961705|FG000|Before Crossover|Withdrawal by Subject|3|||
147215590|NCT00313781|530961706|FG001|Before Crossover|Withdrawal by Subject|1|||
147215591|NCT00313781|530961707|FG002|Before Crossover|Withdrawal by Subject|0|||
147215592|NCT00313781|530961705|FG000|Before Crossover|Other|45|||
147215593|NCT00313781|530961706|FG001|Before Crossover|Other|30|||
147215594|NCT00313781|530961707|FG002|Before Crossover|Other|0|||
147215595|NCT00313781|530961705|FG000|Before Crossover|Crossover|0|||
147215596|NCT00313781|530961706|FG001|Before Crossover|Crossover|37|||
147215597|NCT00313781|530961707|FG002|Before Crossover|Crossover|0|||
147215598|NCT00313781|530961705|FG000|Before Crossover|Randomized, not treated|5|||
147215599|NCT00313781|530961706|FG001|Before Crossover|Randomized, not treated|0|||
147215600|NCT00313781|530961707|FG002|Before Crossover|Randomized, not treated|0|||
147215601|NCT00313781|530961705|FG000|After Crossover|Death|0|||
147442670|NCT01263483|531786068|FG000|Overall Study|Adverse Event|4|||
147442671|NCT01263483|531786069|FG001|Overall Study|Adverse Event|0|||
147442672|NCT01263483|531786070|FG002|Overall Study|Adverse Event|3|||
147442673|NCT01263483|531786068|FG000|Overall Study|Withdrawal by Subject|1|||
147442674|NCT01263483|531786069|FG001|Overall Study|Withdrawal by Subject|0|||
147442675|NCT01263483|531786070|FG002|Overall Study|Withdrawal by Subject|0|||
147442676|NCT01263483|531786068|FG000|Overall Study|Lack of Efficacy|2|||
147442677|NCT01263483|531786069|FG001|Overall Study|Lack of Efficacy|0|||
147442678|NCT01263483|531786070|FG002|Overall Study|Lack of Efficacy|0|||
147442679|NCT01263483|531786068|FG000|Overall Study|Protocol Violation|0|||
147442680|NCT01263483|531786069|FG001|Overall Study|Protocol Violation|1|||
147442681|NCT01263483|531786070|FG002|Overall Study|Protocol Violation|1|||
147442682|NCT01263483|531786068|FG000|Overall Study|Participant Unavailability|0|||
147442683|NCT01263483|531786069|FG001|Overall Study|Participant Unavailability|1|||
147442684|NCT01263483|531786070|FG002|Overall Study|Participant Unavailability|1|||
147442685|NCT04451161|531786071|FG000|Overall Study|Lost to Follow-up|28|||
147442686|NCT04451161|531786072|FG001|Overall Study|Lost to Follow-up|37|||
147442687|NCT04451161|531786073|FG002|Overall Study|Lost to Follow-up|22|||
147442688|NCT04451161|531786074|FG003|Overall Study|Lost to Follow-up|13|||
147442689|NCT04451161|531786075|FG004|Overall Study|Lost to Follow-up|11|||
147442690|NCT04451161|531786076|FG005|Overall Study|Lost to Follow-up|14|||
147442691|NCT04451161|531786071|FG000|Overall Study|Withdrawal by Subject|3|||
147442692|NCT04451161|531786072|FG001|Overall Study|Withdrawal by Subject|0|||
147442693|NCT04451161|531786073|FG002|Overall Study|Withdrawal by Subject|0|||
147442694|NCT04451161|531786074|FG003|Overall Study|Withdrawal by Subject|0|||
147442695|NCT04451161|531786075|FG004|Overall Study|Withdrawal by Subject|2|||
147442696|NCT04451161|531786076|FG005|Overall Study|Withdrawal by Subject|4|||
147442697|NCT00454857|531786077|FG000|Overall Study|Withdrawal by Subject|15|||
147442698|NCT00454857|531786077|FG000|Overall Study|Lost to Follow-up|16|||
147442699|NCT00454857|531786077|FG000|Overall Study|Noncompliance|6|||
147442700|NCT00454857|531786077|FG000|Overall Study|Death|5|||
147442701|NCT00454857|531786077|FG000|Overall Study|Other|11|||
147442702|NCT00454857|531786077|FG000|Overall Study|Reason unknown|1|||
147442703|NCT01431274|531786078|FG000|Overall Study|Adverse Event|51|||
147442704|NCT01431274|531786079|FG001|Overall Study|Adverse Event|37|||
147442705|NCT01431274|531786080|FG002|Overall Study|Adverse Event|43|||
147442706|NCT01431274|531786081|FG003|Overall Study|Adverse Event|30|||
147442707|NCT01431274|531786082|FG004|Overall Study|Adverse Event|37|||
147442708|NCT01431274|531786078|FG000|Overall Study|Consent withdrawn not due to AE|29|||
147442709|NCT01431274|531786079|FG001|Overall Study|Consent withdrawn not due to AE|20|||
147442710|NCT01431274|531786080|FG002|Overall Study|Consent withdrawn not due to AE|17|||
147442711|NCT01431274|531786081|FG003|Overall Study|Consent withdrawn not due to AE|20|||
147442712|NCT01431274|531786082|FG004|Overall Study|Consent withdrawn not due to AE|11|||
147442713|NCT01431274|531786078|FG000|Overall Study|Non compliant with protocol|5|||
147442714|NCT01431274|531786079|FG001|Overall Study|Non compliant with protocol|8|||
147442715|NCT01431274|531786080|FG002|Overall Study|Non compliant with protocol|4|||
147442716|NCT01431274|531786081|FG003|Overall Study|Non compliant with protocol|4|||
147442717|NCT01431274|531786082|FG004|Overall Study|Non compliant with protocol|4|||
147442718|NCT01431274|531786078|FG000|Overall Study|Lost to Follow-up|6|||
147442719|NCT01431274|531786079|FG001|Overall Study|Lost to Follow-up|7|||
147442720|NCT01431274|531786080|FG002|Overall Study|Lost to Follow-up|1|||
147442721|NCT01431274|531786081|FG003|Overall Study|Lost to Follow-up|4|||
147442722|NCT01431274|531786082|FG004|Overall Study|Lost to Follow-up|0|||
147442723|NCT01431274|531786078|FG000|Overall Study|Other reason not stated above|6|||
147442724|NCT01431274|531786079|FG001|Overall Study|Other reason not stated above|5|||
147442725|NCT01431274|531786080|FG002|Overall Study|Other reason not stated above|7|||
147442726|NCT01431274|531786081|FG003|Overall Study|Other reason not stated above|2|||
147215602|NCT00313781|530961706|FG001|After Crossover|Death|0|||
147215603|NCT00313781|530961707|FG002|After Crossover|Death|6|||
147215604|NCT00313781|530961705|FG000|After Crossover|Withdrawal by Subject|0|||
147215605|NCT00313781|530961706|FG001|After Crossover|Withdrawal by Subject|0|||
147215606|NCT00313781|530961707|FG002|After Crossover|Withdrawal by Subject|3|||
147215607|NCT00313781|530961705|FG000|After Crossover|Other|0|||
147215608|NCT00313781|530961706|FG001|After Crossover|Other|0|||
147215609|NCT00313781|530961707|FG002|After Crossover|Other|18|||
147215610|NCT01546623|530961709|FG000|Overall Study|Adverse Event|2|||
147215611|NCT01546623|530961710|FG001|Overall Study|Adverse Event|3|||
147215612|NCT01546623|530961709|FG000|Overall Study|Major Protocol Deviation|1|||
147215613|NCT01546623|530961710|FG001|Overall Study|Major Protocol Deviation|1|||
147215614|NCT01546623|530961709|FG000|Overall Study|High Prostate specific antigen|2|||
147215615|NCT01546623|530961710|FG001|Overall Study|High Prostate specific antigen|1|||
147215616|NCT01546623|530961709|FG000|Overall Study|Did Not Receive Study Drug|1|||
147215617|NCT01546623|530961710|FG001|Overall Study|Did Not Receive Study Drug|1|||
147215618|NCT03567343|530961711|FG000|Overall Study|Lost to Follow-up|2|||
147215619|NCT03567343|530961712|FG001|Overall Study|Lost to Follow-up|1|||
147215620|NCT03567343|530961711|FG000|Overall Study|No longer eligible|2|||
147215621|NCT03567343|530961712|FG001|Overall Study|No longer eligible|1|||
147215622|NCT03567343|530961711|FG000|Overall Study|Adverse Event|1|||
147215623|NCT03567343|530961712|FG001|Overall Study|Adverse Event|0|||
147550751|NCT01829295|532172858|FG000|6-12 Months|Adverse Event|0|||
147550752|NCT01829295|532172859|FG001|6-12 Months|Adverse Event|0|||
147215624|NCT03567343|530961711|FG000|Overall Study|Protocol Violation|1|||
147215625|NCT03567343|530961712|FG001|Overall Study|Protocol Violation|1|||
147215626|NCT01590758|530961713|FG000|Overall Study|Withdrawal by Subject|0|||
147215627|NCT01590758|530961714|FG001|Overall Study|Withdrawal by Subject|3|||
147215628|NCT01590758|530961713|FG000|Overall Study|Physician Decision|1|||
147550753|NCT01829295|532172860|FG002|6-12 Months|Adverse Event|3|||
147550754|NCT01829295|532172861|FG003|6-12 Months|Adverse Event|2|||
147550755|NCT01829295|532172858|FG000|6-12 Months|Lost to Follow-up|2|||
147550756|NCT01829295|532172859|FG001|6-12 Months|Lost to Follow-up|0|||
147550757|NCT01829295|532172860|FG002|6-12 Months|Lost to Follow-up|0|||
147550758|NCT01829295|532172861|FG003|6-12 Months|Lost to Follow-up|0|||
147550759|NCT01829295|532172858|FG000|6-12 Months|Withdrawal by Subject|2|||
147550760|NCT01829295|532172859|FG001|6-12 Months|Withdrawal by Subject|2|||
147550761|NCT01829295|532172860|FG002|6-12 Months|Withdrawal by Subject|0|||
147550762|NCT01829295|532172861|FG003|6-12 Months|Withdrawal by Subject|0|||
147550763|NCT02629965|532172864|FG000|Period 1|Adverse Event|1|||
147550764|NCT02629965|532172865|FG001|Period 1|Adverse Event|0|||
147550765|NCT02629965|532172864|FG000|Period 1|Unexpected worsening of disease|2|||
147550766|NCT02629965|532172865|FG001|Period 1|Unexpected worsening of disease|0|||
147550767|NCT02629965|532172864|FG000|Period 1|Other than listed above|1|||
147550768|NCT02629965|532172865|FG001|Period 1|Other than listed above|2|||
147550769|NCT02629965|532172864|FG000|Period 2|Adverse Event|1|||
147550770|NCT02629965|532172865|FG001|Period 2|Adverse Event|0|||
147550771|NCT03443869|532172866|FG000|Overall Study|Death|3|||
147550772|NCT03443869|532172867|FG001|Overall Study|Death|3|||
147550773|NCT03443869|532172866|FG000|Overall Study|Withdrawal by Subject|34|||
147550774|NCT03443869|532172867|FG001|Overall Study|Withdrawal by Subject|22|||
147550775|NCT03443869|532172866|FG000|Overall Study|Lost to Follow-up|1|||
147550776|NCT03443869|532172867|FG001|Overall Study|Lost to Follow-up|2|||
147550777|NCT03443869|532172866|FG000|Overall Study|Physician Decision|3|||
147550778|NCT03443869|532172867|FG001|Overall Study|Physician Decision|3|||
147550779|NCT03443869|532172866|FG000|Overall Study|Other|4|||
147550780|NCT03443869|532172867|FG001|Overall Study|Other|4|||
147550781|NCT02390219|532172868|FG000|Overall Study|Death|1|||
147550782|NCT02390219|532172868|FG000|Overall Study|Physician Decision|1|||
147550783|NCT02390219|532172868|FG000|Overall Study|Adverse Event|6|||
147550784|NCT02390219|532172868|FG000|Overall Study|Withdrawal by Subject|1|||
147550785|NCT02390219|532172868|FG000|Overall Study|Lost to Follow-up|2|||
147550786|NCT02390219|532172868|FG000|Overall Study|Other|2|||
147550787|NCT00299728|532172869|FG000|Overall Study|Lost to Follow-up|0|||
147550788|NCT00299728|532172870|FG001|Overall Study|Lost to Follow-up|1|||
147550789|NCT00299728|532172869|FG000|Overall Study|Withdrawal by Subject|0|||
147550790|NCT00299728|532172870|FG001|Overall Study|Withdrawal by Subject|1|||
147550791|NCT00299728|532172869|FG000|Overall Study|Progressive disease|0|||
147550792|NCT00299728|532172870|FG001|Overall Study|Progressive disease|1|||
147550793|NCT02230085|532172871|FG000|Overall Study|Physician Decision|1|||
147550794|NCT02230085|532172871|FG000|Overall Study|Withdrawal by Subject|3|||
147550795|NCT00580983|532172872|FG000|Overall Study|Did not complete 12 mon post RT studies|7|||
147550796|NCT01360632|532172873|FG000|Phase A (8 Weeks)|Lost to Follow-up|27|||
147550797|NCT01360632|532172874|FG001|Phase A (8 Weeks)|Lost to Follow-up|0|||
147550798|NCT01360632|532172875|FG002|Phase A (8 Weeks)|Lost to Follow-up|0|||
147550799|NCT01360632|532172876|FG003|Phase A (8 Weeks)|Lost to Follow-up|0|||
147215629|NCT01590758|530961714|FG001|Overall Study|Physician Decision|2|||
147215630|NCT01590758|530961713|FG000|Overall Study|Lost to Follow-up|4|||
147215631|NCT01590758|530961714|FG001|Overall Study|Lost to Follow-up|2|||
147215632|NCT04525885|530961715|FG000|Overall Study|Screen Failure|1|||
147215633|NCT04525885|530961716|FG001|Overall Study|Screen Failure|0|||
147215634|NCT04525885|530961717|FG002|Overall Study|Screen Failure|0|||
147215635|NCT04525885|530961715|FG000|Overall Study|Withdrawal by Subject|14|||
147215636|NCT04525885|530961716|FG001|Overall Study|Withdrawal by Subject|6|||
147215637|NCT04525885|530961717|FG002|Overall Study|Withdrawal by Subject|20|||
147215638|NCT04525885|530961715|FG000|Overall Study|Physician Decision|1|||
147215639|NCT04525885|530961716|FG001|Overall Study|Physician Decision|0|||
147215640|NCT04525885|530961717|FG002|Overall Study|Physician Decision|1|||
147215641|NCT01185353|530961720|FG000|Part A (Weeks 0 Through 12)|Adverse Event|1|||
147550800|NCT01360632|532172877|FG004|Phase A (8 Weeks)|Lost to Follow-up|0|||
147550801|NCT01360632|532172873|FG000|Phase A (8 Weeks)|Adverse Event|60|||
147550802|NCT01360632|532172874|FG001|Phase A (8 Weeks)|Adverse Event|0|||
147550803|NCT01360632|532172875|FG002|Phase A (8 Weeks)|Adverse Event|0|||
147550804|NCT01360632|532172876|FG003|Phase A (8 Weeks)|Adverse Event|0|||
147550805|NCT01360632|532172877|FG004|Phase A (8 Weeks)|Adverse Event|0|||
147215642|NCT01185353|530961721|FG001|Part A (Weeks 0 Through 12)|Adverse Event|1|||
147215643|NCT01185353|530961722|FG002|Part A (Weeks 0 Through 12)|Adverse Event|1|||
147215644|NCT01185353|530961723|FG003|Part A (Weeks 0 Through 12)|Adverse Event|1|||
147550806|NCT01360632|532172873|FG000|Phase A (8 Weeks)|Met Withdrawal Criteria|45|||
147550807|NCT01360632|532172874|FG001|Phase A (8 Weeks)|Met Withdrawal Criteria|0|||
147550808|NCT01360632|532172875|FG002|Phase A (8 Weeks)|Met Withdrawal Criteria|0|||
147215645|NCT01185353|530961724|FG004|Part A (Weeks 0 Through 12)|Adverse Event|5|||
147215646|NCT01185353|530961725|FG005|Part A (Weeks 0 Through 12)|Adverse Event|0|||
147550809|NCT01360632|532172876|FG003|Phase A (8 Weeks)|Met Withdrawal Criteria|0|||
147550810|NCT01360632|532172877|FG004|Phase A (8 Weeks)|Met Withdrawal Criteria|0|||
147550811|NCT01360632|532172873|FG000|Phase A (8 Weeks)|Physician Decision|10|||
147550812|NCT01360632|532172874|FG001|Phase A (8 Weeks)|Physician Decision|0|||
147550813|NCT01360632|532172875|FG002|Phase A (8 Weeks)|Physician Decision|0|||
147550814|NCT01360632|532172876|FG003|Phase A (8 Weeks)|Physician Decision|0|||
147550815|NCT01360632|532172877|FG004|Phase A (8 Weeks)|Physician Decision|0|||
147550816|NCT01360632|532172873|FG000|Phase A (8 Weeks)|Withdrawal by Subject|74|||
147550817|NCT01360632|532172874|FG001|Phase A (8 Weeks)|Withdrawal by Subject|0|||
147550818|NCT01360632|532172875|FG002|Phase A (8 Weeks)|Withdrawal by Subject|0|||
147550819|NCT01360632|532172876|FG003|Phase A (8 Weeks)|Withdrawal by Subject|0|||
147550820|NCT01360632|532172877|FG004|Phase A (8 Weeks)|Withdrawal by Subject|0|||
147550821|NCT01360632|532172873|FG000|Phase A (8 Weeks)|Protocol Deviation|39|||
147550822|NCT01360632|532172874|FG001|Phase A (8 Weeks)|Protocol Deviation|0|||
147550823|NCT01360632|532172875|FG002|Phase A (8 Weeks)|Protocol Deviation|0|||
147550824|NCT01360632|532172876|FG003|Phase A (8 Weeks)|Protocol Deviation|0|||
147550825|NCT01360632|532172877|FG004|Phase A (8 Weeks)|Protocol Deviation|0|||
147550826|NCT01360632|532172873|FG000|Phase B (6 Weeks)|Lost to Follow-up|0|||
147550827|NCT01360632|532172874|FG001|Phase B (6 Weeks)|Lost to Follow-up|1|||
147550828|NCT01360632|532172875|FG002|Phase B (6 Weeks)|Lost to Follow-up|1|||
147550829|NCT01360632|532172876|FG003|Phase B (6 Weeks)|Lost to Follow-up|0|||
147550830|NCT01360632|532172877|FG004|Phase B (6 Weeks)|Lost to Follow-up|0|||
147442727|NCT01431274|531786082|FG004|Overall Study|Other reason not stated above|4|||
147442728|NCT01378858|531786083|FG000|Overall Study|Withdrawal by Subject|4|||
147442729|NCT01378858|531786084|FG001|Overall Study|Withdrawal by Subject|4|||
147442730|NCT02664272|531786085|FG000|Overall Study|Fluoroscopic images not made available|2|||
147442731|NCT03073980|531786086|FG000|Overall Study|Lost to Follow-up|10|||
147442732|NCT03073980|531786087|FG001|Overall Study|Lost to Follow-up|2|||
147442733|NCT03073980|531786088|FG002|Overall Study|Lost to Follow-up|9|||
147442734|NCT03073980|531786086|FG000|Overall Study|No post-procedure data|0|||
147442735|NCT03073980|531786087|FG001|Overall Study|No post-procedure data|0|||
147442736|NCT03073980|531786088|FG002|Overall Study|No post-procedure data|2|||
147442737|NCT01358760|531786089|FG000|Overall Study|Adverse Event|3|||
147442738|NCT01358760|531786090|FG001|Overall Study|Adverse Event|4|||
147442739|NCT01358760|531786091|FG002|Overall Study|Adverse Event|3|||
147442740|NCT01358760|531786089|FG000|Overall Study|Lost to Follow-up|1|||
147442741|NCT01358760|531786090|FG001|Overall Study|Lost to Follow-up|1|||
147442742|NCT01358760|531786091|FG002|Overall Study|Lost to Follow-up|3|||
147442743|NCT01358760|531786089|FG000|Overall Study|Withdrawal by Subject|5|||
147442744|NCT01358760|531786090|FG001|Overall Study|Withdrawal by Subject|3|||
147442745|NCT01358760|531786091|FG002|Overall Study|Withdrawal by Subject|2|||
147442746|NCT01358760|531786089|FG000|Overall Study|Physician Decision|1|||
147442747|NCT01358760|531786090|FG001|Overall Study|Physician Decision|0|||
147442748|NCT01358760|531786091|FG002|Overall Study|Physician Decision|1|||
147442749|NCT01358760|531786089|FG000|Overall Study|Entry criteria not met/Non-compliance|12|||
147442750|NCT01358760|531786090|FG001|Overall Study|Entry criteria not met/Non-compliance|12|||
147442751|NCT01358760|531786091|FG002|Overall Study|Entry criteria not met/Non-compliance|16|||
147442752|NCT01506960|531786092|FG000|Overall Study|Did not meet angiographic criteria|47|||
147442753|NCT02047253|531786095|FG000|Overall Study|Lost to Follow-up|8|||
147442754|NCT03574753|531786096|FG000|Overall Study|Adverse Event|3|||
147442755|NCT03574753|531786096|FG000|Overall Study|Progression/relapse|19|||
147442756|NCT03574753|531786096|FG000|Overall Study|Death|1|||
147442757|NCT00789880|531786099|FG000|Overall Study|Adverse Event|0|||
147442758|NCT00789880|531786100|FG001|Overall Study|Adverse Event|0|||
147442759|NCT00789880|531786101|FG002|Overall Study|Adverse Event|0|||
147442760|NCT00789880|531786102|FG003|Overall Study|Adverse Event|0|||
147442761|NCT00789880|531786103|FG004|Overall Study|Adverse Event|1|||
147442762|NCT00789880|531786104|FG005|Overall Study|Adverse Event|0|||
147442763|NCT00789880|531786099|FG000|Overall Study|Protocol Violation|0|||
147442764|NCT00789880|531786100|FG001|Overall Study|Protocol Violation|1|||
147442765|NCT00789880|531786101|FG002|Overall Study|Protocol Violation|0|||
147442766|NCT00789880|531786102|FG003|Overall Study|Protocol Violation|1|||
147442767|NCT00789880|531786103|FG004|Overall Study|Protocol Violation|0|||
147442768|NCT00789880|531786104|FG005|Overall Study|Protocol Violation|0|||
147442769|NCT00789880|531786099|FG000|Overall Study|Withdrawal by Subject|1|||
147442770|NCT00789880|531786100|FG001|Overall Study|Withdrawal by Subject|0|||
147442771|NCT00789880|531786101|FG002|Overall Study|Withdrawal by Subject|0|||
147442772|NCT00789880|531786102|FG003|Overall Study|Withdrawal by Subject|0|||
147442773|NCT00789880|531786103|FG004|Overall Study|Withdrawal by Subject|2|||
147442774|NCT00789880|531786104|FG005|Overall Study|Withdrawal by Subject|0|||
147442775|NCT00609986|531786108|FG000|Overall Study|Did not receive transplant or treatment|8|||
147442776|NCT00609986|531786109|FG001|Overall Study|Did not receive transplant or treatment|3|||
147442777|NCT03159091|531786110|FG000|Overall Study|Incorrect inclusion ineligible patient|5|||
147442778|NCT03159091|531786111|FG001|Overall Study|Incorrect inclusion ineligible patient|3|||
147442779|NCT03159091|531786110|FG000|Overall Study|Patient has taken no dose of study drug|0|||
147442780|NCT03159091|531786111|FG001|Overall Study|Patient has taken no dose of study drug|1|||
147442781|NCT04814823|531786112|FG000|Overall Study|Could not obtain valid arterial line for subject|2|||
147442782|NCT02044133|531786113|FG000|Overall Study|Lost to Follow-up|1|||
147442783|NCT02044133|531786114|FG001|Overall Study|Lost to Follow-up|1|||
147442784|NCT02044133|531786113|FG000|Overall Study|Death|1|||
147442785|NCT02044133|531786114|FG001|Overall Study|Death|0|||
147550831|NCT01360632|532172873|FG000|Phase B (6 Weeks)|Adverse Event|0|||
147550832|NCT01360632|532172874|FG001|Phase B (6 Weeks)|Adverse Event|3|||
147550833|NCT01360632|532172875|FG002|Phase B (6 Weeks)|Adverse Event|9|||
147550834|NCT01360632|532172876|FG003|Phase B (6 Weeks)|Adverse Event|3|||
147550835|NCT01360632|532172877|FG004|Phase B (6 Weeks)|Adverse Event|0|||
147550836|NCT01360632|532172873|FG000|Phase B (6 Weeks)|Met Withdrawal Criteria|0|||
147550837|NCT01360632|532172874|FG001|Phase B (6 Weeks)|Met Withdrawal Criteria|0|||
147550838|NCT01360632|532172875|FG002|Phase B (6 Weeks)|Met Withdrawal Criteria|2|||
147550839|NCT01360632|532172876|FG003|Phase B (6 Weeks)|Met Withdrawal Criteria|1|||
147550840|NCT01360632|532172877|FG004|Phase B (6 Weeks)|Met Withdrawal Criteria|0|||
147550841|NCT01360632|532172873|FG000|Phase B (6 Weeks)|Physician Decision|0|||
147550842|NCT01360632|532172874|FG001|Phase B (6 Weeks)|Physician Decision|0|||
147550843|NCT01360632|532172875|FG002|Phase B (6 Weeks)|Physician Decision|0|||
147550844|NCT01360632|532172876|FG003|Phase B (6 Weeks)|Physician Decision|1|||
147550845|NCT01360632|532172877|FG004|Phase B (6 Weeks)|Physician Decision|0|||
147550846|NCT01360632|532172873|FG000|Phase B (6 Weeks)|Withdrawal by Subject|0|||
147550847|NCT01360632|532172874|FG001|Phase B (6 Weeks)|Withdrawal by Subject|4|||
147550848|NCT01360632|532172875|FG002|Phase B (6 Weeks)|Withdrawal by Subject|4|||
147550849|NCT01360632|532172876|FG003|Phase B (6 Weeks)|Withdrawal by Subject|7|||
147550850|NCT01360632|532172877|FG004|Phase B (6 Weeks)|Withdrawal by Subject|0|||
147550851|NCT01360632|532172873|FG000|Phase B (6 Weeks)|Protocol Deviation|0|||
147550852|NCT01360632|532172874|FG001|Phase B (6 Weeks)|Protocol Deviation|1|||
147550853|NCT01360632|532172875|FG002|Phase B (6 Weeks)|Protocol Deviation|4|||
147550854|NCT01360632|532172876|FG003|Phase B (6 Weeks)|Protocol Deviation|1|||
147550855|NCT01360632|532172877|FG004|Phase B (6 Weeks)|Protocol Deviation|0|||
147550856|NCT01360632|532172873|FG000|Phase B (6 Weeks)|Lack of Efficacy|0|||
147550857|NCT01360632|532172874|FG001|Phase B (6 Weeks)|Lack of Efficacy|1|||
147550858|NCT01360632|532172875|FG002|Phase B (6 Weeks)|Lack of Efficacy|0|||
147550859|NCT01360632|532172876|FG003|Phase B (6 Weeks)|Lack of Efficacy|0|||
147550860|NCT01360632|532172877|FG004|Phase B (6 Weeks)|Lack of Efficacy|0|||
147550861|NCT01360632|532172873|FG000|Phase A+|Lost to Follow-up|0|||
147550862|NCT01360632|532172874|FG001|Phase A+|Lost to Follow-up|0|||
147550863|NCT01360632|532172875|FG002|Phase A+|Lost to Follow-up|0|||
147550864|NCT01360632|532172876|FG003|Phase A+|Lost to Follow-up|0|||
147550865|NCT01360632|532172877|FG004|Phase A+|Lost to Follow-up|2|||
147215647|NCT01185353|530961726|FG006|Part A (Weeks 0 Through 12)|Adverse Event|0|||
147215648|NCT01185353|530961727|FG007|Part A (Weeks 0 Through 12)|Adverse Event|0|||
147215649|NCT01185353|530961728|FG008|Part A (Weeks 0 Through 12)|Adverse Event|0|||
147215650|NCT01185353|530961729|FG009|Part A (Weeks 0 Through 12)|Adverse Event|0|||
147215651|NCT01185353|530961720|FG000|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
147215652|NCT01185353|530961721|FG001|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
147215653|NCT01185353|530961722|FG002|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
147215654|NCT01185353|530961723|FG003|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
147215655|NCT01185353|530961724|FG004|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|4|||
147215656|NCT01185353|530961725|FG005|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
147215657|NCT01185353|530961726|FG006|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
147215658|NCT01185353|530961727|FG007|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
147215659|NCT01185353|530961728|FG008|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
147215660|NCT01185353|530961729|FG009|Part A (Weeks 0 Through 12)|Entry Criteria Not Met|0|||
147215661|NCT01185353|530961720|FG000|Part A (Weeks 0 Through 12)|Lack of Efficacy|2|||
147215662|NCT01185353|530961721|FG001|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
147215663|NCT01185353|530961722|FG002|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
147215664|NCT01185353|530961723|FG003|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
147215665|NCT01185353|530961724|FG004|Part A (Weeks 0 Through 12)|Lack of Efficacy|1|||
147215666|NCT01185353|530961725|FG005|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
147215667|NCT01185353|530961726|FG006|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
147215668|NCT01185353|530961727|FG007|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
147215669|NCT01185353|530961728|FG008|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
147215670|NCT01185353|530961729|FG009|Part A (Weeks 0 Through 12)|Lack of Efficacy|0|||
147215671|NCT01185353|530961720|FG000|Part A (Weeks 0 Through 12)|Physician Decision|0|||
147215672|NCT01185353|530961721|FG001|Part A (Weeks 0 Through 12)|Physician Decision|0|||
147215673|NCT01185353|530961722|FG002|Part A (Weeks 0 Through 12)|Physician Decision|1|||
147215674|NCT01185353|530961723|FG003|Part A (Weeks 0 Through 12)|Physician Decision|0|||
147215675|NCT01185353|530961724|FG004|Part A (Weeks 0 Through 12)|Physician Decision|2|||
147550866|NCT01360632|532172873|FG000|Phase A+|Adverse Event|0|||
147550867|NCT01360632|532172874|FG001|Phase A+|Adverse Event|0|||
147550868|NCT01360632|532172875|FG002|Phase A+|Adverse Event|0|||
147215676|NCT01185353|530961725|FG005|Part A (Weeks 0 Through 12)|Physician Decision|0|||
147215677|NCT01185353|530961726|FG006|Part A (Weeks 0 Through 12)|Physician Decision|0|||
147550869|NCT01360632|532172876|FG003|Phase A+|Adverse Event|0|||
147550870|NCT01360632|532172877|FG004|Phase A+|Adverse Event|2|||
147550871|NCT01360632|532172873|FG000|Phase A+|Met Withdrawal Criteria|0|||
147550872|NCT01360632|532172874|FG001|Phase A+|Met Withdrawal Criteria|0|||
147550873|NCT01360632|532172875|FG002|Phase A+|Met Withdrawal Criteria|0|||
147550874|NCT01360632|532172876|FG003|Phase A+|Met Withdrawal Criteria|0|||
147550875|NCT01360632|532172877|FG004|Phase A+|Met Withdrawal Criteria|7|||
147550876|NCT01360632|532172873|FG000|Phase A+|Physician Decision|0|||
147550877|NCT01360632|532172874|FG001|Phase A+|Physician Decision|0|||
147550878|NCT01360632|532172875|FG002|Phase A+|Physician Decision|0|||
147550879|NCT01360632|532172876|FG003|Phase A+|Physician Decision|0|||
147550880|NCT01360632|532172877|FG004|Phase A+|Physician Decision|3|||
147550881|NCT01360632|532172873|FG000|Phase A+|Withdrawal by Subject|0|||
147550882|NCT01360632|532172874|FG001|Phase A+|Withdrawal by Subject|0|||
147550883|NCT01360632|532172875|FG002|Phase A+|Withdrawal by Subject|0|||
147550884|NCT01360632|532172876|FG003|Phase A+|Withdrawal by Subject|0|||
147550885|NCT01360632|532172877|FG004|Phase A+|Withdrawal by Subject|8|||
147550886|NCT01360632|532172873|FG000|Phase A+|Protocol Deviation|0|||
147550887|NCT01360632|532172874|FG001|Phase A+|Protocol Deviation|0|||
147550888|NCT01360632|532172875|FG002|Phase A+|Protocol Deviation|0|||
147550889|NCT01360632|532172876|FG003|Phase A+|Protocol Deviation|0|||
147550890|NCT01360632|532172877|FG004|Phase A+|Protocol Deviation|3|||
147550891|NCT01298596|532172878|FG000|Overall Study|Withdrawal by Subject|1|||
147550892|NCT01298596|532172879|FG001|Overall Study|Withdrawal by Subject|1|||
147550893|NCT01298596|532172878|FG000|Overall Study|Death|5|||
147550894|NCT01298596|532172879|FG001|Overall Study|Death|3|||
147550895|NCT01298596|532172878|FG000|Overall Study|Lost to Follow-up|6|||
147550896|NCT01298596|532172879|FG001|Overall Study|Lost to Follow-up|14|||
147550897|NCT01298596|532172878|FG000|Overall Study|Referred for further management|16|||
147550898|NCT01298596|532172879|FG001|Overall Study|Referred for further management|15|||
147550899|NCT04128696|532172880|FG000|Overall Study|Lost to Follow-up|3|||
147550900|NCT04128696|532172881|FG001|Overall Study|Lost to Follow-up|7|||
147550901|NCT04128696|532172880|FG000|Overall Study|Withdrawal by Subject|12|||
147550902|NCT04128696|532172881|FG001|Overall Study|Withdrawal by Subject|11|||
147550903|NCT04128696|532172880|FG000|Overall Study|Study Closed/Terminated|26|||
147550904|NCT04128696|532172881|FG001|Overall Study|Study Closed/Terminated|38|||
147550905|NCT04128696|532172880|FG000|Overall Study|Physician Decision|2|||
147550906|NCT04128696|532172881|FG001|Overall Study|Physician Decision|3|||
147550907|NCT02173301|532172882|FG000|Overall Study|Adverse Event|7|||
147550908|NCT02173301|532172883|FG001|Overall Study|Adverse Event|8|||
147550909|NCT02173301|532172884|FG002|Overall Study|Adverse Event|13|||
147550910|NCT02173301|532172885|FG003|Overall Study|Adverse Event|5|||
147550911|NCT02173301|532172882|FG000|Overall Study|Withdrawal by Subject|8|||
147550912|NCT02173301|532172883|FG001|Overall Study|Withdrawal by Subject|10|||
147550913|NCT02173301|532172884|FG002|Overall Study|Withdrawal by Subject|4|||
147550914|NCT02173301|532172885|FG003|Overall Study|Withdrawal by Subject|8|||
147550915|NCT02173301|532172882|FG000|Overall Study|Lost to Follow-up|4|||
147550916|NCT02173301|532172883|FG001|Overall Study|Lost to Follow-up|4|||
147550917|NCT02173301|532172884|FG002|Overall Study|Lost to Follow-up|2|||
147550918|NCT02173301|532172885|FG003|Overall Study|Lost to Follow-up|2|||
147550919|NCT02173301|532172882|FG000|Overall Study|Protocol Violation|0|||
147550920|NCT02173301|532172883|FG001|Overall Study|Protocol Violation|1|||
147550921|NCT02173301|532172884|FG002|Overall Study|Protocol Violation|0|||
147550922|NCT02173301|532172885|FG003|Overall Study|Protocol Violation|0|||
147215678|NCT01185353|530961727|FG007|Part A (Weeks 0 Through 12)|Physician Decision|0|||
147215679|NCT01185353|530961728|FG008|Part A (Weeks 0 Through 12)|Physician Decision|0|||
147215680|NCT01185353|530961729|FG009|Part A (Weeks 0 Through 12)|Physician Decision|0|||
147215681|NCT01185353|530961720|FG000|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
147215682|NCT01185353|530961721|FG001|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
147215683|NCT01185353|530961722|FG002|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
147215684|NCT01185353|530961723|FG003|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
147442786|NCT02044133|531786113|FG000|Overall Study|Release|3|||
147442787|NCT02044133|531786114|FG001|Overall Study|Release|4|||
147442788|NCT02044133|531786113|FG000|Overall Study|Transfer|1|||
147442789|NCT02044133|531786114|FG001|Overall Study|Transfer|0|||
147442790|NCT02044133|531786113|FG000|Overall Study|refusal of blood sampling|0|||
147442791|NCT02044133|531786114|FG001|Overall Study|refusal of blood sampling|1|||
147442792|NCT04085523|531786115|FG000|Open-Label Period (Weeks 52 to 156)|Withdrawal by Subject|0|||
147442793|NCT04085523|531786116|FG001|Open-Label Period (Weeks 52 to 156)|Withdrawal by Subject|0|||
147442794|NCT04085523|531786117|FG002|Open-Label Period (Weeks 52 to 156)|Withdrawal by Subject|0|||
147442795|NCT04085523|531786118|FG003|Open-Label Period (Weeks 52 to 156)|Withdrawal by Subject|0|||
147442796|NCT04085523|531786119|FG004|Open-Label Period (Weeks 52 to 156)|Withdrawal by Subject|0|||
147442797|NCT04085523|531786120|FG005|Open-Label Period (Weeks 52 to 156)|Withdrawal by Subject|2|||
147442798|NCT05318937|531786125|FG000|Overall Study|Non-Compliance with Study Drug|1|||
147442799|NCT05318937|531786126|FG001|Overall Study|Non-Compliance with Study Drug|0|||
147442800|NCT05318937|531786125|FG000|Overall Study|Lost to Follow-up|0|||
147442801|NCT05318937|531786126|FG001|Overall Study|Lost to Follow-up|1|||
147442802|NCT05318937|531786125|FG000|Overall Study|Withdrawal by Subject|0|||
147442803|NCT05318937|531786126|FG001|Overall Study|Withdrawal by Subject|2|||
147442804|NCT05318937|531786125|FG000|Overall Study|Protocol Violation|0|||
147442805|NCT05318937|531786126|FG001|Overall Study|Protocol Violation|1|||
147442806|NCT04722042|531786127|FG000|Overall Study|Withdrawal by Subject|2|||
147442807|NCT04722042|531786128|FG001|Overall Study|Withdrawal by Subject|1|||
147442808|NCT04722042|531786129|FG002|Overall Study|Withdrawal by Subject|0|||
147442809|NCT01877915|531786130|FG000|Overall Study|Lost to Follow-up|10|||
147442810|NCT01877915|531786131|FG001|Overall Study|Lost to Follow-up|9|||
147442811|NCT01877915|531786130|FG000|Overall Study|Withdrawal by Subject|42|||
147442812|NCT01877915|531786131|FG001|Overall Study|Withdrawal by Subject|55|||
147442813|NCT01877915|531786130|FG000|Overall Study|Other|2|||
147442814|NCT01877915|531786131|FG001|Overall Study|Other|4|||
147442815|NCT05678257|531786136|FG000|Overall Study|Withdrawal by Subject|2|||
147442816|NCT05678257|531786137|FG001|Overall Study|Withdrawal by Subject|0|||
147442817|NCT05678257|531786138|FG002|Overall Study|Withdrawal by Subject|5|||
147442818|NCT05678257|531786136|FG000|Overall Study|Physician Decision|1|||
147442819|NCT05678257|531786137|FG001|Overall Study|Physician Decision|0|||
147442820|NCT05678257|531786138|FG002|Overall Study|Physician Decision|1|||
147442821|NCT05678257|531786136|FG000|Overall Study|Adverse Event|1|||
147442822|NCT05678257|531786137|FG001|Overall Study|Adverse Event|3|||
147442823|NCT05678257|531786138|FG002|Overall Study|Adverse Event|1|||
147215685|NCT01185353|530961724|FG004|Part A (Weeks 0 Through 12)|Protocol Violation|1|||
147215686|NCT01185353|530961725|FG005|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
147215687|NCT01185353|530961726|FG006|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
147215688|NCT01185353|530961727|FG007|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
147215689|NCT01185353|530961728|FG008|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
147215690|NCT01185353|530961729|FG009|Part A (Weeks 0 Through 12)|Protocol Violation|0|||
147215691|NCT01185353|530961720|FG000|Part A (Weeks 0 Through 12)|Withdrawal by Subject|2|||
147215692|NCT01185353|530961721|FG001|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
147215693|NCT01185353|530961722|FG002|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
147215694|NCT01185353|530961723|FG003|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
147215695|NCT01185353|530961724|FG004|Part A (Weeks 0 Through 12)|Withdrawal by Subject|3|||
147215696|NCT01185353|530961725|FG005|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
147215697|NCT01185353|530961726|FG006|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
147215698|NCT01185353|530961727|FG007|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
147215699|NCT01185353|530961728|FG008|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
147215700|NCT01185353|530961729|FG009|Part A (Weeks 0 Through 12)|Withdrawal by Subject|0|||
147215701|NCT01185353|530961720|FG000|Part B (Weeks 12 Through 24)|Adverse Event|0|||
147215702|NCT01185353|530961721|FG001|Part B (Weeks 12 Through 24)|Adverse Event|0|||
147215703|NCT01185353|530961722|FG002|Part B (Weeks 12 Through 24)|Adverse Event|1|||
147215704|NCT01185353|530961723|FG003|Part B (Weeks 12 Through 24)|Adverse Event|0|||
147215705|NCT01185353|530961724|FG004|Part B (Weeks 12 Through 24)|Adverse Event|0|||
147215706|NCT01185353|530961725|FG005|Part B (Weeks 12 Through 24)|Adverse Event|1|||
147215707|NCT01185353|530961726|FG006|Part B (Weeks 12 Through 24)|Adverse Event|0|||
147215708|NCT01185353|530961727|FG007|Part B (Weeks 12 Through 24)|Adverse Event|0|||
147215709|NCT01185353|530961728|FG008|Part B (Weeks 12 Through 24)|Adverse Event|0|||
147215710|NCT01185353|530961729|FG009|Part B (Weeks 12 Through 24)|Adverse Event|0|||
147215711|NCT01185353|530961720|FG000|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
147215712|NCT01185353|530961721|FG001|Part B (Weeks 12 Through 24)|Lack of Efficacy|1|||
147215713|NCT01185353|530961722|FG002|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
147215714|NCT01185353|530961723|FG003|Part B (Weeks 12 Through 24)|Lack of Efficacy|1|||
147215715|NCT01185353|530961724|FG004|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
147215716|NCT01185353|530961725|FG005|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
147215717|NCT01185353|530961726|FG006|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
147215718|NCT01185353|530961727|FG007|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
147215719|NCT01185353|530961728|FG008|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
147215720|NCT01185353|530961729|FG009|Part B (Weeks 12 Through 24)|Lack of Efficacy|0|||
147215721|NCT01185353|530961720|FG000|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
147215722|NCT01185353|530961721|FG001|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
147215723|NCT01185353|530961722|FG002|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
147215724|NCT01185353|530961723|FG003|Part B (Weeks 12 Through 24)|Lost to Follow-up|1|||
147215725|NCT01185353|530961724|FG004|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
147215726|NCT01185353|530961725|FG005|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
147215727|NCT01185353|530961726|FG006|Part B (Weeks 12 Through 24)|Lost to Follow-up|1|||
147215728|NCT01185353|530961727|FG007|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
147215729|NCT01185353|530961728|FG008|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
147215730|NCT01185353|530961729|FG009|Part B (Weeks 12 Through 24)|Lost to Follow-up|0|||
147215731|NCT01185353|530961720|FG000|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
147215732|NCT01185353|530961721|FG001|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
147215733|NCT01185353|530961722|FG002|Part B (Weeks 12 Through 24)|Withdrawal by Subject|1|||
147215734|NCT01185353|530961723|FG003|Part B (Weeks 12 Through 24)|Withdrawal by Subject|2|||
147215735|NCT01185353|530961724|FG004|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
147215736|NCT01185353|530961725|FG005|Part B (Weeks 12 Through 24)|Withdrawal by Subject|3|||
147215737|NCT01185353|530961726|FG006|Part B (Weeks 12 Through 24)|Withdrawal by Subject|4|||
147215738|NCT01185353|530961727|FG007|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
147442824|NCT05678257|531786136|FG000|Overall Study|Progressive disease|11|||
147442825|NCT05678257|531786137|FG001|Overall Study|Progressive disease|18|||
147442826|NCT05678257|531786138|FG002|Overall Study|Progressive disease|7|||
147442827|NCT05678257|531786136|FG000|Overall Study|No longer clinically benefitting|2|||
147442828|NCT05678257|531786137|FG001|Overall Study|No longer clinically benefitting|1|||
147442829|NCT05678257|531786138|FG002|Overall Study|No longer clinically benefitting|0|||
147442830|NCT05678257|531786136|FG000|Overall Study|Sponsor decision|5|||
147442831|NCT05678257|531786137|FG001|Overall Study|Sponsor decision|9|||
147442832|NCT05678257|531786138|FG002|Overall Study|Sponsor decision|8|||
147442833|NCT05678257|531786136|FG000|Overall Study|Protocol Violation|0|||
147442834|NCT05678257|531786137|FG001|Overall Study|Protocol Violation|0|||
147442835|NCT05678257|531786138|FG002|Overall Study|Protocol Violation|1|||
147442836|NCT05678257|531786136|FG000|Overall Study|Patient non-compliance|0|||
147442837|NCT05678257|531786137|FG001|Overall Study|Patient non-compliance|0|||
147442838|NCT05678257|531786138|FG002|Overall Study|Patient non-compliance|3|||
147442839|NCT02046096|531786139|FG000|Overall Study|Death|28|||
147550923|NCT02173301|532172882|FG000|Overall Study|Physician Decision|0|||
147550924|NCT02173301|532172883|FG001|Overall Study|Physician Decision|0|||
147550925|NCT02173301|532172884|FG002|Overall Study|Physician Decision|1|||
147550926|NCT02173301|532172885|FG003|Overall Study|Physician Decision|0|||
147550927|NCT02173301|532172882|FG000|Overall Study|Subject unable to return for week 16 assessment within Sponsor timelines for study completion|1|||
147550928|NCT02173301|532172883|FG001|Overall Study|Subject unable to return for week 16 assessment within Sponsor timelines for study completion|0|||
147550929|NCT02173301|532172884|FG002|Overall Study|Subject unable to return for week 16 assessment within Sponsor timelines for study completion|0|||
147550930|NCT02173301|532172885|FG003|Overall Study|Subject unable to return for week 16 assessment within Sponsor timelines for study completion|0|||
147550931|NCT03740100|532172886|FG000|Overall Study|Adverse Event|1|||
147550932|NCT03740100|532172886|FG000|Overall Study|Death|1|||
147550933|NCT03120520|532172887|FG000|Overall Study|Lost to Follow-up|1|||
147550934|NCT03120520|532172888|FG001|Overall Study|Lost to Follow-up|1|||
147550935|NCT03120520|532172889|FG002|Overall Study|Lost to Follow-up|1|||
147550936|NCT03120520|532172890|FG003|Overall Study|Lost to Follow-up|1|||
147550937|NCT03120520|532172887|FG000|Overall Study|Withdrawal by Subject|3|||
147550938|NCT03120520|532172888|FG001|Overall Study|Withdrawal by Subject|2|||
147550939|NCT03120520|532172889|FG002|Overall Study|Withdrawal by Subject|3|||
147550940|NCT03120520|532172890|FG003|Overall Study|Withdrawal by Subject|2|||
147550941|NCT03120520|532172887|FG000|Overall Study|Other|0|||
147550942|NCT03120520|532172888|FG001|Overall Study|Other|1|||
147550943|NCT03120520|532172889|FG002|Overall Study|Other|0|||
147550944|NCT03120520|532172890|FG003|Overall Study|Other|0|||
147550945|NCT02123459|532172894|FG000|Washout Period (1 Day)|Adverse Event|1|||
147550946|NCT02123459|532172895|FG001|Washout Period (1 Day)|Adverse Event|0|||
147550947|NCT03387059|532172896|FG000|Overall Study|Study termination|5|||
147550948|NCT03387059|532172897|FG001|Overall Study|Study termination|4|||
147550949|NCT00395083|532172898|FG000|Overall Study|Withdrawal by Subject|6|||
147550950|NCT00395083|532172899|FG001|Overall Study|Withdrawal by Subject|5|||
147550951|NCT00395083|532172898|FG000|Overall Study|Developed another disease|4|||
147550952|NCT00395083|532172899|FG001|Overall Study|Developed another disease|3|||
147550953|NCT00972153|532172900|FG000|Overall Study|Equipment malfunction during case|0|||
147550954|NCT00972153|532172901|FG001|Overall Study|Equipment malfunction during case|1|||
147550955|NCT00972153|532172902|FG002|Overall Study|Equipment malfunction during case|0|||
147550956|NCT01077713|532172903|FG000|Overall Study|Withdrawal by Subject|1|||
147550957|NCT01077713|532172904|FG001|Overall Study|Withdrawal by Subject|2|||
147550958|NCT01077713|532172903|FG000|Overall Study|Progressive Disease (PD)|0|||
147550959|NCT01077713|532172904|FG001|Overall Study|Progressive Disease (PD)|1|||
147550960|NCT01077713|532172903|FG000|Overall Study|Death|28|||
147550961|NCT01077713|532172904|FG001|Overall Study|Death|29|||
147550962|NCT01077713|532172903|FG000|Overall Study|Lost to Follow-up|1|||
147550963|NCT01077713|532172904|FG001|Overall Study|Lost to Follow-up|1|||
147550964|NCT01077713|532172903|FG000|Overall Study|Adverse Event|2|||
147550965|NCT01077713|532172904|FG001|Overall Study|Adverse Event|1|||
147550966|NCT01077713|532172903|FG000|Overall Study|Other|4|||
147550967|NCT01077713|532172904|FG001|Overall Study|Other|2|||
147550968|NCT04136626|532172905|FG000|Treatment Phase|Withdrawal by Subject|1|||
147550969|NCT04136626|532172906|FG001|Treatment Phase|Withdrawal by Subject|9|||
147550970|NCT04136626|532172905|FG000|Treatment Phase|Adverse Event|1|||
147550971|NCT04136626|532172906|FG001|Treatment Phase|Adverse Event|0|||
147550972|NCT04136626|532172905|FG000|Treatment Phase|Lost to Follow-up|1|||
147550973|NCT04136626|532172906|FG001|Treatment Phase|Lost to Follow-up|5|||
147550974|NCT04136626|532172905|FG000|12-month Follow-up|Lost to Follow-up|8|||
147550975|NCT04136626|532172906|FG001|12-month Follow-up|Lost to Follow-up|7|||
147550976|NCT00628745|532172907|FG000|Overall Study|Withdrawal by Subject|63|||
147550977|NCT00628745|532172908|FG001|Overall Study|Withdrawal by Subject|3|||
147550978|NCT00628745|532172909|FG002|Overall Study|Withdrawal by Subject|9|||
147550979|NCT00628745|532172910|FG003|Overall Study|Withdrawal by Subject|2|||
147550980|NCT00628745|532172911|FG004|Overall Study|Withdrawal by Subject|69|||
147550981|NCT00628745|532172907|FG000|Overall Study|Does not meet inclusion criteria|0|||
147550982|NCT00628745|532172908|FG001|Overall Study|Does not meet inclusion criteria|12|||
147550983|NCT00628745|532172909|FG002|Overall Study|Does not meet inclusion criteria|0|||
147550984|NCT00628745|532172910|FG003|Overall Study|Does not meet inclusion criteria|0|||
147215739|NCT01185353|530961728|FG008|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
147550985|NCT00628745|532172911|FG004|Overall Study|Does not meet inclusion criteria|18|||
147550986|NCT00628745|532172907|FG000|Overall Study|Participation in an interventional clinical trial|81|||
147550987|NCT00628745|532172908|FG001|Overall Study|Participation in an interventional clinical trial|4|||
147550988|NCT00628745|532172909|FG002|Overall Study|Participation in an interventional clinical trial|7|||
147550989|NCT00628745|532172910|FG003|Overall Study|Participation in an interventional clinical trial|0|||
147550990|NCT00628745|532172911|FG004|Overall Study|Participation in an interventional clinical trial|63|||
147550991|NCT00628745|532172907|FG000|Overall Study|Physician Decision|8|||
147550992|NCT00628745|532172908|FG001|Overall Study|Physician Decision|4|||
147215740|NCT01185353|530961729|FG009|Part B (Weeks 12 Through 24)|Withdrawal by Subject|0|||
147550993|NCT00628745|532172909|FG002|Overall Study|Physician Decision|3|||
147550994|NCT00628745|532172910|FG003|Overall Study|Physician Decision|0|||
147550995|NCT00628745|532172911|FG004|Overall Study|Physician Decision|30|||
147550996|NCT00628745|532172907|FG000|Overall Study|Lost to Follow-up|109|||
147550997|NCT00628745|532172908|FG001|Overall Study|Lost to Follow-up|7|||
147550998|NCT00628745|532172909|FG002|Overall Study|Lost to Follow-up|7|||
147550999|NCT00628745|532172910|FG003|Overall Study|Lost to Follow-up|0|||
147551000|NCT00628745|532172911|FG004|Overall Study|Lost to Follow-up|498|||
147551001|NCT00628745|532172907|FG000|Overall Study|Death|197|||
147551002|NCT00628745|532172908|FG001|Overall Study|Death|81|||
147551003|NCT00628745|532172909|FG002|Overall Study|Death|12|||
147551004|NCT00628745|532172910|FG003|Overall Study|Death|4|||
147551005|NCT00628745|532172911|FG004|Overall Study|Death|939|||
147551006|NCT00628745|532172907|FG000|Overall Study|Participant transferred to another THAOS site|6|||
147551007|NCT00628745|532172908|FG001|Overall Study|Participant transferred to another THAOS site|0|||
147551008|NCT00628745|532172909|FG002|Overall Study|Participant transferred to another THAOS site|0|||
147551009|NCT00628745|532172910|FG003|Overall Study|Participant transferred to another THAOS site|0|||
147551010|NCT00628745|532172911|FG004|Overall Study|Participant transferred to another THAOS site|7|||
147551011|NCT00628745|532172907|FG000|Overall Study|Participant moved out of the area, but did not transfer to another THAOS site|37|||
147551012|NCT00628745|532172908|FG001|Overall Study|Participant moved out of the area, but did not transfer to another THAOS site|29|||
147551013|NCT00628745|532172909|FG002|Overall Study|Participant moved out of the area, but did not transfer to another THAOS site|46|||
147551014|NCT00628745|532172910|FG003|Overall Study|Participant moved out of the area, but did not transfer to another THAOS site|0|||
147551015|NCT00628745|532172911|FG004|Overall Study|Participant moved out of the area, but did not transfer to another THAOS site|91|||
147551016|NCT00628745|532172907|FG000|Overall Study|Site closure|152|||
147551017|NCT00628745|532172908|FG001|Overall Study|Site closure|146|||
147551018|NCT00628745|532172909|FG002|Overall Study|Site closure|6|||
147551019|NCT00628745|532172910|FG003|Overall Study|Site closure|8|||
147551020|NCT00628745|532172911|FG004|Overall Study|Site closure|691|||
147551021|NCT00628745|532172907|FG000|Overall Study|Duplicate participant|0|||
147551022|NCT00628745|532172908|FG001|Overall Study|Duplicate participant|0|||
147551023|NCT00628745|532172909|FG002|Overall Study|Duplicate participant|0|||
147551024|NCT00628745|532172910|FG003|Overall Study|Duplicate participant|0|||
147551025|NCT00628745|532172911|FG004|Overall Study|Duplicate participant|1|||
147551026|NCT00628745|532172907|FG000|Overall Study|Missing|4|||
147551027|NCT00628745|532172908|FG001|Overall Study|Missing|3|||
147551028|NCT00628745|532172909|FG002|Overall Study|Missing|0|||
147551029|NCT00628745|532172910|FG003|Overall Study|Missing|0|||
147551030|NCT00628745|532172911|FG004|Overall Study|Missing|10|||
147551031|NCT00628745|532172907|FG000|Overall Study|Othe reasons|987|||
147551032|NCT00628745|532172908|FG001|Overall Study|Othe reasons|373|||
147551033|NCT00628745|532172909|FG002|Overall Study|Othe reasons|105|||
147551034|NCT00628745|532172910|FG003|Overall Study|Othe reasons|1|||
147551035|NCT00628745|532172911|FG004|Overall Study|Othe reasons|1772|||
147551036|NCT02806232|532174562|FG000|Overall Study|Lost to Follow-up|1|||
147551037|NCT02806232|532174563|FG001|Overall Study|Lost to Follow-up|2|||
147551038|NCT02806232|532174564|FG002|Overall Study|Lost to Follow-up|1|||
147551039|NCT02806232|532174565|FG003|Overall Study|Lost to Follow-up|0|||
147551040|NCT02806232|532174566|FG004|Overall Study|Lost to Follow-up|0|||
147551041|NCT02806232|532174567|FG005|Overall Study|Lost to Follow-up|1|||
147551042|NCT02806232|532174568|FG006|Overall Study|Lost to Follow-up|0|||
147551043|NCT02806232|532174569|FG007|Overall Study|Lost to Follow-up|0|||
147551044|NCT02806232|532174570|FG008|Overall Study|Lost to Follow-up|0|||
147551045|NCT02806232|532174562|FG000|Overall Study|Withdrawal by Subject|0|||
147551046|NCT02806232|532174563|FG001|Overall Study|Withdrawal by Subject|2|||
147551047|NCT02806232|532174564|FG002|Overall Study|Withdrawal by Subject|0|||
147551048|NCT02806232|532174565|FG003|Overall Study|Withdrawal by Subject|0|||
147551049|NCT02806232|532174566|FG004|Overall Study|Withdrawal by Subject|2|||
147551050|NCT02806232|532174567|FG005|Overall Study|Withdrawal by Subject|1|||
147551051|NCT02806232|532174568|FG006|Overall Study|Withdrawal by Subject|0|||
147551052|NCT02806232|532174569|FG007|Overall Study|Withdrawal by Subject|0|||
147551053|NCT02806232|532174570|FG008|Overall Study|Withdrawal by Subject|0|||
147551054|NCT01133821|532174571|FG000|Overall Study|Lost to Follow-up|8|||
147551055|NCT01133821|532174572|FG001|Overall Study|Lost to Follow-up|11|||
147551056|NCT01133821|532174571|FG000|Overall Study|Withdrawal by Subject|8|||
147551057|NCT01133821|532174572|FG001|Overall Study|Withdrawal by Subject|3|||
147551058|NCT01133821|532174571|FG000|Overall Study|preferred other treatment|1|||
147551059|NCT01133821|532174572|FG001|Overall Study|preferred other treatment|1|||
147551060|NCT01133821|532174571|FG000|Overall Study|Protocol Violation|0|||
147551061|NCT01133821|532174572|FG001|Overall Study|Protocol Violation|1|||
147551062|NCT01133821|532174571|FG000|Overall Study|Refused participation|1|||
147551063|NCT01133821|532174572|FG001|Overall Study|Refused participation|3|||
147551064|NCT01267266|532174577|FG000|Enrollment Phase|Withdrawal by Subject|2|||
147551065|NCT01267266|532174578|FG001|Enrollment Phase|Withdrawal by Subject|0|||
147551066|NCT01267266|532174577|FG000|Lead-in Phase|Lack of Efficacy|20|||
147551067|NCT01267266|532174578|FG001|Lead-in Phase|Lack of Efficacy|0|||
147551068|NCT01267266|532174577|FG000|Lead-in Phase|Adverse Event|2|||
147551069|NCT01267266|532174578|FG001|Lead-in Phase|Adverse Event|0|||
147215741|NCT01185353|530961720|FG000|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
147215742|NCT01185353|530961721|FG001|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
147215743|NCT01185353|530961722|FG002|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
147215744|NCT01185353|530961723|FG003|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
147215745|NCT01185353|530961724|FG004|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
147215746|NCT01185353|530961725|FG005|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
147215747|NCT01185353|530961726|FG006|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|1|||
147215748|NCT01185353|530961727|FG007|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
147215749|NCT01185353|530961728|FG008|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
147215750|NCT01185353|530961729|FG009|Part B (Weeks 12 Through 24)|Entry Criteria Not Met|0|||
147442840|NCT02046096|531786140|FG001|Overall Study|Death|45|||
147442841|NCT02046096|531786139|FG000|Overall Study|Lost to Follow-up|9|||
147442842|NCT02046096|531786140|FG001|Overall Study|Lost to Follow-up|20|||
147442843|NCT02046096|531786139|FG000|Overall Study|Withdrawal by Subject|5|||
147442844|NCT02046096|531786140|FG001|Overall Study|Withdrawal by Subject|17|||
147442845|NCT02046096|531786139|FG000|Overall Study|Other endpoint|2|||
147442846|NCT02046096|531786140|FG001|Overall Study|Other endpoint|19|||
147442847|NCT03520959|531786141|FG000|Overall Study|Study terminated by Sponsor|0|||
147442848|NCT03520959|531786142|FG001|Overall Study|Study terminated by Sponsor|1|||
147442849|NCT01449461|531786143|FG000|Overall Study|Adverse Event|0|||
147442850|NCT01449461|531786144|FG001|Overall Study|Adverse Event|3|||
147442851|NCT01449461|531786145|FG002|Overall Study|Adverse Event|2|||
147442852|NCT01449461|531786146|FG003|Overall Study|Adverse Event|3|||
147442853|NCT01449461|531786147|FG004|Overall Study|Adverse Event|4|||
147442854|NCT01449461|531786148|FG005|Overall Study|Adverse Event|4|||
147442855|NCT01449461|531786143|FG000|Overall Study|Death|0|||
147442856|NCT01449461|531786144|FG001|Overall Study|Death|2|||
147442857|NCT01449461|531786145|FG002|Overall Study|Death|0|||
147442858|NCT01449461|531786146|FG003|Overall Study|Death|0|||
147442859|NCT01449461|531786147|FG004|Overall Study|Death|7|||
147442860|NCT01449461|531786148|FG005|Overall Study|Death|1|||
147442861|NCT01449461|531786143|FG000|Overall Study|Physician Decision|0|||
147442862|NCT01449461|531786144|FG001|Overall Study|Physician Decision|1|||
147442863|NCT01449461|531786145|FG002|Overall Study|Physician Decision|0|||
147442864|NCT01449461|531786146|FG003|Overall Study|Physician Decision|4|||
147442865|NCT01449461|531786147|FG004|Overall Study|Physician Decision|1|||
147442866|NCT01449461|531786148|FG005|Overall Study|Physician Decision|0|||
147442867|NCT01449461|531786143|FG000|Overall Study|Documented Progressive Disease|4|||
147442868|NCT01449461|531786144|FG001|Overall Study|Documented Progressive Disease|7|||
147442869|NCT01449461|531786145|FG002|Overall Study|Documented Progressive Disease|14|||
147442870|NCT01449461|531786146|FG003|Overall Study|Documented Progressive Disease|15|||
147442871|NCT01449461|531786147|FG004|Overall Study|Documented Progressive Disease|24|||
147442872|NCT01449461|531786148|FG005|Overall Study|Documented Progressive Disease|5|||
147442873|NCT01449461|531786143|FG000|Overall Study|Clinical Progressive Disease|2|||
147442874|NCT01449461|531786144|FG001|Overall Study|Clinical Progressive Disease|2|||
147442875|NCT01449461|531786145|FG002|Overall Study|Clinical Progressive Disease|0|||
147442876|NCT01449461|531786146|FG003|Overall Study|Clinical Progressive Disease|3|||
147442877|NCT01449461|531786147|FG004|Overall Study|Clinical Progressive Disease|4|||
147442878|NCT01449461|531786148|FG005|Overall Study|Clinical Progressive Disease|2|||
147442879|NCT01449461|531786143|FG000|Overall Study|Protocol Violation|0|||
147442880|NCT01449461|531786144|FG001|Overall Study|Protocol Violation|0|||
147442881|NCT01449461|531786145|FG002|Overall Study|Protocol Violation|0|||
147442882|NCT01449461|531786146|FG003|Overall Study|Protocol Violation|1|||
147442883|NCT01449461|531786147|FG004|Overall Study|Protocol Violation|0|||
147442884|NCT01449461|531786148|FG005|Overall Study|Protocol Violation|0|||
147442885|NCT01449461|531786143|FG000|Overall Study|Site Terminated by Sponsor|0|||
147442886|NCT01449461|531786144|FG001|Overall Study|Site Terminated by Sponsor|1|||
147442887|NCT01449461|531786145|FG002|Overall Study|Site Terminated by Sponsor|2|||
147442888|NCT01449461|531786146|FG003|Overall Study|Site Terminated by Sponsor|3|||
147442889|NCT01449461|531786147|FG004|Overall Study|Site Terminated by Sponsor|4|||
147442890|NCT01449461|531786148|FG005|Overall Study|Site Terminated by Sponsor|1|||
147442891|NCT01449461|531786143|FG000|Overall Study|Withdrawal by Subject|0|||
147442892|NCT01449461|531786144|FG001|Overall Study|Withdrawal by Subject|1|||
147442893|NCT01449461|531786145|FG002|Overall Study|Withdrawal by Subject|0|||
147442894|NCT01449461|531786146|FG003|Overall Study|Withdrawal by Subject|0|||
147442895|NCT01449461|531786147|FG004|Overall Study|Withdrawal by Subject|2|||
147442896|NCT01449461|531786148|FG005|Overall Study|Withdrawal by Subject|1|||
147442897|NCT01449461|531786143|FG000|Overall Study|Reason not Specified|0|||
147442898|NCT01449461|531786144|FG001|Overall Study|Reason not Specified|1|||
147442899|NCT01449461|531786145|FG002|Overall Study|Reason not Specified|0|||
147442900|NCT01449461|531786146|FG003|Overall Study|Reason not Specified|3|||
147442901|NCT01449461|531786147|FG004|Overall Study|Reason not Specified|2|||
147442902|NCT01449461|531786148|FG005|Overall Study|Reason not Specified|1|||
147551070|NCT01267266|532174577|FG000|Lead-in Phase|Withdrawal by Subject|1|||
147551071|NCT01267266|532174578|FG001|Lead-in Phase|Withdrawal by Subject|0|||
147551072|NCT01335477|532174580|FG000|Overall Study|Adverse Event|30|||
147551073|NCT01335477|532174581|FG001|Overall Study|Adverse Event|42|||
147551074|NCT01335477|532174580|FG000|Overall Study|Non compliant with protocol|0|||
147551075|NCT01335477|532174581|FG001|Overall Study|Non compliant with protocol|2|||
147551076|NCT01335477|532174580|FG000|Overall Study|Lost to Follow-up|1|||
147551077|NCT01335477|532174581|FG001|Overall Study|Lost to Follow-up|2|||
147551078|NCT01335477|532174580|FG000|Overall Study|Consent withdrawn, not due to AE|7|||
147551079|NCT01335477|532174581|FG001|Overall Study|Consent withdrawn, not due to AE|9|||
147551080|NCT01335477|532174580|FG000|Overall Study|Not treated|1|||
147551081|NCT01335477|532174581|FG001|Overall Study|Not treated|2|||
147551082|NCT01335477|532174580|FG000|Overall Study|Reason other than those stated above|2|||
147551083|NCT01335477|532174581|FG001|Overall Study|Reason other than those stated above|2|||
147551084|NCT02038634|532174583|FG000|Overall Study|Lost to Follow-up|0|||
147551085|NCT02038634|532174584|FG001|Overall Study|Lost to Follow-up|1|||
147551086|NCT01034137|532174586|FG000|Overall Study|Adverse Event|9|||
147551087|NCT01034137|532174587|FG001|Overall Study|Adverse Event|10|||
147551088|NCT01034137|532174588|FG002|Overall Study|Adverse Event|8|||
147551089|NCT01034137|532174586|FG000|Overall Study|Withdrawal by Subject|4|||
147551090|NCT01034137|532174587|FG001|Overall Study|Withdrawal by Subject|3|||
147551091|NCT01034137|532174588|FG002|Overall Study|Withdrawal by Subject|3|||
147551092|NCT01034137|532174586|FG000|Overall Study|Lack of Efficacy|9|||
147551093|NCT01034137|532174587|FG001|Overall Study|Lack of Efficacy|4|||
147551094|NCT01034137|532174588|FG002|Overall Study|Lack of Efficacy|13|||
147551095|NCT01034137|532174586|FG000|Overall Study|Protocol Violation|2|||
147551096|NCT01034137|532174587|FG001|Overall Study|Protocol Violation|2|||
147551097|NCT01034137|532174588|FG002|Overall Study|Protocol Violation|1|||
147551098|NCT01034137|532174586|FG000|Overall Study|Refused treatment or did not cooperate|2|||
147551099|NCT01034137|532174587|FG001|Overall Study|Refused treatment or did not cooperate|0|||
147551100|NCT01034137|532174588|FG002|Overall Study|Refused treatment or did not cooperate|1|||
147551101|NCT01034137|532174586|FG000|Overall Study|Administrative or other|2|||
147551102|NCT01034137|532174587|FG001|Overall Study|Administrative or other|3|||
147551103|NCT01034137|532174588|FG002|Overall Study|Administrative or other|4|||
147551104|NCT03572933|532174589|FG000|Overall Study|Adverse Event|4|||
147551105|NCT03572933|532174590|FG001|Overall Study|Adverse Event|1|||
147551106|NCT03572933|532174589|FG000|Overall Study|Withdrawal by Subject|0|||
147551107|NCT03572933|532174590|FG001|Overall Study|Withdrawal by Subject|1|||
147551108|NCT02049359|532174595|FG000|Overall Study|Lost to Follow-up|26|||
147551109|NCT02049359|532174596|FG001|Overall Study|Lost to Follow-up|19|||
147551110|NCT01405950|532174597|FG000|Overall Study|Withdrawal by Subject|1|||
147551111|NCT01405950|532174598|FG001|Overall Study|Withdrawal by Subject|0|||
147551112|NCT01405950|532174599|FG002|Overall Study|Withdrawal by Subject|0|||
147551113|NCT01405950|532174600|FG003|Overall Study|Withdrawal by Subject|0|||
147551114|NCT01381900|532174601|FG000|Overall Study|Subject meets glycemic withdrawal crit.|2|||
147551115|NCT01381900|532174602|FG001|Overall Study|Subject meets glycemic withdrawal crit.|0|||
147551116|NCT01381900|532174603|FG002|Overall Study|Subject meets glycemic withdrawal crit.|0|||
147551117|NCT01381900|532174601|FG000|Overall Study|Adverse Event|4|||
147551118|NCT01381900|532174602|FG001|Overall Study|Adverse Event|6|||
147551119|NCT01381900|532174603|FG002|Overall Study|Adverse Event|7|||
147551120|NCT01381900|532174601|FG000|Overall Study|Noncompliance with study drug|0|||
147551121|NCT01381900|532174602|FG001|Overall Study|Noncompliance with study drug|0|||
147551122|NCT01381900|532174603|FG002|Overall Study|Noncompliance with study drug|1|||
147551123|NCT01381900|532174601|FG000|Overall Study|Physician Decision|0|||
147551124|NCT01381900|532174602|FG001|Overall Study|Physician Decision|1|||
147551125|NCT01381900|532174603|FG002|Overall Study|Physician Decision|1|||
147551126|NCT01381900|532174601|FG000|Overall Study|Protocol Violation|0|||
147551127|NCT01381900|532174602|FG001|Overall Study|Protocol Violation|1|||
147551128|NCT01381900|532174603|FG002|Overall Study|Protocol Violation|1|||
147551129|NCT01381900|532174601|FG000|Overall Study|Withdrawal by Subject|0|||
147551130|NCT01381900|532174602|FG001|Overall Study|Withdrawal by Subject|0|||
147551131|NCT01381900|532174603|FG002|Overall Study|Withdrawal by Subject|1|||
147551132|NCT01381900|532174601|FG000|Overall Study|Early withdraw|3|||
147551133|NCT01381900|532174602|FG001|Overall Study|Early withdraw|1|||
147551134|NCT01381900|532174603|FG002|Overall Study|Early withdraw|1|||
147551135|NCT01772368|532174604|FG000|Overall Study|Adverse Event|1|||
147551136|NCT01772368|532174604|FG000|Overall Study|Withdrawal by Subject|3|||
147551137|NCT01772368|532174604|FG000|Overall Study|Protocol Violation|2|||
147551138|NCT01772368|532174604|FG000|Overall Study|Other|1|||
147551139|NCT03347695|532174611|FG000|Overall Study|Death|0|||
147551140|NCT03347695|532174612|FG001|Overall Study|Death|4|||
147551141|NCT03347695|532174611|FG000|Overall Study|Lost to Follow-up|0|||
147551142|NCT03347695|532174612|FG001|Overall Study|Lost to Follow-up|1|||
147551143|NCT00671879|532174615|FG000|Overall Study|Withdrawal by Subject|0|||
147551144|NCT00671879|532174616|FG001|Overall Study|Withdrawal by Subject|4|||
147551145|NCT00671879|532174617|FG002|Overall Study|Withdrawal by Subject|6|||
147442903|NCT05314517|531786150|FG000|Double-blind Period|Adverse Event|4|||
147442904|NCT05314517|531786151|FG001|Double-blind Period|Adverse Event|0|||
147215751|NCT01185353|530961720|FG000|Part C (Weeks 24 Through 76)|Adverse Event|0|||
147215752|NCT01185353|530961721|FG001|Part C (Weeks 24 Through 76)|Adverse Event|0|||
147215753|NCT01185353|530961722|FG002|Part C (Weeks 24 Through 76)|Adverse Event|0|||
147215754|NCT01185353|530961723|FG003|Part C (Weeks 24 Through 76)|Adverse Event|0|||
147215755|NCT01185353|530961724|FG004|Part C (Weeks 24 Through 76)|Adverse Event|0|||
147215756|NCT01185353|530961725|FG005|Part C (Weeks 24 Through 76)|Adverse Event|0|||
147215757|NCT01185353|530961726|FG006|Part C (Weeks 24 Through 76)|Adverse Event|0|||
147215758|NCT01185353|530961727|FG007|Part C (Weeks 24 Through 76)|Adverse Event|8|||
147215759|NCT01185353|530961728|FG008|Part C (Weeks 24 Through 76)|Adverse Event|2|||
147215760|NCT01185353|530961729|FG009|Part C (Weeks 24 Through 76)|Adverse Event|2|||
147215761|NCT01185353|530961720|FG000|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
147215762|NCT01185353|530961721|FG001|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
147215763|NCT01185353|530961722|FG002|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
147215764|NCT01185353|530961723|FG003|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
147215765|NCT01185353|530961724|FG004|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
147215766|NCT01185353|530961725|FG005|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
147215767|NCT01185353|530961726|FG006|Part C (Weeks 24 Through 76)|Withdrawal by Subject|0|||
147215768|NCT01185353|530961727|FG007|Part C (Weeks 24 Through 76)|Withdrawal by Subject|6|||
147215769|NCT01185353|530961728|FG008|Part C (Weeks 24 Through 76)|Withdrawal by Subject|2|||
147215770|NCT01185353|530961729|FG009|Part C (Weeks 24 Through 76)|Withdrawal by Subject|2|||
147215771|NCT01185353|530961720|FG000|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
147215772|NCT01185353|530961721|FG001|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
147215773|NCT01185353|530961722|FG002|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
147215774|NCT01185353|530961723|FG003|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
147215775|NCT01185353|530961724|FG004|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
147215776|NCT01185353|530961725|FG005|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
147215777|NCT01185353|530961726|FG006|Part C (Weeks 24 Through 76)|Lost to Follow-up|0|||
147215778|NCT01185353|530961727|FG007|Part C (Weeks 24 Through 76)|Lost to Follow-up|2|||
147215779|NCT01185353|530961728|FG008|Part C (Weeks 24 Through 76)|Lost to Follow-up|1|||
147215780|NCT01185353|530961729|FG009|Part C (Weeks 24 Through 76)|Lost to Follow-up|1|||
147215781|NCT01185353|530961720|FG000|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
147215782|NCT01185353|530961721|FG001|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
147215783|NCT01185353|530961722|FG002|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
147215784|NCT01185353|530961723|FG003|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
147215785|NCT01185353|530961724|FG004|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
147215786|NCT01185353|530961725|FG005|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
147215787|NCT01185353|530961726|FG006|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
147215788|NCT01185353|530961727|FG007|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
147215789|NCT01185353|530961728|FG008|Part C (Weeks 24 Through 76)|Lack of Efficacy|2|||
147215790|NCT01185353|530961729|FG009|Part C (Weeks 24 Through 76)|Lack of Efficacy|0|||
147215791|NCT01185353|530961720|FG000|Part C (Weeks 24 Through 76)|Death|0|||
147215792|NCT01185353|530961721|FG001|Part C (Weeks 24 Through 76)|Death|0|||
147215793|NCT01185353|530961722|FG002|Part C (Weeks 24 Through 76)|Death|0|||
147215794|NCT01185353|530961723|FG003|Part C (Weeks 24 Through 76)|Death|0|||
147215795|NCT01185353|530961724|FG004|Part C (Weeks 24 Through 76)|Death|0|||
147215796|NCT01185353|530961725|FG005|Part C (Weeks 24 Through 76)|Death|0|||
147215797|NCT01185353|530961726|FG006|Part C (Weeks 24 Through 76)|Death|0|||
147215798|NCT01185353|530961727|FG007|Part C (Weeks 24 Through 76)|Death|0|||
147215799|NCT01185353|530961728|FG008|Part C (Weeks 24 Through 76)|Death|0|||
147215800|NCT01185353|530961729|FG009|Part C (Weeks 24 Through 76)|Death|1|||
147215801|NCT01185353|530961720|FG000|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
147215802|NCT01185353|530961721|FG001|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
147442905|NCT05314517|531786152|FG002|Double-blind Period|Adverse Event|0|||
147442906|NCT05314517|531786153|FG003|Double-blind Period|Adverse Event|0|||
147442907|NCT05314517|531786150|FG000|Double-blind Period|Noncompliance|0|||
147442908|NCT05314517|531786151|FG001|Double-blind Period|Noncompliance|1|||
147442909|NCT05314517|531786152|FG002|Double-blind Period|Noncompliance|0|||
147442910|NCT05314517|531786153|FG003|Double-blind Period|Noncompliance|0|||
147442911|NCT05314517|531786150|FG000|Double-blind Period|Randomized, not treated|1|||
147442912|NCT05314517|531786151|FG001|Double-blind Period|Randomized, not treated|0|||
147442913|NCT05314517|531786152|FG002|Double-blind Period|Randomized, not treated|0|||
147442914|NCT05314517|531786153|FG003|Double-blind Period|Randomized, not treated|0|||
147442915|NCT05314517|531786150|FG000|Open-label Extension|Adverse Event|0|||
147442916|NCT05314517|531786151|FG001|Open-label Extension|Adverse Event|0|||
147215803|NCT01185353|530961722|FG002|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
147215804|NCT01185353|530961723|FG003|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
147215805|NCT01185353|530961724|FG004|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
147215806|NCT01185353|530961725|FG005|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
147215807|NCT01185353|530961726|FG006|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
147215808|NCT01185353|530961727|FG007|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
147215809|NCT01185353|530961728|FG008|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|0|||
147215810|NCT01185353|530961729|FG009|Part C (Weeks 24 Through 76)|Entry Criteria Not Met|1|||
147215811|NCT01185353|530961720|FG000|Part C (Weeks 24 Through 76)|Physician Decision|0|||
147215812|NCT01185353|530961721|FG001|Part C (Weeks 24 Through 76)|Physician Decision|0|||
147215813|NCT01185353|530961722|FG002|Part C (Weeks 24 Through 76)|Physician Decision|0|||
147215814|NCT01185353|530961723|FG003|Part C (Weeks 24 Through 76)|Physician Decision|0|||
147215815|NCT01185353|530961724|FG004|Part C (Weeks 24 Through 76)|Physician Decision|0|||
147215816|NCT01185353|530961725|FG005|Part C (Weeks 24 Through 76)|Physician Decision|0|||
147215817|NCT01185353|530961726|FG006|Part C (Weeks 24 Through 76)|Physician Decision|0|||
147215818|NCT01185353|530961727|FG007|Part C (Weeks 24 Through 76)|Physician Decision|0|||
147215819|NCT01185353|530961728|FG008|Part C (Weeks 24 Through 76)|Physician Decision|0|||
147215820|NCT01185353|530961729|FG009|Part C (Weeks 24 Through 76)|Physician Decision|1|||
147215821|NCT01185353|530961720|FG000|Part C (Weeks 24 Through 76)|Reason missing|0|||
147215822|NCT01185353|530961721|FG001|Part C (Weeks 24 Through 76)|Reason missing|0|||
147215823|NCT01185353|530961722|FG002|Part C (Weeks 24 Through 76)|Reason missing|0|||
147215824|NCT01185353|530961723|FG003|Part C (Weeks 24 Through 76)|Reason missing|0|||
147215825|NCT01185353|530961724|FG004|Part C (Weeks 24 Through 76)|Reason missing|0|||
147215826|NCT01185353|530961725|FG005|Part C (Weeks 24 Through 76)|Reason missing|0|||
147215827|NCT01185353|530961726|FG006|Part C (Weeks 24 Through 76)|Reason missing|0|||
147215828|NCT01185353|530961727|FG007|Part C (Weeks 24 Through 76)|Reason missing|0|||
147215829|NCT01185353|530961728|FG008|Part C (Weeks 24 Through 76)|Reason missing|1|||
147215830|NCT01185353|530961729|FG009|Part C (Weeks 24 Through 76)|Reason missing|0|||
147215831|NCT01185353|530961720|FG000|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
147215832|NCT01185353|530961721|FG001|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
147215833|NCT01185353|530961722|FG002|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
147215834|NCT01185353|530961723|FG003|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
147215835|NCT01185353|530961724|FG004|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
147215836|NCT01185353|530961725|FG005|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
147215837|NCT01185353|530961726|FG006|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
147215838|NCT01185353|530961727|FG007|Part D (Weeks 76 Through 128)|Lost to Follow-up|1|||
147215839|NCT01185353|530961728|FG008|Part D (Weeks 76 Through 128)|Lost to Follow-up|3|||
147215840|NCT01185353|530961729|FG009|Part D (Weeks 76 Through 128)|Lost to Follow-up|0|||
147215841|NCT01185353|530961720|FG000|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
147215842|NCT01185353|530961721|FG001|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
147215843|NCT01185353|530961722|FG002|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
147215844|NCT01185353|530961723|FG003|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
147215845|NCT01185353|530961724|FG004|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
147215846|NCT01185353|530961725|FG005|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
147215847|NCT01185353|530961726|FG006|Part D (Weeks 76 Through 128)|Withdrawal by Subject|0|||
147215848|NCT01185353|530961727|FG007|Part D (Weeks 76 Through 128)|Withdrawal by Subject|1|||
147215849|NCT01185353|530961728|FG008|Part D (Weeks 76 Through 128)|Withdrawal by Subject|2|||
147215850|NCT01185353|530961729|FG009|Part D (Weeks 76 Through 128)|Withdrawal by Subject|1|||
147215851|NCT01185353|530961720|FG000|Part D (Weeks 76 Through 128)|Adverse Event|0|||
147215852|NCT01185353|530961721|FG001|Part D (Weeks 76 Through 128)|Adverse Event|0|||
147215853|NCT01185353|530961722|FG002|Part D (Weeks 76 Through 128)|Adverse Event|0|||
147215854|NCT01185353|530961723|FG003|Part D (Weeks 76 Through 128)|Adverse Event|0|||
147215855|NCT01185353|530961724|FG004|Part D (Weeks 76 Through 128)|Adverse Event|0|||
147215856|NCT01185353|530961725|FG005|Part D (Weeks 76 Through 128)|Adverse Event|0|||
147215857|NCT01185353|530961726|FG006|Part D (Weeks 76 Through 128)|Adverse Event|0|||
147215858|NCT01185353|530961727|FG007|Part D (Weeks 76 Through 128)|Adverse Event|1|||
147215859|NCT01185353|530961728|FG008|Part D (Weeks 76 Through 128)|Adverse Event|2|||
147215860|NCT01185353|530961729|FG009|Part D (Weeks 76 Through 128)|Adverse Event|0|||
147215861|NCT02270944|530961733|FG000|Overall Study|Lost to Follow-up|9|||
147215862|NCT02270944|530961734|FG001|Overall Study|Lost to Follow-up|4|||
147215863|NCT02270944|530961733|FG000|Overall Study|Withdrawal by Subject|2|||
147215864|NCT02270944|530961734|FG001|Overall Study|Withdrawal by Subject|1|||
147215865|NCT01144299|530961735|FG000|Overall Study|Lost to Follow-up|1|||
147215866|NCT01144299|530961736|FG001|Overall Study|Lost to Follow-up|0|||
147215867|NCT01144299|530961735|FG000|Overall Study|Withdrawal by Subject|1|||
147442917|NCT05314517|531786152|FG002|Open-label Extension|Adverse Event|1|||
147442918|NCT05314517|531786153|FG003|Open-label Extension|Adverse Event|2|||
147215868|NCT01144299|530961736|FG001|Overall Study|Withdrawal by Subject|0|||
147215869|NCT02342418|530961739|FG000|Overall Study|Adverse Event|0|||
147215870|NCT02342418|530961740|FG001|Overall Study|Adverse Event|1|||
147215871|NCT04255394|530961741|FG000|Overall Study|Death|35|||
147215872|NCT04255394|530961742|FG001|Overall Study|Death|25|||
147215873|NCT04255394|530961741|FG000|Overall Study|Device removed|2|||
147215874|NCT04255394|530961742|FG001|Overall Study|Device removed|10|||
147215875|NCT04255394|530961741|FG000|Overall Study|Withdrawal by Subject|9|||
147215876|NCT04255394|530961742|FG001|Overall Study|Withdrawal by Subject|8|||
147551146|NCT04633837|532174618|FG000|Overall Study|Participant outcomes data not collected due to technical errors.|5|||
147551147|NCT04633837|532174619|FG001|Overall Study|Participant outcomes data not collected due to technical errors.|0|||
147551148|NCT02668783|532174620|FG000|Overall Study|Pregnancy|0|||
147551149|NCT02668783|532174621|FG001|Overall Study|Pregnancy|1|||
147551150|NCT02668783|532174620|FG000|Overall Study|Protocol Violation|2|||
147551151|NCT02668783|532174621|FG001|Overall Study|Protocol Violation|1|||
147551152|NCT02668783|532174620|FG000|Overall Study|Study terminated by sponsor|9|||
147551153|NCT02668783|532174621|FG001|Overall Study|Study terminated by sponsor|10|||
147551154|NCT02668783|532174620|FG000|Overall Study|Subject moved|1|||
147551155|NCT02668783|532174621|FG001|Overall Study|Subject moved|0|||
147551156|NCT02668783|532174620|FG000|Overall Study|Withdrawal by Subject|1|||
147551157|NCT02668783|532174621|FG001|Overall Study|Withdrawal by Subject|0|||
147551158|NCT02884206|532174622|FG000|Valsartan Run-in Period|Death|1|||
147551159|NCT02884206|532174623|FG001|Valsartan Run-in Period|Death|0|||
147551160|NCT02884206|532174624|FG002|Valsartan Run-in Period|Death|0|||
147551161|NCT02884206|532174622|FG000|Valsartan Run-in Period|Adverse Event|31|||
147551162|NCT02884206|532174623|FG001|Valsartan Run-in Period|Adverse Event|0|||
147551163|NCT02884206|532174624|FG002|Valsartan Run-in Period|Adverse Event|0|||
147551164|NCT02884206|532174622|FG000|Valsartan Run-in Period|Patient/guardian decision|9|||
147551165|NCT02884206|532174623|FG001|Valsartan Run-in Period|Patient/guardian decision|0|||
147551166|NCT02884206|532174624|FG002|Valsartan Run-in Period|Patient/guardian decision|0|||
147551167|NCT02884206|532174622|FG000|Valsartan Run-in Period|Protocol deviation|4|||
147551168|NCT02884206|532174623|FG001|Valsartan Run-in Period|Protocol deviation|0|||
147551169|NCT02884206|532174624|FG002|Valsartan Run-in Period|Protocol deviation|0|||
147551170|NCT02884206|532174622|FG000|Valsartan Run-in Period|Non-compliance with study treatment|1|||
147551171|NCT02884206|532174623|FG001|Valsartan Run-in Period|Non-compliance with study treatment|0|||
147551172|NCT02884206|532174624|FG002|Valsartan Run-in Period|Non-compliance with study treatment|0|||
147551173|NCT02884206|532174622|FG000|Valsartan Run-in Period|Physician Decision|1|||
147551174|NCT02884206|532174623|FG001|Valsartan Run-in Period|Physician Decision|0|||
147551175|NCT02884206|532174624|FG002|Valsartan Run-in Period|Physician Decision|0|||
147551176|NCT02884206|532174622|FG000|LCZ696 Run-in Period|Adverse Event|38|||
147551177|NCT02884206|532174623|FG001|LCZ696 Run-in Period|Adverse Event|0|||
147551178|NCT02884206|532174624|FG002|LCZ696 Run-in Period|Adverse Event|0|||
147551179|NCT02884206|532174622|FG000|LCZ696 Run-in Period|Death|2|||
147551180|NCT02884206|532174623|FG001|LCZ696 Run-in Period|Death|0|||
147551181|NCT02884206|532174624|FG002|LCZ696 Run-in Period|Death|0|||
147551182|NCT02884206|532174622|FG000|LCZ696 Run-in Period|Patient/guardian decision|16|||
147551183|NCT02884206|532174623|FG001|LCZ696 Run-in Period|Patient/guardian decision|0|||
147551184|NCT02884206|532174624|FG002|LCZ696 Run-in Period|Patient/guardian decision|0|||
147551185|NCT02884206|532174622|FG000|LCZ696 Run-in Period|Protocol deviation|6|||
147551186|NCT02884206|532174623|FG001|LCZ696 Run-in Period|Protocol deviation|0|||
147551187|NCT02884206|532174624|FG002|LCZ696 Run-in Period|Protocol deviation|0|||
147551188|NCT02884206|532174622|FG000|LCZ696 Run-in Period|Non-compliance with study treatment|3|||
147551189|NCT02884206|532174623|FG001|LCZ696 Run-in Period|Non-compliance with study treatment|0|||
147551190|NCT02884206|532174624|FG002|LCZ696 Run-in Period|Non-compliance with study treatment|0|||
147551191|NCT02884206|532174622|FG000|LCZ696 Run-in Period|Physician Decision|1|||
147551192|NCT02884206|532174623|FG001|LCZ696 Run-in Period|Physician Decision|0|||
147551193|NCT02884206|532174624|FG002|LCZ696 Run-in Period|Physician Decision|0|||
147551194|NCT02884206|532174622|FG000|LCZ696 Run-in Period|Lost to Follow-up|1|||
147551195|NCT02884206|532174623|FG001|LCZ696 Run-in Period|Lost to Follow-up|0|||
147551196|NCT02884206|532174624|FG002|LCZ696 Run-in Period|Lost to Follow-up|0|||
147551197|NCT02884206|532174622|FG000|Double-Blind Period|Death|0|||
147551198|NCT02884206|532174623|FG001|Double-Blind Period|Death|28|||
147551199|NCT02884206|532174624|FG002|Double-Blind Period|Death|39|||
147551200|NCT02884206|532174622|FG000|Double-Blind Period|Patient/guardian decision|0|||
147551201|NCT02884206|532174623|FG001|Double-Blind Period|Patient/guardian decision|10|||
147551202|NCT02884206|532174624|FG002|Double-Blind Period|Patient/guardian decision|13|||
147551203|NCT02884206|532174622|FG000|Double-Blind Period|Lost to Follow-up|0|||
147551204|NCT02884206|532174623|FG001|Double-Blind Period|Lost to Follow-up|4|||
147551205|NCT02884206|532174624|FG002|Double-Blind Period|Lost to Follow-up|4|||
147551206|NCT02884206|532174622|FG000|Double-Blind Period|Physician Decision|0|||
147551207|NCT02884206|532174623|FG001|Double-Blind Period|Physician Decision|2|||
147551208|NCT02884206|532174624|FG002|Double-Blind Period|Physician Decision|0|||
147551209|NCT02884206|532174622|FG000|Double-Blind Period|Adverse Event|0|||
147551210|NCT02884206|532174623|FG001|Double-Blind Period|Adverse Event|0|||
147551211|NCT02884206|532174624|FG002|Double-Blind Period|Adverse Event|3|||
147551212|NCT02884206|532174622|FG000|Double-Blind Period|Non-compliance with study treatment|0|||
147551213|NCT02884206|532174623|FG001|Double-Blind Period|Non-compliance with study treatment|0|||
147551214|NCT02884206|532174624|FG002|Double-Blind Period|Non-compliance with study treatment|1|||
147551215|NCT00112489|532174625|FG000|Overall Study|Refused further treatment|8|||
147551216|NCT00112489|532174625|FG000|Overall Study|Adverse Event|12|||
147551217|NCT00112489|532174625|FG000|Overall Study|Death|2|||
147551218|NCT00112489|532174625|FG000|Overall Study|Other, Not Specified|9|||
147551219|NCT00112489|532174625|FG000|Overall Study|Patient never treated|2|||
147215877|NCT04255394|530961741|FG000|Overall Study|Screen Failure/Not treated|12|||
147215878|NCT04255394|530961742|FG001|Overall Study|Screen Failure/Not treated|8|||
147215879|NCT04255394|530961741|FG000|Overall Study|Lost to Follow-up|123|||
147215880|NCT04255394|530961742|FG001|Overall Study|Lost to Follow-up|265|||
147215881|NCT04255394|530961741|FG000|Overall Study|Adverse Event|1|||
147215882|NCT04255394|530961742|FG001|Overall Study|Adverse Event|3|||
147215883|NCT01181986|530961751|FG000|Phase 1|Lost to Follow-up|0|||
147215884|NCT01181986|530961752|FG001|Phase 1|Lost to Follow-up|1|||
147215885|NCT01181986|530961753|FG002|Phase 1|Lost to Follow-up|1|||
147215886|NCT01181986|530961751|FG000|Phase 1|Adverse Event|0|||
147215887|NCT01181986|530961752|FG001|Phase 1|Adverse Event|0|||
147215888|NCT01181986|530961753|FG002|Phase 1|Adverse Event|1|||
147215889|NCT01181986|530961751|FG000|Phase 1|Protocol Violation|1|||
147215890|NCT01181986|530961752|FG001|Phase 1|Protocol Violation|0|||
147215891|NCT01181986|530961753|FG002|Phase 1|Protocol Violation|0|||
147215892|NCT01181986|530961751|FG000|Phase 2|Adverse Event|0|||
147215893|NCT01181986|530961752|FG001|Phase 2|Adverse Event|3|||
147215894|NCT01181986|530961753|FG002|Phase 2|Adverse Event|0|||
147215895|NCT01181986|530961751|FG000|Phase 2|Medical condition|0|||
147215896|NCT01181986|530961752|FG001|Phase 2|Medical condition|1|||
147215897|NCT01181986|530961753|FG002|Phase 2|Medical condition|0|||
147215898|NCT01330017|530963346|FG000|Overall Study|Adverse Event|0|||
147215899|NCT01330017|530963347|FG001|Overall Study|Adverse Event|1|||
147215900|NCT01330017|530963348|FG002|Overall Study|Adverse Event|1|||
147215901|NCT01330017|530963349|FG003|Overall Study|Adverse Event|4|||
147215902|NCT01330017|530963350|FG004|Overall Study|Adverse Event|0|||
147215903|NCT01330017|530963346|FG000|Overall Study|Withdrawal by Subject|0|||
147215904|NCT01330017|530963347|FG001|Overall Study|Withdrawal by Subject|0|||
147215905|NCT01330017|530963348|FG002|Overall Study|Withdrawal by Subject|1|||
147215906|NCT01330017|530963349|FG003|Overall Study|Withdrawal by Subject|0|||
147215907|NCT01330017|530963350|FG004|Overall Study|Withdrawal by Subject|1|||
147215908|NCT01330017|530963346|FG000|Overall Study|Lost to Follow-up|0|||
147215909|NCT01330017|530963347|FG001|Overall Study|Lost to Follow-up|0|||
147215910|NCT01330017|530963348|FG002|Overall Study|Lost to Follow-up|1|||
147215911|NCT01330017|530963349|FG003|Overall Study|Lost to Follow-up|0|||
147215912|NCT01330017|530963350|FG004|Overall Study|Lost to Follow-up|0|||
147215913|NCT01330017|530963346|FG000|Overall Study|Protocol Violation|0|||
147215914|NCT01330017|530963347|FG001|Overall Study|Protocol Violation|0|||
147215915|NCT01330017|530963348|FG002|Overall Study|Protocol Violation|0|||
147215916|NCT01330017|530963349|FG003|Overall Study|Protocol Violation|1|||
147215917|NCT01330017|530963350|FG004|Overall Study|Protocol Violation|0|||
147215918|NCT01330017|530963346|FG000|Overall Study|Unknown Reason|5|||
147215919|NCT01330017|530963347|FG001|Overall Study|Unknown Reason|3|||
147215920|NCT01330017|530963348|FG002|Overall Study|Unknown Reason|5|||
147215921|NCT01330017|530963349|FG003|Overall Study|Unknown Reason|7|||
147215922|NCT01330017|530963350|FG004|Overall Study|Unknown Reason|2|||
147215923|NCT00576420|530963352|FG000|Overall Study|Death|0|||
147215924|NCT00576420|530963353|FG001|Overall Study|Death|0|||
147215925|NCT00576420|530963354|FG002|Overall Study|Death|1|||
147215926|NCT01221272|530963355|FG000|Period 1|Adverse Event|2|||
147215927|NCT01221272|530963356|FG001|Period 1|Adverse Event|0|||
147215928|NCT01221272|530963355|FG000|Period 1|Consent Withdrawal|0|||
147215929|NCT01221272|530963356|FG001|Period 1|Consent Withdrawal|1|||
147215930|NCT01221272|530963355|FG000|Period 1|Significant Dosing Noncompliance|0|||
147215931|NCT01221272|530963356|FG001|Period 1|Significant Dosing Noncompliance|1|||
147215932|NCT01221272|530963355|FG000|Period 2|Adverse Event|0|||
147215933|NCT01221272|530963356|FG001|Period 2|Adverse Event|2|||
147215934|NCT02043899|530963360|FG000|Overall Study|Adverse Event|3|||
147215935|NCT02043899|530963360|FG000|Overall Study|Physician Decision|1|||
147215936|NCT02043899|530963360|FG000|Overall Study|Withdrawal by Subject|2|||
147215937|NCT02043899|530963360|FG000|Overall Study|Failure to meet the clinical criteria for [124I]mIBG imaging|5|||
147215938|NCT02043899|530963360|FG000|Overall Study|Technical manufacturing issue or logistical difficulties of [123I]mIBG or [124I]mIBG supply|12|||
147215939|NCT02043899|530963360|FG000|Overall Study|Temporary halt due to out of specification radioactivity|2|||
147215940|NCT02043899|530963360|FG000|Overall Study|Clinical progression necessitating urgent treatment|1|||
147215941|NCT02043899|530963360|FG000|Overall Study|Treatment delayed|1|||
147215942|NCT03254108|530963361|FG000|Overall Study|Adverse Event|0|||
147215943|NCT03254108|530963362|FG001|Overall Study|Adverse Event|2|||
147215944|NCT03254108|530963363|FG002|Overall Study|Adverse Event|0|||
147215945|NCT03254108|530963364|FG003|Overall Study|Adverse Event|1|||
147215946|NCT03254108|530963365|FG004|Overall Study|Adverse Event|1|||
147215947|NCT03254108|530963361|FG000|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|0|||
147215948|NCT03254108|530963362|FG001|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|0|||
147215949|NCT03254108|530963363|FG002|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|0|||
147215950|NCT03254108|530963364|FG003|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|0|||
147215951|NCT03254108|530963365|FG004|Overall Study|AST/ALT is increased to 3 times upper limit of normal or higher|2|||
147215952|NCT01771809|530963366|FG000|Overall Study|Adverse Event|4|||
147215953|NCT01771809|530963367|FG001|Overall Study|Adverse Event|12|||
147215954|NCT01771809|530963366|FG000|Overall Study|Protocol Violation|0|||
147215955|NCT01771809|530963367|FG001|Overall Study|Protocol Violation|1|||
147215956|NCT01771809|530963366|FG000|Overall Study|Withdrawal by Subject|34|||
147215957|NCT01771809|530963367|FG001|Overall Study|Withdrawal by Subject|42|||
147215958|NCT01771809|530963366|FG000|Overall Study|Lost to Follow-up|1|||
147215959|NCT01771809|530963367|FG001|Overall Study|Lost to Follow-up|3|||
147215960|NCT01771809|530963366|FG000|Overall Study|Other (Insufficient clinical response)|22|||
147215961|NCT01771809|530963367|FG001|Overall Study|Other (Insufficient clinical response)|20|||
147215962|NCT01771809|530963366|FG000|Overall Study|Death|1|||
147215963|NCT01771809|530963367|FG001|Overall Study|Death|0|||
147215964|NCT01771809|530963366|FG000|Overall Study|Other (other)|9|||
147215965|NCT01771809|530963367|FG001|Overall Study|Other (other)|5|||
147551220|NCT00112489|532174625|FG000|Overall Study|Ineligible|7|||
147551221|NCT02231710|532174626|FG000|Overall Study|Physician Decision|1|||
147551222|NCT00124020|532174629|FG000|Overall Study|Death|67|||
147551223|NCT00124020|532174630|FG001|Overall Study|Death|71|||
147551224|NCT00124020|532174629|FG000|Overall Study|Withdrawal by Subject|13|||
147551225|NCT00124020|532174630|FG001|Overall Study|Withdrawal by Subject|11|||
147551226|NCT00124020|532174629|FG000|Overall Study|Lost to Follow-up|5|||
147551227|NCT00124020|532174630|FG001|Overall Study|Lost to Follow-up|8|||
147551228|NCT00124020|532174629|FG000|Overall Study|Other|1|||
147551229|NCT00124020|532174630|FG001|Overall Study|Other|1|||
147551230|NCT00124020|532174629|FG000|Overall Study|Transfer to another hospital|2|||
147551231|NCT00124020|532174630|FG001|Overall Study|Transfer to another hospital|0|||
147551232|NCT00268346|532174631|FG000|Overall Study|Adverse Event|0|||
147551233|NCT00268346|532174632|FG001|Overall Study|Adverse Event|1|||
147551234|NCT00268346|532174631|FG000|Overall Study|Death|0|||
147551235|NCT00268346|532174632|FG001|Overall Study|Death|1|||
147551236|NCT00268346|532174631|FG000|Overall Study|Withdrawal by Subject|0|||
147551237|NCT00268346|532174632|FG001|Overall Study|Withdrawal by Subject|1|||
147551238|NCT01799590|532174633|FG000|Overall Study|Adverse Event|13|||
147551239|NCT01799590|532174634|FG001|Overall Study|Adverse Event|7|||
147551240|NCT01799590|532174635|FG002|Overall Study|Adverse Event|5|||
147551241|NCT01799590|532174633|FG000|Overall Study|Pregnancy|2|||
147551242|NCT01799590|532174634|FG001|Overall Study|Pregnancy|0|||
147551243|NCT01799590|532174635|FG002|Overall Study|Pregnancy|0|||
147215966|NCT00362180|530963368|FG000|Treated Period|Withdrawal by Subject|1|||
147215967|NCT00362180|530963369|FG001|Treated Period|Withdrawal by Subject|0|||
147215968|NCT00362180|530963370|FG002|Treated Period|Withdrawal by Subject|0|||
147215969|NCT00362180|530963371|FG003|Treated Period|Withdrawal by Subject|0|||
147215970|NCT00362180|530963372|FG004|Treated Period|Withdrawal by Subject|0|||
147215971|NCT00362180|530963373|FG005|Treated Period|Withdrawal by Subject|0|||
147215972|NCT00362180|530963374|FG006|Treated Period|Withdrawal by Subject|0|||
147215973|NCT00362180|530963375|FG007|Treated Period|Withdrawal by Subject|0|||
147215974|NCT00362180|530963376|FG008|Treated Period|Withdrawal by Subject|0|||
147215975|NCT00362180|530963368|FG000|Treated Period|Adverse Event|0|||
147215976|NCT00362180|530963369|FG001|Treated Period|Adverse Event|0|||
147215977|NCT00362180|530963370|FG002|Treated Period|Adverse Event|0|||
147215978|NCT00362180|530963371|FG003|Treated Period|Adverse Event|0|||
147215979|NCT00362180|530963372|FG004|Treated Period|Adverse Event|0|||
147215980|NCT00362180|530963373|FG005|Treated Period|Adverse Event|1|||
147215981|NCT00362180|530963374|FG006|Treated Period|Adverse Event|0|||
147215982|NCT00362180|530963375|FG007|Treated Period|Adverse Event|1|||
147215983|NCT00362180|530963376|FG008|Treated Period|Adverse Event|0|||
147215984|NCT01106092|530963377|FG000|Overall Study|Withdrawal by Subject|0|||
147215985|NCT01106092|530963378|FG001|Overall Study|Withdrawal by Subject|0|||
147215986|NCT01106092|530963379|FG002|Overall Study|Withdrawal by Subject|0|||
147215987|NCT01106092|530963380|FG003|Overall Study|Withdrawal by Subject|1|||
147215988|NCT02434471|530963385|FG000|Overall Study|Physician Decision|9|||
147215989|NCT04839562|530963390|FG000|Overall Study|Withdrawal by Subject|0|||
147215990|NCT04839562|530963391|FG001|Overall Study|Withdrawal by Subject|1|||
147215991|NCT04839562|530963390|FG000|Overall Study|Physician Decision|0|||
147215992|NCT04839562|530963391|FG001|Overall Study|Physician Decision|1|||
147215993|NCT00003472|530963399|FG000|Overall Study|Not evaluable|3|||
147551244|NCT01799590|532174633|FG000|Overall Study|Lack of Efficacy|3|||
147551245|NCT01799590|532174634|FG001|Overall Study|Lack of Efficacy|1|||
147551246|NCT01799590|532174635|FG002|Overall Study|Lack of Efficacy|3|||
147551247|NCT01799590|532174633|FG000|Overall Study|Participants convenience|4|||
147551248|NCT01799590|532174634|FG001|Overall Study|Participants convenience|4|||
147551249|NCT01799590|532174635|FG002|Overall Study|Participants convenience|2|||
147551250|NCT01799590|532174633|FG000|Overall Study|Aggravation of complications|0|||
147551251|NCT01799590|532174634|FG001|Overall Study|Aggravation of complications|1|||
147215994|NCT01012219|530963400|FG000|Period 1|Withdrawal by Subject|1|||
147215995|NCT01012219|530963400|FG000|Period 2|Withdrawal by Subject|1|||
147215996|NCT01350544|530963405|FG000|Overall Study|Administrative Withdrawal|0|||
147215997|NCT01350544|530963406|FG001|Overall Study|Administrative Withdrawal|1|||
147215998|NCT01350544|530963405|FG000|Overall Study|Death|1|||
147215999|NCT01350544|530963406|FG001|Overall Study|Death|2|||
147216000|NCT01350544|530963405|FG000|Overall Study|Moved out of LA County|2|||
147216001|NCT01350544|530963406|FG001|Overall Study|Moved out of LA County|2|||
147551252|NCT01799590|532174635|FG002|Overall Study|Aggravation of complications|1|||
147551253|NCT01799590|532174633|FG000|Overall Study|Using drugs with restricted days of use|0|||
147551254|NCT01799590|532174634|FG001|Overall Study|Using drugs with restricted days of use|3|||
147551255|NCT01799590|532174635|FG002|Overall Study|Using drugs with restricted days of use|2|||
147551256|NCT01799590|532174633|FG000|Overall Study|Use of prohibited concomitant drugs|1|||
147551257|NCT01799590|532174634|FG001|Overall Study|Use of prohibited concomitant drugs|0|||
147551258|NCT01799590|532174635|FG002|Overall Study|Use of prohibited concomitant drugs|0|||
147551259|NCT01799590|532174633|FG000|Overall Study|Other|3|||
147551260|NCT01799590|532174634|FG001|Overall Study|Other|0|||
147551261|NCT01799590|532174635|FG002|Overall Study|Other|1|||
147551262|NCT00294723|532174638|FG000|Double-Blind Period 52 Weeks|Adverse Event|18|||
147551263|NCT00294723|532174639|FG001|Double-Blind Period 52 Weeks|Adverse Event|25|||
147551264|NCT00294723|532174640|FG002|Double-Blind Period 52 Weeks|Adverse Event|15|||
147551265|NCT00294723|532174638|FG000|Double-Blind Period 52 Weeks|Lack of Efficacy|9|||
147551266|NCT00294723|532174639|FG001|Double-Blind Period 52 Weeks|Lack of Efficacy|15|||
147551267|NCT00294723|532174640|FG002|Double-Blind Period 52 Weeks|Lack of Efficacy|25|||
147551268|NCT00294723|532174638|FG000|Double-Blind Period 52 Weeks|Protocol Violation|11|||
147551269|NCT00294723|532174639|FG001|Double-Blind Period 52 Weeks|Protocol Violation|11|||
147551270|NCT00294723|532174640|FG002|Double-Blind Period 52 Weeks|Protocol Violation|5|||
147551271|NCT00294723|532174638|FG000|Double-Blind Period 52 Weeks|Not specified in study report|36|||
147551272|NCT00294723|532174639|FG001|Double-Blind Period 52 Weeks|Not specified in study report|38|||
147551273|NCT00294723|532174640|FG002|Double-Blind Period 52 Weeks|Not specified in study report|51|||
147551274|NCT00294723|532174638|FG000|Open-Label Extension 52 Weeks|Adverse Event|5|||
147551275|NCT00294723|532174639|FG001|Open-Label Extension 52 Weeks|Adverse Event|5|||
147551276|NCT00294723|532174640|FG002|Open-Label Extension 52 Weeks|Adverse Event|2|||
147551277|NCT00294723|532174638|FG000|Open-Label Extension 52 Weeks|Lack of Efficacy|12|||
147551278|NCT00294723|532174639|FG001|Open-Label Extension 52 Weeks|Lack of Efficacy|15|||
147551279|NCT00294723|532174640|FG002|Open-Label Extension 52 Weeks|Lack of Efficacy|21|||
147551280|NCT00294723|532174638|FG000|Open-Label Extension 52 Weeks|Protocol Violation|4|||
147551281|NCT00294723|532174639|FG001|Open-Label Extension 52 Weeks|Protocol Violation|3|||
147551282|NCT00294723|532174640|FG002|Open-Label Extension 52 Weeks|Protocol Violation|3|||
147551283|NCT00294723|532174638|FG000|Open-Label Extension 52 Weeks|Not specified in study report|19|||
147551284|NCT00294723|532174639|FG001|Open-Label Extension 52 Weeks|Not specified in study report|16|||
147551285|NCT00294723|532174640|FG002|Open-Label Extension 52 Weeks|Not specified in study report|14|||
147551286|NCT00294723|532174638|FG000|Additional Open-Label Extension 91 Weeks|Adverse Event|1|||
147551287|NCT00294723|532174639|FG001|Additional Open-Label Extension 91 Weeks|Adverse Event|1|||
147551288|NCT00294723|532174640|FG002|Additional Open-Label Extension 91 Weeks|Adverse Event|0|||
147551289|NCT00294723|532174638|FG000|Additional Open-Label Extension 91 Weeks|Lack of Efficacy|24|||
147551290|NCT00294723|532174639|FG001|Additional Open-Label Extension 91 Weeks|Lack of Efficacy|14|||
147551291|NCT00294723|532174640|FG002|Additional Open-Label Extension 91 Weeks|Lack of Efficacy|16|||
147551292|NCT00294723|532174638|FG000|Additional Open-Label Extension 91 Weeks|Protocol Violation|1|||
147551293|NCT00294723|532174639|FG001|Additional Open-Label Extension 91 Weeks|Protocol Violation|1|||
147551294|NCT00294723|532174640|FG002|Additional Open-Label Extension 91 Weeks|Protocol Violation|1|||
147551295|NCT00294723|532174638|FG000|Additional Open-Label Extension 91 Weeks|Not specified in study report|2|||
147551296|NCT00294723|532174639|FG001|Additional Open-Label Extension 91 Weeks|Not specified in study report|5|||
147551297|NCT00294723|532174640|FG002|Additional Open-Label Extension 91 Weeks|Not specified in study report|3|||
147551298|NCT00752791|532174641|FG000|Overall Study|Adverse Event|7|||
147551299|NCT00752791|532174641|FG000|Overall Study|Withdrawal by Subject|1|||
147551300|NCT00752791|532174641|FG000|Overall Study|Physician Decision|1|||
147551301|NCT00752791|532174641|FG000|Overall Study|Death|1|||
147551302|NCT00752791|532174641|FG000|Overall Study|Renal transplant|3|||
147551303|NCT00752791|532174641|FG000|Overall Study|Switched to hemodialysis|2|||
147551304|NCT00752791|532174641|FG000|Overall Study|Protocol deviation|1|||
147551305|NCT03341507|532174642|FG000|Overall Study|Cormack-Lehane grade 1 or 2a during conventional laryngoscopy|34|||
147551306|NCT02927847|532174643|FG000|Overall Study|Lost to Follow-up|1|||
147551307|NCT02927847|532174644|FG001|Overall Study|Lost to Follow-up|0|||
147551308|NCT02927847|532174643|FG000|Overall Study|Withdrawal by Subject|4|||
147551309|NCT02927847|532174644|FG001|Overall Study|Withdrawal by Subject|2|||
147551310|NCT02927847|532174643|FG000|Overall Study|PI withdrawn due to missed visits|1|||
147551311|NCT02927847|532174644|FG001|Overall Study|PI withdrawn due to missed visits|1|||
147551312|NCT01755858|532174647|FG000|Overall Study|Adverse Event|1|||
147551313|NCT01755858|532174648|FG001|Overall Study|Adverse Event|1|||
147551314|NCT03255031|532174649|FG000|Overall Study|Adverse Event|5|||
147551315|NCT03255031|532174650|FG001|Overall Study|Adverse Event|3|||
147551316|NCT03255031|532174649|FG000|Overall Study|Physician Decision|2|||
147551317|NCT03255031|532174650|FG001|Overall Study|Physician Decision|1|||
147551318|NCT03255031|532174649|FG000|Overall Study|Withdrawal by Subject|9|||
147551319|NCT03255031|532174650|FG001|Overall Study|Withdrawal by Subject|3|||
147551320|NCT01809314|532174651|FG000|Overall Study|Withdrawal Prior to Treatment|1|||
147551321|NCT01809314|532174651|FG000|Overall Study|Adverse Event|6|||
147216002|NCT01350544|530963405|FG000|Overall Study|Medical Issues|1|||
147216003|NCT01350544|530963406|FG001|Overall Study|Medical Issues|1|||
147216004|NCT01350544|530963405|FG000|Overall Study|Withdrawal by Subject|0|||
147216005|NCT01350544|530963406|FG001|Overall Study|Withdrawal by Subject|1|||
147216006|NCT01350544|530963405|FG000|Overall Study|Incarceration|1|||
147216007|NCT01350544|530963406|FG001|Overall Study|Incarceration|0|||
147216008|NCT01350544|530963405|FG000|Overall Study|Lost to Follow-up|18|||
147216009|NCT01350544|530963406|FG001|Overall Study|Lost to Follow-up|15|||
147216010|NCT01444092|530963409|FG000|Overall Study|Adverse Event|8|||
147216011|NCT01444092|530963409|FG000|Overall Study|Protocol Violation|1|||
147216012|NCT01444092|530963409|FG000|Overall Study|Withdrawal by Subject|1|||
147216013|NCT01444092|530963409|FG000|Overall Study|Other Eligibility criteria|7|||
147216014|NCT01328366|530963410|FG000|Overall Study|Death|1|||
147216015|NCT01328366|530963410|FG000|Overall Study|Withdrawal by Subject|2|||
147216016|NCT01328366|530963410|FG000|Overall Study|Lost to Follow-up|7|||
147216017|NCT03005873|530963411|FG000|Overall Study|Prohibited medication use post radnomization|1|||
147216018|NCT03005873|530963412|FG001|Overall Study|Prohibited medication use post radnomization|1|||
147216019|NCT03005873|530963413|FG002|Overall Study|Prohibited medication use post radnomization|1|||
147216020|NCT03005873|530963411|FG000|Overall Study|Withdrew consent|0|||
147216021|NCT03005873|530963412|FG001|Overall Study|Withdrew consent|1|||
147216022|NCT03005873|530963413|FG002|Overall Study|Withdrew consent|2|||
147216023|NCT03005873|530963411|FG000|Overall Study|Lost to Follow-up|0|||
147216024|NCT03005873|530963412|FG001|Overall Study|Lost to Follow-up|1|||
147216025|NCT03005873|530963413|FG002|Overall Study|Lost to Follow-up|0|||
147216026|NCT03005873|530963411|FG000|Overall Study|Ineligible post randomization|0|||
147216027|NCT03005873|530963412|FG001|Overall Study|Ineligible post randomization|0|||
147216028|NCT03005873|530963413|FG002|Overall Study|Ineligible post randomization|1|||
147216029|NCT04585009|530963414|FG000|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|1|||
147216030|NCT04585009|530963415|FG001|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
147216031|NCT04585009|530963416|FG002|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
147216032|NCT04585009|530963417|FG003|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
147216033|NCT04585009|530963418|FG004|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
147216034|NCT04585009|530963419|FG005|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
147216035|NCT04585009|530963420|FG006|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
147216036|NCT04585009|530963421|FG007|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
147216037|NCT04585009|530963422|FG008|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
147216038|NCT04585009|530963423|FG009|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
147216039|NCT04585009|530963424|FG010|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
147216040|NCT04585009|530963425|FG011|PartA, Cohort1, Treatment Period1(Day1)|Withdrawal by Subject|0|||
147216041|NCT04585009|530963414|FG000|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|1|||
147216042|NCT04585009|530963415|FG001|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
147216043|NCT04585009|530963416|FG002|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
147216044|NCT04585009|530963417|FG003|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
147216045|NCT04585009|530963418|FG004|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
147216046|NCT04585009|530963419|FG005|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
147216047|NCT04585009|530963420|FG006|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
147216048|NCT04585009|530963421|FG007|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
147216049|NCT04585009|530963422|FG008|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
147216050|NCT04585009|530963423|FG009|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
147216051|NCT04585009|530963424|FG010|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
147216052|NCT04585009|530963425|FG011|PartA, Cohort1,Treatment Period2(Day1)|Withdrawal by Subject|0|||
147216053|NCT04585009|530963414|FG000|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
147216054|NCT04585009|530963415|FG001|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
147216055|NCT04585009|530963416|FG002|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
147216056|NCT04585009|530963417|FG003|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
147216057|NCT04585009|530963418|FG004|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
147216058|NCT04585009|530963419|FG005|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
147216059|NCT04585009|530963420|FG006|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
147216060|NCT04585009|530963421|FG007|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|1|||
147551322|NCT01809314|532174651|FG000|Overall Study|Insufficient Therapeutic Response|14|||
147551323|NCT01809314|532174651|FG000|Overall Study|Lost to Follow-up|724|||
147551324|NCT01092702|532174652|FG000|Overall Study|Withdrawal by Subject|7|||
147551325|NCT01092702|532174652|FG000|Overall Study|Lost to Follow-up|2|||
147551326|NCT03567057|532174653|FG000|Overall Study|Adverse Event|56|||
147551327|NCT03567057|532174654|FG001|Overall Study|Adverse Event|53|||
147551328|NCT03567057|532174655|FG002|Overall Study|Adverse Event|28|||
147551329|NCT03567057|532174653|FG000|Overall Study|Withdrawal by Subject|22|||
147551330|NCT03567057|532174654|FG001|Overall Study|Withdrawal by Subject|24|||
147551331|NCT03567057|532174655|FG002|Overall Study|Withdrawal by Subject|13|||
147551332|NCT03567057|532174653|FG000|Overall Study|Lost to Follow-up|3|||
147551333|NCT03567057|532174654|FG001|Overall Study|Lost to Follow-up|5|||
147551334|NCT03567057|532174655|FG002|Overall Study|Lost to Follow-up|2|||
147551335|NCT03567057|532174653|FG000|Overall Study|COVID-19 pandemic|4|||
147551336|NCT03567057|532174654|FG001|Overall Study|COVID-19 pandemic|3|||
147551337|NCT03567057|532174655|FG002|Overall Study|COVID-19 pandemic|0|||
147551338|NCT03567057|532174653|FG000|Overall Study|Non-compliance with study drug|4|||
147551339|NCT03567057|532174654|FG001|Overall Study|Non-compliance with study drug|2|||
147551340|NCT03567057|532174655|FG002|Overall Study|Non-compliance with study drug|0|||
147551341|NCT03567057|532174653|FG000|Overall Study|Lack of Efficacy|3|||
147551342|NCT03567057|532174654|FG001|Overall Study|Lack of Efficacy|0|||
147551343|NCT03567057|532174655|FG002|Overall Study|Lack of Efficacy|1|||
147551344|NCT03567057|532174653|FG000|Overall Study|Death|1|||
147551345|NCT03567057|532174654|FG001|Overall Study|Death|0|||
147551346|NCT03567057|532174655|FG002|Overall Study|Death|0|||
147551347|NCT03567057|532174653|FG000|Overall Study|Physician Decision|1|||
147551348|NCT03567057|532174654|FG001|Overall Study|Physician Decision|0|||
147551349|NCT03567057|532174655|FG002|Overall Study|Physician Decision|0|||
147551350|NCT03567057|532174653|FG000|Overall Study|Unstable medical condition|1|||
147551351|NCT03567057|532174654|FG001|Overall Study|Unstable medical condition|0|||
147551352|NCT03567057|532174655|FG002|Overall Study|Unstable medical condition|0|||
147551353|NCT03567057|532174653|FG000|Overall Study|Medical history event|0|||
147551354|NCT03567057|532174654|FG001|Overall Study|Medical history event|0|||
147551355|NCT03567057|532174655|FG002|Overall Study|Medical history event|1|||
147551356|NCT03567057|532174653|FG000|Overall Study|Other|0|||
147551357|NCT03567057|532174654|FG001|Overall Study|Other|0|||
147551358|NCT03567057|532174655|FG002|Overall Study|Other|1|||
147551359|NCT00490061|532174656|FG000|Overall Study|Physician Decision|1|||
147551360|NCT01580020|532174657|FG000|Overall Study|Lack of Efficacy|0|||
147551361|NCT01580020|532174658|FG001|Overall Study|Lack of Efficacy|5|||
147551362|NCT01580020|532174659|FG002|Overall Study|Lack of Efficacy|0|||
147551363|NCT01580020|532174660|FG003|Overall Study|Lack of Efficacy|1|||
147551364|NCT01580020|532174657|FG000|Overall Study|Withdrawal by Subject|0|||
147551365|NCT01580020|532174658|FG001|Overall Study|Withdrawal by Subject|1|||
147551366|NCT01580020|532174659|FG002|Overall Study|Withdrawal by Subject|1|||
147551367|NCT01580020|532174660|FG003|Overall Study|Withdrawal by Subject|0|||
147551368|NCT01580020|532174657|FG000|Overall Study|Adverse Event|1|||
147216061|NCT04585009|530963422|FG008|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
147216062|NCT04585009|530963423|FG009|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
147216063|NCT04585009|530963424|FG010|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
147551369|NCT01580020|532174658|FG001|Overall Study|Adverse Event|1|||
147551370|NCT01580020|532174659|FG002|Overall Study|Adverse Event|1|||
147551371|NCT01580020|532174660|FG003|Overall Study|Adverse Event|1|||
147551372|NCT01580020|532174657|FG000|Overall Study|Administrative Problems|0|||
147551373|NCT01580020|532174658|FG001|Overall Study|Administrative Problems|0|||
147551374|NCT01580020|532174659|FG002|Overall Study|Administrative Problems|1|||
147551375|NCT01580020|532174660|FG003|Overall Study|Administrative Problems|0|||
147551376|NCT01580020|532174657|FG000|Overall Study|Lost to Follow-up|0|||
147551377|NCT01580020|532174658|FG001|Overall Study|Lost to Follow-up|0|||
147551378|NCT01580020|532174659|FG002|Overall Study|Lost to Follow-up|1|||
147551379|NCT01580020|532174660|FG003|Overall Study|Lost to Follow-up|0|||
147551380|NCT00591253|532174662|FG000|Overall Study|Adverse Event|3|||
147551381|NCT00591253|532174663|FG001|Overall Study|Adverse Event|3|||
147551382|NCT00591253|532174664|FG002|Overall Study|Adverse Event|1|||
147551383|NCT00591253|532174662|FG000|Overall Study|Protocol Violation|2|||
147551384|NCT00591253|532174663|FG001|Overall Study|Protocol Violation|2|||
147551385|NCT00591253|532174664|FG002|Overall Study|Protocol Violation|2|||
147551386|NCT00591253|532174662|FG000|Overall Study|Lost to Follow-up|2|||
147551387|NCT00591253|532174663|FG001|Overall Study|Lost to Follow-up|4|||
147551388|NCT00591253|532174664|FG002|Overall Study|Lost to Follow-up|0|||
147551389|NCT00591253|532174662|FG000|Overall Study|Withdrawal by Subject|1|||
147551390|NCT00591253|532174663|FG001|Overall Study|Withdrawal by Subject|7|||
147551391|NCT00591253|532174664|FG002|Overall Study|Withdrawal by Subject|6|||
147551392|NCT00591253|532174662|FG000|Overall Study|Lack of Efficacy|1|||
147551393|NCT00591253|532174663|FG001|Overall Study|Lack of Efficacy|0|||
147551394|NCT00591253|532174664|FG002|Overall Study|Lack of Efficacy|3|||
147551395|NCT00591253|532174662|FG000|Overall Study|Other|5|||
147551396|NCT00591253|532174663|FG001|Overall Study|Other|5|||
147551397|NCT00591253|532174664|FG002|Overall Study|Other|3|||
147216064|NCT04585009|530963425|FG011|PartA, Cohort2: Treatment Period4(Day1)|Adverse Event|0|||
147551398|NCT01841359|532174665|FG000|Overall Study|Underwent reversal of Roux-en-Y gastric bypass (RYGB)|2|||
147551399|NCT01841359|532174665|FG000|Overall Study|Concommitant medical issues|2|||
147551400|NCT01841359|532174665|FG000|Overall Study|Adverse Event|3|||
147551401|NCT01841359|532174665|FG000|Overall Study|Did not receive study drug at visit 4 prior to mixed meal testing|1|||
147551402|NCT01102777|532174668|FG000|Overall Study|Death|2|||
147551403|NCT01102777|532174669|FG001|Overall Study|Death|6|||
147551404|NCT01102777|532174668|FG000|Overall Study|Lost to Follow-up|7|||
147551405|NCT01102777|532174669|FG001|Overall Study|Lost to Follow-up|10|||
147551406|NCT01875445|532174670|FG000|Overall Study|Lost to Follow-up|5|||
147551407|NCT01875445|532174671|FG001|Overall Study|Lost to Follow-up|0|||
147551408|NCT01875445|532174670|FG000|Overall Study|Withdrawal by Subject|2|||
147551409|NCT01875445|532174671|FG001|Overall Study|Withdrawal by Subject|0|||
147551410|NCT01752920|532174676|FG000|Overall Study|Adverse Event|1|||
147551411|NCT01752920|532174677|FG001|Overall Study|Adverse Event|0|||
147551412|NCT01752920|532174678|FG002|Overall Study|Adverse Event|5|||
147551413|NCT01752920|532174679|FG003|Overall Study|Adverse Event|10|||
147551414|NCT01752920|532174676|FG000|Overall Study|Clinical Disease Progression|6|||
147551415|NCT01752920|532174677|FG001|Overall Study|Clinical Disease Progression|4|||
147551416|NCT01752920|532174678|FG002|Overall Study|Clinical Disease Progression|1|||
147551417|NCT01752920|532174679|FG003|Overall Study|Clinical Disease Progression|13|||
147551418|NCT01752920|532174676|FG000|Overall Study|Physician Decision|1|||
147551419|NCT01752920|532174677|FG001|Overall Study|Physician Decision|0|||
147551420|NCT01752920|532174678|FG002|Overall Study|Physician Decision|0|||
147551421|NCT01752920|532174679|FG003|Overall Study|Physician Decision|3|||
147551422|NCT01752920|532174676|FG000|Overall Study|Radiographic Disease Progression|20|||
147551423|NCT01752920|532174677|FG001|Overall Study|Radiographic Disease Progression|7|||
147551424|NCT01752920|532174678|FG002|Overall Study|Radiographic Disease Progression|12|||
147551425|NCT01752920|532174679|FG003|Overall Study|Radiographic Disease Progression|29|||
147551426|NCT01752920|532174676|FG000|Overall Study|Study Terminated by Sponsor|0|||
147551427|NCT01752920|532174677|FG001|Overall Study|Study Terminated by Sponsor|0|||
147551428|NCT01752920|532174678|FG002|Overall Study|Study Terminated by Sponsor|0|||
147551429|NCT01752920|532174679|FG003|Overall Study|Study Terminated by Sponsor|1|||
147551430|NCT01752920|532174676|FG000|Overall Study|Withdrawal by Subject|0|||
147551431|NCT01752920|532174677|FG001|Overall Study|Withdrawal by Subject|1|||
147551432|NCT01752920|532174678|FG002|Overall Study|Withdrawal by Subject|0|||
147551433|NCT01752920|532174679|FG003|Overall Study|Withdrawal by Subject|1|||
147551434|NCT01752920|532174676|FG000|Overall Study|Lack of clinical benefit|1|||
147551435|NCT01752920|532174677|FG001|Overall Study|Lack of clinical benefit|1|||
147551436|NCT01752920|532174678|FG002|Overall Study|Lack of clinical benefit|1|||
147551437|NCT01752920|532174679|FG003|Overall Study|Lack of clinical benefit|1|||
147551438|NCT01738581|532174680|FG000|Overall Study|Lost to Follow-up|1|||
147551439|NCT01738581|532174681|FG001|Overall Study|Lost to Follow-up|0|||
147216065|NCT04585009|530963414|FG000|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
147216066|NCT04585009|530963415|FG001|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
147216067|NCT04585009|530963416|FG002|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
147216068|NCT04585009|530963417|FG003|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
147216069|NCT04585009|530963418|FG004|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|1|||
147216070|NCT04585009|530963419|FG005|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
147216071|NCT04585009|530963420|FG006|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
147216072|NCT04585009|530963421|FG007|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
147216073|NCT04585009|530963422|FG008|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
147216074|NCT04585009|530963423|FG009|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
147216075|NCT04585009|530963424|FG010|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
147216076|NCT04585009|530963425|FG011|PartA, Cohort2: Treatment Period5(Day1)|Withdrawal by Subject|0|||
147216077|NCT04585009|530963414|FG000|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
147216078|NCT04585009|530963415|FG001|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
147216079|NCT04585009|530963416|FG002|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
147216080|NCT04585009|530963417|FG003|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
147216081|NCT04585009|530963418|FG004|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
147216082|NCT04585009|530963419|FG005|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
147216083|NCT04585009|530963420|FG006|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
147216084|NCT04585009|530963421|FG007|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
147216085|NCT04585009|530963422|FG008|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
147216086|NCT04585009|530963423|FG009|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|1|||
147216087|NCT04585009|530963424|FG010|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
147216088|NCT04585009|530963425|FG011|Part B, Cohorts 3 & 4 (Days 1 to 14)|Adverse Event|0|||
147216089|NCT04585009|530963414|FG000|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
147216090|NCT04585009|530963415|FG001|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
147216091|NCT04585009|530963416|FG002|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
147216092|NCT04585009|530963417|FG003|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
147216093|NCT04585009|530963418|FG004|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
147216094|NCT04585009|530963419|FG005|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
147216095|NCT04585009|530963420|FG006|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
147216096|NCT04585009|530963421|FG007|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
147551440|NCT00210626|532174682|FG000|Overall Study|Adverse Event|1|||
147551441|NCT00210626|532174683|FG001|Overall Study|Adverse Event|2|||
147551442|NCT00210626|532174682|FG000|Overall Study|Protocol Violation|1|||
147551443|NCT00210626|532174683|FG001|Overall Study|Protocol Violation|5|||
147216097|NCT04585009|530963422|FG008|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
147551444|NCT00210626|532174682|FG000|Overall Study|Lost to Follow-up|11|||
147551445|NCT00210626|532174683|FG001|Overall Study|Lost to Follow-up|11|||
147551446|NCT00210626|532174682|FG000|Overall Study|Death|1|||
147551447|NCT00210626|532174683|FG001|Overall Study|Death|0|||
147551448|NCT00210626|532174682|FG000|Overall Study|Withdrawal by Subject|29|||
147551449|NCT00210626|532174683|FG001|Overall Study|Withdrawal by Subject|20|||
147551450|NCT00210626|532174682|FG000|Overall Study|Physician Decision|0|||
147551451|NCT00210626|532174683|FG001|Overall Study|Physician Decision|2|||
147551452|NCT00210626|532174682|FG000|Overall Study|Sponser Request|1|||
147551453|NCT00210626|532174683|FG001|Overall Study|Sponser Request|0|||
147551454|NCT00210626|532174682|FG000|Overall Study|Other|4|||
147551455|NCT00210626|532174683|FG001|Overall Study|Other|5|||
147551456|NCT00771901|532174684|FG000|Overall Study|Dissat w/# of study medication (40/day)|0|||
147551457|NCT00771901|532174685|FG001|Overall Study|Dissat w/# of study medication (40/day)|0|||
147551458|NCT00771901|532174686|FG002|Overall Study|Dissat w/# of study medication (40/day)|4|||
147551459|NCT02862535|532174687|FG000|Overall Study|Death|7|||
147551460|NCT02862535|532174688|FG001|Overall Study|Death|3|||
147551461|NCT02862535|532174689|FG002|Overall Study|Death|2|||
147551462|NCT02862535|532174690|FG003|Overall Study|Death|5|||
147551463|NCT02862535|532174687|FG000|Overall Study|Study Terminated by Sponsor|1|||
147551464|NCT02862535|532174688|FG001|Overall Study|Study Terminated by Sponsor|3|||
147551465|NCT02862535|532174689|FG002|Overall Study|Study Terminated by Sponsor|8|||
147551466|NCT02862535|532174690|FG003|Overall Study|Study Terminated by Sponsor|5|||
147551467|NCT02862535|532174687|FG000|Overall Study|Enrolled, not Treated|1|||
147551468|NCT02862535|532174688|FG001|Overall Study|Enrolled, not Treated|0|||
147551469|NCT02862535|532174689|FG002|Overall Study|Enrolled, not Treated|0|||
147551470|NCT02862535|532174690|FG003|Overall Study|Enrolled, not Treated|1|||
147551471|NCT04147715|532174691|FG000|Overall Study|Adverse Event|0|||
147551472|NCT04147715|532174692|FG001|Overall Study|Adverse Event|0|||
147551473|NCT04147715|532174693|FG002|Overall Study|Adverse Event|0|||
147551474|NCT04147715|532174694|FG003|Overall Study|Adverse Event|0|||
147551475|NCT04147715|532174695|FG004|Overall Study|Adverse Event|0|||
147551476|NCT04147715|532174696|FG005|Overall Study|Adverse Event|0|||
147551477|NCT04147715|532174697|FG006|Overall Study|Adverse Event|0|||
147551478|NCT04147715|532174698|FG007|Overall Study|Adverse Event|2|||
147551479|NCT04147715|532174699|FG008|Overall Study|Adverse Event|1|||
147551480|NCT04147715|532174700|FG009|Overall Study|Adverse Event|0|||
147551481|NCT04147715|532174701|FG010|Overall Study|Adverse Event|0|||
147551482|NCT04147715|532174702|FG011|Overall Study|Adverse Event|0|||
147551483|NCT02418910|532174704|FG000|Overall Study|Lost to Follow-up|3|||
147551484|NCT02418910|532174704|FG000|Overall Study|Withdrawal by Subject|4|||
147551485|NCT02472977|532174707|FG000|Overall Study|Disease progression|4|||
147551486|NCT02472977|532174708|FG001|Overall Study|Disease progression|25|||
147551487|NCT02472977|532174709|FG002|Overall Study|Disease progression|6|||
147551488|NCT02472977|532174707|FG000|Overall Study|Withdrawal by Subject|0|||
147551489|NCT02472977|532174708|FG001|Overall Study|Withdrawal by Subject|1|||
147551490|NCT02472977|532174709|FG002|Overall Study|Withdrawal by Subject|0|||
147551491|NCT02472977|532174707|FG000|Overall Study|Study drug toxicity|2|||
147551492|NCT02472977|532174708|FG001|Overall Study|Study drug toxicity|0|||
147551493|NCT02472977|532174709|FG002|Overall Study|Study drug toxicity|2|||
147551494|NCT02472977|532174707|FG000|Overall Study|Subject request to discontinue treatment|0|||
147551495|NCT02472977|532174708|FG001|Overall Study|Subject request to discontinue treatment|1|||
147551496|NCT02472977|532174709|FG002|Overall Study|Subject request to discontinue treatment|0|||
147551497|NCT00254397|532174711|FG000|Overall Study|Disease Progression|4|||
147551498|NCT00254397|532174712|FG001|Overall Study|Disease Progression|1|||
147551499|NCT00254397|532174713|FG002|Overall Study|Disease Progression|16|||
147551500|NCT00254397|532174714|FG003|Overall Study|Disease Progression|23|||
147551501|NCT00254397|532174711|FG000|Overall Study|Non-Compliant|0|||
147551502|NCT00254397|532174712|FG001|Overall Study|Non-Compliant|0|||
147551503|NCT00254397|532174713|FG002|Overall Study|Non-Compliant|0|||
147551504|NCT00254397|532174714|FG003|Overall Study|Non-Compliant|1|||
147216098|NCT04585009|530963423|FG009|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
147551505|NCT00254397|532174711|FG000|Overall Study|Adverse Event|2|||
147551506|NCT00254397|532174712|FG001|Overall Study|Adverse Event|0|||
147551507|NCT00254397|532174713|FG002|Overall Study|Adverse Event|3|||
147551508|NCT00254397|532174714|FG003|Overall Study|Adverse Event|1|||
147551509|NCT02482805|532176457|FG000|Overall Study|Lost to Follow-up|4|||
147216099|NCT04585009|530963424|FG010|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|0|||
147216100|NCT04585009|530963425|FG011|Part C, Cohort 5 (Days 1 to 7)|Adverse Event|1|||
147216101|NCT01713933|530963426|FG000|Overall Study|Lost to Follow-up|2|||
147216102|NCT01713933|530963426|FG000|Overall Study|Withdrawal by Subject|3|||
147551510|NCT02482805|532176458|FG001|Overall Study|Lost to Follow-up|4|||
147551511|NCT02482805|532176459|FG002|Overall Study|Lost to Follow-up|0|||
147551512|NCT01806597|532176460|FG000|Period 1 (Baseline to Week 16)|Adverse Event|1|||
147551513|NCT01806597|532176461|FG001|Period 1 (Baseline to Week 16)|Adverse Event|1|||
147551514|NCT01806597|532176462|FG002|Period 1 (Baseline to Week 16)|Adverse Event|0|||
147551515|NCT01806597|532176463|FG003|Period 1 (Baseline to Week 16)|Adverse Event|0|||
147551516|NCT01806597|532176464|FG004|Period 1 (Baseline to Week 16)|Adverse Event|2|||
147216103|NCT01713933|530963426|FG000|Overall Study|Excluded from analysis as a BMI outlier|1|||
147216104|NCT02882152|530963429|FG000|Overall Study|Lost to Follow-up|1|||
147216105|NCT02882152|530963430|FG001|Overall Study|Lost to Follow-up|0|||
147216106|NCT01104376|530963435|FG000|Overall Study|Withdrawal by Subject|15|||
147216107|NCT01104376|530963435|FG000|Overall Study|Consented but excluded after labs|13|||
147216108|NCT00797966|530963436|FG000|Phase A|Lost to Follow-up|0|||
147216109|NCT00797966|530963437|FG001|Phase A|Lost to Follow-up|0|||
147216110|NCT00797966|530963438|FG002|Phase A|Lost to Follow-up|0|||
147216111|NCT00797966|530963439|FG003|Phase A|Lost to Follow-up|0|||
147216112|NCT00797966|530963440|FG004|Phase A|Lost to Follow-up|33|||
147216113|NCT00797966|530963441|FG005|Phase A|Lost to Follow-up|0|||
147216114|NCT00797966|530963436|FG000|Phase A|Adverse Event|0|||
147216115|NCT00797966|530963437|FG001|Phase A|Adverse Event|0|||
147216116|NCT00797966|530963438|FG002|Phase A|Adverse Event|0|||
147216117|NCT00797966|530963439|FG003|Phase A|Adverse Event|0|||
147216118|NCT00797966|530963440|FG004|Phase A|Adverse Event|46|||
147216119|NCT00797966|530963441|FG005|Phase A|Adverse Event|0|||
147216120|NCT00797966|530963436|FG000|Phase A|Met withdrawal criteria|0|||
147216121|NCT00797966|530963437|FG001|Phase A|Met withdrawal criteria|0|||
147216122|NCT00797966|530963438|FG002|Phase A|Met withdrawal criteria|0|||
147216123|NCT00797966|530963439|FG003|Phase A|Met withdrawal criteria|0|||
147216124|NCT00797966|530963440|FG004|Phase A|Met withdrawal criteria|4|||
147216125|NCT00797966|530963441|FG005|Phase A|Met withdrawal criteria|0|||
147216126|NCT00797966|530963436|FG000|Phase A|Physician Decision|0|||
147216127|NCT00797966|530963437|FG001|Phase A|Physician Decision|0|||
147216128|NCT00797966|530963438|FG002|Phase A|Physician Decision|0|||
147216129|NCT00797966|530963439|FG003|Phase A|Physician Decision|0|||
147216130|NCT00797966|530963440|FG004|Phase A|Physician Decision|13|||
147216131|NCT00797966|530963441|FG005|Phase A|Physician Decision|0|||
147216132|NCT00797966|530963436|FG000|Phase A|Withdrawal by Subject|0|||
147216133|NCT00797966|530963437|FG001|Phase A|Withdrawal by Subject|0|||
147216134|NCT00797966|530963438|FG002|Phase A|Withdrawal by Subject|0|||
147216135|NCT00797966|530963439|FG003|Phase A|Withdrawal by Subject|0|||
147216136|NCT00797966|530963440|FG004|Phase A|Withdrawal by Subject|33|||
147216137|NCT00797966|530963441|FG005|Phase A|Withdrawal by Subject|0|||
147216138|NCT00797966|530963436|FG000|Phase A|Protocol deviation|0|||
147216139|NCT00797966|530963437|FG001|Phase A|Protocol deviation|0|||
147216140|NCT00797966|530963438|FG002|Phase A|Protocol deviation|0|||
147216141|NCT00797966|530963439|FG003|Phase A|Protocol deviation|0|||
147216142|NCT00797966|530963440|FG004|Phase A|Protocol deviation|56|||
147216143|NCT00797966|530963441|FG005|Phase A|Protocol deviation|0|||
147216144|NCT00797966|530963436|FG000|Phase B|Lost to Follow-up|0|||
147216145|NCT00797966|530963437|FG001|Phase B|Lost to Follow-up|1|||
147216146|NCT00797966|530963438|FG002|Phase B|Lost to Follow-up|3|||
147216147|NCT00797966|530963439|FG003|Phase B|Lost to Follow-up|0|||
147216148|NCT00797966|530963440|FG004|Phase B|Lost to Follow-up|0|||
147551517|NCT01806597|532176465|FG005|Period 1 (Baseline to Week 16)|Adverse Event|0|||
147551518|NCT01806597|532176460|FG000|Period 1 (Baseline to Week 16)|Lack of Efficacy|1|||
147551519|NCT01806597|532176461|FG001|Period 1 (Baseline to Week 16)|Lack of Efficacy|0|||
147551520|NCT01806597|532176462|FG002|Period 1 (Baseline to Week 16)|Lack of Efficacy|0|||
147551521|NCT01806597|532176463|FG003|Period 1 (Baseline to Week 16)|Lack of Efficacy|0|||
147551522|NCT01806597|532176464|FG004|Period 1 (Baseline to Week 16)|Lack of Efficacy|1|||
147551523|NCT01806597|532176465|FG005|Period 1 (Baseline to Week 16)|Lack of Efficacy|0|||
147551524|NCT01806597|532176460|FG000|Period 1 (Baseline to Week 16)|Protocol Violation|0|||
147216149|NCT00797966|530963441|FG005|Phase B|Lost to Follow-up|0|||
147216150|NCT00797966|530963436|FG000|Phase B|Adverse Event|2|||
147216151|NCT00797966|530963437|FG001|Phase B|Adverse Event|1|||
147216152|NCT00797966|530963438|FG002|Phase B|Adverse Event|3|||
147216153|NCT00797966|530963439|FG003|Phase B|Adverse Event|1|||
147216154|NCT00797966|530963440|FG004|Phase B|Adverse Event|0|||
147216155|NCT00797966|530963441|FG005|Phase B|Adverse Event|0|||
147216156|NCT00797966|530963436|FG000|Phase B|Met Withdrawal Criteria|3|||
147216157|NCT00797966|530963437|FG001|Phase B|Met Withdrawal Criteria|3|||
147442919|NCT05314517|531786150|FG000|Open-label Extension|Investigator decision|0|||
147442920|NCT05314517|531786151|FG001|Open-label Extension|Investigator decision|0|||
147442921|NCT05314517|531786152|FG002|Open-label Extension|Investigator decision|1|||
147442922|NCT05314517|531786153|FG003|Open-label Extension|Investigator decision|0|||
147442923|NCT05314517|531786150|FG000|Open-label Extension|Lost to Follow-up|0|||
147442924|NCT05314517|531786151|FG001|Open-label Extension|Lost to Follow-up|0|||
147442925|NCT05314517|531786152|FG002|Open-label Extension|Lost to Follow-up|0|||
147442926|NCT05314517|531786153|FG003|Open-label Extension|Lost to Follow-up|1|||
147442927|NCT05314517|531786150|FG000|Open-label Extension|Withdrawal by Subject|0|||
147442928|NCT05314517|531786151|FG001|Open-label Extension|Withdrawal by Subject|0|||
147442929|NCT05314517|531786152|FG002|Open-label Extension|Withdrawal by Subject|1|||
147442930|NCT05314517|531786153|FG003|Open-label Extension|Withdrawal by Subject|2|||
147442931|NCT05314517|531786150|FG000|Open-label Extension|Use of prohibited medication|0|||
147216158|NCT00797966|530963438|FG002|Phase B|Met Withdrawal Criteria|6|||
147216159|NCT00797966|530963439|FG003|Phase B|Met Withdrawal Criteria|1|||
147216160|NCT00797966|530963440|FG004|Phase B|Met Withdrawal Criteria|0|||
147551525|NCT01806597|532176461|FG001|Period 1 (Baseline to Week 16)|Protocol Violation|1|||
147551526|NCT01806597|532176462|FG002|Period 1 (Baseline to Week 16)|Protocol Violation|0|||
147551527|NCT01806597|532176463|FG003|Period 1 (Baseline to Week 16)|Protocol Violation|0|||
147551528|NCT01806597|532176464|FG004|Period 1 (Baseline to Week 16)|Protocol Violation|0|||
147551529|NCT01806597|532176465|FG005|Period 1 (Baseline to Week 16)|Protocol Violation|0|||
147551530|NCT01806597|532176460|FG000|Period 1 (Baseline to Week 16)|Withdrawal by Subject|3|||
147551531|NCT01806597|532176461|FG001|Period 1 (Baseline to Week 16)|Withdrawal by Subject|2|||
147551532|NCT01806597|532176462|FG002|Period 1 (Baseline to Week 16)|Withdrawal by Subject|0|||
147551533|NCT01806597|532176463|FG003|Period 1 (Baseline to Week 16)|Withdrawal by Subject|0|||
147551534|NCT01806597|532176464|FG004|Period 1 (Baseline to Week 16)|Withdrawal by Subject|2|||
147551535|NCT01806597|532176465|FG005|Period 1 (Baseline to Week 16)|Withdrawal by Subject|0|||
147551536|NCT01806597|532176460|FG000|Period 1 (Baseline to Week 16)|Physician Decision|0|||
147551537|NCT01806597|532176461|FG001|Period 1 (Baseline to Week 16)|Physician Decision|1|||
147551538|NCT01806597|532176462|FG002|Period 1 (Baseline to Week 16)|Physician Decision|0|||
147216161|NCT00797966|530963441|FG005|Phase B|Met Withdrawal Criteria|0|||
147216162|NCT00797966|530963436|FG000|Phase B|Physician Decision|1|||
147216163|NCT00797966|530963437|FG001|Phase B|Physician Decision|0|||
147551539|NCT01806597|532176463|FG003|Period 1 (Baseline to Week 16)|Physician Decision|0|||
147216164|NCT00797966|530963438|FG002|Phase B|Physician Decision|3|||
147216165|NCT00797966|530963439|FG003|Phase B|Physician Decision|1|||
147216166|NCT00797966|530963440|FG004|Phase B|Physician Decision|0|||
147216167|NCT00797966|530963441|FG005|Phase B|Physician Decision|0|||
147216168|NCT00797966|530963436|FG000|Phase B|Withdrawal by Subject|1|||
147216169|NCT00797966|530963437|FG001|Phase B|Withdrawal by Subject|4|||
147216170|NCT00797966|530963438|FG002|Phase B|Withdrawal by Subject|3|||
147216171|NCT00797966|530963439|FG003|Phase B|Withdrawal by Subject|3|||
147216172|NCT00797966|530963440|FG004|Phase B|Withdrawal by Subject|0|||
147216173|NCT00797966|530963441|FG005|Phase B|Withdrawal by Subject|0|||
147216174|NCT00797966|530963436|FG000|Phase B|Protocol Deviation|4|||
147216175|NCT00797966|530963437|FG001|Phase B|Protocol Deviation|8|||
147551540|NCT01806597|532176464|FG004|Period 1 (Baseline to Week 16)|Physician Decision|0|||
147551541|NCT01806597|532176465|FG005|Period 1 (Baseline to Week 16)|Physician Decision|0|||
147551542|NCT01806597|532176460|FG000|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|9|||
147551543|NCT01806597|532176461|FG001|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|6|||
147551544|NCT01806597|532176462|FG002|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|4|||
147551545|NCT01806597|532176463|FG003|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|3|||
147551546|NCT01806597|532176464|FG004|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|1|||
147551547|NCT01806597|532176465|FG005|Treatment Period 2 (Week 16 to Week 132)|Adverse Event|0|||
147551548|NCT01806597|532176460|FG000|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|12|||
147551549|NCT01806597|532176461|FG001|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|5|||
147551550|NCT01806597|532176462|FG002|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|3|||
147551551|NCT01806597|532176463|FG003|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|1|||
147551552|NCT01806597|532176464|FG004|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|0|||
147551553|NCT01806597|532176465|FG005|Treatment Period 2 (Week 16 to Week 132)|Lack of Efficacy|0|||
147551554|NCT01806597|532176460|FG000|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|2|||
147551555|NCT01806597|532176461|FG001|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0|||
147551556|NCT01806597|532176462|FG002|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0|||
147551557|NCT01806597|532176463|FG003|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0|||
147551558|NCT01806597|532176464|FG004|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0|||
147551559|NCT01806597|532176465|FG005|Treatment Period 2 (Week 16 to Week 132)|Lost to Follow-up|0|||
147551560|NCT01806597|532176460|FG000|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|1|||
147551561|NCT01806597|532176461|FG001|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|1|||
147551562|NCT01806597|532176462|FG002|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0|||
147551563|NCT01806597|532176463|FG003|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0|||
147551564|NCT01806597|532176464|FG004|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0|||
147551565|NCT01806597|532176465|FG005|Treatment Period 2 (Week 16 to Week 132)|Physician Decision|0|||
147551566|NCT01806597|532176460|FG000|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|2|||
147551567|NCT01806597|532176461|FG001|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0|||
147551568|NCT01806597|532176462|FG002|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0|||
147216176|NCT00797966|530963438|FG002|Phase B|Protocol Deviation|2|||
147216177|NCT00797966|530963439|FG003|Phase B|Protocol Deviation|6|||
147216178|NCT00797966|530963440|FG004|Phase B|Protocol Deviation|0|||
147216179|NCT00797966|530963441|FG005|Phase B|Protocol Deviation|0|||
147216180|NCT00797966|530963436|FG000|Phase B|Lack of Efficacy|0|||
147216181|NCT00797966|530963437|FG001|Phase B|Lack of Efficacy|1|||
147216182|NCT00797966|530963438|FG002|Phase B|Lack of Efficacy|1|||
147216183|NCT00797966|530963439|FG003|Phase B|Lack of Efficacy|4|||
147216184|NCT00797966|530963440|FG004|Phase B|Lack of Efficacy|0|||
147216185|NCT00797966|530963441|FG005|Phase B|Lack of Efficacy|0|||
147551569|NCT01806597|532176463|FG003|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0|||
147551570|NCT01806597|532176464|FG004|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0|||
147551571|NCT01806597|532176465|FG005|Treatment Period 2 (Week 16 to Week 132)|Protocol Violation|0|||
147551572|NCT01806597|532176460|FG000|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0|||
147551573|NCT01806597|532176461|FG001|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|1|||
147551574|NCT01806597|532176462|FG002|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0|||
147551575|NCT01806597|532176463|FG003|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|1|||
147551576|NCT01806597|532176464|FG004|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0|||
147551577|NCT01806597|532176465|FG005|Treatment Period 2 (Week 16 to Week 132)|study terminated by sponsor|0|||
147551578|NCT01806597|532176460|FG000|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|10|||
147551579|NCT01806597|532176461|FG001|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|5|||
147551580|NCT01806597|532176462|FG002|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|6|||
147551581|NCT01806597|532176463|FG003|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|5|||
147551582|NCT01806597|532176464|FG004|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|0|||
147551583|NCT01806597|532176465|FG005|Treatment Period 2 (Week 16 to Week 132)|Withdrawal by Subject|0|||
147551584|NCT01806597|532176460|FG000|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|2|||
147551585|NCT01806597|532176461|FG001|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|2|||
147551586|NCT01806597|532176462|FG002|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|1|||
147551587|NCT01806597|532176463|FG003|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|1|||
147551588|NCT01806597|532176464|FG004|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|0|||
147551589|NCT01806597|532176465|FG005|Treatment Period 2 (Week 16 to Week 132)|non-compliance with study treatment|0|||
147551590|NCT01806597|532176460|FG000|Treatment Period 2 (Week 16 to Week 132)|Death|1|||
147551591|NCT01806597|532176461|FG001|Treatment Period 2 (Week 16 to Week 132)|Death|0|||
147551592|NCT01806597|532176462|FG002|Treatment Period 2 (Week 16 to Week 132)|Death|0|||
147551593|NCT01806597|532176463|FG003|Treatment Period 2 (Week 16 to Week 132)|Death|0|||
147551594|NCT01806597|532176464|FG004|Treatment Period 2 (Week 16 to Week 132)|Death|0|||
147551595|NCT01806597|532176465|FG005|Treatment Period 2 (Week 16 to Week 132)|Death|0|||
147551596|NCT01806597|532176460|FG000|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0|||
147551597|NCT01806597|532176461|FG001|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0|||
147551598|NCT01806597|532176462|FG002|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0|||
147551599|NCT01806597|532176463|FG003|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0|||
147551600|NCT01806597|532176464|FG004|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|0|||
147551601|NCT01806597|532176465|FG005|Follow-up Period (Week 132 to Week 140)|Withdrawal by Subject|5|||
147551602|NCT01806597|532176460|FG000|Follow-up Period (Week 132 to Week 140)|Adverse Event|0|||
147551603|NCT01806597|532176461|FG001|Follow-up Period (Week 132 to Week 140)|Adverse Event|0|||
147649959|NCT00703118|532539768|FG000|Overall Study|Adverse Event|1|||
147216186|NCT00797966|530963436|FG000|Phase A+|Lost to Follow-up|0|||
147216187|NCT00797966|530963437|FG001|Phase A+|Lost to Follow-up|0|||
147216188|NCT00797966|530963438|FG002|Phase A+|Lost to Follow-up|0|||
147216189|NCT00797966|530963439|FG003|Phase A+|Lost to Follow-up|0|||
147216190|NCT00797966|530963440|FG004|Phase A+|Lost to Follow-up|0|||
147216191|NCT00797966|530963441|FG005|Phase A+|Lost to Follow-up|9|||
147216192|NCT00797966|530963436|FG000|Phase A+|Met withdrawal criteria|0|||
147216193|NCT00797966|530963437|FG001|Phase A+|Met withdrawal criteria|0|||
147216194|NCT00797966|530963438|FG002|Phase A+|Met withdrawal criteria|0|||
147216195|NCT00797966|530963439|FG003|Phase A+|Met withdrawal criteria|0|||
147216196|NCT00797966|530963440|FG004|Phase A+|Met withdrawal criteria|0|||
147216197|NCT00797966|530963441|FG005|Phase A+|Met withdrawal criteria|5|||
147216198|NCT00797966|530963436|FG000|Phase A+|Withdrawal by Subject|0|||
147216199|NCT00797966|530963437|FG001|Phase A+|Withdrawal by Subject|0|||
147216200|NCT00797966|530963438|FG002|Phase A+|Withdrawal by Subject|0|||
147216201|NCT00797966|530963439|FG003|Phase A+|Withdrawal by Subject|0|||
147216202|NCT00797966|530963440|FG004|Phase A+|Withdrawal by Subject|0|||
147216203|NCT00797966|530963441|FG005|Phase A+|Withdrawal by Subject|6|||
147216204|NCT00797966|530963436|FG000|Phase A+|Adverse Event|0|||
147216205|NCT00797966|530963437|FG001|Phase A+|Adverse Event|0|||
147216206|NCT00797966|530963438|FG002|Phase A+|Adverse Event|0|||
147216207|NCT00797966|530963439|FG003|Phase A+|Adverse Event|0|||
147216208|NCT00797966|530963440|FG004|Phase A+|Adverse Event|0|||
147216209|NCT00797966|530963441|FG005|Phase A+|Adverse Event|4|||
147216210|NCT00797966|530963436|FG000|Phase A+|Protocol deviation|0|||
147216211|NCT00797966|530963437|FG001|Phase A+|Protocol deviation|0|||
147216212|NCT00797966|530963438|FG002|Phase A+|Protocol deviation|0|||
147216213|NCT00797966|530963439|FG003|Phase A+|Protocol deviation|0|||
147216214|NCT00797966|530963440|FG004|Phase A+|Protocol deviation|0|||
147216215|NCT00797966|530963441|FG005|Phase A+|Protocol deviation|4|||
147216216|NCT01242813|530963446|FG000|Overall Study|Lost to Follow-up|2|||
147216217|NCT01369329|530963448|FG000|Overall Study|Withdrawal by Subject|8|||
147216218|NCT01369329|530963449|FG001|Overall Study|Withdrawal by Subject|6|||
147551604|NCT01806597|532176462|FG002|Follow-up Period (Week 132 to Week 140)|Adverse Event|0|||
147551605|NCT01806597|532176463|FG003|Follow-up Period (Week 132 to Week 140)|Adverse Event|0|||
147551606|NCT01806597|532176464|FG004|Follow-up Period (Week 132 to Week 140)|Adverse Event|0|||
147551607|NCT01806597|532176465|FG005|Follow-up Period (Week 132 to Week 140)|Adverse Event|2|||
147551608|NCT01806597|532176460|FG000|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0|||
147551609|NCT01806597|532176461|FG001|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0|||
147551610|NCT01806597|532176462|FG002|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0|||
147551611|NCT01806597|532176463|FG003|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0|||
147551612|NCT01806597|532176464|FG004|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|0|||
147551613|NCT01806597|532176465|FG005|Follow-up Period (Week 132 to Week 140)|Lack of Efficacy|2|||
147551614|NCT01806597|532176460|FG000|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0|||
147551615|NCT01806597|532176461|FG001|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0|||
147551616|NCT01806597|532176462|FG002|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0|||
147551617|NCT01806597|532176463|FG003|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0|||
147551618|NCT01806597|532176464|FG004|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|0|||
147551619|NCT01806597|532176465|FG005|Follow-up Period (Week 132 to Week 140)|Lost to Follow-up|2|||
147551620|NCT01806597|532176460|FG000|Follow-up Period (Week 132 to Week 140)|Physician Decision|0|||
147216219|NCT01369329|530963450|FG002|Overall Study|Withdrawal by Subject|10|||
147216220|NCT01369329|530963448|FG000|Overall Study|Lost to Follow-up|2|||
147216221|NCT01369329|530963449|FG001|Overall Study|Lost to Follow-up|2|||
147216222|NCT01369329|530963450|FG002|Overall Study|Lost to Follow-up|2|||
147216223|NCT01369329|530963448|FG000|Overall Study|Other|2|||
147216224|NCT01369329|530963449|FG001|Overall Study|Other|3|||
147216225|NCT01369329|530963450|FG002|Overall Study|Other|2|||
147216226|NCT00701662|530963451|FG000|Overall Study|Lack of Efficacy|1|||
147216227|NCT03337490|530963452|FG000|Overall Study|Withdrawal by Subject|1|||
147216228|NCT03337490|530963453|FG001|Overall Study|Withdrawal by Subject|0|||
147216229|NCT03337490|530963454|FG002|Overall Study|Withdrawal by Subject|0|||
147216230|NCT03337490|530963452|FG000|Overall Study|Lack of Efficacy|10|||
147216231|NCT03337490|530963453|FG001|Overall Study|Lack of Efficacy|12|||
147551621|NCT01806597|532176461|FG001|Follow-up Period (Week 132 to Week 140)|Physician Decision|0|||
147551622|NCT01806597|532176462|FG002|Follow-up Period (Week 132 to Week 140)|Physician Decision|0|||
147551623|NCT01806597|532176463|FG003|Follow-up Period (Week 132 to Week 140)|Physician Decision|0|||
147551624|NCT01806597|532176464|FG004|Follow-up Period (Week 132 to Week 140)|Physician Decision|0|||
147551625|NCT01806597|532176465|FG005|Follow-up Period (Week 132 to Week 140)|Physician Decision|1|||
147551626|NCT01144663|532176466|FG000|Primary Vaccination Phase|Serious adverse event, fatal|2|||
147551627|NCT01144663|532176467|FG001|Primary Vaccination Phase|Serious adverse event, fatal|0|||
147551628|NCT01144663|532176468|FG002|Primary Vaccination Phase|Serious adverse event, fatal|1|||
147551629|NCT01144663|532176469|FG003|Primary Vaccination Phase|Serious adverse event, fatal|0|||
147551630|NCT01144663|532176466|FG000|Primary Vaccination Phase|Adverse Event|1|||
147551631|NCT01144663|532176467|FG001|Primary Vaccination Phase|Adverse Event|0|||
147551632|NCT01144663|532176468|FG002|Primary Vaccination Phase|Adverse Event|0|||
147551633|NCT01144663|532176469|FG003|Primary Vaccination Phase|Adverse Event|1|||
147551634|NCT01144663|532176466|FG000|Primary Vaccination Phase|Protocol Violation|2|||
147551635|NCT01144663|532176467|FG001|Primary Vaccination Phase|Protocol Violation|0|||
147551636|NCT01144663|532176468|FG002|Primary Vaccination Phase|Protocol Violation|1|||
147551637|NCT01144663|532176469|FG003|Primary Vaccination Phase|Protocol Violation|0|||
147551638|NCT01144663|532176466|FG000|Primary Vaccination Phase|Withdrawal by Subject|9|||
147551639|NCT01144663|532176467|FG001|Primary Vaccination Phase|Withdrawal by Subject|5|||
147551640|NCT01144663|532176468|FG002|Primary Vaccination Phase|Withdrawal by Subject|3|||
147551641|NCT01144663|532176469|FG003|Primary Vaccination Phase|Withdrawal by Subject|10|||
147551642|NCT01144663|532176466|FG000|Primary Vaccination Phase|Migrated/moved from study area|4|||
147551643|NCT01144663|532176467|FG001|Primary Vaccination Phase|Migrated/moved from study area|1|||
147551644|NCT01144663|532176468|FG002|Primary Vaccination Phase|Migrated/moved from study area|2|||
147551645|NCT01144663|532176469|FG003|Primary Vaccination Phase|Migrated/moved from study area|3|||
147551646|NCT01144663|532176466|FG000|Primary Vaccination Phase|Lost to Follow-up|2|||
147551647|NCT01144663|532176467|FG001|Primary Vaccination Phase|Lost to Follow-up|0|||
147551648|NCT01144663|532176468|FG002|Primary Vaccination Phase|Lost to Follow-up|1|||
147551649|NCT01144663|532176469|FG003|Primary Vaccination Phase|Lost to Follow-up|2|||
147551650|NCT01144663|532176466|FG000|Primary Vaccination Phase|Other|0|||
147551651|NCT01144663|532176467|FG001|Primary Vaccination Phase|Other|1|||
147551652|NCT01144663|532176468|FG002|Primary Vaccination Phase|Other|0|||
147551653|NCT01144663|532176469|FG003|Primary Vaccination Phase|Other|2|||
147551654|NCT01144663|532176466|FG000|Booster Vaccination Phase|Withdrawal by Subject|0|||
147216232|NCT03337490|530963454|FG002|Overall Study|Lack of Efficacy|35|||
147216233|NCT03337490|530963452|FG000|Overall Study|Physician Decision|0|||
147216234|NCT03337490|530963453|FG001|Overall Study|Physician Decision|1|||
147216235|NCT03337490|530963454|FG002|Overall Study|Physician Decision|0|||
147216236|NCT03337490|530963452|FG000|Overall Study|Lost to Follow-up|0|||
147216237|NCT03337490|530963453|FG001|Overall Study|Lost to Follow-up|1|||
147216238|NCT03337490|530963454|FG002|Overall Study|Lost to Follow-up|0|||
147216239|NCT03560518|530963455|FG000|Double Blind Treatment Period|Miscellaneous Reasons|1|||
147216240|NCT03560518|530963456|FG001|Double Blind Treatment Period|Miscellaneous Reasons|0|||
147216241|NCT03560518|530963457|FG002|Double Blind Treatment Period|Miscellaneous Reasons|0|||
147216242|NCT03560518|530963455|FG000|Double Blind Treatment Period|Study Terminated by the Sponsor|6|||
147216243|NCT03560518|530963456|FG001|Double Blind Treatment Period|Study Terminated by the Sponsor|9|||
147216244|NCT03560518|530963457|FG002|Double Blind Treatment Period|Study Terminated by the Sponsor|10|||
147216245|NCT03560518|530963455|FG000|Double Blind Treatment Period|Protocol Violation|1|||
147216246|NCT03560518|530963456|FG001|Double Blind Treatment Period|Protocol Violation|2|||
147216247|NCT03560518|530963457|FG002|Double Blind Treatment Period|Protocol Violation|0|||
147216248|NCT03560518|530963455|FG000|Double Blind Treatment Period|Pregnancy|0|||
147216249|NCT03560518|530963456|FG001|Double Blind Treatment Period|Pregnancy|2|||
147216250|NCT03560518|530963457|FG002|Double Blind Treatment Period|Pregnancy|0|||
147216251|NCT03560518|530963455|FG000|Double Blind Treatment Period|Lost to Follow-up|5|||
147216252|NCT03560518|530963456|FG001|Double Blind Treatment Period|Lost to Follow-up|6|||
147216253|NCT03560518|530963457|FG002|Double Blind Treatment Period|Lost to Follow-up|6|||
147216254|NCT03560518|530963455|FG000|Double Blind Treatment Period|Withdrawal by Subject|10|||
147216255|NCT03560518|530963456|FG001|Double Blind Treatment Period|Withdrawal by Subject|6|||
147216256|NCT03560518|530963457|FG002|Double Blind Treatment Period|Withdrawal by Subject|5|||
147216257|NCT03560518|530963455|FG000|Double Blind Treatment Period|Lack of Efficacy|2|||
147216258|NCT03560518|530963456|FG001|Double Blind Treatment Period|Lack of Efficacy|1|||
147216259|NCT03560518|530963457|FG002|Double Blind Treatment Period|Lack of Efficacy|1|||
147216260|NCT03560518|530963455|FG000|Double Blind Treatment Period|Adverse Event|0|||
147216261|NCT03560518|530963456|FG001|Double Blind Treatment Period|Adverse Event|3|||
147216262|NCT03560518|530963457|FG002|Double Blind Treatment Period|Adverse Event|1|||
147216263|NCT00159822|530963458|FG000|Voriconazole Treatment Period|Lack of Efficacy|3|||
147216264|NCT00159822|530963458|FG000|Voriconazole Treatment Period|Adverse Event|9|||
147216265|NCT00159822|530963458|FG000|Voriconazole Treatment Period|Death|4|||
147216266|NCT00159822|530963458|FG000|Voriconazole Treatment Period|Protocol Violation|2|||
147216267|NCT00159822|530963458|FG000|Voriconazole Treatment Period|Lost to Follow-up|2|||
147216268|NCT00159822|530963458|FG000|Voriconazole Treatment Period|Withdrawal by Subject|2|||
147216269|NCT00159822|530963458|FG000|Post-treatment Follow-up Period|Death|1|||
147216270|NCT00159822|530963458|FG000|Post-treatment Follow-up Period|Withdrawal by Subject|1|||
147216271|NCT00159822|530963458|FG000|Post-treatment Follow-up Period|Reason unspecified|1|||
147216272|NCT00917644|530963459|FG000|Period: Washout Period of > = 2 Weeks|Protocol Violation|1|||
147216273|NCT00917644|530963460|FG001|Period: Washout Period of > = 2 Weeks|Protocol Violation|0|||
147216274|NCT00917644|530963459|FG000|Period: Washout Period of > = 2 Weeks|Withdrawal by Subject|1|||
147216275|NCT00917644|530963460|FG001|Period: Washout Period of > = 2 Weeks|Withdrawal by Subject|0|||
147216276|NCT00917644|530963459|FG000|Period 2: Second Intervention|family emergency|1|||
147216277|NCT00917644|530963460|FG001|Period 2: Second Intervention|family emergency|0|||
147216278|NCT00958438|530963464|FG000|Overall Study|Protocol Violation|3|||
147216279|NCT00958438|530963465|FG001|Overall Study|Protocol Violation|2|||
147216280|NCT00958438|530963466|FG002|Overall Study|Protocol Violation|2|||
147216281|NCT00958438|530963464|FG000|Overall Study|Withdrawal by Subject|4|||
147216282|NCT00958438|530963465|FG001|Overall Study|Withdrawal by Subject|2|||
147216283|NCT00958438|530963466|FG002|Overall Study|Withdrawal by Subject|1|||
147216284|NCT00958438|530963464|FG000|Overall Study|Adverse Event|0|||
147216285|NCT00958438|530963465|FG001|Overall Study|Adverse Event|3|||
147216286|NCT00958438|530963466|FG002|Overall Study|Adverse Event|0|||
147216287|NCT00958438|530963464|FG000|Overall Study|Physician Decision|1|||
147551655|NCT01144663|532176467|FG001|Booster Vaccination Phase|Withdrawal by Subject|0|||
147216288|NCT00958438|530963465|FG001|Overall Study|Physician Decision|0|||
147216289|NCT00958438|530963466|FG002|Overall Study|Physician Decision|1|||
147216290|NCT00958438|530963464|FG000|Overall Study|Other than specified above|2|||
147216291|NCT00958438|530963465|FG001|Overall Study|Other than specified above|3|||
147551656|NCT01144663|532176468|FG002|Booster Vaccination Phase|Withdrawal by Subject|1|||
147551657|NCT01144663|532176469|FG003|Booster Vaccination Phase|Withdrawal by Subject|1|||
147551658|NCT01144663|532176466|FG000|Booster Vaccination Phase|Migrated/moved from study area|1|||
147216292|NCT00958438|530963466|FG002|Overall Study|Other than specified above|2|||
147216293|NCT02788279|530963467|FG000|Overall Study|Death|62|||
147216294|NCT02788279|530963468|FG001|Overall Study|Death|136|||
147216295|NCT02788279|530963469|FG002|Overall Study|Death|72|||
147551659|NCT01144663|532176467|FG001|Booster Vaccination Phase|Migrated/moved from study area|1|||
147551660|NCT01144663|532176468|FG002|Booster Vaccination Phase|Migrated/moved from study area|1|||
147551661|NCT01144663|532176469|FG003|Booster Vaccination Phase|Migrated/moved from study area|0|||
147551662|NCT01144663|532176466|FG000|Booster Vaccination Phase|Lost to Follow-up|2|||
147551663|NCT01144663|532176467|FG001|Booster Vaccination Phase|Lost to Follow-up|1|||
147551664|NCT01144663|532176468|FG002|Booster Vaccination Phase|Lost to Follow-up|3|||
147551665|NCT01144663|532176469|FG003|Booster Vaccination Phase|Lost to Follow-up|0|||
147216296|NCT02788279|530963467|FG000|Overall Study|Withdrawal by Subject|10|||
147216297|NCT02788279|530963468|FG001|Overall Study|Withdrawal by Subject|15|||
147216298|NCT02788279|530963469|FG002|Overall Study|Withdrawal by Subject|5|||
147216299|NCT02788279|530963467|FG000|Overall Study|Lost to Follow-up|0|||
147216300|NCT02788279|530963468|FG001|Overall Study|Lost to Follow-up|3|||
147216301|NCT02788279|530963469|FG002|Overall Study|Lost to Follow-up|2|||
147216302|NCT02788279|530963467|FG000|Overall Study|Sponsor decision|18|||
147216303|NCT02788279|530963468|FG001|Overall Study|Sponsor decision|29|||
147216304|NCT02788279|530963469|FG002|Overall Study|Sponsor decision|11|||
147216305|NCT01579812|530963471|FG000|Overall Study|Ineligible after treatment start|40|||
147216306|NCT01579812|530963471|FG000|Overall Study|Patient choice|3|||
147216307|NCT01579812|530963471|FG000|Overall Study|Noncompliance|3|||
147216308|NCT01579812|530963471|FG000|Overall Study|Withdrawal by Subject|6|||
147216309|NCT01185301|530963474|FG000|Overall Study|Adverse Event|3|||
147216310|NCT01185301|530963475|FG001|Overall Study|Adverse Event|0|||
147216311|NCT01185301|530963476|FG002|Overall Study|Adverse Event|2|||
147216312|NCT01185301|530963477|FG003|Overall Study|Adverse Event|3|||
147216313|NCT01185301|530963474|FG000|Overall Study|Withdrawal by Subject|7|||
147216314|NCT01185301|530963475|FG001|Overall Study|Withdrawal by Subject|5|||
147216315|NCT01185301|530963476|FG002|Overall Study|Withdrawal by Subject|2|||
147216316|NCT01185301|530963477|FG003|Overall Study|Withdrawal by Subject|3|||
147551666|NCT01144663|532176466|FG000|Extended Safety Follow-Up (ESFU)|Withdrawal by Subject|0|||
147551667|NCT01144663|532176467|FG001|Extended Safety Follow-Up (ESFU)|Withdrawal by Subject|0|||
147551668|NCT01144663|532176468|FG002|Extended Safety Follow-Up (ESFU)|Withdrawal by Subject|1|||
147551669|NCT01144663|532176469|FG003|Extended Safety Follow-Up (ESFU)|Withdrawal by Subject|1|||
147551670|NCT01144663|532176466|FG000|Extended Safety Follow-Up (ESFU)|Migrated/moved from study area|1|||
147551671|NCT01144663|532176467|FG001|Extended Safety Follow-Up (ESFU)|Migrated/moved from study area|3|||
147551672|NCT01144663|532176468|FG002|Extended Safety Follow-Up (ESFU)|Migrated/moved from study area|1|||
147551673|NCT01144663|532176469|FG003|Extended Safety Follow-Up (ESFU)|Migrated/moved from study area|0|||
147551674|NCT01144663|532176466|FG000|Extended Safety Follow-Up (ESFU)|Lost to Follow-up|4|||
147551675|NCT01144663|532176467|FG001|Extended Safety Follow-Up (ESFU)|Lost to Follow-up|6|||
147551676|NCT01144663|532176468|FG002|Extended Safety Follow-Up (ESFU)|Lost to Follow-up|5|||
147551677|NCT01144663|532176469|FG003|Extended Safety Follow-Up (ESFU)|Lost to Follow-up|0|||
147551678|NCT00387712|532176484|FG000|Overall Study|Physician Decision|6|||
147551679|NCT00387712|532176485|FG001|Overall Study|Physician Decision|4|||
147551680|NCT00387712|532176484|FG000|Overall Study|Lost to Follow-up|17|||
147551681|NCT00387712|532176485|FG001|Overall Study|Lost to Follow-up|20|||
147551682|NCT00387712|532176484|FG000|Overall Study|Withdrawal by Subject|6|||
147551683|NCT00387712|532176485|FG001|Overall Study|Withdrawal by Subject|12|||
147551684|NCT02040428|532176486|FG000|Overall Study|Death|4|||
147551685|NCT02040428|532176487|FG001|Overall Study|Death|3|||
147551686|NCT02040428|532176486|FG000|Overall Study|Withdrawal by Subject|1|||
147551687|NCT02040428|532176487|FG001|Overall Study|Withdrawal by Subject|1|||
147551688|NCT01927757|532176499|FG000|Overall Study|Withdrawal by Subject|14|||
147551689|NCT01927757|532176499|FG000|Overall Study|Lost to Follow-up|2|||
147551690|NCT01927757|532176499|FG000|Overall Study|Decision by Sponsor|2|||
147551691|NCT01927757|532176499|FG000|Overall Study|Other|1|||
147551692|NCT01927757|532176499|FG000|Overall Study|Ethical Reasons|4|||
147551693|NCT01399723|532176500|FG000|Overall Study|Lost to Follow-up|0|||
147551694|NCT01399723|532176501|FG001|Overall Study|Lost to Follow-up|1|||
147551695|NCT01464827|532176502|FG000|Overall Study|Adverse Event|0|||
147551696|NCT01464827|532176503|FG001|Overall Study|Adverse Event|0|||
147551697|NCT01464827|532176504|FG002|Overall Study|Adverse Event|0|||
147551698|NCT01464827|532176505|FG003|Overall Study|Adverse Event|0|||
147551699|NCT01464827|532176506|FG004|Overall Study|Adverse Event|0|||
147551700|NCT01464827|532176507|FG005|Overall Study|Adverse Event|0|||
147551701|NCT01464827|532176508|FG006|Overall Study|Adverse Event|0|||
147551702|NCT01464827|532176509|FG007|Overall Study|Adverse Event|0|||
147551703|NCT01464827|532176510|FG008|Overall Study|Adverse Event|0|||
147551704|NCT01464827|532176511|FG009|Overall Study|Adverse Event|0|||
147551705|NCT01464827|532176512|FG010|Overall Study|Adverse Event|0|||
147551706|NCT01464827|532176513|FG011|Overall Study|Adverse Event|0|||
147551707|NCT01464827|532176514|FG012|Overall Study|Adverse Event|1|||
147551708|NCT01464827|532176515|FG013|Overall Study|Adverse Event|0|||
147551709|NCT01464827|532176502|FG000|Overall Study|Withdrawal by Subject|1|||
147551710|NCT01464827|532176503|FG001|Overall Study|Withdrawal by Subject|0|||
147551711|NCT01464827|532176504|FG002|Overall Study|Withdrawal by Subject|0|||
147551712|NCT01464827|532176505|FG003|Overall Study|Withdrawal by Subject|0|||
147551713|NCT01464827|532176506|FG004|Overall Study|Withdrawal by Subject|1|||
147551714|NCT01464827|532176507|FG005|Overall Study|Withdrawal by Subject|0|||
147216317|NCT01185301|530963474|FG000|Overall Study|Lost to Follow-up|2|||
147551715|NCT01464827|532176508|FG006|Overall Study|Withdrawal by Subject|0|||
147216318|NCT01185301|530963475|FG001|Overall Study|Lost to Follow-up|0|||
147216319|NCT01185301|530963476|FG002|Overall Study|Lost to Follow-up|0|||
147551716|NCT01464827|532176509|FG007|Overall Study|Withdrawal by Subject|1|||
147216320|NCT01185301|530963477|FG003|Overall Study|Lost to Follow-up|1|||
147216321|NCT01185301|530963474|FG000|Overall Study|Other Reason|3|||
147216322|NCT01185301|530963475|FG001|Overall Study|Other Reason|2|||
147551717|NCT01464827|532176510|FG008|Overall Study|Withdrawal by Subject|0|||
147649960|NCT00703118|532539769|FG001|Overall Study|Adverse Event|2|||
147216323|NCT01185301|530963476|FG002|Overall Study|Other Reason|2|||
147216324|NCT01185301|530963477|FG003|Overall Study|Other Reason|2|||
147216325|NCT04987944|530963482|FG000|Overall Study|Adverse Event|0|||
147216326|NCT04987944|530963483|FG001|Overall Study|Adverse Event|1|||
147216327|NCT04987944|530963482|FG000|Overall Study|Withdrawal by Subject|0|||
147216328|NCT04987944|530963483|FG001|Overall Study|Withdrawal by Subject|1|||
147216329|NCT04136444|530963489|FG000|Overall Study|Sponsor request due to undisclosed concomitant medication|0|||
147216330|NCT04136444|530963490|FG001|Overall Study|Sponsor request due to undisclosed concomitant medication|1|||
147216331|NCT02095132|530963496|FG000|Overall Study|Adverse Event|0|||
147216332|NCT02095132|530963497|FG001|Overall Study|Adverse Event|0|||
147216333|NCT02095132|530963498|FG002|Overall Study|Adverse Event|0|||
147216334|NCT02095132|530963499|FG003|Overall Study|Adverse Event|0|||
147216335|NCT02095132|530963500|FG004|Overall Study|Adverse Event|1|||
147216336|NCT02095132|530963501|FG005|Overall Study|Adverse Event|0|||
147216337|NCT02095132|530963502|FG006|Overall Study|Adverse Event|1|||
147216338|NCT02095132|530963503|FG007|Overall Study|Adverse Event|0|||
147216339|NCT02095132|530963504|FG008|Overall Study|Adverse Event|0|||
147216340|NCT02095132|530963496|FG000|Overall Study|Death|0|||
147216341|NCT02095132|530963497|FG001|Overall Study|Death|0|||
147216342|NCT02095132|530963498|FG002|Overall Study|Death|0|||
147216343|NCT02095132|530963499|FG003|Overall Study|Death|0|||
147216344|NCT02095132|530963500|FG004|Overall Study|Death|0|||
147216345|NCT02095132|530963501|FG005|Overall Study|Death|0|||
147216346|NCT02095132|530963502|FG006|Overall Study|Death|1|||
147216347|NCT02095132|530963503|FG007|Overall Study|Death|0|||
147216348|NCT02095132|530963504|FG008|Overall Study|Death|0|||
147216349|NCT02095132|530963496|FG000|Overall Study|Lack of Efficacy|3|||
147216350|NCT02095132|530963497|FG001|Overall Study|Lack of Efficacy|5|||
147216351|NCT02095132|530963498|FG002|Overall Study|Lack of Efficacy|2|||
147216352|NCT02095132|530963499|FG003|Overall Study|Lack of Efficacy|8|||
147216353|NCT02095132|530963500|FG004|Overall Study|Lack of Efficacy|3|||
147216354|NCT02095132|530963501|FG005|Overall Study|Lack of Efficacy|6|||
147216355|NCT02095132|530963502|FG006|Overall Study|Lack of Efficacy|10|||
147216356|NCT02095132|530963503|FG007|Overall Study|Lack of Efficacy|9|||
147216357|NCT02095132|530963504|FG008|Overall Study|Lack of Efficacy|8|||
147216358|NCT02095132|530963496|FG000|Overall Study|Physician Decision|1|||
147216359|NCT02095132|530963497|FG001|Overall Study|Physician Decision|0|||
147216360|NCT02095132|530963498|FG002|Overall Study|Physician Decision|0|||
147216361|NCT02095132|530963499|FG003|Overall Study|Physician Decision|0|||
147216362|NCT02095132|530963500|FG004|Overall Study|Physician Decision|0|||
147216363|NCT02095132|530963501|FG005|Overall Study|Physician Decision|0|||
147216364|NCT02095132|530963502|FG006|Overall Study|Physician Decision|1|||
147216365|NCT02095132|530963503|FG007|Overall Study|Physician Decision|0|||
147216366|NCT02095132|530963504|FG008|Overall Study|Physician Decision|2|||
147216367|NCT02095132|530963496|FG000|Overall Study|Withdrawal by Subject|0|||
147216368|NCT02095132|530963497|FG001|Overall Study|Withdrawal by Subject|0|||
147216369|NCT02095132|530963498|FG002|Overall Study|Withdrawal by Subject|2|||
147216370|NCT02095132|530963499|FG003|Overall Study|Withdrawal by Subject|2|||
147216371|NCT02095132|530963500|FG004|Overall Study|Withdrawal by Subject|3|||
147216372|NCT02095132|530963501|FG005|Overall Study|Withdrawal by Subject|0|||
147216373|NCT02095132|530963502|FG006|Overall Study|Withdrawal by Subject|5|||
147216374|NCT02095132|530963503|FG007|Overall Study|Withdrawal by Subject|0|||
147216375|NCT02095132|530963504|FG008|Overall Study|Withdrawal by Subject|0|||
147216376|NCT04905498|530963505|FG000|Overall Study|Lost to Follow-up|0|||
147216377|NCT04905498|530963506|FG001|Overall Study|Lost to Follow-up|2|||
147216378|NCT04905498|530963505|FG000|Overall Study|COVID lockdown|1|||
147216379|NCT04905498|530963506|FG001|Overall Study|COVID lockdown|0|||
147216380|NCT00409175|530963507|FG000|Overall Study|Adverse Event|4|||
147216381|NCT00409175|530963508|FG001|Overall Study|Adverse Event|3|||
147216382|NCT00409175|530963507|FG000|Overall Study|Withdrawal by Subject|1|||
147216383|NCT00409175|530963508|FG001|Overall Study|Withdrawal by Subject|2|||
147216384|NCT00409175|530963507|FG000|Overall Study|Negative genotype|0|||
147216385|NCT00409175|530963508|FG001|Overall Study|Negative genotype|1|||
147216386|NCT00409175|530963507|FG000|Overall Study|Liver transplantation|13|||
147216387|NCT00409175|530963508|FG001|Overall Study|Liver transplantation|13|||
147551718|NCT01464827|532176511|FG009|Overall Study|Withdrawal by Subject|0|||
147551719|NCT01464827|532176512|FG010|Overall Study|Withdrawal by Subject|0|||
147551720|NCT01464827|532176513|FG011|Overall Study|Withdrawal by Subject|0|||
147216388|NCT02946931|530963513|FG000|Overall Study|Did not require collection of CRFs|588|||
147216389|NCT02946931|530963513|FG000|Overall Study|Other than listed|37|||
147216390|NCT02946931|530963513|FG000|Overall Study|Discharge from hospital|118|||
147216391|NCT02946931|530963513|FG000|Overall Study|Adverse Event|81|||
147551721|NCT01464827|532176514|FG012|Overall Study|Withdrawal by Subject|0|||
147216392|NCT02946931|530963513|FG000|Overall Study|CRFs not valid|1|||
147216393|NCT02946931|530963513|FG000|Overall Study|CRFs with missing information on the date of termination of PMS|6|||
147216394|NCT03339297|530963514|FG000|Overall Study|Relapse of Hematologic Disease|1|||
147216395|NCT03339297|530963515|FG001|Overall Study|Relapse of Hematologic Disease|0|||
147216396|NCT03339297|530963514|FG000|Overall Study|Death|10|||
147216397|NCT03339297|530963515|FG001|Overall Study|Death|7|||
147216398|NCT03339297|530963514|FG000|Overall Study|Hepatic Candidosis|1|||
147216399|NCT03339297|530963515|FG001|Overall Study|Hepatic Candidosis|0|||
147216400|NCT03339297|530963514|FG000|Overall Study|Adverse Event, Serious Fatal|0|||
147216401|NCT03339297|530963515|FG001|Overall Study|Adverse Event, Serious Fatal|2|||
147216402|NCT03339297|530963514|FG000|Overall Study|Consent Withdrawn by Participant|3|||
147216403|NCT03339297|530963515|FG001|Overall Study|Consent Withdrawn by Participant|3|||
147216404|NCT03339297|530963514|FG000|Overall Study|Disease Relapse|2|||
147216405|NCT03339297|530963515|FG001|Overall Study|Disease Relapse|0|||
147216406|NCT03339297|530963514|FG000|Overall Study|Physician Decision|1|||
147216407|NCT03339297|530963515|FG001|Overall Study|Physician Decision|1|||
147216408|NCT03339297|530963514|FG000|Overall Study|Relapse of Disease New Transplant Performed|1|||
147216409|NCT03339297|530963515|FG001|Overall Study|Relapse of Disease New Transplant Performed|0|||
147216410|NCT03339297|530963514|FG000|Overall Study|Problems with Donor and Diagnosis of Early Relapse|1|||
147216411|NCT03339297|530963515|FG001|Overall Study|Problems with Donor and Diagnosis of Early Relapse|0|||
147216412|NCT03339297|530963514|FG000|Overall Study|Early Termination, Did Not Proceed to Transplant|1|||
147216413|NCT03339297|530963515|FG001|Overall Study|Early Termination, Did Not Proceed to Transplant|0|||
147216414|NCT03339297|530963514|FG000|Overall Study|Adverse Event, Non-fatal|1|||
147551722|NCT01464827|532176515|FG013|Overall Study|Withdrawal by Subject|0|||
147551723|NCT01464827|532176502|FG000|Overall Study|Lost to Follow-up|0|||
147551724|NCT01464827|532176503|FG001|Overall Study|Lost to Follow-up|2|||
147216415|NCT03339297|530963515|FG001|Overall Study|Adverse Event, Non-fatal|0|||
147216416|NCT03339297|530963514|FG000|Overall Study|Patient Relapsed and Did Not Proceed to Transplant|0|||
147216417|NCT03339297|530963515|FG001|Overall Study|Patient Relapsed and Did Not Proceed to Transplant|1|||
147216418|NCT03339297|530963514|FG000|Overall Study|Patient Was Not Eligible|1|||
147216419|NCT03339297|530963515|FG001|Overall Study|Patient Was Not Eligible|0|||
147216420|NCT00065429|530963518|FG000|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
147216421|NCT00065429|530963519|FG001|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
147216422|NCT00065429|530963520|FG002|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
147216423|NCT00065429|530963521|FG003|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
147216424|NCT00065429|530963522|FG004|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
147216425|NCT00065429|530963523|FG005|Phase I - May 2001 - Oct 2002|Lost to Follow-up|1|||
147216426|NCT00065429|530963524|FG006|Phase I - May 2001 - Oct 2002|Lost to Follow-up|0|||
147216427|NCT00065429|530963518|FG000|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
147216428|NCT00065429|530963519|FG001|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
147216429|NCT00065429|530963520|FG002|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|1|||
147216430|NCT00065429|530963521|FG003|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
147216431|NCT00065429|530963522|FG004|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
147216432|NCT00065429|530963523|FG005|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
147216433|NCT00065429|530963524|FG006|Phase I - May 2001 - Oct 2002|Withdrawal by Subject|0|||
147216434|NCT00065429|530963518|FG000|Phase I - May 2001 - Oct 2002|Physician Decision|1|||
147216435|NCT00065429|530963519|FG001|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
147216436|NCT00065429|530963520|FG002|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
147216437|NCT00065429|530963521|FG003|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
147216438|NCT00065429|530963522|FG004|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
147216439|NCT00065429|530963523|FG005|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
147216440|NCT00065429|530963524|FG006|Phase I - May 2001 - Oct 2002|Physician Decision|0|||
147216441|NCT00065429|530963518|FG000|Phase I - May 2001 - Oct 2002|Death|0|||
147216442|NCT00065429|530963519|FG001|Phase I - May 2001 - Oct 2002|Death|0|||
147216443|NCT00065429|530963520|FG002|Phase I - May 2001 - Oct 2002|Death|0|||
147216444|NCT00065429|530963521|FG003|Phase I - May 2001 - Oct 2002|Death|0|||
147216445|NCT00065429|530963522|FG004|Phase I - May 2001 - Oct 2002|Death|1|||
147216446|NCT00065429|530963523|FG005|Phase I - May 2001 - Oct 2002|Death|0|||
147216447|NCT00065429|530963524|FG006|Phase I - May 2001 - Oct 2002|Death|0|||
147216448|NCT00065429|530963518|FG000|Phase I - May 2001 - Oct 2002|Adverse Event|0|||
147216449|NCT00065429|530963519|FG001|Phase I - May 2001 - Oct 2002|Adverse Event|0|||
147216450|NCT00065429|530963520|FG002|Phase I - May 2001 - Oct 2002|Adverse Event|0|||
147216451|NCT00065429|530963521|FG003|Phase I - May 2001 - Oct 2002|Adverse Event|1|||
147216452|NCT00065429|530963522|FG004|Phase I - May 2001 - Oct 2002|Adverse Event|0|||
147216453|NCT00065429|530963523|FG005|Phase I - May 2001 - Oct 2002|Adverse Event|1|||
147216454|NCT00065429|530963524|FG006|Phase I - May 2001 - Oct 2002|Adverse Event|2|||
147551725|NCT01464827|532176504|FG002|Overall Study|Lost to Follow-up|0|||
147551726|NCT01464827|532176505|FG003|Overall Study|Lost to Follow-up|2|||
147551727|NCT01464827|532176506|FG004|Overall Study|Lost to Follow-up|3|||
147216455|NCT00065429|530963518|FG000|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
147216456|NCT00065429|530963519|FG001|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
147216457|NCT00065429|530963520|FG002|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
147216458|NCT00065429|530963521|FG003|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
147551728|NCT01464827|532176507|FG005|Overall Study|Lost to Follow-up|1|||
147216459|NCT00065429|530963522|FG004|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|4|||
147216460|NCT00065429|530963523|FG005|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
147551729|NCT01464827|532176508|FG006|Overall Study|Lost to Follow-up|2|||
147551730|NCT01464827|532176509|FG007|Overall Study|Lost to Follow-up|2|||
147216461|NCT00065429|530963524|FG006|Phase II - Apr 2003 - Aug 2008|Lack of Efficacy|0|||
147216462|NCT00065429|530963518|FG000|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
147216463|NCT00065429|530963519|FG001|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
147216464|NCT00065429|530963520|FG002|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
147216465|NCT00065429|530963521|FG003|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
147442932|NCT05314517|531786151|FG001|Open-label Extension|Use of prohibited medication|0|||
147442933|NCT05314517|531786152|FG002|Open-label Extension|Use of prohibited medication|1|||
147442934|NCT05314517|531786153|FG003|Open-label Extension|Use of prohibited medication|0|||
147442935|NCT05314517|531786150|FG000|Open-label Extension|Sponsor decision to terminate study|0|||
147442936|NCT05314517|531786151|FG001|Open-label Extension|Sponsor decision to terminate study|0|||
147442937|NCT05314517|531786152|FG002|Open-label Extension|Sponsor decision to terminate study|13|||
147442938|NCT05314517|531786153|FG003|Open-label Extension|Sponsor decision to terminate study|15|||
147442939|NCT04969276|531786154|FG000|Overall Study|Protocol Deviation|0|||
147442940|NCT04969276|531786155|FG001|Overall Study|Protocol Deviation|1|||
147442941|NCT04969276|531786156|FG002|Overall Study|Protocol Deviation|0|||
147442942|NCT04969276|531786154|FG000|Overall Study|Withdrawal by Subject|1|||
147442943|NCT04969276|531786155|FG001|Overall Study|Withdrawal by Subject|10|||
147442944|NCT04969276|531786156|FG002|Overall Study|Withdrawal by Subject|0|||
147442945|NCT04969276|531786154|FG000|Overall Study|Lost to Follow-up|0|||
147442946|NCT04969276|531786155|FG001|Overall Study|Lost to Follow-up|1|||
147442947|NCT04969276|531786156|FG002|Overall Study|Lost to Follow-up|0|||
147442948|NCT04490018|531786160|FG000|Overall Study|Protocol Violation|0|||
147442949|NCT04490018|531786161|FG001|Overall Study|Protocol Violation|2|||
147442950|NCT04490018|531786162|FG002|Overall Study|Protocol Violation|1|||
147442951|NCT04490018|531786160|FG000|Overall Study|Lost to Follow-up|2|||
147442952|NCT04490018|531786161|FG001|Overall Study|Lost to Follow-up|2|||
147442953|NCT04490018|531786162|FG002|Overall Study|Lost to Follow-up|0|||
147442954|NCT04490018|531786160|FG000|Overall Study|Withdrawal by Subject|2|||
147442955|NCT04490018|531786161|FG001|Overall Study|Withdrawal by Subject|1|||
147442956|NCT04490018|531786162|FG002|Overall Study|Withdrawal by Subject|0|||
147442957|NCT04490018|531786160|FG000|Overall Study|Withdrawal by parent/guardian|2|||
147442958|NCT04490018|531786161|FG001|Overall Study|Withdrawal by parent/guardian|3|||
147442959|NCT04490018|531786162|FG002|Overall Study|Withdrawal by parent/guardian|0|||
147442960|NCT00943579|531786164|FG000|Overall Study|Adverse Event|4|||
147442961|NCT00943579|531786165|FG001|Overall Study|Adverse Event|3|||
147442962|NCT00943579|531786164|FG000|Overall Study|Lack of Efficacy|2|||
147442963|NCT00943579|531786165|FG001|Overall Study|Lack of Efficacy|2|||
147442964|NCT00418665|531786166|FG000|Treatment Period|Ineligibility determined|1|||
147442965|NCT00418665|531786167|FG001|Treatment Period|Ineligibility determined|1|||
147442966|NCT00418665|531786168|FG002|Treatment Period|Ineligibility determined|0|||
147442967|NCT00418665|531786166|FG000|Treatment Period|Adverse Event|2|||
147442968|NCT00418665|531786167|FG001|Treatment Period|Adverse Event|2|||
147442969|NCT00418665|531786168|FG002|Treatment Period|Adverse Event|0|||
147442970|NCT00418665|531786166|FG000|Treatment Period|Withdrawal by Subject|0|||
147442971|NCT00418665|531786167|FG001|Treatment Period|Withdrawal by Subject|3|||
147442972|NCT00418665|531786168|FG002|Treatment Period|Withdrawal by Subject|1|||
147442973|NCT00418665|531786166|FG000|Treatment Period|Requirement for alternative therapy|1|||
147442974|NCT00418665|531786167|FG001|Treatment Period|Requirement for alternative therapy|0|||
147442975|NCT00418665|531786168|FG002|Treatment Period|Requirement for alternative therapy|0|||
147442976|NCT00418665|531786166|FG000|Treatment Period|Physician Decision|1|||
147442977|NCT00418665|531786167|FG001|Treatment Period|Physician Decision|0|||
147442978|NCT00418665|531786168|FG002|Treatment Period|Physician Decision|3|||
147442979|NCT00418665|531786166|FG000|Treatment Extension|Adverse Event|1|||
147442980|NCT00418665|531786167|FG001|Treatment Extension|Adverse Event|0|||
147442981|NCT00418665|531786168|FG002|Treatment Extension|Adverse Event|0|||
147442982|NCT00418665|531786166|FG000|Treatment Extension|Withdrawal by Subject|1|||
147442983|NCT00418665|531786167|FG001|Treatment Extension|Withdrawal by Subject|0|||
147442984|NCT00418665|531786168|FG002|Treatment Extension|Withdrawal by Subject|0|||
147442985|NCT00418665|531786166|FG000|Treatment Extension|Requirement for alternative therapy|2|||
147442986|NCT00418665|531786167|FG001|Treatment Extension|Requirement for alternative therapy|2|||
147442987|NCT00418665|531786168|FG002|Treatment Extension|Requirement for alternative therapy|0|||
147442988|NCT00418665|531786166|FG000|Treatment Extension|Physician Decision|2|||
147442989|NCT00418665|531786167|FG001|Treatment Extension|Physician Decision|2|||
147442990|NCT00418665|531786168|FG002|Treatment Extension|Physician Decision|1|||
147442991|NCT00418665|531786166|FG000|Treatment Extension|Death|0|||
147442992|NCT00418665|531786167|FG001|Treatment Extension|Death|0|||
147442993|NCT00418665|531786168|FG002|Treatment Extension|Death|1|||
147442994|NCT01133379|531786169|FG000|Overall Study|Withdrawal by Subject|0|||
147442995|NCT01133379|531786170|FG001|Overall Study|Withdrawal by Subject|1|||
147442996|NCT01133379|531786171|FG002|Overall Study|Withdrawal by Subject|1|||
147442997|NCT01133379|531786169|FG000|Overall Study|Lost to Follow-up|1|||
147442998|NCT01133379|531786170|FG001|Overall Study|Lost to Follow-up|1|||
147442999|NCT01133379|531786171|FG002|Overall Study|Lost to Follow-up|1|||
147443000|NCT00591214|531786174|FG000|Overall Study|Physician Decision|7|||
147216466|NCT00065429|530963522|FG004|Phase II - Apr 2003 - Aug 2008|Adverse Event|2|||
147216467|NCT00065429|530963523|FG005|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
147216468|NCT00065429|530963524|FG006|Phase II - Apr 2003 - Aug 2008|Adverse Event|0|||
147216469|NCT00832624|530963528|FG000|Overall Study|Study Terminated|10|||
147216470|NCT00636363|530963531|FG000|Overall Study|Conjunctivitis|0|||
147216471|NCT00636363|530963532|FG001|Overall Study|Conjunctivitis|0|||
147216472|NCT00636363|530963533|FG002|Overall Study|Conjunctivitis|1|||
147216473|NCT00636363|530963531|FG000|Overall Study|Adverse Event|0|||
147216474|NCT00636363|530963532|FG001|Overall Study|Adverse Event|0|||
147216475|NCT00636363|530963533|FG002|Overall Study|Adverse Event|1|||
147216476|NCT00636363|530963531|FG000|Overall Study|Positive slit lamp finding|0|||
147216477|NCT00636363|530963532|FG001|Overall Study|Positive slit lamp finding|2|||
147216478|NCT00636363|530963533|FG002|Overall Study|Positive slit lamp finding|1|||
147216479|NCT00636363|530963531|FG000|Overall Study|Study related symptoms/complaints|8|||
147216480|NCT00636363|530963532|FG001|Overall Study|Study related symptoms/complaints|7|||
147216481|NCT00636363|530963533|FG002|Overall Study|Study related symptoms/complaints|4|||
147216482|NCT00636363|530963531|FG000|Overall Study|Met ineligibility criteria|0|||
147216483|NCT00636363|530963532|FG001|Overall Study|Met ineligibility criteria|0|||
147216484|NCT00636363|530963533|FG002|Overall Study|Met ineligibility criteria|3|||
147216485|NCT00636363|530963531|FG000|Overall Study|Missed > 1 visit|0|||
147216486|NCT00636363|530963532|FG001|Overall Study|Missed > 1 visit|1|||
147216487|NCT00636363|530963533|FG002|Overall Study|Missed > 1 visit|3|||
147216488|NCT00636363|530963531|FG000|Overall Study|Lack of motivation|1|||
147216489|NCT00636363|530963532|FG001|Overall Study|Lack of motivation|0|||
147216490|NCT00636363|530963533|FG002|Overall Study|Lack of motivation|1|||
147216491|NCT00636363|530963531|FG000|Overall Study|Protocol Violation|0|||
147216492|NCT00636363|530963532|FG001|Overall Study|Protocol Violation|3|||
147216493|NCT00636363|530963533|FG002|Overall Study|Protocol Violation|0|||
147216494|NCT00636363|530963531|FG000|Overall Study|Lost to Follow-up|3|||
147216495|NCT00636363|530963532|FG001|Overall Study|Lost to Follow-up|4|||
147216496|NCT00636363|530963533|FG002|Overall Study|Lost to Follow-up|2|||
147216497|NCT00636363|530963531|FG000|Overall Study|Withdrawal by Subject|1|||
147216498|NCT00636363|530963532|FG001|Overall Study|Withdrawal by Subject|3|||
147216499|NCT00636363|530963533|FG002|Overall Study|Withdrawal by Subject|2|||
147216500|NCT01433250|530963537|FG000|Overall Study|Protocol Violation|0|||
147216501|NCT01433250|530963538|FG001|Overall Study|Protocol Violation|1|||
147216502|NCT01433250|530963537|FG000|Overall Study|Withdrawal by Subject|3|||
147216503|NCT01433250|530963538|FG001|Overall Study|Withdrawal by Subject|2|||
147216504|NCT03148691|530963539|FG000|Overall Study|Protocol Violation|1|||
147216505|NCT03148691|530963540|FG001|Overall Study|Protocol Violation|2|||
147216506|NCT03148691|530963541|FG002|Overall Study|Protocol Violation|7|||
147216507|NCT03148691|530963539|FG000|Overall Study|Lost to Follow-up|0|||
147216508|NCT03148691|530963540|FG001|Overall Study|Lost to Follow-up|0|||
147216509|NCT03148691|530963541|FG002|Overall Study|Lost to Follow-up|1|||
147216510|NCT03148691|530963539|FG000|Overall Study|Other|1|||
147216511|NCT03148691|530963540|FG001|Overall Study|Other|0|||
147216512|NCT03148691|530963541|FG002|Overall Study|Other|0|||
147216513|NCT03148691|530963539|FG000|Overall Study|Withdrawal by Subject|1|||
147216514|NCT03148691|530963540|FG001|Overall Study|Withdrawal by Subject|0|||
147216515|NCT03148691|530963541|FG002|Overall Study|Withdrawal by Subject|0|||
147216516|NCT01340872|530965832|FG000|Double-blind Phase|Adverse Event|6|||
147216517|NCT01340872|530965833|FG001|Double-blind Phase|Adverse Event|4|||
147216518|NCT01340872|530965834|FG002|Double-blind Phase|Adverse Event|0|||
147216519|NCT01340872|530965835|FG003|Double-blind Phase|Adverse Event|0|||
147216520|NCT01340872|530965832|FG000|Double-blind Phase|Withdrawal by Subject|3|||
147216521|NCT01340872|530965833|FG001|Double-blind Phase|Withdrawal by Subject|5|||
147216522|NCT01340872|530965834|FG002|Double-blind Phase|Withdrawal by Subject|0|||
147216523|NCT01340872|530965835|FG003|Double-blind Phase|Withdrawal by Subject|0|||
147216524|NCT01340872|530965832|FG000|Double-blind Phase|Lost to Follow-up|0|||
147216525|NCT01340872|530965833|FG001|Double-blind Phase|Lost to Follow-up|1|||
147216526|NCT01340872|530965834|FG002|Double-blind Phase|Lost to Follow-up|0|||
147216527|NCT01340872|530965835|FG003|Double-blind Phase|Lost to Follow-up|0|||
147216528|NCT01340872|530965832|FG000|Double-blind Phase|Protocol Violation|0|||
147216529|NCT01340872|530965833|FG001|Double-blind Phase|Protocol Violation|1|||
147216530|NCT01340872|530965834|FG002|Double-blind Phase|Protocol Violation|0|||
147216531|NCT01340872|530965835|FG003|Double-blind Phase|Protocol Violation|0|||
147216532|NCT01340872|530965832|FG000|Open-label Phase|Physician Decision|0|||
147216533|NCT01340872|530965833|FG001|Open-label Phase|Physician Decision|0|||
147216534|NCT01340872|530965834|FG002|Open-label Phase|Physician Decision|2|||
147551731|NCT01464827|532176510|FG008|Overall Study|Lost to Follow-up|0|||
147216535|NCT01340872|530965835|FG003|Open-label Phase|Physician Decision|1|||
147216536|NCT01340872|530965832|FG000|Open-label Phase|Pregnancy|0|||
147216537|NCT01340872|530965833|FG001|Open-label Phase|Pregnancy|0|||
147216538|NCT01340872|530965834|FG002|Open-label Phase|Pregnancy|1|||
147216539|NCT01340872|530965835|FG003|Open-label Phase|Pregnancy|0|||
147216540|NCT01340872|530965832|FG000|Open-label Phase|Adverse Event|0|||
147216541|NCT01340872|530965833|FG001|Open-label Phase|Adverse Event|0|||
147216542|NCT01340872|530965834|FG002|Open-label Phase|Adverse Event|8|||
147216543|NCT01340872|530965835|FG003|Open-label Phase|Adverse Event|4|||
147216544|NCT01340872|530965832|FG000|Open-label Phase|Withdrawal by Subject|0|||
147216545|NCT01340872|530965833|FG001|Open-label Phase|Withdrawal by Subject|0|||
147216546|NCT01340872|530965834|FG002|Open-label Phase|Withdrawal by Subject|1|||
147216547|NCT01340872|530965835|FG003|Open-label Phase|Withdrawal by Subject|6|||
147216548|NCT01340872|530965832|FG000|Open-label Phase|Worsening of IBD|0|||
147216549|NCT01340872|530965833|FG001|Open-label Phase|Worsening of IBD|0|||
147551732|NCT01464827|532176511|FG009|Overall Study|Lost to Follow-up|0|||
147551733|NCT01464827|532176512|FG010|Overall Study|Lost to Follow-up|0|||
147551734|NCT01464827|532176513|FG011|Overall Study|Lost to Follow-up|1|||
147551735|NCT01464827|532176514|FG012|Overall Study|Lost to Follow-up|0|||
147551736|NCT01464827|532176515|FG013|Overall Study|Lost to Follow-up|1|||
147551737|NCT01464827|532176502|FG000|Overall Study|Other|2|||
147551738|NCT01464827|532176503|FG001|Overall Study|Other|3|||
147551739|NCT01464827|532176504|FG002|Overall Study|Other|0|||
147551740|NCT01464827|532176505|FG003|Overall Study|Other|2|||
147551741|NCT01464827|532176506|FG004|Overall Study|Other|3|||
147551742|NCT01464827|532176507|FG005|Overall Study|Other|0|||
147551743|NCT01464827|532176508|FG006|Overall Study|Other|1|||
147551744|NCT01464827|532176509|FG007|Overall Study|Other|0|||
147551745|NCT01464827|532176510|FG008|Overall Study|Other|3|||
147551746|NCT01464827|532176511|FG009|Overall Study|Other|1|||
147551747|NCT01464827|532176512|FG010|Overall Study|Other|2|||
147551748|NCT01464827|532176513|FG011|Overall Study|Other|0|||
147551749|NCT01464827|532176514|FG012|Overall Study|Other|1|||
147551750|NCT01464827|532176515|FG013|Overall Study|Other|0|||
147551751|NCT01464827|532176502|FG000|Overall Study|Not Treated|0|||
147551752|NCT01464827|532176503|FG001|Overall Study|Not Treated|2|||
147551753|NCT01464827|532176504|FG002|Overall Study|Not Treated|0|||
147551754|NCT01464827|532176505|FG003|Overall Study|Not Treated|0|||
147551755|NCT01464827|532176506|FG004|Overall Study|Not Treated|1|||
147551756|NCT01464827|532176507|FG005|Overall Study|Not Treated|0|||
147551757|NCT01464827|532176508|FG006|Overall Study|Not Treated|1|||
147551758|NCT01464827|532176509|FG007|Overall Study|Not Treated|0|||
147551759|NCT01464827|532176510|FG008|Overall Study|Not Treated|0|||
147551760|NCT01464827|532176511|FG009|Overall Study|Not Treated|2|||
147551761|NCT01464827|532176512|FG010|Overall Study|Not Treated|0|||
147551762|NCT01464827|532176513|FG011|Overall Study|Not Treated|1|||
147551763|NCT01464827|532176514|FG012|Overall Study|Not Treated|0|||
147551764|NCT01464827|532176515|FG013|Overall Study|Not Treated|2|||
147551765|NCT04604184|532176525|FG000|Overall Study|Adverse Event|5|||
147551766|NCT04604184|532176526|FG001|Overall Study|Adverse Event|5|||
147551767|NCT04604184|532176525|FG000|Overall Study|Death|2|||
147551768|NCT04604184|532176526|FG001|Overall Study|Death|1|||
147551769|NCT04604184|532176525|FG000|Overall Study|Withdrawal by Subject|1|||
147551770|NCT04604184|532176526|FG001|Overall Study|Withdrawal by Subject|3|||
147551771|NCT04604184|532176525|FG000|Overall Study|Not treated|2|||
147551772|NCT04604184|532176526|FG001|Overall Study|Not treated|2|||
147551773|NCT04604184|532176525|FG000|Overall Study|Due to sponsor decision|9|||
147551774|NCT04604184|532176526|FG001|Overall Study|Due to sponsor decision|7|||
147551775|NCT04604184|532176525|FG000|Overall Study|Physician Decision|0|||
147551776|NCT04604184|532176526|FG001|Overall Study|Physician Decision|1|||
147551777|NCT04604184|532176525|FG000|Overall Study|Transfer to healthcare|1|||
147551778|NCT04604184|532176526|FG001|Overall Study|Transfer to healthcare|0|||
147551779|NCT01769378|532176527|FG000|Overall Study|Adverse Event|10|||
147551780|NCT01769378|532176528|FG001|Overall Study|Adverse Event|0|||
147551781|NCT01769378|532176527|FG000|Overall Study|Entry criteria not met|1|||
147551782|NCT01769378|532176528|FG001|Overall Study|Entry criteria not met|0|||
147551783|NCT01769378|532176527|FG000|Overall Study|Protocol Violation|1|||
147551784|NCT01769378|532176528|FG001|Overall Study|Protocol Violation|1|||
147551785|NCT01769378|532176527|FG000|Overall Study|Withdrawal by Subject|10|||
147551786|NCT01769378|532176528|FG001|Overall Study|Withdrawal by Subject|3|||
147551787|NCT01769378|532176527|FG000|Overall Study|Sponsor Decision|1|||
147551788|NCT01769378|532176528|FG001|Overall Study|Sponsor Decision|0|||
147551789|NCT01769378|532176527|FG000|Overall Study|Lost to Follow-up|2|||
147551790|NCT01769378|532176528|FG001|Overall Study|Lost to Follow-up|0|||
147551791|NCT01090765|532176529|FG000|Overall Study|Patient withdrew consent|0|||
147551792|NCT01090765|532176530|FG001|Overall Study|Patient withdrew consent|0|||
147551793|NCT01090765|532176531|FG002|Overall Study|Patient withdrew consent|0|||
147551794|NCT01090765|532176532|FG003|Overall Study|Patient withdrew consent|0|||
147551795|NCT01090765|532176533|FG004|Overall Study|Patient withdrew consent|1|||
147551796|NCT01090765|532176534|FG005|Overall Study|Patient withdrew consent|1|||
147551797|NCT01090765|532176529|FG000|Overall Study|Developed a DVT, needed anticoagulation|0|||
147551798|NCT01090765|532176530|FG001|Overall Study|Developed a DVT, needed anticoagulation|0|||
147551799|NCT01090765|532176531|FG002|Overall Study|Developed a DVT, needed anticoagulation|0|||
147551800|NCT01090765|532176532|FG003|Overall Study|Developed a DVT, needed anticoagulation|1|||
147551801|NCT01090765|532176533|FG004|Overall Study|Developed a DVT, needed anticoagulation|0|||
147551802|NCT01090765|532176534|FG005|Overall Study|Developed a DVT, needed anticoagulation|0|||
147551803|NCT01090765|532176529|FG000|Overall Study|Vasovagal reaction with first infusion|0|||
147551804|NCT01090765|532176530|FG001|Overall Study|Vasovagal reaction with first infusion|0|||
147216550|NCT01340872|530965834|FG002|Open-label Phase|Worsening of IBD|1|||
147551805|NCT01090765|532176531|FG002|Overall Study|Vasovagal reaction with first infusion|0|||
147551806|NCT01090765|532176532|FG003|Overall Study|Vasovagal reaction with first infusion|0|||
147551807|NCT01090765|532176533|FG004|Overall Study|Vasovagal reaction with first infusion|1|||
147216551|NCT01340872|530965835|FG003|Open-label Phase|Worsening of IBD|0|||
147216552|NCT02656680|530965838|FG000|Overall Study|Lost to Follow-up|0|||
147216553|NCT02656680|530965839|FG001|Overall Study|Lost to Follow-up|1|||
147216554|NCT02656680|530965840|FG002|Overall Study|Lost to Follow-up|7|||
147216555|NCT01246466|530965843|FG000|Overall Study|Death|1|||
147216556|NCT01246466|530965843|FG000|Overall Study|Withdrawal by Subject|1|||
147216557|NCT00877773|530965844|FG000|Overall Study|Disease Progression|44|||
147216558|NCT00603590|530965845|FG000|Overall Study|Did not attend study clinic|39|||
147216559|NCT00603590|530965846|FG001|Overall Study|Did not attend study clinic|30|||
147216560|NCT00603590|530965845|FG000|Overall Study|Refused blood test|5|||
147216561|NCT00603590|530965846|FG001|Overall Study|Refused blood test|1|||
147216562|NCT00603590|530965845|FG000|Overall Study|Patient discontinued study drug|22|||
147216563|NCT00603590|530965846|FG001|Overall Study|Patient discontinued study drug|15|||
147216564|NCT00603590|530965845|FG000|Overall Study|Adverse Event|2|||
147216565|NCT00603590|530965846|FG001|Overall Study|Adverse Event|0|||
147216566|NCT00603590|530965845|FG000|Overall Study|Lost to Follow-up|8|||
147216567|NCT00603590|530965846|FG001|Overall Study|Lost to Follow-up|4|||
147216568|NCT00603590|530965845|FG000|Overall Study|Cardiovascular event|0|||
147216569|NCT00603590|530965846|FG001|Overall Study|Cardiovascular event|1|||
147216570|NCT01430754|530965847|FG000|Run-In Phase|Circadian Period Ineligible|24|||
147216571|NCT01430754|530965848|FG001|Run-In Phase|Circadian Period Ineligible|0|||
147216572|NCT01430754|530965847|FG000|Run-In Phase|Protocol Violation|6|||
147216573|NCT01430754|530965848|FG001|Run-In Phase|Protocol Violation|0|||
147216574|NCT01430754|530965847|FG000|Run-In Phase|Adverse Event|2|||
147216575|NCT01430754|530965848|FG001|Run-In Phase|Adverse Event|0|||
147216576|NCT01430754|530965847|FG000|Run-In Phase|Other|2|||
147216577|NCT01430754|530965848|FG001|Run-In Phase|Other|0|||
147216578|NCT01430754|530965847|FG000|Run-In Phase|Withdrawal by Subject|2|||
147216579|NCT01430754|530965848|FG001|Run-In Phase|Withdrawal by Subject|0|||
147216580|NCT01430754|530965847|FG000|Run-In Phase|Lost to Follow-up|1|||
147216581|NCT01430754|530965848|FG001|Run-In Phase|Lost to Follow-up|0|||
147216582|NCT00275821|530965850|FG000|Overall Study|Adverse Event|4|||
147216583|NCT00275821|530965851|FG001|Overall Study|Adverse Event|12|||
147216584|NCT00275821|530965852|FG002|Overall Study|Adverse Event|5|||
147216585|NCT00275821|530965850|FG000|Overall Study|Administrative problems|3|||
147216586|NCT00275821|530965851|FG001|Overall Study|Administrative problems|4|||
147216587|NCT00275821|530965852|FG002|Overall Study|Administrative problems|4|||
147216588|NCT00275821|530965850|FG000|Overall Study|Withdrawal by Subject|0|||
147216589|NCT00275821|530965851|FG001|Overall Study|Withdrawal by Subject|2|||
147216590|NCT00275821|530965852|FG002|Overall Study|Withdrawal by Subject|1|||
147216591|NCT00275821|530965850|FG000|Overall Study|Lost to Follow-up|0|||
147216592|NCT00275821|530965851|FG001|Overall Study|Lost to Follow-up|1|||
147216593|NCT00275821|530965852|FG002|Overall Study|Lost to Follow-up|1|||
147216594|NCT00275821|530965850|FG000|Overall Study|Death|0|||
147216595|NCT00275821|530965851|FG001|Overall Study|Death|2|||
147216596|NCT00275821|530965852|FG002|Overall Study|Death|1|||
147216597|NCT00275821|530965850|FG000|Overall Study|Lack of Efficacy|2|||
147551808|NCT01090765|532176534|FG005|Overall Study|Vasovagal reaction with first infusion|0|||
147551809|NCT01977092|532176535|FG000|Overall Study|Death|3|||
147551810|NCT01977092|532176536|FG001|Overall Study|Death|4|||
147551811|NCT01977092|532176535|FG000|Overall Study|Lost to Follow-up|23|||
147551812|NCT01977092|532176536|FG001|Overall Study|Lost to Follow-up|14|||
147551813|NCT01977092|532176535|FG000|Overall Study|Withdrawal by Subject|2|||
147551814|NCT01977092|532176536|FG001|Overall Study|Withdrawal by Subject|1|||
147216598|NCT00275821|530965851|FG001|Overall Study|Lack of Efficacy|1|||
147551815|NCT01977092|532176535|FG000|Overall Study|In prison|3|||
147551816|NCT01977092|532176536|FG001|Overall Study|In prison|11|||
147551817|NCT00678392|532176537|FG000|Overall Study|Adverse Event|0|||
147216599|NCT00275821|530965852|FG002|Overall Study|Lack of Efficacy|0|||
147551818|NCT00678392|532176538|FG001|Overall Study|Adverse Event|6|||
147216600|NCT00275821|530965850|FG000|Overall Study|Protocol Violation|5|||
147216601|NCT00275821|530965851|FG001|Overall Study|Protocol Violation|1|||
147216602|NCT00275821|530965852|FG002|Overall Study|Protocol Violation|0|||
147216603|NCT01133990|530965854|FG000|Phase 1b (Dose Escalation Phase)|Adverse Event|1|||
147216604|NCT01133990|530965855|FG001|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
147216605|NCT01133990|530965856|FG002|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
147216606|NCT01133990|530965857|FG003|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
147551819|NCT00678392|532176537|FG000|Overall Study|Death|280|||
147551820|NCT00678392|532176538|FG001|Overall Study|Death|269|||
147216607|NCT01133990|530965858|FG004|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
147216608|NCT01133990|530965859|FG005|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
147216609|NCT01133990|530965854|FG000|Phase 1b (Dose Escalation Phase)|Physician Decision|1|||
147216610|NCT01133990|530965855|FG001|Phase 1b (Dose Escalation Phase)|Physician Decision|0|||
147216611|NCT01133990|530965856|FG002|Phase 1b (Dose Escalation Phase)|Physician Decision|0|||
147551821|NCT00678392|532176537|FG000|Overall Study|Lost to Follow-up|15|||
147551822|NCT00678392|532176538|FG001|Overall Study|Lost to Follow-up|13|||
147551823|NCT00678392|532176537|FG000|Overall Study|Objective Progression or Relapse|3|||
147551824|NCT00678392|532176538|FG001|Overall Study|Objective Progression or Relapse|8|||
147551825|NCT00678392|532176537|FG000|Overall Study|Sponsor's Decision|1|||
147551826|NCT00678392|532176538|FG001|Overall Study|Sponsor's Decision|2|||
147551827|NCT00678392|532176537|FG000|Overall Study|Withdrawal by Subject|4|||
147551828|NCT00678392|532176538|FG001|Overall Study|Withdrawal by Subject|4|||
147551829|NCT00678392|532176537|FG000|Overall Study|Randomized But Not Treated|2|||
147551830|NCT00678392|532176538|FG001|Overall Study|Randomized But Not Treated|7|||
147551831|NCT00678392|532176537|FG000|Overall Study|Other|56|||
147551832|NCT00678392|532176538|FG001|Overall Study|Other|53|||
147551833|NCT01958281|532176539|FG000|Overall Study|Lack of Efficacy|5|||
147551834|NCT01958281|532176540|FG001|Overall Study|Lack of Efficacy|2|||
147551835|NCT01958281|532176541|FG002|Overall Study|Lack of Efficacy|0|||
147551836|NCT01958281|532176539|FG000|Overall Study|Adverse Event|0|||
147551837|NCT01958281|532176540|FG001|Overall Study|Adverse Event|2|||
147551838|NCT01958281|532176541|FG002|Overall Study|Adverse Event|0|||
147551839|NCT01958281|532176539|FG000|Overall Study|Withdrew Consent|1|||
147551840|NCT01958281|532176540|FG001|Overall Study|Withdrew Consent|0|||
147551841|NCT01958281|532176541|FG002|Overall Study|Withdrew Consent|0|||
147551842|NCT02784106|532176544|FG000|Double-Blind Treatment Period (12 Weeks)|Adverse Event|3|||
147551843|NCT02784106|532176545|FG001|Double-Blind Treatment Period (12 Weeks)|Adverse Event|5|||
147551844|NCT02784106|532176546|FG002|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
147551845|NCT02784106|532176547|FG003|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
147551846|NCT02784106|532176544|FG000|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|2|||
147551847|NCT02784106|532176545|FG001|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|1|||
147551848|NCT02784106|532176546|FG002|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
147551849|NCT02784106|532176547|FG003|Double-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
147551850|NCT02784106|532176544|FG000|Double-Blind Treatment Period (12 Weeks)|Other|2|||
147551851|NCT02784106|532176545|FG001|Double-Blind Treatment Period (12 Weeks)|Other|0|||
147551852|NCT02784106|532176546|FG002|Double-Blind Treatment Period (12 Weeks)|Other|0|||
147551853|NCT02784106|532176547|FG003|Double-Blind Treatment Period (12 Weeks)|Other|0|||
147551854|NCT02784106|532176544|FG000|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|1|||
147551855|NCT02784106|532176545|FG001|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
147551856|NCT02784106|532176546|FG002|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
147551857|NCT02784106|532176547|FG003|Double-Blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
147551858|NCT02784106|532176544|FG000|Open-Label Extension Period (26 Weeks)|Adverse Event|0|||
147551859|NCT02784106|532176545|FG001|Open-Label Extension Period (26 Weeks)|Adverse Event|0|||
147551860|NCT02784106|532176546|FG002|Open-Label Extension Period (26 Weeks)|Adverse Event|2|||
147551861|NCT02784106|532176547|FG003|Open-Label Extension Period (26 Weeks)|Adverse Event|1|||
147551862|NCT02784106|532176544|FG000|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|0|||
147551863|NCT02784106|532176545|FG001|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|0|||
147551864|NCT02784106|532176546|FG002|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|1|||
147551865|NCT02784106|532176547|FG003|Open-Label Extension Period (26 Weeks)|Lack of Efficacy|1|||
147551866|NCT01418352|532176560|FG000|Overall Study|Lost to Follow-up|2|||
147551867|NCT01418352|532176561|FG001|Overall Study|Lost to Follow-up|0|||
147551868|NCT01418352|532176562|FG002|Overall Study|Lost to Follow-up|0|||
147551869|NCT01418352|532176563|FG003|Overall Study|Lost to Follow-up|0|||
147551870|NCT01418352|532176560|FG000|Overall Study|Adverse Event|0|||
147551871|NCT01418352|532176561|FG001|Overall Study|Adverse Event|1|||
147551872|NCT01418352|532176562|FG002|Overall Study|Adverse Event|0|||
147551873|NCT01418352|532176563|FG003|Overall Study|Adverse Event|0|||
147551874|NCT01418352|532176560|FG000|Overall Study|Sponsor Discontinued Trial Site|0|||
147551875|NCT01418352|532176561|FG001|Overall Study|Sponsor Discontinued Trial Site|2|||
147551876|NCT01418352|532176562|FG002|Overall Study|Sponsor Discontinued Trial Site|2|||
147551877|NCT01418352|532176563|FG003|Overall Study|Sponsor Discontinued Trial Site|2|||
147551878|NCT01418352|532176560|FG000|Overall Study|Subject Withdrew Consent|0|||
147551879|NCT01418352|532176561|FG001|Overall Study|Subject Withdrew Consent|1|||
147551880|NCT01418352|532176562|FG002|Overall Study|Subject Withdrew Consent|2|||
147551881|NCT01418352|532176563|FG003|Overall Study|Subject Withdrew Consent|1|||
147551882|NCT01418352|532176560|FG000|Overall Study|Protocol Deviation|0|||
147551883|NCT01418352|532176561|FG001|Overall Study|Protocol Deviation|0|||
147551884|NCT01418352|532176562|FG002|Overall Study|Protocol Deviation|1|||
147551885|NCT01418352|532176563|FG003|Overall Study|Protocol Deviation|0|||
147551886|NCT01418352|532176560|FG000|Overall Study|Lack of Efficacy as Determined by the Investigator|1|||
147551887|NCT01418352|532176561|FG001|Overall Study|Lack of Efficacy as Determined by the Investigator|0|||
147551888|NCT01418352|532176562|FG002|Overall Study|Lack of Efficacy as Determined by the Investigator|0|||
147551889|NCT01418352|532176563|FG003|Overall Study|Lack of Efficacy as Determined by the Investigator|0|||
147551890|NCT01401478|532176565|FG000|Overall Study|Study drug not available|6|||
147551891|NCT01401478|532176565|FG000|Overall Study|Adverse Event|5|||
147551892|NCT01401478|532176565|FG000|Overall Study|Hyperphosphatemia|5|||
147551893|NCT01401478|532176565|FG000|Overall Study|Lost to Follow-up|5|||
147551894|NCT01401478|532176565|FG000|Overall Study|Kidney transplantation|3|||
147551895|NCT01401478|532176565|FG000|Overall Study|Withdrawal by Subject|3|||
147551896|NCT01401478|532176565|FG000|Overall Study|Blood samples not available|1|||
147551897|NCT01401478|532176565|FG000|Overall Study|Hyperphosphatemia and adverse event|1|||
147551898|NCT01401478|532176565|FG000|Overall Study|Low intact parathyroid hormone|1|||
147551899|NCT01401478|532176565|FG000|Overall Study|Serious adverse event|1|||
147551900|NCT01814137|532176566|FG000|Overall Study|Adverse Event|0|||
147551901|NCT01814137|532176567|FG001|Overall Study|Adverse Event|1|||
147551902|NCT01814137|532176566|FG000|Overall Study|Withdrawal by Subject|2|||
147551903|NCT01814137|532176567|FG001|Overall Study|Withdrawal by Subject|2|||
147551904|NCT01814137|532176566|FG000|Overall Study|Physician Decision|1|||
147551905|NCT01814137|532176567|FG001|Overall Study|Physician Decision|1|||
147551906|NCT01814137|532176566|FG000|Overall Study|Unclassified|2|||
147551907|NCT01814137|532176567|FG001|Overall Study|Unclassified|1|||
147551908|NCT01952574|532176568|FG000|Double-blind Treatment Phase|Withdrawal by Subject|9|||
147551909|NCT01952574|532176569|FG001|Double-blind Treatment Phase|Withdrawal by Subject|3|||
147551910|NCT01952574|532176570|FG002|Double-blind Treatment Phase|Withdrawal by Subject|3|||
147551911|NCT01952574|532176571|FG003|Double-blind Treatment Phase|Withdrawal by Subject|4|||
147551912|NCT01952574|532176572|FG004|Double-blind Treatment Phase|Withdrawal by Subject|0|||
147551913|NCT01952574|532176573|FG005|Double-blind Treatment Phase|Withdrawal by Subject|0|||
147551914|NCT01952574|532176574|FG006|Double-blind Treatment Phase|Withdrawal by Subject|0|||
147551915|NCT01952574|532176568|FG000|Double-blind Treatment Phase|Sponsor Decision|6|||
147551916|NCT01952574|532176569|FG001|Double-blind Treatment Phase|Sponsor Decision|0|||
147551917|NCT01952574|532176570|FG002|Double-blind Treatment Phase|Sponsor Decision|5|||
147551918|NCT01952574|532176571|FG003|Double-blind Treatment Phase|Sponsor Decision|2|||
147551919|NCT01952574|532176572|FG004|Double-blind Treatment Phase|Sponsor Decision|0|||
147551920|NCT01952574|532176573|FG005|Double-blind Treatment Phase|Sponsor Decision|0|||
147551921|NCT01952574|532176574|FG006|Double-blind Treatment Phase|Sponsor Decision|0|||
147551922|NCT01952574|532176568|FG000|Double-blind Treatment Phase|Lost to Follow-up|2|||
147551923|NCT01952574|532176569|FG001|Double-blind Treatment Phase|Lost to Follow-up|0|||
147551924|NCT01952574|532176570|FG002|Double-blind Treatment Phase|Lost to Follow-up|1|||
147551925|NCT01952574|532176571|FG003|Double-blind Treatment Phase|Lost to Follow-up|0|||
147551926|NCT01952574|532176572|FG004|Double-blind Treatment Phase|Lost to Follow-up|0|||
147551927|NCT01952574|532176573|FG005|Double-blind Treatment Phase|Lost to Follow-up|0|||
147551928|NCT01952574|532176574|FG006|Double-blind Treatment Phase|Lost to Follow-up|0|||
147551929|NCT01952574|532176568|FG000|Open-label Treatment Phase|Withdrawal by Subject|0|||
147551930|NCT01952574|532176569|FG001|Open-label Treatment Phase|Withdrawal by Subject|0|||
147551931|NCT01952574|532176570|FG002|Open-label Treatment Phase|Withdrawal by Subject|0|||
147551932|NCT01952574|532176571|FG003|Open-label Treatment Phase|Withdrawal by Subject|0|||
147551933|NCT01952574|532176572|FG004|Open-label Treatment Phase|Withdrawal by Subject|121|||
147551934|NCT01952574|532176573|FG005|Open-label Treatment Phase|Withdrawal by Subject|0|||
147551935|NCT01952574|532176574|FG006|Open-label Treatment Phase|Withdrawal by Subject|0|||
147551936|NCT01952574|532176568|FG000|Open-label Treatment Phase|Decision by Sponsor|0|||
147551937|NCT01952574|532176569|FG001|Open-label Treatment Phase|Decision by Sponsor|0|||
147551938|NCT01952574|532176570|FG002|Open-label Treatment Phase|Decision by Sponsor|0|||
147551939|NCT01952574|532176571|FG003|Open-label Treatment Phase|Decision by Sponsor|0|||
147551940|NCT01952574|532176572|FG004|Open-label Treatment Phase|Decision by Sponsor|17|||
147551941|NCT01952574|532176573|FG005|Open-label Treatment Phase|Decision by Sponsor|0|||
147551942|NCT01952574|532176574|FG006|Open-label Treatment Phase|Decision by Sponsor|0|||
147551943|NCT01952574|532176568|FG000|Open-label Treatment Phase|Missing|0|||
147551944|NCT01952574|532176569|FG001|Open-label Treatment Phase|Missing|0|||
147551945|NCT01952574|532176570|FG002|Open-label Treatment Phase|Missing|0|||
147551946|NCT01952574|532176571|FG003|Open-label Treatment Phase|Missing|0|||
147551947|NCT01952574|532176572|FG004|Open-label Treatment Phase|Missing|4|||
147551948|NCT01952574|532176573|FG005|Open-label Treatment Phase|Missing|0|||
147551949|NCT01952574|532176574|FG006|Open-label Treatment Phase|Missing|0|||
147551950|NCT01952574|532176568|FG000|Open-label Treatment Phase|Lost to Follow-up|0|||
147551951|NCT01952574|532176569|FG001|Open-label Treatment Phase|Lost to Follow-up|0|||
147551952|NCT01952574|532176570|FG002|Open-label Treatment Phase|Lost to Follow-up|0|||
147551953|NCT01952574|532176571|FG003|Open-label Treatment Phase|Lost to Follow-up|0|||
147551954|NCT01952574|532176572|FG004|Open-label Treatment Phase|Lost to Follow-up|19|||
147551955|NCT01952574|532176573|FG005|Open-label Treatment Phase|Lost to Follow-up|0|||
147551956|NCT01952574|532176574|FG006|Open-label Treatment Phase|Lost to Follow-up|0|||
147551957|NCT01952574|532176568|FG000|Open-label Treatment Phase|Death|0|||
147551958|NCT01952574|532176569|FG001|Open-label Treatment Phase|Death|0|||
147551959|NCT01952574|532176570|FG002|Open-label Treatment Phase|Death|0|||
147551960|NCT01952574|532176571|FG003|Open-label Treatment Phase|Death|0|||
147216612|NCT01133990|530965857|FG003|Phase 1b (Dose Escalation Phase)|Physician Decision|0|||
147216613|NCT01133990|530965858|FG004|Phase 1b (Dose Escalation Phase)|Physician Decision|0|||
147216614|NCT01133990|530965859|FG005|Phase 1b (Dose Escalation Phase)|Physician Decision|0|||
147216615|NCT01133990|530965854|FG000|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|1|||
147216616|NCT01133990|530965855|FG001|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
147216617|NCT01133990|530965856|FG002|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
147216618|NCT01133990|530965857|FG003|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
147216619|NCT01133990|530965858|FG004|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
147216620|NCT01133990|530965859|FG005|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
147216621|NCT01133990|530965854|FG000|Phase 1b (Dose Escalation Phase)|Progression of disease|1|||
147216622|NCT01133990|530965855|FG001|Phase 1b (Dose Escalation Phase)|Progression of disease|0|||
147216623|NCT01133990|530965856|FG002|Phase 1b (Dose Escalation Phase)|Progression of disease|0|||
147216624|NCT01133990|530965857|FG003|Phase 1b (Dose Escalation Phase)|Progression of disease|0|||
147216625|NCT01133990|530965858|FG004|Phase 1b (Dose Escalation Phase)|Progression of disease|0|||
147216626|NCT01133990|530965859|FG005|Phase 1b (Dose Escalation Phase)|Progression of disease|0|||
147216627|NCT02282345|530965860|FG000|Overall Study|Progression|0|||
147216628|NCT02282345|530965861|FG001|Overall Study|Progression|1|||
147216629|NCT02683746|530965862|FG000|Overall Study|Adverse Event|3|||
147216630|NCT02683746|530965863|FG001|Overall Study|Adverse Event|2|||
147216631|NCT02683746|530965862|FG000|Overall Study|Lost to Follow-up|5|||
147216632|NCT02683746|530965863|FG001|Overall Study|Lost to Follow-up|6|||
147216633|NCT02683746|530965862|FG000|Overall Study|Withdrawal by Subject|6|||
147216634|NCT02683746|530965863|FG001|Overall Study|Withdrawal by Subject|5|||
147216635|NCT02683746|530965862|FG000|Overall Study|Physician Decision|2|||
147216636|NCT02683746|530965863|FG001|Overall Study|Physician Decision|1|||
147216637|NCT02108262|530965867|FG000|Overall Study|Non-compliance|0|||
147216638|NCT02108262|530965868|FG001|Overall Study|Non-compliance|2|||
147216639|NCT02108262|530965869|FG002|Overall Study|Non-compliance|1|||
147216640|NCT02108262|530965870|FG003|Overall Study|Non-compliance|1|||
147216641|NCT02108262|530965867|FG000|Overall Study|Randomized by error/screen failure|0|||
147216642|NCT02108262|530965868|FG001|Overall Study|Randomized by error/screen failure|0|||
147216643|NCT02108262|530965869|FG002|Overall Study|Randomized by error/screen failure|1|||
147216644|NCT02108262|530965870|FG003|Overall Study|Randomized by error/screen failure|0|||
147216645|NCT02108262|530965867|FG000|Overall Study|Distance to center|0|||
147216646|NCT02108262|530965868|FG001|Overall Study|Distance to center|1|||
147216647|NCT02108262|530965869|FG002|Overall Study|Distance to center|1|||
147216648|NCT02108262|530965870|FG003|Overall Study|Distance to center|0|||
147216649|NCT02108262|530965867|FG000|Overall Study|Adverse Event|0|||
147216650|NCT02108262|530965868|FG001|Overall Study|Adverse Event|11|||
147216651|NCT02108262|530965869|FG002|Overall Study|Adverse Event|6|||
147216652|NCT02108262|530965870|FG003|Overall Study|Adverse Event|12|||
147216653|NCT02108262|530965867|FG000|Overall Study|Death|0|||
147216654|NCT02108262|530965868|FG001|Overall Study|Death|2|||
147216655|NCT02108262|530965869|FG002|Overall Study|Death|2|||
147216656|NCT02108262|530965870|FG003|Overall Study|Death|1|||
147443001|NCT00591214|531786174|FG000|Overall Study|Withdrawal by Subject|1|||
147443002|NCT04857996|531786175|FG000|Overall Study|Completed 24 weeks before study extension to 48 weeks was available as per Protocol version 4.0|4|||
147443003|NCT04857996|531786176|FG001|Overall Study|Completed 24 weeks before study extension to 48 weeks was available as per Protocol version 4.0|5|||
147443004|NCT04857996|531786175|FG000|Overall Study|Lost to Follow-up|1|||
147443005|NCT04857996|531786176|FG001|Overall Study|Lost to Follow-up|3|||
147443006|NCT04857996|531786175|FG000|Overall Study|Site Closure|1|||
147443007|NCT04857996|531786176|FG001|Overall Study|Site Closure|0|||
147443008|NCT04857996|531786175|FG000|Overall Study|Withdrawal by Subject|1|||
147443009|NCT04857996|531786176|FG001|Overall Study|Withdrawal by Subject|0|||
147443010|NCT01129921|531786177|FG000|After Sham Cross-over to Mild, One Year|Lost to Follow-up|2|||
147443011|NCT01129921|531786178|FG001|After Sham Cross-over to Mild, One Year|Lost to Follow-up|1|||
147443012|NCT01129921|531786177|FG000|After Sham Cross-over to Mild, One Year|Lack of Efficacy|0|||
147443013|NCT01129921|531786178|FG001|After Sham Cross-over to Mild, One Year|Lack of Efficacy|1|||
147443014|NCT01129921|531786177|FG000|After Sham Cross-over to Mild, One Year|Withdrawal by Subject|0|||
147443015|NCT01129921|531786178|FG001|After Sham Cross-over to Mild, One Year|Withdrawal by Subject|4|||
147443016|NCT01129921|531786177|FG000|After Sham Cross-over to Mild, One Year|pancreatic cancer progressed|0|||
147443017|NCT01129921|531786178|FG001|After Sham Cross-over to Mild, One Year|pancreatic cancer progressed|1|||
147443018|NCT00847145|531787142|FG000|Overall Study|AE or Death|0|||
147443019|NCT00847145|531787143|FG001|Overall Study|AE or Death|1|||
147443020|NCT00847145|531787144|FG002|Overall Study|AE or Death|1|||
147443021|NCT00847145|531787145|FG003|Overall Study|AE or Death|0|||
147443022|NCT00847145|531787146|FG004|Overall Study|AE or Death|0|||
147443023|NCT00847145|531787147|FG005|Overall Study|AE or Death|0|||
147216657|NCT02108262|530965867|FG000|Overall Study|Lost to Follow-up|0|||
147216658|NCT02108262|530965868|FG001|Overall Study|Lost to Follow-up|0|||
147216659|NCT02108262|530965869|FG002|Overall Study|Lost to Follow-up|1|||
147216660|NCT02108262|530965870|FG003|Overall Study|Lost to Follow-up|0|||
147551961|NCT01952574|532176572|FG004|Open-label Treatment Phase|Death|1|||
147551962|NCT01952574|532176573|FG005|Open-label Treatment Phase|Death|0|||
147551963|NCT01952574|532176574|FG006|Open-label Treatment Phase|Death|0|||
147216661|NCT02108262|530965867|FG000|Overall Study|Physician Decision|0|||
147216662|NCT02108262|530965868|FG001|Overall Study|Physician Decision|0|||
147216663|NCT02108262|530965869|FG002|Overall Study|Physician Decision|2|||
147216664|NCT02108262|530965870|FG003|Overall Study|Physician Decision|0|||
147216665|NCT02108262|530965867|FG000|Overall Study|Withdrawal by Subject|0|||
147216666|NCT02108262|530965868|FG001|Overall Study|Withdrawal by Subject|7|||
147216667|NCT02108262|530965869|FG002|Overall Study|Withdrawal by Subject|3|||
147216668|NCT02108262|530965870|FG003|Overall Study|Withdrawal by Subject|4|||
147216669|NCT02108262|530965867|FG000|Overall Study|Due to key hepatic values|0|||
147216670|NCT02108262|530965868|FG001|Overall Study|Due to key hepatic values|1|||
147216671|NCT02108262|530965869|FG002|Overall Study|Due to key hepatic values|0|||
147216672|NCT02108262|530965870|FG003|Overall Study|Due to key hepatic values|0|||
147216673|NCT02108262|530965867|FG000|Overall Study|Unable to contact patient|0|||
147216674|NCT02108262|530965868|FG001|Overall Study|Unable to contact patient|3|||
147216675|NCT02108262|530965869|FG002|Overall Study|Unable to contact patient|1|||
147216676|NCT02108262|530965870|FG003|Overall Study|Unable to contact patient|2|||
147216677|NCT02108262|530965867|FG000|Overall Study|Patient unable to come to site/attend visit|0|||
147216678|NCT02108262|530965868|FG001|Overall Study|Patient unable to come to site/attend visit|6|||
147216679|NCT02108262|530965869|FG002|Overall Study|Patient unable to come to site/attend visit|11|||
147216680|NCT02108262|530965870|FG003|Overall Study|Patient unable to come to site/attend visit|6|||
147216681|NCT02108262|530965867|FG000|Overall Study|Patient did not want another infusion|0|||
147216682|NCT02108262|530965868|FG001|Overall Study|Patient did not want another infusion|3|||
147216683|NCT02108262|530965869|FG002|Overall Study|Patient did not want another infusion|3|||
147216684|NCT02108262|530965870|FG003|Overall Study|Patient did not want another infusion|2|||
147216685|NCT02108262|530965867|FG000|Overall Study|Vacation|0|||
147216686|NCT02108262|530965868|FG001|Overall Study|Vacation|1|||
147216687|NCT02108262|530965869|FG002|Overall Study|Vacation|0|||
147216688|NCT02108262|530965870|FG003|Overall Study|Vacation|0|||
147216689|NCT02108262|530965867|FG000|Overall Study|Patient decision|0|||
147216690|NCT02108262|530965868|FG001|Overall Study|Patient decision|7|||
147216691|NCT02108262|530965869|FG002|Overall Study|Patient decision|9|||
147216692|NCT02108262|530965870|FG003|Overall Study|Patient decision|14|||
147216693|NCT02108262|530965867|FG000|Overall Study|Missed IV due to pharmacy error|0|||
147216694|NCT02108262|530965868|FG001|Overall Study|Missed IV due to pharmacy error|0|||
147216695|NCT02108262|530965869|FG002|Overall Study|Missed IV due to pharmacy error|1|||
147216696|NCT02108262|530965870|FG003|Overall Study|Missed IV due to pharmacy error|0|||
147216697|NCT00869778|530965874|FG000|Overall Study|Adverse Event|2|||
147216698|NCT00869778|530965875|FG001|Overall Study|Adverse Event|0|||
147216699|NCT00869778|530965876|FG002|Overall Study|Adverse Event|0|||
147216700|NCT00869778|530965874|FG000|Overall Study|Withdrawal by Subject|3|||
147216701|NCT00869778|530965875|FG001|Overall Study|Withdrawal by Subject|4|||
147216702|NCT00869778|530965876|FG002|Overall Study|Withdrawal by Subject|5|||
147216703|NCT00869778|530965874|FG000|Overall Study|Pregnancy|1|||
147216704|NCT00869778|530965875|FG001|Overall Study|Pregnancy|0|||
147216705|NCT00869778|530965876|FG002|Overall Study|Pregnancy|0|||
147216706|NCT00869778|530965874|FG000|Overall Study|Protocol Violation|5|||
147216707|NCT00869778|530965875|FG001|Overall Study|Protocol Violation|3|||
147216708|NCT00869778|530965876|FG002|Overall Study|Protocol Violation|5|||
147216709|NCT00869778|530965874|FG000|Overall Study|Unblinding|1|||
147216710|NCT00869778|530965875|FG001|Overall Study|Unblinding|0|||
147216711|NCT00869778|530965876|FG002|Overall Study|Unblinding|0|||
147216712|NCT03316911|530965882|FG000|Overall Study|Lost to Follow-up|33|||
147216713|NCT03316911|530965883|FG001|Overall Study|Lost to Follow-up|29|||
147216714|NCT01119937|530965884|FG000|Overall Study|Adverse Event|11|||
147216715|NCT01119937|530965885|FG001|Overall Study|Adverse Event|5|||
147216716|NCT01119937|530965884|FG000|Overall Study|Protocol deviation|3|||
147216717|NCT01119937|530965885|FG001|Overall Study|Protocol deviation|1|||
147216718|NCT01119937|530965884|FG000|Overall Study|Unsatisfactory therapeutic effect|3|||
147216719|NCT01119937|530965885|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
147216720|NCT01119937|530965884|FG000|Overall Study|Withdrawal by Subject|2|||
147551964|NCT01952574|532176568|FG000|Clinical Home Use Substudy|Withdrawal by Subject|0|||
147216721|NCT01119937|530965885|FG001|Overall Study|Withdrawal by Subject|1|||
147216722|NCT01270802|530965886|FG000|Overall Study|Withdrawal by Subject|1|||
147216723|NCT01270802|530965887|FG001|Overall Study|Withdrawal by Subject|0|||
147216724|NCT01270802|530965886|FG000|Overall Study|Adverse Event|1|||
147216725|NCT01270802|530965887|FG001|Overall Study|Adverse Event|0|||
147216726|NCT01270802|530965886|FG000|Overall Study|Lost to Follow-up|0|||
147216727|NCT01270802|530965887|FG001|Overall Study|Lost to Follow-up|1|||
147216728|NCT04740905|530965892|FG000|Part 1 (Baseline up to Week 24)|Protocol Violation|0|||
147216729|NCT04740905|530965893|FG001|Part 1 (Baseline up to Week 24)|Protocol Violation|3|||
147216730|NCT04740905|530965892|FG000|Part 1 (Baseline up to Week 24)|Lost to Follow-up|2|||
147216731|NCT04740905|530965893|FG001|Part 1 (Baseline up to Week 24)|Lost to Follow-up|0|||
147216732|NCT04740905|530965892|FG000|Part 1 (Baseline up to Week 24)|Adverse Event|1|||
147216733|NCT04740905|530965893|FG001|Part 1 (Baseline up to Week 24)|Adverse Event|0|||
147216734|NCT04740905|530965892|FG000|Part 1 (Baseline up to Week 24)|Withdrawal by Subject|1|||
147216735|NCT04740905|530965893|FG001|Part 1 (Baseline up to Week 24)|Withdrawal by Subject|0|||
147216736|NCT04740905|530965892|FG000|Part 1 (Baseline up to Week 24)|Death|1|||
147216737|NCT04740905|530965893|FG001|Part 1 (Baseline up to Week 24)|Death|0|||
147216738|NCT04740905|530965892|FG000|Part 2 (Week 24 to Week 72)|Withdrawal by Subject|13|||
147216739|NCT04740905|530965893|FG001|Part 2 (Week 24 to Week 72)|Withdrawal by Subject|12|||
147216740|NCT04740905|530965892|FG000|Part 2 (Week 24 to Week 72)|Lost to Follow-up|7|||
147216741|NCT04740905|530965893|FG001|Part 2 (Week 24 to Week 72)|Lost to Follow-up|6|||
147216742|NCT04740905|530965892|FG000|Part 2 (Week 24 to Week 72)|Adverse Event|0|||
147216743|NCT04740905|530965893|FG001|Part 2 (Week 24 to Week 72)|Adverse Event|4|||
147216744|NCT04740905|530965892|FG000|Part 2 (Week 24 to Week 72)|Physician Decision|0|||
147216745|NCT04740905|530965893|FG001|Part 2 (Week 24 to Week 72)|Physician Decision|4|||
147216746|NCT04740905|530965892|FG000|Part 2 (Week 24 to Week 72)|Patient Missed Week 72 Visit Due to SAE|1|||
147216747|NCT04740905|530965893|FG001|Part 2 (Week 24 to Week 72)|Patient Missed Week 72 Visit Due to SAE|1|||
147216748|NCT04740905|530965892|FG000|Part 2 (Week 24 to Week 72)|Death|1|||
147216749|NCT04740905|530965893|FG001|Part 2 (Week 24 to Week 72)|Death|2|||
147216750|NCT04740905|530965892|FG000|Part 2 (Week 24 to Week 72)|Non-Compliance With Study Drug|2|||
147216751|NCT04740905|530965893|FG001|Part 2 (Week 24 to Week 72)|Non-Compliance With Study Drug|1|||
147216752|NCT04740905|530965892|FG000|Part 2 (Week 24 to Week 72)|Patient Could Not Return to Hospital Due to COVID-19 Epidemic|1|||
147216753|NCT04740905|530965893|FG001|Part 2 (Week 24 to Week 72)|Patient Could Not Return to Hospital Due to COVID-19 Epidemic|0|||
147216754|NCT04740905|530965892|FG000|Part 2 (Week 24 to Week 72)|Patient Refused to Continue Study|1|||
147216755|NCT04740905|530965893|FG001|Part 2 (Week 24 to Week 72)|Patient Refused to Continue Study|0|||
147216756|NCT01566214|530965894|FG000|Overall Study|Lost to Follow-up|3|||
147216757|NCT01566214|530965895|FG001|Overall Study|Lost to Follow-up|0|||
147216758|NCT03051620|530965896|FG000|Overall Study|Lost to Follow-up|6|||
147216759|NCT03051620|530965896|FG000|Overall Study|n=124 enrolled in extension (all completed)|12|||
147216760|NCT00393510|530965897|FG000|Overall Study|Physician Decision|3|||
147216761|NCT00393510|530965898|FG001|Overall Study|Physician Decision|9|||
147216762|NCT03077087|530965902|FG000|Overall Study|Physician Decision|2|||
147216763|NCT00770146|530965903|FG000|Treatment Period|Withdrawal by Subject|6|||
147216764|NCT00770146|530965904|FG001|Treatment Period|Withdrawal by Subject|13|||
147216765|NCT00770146|530965903|FG000|Treatment Period|Adverse Event|2|||
147216766|NCT00770146|530965904|FG001|Treatment Period|Adverse Event|26|||
147216767|NCT00770146|530965903|FG000|Treatment Period|Other|1|||
147216768|NCT00770146|530965904|FG001|Treatment Period|Other|5|||
147216769|NCT00770146|530965903|FG000|Treatment Period|Protocol non-compliance|0|||
147216770|NCT00770146|530965904|FG001|Treatment Period|Protocol non-compliance|1|||
147216771|NCT00770146|530965903|FG000|Follow-up Period|Withdrawal by Subject|7|||
147216772|NCT00770146|530965904|FG001|Follow-up Period|Withdrawal by Subject|13|||
147216773|NCT00770146|530965903|FG000|Follow-up Period|Adverse Event|0|||
147216774|NCT00770146|530965904|FG001|Follow-up Period|Adverse Event|2|||
147216775|NCT00770146|530965903|FG000|Follow-up Period|Other|4|||
147216776|NCT00770146|530965904|FG001|Follow-up Period|Other|5|||
147216777|NCT02412488|530965907|FG000|Overall Study|Lost to Follow-up|10|||
147216778|NCT02412488|530965907|FG000|Overall Study|Withdrawal by Subject|5|||
147216779|NCT02412488|530965907|FG000|Overall Study|Physician Decision|1|||
147216780|NCT02412488|530965907|FG000|Overall Study|No Reveal LINQ Insertion Attempt|1|||
147216781|NCT02412488|530965907|FG000|Overall Study|Reveal LINQ explant|1|||
147216782|NCT01989468|530965908|FG000|Overall Study|Adverse Event|10|||
147216783|NCT01989468|530965909|FG001|Overall Study|Adverse Event|15|||
147216784|NCT01989468|530965910|FG002|Overall Study|Adverse Event|4|||
147216785|NCT01989468|530965911|FG003|Overall Study|Adverse Event|5|||
147216786|NCT01989468|530965912|FG004|Overall Study|Adverse Event|4|||
147216787|NCT01989468|530965908|FG000|Overall Study|Lack of Efficacy|11|||
147216788|NCT01989468|530965909|FG001|Overall Study|Lack of Efficacy|11|||
147216789|NCT01989468|530965910|FG002|Overall Study|Lack of Efficacy|7|||
147216790|NCT01989468|530965911|FG003|Overall Study|Lack of Efficacy|4|||
147216791|NCT01989468|530965912|FG004|Overall Study|Lack of Efficacy|2|||
147216792|NCT01989468|530965908|FG000|Overall Study|Lost to Follow-up|5|||
147216793|NCT01989468|530965909|FG001|Overall Study|Lost to Follow-up|2|||
147216794|NCT01989468|530965910|FG002|Overall Study|Lost to Follow-up|0|||
147216795|NCT01989468|530965911|FG003|Overall Study|Lost to Follow-up|1|||
147216796|NCT01989468|530965912|FG004|Overall Study|Lost to Follow-up|1|||
147216797|NCT01989468|530965908|FG000|Overall Study|Physician Decision|4|||
147216798|NCT01989468|530965909|FG001|Overall Study|Physician Decision|1|||
147443024|NCT00847145|531787148|FG006|Overall Study|AE or Death|0|||
147216799|NCT01989468|530965910|FG002|Overall Study|Physician Decision|0|||
147216800|NCT01989468|530965911|FG003|Overall Study|Physician Decision|1|||
147216801|NCT01989468|530965912|FG004|Overall Study|Physician Decision|0|||
147216802|NCT01989468|530965908|FG000|Overall Study|Pregnancy|0|||
147216803|NCT01989468|530965909|FG001|Overall Study|Pregnancy|1|||
147216804|NCT01989468|530965910|FG002|Overall Study|Pregnancy|0|||
147216805|NCT01989468|530965911|FG003|Overall Study|Pregnancy|0|||
147216806|NCT01989468|530965912|FG004|Overall Study|Pregnancy|0|||
147216807|NCT01989468|530965908|FG000|Overall Study|Technical Problems|3|||
147216808|NCT01989468|530965909|FG001|Overall Study|Technical Problems|1|||
147216809|NCT01989468|530965910|FG002|Overall Study|Technical Problems|3|||
147216810|NCT01989468|530965911|FG003|Overall Study|Technical Problems|1|||
147216811|NCT01989468|530965912|FG004|Overall Study|Technical Problems|0|||
147216812|NCT01989468|530965908|FG000|Overall Study|Subject Guardian Decision|11|||
147216813|NCT01989468|530965909|FG001|Overall Study|Subject Guardian Decision|6|||
147216814|NCT01989468|530965910|FG002|Overall Study|Subject Guardian Decision|4|||
147216815|NCT01989468|530965911|FG003|Overall Study|Subject Guardian Decision|4|||
147216816|NCT01989468|530965912|FG004|Overall Study|Subject Guardian Decision|1|||
147216817|NCT01989468|530965908|FG000|Overall Study|Death|3|||
147216818|NCT01989468|530965909|FG001|Overall Study|Death|0|||
147216819|NCT01989468|530965910|FG002|Overall Study|Death|1|||
147216820|NCT01989468|530965911|FG003|Overall Study|Death|0|||
147216821|NCT01989468|530965912|FG004|Overall Study|Death|0|||
147216822|NCT00674154|530965914|FG000|Overall Study|Withdrawal by Subject|3|||
147216823|NCT00674154|530965915|FG001|Overall Study|Withdrawal by Subject|1|||
147216824|NCT00674154|530965914|FG000|Overall Study|Did not want parathyroidectomy|0|||
147216825|NCT00674154|530965915|FG001|Overall Study|Did not want parathyroidectomy|2|||
147216826|NCT03222492|530965916|FG000|Overall Study|Withdrawal by Subject|0|||
147216827|NCT03222492|530965917|FG001|Overall Study|Withdrawal by Subject|0|||
147216828|NCT03222492|530965918|FG002|Overall Study|Withdrawal by Subject|1|||
147216829|NCT03222492|530965919|FG003|Overall Study|Withdrawal by Subject|0|||
147216830|NCT03222492|530965916|FG000|Overall Study|COVID-19 related|0|||
147216831|NCT03222492|530965917|FG001|Overall Study|COVID-19 related|0|||
147216832|NCT03222492|530965918|FG002|Overall Study|COVID-19 related|1|||
147216833|NCT03222492|530965919|FG003|Overall Study|COVID-19 related|0|||
147216834|NCT00816023|530965920|FG000|Overall Study|Lost to Follow-up|1|||
147216835|NCT00816023|530965921|FG001|Overall Study|Lost to Follow-up|1|||
147216836|NCT00816023|530965922|FG002|Overall Study|Lost to Follow-up|0|||
147216837|NCT00816023|530965923|FG003|Overall Study|Lost to Follow-up|0|||
147216838|NCT00816023|530965920|FG000|Overall Study|Withdrawal by Subject|1|||
147216839|NCT00816023|530965921|FG001|Overall Study|Withdrawal by Subject|0|||
147216840|NCT00816023|530965922|FG002|Overall Study|Withdrawal by Subject|0|||
147216841|NCT00816023|530965923|FG003|Overall Study|Withdrawal by Subject|0|||
147216842|NCT00816023|530965920|FG000|Overall Study|Physician Decision|0|||
147216843|NCT00816023|530965921|FG001|Overall Study|Physician Decision|0|||
147216844|NCT00816023|530965922|FG002|Overall Study|Physician Decision|1|||
147216845|NCT00816023|530965923|FG003|Overall Study|Physician Decision|0|||
147216846|NCT00816023|530965920|FG000|Overall Study|assessments complete prior to window|1|||
147216847|NCT00816023|530965921|FG001|Overall Study|assessments complete prior to window|1|||
147216848|NCT00816023|530965922|FG002|Overall Study|assessments complete prior to window|2|||
147216849|NCT00816023|530965923|FG003|Overall Study|assessments complete prior to window|1|||
147216850|NCT00816023|530965920|FG000|Overall Study|Randomized Not Treated|6|||
147216851|NCT00816023|530965921|FG001|Overall Study|Randomized Not Treated|4|||
147216852|NCT00816023|530965922|FG002|Overall Study|Randomized Not Treated|6|||
147216853|NCT00816023|530965923|FG003|Overall Study|Randomized Not Treated|11|||
147216854|NCT04449029|530965924|FG000|Overall Study|Adverse Event|0|||
147216855|NCT04449029|530965925|FG001|Overall Study|Adverse Event|1|||
147216856|NCT04449029|530965926|FG002|Overall Study|Adverse Event|1|||
147216857|NCT04449029|530965927|FG003|Overall Study|Adverse Event|0|||
147216858|NCT04449029|530965928|FG004|Overall Study|Adverse Event|1|||
147216859|NCT04449029|530965929|FG005|Overall Study|Adverse Event|0|||
147216860|NCT04449029|530965930|FG006|Overall Study|Adverse Event|1|||
147216861|NCT04449029|530965931|FG007|Overall Study|Adverse Event|0|||
147216862|NCT04449029|530965924|FG000|Overall Study|Lost to Follow-up|0|||
147216863|NCT04449029|530965925|FG001|Overall Study|Lost to Follow-up|1|||
147216864|NCT04449029|530965926|FG002|Overall Study|Lost to Follow-up|0|||
147216865|NCT04449029|530965927|FG003|Overall Study|Lost to Follow-up|0|||
147216866|NCT04449029|530965928|FG004|Overall Study|Lost to Follow-up|0|||
147216867|NCT04449029|530965929|FG005|Overall Study|Lost to Follow-up|0|||
147216868|NCT04449029|530965930|FG006|Overall Study|Lost to Follow-up|0|||
147216869|NCT04449029|530965931|FG007|Overall Study|Lost to Follow-up|0|||
147551965|NCT01952574|532176569|FG001|Clinical Home Use Substudy|Withdrawal by Subject|0|||
147551966|NCT01952574|532176570|FG002|Clinical Home Use Substudy|Withdrawal by Subject|0|||
147551967|NCT01952574|532176571|FG003|Clinical Home Use Substudy|Withdrawal by Subject|0|||
147216870|NCT04449029|530965924|FG000|Overall Study|Protocol Violation|0|||
147216871|NCT04449029|530965925|FG001|Overall Study|Protocol Violation|1|||
147216872|NCT04449029|530965926|FG002|Overall Study|Protocol Violation|0|||
147216873|NCT04449029|530965927|FG003|Overall Study|Protocol Violation|0|||
147216874|NCT04449029|530965928|FG004|Overall Study|Protocol Violation|0|||
147216875|NCT04449029|530965929|FG005|Overall Study|Protocol Violation|0|||
147216876|NCT04449029|530965930|FG006|Overall Study|Protocol Violation|0|||
147216877|NCT04449029|530965931|FG007|Overall Study|Protocol Violation|0|||
147216878|NCT04449029|530965924|FG000|Overall Study|Physician Decision|0|||
147216879|NCT04449029|530965925|FG001|Overall Study|Physician Decision|0|||
147216880|NCT04449029|530965926|FG002|Overall Study|Physician Decision|0|||
147216881|NCT04449029|530965927|FG003|Overall Study|Physician Decision|0|||
147216882|NCT04449029|530965928|FG004|Overall Study|Physician Decision|0|||
147216883|NCT04449029|530965929|FG005|Overall Study|Physician Decision|1|||
147216884|NCT04449029|530965930|FG006|Overall Study|Physician Decision|0|||
147216885|NCT04449029|530965931|FG007|Overall Study|Physician Decision|0|||
147216886|NCT04449029|530965924|FG000|Overall Study|Withdrawal by Subject|3|||
147216887|NCT04449029|530965925|FG001|Overall Study|Withdrawal by Subject|0|||
147216888|NCT04449029|530965926|FG002|Overall Study|Withdrawal by Subject|1|||
147216889|NCT04449029|530965927|FG003|Overall Study|Withdrawal by Subject|1|||
147216890|NCT04449029|530965928|FG004|Overall Study|Withdrawal by Subject|5|||
147216891|NCT04449029|530965929|FG005|Overall Study|Withdrawal by Subject|1|||
147216892|NCT04449029|530965930|FG006|Overall Study|Withdrawal by Subject|4|||
147216893|NCT04449029|530965931|FG007|Overall Study|Withdrawal by Subject|0|||
147216894|NCT01073462|530965935|FG000|Overall Study|Death|14|||
147216895|NCT01073462|530965935|FG000|Overall Study|Kidney transplant|10|||
147216896|NCT01073462|530965935|FG000|Overall Study|Low parathyroid hormone levels|8|||
147216897|NCT01073462|530965935|FG000|Overall Study|Serious adverse event|2|||
147216898|NCT01073462|530965935|FG000|Overall Study|Lost to Follow-up|7|||
147216899|NCT03554486|530965936|FG000|Run-in Period (2 Weeks)|Need for steroid injection|1|||
147216900|NCT03554486|530965937|FG001|Run-in Period (2 Weeks)|Need for steroid injection|0|||
147216901|NCT03554486|530965938|FG002|Run-in Period (2 Weeks)|Need for steroid injection|0|||
147216902|NCT03554486|530965936|FG000|Run-in Period (2 Weeks)|Lost to Follow-up|2|||
147216903|NCT03554486|530965937|FG001|Run-in Period (2 Weeks)|Lost to Follow-up|0|||
147216904|NCT03554486|530965938|FG002|Run-in Period (2 Weeks)|Lost to Follow-up|0|||
147216905|NCT03554486|530965936|FG000|Treatment Period 1 (2 Weeks)|Withdrawal by Subject|0|||
147216906|NCT03554486|530965937|FG001|Treatment Period 1 (2 Weeks)|Withdrawal by Subject|1|||
147216907|NCT03554486|530965938|FG002|Treatment Period 1 (2 Weeks)|Withdrawal by Subject|1|||
147216908|NCT02509117|530965942|FG000|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
147216909|NCT02509117|530965943|FG001|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|1|||
147216910|NCT02509117|530965944|FG002|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
147216911|NCT02509117|530965945|FG003|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
147216912|NCT02509117|530965946|FG004|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
147216913|NCT02509117|530965947|FG005|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
147216914|NCT02509117|530965948|FG006|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
147216915|NCT02509117|530965949|FG007|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
147216916|NCT02509117|530965950|FG008|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
147216917|NCT02509117|530965951|FG009|Period 1-Part A:4 Days; Part B,C:19 Days|Randomized, not treated|0|||
147216918|NCT02509117|530965942|FG000|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
147216919|NCT02509117|530965943|FG001|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
147216920|NCT02509117|530965944|FG002|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
147216921|NCT02509117|530965945|FG003|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
147216922|NCT02509117|530965946|FG004|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
147216923|NCT02509117|530965947|FG005|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
147216924|NCT02509117|530965948|FG006|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
147216925|NCT02509117|530965949|FG007|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
147216926|NCT02509117|530965950|FG008|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|0|||
147216927|NCT02509117|530965951|FG009|Period 1-Part A:4 Days; Part B,C:19 Days|Investigator's Discretion|1|||
147216928|NCT02509117|530965942|FG000|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
147216929|NCT02509117|530965943|FG001|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
147216930|NCT02509117|530965944|FG002|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
147216931|NCT02509117|530965945|FG003|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
147216932|NCT02509117|530965946|FG004|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
147216933|NCT02509117|530965947|FG005|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
147216934|NCT02509117|530965948|FG006|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
147216935|NCT02509117|530965949|FG007|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
147216936|NCT02509117|530965950|FG008|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|0|||
147216937|NCT02509117|530965951|FG009|Period 1-Part A:4 Days; Part B,C:19 Days|Withdrawal by Subject|1|||
147216938|NCT04345367|530965952|FG000|Overall Study|Other|3|||
147216939|NCT04345367|530965953|FG001|Overall Study|Other|4|||
147443025|NCT00847145|531787149|FG007|Overall Study|AE or Death|0|||
147443026|NCT00847145|531787142|FG000|Overall Study|Withdrawal by Subject|3|||
147443027|NCT00847145|531787143|FG001|Overall Study|Withdrawal by Subject|4|||
147443028|NCT00847145|531787144|FG002|Overall Study|Withdrawal by Subject|6|||
147443029|NCT00847145|531787145|FG003|Overall Study|Withdrawal by Subject|1|||
147443030|NCT00847145|531787146|FG004|Overall Study|Withdrawal by Subject|0|||
147443031|NCT00847145|531787147|FG005|Overall Study|Withdrawal by Subject|0|||
147443032|NCT00847145|531787148|FG006|Overall Study|Withdrawal by Subject|1|||
147443033|NCT00847145|531787149|FG007|Overall Study|Withdrawal by Subject|1|||
147443034|NCT00847145|531787142|FG000|Overall Study|Lost to Follow-up|3|||
147443035|NCT00847145|531787143|FG001|Overall Study|Lost to Follow-up|1|||
147216940|NCT04345367|530965952|FG000|Overall Study|Medication Error Without Associated Adverse Event|1|||
147216941|NCT04345367|530965953|FG001|Overall Study|Medication Error Without Associated Adverse Event|0|||
147216942|NCT04345367|530965952|FG000|Overall Study|Withdrawal by Subject|11|||
147216943|NCT04345367|530965953|FG001|Overall Study|Withdrawal by Subject|11|||
147216944|NCT04345367|530965952|FG000|Overall Study|Protocol Violation|4|||
147216945|NCT04345367|530965953|FG001|Overall Study|Protocol Violation|3|||
147216946|NCT04345367|530965952|FG000|Overall Study|Lost to Follow-up|2|||
147216947|NCT04345367|530965953|FG001|Overall Study|Lost to Follow-up|4|||
147216948|NCT04345367|530965952|FG000|Overall Study|Lack of Efficacy|2|||
147216949|NCT04345367|530965953|FG001|Overall Study|Lack of Efficacy|0|||
147216950|NCT04345367|530965952|FG000|Overall Study|Death|2|||
147216951|NCT04345367|530965953|FG001|Overall Study|Death|0|||
147216952|NCT04345367|530965952|FG000|Overall Study|Adverse Event|10|||
147216953|NCT04345367|530965953|FG001|Overall Study|Adverse Event|9|||
147216954|NCT02576145|530965959|FG000|Overall Study|Adverse Event|1|||
147216955|NCT02576145|530965960|FG001|Overall Study|Adverse Event|0|||
147216956|NCT02576145|530965959|FG000|Overall Study|Withdrawal by Subject|1|||
147216957|NCT02576145|530965960|FG001|Overall Study|Withdrawal by Subject|0|||
147216958|NCT02576145|530965959|FG000|Overall Study|Acute rejection|1|||
147216959|NCT02576145|530965960|FG001|Overall Study|Acute rejection|0|||
147216960|NCT02576145|530965959|FG000|Overall Study|Tetanus Titers Decreased|0|||
147216961|NCT02576145|530965960|FG001|Overall Study|Tetanus Titers Decreased|1|||
147216962|NCT01227824|530965961|FG000|Double-blind Phase: 96 Weeks Duration|Adverse Event|12|||
147216963|NCT01227824|530965962|FG001|Double-blind Phase: 96 Weeks Duration|Adverse Event|7|||
147216964|NCT01227824|530965963|FG002|Double-blind Phase: 96 Weeks Duration|Adverse Event|0|||
147216965|NCT01227824|530965961|FG000|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|22|||
147216966|NCT01227824|530965962|FG001|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|25|||
147216967|NCT01227824|530965963|FG002|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|0|||
147216968|NCT01227824|530965961|FG000|Double-blind Phase: 96 Weeks Duration|Protocol Violation|18|||
147216969|NCT01227824|530965962|FG001|Double-blind Phase: 96 Weeks Duration|Protocol Violation|16|||
147216970|NCT01227824|530965963|FG002|Double-blind Phase: 96 Weeks Duration|Protocol Violation|0|||
147216971|NCT01227824|530965961|FG000|Double-blind Phase: 96 Weeks Duration|Met Protocol-defined Stopping Criteria|6|||
147216972|NCT01227824|530965962|FG001|Double-blind Phase: 96 Weeks Duration|Met Protocol-defined Stopping Criteria|3|||
147216973|NCT01227824|530965963|FG002|Double-blind Phase: 96 Weeks Duration|Met Protocol-defined Stopping Criteria|0|||
147216974|NCT01227824|530965961|FG000|Double-blind Phase: 96 Weeks Duration|Study Closed/Terminated|6|||
147216975|NCT01227824|530965962|FG001|Double-blind Phase: 96 Weeks Duration|Study Closed/Terminated|4|||
147216976|NCT01227824|530965963|FG002|Double-blind Phase: 96 Weeks Duration|Study Closed/Terminated|0|||
147216977|NCT01227824|530965961|FG000|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|22|||
147216978|NCT01227824|530965962|FG001|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|10|||
147216979|NCT01227824|530965963|FG002|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|0|||
147216980|NCT01227824|530965961|FG000|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|18|||
147216981|NCT01227824|530965962|FG001|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|14|||
147216982|NCT01227824|530965963|FG002|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|0|||
147216983|NCT01227824|530965961|FG000|Double-blind Phase: 96 Weeks Duration|Physician Decision|3|||
147216984|NCT01227824|530965962|FG001|Double-blind Phase: 96 Weeks Duration|Physician Decision|0|||
147216985|NCT01227824|530965963|FG002|Double-blind Phase: 96 Weeks Duration|Physician Decision|0|||
147216986|NCT01227824|530965961|FG000|Open-label Phase: Median of 1267 Days|Adverse Event|0|||
147216987|NCT01227824|530965962|FG001|Open-label Phase: Median of 1267 Days|Adverse Event|0|||
147216988|NCT01227824|530965963|FG002|Open-label Phase: Median of 1267 Days|Adverse Event|4|||
147216989|NCT01227824|530965961|FG000|Open-label Phase: Median of 1267 Days|Lack of Efficacy|0|||
147216990|NCT01227824|530965962|FG001|Open-label Phase: Median of 1267 Days|Lack of Efficacy|0|||
147216991|NCT01227824|530965963|FG002|Open-label Phase: Median of 1267 Days|Lack of Efficacy|5|||
147216992|NCT01227824|530965961|FG000|Open-label Phase: Median of 1267 Days|Protocol Violation|0|||
147216993|NCT01227824|530965962|FG001|Open-label Phase: Median of 1267 Days|Protocol Violation|0|||
147216994|NCT01227824|530965963|FG002|Open-label Phase: Median of 1267 Days|Protocol Violation|5|||
147216995|NCT01227824|530965961|FG000|Open-label Phase: Median of 1267 Days|Met Protocol-defined Stopping Criteria|0|||
147216996|NCT01227824|530965962|FG001|Open-label Phase: Median of 1267 Days|Met Protocol-defined Stopping Criteria|0|||
147216997|NCT01227824|530965963|FG002|Open-label Phase: Median of 1267 Days|Met Protocol-defined Stopping Criteria|4|||
147443036|NCT00847145|531787144|FG002|Overall Study|Lost to Follow-up|1|||
147443037|NCT00847145|531787145|FG003|Overall Study|Lost to Follow-up|0|||
147443038|NCT00847145|531787146|FG004|Overall Study|Lost to Follow-up|4|||
147443039|NCT00847145|531787147|FG005|Overall Study|Lost to Follow-up|4|||
147443040|NCT00847145|531787148|FG006|Overall Study|Lost to Follow-up|8|||
147443041|NCT00847145|531787149|FG007|Overall Study|Lost to Follow-up|2|||
147443042|NCT00847145|531787142|FG000|Overall Study|Inappropriate enrollment|0|||
147443043|NCT00847145|531787143|FG001|Overall Study|Inappropriate enrollment|0|||
147443044|NCT00847145|531787144|FG002|Overall Study|Inappropriate enrollment|0|||
147443045|NCT00847145|531787145|FG003|Overall Study|Inappropriate enrollment|0|||
147443046|NCT00847145|531787146|FG004|Overall Study|Inappropriate enrollment|1|||
147216998|NCT01227824|530965961|FG000|Open-label Phase: Median of 1267 Days|Lost to Follow-up|0|||
147216999|NCT01227824|530965962|FG001|Open-label Phase: Median of 1267 Days|Lost to Follow-up|0|||
147217000|NCT01227824|530965963|FG002|Open-label Phase: Median of 1267 Days|Lost to Follow-up|15|||
147217001|NCT01227824|530965961|FG000|Open-label Phase: Median of 1267 Days|Withdrawal by Subject|0|||
147217002|NCT01227824|530965962|FG001|Open-label Phase: Median of 1267 Days|Withdrawal by Subject|0|||
147217003|NCT01227824|530965963|FG002|Open-label Phase: Median of 1267 Days|Withdrawal by Subject|8|||
147217004|NCT01227824|530965961|FG000|Open-label Phase: Median of 1267 Days|Physician Decision|0|||
147217005|NCT01227824|530965962|FG001|Open-label Phase: Median of 1267 Days|Physician Decision|0|||
147217006|NCT01227824|530965963|FG002|Open-label Phase: Median of 1267 Days|Physician Decision|3|||
147217007|NCT00781885|530965964|FG000|Overall Study|Physician Decision|1|||
147217008|NCT01755026|530965965|FG000|Overall Study|Adverse Event|1|||
147217009|NCT01755026|530965966|FG001|Overall Study|Adverse Event|0|||
147217010|NCT01755026|530965965|FG000|Overall Study|Withdrawal by Subject|1|||
147217011|NCT01755026|530965966|FG001|Overall Study|Withdrawal by Subject|1|||
147217012|NCT01700387|530965974|FG000|Overall Study|Withdrawal by Subject|1|||
147217013|NCT01700387|530965975|FG001|Overall Study|Withdrawal by Subject|2|||
147217014|NCT01700387|530965974|FG000|Overall Study|Adverse Event|1|||
147217015|NCT01700387|530965975|FG001|Overall Study|Adverse Event|1|||
147217016|NCT01700387|530965974|FG000|Overall Study|Lost to Follow-up|2|||
147217017|NCT01700387|530965975|FG001|Overall Study|Lost to Follow-up|1|||
147217018|NCT02730793|530965978|FG000|Overall Study|Physician Decision|0|||
147217019|NCT02730793|530965979|FG001|Overall Study|Physician Decision|1|||
147217020|NCT02730793|530965978|FG000|Overall Study|Withdrawal by Subject|0|||
147217021|NCT02730793|530965979|FG001|Overall Study|Withdrawal by Subject|1|||
147217022|NCT02365233|530965980|FG000|Overall Study|IRB withheld the data|1|||
147217023|NCT02365233|530965981|FG001|Overall Study|IRB withheld the data|2|||
147217024|NCT02365233|530965982|FG002|Overall Study|IRB withheld the data|2|||
147217025|NCT00995566|530965983|FG000|Overall Study|Adverse Event|2|||
147217026|NCT00995566|530965983|FG000|Overall Study|Early study termination|52|||
147217027|NCT00545129|530965984|FG000|Overall Study|Lack of Efficacy|2|||
147217028|NCT00545129|530965985|FG001|Overall Study|Lack of Efficacy|5|||
147217029|NCT00545129|530965984|FG000|Overall Study|Death|2|||
147217030|NCT00545129|530965985|FG001|Overall Study|Death|1|||
147217031|NCT00545129|530965984|FG000|Overall Study|Adverse Event|1|||
147217032|NCT00545129|530965985|FG001|Overall Study|Adverse Event|1|||
147217033|NCT00545129|530965984|FG000|Overall Study|Rollover to Study A4091029 (NCT00830180)|9|||
147217034|NCT00545129|530965985|FG001|Overall Study|Rollover to Study A4091029 (NCT00830180)|14|||
147217035|NCT00545129|530965984|FG000|Overall Study|Other|3|||
147217036|NCT00545129|530965985|FG001|Overall Study|Other|3|||
147217037|NCT03678870|530965986|FG000|Overall Study|prescribed non- protocol medications|10|||
147217038|NCT03678870|530965987|FG001|Overall Study|prescribed non- protocol medications|6|||
147217039|NCT03678870|530965986|FG000|Overall Study|Lost to Follow-up|3|||
147217040|NCT03678870|530965987|FG001|Overall Study|Lost to Follow-up|2|||
147217041|NCT01454778|530965988|FG000|Overall Study|Lost to Follow-up|2|||
147217042|NCT01454778|530965988|FG000|Overall Study|Death|1|||
147217043|NCT00348881|530965989|FG000|Overall Study|Lost to Follow-up|12|||
147217044|NCT00348881|530965990|FG001|Overall Study|Lost to Follow-up|6|||
147217045|NCT00348881|530965989|FG000|Overall Study|Withdrawal by Subject|3|||
147217046|NCT00348881|530965990|FG001|Overall Study|Withdrawal by Subject|4|||
147217047|NCT00348881|530965989|FG000|Overall Study|Adverse Event|2|||
147217048|NCT00348881|530965990|FG001|Overall Study|Adverse Event|0|||
147217049|NCT00348881|530965989|FG000|Overall Study|Serious Adverse Event|0|||
147217050|NCT00348881|530965990|FG001|Overall Study|Serious Adverse Event|2|||
147217051|NCT01981551|530965997|FG000|Overall Study|Refused further treatment|8|||
147217052|NCT01981551|530965997|FG000|Overall Study|Adverse Event|1|||
147217053|NCT02880956|530965998|FG000|Overall Study|Adverse Event|3|||
147217054|NCT02880956|530965999|FG001|Overall Study|Adverse Event|6|||
147217055|NCT02880956|530966000|FG002|Overall Study|Adverse Event|5|||
147217056|NCT02880956|530966001|FG003|Overall Study|Adverse Event|4|||
147217057|NCT02880956|530965998|FG000|Overall Study|Withdrawal by Subject|9|||
147217058|NCT02880956|530965999|FG001|Overall Study|Withdrawal by Subject|4|||
147217059|NCT02880956|530966000|FG002|Overall Study|Withdrawal by Subject|6|||
147217060|NCT02880956|530966001|FG003|Overall Study|Withdrawal by Subject|11|||
147217061|NCT02880956|530965998|FG000|Overall Study|Lost to Follow-up|0|||
147217062|NCT02880956|530965999|FG001|Overall Study|Lost to Follow-up|1|||
147217063|NCT02880956|530966000|FG002|Overall Study|Lost to Follow-up|0|||
147217064|NCT02880956|530966001|FG003|Overall Study|Lost to Follow-up|0|||
147217065|NCT02880956|530965998|FG000|Overall Study|COVID-19 Logistical Restrictions|1|||
147217066|NCT02880956|530965999|FG001|Overall Study|COVID-19 Logistical Restrictions|2|||
147217067|NCT02880956|530966000|FG002|Overall Study|COVID-19 Logistical Restrictions|0|||
147551968|NCT01952574|532176572|FG004|Clinical Home Use Substudy|Withdrawal by Subject|0|||
147649961|NCT00703118|532539770|FG002|Overall Study|Adverse Event|2|||
147217068|NCT02880956|530966001|FG003|Overall Study|COVID-19 Logistical Restrictions|0|||
147217069|NCT02880956|530965998|FG000|Overall Study|Other, Not Specified|4|||
147217070|NCT02880956|530965999|FG001|Overall Study|Other, Not Specified|2|||
147217071|NCT02880956|530966000|FG002|Overall Study|Other, Not Specified|0|||
147551969|NCT01952574|532176573|FG005|Clinical Home Use Substudy|Withdrawal by Subject|1|||
147551970|NCT01952574|532176574|FG006|Clinical Home Use Substudy|Withdrawal by Subject|0|||
147551971|NCT01952574|532176568|FG000|Clinical Home Use Substudy|Decision by Sponsor|0|||
147551972|NCT01952574|532176569|FG001|Clinical Home Use Substudy|Decision by Sponsor|0|||
147551973|NCT01952574|532176570|FG002|Clinical Home Use Substudy|Decision by Sponsor|0|||
147551974|NCT01952574|532176571|FG003|Clinical Home Use Substudy|Decision by Sponsor|0|||
147551975|NCT01952574|532176572|FG004|Clinical Home Use Substudy|Decision by Sponsor|0|||
147551976|NCT01952574|532176573|FG005|Clinical Home Use Substudy|Decision by Sponsor|2|||
147551977|NCT01952574|532176574|FG006|Clinical Home Use Substudy|Decision by Sponsor|1|||
147551978|NCT00770991|532176578|FG000|Overall Study|Physician Decision|2|||
147551979|NCT00770991|532176579|FG001|Overall Study|Physician Decision|0|||
147551980|NCT00770991|532176578|FG000|Overall Study|Withdrawal by Subject|1|||
147551981|NCT00770991|532176579|FG001|Overall Study|Withdrawal by Subject|0|||
147551982|NCT00770991|532176578|FG000|Overall Study|Adverse Event|1|||
147551983|NCT00770991|532176579|FG001|Overall Study|Adverse Event|5|||
147551984|NCT00770991|532176578|FG000|Overall Study|Pregnancy|1|||
147551985|NCT00770991|532176579|FG001|Overall Study|Pregnancy|0|||
147551986|NCT02444533|532176581|FG000|Overall Study|Not able to complete forms|0|||
147551987|NCT02444533|532176582|FG001|Overall Study|Not able to complete forms|2|||
147551988|NCT02444533|532176581|FG000|Overall Study|Only gave post-procedure complications|2|||
147551989|NCT02444533|532176582|FG001|Overall Study|Only gave post-procedure complications|2|||
147551990|NCT00886483|532176587|FG000|Overall Study|Lost to Follow-up|0|||
147551991|NCT00886483|532176588|FG001|Overall Study|Lost to Follow-up|1|||
147551992|NCT00886483|532176587|FG000|Overall Study|Pursue medications|1|||
147551993|NCT00886483|532176588|FG001|Overall Study|Pursue medications|2|||
147551994|NCT00886483|532176587|FG000|Overall Study|Distance to center, poor grades|1|||
147551995|NCT00886483|532176588|FG001|Overall Study|Distance to center, poor grades|0|||
147551996|NCT02168270|532176590|FG000|Overall Study|Lack of Efficacy|4|||
147551997|NCT00593333|532176591|FG000|Overall Study|Lost to Follow-up|10|||
147551998|NCT00593333|532176592|FG001|Overall Study|Lost to Follow-up|11|||
147551999|NCT02175966|532176593|FG000|Follow-up Period|Lack of Efficacy|10|||
147552000|NCT02175966|532176594|FG001|Follow-up Period|Lack of Efficacy|6|||
147552001|NCT01086215|532176599|FG000|Overall Study|Death|14|||
147552002|NCT01086215|532176600|FG001|Overall Study|Death|8|||
147552003|NCT01086215|532176601|FG002|Overall Study|Death|8|||
147552004|NCT01086215|532176602|FG003|Overall Study|Death|1|||
147552005|NCT01086215|532176599|FG000|Overall Study|Lost to Follow-up|22|||
147552006|NCT01086215|532176600|FG001|Overall Study|Lost to Follow-up|39|||
147552007|NCT01086215|532176601|FG002|Overall Study|Lost to Follow-up|18|||
147552008|NCT01086215|532176602|FG003|Overall Study|Lost to Follow-up|2|||
147552009|NCT01965652|532176603|FG000|Overall Study|Adverse Event|40|||
147552010|NCT01965652|532176604|FG001|Overall Study|Adverse Event|37|||
147552011|NCT01965652|532176603|FG000|Overall Study|Withdrawal by Subject|62|||
147552012|NCT01965652|532176604|FG001|Overall Study|Withdrawal by Subject|69|||
147552013|NCT01965652|532176603|FG000|Overall Study|Lost to Follow-up|53|||
147552014|NCT01965652|532176604|FG001|Overall Study|Lost to Follow-up|40|||
147552015|NCT01965652|532176603|FG000|Overall Study|Protocol Violation|34|||
147217072|NCT02880956|530966001|FG003|Overall Study|Other, Not Specified|3|||
147217073|NCT03658876|530967830|FG000|Overall Study|Protocol Violation|3|||
147217074|NCT03658876|530967831|FG001|Overall Study|Protocol Violation|2|||
147217075|NCT03658876|530967830|FG000|Overall Study|Withdrawal by Subject|2|||
147217076|NCT03658876|530967831|FG001|Overall Study|Withdrawal by Subject|0|||
147217077|NCT03658876|530967830|FG000|Overall Study|Death|0|||
147552016|NCT01965652|532176604|FG001|Overall Study|Protocol Violation|38|||
147552017|NCT01965652|532176603|FG000|Overall Study|Death|3|||
147552018|NCT01965652|532176604|FG001|Overall Study|Death|4|||
147552019|NCT01965652|532176603|FG000|Overall Study|Other - Miscellaneous|18|||
147552020|NCT01965652|532176604|FG001|Overall Study|Other - Miscellaneous|21|||
147552021|NCT01965652|532176603|FG000|Overall Study|Pregnancy|0|||
147552022|NCT01965652|532176604|FG001|Overall Study|Pregnancy|1|||
147552023|NCT01121900|532176607|FG000|First Intervention Period|Adverse Event|1|||
147217078|NCT03658876|530967831|FG001|Overall Study|Death|1|||
147217079|NCT03658876|530967830|FG000|Overall Study|Intercurrent illness|6|||
147552024|NCT01121900|532176608|FG001|First Intervention Period|Adverse Event|1|||
147552025|NCT01121900|532176607|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
147552026|NCT01121900|532176608|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
147552027|NCT03469271|532176609|FG000|Overall Study|Withdrawal by Subject|2|||
147552028|NCT03469271|532176610|FG001|Overall Study|Withdrawal by Subject|0|||
147552029|NCT03469271|532176611|FG002|Overall Study|Withdrawal by Subject|0|||
147552030|NCT03469271|532176612|FG003|Overall Study|Withdrawal by Subject|1|||
147552031|NCT01328054|532176615|FG000|Lapatinib on Day 3 and Day 4 (2 Days)|Adverse Event|0|||
147552032|NCT01328054|532176616|FG001|Lapatinib on Day 3 and Day 4 (2 Days)|Adverse Event|2|||
147552033|NCT01328054|532176615|FG000|Lapatinib on Day 3 and Day 4 (2 Days)|Physician Decision|0|||
147552034|NCT01328054|532176616|FG001|Lapatinib on Day 3 and Day 4 (2 Days)|Physician Decision|1|||
147217080|NCT03658876|530967831|FG001|Overall Study|Intercurrent illness|4|||
147552035|NCT01328054|532176615|FG000|Lapatinib on Day 3 and Day 4 (2 Days)|Withdrawal by Subject|0|||
147552036|NCT01328054|532176616|FG001|Lapatinib on Day 3 and Day 4 (2 Days)|Withdrawal by Subject|2|||
147552037|NCT03760510|532176617|FG000|Overall Study|Not ventilated for 24 hours|105|||
147552038|NCT03760510|532176618|FG001|Overall Study|Not ventilated for 24 hours|97|||
147552039|NCT00871728|532176619|FG000|Overall Study|Adverse Event|1|||
147217081|NCT03658876|530967830|FG000|Overall Study|Transplantation/other operation|1|||
147217082|NCT03658876|530967831|FG001|Overall Study|Transplantation/other operation|5|||
147217083|NCT02616146|530967832|FG000|Overall Study|Adverse Event|64|||
147217084|NCT02616146|530967833|FG001|Overall Study|Adverse Event|24|||
147217085|NCT02616146|530967832|FG000|Overall Study|Lost to Follow-up|23|||
147217086|NCT02616146|530967833|FG001|Overall Study|Lost to Follow-up|13|||
147217087|NCT02616146|530967832|FG000|Overall Study|Non-compliance with study protocol|2|||
147217088|NCT02616146|530967833|FG001|Overall Study|Non-compliance with study protocol|0|||
147217089|NCT02616146|530967832|FG000|Overall Study|Non-compliance with study drug|4|||
147217090|NCT02616146|530967833|FG001|Overall Study|Non-compliance with study drug|2|||
147217091|NCT02616146|530967832|FG000|Overall Study|Pregnancy|2|||
147217092|NCT02616146|530967833|FG001|Overall Study|Pregnancy|2|||
147217093|NCT02616146|530967832|FG000|Overall Study|Pregnancy wish|3|||
147217094|NCT02616146|530967833|FG001|Overall Study|Pregnancy wish|0|||
147217095|NCT02616146|530967832|FG000|Overall Study|Protocol Violation|6|||
147217096|NCT02616146|530967833|FG001|Overall Study|Protocol Violation|3|||
147217097|NCT02616146|530967832|FG000|Overall Study|Study terminated by sponsor|1372|||
147217098|NCT02616146|530967833|FG001|Overall Study|Study terminated by sponsor|432|||
147217099|NCT02616146|530967832|FG000|Overall Study|Participant moved|4|||
147217100|NCT02616146|530967833|FG001|Overall Study|Participant moved|3|||
147217101|NCT02616146|530967832|FG000|Overall Study|Withdrawal by Subject|30|||
147217102|NCT02616146|530967833|FG001|Overall Study|Withdrawal by Subject|24|||
147217103|NCT02616146|530967832|FG000|Overall Study|Physician Decision|2|||
147217104|NCT02616146|530967833|FG001|Overall Study|Physician Decision|1|||
147217105|NCT03039621|530967834|FG000|Overall Study|Violation of inclusion criteria|3|||
147217106|NCT03039621|530967835|FG001|Overall Study|Violation of inclusion criteria|2|||
147217107|NCT03039621|530967834|FG000|Overall Study|Non-compliance with protocol requirement|4|||
147217108|NCT03039621|530967835|FG001|Overall Study|Non-compliance with protocol requirement|5|||
147217109|NCT03039621|530967834|FG000|Overall Study|Necessity to use drugs forbidden by pro|4|||
147217110|NCT03039621|530967835|FG001|Overall Study|Necessity to use drugs forbidden by pro|7|||
147217111|NCT03039621|530967834|FG000|Overall Study|Violation of non-inclusion criteria|1|||
147217112|NCT03039621|530967835|FG001|Overall Study|Violation of non-inclusion criteria|2|||
147217113|NCT05338671|530967839|FG000|Overall Study|Lost to Follow-up|2|||
147217114|NCT05338671|530967840|FG001|Overall Study|Lost to Follow-up|2|||
147217115|NCT05338671|530967839|FG000|Overall Study|Root canal completed in a single visit|1|||
147217116|NCT05338671|530967840|FG001|Overall Study|Root canal completed in a single visit|0|||
147217117|NCT03085914|530967843|FG000|Overall Study|Death|6|||
147217118|NCT03085914|530967844|FG001|Overall Study|Death|6|||
147217119|NCT03085914|530967845|FG002|Overall Study|Death|4|||
147217120|NCT03085914|530967846|FG003|Overall Study|Death|1|||
147217121|NCT03085914|530967847|FG004|Overall Study|Death|5|||
147217122|NCT03085914|530967848|FG005|Overall Study|Death|2|||
147217123|NCT03085914|530967849|FG006|Overall Study|Death|2|||
147217124|NCT03085914|530967843|FG000|Overall Study|Withdrawal by Subject|1|||
147217125|NCT03085914|530967844|FG001|Overall Study|Withdrawal by Subject|1|||
147217126|NCT03085914|530967845|FG002|Overall Study|Withdrawal by Subject|2|||
147217127|NCT03085914|530967846|FG003|Overall Study|Withdrawal by Subject|2|||
147217128|NCT03085914|530967847|FG004|Overall Study|Withdrawal by Subject|2|||
147217129|NCT03085914|530967848|FG005|Overall Study|Withdrawal by Subject|0|||
147217130|NCT03085914|530967849|FG006|Overall Study|Withdrawal by Subject|1|||
147217131|NCT03085914|530967843|FG000|Overall Study|Lost to Follow-up|0|||
147217132|NCT03085914|530967844|FG001|Overall Study|Lost to Follow-up|0|||
147217133|NCT03085914|530967845|FG002|Overall Study|Lost to Follow-up|1|||
147217134|NCT03085914|530967846|FG003|Overall Study|Lost to Follow-up|0|||
147217135|NCT03085914|530967847|FG004|Overall Study|Lost to Follow-up|0|||
147217136|NCT03085914|530967848|FG005|Overall Study|Lost to Follow-up|1|||
147552040|NCT00871728|532176619|FG000|Overall Study|Protocol Violation|7|||
147552041|NCT00871728|532176619|FG000|Overall Study|Lost to Follow-up|2|||
147552042|NCT00871728|532176619|FG000|Overall Study|Failed to Visit Hospital|4|||
147552043|NCT00871728|532176619|FG000|Overall Study|Participant Non-compliance|1|||
147217137|NCT03085914|530967849|FG006|Overall Study|Lost to Follow-up|1|||
147217138|NCT03085914|530967843|FG000|Overall Study|Reason was not specified,|2|||
147217139|NCT03085914|530967844|FG001|Overall Study|Reason was not specified,|2|||
147217140|NCT03085914|530967845|FG002|Overall Study|Reason was not specified,|2|||
147217141|NCT03085914|530967846|FG003|Overall Study|Reason was not specified,|3|||
147552044|NCT00871728|532176619|FG000|Overall Study|Withdrawal of Informed Consent|5|||
147552045|NCT00566709|532176627|FG000|Overall Study|Protocol Violation|5|||
147217142|NCT03085914|530967847|FG004|Overall Study|Reason was not specified,|3|||
147217143|NCT03085914|530967848|FG005|Overall Study|Reason was not specified,|3|||
147217144|NCT03085914|530967849|FG006|Overall Study|Reason was not specified,|6|||
147217145|NCT03085914|530967843|FG000|Overall Study|Progressive Disease|0|||
147217146|NCT03085914|530967844|FG001|Overall Study|Progressive Disease|0|||
147217147|NCT03085914|530967845|FG002|Overall Study|Progressive Disease|2|||
147217148|NCT03085914|530967846|FG003|Overall Study|Progressive Disease|2|||
147217149|NCT03085914|530967847|FG004|Overall Study|Progressive Disease|1|||
147217150|NCT03085914|530967848|FG005|Overall Study|Progressive Disease|1|||
147217151|NCT03085914|530967849|FG006|Overall Study|Progressive Disease|1|||
147217152|NCT03085914|530967843|FG000|Overall Study|Study Terminated by the Sponsor|0|||
147217153|NCT03085914|530967844|FG001|Overall Study|Study Terminated by the Sponsor|0|||
147217154|NCT03085914|530967845|FG002|Overall Study|Study Terminated by the Sponsor|0|||
147217155|NCT03085914|530967846|FG003|Overall Study|Study Terminated by the Sponsor|1|||
147217156|NCT03085914|530967847|FG004|Overall Study|Study Terminated by the Sponsor|2|||
147217157|NCT03085914|530967848|FG005|Overall Study|Study Terminated by the Sponsor|1|||
147217158|NCT03085914|530967849|FG006|Overall Study|Study Terminated by the Sponsor|0|||
147552046|NCT00566709|532176628|FG001|Overall Study|Protocol Violation|0|||
147552047|NCT03775681|532176631|FG000|Overall Study|Physician Decision|3|||
147552048|NCT00616928|532176632|FG000|Overall Study|Adverse Event|6|||
147552049|NCT00616928|532176633|FG001|Overall Study|Adverse Event|3|||
147217159|NCT01215916|530967850|FG000|Overall Study|Progressive Disease|0|||
147217160|NCT01215916|530967851|FG001|Overall Study|Progressive Disease|2|||
147217161|NCT01215916|530967852|FG002|Overall Study|Progressive Disease|1|||
147217162|NCT01215916|530967853|FG003|Overall Study|Progressive Disease|2|||
147217163|NCT01215916|530967854|FG004|Overall Study|Progressive Disease|5|||
147217164|NCT01215916|530967855|FG005|Overall Study|Progressive Disease|4|||
147217165|NCT01215916|530967856|FG006|Overall Study|Progressive Disease|5|||
147217166|NCT01215916|530967857|FG007|Overall Study|Progressive Disease|3|||
147217167|NCT01215916|530967858|FG008|Overall Study|Progressive Disease|1|||
147217168|NCT01215916|530967850|FG000|Overall Study|Adverse Event|1|||
147217169|NCT01215916|530967851|FG001|Overall Study|Adverse Event|1|||
147217170|NCT01215916|530967852|FG002|Overall Study|Adverse Event|0|||
147217171|NCT01215916|530967853|FG003|Overall Study|Adverse Event|1|||
147217172|NCT01215916|530967854|FG004|Overall Study|Adverse Event|0|||
147217173|NCT01215916|530967855|FG005|Overall Study|Adverse Event|0|||
147217174|NCT01215916|530967856|FG006|Overall Study|Adverse Event|3|||
147217175|NCT01215916|530967857|FG007|Overall Study|Adverse Event|0|||
147217176|NCT01215916|530967858|FG008|Overall Study|Adverse Event|0|||
147217177|NCT01215916|530967850|FG000|Overall Study|Withdrawal by Subject|0|||
147217178|NCT01215916|530967851|FG001|Overall Study|Withdrawal by Subject|1|||
147217179|NCT01215916|530967852|FG002|Overall Study|Withdrawal by Subject|1|||
147217180|NCT01215916|530967853|FG003|Overall Study|Withdrawal by Subject|2|||
147217181|NCT01215916|530967854|FG004|Overall Study|Withdrawal by Subject|0|||
147217182|NCT01215916|530967855|FG005|Overall Study|Withdrawal by Subject|0|||
147217183|NCT01215916|530967856|FG006|Overall Study|Withdrawal by Subject|1|||
147217184|NCT01215916|530967857|FG007|Overall Study|Withdrawal by Subject|0|||
147217185|NCT01215916|530967858|FG008|Overall Study|Withdrawal by Subject|0|||
147217186|NCT01215916|530967850|FG000|Overall Study|Death|0|||
147217187|NCT01215916|530967851|FG001|Overall Study|Death|1|||
147217188|NCT01215916|530967852|FG002|Overall Study|Death|0|||
147217189|NCT01215916|530967853|FG003|Overall Study|Death|0|||
147217190|NCT01215916|530967854|FG004|Overall Study|Death|1|||
147217191|NCT01215916|530967855|FG005|Overall Study|Death|0|||
147217192|NCT01215916|530967856|FG006|Overall Study|Death|0|||
147217193|NCT01215916|530967857|FG007|Overall Study|Death|0|||
147217194|NCT01215916|530967858|FG008|Overall Study|Death|1|||
147217195|NCT01215916|530967850|FG000|Overall Study|Physician Decision|0|||
147217196|NCT01215916|530967851|FG001|Overall Study|Physician Decision|0|||
147217197|NCT01215916|530967852|FG002|Overall Study|Physician Decision|1|||
147217198|NCT01215916|530967853|FG003|Overall Study|Physician Decision|1|||
147217199|NCT01215916|530967854|FG004|Overall Study|Physician Decision|0|||
147217200|NCT01215916|530967855|FG005|Overall Study|Physician Decision|0|||
147217201|NCT01215916|530967856|FG006|Overall Study|Physician Decision|0|||
147217202|NCT01215916|530967857|FG007|Overall Study|Physician Decision|0|||
147217203|NCT01215916|530967858|FG008|Overall Study|Physician Decision|0|||
147217204|NCT02353143|530967859|FG000|Overall Study|Withdrawal by Subject|1|||
147217205|NCT02353143|530967860|FG001|Overall Study|Withdrawal by Subject|0|||
147217206|NCT02353143|530967861|FG002|Overall Study|Withdrawal by Subject|0|||
147217207|NCT02353143|530967862|FG003|Overall Study|Withdrawal by Subject|0|||
147217208|NCT02353143|530967863|FG004|Overall Study|Withdrawal by Subject|1|||
147217209|NCT02353143|530967864|FG005|Overall Study|Withdrawal by Subject|0|||
147217210|NCT02353143|530967865|FG006|Overall Study|Withdrawal by Subject|0|||
147217211|NCT02353143|530967866|FG007|Overall Study|Withdrawal by Subject|1|||
147217212|NCT02353143|530967867|FG008|Overall Study|Withdrawal by Subject|1|||
147217213|NCT02353143|530967859|FG000|Overall Study|Lack of Efficacy|2|||
147217214|NCT02353143|530967860|FG001|Overall Study|Lack of Efficacy|1|||
147217215|NCT02353143|530967861|FG002|Overall Study|Lack of Efficacy|2|||
147217216|NCT02353143|530967862|FG003|Overall Study|Lack of Efficacy|4|||
147217217|NCT02353143|530967863|FG004|Overall Study|Lack of Efficacy|13|||
147217218|NCT02353143|530967864|FG005|Overall Study|Lack of Efficacy|2|||
147552050|NCT00616928|532176634|FG002|Overall Study|Adverse Event|2|||
147552051|NCT00616928|532176635|FG003|Overall Study|Adverse Event|2|||
147217219|NCT02353143|530967865|FG006|Overall Study|Lack of Efficacy|2|||
147217220|NCT02353143|530967866|FG007|Overall Study|Lack of Efficacy|2|||
147552052|NCT00616928|532176632|FG000|Overall Study|Other|51|||
147552053|NCT00616928|532176633|FG001|Overall Study|Other|8|||
147552054|NCT00616928|532176634|FG002|Overall Study|Other|15|||
147552055|NCT00616928|532176635|FG003|Overall Study|Other|5|||
147552056|NCT00616928|532176632|FG000|Overall Study|Lost to Follow-up|5|||
147552057|NCT00616928|532176633|FG001|Overall Study|Lost to Follow-up|7|||
147552058|NCT00616928|532176634|FG002|Overall Study|Lost to Follow-up|0|||
147552059|NCT00616928|532176635|FG003|Overall Study|Lost to Follow-up|0|||
147552060|NCT00895583|532176636|FG000|Overall Study|Adverse Event|28|||
147552061|NCT00895583|532176637|FG001|Overall Study|Adverse Event|4|||
147552062|NCT00895583|532176636|FG000|Overall Study|Death|2|||
147552063|NCT00895583|532176637|FG001|Overall Study|Death|1|||
147552064|NCT00895583|532176636|FG000|Overall Study|Physician Decision|3|||
147552065|NCT00895583|532176637|FG001|Overall Study|Physician Decision|1|||
147552066|NCT00895583|532176636|FG000|Overall Study|Lost to Follow-up|1|||
147552067|NCT00895583|532176637|FG001|Overall Study|Lost to Follow-up|3|||
147552068|NCT00895583|532176636|FG000|Overall Study|Protocol Violation|1|||
147552069|NCT00895583|532176637|FG001|Overall Study|Protocol Violation|0|||
147552070|NCT00895583|532176636|FG000|Overall Study|Withdrawal by Subject|4|||
147552071|NCT00895583|532176637|FG001|Overall Study|Withdrawal by Subject|2|||
147552072|NCT00895583|532176636|FG000|Overall Study|Lack of Efficacy|5|||
147552073|NCT00895583|532176637|FG001|Overall Study|Lack of Efficacy|0|||
147552074|NCT00895583|532176636|FG000|Overall Study|Other|0|||
147552075|NCT00895583|532176637|FG001|Overall Study|Other|1|||
147552076|NCT03529955|532176638|FG000|Overall Study|Adverse Event|1|||
147552077|NCT03529955|532176638|FG000|Overall Study|Lack of Efficacy|1|||
147552078|NCT03016078|532176644|FG000|Overall Study|Protocol Violation|1|||
147552079|NCT03016078|532176644|FG000|Overall Study|Protocol Violation|1|||
147552080|NCT02378506|532176646|FG000|Overall Study|Lack of Efficacy|3|||
147552081|NCT02378506|532176646|FG000|Overall Study|Withdrawal by Subject|4|||
147552082|NCT02378506|532176646|FG000|Overall Study|Protocol Violation|2|||
147552083|NCT02378506|532176646|FG000|Overall Study|Death|1|||
147552084|NCT02378506|532176646|FG000|Overall Study|Adverse Event|14|||
147552085|NCT02378506|532176646|FG000|Overall Study|Randomized But Not Treated|1|||
147552086|NCT01070394|532176648|FG000|Overall Study|Adverse Event|6|||
147552087|NCT01070394|532176648|FG000|Overall Study|Withdrawal by Subject|1|||
147217221|NCT02353143|530967867|FG008|Overall Study|Lack of Efficacy|1|||
147217222|NCT02353143|530967859|FG000|Overall Study|reason not specified|1|||
147217223|NCT02353143|530967860|FG001|Overall Study|reason not specified|2|||
147217224|NCT02353143|530967861|FG002|Overall Study|reason not specified|0|||
147217225|NCT02353143|530967862|FG003|Overall Study|reason not specified|0|||
147217226|NCT02353143|530967863|FG004|Overall Study|reason not specified|6|||
147217227|NCT02353143|530967864|FG005|Overall Study|reason not specified|1|||
147217228|NCT02353143|530967865|FG006|Overall Study|reason not specified|0|||
147217229|NCT02353143|530967866|FG007|Overall Study|reason not specified|3|||
147217230|NCT02353143|530967867|FG008|Overall Study|reason not specified|1|||
147217231|NCT02353143|530967859|FG000|Overall Study|Physician Decision|0|||
147217232|NCT02353143|530967860|FG001|Overall Study|Physician Decision|4|||
147217233|NCT02353143|530967861|FG002|Overall Study|Physician Decision|2|||
147217234|NCT02353143|530967862|FG003|Overall Study|Physician Decision|3|||
147217235|NCT02353143|530967863|FG004|Overall Study|Physician Decision|4|||
147217236|NCT02353143|530967864|FG005|Overall Study|Physician Decision|0|||
147217237|NCT02353143|530967865|FG006|Overall Study|Physician Decision|1|||
147217238|NCT02353143|530967866|FG007|Overall Study|Physician Decision|2|||
147217239|NCT02353143|530967867|FG008|Overall Study|Physician Decision|0|||
147217240|NCT02353143|530967859|FG000|Overall Study|Adverse Event|0|||
147217241|NCT02353143|530967860|FG001|Overall Study|Adverse Event|0|||
147217242|NCT02353143|530967861|FG002|Overall Study|Adverse Event|1|||
147217243|NCT02353143|530967862|FG003|Overall Study|Adverse Event|0|||
147552088|NCT01715415|532176660|FG000|Double-blind Treatment|Did Not Receive Study Drug|0|||
147552089|NCT01715415|532176661|FG001|Double-blind Treatment|Did Not Receive Study Drug|1|||
147552090|NCT01715415|532176660|FG000|Double-blind Treatment|Adverse Event|3|||
147217244|NCT02353143|530967863|FG004|Overall Study|Adverse Event|1|||
147552091|NCT01715415|532176661|FG001|Double-blind Treatment|Adverse Event|0|||
147552092|NCT01715415|532176660|FG000|Double-blind Treatment|Withdrawal by Subject|1|||
147217245|NCT02353143|530967864|FG005|Overall Study|Adverse Event|1|||
147217246|NCT02353143|530967865|FG006|Overall Study|Adverse Event|0|||
147217247|NCT02353143|530967866|FG007|Overall Study|Adverse Event|0|||
147217248|NCT02353143|530967867|FG008|Overall Study|Adverse Event|0|||
147552093|NCT01715415|532176661|FG001|Double-blind Treatment|Withdrawal by Subject|1|||
147552094|NCT01715415|532176660|FG000|Double-blind Treatment|Other|1|||
147552095|NCT01715415|532176661|FG001|Double-blind Treatment|Other|0|||
147552096|NCT01715415|532176660|FG000|Open-label Treatment|Adverse Event|0|||
147552097|NCT01715415|532176661|FG001|Open-label Treatment|Adverse Event|1|||
147217249|NCT02353143|530967859|FG000|Overall Study|patient receiving other treatment for AML|0|||
147552098|NCT01715415|532176660|FG000|Open-label Treatment|Subject Noncompliant|0|||
147552099|NCT01715415|532176661|FG001|Open-label Treatment|Subject Noncompliant|1|||
147552100|NCT01015612|532176662|FG000|Overall Study|Death|113|||
147552101|NCT01015612|532176662|FG000|Overall Study|Withdrawal by Subject|40|||
147552102|NCT02497391|532178487|FG000|Period 2 (14 Days)|Withdrawal by Subject|1|||
147552103|NCT02497391|532178488|FG001|Period 2 (14 Days)|Withdrawal by Subject|0|||
147217250|NCT02353143|530967860|FG001|Overall Study|patient receiving other treatment for AML|0|||
147217251|NCT02353143|530967861|FG002|Overall Study|patient receiving other treatment for AML|1|||
147217252|NCT02353143|530967862|FG003|Overall Study|patient receiving other treatment for AML|0|||
147217253|NCT02353143|530967863|FG004|Overall Study|patient receiving other treatment for AML|0|||
147217254|NCT02353143|530967864|FG005|Overall Study|patient receiving other treatment for AML|0|||
147217255|NCT02353143|530967865|FG006|Overall Study|patient receiving other treatment for AML|0|||
147217256|NCT02353143|530967866|FG007|Overall Study|patient receiving other treatment for AML|0|||
147217257|NCT02353143|530967867|FG008|Overall Study|patient receiving other treatment for AML|0|||
147217258|NCT02353143|530967859|FG000|Overall Study|Dose limiting toxicity (DLT)|0|||
147217259|NCT02353143|530967860|FG001|Overall Study|Dose limiting toxicity (DLT)|0|||
147217260|NCT02353143|530967861|FG002|Overall Study|Dose limiting toxicity (DLT)|0|||
147217261|NCT02353143|530967862|FG003|Overall Study|Dose limiting toxicity (DLT)|1|||
147217262|NCT02353143|530967863|FG004|Overall Study|Dose limiting toxicity (DLT)|1|||
147217263|NCT02353143|530967864|FG005|Overall Study|Dose limiting toxicity (DLT)|1|||
147217264|NCT02353143|530967865|FG006|Overall Study|Dose limiting toxicity (DLT)|0|||
147217265|NCT02353143|530967866|FG007|Overall Study|Dose limiting toxicity (DLT)|0|||
147217266|NCT02353143|530967867|FG008|Overall Study|Dose limiting toxicity (DLT)|1|||
147217267|NCT01029405|530967868|FG000|Overall Study|Withdrawal by Subject|0|||
147217268|NCT01029405|530967869|FG001|Overall Study|Withdrawal by Subject|1|||
147217269|NCT01029405|530967870|FG002|Overall Study|Withdrawal by Subject|2|||
147217270|NCT01029405|530967871|FG003|Overall Study|Withdrawal by Subject|0|||
147217271|NCT01029405|530967868|FG000|Overall Study|Protocol Violation|0|||
147217272|NCT01029405|530967869|FG001|Overall Study|Protocol Violation|0|||
147217273|NCT01029405|530967870|FG002|Overall Study|Protocol Violation|0|||
147217274|NCT01029405|530967871|FG003|Overall Study|Protocol Violation|1|||
147217275|NCT01029405|530967868|FG000|Overall Study|Adverse Event|0|||
147217276|NCT01029405|530967869|FG001|Overall Study|Adverse Event|0|||
147217277|NCT01029405|530967870|FG002|Overall Study|Adverse Event|1|||
147217278|NCT01029405|530967871|FG003|Overall Study|Adverse Event|1|||
147217279|NCT01029405|530967868|FG000|Overall Study|Lost to Follow-up|2|||
147217280|NCT01029405|530967869|FG001|Overall Study|Lost to Follow-up|1|||
147217281|NCT01029405|530967870|FG002|Overall Study|Lost to Follow-up|1|||
147217282|NCT01029405|530967871|FG003|Overall Study|Lost to Follow-up|2|||
147217283|NCT01029405|530967868|FG000|Overall Study|Other|0|||
147217284|NCT01029405|530967869|FG001|Overall Study|Other|1|||
147217285|NCT01029405|530967870|FG002|Overall Study|Other|0|||
147217286|NCT01029405|530967871|FG003|Overall Study|Other|1|||
147217287|NCT01534182|530967872|FG000|Overall Study|Administrative problems|1|||
147217288|NCT01534182|530967873|FG001|Overall Study|Administrative problems|0|||
147217289|NCT01534182|530967872|FG000|Overall Study|Withdrawal by Subject|4|||
147217290|NCT01534182|530967873|FG001|Overall Study|Withdrawal by Subject|7|||
147217291|NCT01534182|530967872|FG000|Overall Study|Adverse Event|7|||
147217292|NCT01534182|530967873|FG001|Overall Study|Adverse Event|3|||
147217293|NCT02025556|530967881|FG000|Overall Study|Adverse Event|0|||
147217294|NCT02025556|530967882|FG001|Overall Study|Adverse Event|4|||
147217295|NCT02025556|530967883|FG002|Overall Study|Adverse Event|2|||
147217296|NCT02025556|530967881|FG000|Overall Study|Lack of Efficacy|2|||
147217297|NCT02025556|530967882|FG001|Overall Study|Lack of Efficacy|1|||
147217298|NCT02025556|530967883|FG002|Overall Study|Lack of Efficacy|0|||
147217299|NCT02025556|530967881|FG000|Overall Study|Protocol Violation|2|||
147217300|NCT02025556|530967882|FG001|Overall Study|Protocol Violation|1|||
147217301|NCT02025556|530967883|FG002|Overall Study|Protocol Violation|0|||
147217302|NCT02025556|530967881|FG000|Overall Study|Withdrawal by Subject|0|||
147217303|NCT02025556|530967882|FG001|Overall Study|Withdrawal by Subject|3|||
147217304|NCT02025556|530967883|FG002|Overall Study|Withdrawal by Subject|6|||
147217305|NCT02025556|530967881|FG000|Overall Study|Lost to Follow-up|2|||
147217306|NCT02025556|530967882|FG001|Overall Study|Lost to Follow-up|4|||
147217307|NCT02025556|530967883|FG002|Overall Study|Lost to Follow-up|0|||
147217308|NCT02025556|530967881|FG000|Overall Study|Reason not reported|0|||
147217309|NCT02025556|530967882|FG001|Overall Study|Reason not reported|0|||
147217310|NCT02025556|530967883|FG002|Overall Study|Reason not reported|1|||
147217311|NCT02486627|530967884|FG000|Overall Study|Death|1|||
147217312|NCT02486627|530967885|FG001|Overall Study|Death|0|||
147217313|NCT02486627|530967884|FG000|Overall Study|Other Unspecified|0|||
147217314|NCT02486627|530967885|FG001|Overall Study|Other Unspecified|2|||
147217315|NCT02486627|530967884|FG000|Overall Study|Consent Withdrawn by Participant|4|||
147217316|NCT02486627|530967885|FG001|Overall Study|Consent Withdrawn by Participant|3|||
147217317|NCT02486627|530967884|FG000|Overall Study|Significant Participant Noncompliance|1|||
147217318|NCT02486627|530967885|FG001|Overall Study|Significant Participant Noncompliance|1|||
147217319|NCT02486627|530967884|FG000|Overall Study|Lost to Follow-up|1|||
147217320|NCT02486627|530967885|FG001|Overall Study|Lost to Follow-up|3|||
147217321|NCT00247611|530967890|FG000|Baselined|Completed baseline, never placed on ARVs|8|||
147217322|NCT00247611|530967891|FG001|Baselined|Completed baseline, never placed on ARVs|5|||
147217323|NCT00247611|530967890|FG000|Baselined|Completed baseline only|9|||
147217324|NCT00247611|530967891|FG001|Baselined|Completed baseline only|8|||
147217325|NCT00796991|530967898|FG000|Overall Study|Adverse Event|0|||
147217326|NCT00796991|530967899|FG001|Overall Study|Adverse Event|0|||
147217327|NCT00796991|530967900|FG002|Overall Study|Adverse Event|1|||
147217328|NCT00796991|530967898|FG000|Overall Study|Death|2|||
147217329|NCT00796991|530967899|FG001|Overall Study|Death|0|||
147217330|NCT00796991|530967900|FG002|Overall Study|Death|0|||
147217331|NCT00796991|530967898|FG000|Overall Study|Disease Progression|10|||
147217332|NCT00796991|530967899|FG001|Overall Study|Disease Progression|9|||
147217333|NCT00796991|530967900|FG002|Overall Study|Disease Progression|7|||
147217334|NCT00796991|530967898|FG000|Overall Study|Study Drug Toxicity|3|||
147217335|NCT00796991|530967899|FG001|Overall Study|Study Drug Toxicity|3|||
147217336|NCT00796991|530967900|FG002|Overall Study|Study Drug Toxicity|5|||
147217337|NCT00796991|530967898|FG000|Overall Study|Withdrawal by Subject|0|||
147217338|NCT00796991|530967899|FG001|Overall Study|Withdrawal by Subject|0|||
147217339|NCT00796991|530967900|FG002|Overall Study|Withdrawal by Subject|1|||
147217340|NCT00171834|530967901|FG000|Overall Study|Adverse Event|2|||
147217341|NCT00171834|530967902|FG001|Overall Study|Adverse Event|1|||
147217342|NCT00171834|530967903|FG002|Overall Study|Adverse Event|3|||
147217343|NCT00171834|530967904|FG003|Overall Study|Adverse Event|2|||
147217344|NCT00171834|530967905|FG004|Overall Study|Adverse Event|2|||
147217345|NCT00171834|530967906|FG005|Overall Study|Adverse Event|15|||
147217346|NCT00171834|530967907|FG006|Overall Study|Adverse Event|1|||
147217347|NCT00171834|530967901|FG000|Overall Study|Withdrawal by Subject|0|||
147217348|NCT00171834|530967902|FG001|Overall Study|Withdrawal by Subject|2|||
147217349|NCT00171834|530967903|FG002|Overall Study|Withdrawal by Subject|0|||
147217350|NCT00171834|530967904|FG003|Overall Study|Withdrawal by Subject|1|||
147217351|NCT00171834|530967905|FG004|Overall Study|Withdrawal by Subject|1|||
147217352|NCT00171834|530967906|FG005|Overall Study|Withdrawal by Subject|1|||
147217353|NCT00171834|530967907|FG006|Overall Study|Withdrawal by Subject|0|||
147217354|NCT00171834|530967901|FG000|Overall Study|Death from study indication|0|||
147217355|NCT00171834|530967902|FG001|Overall Study|Death from study indication|1|||
147217356|NCT00171834|530967903|FG002|Overall Study|Death from study indication|0|||
147217357|NCT00171834|530967904|FG003|Overall Study|Death from study indication|0|||
147217358|NCT00171834|530967905|FG004|Overall Study|Death from study indication|1|||
147217359|NCT00171834|530967906|FG005|Overall Study|Death from study indication|0|||
147217360|NCT00171834|530967907|FG006|Overall Study|Death from study indication|0|||
147217361|NCT00171834|530967901|FG000|Overall Study|Disease Progression|4|||
147217362|NCT00171834|530967902|FG001|Overall Study|Disease Progression|8|||
147217363|NCT00171834|530967903|FG002|Overall Study|Disease Progression|8|||
147217364|NCT00171834|530967904|FG003|Overall Study|Disease Progression|9|||
147217365|NCT00171834|530967905|FG004|Overall Study|Disease Progression|2|||
147217366|NCT00171834|530967906|FG005|Overall Study|Disease Progression|18|||
147217367|NCT00171834|530967907|FG006|Overall Study|Disease Progression|3|||
147217368|NCT00171834|530967901|FG000|Overall Study|Treatment Duration Completed|0|||
147217369|NCT00171834|530967902|FG001|Overall Study|Treatment Duration Completed|0|||
147217370|NCT00171834|530967903|FG002|Overall Study|Treatment Duration Completed|1|||
147217371|NCT00171834|530967904|FG003|Overall Study|Treatment Duration Completed|0|||
147217372|NCT00171834|530967905|FG004|Overall Study|Treatment Duration Completed|2|||
147217373|NCT00171834|530967906|FG005|Overall Study|Treatment Duration Completed|1|||
147217374|NCT00171834|530967907|FG006|Overall Study|Treatment Duration Completed|0|||
147217375|NCT02431260|530967908|FG000|Overall Study|Subject Decision|0|||
147217376|NCT02431260|530967909|FG001|Overall Study|Subject Decision|1|||
147217377|NCT02431260|530967910|FG002|Overall Study|Subject Decision|1|||
147217378|NCT02431260|530967911|FG003|Overall Study|Subject Decision|0|||
147217379|NCT02431260|530967912|FG004|Overall Study|Subject Decision|0|||
147217380|NCT02431260|530967913|FG005|Overall Study|Subject Decision|0|||
147217381|NCT02431260|530967914|FG006|Overall Study|Subject Decision|0|||
147217382|NCT02431260|530967915|FG007|Overall Study|Subject Decision|0|||
147217383|NCT02431260|530967916|FG008|Overall Study|Subject Decision|1|||
147217384|NCT02431260|530967917|FG009|Overall Study|Subject Decision|1|||
147217385|NCT02431260|530967918|FG010|Overall Study|Subject Decision|0|||
147217386|NCT02431260|530967919|FG011|Overall Study|Subject Decision|1|||
147217387|NCT02431260|530967920|FG012|Overall Study|Subject Decision|0|||
147217388|NCT02431260|530967921|FG013|Overall Study|Subject Decision|0|||
147217389|NCT02431260|530967908|FG000|Overall Study|Death|4|||
147217390|NCT02431260|530967909|FG001|Overall Study|Death|4|||
147217391|NCT02431260|530967910|FG002|Overall Study|Death|3|||
147217392|NCT02431260|530967911|FG003|Overall Study|Death|4|||
147217393|NCT02431260|530967912|FG004|Overall Study|Death|2|||
147217394|NCT02431260|530967913|FG005|Overall Study|Death|2|||
147217395|NCT02431260|530967914|FG006|Overall Study|Death|3|||
147217396|NCT02431260|530967915|FG007|Overall Study|Death|1|||
147217397|NCT02431260|530967916|FG008|Overall Study|Death|6|||
147217398|NCT02431260|530967917|FG009|Overall Study|Death|6|||
147217399|NCT02431260|530967918|FG010|Overall Study|Death|3|||
147217400|NCT02431260|530967919|FG011|Overall Study|Death|2|||
147217401|NCT02431260|530967920|FG012|Overall Study|Death|5|||
147217402|NCT02431260|530967921|FG013|Overall Study|Death|1|||
147217403|NCT02431260|530967908|FG000|Overall Study|Lost to Follow-up|0|||
147217404|NCT02431260|530967909|FG001|Overall Study|Lost to Follow-up|0|||
147217405|NCT02431260|530967910|FG002|Overall Study|Lost to Follow-up|0|||
147217406|NCT02431260|530967911|FG003|Overall Study|Lost to Follow-up|0|||
147306820|NCT01852058|531290777|FG004|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|1|||
147306821|NCT01852058|531290778|FG005|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
147306822|NCT01852058|531290779|FG006|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
147306823|NCT01852058|531290780|FG007|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
147306824|NCT01852058|531290781|FG008|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
147306825|NCT01852058|531290782|FG009|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
147306826|NCT01852058|531290783|FG010|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
147217407|NCT02431260|530967912|FG004|Overall Study|Lost to Follow-up|0|||
147217408|NCT02431260|530967913|FG005|Overall Study|Lost to Follow-up|1|||
147217409|NCT02431260|530967914|FG006|Overall Study|Lost to Follow-up|0|||
147217410|NCT02431260|530967915|FG007|Overall Study|Lost to Follow-up|0|||
147217411|NCT02431260|530967916|FG008|Overall Study|Lost to Follow-up|0|||
147306827|NCT01852058|531290784|FG011|Treatment Cycle2:Retreatment 1,Study 121|Adverse Event|0|||
147306828|NCT01852058|531290773|FG000|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
147306829|NCT01852058|531290774|FG001|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
147306830|NCT01852058|531290775|FG002|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
147217412|NCT02431260|530967917|FG009|Overall Study|Lost to Follow-up|0|||
147217413|NCT02431260|530967918|FG010|Overall Study|Lost to Follow-up|0|||
147217414|NCT02431260|530967919|FG011|Overall Study|Lost to Follow-up|0|||
147217415|NCT02431260|530967920|FG012|Overall Study|Lost to Follow-up|0|||
147217416|NCT02431260|530967921|FG013|Overall Study|Lost to Follow-up|0|||
147217417|NCT02431260|530967908|FG000|Overall Study|Study Terminated by the Sponsor|0|||
147217418|NCT02431260|530967909|FG001|Overall Study|Study Terminated by the Sponsor|0|||
147217419|NCT02431260|530967910|FG002|Overall Study|Study Terminated by the Sponsor|2|||
147217420|NCT02431260|530967911|FG003|Overall Study|Study Terminated by the Sponsor|1|||
147217421|NCT02431260|530967912|FG004|Overall Study|Study Terminated by the Sponsor|1|||
147217422|NCT02431260|530967913|FG005|Overall Study|Study Terminated by the Sponsor|0|||
147217423|NCT02431260|530967914|FG006|Overall Study|Study Terminated by the Sponsor|1|||
147217424|NCT02431260|530967915|FG007|Overall Study|Study Terminated by the Sponsor|2|||
147217425|NCT02431260|530967916|FG008|Overall Study|Study Terminated by the Sponsor|1|||
147217426|NCT02431260|530967917|FG009|Overall Study|Study Terminated by the Sponsor|1|||
147217427|NCT02431260|530967918|FG010|Overall Study|Study Terminated by the Sponsor|1|||
147217428|NCT02431260|530967919|FG011|Overall Study|Study Terminated by the Sponsor|0|||
147217429|NCT02431260|530967920|FG012|Overall Study|Study Terminated by the Sponsor|4|||
147217430|NCT02431260|530967921|FG013|Overall Study|Study Terminated by the Sponsor|0|||
147217431|NCT02431260|530967908|FG000|Overall Study|Physician Decision|0|||
147217432|NCT02431260|530967909|FG001|Overall Study|Physician Decision|0|||
147217433|NCT02431260|530967910|FG002|Overall Study|Physician Decision|0|||
147217434|NCT02431260|530967911|FG003|Overall Study|Physician Decision|0|||
147217435|NCT02431260|530967912|FG004|Overall Study|Physician Decision|0|||
147217436|NCT02431260|530967913|FG005|Overall Study|Physician Decision|1|||
147217437|NCT02431260|530967914|FG006|Overall Study|Physician Decision|0|||
147217438|NCT02431260|530967915|FG007|Overall Study|Physician Decision|0|||
147217439|NCT02431260|530967916|FG008|Overall Study|Physician Decision|0|||
147217440|NCT02431260|530967917|FG009|Overall Study|Physician Decision|0|||
147217441|NCT02431260|530967918|FG010|Overall Study|Physician Decision|0|||
147217442|NCT02431260|530967919|FG011|Overall Study|Physician Decision|0|||
147217443|NCT02431260|530967920|FG012|Overall Study|Physician Decision|0|||
147217444|NCT02431260|530967921|FG013|Overall Study|Physician Decision|0|||
147217445|NCT02431260|530967908|FG000|Overall Study|Other Unspecified|0|||
147217446|NCT02431260|530967909|FG001|Overall Study|Other Unspecified|0|||
147217447|NCT02431260|530967910|FG002|Overall Study|Other Unspecified|0|||
147217448|NCT02431260|530967911|FG003|Overall Study|Other Unspecified|0|||
147217449|NCT02431260|530967912|FG004|Overall Study|Other Unspecified|0|||
147217450|NCT02431260|530967913|FG005|Overall Study|Other Unspecified|0|||
147217451|NCT02431260|530967914|FG006|Overall Study|Other Unspecified|0|||
147217452|NCT02431260|530967915|FG007|Overall Study|Other Unspecified|0|||
147217453|NCT02431260|530967916|FG008|Overall Study|Other Unspecified|0|||
147217454|NCT02431260|530967917|FG009|Overall Study|Other Unspecified|0|||
147217455|NCT02431260|530967918|FG010|Overall Study|Other Unspecified|0|||
147217456|NCT02431260|530967919|FG011|Overall Study|Other Unspecified|1|||
147217457|NCT02431260|530967920|FG012|Overall Study|Other Unspecified|1|||
147217458|NCT02431260|530967921|FG013|Overall Study|Other Unspecified|0|||
147217459|NCT00439738|530967923|FG000|Overall Study|Withdrawal by Subject|16|||
147217460|NCT00439738|530967924|FG001|Overall Study|Withdrawal by Subject|13|||
147217461|NCT00439738|530967923|FG000|Overall Study|Adverse Event|6|||
147217462|NCT00439738|530967924|FG001|Overall Study|Adverse Event|4|||
147217463|NCT00439738|530967923|FG000|Overall Study|Lost to Follow-up|5|||
147217464|NCT00439738|530967924|FG001|Overall Study|Lost to Follow-up|6|||
147217465|NCT00439738|530967923|FG000|Overall Study|Protocol Violation|6|||
147217466|NCT00439738|530967924|FG001|Overall Study|Protocol Violation|3|||
147217467|NCT00439738|530967923|FG000|Overall Study|Lack of Efficacy|2|||
147217468|NCT00439738|530967924|FG001|Overall Study|Lack of Efficacy|2|||
147217469|NCT00439738|530967923|FG000|Overall Study|Abnormal Lab Values|1|||
147217470|NCT00439738|530967924|FG001|Overall Study|Abnormal Lab Values|0|||
147217471|NCT00392379|530967925|FG000|Overall Study|Withdrawal by Subject|17|||
147217472|NCT00392379|530967926|FG001|Overall Study|Withdrawal by Subject|28|||
147217473|NCT00392379|530967925|FG000|Overall Study|Lost to Follow-up|4|||
147217474|NCT00392379|530967926|FG001|Overall Study|Lost to Follow-up|9|||
147217475|NCT00392379|530967925|FG000|Overall Study|Adverse Event|1|||
147217476|NCT00392379|530967926|FG001|Overall Study|Adverse Event|1|||
147217477|NCT01978938|530967927|FG000|Overall Study|Lost to Follow-up|12|||
147217478|NCT01978938|530967928|FG001|Overall Study|Lost to Follow-up|6|||
147217479|NCT01978938|530967927|FG000|Overall Study|Withdrawal by Subject|8|||
147217480|NCT01978938|530967928|FG001|Overall Study|Withdrawal by Subject|4|||
147217481|NCT01978938|530967927|FG000|Overall Study|Adverse Event, non-fatal|2|||
147217482|NCT01978938|530967928|FG001|Overall Study|Adverse Event, non-fatal|1|||
147217483|NCT01978938|530967927|FG000|Overall Study|Participant noncompliance|1|||
147217484|NCT01978938|530967928|FG001|Overall Study|Participant noncompliance|1|||
147217485|NCT01978938|530967927|FG000|Overall Study|Did not meet inclusion criteria|0|||
147217486|NCT01978938|530967928|FG001|Overall Study|Did not meet inclusion criteria|1|||
147217487|NCT01978938|530967927|FG000|Overall Study|Previously scheduled procedure|0|||
147217488|NCT01978938|530967928|FG001|Overall Study|Previously scheduled procedure|1|||
147217489|NCT01806662|530967932|FG000|First Intervention (Weeks 0-16)|Withdrawal by Subject|4|||
147217490|NCT01806662|530967933|FG001|First Intervention (Weeks 0-16)|Withdrawal by Subject|0|||
147217491|NCT01806662|530967932|FG000|First Intervention (Weeks 0-16)|Adverse Event|0|||
147217492|NCT01806662|530967933|FG001|First Intervention (Weeks 0-16)|Adverse Event|1|||
147217493|NCT01806662|530967932|FG000|Second Intervention (Weeks 16-32)|Lack of Efficacy|2|||
147217494|NCT01806662|530967933|FG001|Second Intervention (Weeks 16-32)|Lack of Efficacy|3|||
147217495|NCT01806662|530967932|FG000|Second Intervention (Weeks 16-32)|Lost to Follow-up|0|||
147217496|NCT01806662|530967933|FG001|Second Intervention (Weeks 16-32)|Lost to Follow-up|1|||
147217497|NCT00043550|530967934|FG000|Overall Study|Withdrawal by Subject|22|||
147217498|NCT00043550|530967935|FG001|Overall Study|Withdrawal by Subject|12|||
147217499|NCT00043550|530967936|FG002|Overall Study|Withdrawal by Subject|20|||
147217500|NCT00710762|530967943|FG000|Overall Study|Progressive disease|27|||
147217501|NCT00710762|530967944|FG001|Overall Study|Progressive disease|30|||
147217502|NCT00710762|530967943|FG000|Overall Study|Adverse Event other disease worsening|2|||
147217503|NCT00710762|530967944|FG001|Overall Study|Adverse Event other disease worsening|1|||
147217504|NCT00710762|530967943|FG000|Overall Study|Other Adverse Event|7|||
147217505|NCT00710762|530967944|FG001|Overall Study|Other Adverse Event|7|||
147217506|NCT00710762|530967943|FG000|Overall Study|Lost to Follow-up|1|||
147217507|NCT00710762|530967944|FG001|Overall Study|Lost to Follow-up|0|||
147217508|NCT00710762|530967943|FG000|Overall Study|Reason other than listed above|2|||
147217509|NCT00710762|530967944|FG001|Overall Study|Reason other than listed above|2|||
147217510|NCT01375075|530967945|FG000|Overall Study|Adverse Event|0|||
147217511|NCT01375075|530967946|FG001|Overall Study|Adverse Event|0|||
147217512|NCT01375075|530967947|FG002|Overall Study|Adverse Event|3|||
147217513|NCT01375075|530967948|FG003|Overall Study|Adverse Event|1|||
147217514|NCT01375075|530967949|FG004|Overall Study|Adverse Event|0|||
147217515|NCT01375075|530967950|FG005|Overall Study|Adverse Event|1|||
147217516|NCT01375075|530967945|FG000|Overall Study|Entry Criterion Not Met|1|||
147217517|NCT01375075|530967946|FG001|Overall Study|Entry Criterion Not Met|0|||
147217518|NCT01375075|530967947|FG002|Overall Study|Entry Criterion Not Met|0|||
147217519|NCT01375075|530967948|FG003|Overall Study|Entry Criterion Not Met|0|||
147217520|NCT01375075|530967949|FG004|Overall Study|Entry Criterion Not Met|0|||
147217521|NCT01375075|530967950|FG005|Overall Study|Entry Criterion Not Met|1|||
147217522|NCT01375075|530967945|FG000|Overall Study|Withdrawal by Subject|0|||
147217523|NCT01375075|530967946|FG001|Overall Study|Withdrawal by Subject|1|||
147217524|NCT01375075|530967947|FG002|Overall Study|Withdrawal by Subject|0|||
147217525|NCT01375075|530967948|FG003|Overall Study|Withdrawal by Subject|0|||
147217526|NCT01375075|530967949|FG004|Overall Study|Withdrawal by Subject|0|||
147217527|NCT01375075|530967950|FG005|Overall Study|Withdrawal by Subject|1|||
147217528|NCT00821509|530967951|FG000|Overall Study|Withdrawal by Subject|12|||
147217529|NCT00821509|530967952|FG001|Overall Study|Withdrawal by Subject|11|||
147217530|NCT00821509|530967953|FG002|Overall Study|Withdrawal by Subject|34|||
147217531|NCT03104816|530967955|FG000|Overall Study|Lack of Efficacy|0|||
147217532|NCT03104816|530967956|FG001|Overall Study|Lack of Efficacy|2|||
147217533|NCT03104816|530967957|FG002|Overall Study|Lack of Efficacy|0|||
147217534|NCT03104816|530967955|FG000|Overall Study|Protocol Violation|2|||
147217535|NCT03104816|530967956|FG001|Overall Study|Protocol Violation|0|||
147217536|NCT03104816|530967957|FG002|Overall Study|Protocol Violation|2|||
147217537|NCT01894568|530967958|FG000|Overall Study|Adverse Event|2|||
147217538|NCT01894568|530967959|FG001|Overall Study|Adverse Event|3|||
147217539|NCT01894568|530967958|FG000|Overall Study|Protocol required discontinuation|2|||
147217540|NCT01894568|530967959|FG001|Overall Study|Protocol required discontinuation|1|||
147217541|NCT01894568|530967958|FG000|Overall Study|Withdrawal by Subject|5|||
147217542|NCT01894568|530967959|FG001|Overall Study|Withdrawal by Subject|5|||
147217543|NCT01894568|530967958|FG000|Overall Study|Physician Decision|1|||
147217544|NCT01894568|530967959|FG001|Overall Study|Physician Decision|0|||
147217545|NCT01894568|530967958|FG000|Overall Study|Lost to Follow-up|0|||
147217546|NCT01894568|530967959|FG001|Overall Study|Lost to Follow-up|1|||
147217547|NCT00807573|530967960|FG000|Overall Study|Withdrawal by Subject|1|||
147217548|NCT00807573|530967960|FG000|Overall Study|Adverse Event|1|||
147217549|NCT01426789|530967961|FG000|Part 1|Protocol deviation|0|||
147217550|NCT01426789|530967962|FG001|Part 1|Protocol deviation|1|||
147217551|NCT01426789|530967963|FG002|Part 1|Protocol deviation|0|||
147217552|NCT01426789|530967964|FG003|Part 1|Protocol deviation|0|||
147217553|NCT01426789|530967965|FG004|Part 1|Protocol deviation|0|||
147217554|NCT01426789|530967966|FG005|Part 1|Protocol deviation|0|||
147217555|NCT01426789|530967961|FG000|Part 1|Lost to Follow-up|1|||
147217556|NCT01426789|530967962|FG001|Part 1|Lost to Follow-up|2|||
147217557|NCT01426789|530967963|FG002|Part 1|Lost to Follow-up|0|||
147217558|NCT01426789|530967964|FG003|Part 1|Lost to Follow-up|0|||
147217559|NCT01426789|530967965|FG004|Part 1|Lost to Follow-up|0|||
147217560|NCT01426789|530967966|FG005|Part 1|Lost to Follow-up|0|||
147217561|NCT01426789|530967961|FG000|Part 1|Lack of Efficacy|2|||
147217562|NCT01426789|530967962|FG001|Part 1|Lack of Efficacy|1|||
147217563|NCT01426789|530967963|FG002|Part 1|Lack of Efficacy|0|||
147217564|NCT01426789|530967964|FG003|Part 1|Lack of Efficacy|0|||
147217565|NCT01426789|530967965|FG004|Part 1|Lack of Efficacy|0|||
147217566|NCT01426789|530967966|FG005|Part 1|Lack of Efficacy|0|||
147217567|NCT01426789|530967961|FG000|Part 1|Adverse Event|3|||
147217568|NCT01426789|530967962|FG001|Part 1|Adverse Event|0|||
147217569|NCT01426789|530967963|FG002|Part 1|Adverse Event|0|||
147217570|NCT01426789|530967964|FG003|Part 1|Adverse Event|0|||
147217571|NCT01426789|530967965|FG004|Part 1|Adverse Event|0|||
147217572|NCT01426789|530967966|FG005|Part 1|Adverse Event|0|||
147217573|NCT01426789|530967961|FG000|Part 2|Protocol deviation|0|||
147217574|NCT01426789|530967962|FG001|Part 2|Protocol deviation|0|||
147217575|NCT01426789|530967963|FG002|Part 2|Protocol deviation|1|||
147217576|NCT01426789|530967964|FG003|Part 2|Protocol deviation|0|||
147217577|NCT01426789|530967965|FG004|Part 2|Protocol deviation|0|||
147217578|NCT01426789|530967966|FG005|Part 2|Protocol deviation|0|||
147217579|NCT01426789|530967961|FG000|Part 2|Death|0|||
147217580|NCT01426789|530967962|FG001|Part 2|Death|0|||
147217581|NCT01426789|530967963|FG002|Part 2|Death|1|||
147217582|NCT01426789|530967964|FG003|Part 2|Death|0|||
147217583|NCT01426789|530967965|FG004|Part 2|Death|1|||
147217584|NCT01426789|530967966|FG005|Part 2|Death|0|||
147217585|NCT01426789|530967961|FG000|Part 2|Administrative problems|0|||
147217586|NCT01426789|530967962|FG001|Part 2|Administrative problems|0|||
147217587|NCT01426789|530967963|FG002|Part 2|Administrative problems|2|||
147217588|NCT01426789|530967964|FG003|Part 2|Administrative problems|0|||
147217589|NCT01426789|530967965|FG004|Part 2|Administrative problems|1|||
147217590|NCT01426789|530967966|FG005|Part 2|Administrative problems|0|||
147217591|NCT01426789|530967961|FG000|Part 2|Lost to Follow-up|0|||
147217592|NCT01426789|530967962|FG001|Part 2|Lost to Follow-up|0|||
147217593|NCT01426789|530967963|FG002|Part 2|Lost to Follow-up|4|||
147217594|NCT01426789|530967964|FG003|Part 2|Lost to Follow-up|0|||
147217595|NCT01426789|530967965|FG004|Part 2|Lost to Follow-up|1|||
147217596|NCT01426789|530967966|FG005|Part 2|Lost to Follow-up|0|||
147217597|NCT01426789|530967961|FG000|Part 2|Withdrawal by Subject|0|||
147217598|NCT01426789|530967962|FG001|Part 2|Withdrawal by Subject|0|||
147217599|NCT01426789|530967963|FG002|Part 2|Withdrawal by Subject|0|||
147217600|NCT01426789|530967964|FG003|Part 2|Withdrawal by Subject|1|||
147217601|NCT01426789|530967965|FG004|Part 2|Withdrawal by Subject|2|||
147552104|NCT02497391|532178489|FG002|Period 2 (14 Days)|Withdrawal by Subject|1|||
147217602|NCT01426789|530967966|FG005|Part 2|Withdrawal by Subject|0|||
147217603|NCT01426789|530967961|FG000|Part 2|Lack of Efficacy|0|||
147217604|NCT01426789|530967962|FG001|Part 2|Lack of Efficacy|0|||
147217605|NCT01426789|530967963|FG002|Part 2|Lack of Efficacy|5|||
147217606|NCT01426789|530967964|FG003|Part 2|Lack of Efficacy|0|||
147217607|NCT01426789|530967965|FG004|Part 2|Lack of Efficacy|2|||
147217608|NCT01426789|530967966|FG005|Part 2|Lack of Efficacy|0|||
147217609|NCT01426789|530967961|FG000|Part 2|Adverse Event|0|||
147217610|NCT01426789|530967962|FG001|Part 2|Adverse Event|0|||
147217611|NCT01426789|530967963|FG002|Part 2|Adverse Event|2|||
147217612|NCT01426789|530967964|FG003|Part 2|Adverse Event|0|||
147217613|NCT01426789|530967965|FG004|Part 2|Adverse Event|1|||
147217614|NCT01426789|530967966|FG005|Part 2|Adverse Event|0|||
147217615|NCT04054947|530967967|FG000|Overall Study|Withdrawal by Subject|1|||
147217616|NCT04054947|530967968|FG001|Overall Study|Withdrawal by Subject|0|||
147217617|NCT04054947|530967967|FG000|Overall Study|Lost to Follow-up|2|||
147217618|NCT04054947|530967968|FG001|Overall Study|Lost to Follow-up|5|||
147217619|NCT00311584|530967969|FG000|Overall Study|Death|1|||
147217620|NCT00311584|530967970|FG001|Overall Study|Death|0|||
147217621|NCT00311584|530967969|FG000|Overall Study|Lack of Efficacy|12|||
147217622|NCT00311584|530967970|FG001|Overall Study|Lack of Efficacy|15|||
147217623|NCT00311584|530967969|FG000|Overall Study|Physician Decision|4|||
147217624|NCT00311584|530967970|FG001|Overall Study|Physician Decision|5|||
147217625|NCT00311584|530967969|FG000|Overall Study|Withdrawal by Subject|1|||
147217626|NCT00311584|530967970|FG001|Overall Study|Withdrawal by Subject|1|||
147217627|NCT00311584|530967969|FG000|Overall Study|ineligible|2|||
147217628|NCT00311584|530967970|FG001|Overall Study|ineligible|2|||
147217629|NCT03720652|530967971|FG000|Overall Study|Withdrawal by Subject|2|||
147217630|NCT03720652|530967972|FG001|Overall Study|Withdrawal by Subject|7|||
147217631|NCT03720652|530967971|FG000|Overall Study|Lost to Follow-up|0|||
147217632|NCT03720652|530967972|FG001|Overall Study|Lost to Follow-up|4|||
147217633|NCT03073733|530967979|FG000|Overall Study|Lost to Follow-up|1|||
147217634|NCT03073733|530967980|FG001|Overall Study|Lost to Follow-up|0|||
147217635|NCT03073733|530967981|FG002|Overall Study|Lost to Follow-up|0|||
147217636|NCT03073733|530967979|FG000|Overall Study|Physician Decision|0|||
147217637|NCT03073733|530967980|FG001|Overall Study|Physician Decision|1|||
147217638|NCT03073733|530967981|FG002|Overall Study|Physician Decision|0|||
147217639|NCT03073733|530967979|FG000|Overall Study|Withdrawal by Subject|0|||
147217640|NCT03073733|530967980|FG001|Overall Study|Withdrawal by Subject|0|||
147217641|NCT03073733|530967981|FG002|Overall Study|Withdrawal by Subject|1|||
147217642|NCT00835731|530967982|FG000|Overall Study|Withdrawal by Subject|1|||
147217643|NCT00835731|530967983|FG001|Overall Study|Withdrawal by Subject|0|||
147217644|NCT00835731|530967982|FG000|Overall Study|Physician Decision|1|||
147217645|NCT00835731|530967983|FG001|Overall Study|Physician Decision|1|||
147217646|NCT01227629|530967984|FG000|Overall Study|Adverse Event|2|||
147217647|NCT01227629|530967985|FG001|Overall Study|Adverse Event|2|||
147217648|NCT01227629|530967986|FG002|Overall Study|Adverse Event|1|||
147217649|NCT01227629|530967987|FG003|Overall Study|Adverse Event|6|||
147217650|NCT01227629|530967988|FG004|Overall Study|Adverse Event|1|||
147217651|NCT01227629|530967989|FG005|Overall Study|Adverse Event|1|||
147217652|NCT01227629|530967990|FG006|Overall Study|Adverse Event|6|||
147217653|NCT01227629|530967991|FG007|Overall Study|Adverse Event|6|||
147217654|NCT01227629|530967992|FG008|Overall Study|Adverse Event|4|||
147217655|NCT01227629|530967993|FG009|Overall Study|Adverse Event|0|||
147217656|NCT01227629|530967984|FG000|Overall Study|Protocol Violation|0|||
147217657|NCT01227629|530967985|FG001|Overall Study|Protocol Violation|0|||
147217658|NCT01227629|530967986|FG002|Overall Study|Protocol Violation|0|||
147217659|NCT01227629|530967987|FG003|Overall Study|Protocol Violation|1|||
147217660|NCT01227629|530967988|FG004|Overall Study|Protocol Violation|0|||
147217661|NCT01227629|530967989|FG005|Overall Study|Protocol Violation|0|||
147217662|NCT01227629|530967990|FG006|Overall Study|Protocol Violation|0|||
147217663|NCT01227629|530967991|FG007|Overall Study|Protocol Violation|0|||
147217664|NCT01227629|530967992|FG008|Overall Study|Protocol Violation|0|||
147217665|NCT01227629|530967993|FG009|Overall Study|Protocol Violation|0|||
147217666|NCT01227629|530967984|FG000|Overall Study|Lost to Follow-up|0|||
147217667|NCT01227629|530967985|FG001|Overall Study|Lost to Follow-up|0|||
147217668|NCT01227629|530967986|FG002|Overall Study|Lost to Follow-up|0|||
147217669|NCT01227629|530967987|FG003|Overall Study|Lost to Follow-up|0|||
147217670|NCT01227629|530967988|FG004|Overall Study|Lost to Follow-up|1|||
147217671|NCT01227629|530967989|FG005|Overall Study|Lost to Follow-up|0|||
147217672|NCT01227629|530967990|FG006|Overall Study|Lost to Follow-up|0|||
147217673|NCT01227629|530967991|FG007|Overall Study|Lost to Follow-up|0|||
147217674|NCT01227629|530967992|FG008|Overall Study|Lost to Follow-up|0|||
147217675|NCT01227629|530967993|FG009|Overall Study|Lost to Follow-up|0|||
147217676|NCT01227629|530967984|FG000|Overall Study|Withdrawal by Subject|0|||
147217677|NCT01227629|530967985|FG001|Overall Study|Withdrawal by Subject|0|||
147217678|NCT01227629|530967986|FG002|Overall Study|Withdrawal by Subject|0|||
147217679|NCT01227629|530967987|FG003|Overall Study|Withdrawal by Subject|0|||
147217680|NCT01227629|530967988|FG004|Overall Study|Withdrawal by Subject|0|||
147217681|NCT01227629|530967989|FG005|Overall Study|Withdrawal by Subject|0|||
147217682|NCT01227629|530967990|FG006|Overall Study|Withdrawal by Subject|2|||
147217683|NCT01227629|530967991|FG007|Overall Study|Withdrawal by Subject|0|||
147443047|NCT00847145|531787147|FG005|Overall Study|Inappropriate enrollment|0|||
147217684|NCT01227629|530967992|FG008|Overall Study|Withdrawal by Subject|0|||
147217685|NCT01227629|530967993|FG009|Overall Study|Withdrawal by Subject|1|||
147217686|NCT01227629|530967984|FG000|Overall Study|Other|0|||
147217687|NCT01227629|530967985|FG001|Overall Study|Other|0|||
147217688|NCT01227629|530967986|FG002|Overall Study|Other|0|||
147217689|NCT01227629|530967987|FG003|Overall Study|Other|1|||
147217690|NCT01227629|530967988|FG004|Overall Study|Other|0|||
147217691|NCT01227629|530967989|FG005|Overall Study|Other|0|||
147217692|NCT01227629|530967990|FG006|Overall Study|Other|0|||
147217693|NCT01227629|530967991|FG007|Overall Study|Other|0|||
147217694|NCT01227629|530967992|FG008|Overall Study|Other|2|||
147217695|NCT01227629|530967993|FG009|Overall Study|Other|1|||
147217696|NCT03976648|530967995|FG000|Overall Study|Adverse Event|0|||
147217697|NCT03976648|530967996|FG001|Overall Study|Adverse Event|2|||
147217698|NCT03976648|530967995|FG000|Overall Study|Study terminated by sponsor|21|||
147217699|NCT03976648|530967996|FG001|Overall Study|Study terminated by sponsor|8|||
147217700|NCT00881868|530967997|FG000|Overall Study|Adverse Event|0|||
147217701|NCT00881868|530967998|FG001|Overall Study|Adverse Event|1|||
147217702|NCT00881868|530967997|FG000|Overall Study|Lost to Follow-up|2|||
147217703|NCT00881868|530967998|FG001|Overall Study|Lost to Follow-up|1|||
147217704|NCT00881868|530967997|FG000|Overall Study|Physician Decision|4|||
147217705|NCT00881868|530967998|FG001|Overall Study|Physician Decision|0|||
147217706|NCT00881868|530967997|FG000|Overall Study|Protocol Violation|2|||
147217707|NCT00881868|530967998|FG001|Overall Study|Protocol Violation|0|||
147217708|NCT01155167|530967999|FG000|Overall Study|Insufficient ultrasound data|2|||
147217709|NCT01155167|530968000|FG001|Overall Study|Insufficient ultrasound data|0|||
147217710|NCT01155167|530967999|FG000|Overall Study|Access site changed to femoral artery|1|||
147217711|NCT01155167|530968000|FG001|Overall Study|Access site changed to femoral artery|0|||
147306831|NCT01852058|531290776|FG003|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
147306832|NCT01852058|531290777|FG004|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|1|||
147306833|NCT01852058|531290778|FG005|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|1|||
147306834|NCT01852058|531290779|FG006|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
147306835|NCT01852058|531290780|FG007|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
147443048|NCT00847145|531787148|FG006|Overall Study|Inappropriate enrollment|0|||
147217712|NCT00960570|530968001|FG000|21 Day Washout Period|Adverse Event|1|||
147217713|NCT00960570|530968001|FG000|21 Day Washout Period|Withdrawal by Subject|1|||
147217714|NCT00960570|530968001|FG000|1 Day Period Between Dosing|Adverse Event|2|||
147443049|NCT00847145|531787149|FG007|Overall Study|Inappropriate enrollment|0|||
147306836|NCT01852058|531290781|FG008|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
147306837|NCT01852058|531290782|FG009|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
147306838|NCT01852058|531290783|FG010|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
147306839|NCT01852058|531290784|FG011|Treatment Cycle2:Retreatment 1,Study 121|Lack of Efficacy|0|||
147306840|NCT01852058|531290773|FG000|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
147306841|NCT01852058|531290774|FG001|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
147306842|NCT01852058|531290775|FG002|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
147306843|NCT01852058|531290776|FG003|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
147306844|NCT01852058|531290777|FG004|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|1|||
147306845|NCT01852058|531290778|FG005|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
147306846|NCT01852058|531290779|FG006|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
147306847|NCT01852058|531290780|FG007|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
147306848|NCT01852058|531290781|FG008|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
147306849|NCT01852058|531290782|FG009|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
147306850|NCT01852058|531290783|FG010|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
147306851|NCT01852058|531290784|FG011|Treatment Cycle2:Retreatment 1,Study 121|Lost to Follow-up|0|||
147306852|NCT01852058|531290773|FG000|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
147306853|NCT01852058|531290774|FG001|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
147306854|NCT01852058|531290775|FG002|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
147306855|NCT01852058|531290776|FG003|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
147217715|NCT00960570|530968001|FG000|1 Day Period Between Dosing|Withdrawal by Subject|1|||
147217716|NCT01451437|530968002|FG000|Overall Study|Adverse Event|0|||
147217717|NCT01451437|530968003|FG001|Overall Study|Adverse Event|0|||
147217718|NCT01451437|530968004|FG002|Overall Study|Adverse Event|0|||
147217719|NCT01451437|530968005|FG003|Overall Study|Adverse Event|0|||
147217720|NCT01451437|530968006|FG004|Overall Study|Adverse Event|0|||
147217721|NCT01451437|530968007|FG005|Overall Study|Adverse Event|1|||
147217722|NCT01451437|530968008|FG006|Overall Study|Adverse Event|1|||
147217723|NCT01451437|530968009|FG007|Overall Study|Adverse Event|2|||
147217724|NCT01451437|530968010|FG008|Overall Study|Adverse Event|1|||
147217725|NCT01451437|530968002|FG000|Overall Study|Physician Decision|1|||
147217726|NCT01451437|530968003|FG001|Overall Study|Physician Decision|1|||
147217727|NCT01451437|530968004|FG002|Overall Study|Physician Decision|2|||
147217728|NCT01451437|530968005|FG003|Overall Study|Physician Decision|0|||
147217729|NCT01451437|530968006|FG004|Overall Study|Physician Decision|0|||
147217730|NCT01451437|530968007|FG005|Overall Study|Physician Decision|0|||
147217731|NCT01451437|530968008|FG006|Overall Study|Physician Decision|0|||
147217732|NCT01451437|530968009|FG007|Overall Study|Physician Decision|0|||
147217733|NCT01451437|530968010|FG008|Overall Study|Physician Decision|0|||
147217734|NCT01451437|530968002|FG000|Overall Study|Disease Progression|0|||
147217735|NCT01451437|530968003|FG001|Overall Study|Disease Progression|0|||
147217736|NCT01451437|530968004|FG002|Overall Study|Disease Progression|1|||
147217737|NCT01451437|530968005|FG003|Overall Study|Disease Progression|1|||
147217738|NCT01451437|530968006|FG004|Overall Study|Disease Progression|3|||
147217739|NCT01451437|530968007|FG005|Overall Study|Disease Progression|2|||
147217740|NCT01451437|530968008|FG006|Overall Study|Disease Progression|3|||
147217741|NCT01451437|530968009|FG007|Overall Study|Disease Progression|1|||
147217742|NCT01451437|530968010|FG008|Overall Study|Disease Progression|3|||
147217743|NCT01451437|530968002|FG000|Overall Study|Protocol Violation|0|||
147217744|NCT01451437|530968003|FG001|Overall Study|Protocol Violation|0|||
147217745|NCT01451437|530968004|FG002|Overall Study|Protocol Violation|0|||
147217746|NCT01451437|530968005|FG003|Overall Study|Protocol Violation|0|||
147217747|NCT01451437|530968006|FG004|Overall Study|Protocol Violation|0|||
147217748|NCT01451437|530968007|FG005|Overall Study|Protocol Violation|0|||
147217749|NCT01451437|530968008|FG006|Overall Study|Protocol Violation|1|||
147217750|NCT01451437|530968009|FG007|Overall Study|Protocol Violation|0|||
147217751|NCT01451437|530968010|FG008|Overall Study|Protocol Violation|0|||
147217752|NCT01451437|530968002|FG000|Overall Study|Withdrawal by Subject|0|||
147217753|NCT01451437|530968003|FG001|Overall Study|Withdrawal by Subject|0|||
147217754|NCT01451437|530968004|FG002|Overall Study|Withdrawal by Subject|0|||
147217755|NCT01451437|530968005|FG003|Overall Study|Withdrawal by Subject|0|||
147217756|NCT01451437|530968006|FG004|Overall Study|Withdrawal by Subject|1|||
147217757|NCT01451437|530968007|FG005|Overall Study|Withdrawal by Subject|0|||
147217758|NCT01451437|530968008|FG006|Overall Study|Withdrawal by Subject|1|||
147217759|NCT01451437|530968009|FG007|Overall Study|Withdrawal by Subject|0|||
147217760|NCT01451437|530968010|FG008|Overall Study|Withdrawal by Subject|0|||
147217761|NCT02081859|530968013|FG000|Overall Study|No fertilization|2|||
147217762|NCT02081859|530968014|FG001|Overall Study|No fertilization|2|||
147306856|NCT01852058|531290777|FG004|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|3|||
147443050|NCT00847145|531787142|FG000|Overall Study|Protocol Violation|0|||
147217763|NCT02081859|530968013|FG000|Overall Study|No sperm|1|||
147217764|NCT02081859|530968014|FG001|Overall Study|No sperm|0|||
147217765|NCT02081859|530968013|FG000|Overall Study|Unanticipated freeze all cycle|2|||
147217766|NCT02081859|530968014|FG001|Overall Study|Unanticipated freeze all cycle|6|||
147306857|NCT01852058|531290778|FG005|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|1|||
147306858|NCT01852058|531290779|FG006|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
147306859|NCT01852058|531290780|FG007|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
147306860|NCT01852058|531290781|FG008|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
147306861|NCT01852058|531290782|FG009|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
147306862|NCT01852058|531290783|FG010|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
147306863|NCT01852058|531290784|FG011|Treatment Cycle2:Retreatment 1,Study 121|Withdrawal by Subject|0|||
147306864|NCT01852058|531290773|FG000|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
147306865|NCT01852058|531290774|FG001|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
147306866|NCT01852058|531290775|FG002|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
147306867|NCT01852058|531290776|FG003|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|1|||
147306868|NCT01852058|531290777|FG004|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
147306869|NCT01852058|531290778|FG005|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
147306870|NCT01852058|531290779|FG006|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
147306871|NCT01852058|531290780|FG007|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
147306872|NCT01852058|531290781|FG008|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
147217767|NCT02081859|530968013|FG000|Overall Study|< 4 embryos|27|||
147217768|NCT02081859|530968014|FG001|Overall Study|< 4 embryos|23|||
147217769|NCT02081859|530968013|FG000|Overall Study|Other reasons|2|||
147217770|NCT02081859|530968014|FG001|Overall Study|Other reasons|0|||
147217771|NCT02055365|530969729|FG000|Overall Study|Prematurely Withdrawn|1|||
147217772|NCT01258998|530969732|FG000|Overall Study|Ineligible|1|||
147217773|NCT01143389|530969733|FG000|Overall Study|Lost to Follow-up|26|||
147217774|NCT01143389|530969734|FG001|Overall Study|Lost to Follow-up|25|||
147217775|NCT00002931|530969738|FG000|Overall Study|rapidly progressing disease during|2|||
147217776|NCT02276027|530969739|FG000|Overall Study|Death|1|||
147217777|NCT02276027|530969740|FG001|Overall Study|Death|0|||
147217778|NCT02276027|530969741|FG002|Overall Study|Death|0|||
147217779|NCT02276027|530969742|FG003|Overall Study|Death|2|||
147217780|NCT02276027|530969739|FG000|Overall Study|Physician Decision|0|||
147217781|NCT02276027|530969740|FG001|Overall Study|Physician Decision|0|||
147217782|NCT02276027|530969741|FG002|Overall Study|Physician Decision|0|||
147217783|NCT02276027|530969742|FG003|Overall Study|Physician Decision|1|||
147217784|NCT02276027|530969739|FG000|Overall Study|Progressive disease|1|||
147217785|NCT02276027|530969740|FG001|Overall Study|Progressive disease|13|||
147217786|NCT02276027|530969741|FG002|Overall Study|Progressive disease|12|||
147217787|NCT02276027|530969742|FG003|Overall Study|Progressive disease|14|||
147217788|NCT02276027|530969739|FG000|Overall Study|Subject/guardian decision|0|||
147217789|NCT02276027|530969740|FG001|Overall Study|Subject/guardian decision|1|||
147217790|NCT02276027|530969741|FG002|Overall Study|Subject/guardian decision|0|||
147217791|NCT02276027|530969742|FG003|Overall Study|Subject/guardian decision|3|||
147217792|NCT02276027|530969739|FG000|Overall Study|Adverse Event|0|||
147217793|NCT02276027|530969740|FG001|Overall Study|Adverse Event|2|||
147217794|NCT02276027|530969741|FG002|Overall Study|Adverse Event|8|||
147217795|NCT02276027|530969742|FG003|Overall Study|Adverse Event|2|||
147217796|NCT03224598|530969743|FG000|Overall Study|Lost to Follow-up|0|||
147217797|NCT03224598|530969744|FG001|Overall Study|Lost to Follow-up|2|||
147217798|NCT03224598|530969745|FG002|Overall Study|Lost to Follow-up|0|||
147217799|NCT03224598|530969743|FG000|Overall Study|Other|0|||
147217800|NCT03224598|530969744|FG001|Overall Study|Other|1|||
147217801|NCT03224598|530969745|FG002|Overall Study|Other|0|||
147217802|NCT02446171|530969748|FG000|Overall Study|Withdrawal by Subject|0|||
147217803|NCT02446171|530969749|FG001|Overall Study|Withdrawal by Subject|0|||
147217804|NCT02446171|530969750|FG002|Overall Study|Withdrawal by Subject|2|||
147217805|NCT02446171|530969751|FG003|Overall Study|Withdrawal by Subject|0|||
147217806|NCT01142089|530969752|FG000|Overall Study|Physician Decision|1|||
147217807|NCT01142089|530969753|FG001|Overall Study|Physician Decision|0|||
147217808|NCT01142089|530969752|FG000|Overall Study|Withdrawal by Subject|1|||
147217809|NCT01142089|530969753|FG001|Overall Study|Withdrawal by Subject|2|||
147217810|NCT01142089|530969752|FG000|Overall Study|Use of prohibited medications|0|||
147217811|NCT01142089|530969753|FG001|Overall Study|Use of prohibited medications|1|||
147217812|NCT01142089|530969752|FG000|Overall Study|Noncompliance with study procedures|2|||
147217813|NCT01142089|530969753|FG001|Overall Study|Noncompliance with study procedures|1|||
147217814|NCT01142089|530969752|FG000|Overall Study|Patient required rescue medication|8|||
147217815|NCT01142089|530969753|FG001|Overall Study|Patient required rescue medication|17|||
147217816|NCT02907892|530969758|FG000|Overall Study|Lost to Follow-up|27|||
147217817|NCT02907892|530969759|FG001|Overall Study|Lost to Follow-up|40|||
147217818|NCT01974765|530969760|FG000|Overall Study|Withdrawal by Subject|1|||
147217819|NCT01974765|530969760|FG000|Overall Study|Death|1|||
147217820|NCT01974765|530969760|FG000|Overall Study|Adverse Event|2|||
147217821|NCT01525901|530969761|FG000|Period 2: 12 Weeks|Adverse Event|0|||
147217822|NCT01525901|530969762|FG001|Period 2: 12 Weeks|Adverse Event|1|||
147217823|NCT01525901|530969763|FG002|Period 2: 12 Weeks|Adverse Event|0|||
147217824|NCT01525901|530969764|FG003|Period 2: 12 Weeks|Adverse Event|0|||
147217825|NCT05027971|530969767|FG000|Overall Study|Physician Decision|7|||
147217826|NCT05027971|530969768|FG001|Overall Study|Physician Decision|3|||
147217827|NCT05027971|530969767|FG000|Overall Study|Lost to Follow-up|1|||
147217828|NCT05027971|530969768|FG001|Overall Study|Lost to Follow-up|1|||
147217829|NCT05027971|530969767|FG000|Overall Study|Withdrawal by Subject|0|||
147217830|NCT05027971|530969768|FG001|Overall Study|Withdrawal by Subject|2|||
147217831|NCT05027971|530969767|FG000|Overall Study|Non-study fiber used.|0|||
147217832|NCT05027971|530969768|FG001|Overall Study|Non-study fiber used.|1|||
147217833|NCT05027971|530969767|FG000|Overall Study|Protocol Violation|0|||
147217834|NCT05027971|530969768|FG001|Overall Study|Protocol Violation|2|||
147217835|NCT02112045|530969769|FG000|Overall Study|Withdrawal by Subject|1|||
147217836|NCT02112045|530969770|FG001|Overall Study|Withdrawal by Subject|0|||
147217837|NCT00627445|530969771|FG000|Overall Study|Adverse Event|3|||
147217838|NCT00627445|530969772|FG001|Overall Study|Adverse Event|3|||
147217839|NCT00627445|530969771|FG000|Overall Study|Lack of Efficacy|0|||
147217840|NCT00627445|530969772|FG001|Overall Study|Lack of Efficacy|1|||
147217841|NCT00627445|530969771|FG000|Overall Study|Other|6|||
147217842|NCT00627445|530969772|FG001|Overall Study|Other|8|||
147217843|NCT01238588|530969773|FG000|Overall Study|Withdrawal by Subject|1|||
147217844|NCT01238588|530969773|FG000|Overall Study|Physician Decision|2|||
147217845|NCT05395091|530969779|FG000|Baseline to Month 12|Adverse Event|7|||
147217846|NCT05395091|530969780|FG001|Baseline to Month 12|Adverse Event|2|||
147217847|NCT05395091|530969781|FG002|Baseline to Month 12|Adverse Event|0|||
147217848|NCT05395091|530969779|FG000|Baseline to Month 12|Death|3|||
147217849|NCT05395091|530969780|FG001|Baseline to Month 12|Death|1|||
147217850|NCT05395091|530969781|FG002|Baseline to Month 12|Death|0|||
147217851|NCT05395091|530969779|FG000|Baseline to Month 12|Withdrawal by Subject|11|||
147217852|NCT05395091|530969780|FG001|Baseline to Month 12|Withdrawal by Subject|16|||
147217853|NCT05395091|530969781|FG002|Baseline to Month 12|Withdrawal by Subject|0|||
147217854|NCT05395091|530969779|FG000|Baseline to Month 12|Protocol Violation|2|||
147217855|NCT05395091|530969780|FG001|Baseline to Month 12|Protocol Violation|3|||
147217856|NCT05395091|530969781|FG002|Baseline to Month 12|Protocol Violation|0|||
147217857|NCT05395091|530969779|FG000|Baseline to Month 12|Physician Decision|1|||
147217858|NCT05395091|530969780|FG001|Baseline to Month 12|Physician Decision|0|||
147217859|NCT05395091|530969781|FG002|Baseline to Month 12|Physician Decision|0|||
147217860|NCT05395091|530969779|FG000|Month 12 to Month 18|Death|1|||
147217861|NCT05395091|530969780|FG001|Month 12 to Month 18|Death|0|||
147217862|NCT05395091|530969781|FG002|Month 12 to Month 18|Death|0|||
147217863|NCT05395091|530969779|FG000|Month 12 to Month 18|Withdrawal by Subject|3|||
147217864|NCT05395091|530969780|FG001|Month 12 to Month 18|Withdrawal by Subject|2|||
147217865|NCT05395091|530969781|FG002|Month 12 to Month 18|Withdrawal by Subject|1|||
147217866|NCT05395091|530969779|FG000|Month 12 to Month 18|Lost to Follow-up|1|||
147217867|NCT05395091|530969780|FG001|Month 12 to Month 18|Lost to Follow-up|0|||
147217868|NCT05395091|530969781|FG002|Month 12 to Month 18|Lost to Follow-up|1|||
147217869|NCT05395091|530969779|FG000|Month 12 to Month 18|Other reasons|0|||
147217870|NCT05395091|530969780|FG001|Month 12 to Month 18|Other reasons|0|||
147217871|NCT05395091|530969781|FG002|Month 12 to Month 18|Other reasons|1|||
147217872|NCT01509053|530969783|FG000|Oral Aripirazole (Phase A)|Sponsor discontinued study|11|||
147217873|NCT01509053|530969783|FG000|Aripiprazole IM Depot Treatment Phase(B)|Adverse Event|1|||
147217874|NCT01509053|530969783|FG000|Aripiprazole IM Depot Treatment Phase(B)|Sponsor discontinued study|13|||
147217875|NCT01509053|530969783|FG000|Aripiprazole IM Depot Treatment Phase(B)|Subject was withdrawn by investigator|1|||
147217876|NCT01509053|530969783|FG000|Aripiprazole IM Depot Treatment Phase(B)|Subject withdrew consent|1|||
147217877|NCT01509053|530969783|FG000|Aripiprazole IM Depot Extension Phase(C)|Sponsor discontinued study|3|||
147217878|NCT01915303|530969786|FG000|Core Phase|Adverse Event|7|||
147217879|NCT01915303|530969786|FG000|Core Phase|Unsatisfactory therapeutic effect|3|||
147217880|NCT01915303|530969786|FG000|Core Phase|Death|2|||
147217881|NCT01915303|530969786|FG000|Core Phase|Protocol Violation|2|||
147217882|NCT01915303|530969786|FG000|Core Phase|Abnormal lab value|1|||
147217883|NCT01915303|530969786|FG000|Core Phase|Withdrawal by Subject|1|||
147217884|NCT01915303|530969786|FG000|Extension Phase|Unsatisfactory therapeutic effect|8|||
147217885|NCT01915303|530969786|FG000|Extension Phase|Withdrawal by Subject|4|||
147217886|NCT01915303|530969786|FG000|Extension Phase|Adverse Event|3|||
147217887|NCT01915303|530969786|FG000|Extension Phase|Death|1|||
147217888|NCT01915303|530969786|FG000|Extension Phase|Protocol Violation|1|||
147217889|NCT00834080|530969788|FG000|Overall Study|Adverse Event|7|||
147217890|NCT00834080|530969788|FG000|Overall Study|Lost to Follow-up|7|||
147217891|NCT00834080|530969788|FG000|Overall Study|Withdrawal by Subject|5|||
147217892|NCT00834080|530969788|FG000|Overall Study|Other - Pregnancy|1|||
147217893|NCT00834080|530969788|FG000|Overall Study|Other - False positive tests of the UDS|1|||
147217894|NCT00834080|530969788|FG000|Overall Study|Physician Decision|1|||
147217895|NCT00834080|530969788|FG000|Overall Study|Subject Relocated|1|||
147217896|NCT00796523|530969792|FG000|Overall Study|Lost to Follow-up|9|||
147217897|NCT00796523|530969793|FG001|Overall Study|Lost to Follow-up|7|||
147217898|NCT00321646|530969795|FG000|Neoadjuvant Chemotherapy|Withdrawal by Subject|1|||
147217899|NCT00321646|530969795|FG000|Neoadjuvant Chemotherapy|Adverse Event|2|||
147217900|NCT00321646|530969795|FG000|Neoadjuvant Chemotherapy|Disease progression|1|||
147217901|NCT01284491|530969797|FG000|Overall Study|Study termination|13|||
147217902|NCT02694757|530969798|FG000|Overall Study|Lack of Efficacy|3|||
147217903|NCT00095147|530969799|FG000|Double-blind Period 1 (Days 1-197)|Death|1|||
147217904|NCT00095147|530969800|FG001|Double-blind Period 1 (Days 1-197)|Death|0|||
147217905|NCT00095147|530969801|FG002|Double-blind Period 1 (Days 1-197)|Death|0|||
147217906|NCT00095147|530969802|FG003|Double-blind Period 1 (Days 1-197)|Death|0|||
147217907|NCT00095147|530969803|FG004|Double-blind Period 1 (Days 1-197)|Death|0|||
147217908|NCT00095147|530969799|FG000|Double-blind Period 1 (Days 1-197)|Adverse Event|2|||
147217909|NCT00095147|530969800|FG001|Double-blind Period 1 (Days 1-197)|Adverse Event|8|||
147217910|NCT00095147|530969801|FG002|Double-blind Period 1 (Days 1-197)|Adverse Event|1|||
147217911|NCT00095147|530969802|FG003|Double-blind Period 1 (Days 1-197)|Adverse Event|0|||
147217912|NCT00095147|530969803|FG004|Double-blind Period 1 (Days 1-197)|Adverse Event|0|||
147217913|NCT00095147|530969799|FG000|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|2|||
147217914|NCT00095147|530969800|FG001|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|2|||
147217915|NCT00095147|530969801|FG002|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|1|||
147217916|NCT00095147|530969802|FG003|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|0|||
147217917|NCT00095147|530969803|FG004|Double-blind Period 1 (Days 1-197)|Lack of Efficacy|0|||
147217918|NCT00095147|530969799|FG000|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|2|||
147217919|NCT00095147|530969800|FG001|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|2|||
147217920|NCT00095147|530969801|FG002|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|0|||
147217921|NCT00095147|530969802|FG003|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|0|||
147217922|NCT00095147|530969803|FG004|Double-blind Period 1 (Days 1-197)|Lost to Follow-up|0|||
147217923|NCT00095147|530969799|FG000|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|1|||
147217924|NCT00095147|530969800|FG001|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|0|||
147217925|NCT00095147|530969801|FG002|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|1|||
147217926|NCT00095147|530969802|FG003|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|0|||
147217927|NCT00095147|530969803|FG004|Double-blind Period 1 (Days 1-197)|Withdrawal of consent|0|||
147217928|NCT00095147|530969799|FG000|Double-blind Period 1 (Days 1-197)|Pregnancy|1|||
147217929|NCT00095147|530969800|FG001|Double-blind Period 1 (Days 1-197)|Pregnancy|1|||
147217930|NCT00095147|530969801|FG002|Double-blind Period 1 (Days 1-197)|Pregnancy|0|||
147217931|NCT00095147|530969802|FG003|Double-blind Period 1 (Days 1-197)|Pregnancy|0|||
147217932|NCT00095147|530969803|FG004|Double-blind Period 1 (Days 1-197)|Pregnancy|0|||
147217933|NCT00095147|530969799|FG000|Double-blind Period 2 (Days 198-365)|Death|0|||
147217934|NCT00095147|530969800|FG001|Double-blind Period 2 (Days 198-365)|Death|1|||
147217935|NCT00095147|530969801|FG002|Double-blind Period 2 (Days 198-365)|Death|0|||
147217936|NCT00095147|530969802|FG003|Double-blind Period 2 (Days 198-365)|Death|1|||
147217937|NCT00095147|530969803|FG004|Double-blind Period 2 (Days 198-365)|Death|0|||
147217938|NCT00095147|530969799|FG000|Double-blind Period 2 (Days 198-365)|Adverse Event|2|||
147217939|NCT00095147|530969800|FG001|Double-blind Period 2 (Days 198-365)|Adverse Event|4|||
147217940|NCT00095147|530969801|FG002|Double-blind Period 2 (Days 198-365)|Adverse Event|0|||
147217941|NCT00095147|530969802|FG003|Double-blind Period 2 (Days 198-365)|Adverse Event|0|||
147217942|NCT00095147|530969803|FG004|Double-blind Period 2 (Days 198-365)|Adverse Event|0|||
147217943|NCT00095147|530969799|FG000|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|2|||
147217944|NCT00095147|530969800|FG001|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|4|||
147217945|NCT00095147|530969801|FG002|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|0|||
147217946|NCT00095147|530969802|FG003|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|1|||
147217947|NCT00095147|530969803|FG004|Double-blind Period 2 (Days 198-365)|Lack of Efficacy|0|||
147217948|NCT00095147|530969799|FG000|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|3|||
147217949|NCT00095147|530969800|FG001|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|2|||
147217950|NCT00095147|530969801|FG002|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|0|||
147217951|NCT00095147|530969802|FG003|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|0|||
147217952|NCT00095147|530969803|FG004|Double-blind Period 2 (Days 198-365)|Withdrawal of consent|0|||
147217953|NCT00095147|530969799|FG000|Double-blind Period 2 (Days 198-365)|Participant relocation|1|||
147217954|NCT00095147|530969800|FG001|Double-blind Period 2 (Days 198-365)|Participant relocation|0|||
147217955|NCT00095147|530969801|FG002|Double-blind Period 2 (Days 198-365)|Participant relocation|0|||
147217956|NCT00095147|530969802|FG003|Double-blind Period 2 (Days 198-365)|Participant relocation|1|||
147217957|NCT00095147|530969803|FG004|Double-blind Period 2 (Days 198-365)|Participant relocation|0|||
147217958|NCT00095147|530969799|FG000|Long-term Extension Period|Death|0|||
147217959|NCT00095147|530969800|FG001|Long-term Extension Period|Death|0|||
147217960|NCT00095147|530969801|FG002|Long-term Extension Period|Death|0|||
147217961|NCT00095147|530969802|FG003|Long-term Extension Period|Death|0|||
147217962|NCT00095147|530969803|FG004|Long-term Extension Period|Death|3|||
147217963|NCT00095147|530969799|FG000|Long-term Extension Period|Adverse Event|0|||
147217964|NCT00095147|530969800|FG001|Long-term Extension Period|Adverse Event|0|||
147217965|NCT00095147|530969801|FG002|Long-term Extension Period|Adverse Event|0|||
147217966|NCT00095147|530969802|FG003|Long-term Extension Period|Adverse Event|0|||
147217967|NCT00095147|530969803|FG004|Long-term Extension Period|Adverse Event|11|||
147552105|NCT02497391|532178490|FG003|Period 2 (14 Days)|Withdrawal by Subject|0|||
147552106|NCT02497391|532178491|FG004|Period 2 (14 Days)|Withdrawal by Subject|0|||
147217968|NCT00095147|530969799|FG000|Long-term Extension Period|Lack of Efficacy|0|||
147217969|NCT00095147|530969800|FG001|Long-term Extension Period|Lack of Efficacy|0|||
147217970|NCT00095147|530969801|FG002|Long-term Extension Period|Lack of Efficacy|0|||
147217971|NCT00095147|530969802|FG003|Long-term Extension Period|Lack of Efficacy|0|||
147217972|NCT00095147|530969803|FG004|Long-term Extension Period|Lack of Efficacy|9|||
147306873|NCT01852058|531290782|FG009|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
147306874|NCT01852058|531290783|FG010|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
147306875|NCT01852058|531290784|FG011|Treatment Cycle2:Retreatment 1,Study 121|Protocol Deviation|0|||
147306876|NCT01852058|531290773|FG000|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
147306877|NCT01852058|531290774|FG001|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
147306878|NCT01852058|531290775|FG002|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
147306879|NCT01852058|531290776|FG003|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
147306880|NCT01852058|531290777|FG004|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|1|||
147306881|NCT01852058|531290778|FG005|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|7|||
147306882|NCT01852058|531290779|FG006|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
147306883|NCT01852058|531290780|FG007|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
147306884|NCT01852058|531290781|FG008|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
147306885|NCT01852058|531290782|FG009|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
147306886|NCT01852058|531290783|FG010|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
147306887|NCT01852058|531290784|FG011|Treatment Cycle2:Retreatment 1,Study 121|Reason not Specified|0|||
147306888|NCT01852058|531290773|FG000|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
147306889|NCT01852058|531290774|FG001|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
147306890|NCT01852058|531290775|FG002|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
147306891|NCT01852058|531290776|FG003|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
147306892|NCT01852058|531290777|FG004|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
147306893|NCT01852058|531290778|FG005|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
147306894|NCT01852058|531290779|FG006|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
147306895|NCT01852058|531290780|FG007|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|1|||
147306896|NCT01852058|531290781|FG008|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
147306897|NCT01852058|531290782|FG009|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
147306898|NCT01852058|531290783|FG010|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
147306899|NCT01852058|531290784|FG011|Treatment Cycle3:Retreatment 2,Study 121|Withdrawal by Subject|0|||
147306900|NCT01852058|531290773|FG000|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
147306901|NCT01852058|531290774|FG001|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
147306902|NCT01852058|531290775|FG002|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
147306903|NCT01852058|531290776|FG003|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
147306904|NCT01852058|531290777|FG004|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
147306905|NCT01852058|531290778|FG005|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
147306906|NCT01852058|531290779|FG006|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
147306907|NCT01852058|531290780|FG007|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
147306908|NCT01852058|531290781|FG008|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|1|||
147306909|NCT01852058|531290782|FG009|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
147306910|NCT01852058|531290783|FG010|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
147306911|NCT01852058|531290784|FG011|Treatment Cycle3:Retreatment 2,Study 121|Reason Not Specified|0|||
147443051|NCT00847145|531787143|FG001|Overall Study|Protocol Violation|0|||
147443052|NCT00847145|531787144|FG002|Overall Study|Protocol Violation|3|||
147217973|NCT00095147|530969799|FG000|Long-term Extension Period|Lost to Follow-up|0|||
147217974|NCT00095147|530969800|FG001|Long-term Extension Period|Lost to Follow-up|0|||
147217975|NCT00095147|530969801|FG002|Long-term Extension Period|Lost to Follow-up|0|||
147217976|NCT00095147|530969802|FG003|Long-term Extension Period|Lost to Follow-up|0|||
147217977|NCT00095147|530969803|FG004|Long-term Extension Period|Lost to Follow-up|6|||
147217978|NCT00095147|530969799|FG000|Long-term Extension Period|Withdrawal of consent|0|||
147217979|NCT00095147|530969800|FG001|Long-term Extension Period|Withdrawal of consent|0|||
147217980|NCT00095147|530969801|FG002|Long-term Extension Period|Withdrawal of consent|0|||
147217981|NCT00095147|530969802|FG003|Long-term Extension Period|Withdrawal of consent|0|||
147217982|NCT00095147|530969803|FG004|Long-term Extension Period|Withdrawal of consent|12|||
147217983|NCT00095147|530969799|FG000|Long-term Extension Period|Pregnancy|0|||
147217984|NCT00095147|530969800|FG001|Long-term Extension Period|Pregnancy|0|||
147217985|NCT00095147|530969801|FG002|Long-term Extension Period|Pregnancy|0|||
147217986|NCT00095147|530969802|FG003|Long-term Extension Period|Pregnancy|0|||
147217987|NCT00095147|530969803|FG004|Long-term Extension Period|Pregnancy|1|||
147217988|NCT00095147|530969799|FG000|Long-term Extension Period|No longer meets study criteria|0|||
147217989|NCT00095147|530969800|FG001|Long-term Extension Period|No longer meets study criteria|0|||
147217990|NCT00095147|530969801|FG002|Long-term Extension Period|No longer meets study criteria|0|||
147217991|NCT00095147|530969802|FG003|Long-term Extension Period|No longer meets study criteria|0|||
147306912|NCT00263328|531290786|FG000|Overall Study|Death|0|||
147306913|NCT00263328|531290787|FG001|Overall Study|Death|0|||
147306914|NCT00263328|531290788|FG002|Overall Study|Death|1|||
147306915|NCT00263328|531290786|FG000|Overall Study|Lost to Follow-up|1|||
147306916|NCT00263328|531290787|FG001|Overall Study|Lost to Follow-up|1|||
147306917|NCT00263328|531290788|FG002|Overall Study|Lost to Follow-up|0|||
147306918|NCT00263328|531290786|FG000|Overall Study|Withdrawal by Subject|3|||
147306919|NCT00263328|531290787|FG001|Overall Study|Withdrawal by Subject|0|||
147306920|NCT00263328|531290788|FG002|Overall Study|Withdrawal by Subject|1|||
147306921|NCT00263328|531290786|FG000|Overall Study|Other|3|||
147306922|NCT00263328|531290787|FG001|Overall Study|Other|0|||
147306923|NCT00263328|531290788|FG002|Overall Study|Other|1|||
147306924|NCT00263328|531290786|FG000|Overall Study|Adverse Event|1|||
147306925|NCT00263328|531290787|FG001|Overall Study|Adverse Event|1|||
147306926|NCT00263328|531290788|FG002|Overall Study|Adverse Event|4|||
147306927|NCT02613221|531290793|FG000|Overall Study|Lack of efficacy (exacerbation)|50|||
147306928|NCT02613221|531290793|FG000|Overall Study|Adverse Event|2|||
147306929|NCT02613221|531290793|FG000|Overall Study|Voluntary Discontinuation|1|||
147306930|NCT02613221|531290793|FG000|Overall Study|Delayed Treatment|1|||
147306931|NCT02613221|531290793|FG000|Overall Study|Enrolled but Not Treated|1|||
147306932|NCT01301274|531290794|FG000|Overall Study|Physician Decision|2|||
147306933|NCT01301274|531290795|FG001|Overall Study|Physician Decision|1|||
147306934|NCT00661661|531290796|FG000|Overall Study|Adverse Event|99|||
147306935|NCT00661661|531290797|FG001|Overall Study|Adverse Event|24|||
147306936|NCT00661661|531290796|FG000|Overall Study|Lack of Efficacy|3|||
147306937|NCT00661661|531290797|FG001|Overall Study|Lack of Efficacy|2|||
147306938|NCT00661661|531290796|FG000|Overall Study|Lost to Follow-up|0|||
147306939|NCT00661661|531290797|FG001|Overall Study|Lost to Follow-up|1|||
147306940|NCT00661661|531290796|FG000|Overall Study|Withdrawal by Subject|15|||
147306941|NCT00661661|531290797|FG001|Overall Study|Withdrawal by Subject|5|||
147306942|NCT00661661|531290796|FG000|Overall Study|Other|22|||
147306943|NCT00661661|531290797|FG001|Overall Study|Other|7|||
147306944|NCT00661661|531290796|FG000|Overall Study|Not assigned treatment|1|||
147306945|NCT00661661|531290797|FG001|Overall Study|Not assigned treatment|0|||
147306946|NCT03403426|531290804|FG000|Overall Study|Death|1|||
147306947|NCT03403426|531290804|FG000|Overall Study|Lost to Follow-up|2|||
147306948|NCT03520400|531290807|FG000|Overall Study|Physician Decision|15|||
147306949|NCT03520400|531290808|FG001|Overall Study|Physician Decision|7|||
147306950|NCT01933880|531290809|FG000|Overall Study|Withdrawal by Subject|5|||
147306951|NCT01933880|531290810|FG001|Overall Study|Withdrawal by Subject|0|||
147306952|NCT01933880|531290809|FG000|Overall Study|Lack of Efficacy|1|||
147306953|NCT01933880|531290810|FG001|Overall Study|Lack of Efficacy|0|||
147306954|NCT01933880|531290809|FG000|Overall Study|Concomitant medication Interference|0|||
147306955|NCT01933880|531290810|FG001|Overall Study|Concomitant medication Interference|1|||
147306956|NCT01933880|531290809|FG000|Overall Study|Followup exceeded 4 days to visit window|19|||
147306957|NCT01933880|531290810|FG001|Overall Study|Followup exceeded 4 days to visit window|0|||
147306958|NCT01933880|531290809|FG000|Overall Study|Other|4|||
147306959|NCT01933880|531290810|FG001|Overall Study|Other|0|||
147306960|NCT01933880|531290809|FG000|Overall Study|Protocol Violation|1|||
147306961|NCT01933880|531290810|FG001|Overall Study|Protocol Violation|0|||
147306962|NCT00510458|531290811|FG000|Overall Study|5 year not evaluable/missed|21|||
147306963|NCT00510458|531290811|FG000|Overall Study|Death|1|||
147306964|NCT00510458|531290811|FG000|Overall Study|Terminated|14|||
147306965|NCT00510458|531290811|FG000|Overall Study|Lost to Follow-up|6|||
147306966|NCT00510458|531290811|FG000|Overall Study|Withdrawal by Subject|3|||
147306967|NCT00510458|531290811|FG000|Overall Study|Revision|2|||
147306968|NCT02569710|531290812|FG000|Overall Study|Adverse Event|1|||
147306969|NCT02569710|531290813|FG001|Overall Study|Adverse Event|0|||
147306970|NCT02569710|531290814|FG002|Overall Study|Adverse Event|0|||
147306971|NCT02569710|531290815|FG003|Overall Study|Adverse Event|0|||
147306972|NCT02569710|531290816|FG004|Overall Study|Adverse Event|0|||
147306973|NCT02569710|531290817|FG005|Overall Study|Adverse Event|0|||
147306974|NCT02569710|531290818|FG006|Overall Study|Adverse Event|0|||
147306975|NCT02569710|531290819|FG007|Overall Study|Adverse Event|0|||
147306976|NCT02569710|531290820|FG008|Overall Study|Adverse Event|0|||
147306977|NCT02569710|531290821|FG009|Overall Study|Adverse Event|0|||
147306978|NCT02569710|531290812|FG000|Overall Study|Lost to Follow-up|0|||
147306979|NCT02569710|531290813|FG001|Overall Study|Lost to Follow-up|0|||
147306980|NCT02569710|531290814|FG002|Overall Study|Lost to Follow-up|0|||
147306981|NCT02569710|531290815|FG003|Overall Study|Lost to Follow-up|0|||
147306982|NCT02569710|531290816|FG004|Overall Study|Lost to Follow-up|0|||
147306983|NCT02569710|531290817|FG005|Overall Study|Lost to Follow-up|0|||
147306984|NCT02569710|531290818|FG006|Overall Study|Lost to Follow-up|1|||
147306985|NCT02569710|531290819|FG007|Overall Study|Lost to Follow-up|0|||
147306986|NCT02569710|531290820|FG008|Overall Study|Lost to Follow-up|1|||
147306987|NCT02569710|531290821|FG009|Overall Study|Lost to Follow-up|0|||
147306988|NCT02569710|531290812|FG000|Overall Study|Virologic failure|0|||
147306989|NCT02569710|531290813|FG001|Overall Study|Virologic failure|0|||
147306990|NCT02569710|531290814|FG002|Overall Study|Virologic failure|0|||
147306991|NCT02569710|531290815|FG003|Overall Study|Virologic failure|0|||
147306992|NCT02569710|531290816|FG004|Overall Study|Virologic failure|1|||
147306993|NCT02569710|531290817|FG005|Overall Study|Virologic failure|0|||
147306994|NCT02569710|531290818|FG006|Overall Study|Virologic failure|1|||
147306995|NCT02569710|531290819|FG007|Overall Study|Virologic failure|0|||
147306996|NCT02569710|531290820|FG008|Overall Study|Virologic failure|0|||
147306997|NCT02569710|531290821|FG009|Overall Study|Virologic failure|0|||
147306998|NCT02569710|531290812|FG000|Overall Study|Withdrawal by Subject|0|||
147306999|NCT02569710|531290813|FG001|Overall Study|Withdrawal by Subject|0|||
147307000|NCT02569710|531290814|FG002|Overall Study|Withdrawal by Subject|0|||
147307001|NCT02569710|531290815|FG003|Overall Study|Withdrawal by Subject|0|||
147307002|NCT02569710|531290816|FG004|Overall Study|Withdrawal by Subject|0|||
147307003|NCT02569710|531290817|FG005|Overall Study|Withdrawal by Subject|1|||
147307004|NCT02569710|531290818|FG006|Overall Study|Withdrawal by Subject|0|||
147307005|NCT02569710|531290819|FG007|Overall Study|Withdrawal by Subject|0|||
147307006|NCT02569710|531290820|FG008|Overall Study|Withdrawal by Subject|0|||
147307007|NCT02569710|531290821|FG009|Overall Study|Withdrawal by Subject|0|||
147307008|NCT01125722|531290822|FG000|Overall Study|Withdrawal by Subject|2|||
147307009|NCT01125722|531290823|FG001|Overall Study|Withdrawal by Subject|1|||
147307010|NCT01125722|531290822|FG000|Overall Study|Lost to Follow-up|1|||
147307011|NCT01125722|531290823|FG001|Overall Study|Lost to Follow-up|0|||
147307012|NCT03474549|531290824|FG000|Overall Study|Death|31|||
147307013|NCT03474549|531290824|FG000|Overall Study|Lost to Follow-up|4|||
147307014|NCT03474549|531290824|FG000|Overall Study|Withdrawal by Subject|2|||
147307015|NCT03573908|531290828|FG000|Treatment Period|Adverse Event|4|||
147307016|NCT03573908|531290829|FG001|Treatment Period|Adverse Event|9|||
147307017|NCT03573908|531290830|FG002|Treatment Period|Adverse Event|0|||
147307018|NCT03573908|531290831|FG003|Treatment Period|Adverse Event|0|||
147307019|NCT03573908|531290832|FG004|Treatment Period|Adverse Event|0|||
147307020|NCT03573908|531290828|FG000|Treatment Period|Protocol Violation|1|||
147307021|NCT03573908|531290829|FG001|Treatment Period|Protocol Violation|0|||
147307022|NCT03573908|531290830|FG002|Treatment Period|Protocol Violation|0|||
147307023|NCT03573908|531290831|FG003|Treatment Period|Protocol Violation|0|||
147307024|NCT03573908|531290832|FG004|Treatment Period|Protocol Violation|0|||
147307025|NCT03573908|531290828|FG000|Treatment Period|Withdrawal by Subject|7|||
147307026|NCT03573908|531290829|FG001|Treatment Period|Withdrawal by Subject|5|||
147307027|NCT03573908|531290830|FG002|Treatment Period|Withdrawal by Subject|0|||
147307028|NCT03573908|531290831|FG003|Treatment Period|Withdrawal by Subject|0|||
147307029|NCT03573908|531290832|FG004|Treatment Period|Withdrawal by Subject|0|||
147307030|NCT03573908|531290828|FG000|Treatment Period|Lost to Follow-up|7|||
147307031|NCT03573908|531290829|FG001|Treatment Period|Lost to Follow-up|6|||
147307032|NCT03573908|531290830|FG002|Treatment Period|Lost to Follow-up|0|||
147307033|NCT03573908|531290831|FG003|Treatment Period|Lost to Follow-up|0|||
147307034|NCT03573908|531290832|FG004|Treatment Period|Lost to Follow-up|0|||
147307035|NCT03573908|531290828|FG000|Treatment Period|Pregnancy|1|||
147307036|NCT03573908|531290829|FG001|Treatment Period|Pregnancy|0|||
147307037|NCT03573908|531290830|FG002|Treatment Period|Pregnancy|0|||
147307038|NCT03573908|531290831|FG003|Treatment Period|Pregnancy|0|||
147307039|NCT03573908|531290832|FG004|Treatment Period|Pregnancy|0|||
147307040|NCT03573908|531290828|FG000|Treatment Period|Other, Not Specified|4|||
147307041|NCT03573908|531290829|FG001|Treatment Period|Other, Not Specified|6|||
147307042|NCT03573908|531290830|FG002|Treatment Period|Other, Not Specified|0|||
147307043|NCT03573908|531290831|FG003|Treatment Period|Other, Not Specified|0|||
147307044|NCT03573908|531290832|FG004|Treatment Period|Other, Not Specified|0|||
147307045|NCT03573908|531290828|FG000|Randomized Withdrawal Period|Adverse Event|0|||
147307046|NCT03573908|531290829|FG001|Randomized Withdrawal Period|Adverse Event|0|||
147307047|NCT03573908|531290830|FG002|Randomized Withdrawal Period|Adverse Event|3|||
147307048|NCT03573908|531290831|FG003|Randomized Withdrawal Period|Adverse Event|0|||
147307049|NCT03573908|531290832|FG004|Randomized Withdrawal Period|Adverse Event|0|||
147307050|NCT03573908|531290828|FG000|Randomized Withdrawal Period|Withdrawal by Subject|0|||
147307051|NCT03573908|531290829|FG001|Randomized Withdrawal Period|Withdrawal by Subject|0|||
147307052|NCT03573908|531290830|FG002|Randomized Withdrawal Period|Withdrawal by Subject|0|||
147307053|NCT03573908|531290831|FG003|Randomized Withdrawal Period|Withdrawal by Subject|0|||
147307054|NCT03573908|531290832|FG004|Randomized Withdrawal Period|Withdrawal by Subject|2|||
147307055|NCT03573908|531290828|FG000|Randomized Withdrawal Period|Lost to Follow-up|0|||
147307056|NCT03573908|531290829|FG001|Randomized Withdrawal Period|Lost to Follow-up|0|||
147307057|NCT03573908|531290830|FG002|Randomized Withdrawal Period|Lost to Follow-up|1|||
147307058|NCT03573908|531290831|FG003|Randomized Withdrawal Period|Lost to Follow-up|0|||
147307059|NCT03573908|531290832|FG004|Randomized Withdrawal Period|Lost to Follow-up|0|||
147307060|NCT03573908|531290828|FG000|Randomized Withdrawal Period|Other, Not Specified|0|||
147307061|NCT03573908|531290829|FG001|Randomized Withdrawal Period|Other, Not Specified|0|||
147443053|NCT00847145|531787145|FG003|Overall Study|Protocol Violation|0|||
147307062|NCT03573908|531290830|FG002|Randomized Withdrawal Period|Other, Not Specified|4|||
147307063|NCT03573908|531290831|FG003|Randomized Withdrawal Period|Other, Not Specified|2|||
147307064|NCT03573908|531290832|FG004|Randomized Withdrawal Period|Other, Not Specified|0|||
147307065|NCT04006925|531290833|FG000|Overall Study|Side effects|2|||
147307066|NCT04006925|531290834|FG001|Overall Study|Side effects|0|||
147307067|NCT00738101|531290841|FG000|Overall Study|Physician Decision|5|||
147307068|NCT00738101|531290841|FG000|Overall Study|Death|1|||
147307069|NCT00738101|531290841|FG000|Overall Study|Repeat enrollment|1|||
147307070|NCT00709059|531290846|FG000|Overall Study|Lost to Follow-up|34|||
147307071|NCT00709059|531290846|FG000|Overall Study|Withdrawal by Subject|19|||
147307072|NCT00709059|531290846|FG000|Overall Study|Physician Decision|7|||
147307073|NCT00709059|531290846|FG000|Overall Study|Disease complication|3|||
147307074|NCT00709059|531290846|FG000|Overall Study|Side effects|20|||
147307075|NCT00709059|531290846|FG000|Overall Study|Serious side effects|11|||
147307076|NCT01396317|531290847|FG000|Overall Study|Adverse Event|1|||
147307077|NCT01396317|531290848|FG001|Overall Study|Adverse Event|0|||
147307078|NCT03315130|531290849|FG000|Main Portion (12 Weeks)|Subject withdrew consent|0|||
147307079|NCT03315130|531290850|FG001|Main Portion (12 Weeks)|Subject withdrew consent|1|||
147307080|NCT03315130|531290851|FG002|Main Portion (12 Weeks)|Subject withdrew consent|0|||
147307081|NCT03315130|531290852|FG003|Main Portion (12 Weeks)|Subject withdrew consent|0|||
147307082|NCT03315130|531290849|FG000|Main Portion (12 Weeks)|Lost to Follow-up|0|||
147307083|NCT03315130|531290850|FG001|Main Portion (12 Weeks)|Lost to Follow-up|1|||
147307084|NCT03315130|531290851|FG002|Main Portion (12 Weeks)|Lost to Follow-up|0|||
147307085|NCT03315130|531290852|FG003|Main Portion (12 Weeks)|Lost to Follow-up|0|||
147307086|NCT03315130|531290849|FG000|EP:Before Switch to 0.3 mg/kg(Week13-48)|Subject withdrew consent|1|||
147307087|NCT03315130|531290850|FG001|EP:Before Switch to 0.3 mg/kg(Week13-48)|Subject withdrew consent|0|||
147307088|NCT03315130|531290851|FG002|EP:Before Switch to 0.3 mg/kg(Week13-48)|Subject withdrew consent|0|||
147307089|NCT03315130|531290852|FG003|EP:Before Switch to 0.3 mg/kg(Week13-48)|Subject withdrew consent|0|||
147307090|NCT03315130|531290849|FG000|EP:After Switch to 0.3 mg/kg(Week48-122)|Withdrawal by Subject|0|||
147307091|NCT03315130|531290850|FG001|EP:After Switch to 0.3 mg/kg(Week48-122)|Withdrawal by Subject|1|||
147307092|NCT03315130|531290851|FG002|EP:After Switch to 0.3 mg/kg(Week48-122)|Withdrawal by Subject|0|||
147307093|NCT03315130|531290852|FG003|EP:After Switch to 0.3 mg/kg(Week48-122)|Withdrawal by Subject|0|||
147307094|NCT03315130|531290849|FG000|EP:After Switch to 0.3 mg/kg(Week48-122)|Subject withdrew consent|0|||
147307095|NCT03315130|531290850|FG001|EP:After Switch to 0.3 mg/kg(Week48-122)|Subject withdrew consent|1|||
147307096|NCT03315130|531290851|FG002|EP:After Switch to 0.3 mg/kg(Week48-122)|Subject withdrew consent|0|||
147307097|NCT03315130|531290852|FG003|EP:After Switch to 0.3 mg/kg(Week48-122)|Subject withdrew consent|0|||
147307098|NCT03315130|531290849|FG000|EP:After Switch to 0.3 mg/kg(Week48-122)|Death|0|||
147307099|NCT03315130|531290850|FG001|EP:After Switch to 0.3 mg/kg(Week48-122)|Death|2|||
147307100|NCT03315130|531290851|FG002|EP:After Switch to 0.3 mg/kg(Week48-122)|Death|0|||
147307101|NCT03315130|531290852|FG003|EP:After Switch to 0.3 mg/kg(Week48-122)|Death|1|||
147307102|NCT00524030|531290853|FG000|Overall Study|Lack of Efficacy|10|||
147307103|NCT00524030|531290854|FG001|Overall Study|Lack of Efficacy|24|||
147307104|NCT00524030|531290853|FG000|Overall Study|Lost to Follow-up|0|||
147307105|NCT00524030|531290854|FG001|Overall Study|Lost to Follow-up|2|||
147307106|NCT00524030|531290853|FG000|Overall Study|Withdrawal by Subject|3|||
147307107|NCT00524030|531290854|FG001|Overall Study|Withdrawal by Subject|8|||
147307108|NCT00524030|531290853|FG000|Overall Study|Noncompliance/Investigator discretion|0|||
147307109|NCT00524030|531290854|FG001|Overall Study|Noncompliance/Investigator discretion|2|||
147307110|NCT00524030|531290853|FG000|Overall Study|Protocol Violation|0|||
147307111|NCT00524030|531290854|FG001|Overall Study|Protocol Violation|1|||
147307112|NCT00524030|531290853|FG000|Overall Study|Pregnancy|1|||
147307113|NCT00524030|531290854|FG001|Overall Study|Pregnancy|0|||
147217992|NCT00095147|530969803|FG004|Long-term Extension Period|No longer meets study criteria|1|||
147217993|NCT00095147|530969799|FG000|Long-term Extension Period|Participant chose to use Revellex|0|||
147217994|NCT00095147|530969800|FG001|Long-term Extension Period|Participant chose to use Revellex|0|||
147217995|NCT00095147|530969801|FG002|Long-term Extension Period|Participant chose to use Revellex|0|||
147217996|NCT00095147|530969802|FG003|Long-term Extension Period|Participant chose to use Revellex|0|||
147217997|NCT00095147|530969803|FG004|Long-term Extension Period|Participant chose to use Revellex|1|||
147217998|NCT00095147|530969799|FG000|Long-term Extension Period|Leaving country|0|||
147217999|NCT00095147|530969800|FG001|Long-term Extension Period|Leaving country|0|||
147307114|NCT00524030|531290853|FG000|Overall Study|Adverse Event|3|||
147307115|NCT00524030|531290854|FG001|Overall Study|Adverse Event|21|||
147307116|NCT00524030|531290853|FG000|Overall Study|Death|0|||
147307117|NCT00524030|531290854|FG001|Overall Study|Death|1|||
147307118|NCT02944656|531290862|FG000|Overall Study|No longer eligible|3|||
147307119|NCT02944656|531290863|FG001|Overall Study|No longer eligible|0|||
147307120|NCT02944656|531290862|FG000|Overall Study|Lost to Follow-up|7|||
147307121|NCT02944656|531290863|FG001|Overall Study|Lost to Follow-up|10|||
147218000|NCT00095147|530969801|FG002|Long-term Extension Period|Leaving country|0|||
147443054|NCT00847145|531787146|FG004|Overall Study|Protocol Violation|1|||
147307122|NCT04398537|531290864|FG000|Overall Study|Physician Decision|10|||
147443055|NCT00847145|531787147|FG005|Overall Study|Protocol Violation|0|||
147307123|NCT04398537|531290865|FG001|Overall Study|Physician Decision|15|||
147307124|NCT03535337|531290866|FG000|Stage 2 Randomization|Lost to Follow-up|0|||
147307125|NCT03535337|531290867|FG001|Stage 2 Randomization|Lost to Follow-up|0|||
147307126|NCT03535337|531290868|FG002|Stage 2 Randomization|Lost to Follow-up|2|||
147307127|NCT03535337|531290869|FG003|Stage 2 Randomization|Lost to Follow-up|1|||
147307128|NCT03535337|531290870|FG004|Stage 2 Randomization|Lost to Follow-up|5|||
147307129|NCT03535337|531290871|FG005|Stage 2 Randomization|Lost to Follow-up|4|||
147307130|NCT03535337|531290872|FG006|Stage 2 Randomization|Lost to Follow-up|3|||
147307131|NCT03535337|531290873|FG007|Stage 2 Randomization|Lost to Follow-up|6|||
147307132|NCT03535337|531290874|FG008|Stage 2 Randomization|Lost to Follow-up|0|||
147307133|NCT03535337|531290875|FG009|Stage 2 Randomization|Lost to Follow-up|2|||
147307134|NCT02243631|531292913|FG000|Overall Study|no synovial fluid on second aspirate|0|||
147307135|NCT02243631|531292914|FG001|Overall Study|no synovial fluid on second aspirate|1|||
147307136|NCT01590771|531292921|FG000|Overall Study|Other Protocol Specified Criteria|5|||
147307137|NCT01590771|531292922|FG001|Overall Study|Other Protocol Specified Criteria|14|||
147307138|NCT01590771|531292921|FG000|Overall Study|Withdrawal by Subject|8|||
147307139|NCT01590771|531292922|FG001|Overall Study|Withdrawal by Subject|15|||
147307140|NCT01590771|531292921|FG000|Overall Study|Protocol Violation|1|||
147307141|NCT01590771|531292922|FG001|Overall Study|Protocol Violation|2|||
147307142|NCT01590771|531292921|FG000|Overall Study|Lost to Follow-up|1|||
147307143|NCT01590771|531292922|FG001|Overall Study|Lost to Follow-up|1|||
147307144|NCT01590771|531292921|FG000|Overall Study|Lack of Efficacy|1|||
147307145|NCT01590771|531292922|FG001|Overall Study|Lack of Efficacy|0|||
147307146|NCT01590771|531292921|FG000|Overall Study|Adverse Event|3|||
147307147|NCT01590771|531292922|FG001|Overall Study|Adverse Event|7|||
147307148|NCT01785628|531292925|FG000|Overall Study|Lost to Follow-up|2|||
147307149|NCT01785628|531292926|FG001|Overall Study|Lost to Follow-up|3|||
147307150|NCT02200939|531292927|FG000|Overall Study|Participant withdrew consent|0|||
147307151|NCT02200939|531292928|FG001|Overall Study|Participant withdrew consent|1|||
147307152|NCT02200939|531292927|FG000|Overall Study|Lost to Follow-up|2|||
147307153|NCT02200939|531292928|FG001|Overall Study|Lost to Follow-up|9|||
147307154|NCT02200939|531292927|FG000|Overall Study|Subject moved out of town and unable to make it back to study|0|||
147307155|NCT02200939|531292928|FG001|Overall Study|Subject moved out of town and unable to make it back to study|1|||
147307156|NCT02746575|531292929|FG000|Overall Study|Surgery cancelled or time chaned|13|||
147307157|NCT02746575|531292929|FG000|Overall Study|Received epidural|10|||
147307158|NCT02746575|531292929|FG000|Overall Study|Withdrawal by Subject|3|||
147307159|NCT02746575|531292929|FG000|Overall Study|Bradycardia/hypotension|9|||
147307160|NCT02746575|531292929|FG000|Overall Study|Study paused|8|||
147307161|NCT02746575|531292929|FG000|Overall Study|put on beta-blocker|3|||
147307162|NCT02746575|531292929|FG000|Overall Study|type of surgery|1|||
147307163|NCT02746575|531292929|FG000|Overall Study|typ of surgery|1|||
147307164|NCT02746575|531292929|FG000|Overall Study|PI unavailable|1|||
147307165|NCT02746575|531292929|FG000|Overall Study|Unknown history of CVA|1|||
147307166|NCT04867785|531292930|FG000|Overall Study|Adverse Event|1|||
147307167|NCT04867785|531292931|FG001|Overall Study|Adverse Event|0|||
147552107|NCT02497391|532178492|FG005|Period 2 (14 Days)|Withdrawal by Subject|0|||
147552108|NCT02497391|532178487|FG000|Period 2 (14 Days)|Sponsor Decision|3|||
147552109|NCT02497391|532178488|FG001|Period 2 (14 Days)|Sponsor Decision|1|||
147218001|NCT00095147|530969802|FG003|Long-term Extension Period|Leaving country|0|||
147218002|NCT00095147|530969803|FG004|Long-term Extension Period|Leaving country|1|||
147218003|NCT02395302|530969804|FG000|Overall Study|Screen Failure|3|||
147218004|NCT02395302|530969804|FG000|Overall Study|Run In Failure|7|||
147218005|NCT02395302|530969804|FG000|Overall Study|Withdrawal by Subject|2|||
147218006|NCT02395302|530969804|FG000|Overall Study|Physician Decision|2|||
147218007|NCT02650921|530969805|FG000|Overall Study|Withdrawal by Subject|4|||
147218008|NCT02650921|530969805|FG000|Overall Study|Lost to Follow-up|2|||
147218009|NCT02650921|530969805|FG000|Overall Study|Adverse Event|1|||
147218010|NCT02650921|530969805|FG000|Overall Study|Due to Medical Condition|1|||
147218011|NCT00783302|530969806|FG000|Overall Study|Lost to Follow-up|17|||
147218012|NCT00783302|530969806|FG000|Overall Study|Technical Problems|11|||
147218013|NCT00783302|530969806|FG000|Overall Study|Protocol Violation|3|||
147218014|NCT00783302|530969806|FG000|Overall Study|Physician Decision|1|||
147218015|NCT00783302|530969806|FG000|Overall Study|Withdrawal by Subject|3|||
147218016|NCT00160667|530969807|FG000|Overall Study|Adverse Event|3|||
147307168|NCT04867785|531292932|FG002|Overall Study|Adverse Event|1|||
147307169|NCT04867785|531292933|FG003|Overall Study|Adverse Event|0|||
147307170|NCT04867785|531292934|FG004|Overall Study|Adverse Event|0|||
147307171|NCT04867785|531292935|FG005|Overall Study|Adverse Event|0|||
147307172|NCT04867785|531292936|FG006|Overall Study|Adverse Event|0|||
147307173|NCT04867785|531292937|FG007|Overall Study|Adverse Event|2|||
147307174|NCT04867785|531292930|FG000|Overall Study|Lost to Follow-up|4|||
147307175|NCT04867785|531292931|FG001|Overall Study|Lost to Follow-up|4|||
147552110|NCT02497391|532178489|FG002|Period 2 (14 Days)|Sponsor Decision|2|||
147218017|NCT00160667|530969808|FG001|Overall Study|Adverse Event|1|||
147218018|NCT00160667|530969809|FG002|Overall Study|Adverse Event|4|||
147218019|NCT00160667|530969807|FG000|Overall Study|Withdrawal by Subject|2|||
147307176|NCT04867785|531292932|FG002|Overall Study|Lost to Follow-up|3|||
147218020|NCT00160667|530969808|FG001|Overall Study|Withdrawal by Subject|0|||
147218021|NCT00160667|530969809|FG002|Overall Study|Withdrawal by Subject|1|||
147218022|NCT00160667|530969807|FG000|Overall Study|Lack of Efficacy|0|||
147218023|NCT00160667|530969808|FG001|Overall Study|Lack of Efficacy|1|||
147218024|NCT00160667|530969809|FG002|Overall Study|Lack of Efficacy|0|||
147218025|NCT00160667|530969807|FG000|Overall Study|Protocol Violation|0|||
147218026|NCT00160667|530969808|FG001|Overall Study|Protocol Violation|1|||
147218027|NCT00160667|530969809|FG002|Overall Study|Protocol Violation|0|||
147218028|NCT00160667|530969807|FG000|Overall Study|Patient decision|0|||
147218029|NCT00160667|530969808|FG001|Overall Study|Patient decision|0|||
147218030|NCT00160667|530969809|FG002|Overall Study|Patient decision|1|||
147218031|NCT01917656|530969813|FG000|Overall Study|Adverse Event|11|||
147218032|NCT01917656|530969814|FG001|Overall Study|Adverse Event|0|||
147218033|NCT01917656|530969813|FG000|Overall Study|Withdrawal criteria|8|||
147218034|NCT01917656|530969814|FG001|Overall Study|Withdrawal criteria|14|||
147218035|NCT01917656|530969813|FG000|Overall Study|Unclassified|0|||
147218036|NCT01917656|530969814|FG001|Overall Study|Unclassified|3|||
147218037|NCT01917656|530969813|FG000|Overall Study|Withdrawal by Subject|4|||
147218038|NCT01917656|530969814|FG001|Overall Study|Withdrawal by Subject|3|||
147218039|NCT01917656|530969813|FG000|Overall Study|Lost to Follow-up|3|||
147218040|NCT01917656|530969814|FG001|Overall Study|Lost to Follow-up|4|||
147218041|NCT02285062|530969815|FG000|Pre-Treatment Period|Protocol Violation|0|||
147218042|NCT02285062|530969816|FG001|Pre-Treatment Period|Protocol Violation|2|||
147218043|NCT02285062|530969815|FG000|Pre-Treatment Period|Participant withdrew consent|1|||
147218044|NCT02285062|530969816|FG001|Pre-Treatment Period|Participant withdrew consent|0|||
147218045|NCT02015221|530969817|FG000|Overall Study|Withdrawal by Subject|8|||
147218046|NCT02015221|530969818|FG001|Overall Study|Withdrawal by Subject|6|||
147218047|NCT02015221|530969817|FG000|Overall Study|Lost to Follow-up|1|||
147218048|NCT02015221|530969818|FG001|Overall Study|Lost to Follow-up|0|||
147218049|NCT01306929|530969819|FG000|Overall Study|Withdrawal by Subject|23|||
147218050|NCT01306929|530969819|FG000|Overall Study|Adverse Event|21|||
147218051|NCT01306929|530969819|FG000|Overall Study|Physician Decision|13|||
147218052|NCT01306929|530969819|FG000|Overall Study|Death|8|||
147218053|NCT01306929|530969819|FG000|Overall Study|Withdrawal by parent/guardian|5|||
147218054|NCT01306929|530969819|FG000|Overall Study|Protocol Violation|3|||
147218055|NCT01306929|530969819|FG000|Overall Study|Non-compliance with study drug|2|||
147218056|NCT01306929|530969819|FG000|Overall Study|Lost to Follow-up|2|||
147218057|NCT01306929|530969819|FG000|Overall Study|Various|17|||
147218058|NCT03709576|530969825|FG000|Overall Study|progression prior to enrollment|1|||
147218059|NCT03041129|530969829|FG000|Overall Study|Withdrawal by Subject|2|||
147218060|NCT03041129|530969830|FG001|Overall Study|Withdrawal by Subject|0|||
147218061|NCT03041129|530969831|FG002|Overall Study|Withdrawal by Subject|0|||
147218062|NCT03041129|530969832|FG003|Overall Study|Withdrawal by Subject|0|||
147218063|NCT00890045|530969835|FG000|Overall Study|Death|0|||
147218064|NCT00890045|530969836|FG001|Overall Study|Death|1|||
147218065|NCT00890045|530969835|FG000|Overall Study|Did not receive HeRO Graft|0|||
147218066|NCT00890045|530969836|FG001|Overall Study|Did not receive HeRO Graft|2|||
147218067|NCT00890045|530969835|FG000|Overall Study|Lost to Follow-up|5|||
147218068|NCT00890045|530969836|FG001|Overall Study|Lost to Follow-up|7|||
147218069|NCT00510653|530969837|FG000|Overall Study|Withdrawal by Subject|8|||
147218070|NCT00510653|530969837|FG000|Overall Study|Monetary|3|||
147218071|NCT00483756|530969840|FG000|Overall Study|Death|2|||
147218072|NCT00483756|530969841|FG001|Overall Study|Death|0|||
147218073|NCT00483756|530969842|FG002|Overall Study|Death|1|||
147218074|NCT00483756|530969840|FG000|Overall Study|Adverse Event|19|||
147218075|NCT00483756|530969841|FG001|Overall Study|Adverse Event|38|||
147218076|NCT00483756|530969842|FG002|Overall Study|Adverse Event|40|||
147218077|NCT00483756|530969840|FG000|Overall Study|Lack of Efficacy|1|||
147218078|NCT00483756|530969841|FG001|Overall Study|Lack of Efficacy|0|||
147218079|NCT00483756|530969842|FG002|Overall Study|Lack of Efficacy|0|||
147218080|NCT00483756|530969840|FG000|Overall Study|Lost to Follow-up|3|||
147218081|NCT00483756|530969841|FG001|Overall Study|Lost to Follow-up|1|||
147218082|NCT00483756|530969842|FG002|Overall Study|Lost to Follow-up|0|||
147218083|NCT00483756|530969840|FG000|Overall Study|Withdrawal by Subject|5|||
147218084|NCT00483756|530969841|FG001|Overall Study|Withdrawal by Subject|3|||
147218085|NCT00483756|530969842|FG002|Overall Study|Withdrawal by Subject|4|||
147218086|NCT00483756|530969840|FG000|Overall Study|Other|2|||
147218087|NCT00483756|530969841|FG001|Overall Study|Other|4|||
147218088|NCT00483756|530969842|FG002|Overall Study|Other|3|||
147218089|NCT00483756|530969840|FG000|Overall Study|Randomized, Not Treated|1|||
147218090|NCT00483756|530969841|FG001|Overall Study|Randomized, Not Treated|4|||
147218091|NCT00483756|530969842|FG002|Overall Study|Randomized, Not Treated|4|||
147218092|NCT01947855|530969843|FG000|Overall Study|Withdrawal by Subject|1|||
147218093|NCT01947855|530969844|FG001|Overall Study|Withdrawal by Subject|0|||
147218094|NCT01947855|530969845|FG002|Overall Study|Withdrawal by Subject|0|||
147218095|NCT00436501|530969846|FG000|Phase 2: MTD VEGF Trap + Docetaxel|Withdrawal by Subject|0|||
147218096|NCT00436501|530969847|FG001|Phase 2: MTD VEGF Trap + Docetaxel|Withdrawal by Subject|2|||
147218097|NCT00436501|530969846|FG000|Phase 2: MTD VEGF Trap + Docetaxel|Incomplete Assessment|0|||
147307177|NCT04867785|531292933|FG003|Overall Study|Lost to Follow-up|2|||
147307178|NCT04867785|531292934|FG004|Overall Study|Lost to Follow-up|0|||
147307179|NCT04867785|531292935|FG005|Overall Study|Lost to Follow-up|1|||
147307180|NCT04867785|531292936|FG006|Overall Study|Lost to Follow-up|0|||
147307181|NCT04867785|531292937|FG007|Overall Study|Lost to Follow-up|1|||
147307182|NCT04867785|531292930|FG000|Overall Study|Withdrawal by Subject|6|||
147307183|NCT04867785|531292931|FG001|Overall Study|Withdrawal by Subject|2|||
147307184|NCT04867785|531292932|FG002|Overall Study|Withdrawal by Subject|2|||
147307185|NCT04867785|531292933|FG003|Overall Study|Withdrawal by Subject|1|||
147307186|NCT04867785|531292934|FG004|Overall Study|Withdrawal by Subject|2|||
147307187|NCT04867785|531292935|FG005|Overall Study|Withdrawal by Subject|0|||
147307188|NCT04867785|531292936|FG006|Overall Study|Withdrawal by Subject|2|||
147307189|NCT04867785|531292937|FG007|Overall Study|Withdrawal by Subject|5|||
147307190|NCT04867785|531292930|FG000|Overall Study|Physician Decision|0|||
147307191|NCT04867785|531292931|FG001|Overall Study|Physician Decision|0|||
147307192|NCT04867785|531292932|FG002|Overall Study|Physician Decision|0|||
147307193|NCT04867785|531292933|FG003|Overall Study|Physician Decision|0|||
147307194|NCT04867785|531292934|FG004|Overall Study|Physician Decision|0|||
147307195|NCT04867785|531292935|FG005|Overall Study|Physician Decision|0|||
147307196|NCT04867785|531292936|FG006|Overall Study|Physician Decision|0|||
147307197|NCT04867785|531292937|FG007|Overall Study|Physician Decision|1|||
147307198|NCT04867785|531292930|FG000|Overall Study|Inadvertent Enrollment|0|||
147307199|NCT04867785|531292931|FG001|Overall Study|Inadvertent Enrollment|0|||
147307200|NCT04867785|531292932|FG002|Overall Study|Inadvertent Enrollment|0|||
147307201|NCT04867785|531292933|FG003|Overall Study|Inadvertent Enrollment|1|||
147307202|NCT04867785|531292934|FG004|Overall Study|Inadvertent Enrollment|1|||
147307203|NCT04867785|531292935|FG005|Overall Study|Inadvertent Enrollment|0|||
147307204|NCT04867785|531292936|FG006|Overall Study|Inadvertent Enrollment|0|||
147307205|NCT04867785|531292937|FG007|Overall Study|Inadvertent Enrollment|1|||
147307206|NCT04867785|531292930|FG000|Overall Study|Eligibility Criteria Not Met|0|||
147307207|NCT04867785|531292931|FG001|Overall Study|Eligibility Criteria Not Met|0|||
147307208|NCT04867785|531292932|FG002|Overall Study|Eligibility Criteria Not Met|0|||
147307209|NCT04867785|531292933|FG003|Overall Study|Eligibility Criteria Not Met|0|||
147307210|NCT04867785|531292934|FG004|Overall Study|Eligibility Criteria Not Met|0|||
147307211|NCT04867785|531292935|FG005|Overall Study|Eligibility Criteria Not Met|0|||
147307212|NCT04867785|531292936|FG006|Overall Study|Eligibility Criteria Not Met|0|||
147307213|NCT04867785|531292937|FG007|Overall Study|Eligibility Criteria Not Met|1|||
147307214|NCT01486758|531292938|FG000|Overall Study|Lost to Follow-up|0|||
147307215|NCT01486758|531292939|FG001|Overall Study|Lost to Follow-up|1|||
147307216|NCT02494921|531292940|FG000|Phase 1b, Dose Level I|Adverse Event|2|||
147307217|NCT02494921|531292941|FG001|Phase 1b, Dose Level I|Adverse Event|0|||
147307218|NCT02494921|531292942|FG002|Phase 1b, Dose Level I|Adverse Event|0|||
147307219|NCT02494921|531292943|FG003|Phase 1b, Dose Level I|Adverse Event|0|||
147307220|NCT02494921|531292944|FG004|Phase 1b, Dose Level I|Adverse Event|0|||
147307221|NCT02494921|531292940|FG000|Phase 1b, Dose Level IA|Adverse Event|0|||
147307222|NCT02494921|531292941|FG001|Phase 1b, Dose Level IA|Adverse Event|1|||
147307223|NCT02494921|531292942|FG002|Phase 1b, Dose Level IA|Adverse Event|0|||
147307224|NCT02494921|531292943|FG003|Phase 1b, Dose Level IA|Adverse Event|0|||
147307225|NCT02494921|531292944|FG004|Phase 1b, Dose Level IA|Adverse Event|0|||
147307226|NCT02494921|531292940|FG000|Phase 1b, Dose Level IIC|Physician Decision|0|||
147307227|NCT02494921|531292941|FG001|Phase 1b, Dose Level IIC|Physician Decision|0|||
147307228|NCT02494921|531292942|FG002|Phase 1b, Dose Level IIC|Physician Decision|1|||
147307229|NCT02494921|531292943|FG003|Phase 1b, Dose Level IIC|Physician Decision|0|||
147307230|NCT02494921|531292944|FG004|Phase 1b, Dose Level IIC|Physician Decision|0|||
147307231|NCT03239873|531292945|FG000|Overall Study|Lost to Follow-up|15|||
147307232|NCT03239873|531292946|FG001|Overall Study|Lost to Follow-up|16|||
147307233|NCT03239873|531292945|FG000|Overall Study|Physician Decision|1|||
147307234|NCT03239873|531292946|FG001|Overall Study|Physician Decision|0|||
147307235|NCT03239873|531292945|FG000|Overall Study|Withdrawal by Parent/Guardian|12|||
147307236|NCT03239873|531292946|FG001|Overall Study|Withdrawal by Parent/Guardian|11|||
147307237|NCT03239873|531292945|FG000|Overall Study|Withdrawal by Subject|2|||
147307238|NCT03239873|531292946|FG001|Overall Study|Withdrawal by Subject|0|||
147307239|NCT03239873|531292945|FG000|Overall Study|Contraindication to study medication|1|||
147307240|NCT03239873|531292946|FG001|Overall Study|Contraindication to study medication|0|||
147307241|NCT03239873|531292945|FG000|Overall Study|Protocol Violation|1|||
147307242|NCT03239873|531292946|FG001|Overall Study|Protocol Violation|0|||
147307243|NCT03585296|531292951|FG000|Overall Study|Adverse Event|1|||
147307244|NCT03585296|531292951|FG000|Overall Study|Lost to Follow-up|2|||
147307245|NCT03585296|531292951|FG000|Overall Study|Withdrawal by Subject|2|||
147307246|NCT03980184|531292954|FG000|Overall Study|Dropped out before treatment|2|||
147307247|NCT03980184|531292955|FG001|Overall Study|Dropped out before treatment|2|||
147307248|NCT03980184|531292954|FG000|Overall Study|Lost to Follow-up|11|||
147307249|NCT03980184|531292955|FG001|Overall Study|Lost to Follow-up|13|||
147307250|NCT00462670|531292956|FG000|Overall Study|Adverse Event|3|||
147307251|NCT00462670|531292957|FG001|Overall Study|Adverse Event|5|||
147307252|NCT00462670|531292956|FG000|Overall Study|Lack of Efficacy|1|||
147307253|NCT00462670|531292957|FG001|Overall Study|Lack of Efficacy|0|||
147307254|NCT00462670|531292956|FG000|Overall Study|Protocol Violation|1|||
147307255|NCT00462670|531292957|FG001|Overall Study|Protocol Violation|0|||
147307256|NCT00462670|531292956|FG000|Overall Study|Resolution of signs and symptoms|0|||
147307257|NCT00462670|531292957|FG001|Overall Study|Resolution of signs and symptoms|2|||
147307258|NCT02002884|531292958|FG000|Main Period (MP)|Other|0|||
147307259|NCT02002884|531292959|FG001|Main Period (MP)|Other|3|||
147307260|NCT02002884|531292960|FG002|Main Period (MP)|Other|3|||
147307261|NCT02002884|531292961|FG003|Main Period (MP)|Other|0|||
147307262|NCT02002884|531292958|FG000|Main Period (MP)|Adverse Event|0|||
147307263|NCT02002884|531292959|FG001|Main Period (MP)|Adverse Event|1|||
147307264|NCT02002884|531292960|FG002|Main Period (MP)|Adverse Event|1|||
147307265|NCT02002884|531292961|FG003|Main Period (MP)|Adverse Event|0|||
147218098|NCT00436501|530969847|FG001|Phase 2: MTD VEGF Trap + Docetaxel|Incomplete Assessment|1|||
147218099|NCT00495040|530969848|FG000|Overall Study|Withdrawal by Subject|3|||
147218100|NCT00621621|530969853|FG000|Overall Study|Subjects were exited at EP study|30|||
147218101|NCT00621621|530969854|FG001|Overall Study|Subjects were exited at EP study|0|||
147218102|NCT03011892|530969857|FG000|Double Blind (DB) Period|Adverse Event|0|||
147218103|NCT03011892|530969858|FG001|Double Blind (DB) Period|Adverse Event|1|||
147218104|NCT03011892|530969859|FG002|Double Blind (DB) Period|Adverse Event|1|||
147218105|NCT03011892|530969860|FG003|Double Blind (DB) Period|Adverse Event|0|||
147218106|NCT03011892|530969861|FG004|Double Blind (DB) Period|Adverse Event|0|||
147218107|NCT03011892|530969862|FG005|Double Blind (DB) Period|Adverse Event|0|||
147218108|NCT03011892|530969863|FG006|Double Blind (DB) Period|Adverse Event|0|||
147218109|NCT03011892|530969864|FG007|Double Blind (DB) Period|Adverse Event|0|||
147218110|NCT03011892|530969865|FG008|Double Blind (DB) Period|Adverse Event|0|||
147218111|NCT03011892|530969866|FG009|Double Blind (DB) Period|Adverse Event|0|||
147218112|NCT03011892|530969867|FG010|Double Blind (DB) Period|Adverse Event|0|||
147218113|NCT03011892|530969868|FG011|Double Blind (DB) Period|Adverse Event|0|||
147218114|NCT03011892|530969857|FG000|Double Blind (DB) Period|Lack of Efficacy|1|||
147218115|NCT03011892|530969858|FG001|Double Blind (DB) Period|Lack of Efficacy|0|||
147218116|NCT03011892|530969859|FG002|Double Blind (DB) Period|Lack of Efficacy|0|||
147218117|NCT03011892|530969860|FG003|Double Blind (DB) Period|Lack of Efficacy|0|||
147218118|NCT03011892|530969861|FG004|Double Blind (DB) Period|Lack of Efficacy|0|||
147218119|NCT03011892|530969862|FG005|Double Blind (DB) Period|Lack of Efficacy|0|||
147218120|NCT03011892|530969863|FG006|Double Blind (DB) Period|Lack of Efficacy|0|||
147218121|NCT03011892|530969864|FG007|Double Blind (DB) Period|Lack of Efficacy|0|||
147218122|NCT03011892|530969865|FG008|Double Blind (DB) Period|Lack of Efficacy|0|||
147218123|NCT03011892|530969866|FG009|Double Blind (DB) Period|Lack of Efficacy|0|||
147218124|NCT03011892|530969867|FG010|Double Blind (DB) Period|Lack of Efficacy|0|||
147218125|NCT03011892|530969868|FG011|Double Blind (DB) Period|Lack of Efficacy|0|||
147218126|NCT03011892|530969857|FG000|Double Blind (DB) Period|Lost to Follow-up|0|||
147218127|NCT03011892|530969858|FG001|Double Blind (DB) Period|Lost to Follow-up|3|||
147218128|NCT03011892|530969859|FG002|Double Blind (DB) Period|Lost to Follow-up|2|||
147218129|NCT03011892|530969860|FG003|Double Blind (DB) Period|Lost to Follow-up|5|||
147218130|NCT03011892|530969861|FG004|Double Blind (DB) Period|Lost to Follow-up|0|||
147218131|NCT03011892|530969862|FG005|Double Blind (DB) Period|Lost to Follow-up|2|||
147218132|NCT03011892|530969863|FG006|Double Blind (DB) Period|Lost to Follow-up|0|||
147218133|NCT03011892|530969864|FG007|Double Blind (DB) Period|Lost to Follow-up|0|||
147218134|NCT03011892|530969865|FG008|Double Blind (DB) Period|Lost to Follow-up|0|||
147218135|NCT03011892|530969866|FG009|Double Blind (DB) Period|Lost to Follow-up|0|||
147218136|NCT03011892|530969867|FG010|Double Blind (DB) Period|Lost to Follow-up|0|||
147218137|NCT03011892|530969868|FG011|Double Blind (DB) Period|Lost to Follow-up|0|||
147218138|NCT03011892|530969857|FG000|Double Blind (DB) Period|Other|1|||
147218139|NCT03011892|530969858|FG001|Double Blind (DB) Period|Other|1|||
147218140|NCT03011892|530969859|FG002|Double Blind (DB) Period|Other|1|||
147218141|NCT03011892|530969860|FG003|Double Blind (DB) Period|Other|0|||
147218142|NCT03011892|530969861|FG004|Double Blind (DB) Period|Other|1|||
147218143|NCT03011892|530969862|FG005|Double Blind (DB) Period|Other|0|||
147218144|NCT03011892|530969863|FG006|Double Blind (DB) Period|Other|0|||
147218145|NCT03011892|530969864|FG007|Double Blind (DB) Period|Other|0|||
147218146|NCT03011892|530969865|FG008|Double Blind (DB) Period|Other|0|||
147218147|NCT03011892|530969866|FG009|Double Blind (DB) Period|Other|0|||
147218148|NCT03011892|530969867|FG010|Double Blind (DB) Period|Other|0|||
147218149|NCT03011892|530969868|FG011|Double Blind (DB) Period|Other|0|||
147218150|NCT03011892|530969857|FG000|Double Blind (DB) Period|Physician Decision|1|||
147218151|NCT03011892|530969858|FG001|Double Blind (DB) Period|Physician Decision|0|||
147307266|NCT02002884|531292958|FG000|Main Period (MP)|Withdrawal by Subject|6|||
147307267|NCT02002884|531292959|FG001|Main Period (MP)|Withdrawal by Subject|2|||
147218152|NCT03011892|530969859|FG002|Double Blind (DB) Period|Physician Decision|1|||
147218153|NCT03011892|530969860|FG003|Double Blind (DB) Period|Physician Decision|0|||
147218154|NCT03011892|530969861|FG004|Double Blind (DB) Period|Physician Decision|0|||
147218155|NCT03011892|530969862|FG005|Double Blind (DB) Period|Physician Decision|0|||
147307268|NCT02002884|531292960|FG002|Main Period (MP)|Withdrawal by Subject|2|||
147307269|NCT02002884|531292961|FG003|Main Period (MP)|Withdrawal by Subject|0|||
147307270|NCT02002884|531292958|FG000|Main Period (MP)|Lost to Follow-up|0|||
147307271|NCT02002884|531292959|FG001|Main Period (MP)|Lost to Follow-up|0|||
147307272|NCT02002884|531292960|FG002|Main Period (MP)|Lost to Follow-up|2|||
147307273|NCT02002884|531292961|FG003|Main Period (MP)|Lost to Follow-up|0|||
147307274|NCT02002884|531292958|FG000|Open-Label Extension Period (OLEX)|Other|0|||
147307275|NCT02002884|531292959|FG001|Open-Label Extension Period (OLEX)|Other|0|||
147307276|NCT02002884|531292960|FG002|Open-Label Extension Period (OLEX)|Other|0|||
147307277|NCT02002884|531292961|FG003|Open-Label Extension Period (OLEX)|Other|24|||
147307278|NCT02002884|531292958|FG000|Open-Label Extension Period (OLEX)|Physician Decision|0|||
147307279|NCT02002884|531292959|FG001|Open-Label Extension Period (OLEX)|Physician Decision|0|||
147307280|NCT02002884|531292960|FG002|Open-Label Extension Period (OLEX)|Physician Decision|0|||
147307281|NCT02002884|531292961|FG003|Open-Label Extension Period (OLEX)|Physician Decision|1|||
147307282|NCT02002884|531292958|FG000|Open-Label Extension Period (OLEX)|Adverse Event|0|||
147307283|NCT02002884|531292959|FG001|Open-Label Extension Period (OLEX)|Adverse Event|0|||
147307284|NCT02002884|531292960|FG002|Open-Label Extension Period (OLEX)|Adverse Event|0|||
147307285|NCT02002884|531292961|FG003|Open-Label Extension Period (OLEX)|Adverse Event|5|||
147307286|NCT02002884|531292958|FG000|Open-Label Extension Period (OLEX)|Withdrawal by Subject|0|||
147307287|NCT02002884|531292959|FG001|Open-Label Extension Period (OLEX)|Withdrawal by Subject|0|||
147307288|NCT02002884|531292960|FG002|Open-Label Extension Period (OLEX)|Withdrawal by Subject|0|||
147307289|NCT02002884|531292961|FG003|Open-Label Extension Period (OLEX)|Withdrawal by Subject|10|||
147307290|NCT02002884|531292958|FG000|Open-Label Extension Period (OLEX)|Lost to Follow-up|0|||
147307291|NCT02002884|531292959|FG001|Open-Label Extension Period (OLEX)|Lost to Follow-up|0|||
147307292|NCT02002884|531292960|FG002|Open-Label Extension Period (OLEX)|Lost to Follow-up|0|||
147307293|NCT02002884|531292961|FG003|Open-Label Extension Period (OLEX)|Lost to Follow-up|10|||
147307294|NCT02966002|531292962|FG000|Overall Study|Withdrawal by Subject|2|||
147307295|NCT02966002|531292962|FG000|Overall Study|Adverse Event|1|||
147307296|NCT02966002|531292962|FG000|Overall Study|Lost to Follow-up|1|||
147307297|NCT02291432|531292964|FG000|Overall Study|Withdrawal by Subject|2|||
147307298|NCT02145078|531292967|FG000|Overall Study|Death|1|||
147307299|NCT02145078|531292967|FG000|Overall Study|Reason not given|3|||
147307300|NCT03327402|531292968|FG000|Overall Study|Withdrawal by Subject|1|||
147307301|NCT03327402|531292968|FG000|Overall Study|Other (Visit Out-Of-Window)|1|||
147307302|NCT01454830|531292971|FG000|Overall Study|Withdrawal by Subject|4|||
147307303|NCT01454830|531292972|FG001|Overall Study|Withdrawal by Subject|4|||
147307304|NCT01454830|531292971|FG000|Overall Study|Post-allocation Exclude- AHI<10|18|||
147307305|NCT01454830|531292972|FG001|Overall Study|Post-allocation Exclude- AHI<10|12|||
147307306|NCT01454830|531292971|FG000|Overall Study|Post-allocation Exclude-refused PAP|0|||
147307307|NCT01454830|531292972|FG001|Overall Study|Post-allocation Exclude-refused PAP|2|||
147307308|NCT01454830|531292971|FG000|Overall Study|Post-allocation Exclude-other treatment|6|||
147307309|NCT01454830|531292972|FG001|Overall Study|Post-allocation Exclude-other treatment|7|||
147307310|NCT01454830|531292971|FG000|Overall Study|Withdrawal - no polysomnography|3|||
147307311|NCT01454830|531292972|FG001|Overall Study|Withdrawal - no polysomnography|2|||
147307312|NCT00584805|531292975|FG000|Overall Study|No longer at risk of exposure|39|||
147307313|NCT00584805|531292975|FG000|Overall Study|Relocation|36|||
147307314|NCT00584805|531292975|FG000|Overall Study|Withdrawal by Subject|18|||
147307315|NCT00584805|531292975|FG000|Overall Study|Non-compliance|1|||
147307316|NCT00584805|531292975|FG000|Overall Study|Lost to follow up|3|||
147307317|NCT00584805|531292975|FG000|Overall Study|Screen failures|2|||
147307318|NCT03097861|531292977|FG000|Overall Study|Adverse Event|3|||
147307319|NCT03097861|531292978|FG001|Overall Study|Adverse Event|8|||
147307320|NCT03097861|531292979|FG002|Overall Study|Adverse Event|4|||
147307321|NCT03097861|531292977|FG000|Overall Study|Investigator Decision|0|||
147307322|NCT03097861|531292978|FG001|Overall Study|Investigator Decision|1|||
147307323|NCT03097861|531292979|FG002|Overall Study|Investigator Decision|0|||
147307324|NCT03097861|531292977|FG000|Overall Study|Lost to Follow-up|0|||
147307325|NCT03097861|531292978|FG001|Overall Study|Lost to Follow-up|7|||
147307326|NCT03097861|531292979|FG002|Overall Study|Lost to Follow-up|1|||
147307327|NCT03097861|531292977|FG000|Overall Study|Withdrawal by Subject|1|||
147307328|NCT03097861|531292978|FG001|Overall Study|Withdrawal by Subject|5|||
147307329|NCT03097861|531292979|FG002|Overall Study|Withdrawal by Subject|3|||
147307330|NCT03097861|531292977|FG000|Overall Study|Reason not provided|3|||
147307331|NCT03097861|531292978|FG001|Overall Study|Reason not provided|1|||
147307332|NCT03097861|531292979|FG002|Overall Study|Reason not provided|1|||
147307333|NCT01785563|531292980|FG000|Overall Study|Physician Decision|10|||
147307334|NCT01785563|531292980|FG000|Overall Study|Withdrawal by Subject|1|||
147307335|NCT01785563|531292980|FG000|Overall Study|Protocol Violation|2|||
147307336|NCT01616771|531292981|FG000|Smaller Sized GVL for 5 Sec|lack of GVL size|4|||
147307337|NCT00744328|531292982|FG000|Overall Study|Lost to Follow-up|2|||
147307338|NCT00744328|531292983|FG001|Overall Study|Lost to Follow-up|5|||
147307339|NCT00744328|531292984|FG002|Overall Study|Lost to Follow-up|3|||
147307340|NCT00744328|531292982|FG000|Overall Study|Withdrawal by Subject|5|||
147307341|NCT00744328|531292983|FG001|Overall Study|Withdrawal by Subject|3|||
147307342|NCT00744328|531292984|FG002|Overall Study|Withdrawal by Subject|4|||
147307343|NCT00744328|531292982|FG000|Overall Study|Found ineligible after randomization|0|||
147307344|NCT00744328|531292983|FG001|Overall Study|Found ineligible after randomization|0|||
147218156|NCT03011892|530969863|FG006|Double Blind (DB) Period|Physician Decision|0|||
147218157|NCT03011892|530969864|FG007|Double Blind (DB) Period|Physician Decision|0|||
147218158|NCT03011892|530969865|FG008|Double Blind (DB) Period|Physician Decision|0|||
147218159|NCT03011892|530969866|FG009|Double Blind (DB) Period|Physician Decision|0|||
147218160|NCT03011892|530969867|FG010|Double Blind (DB) Period|Physician Decision|0|||
147218161|NCT03011892|530969868|FG011|Double Blind (DB) Period|Physician Decision|0|||
147218162|NCT03011892|530969857|FG000|Double Blind (DB) Period|Pregnancy|0|||
147218163|NCT03011892|530969858|FG001|Double Blind (DB) Period|Pregnancy|0|||
147218164|NCT03011892|530969859|FG002|Double Blind (DB) Period|Pregnancy|0|||
147218165|NCT03011892|530969860|FG003|Double Blind (DB) Period|Pregnancy|0|||
147218166|NCT03011892|530969861|FG004|Double Blind (DB) Period|Pregnancy|1|||
147218167|NCT03011892|530969862|FG005|Double Blind (DB) Period|Pregnancy|0|||
147218168|NCT03011892|530969863|FG006|Double Blind (DB) Period|Pregnancy|0|||
147218169|NCT03011892|530969864|FG007|Double Blind (DB) Period|Pregnancy|0|||
147218170|NCT03011892|530969865|FG008|Double Blind (DB) Period|Pregnancy|0|||
147218171|NCT03011892|530969866|FG009|Double Blind (DB) Period|Pregnancy|0|||
147218172|NCT03011892|530969867|FG010|Double Blind (DB) Period|Pregnancy|0|||
147218173|NCT03011892|530969868|FG011|Double Blind (DB) Period|Pregnancy|0|||
147218174|NCT03011892|530969857|FG000|Double Blind (DB) Period|Protocol Violation|1|||
147218175|NCT03011892|530969858|FG001|Double Blind (DB) Period|Protocol Violation|0|||
147218176|NCT03011892|530969859|FG002|Double Blind (DB) Period|Protocol Violation|0|||
147218177|NCT03011892|530969860|FG003|Double Blind (DB) Period|Protocol Violation|0|||
147218178|NCT03011892|530969861|FG004|Double Blind (DB) Period|Protocol Violation|0|||
147218179|NCT03011892|530969862|FG005|Double Blind (DB) Period|Protocol Violation|0|||
147218180|NCT03011892|530969863|FG006|Double Blind (DB) Period|Protocol Violation|0|||
147218181|NCT03011892|530969864|FG007|Double Blind (DB) Period|Protocol Violation|0|||
147218182|NCT03011892|530969865|FG008|Double Blind (DB) Period|Protocol Violation|0|||
147218183|NCT03011892|530969866|FG009|Double Blind (DB) Period|Protocol Violation|0|||
147218184|NCT03011892|530969867|FG010|Double Blind (DB) Period|Protocol Violation|0|||
147218185|NCT03011892|530969868|FG011|Double Blind (DB) Period|Protocol Violation|0|||
147218186|NCT03011892|530969857|FG000|Double Blind (DB) Period|Withdrawal by Subject|7|||
147218187|NCT03011892|530969858|FG001|Double Blind (DB) Period|Withdrawal by Subject|5|||
147218188|NCT03011892|530969859|FG002|Double Blind (DB) Period|Withdrawal by Subject|1|||
147218189|NCT03011892|530969860|FG003|Double Blind (DB) Period|Withdrawal by Subject|2|||
147218190|NCT03011892|530969861|FG004|Double Blind (DB) Period|Withdrawal by Subject|4|||
147218191|NCT03011892|530969862|FG005|Double Blind (DB) Period|Withdrawal by Subject|3|||
147218192|NCT03011892|530969863|FG006|Double Blind (DB) Period|Withdrawal by Subject|0|||
147218193|NCT03011892|530969864|FG007|Double Blind (DB) Period|Withdrawal by Subject|0|||
147218194|NCT03011892|530969865|FG008|Double Blind (DB) Period|Withdrawal by Subject|0|||
147218195|NCT03011892|530969866|FG009|Double Blind (DB) Period|Withdrawal by Subject|0|||
147218196|NCT03011892|530969867|FG010|Double Blind (DB) Period|Withdrawal by Subject|0|||
147218197|NCT03011892|530969868|FG011|Double Blind (DB) Period|Withdrawal by Subject|0|||
147218198|NCT03011892|530969857|FG000|Double Blind (DB) Period|Randomized but not treated|0|||
147218199|NCT03011892|530969858|FG001|Double Blind (DB) Period|Randomized but not treated|0|||
147218200|NCT03011892|530969859|FG002|Double Blind (DB) Period|Randomized but not treated|0|||
147218201|NCT03011892|530969860|FG003|Double Blind (DB) Period|Randomized but not treated|0|||
147552111|NCT02497391|532178490|FG003|Period 2 (14 Days)|Sponsor Decision|3|||
147552112|NCT02497391|532178491|FG004|Period 2 (14 Days)|Sponsor Decision|2|||
147552113|NCT02497391|532178492|FG005|Period 2 (14 Days)|Sponsor Decision|3|||
147552114|NCT02497391|532178487|FG000|Period 3 (14 Days)|Adverse Event|0|||
147552115|NCT02497391|532178488|FG001|Period 3 (14 Days)|Adverse Event|1|||
147552116|NCT02497391|532178489|FG002|Period 3 (14 Days)|Adverse Event|0|||
147552117|NCT02497391|532178490|FG003|Period 3 (14 Days)|Adverse Event|0|||
147307345|NCT00744328|531292984|FG002|Overall Study|Found ineligible after randomization|1|||
147307346|NCT00154310|531292985|FG000|Overall Study|Adverse Event|19|||
147307347|NCT00154310|531292986|FG001|Overall Study|Adverse Event|9|||
147307348|NCT00154310|531292985|FG000|Overall Study|Lack of Efficacy|5|||
147307349|NCT00154310|531292986|FG001|Overall Study|Lack of Efficacy|4|||
147307350|NCT00154310|531292985|FG000|Overall Study|Protocol Violation|4|||
147552118|NCT02497391|532178491|FG004|Period 3 (14 Days)|Adverse Event|0|||
147307351|NCT00154310|531292986|FG001|Overall Study|Protocol Violation|2|||
147307352|NCT00154310|531292985|FG000|Overall Study|Withdrawal by Subject|9|||
147552119|NCT02497391|532178492|FG005|Period 3 (14 Days)|Adverse Event|0|||
147552120|NCT02497391|532178487|FG000|Period 3 (14 Days)|Sponsor Decision|0|||
147552121|NCT02497391|532178488|FG001|Period 3 (14 Days)|Sponsor Decision|0|||
147552122|NCT02497391|532178489|FG002|Period 3 (14 Days)|Sponsor Decision|0|||
147552123|NCT02497391|532178490|FG003|Period 3 (14 Days)|Sponsor Decision|0|||
147552124|NCT02497391|532178491|FG004|Period 3 (14 Days)|Sponsor Decision|1|||
147552125|NCT02497391|532178492|FG005|Period 3 (14 Days)|Sponsor Decision|0|||
147552126|NCT02497391|532178487|FG000|Period 3 (14 Days)|Withdrawal by Subject|0|||
147552127|NCT02497391|532178488|FG001|Period 3 (14 Days)|Withdrawal by Subject|0|||
147552128|NCT02497391|532178489|FG002|Period 3 (14 Days)|Withdrawal by Subject|1|||
147552129|NCT02497391|532178490|FG003|Period 3 (14 Days)|Withdrawal by Subject|0|||
147552130|NCT02497391|532178491|FG004|Period 3 (14 Days)|Withdrawal by Subject|0|||
147552131|NCT02497391|532178492|FG005|Period 3 (14 Days)|Withdrawal by Subject|0|||
147552132|NCT01664052|532178493|FG000|Phase 1|No device placement|6|||
147552133|NCT01664052|532178494|FG001|Phase 1|No device placement|0|||
147552134|NCT01664052|532178493|FG000|Phase 1|No HSG 1 hr post placement|1|||
147552135|NCT01664052|532178494|FG001|Phase 1|No HSG 1 hr post placement|0|||
147552136|NCT01664052|532178493|FG000|Phase 2|No device placement|0|||
147552137|NCT01664052|532178494|FG001|Phase 2|No device placement|4|||
147552138|NCT03740698|532178495|FG000|Overall Study|Physician Decision|0|||
147552139|NCT03740698|532178496|FG001|Overall Study|Physician Decision|1|||
147552140|NCT03740698|532178497|FG002|Overall Study|Physician Decision|1|||
147552141|NCT01466686|532178501|FG000|Overall Study|Withdrawal by Subject|1|||
147552142|NCT00633152|532178506|FG000|Overall Study|Adverse Event|1|||
147552143|NCT00633152|532178507|FG001|Overall Study|Adverse Event|0|||
147552144|NCT00633152|532178506|FG000|Overall Study|Randomized, did not receive study drug|5|||
147552145|NCT00633152|532178507|FG001|Overall Study|Randomized, did not receive study drug|2|||
147552146|NCT00633152|532178506|FG000|Overall Study|Withdrawal by Subject|1|||
147552147|NCT00633152|532178507|FG001|Overall Study|Withdrawal by Subject|1|||
147552148|NCT00633152|532178506|FG000|Overall Study|Lost to Follow-up|4|||
147552149|NCT00633152|532178507|FG001|Overall Study|Lost to Follow-up|1|||
147552150|NCT00633152|532178506|FG000|Overall Study|Miscellaneous Other|3|||
147552151|NCT00633152|532178507|FG001|Overall Study|Miscellaneous Other|2|||
147552152|NCT05216978|532178509|FG000|Overall Study|Withdrawal by Subject|3|||
147552153|NCT05216978|532178509|FG000|Overall Study|Lost to Follow-up|5|||
147552154|NCT00658320|532178511|FG000|Core Study: 12 Months|Subject withdrew consent|5|||
147552155|NCT00658320|532178512|FG001|Core Study: 12 Months|Subject withdrew consent|3|||
147552156|NCT00658320|532178511|FG000|Extension Study: Month 12 to Month 24|Subject withdrew consent|3|||
147552157|NCT00658320|532178512|FG001|Extension Study: Month 12 to Month 24|Subject withdrew consent|0|||
147552158|NCT00658320|532178511|FG000|Extension Study: Month 12 to Month 24|Did not receive study drug in Extension|3|||
147552159|NCT00658320|532178512|FG001|Extension Study: Month 12 to Month 24|Did not receive study drug in Extension|7|||
147552160|NCT00658320|532178511|FG000|Extension Study: After Month 24|Subject withdrew consent|2|||
147552161|NCT00658320|532178512|FG001|Extension Study: After Month 24|Subject withdrew consent|0|||
147552162|NCT02410252|532178522|FG000|Overall Study|Withdrawal by Subject|4|||
147552163|NCT02410252|532178522|FG000|Overall Study|Physician Decision|2|||
147552164|NCT01007916|532178532|FG000|Period 1, 4 Weeks of Wear|Failed inclusion/exclusion|1|||
147552165|NCT01007916|532178533|FG001|Period 1, 4 Weeks of Wear|Failed inclusion/exclusion|0|||
147552166|NCT01007916|532178532|FG000|Period 2, 4 Weeks of Wear|Relocation|1|||
147552167|NCT01007916|532178533|FG001|Period 2, 4 Weeks of Wear|Relocation|0|||
147552168|NCT02961920|532178537|FG000|Overall Study|did not achive stydy protocol schedule|1|||
147552169|NCT02961920|532178538|FG001|Overall Study|did not achive stydy protocol schedule|1|||
147307353|NCT00154310|531292986|FG001|Overall Study|Withdrawal by Subject|3|||
147552170|NCT03907280|532178541|FG000|Treatment Period 3 + Washout Period 3|Not treated with BI 1265162 because of Serious Adverse Event in Treatment Period 2|0|||
147307354|NCT00154310|531292985|FG000|Overall Study|Lost to Follow-up|0|||
147307355|NCT00154310|531292986|FG001|Overall Study|Lost to Follow-up|8|||
147552171|NCT03907280|532178542|FG001|Treatment Period 3 + Washout Period 3|Not treated with BI 1265162 because of Serious Adverse Event in Treatment Period 2|1|||
147552172|NCT03907280|532178543|FG002|Treatment Period 3 + Washout Period 3|Not treated with BI 1265162 because of Serious Adverse Event in Treatment Period 2|0|||
147307356|NCT00154310|531292985|FG000|Overall Study|Administrative problems|0|||
147307357|NCT00154310|531292986|FG001|Overall Study|Administrative problems|1|||
147307358|NCT00154310|531292985|FG000|Overall Study|Death|0|||
147552173|NCT04480463|532178546|FG000|Overall Study|Death|0|||
147552174|NCT04480463|532178547|FG001|Overall Study|Death|1|||
147552175|NCT04480463|532178546|FG000|Overall Study|Adverse Event|6|||
147552176|NCT04480463|532178547|FG001|Overall Study|Adverse Event|8|||
147552177|NCT04480463|532178546|FG000|Overall Study|Lost to Follow-up|3|||
147552178|NCT04480463|532178547|FG001|Overall Study|Lost to Follow-up|2|||
147552179|NCT04480463|532178546|FG000|Overall Study|Physician Decision|2|||
147552180|NCT04480463|532178547|FG001|Overall Study|Physician Decision|5|||
147552181|NCT04480463|532178546|FG000|Overall Study|Decision by the sponsor or administrative decision for a reason other than that of an AE|2|||
147552182|NCT04480463|532178547|FG001|Overall Study|Decision by the sponsor or administrative decision for a reason other than that of an AE|3|||
147552183|NCT04480463|532178546|FG000|Overall Study|Protocol Violation|2|||
147552184|NCT04480463|532178547|FG001|Overall Study|Protocol Violation|1|||
147552185|NCT04480463|532178546|FG000|Overall Study|Withdrawal by Subject|6|||
147552186|NCT04480463|532178547|FG001|Overall Study|Withdrawal by Subject|7|||
147552187|NCT04480463|532178546|FG000|Overall Study|Subject missed any of first 2 doses (IVT I injection of IP at Day 1 or Week 4) after randomization|0|||
147552188|NCT04480463|532178547|FG001|Overall Study|Subject missed any of first 2 doses (IVT I injection of IP at Day 1 or Week 4) after randomization|1|||
147552189|NCT04480463|532178546|FG000|Overall Study|A decrease in BCVA of ≥30 letters compared with the last assessment of VA|1|||
147552190|NCT04480463|532178547|FG001|Overall Study|A decrease in BCVA of ≥30 letters compared with the last assessment of VA|0|||
147552191|NCT04480463|532178546|FG000|Overall Study|Subretinal hemorrhage involving center of fovea or, size of hemorrhage was ≥50% of total lesion area|1|||
147552192|NCT04480463|532178547|FG001|Overall Study|Subretinal hemorrhage involving center of fovea or, size of hemorrhage was ≥50% of total lesion area|0|||
147552193|NCT04480463|532178546|FG000|Overall Study|Other|6|||
147552194|NCT04480463|532178547|FG001|Overall Study|Other|4|||
147552195|NCT00444795|532178548|FG000|Overall Study|Not Treated|1|||
147552196|NCT00444795|532178548|FG000|Overall Study|Treated Prior to the Contract Date|2|||
147552197|NCT02322879|532178549|FG000|First Intervention|Physician Decision|1|||
147552198|NCT02322879|532178550|FG001|First Intervention|Physician Decision|0|||
147552199|NCT04081337|532178551|FG000|Overall Study|Adverse Event|0|||
147552200|NCT04081337|532178552|FG001|Overall Study|Adverse Event|1|||
147552201|NCT04081337|532178551|FG000|Overall Study|Withdrawal by Subject|2|||
147552202|NCT04081337|532178552|FG001|Overall Study|Withdrawal by Subject|0|||
147552203|NCT04081337|532178551|FG000|Overall Study|Physician Decision|1|||
147552204|NCT04081337|532178552|FG001|Overall Study|Physician Decision|2|||
147552205|NCT04081337|532178551|FG000|Overall Study|Lost to Follow-up|1|||
147552206|NCT04081337|532178552|FG001|Overall Study|Lost to Follow-up|0|||
147552207|NCT00130520|532178553|FG000|Overall Study|Adverse Event|11|||
147552208|NCT00130520|532178553|FG000|Overall Study|Death|1|||
147552209|NCT00130520|532178553|FG000|Overall Study|Physician Decision|1|||
147552210|NCT00130520|532178553|FG000|Overall Study|Withdrawal by Subject|1|||
147552211|NCT00130520|532178553|FG000|Overall Study|Disease Progression|23|||
147552212|NCT00130520|532178553|FG000|Overall Study|Protocol non-compliance|1|||
147552213|NCT00130520|532178553|FG000|Overall Study|Did not meet re-treatment criteria|1|||
147552214|NCT03487796|532178554|FG000|Overall Study|Lost to Follow-up|18|||
147552215|NCT03487796|532178555|FG001|Overall Study|Lost to Follow-up|6|||
147552216|NCT00613574|532178558|FG000|Overall Study|Adverse Event|3|||
147552217|NCT00613574|532178558|FG000|Overall Study|Lost to Follow-up|2|||
147552218|NCT00613574|532178558|FG000|Overall Study|Other|1|||
147552219|NCT05487456|532178560|FG000|Overall Study|Withdrawal by Subject|0|||
147552220|NCT05487456|532178561|FG001|Overall Study|Withdrawal by Subject|0|||
147552221|NCT05487456|532178562|FG002|Overall Study|Withdrawal by Subject|1|||
147552222|NCT05487456|532178563|FG003|Overall Study|Withdrawal by Subject|0|||
147552223|NCT02711956|532178564|FG000|Overall Study|Adverse Event|0|||
147552224|NCT02711956|532178565|FG001|Overall Study|Adverse Event|0|||
147552225|NCT02711956|532178566|FG002|Overall Study|Adverse Event|0|||
147552226|NCT02711956|532178567|FG003|Overall Study|Adverse Event|1|||
147552227|NCT02711956|532178568|FG004|Overall Study|Adverse Event|2|||
147552228|NCT02711956|532178569|FG005|Overall Study|Adverse Event|0|||
147552229|NCT02711956|532178570|FG006|Overall Study|Adverse Event|0|||
147552230|NCT02711956|532178571|FG007|Overall Study|Adverse Event|1|||
147552231|NCT02711956|532178572|FG008|Overall Study|Adverse Event|1|||
147552232|NCT02711956|532178573|FG009|Overall Study|Adverse Event|1|||
147552233|NCT02711956|532178574|FG010|Overall Study|Adverse Event|1|||
147552234|NCT02711956|532178575|FG011|Overall Study|Adverse Event|0|||
147552235|NCT02711956|532178576|FG012|Overall Study|Adverse Event|0|||
147552236|NCT02711956|532178577|FG013|Overall Study|Adverse Event|0|||
147552237|NCT02711956|532178578|FG014|Overall Study|Adverse Event|2|||
147552238|NCT02711956|532178564|FG000|Overall Study|Physician Decision|0|||
147552239|NCT02711956|532178565|FG001|Overall Study|Physician Decision|0|||
147552240|NCT02711956|532178566|FG002|Overall Study|Physician Decision|0|||
147552241|NCT02711956|532178567|FG003|Overall Study|Physician Decision|2|||
147552242|NCT02711956|532178568|FG004|Overall Study|Physician Decision|0|||
147552243|NCT02711956|532178569|FG005|Overall Study|Physician Decision|0|||
147552244|NCT02711956|532178570|FG006|Overall Study|Physician Decision|0|||
147552245|NCT02711956|532178571|FG007|Overall Study|Physician Decision|0|||
147552246|NCT02711956|532178572|FG008|Overall Study|Physician Decision|0|||
147552247|NCT02711956|532178573|FG009|Overall Study|Physician Decision|0|||
147552248|NCT02711956|532178574|FG010|Overall Study|Physician Decision|0|||
147552249|NCT02711956|532178575|FG011|Overall Study|Physician Decision|0|||
147552250|NCT02711956|532178576|FG012|Overall Study|Physician Decision|0|||
147307359|NCT00154310|531292986|FG001|Overall Study|Death|1|||
147307360|NCT04041440|531292987|FG000|Overall Study|Withdrawal by Subject|0|||
147307361|NCT04041440|531292988|FG001|Overall Study|Withdrawal by Subject|1|||
147307362|NCT04041440|531292987|FG000|Overall Study|Lost to Follow-up|0|||
147307363|NCT04041440|531292988|FG001|Overall Study|Lost to Follow-up|1|||
147307364|NCT02247804|531292989|FG000|Treatment Period 1|Adverse Event|9|||
147307365|NCT02247804|531292990|FG001|Treatment Period 1|Adverse Event|2|||
147307366|NCT02247804|531292991|FG002|Treatment Period 1|Adverse Event|0|||
147307367|NCT02247804|531292989|FG000|Treatment Period 1|Lack of Efficacy|0|||
147307368|NCT02247804|531292990|FG001|Treatment Period 1|Lack of Efficacy|0|||
147307369|NCT02247804|531292991|FG002|Treatment Period 1|Lack of Efficacy|2|||
147307370|NCT02247804|531292989|FG000|Treatment Period 1|Lost to Follow-up|1|||
147307371|NCT02247804|531292990|FG001|Treatment Period 1|Lost to Follow-up|0|||
147307372|NCT02247804|531292991|FG002|Treatment Period 1|Lost to Follow-up|2|||
147307373|NCT02247804|531292989|FG000|Treatment Period 1|Personal Reasons|7|||
147307374|NCT02247804|531292990|FG001|Treatment Period 1|Personal Reasons|1|||
147307375|NCT02247804|531292991|FG002|Treatment Period 1|Personal Reasons|2|||
147307376|NCT02247804|531292989|FG000|Treatment Period 1|Protocol Deviation|0|||
147307377|NCT02247804|531292990|FG001|Treatment Period 1|Protocol Deviation|0|||
147307378|NCT02247804|531292991|FG002|Treatment Period 1|Protocol Deviation|1|||
147307379|NCT02247804|531292989|FG000|Treatment Period 1|Randomized but not Treated|5|||
147307380|NCT02247804|531292990|FG001|Treatment Period 1|Randomized but not Treated|1|||
147307381|NCT02247804|531292991|FG002|Treatment Period 1|Randomized but not Treated|1|||
147307382|NCT02247804|531292989|FG000|Treatment Period 2|Adverse Event|6|||
147307383|NCT02247804|531292990|FG001|Treatment Period 2|Adverse Event|3|||
147307384|NCT02247804|531292991|FG002|Treatment Period 2|Adverse Event|3|||
147307385|NCT02247804|531292989|FG000|Treatment Period 2|Lack of Efficacy|0|||
147307386|NCT02247804|531292990|FG001|Treatment Period 2|Lack of Efficacy|0|||
147307387|NCT02247804|531292991|FG002|Treatment Period 2|Lack of Efficacy|1|||
147307388|NCT02247804|531292989|FG000|Treatment Period 2|Lost to Follow-up|0|||
147307389|NCT02247804|531292990|FG001|Treatment Period 2|Lost to Follow-up|1|||
147307390|NCT02247804|531292991|FG002|Treatment Period 2|Lost to Follow-up|1|||
147218202|NCT03011892|530969861|FG004|Double Blind (DB) Period|Randomized but not treated|1|||
147218203|NCT03011892|530969862|FG005|Double Blind (DB) Period|Randomized but not treated|0|||
147218204|NCT03011892|530969863|FG006|Double Blind (DB) Period|Randomized but not treated|0|||
147218205|NCT03011892|530969864|FG007|Double Blind (DB) Period|Randomized but not treated|0|||
147218206|NCT03011892|530969865|FG008|Double Blind (DB) Period|Randomized but not treated|0|||
147218207|NCT03011892|530969866|FG009|Double Blind (DB) Period|Randomized but not treated|0|||
147218208|NCT03011892|530969867|FG010|Double Blind (DB) Period|Randomized but not treated|0|||
147218209|NCT03011892|530969868|FG011|Double Blind (DB) Period|Randomized but not treated|0|||
147218210|NCT03011892|530969857|FG000|Open Label (OL) Period|Lost to Follow-up|0|||
147218211|NCT03011892|530969858|FG001|Open Label (OL) Period|Lost to Follow-up|0|||
147218212|NCT03011892|530969859|FG002|Open Label (OL) Period|Lost to Follow-up|0|||
147218213|NCT03011892|530969860|FG003|Open Label (OL) Period|Lost to Follow-up|0|||
147218214|NCT03011892|530969861|FG004|Open Label (OL) Period|Lost to Follow-up|0|||
147218215|NCT03011892|530969862|FG005|Open Label (OL) Period|Lost to Follow-up|0|||
147218216|NCT03011892|530969863|FG006|Open Label (OL) Period|Lost to Follow-up|4|||
147218217|NCT03011892|530969864|FG007|Open Label (OL) Period|Lost to Follow-up|2|||
147218218|NCT03011892|530969865|FG008|Open Label (OL) Period|Lost to Follow-up|1|||
147218219|NCT03011892|530969866|FG009|Open Label (OL) Period|Lost to Follow-up|0|||
147218220|NCT03011892|530969867|FG010|Open Label (OL) Period|Lost to Follow-up|1|||
147218221|NCT03011892|530969868|FG011|Open Label (OL) Period|Lost to Follow-up|1|||
147307391|NCT02247804|531292989|FG000|Treatment Period 2|Personal Reasons|2|||
147307392|NCT02247804|531292990|FG001|Treatment Period 2|Personal Reasons|1|||
147307393|NCT02247804|531292991|FG002|Treatment Period 2|Personal Reasons|1|||
147307394|NCT02247804|531292989|FG000|Treatment Period 2|Reason not Specified|0|||
147307395|NCT02247804|531292990|FG001|Treatment Period 2|Reason not Specified|0|||
147307396|NCT02247804|531292991|FG002|Treatment Period 2|Reason not Specified|2|||
147307397|NCT02247804|531292989|FG000|Treatment Period 3|Adverse Event|4|||
147443056|NCT00847145|531787148|FG006|Overall Study|Protocol Violation|0|||
147443057|NCT00847145|531787149|FG007|Overall Study|Protocol Violation|1|||
147443058|NCT00980200|531787153|FG000|7-day Treatment Period 1|Withdrawal by Subject|0|||
147443059|NCT00980200|531787154|FG001|7-day Treatment Period 1|Withdrawal by Subject|1|||
147443060|NCT00980200|531787155|FG002|7-day Treatment Period 1|Withdrawal by Subject|0|||
147443061|NCT00980200|531787156|FG003|7-day Treatment Period 1|Withdrawal by Subject|0|||
147443062|NCT00980200|531787157|FG004|7-day Treatment Period 1|Withdrawal by Subject|0|||
147443063|NCT00980200|531787153|FG000|7-day Treatment Period 3|Lack of Efficacy|0|||
147443064|NCT00980200|531787154|FG001|7-day Treatment Period 3|Lack of Efficacy|1|||
147443065|NCT00980200|531787155|FG002|7-day Treatment Period 3|Lack of Efficacy|0|||
147443066|NCT00980200|531787156|FG003|7-day Treatment Period 3|Lack of Efficacy|0|||
147443067|NCT00980200|531787157|FG004|7-day Treatment Period 3|Lack of Efficacy|1|||
147443068|NCT03703882|531787158|FG000|Overall Study|Adverse Event|1|||
147443069|NCT03703882|531787159|FG001|Overall Study|Adverse Event|0|||
147443070|NCT03703882|531787158|FG000|Overall Study|Lost to Follow-up|0|||
147443071|NCT03703882|531787159|FG001|Overall Study|Lost to Follow-up|2|||
147307398|NCT02247804|531292990|FG001|Treatment Period 3|Adverse Event|3|||
147307399|NCT02247804|531292991|FG002|Treatment Period 3|Adverse Event|3|||
147307400|NCT02247804|531292989|FG000|Treatment Period 3|Lack of Efficacy|0|||
147307401|NCT02247804|531292990|FG001|Treatment Period 3|Lack of Efficacy|1|||
147307402|NCT02247804|531292991|FG002|Treatment Period 3|Lack of Efficacy|0|||
147307403|NCT02247804|531292989|FG000|Treatment Period 3|Lost to Follow-up|1|||
147307404|NCT02247804|531292990|FG001|Treatment Period 3|Lost to Follow-up|2|||
147307405|NCT02247804|531292991|FG002|Treatment Period 3|Lost to Follow-up|2|||
147307406|NCT02247804|531292989|FG000|Treatment Period 3|Personal Reasons|4|||
147307407|NCT02247804|531292990|FG001|Treatment Period 3|Personal Reasons|3|||
147307408|NCT02247804|531292991|FG002|Treatment Period 3|Personal Reasons|2|||
147307409|NCT02247804|531292989|FG000|Treatment Period 3|Reason not Specified|2|||
147307410|NCT02247804|531292990|FG001|Treatment Period 3|Reason not Specified|1|||
147307411|NCT02247804|531292991|FG002|Treatment Period 3|Reason not Specified|3|||
147307412|NCT03447730|531292996|FG000|Overall Study|Adverse Event|0|||
147307413|NCT03447730|531292997|FG001|Overall Study|Adverse Event|2|||
147307414|NCT03447730|531292998|FG002|Overall Study|Adverse Event|0|||
147307415|NCT01350505|531293002|FG000|Overall Study|Lost to Follow-up|4|||
147307416|NCT04251065|531293006|FG000|Overall Study|Death|2|||
147307417|NCT04251065|531293006|FG000|Overall Study|Lack of Efficacy|3|||
147307418|NCT04251065|531293006|FG000|Overall Study|Death|1|||
147307419|NCT01054573|531293007|FG000|Overall Study|Adverse Event|1|||
147307420|NCT01054573|531293008|FG001|Overall Study|Adverse Event|0|||
147307421|NCT01054573|531293009|FG002|Overall Study|Adverse Event|1|||
147307422|NCT01054573|531293010|FG003|Overall Study|Adverse Event|1|||
147307423|NCT01054573|531293007|FG000|Overall Study|Lost to Follow-up|0|||
147307424|NCT01054573|531293008|FG001|Overall Study|Lost to Follow-up|2|||
147307425|NCT01054573|531293009|FG002|Overall Study|Lost to Follow-up|0|||
147307426|NCT01054573|531293010|FG003|Overall Study|Lost to Follow-up|0|||
147307427|NCT01054573|531293007|FG000|Overall Study|Withdrawal by Subject|0|||
147218222|NCT03011892|530969857|FG000|Open Label (OL) Period|Withdrawal by Subject|0|||
147218223|NCT03011892|530969858|FG001|Open Label (OL) Period|Withdrawal by Subject|0|||
147218224|NCT03011892|530969859|FG002|Open Label (OL) Period|Withdrawal by Subject|0|||
147218225|NCT03011892|530969860|FG003|Open Label (OL) Period|Withdrawal by Subject|0|||
147218226|NCT03011892|530969861|FG004|Open Label (OL) Period|Withdrawal by Subject|0|||
147218227|NCT03011892|530969862|FG005|Open Label (OL) Period|Withdrawal by Subject|0|||
147218228|NCT03011892|530969863|FG006|Open Label (OL) Period|Withdrawal by Subject|3|||
147218229|NCT03011892|530969864|FG007|Open Label (OL) Period|Withdrawal by Subject|0|||
147218230|NCT03011892|530969865|FG008|Open Label (OL) Period|Withdrawal by Subject|1|||
147218231|NCT03011892|530969866|FG009|Open Label (OL) Period|Withdrawal by Subject|0|||
147218232|NCT03011892|530969867|FG010|Open Label (OL) Period|Withdrawal by Subject|1|||
147218233|NCT03011892|530969868|FG011|Open Label (OL) Period|Withdrawal by Subject|2|||
147218234|NCT03011892|530969857|FG000|Open Label (OL) Period|Reason not specified|0|||
147218235|NCT03011892|530969858|FG001|Open Label (OL) Period|Reason not specified|0|||
147218236|NCT03011892|530969859|FG002|Open Label (OL) Period|Reason not specified|0|||
147218237|NCT03011892|530969860|FG003|Open Label (OL) Period|Reason not specified|0|||
147218238|NCT03011892|530969861|FG004|Open Label (OL) Period|Reason not specified|0|||
147218239|NCT03011892|530969862|FG005|Open Label (OL) Period|Reason not specified|0|||
147218240|NCT03011892|530969863|FG006|Open Label (OL) Period|Reason not specified|0|||
147218241|NCT03011892|530969864|FG007|Open Label (OL) Period|Reason not specified|1|||
147218242|NCT03011892|530969865|FG008|Open Label (OL) Period|Reason not specified|0|||
147218243|NCT03011892|530969866|FG009|Open Label (OL) Period|Reason not specified|0|||
147218244|NCT03011892|530969867|FG010|Open Label (OL) Period|Reason not specified|0|||
147218245|NCT03011892|530969868|FG011|Open Label (OL) Period|Reason not specified|0|||
147218246|NCT02282293|530969869|FG000|Overall Study|Lost to Follow-up|2|||
147218247|NCT02282293|530969870|FG001|Overall Study|Lost to Follow-up|2|||
147218248|NCT02282293|530969869|FG000|Overall Study|Unable to comply with study procedures|1|||
147218249|NCT02282293|530969870|FG001|Overall Study|Unable to comply with study procedures|0|||
147218250|NCT02282293|530969869|FG000|Overall Study|Moved out of study area|0|||
147218251|NCT02282293|530969870|FG001|Overall Study|Moved out of study area|1|||
147218252|NCT00384111|530969883|FG000|Overall Study|Disease Progression|3|||
147218253|NCT00384111|530969883|FG000|Overall Study|Adverse Event|1|||
147218254|NCT00384111|530969883|FG000|Overall Study|Investigator Decision|3|||
147218255|NCT00384111|530969883|FG000|Overall Study|Study Terminated by the Sponsor|19|||
147218256|NCT00906971|530969884|FG000|Overall Study|Withdrawal by Subject|8|||
147218257|NCT00906971|530969885|FG001|Overall Study|Withdrawal by Subject|2|||
147218258|NCT00906971|530969884|FG000|Overall Study|Lost to Follow-up|0|||
147218259|NCT00906971|530969885|FG001|Overall Study|Lost to Follow-up|1|||
147218260|NCT01551420|530969886|FG000|In-laboratory (Part A)|Lost to Follow-up|2|||
147218261|NCT01551420|530969887|FG001|In-laboratory (Part A)|Lost to Follow-up|1|||
147218262|NCT01551420|530969886|FG000|In-laboratory (Part A)|Withdrawal by Subject|2|||
147218263|NCT01551420|530969887|FG001|In-laboratory (Part A)|Withdrawal by Subject|0|||
147218264|NCT01551420|530969886|FG000|In-laboratory (Part A)|Scheduling conflict|2|||
147218265|NCT01551420|530969887|FG001|In-laboratory (Part A)|Scheduling conflict|1|||
147218266|NCT01551420|530969886|FG000|Screened for Part B Eligibility|Declined participation|8|||
147218267|NCT01551420|530969887|FG001|Screened for Part B Eligibility|Declined participation|1|||
147218268|NCT01551420|530969886|FG000|Screened for Part B Eligibility|Deemed ineligible by staff|1|||
147218269|NCT01551420|530969887|FG001|Screened for Part B Eligibility|Deemed ineligible by staff|2|||
147218270|NCT01551420|530969886|FG000|Home Use (Part B)|Withdrawal by Subject|6|||
147218271|NCT01551420|530969887|FG001|Home Use (Part B)|Withdrawal by Subject|0|||
147218272|NCT01551420|530969886|FG000|Home Use (Part B)|Withdrawal by staff|0|||
147218273|NCT01551420|530969887|FG001|Home Use (Part B)|Withdrawal by staff|1|||
147218274|NCT00169442|530969888|FG000|Overall Study|Withdrawal by Subject|0|||
147218275|NCT00169442|530969889|FG001|Overall Study|Withdrawal by Subject|0|||
147218276|NCT00169442|530969890|FG002|Overall Study|Withdrawal by Subject|1|||
147218277|NCT00169442|530969891|FG003|Overall Study|Withdrawal by Subject|0|||
147218278|NCT00169442|530969892|FG004|Overall Study|Withdrawal by Subject|0|||
147307428|NCT01054573|531293008|FG001|Overall Study|Withdrawal by Subject|2|||
147307429|NCT01054573|531293009|FG002|Overall Study|Withdrawal by Subject|2|||
147218279|NCT00169442|530969893|FG005|Overall Study|Withdrawal by Subject|0|||
147218280|NCT00169442|530969888|FG000|Overall Study|Migrated/moved from study area|0|||
147218281|NCT00169442|530969889|FG001|Overall Study|Migrated/moved from study area|0|||
147218282|NCT00169442|530969890|FG002|Overall Study|Migrated/moved from study area|0|||
147218283|NCT00169442|530969891|FG003|Overall Study|Migrated/moved from study area|0|||
147307430|NCT01054573|531293010|FG003|Overall Study|Withdrawal by Subject|1|||
147218284|NCT00169442|530969892|FG004|Overall Study|Migrated/moved from study area|0|||
147218285|NCT00169442|530969893|FG005|Overall Study|Migrated/moved from study area|2|||
147218286|NCT00169442|530969888|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
147218287|NCT00169442|530969889|FG001|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
147218288|NCT00169442|530969890|FG002|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
147307431|NCT05266963|531293011|FG000|Drug Period A|Withdrawal by Subject|0|||
147218289|NCT00169442|530969891|FG003|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
147218290|NCT00169442|530969892|FG004|Overall Study|Lost to follow-up (incompl. vaccination)|1|||
147218291|NCT00169442|530969893|FG005|Overall Study|Lost to follow-up (incompl. vaccination)|0|||
147218292|NCT00169442|530969888|FG000|Overall Study|Lost to follow-up (compl. vaccination)|0|||
147218293|NCT00169442|530969889|FG001|Overall Study|Lost to follow-up (compl. vaccination)|1|||
147218294|NCT00169442|530969890|FG002|Overall Study|Lost to follow-up (compl. vaccination)|0|||
147218295|NCT00169442|530969891|FG003|Overall Study|Lost to follow-up (compl. vaccination)|0|||
147218296|NCT00169442|530969892|FG004|Overall Study|Lost to follow-up (compl. vaccination)|0|||
147218297|NCT00169442|530969893|FG005|Overall Study|Lost to follow-up (compl. vaccination)|0|||
147218298|NCT04463069|530969896|FG000|Overall Study|Withdrawal by Subject|2|||
147218299|NCT04463069|530969897|FG001|Overall Study|Withdrawal by Subject|10|||
147218300|NCT04463069|530969896|FG000|Overall Study|Participants' parents refused to participate after learning the assignment results|0|||
147218301|NCT04463069|530969897|FG001|Overall Study|Participants' parents refused to participate after learning the assignment results|13|||
147218302|NCT00336583|530971432|FG000|Overall Study|Lost to Follow-up|1|||
147218303|NCT00336583|530971432|FG000|Overall Study|Death|1|||
147218304|NCT04966910|530971433|FG000|Baseline|Participant did not complete measure|0|||
147218305|NCT04966910|530971434|FG001|Baseline|Participant did not complete measure|0|||
147218306|NCT04966910|530971435|FG002|Baseline|Participant did not complete measure|1|||
147218307|NCT04966910|530971436|FG003|Baseline|Participant did not complete measure|0|||
147218308|NCT04966910|530971433|FG000|4-Week Follow-Up|Clients did not complete measure at this timepoint|5|||
147218309|NCT04966910|530971434|FG001|4-Week Follow-Up|Clients did not complete measure at this timepoint|4|||
147218310|NCT04966910|530971435|FG002|4-Week Follow-Up|Clients did not complete measure at this timepoint|0|||
147218311|NCT04966910|530971436|FG003|4-Week Follow-Up|Clients did not complete measure at this timepoint|0|||
147218312|NCT04966910|530971433|FG000|9-Week Follow-Up|Withdrawal by Subject|0|||
147218313|NCT04966910|530971434|FG001|9-Week Follow-Up|Withdrawal by Subject|0|||
147218314|NCT04966910|530971435|FG002|9-Week Follow-Up|Withdrawal by Subject|0|||
147218315|NCT04966910|530971436|FG003|9-Week Follow-Up|Withdrawal by Subject|2|||
147218316|NCT04966910|530971433|FG000|9-Week Follow-Up|Participant did not complete measure|3|||
147218317|NCT04966910|530971434|FG001|9-Week Follow-Up|Participant did not complete measure|1|||
147218318|NCT04966910|530971435|FG002|9-Week Follow-Up|Participant did not complete measure|0|||
147218319|NCT04966910|530971436|FG003|9-Week Follow-Up|Participant did not complete measure|0|||
147218320|NCT03328182|530971446|FG000|Overall Study|Withdrawal by Subject|1|||
147218321|NCT03328182|530971446|FG000|Overall Study|Protocol Violation|2|||
147218322|NCT03328182|530971446|FG000|Overall Study|No Product Evaluated|1|||
147218323|NCT04531462|530971447|FG000|Overall Study|Withdrawal by Subject|3|||
147218324|NCT04531462|530971448|FG001|Overall Study|Withdrawal by Subject|1|||
147218325|NCT04531462|530971447|FG000|Overall Study|Adverse Event|3|||
147218326|NCT04531462|530971448|FG001|Overall Study|Adverse Event|3|||
147218327|NCT00504582|530971449|FG000|Overall Study|Lost to Follow-up|1|||
147218328|NCT00504582|530971450|FG001|Overall Study|Lost to Follow-up|0|||
147218329|NCT00504582|530971451|FG002|Overall Study|Lost to Follow-up|0|||
147218330|NCT00348933|530971454|FG000|Overall Study|Withdrawal by Subject|10|||
147218331|NCT00348933|530971454|FG000|Overall Study|Lost to Follow-up|6|||
147218332|NCT00348933|530971454|FG000|Overall Study|Protocol Violation|2|||
147218333|NCT00348933|530971454|FG000|Overall Study|Adverse Event|7|||
147218334|NCT01264081|530971455|FG000|Participants Screened|Screening failures|30|||
147218335|NCT01264081|530971455|FG000|Started Treatment|Withdrawal by Subject|1|||
147218336|NCT01264081|530971455|FG000|Started Treatment|Not complete cycle 1 due to death|1|||
147218337|NCT01489111|530971456|FG000|Overall Study|Withdrawal criterion|1|||
147218338|NCT02716896|530971457|FG000|Overall Study|Physician Decision|0|||
147218339|NCT02716896|530971458|FG001|Overall Study|Physician Decision|1|||
147218340|NCT01727700|530971459|FG000|Overall Study|Adverse Event|0|||
147218341|NCT01727700|530971460|FG001|Overall Study|Adverse Event|7|||
147218342|NCT01727700|530971461|FG002|Overall Study|Adverse Event|1|||
147218343|NCT01727700|530971459|FG000|Overall Study|Particpant withdrew consent|0|||
147218344|NCT01727700|530971460|FG001|Overall Study|Particpant withdrew consent|3|||
147218345|NCT01727700|530971461|FG002|Overall Study|Particpant withdrew consent|1|||
147218346|NCT01727700|530971459|FG000|Overall Study|Protocol Violation|2|||
147218347|NCT01727700|530971460|FG001|Overall Study|Protocol Violation|0|||
147218348|NCT01727700|530971461|FG002|Overall Study|Protocol Violation|0|||
147218349|NCT01757691|530971466|FG000|Overall Study|Administrative problems|2|||
147218350|NCT01757691|530971467|FG001|Overall Study|Administrative problems|0|||
147218351|NCT02054481|530971471|FG000|Overall Study|Adverse Event|1|||
147218352|NCT02054481|530971472|FG001|Overall Study|Adverse Event|1|||
147218353|NCT02054481|530971473|FG002|Overall Study|Adverse Event|0|||
147218354|NCT02054481|530971474|FG003|Overall Study|Adverse Event|1|||
147307432|NCT05266963|531293012|FG001|Drug Period A|Withdrawal by Subject|1|||
147218355|NCT02054481|530971471|FG000|Overall Study|Lost to Follow-up|1|||
147218356|NCT02054481|530971472|FG001|Overall Study|Lost to Follow-up|0|||
147218357|NCT02054481|530971473|FG002|Overall Study|Lost to Follow-up|0|||
147218358|NCT02054481|530971474|FG003|Overall Study|Lost to Follow-up|0|||
147218359|NCT02054481|530971471|FG000|Overall Study|Other reason|2|||
147218360|NCT02054481|530971472|FG001|Overall Study|Other reason|1|||
147218361|NCT02054481|530971473|FG002|Overall Study|Other reason|2|||
147218362|NCT02054481|530971474|FG003|Overall Study|Other reason|0|||
147218363|NCT02320903|530971475|FG000|Overall Study|Withdrawal by Subject|0|||
147218364|NCT02320903|530971476|FG001|Overall Study|Withdrawal by Subject|9|||
147218365|NCT02320903|530971477|FG002|Overall Study|Withdrawal by Subject|9|||
147218366|NCT02320903|530971475|FG000|Overall Study|Exited therapy; no longer eligible|8|||
147218367|NCT02320903|530971476|FG001|Overall Study|Exited therapy; no longer eligible|2|||
147218368|NCT02320903|530971477|FG002|Overall Study|Exited therapy; no longer eligible|2|||
147218369|NCT02320903|530971475|FG000|Overall Study|Lost to Follow-up|0|||
147218370|NCT02320903|530971476|FG001|Overall Study|Lost to Follow-up|5|||
147218371|NCT02320903|530971477|FG002|Overall Study|Lost to Follow-up|5|||
147218372|NCT00883688|530971479|FG000|Overall Study|Ineligible|2|||
147218373|NCT00464490|530971480|FG000|Overall Study|Physician Decision|11|||
147218374|NCT00464490|530971481|FG001|Overall Study|Physician Decision|11|||
147218375|NCT03188042|530971482|FG000|Overall Study|Withdrawal by Subject|1|||
147218376|NCT03188042|530971483|FG001|Overall Study|Withdrawal by Subject|1|||
147218377|NCT03860935|530971490|FG000|Overall Study|Withdrawal of Consent|15|||
147218378|NCT03860935|530971491|FG001|Overall Study|Withdrawal of Consent|6|||
147218379|NCT03860935|530971490|FG000|Overall Study|Death|75|||
147218380|NCT03860935|530971491|FG001|Overall Study|Death|51|||
147218381|NCT03086967|530971492|FG000|Overall Study|Screen Failure|2|||
147218382|NCT03086967|530971493|FG001|Overall Study|Screen Failure|2|||
147218383|NCT04461600|530971494|FG000|Overall Study|Death|6|||
147218384|NCT04461600|530971495|FG001|Overall Study|Death|5|||
147218385|NCT04461600|530971494|FG000|Overall Study|Withdrawal by Subject|0|||
147218386|NCT04461600|530971495|FG001|Overall Study|Withdrawal by Subject|1|||
147218387|NCT04575597|530971499|FG000|Overall Study|Death|0|||
147218388|NCT04575597|530971500|FG001|Overall Study|Death|0|||
147218389|NCT04575597|530971501|FG002|Overall Study|Death|0|||
147218390|NCT04575597|530971502|FG003|Overall Study|Death|1|||
147218391|NCT04575597|530971503|FG004|Overall Study|Death|3|||
147218392|NCT04575597|530971504|FG005|Overall Study|Death|14|||
147218393|NCT04575597|530971499|FG000|Overall Study|Lost to Follow-up|2|||
147218394|NCT04575597|530971500|FG001|Overall Study|Lost to Follow-up|1|||
147218395|NCT04575597|530971501|FG002|Overall Study|Lost to Follow-up|1|||
147218396|NCT04575597|530971502|FG003|Overall Study|Lost to Follow-up|2|||
147218397|NCT04575597|530971503|FG004|Overall Study|Lost to Follow-up|10|||
147218398|NCT04575597|530971504|FG005|Overall Study|Lost to Follow-up|8|||
147218399|NCT04575597|530971499|FG000|Overall Study|Withdrawal by Subject|2|||
147218400|NCT04575597|530971500|FG001|Overall Study|Withdrawal by Subject|2|||
147218401|NCT04575597|530971501|FG002|Overall Study|Withdrawal by Subject|4|||
147218402|NCT04575597|530971502|FG003|Overall Study|Withdrawal by Subject|2|||
147218403|NCT04575597|530971503|FG004|Overall Study|Withdrawal by Subject|25|||
147218404|NCT04575597|530971504|FG005|Overall Study|Withdrawal by Subject|28|||
147218405|NCT04575597|530971499|FG000|Overall Study|Not Recorded|0|||
147218406|NCT04575597|530971500|FG001|Overall Study|Not Recorded|0|||
147218407|NCT04575597|530971501|FG002|Overall Study|Not Recorded|0|||
147218408|NCT04575597|530971502|FG003|Overall Study|Not Recorded|0|||
147218409|NCT04575597|530971503|FG004|Overall Study|Not Recorded|0|||
147218410|NCT04575597|530971504|FG005|Overall Study|Not Recorded|2|||
147218411|NCT04575597|530971499|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
147218412|NCT04575597|530971500|FG001|Overall Study|Randomized By Mistake Without Study Treatment|0|||
147218413|NCT04575597|530971501|FG002|Overall Study|Randomized By Mistake Without Study Treatment|0|||
147218414|NCT04575597|530971502|FG003|Overall Study|Randomized By Mistake Without Study Treatment|0|||
147218415|NCT04575597|530971503|FG004|Overall Study|Randomized By Mistake Without Study Treatment|3|||
147218416|NCT04575597|530971504|FG005|Overall Study|Randomized By Mistake Without Study Treatment|2|||
147218417|NCT01209832|530971505|FG000|Period 1|Sponsor Decision and was not dosed|1|||
147218418|NCT01209832|530971505|FG000|Period 2|Sponsor Decision|1|||
147218419|NCT01268579|530971506|FG000|Overall Study|Adverse Event|1|||
147218420|NCT01268579|530971506|FG000|Overall Study|Withdrawal by Subject|2|||
147218421|NCT02692651|530971507|FG000|Study Treatment|Death|7|||
147218422|NCT02692651|530971508|FG001|Study Treatment|Death|3|||
147218423|NCT02692651|530971507|FG000|Study Treatment|comfort care|1|||
147218424|NCT02692651|530971508|FG001|Study Treatment|comfort care|1|||
147218425|NCT02692651|530971507|FG000|Study Treatment|Protocol violation per treating team preference|8|||
147218426|NCT02692651|530971508|FG001|Study Treatment|Protocol violation per treating team preference|6|||
147218427|NCT02692651|530971507|FG000|Post Study Treatment Follow-up|Death|4|||
147218428|NCT02692651|530971508|FG001|Post Study Treatment Follow-up|Death|4|||
147218429|NCT02480712|530971509|FG000|Overall Study|Enrolled but Never Treated|1|||
147218430|NCT02480712|530971509|FG000|Overall Study|Lost to Follow-up|5|||
147218431|NCT02480712|530971509|FG000|Overall Study|Withdrew Consent|3|||
147218432|NCT02480712|530971509|FG000|Overall Study|Death|1|||
147218433|NCT02480712|530971509|FG000|Overall Study|Lack of Efficacy|1|||
147218434|NCT01087788|530971516|FG000|24-weeks Double-blind Period|Lack of Efficacy|2|||
147218435|NCT01087788|530971517|FG001|24-weeks Double-blind Period|Lack of Efficacy|0|||
147218436|NCT01087788|530971518|FG002|24-weeks Double-blind Period|Lack of Efficacy|1|||
147218437|NCT01087788|530971516|FG000|24-weeks Double-blind Period|Protocol Violation|0|||
147307433|NCT00152009|531293013|FG000|Overall Study|Adverse Event|9|||
147307434|NCT00152009|531293014|FG001|Overall Study|Adverse Event|13|||
147307435|NCT00152009|531293015|FG002|Overall Study|Adverse Event|20|||
147307436|NCT00152009|531293016|FG003|Overall Study|Adverse Event|1|||
147307437|NCT00152009|531293013|FG000|Overall Study|Protocol Violation|3|||
147307438|NCT00152009|531293014|FG001|Overall Study|Protocol Violation|0|||
147307439|NCT00152009|531293015|FG002|Overall Study|Protocol Violation|0|||
147307440|NCT00152009|531293016|FG003|Overall Study|Protocol Violation|1|||
147307441|NCT00152009|531293013|FG000|Overall Study|Withdrawal by Subject|2|||
147307442|NCT00152009|531293014|FG001|Overall Study|Withdrawal by Subject|3|||
147307443|NCT00152009|531293015|FG002|Overall Study|Withdrawal by Subject|4|||
147307444|NCT00152009|531293016|FG003|Overall Study|Withdrawal by Subject|9|||
147307445|NCT00152009|531293013|FG000|Overall Study|Lost to Follow-up|2|||
147307446|NCT00152009|531293014|FG001|Overall Study|Lost to Follow-up|4|||
147307447|NCT00152009|531293015|FG002|Overall Study|Lost to Follow-up|3|||
147307448|NCT00152009|531293016|FG003|Overall Study|Lost to Follow-up|3|||
147307449|NCT00152009|531293013|FG000|Overall Study|Lack of Efficacy|8|||
147307450|NCT00152009|531293014|FG001|Overall Study|Lack of Efficacy|6|||
147307451|NCT00152009|531293015|FG002|Overall Study|Lack of Efficacy|7|||
147307452|NCT00152009|531293016|FG003|Overall Study|Lack of Efficacy|15|||
147307453|NCT00152009|531293013|FG000|Overall Study|ECG abnormalities|2|||
147307454|NCT00152009|531293014|FG001|Overall Study|ECG abnormalities|2|||
147307455|NCT00152009|531293015|FG002|Overall Study|ECG abnormalities|2|||
147307456|NCT00152009|531293016|FG003|Overall Study|ECG abnormalities|1|||
147307457|NCT00152009|531293013|FG000|Overall Study|Sponsor's decision|3|||
147307458|NCT00152009|531293014|FG001|Overall Study|Sponsor's decision|3|||
147307459|NCT00152009|531293015|FG002|Overall Study|Sponsor's decision|1|||
147307460|NCT00152009|531293016|FG003|Overall Study|Sponsor's decision|3|||
147307461|NCT01306201|531293017|FG000|Overall Study|Arrhythmia|4|||
147307462|NCT01306201|531293017|FG000|Overall Study|Files could not be processed|3|||
147307463|NCT01306201|531293017|FG000|Overall Study|Files unreadable|3|||
147307464|NCT04702568|531293018|FG000|Overall Study|Transitioned to the BCX9930-205 roll-over study|10|||
147307465|NCT04702568|531293019|FG001|Overall Study|Transitioned to the BCX9930-205 roll-over study|4|||
147307466|NCT04702568|531293018|FG000|Overall Study|Pregnancy|1|||
147307467|NCT04702568|531293019|FG001|Overall Study|Pregnancy|0|||
147307468|NCT04702568|531293018|FG000|Overall Study|Bone marrow transplant|1|||
147307469|NCT04702568|531293019|FG001|Overall Study|Bone marrow transplant|0|||
147307470|NCT04702568|531293018|FG000|Overall Study|Withdrawn due to Investigator decision|0|||
147307471|NCT04702568|531293019|FG001|Overall Study|Withdrawn due to Investigator decision|1|||
147307472|NCT04702568|531293018|FG000|Overall Study|Withdrawal by Subject|0|||
147307473|NCT04702568|531293019|FG001|Overall Study|Withdrawal by Subject|2|||
147307474|NCT00393523|531293020|FG000|Overall Study|Lost to Follow-up|0|||
147307475|NCT00393523|531293021|FG001|Overall Study|Lost to Follow-up|0|||
147307476|NCT00393523|531293022|FG002|Overall Study|Lost to Follow-up|0|||
147307477|NCT00393523|531293023|FG003|Overall Study|Lost to Follow-up|2|||
147307478|NCT00393523|531293024|FG004|Overall Study|Lost to Follow-up|1|||
147307479|NCT00393523|531293020|FG000|Overall Study|Protocol Violation|6|||
147307480|NCT00393523|531293021|FG001|Overall Study|Protocol Violation|2|||
147307481|NCT00393523|531293022|FG002|Overall Study|Protocol Violation|0|||
147307482|NCT00393523|531293023|FG003|Overall Study|Protocol Violation|1|||
147307483|NCT00393523|531293024|FG004|Overall Study|Protocol Violation|0|||
147307484|NCT00393523|531293020|FG000|Overall Study|Withdrawal by Subject|6|||
147307485|NCT00393523|531293021|FG001|Overall Study|Withdrawal by Subject|7|||
147307486|NCT00393523|531293022|FG002|Overall Study|Withdrawal by Subject|2|||
147307487|NCT00393523|531293023|FG003|Overall Study|Withdrawal by Subject|3|||
147307488|NCT00393523|531293024|FG004|Overall Study|Withdrawal by Subject|0|||
147307489|NCT00393523|531293020|FG000|Overall Study|Difficulties in specimen collection|0|||
147307490|NCT00393523|531293021|FG001|Overall Study|Difficulties in specimen collection|0|||
147307491|NCT00393523|531293022|FG002|Overall Study|Difficulties in specimen collection|1|||
147307492|NCT00393523|531293023|FG003|Overall Study|Difficulties in specimen collection|0|||
147307493|NCT00393523|531293024|FG004|Overall Study|Difficulties in specimen collection|0|||
147307494|NCT00393523|531293020|FG000|Overall Study|Vaccine supply issue|0|||
147307495|NCT00393523|531293021|FG001|Overall Study|Vaccine supply issue|0|||
147307496|NCT00393523|531293022|FG002|Overall Study|Vaccine supply issue|1|||
147307497|NCT00393523|531293023|FG003|Overall Study|Vaccine supply issue|0|||
147307498|NCT00393523|531293024|FG004|Overall Study|Vaccine supply issue|0|||
147307499|NCT02912468|531293025|FG000|Overall Study|Adverse Event|3|||
147307500|NCT02912468|531293026|FG001|Overall Study|Adverse Event|2|||
147307501|NCT02912468|531293025|FG000|Overall Study|Withdrawal by Subject|6|||
147307502|NCT02912468|531293026|FG001|Overall Study|Withdrawal by Subject|2|||
147307503|NCT02912468|531293025|FG000|Overall Study|Randomized and not treated|0|||
147307504|NCT02912468|531293026|FG001|Overall Study|Randomized and not treated|1|||
147307505|NCT04091360|531293027|FG000|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
147307506|NCT04091360|531293028|FG001|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
147307507|NCT04091360|531293029|FG002|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
147307508|NCT04091360|531293030|FG003|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
147307509|NCT04091360|531293031|FG004|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
147307510|NCT04091360|531293032|FG005|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
147307511|NCT04091360|531293033|FG006|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
147307512|NCT04091360|531293034|FG007|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|0|||
147307513|NCT04091360|531293035|FG008|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|1|||
147307514|NCT04091360|531293036|FG009|Part B (R, PC, XO) Twice Daily for 7 Day|Adverse Event|1|||
147218438|NCT01087788|530971517|FG001|24-weeks Double-blind Period|Protocol Violation|1|||
147218439|NCT01087788|530971518|FG002|24-weeks Double-blind Period|Protocol Violation|0|||
147218440|NCT01087788|530971516|FG000|24-weeks Double-blind Period|Lost to Follow-up|4|||
147218441|NCT01087788|530971517|FG001|24-weeks Double-blind Period|Lost to Follow-up|1|||
147218442|NCT01087788|530971518|FG002|24-weeks Double-blind Period|Lost to Follow-up|1|||
147218443|NCT01087788|530971516|FG000|24-weeks Double-blind Period|Withdrawal by Subject|7|||
147218444|NCT01087788|530971517|FG001|24-weeks Double-blind Period|Withdrawal by Subject|2|||
147218445|NCT01087788|530971518|FG002|24-weeks Double-blind Period|Withdrawal by Subject|5|||
147218446|NCT01087788|530971516|FG000|24-weeks Double-blind Period|AE, serious fatal|0|||
147218447|NCT01087788|530971517|FG001|24-weeks Double-blind Period|AE, serious fatal|1|||
147218448|NCT01087788|530971518|FG002|24-weeks Double-blind Period|AE, serious fatal|1|||
147218449|NCT01087788|530971516|FG000|24-weeks Double-blind Period|AE, serious non-fatal|0|||
147218450|NCT01087788|530971517|FG001|24-weeks Double-blind Period|AE, serious non-fatal|2|||
147218451|NCT01087788|530971518|FG002|24-weeks Double-blind Period|AE, serious non-fatal|3|||
147218452|NCT01087788|530971516|FG000|24-weeks Double-blind Period|AE, non-serious non-fatal|2|||
147218453|NCT01087788|530971517|FG001|24-weeks Double-blind Period|AE, non-serious non-fatal|1|||
147218454|NCT01087788|530971518|FG002|24-weeks Double-blind Period|AE, non-serious non-fatal|2|||
147218455|NCT01087788|530971516|FG000|24-weeks Double-blind Period|AE, unknown type|0|||
147218456|NCT01087788|530971517|FG001|24-weeks Double-blind Period|AE, unknown type|0|||
147218457|NCT01087788|530971518|FG002|24-weeks Double-blind Period|AE, unknown type|1|||
147218458|NCT01087788|530971516|FG000|24-weeks Double-blind Period|Patient (P) does not want to attend|1|||
147218459|NCT01087788|530971517|FG001|24-weeks Double-blind Period|Patient (P) does not want to attend|0|||
147218460|NCT01087788|530971518|FG002|24-weeks Double-blind Period|Patient (P) does not want to attend|0|||
147218461|NCT01087788|530971516|FG000|24-weeks Double-blind Period|Protocol violation (decision of monitor)|0|||
147218462|NCT01087788|530971517|FG001|24-weeks Double-blind Period|Protocol violation (decision of monitor)|1|||
147218463|NCT01087788|530971518|FG002|24-weeks Double-blind Period|Protocol violation (decision of monitor)|0|||
147218464|NCT01087788|530971516|FG000|24-weeks Double-blind Period|Exclusion criteria were not met|0|||
147218465|NCT01087788|530971517|FG001|24-weeks Double-blind Period|Exclusion criteria were not met|1|||
147218466|NCT01087788|530971518|FG002|24-weeks Double-blind Period|Exclusion criteria were not met|0|||
147218467|NCT01087788|530971516|FG000|24-weeks Double-blind Period|P cannot comply with scheduled visits|0|||
147218468|NCT01087788|530971517|FG001|24-weeks Double-blind Period|P cannot comply with scheduled visits|0|||
147307515|NCT04091360|531293027|FG000|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
147218469|NCT01087788|530971518|FG002|24-weeks Double-blind Period|P cannot comply with scheduled visits|1|||
147307516|NCT04091360|531293028|FG001|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
147307517|NCT04091360|531293029|FG002|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
147307518|NCT04091360|531293030|FG003|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
147552251|NCT02711956|532178577|FG013|Overall Study|Physician Decision|0|||
147307519|NCT04091360|531293031|FG004|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
147218470|NCT01087788|530971516|FG000|24-weeks Dose-blind Period|Lack of Efficacy|0|||
147218471|NCT01087788|530971517|FG001|24-weeks Dose-blind Period|Lack of Efficacy|2|||
147218472|NCT01087788|530971518|FG002|24-weeks Dose-blind Period|Lack of Efficacy|1|||
147307520|NCT04091360|531293032|FG005|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
147307521|NCT04091360|531293033|FG006|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|1|||
147307522|NCT04091360|531293034|FG007|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|1|||
147307523|NCT04091360|531293035|FG008|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
147307524|NCT04091360|531293036|FG009|Part B (R, PC, XO) Twice Daily for 7 Day|Physician Decision|0|||
147307525|NCT04091360|531293027|FG000|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
147307526|NCT04091360|531293028|FG001|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
147307527|NCT04091360|531293029|FG002|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
147307528|NCT04091360|531293030|FG003|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
147307529|NCT04091360|531293031|FG004|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
147307530|NCT04091360|531293032|FG005|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
147307531|NCT04091360|531293033|FG006|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|1|||
147307532|NCT04091360|531293034|FG007|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
147307533|NCT04091360|531293035|FG008|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|0|||
147307534|NCT04091360|531293036|FG009|Part B (R, PC, XO) Twice Daily for 7 Day|Withdrawal by Subject|1|||
147307535|NCT00423852|531293041|FG000|Overall Study|Removed pior to the high-dose portion|3|||
147307536|NCT00980005|531293042|FG000|Overall Study|Withdrawal by Subject|6|||
147307537|NCT00980005|531293043|FG001|Overall Study|Withdrawal by Subject|17|||
147218473|NCT01087788|530971516|FG000|24-weeks Dose-blind Period|Lost to Follow-up|1|||
147218474|NCT01087788|530971517|FG001|24-weeks Dose-blind Period|Lost to Follow-up|0|||
147218475|NCT01087788|530971518|FG002|24-weeks Dose-blind Period|Lost to Follow-up|1|||
147218476|NCT01087788|530971516|FG000|24-weeks Dose-blind Period|Withdrawal by Subject|1|||
147218477|NCT01087788|530971517|FG001|24-weeks Dose-blind Period|Withdrawal by Subject|0|||
147218478|NCT01087788|530971518|FG002|24-weeks Dose-blind Period|Withdrawal by Subject|0|||
147218479|NCT01087788|530971516|FG000|24-weeks Dose-blind Period|AE, serious fatal|0|||
147218480|NCT01087788|530971517|FG001|24-weeks Dose-blind Period|AE, serious fatal|1|||
147218481|NCT01087788|530971518|FG002|24-weeks Dose-blind Period|AE, serious fatal|0|||
147218482|NCT01087788|530971516|FG000|24-weeks Dose-blind Period|AE, serious non-fatal|2|||
147218483|NCT01087788|530971517|FG001|24-weeks Dose-blind Period|AE, serious non-fatal|1|||
147218484|NCT01087788|530971518|FG002|24-weeks Dose-blind Period|AE, serious non-fatal|2|||
147218485|NCT01087788|530971516|FG000|24-weeks Dose-blind Period|AE, non-serious non-fatal|2|||
147218486|NCT01087788|530971517|FG001|24-weeks Dose-blind Period|AE, non-serious non-fatal|1|||
147218487|NCT01087788|530971518|FG002|24-weeks Dose-blind Period|AE, non-serious non-fatal|1|||
147218488|NCT01087788|530971516|FG000|24-weeks Dose-blind Period|Sponsor decision following missed visits|1|||
147218489|NCT01087788|530971517|FG001|24-weeks Dose-blind Period|Sponsor decision following missed visits|0|||
147218490|NCT01087788|530971518|FG002|24-weeks Dose-blind Period|Sponsor decision following missed visits|0|||
147218491|NCT01087788|530971516|FG000|24-weeks Dose-blind Period|Patient moved|0|||
147218492|NCT01087788|530971517|FG001|24-weeks Dose-blind Period|Patient moved|0|||
147218493|NCT01087788|530971518|FG002|24-weeks Dose-blind Period|Patient moved|1|||
147218494|NCT01087788|530971516|FG000|Open-Label Period (OL-P)|Lack of Efficacy|4|||
147218495|NCT01087788|530971517|FG001|Open-Label Period (OL-P)|Lack of Efficacy|2|||
147218496|NCT01087788|530971518|FG002|Open-Label Period (OL-P)|Lack of Efficacy|3|||
147218497|NCT01087788|530971516|FG000|Open-Label Period (OL-P)|Protocol Violation|2|||
147218498|NCT01087788|530971517|FG001|Open-Label Period (OL-P)|Protocol Violation|1|||
147218499|NCT01087788|530971518|FG002|Open-Label Period (OL-P)|Protocol Violation|0|||
147218500|NCT01087788|530971516|FG000|Open-Label Period (OL-P)|Lost to Follow-up|0|||
147218501|NCT01087788|530971517|FG001|Open-Label Period (OL-P)|Lost to Follow-up|4|||
147218502|NCT01087788|530971518|FG002|Open-Label Period (OL-P)|Lost to Follow-up|2|||
147218503|NCT01087788|530971516|FG000|Open-Label Period (OL-P)|Withdrawal by Subject|13|||
147218504|NCT01087788|530971517|FG001|Open-Label Period (OL-P)|Withdrawal by Subject|8|||
147218505|NCT01087788|530971518|FG002|Open-Label Period (OL-P)|Withdrawal by Subject|10|||
147218506|NCT01087788|530971516|FG000|Open-Label Period (OL-P)|AE, serious fatal|2|||
147218507|NCT01087788|530971517|FG001|Open-Label Period (OL-P)|AE, serious fatal|0|||
147218508|NCT01087788|530971518|FG002|Open-Label Period (OL-P)|AE, serious fatal|1|||
147218509|NCT01087788|530971516|FG000|Open-Label Period (OL-P)|AE, serious non-fatal|1|||
147218510|NCT01087788|530971517|FG001|Open-Label Period (OL-P)|AE, serious non-fatal|3|||
147218511|NCT01087788|530971518|FG002|Open-Label Period (OL-P)|AE, serious non-fatal|4|||
147218512|NCT01087788|530971516|FG000|Open-Label Period (OL-P)|AE, non-serious non-fatal|6|||
147218513|NCT01087788|530971517|FG001|Open-Label Period (OL-P)|AE, non-serious non-fatal|4|||
147443072|NCT03703882|531787158|FG000|Overall Study|Non-compliance with study drug|0|||
147218514|NCT01087788|530971518|FG002|Open-Label Period (OL-P)|AE, non-serious non-fatal|4|||
147218515|NCT01087788|530971516|FG000|Open-Label Period (OL-P)|SAE, non-fatal+AE, non-serious non-fatal|0|||
147443073|NCT03703882|531787159|FG001|Overall Study|Non-compliance with study drug|1|||
147218516|NCT01087788|530971517|FG001|Open-Label Period (OL-P)|SAE, non-fatal+AE, non-serious non-fatal|1|||
147218517|NCT01087788|530971518|FG002|Open-Label Period (OL-P)|SAE, non-fatal+AE, non-serious non-fatal|0|||
147218518|NCT01087788|530971516|FG000|Open-Label Period (OL-P)|AE, non-serious unknown|1|||
147218519|NCT01087788|530971517|FG001|Open-Label Period (OL-P)|AE, non-serious unknown|0|||
147218520|NCT01087788|530971518|FG002|Open-Label Period (OL-P)|AE, non-serious unknown|0|||
147218521|NCT01087788|530971516|FG000|Open-Label Period (OL-P)|Sponsor request|1|||
147218522|NCT01087788|530971517|FG001|Open-Label Period (OL-P)|Sponsor request|0|||
147218523|NCT01087788|530971518|FG002|Open-Label Period (OL-P)|Sponsor request|0|||
147218524|NCT01087788|530971516|FG000|Open-Label Period (OL-P)|Principal investigator decision|0|||
147218525|NCT01087788|530971517|FG001|Open-Label Period (OL-P)|Principal investigator decision|1|||
147218526|NCT01087788|530971518|FG002|Open-Label Period (OL-P)|Principal investigator decision|2|||
147218527|NCT01087788|530971516|FG000|Open-Label Period (OL-P)|No participation in study extension|0|||
147218528|NCT01087788|530971517|FG001|Open-Label Period (OL-P)|No participation in study extension|0|||
147218529|NCT01087788|530971518|FG002|Open-Label Period (OL-P)|No participation in study extension|1|||
147218530|NCT01087788|530971516|FG000|Open-Label Period (OL-P)|Personal reasons|0|||
147218531|NCT01087788|530971517|FG001|Open-Label Period (OL-P)|Personal reasons|0|||
147218532|NCT01087788|530971518|FG002|Open-Label Period (OL-P)|Personal reasons|1|||
147218533|NCT04604132|530971519|FG000|Overall Study|Adverse Event|2|||
147218534|NCT04604132|530971520|FG001|Overall Study|Adverse Event|0|||
147218535|NCT04604132|530971521|FG002|Overall Study|Adverse Event|0|||
147218536|NCT04604132|530971522|FG003|Overall Study|Adverse Event|1|||
147218537|NCT04604132|530971523|FG004|Overall Study|Adverse Event|2|||
147218538|NCT04604132|530971519|FG000|Overall Study|Study terminated by sponsor|0|||
147218539|NCT04604132|530971520|FG001|Overall Study|Study terminated by sponsor|0|||
147218540|NCT04604132|530971521|FG002|Overall Study|Study terminated by sponsor|0|||
147218541|NCT04604132|530971522|FG003|Overall Study|Study terminated by sponsor|0|||
147218542|NCT04604132|530971523|FG004|Overall Study|Study terminated by sponsor|1|||
147218543|NCT04604132|530971519|FG000|Overall Study|Progressive disease: Clinical progression|0|||
147218544|NCT04604132|530971520|FG001|Overall Study|Progressive disease: Clinical progression|0|||
147218545|NCT04604132|530971521|FG002|Overall Study|Progressive disease: Clinical progression|1|||
147218546|NCT04604132|530971522|FG003|Overall Study|Progressive disease: Clinical progression|0|||
147307538|NCT00980005|531293042|FG000|Overall Study|Lost to Follow-up|37|||
147307539|NCT00980005|531293043|FG001|Overall Study|Lost to Follow-up|43|||
147307540|NCT00980005|531293042|FG000|Overall Study|Other|4|||
147218547|NCT04604132|530971523|FG004|Overall Study|Progressive disease: Clinical progression|0|||
147218548|NCT04604132|530971519|FG000|Overall Study|Progressive disease: Radiological progression|8|||
147218549|NCT04604132|530971520|FG001|Overall Study|Progressive disease: Radiological progression|7|||
147218550|NCT04604132|530971521|FG002|Overall Study|Progressive disease: Radiological progression|10|||
147218551|NCT04604132|530971522|FG003|Overall Study|Progressive disease: Radiological progression|4|||
147218552|NCT04604132|530971523|FG004|Overall Study|Progressive disease: Radiological progression|3|||
147218553|NCT04604132|530971519|FG000|Overall Study|Death|3|||
147218554|NCT04604132|530971520|FG001|Overall Study|Death|1|||
147218555|NCT04604132|530971521|FG002|Overall Study|Death|2|||
147218556|NCT04604132|530971522|FG003|Overall Study|Death|1|||
147218557|NCT04604132|530971523|FG004|Overall Study|Death|0|||
147218558|NCT00952380|530971524|FG000|Overall Study|Other|0|||
147218559|NCT00952380|530971525|FG001|Overall Study|Other|0|||
147218560|NCT00952380|530971526|FG002|Overall Study|Other|0|||
147218561|NCT00952380|530971527|FG003|Overall Study|Other|0|||
147218562|NCT00952380|530971528|FG004|Overall Study|Other|1|||
147218563|NCT00952380|530971524|FG000|Overall Study|Withdrawal by Subject|0|||
147218564|NCT00952380|530971525|FG001|Overall Study|Withdrawal by Subject|0|||
147218565|NCT00952380|530971526|FG002|Overall Study|Withdrawal by Subject|1|||
147218566|NCT00952380|530971527|FG003|Overall Study|Withdrawal by Subject|0|||
147218567|NCT00952380|530971528|FG004|Overall Study|Withdrawal by Subject|2|||
147218568|NCT00952380|530971524|FG000|Overall Study|Adverse Event|0|||
147218569|NCT00952380|530971525|FG001|Overall Study|Adverse Event|1|||
147218570|NCT00952380|530971526|FG002|Overall Study|Adverse Event|0|||
147218571|NCT00952380|530971527|FG003|Overall Study|Adverse Event|0|||
147218572|NCT00952380|530971528|FG004|Overall Study|Adverse Event|3|||
147218573|NCT00952380|530971524|FG000|Overall Study|Physician Decision|0|||
147218574|NCT00952380|530971525|FG001|Overall Study|Physician Decision|0|||
147218575|NCT00952380|530971526|FG002|Overall Study|Physician Decision|1|||
147218576|NCT00952380|530971527|FG003|Overall Study|Physician Decision|2|||
147307541|NCT00980005|531293043|FG001|Overall Study|Other|3|||
147307542|NCT04145037|531293044|FG000|Overall Study|Study terminated|2|||
147307543|NCT04145037|531293045|FG001|Overall Study|Study terminated|0|||
147443074|NCT03703882|531787158|FG000|Overall Study|Physician Decision|0|||
147307544|NCT04145037|531293044|FG000|Overall Study|Withdrawal by Subject|1|||
147307545|NCT04145037|531293045|FG001|Overall Study|Withdrawal by Subject|0|||
147443075|NCT03703882|531787159|FG001|Overall Study|Physician Decision|1|||
147443076|NCT03703882|531787158|FG000|Overall Study|Progressive disease|1|||
147443077|NCT03703882|531787159|FG001|Overall Study|Progressive disease|0|||
147443078|NCT03703882|531787158|FG000|Overall Study|Withdrawal by parent/guardian|1|||
147443079|NCT03703882|531787159|FG001|Overall Study|Withdrawal by parent/guardian|0|||
147218577|NCT00952380|530971528|FG004|Overall Study|Physician Decision|0|||
147218578|NCT00952380|530971524|FG000|Overall Study|Non-compliant to protocol|0|||
147218579|NCT00952380|530971525|FG001|Overall Study|Non-compliant to protocol|0|||
147218580|NCT00952380|530971526|FG002|Overall Study|Non-compliant to protocol|0|||
147218581|NCT00952380|530971527|FG003|Overall Study|Non-compliant to protocol|1|||
147218582|NCT00952380|530971528|FG004|Overall Study|Non-compliant to protocol|0|||
147218583|NCT00534313|530971532|FG000|Short-term Period|Adverse Event|1|||
147218584|NCT00534313|530971533|FG001|Short-term Period|Adverse Event|2|||
147218585|NCT00534313|530971534|FG002|Short-term Period|Adverse Event|1|||
147218586|NCT00534313|530971535|FG003|Short-term Period|Adverse Event|3|||
147218587|NCT00534313|530971532|FG000|Short-term Period|Lack of Efficacy|3|||
147218588|NCT00534313|530971533|FG001|Short-term Period|Lack of Efficacy|4|||
147218589|NCT00534313|530971534|FG002|Short-term Period|Lack of Efficacy|0|||
147218590|NCT00534313|530971535|FG003|Short-term Period|Lack of Efficacy|3|||
147218591|NCT00534313|530971532|FG000|Short-term Period|Participant not meeting study criteria|0|||
147218592|NCT00534313|530971533|FG001|Short-term Period|Participant not meeting study criteria|0|||
147218593|NCT00534313|530971534|FG002|Short-term Period|Participant not meeting study criteria|0|||
147218594|NCT00534313|530971535|FG003|Short-term Period|Participant not meeting study criteria|1|||
147218595|NCT00534313|530971532|FG000|Short-term Period|Participant withdrew consent|2|||
147218596|NCT00534313|530971533|FG001|Short-term Period|Participant withdrew consent|0|||
147218597|NCT00534313|530971534|FG002|Short-term Period|Participant withdrew consent|0|||
147218598|NCT00534313|530971535|FG003|Short-term Period|Participant withdrew consent|2|||
147218599|NCT00534313|530971532|FG000|Short-term Period|Pregnancy|0|||
147218600|NCT00534313|530971533|FG001|Short-term Period|Pregnancy|0|||
147218601|NCT00534313|530971534|FG002|Short-term Period|Pregnancy|1|||
147218602|NCT00534313|530971535|FG003|Short-term Period|Pregnancy|0|||
147218603|NCT00534313|530971532|FG000|Long-term Period|Adverse Event|2|||
147218604|NCT00534313|530971533|FG001|Long-term Period|Adverse Event|1|||
147218605|NCT00534313|530971534|FG002|Long-term Period|Adverse Event|0|||
147218606|NCT00534313|530971535|FG003|Long-term Period|Adverse Event|1|||
147218607|NCT00534313|530971532|FG000|Long-term Period|Lack of Efficacy|14|||
147218608|NCT00534313|530971533|FG001|Long-term Period|Lack of Efficacy|10|||
147218609|NCT00534313|530971534|FG002|Long-term Period|Lack of Efficacy|14|||
147218610|NCT00534313|530971535|FG003|Long-term Period|Lack of Efficacy|12|||
147218611|NCT00534313|530971532|FG000|Long-term Period|Lost to Follow-up|1|||
147218612|NCT00534313|530971533|FG001|Long-term Period|Lost to Follow-up|2|||
147218613|NCT00534313|530971534|FG002|Long-term Period|Lost to Follow-up|0|||
147218614|NCT00534313|530971535|FG003|Long-term Period|Lost to Follow-up|0|||
147218615|NCT00534313|530971532|FG000|Long-term Period|Withdrawal by Subject|2|||
147218616|NCT00534313|530971533|FG001|Long-term Period|Withdrawal by Subject|2|||
147218617|NCT00534313|530971534|FG002|Long-term Period|Withdrawal by Subject|0|||
147218618|NCT00534313|530971535|FG003|Long-term Period|Withdrawal by Subject|0|||
147218619|NCT00534313|530971532|FG000|Long-term Period|No longer meets study criteria|0|||
147218620|NCT00534313|530971533|FG001|Long-term Period|No longer meets study criteria|1|||
147218621|NCT00534313|530971534|FG002|Long-term Period|No longer meets study criteria|0|||
147218622|NCT00534313|530971535|FG003|Long-term Period|No longer meets study criteria|0|||
147218623|NCT00534313|530971532|FG000|Long-term Period|Poor compliance/noncompliance|0|||
147218624|NCT00534313|530971533|FG001|Long-term Period|Poor compliance/noncompliance|1|||
147218625|NCT00534313|530971534|FG002|Long-term Period|Poor compliance/noncompliance|1|||
147218626|NCT00534313|530971535|FG003|Long-term Period|Poor compliance/noncompliance|0|||
147218627|NCT00534313|530971532|FG000|Long-term Period|Administrative reason by sponsor|17|||
147218628|NCT00534313|530971533|FG001|Long-term Period|Administrative reason by sponsor|15|||
147218629|NCT00534313|530971534|FG002|Long-term Period|Administrative reason by sponsor|26|||
147218630|NCT00534313|530971535|FG003|Long-term Period|Administrative reason by sponsor|18|||
147218631|NCT00534313|530971532|FG000|Long-term Period|Other|1|||
147218632|NCT00534313|530971533|FG001|Long-term Period|Other|2|||
147218633|NCT00534313|530971534|FG002|Long-term Period|Other|2|||
147218634|NCT00534313|530971535|FG003|Long-term Period|Other|2|||
147218635|NCT00927940|530971536|FG000|Overall Study|Death|1|||
147218636|NCT03007888|530971537|FG000|First Intervention (14 Days)|Adverse Event|1|||
147218637|NCT03007888|530971538|FG001|First Intervention (14 Days)|Adverse Event|0|||
147218638|NCT00827931|530971540|FG000|Overall Study|Death|3|||
147218639|NCT00827931|530971541|FG001|Overall Study|Death|5|||
147218640|NCT00827931|530971540|FG000|Overall Study|Adverse Event|1|||
147218641|NCT00827931|530971541|FG001|Overall Study|Adverse Event|0|||
147218642|NCT00827931|530971540|FG000|Overall Study|Lost to Follow-up|1|||
147218643|NCT00827931|530971541|FG001|Overall Study|Lost to Follow-up|0|||
147443080|NCT03703882|531787158|FG000|Overall Study|Starting another treatment|0|||
147218644|NCT00827931|530971540|FG000|Overall Study|Withdrawal by Subject|0|||
147218645|NCT00827931|530971541|FG001|Overall Study|Withdrawal by Subject|1|||
147218646|NCT00827931|530971540|FG000|Overall Study|Other|1|||
147218647|NCT00827931|530971541|FG001|Overall Study|Other|0|||
147218648|NCT01870076|530971542|FG000|Overall Study|Withdrawal by Subject|1|||
147218649|NCT01870076|530971543|FG001|Overall Study|Withdrawal by Subject|0|||
147218650|NCT01870076|530971544|FG002|Overall Study|Withdrawal by Subject|1|||
147218651|NCT01870076|530971545|FG003|Overall Study|Withdrawal by Subject|0|||
147218652|NCT00492063|530971546|FG000|Overall Study|Death|0|||
147218653|NCT00492063|530971547|FG001|Overall Study|Death|0|||
147218654|NCT00492063|530971548|FG002|Overall Study|Death|1|||
147218655|NCT00492063|530971549|FG003|Overall Study|Death|2|||
147218656|NCT00492063|530971546|FG000|Overall Study|Withdrawal by Subject|4|||
147218657|NCT00492063|530971547|FG001|Overall Study|Withdrawal by Subject|3|||
147218658|NCT00492063|530971548|FG002|Overall Study|Withdrawal by Subject|5|||
147218659|NCT00492063|530971549|FG003|Overall Study|Withdrawal by Subject|4|||
147218660|NCT00492063|530971546|FG000|Overall Study|Lost to Follow-up|6|||
147218661|NCT00492063|530971547|FG001|Overall Study|Lost to Follow-up|11|||
147218662|NCT00492063|530971548|FG002|Overall Study|Lost to Follow-up|5|||
147218663|NCT00492063|530971549|FG003|Overall Study|Lost to Follow-up|3|||
147218664|NCT00492063|530971546|FG000|Overall Study|Protocol Violation|0|||
147218665|NCT00492063|530971547|FG001|Overall Study|Protocol Violation|0|||
147218666|NCT00492063|530971548|FG002|Overall Study|Protocol Violation|0|||
147218667|NCT00492063|530971549|FG003|Overall Study|Protocol Violation|1|||
147218668|NCT00608569|530971552|FG000|Overall Study|Death|4|||
147218669|NCT00608569|530971553|FG001|Overall Study|Death|3|||
147218670|NCT00608569|530971552|FG000|Overall Study|Lost to Follow-up|4|||
147218671|NCT00608569|530971553|FG001|Overall Study|Lost to Follow-up|5|||
147218672|NCT00608569|530971552|FG000|Overall Study|Withdrawal by Subject|1|||
147218673|NCT00608569|530971553|FG001|Overall Study|Withdrawal by Subject|0|||
147218674|NCT00608569|530971552|FG000|Overall Study|Adverse Event|1|||
147218675|NCT00608569|530971553|FG001|Overall Study|Adverse Event|0|||
147218676|NCT00608569|530971552|FG000|Overall Study|Unable to adhere with study requirements|0|||
147218677|NCT00608569|530971553|FG001|Overall Study|Unable to adhere with study requirements|1|||
147218678|NCT02312687|530971556|FG000|Overall Study|Other, Not Specified|1|||
147218679|NCT03645434|530971565|FG000|Period 1|Adverse Event|0|||
147218680|NCT03645434|530971566|FG001|Period 1|Adverse Event|0|||
147218681|NCT03645434|530971567|FG002|Period 1|Adverse Event|0|||
147218682|NCT03645434|530971568|FG003|Period 1|Adverse Event|1|||
147218683|NCT03645434|530971569|FG004|Period 1|Adverse Event|0|||
147218684|NCT03645434|530971570|FG005|Period 1|Adverse Event|0|||
147218685|NCT03645434|530971565|FG000|Period 1|COPD exacerbation|0|||
147218686|NCT03645434|530971566|FG001|Period 1|COPD exacerbation|0|||
147218687|NCT03645434|530971567|FG002|Period 1|COPD exacerbation|0|||
147218688|NCT03645434|530971568|FG003|Period 1|COPD exacerbation|0|||
147218689|NCT03645434|530971569|FG004|Period 1|COPD exacerbation|1|||
147218690|NCT03645434|530971570|FG005|Period 1|COPD exacerbation|0|||
147218691|NCT00167778|530971571|FG000|Overall Study|Withdrawal by Subject|1|||
147218692|NCT02654717|530971572|FG000|Overall Study|Adverse Event|2|||
147218693|NCT02654717|530971573|FG001|Overall Study|Adverse Event|2|||
147218694|NCT02654717|530971572|FG000|Overall Study|Protocol Violation|1|||
147218695|NCT02654717|530971573|FG001|Overall Study|Protocol Violation|2|||
147218696|NCT02654717|530971572|FG000|Overall Study|Withdrawal by Subject|0|||
147218697|NCT02654717|530971573|FG001|Overall Study|Withdrawal by Subject|1|||
147218698|NCT02654717|530971572|FG000|Overall Study|Non-permitted medication|3|||
147218699|NCT02654717|530971573|FG001|Overall Study|Non-permitted medication|0|||
147218700|NCT01475071|530973021|FG000|Overall Study|Physician Decision|1|||
147218701|NCT01475071|530973021|FG000|Overall Study|Withdrawal by Subject|6|||
147218702|NCT01475071|530973021|FG000|Overall Study|Lost to Follow-up|1|||
147218703|NCT02230527|530973023|FG000|Overall Study|Withdrawal by Subject|1|||
147218704|NCT02230527|530973024|FG001|Overall Study|Withdrawal by Subject|1|||
147218705|NCT02230527|530973023|FG000|Overall Study|Death|1|||
147218706|NCT02230527|530973024|FG001|Overall Study|Death|0|||
147218707|NCT02230527|530973023|FG000|Overall Study|Lost to Follow-up|2|||
147218708|NCT02230527|530973024|FG001|Overall Study|Lost to Follow-up|1|||
147218709|NCT02230527|530973023|FG000|Overall Study|Other|1|||
147218710|NCT02230527|530973024|FG001|Overall Study|Other|0|||
147218711|NCT01752036|530973025|FG000|Overall Study|Death|2|||
147218712|NCT01011478|530973026|FG000|Overall Study|No follow up data|12|||
147218713|NCT01011478|530973027|FG001|Overall Study|No follow up data|7|||
147218714|NCT02278471|530973028|FG000|Overall Study|Lost to Follow-up|6|||
147218715|NCT02278471|530973029|FG001|Overall Study|Lost to Follow-up|15|||
147218716|NCT02278471|530973028|FG000|Overall Study|Death|2|||
147218717|NCT02278471|530973029|FG001|Overall Study|Death|2|||
147218718|NCT02278471|530973028|FG000|Overall Study|Withdrawal by Subject|0|||
147218719|NCT02278471|530973029|FG001|Overall Study|Withdrawal by Subject|3|||
147218720|NCT00640835|530973030|FG000|Overall Study|Adverse Event|5|||
147218721|NCT00640835|530973031|FG001|Overall Study|Adverse Event|3|||
147218722|NCT00640835|530973030|FG000|Overall Study|Withdrawal by Subject|12|||
147218723|NCT00640835|530973031|FG001|Overall Study|Withdrawal by Subject|14|||
147218724|NCT00640835|530973030|FG000|Overall Study|Physician Decision|10|||
147218725|NCT00640835|530973031|FG001|Overall Study|Physician Decision|14|||
147218726|NCT00640835|530973030|FG000|Overall Study|Sponsor's Decision|11|||
147218727|NCT00640835|530973031|FG001|Overall Study|Sponsor's Decision|7|||
147218728|NCT00640835|530973030|FG000|Overall Study|Protocol Violation|2|||
147218729|NCT00640835|530973031|FG001|Overall Study|Protocol Violation|2|||
147218730|NCT00640835|530973030|FG000|Overall Study|Lost to Follow-up|17|||
147218731|NCT00640835|530973031|FG001|Overall Study|Lost to Follow-up|13|||
147218732|NCT00640835|530973030|FG000|Overall Study|Other Reason|19|||
147218733|NCT00640835|530973031|FG001|Overall Study|Other Reason|4|||
147218734|NCT01437995|530973032|FG000|Overall Study|Lost to Follow-up|11|||
147307546|NCT04145037|531293044|FG000|Overall Study|Lost to Follow-up|1|||
147307547|NCT04145037|531293045|FG001|Overall Study|Lost to Follow-up|0|||
147307548|NCT00098254|531293050|FG000|Overall Study|Adverse Event|2|||
147307549|NCT00098254|531293050|FG000|Overall Study|Death|1|||
147307550|NCT00744263|531293053|FG000|Overall Study|Death|3006|||
147307551|NCT00744263|531293054|FG001|Overall Study|Death|3005|||
147307552|NCT00744263|531293053|FG000|Overall Study|Lost to Follow-up|2038|||
147307553|NCT00744263|531293054|FG001|Overall Study|Lost to Follow-up|2135|||
147307554|NCT00744263|531293053|FG000|Overall Study|Withdrawal by Subject|166|||
147307555|NCT00744263|531293054|FG001|Overall Study|Withdrawal by Subject|150|||
147307556|NCT00744263|531293053|FG000|Overall Study|Physician Decision|20|||
147307557|NCT00744263|531293054|FG001|Overall Study|Physician Decision|23|||
147307558|NCT00744263|531293053|FG000|Overall Study|Protocol Violation|3|||
147307559|NCT00744263|531293054|FG001|Overall Study|Protocol Violation|5|||
147307560|NCT00744263|531293053|FG000|Overall Study|Adverse Event|1|||
147307561|NCT00744263|531293054|FG001|Overall Study|Adverse Event|0|||
147307562|NCT00744263|531293053|FG000|Overall Study|Other|2|||
147443081|NCT03703882|531787159|FG001|Overall Study|Starting another treatment|1|||
147218735|NCT01437995|530973033|FG001|Overall Study|Lost to Follow-up|18|||
147218736|NCT01437995|530973034|FG002|Overall Study|Lost to Follow-up|20|||
147218737|NCT04618770|530973035|FG000|Overall Study|Censored from Analysis|12|||
147218738|NCT04618770|530973035|FG000|Overall Study|Early Termination|25|||
147218739|NCT04456673|530973036|FG000|Overall Study|Adverse Event|7|||
147218740|NCT04456673|530973037|FG001|Overall Study|Adverse Event|14|||
147218741|NCT04456673|530973036|FG000|Overall Study|Poor compliance to protocol|1|||
147218742|NCT04456673|530973037|FG001|Overall Study|Poor compliance to protocol|0|||
147218743|NCT04456673|530973036|FG000|Overall Study|Withdrawal by Subject|31|||
147218744|NCT04456673|530973037|FG001|Overall Study|Withdrawal by Subject|23|||
147218745|NCT04456673|530973036|FG000|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|4|||
147218746|NCT04456673|530973037|FG001|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|5|||
147218747|NCT04391049|530973038|FG000|Overall Study|Protocol Violation|1|||
147218748|NCT03874429|530973039|FG000|Overall Study|Adverse Event|2|||
147218749|NCT03874429|530973040|FG001|Overall Study|Adverse Event|2|||
147218750|NCT03874429|530973039|FG000|Overall Study|Lack of Efficacy|0|||
147218751|NCT03874429|530973040|FG001|Overall Study|Lack of Efficacy|1|||
147218752|NCT03874429|530973039|FG000|Overall Study|Covid-19 pandemic|4|||
147218753|NCT03874429|530973040|FG001|Overall Study|Covid-19 pandemic|2|||
147218754|NCT00775203|530973041|FG000|Overall Study|Adverse Event|25|||
147218755|NCT00775203|530973042|FG001|Overall Study|Adverse Event|6|||
147218756|NCT00775203|530973041|FG000|Overall Study|Lack of Efficacy|8|||
147218757|NCT00775203|530973042|FG001|Overall Study|Lack of Efficacy|9|||
147218758|NCT00775203|530973041|FG000|Overall Study|Withdrawal by Subject|11|||
147218759|NCT00775203|530973042|FG001|Overall Study|Withdrawal by Subject|9|||
147218760|NCT00775203|530973041|FG000|Overall Study|Lost to Follow-up|11|||
147218761|NCT00775203|530973042|FG001|Overall Study|Lost to Follow-up|15|||
147218762|NCT00775203|530973041|FG000|Overall Study|Administrative reason|2|||
147218763|NCT00775203|530973042|FG001|Overall Study|Administrative reason|0|||
147218764|NCT00775203|530973041|FG000|Overall Study|Noncompliance|4|||
147218765|NCT00775203|530973042|FG001|Overall Study|Noncompliance|2|||
147218766|NCT00775203|530973041|FG000|Overall Study|Protocol Violation|0|||
147218767|NCT00775203|530973042|FG001|Overall Study|Protocol Violation|1|||
147218768|NCT00775203|530973041|FG000|Overall Study|Entered other study|1|||
147218769|NCT00775203|530973042|FG001|Overall Study|Entered other study|0|||
147218770|NCT00775203|530973041|FG000|Overall Study|Physician Decision|0|||
147218771|NCT00775203|530973042|FG001|Overall Study|Physician Decision|1|||
147218772|NCT00704522|530973043|FG000|Overall Study|Lack of Efficacy|65|||
147218773|NCT00704522|530973044|FG001|Overall Study|Lack of Efficacy|17|||
147218774|NCT00704522|530973043|FG000|Overall Study|Failure to appear again at hospital|56|||
147218775|NCT00704522|530973044|FG001|Overall Study|Failure to appear again at hospital|10|||
147218776|NCT00704522|530973043|FG000|Overall Study|Withdrawal by Subject|17|||
147218777|NCT00704522|530973044|FG001|Overall Study|Withdrawal by Subject|8|||
147218778|NCT00704522|530973043|FG000|Overall Study|Adverse Event|9|||
147218779|NCT00704522|530973044|FG001|Overall Study|Adverse Event|1|||
147218780|NCT00704522|530973043|FG000|Overall Study|Undefined causes|9|||
147218781|NCT00704522|530973044|FG001|Overall Study|Undefined causes|7|||
147218782|NCT00704522|530973043|FG000|Overall Study|No information on therapy end|27|||
147218783|NCT00704522|530973044|FG001|Overall Study|No information on therapy end|2|||
147218784|NCT04896229|530973046|FG000|Overall Study|Lost to Follow-up|113|||
147218785|NCT04896229|530973047|FG001|Overall Study|Lost to Follow-up|113|||
147218786|NCT04395001|530973048|FG000|Overall Study|Lost to Follow-up|8|||
147218787|NCT04395001|530973049|FG001|Overall Study|Lost to Follow-up|9|||
147307563|NCT00744263|531293054|FG001|Overall Study|Other|2|||
147307564|NCT00211237|531293057|FG000|Baseline|Withdrew|1|||
147307565|NCT00211237|531293058|FG001|Baseline|Withdrew|3|||
147307566|NCT00211237|531293059|FG002|Baseline|Withdrew|0|||
147307567|NCT00211237|531293057|FG000|Baseline|Refused random assignment|1|||
147307568|NCT00211237|531293058|FG001|Baseline|Refused random assignment|0|||
147552252|NCT02711956|532178578|FG014|Overall Study|Physician Decision|0|||
147218788|NCT04395001|530973050|FG002|Overall Study|Lost to Follow-up|5|||
147218789|NCT04395001|530973048|FG000|Overall Study|Withdrawal by Subject|3|||
147218790|NCT04395001|530973049|FG001|Overall Study|Withdrawal by Subject|1|||
147218791|NCT04395001|530973050|FG002|Overall Study|Withdrawal by Subject|3|||
147218792|NCT04395001|530973048|FG000|Overall Study|missed appointment|7|||
147218793|NCT04395001|530973049|FG001|Overall Study|missed appointment|4|||
147218794|NCT04395001|530973050|FG002|Overall Study|missed appointment|1|||
147218795|NCT04418661|530973051|FG000|Overall Study|Adverse Event|0|||
147218796|NCT04418661|530973052|FG001|Overall Study|Adverse Event|1|||
147218797|NCT04418661|530973053|FG002|Overall Study|Adverse Event|5|||
147218798|NCT04418661|530973054|FG003|Overall Study|Adverse Event|3|||
147218799|NCT04418661|530973055|FG004|Overall Study|Adverse Event|0|||
147218800|NCT04418661|530973056|FG005|Overall Study|Adverse Event|2|||
147218801|NCT04418661|530973051|FG000|Overall Study|Progressive disease|4|||
147218802|NCT04418661|530973052|FG001|Overall Study|Progressive disease|11|||
147218803|NCT04418661|530973053|FG002|Overall Study|Progressive disease|6|||
147218804|NCT04418661|530973054|FG003|Overall Study|Progressive disease|11|||
147218805|NCT04418661|530973055|FG004|Overall Study|Progressive disease|1|||
147218806|NCT04418661|530973056|FG005|Overall Study|Progressive disease|12|||
147218807|NCT04418661|530973051|FG000|Overall Study|Withdrawal by Subject|0|||
147218808|NCT04418661|530973052|FG001|Overall Study|Withdrawal by Subject|1|||
147218809|NCT04418661|530973053|FG002|Overall Study|Withdrawal by Subject|0|||
147218810|NCT04418661|530973054|FG003|Overall Study|Withdrawal by Subject|1|||
147218811|NCT04418661|530973055|FG004|Overall Study|Withdrawal by Subject|0|||
147218812|NCT04418661|530973056|FG005|Overall Study|Withdrawal by Subject|0|||
147218813|NCT04418661|530973051|FG000|Overall Study|Other|0|||
147218814|NCT04418661|530973052|FG001|Overall Study|Other|0|||
147218815|NCT04418661|530973053|FG002|Overall Study|Other|1|||
147218816|NCT04418661|530973054|FG003|Overall Study|Other|3|||
147218817|NCT04418661|530973055|FG004|Overall Study|Other|0|||
147218818|NCT04418661|530973056|FG005|Overall Study|Other|1|||
147218819|NCT00329901|530973060|FG000|Overall Study|Withdrawal by Subject|4|||
147218820|NCT00329901|530973061|FG001|Overall Study|Withdrawal by Subject|3|||
147218821|NCT00329901|530973062|FG002|Overall Study|Withdrawal by Subject|2|||
147218822|NCT00329901|530973060|FG000|Overall Study|Lost to Follow-up|2|||
147218823|NCT00329901|530973061|FG001|Overall Study|Lost to Follow-up|0|||
147218824|NCT00329901|530973062|FG002|Overall Study|Lost to Follow-up|1|||
147218825|NCT00329901|530973060|FG000|Overall Study|Protocol Violation|1|||
147218826|NCT00329901|530973061|FG001|Overall Study|Protocol Violation|0|||
147218827|NCT00329901|530973062|FG002|Overall Study|Protocol Violation|1|||
147218828|NCT00329901|530973060|FG000|Overall Study|Unable to classify|2|||
147218829|NCT00329901|530973061|FG001|Overall Study|Unable to classify|2|||
147218830|NCT00329901|530973062|FG002|Overall Study|Unable to classify|0|||
147218831|NCT00992589|530973063|FG000|Open-Label Phase|Adverse Event|4|||
147218832|NCT00992589|530973064|FG001|Open-Label Phase|Adverse Event|0|||
147218833|NCT00992589|530973065|FG002|Open-Label Phase|Adverse Event|0|||
147218834|NCT00992589|530973066|FG003|Open-Label Phase|Adverse Event|0|||
147218835|NCT00992589|530973063|FG000|Open-Label Phase|Withdrawal by Subject|20|||
147218836|NCT00992589|530973064|FG001|Open-Label Phase|Withdrawal by Subject|0|||
147218837|NCT00992589|530973065|FG002|Open-Label Phase|Withdrawal by Subject|0|||
147218838|NCT00992589|530973066|FG003|Open-Label Phase|Withdrawal by Subject|0|||
147218839|NCT00992589|530973063|FG000|Open-Label Phase|Lost to Follow-up|1|||
147218840|NCT00992589|530973064|FG001|Open-Label Phase|Lost to Follow-up|0|||
147218841|NCT00992589|530973065|FG002|Open-Label Phase|Lost to Follow-up|0|||
147218842|NCT00992589|530973066|FG003|Open-Label Phase|Lost to Follow-up|0|||
147218843|NCT00992589|530973063|FG000|Open-Label Phase|Protocol Violation|3|||
147218844|NCT00992589|530973064|FG001|Open-Label Phase|Protocol Violation|0|||
147218845|NCT00992589|530973065|FG002|Open-Label Phase|Protocol Violation|0|||
147218846|NCT00992589|530973066|FG003|Open-Label Phase|Protocol Violation|0|||
147218847|NCT00992589|530973063|FG000|Open-Label Phase|Physician Decision|4|||
147218848|NCT00992589|530973064|FG001|Open-Label Phase|Physician Decision|0|||
147218849|NCT00992589|530973065|FG002|Open-Label Phase|Physician Decision|0|||
147218850|NCT00992589|530973066|FG003|Open-Label Phase|Physician Decision|0|||
147218851|NCT00992589|530973063|FG000|Open-Label Phase|Other|45|||
147218852|NCT00992589|530973064|FG001|Open-Label Phase|Other|0|||
147218853|NCT00992589|530973065|FG002|Open-Label Phase|Other|0|||
147218854|NCT00992589|530973066|FG003|Open-Label Phase|Other|0|||
147218855|NCT00992589|530973063|FG000|Double-Blind Phase|Adverse Event|0|||
147218856|NCT00992589|530973064|FG001|Double-Blind Phase|Adverse Event|6|||
147218857|NCT00992589|530973065|FG002|Double-Blind Phase|Adverse Event|2|||
147218858|NCT00992589|530973066|FG003|Double-Blind Phase|Adverse Event|3|||
147218859|NCT00992589|530973063|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
147218860|NCT00992589|530973064|FG001|Double-Blind Phase|Withdrawal by Subject|6|||
147218861|NCT00992589|530973065|FG002|Double-Blind Phase|Withdrawal by Subject|5|||
147218862|NCT00992589|530973066|FG003|Double-Blind Phase|Withdrawal by Subject|2|||
147218863|NCT00992589|530973063|FG000|Double-Blind Phase|Lost to Follow-up|0|||
147218864|NCT00992589|530973064|FG001|Double-Blind Phase|Lost to Follow-up|0|||
147218865|NCT00992589|530973065|FG002|Double-Blind Phase|Lost to Follow-up|0|||
147218866|NCT00992589|530973066|FG003|Double-Blind Phase|Lost to Follow-up|2|||
147218867|NCT00992589|530973063|FG000|Double-Blind Phase|Other|0|||
147218868|NCT00992589|530973064|FG001|Double-Blind Phase|Other|1|||
147218869|NCT00992589|530973065|FG002|Double-Blind Phase|Other|6|||
147552253|NCT02711956|532178564|FG000|Overall Study|Withdrawal by Subject|0|||
147552254|NCT02711956|532178565|FG001|Overall Study|Withdrawal by Subject|0|||
147552255|NCT02711956|532178566|FG002|Overall Study|Withdrawal by Subject|0|||
147552256|NCT02711956|532178567|FG003|Overall Study|Withdrawal by Subject|0|||
147552257|NCT02711956|532178568|FG004|Overall Study|Withdrawal by Subject|0|||
147552258|NCT02711956|532178569|FG005|Overall Study|Withdrawal by Subject|0|||
147552259|NCT02711956|532178570|FG006|Overall Study|Withdrawal by Subject|1|||
147552260|NCT02711956|532178571|FG007|Overall Study|Withdrawal by Subject|0|||
147552261|NCT02711956|532178572|FG008|Overall Study|Withdrawal by Subject|0|||
147552262|NCT02711956|532178573|FG009|Overall Study|Withdrawal by Subject|0|||
147552263|NCT02711956|532178574|FG010|Overall Study|Withdrawal by Subject|0|||
147552264|NCT02711956|532178575|FG011|Overall Study|Withdrawal by Subject|1|||
147552265|NCT02711956|532178576|FG012|Overall Study|Withdrawal by Subject|6|||
147552266|NCT02711956|532178577|FG013|Overall Study|Withdrawal by Subject|0|||
147552267|NCT02711956|532178578|FG014|Overall Study|Withdrawal by Subject|1|||
147552268|NCT02711956|532178564|FG000|Overall Study|Clinical progression|1|||
147307569|NCT00211237|531293059|FG002|Baseline|Refused random assignment|0|||
147307570|NCT00211237|531293057|FG000|1 Month|Death|2|||
147552269|NCT02711956|532178565|FG001|Overall Study|Clinical progression|0|||
147552270|NCT02711956|532178566|FG002|Overall Study|Clinical progression|0|||
147552271|NCT02711956|532178567|FG003|Overall Study|Clinical progression|0|||
147552272|NCT02711956|532178568|FG004|Overall Study|Clinical progression|0|||
147552273|NCT02711956|532178569|FG005|Overall Study|Clinical progression|0|||
147552274|NCT02711956|532178570|FG006|Overall Study|Clinical progression|1|||
147552275|NCT02711956|532178571|FG007|Overall Study|Clinical progression|0|||
147552276|NCT02711956|532178572|FG008|Overall Study|Clinical progression|1|||
147552277|NCT02711956|532178573|FG009|Overall Study|Clinical progression|0|||
147552278|NCT02711956|532178574|FG010|Overall Study|Clinical progression|0|||
147552279|NCT02711956|532178575|FG011|Overall Study|Clinical progression|2|||
147552280|NCT02711956|532178576|FG012|Overall Study|Clinical progression|4|||
147307571|NCT00211237|531293058|FG001|1 Month|Death|1|||
147307572|NCT00211237|531293059|FG002|1 Month|Death|0|||
147307573|NCT00211237|531293057|FG000|1 Month|Lost to Follow-up|0|||
147307574|NCT00211237|531293058|FG001|1 Month|Lost to Follow-up|2|||
147307575|NCT00211237|531293059|FG002|1 Month|Lost to Follow-up|0|||
147307576|NCT00211237|531293057|FG000|1 Month|Withdrew|0|||
147307577|NCT00211237|531293058|FG001|1 Month|Withdrew|4|||
147307578|NCT00211237|531293059|FG002|1 Month|Withdrew|0|||
147307579|NCT00211237|531293057|FG000|1 Month|Additional surgery needed|1|||
147552281|NCT02711956|532178577|FG013|Overall Study|Clinical progression|1|||
147552282|NCT02711956|532178578|FG014|Overall Study|Clinical progression|1|||
147552283|NCT02711956|532178564|FG000|Overall Study|Radiographic progression|1|||
147552284|NCT02711956|532178565|FG001|Overall Study|Radiographic progression|1|||
147552285|NCT02711956|532178566|FG002|Overall Study|Radiographic progression|2|||
147552286|NCT02711956|532178567|FG003|Overall Study|Radiographic progression|0|||
147552287|NCT02711956|532178568|FG004|Overall Study|Radiographic progression|1|||
147552288|NCT02711956|532178569|FG005|Overall Study|Radiographic progression|0|||
147552289|NCT02711956|532178570|FG006|Overall Study|Radiographic progression|0|||
147552290|NCT02711956|532178571|FG007|Overall Study|Radiographic progression|0|||
147218870|NCT00992589|530973066|FG003|Double-Blind Phase|Other|3|||
147218871|NCT00045942|530973067|FG000|PKC412A2104 (Core)|Withdrawal by Subject|1|||
147218872|NCT00045942|530973068|FG001|PKC412A2104 (Core)|Withdrawal by Subject|0|||
147218873|NCT00045942|530973069|FG002|PKC412A2104 (Core)|Withdrawal by Subject|0|||
147218874|NCT00045942|530973070|FG003|PKC412A2104 (Core)|Withdrawal by Subject|0|||
147218875|NCT00045942|530973071|FG004|PKC412A2104 (Core)|Withdrawal by Subject|0|||
147218876|NCT00045942|530973072|FG005|PKC412A2104 (Core)|Withdrawal by Subject|0|||
147218877|NCT00045942|530973073|FG006|PKC412A2104 (Core)|Withdrawal by Subject|0|||
147218878|NCT00045942|530973074|FG007|PKC412A2104 (Core)|Withdrawal by Subject|0|||
147218879|NCT00045942|530973075|FG008|PKC412A2104 (Core)|Withdrawal by Subject|0|||
147307580|NCT00211237|531293058|FG001|1 Month|Additional surgery needed|0|||
147307581|NCT00211237|531293059|FG002|1 Month|Additional surgery needed|0|||
147552291|NCT02711956|532178572|FG008|Overall Study|Radiographic progression|2|||
147552292|NCT02711956|532178573|FG009|Overall Study|Radiographic progression|1|||
147552293|NCT02711956|532178574|FG010|Overall Study|Radiographic progression|0|||
147218880|NCT00045942|530973067|FG000|PKC412A2104 (Core)|Adverse Event|5|||
147307582|NCT00211237|531293057|FG000|1 Month|Non-medical problem|0|||
147307583|NCT00211237|531293058|FG001|1 Month|Non-medical problem|2|||
147552294|NCT02711956|532178575|FG011|Overall Study|Radiographic progression|5|||
147552295|NCT02711956|532178576|FG012|Overall Study|Radiographic progression|3|||
147552296|NCT02711956|532178577|FG013|Overall Study|Radiographic progression|0|||
147552297|NCT02711956|532178578|FG014|Overall Study|Radiographic progression|1|||
147218881|NCT00045942|530973068|FG001|PKC412A2104 (Core)|Adverse Event|0|||
147307584|NCT00211237|531293059|FG002|1 Month|Non-medical problem|0|||
147307585|NCT00211237|531293057|FG000|3 Months|Death|7|||
147307586|NCT00211237|531293058|FG001|3 Months|Death|3|||
147218882|NCT00045942|530973069|FG002|PKC412A2104 (Core)|Adverse Event|0|||
147218883|NCT00045942|530973070|FG003|PKC412A2104 (Core)|Adverse Event|0|||
147218884|NCT00045942|530973071|FG004|PKC412A2104 (Core)|Adverse Event|0|||
147218885|NCT00045942|530973072|FG005|PKC412A2104 (Core)|Adverse Event|0|||
147218886|NCT00045942|530973073|FG006|PKC412A2104 (Core)|Adverse Event|0|||
147218887|NCT00045942|530973074|FG007|PKC412A2104 (Core)|Adverse Event|0|||
147218888|NCT00045942|530973075|FG008|PKC412A2104 (Core)|Adverse Event|0|||
147218889|NCT00045942|530973067|FG000|PKC412A2104 (Core)|Lack of Efficacy|13|||
147218890|NCT00045942|530973068|FG001|PKC412A2104 (Core)|Lack of Efficacy|0|||
147218891|NCT00045942|530973069|FG002|PKC412A2104 (Core)|Lack of Efficacy|0|||
147218892|NCT00045942|530973070|FG003|PKC412A2104 (Core)|Lack of Efficacy|0|||
147218893|NCT00045942|530973071|FG004|PKC412A2104 (Core)|Lack of Efficacy|0|||
147218894|NCT00045942|530973072|FG005|PKC412A2104 (Core)|Lack of Efficacy|0|||
147218895|NCT00045942|530973073|FG006|PKC412A2104 (Core)|Lack of Efficacy|0|||
147218896|NCT00045942|530973074|FG007|PKC412A2104 (Core)|Lack of Efficacy|0|||
147218897|NCT00045942|530973075|FG008|PKC412A2104 (Core)|Lack of Efficacy|0|||
147218898|NCT00045942|530973067|FG000|PKC412A2104 (Core)|Death|1|||
147218899|NCT00045942|530973068|FG001|PKC412A2104 (Core)|Death|0|||
147218900|NCT00045942|530973069|FG002|PKC412A2104 (Core)|Death|0|||
147218901|NCT00045942|530973070|FG003|PKC412A2104 (Core)|Death|0|||
147218902|NCT00045942|530973071|FG004|PKC412A2104 (Core)|Death|0|||
147218903|NCT00045942|530973072|FG005|PKC412A2104 (Core)|Death|0|||
147218904|NCT00045942|530973073|FG006|PKC412A2104 (Core)|Death|0|||
147218905|NCT00045942|530973074|FG007|PKC412A2104 (Core)|Death|0|||
147218906|NCT00045942|530973075|FG008|PKC412A2104 (Core)|Death|0|||
147218907|NCT00045942|530973067|FG000|PKC412A2104E1|Withdrawal by Subject|0|||
147218908|NCT00045942|530973068|FG001|PKC412A2104E1|Withdrawal by Subject|0|||
147218909|NCT00045942|530973069|FG002|PKC412A2104E1|Withdrawal by Subject|2|||
147218910|NCT00045942|530973070|FG003|PKC412A2104E1|Withdrawal by Subject|5|||
147218911|NCT00045942|530973071|FG004|PKC412A2104E1|Withdrawal by Subject|2|||
147218912|NCT00045942|530973072|FG005|PKC412A2104E1|Withdrawal by Subject|0|||
147218913|NCT00045942|530973073|FG006|PKC412A2104E1|Withdrawal by Subject|0|||
147218914|NCT00045942|530973074|FG007|PKC412A2104E1|Withdrawal by Subject|0|||
147218915|NCT00045942|530973075|FG008|PKC412A2104E1|Withdrawal by Subject|0|||
147218916|NCT00045942|530973067|FG000|PKC412A2104E1|Condition no longer requires study drug|0|||
147218917|NCT00045942|530973068|FG001|PKC412A2104E1|Condition no longer requires study drug|1|||
147218918|NCT00045942|530973069|FG002|PKC412A2104E1|Condition no longer requires study drug|1|||
147218919|NCT00045942|530973070|FG003|PKC412A2104E1|Condition no longer requires study drug|0|||
147218920|NCT00045942|530973071|FG004|PKC412A2104E1|Condition no longer requires study drug|1|||
147218921|NCT00045942|530973072|FG005|PKC412A2104E1|Condition no longer requires study drug|0|||
147218922|NCT00045942|530973073|FG006|PKC412A2104E1|Condition no longer requires study drug|0|||
147218923|NCT00045942|530973074|FG007|PKC412A2104E1|Condition no longer requires study drug|0|||
147218924|NCT00045942|530973075|FG008|PKC412A2104E1|Condition no longer requires study drug|0|||
147218925|NCT00045942|530973067|FG000|PKC412A2104E1|Lack of Efficacy|0|||
147218926|NCT00045942|530973068|FG001|PKC412A2104E1|Lack of Efficacy|11|||
147218927|NCT00045942|530973069|FG002|PKC412A2104E1|Lack of Efficacy|11|||
147218928|NCT00045942|530973070|FG003|PKC412A2104E1|Lack of Efficacy|23|||
147218929|NCT00045942|530973071|FG004|PKC412A2104E1|Lack of Efficacy|17|||
147218930|NCT00045942|530973072|FG005|PKC412A2104E1|Lack of Efficacy|0|||
147218931|NCT00045942|530973073|FG006|PKC412A2104E1|Lack of Efficacy|0|||
147218932|NCT00045942|530973074|FG007|PKC412A2104E1|Lack of Efficacy|0|||
147218933|NCT00045942|530973075|FG008|PKC412A2104E1|Lack of Efficacy|0|||
147218934|NCT00045942|530973067|FG000|PKC412A2104E1|Abnormal laboratory value|0|||
147218935|NCT00045942|530973068|FG001|PKC412A2104E1|Abnormal laboratory value|1|||
147218936|NCT00045942|530973069|FG002|PKC412A2104E1|Abnormal laboratory value|0|||
147218937|NCT00045942|530973070|FG003|PKC412A2104E1|Abnormal laboratory value|0|||
147218938|NCT00045942|530973071|FG004|PKC412A2104E1|Abnormal laboratory value|0|||
147218939|NCT00045942|530973072|FG005|PKC412A2104E1|Abnormal laboratory value|0|||
147218940|NCT00045942|530973073|FG006|PKC412A2104E1|Abnormal laboratory value|0|||
147218941|NCT00045942|530973074|FG007|PKC412A2104E1|Abnormal laboratory value|0|||
147218942|NCT00045942|530973075|FG008|PKC412A2104E1|Abnormal laboratory value|0|||
147218943|NCT00045942|530973067|FG000|PKC412A2104E1|Adverse Event|0|||
147218944|NCT00045942|530973068|FG001|PKC412A2104E1|Adverse Event|1|||
147218945|NCT00045942|530973069|FG002|PKC412A2104E1|Adverse Event|1|||
147218946|NCT00045942|530973070|FG003|PKC412A2104E1|Adverse Event|3|||
147218947|NCT00045942|530973071|FG004|PKC412A2104E1|Adverse Event|6|||
147218948|NCT00045942|530973072|FG005|PKC412A2104E1|Adverse Event|0|||
147218949|NCT00045942|530973073|FG006|PKC412A2104E1|Adverse Event|0|||
147218950|NCT00045942|530973074|FG007|PKC412A2104E1|Adverse Event|0|||
147218951|NCT00045942|530973075|FG008|PKC412A2104E1|Adverse Event|0|||
147218952|NCT00045942|530973067|FG000|PKC412A2104E1|Death|0|||
147218953|NCT00045942|530973068|FG001|PKC412A2104E1|Death|4|||
147218954|NCT00045942|530973069|FG002|PKC412A2104E1|Death|1|||
147218955|NCT00045942|530973070|FG003|PKC412A2104E1|Death|1|||
147218956|NCT00045942|530973071|FG004|PKC412A2104E1|Death|1|||
147218957|NCT00045942|530973072|FG005|PKC412A2104E1|Death|0|||
147218958|NCT00045942|530973073|FG006|PKC412A2104E1|Death|0|||
147218959|NCT00045942|530973074|FG007|PKC412A2104E1|Death|0|||
147307587|NCT00211237|531293059|FG002|3 Months|Death|0|||
147307588|NCT00211237|531293057|FG000|3 Months|Could not comply with protocol|1|||
147307589|NCT00211237|531293058|FG001|3 Months|Could not comply with protocol|0|||
147307590|NCT00211237|531293059|FG002|3 Months|Could not comply with protocol|0|||
147307591|NCT00211237|531293057|FG000|3 Months|Withdrew|0|||
147307592|NCT00211237|531293058|FG001|3 Months|Withdrew|1|||
147307593|NCT00211237|531293059|FG002|3 Months|Withdrew|0|||
147307594|NCT00211237|531293057|FG000|3 Months|Non-medical problem|0|||
147307595|NCT00211237|531293058|FG001|3 Months|Non-medical problem|0|||
147307596|NCT00211237|531293059|FG002|3 Months|Non-medical problem|1|||
147307597|NCT00211237|531293057|FG000|6 Months|Death|6|||
147307598|NCT00211237|531293058|FG001|6 Months|Death|0|||
147307599|NCT00211237|531293059|FG002|6 Months|Death|3|||
147307600|NCT00211237|531293057|FG000|6 Months|Lost to Follow-up|2|||
147307601|NCT00211237|531293058|FG001|6 Months|Lost to Follow-up|0|||
147218960|NCT00045942|530973075|FG008|PKC412A2104E1|Death|0|||
147218961|NCT00045942|530973067|FG000|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
147218962|NCT00045942|530973068|FG001|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
147218963|NCT00045942|530973069|FG002|PKC412A2104E1|Enrolled into PKC412A2104E2|1|||
147218964|NCT00045942|530973070|FG003|PKC412A2104E1|Enrolled into PKC412A2104E2|1|||
147218965|NCT00045942|530973071|FG004|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
147218966|NCT00045942|530973072|FG005|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
147218967|NCT00045942|530973073|FG006|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
147218968|NCT00045942|530973074|FG007|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
147218969|NCT00045942|530973075|FG008|PKC412A2104E1|Enrolled into PKC412A2104E2|0|||
147218970|NCT00045942|530973067|FG000|PKC412A2104E2|Lost to Follow-up|0|||
147218971|NCT00045942|530973068|FG001|PKC412A2104E2|Lost to Follow-up|0|||
147218972|NCT00045942|530973069|FG002|PKC412A2104E2|Lost to Follow-up|0|||
147218973|NCT00045942|530973070|FG003|PKC412A2104E2|Lost to Follow-up|0|||
147218974|NCT00045942|530973071|FG004|PKC412A2104E2|Lost to Follow-up|0|||
147218975|NCT00045942|530973072|FG005|PKC412A2104E2|Lost to Follow-up|0|||
147218976|NCT00045942|530973073|FG006|PKC412A2104E2|Lost to Follow-up|0|||
147218977|NCT00045942|530973074|FG007|PKC412A2104E2|Lost to Follow-up|3|||
147218978|NCT00045942|530973075|FG008|PKC412A2104E2|Lost to Follow-up|0|||
147218979|NCT00045942|530973067|FG000|PKC412A2104E2|Withdrawal by Subject|0|||
147218980|NCT00045942|530973068|FG001|PKC412A2104E2|Withdrawal by Subject|0|||
147218981|NCT00045942|530973069|FG002|PKC412A2104E2|Withdrawal by Subject|0|||
147218982|NCT00045942|530973070|FG003|PKC412A2104E2|Withdrawal by Subject|0|||
147218983|NCT00045942|530973071|FG004|PKC412A2104E2|Withdrawal by Subject|0|||
147218984|NCT00045942|530973072|FG005|PKC412A2104E2|Withdrawal by Subject|1|||
147218985|NCT00045942|530973073|FG006|PKC412A2104E2|Withdrawal by Subject|0|||
147218986|NCT00045942|530973074|FG007|PKC412A2104E2|Withdrawal by Subject|1|||
147218987|NCT00045942|530973075|FG008|PKC412A2104E2|Withdrawal by Subject|0|||
147218988|NCT00045942|530973067|FG000|PKC412A2104E2|Lack of Efficacy|0|||
147218989|NCT00045942|530973068|FG001|PKC412A2104E2|Lack of Efficacy|0|||
147218990|NCT00045942|530973069|FG002|PKC412A2104E2|Lack of Efficacy|0|||
147218991|NCT00045942|530973070|FG003|PKC412A2104E2|Lack of Efficacy|0|||
147218992|NCT00045942|530973071|FG004|PKC412A2104E2|Lack of Efficacy|0|||
147218993|NCT00045942|530973072|FG005|PKC412A2104E2|Lack of Efficacy|3|||
147218994|NCT00045942|530973073|FG006|PKC412A2104E2|Lack of Efficacy|2|||
147218995|NCT00045942|530973074|FG007|PKC412A2104E2|Lack of Efficacy|2|||
147218996|NCT00045942|530973075|FG008|PKC412A2104E2|Lack of Efficacy|6|||
147218997|NCT00045942|530973067|FG000|PKC412A2104E2|Adverse Event|0|||
147218998|NCT00045942|530973068|FG001|PKC412A2104E2|Adverse Event|0|||
147218999|NCT00045942|530973069|FG002|PKC412A2104E2|Adverse Event|0|||
147219000|NCT00045942|530973070|FG003|PKC412A2104E2|Adverse Event|0|||
147219001|NCT00045942|530973071|FG004|PKC412A2104E2|Adverse Event|0|||
147219002|NCT00045942|530973072|FG005|PKC412A2104E2|Adverse Event|4|||
147219003|NCT00045942|530973073|FG006|PKC412A2104E2|Adverse Event|3|||
147219004|NCT00045942|530973074|FG007|PKC412A2104E2|Adverse Event|1|||
147219005|NCT00045942|530973075|FG008|PKC412A2104E2|Adverse Event|0|||
147219006|NCT00045942|530973067|FG000|PKC412A2104E2|Death|0|||
147219007|NCT00045942|530973068|FG001|PKC412A2104E2|Death|0|||
147307602|NCT00211237|531293059|FG002|6 Months|Lost to Follow-up|0|||
147307603|NCT00211237|531293057|FG000|6 Months|Could not comply with protocol|0|||
147219008|NCT00045942|530973069|FG002|PKC412A2104E2|Death|0|||
147219009|NCT00045942|530973070|FG003|PKC412A2104E2|Death|0|||
147219010|NCT00045942|530973071|FG004|PKC412A2104E2|Death|0|||
147219011|NCT00045942|530973072|FG005|PKC412A2104E2|Death|1|||
147219012|NCT00045942|530973073|FG006|PKC412A2104E2|Death|2|||
147219013|NCT00045942|530973074|FG007|PKC412A2104E2|Death|0|||
147307604|NCT00211237|531293058|FG001|6 Months|Could not comply with protocol|2|||
147307605|NCT00211237|531293059|FG002|6 Months|Could not comply with protocol|0|||
147307606|NCT00211237|531293057|FG000|12 Months|Death|8|||
147307607|NCT00211237|531293058|FG001|12 Months|Death|2|||
147219014|NCT00045942|530973075|FG008|PKC412A2104E2|Death|0|||
147219015|NCT01101308|530973076|FG000|Period 1|Adverse Event|2|||
147219016|NCT01101308|530973077|FG001|Period 1|Adverse Event|1|||
147219017|NCT01101308|530973076|FG000|Period 1|Positive for cotinine|1|||
147307608|NCT00211237|531293059|FG002|12 Months|Death|3|||
147307609|NCT00211237|531293057|FG000|12 Months|Lost to Follow-up|1|||
147219018|NCT01101308|530973077|FG001|Period 1|Positive for cotinine|0|||
147219019|NCT02984943|530973078|FG000|Overall Study|Withdrawal by Subject|3|||
147219020|NCT02984943|530973078|FG000|Overall Study|Physician Decision|1|||
147219021|NCT00711516|530973083|FG000|Overall Study|Adverse Event|1|||
147219022|NCT00711516|530973084|FG001|Overall Study|Adverse Event|1|||
147219023|NCT00711516|530973083|FG000|Overall Study|Withdrawal by Subject|0|||
147219024|NCT00711516|530973084|FG001|Overall Study|Withdrawal by Subject|1|||
147219025|NCT00711516|530973083|FG000|Overall Study|Protocol Violation|0|||
147219026|NCT00711516|530973084|FG001|Overall Study|Protocol Violation|1|||
147219027|NCT01895361|530973088|FG000|Overall Study|Adverse Event|1|||
147219028|NCT01895361|530973089|FG001|Overall Study|Adverse Event|1|||
147219029|NCT01895361|530973090|FG002|Overall Study|Adverse Event|3|||
147219030|NCT01895361|530973088|FG000|Overall Study|Death|2|||
147219031|NCT01895361|530973089|FG001|Overall Study|Death|1|||
147219032|NCT01895361|530973090|FG002|Overall Study|Death|2|||
147307610|NCT00211237|531293058|FG001|12 Months|Lost to Follow-up|0|||
147307611|NCT00211237|531293059|FG002|12 Months|Lost to Follow-up|1|||
147307612|NCT00211237|531293057|FG000|12 Months|Withdrew|0|||
147307613|NCT00211237|531293058|FG001|12 Months|Withdrew|0|||
147307614|NCT00211237|531293059|FG002|12 Months|Withdrew|1|||
147307615|NCT00211237|531293057|FG000|12 Months|unrelated medical problem|0|||
147307616|NCT00211237|531293058|FG001|12 Months|unrelated medical problem|0|||
147307617|NCT00211237|531293059|FG002|12 Months|unrelated medical problem|1|||
147307618|NCT04078035|531293062|FG000|Session 2|Lost to Follow-up|3|||
147307619|NCT04078035|531293063|FG001|Session 2|Lost to Follow-up|1|||
147307620|NCT04078035|531293062|FG000|Session 2|Unable to insert IV - participant elected to withdraw|8|||
147307621|NCT04078035|531293063|FG001|Session 2|Unable to insert IV - participant elected to withdraw|8|||
147307622|NCT05644353|531293066|FG000|Overall Study|Physician Decision|1|||
147307623|NCT05644353|531293067|FG001|Overall Study|Physician Decision|0|||
147307624|NCT05644353|531293068|FG002|Overall Study|Physician Decision|0|||
147307625|NCT05644353|531293069|FG003|Overall Study|Physician Decision|0|||
147307626|NCT05644353|531293070|FG004|Overall Study|Physician Decision|0|||
147307627|NCT05644353|531293071|FG005|Overall Study|Physician Decision|0|||
147307628|NCT05644353|531293066|FG000|Overall Study|Protocol Violation|1|||
147307629|NCT05644353|531293067|FG001|Overall Study|Protocol Violation|0|||
147307630|NCT05644353|531293068|FG002|Overall Study|Protocol Violation|0|||
147307631|NCT05644353|531293069|FG003|Overall Study|Protocol Violation|0|||
147307632|NCT05644353|531293070|FG004|Overall Study|Protocol Violation|0|||
147307633|NCT05644353|531293071|FG005|Overall Study|Protocol Violation|0|||
147307634|NCT05644353|531293066|FG000|Overall Study|Withdrawal by Subject|0|||
147307635|NCT05644353|531293067|FG001|Overall Study|Withdrawal by Subject|2|||
147307636|NCT05644353|531293068|FG002|Overall Study|Withdrawal by Subject|0|||
147307637|NCT05644353|531293069|FG003|Overall Study|Withdrawal by Subject|0|||
147307638|NCT05644353|531293070|FG004|Overall Study|Withdrawal by Subject|1|||
147307639|NCT05644353|531293071|FG005|Overall Study|Withdrawal by Subject|0|||
147307640|NCT05644353|531293066|FG000|Overall Study|Lost to Follow-up|0|||
147307641|NCT05644353|531293067|FG001|Overall Study|Lost to Follow-up|0|||
147307642|NCT05644353|531293068|FG002|Overall Study|Lost to Follow-up|1|||
147307643|NCT05644353|531293069|FG003|Overall Study|Lost to Follow-up|0|||
147307644|NCT05644353|531293070|FG004|Overall Study|Lost to Follow-up|0|||
147307645|NCT05644353|531293071|FG005|Overall Study|Lost to Follow-up|0|||
147307646|NCT03929562|531293072|FG000|From Baseline to 1 Month Follow Up|Lost to Follow-up|2|||
147307647|NCT03929562|531293073|FG001|From Baseline to 1 Month Follow Up|Lost to Follow-up|1|||
147307648|NCT03929562|531293072|FG000|From Baseline to 1 Month Follow Up|Withdrawal by Subject|2|||
147307649|NCT03929562|531293073|FG001|From Baseline to 1 Month Follow Up|Withdrawal by Subject|0|||
147307650|NCT03929562|531293072|FG000|1 Month Follow Up to 4 Month Follow Up|Lost to Follow-up|2|||
147307651|NCT03929562|531293073|FG001|1 Month Follow Up to 4 Month Follow Up|Lost to Follow-up|0|||
147307652|NCT01036022|531293074|FG000|Overall Study|Adverse Event|1|||
147307653|NCT01036022|531293075|FG001|Overall Study|Adverse Event|3|||
147552298|NCT02711956|532178564|FG000|Overall Study|PSA progression with clinical progression|0|||
147307654|NCT01036022|531293076|FG002|Overall Study|Adverse Event|2|||
147307655|NCT01036022|531293077|FG003|Overall Study|Adverse Event|1|||
147307656|NCT01036022|531293078|FG004|Overall Study|Adverse Event|0|||
147307657|NCT01036022|531293079|FG005|Overall Study|Adverse Event|2|||
147307658|NCT01036022|531293074|FG000|Overall Study|Lack of Efficacy|1|||
147307659|NCT01036022|531293075|FG001|Overall Study|Lack of Efficacy|1|||
147307660|NCT01036022|531293076|FG002|Overall Study|Lack of Efficacy|1|||
147307661|NCT01036022|531293077|FG003|Overall Study|Lack of Efficacy|0|||
147307662|NCT01036022|531293078|FG004|Overall Study|Lack of Efficacy|1|||
147307663|NCT01036022|531293079|FG005|Overall Study|Lack of Efficacy|1|||
147307664|NCT01036022|531293074|FG000|Overall Study|Physician Decision|0|||
147307665|NCT01036022|531293075|FG001|Overall Study|Physician Decision|0|||
147307666|NCT01036022|531293076|FG002|Overall Study|Physician Decision|1|||
147307667|NCT01036022|531293077|FG003|Overall Study|Physician Decision|0|||
147219033|NCT01895361|530973088|FG000|Overall Study|Lost to Follow-up|4|||
147219034|NCT01895361|530973089|FG001|Overall Study|Lost to Follow-up|4|||
147219035|NCT01895361|530973090|FG002|Overall Study|Lost to Follow-up|6|||
147219036|NCT01895361|530973088|FG000|Overall Study|Non-compliance with study|1|||
147219037|NCT01895361|530973089|FG001|Overall Study|Non-compliance with study|3|||
147219038|NCT01895361|530973090|FG002|Overall Study|Non-compliance with study|1|||
147219039|NCT01895361|530973088|FG000|Overall Study|Physician Decision|2|||
147219040|NCT01895361|530973089|FG001|Overall Study|Physician Decision|2|||
147219041|NCT01895361|530973090|FG002|Overall Study|Physician Decision|2|||
147219042|NCT01895361|530973088|FG000|Overall Study|Withdrawal by Subject|7|||
147219043|NCT01895361|530973089|FG001|Overall Study|Withdrawal by Subject|6|||
147219044|NCT01895361|530973090|FG002|Overall Study|Withdrawal by Subject|6|||
147219045|NCT01895361|530973088|FG000|Overall Study|Lack of Efficacy|0|||
147219046|NCT01895361|530973089|FG001|Overall Study|Lack of Efficacy|1|||
147219047|NCT01895361|530973090|FG002|Overall Study|Lack of Efficacy|0|||
147219048|NCT01895361|530973088|FG000|Overall Study|Reasons different from categories above|7|||
147307668|NCT01036022|531293078|FG004|Overall Study|Physician Decision|0|||
147219049|NCT01895361|530973089|FG001|Overall Study|Reasons different from categories above|3|||
147219050|NCT01895361|530973090|FG002|Overall Study|Reasons different from categories above|4|||
147219051|NCT05463198|530973100|FG000|Overall Study|Withdrawal by Subject|19|||
147219052|NCT05463198|530973100|FG000|Overall Study|Procedure Notes Missing|18|||
147219053|NCT01860846|530973101|FG000|Overall Study|Lost to Follow-up|33|||
147219054|NCT02239120|530973104|FG000|Overall Study|Death|56|||
147219055|NCT02239120|530973105|FG001|Overall Study|Death|58|||
147219056|NCT02239120|530973104|FG000|Overall Study|Lost to Follow-up|19|||
147219057|NCT02239120|530973105|FG001|Overall Study|Lost to Follow-up|14|||
147219058|NCT00466687|530973106|FG000|Overall Study|Adverse Event|1|||
147219059|NCT00466687|530973106|FG000|Overall Study|Other complicating illness|3|||
147219060|NCT00466687|530973106|FG000|Overall Study|Withdrawal by Subject|1|||
147219061|NCT00466687|530973106|FG000|Overall Study|Disease progression|29|||
147219062|NCT00046891|530973107|FG000|Overall Study|Cancels|5|||
147219063|NCT00046891|530973108|FG001|Overall Study|Cancels|9|||
147219064|NCT00046891|530973107|FG000|Overall Study|Ineligible|1|||
147219065|NCT00046891|530973108|FG001|Overall Study|Ineligible|1|||
147219066|NCT00046891|530973107|FG000|Overall Study|Withdrawal by Subject|18|||
147219067|NCT00046891|530973108|FG001|Overall Study|Withdrawal by Subject|15|||
147219068|NCT00046891|530973107|FG000|Overall Study|Adverse Event|5|||
147219069|NCT00046891|530973108|FG001|Overall Study|Adverse Event|5|||
147219070|NCT02536404|530973112|FG000|Overall Study|Adverse Event|5|||
147219071|NCT02536404|530973113|FG001|Overall Study|Adverse Event|0|||
147219072|NCT02536404|530973112|FG000|Overall Study|Withdrawal by Subject|4|||
147219073|NCT02536404|530973113|FG001|Overall Study|Withdrawal by Subject|1|||
147219074|NCT02536404|530973112|FG000|Overall Study|Physician Decision|10|||
147219075|NCT02536404|530973113|FG001|Overall Study|Physician Decision|0|||
147219076|NCT02536404|530973112|FG000|Overall Study|Sponsor decision|1|||
147219077|NCT02536404|530973113|FG001|Overall Study|Sponsor decision|0|||
147219078|NCT02158364|530973114|FG000|Overall Study|Case report forms uncollected|10|||
147219079|NCT02158364|530973114|FG000|Overall Study|Protocol Deviation|50|||
147219080|NCT01944839|530973115|FG000|Overall Study|Physician Decision|2|||
147219081|NCT01944839|530973116|FG001|Overall Study|Physician Decision|2|||
147219082|NCT01944839|530973115|FG000|Overall Study|Protocol Violation|0|||
147219083|NCT01944839|530973116|FG001|Overall Study|Protocol Violation|1|||
147219084|NCT01944839|530973115|FG000|Overall Study|Adverse Event|10|||
147219085|NCT01944839|530973116|FG001|Overall Study|Adverse Event|5|||
147219086|NCT01944839|530973115|FG000|Overall Study|Withdrawal by Subject|9|||
147219087|NCT01944839|530973116|FG001|Overall Study|Withdrawal by Subject|17|||
147219088|NCT01944839|530973115|FG000|Overall Study|Lost to Follow-up|1|||
147219089|NCT01944839|530973116|FG001|Overall Study|Lost to Follow-up|0|||
147219090|NCT01944839|530973115|FG000|Overall Study|Subject non-compliance|0|||
147219091|NCT01944839|530973116|FG001|Overall Study|Subject non-compliance|3|||
147219092|NCT00609362|530973117|FG000|Overall Study|Withdrawal by Subject|2|||
147219093|NCT00609362|530973118|FG001|Overall Study|Withdrawal by Subject|1|||
147219094|NCT00609362|530973117|FG000|Overall Study|Adverse Event|1|||
147219095|NCT00609362|530973118|FG001|Overall Study|Adverse Event|0|||
147219096|NCT01239732|530973121|FG000|Overall Study|Termination of study per protocol|667|||
147219097|NCT01239732|530973121|FG000|Overall Study|Death|226|||
147219098|NCT01239732|530973121|FG000|Overall Study|Withdrawal by Subject|87|||
147307669|NCT01036022|531293079|FG005|Overall Study|Physician Decision|0|||
147307670|NCT01036022|531293074|FG000|Overall Study|Withdrawal by Subject|0|||
147219099|NCT01239732|530973121|FG000|Overall Study|Adverse Event|6|||
147219100|NCT01239732|530973121|FG000|Overall Study|Protocol Violation|3|||
147219101|NCT01239732|530973121|FG000|Overall Study|Participant non compliance|5|||
147307671|NCT01036022|531293075|FG001|Overall Study|Withdrawal by Subject|0|||
147219102|NCT01239732|530973121|FG000|Overall Study|Study termination by sponsor|2|||
147219103|NCT01239732|530973121|FG000|Overall Study|Investigator's decision|4|||
147219104|NCT01239732|530973121|FG000|Overall Study|Treatment failure|2|||
147219105|NCT01239732|530973121|FG000|Overall Study|Other|19|||
147219106|NCT01381562|530973122|FG000|Overall Study|Adverse Event|0|||
147219107|NCT01381562|530973123|FG001|Overall Study|Adverse Event|1|||
147219108|NCT01381562|530973124|FG002|Overall Study|Adverse Event|0|||
147219109|NCT00308581|530973129|FG000|Induction Phase|Adverse Event|0|||
147219110|NCT00308581|530973130|FG001|Induction Phase|Adverse Event|0|||
147307672|NCT01036022|531293076|FG002|Overall Study|Withdrawal by Subject|0|||
147307673|NCT01036022|531293077|FG003|Overall Study|Withdrawal by Subject|1|||
147307674|NCT01036022|531293078|FG004|Overall Study|Withdrawal by Subject|2|||
147307675|NCT01036022|531293079|FG005|Overall Study|Withdrawal by Subject|0|||
147307676|NCT02969525|531293083|FG000|Double-Blind Period|Adverse Event|0|||
147307677|NCT02969525|531293084|FG001|Double-Blind Period|Adverse Event|0|||
147307678|NCT02969525|531293085|FG002|Double-Blind Period|Adverse Event|1|||
147307679|NCT02969525|531293086|FG003|Double-Blind Period|Adverse Event|1|||
147307680|NCT02969525|531293087|FG004|Double-Blind Period|Adverse Event|0|||
147307681|NCT02969525|531293088|FG005|Double-Blind Period|Adverse Event|0|||
147307682|NCT02969525|531293089|FG006|Double-Blind Period|Adverse Event|0|||
147307683|NCT02969525|531293090|FG007|Double-Blind Period|Adverse Event|0|||
147307684|NCT02969525|531293091|FG008|Double-Blind Period|Adverse Event|0|||
147307685|NCT02969525|531293092|FG009|Double-Blind Period|Adverse Event|0|||
147307686|NCT02969525|531293093|FG010|Double-Blind Period|Adverse Event|0|||
147307687|NCT02969525|531293094|FG011|Double-Blind Period|Adverse Event|0|||
147307688|NCT02969525|531293083|FG000|Double-Blind Period|LOW EGFR|0|||
147307689|NCT02969525|531293084|FG001|Double-Blind Period|LOW EGFR|0|||
147307690|NCT02969525|531293085|FG002|Double-Blind Period|LOW EGFR|0|||
147307691|NCT02969525|531293086|FG003|Double-Blind Period|LOW EGFR|1|||
147307692|NCT02969525|531293087|FG004|Double-Blind Period|LOW EGFR|0|||
147307693|NCT02969525|531293088|FG005|Double-Blind Period|LOW EGFR|0|||
147307694|NCT02969525|531293089|FG006|Double-Blind Period|LOW EGFR|0|||
147307695|NCT02969525|531293090|FG007|Double-Blind Period|LOW EGFR|0|||
147307696|NCT02969525|531293091|FG008|Double-Blind Period|LOW EGFR|0|||
147307697|NCT02969525|531293092|FG009|Double-Blind Period|LOW EGFR|0|||
147307698|NCT02969525|531293093|FG010|Double-Blind Period|LOW EGFR|0|||
147307699|NCT02969525|531293094|FG011|Double-Blind Period|LOW EGFR|0|||
147307700|NCT02969525|531293083|FG000|Double-Blind Period|Study medication discontinued prior Wk12|2|||
147307701|NCT02969525|531293084|FG001|Double-Blind Period|Study medication discontinued prior Wk12|0|||
147307702|NCT02969525|531293085|FG002|Double-Blind Period|Study medication discontinued prior Wk12|0|||
147307703|NCT02969525|531293086|FG003|Double-Blind Period|Study medication discontinued prior Wk12|2|||
147307704|NCT02969525|531293087|FG004|Double-Blind Period|Study medication discontinued prior Wk12|0|||
147307705|NCT02969525|531293088|FG005|Double-Blind Period|Study medication discontinued prior Wk12|0|||
147307706|NCT02969525|531293089|FG006|Double-Blind Period|Study medication discontinued prior Wk12|0|||
147307707|NCT02969525|531293090|FG007|Double-Blind Period|Study medication discontinued prior Wk12|0|||
147307708|NCT02969525|531293091|FG008|Double-Blind Period|Study medication discontinued prior Wk12|0|||
147307709|NCT02969525|531293092|FG009|Double-Blind Period|Study medication discontinued prior Wk12|0|||
147307710|NCT02969525|531293093|FG010|Double-Blind Period|Study medication discontinued prior Wk12|0|||
147307711|NCT02969525|531293094|FG011|Double-Blind Period|Study medication discontinued prior Wk12|0|||
147307712|NCT02969525|531293083|FG000|Dose-Blind Period|Adverse Event|0|||
147307713|NCT02969525|531293084|FG001|Dose-Blind Period|Adverse Event|0|||
147307714|NCT02969525|531293085|FG002|Dose-Blind Period|Adverse Event|0|||
147307715|NCT02969525|531293086|FG003|Dose-Blind Period|Adverse Event|0|||
147307716|NCT02969525|531293087|FG004|Dose-Blind Period|Adverse Event|0|||
147307717|NCT02969525|531293088|FG005|Dose-Blind Period|Adverse Event|0|||
147307718|NCT02969525|531293089|FG006|Dose-Blind Period|Adverse Event|0|||
147307719|NCT02969525|531293090|FG007|Dose-Blind Period|Adverse Event|0|||
147307720|NCT02969525|531293091|FG008|Dose-Blind Period|Adverse Event|0|||
147307721|NCT02969525|531293092|FG009|Dose-Blind Period|Adverse Event|1|||
147307722|NCT02969525|531293093|FG010|Dose-Blind Period|Adverse Event|1|||
147307723|NCT02969525|531293094|FG011|Dose-Blind Period|Adverse Event|1|||
147307724|NCT02969525|531293083|FG000|Dose-Blind Period|Withdrawal by Subject|0|||
147307725|NCT02969525|531293084|FG001|Dose-Blind Period|Withdrawal by Subject|0|||
147307726|NCT02969525|531293085|FG002|Dose-Blind Period|Withdrawal by Subject|0|||
147307727|NCT02969525|531293086|FG003|Dose-Blind Period|Withdrawal by Subject|0|||
147307728|NCT02969525|531293087|FG004|Dose-Blind Period|Withdrawal by Subject|0|||
147307729|NCT02969525|531293088|FG005|Dose-Blind Period|Withdrawal by Subject|0|||
147307730|NCT02969525|531293089|FG006|Dose-Blind Period|Withdrawal by Subject|2|||
147307731|NCT02969525|531293090|FG007|Dose-Blind Period|Withdrawal by Subject|0|||
147307732|NCT02969525|531293091|FG008|Dose-Blind Period|Withdrawal by Subject|1|||
147307733|NCT02969525|531293092|FG009|Dose-Blind Period|Withdrawal by Subject|2|||
147307734|NCT02969525|531293093|FG010|Dose-Blind Period|Withdrawal by Subject|0|||
147307735|NCT02969525|531293094|FG011|Dose-Blind Period|Withdrawal by Subject|0|||
147307736|NCT02969525|531293083|FG000|Dose-Blind Period|Non-cooperating patient|0|||
147307737|NCT02969525|531293084|FG001|Dose-Blind Period|Non-cooperating patient|0|||
147307738|NCT02969525|531293085|FG002|Dose-Blind Period|Non-cooperating patient|0|||
147307739|NCT02969525|531293086|FG003|Dose-Blind Period|Non-cooperating patient|0|||
147307740|NCT02969525|531293087|FG004|Dose-Blind Period|Non-cooperating patient|0|||
147307741|NCT02969525|531293088|FG005|Dose-Blind Period|Non-cooperating patient|0|||
147307742|NCT02969525|531293089|FG006|Dose-Blind Period|Non-cooperating patient|0|||
147307743|NCT02969525|531293090|FG007|Dose-Blind Period|Non-cooperating patient|0|||
147307744|NCT02969525|531293091|FG008|Dose-Blind Period|Non-cooperating patient|0|||
147307745|NCT02969525|531293092|FG009|Dose-Blind Period|Non-cooperating patient|0|||
147307746|NCT02969525|531293093|FG010|Dose-Blind Period|Non-cooperating patient|0|||
147219111|NCT00308581|530973131|FG002|Induction Phase|Adverse Event|37|||
147219112|NCT00308581|530973129|FG000|Induction Phase|Lack of Efficacy|0|||
147219113|NCT00308581|530973130|FG001|Induction Phase|Lack of Efficacy|0|||
147219114|NCT00308581|530973131|FG002|Induction Phase|Lack of Efficacy|121|||
147219115|NCT00308581|530973129|FG000|Induction Phase|Withdrawal by Subject|0|||
147219116|NCT00308581|530973130|FG001|Induction Phase|Withdrawal by Subject|0|||
147219117|NCT00308581|530973131|FG002|Induction Phase|Withdrawal by Subject|5|||
147219118|NCT00308581|530973129|FG000|Induction Phase|Unknown reason|0|||
147219119|NCT00308581|530973130|FG001|Induction Phase|Unknown reason|0|||
147219120|NCT00308581|530973131|FG002|Induction Phase|Unknown reason|3|||
147219121|NCT00308581|530973129|FG000|Randomized Maintenance Phase|Adverse Event|10|||
147219122|NCT00308581|530973130|FG001|Randomized Maintenance Phase|Adverse Event|17|||
147219123|NCT00308581|530973131|FG002|Randomized Maintenance Phase|Adverse Event|0|||
147219124|NCT00308581|530973129|FG000|Randomized Maintenance Phase|Lack of Efficacy|9|||
147219125|NCT00308581|530973130|FG001|Randomized Maintenance Phase|Lack of Efficacy|21|||
147219126|NCT00308581|530973131|FG002|Randomized Maintenance Phase|Lack of Efficacy|0|||
147219127|NCT00308581|530973129|FG000|Randomized Maintenance Phase|Lost to Follow-up|0|||
147219128|NCT00308581|530973130|FG001|Randomized Maintenance Phase|Lost to Follow-up|2|||
147219129|NCT00308581|530973131|FG002|Randomized Maintenance Phase|Lost to Follow-up|0|||
147219130|NCT00308581|530973129|FG000|Randomized Maintenance Phase|Withdrawal by Subject|1|||
147219131|NCT00308581|530973130|FG001|Randomized Maintenance Phase|Withdrawal by Subject|4|||
147219132|NCT00308581|530973131|FG002|Randomized Maintenance Phase|Withdrawal by Subject|0|||
147219133|NCT00308581|530973129|FG000|Randomized Maintenance Phase|Switched to Q2W open-label treatment|82|||
147219134|NCT00308581|530973130|FG001|Randomized Maintenance Phase|Switched to Q2W open-label treatment|59|||
147219135|NCT00308581|530973131|FG002|Randomized Maintenance Phase|Switched to Q2W open-label treatment|0|||
147219136|NCT00308581|530973129|FG000|Randomized Maintenance Phase|Unknown reason|3|||
147219137|NCT00308581|530973130|FG001|Randomized Maintenance Phase|Unknown reason|0|||
147219138|NCT00308581|530973131|FG002|Randomized Maintenance Phase|Unknown reason|0|||
147219139|NCT01892384|530973133|FG000|Overall Study|Withdrawal by Subject|1|||
147219140|NCT01892384|530973134|FG001|Overall Study|Withdrawal by Subject|1|||
147219141|NCT01892384|530973135|FG002|Overall Study|Withdrawal by Subject|0|||
147219142|NCT01892384|530973136|FG003|Overall Study|Withdrawal by Subject|0|||
147219143|NCT03985878|530973139|FG000|Overall Study|Transitioned to Another Sarepta Study|2|||
147219144|NCT03985878|530973139|FG000|Overall Study|Study Terminated by Sponsor|12|||
147219145|NCT03985878|530973139|FG000|Overall Study|Withdrawal by Subject|1|||
147219146|NCT01514370|530973141|FG000|Overall Study|Protocol Violation|2|||
147219147|NCT01514370|530973142|FG001|Overall Study|Protocol Violation|3|||
147219148|NCT01514370|530973141|FG000|Overall Study|Lost to Follow-up|0|||
147219149|NCT01514370|530973142|FG001|Overall Study|Lost to Follow-up|2|||
147219150|NCT01514370|530973141|FG000|Overall Study|Withdrawal by Subject|2|||
147219151|NCT01514370|530973142|FG001|Overall Study|Withdrawal by Subject|1|||
147219152|NCT01514370|530973141|FG000|Overall Study|Adverse Event|1|||
147219153|NCT01514370|530973142|FG001|Overall Study|Adverse Event|3|||
147219154|NCT01514370|530973141|FG000|Overall Study|Other|6|||
147219155|NCT01514370|530973142|FG001|Overall Study|Other|7|||
147219156|NCT01159431|530973143|FG000|Overall Study|Adverse Event|1|||
147219157|NCT01159431|530973144|FG001|Overall Study|Adverse Event|2|||
147219158|NCT01159431|530973143|FG000|Overall Study|non-compliance|1|||
147219159|NCT01159431|530973144|FG001|Overall Study|non-compliance|1|||
147219160|NCT01159431|530973143|FG000|Overall Study|Lack of Efficacy|0|||
147219161|NCT01159431|530973144|FG001|Overall Study|Lack of Efficacy|3|||
147219162|NCT00129311|530973148|FG000|Overall Study|Withdrawal by Subject|12|||
147219163|NCT00129311|530973149|FG001|Overall Study|Withdrawal by Subject|19|||
147219164|NCT00604214|530973150|FG000|Baseline to Day 28|Death|223|||
147219165|NCT00604214|530973151|FG001|Baseline to Day 28|Death|202|||
147219166|NCT00604214|530973150|FG000|Baseline to Day 28|Lost to Follow-up|2|||
147219167|NCT00604214|530973151|FG001|Baseline to Day 28|Lost to Follow-up|4|||
147219168|NCT00604214|530973150|FG000|Baseline to Day 28|Withdrawal by Subject|3|||
147552299|NCT02711956|532178565|FG001|Overall Study|PSA progression with clinical progression|0|||
147552300|NCT02711956|532178566|FG002|Overall Study|PSA progression with clinical progression|0|||
147552301|NCT02711956|532178567|FG003|Overall Study|PSA progression with clinical progression|0|||
147552302|NCT02711956|532178568|FG004|Overall Study|PSA progression with clinical progression|1|||
147219169|NCT00604214|530973151|FG001|Baseline to Day 28|Withdrawal by Subject|7|||
147219170|NCT00604214|530973150|FG000|Day 29 to Day 90|Death|64|||
147219171|NCT00604214|530973151|FG001|Day 29 to Day 90|Death|67|||
147219172|NCT00604214|530973150|FG000|Day 29 to Day 90|Lost to Follow-up|4|||
147219173|NCT00604214|530973151|FG001|Day 29 to Day 90|Lost to Follow-up|6|||
147552303|NCT02711956|532178569|FG005|Overall Study|PSA progression with clinical progression|0|||
147219174|NCT00604214|530973150|FG000|Day 29 to Day 90|Withdrawal by Subject|0|||
147219175|NCT00604214|530973151|FG001|Day 29 to Day 90|Withdrawal by Subject|6|||
147219176|NCT00604214|530973150|FG000|Day 91 to Day 180|Death|19|||
147219177|NCT00604214|530973151|FG001|Day 91 to Day 180|Death|23|||
147219178|NCT00604214|530973150|FG000|Day 91 to Day 180|Lost to Follow-up|6|||
147219179|NCT00604214|530973151|FG001|Day 91 to Day 180|Lost to Follow-up|8|||
147219180|NCT00604214|530973150|FG000|Day 91 to Day 180|Withdrawal by Subject|1|||
147307747|NCT02969525|531293094|FG011|Dose-Blind Period|Non-cooperating patient|1|||
147307748|NCT02969525|531293083|FG000|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
147307749|NCT02969525|531293084|FG001|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
147307750|NCT02969525|531293085|FG002|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
147307751|NCT02969525|531293086|FG003|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
147307752|NCT02969525|531293087|FG004|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
147307753|NCT02969525|531293088|FG005|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
147307754|NCT02969525|531293089|FG006|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
147307755|NCT02969525|531293090|FG007|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
147307756|NCT02969525|531293091|FG008|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
147307757|NCT02969525|531293092|FG009|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
147307758|NCT02969525|531293093|FG010|Dose-Blind Period|Withdrew before Safety Follow-up visit|1|||
147307759|NCT02969525|531293094|FG011|Dose-Blind Period|Withdrew before Safety Follow-up visit|0|||
147307760|NCT03445065|531293095|FG000|Overall Study|Withdrawal by Subject|3|||
147307761|NCT03445065|531293096|FG001|Overall Study|Withdrawal by Subject|6|||
147307762|NCT03445065|531293097|FG002|Overall Study|Withdrawal by Subject|2|||
147307763|NCT03445065|531293098|FG003|Overall Study|Withdrawal by Subject|2|||
147307764|NCT03445065|531293095|FG000|Overall Study|Other|4|||
147307765|NCT03445065|531293096|FG001|Overall Study|Other|3|||
147307766|NCT03445065|531293097|FG002|Overall Study|Other|3|||
147307767|NCT03445065|531293098|FG003|Overall Study|Other|1|||
147307768|NCT02089230|531293099|FG000|Overall Study|Death|0|||
147307769|NCT02089230|531293100|FG001|Overall Study|Death|0|||
147307770|NCT02089230|531293101|FG002|Overall Study|Death|2|||
147307771|NCT02089230|531293099|FG000|Overall Study|Seeking Alternative Therapy|0|||
147307772|NCT02089230|531293100|FG001|Overall Study|Seeking Alternative Therapy|0|||
147307773|NCT02089230|531293101|FG002|Overall Study|Seeking Alternative Therapy|4|||
147307774|NCT01598298|531293102|FG000|Overall Study|Not eligible|5|||
147307775|NCT01598298|531293103|FG001|Overall Study|Not eligible|5|||
147307776|NCT01598298|531293102|FG000|Overall Study|Adverse Event|21|||
147307777|NCT01598298|531293103|FG001|Overall Study|Adverse Event|19|||
147307778|NCT01598298|531293102|FG000|Overall Study|Progression/relapse|0|||
147307779|NCT01598298|531293103|FG001|Overall Study|Progression/relapse|2|||
147307780|NCT01598298|531293102|FG000|Overall Study|Withdrawal by Subject|10|||
147307781|NCT01598298|531293103|FG001|Overall Study|Withdrawal by Subject|15|||
147307782|NCT01598298|531293102|FG000|Overall Study|Other reason (not protocol specified)|4|||
147307783|NCT01598298|531293103|FG001|Overall Study|Other reason (not protocol specified)|0|||
147307784|NCT04567693|531294536|FG000|Overall Study|Death|0|||
147307785|NCT04567693|531294537|FG001|Overall Study|Death|0|||
147307786|NCT04567693|531294538|FG002|Overall Study|Death|2|||
147307787|NCT04567693|531294536|FG000|Overall Study|Lost to Follow-up|1|||
147307788|NCT04567693|531294537|FG001|Overall Study|Lost to Follow-up|0|||
147307789|NCT04567693|531294538|FG002|Overall Study|Lost to Follow-up|2|||
147307790|NCT04567693|531294536|FG000|Overall Study|Withdrawal by investigative team (participants did not meet eligibility criteria)|1|||
147307791|NCT04567693|531294537|FG001|Overall Study|Withdrawal by investigative team (participants did not meet eligibility criteria)|0|||
147307792|NCT04567693|531294538|FG002|Overall Study|Withdrawal by investigative team (participants did not meet eligibility criteria)|2|||
147307793|NCT03722264|531294543|FG000|Overall Study|Physician Decision|3|||
147307794|NCT04105972|531294554|FG000|Overall Study|Adverse Event|2|||
147307795|NCT04105972|531294555|FG001|Overall Study|Adverse Event|1|||
147307796|NCT00553202|531294558|FG000|Overall Study|Death|16|||
147307797|NCT00553202|531294558|FG000|Overall Study|Lost to Follow-up|1|||
147307798|NCT00553202|531294558|FG000|Overall Study|Physician Decision|28|||
147307799|NCT00553202|531294558|FG000|Overall Study|Withdrawal by Subject|1|||
147307800|NCT00553202|531294558|FG000|Overall Study|No donor identified|16|||
147307801|NCT00553202|531294558|FG000|Overall Study|Fails to meet organ function|6|||
147307802|NCT00041756|531294560|FG000|Overall Study|Adverse Event|4|||
147307803|NCT00041756|531294561|FG001|Overall Study|Adverse Event|10|||
147307804|NCT00041756|531294562|FG002|Overall Study|Adverse Event|6|||
147307805|NCT00041756|531294563|FG003|Overall Study|Adverse Event|11|||
147307806|NCT00041756|531294564|FG004|Overall Study|Adverse Event|34|||
147307807|NCT00041756|531294560|FG000|Overall Study|Protocol Violation|1|||
147307808|NCT00041756|531294561|FG001|Overall Study|Protocol Violation|1|||
147307809|NCT00041756|531294562|FG002|Overall Study|Protocol Violation|2|||
147307810|NCT00041756|531294563|FG003|Overall Study|Protocol Violation|2|||
147307811|NCT00041756|531294564|FG004|Overall Study|Protocol Violation|1|||
147307812|NCT00041756|531294560|FG000|Overall Study|Withdrawal by Subject|3|||
147307813|NCT00041756|531294561|FG001|Overall Study|Withdrawal by Subject|3|||
147307814|NCT00041756|531294562|FG002|Overall Study|Withdrawal by Subject|4|||
147307815|NCT00041756|531294563|FG003|Overall Study|Withdrawal by Subject|2|||
147307816|NCT00041756|531294564|FG004|Overall Study|Withdrawal by Subject|3|||
147307817|NCT00041756|531294560|FG000|Overall Study|Lost to Follow-up|0|||
147307818|NCT00041756|531294561|FG001|Overall Study|Lost to Follow-up|1|||
147307819|NCT00041756|531294562|FG002|Overall Study|Lost to Follow-up|0|||
147307820|NCT00041756|531294563|FG003|Overall Study|Lost to Follow-up|1|||
147307821|NCT00041756|531294564|FG004|Overall Study|Lost to Follow-up|0|||
147219181|NCT00604214|530973151|FG001|Day 91 to Day 180|Withdrawal by Subject|1|||
147219182|NCT00534599|530973152|FG000|Overall Study|Adverse Event|25|||
147219183|NCT00534599|530973153|FG001|Overall Study|Adverse Event|4|||
147219184|NCT00534599|530973152|FG000|Overall Study|Incorrect enrollment|2|||
147219185|NCT00534599|530973153|FG001|Overall Study|Incorrect enrollment|1|||
147219186|NCT00534599|530973152|FG000|Overall Study|Mis-randomization|2|||
147219187|NCT00534599|530973153|FG001|Overall Study|Mis-randomization|2|||
147219188|NCT00534599|530973152|FG000|Overall Study|Developed study-specific d/c criteria|5|||
147219189|NCT00534599|530973153|FG001|Overall Study|Developed study-specific d/c criteria|0|||
147219190|NCT00534599|530973152|FG000|Overall Study|Lack of Efficacy|0|||
147219191|NCT00534599|530973153|FG001|Overall Study|Lack of Efficacy|1|||
147219192|NCT00534599|530973152|FG000|Overall Study|Generalized anxiety disorder worsened|0|||
147219193|NCT00534599|530973153|FG001|Overall Study|Generalized anxiety disorder worsened|1|||
147219194|NCT00534599|530973152|FG000|Overall Study|Protocol Violation|1|||
147219195|NCT00534599|530973153|FG001|Overall Study|Protocol Violation|3|||
147219196|NCT00534599|530973152|FG000|Overall Study|Lost to Follow-up|11|||
147219197|NCT00534599|530973153|FG001|Overall Study|Lost to Follow-up|14|||
147219198|NCT00534599|530973152|FG000|Overall Study|Withdrawal by Subject|4|||
147219199|NCT00534599|530973153|FG001|Overall Study|Withdrawal by Subject|6|||
147219200|NCT00534599|530973152|FG000|Overall Study|Other|7|||
147219201|NCT00534599|530973153|FG001|Overall Study|Other|0|||
147219202|NCT00853970|530973156|FG000|Overall Study|Withdrawal by Subject|2|||
147219203|NCT00853970|530973157|FG001|Overall Study|Withdrawal by Subject|1|||
147219204|NCT00853970|530973156|FG000|Overall Study|Cancelled surgery|4|||
147219205|NCT00853970|530973157|FG001|Overall Study|Cancelled surgery|2|||
147219206|NCT03603509|530975384|FG000|Overall Study|Lost to Follow-up|3|||
147219207|NCT03603509|530975385|FG001|Overall Study|Lost to Follow-up|4|||
147219208|NCT00773383|530975387|FG000|Overall Study|Adverse Event|4|||
147219209|NCT00773383|530975387|FG000|Overall Study|Death|1|||
147219210|NCT00773383|530975387|FG000|Overall Study|Progression of Disease|23|||
147219211|NCT00773383|530975387|FG000|Overall Study|Other|2|||
147219212|NCT00773383|530975387|FG000|Overall Study|No study dose received|1|||
147219213|NCT03384693|530975388|FG000|Overall Study|Adverse Event|3|||
147219214|NCT03811093|530975406|FG000|Overall Study|Lack of Efficacy, Withdrawal by Subject|0|||
147219215|NCT03811093|530975407|FG001|Overall Study|Lack of Efficacy, Withdrawal by Subject|4|||
147219216|NCT03811093|530975406|FG000|Overall Study|Unable to measure body fat percentage|2|||
147219217|NCT03811093|530975407|FG001|Overall Study|Unable to measure body fat percentage|0|||
147219218|NCT01095094|530975409|FG000|Overall Study|Withdrawal by Subject|1|||
147219219|NCT01095094|530975409|FG000|Overall Study|Death|1|||
147219220|NCT01095094|530975409|FG000|Overall Study|Physician Decision|1|||
147219221|NCT03699475|530975411|FG000|Overall Study|Death|1|||
147219222|NCT00137839|530975412|FG000|Overall Study|Adverse Event|7|||
147219223|NCT00137839|530975412|FG000|Overall Study|Physician Decision|7|||
147219224|NCT00137839|530975412|FG000|Overall Study|Death|8|||
147219225|NCT00137839|530975412|FG000|Overall Study|Disease Progression|60|||
147219226|NCT00137839|530975412|FG000|Overall Study|Not Start Treatment|1|||
147219227|NCT00137839|530975412|FG000|Overall Study|Prolonged Treatment Delay|1|||
147219228|NCT00528970|530975413|FG000|Overall Study|Adverse Event|6|||
147219229|NCT00528970|530975414|FG001|Overall Study|Adverse Event|8|||
147219230|NCT00528970|530975415|FG002|Overall Study|Adverse Event|5|||
147219231|NCT00528970|530975413|FG000|Overall Study|Lost to Follow-up|0|||
147219232|NCT00528970|530975414|FG001|Overall Study|Lost to Follow-up|0|||
147219233|NCT00528970|530975415|FG002|Overall Study|Lost to Follow-up|1|||
147219234|NCT00528970|530975413|FG000|Overall Study|Other than specified|2|||
147219235|NCT00528970|530975414|FG001|Overall Study|Other than specified|3|||
147219236|NCT00528970|530975415|FG002|Overall Study|Other than specified|3|||
147219237|NCT00528970|530975413|FG000|Overall Study|Protocol Violation|2|||
147219238|NCT00528970|530975414|FG001|Overall Study|Protocol Violation|1|||
147219239|NCT00528970|530975415|FG002|Overall Study|Protocol Violation|4|||
147219240|NCT00528970|530975413|FG000|Overall Study|Lack of Efficacy|0|||
147219241|NCT00528970|530975414|FG001|Overall Study|Lack of Efficacy|0|||
147219242|NCT00528970|530975415|FG002|Overall Study|Lack of Efficacy|1|||
147219243|NCT00528970|530975413|FG000|Overall Study|Withdrawal by Subject|4|||
147219244|NCT00528970|530975414|FG001|Overall Study|Withdrawal by Subject|3|||
147219245|NCT00528970|530975415|FG002|Overall Study|Withdrawal by Subject|5|||
147219246|NCT00528970|530975413|FG000|Overall Study|Randomized but not treated|0|||
147219247|NCT00528970|530975414|FG001|Overall Study|Randomized but not treated|0|||
147219248|NCT00528970|530975415|FG002|Overall Study|Randomized but not treated|1|||
147307822|NCT00041756|531294560|FG000|Overall Study|Unable to meet protocol criteria|0|||
147219249|NCT03739242|530975423|FG000|Overall Study|Withdrawal by Subject|1|||
147219250|NCT03739242|530975424|FG001|Overall Study|Withdrawal by Subject|1|||
147219251|NCT03739242|530975423|FG000|Overall Study|Protocol Violation|0|||
147219252|NCT03739242|530975424|FG001|Overall Study|Protocol Violation|1|||
147219253|NCT01122394|530975425|FG000|Overall Study|Withdrawal by Subject|1|||
147219254|NCT01122394|530975426|FG001|Overall Study|Withdrawal by Subject|1|||
147219255|NCT01122394|530975425|FG000|Overall Study|Lost to Follow-up|2|||
147219256|NCT01122394|530975426|FG001|Overall Study|Lost to Follow-up|2|||
147219257|NCT01122394|530975425|FG000|Overall Study|Adverse Event|0|||
147219258|NCT01122394|530975426|FG001|Overall Study|Adverse Event|1|||
147219259|NCT00039871|530975427|FG000|Overall Study|Adverse Event|165|||
147219260|NCT00039871|530975427|FG000|Overall Study|Lost to Follow-up|18|||
147219261|NCT00039871|530975427|FG000|Overall Study|Protocol Violation|24|||
147219262|NCT00039871|530975427|FG000|Overall Study|Withdrawal by Subject|97|||
147219263|NCT00039871|530975427|FG000|Overall Study|Did not meet eligibility criteria|11|||
147219264|NCT00039871|530975427|FG000|Overall Study|Administrative|1|||
147219265|NCT00039871|530975427|FG000|Overall Study|Discontinued at Week 12 per protocol|1061|||
147219266|NCT00039871|530975427|FG000|Overall Study|Never entered follow-up|7|||
147219267|NCT02446743|530975428|FG000|Overall Study|Withdrawal by Subject|1|||
147219268|NCT02446743|530975429|FG001|Overall Study|Withdrawal by Subject|1|||
147219269|NCT02446743|530975428|FG000|Overall Study|Lost to Follow-up|1|||
147219270|NCT02446743|530975429|FG001|Overall Study|Lost to Follow-up|0|||
147219271|NCT02446743|530975428|FG000|Overall Study|Adverse Event|1|||
147219272|NCT02446743|530975429|FG001|Overall Study|Adverse Event|1|||
147219273|NCT02446743|530975428|FG000|Overall Study|Other|2|||
147219274|NCT02446743|530975429|FG001|Overall Study|Other|3|||
147219275|NCT03361176|530975430|FG000|Overall Study|Lost to Follow-up|1|||
147219276|NCT03361176|530975431|FG001|Overall Study|Lost to Follow-up|2|||
147219277|NCT03361176|530975430|FG000|Overall Study|Adverse Event|0|||
147219278|NCT03361176|530975431|FG001|Overall Study|Adverse Event|2|||
147219279|NCT03361176|530975430|FG000|Overall Study|Withdrawal by Subject|0|||
147219280|NCT03361176|530975431|FG001|Overall Study|Withdrawal by Subject|1|||
147219281|NCT02478398|530975432|FG000|Overall Study|Adverse Event|20|||
147219282|NCT02478398|530975433|FG001|Overall Study|Adverse Event|5|||
147219283|NCT02478398|530975432|FG000|Overall Study|Lost to Follow-up|5|||
147219284|NCT02478398|530975433|FG001|Overall Study|Lost to Follow-up|4|||
147219285|NCT02478398|530975432|FG000|Overall Study|Non-Compliance With Study Drug|5|||
147219286|NCT02478398|530975433|FG001|Overall Study|Non-Compliance With Study Drug|1|||
147219287|NCT02478398|530975432|FG000|Overall Study|Protocol Violation|3|||
147219288|NCT02478398|530975433|FG001|Overall Study|Protocol Violation|1|||
147219289|NCT02478398|530975432|FG000|Overall Study|Withdrawal By Parent/Guardian|9|||
147219290|NCT02478398|530975433|FG001|Overall Study|Withdrawal By Parent/Guardian|6|||
147219291|NCT02478398|530975432|FG000|Overall Study|Withdrawal By Participant|10|||
147219292|NCT02478398|530975433|FG001|Overall Study|Withdrawal By Participant|4|||
147219293|NCT00923364|530975434|FG000|Overall Study|Death|3|||
147219294|NCT00923364|530975435|FG001|Overall Study|Death|0|||
147219295|NCT00923364|530975434|FG000|Overall Study|Did not go to transplant|1|||
147219296|NCT00923364|530975435|FG001|Overall Study|Did not go to transplant|0|||
147219297|NCT03023046|530975438|FG000|Overall Study|Withdrawal by Subject|1|||
147219298|NCT01205581|530975439|FG000|Overall Study|Withdrawal by Subject|1|||
147219299|NCT01205581|530975440|FG001|Overall Study|Withdrawal by Subject|0|||
147219300|NCT01205581|530975441|FG002|Overall Study|Withdrawal by Subject|0|||
147219301|NCT01205581|530975442|FG003|Overall Study|Withdrawal by Subject|0|||
147219302|NCT01205581|530975443|FG004|Overall Study|Withdrawal by Subject|0|||
147219303|NCT01205581|530975444|FG005|Overall Study|Withdrawal by Subject|0|||
147219304|NCT00635024|530975445|FG000|Overall Study|Adverse Event|1|||
147219305|NCT00713310|530975446|FG000|Overall Study|Adverse Event|5|||
147219306|NCT00713310|530975447|FG001|Overall Study|Adverse Event|2|||
147219307|NCT00713310|530975446|FG000|Overall Study|Lack of Efficacy|0|||
147219308|NCT00713310|530975447|FG001|Overall Study|Lack of Efficacy|2|||
147219309|NCT00713310|530975446|FG000|Overall Study|Withdrawal by Subject|0|||
147219310|NCT00713310|530975447|FG001|Overall Study|Withdrawal by Subject|2|||
147219311|NCT05508074|530975448|FG000|Overall Study|Death|2|||
147219312|NCT05508074|530975449|FG001|Overall Study|Death|5|||
147219313|NCT05508074|530975448|FG000|Overall Study|Withdrawal by Subject|1|||
147219314|NCT05508074|530975449|FG001|Overall Study|Withdrawal by Subject|2|||
147219315|NCT05508074|530975448|FG000|Overall Study|Adverse Event|0|||
147307823|NCT00041756|531294561|FG001|Overall Study|Unable to meet protocol criteria|0|||
147307824|NCT00041756|531294562|FG002|Overall Study|Unable to meet protocol criteria|1|||
147307825|NCT00041756|531294563|FG003|Overall Study|Unable to meet protocol criteria|0|||
147219316|NCT05508074|530975449|FG001|Overall Study|Adverse Event|1|||
147219317|NCT05508074|530975448|FG000|Overall Study|Physician Decision|0|||
147219318|NCT05508074|530975449|FG001|Overall Study|Physician Decision|1|||
147219319|NCT05508074|530975448|FG000|Overall Study|wrongly randomized|0|||
147219320|NCT05508074|530975449|FG001|Overall Study|wrongly randomized|1|||
147219321|NCT05508074|530975448|FG000|Overall Study|non-compliance|0|||
147219322|NCT05508074|530975449|FG001|Overall Study|non-compliance|1|||
147219323|NCT02142387|530975450|FG000|Overall Study|<19 years old|49|||
147219324|NCT02142387|530975451|FG001|Overall Study|<19 years old|326|||
147219325|NCT02142387|530975450|FG000|Overall Study|non-cardiac etiology|504|||
147219326|NCT02142387|530975451|FG001|Overall Study|non-cardiac etiology|3431|||
147219327|NCT02142387|530975450|FG000|Overall Study|CPR not performed|74|||
147219328|NCT02142387|530975451|FG001|Overall Study|CPR not performed|473|||
147219329|NCT02142387|530975450|FG000|Overall Study|witnessed by paramedic|139|||
147219330|NCT02142387|530975451|FG001|Overall Study|witnessed by paramedic|917|||
147219331|NCT02142387|530975450|FG000|Overall Study|incomplete data|1|||
147219332|NCT02142387|530975451|FG001|Overall Study|incomplete data|9|||
147307826|NCT00041756|531294564|FG004|Overall Study|Unable to meet protocol criteria|1|||
147307827|NCT00041756|531294560|FG000|Overall Study|Data Monitoring Committee Recommendation|0|||
147307828|NCT00041756|531294561|FG001|Overall Study|Data Monitoring Committee Recommendation|0|||
147307829|NCT00041756|531294562|FG002|Overall Study|Data Monitoring Committee Recommendation|0|||
147307830|NCT00041756|531294563|FG003|Overall Study|Data Monitoring Committee Recommendation|0|||
147307831|NCT00041756|531294564|FG004|Overall Study|Data Monitoring Committee Recommendation|21|||
147307832|NCT01111838|531294571|FG000|Overall Study|Patient Ineligible|2|||
147307833|NCT01111838|531294571|FG000|Overall Study|Not Treated|3|||
147307834|NCT01111838|531294571|FG000|Overall Study|Clinical deterioration|1|||
147307835|NCT01111838|531294571|FG000|Overall Study|Other Complicating Disease|1|||
147307836|NCT01872910|531294575|FG000|Overall Study|Lost to Follow-up|2|||
147307837|NCT01872910|531294576|FG001|Overall Study|Lost to Follow-up|0|||
147307838|NCT01872910|531294577|FG002|Overall Study|Lost to Follow-up|2|||
147307839|NCT01872910|531294578|FG003|Overall Study|Lost to Follow-up|0|||
147307840|NCT01872910|531294579|FG004|Overall Study|Lost to Follow-up|0|||
147307841|NCT01872910|531294580|FG005|Overall Study|Lost to Follow-up|0|||
147307842|NCT01540565|531294581|FG000|Overall Study|Ineligible|2|||
147307843|NCT02091739|531294582|FG000|MP: 16 Weeks|Adverse Event|1|||
147307844|NCT02091739|531294583|FG001|MP: 16 Weeks|Adverse Event|1|||
147307845|NCT02091739|531294584|FG002|MP: 16 Weeks|Adverse Event|1|||
147307846|NCT02091739|531294585|FG003|MP: 16 Weeks|Adverse Event|0|||
147307847|NCT02091739|531294586|FG004|MP: 16 Weeks|Adverse Event|0|||
147307848|NCT02091739|531294582|FG000|MP: 16 Weeks|Withdrawal by Subject|3|||
147307849|NCT02091739|531294583|FG001|MP: 16 Weeks|Withdrawal by Subject|4|||
147307850|NCT02091739|531294584|FG002|MP: 16 Weeks|Withdrawal by Subject|0|||
147307851|NCT02091739|531294585|FG003|MP: 16 Weeks|Withdrawal by Subject|0|||
147307852|NCT02091739|531294586|FG004|MP: 16 Weeks|Withdrawal by Subject|0|||
147307853|NCT02091739|531294582|FG000|MP: 16 Weeks|Lost to Follow-up|0|||
147307854|NCT02091739|531294583|FG001|MP: 16 Weeks|Lost to Follow-up|0|||
147307855|NCT02091739|531294584|FG002|MP: 16 Weeks|Lost to Follow-up|1|||
147307856|NCT02091739|531294585|FG003|MP: 16 Weeks|Lost to Follow-up|0|||
147307857|NCT02091739|531294586|FG004|MP: 16 Weeks|Lost to Follow-up|0|||
147307858|NCT02091739|531294582|FG000|EP: 48 Weeks|Other|0|||
147307859|NCT02091739|531294583|FG001|EP: 48 Weeks|Other|0|||
147307860|NCT02091739|531294584|FG002|EP: 48 Weeks|Other|0|||
147307861|NCT02091739|531294585|FG003|EP: 48 Weeks|Other|1|||
147307862|NCT02091739|531294586|FG004|EP: 48 Weeks|Other|0|||
147307863|NCT02091739|531294582|FG000|EP: 48 Weeks|Death|0|||
147307864|NCT02091739|531294583|FG001|EP: 48 Weeks|Death|0|||
147307865|NCT02091739|531294584|FG002|EP: 48 Weeks|Death|0|||
147307866|NCT02091739|531294585|FG003|EP: 48 Weeks|Death|3|||
147307867|NCT02091739|531294586|FG004|EP: 48 Weeks|Death|2|||
147307868|NCT02091739|531294582|FG000|EP: 48 Weeks|Adverse Event|0|||
147307869|NCT02091739|531294583|FG001|EP: 48 Weeks|Adverse Event|0|||
147307870|NCT02091739|531294584|FG002|EP: 48 Weeks|Adverse Event|0|||
147307871|NCT02091739|531294585|FG003|EP: 48 Weeks|Adverse Event|2|||
147307872|NCT02091739|531294586|FG004|EP: 48 Weeks|Adverse Event|6|||
147307873|NCT02091739|531294582|FG000|EP: 48 Weeks|Withdrawal by Subject|0|||
147307874|NCT02091739|531294583|FG001|EP: 48 Weeks|Withdrawal by Subject|0|||
147307875|NCT02091739|531294584|FG002|EP: 48 Weeks|Withdrawal by Subject|0|||
147307876|NCT02091739|531294585|FG003|EP: 48 Weeks|Withdrawal by Subject|2|||
147307877|NCT02091739|531294586|FG004|EP: 48 Weeks|Withdrawal by Subject|6|||
147307878|NCT03469349|531294587|FG000|Overall Study|Withdrawal by Subject|1|||
147307879|NCT03469349|531294588|FG001|Overall Study|Withdrawal by Subject|3|||
147219333|NCT02142387|530975450|FG000|Overall Study|occurred not at home|298|||
147219334|NCT02142387|530975451|FG001|Overall Study|occurred not at home|2474|||
147219335|NCT03490981|530975452|FG000|Overall Study|Lost to Follow-up|1|||
147219336|NCT03490981|530975453|FG001|Overall Study|Lost to Follow-up|2|||
147219337|NCT00420641|530975456|FG000|Overall Study|Adverse Event|3|||
147219338|NCT00420641|530975457|FG001|Overall Study|Adverse Event|25|||
147219339|NCT00420641|530975458|FG002|Overall Study|Adverse Event|10|||
147219340|NCT00420641|530975456|FG000|Overall Study|Lost to Follow-up|2|||
147219341|NCT00420641|530975457|FG001|Overall Study|Lost to Follow-up|4|||
147219342|NCT00420641|530975458|FG002|Overall Study|Lost to Follow-up|2|||
147219343|NCT00420641|530975456|FG000|Overall Study|Protocol Violation|8|||
147307880|NCT03469349|531294587|FG000|Overall Study|Progressive Disease|0|||
147307881|NCT03469349|531294588|FG001|Overall Study|Progressive Disease|1|||
147307882|NCT03469349|531294587|FG000|Overall Study|Lost to Follow-up|2|||
147307883|NCT03469349|531294588|FG001|Overall Study|Lost to Follow-up|2|||
147307884|NCT03469349|531294587|FG000|Overall Study|Adverse Event|2|||
147307885|NCT03469349|531294588|FG001|Overall Study|Adverse Event|4|||
147307886|NCT02086162|531294591|FG000|Overall Study|Withdrawal by Subject|4|||
147307887|NCT02086162|531294592|FG001|Overall Study|Withdrawal by Subject|4|||
147307888|NCT02086162|531294591|FG000|Overall Study|moved|1|||
147307889|NCT02086162|531294592|FG001|Overall Study|moved|1|||
147307890|NCT02086162|531294591|FG000|Overall Study|Lost to Follow-up|4|||
147307891|NCT02086162|531294592|FG001|Overall Study|Lost to Follow-up|2|||
147307892|NCT02086162|531294591|FG000|Overall Study|Death|1|||
147219344|NCT00420641|530975457|FG001|Overall Study|Protocol Violation|8|||
147307893|NCT02086162|531294592|FG001|Overall Study|Death|0|||
147219345|NCT00420641|530975458|FG002|Overall Study|Protocol Violation|7|||
147219346|NCT00420641|530975456|FG000|Overall Study|Withdrawal by Subject|15|||
147219347|NCT00420641|530975457|FG001|Overall Study|Withdrawal by Subject|21|||
147219348|NCT00420641|530975458|FG002|Overall Study|Withdrawal by Subject|14|||
147219349|NCT00420641|530975456|FG000|Overall Study|Lack of Efficacy|6|||
147219350|NCT00420641|530975457|FG001|Overall Study|Lack of Efficacy|5|||
147219351|NCT00420641|530975458|FG002|Overall Study|Lack of Efficacy|4|||
147219352|NCT00420641|530975456|FG000|Overall Study|Non-compliance|7|||
147219353|NCT00420641|530975457|FG001|Overall Study|Non-compliance|5|||
147219354|NCT00420641|530975458|FG002|Overall Study|Non-compliance|4|||
147219355|NCT00420641|530975456|FG000|Overall Study|Other|4|||
147219356|NCT00420641|530975457|FG001|Overall Study|Other|4|||
147219357|NCT00420641|530975458|FG002|Overall Study|Other|3|||
147219358|NCT03459690|530975465|FG000|Overall Study|Lost to Follow-up|0|||
147219359|NCT03459690|530975466|FG001|Overall Study|Lost to Follow-up|1|||
147219360|NCT03459690|530975465|FG000|Overall Study|Withdrawal by Subject|1|||
147219361|NCT03459690|530975466|FG001|Overall Study|Withdrawal by Subject|1|||
147219362|NCT02586506|530975467|FG000|Overall Study|Protocol Violation|6|||
147219363|NCT02586506|530975467|FG000|Overall Study|Lost to Follow-up|1|||
147219364|NCT02586506|530975467|FG000|Overall Study|Other Reason|2|||
147219365|NCT04381988|530975474|FG000|Overall Study|The study was terminated|4|||
147219366|NCT04381988|530975475|FG001|Overall Study|The study was terminated|0|||
147219367|NCT05093790|530975476|FG000|Overall Study|Failure to meet continuation criteria|0|||
147219368|NCT05093790|530975477|FG001|Overall Study|Failure to meet continuation criteria|0|||
147219369|NCT05093790|530975478|FG002|Overall Study|Failure to meet continuation criteria|1|||
147219370|NCT05093790|530975479|FG003|Overall Study|Failure to meet continuation criteria|0|||
147219371|NCT05093790|530975476|FG000|Overall Study|Adverse Event|1|||
147219372|NCT05093790|530975477|FG001|Overall Study|Adverse Event|0|||
147219373|NCT05093790|530975478|FG002|Overall Study|Adverse Event|0|||
147219374|NCT05093790|530975479|FG003|Overall Study|Adverse Event|0|||
147219375|NCT00924170|530975480|FG000|Overall Study|Refused further treatment|0|||
147219376|NCT00924170|530975481|FG001|Overall Study|Refused further treatment|1|||
147219377|NCT00924170|530975480|FG000|Overall Study|Physician Decision|0|||
147219378|NCT00924170|530975481|FG001|Overall Study|Physician Decision|1|||
147219379|NCT00924170|530975480|FG000|Overall Study|Progressive disease|3|||
147219380|NCT00924170|530975481|FG001|Overall Study|Progressive disease|6|||
147219381|NCT00924170|530975480|FG000|Overall Study|Stopped due to neutralizing antibodies|3|||
147219382|NCT00924170|530975481|FG001|Overall Study|Stopped due to neutralizing antibodies|0|||
147219383|NCT00924170|530975480|FG000|Overall Study|Death|1|||
147219384|NCT00924170|530975481|FG001|Overall Study|Death|0|||
147219385|NCT04098224|530975482|FG000|Overall Study|Adverse Event|1|||
147219386|NCT04098224|530975483|FG001|Overall Study|Adverse Event|0|||
147219387|NCT04098224|530975482|FG000|Overall Study|Physician Decision|1|||
147219388|NCT04098224|530975483|FG001|Overall Study|Physician Decision|0|||
147219389|NCT04098224|530975482|FG000|Overall Study|Patient not required enteral feeding|1|||
147219390|NCT04098224|530975483|FG001|Overall Study|Patient not required enteral feeding|0|||
147219391|NCT04098224|530975482|FG000|Overall Study|Patient failure nasogastric tube|1|||
147219392|NCT04098224|530975483|FG001|Overall Study|Patient failure nasogastric tube|0|||
147219393|NCT04098224|530975482|FG000|Overall Study|Patient early extubation|1|||
147219394|NCT04098224|530975483|FG001|Overall Study|Patient early extubation|3|||
147219395|NCT01878149|530975486|FG000|Overall Study|Did Not Meet Eligibility Criteria|2|||
147219396|NCT01878149|530975487|FG001|Overall Study|Did Not Meet Eligibility Criteria|2|||
147219397|NCT04672252|530975490|FG000|Overall Study|Protocol Violation|1|||
147219398|NCT04672252|530975491|FG001|Overall Study|Protocol Violation|0|||
147219399|NCT01587898|530975494|FG000|Overall Study|Adverse Event|1|||
147219400|NCT01587898|530975495|FG001|Overall Study|Adverse Event|1|||
147219401|NCT01587898|530975496|FG002|Overall Study|Adverse Event|0|||
147219402|NCT01587898|530975497|FG003|Overall Study|Adverse Event|0|||
147219403|NCT01587898|530975494|FG000|Overall Study|Protocol Violation|0|||
147219404|NCT01587898|530975495|FG001|Overall Study|Protocol Violation|2|||
147219405|NCT01587898|530975496|FG002|Overall Study|Protocol Violation|1|||
147219406|NCT01587898|530975497|FG003|Overall Study|Protocol Violation|1|||
147219407|NCT01587898|530975494|FG000|Overall Study|Lost to Follow-up|0|||
147219408|NCT01587898|530975495|FG001|Overall Study|Lost to Follow-up|0|||
147219409|NCT01587898|530975496|FG002|Overall Study|Lost to Follow-up|0|||
147219410|NCT01587898|530975497|FG003|Overall Study|Lost to Follow-up|1|||
147219411|NCT01587898|530975494|FG000|Overall Study|Withdrawal by Subject|2|||
147219412|NCT01587898|530975495|FG001|Overall Study|Withdrawal by Subject|1|||
147219413|NCT01587898|530975496|FG002|Overall Study|Withdrawal by Subject|0|||
147219414|NCT01587898|530975497|FG003|Overall Study|Withdrawal by Subject|0|||
147219415|NCT01587898|530975494|FG000|Overall Study|Met haemoglobin stopping criteria|1|||
147219416|NCT01587898|530975495|FG001|Overall Study|Met haemoglobin stopping criteria|1|||
147219417|NCT01587898|530975496|FG002|Overall Study|Met haemoglobin stopping criteria|1|||
147219418|NCT01587898|530975497|FG003|Overall Study|Met haemoglobin stopping criteria|0|||
147219419|NCT00502203|530975498|FG000|Overall Study|Inevaluable|1|||
147219420|NCT01903252|530975501|FG000|Double-Blind Induction|Adverse Event|20|||
147219421|NCT01903252|530975502|FG001|Double-Blind Induction|Adverse Event|18|||
147219422|NCT01903252|530975503|FG002|Double-Blind Induction|Adverse Event|0|||
147219423|NCT01903252|530975504|FG003|Double-Blind Induction|Adverse Event|0|||
147219424|NCT01903252|530975505|FG004|Double-Blind Induction|Adverse Event|0|||
147219425|NCT01903252|530975506|FG005|Double-Blind Induction|Adverse Event|0|||
147219426|NCT01903252|530975501|FG000|Double-Blind Induction|Withdrawal by Subject|10|||
147219427|NCT01903252|530975502|FG001|Double-Blind Induction|Withdrawal by Subject|13|||
147219428|NCT01903252|530975503|FG002|Double-Blind Induction|Withdrawal by Subject|0|||
147219429|NCT01903252|530975504|FG003|Double-Blind Induction|Withdrawal by Subject|0|||
147219430|NCT01903252|530975505|FG004|Double-Blind Induction|Withdrawal by Subject|0|||
147219431|NCT01903252|530975506|FG005|Double-Blind Induction|Withdrawal by Subject|0|||
147219432|NCT01903252|530975501|FG000|Double-Blind Induction|Physician Decision|2|||
147219433|NCT01903252|530975502|FG001|Double-Blind Induction|Physician Decision|3|||
147219434|NCT01903252|530975503|FG002|Double-Blind Induction|Physician Decision|0|||
147219435|NCT01903252|530975504|FG003|Double-Blind Induction|Physician Decision|0|||
147219436|NCT01903252|530975505|FG004|Double-Blind Induction|Physician Decision|0|||
147219437|NCT01903252|530975506|FG005|Double-Blind Induction|Physician Decision|0|||
147219438|NCT01903252|530975501|FG000|Double-Blind Induction|non-compliance,|7|||
147219439|NCT01903252|530975502|FG001|Double-Blind Induction|non-compliance,|7|||
147219440|NCT01903252|530975503|FG002|Double-Blind Induction|non-compliance,|0|||
147219441|NCT01903252|530975504|FG003|Double-Blind Induction|non-compliance,|0|||
147219442|NCT01903252|530975505|FG004|Double-Blind Induction|non-compliance,|0|||
147219443|NCT01903252|530975506|FG005|Double-Blind Induction|non-compliance,|0|||
147219444|NCT01903252|530975501|FG000|Extended Induction, Open-Label|Adverse Event|0|||
147219445|NCT01903252|530975502|FG001|Extended Induction, Open-Label|Adverse Event|0|||
147219446|NCT01903252|530975503|FG002|Extended Induction, Open-Label|Adverse Event|17|||
147219447|NCT01903252|530975504|FG003|Extended Induction, Open-Label|Adverse Event|0|||
147219448|NCT01903252|530975505|FG004|Extended Induction, Open-Label|Adverse Event|0|||
147219449|NCT01903252|530975506|FG005|Extended Induction, Open-Label|Adverse Event|0|||
147219450|NCT01903252|530975501|FG000|Extended Induction, Open-Label|Withdrawal by Subject|0|||
147219451|NCT01903252|530975502|FG001|Extended Induction, Open-Label|Withdrawal by Subject|0|||
147219452|NCT01903252|530975503|FG002|Extended Induction, Open-Label|Withdrawal by Subject|5|||
147219453|NCT01903252|530975504|FG003|Extended Induction, Open-Label|Withdrawal by Subject|0|||
147219454|NCT01903252|530975505|FG004|Extended Induction, Open-Label|Withdrawal by Subject|0|||
147219455|NCT01903252|530975506|FG005|Extended Induction, Open-Label|Withdrawal by Subject|0|||
147219456|NCT01903252|530975501|FG000|Extended Induction, Open-Label|Physician Decision|0|||
147219457|NCT01903252|530975502|FG001|Extended Induction, Open-Label|Physician Decision|0|||
147219458|NCT01903252|530975503|FG002|Extended Induction, Open-Label|Physician Decision|1|||
147219459|NCT01903252|530975504|FG003|Extended Induction, Open-Label|Physician Decision|0|||
147219460|NCT01903252|530975505|FG004|Extended Induction, Open-Label|Physician Decision|0|||
147219461|NCT01903252|530975506|FG005|Extended Induction, Open-Label|Physician Decision|0|||
147219462|NCT01903252|530975501|FG000|Maintenance, Open-Label|Adverse Event|0|||
147219463|NCT01903252|530975502|FG001|Maintenance, Open-Label|Adverse Event|0|||
147219464|NCT01903252|530975503|FG002|Maintenance, Open-Label|Adverse Event|0|||
147219465|NCT01903252|530975504|FG003|Maintenance, Open-Label|Adverse Event|3|||
147219466|NCT01903252|530975505|FG004|Maintenance, Open-Label|Adverse Event|9|||
147219467|NCT01903252|530975506|FG005|Maintenance, Open-Label|Adverse Event|14|||
147219468|NCT01903252|530975501|FG000|Maintenance, Open-Label|Withdrawal by Subject|0|||
147219469|NCT01903252|530975502|FG001|Maintenance, Open-Label|Withdrawal by Subject|0|||
147219470|NCT01903252|530975503|FG002|Maintenance, Open-Label|Withdrawal by Subject|0|||
147219471|NCT01903252|530975504|FG003|Maintenance, Open-Label|Withdrawal by Subject|1|||
147219472|NCT01903252|530975505|FG004|Maintenance, Open-Label|Withdrawal by Subject|6|||
147219473|NCT01903252|530975506|FG005|Maintenance, Open-Label|Withdrawal by Subject|2|||
147219474|NCT01903252|530975501|FG000|Maintenance, Open-Label|Other|0|||
147219475|NCT01903252|530975502|FG001|Maintenance, Open-Label|Other|0|||
147219476|NCT01903252|530975503|FG002|Maintenance, Open-Label|Other|0|||
147219477|NCT01903252|530975504|FG003|Maintenance, Open-Label|Other|2|||
147219478|NCT01903252|530975505|FG004|Maintenance, Open-Label|Other|6|||
147219479|NCT01903252|530975506|FG005|Maintenance, Open-Label|Other|2|||
147219480|NCT03735238|530975507|FG000|Overall Study|Did not want to participate in research|3|||
147219481|NCT03735238|530975507|FG000|Overall Study|Time constraints, patient preference or percieved burden of survey completion|26|||
147219482|NCT02660138|530975508|FG000|Overall Study|Adverse Event|0|||
147219483|NCT02660138|530975509|FG001|Overall Study|Adverse Event|3|||
147219484|NCT02660138|530975510|FG002|Overall Study|Adverse Event|2|||
147219485|NCT02660138|530975508|FG000|Overall Study|Lack of Efficacy|1|||
147219486|NCT02660138|530975509|FG001|Overall Study|Lack of Efficacy|2|||
147219487|NCT02660138|530975510|FG002|Overall Study|Lack of Efficacy|1|||
147219488|NCT02660138|530975508|FG000|Overall Study|Withdrawal by Subject|7|||
147219489|NCT02660138|530975509|FG001|Overall Study|Withdrawal by Subject|6|||
147219490|NCT02660138|530975510|FG002|Overall Study|Withdrawal by Subject|6|||
147219491|NCT02660138|530975508|FG000|Overall Study|Lost to Follow-up|4|||
147219492|NCT02660138|530975509|FG001|Overall Study|Lost to Follow-up|4|||
147219493|NCT02660138|530975510|FG002|Overall Study|Lost to Follow-up|1|||
147219494|NCT02660138|530975508|FG000|Overall Study|Sponsor Decision to Terminate Study|57|||
147307894|NCT01827254|531294596|FG000|Overall Study|Death|10|||
147307895|NCT01827254|531294596|FG000|Overall Study|Case report form not completed|4|||
147307896|NCT01827254|531294596|FG000|Overall Study|Invalidated centre|3|||
147219495|NCT02660138|530975509|FG001|Overall Study|Sponsor Decision to Terminate Study|57|||
147219496|NCT02660138|530975510|FG002|Overall Study|Sponsor Decision to Terminate Study|62|||
147219497|NCT02660138|530975508|FG000|Overall Study|Other|1|||
147307897|NCT01827254|531294596|FG000|Overall Study|Discontinued prior initiation: sunitinib|1|||
147307898|NCT01827254|531294596|FG000|Overall Study|Did not complete re-challenge|1|||
147307899|NCT01827254|531294596|FG000|Overall Study|Disease progression|36|||
147307900|NCT01827254|531294596|FG000|Overall Study|Intolerance to treatment|4|||
147307901|NCT01834222|531294597|FG000|Overall Study|Not meet inclusion/exclusion criteria|1|||
147307902|NCT00692406|531294603|FG000|Overall Study|PI dropped, bad data|57|||
147219498|NCT02660138|530975509|FG001|Overall Study|Other|1|||
147219499|NCT02660138|530975510|FG002|Overall Study|Other|0|||
147219500|NCT02660138|530975508|FG000|Overall Study|Not treated|0|||
147219501|NCT02660138|530975509|FG001|Overall Study|Not treated|1|||
147219502|NCT02660138|530975510|FG002|Overall Study|Not treated|0|||
147219503|NCT00899353|530975511|FG000|Overall Study|Adverse Event|2|||
147219504|NCT00899353|530975511|FG000|Overall Study|Lost to Follow-up|1|||
147219505|NCT00899353|530975511|FG000|Overall Study|Withdrawal by Subject|2|||
147219506|NCT03400956|530975520|FG000|Treatment Period 1|Adverse Event|0|||
147219507|NCT03400956|530975521|FG001|Treatment Period 1|Adverse Event|1|||
147219508|NCT03400956|530975522|FG002|Treatment Period 1|Adverse Event|0|||
147219509|NCT03400956|530975520|FG000|Treatment Period 1|Lost to Follow-up|0|||
147219510|NCT03400956|530975521|FG001|Treatment Period 1|Lost to Follow-up|0|||
147219511|NCT03400956|530975522|FG002|Treatment Period 1|Lost to Follow-up|1|||
147219512|NCT03400956|530975520|FG000|Treatment Period 1|Protocol Violation|0|||
147219513|NCT03400956|530975521|FG001|Treatment Period 1|Protocol Violation|2|||
147219514|NCT03400956|530975522|FG002|Treatment Period 1|Protocol Violation|0|||
147219515|NCT03400956|530975520|FG000|Treatment Period 1|Study terminated by sponsor|3|||
147219516|NCT03400956|530975521|FG001|Treatment Period 1|Study terminated by sponsor|1|||
147219517|NCT03400956|530975522|FG002|Treatment Period 1|Study terminated by sponsor|1|||
147219518|NCT03400956|530975520|FG000|Treatment Period 1|Withdrawal by Subject|0|||
147219519|NCT03400956|530975521|FG001|Treatment Period 1|Withdrawal by Subject|2|||
147219520|NCT03400956|530975522|FG002|Treatment Period 1|Withdrawal by Subject|4|||
147219521|NCT03400956|530975520|FG000|Treatment Period 1|Other|1|||
147219522|NCT03400956|530975521|FG001|Treatment Period 1|Other|2|||
147219523|NCT03400956|530975522|FG002|Treatment Period 1|Other|3|||
147219524|NCT03400956|530975520|FG000|Post-treatment Period 1|Adverse Event|0|||
147219525|NCT03400956|530975521|FG001|Post-treatment Period 1|Adverse Event|0|||
147219526|NCT03400956|530975522|FG002|Post-treatment Period 1|Adverse Event|1|||
147219527|NCT03400956|530975520|FG000|Post-treatment Period 1|Physician Decision|2|||
147219528|NCT03400956|530975521|FG001|Post-treatment Period 1|Physician Decision|3|||
147219529|NCT03400956|530975522|FG002|Post-treatment Period 1|Physician Decision|0|||
147219530|NCT03400956|530975520|FG000|Post-treatment Period 1|Study terminated by sponsor|11|||
147219531|NCT03400956|530975521|FG001|Post-treatment Period 1|Study terminated by sponsor|10|||
147219532|NCT03400956|530975522|FG002|Post-treatment Period 1|Study terminated by sponsor|11|||
147219533|NCT03400956|530975520|FG000|Post-treatment Period 1|Withdrawal by Subject|5|||
147219534|NCT03400956|530975521|FG001|Post-treatment Period 1|Withdrawal by Subject|0|||
147219535|NCT03400956|530975522|FG002|Post-treatment Period 1|Withdrawal by Subject|0|||
147219536|NCT03400956|530975520|FG000|Post-treatment Period 1|Other|4|||
147219537|NCT03400956|530975521|FG001|Post-treatment Period 1|Other|3|||
147219538|NCT03400956|530975522|FG002|Post-treatment Period 1|Other|4|||
147219539|NCT03400956|530975520|FG000|Treatment Period 2|Adverse Event|2|||
147219540|NCT03400956|530975521|FG001|Treatment Period 2|Adverse Event|1|||
147219541|NCT03400956|530975522|FG002|Treatment Period 2|Adverse Event|1|||
147219542|NCT03400956|530975520|FG000|Treatment Period 2|Lost to Follow-up|1|||
147219543|NCT03400956|530975521|FG001|Treatment Period 2|Lost to Follow-up|1|||
147219544|NCT03400956|530975522|FG002|Treatment Period 2|Lost to Follow-up|0|||
147219545|NCT03400956|530975520|FG000|Treatment Period 2|Withdrawal by Subject|0|||
147219546|NCT03400956|530975521|FG001|Treatment Period 2|Withdrawal by Subject|0|||
147219547|NCT03400956|530975522|FG002|Treatment Period 2|Withdrawal by Subject|3|||
147307903|NCT02597933|531294604|FG000|Overall Study|Withdrawal by Subject|7|||
147219548|NCT03400956|530975520|FG000|Treatment Period 2|Other|1|||
147307904|NCT02597933|531294605|FG001|Overall Study|Withdrawal by Subject|5|||
147307905|NCT02597933|531294604|FG000|Overall Study|Protocol Violation|2|||
147307906|NCT02597933|531294605|FG001|Overall Study|Protocol Violation|2|||
147307907|NCT02597933|531294604|FG000|Overall Study|Adverse Event|20|||
147219549|NCT03400956|530975521|FG001|Treatment Period 2|Other|1|||
147219550|NCT03400956|530975522|FG002|Treatment Period 2|Other|0|||
147219551|NCT03400956|530975520|FG000|Follow-up Period|Withdrawal by Subject|0|||
147219552|NCT03400956|530975521|FG001|Follow-up Period|Withdrawal by Subject|0|||
147219553|NCT03400956|530975522|FG002|Follow-up Period|Withdrawal by Subject|1|||
147219554|NCT03400956|530975520|FG000|Follow-up Period|Other|0|||
147219555|NCT03400956|530975521|FG001|Follow-up Period|Other|0|||
147219556|NCT03400956|530975522|FG002|Follow-up Period|Other|1|||
147219557|NCT03044574|530975525|FG000|Overall Study|Lost to Follow-up|37|||
147307908|NCT02597933|531294605|FG001|Overall Study|Adverse Event|28|||
147307909|NCT02597933|531294604|FG000|Overall Study|Not treated|2|||
147307910|NCT02597933|531294605|FG001|Overall Study|Not treated|2|||
147219558|NCT03044574|530975526|FG001|Overall Study|Lost to Follow-up|45|||
147219559|NCT00592774|530975527|FG000|Overall Study|Adverse Event|5|||
147219560|NCT00592774|530975528|FG001|Overall Study|Adverse Event|19|||
147219561|NCT00592774|530975529|FG002|Overall Study|Adverse Event|2|||
147219562|NCT00592774|530975530|FG003|Overall Study|Adverse Event|14|||
147219563|NCT00592774|530975531|FG004|Overall Study|Adverse Event|8|||
147219564|NCT00592774|530975527|FG000|Overall Study|Protocol Violation|0|||
147219565|NCT00592774|530975528|FG001|Overall Study|Protocol Violation|1|||
147219566|NCT00592774|530975529|FG002|Overall Study|Protocol Violation|0|||
147219567|NCT00592774|530975530|FG003|Overall Study|Protocol Violation|0|||
147219568|NCT00592774|530975531|FG004|Overall Study|Protocol Violation|1|||
147219569|NCT00592774|530975527|FG000|Overall Study|Withdrawal by Subject|3|||
147219570|NCT00592774|530975528|FG001|Overall Study|Withdrawal by Subject|7|||
147219571|NCT00592774|530975529|FG002|Overall Study|Withdrawal by Subject|0|||
147219572|NCT00592774|530975530|FG003|Overall Study|Withdrawal by Subject|0|||
147219573|NCT00592774|530975531|FG004|Overall Study|Withdrawal by Subject|0|||
147219574|NCT00592774|530975527|FG000|Overall Study|Lack of Efficacy|3|||
147219575|NCT00592774|530975528|FG001|Overall Study|Lack of Efficacy|3|||
147219576|NCT00592774|530975529|FG002|Overall Study|Lack of Efficacy|0|||
147219577|NCT00592774|530975530|FG003|Overall Study|Lack of Efficacy|0|||
147219578|NCT00592774|530975531|FG004|Overall Study|Lack of Efficacy|2|||
147219579|NCT00592774|530975527|FG000|Overall Study|Physician Decision|0|||
147219580|NCT00592774|530975528|FG001|Overall Study|Physician Decision|1|||
147219581|NCT00592774|530975529|FG002|Overall Study|Physician Decision|1|||
147219582|NCT00592774|530975530|FG003|Overall Study|Physician Decision|0|||
147219583|NCT00592774|530975531|FG004|Overall Study|Physician Decision|1|||
147219584|NCT00592774|530975527|FG000|Overall Study|Other|0|||
147219585|NCT00592774|530975528|FG001|Overall Study|Other|1|||
147219586|NCT00592774|530975529|FG002|Overall Study|Other|1|||
147219587|NCT00592774|530975530|FG003|Overall Study|Other|0|||
147219588|NCT00592774|530975531|FG004|Overall Study|Other|2|||
147219589|NCT01924429|530975535|FG000|Washout Period (2 Weeks)|Withdrawal by Subject|3|||
147219590|NCT01924429|530975536|FG001|Washout Period (2 Weeks)|Withdrawal by Subject|2|||
147219591|NCT01606878|530975539|FG000|Overall Study|Adverse Event|1|||
147219592|NCT01606878|530975540|FG001|Overall Study|Adverse Event|1|||
147219593|NCT01606878|530975541|FG002|Overall Study|Adverse Event|0|||
147219594|NCT01606878|530975542|FG003|Overall Study|Adverse Event|0|||
147219595|NCT01606878|530975543|FG004|Overall Study|Adverse Event|0|||
147219596|NCT01606878|530975544|FG005|Overall Study|Adverse Event|0|||
147219597|NCT01606878|530975545|FG006|Overall Study|Adverse Event|1|||
147219598|NCT01606878|530975546|FG007|Overall Study|Adverse Event|0|||
147219599|NCT01606878|530975547|FG008|Overall Study|Adverse Event|1|||
147219600|NCT01606878|530975548|FG009|Overall Study|Adverse Event|3|||
147219601|NCT01606878|530975549|FG010|Overall Study|Adverse Event|0|||
147219602|NCT01606878|530975539|FG000|Overall Study|Lack of Efficacy|1|||
147219603|NCT01606878|530975540|FG001|Overall Study|Lack of Efficacy|1|||
147219604|NCT01606878|530975541|FG002|Overall Study|Lack of Efficacy|1|||
147219605|NCT01606878|530975542|FG003|Overall Study|Lack of Efficacy|2|||
147219606|NCT01606878|530975543|FG004|Overall Study|Lack of Efficacy|1|||
147219607|NCT01606878|530975544|FG005|Overall Study|Lack of Efficacy|2|||
147219608|NCT01606878|530975545|FG006|Overall Study|Lack of Efficacy|1|||
147219609|NCT01606878|530975546|FG007|Overall Study|Lack of Efficacy|2|||
147219610|NCT01606878|530975547|FG008|Overall Study|Lack of Efficacy|2|||
147219611|NCT01606878|530975548|FG009|Overall Study|Lack of Efficacy|0|||
147219612|NCT01606878|530975549|FG010|Overall Study|Lack of Efficacy|1|||
147307911|NCT02597933|531294604|FG000|Overall Study|Other than stated above|7|||
147307912|NCT02597933|531294605|FG001|Overall Study|Other than stated above|14|||
147307913|NCT04599101|531294613|FG000|Overall Study|Lost to Follow-up|5|||
147307914|NCT04599101|531294614|FG001|Overall Study|Lost to Follow-up|5|||
147307915|NCT00525265|531294619|FG000|Overall Study|Protocol Violation|1|||
147307916|NCT00525265|531294620|FG001|Overall Study|Protocol Violation|0|||
147219613|NCT01606878|530975539|FG000|Overall Study|Physician Decision|1|||
147219614|NCT01606878|530975540|FG001|Overall Study|Physician Decision|0|||
147219615|NCT01606878|530975541|FG002|Overall Study|Physician Decision|2|||
147219616|NCT01606878|530975542|FG003|Overall Study|Physician Decision|1|||
147219617|NCT01606878|530975543|FG004|Overall Study|Physician Decision|1|||
147219618|NCT01606878|530975544|FG005|Overall Study|Physician Decision|1|||
147219619|NCT01606878|530975545|FG006|Overall Study|Physician Decision|2|||
147219620|NCT01606878|530975546|FG007|Overall Study|Physician Decision|0|||
147219621|NCT01606878|530975547|FG008|Overall Study|Physician Decision|1|||
147219622|NCT01606878|530975548|FG009|Overall Study|Physician Decision|0|||
147219623|NCT01606878|530975549|FG010|Overall Study|Physician Decision|0|||
147219624|NCT01606878|530975539|FG000|Overall Study|Withdrawal by Subject|3|||
147219625|NCT01606878|530975540|FG001|Overall Study|Withdrawal by Subject|2|||
147219626|NCT01606878|530975541|FG002|Overall Study|Withdrawal by Subject|2|||
147219627|NCT01606878|530975542|FG003|Overall Study|Withdrawal by Subject|0|||
147219628|NCT01606878|530975543|FG004|Overall Study|Withdrawal by Subject|1|||
147307917|NCT01913639|531294621|FG000|Overall Study|Not Eligible|3|||
147307918|NCT00130793|531294631|FG000|Overall Study|Lost to Follow-up|1|||
147307919|NCT00130793|531294632|FG001|Overall Study|Lost to Follow-up|4|||
147307920|NCT00130793|531294631|FG000|Overall Study|Withdrew consent|2|||
147307921|NCT00130793|531294632|FG001|Overall Study|Withdrew consent|0|||
147307922|NCT01515189|531294633|FG000|Induction|Disease Progression|109|||
147307923|NCT01515189|531294634|FG001|Induction|Disease Progression|155|||
147307924|NCT01515189|531294633|FG000|Induction|Study drug toxicity|86|||
147307925|NCT01515189|531294634|FG001|Induction|Study drug toxicity|36|||
147307926|NCT01515189|531294633|FG000|Induction|Death|24|||
147307927|NCT01515189|531294634|FG001|Induction|Death|17|||
147307928|NCT01515189|531294633|FG000|Induction|Adverse Event|14|||
147307929|NCT01515189|531294634|FG001|Induction|Adverse Event|9|||
147307930|NCT01515189|531294633|FG000|Induction|Withdrawal by Subject|3|||
147307931|NCT01515189|531294634|FG001|Induction|Withdrawal by Subject|9|||
147307932|NCT01515189|531294633|FG000|Induction|No longer meets study criteria|0|||
147307933|NCT01515189|531294634|FG001|Induction|No longer meets study criteria|2|||
147307934|NCT01515189|531294633|FG000|Induction|Lost to Follow-up|1|||
147307935|NCT01515189|531294634|FG001|Induction|Lost to Follow-up|0|||
147307936|NCT01515189|531294633|FG000|Induction|Other|0|||
147307937|NCT01515189|531294634|FG001|Induction|Other|4|||
147307938|NCT01515189|531294633|FG000|First Re-Induction Phase|Disease progression|6|||
147307939|NCT01515189|531294634|FG001|First Re-Induction Phase|Disease progression|14|||
147307940|NCT01515189|531294633|FG000|First Re-Induction Phase|Study drug toxicity|5|||
147307941|NCT01515189|531294634|FG001|First Re-Induction Phase|Study drug toxicity|0|||
147307942|NCT01515189|531294633|FG000|First Re-Induction Phase|Withdrawal by Subject|1|||
147307943|NCT01515189|531294634|FG001|First Re-Induction Phase|Withdrawal by Subject|1|||
147307944|NCT01515189|531294633|FG000|First Re-Induction Phase|No longer meets study criteria|1|||
147307945|NCT01515189|531294634|FG001|First Re-Induction Phase|No longer meets study criteria|0|||
147307946|NCT01515189|531294633|FG000|First Re-Induction Phase|Other|1|||
147307947|NCT01515189|531294634|FG001|First Re-Induction Phase|Other|0|||
147307948|NCT01013792|531294635|FG000|Overall Study|Study suspended|2|||
147307949|NCT01013792|531294636|FG001|Overall Study|Study suspended|1|||
147307950|NCT01013792|531294635|FG000|Overall Study|Adverse Event|0|||
147307951|NCT01013792|531294636|FG001|Overall Study|Adverse Event|3|||
147307952|NCT01013792|531294635|FG000|Overall Study|Lost to Follow-up|0|||
147307953|NCT01013792|531294636|FG001|Overall Study|Lost to Follow-up|1|||
147307954|NCT02100722|531294637|FG000|Overall Study|Withdrawal pre-procedure|4|||
147307955|NCT02100722|531294638|FG001|Overall Study|Withdrawal pre-procedure|9|||
147307956|NCT02100722|531294637|FG000|Overall Study|Withdrawal post-procedure|0|||
147307957|NCT02100722|531294638|FG001|Overall Study|Withdrawal post-procedure|3|||
147307958|NCT02100722|531294637|FG000|Overall Study|Lost to Follow-up|2|||
147307959|NCT02100722|531294638|FG001|Overall Study|Lost to Follow-up|2|||
147307960|NCT02100722|531294637|FG000|Overall Study|Continuing on study|751|||
147443082|NCT03703882|531787158|FG000|Overall Study|noncompliance with study procedures|0|||
147219629|NCT01606878|530975544|FG005|Overall Study|Withdrawal by Subject|1|||
147219630|NCT01606878|530975545|FG006|Overall Study|Withdrawal by Subject|2|||
147219631|NCT01606878|530975546|FG007|Overall Study|Withdrawal by Subject|1|||
147219632|NCT01606878|530975547|FG008|Overall Study|Withdrawal by Subject|2|||
147219633|NCT01606878|530975548|FG009|Overall Study|Withdrawal by Subject|0|||
147219634|NCT01606878|530975549|FG010|Overall Study|Withdrawal by Subject|2|||
147219635|NCT04085367|530977091|FG000|Overall Study|Adverse Event|1|||
147219636|NCT04085367|530977092|FG001|Overall Study|Adverse Event|1|||
147219637|NCT04085367|530977091|FG000|Overall Study|Withdrawal by Subject|13|||
147219638|NCT04085367|530977092|FG001|Overall Study|Withdrawal by Subject|4|||
147219639|NCT04085367|530977091|FG000|Overall Study|Lost to Follow-up|3|||
147219640|NCT04085367|530977092|FG001|Overall Study|Lost to Follow-up|1|||
147307961|NCT02100722|531294638|FG001|Overall Study|Continuing on study|729|||
147307962|NCT02541383|531294641|FG000|Overall Study|Death|50|||
147307963|NCT02541383|531294642|FG001|Overall Study|Death|37|||
147307964|NCT02541383|531294643|FG002|Overall Study|Death|48|||
147307965|NCT02541383|531294644|FG003|Overall Study|Death|41|||
147307966|NCT02541383|531294645|FG004|Overall Study|Death|21|||
147307967|NCT02541383|531294646|FG005|Overall Study|Death|25|||
147307968|NCT02541383|531294641|FG000|Overall Study|Lost to Follow-up|5|||
147307969|NCT02541383|531294642|FG001|Overall Study|Lost to Follow-up|3|||
147307970|NCT02541383|531294643|FG002|Overall Study|Lost to Follow-up|1|||
147307971|NCT02541383|531294644|FG003|Overall Study|Lost to Follow-up|1|||
147307972|NCT02541383|531294645|FG004|Overall Study|Lost to Follow-up|3|||
147219641|NCT04085367|530977091|FG000|Overall Study|Other unspecified|2|||
147219642|NCT04085367|530977092|FG001|Overall Study|Other unspecified|1|||
147219643|NCT04085367|530977091|FG000|Overall Study|Status Unknown|1|||
147307973|NCT02541383|531294646|FG005|Overall Study|Lost to Follow-up|0|||
147307974|NCT02541383|531294641|FG000|Overall Study|Consent withdrawn|5|||
147307975|NCT02541383|531294642|FG001|Overall Study|Consent withdrawn|6|||
147307976|NCT02541383|531294643|FG002|Overall Study|Consent withdrawn|1|||
147307977|NCT02541383|531294644|FG003|Overall Study|Consent withdrawn|1|||
147307978|NCT02541383|531294645|FG004|Overall Study|Consent withdrawn|0|||
147307979|NCT02541383|531294646|FG005|Overall Study|Consent withdrawn|0|||
147307980|NCT02541383|531294641|FG000|Overall Study|Sponsor's decision|1|||
147219644|NCT04085367|530977092|FG001|Overall Study|Status Unknown|1|||
147219645|NCT00130442|530977096|FG000|Overall Study|Withdrawal by Subject|0|||
147219646|NCT00130442|530977097|FG001|Overall Study|Withdrawal by Subject|1|||
147219647|NCT00130442|530977096|FG000|Overall Study|did not meet criteria|1|||
147219648|NCT00130442|530977097|FG001|Overall Study|did not meet criteria|1|||
147219649|NCT00814333|530977098|FG000|Enrollment|Lost to Follow-up|1|||
147219650|NCT00814333|530977099|FG001|Enrollment|Lost to Follow-up|0|||
147219651|NCT01527357|530977100|FG000|Overall Study|Death|8|||
147219652|NCT01527357|530977101|FG001|Overall Study|Death|2|||
147219653|NCT01527357|530977100|FG000|Overall Study|Lost to Follow-up|6|||
147219654|NCT01527357|530977101|FG001|Overall Study|Lost to Follow-up|4|||
147219655|NCT01527357|530977100|FG000|Overall Study|Withdrew Consent|1|||
147219656|NCT01527357|530977101|FG001|Overall Study|Withdrew Consent|1|||
147219657|NCT01527357|530977100|FG000|Overall Study|Non-compliance|0|||
147219658|NCT01527357|530977101|FG001|Overall Study|Non-compliance|1|||
147219659|NCT01527357|530977100|FG000|Overall Study|No Day 29 Visit|0|||
147219660|NCT01527357|530977101|FG001|Overall Study|No Day 29 Visit|1|||
147219661|NCT01527357|530977100|FG000|Overall Study|Did Not Receive Treatment|2|||
147219662|NCT01527357|530977101|FG001|Overall Study|Did Not Receive Treatment|0|||
147219663|NCT00910247|530977102|FG000|Overall Study|Adverse Event|15|||
147219664|NCT00910247|530977102|FG000|Overall Study|Death|2|||
147219665|NCT00910247|530977102|FG000|Overall Study|Lost to Follow-up|10|||
147219666|NCT00910247|530977102|FG000|Overall Study|Physician Decision|3|||
147219667|NCT00910247|530977102|FG000|Overall Study|Protocol Violation|10|||
147219668|NCT00910247|530977102|FG000|Overall Study|Withdrawal by Subject|25|||
147219669|NCT00910247|530977102|FG000|Overall Study|Not collected|4|||
147219670|NCT02519855|530977104|FG000|Overall Study|Adverse Event|0|||
147219671|NCT02519855|530977105|FG001|Overall Study|Adverse Event|1|||
147219672|NCT02519855|530977104|FG000|Overall Study|Lost to Follow-up|3|||
147219673|NCT02519855|530977105|FG001|Overall Study|Lost to Follow-up|3|||
147219674|NCT00003830|530977106|FG000|Overall Study|No follow up data|3|||
147219675|NCT00003830|530977107|FG001|Overall Study|No follow up data|0|||
147219676|NCT00003830|530977106|FG000|Overall Study|Sentinel node positive patients|829|||
147219677|NCT00003830|530977107|FG001|Overall Study|Sentinel node positive patients|793|||
147219678|NCT05347147|530977108|FG000|Overall Study|Lost to Follow-up|0|||
147219679|NCT05347147|530977109|FG001|Overall Study|Lost to Follow-up|1|||
147219680|NCT05347147|530977108|FG000|Overall Study|Sponsor request|3|||
147219681|NCT05347147|530977109|FG001|Overall Study|Sponsor request|3|||
147219682|NCT05347147|530977108|FG000|Overall Study|Study termination|2|||
147219683|NCT05347147|530977109|FG001|Overall Study|Study termination|1|||
147219684|NCT03565367|530977110|FG000|Overall Study|No scan due to technical issues|4|||
147219685|NCT03565367|530977111|FG001|Overall Study|No scan due to technical issues|0|||
147219686|NCT01397825|530977116|FG000|Overall Study|Progressive Disease|10|||
147219687|NCT01397825|530977117|FG001|Overall Study|Progressive Disease|3|||
147219688|NCT01397825|530977118|FG002|Overall Study|Progressive Disease|11|||
147219689|NCT01397825|530977119|FG003|Overall Study|Progressive Disease|1|||
147219690|NCT01397825|530977120|FG004|Overall Study|Progressive Disease|0|||
147219691|NCT01397825|530977116|FG000|Overall Study|Symptomatic Deterioration|2|||
147219692|NCT01397825|530977117|FG001|Overall Study|Symptomatic Deterioration|0|||
147219693|NCT01397825|530977118|FG002|Overall Study|Symptomatic Deterioration|4|||
147219694|NCT01397825|530977119|FG003|Overall Study|Symptomatic Deterioration|0|||
147219695|NCT01397825|530977120|FG004|Overall Study|Symptomatic Deterioration|0|||
147219696|NCT01397825|530977116|FG000|Overall Study|Adverse Event|0|||
147219697|NCT01397825|530977117|FG001|Overall Study|Adverse Event|1|||
147219698|NCT01397825|530977118|FG002|Overall Study|Adverse Event|5|||
147219699|NCT01397825|530977119|FG003|Overall Study|Adverse Event|1|||
147219700|NCT01397825|530977120|FG004|Overall Study|Adverse Event|0|||
147219701|NCT01397825|530977116|FG000|Overall Study|Withdrawal by Subject|1|||
147219702|NCT01397825|530977117|FG001|Overall Study|Withdrawal by Subject|0|||
147219703|NCT01397825|530977118|FG002|Overall Study|Withdrawal by Subject|5|||
147219704|NCT01397825|530977119|FG003|Overall Study|Withdrawal by Subject|1|||
147219705|NCT01397825|530977120|FG004|Overall Study|Withdrawal by Subject|0|||
147219706|NCT01931670|530977121|FG000|Treatment Period|Exclusionary Medication Received|1|||
147219707|NCT01931670|530977122|FG001|Treatment Period|Exclusionary Medication Received|1|||
147649962|NCT00703118|532539768|FG000|Overall Study|Subject Ineligible To Continue The Trial|6|||
147219708|NCT01931670|530977123|FG002|Treatment Period|Exclusionary Medication Received|1|||
147219709|NCT01931670|530977121|FG000|Treatment Period|Surgery/Invasive Intervention|4|||
147219710|NCT01931670|530977122|FG001|Treatment Period|Surgery/Invasive Intervention|2|||
147219711|NCT01931670|530977123|FG002|Treatment Period|Surgery/Invasive Intervention|0|||
147219712|NCT01931670|530977121|FG000|Treatment Period|Subject Noncompliant|4|||
147219713|NCT01931670|530977122|FG001|Treatment Period|Subject Noncompliant|9|||
147219714|NCT01931670|530977123|FG002|Treatment Period|Subject Noncompliant|5|||
147219715|NCT01931670|530977121|FG000|Treatment Period|Adverse Event|19|||
147219716|NCT01931670|530977122|FG001|Treatment Period|Adverse Event|8|||
147219717|NCT01931670|530977123|FG002|Treatment Period|Adverse Event|21|||
147219718|NCT01931670|530977121|FG000|Treatment Period|Lack of Efficacy|11|||
147219719|NCT01931670|530977122|FG001|Treatment Period|Lack of Efficacy|2|||
147219720|NCT01931670|530977123|FG002|Treatment Period|Lack of Efficacy|2|||
147307981|NCT02541383|531294642|FG001|Overall Study|Sponsor's decision|1|||
147307982|NCT02541383|531294643|FG002|Overall Study|Sponsor's decision|0|||
147307983|NCT02541383|531294644|FG003|Overall Study|Sponsor's decision|0|||
147307984|NCT02541383|531294645|FG004|Overall Study|Sponsor's decision|0|||
147307985|NCT02541383|531294646|FG005|Overall Study|Sponsor's decision|0|||
147307986|NCT03500640|531294647|FG000|DPP Core Program (0-6 Months)|Lost to Follow-up|26|||
147307987|NCT03500640|531294648|FG001|DPP Core Program (0-6 Months)|Lost to Follow-up|0|||
147307988|NCT03500640|531294649|FG002|DPP Core Program (0-6 Months)|Lost to Follow-up|0|||
147307989|NCT03500640|531294647|FG000|DPP Core Program (0-6 Months)|Withdrawal by Subject|21|||
147307990|NCT03500640|531294648|FG001|DPP Core Program (0-6 Months)|Withdrawal by Subject|0|||
147307991|NCT03500640|531294649|FG002|DPP Core Program (0-6 Months)|Withdrawal by Subject|0|||
147307992|NCT03500640|531294647|FG000|DPP Core Program (0-6 Months)|No Exercise Clearance|3|||
147307993|NCT03500640|531294648|FG001|DPP Core Program (0-6 Months)|No Exercise Clearance|0|||
147307994|NCT03500640|531294649|FG002|DPP Core Program (0-6 Months)|No Exercise Clearance|0|||
147307995|NCT03500640|531294647|FG000|DPP Core Program (0-6 Months)|Spouses (Per Protocol) Excluded|6|||
147307996|NCT03500640|531294648|FG001|DPP Core Program (0-6 Months)|Spouses (Per Protocol) Excluded|0|||
147307997|NCT03500640|531294649|FG002|DPP Core Program (0-6 Months)|Spouses (Per Protocol) Excluded|0|||
147307998|NCT03500640|531294647|FG000|Follow-Up Contacts (7-12 Months)|Lost to Follow-up|0|||
147307999|NCT03500640|531294648|FG001|Follow-Up Contacts (7-12 Months)|Lost to Follow-up|33|||
147308000|NCT03500640|531294649|FG002|Follow-Up Contacts (7-12 Months)|Lost to Follow-up|41|||
147308001|NCT03500640|531294647|FG000|Follow-Up Contacts (7-12 Months)|Withdrawal by Subject|0|||
147308002|NCT03500640|531294648|FG001|Follow-Up Contacts (7-12 Months)|Withdrawal by Subject|1|||
147308003|NCT03500640|531294649|FG002|Follow-Up Contacts (7-12 Months)|Withdrawal by Subject|4|||
147308004|NCT03500640|531294647|FG000|Follow-up Contacts (13-18 Months)|Lost to Follow-up|0|||
147308005|NCT03500640|531294648|FG001|Follow-up Contacts (13-18 Months)|Lost to Follow-up|1|||
147308006|NCT03500640|531294649|FG002|Follow-up Contacts (13-18 Months)|Lost to Follow-up|9|||
147308007|NCT03500640|531294647|FG000|Follow-up Contacts (13-18 Months)|Withdrawal by Subject|0|||
147308008|NCT03500640|531294648|FG001|Follow-up Contacts (13-18 Months)|Withdrawal by Subject|1|||
147308009|NCT03500640|531294649|FG002|Follow-up Contacts (13-18 Months)|Withdrawal by Subject|1|||
147308010|NCT03500640|531294647|FG000|Follow-Up Contacts (19-24 Months)|Withdrawal by Subject|0|||
147308011|NCT03500640|531294648|FG001|Follow-Up Contacts (19-24 Months)|Withdrawal by Subject|2|||
147308012|NCT03500640|531294649|FG002|Follow-Up Contacts (19-24 Months)|Withdrawal by Subject|1|||
147308013|NCT03500640|531294647|FG000|Follow-Up Contacts (19-24 Months)|Death|0|||
147308014|NCT03500640|531294648|FG001|Follow-Up Contacts (19-24 Months)|Death|1|||
147308015|NCT03500640|531294649|FG002|Follow-Up Contacts (19-24 Months)|Death|0|||
147308016|NCT04395183|531294660|FG000|Overall Study|Withdrawal by Subject|1|||
147308017|NCT04395183|531294661|FG001|Overall Study|Withdrawal by Subject|0|||
147308018|NCT04395183|531294662|FG002|Overall Study|Withdrawal by Subject|2|||
147308019|NCT04395183|531294663|FG003|Overall Study|Withdrawal by Subject|2|||
147308020|NCT01008475|531294664|FG000|Overall Study|Ongoing treatment at data cut-off date|0|||
147308021|NCT01008475|531294665|FG001|Overall Study|Ongoing treatment at data cut-off date|0|||
147308022|NCT01008475|531294666|FG002|Overall Study|Ongoing treatment at data cut-off date|0|||
147308023|NCT01008475|531294667|FG003|Overall Study|Ongoing treatment at data cut-off date|0|||
147308024|NCT01008475|531294668|FG004|Overall Study|Ongoing treatment at data cut-off date|5|||
147308025|NCT01008475|531294669|FG005|Overall Study|Ongoing treatment at data cut-off date|6|||
147308026|NCT01008475|531294670|FG006|Overall Study|Ongoing treatment at data cut-off date|4|||
147308027|NCT02668016|531294671|FG000|Month 2|Withdrew due to other health condition preventing continuation with the protocol|1|||
147308028|NCT02668016|531294671|FG000|Month 2|Withdrew due to repeated failure to provide treatment scores|1|||
147308029|NCT02668016|531294671|FG000|Month 2|Not applicable - stopped trial medication for rest of month but continued in the trial|4|||
147308030|NCT02668016|531294671|FG000|Month 4|Withdrawal due to severe symptoms|1|||
147308031|NCT02668016|531294671|FG000|Month 4|Withdrawal due to non-compliance with trial protocol|1|||
147308032|NCT02668016|531294671|FG000|Month 4|Not applicable - stopped trial medication for rest of month but continued in the trial|3|||
147308033|NCT02668016|531294671|FG000|Month 6|Withdrawal as decided side effects non longer statin mediated|1|||
147308034|NCT02668016|531294671|FG000|Month 6|Withdrawal due to severe symptoms|2|||
147552304|NCT02711956|532178570|FG006|Overall Study|PSA progression with clinical progression|0|||
147552305|NCT02711956|532178571|FG007|Overall Study|PSA progression with clinical progression|0|||
147308035|NCT02668016|531294671|FG000|Month 6|Withdrawal due to other health issues preventing continuation with the protocol|1|||
147308036|NCT02668016|531294671|FG000|Month 6|Not applicable - stopped trial medication for rest of month but continued in the trial|2|||
147308037|NCT02668016|531294671|FG000|Month 8|Withdrawal due to severe symptoms|1|||
147308038|NCT02668016|531294671|FG000|Month 8|Not applicable - stopped trial medication for rest of month but continued in the trial|6|||
147308039|NCT02668016|531294671|FG000|Month 10|Withdrawal due to intercurrent social stresses|1|||
147308040|NCT02668016|531294671|FG000|Month 10|Withdrawal due to severe symptoms|1|||
147308041|NCT02668016|531294671|FG000|Month 10|Not applicable - stopped trial medication for rest of month but continued in the trial|6|||
147308042|NCT01657266|531294674|FG000|Overall Study|Lost to Follow-up|2|||
147308043|NCT01657266|531294675|FG001|Overall Study|Lost to Follow-up|2|||
147308044|NCT01657266|531294674|FG000|Overall Study|Adverse Event|2|||
147308045|NCT01657266|531294675|FG001|Overall Study|Adverse Event|3|||
147308046|NCT00736489|531294682|FG000|Period 1|Lost to Follow-up|1|||
147308047|NCT00736489|531294683|FG001|Period 1|Lost to Follow-up|0|||
147308048|NCT00736489|531294684|FG002|Period 1|Lost to Follow-up|0|||
147308049|NCT00736489|531294685|FG003|Period 1|Lost to Follow-up|0|||
147308050|NCT00736489|531294686|FG004|Period 1|Lost to Follow-up|0|||
147308051|NCT00736489|531294687|FG005|Period 1|Lost to Follow-up|0|||
147308052|NCT00736489|531294682|FG000|Period 1|Withdrawal by Subject|0|||
147308053|NCT00736489|531294683|FG001|Period 1|Withdrawal by Subject|0|||
147308054|NCT00736489|531294684|FG002|Period 1|Withdrawal by Subject|0|||
147308055|NCT00736489|531294685|FG003|Period 1|Withdrawal by Subject|0|||
147308056|NCT00736489|531294686|FG004|Period 1|Withdrawal by Subject|0|||
147308057|NCT00736489|531294687|FG005|Period 1|Withdrawal by Subject|1|||
147308058|NCT02234063|531294696|FG000|Overall Study|Lost to Follow-up|235|||
147308059|NCT02234063|531294697|FG001|Overall Study|Lost to Follow-up|42|||
147308060|NCT02234063|531294696|FG000|Overall Study|Withdrawal by Subject|20|||
147308061|NCT02234063|531294697|FG001|Overall Study|Withdrawal by Subject|1|||
147308062|NCT01555164|531294700|FG000|Overall Study|Adverse Event|5|||
147552306|NCT02711956|532178572|FG008|Overall Study|PSA progression with clinical progression|0|||
147552307|NCT02711956|532178573|FG009|Overall Study|PSA progression with clinical progression|0|||
147552308|NCT02711956|532178574|FG010|Overall Study|PSA progression with clinical progression|0|||
147552309|NCT02711956|532178575|FG011|Overall Study|PSA progression with clinical progression|0|||
147552310|NCT02711956|532178576|FG012|Overall Study|PSA progression with clinical progression|1|||
147552311|NCT02711956|532178577|FG013|Overall Study|PSA progression with clinical progression|1|||
147552312|NCT02711956|532178578|FG014|Overall Study|PSA progression with clinical progression|0|||
147308063|NCT01555164|531294701|FG001|Overall Study|Adverse Event|7|||
147308064|NCT01555164|531294700|FG000|Overall Study|Hyperglycemia|0|||
147308065|NCT01555164|531294701|FG001|Overall Study|Hyperglycemia|1|||
147308066|NCT01555164|531294700|FG000|Overall Study|Investigator's Discretion|2|||
147308067|NCT01555164|531294701|FG001|Overall Study|Investigator's Discretion|2|||
147552313|NCT02711956|532178564|FG000|Overall Study|PSA progression with radiographic progression|0|||
147552314|NCT02711956|532178565|FG001|Overall Study|PSA progression with radiographic progression|1|||
147552315|NCT02711956|532178566|FG002|Overall Study|PSA progression with radiographic progression|0|||
147552316|NCT02711956|532178567|FG003|Overall Study|PSA progression with radiographic progression|0|||
147552317|NCT02711956|532178568|FG004|Overall Study|PSA progression with radiographic progression|0|||
147552318|NCT02711956|532178569|FG005|Overall Study|PSA progression with radiographic progression|2|||
147552319|NCT02711956|532178570|FG006|Overall Study|PSA progression with radiographic progression|2|||
147552320|NCT02711956|532178571|FG007|Overall Study|PSA progression with radiographic progression|1|||
147552321|NCT02711956|532178572|FG008|Overall Study|PSA progression with radiographic progression|0|||
147552322|NCT02711956|532178573|FG009|Overall Study|PSA progression with radiographic progression|1|||
147552323|NCT02711956|532178574|FG010|Overall Study|PSA progression with radiographic progression|0|||
147219721|NCT01931670|530977121|FG000|Treatment Period|Pregnancy|7|||
147219722|NCT01931670|530977122|FG001|Treatment Period|Pregnancy|2|||
147219723|NCT01931670|530977123|FG002|Treatment Period|Pregnancy|0|||
147219724|NCT01931670|530977121|FG000|Treatment Period|Other|8|||
147219725|NCT01931670|530977122|FG001|Treatment Period|Other|7|||
147219726|NCT01931670|530977123|FG002|Treatment Period|Other|2|||
147219727|NCT01931670|530977121|FG000|Treatment Period|Consent Withdrawn by Subject|17|||
147219728|NCT01931670|530977122|FG001|Treatment Period|Consent Withdrawn by Subject|12|||
147219729|NCT01931670|530977123|FG002|Treatment Period|Consent Withdrawn by Subject|7|||
147219730|NCT01931670|530977121|FG000|Treatment Period|Lost to Follow-up|19|||
147219731|NCT01931670|530977122|FG001|Treatment Period|Lost to Follow-up|5|||
147219732|NCT01931670|530977123|FG002|Treatment Period|Lost to Follow-up|7|||
147219733|NCT01931670|530977121|FG000|Post-Treatment Follow-Up (PTFU) Period|Exclusionary Medication Received|3|||
147219734|NCT01931670|530977122|FG001|Post-Treatment Follow-Up (PTFU) Period|Exclusionary Medication Received|0|||
147219735|NCT01931670|530977123|FG002|Post-Treatment Follow-Up (PTFU) Period|Exclusionary Medication Received|0|||
147219736|NCT01931670|530977121|FG000|Post-Treatment Follow-Up (PTFU) Period|Adverse Event|0|||
147219737|NCT01931670|530977122|FG001|Post-Treatment Follow-Up (PTFU) Period|Adverse Event|2|||
147219738|NCT01931670|530977123|FG002|Post-Treatment Follow-Up (PTFU) Period|Adverse Event|1|||
147219739|NCT01931670|530977121|FG000|Post-Treatment Follow-Up (PTFU) Period|Surgery/Invasive Intervention|4|||
147219740|NCT01931670|530977122|FG001|Post-Treatment Follow-Up (PTFU) Period|Surgery/Invasive Intervention|4|||
147219741|NCT01931670|530977123|FG002|Post-Treatment Follow-Up (PTFU) Period|Surgery/Invasive Intervention|2|||
147219742|NCT01931670|530977121|FG000|Post-Treatment Follow-Up (PTFU) Period|Other|6|||
147219743|NCT01931670|530977122|FG001|Post-Treatment Follow-Up (PTFU) Period|Other|3|||
147308068|NCT01555164|531294700|FG000|Overall Study|Lost to Follow-up|4|||
147308069|NCT01555164|531294701|FG001|Overall Study|Lost to Follow-up|3|||
147308070|NCT01555164|531294700|FG000|Overall Study|Protocol Violation|9|||
147308071|NCT01555164|531294701|FG001|Overall Study|Protocol Violation|5|||
147308072|NCT01555164|531294700|FG000|Overall Study|Subject Non-compliance|14|||
147308073|NCT01555164|531294701|FG001|Overall Study|Subject Non-compliance|6|||
147308074|NCT01555164|531294700|FG000|Overall Study|Subject Withdrew Consent|6|||
147219744|NCT01931670|530977123|FG002|Post-Treatment Follow-Up (PTFU) Period|Other|3|||
147219745|NCT01931670|530977121|FG000|Post-Treatment Follow-Up (PTFU) Period|Consent Withdrawn by Subject|6|||
147219746|NCT01931670|530977122|FG001|Post-Treatment Follow-Up (PTFU) Period|Consent Withdrawn by Subject|3|||
147219747|NCT01931670|530977123|FG002|Post-Treatment Follow-Up (PTFU) Period|Consent Withdrawn by Subject|13|||
147219748|NCT01931670|530977121|FG000|Post-Treatment Follow-Up (PTFU) Period|Lost to Follow-up|0|||
147219749|NCT01931670|530977122|FG001|Post-Treatment Follow-Up (PTFU) Period|Lost to Follow-up|0|||
147219750|NCT01931670|530977123|FG002|Post-Treatment Follow-Up (PTFU) Period|Lost to Follow-up|2|||
147308075|NCT01555164|531294701|FG001|Overall Study|Subject Withdrew Consent|11|||
147308076|NCT03443713|531294702|FG000|First at Home Period (9-14 Days)|Withdrawal by Subject|0|||
147308077|NCT03443713|531294703|FG001|First at Home Period (9-14 Days)|Withdrawal by Subject|0|||
147308078|NCT03443713|531294704|FG002|First at Home Period (9-14 Days)|Withdrawal by Subject|1|||
147308079|NCT01672853|531294707|FG000|Overall Study|Protocol Specified Criteria for Withdraw|0|||
147308080|NCT01672853|531294708|FG001|Overall Study|Protocol Specified Criteria for Withdraw|4|||
147308081|NCT01672853|531294709|FG002|Overall Study|Protocol Specified Criteria for Withdraw|0|||
147308082|NCT01672853|531294707|FG000|Overall Study|Pregnancy|0|||
147308083|NCT01672853|531294708|FG001|Overall Study|Pregnancy|1|||
147308084|NCT01672853|531294709|FG002|Overall Study|Pregnancy|0|||
147308085|NCT01672853|531294707|FG000|Overall Study|Investigator's Discretion|1|||
147308086|NCT01672853|531294708|FG001|Overall Study|Investigator's Discretion|0|||
147308087|NCT01672853|531294709|FG002|Overall Study|Investigator's Discretion|0|||
147308088|NCT01672853|531294707|FG000|Overall Study|Withdrew Consent|5|||
147308089|NCT01672853|531294708|FG001|Overall Study|Withdrew Consent|5|||
147308090|NCT01672853|531294709|FG002|Overall Study|Withdrew Consent|5|||
147308091|NCT01672853|531294707|FG000|Overall Study|Adverse Event|4|||
147308092|NCT01672853|531294708|FG001|Overall Study|Adverse Event|6|||
147308093|NCT01672853|531294709|FG002|Overall Study|Adverse Event|8|||
147308094|NCT01672853|531294707|FG000|Overall Study|Lost to Follow-up|0|||
147308095|NCT01672853|531294708|FG001|Overall Study|Lost to Follow-up|1|||
147308096|NCT01672853|531294709|FG002|Overall Study|Lost to Follow-up|0|||
147308097|NCT01672853|531294707|FG000|Overall Study|Randomized but Never Treated|0|||
147308098|NCT01672853|531294708|FG001|Overall Study|Randomized but Never Treated|0|||
147308099|NCT01672853|531294709|FG002|Overall Study|Randomized but Never Treated|1|||
147308100|NCT00976482|531296153|FG000|Overall Study|Death|208|||
147308101|NCT00976482|531296153|FG000|Overall Study|Withdrawal by Subject|45|||
147308102|NCT00976482|531296153|FG000|Overall Study|Center terminated|1|||
147308103|NCT00976482|531296153|FG000|Overall Study|Protocol Violation|5|||
147308104|NCT00720902|531296154|FG000|Overall Study|Withdrawal by Subject|1|||
147308105|NCT00720902|531296155|FG001|Overall Study|Withdrawal by Subject|0|||
147308106|NCT00720902|531296154|FG000|Overall Study|Unable to perform testing, lack of test agent and the Study terminated|3|||
147308107|NCT00720902|531296155|FG001|Overall Study|Unable to perform testing, lack of test agent and the Study terminated|0|||
147308108|NCT02959671|531296156|FG000|Overall Study|Adverse Event|2|||
147308109|NCT02959671|531296156|FG000|Overall Study|Participants signed a consent; however enrollment was complete before they started study activity.|3|||
147308110|NCT03462706|531296159|FG000|Overall Study|Polyp was pedunculated|1|||
147308111|NCT03462706|531296160|FG001|Overall Study|Polyp was pedunculated|0|||
147219751|NCT00976508|530977125|FG000|Overall Study|Death|7|||
147219752|NCT00976508|530977126|FG001|Overall Study|Death|1|||
147308112|NCT03462706|531296161|FG002|Overall Study|Polyp was pedunculated|1|||
147308113|NCT03462706|531296162|FG003|Overall Study|Polyp was pedunculated|0|||
147552324|NCT02711956|532178575|FG011|Overall Study|PSA progression with radiographic progression|1|||
147219753|NCT00976508|530977125|FG000|Overall Study|Lost to Follow-up|1|||
147219754|NCT00976508|530977126|FG001|Overall Study|Lost to Follow-up|0|||
147219755|NCT00976508|530977125|FG000|Overall Study|Withdrawal by Subject|1|||
147219756|NCT00976508|530977126|FG001|Overall Study|Withdrawal by Subject|0|||
147219757|NCT00976508|530977125|FG000|Overall Study|Disease Progression|4|||
147219758|NCT00976508|530977126|FG001|Overall Study|Disease Progression|4|||
147219759|NCT00976508|530977125|FG000|Overall Study|Subject Enrolled in Hospice|1|||
147219760|NCT00976508|530977126|FG001|Overall Study|Subject Enrolled in Hospice|0|||
147219761|NCT00976508|530977125|FG000|Overall Study|Terminated by the Sponsor|0|||
147219762|NCT00976508|530977126|FG001|Overall Study|Terminated by the Sponsor|1|||
147219763|NCT04352127|530977127|FG000|Overall Study|Unable to obtain readings|4|||
147219764|NCT04352127|530977128|FG001|Overall Study|Unable to obtain readings|1|||
147219765|NCT01992159|530977129|FG000|Overall Study|Withdrawal by Subject|4|||
147219766|NCT01992159|530977130|FG001|Overall Study|Withdrawal by Subject|7|||
147219767|NCT01992159|530977131|FG002|Overall Study|Withdrawal by Subject|0|||
147552325|NCT02711956|532178576|FG012|Overall Study|PSA progression with radiographic progression|2|||
147219768|NCT01992159|530977132|FG003|Overall Study|Withdrawal by Subject|3|||
147219769|NCT01992159|530977129|FG000|Overall Study|Adverse Event|0|||
147219770|NCT01992159|530977130|FG001|Overall Study|Adverse Event|1|||
147308114|NCT03462706|531296159|FG000|Overall Study|Polyp was next to a cancer and not removed|0|||
147308115|NCT03462706|531296160|FG001|Overall Study|Polyp was next to a cancer and not removed|0|||
147308116|NCT03462706|531296161|FG002|Overall Study|Polyp was next to a cancer and not removed|0|||
147552326|NCT02711956|532178577|FG013|Overall Study|PSA progression with radiographic progression|3|||
147219771|NCT01992159|530977131|FG002|Overall Study|Adverse Event|0|||
147308117|NCT03462706|531296162|FG003|Overall Study|Polyp was next to a cancer and not removed|1|||
147308118|NCT02254408|531296169|FG000|Overall Study|Randomized But Not Treated|1|||
147308119|NCT02254408|531296170|FG001|Overall Study|Randomized But Not Treated|3|||
147308120|NCT02254408|531296169|FG000|Overall Study|Adverse Event|1|||
147308121|NCT02254408|531296170|FG001|Overall Study|Adverse Event|0|||
147308122|NCT02254408|531296169|FG000|Overall Study|Death|2|||
147219772|NCT01992159|530977132|FG003|Overall Study|Adverse Event|1|||
147219773|NCT01992159|530977129|FG000|Overall Study|Death|0|||
147219774|NCT01992159|530977130|FG001|Overall Study|Death|0|||
147219775|NCT01992159|530977131|FG002|Overall Study|Death|1|||
147219776|NCT01992159|530977132|FG003|Overall Study|Death|0|||
147219777|NCT01236118|530977135|FG000|Overall Study|Adverse Event|2|||
147219778|NCT01236118|530977136|FG001|Overall Study|Adverse Event|0|||
147219779|NCT01236118|530977137|FG002|Overall Study|Adverse Event|2|||
147219780|NCT01236118|530977135|FG000|Overall Study|Physician Decision|0|||
147219781|NCT01236118|530977136|FG001|Overall Study|Physician Decision|1|||
147219782|NCT01236118|530977137|FG002|Overall Study|Physician Decision|0|||
147219783|NCT01236118|530977135|FG000|Overall Study|Withdrawal by Subject|0|||
147219784|NCT01236118|530977136|FG001|Overall Study|Withdrawal by Subject|0|||
147219785|NCT01236118|530977137|FG002|Overall Study|Withdrawal by Subject|1|||
147219786|NCT04535167|530977138|FG000|Treatment|Adverse Event|0|||
147219787|NCT04535167|530977139|FG001|Treatment|Adverse Event|0|||
147219788|NCT04535167|530977140|FG002|Treatment|Adverse Event|0|||
147219789|NCT04535167|530977141|FG003|Treatment|Adverse Event|0|||
147219790|NCT04535167|530977142|FG004|Treatment|Adverse Event|0|||
147219791|NCT04535167|530977143|FG005|Treatment|Adverse Event|0|||
147219792|NCT04535167|530977144|FG006|Treatment|Adverse Event|1|||
147219793|NCT04535167|530977138|FG000|Follow-Up|Death|0|||
147219794|NCT04535167|530977139|FG001|Follow-Up|Death|0|||
147219795|NCT04535167|530977140|FG002|Follow-Up|Death|0|||
147219796|NCT04535167|530977141|FG003|Follow-Up|Death|0|||
147219797|NCT04535167|530977142|FG004|Follow-Up|Death|0|||
147219798|NCT04535167|530977143|FG005|Follow-Up|Death|0|||
147219799|NCT04535167|530977144|FG006|Follow-Up|Death|1|||
147219800|NCT04535167|530977138|FG000|Follow-Up|Lost to Follow-up|0|||
147219801|NCT04535167|530977139|FG001|Follow-Up|Lost to Follow-up|0|||
147219802|NCT04535167|530977140|FG002|Follow-Up|Lost to Follow-up|0|||
147219803|NCT04535167|530977141|FG003|Follow-Up|Lost to Follow-up|1|||
147219804|NCT04535167|530977142|FG004|Follow-Up|Lost to Follow-up|0|||
147219805|NCT04535167|530977143|FG005|Follow-Up|Lost to Follow-up|0|||
147219806|NCT04535167|530977144|FG006|Follow-Up|Lost to Follow-up|0|||
147219807|NCT00075270|530977145|FG000|Overall Study|Withdrawal by Subject|28|||
147219808|NCT00075270|530977146|FG001|Overall Study|Withdrawal by Subject|21|||
147219809|NCT00075270|530977145|FG000|Overall Study|Lost to Follow-up|25|||
147219810|NCT00075270|530977146|FG001|Overall Study|Lost to Follow-up|28|||
147219811|NCT00075270|530977145|FG000|Overall Study|Protocol Violation|0|||
147219812|NCT00075270|530977146|FG001|Overall Study|Protocol Violation|2|||
147219813|NCT00075270|530977145|FG000|Overall Study|Death|198|||
147219814|NCT00075270|530977146|FG001|Overall Study|Death|215|||
147219815|NCT00075270|530977145|FG000|Overall Study|Other/Unknown|9|||
147219816|NCT00075270|530977146|FG001|Overall Study|Other/Unknown|5|||
147219817|NCT00075270|530977145|FG000|Overall Study|Missing|26|||
147219818|NCT00075270|530977146|FG001|Overall Study|Missing|13|||
147219819|NCT02160002|530977147|FG000|Overall Study|Withdrawal by Subject|2|||
147219820|NCT02160002|530977148|FG001|Overall Study|Withdrawal by Subject|1|||
147219821|NCT05028361|530977151|FG000|Overall Study|Withdrawal by Subject|1|||
147219822|NCT05028361|530977152|FG001|Overall Study|Withdrawal by Subject|0|||
147219823|NCT01993836|530977153|FG000|Overall Study|Surgery Cancelled|3|||
147219824|NCT01993836|530977154|FG001|Overall Study|Surgery Cancelled|0|||
147219825|NCT01993836|530977155|FG002|Overall Study|Surgery Cancelled|0|||
147219826|NCT01993836|530977153|FG000|Overall Study|Physician Decision|2|||
147308123|NCT02254408|531296170|FG001|Overall Study|Death|3|||
147308124|NCT02254408|531296169|FG000|Overall Study|Investigator's Discretion|0|||
147308125|NCT02254408|531296170|FG001|Overall Study|Investigator's Discretion|1|||
147308126|NCT02254408|531296169|FG000|Overall Study|Withdrawal by Subject|3|||
147443083|NCT03703882|531787159|FG001|Overall Study|noncompliance with study procedures|1|||
147219827|NCT01993836|530977154|FG001|Overall Study|Physician Decision|1|||
147219828|NCT01993836|530977155|FG002|Overall Study|Physician Decision|0|||
147219829|NCT01993836|530977153|FG000|Overall Study|Death|0|||
147219830|NCT01993836|530977154|FG001|Overall Study|Death|2|||
147219831|NCT01993836|530977155|FG002|Overall Study|Death|0|||
147219832|NCT01993836|530977153|FG000|Overall Study|Withdrawal by Subject|12|||
147219833|NCT01993836|530977154|FG001|Overall Study|Withdrawal by Subject|10|||
147219834|NCT01993836|530977155|FG002|Overall Study|Withdrawal by Subject|5|||
147443084|NCT01617460|531787160|FG000|Overall Study|Adverse Event|10|||
147219835|NCT00686634|530977156|FG000|Overall Study|Protocol Violation|6|||
147219836|NCT00779259|530977157|FG000|Quinine Alone|Adverse Event|2|||
147219837|NCT03312751|530977160|FG000|Overall Study|Death|7|||
147219838|NCT03312751|530977161|FG001|Overall Study|Death|9|||
147219839|NCT03312751|530977160|FG000|Overall Study|Study discontinuation due to other reason|0|||
147308127|NCT02254408|531296170|FG001|Overall Study|Withdrawal by Subject|3|||
147308128|NCT02254408|531296169|FG000|Overall Study|Lost to Follow-up|1|||
147308129|NCT02254408|531296170|FG001|Overall Study|Lost to Follow-up|0|||
147308130|NCT01161472|531296174|FG000|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|1|||
147308131|NCT01161472|531296175|FG001|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|0|||
147308132|NCT01161472|531296176|FG002|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|0|||
147308133|NCT01161472|531296177|FG003|Washout Period (At Least 3 to 6 Days)|Withdrawal by Subject|0|||
147308134|NCT02914184|531296179|FG000|Overall Study|Lost to Follow-up|7|||
147308135|NCT02914184|531296180|FG001|Overall Study|Lost to Follow-up|10|||
147308136|NCT02914184|531296181|FG002|Overall Study|Lost to Follow-up|8|||
147308137|NCT02914184|531296182|FG003|Overall Study|Lost to Follow-up|7|||
147308138|NCT02914184|531296179|FG000|Overall Study|Withdrawal by Subject|4|||
147308139|NCT02914184|531296180|FG001|Overall Study|Withdrawal by Subject|2|||
147308140|NCT02914184|531296181|FG002|Overall Study|Withdrawal by Subject|7|||
147308141|NCT02914184|531296182|FG003|Overall Study|Withdrawal by Subject|3|||
147308142|NCT02914184|531296179|FG000|Overall Study|Other|1|||
147308143|NCT02914184|531296180|FG001|Overall Study|Other|0|||
147308144|NCT02914184|531296181|FG002|Overall Study|Other|0|||
147308145|NCT02914184|531296182|FG003|Overall Study|Other|0|||
147308146|NCT02914184|531296179|FG000|Overall Study|Migrated/moved from the study area|2|||
147308147|NCT02914184|531296180|FG001|Overall Study|Migrated/moved from the study area|1|||
147308148|NCT02914184|531296181|FG002|Overall Study|Migrated/moved from the study area|2|||
147308149|NCT02914184|531296182|FG003|Overall Study|Migrated/moved from the study area|1|||
147308150|NCT00798174|531296183|FG000|Overall Study|inability to implant azygos coil|3|||
147308151|NCT00798174|531296184|FG001|Overall Study|inability to implant azygos coil|3|||
147308152|NCT00798174|531296183|FG000|Overall Study|Inability to sedate for DFT testing|1|||
147308153|NCT00798174|531296184|FG001|Overall Study|Inability to sedate for DFT testing|0|||
147308154|NCT00768430|531296185|FG000|7 Day Endpoint|Withdrawal by Subject|2|||
147308155|NCT00768430|531296186|FG001|7 Day Endpoint|Withdrawal by Subject|3|||
147308156|NCT00802659|531296187|FG000|Overall Study|Physician Decision|0|||
147308157|NCT00802659|531296188|FG001|Overall Study|Physician Decision|1|||
147308158|NCT00802659|531296189|FG002|Overall Study|Physician Decision|0|||
147308159|NCT00802659|531296190|FG003|Overall Study|Physician Decision|0|||
147308160|NCT03093428|531296192|FG000|Overall Study|Not eligible for treatment|2|||
147308161|NCT03093428|531296193|FG001|Overall Study|Not eligible for treatment|1|||
147308162|NCT03093428|531296192|FG000|Overall Study|Progression|14|||
147308163|NCT03093428|531296193|FG001|Overall Study|Progression|4|||
147308164|NCT03093428|531296192|FG000|Overall Study|Death|1|||
147308165|NCT03093428|531296193|FG001|Overall Study|Death|0|||
147308166|NCT03093428|531296192|FG000|Overall Study|Adverse Event|1|||
147308167|NCT03093428|531296193|FG001|Overall Study|Adverse Event|0|||
147308168|NCT03093428|531296192|FG000|Overall Study|Withdrawal by Subject|1|||
147308169|NCT03093428|531296193|FG001|Overall Study|Withdrawal by Subject|1|||
147308170|NCT05340751|531296195|FG000|Overall Study|Physician Decision|3|||
147308171|NCT00067990|531296196|FG000|Overall Study|Death|5|||
147308172|NCT00067990|531296197|FG001|Overall Study|Death|7|||
147308173|NCT00067990|531296196|FG000|Overall Study|ESRD, Non IF/TA|1|||
147308174|NCT00067990|531296197|FG001|Overall Study|ESRD, Non IF/TA|3|||
147308175|NCT00067990|531296196|FG000|Overall Study|Withdrawal by Subject|4|||
147308176|NCT00067990|531296197|FG001|Overall Study|Withdrawal by Subject|12|||
147308177|NCT02176421|531296198|FG000|Overall Study|Lost to Follow-up|4|||
147308178|NCT02176421|531296198|FG000|Overall Study|Adverse Event|1|||
147308179|NCT03810313|531296201|FG000|Overall Study|Study terminated by sponsor|164|||
147308180|NCT03810313|531296202|FG001|Overall Study|Study terminated by sponsor|159|||
147308181|NCT03810313|531296201|FG000|Overall Study|Subject decision|10|||
147308182|NCT03810313|531296202|FG001|Overall Study|Subject decision|11|||
147308183|NCT03810313|531296201|FG000|Overall Study|Lost to Follow-up|3|||
147308184|NCT03810313|531296202|FG001|Overall Study|Lost to Follow-up|3|||
147308185|NCT03810313|531296201|FG000|Overall Study|Adverse Event|2|||
147308186|NCT03810313|531296202|FG001|Overall Study|Adverse Event|1|||
147308187|NCT03810313|531296201|FG000|Overall Study|Death|2|||
147649963|NCT00703118|532539769|FG001|Overall Study|Subject Ineligible To Continue The Trial|3|||
147308188|NCT03810313|531296202|FG001|Overall Study|Death|1|||
147308189|NCT03810313|531296201|FG000|Overall Study|Physician Decision|0|||
147308190|NCT03810313|531296202|FG001|Overall Study|Physician Decision|1|||
147308191|NCT03820323|531296203|FG000|Overall Study|Lost to Follow-up|2|||
147443085|NCT01617460|531787160|FG000|Overall Study|Physician Decision|16|||
147443086|NCT01617460|531787160|FG000|Overall Study|Protocol Violation|5|||
147443087|NCT01617460|531787160|FG000|Overall Study|Withdrawal by Subject|9|||
147308192|NCT03820323|531296204|FG001|Overall Study|Lost to Follow-up|1|||
147308193|NCT03820323|531296203|FG000|Overall Study|Missed 12-month visit|22|||
147308194|NCT03820323|531296204|FG001|Overall Study|Missed 12-month visit|14|||
147308195|NCT03820323|531296203|FG000|Overall Study|Death|2|||
147308196|NCT03820323|531296204|FG001|Overall Study|Death|1|||
147308197|NCT03820323|531296203|FG000|Overall Study|Transferred out|13|||
147308198|NCT03820323|531296204|FG001|Overall Study|Transferred out|11|||
147308199|NCT03820323|531296203|FG000|Overall Study|Terminated|0|||
147308200|NCT03820323|531296204|FG001|Overall Study|Terminated|3|||
147308201|NCT03820323|531296203|FG000|Overall Study|Withdrawal by Subject|1|||
147308202|NCT03820323|531296204|FG001|Overall Study|Withdrawal by Subject|6|||
147308203|NCT01617005|531296205|FG000|Overall Study|Pregnancy|1|||
147308204|NCT01617005|531296205|FG000|Overall Study|Lack of motivation for treatment|1|||
147308205|NCT01320735|531296206|FG000|Overall Study|Adverse Event|3|||
147308206|NCT01320735|531296206|FG000|Overall Study|Withdrawal by Subject|3|||
147308207|NCT01320735|531296206|FG000|Overall Study|Lost to Follow-up|13|||
147308208|NCT01320735|531296206|FG000|Overall Study|Administrative Reason|6|||
147308209|NCT01320735|531296206|FG000|Overall Study|Progression/Hormone-Refractory Pca|55|||
147308210|NCT01320735|531296206|FG000|Overall Study|Protocol Violation|1|||
147308211|NCT01320735|531296206|FG000|Overall Study|Other|1|||
147308212|NCT01320735|531296206|FG000|Overall Study|No Decrease of Prostate Specific Antigen|7|||
147308213|NCT01320735|531296206|FG000|Overall Study|Investigator Unable to be Contacted|17|||
147308214|NCT02307513|531296207|FG000|Placebo Controlled Phase (Weeks 0-12)|Adverse Event|4|||
147308215|NCT02307513|531296208|FG001|Placebo Controlled Phase (Weeks 0-12)|Adverse Event|3|||
147308216|NCT02307513|531296207|FG000|Placebo Controlled Phase (Weeks 0-12)|Lack of Efficacy|8|||
147308217|NCT02307513|531296208|FG001|Placebo Controlled Phase (Weeks 0-12)|Lack of Efficacy|0|||
147308218|NCT02307513|531296207|FG000|Placebo Controlled Phase (Weeks 0-12)|Non-Compliance with Study Drug|1|||
147308219|NCT02307513|531296208|FG001|Placebo Controlled Phase (Weeks 0-12)|Non-Compliance with Study Drug|0|||
147308220|NCT02307513|531296207|FG000|Placebo Controlled Phase (Weeks 0-12)|Withdrawal by Subject|5|||
147308221|NCT02307513|531296208|FG001|Placebo Controlled Phase (Weeks 0-12)|Withdrawal by Subject|4|||
147308222|NCT02307513|531296207|FG000|Placebo Controlled Phase (Weeks 0-12)|Lost to Follow-up|1|||
147308223|NCT02307513|531296208|FG001|Placebo Controlled Phase (Weeks 0-12)|Lost to Follow-up|0|||
147308224|NCT02307513|531296207|FG000|Placebo Controlled Phase (Weeks 0-12)|Protocol Violation|1|||
147308225|NCT02307513|531296208|FG001|Placebo Controlled Phase (Weeks 0-12)|Protocol Violation|1|||
147308226|NCT02307513|531296207|FG000|Active Treatment Phase (Weeks 13-64)|Miscellaneous|0|||
147308227|NCT02307513|531296208|FG001|Active Treatment Phase (Weeks 13-64)|Miscellaneous|1|||
147308228|NCT02307513|531296207|FG000|Active Treatment Phase (Weeks 13-64)|Adverse Event|4|||
147308229|NCT02307513|531296208|FG001|Active Treatment Phase (Weeks 13-64)|Adverse Event|9|||
147308230|NCT02307513|531296207|FG000|Active Treatment Phase (Weeks 13-64)|Lack of Efficacy|2|||
147308231|NCT02307513|531296208|FG001|Active Treatment Phase (Weeks 13-64)|Lack of Efficacy|2|||
147308232|NCT02307513|531296207|FG000|Active Treatment Phase (Weeks 13-64)|Withdrawal by Subject|7|||
147308233|NCT02307513|531296208|FG001|Active Treatment Phase (Weeks 13-64)|Withdrawal by Subject|7|||
147308234|NCT02307513|531296207|FG000|Active Treatment Phase (Weeks 13-64)|Lost to Follow-up|1|||
147308235|NCT02307513|531296208|FG001|Active Treatment Phase (Weeks 13-64)|Lost to Follow-up|1|||
147308236|NCT02307513|531296207|FG000|Active Treatment Phase (Weeks 13-64)|Pregnancy|1|||
147308237|NCT02307513|531296208|FG001|Active Treatment Phase (Weeks 13-64)|Pregnancy|0|||
147308238|NCT02307513|531296207|FG000|Long-term Extension|Physician Decision|1|||
147308239|NCT02307513|531296208|FG001|Long-term Extension|Physician Decision|0|||
147308240|NCT05952297|531296210|FG000|Overall Study|Withdrawal by Subject|1|||
147308241|NCT05952297|531296211|FG001|Overall Study|Withdrawal by Subject|0|||
147308242|NCT01107743|531296214|FG000|Overall Study|Protocol Violation|46|||
147308243|NCT00308737|531296215|FG000|Overall Study|Adverse Event|104|||
147308244|NCT00308737|531296216|FG001|Overall Study|Adverse Event|9|||
147308245|NCT00308737|531296217|FG002|Overall Study|Adverse Event|0|||
147308246|NCT00308737|531296215|FG000|Overall Study|Death|4|||
147308247|NCT00308737|531296216|FG001|Overall Study|Death|3|||
147308248|NCT00308737|531296217|FG002|Overall Study|Death|0|||
147308249|NCT00308737|531296215|FG000|Overall Study|Lost to Follow-up|56|||
147308250|NCT00308737|531296216|FG001|Overall Study|Lost to Follow-up|80|||
147308251|NCT00308737|531296217|FG002|Overall Study|Lost to Follow-up|5|||
147308252|NCT00308737|531296215|FG000|Overall Study|Physician Decision|15|||
147308253|NCT00308737|531296216|FG001|Overall Study|Physician Decision|2|||
147308254|NCT00308737|531296217|FG002|Overall Study|Physician Decision|1|||
147308255|NCT00308737|531296215|FG000|Overall Study|Protocol Violation|34|||
147308256|NCT00308737|531296216|FG001|Overall Study|Protocol Violation|9|||
147308257|NCT00308737|531296217|FG002|Overall Study|Protocol Violation|5|||
147308258|NCT00308737|531296215|FG000|Overall Study|Withdrawal by Subject|218|||
147308259|NCT00308737|531296216|FG001|Overall Study|Withdrawal by Subject|166|||
147308260|NCT00308737|531296217|FG002|Overall Study|Withdrawal by Subject|18|||
147443088|NCT00457015|531787164|FG000|Overall Study|Left study site against medical advice|0|||
147308261|NCT00308737|531296215|FG000|Overall Study|Various|32|||
147308262|NCT00308737|531296216|FG001|Overall Study|Various|20|||
147308263|NCT00308737|531296217|FG002|Overall Study|Various|8|||
147308264|NCT01225822|531296218|FG000|Overall Study|Adverse Event|13|||
147308265|NCT01225822|531296219|FG001|Overall Study|Adverse Event|31|||
147308266|NCT01225822|531296220|FG002|Overall Study|Adverse Event|18|||
147308267|NCT01225822|531296221|FG003|Overall Study|Adverse Event|23|||
147308268|NCT01225822|531296222|FG004|Overall Study|Adverse Event|14|||
147308269|NCT01225822|531296218|FG000|Overall Study|Protocol Violation|6|||
147308270|NCT01225822|531296219|FG001|Overall Study|Protocol Violation|8|||
147308271|NCT01225822|531296220|FG002|Overall Study|Protocol Violation|6|||
147308272|NCT01225822|531296221|FG003|Overall Study|Protocol Violation|7|||
147308273|NCT01225822|531296222|FG004|Overall Study|Protocol Violation|4|||
147308274|NCT01225822|531296218|FG000|Overall Study|Lost to Follow-up|0|||
147308275|NCT01225822|531296219|FG001|Overall Study|Lost to Follow-up|0|||
147308276|NCT01225822|531296220|FG002|Overall Study|Lost to Follow-up|0|||
147308277|NCT01225822|531296221|FG003|Overall Study|Lost to Follow-up|1|||
147308278|NCT01225822|531296222|FG004|Overall Study|Lost to Follow-up|0|||
147308279|NCT01225822|531296218|FG000|Overall Study|Withdrawal by Subject|6|||
147308280|NCT01225822|531296219|FG001|Overall Study|Withdrawal by Subject|7|||
147308281|NCT01225822|531296220|FG002|Overall Study|Withdrawal by Subject|7|||
147308282|NCT01225822|531296221|FG003|Overall Study|Withdrawal by Subject|11|||
147308283|NCT01225822|531296222|FG004|Overall Study|Withdrawal by Subject|6|||
147308284|NCT01225822|531296218|FG000|Overall Study|Other|13|||
147308285|NCT01225822|531296219|FG001|Overall Study|Other|10|||
147308286|NCT01225822|531296220|FG002|Overall Study|Other|7|||
147308287|NCT01225822|531296221|FG003|Overall Study|Other|10|||
147308288|NCT01225822|531296222|FG004|Overall Study|Other|7|||
147308289|NCT01290822|531296223|FG000|Overall Study|Withdrawal by Subject|1|||
147308290|NCT01290822|531296223|FG000|Overall Study|Physician Decision|10|||
147308291|NCT01003639|531296224|FG000|Overall Study|Lost to Follow-up|6|||
147308292|NCT01003639|531296225|FG001|Overall Study|Lost to Follow-up|9|||
147308293|NCT01003639|531296224|FG000|Overall Study|Withdrawal by Subject|9|||
147308294|NCT01003639|531296225|FG001|Overall Study|Withdrawal by Subject|5|||
147308295|NCT01003639|531296224|FG000|Overall Study|Lack of Efficacy|1|||
147308296|NCT01003639|531296225|FG001|Overall Study|Lack of Efficacy|6|||
147308297|NCT01003639|531296224|FG000|Overall Study|Adverse Event|0|||
147308298|NCT01003639|531296225|FG001|Overall Study|Adverse Event|1|||
147308299|NCT01003639|531296224|FG000|Overall Study|Protocol Violation|0|||
147308300|NCT01003639|531296225|FG001|Overall Study|Protocol Violation|1|||
147308301|NCT01003639|531296224|FG000|Overall Study|Physician Decision|1|||
147219840|NCT03312751|530977161|FG001|Overall Study|Study discontinuation due to other reason|1|||
147219841|NCT01107379|530977165|FG000|Overall Study|Withdrawal by Subject|18|||
147219842|NCT01107379|530977165|FG000|Overall Study|Lost to Follow-up|3|||
147219843|NCT04559529|530977166|FG000|First Intervention (1 Day)|Adverse Event|0|||
147219844|NCT04559529|530977167|FG001|First Intervention (1 Day)|Adverse Event|0|||
147219845|NCT04559529|530977168|FG002|First Intervention (1 Day)|Adverse Event|0|||
147219846|NCT04559529|530977169|FG003|First Intervention (1 Day)|Adverse Event|1|||
147219847|NCT04559529|530977166|FG000|First Intervention (1 Day)|Withdrawn due to inability to complete imaging|0|||
147219848|NCT04559529|530977167|FG001|First Intervention (1 Day)|Withdrawn due to inability to complete imaging|0|||
147219849|NCT04559529|530977168|FG002|First Intervention (1 Day)|Withdrawn due to inability to complete imaging|1|||
147219850|NCT04559529|530977169|FG003|First Intervention (1 Day)|Withdrawn due to inability to complete imaging|0|||
147219851|NCT04559529|530977166|FG000|Second Intervention (1 Day)|Lost to Follow-up|0|||
147219852|NCT04559529|530977167|FG001|Second Intervention (1 Day)|Lost to Follow-up|0|||
147219853|NCT04559529|530977168|FG002|Second Intervention (1 Day)|Lost to Follow-up|1|||
147219854|NCT04559529|530977169|FG003|Second Intervention (1 Day)|Lost to Follow-up|0|||
147219855|NCT01203852|530977172|FG000|Metoprolol 8 Weeks|Physician Decision|470|||
147219856|NCT01203852|530977172|FG000|Washout 2 Weeks|Physician Decision|46|||
147219857|NCT02582684|530977173|FG000|Overall Study|Unable to contact subject/parent|4|||
147219858|NCT02582684|530977173|FG000|Overall Study|Subject not able to get to clinic|10|||
147219859|NCT02582684|530977173|FG000|Overall Study|Subject withdrew consent|1|||
147219860|NCT02582684|530977173|FG000|Overall Study|Found to be ineligible after enrollment|2|||
147219861|NCT01738477|530977178|FG000|Overall Study|Lost to Follow-up|1|||
147219862|NCT01738477|530977179|FG001|Overall Study|Lost to Follow-up|4|||
147219863|NCT01302834|530977180|FG000|Overall Study|Protocol Violation|17|||
147219864|NCT01302834|530977181|FG001|Overall Study|Protocol Violation|23|||
147219865|NCT01302834|530977180|FG000|Overall Study|HIV positive|1|||
147219866|NCT01302834|530977181|FG001|Overall Study|HIV positive|3|||
147219867|NCT00899392|530977182|FG000|Overall Study|Subject didn't finish/partial pilot data|21|||
147219868|NCT00899392|530977183|FG001|Overall Study|Subject didn't finish/partial pilot data|24|||
147219869|NCT02437110|530977184|FG000|Screening|Lost to Follow-up|3|||
147219870|NCT02437110|530977184|FG000|Screening|Physician Decision|1|||
147219871|NCT02437110|530977184|FG000|ART|Adverse Event|3|||
147219872|NCT02437110|530977184|FG000|ART|Protocol Violation|3|||
147219873|NCT02437110|530977184|FG000|ART|Withdrawal by Subject|4|||
147219874|NCT02437110|530977184|FG000|ART|Lost to follow-up prior to start of intervention|1|||
147308302|NCT01003639|531296225|FG001|Overall Study|Physician Decision|0|||
147308303|NCT00284089|531296228|FG000|Multiple Dose Phase|Adverse Event|1|||
147308304|NCT00284089|531296229|FG001|Multiple Dose Phase|Adverse Event|0|||
147308305|NCT00284089|531296230|FG002|Multiple Dose Phase|Adverse Event|1|||
147219875|NCT02437110|530977184|FG000|ART|Physician decision prior to start of intervention|2|||
147219876|NCT02437110|530977184|FG000|ART|Withdrawal by subject prior to starting intervention|1|||
147219877|NCT02437110|530977184|FG000|Post-ART|Lost to Follow-up|3|||
147219878|NCT02437110|530977184|FG000|Post-ART|Protocol Violation|4|||
147308306|NCT00284089|531296231|FG003|Multiple Dose Phase|Adverse Event|1|||
147308307|NCT00284089|531296228|FG000|Multiple Dose Phase|Protocol Violation|0|||
147308308|NCT00284089|531296229|FG001|Multiple Dose Phase|Protocol Violation|0|||
147308309|NCT00284089|531296230|FG002|Multiple Dose Phase|Protocol Violation|1|||
147308310|NCT00284089|531296231|FG003|Multiple Dose Phase|Protocol Violation|0|||
147308311|NCT00284089|531296228|FG000|Multiple Dose Phase|Withdrawal by Subject|0|||
147308312|NCT00284089|531296229|FG001|Multiple Dose Phase|Withdrawal by Subject|0|||
147308313|NCT00284089|531296230|FG002|Multiple Dose Phase|Withdrawal by Subject|1|||
147308314|NCT00284089|531296231|FG003|Multiple Dose Phase|Withdrawal by Subject|2|||
147308315|NCT00284089|531296228|FG000|Multiple Dose Phase|Death|0|||
147308316|NCT00284089|531296229|FG001|Multiple Dose Phase|Death|0|||
147219879|NCT02437110|530977184|FG000|Post-ART|Withdrawal by Subject|3|||
147219880|NCT01431638|530977185|FG000|Overall Study|Adverse Event|1|||
147219881|NCT01431638|530977186|FG001|Overall Study|Adverse Event|3|||
147219882|NCT01431638|530977187|FG002|Overall Study|Adverse Event|1|||
147219883|NCT01431638|530977185|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
147219884|NCT01431638|530977186|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
147219885|NCT01431638|530977187|FG002|Overall Study|Unsatisfactory therapeutic effect|4|||
147219886|NCT01431638|530977185|FG000|Overall Study|Participants condition no longer requires study drug|0|||
147219887|NCT01431638|530977186|FG001|Overall Study|Participants condition no longer requires study drug|1|||
147219888|NCT01431638|530977187|FG002|Overall Study|Participants condition no longer requires study drug|0|||
147219889|NCT01431638|530977185|FG000|Overall Study|Participant withdrew consent|14|||
147219890|NCT01431638|530977186|FG001|Overall Study|Participant withdrew consent|5|||
147219891|NCT01431638|530977187|FG002|Overall Study|Participant withdrew consent|8|||
147219892|NCT01431638|530977185|FG000|Overall Study|Lost to Follow-up|7|||
147219893|NCT01431638|530977186|FG001|Overall Study|Lost to Follow-up|9|||
147219894|NCT01431638|530977187|FG002|Overall Study|Lost to Follow-up|7|||
147219895|NCT01431638|530977185|FG000|Overall Study|Administrative problems|1|||
147219896|NCT01431638|530977186|FG001|Overall Study|Administrative problems|4|||
147219897|NCT01431638|530977187|FG002|Overall Study|Administrative problems|6|||
147219898|NCT01431638|530977185|FG000|Overall Study|Death|1|||
147219899|NCT01431638|530977186|FG001|Overall Study|Death|0|||
147219900|NCT01431638|530977187|FG002|Overall Study|Death|0|||
147219901|NCT01431638|530977185|FG000|Overall Study|Protocol deviation|1|||
147219902|NCT01431638|530977186|FG001|Overall Study|Protocol deviation|1|||
147219903|NCT01431638|530977187|FG002|Overall Study|Protocol deviation|4|||
147552327|NCT02711956|532178578|FG014|Overall Study|PSA progression with radiographic progression|3|||
147552328|NCT01625377|532178581|FG000|Overall Study|Death|1|||
147552329|NCT01625377|532178582|FG001|Overall Study|Death|1|||
147552330|NCT01625377|532178581|FG000|Overall Study|Administrative Problem|1|||
147552331|NCT01625377|532178582|FG001|Overall Study|Administrative Problem|1|||
147552332|NCT01625377|532178581|FG000|Overall Study|Protocol Violation|0|||
147552333|NCT01625377|532178582|FG001|Overall Study|Protocol Violation|3|||
147552334|NCT01625377|532178581|FG000|Overall Study|Adverse Event|3|||
147552335|NCT01625377|532178582|FG001|Overall Study|Adverse Event|16|||
147552336|NCT01625377|532178581|FG000|Overall Study|Graft loss|1|||
147552337|NCT01625377|532178582|FG001|Overall Study|Graft loss|0|||
147552338|NCT01625377|532178581|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
147552339|NCT01625377|532178582|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
147552340|NCT01625377|532178581|FG000|Overall Study|Abnormal laboratory values|1|||
147552341|NCT01625377|532178582|FG001|Overall Study|Abnormal laboratory values|0|||
147552342|NCT02043366|532178583|FG000|Overall Study|Lost to Follow-up|2|||
147552343|NCT02043366|532178584|FG001|Overall Study|Lost to Follow-up|2|||
147552344|NCT02043366|532178585|FG002|Overall Study|Lost to Follow-up|2|||
147552345|NCT02043366|532178586|FG003|Overall Study|Lost to Follow-up|2|||
147552346|NCT02043366|532178587|FG004|Overall Study|Lost to Follow-up|2|||
147552347|NCT02043366|532178588|FG005|Overall Study|Lost to Follow-up|2|||
147219904|NCT01431638|530977185|FG000|Overall Study|Participants Did not enter extension study from core study|39|||
147219905|NCT01431638|530977186|FG001|Overall Study|Participants Did not enter extension study from core study|46|||
147219906|NCT01431638|530977187|FG002|Overall Study|Participants Did not enter extension study from core study|32|||
147219907|NCT01261780|530977188|FG000|Overall Study|Withdrawal by Subject|1|||
147219908|NCT01261780|530977189|FG001|Overall Study|Withdrawal by Subject|0|||
147219909|NCT01261780|530977188|FG000|Overall Study|Event not related to subject|1|||
147219910|NCT01261780|530977189|FG001|Overall Study|Event not related to subject|2|||
147219911|NCT03562767|530977190|FG000|Overall Study|Physician Decision|2|||
147219912|NCT03562767|530977191|FG001|Overall Study|Physician Decision|0|||
147219913|NCT03562767|530977192|FG002|Overall Study|Physician Decision|0|||
147219914|NCT03562767|530977190|FG000|Overall Study|Logistic Reason|1|||
147219915|NCT03562767|530977191|FG001|Overall Study|Logistic Reason|3|||
147308317|NCT00284089|531296230|FG002|Multiple Dose Phase|Death|1|||
147308318|NCT00284089|531296231|FG003|Multiple Dose Phase|Death|1|||
147308319|NCT00284089|531296228|FG000|Extension Phase|Adverse Event|0|||
147308320|NCT00284089|531296229|FG001|Extension Phase|Adverse Event|0|||
147308321|NCT00284089|531296230|FG002|Extension Phase|Adverse Event|2|||
147552348|NCT01489956|532178591|FG000|Overall Study|Lost to Follow-up|1|||
147552349|NCT01489956|532178592|FG001|Overall Study|Lost to Follow-up|0|||
147649964|NCT00703118|532539770|FG002|Overall Study|Subject Ineligible To Continue The Trial|2|||
147552350|NCT01489956|532178593|FG002|Overall Study|Lost to Follow-up|0|||
147552351|NCT01489956|532178591|FG000|Overall Study|Withdrawal by Subject|0|||
147552352|NCT01489956|532178592|FG001|Overall Study|Withdrawal by Subject|0|||
147308322|NCT00284089|531296231|FG003|Extension Phase|Adverse Event|2|||
147308323|NCT00284089|531296228|FG000|Extension Phase|condition no longer requires study drug|2|||
147308324|NCT00284089|531296229|FG001|Extension Phase|condition no longer requires study drug|0|||
147308325|NCT00284089|531296230|FG002|Extension Phase|condition no longer requires study drug|2|||
147308326|NCT00284089|531296231|FG003|Extension Phase|condition no longer requires study drug|7|||
147308327|NCT00284089|531296228|FG000|Extension Phase|Protocol Violation|0|||
147308328|NCT00284089|531296229|FG001|Extension Phase|Protocol Violation|0|||
147308329|NCT00284089|531296230|FG002|Extension Phase|Protocol Violation|1|||
147308330|NCT00284089|531296231|FG003|Extension Phase|Protocol Violation|0|||
147308331|NCT00284089|531296228|FG000|Extension Phase|Withdrawal by Subject|0|||
147308332|NCT00284089|531296229|FG001|Extension Phase|Withdrawal by Subject|0|||
147308333|NCT00284089|531296230|FG002|Extension Phase|Withdrawal by Subject|1|||
147308334|NCT00284089|531296231|FG003|Extension Phase|Withdrawal by Subject|3|||
147308335|NCT00089895|531296232|FG000|Overall Study|Consent Withdrawn|11|||
147308336|NCT00089895|531296233|FG001|Overall Study|Consent Withdrawn|14|||
147308337|NCT00089895|531296232|FG000|Overall Study|Technical reason|7|||
147308338|NCT00089895|531296233|FG001|Overall Study|Technical reason|2|||
147308339|NCT00089895|531296232|FG000|Overall Study|Surgery|0|||
147308340|NCT00089895|531296233|FG001|Overall Study|Surgery|1|||
147308341|NCT00089895|531296232|FG000|Overall Study|Bleeding|0|||
147308342|NCT00089895|531296233|FG001|Overall Study|Bleeding|2|||
147308343|NCT00089895|531296232|FG000|Overall Study|Physician Decision|3|||
147308344|NCT00089895|531296233|FG001|Overall Study|Physician Decision|7|||
147308345|NCT00089895|531296232|FG000|Overall Study|Exclusion criteria met|6|||
147308346|NCT00089895|531296233|FG001|Overall Study|Exclusion criteria met|6|||
147308347|NCT00089895|531296232|FG000|Overall Study|Not otherwise specified|4|||
147308348|NCT00089895|531296233|FG001|Overall Study|Not otherwise specified|8|||
147308349|NCT00089895|531296232|FG000|Overall Study|Missing|4|||
147308350|NCT00089895|531296233|FG001|Overall Study|Missing|2|||
147308351|NCT02778399|531296234|FG000|Up to Week 12 Treatment Period|Adverse Event|1|||
147308352|NCT02778399|531296235|FG001|Up to Week 12 Treatment Period|Adverse Event|2|||
147308353|NCT02778399|531296236|FG002|Up to Week 12 Treatment Period|Adverse Event|3|||
147308354|NCT02778399|531296237|FG003|Up to Week 12 Treatment Period|Adverse Event|2|||
147308355|NCT02778399|531296238|FG004|Up to Week 12 Treatment Period|Adverse Event|3|||
147308356|NCT02778399|531296239|FG005|Up to Week 12 Treatment Period|Adverse Event|3|||
147308357|NCT02778399|531296234|FG000|Up to Week 12 Treatment Period|Withdrawal by Subject|5|||
147308358|NCT02778399|531296235|FG001|Up to Week 12 Treatment Period|Withdrawal by Subject|2|||
147308359|NCT02778399|531296236|FG002|Up to Week 12 Treatment Period|Withdrawal by Subject|1|||
147308360|NCT02778399|531296237|FG003|Up to Week 12 Treatment Period|Withdrawal by Subject|4|||
147308361|NCT02778399|531296238|FG004|Up to Week 12 Treatment Period|Withdrawal by Subject|2|||
147308362|NCT02778399|531296239|FG005|Up to Week 12 Treatment Period|Withdrawal by Subject|3|||
147219916|NCT03562767|530977192|FG002|Overall Study|Logistic Reason|0|||
147219917|NCT02048241|530977193|FG000|Overall Study|Withdrawal by Subject|0|||
147219918|NCT02048241|530977194|FG001|Overall Study|Withdrawal by Subject|1|||
147219919|NCT04658940|530977198|FG000|Overall Study|Withdrawal by Subject|1|||
147308363|NCT02778399|531296234|FG000|Up to Week 12 Treatment Period|Protocol Violation|0|||
147308364|NCT02778399|531296235|FG001|Up to Week 12 Treatment Period|Protocol Violation|0|||
147308365|NCT02778399|531296236|FG002|Up to Week 12 Treatment Period|Protocol Violation|0|||
147308366|NCT02778399|531296237|FG003|Up to Week 12 Treatment Period|Protocol Violation|0|||
147308367|NCT02778399|531296238|FG004|Up to Week 12 Treatment Period|Protocol Violation|1|||
147308368|NCT02778399|531296239|FG005|Up to Week 12 Treatment Period|Protocol Violation|0|||
147308369|NCT02778399|531296234|FG000|Up to Week 12 Treatment Period|Lost to Follow-up|3|||
147308370|NCT02778399|531296235|FG001|Up to Week 12 Treatment Period|Lost to Follow-up|0|||
147308371|NCT02778399|531296236|FG002|Up to Week 12 Treatment Period|Lost to Follow-up|0|||
147219920|NCT01700439|530977204|FG000|Overall Study|Lost to Follow-up|47|||
147219921|NCT01700439|530977204|FG000|Overall Study|Withdrawal by Subject|183|||
147219922|NCT01700439|530977204|FG000|Overall Study|Death|186|||
147219923|NCT01829243|530977211|FG000|First Intervention|Screen Failure|4|||
147219924|NCT01829243|530977212|FG001|First Intervention|Screen Failure|2|||
147219925|NCT00053898|530977217|FG000|Overall Study|No follow-up data from any source|9|||
147219926|NCT00053898|530977218|FG001|Overall Study|No follow-up data from any source|12|||
147219927|NCT00053898|530977217|FG000|Overall Study|Follow-up from telephone contact only|5|||
147219928|NCT00053898|530977218|FG001|Overall Study|Follow-up from telephone contact only|1|||
147219929|NCT00266877|530977219|FG000|Overall Study|Death|1|||
147308372|NCT02778399|531296237|FG003|Up to Week 12 Treatment Period|Lost to Follow-up|0|||
147308373|NCT02778399|531296238|FG004|Up to Week 12 Treatment Period|Lost to Follow-up|0|||
147219930|NCT00266877|530977220|FG001|Overall Study|Death|1|||
147219931|NCT00266877|530977221|FG002|Overall Study|Death|1|||
147308374|NCT02778399|531296239|FG005|Up to Week 12 Treatment Period|Lost to Follow-up|2|||
147308375|NCT02778399|531296234|FG000|Up to Week 12 Treatment Period|other - reason not stated|0|||
147443089|NCT00457015|531787165|FG001|Overall Study|Left study site against medical advice|1|||
147649965|NCT00703118|532539768|FG000|Overall Study|Lost to Follow-up|6|||
147308376|NCT02778399|531296235|FG001|Up to Week 12 Treatment Period|other - reason not stated|0|||
147308377|NCT02778399|531296236|FG002|Up to Week 12 Treatment Period|other - reason not stated|0|||
147219932|NCT00266877|530977219|FG000|Overall Study|Adverse Event|6|||
147308378|NCT02778399|531296237|FG003|Up to Week 12 Treatment Period|other - reason not stated|1|||
147308379|NCT02778399|531296238|FG004|Up to Week 12 Treatment Period|other - reason not stated|2|||
147308380|NCT02778399|531296239|FG005|Up to Week 12 Treatment Period|other - reason not stated|0|||
147219933|NCT00266877|530977220|FG001|Overall Study|Adverse Event|4|||
147219934|NCT00266877|530977221|FG002|Overall Study|Adverse Event|1|||
147219935|NCT00266877|530977219|FG000|Overall Study|Physician Decision|2|||
147219936|NCT00266877|530977220|FG001|Overall Study|Physician Decision|1|||
147219937|NCT00266877|530977221|FG002|Overall Study|Physician Decision|1|||
147219938|NCT00266877|530977219|FG000|Overall Study|Withdrawal by Subject|3|||
147219939|NCT00266877|530977220|FG001|Overall Study|Withdrawal by Subject|1|||
147219940|NCT00266877|530977221|FG002|Overall Study|Withdrawal by Subject|1|||
147219941|NCT00266877|530977219|FG000|Overall Study|Disease Progression|72|||
147219942|NCT00266877|530977220|FG001|Overall Study|Disease Progression|37|||
147219943|NCT00266877|530977221|FG002|Overall Study|Disease Progression|23|||
147219944|NCT00266877|530977219|FG000|Overall Study|Symptomatic Deterioration|6|||
147219945|NCT00266877|530977220|FG001|Overall Study|Symptomatic Deterioration|3|||
147219946|NCT00266877|530977221|FG002|Overall Study|Symptomatic Deterioration|1|||
147219947|NCT00266877|530977219|FG000|Overall Study|Hospitalization|1|||
147219948|NCT00266877|530977220|FG001|Overall Study|Hospitalization|0|||
147219949|NCT00266877|530977221|FG002|Overall Study|Hospitalization|0|||
147219950|NCT00266877|530977219|FG000|Overall Study|Concomitant Radiotherapy|0|||
147219951|NCT00266877|530977220|FG001|Overall Study|Concomitant Radiotherapy|1|||
147219952|NCT00266877|530977221|FG002|Overall Study|Concomitant Radiotherapy|0|||
147219953|NCT01077375|530977226|FG000|Overall Study|Adverse Event|2|||
147219954|NCT01077375|530977227|FG001|Overall Study|Adverse Event|15|||
147219955|NCT01077375|530977226|FG000|Overall Study|Lack of Efficacy|6|||
147219956|NCT01077375|530977227|FG001|Overall Study|Lack of Efficacy|8|||
147219957|NCT01077375|530977226|FG000|Overall Study|Withdrawal by Subject|0|||
147219958|NCT01077375|530977227|FG001|Overall Study|Withdrawal by Subject|6|||
147219959|NCT01077375|530977226|FG000|Overall Study|Lost to Follow-up|2|||
147219960|NCT01077375|530977227|FG001|Overall Study|Lost to Follow-up|5|||
147219961|NCT01077375|530977226|FG000|Overall Study|Other Reason|0|||
147219962|NCT01077375|530977227|FG001|Overall Study|Other Reason|1|||
147219963|NCT01089361|530977231|FG000|Overall Study|Death|1|||
147219964|NCT01089361|530977232|FG001|Overall Study|Death|0|||
147219965|NCT03353740|530977233|FG000|Overall Study|Images for these participants not viable|52|||
147219966|NCT02232880|530977234|FG000|Overall Study|study stopped prior to randomization|1|||
147249822|NCT00582166|531083778|FG000|Overall Study|Ineligible pathology|1|||
147249823|NCT02532972|531083779|FG000|Overall Study|Withdrawal by Subject|1|||
147249824|NCT01606436|531083782|FG000|Overall Study|Withdrawal by Subject|0|||
147249825|NCT01606436|531083783|FG001|Overall Study|Withdrawal by Subject|0|||
147249826|NCT01606436|531083784|FG002|Overall Study|Withdrawal by Subject|1|||
147249827|NCT01606436|531083785|FG003|Overall Study|Withdrawal by Subject|1|||
147249828|NCT01606436|531083786|FG004|Overall Study|Withdrawal by Subject|1|||
147249829|NCT01606436|531083787|FG005|Overall Study|Withdrawal by Subject|0|||
147249830|NCT01606436|531083782|FG000|Overall Study|Adverse Event|0|||
147249831|NCT01606436|531083783|FG001|Overall Study|Adverse Event|0|||
147249832|NCT01606436|531083784|FG002|Overall Study|Adverse Event|1|||
147249833|NCT01606436|531083785|FG003|Overall Study|Adverse Event|0|||
147249834|NCT01606436|531083786|FG004|Overall Study|Adverse Event|0|||
147249835|NCT01606436|531083787|FG005|Overall Study|Adverse Event|0|||
147249836|NCT01606436|531083782|FG000|Overall Study|Sponsor Decision|0|||
147249837|NCT01606436|531083783|FG001|Overall Study|Sponsor Decision|0|||
147249838|NCT01606436|531083784|FG002|Overall Study|Sponsor Decision|0|||
147249839|NCT01606436|531083785|FG003|Overall Study|Sponsor Decision|1|||
147249840|NCT01606436|531083786|FG004|Overall Study|Sponsor Decision|0|||
147249841|NCT01606436|531083787|FG005|Overall Study|Sponsor Decision|0|||
147308381|NCT02778399|531296234|FG000|Week 12 to Week 24 Treatment Period|Adverse Event|2|||
147308382|NCT02778399|531296235|FG001|Week 12 to Week 24 Treatment Period|Adverse Event|0|||
147308383|NCT02778399|531296236|FG002|Week 12 to Week 24 Treatment Period|Adverse Event|2|||
147308384|NCT02778399|531296237|FG003|Week 12 to Week 24 Treatment Period|Adverse Event|1|||
147249842|NCT02859454|531083788|FG000|Overall Study|PI discretion/off study prior to trtmt|1|||
147249843|NCT00110149|531083789|FG000|Overall Study|Physician Decision|3|||
147249844|NCT02452398|531083790|FG000|Overall Study|Adverse Event|1|||
147249845|NCT02452398|531083790|FG000|Overall Study|Lost to Follow-up|28|||
147249846|NCT02452398|531083790|FG000|Overall Study|Physician Decision|2|||
147249847|NCT02452398|531083790|FG000|Overall Study|Withdrawal by Subject|6|||
147249848|NCT02452398|531083790|FG000|Overall Study|Moved away|4|||
147249849|NCT01018186|531083793|FG000|2-week Run-in Period|Protocol Violation|1|||
147249850|NCT01018186|531083794|FG001|2-week Run-in Period|Protocol Violation|0|||
147249851|NCT01018186|531083795|FG002|2-week Run-in Period|Protocol Violation|0|||
147249852|NCT01018186|531083796|FG003|2-week Run-in Period|Protocol Violation|0|||
147249853|NCT01018186|531083793|FG000|2-week Run-in Period|Lost to Follow-up|2|||
147249854|NCT01018186|531083794|FG001|2-week Run-in Period|Lost to Follow-up|0|||
147249855|NCT01018186|531083795|FG002|2-week Run-in Period|Lost to Follow-up|0|||
147308385|NCT02778399|531296238|FG004|Week 12 to Week 24 Treatment Period|Adverse Event|3|||
147308386|NCT02778399|531296239|FG005|Week 12 to Week 24 Treatment Period|Adverse Event|2|||
147308387|NCT02778399|531296234|FG000|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|3|||
147308388|NCT02778399|531296235|FG001|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|2|||
147308389|NCT02778399|531296236|FG002|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|0|||
147308390|NCT02778399|531296237|FG003|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|3|||
147308391|NCT02778399|531296238|FG004|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|2|||
147308392|NCT02778399|531296239|FG005|Week 12 to Week 24 Treatment Period|Withdrawal by Subject|2|||
147308393|NCT02778399|531296234|FG000|Week 12 to Week 24 Treatment Period|Protocol Violation|0|||
147308394|NCT02778399|531296235|FG001|Week 12 to Week 24 Treatment Period|Protocol Violation|1|||
147308395|NCT02778399|531296236|FG002|Week 12 to Week 24 Treatment Period|Protocol Violation|0|||
147308396|NCT02778399|531296237|FG003|Week 12 to Week 24 Treatment Period|Protocol Violation|0|||
147219967|NCT02233946|530978511|FG000|Baseline|Withdrawal by Subject|2|||
147219968|NCT02233946|530978512|FG001|Baseline|Withdrawal by Subject|0|||
147219969|NCT02233946|530978511|FG000|3-months Follow-up|Lost to Follow-up|53|||
147219970|NCT02233946|530978512|FG001|3-months Follow-up|Lost to Follow-up|29|||
147219971|NCT02233946|530978511|FG000|6-months Follow-up|Lost to Follow-up|21|||
147219972|NCT02233946|530978512|FG001|6-months Follow-up|Lost to Follow-up|2|||
147219973|NCT02233946|530978511|FG000|9-month Follow-up|Lost to Follow-up|20|||
147219974|NCT02233946|530978512|FG001|9-month Follow-up|Lost to Follow-up|11|||
147219975|NCT02233946|530978511|FG000|12-month Follow-up|Lost to Follow-up|28|||
147219976|NCT02233946|530978512|FG001|12-month Follow-up|Lost to Follow-up|11|||
147219977|NCT01879579|530978513|FG000|Overall Study|Phone incompatible with texting platform|3|||
147219978|NCT01879579|530978514|FG001|Overall Study|Phone incompatible with texting platform|0|||
147219979|NCT01879579|530978513|FG000|Overall Study|Did not enroll in texting platform|1|||
147219980|NCT01879579|530978514|FG001|Overall Study|Did not enroll in texting platform|0|||
147219981|NCT01879579|530978513|FG000|Overall Study|Did not initiate insulin treatment|1|||
147219982|NCT01879579|530978514|FG001|Overall Study|Did not initiate insulin treatment|0|||
147219983|NCT01879579|530978513|FG000|Overall Study|Phenotypic type 1 diabetes|0|||
147219984|NCT01879579|530978514|FG001|Overall Study|Phenotypic type 1 diabetes|1|||
147219985|NCT01879579|530978513|FG000|Overall Study|Discontinued insulin - possible allergy|0|||
147219986|NCT01879579|530978514|FG001|Overall Study|Discontinued insulin - possible allergy|1|||
147219987|NCT02927067|530978515|FG000|Overall Study|Withdrawn Consent|20|||
147219988|NCT02927067|530978516|FG001|Overall Study|Withdrawn Consent|12|||
147219989|NCT02927067|530978515|FG000|Overall Study|Death|18|||
147219990|NCT02927067|530978516|FG001|Overall Study|Death|31|||
147219991|NCT02927067|530978515|FG000|Overall Study|Adverse Event|13|||
147219992|NCT02927067|530978516|FG001|Overall Study|Adverse Event|10|||
147219993|NCT02927067|530978515|FG000|Overall Study|Noncompliance|5|||
147219994|NCT02927067|530978516|FG001|Overall Study|Noncompliance|2|||
147219995|NCT02927067|530978515|FG000|Overall Study|Reason not Specified|4|||
147219996|NCT02927067|530978516|FG001|Overall Study|Reason not Specified|6|||
147219997|NCT02292784|530978519|FG000|Overall Study|Lost to Follow-up|1|||
147219998|NCT02292784|530978520|FG001|Overall Study|Lost to Follow-up|17|||
147219999|NCT02292784|530978521|FG002|Overall Study|Lost to Follow-up|18|||
147220000|NCT02292784|530978519|FG000|Overall Study|Withdrawal by Subject|0|||
147220001|NCT02292784|530978520|FG001|Overall Study|Withdrawal by Subject|3|||
147220002|NCT02292784|530978521|FG002|Overall Study|Withdrawal by Subject|3|||
147220003|NCT00134784|530978522|FG000|Overall Study|Withdrawal by Subject|2|||
147220004|NCT00134784|530978523|FG001|Overall Study|Withdrawal by Subject|2|||
147220005|NCT00134784|530978524|FG002|Overall Study|Withdrawal by Subject|2|||
147220006|NCT00134784|530978525|FG003|Overall Study|Withdrawal by Subject|1|||
147220007|NCT02919969|530978526|FG000|Overall Study|Lack of Efficacy|22|||
147220008|NCT02919969|530978526|FG000|Overall Study|Death|4|||
147220009|NCT02919969|530978526|FG000|Overall Study|Physician Decision|3|||
147220010|NCT02919969|530978526|FG000|Overall Study|Withdrawal by Subject|2|||
147220011|NCT03621475|530978527|FG000|Overall Study|No longer required restraints at initiation|0|||
147220012|NCT03621475|530978528|FG001|Overall Study|No longer required restraints at initiation|1|||
147220013|NCT01842633|530978529|FG000|Overall Study|Screen Failure|1|||
147220014|NCT01842633|530978530|FG001|Overall Study|Screen Failure|0|||
147220015|NCT01842633|530978531|FG002|Overall Study|Screen Failure|0|||
147220016|NCT01842633|530978529|FG000|Overall Study|Adverse Event|1|||
147220017|NCT01842633|530978530|FG001|Overall Study|Adverse Event|1|||
147220018|NCT01842633|530978531|FG002|Overall Study|Adverse Event|0|||
147220019|NCT01842633|530978529|FG000|Overall Study|Withdrawal by Subject|0|||
147220020|NCT01842633|530978530|FG001|Overall Study|Withdrawal by Subject|1|||
147220021|NCT01842633|530978531|FG002|Overall Study|Withdrawal by Subject|0|||
147220022|NCT01842633|530978529|FG000|Overall Study|Technical issues|1|||
147220023|NCT01842633|530978530|FG001|Overall Study|Technical issues|0|||
147220024|NCT01842633|530978531|FG002|Overall Study|Technical issues|0|||
147220025|NCT00706849|530978537|FG000|Treatment Period|Adverse Event|0|||
147220026|NCT00706849|530978538|FG001|Treatment Period|Adverse Event|9|||
147220027|NCT00706849|530978537|FG000|Treatment Period|Other|0|||
147220028|NCT00706849|530978538|FG001|Treatment Period|Other|1|||
147220029|NCT00706849|530978537|FG000|Follow-up Period|Withdrawal by Subject|0|||
147308397|NCT02778399|531296238|FG004|Week 12 to Week 24 Treatment Period|Protocol Violation|0|||
147220030|NCT00706849|530978538|FG001|Follow-up Period|Withdrawal by Subject|2|||
147220031|NCT00706849|530978537|FG000|Follow-up Period|Protocol non-compliance|0|||
147220032|NCT00706849|530978538|FG001|Follow-up Period|Protocol non-compliance|1|||
147220033|NCT02616601|530978539|FG000|Overall Study|Withdrawal by Subject|4|||
147220034|NCT02616601|530978540|FG001|Overall Study|Withdrawal by Subject|4|||
147220035|NCT02616601|530978541|FG002|Overall Study|Withdrawal by Subject|3|||
147220036|NCT02616601|530978539|FG000|Overall Study|Adverse Event|2|||
147220037|NCT02616601|530978540|FG001|Overall Study|Adverse Event|0|||
147220038|NCT02616601|530978541|FG002|Overall Study|Adverse Event|2|||
147220039|NCT02616601|530978539|FG000|Overall Study|Death|1|||
147220040|NCT02616601|530978540|FG001|Overall Study|Death|0|||
147220041|NCT02616601|530978541|FG002|Overall Study|Death|0|||
147220042|NCT02616601|530978539|FG000|Overall Study|Lost to Follow-up|1|||
147220043|NCT02616601|530978540|FG001|Overall Study|Lost to Follow-up|0|||
147220044|NCT02616601|530978541|FG002|Overall Study|Lost to Follow-up|1|||
147220045|NCT02616601|530978539|FG000|Overall Study|Non-Compliance with Test Article|1|||
147220046|NCT02616601|530978540|FG001|Overall Study|Non-Compliance with Test Article|0|||
147220047|NCT02616601|530978541|FG002|Overall Study|Non-Compliance with Test Article|1|||
147220048|NCT03718299|530978542|FG000|Overall Study|Adverse Event|1|||
147220049|NCT03718299|530978542|FG000|Overall Study|Withdrawal by Subject|6|||
147220050|NCT03718299|530978542|FG000|Overall Study|Physician Decision|2|||
147220051|NCT03718299|530978542|FG000|Overall Study|Lost to Follow-up|1|||
147220052|NCT04389970|530978543|FG000|Overall Study|Lost to Follow-up|1|||
147220053|NCT01343823|530978544|FG000|Overall Study|Study Terminated|1|||
147220054|NCT01343823|530978545|FG001|Overall Study|Study Terminated|0|||
147220055|NCT01343823|530978546|FG002|Overall Study|Study Terminated|0|||
147220056|NCT01343823|530978547|FG003|Overall Study|Study Terminated|1|||
147220057|NCT01343823|530978544|FG000|Overall Study|Withdrawal by Subject|1|||
147220058|NCT01343823|530978545|FG001|Overall Study|Withdrawal by Subject|0|||
147220059|NCT01343823|530978546|FG002|Overall Study|Withdrawal by Subject|0|||
147220060|NCT01343823|530978547|FG003|Overall Study|Withdrawal by Subject|0|||
147220061|NCT02195687|530978559|FG000|Overall Study|Personal Reasons|1|||
147220062|NCT02195687|530978560|FG001|Overall Study|Personal Reasons|1|||
147220063|NCT02195687|530978559|FG000|Overall Study|Lost to Follow-up|4|||
147220064|NCT02195687|530978560|FG001|Overall Study|Lost to Follow-up|1|||
147220065|NCT02047318|530978561|FG000|Core Study Period|Did not consent to 52-week follow- up|8|||
147220066|NCT02047318|530978561|FG000|Core Study Period|Adverse Event|1|||
147220067|NCT02047318|530978561|FG000|Core Study Period|Withdrawal by caregiver|3|||
147220068|NCT02047318|530978561|FG000|Long-term Follow-up Treatment Period|consent withdrawn by subject|1|||
147220069|NCT02296138|530978562|FG000|Overall Study|Adverse Event|348|||
147220070|NCT02296138|530978563|FG001|Overall Study|Adverse Event|259|||
147220071|NCT02296138|530978562|FG000|Overall Study|Lack of Efficacy|59|||
147220072|NCT02296138|530978563|FG001|Overall Study|Lack of Efficacy|37|||
147220073|NCT02296138|530978562|FG000|Overall Study|Protocol Violation|35|||
147220074|NCT02296138|530978563|FG001|Overall Study|Protocol Violation|36|||
147220075|NCT02296138|530978562|FG000|Overall Study|Lost to Follow-up|9|||
147220076|NCT02296138|530978563|FG001|Overall Study|Lost to Follow-up|12|||
147220077|NCT02296138|530978562|FG000|Overall Study|Withdrawal by Subject|184|||
147220078|NCT02296138|530978563|FG001|Overall Study|Withdrawal by Subject|131|||
147220079|NCT02296138|530978562|FG000|Overall Study|Not Treated|1|||
147220080|NCT02296138|530978563|FG001|Overall Study|Not Treated|1|||
147220081|NCT02296138|530978562|FG000|Overall Study|Patients with data irregularities|10|||
147220082|NCT02296138|530978563|FG001|Overall Study|Patients with data irregularities|11|||
147220083|NCT02296138|530978562|FG000|Overall Study|Other than specified|15|||
147220084|NCT02296138|530978563|FG001|Overall Study|Other than specified|13|||
147220085|NCT01653132|530978564|FG000|First Intervention|Protocol Violation|1|||
147220086|NCT01653132|530978565|FG001|First Intervention|Protocol Violation|0|||
147220087|NCT02677324|530978566|FG000|Overall Study|Disease Progression|6|||
147220088|NCT02677324|530978566|FG000|Overall Study|Inability to Swallow pills|1|||
147220089|NCT02677324|530978566|FG000|Overall Study|Non-compliance|1|||
147220090|NCT02677324|530978566|FG000|Overall Study|Lack of Efficacy|1|||
147220091|NCT02677324|530978566|FG000|Overall Study|Medical insurance coverage|1|||
147220092|NCT02677324|530978566|FG000|Overall Study|Adverse Event|1|||
147220093|NCT02677324|530978566|FG000|Overall Study|IgM Myeloma diagnosis|1|||
147220094|NCT00761150|530978569|FG000|Open-label Period|Adverse Event|36|||
147220095|NCT00761150|530978570|FG001|Open-label Period|Adverse Event|0|||
147220096|NCT00761150|530978571|FG002|Open-label Period|Adverse Event|0|||
147220097|NCT00761150|530978569|FG000|Open-label Period|Did not meet DB randomization criteria|11|||
147220098|NCT00761150|530978570|FG001|Open-label Period|Did not meet DB randomization criteria|0|||
147220099|NCT00761150|530978571|FG002|Open-label Period|Did not meet DB randomization criteria|0|||
147220100|NCT00761150|530978569|FG000|Open-label Period|Lost to Follow-up|7|||
147220101|NCT00761150|530978570|FG001|Open-label Period|Lost to Follow-up|0|||
147220102|NCT00761150|530978571|FG002|Open-label Period|Lost to Follow-up|0|||
147220103|NCT00761150|530978569|FG000|Open-label Period|Lack of Efficacy|4|||
147220104|NCT00761150|530978570|FG001|Open-label Period|Lack of Efficacy|0|||
147220105|NCT00761150|530978571|FG002|Open-label Period|Lack of Efficacy|0|||
147220106|NCT00761150|530978569|FG000|Open-label Period|Withdrawal by Subject|5|||
147220107|NCT00761150|530978570|FG001|Open-label Period|Withdrawal by Subject|0|||
147220108|NCT00761150|530978571|FG002|Open-label Period|Withdrawal by Subject|0|||
147220109|NCT00761150|530978569|FG000|Open-label Period|Noncompliance|2|||
147220110|NCT00761150|530978570|FG001|Open-label Period|Noncompliance|0|||
147220111|NCT00761150|530978571|FG002|Open-label Period|Noncompliance|0|||
147220112|NCT00761150|530978569|FG000|Open-label Period|Other|5|||
147220113|NCT00761150|530978570|FG001|Open-label Period|Other|0|||
147220114|NCT00761150|530978571|FG002|Open-label Period|Other|0|||
147220115|NCT00761150|530978569|FG000|Double-blind Period|Lack of Efficacy|0|||
147220116|NCT00761150|530978570|FG001|Double-blind Period|Lack of Efficacy|2|||
147220117|NCT00761150|530978571|FG002|Double-blind Period|Lack of Efficacy|19|||
147220118|NCT00761150|530978569|FG000|Double-blind Period|Adverse Event|0|||
147220119|NCT00761150|530978570|FG001|Double-blind Period|Adverse Event|3|||
147220120|NCT00761150|530978571|FG002|Double-blind Period|Adverse Event|3|||
147220121|NCT00761150|530978569|FG000|Double-blind Period|Withdrawal by Subject|0|||
147220122|NCT00761150|530978570|FG001|Double-blind Period|Withdrawal by Subject|3|||
147220123|NCT00761150|530978571|FG002|Double-blind Period|Withdrawal by Subject|2|||
147220124|NCT00761150|530978569|FG000|Double-blind Period|Lost to Follow-up|0|||
147220125|NCT00761150|530978570|FG001|Double-blind Period|Lost to Follow-up|2|||
147220126|NCT00761150|530978571|FG002|Double-blind Period|Lost to Follow-up|1|||
147220127|NCT00761150|530978569|FG000|Double-blind Period|Did not meet DB randomization criteria|0|||
147220128|NCT00761150|530978570|FG001|Double-blind Period|Did not meet DB randomization criteria|0|||
147220129|NCT00761150|530978571|FG002|Double-blind Period|Did not meet DB randomization criteria|1|||
147220130|NCT00761150|530978569|FG000|Double-blind Period|Noncompliance|0|||
147220131|NCT00761150|530978570|FG001|Double-blind Period|Noncompliance|1|||
147220132|NCT00761150|530978571|FG002|Double-blind Period|Noncompliance|0|||
147220133|NCT00761150|530978569|FG000|Double-blind Period|Other|0|||
147220134|NCT00761150|530978570|FG001|Double-blind Period|Other|3|||
147220135|NCT00761150|530978571|FG002|Double-blind Period|Other|3|||
147220136|NCT00282464|530978572|FG000|Overall Study|Adverse Event|26|||
147220137|NCT00282464|530978573|FG001|Overall Study|Adverse Event|20|||
147220138|NCT00282464|530978572|FG000|Overall Study|Lack of Efficacy|8|||
147220139|NCT00282464|530978573|FG001|Overall Study|Lack of Efficacy|8|||
147220140|NCT00282464|530978572|FG000|Overall Study|Lost to Follow-up|10|||
147220141|NCT00282464|530978573|FG001|Overall Study|Lost to Follow-up|10|||
147220142|NCT00282464|530978572|FG000|Overall Study|Withdrawal by Subject|24|||
147220143|NCT00282464|530978573|FG001|Overall Study|Withdrawal by Subject|10|||
147220144|NCT00282464|530978572|FG000|Overall Study|laboratory abnormality|1|||
147220145|NCT00282464|530978573|FG001|Overall Study|laboratory abnormality|2|||
147220146|NCT00282464|530978572|FG000|Overall Study|Protocol Violation|0|||
147220147|NCT00282464|530978573|FG001|Overall Study|Protocol Violation|7|||
147220148|NCT00282464|530978572|FG000|Overall Study|Patient moved|1|||
147220149|NCT00282464|530978573|FG001|Overall Study|Patient moved|0|||
147220150|NCT00282464|530978572|FG000|Overall Study|patient non-compliant|3|||
147220151|NCT00282464|530978573|FG001|Overall Study|patient non-compliant|0|||
147220152|NCT00282464|530978572|FG000|Overall Study|patient no show|0|||
147220153|NCT00282464|530978573|FG001|Overall Study|patient no show|1|||
147220154|NCT00282464|530978572|FG000|Overall Study|patient incarcerated|0|||
147220155|NCT00282464|530978573|FG001|Overall Study|patient incarcerated|1|||
147220156|NCT00282464|530978572|FG000|Overall Study|family crisis|0|||
147220157|NCT00282464|530978573|FG001|Overall Study|family crisis|1|||
147220158|NCT00282464|530978572|FG000|Overall Study|dispensed wrong kit|0|||
147220159|NCT00282464|530978573|FG001|Overall Study|dispensed wrong kit|1|||
147220160|NCT00282464|530978572|FG000|Overall Study|dropped due to missed visits|0|||
147220161|NCT00282464|530978573|FG001|Overall Study|dropped due to missed visits|1|||
147220162|NCT00475423|530978574|FG000|Overall Study|Protocol Violation|5|||
147220163|NCT00475423|530978574|FG000|Overall Study|Adverse Event|4|||
147220164|NCT00475423|530978574|FG000|Overall Study|Withdrawal by Subject|6|||
147220165|NCT00475423|530978574|FG000|Overall Study|Lack of Efficacy|8|||
147220166|NCT00475423|530978574|FG000|Overall Study|Death|1|||
147220167|NCT00475423|530978574|FG000|Overall Study|Reason not specified|1|||
147220168|NCT00475423|530978574|FG000|Overall Study|Lost to Follow-up|7|||
147220169|NCT01214174|530978575|FG000|Overall Study|Withdrawal by Subject|0|||
147220170|NCT01214174|530978576|FG001|Overall Study|Withdrawal by Subject|0|||
147220171|NCT01214174|530978577|FG002|Overall Study|Withdrawal by Subject|1|||
147220172|NCT00868517|530978581|FG000|Overall Study|Withdrawal by Subject|3|||
147220173|NCT00868517|530978582|FG001|Overall Study|Withdrawal by Subject|3|||
147220174|NCT00868517|530978583|FG002|Overall Study|Withdrawal by Subject|2|||
147220175|NCT00868517|530978581|FG000|Overall Study|Protocol Violation|1|||
147220176|NCT00868517|530978582|FG001|Overall Study|Protocol Violation|1|||
147220177|NCT00868517|530978583|FG002|Overall Study|Protocol Violation|0|||
147220178|NCT02496676|530978585|FG000|Phase 1 - Period 1|Adverse Event|0|||
147220179|NCT02496676|530978586|FG001|Phase 1 - Period 1|Adverse Event|1|||
147220180|NCT02496676|530978585|FG000|Phase 2 - IV MgSO4|Adverse Event|0|||
147220181|NCT02496676|530978586|FG001|Phase 2 - IV MgSO4|Adverse Event|1|||
147220182|NCT02963831|530978587|FG000|Overall Study|Progressive Disease|3|||
147220183|NCT02963831|530978588|FG001|Overall Study|Progressive Disease|3|||
147220184|NCT02963831|530978589|FG002|Overall Study|Progressive Disease|16|||
147649966|NCT00703118|532539769|FG001|Overall Study|Lost to Follow-up|4|||
147220185|NCT02963831|530978590|FG003|Overall Study|Progressive Disease|27|||
147220186|NCT02963831|530978587|FG000|Overall Study|Withdrawal by Subject|1|||
147220187|NCT02963831|530978588|FG001|Overall Study|Withdrawal by Subject|0|||
147220188|NCT02963831|530978589|FG002|Overall Study|Withdrawal by Subject|2|||
147220189|NCT02963831|530978590|FG003|Overall Study|Withdrawal by Subject|4|||
147220190|NCT02963831|530978587|FG000|Overall Study|Adverse Event|0|||
147220191|NCT02963831|530978588|FG001|Overall Study|Adverse Event|1|||
147220192|NCT02963831|530978589|FG002|Overall Study|Adverse Event|1|||
147220193|NCT02963831|530978590|FG003|Overall Study|Adverse Event|2|||
147220194|NCT02963831|530978587|FG000|Overall Study|Death|0|||
147220195|NCT02963831|530978588|FG001|Overall Study|Death|0|||
147220196|NCT02963831|530978589|FG002|Overall Study|Death|0|||
147220197|NCT02963831|530978590|FG003|Overall Study|Death|2|||
147220198|NCT01966432|530978591|FG000|Overall Study|Lost to Follow-up|3|||
147220199|NCT01966432|530978592|FG001|Overall Study|Lost to Follow-up|2|||
147220200|NCT01966432|530978593|FG002|Overall Study|Lost to Follow-up|5|||
147220201|NCT01966432|530978591|FG000|Overall Study|Withdrawal by Subject|1|||
147220202|NCT01966432|530978592|FG001|Overall Study|Withdrawal by Subject|3|||
147220203|NCT01966432|530978593|FG002|Overall Study|Withdrawal by Subject|0|||
147220204|NCT01966432|530978591|FG000|Overall Study|Subject Incarcerated|0|||
147220205|NCT01966432|530978592|FG001|Overall Study|Subject Incarcerated|0|||
147220206|NCT01966432|530978593|FG002|Overall Study|Subject Incarcerated|1|||
147220207|NCT01966432|530978591|FG000|Overall Study|SBIRT program ended|1|||
147220208|NCT01966432|530978592|FG001|Overall Study|SBIRT program ended|8|||
147220209|NCT01966432|530978593|FG002|Overall Study|SBIRT program ended|20|||
147220210|NCT02815280|530978598|FG000|Double-Blind Phase|Adverse Event|1|||
147220211|NCT02815280|530978599|FG001|Double-Blind Phase|Adverse Event|1|||
147220212|NCT02815280|530978598|FG000|Double-Blind Phase|Lost to Follow-up|10|||
147220213|NCT02815280|530978599|FG001|Double-Blind Phase|Lost to Follow-up|9|||
147220214|NCT02815280|530978598|FG000|Double-Blind Phase|Withdrawal by Subject|20|||
147220215|NCT02815280|530978599|FG001|Double-Blind Phase|Withdrawal by Subject|11|||
147220216|NCT02815280|530978598|FG000|Double-Blind Phase|Protocol Violation|2|||
147220217|NCT02815280|530978599|FG001|Double-Blind Phase|Protocol Violation|2|||
147220218|NCT02815280|530978598|FG000|Double-Blind Phase|Subject: withdrew consent; non-compliant with visits; moved;lack of efficacy;positive pregnancy test|3|||
147220219|NCT02815280|530978599|FG001|Double-Blind Phase|Subject: withdrew consent; non-compliant with visits; moved;lack of efficacy;positive pregnancy test|2|||
147220220|NCT02815280|530978598|FG000|Open-Label Phase|Adverse Event|2|||
147220221|NCT02815280|530978599|FG001|Open-Label Phase|Adverse Event|3|||
147220222|NCT02815280|530978598|FG000|Open-Label Phase|Lost to Follow-up|18|||
147220223|NCT02815280|530978599|FG001|Open-Label Phase|Lost to Follow-up|9|||
147220224|NCT02815280|530978598|FG000|Open-Label Phase|Withdrawal by Subject|33|||
147220225|NCT02815280|530978599|FG001|Open-Label Phase|Withdrawal by Subject|18|||
147220226|NCT02815280|530978598|FG000|Open-Label Phase|Protocol Violation|3|||
147220227|NCT02815280|530978599|FG001|Open-Label Phase|Protocol Violation|0|||
147220228|NCT02815280|530978598|FG000|Open-Label Phase|Administrative|26|||
147220229|NCT02815280|530978599|FG001|Open-Label Phase|Administrative|12|||
147220230|NCT02815280|530978598|FG000|Open-Label Phase|Positive pregnancy test; subject- noncompliance; withdrew consent; lack of efficacy etc.|5|||
147220231|NCT02815280|530978599|FG001|Open-Label Phase|Positive pregnancy test; subject- noncompliance; withdrew consent; lack of efficacy etc.|2|||
147220232|NCT02514473|530978603|FG000|Overall Study|Adverse Event|0|||
147220233|NCT02514473|530978604|FG001|Overall Study|Adverse Event|2|||
147220234|NCT02514473|530978603|FG000|Overall Study|Withdrawal by Subject|2|||
147220235|NCT02514473|530978604|FG001|Overall Study|Withdrawal by Subject|1|||
147220236|NCT02514473|530978603|FG000|Overall Study|Lost to Follow-up|0|||
147220237|NCT02514473|530978604|FG001|Overall Study|Lost to Follow-up|1|||
147220238|NCT02514473|530978603|FG000|Overall Study|Other|1|||
147220239|NCT02514473|530978604|FG001|Overall Study|Other|1|||
147220240|NCT03915860|530978605|FG000|Overall Study|Adverse Event|3|||
147220241|NCT03915860|530978605|FG000|Overall Study|Withdrawal by Subject|6|||
147220242|NCT03915860|530978605|FG000|Overall Study|Lost to Follow-up|2|||
147220243|NCT03915860|530978605|FG000|Overall Study|Other than specified|3|||
147220244|NCT01009281|530978606|FG000|Overall Study|Administrative problems|7|||
147220245|NCT00548405|530978607|FG000|Overall Study|Adverse Event|6|||
147220246|NCT00548405|530978608|FG001|Overall Study|Adverse Event|2|||
147220247|NCT00548405|530978609|FG002|Overall Study|Adverse Event|0|||
147220248|NCT00548405|530978607|FG000|Overall Study|Lack of Efficacy|6|||
147220249|NCT00548405|530978608|FG001|Overall Study|Lack of Efficacy|0|||
147220250|NCT00548405|530978609|FG002|Overall Study|Lack of Efficacy|0|||
147220251|NCT00548405|530978607|FG000|Overall Study|Physician Decision|3|||
147220252|NCT00548405|530978608|FG001|Overall Study|Physician Decision|4|||
147220253|NCT00548405|530978609|FG002|Overall Study|Physician Decision|1|||
147220254|NCT00548405|530978607|FG000|Overall Study|Pregnancy|1|||
147308398|NCT02778399|531296239|FG005|Week 12 to Week 24 Treatment Period|Protocol Violation|0|||
147308399|NCT02778399|531296234|FG000|Week 12 to Week 24 Treatment Period|Lost to Follow-up|2|||
147308400|NCT02778399|531296235|FG001|Week 12 to Week 24 Treatment Period|Lost to Follow-up|1|||
147308401|NCT02778399|531296236|FG002|Week 12 to Week 24 Treatment Period|Lost to Follow-up|0|||
147308402|NCT02778399|531296237|FG003|Week 12 to Week 24 Treatment Period|Lost to Follow-up|1|||
147308403|NCT02778399|531296238|FG004|Week 12 to Week 24 Treatment Period|Lost to Follow-up|0|||
147308404|NCT02778399|531296239|FG005|Week 12 to Week 24 Treatment Period|Lost to Follow-up|2|||
147308405|NCT02778399|531296234|FG000|Week 12 to Week 24 Treatment Period|Pregnancy|1|||
147308406|NCT02778399|531296235|FG001|Week 12 to Week 24 Treatment Period|Pregnancy|0|||
147308407|NCT02778399|531296236|FG002|Week 12 to Week 24 Treatment Period|Pregnancy|2|||
147308408|NCT02778399|531296237|FG003|Week 12 to Week 24 Treatment Period|Pregnancy|0|||
147308409|NCT02778399|531296238|FG004|Week 12 to Week 24 Treatment Period|Pregnancy|0|||
147308410|NCT02778399|531296239|FG005|Week 12 to Week 24 Treatment Period|Pregnancy|0|||
147308411|NCT02778399|531296234|FG000|Week 12 to Week 24 Treatment Period|other - reason not stated|0|||
147308412|NCT02778399|531296235|FG001|Week 12 to Week 24 Treatment Period|other - reason not stated|0|||
147308413|NCT02778399|531296236|FG002|Week 12 to Week 24 Treatment Period|other - reason not stated|1|||
147308414|NCT02778399|531296237|FG003|Week 12 to Week 24 Treatment Period|other - reason not stated|0|||
147308415|NCT02778399|531296238|FG004|Week 12 to Week 24 Treatment Period|other - reason not stated|1|||
147308416|NCT02778399|531296239|FG005|Week 12 to Week 24 Treatment Period|other - reason not stated|1|||
147308417|NCT00405639|531296242|FG000|Overall Study|Withdrawal by Subject|1|||
147308418|NCT00405639|531296243|FG001|Overall Study|Withdrawal by Subject|0|||
147308419|NCT00405639|531296242|FG000|Overall Study|Adverse Event|1|||
147308420|NCT00405639|531296243|FG001|Overall Study|Adverse Event|0|||
147308421|NCT00405639|531296242|FG000|Overall Study|Seizure prior to receiving BNP|1|||
147308422|NCT00405639|531296243|FG001|Overall Study|Seizure prior to receiving BNP|0|||
147308423|NCT00612534|531296246|FG000|Overall Study|Adverse Event|0|||
147308424|NCT00612534|531296247|FG001|Overall Study|Adverse Event|4|||
147308425|NCT00612534|531296248|FG002|Overall Study|Adverse Event|2|||
147308426|NCT00612534|531296249|FG003|Overall Study|Adverse Event|1|||
147308427|NCT00612534|531296246|FG000|Overall Study|Lack of Efficacy|13|||
147308428|NCT00612534|531296247|FG001|Overall Study|Lack of Efficacy|12|||
147308429|NCT00612534|531296248|FG002|Overall Study|Lack of Efficacy|5|||
147308430|NCT00612534|531296249|FG003|Overall Study|Lack of Efficacy|16|||
147308431|NCT00612534|531296246|FG000|Overall Study|Other Reason|0|||
147308432|NCT00612534|531296247|FG001|Overall Study|Other Reason|1|||
147308433|NCT00612534|531296248|FG002|Overall Study|Other Reason|0|||
147308434|NCT00612534|531296249|FG003|Overall Study|Other Reason|0|||
147308435|NCT02487095|531296253|FG000|Dose Expansion|Unable to scan/restage participant|0|||
147308436|NCT02487095|531296254|FG001|Dose Expansion|Unable to scan/restage participant|0|||
147308437|NCT02487095|531296255|FG002|Dose Expansion|Unable to scan/restage participant|0|||
147308438|NCT02487095|531296256|FG003|Dose Expansion|Unable to scan/restage participant|0|||
147308439|NCT02487095|531296257|FG004|Dose Expansion|Unable to scan/restage participant|1|||
147308440|NCT03108157|531296260|FG000|Overall Study|Protocol Violation|15|||
147308441|NCT03108157|531296261|FG001|Overall Study|Protocol Violation|4|||
147308442|NCT01279343|531296264|FG000|Overall Study|Did not receive treatment|2|||
147308443|NCT01279343|531296265|FG001|Overall Study|Did not receive treatment|6|||
147308444|NCT04534114|531296266|FG000|Main Treatment Period|COVID-19 pandemic: Participant decision|0|||
147308445|NCT04534114|531296267|FG001|Main Treatment Period|COVID-19 pandemic: Participant decision|1|||
147308446|NCT04534114|531296268|FG002|Main Treatment Period|COVID-19 pandemic: Participant decision|0|||
147308447|NCT04534114|531296269|FG003|Main Treatment Period|COVID-19 pandemic: Participant decision|0|||
147308448|NCT04534114|531296266|FG000|Main Treatment Period|COVID-19 pandemic: Death|0|||
147308449|NCT04534114|531296267|FG001|Main Treatment Period|COVID-19 pandemic: Death|1|||
147308450|NCT04534114|531296268|FG002|Main Treatment Period|COVID-19 pandemic: Death|0|||
147308451|NCT04534114|531296269|FG003|Main Treatment Period|COVID-19 pandemic: Death|2|||
147308452|NCT04534114|531296266|FG000|Main Treatment Period|COVID-19 pandemic: Adverse event|0|||
147308453|NCT04534114|531296267|FG001|Main Treatment Period|COVID-19 pandemic: Adverse event|1|||
147308454|NCT04534114|531296268|FG002|Main Treatment Period|COVID-19 pandemic: Adverse event|1|||
147308455|NCT04534114|531296269|FG003|Main Treatment Period|COVID-19 pandemic: Adverse event|0|||
147308456|NCT04534114|531296266|FG000|Main Treatment Period|COVID-19 pandemic: withdrawal following protocol|1|||
147308457|NCT04534114|531296267|FG001|Main Treatment Period|COVID-19 pandemic: withdrawal following protocol|3|||
147308458|NCT04534114|531296268|FG002|Main Treatment Period|COVID-19 pandemic: withdrawal following protocol|3|||
147308459|NCT04534114|531296269|FG003|Main Treatment Period|COVID-19 pandemic: withdrawal following protocol|1|||
147308460|NCT04534114|531296266|FG000|Main Treatment Period|Physician Decision|0|||
147308461|NCT04534114|531296267|FG001|Main Treatment Period|Physician Decision|0|||
147308462|NCT04534114|531296268|FG002|Main Treatment Period|Physician Decision|0|||
147308463|NCT04534114|531296269|FG003|Main Treatment Period|Physician Decision|1|||
147308464|NCT04534114|531296266|FG000|Main Treatment Period|Death|1|||
147308465|NCT04534114|531296267|FG001|Main Treatment Period|Death|0|||
147308466|NCT04534114|531296268|FG002|Main Treatment Period|Death|0|||
147308467|NCT04534114|531296269|FG003|Main Treatment Period|Death|1|||
147308468|NCT04534114|531296266|FG000|Main Treatment Period|Other reason|1|||
147308469|NCT04534114|531296267|FG001|Main Treatment Period|Other reason|1|||
147308470|NCT04534114|531296268|FG002|Main Treatment Period|Other reason|0|||
147308471|NCT04534114|531296269|FG003|Main Treatment Period|Other reason|0|||
147308472|NCT04534114|531296266|FG000|Main Treatment Period|Participant decision|1|||
147308473|NCT04534114|531296267|FG001|Main Treatment Period|Participant decision|3|||
147308474|NCT04534114|531296268|FG002|Main Treatment Period|Participant decision|3|||
147308475|NCT04534114|531296269|FG003|Main Treatment Period|Participant decision|1|||
147308476|NCT04534114|531296266|FG000|Main Treatment Period|Protocol-specified withdrawal criterion met|2|||
147308477|NCT04534114|531296267|FG001|Main Treatment Period|Protocol-specified withdrawal criterion met|1|||
147308478|NCT04534114|531296268|FG002|Main Treatment Period|Protocol-specified withdrawal criterion met|4|||
147308479|NCT04534114|531296269|FG003|Main Treatment Period|Protocol-specified withdrawal criterion met|6|||
147308480|NCT04534114|531296266|FG000|Main Treatment Period|Adverse Event|4|||
147308481|NCT04534114|531296267|FG001|Main Treatment Period|Adverse Event|2|||
147308482|NCT04534114|531296268|FG002|Main Treatment Period|Adverse Event|1|||
147308483|NCT04534114|531296269|FG003|Main Treatment Period|Adverse Event|2|||
147308484|NCT04534114|531296266|FG000|Extension Treatment Period|COVID-19 pandemic: Death|0|||
147308485|NCT04534114|531296267|FG001|Extension Treatment Period|COVID-19 pandemic: Death|0|||
147308486|NCT04534114|531296268|FG002|Extension Treatment Period|COVID-19 pandemic: Death|0|||
147308487|NCT04534114|531296269|FG003|Extension Treatment Period|COVID-19 pandemic: Death|1|||
147308488|NCT04534114|531296266|FG000|Extension Treatment Period|COVID-19 pandemic: withdrawal following protocol|1|||
147308489|NCT04534114|531296267|FG001|Extension Treatment Period|COVID-19 pandemic: withdrawal following protocol|0|||
147308490|NCT04534114|531296268|FG002|Extension Treatment Period|COVID-19 pandemic: withdrawal following protocol|0|||
147308491|NCT04534114|531296269|FG003|Extension Treatment Period|COVID-19 pandemic: withdrawal following protocol|0|||
147308492|NCT04534114|531296266|FG000|Extension Treatment Period|Other reason|0|||
147308493|NCT04534114|531296267|FG001|Extension Treatment Period|Other reason|1|||
147308494|NCT04534114|531296268|FG002|Extension Treatment Period|Other reason|0|||
147308495|NCT04534114|531296269|FG003|Extension Treatment Period|Other reason|0|||
147308496|NCT04534114|531296266|FG000|Extension Treatment Period|Death|0|||
147308497|NCT04534114|531296267|FG001|Extension Treatment Period|Death|0|||
147308498|NCT04534114|531296268|FG002|Extension Treatment Period|Death|1|||
147308499|NCT04534114|531296269|FG003|Extension Treatment Period|Death|2|||
147308500|NCT04534114|531296266|FG000|Extension Treatment Period|Adverse Event|0|||
147308501|NCT04534114|531296267|FG001|Extension Treatment Period|Adverse Event|1|||
147308502|NCT04534114|531296268|FG002|Extension Treatment Period|Adverse Event|0|||
147308503|NCT04534114|531296269|FG003|Extension Treatment Period|Adverse Event|1|||
147308504|NCT04534114|531296266|FG000|Extension Treatment Period|Protocol-specified Withdrawal Criterion Met|2|||
147308505|NCT04534114|531296267|FG001|Extension Treatment Period|Protocol-specified Withdrawal Criterion Met|2|||
147308506|NCT04534114|531296268|FG002|Extension Treatment Period|Protocol-specified Withdrawal Criterion Met|0|||
147308507|NCT04534114|531296269|FG003|Extension Treatment Period|Protocol-specified Withdrawal Criterion Met|1|||
147308508|NCT03287414|531296270|FG000|Treatment Epoch|Adverse Event|0|||
147308509|NCT03287414|531296271|FG001|Treatment Epoch|Adverse Event|1|||
147308510|NCT03287414|531296270|FG000|Treatment Epoch|Study terminated by sponsor|2|||
147308511|NCT03287414|531296271|FG001|Treatment Epoch|Study terminated by sponsor|2|||
147308512|NCT03287414|531296270|FG000|Treatment Epoch|Subject/Guardian decision|4|||
147308513|NCT03287414|531296271|FG001|Treatment Epoch|Subject/Guardian decision|0|||
147308514|NCT03287414|531296270|FG000|Treatment Epoch|"Discontinued early with reason other selected"|1|||
147308515|NCT03287414|531296271|FG001|Treatment Epoch|"Discontinued early with reason other selected"|1|||
147308516|NCT03287414|531296270|FG000|Treatment Epoch|Withdrawal by Subject|1|||
147308517|NCT03287414|531296271|FG001|Treatment Epoch|Withdrawal by Subject|0|||
147308518|NCT03287414|531296270|FG000|PD/Safety Follow-up Epoch|Lost to Follow-up|1|||
147308519|NCT03287414|531296271|FG001|PD/Safety Follow-up Epoch|Lost to Follow-up|0|||
147308520|NCT03287414|531296270|FG000|PD/Safety Follow-up Epoch|Subject/Guardian decision|1|||
147308521|NCT03287414|531296271|FG001|PD/Safety Follow-up Epoch|Subject/Guardian decision|0|||
147308522|NCT02759185|531296272|FG000|Stage 1|Adverse Event|0|||
147308523|NCT02759185|531296273|FG001|Stage 1|Adverse Event|1|||
147308524|NCT02759185|531296274|FG002|Stage 1|Adverse Event|3|||
147308525|NCT02759185|531296275|FG003|Stage 1|Adverse Event|0|||
147308526|NCT02759185|531296276|FG004|Stage 1|Adverse Event|0|||
147552353|NCT01489956|532178593|FG002|Overall Study|Withdrawal by Subject|1|||
147308527|NCT02759185|531296277|FG005|Stage 1|Adverse Event|0|||
147308528|NCT02759185|531296278|FG006|Stage 1|Adverse Event|0|||
147308529|NCT02759185|531296272|FG000|Stage 1|Withdrawal by Subject|1|||
147308530|NCT02759185|531296273|FG001|Stage 1|Withdrawal by Subject|0|||
147308531|NCT02759185|531296274|FG002|Stage 1|Withdrawal by Subject|0|||
147308532|NCT02759185|531296275|FG003|Stage 1|Withdrawal by Subject|0|||
147308533|NCT02759185|531296276|FG004|Stage 1|Withdrawal by Subject|0|||
147308534|NCT02759185|531296277|FG005|Stage 1|Withdrawal by Subject|0|||
147308535|NCT02759185|531296278|FG006|Stage 1|Withdrawal by Subject|0|||
147308536|NCT02759185|531296272|FG000|Stage 2|Adverse Event|0|||
147308537|NCT02759185|531296273|FG001|Stage 2|Adverse Event|0|||
147308538|NCT02759185|531296274|FG002|Stage 2|Adverse Event|0|||
147308539|NCT02759185|531296275|FG003|Stage 2|Adverse Event|0|||
147308540|NCT02759185|531296276|FG004|Stage 2|Adverse Event|1|||
147308541|NCT02759185|531296277|FG005|Stage 2|Adverse Event|2|||
147308542|NCT02759185|531296278|FG006|Stage 2|Adverse Event|0|||
147308543|NCT02759185|531296272|FG000|Stage 2|Withdrawal by Subject|0|||
147308544|NCT02759185|531296273|FG001|Stage 2|Withdrawal by Subject|0|||
147308545|NCT02759185|531296274|FG002|Stage 2|Withdrawal by Subject|0|||
147308546|NCT02759185|531296275|FG003|Stage 2|Withdrawal by Subject|0|||
147308547|NCT02759185|531296276|FG004|Stage 2|Withdrawal by Subject|1|||
147308548|NCT02759185|531296277|FG005|Stage 2|Withdrawal by Subject|1|||
147308549|NCT02759185|531296278|FG006|Stage 2|Withdrawal by Subject|1|||
147308550|NCT01122381|531296286|FG000|Overall Study|study terminated early|0|||
147308551|NCT01122381|531296287|FG001|Overall Study|study terminated early|1|||
147308552|NCT02395133|531296288|FG000|Overall Study|Adverse Event|4|||
147443090|NCT03670953|531787166|FG000|Dose Adjustment (Weeks 1- 3)|Adverse Event|4|||
147220255|NCT00548405|530978608|FG001|Overall Study|Pregnancy|0|||
147220256|NCT00548405|530978609|FG002|Overall Study|Pregnancy|0|||
147220257|NCT00548405|530978607|FG000|Overall Study|Protocol Violation|1|||
147220258|NCT00548405|530978608|FG001|Overall Study|Protocol Violation|0|||
147220259|NCT00548405|530978609|FG002|Overall Study|Protocol Violation|0|||
147220260|NCT00548405|530978607|FG000|Overall Study|Withdrawal by Subject|36|||
147220261|NCT00548405|530978608|FG001|Overall Study|Withdrawal by Subject|12|||
147220262|NCT00548405|530978609|FG002|Overall Study|Withdrawal by Subject|5|||
147220263|NCT00548405|530978607|FG000|Overall Study|Lost to Follow-up|1|||
147220264|NCT00548405|530978608|FG001|Overall Study|Lost to Follow-up|1|||
147220265|NCT00548405|530978609|FG002|Overall Study|Lost to Follow-up|2|||
147220266|NCT00548405|530978607|FG000|Overall Study|Death|0|||
147220267|NCT00548405|530978608|FG001|Overall Study|Death|1|||
147220268|NCT00548405|530978609|FG002|Overall Study|Death|1|||
147220269|NCT00548405|530978607|FG000|Overall Study|Sponsor decision|1|||
147220270|NCT00548405|530978608|FG001|Overall Study|Sponsor decision|0|||
147220271|NCT00548405|530978609|FG002|Overall Study|Sponsor decision|0|||
147220272|NCT00548405|530978607|FG000|Overall Study|Randomized but not treated|1|||
147220273|NCT00548405|530978608|FG001|Overall Study|Randomized but not treated|0|||
147220274|NCT00548405|530978609|FG002|Overall Study|Randomized but not treated|0|||
147220275|NCT01624870|530978610|FG000|Overall Study|Death|19|||
147220276|NCT01624870|530978610|FG000|Overall Study|Withdrawal by Subject|1|||
147220277|NCT01624870|530978610|FG000|Overall Study|CoreValve not implanted|6|||
147220278|NCT01624870|530978610|FG000|Overall Study|Lost to follow up|1|||
147220279|NCT03901456|530978611|FG000|Overall Study|Withdrawal by Subject|0|||
147220280|NCT03901456|530978612|FG001|Overall Study|Withdrawal by Subject|0|||
147220281|NCT03901456|530978613|FG002|Overall Study|Withdrawal by Subject|1|||
147220282|NCT03901456|530978611|FG000|Overall Study|Lost to Follow-up|0|||
147220283|NCT03901456|530978612|FG001|Overall Study|Lost to Follow-up|1|||
147220284|NCT03901456|530978613|FG002|Overall Study|Lost to Follow-up|0|||
147220285|NCT03836001|530978620|FG000|Blinded Phase (2 Months)|Adverse Event|0|||
147220286|NCT03836001|530978621|FG001|Blinded Phase (2 Months)|Adverse Event|1|||
147220287|NCT03836001|530978622|FG002|Blinded Phase (2 Months)|Adverse Event|0|||
147220288|NCT03836001|530978620|FG000|Blinded Phase (2 Months)|Physician Decision|0|||
147220289|NCT03836001|530978621|FG001|Blinded Phase (2 Months)|Physician Decision|1|||
147220290|NCT03836001|530978622|FG002|Blinded Phase (2 Months)|Physician Decision|0|||
147220291|NCT03836001|530978620|FG000|Open-label Extension (3 or 12 Months)|Lost to Follow-up|0|||
147220292|NCT03836001|530978621|FG001|Open-label Extension (3 or 12 Months)|Lost to Follow-up|0|||
147220293|NCT03836001|530978622|FG002|Open-label Extension (3 or 12 Months)|Lost to Follow-up|1|||
147220294|NCT03836001|530978620|FG000|Open-label Extension (3 or 12 Months)|Enrolled in other clinical study|0|||
147220295|NCT03836001|530978621|FG001|Open-label Extension (3 or 12 Months)|Enrolled in other clinical study|0|||
147220296|NCT03836001|530978622|FG002|Open-label Extension (3 or 12 Months)|Enrolled in other clinical study|1|||
147220297|NCT01642732|530978623|FG000|Overall Study|Withdrawal by Subject|1|||
147220298|NCT00402233|530978630|FG000|Overall Study|Adverse Event|1|||
147220299|NCT00402233|530978631|FG001|Overall Study|Adverse Event|7|||
147220300|NCT00402233|530978632|FG002|Overall Study|Adverse Event|9|||
147220301|NCT00402233|530978633|FG003|Overall Study|Adverse Event|9|||
147220302|NCT00402233|530978630|FG000|Overall Study|Protocol Violation|0|||
147220303|NCT00402233|530978631|FG001|Overall Study|Protocol Violation|1|||
147220304|NCT00402233|530978632|FG002|Overall Study|Protocol Violation|0|||
147220305|NCT00402233|530978633|FG003|Overall Study|Protocol Violation|0|||
147220306|NCT00402233|530978630|FG000|Overall Study|Withdrawal by Subject|2|||
147220307|NCT00402233|530978631|FG001|Overall Study|Withdrawal by Subject|1|||
147308553|NCT02395133|531296289|FG001|Overall Study|Adverse Event|1|||
147308554|NCT02395133|531296290|FG002|Overall Study|Adverse Event|3|||
147308555|NCT02395133|531296291|FG003|Overall Study|Adverse Event|0|||
147308556|NCT02395133|531296288|FG000|Overall Study|Lack of Efficacy|1|||
147308557|NCT02395133|531296289|FG001|Overall Study|Lack of Efficacy|0|||
147443091|NCT03670953|531787167|FG001|Dose Adjustment (Weeks 1- 3)|Adverse Event|0|||
147443092|NCT03670953|531787168|FG002|Dose Adjustment (Weeks 1- 3)|Adverse Event|0|||
147308558|NCT02395133|531296290|FG002|Overall Study|Lack of Efficacy|1|||
147308559|NCT02395133|531296291|FG003|Overall Study|Lack of Efficacy|1|||
147308560|NCT02395133|531296288|FG000|Overall Study|Protocol Violation|1|||
147308561|NCT02395133|531296289|FG001|Overall Study|Protocol Violation|1|||
147308562|NCT02395133|531296290|FG002|Overall Study|Protocol Violation|0|||
147308563|NCT02395133|531296291|FG003|Overall Study|Protocol Violation|3|||
147308564|NCT02395133|531296288|FG000|Overall Study|Lost to Follow-up|0|||
147308565|NCT02395133|531296289|FG001|Overall Study|Lost to Follow-up|1|||
147308566|NCT02395133|531296290|FG002|Overall Study|Lost to Follow-up|1|||
147308567|NCT02395133|531296291|FG003|Overall Study|Lost to Follow-up|0|||
147308568|NCT02395133|531296288|FG000|Overall Study|Pregnancy|0|||
147308569|NCT02395133|531296289|FG001|Overall Study|Pregnancy|0|||
147308570|NCT02395133|531296290|FG002|Overall Study|Pregnancy|3|||
147308571|NCT02395133|531296291|FG003|Overall Study|Pregnancy|0|||
147308572|NCT02395133|531296288|FG000|Overall Study|Consent withdrawn with no reason given|1|||
147308573|NCT02395133|531296289|FG001|Overall Study|Consent withdrawn with no reason given|3|||
147308574|NCT02395133|531296290|FG002|Overall Study|Consent withdrawn with no reason given|0|||
147308575|NCT02395133|531296291|FG003|Overall Study|Consent withdrawn with no reason given|2|||
147308576|NCT02395133|531296288|FG000|Overall Study|Consent withdrawn with personal reason|0|||
147308577|NCT02395133|531296289|FG001|Overall Study|Consent withdrawn with personal reason|1|||
147308578|NCT02395133|531296290|FG002|Overall Study|Consent withdrawn with personal reason|0|||
147308579|NCT02395133|531296291|FG003|Overall Study|Consent withdrawn with personal reason|3|||
147220308|NCT00402233|530978632|FG002|Overall Study|Withdrawal by Subject|2|||
147220309|NCT00402233|530978633|FG003|Overall Study|Withdrawal by Subject|2|||
147308580|NCT02395133|531296288|FG000|Overall Study|Sponsor decision|2|||
147308581|NCT02395133|531296289|FG001|Overall Study|Sponsor decision|0|||
147308582|NCT02395133|531296290|FG002|Overall Study|Sponsor decision|0|||
147220310|NCT00402233|530978630|FG000|Overall Study|Worsening of disease under study|2|||
147220311|NCT00402233|530978631|FG001|Overall Study|Worsening of disease under study|0|||
147220312|NCT00402233|530978632|FG002|Overall Study|Worsening of disease under study|0|||
147220313|NCT00402233|530978633|FG003|Overall Study|Worsening of disease under study|0|||
147220314|NCT00402233|530978630|FG000|Overall Study|Worsening of other pre-existing disease|0|||
147220315|NCT00402233|530978631|FG001|Overall Study|Worsening of other pre-existing disease|1|||
147220316|NCT00402233|530978632|FG002|Overall Study|Worsening of other pre-existing disease|0|||
147220317|NCT00402233|530978633|FG003|Overall Study|Worsening of other pre-existing disease|0|||
147220318|NCT00821327|530978634|FG000|Overall Study|Adverse Event|13|||
147220319|NCT00821327|530978634|FG000|Overall Study|Patient Request|1|||
147220320|NCT00821327|530978634|FG000|Overall Study|Investigator Request|2|||
147220321|NCT00821327|530978634|FG000|Overall Study|Sponsor Request|1|||
147220322|NCT00821327|530978634|FG000|Overall Study|Disease Progression|13|||
147220323|NCT00821327|530978634|FG000|Overall Study|Other/Unknown|5|||
147220324|NCT02119676|530978635|FG000|Overall Study|Adverse Event|9|||
147220325|NCT02119676|530978636|FG001|Overall Study|Adverse Event|17|||
147220326|NCT02119676|530978637|FG002|Overall Study|Adverse Event|10|||
147220327|NCT02119676|530978638|FG003|Overall Study|Adverse Event|10|||
147220328|NCT02119676|530978635|FG000|Overall Study|Disease progression|53|||
147220329|NCT02119676|530978636|FG001|Overall Study|Disease progression|55|||
147220330|NCT02119676|530978637|FG002|Overall Study|Disease progression|68|||
147308583|NCT02395133|531296291|FG003|Overall Study|Sponsor decision|1|||
147308584|NCT02395133|531296288|FG000|Overall Study|Other than specified above|5|||
147308585|NCT02395133|531296289|FG001|Overall Study|Other than specified above|2|||
147308586|NCT02395133|531296290|FG002|Overall Study|Other than specified above|2|||
147308587|NCT02395133|531296291|FG003|Overall Study|Other than specified above|4|||
147308588|NCT00962247|531296292|FG000|25% Reduction of Sedentary Activity|Protocol Violation|4|||
147308589|NCT00962247|531296292|FG000|25% Reduction of Sedentary Activity|Withdrawal by Subject|1|||
147308590|NCT01861522|531296295|FG000|Overall Study|Adverse Event|1|||
147308591|NCT01861522|531296296|FG001|Overall Study|Adverse Event|0|||
147220331|NCT02119676|530978638|FG003|Overall Study|Disease progression|73|||
147220332|NCT02119676|530978635|FG000|Overall Study|Patient decision, inc. consent withdrawn|4|||
147220333|NCT02119676|530978636|FG001|Overall Study|Patient decision, inc. consent withdrawn|5|||
147220334|NCT02119676|530978637|FG002|Overall Study|Patient decision, inc. consent withdrawn|5|||
147220335|NCT02119676|530978638|FG003|Overall Study|Patient decision, inc. consent withdrawn|6|||
147220336|NCT02119676|530978635|FG000|Overall Study|Physician Decision|4|||
147220337|NCT02119676|530978636|FG001|Overall Study|Physician Decision|2|||
147220338|NCT02119676|530978637|FG002|Overall Study|Physician Decision|3|||
147220339|NCT02119676|530978638|FG003|Overall Study|Physician Decision|2|||
147220340|NCT02119676|530978635|FG000|Overall Study|Death|9|||
147308592|NCT01861522|531296295|FG000|Overall Study|Withdrawal by Subject|2|||
147308593|NCT01861522|531296296|FG001|Overall Study|Withdrawal by Subject|0|||
147308594|NCT02073097|531296297|FG000|Overall Study|Adverse Event|0|||
147443093|NCT03670953|531787169|FG003|Dose Adjustment (Weeks 1- 3)|Adverse Event|0|||
147308595|NCT02073097|531296298|FG001|Overall Study|Adverse Event|0|||
147308596|NCT02073097|531296299|FG002|Overall Study|Adverse Event|0|||
147308597|NCT02073097|531296300|FG003|Overall Study|Adverse Event|0|||
147308598|NCT02073097|531296301|FG004|Overall Study|Adverse Event|0|||
147308599|NCT02073097|531296302|FG005|Overall Study|Adverse Event|0|||
147308600|NCT02073097|531296303|FG006|Overall Study|Adverse Event|0|||
147308601|NCT02073097|531296304|FG007|Overall Study|Adverse Event|2|||
147308602|NCT02073097|531296297|FG000|Overall Study|Withdrawal by Subject|0|||
147308603|NCT02073097|531296298|FG001|Overall Study|Withdrawal by Subject|0|||
147308604|NCT02073097|531296299|FG002|Overall Study|Withdrawal by Subject|0|||
147308605|NCT02073097|531296300|FG003|Overall Study|Withdrawal by Subject|0|||
147308606|NCT02073097|531296301|FG004|Overall Study|Withdrawal by Subject|0|||
147308607|NCT02073097|531296302|FG005|Overall Study|Withdrawal by Subject|0|||
147308608|NCT02073097|531296303|FG006|Overall Study|Withdrawal by Subject|0|||
147308609|NCT02073097|531296304|FG007|Overall Study|Withdrawal by Subject|2|||
147308610|NCT02073097|531296297|FG000|Overall Study|Death|0|||
147308611|NCT02073097|531296298|FG001|Overall Study|Death|0|||
147308612|NCT02073097|531296299|FG002|Overall Study|Death|0|||
147308613|NCT02073097|531296300|FG003|Overall Study|Death|0|||
147308614|NCT02073097|531296301|FG004|Overall Study|Death|0|||
147308615|NCT02073097|531296302|FG005|Overall Study|Death|0|||
147308616|NCT02073097|531296303|FG006|Overall Study|Death|0|||
147308617|NCT02073097|531296304|FG007|Overall Study|Death|1|||
147308618|NCT02073097|531296297|FG000|Overall Study|Physician Decision|0|||
147308619|NCT02073097|531296298|FG001|Overall Study|Physician Decision|0|||
147308620|NCT02073097|531296299|FG002|Overall Study|Physician Decision|0|||
147308621|NCT02073097|531296300|FG003|Overall Study|Physician Decision|0|||
147308622|NCT02073097|531296301|FG004|Overall Study|Physician Decision|0|||
147308623|NCT02073097|531296302|FG005|Overall Study|Physician Decision|0|||
147308624|NCT02073097|531296303|FG006|Overall Study|Physician Decision|0|||
147308625|NCT02073097|531296304|FG007|Overall Study|Physician Decision|1|||
147308626|NCT00386308|531297759|FG000|Overall Study|Adverse Event|3|||
147308627|NCT00386308|531297760|FG001|Overall Study|Adverse Event|3|||
147308628|NCT00386308|531297759|FG000|Overall Study|Protocol Violation|2|||
147308629|NCT00386308|531297760|FG001|Overall Study|Protocol Violation|5|||
147308630|NCT00386308|531297759|FG000|Overall Study|Lack of Efficacy|0|||
147308631|NCT00386308|531297760|FG001|Overall Study|Lack of Efficacy|2|||
147308632|NCT00386308|531297759|FG000|Overall Study|Lost to Follow-up|10|||
147308633|NCT00386308|531297760|FG001|Overall Study|Lost to Follow-up|6|||
147308634|NCT00386308|531297759|FG000|Overall Study|Withdrawal by Subject|6|||
147308635|NCT00386308|531297760|FG001|Overall Study|Withdrawal by Subject|2|||
147308636|NCT00386308|531297759|FG000|Overall Study|Other Event|8|||
147308637|NCT00386308|531297760|FG001|Overall Study|Other Event|1|||
147308638|NCT01336634|531297761|FG000|Overall Study|Study closed/terminated|5|||
147308639|NCT01336634|531297762|FG001|Overall Study|Study closed/terminated|6|||
147308640|NCT01336634|531297763|FG002|Overall Study|Study closed/terminated|6|||
147308641|NCT01336634|531297761|FG000|Overall Study|Lost to Follow-up|2|||
147308642|NCT01336634|531297762|FG001|Overall Study|Lost to Follow-up|1|||
147308643|NCT01336634|531297763|FG002|Overall Study|Lost to Follow-up|1|||
147308644|NCT01336634|531297761|FG000|Overall Study|Physician Decision|1|||
147308645|NCT01336634|531297762|FG001|Overall Study|Physician Decision|1|||
147308646|NCT01336634|531297763|FG002|Overall Study|Physician Decision|0|||
147308647|NCT01336634|531297761|FG000|Overall Study|Withdrawal by Subject|6|||
147308648|NCT01336634|531297762|FG001|Overall Study|Withdrawal by Subject|0|||
147308649|NCT01336634|531297763|FG002|Overall Study|Withdrawal by Subject|2|||
147308650|NCT02567825|531297770|FG000|Overall Study|No follow-up post-randomization|5|||
147308651|NCT02567825|531297771|FG001|Overall Study|No follow-up post-randomization|1|||
147308652|NCT02567825|531297770|FG000|Overall Study|Follow-up less than 23 months|16|||
147308653|NCT02567825|531297771|FG001|Overall Study|Follow-up less than 23 months|20|||
147308654|NCT04741802|531297772|FG000|Overall Study|Death|1|||
147308655|NCT04741802|531297772|FG000|Overall Study|Lost to Follow-up|11|||
147308656|NCT03101241|531297773|FG000|Overall Study|Intercurrent condition necessitating discontinuation|4|||
147308657|NCT03101241|531297774|FG001|Overall Study|Intercurrent condition necessitating discontinuation|2|||
147308658|NCT03101241|531297773|FG000|Overall Study|Participant withdrew consent|3|||
147308659|NCT03101241|531297774|FG001|Overall Study|Participant withdrew consent|1|||
147308660|NCT03101241|531297773|FG000|Overall Study|Investigator decision that withdrawal was in best interest of participant|2|||
147308661|NCT03101241|531297774|FG001|Overall Study|Investigator decision that withdrawal was in best interest of participant|0|||
147308662|NCT03101241|531297773|FG000|Overall Study|Lost to Follow-up|2|||
147308663|NCT03101241|531297774|FG001|Overall Study|Lost to Follow-up|0|||
147308664|NCT03101241|531297773|FG000|Overall Study|Lack of Efficacy|0|||
147308665|NCT03101241|531297774|FG001|Overall Study|Lack of Efficacy|1|||
147308666|NCT03101241|531297773|FG000|Overall Study|Lack of efficacy/subject withdrew consent|0|||
147308667|NCT03101241|531297774|FG001|Overall Study|Lack of efficacy/subject withdrew consent|1|||
147308668|NCT01381874|531297775|FG000|Overall Study|Lost to Follow-up|1|||
147308669|NCT01381874|531297776|FG001|Overall Study|Lost to Follow-up|1|||
147308670|NCT01381874|531297777|FG002|Overall Study|Lost to Follow-up|0|||
147308671|NCT01381874|531297775|FG000|Overall Study|Withdrawal by Subject|9|||
147308672|NCT01381874|531297776|FG001|Overall Study|Withdrawal by Subject|10|||
147308673|NCT01381874|531297777|FG002|Overall Study|Withdrawal by Subject|9|||
147308674|NCT01381874|531297775|FG000|Overall Study|Other|67|||
147308675|NCT01381874|531297776|FG001|Overall Study|Other|52|||
147308676|NCT01381874|531297777|FG002|Overall Study|Other|67|||
147308677|NCT04488003|531297778|FG000|Assessed for Eligibility|Screen Failure|24|||
147308678|NCT04488003|531297779|FG001|Assessed for Eligibility|Screen Failure|0|||
147308679|NCT04488003|531297780|FG002|Assessed for Eligibility|Screen Failure|0|||
147308680|NCT04488003|531297778|FG000|Assessed for Eligibility|Adverse Event|1|||
147308681|NCT04488003|531297779|FG001|Assessed for Eligibility|Adverse Event|0|||
147308682|NCT04488003|531297780|FG002|Assessed for Eligibility|Adverse Event|0|||
147308683|NCT04488003|531297778|FG000|Assessed for Eligibility|Death|1|||
147308684|NCT04488003|531297779|FG001|Assessed for Eligibility|Death|0|||
147308685|NCT04488003|531297780|FG002|Assessed for Eligibility|Death|0|||
147308686|NCT04488003|531297778|FG000|Assessed for Eligibility|Physician Decision|1|||
147308687|NCT04488003|531297779|FG001|Assessed for Eligibility|Physician Decision|0|||
147308688|NCT04488003|531297780|FG002|Assessed for Eligibility|Physician Decision|0|||
147308689|NCT04488003|531297778|FG000|Allocated to Treatment|Progressive Disease|51|||
147308690|NCT04488003|531297779|FG001|Allocated to Treatment|Progressive Disease|0|||
147308691|NCT04488003|531297780|FG002|Allocated to Treatment|Progressive Disease|0|||
147308692|NCT04488003|531297778|FG000|Allocated to Treatment|Withdrawal by Subject|7|||
147308693|NCT04488003|531297779|FG001|Allocated to Treatment|Withdrawal by Subject|0|||
147308694|NCT04488003|531297780|FG002|Allocated to Treatment|Withdrawal by Subject|0|||
147308695|NCT04488003|531297778|FG000|Allocated to Treatment|Adverse Event|6|||
147308696|NCT04488003|531297779|FG001|Allocated to Treatment|Adverse Event|0|||
147308697|NCT04488003|531297780|FG002|Allocated to Treatment|Adverse Event|0|||
147308698|NCT04488003|531297778|FG000|Allocated to Treatment|Other|5|||
147308699|NCT04488003|531297779|FG001|Allocated to Treatment|Other|0|||
147308700|NCT04488003|531297780|FG002|Allocated to Treatment|Other|0|||
147308701|NCT04488003|531297778|FG000|Allocated to Treatment|Physician Decision|4|||
147308702|NCT04488003|531297779|FG001|Allocated to Treatment|Physician Decision|0|||
147308703|NCT04488003|531297780|FG002|Allocated to Treatment|Physician Decision|0|||
147308704|NCT04488003|531297778|FG000|Allocated to Treatment|Death|4|||
147308705|NCT04488003|531297779|FG001|Allocated to Treatment|Death|0|||
147308706|NCT04488003|531297780|FG002|Allocated to Treatment|Death|0|||
147308707|NCT01248962|531297781|FG000|Overall Study|Withdrawal by Subject|1|||
147308708|NCT01248962|531297782|FG001|Overall Study|Withdrawal by Subject|1|||
147308709|NCT01248962|531297781|FG000|Overall Study|Adverse Event|2|||
147308710|NCT01248962|531297782|FG001|Overall Study|Adverse Event|1|||
147308711|NCT01248962|531297781|FG000|Overall Study|Complete Response after 4 Cycles|1|||
147308712|NCT01248962|531297782|FG001|Overall Study|Complete Response after 4 Cycles|0|||
147308713|NCT01248962|531297781|FG000|Overall Study|Complete Response after 3 Cycles|0|||
147308714|NCT01248962|531297782|FG001|Overall Study|Complete Response after 3 Cycles|1|||
147308715|NCT01248962|531297781|FG000|Overall Study|Progression of Disease prior to 5 Cycles|12|||
147308716|NCT01248962|531297782|FG001|Overall Study|Progression of Disease prior to 5 Cycles|13|||
147308717|NCT01003184|531297783|FG000|Overall Study|Adverse Event|12|||
147308718|NCT01003184|531297784|FG001|Overall Study|Adverse Event|5|||
147308719|NCT01003184|531297783|FG000|Overall Study|Lost to Follow-up|1|||
147308720|NCT01003184|531297784|FG001|Overall Study|Lost to Follow-up|0|||
147308721|NCT01003184|531297783|FG000|Overall Study|Loss of glucose control|1|||
147308722|NCT01003184|531297784|FG001|Overall Study|Loss of glucose control|1|||
147308723|NCT01003184|531297783|FG000|Overall Study|Protocol Violation|3|||
147308724|NCT01003184|531297784|FG001|Overall Study|Protocol Violation|0|||
147308725|NCT01003184|531297783|FG000|Overall Study|Withdrawal by Subject|1|||
147308726|NCT01003184|531297784|FG001|Overall Study|Withdrawal by Subject|6|||
147308727|NCT01003184|531297783|FG000|Overall Study|Physician Decision|1|||
147308728|NCT01003184|531297784|FG001|Overall Study|Physician Decision|0|||
147308729|NCT00557622|531297785|FG000|4-Week Run-in Phase|Withdrawal by Subject|1|||
147308730|NCT00557622|531297786|FG001|4-Week Run-in Phase|Withdrawal by Subject|0|||
147308731|NCT00557622|531297785|FG000|4-Week Run-in Phase|Protocol-defined stopping criteria|1|||
147308732|NCT00557622|531297786|FG001|4-Week Run-in Phase|Protocol-defined stopping criteria|0|||
147308733|NCT00557622|531297785|FG000|12-Week Treatment Phase|Lost to Follow-up|0|||
147308734|NCT00557622|531297786|FG001|12-Week Treatment Phase|Lost to Follow-up|1|||
147308735|NCT04848662|531297787|FG000|Period 2 (Second Treatment Intervention)|Physician Decision|1|||
147308736|NCT04848662|531297788|FG001|Period 2 (Second Treatment Intervention)|Physician Decision|0|||
147308737|NCT03151395|531297795|FG000|Overall Study|Adverse Event|2|||
147649967|NCT00703118|532539770|FG002|Overall Study|Lost to Follow-up|4|||
147308738|NCT03151395|531297795|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|6|||
147308739|NCT03151395|531297795|FG000|Overall Study|Subjects could not perform last visit before study completion date due to local COVID19 restrictions|3|||
147308740|NCT03151395|531297795|FG000|Overall Study|Unspecified reason|4|||
147308741|NCT02494206|531297809|FG000|Overall Study|Adverse Event|1|||
147308742|NCT02494206|531297809|FG000|Overall Study|Disease Progression|1|||
147308743|NCT05796518|531297812|FG000|Overall Study|Were enrolled but did not complete the intervention|2|||
147308744|NCT01535274|531297813|FG000|Overall Study|Determined to be ineligible|0|||
147308745|NCT01535274|531297814|FG001|Overall Study|Determined to be ineligible|1|||
147308746|NCT01535274|531297813|FG000|Overall Study|Misallocated to propofol intervention|0|||
147308747|NCT01535274|531297814|FG001|Overall Study|Misallocated to propofol intervention|1|||
147308748|NCT02690077|531297815|FG000|Overall Study|Excluded from analyses for no OR worksheet or questionnaire completed|5|||
147308749|NCT02690077|531297816|FG001|Overall Study|Excluded from analyses for no OR worksheet or questionnaire completed|8|||
147308750|NCT02690077|531297815|FG000|Overall Study|Withdrawal by Subject|0|||
147308751|NCT02690077|531297816|FG001|Overall Study|Withdrawal by Subject|5|||
147308752|NCT02690077|531297815|FG000|Overall Study|Excluded by IRB|0|||
147308753|NCT02690077|531297816|FG001|Overall Study|Excluded by IRB|2|||
147308754|NCT02667886|531297817|FG000|Dose Escalation (Part A)|Adverse Event|1|||
147308755|NCT02667886|531297818|FG001|Dose Escalation (Part A)|Adverse Event|3|||
147308756|NCT02667886|531297819|FG002|Dose Escalation (Part A)|Adverse Event|1|||
147308757|NCT02667886|531297820|FG003|Dose Escalation (Part A)|Adverse Event|0|||
147308758|NCT02667886|531297821|FG004|Dose Escalation (Part A)|Adverse Event|0|||
147308759|NCT02667886|531297817|FG000|Dose Escalation (Part A)|Disease Progression|1|||
147308760|NCT02667886|531297818|FG001|Dose Escalation (Part A)|Disease Progression|4|||
147220341|NCT02119676|530978636|FG001|Overall Study|Death|3|||
147220342|NCT02119676|530978637|FG002|Overall Study|Death|2|||
147220343|NCT02119676|530978638|FG003|Overall Study|Death|1|||
147220344|NCT02119676|530978635|FG000|Overall Study|Noncompliance|0|||
147220345|NCT02119676|530978636|FG001|Overall Study|Noncompliance|1|||
147220346|NCT02119676|530978637|FG002|Overall Study|Noncompliance|0|||
147220347|NCT02119676|530978638|FG003|Overall Study|Noncompliance|0|||
147220348|NCT02119676|530978635|FG000|Overall Study|Lost to Follow-up|0|||
147220349|NCT02119676|530978636|FG001|Overall Study|Lost to Follow-up|0|||
147220350|NCT02119676|530978637|FG002|Overall Study|Lost to Follow-up|1|||
147220351|NCT02119676|530978638|FG003|Overall Study|Lost to Follow-up|0|||
147220352|NCT02119676|530978635|FG000|Overall Study|Protocol deviation|0|||
147220353|NCT02119676|530978636|FG001|Overall Study|Protocol deviation|0|||
147220354|NCT02119676|530978637|FG002|Overall Study|Protocol deviation|1|||
147220355|NCT02119676|530978638|FG003|Overall Study|Protocol deviation|0|||
147220356|NCT02119676|530978635|FG000|Overall Study|Other, unspecified|2|||
147220357|NCT02119676|530978636|FG001|Overall Study|Other, unspecified|1|||
147220358|NCT02119676|530978637|FG002|Overall Study|Other, unspecified|3|||
147220359|NCT02119676|530978638|FG003|Overall Study|Other, unspecified|4|||
147220360|NCT02119676|530978635|FG000|Overall Study|Did not receive study med|2|||
147220361|NCT02119676|530978636|FG001|Overall Study|Did not receive study med|2|||
147220362|NCT02119676|530978637|FG002|Overall Study|Did not receive study med|4|||
147220363|NCT02119676|530978638|FG003|Overall Study|Did not receive study med|5|||
147220364|NCT00278915|530978641|FG000|Overall Study|Disease progression|1|||
147220365|NCT01007253|530978642|FG000|Washout Period (2 Weeks) # 3|Physician Decision|1|||
147220366|NCT01007253|530978643|FG001|Washout Period (2 Weeks) # 3|Physician Decision|0|||
147220367|NCT01007253|530978644|FG002|Washout Period (2 Weeks) # 3|Physician Decision|0|||
147220368|NCT01007253|530978645|FG003|Washout Period (2 Weeks) # 3|Physician Decision|0|||
147220369|NCT02486718|530978646|FG000|Enrollment Phase|Death|19|||
147220370|NCT02486718|530978647|FG001|Enrollment Phase|Death|0|||
147220371|NCT02486718|530978648|FG002|Enrollment Phase|Death|0|||
147220372|NCT02486718|530978646|FG000|Enrollment Phase|Symptomatic deterioration|1|||
147220373|NCT02486718|530978647|FG001|Enrollment Phase|Symptomatic deterioration|0|||
147220374|NCT02486718|530978648|FG002|Enrollment Phase|Symptomatic deterioration|0|||
147220375|NCT02486718|530978646|FG000|Enrollment Phase|Withdrawal by Subject|86|||
147220376|NCT02486718|530978647|FG001|Enrollment Phase|Withdrawal by Subject|0|||
147220377|NCT02486718|530978648|FG002|Enrollment Phase|Withdrawal by Subject|0|||
147220378|NCT02486718|530978646|FG000|Enrollment Phase|Protocol Violation|18|||
147220379|NCT02486718|530978647|FG001|Enrollment Phase|Protocol Violation|0|||
147220380|NCT02486718|530978648|FG002|Enrollment Phase|Protocol Violation|0|||
147220381|NCT02486718|530978646|FG000|Enrollment Phase|Physician Decision|18|||
147220382|NCT02486718|530978647|FG001|Enrollment Phase|Physician Decision|0|||
147220383|NCT02486718|530978648|FG002|Enrollment Phase|Physician Decision|0|||
147220384|NCT02486718|530978646|FG000|Enrollment Phase|Reason not provided|41|||
147308761|NCT02667886|531297819|FG002|Dose Escalation (Part A)|Disease Progression|3|||
147308762|NCT02667886|531297820|FG003|Dose Escalation (Part A)|Disease Progression|0|||
147308763|NCT02667886|531297821|FG004|Dose Escalation (Part A)|Disease Progression|0|||
147308764|NCT02667886|531297817|FG000|Dose Escalation (Part A)|Dose-limiting toxicity (DLT)|0|||
147308765|NCT02667886|531297818|FG001|Dose Escalation (Part A)|Dose-limiting toxicity (DLT)|0|||
147308766|NCT02667886|531297819|FG002|Dose Escalation (Part A)|Dose-limiting toxicity (DLT)|2|||
147308767|NCT02667886|531297820|FG003|Dose Escalation (Part A)|Dose-limiting toxicity (DLT)|0|||
147308768|NCT02667886|531297821|FG004|Dose Escalation (Part A)|Dose-limiting toxicity (DLT)|0|||
147308769|NCT02667886|531297817|FG000|Dose Expansion (Part B)|Adverse Event|0|||
147308770|NCT02667886|531297818|FG001|Dose Expansion (Part B)|Adverse Event|0|||
147552354|NCT00718159|532178596|FG000|Overall Study|Progressive Disease|3|||
147220385|NCT02486718|530978647|FG001|Enrollment Phase|Reason not provided|0|||
147220386|NCT02486718|530978648|FG002|Enrollment Phase|Reason not provided|0|||
147220387|NCT02486718|530978646|FG000|Enrollment Phase|Disease relapse|54|||
147220388|NCT02486718|530978647|FG001|Enrollment Phase|Disease relapse|0|||
147220389|NCT02486718|530978648|FG002|Enrollment Phase|Disease relapse|0|||
147220390|NCT02486718|530978646|FG000|Enrollment Phase|Lost to Follow-up|4|||
147308771|NCT02667886|531297819|FG002|Dose Expansion (Part B)|Adverse Event|0|||
147308772|NCT02667886|531297820|FG003|Dose Expansion (Part B)|Adverse Event|9|||
147308773|NCT02667886|531297821|FG004|Dose Expansion (Part B)|Adverse Event|0|||
147308774|NCT02667886|531297817|FG000|Dose Expansion (Part B)|Clinical Deterioration|0|||
147308775|NCT02667886|531297818|FG001|Dose Expansion (Part B)|Clinical Deterioration|0|||
147308776|NCT02667886|531297819|FG002|Dose Expansion (Part B)|Clinical Deterioration|0|||
147308777|NCT02667886|531297820|FG003|Dose Expansion (Part B)|Clinical Deterioration|3|||
147308778|NCT02667886|531297821|FG004|Dose Expansion (Part B)|Clinical Deterioration|0|||
147308779|NCT02667886|531297817|FG000|Dose Expansion (Part B)|Disease Progression|0|||
147308780|NCT02667886|531297818|FG001|Dose Expansion (Part B)|Disease Progression|0|||
147308781|NCT02667886|531297819|FG002|Dose Expansion (Part B)|Disease Progression|0|||
147308782|NCT02667886|531297820|FG003|Dose Expansion (Part B)|Disease Progression|38|||
147308783|NCT02667886|531297821|FG004|Dose Expansion (Part B)|Disease Progression|0|||
147308784|NCT02667886|531297817|FG000|Dose Expansion (Part B)|Withdrawal by Subject|0|||
147308785|NCT02667886|531297818|FG001|Dose Expansion (Part B)|Withdrawal by Subject|0|||
147308786|NCT02667886|531297819|FG002|Dose Expansion (Part B)|Withdrawal by Subject|0|||
147308787|NCT02667886|531297820|FG003|Dose Expansion (Part B)|Withdrawal by Subject|4|||
147308788|NCT02667886|531297821|FG004|Dose Expansion (Part B)|Withdrawal by Subject|0|||
147308789|NCT02667886|531297817|FG000|Dose Escalation and Expansion (Part C)|Adverse Event|0|||
147308790|NCT02667886|531297818|FG001|Dose Escalation and Expansion (Part C)|Adverse Event|0|||
147308791|NCT02667886|531297819|FG002|Dose Escalation and Expansion (Part C)|Adverse Event|0|||
147308792|NCT02667886|531297820|FG003|Dose Escalation and Expansion (Part C)|Adverse Event|0|||
147308793|NCT02667886|531297821|FG004|Dose Escalation and Expansion (Part C)|Adverse Event|1|||
147308794|NCT02667886|531297817|FG000|Dose Escalation and Expansion (Part C)|DLT|0|||
147308795|NCT02667886|531297818|FG001|Dose Escalation and Expansion (Part C)|DLT|0|||
147308796|NCT02667886|531297819|FG002|Dose Escalation and Expansion (Part C)|DLT|0|||
147308797|NCT02667886|531297820|FG003|Dose Escalation and Expansion (Part C)|DLT|0|||
147308798|NCT02667886|531297821|FG004|Dose Escalation and Expansion (Part C)|DLT|2|||
147308799|NCT00594217|531297822|FG000|Overall Study|Withdrawal by Subject|1|||
147308800|NCT00594217|531297823|FG001|Overall Study|Withdrawal by Subject|3|||
147308801|NCT04186403|531297824|FG000|Overall Study|Adverse Event|1|||
147308802|NCT04186403|531297825|FG001|Overall Study|Adverse Event|8|||
147308803|NCT04186403|531297824|FG000|Overall Study|Lost to Follow-up|7|||
147308804|NCT04186403|531297825|FG001|Overall Study|Lost to Follow-up|3|||
147308805|NCT04186403|531297824|FG000|Overall Study|Physician Decision|1|||
147308806|NCT04186403|531297825|FG001|Overall Study|Physician Decision|0|||
147308807|NCT04186403|531297824|FG000|Overall Study|Withdrawal by Subject|7|||
147308808|NCT04186403|531297825|FG001|Overall Study|Withdrawal by Subject|8|||
147308809|NCT04186403|531297824|FG000|Overall Study|Other: Not Related to Covid-19|3|||
147308810|NCT04186403|531297825|FG001|Overall Study|Other: Not Related to Covid-19|0|||
147308811|NCT01407354|531297826|FG000|First Intervention|Withdrawal by Subject|0|||
147308812|NCT01407354|531297827|FG001|First Intervention|Withdrawal by Subject|2|||
147308813|NCT01407354|531297826|FG000|First Intervention|Adverse Event|1|||
147308814|NCT01407354|531297827|FG001|First Intervention|Adverse Event|0|||
147308815|NCT01407354|531297826|FG000|First Intervention|Physician Decision|1|||
147308816|NCT01407354|531297827|FG001|First Intervention|Physician Decision|0|||
147308817|NCT02223754|531297828|FG000|Period 1|Adverse Event|1|||
147308818|NCT02223754|531297829|FG001|Period 1|Adverse Event|0|||
147308819|NCT02223754|531297828|FG000|Period 1|Lost to Follow-up|0|||
147308820|NCT02223754|531297829|FG001|Period 1|Lost to Follow-up|1|||
147308821|NCT02223754|531297828|FG000|Period 1|Protocol Violation|2|||
147308822|NCT02223754|531297829|FG001|Period 1|Protocol Violation|4|||
147308823|NCT02223754|531297828|FG000|Period 1|Withdrawal by Subject|0|||
147220391|NCT02486718|530978647|FG001|Enrollment Phase|Lost to Follow-up|0|||
147220392|NCT02486718|530978648|FG002|Enrollment Phase|Lost to Follow-up|0|||
147220393|NCT02486718|530978646|FG000|Enrollment Phase|Adverse Event|34|||
147220394|NCT02486718|530978647|FG001|Enrollment Phase|Adverse Event|0|||
147220395|NCT02486718|530978648|FG002|Enrollment Phase|Adverse Event|0|||
147220396|NCT02486718|530978646|FG000|Randomized Phase|Withdrawal by Subject|0|||
147220397|NCT02486718|530978647|FG001|Randomized Phase|Withdrawal by Subject|44|||
147220398|NCT02486718|530978648|FG002|Randomized Phase|Withdrawal by Subject|47|||
147308824|NCT02223754|531297829|FG001|Period 1|Withdrawal by Subject|4|||
147308825|NCT02223754|531297828|FG000|Period 1|Test Article No Longer Available|1|||
147308826|NCT02223754|531297829|FG001|Period 1|Test Article No Longer Available|5|||
147308827|NCT02223754|531297828|FG000|Period 1|Unsatisfactory Visual Response|0|||
147308828|NCT02223754|531297829|FG001|Period 1|Unsatisfactory Visual Response|1|||
147220399|NCT02486718|530978646|FG000|Randomized Phase|Protocol Violation|0|||
147220400|NCT02486718|530978647|FG001|Randomized Phase|Protocol Violation|2|||
147220401|NCT02486718|530978648|FG002|Randomized Phase|Protocol Violation|0|||
147220402|NCT02486718|530978646|FG000|Randomized Phase|Physician Decision|0|||
147308829|NCT02223754|531297828|FG000|Period 2|Adverse Event|0|||
147308830|NCT02223754|531297829|FG001|Period 2|Adverse Event|1|||
147308831|NCT02223754|531297828|FG000|Period 2|Protocol Violation|1|||
147308832|NCT02223754|531297829|FG001|Period 2|Protocol Violation|0|||
147308833|NCT02223754|531297828|FG000|Period 2|Lens Discomfort|1|||
147220403|NCT02486718|530978647|FG001|Randomized Phase|Physician Decision|0|||
147308834|NCT02223754|531297829|FG001|Period 2|Lens Discomfort|1|||
147308835|NCT02223754|531297828|FG000|Period 2|Lost to Follow-up|1|||
147308836|NCT02223754|531297829|FG001|Period 2|Lost to Follow-up|0|||
147308837|NCT02223754|531297828|FG000|Period 2|Test Article No Longer Available|0|||
147308838|NCT02223754|531297829|FG001|Period 2|Test Article No Longer Available|1|||
147308839|NCT01807650|531297837|FG000|Overall Study|Lack of Full Wound Closure at Day 28|13|||
147308840|NCT01807650|531297837|FG000|Overall Study|Adverse Event|5|||
147308841|NCT01807650|531297837|FG000|Overall Study|Other|2|||
147308842|NCT02946918|531297844|FG000|Overall Study|Patient unblinded himself|1|||
147308843|NCT02946918|531297845|FG001|Overall Study|Patient unblinded himself|0|||
147308844|NCT02946918|531297844|FG000|Overall Study|Physician Decision|0|||
147308845|NCT02946918|531297845|FG001|Overall Study|Physician Decision|2|||
147308846|NCT02946918|531297844|FG000|Overall Study|Ran out of study medication|0|||
147308847|NCT02946918|531297845|FG001|Overall Study|Ran out of study medication|1|||
147308848|NCT02716038|531297846|FG000|Overall Study|Not evaluable|1|||
147308849|NCT02716038|531297846|FG000|Overall Study|Not brought to surgery due to brain metastasis|1|||
147308850|NCT02716038|531297846|FG000|Overall Study|Unresectable|3|||
147308851|NCT00069784|531297847|FG000|Overall Study|Adverse Event|105|||
147308852|NCT00069784|531297848|FG001|Overall Study|Adverse Event|0|||
147308853|NCT00069784|531297847|FG000|Overall Study|Withdrawal by Subject|1090|||
147308854|NCT00069784|531297848|FG001|Overall Study|Withdrawal by Subject|0|||
147308855|NCT00069784|531297847|FG000|Overall Study|Other|17|||
147308856|NCT00069784|531297848|FG001|Overall Study|Other|0|||
147308857|NCT02669095|531297854|FG000|Overall Study|Adverse Event|1|||
147308858|NCT02669095|531297855|FG001|Overall Study|Adverse Event|0|||
147308859|NCT02669095|531297854|FG000|Overall Study|Unsatisfactory Lens Fitting|0|||
147308860|NCT02669095|531297855|FG001|Overall Study|Unsatisfactory Lens Fitting|1|||
147308861|NCT02669095|531297854|FG000|Overall Study|Torn Lens|0|||
147308862|NCT02669095|531297855|FG001|Overall Study|Torn Lens|1|||
147308863|NCT02669095|531297854|FG000|Overall Study|Visit 5 assessments not completed|0|||
147308864|NCT02669095|531297855|FG001|Overall Study|Visit 5 assessments not completed|1|||
147308865|NCT00886639|531297859|FG000|Overall Study|acute exacerbation|14|||
147308866|NCT00886639|531297859|FG000|Overall Study|non-compliance|2|||
147308867|NCT00926003|531297860|FG000|Post-Training Evaluation|Withdrawal by Subject|1|||
147308868|NCT00926003|531297861|FG001|Post-Training Evaluation|Withdrawal by Subject|0|||
147308869|NCT00926003|531297862|FG002|Post-Training Evaluation|Withdrawal by Subject|0|||
147308870|NCT00926003|531297860|FG000|Post-Training 3-month Follow-up|Lost to Follow-up|1|||
147308871|NCT00926003|531297861|FG001|Post-Training 3-month Follow-up|Lost to Follow-up|0|||
147308872|NCT00926003|531297862|FG002|Post-Training 3-month Follow-up|Lost to Follow-up|0|||
147308873|NCT01871558|531297865|FG000|Overall Study|Other reason|0|||
147308874|NCT01871558|531297866|FG001|Overall Study|Other reason|1|||
147308875|NCT01871558|531297865|FG000|Overall Study|antidiabetic drug prematurely stopped|1|||
147308876|NCT01871558|531297866|FG001|Overall Study|antidiabetic drug prematurely stopped|1|||
147308877|NCT01871558|531297865|FG000|Overall Study|Withdrawal by Subject|2|||
147308878|NCT01871558|531297866|FG001|Overall Study|Withdrawal by Subject|0|||
147308879|NCT03203694|531297867|FG000|Overall Study|Withdrawal by Subject|2|||
147308880|NCT03203694|531297868|FG001|Overall Study|Withdrawal by Subject|0|||
147308881|NCT03203694|531297869|FG002|Overall Study|Withdrawal by Subject|0|||
147308882|NCT03203694|531297870|FG003|Overall Study|Withdrawal by Subject|0|||
147308883|NCT03203694|531297871|FG004|Overall Study|Withdrawal by Subject|0|||
147308884|NCT03203694|531297872|FG005|Overall Study|Withdrawal by Subject|0|||
147308885|NCT01709305|531297875|FG000|Phase 1|Clinical Adverse Event|80|||
147308886|NCT01709305|531297876|FG001|Phase 1|Clinical Adverse Event|0|||
147308887|NCT01709305|531297877|FG002|Phase 1|Clinical Adverse Event|0|||
147308888|NCT01709305|531297878|FG003|Phase 1|Clinical Adverse Event|0|||
147308889|NCT01709305|531297879|FG004|Phase 1|Clinical Adverse Event|0|||
147308890|NCT01709305|531297875|FG000|Phase 1|Death|2|||
147308891|NCT01709305|531297876|FG001|Phase 1|Death|0|||
147308892|NCT01709305|531297877|FG002|Phase 1|Death|0|||
147308893|NCT01709305|531297878|FG003|Phase 1|Death|0|||
147308894|NCT01709305|531297879|FG004|Phase 1|Death|0|||
147308895|NCT01709305|531297875|FG000|Phase 1|Hyperglycemia (lack of efficacy)|13|||
147308896|NCT01709305|531297876|FG001|Phase 1|Hyperglycemia (lack of efficacy)|0|||
147308897|NCT01709305|531297877|FG002|Phase 1|Hyperglycemia (lack of efficacy)|0|||
147308898|NCT01709305|531297878|FG003|Phase 1|Hyperglycemia (lack of efficacy)|0|||
147308899|NCT01709305|531297879|FG004|Phase 1|Hyperglycemia (lack of efficacy)|0|||
147649968|NCT00703118|532539768|FG000|Overall Study|Withdrawal by Subject|8|||
147308900|NCT01709305|531297875|FG000|Phase 1|Laboratory Adverse Event|16|||
147308901|NCT01709305|531297876|FG001|Phase 1|Laboratory Adverse Event|0|||
147308902|NCT01709305|531297877|FG002|Phase 1|Laboratory Adverse Event|0|||
147308903|NCT01709305|531297878|FG003|Phase 1|Laboratory Adverse Event|0|||
147308904|NCT01709305|531297879|FG004|Phase 1|Laboratory Adverse Event|0|||
147308905|NCT01709305|531297875|FG000|Phase 1|Lost to Follow-up|147|||
147308906|NCT01709305|531297876|FG001|Phase 1|Lost to Follow-up|0|||
147308907|NCT01709305|531297877|FG002|Phase 1|Lost to Follow-up|0|||
147308908|NCT01709305|531297878|FG003|Phase 1|Lost to Follow-up|0|||
147308909|NCT01709305|531297879|FG004|Phase 1|Lost to Follow-up|0|||
147308910|NCT01709305|531297875|FG000|Phase 1|Travel, moving, etc.|30|||
147308911|NCT01709305|531297876|FG001|Phase 1|Travel, moving, etc.|0|||
147308912|NCT01709305|531297877|FG002|Phase 1|Travel, moving, etc.|0|||
147308913|NCT01709305|531297878|FG003|Phase 1|Travel, moving, etc.|0|||
147308914|NCT01709305|531297879|FG004|Phase 1|Travel, moving, etc.|0|||
147308915|NCT01709305|531297875|FG000|Phase 1|Physician Decision|13|||
147308916|NCT01709305|531297876|FG001|Phase 1|Physician Decision|0|||
147308917|NCT01709305|531297877|FG002|Phase 1|Physician Decision|0|||
147308918|NCT01709305|531297878|FG003|Phase 1|Physician Decision|0|||
147308919|NCT01709305|531297879|FG004|Phase 1|Physician Decision|0|||
147308920|NCT01709305|531297875|FG000|Phase 1|Protocol Violation|118|||
147308921|NCT01709305|531297876|FG001|Phase 1|Protocol Violation|0|||
147308922|NCT01709305|531297877|FG002|Phase 1|Protocol Violation|0|||
147308923|NCT01709305|531297878|FG003|Phase 1|Protocol Violation|0|||
147308924|NCT01709305|531297879|FG004|Phase 1|Protocol Violation|0|||
147308925|NCT01709305|531297875|FG000|Phase 1|Withdrawal by Subject|218|||
147308926|NCT01709305|531297876|FG001|Phase 1|Withdrawal by Subject|0|||
147308927|NCT01709305|531297877|FG002|Phase 1|Withdrawal by Subject|0|||
147308928|NCT01709305|531297878|FG003|Phase 1|Withdrawal by Subject|0|||
147308929|NCT01709305|531297879|FG004|Phase 1|Withdrawal by Subject|0|||
147552355|NCT00718159|532178597|FG001|Overall Study|Progressive Disease|3|||
147220404|NCT02486718|530978648|FG002|Randomized Phase|Physician Decision|3|||
147220405|NCT02486718|530978646|FG000|Randomized Phase|Lost to Follow-up|0|||
147220406|NCT02486718|530978647|FG001|Randomized Phase|Lost to Follow-up|5|||
147220407|NCT02486718|530978648|FG002|Randomized Phase|Lost to Follow-up|11|||
147220408|NCT02486718|530978646|FG000|Randomized Phase|Disease Relapse|0|||
147220409|NCT02486718|530978647|FG001|Randomized Phase|Disease Relapse|1|||
147220410|NCT02486718|530978648|FG002|Randomized Phase|Disease Relapse|0|||
147220411|NCT02486718|530978646|FG000|Randomized Phase|Death|0|||
147220412|NCT02486718|530978647|FG001|Randomized Phase|Death|154|||
147220413|NCT02486718|530978648|FG002|Randomized Phase|Death|155|||
147220414|NCT02486718|530978646|FG000|Randomized Phase|Ongoing|0|||
147220415|NCT02486718|530978647|FG001|Randomized Phase|Ongoing|301|||
147220416|NCT02486718|530978648|FG002|Randomized Phase|Ongoing|282|||
147220417|NCT02093351|530980110|FG000|Part A|Adverse Event|0|||
147220418|NCT02093351|530980111|FG001|Part A|Adverse Event|1|||
147220419|NCT02093351|530980112|FG002|Part A|Adverse Event|1|||
147220420|NCT02093351|530980113|FG003|Part A|Adverse Event|0|||
147220421|NCT02093351|530980110|FG000|Part A|Condition under investigation worsened|2|||
147220422|NCT02093351|530980111|FG001|Part A|Condition under investigation worsened|0|||
147220423|NCT02093351|530980112|FG002|Part A|Condition under investigation worsened|2|||
147220424|NCT02093351|530980113|FG003|Part A|Condition under investigation worsened|0|||
147220425|NCT02093351|530980110|FG000|Part A|Death|0|||
147220426|NCT02093351|530980111|FG001|Part A|Death|1|||
147220427|NCT02093351|530980112|FG002|Part A|Death|0|||
147220428|NCT02093351|530980113|FG003|Part A|Death|0|||
147220429|NCT02093351|530980110|FG000|Part B|Patient decision|0|||
147220430|NCT02093351|530980111|FG001|Part B|Patient decision|0|||
147220431|NCT02093351|530980112|FG002|Part B|Patient decision|0|||
147220432|NCT02093351|530980113|FG003|Part B|Patient decision|3|||
147220433|NCT02093351|530980110|FG000|Part B|Disease progression|0|||
147220434|NCT02093351|530980111|FG001|Part B|Disease progression|0|||
147220435|NCT02093351|530980112|FG002|Part B|Disease progression|0|||
147220436|NCT02093351|530980113|FG003|Part B|Disease progression|4|||
147220437|NCT02093351|530980110|FG000|Part B|Complete response|0|||
147220438|NCT02093351|530980111|FG001|Part B|Complete response|0|||
147220439|NCT02093351|530980112|FG002|Part B|Complete response|0|||
147220440|NCT02093351|530980113|FG003|Part B|Complete response|1|||
147220441|NCT02093351|530980110|FG000|Part B|Adverse event + disease progression|0|||
147220442|NCT02093351|530980111|FG001|Part B|Adverse event + disease progression|0|||
147220443|NCT02093351|530980112|FG002|Part B|Adverse event + disease progression|0|||
147220444|NCT02093351|530980113|FG003|Part B|Adverse event + disease progression|1|||
147552356|NCT00718159|532178598|FG002|Overall Study|Progressive Disease|2|||
147552357|NCT00718159|532178599|FG003|Overall Study|Progressive Disease|0|||
147220445|NCT02093351|530980110|FG000|Part B|Lack of therapeutic response|0|||
147220446|NCT02093351|530980111|FG001|Part B|Lack of therapeutic response|0|||
147220447|NCT02093351|530980112|FG002|Part B|Lack of therapeutic response|0|||
147220448|NCT02093351|530980113|FG003|Part B|Lack of therapeutic response|12|||
147220449|NCT02093351|530980110|FG000|Part B|Condition under investigation worsened|0|||
147220450|NCT02093351|530980111|FG001|Part B|Condition under investigation worsened|0|||
147220451|NCT02093351|530980112|FG002|Part B|Condition under investigation worsened|0|||
147308930|NCT01709305|531297875|FG000|Phase 2|Clinical Adverse Event|0|||
147308931|NCT01709305|531297876|FG001|Phase 2|Clinical Adverse Event|10|||
147308932|NCT01709305|531297877|FG002|Phase 2|Clinical Adverse Event|10|||
147308933|NCT01709305|531297878|FG003|Phase 2|Clinical Adverse Event|6|||
147308934|NCT01709305|531297879|FG004|Phase 2|Clinical Adverse Event|11|||
147308935|NCT01709305|531297875|FG000|Phase 2|Death|0|||
147220452|NCT02093351|530980113|FG003|Part B|Condition under investigation worsened|39|||
147220453|NCT02093351|530980110|FG000|Part B|Adverse Event|0|||
147220454|NCT02093351|530980111|FG001|Part B|Adverse Event|0|||
147220455|NCT02093351|530980112|FG002|Part B|Adverse Event|0|||
147220456|NCT02093351|530980113|FG003|Part B|Adverse Event|2|||
147220457|NCT02093351|530980110|FG000|Part B|Death|0|||
147552358|NCT00718159|532178600|FG004|Overall Study|Progressive Disease|6|||
147308936|NCT01709305|531297876|FG001|Phase 2|Death|0|||
147308937|NCT01709305|531297877|FG002|Phase 2|Death|1|||
147308938|NCT01709305|531297878|FG003|Phase 2|Death|0|||
147308939|NCT01709305|531297879|FG004|Phase 2|Death|0|||
147308940|NCT01709305|531297875|FG000|Phase 2|Hyperglycemia (lack of efficacy)|0|||
147308941|NCT01709305|531297876|FG001|Phase 2|Hyperglycemia (lack of efficacy)|0|||
147308942|NCT01709305|531297877|FG002|Phase 2|Hyperglycemia (lack of efficacy)|0|||
147308943|NCT01709305|531297878|FG003|Phase 2|Hyperglycemia (lack of efficacy)|0|||
147308944|NCT01709305|531297879|FG004|Phase 2|Hyperglycemia (lack of efficacy)|2|||
147308945|NCT01709305|531297875|FG000|Phase 2|Laboratory Adverse Event|0|||
147308946|NCT01709305|531297876|FG001|Phase 2|Laboratory Adverse Event|1|||
147308947|NCT01709305|531297877|FG002|Phase 2|Laboratory Adverse Event|0|||
147308948|NCT01709305|531297878|FG003|Phase 2|Laboratory Adverse Event|1|||
147308949|NCT01709305|531297879|FG004|Phase 2|Laboratory Adverse Event|1|||
147308950|NCT01709305|531297875|FG000|Phase 2|Lost to Follow-up|0|||
147308951|NCT01709305|531297876|FG001|Phase 2|Lost to Follow-up|10|||
147308952|NCT01709305|531297877|FG002|Phase 2|Lost to Follow-up|6|||
147308953|NCT01709305|531297878|FG003|Phase 2|Lost to Follow-up|9|||
147308954|NCT01709305|531297879|FG004|Phase 2|Lost to Follow-up|5|||
147308955|NCT01709305|531297875|FG000|Phase 2|Travel, moving, etc.|0|||
147308956|NCT01709305|531297876|FG001|Phase 2|Travel, moving, etc.|2|||
147308957|NCT01709305|531297877|FG002|Phase 2|Travel, moving, etc.|3|||
147308958|NCT01709305|531297878|FG003|Phase 2|Travel, moving, etc.|3|||
147308959|NCT01709305|531297879|FG004|Phase 2|Travel, moving, etc.|5|||
147308960|NCT01709305|531297875|FG000|Phase 2|Physician Decision|0|||
147308961|NCT01709305|531297876|FG001|Phase 2|Physician Decision|2|||
147308962|NCT01709305|531297877|FG002|Phase 2|Physician Decision|0|||
147308963|NCT01709305|531297878|FG003|Phase 2|Physician Decision|1|||
147308964|NCT01709305|531297879|FG004|Phase 2|Physician Decision|2|||
147308965|NCT01709305|531297875|FG000|Phase 2|Protocol Violation|0|||
147308966|NCT01709305|531297876|FG001|Phase 2|Protocol Violation|19|||
147308967|NCT01709305|531297877|FG002|Phase 2|Protocol Violation|19|||
147308968|NCT01709305|531297878|FG003|Phase 2|Protocol Violation|13|||
147308969|NCT01709305|531297879|FG004|Phase 2|Protocol Violation|9|||
147308970|NCT01709305|531297875|FG000|Phase 2|Withdrawal by Subject|0|||
147220458|NCT02093351|530980111|FG001|Part B|Death|0|||
147220459|NCT02093351|530980112|FG002|Part B|Death|0|||
147220460|NCT02093351|530980113|FG003|Part B|Death|1|||
147220461|NCT01099709|530980114|FG000|Period 1|Withdrawal by Subject|0|||
147308971|NCT01709305|531297876|FG001|Phase 2|Withdrawal by Subject|8|||
147308972|NCT01709305|531297877|FG002|Phase 2|Withdrawal by Subject|6|||
147308973|NCT01709305|531297878|FG003|Phase 2|Withdrawal by Subject|15|||
147220462|NCT01099709|530980115|FG001|Period 1|Withdrawal by Subject|1|||
147220463|NCT01099709|530980114|FG000|Period 1|Positive cotinine test|0|||
147220464|NCT01099709|530980115|FG001|Period 1|Positive cotinine test|1|||
147220465|NCT01099709|530980114|FG000|Period 1|Adverse Event|1|||
147220466|NCT01099709|530980115|FG001|Period 1|Adverse Event|0|||
147220467|NCT01611454|530980116|FG000|Overall Study|Lack of Efficacy|18|||
147220468|NCT01611454|530980117|FG001|Overall Study|Lack of Efficacy|10|||
147220469|NCT00920907|530980118|FG000|Induction Period|Adverse Event|0|||
147220470|NCT00920907|530980119|FG001|Induction Period|Adverse Event|2|||
147220471|NCT00920907|530980118|FG000|Induction Period|Death|1|||
147220472|NCT00920907|530980119|FG001|Induction Period|Death|1|||
147220473|NCT00920907|530980118|FG000|Induction Period|Disease Progression|12|||
147220474|NCT00920907|530980119|FG001|Induction Period|Disease Progression|11|||
147220475|NCT00920907|530980118|FG000|Induction Period|Study Drug Toxicity|8|||
147308974|NCT01709305|531297879|FG004|Phase 2|Withdrawal by Subject|12|||
147308975|NCT01103960|531297880|FG000|Overall Study|Adverse Event|2|||
147308976|NCT01103960|531297881|FG001|Overall Study|Adverse Event|1|||
147308977|NCT01103960|531297880|FG000|Overall Study|Withdrawal by Subject|2|||
147308978|NCT01103960|531297881|FG001|Overall Study|Withdrawal by Subject|1|||
147308979|NCT01103960|531297880|FG000|Overall Study|Other|1|||
147308980|NCT01103960|531297881|FG001|Overall Study|Other|0|||
147308981|NCT02294474|531297884|FG000|Overall Study|Adverse Event|7|||
147308982|NCT02294474|531297885|FG001|Overall Study|Adverse Event|7|||
147308983|NCT02294474|531297884|FG000|Overall Study|Lack of Efficacy|2|||
147308984|NCT02294474|531297885|FG001|Overall Study|Lack of Efficacy|1|||
147308985|NCT02294474|531297884|FG000|Overall Study|Protocol Violation|4|||
147308986|NCT02294474|531297885|FG001|Overall Study|Protocol Violation|2|||
147220476|NCT00920907|530980119|FG001|Induction Period|Study Drug Toxicity|6|||
147308987|NCT02294474|531297884|FG000|Overall Study|Other than specified above|12|||
147308988|NCT02294474|531297885|FG001|Overall Study|Other than specified above|12|||
147552359|NCT00718159|532178601|FG005|Overall Study|Progressive Disease|0|||
147308989|NCT00118898|531297889|FG000|Overall Study|Death|6|||
147308990|NCT00118898|531297890|FG001|Overall Study|Death|11|||
147220477|NCT00920907|530980118|FG000|Induction Period|No longer meets study criteria|0|||
147220478|NCT00920907|530980119|FG001|Induction Period|No longer meets study criteria|1|||
147308991|NCT00118898|531297891|FG002|Overall Study|Death|6|||
147308992|NCT00118898|531297892|FG003|Overall Study|Death|8|||
147308993|NCT00118898|531297889|FG000|Overall Study|Lost to Follow-up|26|||
147308994|NCT00118898|531297890|FG001|Overall Study|Lost to Follow-up|34|||
147308995|NCT00118898|531297891|FG002|Overall Study|Lost to Follow-up|33|||
147220479|NCT00920907|530980118|FG000|Induction Period|Withdrawal by Subject|1|||
147220480|NCT00920907|530980119|FG001|Induction Period|Withdrawal by Subject|1|||
147220481|NCT00920907|530980118|FG000|Maintenance Period|Disease Progression|3|||
147220482|NCT00920907|530980119|FG001|Maintenance Period|Disease Progression|7|||
147220483|NCT00920907|530980118|FG000|Maintenance Period|Administrative (study closure)|7|||
147220484|NCT00920907|530980119|FG001|Maintenance Period|Administrative (study closure)|2|||
147220485|NCT00920907|530980118|FG000|Maintenance Period|Study Drug Toxicity|0|||
147220486|NCT00920907|530980119|FG001|Maintenance Period|Study Drug Toxicity|2|||
147220487|NCT00920907|530980118|FG000|Maintenance Period|Death|1|||
147220488|NCT00920907|530980119|FG001|Maintenance Period|Death|1|||
147220489|NCT00920907|530980118|FG000|Maintenance Period|Withdrawal by Subject|1|||
147220490|NCT00920907|530980119|FG001|Maintenance Period|Withdrawal by Subject|0|||
147220491|NCT00920907|530980118|FG000|Maintenance Period|Adverse Event|0|||
147220492|NCT00920907|530980119|FG001|Maintenance Period|Adverse Event|1|||
147220493|NCT01275339|530980120|FG000|Overall Study|Referred for surgery for AS symptoms|1|||
147220494|NCT01275339|530980121|FG001|Overall Study|Referred for surgery for AS symptoms|0|||
147220495|NCT01275339|530980122|FG002|Overall Study|Referred for surgery for AS symptoms|0|||
147220496|NCT01275339|530980123|FG003|Overall Study|Referred for surgery for AS symptoms|0|||
147220497|NCT01275339|530980120|FG000|Overall Study|Withdrawal by Subject|0|||
147220498|NCT01275339|530980121|FG001|Overall Study|Withdrawal by Subject|0|||
147220499|NCT01275339|530980122|FG002|Overall Study|Withdrawal by Subject|1|||
147220500|NCT01275339|530980123|FG003|Overall Study|Withdrawal by Subject|0|||
147220501|NCT00718081|530980124|FG000|Overall Study|Adverse Event|0|||
147220502|NCT00718081|530980125|FG001|Overall Study|Adverse Event|1|||
147220503|NCT00718081|530980126|FG002|Overall Study|Adverse Event|0|||
147220504|NCT00718081|530980124|FG000|Overall Study|Lack of Efficacy|7|||
147220505|NCT00718081|530980125|FG001|Overall Study|Lack of Efficacy|3|||
147220506|NCT00718081|530980126|FG002|Overall Study|Lack of Efficacy|21|||
147220507|NCT00815516|530980127|FG000|Overall Study|Death|3|||
147220508|NCT00815516|530980128|FG001|Overall Study|Death|1|||
147220509|NCT00815516|530980127|FG000|Overall Study|Physician Decision|1|||
147220510|NCT00815516|530980128|FG001|Overall Study|Physician Decision|0|||
147220511|NCT02311582|530980142|FG000|Overall Study|Was enrolled but did not receive any MK-3475 treatment|0|||
147220512|NCT02311582|530980143|FG001|Overall Study|Was enrolled but did not receive any MK-3475 treatment|0|||
147220513|NCT02311582|530980144|FG002|Overall Study|Was enrolled but did not receive any MK-3475 treatment|0|||
147220514|NCT02311582|530980145|FG003|Overall Study|Was enrolled but did not receive any MK-3475 treatment|6|||
147220515|NCT02311582|530980146|FG004|Overall Study|Was enrolled but did not receive any MK-3475 treatment|4|||
147220516|NCT03404960|530980148|FG000|Overall Study|Adverse Event|0|||
147220517|NCT03404960|530980149|FG001|Overall Study|Adverse Event|2|||
147220518|NCT03404960|530980148|FG000|Overall Study|Rapidly declined before 1st follow-up scan|0|||
147220519|NCT03404960|530980149|FG001|Overall Study|Rapidly declined before 1st follow-up scan|2|||
147220520|NCT03404960|530980148|FG000|Overall Study|Bowel obstruction|0|||
147220521|NCT03404960|530980149|FG001|Overall Study|Bowel obstruction|1|||
147220522|NCT03404960|530980148|FG000|Overall Study|Incorrect pathological diagnosis on internal review|2|||
147220523|NCT03404960|530980149|FG001|Overall Study|Incorrect pathological diagnosis on internal review|0|||
147220524|NCT00246571|530980152|FG000|Overall Study|Adverse Event|7|||
147220525|NCT00246571|530980153|FG001|Overall Study|Adverse Event|0|||
147220526|NCT00246571|530980152|FG000|Overall Study|Protocol Violation|0|||
147220527|NCT00246571|530980153|FG001|Overall Study|Protocol Violation|1|||
147220528|NCT00246571|530980152|FG000|Overall Study|Withdrawal by Subject|2|||
147220529|NCT00246571|530980153|FG001|Overall Study|Withdrawal by Subject|3|||
147220530|NCT00246571|530980152|FG000|Overall Study|Lack of Efficacy|84|||
147220531|NCT00246571|530980153|FG001|Overall Study|Lack of Efficacy|21|||
147220532|NCT00246571|530980152|FG000|Overall Study|Death|17|||
147220533|NCT00246571|530980153|FG001|Overall Study|Death|3|||
147220534|NCT00246571|530980152|FG000|Overall Study|Sponsor|0|||
147220535|NCT00246571|530980153|FG001|Overall Study|Sponsor|1|||
147220536|NCT00246571|530980152|FG000|Overall Study|Did not meet entrance criteria|2|||
147220537|NCT00246571|530980153|FG001|Overall Study|Did not meet entrance criteria|1|||
147220538|NCT00246571|530980152|FG000|Overall Study|Laboratory abnormalities|1|||
147220539|NCT00246571|530980153|FG001|Overall Study|Laboratory abnormalities|0|||
147220540|NCT00246571|530980152|FG000|Overall Study|Crossover participants|0|||
147220541|NCT00246571|530980153|FG001|Overall Study|Crossover participants|74|||
147220542|NCT03422627|530980154|FG000|Overall Study|Protocol-specified Criteria|1|||
147220543|NCT03422627|530980155|FG001|Overall Study|Protocol-specified Criteria|1|||
147220544|NCT03422627|530980156|FG002|Overall Study|Protocol-specified Criteria|0|||
147220545|NCT03422627|530980157|FG003|Overall Study|Protocol-specified Criteria|0|||
147220546|NCT03422627|530980158|FG004|Overall Study|Protocol-specified Criteria|2|||
147220547|NCT03422627|530980154|FG000|Overall Study|Requirement for Alternative Therapy|1|||
147443094|NCT03670953|531787166|FG000|Dose Adjustment (Weeks 1- 3)|Lack of Efficacy|1|||
147220548|NCT03422627|530980155|FG001|Overall Study|Requirement for Alternative Therapy|1|||
147220549|NCT03422627|530980156|FG002|Overall Study|Requirement for Alternative Therapy|2|||
147220550|NCT03422627|530980157|FG003|Overall Study|Requirement for Alternative Therapy|0|||
147220551|NCT03422627|530980158|FG004|Overall Study|Requirement for Alternative Therapy|0|||
147552360|NCT00718159|532178602|FG006|Overall Study|Progressive Disease|0|||
147552361|NCT00718159|532178596|FG000|Overall Study|Death due to Adverse Event|0|||
147552362|NCT00718159|532178597|FG001|Overall Study|Death due to Adverse Event|0|||
147552363|NCT00718159|532178598|FG002|Overall Study|Death due to Adverse Event|0|||
147552364|NCT00718159|532178599|FG003|Overall Study|Death due to Adverse Event|2|||
147552365|NCT00718159|532178600|FG004|Overall Study|Death due to Adverse Event|2|||
147552366|NCT00718159|532178601|FG005|Overall Study|Death due to Adverse Event|0|||
147552367|NCT00718159|532178602|FG006|Overall Study|Death due to Adverse Event|0|||
147552368|NCT00718159|532178596|FG000|Overall Study|Death due to Study Drug Toxicity|0|||
147552369|NCT00718159|532178597|FG001|Overall Study|Death due to Study Drug Toxicity|0|||
147552370|NCT00718159|532178598|FG002|Overall Study|Death due to Study Drug Toxicity|1|||
147552371|NCT00718159|532178599|FG003|Overall Study|Death due to Study Drug Toxicity|2|||
147552372|NCT00718159|532178600|FG004|Overall Study|Death due to Study Drug Toxicity|0|||
147552373|NCT00718159|532178601|FG005|Overall Study|Death due to Study Drug Toxicity|0|||
147552374|NCT00718159|532178602|FG006|Overall Study|Death due to Study Drug Toxicity|0|||
147552375|NCT00718159|532178596|FG000|Overall Study|Investigator Decision|0|||
147552376|NCT00718159|532178597|FG001|Overall Study|Investigator Decision|0|||
147552377|NCT00718159|532178598|FG002|Overall Study|Investigator Decision|0|||
147552378|NCT00718159|532178599|FG003|Overall Study|Investigator Decision|0|||
147552379|NCT00718159|532178600|FG004|Overall Study|Investigator Decision|0|||
147552380|NCT00718159|532178601|FG005|Overall Study|Investigator Decision|1|||
147552381|NCT00718159|532178602|FG006|Overall Study|Investigator Decision|1|||
147552382|NCT00782509|532178603|FG000|Overall Study|Adverse Event|20|||
147552383|NCT00782509|532178604|FG001|Overall Study|Adverse Event|10|||
147552384|NCT00782509|532178605|FG002|Overall Study|Adverse Event|20|||
147552385|NCT00782509|532178603|FG000|Overall Study|Lost to Follow-up|1|||
147552386|NCT00782509|532178604|FG001|Overall Study|Lost to Follow-up|2|||
147552387|NCT00782509|532178605|FG002|Overall Study|Lost to Follow-up|3|||
147552388|NCT00782509|532178603|FG000|Overall Study|Withdrawal by Subject|3|||
147552389|NCT00782509|532178604|FG001|Overall Study|Withdrawal by Subject|5|||
147552390|NCT00782509|532178605|FG002|Overall Study|Withdrawal by Subject|8|||
147552391|NCT00782509|532178603|FG000|Overall Study|Non compliance with protocol|2|||
147552392|NCT00782509|532178604|FG001|Overall Study|Non compliance with protocol|0|||
147552393|NCT00782509|532178605|FG002|Overall Study|Non compliance with protocol|0|||
147552394|NCT00782509|532178603|FG000|Overall Study|Other reasons not stated above|5|||
147552395|NCT00782509|532178604|FG001|Overall Study|Other reasons not stated above|2|||
147552396|NCT00782509|532178605|FG002|Overall Study|Other reasons not stated above|3|||
147552397|NCT00782509|532178603|FG000|Overall Study|Lack of Efficacy|10|||
147552398|NCT00782509|532178604|FG001|Overall Study|Lack of Efficacy|5|||
147552399|NCT00782509|532178605|FG002|Overall Study|Lack of Efficacy|2|||
147552400|NCT00175019|532178606|FG000|Overall Study|Adverse Event|54|||
147552401|NCT00175019|532178607|FG001|Overall Study|Adverse Event|22|||
147552402|NCT00175019|532178608|FG002|Overall Study|Adverse Event|2|||
147552403|NCT00175019|532178606|FG000|Overall Study|Protocol Violation|6|||
147552404|NCT00175019|532178607|FG001|Overall Study|Protocol Violation|3|||
147552405|NCT00175019|532178608|FG002|Overall Study|Protocol Violation|3|||
147220552|NCT03422627|530980154|FG000|Overall Study|Disease Progression|1|||
147220553|NCT03422627|530980155|FG001|Overall Study|Disease Progression|0|||
147220554|NCT03422627|530980156|FG002|Overall Study|Disease Progression|1|||
147552406|NCT00175019|532178606|FG000|Overall Study|Lost to Follow-up|42|||
147552407|NCT00175019|532178607|FG001|Overall Study|Lost to Follow-up|39|||
147552408|NCT00175019|532178608|FG002|Overall Study|Lost to Follow-up|9|||
147552409|NCT00175019|532178606|FG000|Overall Study|Did not continue under Amendment 4|1|||
147552410|NCT00175019|532178607|FG001|Overall Study|Did not continue under Amendment 4|1|||
147552411|NCT00175019|532178608|FG002|Overall Study|Did not continue under Amendment 4|2|||
147552412|NCT00175019|532178606|FG000|Overall Study|Personal Reason(s)|39|||
147552413|NCT00175019|532178607|FG001|Overall Study|Personal Reason(s)|31|||
147552414|NCT00175019|532178608|FG002|Overall Study|Personal Reason(s)|8|||
147552415|NCT00175019|532178606|FG000|Overall Study|Therapeutic Failure|10|||
147552416|NCT00175019|532178607|FG001|Overall Study|Therapeutic Failure|38|||
147552417|NCT00175019|532178608|FG002|Overall Study|Therapeutic Failure|22|||
147552418|NCT00175019|532178606|FG000|Overall Study|Gout Flare|2|||
147552419|NCT00175019|532178607|FG001|Overall Study|Gout Flare|3|||
147220555|NCT03422627|530980157|FG003|Overall Study|Disease Progression|2|||
147220556|NCT03422627|530980158|FG004|Overall Study|Disease Progression|0|||
147220557|NCT03422627|530980154|FG000|Overall Study|Adverse Event|2|||
147220558|NCT03422627|530980155|FG001|Overall Study|Adverse Event|1|||
147552420|NCT00175019|532178608|FG002|Overall Study|Gout Flare|0|||
147552421|NCT00175019|532178606|FG000|Overall Study|Reason Not Specified|40|||
147552422|NCT00175019|532178607|FG001|Overall Study|Reason Not Specified|34|||
147552423|NCT00175019|532178608|FG002|Overall Study|Reason Not Specified|11|||
147552424|NCT01405820|532178609|FG000|Randomized Treatment Period|Adverse Event|3|||
147552425|NCT01405820|532178610|FG001|Randomized Treatment Period|Adverse Event|3|||
147552426|NCT01405820|532178611|FG002|Randomized Treatment Period|Adverse Event|3|||
147552427|NCT01405820|532178612|FG003|Randomized Treatment Period|Adverse Event|0|||
147552428|NCT01405820|532178613|FG004|Randomized Treatment Period|Adverse Event|2|||
147552429|NCT01405820|532178614|FG005|Randomized Treatment Period|Adverse Event|1|||
147552430|NCT01405820|532178609|FG000|Randomized Treatment Period|Withdrawal by Subject|6|||
147552431|NCT01405820|532178610|FG001|Randomized Treatment Period|Withdrawal by Subject|2|||
147552432|NCT01405820|532178611|FG002|Randomized Treatment Period|Withdrawal by Subject|2|||
147552433|NCT01405820|532178612|FG003|Randomized Treatment Period|Withdrawal by Subject|2|||
147552434|NCT01405820|532178613|FG004|Randomized Treatment Period|Withdrawal by Subject|0|||
147552435|NCT01405820|532178614|FG005|Randomized Treatment Period|Withdrawal by Subject|0|||
147552436|NCT01405820|532178609|FG000|Randomized Treatment Period|Other|2|||
147552437|NCT01405820|532178610|FG001|Randomized Treatment Period|Other|2|||
147552438|NCT01405820|532178611|FG002|Randomized Treatment Period|Other|1|||
147308996|NCT00118898|531297892|FG003|Overall Study|Lost to Follow-up|33|||
147308997|NCT00118898|531297889|FG000|Overall Study|Withdrawal by Subject|10|||
147552439|NCT01405820|532178612|FG003|Randomized Treatment Period|Other|1|||
147552440|NCT01405820|532178613|FG004|Randomized Treatment Period|Other|0|||
147552441|NCT01405820|532178614|FG005|Randomized Treatment Period|Other|0|||
147552442|NCT01405820|532178609|FG000|Randomized Treatment Period|Physician Decision|0|||
147552443|NCT01405820|532178610|FG001|Randomized Treatment Period|Physician Decision|2|||
147552444|NCT01405820|532178611|FG002|Randomized Treatment Period|Physician Decision|1|||
147552445|NCT01405820|532178612|FG003|Randomized Treatment Period|Physician Decision|0|||
147552446|NCT01405820|532178613|FG004|Randomized Treatment Period|Physician Decision|0|||
147552447|NCT01405820|532178614|FG005|Randomized Treatment Period|Physician Decision|0|||
147552448|NCT01405820|532178609|FG000|Randomized Treatment Period|Rescue|0|||
147552449|NCT01405820|532178610|FG001|Randomized Treatment Period|Rescue|1|||
147552450|NCT01405820|532178611|FG002|Randomized Treatment Period|Rescue|13|||
147552451|NCT01405820|532178612|FG003|Randomized Treatment Period|Rescue|10|||
147552452|NCT01405820|532178613|FG004|Randomized Treatment Period|Rescue|8|||
147552453|NCT01405820|532178614|FG005|Randomized Treatment Period|Rescue|8|||
147552454|NCT01405820|532178609|FG000|Randomized Treatment Period|Incorrect Study Treatment|0|||
147220559|NCT03422627|530980156|FG002|Overall Study|Adverse Event|0|||
147220560|NCT03422627|530980157|FG003|Overall Study|Adverse Event|0|||
147220561|NCT03422627|530980158|FG004|Overall Study|Adverse Event|2|||
147220562|NCT03422627|530980154|FG000|Overall Study|Ineligibility Determined|0|||
147220563|NCT03422627|530980155|FG001|Overall Study|Ineligibility Determined|1|||
147220564|NCT03422627|530980156|FG002|Overall Study|Ineligibility Determined|0|||
147220565|NCT03422627|530980157|FG003|Overall Study|Ineligibility Determined|0|||
147220566|NCT03422627|530980158|FG004|Overall Study|Ineligibility Determined|0|||
147220567|NCT03422627|530980154|FG000|Overall Study|Death|0|||
147220568|NCT03422627|530980155|FG001|Overall Study|Death|1|||
147552455|NCT01405820|532178610|FG001|Randomized Treatment Period|Incorrect Study Treatment|0|||
147552456|NCT01405820|532178611|FG002|Randomized Treatment Period|Incorrect Study Treatment|3|||
147552457|NCT01405820|532178612|FG003|Randomized Treatment Period|Incorrect Study Treatment|0|||
147552458|NCT01405820|532178613|FG004|Randomized Treatment Period|Incorrect Study Treatment|2|||
147552459|NCT01405820|532178614|FG005|Randomized Treatment Period|Incorrect Study Treatment|0|||
147552460|NCT01405820|532178609|FG000|Randomized Treatment Period|Treatment Arm Closed|0|||
147552461|NCT01405820|532178610|FG001|Randomized Treatment Period|Treatment Arm Closed|0|||
147552462|NCT01405820|532178611|FG002|Randomized Treatment Period|Treatment Arm Closed|20|||
147552463|NCT01405820|532178612|FG003|Randomized Treatment Period|Treatment Arm Closed|36|||
147552464|NCT01405820|532178613|FG004|Randomized Treatment Period|Treatment Arm Closed|33|||
147552465|NCT01405820|532178614|FG005|Randomized Treatment Period|Treatment Arm Closed|28|||
147552466|NCT01405820|532178609|FG000|Randomized Treatment Period|Death|0|||
147552467|NCT01405820|532178610|FG001|Randomized Treatment Period|Death|0|||
147552468|NCT01405820|532178611|FG002|Randomized Treatment Period|Death|0|||
147552469|NCT01405820|532178612|FG003|Randomized Treatment Period|Death|1|||
147552470|NCT01405820|532178613|FG004|Randomized Treatment Period|Death|0|||
147552471|NCT01405820|532178614|FG005|Randomized Treatment Period|Death|0|||
147552472|NCT01405820|532178609|FG000|Randomized Treatment Period|Withdrew Prior to Dosing|0|||
147552473|NCT01405820|532178610|FG001|Randomized Treatment Period|Withdrew Prior to Dosing|0|||
147552474|NCT01405820|532178611|FG002|Randomized Treatment Period|Withdrew Prior to Dosing|0|||
147552475|NCT01405820|532178612|FG003|Randomized Treatment Period|Withdrew Prior to Dosing|1|||
147552476|NCT01405820|532178613|FG004|Randomized Treatment Period|Withdrew Prior to Dosing|0|||
147552477|NCT01405820|532178614|FG005|Randomized Treatment Period|Withdrew Prior to Dosing|0|||
147552478|NCT01405820|532178609|FG000|Open-Label Treatment Period|Withdrawal by Subject|3|||
147552479|NCT01405820|532178610|FG001|Open-Label Treatment Period|Withdrawal by Subject|1|||
147552480|NCT01405820|532178611|FG002|Open-Label Treatment Period|Withdrawal by Subject|1|||
147552481|NCT01405820|532178612|FG003|Open-Label Treatment Period|Withdrawal by Subject|1|||
147220569|NCT03422627|530980156|FG002|Overall Study|Death|1|||
147220570|NCT03422627|530980157|FG003|Overall Study|Death|0|||
147552482|NCT01405820|532178613|FG004|Open-Label Treatment Period|Withdrawal by Subject|0|||
147552483|NCT01405820|532178614|FG005|Open-Label Treatment Period|Withdrawal by Subject|1|||
147552484|NCT01405820|532178609|FG000|Open-Label Treatment Period|Other|1|||
147552485|NCT01405820|532178610|FG001|Open-Label Treatment Period|Other|1|||
147220571|NCT03422627|530980158|FG004|Overall Study|Death|0|||
147308998|NCT00118898|531297890|FG001|Overall Study|Withdrawal by Subject|5|||
147552486|NCT01405820|532178611|FG002|Open-Label Treatment Period|Other|1|||
147552487|NCT01405820|532178612|FG003|Open-Label Treatment Period|Other|1|||
147220572|NCT03422627|530980154|FG000|Overall Study|Withdrawal by Subject|0|||
147552488|NCT01405820|532178613|FG004|Open-Label Treatment Period|Other|1|||
147552489|NCT01405820|532178614|FG005|Open-Label Treatment Period|Other|1|||
147552490|NCT01405820|532178609|FG000|Open-Label Treatment Period|Physician Decision|0|||
147552491|NCT01405820|532178610|FG001|Open-Label Treatment Period|Physician Decision|0|||
147552492|NCT01405820|532178611|FG002|Open-Label Treatment Period|Physician Decision|1|||
147552493|NCT01405820|532178612|FG003|Open-Label Treatment Period|Physician Decision|2|||
147552494|NCT01405820|532178613|FG004|Open-Label Treatment Period|Physician Decision|1|||
147552495|NCT01405820|532178614|FG005|Open-Label Treatment Period|Physician Decision|0|||
147552496|NCT01405820|532178609|FG000|Open-Label Treatment Period|Adverse Event|0|||
147552497|NCT01405820|532178610|FG001|Open-Label Treatment Period|Adverse Event|0|||
147552498|NCT01405820|532178611|FG002|Open-Label Treatment Period|Adverse Event|0|||
147552499|NCT01405820|532178612|FG003|Open-Label Treatment Period|Adverse Event|1|||
147552500|NCT01405820|532178613|FG004|Open-Label Treatment Period|Adverse Event|0|||
147552501|NCT01405820|532178614|FG005|Open-Label Treatment Period|Adverse Event|0|||
147552502|NCT03222141|532178615|FG000|Overall Study|Death|15|||
147552503|NCT03222141|532178615|FG000|Overall Study|Lost to Follow-up|3|||
147552504|NCT00441584|532178616|FG000|Overall Study|Lack of Efficacy|79|||
147552505|NCT00441584|532178616|FG000|Overall Study|Withdrawal by Subject|8|||
147552506|NCT00441584|532178616|FG000|Overall Study|Adverse Event|6|||
147552507|NCT00441584|532178616|FG000|Overall Study|Protocol Violation|5|||
147552508|NCT00441584|532178616|FG000|Overall Study|Lost to Follow-up|4|||
147552509|NCT00441584|532178616|FG000|Overall Study|Failure to meet eligibility criteria|3|||
147552510|NCT00619619|532178617|FG000|Overall Study|Physician Decision|0|||
147552511|NCT00619619|532178618|FG001|Overall Study|Physician Decision|0|||
147552512|NCT00619619|532178619|FG002|Overall Study|Physician Decision|1|||
147552513|NCT00619619|532178620|FG003|Overall Study|Physician Decision|0|||
147552514|NCT00619619|532178621|FG004|Overall Study|Physician Decision|0|||
147552515|NCT00619619|532178622|FG005|Overall Study|Physician Decision|0|||
147552516|NCT00619619|532178623|FG006|Overall Study|Physician Decision|0|||
147552517|NCT00619619|532178624|FG007|Overall Study|Physician Decision|0|||
147552518|NCT00619619|532178617|FG000|Overall Study|Protocol Violation|0|||
147552519|NCT00619619|532178618|FG001|Overall Study|Protocol Violation|0|||
147552520|NCT00619619|532178619|FG002|Overall Study|Protocol Violation|0|||
147552521|NCT00619619|532178620|FG003|Overall Study|Protocol Violation|1|||
147552522|NCT00619619|532178621|FG004|Overall Study|Protocol Violation|0|||
147552523|NCT00619619|532178622|FG005|Overall Study|Protocol Violation|0|||
147552524|NCT00619619|532178623|FG006|Overall Study|Protocol Violation|1|||
147552525|NCT00619619|532178624|FG007|Overall Study|Protocol Violation|1|||
147552526|NCT00619619|532178617|FG000|Overall Study|Adverse Event|0|||
147552527|NCT00619619|532178618|FG001|Overall Study|Adverse Event|0|||
147552528|NCT00619619|532178619|FG002|Overall Study|Adverse Event|0|||
147552529|NCT00619619|532178620|FG003|Overall Study|Adverse Event|0|||
147552530|NCT00619619|532178621|FG004|Overall Study|Adverse Event|2|||
147552531|NCT00619619|532178622|FG005|Overall Study|Adverse Event|0|||
147552532|NCT00619619|532178623|FG006|Overall Study|Adverse Event|0|||
147552533|NCT00619619|532178624|FG007|Overall Study|Adverse Event|2|||
147552534|NCT01798485|532178626|FG000|Overall Study|Adverse Event|32|||
147552535|NCT01798485|532178627|FG001|Overall Study|Adverse Event|40|||
147552536|NCT01798485|532178626|FG000|Overall Study|Withdrawal by Subject|27|||
147552537|NCT01798485|532178627|FG001|Overall Study|Withdrawal by Subject|31|||
147552538|NCT01798485|532178626|FG000|Overall Study|Lost to Follow-up|0|||
147552539|NCT01798485|532178627|FG001|Overall Study|Lost to Follow-up|3|||
147552540|NCT01798485|532178626|FG000|Overall Study|Physician Decision|14|||
147552541|NCT01798485|532178627|FG001|Overall Study|Physician Decision|10|||
147552542|NCT01798485|532178626|FG000|Overall Study|Objective Disease Progression|152|||
147552543|NCT01798485|532178627|FG001|Overall Study|Objective Disease Progression|106|||
147552544|NCT01798485|532178626|FG000|Overall Study|Death|25|||
147552545|NCT01798485|532178627|FG001|Overall Study|Death|22|||
147552546|NCT01798485|532178626|FG000|Overall Study|Sponsor Decision|61|||
147220573|NCT03422627|530980155|FG001|Overall Study|Withdrawal by Subject|0|||
147220574|NCT03422627|530980156|FG002|Overall Study|Withdrawal by Subject|0|||
147552547|NCT01798485|532178627|FG001|Overall Study|Sponsor Decision|54|||
147552548|NCT01798485|532178626|FG000|Overall Study|Clinical Progression|35|||
147552549|NCT01798485|532178627|FG001|Overall Study|Clinical Progression|24|||
147552550|NCT02087046|532178628|FG000|Overall Study|Adverse Event|4|||
147552551|NCT02087046|532178628|FG000|Overall Study|Death|1|||
147552552|NCT02087046|532178628|FG000|Overall Study|Lost to Follow-up|3|||
147552553|NCT02087046|532178628|FG000|Overall Study|Withdrawal by Subject|2|||
147552554|NCT02087046|532178628|FG000|Overall Study|Physician Decision|1|||
147552555|NCT01107535|532178629|FG000|Overall Study|Death|5|||
147552556|NCT01155583|532178630|FG000|Phase I|Screen failure - did not start treatment|0|||
147552557|NCT01155583|532178631|FG001|Phase I|Screen failure - did not start treatment|0|||
147552558|NCT01155583|532178632|FG002|Phase I|Screen failure - did not start treatment|0|||
147552559|NCT01155583|532178633|FG003|Phase I|Screen failure - did not start treatment|0|||
147552560|NCT01155583|532178634|FG004|Phase I|Screen failure - did not start treatment|1|||
147552561|NCT01155583|532178635|FG005|Phase I|Screen failure - did not start treatment|0|||
147552562|NCT01155583|532178636|FG006|Phase I|Screen failure - did not start treatment|0|||
147308999|NCT00118898|531297891|FG002|Overall Study|Withdrawal by Subject|8|||
147309000|NCT00118898|531297892|FG003|Overall Study|Withdrawal by Subject|8|||
147309001|NCT00118898|531297889|FG000|Overall Study|Site Closure|33|||
147309002|NCT00118898|531297890|FG001|Overall Study|Site Closure|31|||
147309003|NCT00118898|531297891|FG002|Overall Study|Site Closure|28|||
147309004|NCT00118898|531297892|FG003|Overall Study|Site Closure|37|||
147309005|NCT00118898|531297889|FG000|Overall Study|Severe debilitation|1|||
147309006|NCT00118898|531297890|FG001|Overall Study|Severe debilitation|4|||
147309007|NCT00118898|531297891|FG002|Overall Study|Severe debilitation|6|||
147309008|NCT00118898|531297892|FG003|Overall Study|Severe debilitation|4|||
147309009|NCT00118898|531297889|FG000|Overall Study|Not compliant with requirements|11|||
147309010|NCT00118898|531297890|FG001|Overall Study|Not compliant with requirements|13|||
147309011|NCT00118898|531297891|FG002|Overall Study|Not compliant with requirements|11|||
147309012|NCT00118898|531297892|FG003|Overall Study|Not compliant with requirements|11|||
147309013|NCT00118898|531297889|FG000|Overall Study|Not able to get to clinic|34|||
147309014|NCT00118898|531297890|FG001|Overall Study|Not able to get to clinic|43|||
147309015|NCT00118898|531297891|FG002|Overall Study|Not able to get to clinic|31|||
147309016|NCT00118898|531297892|FG003|Overall Study|Not able to get to clinic|40|||
147309017|NCT01338012|531297895|FG000|Overall Study|Death|4|||
147309018|NCT01338012|531297895|FG000|Overall Study|Study terminated|4|||
147309019|NCT02714205|531297896|FG000|Overall Study|Cannot tolerate medication|1|||
147309020|NCT02714205|531297897|FG001|Overall Study|Cannot tolerate medication|0|||
147309021|NCT02714205|531297896|FG000|Overall Study|Adverse Event|2|||
147309022|NCT02714205|531297897|FG001|Overall Study|Adverse Event|0|||
147309023|NCT02714205|531297896|FG000|Overall Study|Too busy|1|||
147309024|NCT02714205|531297897|FG001|Overall Study|Too busy|0|||
147309025|NCT02714205|531297896|FG000|Overall Study|Incomplete outcome data|0|||
147309026|NCT02714205|531297897|FG001|Overall Study|Incomplete outcome data|1|||
147309027|NCT05879198|531297898|FG000|Overall Study|Lost to Follow-up|1|||
147309028|NCT03813147|531297899|FG000|Overall Study|Lack of Efficacy|4|||
147309029|NCT03813147|531297900|FG001|Overall Study|Lack of Efficacy|4|||
147309030|NCT03813147|531297899|FG000|Overall Study|Physician Decision|2|||
147309031|NCT03813147|531297900|FG001|Overall Study|Physician Decision|1|||
147309032|NCT01693692|531297901|FG000|Overall Study|Withdrawal by Subject|12|||
147309033|NCT01693692|531297902|FG001|Overall Study|Withdrawal by Subject|10|||
147309034|NCT01693692|531297903|FG002|Overall Study|Withdrawal by Subject|11|||
147309035|NCT01693692|531297901|FG000|Overall Study|Adverse Event|7|||
147309036|NCT01693692|531297902|FG001|Overall Study|Adverse Event|14|||
147309037|NCT01693692|531297903|FG002|Overall Study|Adverse Event|9|||
147309038|NCT01693692|531297901|FG000|Overall Study|Physician Decision|0|||
147309039|NCT01693692|531297902|FG001|Overall Study|Physician Decision|0|||
147309040|NCT01693692|531297903|FG002|Overall Study|Physician Decision|1|||
147309041|NCT01693692|531297901|FG000|Overall Study|Protocol Violation|5|||
147309042|NCT01693692|531297902|FG001|Overall Study|Protocol Violation|4|||
147309043|NCT01693692|531297903|FG002|Overall Study|Protocol Violation|6|||
147309044|NCT01693692|531297901|FG000|Overall Study|Lost to Follow-up|2|||
147552563|NCT01155583|532178637|FG007|Phase I|Screen failure - did not start treatment|2|||
147552564|NCT01155583|532178638|FG008|Phase I|Screen failure - did not start treatment|0|||
147309045|NCT01693692|531297902|FG001|Overall Study|Lost to Follow-up|2|||
147309046|NCT01693692|531297903|FG002|Overall Study|Lost to Follow-up|3|||
147309047|NCT01693692|531297901|FG000|Overall Study|Other|4|||
147309048|NCT01693692|531297902|FG001|Overall Study|Other|4|||
147309049|NCT01693692|531297903|FG002|Overall Study|Other|6|||
147309050|NCT01167179|531299925|FG000|Overall Study|disease recurrence|4|||
147309051|NCT01167179|531299926|FG001|Overall Study|disease recurrence|4|||
147309052|NCT01167179|531299925|FG000|Overall Study|Death|4|||
147309053|NCT01167179|531299926|FG001|Overall Study|Death|10|||
147220575|NCT03422627|530980157|FG003|Overall Study|Withdrawal by Subject|1|||
147220576|NCT03422627|530980158|FG004|Overall Study|Withdrawal by Subject|0|||
147220577|NCT02455557|530980159|FG000|Overall Study|Withdrawal by Subject|2|||
147220578|NCT04656275|530980160|FG000|Overall Study|Study terminated by sponsor|2|||
147220579|NCT04656275|530980161|FG001|Overall Study|Study terminated by sponsor|4|||
147220580|NCT00934648|530980165|FG000|Overall Study|Failure to return|8|||
147220581|NCT00934648|530980165|FG000|Overall Study|Withdrawal by Subject|1|||
147220582|NCT04369924|530980168|FG000|Overall Study|Lost to Follow-up|302|||
147220583|NCT04369924|530980169|FG001|Overall Study|Lost to Follow-up|339|||
147220584|NCT03828370|530980170|FG000|3 Month Follow-up|Lost to Follow-up|4|||
147220585|NCT03828370|530980171|FG001|3 Month Follow-up|Lost to Follow-up|12|||
147220586|NCT03828370|530980170|FG000|9 Month Follow up|Lost to Follow-up|12|||
147220587|NCT03828370|530980171|FG001|9 Month Follow up|Lost to Follow-up|20|||
147220588|NCT00290407|530980172|FG000|Overall Study|Physician Decision|2|||
147220589|NCT01933789|530980181|FG000|Overall Study|Death|0|||
147220590|NCT01933789|530980182|FG001|Overall Study|Death|0|||
147220591|NCT01933789|530980183|FG002|Overall Study|Death|0|||
147220592|NCT01933789|530980184|FG003|Overall Study|Death|0|||
147220593|NCT01933789|530980185|FG004|Overall Study|Death|21|||
147220594|NCT01933789|530980186|FG005|Overall Study|Death|32|||
147220595|NCT01933789|530980187|FG006|Overall Study|Death|0|||
147220596|NCT01933789|530980188|FG007|Overall Study|Death|0|||
147220597|NCT01933789|530980189|FG008|Overall Study|Death|0|||
147220598|NCT01933789|530980181|FG000|Overall Study|Lost to Follow-up|0|||
147220599|NCT01933789|530980182|FG001|Overall Study|Lost to Follow-up|0|||
147220600|NCT01933789|530980183|FG002|Overall Study|Lost to Follow-up|0|||
147220601|NCT01933789|530980184|FG003|Overall Study|Lost to Follow-up|1|||
147220602|NCT01933789|530980185|FG004|Overall Study|Lost to Follow-up|8|||
147220603|NCT01933789|530980186|FG005|Overall Study|Lost to Follow-up|9|||
147220604|NCT01933789|530980187|FG006|Overall Study|Lost to Follow-up|1|||
147220605|NCT01933789|530980188|FG007|Overall Study|Lost to Follow-up|4|||
147220606|NCT01933789|530980189|FG008|Overall Study|Lost to Follow-up|0|||
147220607|NCT01933789|530980181|FG000|Overall Study|Withdrawal by Subject|2|||
147220608|NCT01933789|530980182|FG001|Overall Study|Withdrawal by Subject|1|||
147220609|NCT01933789|530980183|FG002|Overall Study|Withdrawal by Subject|0|||
147220610|NCT01933789|530980184|FG003|Overall Study|Withdrawal by Subject|0|||
147220611|NCT01933789|530980185|FG004|Overall Study|Withdrawal by Subject|17|||
147220612|NCT01933789|530980186|FG005|Overall Study|Withdrawal by Subject|16|||
147220613|NCT01933789|530980187|FG006|Overall Study|Withdrawal by Subject|1|||
147220614|NCT01933789|530980188|FG007|Overall Study|Withdrawal by Subject|4|||
147220615|NCT01933789|530980189|FG008|Overall Study|Withdrawal by Subject|0|||
147220616|NCT01933789|530980181|FG000|Overall Study|Became Ineligible|4|||
147220617|NCT01933789|530980182|FG001|Overall Study|Became Ineligible|0|||
147220618|NCT01933789|530980183|FG002|Overall Study|Became Ineligible|0|||
147220619|NCT01933789|530980184|FG003|Overall Study|Became Ineligible|0|||
147220620|NCT01933789|530980185|FG004|Overall Study|Became Ineligible|13|||
147220621|NCT01933789|530980186|FG005|Overall Study|Became Ineligible|10|||
147220622|NCT01933789|530980187|FG006|Overall Study|Became Ineligible|13|||
147220623|NCT01933789|530980188|FG007|Overall Study|Became Ineligible|6|||
147220624|NCT01933789|530980189|FG008|Overall Study|Became Ineligible|0|||
147220625|NCT01925989|530980192|FG000|Period 1|Sponsor Decision|1|||
147220626|NCT01925989|530980193|FG001|Period 1|Sponsor Decision|1|||
147220627|NCT01925989|530980194|FG002|Period 1|Sponsor Decision|0|||
147220628|NCT01925989|530980192|FG000|Period 1|Withdrawal by Subject|0|||
147220629|NCT01925989|530980193|FG001|Period 1|Withdrawal by Subject|1|||
147220630|NCT01925989|530980194|FG002|Period 1|Withdrawal by Subject|0|||
147220631|NCT05442775|530980195|FG000|Overall Study|Trial terminated|61|||
147220632|NCT05442775|530980195|FG000|Overall Study|Lack of Efficacy|4|||
147220633|NCT05442775|530980195|FG000|Overall Study|Withdrawal by Subject|4|||
147649969|NCT00703118|532539769|FG001|Overall Study|Withdrawal by Subject|7|||
147220634|NCT05442775|530980195|FG000|Overall Study|Death|1|||
147220635|NCT05442775|530980195|FG000|Overall Study|Participant removed at Sponsor request|1|||
147220636|NCT02106923|530980210|FG000|Overall Study|Protocol Violation|0|||
147649970|NCT00703118|532539770|FG002|Overall Study|Withdrawal by Subject|13|||
147649971|NCT00703118|532539768|FG000|Overall Study|Other|0|||
147649972|NCT00703118|532539769|FG001|Overall Study|Other|0|||
147220637|NCT02106923|530980211|FG001|Overall Study|Protocol Violation|0|||
147220638|NCT02106923|530980212|FG002|Overall Study|Protocol Violation|0|||
147220639|NCT02106923|530980213|FG003|Overall Study|Protocol Violation|0|||
147220640|NCT02106923|530980214|FG004|Overall Study|Protocol Violation|0|||
147220641|NCT02106923|530980215|FG005|Overall Study|Protocol Violation|1|||
147649973|NCT00703118|532539770|FG002|Overall Study|Other|1|||
147649974|NCT04165135|532539771|FG000|Overall Study|Protocol Violation|10|||
147649975|NCT04165135|532539771|FG000|Overall Study|Participants withdrawal of consent|5|||
147649976|NCT00530790|532539772|FG000|Overall Study|Adverse Event|2|||
147649977|NCT00530790|532539772|FG000|Overall Study|Withdrawal by Subject|2|||
147649978|NCT00530790|532539772|FG000|Overall Study|Physician Decision|1|||
147649979|NCT05053035|532539779|FG000|Overall Study|Withdrawal by Subject|1|||
147649980|NCT05053035|532539780|FG001|Overall Study|Withdrawal by Subject|0|||
147649981|NCT01618916|532539782|FG000|Overall Study|Adverse Event|1|||
147649982|NCT01618916|532539783|FG001|Overall Study|Adverse Event|0|||
147649983|NCT01618916|532539784|FG002|Overall Study|Adverse Event|0|||
147649984|NCT01618916|532539785|FG003|Overall Study|Adverse Event|0|||
147220642|NCT03485495|530980216|FG000|Overall Study|Non-compliance with inclusion criteria|1|||
147220643|NCT03485495|530980217|FG001|Overall Study|Non-compliance with inclusion criteria|0|||
147220644|NCT01323920|530980218|FG000|Overall Study|Death|5|||
147220645|NCT01323920|530980218|FG000|Overall Study|Withdrawal by Subject|1|||
147220646|NCT02217527|530980221|FG000|Drug Condition 1: First Study Phase|Withdrawal by Subject|1|||
147220647|NCT02217527|530980222|FG001|Drug Condition 1: First Study Phase|Withdrawal by Subject|3|||
147220648|NCT02217527|530980221|FG000|Drug Condition 2: Second Study Phase|Withdrawal by Subject|0|||
147220649|NCT02217527|530980222|FG001|Drug Condition 2: Second Study Phase|Withdrawal by Subject|1|||
147220650|NCT00938886|530980223|FG000|Overall Study|Death|0|||
147220651|NCT00938886|530980224|FG001|Overall Study|Death|1|||
147220652|NCT00938886|530980223|FG000|Overall Study|Withdrawal by Subject|4|||
147220653|NCT00938886|530980224|FG001|Overall Study|Withdrawal by Subject|7|||
147443095|NCT03670953|531787167|FG001|Dose Adjustment (Weeks 1- 3)|Lack of Efficacy|0|||
147443096|NCT03670953|531787168|FG002|Dose Adjustment (Weeks 1- 3)|Lack of Efficacy|0|||
147443097|NCT03670953|531787169|FG003|Dose Adjustment (Weeks 1- 3)|Lack of Efficacy|0|||
147443098|NCT03670953|531787166|FG000|Dose Adjustment (Weeks 1- 3)|Protocol Violation|6|||
147443099|NCT03670953|531787167|FG001|Dose Adjustment (Weeks 1- 3)|Protocol Violation|0|||
147443100|NCT03670953|531787168|FG002|Dose Adjustment (Weeks 1- 3)|Protocol Violation|0|||
147443101|NCT03670953|531787169|FG003|Dose Adjustment (Weeks 1- 3)|Protocol Violation|0|||
147443102|NCT03670953|531787166|FG000|Dose Adjustment (Weeks 1- 3)|Withdrawal by Subject|9|||
147443103|NCT03670953|531787167|FG001|Dose Adjustment (Weeks 1- 3)|Withdrawal by Subject|0|||
147443104|NCT03670953|531787168|FG002|Dose Adjustment (Weeks 1- 3)|Withdrawal by Subject|0|||
147443105|NCT03670953|531787169|FG003|Dose Adjustment (Weeks 1- 3)|Withdrawal by Subject|0|||
147443106|NCT03670953|531787166|FG000|Dose Adjustment (Weeks 1- 3)|Miscellaneous|21|||
147443107|NCT03670953|531787167|FG001|Dose Adjustment (Weeks 1- 3)|Miscellaneous|0|||
147443108|NCT03670953|531787168|FG002|Dose Adjustment (Weeks 1- 3)|Miscellaneous|0|||
147443109|NCT03670953|531787169|FG003|Dose Adjustment (Weeks 1- 3)|Miscellaneous|0|||
147443110|NCT03670953|531787166|FG000|Dose Conversion (Weeks 4 - 7)|Adverse Event|0|||
147443111|NCT03670953|531787167|FG001|Dose Conversion (Weeks 4 - 7)|Adverse Event|35|||
147443112|NCT03670953|531787168|FG002|Dose Conversion (Weeks 4 - 7)|Adverse Event|0|||
147443113|NCT03670953|531787169|FG003|Dose Conversion (Weeks 4 - 7)|Adverse Event|0|||
147443114|NCT03670953|531787166|FG000|Dose Conversion (Weeks 4 - 7)|Lack of Efficacy|0|||
147443115|NCT03670953|531787167|FG001|Dose Conversion (Weeks 4 - 7)|Lack of Efficacy|10|||
147443116|NCT03670953|531787168|FG002|Dose Conversion (Weeks 4 - 7)|Lack of Efficacy|0|||
147443117|NCT03670953|531787169|FG003|Dose Conversion (Weeks 4 - 7)|Lack of Efficacy|0|||
147443118|NCT03670953|531787166|FG000|Dose Conversion (Weeks 4 - 7)|Protocol Violation|0|||
147443119|NCT03670953|531787167|FG001|Dose Conversion (Weeks 4 - 7)|Protocol Violation|1|||
147443120|NCT03670953|531787168|FG002|Dose Conversion (Weeks 4 - 7)|Protocol Violation|0|||
147443121|NCT03670953|531787169|FG003|Dose Conversion (Weeks 4 - 7)|Protocol Violation|0|||
147443122|NCT03670953|531787166|FG000|Dose Conversion (Weeks 4 - 7)|Non compliance|0|||
147443123|NCT03670953|531787167|FG001|Dose Conversion (Weeks 4 - 7)|Non compliance|2|||
147443124|NCT03670953|531787168|FG002|Dose Conversion (Weeks 4 - 7)|Non compliance|0|||
147443125|NCT03670953|531787169|FG003|Dose Conversion (Weeks 4 - 7)|Non compliance|0|||
147443126|NCT03670953|531787166|FG000|Dose Conversion (Weeks 4 - 7)|Lost to Follow-up|0|||
147443127|NCT03670953|531787167|FG001|Dose Conversion (Weeks 4 - 7)|Lost to Follow-up|1|||
147443128|NCT03670953|531787168|FG002|Dose Conversion (Weeks 4 - 7)|Lost to Follow-up|0|||
147443129|NCT03670953|531787169|FG003|Dose Conversion (Weeks 4 - 7)|Lost to Follow-up|0|||
147443130|NCT03670953|531787166|FG000|Dose Conversion (Weeks 4 - 7)|Withdrawal by Subject|0|||
147443131|NCT03670953|531787167|FG001|Dose Conversion (Weeks 4 - 7)|Withdrawal by Subject|32|||
147443132|NCT03670953|531787168|FG002|Dose Conversion (Weeks 4 - 7)|Withdrawal by Subject|0|||
147443133|NCT03670953|531787169|FG003|Dose Conversion (Weeks 4 - 7)|Withdrawal by Subject|0|||
147443134|NCT03670953|531787166|FG000|Dose Conversion (Weeks 4 - 7)|Miscellaneous|0|||
147443135|NCT03670953|531787167|FG001|Dose Conversion (Weeks 4 - 7)|Miscellaneous|2|||
147443136|NCT03670953|531787168|FG002|Dose Conversion (Weeks 4 - 7)|Miscellaneous|0|||
147443137|NCT03670953|531787169|FG003|Dose Conversion (Weeks 4 - 7)|Miscellaneous|0|||
147443138|NCT03670953|531787166|FG000|Double Blind Maintenance (Weeks 8 - 20)|Adverse Event|0|||
147443139|NCT03670953|531787167|FG001|Double Blind Maintenance (Weeks 8 - 20)|Adverse Event|0|||
147443140|NCT03670953|531787168|FG002|Double Blind Maintenance (Weeks 8 - 20)|Adverse Event|14|||
147649985|NCT01618916|532539786|FG004|Overall Study|Adverse Event|0|||
147649986|NCT01618916|532539787|FG005|Overall Study|Adverse Event|0|||
147649987|NCT01618916|532539782|FG000|Overall Study|Withdrawal by Subject|0|||
147309054|NCT01167179|531299925|FG000|Overall Study|Withdrawal by Subject|1|||
147309055|NCT01167179|531299926|FG001|Overall Study|Withdrawal by Subject|2|||
147309056|NCT01167179|531299925|FG000|Overall Study|diverse|6|||
147309057|NCT01167179|531299926|FG001|Overall Study|diverse|5|||
147309058|NCT01806740|531299930|FG000|Overall Study|Withdrawal by Subject|4|||
147309059|NCT01806740|531299930|FG000|Overall Study|Physician Decision|1|||
147309060|NCT01806740|531299930|FG000|Overall Study|Patient's refusal of treatment|1|||
147309061|NCT04666922|531299931|FG000|Overall Study|Withdrawal by Subject|1|||
147309062|NCT04666922|531299932|FG001|Overall Study|Withdrawal by Subject|0|||
147309063|NCT04666922|531299933|FG002|Overall Study|Withdrawal by Subject|0|||
147309064|NCT04666922|531299934|FG003|Overall Study|Withdrawal by Subject|0|||
147309065|NCT04666922|531299935|FG004|Overall Study|Withdrawal by Subject|0|||
147309066|NCT04666922|531299936|FG005|Overall Study|Withdrawal by Subject|0|||
147309067|NCT04666922|531299937|FG006|Overall Study|Withdrawal by Subject|0|||
147309068|NCT01382940|531299938|FG000|Overall Study|Adverse Event|19|||
147309069|NCT01382940|531299938|FG000|Overall Study|Lost to Follow-up|4|||
147309070|NCT01382940|531299938|FG000|Overall Study|Physician Decision|7|||
147309071|NCT01382940|531299938|FG000|Overall Study|Withdrawal by Subject|23|||
147309072|NCT01382940|531299938|FG000|Overall Study|Protocol Violation|20|||
147552565|NCT01155583|532178630|FG000|Phase I|Withdrawal by Subject|0|||
147552566|NCT01155583|532178631|FG001|Phase I|Withdrawal by Subject|0|||
147552567|NCT01155583|532178632|FG002|Phase I|Withdrawal by Subject|0|||
147552568|NCT01155583|532178633|FG003|Phase I|Withdrawal by Subject|0|||
147552569|NCT01155583|532178634|FG004|Phase I|Withdrawal by Subject|0|||
147552570|NCT01155583|532178635|FG005|Phase I|Withdrawal by Subject|0|||
147552571|NCT01155583|532178636|FG006|Phase I|Withdrawal by Subject|0|||
147552572|NCT01155583|532178637|FG007|Phase I|Withdrawal by Subject|1|||
147552573|NCT01155583|532178638|FG008|Phase I|Withdrawal by Subject|0|||
147552574|NCT00585351|532178639|FG000|Notification Period (Informed Consent)|Physician Decision|0|||
147552575|NCT00585351|532178640|FG001|Notification Period (Informed Consent)|Physician Decision|2|||
147552576|NCT00585351|532178641|FG002|Notification Period (Informed Consent)|Physician Decision|0|||
147552577|NCT00585351|532178642|FG003|Notification Period (Informed Consent)|Physician Decision|0|||
147552578|NCT00585351|532178643|FG004|Notification Period (Informed Consent)|Physician Decision|0|||
147552579|NCT00585351|532178644|FG005|Notification Period (Informed Consent)|Physician Decision|0|||
147552580|NCT00585351|532178645|FG006|Notification Period (Informed Consent)|Physician Decision|0|||
147552581|NCT00585351|532178646|FG007|Notification Period (Informed Consent)|Physician Decision|0|||
147552582|NCT00585351|532178639|FG000|Notification Period (Informed Consent)|Flight aborted|2|||
147552583|NCT00585351|532178640|FG001|Notification Period (Informed Consent)|Flight aborted|1|||
147552584|NCT00585351|532178641|FG002|Notification Period (Informed Consent)|Flight aborted|0|||
147309073|NCT02105636|531299943|FG000|Pre-Treatment|Disease Progression|1|||
147309074|NCT02105636|531299944|FG001|Pre-Treatment|Disease Progression|0|||
147309075|NCT02105636|531299943|FG000|Pre-Treatment|Participant request to discontinue study treatment|1|||
147309076|NCT02105636|531299944|FG001|Pre-Treatment|Participant request to discontinue study treatment|2|||
147309077|NCT02105636|531299943|FG000|Pre-Treatment|Participant withdrew consent|0|||
147309078|NCT02105636|531299944|FG001|Pre-Treatment|Participant withdrew consent|6|||
147309079|NCT02105636|531299943|FG000|Pre-Treatment|Participant no longer meets study criteria|2|||
147309080|NCT02105636|531299944|FG001|Pre-Treatment|Participant no longer meets study criteria|2|||
147309081|NCT02105636|531299943|FG000|Treatment|Study Drug Toxicity|14|||
147309082|NCT02105636|531299944|FG001|Treatment|Study Drug Toxicity|10|||
147309083|NCT02105636|531299943|FG000|Treatment|Adverse event unrelated to study drug|19|||
147309084|NCT02105636|531299944|FG001|Treatment|Adverse event unrelated to study drug|3|||
147309085|NCT02105636|531299943|FG000|Treatment|Participant request to discontinue study treatment|8|||
147309086|NCT02105636|531299944|FG001|Treatment|Participant request to discontinue study treatment|6|||
147309087|NCT02105636|531299943|FG000|Treatment|Participant withdrew consent|5|||
147309088|NCT02105636|531299944|FG001|Treatment|Participant withdrew consent|1|||
147309089|NCT02105636|531299943|FG000|Treatment|Lost to Follow-up|1|||
147309090|NCT02105636|531299944|FG001|Treatment|Lost to Follow-up|0|||
147552585|NCT00585351|532178642|FG003|Notification Period (Informed Consent)|Flight aborted|0|||
147552586|NCT00585351|532178643|FG004|Notification Period (Informed Consent)|Flight aborted|0|||
147552587|NCT00585351|532178644|FG005|Notification Period (Informed Consent)|Flight aborted|0|||
147649988|NCT01618916|532539783|FG001|Overall Study|Withdrawal by Subject|1|||
147220654|NCT00938886|530980223|FG000|Overall Study|Lost to Follow-up|3|||
147220655|NCT00938886|530980224|FG001|Overall Study|Lost to Follow-up|2|||
147220656|NCT03579602|530980225|FG000|Overall Study|Subject unable to receive study drug|0|||
147220657|NCT03579602|530980226|FG001|Overall Study|Subject unable to receive study drug|2|||
147220658|NCT03579602|530980225|FG000|Overall Study|Subject did not complete all study visits as planned|0|||
147220659|NCT03579602|530980226|FG001|Overall Study|Subject did not complete all study visits as planned|1|||
147220660|NCT02518464|530980228|FG000|Overall Study|Adverse Event|2|||
147220661|NCT01120067|530980231|FG000|Overall Study|Lost to Follow-up|3|||
147220662|NCT01120067|530980232|FG001|Overall Study|Lost to Follow-up|1|||
147220663|NCT01120067|530980231|FG000|Overall Study|fail to engage >3 sessions|2|||
147220664|NCT01120067|530980232|FG001|Overall Study|fail to engage >3 sessions|0|||
147220665|NCT03021564|530980236|FG000|Overall Study|Death|84|||
147649989|NCT01618916|532539784|FG002|Overall Study|Withdrawal by Subject|1|||
147649990|NCT01618916|532539785|FG003|Overall Study|Withdrawal by Subject|0|||
147552588|NCT00585351|532178645|FG006|Notification Period (Informed Consent)|Flight aborted|0|||
147552589|NCT00585351|532178646|FG007|Notification Period (Informed Consent)|Flight aborted|0|||
147552590|NCT00585351|532178639|FG000|Notification Period (Informed Consent)|No study medication on flight|0|||
147552591|NCT00585351|532178640|FG001|Notification Period (Informed Consent)|No study medication on flight|1|||
147552592|NCT00585351|532178641|FG002|Notification Period (Informed Consent)|No study medication on flight|0|||
147552593|NCT00585351|532178642|FG003|Notification Period (Informed Consent)|No study medication on flight|0|||
147552594|NCT00585351|532178643|FG004|Notification Period (Informed Consent)|No study medication on flight|0|||
147552595|NCT00585351|532178644|FG005|Notification Period (Informed Consent)|No study medication on flight|0|||
147552596|NCT00585351|532178645|FG006|Notification Period (Informed Consent)|No study medication on flight|0|||
147552597|NCT00585351|532178646|FG007|Notification Period (Informed Consent)|No study medication on flight|0|||
147552598|NCT00585351|532178639|FG000|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|21|||
147552599|NCT00585351|532178640|FG001|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|21|||
147552600|NCT00585351|532178641|FG002|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
147552601|NCT00585351|532178642|FG003|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
147552602|NCT00585351|532178643|FG004|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
147649991|NCT01618916|532539786|FG004|Overall Study|Withdrawal by Subject|1|||
147220666|NCT03021564|530980237|FG001|Overall Study|Death|466|||
147220667|NCT03021564|530980236|FG000|Overall Study|Lost to Follow-up|0|||
147552603|NCT00585351|532178644|FG005|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
147552604|NCT00585351|532178645|FG006|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
147552605|NCT00585351|532178646|FG007|Notification Period (Informed Consent)|Subject refused consent for AIRDOC|0|||
147552606|NCT00585351|532178639|FG000|Enrollment Period (Intervention)|Lost to Follow-up|0|||
147552607|NCT00585351|532178640|FG001|Enrollment Period (Intervention)|Lost to Follow-up|0|||
147552608|NCT00585351|532178641|FG002|Enrollment Period (Intervention)|Lost to Follow-up|0|||
147552609|NCT00585351|532178642|FG003|Enrollment Period (Intervention)|Lost to Follow-up|0|||
147552610|NCT00585351|532178643|FG004|Enrollment Period (Intervention)|Lost to Follow-up|0|||
147552611|NCT00585351|532178644|FG005|Enrollment Period (Intervention)|Lost to Follow-up|0|||
147552612|NCT00585351|532178645|FG006|Enrollment Period (Intervention)|Lost to Follow-up|1|||
147552613|NCT00585351|532178646|FG007|Enrollment Period (Intervention)|Lost to Follow-up|1|||
147552614|NCT00585351|532178639|FG000|Enrollment Period (Intervention)|Death|0|||
147552615|NCT00585351|532178640|FG001|Enrollment Period (Intervention)|Death|0|||
147552616|NCT00585351|532178641|FG002|Enrollment Period (Intervention)|Death|0|||
147552617|NCT00585351|532178642|FG003|Enrollment Period (Intervention)|Death|0|||
147552618|NCT00585351|532178643|FG004|Enrollment Period (Intervention)|Death|1|||
147552619|NCT00585351|532178644|FG005|Enrollment Period (Intervention)|Death|0|||
147552620|NCT00585351|532178645|FG006|Enrollment Period (Intervention)|Death|1|||
147552621|NCT00585351|532178646|FG007|Enrollment Period (Intervention)|Death|0|||
147552622|NCT00585351|532178639|FG000|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
147552623|NCT00585351|532178640|FG001|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
147552624|NCT00585351|532178641|FG002|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
147552625|NCT00585351|532178642|FG003|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
147552626|NCT00585351|532178643|FG004|Enrollment Period (Intervention)|Unknown if alive or deceased|1|||
147552627|NCT00585351|532178644|FG005|Enrollment Period (Intervention)|Unknown if alive or deceased|2|||
147552628|NCT00585351|532178645|FG006|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
147552629|NCT00585351|532178646|FG007|Enrollment Period (Intervention)|Unknown if alive or deceased|0|||
147649992|NCT01618916|532539787|FG005|Overall Study|Withdrawal by Subject|0|||
147649993|NCT01618916|532539782|FG000|Overall Study|Lost to Follow-up|1|||
147649994|NCT01618916|532539783|FG001|Overall Study|Lost to Follow-up|0|||
147649995|NCT01618916|532539784|FG002|Overall Study|Lost to Follow-up|0|||
147649996|NCT01618916|532539785|FG003|Overall Study|Lost to Follow-up|2|||
147649997|NCT01618916|532539786|FG004|Overall Study|Lost to Follow-up|0|||
147649998|NCT01618916|532539787|FG005|Overall Study|Lost to Follow-up|0|||
147649999|NCT03004924|532539788|FG000|Overall Study|Adverse Event|6|||
147650000|NCT03004924|532539789|FG001|Overall Study|Adverse Event|5|||
147650001|NCT03004924|532539790|FG002|Overall Study|Adverse Event|10|||
147650002|NCT03004924|532539788|FG000|Overall Study|Protocol Violation|4|||
147650003|NCT03004924|532539789|FG001|Overall Study|Protocol Violation|0|||
147650004|NCT03004924|532539790|FG002|Overall Study|Protocol Violation|1|||
147650005|NCT03004924|532539788|FG000|Overall Study|Withdrawal by Subject|5|||
147650006|NCT03004924|532539789|FG001|Overall Study|Withdrawal by Subject|3|||
147650007|NCT03004924|532539790|FG002|Overall Study|Withdrawal by Subject|5|||
147650008|NCT03004924|532539788|FG000|Overall Study|Lost to Follow-up|6|||
147650009|NCT03004924|532539789|FG001|Overall Study|Lost to Follow-up|1|||
147220668|NCT03021564|530980237|FG001|Overall Study|Lost to Follow-up|2|||
147220669|NCT02889562|530980238|FG000|Overall Study|Physician Decision|0|||
147220670|NCT02889562|530980239|FG001|Overall Study|Physician Decision|1|||
147220671|NCT02889562|530980238|FG000|Overall Study|Withdrawal by Subject|0|||
147552630|NCT01001169|532178647|FG000|Overall Study|Withdrawal by Subject|2|||
147552631|NCT01001169|532178648|FG001|Overall Study|Withdrawal by Subject|1|||
147552632|NCT02536378|532178653|FG000|Overall Study|Physician Decision|0|||
147552633|NCT02536378|532178654|FG001|Overall Study|Physician Decision|2|||
147552634|NCT02536378|532178653|FG000|Overall Study|Withdrawal by Subject|0|||
147552635|NCT02536378|532178654|FG001|Overall Study|Withdrawal by Subject|1|||
147552636|NCT02536378|532178653|FG000|Overall Study|Death|1|||
147552637|NCT02536378|532178654|FG001|Overall Study|Death|2|||
147552638|NCT02536378|532178653|FG000|Overall Study|Patient refused further follow up|6|||
147552639|NCT02536378|532178654|FG001|Overall Study|Patient refused further follow up|2|||
147552640|NCT00602030|532178655|FG000|Lead-in Phase|Disease Progression|2|||
147552641|NCT00602030|532178656|FG001|Lead-in Phase|Disease Progression|3|||
147552642|NCT00602030|532178657|FG002|Lead-in Phase|Disease Progression|0|||
147552643|NCT00602030|532178658|FG003|Lead-in Phase|Disease Progression|0|||
147552644|NCT00602030|532178659|FG004|Lead-in Phase|Disease Progression|0|||
147552645|NCT00602030|532178655|FG000|Lead-in Phase|Adverse Event|0|||
147552646|NCT00602030|532178656|FG001|Lead-in Phase|Adverse Event|2|||
147552647|NCT00602030|532178657|FG002|Lead-in Phase|Adverse Event|0|||
147552648|NCT00602030|532178658|FG003|Lead-in Phase|Adverse Event|0|||
147552649|NCT00602030|532178659|FG004|Lead-in Phase|Adverse Event|0|||
147552650|NCT00602030|532178655|FG000|Double-blind Phase|Disease progression|0|||
147552651|NCT00602030|532178656|FG001|Double-blind Phase|Disease progression|0|||
147552652|NCT00602030|532178657|FG002|Double-blind Phase|Disease progression|33|||
147552653|NCT00602030|532178658|FG003|Double-blind Phase|Disease progression|30|||
147552654|NCT00602030|532178659|FG004|Double-blind Phase|Disease progression|0|||
147552655|NCT00602030|532178655|FG000|Double-blind Phase|Adverse Event|0|||
147552656|NCT00602030|532178656|FG001|Double-blind Phase|Adverse Event|0|||
147552657|NCT00602030|532178657|FG002|Double-blind Phase|Adverse Event|9|||
147552658|NCT00602030|532178658|FG003|Double-blind Phase|Adverse Event|18|||
147552659|NCT00602030|532178659|FG004|Double-blind Phase|Adverse Event|0|||
147552660|NCT00602030|532178655|FG000|Double-blind Phase|Consent withdrawal|0|||
147552661|NCT00602030|532178656|FG001|Double-blind Phase|Consent withdrawal|0|||
147552662|NCT00602030|532178657|FG002|Double-blind Phase|Consent withdrawal|4|||
147552663|NCT00602030|532178658|FG003|Double-blind Phase|Consent withdrawal|3|||
147552664|NCT00602030|532178659|FG004|Double-blind Phase|Consent withdrawal|0|||
147552665|NCT00602030|532178655|FG000|Double-blind Phase|Death|0|||
147552666|NCT00602030|532178656|FG001|Double-blind Phase|Death|0|||
147552667|NCT00602030|532178657|FG002|Double-blind Phase|Death|3|||
147552668|NCT00602030|532178658|FG003|Double-blind Phase|Death|3|||
147552669|NCT00602030|532178659|FG004|Double-blind Phase|Death|0|||
147552670|NCT00602030|532178655|FG000|Double-blind Phase|Administrative decision|0|||
147552671|NCT00602030|532178656|FG001|Double-blind Phase|Administrative decision|0|||
147552672|NCT00602030|532178657|FG002|Double-blind Phase|Administrative decision|0|||
147552673|NCT00602030|532178658|FG003|Double-blind Phase|Administrative decision|2|||
147552674|NCT00602030|532178659|FG004|Double-blind Phase|Administrative decision|0|||
147552675|NCT00602030|532178655|FG000|Double-blind Phase|Ineligibility|0|||
147552676|NCT00602030|532178656|FG001|Double-blind Phase|Ineligibility|0|||
147552677|NCT00602030|532178657|FG002|Double-blind Phase|Ineligibility|0|||
147552678|NCT00602030|532178658|FG003|Double-blind Phase|Ineligibility|1|||
147552679|NCT00602030|532178659|FG004|Double-blind Phase|Ineligibility|0|||
147650010|NCT03004924|532539790|FG002|Overall Study|Lost to Follow-up|4|||
147650011|NCT03004924|532539788|FG000|Overall Study|Lack of Efficacy|2|||
147650012|NCT03004924|532539789|FG001|Overall Study|Lack of Efficacy|4|||
147650013|NCT03004924|532539790|FG002|Overall Study|Lack of Efficacy|2|||
147650014|NCT03004924|532539788|FG000|Overall Study|Physician Decision|1|||
147650015|NCT03004924|532539789|FG001|Overall Study|Physician Decision|0|||
147650016|NCT03004924|532539790|FG002|Overall Study|Physician Decision|1|||
147552680|NCT00602030|532178655|FG000|Double-blind Phase|Protocol deviation/noncompliance|0|||
147552681|NCT00602030|532178656|FG001|Double-blind Phase|Protocol deviation/noncompliance|0|||
147552682|NCT00602030|532178657|FG002|Double-blind Phase|Protocol deviation/noncompliance|1|||
147552683|NCT00602030|532178658|FG003|Double-blind Phase|Protocol deviation/noncompliance|0|||
147552684|NCT00602030|532178659|FG004|Double-blind Phase|Protocol deviation/noncompliance|0|||
147552685|NCT00602030|532178655|FG000|Double-blind Phase|Reason not specified|0|||
147552686|NCT00602030|532178656|FG001|Double-blind Phase|Reason not specified|0|||
147552687|NCT00602030|532178657|FG002|Double-blind Phase|Reason not specified|4|||
147552688|NCT00602030|532178658|FG003|Double-blind Phase|Reason not specified|2|||
147552689|NCT00602030|532178659|FG004|Double-blind Phase|Reason not specified|0|||
147552690|NCT00602030|532178655|FG000|Crossover Phase|Disease Progression|0|||
147220672|NCT02889562|530980239|FG001|Overall Study|Withdrawal by Subject|1|||
147220673|NCT01470989|530980242|FG000|Overall Study|Participants did not entered extension studies 1, 2 and 3|103|||
147220674|NCT01470989|530980243|FG001|Overall Study|Participants did not entered extension studies 1, 2 and 3|136|||
147220675|NCT01470989|530980242|FG000|Overall Study|Adverse Event|2|||
147220676|NCT01470989|530980243|FG001|Overall Study|Adverse Event|5|||
147220677|NCT01470989|530980242|FG000|Overall Study|Abnormal laboratory value|1|||
147220678|NCT01470989|530980243|FG001|Overall Study|Abnormal laboratory value|1|||
147443141|NCT03670953|531787169|FG003|Double Blind Maintenance (Weeks 8 - 20)|Adverse Event|3|||
147443142|NCT03670953|531787166|FG000|Double Blind Maintenance (Weeks 8 - 20)|Lack of Efficacy|0|||
147443143|NCT03670953|531787167|FG001|Double Blind Maintenance (Weeks 8 - 20)|Lack of Efficacy|0|||
147443144|NCT03670953|531787168|FG002|Double Blind Maintenance (Weeks 8 - 20)|Lack of Efficacy|5|||
147443145|NCT03670953|531787169|FG003|Double Blind Maintenance (Weeks 8 - 20)|Lack of Efficacy|8|||
147443146|NCT03670953|531787166|FG000|Double Blind Maintenance (Weeks 8 - 20)|Protocol Violation|0|||
147443147|NCT03670953|531787167|FG001|Double Blind Maintenance (Weeks 8 - 20)|Protocol Violation|0|||
147443148|NCT03670953|531787168|FG002|Double Blind Maintenance (Weeks 8 - 20)|Protocol Violation|3|||
147443149|NCT03670953|531787169|FG003|Double Blind Maintenance (Weeks 8 - 20)|Protocol Violation|1|||
147443150|NCT03670953|531787166|FG000|Double Blind Maintenance (Weeks 8 - 20)|Non compliance|0|||
147443151|NCT03670953|531787167|FG001|Double Blind Maintenance (Weeks 8 - 20)|Non compliance|0|||
147443152|NCT03670953|531787168|FG002|Double Blind Maintenance (Weeks 8 - 20)|Non compliance|1|||
147443153|NCT03670953|531787169|FG003|Double Blind Maintenance (Weeks 8 - 20)|Non compliance|0|||
147443154|NCT03670953|531787166|FG000|Double Blind Maintenance (Weeks 8 - 20)|Withdrawal by Subject|0|||
147443155|NCT03670953|531787167|FG001|Double Blind Maintenance (Weeks 8 - 20)|Withdrawal by Subject|0|||
147443156|NCT03670953|531787168|FG002|Double Blind Maintenance (Weeks 8 - 20)|Withdrawal by Subject|10|||
147443157|NCT03670953|531787169|FG003|Double Blind Maintenance (Weeks 8 - 20)|Withdrawal by Subject|11|||
147443158|NCT03670953|531787166|FG000|Double Blind Maintenance (Weeks 8 - 20)|Miscellaneous|0|||
147443159|NCT03670953|531787167|FG001|Double Blind Maintenance (Weeks 8 - 20)|Miscellaneous|0|||
147443160|NCT03670953|531787168|FG002|Double Blind Maintenance (Weeks 8 - 20)|Miscellaneous|1|||
147443161|NCT03670953|531787169|FG003|Double Blind Maintenance (Weeks 8 - 20)|Miscellaneous|0|||
147443162|NCT00362414|531787171|FG000|Overall Study|Death|2|||
147443163|NCT00362414|531787171|FG000|Overall Study|Adverse Event|1|||
147443164|NCT02603120|531787172|FG000|Double-Blind Treatment Phase|Withdrew consent|4|||
147443165|NCT02603120|531787173|FG001|Double-Blind Treatment Phase|Withdrew consent|8|||
147443166|NCT02603120|531787172|FG000|Double-Blind Treatment Phase|Adverse Event|3|||
147443167|NCT02603120|531787173|FG001|Double-Blind Treatment Phase|Adverse Event|3|||
147443168|NCT02603120|531787172|FG000|Double-Blind Treatment Phase|Lost to Follow-up|4|||
147443169|NCT02603120|531787173|FG001|Double-Blind Treatment Phase|Lost to Follow-up|2|||
147443170|NCT02603120|531787172|FG000|Double-Blind Treatment Phase|Death|2|||
147443171|NCT02603120|531787173|FG001|Double-Blind Treatment Phase|Death|0|||
147443172|NCT02603120|531787172|FG000|Double-Blind Treatment Phase|Investigator's discretion|2|||
147443173|NCT02603120|531787173|FG001|Double-Blind Treatment Phase|Investigator's discretion|0|||
147443174|NCT02603120|531787172|FG000|Double-Blind Treatment Phase|Pregnancy|1|||
147443175|NCT02603120|531787173|FG001|Double-Blind Treatment Phase|Pregnancy|1|||
147443176|NCT02603120|531787172|FG000|Double-Blind Treatment Phase|Non-compliance with study drug|1|||
147443177|NCT02603120|531787173|FG001|Double-Blind Treatment Phase|Non-compliance with study drug|0|||
147443178|NCT02603120|531787172|FG000|Double-Blind Treatment Phase|Did not receive study drug|2|||
147443179|NCT02603120|531787173|FG001|Double-Blind Treatment Phase|Did not receive study drug|2|||
147443180|NCT02603120|531787172|FG000|OL Extension B/F/TAF Treatment Phase|Lost to Follow-up|3|||
147443181|NCT02603120|531787173|FG001|OL Extension B/F/TAF Treatment Phase|Lost to Follow-up|4|||
147443182|NCT02603120|531787172|FG000|OL Extension B/F/TAF Treatment Phase|Investigator's discretion|1|||
147443183|NCT02603120|531787173|FG001|OL Extension B/F/TAF Treatment Phase|Investigator's discretion|2|||
147443184|NCT02603120|531787172|FG000|OL Extension B/F/TAF Treatment Phase|Withdrew consent|1|||
147443185|NCT02603120|531787173|FG001|OL Extension B/F/TAF Treatment Phase|Withdrew consent|2|||
147443186|NCT02603120|531787172|FG000|OL Extension B/F/TAF Treatment Phase|Adverse Event|0|||
147443187|NCT02603120|531787173|FG001|OL Extension B/F/TAF Treatment Phase|Adverse Event|1|||
147443188|NCT02603120|531787172|FG000|OL Extension B/F/TAF Treatment Phase|Death|0|||
147443189|NCT02603120|531787173|FG001|OL Extension B/F/TAF Treatment Phase|Death|1|||
147443190|NCT02603120|531787172|FG000|OL Extension B/F/TAF Treatment Phase|Lack of Efficacy|0|||
147443191|NCT02603120|531787173|FG001|OL Extension B/F/TAF Treatment Phase|Lack of Efficacy|1|||
147443192|NCT01227187|531787176|FG000|Overall Study|Physician Decision|0|||
147443193|NCT01227187|531787177|FG001|Overall Study|Physician Decision|0|||
147443194|NCT01227187|531787178|FG002|Overall Study|Physician Decision|0|||
147443195|NCT01227187|531787179|FG003|Overall Study|Physician Decision|1|||
147443196|NCT00840086|531787180|FG000|Overall Study|Adverse Event|1|||
147552691|NCT00602030|532178656|FG001|Crossover Phase|Disease Progression|0|||
147552692|NCT00602030|532178657|FG002|Crossover Phase|Disease Progression|0|||
147552693|NCT00602030|532178658|FG003|Crossover Phase|Disease Progression|0|||
147552694|NCT00602030|532178659|FG004|Crossover Phase|Disease Progression|11|||
147552695|NCT00602030|532178655|FG000|Crossover Phase|Adverse Event|0|||
147552696|NCT00602030|532178656|FG001|Crossover Phase|Adverse Event|0|||
147552697|NCT00602030|532178657|FG002|Crossover Phase|Adverse Event|0|||
147552698|NCT00602030|532178658|FG003|Crossover Phase|Adverse Event|0|||
147552699|NCT00602030|532178659|FG004|Crossover Phase|Adverse Event|3|||
147552700|NCT00602030|532178655|FG000|Crossover Phase|Consent withdrawal|0|||
147552701|NCT00602030|532178656|FG001|Crossover Phase|Consent withdrawal|0|||
147552702|NCT00602030|532178657|FG002|Crossover Phase|Consent withdrawal|0|||
147552703|NCT00602030|532178658|FG003|Crossover Phase|Consent withdrawal|0|||
147552704|NCT00602030|532178659|FG004|Crossover Phase|Consent withdrawal|2|||
147552705|NCT00798889|532178660|FG000|Overall Study|Adverse Event|53|||
147552706|NCT00798889|532178660|FG000|Overall Study|Protocol Violation|2|||
147552707|NCT00798889|532178660|FG000|Overall Study|Withdrawal by Subject|31|||
147552708|NCT00798889|532178660|FG000|Overall Study|Lost to Follow-up|1|||
147552709|NCT00798889|532178660|FG000|Overall Study|Lack of Efficacy|213|||
147552710|NCT00798889|532178660|FG000|Overall Study|Decision of Sponsor|11|||
147552711|NCT00798889|532178660|FG000|Overall Study|Enrolled, Not treated|3|||
147552712|NCT05085964|532178661|FG000|Overall Study|Premature termination of study|21|||
147650017|NCT03004924|532539788|FG000|Overall Study|Withdrawal by parent/guardian|1|||
147650018|NCT03004924|532539789|FG001|Overall Study|Withdrawal by parent/guardian|0|||
147650019|NCT03004924|532539790|FG002|Overall Study|Withdrawal by parent/guardian|2|||
147650020|NCT03004924|532539788|FG000|Overall Study|Screen Failure|1|||
147650021|NCT03004924|532539789|FG001|Overall Study|Screen Failure|0|||
147650022|NCT03004924|532539790|FG002|Overall Study|Screen Failure|0|||
147552713|NCT05085964|532178662|FG001|Overall Study|Premature termination of study|0|||
147552714|NCT03156270|532178667|FG000|Overall Study|Failed pre-treatment screening|1|||
147650023|NCT03004924|532539788|FG000|Overall Study|Pregnancy|0|||
147552715|NCT03156270|532178667|FG000|Overall Study|Lost to Follow-up|1|||
147552716|NCT00446654|532178668|FG000|Overall Study|Withdrawal by Subject|1|||
147552717|NCT00446654|532178669|FG001|Overall Study|Withdrawal by Subject|0|||
147650024|NCT03004924|532539789|FG001|Overall Study|Pregnancy|1|||
147552718|NCT00446654|532178668|FG000|Overall Study|Adverse Event|1|||
147552719|NCT00446654|532178669|FG001|Overall Study|Adverse Event|0|||
147552720|NCT02087059|532178671|FG000|Overall Study|Disease Progression|1|||
147552721|NCT02087059|532178671|FG000|Overall Study|Adverse Event|5|||
147552722|NCT02087059|532178671|FG000|Overall Study|Lost to Follow-up|1|||
147552723|NCT00947856|532178672|FG000|Treatment Period|Progressive Disease|33|||
147552724|NCT00947856|532178673|FG001|Treatment Period|Progressive Disease|12|||
147552725|NCT00947856|532178672|FG000|Treatment Period|Adverse Event|15|||
147552726|NCT00947856|532178673|FG001|Treatment Period|Adverse Event|9|||
147552727|NCT00947856|532178672|FG000|Treatment Period|Physician Decision|14|||
147552728|NCT00947856|532178673|FG001|Treatment Period|Physician Decision|6|||
147552729|NCT00947856|532178672|FG000|Treatment Period|Study Stopped by Sponsor|4|||
147552730|NCT00947856|532178673|FG001|Treatment Period|Study Stopped by Sponsor|4|||
147552731|NCT00947856|532178672|FG000|Treatment Period|Withdrawal by Subject|12|||
147552732|NCT00947856|532178673|FG001|Treatment Period|Withdrawal by Subject|1|||
147552733|NCT00947856|532178672|FG000|Follow-up Period|Study Stopped by Sponsor|40|||
147552734|NCT00947856|532178673|FG001|Follow-up Period|Study Stopped by Sponsor|20|||
147552735|NCT00947856|532178672|FG000|Follow-up Period|Re-enrolled for Retreatment|2|||
147552736|NCT00947856|532178673|FG001|Follow-up Period|Re-enrolled for Retreatment|3|||
147552737|NCT00947856|532178672|FG000|Follow-up Period|Lost to Follow-up|7|||
147552738|NCT00947856|532178673|FG001|Follow-up Period|Lost to Follow-up|0|||
147552739|NCT00947856|532178672|FG000|Follow-up Period|Patient unavailable for site visits|1|||
147552740|NCT00947856|532178673|FG001|Follow-up Period|Patient unavailable for site visits|0|||
147552741|NCT00947856|532178672|FG000|Follow-up Period|Withdrawal by Subject|1|||
147552742|NCT00947856|532178673|FG001|Follow-up Period|Withdrawal by Subject|0|||
147552743|NCT01261325|532178674|FG000|Overall Study|Lack of Efficacy|1|||
147552744|NCT01261325|532178675|FG001|Overall Study|Lack of Efficacy|1|||
147552745|NCT01261325|532178676|FG002|Overall Study|Lack of Efficacy|0|||
147552746|NCT01261325|532178674|FG000|Overall Study|Withdrawal by Subject|2|||
147552747|NCT01261325|532178675|FG001|Overall Study|Withdrawal by Subject|2|||
147552748|NCT01261325|532178676|FG002|Overall Study|Withdrawal by Subject|4|||
147552749|NCT01261325|532178674|FG000|Overall Study|SAE, non-fatal|1|||
147552750|NCT01261325|532178675|FG001|Overall Study|SAE, non-fatal|5|||
147220679|NCT01470989|530980242|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
147220680|NCT01470989|530980243|FG001|Overall Study|Unsatisfactory therapeutic effect|6|||
147220681|NCT01470989|530980242|FG000|Overall Study|Withdrawal by Subject|19|||
147443197|NCT00840086|531787180|FG000|Overall Study|Protocol Violation|2|||
147443198|NCT00840086|531787180|FG000|Overall Study|Lost to Follow-up|1|||
147443199|NCT03332498|531787181|FG000|Overall Study|Severe illness prior to Day 1 of treatment|0|||
147443200|NCT03332498|531787182|FG001|Overall Study|Severe illness prior to Day 1 of treatment|0|||
147443201|NCT03332498|531787183|FG002|Overall Study|Severe illness prior to Day 1 of treatment|2|||
147443202|NCT02554019|531787184|FG000|Overall Study|Withdrawal by Subject|1|||
147443203|NCT02554019|531787185|FG001|Overall Study|Withdrawal by Subject|0|||
147443204|NCT02554019|531787186|FG002|Overall Study|Withdrawal by Subject|2|||
147443205|NCT02554019|531787184|FG000|Overall Study|Adverse Event|1|||
147443206|NCT02554019|531787185|FG001|Overall Study|Adverse Event|0|||
147443207|NCT02554019|531787186|FG002|Overall Study|Adverse Event|0|||
147443208|NCT02181816|531787187|FG000|Overall Study|Case Report Forms Uncollected|38|||
147443209|NCT02181816|531787187|FG000|Overall Study|Protocol Deviation|21|||
147443210|NCT02113436|531787188|FG000|Period 1: 8 Weeks|Adverse Event|1|||
147443211|NCT02113436|531787189|FG001|Period 1: 8 Weeks|Adverse Event|0|||
147443212|NCT02113436|531787190|FG002|Period 1: 8 Weeks|Adverse Event|0|||
147443213|NCT02113436|531787191|FG003|Period 1: 8 Weeks|Adverse Event|0|||
147443214|NCT02113436|531787188|FG000|Period 1: 8 Weeks|Protocol Violation|1|||
147443215|NCT02113436|531787189|FG001|Period 1: 8 Weeks|Protocol Violation|0|||
147443216|NCT02113436|531787190|FG002|Period 1: 8 Weeks|Protocol Violation|0|||
147443217|NCT02113436|531787191|FG003|Period 1: 8 Weeks|Protocol Violation|0|||
147443218|NCT02113436|531787188|FG000|Period 1: 8 Weeks|Par. Reached Stopping Criteria|5|||
147443219|NCT02113436|531787189|FG001|Period 1: 8 Weeks|Par. Reached Stopping Criteria|2|||
147443220|NCT02113436|531787190|FG002|Period 1: 8 Weeks|Par. Reached Stopping Criteria|0|||
147443221|NCT02113436|531787191|FG003|Period 1: 8 Weeks|Par. Reached Stopping Criteria|0|||
147443222|NCT02113436|531787188|FG000|Period 1: 8 Weeks|Withdrawal by Subject|1|||
147443223|NCT02113436|531787189|FG001|Period 1: 8 Weeks|Withdrawal by Subject|0|||
147443224|NCT02113436|531787190|FG002|Period 1: 8 Weeks|Withdrawal by Subject|0|||
147443225|NCT02113436|531787191|FG003|Period 1: 8 Weeks|Withdrawal by Subject|0|||
147443226|NCT02113436|531787188|FG000|Period 2: 16 Weeks|Adverse Event|0|||
147443227|NCT02113436|531787189|FG001|Period 2: 16 Weeks|Adverse Event|0|||
147443228|NCT02113436|531787190|FG002|Period 2: 16 Weeks|Adverse Event|4|||
147443229|NCT02113436|531787191|FG003|Period 2: 16 Weeks|Adverse Event|5|||
147443230|NCT02113436|531787188|FG000|Period 2: 16 Weeks|Par. Reached Stopping Criteria|0|||
147443231|NCT02113436|531787189|FG001|Period 2: 16 Weeks|Par. Reached Stopping Criteria|0|||
147443232|NCT02113436|531787190|FG002|Period 2: 16 Weeks|Par. Reached Stopping Criteria|2|||
147309091|NCT02105636|531299943|FG000|Treatment|Maximum Clinical Benefit|1|||
147309092|NCT02105636|531299944|FG001|Treatment|Maximum Clinical Benefit|3|||
147309093|NCT02105636|531299943|FG000|Treatment|Poor/Non-compliance|0|||
147309094|NCT02105636|531299944|FG001|Treatment|Poor/Non-compliance|1|||
147309095|NCT02105636|531299943|FG000|Treatment|Participant no longer meets study criteria|1|||
147309096|NCT02105636|531299944|FG001|Treatment|Participant no longer meets study criteria|0|||
147309097|NCT02105636|531299943|FG000|Treatment|Other reasons|1|||
147309098|NCT02105636|531299944|FG001|Treatment|Other reasons|0|||
147309099|NCT02105636|531299943|FG000|Treatment|Disease Progression|185|||
147309100|NCT02105636|531299944|FG001|Treatment|Disease Progression|87|||
147309101|NCT02802319|531299948|FG000|Overall Study|Physician Decision|2|||
147309102|NCT02802319|531299949|FG001|Overall Study|Physician Decision|1|||
147309103|NCT02802319|531299948|FG000|Overall Study|Lost to Follow-up|0|||
147309104|NCT02802319|531299949|FG001|Overall Study|Lost to Follow-up|4|||
147309105|NCT04651114|531299950|FG000|Overall Study|Withdrawal by Subject|8|||
147309106|NCT01923896|531299955|FG000|Overall Study|Adverse Event|1|||
147443233|NCT02113436|531787191|FG003|Period 2: 16 Weeks|Par. Reached Stopping Criteria|5|||
147443234|NCT02113436|531787188|FG000|Period 2: 16 Weeks|Physician Decision|0|||
147443235|NCT02113436|531787189|FG001|Period 2: 16 Weeks|Physician Decision|0|||
147443236|NCT02113436|531787190|FG002|Period 2: 16 Weeks|Physician Decision|2|||
147443237|NCT02113436|531787191|FG003|Period 2: 16 Weeks|Physician Decision|0|||
147443238|NCT02113436|531787188|FG000|Period 2: 16 Weeks|Withdrawal by Subject|0|||
147443239|NCT02113436|531787189|FG001|Period 2: 16 Weeks|Withdrawal by Subject|0|||
147443240|NCT02113436|531787190|FG002|Period 2: 16 Weeks|Withdrawal by Subject|1|||
147443241|NCT02113436|531787191|FG003|Period 2: 16 Weeks|Withdrawal by Subject|1|||
147443242|NCT02159729|531787192|FG000|Overall Study|Adverse Event|0|||
147443243|NCT02159729|531787193|FG001|Overall Study|Adverse Event|1|||
147443244|NCT02159729|531787192|FG000|Overall Study|Subject's Request|13|||
147443245|NCT02159729|531787193|FG001|Overall Study|Subject's Request|10|||
147443246|NCT02159729|531787192|FG000|Overall Study|Lost to Follow-up|24|||
147443247|NCT02159729|531787193|FG001|Overall Study|Lost to Follow-up|9|||
147443248|NCT02159729|531787192|FG000|Overall Study|Non compliance|2|||
147443249|NCT02159729|531787193|FG001|Overall Study|Non compliance|0|||
147443250|NCT02159729|531787192|FG000|Overall Study|Other Unspecified|3|||
147443251|NCT02159729|531787193|FG001|Overall Study|Other Unspecified|1|||
147443252|NCT01148537|531787194|FG000|Overall Study|Withdrawal by Subject|1|||
147443253|NCT01148537|531787195|FG001|Overall Study|Withdrawal by Subject|0|||
147443254|NCT01148537|531787196|FG002|Overall Study|Withdrawal by Subject|2|||
147443255|NCT01148537|531787194|FG000|Overall Study|Adverse Event|2|||
147443256|NCT01148537|531787195|FG001|Overall Study|Adverse Event|0|||
147443257|NCT01148537|531787196|FG002|Overall Study|Adverse Event|1|||
147443258|NCT00827606|531787199|FG000|Overall Study|Protocol Violation|4|||
147443259|NCT00827606|531787200|FG001|Overall Study|Protocol Violation|3|||
147443260|NCT00827606|531787199|FG000|Overall Study|Lost to Follow-up|3|||
147443261|NCT00827606|531787200|FG001|Overall Study|Lost to Follow-up|1|||
147443262|NCT00827606|531787199|FG000|Overall Study|Withdrawal by Subject|7|||
147443263|NCT00827606|531787200|FG001|Overall Study|Withdrawal by Subject|6|||
147443264|NCT00827606|531787199|FG000|Overall Study|Pregnancy|0|||
147443265|NCT00827606|531787200|FG001|Overall Study|Pregnancy|1|||
147443266|NCT00827606|531787199|FG000|Overall Study|Other|5|||
147443267|NCT00827606|531787200|FG001|Overall Study|Other|13|||
147443268|NCT00827606|531787199|FG000|Overall Study|LDL below 2.59 mmol/L|4|||
147443269|NCT00827606|531787200|FG001|Overall Study|LDL below 2.59 mmol/L|12|||
147443270|NCT00827606|531787199|FG000|Overall Study|Adverse Event|4|||
147443271|NCT00827606|531787200|FG001|Overall Study|Adverse Event|2|||
147443272|NCT00243386|531787203|FG000|On-Demand Regimen (Study Part 1)|Withdrawal by Subject|1|||
147443273|NCT00243386|531787204|FG001|On-Demand Regimen (Study Part 1)|Withdrawal by Subject|0|||
147443274|NCT00243386|531787205|FG002|On-Demand Regimen (Study Part 1)|Withdrawal by Subject|0|||
147443275|NCT00243386|531787203|FG000|On-Demand Regimen (Study Part 1)|Lost to Follow-up|1|||
147443276|NCT00243386|531787204|FG001|On-Demand Regimen (Study Part 1)|Lost to Follow-up|0|||
147443277|NCT00243386|531787205|FG002|On-Demand Regimen (Study Part 1)|Lost to Follow-up|0|||
147443278|NCT00243386|531787203|FG000|On-Demand Regimen (Study Part 1)|Screen Failures|2|||
147443279|NCT00243386|531787204|FG001|On-Demand Regimen (Study Part 1)|Screen Failures|0|||
147443280|NCT00243386|531787205|FG002|On-Demand Regimen (Study Part 1)|Screen Failures|0|||
147443281|NCT00243386|531787203|FG000|End of Part 1, But Prior to Prophylaxis|Withdrawal by Subject|1|||
147443282|NCT00243386|531787204|FG001|End of Part 1, But Prior to Prophylaxis|Withdrawal by Subject|0|||
147443283|NCT00243386|531787205|FG002|End of Part 1, But Prior to Prophylaxis|Withdrawal by Subject|0|||
147443284|NCT00243386|531787203|FG000|End of Part 1, But Prior to Prophylaxis|Lost to Follow-up|1|||
147443285|NCT00243386|531787204|FG001|End of Part 1, But Prior to Prophylaxis|Lost to Follow-up|0|||
147443286|NCT00243386|531787205|FG002|End of Part 1, But Prior to Prophylaxis|Lost to Follow-up|0|||
147309107|NCT01923896|531299956|FG001|Overall Study|Adverse Event|0|||
147309108|NCT03545113|531299959|FG000|Overall Study|Surgery Cancelled|1|||
147309109|NCT03545113|531299960|FG001|Overall Study|Surgery Cancelled|0|||
147309110|NCT03545113|531299959|FG000|Overall Study|Death|1|||
147309111|NCT03545113|531299960|FG001|Overall Study|Death|0|||
147552751|NCT01261325|532178676|FG002|Overall Study|SAE, non-fatal|1|||
147552752|NCT01261325|532178674|FG000|Overall Study|AE, non-serious non-fatal|9|||
147552753|NCT01261325|532178675|FG001|Overall Study|AE, non-serious non-fatal|15|||
147309112|NCT03545113|531299959|FG000|Overall Study|Adverse Event|2|||
147443287|NCT00243386|531787203|FG000|End of Part 1, But Prior to Prophylaxis|Withdrawn for Non-Compliance|1|||
147220682|NCT01470989|530980243|FG001|Overall Study|Withdrawal by Subject|17|||
147220683|NCT01470989|530980242|FG000|Overall Study|Lost to Follow-up|18|||
147220684|NCT01470989|530980243|FG001|Overall Study|Lost to Follow-up|13|||
147220685|NCT01470989|530980242|FG000|Overall Study|Administrative problems|2|||
147220686|NCT01470989|530980243|FG001|Overall Study|Administrative problems|4|||
147220687|NCT01470989|530980242|FG000|Overall Study|Death|2|||
147552754|NCT01261325|532178676|FG002|Overall Study|AE, non-serious non-fatal|13|||
147552755|NCT01261325|532178674|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
147552756|NCT01261325|532178675|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
147552757|NCT01261325|532178676|FG002|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
147552758|NCT01261325|532178674|FG000|Overall Study|Non Compliance|2|||
147552759|NCT01261325|532178675|FG001|Overall Study|Non Compliance|0|||
147552760|NCT01261325|532178676|FG002|Overall Study|Non Compliance|0|||
147552761|NCT01261325|532178674|FG000|Overall Study|Patient Randomized by Mistake|0|||
147552762|NCT01261325|532178675|FG001|Overall Study|Patient Randomized by Mistake|1|||
147552763|NCT01261325|532178676|FG002|Overall Study|Patient Randomized by Mistake|0|||
147552764|NCT01261325|532178674|FG000|Overall Study|Erroneously Randomized|1|||
147552765|NCT01261325|532178675|FG001|Overall Study|Erroneously Randomized|0|||
147443288|NCT00243386|531787204|FG001|End of Part 1, But Prior to Prophylaxis|Withdrawn for Non-Compliance|0|||
147443289|NCT00243386|531787205|FG002|End of Part 1, But Prior to Prophylaxis|Withdrawn for Non-Compliance|0|||
147443290|NCT00243386|531787203|FG000|PK-Driven or Standard Prophylaxis|Withdrawn for Non-Compliance|0|||
147443291|NCT00243386|531787204|FG001|PK-Driven or Standard Prophylaxis|Withdrawn for Non-Compliance|2|||
147443292|NCT00243386|531787205|FG002|PK-Driven or Standard Prophylaxis|Withdrawn for Non-Compliance|0|||
147443293|NCT00243386|531787203|FG000|PK-Driven or Standard Prophylaxis|Lack of Efficacy|0|||
147443294|NCT00243386|531787204|FG001|PK-Driven or Standard Prophylaxis|Lack of Efficacy|1|||
147443295|NCT00243386|531787205|FG002|PK-Driven or Standard Prophylaxis|Lack of Efficacy|0|||
147443296|NCT04037748|531787206|FG000|Treatment Period 1|Withdrawal by Subject|3|||
147443297|NCT04037748|531787207|FG001|Treatment Period 1|Withdrawal by Subject|0|||
147443298|NCT04037748|531787206|FG000|Treatment Period 1|Adverse Event|1|||
147443299|NCT04037748|531787207|FG001|Treatment Period 1|Adverse Event|1|||
147443300|NCT04037748|531787206|FG000|Treatment Period 1|Protocol Violation|4|||
147650025|NCT03004924|532539790|FG002|Overall Study|Pregnancy|0|||
147650026|NCT03004924|532539788|FG000|Overall Study|Terminated by Sponsor|0|||
147650027|NCT03004924|532539789|FG001|Overall Study|Terminated by Sponsor|0|||
147220688|NCT01470989|530980243|FG001|Overall Study|Death|2|||
147220689|NCT01470989|530980242|FG000|Overall Study|Protocol deviation|1|||
147220690|NCT01470989|530980243|FG001|Overall Study|Protocol deviation|2|||
147443301|NCT04037748|531787207|FG001|Treatment Period 1|Protocol Violation|5|||
147443302|NCT04037748|531787206|FG000|Treatment Period 2|Adverse Event|0|||
147443303|NCT04037748|531787207|FG001|Treatment Period 2|Adverse Event|1|||
147443304|NCT04037748|531787206|FG000|Treatment Period 2|Protocol Violation|2|||
147443305|NCT04037748|531787207|FG001|Treatment Period 2|Protocol Violation|0|||
147443306|NCT00133991|531787208|FG000|Overall Study|Death|4|||
147443307|NCT04995055|531787212|FG000|Period 1|COVID-19 Related|1|||
147443308|NCT04995055|531787213|FG001|Period 1|COVID-19 Related|0|||
147443309|NCT04995055|531787212|FG000|Period 1|Withdrawal by Subject|0|||
147443310|NCT04995055|531787213|FG001|Period 1|Withdrawal by Subject|1|||
147443311|NCT04995055|531787212|FG000|Period 1|Subject discontinued due to timing|4|||
147443312|NCT04995055|531787213|FG001|Period 1|Subject discontinued due to timing|4|||
147443313|NCT04695392|531787214|FG000|Overall Study|Withdrawn by parent/guardian|0|||
147650028|NCT03004924|532539790|FG002|Overall Study|Terminated by Sponsor|1|||
147650029|NCT03004924|532539788|FG000|Overall Study|Missed Study Visit|0|||
147650030|NCT03004924|532539789|FG001|Overall Study|Missed Study Visit|0|||
147650031|NCT03004924|532539790|FG002|Overall Study|Missed Study Visit|2|||
147650032|NCT03004924|532539788|FG000|Overall Study|HSV1 Positive|1|||
147650033|NCT03004924|532539789|FG001|Overall Study|HSV1 Positive|0|||
147650034|NCT03004924|532539790|FG002|Overall Study|HSV1 Positive|0|||
147650035|NCT02005627|532539791|FG000|Overall Study|Lost to Follow-up|1|||
147650036|NCT02005627|532539792|FG001|Overall Study|Lost to Follow-up|2|||
147650037|NCT02005627|532539791|FG000|Overall Study|Withdrawal by Subject|1|||
147650038|NCT02005627|532539792|FG001|Overall Study|Withdrawal by Subject|2|||
147650039|NCT01119846|532539798|FG000|Overall Study|Adverse Event|1|||
147650040|NCT01119846|532539799|FG001|Overall Study|Adverse Event|0|||
147650041|NCT01119846|532539800|FG002|Overall Study|Adverse Event|6|||
147650042|NCT01119846|532539798|FG000|Overall Study|Physician Decision|1|||
147650043|NCT01119846|532539799|FG001|Overall Study|Physician Decision|0|||
147650044|NCT01119846|532539800|FG002|Overall Study|Physician Decision|0|||
147650045|NCT01119846|532539798|FG000|Overall Study|Protocol Violation|0|||
147650046|NCT01119846|532539799|FG001|Overall Study|Protocol Violation|0|||
147650047|NCT01119846|532539800|FG002|Overall Study|Protocol Violation|1|||
147650048|NCT01119846|532539798|FG000|Overall Study|Withdrawal by Subject|0|||
147552766|NCT01261325|532178676|FG002|Overall Study|Erroneously Randomized|0|||
147552767|NCT01261325|532178674|FG000|Overall Study|Screen Failure|1|||
147552768|NCT01261325|532178675|FG001|Overall Study|Screen Failure|0|||
147552769|NCT01261325|532178676|FG002|Overall Study|Screen Failure|0|||
147552770|NCT01261325|532178674|FG000|Overall Study|Randomized in Error|0|||
147552771|NCT01261325|532178675|FG001|Overall Study|Randomized in Error|0|||
147552772|NCT01261325|532178676|FG002|Overall Study|Randomized in Error|1|||
147650049|NCT01119846|532539799|FG001|Overall Study|Withdrawal by Subject|0|||
147650050|NCT01119846|532539800|FG002|Overall Study|Withdrawal by Subject|4|||
147650051|NCT00048997|532539803|FG000|Overall Study|Protocol Violation|7|||
147650052|NCT00048997|532539804|FG001|Overall Study|Protocol Violation|2|||
147650053|NCT00048997|532539803|FG000|Overall Study|Withdrawal by Subject|6|||
147650054|NCT00048997|532539804|FG001|Overall Study|Withdrawal by Subject|1|||
147650055|NCT00048165|532539806|FG000|Completed 6 Months Study|Administration/Other|8|||
147650056|NCT00048165|532539807|FG001|Completed 6 Months Study|Administration/Other|8|||
147650057|NCT00048165|532539806|FG000|Completed 6 Months Study|Abnormality of laboratory test|1|||
147650058|NCT00048165|532539807|FG001|Completed 6 Months Study|Abnormality of laboratory test|0|||
147650059|NCT00048165|532539806|FG000|Completed 6 Months Study|Adverse event/intermittent illness|14|||
147650060|NCT00048165|532539807|FG001|Completed 6 Months Study|Adverse event/intermittent illness|11|||
147650061|NCT00048165|532539806|FG000|Completed 6 Months Study|Death|12|||
147650062|NCT00048165|532539807|FG001|Completed 6 Months Study|Death|6|||
147650063|NCT00048165|532539806|FG000|Completed 6 Months Study|Insufficient therapy|1|||
147650064|NCT00048165|532539807|FG001|Completed 6 Months Study|Insufficient therapy|4|||
147650065|NCT00048165|532539806|FG000|Completed 6 Months Study|Other violation|4|||
147650066|NCT00048165|532539807|FG001|Completed 6 Months Study|Other violation|6|||
147650067|NCT00048165|532539806|FG000|Completed 6 Months Study|Refused treatment|5|||
147650068|NCT00048165|532539807|FG001|Completed 6 Months Study|Refused treatment|5|||
147650069|NCT00048165|532539806|FG000|Completed 6 Months Study|Violation criteria|0|||
147650070|NCT00048165|532539807|FG001|Completed 6 Months Study|Violation criteria|2|||
147650071|NCT00048165|532539806|FG000|Completed 6 Months Study|Did not receive study drug|6|||
147650072|NCT00048165|532539807|FG001|Completed 6 Months Study|Did not receive study drug|6|||
147650073|NCT00048165|532539806|FG000|Completed 12 Months Study|Administration/Other|0|||
147650074|NCT00048165|532539807|FG001|Completed 12 Months Study|Administration/Other|2|||
147650075|NCT00048165|532539806|FG000|Completed 12 Months Study|Death|2|||
147650076|NCT00048165|532539807|FG001|Completed 12 Months Study|Death|1|||
147650077|NCT00048165|532539806|FG000|Completed 12 Months Study|Did not co-operate/Withdrew|1|||
147650078|NCT00048165|532539807|FG001|Completed 12 Months Study|Did not co-operate/Withdrew|0|||
147650079|NCT01084538|532539815|FG000|Overall Study|Drug not available|30|||
147650080|NCT01084538|532539815|FG000|Overall Study|Adverse Event|9|||
147650081|NCT01084538|532539815|FG000|Overall Study|Kidney transplant|6|||
147650082|NCT01084538|532539815|FG000|Overall Study|Serious Adverse Event|3|||
147650083|NCT01084538|532539815|FG000|Overall Study|Lack of effectiveness|2|||
147650084|NCT01084538|532539815|FG000|Overall Study|Patient noncompliance|2|||
147650085|NCT01084538|532539815|FG000|Overall Study|Hyperphosphatemia|2|||
147650086|NCT01084538|532539815|FG000|Overall Study|Nodular hyperplasia of parathyroid gland|2|||
147650087|NCT01084538|532539815|FG000|Overall Study|Change of residence|2|||
147650088|NCT01084538|532539815|FG000|Overall Study|Over-suppression of parathyroid gland|2|||
147650089|NCT01084538|532539815|FG000|Overall Study|Reason unknown|8|||
147650090|NCT00803205|532539816|FG000|Overall Study|Adverse Event|7|||
147220691|NCT00969280|530980244|FG000|Overall Study|Protocol Violation|2|||
147220692|NCT00969280|530980245|FG001|Overall Study|Protocol Violation|1|||
147220693|NCT00969280|530980244|FG000|Overall Study|Withdrawal by Subject|0|||
147220694|NCT00969280|530980245|FG001|Overall Study|Withdrawal by Subject|1|||
147650091|NCT00803205|532539817|FG001|Overall Study|Adverse Event|2|||
147650092|NCT00803205|532539816|FG000|Overall Study|Lost to Follow-up|1|||
147650093|NCT00803205|532539817|FG001|Overall Study|Lost to Follow-up|0|||
147650094|NCT00803205|532539816|FG000|Overall Study|Withdrawal by Subject|9|||
147650095|NCT00803205|532539817|FG001|Overall Study|Withdrawal by Subject|9|||
147650096|NCT00803205|532539816|FG000|Overall Study|Physician Decision|1|||
147650097|NCT00803205|532539817|FG001|Overall Study|Physician Decision|0|||
147650098|NCT00803205|532539816|FG000|Overall Study|Protocol Violation|1|||
147650099|NCT00803205|532539817|FG001|Overall Study|Protocol Violation|1|||
147650100|NCT00803205|532539816|FG000|Overall Study|Medical Monitor Decision|1|||
147650101|NCT00803205|532539817|FG001|Overall Study|Medical Monitor Decision|0|||
147650102|NCT00803205|532539816|FG000|Overall Study|Acquired a Lung Infection|0|||
147650103|NCT00803205|532539817|FG001|Overall Study|Acquired a Lung Infection|1|||
147650104|NCT00803205|532539816|FG000|Overall Study|Sponsor Decision|0|||
147650105|NCT00803205|532539817|FG001|Overall Study|Sponsor Decision|1|||
147650106|NCT01490697|532539820|FG000|Overall Study|Did Not Meet PTSD Diagnostic Criteria|1|||
147552773|NCT01261325|532178674|FG000|Overall Study|Protocol Violation|0|||
147552774|NCT01261325|532178675|FG001|Overall Study|Protocol Violation|3|||
147552775|NCT01261325|532178676|FG002|Overall Study|Protocol Violation|1|||
147552776|NCT01261325|532178674|FG000|Overall Study|Lost to Follow-up|0|||
147309113|NCT03545113|531299960|FG001|Overall Study|Adverse Event|0|||
147309114|NCT03545113|531299959|FG000|Overall Study|Received different surgery|1|||
147309115|NCT03545113|531299960|FG001|Overall Study|Received different surgery|0|||
147309116|NCT00235443|531299961|FG000|Overall Study|Adverse Event|4|||
147309117|NCT00235443|531299962|FG001|Overall Study|Adverse Event|12|||
147309118|NCT00235443|531299963|FG002|Overall Study|Adverse Event|17|||
147309119|NCT00235443|531299964|FG003|Overall Study|Adverse Event|44|||
147309120|NCT00235443|531299965|FG004|Overall Study|Adverse Event|10|||
147309121|NCT00235443|531299966|FG005|Overall Study|Adverse Event|15|||
147309122|NCT00235443|531299961|FG000|Overall Study|Lack of Efficacy|0|||
147309123|NCT00235443|531299962|FG001|Overall Study|Lack of Efficacy|1|||
147309124|NCT00235443|531299963|FG002|Overall Study|Lack of Efficacy|5|||
147309125|NCT00235443|531299964|FG003|Overall Study|Lack of Efficacy|12|||
147309126|NCT00235443|531299965|FG004|Overall Study|Lack of Efficacy|2|||
147309127|NCT00235443|531299966|FG005|Overall Study|Lack of Efficacy|9|||
147309128|NCT00235443|531299961|FG000|Overall Study|Withdrawal by Subject|3|||
147309129|NCT00235443|531299962|FG001|Overall Study|Withdrawal by Subject|9|||
147309130|NCT00235443|531299963|FG002|Overall Study|Withdrawal by Subject|25|||
147309131|NCT00235443|531299964|FG003|Overall Study|Withdrawal by Subject|24|||
147309132|NCT00235443|531299965|FG004|Overall Study|Withdrawal by Subject|10|||
147309133|NCT00235443|531299966|FG005|Overall Study|Withdrawal by Subject|12|||
147309134|NCT00235443|531299961|FG000|Overall Study|Lost to Follow-up|0|||
147309135|NCT00235443|531299962|FG001|Overall Study|Lost to Follow-up|8|||
147309136|NCT00235443|531299963|FG002|Overall Study|Lost to Follow-up|6|||
147309137|NCT00235443|531299964|FG003|Overall Study|Lost to Follow-up|6|||
147309138|NCT00235443|531299965|FG004|Overall Study|Lost to Follow-up|4|||
147309139|NCT00235443|531299966|FG005|Overall Study|Lost to Follow-up|3|||
147309140|NCT00235443|531299961|FG000|Overall Study|Unsatisfactory compliance|0|||
147309141|NCT00235443|531299962|FG001|Overall Study|Unsatisfactory compliance|2|||
147309142|NCT00235443|531299963|FG002|Overall Study|Unsatisfactory compliance|3|||
147309143|NCT00235443|531299964|FG003|Overall Study|Unsatisfactory compliance|4|||
147309144|NCT00235443|531299965|FG004|Overall Study|Unsatisfactory compliance|1|||
147309145|NCT00235443|531299966|FG005|Overall Study|Unsatisfactory compliance|0|||
147309146|NCT00235443|531299961|FG000|Overall Study|Other reasons for premature termination|1|||
147309147|NCT00235443|531299962|FG001|Overall Study|Other reasons for premature termination|6|||
147309148|NCT00235443|531299963|FG002|Overall Study|Other reasons for premature termination|6|||
147309149|NCT00235443|531299964|FG003|Overall Study|Other reasons for premature termination|7|||
147552777|NCT01261325|532178675|FG001|Overall Study|Lost to Follow-up|1|||
147552778|NCT01261325|532178676|FG002|Overall Study|Lost to Follow-up|3|||
147552779|NCT01261325|532178674|FG000|Overall Study|AE, serious fatal|0|||
147220695|NCT00969280|530980244|FG000|Overall Study|infection of influenza A(H1N1)|0|||
147220696|NCT00969280|530980245|FG001|Overall Study|infection of influenza A(H1N1)|1|||
147220697|NCT00217464|530980246|FG000|Overall Study|Progression|15|||
147220698|NCT00217464|530980246|FG000|Overall Study|Other|2|||
147220699|NCT00527488|530980251|FG000|Overall Study|Withdrawn prior to dosing|0|||
147220700|NCT00527488|530980252|FG001|Overall Study|Withdrawn prior to dosing|1|||
147220701|NCT00527488|530980253|FG002|Overall Study|Withdrawn prior to dosing|1|||
147220702|NCT00527488|530980254|FG003|Overall Study|Withdrawn prior to dosing|0|||
147220703|NCT02545543|530980255|FG000|Overall Study|Lost to Follow-up|67|||
147220704|NCT02545543|530980256|FG001|Overall Study|Lost to Follow-up|25|||
147220705|NCT02545543|530980255|FG000|Overall Study|Physician Decision|3|||
147220706|NCT02545543|530980256|FG001|Overall Study|Physician Decision|0|||
147220707|NCT02545543|530980255|FG000|Overall Study|Withdrawal by Subject|9|||
147220708|NCT02545543|530980256|FG001|Overall Study|Withdrawal by Subject|8|||
147220709|NCT02545543|530980255|FG000|Overall Study|Noncomplaince|1|||
147220710|NCT02545543|530980256|FG001|Overall Study|Noncomplaince|0|||
147309150|NCT00235443|531299965|FG004|Overall Study|Other reasons for premature termination|3|||
147552780|NCT01261325|532178675|FG001|Overall Study|AE, serious fatal|0|||
147552781|NCT01261325|532178676|FG002|Overall Study|AE, serious fatal|2|||
147552782|NCT02330081|532178687|FG000|Overall Study|Adverse Event|1|||
147552783|NCT02330081|532178687|FG000|Overall Study|Donation did not meet criteria|1|||
147220711|NCT02545543|530980255|FG000|Overall Study|Enrolment of subject at >1 study site|1|||
147220712|NCT02545543|530980256|FG001|Overall Study|Enrolment of subject at >1 study site|1|||
147220713|NCT04675151|530980257|FG000|Overall Study|Protocol Violation|1|||
147220714|NCT04675151|530980258|FG001|Overall Study|Protocol Violation|0|||
147220715|NCT04675151|530980259|FG002|Overall Study|Protocol Violation|0|||
147309151|NCT00235443|531299966|FG005|Overall Study|Other reasons for premature termination|6|||
147309152|NCT02032173|531299967|FG000|Overall Study|Discontinuation due to sponsor decision|31|||
147309153|NCT00474929|531299973|FG000|Overall Study|Withdrawal by Subject|0|||
147309154|NCT00474929|531299974|FG001|Overall Study|Withdrawal by Subject|1|||
147309155|NCT00474929|531299975|FG002|Overall Study|Withdrawal by Subject|0|||
147309156|NCT00474929|531299976|FG003|Overall Study|Withdrawal by Subject|0|||
147309157|NCT00474929|531299977|FG004|Overall Study|Withdrawal by Subject|0|||
147220716|NCT04675151|530980260|FG003|Overall Study|Protocol Violation|1|||
147220717|NCT04035486|530980261|FG000|Overall Study|Ongoing Study at Data Cut Off (03APR2023)|7|||
147220718|NCT04035486|530980262|FG001|Overall Study|Ongoing Study at Data Cut Off (03APR2023)|10|||
147220719|NCT04035486|530980263|FG002|Overall Study|Ongoing Study at Data Cut Off (03APR2023)|197|||
147220720|NCT04035486|530980264|FG003|Overall Study|Ongoing Study at Data Cut Off (03APR2023)|191|||
147220721|NCT04035486|530980261|FG000|Overall Study|Death|6|||
147220722|NCT04035486|530980262|FG001|Overall Study|Death|3|||
147552784|NCT02330081|532178687|FG000|Overall Study|Protocol Violation|6|||
147552785|NCT02668302|532178693|FG000|Overall Study|Withdrawal by Subject|1|||
147552786|NCT02668302|532178694|FG001|Overall Study|Withdrawal by Subject|0|||
147552787|NCT03558997|532178695|FG000|Overall Study|Adverse Event|0|||
147552788|NCT03558997|532178696|FG001|Overall Study|Adverse Event|2|||
147552789|NCT03558997|532178697|FG002|Overall Study|Adverse Event|5|||
147552790|NCT03558997|532178698|FG003|Overall Study|Adverse Event|1|||
147552791|NCT03558997|532178695|FG000|Overall Study|Physician Decision|0|||
147552792|NCT03558997|532178696|FG001|Overall Study|Physician Decision|0|||
147552793|NCT03558997|532178697|FG002|Overall Study|Physician Decision|1|||
147552794|NCT03558997|532178698|FG003|Overall Study|Physician Decision|0|||
147552795|NCT03558997|532178695|FG000|Overall Study|Withdrawal by Subject|1|||
147552796|NCT03558997|532178696|FG001|Overall Study|Withdrawal by Subject|0|||
147552797|NCT03558997|532178697|FG002|Overall Study|Withdrawal by Subject|1|||
147552798|NCT03558997|532178698|FG003|Overall Study|Withdrawal by Subject|1|||
147552799|NCT03558997|532178695|FG000|Overall Study|Lost to Follow-up|0|||
147552800|NCT03558997|532178696|FG001|Overall Study|Lost to Follow-up|0|||
147552801|NCT03558997|532178697|FG002|Overall Study|Lost to Follow-up|1|||
147552802|NCT03558997|532178698|FG003|Overall Study|Lost to Follow-up|0|||
147552803|NCT03586830|532178701|FG000|Overall Study|Site terminated by Sponsor|1|||
147552804|NCT03586830|532178702|FG001|Overall Study|Site terminated by Sponsor|4|||
147552805|NCT03586830|532178703|FG002|Overall Study|Site terminated by Sponsor|3|||
147552806|NCT03586830|532178704|FG003|Overall Study|Site terminated by Sponsor|3|||
147552807|NCT03586830|532178701|FG000|Overall Study|Lost to Follow-up|0|||
147552808|NCT03586830|532178702|FG001|Overall Study|Lost to Follow-up|2|||
147552809|NCT03586830|532178703|FG002|Overall Study|Lost to Follow-up|2|||
147552810|NCT03586830|532178704|FG003|Overall Study|Lost to Follow-up|1|||
147552811|NCT03586830|532178701|FG000|Overall Study|Withdrawal by Subject|1|||
147552812|NCT03586830|532178702|FG001|Overall Study|Withdrawal by Subject|0|||
147552813|NCT03586830|532178703|FG002|Overall Study|Withdrawal by Subject|3|||
147552814|NCT03586830|532178704|FG003|Overall Study|Withdrawal by Subject|1|||
147552815|NCT02034799|532179974|FG000|Overall Study|Withdrawal by Subject|0|||
147220723|NCT04035486|530980263|FG002|Overall Study|Death|70|||
147220724|NCT04035486|530980264|FG003|Overall Study|Death|77|||
147220725|NCT04035486|530980261|FG000|Overall Study|Screen Failure|0|||
147220726|NCT04035486|530980262|FG001|Overall Study|Screen Failure|0|||
147220727|NCT04035486|530980263|FG002|Overall Study|Screen Failure|1|||
147220728|NCT04035486|530980264|FG003|Overall Study|Screen Failure|1|||
147220729|NCT04035486|530980261|FG000|Overall Study|Withdrawal by Subject|1|||
147220730|NCT04035486|530980262|FG001|Overall Study|Withdrawal by Subject|1|||
147220731|NCT04035486|530980263|FG002|Overall Study|Withdrawal by Subject|11|||
147220732|NCT04035486|530980264|FG003|Overall Study|Withdrawal by Subject|9|||
147220733|NCT01730937|530980265|FG000|Overall Study|Protocol Violation|5|||
147220734|NCT01730937|530980266|FG001|Overall Study|Protocol Violation|11|||
147220735|NCT03947684|530980267|FG000|Overall Study|Lost to Follow-up|13|||
147650107|NCT01490697|532539821|FG001|Overall Study|Did Not Meet PTSD Diagnostic Criteria|2|||
147552816|NCT02034799|532179975|FG001|Overall Study|Withdrawal by Subject|2|||
147552817|NCT02034799|532179974|FG000|Overall Study|Lost to Follow-up|0|||
147552818|NCT02034799|532179975|FG001|Overall Study|Lost to Follow-up|1|||
147552819|NCT02034799|532179974|FG000|Overall Study|Death|2|||
147650108|NCT00379808|532539822|FG000|Intervention Period 2 (4 Weeks)|Lost to Follow-up|0|||
147650109|NCT00379808|532539823|FG001|Intervention Period 2 (4 Weeks)|Lost to Follow-up|1|||
147650110|NCT02442206|532541174|FG000|Period 1|Adverse Event|1|||
147650111|NCT02442206|532541175|FG001|Period 1|Adverse Event|1|||
147650112|NCT02442206|532541174|FG000|Period 1|withdrew consent|0|||
147650113|NCT02442206|532541175|FG001|Period 1|withdrew consent|1|||
147650114|NCT02442206|532541174|FG000|Period 1|COPD exacerbation|0|||
147650115|NCT02442206|532541175|FG001|Period 1|COPD exacerbation|1|||
147220736|NCT03947684|530980268|FG001|Overall Study|Lost to Follow-up|5|||
147220737|NCT03947684|530980269|FG002|Overall Study|Lost to Follow-up|1|||
147220738|NCT03947684|530980267|FG000|Overall Study|Withdrawal by Subject|11|||
147220739|NCT03947684|530980268|FG001|Overall Study|Withdrawal by Subject|4|||
147220740|NCT03947684|530980269|FG002|Overall Study|Withdrawal by Subject|0|||
147220741|NCT03947684|530980267|FG000|Overall Study|Physician Decision|1|||
147220742|NCT03947684|530980268|FG001|Overall Study|Physician Decision|0|||
147552820|NCT02034799|532179975|FG001|Overall Study|Death|1|||
147552821|NCT03433001|532179986|FG000|Overall Study|Lack of Efficacy|109|||
147552822|NCT03433001|532179986|FG000|Overall Study|Adverse Event|69|||
147650116|NCT02442206|532541174|FG000|Period 2|Adverse Event|1|||
147650117|NCT02442206|532541175|FG001|Period 2|Adverse Event|0|||
147650118|NCT01709409|532541182|FG000|Overall Study|Protocol Violation|1|||
147650119|NCT01709409|532541183|FG001|Overall Study|Protocol Violation|0|||
147309158|NCT00474929|531299973|FG000|Overall Study|Unrelated medical condition|0|||
147309159|NCT00474929|531299974|FG001|Overall Study|Unrelated medical condition|0|||
147309160|NCT00474929|531299975|FG002|Overall Study|Unrelated medical condition|1|||
147309161|NCT00474929|531299976|FG003|Overall Study|Unrelated medical condition|0|||
147220743|NCT03947684|530980269|FG002|Overall Study|Physician Decision|0|||
147220744|NCT03947684|530980267|FG000|Overall Study|Lack of adherence to study protocol|2|||
147220745|NCT03947684|530980268|FG001|Overall Study|Lack of adherence to study protocol|0|||
147220746|NCT03947684|530980269|FG002|Overall Study|Lack of adherence to study protocol|0|||
147220747|NCT03875235|530980270|FG000|Overall Study|Ongoing study treatment|63|||
147220748|NCT03875235|530980271|FG001|Overall Study|Ongoing study treatment|20|||
147220749|NCT03875235|530980270|FG000|Overall Study|Off treatment|77|||
147220750|NCT03875235|530980271|FG001|Overall Study|Off treatment|91|||
147220751|NCT03875235|530980270|FG000|Overall Study|Withdrawal by Subject|3|||
147220752|NCT03875235|530980271|FG001|Overall Study|Withdrawal by Subject|10|||
147220753|NCT03875235|530980270|FG000|Overall Study|Death|198|||
147220754|NCT03875235|530980271|FG001|Overall Study|Death|223|||
147220755|NCT00622739|530981668|FG000|Overall Study|Physician Decision|1|||
147220756|NCT00622739|530981669|FG001|Overall Study|Physician Decision|0|||
147220757|NCT00622739|530981668|FG000|Overall Study|Adverse Event|1|||
147220758|NCT00622739|530981669|FG001|Overall Study|Adverse Event|2|||
147220759|NCT00622739|530981668|FG000|Overall Study|Lack of Efficacy|0|||
147220760|NCT00622739|530981669|FG001|Overall Study|Lack of Efficacy|2|||
147220761|NCT00622739|530981668|FG000|Overall Study|Withdrawal by Subject|0|||
147220762|NCT00622739|530981669|FG001|Overall Study|Withdrawal by Subject|1|||
147220763|NCT00622739|530981668|FG000|Overall Study|Lost to Follow-up|0|||
147220764|NCT00622739|530981669|FG001|Overall Study|Lost to Follow-up|1|||
147220765|NCT03123185|530981677|FG000|Overall Study|Withdrawal by Subject|0|||
147220766|NCT03123185|530981678|FG001|Overall Study|Withdrawal by Subject|0|||
147220767|NCT03123185|530981679|FG002|Overall Study|Withdrawal by Subject|0|||
147220768|NCT03123185|530981680|FG003|Overall Study|Withdrawal by Subject|0|||
147220769|NCT03123185|530981681|FG004|Overall Study|Withdrawal by Subject|0|||
147220770|NCT03123185|530981682|FG005|Overall Study|Withdrawal by Subject|0|||
147220771|NCT03123185|530981683|FG006|Overall Study|Withdrawal by Subject|0|||
147220772|NCT03123185|530981684|FG007|Overall Study|Withdrawal by Subject|0|||
147220773|NCT03123185|530981685|FG008|Overall Study|Withdrawal by Subject|0|||
147309162|NCT00474929|531299977|FG004|Overall Study|Unrelated medical condition|0|||
147309163|NCT00474929|531299973|FG000|Overall Study|Physician Decision|0|||
147220774|NCT03123185|530981686|FG009|Overall Study|Withdrawal by Subject|0|||
147309164|NCT00474929|531299974|FG001|Overall Study|Physician Decision|0|||
147309165|NCT00474929|531299975|FG002|Overall Study|Physician Decision|1|||
147220775|NCT03123185|530981687|FG010|Overall Study|Withdrawal by Subject|0|||
147220776|NCT03123185|530981688|FG011|Overall Study|Withdrawal by Subject|0|||
147309166|NCT00474929|531299976|FG003|Overall Study|Physician Decision|2|||
147552823|NCT03433001|532179986|FG000|Overall Study|Withdrawal by Subject|10|||
147552824|NCT03433001|532179986|FG000|Overall Study|Death|12|||
147552825|NCT03433001|532179986|FG000|Overall Study|Lost to Follow-up|4|||
147552826|NCT03433001|532179986|FG000|Overall Study|Other|25|||
147552827|NCT02058628|532179987|FG000|Overall Study|Adverse Event|1|||
147552828|NCT02058628|532179988|FG001|Overall Study|Adverse Event|0|||
147552829|NCT02058628|532179987|FG000|Overall Study|Withdrawal by Subject|2|||
147552830|NCT02058628|532179988|FG001|Overall Study|Withdrawal by Subject|2|||
147552831|NCT02058628|532179987|FG000|Overall Study|Lost to Follow-up|2|||
147552832|NCT02058628|532179988|FG001|Overall Study|Lost to Follow-up|4|||
147552833|NCT02058628|532179987|FG000|Overall Study|Not in time schedule|0|||
147552834|NCT02058628|532179988|FG001|Overall Study|Not in time schedule|1|||
147552835|NCT02058628|532179987|FG000|Overall Study|The visit date was not in timeline|0|||
147552836|NCT02058628|532179988|FG001|Overall Study|The visit date was not in timeline|1|||
147552837|NCT02058628|532179987|FG000|Overall Study|A lot of time for study for participant|1|||
147552838|NCT02058628|532179988|FG001|Overall Study|A lot of time for study for participant|0|||
147552839|NCT02058628|532179987|FG000|Overall Study|Non compliance|1|||
147552840|NCT02058628|532179988|FG001|Overall Study|Non compliance|0|||
147552841|NCT01452529|532179989|FG000|Run-in Period|Adverse Event|96|||
147220777|NCT03123185|530981689|FG012|Overall Study|Withdrawal by Subject|1|||
147220778|NCT03123185|530981690|FG013|Overall Study|Withdrawal by Subject|0|||
147552842|NCT01452529|532179990|FG001|Run-in Period|Adverse Event|0|||
147552843|NCT01452529|532179991|FG002|Run-in Period|Adverse Event|0|||
147552844|NCT01452529|532179989|FG000|Run-in Period|Withdrawal by Subject|49|||
147552845|NCT01452529|532179990|FG001|Run-in Period|Withdrawal by Subject|0|||
147552846|NCT01452529|532179991|FG002|Run-in Period|Withdrawal by Subject|0|||
147552847|NCT01452529|532179989|FG000|Run-in Period|Lost to Follow-up|19|||
147220779|NCT03468543|530981691|FG000|Overall Study|Protocol stopping rules met|3|||
147220780|NCT00470158|530981692|FG000|Overall Study|Death|0|||
147552848|NCT01452529|532179990|FG001|Run-in Period|Lost to Follow-up|0|||
147650120|NCT02412878|532541184|FG000|Overall Study|Withdrawal by Subject|19|||
147650121|NCT02412878|532541185|FG001|Overall Study|Withdrawal by Subject|10|||
147650122|NCT02412878|532541184|FG000|Overall Study|Lost to Follow-up|2|||
147650123|NCT02412878|532541185|FG001|Overall Study|Lost to Follow-up|3|||
147650124|NCT02190721|532541186|FG000|Overall Study|Patient was out of the city|0|||
147650125|NCT02190721|532541187|FG001|Overall Study|Patient was out of the city|1|||
147650126|NCT02190721|532541188|FG002|Overall Study|Patient was out of the city|0|||
147650127|NCT04571385|532541189|FG000|Overall Study|Participant non-compliance|1|||
147650128|NCT04571385|532541190|FG001|Overall Study|Participant non-compliance|0|||
147650129|NCT04571385|532541191|FG002|Overall Study|Participant non-compliance|0|||
147650130|NCT04571385|532541189|FG000|Overall Study|Converted to Sinus Rhythm (SR) before the infusion|0|||
147650131|NCT04571385|532541190|FG001|Overall Study|Converted to Sinus Rhythm (SR) before the infusion|1|||
147650132|NCT04571385|532541191|FG002|Overall Study|Converted to Sinus Rhythm (SR) before the infusion|0|||
147650133|NCT04571385|532541189|FG000|Overall Study|Screen failure|0|||
147650134|NCT04571385|532541190|FG001|Overall Study|Screen failure|0|||
147650135|NCT04571385|532541191|FG002|Overall Study|Screen failure|1|||
147650136|NCT01212159|532541193|FG000|Overall Study|Withdrawal by Subject|12|||
147650137|NCT01212159|532541194|FG001|Overall Study|Withdrawal by Subject|12|||
147650138|NCT04676152|532541195|FG000|Overall Study|screen fail|9|||
147650139|NCT01928199|532541196|FG000|Overall Study|Lost to Follow-up|2|||
147650140|NCT01928199|532541197|FG001|Overall Study|Lost to Follow-up|1|||
147650141|NCT01928199|532541196|FG000|Overall Study|Withdrawal by Subject|3|||
147650142|NCT01928199|532541197|FG001|Overall Study|Withdrawal by Subject|5|||
147650143|NCT03517449|532541209|FG000|Overall Study|Death|184|||
147650144|NCT03517449|532541210|FG001|Overall Study|Death|236|||
147650145|NCT03517449|532541209|FG000|Overall Study|Lost to Follow-up|0|||
147650146|NCT03517449|532541210|FG001|Overall Study|Lost to Follow-up|2|||
147650147|NCT03517449|532541209|FG000|Overall Study|Withdrawal by Subject|7|||
147309167|NCT00474929|531299977|FG004|Overall Study|Physician Decision|0|||
147309168|NCT03661996|531299980|FG000|Overall Study|Adverse Event|0|||
147309169|NCT03661996|531299981|FG001|Overall Study|Adverse Event|0|||
147650148|NCT03517449|532541210|FG001|Overall Study|Withdrawal by Subject|26|||
147650149|NCT03517449|532541209|FG000|Overall Study|Participants Ongoing|220|||
147650150|NCT03517449|532541210|FG001|Overall Study|Participants Ongoing|152|||
147650151|NCT00269477|532541223|FG000|Overall Study|Protocol Violation|5|||
147650152|NCT00269477|532541224|FG001|Overall Study|Protocol Violation|5|||
147650153|NCT00269477|532541225|FG002|Overall Study|Protocol Violation|1|||
147650154|NCT00269477|532541226|FG003|Overall Study|Protocol Violation|0|||
147650155|NCT00269477|532541223|FG000|Overall Study|Missed post-vaccination blood draw|0|||
147650156|NCT00269477|532541224|FG001|Overall Study|Missed post-vaccination blood draw|1|||
147650157|NCT00269477|532541225|FG002|Overall Study|Missed post-vaccination blood draw|0|||
147443314|NCT04695392|531787215|FG001|Overall Study|Withdrawn by parent/guardian|1|||
147443315|NCT04695392|531787214|FG000|Overall Study|Withdrawn by physician|0|||
147443316|NCT04695392|531787215|FG001|Overall Study|Withdrawn by physician|1|||
147443317|NCT00807742|531787216|FG000|Overall Study|Death|9|||
147443318|NCT00807742|531787217|FG001|Overall Study|Death|2|||
147443319|NCT00807742|531787216|FG000|Overall Study|Withdrawal by Subject|2|||
147443320|NCT00807742|531787217|FG001|Overall Study|Withdrawal by Subject|1|||
147443321|NCT00807742|531787216|FG000|Overall Study|Lost to Follow-up|35|||
147443322|NCT00807742|531787217|FG001|Overall Study|Lost to Follow-up|51|||
147443323|NCT03834519|531787218|FG000|Overall Study|Lost to Follow-up|2|||
147443324|NCT03834519|531787219|FG001|Overall Study|Lost to Follow-up|1|||
147443325|NCT03834519|531787218|FG000|Overall Study|Withdrawal by Subject|5|||
147443326|NCT03834519|531787219|FG001|Overall Study|Withdrawal by Subject|8|||
147443327|NCT03834519|531787218|FG000|Overall Study|Death|368|||
147443328|NCT03834519|531787219|FG001|Overall Study|Death|174|||
147443329|NCT03834519|531787218|FG000|Overall Study|Physician Decision|5|||
147220781|NCT00470158|530981693|FG001|Overall Study|Death|0|||
147552849|NCT01452529|532179991|FG002|Run-in Period|Lost to Follow-up|0|||
147552850|NCT01452529|532179989|FG000|Run-in Period|Lack of Efficacy|46|||
147552851|NCT01452529|532179990|FG001|Run-in Period|Lack of Efficacy|0|||
147552852|NCT01452529|532179991|FG002|Run-in Period|Lack of Efficacy|0|||
147552853|NCT01452529|532179989|FG000|Run-in Period|Confirmed or suspected diversion|23|||
147552854|NCT01452529|532179990|FG001|Run-in Period|Confirmed or suspected diversion|0|||
147552855|NCT01452529|532179991|FG002|Run-in Period|Confirmed or suspected diversion|0|||
147552856|NCT01452529|532179989|FG000|Run-in Period|Administrative|21|||
147552857|NCT01452529|532179990|FG001|Run-in Period|Administrative|0|||
147552858|NCT01452529|532179991|FG002|Run-in Period|Administrative|0|||
147552859|NCT01452529|532179989|FG000|Run-in Period|Did not qualify for Double-Blind Phase|59|||
147552860|NCT01452529|532179990|FG001|Run-in Period|Did not qualify for Double-Blind Phase|0|||
147552861|NCT01452529|532179991|FG002|Run-in Period|Did not qualify for Double-Blind Phase|0|||
147552862|NCT01452529|532179989|FG000|Double-blind (DB) Period|Adverse Event|0|||
147552863|NCT01452529|532179990|FG001|Double-blind (DB) Period|Adverse Event|18|||
147552864|NCT01452529|532179991|FG002|Double-blind (DB) Period|Adverse Event|11|||
147552865|NCT01452529|532179989|FG000|Double-blind (DB) Period|Withdrawal by Subject|0|||
147552866|NCT01452529|532179990|FG001|Double-blind (DB) Period|Withdrawal by Subject|15|||
147552867|NCT01452529|532179991|FG002|Double-blind (DB) Period|Withdrawal by Subject|14|||
147552868|NCT01452529|532179989|FG000|Double-blind (DB) Period|Lost to Follow-up|0|||
147552869|NCT01452529|532179990|FG001|Double-blind (DB) Period|Lost to Follow-up|5|||
147552870|NCT01452529|532179991|FG002|Double-blind (DB) Period|Lost to Follow-up|3|||
147552871|NCT01452529|532179989|FG000|Double-blind (DB) Period|Lack of Efficacy|0|||
147552872|NCT01452529|532179990|FG001|Double-blind (DB) Period|Lack of Efficacy|16|||
147552873|NCT01452529|532179991|FG002|Double-blind (DB) Period|Lack of Efficacy|44|||
147552874|NCT01452529|532179989|FG000|Double-blind (DB) Period|Confirmed or suspected diversion|0|||
147552875|NCT01452529|532179990|FG001|Double-blind (DB) Period|Confirmed or suspected diversion|2|||
147552876|NCT01452529|532179991|FG002|Double-blind (DB) Period|Confirmed or suspected diversion|3|||
147552877|NCT01452529|532179989|FG000|Double-blind (DB) Period|Administrative|0|||
147650158|NCT00269477|532541226|FG003|Overall Study|Missed post-vaccination blood draw|0|||
147650159|NCT00431067|532541227|FG000|Overall Study|Other Adverse Event|9|||
147650160|NCT00431067|532541227|FG000|Overall Study|Progressive disease|30|||
147650161|NCT00431067|532541227|FG000|Overall Study|Non-compliance,lost to follow-up|2|||
147650162|NCT00938587|532541228|FG000|Overall Study|Adverse Event|2|||
147650163|NCT00938587|532541229|FG001|Overall Study|Adverse Event|0|||
147650164|NCT00938587|532541230|FG002|Overall Study|Adverse Event|0|||
147650165|NCT00938587|532541231|FG003|Overall Study|Adverse Event|2|||
147650166|NCT00938587|532541228|FG000|Overall Study|Did not meet entrance criteria|0|||
147650167|NCT00938587|532541229|FG001|Overall Study|Did not meet entrance criteria|0|||
147650168|NCT00938587|532541230|FG002|Overall Study|Did not meet entrance criteria|1|||
147650169|NCT00938587|532541231|FG003|Overall Study|Did not meet entrance criteria|0|||
147650170|NCT00938587|532541228|FG000|Overall Study|Withdrawal by Subject|1|||
147650171|NCT00938587|532541229|FG001|Overall Study|Withdrawal by Subject|1|||
147650172|NCT00938587|532541230|FG002|Overall Study|Withdrawal by Subject|0|||
147650173|NCT00938587|532541231|FG003|Overall Study|Withdrawal by Subject|0|||
147650174|NCT00548249|532541232|FG000|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|3|||
147650175|NCT00548249|532541233|FG001|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|4|||
147650176|NCT00548249|532541234|FG002|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|4|||
147650177|NCT00548249|532541235|FG003|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|2|||
147650178|NCT00548249|532541236|FG004|Overall Study|Hemoglobin (Hgb) decrease >=1.0 g/dL|4|||
147650179|NCT00548249|532541232|FG000|Overall Study|Transferrin Saturation (TSAT) <20%|5|||
147650180|NCT00548249|532541233|FG001|Overall Study|Transferrin Saturation (TSAT) <20%|1|||
147650181|NCT00548249|532541234|FG002|Overall Study|Transferrin Saturation (TSAT) <20%|3|||
147650182|NCT00548249|532541235|FG003|Overall Study|Transferrin Saturation (TSAT) <20%|1|||
147650183|NCT00548249|532541236|FG004|Overall Study|Transferrin Saturation (TSAT) <20%|2|||
147650184|NCT00548249|532541232|FG000|Overall Study|Protocol Violation|1|||
147650185|NCT00548249|532541233|FG001|Overall Study|Protocol Violation|1|||
147650186|NCT00548249|532541234|FG002|Overall Study|Protocol Violation|4|||
147650187|NCT00548249|532541235|FG003|Overall Study|Protocol Violation|0|||
147650188|NCT00548249|532541236|FG004|Overall Study|Protocol Violation|3|||
147650189|NCT00548249|532541232|FG000|Overall Study|Miscellaneous|2|||
147650190|NCT00548249|532541233|FG001|Overall Study|Miscellaneous|3|||
147650191|NCT00548249|532541234|FG002|Overall Study|Miscellaneous|2|||
147650192|NCT00548249|532541235|FG003|Overall Study|Miscellaneous|0|||
147220782|NCT00470158|530981694|FG002|Overall Study|Death|0|||
147650193|NCT00548249|532541236|FG004|Overall Study|Miscellaneous|2|||
147650194|NCT00548249|532541232|FG000|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|0|||
147650195|NCT00548249|532541233|FG001|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|0|||
147650196|NCT00548249|532541234|FG002|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|2|||
147309170|NCT03661996|531299982|FG002|Overall Study|Adverse Event|1|||
147309171|NCT03661996|531299983|FG003|Overall Study|Adverse Event|1|||
147309172|NCT03661996|531299984|FG004|Overall Study|Adverse Event|0|||
147309173|NCT03661996|531299980|FG000|Overall Study|Lost to Follow-up|5|||
147309174|NCT03661996|531299981|FG001|Overall Study|Lost to Follow-up|1|||
147309175|NCT03661996|531299982|FG002|Overall Study|Lost to Follow-up|2|||
147309176|NCT03661996|531299983|FG003|Overall Study|Lost to Follow-up|2|||
147309177|NCT03661996|531299984|FG004|Overall Study|Lost to Follow-up|6|||
147552878|NCT01452529|532179990|FG001|Double-blind (DB) Period|Administrative|11|||
147552879|NCT01452529|532179991|FG002|Double-blind (DB) Period|Administrative|7|||
147552880|NCT04527471|532179995|FG000|Overall Study|Adverse Event|1|||
147552881|NCT04527471|532179996|FG001|Overall Study|Adverse Event|0|||
147552882|NCT04527471|532179995|FG000|Overall Study|Lost to Follow-up|1|||
147552883|NCT04527471|532179996|FG001|Overall Study|Lost to Follow-up|0|||
147552884|NCT02891200|532179997|FG000|Overall Study|Lost to Follow-up|31|||
147552885|NCT02891200|532179998|FG001|Overall Study|Lost to Follow-up|36|||
147309178|NCT03661996|531299980|FG000|Overall Study|Physician Decision|1|||
147309179|NCT03661996|531299981|FG001|Overall Study|Physician Decision|1|||
147309180|NCT03661996|531299982|FG002|Overall Study|Physician Decision|1|||
147309181|NCT03661996|531299983|FG003|Overall Study|Physician Decision|2|||
147552886|NCT02891200|532179997|FG000|Overall Study|Death|10|||
147650197|NCT00548249|532541235|FG003|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|1|||
147650198|NCT00548249|532541236|FG004|Overall Study|Pre-dialysis (Pre-HD) TSAT >=50%|4|||
147650199|NCT00548249|532541232|FG000|Overall Study|Adverse Event|2|||
147650200|NCT00548249|532541233|FG001|Overall Study|Adverse Event|2|||
147650201|NCT00548249|532541234|FG002|Overall Study|Adverse Event|0|||
147650202|NCT00548249|532541235|FG003|Overall Study|Adverse Event|1|||
147650203|NCT00548249|532541236|FG004|Overall Study|Adverse Event|1|||
147650204|NCT00548249|532541232|FG000|Overall Study|Post-dialysis high TSAT or low UIBC|0|||
147650205|NCT00548249|532541233|FG001|Overall Study|Post-dialysis high TSAT or low UIBC|0|||
147650206|NCT00548249|532541234|FG002|Overall Study|Post-dialysis high TSAT or low UIBC|1|||
147650207|NCT00548249|532541235|FG003|Overall Study|Post-dialysis high TSAT or low UIBC|3|||
147650208|NCT00548249|532541236|FG004|Overall Study|Post-dialysis high TSAT or low UIBC|2|||
147650209|NCT00548249|532541232|FG000|Overall Study|Erythropoietin (ESA)Dose Change Required|0|||
147650210|NCT00548249|532541233|FG001|Overall Study|Erythropoietin (ESA)Dose Change Required|0|||
147650211|NCT00548249|532541234|FG002|Overall Study|Erythropoietin (ESA)Dose Change Required|1|||
147650212|NCT00548249|532541235|FG003|Overall Study|Erythropoietin (ESA)Dose Change Required|2|||
147650213|NCT00548249|532541236|FG004|Overall Study|Erythropoietin (ESA)Dose Change Required|2|||
147650214|NCT00548249|532541232|FG000|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1|||
147650215|NCT00548249|532541233|FG001|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1|||
147650216|NCT00548249|532541234|FG002|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1|||
147650217|NCT00548249|532541235|FG003|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|1|||
147650218|NCT00548249|532541236|FG004|Overall Study|Hemoglobin (Hgb) >= 12.6 g/dL|0|||
147650219|NCT00548249|532541232|FG000|Overall Study|Prolonged hospitalization|0|||
147650220|NCT00548249|532541233|FG001|Overall Study|Prolonged hospitalization|0|||
147650221|NCT00548249|532541234|FG002|Overall Study|Prolonged hospitalization|2|||
147650222|NCT00548249|532541235|FG003|Overall Study|Prolonged hospitalization|1|||
147650223|NCT00548249|532541236|FG004|Overall Study|Prolonged hospitalization|0|||
147650224|NCT00548249|532541232|FG000|Overall Study|Withdrawal by Subject|2|||
147650225|NCT00548249|532541233|FG001|Overall Study|Withdrawal by Subject|0|||
147650226|NCT00548249|532541234|FG002|Overall Study|Withdrawal by Subject|0|||
147650227|NCT00548249|532541235|FG003|Overall Study|Withdrawal by Subject|0|||
147650228|NCT00548249|532541236|FG004|Overall Study|Withdrawal by Subject|0|||
147650229|NCT00548249|532541232|FG000|Overall Study|Corrected Q-wave T-wave (QTc) increase|0|||
147650230|NCT00548249|532541233|FG001|Overall Study|Corrected Q-wave T-wave (QTc) increase|1|||
147650231|NCT00548249|532541234|FG002|Overall Study|Corrected Q-wave T-wave (QTc) increase|0|||
147309182|NCT03661996|531299984|FG004|Overall Study|Physician Decision|0|||
147443330|NCT03834519|531787219|FG001|Overall Study|Physician Decision|1|||
147443331|NCT03834519|531787218|FG000|Overall Study|Sponsor decision|149|||
147443332|NCT03834519|531787219|FG001|Overall Study|Sponsor decision|80|||
147443333|NCT05248295|531787220|FG000|Overall Study|found ineligible|4|||
147443334|NCT05248295|531787221|FG001|Overall Study|found ineligible|1|||
147443335|NCT05248295|531787220|FG000|Overall Study|Withdrawal by Subject|0|||
147443336|NCT05248295|531787221|FG001|Overall Study|Withdrawal by Subject|1|||
147443337|NCT05248295|531787220|FG000|Overall Study|Data loss: audio recording error|1|||
147443338|NCT05248295|531787221|FG001|Overall Study|Data loss: audio recording error|1|||
147443339|NCT04655144|531787222|FG000|Overall Study|Consumed THC|1|||
147552887|NCT02891200|532179998|FG001|Overall Study|Death|9|||
147443340|NCT04655144|531787223|FG001|Overall Study|Consumed THC|0|||
147443341|NCT04655144|531787222|FG000|Overall Study|Unilateral embolization|0|||
147443342|NCT04655144|531787223|FG001|Overall Study|Unilateral embolization|1|||
147443343|NCT01484977|531787226|FG000|Overall Study|Adverse Event|8|||
147443344|NCT01484977|531787226|FG000|Overall Study|Lack of Efficacy|4|||
147443345|NCT01484977|531787226|FG000|Overall Study|Protocol Violation|6|||
147443346|NCT01484977|531787226|FG000|Overall Study|Lost to Follow-up|1|||
147443347|NCT01484977|531787226|FG000|Overall Study|Withdrawal by Subject|4|||
147443348|NCT01484977|531787226|FG000|Overall Study|Subject Protocol Non-compliant|1|||
147443349|NCT01484977|531787226|FG000|Overall Study|Moving Overseas|1|||
147443350|NCT01484977|531787226|FG000|Overall Study|Low White Blood Cell Count|1|||
147443351|NCT01484977|531787226|FG000|Overall Study|Lack of Compliance|1|||
147443352|NCT00853749|531787227|FG000|Overall Study|Lost to Follow-up|0|||
147443353|NCT00853749|531787228|FG001|Overall Study|Lost to Follow-up|1|||
147650232|NCT00548249|532541235|FG003|Overall Study|Corrected Q-wave T-wave (QTc) increase|0|||
147650233|NCT00548249|532541236|FG004|Overall Study|Corrected Q-wave T-wave (QTc) increase|1|||
147650234|NCT00548249|532541232|FG000|Overall Study|Sponsor's request|0|||
147220783|NCT00470158|530981695|FG003|Overall Study|Death|0|||
147220784|NCT00470158|530981696|FG004|Overall Study|Death|2|||
147220785|NCT00470158|530981692|FG000|Overall Study|Lost to Follow-up|7|||
147220786|NCT00470158|530981693|FG001|Overall Study|Lost to Follow-up|8|||
147220787|NCT00470158|530981694|FG002|Overall Study|Lost to Follow-up|8|||
147220788|NCT00470158|530981695|FG003|Overall Study|Lost to Follow-up|5|||
147650235|NCT00548249|532541233|FG001|Overall Study|Sponsor's request|0|||
147650236|NCT00548249|532541234|FG002|Overall Study|Sponsor's request|0|||
147650237|NCT00548249|532541235|FG003|Overall Study|Sponsor's request|1|||
147650238|NCT00548249|532541236|FG004|Overall Study|Sponsor's request|0|||
147650239|NCT01404949|532541243|FG000|Overall Study|Not Treated|1|||
147650240|NCT04527978|532541249|FG000|First Wear Period (8 -0/+3 Days)|Adverse Event|1|||
147650241|NCT04527978|532541250|FG001|First Wear Period (8 -0/+3 Days)|Adverse Event|0|||
147650242|NCT00055497|532541251|FG000|Overall Study|Adverse Event|1|||
147650243|NCT00055497|532541252|FG001|Overall Study|Adverse Event|1|||
147650244|NCT00055497|532541253|FG002|Overall Study|Adverse Event|1|||
147650245|NCT00055497|532541254|FG003|Overall Study|Adverse Event|28|||
147650246|NCT00055497|532541251|FG000|Overall Study|Withdrawal by Subject|3|||
147650247|NCT00055497|532541252|FG001|Overall Study|Withdrawal by Subject|1|||
147650248|NCT00055497|532541253|FG002|Overall Study|Withdrawal by Subject|1|||
147650249|NCT00055497|532541254|FG003|Overall Study|Withdrawal by Subject|15|||
147650250|NCT00055497|532541251|FG000|Overall Study|Lost to Follow-up|0|||
147650251|NCT00055497|532541252|FG001|Overall Study|Lost to Follow-up|1|||
147650252|NCT00055497|532541253|FG002|Overall Study|Lost to Follow-up|0|||
147650253|NCT00055497|532541254|FG003|Overall Study|Lost to Follow-up|5|||
147650254|NCT00055497|532541251|FG000|Overall Study|Protocol Violation|0|||
147650255|NCT00055497|532541252|FG001|Overall Study|Protocol Violation|0|||
147650256|NCT00055497|532541253|FG002|Overall Study|Protocol Violation|0|||
147650257|NCT00055497|532541254|FG003|Overall Study|Protocol Violation|3|||
147650258|NCT00055497|532541251|FG000|Overall Study|Lack of Efficacy|1|||
147650259|NCT00055497|532541252|FG001|Overall Study|Lack of Efficacy|0|||
147650260|NCT00055497|532541253|FG002|Overall Study|Lack of Efficacy|0|||
147650261|NCT00055497|532541254|FG003|Overall Study|Lack of Efficacy|27|||
147650262|NCT00055497|532541251|FG000|Overall Study|Administrative Reasons|0|||
147220789|NCT00470158|530981696|FG004|Overall Study|Lost to Follow-up|4|||
147650263|NCT00055497|532541252|FG001|Overall Study|Administrative Reasons|0|||
147650264|NCT00055497|532541253|FG002|Overall Study|Administrative Reasons|0|||
147650265|NCT00055497|532541254|FG003|Overall Study|Administrative Reasons|1|||
147650266|NCT00055497|532541251|FG000|Overall Study|Other|0|||
147650267|NCT00055497|532541252|FG001|Overall Study|Other|0|||
147650268|NCT00055497|532541253|FG002|Overall Study|Other|0|||
147650269|NCT00055497|532541254|FG003|Overall Study|Other|11|||
147650270|NCT00731731|532541256|FG000|Overall Study|Protocol Violation|0|||
147650271|NCT00731731|532541257|FG001|Overall Study|Protocol Violation|0|||
147650272|NCT00731731|532541258|FG002|Overall Study|Protocol Violation|1|||
147650273|NCT00731731|532541256|FG000|Overall Study|Cancel prior to treatment|0|||
147650274|NCT00731731|532541257|FG001|Overall Study|Cancel prior to treatment|0|||
147650275|NCT00731731|532541258|FG002|Overall Study|Cancel prior to treatment|2|||
147650276|NCT01429441|532541259|FG000|Overall Study|Adverse Event|5|||
147650277|NCT01429441|532541260|FG001|Overall Study|Adverse Event|1|||
147650278|NCT01429441|532541259|FG000|Overall Study|Death|0|||
147650279|NCT01429441|532541260|FG001|Overall Study|Death|2|||
147650280|NCT01429441|532541259|FG000|Overall Study|Lost to Follow-up|5|||
147650281|NCT01429441|532541260|FG001|Overall Study|Lost to Follow-up|2|||
147650282|NCT01429441|532541259|FG000|Overall Study|Physician Decision|1|||
147650283|NCT01429441|532541260|FG001|Overall Study|Physician Decision|0|||
147650284|NCT01429441|532541259|FG000|Overall Study|Withdrawal by Subject|27|||
147650285|NCT01429441|532541260|FG001|Overall Study|Withdrawal by Subject|18|||
147650286|NCT01606748|532541265|FG000|Overall Study|Adverse Event|1|||
147650287|NCT01606748|532541266|FG001|Overall Study|Adverse Event|0|||
147650288|NCT01606748|532541265|FG000|Overall Study|Progressive Disease|1|||
147650289|NCT01606748|532541266|FG001|Overall Study|Progressive Disease|0|||
147650290|NCT01606748|532541265|FG000|Overall Study|Withdrawal by Subject|1|||
147220790|NCT00470158|530981692|FG000|Overall Study|Protocol Violation|1|||
147220791|NCT00470158|530981693|FG001|Overall Study|Protocol Violation|0|||
147220792|NCT00470158|530981694|FG002|Overall Study|Protocol Violation|0|||
147220793|NCT00470158|530981695|FG003|Overall Study|Protocol Violation|0|||
147220794|NCT00470158|530981696|FG004|Overall Study|Protocol Violation|0|||
147650291|NCT01606748|532541266|FG001|Overall Study|Withdrawal by Subject|0|||
147650292|NCT00621517|532541270|FG000|Overall Study|Lost to Follow-up|3|||
147650293|NCT00621517|532541271|FG001|Overall Study|Lost to Follow-up|3|||
147650294|NCT00621517|532541270|FG000|Overall Study|Withdrawal by Subject|3|||
147650295|NCT00621517|532541271|FG001|Overall Study|Withdrawal by Subject|4|||
147650296|NCT00621517|532541270|FG000|Overall Study|Adverse Event|1|||
147650297|NCT00621517|532541271|FG001|Overall Study|Adverse Event|0|||
147220795|NCT00880685|530981697|FG000|Memantine 10mg|Lost to Follow-up|2|||
147650298|NCT01863732|532541272|FG000|Overall Study|Adverse Event|2|||
147552888|NCT02891200|532179997|FG000|Overall Study|Withdrawal by Subject|1|||
147552889|NCT02891200|532179998|FG001|Overall Study|Withdrawal by Subject|4|||
147552890|NCT00988169|532180001|FG000|Overall Study|Withdrawal by Subject|1|||
147552891|NCT02637076|532180002|FG000|Overall Study|due to technical difficulties, the 1 hour post PET scan was not completed at the one hour time point|1|||
147552892|NCT02637076|532180003|FG001|Overall Study|due to technical difficulties, the 1 hour post PET scan was not completed at the one hour time point|1|||
147552893|NCT02637076|532180002|FG000|Overall Study|Withdrawal by Subject|0|||
147552894|NCT02637076|532180003|FG001|Overall Study|Withdrawal by Subject|4|||
147552895|NCT02295774|532180005|FG000|Overall Study|Physician Decision|1|||
147552896|NCT02295774|532180005|FG000|Overall Study|Withdrawal by Subject|2|||
147552897|NCT03083483|532180006|FG000|Overall Study|Adverse Event|1|||
147552898|NCT03083483|532180007|FG001|Overall Study|Adverse Event|1|||
147552899|NCT03083483|532180008|FG002|Overall Study|Adverse Event|1|||
147552900|NCT03083483|532180006|FG000|Overall Study|Lost to Follow-up|2|||
147552901|NCT03083483|532180007|FG001|Overall Study|Lost to Follow-up|1|||
147552902|NCT03083483|532180008|FG002|Overall Study|Lost to Follow-up|1|||
147552903|NCT03083483|532180006|FG000|Overall Study|technological issues|1|||
147552904|NCT03083483|532180007|FG001|Overall Study|technological issues|0|||
147552905|NCT03083483|532180008|FG002|Overall Study|technological issues|1|||
147552906|NCT01751412|532180009|FG000|Overall Study|Disease Progression Before Treatment|1|||
147552907|NCT00582036|532180010|FG000|Overall Study|Withdrawal by Subject|0|||
147552908|NCT00582036|532180011|FG001|Overall Study|Withdrawal by Subject|1|||
147552909|NCT03294538|532180014|FG000|Overall Study|Adverse Event|0|||
147552910|NCT03294538|532180015|FG001|Overall Study|Adverse Event|1|||
147552911|NCT03294538|532180016|FG002|Overall Study|Adverse Event|1|||
147552912|NCT03294538|532180014|FG000|Overall Study|Lost to Follow-up|1|||
147552913|NCT03294538|532180015|FG001|Overall Study|Lost to Follow-up|0|||
147552914|NCT03294538|532180016|FG002|Overall Study|Lost to Follow-up|0|||
147552915|NCT03294538|532180014|FG000|Overall Study|Outside of Visit Window|4|||
147552916|NCT03294538|532180015|FG001|Overall Study|Outside of Visit Window|4|||
147552917|NCT03294538|532180016|FG002|Overall Study|Outside of Visit Window|1|||
147552918|NCT02623959|532180019|FG000|Overall Study|Progression|0|||
147552919|NCT02623959|532180020|FG001|Overall Study|Progression|1|||
147552920|NCT00415532|532180024|FG000|Treatment Period|Adverse Event|2|||
147552921|NCT00415532|532180025|FG001|Treatment Period|Adverse Event|3|||
147552922|NCT00415532|532180024|FG000|Treatment Period|Death|2|||
147552923|NCT00415532|532180025|FG001|Treatment Period|Death|1|||
147552924|NCT00415532|532180024|FG000|Treatment Period|Lost to Follow-up|1|||
147552925|NCT00415532|532180025|FG001|Treatment Period|Lost to Follow-up|1|||
147552926|NCT00415532|532180024|FG000|Treatment Period|Protocol Violation|1|||
147552927|NCT00415532|532180025|FG001|Treatment Period|Protocol Violation|0|||
147552928|NCT00415532|532180024|FG000|Treatment Period|Withdrawal by Subject|6|||
147552929|NCT00415532|532180025|FG001|Treatment Period|Withdrawal by Subject|6|||
147552930|NCT00415532|532180024|FG000|Treatment Period|Other|2|||
147552931|NCT00415532|532180025|FG001|Treatment Period|Other|2|||
147552932|NCT00415532|532180024|FG000|Treatment Period|Ineligibility determined|1|||
147552933|NCT00415532|532180025|FG001|Treatment Period|Ineligibility determined|1|||
147552934|NCT00415532|532180024|FG000|Treatment Period|Noncompliance|1|||
147552935|NCT00415532|532180025|FG001|Treatment Period|Noncompliance|1|||
147552936|NCT00415532|532180024|FG000|Treatment Period|Requirement for alternative therapy|1|||
147552937|NCT00415532|532180025|FG001|Treatment Period|Requirement for alternative therapy|0|||
147552938|NCT00415532|532180024|FG000|Safety Follow Up Period|Adverse Event|1|||
147552939|NCT00415532|532180025|FG001|Safety Follow Up Period|Adverse Event|3|||
147552940|NCT00415532|532180024|FG000|Safety Follow Up Period|Death|3|||
147552941|NCT00415532|532180025|FG001|Safety Follow Up Period|Death|0|||
147552942|NCT00415532|532180024|FG000|Safety Follow Up Period|Withdrawal by Subject|2|||
147552943|NCT00415532|532180025|FG001|Safety Follow Up Period|Withdrawal by Subject|3|||
147552944|NCT00415532|532180024|FG000|Safety Follow Up Period|Other|1|||
147552945|NCT00415532|532180025|FG001|Safety Follow Up Period|Other|4|||
147552946|NCT00415532|532180024|FG000|Safety Follow Up Period|Ineligibility determined|1|||
147552947|NCT00415532|532180025|FG001|Safety Follow Up Period|Ineligibility determined|1|||
147443354|NCT01392677|531787229|FG000|Overall Study|Adverse Event|3|||
147443355|NCT01392677|531787230|FG001|Overall Study|Adverse Event|1|||
147650299|NCT01863732|532541273|FG001|Overall Study|Adverse Event|0|||
147220796|NCT00880685|530981697|FG000|Memantine 20mg|Withdrawal by Subject|1|||
147220797|NCT01249118|530981698|FG000|First Washout Period|Physician Decision|0|||
147220798|NCT01249118|530981699|FG001|First Washout Period|Physician Decision|1|||
147220799|NCT01249118|530981700|FG002|First Washout Period|Physician Decision|0|||
147220800|NCT04179890|530981701|FG000|Overall Study|Patients not harbouring uncommon or compound EGFR mutations|3|||
147220801|NCT04179890|530981702|FG001|Overall Study|Patients not harbouring uncommon or compound EGFR mutations|0|||
147220802|NCT04179890|530981701|FG000|Overall Study|Patients who did not start EGFR-TKI treatment at least 12 months prior to data entry|1|||
147220803|NCT04179890|530981702|FG001|Overall Study|Patients who did not start EGFR-TKI treatment at least 12 months prior to data entry|0|||
147650300|NCT01863732|532541274|FG002|Overall Study|Adverse Event|3|||
147650301|NCT01863732|532541275|FG003|Overall Study|Adverse Event|3|||
147650302|NCT01863732|532541272|FG000|Overall Study|Lack of Efficacy|1|||
147220804|NCT04179890|530981701|FG000|Overall Study|Patients treated for EGFR mutated NSCLC within a clinical trial|3|||
147650303|NCT01863732|532541273|FG001|Overall Study|Lack of Efficacy|0|||
147650304|NCT01863732|532541274|FG002|Overall Study|Lack of Efficacy|2|||
147650305|NCT01863732|532541275|FG003|Overall Study|Lack of Efficacy|1|||
147650306|NCT01863732|532541272|FG000|Overall Study|Lost to Follow-up|2|||
147650307|NCT01863732|532541273|FG001|Overall Study|Lost to Follow-up|2|||
147650308|NCT01863732|532541274|FG002|Overall Study|Lost to Follow-up|1|||
147650309|NCT01863732|532541275|FG003|Overall Study|Lost to Follow-up|1|||
147650310|NCT01863732|532541272|FG000|Overall Study|Physician Decision|1|||
147650311|NCT01863732|532541273|FG001|Overall Study|Physician Decision|0|||
147650312|NCT01863732|532541274|FG002|Overall Study|Physician Decision|1|||
147650313|NCT01863732|532541275|FG003|Overall Study|Physician Decision|0|||
147650314|NCT01863732|532541272|FG000|Overall Study|Pregnancy|0|||
147650315|NCT01863732|532541273|FG001|Overall Study|Pregnancy|0|||
147650316|NCT01863732|532541274|FG002|Overall Study|Pregnancy|0|||
147650317|NCT01863732|532541275|FG003|Overall Study|Pregnancy|1|||
147650318|NCT01863732|532541272|FG000|Overall Study|Technical problems|0|||
147650319|NCT01863732|532541273|FG001|Overall Study|Technical problems|1|||
147650320|NCT01863732|532541274|FG002|Overall Study|Technical problems|1|||
147650321|NCT01863732|532541275|FG003|Overall Study|Technical problems|0|||
147650322|NCT01863732|532541272|FG000|Overall Study|Subject/guardian decision|6|||
147650323|NCT01863732|532541273|FG001|Overall Study|Subject/guardian decision|9|||
147650324|NCT01863732|532541274|FG002|Overall Study|Subject/guardian decision|3|||
147650325|NCT01863732|532541275|FG003|Overall Study|Subject/guardian decision|1|||
147650326|NCT01863732|532541272|FG000|Overall Study|Death|1|||
147650327|NCT01863732|532541273|FG001|Overall Study|Death|0|||
147220805|NCT04179890|530981702|FG001|Overall Study|Patients treated for EGFR mutated NSCLC within a clinical trial|0|||
147650328|NCT01863732|532541274|FG002|Overall Study|Death|0|||
147650329|NCT01863732|532541275|FG003|Overall Study|Death|1|||
147650330|NCT03084315|532541276|FG000|Overall Study|Lost to Follow-up|8|||
147650331|NCT03084315|532541277|FG001|Overall Study|Lost to Follow-up|7|||
147650332|NCT03084315|532541276|FG000|Overall Study|Withdrawal by Subject|2|||
147650333|NCT03084315|532541277|FG001|Overall Study|Withdrawal by Subject|2|||
147650334|NCT02906033|532541280|FG000|Baseline|Protocol Violation|37|||
147650335|NCT02906033|532541281|FG001|Baseline|Protocol Violation|33|||
147650336|NCT02906033|532541280|FG000|Follow-up|Lost to Follow-up|46|||
147650337|NCT02906033|532541281|FG001|Follow-up|Lost to Follow-up|62|||
147650338|NCT00094536|532541286|FG000|Inclusion Exclusion Evaluation|Did not qualify for study treatment|24|||
147650339|NCT00094536|532541286|FG000|Treatment and Follow-up|Adverse Event|4|||
147650340|NCT00094536|532541286|FG000|Treatment and Follow-up|Lack of Efficacy|9|||
147650341|NCT00094536|532541286|FG000|Treatment and Follow-up|Lost to Follow-up|7|||
147650342|NCT00094536|532541286|FG000|Treatment and Follow-up|Withdrawal by Subject|1|||
147650343|NCT00094536|532541286|FG000|Treatment and Follow-up|Subject non-compliance|9|||
147650344|NCT00094536|532541286|FG000|Treatment and Follow-up|Unable to attend visits|1|||
147650345|NCT02655419|532541287|FG000|Overall Study|Enrolled but not treated|1|||
147650346|NCT02655419|532541288|FG001|Overall Study|Enrolled but not treated|5|||
147220806|NCT04179890|530981701|FG000|Overall Study|Patients with active brain metastases at start of EGFR-TKI therapy|2|||
147220807|NCT04179890|530981702|FG001|Overall Study|Patients with active brain metastases at start of EGFR-TKI therapy|0|||
147220808|NCT04179890|530981701|FG000|Overall Study|Patients not treated with afatinib in first-line or with osimertinib in second line|0|||
147220809|NCT04179890|530981702|FG001|Overall Study|Patients not treated with afatinib in first-line or with osimertinib in second line|8|||
147220810|NCT04179890|530981701|FG000|Overall Study|Patients not starting osimertinib treatment at least 10 months prior to data entry|0|||
147220811|NCT04179890|530981702|FG001|Overall Study|Patients not starting osimertinib treatment at least 10 months prior to data entry|4|||
147220812|NCT04179890|530981701|FG000|Overall Study|Patients with active brain metastases at start of EGFR-TKI therapy (independent of treatment line)|0|||
147220813|NCT04179890|530981702|FG001|Overall Study|Patients with active brain metastases at start of EGFR-TKI therapy (independent of treatment line)|2|||
147220814|NCT04179890|530981701|FG000|Overall Study|Patients without common EGFR mutations (Del19, L858R)|0|||
147220815|NCT04179890|530981702|FG001|Overall Study|Patients without common EGFR mutations (Del19, L858R)|1|||
147220816|NCT04179890|530981701|FG000|Overall Study|Patients treated for EGFR mutated NSCLC within a clinical trial or participated in GioTag study|0|||
147220817|NCT04179890|530981702|FG001|Overall Study|Patients treated for EGFR mutated NSCLC within a clinical trial or participated in GioTag study|1|||
147220818|NCT00978432|530981704|FG000|Overall Study|Withdrawal by Subject|0|||
147220819|NCT00978432|530981705|FG001|Overall Study|Withdrawal by Subject|0|||
147220820|NCT00978432|530981706|FG002|Overall Study|Withdrawal by Subject|1|||
147220821|NCT00978432|530981704|FG000|Overall Study|Lack of Efficacy|1|||
147220822|NCT00978432|530981705|FG001|Overall Study|Lack of Efficacy|1|||
147220823|NCT00978432|530981706|FG002|Overall Study|Lack of Efficacy|3|||
147220824|NCT00978432|530981704|FG000|Overall Study|Adverse Event|2|||
147220825|NCT00978432|530981705|FG001|Overall Study|Adverse Event|0|||
147220826|NCT00978432|530981706|FG002|Overall Study|Adverse Event|1|||
147220827|NCT02579928|530981707|FG000|Overall Study|Withdrawal by Subject|1|||
147220828|NCT02579928|530981708|FG001|Overall Study|Withdrawal by Subject|0|||
147220829|NCT04300751|530981711|FG000|Overall Study|Withdrawal by Subject|1|||
147220830|NCT04972630|530981716|FG000|Overall Study|Death due to disease progression, lost to follow-up, consent withdrawal|37|||
147220831|NCT04972630|530981717|FG001|Overall Study|Death due to disease progression, lost to follow-up, consent withdrawal|37|||
147220832|NCT04972630|530981718|FG002|Overall Study|Death due to disease progression, lost to follow-up, consent withdrawal|0|||
147220833|NCT04251156|530981719|FG000|Overall Study|Lost to Follow-up|1|||
147220834|NCT04251156|530981720|FG001|Overall Study|Lost to Follow-up|1|||
147220835|NCT04251156|530981719|FG000|Overall Study|Withdrawal by Subject|4|||
147220836|NCT04251156|530981720|FG001|Overall Study|Withdrawal by Subject|4|||
147220837|NCT00807027|530981721|FG000|Overall Study|Withdrawal by Subject|13|||
147220838|NCT00807027|530981722|FG001|Overall Study|Withdrawal by Subject|14|||
147220839|NCT00807027|530981721|FG000|Overall Study|Protocol Violation|1|||
147220840|NCT00807027|530981722|FG001|Overall Study|Protocol Violation|1|||
147220841|NCT00807027|530981721|FG000|Overall Study|Adverse Event|2|||
147220842|NCT00807027|530981722|FG001|Overall Study|Adverse Event|2|||
147220843|NCT03997383|530981723|FG000|Double-blind Treatment Period|Adverse Event|4|||
147220844|NCT03997383|530981724|FG001|Double-blind Treatment Period|Adverse Event|3|||
147220845|NCT03997383|530981723|FG000|Double-blind Treatment Period|Death|4|||
147220846|NCT03997383|530981724|FG001|Double-blind Treatment Period|Death|4|||
147220847|NCT03997383|530981723|FG000|Double-blind Treatment Period|Physician Decision|2|||
147220848|NCT03997383|530981724|FG001|Double-blind Treatment Period|Physician Decision|0|||
147220849|NCT03997383|530981723|FG000|Double-blind Treatment Period|Withdrawal by Subject|3|||
147220850|NCT03997383|530981724|FG001|Double-blind Treatment Period|Withdrawal by Subject|6|||
147220851|NCT03997383|530981723|FG000|Open-label Extension Period|Ongoing|148|||
147220852|NCT03997383|530981724|FG001|Open-label Extension Period|Ongoing|151|||
147220853|NCT03997383|530981723|FG000|Open-label Extension Period|Adverse Event|4|||
147443356|NCT01392677|531787229|FG000|Overall Study|Withdrawal by Subject|0|||
147443357|NCT01392677|531787230|FG001|Overall Study|Withdrawal by Subject|2|||
147443358|NCT01392677|531787229|FG000|Overall Study|Incorrect enrollment|2|||
147443359|NCT01392677|531787230|FG001|Overall Study|Incorrect enrollment|3|||
147443360|NCT01392677|531787229|FG000|Overall Study|Other reason|3|||
147443361|NCT01392677|531787230|FG001|Overall Study|Other reason|2|||
147443362|NCT00121108|531787233|FG000|Overall Study|Lost to Follow-up|10|||
147443363|NCT00121108|531787234|FG001|Overall Study|Lost to Follow-up|22|||
147443364|NCT00121108|531787233|FG000|Overall Study|Withdrawal by Subject|106|||
147443365|NCT00121108|531787234|FG001|Overall Study|Withdrawal by Subject|195|||
147220854|NCT03997383|530981724|FG001|Open-label Extension Period|Adverse Event|1|||
147220855|NCT03997383|530981723|FG000|Open-label Extension Period|Death|8|||
147220856|NCT03997383|530981724|FG001|Open-label Extension Period|Death|9|||
147220857|NCT03997383|530981723|FG000|Open-label Extension Period|Physician Decision|1|||
147650347|NCT02655419|532541287|FG000|Overall Study|Withdrawal by Subject|4|||
147650348|NCT02655419|532541288|FG001|Overall Study|Withdrawal by Subject|1|||
147650349|NCT02655419|532541287|FG000|Overall Study|Other|0|||
147650350|NCT02655419|532541288|FG001|Overall Study|Other|1|||
147552948|NCT00415532|532180024|FG000|Safety Follow Up Period|Noncompliance|1|||
147220858|NCT03997383|530981724|FG001|Open-label Extension Period|Physician Decision|1|||
147552949|NCT00415532|532180025|FG001|Safety Follow Up Period|Noncompliance|0|||
147552950|NCT00415532|532180024|FG000|Safety Follow Up Period|Requirement for alternative therapy|0|||
147552951|NCT00415532|532180025|FG001|Safety Follow Up Period|Requirement for alternative therapy|1|||
147552952|NCT03687125|532180026|FG000|Overall Study|Progressive Disease|2|||
147220859|NCT03997383|530981723|FG000|Open-label Extension Period|Subject Stopped Participation in the Study|3|||
147220860|NCT03997383|530981724|FG001|Open-label Extension Period|Subject Stopped Participation in the Study|6|||
147309183|NCT03661996|531299980|FG000|Overall Study|Protocol Violation|0|||
147443366|NCT00121108|531787233|FG000|Overall Study|Death|5|||
147443367|NCT00121108|531787234|FG001|Overall Study|Death|8|||
147443368|NCT01380379|531787237|FG000|Overall Study|Pregnancy|1|||
147443369|NCT01538628|531787240|FG000|Overall Study|Withdrawal by Subject|1|||
147443370|NCT01538628|531787241|FG001|Overall Study|Withdrawal by Subject|1|||
147443371|NCT01538628|531787240|FG000|Overall Study|Lost to Follow-up|0|||
147443372|NCT01538628|531787241|FG001|Overall Study|Lost to Follow-up|1|||
147443373|NCT01357577|531787242|FG000|Overall Study|Lost to Follow-up|20|||
147443374|NCT01357577|531787243|FG001|Overall Study|Lost to Follow-up|16|||
147443375|NCT01357577|531787242|FG000|Overall Study|Withdrawal by Subject|16|||
147443376|NCT01357577|531787243|FG001|Overall Study|Withdrawal by Subject|8|||
147443377|NCT01357577|531787242|FG000|Overall Study|look at data in database?|1|||
147443378|NCT01357577|531787243|FG001|Overall Study|look at data in database?|2|||
147552953|NCT03687125|532180027|FG001|Overall Study|Progressive Disease|1|||
147552954|NCT03687125|532180026|FG000|Overall Study|Protocol Violation|1|||
147220861|NCT03997383|530981723|FG000|Open-label Extension Period|Reason Not Specified|2|||
147220862|NCT03997383|530981724|FG001|Open-label Extension Period|Reason Not Specified|0|||
147552955|NCT03687125|532180027|FG001|Overall Study|Protocol Violation|0|||
147552956|NCT01992107|532180028|FG000|Overall Study|Administrative reasons|2|||
147552957|NCT01992107|532180029|FG001|Overall Study|Administrative reasons|0|||
147552958|NCT01992107|532180030|FG002|Overall Study|Administrative reasons|0|||
147552959|NCT01992107|532180028|FG000|Overall Study|Adverse Event|0|||
147552960|NCT01992107|532180029|FG001|Overall Study|Adverse Event|1|||
147552961|NCT01992107|532180030|FG002|Overall Study|Adverse Event|0|||
147552962|NCT01992107|532180028|FG000|Overall Study|Lost to Follow-up|46|||
147552963|NCT01992107|532180029|FG001|Overall Study|Lost to Follow-up|22|||
147552964|NCT01992107|532180030|FG002|Overall Study|Lost to Follow-up|26|||
147650351|NCT01900431|532541289|FG000|Principal Treatment Period (Part A)|Adverse Event|1|||
147650352|NCT01900431|532541290|FG001|Principal Treatment Period (Part A)|Adverse Event|3|||
147220863|NCT05954143|530981725|FG000|Overall Study|Progressive Disease|1|||
147220864|NCT05954143|530981726|FG001|Overall Study|Progressive Disease|0|||
147220865|NCT05954143|530981725|FG000|Overall Study|Physician Decision|1|||
147220866|NCT05954143|530981726|FG001|Overall Study|Physician Decision|0|||
147220867|NCT05954143|530981725|FG000|Overall Study|Study Terminated by Sponsor|2|||
147220868|NCT05954143|530981726|FG001|Overall Study|Study Terminated by Sponsor|4|||
147220869|NCT05954143|530981725|FG000|Overall Study|Death|1|||
147220870|NCT05954143|530981726|FG001|Overall Study|Death|0|||
147220871|NCT05954143|530981725|FG000|Overall Study|Withdrawal by Subject|0|||
147220872|NCT05954143|530981726|FG001|Overall Study|Withdrawal by Subject|1|||
147220873|NCT05954143|530981725|FG000|Overall Study|Other|1|||
147220874|NCT05954143|530981726|FG001|Overall Study|Other|0|||
147220875|NCT01129024|530981727|FG000|Overall Study|Physician Decision|5|||
147220876|NCT01129024|530981727|FG000|Overall Study|Study Terminated by Sponsor|8|||
147220877|NCT01129024|530981727|FG000|Overall Study|Withdrawal by Subject|2|||
147220878|NCT01129024|530981727|FG000|Overall Study|Lack of Efficacy|3|||
147220879|NCT01129024|530981727|FG000|Overall Study|Needed a Platelet Transfusion|1|||
147650353|NCT01900431|532541291|FG002|Principal Treatment Period (Part A)|Adverse Event|0|||
147650354|NCT01900431|532541289|FG000|Principal Treatment Period (Part A)|Lack of Efficacy|6|||
147650355|NCT01900431|532541290|FG001|Principal Treatment Period (Part A)|Lack of Efficacy|6|||
147650356|NCT01900431|532541291|FG002|Principal Treatment Period (Part A)|Lack of Efficacy|0|||
147650357|NCT01900431|532541289|FG000|Principal Treatment Period (Part A)|Other than specified above|0|||
147650358|NCT01900431|532541290|FG001|Principal Treatment Period (Part A)|Other than specified above|1|||
147650359|NCT01900431|532541291|FG002|Principal Treatment Period (Part A)|Other than specified above|0|||
147650360|NCT01900431|532541289|FG000|Extended Treatment Period (Part B)|Adverse Event|0|||
147650361|NCT01900431|532541290|FG001|Extended Treatment Period (Part B)|Adverse Event|2|||
147650362|NCT01900431|532541291|FG002|Extended Treatment Period (Part B)|Adverse Event|0|||
147650363|NCT01900431|532541289|FG000|Extended Treatment Period (Part B)|Lack of Efficacy|1|||
147650364|NCT01900431|532541290|FG001|Extended Treatment Period (Part B)|Lack of Efficacy|7|||
147650365|NCT01900431|532541291|FG002|Extended Treatment Period (Part B)|Lack of Efficacy|0|||
147650366|NCT01900431|532541289|FG000|Extended Treatment Period (Part B)|Other than specified above|0|||
147650367|NCT01900431|532541290|FG001|Extended Treatment Period (Part B)|Other than specified above|1|||
147650368|NCT01900431|532541291|FG002|Extended Treatment Period (Part B)|Other than specified above|0|||
147650369|NCT01900431|532541289|FG000|Open-Label Treatment Period (Part C)|Adverse Event|0|||
147650370|NCT01900431|532541290|FG001|Open-Label Treatment Period (Part C)|Adverse Event|0|||
147650371|NCT01900431|532541291|FG002|Open-Label Treatment Period (Part C)|Adverse Event|2|||
147650372|NCT01900431|532541289|FG000|Open-Label Treatment Period (Part C)|Lack of Efficacy|0|||
147220880|NCT02361580|530981728|FG000|Overall Study|Lost to Follow-up|6|||
147650373|NCT01900431|532541290|FG001|Open-Label Treatment Period (Part C)|Lack of Efficacy|0|||
147650374|NCT01900431|532541291|FG002|Open-Label Treatment Period (Part C)|Lack of Efficacy|3|||
147650375|NCT01900431|532541289|FG000|Open-Label Treatment Period (Part C)|Withdrawal by Subject|0|||
147650376|NCT01900431|532541290|FG001|Open-Label Treatment Period (Part C)|Withdrawal by Subject|0|||
147650377|NCT01900431|532541291|FG002|Open-Label Treatment Period (Part C)|Withdrawal by Subject|3|||
147650378|NCT03782974|532541294|FG000|Overall Study|Withdrawal by Subject|7|||
147650379|NCT03782974|532541295|FG001|Overall Study|Withdrawal by Subject|7|||
147650380|NCT03782974|532541294|FG000|Overall Study|Pregnancy|1|||
147650381|NCT03782974|532541295|FG001|Overall Study|Pregnancy|0|||
147650382|NCT00448812|532541302|FG000|Year 2|Missed visit but remained in study|4|||
147650383|NCT00448812|532541303|FG001|Year 2|Missed visit but remained in study|1|||
147650384|NCT00448812|532541302|FG000|Year 3|Withdrawal by Subject|1|||
147650385|NCT00448812|532541303|FG001|Year 3|Withdrawal by Subject|3|||
147650386|NCT00448812|532541302|FG000|Year 3|Lost to Follow-up|1|||
147650387|NCT00448812|532541303|FG001|Year 3|Lost to Follow-up|0|||
147220881|NCT02361580|530981729|FG001|Overall Study|Lost to Follow-up|3|||
147220882|NCT00708201|530981730|FG000|Overall Study|Adverse Event|4|||
147552965|NCT01992107|532180028|FG000|Overall Study|noncompliance and were unavailable|7|||
147220883|NCT00708201|530981731|FG001|Overall Study|Adverse Event|4|||
147552966|NCT01992107|532180029|FG001|Overall Study|noncompliance and were unavailable|3|||
147650388|NCT00448812|532541302|FG000|Year 3|Missed visit but remained in study|2|||
147650389|NCT00448812|532541303|FG001|Year 3|Missed visit but remained in study|0|||
147650390|NCT00448812|532541302|FG000|Year 5|Missed visit but remained in study|1|||
147650391|NCT00448812|532541303|FG001|Year 5|Missed visit but remained in study|0|||
147650392|NCT01687283|532542886|FG000|Overall Study|Adverse Event|11|||
147650393|NCT01687283|532542887|FG001|Overall Study|Adverse Event|4|||
147650394|NCT01687283|532542886|FG000|Overall Study|Lack of Efficacy|3|||
147650395|NCT01687283|532542887|FG001|Overall Study|Lack of Efficacy|1|||
147650396|NCT01687283|532542886|FG000|Overall Study|Protocol Violation|1|||
147650397|NCT01687283|532542887|FG001|Overall Study|Protocol Violation|3|||
147650398|NCT01687283|532542886|FG000|Overall Study|protocol defined stopping criteria|8|||
147650399|NCT01687283|532542887|FG001|Overall Study|protocol defined stopping criteria|10|||
147650400|NCT01687283|532542886|FG000|Overall Study|Lost to Follow-up|1|||
147650401|NCT01687283|532542887|FG001|Overall Study|Lost to Follow-up|1|||
147650402|NCT01687283|532542886|FG000|Overall Study|Investigator discretion|2|||
147650403|NCT01687283|532542887|FG001|Overall Study|Investigator discretion|0|||
147650404|NCT01687283|532542886|FG000|Overall Study|Withdrawal by Subject|9|||
147650405|NCT01687283|532542887|FG001|Overall Study|Withdrawal by Subject|8|||
147650406|NCT01153009|532542891|FG000|Overall Study|Adverse Event|4|||
147650407|NCT01153009|532542892|FG001|Overall Study|Adverse Event|14|||
147650408|NCT01153009|532542893|FG002|Overall Study|Adverse Event|14|||
147650409|NCT01153009|532542894|FG003|Overall Study|Adverse Event|10|||
147650410|NCT01153009|532542891|FG000|Overall Study|Lack of Efficacy|9|||
147650411|NCT01153009|532542892|FG001|Overall Study|Lack of Efficacy|0|||
147650412|NCT01153009|532542893|FG002|Overall Study|Lack of Efficacy|2|||
147650413|NCT01153009|532542894|FG003|Overall Study|Lack of Efficacy|1|||
147650414|NCT01153009|532542891|FG000|Overall Study|Noncompliance with Study Medication|1|||
147650415|NCT01153009|532542892|FG001|Overall Study|Noncompliance with Study Medication|3|||
147650416|NCT01153009|532542893|FG002|Overall Study|Noncompliance with Study Medication|4|||
147650417|NCT01153009|532542894|FG003|Overall Study|Noncompliance with Study Medication|1|||
147650418|NCT01153009|532542891|FG000|Overall Study|Protocol Deviations|4|||
147650419|NCT01153009|532542892|FG001|Overall Study|Protocol Deviations|3|||
147650420|NCT01153009|532542893|FG002|Overall Study|Protocol Deviations|3|||
147650421|NCT01153009|532542894|FG003|Overall Study|Protocol Deviations|2|||
147650422|NCT01153009|532542891|FG000|Overall Study|Withdrawal of Consent|5|||
147650423|NCT01153009|532542892|FG001|Overall Study|Withdrawal of Consent|5|||
147650424|NCT01153009|532542893|FG002|Overall Study|Withdrawal of Consent|4|||
147650425|NCT01153009|532542894|FG003|Overall Study|Withdrawal of Consent|6|||
147650426|NCT01153009|532542891|FG000|Overall Study|Lost to Follow-up|8|||
147650427|NCT01153009|532542892|FG001|Overall Study|Lost to Follow-up|8|||
147650428|NCT01153009|532542893|FG002|Overall Study|Lost to Follow-up|11|||
147650429|NCT01153009|532542894|FG003|Overall Study|Lost to Follow-up|15|||
147650430|NCT01153009|532542891|FG000|Overall Study|Other|1|||
147650431|NCT01153009|532542892|FG001|Overall Study|Other|1|||
147650432|NCT01153009|532542893|FG002|Overall Study|Other|3|||
147650433|NCT01153009|532542894|FG003|Overall Study|Other|2|||
147650434|NCT00410072|532542895|FG000|Day 1 to Week 48|Adverse Event|1|||
147650435|NCT00410072|532542896|FG001|Day 1 to Week 48|Adverse Event|2|||
147650436|NCT00410072|532542895|FG000|Day 1 to Week 48|Lost to Follow-up|5|||
147650437|NCT00410072|532542896|FG001|Day 1 to Week 48|Lost to Follow-up|2|||
147650438|NCT00410072|532542895|FG000|Day 1 to Week 48|Other|0|||
147650439|NCT00410072|532542896|FG001|Day 1 to Week 48|Other|1|||
147650440|NCT00410072|532542895|FG000|Day 1 to Week 48|poor compliance/noncompliance|0|||
147650441|NCT00410072|532542896|FG001|Day 1 to Week 48|poor compliance/noncompliance|3|||
147650442|NCT00410072|532542895|FG000|Day 1 to Week 48|Pregnancy|0|||
147650443|NCT00410072|532542896|FG001|Day 1 to Week 48|Pregnancy|2|||
147650444|NCT00410072|532542895|FG000|Day 1 to Week 48|Withdrawal by Subject|0|||
147650445|NCT00410072|532542896|FG001|Day 1 to Week 48|Withdrawal by Subject|2|||
147650446|NCT00410072|532542895|FG000|After Week 48 to Week 96|Adverse Event|1|||
147650447|NCT00410072|532542896|FG001|After Week 48 to Week 96|Adverse Event|2|||
147650448|NCT00410072|532542895|FG000|After Week 48 to Week 96|Death|0|||
147220884|NCT00708201|530981730|FG000|Overall Study|Withdrawal by Subject|1|||
147220885|NCT00708201|530981731|FG001|Overall Study|Withdrawal by Subject|1|||
147220886|NCT00708201|530981730|FG000|Overall Study|Lost to Follow-up|2|||
147443379|NCT03080883|531787244|FG000|Overall Study|Withdrawal by Subject|11|||
147650449|NCT00410072|532542896|FG001|After Week 48 to Week 96|Death|1|||
147650450|NCT00410072|532542895|FG000|After Week 48 to Week 96|Lack of Efficacy|1|||
147650451|NCT00410072|532542896|FG001|After Week 48 to Week 96|Lack of Efficacy|0|||
147650452|NCT00410072|532542895|FG000|After Week 48 to Week 96|Lost to Follow-up|2|||
147650453|NCT00410072|532542896|FG001|After Week 48 to Week 96|Lost to Follow-up|4|||
147650454|NCT00410072|532542895|FG000|After Week 48 to Week 96|Other|2|||
147650455|NCT00410072|532542896|FG001|After Week 48 to Week 96|Other|0|||
147650456|NCT00410072|532542895|FG000|After Week 48 to Week 96|Poor compliance/noncompliance|0|||
147650457|NCT00410072|532542896|FG001|After Week 48 to Week 96|Poor compliance/noncompliance|1|||
147650458|NCT00410072|532542895|FG000|After Week 48 to Week 96|Pregnancy|0|||
147650459|NCT00410072|532542896|FG001|After Week 48 to Week 96|Pregnancy|2|||
147650460|NCT00410072|532542895|FG000|After Week 48 to Week 96|Withdrawal by Subject|0|||
147443380|NCT03080883|531787245|FG001|Overall Study|Withdrawal by Subject|15|||
147650461|NCT00410072|532542896|FG001|After Week 48 to Week 96|Withdrawal by Subject|1|||
147650462|NCT03307837|532542898|FG000|Overall Study|Withdrawal by Subject|0|||
147650463|NCT03307837|532542899|FG001|Overall Study|Withdrawal by Subject|0|||
147650464|NCT03307837|532542900|FG002|Overall Study|Withdrawal by Subject|1|||
147650465|NCT03307837|532542901|FG003|Overall Study|Withdrawal by Subject|0|||
147443381|NCT03080883|531787244|FG000|Overall Study|Adverse Event|22|||
147443382|NCT03080883|531787245|FG001|Overall Study|Adverse Event|22|||
147443383|NCT03080883|531787244|FG000|Overall Study|Alternative Therapy|0|||
147650466|NCT03307837|532542902|FG004|Overall Study|Withdrawal by Subject|0|||
147650467|NCT03307837|532542903|FG005|Overall Study|Withdrawal by Subject|1|||
147650468|NCT03307837|532542898|FG000|Overall Study|Lost to Follow-up|1|||
147650469|NCT03307837|532542899|FG001|Overall Study|Lost to Follow-up|1|||
147650470|NCT03307837|532542900|FG002|Overall Study|Lost to Follow-up|0|||
147220887|NCT00708201|530981731|FG001|Overall Study|Lost to Follow-up|0|||
147650471|NCT03307837|532542901|FG003|Overall Study|Lost to Follow-up|0|||
147650472|NCT03307837|532542902|FG004|Overall Study|Lost to Follow-up|0|||
147650473|NCT03307837|532542903|FG005|Overall Study|Lost to Follow-up|1|||
147650474|NCT00904917|532542905|FG000|Overall Study|Lost to Follow-up|2|||
147650475|NCT00904917|532542906|FG001|Overall Study|Lost to Follow-up|2|||
147650476|NCT00904917|532542907|FG002|Overall Study|Lost to Follow-up|2|||
147650477|NCT00904917|532542908|FG003|Overall Study|Lost to Follow-up|2|||
147220888|NCT00708201|530981730|FG000|Overall Study|Protocol Violation|0|||
147650478|NCT00762034|532542909|FG000|Induction Period|Protocol Violation|1|||
147220889|NCT00708201|530981731|FG001|Overall Study|Protocol Violation|1|||
147220890|NCT00761748|530981732|FG000|First Intervention (21 +/- 3 Days)|Adverse Event|3|||
147220891|NCT00761748|530981733|FG001|First Intervention (21 +/- 3 Days)|Adverse Event|0|||
147220892|NCT00761748|530981732|FG000|First Intervention (21 +/- 3 Days)|Lost to Follow-up|0|||
147220893|NCT00761748|530981733|FG001|First Intervention (21 +/- 3 Days)|Lost to Follow-up|3|||
147220894|NCT01857310|530981734|FG000|Secondary Analysis: Semen Quality at 6m|Lost to Follow-up|315|||
147220895|NCT01857310|530981735|FG001|Secondary Analysis: Semen Quality at 6m|Lost to Follow-up|282|||
147220896|NCT00812487|530981736|FG000|Overall Study|Lost to Follow-up|2|||
147220897|NCT00812487|530981737|FG001|Overall Study|Lost to Follow-up|0|||
147220898|NCT00812487|530981736|FG000|Overall Study|Withdrawal by Subject|3|||
147220899|NCT00812487|530981737|FG001|Overall Study|Withdrawal by Subject|2|||
147220900|NCT00812487|530981736|FG000|Overall Study|Transfer to ICU prior to intervention|1|||
147220901|NCT00812487|530981737|FG001|Overall Study|Transfer to ICU prior to intervention|0|||
147650479|NCT00762034|532542910|FG001|Induction Period|Protocol Violation|2|||
147220902|NCT00812487|530981736|FG000|Overall Study|Protocol Violation|0|||
147650480|NCT00762034|532542909|FG000|Induction Period|Entry Criterion Not Met|12|||
147552967|NCT01992107|532180030|FG002|Overall Study|noncompliance and were unavailable|2|||
147552968|NCT01992107|532180028|FG000|Overall Study|Withdrawal by Subject|13|||
147552969|NCT01992107|532180029|FG001|Overall Study|Withdrawal by Subject|7|||
147552970|NCT01992107|532180030|FG002|Overall Study|Withdrawal by Subject|8|||
147220903|NCT00812487|530981737|FG001|Overall Study|Protocol Violation|1|||
147220904|NCT00998764|530981738|FG000|Overall Study|Lack of Efficacy|3|||
147220905|NCT00998764|530981739|FG001|Overall Study|Lack of Efficacy|6|||
147220906|NCT00998764|530981738|FG000|Overall Study|Adverse Event|17|||
147220907|NCT00998764|530981739|FG001|Overall Study|Adverse Event|12|||
147220908|NCT00998764|530981738|FG000|Overall Study|Withdrawal by Subject|19|||
147220909|NCT00998764|530981739|FG001|Overall Study|Withdrawal by Subject|25|||
147220910|NCT00998764|530981738|FG000|Overall Study|Physician Decision|3|||
147220911|NCT00998764|530981739|FG001|Overall Study|Physician Decision|3|||
147220912|NCT00998764|530981738|FG000|Overall Study|Death|3|||
147220913|NCT00998764|530981739|FG001|Overall Study|Death|1|||
147220914|NCT00998764|530981738|FG000|Overall Study|Discontinuation of Study by Sponsor|164|||
147220915|NCT00998764|530981739|FG001|Overall Study|Discontinuation of Study by Sponsor|217|||
147220916|NCT00998764|530981738|FG000|Overall Study|Protocol Violation|0|||
147220917|NCT00998764|530981739|FG001|Overall Study|Protocol Violation|1|||
147220918|NCT00998764|530981738|FG000|Overall Study|Failed to Return|1|||
147220919|NCT00998764|530981739|FG001|Overall Study|Failed to Return|1|||
147220920|NCT00998764|530981738|FG000|Overall Study|Lost to Follow-up|1|||
147220921|NCT00998764|530981739|FG001|Overall Study|Lost to Follow-up|1|||
147220922|NCT00998764|530981738|FG000|Overall Study|Loss of Caregiver|0|||
147220923|NCT00998764|530981739|FG001|Overall Study|Loss of Caregiver|3|||
147220924|NCT00998764|530981738|FG000|Overall Study|Other|4|||
147220925|NCT00998764|530981739|FG001|Overall Study|Other|4|||
147220926|NCT00998764|530981738|FG000|Overall Study|Recurrent Episode of vasogenic edema|1|||
147552971|NCT02022007|532180031|FG000|Overall Study|Withdrawal by Subject|1|||
147552972|NCT02022007|532180032|FG001|Overall Study|Withdrawal by Subject|1|||
147552973|NCT02022007|532180033|FG002|Overall Study|Withdrawal by Subject|1|||
147552974|NCT02022007|532180031|FG000|Overall Study|Noncompliant|0|||
147552975|NCT02022007|532180032|FG001|Overall Study|Noncompliant|0|||
147552976|NCT02022007|532180033|FG002|Overall Study|Noncompliant|1|||
147552977|NCT01214603|532180034|FG000|Overall Study|Adverse Event|0|||
147552978|NCT01214603|532180035|FG001|Overall Study|Adverse Event|0|||
147650481|NCT00762034|532542910|FG001|Induction Period|Entry Criterion Not Met|11|||
147220927|NCT00998764|530981739|FG001|Overall Study|Recurrent Episode of vasogenic edema|0|||
147220928|NCT04761627|530981742|FG000|Run-in Period|Death|1|||
147220929|NCT04761627|530981743|FG001|Run-in Period|Death|0|||
147220930|NCT04761627|530981744|FG002|Run-in Period|Death|0|||
147443384|NCT03080883|531787245|FG001|Overall Study|Alternative Therapy|3|||
147220931|NCT04761627|530981742|FG000|Run-in Period|Required alternative therapy|2|||
147443385|NCT03080883|531787244|FG000|Overall Study|Other Complicating Disease|9|||
147220932|NCT04761627|530981743|FG001|Run-in Period|Required alternative therapy|0|||
147220933|NCT04761627|530981744|FG002|Run-in Period|Required alternative therapy|0|||
147220934|NCT04761627|530981742|FG000|Run-in Period|Lost to Follow-up|2|||
147220935|NCT04761627|530981743|FG001|Run-in Period|Lost to Follow-up|0|||
147220936|NCT04761627|530981744|FG002|Run-in Period|Lost to Follow-up|0|||
147220937|NCT04761627|530981742|FG000|Run-in Period|Protocol Violation|3|||
147220938|NCT04761627|530981743|FG001|Run-in Period|Protocol Violation|0|||
147220939|NCT04761627|530981744|FG002|Run-in Period|Protocol Violation|0|||
147220940|NCT04761627|530981742|FG000|Run-in Period|Abnormal liver function|1|||
147220941|NCT04761627|530981743|FG001|Run-in Period|Abnormal liver function|0|||
147220942|NCT04761627|530981744|FG002|Run-in Period|Abnormal liver function|0|||
147220943|NCT04761627|530981742|FG000|Run-in Period|Adverse Event|6|||
147220944|NCT04761627|530981743|FG001|Run-in Period|Adverse Event|0|||
147220945|NCT04761627|530981744|FG002|Run-in Period|Adverse Event|0|||
147220946|NCT04761627|530981742|FG000|Run-in Period|Withdrawal by Subject|7|||
147220947|NCT04761627|530981743|FG001|Run-in Period|Withdrawal by Subject|0|||
147220948|NCT04761627|530981744|FG002|Run-in Period|Withdrawal by Subject|0|||
147220949|NCT04761627|530981742|FG000|Run-in Period|Did not meet PASI 50|15|||
147220950|NCT04761627|530981743|FG001|Run-in Period|Did not meet PASI 50|0|||
147220951|NCT04761627|530981744|FG002|Run-in Period|Did not meet PASI 50|0|||
147220952|NCT04761627|530981742|FG000|Run-in Period|Study site closure|2|||
147220953|NCT04761627|530981743|FG001|Run-in Period|Study site closure|0|||
147220954|NCT04761627|530981744|FG002|Run-in Period|Study site closure|0|||
147220955|NCT04761627|530981742|FG000|Run-in Period|Pregnancy|2|||
147220956|NCT04761627|530981743|FG001|Run-in Period|Pregnancy|0|||
147220957|NCT04761627|530981744|FG002|Run-in Period|Pregnancy|0|||
147220958|NCT04761627|530981742|FG000|Post-randomization Period|Military service|0|||
147220959|NCT04761627|530981743|FG001|Post-randomization Period|Military service|1|||
147220960|NCT04761627|530981744|FG002|Post-randomization Period|Military service|0|||
147220961|NCT04761627|530981742|FG000|Post-randomization Period|Adverse Event|0|||
147220962|NCT04761627|530981743|FG001|Post-randomization Period|Adverse Event|4|||
147220963|NCT04761627|530981744|FG002|Post-randomization Period|Adverse Event|2|||
147220964|NCT04761627|530981742|FG000|Post-randomization Period|Lost to Follow-up|0|||
147220965|NCT04761627|530981743|FG001|Post-randomization Period|Lost to Follow-up|6|||
147220966|NCT04761627|530981744|FG002|Post-randomization Period|Lost to Follow-up|6|||
147443386|NCT03080883|531787245|FG001|Overall Study|Other Complicating Disease|5|||
147220967|NCT04761627|530981742|FG000|Post-randomization Period|Withdrawal by Subject|0|||
147220968|NCT04761627|530981743|FG001|Post-randomization Period|Withdrawal by Subject|7|||
147220969|NCT04761627|530981744|FG002|Post-randomization Period|Withdrawal by Subject|6|||
147220970|NCT04761627|530981742|FG000|Post-randomization Period|Pregnancy|0|||
147220971|NCT04761627|530981743|FG001|Post-randomization Period|Pregnancy|0|||
147220972|NCT04761627|530981744|FG002|Post-randomization Period|Pregnancy|1|||
147220973|NCT04761627|530981742|FG000|Post-randomization Period|Study site closure|0|||
147220974|NCT04761627|530981743|FG001|Post-randomization Period|Study site closure|0|||
147220975|NCT04761627|530981744|FG002|Post-randomization Period|Study site closure|1|||
147220976|NCT04761627|530981742|FG000|Post-randomization Period|Family planning|0|||
147220977|NCT04761627|530981743|FG001|Post-randomization Period|Family planning|1|||
147443387|NCT03080883|531787244|FG000|Overall Study|Death|21|||
147443388|NCT03080883|531787245|FG001|Overall Study|Death|16|||
147443389|NCT03080883|531787244|FG000|Overall Study|Physician Decision|2|||
147443390|NCT03080883|531787245|FG001|Overall Study|Physician Decision|2|||
147443391|NCT03080883|531787244|FG000|Overall Study|Disease Progression|2|||
147220978|NCT04761627|530981744|FG002|Post-randomization Period|Family planning|0|||
147220979|NCT06390839|530981745|FG000|Overall Study|Ineligible|2|||
147220980|NCT06390839|530981745|FG000|Overall Study|Never start protocol therapy|3|||
147220981|NCT06390839|530981745|FG000|Overall Study|Adverse Event|1|||
147220982|NCT06390839|530981745|FG000|Overall Study|Alternative therapy|2|||
147220983|NCT06390839|530981745|FG000|Overall Study|Death|3|||
147220984|NCT06390839|530981745|FG000|Overall Study|Disease progression|28|||
147220985|NCT06390839|530981745|FG000|Overall Study|Withdrawal by Subject|2|||
147220986|NCT06390839|530981745|FG000|Overall Study|Complicating disease|1|||
147220987|NCT06390839|530981745|FG000|Overall Study|Noncompliance|1|||
147220988|NCT02720094|530981751|FG000|Overall Study|Ongoing|2210|||
147220989|NCT02720094|530981752|FG001|Overall Study|Ongoing|2203|||
147220990|NCT02720094|530981751|FG000|Overall Study|Scheduled exit visit/end of study|2|||
147220991|NCT02720094|530981752|FG001|Overall Study|Scheduled exit visit/end of study|1|||
147220992|NCT02720094|530981751|FG000|Overall Study|Death|4|||
147220993|NCT02720094|530981752|FG001|Overall Study|Death|7|||
147220994|NCT02720094|530981751|FG000|Overall Study|Withdrawal by Subject|55|||
147220995|NCT02720094|530981752|FG001|Overall Study|Withdrawal by Subject|56|||
147220996|NCT02720094|530981751|FG000|Overall Study|Lost to Follow-up|2|||
147220997|NCT02720094|530981752|FG001|Overall Study|Lost to Follow-up|7|||
147220998|NCT02720094|530981751|FG000|Overall Study|Physician Decision|1|||
147443392|NCT03080883|531787245|FG001|Overall Study|Disease Progression|8|||
147220999|NCT02720094|530981752|FG001|Overall Study|Physician Decision|3|||
147443393|NCT03080883|531787244|FG000|Overall Study|Lost to Follow-up|1|||
147443394|NCT03080883|531787245|FG001|Overall Study|Lost to Follow-up|1|||
147221000|NCT02720094|530981751|FG000|Overall Study|Inappropriate enrollment|1|||
147221001|NCT02720094|530981752|FG001|Overall Study|Inappropriate enrollment|3|||
147221002|NCT02720094|530981751|FG000|Overall Study|Relocation|1|||
147221003|NCT02720094|530981752|FG001|Overall Study|Relocation|1|||
147221004|NCT00732940|530981759|FG000|Overall Study|Withdrawal by Subject|1|||
147221005|NCT00732940|530981760|FG001|Overall Study|Withdrawal by Subject|2|||
147221006|NCT00732940|530981759|FG000|Overall Study|Adverse Event|0|||
147552979|NCT01214603|532180036|FG002|Overall Study|Adverse Event|1|||
147552980|NCT01214603|532180034|FG000|Overall Study|Death|1|||
147552981|NCT01214603|532180035|FG001|Overall Study|Death|0|||
147552982|NCT01214603|532180036|FG002|Overall Study|Death|0|||
147552983|NCT01214603|532180034|FG000|Overall Study|Progressive Disease|4|||
147552984|NCT01214603|532180035|FG001|Overall Study|Progressive Disease|1|||
147552985|NCT01214603|532180036|FG002|Overall Study|Progressive Disease|3|||
147552986|NCT01507896|532180037|FG000|Overall Study|Withdrawal by Subject|1|||
147552987|NCT01507896|532180037|FG000|Overall Study|The surgery was denied by the sponsor.|1|||
147221007|NCT00732940|530981760|FG001|Overall Study|Adverse Event|1|||
147221008|NCT00732940|530981759|FG000|Overall Study|Lost to Follow-up|1|||
147221009|NCT00732940|530981760|FG001|Overall Study|Lost to Follow-up|0|||
147221010|NCT00459979|530981764|FG000|Overall Study|Withdrawal by Subject|1|||
147221011|NCT00459979|530981764|FG000|Overall Study|Protocol Violation|1|||
147552988|NCT01821625|532180048|FG000|Overall Study|Withdrawal by Subject|2|||
147552989|NCT01821625|532180048|FG000|Overall Study|Lack of Efficacy|2|||
147552990|NCT01821625|532180048|FG000|Overall Study|Adverse Event|1|||
147552991|NCT01821625|532180048|FG000|Overall Study|Medical contraindication|1|||
147552992|NCT00321711|532180055|FG000|Part A|Adverse Event|3|||
147221012|NCT00989573|530981765|FG000|Overall Study|Adverse Event|8|||
147221013|NCT00989573|530981766|FG001|Overall Study|Adverse Event|12|||
147552993|NCT00321711|532180056|FG001|Part A|Adverse Event|3|||
147552994|NCT00321711|532180057|FG002|Part A|Adverse Event|2|||
147552995|NCT00321711|532180058|FG003|Part A|Adverse Event|0|||
147552996|NCT00321711|532180059|FG004|Part A|Adverse Event|0|||
147552997|NCT00321711|532180055|FG000|Part A|Withdrawal by Subject|1|||
147221014|NCT00989573|530981767|FG002|Overall Study|Adverse Event|4|||
147221015|NCT00989573|530981765|FG000|Overall Study|Physician Decision|0|||
147221016|NCT00989573|530981766|FG001|Overall Study|Physician Decision|2|||
147221017|NCT00989573|530981767|FG002|Overall Study|Physician Decision|0|||
147221018|NCT00989573|530981765|FG000|Overall Study|Protocol Violation|1|||
147221019|NCT00989573|530981766|FG001|Overall Study|Protocol Violation|1|||
147221020|NCT00989573|530981767|FG002|Overall Study|Protocol Violation|1|||
147221021|NCT00989573|530981765|FG000|Overall Study|Withdrawal by Subject|4|||
147221022|NCT00989573|530981766|FG001|Overall Study|Withdrawal by Subject|7|||
147221023|NCT00989573|530981767|FG002|Overall Study|Withdrawal by Subject|3|||
147221024|NCT05214573|530981770|FG000|Overall Study|Physician Decision|5924|||
147221025|NCT05214573|530981771|FG001|Overall Study|Physician Decision|0|||
147221026|NCT00814801|530981772|FG000|Overall Study|Adverse Event|15|||
147221027|NCT00814801|530981773|FG001|Overall Study|Adverse Event|16|||
147221028|NCT00814801|530981774|FG002|Overall Study|Adverse Event|19|||
147221029|NCT00814801|530981772|FG000|Overall Study|Withdrawal by Subject|9|||
147221030|NCT00814801|530981773|FG001|Overall Study|Withdrawal by Subject|11|||
147221031|NCT00814801|530981774|FG002|Overall Study|Withdrawal by Subject|14|||
147221032|NCT00814801|530981772|FG000|Overall Study|Inappropriate as a subject|1|||
147221033|NCT00814801|530981773|FG001|Overall Study|Inappropriate as a subject|1|||
147221034|NCT00814801|530981774|FG002|Overall Study|Inappropriate as a subject|1|||
147221035|NCT00814801|530981772|FG000|Overall Study|Change of patients for CIBIC plus-J|1|||
147221036|NCT00814801|530981773|FG001|Overall Study|Change of patients for CIBIC plus-J|1|||
147221037|NCT00814801|530981774|FG002|Overall Study|Change of patients for CIBIC plus-J|0|||
147221038|NCT00814801|530981772|FG000|Overall Study|Missing or change of caregiver|6|||
147221039|NCT00814801|530981773|FG001|Overall Study|Missing or change of caregiver|2|||
147221040|NCT00814801|530981774|FG002|Overall Study|Missing or change of caregiver|4|||
147221041|NCT00814801|530981772|FG000|Overall Study|Non-compliance|0|||
147221042|NCT00814801|530981773|FG001|Overall Study|Non-compliance|1|||
147221043|NCT00814801|530981774|FG002|Overall Study|Non-compliance|1|||
147221044|NCT00814801|530981772|FG000|Overall Study|Other|2|||
147221045|NCT00814801|530981773|FG001|Overall Study|Other|6|||
147221046|NCT00814801|530981774|FG002|Overall Study|Other|4|||
147221047|NCT02520089|530981777|FG000|Overall Study|Lost to Follow-up|3|||
147221048|NCT02520089|530981778|FG001|Overall Study|Lost to Follow-up|4|||
147221049|NCT02216812|530981781|FG000|Overall Study|Lost to Follow-up|10|||
147221050|NCT02216812|530981782|FG001|Overall Study|Lost to Follow-up|5|||
147221051|NCT02829944|530981790|FG000|Overall Study|Physician Decision|0|||
147221052|NCT02829944|530981791|FG001|Overall Study|Physician Decision|1|||
147221053|NCT02829944|530981790|FG000|Overall Study|Screen Failure|2|||
147221054|NCT02829944|530981791|FG001|Overall Study|Screen Failure|2|||
147221055|NCT02829944|530981790|FG000|Overall Study|Inadequate Neuraxial Block|1|||
147221056|NCT02829944|530981791|FG001|Overall Study|Inadequate Neuraxial Block|1|||
147221057|NCT02829944|530981790|FG000|Overall Study|Withdrawal by Subject|2|||
147221058|NCT02829944|530981791|FG001|Overall Study|Withdrawal by Subject|1|||
147221059|NCT02829944|530981790|FG000|Overall Study|Catheter Displacement|1|||
147221060|NCT02829944|530981791|FG001|Overall Study|Catheter Displacement|0|||
147221061|NCT02829944|530981790|FG000|Overall Study|Catheter broke|0|||
147221062|NCT02829944|530981791|FG001|Overall Study|Catheter broke|1|||
147221063|NCT02829944|530981790|FG000|Overall Study|Staff unavailable|0|||
147221064|NCT02829944|530981791|FG001|Overall Study|Staff unavailable|1|||
147221065|NCT01395784|530981801|FG000|Overall Study|Lost to Follow-up|7|||
147221066|NCT01395784|530981801|FG000|Overall Study|Withdrawal by Subject|3|||
147221067|NCT01395784|530981801|FG000|Overall Study|Physician Decision|5|||
147221068|NCT05772702|530981802|FG000|Overall Study|Adverse Event|1|||
147221069|NCT04268823|530981803|FG000|Overall Study|Adverse Event|1|||
147221070|NCT04268823|530981804|FG001|Overall Study|Adverse Event|0|||
147221071|NCT04268823|530981803|FG000|Overall Study|Participant Decision|1|||
147221072|NCT04268823|530981804|FG001|Overall Study|Participant Decision|0|||
147221073|NCT00884377|530982732|FG000|Overall Study|Withdrawal by Subject|1|||
147221074|NCT00884377|530982733|FG001|Overall Study|Withdrawal by Subject|0|||
147221075|NCT00884377|530982732|FG000|Overall Study|Could not confirm diagnosis|1|||
147221076|NCT00884377|530982733|FG001|Overall Study|Could not confirm diagnosis|0|||
147552998|NCT00321711|532180056|FG001|Part A|Withdrawal by Subject|1|||
147552999|NCT00321711|532180057|FG002|Part A|Withdrawal by Subject|1|||
147553000|NCT00321711|532180058|FG003|Part A|Withdrawal by Subject|0|||
147553001|NCT00321711|532180059|FG004|Part A|Withdrawal by Subject|0|||
147221077|NCT00884377|530982732|FG000|Overall Study|Physician Decision|0|||
147221078|NCT00884377|530982733|FG001|Overall Study|Physician Decision|1|||
147221079|NCT05247398|530982737|FG000|Overall Study|Withdrawal by Subject|1|||
147221080|NCT04214288|530982738|FG000|Overall Study|Ongoing in the study|41|||
147221081|NCT04214288|530982739|FG001|Overall Study|Ongoing in the study|51|||
147553002|NCT00321711|532180055|FG000|Part A|Disease progression|0|||
147221082|NCT04214288|530982740|FG002|Overall Study|Ongoing in the study|12|||
147221083|NCT04214288|530982741|FG003|Overall Study|Ongoing in the study|39|||
147221084|NCT04214288|530982738|FG000|Overall Study|Adverse Event|1|||
147553003|NCT00321711|532180056|FG001|Part A|Disease progression|1|||
147221085|NCT04214288|530982739|FG001|Overall Study|Adverse Event|0|||
147309184|NCT03661996|531299981|FG001|Overall Study|Protocol Violation|0|||
147309185|NCT03661996|531299982|FG002|Overall Study|Protocol Violation|0|||
147309186|NCT03661996|531299983|FG003|Overall Study|Protocol Violation|0|||
147309187|NCT03661996|531299984|FG004|Overall Study|Protocol Violation|1|||
147309188|NCT03661996|531299980|FG000|Overall Study|Withdrawal by Subject|3|||
147309189|NCT03661996|531299981|FG001|Overall Study|Withdrawal by Subject|5|||
147309190|NCT03661996|531299982|FG002|Overall Study|Withdrawal by Subject|1|||
147309191|NCT03661996|531299983|FG003|Overall Study|Withdrawal by Subject|7|||
147309192|NCT03661996|531299984|FG004|Overall Study|Withdrawal by Subject|7|||
147309193|NCT03661996|531299980|FG000|Overall Study|Sponsors Decision|2|||
147309194|NCT03661996|531299981|FG001|Overall Study|Sponsors Decision|0|||
147309195|NCT03661996|531299982|FG002|Overall Study|Sponsors Decision|0|||
147309196|NCT03661996|531299983|FG003|Overall Study|Sponsors Decision|0|||
147309197|NCT03661996|531299984|FG004|Overall Study|Sponsors Decision|0|||
147309198|NCT03661996|531299980|FG000|Overall Study|Other|1|||
147309199|NCT03661996|531299981|FG001|Overall Study|Other|1|||
147309200|NCT03661996|531299982|FG002|Overall Study|Other|1|||
147309201|NCT03661996|531299983|FG003|Overall Study|Other|1|||
147309202|NCT03661996|531299984|FG004|Overall Study|Other|0|||
147309203|NCT03321513|531299985|FG000|Overall Study|Death|11|||
147309204|NCT03321513|531299986|FG001|Overall Study|Death|5|||
147309205|NCT03321513|531299985|FG000|Overall Study|Withdrawal by Subject|5|||
147309206|NCT03321513|531299986|FG001|Overall Study|Withdrawal by Subject|10|||
147309207|NCT03321513|531299985|FG000|Overall Study|Lost to Follow-up|10|||
147309208|NCT03321513|531299986|FG001|Overall Study|Lost to Follow-up|11|||
147309209|NCT03029247|531299987|FG000|Hgb Maintenance Phase (8 Weeks)|Withdrawal by Subject|3|||
147309210|NCT03029247|531299988|FG001|Hgb Maintenance Phase (8 Weeks)|Withdrawal by Subject|0|||
147309211|NCT03029247|531299987|FG000|Hgb Maintenance Phase (8 Weeks)|Physician Decision|1|||
147309212|NCT03029247|531299988|FG001|Hgb Maintenance Phase (8 Weeks)|Physician Decision|1|||
147309213|NCT03029247|531299987|FG000|Hgb Maintenance Phase (8 Weeks)|Protocol-specified withdrawal criterion|7|||
147309214|NCT03029247|531299988|FG001|Hgb Maintenance Phase (8 Weeks)|Protocol-specified withdrawal criterion|4|||
147309215|NCT03029247|531299987|FG000|Hgb Maintenance Phase (8 Weeks)|Adverse Event|2|||
147309216|NCT03029247|531299988|FG001|Hgb Maintenance Phase (8 Weeks)|Adverse Event|2|||
147309217|NCT02593305|531299989|FG000|Post 1|Comparison only group. No intervention.|0|||
147309218|NCT02593305|531299990|FG001|Post 1|Comparison only group. No intervention.|0|||
147309219|NCT02593305|531299991|FG002|Post 1|Comparison only group. No intervention.|10|||
147309220|NCT01993017|531299992|FG000|Overall Study|Death|23|||
147309221|NCT01993017|531299993|FG001|Overall Study|Death|26|||
147309222|NCT01993017|531299994|FG002|Overall Study|Death|18|||
147309223|NCT01993017|531299992|FG000|Overall Study|Could not be contacted|43|||
147309224|NCT01993017|531299993|FG001|Overall Study|Could not be contacted|42|||
147309225|NCT01993017|531299994|FG002|Overall Study|Could not be contacted|38|||
147309226|NCT01993017|531299992|FG000|Overall Study|Dropped out|19|||
147309227|NCT01993017|531299993|FG001|Overall Study|Dropped out|6|||
147309228|NCT01993017|531299994|FG002|Overall Study|Dropped out|11|||
147309229|NCT01993017|531299992|FG000|Overall Study|Other reasons|17|||
147309230|NCT01993017|531299993|FG001|Overall Study|Other reasons|11|||
147309231|NCT01993017|531299994|FG002|Overall Study|Other reasons|7|||
147309232|NCT01993017|531299992|FG000|Overall Study|Ineligible after randomization|4|||
147309233|NCT01993017|531299993|FG001|Overall Study|Ineligible after randomization|5|||
147309234|NCT01993017|531299994|FG002|Overall Study|Ineligible after randomization|5|||
147309235|NCT00068380|531299995|FG000|Overall Study|Withdrawal by Subject|3|||
147309236|NCT00068380|531299995|FG000|Overall Study|Adverse Event|2|||
147309237|NCT01976364|531299996|FG000|Main Study (36 Months)|Adverse Event|63|||
147309238|NCT01976364|531299997|FG001|Main Study (36 Months)|Adverse Event|0|||
147309239|NCT01976364|531299998|FG002|Main Study (36 Months)|Adverse Event|0|||
147309240|NCT01976364|531299996|FG000|Main Study (36 Months)|Withdrawn due to pregnancy|5|||
147309241|NCT01976364|531299997|FG001|Main Study (36 Months)|Withdrawn due to pregnancy|0|||
147309242|NCT01976364|531299998|FG002|Main Study (36 Months)|Withdrawn due to pregnancy|0|||
147309243|NCT01976364|531299996|FG000|Main Study (36 Months)|Other|13|||
147309244|NCT01976364|531299997|FG001|Main Study (36 Months)|Other|0|||
147309245|NCT01976364|531299998|FG002|Main Study (36 Months)|Other|0|||
147309246|NCT01976364|531299996|FG000|Main Study (36 Months)|No longer met eligibility criteria|2|||
147309247|NCT01976364|531299997|FG001|Main Study (36 Months)|No longer met eligibility criteria|0|||
147309248|NCT01976364|531299998|FG002|Main Study (36 Months)|No longer met eligibility criteria|0|||
147309249|NCT01976364|531299996|FG000|Main Study (36 Months)|Medication error|1|||
147309250|NCT01976364|531299997|FG001|Main Study (36 Months)|Medication error|0|||
147309251|NCT01976364|531299998|FG002|Main Study (36 Months)|Medication error|0|||
147309252|NCT01976364|531299996|FG000|Main Study (36 Months)|Lost to Follow-up|10|||
147309253|NCT01976364|531299997|FG001|Main Study (36 Months)|Lost to Follow-up|0|||
147309254|NCT01976364|531299998|FG002|Main Study (36 Months)|Lost to Follow-up|0|||
147309255|NCT01976364|531299996|FG000|Main Study (36 Months)|Lack of Efficacy|40|||
147309256|NCT01976364|531299997|FG001|Main Study (36 Months)|Lack of Efficacy|0|||
147309257|NCT01976364|531299998|FG002|Main Study (36 Months)|Lack of Efficacy|0|||
147309258|NCT01976364|531299996|FG000|Main Study (36 Months)|Protocol Violation|13|||
147309259|NCT01976364|531299997|FG001|Main Study (36 Months)|Protocol Violation|0|||
147221086|NCT04214288|530982740|FG002|Overall Study|Adverse Event|0|||
147221087|NCT04214288|530982741|FG003|Overall Study|Adverse Event|0|||
147221088|NCT04214288|530982738|FG000|Overall Study|Death|22|||
147221089|NCT04214288|530982739|FG001|Overall Study|Death|13|||
147221090|NCT04214288|530982740|FG002|Overall Study|Death|7|||
147221091|NCT04214288|530982741|FG003|Overall Study|Death|19|||
147221092|NCT04214288|530982738|FG000|Overall Study|Lost to Follow-up|1|||
147221093|NCT04214288|530982739|FG001|Overall Study|Lost to Follow-up|2|||
147221094|NCT04214288|530982740|FG002|Overall Study|Lost to Follow-up|1|||
147221095|NCT04214288|530982741|FG003|Overall Study|Lost to Follow-up|0|||
147221096|NCT04214288|530982738|FG000|Overall Study|Other|1|||
147221097|NCT04214288|530982739|FG001|Overall Study|Other|2|||
147221098|NCT04214288|530982740|FG002|Overall Study|Other|0|||
147221099|NCT04214288|530982741|FG003|Overall Study|Other|6|||
147221100|NCT04214288|530982738|FG000|Overall Study|Protocol Violation|0|||
147221101|NCT04214288|530982739|FG001|Overall Study|Protocol Violation|1|||
147221102|NCT04214288|530982740|FG002|Overall Study|Protocol Violation|0|||
147221103|NCT04214288|530982741|FG003|Overall Study|Protocol Violation|0|||
147221104|NCT04214288|530982738|FG000|Overall Study|Withdrawal by Subject|8|||
147221105|NCT04214288|530982739|FG001|Overall Study|Withdrawal by Subject|4|||
147221106|NCT04214288|530982740|FG002|Overall Study|Withdrawal by Subject|0|||
147221107|NCT04214288|530982741|FG003|Overall Study|Withdrawal by Subject|9|||
147221108|NCT04798781|530982742|FG000|Overall Study|Withdrawal by Subject|1|||
147221109|NCT00924781|530982743|FG000|Overall Study|Study terminated by sponsor|12|||
147221110|NCT00924781|530982744|FG001|Overall Study|Study terminated by sponsor|10|||
147221111|NCT02554279|530982745|FG000|Overall Study|Adverse Event|2|||
147221112|NCT02554279|530982746|FG001|Overall Study|Adverse Event|5|||
147221113|NCT02554279|530982745|FG000|Overall Study|Lost to Follow-up|3|||
147221114|NCT02554279|530982746|FG001|Overall Study|Lost to Follow-up|2|||
147221115|NCT02554279|530982745|FG000|Overall Study|Withdrawal by Subject|6|||
147221116|NCT02554279|530982746|FG001|Overall Study|Withdrawal by Subject|4|||
147221117|NCT02554279|530982745|FG000|Overall Study|Protocol Violation|2|||
147221118|NCT02554279|530982746|FG001|Overall Study|Protocol Violation|1|||
147221119|NCT02554279|530982745|FG000|Overall Study|Other reason|19|||
147221120|NCT02554279|530982746|FG001|Overall Study|Other reason|6|||
147221121|NCT01117792|530982747|FG000|Overall Study|Death|1|||
147221122|NCT01117792|530982747|FG000|Overall Study|Adverse Event|3|||
147221123|NCT05867342|530982748|FG000|Overall Study|Investigator Decision|3|||
147221124|NCT05867342|530982749|FG001|Overall Study|Investigator Decision|3|||
147221125|NCT00723203|530982750|FG000|Overall Study|Withdrawal by Subject|3|||
147221126|NCT00274924|530982754|FG000|Step 1 (R-CHOP X 3 Cycles)|Patient ineligible|4|||
147221127|NCT00274924|530982755|FG001|Step 1 (R-CHOP X 3 Cycles)|Patient ineligible|14|||
147221128|NCT00274924|530982756|FG002|Step 1 (R-CHOP X 3 Cycles)|Patient ineligible|1|||
147221129|NCT00274924|530982754|FG000|Step 1 (R-CHOP X 3 Cycles)|Did not start treatment|0|||
147221130|NCT00274924|530982755|FG001|Step 1 (R-CHOP X 3 Cycles)|Did not start treatment|0|||
147221131|NCT00274924|530982756|FG002|Step 1 (R-CHOP X 3 Cycles)|Did not start treatment|1|||
147221132|NCT00274924|530982754|FG000|Step 1 (R-CHOP X 3 Cycles)|Adverse Event|0|||
147221133|NCT00274924|530982755|FG001|Step 1 (R-CHOP X 3 Cycles)|Adverse Event|0|||
147221134|NCT00274924|530982756|FG002|Step 1 (R-CHOP X 3 Cycles)|Adverse Event|1|||
147650482|NCT00762034|532542909|FG000|Induction Period|Adverse Event|27|||
147650483|NCT00762034|532542910|FG001|Induction Period|Adverse Event|38|||
147650484|NCT00762034|532542909|FG000|Induction Period|Lost to Follow-up|1|||
147650485|NCT00762034|532542910|FG001|Induction Period|Lost to Follow-up|1|||
147650486|NCT00762034|532542909|FG000|Induction Period|Progressive Disease|73|||
147650487|NCT00762034|532542910|FG001|Induction Period|Progressive Disease|55|||
147650488|NCT00762034|532542909|FG000|Induction Period|Physician Decision|21|||
147650489|NCT00762034|532542910|FG001|Induction Period|Physician Decision|20|||
147650490|NCT00762034|532542909|FG000|Induction Period|Withdrawal by Subject|15|||
147650491|NCT00762034|532542910|FG001|Induction Period|Withdrawal by Subject|19|||
147650492|NCT00762034|532542909|FG000|Induction Period|Deaths Not Due to Study Disease|19|||
147650493|NCT00762034|532542910|FG001|Induction Period|Deaths Not Due to Study Disease|14|||
147650494|NCT00762034|532542909|FG000|Induction Period|Deaths Due to Study Disease|9|||
147650495|NCT00762034|532542910|FG001|Induction Period|Deaths Due to Study Disease|9|||
147650496|NCT00762034|532542909|FG000|Maintenance Period|Protocol Violation|1|||
147650497|NCT00762034|532542910|FG001|Maintenance Period|Protocol Violation|3|||
147650498|NCT00762034|532542909|FG000|Maintenance Period|Entry Criterion Not Met|0|||
147650499|NCT00762034|532542910|FG001|Maintenance Period|Entry Criterion Not Met|2|||
147650500|NCT00762034|532542909|FG000|Maintenance Period|Adverse Event|42|||
147650501|NCT00762034|532542910|FG001|Maintenance Period|Adverse Event|26|||
147650502|NCT00762034|532542909|FG000|Maintenance Period|Progressive Disease|186|||
147650503|NCT00762034|532542910|FG001|Maintenance Period|Progressive Disease|224|||
147650504|NCT00762034|532542909|FG000|Maintenance Period|Physician Decision|25|||
147221135|NCT00274924|530982754|FG000|Step 1 (R-CHOP X 3 Cycles)|Withdrawal by Subject|0|||
147221136|NCT00274924|530982755|FG001|Step 1 (R-CHOP X 3 Cycles)|Withdrawal by Subject|0|||
147221137|NCT00274924|530982756|FG002|Step 1 (R-CHOP X 3 Cycles)|Withdrawal by Subject|1|||
147443395|NCT01469182|531788660|FG000|Overall Study|Adverse Event|21|||
147650505|NCT00762034|532542910|FG001|Maintenance Period|Physician Decision|20|||
147309260|NCT01976364|531299998|FG002|Main Study (36 Months)|Protocol Violation|0|||
147309261|NCT01976364|531299996|FG000|Main Study (36 Months)|Withdrawal by Subject|69|||
147309262|NCT01976364|531299997|FG001|Main Study (36 Months)|Withdrawal by Subject|0|||
147309263|NCT01976364|531299998|FG002|Main Study (36 Months)|Withdrawal by Subject|0|||
147309264|NCT01976364|531299996|FG000|Main Study (36 Months)|Death|5|||
147309265|NCT01976364|531299997|FG001|Main Study (36 Months)|Death|0|||
147309266|NCT01976364|531299998|FG002|Main Study (36 Months)|Death|0|||
147309267|NCT01976364|531299996|FG000|Sub-study (12 Months)|Lost to Follow-up|0|||
147309268|NCT01976364|531299997|FG001|Sub-study (12 Months)|Lost to Follow-up|1|||
147309269|NCT01976364|531299998|FG002|Sub-study (12 Months)|Lost to Follow-up|0|||
147309270|NCT01976364|531299996|FG000|Sub-study (12 Months)|Withdrawal by Subject|0|||
147309271|NCT01976364|531299997|FG001|Sub-study (12 Months)|Withdrawal by Subject|0|||
147309272|NCT01976364|531299998|FG002|Sub-study (12 Months)|Withdrawal by Subject|1|||
147309273|NCT01976364|531299996|FG000|Sub-study (12 Months)|Protocol Violation|0|||
147309274|NCT01976364|531299997|FG001|Sub-study (12 Months)|Protocol Violation|1|||
147309275|NCT01976364|531299998|FG002|Sub-study (12 Months)|Protocol Violation|1|||
147309276|NCT01976364|531299996|FG000|Sub-study (12 Months)|Adverse Event|0|||
147309277|NCT01976364|531299997|FG001|Sub-study (12 Months)|Adverse Event|4|||
147309278|NCT01976364|531299998|FG002|Sub-study (12 Months)|Adverse Event|3|||
147309279|NCT02757521|531299999|FG000|Overall Study|Adverse Event|1|||
147309280|NCT02757521|531300000|FG001|Overall Study|Adverse Event|0|||
147309281|NCT01190215|531300001|FG000|Up to Month 6|Lost to Follow-up|2|||
147309282|NCT01190215|531300002|FG001|Up to Month 6|Lost to Follow-up|0|||
147309283|NCT00003511|531300003|FG000|Overall Study|Not evaluable|4|||
147309284|NCT01683994|531300027|FG000|Overall Study|Withdrawal by Subject|1|||
147309285|NCT01683994|531300028|FG001|Overall Study|Withdrawal by Subject|0|||
147309286|NCT01683994|531300029|FG002|Overall Study|Withdrawal by Subject|0|||
147309287|NCT01683994|531300030|FG003|Overall Study|Withdrawal by Subject|1|||
147309288|NCT01683994|531300031|FG004|Overall Study|Withdrawal by Subject|0|||
147309289|NCT01683994|531300027|FG000|Overall Study|Intercurrent illness|0|||
147309290|NCT01683994|531300028|FG001|Overall Study|Intercurrent illness|0|||
147309291|NCT01683994|531300029|FG002|Overall Study|Intercurrent illness|0|||
147309292|NCT01683994|531300030|FG003|Overall Study|Intercurrent illness|2|||
147309293|NCT01683994|531300031|FG004|Overall Study|Intercurrent illness|1|||
147309294|NCT00999661|531300032|FG000|Overall Study|Lost to Follow-up|59|||
147309295|NCT00999661|531300032|FG000|Overall Study|Adverse Event|1|||
147309296|NCT00999661|531300032|FG000|Overall Study|Withdrawal by Subject|1|||
147309297|NCT00999661|531300032|FG000|Overall Study|Not meeting eligibility criteria|9|||
147309298|NCT00917267|531300033|FG000|Overall Study|Adverse Event|15|||
147309299|NCT00917267|531300034|FG001|Overall Study|Adverse Event|36|||
147309300|NCT00917267|531300033|FG000|Overall Study|Physician Decision|2|||
147309301|NCT00917267|531300034|FG001|Overall Study|Physician Decision|4|||
147309302|NCT00917267|531300033|FG000|Overall Study|Protocol Violation|9|||
147309303|NCT00917267|531300034|FG001|Overall Study|Protocol Violation|18|||
147309304|NCT00917267|531300033|FG000|Overall Study|Withdrawal by Subject|5|||
147309305|NCT00917267|531300034|FG001|Overall Study|Withdrawal by Subject|12|||
147309306|NCT00917267|531300033|FG000|Overall Study|Lost to follow up|0|||
147309307|NCT00917267|531300034|FG001|Overall Study|Lost to follow up|2|||
147309308|NCT00917267|531300033|FG000|Overall Study|Entry Criteria Not Met|1|||
147309309|NCT00917267|531300034|FG001|Overall Study|Entry Criteria Not Met|0|||
147309310|NCT00917267|531300033|FG000|Overall Study|Sponsor Decision|5|||
147309311|NCT00917267|531300034|FG001|Overall Study|Sponsor Decision|5|||
147309312|NCT00917267|531300033|FG000|Overall Study|Lack of Efficacy-Loss of Glucose Control|2|||
147309313|NCT00917267|531300034|FG001|Overall Study|Lack of Efficacy-Loss of Glucose Control|2|||
147309314|NCT02960763|531300036|FG000|Step 1|Withdrawal by Subject|10|||
147309315|NCT02960763|531300037|FG001|Step 1|Withdrawal by Subject|8|||
147309316|NCT02960763|531300038|FG002|Step 1|Withdrawal by Subject|13|||
147309317|NCT02960763|531300039|FG003|Step 1|Withdrawal by Subject|0|||
147309318|NCT02960763|531300040|FG004|Step 1|Withdrawal by Subject|0|||
147309319|NCT02960763|531300036|FG000|Step 1|Lost to Follow-up|7|||
147309320|NCT02960763|531300037|FG001|Step 1|Lost to Follow-up|9|||
147309321|NCT02960763|531300038|FG002|Step 1|Lost to Follow-up|12|||
147309322|NCT02960763|531300039|FG003|Step 1|Lost to Follow-up|0|||
147309323|NCT02960763|531300040|FG004|Step 1|Lost to Follow-up|0|||
147309324|NCT02960763|531300036|FG000|Step 1|Death|1|||
147309325|NCT02960763|531300037|FG001|Step 1|Death|1|||
147309326|NCT02960763|531300038|FG002|Step 1|Death|1|||
147309327|NCT02960763|531300039|FG003|Step 1|Death|0|||
147309328|NCT02960763|531300040|FG004|Step 1|Death|0|||
147309329|NCT02960763|531300036|FG000|Step 1|Investigator discretion|1|||
147309330|NCT02960763|531300037|FG001|Step 1|Investigator discretion|0|||
147309331|NCT02960763|531300038|FG002|Step 1|Investigator discretion|1|||
147309332|NCT02960763|531300039|FG003|Step 1|Investigator discretion|0|||
147309333|NCT02960763|531300040|FG004|Step 1|Investigator discretion|0|||
147309334|NCT02960763|531300036|FG000|Step 1|Other|0|||
147309335|NCT02960763|531300037|FG001|Step 1|Other|0|||
147309336|NCT02960763|531300038|FG002|Step 1|Other|1|||
147309337|NCT02960763|531300039|FG003|Step 1|Other|0|||
147309338|NCT02960763|531300040|FG004|Step 1|Other|0|||
147309339|NCT02960763|531300036|FG000|Step 2|Withdrawal by Subject|0|||
147309340|NCT02960763|531300037|FG001|Step 2|Withdrawal by Subject|0|||
147309341|NCT02960763|531300038|FG002|Step 2|Withdrawal by Subject|0|||
147309342|NCT02960763|531300039|FG003|Step 2|Withdrawal by Subject|7|||
147309343|NCT02960763|531300040|FG004|Step 2|Withdrawal by Subject|3|||
147309344|NCT02960763|531300036|FG000|Step 2|Lost to Follow-up|0|||
147309345|NCT02960763|531300037|FG001|Step 2|Lost to Follow-up|0|||
147309346|NCT02960763|531300038|FG002|Step 2|Lost to Follow-up|0|||
147309347|NCT02960763|531300039|FG003|Step 2|Lost to Follow-up|4|||
147309348|NCT02960763|531300040|FG004|Step 2|Lost to Follow-up|1|||
147309349|NCT02960763|531300036|FG000|Step 2|Investigator discretion|0|||
147650506|NCT00762034|532542909|FG000|Maintenance Period|Withdrawal by Subject|34|||
147650507|NCT00762034|532542910|FG001|Maintenance Period|Withdrawal by Subject|14|||
147650508|NCT00762034|532542909|FG000|Maintenance Period|Death not due to study disease|2|||
147650509|NCT00762034|532542910|FG001|Maintenance Period|Death not due to study disease|5|||
147650510|NCT00762034|532542909|FG000|Maintenance Period|Death due to study disease|3|||
147650511|NCT00762034|532542910|FG001|Maintenance Period|Death due to study disease|3|||
147650512|NCT00762034|532542909|FG000|Maintenance Period|Other|1|||
147650513|NCT00762034|532542910|FG001|Maintenance Period|Other|1|||
147650514|NCT02107313|532542911|FG000|Overall Study|One participant did not do the FED cohor|0|||
147650515|NCT02107313|532542912|FG001|Overall Study|One participant did not do the FED cohor|1|||
147650516|NCT01031004|532542915|FG000|Overall Study|Protocol Violation|0|||
147650517|NCT01031004|532542916|FG001|Overall Study|Protocol Violation|1|||
147650518|NCT01031004|532542915|FG000|Overall Study|Lost to Follow-up|1|||
147650519|NCT01031004|532542916|FG001|Overall Study|Lost to Follow-up|0|||
147309350|NCT02960763|531300037|FG001|Step 2|Investigator discretion|0|||
147309351|NCT02960763|531300038|FG002|Step 2|Investigator discretion|0|||
147309352|NCT02960763|531300039|FG003|Step 2|Investigator discretion|0|||
147309353|NCT02960763|531300040|FG004|Step 2|Investigator discretion|1|||
147309354|NCT00312858|531300042|FG000|Overall Study|Adverse Event|0|||
147309355|NCT00312858|531300043|FG001|Overall Study|Adverse Event|1|||
147309356|NCT00312858|531300042|FG000|Overall Study|Lost to Follow-up|25|||
147309357|NCT00312858|531300043|FG001|Overall Study|Lost to Follow-up|42|||
147309358|NCT00312858|531300042|FG000|Overall Study|Protocol Violation|3|||
147309359|NCT00312858|531300043|FG001|Overall Study|Protocol Violation|8|||
147309360|NCT00312858|531300042|FG000|Overall Study|Withdraw by Participant|20|||
147309361|NCT00312858|531300043|FG001|Overall Study|Withdraw by Participant|20|||
147309362|NCT00312858|531300042|FG000|Overall Study|Participant Moved|11|||
147650520|NCT01641471|532542917|FG000|Overall Study|Withdrawal by Subject|19|||
147650521|NCT01641471|532542918|FG001|Overall Study|Withdrawal by Subject|19|||
147650522|NCT01641471|532542917|FG000|Overall Study|Lost to Follow-up|2|||
147650523|NCT01641471|532542918|FG001|Overall Study|Lost to Follow-up|4|||
147650524|NCT01641471|532542917|FG000|Overall Study|Protocol Violation|2|||
147650525|NCT01641471|532542918|FG001|Overall Study|Protocol Violation|4|||
147650526|NCT02815267|532542926|FG000|Double-Blind Phase|Adverse Event|0|||
147650527|NCT02815267|532542927|FG001|Double-Blind Phase|Adverse Event|3|||
147650528|NCT02815267|532542926|FG000|Double-Blind Phase|Lost to Follow-up|17|||
147650529|NCT02815267|532542927|FG001|Double-Blind Phase|Lost to Follow-up|9|||
147650530|NCT02815267|532542926|FG000|Double-Blind Phase|Withdrawal by Subject|11|||
147650531|NCT02815267|532542927|FG001|Double-Blind Phase|Withdrawal by Subject|10|||
147650532|NCT02815267|532542926|FG000|Double-Blind Phase|Protocol Violation|3|||
147650533|NCT02815267|532542927|FG001|Double-Blind Phase|Protocol Violation|2|||
147650534|NCT02815267|532542926|FG000|Double-Blind Phase|Site withdrawal|1|||
147650535|NCT02815267|532542927|FG001|Double-Blind Phase|Site withdrawal|6|||
147650536|NCT02815267|532542926|FG000|Double-Blind Phase|Received a disallowed medication|1|||
147650537|NCT02815267|532542927|FG001|Double-Blind Phase|Received a disallowed medication|1|||
147650538|NCT02815267|532542926|FG000|Open-Label Phase|Adverse Event|1|||
147650539|NCT02815267|532542927|FG001|Open-Label Phase|Adverse Event|1|||
147221138|NCT00274924|530982754|FG000|Step 1 (R-CHOP X 3 Cycles)|Lost to Follow-up|0|||
147221139|NCT00274924|530982755|FG001|Step 1 (R-CHOP X 3 Cycles)|Lost to Follow-up|0|||
147221140|NCT00274924|530982756|FG002|Step 1 (R-CHOP X 3 Cycles)|Lost to Follow-up|1|||
147221141|NCT00274924|530982754|FG000|Step 1 (R-CHOP X 3 Cycles)|Other complicating disease|0|||
147221142|NCT00274924|530982755|FG001|Step 1 (R-CHOP X 3 Cycles)|Other complicating disease|0|||
147221143|NCT00274924|530982756|FG002|Step 1 (R-CHOP X 3 Cycles)|Other complicating disease|1|||
147221144|NCT00274924|530982754|FG000|Step 2 (Tx Based on Mid-treatment PET)|Patient ineligible|4|||
147221145|NCT00274924|530982755|FG001|Step 2 (Tx Based on Mid-treatment PET)|Patient ineligible|15|||
147221146|NCT00274924|530982756|FG002|Step 2 (Tx Based on Mid-treatment PET)|Patient ineligible|0|||
147221147|NCT00274924|530982754|FG000|Step 2 (Tx Based on Mid-treatment PET)|Adverse Event|1|||
147221148|NCT00274924|530982755|FG001|Step 2 (Tx Based on Mid-treatment PET)|Adverse Event|0|||
147221149|NCT00274924|530982756|FG002|Step 2 (Tx Based on Mid-treatment PET)|Adverse Event|0|||
147221150|NCT00274924|530982754|FG000|Step 2 (Tx Based on Mid-treatment PET)|Withdrawal by Subject|1|||
147309363|NCT00312858|531300043|FG001|Overall Study|Participant Moved|10|||
147309364|NCT00312858|531300042|FG000|Overall Study|Other|9|||
147309365|NCT00312858|531300043|FG001|Overall Study|Other|12|||
147309366|NCT03638635|531300044|FG000|Initial Hospitalization|Study terminated prematurely|0|||
147650540|NCT02815267|532542926|FG000|Open-Label Phase|Lost to Follow-up|23|||
147650541|NCT02815267|532542927|FG001|Open-Label Phase|Lost to Follow-up|9|||
147650542|NCT02815267|532542926|FG000|Open-Label Phase|Withdrawal by Subject|24|||
147650543|NCT02815267|532542927|FG001|Open-Label Phase|Withdrawal by Subject|13|||
147650544|NCT02815267|532542926|FG000|Open-Label Phase|Protocol Violation|0|||
147650545|NCT02815267|532542927|FG001|Open-Label Phase|Protocol Violation|1|||
147650546|NCT02815267|532542926|FG000|Open-Label Phase|Administrative|21|||
147221151|NCT00274924|530982755|FG001|Step 2 (Tx Based on Mid-treatment PET)|Withdrawal by Subject|0|||
147221152|NCT00274924|530982756|FG002|Step 2 (Tx Based on Mid-treatment PET)|Withdrawal by Subject|0|||
147221153|NCT00274924|530982754|FG000|Step 2 (Tx Based on Mid-treatment PET)|Other complicating disease|1|||
147221154|NCT00274924|530982755|FG001|Step 2 (Tx Based on Mid-treatment PET)|Other complicating disease|0|||
147650547|NCT02815267|532542927|FG001|Open-Label Phase|Administrative|12|||
147650548|NCT02815267|532542926|FG000|Open-Label Phase|Other|2|||
147650549|NCT02815267|532542927|FG001|Open-Label Phase|Other|5|||
147650550|NCT01108237|532542928|FG000|Overall Study|No alignment data|2|||
147650551|NCT01108237|532542929|FG001|Overall Study|No alignment data|15|||
147650552|NCT01108237|532542928|FG000|Overall Study|Did not meet criteria for analysis|7|||
147650553|NCT01108237|532542929|FG001|Overall Study|Did not meet criteria for analysis|0|||
147650554|NCT02178358|532542930|FG000|Overall Study|Withdrawal by Subject|0|||
147650555|NCT02178358|532542931|FG001|Overall Study|Withdrawal by Subject|2|||
147650556|NCT02178358|532542932|FG002|Overall Study|Withdrawal by Subject|2|||
147650557|NCT02178358|532542930|FG000|Overall Study|Lost to Follow-up|1|||
147650558|NCT02178358|532542931|FG001|Overall Study|Lost to Follow-up|0|||
147650559|NCT02178358|532542932|FG002|Overall Study|Lost to Follow-up|0|||
147650560|NCT00948922|532542933|FG000|Overall Study|Did not start study treatment|2|||
147650561|NCT00948922|532542934|FG001|Overall Study|Did not start study treatment|5|||
147650562|NCT00948922|532542935|FG002|Overall Study|Did not start study treatment|0|||
147221155|NCT00274924|530982756|FG002|Step 2 (Tx Based on Mid-treatment PET)|Other complicating disease|0|||
147221156|NCT00274924|530982754|FG000|Step 2 (Tx Based on Mid-treatment PET)|Death|0|||
147221157|NCT00274924|530982755|FG001|Step 2 (Tx Based on Mid-treatment PET)|Death|1|||
147221158|NCT00274924|530982756|FG002|Step 2 (Tx Based on Mid-treatment PET)|Death|0|||
147221159|NCT00274924|530982754|FG000|Step 2 (Tx Based on Mid-treatment PET)|Lack of Efficacy|0|||
147221160|NCT00274924|530982755|FG001|Step 2 (Tx Based on Mid-treatment PET)|Lack of Efficacy|1|||
147221161|NCT00274924|530982756|FG002|Step 2 (Tx Based on Mid-treatment PET)|Lack of Efficacy|0|||
147221162|NCT00274924|530982754|FG000|Step 2 (Tx Based on Mid-treatment PET)|Alternative therapy|0|||
147221163|NCT00274924|530982755|FG001|Step 2 (Tx Based on Mid-treatment PET)|Alternative therapy|1|||
147221164|NCT00274924|530982756|FG002|Step 2 (Tx Based on Mid-treatment PET)|Alternative therapy|0|||
147221165|NCT01055496|530982757|FG000|Overall Study|Withdrawal by Subject|2|||
147221166|NCT01055496|530982758|FG001|Overall Study|Withdrawal by Subject|4|||
147221167|NCT01055496|530982757|FG000|Overall Study|Death|13|||
147221168|NCT01055496|530982758|FG001|Overall Study|Death|23|||
147221169|NCT01055496|530982757|FG000|Overall Study|Lost to Follow-up|0|||
147221170|NCT01055496|530982758|FG001|Overall Study|Lost to Follow-up|2|||
147221171|NCT01055496|530982757|FG000|Overall Study|Other - Unspecified|0|||
147221172|NCT01055496|530982758|FG001|Overall Study|Other - Unspecified|1|||
147221173|NCT00584740|530982759|FG000|Overall Study|Adverse Event|1|||
147221174|NCT00584740|530982760|FG001|Overall Study|Adverse Event|1|||
147221175|NCT00584740|530982759|FG000|Overall Study|Lack of Efficacy|8|||
147221176|NCT00584740|530982760|FG001|Overall Study|Lack of Efficacy|2|||
147221177|NCT00584740|530982759|FG000|Overall Study|Withdrawal by Subject|3|||
147221178|NCT00584740|530982760|FG001|Overall Study|Withdrawal by Subject|2|||
147221179|NCT00584740|530982759|FG000|Overall Study|Lost to Follow-up|0|||
147221180|NCT00584740|530982760|FG001|Overall Study|Lost to Follow-up|1|||
147221181|NCT01673282|530982761|FG000|Overall Study|Adverse Drug Reaction - Vimpat|9|||
147221182|NCT01673282|530982762|FG001|Overall Study|Adverse Drug Reaction - Vimpat|5|||
147221183|NCT01673282|530982761|FG000|Overall Study|Lack of Efficacy|9|||
147221184|NCT01673282|530982762|FG001|Overall Study|Lack of Efficacy|2|||
147221185|NCT01673282|530982761|FG000|Overall Study|Lost to Follow-up|11|||
147221186|NCT01673282|530982762|FG001|Overall Study|Lost to Follow-up|10|||
147221187|NCT01673282|530982761|FG000|Overall Study|Withdrawal by Subject|3|||
147221188|NCT01673282|530982762|FG001|Overall Study|Withdrawal by Subject|3|||
147309367|NCT03638635|531300045|FG001|Initial Hospitalization|Study terminated prematurely|1|||
147309368|NCT03638635|531300044|FG000|Initial Hospitalization|Withdrawal by study personnel|0|||
147650563|NCT00948922|532542933|FG000|Overall Study|Withdrawal by Subject|0|||
147650564|NCT00948922|532542934|FG001|Overall Study|Withdrawal by Subject|2|||
147650565|NCT00948922|532542935|FG002|Overall Study|Withdrawal by Subject|1|||
147650566|NCT00948922|532542933|FG000|Overall Study|Death|3|||
147650567|NCT00948922|532542934|FG001|Overall Study|Death|0|||
147650568|NCT00948922|532542935|FG002|Overall Study|Death|0|||
147650569|NCT00948922|532542933|FG000|Overall Study|Disease progression|0|||
147650570|NCT00948922|532542934|FG001|Overall Study|Disease progression|1|||
147309369|NCT03638635|531300045|FG001|Initial Hospitalization|Withdrawal by study personnel|1|||
147650571|NCT00948922|532542935|FG002|Overall Study|Disease progression|0|||
147650572|NCT00948922|532542933|FG000|Overall Study|Insurance issues|1|||
147650573|NCT00948922|532542934|FG001|Overall Study|Insurance issues|0|||
147221189|NCT01673282|530982761|FG000|Overall Study|Other|1|||
147221190|NCT01673282|530982762|FG001|Overall Study|Other|6|||
147650574|NCT00948922|532542935|FG002|Overall Study|Insurance issues|0|||
147650575|NCT00948922|532542933|FG000|Overall Study|Transplant eligibility issues|2|||
147650576|NCT00948922|532542934|FG001|Overall Study|Transplant eligibility issues|3|||
147650577|NCT00948922|532542935|FG002|Overall Study|Transplant eligibility issues|0|||
147650578|NCT00948922|532542933|FG000|Overall Study|Not evaluable at time of analysis|0|||
147650579|NCT00948922|532542934|FG001|Overall Study|Not evaluable at time of analysis|3|||
147650580|NCT00948922|532542935|FG002|Overall Study|Not evaluable at time of analysis|0|||
147650581|NCT02784288|532542936|FG000|Overall Study|Patients neck dissection had spillage and therefore needed to come off protocol|1|||
147650582|NCT02757625|532542937|FG000|Overall Study|Investigator's discretion|0|||
147650583|NCT02757625|532542938|FG001|Overall Study|Investigator's discretion|0|||
147650584|NCT02757625|532542939|FG002|Overall Study|Investigator's discretion|1|||
147650585|NCT02757625|532542940|FG003|Overall Study|Investigator's discretion|0|||
147650586|NCT02757625|532542937|FG000|Overall Study|Adverse Event|0|||
147650587|NCT02757625|532542938|FG001|Overall Study|Adverse Event|0|||
147650588|NCT02757625|532542939|FG002|Overall Study|Adverse Event|1|||
147650589|NCT02757625|532542940|FG003|Overall Study|Adverse Event|0|||
147650590|NCT02131233|532542941|FG000|Overall Study|Not Treated|2|||
147650591|NCT02131233|532542942|FG001|Overall Study|Not Treated|3|||
147650592|NCT02131233|532542941|FG000|Overall Study|Adverse Event|7|||
147650593|NCT02131233|532542942|FG001|Overall Study|Adverse Event|6|||
147650594|NCT02131233|532542941|FG000|Overall Study|Death|0|||
147650595|NCT02131233|532542942|FG001|Overall Study|Death|1|||
147650596|NCT02131233|532542941|FG000|Overall Study|Lack of Efficacy|6|||
147650597|NCT02131233|532542942|FG001|Overall Study|Lack of Efficacy|3|||
147650598|NCT02131233|532542941|FG000|Overall Study|Lost to Follow-up|14|||
147650599|NCT02131233|532542942|FG001|Overall Study|Lost to Follow-up|13|||
147650600|NCT02131233|532542941|FG000|Overall Study|Non-Compliance With Study Drug|8|||
147650601|NCT02131233|532542942|FG001|Overall Study|Non-Compliance With Study Drug|5|||
147650602|NCT02131233|532542941|FG000|Overall Study|Physician Decision|7|||
147650603|NCT02131233|532542942|FG001|Overall Study|Physician Decision|0|||
147650604|NCT02131233|532542941|FG000|Overall Study|Pregnancy|4|||
147650605|NCT02131233|532542942|FG001|Overall Study|Pregnancy|0|||
147650606|NCT02131233|532542941|FG000|Overall Study|Withdrawal by Subject|18|||
147650607|NCT02131233|532542942|FG001|Overall Study|Withdrawal by Subject|11|||
147650608|NCT00645671|532542943|FG000|Overall Study|Protocol Violation|1|||
147650609|NCT00645671|532542944|FG001|Overall Study|Protocol Violation|0|||
147650610|NCT00645671|532542943|FG000|Overall Study|Withdrawal by Subject|0|||
147650611|NCT00645671|532542944|FG001|Overall Study|Withdrawal by Subject|4|||
147650612|NCT00645671|532542943|FG000|Overall Study|Adverse Event|0|||
147650613|NCT00645671|532542944|FG001|Overall Study|Adverse Event|1|||
147650614|NCT00645671|532542943|FG000|Overall Study|Physician Decision|0|||
147650615|NCT00645671|532542944|FG001|Overall Study|Physician Decision|1|||
147650616|NCT02095197|532542945|FG000|Overall Study|Lost to Follow-up|0|||
147650617|NCT02095197|532542946|FG001|Overall Study|Lost to Follow-up|3|||
147650618|NCT01597492|532542948|FG000|Overall Study|Withdrawal by Subject|1|||
147650619|NCT01597492|532542949|FG001|Overall Study|Withdrawal by Subject|2|||
147650620|NCT01597492|532542948|FG000|Overall Study|Adverse Event|3|||
147650621|NCT01597492|532542949|FG001|Overall Study|Adverse Event|0|||
147650622|NCT01597492|532542948|FG000|Overall Study|Lost to Follow-up|0|||
147650623|NCT01597492|532542949|FG001|Overall Study|Lost to Follow-up|2|||
147650624|NCT01597492|532542948|FG000|Overall Study|Other Reason|2|||
147650625|NCT01597492|532542949|FG001|Overall Study|Other Reason|0|||
147221191|NCT02915874|530982763|FG000|Overall Study|Lost to Follow-up|5|||
147221192|NCT02915874|530982764|FG001|Overall Study|Lost to Follow-up|4|||
147221193|NCT02915874|530982763|FG000|Overall Study|Withdrawal by Subject|1|||
147221194|NCT02915874|530982764|FG001|Overall Study|Withdrawal by Subject|1|||
147650626|NCT01204918|532542950|FG000|Overall Study|Withdrawal by Subject|4|||
147650627|NCT01204918|532542951|FG001|Overall Study|Withdrawal by Subject|10|||
147650628|NCT01204918|532542952|FG002|Overall Study|Withdrawal by Subject|5|||
147650629|NCT01280682|532542955|FG000|Overall Study|Lost to Follow-up|0|||
147650630|NCT01280682|532542956|FG001|Overall Study|Lost to Follow-up|6|||
147650631|NCT01280682|532542955|FG000|Overall Study|Withdrawal by Subject|0|||
147650632|NCT01280682|532542956|FG001|Overall Study|Withdrawal by Subject|7|||
147650633|NCT00849290|532542957|FG000|Overall Study|Adverse Event|3|||
147650634|NCT00849290|532542957|FG000|Overall Study|Death|14|||
147650635|NCT00849290|532542957|FG000|Overall Study|Withdrawal by Subject|11|||
147650636|NCT00849290|532542957|FG000|Overall Study|Lost to Follow-up|2|||
147650637|NCT00849290|532542957|FG000|Overall Study|Protocol Violation|5|||
147650638|NCT00849290|532542957|FG000|Overall Study|Disease Progression|20|||
147650639|NCT03760458|532542962|FG000|Main Study (Through Week 48)|Withdrawal by Subject|1|||
147650640|NCT03760458|532542963|FG001|Main Study (Through Week 48)|Withdrawal by Subject|1|||
147221195|NCT02915874|530982763|FG000|Overall Study|Started New Anxiety Medication|0|||
147650641|NCT03760458|532542964|FG002|Main Study (Through Week 48)|Withdrawal by Subject|0|||
147650642|NCT03760458|532542965|FG003|Main Study (Through Week 48)|Withdrawal by Subject|0|||
147650643|NCT03760458|532542966|FG004|Main Study (Through Week 48)|Withdrawal by Subject|0|||
147650644|NCT00750919|532542967|FG000|Overall Study|Adverse Event|9|||
147650645|NCT00750919|532542967|FG000|Overall Study|Withdrawal by Subject|1|||
147553004|NCT00321711|532180057|FG002|Part A|Disease progression|0|||
147553005|NCT00321711|532180058|FG003|Part A|Disease progression|0|||
147553006|NCT00321711|532180059|FG004|Part A|Disease progression|0|||
147553007|NCT00321711|532180055|FG000|Part A|Requirement for alternative therapy|0|||
147553008|NCT00321711|532180056|FG001|Part A|Requirement for alternative therapy|2|||
147553009|NCT00321711|532180057|FG002|Part A|Requirement for alternative therapy|1|||
147553010|NCT00321711|532180058|FG003|Part A|Requirement for alternative therapy|0|||
147553011|NCT00321711|532180059|FG004|Part A|Requirement for alternative therapy|0|||
147553012|NCT00321711|532180055|FG000|Part A|Physician Decision|0|||
147553013|NCT00321711|532180056|FG001|Part A|Physician Decision|1|||
147553014|NCT00321711|532180057|FG002|Part A|Physician Decision|3|||
147553015|NCT00321711|532180058|FG003|Part A|Physician Decision|0|||
147553016|NCT00321711|532180059|FG004|Part A|Physician Decision|0|||
147553017|NCT00321711|532180055|FG000|Part A|Other|1|||
147553018|NCT00321711|532180056|FG001|Part A|Other|2|||
147553019|NCT00321711|532180057|FG002|Part A|Other|3|||
147553020|NCT00321711|532180058|FG003|Part A|Other|0|||
147553021|NCT00321711|532180059|FG004|Part A|Other|0|||
147650646|NCT00750919|532542967|FG000|Overall Study|Lack of Efficacy|8|||
147650647|NCT00750919|532542967|FG000|Overall Study|Could not cooperate, unrelated to trial|4|||
147650648|NCT00750919|532542967|FG000|Overall Study|Other|36|||
147650649|NCT01464619|532542968|FG000|Overall Study|Lost to Follow-up|3|||
147650650|NCT01464619|532542969|FG001|Overall Study|Lost to Follow-up|4|||
147650651|NCT00080483|532542974|FG000|Overall Study|Lost to Follow-up|1|||
147650652|NCT00080483|532542975|FG001|Overall Study|Lost to Follow-up|1|||
147650653|NCT00080483|532542974|FG000|Overall Study|Physician Decision|1|||
147650654|NCT00080483|532542975|FG001|Overall Study|Physician Decision|1|||
147650655|NCT00002525|532542977|FG000|Overall Study|Adverse Event|36|||
147650656|NCT00002525|532542978|FG001|Overall Study|Adverse Event|0|||
147650657|NCT00002525|532542977|FG000|Overall Study|Death|5|||
147650658|NCT00002525|532542978|FG001|Overall Study|Death|0|||
147650659|NCT00002525|532542977|FG000|Overall Study|Withdrawal by Subject|11|||
147650660|NCT00002525|532542978|FG001|Overall Study|Withdrawal by Subject|0|||
147650661|NCT00002525|532542977|FG000|Overall Study|Start non-protocol therapy|1|||
147650662|NCT00002525|532542978|FG001|Overall Study|Start non-protocol therapy|0|||
147650663|NCT00002525|532542977|FG000|Overall Study|Other complicating disease|1|||
147650664|NCT00002525|532542978|FG001|Overall Study|Other complicating disease|0|||
147650665|NCT00002525|532542977|FG000|Overall Study|Duke's A, B1, D disease|92|||
147650666|NCT00002525|532542978|FG001|Overall Study|Duke's A, B1, D disease|0|||
147650667|NCT00002525|532542977|FG000|Overall Study|Error|6|||
147650668|NCT00002525|532542978|FG001|Overall Study|Error|0|||
147650669|NCT00002525|532542977|FG000|Overall Study|Other|26|||
147650670|NCT00002525|532542978|FG001|Overall Study|Other|0|||
147650671|NCT00002525|532542977|FG000|Overall Study|Never start protocol therapy|8|||
147650672|NCT00002525|532542978|FG001|Overall Study|Never start protocol therapy|0|||
147650673|NCT02651688|532542981|FG000|Overall Study|Non-compliance|0|||
147650674|NCT02651688|532542982|FG001|Overall Study|Non-compliance|0|||
147650675|NCT02651688|532542983|FG002|Overall Study|Non-compliance|1|||
147650676|NCT02651688|532542981|FG000|Overall Study|Principal Investigator (PI) decision|0|||
147650677|NCT02651688|532542982|FG001|Overall Study|Principal Investigator (PI) decision|2|||
147650678|NCT02651688|532542983|FG002|Overall Study|Principal Investigator (PI) decision|0|||
147650679|NCT02651688|532542981|FG000|Overall Study|Lost to Follow-up|1|||
147650680|NCT02651688|532542982|FG001|Overall Study|Lost to Follow-up|3|||
147650681|NCT02651688|532542983|FG002|Overall Study|Lost to Follow-up|0|||
147650682|NCT02651688|532542981|FG000|Overall Study|Withdrawal by Subject|1|||
147650683|NCT02651688|532542982|FG001|Overall Study|Withdrawal by Subject|0|||
147650684|NCT02651688|532542983|FG002|Overall Study|Withdrawal by Subject|2|||
147650685|NCT02112877|532542984|FG000|Overall Study|Withdrawal by Subject|1|||
147650686|NCT02112877|532542985|FG001|Overall Study|Withdrawal by Subject|7|||
147650687|NCT02112877|532542984|FG000|Overall Study|Visit Missed|1|||
147650688|NCT02112877|532542985|FG001|Overall Study|Visit Missed|6|||
147650689|NCT00625183|532542986|FG000|Overall Study|Disease Progression|1|||
147650690|NCT02279745|532542989|FG000|Overall Study|Adverse Event|7|||
147650691|NCT02279745|532542989|FG000|Overall Study|Death|6|||
147650692|NCT02279745|532542989|FG000|Overall Study|Clinical Worsening as Defined by Protocol|2|||
147650693|NCT02279745|532542989|FG000|Overall Study|Withdrawal by Subject|2|||
147650694|NCT02279745|532542989|FG000|Overall Study|Pregnancy|1|||
147650695|NCT02279745|532542989|FG000|Overall Study|Study Non-compliance|1|||
147650696|NCT02279745|532542989|FG000|Overall Study|Did Not Transition to Study ROR-PH-303|1|||
147553022|NCT00321711|532180055|FG000|Part A|Protocol deviation|0|||
147553023|NCT00321711|532180056|FG001|Part A|Protocol deviation|0|||
147553024|NCT00321711|532180057|FG002|Part A|Protocol deviation|1|||
147553025|NCT00321711|532180058|FG003|Part A|Protocol deviation|0|||
147553026|NCT00321711|532180059|FG004|Part A|Protocol deviation|0|||
147553027|NCT00321711|532180055|FG000|Part B|Noncompliance|0|||
147650697|NCT00380718|532542990|FG000|Overall Study|Adverse Event|1|||
147650698|NCT00380718|532542990|FG000|Overall Study|Death after 30-day post-therapy followup|17|||
147650699|NCT01578499|532542992|FG000|Overall Study|Reason not Specified|0|||
147650700|NCT01578499|532542993|FG001|Overall Study|Reason not Specified|1|||
147309370|NCT03638635|531300044|FG000|Follow-Up (30 Days After Discharge)|Study terminated prematurely|39|||
147309371|NCT03638635|531300045|FG001|Follow-Up (30 Days After Discharge)|Study terminated prematurely|22|||
147309372|NCT02318719|531300048|FG000|Double-blind Phase|Adverse Event|7|||
147309373|NCT02318719|531300049|FG001|Double-blind Phase|Adverse Event|6|||
147309374|NCT02318719|531300050|FG002|Double-blind Phase|Adverse Event|12|||
147309375|NCT02318719|531300051|FG003|Double-blind Phase|Adverse Event|4|||
147309376|NCT02318719|531300052|FG004|Double-blind Phase|Adverse Event|0|||
147309377|NCT02318719|531300048|FG000|Double-blind Phase|Lack of Efficacy|5|||
147309378|NCT02318719|531300049|FG001|Double-blind Phase|Lack of Efficacy|0|||
147309379|NCT02318719|531300050|FG002|Double-blind Phase|Lack of Efficacy|1|||
147309380|NCT02318719|531300051|FG003|Double-blind Phase|Lack of Efficacy|1|||
147309381|NCT02318719|531300052|FG004|Double-blind Phase|Lack of Efficacy|0|||
147309382|NCT02318719|531300048|FG000|Double-blind Phase|Protocol Violation|0|||
147309383|NCT02318719|531300049|FG001|Double-blind Phase|Protocol Violation|1|||
147309384|NCT02318719|531300050|FG002|Double-blind Phase|Protocol Violation|3|||
147309385|NCT02318719|531300051|FG003|Double-blind Phase|Protocol Violation|0|||
147309386|NCT02318719|531300052|FG004|Double-blind Phase|Protocol Violation|0|||
147309387|NCT02318719|531300048|FG000|Double-blind Phase|Withdrawal by Subject|25|||
147309388|NCT02318719|531300049|FG001|Double-blind Phase|Withdrawal by Subject|7|||
147309389|NCT02318719|531300050|FG002|Double-blind Phase|Withdrawal by Subject|9|||
147309390|NCT02318719|531300051|FG003|Double-blind Phase|Withdrawal by Subject|10|||
147309391|NCT02318719|531300052|FG004|Double-blind Phase|Withdrawal by Subject|0|||
147309392|NCT02318719|531300048|FG000|Double-blind Phase|Other|1|||
147309393|NCT02318719|531300049|FG001|Double-blind Phase|Other|2|||
147309394|NCT02318719|531300050|FG002|Double-blind Phase|Other|0|||
147309395|NCT02318719|531300051|FG003|Double-blind Phase|Other|0|||
147309396|NCT02318719|531300052|FG004|Double-blind Phase|Other|0|||
147309397|NCT02318719|531300048|FG000|Open-label Extension Phase|Adverse Event|0|||
147309398|NCT02318719|531300049|FG001|Open-label Extension Phase|Adverse Event|0|||
147309399|NCT02318719|531300050|FG002|Open-label Extension Phase|Adverse Event|0|||
147309400|NCT02318719|531300051|FG003|Open-label Extension Phase|Adverse Event|0|||
147309401|NCT02318719|531300052|FG004|Open-label Extension Phase|Adverse Event|15|||
147309402|NCT02318719|531300048|FG000|Open-label Extension Phase|Death|0|||
147309403|NCT02318719|531300049|FG001|Open-label Extension Phase|Death|0|||
147309404|NCT02318719|531300050|FG002|Open-label Extension Phase|Death|0|||
147309405|NCT02318719|531300051|FG003|Open-label Extension Phase|Death|0|||
147309406|NCT02318719|531300052|FG004|Open-label Extension Phase|Death|1|||
147309407|NCT02318719|531300048|FG000|Open-label Extension Phase|Lack of Efficacy|0|||
147309408|NCT02318719|531300049|FG001|Open-label Extension Phase|Lack of Efficacy|0|||
147309409|NCT02318719|531300050|FG002|Open-label Extension Phase|Lack of Efficacy|0|||
147309410|NCT02318719|531300051|FG003|Open-label Extension Phase|Lack of Efficacy|0|||
147309411|NCT02318719|531300052|FG004|Open-label Extension Phase|Lack of Efficacy|1|||
147309412|NCT02318719|531300048|FG000|Open-label Extension Phase|Withdrawal by Subject|0|||
147309413|NCT02318719|531300049|FG001|Open-label Extension Phase|Withdrawal by Subject|0|||
147309414|NCT02318719|531300050|FG002|Open-label Extension Phase|Withdrawal by Subject|0|||
147309415|NCT02318719|531300051|FG003|Open-label Extension Phase|Withdrawal by Subject|0|||
147309416|NCT02318719|531300052|FG004|Open-label Extension Phase|Withdrawal by Subject|31|||
147309417|NCT02318719|531300048|FG000|Open-label Extension Phase|Other|0|||
147309418|NCT02318719|531300049|FG001|Open-label Extension Phase|Other|0|||
147309419|NCT02318719|531300050|FG002|Open-label Extension Phase|Other|0|||
147309420|NCT02318719|531300051|FG003|Open-label Extension Phase|Other|0|||
147309421|NCT02318719|531300052|FG004|Open-label Extension Phase|Other|7|||
147309422|NCT00432835|531300056|FG000|Overall Study|Adverse event: lead dislodgement.|6|||
147309423|NCT00432835|531300057|FG001|Overall Study|Adverse event: lead dislodgement.|7|||
147309424|NCT00289770|531300058|FG000|Year 15|Withdrawal by Subject|1|||
147309425|NCT00423293|531300059|FG000|Overall Study|Ineligible / No protocol treatment|11|||
147309426|NCT01014975|531300066|FG000|Overall Study|Withdrawal by Subject|1|||
147309427|NCT01014975|531300067|FG001|Overall Study|Withdrawal by Subject|0|||
147309428|NCT01014975|531300068|FG002|Overall Study|Withdrawal by Subject|1|||
147309429|NCT01014975|531300066|FG000|Overall Study|Death|3|||
147309430|NCT01014975|531300067|FG001|Overall Study|Death|3|||
147443396|NCT01469182|531788661|FG001|Overall Study|Adverse Event|3|||
147309431|NCT01014975|531300068|FG002|Overall Study|Death|4|||
147309432|NCT01014975|531300066|FG000|Overall Study|Lost to Follow-up|0|||
147309433|NCT01014975|531300067|FG001|Overall Study|Lost to Follow-up|0|||
147309434|NCT01014975|531300068|FG002|Overall Study|Lost to Follow-up|1|||
147309435|NCT02632786|531300073|FG000|Overall Study|Adverse Event|2|||
147309436|NCT02632786|531300074|FG001|Overall Study|Adverse Event|1|||
147309437|NCT02632786|531300073|FG000|Overall Study|Death|3|||
147443397|NCT01469182|531788660|FG000|Overall Study|Lost to Follow-up|3|||
147443398|NCT01469182|531788661|FG001|Overall Study|Lost to Follow-up|0|||
147443399|NCT01469182|531788660|FG000|Overall Study|Withdrawal by Subject|4|||
147309438|NCT02632786|531300074|FG001|Overall Study|Death|2|||
147309439|NCT02632786|531300073|FG000|Overall Study|Physician Decision|5|||
147309440|NCT02632786|531300074|FG001|Overall Study|Physician Decision|4|||
147309441|NCT02632786|531300073|FG000|Overall Study|Withdrawal by Subject|1|||
147309442|NCT02632786|531300074|FG001|Overall Study|Withdrawal by Subject|0|||
147309443|NCT04250337|531300075|FG000|Overall Study|Adverse Event|0|||
147553028|NCT00321711|532180056|FG001|Part B|Noncompliance|0|||
147553029|NCT00321711|532180057|FG002|Part B|Noncompliance|0|||
147553030|NCT00321711|532180058|FG003|Part B|Noncompliance|0|||
147553031|NCT00321711|532180059|FG004|Part B|Noncompliance|1|||
147553032|NCT00321711|532180055|FG000|Part B|Adverse Event|0|||
147553033|NCT00321711|532180056|FG001|Part B|Adverse Event|0|||
147553034|NCT00321711|532180057|FG002|Part B|Adverse Event|0|||
147553035|NCT00321711|532180058|FG003|Part B|Adverse Event|2|||
147553036|NCT00321711|532180059|FG004|Part B|Adverse Event|1|||
147553037|NCT00321711|532180055|FG000|Part B|Disease progression|0|||
147553038|NCT00321711|532180056|FG001|Part B|Disease progression|0|||
147553039|NCT00321711|532180057|FG002|Part B|Disease progression|0|||
147553040|NCT00321711|532180058|FG003|Part B|Disease progression|1|||
147553041|NCT00321711|532180059|FG004|Part B|Disease progression|0|||
147553042|NCT00321711|532180055|FG000|Part B|Physician Decision|0|||
147553043|NCT00321711|532180056|FG001|Part B|Physician Decision|0|||
147553044|NCT00321711|532180057|FG002|Part B|Physician Decision|0|||
147553045|NCT00321711|532180058|FG003|Part B|Physician Decision|1|||
147553046|NCT00321711|532180059|FG004|Part B|Physician Decision|2|||
147553047|NCT00321711|532180055|FG000|Part B|Death|0|||
147553048|NCT00321711|532180056|FG001|Part B|Death|0|||
147553049|NCT00321711|532180057|FG002|Part B|Death|0|||
147553050|NCT00321711|532180058|FG003|Part B|Death|2|||
147553051|NCT00321711|532180059|FG004|Part B|Death|1|||
147553052|NCT01186978|532180060|FG000|Overall Study|Withdrawal by Subject|1|||
147553053|NCT01227668|532180061|FG000|Phase 1 (Stabilization Phase)|Adverse Event|12|||
147553054|NCT01227668|532180062|FG001|Phase 1 (Stabilization Phase)|Adverse Event|0|||
147553055|NCT01227668|532180061|FG000|Phase 1 (Stabilization Phase)|Withdrawal by Subject|7|||
147553056|NCT01227668|532180062|FG001|Phase 1 (Stabilization Phase)|Withdrawal by Subject|0|||
147553057|NCT01227668|532180061|FG000|Phase 1 (Stabilization Phase)|Lost to Follow-up|8|||
147553058|NCT01227668|532180062|FG001|Phase 1 (Stabilization Phase)|Lost to Follow-up|0|||
147553059|NCT01227668|532180061|FG000|Phase 1 (Stabilization Phase)|Sponsor's administrative reason|11|||
147553060|NCT01227668|532180062|FG001|Phase 1 (Stabilization Phase)|Sponsor's administrative reason|0|||
147553061|NCT01227668|532180061|FG000|Phase 1 (Stabilization Phase)|No longer meets study criteria|7|||
147553062|NCT01227668|532180062|FG001|Phase 1 (Stabilization Phase)|No longer meets study criteria|0|||
147553063|NCT01227668|532180061|FG000|Phase 1 (Stabilization Phase)|Lack of Efficacy|25|||
147553064|NCT01227668|532180062|FG001|Phase 1 (Stabilization Phase)|Lack of Efficacy|0|||
147553065|NCT01227668|532180061|FG000|Phase 1 (Stabilization Phase)|Poor compliance/noncompliance|2|||
147553066|NCT01227668|532180062|FG001|Phase 1 (Stabilization Phase)|Poor compliance/noncompliance|0|||
147553067|NCT01227668|532180061|FG000|Phase 2 (Randomization Phase)|Adverse Event|0|||
147553068|NCT01227668|532180062|FG001|Phase 2 (Randomization Phase)|Adverse Event|1|||
147553069|NCT01227668|532180061|FG000|Phase 2 (Randomization Phase)|Withdrawal by Subject|5|||
147553070|NCT01227668|532180062|FG001|Phase 2 (Randomization Phase)|Withdrawal by Subject|0|||
147553071|NCT01227668|532180061|FG000|Phase 2 (Randomization Phase)|Lost to Follow-up|1|||
147553072|NCT01227668|532180062|FG001|Phase 2 (Randomization Phase)|Lost to Follow-up|0|||
147553073|NCT01227668|532180061|FG000|Phase 2 (Randomization Phase)|Lack of Efficacy|13|||
147553074|NCT01227668|532180062|FG001|Phase 2 (Randomization Phase)|Lack of Efficacy|23|||
147553075|NCT01227668|532180061|FG000|Phase 2 (Randomization Phase)|Poor compliance/noncompliance|0|||
147553076|NCT01227668|532180062|FG001|Phase 2 (Randomization Phase)|Poor compliance/noncompliance|1|||
147553077|NCT02115256|532180067|FG000|Overall Study|Withdrawal by Subject|0|||
147553078|NCT02115256|532180068|FG001|Overall Study|Withdrawal by Subject|1|||
147553079|NCT01626859|532180071|FG000|Overall Study|Adverse Event|1|||
147553080|NCT01626859|532180072|FG001|Overall Study|Adverse Event|3|||
147553081|NCT01626859|532180073|FG002|Overall Study|Adverse Event|2|||
147553082|NCT01626859|532180071|FG000|Overall Study|Physician Decision|0|||
147553083|NCT01626859|532180072|FG001|Overall Study|Physician Decision|1|||
147553084|NCT01626859|532180073|FG002|Overall Study|Physician Decision|0|||
147553085|NCT01626859|532180071|FG000|Overall Study|Withdrawal by Subject|1|||
147553086|NCT01626859|532180072|FG001|Overall Study|Withdrawal by Subject|4|||
147553087|NCT01626859|532180073|FG002|Overall Study|Withdrawal by Subject|2|||
147553088|NCT02826603|532180074|FG000|Overall Study|Adverse Event|17|||
147553089|NCT02826603|532180075|FG001|Overall Study|Adverse Event|9|||
147553090|NCT02826603|532180074|FG000|Overall Study|Lack of Efficacy|4|||
147553091|NCT02826603|532180075|FG001|Overall Study|Lack of Efficacy|9|||
147553092|NCT02826603|532180074|FG000|Overall Study|Lost to Follow-up|13|||
147553093|NCT02826603|532180075|FG001|Overall Study|Lost to Follow-up|12|||
147553094|NCT02826603|532180074|FG000|Overall Study|Noncompliance with treatment|0|||
147553095|NCT02826603|532180075|FG001|Overall Study|Noncompliance with treatment|2|||
147553096|NCT02826603|532180074|FG000|Overall Study|Physician Decision|1|||
147553097|NCT02826603|532180075|FG001|Overall Study|Physician Decision|7|||
147553098|NCT02826603|532180074|FG000|Overall Study|Pregnancy|1|||
147553099|NCT02826603|532180075|FG001|Overall Study|Pregnancy|2|||
147650701|NCT01578499|532542992|FG000|Overall Study|Lost to Follow-up|2|||
147553100|NCT02826603|532180074|FG000|Overall Study|Protocol Violation|3|||
147553101|NCT02826603|532180075|FG001|Overall Study|Protocol Violation|3|||
147309444|NCT04250337|531300076|FG001|Overall Study|Adverse Event|3|||
147309445|NCT04250337|531300075|FG000|Overall Study|Lack of Efficacy|1|||
147309446|NCT04250337|531300076|FG001|Overall Study|Lack of Efficacy|3|||
147309447|NCT04250337|531300075|FG000|Overall Study|Physician Decision|1|||
147309448|NCT04250337|531300076|FG001|Overall Study|Physician Decision|0|||
147309449|NCT04250337|531300075|FG000|Overall Study|Protocol Deviation|2|||
147309450|NCT04250337|531300076|FG001|Overall Study|Protocol Deviation|2|||
147309451|NCT04250337|531300075|FG000|Overall Study|Withdrawal by Subject|4|||
147309452|NCT04250337|531300076|FG001|Overall Study|Withdrawal by Subject|3|||
147309453|NCT04498247|531300079|FG000|Overall Study|Lost to Follow-up|0|||
147309454|NCT04498247|531300080|FG001|Overall Study|Lost to Follow-up|0|||
147553102|NCT02826603|532180074|FG000|Overall Study|Withdrawal by Subject|20|||
147553103|NCT02826603|532180075|FG001|Overall Study|Withdrawal by Subject|19|||
147553104|NCT02826603|532180074|FG000|Overall Study|Death|2|||
147553105|NCT02826603|532180075|FG001|Overall Study|Death|0|||
147553106|NCT02826603|532180074|FG000|Overall Study|New therapy for study indication|0|||
147553107|NCT02826603|532180075|FG001|Overall Study|New therapy for study indication|1|||
147309455|NCT04498247|531300081|FG002|Overall Study|Lost to Follow-up|0|||
147309456|NCT04498247|531300082|FG003|Overall Study|Lost to Follow-up|1|||
147309457|NCT04498247|531300083|FG004|Overall Study|Lost to Follow-up|0|||
147309458|NCT04498247|531300084|FG005|Overall Study|Lost to Follow-up|0|||
147309459|NCT04498247|531300085|FG006|Overall Study|Lost to Follow-up|0|||
147309460|NCT04498247|531300086|FG007|Overall Study|Lost to Follow-up|0|||
147309461|NCT04498247|531300079|FG000|Overall Study|Mistakenly Randomized; Not Treated|1|||
147309462|NCT04498247|531300080|FG001|Overall Study|Mistakenly Randomized; Not Treated|0|||
147309463|NCT04498247|531300081|FG002|Overall Study|Mistakenly Randomized; Not Treated|0|||
147309464|NCT04498247|531300082|FG003|Overall Study|Mistakenly Randomized; Not Treated|0|||
147309465|NCT04498247|531300083|FG004|Overall Study|Mistakenly Randomized; Not Treated|0|||
147309466|NCT04498247|531300084|FG005|Overall Study|Mistakenly Randomized; Not Treated|0|||
147309467|NCT04498247|531300085|FG006|Overall Study|Mistakenly Randomized; Not Treated|0|||
147309468|NCT04498247|531300086|FG007|Overall Study|Mistakenly Randomized; Not Treated|0|||
147309469|NCT04498247|531300079|FG000|Overall Study|Withdrawal by Subject|0|||
147309470|NCT04498247|531300080|FG001|Overall Study|Withdrawal by Subject|8|||
147309471|NCT04498247|531300081|FG002|Overall Study|Withdrawal by Subject|0|||
147309472|NCT04498247|531300082|FG003|Overall Study|Withdrawal by Subject|7|||
147309473|NCT04498247|531300083|FG004|Overall Study|Withdrawal by Subject|0|||
147309474|NCT04498247|531300084|FG005|Overall Study|Withdrawal by Subject|0|||
147309475|NCT04498247|531300085|FG006|Overall Study|Withdrawal by Subject|1|||
147309476|NCT04498247|531300086|FG007|Overall Study|Withdrawal by Subject|0|||
147309477|NCT04498247|531300079|FG000|Overall Study|Received a non-study COVID-19 vaccine.|0|||
147309478|NCT04498247|531300080|FG001|Overall Study|Received a non-study COVID-19 vaccine.|4|||
147309479|NCT04498247|531300081|FG002|Overall Study|Received a non-study COVID-19 vaccine.|0|||
147309480|NCT04498247|531300082|FG003|Overall Study|Received a non-study COVID-19 vaccine.|3|||
147309481|NCT04498247|531300083|FG004|Overall Study|Received a non-study COVID-19 vaccine.|0|||
147309482|NCT04498247|531300084|FG005|Overall Study|Received a non-study COVID-19 vaccine.|0|||
147309483|NCT04498247|531300085|FG006|Overall Study|Received a non-study COVID-19 vaccine.|7|||
147309484|NCT04498247|531300086|FG007|Overall Study|Received a non-study COVID-19 vaccine.|0|||
147309485|NCT00669903|531300087|FG000|Overall Study|Adverse Event|0|||
147309486|NCT00669903|531300088|FG001|Overall Study|Adverse Event|1|||
147309487|NCT00669903|531300089|FG002|Overall Study|Adverse Event|3|||
147309488|NCT00669903|531300090|FG003|Overall Study|Adverse Event|1|||
147309489|NCT00669903|531300087|FG000|Overall Study|Withdrawal by Subject|0|||
147309490|NCT00669903|531300088|FG001|Overall Study|Withdrawal by Subject|2|||
147309491|NCT00669903|531300089|FG002|Overall Study|Withdrawal by Subject|2|||
147309492|NCT00669903|531300090|FG003|Overall Study|Withdrawal by Subject|2|||
147309493|NCT00669903|531300087|FG000|Overall Study|Lost to Follow-up|1|||
147309494|NCT00669903|531300088|FG001|Overall Study|Lost to Follow-up|1|||
147309495|NCT00669903|531300089|FG002|Overall Study|Lost to Follow-up|0|||
147309496|NCT00669903|531300090|FG003|Overall Study|Lost to Follow-up|1|||
147309497|NCT00669903|531300087|FG000|Overall Study|Protocol Violation|0|||
147309498|NCT00669903|531300088|FG001|Overall Study|Protocol Violation|1|||
147309499|NCT00669903|531300089|FG002|Overall Study|Protocol Violation|0|||
147553108|NCT00905489|532180076|FG000|Pharmaco-kinetic (PK) Phase|Protocol Violation|2|||
147553109|NCT00905489|532180076|FG000|Pharmaco-kinetic (PK) Phase|Other reason not defined above|3|||
147553110|NCT00905489|532180076|FG000|Optional Extension Phase (OEP)|Adverse Event|1|||
147553111|NCT00583596|532180077|FG000|Overall Study|Lost to Follow-up|110|||
147309500|NCT00669903|531300090|FG003|Overall Study|Protocol Violation|0|||
147309501|NCT01678820|531300091|FG000|Overall Study|Study Terminated by Sponsor|45|||
147309502|NCT01678820|531300092|FG001|Overall Study|Study Terminated by Sponsor|43|||
147309503|NCT01678820|531300093|FG002|Overall Study|Study Terminated by Sponsor|43|||
147309504|NCT01678820|531300091|FG000|Overall Study|Withdrawal by Subject|2|||
147309505|NCT01678820|531300092|FG001|Overall Study|Withdrawal by Subject|5|||
147309506|NCT01678820|531300093|FG002|Overall Study|Withdrawal by Subject|2|||
147309507|NCT01678820|531300091|FG000|Overall Study|Protocol Specified Criteria|2|||
147553112|NCT00583596|532180077|FG000|Overall Study|Excluded due to Hurricane Katrina|30|||
147309508|NCT01678820|531300092|FG001|Overall Study|Protocol Specified Criteria|3|||
147309509|NCT01678820|531300093|FG002|Overall Study|Protocol Specified Criteria|1|||
147309510|NCT01678820|531300091|FG000|Overall Study|Adverse Event|2|||
147309511|NCT01678820|531300092|FG001|Overall Study|Adverse Event|2|||
147309512|NCT01678820|531300093|FG002|Overall Study|Adverse Event|2|||
147309513|NCT01678820|531300091|FG000|Overall Study|Lost to Follow-up|7|||
147309514|NCT01678820|531300092|FG001|Overall Study|Lost to Follow-up|2|||
147309515|NCT01678820|531300093|FG002|Overall Study|Lost to Follow-up|2|||
147309516|NCT01678820|531300091|FG000|Overall Study|Non-compliance with study drug|0|||
147309517|NCT01678820|531300092|FG001|Overall Study|Non-compliance with study drug|1|||
147309518|NCT01678820|531300093|FG002|Overall Study|Non-compliance with study drug|0|||
147309519|NCT01678820|531300091|FG000|Overall Study|Physician Decision|0|||
147309520|NCT01678820|531300092|FG001|Overall Study|Physician Decision|0|||
147309521|NCT01678820|531300093|FG002|Overall Study|Physician Decision|1|||
147309522|NCT01678820|531300091|FG000|Overall Study|Protocol Violation|4|||
147309523|NCT01678820|531300092|FG001|Overall Study|Protocol Violation|5|||
147309524|NCT01678820|531300093|FG002|Overall Study|Protocol Violation|4|||
147309525|NCT01678820|531300091|FG000|Overall Study|Not treated with double-blind study drug|0|||
147309526|NCT01678820|531300092|FG001|Overall Study|Not treated with double-blind study drug|2|||
147309527|NCT01678820|531300093|FG002|Overall Study|Not treated with double-blind study drug|2|||
147309528|NCT00245856|531300094|FG000|Period Two|Withdrawal by Subject|0|||
147309529|NCT00245856|531300095|FG001|Period Two|Withdrawal by Subject|1|||
147309530|NCT01539863|531300096|FG000|Overall Study|Lost to Follow-up|5|||
147309531|NCT01539863|531300097|FG001|Overall Study|Lost to Follow-up|4|||
147309532|NCT03662997|531300098|FG000|Overall Study|Adverse Event|0|||
147309533|NCT03662997|531300099|FG001|Overall Study|Adverse Event|2|||
147309534|NCT03662997|531300100|FG002|Overall Study|Adverse Event|0|||
147309535|NCT03662997|531300101|FG003|Overall Study|Adverse Event|0|||
147309536|NCT00007475|531300102|FG000|Overall Study|Withdrawal by Subject|1|||
147309537|NCT00007475|531300103|FG001|Overall Study|Withdrawal by Subject|0|||
147309538|NCT00007475|531300104|FG002|Overall Study|Withdrawal by Subject|0|||
147309539|NCT00007475|531300105|FG003|Overall Study|Withdrawal by Subject|0|||
147309540|NCT00007475|531300102|FG000|Overall Study|Adverse Event|3|||
147309541|NCT00007475|531300103|FG001|Overall Study|Adverse Event|0|||
147309542|NCT00007475|531300104|FG002|Overall Study|Adverse Event|0|||
147309543|NCT00007475|531300105|FG003|Overall Study|Adverse Event|0|||
147309544|NCT01719224|531300106|FG000|Intervention 1: Sleeping Position 1|Withdrawal by Subject|4|||
147309545|NCT01719224|531300107|FG001|Intervention 1: Sleeping Position 1|Withdrawal by Subject|2|||
147309546|NCT03000673|531300108|FG000|Overall Study|Withdrawal by Subject|1|||
147309547|NCT03000673|531300109|FG001|Overall Study|Withdrawal by Subject|0|||
147309548|NCT03000673|531300110|FG002|Overall Study|Withdrawal by Subject|0|||
147309549|NCT03000673|531300111|FG003|Overall Study|Withdrawal by Subject|0|||
147309550|NCT01512745|531300113|FG000|Overall Study|Adverse Event|22|||
147309551|NCT01512745|531300114|FG001|Overall Study|Adverse Event|3|||
147309552|NCT01512745|531300113|FG000|Overall Study|Death|9|||
147309553|NCT01512745|531300114|FG001|Overall Study|Death|13|||
147309554|NCT01512745|531300113|FG000|Overall Study|Withdrawal by Subject|2|||
147309555|NCT01512745|531300114|FG001|Overall Study|Withdrawal by Subject|2|||
147309556|NCT01512745|531300113|FG000|Overall Study|Lost to Follow-up|4|||
147309557|NCT01512745|531300114|FG001|Overall Study|Lost to Follow-up|0|||
147309558|NCT01512745|531300113|FG000|Overall Study|Lack of Efficacy|2|||
147309559|NCT01512745|531300114|FG001|Overall Study|Lack of Efficacy|2|||
147309560|NCT01512745|531300113|FG000|Overall Study|Protocol Violation|1|||
147309561|NCT01512745|531300114|FG001|Overall Study|Protocol Violation|0|||
147309562|NCT02357810|531300115|FG000|Registered and Started Treatment|Withdrawal by Subject|1|||
147309563|NCT02357810|531300115|FG000|Registered and Started Treatment|Found not to be eligible for the study|26|||
147309564|NCT02357810|531300115|FG000|Reached 12 Weeks Response|Adverse Event|5|||
147309565|NCT02357810|531300115|FG000|Reached 12 Weeks Response|Progressive Disease|39|||
147309566|NCT02357810|531300115|FG000|Reached 12 Weeks Response|Withdrawal by Subject|8|||
147309567|NCT02357810|531300115|FG000|Reached 12 Weeks Response|Protocol Violation|1|||
147309568|NCT02357810|531300115|FG000|Reached 12 Weeks Response|Death|1|||
147309569|NCT02357810|531300115|FG000|Reached 12 Weeks Response|Physician Decision|1|||
147309570|NCT02357810|531300115|FG000|Reached 12 Weeks Response|Other|1|||
147309571|NCT02357810|531300115|FG000|12 Week Response and Further Treatment|Adverse Event|5|||
147309572|NCT02357810|531300115|FG000|12 Week Response and Further Treatment|Withdrawal by Subject|1|||
147553113|NCT00583596|532180077|FG000|Overall Study|Death|2|||
147309573|NCT02357810|531300115|FG000|12 Week Response and Further Treatment|Progressive Disease|15|||
147309574|NCT02357810|531300115|FG000|12 Week Response and Further Treatment|Wound Complications|1|||
147309575|NCT02357810|531300115|FG000|Follow-up at Treatment Discontinuation|Withdrawal by Subject|4|||
147309576|NCT02357810|531300115|FG000|Follow-up at Treatment Discontinuation|Lost to Follow-up|3|||
147553114|NCT00583596|532180077|FG000|Overall Study|Withdrawal by Subject|6|||
147309577|NCT00152971|531300117|FG000|Overall Study|Adverse Event|12|||
147309578|NCT00152971|531300118|FG001|Overall Study|Adverse Event|10|||
147553115|NCT00583596|532180077|FG000|Overall Study|Lost to Follow-up|94|||
147309579|NCT00152971|531300119|FG002|Overall Study|Adverse Event|9|||
147553116|NCT00583596|532180077|FG000|Overall Study|Data not complete|1|||
147650702|NCT01578499|532542993|FG001|Overall Study|Lost to Follow-up|1|||
147650703|NCT01578499|532542992|FG000|Overall Study|Withdrawal by Subject|10|||
147650704|NCT01578499|532542993|FG001|Overall Study|Withdrawal by Subject|16|||
147650705|NCT01578499|532542992|FG000|Overall Study|Death|20|||
147650706|NCT01578499|532542993|FG001|Overall Study|Death|25|||
147650707|NCT01578499|532542992|FG000|Overall Study|Died and End of Study Page not Completed|2|||
147650708|NCT01578499|532542993|FG001|Overall Study|Died and End of Study Page not Completed|0|||
147650709|NCT01706575|532542996|FG000|Overall Study|Participant Withdrew Consent|4|||
147650710|NCT01706575|532542996|FG000|Overall Study|Lost to Follow-up|2|||
147650711|NCT01706575|532542996|FG000|Overall Study|Started but not Treated|6|||
147650712|NCT02912455|532542997|FG000|Overall Study|Withdrawal by Subject|0|||
147650713|NCT02912455|532542998|FG001|Overall Study|Withdrawal by Subject|1|||
147650714|NCT02912455|532542997|FG000|Overall Study|Lack of Efficacy|0|||
147650715|NCT02912455|532542998|FG001|Overall Study|Lack of Efficacy|1|||
147650716|NCT02912455|532542997|FG000|Overall Study|Lost to Follow-up|2|||
147650717|NCT02912455|532542998|FG001|Overall Study|Lost to Follow-up|1|||
147650718|NCT02670382|532542999|FG000|Placebo lead-in Phase|Withdrawal by Subject|2|||
147650719|NCT02670382|532543000|FG001|Placebo lead-in Phase|Withdrawal by Subject|1|||
147650720|NCT03244618|532543003|FG000|Overall Study|Lost to Follow-up|3|||
147650721|NCT03244618|532543004|FG001|Overall Study|Lost to Follow-up|4|||
147650722|NCT03244618|532543003|FG000|Overall Study|Protocol Violation|4|||
147650723|NCT03244618|532543004|FG001|Overall Study|Protocol Violation|3|||
147650724|NCT03244618|532543003|FG000|Overall Study|Withdrawal by Subject|0|||
147650725|NCT03244618|532543004|FG001|Overall Study|Withdrawal by Subject|2|||
147650726|NCT01810783|532543006|FG000|Overall Study|Adverse Event|32|||
147650727|NCT01810783|532543006|FG000|Overall Study|Withdrawal by Subject|22|||
147650728|NCT01810783|532543006|FG000|Overall Study|Lack of Efficacy|12|||
147650729|NCT01810783|532543006|FG000|Overall Study|Lost to Follow-up|10|||
147650730|NCT01810783|532543006|FG000|Overall Study|Protocol Violation|5|||
147650731|NCT01810783|532543006|FG000|Overall Study|Non-compliance with IMP|4|||
147650732|NCT01810783|532543006|FG000|Overall Study|Adminstrative or other reason(s)|23|||
147650733|NCT01810783|532543006|FG000|Overall Study|Enrolled, not treated|1|||
147650734|NCT00630747|532543007|FG000|Overall Study|Death|1|||
147650735|NCT00630747|532543007|FG000|Overall Study|Transferred to Study TKT031NPU|7|||
147650736|NCT00630747|532543007|FG000|Overall Study|Returned to country of origin|1|||
147650737|NCT04503668|532543010|FG000|Overall Study|Incomplete data|4|||
147650738|NCT04503668|532543011|FG001|Overall Study|Incomplete data|3|||
147650739|NCT04503668|532543010|FG000|Overall Study|Withdrawal by Subject|1|||
147650740|NCT04503668|532543011|FG001|Overall Study|Withdrawal by Subject|1|||
147650741|NCT04503668|532543010|FG000|Overall Study|Adverse Event|2|||
147650742|NCT04503668|532543011|FG001|Overall Study|Adverse Event|0|||
147650743|NCT03403621|532543012|FG000|Overall Study|Withdrawal by Subject|2|||
147650744|NCT03403621|532543013|FG001|Overall Study|Withdrawal by Subject|2|||
147650745|NCT00395642|532543014|FG000|Overall Study|Death|4|||
147650746|NCT00395642|532543014|FG000|Overall Study|Lost to Follow-up|1|||
147650747|NCT00395642|532543014|FG000|Overall Study|Physician Decision|7|||
147650748|NCT00395642|532543014|FG000|Overall Study|Withdrawal by Subject|1|||
147650749|NCT01078298|532543017|FG000|Overall Study|Lost to Follow-up|12|||
147650750|NCT01078298|532543018|FG001|Overall Study|Lost to Follow-up|13|||
147650751|NCT01078298|532543017|FG000|Overall Study|Withdrawal by Subject|31|||
147650752|NCT01078298|532543018|FG001|Overall Study|Withdrawal by Subject|33|||
147650753|NCT01078298|532543017|FG000|Overall Study|Protocol Violation|6|||
147650754|NCT01078298|532543018|FG001|Overall Study|Protocol Violation|6|||
147650755|NCT01078298|532543017|FG000|Overall Study|Adverse Event|6|||
147650756|NCT01078298|532543018|FG001|Overall Study|Adverse Event|5|||
147650757|NCT01078298|532543017|FG000|Overall Study|Death|2|||
147650758|NCT01078298|532543018|FG001|Overall Study|Death|0|||
147650759|NCT01078298|532543017|FG000|Overall Study|Did not meet entrance criteria|0|||
147650760|NCT01078298|532543018|FG001|Overall Study|Did not meet entrance criteria|1|||
147650761|NCT01078298|532543017|FG000|Overall Study|Other|24|||
147221196|NCT02915874|530982764|FG001|Overall Study|Started New Anxiety Medication|1|||
147221197|NCT05318183|530982766|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|2|||
147221198|NCT05318183|530982767|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|3|||
147221199|NCT05318183|530982766|FG000|First Intervention (2 Weeks)|Lost to Follow-up|2|||
147221200|NCT05318183|530982767|FG001|First Intervention (2 Weeks)|Lost to Follow-up|0|||
147221201|NCT05318183|530982766|FG000|Second Intervention (2 Weeks)|Protocol Violation|0|||
147221202|NCT05318183|530982767|FG001|Second Intervention (2 Weeks)|Protocol Violation|2|||
147650762|NCT01078298|532543018|FG001|Overall Study|Other|32|||
147650763|NCT00659776|532543022|FG000|Overall Study|Withdrawal by Subject|12|||
147650764|NCT00659776|532543023|FG001|Overall Study|Withdrawal by Subject|2|||
147650765|NCT00659776|532543024|FG002|Overall Study|Withdrawal by Subject|0|||
147650766|NCT00628927|532543025|FG000|Overall Study|Problems performing blood draw|6|||
147650767|NCT00628927|532543026|FG001|Overall Study|Problems performing blood draw|0|||
147650768|NCT00628927|532543025|FG000|Overall Study|Lost to Follow-up|1|||
147650769|NCT00628927|532543026|FG001|Overall Study|Lost to Follow-up|0|||
147650770|NCT00628927|532543025|FG000|Overall Study|Equipment failure|1|||
147650771|NCT00628927|532543026|FG001|Overall Study|Equipment failure|0|||
147553117|NCT00583596|532180077|FG000|Overall Study|Not consented|15|||
147553118|NCT00583596|532180077|FG000|Overall Study|Outside f-up window|26|||
147553119|NCT01855126|532180078|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|4|||
147553120|NCT01855126|532180079|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|6|||
147553121|NCT01855126|532180078|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|2|||
147553122|NCT01855126|532180079|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|2|||
147553123|NCT04535583|532180091|FG000|Overall Study|Lost to Follow-up|1|||
147553124|NCT04535583|532180091|FG000|Overall Study|Physician Decision|1|||
147553125|NCT04535583|532180091|FG000|Overall Study|Withdrawal by Subject|1|||
147553126|NCT01078090|532180092|FG000|Overall Study|Lost to Follow-up|2363|||
147553127|NCT01078090|532180092|FG000|Overall Study|Adverse drug reaction (ADR)|453|||
147553128|NCT01078090|532180092|FG000|Overall Study|Lack of Efficacy|1193|||
147553129|NCT01078090|532180092|FG000|Overall Study|ADR and lack of efficacy|61|||
147553130|NCT01078090|532180092|FG000|Overall Study|Other|523|||
147553131|NCT01748890|532180094|FG000|Overall Study|Insufficient recruitment for analysis|4|||
147553132|NCT00526890|532180095|FG000|Overall Study|Adverse Event|2|||
147553133|NCT01688037|532180096|FG000|Double-Blind Period (Week 0 to 6)|Adverse Event|1|||
147553134|NCT01688037|532180097|FG001|Double-Blind Period (Week 0 to 6)|Adverse Event|0|||
147553135|NCT01688037|532180098|FG002|Double-Blind Period (Week 0 to 6)|Adverse Event|1|||
147650772|NCT01298141|532543027|FG000|Overall Study|Adverse Event|3|||
147650773|NCT01298141|532543027|FG000|Overall Study|Refusal of Required Study Procedures|1|||
147553136|NCT01688037|532180096|FG000|Double-Blind Period (Week 0 to 6)|Non-compliance|1|||
147553137|NCT01688037|532180097|FG001|Double-Blind Period (Week 0 to 6)|Non-compliance|2|||
147553138|NCT01688037|532180098|FG002|Double-Blind Period (Week 0 to 6)|Non-compliance|3|||
147650774|NCT01298141|532543027|FG000|Overall Study|Withdrawal by Subject|6|||
147553139|NCT01688037|532180096|FG000|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|4|||
147553140|NCT01688037|532180097|FG001|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|0|||
147553141|NCT01688037|532180098|FG002|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|1|||
147221203|NCT05318183|530982766|FG000|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
147221204|NCT05318183|530982767|FG001|Second Intervention (2 Weeks)|Withdrawal by Subject|1|||
147221205|NCT01046825|530982768|FG000|Overall Study|Failed to achieve CR to Induction Therapy|0|||
147221206|NCT01046825|530982769|FG001|Overall Study|Failed to achieve CR to Induction Therapy|1|||
147221207|NCT01046825|530982770|FG002|Overall Study|Failed to achieve CR to Induction Therapy|0|||
147221208|NCT01046825|530982771|FG003|Overall Study|Failed to achieve CR to Induction Therapy|0|||
147221209|NCT01046825|530982772|FG004|Overall Study|Failed to achieve CR to Induction Therapy|0|||
147221210|NCT01046825|530982768|FG000|Overall Study|Physician Decision|0|||
147221211|NCT01046825|530982769|FG001|Overall Study|Physician Decision|1|||
147221212|NCT01046825|530982770|FG002|Overall Study|Physician Decision|2|||
147221213|NCT01046825|530982771|FG003|Overall Study|Physician Decision|0|||
147221214|NCT01046825|530982772|FG004|Overall Study|Physician Decision|0|||
147221215|NCT01046825|530982768|FG000|Overall Study|Participant or family decision to withdraw from protocol treatment|0|||
147221216|NCT01046825|530982769|FG001|Overall Study|Participant or family decision to withdraw from protocol treatment|0|||
147553142|NCT01688037|532180096|FG000|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|1|||
147553143|NCT01688037|532180097|FG001|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|0|||
147553144|NCT01688037|532180098|FG002|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|1|||
147553145|NCT01688037|532180096|FG000|Double-Blind Period (Week 0 to 6)|Physician Decision|0|||
147553146|NCT01688037|532180097|FG001|Double-Blind Period (Week 0 to 6)|Physician Decision|1|||
147553147|NCT01688037|532180098|FG002|Double-Blind Period (Week 0 to 6)|Physician Decision|0|||
147553148|NCT01688037|532180096|FG000|Open-Label Period (Week 6 to 12)|Adverse Event|4|||
147553149|NCT01688037|532180097|FG001|Open-Label Period (Week 6 to 12)|Adverse Event|1|||
147553150|NCT01688037|532180098|FG002|Open-Label Period (Week 6 to 12)|Adverse Event|1|||
147553151|NCT01688037|532180096|FG000|Open-Label Period (Week 6 to 12)|Non-compliance|0|||
147553152|NCT01688037|532180097|FG001|Open-Label Period (Week 6 to 12)|Non-compliance|0|||
147553153|NCT01688037|532180098|FG002|Open-Label Period (Week 6 to 12)|Non-compliance|2|||
147553154|NCT01688037|532180096|FG000|Open-Label Period (Week 6 to 12)|Withdrawal by Subject|1|||
147553155|NCT01688037|532180097|FG001|Open-Label Period (Week 6 to 12)|Withdrawal by Subject|2|||
147553156|NCT01688037|532180098|FG002|Open-Label Period (Week 6 to 12)|Withdrawal by Subject|0|||
147553157|NCT01688037|532180096|FG000|Open-Label Period (Week 6 to 12)|Lost to Follow-up|0|||
147553158|NCT01688037|532180097|FG001|Open-Label Period (Week 6 to 12)|Lost to Follow-up|0|||
147553159|NCT01688037|532180098|FG002|Open-Label Period (Week 6 to 12)|Lost to Follow-up|1|||
147553160|NCT01688037|532180096|FG000|Follow-up Period (Week 12 to 16)|Withdrawal by Subject|0|||
147553161|NCT01688037|532180097|FG001|Follow-up Period (Week 12 to 16)|Withdrawal by Subject|1|||
147553162|NCT01688037|532180098|FG002|Follow-up Period (Week 12 to 16)|Withdrawal by Subject|0|||
147553163|NCT03035227|532180099|FG000|Overall Study|study stopped due to PI leaving institut|1|||
147553164|NCT03035227|532180100|FG001|Overall Study|study stopped due to PI leaving institut|1|||
147553165|NCT02100956|532180101|FG000|At Least One Week Between Injections|Adverse Event|0|||
147553166|NCT02100956|532180102|FG001|At Least One Week Between Injections|Adverse Event|1|||
147553167|NCT02220907|532180103|FG000|Overall Study|Adverse Event|7|||
147553168|NCT02220907|532180103|FG000|Overall Study|Physician Decision|1|||
147553169|NCT02220907|532180103|FG000|Overall Study|Withdrawal by Subject|2|||
147553170|NCT02220907|532180103|FG000|Overall Study|Conflict with the stopping criteria|1|||
147553171|NCT03280537|532180108|FG000|Overall Study|Withdrawal by Subject|2|||
147553172|NCT03280537|532180109|FG001|Overall Study|Withdrawal by Subject|4|||
147553173|NCT02995837|532180110|FG000|Overall Study|Lost to Follow-up|9|||
147553174|NCT02995837|532180111|FG001|Overall Study|Lost to Follow-up|8|||
147553175|NCT01859702|532180112|FG000|Overall Study|Protocol deviation|3|||
147553176|NCT01859702|532180112|FG000|Overall Study|Adverse Event|2|||
147553177|NCT00458302|532181503|FG000|Overall Study|Adverse Event|4|||
147553178|NCT00458302|532181504|FG001|Overall Study|Adverse Event|14|||
147553179|NCT00458302|532181503|FG000|Overall Study|Pregnancy|2|||
147553180|NCT00458302|532181504|FG001|Overall Study|Pregnancy|1|||
147553181|NCT00458302|532181503|FG000|Overall Study|Protocol Violation|0|||
147553182|NCT00458302|532181504|FG001|Overall Study|Protocol Violation|2|||
147553183|NCT00458302|532181503|FG000|Overall Study|Withdrawal by Subject|6|||
147553184|NCT00458302|532181504|FG001|Overall Study|Withdrawal by Subject|4|||
147553185|NCT00458302|532181503|FG000|Overall Study|Inc/Exc Criteria Not Met|1|||
147553186|NCT00458302|532181504|FG001|Overall Study|Inc/Exc Criteria Not Met|1|||
147553187|NCT00458302|532181503|FG000|Overall Study|Study Termination By Sponsor|1|||
147650775|NCT01298141|532543027|FG000|Overall Study|Termination of Study by the Investigator|5|||
147309580|NCT00152971|531300117|FG000|Overall Study|Protocol Violation|10|||
147650776|NCT01298141|532543027|FG000|Overall Study|Other|5|||
147650777|NCT01298141|532543027|FG000|Overall Study|Lost to Follow-up|1|||
147650778|NCT01298141|532543027|FG000|Overall Study|Death|6|||
147650779|NCT01298141|532543027|FG000|Overall Study|Not treated|4|||
147650780|NCT01421147|532544531|FG000|Treatment Period|Adverse Event|2|||
147650781|NCT01421147|532544532|FG001|Treatment Period|Adverse Event|3|||
147650782|NCT01421147|532544531|FG000|Treatment Period|Lost to Follow-up|2|||
147650783|NCT01421147|532544532|FG001|Treatment Period|Lost to Follow-up|1|||
147650784|NCT01421147|532544531|FG000|Treatment Period|Physician Decision|2|||
147650785|NCT01421147|532544532|FG001|Treatment Period|Physician Decision|2|||
147650786|NCT01421147|532544531|FG000|Treatment Period|Withdrawal by Subject|10|||
147221217|NCT01046825|530982770|FG002|Overall Study|Participant or family decision to withdraw from protocol treatment|1|||
147221218|NCT01046825|530982771|FG003|Overall Study|Participant or family decision to withdraw from protocol treatment|0|||
147221219|NCT01046825|530982772|FG004|Overall Study|Participant or family decision to withdraw from protocol treatment|0|||
147221220|NCT01046825|530982768|FG000|Overall Study|Found to be ineligible|0|||
147221221|NCT01046825|530982769|FG001|Overall Study|Found to be ineligible|1|||
147221222|NCT01046825|530982770|FG002|Overall Study|Found to be ineligible|0|||
147221223|NCT01046825|530982771|FG003|Overall Study|Found to be ineligible|0|||
147221224|NCT01046825|530982772|FG004|Overall Study|Found to be ineligible|0|||
147221225|NCT01046825|530982768|FG000|Overall Study|Death|0|||
147221226|NCT01046825|530982769|FG001|Overall Study|Death|0|||
147221227|NCT01046825|530982770|FG002|Overall Study|Death|0|||
147221228|NCT01046825|530982771|FG003|Overall Study|Death|1|||
147221229|NCT01046825|530982772|FG004|Overall Study|Death|0|||
147221230|NCT01046825|530982768|FG000|Overall Study|Did not submit biology samples|0|||
147221231|NCT01046825|530982769|FG001|Overall Study|Did not submit biology samples|0|||
147221232|NCT01046825|530982770|FG002|Overall Study|Did not submit biology samples|0|||
147221233|NCT01046825|530982771|FG003|Overall Study|Did not submit biology samples|0|||
147221234|NCT01046825|530982772|FG004|Overall Study|Did not submit biology samples|13|||
147221235|NCT06400251|530982774|FG000|Overall Study|Never Start Protocol Therapy|1|||
147221236|NCT06400251|530982774|FG000|Overall Study|Ineligible|2|||
147221237|NCT06400251|530982774|FG000|Overall Study|Mutation Status Not Confirmed|3|||
147221238|NCT06400251|530982774|FG000|Overall Study|Disease Progression|25|||
147221239|NCT06400251|530982774|FG000|Overall Study|Adverse Event|1|||
147221240|NCT06400251|530982774|FG000|Overall Study|Complicating Disease|1|||
147221241|NCT06400251|530982774|FG000|Overall Study|Physician Decision|2|||
147221242|NCT01150474|530982775|FG000|Overall Study|Withdrawal by Subject|5|||
147221243|NCT01150474|530982776|FG001|Overall Study|Withdrawal by Subject|2|||
147221244|NCT01150474|530982775|FG000|Overall Study|Cancer found|1|||
147221245|NCT01150474|530982776|FG001|Overall Study|Cancer found|0|||
147221246|NCT01150474|530982775|FG000|Overall Study|Multiple Studies|0|||
147221247|NCT01150474|530982776|FG001|Overall Study|Multiple Studies|1|||
147221248|NCT01150474|530982775|FG000|Overall Study|Rectotomy|1|||
147221249|NCT01150474|530982776|FG001|Overall Study|Rectotomy|0|||
147221250|NCT01150474|530982775|FG000|Overall Study|Drug did not arrive in time|1|||
147221251|NCT01150474|530982776|FG001|Overall Study|Drug did not arrive in time|0|||
147221252|NCT01150474|530982775|FG000|Overall Study|Drug not administered|1|||
147221253|NCT01150474|530982776|FG001|Overall Study|Drug not administered|0|||
147221254|NCT01150474|530982775|FG000|Overall Study|Surgery Changed|1|||
147221255|NCT01150474|530982776|FG001|Overall Study|Surgery Changed|0|||
147221256|NCT00219544|530982777|FG000|Single Blind Treatment Period|Lack of Efficacy|5|||
147221257|NCT00219544|530982778|FG001|Single Blind Treatment Period|Lack of Efficacy|0|||
147221258|NCT00219544|530982777|FG000|Single Blind Treatment Period|Adverse Event|9|||
147221259|NCT00219544|530982778|FG001|Single Blind Treatment Period|Adverse Event|0|||
147221260|NCT00219544|530982777|FG000|Single Blind Treatment Period|Protocol Violation|4|||
147221261|NCT00219544|530982778|FG001|Single Blind Treatment Period|Protocol Violation|0|||
147221262|NCT00219544|530982777|FG000|Single Blind Treatment Period|Lost to Follow-up|2|||
147221263|NCT00219544|530982778|FG001|Single Blind Treatment Period|Lost to Follow-up|0|||
147221264|NCT00219544|530982777|FG000|Single Blind Treatment Period|Investigator decision to withdraw|1|||
147221265|NCT00219544|530982778|FG001|Single Blind Treatment Period|Investigator decision to withdraw|0|||
147221266|NCT00219544|530982777|FG000|Single Blind Treatment Period|Withdrawal by Subject|1|||
147221267|NCT00219544|530982778|FG001|Single Blind Treatment Period|Withdrawal by Subject|0|||
147221268|NCT01163032|530982779|FG000|Randomization Phase|Withdrawal by Subject|2|||
147221269|NCT01163032|530982780|FG001|Randomization Phase|Withdrawal by Subject|3|||
147221270|NCT01163032|530982781|FG002|Randomization Phase|Withdrawal by Subject|0|||
147221271|NCT01163032|530982779|FG000|Randomization Phase|Adverse Event|3|||
147221272|NCT01163032|530982780|FG001|Randomization Phase|Adverse Event|3|||
147221273|NCT01163032|530982781|FG002|Randomization Phase|Adverse Event|0|||
147221274|NCT01163032|530982779|FG000|Randomization Phase|Protocol Violation|0|||
147221275|NCT01163032|530982780|FG001|Randomization Phase|Protocol Violation|1|||
147221276|NCT01163032|530982781|FG002|Randomization Phase|Protocol Violation|0|||
147221277|NCT01163032|530982779|FG000|Randomization Phase|Various*|5|||
147221278|NCT01163032|530982780|FG001|Randomization Phase|Various*|4|||
147221279|NCT01163032|530982781|FG002|Randomization Phase|Various*|0|||
147650787|NCT01421147|532544532|FG001|Treatment Period|Withdrawal by Subject|5|||
147221280|NCT01163032|530982779|FG000|Randomization Phase|Unsatisfactory Therapeutic Effect|0|||
147221281|NCT01163032|530982780|FG001|Randomization Phase|Unsatisfactory Therapeutic Effect|1|||
147221282|NCT01163032|530982781|FG002|Randomization Phase|Unsatisfactory Therapeutic Effect|0|||
147650788|NCT01421147|532544531|FG000|Extension Period|Adverse Event|0|||
147650789|NCT01421147|532544532|FG001|Extension Period|Adverse Event|2|||
147650790|NCT01421147|532544531|FG000|Extension Period|Death|0|||
147650791|NCT01421147|532544532|FG001|Extension Period|Death|1|||
147650792|NCT01421147|532544531|FG000|Extension Period|Lost to Follow-up|2|||
147650793|NCT01421147|532544532|FG001|Extension Period|Lost to Follow-up|5|||
147650794|NCT01421147|532544531|FG000|Extension Period|Physician Decision|1|||
147650795|NCT01421147|532544532|FG001|Extension Period|Physician Decision|0|||
147650796|NCT01421147|532544531|FG000|Extension Period|Withdrawal by Subject|5|||
147650797|NCT01421147|532544532|FG001|Extension Period|Withdrawal by Subject|3|||
147221283|NCT01163032|530982779|FG000|Open Label Extension Phase|Adverse Event|0|||
147221284|NCT01163032|530982780|FG001|Open Label Extension Phase|Adverse Event|0|||
147221285|NCT01163032|530982781|FG002|Open Label Extension Phase|Adverse Event|3|||
147221286|NCT01163032|530982779|FG000|Open Label Extension Phase|Withdrawal by Subject|0|||
147221287|NCT01163032|530982780|FG001|Open Label Extension Phase|Withdrawal by Subject|0|||
147221288|NCT01163032|530982781|FG002|Open Label Extension Phase|Withdrawal by Subject|3|||
147221289|NCT01163032|530982779|FG000|Open Label Extension Phase|Protocol Violation|0|||
147221290|NCT01163032|530982780|FG001|Open Label Extension Phase|Protocol Violation|0|||
147221291|NCT01163032|530982781|FG002|Open Label Extension Phase|Protocol Violation|1|||
147221292|NCT01163032|530982779|FG000|Open Label Extension Phase|Study Termination|0|||
147221293|NCT01163032|530982780|FG001|Open Label Extension Phase|Study Termination|0|||
147221294|NCT01163032|530982781|FG002|Open Label Extension Phase|Study Termination|7|||
147221295|NCT01163032|530982779|FG000|Open Label Extension Phase|Unsatisfactory Therapeutic Effect|0|||
147221296|NCT01163032|530982780|FG001|Open Label Extension Phase|Unsatisfactory Therapeutic Effect|0|||
147221297|NCT01163032|530982781|FG002|Open Label Extension Phase|Unsatisfactory Therapeutic Effect|2|||
147553188|NCT00458302|532181504|FG001|Overall Study|Study Termination By Sponsor|0|||
147553189|NCT00458302|532181503|FG000|Overall Study|Lost to Follow-up|2|||
147553190|NCT00458302|532181504|FG001|Overall Study|Lost to Follow-up|0|||
147553191|NCT00458302|532181503|FG000|Overall Study|Other|4|||
147553192|NCT00458302|532181504|FG001|Overall Study|Other|2|||
147553193|NCT02224456|532181505|FG000|Overall Study|Lack of Efficacy|1|||
147553194|NCT02224456|532181505|FG000|Overall Study|Lost to Follow-up|15|||
147553195|NCT02224456|532181505|FG000|Overall Study|Withdrawal by Subject|9|||
147553196|NCT02224456|532181505|FG000|Overall Study|Physician Decision|3|||
147553197|NCT02224456|532181505|FG000|Overall Study|Death|2|||
147553198|NCT02224456|532181505|FG000|Overall Study|Pregnancy|4|||
147553199|NCT02224456|532181505|FG000|Overall Study|Protocol Violation|1|||
147553200|NCT02224456|532181505|FG000|Overall Study|Treatment Interruptions of ≥28 days|1|||
147553201|NCT01241461|532181506|FG000|Overall Study|Progressive Disease|3|||
147553202|NCT01241461|532181507|FG001|Overall Study|Progressive Disease|6|||
147553203|NCT01379781|532181511|FG000|Overall Study|Lost to Follow-up|11|||
147553204|NCT01379781|532181512|FG001|Overall Study|Lost to Follow-up|8|||
147553205|NCT03273387|532181516|FG000|Overall Study|Death|2|||
147553206|NCT03273387|532181517|FG001|Overall Study|Death|2|||
147553207|NCT03273387|532181516|FG000|Overall Study|Withdrawal by Subject|1|||
147553208|NCT03273387|532181517|FG001|Overall Study|Withdrawal by Subject|1|||
147553209|NCT01162499|532181526|FG000|Intervention 1 (4 Hours)|Unable to establish IV access|0|||
147553210|NCT01162499|532181527|FG001|Intervention 1 (4 Hours)|Unable to establish IV access|1|||
147553211|NCT00832078|532181528|FG000|Test Day 1-2 Period|Lack of Efficacy|0|||
147221298|NCT01037088|530982784|FG000|Overall Study|Withdrawal by Subject|3|||
147221299|NCT01958827|530982785|FG000|Overall Study|Adverse Event|3|||
147221300|NCT01958827|530982785|FG000|Overall Study|Lack of Efficacy|6|||
147221301|NCT01958827|530982785|FG000|Overall Study|Concomitant Prohibited Medicine for AE|1|||
147553212|NCT00832078|532181529|FG001|Test Day 1-2 Period|Lack of Efficacy|2|||
147553213|NCT00832078|532181528|FG000|Test Day 2 - 2 Period|Lack of Efficacy|1|||
147553214|NCT00832078|532181529|FG001|Test Day 2 - 2 Period|Lack of Efficacy|0|||
147553215|NCT03551730|532181530|FG000|Overall Study|Adverse Event|1|||
147650798|NCT00171158|532544535|FG000|Core Study|Death|27|||
147221302|NCT03036800|530982786|FG000|Overall Study|Protocol Violation|1|||
147221303|NCT03036800|530982787|FG001|Overall Study|Protocol Violation|0|||
147553216|NCT03551730|532181531|FG001|Overall Study|Adverse Event|0|||
147650799|NCT00171158|532544535|FG000|Core Study|Unsatisfactory therapeutic effect|163|||
147650800|NCT00171158|532544535|FG000|Core Study|Protocol Violation|4|||
147650801|NCT00171158|532544535|FG000|Core Study|Administrative problems|1|||
147650802|NCT00171158|532544535|FG000|Core Study|Adverse event, non-fatal|21|||
147650803|NCT00171158|532544535|FG000|Core Study|Consent withdrawn by subject|6|||
147650804|NCT00171158|532544535|FG000|Core Study|No longer required drug (BMT)|14|||
147553217|NCT03551730|532181532|FG002|Overall Study|Adverse Event|0|||
147553218|NCT03551730|532181533|FG003|Overall Study|Adverse Event|0|||
147650805|NCT00171158|532544535|FG000|Core Study|Abnormal Laboratory Values|2|||
147650806|NCT00171158|532544535|FG000|Core Study|Lost to Follow-up|1|||
147650807|NCT00171158|532544535|FG000|E2 Extension|Other|7|||
147650808|NCT02757352|532544537|FG000|Double-Blind Period (Week 0 - Week 16)|Adverse Event|2|||
147650809|NCT02757352|532544538|FG001|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
147650810|NCT02757352|532544539|FG002|Double-Blind Period (Week 0 - Week 16)|Adverse Event|1|||
147650811|NCT02757352|532544540|FG003|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
147650812|NCT02757352|532544541|FG004|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
147650813|NCT02757352|532544542|FG005|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
147650814|NCT02757352|532544543|FG006|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
147650815|NCT02757352|532544544|FG007|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
147650816|NCT02757352|532544545|FG008|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
147650817|NCT02757352|532544546|FG009|Double-Blind Period (Week 0 - Week 16)|Adverse Event|0|||
147650818|NCT02757352|532544537|FG000|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
147650819|NCT02757352|532544538|FG001|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
147650820|NCT02757352|532544539|FG002|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|1|||
147650821|NCT02757352|532544540|FG003|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
147650822|NCT02757352|532544541|FG004|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
147650823|NCT02757352|532544542|FG005|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
147650824|NCT02757352|532544543|FG006|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
147650825|NCT02757352|532544544|FG007|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
147650826|NCT02757352|532544545|FG008|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
147650827|NCT02757352|532544546|FG009|Double-Blind Period (Week 0 - Week 16)|Lost to Follow-up|0|||
147650828|NCT02757352|532544537|FG000|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|6|||
147650829|NCT02757352|532544538|FG001|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|1|||
147650830|NCT02757352|532544539|FG002|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|2|||
147650831|NCT02757352|532544540|FG003|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
147650832|NCT02757352|532544541|FG004|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
147650833|NCT02757352|532544542|FG005|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
147650834|NCT02757352|532544543|FG006|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
147650835|NCT02757352|532544544|FG007|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
147650836|NCT02757352|532544545|FG008|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
147650837|NCT02757352|532544546|FG009|Double-Blind Period (Week 0 - Week 16)|Withdrawal by Subject|0|||
147650838|NCT02757352|532544537|FG000|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
147650839|NCT02757352|532544538|FG001|Double-Blind Period (Week 16 - Week 52)|Adverse Event|1|||
147650840|NCT02757352|532544539|FG002|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
147650841|NCT02757352|532544540|FG003|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
147650842|NCT02757352|532544541|FG004|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
147650843|NCT02757352|532544542|FG005|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
147650844|NCT02757352|532544543|FG006|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
147650845|NCT02757352|532544544|FG007|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
147650846|NCT02757352|532544545|FG008|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
147650847|NCT02757352|532544546|FG009|Double-Blind Period (Week 16 - Week 52)|Adverse Event|0|||
147650848|NCT02757352|532544537|FG000|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
147650849|NCT02757352|532544538|FG001|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|1|||
147650850|NCT02757352|532544539|FG002|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
147650851|NCT02757352|532544540|FG003|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
147650852|NCT02757352|532544541|FG004|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
147650853|NCT02757352|532544542|FG005|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
147650854|NCT02757352|532544543|FG006|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
147650855|NCT02757352|532544544|FG007|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
147650856|NCT02757352|532544545|FG008|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
147650857|NCT02757352|532544546|FG009|Double-Blind Period (Week 16 - Week 52)|Lack of Efficacy|0|||
147650858|NCT02757352|532544537|FG000|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|1|||
147650859|NCT02757352|532544538|FG001|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|1|||
147650860|NCT02757352|532544539|FG002|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|4|||
147650861|NCT02757352|532544540|FG003|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
147650862|NCT02757352|532544541|FG004|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
147650863|NCT02757352|532544542|FG005|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
147650864|NCT02757352|532544543|FG006|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
147650865|NCT02757352|532544544|FG007|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
147650866|NCT02757352|532544545|FG008|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
147309581|NCT00152971|531300118|FG001|Overall Study|Protocol Violation|11|||
147443400|NCT01469182|531788661|FG001|Overall Study|Withdrawal by Subject|1|||
147443401|NCT01469182|531788660|FG000|Overall Study|Protocol Violation|4|||
147650867|NCT02757352|532544546|FG009|Double-Blind Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
147650868|NCT02757352|532544537|FG000|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|62|||
147650869|NCT02757352|532544538|FG001|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|40|||
147221304|NCT03036800|530982786|FG000|Overall Study|Non-compliance|1|||
147221305|NCT03036800|530982787|FG001|Overall Study|Non-compliance|0|||
147221306|NCT03036800|530982786|FG000|Overall Study|Lost to Follow-up|1|||
147221307|NCT03036800|530982787|FG001|Overall Study|Lost to Follow-up|0|||
147221308|NCT03036800|530982786|FG000|Overall Study|Death|1|||
147221309|NCT03036800|530982787|FG001|Overall Study|Death|0|||
147221310|NCT03036800|530982786|FG000|Overall Study|Tolerance|5|||
147221311|NCT03036800|530982787|FG001|Overall Study|Tolerance|0|||
147221312|NCT03036800|530982786|FG000|Overall Study|Unknown/no reason given|50|||
147221313|NCT03036800|530982787|FG001|Overall Study|Unknown/no reason given|39|||
147221314|NCT01077154|530982792|FG000|Overall Study|Protocol-specified Criteria: Study Ended|1524|||
147221315|NCT01077154|530982793|FG001|Overall Study|Protocol-specified Criteria: Study Ended|1514|||
147221316|NCT01077154|530982792|FG000|Overall Study|Withdrawal by Subject|369|||
147221317|NCT01077154|530982793|FG001|Overall Study|Withdrawal by Subject|385|||
147221318|NCT01077154|530982792|FG000|Overall Study|Death|215|||
147221319|NCT01077154|530982793|FG001|Overall Study|Death|214|||
147221320|NCT01077154|530982792|FG000|Overall Study|Lost to Follow-up|43|||
147221321|NCT01077154|530982793|FG001|Overall Study|Lost to Follow-up|35|||
147221322|NCT01077154|530982792|FG000|Overall Study|Noncompliance|22|||
147221323|NCT01077154|530982793|FG001|Overall Study|Noncompliance|20|||
147221324|NCT01077154|530982792|FG000|Overall Study|Disease Progression|18|||
147221325|NCT01077154|530982793|FG001|Overall Study|Disease Progression|20|||
147221326|NCT01077154|530982792|FG000|Overall Study|Ineligibility Determined|10|||
147221327|NCT01077154|530982793|FG001|Overall Study|Ineligibility Determined|14|||
147221328|NCT01077154|530982792|FG000|Overall Study|Other|14|||
147221329|NCT01077154|530982793|FG001|Overall Study|Other|11|||
147221330|NCT01077154|530982792|FG000|Overall Study|Adverse Event|9|||
147221331|NCT01077154|530982793|FG001|Overall Study|Adverse Event|9|||
147221332|NCT01077154|530982792|FG000|Overall Study|Administrative Decision|1|||
147221333|NCT01077154|530982793|FG001|Overall Study|Administrative Decision|6|||
147221334|NCT01077154|530982792|FG000|Overall Study|Protocol Deviation|1|||
147221335|NCT01077154|530982793|FG001|Overall Study|Protocol Deviation|0|||
147221336|NCT02207946|530982794|FG000|Overall Study|Lost to Follow-up|1|||
147221337|NCT02207946|530982795|FG001|Overall Study|Lost to Follow-up|0|||
147221338|NCT02207946|530982794|FG000|Overall Study|Adverse Event|0|||
147221339|NCT02207946|530982795|FG001|Overall Study|Adverse Event|1|||
147221340|NCT03764033|530982799|FG000|Treatment Phase|Withdrawal by Subject|8|||
147553219|NCT01628120|532181537|FG000|Overall Study|Withdrawal by Subject|7|||
147553220|NCT01628120|532181537|FG000|Overall Study|Adverse Event|12|||
147553221|NCT01628120|532181537|FG000|Overall Study|Lost to Follow-up|1|||
147553222|NCT01628120|532181537|FG000|Overall Study|Not met Inclusion/Exclusion Criteria|2|||
147553223|NCT01628120|532181537|FG000|Overall Study|Non-compliant with Study Procedures|1|||
147553224|NCT01628120|532181537|FG000|Overall Study|Not Treated|3|||
147553225|NCT01628120|532181537|FG000|Overall Study|Sponsor Decision|5|||
147553226|NCT01628120|532181537|FG000|Overall Study|Switched Dialysis Method|2|||
147553227|NCT01628120|532181537|FG000|Overall Study|Missed Study Drug More than 2 Weeks|3|||
147553228|NCT01628120|532181537|FG000|Overall Study|Moved or Relocated|5|||
147553229|NCT01628120|532181537|FG000|Overall Study|Kidney Transplant|2|||
147553230|NCT01628120|532181537|FG000|Overall Study|Use of Standard of Care|1|||
147553231|NCT01165996|532181538|FG000|Overall Study|Death|1|||
147553232|NCT01165996|532181538|FG000|Overall Study|Physician Decision|1|||
147553233|NCT00096265|532181539|FG000|Overall Study|Ineligible|1|||
147553234|NCT00096265|532181540|FG001|Overall Study|Ineligible|0|||
147553235|NCT00096265|532181541|FG002|Overall Study|Ineligible|0|||
147553236|NCT00704418|532181544|FG000|Overall Study|Withdrawal by Subject|2|||
147553237|NCT00704418|532181545|FG001|Overall Study|Withdrawal by Subject|0|||
147553238|NCT00704418|532181544|FG000|Overall Study|Over-enrolled/surgery postponed|3|||
147553239|NCT00704418|532181545|FG001|Overall Study|Over-enrolled/surgery postponed|6|||
147553240|NCT01579474|532181546|FG000|Overall Study|Adverse Event|1|||
147553241|NCT01579474|532181547|FG001|Overall Study|Adverse Event|13|||
147553242|NCT01579474|532181548|FG002|Overall Study|Adverse Event|2|||
147553243|NCT01579474|532181549|FG003|Overall Study|Adverse Event|0|||
147553244|NCT01579474|532181550|FG004|Overall Study|Adverse Event|0|||
147553245|NCT01579474|532181551|FG005|Overall Study|Adverse Event|1|||
147553246|NCT01579474|532181546|FG000|Overall Study|Lack of Efficacy|1|||
147553247|NCT01579474|532181547|FG001|Overall Study|Lack of Efficacy|0|||
147553248|NCT01579474|532181548|FG002|Overall Study|Lack of Efficacy|0|||
147553249|NCT01579474|532181549|FG003|Overall Study|Lack of Efficacy|0|||
147553250|NCT01579474|532181550|FG004|Overall Study|Lack of Efficacy|1|||
147553251|NCT01579474|532181551|FG005|Overall Study|Lack of Efficacy|0|||
147553252|NCT01579474|532181546|FG000|Overall Study|Withdrawal by Subject|1|||
147553253|NCT01579474|532181547|FG001|Overall Study|Withdrawal by Subject|0|||
147553254|NCT01579474|532181548|FG002|Overall Study|Withdrawal by Subject|0|||
147221341|NCT03764033|530982800|FG001|Treatment Phase|Withdrawal by Subject|3|||
147221342|NCT03764033|530982799|FG000|Treatment Phase|Withdrawn by PI due to frequent no-shows and cancellations of study appointments.|0|||
147221343|NCT03764033|530982800|FG001|Treatment Phase|Withdrawn by PI due to frequent no-shows and cancellations of study appointments.|1|||
147553255|NCT01579474|532181549|FG003|Overall Study|Withdrawal by Subject|0|||
147553256|NCT01579474|532181550|FG004|Overall Study|Withdrawal by Subject|0|||
147221344|NCT03764033|530982799|FG000|Six Month Follow-Up|Lost to Follow-up|0|||
147221345|NCT03764033|530982800|FG001|Six Month Follow-Up|Lost to Follow-up|5|||
147221346|NCT01006603|530982803|FG000|Overall Study|Withdrawal by Subject|17|||
147221347|NCT01006603|530982804|FG001|Overall Study|Withdrawal by Subject|19|||
147221348|NCT01006603|530982803|FG000|Overall Study|Lost to Follow-up|0|||
147221349|NCT01006603|530982804|FG001|Overall Study|Lost to Follow-up|1|||
147221350|NCT01006603|530982803|FG000|Overall Study|Safety reason|1|||
147221351|NCT01006603|530982804|FG001|Overall Study|Safety reason|1|||
147221352|NCT01006603|530982803|FG000|Overall Study|Protocol Violation|1|||
147221353|NCT01006603|530982804|FG001|Overall Study|Protocol Violation|3|||
147221354|NCT01006603|530982803|FG000|Overall Study|Incorrect enrolment|0|||
147221355|NCT01006603|530982804|FG001|Overall Study|Incorrect enrolment|2|||
147221356|NCT01006603|530982803|FG000|Overall Study|Adverse Event|15|||
147221357|NCT01006603|530982804|FG001|Overall Study|Adverse Event|7|||
147221358|NCT01006603|530982803|FG000|Overall Study|Death|1|||
147221359|NCT01006603|530982804|FG001|Overall Study|Death|1|||
147221360|NCT01006603|530982803|FG000|Overall Study|Study specific discontinuation criteria|33|||
147221361|NCT01006603|530982804|FG001|Overall Study|Study specific discontinuation criteria|34|||
147221362|NCT01006603|530982803|FG000|Overall Study|Other|3|||
147221363|NCT01006603|530982804|FG001|Overall Study|Other|7|||
147221364|NCT01892722|530982806|FG000|Overall Study|Protocol deviation|0|||
147221365|NCT01892722|530982807|FG001|Overall Study|Protocol deviation|1|||
147221366|NCT01892722|530982806|FG000|Overall Study|Administrative problems|0|||
147221367|NCT01892722|530982807|FG001|Overall Study|Administrative problems|1|||
147221368|NCT01892722|530982806|FG000|Overall Study|Patient/guardian decision|0|||
147221369|NCT01892722|530982807|FG001|Overall Study|Patient/guardian decision|2|||
147221370|NCT01892722|530982806|FG000|Overall Study|Physician Decision|1|||
147221371|NCT01892722|530982807|FG001|Overall Study|Physician Decision|2|||
147221372|NCT01892722|530982806|FG000|Overall Study|Adverse Event|3|||
147221373|NCT01892722|530982807|FG001|Overall Study|Adverse Event|2|||
147221374|NCT01892722|530982806|FG000|Overall Study|Lack of Efficacy|0|||
147221375|NCT01892722|530982807|FG001|Overall Study|Lack of Efficacy|7|||
147221376|NCT01892722|530982806|FG000|Overall Study|Withdrawal by Subject|3|||
147221377|NCT01892722|530982807|FG001|Overall Study|Withdrawal by Subject|5|||
147221378|NCT05568888|530982808|FG000|Overall Study|Physician Decision|1|||
147221379|NCT05568888|530982809|FG001|Overall Study|Physician Decision|0|||
147221380|NCT05568888|530982808|FG000|Overall Study|Protocol Deviation|2|||
147221381|NCT05568888|530982809|FG001|Overall Study|Protocol Deviation|1|||
147221382|NCT05568888|530982808|FG000|Overall Study|Withdrawal by Subject/Legally Authorized Representative|47|||
147221383|NCT05568888|530982809|FG001|Overall Study|Withdrawal by Subject/Legally Authorized Representative|53|||
147221384|NCT05568888|530982808|FG000|Overall Study|Withdrawal by Parent/Guardian|10|||
147221385|NCT05568888|530982809|FG001|Overall Study|Withdrawal by Parent/Guardian|14|||
147221386|NCT05568888|530982808|FG000|Overall Study|No IP Administered/Subject Excluded|1|||
147221387|NCT05568888|530982809|FG001|Overall Study|No IP Administered/Subject Excluded|4|||
147221388|NCT02003365|530983307|FG000|Overall Study|Lost to Follow-up|0|||
147221389|NCT02003365|530983308|FG001|Overall Study|Lost to Follow-up|0|||
147221390|NCT02003365|530983309|FG002|Overall Study|Lost to Follow-up|1|||
147221391|NCT00625742|530983310|FG000|Overall Study|Disease Progression|2|||
147221392|NCT00625742|530983310|FG000|Overall Study|Withdrawal by Subject|1|||
147221393|NCT00625742|530983310|FG000|Overall Study|Adverse Event|4|||
147221394|NCT00625742|530983310|FG000|Overall Study|Lost to Follow-up|4|||
147221395|NCT00625742|530983310|FG000|Overall Study|Ineligible|1|||
147221396|NCT02316548|530983311|FG000|Overall Study|Protocol Violation|0|||
147221397|NCT02316548|530983312|FG001|Overall Study|Protocol Violation|1|||
147221398|NCT00371761|530983313|FG000|Overall Study|Adverse Event|1|||
147221399|NCT00371761|530983314|FG001|Overall Study|Adverse Event|1|||
147221400|NCT00371761|530983313|FG000|Overall Study|Withdrawal by Subject|1|||
147221401|NCT00371761|530983314|FG001|Overall Study|Withdrawal by Subject|3|||
147221402|NCT00371761|530983313|FG000|Overall Study|Investigator Judgment|2|||
147221403|NCT00371761|530983314|FG001|Overall Study|Investigator Judgment|3|||
147221404|NCT00371761|530983313|FG000|Overall Study|Study termination|4|||
147221405|NCT00371761|530983314|FG001|Overall Study|Study termination|3|||
147221406|NCT05171816|530983318|FG000|Overall Study|Death|18|||
147221407|NCT05171816|530983319|FG001|Overall Study|Death|16|||
147221408|NCT02937571|530983320|FG000|Overall Study|Adverse Event|0|||
147221409|NCT02937571|530983321|FG001|Overall Study|Adverse Event|0|||
147309582|NCT00152971|531300119|FG002|Overall Study|Protocol Violation|8|||
147221410|NCT02937571|530983322|FG002|Overall Study|Adverse Event|4|||
147221411|NCT02937571|530983320|FG000|Overall Study|Withdrawal by Subject|0|||
147221412|NCT02937571|530983321|FG001|Overall Study|Withdrawal by Subject|0|||
147221413|NCT02937571|530983322|FG002|Overall Study|Withdrawal by Subject|3|||
147309583|NCT00152971|531300117|FG000|Overall Study|Lost to Follow-up|17|||
147221414|NCT03675321|530983323|FG000|Overall Study|Lack of Efficacy|2|||
147221415|NCT03675321|530983324|FG001|Overall Study|Lack of Efficacy|2|||
147309584|NCT00152971|531300118|FG001|Overall Study|Lost to Follow-up|14|||
147221416|NCT03675321|530983323|FG000|Overall Study|Withdrawal by Subject|1|||
147221417|NCT03675321|530983324|FG001|Overall Study|Withdrawal by Subject|3|||
147221418|NCT05040971|530983325|FG000|Overall Study|Withdrawal by Subject|0|||
147221419|NCT05040971|530983326|FG001|Overall Study|Withdrawal by Subject|2|||
147221420|NCT05040971|530983325|FG000|Overall Study|Lost to Follow-up|8|||
147221421|NCT05040971|530983326|FG001|Overall Study|Lost to Follow-up|3|||
147221422|NCT05040971|530983325|FG000|Overall Study|Death|2|||
147221423|NCT05040971|530983326|FG001|Overall Study|Death|0|||
147221424|NCT04391569|530983332|FG000|Overall Study|Death|15|||
147221425|NCT04391569|530983333|FG001|Overall Study|Death|10|||
147221426|NCT04391569|530983332|FG000|Overall Study|Withdrawal by Subject|1|||
147221427|NCT04391569|530983333|FG001|Overall Study|Withdrawal by Subject|0|||
147221428|NCT04391569|530983332|FG000|Overall Study|Lost to Follow-up|3|||
147221429|NCT04391569|530983333|FG001|Overall Study|Lost to Follow-up|2|||
147221430|NCT04391569|530983332|FG000|Overall Study|Lack of Efficacy|0|||
147221431|NCT04391569|530983333|FG001|Overall Study|Lack of Efficacy|1|||
147221432|NCT04391569|530983332|FG000|Overall Study|Participant discharged to hospice facility|0|||
147221433|NCT04391569|530983333|FG001|Overall Study|Participant discharged to hospice facility|1|||
147221434|NCT04391569|530983332|FG000|Overall Study|Participant family decision|1|||
147221435|NCT04391569|530983333|FG001|Overall Study|Participant family decision|0|||
147221436|NCT04391569|530983332|FG000|Overall Study|Participant discharged prematurely|1|||
147221437|NCT04391569|530983333|FG001|Overall Study|Participant discharged prematurely|0|||
147221438|NCT02751931|530983334|FG000|Overall Study|Adverse Event|3|||
147221439|NCT02751931|530983335|FG001|Overall Study|Adverse Event|0|||
147221440|NCT02751931|530983334|FG000|Overall Study|Other: Miscelleneous|10|||
147221441|NCT02751931|530983335|FG001|Overall Study|Other: Miscelleneous|8|||
147221442|NCT05856760|530983336|FG000|Overall Study|Adverse Event|2|||
147221443|NCT05856760|530983336|FG000|Overall Study|Physician Decision|1|||
147221444|NCT05856760|530983336|FG000|Overall Study|Protocol Violation|1|||
147221445|NCT05856760|530983336|FG000|Overall Study|Withdrawal by Subject|3|||
147221446|NCT02477696|530983340|FG000|Overall Study|Death|89|||
147221447|NCT02477696|530983341|FG001|Overall Study|Death|106|||
147221448|NCT02477696|530983340|FG000|Overall Study|Lost to Follow-up|7|||
147553257|NCT01579474|532181551|FG005|Overall Study|Withdrawal by Subject|0|||
147553258|NCT01075763|532181552|FG000|Overall Study|Lost to Follow-up|2|||
147553259|NCT01075763|532181553|FG001|Overall Study|Lost to Follow-up|1|||
147553260|NCT01075763|532181552|FG000|Overall Study|Lack of Efficacy|0|||
147221449|NCT02477696|530983341|FG001|Overall Study|Lost to Follow-up|5|||
147553261|NCT01075763|532181553|FG001|Overall Study|Lack of Efficacy|1|||
147221450|NCT02477696|530983340|FG000|Overall Study|Withdrawal by Subject|37|||
147221451|NCT02477696|530983341|FG001|Overall Study|Withdrawal by Subject|34|||
147221452|NCT02477696|530983340|FG000|Overall Study|Physician Decision|7|||
147221453|NCT02477696|530983341|FG001|Overall Study|Physician Decision|9|||
147221454|NCT02477696|530983340|FG000|Overall Study|Study terminated by sponsor|103|||
147221455|NCT02477696|530983341|FG001|Overall Study|Study terminated by sponsor|99|||
147221456|NCT02477696|530983340|FG000|Overall Study|Other reasons including transition to commercial drug|23|||
147221457|NCT02477696|530983341|FG001|Overall Study|Other reasons including transition to commercial drug|12|||
147221458|NCT02477696|530983340|FG000|Overall Study|Missing/Unknown|2|||
147221459|NCT02477696|530983341|FG001|Overall Study|Missing/Unknown|0|||
147221460|NCT04153149|530983344|FG000|Double Blind Period|Death|63|||
147553262|NCT01075763|532181552|FG000|Overall Study|Withdrawal by Subject|2|||
147553263|NCT01075763|532181553|FG001|Overall Study|Withdrawal by Subject|2|||
147221461|NCT04153149|530983345|FG001|Double Blind Period|Death|49|||
147221462|NCT04153149|530983346|FG002|Double Blind Period|Death|0|||
147221463|NCT04153149|530983347|FG003|Double Blind Period|Death|0|||
147221464|NCT04153149|530983344|FG000|Double Blind Period|Withdrawal by Subject|16|||
147221465|NCT04153149|530983345|FG001|Double Blind Period|Withdrawal by Subject|11|||
147221466|NCT04153149|530983346|FG002|Double Blind Period|Withdrawal by Subject|0|||
147221467|NCT04153149|530983347|FG003|Double Blind Period|Withdrawal by Subject|0|||
147221468|NCT04153149|530983344|FG000|Double Blind Period|Adverse Event|6|||
147221469|NCT04153149|530983345|FG001|Double Blind Period|Adverse Event|2|||
147221470|NCT04153149|530983346|FG002|Double Blind Period|Adverse Event|0|||
147221471|NCT04153149|530983347|FG003|Double Blind Period|Adverse Event|0|||
147221472|NCT04153149|530983344|FG000|Double Blind Period|Lost to Follow-up|2|||
147221473|NCT04153149|530983345|FG001|Double Blind Period|Lost to Follow-up|1|||
147221474|NCT04153149|530983346|FG002|Double Blind Period|Lost to Follow-up|0|||
147221475|NCT04153149|530983347|FG003|Double Blind Period|Lost to Follow-up|0|||
147221476|NCT04153149|530983344|FG000|Double Blind Period|Withdrawal by guardian|0|||
147221477|NCT04153149|530983345|FG001|Double Blind Period|Withdrawal by guardian|2|||
147221478|NCT04153149|530983346|FG002|Double Blind Period|Withdrawal by guardian|0|||
147221479|NCT04153149|530983347|FG003|Double Blind Period|Withdrawal by guardian|0|||
147221480|NCT04153149|530983344|FG000|Double Blind Period|Reason Not Specified|5|||
147221481|NCT04153149|530983345|FG001|Double Blind Period|Reason Not Specified|4|||
147221482|NCT04153149|530983346|FG002|Double Blind Period|Reason Not Specified|0|||
147221483|NCT04153149|530983347|FG003|Double Blind Period|Reason Not Specified|0|||
147221484|NCT04153149|530983344|FG000|Double Blind Period|Physician Decision|2|||
147221485|NCT04153149|530983345|FG001|Double Blind Period|Physician Decision|0|||
147221486|NCT04153149|530983346|FG002|Double Blind Period|Physician Decision|0|||
147221487|NCT04153149|530983347|FG003|Double Blind Period|Physician Decision|0|||
147221488|NCT04153149|530983344|FG000|Open Label Extension Period|Death|0|||
147221489|NCT04153149|530983345|FG001|Open Label Extension Period|Death|0|||
147221490|NCT04153149|530983346|FG002|Open Label Extension Period|Death|7|||
147221491|NCT04153149|530983347|FG003|Open Label Extension Period|Death|3|||
147221492|NCT04153149|530983344|FG000|Open Label Extension Period|Withdrawal by guardian|0|||
147221493|NCT04153149|530983345|FG001|Open Label Extension Period|Withdrawal by guardian|0|||
147221494|NCT04153149|530983346|FG002|Open Label Extension Period|Withdrawal by guardian|1|||
147221495|NCT04153149|530983347|FG003|Open Label Extension Period|Withdrawal by guardian|0|||
147221496|NCT04153149|530983344|FG000|Open Label Extension Period|Participant Withdrew from Treatment but Ongoing in Safety Follow-up|0|||
147221497|NCT04153149|530983345|FG001|Open Label Extension Period|Participant Withdrew from Treatment but Ongoing in Safety Follow-up|0|||
147221498|NCT04153149|530983346|FG002|Open Label Extension Period|Participant Withdrew from Treatment but Ongoing in Safety Follow-up|0|||
147221499|NCT04153149|530983347|FG003|Open Label Extension Period|Participant Withdrew from Treatment but Ongoing in Safety Follow-up|1|||
147221500|NCT04153149|530983344|FG000|Open Label Extension Period|Study Treatment Ongoing|0|||
147221501|NCT04153149|530983345|FG001|Open Label Extension Period|Study Treatment Ongoing|0|||
147221502|NCT04153149|530983346|FG002|Open Label Extension Period|Study Treatment Ongoing|213|||
147221503|NCT04153149|530983347|FG003|Open Label Extension Period|Study Treatment Ongoing|237|||
147221504|NCT00773838|530984005|FG000|Overall Study|Adverse Event|29|||
147221505|NCT00773838|530984005|FG000|Overall Study|Lost to Follow-up|1|||
147221506|NCT00773838|530984005|FG000|Overall Study|Physician Decision|8|||
147221507|NCT00773838|530984005|FG000|Overall Study|Progressive Disease|82|||
147221508|NCT00773838|530984005|FG000|Overall Study|Protocol Violation|2|||
147221509|NCT00773838|530984005|FG000|Overall Study|Withdrawal by Subject|21|||
147221510|NCT01589770|530984007|FG000|Overall Study|EGFR <60ml/min|6|||
147221511|NCT01589770|530984008|FG001|Overall Study|EGFR <60ml/min|4|||
147221512|NCT01589770|530984007|FG000|Overall Study|claustrophobic when entering cardiac MRI|2|||
147221513|NCT01589770|530984008|FG001|Overall Study|claustrophobic when entering cardiac MRI|1|||
147221514|NCT02283177|530984011|FG000|Overall Study|Withdrawal by Subject|1|||
147221515|NCT02283177|530984012|FG001|Overall Study|Withdrawal by Subject|1|||
147221516|NCT01101191|530984013|FG000|Period 1|Withdrawal by Subject|1|||
147221517|NCT01101191|530984014|FG001|Period 1|Withdrawal by Subject|0|||
147221518|NCT01101191|530984013|FG000|Period 1|Adverse Event|1|||
147221519|NCT01101191|530984014|FG001|Period 1|Adverse Event|2|||
147221520|NCT03473548|530984022|FG000|Overall Study|Did not attempt HST testing|3|||
147221521|NCT03473548|530984023|FG001|Overall Study|Did not attempt HST testing|0|||
147221522|NCT01986933|530984030|FG000|Placebo-controlled (Part A)|Adverse Event|1|||
147221523|NCT01986933|530984031|FG001|Placebo-controlled (Part A)|Adverse Event|5|||
147221524|NCT01986933|530984032|FG002|Placebo-controlled (Part A)|Adverse Event|2|||
147221525|NCT01986933|530984033|FG003|Placebo-controlled (Part A)|Adverse Event|2|||
147221526|NCT01986933|530984034|FG004|Placebo-controlled (Part A)|Adverse Event|4|||
147221527|NCT01986933|530984030|FG000|Placebo-controlled (Part A)|Lack of Efficacy|3|||
147221528|NCT01986933|530984031|FG001|Placebo-controlled (Part A)|Lack of Efficacy|1|||
147221529|NCT01986933|530984032|FG002|Placebo-controlled (Part A)|Lack of Efficacy|1|||
147221530|NCT01986933|530984033|FG003|Placebo-controlled (Part A)|Lack of Efficacy|2|||
147221531|NCT01986933|530984034|FG004|Placebo-controlled (Part A)|Lack of Efficacy|1|||
147221532|NCT01986933|530984030|FG000|Placebo-controlled (Part A)|Withdrawal by Subject|5|||
147221533|NCT01986933|530984031|FG001|Placebo-controlled (Part A)|Withdrawal by Subject|2|||
147309585|NCT00152971|531300119|FG002|Overall Study|Lost to Follow-up|13|||
147221534|NCT01986933|530984032|FG002|Placebo-controlled (Part A)|Withdrawal by Subject|6|||
147221535|NCT01986933|530984033|FG003|Placebo-controlled (Part A)|Withdrawal by Subject|2|||
147221536|NCT01986933|530984034|FG004|Placebo-controlled (Part A)|Withdrawal by Subject|7|||
147221537|NCT01986933|530984030|FG000|Placebo-controlled (Part A)|Lost to Follow-up|0|||
147221538|NCT01986933|530984031|FG001|Placebo-controlled (Part A)|Lost to Follow-up|1|||
147221539|NCT01986933|530984032|FG002|Placebo-controlled (Part A)|Lost to Follow-up|0|||
147221540|NCT01986933|530984033|FG003|Placebo-controlled (Part A)|Lost to Follow-up|1|||
147221541|NCT01986933|530984034|FG004|Placebo-controlled (Part A)|Lost to Follow-up|0|||
147221542|NCT01986933|530984030|FG000|Placebo-controlled (Part A)|Others (not classified above reasons)|0|||
147221543|NCT01986933|530984031|FG001|Placebo-controlled (Part A)|Others (not classified above reasons)|0|||
147221544|NCT01986933|530984032|FG002|Placebo-controlled (Part A)|Others (not classified above reasons)|0|||
147221545|NCT01986933|530984033|FG003|Placebo-controlled (Part A)|Others (not classified above reasons)|0|||
147221546|NCT01986933|530984034|FG004|Placebo-controlled (Part A)|Others (not classified above reasons)|2|||
147221547|NCT01986933|530984030|FG000|Active-to-active (Part B)|Adverse Event|0|||
147221548|NCT01986933|530984031|FG001|Active-to-active (Part B)|Adverse Event|2|||
147221549|NCT01986933|530984032|FG002|Active-to-active (Part B)|Adverse Event|0|||
147221550|NCT01986933|530984033|FG003|Active-to-active (Part B)|Adverse Event|1|||
147221551|NCT01986933|530984034|FG004|Active-to-active (Part B)|Adverse Event|3|||
147221552|NCT01986933|530984030|FG000|Active-to-active (Part B)|Lack of Efficacy|0|||
147221553|NCT01986933|530984031|FG001|Active-to-active (Part B)|Lack of Efficacy|3|||
147221554|NCT01986933|530984032|FG002|Active-to-active (Part B)|Lack of Efficacy|2|||
147221555|NCT01986933|530984033|FG003|Active-to-active (Part B)|Lack of Efficacy|0|||
147221556|NCT01986933|530984034|FG004|Active-to-active (Part B)|Lack of Efficacy|4|||
147221557|NCT01986933|530984030|FG000|Active-to-active (Part B)|Pregnancy|0|||
147221558|NCT01986933|530984031|FG001|Active-to-active (Part B)|Pregnancy|0|||
147221559|NCT01986933|530984032|FG002|Active-to-active (Part B)|Pregnancy|0|||
147221560|NCT01986933|530984033|FG003|Active-to-active (Part B)|Pregnancy|0|||
147221561|NCT01986933|530984034|FG004|Active-to-active (Part B)|Pregnancy|1|||
147221562|NCT01986933|530984030|FG000|Active-to-active (Part B)|Physician Decision|0|||
147221563|NCT01986933|530984031|FG001|Active-to-active (Part B)|Physician Decision|0|||
147221564|NCT01986933|530984032|FG002|Active-to-active (Part B)|Physician Decision|1|||
147221565|NCT01986933|530984033|FG003|Active-to-active (Part B)|Physician Decision|1|||
147221566|NCT01986933|530984034|FG004|Active-to-active (Part B)|Physician Decision|0|||
147221567|NCT01986933|530984030|FG000|Active-to-active (Part B)|Withdrawal by Subject|0|||
147221568|NCT01986933|530984031|FG001|Active-to-active (Part B)|Withdrawal by Subject|4|||
147221569|NCT01986933|530984032|FG002|Active-to-active (Part B)|Withdrawal by Subject|7|||
147221570|NCT01986933|530984033|FG003|Active-to-active (Part B)|Withdrawal by Subject|6|||
147221571|NCT01986933|530984034|FG004|Active-to-active (Part B)|Withdrawal by Subject|6|||
147221572|NCT01986933|530984030|FG000|Active-to-active (Part B)|Lost to Follow-up|0|||
147221573|NCT01986933|530984031|FG001|Active-to-active (Part B)|Lost to Follow-up|0|||
147221574|NCT01986933|530984032|FG002|Active-to-active (Part B)|Lost to Follow-up|0|||
147221575|NCT01986933|530984033|FG003|Active-to-active (Part B)|Lost to Follow-up|0|||
147221576|NCT01986933|530984034|FG004|Active-to-active (Part B)|Lost to Follow-up|1|||
147221577|NCT01986933|530984030|FG000|Active-to-active (Part B)|Others (not classified above reasons)|0|||
147221578|NCT01986933|530984031|FG001|Active-to-active (Part B)|Others (not classified above reasons)|1|||
147221579|NCT01986933|530984032|FG002|Active-to-active (Part B)|Others (not classified above reasons)|0|||
147221580|NCT01986933|530984033|FG003|Active-to-active (Part B)|Others (not classified above reasons)|1|||
147221581|NCT01986933|530984034|FG004|Active-to-active (Part B)|Others (not classified above reasons)|1|||
147221582|NCT01986933|530984030|FG000|Placebo-to-active (Part B)|Adverse Event|0|||
147221583|NCT01986933|530984031|FG001|Placebo-to-active (Part B)|Adverse Event|1|||
147221584|NCT01986933|530984032|FG002|Placebo-to-active (Part B)|Adverse Event|0|||
147221585|NCT01986933|530984033|FG003|Placebo-to-active (Part B)|Adverse Event|1|||
147221586|NCT01986933|530984034|FG004|Placebo-to-active (Part B)|Adverse Event|0|||
147221587|NCT01986933|530984030|FG000|Placebo-to-active (Part B)|Lack of Efficacy|0|||
147221588|NCT01986933|530984031|FG001|Placebo-to-active (Part B)|Lack of Efficacy|0|||
147221589|NCT01986933|530984032|FG002|Placebo-to-active (Part B)|Lack of Efficacy|0|||
147221590|NCT01986933|530984033|FG003|Placebo-to-active (Part B)|Lack of Efficacy|1|||
147221591|NCT01986933|530984034|FG004|Placebo-to-active (Part B)|Lack of Efficacy|0|||
147221592|NCT01986933|530984030|FG000|Placebo-to-active (Part B)|Protocol Violation|0|||
147221593|NCT01986933|530984031|FG001|Placebo-to-active (Part B)|Protocol Violation|0|||
147221594|NCT01986933|530984032|FG002|Placebo-to-active (Part B)|Protocol Violation|1|||
147221595|NCT01986933|530984033|FG003|Placebo-to-active (Part B)|Protocol Violation|0|||
147221596|NCT01986933|530984034|FG004|Placebo-to-active (Part B)|Protocol Violation|0|||
147221597|NCT01986933|530984030|FG000|Placebo-to-active (Part B)|Withdrawal by Subject|0|||
147221598|NCT01986933|530984031|FG001|Placebo-to-active (Part B)|Withdrawal by Subject|3|||
147221599|NCT01986933|530984032|FG002|Placebo-to-active (Part B)|Withdrawal by Subject|4|||
147221600|NCT01986933|530984033|FG003|Placebo-to-active (Part B)|Withdrawal by Subject|3|||
147221601|NCT01986933|530984034|FG004|Placebo-to-active (Part B)|Withdrawal by Subject|0|||
147221602|NCT01986933|530984030|FG000|Placebo-to-active (Part B)|Lost to Follow-up|0|||
147221603|NCT01986933|530984031|FG001|Placebo-to-active (Part B)|Lost to Follow-up|1|||
147221604|NCT01986933|530984032|FG002|Placebo-to-active (Part B)|Lost to Follow-up|0|||
147221605|NCT01986933|530984033|FG003|Placebo-to-active (Part B)|Lost to Follow-up|0|||
147221606|NCT01986933|530984034|FG004|Placebo-to-active (Part B)|Lost to Follow-up|0|||
147221607|NCT03370276|530984037|FG000|Overall Study|Death|0|||
147221608|NCT03370276|530984038|FG001|Overall Study|Death|2|||
147221609|NCT03370276|530984039|FG002|Overall Study|Death|5|||
147221610|NCT04030026|530984040|FG000|Treatment Period 1 (22 Days)|COVID-19 pandemic restrictions|0|||
147221611|NCT04030026|530984041|FG001|Treatment Period 1 (22 Days)|COVID-19 pandemic restrictions|1|||
147221612|NCT04030026|530984040|FG000|Treatment Period 1 (22 Days)|Withdrawal by Participant|1|||
147221613|NCT04030026|530984041|FG001|Treatment Period 1 (22 Days)|Withdrawal by Participant|0|||
147221614|NCT04030026|530984040|FG000|Treatment Period 1 (22 Days)|Protocol Deviation|0|||
147221615|NCT04030026|530984041|FG001|Treatment Period 1 (22 Days)|Protocol Deviation|1|||
147221616|NCT04030026|530984040|FG000|Treatment Period 1 (22 Days)|Physician Decision|1|||
147221617|NCT04030026|530984041|FG001|Treatment Period 1 (22 Days)|Physician Decision|0|||
147221618|NCT04030026|530984040|FG000|Treatment Period 2 (22 Days)|Adverse Event|0|||
147221619|NCT04030026|530984041|FG001|Treatment Period 2 (22 Days)|Adverse Event|6|||
147221620|NCT04030026|530984040|FG000|Treatment Period 2 (22 Days)|COVID-19 pandemic restrictions|1|||
147221621|NCT04030026|530984041|FG001|Treatment Period 2 (22 Days)|COVID-19 pandemic restrictions|1|||
147221622|NCT04030026|530984040|FG000|Treatment Period 2 (22 Days)|Withdrawal by Participant|0|||
147221623|NCT04030026|530984041|FG001|Treatment Period 2 (22 Days)|Withdrawal by Participant|2|||
147221624|NCT00811642|530984042|FG000|Overall Study|Adverse Event|3|||
147221625|NCT00811642|530984042|FG000|Overall Study|Protocol Violation|1|||
147221626|NCT00811642|530984042|FG000|Overall Study|Death|2|||
147221627|NCT00811642|530984042|FG000|Overall Study|Withdrawal by Subject|7|||
147221628|NCT00811642|530984042|FG000|Overall Study|Cumulative use of antifungal agent|2|||
147221629|NCT01602666|530984043|FG000|Induction Chemotherapy|Death|2|||
147221630|NCT01602666|530984044|FG001|Induction Chemotherapy|Death|1|||
147221631|NCT01602666|530984043|FG000|Induction Chemotherapy|Lack of Efficacy|16|||
147221632|NCT01602666|530984044|FG001|Induction Chemotherapy|Lack of Efficacy|7|||
147221633|NCT01602666|530984043|FG000|Induction Chemotherapy|Physician Decision|12|||
147221634|NCT01602666|530984044|FG001|Induction Chemotherapy|Physician Decision|5|||
147221635|NCT01602666|530984043|FG000|Induction Chemotherapy|Withdrawal by Subject|0|||
147221636|NCT01602666|530984044|FG001|Induction Chemotherapy|Withdrawal by Subject|2|||
147221637|NCT01602666|530984043|FG000|Induction Chemotherapy|Refusal of further protocol therapy|5|||
147221638|NCT01602666|530984044|FG001|Induction Chemotherapy|Refusal of further protocol therapy|6|||
147221639|NCT01602666|530984043|FG000|Induction Chemotherapy|Radiotherapy can't be initiated in 6 wks|2|||
147221640|NCT01602666|530984044|FG001|Induction Chemotherapy|Radiotherapy can't be initiated in 6 wks|3|||
147221641|NCT01602666|530984043|FG000|Radiation Therapy on Protocol|Lost to Follow-up|4|||
147221642|NCT01602666|530984044|FG001|Radiation Therapy on Protocol|Lost to Follow-up|5|||
147221643|NCT01602666|530984043|FG000|Radiation Therapy on Protocol|Withdrawal by Subject|2|||
147221644|NCT01602666|530984044|FG001|Radiation Therapy on Protocol|Withdrawal by Subject|3|||
147221645|NCT01602666|530984043|FG000|Radiation Therapy on Protocol|In-evaluable for reduced dose(30.6 Gy)|4|||
147221646|NCT01602666|530984044|FG001|Radiation Therapy on Protocol|In-evaluable for reduced dose(30.6 Gy)|0|||
147221647|NCT01602666|530984043|FG000|Radiation Therapy on Protocol|In-evaluable for reduced dose(18 Gy)|0|||
147221648|NCT01602666|530984044|FG001|Radiation Therapy on Protocol|In-evaluable for reduced dose(18 Gy)|14|||
147221649|NCT01602666|530984043|FG000|Radiation Therapy on Protocol|In-evaluable for RT dose (24Gy)|0|||
147221650|NCT01602666|530984044|FG001|Radiation Therapy on Protocol|In-evaluable for RT dose (24Gy)|9|||
147221651|NCT02361346|530984045|FG000|Part 1 and 2 ( Up to Day 112)|Death|0|||
147221652|NCT02361346|530984046|FG001|Part 1 and 2 ( Up to Day 112)|Death|0|||
147221653|NCT02361346|530984047|FG002|Part 1 and 2 ( Up to Day 112)|Death|0|||
147221654|NCT02361346|530984048|FG003|Part 1 and 2 ( Up to Day 112)|Death|1|||
147221655|NCT02361346|530984049|FG004|Part 1 and 2 ( Up to Day 112)|Death|0|||
147221656|NCT02361346|530984050|FG005|Part 1 and 2 ( Up to Day 112)|Death|0|||
147221657|NCT02361346|530984051|FG006|Part 1 and 2 ( Up to Day 112)|Death|0|||
147221658|NCT02361346|530984052|FG007|Part 1 and 2 ( Up to Day 112)|Death|0|||
147221659|NCT02361346|530984053|FG008|Part 1 and 2 ( Up to Day 112)|Death|0|||
147221660|NCT02361346|530984045|FG000|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
147221661|NCT02361346|530984046|FG001|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
147221662|NCT02361346|530984047|FG002|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
147221663|NCT02361346|530984048|FG003|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
147221664|NCT02361346|530984049|FG004|Part 1 and 2 ( Up to Day 112)|Adverse Event|2|||
147221665|NCT02361346|530984050|FG005|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
147221666|NCT02361346|530984051|FG006|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
147221667|NCT02361346|530984052|FG007|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
147221668|NCT02361346|530984053|FG008|Part 1 and 2 ( Up to Day 112)|Adverse Event|0|||
147221669|NCT02361346|530984045|FG000|Part 3 (Up to Day 112)|Adverse Event|0|||
147221670|NCT02361346|530984046|FG001|Part 3 (Up to Day 112)|Adverse Event|0|||
147553264|NCT00586521|532181554|FG000|On Demand Treatment (Months 1-6)|Withdrawal by Subject|1|||
147553265|NCT03734237|532181558|FG000|Overall Study|Lost to Follow-up|1|||
147221671|NCT02361346|530984047|FG002|Part 3 (Up to Day 112)|Adverse Event|0|||
147221672|NCT02361346|530984048|FG003|Part 3 (Up to Day 112)|Adverse Event|0|||
147221673|NCT02361346|530984049|FG004|Part 3 (Up to Day 112)|Adverse Event|0|||
147221674|NCT02361346|530984050|FG005|Part 3 (Up to Day 112)|Adverse Event|0|||
147221675|NCT02361346|530984051|FG006|Part 3 (Up to Day 112)|Adverse Event|0|||
147221676|NCT02361346|530984052|FG007|Part 3 (Up to Day 112)|Adverse Event|1|||
147221677|NCT02361346|530984053|FG008|Part 3 (Up to Day 112)|Adverse Event|0|||
147221678|NCT02361346|530984045|FG000|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
147221679|NCT02361346|530984046|FG001|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
147221680|NCT02361346|530984047|FG002|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
147221681|NCT02361346|530984048|FG003|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
147221682|NCT02361346|530984049|FG004|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
147221683|NCT02361346|530984050|FG005|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
147221684|NCT02361346|530984051|FG006|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
147221685|NCT02361346|530984052|FG007|Part 3 (Up to Day 112)|Withdrawal by Subject|1|||
147221686|NCT02361346|530984053|FG008|Part 3 (Up to Day 112)|Withdrawal by Subject|0|||
147221687|NCT02361346|530984045|FG000|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
147221688|NCT02361346|530984046|FG001|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
147221689|NCT02361346|530984047|FG002|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
147221690|NCT02361346|530984048|FG003|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
147221691|NCT02361346|530984049|FG004|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
147221692|NCT02361346|530984050|FG005|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
147221693|NCT02361346|530984051|FG006|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
147221694|NCT02361346|530984052|FG007|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|7|||
147221695|NCT02361346|530984053|FG008|Part 3 (Up to Day 112)|Disease progression (radiographic per lugano)|0|||
147221696|NCT02361346|530984045|FG000|Part 3 (Up to Day 112)|Clinical disease progression|0|||
147221697|NCT02361346|530984046|FG001|Part 3 (Up to Day 112)|Clinical disease progression|0|||
147221698|NCT02361346|530984047|FG002|Part 3 (Up to Day 112)|Clinical disease progression|0|||
147221699|NCT02361346|530984048|FG003|Part 3 (Up to Day 112)|Clinical disease progression|0|||
147221700|NCT02361346|530984049|FG004|Part 3 (Up to Day 112)|Clinical disease progression|0|||
147221701|NCT02361346|530984050|FG005|Part 3 (Up to Day 112)|Clinical disease progression|0|||
147221702|NCT02361346|530984051|FG006|Part 3 (Up to Day 112)|Clinical disease progression|0|||
147221703|NCT02361346|530984052|FG007|Part 3 (Up to Day 112)|Clinical disease progression|2|||
147221704|NCT02361346|530984053|FG008|Part 3 (Up to Day 112)|Clinical disease progression|0|||
147221705|NCT01163318|530984054|FG000|Overall Study|Off-Label Use of Adalimumab|8|||
147221706|NCT01163318|530984054|FG000|Overall Study|Did Not Continue Use of Adalimumab|26|||
147221707|NCT01163318|530984054|FG000|Overall Study|History/comorbidity of malignant tumor|3|||
147221708|NCT01163318|530984054|FG000|Overall Study|Participants Without Case Report Form|7|||
147221709|NCT01163318|530984054|FG000|Overall Study|Multiple Reasons Per Participant|224|||
147221710|NCT03587727|530984059|FG000|Overall Study|10 did not complete either of the pre-op MMTT or post-op MMTT.|10|||
147221711|NCT03587727|530984059|FG000|Overall Study|4 completed the pre-op MMTT but did not complete the post-op MMTT.|4|||
147221712|NCT04102189|530984060|FG000|Overall Study|Withdrawal by Subject|1|||
147221713|NCT04102189|530984061|FG001|Overall Study|Withdrawal by Subject|2|||
147221714|NCT04102189|530984060|FG000|Overall Study|Withdrawal by parent/guardian|0|||
147221715|NCT04102189|530984061|FG001|Overall Study|Withdrawal by parent/guardian|1|||
147221716|NCT04102189|530984060|FG000|Overall Study|Lost to Follow-up|1|||
147221717|NCT04102189|530984061|FG001|Overall Study|Lost to Follow-up|0|||
147221718|NCT03576274|530984064|FG000|Overall Study|Lost to Follow-up|3|||
147221719|NCT03576274|530984065|FG001|Overall Study|Lost to Follow-up|2|||
147221720|NCT03576274|530984066|FG002|Overall Study|Lost to Follow-up|3|||
147221721|NCT03576274|530984067|FG003|Overall Study|Lost to Follow-up|1|||
147221722|NCT03576274|530984068|FG004|Overall Study|Lost to Follow-up|3|||
147221723|NCT03576274|530984064|FG000|Overall Study|Withdrawal by Subject|5|||
147221724|NCT03576274|530984065|FG001|Overall Study|Withdrawal by Subject|3|||
147221725|NCT03576274|530984066|FG002|Overall Study|Withdrawal by Subject|2|||
147221726|NCT03576274|530984067|FG003|Overall Study|Withdrawal by Subject|8|||
147221727|NCT03576274|530984068|FG004|Overall Study|Withdrawal by Subject|6|||
147221728|NCT00562627|530985761|FG000|Overall Study|Protocol Violation|1|||
147221729|NCT00562627|530985762|FG001|Overall Study|Protocol Violation|1|||
147221730|NCT00562627|530985763|FG002|Overall Study|Protocol Violation|1|||
147221731|NCT00997438|530985764|FG000|Overall Study|Blood draw difficulty|2|||
147221732|NCT00997438|530985765|FG001|Overall Study|Blood draw difficulty|0|||
147221733|NCT00997438|530985766|FG002|Overall Study|Blood draw difficulty|1|||
147221734|NCT00997438|530985764|FG000|Overall Study|Withdrawal by Subject|1|||
147221735|NCT00997438|530985765|FG001|Overall Study|Withdrawal by Subject|1|||
147221736|NCT00997438|530985766|FG002|Overall Study|Withdrawal by Subject|0|||
147221737|NCT00997438|530985764|FG000|Overall Study|Exclusion criteria at visit 1|2|||
147221738|NCT00997438|530985765|FG001|Overall Study|Exclusion criteria at visit 1|2|||
147221739|NCT00997438|530985766|FG002|Overall Study|Exclusion criteria at visit 1|3|||
147221740|NCT04393298|530985767|FG000|Overall Study|Adverse Event|0|||
147221741|NCT04393298|530985768|FG001|Overall Study|Adverse Event|0|||
147221742|NCT04393298|530985769|FG002|Overall Study|Adverse Event|0|||
147221743|NCT04393298|530985770|FG003|Overall Study|Adverse Event|0|||
147221744|NCT04393298|530985771|FG004|Overall Study|Adverse Event|1|||
147221745|NCT04393298|530985772|FG005|Overall Study|Adverse Event|0|||
147221746|NCT04393298|530985773|FG006|Overall Study|Adverse Event|0|||
147221747|NCT04393298|530985774|FG007|Overall Study|Adverse Event|0|||
147221748|NCT04393298|530985775|FG008|Overall Study|Adverse Event|2|||
147221749|NCT04393298|530985776|FG009|Overall Study|Adverse Event|0|||
147221750|NCT04393298|530985777|FG010|Overall Study|Adverse Event|0|||
147221751|NCT04393298|530985778|FG011|Overall Study|Adverse Event|0|||
147221752|NCT04393298|530985779|FG012|Overall Study|Adverse Event|1|||
147221753|NCT04393298|530985780|FG013|Overall Study|Adverse Event|1|||
147221754|NCT04393298|530985781|FG014|Overall Study|Adverse Event|0|||
147221755|NCT04393298|530985767|FG000|Overall Study|Consent withdrawn by participant, not due to AE|0|||
147221756|NCT04393298|530985768|FG001|Overall Study|Consent withdrawn by participant, not due to AE|0|||
147221757|NCT04393298|530985769|FG002|Overall Study|Consent withdrawn by participant, not due to AE|1|||
147221758|NCT04393298|530985770|FG003|Overall Study|Consent withdrawn by participant, not due to AE|0|||
147221759|NCT04393298|530985771|FG004|Overall Study|Consent withdrawn by participant, not due to AE|0|||
147221760|NCT04393298|530985772|FG005|Overall Study|Consent withdrawn by participant, not due to AE|0|||
147221761|NCT04393298|530985773|FG006|Overall Study|Consent withdrawn by participant, not due to AE|0|||
147221762|NCT04393298|530985774|FG007|Overall Study|Consent withdrawn by participant, not due to AE|0|||
147221763|NCT04393298|530985775|FG008|Overall Study|Consent withdrawn by participant, not due to AE|0|||
147221764|NCT04393298|530985776|FG009|Overall Study|Consent withdrawn by participant, not due to AE|0|||
147221765|NCT04393298|530985777|FG010|Overall Study|Consent withdrawn by participant, not due to AE|0|||
147221766|NCT04393298|530985778|FG011|Overall Study|Consent withdrawn by participant, not due to AE|0|||
147221767|NCT04393298|530985779|FG012|Overall Study|Consent withdrawn by participant, not due to AE|0|||
147221768|NCT04393298|530985780|FG013|Overall Study|Consent withdrawn by participant, not due to AE|0|||
147221769|NCT04393298|530985781|FG014|Overall Study|Consent withdrawn by participant, not due to AE|3|||
147221770|NCT04393298|530985767|FG000|Overall Study|Lack of Efficacy|0|||
147221771|NCT04393298|530985768|FG001|Overall Study|Lack of Efficacy|0|||
147221772|NCT04393298|530985769|FG002|Overall Study|Lack of Efficacy|0|||
147221773|NCT04393298|530985770|FG003|Overall Study|Lack of Efficacy|0|||
147221774|NCT04393298|530985771|FG004|Overall Study|Lack of Efficacy|0|||
147221775|NCT04393298|530985772|FG005|Overall Study|Lack of Efficacy|0|||
147221776|NCT04393298|530985773|FG006|Overall Study|Lack of Efficacy|0|||
147221777|NCT04393298|530985774|FG007|Overall Study|Lack of Efficacy|0|||
147553266|NCT03734237|532181559|FG001|Overall Study|Lost to Follow-up|3|||
147221778|NCT04393298|530985775|FG008|Overall Study|Lack of Efficacy|0|||
147221779|NCT04393298|530985776|FG009|Overall Study|Lack of Efficacy|0|||
147221780|NCT04393298|530985777|FG010|Overall Study|Lack of Efficacy|0|||
147553267|NCT03734237|532181560|FG002|Overall Study|Lost to Follow-up|0|||
147221781|NCT04393298|530985778|FG011|Overall Study|Lack of Efficacy|0|||
147221782|NCT04393298|530985779|FG012|Overall Study|Lack of Efficacy|0|||
147221783|NCT04393298|530985780|FG013|Overall Study|Lack of Efficacy|0|||
147221784|NCT04393298|530985781|FG014|Overall Study|Lack of Efficacy|1|||
147221785|NCT04393298|530985767|FG000|Overall Study|Progression|1|||
147221786|NCT04393298|530985768|FG001|Overall Study|Progression|0|||
147221787|NCT04393298|530985769|FG002|Overall Study|Progression|0|||
147221788|NCT04393298|530985770|FG003|Overall Study|Progression|0|||
147221789|NCT04393298|530985771|FG004|Overall Study|Progression|0|||
147221790|NCT04393298|530985772|FG005|Overall Study|Progression|0|||
147221791|NCT04393298|530985773|FG006|Overall Study|Progression|0|||
147221792|NCT04393298|530985774|FG007|Overall Study|Progression|0|||
147221793|NCT04393298|530985775|FG008|Overall Study|Progression|0|||
147221794|NCT04393298|530985776|FG009|Overall Study|Progression|0|||
147221795|NCT04393298|530985777|FG010|Overall Study|Progression|1|||
147221796|NCT04393298|530985778|FG011|Overall Study|Progression|1|||
147221797|NCT04393298|530985779|FG012|Overall Study|Progression|0|||
147221798|NCT04393298|530985780|FG013|Overall Study|Progression|0|||
147221799|NCT04393298|530985781|FG014|Overall Study|Progression|0|||
147221800|NCT04393298|530985767|FG000|Overall Study|Passed Away on The 30 Oct 2020|1|||
147221801|NCT04393298|530985768|FG001|Overall Study|Passed Away on The 30 Oct 2020|0|||
147221802|NCT04393298|530985769|FG002|Overall Study|Passed Away on The 30 Oct 2020|0|||
147221803|NCT04393298|530985770|FG003|Overall Study|Passed Away on The 30 Oct 2020|0|||
147221804|NCT04393298|530985771|FG004|Overall Study|Passed Away on The 30 Oct 2020|0|||
147221805|NCT04393298|530985772|FG005|Overall Study|Passed Away on The 30 Oct 2020|0|||
147221806|NCT04393298|530985773|FG006|Overall Study|Passed Away on The 30 Oct 2020|0|||
147221807|NCT04393298|530985774|FG007|Overall Study|Passed Away on The 30 Oct 2020|0|||
147221808|NCT04393298|530985775|FG008|Overall Study|Passed Away on The 30 Oct 2020|0|||
147221809|NCT04393298|530985776|FG009|Overall Study|Passed Away on The 30 Oct 2020|0|||
147221810|NCT04393298|530985777|FG010|Overall Study|Passed Away on The 30 Oct 2020|0|||
147221811|NCT04393298|530985778|FG011|Overall Study|Passed Away on The 30 Oct 2020|0|||
147221812|NCT04393298|530985779|FG012|Overall Study|Passed Away on The 30 Oct 2020|0|||
147221813|NCT04393298|530985780|FG013|Overall Study|Passed Away on The 30 Oct 2020|0|||
147221814|NCT04393298|530985781|FG014|Overall Study|Passed Away on The 30 Oct 2020|0|||
147221815|NCT04393298|530985767|FG000|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
147221816|NCT04393298|530985768|FG001|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|1|||
147443402|NCT01469182|531788661|FG001|Overall Study|Protocol Violation|2|||
147443403|NCT01469182|531788660|FG000|Overall Study|Did not meet Protocol Eligibility|3|||
147443404|NCT01469182|531788661|FG001|Overall Study|Did not meet Protocol Eligibility|0|||
147443405|NCT01761292|531788663|FG000|Part 1|Adverse Event|1|||
147443406|NCT01761292|531788663|FG000|Part 1|not receiving treatment in Part 1|1|||
147443407|NCT01761292|531788663|FG000|Extension 1|Withdrawal by Subject|1|||
147443408|NCT02463409|531788664|FG000|Overall Study|Withdrawal by Subject|1|||
147221817|NCT04393298|530985769|FG002|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
147221818|NCT04393298|530985770|FG003|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
147221819|NCT04393298|530985771|FG004|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
147221820|NCT04393298|530985772|FG005|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
147221821|NCT04393298|530985773|FG006|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
147221822|NCT04393298|530985774|FG007|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
147221823|NCT04393298|530985775|FG008|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
147221824|NCT04393298|530985776|FG009|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
147221825|NCT04393298|530985777|FG010|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
147221826|NCT04393298|530985778|FG011|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
147221827|NCT04393298|530985779|FG012|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
147221828|NCT04393298|530985780|FG013|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
147221829|NCT04393298|530985781|FG014|Overall Study|Disease Progression Confirmed by Scans (CT/MRI)|0|||
147221830|NCT04393298|530985767|FG000|Overall Study|Clinical Progression|0|||
147221831|NCT04393298|530985768|FG001|Overall Study|Clinical Progression|2|||
147221832|NCT04393298|530985769|FG002|Overall Study|Clinical Progression|0|||
147221833|NCT04393298|530985770|FG003|Overall Study|Clinical Progression|0|||
147221834|NCT04393298|530985771|FG004|Overall Study|Clinical Progression|0|||
147221835|NCT04393298|530985772|FG005|Overall Study|Clinical Progression|0|||
147221836|NCT04393298|530985773|FG006|Overall Study|Clinical Progression|0|||
147221837|NCT04393298|530985774|FG007|Overall Study|Clinical Progression|0|||
147221838|NCT04393298|530985775|FG008|Overall Study|Clinical Progression|0|||
147221839|NCT04393298|530985776|FG009|Overall Study|Clinical Progression|0|||
147221840|NCT04393298|530985777|FG010|Overall Study|Clinical Progression|0|||
147221841|NCT04393298|530985778|FG011|Overall Study|Clinical Progression|0|||
147221842|NCT04393298|530985779|FG012|Overall Study|Clinical Progression|0|||
147221843|NCT04393298|530985780|FG013|Overall Study|Clinical Progression|0|||
147221844|NCT04393298|530985781|FG014|Overall Study|Clinical Progression|0|||
147221845|NCT04393298|530985767|FG000|Overall Study|Disease Progression|0|||
147221846|NCT04393298|530985768|FG001|Overall Study|Disease Progression|1|||
147221847|NCT04393298|530985769|FG002|Overall Study|Disease Progression|0|||
147221848|NCT04393298|530985770|FG003|Overall Study|Disease Progression|0|||
147221849|NCT04393298|530985771|FG004|Overall Study|Disease Progression|0|||
147221850|NCT04393298|530985772|FG005|Overall Study|Disease Progression|3|||
147221851|NCT04393298|530985773|FG006|Overall Study|Disease Progression|2|||
147221852|NCT04393298|530985774|FG007|Overall Study|Disease Progression|1|||
147221853|NCT04393298|530985775|FG008|Overall Study|Disease Progression|2|||
147221854|NCT04393298|530985776|FG009|Overall Study|Disease Progression|1|||
147221855|NCT04393298|530985777|FG010|Overall Study|Disease Progression|0|||
147221856|NCT04393298|530985778|FG011|Overall Study|Disease Progression|3|||
147221857|NCT04393298|530985779|FG012|Overall Study|Disease Progression|0|||
147221858|NCT04393298|530985780|FG013|Overall Study|Disease Progression|0|||
147221859|NCT04393298|530985781|FG014|Overall Study|Disease Progression|1|||
147221860|NCT04393298|530985767|FG000|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
147221861|NCT04393298|530985768|FG001|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
147221862|NCT04393298|530985769|FG002|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|1|||
147221863|NCT04393298|530985770|FG003|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
147221864|NCT04393298|530985771|FG004|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
147221865|NCT04393298|530985772|FG005|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
147221866|NCT04393298|530985773|FG006|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
147221867|NCT04393298|530985774|FG007|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
147221868|NCT04393298|530985775|FG008|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
147221869|NCT04393298|530985776|FG009|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
147221870|NCT04393298|530985777|FG010|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
147221871|NCT04393298|530985778|FG011|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
147221872|NCT04393298|530985779|FG012|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
147221873|NCT04393298|530985780|FG013|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
147221874|NCT04393298|530985781|FG014|Overall Study|Since no Treatment Administered at Cycle 2 Day 15|0|||
147221875|NCT04393298|530985767|FG000|Overall Study|Further Deterioration Noted at Clinic review|0|||
147221876|NCT04393298|530985768|FG001|Overall Study|Further Deterioration Noted at Clinic review|0|||
147221877|NCT04393298|530985769|FG002|Overall Study|Further Deterioration Noted at Clinic review|1|||
147221878|NCT04393298|530985770|FG003|Overall Study|Further Deterioration Noted at Clinic review|0|||
147221879|NCT04393298|530985771|FG004|Overall Study|Further Deterioration Noted at Clinic review|0|||
147221880|NCT04393298|530985772|FG005|Overall Study|Further Deterioration Noted at Clinic review|0|||
147221881|NCT04393298|530985773|FG006|Overall Study|Further Deterioration Noted at Clinic review|0|||
147221882|NCT04393298|530985774|FG007|Overall Study|Further Deterioration Noted at Clinic review|0|||
147221883|NCT04393298|530985775|FG008|Overall Study|Further Deterioration Noted at Clinic review|0|||
147221884|NCT04393298|530985776|FG009|Overall Study|Further Deterioration Noted at Clinic review|0|||
147221885|NCT04393298|530985777|FG010|Overall Study|Further Deterioration Noted at Clinic review|0|||
147221886|NCT04393298|530985778|FG011|Overall Study|Further Deterioration Noted at Clinic review|0|||
147221887|NCT04393298|530985779|FG012|Overall Study|Further Deterioration Noted at Clinic review|0|||
147221888|NCT04393298|530985780|FG013|Overall Study|Further Deterioration Noted at Clinic review|0|||
147221889|NCT04393298|530985781|FG014|Overall Study|Further Deterioration Noted at Clinic review|0|||
147221890|NCT04393298|530985767|FG000|Overall Study|Progressive Disease (PD)|0|||
147221891|NCT04393298|530985768|FG001|Overall Study|Progressive Disease (PD)|0|||
147221892|NCT04393298|530985769|FG002|Overall Study|Progressive Disease (PD)|0|||
147221893|NCT04393298|530985770|FG003|Overall Study|Progressive Disease (PD)|3|||
147221894|NCT04393298|530985771|FG004|Overall Study|Progressive Disease (PD)|0|||
147221895|NCT04393298|530985772|FG005|Overall Study|Progressive Disease (PD)|0|||
147221896|NCT04393298|530985773|FG006|Overall Study|Progressive Disease (PD)|0|||
147221897|NCT04393298|530985774|FG007|Overall Study|Progressive Disease (PD)|0|||
147221898|NCT04393298|530985775|FG008|Overall Study|Progressive Disease (PD)|0|||
147221899|NCT04393298|530985776|FG009|Overall Study|Progressive Disease (PD)|0|||
147221900|NCT04393298|530985777|FG010|Overall Study|Progressive Disease (PD)|0|||
147221901|NCT04393298|530985778|FG011|Overall Study|Progressive Disease (PD)|0|||
147221902|NCT04393298|530985779|FG012|Overall Study|Progressive Disease (PD)|0|||
147221903|NCT04393298|530985780|FG013|Overall Study|Progressive Disease (PD)|0|||
147221904|NCT04393298|530985781|FG014|Overall Study|Progressive Disease (PD)|0|||
147221905|NCT04393298|530985767|FG000|Overall Study|Started a New Cancer Treatment|0|||
147221906|NCT04393298|530985768|FG001|Overall Study|Started a New Cancer Treatment|0|||
147221907|NCT04393298|530985769|FG002|Overall Study|Started a New Cancer Treatment|0|||
147221908|NCT04393298|530985770|FG003|Overall Study|Started a New Cancer Treatment|0|||
147221909|NCT04393298|530985771|FG004|Overall Study|Started a New Cancer Treatment|1|||
147221910|NCT04393298|530985772|FG005|Overall Study|Started a New Cancer Treatment|0|||
147221911|NCT04393298|530985773|FG006|Overall Study|Started a New Cancer Treatment|0|||
147221912|NCT04393298|530985774|FG007|Overall Study|Started a New Cancer Treatment|0|||
147221913|NCT04393298|530985775|FG008|Overall Study|Started a New Cancer Treatment|0|||
147221914|NCT04393298|530985776|FG009|Overall Study|Started a New Cancer Treatment|0|||
147443409|NCT02463409|531788664|FG000|Overall Study|Screen failure|1|||
147443410|NCT00916357|531788665|FG000|Period 1|Withdrawal by Subject|1|||
147443411|NCT00916357|531788666|FG001|Period 1|Withdrawal by Subject|0|||
147443412|NCT00916357|531788667|FG002|Period 1|Withdrawal by Subject|0|||
147443413|NCT00916357|531788668|FG003|Period 1|Withdrawal by Subject|0|||
147443414|NCT00916357|531788669|FG004|Period 1|Withdrawal by Subject|0|||
147443415|NCT00916357|531788670|FG005|Period 1|Withdrawal by Subject|0|||
147443416|NCT00916357|531788665|FG000|Period 2|Weight loss > 3 kilograms (kg)|0|||
147443417|NCT00916357|531788666|FG001|Period 2|Weight loss > 3 kilograms (kg)|0|||
147221915|NCT04393298|530985777|FG010|Overall Study|Started a New Cancer Treatment|0|||
147221916|NCT04393298|530985778|FG011|Overall Study|Started a New Cancer Treatment|0|||
147221917|NCT04393298|530985779|FG012|Overall Study|Started a New Cancer Treatment|0|||
147221918|NCT04393298|530985780|FG013|Overall Study|Started a New Cancer Treatment|0|||
147221919|NCT04393298|530985781|FG014|Overall Study|Started a New Cancer Treatment|0|||
147221920|NCT04393298|530985767|FG000|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
147221921|NCT04393298|530985768|FG001|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
147221922|NCT04393298|530985769|FG002|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
147221923|NCT04393298|530985770|FG003|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
147221924|NCT04393298|530985771|FG004|Overall Study|Sponsor decision- sepsis (treatment delay)|1|||
147221925|NCT04393298|530985772|FG005|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
147221926|NCT04393298|530985773|FG006|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
147221927|NCT04393298|530985774|FG007|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
147221928|NCT04393298|530985775|FG008|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
147221929|NCT04393298|530985776|FG009|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
147221930|NCT04393298|530985777|FG010|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
147221931|NCT04393298|530985778|FG011|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
147221932|NCT04393298|530985779|FG012|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
147221933|NCT04393298|530985780|FG013|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
147221934|NCT04393298|530985781|FG014|Overall Study|Sponsor decision- sepsis (treatment delay)|0|||
147221935|NCT04393298|530985767|FG000|Overall Study|Due to symptoms (New Brain Metastases)|0|||
147221936|NCT04393298|530985768|FG001|Overall Study|Due to symptoms (New Brain Metastases)|0|||
147221937|NCT04393298|530985769|FG002|Overall Study|Due to symptoms (New Brain Metastases)|0|||
147221938|NCT04393298|530985770|FG003|Overall Study|Due to symptoms (New Brain Metastases)|0|||
147221939|NCT04393298|530985771|FG004|Overall Study|Due to symptoms (New Brain Metastases)|0|||
147221940|NCT04393298|530985772|FG005|Overall Study|Due to symptoms (New Brain Metastases)|1|||
147221941|NCT04393298|530985773|FG006|Overall Study|Due to symptoms (New Brain Metastases)|0|||
147221942|NCT04393298|530985774|FG007|Overall Study|Due to symptoms (New Brain Metastases)|0|||
147221943|NCT04393298|530985775|FG008|Overall Study|Due to symptoms (New Brain Metastases)|0|||
147443418|NCT00916357|531788667|FG002|Period 2|Weight loss > 3 kilograms (kg)|0|||
147443419|NCT00916357|531788668|FG003|Period 2|Weight loss > 3 kilograms (kg)|1|||
147221944|NCT04393298|530985776|FG009|Overall Study|Due to symptoms (New Brain Metastases)|0|||
147309586|NCT00152971|531300117|FG000|Overall Study|Withdrawal by Subject|9|||
147443420|NCT00916357|531788669|FG004|Period 2|Weight loss > 3 kilograms (kg)|0|||
147443421|NCT00916357|531788670|FG005|Period 2|Weight loss > 3 kilograms (kg)|0|||
147443422|NCT03577730|531788671|FG000|Overall Study|Physician Decision|3|||
147443423|NCT03577730|531788672|FG001|Overall Study|Physician Decision|1|||
147443424|NCT03577730|531788671|FG000|Overall Study|Did not receive allocated intervention|1|||
147443425|NCT03577730|531788672|FG001|Overall Study|Did not receive allocated intervention|0|||
147443426|NCT02634151|531788674|FG000|Overall Study|Withdrawal by Subject|1|||
147443427|NCT02634151|531788675|FG001|Overall Study|Withdrawal by Subject|0|||
147443428|NCT02634151|531788674|FG000|Overall Study|Non-Compliance|0|||
147443429|NCT02634151|531788675|FG001|Overall Study|Non-Compliance|1|||
147443430|NCT02634151|531788674|FG000|Overall Study|Other|0|||
147221945|NCT04393298|530985777|FG010|Overall Study|Due to symptoms (New Brain Metastases)|0|||
147221946|NCT04393298|530985778|FG011|Overall Study|Due to symptoms (New Brain Metastases)|0|||
147221947|NCT04393298|530985779|FG012|Overall Study|Due to symptoms (New Brain Metastases)|0|||
147221948|NCT04393298|530985780|FG013|Overall Study|Due to symptoms (New Brain Metastases)|0|||
147221949|NCT04393298|530985781|FG014|Overall Study|Due to symptoms (New Brain Metastases)|0|||
147221950|NCT04393298|530985767|FG000|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
147221951|NCT04393298|530985768|FG001|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
147221952|NCT04393298|530985769|FG002|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
147221953|NCT04393298|530985770|FG003|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
147221954|NCT04393298|530985771|FG004|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
147221955|NCT04393298|530985772|FG005|Overall Study|Clinical Progression: Not suitable for SFU return|1|||
147221956|NCT04393298|530985773|FG006|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
147221957|NCT04393298|530985774|FG007|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
147221958|NCT04393298|530985775|FG008|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
147221959|NCT04393298|530985776|FG009|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
147221960|NCT04393298|530985777|FG010|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
147221961|NCT04393298|530985778|FG011|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
147221962|NCT04393298|530985779|FG012|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
147221963|NCT04393298|530985780|FG013|Overall Study|Clinical Progression: Not suitable for SFU return|0|||
147221964|NCT04393298|530985781|FG014|Overall Study|Clinical Progression: Not suitable for SFU return|1|||
147221965|NCT04393298|530985767|FG000|Overall Study|Death|0|||
147221966|NCT04393298|530985768|FG001|Overall Study|Death|0|||
147221967|NCT04393298|530985769|FG002|Overall Study|Death|0|||
147221968|NCT04393298|530985770|FG003|Overall Study|Death|0|||
147221969|NCT04393298|530985771|FG004|Overall Study|Death|0|||
147221970|NCT04393298|530985772|FG005|Overall Study|Death|1|||
147221971|NCT04393298|530985773|FG006|Overall Study|Death|1|||
147221972|NCT04393298|530985774|FG007|Overall Study|Death|0|||
147221973|NCT04393298|530985775|FG008|Overall Study|Death|1|||
147221974|NCT04393298|530985776|FG009|Overall Study|Death|1|||
147221975|NCT04393298|530985777|FG010|Overall Study|Death|0|||
147221976|NCT04393298|530985778|FG011|Overall Study|Death|1|||
147221977|NCT04393298|530985779|FG012|Overall Study|Death|1|||
147221978|NCT04393298|530985780|FG013|Overall Study|Death|0|||
147221979|NCT04393298|530985781|FG014|Overall Study|Death|1|||
147221980|NCT04393298|530985767|FG000|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
147221981|NCT04393298|530985768|FG001|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
147221982|NCT04393298|530985769|FG002|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
147221983|NCT04393298|530985770|FG003|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
147221984|NCT04393298|530985771|FG004|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
147221985|NCT04393298|530985772|FG005|Overall Study|Progressive Disease - New Brain Mets on CT Head|1|||
147221986|NCT04393298|530985773|FG006|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
147221987|NCT04393298|530985774|FG007|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
147221988|NCT04393298|530985775|FG008|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
147221989|NCT04393298|530985776|FG009|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
147221990|NCT04393298|530985777|FG010|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
147221991|NCT04393298|530985778|FG011|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
147221992|NCT04393298|530985779|FG012|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
147221993|NCT04393298|530985780|FG013|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
147221994|NCT04393298|530985781|FG014|Overall Study|Progressive Disease - New Brain Mets on CT Head|0|||
147221995|NCT04393298|530985767|FG000|Overall Study|Progressive Disease and Subsequent Death|0|||
147221996|NCT04393298|530985768|FG001|Overall Study|Progressive Disease and Subsequent Death|0|||
147221997|NCT04393298|530985769|FG002|Overall Study|Progressive Disease and Subsequent Death|0|||
147221998|NCT04393298|530985770|FG003|Overall Study|Progressive Disease and Subsequent Death|0|||
147221999|NCT04393298|530985771|FG004|Overall Study|Progressive Disease and Subsequent Death|0|||
147222000|NCT04393298|530985772|FG005|Overall Study|Progressive Disease and Subsequent Death|0|||
147222001|NCT04393298|530985773|FG006|Overall Study|Progressive Disease and Subsequent Death|1|||
147222002|NCT04393298|530985774|FG007|Overall Study|Progressive Disease and Subsequent Death|0|||
147222003|NCT04393298|530985775|FG008|Overall Study|Progressive Disease and Subsequent Death|0|||
147222004|NCT04393298|530985776|FG009|Overall Study|Progressive Disease and Subsequent Death|0|||
147222005|NCT04393298|530985777|FG010|Overall Study|Progressive Disease and Subsequent Death|0|||
147222006|NCT04393298|530985778|FG011|Overall Study|Progressive Disease and Subsequent Death|0|||
147222007|NCT04393298|530985779|FG012|Overall Study|Progressive Disease and Subsequent Death|0|||
147222008|NCT04393298|530985780|FG013|Overall Study|Progressive Disease and Subsequent Death|0|||
147222009|NCT04393298|530985781|FG014|Overall Study|Progressive Disease and Subsequent Death|0|||
147222010|NCT04393298|530985767|FG000|Overall Study|Patient Passed Away|0|||
147222011|NCT04393298|530985768|FG001|Overall Study|Patient Passed Away|0|||
147222012|NCT04393298|530985769|FG002|Overall Study|Patient Passed Away|0|||
147222013|NCT04393298|530985770|FG003|Overall Study|Patient Passed Away|0|||
147443431|NCT02634151|531788675|FG001|Overall Study|Other|1|||
147443432|NCT02347098|531788676|FG000|Overall Study|Death|1|||
147553268|NCT03734237|532181558|FG000|Overall Study|Withdrawal by Subject|7|||
147553269|NCT03734237|532181559|FG001|Overall Study|Withdrawal by Subject|9|||
147553270|NCT03734237|532181560|FG002|Overall Study|Withdrawal by Subject|10|||
147553271|NCT00818623|532181565|FG000|Overall Study|Adverse Event|1|||
147553272|NCT00818623|532181566|FG001|Overall Study|Adverse Event|0|||
147553273|NCT00818623|532181567|FG002|Overall Study|Adverse Event|1|||
147659415|NCT01064414|532576182|FG001|Core Period: Baseline to Week 26|Death|1|||
147222014|NCT04393298|530985771|FG004|Overall Study|Patient Passed Away|0|||
147222015|NCT04393298|530985772|FG005|Overall Study|Patient Passed Away|0|||
147222016|NCT04393298|530985773|FG006|Overall Study|Patient Passed Away|0|||
147222017|NCT04393298|530985774|FG007|Overall Study|Patient Passed Away|1|||
147222018|NCT04393298|530985775|FG008|Overall Study|Patient Passed Away|0|||
147222019|NCT04393298|530985776|FG009|Overall Study|Patient Passed Away|0|||
147222020|NCT04393298|530985777|FG010|Overall Study|Patient Passed Away|0|||
147222021|NCT04393298|530985778|FG011|Overall Study|Patient Passed Away|0|||
147222022|NCT04393298|530985779|FG012|Overall Study|Patient Passed Away|0|||
147222023|NCT04393298|530985780|FG013|Overall Study|Patient Passed Away|0|||
147222024|NCT04393298|530985781|FG014|Overall Study|Patient Passed Away|0|||
147222025|NCT04393298|530985767|FG000|Overall Study|Patient Deceased|0|||
147222026|NCT04393298|530985768|FG001|Overall Study|Patient Deceased|0|||
147222027|NCT04393298|530985769|FG002|Overall Study|Patient Deceased|0|||
147222028|NCT04393298|530985770|FG003|Overall Study|Patient Deceased|0|||
147222029|NCT04393298|530985771|FG004|Overall Study|Patient Deceased|0|||
147222030|NCT04393298|530985772|FG005|Overall Study|Patient Deceased|0|||
147222031|NCT04393298|530985773|FG006|Overall Study|Patient Deceased|0|||
147222032|NCT04393298|530985774|FG007|Overall Study|Patient Deceased|1|||
147222033|NCT04393298|530985775|FG008|Overall Study|Patient Deceased|0|||
147222034|NCT04393298|530985776|FG009|Overall Study|Patient Deceased|0|||
147222035|NCT04393298|530985777|FG010|Overall Study|Patient Deceased|0|||
147222036|NCT04393298|530985778|FG011|Overall Study|Patient Deceased|0|||
147222037|NCT04393298|530985779|FG012|Overall Study|Patient Deceased|0|||
147222038|NCT04393298|530985780|FG013|Overall Study|Patient Deceased|0|||
147222039|NCT04393298|530985781|FG014|Overall Study|Patient Deceased|0|||
147222040|NCT04393298|530985767|FG000|Overall Study|Patient Discharged to Hospice|0|||
147222041|NCT04393298|530985768|FG001|Overall Study|Patient Discharged to Hospice|0|||
147222042|NCT04393298|530985769|FG002|Overall Study|Patient Discharged to Hospice|0|||
147222043|NCT04393298|530985770|FG003|Overall Study|Patient Discharged to Hospice|0|||
147222044|NCT04393298|530985771|FG004|Overall Study|Patient Discharged to Hospice|0|||
147222045|NCT04393298|530985772|FG005|Overall Study|Patient Discharged to Hospice|0|||
147222046|NCT04393298|530985773|FG006|Overall Study|Patient Discharged to Hospice|0|||
147222047|NCT04393298|530985774|FG007|Overall Study|Patient Discharged to Hospice|0|||
147222048|NCT04393298|530985775|FG008|Overall Study|Patient Discharged to Hospice|1|||
147222049|NCT04393298|530985776|FG009|Overall Study|Patient Discharged to Hospice|0|||
147222050|NCT04393298|530985777|FG010|Overall Study|Patient Discharged to Hospice|0|||
147222051|NCT04393298|530985778|FG011|Overall Study|Patient Discharged to Hospice|0|||
147222052|NCT04393298|530985779|FG012|Overall Study|Patient Discharged to Hospice|0|||
147222053|NCT04393298|530985780|FG013|Overall Study|Patient Discharged to Hospice|0|||
147222054|NCT04393298|530985781|FG014|Overall Study|Patient Discharged to Hospice|0|||
147222055|NCT04393298|530985767|FG000|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
147222056|NCT04393298|530985768|FG001|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
147222057|NCT04393298|530985769|FG002|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
147222058|NCT04393298|530985770|FG003|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
147222059|NCT04393298|530985771|FG004|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
147222060|NCT04393298|530985772|FG005|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
147222061|NCT04393298|530985773|FG006|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
147222062|NCT04393298|530985774|FG007|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
147222063|NCT04393298|530985775|FG008|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
147222064|NCT04393298|530985776|FG009|Overall Study|Symptomatic Cancer - Unfit to take a call|1|||
147222065|NCT04393298|530985777|FG010|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
147222066|NCT04393298|530985778|FG011|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
147222067|NCT04393298|530985779|FG012|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
147222068|NCT04393298|530985780|FG013|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
147222069|NCT04393298|530985781|FG014|Overall Study|Symptomatic Cancer - Unfit to take a call|0|||
147222070|NCT04393298|530985767|FG000|Overall Study|Clinical Progression in Combination with AE|0|||
147222071|NCT04393298|530985768|FG001|Overall Study|Clinical Progression in Combination with AE|0|||
147222072|NCT04393298|530985769|FG002|Overall Study|Clinical Progression in Combination with AE|0|||
147222073|NCT04393298|530985770|FG003|Overall Study|Clinical Progression in Combination with AE|0|||
147222074|NCT04393298|530985771|FG004|Overall Study|Clinical Progression in Combination with AE|0|||
147222075|NCT04393298|530985772|FG005|Overall Study|Clinical Progression in Combination with AE|0|||
147222076|NCT04393298|530985773|FG006|Overall Study|Clinical Progression in Combination with AE|0|||
147222077|NCT04393298|530985774|FG007|Overall Study|Clinical Progression in Combination with AE|0|||
147222078|NCT04393298|530985775|FG008|Overall Study|Clinical Progression in Combination with AE|0|||
147222079|NCT04393298|530985776|FG009|Overall Study|Clinical Progression in Combination with AE|1|||
147222080|NCT04393298|530985777|FG010|Overall Study|Clinical Progression in Combination with AE|0|||
147222081|NCT04393298|530985778|FG011|Overall Study|Clinical Progression in Combination with AE|0|||
147222082|NCT04393298|530985779|FG012|Overall Study|Clinical Progression in Combination with AE|0|||
147222083|NCT04393298|530985780|FG013|Overall Study|Clinical Progression in Combination with AE|0|||
147222084|NCT04393298|530985781|FG014|Overall Study|Clinical Progression in Combination with AE|0|||
147222085|NCT03754972|530985784|FG000|Overall Study|Protocol Violation|25|||
147222086|NCT01155479|530985785|FG000|Part I|Adverse Event|13|||
147222087|NCT01155479|530985786|FG001|Part I|Adverse Event|8|||
147222088|NCT01155479|530985787|FG002|Part I|Adverse Event|18|||
147222089|NCT01155479|530985788|FG003|Part I|Adverse Event|7|||
147222090|NCT01155479|530985789|FG004|Part I|Adverse Event|6|||
147222091|NCT01155479|530985785|FG000|Part I|Administrative|2|||
147222092|NCT01155479|530985786|FG001|Part I|Administrative|2|||
147222093|NCT01155479|530985787|FG002|Part I|Administrative|2|||
147222094|NCT01155479|530985788|FG003|Part I|Administrative|0|||
147222095|NCT01155479|530985789|FG004|Part I|Administrative|0|||
147222096|NCT01155479|530985785|FG000|Part I|Did Not Meet Protocol Eligibility|3|||
147222097|NCT01155479|530985786|FG001|Part I|Did Not Meet Protocol Eligibility|1|||
147222098|NCT01155479|530985787|FG002|Part I|Did Not Meet Protocol Eligibility|2|||
147222099|NCT01155479|530985788|FG003|Part I|Did Not Meet Protocol Eligibility|1|||
147222100|NCT01155479|530985789|FG004|Part I|Did Not Meet Protocol Eligibility|3|||
147222101|NCT01155479|530985785|FG000|Part I|Withdrawal by Subject|11|||
147222102|NCT01155479|530985786|FG001|Part I|Withdrawal by Subject|13|||
147222103|NCT01155479|530985787|FG002|Part I|Withdrawal by Subject|8|||
147222104|NCT01155479|530985788|FG003|Part I|Withdrawal by Subject|8|||
147222105|NCT01155479|530985789|FG004|Part I|Withdrawal by Subject|9|||
147222106|NCT01155479|530985785|FG000|Part I|Lost to Follow-up|0|||
147222107|NCT01155479|530985786|FG001|Part I|Lost to Follow-up|0|||
147222108|NCT01155479|530985787|FG002|Part I|Lost to Follow-up|1|||
147222109|NCT01155479|530985788|FG003|Part I|Lost to Follow-up|1|||
147222110|NCT01155479|530985789|FG004|Part I|Lost to Follow-up|0|||
147222111|NCT01155479|530985785|FG000|Part I|Treatment Failure|3|||
147222112|NCT01155479|530985786|FG001|Part I|Treatment Failure|0|||
147222113|NCT01155479|530985787|FG002|Part I|Treatment Failure|3|||
147222114|NCT01155479|530985788|FG003|Part I|Treatment Failure|1|||
147222115|NCT01155479|530985789|FG004|Part I|Treatment Failure|2|||
147222116|NCT01155479|530985785|FG000|Part I|Did Not Receive Treatment|4|||
147222117|NCT01155479|530985786|FG001|Part I|Did Not Receive Treatment|2|||
147222118|NCT01155479|530985787|FG002|Part I|Did Not Receive Treatment|2|||
147222119|NCT01155479|530985788|FG003|Part I|Did Not Receive Treatment|6|||
147222120|NCT01155479|530985789|FG004|Part I|Did Not Receive Treatment|1|||
147222121|NCT01155479|530985785|FG000|Part I|Non-Compliance with Protocol|2|||
147222122|NCT01155479|530985786|FG001|Part I|Non-Compliance with Protocol|1|||
147443433|NCT02347098|531788677|FG001|Overall Study|Death|0|||
147443434|NCT02347098|531788676|FG000|Overall Study|Withdrawal by Subject|1|||
147443435|NCT02347098|531788677|FG001|Overall Study|Withdrawal by Subject|0|||
147443436|NCT02347098|531788676|FG000|Overall Study|Lost to Follow-up|2|||
147222123|NCT01155479|530985787|FG002|Part I|Non-Compliance with Protocol|3|||
147222124|NCT01155479|530985788|FG003|Part I|Non-Compliance with Protocol|3|||
147222125|NCT01155479|530985789|FG004|Part I|Non-Compliance with Protocol|2|||
147222126|NCT01155479|530985785|FG000|Part II|Adverse Event|7|||
147443437|NCT02347098|531788677|FG001|Overall Study|Lost to Follow-up|2|||
147553274|NCT00818623|532181568|FG003|Overall Study|Adverse Event|0|||
147553275|NCT00818623|532181569|FG004|Overall Study|Adverse Event|0|||
147553276|NCT00818623|532181570|FG005|Overall Study|Adverse Event|1|||
147553277|NCT00818623|532181571|FG006|Overall Study|Adverse Event|0|||
147553278|NCT00818623|532181572|FG007|Overall Study|Adverse Event|0|||
147553279|NCT00818623|532181565|FG000|Overall Study|Bad prostate specific antigen response|0|||
147553280|NCT00818623|532181566|FG001|Overall Study|Bad prostate specific antigen response|3|||
147553281|NCT00818623|532181567|FG002|Overall Study|Bad prostate specific antigen response|2|||
147553282|NCT00818623|532181568|FG003|Overall Study|Bad prostate specific antigen response|5|||
147553283|NCT00818623|532181569|FG004|Overall Study|Bad prostate specific antigen response|0|||
147222127|NCT01155479|530985786|FG001|Part II|Adverse Event|6|||
147222128|NCT01155479|530985787|FG002|Part II|Adverse Event|8|||
147222129|NCT01155479|530985788|FG003|Part II|Adverse Event|3|||
147222130|NCT01155479|530985789|FG004|Part II|Adverse Event|4|||
147222131|NCT01155479|530985785|FG000|Part II|Administrative|43|||
147222132|NCT01155479|530985786|FG001|Part II|Administrative|49|||
147222133|NCT01155479|530985787|FG002|Part II|Administrative|36|||
147222134|NCT01155479|530985788|FG003|Part II|Administrative|38|||
147222135|NCT01155479|530985789|FG004|Part II|Administrative|46|||
147222136|NCT01155479|530985785|FG000|Part II|Withdrawal by Subject|8|||
147222137|NCT01155479|530985786|FG001|Part II|Withdrawal by Subject|4|||
147222138|NCT01155479|530985787|FG002|Part II|Withdrawal by Subject|12|||
147222139|NCT01155479|530985788|FG003|Part II|Withdrawal by Subject|7|||
147222140|NCT01155479|530985789|FG004|Part II|Withdrawal by Subject|3|||
147222141|NCT01155479|530985785|FG000|Part II|Lost to Follow-up|1|||
147222142|NCT01155479|530985786|FG001|Part II|Lost to Follow-up|0|||
147222143|NCT01155479|530985787|FG002|Part II|Lost to Follow-up|0|||
147222144|NCT01155479|530985788|FG003|Part II|Lost to Follow-up|0|||
147222145|NCT01155479|530985789|FG004|Part II|Lost to Follow-up|1|||
147222146|NCT01155479|530985785|FG000|Part II|Treatment Failure|0|||
147222147|NCT01155479|530985786|FG001|Part II|Treatment Failure|1|||
147222148|NCT01155479|530985787|FG002|Part II|Treatment Failure|2|||
147222149|NCT01155479|530985788|FG003|Part II|Treatment Failure|0|||
147222150|NCT01155479|530985789|FG004|Part II|Treatment Failure|1|||
147222151|NCT01155479|530985785|FG000|Part II|Non-Compliance with Protocol|0|||
147222152|NCT01155479|530985786|FG001|Part II|Non-Compliance with Protocol|1|||
147222153|NCT01155479|530985787|FG002|Part II|Non-Compliance with Protocol|0|||
147222154|NCT01155479|530985788|FG003|Part II|Non-Compliance with Protocol|2|||
147222155|NCT01155479|530985789|FG004|Part II|Non-Compliance with Protocol|0|||
147222156|NCT02360605|530985790|FG000|Overall Study|Withdrawal by Subject|4|||
147222157|NCT02360605|530985791|FG001|Overall Study|Withdrawal by Subject|9|||
147222158|NCT02360605|530985790|FG000|Overall Study|Lost to Follow-up|7|||
147222159|NCT02360605|530985791|FG001|Overall Study|Lost to Follow-up|8|||
147222160|NCT02360605|530985790|FG000|Overall Study|Death|0|||
147222161|NCT02360605|530985791|FG001|Overall Study|Death|1|||
147222162|NCT02497976|530985796|FG000|Overall Study|Withdrawal by Subject|2|||
147222163|NCT02497976|530985797|FG001|Overall Study|Withdrawal by Subject|0|||
147222164|NCT02497976|530985796|FG000|Overall Study|Moved out of area|0|||
147222165|NCT02497976|530985797|FG001|Overall Study|Moved out of area|1|||
147222166|NCT00058539|530985798|FG000|Overall Study|Disease progression|24|||
147222167|NCT00058539|530985798|FG000|Overall Study|Adverse Event|3|||
147222168|NCT00058539|530985798|FG000|Overall Study|Withdrawal by Subject|5|||
147553284|NCT00818623|532181570|FG005|Overall Study|Bad prostate specific antigen response|1|||
147553285|NCT00818623|532181571|FG006|Overall Study|Bad prostate specific antigen response|0|||
147553286|NCT00818623|532181572|FG007|Overall Study|Bad prostate specific antigen response|0|||
147553287|NCT00818623|532181565|FG000|Overall Study|Withdrawal by Subject|0|||
147222169|NCT00058539|530985798|FG000|Overall Study|Physician Decision|9|||
147222170|NCT00058539|530985798|FG000|Overall Study|Death|1|||
147222171|NCT01903525|530985801|FG000|Overall Study|Lost to Follow-up|5|||
147222172|NCT01903525|530985802|FG001|Overall Study|Lost to Follow-up|9|||
147222173|NCT01903525|530985801|FG000|Overall Study|Adverse Event|0|||
147222174|NCT01903525|530985802|FG001|Overall Study|Adverse Event|1|||
147222175|NCT03977454|530985803|FG000|Overall Study|immediate postoperative revision|2|||
147222176|NCT03977454|530985804|FG001|Overall Study|immediate postoperative revision|2|||
147222177|NCT02483533|530985807|FG000|Overall Study|Lack of Efficacy|50|||
147222178|NCT02483533|530985808|FG001|Overall Study|Lack of Efficacy|50|||
147222179|NCT04365257|530985809|FG000|Overall Study|Physician Decision|1|||
147222180|NCT04365257|530985810|FG001|Overall Study|Physician Decision|0|||
147222181|NCT04365257|530985809|FG000|Overall Study|Patient Noncompliance|1|||
147222182|NCT04365257|530985810|FG001|Overall Study|Patient Noncompliance|0|||
147222183|NCT04365257|530985809|FG000|Overall Study|Withdrawal by Subject|0|||
147222184|NCT04365257|530985810|FG001|Overall Study|Withdrawal by Subject|1|||
147222185|NCT02129777|530985813|FG000|Double-Blind Period|Adverse Event|0|||
147222186|NCT02129777|530985814|FG001|Double-Blind Period|Adverse Event|0|||
147553288|NCT00818623|532181566|FG001|Overall Study|Withdrawal by Subject|1|||
147222187|NCT02129777|530985815|FG002|Double-Blind Period|Adverse Event|0|||
147222188|NCT02129777|530985816|FG003|Double-Blind Period|Adverse Event|0|||
147222189|NCT02129777|530985817|FG004|Double-Blind Period|Adverse Event|1|||
147222190|NCT02129777|530985818|FG005|Double-Blind Period|Adverse Event|0|||
147222191|NCT02129777|530985819|FG006|Double-Blind Period|Adverse Event|0|||
147222192|NCT02129777|530985813|FG000|Double-Blind Period|Lost to Follow-up|1|||
147222193|NCT02129777|530985814|FG001|Double-Blind Period|Lost to Follow-up|1|||
147222194|NCT02129777|530985815|FG002|Double-Blind Period|Lost to Follow-up|1|||
147222195|NCT02129777|530985816|FG003|Double-Blind Period|Lost to Follow-up|2|||
147222196|NCT02129777|530985817|FG004|Double-Blind Period|Lost to Follow-up|0|||
147222197|NCT02129777|530985818|FG005|Double-Blind Period|Lost to Follow-up|0|||
147222198|NCT02129777|530985819|FG006|Double-Blind Period|Lost to Follow-up|0|||
147222199|NCT02129777|530985813|FG000|Double-Blind Period|Withdrawal by Subject|2|||
147222200|NCT02129777|530985814|FG001|Double-Blind Period|Withdrawal by Subject|4|||
147222201|NCT02129777|530985815|FG002|Double-Blind Period|Withdrawal by Subject|3|||
147222202|NCT02129777|530985816|FG003|Double-Blind Period|Withdrawal by Subject|2|||
147222203|NCT02129777|530985817|FG004|Double-Blind Period|Withdrawal by Subject|3|||
147222204|NCT02129777|530985818|FG005|Double-Blind Period|Withdrawal by Subject|0|||
147222205|NCT02129777|530985819|FG006|Double-Blind Period|Withdrawal by Subject|0|||
147222206|NCT02129777|530985813|FG000|Double-Blind Period|Pregnancy|0|||
147222207|NCT02129777|530985814|FG001|Double-Blind Period|Pregnancy|0|||
147222208|NCT02129777|530985815|FG002|Double-Blind Period|Pregnancy|0|||
147222209|NCT02129777|530985816|FG003|Double-Blind Period|Pregnancy|0|||
147553289|NCT00818623|532181567|FG002|Overall Study|Withdrawal by Subject|1|||
147553290|NCT00818623|532181568|FG003|Overall Study|Withdrawal by Subject|0|||
147553291|NCT00818623|532181569|FG004|Overall Study|Withdrawal by Subject|0|||
147553292|NCT00818623|532181570|FG005|Overall Study|Withdrawal by Subject|1|||
147553293|NCT00818623|532181571|FG006|Overall Study|Withdrawal by Subject|1|||
147553294|NCT00818623|532181572|FG007|Overall Study|Withdrawal by Subject|1|||
147553295|NCT00818623|532181565|FG000|Overall Study|Protocol Violation|1|||
147553296|NCT00818623|532181566|FG001|Overall Study|Protocol Violation|0|||
147222210|NCT02129777|530985817|FG004|Double-Blind Period|Pregnancy|1|||
147222211|NCT02129777|530985818|FG005|Double-Blind Period|Pregnancy|0|||
147222212|NCT02129777|530985819|FG006|Double-Blind Period|Pregnancy|0|||
147222213|NCT02129777|530985813|FG000|Double-Blind Period|Lack of Efficacy|3|||
147222214|NCT02129777|530985814|FG001|Double-Blind Period|Lack of Efficacy|1|||
147222215|NCT02129777|530985815|FG002|Double-Blind Period|Lack of Efficacy|0|||
147222216|NCT02129777|530985816|FG003|Double-Blind Period|Lack of Efficacy|3|||
147222217|NCT02129777|530985817|FG004|Double-Blind Period|Lack of Efficacy|2|||
147222218|NCT02129777|530985818|FG005|Double-Blind Period|Lack of Efficacy|0|||
147222219|NCT02129777|530985819|FG006|Double-Blind Period|Lack of Efficacy|0|||
147222220|NCT02129777|530985813|FG000|Double-Blind Period|Other|1|||
147222221|NCT02129777|530985814|FG001|Double-Blind Period|Other|2|||
147222222|NCT02129777|530985815|FG002|Double-Blind Period|Other|0|||
147222223|NCT02129777|530985816|FG003|Double-Blind Period|Other|0|||
147222224|NCT02129777|530985817|FG004|Double-Blind Period|Other|0|||
147222225|NCT02129777|530985818|FG005|Double-Blind Period|Other|0|||
147222226|NCT02129777|530985819|FG006|Double-Blind Period|Other|0|||
147222227|NCT02129777|530985813|FG000|Open-Label Period|Lack of Efficacy|0|||
147222228|NCT02129777|530985814|FG001|Open-Label Period|Lack of Efficacy|0|||
147222229|NCT02129777|530985815|FG002|Open-Label Period|Lack of Efficacy|0|||
147222230|NCT02129777|530985816|FG003|Open-Label Period|Lack of Efficacy|0|||
147222231|NCT02129777|530985817|FG004|Open-Label Period|Lack of Efficacy|0|||
147222232|NCT02129777|530985818|FG005|Open-Label Period|Lack of Efficacy|0|||
147222233|NCT02129777|530985819|FG006|Open-Label Period|Lack of Efficacy|5|||
147222234|NCT02129777|530985813|FG000|Open-Label Period|Lost to Follow-up|0|||
147222235|NCT02129777|530985814|FG001|Open-Label Period|Lost to Follow-up|0|||
147222236|NCT02129777|530985815|FG002|Open-Label Period|Lost to Follow-up|0|||
147222237|NCT02129777|530985816|FG003|Open-Label Period|Lost to Follow-up|0|||
147222238|NCT02129777|530985817|FG004|Open-Label Period|Lost to Follow-up|0|||
147222239|NCT02129777|530985818|FG005|Open-Label Period|Lost to Follow-up|1|||
147222240|NCT02129777|530985819|FG006|Open-Label Period|Lost to Follow-up|1|||
147222241|NCT02129777|530985813|FG000|Open-Label Period|Withdrawal by Subject|0|||
147222242|NCT02129777|530985814|FG001|Open-Label Period|Withdrawal by Subject|0|||
147222243|NCT02129777|530985815|FG002|Open-Label Period|Withdrawal by Subject|0|||
147222244|NCT02129777|530985816|FG003|Open-Label Period|Withdrawal by Subject|0|||
147222245|NCT02129777|530985817|FG004|Open-Label Period|Withdrawal by Subject|0|||
147222246|NCT02129777|530985818|FG005|Open-Label Period|Withdrawal by Subject|1|||
147553297|NCT00818623|532181567|FG002|Overall Study|Protocol Violation|0|||
147222247|NCT02129777|530985819|FG006|Open-Label Period|Withdrawal by Subject|3|||
147222248|NCT02129777|530985813|FG000|Open-Label Period|Study Termination|0|||
147309587|NCT00152971|531300118|FG001|Overall Study|Withdrawal by Subject|8|||
147553298|NCT00818623|532181568|FG003|Overall Study|Protocol Violation|0|||
147222249|NCT02129777|530985814|FG001|Open-Label Period|Study Termination|0|||
147222250|NCT02129777|530985815|FG002|Open-Label Period|Study Termination|0|||
147222251|NCT02129777|530985816|FG003|Open-Label Period|Study Termination|0|||
147222252|NCT02129777|530985817|FG004|Open-Label Period|Study Termination|0|||
147222253|NCT02129777|530985818|FG005|Open-Label Period|Study Termination|10|||
147222254|NCT02129777|530985819|FG006|Open-Label Period|Study Termination|39|||
147222255|NCT01609478|530985824|FG000|Overall Study|Adverse Event|3|||
147222256|NCT01609478|530985825|FG001|Overall Study|Adverse Event|1|||
147222257|NCT01609478|530985826|FG002|Overall Study|Adverse Event|5|||
147222258|NCT01609478|530985824|FG000|Overall Study|Protocol Deviation|0|||
147222259|NCT01609478|530985825|FG001|Overall Study|Protocol Deviation|1|||
147222260|NCT01609478|530985826|FG002|Overall Study|Protocol Deviation|1|||
147222261|NCT01609478|530985824|FG000|Overall Study|Non-Compliance with study treatment|1|||
147222262|NCT01609478|530985825|FG001|Overall Study|Non-Compliance with study treatment|0|||
147222263|NCT01609478|530985826|FG002|Overall Study|Non-Compliance with study treatment|0|||
147222264|NCT01609478|530985824|FG000|Overall Study|Physician Decision|1|||
147222265|NCT01609478|530985825|FG001|Overall Study|Physician Decision|0|||
147222266|NCT01609478|530985826|FG002|Overall Study|Physician Decision|1|||
147222267|NCT01609478|530985824|FG000|Overall Study|Withdrawal by Subject|2|||
147222268|NCT01609478|530985825|FG001|Overall Study|Withdrawal by Subject|0|||
147222269|NCT01609478|530985826|FG002|Overall Study|Withdrawal by Subject|2|||
147222270|NCT03116347|530985827|FG000|Overall Study|Withdrawal by Subject|1|||
147222271|NCT03116347|530985828|FG001|Overall Study|Withdrawal by Subject|2|||
147222272|NCT00476047|530985829|FG000|Overall Study|Lost to Follow-up|1|||
147222273|NCT04966741|530985830|FG000|Overall Study|Lost to Follow-up|1|||
147222274|NCT04966741|530985831|FG001|Overall Study|Lost to Follow-up|0|||
147222275|NCT02241889|530985836|FG000|Overall Study|device issues|0|||
147222276|NCT02241889|530985837|FG001|Overall Study|device issues|0|||
147222277|NCT02241889|530985838|FG002|Overall Study|device issues|1|||
147222278|NCT02241889|530985839|FG003|Overall Study|device issues|0|||
147222279|NCT02241889|530985840|FG004|Overall Study|device issues|0|||
147222280|NCT02241889|530985841|FG005|Overall Study|device issues|0|||
147222281|NCT02241889|530985836|FG000|Overall Study|Withdrawal by Subject|0|||
147222282|NCT02241889|530985837|FG001|Overall Study|Withdrawal by Subject|0|||
147222283|NCT02241889|530985838|FG002|Overall Study|Withdrawal by Subject|0|||
147222284|NCT02241889|530985839|FG003|Overall Study|Withdrawal by Subject|0|||
147222285|NCT02241889|530985840|FG004|Overall Study|Withdrawal by Subject|0|||
147222286|NCT02241889|530985841|FG005|Overall Study|Withdrawal by Subject|1|||
147222287|NCT00509262|530985842|FG000|Overall Study|Adverse Event|16|||
147222288|NCT00509262|530985843|FG001|Overall Study|Adverse Event|18|||
147222289|NCT00509262|530985842|FG000|Overall Study|Other|2|||
147222290|NCT00509262|530985843|FG001|Overall Study|Other|2|||
147222291|NCT00509262|530985842|FG000|Overall Study|Lack of Efficacy|1|||
147222292|NCT00509262|530985843|FG001|Overall Study|Lack of Efficacy|0|||
147222293|NCT00509262|530985842|FG000|Overall Study|Lost to Follow-up|1|||
147222294|NCT00509262|530985843|FG001|Overall Study|Lost to Follow-up|6|||
147222295|NCT00509262|530985842|FG000|Overall Study|Physician Decision|1|||
147222296|NCT00509262|530985843|FG001|Overall Study|Physician Decision|3|||
147222297|NCT00509262|530985842|FG000|Overall Study|Protocol Violation|2|||
147222298|NCT00509262|530985843|FG001|Overall Study|Protocol Violation|2|||
147222299|NCT00509262|530985842|FG000|Overall Study|Withdrawal by Subject|24|||
147222300|NCT00509262|530985843|FG001|Overall Study|Withdrawal by Subject|11|||
147222301|NCT01853618|530985844|FG000|Overall Study|Bile duct stent blockage/progressive dis|1|||
147222302|NCT01853618|530985845|FG001|Overall Study|Bile duct stent blockage/progressive dis|0|||
147222303|NCT01853618|530985846|FG002|Overall Study|Bile duct stent blockage/progressive dis|0|||
147222304|NCT01853618|530985847|FG003|Overall Study|Bile duct stent blockage/progressive dis|0|||
147222305|NCT01853618|530985848|FG004|Overall Study|Bile duct stent blockage/progressive dis|0|||
147222306|NCT01853618|530985844|FG000|Overall Study|Progressive disease|1|||
147222307|NCT01853618|530985845|FG001|Overall Study|Progressive disease|1|||
147222308|NCT01853618|530985846|FG002|Overall Study|Progressive disease|1|||
147222309|NCT01853618|530985847|FG003|Overall Study|Progressive disease|1|||
147222310|NCT01853618|530985848|FG004|Overall Study|Progressive disease|2|||
147222311|NCT01853618|530985844|FG000|Overall Study|Physician Decision|0|||
147222312|NCT01853618|530985845|FG001|Overall Study|Physician Decision|1|||
147222313|NCT01853618|530985846|FG002|Overall Study|Physician Decision|1|||
147222314|NCT01853618|530985847|FG003|Overall Study|Physician Decision|0|||
147222315|NCT01853618|530985848|FG004|Overall Study|Physician Decision|0|||
147222316|NCT01853618|530985844|FG000|Overall Study|Refused further treatment|0|||
147222317|NCT01853618|530985845|FG001|Overall Study|Refused further treatment|0|||
147222318|NCT01853618|530985846|FG002|Overall Study|Refused further treatment|0|||
147222319|NCT01853618|530985847|FG003|Overall Study|Refused further treatment|0|||
147222320|NCT01853618|530985848|FG004|Overall Study|Refused further treatment|1|||
147222321|NCT01658813|530985849|FG000|Overall Study|Disease progression|3|||
147222322|NCT02398227|530985854|FG000|Overall Study|Lost to Follow-up|21|||
147222323|NCT02398227|530985855|FG001|Overall Study|Lost to Follow-up|12|||
147222324|NCT02398227|530985854|FG000|Overall Study|Withdrawal by Subject|5|||
147222325|NCT02398227|530985855|FG001|Overall Study|Withdrawal by Subject|6|||
147222326|NCT02398227|530985854|FG000|Overall Study|Removed from treatment and dropped out|1|||
147222327|NCT02398227|530985855|FG001|Overall Study|Removed from treatment and dropped out|0|||
147222328|NCT01715129|530985856|FG000|Overall Study|Adverse Event, fatal|1|||
147222329|NCT01715129|530985856|FG000|Overall Study|Lack of Efficacy|3|||
147222330|NCT01715129|530985856|FG000|Overall Study|Protocol Violation|1|||
147222331|NCT01715129|530985856|FG000|Overall Study|Consent Withdrawn|2|||
147222332|NCT01715129|530985856|FG000|Overall Study|Lost to Follow-up|1|||
147222333|NCT01715129|530985856|FG000|Overall Study|Other|1|||
147222334|NCT02009384|530985857|FG000|Overall Study|Death|2|||
147222335|NCT01146860|530985858|FG000|Overall Study|Withdrawal by Subject|0|||
147222336|NCT01146860|530985859|FG001|Overall Study|Withdrawal by Subject|1|||
147222337|NCT00722371|530985860|FG000|Overall Study|Adverse Event|6|||
147222338|NCT00722371|530985861|FG001|Overall Study|Adverse Event|13|||
147222339|NCT00722371|530985862|FG002|Overall Study|Adverse Event|9|||
147222340|NCT00722371|530985863|FG003|Overall Study|Adverse Event|10|||
147222341|NCT00722371|530985864|FG004|Overall Study|Adverse Event|6|||
147222342|NCT00722371|530985865|FG005|Overall Study|Adverse Event|8|||
147222343|NCT00722371|530985866|FG006|Overall Study|Adverse Event|4|||
147222344|NCT00722371|530985860|FG000|Overall Study|Contraindication|0|||
147222345|NCT00722371|530985861|FG001|Overall Study|Contraindication|0|||
147222346|NCT00722371|530985862|FG002|Overall Study|Contraindication|1|||
147222347|NCT00722371|530985863|FG003|Overall Study|Contraindication|0|||
147222348|NCT00722371|530985864|FG004|Overall Study|Contraindication|0|||
147222349|NCT00722371|530985865|FG005|Overall Study|Contraindication|0|||
147222350|NCT00722371|530985866|FG006|Overall Study|Contraindication|0|||
147222351|NCT00722371|530985860|FG000|Overall Study|Creatinine / Creatinine clearance|2|||
147222352|NCT00722371|530985861|FG001|Overall Study|Creatinine / Creatinine clearance|1|||
147222353|NCT00722371|530985862|FG002|Overall Study|Creatinine / Creatinine clearance|2|||
147222354|NCT00722371|530985863|FG003|Overall Study|Creatinine / Creatinine clearance|3|||
147222355|NCT00722371|530985864|FG004|Overall Study|Creatinine / Creatinine clearance|2|||
147222356|NCT00722371|530985865|FG005|Overall Study|Creatinine / Creatinine clearance|1|||
147222357|NCT00722371|530985866|FG006|Overall Study|Creatinine / Creatinine clearance|1|||
147222358|NCT00722371|530985860|FG000|Overall Study|Excluded medication|0|||
147222359|NCT00722371|530985861|FG001|Overall Study|Excluded medication|1|||
147222360|NCT00722371|530985862|FG002|Overall Study|Excluded medication|1|||
147222361|NCT00722371|530985863|FG003|Overall Study|Excluded medication|0|||
147222362|NCT00722371|530985864|FG004|Overall Study|Excluded medication|0|||
147222363|NCT00722371|530985865|FG005|Overall Study|Excluded medication|0|||
147222364|NCT00722371|530985866|FG006|Overall Study|Excluded medication|1|||
147222365|NCT00722371|530985860|FG000|Overall Study|Hyperglycemia|2|||
147222366|NCT00722371|530985861|FG001|Overall Study|Hyperglycemia|6|||
147222367|NCT00722371|530985862|FG002|Overall Study|Hyperglycemia|4|||
147222368|NCT00722371|530985863|FG003|Overall Study|Hyperglycemia|2|||
147222369|NCT00722371|530985864|FG004|Overall Study|Hyperglycemia|5|||
147222370|NCT00722371|530985865|FG005|Overall Study|Hyperglycemia|1|||
147222371|NCT00722371|530985866|FG006|Overall Study|Hyperglycemia|1|||
147222372|NCT00722371|530985860|FG000|Overall Study|Hypoglycemia|1|||
147222373|NCT00722371|530985861|FG001|Overall Study|Hypoglycemia|0|||
147222374|NCT00722371|530985862|FG002|Overall Study|Hypoglycemia|0|||
147222375|NCT00722371|530985863|FG003|Overall Study|Hypoglycemia|0|||
147222376|NCT00722371|530985864|FG004|Overall Study|Hypoglycemia|0|||
147222377|NCT00722371|530985865|FG005|Overall Study|Hypoglycemia|0|||
147222378|NCT00722371|530985866|FG006|Overall Study|Hypoglycemia|0|||
147222379|NCT00722371|530985860|FG000|Overall Study|Lack of Efficacy|4|||
147222380|NCT00722371|530985861|FG001|Overall Study|Lack of Efficacy|6|||
147222381|NCT00722371|530985862|FG002|Overall Study|Lack of Efficacy|6|||
147222382|NCT00722371|530985863|FG003|Overall Study|Lack of Efficacy|6|||
147222383|NCT00722371|530985864|FG004|Overall Study|Lack of Efficacy|2|||
147222384|NCT00722371|530985865|FG005|Overall Study|Lack of Efficacy|3|||
147222385|NCT00722371|530985866|FG006|Overall Study|Lack of Efficacy|0|||
147222386|NCT00722371|530985860|FG000|Overall Study|Lost to Follow-up|11|||
147222387|NCT00722371|530985861|FG001|Overall Study|Lost to Follow-up|14|||
147222388|NCT00722371|530985862|FG002|Overall Study|Lost to Follow-up|21|||
147222389|NCT00722371|530985863|FG003|Overall Study|Lost to Follow-up|13|||
147222390|NCT00722371|530985864|FG004|Overall Study|Lost to Follow-up|8|||
147222391|NCT00722371|530985865|FG005|Overall Study|Lost to Follow-up|16|||
147222392|NCT00722371|530985866|FG006|Overall Study|Lost to Follow-up|13|||
147222393|NCT00722371|530985860|FG000|Overall Study|Physician Decision|5|||
147222394|NCT00722371|530985861|FG001|Overall Study|Physician Decision|2|||
147222395|NCT00722371|530985862|FG002|Overall Study|Physician Decision|2|||
147222396|NCT00722371|530985863|FG003|Overall Study|Physician Decision|5|||
147222397|NCT00722371|530985864|FG004|Overall Study|Physician Decision|2|||
147222398|NCT00722371|530985865|FG005|Overall Study|Physician Decision|3|||
147222399|NCT00722371|530985866|FG006|Overall Study|Physician Decision|4|||
147222400|NCT00722371|530985860|FG000|Overall Study|Pregnancy|1|||
147222401|NCT00722371|530985861|FG001|Overall Study|Pregnancy|1|||
147222402|NCT00722371|530985862|FG002|Overall Study|Pregnancy|0|||
147222403|NCT00722371|530985863|FG003|Overall Study|Pregnancy|0|||
147222404|NCT00722371|530985864|FG004|Overall Study|Pregnancy|0|||
147222405|NCT00722371|530985865|FG005|Overall Study|Pregnancy|1|||
147222406|NCT00722371|530985866|FG006|Overall Study|Pregnancy|0|||
147222407|NCT00722371|530985860|FG000|Overall Study|Protocol Violation|6|||
147222408|NCT00722371|530985861|FG001|Overall Study|Protocol Violation|1|||
147222409|NCT00722371|530985862|FG002|Overall Study|Protocol Violation|0|||
147222410|NCT00722371|530985863|FG003|Overall Study|Protocol Violation|1|||
147222411|NCT00722371|530985864|FG004|Overall Study|Protocol Violation|4|||
147222412|NCT00722371|530985865|FG005|Overall Study|Protocol Violation|2|||
147222413|NCT00722371|530985866|FG006|Overall Study|Protocol Violation|1|||
147222414|NCT00722371|530985860|FG000|Overall Study|Withdrawal by Subject|18|||
147222415|NCT00722371|530985861|FG001|Overall Study|Withdrawal by Subject|27|||
147222416|NCT00722371|530985862|FG002|Overall Study|Withdrawal by Subject|19|||
147222417|NCT00722371|530985863|FG003|Overall Study|Withdrawal by Subject|23|||
147222418|NCT00722371|530985864|FG004|Overall Study|Withdrawal by Subject|19|||
147222419|NCT00722371|530985865|FG005|Overall Study|Withdrawal by Subject|18|||
147222420|NCT00722371|530985866|FG006|Overall Study|Withdrawal by Subject|26|||
147222421|NCT01092832|530985867|FG000|Overall Study|Other|1|||
147222422|NCT01092832|530985868|FG001|Overall Study|Other|0|||
147222423|NCT02674854|530985869|FG000|Overall Study|Adverse Event|17|||
147222424|NCT02674854|530985870|FG001|Overall Study|Adverse Event|15|||
147222425|NCT02674854|530985871|FG002|Overall Study|Adverse Event|5|||
147222426|NCT02674854|530985869|FG000|Overall Study|Withdrawal by Subject|1|||
147222427|NCT02674854|530985870|FG001|Overall Study|Withdrawal by Subject|5|||
147222428|NCT02674854|530985871|FG002|Overall Study|Withdrawal by Subject|4|||
147222429|NCT02674854|530985869|FG000|Overall Study|No-compliant subject|1|||
147222430|NCT02674854|530985870|FG001|Overall Study|No-compliant subject|0|||
147222431|NCT02674854|530985871|FG002|Overall Study|No-compliant subject|1|||
147553299|NCT00818623|532181569|FG004|Overall Study|Protocol Violation|1|||
147222432|NCT02674854|530985869|FG000|Overall Study|Lost to Follow-up|1|||
147553300|NCT00818623|532181570|FG005|Overall Study|Protocol Violation|0|||
147222433|NCT02674854|530985870|FG001|Overall Study|Lost to Follow-up|0|||
147553301|NCT00818623|532181571|FG006|Overall Study|Protocol Violation|1|||
147553302|NCT00818623|532181572|FG007|Overall Study|Protocol Violation|0|||
147553303|NCT00818623|532181565|FG000|Overall Study|Need of additional treatment|0|||
147553304|NCT00818623|532181566|FG001|Overall Study|Need of additional treatment|0|||
147553305|NCT00818623|532181567|FG002|Overall Study|Need of additional treatment|0|||
147553306|NCT00818623|532181568|FG003|Overall Study|Need of additional treatment|0|||
147553307|NCT00818623|532181569|FG004|Overall Study|Need of additional treatment|1|||
147553308|NCT00818623|532181570|FG005|Overall Study|Need of additional treatment|0|||
147553309|NCT00818623|532181571|FG006|Overall Study|Need of additional treatment|0|||
147553310|NCT00818623|532181572|FG007|Overall Study|Need of additional treatment|0|||
147553311|NCT00818623|532181565|FG000|Overall Study|Lack of trial drug at site|0|||
147553312|NCT00818623|532181566|FG001|Overall Study|Lack of trial drug at site|0|||
147553313|NCT00818623|532181567|FG002|Overall Study|Lack of trial drug at site|0|||
147553314|NCT00818623|532181568|FG003|Overall Study|Lack of trial drug at site|0|||
147553315|NCT00818623|532181569|FG004|Overall Study|Lack of trial drug at site|2|||
147553316|NCT00818623|532181570|FG005|Overall Study|Lack of trial drug at site|0|||
147553317|NCT00818623|532181571|FG006|Overall Study|Lack of trial drug at site|1|||
147553318|NCT00818623|532181572|FG007|Overall Study|Lack of trial drug at site|0|||
147553319|NCT00818623|532181565|FG000|Overall Study|Disease progression|0|||
147553320|NCT00818623|532181566|FG001|Overall Study|Disease progression|0|||
147553321|NCT00818623|532181567|FG002|Overall Study|Disease progression|0|||
147553322|NCT00818623|532181568|FG003|Overall Study|Disease progression|0|||
147553323|NCT00818623|532181569|FG004|Overall Study|Disease progression|0|||
147553324|NCT00818623|532181570|FG005|Overall Study|Disease progression|0|||
147553325|NCT00818623|532181571|FG006|Overall Study|Disease progression|1|||
147553326|NCT00818623|532181572|FG007|Overall Study|Disease progression|0|||
147553327|NCT00617461|532181573|FG000|First Treatment Intervention Period|Adverse Event|2|||
147553328|NCT00617461|532181574|FG001|First Treatment Intervention Period|Adverse Event|0|||
147553329|NCT00617461|532181573|FG000|First Treatment Intervention Period|Lack of Efficacy|1|||
147222434|NCT02674854|530985871|FG002|Overall Study|Lost to Follow-up|2|||
147222435|NCT02674854|530985869|FG000|Overall Study|Lack of Efficacy|0|||
147222436|NCT02674854|530985870|FG001|Overall Study|Lack of Efficacy|3|||
147553330|NCT00617461|532181574|FG001|First Treatment Intervention Period|Lack of Efficacy|0|||
147553331|NCT00617461|532181573|FG000|First Treatment Intervention Period|Protocol Violation|2|||
147553332|NCT00617461|532181574|FG001|First Treatment Intervention Period|Protocol Violation|1|||
147553333|NCT00617461|532181573|FG000|First Treatment Intervention Period|Lost to Follow-up|0|||
147553334|NCT00617461|532181574|FG001|First Treatment Intervention Period|Lost to Follow-up|1|||
147222437|NCT02674854|530985871|FG002|Overall Study|Lack of Efficacy|0|||
147553335|NCT00617461|532181573|FG000|First Treatment Intervention Period|Investigator Discretion|1|||
147553336|NCT00617461|532181574|FG001|First Treatment Intervention Period|Investigator Discretion|1|||
147553337|NCT00617461|532181573|FG000|First Treatment Intervention Period|Withdrawal by Subject|4|||
147553338|NCT00617461|532181574|FG001|First Treatment Intervention Period|Withdrawal by Subject|0|||
147553339|NCT00617461|532181573|FG000|4-Day Crossover Period|Withdrawal by Subject|1|||
147553340|NCT00617461|532181574|FG001|4-Day Crossover Period|Withdrawal by Subject|0|||
147222438|NCT02674854|530985869|FG000|Overall Study|Disallowed Concurrent Medication|2|||
147222439|NCT02674854|530985870|FG001|Overall Study|Disallowed Concurrent Medication|2|||
147222440|NCT02674854|530985871|FG002|Overall Study|Disallowed Concurrent Medication|0|||
147222441|NCT02674854|530985869|FG000|Overall Study|Protocol Violation|1|||
147222442|NCT02674854|530985870|FG001|Overall Study|Protocol Violation|1|||
147222443|NCT02674854|530985871|FG002|Overall Study|Protocol Violation|2|||
147222444|NCT02674854|530985869|FG000|Overall Study|Death|0|||
147222445|NCT02674854|530985870|FG001|Overall Study|Death|1|||
147222446|NCT02674854|530985871|FG002|Overall Study|Death|0|||
147222447|NCT02674854|530985869|FG000|Overall Study|Subject missed V6.2|1|||
147222448|NCT02674854|530985870|FG001|Overall Study|Subject missed V6.2|0|||
147222449|NCT02674854|530985871|FG002|Overall Study|Subject missed V6.2|0|||
147222450|NCT02635646|530985873|FG000|Overall Study|Lost to Follow-up|24|||
147222451|NCT02635646|530985874|FG001|Overall Study|Lost to Follow-up|25|||
147222452|NCT02635646|530985873|FG000|Overall Study|Pregnancy|1|||
147222453|NCT02635646|530985874|FG001|Overall Study|Pregnancy|1|||
147222454|NCT00913692|530985875|FG000|Screening (4 Months)|Physician Decision|3|||
147222455|NCT00913692|530985875|FG000|Screening (4 Months)|Not eligible after screening phase.|6|||
147222456|NCT00913692|530985875|FG000|Treatment Phase 1 (5 Months)|Physician Decision|1|||
147553341|NCT00617461|532181573|FG000|Second Treatment Intervention Period|Adverse Event|0|||
147553342|NCT00617461|532181574|FG001|Second Treatment Intervention Period|Adverse Event|1|||
147553343|NCT00617461|532181573|FG000|Second Treatment Intervention Period|Lack of Efficacy|0|||
147553344|NCT00617461|532181574|FG001|Second Treatment Intervention Period|Lack of Efficacy|3|||
147553345|NCT00617461|532181573|FG000|6-Day Down-Titration Period|Withdrawal by Subject|1|||
147553346|NCT00617461|532181574|FG001|6-Day Down-Titration Period|Withdrawal by Subject|0|||
147553347|NCT00617461|532181573|FG000|6-Day Down-Titration Period|Did Not Attend Down-titration Visit|1|||
147553348|NCT00617461|532181574|FG001|6-Day Down-Titration Period|Did Not Attend Down-titration Visit|2|||
147553349|NCT00358826|532181575|FG000|Core Study|Adverse Event|1|||
147553350|NCT00358826|532181576|FG001|Core Study|Adverse Event|3|||
147553351|NCT00358826|532181577|FG002|Core Study|Adverse Event|1|||
147553352|NCT00358826|532181578|FG003|Core Study|Adverse Event|1|||
147553353|NCT00358826|532181579|FG004|Core Study|Adverse Event|0|||
147553354|NCT00358826|532181580|FG005|Core Study|Adverse Event|0|||
147553355|NCT00358826|532181581|FG006|Core Study|Adverse Event|0|||
147553356|NCT00358826|532181582|FG007|Core Study|Adverse Event|0|||
147553357|NCT00358826|532181575|FG000|Core Study|Withdrawal by Subject|2|||
147553358|NCT00358826|532181576|FG001|Core Study|Withdrawal by Subject|2|||
147553359|NCT00358826|532181577|FG002|Core Study|Withdrawal by Subject|0|||
147553360|NCT00358826|532181578|FG003|Core Study|Withdrawal by Subject|0|||
147553361|NCT00358826|532181579|FG004|Core Study|Withdrawal by Subject|0|||
147553362|NCT00358826|532181580|FG005|Core Study|Withdrawal by Subject|0|||
147553363|NCT00358826|532181581|FG006|Core Study|Withdrawal by Subject|0|||
147553364|NCT00358826|532181582|FG007|Core Study|Withdrawal by Subject|0|||
147553365|NCT00358826|532181575|FG000|Core Study|Lost to Follow-up|0|||
147553366|NCT00358826|532181576|FG001|Core Study|Lost to Follow-up|0|||
147553367|NCT00358826|532181577|FG002|Core Study|Lost to Follow-up|0|||
147553368|NCT00358826|532181578|FG003|Core Study|Lost to Follow-up|1|||
147553369|NCT00358826|532181579|FG004|Core Study|Lost to Follow-up|0|||
147553370|NCT00358826|532181580|FG005|Core Study|Lost to Follow-up|0|||
147553371|NCT00358826|532181581|FG006|Core Study|Lost to Follow-up|0|||
147553372|NCT00358826|532181582|FG007|Core Study|Lost to Follow-up|0|||
147553373|NCT00358826|532181575|FG000|Core Study|Physician Decision|0|||
147553374|NCT00358826|532181576|FG001|Core Study|Physician Decision|0|||
147553375|NCT00358826|532181577|FG002|Core Study|Physician Decision|1|||
147553376|NCT00358826|532181578|FG003|Core Study|Physician Decision|0|||
147553377|NCT00358826|532181579|FG004|Core Study|Physician Decision|0|||
147553378|NCT00358826|532181580|FG005|Core Study|Physician Decision|0|||
147553379|NCT00358826|532181581|FG006|Core Study|Physician Decision|0|||
147553380|NCT00358826|532181582|FG007|Core Study|Physician Decision|0|||
147553381|NCT00358826|532181575|FG000|MDCT Substudy|Adverse Event|0|||
147553382|NCT00358826|532181576|FG001|MDCT Substudy|Adverse Event|0|||
147553383|NCT00358826|532181577|FG002|MDCT Substudy|Adverse Event|0|||
147553384|NCT00358826|532181578|FG003|MDCT Substudy|Adverse Event|0|||
147553385|NCT00358826|532181579|FG004|MDCT Substudy|Adverse Event|1|||
147553386|NCT00358826|532181580|FG005|MDCT Substudy|Adverse Event|0|||
147222457|NCT03761797|530985876|FG000|Overall Study|Changing hospital|11|||
147222458|NCT03761797|530985876|FG000|Overall Study|Improvement/remission|6|||
147222459|NCT03761797|530985876|FG000|Overall Study|Withdrawal by Subject|19|||
147222460|NCT03761797|530985876|FG000|Overall Study|Lost to Follow-up|33|||
147222461|NCT03761797|530985876|FG000|Overall Study|Adverse Event|37|||
147222462|NCT03761797|530985876|FG000|Overall Study|Case report form (CRF) not collected|5|||
147222463|NCT03761797|530985876|FG000|Overall Study|No patient visit after entry|13|||
147222464|NCT03761797|530985876|FG000|Overall Study|Switch to other diabetes medication|10|||
147222465|NCT03761797|530985876|FG000|Overall Study|Prevention for recurrence of cystitis|1|||
147222466|NCT03761797|530985876|FG000|Overall Study|Postoperative therapy of esophageal cancer|1|||
147222467|NCT03761797|530985876|FG000|Overall Study|Insufficient effectives|2|||
147222468|NCT03761797|530985876|FG000|Overall Study|Excessive alcohol intake|1|||
147222469|NCT00879879|530985881|FG000|Overall Study|Death|1|||
147222470|NCT00879879|530985881|FG000|Overall Study|Withdrawal by Subject|1|||
147222471|NCT00879879|530985881|FG000|Overall Study|Physician Decision|1|||
147443438|NCT02347098|531788676|FG000|Overall Study|Refuse Follow-up Visit|1|||
147443439|NCT02347098|531788677|FG001|Overall Study|Refuse Follow-up Visit|5|||
147222472|NCT00645788|530985886|FG000|Overall Study|Did not receive study drug|1|||
147222473|NCT00645788|530985887|FG001|Overall Study|Did not receive study drug|1|||
147443440|NCT02347098|531788676|FG000|Overall Study|no visit due to illness|2|||
147222474|NCT00645788|530985888|FG002|Overall Study|Did not receive study drug|0|||
147222475|NCT00645788|530985889|FG003|Overall Study|Did not receive study drug|0|||
147222476|NCT00645788|530985886|FG000|Overall Study|Adverse Event|4|||
147222477|NCT00645788|530985887|FG001|Overall Study|Adverse Event|9|||
147222478|NCT00645788|530985888|FG002|Overall Study|Adverse Event|5|||
147222479|NCT00645788|530985889|FG003|Overall Study|Adverse Event|3|||
147222480|NCT00645788|530985886|FG000|Overall Study|Lost to Follow-up|1|||
147222481|NCT00645788|530985887|FG001|Overall Study|Lost to Follow-up|0|||
147222482|NCT00645788|530985888|FG002|Overall Study|Lost to Follow-up|0|||
147222483|NCT00645788|530985889|FG003|Overall Study|Lost to Follow-up|0|||
147222484|NCT00645788|530985886|FG000|Overall Study|Protocol Violation|1|||
147222485|NCT00645788|530985887|FG001|Overall Study|Protocol Violation|0|||
147222486|NCT00645788|530985888|FG002|Overall Study|Protocol Violation|2|||
147222487|NCT00645788|530985889|FG003|Overall Study|Protocol Violation|0|||
147222488|NCT00645788|530985886|FG000|Overall Study|Withdrawal by Subject|0|||
147222489|NCT00645788|530985887|FG001|Overall Study|Withdrawal by Subject|1|||
147222490|NCT00645788|530985888|FG002|Overall Study|Withdrawal by Subject|0|||
147222491|NCT00645788|530985889|FG003|Overall Study|Withdrawal by Subject|2|||
147222492|NCT00645788|530985886|FG000|Overall Study|Pulmonary exacerbation|13|||
147222493|NCT00645788|530985887|FG001|Overall Study|Pulmonary exacerbation|16|||
147222494|NCT00645788|530985888|FG002|Overall Study|Pulmonary exacerbation|11|||
147222495|NCT00645788|530985889|FG003|Overall Study|Pulmonary exacerbation|9|||
147222496|NCT03149848|530985890|FG000|Period 1 (Day 1 to Day 14)|Protocol-Defined Stopping criteria|1|||
147222497|NCT03149848|530985890|FG000|Period 2 (Day 15 to Day 28)|Adverse Event|2|||
147222498|NCT00400153|530985895|FG000|Overall Study|AE due to study disease worsening|14|||
147222499|NCT00400153|530985896|FG001|Overall Study|AE due to study disease worsening|19|||
147222500|NCT00400153|530985897|FG002|Overall Study|AE due to study disease worsening|20|||
147222501|NCT00400153|530985895|FG000|Overall Study|AE due to other disease worsening|2|||
147222502|NCT00400153|530985896|FG001|Overall Study|AE due to other disease worsening|1|||
147222503|NCT00400153|530985897|FG002|Overall Study|AE due to other disease worsening|0|||
147222504|NCT00400153|530985895|FG000|Overall Study|AE due to other condition|3|||
147222505|NCT00400153|530985896|FG001|Overall Study|AE due to other condition|14|||
147222506|NCT00400153|530985897|FG002|Overall Study|AE due to other condition|15|||
147222507|NCT00400153|530985895|FG000|Overall Study|Protocol Violation|7|||
147222508|NCT00400153|530985896|FG001|Overall Study|Protocol Violation|4|||
147222509|NCT00400153|530985897|FG002|Overall Study|Protocol Violation|9|||
147222510|NCT00400153|530985895|FG000|Overall Study|Lost to Follow-up|2|||
147222511|NCT00400153|530985896|FG001|Overall Study|Lost to Follow-up|1|||
147222512|NCT00400153|530985897|FG002|Overall Study|Lost to Follow-up|4|||
147222513|NCT00400153|530985895|FG000|Overall Study|Withdrawal by Subject|12|||
147222514|NCT00400153|530985896|FG001|Overall Study|Withdrawal by Subject|11|||
147222515|NCT00400153|530985897|FG002|Overall Study|Withdrawal by Subject|10|||
147222516|NCT00400153|530985895|FG000|Overall Study|Other reasons - not mentioned above|8|||
147222517|NCT00400153|530985896|FG001|Overall Study|Other reasons - not mentioned above|5|||
147222518|NCT00400153|530985897|FG002|Overall Study|Other reasons - not mentioned above|3|||
147222519|NCT00327470|530985900|FG000|Overall Study|Randomized, but not treated|0|||
147222520|NCT00327470|530985901|FG001|Overall Study|Randomized, but not treated|2|||
147222521|NCT00327470|530985900|FG000|Overall Study|Adverse Event|9|||
147222522|NCT00327470|530985901|FG001|Overall Study|Adverse Event|14|||
147222523|NCT00327470|530985900|FG000|Overall Study|Lack of Efficacy|7|||
147222524|NCT00327470|530985901|FG001|Overall Study|Lack of Efficacy|19|||
147222525|NCT00327470|530985900|FG000|Overall Study|Other|5|||
147222526|NCT00327470|530985901|FG001|Overall Study|Other|9|||
147222527|NCT00327470|530985900|FG000|Overall Study|Lost to Follow-up|1|||
147222528|NCT00327470|530985901|FG001|Overall Study|Lost to Follow-up|3|||
147222529|NCT00327470|530985900|FG000|Overall Study|Withdrawal by Subject|6|||
147222530|NCT00327470|530985901|FG001|Overall Study|Withdrawal by Subject|12|||
147222531|NCT00327470|530985900|FG000|Overall Study|Death|1|||
147222532|NCT00327470|530985901|FG001|Overall Study|Death|4|||
147222533|NCT04738318|530985902|FG000|Overall Study|Protocol Violation|1|||
147222534|NCT04738318|530985903|FG001|Overall Study|Protocol Violation|0|||
147222535|NCT01226121|530985904|FG000|Overall Study|Lost to Follow-up|2|||
147222536|NCT01226121|530985905|FG001|Overall Study|Lost to Follow-up|0|||
147222537|NCT01226121|530985906|FG002|Overall Study|Lost to Follow-up|1|||
147222538|NCT04231981|530985907|FG000|Overall Study|Adverse Event|1|||
147222539|NCT04231981|530985907|FG000|Overall Study|Death|16|||
147222540|NCT04231981|530985907|FG000|Overall Study|Lost to Follow-up|1|||
147222541|NCT02581943|530985908|FG000|Overall Study|Death|5|||
147222542|NCT02581943|530985909|FG001|Overall Study|Death|2|||
147222543|NCT02581943|530985908|FG000|Overall Study|Disease Progression|12|||
147222544|NCT02581943|530985909|FG001|Overall Study|Disease Progression|15|||
147222545|NCT02581943|530985908|FG000|Overall Study|Withdrawal by Subject|1|||
147222546|NCT02581943|530985909|FG001|Overall Study|Withdrawal by Subject|2|||
147222547|NCT00378079|530985910|FG000|Overall Study|Lost to Follow-up|6|||
147222548|NCT00378079|530985911|FG001|Overall Study|Lost to Follow-up|1|||
147222549|NCT00378079|530985912|FG002|Overall Study|Lost to Follow-up|0|||
147222550|NCT01233687|530985913|FG000|Phase II AMG 102 + Erlotinib|Death|1|||
147222551|NCT01233687|530985913|FG000|Phase II AMG 102 + Erlotinib|Physician Decision|2|||
147222552|NCT01233687|530985913|FG000|Phase II AMG 102 + Erlotinib|Withdrawal by Subject|1|||
147222553|NCT02290431|530985914|FG000|Overall Study|Adverse Event|20|||
147222554|NCT02290431|530985914|FG000|Overall Study|Progressive disease|4|||
147222555|NCT02290431|530985914|FG000|Overall Study|Study terminated by Sponsor|1|||
147222556|NCT02290431|530985914|FG000|Overall Study|Physician Decision|2|||
147222557|NCT02197234|530985919|FG000|Part A: Day 3-30 (AZD9291 Alone)|Condition under investigation worsened|1|||
147222558|NCT02197234|530985919|FG000|Part A: Day 3-30 (AZD9291 Alone)|Withdrawal by Subject|1|||
147222559|NCT02197234|530985919|FG000|Part B: Day 33 to End Part B (AZD9291)|Adverse Event|1|||
147222560|NCT02197234|530985919|FG000|Part B: Day 33 to End Part B (AZD9291)|Withdrawal by Subject|1|||
147222561|NCT02197234|530985919|FG000|Part B: Day 33 to End Part B (AZD9291)|Death|6|||
147222562|NCT02197234|530985919|FG000|Part B: Day 33 to End Part B (AZD9291)|Condition under investigation worsened|22|||
147222563|NCT03783702|530985920|FG000|Overall Study|Lost to Follow-up|6|||
147222564|NCT03783702|530985921|FG001|Overall Study|Lost to Follow-up|8|||
147222565|NCT03783702|530985920|FG000|Overall Study|Protocol Violation|1|||
147222566|NCT03783702|530985921|FG001|Overall Study|Protocol Violation|3|||
147222567|NCT02274038|530985922|FG000|Overall Study|Death|1|||
147222568|NCT04473482|530985923|FG000|Overall Study|Death|0|||
147553387|NCT00358826|532181581|FG006|MDCT Substudy|Adverse Event|0|||
147222569|NCT04473482|530985924|FG001|Overall Study|Death|3|||
147222570|NCT04473482|530985923|FG000|Overall Study|Lost to Follow-up|9|||
147553388|NCT00358826|532181582|FG007|MDCT Substudy|Adverse Event|0|||
147222571|NCT04473482|530985924|FG001|Overall Study|Lost to Follow-up|7|||
147222572|NCT04473482|530985923|FG000|Overall Study|Withdrawal by Subject|2|||
147222573|NCT04473482|530985924|FG001|Overall Study|Withdrawal by Subject|1|||
147222574|NCT00745615|530985931|FG000|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|3|||
147222575|NCT00745615|530985932|FG001|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|1|||
147222576|NCT00745615|530985933|FG002|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|0|||
147222577|NCT00745615|530985934|FG003|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|4|||
147222578|NCT00745615|530985935|FG004|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|0|||
147222579|NCT00745615|530985936|FG005|Double-Blind Extension (36 Weeks)|Withdrawal by Subject|0|||
147222580|NCT00745615|530985931|FG000|Double-Blind Extension (36 Weeks)|Physician Decision|0|||
147222581|NCT00745615|530985932|FG001|Double-Blind Extension (36 Weeks)|Physician Decision|1|||
147222582|NCT00745615|530985933|FG002|Double-Blind Extension (36 Weeks)|Physician Decision|0|||
147222583|NCT00745615|530985934|FG003|Double-Blind Extension (36 Weeks)|Physician Decision|0|||
147222584|NCT00745615|530985935|FG004|Double-Blind Extension (36 Weeks)|Physician Decision|0|||
147222585|NCT00745615|530985936|FG005|Double-Blind Extension (36 Weeks)|Physician Decision|0|||
147222586|NCT00745615|530985931|FG000|Double-Blind Extension (36 Weeks)|Adverse Event|2|||
147222587|NCT00745615|530985932|FG001|Double-Blind Extension (36 Weeks)|Adverse Event|3|||
147222588|NCT00745615|530985933|FG002|Double-Blind Extension (36 Weeks)|Adverse Event|1|||
147222589|NCT00745615|530985934|FG003|Double-Blind Extension (36 Weeks)|Adverse Event|1|||
147222590|NCT00745615|530985935|FG004|Double-Blind Extension (36 Weeks)|Adverse Event|0|||
147222591|NCT00745615|530985936|FG005|Double-Blind Extension (36 Weeks)|Adverse Event|0|||
147222592|NCT00745615|530985931|FG000|Double-Blind Extension (36 Weeks)|Pregnancy|0|||
147222593|NCT00745615|530985932|FG001|Double-Blind Extension (36 Weeks)|Pregnancy|1|||
147222594|NCT00745615|530985933|FG002|Double-Blind Extension (36 Weeks)|Pregnancy|0|||
147222595|NCT00745615|530985934|FG003|Double-Blind Extension (36 Weeks)|Pregnancy|0|||
147222596|NCT00745615|530985935|FG004|Double-Blind Extension (36 Weeks)|Pregnancy|0|||
147222597|NCT00745615|530985936|FG005|Double-Blind Extension (36 Weeks)|Pregnancy|0|||
147222598|NCT00745615|530985931|FG000|Double-Blind Extension (36 Weeks)|Other Than Specified|0|||
147222599|NCT00745615|530985932|FG001|Double-Blind Extension (36 Weeks)|Other Than Specified|1|||
147222600|NCT00745615|530985933|FG002|Double-Blind Extension (36 Weeks)|Other Than Specified|0|||
147222601|NCT00745615|530985934|FG003|Double-Blind Extension (36 Weeks)|Other Than Specified|0|||
147222602|NCT00745615|530985935|FG004|Double-Blind Extension (36 Weeks)|Other Than Specified|0|||
147222603|NCT00745615|530985936|FG005|Double-Blind Extension (36 Weeks)|Other Than Specified|0|||
147222604|NCT00745615|530985931|FG000|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|0|||
147222605|NCT00745615|530985932|FG001|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|0|||
147222606|NCT00745615|530985933|FG002|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|0|||
147222607|NCT00745615|530985934|FG003|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|0|||
147222608|NCT00745615|530985935|FG004|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|50|||
147222609|NCT00745615|530985936|FG005|Open-Label (up to Approx 10.5 Years)|Study Terminated by Sponsor|50|||
147222610|NCT00745615|530985931|FG000|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|0|||
147222611|NCT00745615|530985932|FG001|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|0|||
147222612|NCT00745615|530985933|FG002|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|0|||
147222613|NCT00745615|530985934|FG003|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|0|||
147222614|NCT00745615|530985935|FG004|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|19|||
147222615|NCT00745615|530985936|FG005|Open-Label (up to Approx 10.5 Years)|Withdrawal by Subject|19|||
147222616|NCT00745615|530985931|FG000|Open-Label (up to Approx 10.5 Years)|Physician Decision|0|||
147222617|NCT00745615|530985932|FG001|Open-Label (up to Approx 10.5 Years)|Physician Decision|0|||
147222618|NCT00745615|530985933|FG002|Open-Label (up to Approx 10.5 Years)|Physician Decision|0|||
147222619|NCT00745615|530985934|FG003|Open-Label (up to Approx 10.5 Years)|Physician Decision|0|||
147222620|NCT00745615|530985935|FG004|Open-Label (up to Approx 10.5 Years)|Physician Decision|9|||
147222621|NCT00745615|530985936|FG005|Open-Label (up to Approx 10.5 Years)|Physician Decision|11|||
147222622|NCT00745615|530985931|FG000|Open-Label (up to Approx 10.5 Years)|Adverse Event|0|||
147222623|NCT00745615|530985932|FG001|Open-Label (up to Approx 10.5 Years)|Adverse Event|0|||
147222624|NCT00745615|530985933|FG002|Open-Label (up to Approx 10.5 Years)|Adverse Event|0|||
147222625|NCT00745615|530985934|FG003|Open-Label (up to Approx 10.5 Years)|Adverse Event|0|||
147222626|NCT00745615|530985935|FG004|Open-Label (up to Approx 10.5 Years)|Adverse Event|2|||
147222627|NCT00745615|530985936|FG005|Open-Label (up to Approx 10.5 Years)|Adverse Event|8|||
147222628|NCT00745615|530985931|FG000|Open-Label (up to Approx 10.5 Years)|Pregnancy|0|||
147222629|NCT00745615|530985932|FG001|Open-Label (up to Approx 10.5 Years)|Pregnancy|0|||
147222630|NCT00745615|530985933|FG002|Open-Label (up to Approx 10.5 Years)|Pregnancy|0|||
147309588|NCT00152971|531300119|FG002|Overall Study|Withdrawal by Subject|14|||
147222631|NCT00745615|530985934|FG003|Open-Label (up to Approx 10.5 Years)|Pregnancy|0|||
147222632|NCT00745615|530985935|FG004|Open-Label (up to Approx 10.5 Years)|Pregnancy|2|||
147222633|NCT00745615|530985936|FG005|Open-Label (up to Approx 10.5 Years)|Pregnancy|5|||
147222634|NCT00745615|530985931|FG000|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|0|||
147222635|NCT00745615|530985932|FG001|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|0|||
147309589|NCT00152971|531300117|FG000|Overall Study|Other|3|||
147553389|NCT00358826|532181575|FG000|MDCT Substudy|Lost to Follow-up|0|||
147553390|NCT00358826|532181576|FG001|MDCT Substudy|Lost to Follow-up|0|||
147553391|NCT00358826|532181577|FG002|MDCT Substudy|Lost to Follow-up|0|||
147553392|NCT00358826|532181578|FG003|MDCT Substudy|Lost to Follow-up|0|||
147553393|NCT00358826|532181579|FG004|MDCT Substudy|Lost to Follow-up|0|||
147553394|NCT00358826|532181580|FG005|MDCT Substudy|Lost to Follow-up|1|||
147553395|NCT00358826|532181581|FG006|MDCT Substudy|Lost to Follow-up|0|||
147553396|NCT00358826|532181582|FG007|MDCT Substudy|Lost to Follow-up|0|||
147553397|NCT00358826|532181575|FG000|MDCT Substudy|Withdrawal by Subject|0|||
147553398|NCT00358826|532181576|FG001|MDCT Substudy|Withdrawal by Subject|0|||
147553399|NCT00358826|532181577|FG002|MDCT Substudy|Withdrawal by Subject|0|||
147553400|NCT00358826|532181578|FG003|MDCT Substudy|Withdrawal by Subject|0|||
147553401|NCT00358826|532181579|FG004|MDCT Substudy|Withdrawal by Subject|0|||
147553402|NCT00358826|532181580|FG005|MDCT Substudy|Withdrawal by Subject|1|||
147553403|NCT00358826|532181581|FG006|MDCT Substudy|Withdrawal by Subject|0|||
147553404|NCT00358826|532181582|FG007|MDCT Substudy|Withdrawal by Subject|0|||
147553405|NCT00457665|532181585|FG000|12 Months|Drug allergy|1|||
147553406|NCT00457665|532181586|FG001|12 Months|Drug allergy|1|||
147553407|NCT00457665|532181585|FG000|12 Months|High HIV viral load|5|||
147553408|NCT00457665|532181586|FG001|12 Months|High HIV viral load|1|||
147553409|NCT00457665|532181585|FG000|12 Months|Lipodystrophy|2|||
147553410|NCT00457665|532181586|FG001|12 Months|Lipodystrophy|0|||
147553411|NCT00457665|532181585|FG000|12 Months|Withdrawal by Subject|0|||
147553412|NCT00457665|532181586|FG001|12 Months|Withdrawal by Subject|2|||
147553413|NCT00457665|532181585|FG000|12 Months|Abnormal Liver function tests|0|||
147553414|NCT00457665|532181586|FG001|12 Months|Abnormal Liver function tests|5|||
147553415|NCT00457665|532181585|FG000|24 Months|Withdrawal by Subject|3|||
147553416|NCT00457665|532181586|FG001|24 Months|Withdrawal by Subject|2|||
147553417|NCT00457665|532181585|FG000|24 Months|Lipodystrophy|1|||
147222636|NCT00745615|530985933|FG002|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|0|||
147222637|NCT00745615|530985934|FG003|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|0|||
147222638|NCT00745615|530985935|FG004|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|1|||
147222639|NCT00745615|530985936|FG005|Open-Label (up to Approx 10.5 Years)|Lost to Follow-up|3|||
147553418|NCT00457665|532181586|FG001|24 Months|Lipodystrophy|1|||
147222640|NCT00745615|530985931|FG000|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0|||
147309590|NCT00152971|531300118|FG001|Overall Study|Other|5|||
147553419|NCT00457665|532181585|FG000|24 Months|Abnormal liver function tests|1|||
147553420|NCT00457665|532181586|FG001|24 Months|Abnormal liver function tests|5|||
147553421|NCT02535000|532181588|FG000|Overall Study|Cancellation of surgery.|1|||
147553422|NCT02535000|532181589|FG001|Overall Study|Cancellation of surgery.|2|||
147222641|NCT00745615|530985932|FG001|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0|||
147222642|NCT00745615|530985933|FG002|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0|||
147222643|NCT00745615|530985934|FG003|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0|||
147222644|NCT00745615|530985935|FG004|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|0|||
147222645|NCT00745615|530985936|FG005|Open-Label (up to Approx 10.5 Years)|Lack of Efficacy|1|||
147222646|NCT00745615|530985931|FG000|Open-Label (up to Approx 10.5 Years)|Death|0|||
147222647|NCT00745615|530985932|FG001|Open-Label (up to Approx 10.5 Years)|Death|0|||
147222648|NCT00745615|530985933|FG002|Open-Label (up to Approx 10.5 Years)|Death|0|||
147222649|NCT00745615|530985934|FG003|Open-Label (up to Approx 10.5 Years)|Death|0|||
147222650|NCT00745615|530985935|FG004|Open-Label (up to Approx 10.5 Years)|Death|0|||
147222651|NCT00745615|530985936|FG005|Open-Label (up to Approx 10.5 Years)|Death|1|||
147222652|NCT00745615|530985931|FG000|Open-Label (up to Approx 10.5 Years)|Other Than Specified|0|||
147222653|NCT00745615|530985932|FG001|Open-Label (up to Approx 10.5 Years)|Other Than Specified|0|||
147222654|NCT00745615|530985933|FG002|Open-Label (up to Approx 10.5 Years)|Other Than Specified|0|||
147222655|NCT00745615|530985934|FG003|Open-Label (up to Approx 10.5 Years)|Other Than Specified|0|||
147222656|NCT00745615|530985935|FG004|Open-Label (up to Approx 10.5 Years)|Other Than Specified|8|||
147222657|NCT00745615|530985936|FG005|Open-Label (up to Approx 10.5 Years)|Other Than Specified|10|||
147222658|NCT00570232|530985937|FG000|Overall Study|Adverse Event|10|||
147222659|NCT00570232|530985937|FG000|Overall Study|discontinued due to medical condition|3|||
147222660|NCT00570232|530985937|FG000|Overall Study|discontinued due to recurrence|8|||
147222661|NCT00570232|530985937|FG000|Overall Study|discontinued due to noncompliance|2|||
147222662|NCT01076075|530985938|FG000|Overall Study|Adverse Event|3|||
147222663|NCT01076075|530985939|FG001|Overall Study|Adverse Event|9|||
147222664|NCT01076075|530985938|FG000|Overall Study|Lack of Efficacy|5|||
147222665|NCT01076075|530985939|FG001|Overall Study|Lack of Efficacy|4|||
147222666|NCT01076075|530985938|FG000|Overall Study|Lost to Follow-up|6|||
147222667|NCT01076075|530985939|FG001|Overall Study|Lost to Follow-up|5|||
147222668|NCT01076075|530985938|FG000|Overall Study|other|19|||
147222669|NCT01076075|530985939|FG001|Overall Study|other|9|||
147222670|NCT01076075|530985938|FG000|Overall Study|Protocol Violation|0|||
147222671|NCT01076075|530985939|FG001|Overall Study|Protocol Violation|1|||
147222672|NCT01076075|530985938|FG000|Overall Study|Withdrawal by Subject|8|||
147222673|NCT01076075|530985939|FG001|Overall Study|Withdrawal by Subject|19|||
147222674|NCT01445886|530985940|FG000|Overall Study|Lost to Follow-up|2|||
147222675|NCT01445886|530985940|FG000|Overall Study|Protocol Violation|3|||
147222676|NCT04078178|530987204|FG000|Lead-In Period (4-Weeks)|Withdrawal by Subject|0|||
147222677|NCT04078178|530987205|FG001|Lead-In Period (4-Weeks)|Withdrawal by Subject|1|||
147222678|NCT04078178|530987204|FG000|Lead-In Period (4-Weeks)|Screen Fail|1|||
147222679|NCT04078178|530987205|FG001|Lead-In Period (4-Weeks)|Screen Fail|2|||
147222680|NCT04078178|530987204|FG000|Baseline/Initial Treatment (8 Weeks)|Withdrawal by Subject|1|||
147222681|NCT04078178|530987205|FG001|Baseline/Initial Treatment (8 Weeks)|Withdrawal by Subject|2|||
147222682|NCT04078178|530987204|FG000|Baseline/Initial Treatment (8 Weeks)|Early Termination|1|||
147222683|NCT04078178|530987205|FG001|Baseline/Initial Treatment (8 Weeks)|Early Termination|0|||
147222684|NCT04078178|530987204|FG000|Crossover Treatment (8 Weeks)|Early Termination|0|||
147222685|NCT04078178|530987205|FG001|Crossover Treatment (8 Weeks)|Early Termination|1|||
147222686|NCT02038829|530987206|FG000|Washout Period 1|Death|0|||
147222687|NCT02038829|530987207|FG001|Washout Period 1|Death|0|||
147222688|NCT02038829|530987208|FG002|Washout Period 1|Death|0|||
147222689|NCT02038829|530987209|FG003|Washout Period 1|Death|0|||
147222690|NCT02038829|530987210|FG004|Washout Period 1|Death|1|||
147222691|NCT02038829|530987211|FG005|Washout Period 1|Death|0|||
147222692|NCT02038829|530987212|FG006|Washout Period 1|Death|0|||
147222693|NCT02038829|530987213|FG007|Washout Period 1|Death|0|||
147222694|NCT02038829|530987214|FG008|Washout Period 1|Death|0|||
147222695|NCT02038829|530987215|FG009|Washout Period 1|Death|0|||
147222696|NCT02038829|530987216|FG010|Washout Period 1|Death|0|||
147222697|NCT02038829|530987217|FG011|Washout Period 1|Death|0|||
147222698|NCT02038829|530987206|FG000|Treatment Period 2|Adverse Event|0|||
147222699|NCT02038829|530987207|FG001|Treatment Period 2|Adverse Event|0|||
147222700|NCT02038829|530987208|FG002|Treatment Period 2|Adverse Event|0|||
147222701|NCT02038829|530987209|FG003|Treatment Period 2|Adverse Event|0|||
147222702|NCT02038829|530987210|FG004|Treatment Period 2|Adverse Event|0|||
147222703|NCT02038829|530987211|FG005|Treatment Period 2|Adverse Event|0|||
147222704|NCT02038829|530987212|FG006|Treatment Period 2|Adverse Event|0|||
147222705|NCT02038829|530987213|FG007|Treatment Period 2|Adverse Event|0|||
147222706|NCT02038829|530987214|FG008|Treatment Period 2|Adverse Event|0|||
147222707|NCT02038829|530987215|FG009|Treatment Period 2|Adverse Event|0|||
147222708|NCT02038829|530987216|FG010|Treatment Period 2|Adverse Event|1|||
147222709|NCT02038829|530987217|FG011|Treatment Period 2|Adverse Event|0|||
147222710|NCT02038829|530987206|FG000|Treatment Period 2|Withdrawal by Subject|1|||
147222711|NCT02038829|530987207|FG001|Treatment Period 2|Withdrawal by Subject|0|||
147222712|NCT02038829|530987208|FG002|Treatment Period 2|Withdrawal by Subject|0|||
147222713|NCT02038829|530987209|FG003|Treatment Period 2|Withdrawal by Subject|0|||
147222714|NCT02038829|530987210|FG004|Treatment Period 2|Withdrawal by Subject|0|||
147222715|NCT02038829|530987211|FG005|Treatment Period 2|Withdrawal by Subject|0|||
147222716|NCT02038829|530987212|FG006|Treatment Period 2|Withdrawal by Subject|0|||
147222717|NCT02038829|530987213|FG007|Treatment Period 2|Withdrawal by Subject|0|||
147222718|NCT02038829|530987214|FG008|Treatment Period 2|Withdrawal by Subject|0|||
147222719|NCT02038829|530987215|FG009|Treatment Period 2|Withdrawal by Subject|0|||
147222720|NCT02038829|530987216|FG010|Treatment Period 2|Withdrawal by Subject|0|||
147222721|NCT02038829|530987217|FG011|Treatment Period 2|Withdrawal by Subject|0|||
147222722|NCT02038829|530987206|FG000|Washout Period 2|Adverse Event|0|||
147222723|NCT02038829|530987207|FG001|Washout Period 2|Adverse Event|0|||
147222724|NCT02038829|530987208|FG002|Washout Period 2|Adverse Event|0|||
147222725|NCT02038829|530987209|FG003|Washout Period 2|Adverse Event|0|||
147222726|NCT02038829|530987210|FG004|Washout Period 2|Adverse Event|0|||
147222727|NCT02038829|530987211|FG005|Washout Period 2|Adverse Event|0|||
147222728|NCT02038829|530987212|FG006|Washout Period 2|Adverse Event|0|||
147222729|NCT02038829|530987213|FG007|Washout Period 2|Adverse Event|0|||
147222730|NCT02038829|530987214|FG008|Washout Period 2|Adverse Event|1|||
147309591|NCT00152971|531300119|FG002|Overall Study|Other|5|||
147222731|NCT02038829|530987215|FG009|Washout Period 2|Adverse Event|0|||
147222732|NCT02038829|530987216|FG010|Washout Period 2|Adverse Event|0|||
147222733|NCT02038829|530987217|FG011|Washout Period 2|Adverse Event|0|||
147222734|NCT02038829|530987206|FG000|Washout Period 2|Withdrawal by Subject|0|||
147222735|NCT02038829|530987207|FG001|Washout Period 2|Withdrawal by Subject|0|||
147222736|NCT02038829|530987208|FG002|Washout Period 2|Withdrawal by Subject|0|||
147222737|NCT02038829|530987209|FG003|Washout Period 2|Withdrawal by Subject|0|||
147222738|NCT02038829|530987210|FG004|Washout Period 2|Withdrawal by Subject|0|||
147553423|NCT01620489|532181593|FG000|Overall Study|Adverse Event|17|||
147553424|NCT01620489|532181594|FG001|Overall Study|Adverse Event|4|||
147553425|NCT01620489|532181593|FG000|Overall Study|Protocol Violation|0|||
147553426|NCT01620489|532181594|FG001|Overall Study|Protocol Violation|3|||
147553427|NCT01620489|532181593|FG000|Overall Study|Withdrawal Criteria|17|||
147553428|NCT01620489|532181594|FG001|Overall Study|Withdrawal Criteria|25|||
147553429|NCT01620489|532181593|FG000|Overall Study|Unclassified|1|||
147553430|NCT01620489|532181594|FG001|Overall Study|Unclassified|2|||
147553431|NCT01851590|532181596|FG000|Overall Study|Withdrawal by Subject|0|||
147553432|NCT01851590|532181597|FG001|Overall Study|Withdrawal by Subject|0|||
147553433|NCT01851590|532181598|FG002|Overall Study|Withdrawal by Subject|1|||
147553434|NCT01851590|532181596|FG000|Overall Study|Adverse Event|0|||
147553435|NCT01851590|532181597|FG001|Overall Study|Adverse Event|0|||
147553436|NCT01851590|532181598|FG002|Overall Study|Adverse Event|2|||
147553437|NCT01851590|532181596|FG000|Overall Study|Lack of Efficacy|0|||
147553438|NCT01851590|532181597|FG001|Overall Study|Lack of Efficacy|1|||
147553439|NCT01851590|532181598|FG002|Overall Study|Lack of Efficacy|0|||
147553440|NCT00696709|532181599|FG000|Overall Study|Withdrawal by Subject|1|||
147553441|NCT00696709|532181600|FG001|Overall Study|Withdrawal by Subject|2|||
147553442|NCT00696709|532181601|FG002|Overall Study|Withdrawal by Subject|1|||
147553443|NCT00696709|532181602|FG003|Overall Study|Withdrawal by Subject|4|||
147553444|NCT00696709|532181603|FG004|Overall Study|Withdrawal by Subject|3|||
147553445|NCT00696709|532181599|FG000|Overall Study|Protocol Violation|1|||
147553446|NCT00696709|532181600|FG001|Overall Study|Protocol Violation|0|||
147553447|NCT00696709|532181601|FG002|Overall Study|Protocol Violation|0|||
147553448|NCT00696709|532181602|FG003|Overall Study|Protocol Violation|0|||
147553449|NCT00696709|532181603|FG004|Overall Study|Protocol Violation|0|||
147553450|NCT00696709|532181599|FG000|Overall Study|Lost to Follow-up|1|||
147553451|NCT00696709|532181600|FG001|Overall Study|Lost to Follow-up|1|||
147553452|NCT00696709|532181601|FG002|Overall Study|Lost to Follow-up|0|||
147553453|NCT00696709|532181602|FG003|Overall Study|Lost to Follow-up|0|||
147222739|NCT02038829|530987211|FG005|Washout Period 2|Withdrawal by Subject|1|||
147222740|NCT02038829|530987212|FG006|Washout Period 2|Withdrawal by Subject|0|||
147222741|NCT02038829|530987213|FG007|Washout Period 2|Withdrawal by Subject|0|||
147222742|NCT02038829|530987214|FG008|Washout Period 2|Withdrawal by Subject|0|||
147222743|NCT02038829|530987215|FG009|Washout Period 2|Withdrawal by Subject|0|||
147222744|NCT02038829|530987216|FG010|Washout Period 2|Withdrawal by Subject|0|||
147222745|NCT02038829|530987217|FG011|Washout Period 2|Withdrawal by Subject|0|||
147222746|NCT02038829|530987206|FG000|Treatment Period 4|Adverse Event|0|||
147222747|NCT02038829|530987207|FG001|Treatment Period 4|Adverse Event|1|||
147222748|NCT02038829|530987208|FG002|Treatment Period 4|Adverse Event|0|||
147222749|NCT02038829|530987209|FG003|Treatment Period 4|Adverse Event|0|||
147222750|NCT02038829|530987210|FG004|Treatment Period 4|Adverse Event|0|||
147222751|NCT02038829|530987211|FG005|Treatment Period 4|Adverse Event|0|||
147222752|NCT02038829|530987212|FG006|Treatment Period 4|Adverse Event|0|||
147222753|NCT02038829|530987213|FG007|Treatment Period 4|Adverse Event|0|||
147222754|NCT02038829|530987214|FG008|Treatment Period 4|Adverse Event|0|||
147222755|NCT02038829|530987215|FG009|Treatment Period 4|Adverse Event|0|||
147222756|NCT02038829|530987216|FG010|Treatment Period 4|Adverse Event|0|||
147222757|NCT02038829|530987217|FG011|Treatment Period 4|Adverse Event|0|||
147222758|NCT02038829|530987206|FG000|Washout Period 4|Adverse Event|0|||
147553454|NCT00696709|532181603|FG004|Overall Study|Lost to Follow-up|0|||
147553455|NCT00696709|532181599|FG000|Overall Study|Adverse Event|0|||
147553456|NCT00696709|532181600|FG001|Overall Study|Adverse Event|0|||
147553457|NCT00696709|532181601|FG002|Overall Study|Adverse Event|0|||
147553458|NCT00696709|532181602|FG003|Overall Study|Adverse Event|1|||
147553459|NCT00696709|532181603|FG004|Overall Study|Adverse Event|0|||
147553460|NCT00310856|532181604|FG000|Overall Study|Withdrawal by Subject|2|||
147222759|NCT02038829|530987207|FG001|Washout Period 4|Adverse Event|0|||
147222760|NCT02038829|530987208|FG002|Washout Period 4|Adverse Event|0|||
147222761|NCT02038829|530987209|FG003|Washout Period 4|Adverse Event|0|||
147222762|NCT02038829|530987210|FG004|Washout Period 4|Adverse Event|0|||
147222763|NCT02038829|530987211|FG005|Washout Period 4|Adverse Event|0|||
147222764|NCT02038829|530987212|FG006|Washout Period 4|Adverse Event|1|||
147222765|NCT02038829|530987213|FG007|Washout Period 4|Adverse Event|0|||
147222766|NCT02038829|530987214|FG008|Washout Period 4|Adverse Event|0|||
147553461|NCT00310856|532181605|FG001|Overall Study|Withdrawal by Subject|2|||
147553462|NCT00310856|532181606|FG002|Overall Study|Withdrawal by Subject|2|||
147553463|NCT00310856|532181604|FG000|Overall Study|Lost to Follow-up|1|||
147553464|NCT00310856|532181605|FG001|Overall Study|Lost to Follow-up|2|||
147553465|NCT00310856|532181606|FG002|Overall Study|Lost to Follow-up|6|||
147553466|NCT00310856|532181604|FG000|Overall Study|Inappropriate enrollment|1|||
147553467|NCT00310856|532181605|FG001|Overall Study|Inappropriate enrollment|1|||
147553468|NCT00310856|532181606|FG002|Overall Study|Inappropriate enrollment|0|||
147553469|NCT00310856|532181604|FG000|Overall Study|Unable to classify|1|||
147553470|NCT00310856|532181605|FG001|Overall Study|Unable to classify|0|||
147553471|NCT00310856|532181606|FG002|Overall Study|Unable to classify|0|||
147553472|NCT01306253|532181613|FG000|Overall Study|Lost to Follow-up|1|||
147553473|NCT01306253|532181614|FG001|Overall Study|Lost to Follow-up|1|||
147553474|NCT00543439|532181615|FG000|Period 1|Adverse Event|0|||
147553475|NCT00543439|532181616|FG001|Period 1|Adverse Event|2|||
147553476|NCT00543439|532181617|FG002|Period 1|Adverse Event|1|||
147553477|NCT00543439|532181615|FG000|Period 1|Withdrawal by Subject|1|||
147553478|NCT00543439|532181616|FG001|Period 1|Withdrawal by Subject|1|||
147553479|NCT00543439|532181617|FG002|Period 1|Withdrawal by Subject|0|||
147553480|NCT00543439|532181615|FG000|Period 1|Physician Decision|0|||
147553481|NCT00543439|532181616|FG001|Period 1|Physician Decision|0|||
147553482|NCT00543439|532181617|FG002|Period 1|Physician Decision|1|||
147553483|NCT00543439|532181615|FG000|Period 2|Protocol Violation|1|||
147553484|NCT00543439|532181616|FG001|Period 2|Protocol Violation|0|||
147553485|NCT00543439|532181617|FG002|Period 2|Protocol Violation|1|||
147553486|NCT00543439|532181615|FG000|Period 2|Adverse Event|0|||
147553487|NCT00543439|532181616|FG001|Period 2|Adverse Event|1|||
147553488|NCT00543439|532181617|FG002|Period 2|Adverse Event|1|||
147553489|NCT01709383|532181622|FG000|Overall Study|Lost to Follow-up|1|||
147553490|NCT01709383|532181623|FG001|Overall Study|Lost to Follow-up|0|||
147553491|NCT03264066|532181624|FG000|Overall Study|Adverse Event|1|||
147553492|NCT03264066|532181625|FG001|Overall Study|Adverse Event|1|||
147553493|NCT03264066|532181626|FG002|Overall Study|Adverse Event|0|||
147553494|NCT03264066|532181627|FG003|Overall Study|Adverse Event|0|||
147553495|NCT03264066|532181628|FG004|Overall Study|Adverse Event|0|||
147553496|NCT03264066|532181629|FG005|Overall Study|Adverse Event|0|||
147553497|NCT03264066|532181624|FG000|Overall Study|Death|12|||
147553498|NCT03264066|532181625|FG001|Overall Study|Death|12|||
147553499|NCT03264066|532181626|FG002|Overall Study|Death|8|||
147553500|NCT03264066|532181627|FG003|Overall Study|Death|10|||
147553501|NCT03264066|532181628|FG004|Overall Study|Death|6|||
147553502|NCT03264066|532181629|FG005|Overall Study|Death|1|||
147553503|NCT03264066|532181624|FG000|Overall Study|Lost to Follow-up|1|||
147553504|NCT03264066|532181625|FG001|Overall Study|Lost to Follow-up|0|||
147553505|NCT03264066|532181626|FG002|Overall Study|Lost to Follow-up|0|||
147553506|NCT03264066|532181627|FG003|Overall Study|Lost to Follow-up|0|||
147553507|NCT03264066|532181628|FG004|Overall Study|Lost to Follow-up|0|||
147553508|NCT03264066|532181629|FG005|Overall Study|Lost to Follow-up|0|||
147553509|NCT03264066|532181624|FG000|Overall Study|Progressive Disease|0|||
147553510|NCT03264066|532181625|FG001|Overall Study|Progressive Disease|2|||
147553511|NCT03264066|532181626|FG002|Overall Study|Progressive Disease|1|||
147553512|NCT03264066|532181627|FG003|Overall Study|Progressive Disease|0|||
147222767|NCT02038829|530987215|FG009|Washout Period 4|Adverse Event|0|||
147222768|NCT02038829|530987216|FG010|Washout Period 4|Adverse Event|0|||
147222769|NCT02038829|530987217|FG011|Washout Period 4|Adverse Event|0|||
147222770|NCT02038829|530987206|FG000|Treatment Period 6|Adverse Event|0|||
147222771|NCT02038829|530987207|FG001|Treatment Period 6|Adverse Event|0|||
147222772|NCT02038829|530987208|FG002|Treatment Period 6|Adverse Event|1|||
147222773|NCT02038829|530987209|FG003|Treatment Period 6|Adverse Event|0|||
147222774|NCT02038829|530987210|FG004|Treatment Period 6|Adverse Event|0|||
147222775|NCT02038829|530987211|FG005|Treatment Period 6|Adverse Event|0|||
147222776|NCT02038829|530987212|FG006|Treatment Period 6|Adverse Event|0|||
147222777|NCT02038829|530987213|FG007|Treatment Period 6|Adverse Event|0|||
147222778|NCT02038829|530987214|FG008|Treatment Period 6|Adverse Event|0|||
147222779|NCT02038829|530987215|FG009|Treatment Period 6|Adverse Event|0|||
147222780|NCT02038829|530987216|FG010|Treatment Period 6|Adverse Event|0|||
147222781|NCT02038829|530987217|FG011|Treatment Period 6|Adverse Event|0|||
147222782|NCT05128929|530987224|FG000|Overall Study|Adverse Event|0|||
147222783|NCT05128929|530987225|FG001|Overall Study|Adverse Event|1|||
147443441|NCT02347098|531788677|FG001|Overall Study|no visit due to illness|1|||
147443442|NCT01444742|531788678|FG000|Overall Study|Death|1|||
147443443|NCT02187172|531788679|FG000|Overall Study|Lost to Follow-up|1|||
147443444|NCT02187172|531788680|FG001|Overall Study|Lost to Follow-up|2|||
147443445|NCT02187172|531788679|FG000|Overall Study|Lack of Efficacy|1|||
147443446|NCT02187172|531788680|FG001|Overall Study|Lack of Efficacy|2|||
147443447|NCT02187172|531788679|FG000|Overall Study|Adverse Event|0|||
147443448|NCT02187172|531788680|FG001|Overall Study|Adverse Event|1|||
147443449|NCT02187172|531788679|FG000|Overall Study|Physician Decision|1|||
147443450|NCT02187172|531788680|FG001|Overall Study|Physician Decision|1|||
147443451|NCT02830880|531788681|FG000|Overall Study|Adverse reaction to chemotherapy|1|||
147443452|NCT02830880|531788681|FG000|Overall Study|Death|1|||
147443453|NCT02830880|531788681|FG000|Overall Study|Physician Decision|1|||
147443454|NCT02349048|531788686|FG000|Overall Study|Withdrawal by Subject|4|||
147443455|NCT02349048|531788687|FG001|Overall Study|Withdrawal by Subject|0|||
147443456|NCT02349048|531788686|FG000|Overall Study|Lost to Follow-up|1|||
147443457|NCT02349048|531788687|FG001|Overall Study|Lost to Follow-up|0|||
147443458|NCT00094770|531788690|FG000|Year 1 ( Week 0 to Week 52)|Adverse Event|25|||
147443459|NCT00094770|531788691|FG001|Year 1 ( Week 0 to Week 52)|Adverse Event|26|||
147443460|NCT00094770|531788690|FG000|Year 1 ( Week 0 to Week 52)|Lack of Efficacy|86|||
147443461|NCT00094770|531788691|FG001|Year 1 ( Week 0 to Week 52)|Lack of Efficacy|58|||
147443462|NCT00094770|531788690|FG000|Year 1 ( Week 0 to Week 52)|Lost to Follow-up|19|||
147443463|NCT00094770|531788691|FG001|Year 1 ( Week 0 to Week 52)|Lost to Follow-up|10|||
147443464|NCT00094770|531788690|FG000|Year 1 ( Week 0 to Week 52)|Protocol Violation|10|||
147222784|NCT02987660|530987230|FG000|Overall Study|Study terminated by sponsor|10|||
147222785|NCT02987660|530987231|FG001|Overall Study|Study terminated by sponsor|10|||
147222786|NCT03707184|530987232|FG000|Overall Study|Withdrawal by Subject|2|||
147222787|NCT04950608|530987233|FG000|Overall Study|Withdrawal by Subject|2|||
147222788|NCT04950608|530987233|FG000|Overall Study|Physician Decision|3|||
147222789|NCT05007717|530987234|FG000|Overall Study|Death|3|||
147222790|NCT05007717|530987235|FG001|Overall Study|Death|2|||
147222791|NCT03553836|530987236|FG000|Overall Study|Ongoing in Study|460|||
147222792|NCT03553836|530987237|FG001|Overall Study|Ongoing in Study|459|||
147222793|NCT03553836|530987236|FG000|Overall Study|Withdrawal by Subject|9|||
147443465|NCT00094770|531788691|FG001|Year 1 ( Week 0 to Week 52)|Protocol Violation|10|||
147443466|NCT00094770|531788690|FG000|Year 1 ( Week 0 to Week 52)|Protocol Specified Discontinuation|19|||
147553513|NCT03264066|532181628|FG004|Overall Study|Progressive Disease|0|||
147553514|NCT03264066|532181629|FG005|Overall Study|Progressive Disease|0|||
147553515|NCT03264066|532181624|FG000|Overall Study|Study Terminated by Sponsor|5|||
147553516|NCT03264066|532181625|FG001|Overall Study|Study Terminated by Sponsor|5|||
147553517|NCT03264066|532181626|FG002|Overall Study|Study Terminated by Sponsor|8|||
147553518|NCT03264066|532181627|FG003|Overall Study|Study Terminated by Sponsor|5|||
147553519|NCT03264066|532181628|FG004|Overall Study|Study Terminated by Sponsor|1|||
147553520|NCT03264066|532181629|FG005|Overall Study|Study Terminated by Sponsor|2|||
147553521|NCT03264066|532181624|FG000|Overall Study|Withdrawal by Subject|1|||
147553522|NCT03264066|532181625|FG001|Overall Study|Withdrawal by Subject|0|||
147553523|NCT03264066|532181626|FG002|Overall Study|Withdrawal by Subject|0|||
147553524|NCT03264066|532181627|FG003|Overall Study|Withdrawal by Subject|5|||
147553525|NCT03264066|532181628|FG004|Overall Study|Withdrawal by Subject|0|||
147553526|NCT03264066|532181629|FG005|Overall Study|Withdrawal by Subject|0|||
147553527|NCT01484028|532181630|FG000|Period 1|Lost to Follow-up|0|||
147553528|NCT01484028|532181631|FG001|Period 1|Lost to Follow-up|1|||
147553529|NCT01484028|532181632|FG002|Period 1|Lost to Follow-up|0|||
147553530|NCT01484028|532181633|FG003|Period 1|Lost to Follow-up|0|||
147553531|NCT01484028|532181630|FG000|Period 1|Non-Compliance to Protocol|0|||
147553532|NCT01484028|532181631|FG001|Period 1|Non-Compliance to Protocol|1|||
147553533|NCT01484028|532181632|FG002|Period 1|Non-Compliance to Protocol|0|||
147553534|NCT01484028|532181633|FG003|Period 1|Non-Compliance to Protocol|1|||
147553535|NCT01484028|532181630|FG000|Period 1|Lens Discomfort|0|||
147553536|NCT01484028|532181631|FG001|Period 1|Lens Discomfort|1|||
147553537|NCT01484028|532181632|FG002|Period 1|Lens Discomfort|0|||
147553538|NCT01484028|532181633|FG003|Period 1|Lens Discomfort|0|||
147553539|NCT01193517|532181634|FG000|Overall Study|Early Progression|1|||
147553540|NCT01193517|532181635|FG001|Overall Study|Early Progression|0|||
147553541|NCT01193517|532181636|FG002|Overall Study|Early Progression|0|||
147553542|NCT00146770|532181637|FG000|Overall Study|Adverse Event|2|||
147553543|NCT00146770|532181638|FG001|Overall Study|Adverse Event|0|||
147553544|NCT00146770|532181637|FG000|Overall Study|Pregnancy|1|||
147553545|NCT00146770|532181638|FG001|Overall Study|Pregnancy|0|||
147553546|NCT00146770|532181637|FG000|Overall Study|Withdrawal by Subject|2|||
147553547|NCT00146770|532181638|FG001|Overall Study|Withdrawal by Subject|0|||
147553548|NCT01626885|532181641|FG000|Overall Study|Adverse Event|8|||
147553549|NCT01626885|532181641|FG000|Overall Study|Withdrawal by Subject|4|||
147553550|NCT01533428|532181642|FG000|Overall Study|Adverse Event|0|||
147553551|NCT01533428|532181643|FG001|Overall Study|Adverse Event|1|||
147553552|NCT01533428|532181642|FG000|Overall Study|Lost to Follow-up|2|||
147553553|NCT01533428|532181643|FG001|Overall Study|Lost to Follow-up|1|||
147553554|NCT01533428|532181642|FG000|Overall Study|Withdrawal by Subject|7|||
147553555|NCT01533428|532181643|FG001|Overall Study|Withdrawal by Subject|6|||
147553556|NCT02669264|532181646|FG000|Overall Study|Death|5|||
147553557|NCT02669264|532181647|FG001|Overall Study|Death|5|||
147553558|NCT02669264|532181648|FG002|Overall Study|Death|3|||
147553559|NCT02669264|532181649|FG003|Overall Study|Death|3|||
147553560|NCT02669264|532181650|FG004|Overall Study|Death|3|||
147553561|NCT02669264|532181651|FG005|Overall Study|Death|6|||
147553562|NCT02669264|532181652|FG006|Overall Study|Death|3|||
147553563|NCT02669264|532181646|FG000|Overall Study|Withdrawal by Subject|0|||
147553564|NCT02669264|532181647|FG001|Overall Study|Withdrawal by Subject|1|||
147553565|NCT02669264|532181648|FG002|Overall Study|Withdrawal by Subject|0|||
147309592|NCT00152971|531300117|FG000|Treatment|Adverse Event|49|||
147553566|NCT02669264|532181649|FG003|Overall Study|Withdrawal by Subject|0|||
147553567|NCT02669264|532181650|FG004|Overall Study|Withdrawal by Subject|1|||
147309593|NCT00152971|531300118|FG001|Treatment|Adverse Event|40|||
147553568|NCT02669264|532181651|FG005|Overall Study|Withdrawal by Subject|0|||
147553569|NCT02669264|532181652|FG006|Overall Study|Withdrawal by Subject|0|||
147553570|NCT02669264|532181646|FG000|Overall Study|Lost to Follow-up|0|||
147553571|NCT02669264|532181647|FG001|Overall Study|Lost to Follow-up|0|||
147553572|NCT02669264|532181648|FG002|Overall Study|Lost to Follow-up|0|||
147553573|NCT02669264|532181649|FG003|Overall Study|Lost to Follow-up|0|||
147553574|NCT02669264|532181650|FG004|Overall Study|Lost to Follow-up|1|||
147553575|NCT02669264|532181651|FG005|Overall Study|Lost to Follow-up|0|||
147553576|NCT02669264|532181652|FG006|Overall Study|Lost to Follow-up|0|||
147553577|NCT02669264|532181646|FG000|Overall Study|Miscellaneous|0|||
147553578|NCT02669264|532181647|FG001|Overall Study|Miscellaneous|0|||
147553579|NCT02669264|532181648|FG002|Overall Study|Miscellaneous|0|||
147553580|NCT02669264|532181649|FG003|Overall Study|Miscellaneous|0|||
147553581|NCT02669264|532181650|FG004|Overall Study|Miscellaneous|0|||
147553582|NCT02669264|532181651|FG005|Overall Study|Miscellaneous|0|||
147553583|NCT02669264|532181652|FG006|Overall Study|Miscellaneous|2|||
147553584|NCT00859469|532181654|FG000|Overall Study|Adverse Event|2|||
147553585|NCT00859469|532181654|FG000|Overall Study|Lack of Efficacy|9|||
147553586|NCT00859469|532181654|FG000|Overall Study|Withdrawal by Subject|1|||
147553587|NCT00859469|532181654|FG000|Overall Study|Death|16|||
147553588|NCT04345471|532181655|FG000|Overall Study|Adverse Event|8|||
147553589|NCT04345471|532181656|FG001|Overall Study|Adverse Event|5|||
147553590|NCT04345471|532181657|FG002|Overall Study|Adverse Event|6|||
147222794|NCT03553836|530987237|FG001|Overall Study|Withdrawal by Subject|10|||
147222795|NCT03553836|530987236|FG000|Overall Study|Lost to Follow-up|1|||
147222796|NCT03553836|530987237|FG001|Overall Study|Lost to Follow-up|3|||
147222797|NCT03553836|530987236|FG000|Overall Study|Death|17|||
147222798|NCT03553836|530987237|FG001|Overall Study|Death|17|||
147222799|NCT04062123|530987238|FG000|Overall Study|Withdrawal by Subject|0|||
147222800|NCT04062123|530987239|FG001|Overall Study|Withdrawal by Subject|1|||
147222801|NCT04062123|530987240|FG002|Overall Study|Withdrawal by Subject|0|||
147553591|NCT04345471|532181655|FG000|Overall Study|Lack of Efficacy|1|||
147553592|NCT04345471|532181656|FG001|Overall Study|Lack of Efficacy|1|||
147553593|NCT04345471|532181657|FG002|Overall Study|Lack of Efficacy|0|||
147553594|NCT04345471|532181655|FG000|Overall Study|Protocol Violation|0|||
147553595|NCT04345471|532181656|FG001|Overall Study|Protocol Violation|1|||
147553596|NCT04345471|532181657|FG002|Overall Study|Protocol Violation|2|||
147222802|NCT04626310|530987244|FG000|Overall Study|4-miss from treatment|6|||
147222803|NCT04626310|530987245|FG001|Overall Study|4-miss from treatment|5|||
147222804|NCT04626310|530987246|FG002|Overall Study|4-miss from treatment|5|||
147222805|NCT04626310|530987244|FG000|Overall Study|Withdrawal by Subject|1|||
147222806|NCT04626310|530987245|FG001|Overall Study|Withdrawal by Subject|0|||
147222807|NCT04626310|530987246|FG002|Overall Study|Withdrawal by Subject|3|||
147222808|NCT02278341|530987247|FG000|Overall Study|Randomized but never received study drug|1|||
147222809|NCT02278341|530987248|FG001|Overall Study|Randomized but never received study drug|1|||
147222810|NCT02278341|530987247|FG000|Overall Study|Adverse Event|3|||
147222811|NCT02278341|530987248|FG001|Overall Study|Adverse Event|0|||
147222812|NCT02278341|530987247|FG000|Overall Study|Death|68|||
147309594|NCT00152971|531300119|FG002|Treatment|Adverse Event|54|||
147222813|NCT02278341|530987248|FG001|Overall Study|Death|56|||
147222814|NCT02278341|530987247|FG000|Overall Study|Withdrawal by Subject|30|||
147222815|NCT02278341|530987248|FG001|Overall Study|Withdrawal by Subject|19|||
147222816|NCT02278341|530987247|FG000|Overall Study|Lost to Follow-up|0|||
147222817|NCT02278341|530987248|FG001|Overall Study|Lost to Follow-up|1|||
147222818|NCT02278341|530987247|FG000|Overall Study|Physician Decision|1|||
147222819|NCT02278341|530987248|FG001|Overall Study|Physician Decision|1|||
147222820|NCT02278341|530987247|FG000|Overall Study|Miscellaneous|15|||
147222821|NCT02278341|530987248|FG001|Overall Study|Miscellaneous|14|||
147443467|NCT00094770|531788691|FG001|Year 1 ( Week 0 to Week 52)|Protocol Specified Discontinuation|25|||
147443468|NCT00094770|531788690|FG000|Year 1 ( Week 0 to Week 52)|Patient Moved|6|||
147443469|NCT00094770|531788691|FG001|Year 1 ( Week 0 to Week 52)|Patient Moved|2|||
147443470|NCT00094770|531788690|FG000|Year 1 ( Week 0 to Week 52)|Withdrawal by Subject|25|||
147443471|NCT00094770|531788691|FG001|Year 1 ( Week 0 to Week 52)|Withdrawal by Subject|28|||
147553597|NCT04345471|532181655|FG000|Overall Study|Withdrawal by Subject|10|||
147553598|NCT04345471|532181656|FG001|Overall Study|Withdrawal by Subject|5|||
147553599|NCT04345471|532181657|FG002|Overall Study|Withdrawal by Subject|10|||
147553600|NCT01098240|532181660|FG000|Open-Label Phase|Study Terminated by Sponsor|27|||
147553601|NCT01098240|532181661|FG001|Open-Label Phase|Study Terminated by Sponsor|0|||
147553602|NCT01098240|532181662|FG002|Open-Label Phase|Study Terminated by Sponsor|0|||
147553603|NCT01098240|532181660|FG000|Open-Label Phase|Protocol Violation|4|||
147553604|NCT01098240|532181661|FG001|Open-Label Phase|Protocol Violation|0|||
147553605|NCT01098240|532181662|FG002|Open-Label Phase|Protocol Violation|0|||
147553606|NCT01098240|532181660|FG000|Open-Label Phase|Lost to Follow-up|13|||
147553607|NCT01098240|532181661|FG001|Open-Label Phase|Lost to Follow-up|0|||
147553608|NCT01098240|532181662|FG002|Open-Label Phase|Lost to Follow-up|0|||
147553609|NCT01098240|532181660|FG000|Open-Label Phase|Other|19|||
147553610|NCT01098240|532181661|FG001|Open-Label Phase|Other|0|||
147553611|NCT01098240|532181662|FG002|Open-Label Phase|Other|0|||
147553612|NCT01098240|532181660|FG000|Open-Label Phase|Did Not Meet Entrance Criteria|50|||
147553613|NCT01098240|532181661|FG001|Open-Label Phase|Did Not Meet Entrance Criteria|0|||
147553614|NCT01098240|532181662|FG002|Open-Label Phase|Did Not Meet Entrance Criteria|0|||
147553615|NCT01098240|532181660|FG000|Open-Label Phase|Pregnancy|1|||
147553616|NCT01098240|532181661|FG001|Open-Label Phase|Pregnancy|0|||
147553617|NCT01098240|532181662|FG002|Open-Label Phase|Pregnancy|0|||
147553618|NCT01098240|532181660|FG000|Open-Label Phase|Withdrawal by Subject|9|||
147553619|NCT01098240|532181661|FG001|Open-Label Phase|Withdrawal by Subject|0|||
147553620|NCT01098240|532181662|FG002|Open-Label Phase|Withdrawal by Subject|0|||
147553621|NCT01098240|532181660|FG000|Open-Label Phase|Adverse Event|12|||
147553622|NCT01098240|532181661|FG001|Open-Label Phase|Adverse Event|0|||
147553623|NCT01098240|532181662|FG002|Open-Label Phase|Adverse Event|0|||
147553624|NCT01098240|532181660|FG000|Double-Blind Phase|Study Terminated by Sponsor|0|||
147553625|NCT01098240|532181661|FG001|Double-Blind Phase|Study Terminated by Sponsor|5|||
147553626|NCT01098240|532181662|FG002|Double-Blind Phase|Study Terminated by Sponsor|8|||
147553627|NCT01098240|532181660|FG000|Double-Blind Phase|Protocol Violation|0|||
147553628|NCT01098240|532181661|FG001|Double-Blind Phase|Protocol Violation|2|||
147553629|NCT01098240|532181662|FG002|Double-Blind Phase|Protocol Violation|4|||
147553630|NCT01098240|532181660|FG000|Double-Blind Phase|Lost to Follow-up|0|||
147553631|NCT01098240|532181661|FG001|Double-Blind Phase|Lost to Follow-up|2|||
147553632|NCT01098240|532181662|FG002|Double-Blind Phase|Lost to Follow-up|0|||
147553633|NCT01098240|532181660|FG000|Double-Blind Phase|Other|0|||
147553634|NCT01098240|532181661|FG001|Double-Blind Phase|Other|2|||
147553635|NCT01098240|532181662|FG002|Double-Blind Phase|Other|2|||
147553636|NCT01098240|532181660|FG000|Double-Blind Phase|Did Not Meet Entrance Criteria|0|||
147553637|NCT01098240|532181661|FG001|Double-Blind Phase|Did Not Meet Entrance Criteria|1|||
147553638|NCT01098240|532181662|FG002|Double-Blind Phase|Did Not Meet Entrance Criteria|0|||
147553639|NCT01098240|532181660|FG000|Double-Blind Phase|Insufficient Clinical Response|0|||
147553640|NCT01098240|532181661|FG001|Double-Blind Phase|Insufficient Clinical Response|1|||
147443472|NCT00094770|531788690|FG000|Year 1 ( Week 0 to Week 52)|Site Terminated|2|||
147443473|NCT00094770|531788691|FG001|Year 1 ( Week 0 to Week 52)|Site Terminated|2|||
147443474|NCT00094770|531788690|FG000|Year 1 ( Week 0 to Week 52)|Other|10|||
147443475|NCT00094770|531788691|FG001|Year 1 ( Week 0 to Week 52)|Other|11|||
147443476|NCT00094770|531788690|FG000|Year 2 (Week 0 to Week 104)|Adverse Event|35|||
147443477|NCT00094770|531788691|FG001|Year 2 (Week 0 to Week 104)|Adverse Event|36|||
147553641|NCT01098240|532181662|FG002|Double-Blind Phase|Insufficient Clinical Response|2|||
147553642|NCT01098240|532181660|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
147553643|NCT01098240|532181661|FG001|Double-Blind Phase|Withdrawal by Subject|1|||
147553644|NCT01098240|532181662|FG002|Double-Blind Phase|Withdrawal by Subject|3|||
147553645|NCT01098240|532181660|FG000|Double-Blind Phase|Adverse Event|0|||
147553646|NCT01098240|532181661|FG001|Double-Blind Phase|Adverse Event|3|||
147553647|NCT01098240|532181662|FG002|Double-Blind Phase|Adverse Event|3|||
147553648|NCT01588106|532181663|FG000|Overall Study|Withdrawal by Subject|5|||
147553649|NCT01588106|532181664|FG001|Overall Study|Withdrawal by Subject|4|||
147553650|NCT00982410|532183768|FG000|3-month Follow-up Assessment|Could not reach to schedule|8|||
147553651|NCT00982410|532183769|FG001|3-month Follow-up Assessment|Could not reach to schedule|9|||
147553652|NCT00982410|532183768|FG000|3-month Follow-up Assessment|Scheduled, no-show|1|||
147553653|NCT00982410|532183769|FG001|3-month Follow-up Assessment|Scheduled, no-show|2|||
147553654|NCT00982410|532183768|FG000|3-month Follow-up Assessment|Withdrawal by Subject|0|||
147553655|NCT00982410|532183769|FG001|3-month Follow-up Assessment|Withdrawal by Subject|2|||
147553656|NCT00982410|532183768|FG000|6-month Follow-up Assessment|Could not reach to schedule|5|||
147443478|NCT00094770|531788690|FG000|Year 2 (Week 0 to Week 104)|Lack of Efficacy|180|||
147553657|NCT00982410|532183769|FG001|6-month Follow-up Assessment|Could not reach to schedule|7|||
147553658|NCT00982410|532183768|FG000|6-month Follow-up Assessment|participant no transportation|1|||
147553659|NCT00982410|532183769|FG001|6-month Follow-up Assessment|participant no transportation|0|||
147553660|NCT00982410|532183768|FG000|6-month Follow-up Assessment|incarceration|0|||
147553661|NCT00982410|532183769|FG001|6-month Follow-up Assessment|incarceration|2|||
147553662|NCT00982410|532183768|FG000|6-month Follow-up Assessment|patent surgery|0|||
147553663|NCT00982410|532183769|FG001|6-month Follow-up Assessment|patent surgery|1|||
147553664|NCT00982410|532183768|FG000|6-month Follow-up Assessment|scheduled, no-show|0|||
147553665|NCT00982410|532183769|FG001|6-month Follow-up Assessment|scheduled, no-show|1|||
147553666|NCT00982410|532183768|FG000|12-month Follow-up Assessment|Death|0|||
147553667|NCT00982410|532183769|FG001|12-month Follow-up Assessment|Death|2|||
147553668|NCT00982410|532183768|FG000|12-month Follow-up Assessment|could not reach to schedule|6|||
147553669|NCT00982410|532183769|FG001|12-month Follow-up Assessment|could not reach to schedule|5|||
147553670|NCT00982410|532183768|FG000|12-month Follow-up Assessment|Withdrawal by Subject|0|||
147553671|NCT00982410|532183769|FG001|12-month Follow-up Assessment|Withdrawal by Subject|1|||
147553672|NCT00982410|532183768|FG000|12-month Follow-up Assessment|incarceration|2|||
147553673|NCT00982410|532183769|FG001|12-month Follow-up Assessment|incarceration|1|||
147222822|NCT04902326|530987249|FG000|Overall Study|Withdrawal by Subject|1|||
147222823|NCT04902326|530987250|FG001|Overall Study|Withdrawal by Subject|3|||
147553674|NCT00982410|532183768|FG000|12-month Follow-up Assessment|scheduled, no-show|1|||
147650870|NCT02757352|532544539|FG002|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|42|||
147443479|NCT00094770|531788691|FG001|Year 2 (Week 0 to Week 104)|Lack of Efficacy|162|||
147443480|NCT00094770|531788690|FG000|Year 2 (Week 0 to Week 104)|Lost to Follow-up|25|||
147443481|NCT00094770|531788691|FG001|Year 2 (Week 0 to Week 104)|Lost to Follow-up|15|||
147443482|NCT00094770|531788690|FG000|Year 2 (Week 0 to Week 104)|Protocol Violation|13|||
147443483|NCT00094770|531788691|FG001|Year 2 (Week 0 to Week 104)|Protocol Violation|12|||
147443484|NCT00094770|531788690|FG000|Year 2 (Week 0 to Week 104)|Protocol Specified Discontinuation|29|||
147443485|NCT00094770|531788691|FG001|Year 2 (Week 0 to Week 104)|Protocol Specified Discontinuation|30|||
147443486|NCT00094770|531788690|FG000|Year 2 (Week 0 to Week 104)|Patient Moved|6|||
147553675|NCT00982410|532183769|FG001|12-month Follow-up Assessment|scheduled, no-show|0|||
147553676|NCT04014959|532183770|FG000|Baseline MRI and Assessments|Physician Decision|2|||
147553677|NCT04014959|532183770|FG000|Targeting TMS Scan|Lost to Follow-up|1|||
147553678|NCT04014959|532183770|FG000|Mini TMS Sessions (3 Visits)|Withdrawal by Subject|1|||
147553679|NCT02004847|532183771|FG000|Overall Study|Protocol Violation|1|||
147553680|NCT02004847|532183772|FG001|Overall Study|Protocol Violation|1|||
147553681|NCT00759148|532183776|FG000|Overall Study|Adverse Event|1|||
147553682|NCT00759148|532183777|FG001|Overall Study|Adverse Event|6|||
147553683|NCT00759148|532183776|FG000|Overall Study|Withdrawal by Subject|3|||
147553684|NCT00759148|532183777|FG001|Overall Study|Withdrawal by Subject|7|||
147553685|NCT00759148|532183776|FG000|Overall Study|Lost to Follow-up|3|||
147553686|NCT00759148|532183777|FG001|Overall Study|Lost to Follow-up|9|||
147553687|NCT00759148|532183776|FG000|Overall Study|Treatment Failure|6|||
147553688|NCT00759148|532183777|FG001|Overall Study|Treatment Failure|10|||
147553689|NCT00759148|532183776|FG000|Overall Study|Reason not given|1|||
147553690|NCT00759148|532183777|FG001|Overall Study|Reason not given|0|||
147553691|NCT03381248|532183778|FG000|0-6 Months|Withdrawal by Subject|4|||
147553692|NCT03381248|532183779|FG001|0-6 Months|Withdrawal by Subject|1|||
147553693|NCT03381248|532183778|FG000|0-6 Months|Lost to Follow-up|3|||
147553694|NCT03381248|532183779|FG001|0-6 Months|Lost to Follow-up|2|||
147553695|NCT03381248|532183778|FG000|0-6 Months|Lack of Efficacy|1|||
147553696|NCT03381248|532183779|FG001|0-6 Months|Lack of Efficacy|0|||
147553697|NCT03381248|532183778|FG000|0-6 Months|Adverse Event|1|||
147222824|NCT04902326|530987251|FG002|Overall Study|Withdrawal by Subject|0|||
147222825|NCT04902326|530987252|FG003|Overall Study|Withdrawal by Subject|1|||
147222826|NCT04902326|530987249|FG000|Overall Study|Lost to Follow-up|14|||
147222827|NCT04902326|530987250|FG001|Overall Study|Lost to Follow-up|14|||
147222828|NCT04902326|530987251|FG002|Overall Study|Lost to Follow-up|14|||
147222829|NCT04902326|530987252|FG003|Overall Study|Lost to Follow-up|6|||
147222830|NCT02604017|530987254|FG000|Overall Study|Withdrew Consent|0|||
147222831|NCT02604017|530987255|FG001|Overall Study|Withdrew Consent|2|||
147222832|NCT02604017|530987254|FG000|Overall Study|Lost to Follow-up|5|||
147222833|NCT02604017|530987255|FG001|Overall Study|Lost to Follow-up|6|||
147222834|NCT02604017|530987254|FG000|Overall Study|Other|1|||
147222835|NCT02604017|530987255|FG001|Overall Study|Other|0|||
147222836|NCT01041495|530987256|FG000|Overall Study|Withdrawal by Subject|2|||
147222837|NCT01041495|530987257|FG001|Overall Study|Withdrawal by Subject|5|||
147222838|NCT01041495|530987256|FG000|Overall Study|Adverse Event|2|||
147222839|NCT01041495|530987257|FG001|Overall Study|Adverse Event|1|||
147222840|NCT01041495|530987256|FG000|Overall Study|Lost to Follow-up|0|||
147443487|NCT00094770|531788691|FG001|Year 2 (Week 0 to Week 104)|Patient Moved|2|||
147553698|NCT03381248|532183779|FG001|0-6 Months|Adverse Event|0|||
147553699|NCT03381248|532183778|FG000|0-6 Months|Protocol Violation|2|||
147553700|NCT03381248|532183779|FG001|0-6 Months|Protocol Violation|1|||
147553701|NCT03381248|532183778|FG000|0-6 Months|Physician Decision|1|||
147553702|NCT03381248|532183779|FG001|0-6 Months|Physician Decision|0|||
147553703|NCT03381248|532183778|FG000|0-6 Months|Planning another procedure|1|||
147222841|NCT01041495|530987257|FG001|Overall Study|Lost to Follow-up|1|||
147222842|NCT01487577|530987258|FG000|Overall Study|Became ineligible after signing consent|1|||
147222843|NCT01479985|530987262|FG000|Overall Study|Tablet malfunction, no data saved|1|||
147222844|NCT01479985|530987263|FG001|Overall Study|Tablet malfunction, no data saved|1|||
147222845|NCT01479985|530987262|FG000|Overall Study|No decisional conflict scale responses|0|||
147222846|NCT01479985|530987263|FG001|Overall Study|No decisional conflict scale responses|2|||
147222847|NCT01479985|530987262|FG000|Overall Study|No post-visit survey|5|||
147222848|NCT01479985|530987263|FG001|Overall Study|No post-visit survey|3|||
147222849|NCT01653782|530987264|FG000|Overall Study|Withdrawal by Subject|9|||
147222850|NCT01653782|530987265|FG001|Overall Study|Withdrawal by Subject|15|||
147222851|NCT01653782|530987266|FG002|Overall Study|Withdrawal by Subject|4|||
147222852|NCT01653782|530987264|FG000|Overall Study|Lost to Follow-up|7|||
147222853|NCT01653782|530987265|FG001|Overall Study|Lost to Follow-up|3|||
147222854|NCT01653782|530987266|FG002|Overall Study|Lost to Follow-up|2|||
147222855|NCT01850602|530987272|FG000|Overall Study|Adverse Event|7|||
147222856|NCT01850602|530987273|FG001|Overall Study|Adverse Event|10|||
147222857|NCT01850602|530987272|FG000|Overall Study|Physician Decision|2|||
147222858|NCT01850602|530987273|FG001|Overall Study|Physician Decision|1|||
147222859|NCT01850602|530987272|FG000|Overall Study|Withdrawal by Subject|2|||
147222860|NCT01850602|530987273|FG001|Overall Study|Withdrawal by Subject|4|||
147222861|NCT01850602|530987272|FG000|Overall Study|Decrease in serum calcium|2|||
147222862|NCT01850602|530987273|FG001|Overall Study|Decrease in serum calcium|3|||
147222863|NCT01850602|530987272|FG000|Overall Study|Increase in serum ferritin|1|||
147222864|NCT01850602|530987273|FG001|Overall Study|Increase in serum ferritin|0|||
147222865|NCT00367770|530987274|FG000|Overall Study|Adverse Event|1|||
147222866|NCT00367770|530987274|FG000|Overall Study|Withdrawal by Subject|1|||
147222867|NCT01315236|530987278|FG000|Double-blind Phase|Death|1|||
147222868|NCT01315236|530987279|FG001|Double-blind Phase|Death|0|||
147222869|NCT01315236|530987278|FG000|Double-blind Phase|Adverse Event|1|||
147222870|NCT01315236|530987279|FG001|Double-blind Phase|Adverse Event|0|||
147222871|NCT01315236|530987278|FG000|Double-blind Phase|Withdrawal of Consent|1|||
147222872|NCT01315236|530987279|FG001|Double-blind Phase|Withdrawal of Consent|0|||
147553704|NCT03381248|532183779|FG001|0-6 Months|Planning another procedure|2|||
147553705|NCT03381248|532183778|FG000|6-12 Months|Withdrawal by Subject|1|||
147553706|NCT03381248|532183779|FG001|6-12 Months|Withdrawal by Subject|3|||
147553707|NCT03381248|532183778|FG000|6-12 Months|Lost to Follow-up|0|||
147553708|NCT03381248|532183779|FG001|6-12 Months|Lost to Follow-up|2|||
147553709|NCT03381248|532183778|FG000|6-12 Months|Protocol Violation|3|||
147553710|NCT03381248|532183779|FG001|6-12 Months|Protocol Violation|2|||
147553711|NCT03381248|532183778|FG000|6-12 Months|Planning another procedure|6|||
147553712|NCT03381248|532183779|FG001|6-12 Months|Planning another procedure|2|||
147553713|NCT03381248|532183778|FG000|12 - 24 Months (Extension Study)|Withdrawal by Subject|3|||
147553714|NCT03381248|532183779|FG001|12 - 24 Months (Extension Study)|Withdrawal by Subject|0|||
147553715|NCT03381248|532183778|FG000|12 - 24 Months (Extension Study)|Lost to Follow-up|1|||
147553716|NCT03381248|532183779|FG001|12 - 24 Months (Extension Study)|Lost to Follow-up|0|||
147553717|NCT03381248|532183778|FG000|12 - 24 Months (Extension Study)|Received another procedure|5|||
147553718|NCT03381248|532183779|FG001|12 - 24 Months (Extension Study)|Received another procedure|0|||
147553719|NCT05188521|532183780|FG000|Baricitinib 2mg Initial Study|Travel issues|1|||
147553720|NCT05188521|532183781|FG001|Baricitinib 2mg Initial Study|Travel issues|0|||
147309595|NCT00152971|531300117|FG000|Treatment|Protocol Violation|8|||
147553721|NCT04582266|532183782|FG000|Overall Study|Lost to Follow-up|7|||
147553722|NCT04582266|532183783|FG001|Overall Study|Lost to Follow-up|5|||
147553723|NCT04582266|532183782|FG000|Overall Study|Withdrawal by Subject|1|||
147659416|NCT01064414|532576183|FG002|Core Period: Baseline to Week 26|Death|0|||
147553724|NCT04582266|532183783|FG001|Overall Study|Withdrawal by Subject|0|||
147553725|NCT04582266|532183782|FG000|Overall Study|Logistical and Personnel Constraints at Time of Infusion|1|||
147553726|NCT04582266|532183783|FG001|Overall Study|Logistical and Personnel Constraints at Time of Infusion|0|||
147553727|NCT01341639|532183784|FG000|Infant Series|Protocol Violation|1|||
147553728|NCT01341639|532183785|FG001|Infant Series|Protocol Violation|0|||
147553729|NCT01341639|532183784|FG000|Infant Series|Not Vaccinated|0|||
147553730|NCT01341639|532183785|FG001|Infant Series|Not Vaccinated|1|||
147553731|NCT01341639|532183784|FG000|Infant Series|Adverse Event|0|||
147553732|NCT01341639|532183785|FG001|Infant Series|Adverse Event|5|||
147553733|NCT01341639|532183784|FG000|Infant Series|Withdrawal by Subject|11|||
147553734|NCT01341639|532183785|FG001|Infant Series|Withdrawal by Subject|8|||
147553735|NCT01341639|532183784|FG000|Infant Series|Lost to Follow-up|0|||
147553736|NCT01341639|532183785|FG001|Infant Series|Lost to Follow-up|2|||
147553737|NCT01341639|532183784|FG000|Infant Series|Site 0048 Participants|17|||
147553738|NCT01341639|532183785|FG001|Infant Series|Site 0048 Participants|16|||
147553739|NCT01341639|532183784|FG000|Interim Period|Withdrawal by Subject|6|||
147553740|NCT01341639|532183785|FG001|Interim Period|Withdrawal by Subject|7|||
147553741|NCT01341639|532183784|FG000|Interim Period|Lost to Follow-up|2|||
147553742|NCT01341639|532183785|FG001|Interim Period|Lost to Follow-up|0|||
147553743|NCT01341639|532183784|FG000|Interim Period|Physician Decision|0|||
147553744|NCT01341639|532183785|FG001|Interim Period|Physician Decision|1|||
147553745|NCT01341639|532183784|FG000|Interim Period|Protocol Violation|0|||
147553746|NCT01341639|532183785|FG001|Interim Period|Protocol Violation|1|||
147553747|NCT01341639|532183784|FG000|Post-Treatment|Withdrawal by Subject|0|||
147553748|NCT01341639|532183785|FG001|Post-Treatment|Withdrawal by Subject|1|||
147553749|NCT01341639|532183784|FG000|Post-Treatment|Adverse Event|0|||
147553750|NCT01341639|532183785|FG001|Post-Treatment|Adverse Event|2|||
147553751|NCT02247479|532183786|FG000|Overall Study|Adverse Event|8|||
147553752|NCT02247479|532183787|FG001|Overall Study|Adverse Event|9|||
147553753|NCT02247479|532183788|FG002|Overall Study|Adverse Event|8|||
147553754|NCT02247479|532183786|FG000|Overall Study|Death|5|||
147553755|NCT02247479|532183787|FG001|Overall Study|Death|4|||
147553756|NCT02247479|532183788|FG002|Overall Study|Death|6|||
147553757|NCT02247479|532183786|FG000|Overall Study|Lost to Follow-up|3|||
147553758|NCT02247479|532183787|FG001|Overall Study|Lost to Follow-up|3|||
147553759|NCT02247479|532183788|FG002|Overall Study|Lost to Follow-up|1|||
147553760|NCT02247479|532183786|FG000|Overall Study|Non-compliance|0|||
147553761|NCT02247479|532183787|FG001|Overall Study|Non-compliance|0|||
147553762|NCT02247479|532183788|FG002|Overall Study|Non-compliance|1|||
147553763|NCT02247479|532183786|FG000|Overall Study|Withdrawal by Subject|25|||
147553764|NCT02247479|532183787|FG001|Overall Study|Withdrawal by Subject|29|||
147553765|NCT02247479|532183788|FG002|Overall Study|Withdrawal by Subject|24|||
147553766|NCT02247479|532183786|FG000|Overall Study|Study Terminated by Sponsor|98|||
147553767|NCT02247479|532183787|FG001|Overall Study|Study Terminated by Sponsor|88|||
147553768|NCT02247479|532183788|FG002|Overall Study|Study Terminated by Sponsor|94|||
147553769|NCT02247479|532183786|FG000|Overall Study|Physician Decision|1|||
147553770|NCT02247479|532183787|FG001|Overall Study|Physician Decision|0|||
147553771|NCT02247479|532183788|FG002|Overall Study|Physician Decision|2|||
147553772|NCT02247479|532183786|FG000|Overall Study|Unspecified Reason|2|||
147553773|NCT02247479|532183787|FG001|Overall Study|Unspecified Reason|5|||
147553774|NCT02247479|532183788|FG002|Overall Study|Unspecified Reason|2|||
147309596|NCT00152971|531300118|FG001|Treatment|Protocol Violation|6|||
147553775|NCT01132118|532183789|FG000|First Intervention (8 Weeks)|Adverse Event|1|||
147553776|NCT01132118|532183790|FG001|First Intervention (8 Weeks)|Adverse Event|0|||
147553777|NCT01132118|532183789|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|2|||
147553778|NCT01132118|532183790|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|3|||
147553779|NCT01132118|532183789|FG000|Second Intervention (8 Weeks)|Adverse Event|0|||
147553780|NCT01132118|532183790|FG001|Second Intervention (8 Weeks)|Adverse Event|1|||
147553781|NCT01299038|532183793|FG000|Overall Study|Withdrawal by Subject|1|||
147553782|NCT01299038|532183794|FG001|Overall Study|Withdrawal by Subject|0|||
147553783|NCT00322556|532183795|FG000|Overall Study|Adverse Event|1|||
147553784|NCT00322556|532183795|FG000|Overall Study|Withdrawal by Subject|1|||
147309597|NCT00152971|531300119|FG002|Treatment|Protocol Violation|10|||
147222873|NCT01315236|530987278|FG000|Double-blind Phase|Lost to Follow-up|1|||
147222874|NCT01315236|530987279|FG001|Double-blind Phase|Lost to Follow-up|0|||
147222875|NCT01315236|530987278|FG000|Open-label Phase|Death|1|||
147222876|NCT01315236|530987279|FG001|Open-label Phase|Death|0|||
147222877|NCT01315236|530987278|FG000|Open-label Phase|Adverse Event|0|||
147222878|NCT01315236|530987279|FG001|Open-label Phase|Adverse Event|1|||
147222879|NCT01315236|530987278|FG000|Open-label Phase|Other|0|||
147222880|NCT01315236|530987279|FG001|Open-label Phase|Other|1|||
147222881|NCT01315236|530987278|FG000|12-Month Follow-up Period|Death|0|||
147222882|NCT01315236|530987279|FG001|12-Month Follow-up Period|Death|1|||
147222883|NCT01315236|530987278|FG000|12-Month Follow-up Period|Did not return to the site for Month 12|1|||
147222884|NCT01315236|530987279|FG001|12-Month Follow-up Period|Did not return to the site for Month 12|0|||
147309598|NCT00152971|531300117|FG000|Treatment|Lost to Follow-up|1|||
147222885|NCT01634178|530987280|FG000|Treatment Period 1|Adverse Event|0|||
147222886|NCT01634178|530987281|FG001|Treatment Period 1|Adverse Event|1|||
147222887|NCT01634178|530987280|FG000|Treatment Period 2|Adverse Event|1|||
147222888|NCT01634178|530987281|FG001|Treatment Period 2|Adverse Event|0|||
147553785|NCT00322556|532183795|FG000|Overall Study|Lost to Follow-up|3|||
147553786|NCT00322556|532183795|FG000|Overall Study|Other Reason|7|||
147553787|NCT01590433|532183796|FG000|Overall Study|Lost to Follow-up|20|||
147553788|NCT01590433|532183797|FG001|Overall Study|Lost to Follow-up|8|||
147553789|NCT01590433|532183796|FG000|Overall Study|Withdrawal by Subject|21|||
147553790|NCT01590433|532183797|FG001|Overall Study|Withdrawal by Subject|11|||
147553791|NCT01590433|532183796|FG000|Overall Study|Adverse Event|11|||
147553792|NCT01590433|532183797|FG001|Overall Study|Adverse Event|3|||
147553793|NCT00555009|532183798|FG000|Overall Study|Withdrawal by Subject|0|||
147553794|NCT00555009|532183799|FG001|Overall Study|Withdrawal by Subject|1|||
147553795|NCT00555009|532183798|FG000|Overall Study|Terminated by Sponsor|2|||
147553796|NCT00555009|532183799|FG001|Overall Study|Terminated by Sponsor|5|||
147553797|NCT01506323|532183808|FG000|Overall Study|Lost to Follow-up|5|||
147553798|NCT01506323|532183809|FG001|Overall Study|Lost to Follow-up|4|||
147553799|NCT01506323|532183808|FG000|Overall Study|Withdrawal by Subject|4|||
147553800|NCT01506323|532183809|FG001|Overall Study|Withdrawal by Subject|4|||
147553801|NCT01506323|532183808|FG000|Overall Study|Lack of Efficacy|1|||
147553802|NCT01506323|532183809|FG001|Overall Study|Lack of Efficacy|3|||
147553803|NCT01506323|532183808|FG000|Overall Study|Moved out of area|5|||
147553804|NCT01506323|532183809|FG001|Overall Study|Moved out of area|2|||
147553805|NCT01506323|532183808|FG000|Overall Study|Schedule or Transportation conflict|8|||
147553806|NCT01506323|532183809|FG001|Overall Study|Schedule or Transportation conflict|0|||
147222889|NCT00287079|530987284|FG000|Overall Study|Qualifying relapse|12|||
147222890|NCT00287079|530987285|FG001|Overall Study|Qualifying relapse|1|||
147222891|NCT00287079|530987284|FG000|Overall Study|Non-qualifying relapse|1|||
147222892|NCT00287079|530987285|FG001|Overall Study|Non-qualifying relapse|0|||
147222893|NCT00287079|530987284|FG000|Overall Study|Adverse Event|5|||
147222894|NCT00287079|530987285|FG001|Overall Study|Adverse Event|0|||
147222895|NCT00287079|530987284|FG000|Overall Study|Protocol Violation|1|||
147222896|NCT00287079|530987285|FG001|Overall Study|Protocol Violation|0|||
147222897|NCT00287079|530987284|FG000|Overall Study|Other|3|||
147222898|NCT00287079|530987285|FG001|Overall Study|Other|0|||
147222899|NCT00470184|530987286|FG000|Overall Study|Not Treated(became ineligible)|4|||
147222900|NCT00470184|530987286|FG000|Overall Study|Not treated (other)|1|||
147222901|NCT00470184|530987286|FG000|Overall Study|disease Progression|4|||
147222902|NCT00470184|530987286|FG000|Overall Study|Adverse Event|3|||
147222903|NCT00470184|530987286|FG000|Overall Study|Withdrawal by Subject|4|||
147222904|NCT00470184|530987286|FG000|Overall Study|other|5|||
147222905|NCT00470184|530987286|FG000|Overall Study|recurrence|1|||
147222906|NCT01721577|530987287|FG000|Overall Study|Lack of Efficacy|1|||
147222907|NCT01721577|530987288|FG001|Overall Study|Lack of Efficacy|0|||
147222908|NCT01721577|530987287|FG000|Overall Study|Death|1|||
147222909|NCT01721577|530987288|FG001|Overall Study|Death|0|||
147222910|NCT01721577|530987287|FG000|Overall Study|Dose Escalation to 400mg BID|0|||
147222911|NCT01721577|530987288|FG001|Overall Study|Dose Escalation to 400mg BID|1|||
147222912|NCT01721577|530987287|FG000|Overall Study|Adverse Event|0|||
147222913|NCT01721577|530987288|FG001|Overall Study|Adverse Event|2|||
147222914|NCT01282203|530987291|FG000|Overall Study|Adverse Event|1|||
147222915|NCT03282565|530987294|FG000|Overall Study|COVID-19 Research Shutdown|0|||
147222916|NCT03282565|530987295|FG001|Overall Study|COVID-19 Research Shutdown|2|||
147222917|NCT03282565|530987296|FG002|Overall Study|COVID-19 Research Shutdown|2|||
147222918|NCT00740051|530987297|FG000|Overall Study|Lack of Efficacy|2|||
147222919|NCT00740051|530987298|FG001|Overall Study|Lack of Efficacy|5|||
147222920|NCT00740051|530987297|FG000|Overall Study|Adverse Event|1|||
147222921|NCT00740051|530987298|FG001|Overall Study|Adverse Event|4|||
147222922|NCT00740051|530987297|FG000|Overall Study|Protocol Violation|2|||
147222923|NCT00740051|530987298|FG001|Overall Study|Protocol Violation|6|||
147222924|NCT00740051|530987297|FG000|Overall Study|Lost to Follow-up|3|||
147222925|NCT00740051|530987298|FG001|Overall Study|Lost to Follow-up|8|||
147222926|NCT00740051|530987297|FG000|Overall Study|Withdrawal by Subject|6|||
147222927|NCT00740051|530987298|FG001|Overall Study|Withdrawal by Subject|8|||
147222928|NCT00740051|530987297|FG000|Overall Study|Other reason (not specified)|4|||
147222929|NCT00740051|530987298|FG001|Overall Study|Other reason (not specified)|1|||
147222930|NCT02011893|530987299|FG000|Enrollment to Randomization|Adverse Event|2|||
147222931|NCT02011893|530987300|FG001|Enrollment to Randomization|Adverse Event|0|||
147222932|NCT02011893|530987301|FG002|Enrollment to Randomization|Adverse Event|0|||
147222933|NCT02011893|530987299|FG000|Enrollment to Randomization|Physician Decision|10|||
147222934|NCT02011893|530987300|FG001|Enrollment to Randomization|Physician Decision|0|||
147222935|NCT02011893|530987301|FG002|Enrollment to Randomization|Physician Decision|0|||
147222936|NCT02011893|530987299|FG000|Enrollment to Randomization|Withdrawal by Subject|21|||
147222937|NCT02011893|530987300|FG001|Enrollment to Randomization|Withdrawal by Subject|0|||
147222938|NCT02011893|530987301|FG002|Enrollment to Randomization|Withdrawal by Subject|0|||
147222939|NCT02011893|530987299|FG000|Enrollment to Randomization|Screening Failure|29|||
147222940|NCT02011893|530987300|FG001|Enrollment to Randomization|Screening Failure|0|||
147222941|NCT02011893|530987301|FG002|Enrollment to Randomization|Screening Failure|0|||
147222942|NCT02011893|530987299|FG000|Enrollment to Randomization|Temporary Trial Stimulation Failure|9|||
147222943|NCT02011893|530987300|FG001|Enrollment to Randomization|Temporary Trial Stimulation Failure|0|||
147222944|NCT02011893|530987301|FG002|Enrollment to Randomization|Temporary Trial Stimulation Failure|0|||
147553807|NCT01506323|532183808|FG000|Overall Study|Started another treatment|1|||
147222945|NCT02011893|530987299|FG000|Enrollment to Randomization|Insurance/Financial Reasons|2|||
147222946|NCT02011893|530987300|FG001|Enrollment to Randomization|Insurance/Financial Reasons|0|||
147222947|NCT02011893|530987301|FG002|Enrollment to Randomization|Insurance/Financial Reasons|0|||
147553808|NCT01506323|532183809|FG001|Overall Study|Started another treatment|0|||
147553809|NCT02232074|532183810|FG000|Overall Study|Withdrawal by Subject|5|||
147222948|NCT02011893|530987299|FG000|Period 1 (Randomization to 12 Weeks)|Physician Decision|0|||
147222949|NCT02011893|530987300|FG001|Period 1 (Randomization to 12 Weeks)|Physician Decision|0|||
147553810|NCT02232074|532183811|FG001|Overall Study|Withdrawal by Subject|3|||
147553811|NCT02232074|532183810|FG000|Overall Study|No legal concerns at baseline|36|||
147553812|NCT02232074|532183811|FG001|Overall Study|No legal concerns at baseline|41|||
147553813|NCT02232074|532183810|FG000|Overall Study|deemed ineligible|0|||
147553814|NCT02232074|532183811|FG001|Overall Study|deemed ineligible|1|||
147553815|NCT01844583|532183821|FG000|Overall Study|Didn't complete dosing;PK/ECG assessment|8|||
147553816|NCT01844583|532183822|FG001|Overall Study|Didn't complete dosing;PK/ECG assessment|10|||
147222950|NCT02011893|530987301|FG002|Period 1 (Randomization to 12 Weeks)|Physician Decision|1|||
147222951|NCT02011893|530987299|FG000|Period 1 (Randomization to 12 Weeks)|Withdrawal by Subject|0|||
147222952|NCT02011893|530987300|FG001|Period 1 (Randomization to 12 Weeks)|Withdrawal by Subject|0|||
147222953|NCT02011893|530987301|FG002|Period 1 (Randomization to 12 Weeks)|Withdrawal by Subject|2|||
147222954|NCT02011893|530987299|FG000|Period 2 (12 Weeks to 24 Weeks)|Physician Decision|0|||
147222955|NCT02011893|530987300|FG001|Period 2 (12 Weeks to 24 Weeks)|Physician Decision|0|||
147222956|NCT02011893|530987301|FG002|Period 2 (12 Weeks to 24 Weeks)|Physician Decision|1|||
147222957|NCT00930982|530987302|FG000|Overall Study|Adverse Event|19|||
147222958|NCT00930982|530987303|FG001|Overall Study|Adverse Event|23|||
147222959|NCT00930982|530987302|FG000|Overall Study|Protocol Violation|1|||
147222960|NCT00930982|530987303|FG001|Overall Study|Protocol Violation|5|||
147222961|NCT00930982|530987302|FG000|Overall Study|Withdrawal by Subject|1|||
147222962|NCT00930982|530987303|FG001|Overall Study|Withdrawal by Subject|1|||
147222963|NCT00991952|530987304|FG000|Overall Study|Adverse Event|0|||
147222964|NCT00991952|530987305|FG001|Overall Study|Adverse Event|1|||
147222965|NCT00518973|530987306|FG000|Overall Study|Withdrawal by Subject|3|||
147222966|NCT00518973|530987307|FG001|Overall Study|Withdrawal by Subject|2|||
147222967|NCT03452527|530987308|FG000|Overall Study|Withdrawal by Subject|1|||
147222968|NCT03452527|530987309|FG001|Overall Study|Withdrawal by Subject|1|||
147222969|NCT03452527|530987308|FG000|Overall Study|Study Terminated|2|||
147222970|NCT03452527|530987309|FG001|Overall Study|Study Terminated|3|||
147222971|NCT00582816|530987310|FG000|Overall Study|Engraftment Failure|3|||
147222972|NCT01565499|530987314|FG000|Overall Study|Physician Decision|1|||
147222973|NCT01565499|530987314|FG000|Overall Study|Adverse Event|5|||
147222974|NCT01565499|530987314|FG000|Overall Study|Withdrawal by Subject|2|||
147222975|NCT01255787|530987317|FG000|Overall Study|Pretreatment Event or Adverse Event (AE)|6|||
147222976|NCT01255787|530987318|FG001|Overall Study|Pretreatment Event or Adverse Event (AE)|2|||
147222977|NCT01255787|530987319|FG002|Overall Study|Pretreatment Event or Adverse Event (AE)|9|||
147222978|NCT01255787|530987320|FG003|Overall Study|Pretreatment Event or Adverse Event (AE)|9|||
147222979|NCT01255787|530987317|FG000|Overall Study|Major Protocol Deviation|1|||
147222980|NCT01255787|530987318|FG001|Overall Study|Major Protocol Deviation|1|||
147222981|NCT01255787|530987319|FG002|Overall Study|Major Protocol Deviation|0|||
147222982|NCT01255787|530987320|FG003|Overall Study|Major Protocol Deviation|4|||
147222983|NCT01255787|530987317|FG000|Overall Study|Lost to Follow-up|1|||
147222984|NCT01255787|530987318|FG001|Overall Study|Lost to Follow-up|2|||
147222985|NCT01255787|530987319|FG002|Overall Study|Lost to Follow-up|4|||
147222986|NCT01255787|530987320|FG003|Overall Study|Lost to Follow-up|2|||
147222987|NCT01255787|530987317|FG000|Overall Study|Withdrawal of Consent|3|||
147222988|NCT01255787|530987318|FG001|Overall Study|Withdrawal of Consent|9|||
147222989|NCT01255787|530987319|FG002|Overall Study|Withdrawal of Consent|3|||
147222990|NCT01255787|530987320|FG003|Overall Study|Withdrawal of Consent|4|||
147222991|NCT01255787|530987317|FG000|Overall Study|Pregnancy|0|||
147222992|NCT01255787|530987318|FG001|Overall Study|Pregnancy|0|||
147222993|NCT01255787|530987319|FG002|Overall Study|Pregnancy|0|||
147222994|NCT01255787|530987320|FG003|Overall Study|Pregnancy|1|||
147222995|NCT01255787|530987317|FG000|Overall Study|Lack of Efficacy|2|||
147222996|NCT01255787|530987318|FG001|Overall Study|Lack of Efficacy|2|||
147222997|NCT01255787|530987319|FG002|Overall Study|Lack of Efficacy|2|||
147222998|NCT01255787|530987320|FG003|Overall Study|Lack of Efficacy|2|||
147222999|NCT01255787|530987317|FG000|Overall Study|Noncompliance with Study Drug|3|||
147223000|NCT01255787|530987318|FG001|Overall Study|Noncompliance with Study Drug|1|||
147223001|NCT01255787|530987319|FG002|Overall Study|Noncompliance with Study Drug|0|||
147223002|NCT01255787|530987320|FG003|Overall Study|Noncompliance with Study Drug|0|||
147223003|NCT03170232|530987321|FG000|Overall Study|Adverse Event|0|||
147223004|NCT03170232|530987322|FG001|Overall Study|Adverse Event|1|||
147223005|NCT03170232|530987321|FG000|Overall Study|Protocol Violation|0|||
147223006|NCT03170232|530987322|FG001|Overall Study|Protocol Violation|1|||
147223007|NCT03170232|530987321|FG000|Overall Study|Lack of Efficacy|0|||
147223008|NCT03170232|530987322|FG001|Overall Study|Lack of Efficacy|1|||
147223009|NCT03170232|530987321|FG000|Overall Study|Study closed/terminated|26|||
147223010|NCT03170232|530987322|FG001|Overall Study|Study closed/terminated|23|||
147223011|NCT03170232|530987321|FG000|Overall Study|Lost to Follow-up|1|||
147223012|NCT03170232|530987322|FG001|Overall Study|Lost to Follow-up|0|||
147223013|NCT03170232|530987321|FG000|Overall Study|Withdrawal by Subject|0|||
147223014|NCT03170232|530987322|FG001|Overall Study|Withdrawal by Subject|1|||
147553817|NCT00449072|532183825|FG000|Overall Study|Adverse Event|3|||
147223015|NCT01423604|530987325|FG000|Safety Run-In|Adverse Event|3|||
147223016|NCT01423604|530987326|FG001|Safety Run-In|Adverse Event|0|||
147223017|NCT01423604|530987325|FG000|Safety Run-In|Death|1|||
147223018|NCT01423604|530987326|FG001|Safety Run-In|Death|0|||
147223019|NCT01423604|530987325|FG000|Safety Run-In|Physician Decision|1|||
147223020|NCT01423604|530987326|FG001|Safety Run-In|Physician Decision|0|||
147223021|NCT01423604|530987325|FG000|Safety Run-In|Disease progression|3|||
147223022|NCT01423604|530987326|FG001|Safety Run-In|Disease progression|0|||
147223023|NCT01423604|530987325|FG000|Safety Run-In|Patient decision|1|||
147223024|NCT01423604|530987326|FG001|Safety Run-In|Patient decision|0|||
147223025|NCT01423604|530987325|FG000|Randomized|Adverse Event|4|||
147223026|NCT01423604|530987326|FG001|Randomized|Adverse Event|10|||
147223027|NCT01423604|530987325|FG000|Randomized|Death|1|||
147223028|NCT01423604|530987326|FG001|Randomized|Death|0|||
147223029|NCT01423604|530987325|FG000|Randomized|Physician Decision|16|||
147223030|NCT01423604|530987326|FG001|Randomized|Physician Decision|13|||
147223031|NCT01423604|530987325|FG000|Randomized|Other - unspecified|37|||
147223032|NCT01423604|530987326|FG001|Randomized|Other - unspecified|31|||
147223033|NCT01423604|530987325|FG000|Randomized|Patient decision|5|||
147223034|NCT01423604|530987326|FG001|Randomized|Patient decision|9|||
147223035|NCT00586664|530987332|FG000|Overall Study|Withdrawal by Subject|3|||
147223036|NCT00586664|530987333|FG001|Overall Study|Withdrawal by Subject|7|||
147223037|NCT00586664|530987334|FG002|Overall Study|Withdrawal by Subject|1|||
147223038|NCT00586664|530987332|FG000|Overall Study|Exclusion criteria met|2|||
147223039|NCT00586664|530987333|FG001|Overall Study|Exclusion criteria met|0|||
147223040|NCT00586664|530987334|FG002|Overall Study|Exclusion criteria met|0|||
147223041|NCT01585584|530987340|FG000|Overall Study|Lack of Efficacy|1|||
147223042|NCT01585584|530987340|FG000|Overall Study|Withdrawal by Subject|1|||
147223043|NCT01585584|530987340|FG000|Overall Study|Physician Decision|2|||
147223044|NCT00686998|530987341|FG000|Overall Study|Adverse Event|3|||
147223045|NCT00686998|530987342|FG001|Overall Study|Adverse Event|2|||
147223046|NCT00686998|530987343|FG002|Overall Study|Adverse Event|1|||
147223047|NCT00686998|530987341|FG000|Overall Study|Withdrawal by Subject|2|||
147223048|NCT00686998|530987342|FG001|Overall Study|Withdrawal by Subject|1|||
147223049|NCT00686998|530987343|FG002|Overall Study|Withdrawal by Subject|2|||
147223050|NCT00686998|530987341|FG000|Overall Study|Lack of Efficacy|7|||
147223051|NCT00686998|530987342|FG001|Overall Study|Lack of Efficacy|5|||
147223052|NCT00686998|530987343|FG002|Overall Study|Lack of Efficacy|0|||
147223053|NCT00686998|530987341|FG000|Overall Study|Other|0|||
147223054|NCT00686998|530987342|FG001|Overall Study|Other|0|||
147223055|NCT00686998|530987343|FG002|Overall Study|Other|1|||
147223056|NCT00686998|530987341|FG000|Overall Study|Safety Reasons|1|||
147223057|NCT00686998|530987342|FG001|Overall Study|Safety Reasons|0|||
147223058|NCT00686998|530987343|FG002|Overall Study|Safety Reasons|0|||
147223059|NCT05985980|530987344|FG000|Overall Study|Withdrawal by Subject|1|||
147223060|NCT05985980|530987344|FG000|Overall Study|Withdrawal by Subject|1|||
147223061|NCT05985980|530987344|FG000|Overall Study|Withdrawal by Subject|1|||
147223062|NCT05985980|530987344|FG000|Overall Study|Withdrawal by Subject|1|||
147223063|NCT04854642|530989080|FG000|Overall Study|Adverse Event|1|||
147223064|NCT04854642|530989081|FG001|Overall Study|Adverse Event|2|||
147223065|NCT04854642|530989080|FG000|Overall Study|Withdrawal by Subject|0|||
147223066|NCT04854642|530989081|FG001|Overall Study|Withdrawal by Subject|1|||
147223067|NCT01709578|530989082|FG000|Overall Study|Rescued and entered in long term safety|63|||
147223068|NCT01709578|530989083|FG001|Overall Study|Rescued and entered in long term safety|25|||
147223069|NCT01709578|530989084|FG002|Overall Study|Rescued and entered in long term safety|26|||
147223070|NCT01709578|530989082|FG000|Overall Study|Adverse Event|9|||
147223071|NCT01709578|530989083|FG001|Overall Study|Adverse Event|18|||
147223072|NCT01709578|530989084|FG002|Overall Study|Adverse Event|17|||
147223073|NCT01709578|530989082|FG000|Overall Study|Lack of Efficacy|5|||
147223074|NCT01709578|530989083|FG001|Overall Study|Lack of Efficacy|4|||
147223075|NCT01709578|530989084|FG002|Overall Study|Lack of Efficacy|2|||
147223076|NCT01709578|530989082|FG000|Overall Study|Poor compliance to protocol|1|||
147223077|NCT01709578|530989083|FG001|Overall Study|Poor compliance to protocol|2|||
147223078|NCT01709578|530989084|FG002|Overall Study|Poor compliance to protocol|1|||
147223079|NCT01709578|530989082|FG000|Overall Study|Other, not related to safety or efficacy|2|||
147223080|NCT01709578|530989083|FG001|Overall Study|Other, not related to safety or efficacy|7|||
147223081|NCT01709578|530989084|FG002|Overall Study|Other, not related to safety or efficacy|5|||
147223082|NCT01107418|530989085|FG000|Overall Study|Disease Progression|45|||
147223083|NCT01107418|530989085|FG000|Overall Study|Adverse Event|3|||
147223084|NCT01107418|530989085|FG000|Overall Study|Withdrawal by Subject|1|||
147223085|NCT01107418|530989085|FG000|Overall Study|Study Closing|1|||
147223086|NCT01107418|530989085|FG000|Overall Study|Started Other Therapy|1|||
147223087|NCT01107418|530989085|FG000|Overall Study|Entered Extension Study|1|||
147223088|NCT00597701|530989086|FG000|Overall Study|Withdrawal by Subject|5|||
147223089|NCT00597701|530989087|FG001|Overall Study|Withdrawal by Subject|5|||
147223090|NCT00597701|530989086|FG000|Overall Study|Death|0|||
147223091|NCT00597701|530989087|FG001|Overall Study|Death|1|||
147223092|NCT00597701|530989086|FG000|Overall Study|Physician Decision|2|||
147223093|NCT00597701|530989087|FG001|Overall Study|Physician Decision|0|||
147553818|NCT00449072|532183826|FG001|Overall Study|Adverse Event|1|||
147553819|NCT00449072|532183825|FG000|Overall Study|Protocol Violation|14|||
147223094|NCT00597701|530989086|FG000|Overall Study|Did not start intervention (pharmacy er)|0|||
147223095|NCT00597701|530989087|FG001|Overall Study|Did not start intervention (pharmacy er)|2|||
147223096|NCT01155219|530989091|FG000|Overall Study|Adverse Event|3|||
147223097|NCT01155219|530989092|FG001|Overall Study|Adverse Event|1|||
147223098|NCT01155219|530989091|FG000|Overall Study|non-medical reason|1|||
147223099|NCT01155219|530989092|FG001|Overall Study|non-medical reason|2|||
147223100|NCT01314911|530989094|FG000|Overall Study|Lost to Follow-up|3|||
147223101|NCT01314911|530989095|FG001|Overall Study|Lost to Follow-up|2|||
147223102|NCT01314911|530989094|FG000|Overall Study|Withdrawal by Subject|1|||
147223103|NCT01314911|530989095|FG001|Overall Study|Withdrawal by Subject|3|||
147223104|NCT01314911|530989094|FG000|Overall Study|Received Non-randomized Study Drug|0|||
147223105|NCT01314911|530989095|FG001|Overall Study|Received Non-randomized Study Drug|1|||
147223106|NCT01314911|530989094|FG000|Overall Study|Never Started Treatment|1|||
147223107|NCT01314911|530989095|FG001|Overall Study|Never Started Treatment|0|||
147223108|NCT01394718|530989099|FG000|Overall Study|Met protocol-specific stopping criteria|2|||
147223109|NCT01394718|530989100|FG001|Overall Study|Met protocol-specific stopping criteria|1|||
147223110|NCT03387150|530989101|FG000|Overall Study|Withdrawal by Subject|3|||
147223111|NCT03387150|530989102|FG001|Overall Study|Withdrawal by Subject|0|||
147223112|NCT03387150|530989103|FG002|Overall Study|Withdrawal by Subject|3|||
147223113|NCT03387150|530989104|FG003|Overall Study|Withdrawal by Subject|4|||
147223114|NCT03387150|530989105|FG004|Overall Study|Withdrawal by Subject|1|||
147223115|NCT03387150|530989106|FG005|Overall Study|Withdrawal by Subject|2|||
147223116|NCT03387150|530989107|FG006|Overall Study|Withdrawal by Subject|0|||
147223117|NCT03387150|530989101|FG000|Overall Study|Lost to Follow-up|3|||
147223118|NCT03387150|530989102|FG001|Overall Study|Lost to Follow-up|2|||
147223119|NCT03387150|530989103|FG002|Overall Study|Lost to Follow-up|2|||
147223120|NCT03387150|530989104|FG003|Overall Study|Lost to Follow-up|3|||
147223121|NCT03387150|530989105|FG004|Overall Study|Lost to Follow-up|3|||
147223122|NCT03387150|530989106|FG005|Overall Study|Lost to Follow-up|3|||
147223123|NCT03387150|530989107|FG006|Overall Study|Lost to Follow-up|0|||
147223124|NCT03387150|530989101|FG000|Overall Study|Participant unable to adhere to visit|0|||
147223125|NCT03387150|530989102|FG001|Overall Study|Participant unable to adhere to visit|1|||
147223126|NCT03387150|530989103|FG002|Overall Study|Participant unable to adhere to visit|0|||
147223127|NCT03387150|530989104|FG003|Overall Study|Participant unable to adhere to visit|0|||
147553820|NCT00449072|532183826|FG001|Overall Study|Protocol Violation|12|||
147553821|NCT00449072|532183825|FG000|Overall Study|Lost to Follow-up|5|||
147443488|NCT00094770|531788690|FG000|Year 2 (Week 0 to Week 104)|Withdrawal by Subject|28|||
147443489|NCT00094770|531788691|FG001|Year 2 (Week 0 to Week 104)|Withdrawal by Subject|38|||
147443490|NCT00094770|531788690|FG000|Year 2 (Week 0 to Week 104)|Site Terminated|2|||
147443491|NCT00094770|531788691|FG001|Year 2 (Week 0 to Week 104)|Site Terminated|2|||
147443492|NCT00094770|531788690|FG000|Year 2 (Week 0 to Week 104)|Other|15|||
147443493|NCT00094770|531788691|FG001|Year 2 (Week 0 to Week 104)|Other|23|||
147443494|NCT00253643|531788692|FG000|Overall Study|Withdrawal by Subject|0|||
147443495|NCT00253643|531788693|FG001|Overall Study|Withdrawal by Subject|0|||
147443496|NCT00253643|531788694|FG002|Overall Study|Withdrawal by Subject|1|||
147443497|NCT00253643|531788695|FG003|Overall Study|Withdrawal by Subject|1|||
147443498|NCT00253643|531788692|FG000|Overall Study|Non-Compliance|0|||
147443499|NCT00253643|531788693|FG001|Overall Study|Non-Compliance|0|||
147443500|NCT00253643|531788694|FG002|Overall Study|Non-Compliance|0|||
147443501|NCT00253643|531788695|FG003|Overall Study|Non-Compliance|2|||
147443502|NCT01368536|531788696|FG000|Overall Study|Adverse Event|5|||
147443503|NCT01368536|531788697|FG001|Overall Study|Adverse Event|6|||
147443504|NCT01368536|531788698|FG002|Overall Study|Adverse Event|8|||
147443505|NCT01368536|531788696|FG000|Overall Study|Abnormal laboratory value(s)|0|||
147443506|NCT01368536|531788697|FG001|Overall Study|Abnormal laboratory value(s)|1|||
147443507|NCT01368536|531788698|FG002|Overall Study|Abnormal laboratory value(s)|2|||
147443508|NCT01368536|531788696|FG000|Overall Study|Abnormal test procedure result(s)|0|||
147443509|NCT01368536|531788697|FG001|Overall Study|Abnormal test procedure result(s)|0|||
147443510|NCT01368536|531788698|FG002|Overall Study|Abnormal test procedure result(s)|1|||
147443511|NCT01368536|531788696|FG000|Overall Study|Unsatisfactory therapeutic effect|7|||
147443512|NCT01368536|531788697|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
147443513|NCT01368536|531788698|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
147443514|NCT01368536|531788696|FG000|Overall Study|No longer required study medication|0|||
147443515|NCT01368536|531788697|FG001|Overall Study|No longer required study medication|0|||
147443516|NCT01368536|531788698|FG002|Overall Study|No longer required study medication|1|||
147443517|NCT01368536|531788696|FG000|Overall Study|Withdrawal by Subject|2|||
147443518|NCT01368536|531788697|FG001|Overall Study|Withdrawal by Subject|5|||
147443519|NCT01368536|531788698|FG002|Overall Study|Withdrawal by Subject|4|||
147443520|NCT01368536|531788696|FG000|Overall Study|Lost to Follow-up|3|||
147443521|NCT01368536|531788697|FG001|Overall Study|Lost to Follow-up|3|||
147443522|NCT01368536|531788698|FG002|Overall Study|Lost to Follow-up|5|||
147443523|NCT01368536|531788696|FG000|Overall Study|Administrative problems|34|||
147443524|NCT01368536|531788697|FG001|Overall Study|Administrative problems|39|||
147443525|NCT01368536|531788698|FG002|Overall Study|Administrative problems|35|||
147443526|NCT01368536|531788696|FG000|Overall Study|Protocol deviation|0|||
147443527|NCT01368536|531788697|FG001|Overall Study|Protocol deviation|3|||
147443528|NCT01368536|531788698|FG002|Overall Study|Protocol deviation|1|||
147443529|NCT00383084|531788699|FG000|Overall Study|Withdrawal by Subject|12|||
147443530|NCT00383084|531788700|FG001|Overall Study|Withdrawal by Subject|10|||
147443531|NCT01648790|531788701|FG000|Treatment 3|Withdrawal by Subject|0|||
147223128|NCT03387150|530989105|FG004|Overall Study|Participant unable to adhere to visit|2|||
147223129|NCT03387150|530989106|FG005|Overall Study|Participant unable to adhere to visit|2|||
147223130|NCT03387150|530989107|FG006|Overall Study|Participant unable to adhere to visit|0|||
147223131|NCT04006119|530989108|FG000|Run in Cemiplimab Period|Lack of Efficacy|1|||
147223132|NCT04006119|530989108|FG000|End of Treatment Veledimex|Adverse Event|2|||
147223133|NCT04006119|530989108|FG000|Adjuvant Cemiplimab Period|Lack of Efficacy|28|||
147223134|NCT04006119|530989108|FG000|Adjuvant Cemiplimab Period|Adverse Event|3|||
147223135|NCT04006119|530989108|FG000|Adjuvant Cemiplimab Period|Withdrawal by Subject|4|||
147223136|NCT04006119|530989108|FG000|Adjuvant Cemiplimab Period|Sponsor Study Termination rollover to Compassionate Use|2|||
147223137|NCT04617795|530989109|FG000|Main Study|Lost to Follow-up|1|||
147223138|NCT04617795|530989110|FG001|Main Study|Lost to Follow-up|0|||
147223139|NCT00472459|530989111|FG000|Overall Study|Adverse Event|13|||
147223140|NCT00472459|530989112|FG001|Overall Study|Adverse Event|13|||
147223141|NCT00472459|530989111|FG000|Overall Study|Withdrawal by Subject|5|||
147223142|NCT00472459|530989112|FG001|Overall Study|Withdrawal by Subject|5|||
147223143|NCT00472459|530989111|FG000|Overall Study|Protocol Violation|3|||
147223144|NCT00472459|530989112|FG001|Overall Study|Protocol Violation|3|||
147223145|NCT00472459|530989111|FG000|Overall Study|Heavy workload, Not satisfied, Squamous Cell Carcinoma|4|||
147223146|NCT00472459|530989112|FG001|Overall Study|Heavy workload, Not satisfied, Squamous Cell Carcinoma|4|||
147223147|NCT00472459|530989111|FG000|Overall Study|Lost to Follow-up|1|||
147223148|NCT00472459|530989112|FG001|Overall Study|Lost to Follow-up|1|||
147223149|NCT04850313|530989113|FG000|Overall Study|Withdrawal by Subject|0|||
147223150|NCT04850313|530989114|FG001|Overall Study|Withdrawal by Subject|1|||
147223151|NCT03269552|530989117|FG000|Overall Study|Adverse Event|2|||
147223152|NCT02186301|530989118|FG000|Overall Study|Progressive Disease|7|||
147223153|NCT02186301|530989119|FG001|Overall Study|Progressive Disease|22|||
147223154|NCT02186301|530989120|FG002|Overall Study|Progressive Disease|27|||
147223155|NCT02186301|530989118|FG000|Overall Study|Adverse Event|5|||
147223156|NCT02186301|530989119|FG001|Overall Study|Adverse Event|5|||
147223157|NCT02186301|530989120|FG002|Overall Study|Adverse Event|5|||
147553822|NCT00449072|532183826|FG001|Overall Study|Lost to Follow-up|7|||
147223158|NCT02186301|530989118|FG000|Overall Study|Death|1|||
147223159|NCT02186301|530989119|FG001|Overall Study|Death|0|||
147223160|NCT02186301|530989120|FG002|Overall Study|Death|0|||
147223161|NCT02186301|530989118|FG000|Overall Study|Withdrawal by Subject|5|||
147553823|NCT00449072|532183825|FG000|Overall Study|Withdrawal by Subject|11|||
147553824|NCT00449072|532183826|FG001|Overall Study|Withdrawal by Subject|8|||
147553825|NCT00449072|532183825|FG000|Overall Study|Lack of Efficacy|1|||
147553826|NCT00449072|532183826|FG001|Overall Study|Lack of Efficacy|1|||
147553827|NCT00449072|532183825|FG000|Overall Study|Physician Decision|1|||
147553828|NCT00449072|532183826|FG001|Overall Study|Physician Decision|0|||
147553829|NCT00449072|532183825|FG000|Overall Study|Not treated|0|||
147553830|NCT00449072|532183826|FG001|Overall Study|Not treated|1|||
147553831|NCT00449072|532183825|FG000|Overall Study|Excluded medication|0|||
147553832|NCT00449072|532183826|FG001|Overall Study|Excluded medication|2|||
147553833|NCT00449072|532183825|FG000|Overall Study|Non-compliance|2|||
147553834|NCT00449072|532183826|FG001|Overall Study|Non-compliance|5|||
147553835|NCT00449072|532183825|FG000|Overall Study|Sponsor decision|1|||
147553836|NCT00449072|532183826|FG001|Overall Study|Sponsor decision|3|||
147553837|NCT00449072|532183825|FG000|Overall Study|Relocation|3|||
147553838|NCT00449072|532183826|FG001|Overall Study|Relocation|2|||
147553839|NCT01787825|532183827|FG000|Overall Study|Subject Did Not Ingest Capsules|1|||
147553840|NCT01787825|532183828|FG001|Overall Study|Subject Did Not Ingest Capsules|0|||
147553841|NCT01787825|532183827|FG000|Overall Study|Data Not Analyzable|5|||
147553842|NCT01787825|532183828|FG001|Overall Study|Data Not Analyzable|1|||
147553843|NCT00989261|532183834|FG000|Overall Study|Still in follow up|12|||
147553844|NCT00989261|532183835|FG001|Overall Study|Still in follow up|21|||
147553845|NCT00989261|532183834|FG000|Overall Study|Withdrawal by Subject|0|||
147553846|NCT00989261|532183835|FG001|Overall Study|Withdrawal by Subject|1|||
147553847|NCT00989261|532183834|FG000|Overall Study|Lost to Follow-up|3|||
147553848|NCT00989261|532183835|FG001|Overall Study|Lost to Follow-up|0|||
147553849|NCT01238848|532183836|FG000|Overall Study|Physician Decision|13|||
147553850|NCT01238848|532183837|FG001|Overall Study|Physician Decision|5|||
147553851|NCT00576901|532183838|FG000|Overall Study|Withdrawal by Subject|1|||
147553852|NCT00576901|532183838|FG000|Overall Study|Disease course|1|||
147553853|NCT00576901|532183838|FG000|Overall Study|Protocol Violation|1|||
147553854|NCT02398188|532183839|FG000|Overall Study|Adverse Event|2|||
147553855|NCT02398188|532183840|FG001|Overall Study|Adverse Event|3|||
147553856|NCT02398188|532183839|FG000|Overall Study|Lost to Follow-up|5|||
147553857|NCT02398188|532183840|FG001|Overall Study|Lost to Follow-up|0|||
147553858|NCT02398188|532183839|FG000|Overall Study|Non-compliance|4|||
147553859|NCT02398188|532183840|FG001|Overall Study|Non-compliance|4|||
147553860|NCT02398188|532183839|FG000|Overall Study|Protocol Violation|6|||
147553861|NCT02398188|532183840|FG001|Overall Study|Protocol Violation|10|||
147223162|NCT02186301|530989119|FG001|Overall Study|Withdrawal by Subject|1|||
147223163|NCT02186301|530989120|FG002|Overall Study|Withdrawal by Subject|3|||
147223164|NCT02186301|530989118|FG000|Overall Study|Physician Decision|1|||
147223165|NCT02186301|530989119|FG001|Overall Study|Physician Decision|0|||
147223166|NCT02186301|530989120|FG002|Overall Study|Physician Decision|1|||
147553862|NCT02398188|532183839|FG000|Overall Study|Sponsor Decision|2|||
147553863|NCT02398188|532183840|FG001|Overall Study|Sponsor Decision|1|||
147553864|NCT02398188|532183839|FG000|Overall Study|Pregnancy|1|||
147553865|NCT02398188|532183840|FG001|Overall Study|Pregnancy|0|||
147553866|NCT02398188|532183839|FG000|Overall Study|Withdrawal by Subject|7|||
147553867|NCT02398188|532183840|FG001|Overall Study|Withdrawal by Subject|16|||
147553868|NCT01259869|532183841|FG000|Overall Study|Duplicated registration|1|||
147553869|NCT03209570|532183846|FG000|Overall Study|Death|1|||
147553870|NCT03209570|532183847|FG001|Overall Study|Death|0|||
147553871|NCT03209570|532183846|FG000|Overall Study|Incomplete Data|8|||
147553872|NCT03209570|532183847|FG001|Overall Study|Incomplete Data|10|||
147553873|NCT03209570|532183846|FG000|Overall Study|Protocol Violation|1|||
147553874|NCT03209570|532183847|FG001|Overall Study|Protocol Violation|0|||
147553875|NCT03209570|532183846|FG000|Overall Study|Withdrawal by Subject|0|||
147553876|NCT03209570|532183847|FG001|Overall Study|Withdrawal by Subject|3|||
147553877|NCT00220701|532183848|FG000|Overall Study|Lost to Follow-up|5|||
147553878|NCT00220701|532183849|FG001|Overall Study|Lost to Follow-up|4|||
147553879|NCT00755326|532183851|FG000|Overall Study|Lost to Follow-up|2|||
147553880|NCT00755326|532183852|FG001|Overall Study|Lost to Follow-up|3|||
147553881|NCT00368966|532183859|FG000|Infant Series|Withdrawal by Subject|11|||
147553882|NCT00368966|532183860|FG001|Infant Series|Withdrawal by Subject|6|||
147553883|NCT00368966|532183859|FG000|Infant Series|Protocol Violation|2|||
147553884|NCT00368966|532183860|FG001|Infant Series|Protocol Violation|1|||
147553885|NCT00368966|532183859|FG000|Infant Series|Lost to Follow-up|2|||
147553886|NCT00368966|532183860|FG001|Infant Series|Lost to Follow-up|0|||
147553887|NCT00368966|532183859|FG000|Infant Series|Randomization error|0|||
147553888|NCT00368966|532183860|FG001|Infant Series|Randomization error|1|||
147553889|NCT00368966|532183859|FG000|Infant Series|Failed to meet eligibility criteria|0|||
147223167|NCT02186301|530989118|FG000|Overall Study|Study Terminated by Sponsor|1|||
147223168|NCT02186301|530989119|FG001|Overall Study|Study Terminated by Sponsor|0|||
147223169|NCT02186301|530989120|FG002|Overall Study|Study Terminated by Sponsor|11|||
147553890|NCT00368966|532183860|FG001|Infant Series|Failed to meet eligibility criteria|1|||
147553891|NCT00368966|532183859|FG000|Infant Series|Adverse Event|0|||
147553892|NCT00368966|532183860|FG001|Infant Series|Adverse Event|1|||
147553893|NCT00368966|532183859|FG000|Infant Series|Failed to return|1|||
147553894|NCT00368966|532183860|FG001|Infant Series|Failed to return|0|||
147553895|NCT00368966|532183859|FG000|After Infant|Failed to return|3|||
147553896|NCT00368966|532183860|FG001|After Infant|Failed to return|1|||
147553897|NCT00368966|532183859|FG000|After Infant|Adverse Event|1|||
147553898|NCT00368966|532183860|FG001|After Infant|Adverse Event|2|||
147553899|NCT00368966|532183859|FG000|After Infant|Withdrawal by Subject|1|||
147553900|NCT00368966|532183860|FG001|After Infant|Withdrawal by Subject|1|||
147553901|NCT00368966|532183859|FG000|After Infant|Death|1|||
147553902|NCT00368966|532183860|FG001|After Infant|Death|0|||
147553903|NCT00368966|532183859|FG000|After Infant|Lost to Follow-up|0|||
147223170|NCT02186301|530989118|FG000|Overall Study|Protocol Deviation|0|||
147223171|NCT02186301|530989119|FG001|Overall Study|Protocol Deviation|2|||
147223172|NCT02186301|530989120|FG002|Overall Study|Protocol Deviation|0|||
147553904|NCT00368966|532183860|FG001|After Infant|Lost to Follow-up|1|||
147553905|NCT00368966|532183859|FG000|Toddler Dose|Withdrawal by Subject|1|||
147553906|NCT00368966|532183860|FG001|Toddler Dose|Withdrawal by Subject|1|||
147553907|NCT00368966|532183859|FG000|Toddler Dose|Lost to Follow-up|0|||
147553908|NCT00368966|532183860|FG001|Toddler Dose|Lost to Follow-up|2|||
147553909|NCT01689974|532183861|FG000|Overall Study|Termination of Study|5|||
147553910|NCT01689974|532183862|FG001|Overall Study|Termination of Study|5|||
147553911|NCT01333033|532183863|FG000|Overall Study|Ineligible|0|||
147553912|NCT01333033|532183864|FG001|Overall Study|Ineligible|0|||
147553913|NCT01333033|532183865|FG002|Overall Study|Ineligible|0|||
147553914|NCT01333033|532183866|FG003|Overall Study|Ineligible|0|||
147553915|NCT01333033|532183867|FG004|Overall Study|Ineligible|6|||
147553916|NCT01333033|532183868|FG005|Overall Study|Ineligible|8|||
147553917|NCT01333033|532183863|FG000|Overall Study|Withdrawal by Subject|0|||
147553918|NCT01333033|532183864|FG001|Overall Study|Withdrawal by Subject|0|||
147553919|NCT01333033|532183865|FG002|Overall Study|Withdrawal by Subject|0|||
147553920|NCT01333033|532183866|FG003|Overall Study|Withdrawal by Subject|0|||
147553921|NCT01333033|532183867|FG004|Overall Study|Withdrawal by Subject|4|||
147553922|NCT01333033|532183868|FG005|Overall Study|Withdrawal by Subject|2|||
147553923|NCT01333033|532183863|FG000|Overall Study|PET inevaluable|0|||
147553924|NCT01333033|532183864|FG001|Overall Study|PET inevaluable|0|||
147553925|NCT01333033|532183865|FG002|Overall Study|PET inevaluable|0|||
147553926|NCT01333033|532183866|FG003|Overall Study|PET inevaluable|0|||
147553927|NCT01333033|532183867|FG004|Overall Study|PET inevaluable|2|||
147553928|NCT01333033|532183868|FG005|Overall Study|PET inevaluable|4|||
147553929|NCT01333033|532183863|FG000|Overall Study|Adverse Event|0|||
147553930|NCT01333033|532183864|FG001|Overall Study|Adverse Event|0|||
147553931|NCT01333033|532183865|FG002|Overall Study|Adverse Event|0|||
147553932|NCT01333033|532183866|FG003|Overall Study|Adverse Event|0|||
147553933|NCT01333033|532183867|FG004|Overall Study|Adverse Event|2|||
147553934|NCT01333033|532183868|FG005|Overall Study|Adverse Event|1|||
147553935|NCT01333033|532183863|FG000|Overall Study|Progression|0|||
147553936|NCT01333033|532183864|FG001|Overall Study|Progression|0|||
147553937|NCT01333033|532183865|FG002|Overall Study|Progression|0|||
147553938|NCT01333033|532183866|FG003|Overall Study|Progression|0|||
147553939|NCT01333033|532183867|FG004|Overall Study|Progression|0|||
147553940|NCT01333033|532183868|FG005|Overall Study|Progression|1|||
147553941|NCT01333033|532183863|FG000|Overall Study|MD Decision|0|||
147553942|NCT01333033|532183864|FG001|Overall Study|MD Decision|0|||
147553943|NCT01333033|532183865|FG002|Overall Study|MD Decision|0|||
147553944|NCT01333033|532183866|FG003|Overall Study|MD Decision|0|||
147553945|NCT01333033|532183867|FG004|Overall Study|MD Decision|0|||
147553946|NCT01333033|532183868|FG005|Overall Study|MD Decision|2|||
147553947|NCT01388647|532183871|FG000|Overall Study|Adverse Event|1|||
147553948|NCT01388647|532183872|FG001|Overall Study|Adverse Event|2|||
147553949|NCT01336894|532183874|FG000|Follow-up|Study terminated prematurely|2|||
147553950|NCT01336894|532183875|FG001|Follow-up|Study terminated prematurely|7|||
147553951|NCT00903383|532183884|FG000|Overall Study|Adverse Event|1|||
147553952|NCT00903383|532183885|FG001|Overall Study|Adverse Event|2|||
147553953|NCT00903383|532183886|FG002|Overall Study|Adverse Event|3|||
147553954|NCT00903383|532183887|FG003|Overall Study|Adverse Event|1|||
147553955|NCT00903383|532183884|FG000|Overall Study|Physician Decision|1|||
147553956|NCT00903383|532183885|FG001|Overall Study|Physician Decision|2|||
147553957|NCT00903383|532183886|FG002|Overall Study|Physician Decision|0|||
147553958|NCT00903383|532183887|FG003|Overall Study|Physician Decision|0|||
147553959|NCT00903383|532183884|FG000|Overall Study|Lost to Follow-up|0|||
147553960|NCT00903383|532183885|FG001|Overall Study|Lost to Follow-up|0|||
147553961|NCT00903383|532183886|FG002|Overall Study|Lost to Follow-up|0|||
147553962|NCT00903383|532183887|FG003|Overall Study|Lost to Follow-up|1|||
147553963|NCT00903383|532183884|FG000|Overall Study|Decision of Sponsor|1|||
147553964|NCT00903383|532183885|FG001|Overall Study|Decision of Sponsor|0|||
147553965|NCT00903383|532183886|FG002|Overall Study|Decision of Sponsor|0|||
147553966|NCT00903383|532183887|FG003|Overall Study|Decision of Sponsor|0|||
147553967|NCT00903383|532183884|FG000|Overall Study|Withdrawal by Subject|4|||
147553968|NCT00903383|532183885|FG001|Overall Study|Withdrawal by Subject|1|||
147553969|NCT00903383|532183886|FG002|Overall Study|Withdrawal by Subject|0|||
147553970|NCT00903383|532183887|FG003|Overall Study|Withdrawal by Subject|2|||
147553971|NCT00903383|532183884|FG000|Overall Study|Patient Decision - Lack of Efficacy|0|||
147553972|NCT00903383|532183885|FG001|Overall Study|Patient Decision - Lack of Efficacy|1|||
147553973|NCT00903383|532183886|FG002|Overall Study|Patient Decision - Lack of Efficacy|0|||
147553974|NCT00903383|532183887|FG003|Overall Study|Patient Decision - Lack of Efficacy|0|||
147553975|NCT00903383|532183884|FG000|Overall Study|Patient Decision|0|||
147553976|NCT00903383|532183885|FG001|Overall Study|Patient Decision|0|||
147553977|NCT00903383|532183886|FG002|Overall Study|Patient Decision|0|||
147553978|NCT00903383|532183887|FG003|Overall Study|Patient Decision|1|||
147553979|NCT01076166|532183888|FG000|Overall Study|Adverse Event|3|||
147553980|NCT01076166|532183888|FG000|Overall Study|Symptoms improved/resolved|6|||
147553981|NCT00638157|532183891|FG000|Overall Study|Adverse Event|0|||
147553982|NCT00638157|532183892|FG001|Overall Study|Adverse Event|1|||
147553983|NCT00638157|532183891|FG000|Overall Study|Clinical (symptomatic) failure|1|||
147553984|NCT00638157|532183892|FG001|Overall Study|Clinical (symptomatic) failure|1|||
147553985|NCT00638157|532183891|FG000|Overall Study|Microbiological failure|1|||
147553986|NCT00638157|532183892|FG001|Overall Study|Microbiological failure|0|||
147553987|NCT00638157|532183891|FG000|Overall Study|Lost to Follow-up|1|||
147553988|NCT00638157|532183892|FG001|Overall Study|Lost to Follow-up|0|||
147223173|NCT02186301|530989118|FG000|Overall Study|Missing|0|||
147223174|NCT02186301|530989119|FG001|Overall Study|Missing|0|||
147223175|NCT02186301|530989120|FG002|Overall Study|Missing|2|||
147223176|NCT02186301|530989118|FG000|Overall Study|Other|0|||
147223177|NCT02186301|530989119|FG001|Overall Study|Other|0|||
147223178|NCT02186301|530989120|FG002|Overall Study|Other|1|||
147223179|NCT03560739|530989122|FG000|Overall Study|Adverse Event|0|||
147223180|NCT03560739|530989123|FG001|Overall Study|Adverse Event|1|||
147223181|NCT03560739|530989124|FG002|Overall Study|Adverse Event|0|||
147223182|NCT03560739|530989125|FG003|Overall Study|Adverse Event|0|||
147223183|NCT01362595|530989126|FG000|Overall Study|Screen failure|10|||
147223184|NCT01362595|530989126|FG000|Overall Study|Withdrawal by Subject|2|||
147223185|NCT00959374|530989127|FG000|Overall Study|Withdrawal by Subject|2|||
147223186|NCT00959374|530989127|FG000|Overall Study|Lost to Follow-up|14|||
147223187|NCT00959374|530989127|FG000|Overall Study|Death|1|||
147223188|NCT00959374|530989127|FG000|Overall Study|Protocol Violation|1|||
147223189|NCT00959374|530989127|FG000|Overall Study|Implant Removed/Not Replaced|4|||
147223190|NCT00959374|530989127|FG000|Overall Study|Physician Decision|1|||
147223191|NCT02448680|530989128|FG000|Overall Study|Physician Decision|1|||
147223192|NCT02448680|530989129|FG001|Overall Study|Physician Decision|1|||
147223193|NCT02448680|530989128|FG000|Overall Study|Withdrawal by Subject|0|||
147223194|NCT02448680|530989129|FG001|Overall Study|Withdrawal by Subject|2|||
147223195|NCT01741012|530989133|FG000|Overall Study|Lost to Follow-up|1|||
147223196|NCT01741012|530989133|FG000|Overall Study|Withdrawal by Subject|2|||
147223197|NCT00095238|530989134|FG000|Overall Study|Lack of Efficacy|9|||
147223198|NCT00095238|530989135|FG001|Overall Study|Lack of Efficacy|9|||
147223199|NCT00095238|530989134|FG000|Overall Study|Adverse Event|331|||
147223200|NCT00095238|530989135|FG001|Overall Study|Adverse Event|287|||
147223201|NCT00095238|530989134|FG000|Overall Study|Subject Withdrew Consent|208|||
147223202|NCT00095238|530989135|FG001|Overall Study|Subject Withdrew Consent|223|||
147223203|NCT00095238|530989134|FG000|Overall Study|Death|154|||
147553989|NCT00638157|532183891|FG000|Overall Study|Physician Decision|1|||
147553990|NCT00638157|532183892|FG001|Overall Study|Physician Decision|0|||
147553991|NCT00638157|532183891|FG000|Overall Study|Other|1|||
147223204|NCT00095238|530989135|FG001|Overall Study|Death|170|||
147223205|NCT00095238|530989134|FG000|Overall Study|Lost to Follow-up|19|||
147223206|NCT00095238|530989135|FG001|Overall Study|Lost to Follow-up|24|||
147223207|NCT00095238|530989134|FG000|Overall Study|Noncompliance|44|||
147223208|NCT00095238|530989135|FG001|Overall Study|Noncompliance|45|||
147553992|NCT00638157|532183892|FG001|Overall Study|Other|2|||
147553993|NCT00638157|532183891|FG000|Overall Study|Randomized, not treated|2|||
147553994|NCT00638157|532183892|FG001|Overall Study|Randomized, not treated|0|||
147553995|NCT02110706|532183893|FG000|Overall Study|Adverse Event|2|||
147223209|NCT00095238|530989134|FG000|Overall Study|No longer met study criteria|4|||
147553996|NCT02110706|532183894|FG001|Overall Study|Adverse Event|3|||
147223210|NCT00095238|530989135|FG001|Overall Study|No longer met study criteria|5|||
147553997|NCT02110706|532183893|FG000|Overall Study|Patients who didn't receive 2nd infusion|3|||
147223211|NCT00095238|530989134|FG000|Overall Study|Study terminated by sponsor|0|||
147223212|NCT00095238|530989135|FG001|Overall Study|Study terminated by sponsor|1|||
147223213|NCT00095238|530989134|FG000|Overall Study|Missing|1|||
147223214|NCT00095238|530989135|FG001|Overall Study|Missing|0|||
147223215|NCT00095238|530989134|FG000|Overall Study|Other Reasons|87|||
147223216|NCT00095238|530989135|FG001|Overall Study|Other Reasons|88|||
147223217|NCT03505671|530989136|FG000|Overall Study|Withdrawal by Subject|2|||
147223218|NCT03505671|530989137|FG001|Overall Study|Withdrawal by Subject|1|||
147553998|NCT02110706|532183894|FG001|Overall Study|Patients who didn't receive 2nd infusion|1|||
147223219|NCT03505671|530989136|FG000|Overall Study|Lost to Follow-up|1|||
147223220|NCT03505671|530989137|FG001|Overall Study|Lost to Follow-up|0|||
147223221|NCT00749580|530989140|FG000|Overall Study|Lost to Follow-up|4|||
147223222|NCT00749580|530989141|FG001|Overall Study|Lost to Follow-up|8|||
147223223|NCT00749580|530989140|FG000|Overall Study|Adverse Event|0|||
147223224|NCT00749580|530989141|FG001|Overall Study|Adverse Event|1|||
147553999|NCT02970669|532183897|FG000|Double-blind Period|Adverse Event|4|||
147554000|NCT02970669|532183898|FG001|Double-blind Period|Adverse Event|0|||
147223225|NCT03410823|530989142|FG000|Overall Study|Death|1|||
147223226|NCT03410823|530989142|FG000|Overall Study|Withdrawal by Subject|2|||
147223227|NCT03410823|530989142|FG000|Overall Study|Withdraw due to COVID-19 shutdown|2|||
147223228|NCT06460493|530989143|FG000|Overall Study|Withdrawal by Subject|2|||
147554001|NCT02970669|532183897|FG000|Double-blind Period|Death|1|||
147554002|NCT02970669|532183898|FG001|Double-blind Period|Death|0|||
147223229|NCT04704154|530989144|FG000|Overall Study|Adverse Event|3|||
147223230|NCT04704154|530989145|FG001|Overall Study|Adverse Event|2|||
147223231|NCT04704154|530989146|FG002|Overall Study|Adverse Event|4|||
147554003|NCT02970669|532183897|FG000|Double-blind Period|Study terminated by sponsor|1|||
147554004|NCT02970669|532183898|FG001|Double-blind Period|Study terminated by sponsor|2|||
147554005|NCT02970669|532183897|FG000|Double-blind Period|Physician Decision|0|||
147554006|NCT02970669|532183898|FG001|Double-blind Period|Physician Decision|2|||
147554007|NCT02970669|532183897|FG000|Double-blind Period|Withdrawal by Subject|2|||
147554008|NCT02970669|532183898|FG001|Double-blind Period|Withdrawal by Subject|2|||
147554009|NCT02970669|532183897|FG000|Open-label Period|Withdrawal by Subject|2|||
147554010|NCT02970669|532183898|FG001|Open-label Period|Withdrawal by Subject|2|||
147554011|NCT02970669|532183897|FG000|Open-label Period|Adverse Event|1|||
147554012|NCT02970669|532183898|FG001|Open-label Period|Adverse Event|0|||
147554013|NCT02970669|532183897|FG000|Open-label Period|Physician Decision|1|||
147554014|NCT02970669|532183898|FG001|Open-label Period|Physician Decision|0|||
147554015|NCT00876733|532183903|FG000|Overall Study|Adverse Event|34|||
147554016|NCT00876733|532183904|FG001|Overall Study|Adverse Event|20|||
147554017|NCT00876733|532183905|FG002|Overall Study|Adverse Event|10|||
147554018|NCT00876733|532183906|FG003|Overall Study|Adverse Event|3|||
147554019|NCT00876733|532183903|FG000|Overall Study|Lack of Efficacy|17|||
147554020|NCT00876733|532183904|FG001|Overall Study|Lack of Efficacy|9|||
147554021|NCT00876733|532183905|FG002|Overall Study|Lack of Efficacy|10|||
147554022|NCT00876733|532183906|FG003|Overall Study|Lack of Efficacy|1|||
147554023|NCT00876733|532183903|FG000|Overall Study|Lost to Follow-up|26|||
147554024|NCT00876733|532183904|FG001|Overall Study|Lost to Follow-up|10|||
147223232|NCT04704154|530989147|FG003|Overall Study|Adverse Event|2|||
147223233|NCT04704154|530989148|FG004|Overall Study|Adverse Event|3|||
147554025|NCT00876733|532183905|FG002|Overall Study|Lost to Follow-up|3|||
147554026|NCT00876733|532183906|FG003|Overall Study|Lost to Follow-up|2|||
147554027|NCT00876733|532183903|FG000|Overall Study|Data not available|14|||
147554028|NCT00876733|532183904|FG001|Overall Study|Data not available|3|||
147554029|NCT00876733|532183905|FG002|Overall Study|Data not available|7|||
147223234|NCT04704154|530989149|FG005|Overall Study|Adverse Event|0|||
147223235|NCT04704154|530989144|FG000|Overall Study|Death|3|||
147223236|NCT04704154|530989145|FG001|Overall Study|Death|0|||
147223237|NCT04704154|530989146|FG002|Overall Study|Death|0|||
147223238|NCT04704154|530989147|FG003|Overall Study|Death|0|||
147223239|NCT04704154|530989148|FG004|Overall Study|Death|3|||
147223240|NCT04704154|530989149|FG005|Overall Study|Death|0|||
147223241|NCT04704154|530989144|FG000|Overall Study|Physician Decision|1|||
147223242|NCT04704154|530989145|FG001|Overall Study|Physician Decision|0|||
147223243|NCT04704154|530989146|FG002|Overall Study|Physician Decision|1|||
147443532|NCT01648790|531788702|FG001|Treatment 3|Withdrawal by Subject|0|||
147223244|NCT04704154|530989147|FG003|Overall Study|Physician Decision|0|||
147223245|NCT04704154|530989148|FG004|Overall Study|Physician Decision|2|||
147223246|NCT04704154|530989149|FG005|Overall Study|Physician Decision|0|||
147443533|NCT01648790|531788703|FG002|Treatment 3|Withdrawal by Subject|0|||
147443534|NCT01648790|531788704|FG003|Treatment 3|Withdrawal by Subject|1|||
147443535|NCT01648790|531788705|FG004|Treatment 3|Withdrawal by Subject|0|||
147443536|NCT01486927|531788706|FG000|Overall Study|Knee surgery (prior to surgery substudy)|1|||
147443537|NCT01486927|531788706|FG000|Overall Study|Physician Decision|1|||
147443538|NCT01486927|531788706|FG000|Overall Study|50 Exposure days not reached|2|||
147443539|NCT01486927|531788706|FG000|Overall Study|Withdrawal by Subject|8|||
147443540|NCT01486927|531788706|FG000|Overall Study|Subject did not reach 6 mo of treatment|1|||
147443541|NCT02636582|531788710|FG000|Overall Study|Surgical Pathology|1|||
147443542|NCT02636582|531788711|FG001|Overall Study|Surgical Pathology|0|||
147443543|NCT00573430|531788712|FG000|Overall Study|Incorrect enrollment of randomization|0|||
147309599|NCT00152971|531300118|FG001|Treatment|Lost to Follow-up|2|||
147309600|NCT00152971|531300119|FG002|Treatment|Lost to Follow-up|1|||
147443544|NCT00573430|531788713|FG001|Overall Study|Incorrect enrollment of randomization|4|||
147443545|NCT00573430|531788714|FG002|Overall Study|Incorrect enrollment of randomization|3|||
147443546|NCT00573430|531788712|FG000|Overall Study|Adverse Event|0|||
147443547|NCT00573430|531788713|FG001|Overall Study|Adverse Event|0|||
147443548|NCT00573430|531788714|FG002|Overall Study|Adverse Event|2|||
147443549|NCT00573430|531788712|FG000|Overall Study|Withdrawal by Subject|1|||
147443550|NCT00573430|531788713|FG001|Overall Study|Withdrawal by Subject|0|||
147443551|NCT00573430|531788714|FG002|Overall Study|Withdrawal by Subject|1|||
147443552|NCT00573430|531788712|FG000|Overall Study|Protocol Violation|0|||
147443553|NCT00573430|531788713|FG001|Overall Study|Protocol Violation|1|||
147443554|NCT00573430|531788714|FG002|Overall Study|Protocol Violation|1|||
147443555|NCT00573430|531788712|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
147443556|NCT00573430|531788713|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
147443557|NCT00573430|531788714|FG002|Overall Study|Eligibility criteria not fulfilled|3|||
147443558|NCT01278745|531788715|FG000|Overall Study|Death|2|||
147443559|NCT01278745|531788716|FG001|Overall Study|Death|5|||
147443560|NCT01278745|531788717|FG002|Overall Study|Death|7|||
147443561|NCT01278745|531788718|FG003|Overall Study|Death|0|||
147443562|NCT01278745|531788715|FG000|Overall Study|Physician Decision|1|||
147443563|NCT01278745|531788716|FG001|Overall Study|Physician Decision|0|||
147443564|NCT01278745|531788717|FG002|Overall Study|Physician Decision|0|||
147443565|NCT01278745|531788718|FG003|Overall Study|Physician Decision|9|||
147443566|NCT01278745|531788715|FG000|Overall Study|Withdrawal by Subject|1|||
147443567|NCT01278745|531788716|FG001|Overall Study|Withdrawal by Subject|1|||
147443568|NCT01278745|531788717|FG002|Overall Study|Withdrawal by Subject|5|||
147443569|NCT01278745|531788718|FG003|Overall Study|Withdrawal by Subject|1|||
147443570|NCT01278745|531788715|FG000|Overall Study|Sponsor Decision|1|||
147443571|NCT01278745|531788716|FG001|Overall Study|Sponsor Decision|0|||
147443572|NCT01278745|531788717|FG002|Overall Study|Sponsor Decision|62|||
147443573|NCT01278745|531788718|FG003|Overall Study|Sponsor Decision|6|||
147443574|NCT01278745|531788715|FG000|Overall Study|Ineligible|0|||
147443575|NCT01278745|531788716|FG001|Overall Study|Ineligible|0|||
147443576|NCT01278745|531788717|FG002|Overall Study|Ineligible|42|||
147443577|NCT01278745|531788718|FG003|Overall Study|Ineligible|61|||
147443578|NCT01278745|531788715|FG000|Overall Study|Moves,enrollment in mx studies, et al.|0|||
147443579|NCT01278745|531788716|FG001|Overall Study|Moves,enrollment in mx studies, et al.|0|||
147443580|NCT01278745|531788717|FG002|Overall Study|Moves,enrollment in mx studies, et al.|5|||
147443581|NCT01278745|531788718|FG003|Overall Study|Moves,enrollment in mx studies, et al.|1|||
147443582|NCT01843842|531788721|FG000|Overall Study|Do not meet inclusion criteria|1|||
147443583|NCT01843842|531788722|FG001|Overall Study|Do not meet inclusion criteria|1|||
147443584|NCT02953340|531788723|FG000|Overall Study|Death|0|||
147443585|NCT02953340|531788724|FG001|Overall Study|Death|1|||
147443586|NCT02953340|531788723|FG000|Overall Study|Investigator Decision|3|||
147443587|NCT02953340|531788724|FG001|Overall Study|Investigator Decision|3|||
147443588|NCT02953340|531788723|FG000|Overall Study|Initiated Non-Protocol Therapy|5|||
147443589|NCT02953340|531788724|FG001|Overall Study|Initiated Non-Protocol Therapy|14|||
147443590|NCT02953340|531788723|FG000|Overall Study|Myeloid Growth Factors Treatment|0|||
147443591|NCT02953340|531788724|FG001|Overall Study|Myeloid Growth Factors Treatment|1|||
147443592|NCT02953340|531788723|FG000|Overall Study|Withdrawal by Subject|9|||
147443593|NCT02953340|531788724|FG001|Overall Study|Withdrawal by Subject|9|||
147443594|NCT02953340|531788723|FG000|Overall Study|Sponsor decision|0|||
147443595|NCT02953340|531788724|FG001|Overall Study|Sponsor decision|2|||
147443596|NCT02953340|531788723|FG000|Overall Study|Lost to Follow-up|3|||
147443597|NCT02953340|531788724|FG001|Overall Study|Lost to Follow-up|2|||
147443598|NCT02953340|531788723|FG000|Overall Study|Reason not specified|2|||
147443599|NCT02953340|531788724|FG001|Overall Study|Reason not specified|2|||
147443600|NCT01376778|531788725|FG000|Overall Study|Lost to Follow-up|3|||
147443601|NCT01376778|531788726|FG001|Overall Study|Lost to Follow-up|2|||
147443602|NCT00632099|531788727|FG000|Overall Study|Lost to Follow-up|3|||
147443603|NCT00632099|531788728|FG001|Overall Study|Lost to Follow-up|3|||
147223247|NCT04704154|530989144|FG000|Overall Study|Participant Decision|1|||
147223248|NCT04704154|530989145|FG001|Overall Study|Participant Decision|1|||
147223249|NCT04704154|530989146|FG002|Overall Study|Participant Decision|0|||
147223250|NCT04704154|530989147|FG003|Overall Study|Participant Decision|0|||
147223251|NCT04704154|530989148|FG004|Overall Study|Participant Decision|0|||
147223252|NCT04704154|530989149|FG005|Overall Study|Participant Decision|0|||
147223253|NCT04704154|530989144|FG000|Overall Study|Progressive Disease|19|||
147223254|NCT04704154|530989145|FG001|Overall Study|Progressive Disease|17|||
147223255|NCT04704154|530989146|FG002|Overall Study|Progressive Disease|20|||
147223256|NCT04704154|530989147|FG003|Overall Study|Progressive Disease|18|||
147223257|NCT04704154|530989148|FG004|Overall Study|Progressive Disease|36|||
147223258|NCT04704154|530989149|FG005|Overall Study|Progressive Disease|30|||
147223259|NCT04704154|530989144|FG000|Overall Study|Completed max. allowed treatment. A max. of 24 infusions of Nivolumab were allowed for participants|2|||
147223260|NCT04704154|530989145|FG001|Overall Study|Completed max. allowed treatment. A max. of 24 infusions of Nivolumab were allowed for participants|0|||
147554030|NCT00876733|532183906|FG003|Overall Study|Data not available|1|||
147554031|NCT02611752|532183909|FG000|Overall Study|Adverse Event|0|||
147554032|NCT02611752|532183910|FG001|Overall Study|Adverse Event|1|||
147554033|NCT02843074|532183911|FG000|Overall Study|Withdrawal by Subject|5|||
147554034|NCT02843074|532183911|FG000|Overall Study|Progressive disease|1|||
147554035|NCT02843074|532183911|FG000|Overall Study|Physician Decision|1|||
147554036|NCT02843074|532183911|FG000|Overall Study|Lost to Follow-up|1|||
147554037|NCT02843074|532183911|FG000|Overall Study|Death|9|||
147554038|NCT03521999|532183912|FG000|Completed 1 Month Up|Lost to Follow-up|59|||
147554039|NCT03521999|532183913|FG001|Completed 1 Month Up|Lost to Follow-up|58|||
147554040|NCT03521999|532183912|FG000|Completed 3 Month Follow up|Lost to Follow-up|64|||
147554041|NCT03521999|532183913|FG001|Completed 3 Month Follow up|Lost to Follow-up|59|||
147554042|NCT03521999|532183912|FG000|Completed 3 Month Follow up|Death|0|||
147554043|NCT03521999|532183913|FG001|Completed 3 Month Follow up|Death|1|||
147554044|NCT03521999|532183912|FG000|Completed 6 Month Follow|Lost to Follow-up|66|||
147554045|NCT03521999|532183913|FG001|Completed 6 Month Follow|Lost to Follow-up|70|||
147554046|NCT01564758|532183914|FG000|Overall Study|Death|8|||
147554047|NCT01564758|532183914|FG000|Overall Study|Adverse Event|3|||
147554048|NCT01564758|532183914|FG000|Overall Study|Other|3|||
147554049|NCT01185288|532183918|FG000|Overall Study|Adverse Event|7|||
147554050|NCT01185288|532183919|FG001|Overall Study|Adverse Event|6|||
147554051|NCT01185288|532183918|FG000|Overall Study|Withdrawal by Subject|6|||
147554052|NCT01185288|532183919|FG001|Overall Study|Withdrawal by Subject|4|||
147554053|NCT01185288|532183918|FG000|Overall Study|Lost to Follow-up|2|||
147554054|NCT01185288|532183919|FG001|Overall Study|Lost to Follow-up|5|||
147554055|NCT01185288|532183918|FG000|Overall Study|Lack of Efficacy|2|||
147554056|NCT01185288|532183919|FG001|Overall Study|Lack of Efficacy|0|||
147223261|NCT04704154|530989146|FG002|Overall Study|Completed max. allowed treatment. A max. of 24 infusions of Nivolumab were allowed for participants|1|||
147223262|NCT04704154|530989147|FG003|Overall Study|Completed max. allowed treatment. A max. of 24 infusions of Nivolumab were allowed for participants|0|||
147554057|NCT01185288|532183918|FG000|Overall Study|Investigator discretion|1|||
147554058|NCT01185288|532183919|FG001|Overall Study|Investigator discretion|0|||
147554059|NCT01185288|532183918|FG000|Overall Study|Did not meet inclusion criteria|1|||
147554060|NCT01185288|532183919|FG001|Overall Study|Did not meet inclusion criteria|0|||
147554061|NCT01185288|532183918|FG000|Overall Study|Noncompliance|0|||
147554062|NCT01185288|532183919|FG001|Overall Study|Noncompliance|1|||
147554063|NCT02427607|532183920|FG000|Overall Study|Withdrawal by Subject|1|||
147554064|NCT02277769|532183921|FG000|Overall Study|Protocol Violation|3|||
147554065|NCT02277769|532183922|FG001|Overall Study|Protocol Violation|3|||
147554066|NCT02277769|532183923|FG002|Overall Study|Protocol Violation|5|||
147554067|NCT02277769|532183921|FG000|Overall Study|Lack of Efficacy|17|||
147554068|NCT02277769|532183922|FG001|Overall Study|Lack of Efficacy|0|||
147554069|NCT02277769|532183923|FG002|Overall Study|Lack of Efficacy|4|||
147554070|NCT02277769|532183921|FG000|Overall Study|Adverse Event|14|||
147554071|NCT02277769|532183922|FG001|Overall Study|Adverse Event|2|||
147554072|NCT02277769|532183923|FG002|Overall Study|Adverse Event|4|||
147554073|NCT02277769|532183921|FG000|Overall Study|Other than specified above|12|||
147554074|NCT02277769|532183922|FG001|Overall Study|Other than specified above|8|||
147554075|NCT02277769|532183923|FG002|Overall Study|Other than specified above|5|||
147554076|NCT00656019|532183924|FG000|Overall Study|Not Eligible|10|||
147554077|NCT00656019|532183925|FG001|Overall Study|Not Eligible|0|||
147554078|NCT00656019|532183926|FG002|Overall Study|Not Eligible|0|||
147554079|NCT00656019|532183927|FG003|Overall Study|Not Eligible|0|||
147554080|NCT00656019|532183924|FG000|Overall Study|Withdrawal by Subject|2|||
147554081|NCT00656019|532183925|FG001|Overall Study|Withdrawal by Subject|0|||
147554082|NCT00656019|532183926|FG002|Overall Study|Withdrawal by Subject|0|||
147223263|NCT04704154|530989148|FG004|Overall Study|Completed max. allowed treatment. A max. of 24 infusions of Nivolumab were allowed for participants|1|||
147223264|NCT04704154|530989149|FG005|Overall Study|Completed max. allowed treatment. A max. of 24 infusions of Nivolumab were allowed for participants|0|||
147223265|NCT04704154|530989144|FG000|Overall Study|Patient continued in rollover study for regorafenib|1|||
147223266|NCT04704154|530989145|FG001|Overall Study|Patient continued in rollover study for regorafenib|0|||
147554083|NCT00656019|532183927|FG003|Overall Study|Withdrawal by Subject|0|||
147554084|NCT00656019|532183924|FG000|Overall Study|Lost to Follow-up|2|||
147554085|NCT00656019|532183925|FG001|Overall Study|Lost to Follow-up|1|||
147554086|NCT00656019|532183926|FG002|Overall Study|Lost to Follow-up|0|||
147554087|NCT00656019|532183927|FG003|Overall Study|Lost to Follow-up|0|||
147554088|NCT03083132|532183932|FG000|First 12 Weeks (Placebo vs Modafinil)|Withdrawal by Subject|0|||
147554089|NCT03083132|532183933|FG001|First 12 Weeks (Placebo vs Modafinil)|Withdrawal by Subject|2|||
147554090|NCT03083132|532183932|FG000|Last 12 Weeks (Drug for All Subjects)|Physician Decision|1|||
147554091|NCT03083132|532183933|FG001|Last 12 Weeks (Drug for All Subjects)|Physician Decision|0|||
147554092|NCT03083132|532183932|FG000|Last 12 Weeks (Drug for All Subjects)|Withdrawal by Subject|0|||
147554093|NCT03083132|532183933|FG001|Last 12 Weeks (Drug for All Subjects)|Withdrawal by Subject|1|||
147554094|NCT03118739|532183934|FG000|Overall Study|Physician Decision|0|||
147554095|NCT03118739|532183935|FG001|Overall Study|Physician Decision|1|||
147554096|NCT03118739|532183934|FG000|Overall Study|Withdrawal by Subject|5|||
147554097|NCT03118739|532183935|FG001|Overall Study|Withdrawal by Subject|3|||
147223267|NCT04704154|530989146|FG002|Overall Study|Patient continued in rollover study for regorafenib|4|||
147223268|NCT04704154|530989147|FG003|Overall Study|Patient continued in rollover study for regorafenib|0|||
147223269|NCT04704154|530989148|FG004|Overall Study|Patient continued in rollover study for regorafenib|0|||
147223270|NCT04704154|530989149|FG005|Overall Study|Patient continued in rollover study for regorafenib|0|||
147223271|NCT03220438|530989150|FG000|Overall Study|Lost to Follow-up|0|||
147223272|NCT03220438|530989151|FG001|Overall Study|Lost to Follow-up|0|||
147223273|NCT03220438|530989152|FG002|Overall Study|Lost to Follow-up|1|||
147223274|NCT03220438|530989153|FG003|Overall Study|Lost to Follow-up|0|||
147223275|NCT04565236|530989154|FG000|Overall Study|Patient/Guardian Decision|0|||
147223276|NCT04565236|530989155|FG001|Overall Study|Patient/Guardian Decision|0|||
147223277|NCT04565236|530989156|FG002|Overall Study|Patient/Guardian Decision|1|||
147223278|NCT04565236|530989157|FG003|Overall Study|Patient/Guardian Decision|0|||
147223279|NCT01117051|530989161|FG000|Overall Study|Withdrawal by Subject|5|||
147223280|NCT01117051|530989162|FG001|Overall Study|Withdrawal by Subject|3|||
147223281|NCT01117051|530989161|FG000|Overall Study|Adverse Event|4|||
147223282|NCT01117051|530989162|FG001|Overall Study|Adverse Event|3|||
147223283|NCT01117051|530989161|FG000|Overall Study|Lost to Follow-up|0|||
147223284|NCT01117051|530989162|FG001|Overall Study|Lost to Follow-up|1|||
147223285|NCT01117051|530989161|FG000|Overall Study|Did not meet in-/exclusion criteria|0|||
147223286|NCT01117051|530989162|FG001|Overall Study|Did not meet in-/exclusion criteria|1|||
147223287|NCT01117051|530989161|FG000|Overall Study|Sponsor's decision|3|||
147223288|NCT01117051|530989162|FG001|Overall Study|Sponsor's decision|1|||
147223289|NCT01117051|530989161|FG000|Overall Study|Surgical procedure|0|||
147223290|NCT01117051|530989162|FG001|Overall Study|Surgical procedure|1|||
147223291|NCT01117051|530989161|FG000|Overall Study|Randomized by mistake|0|||
147223292|NCT01117051|530989162|FG001|Overall Study|Randomized by mistake|1|||
147223293|NCT01117051|530989161|FG000|Overall Study|Convenience issue|1|||
147223294|NCT01117051|530989162|FG001|Overall Study|Convenience issue|0|||
147223295|NCT03584373|530989163|FG000|Overall Study|Lost to Follow-up|7|||
147223296|NCT03584373|530989164|FG001|Overall Study|Lost to Follow-up|8|||
147223297|NCT03780400|530989165|FG000|Overall Study|Lost to Follow-up|5|||
147223298|NCT03780400|530989165|FG000|Overall Study|Withdrawal by Subject|2|||
147223299|NCT01001299|530989167|FG000|Overall Study|Insufficient Therapeutic Response|20|||
147223300|NCT01001299|530989167|FG000|Overall Study|Adverse event or Intercurrent Illness|1|||
147223301|NCT01001299|530989167|FG000|Overall Study|Death|1|||
147223302|NCT01001299|530989167|FG000|Overall Study|Began Taking Commercially Available Drug|2|||
147223303|NCT01001299|530989167|FG000|Overall Study|Withdrew Consent|1|||
147223304|NCT01923168|530989168|FG000|Overall Study|Protocol Violation|1|||
147223305|NCT01923168|530989169|FG001|Overall Study|Protocol Violation|1|||
147223306|NCT01923168|530989170|FG002|Overall Study|Protocol Violation|0|||
147223307|NCT01923168|530989168|FG000|Overall Study|Subject/guardian decision|14|||
147223308|NCT01923168|530989169|FG001|Overall Study|Subject/guardian decision|14|||
147223309|NCT01923168|530989170|FG002|Overall Study|Subject/guardian decision|4|||
147223310|NCT01923168|530989168|FG000|Overall Study|Adverse Event|12|||
147223311|NCT01923168|530989169|FG001|Overall Study|Adverse Event|12|||
147223312|NCT01923168|530989170|FG002|Overall Study|Adverse Event|0|||
147223313|NCT01923168|530989168|FG000|Overall Study|Physician Decision|6|||
147223314|NCT01923168|530989169|FG001|Overall Study|Physician Decision|9|||
147223315|NCT01923168|530989170|FG002|Overall Study|Physician Decision|5|||
147223316|NCT01923168|530989168|FG000|Overall Study|Progressive disease|4|||
147309601|NCT00152971|531300117|FG000|Treatment|Withdrawal by Subject|4|||
147309602|NCT00152971|531300118|FG001|Treatment|Withdrawal by Subject|4|||
147309603|NCT00152971|531300119|FG002|Treatment|Withdrawal by Subject|5|||
147309604|NCT00152971|531300117|FG000|Treatment|Other|9|||
147309605|NCT00152971|531300118|FG001|Treatment|Other|11|||
147309606|NCT00152971|531300119|FG002|Treatment|Other|10|||
147309607|NCT00675506|531300120|FG000|Overall Study|Lost to Follow-up|1|||
147309608|NCT00675506|531300121|FG001|Overall Study|Lost to Follow-up|5|||
147309609|NCT00675506|531300120|FG000|Overall Study|Lost interest|3|||
147309610|NCT00675506|531300121|FG001|Overall Study|Lost interest|5|||
147309611|NCT00675506|531300120|FG000|Overall Study|Elevated fasting glucose|2|||
147309612|NCT00675506|531300121|FG001|Overall Study|Elevated fasting glucose|1|||
147309613|NCT00675506|531300120|FG000|Overall Study|Elevated IGF-1 prior to treatment|1|||
147309614|NCT00675506|531300121|FG001|Overall Study|Elevated IGF-1 prior to treatment|0|||
147309615|NCT00675506|531300120|FG000|Overall Study|Elevated IGF-1|2|||
147309616|NCT00675506|531300121|FG001|Overall Study|Elevated IGF-1|0|||
147309617|NCT00675506|531300120|FG000|Overall Study|Hypersensitivity Reaction|1|||
147309618|NCT00675506|531300121|FG001|Overall Study|Hypersensitivity Reaction|0|||
147309619|NCT00675506|531300120|FG000|Overall Study|Disclosed history of cancer|1|||
147309620|NCT00675506|531300121|FG001|Overall Study|Disclosed history of cancer|0|||
147309621|NCT00675506|531300120|FG000|Overall Study|Declined participation|1|||
147554098|NCT03118739|532183934|FG000|Overall Study|Lost to Follow-up|2|||
147554099|NCT03118739|532183935|FG001|Overall Study|Lost to Follow-up|0|||
147309622|NCT00675506|531300121|FG001|Overall Study|Declined participation|0|||
147309623|NCT00675506|531300120|FG000|Overall Study|Schedule conflict|0|||
147309624|NCT00675506|531300121|FG001|Overall Study|Schedule conflict|1|||
147309625|NCT04986982|531300122|FG000|Overall Study|Withdrawal by Subject|3|||
147309626|NCT04986982|531300123|FG001|Overall Study|Withdrawal by Subject|1|||
147309627|NCT04986982|531300122|FG000|Overall Study|Lack of Efficacy|0|||
147309628|NCT04986982|531300123|FG001|Overall Study|Lack of Efficacy|2|||
147309629|NCT04986982|531300122|FG000|Overall Study|Ineligibility|3|||
147309630|NCT04986982|531300123|FG001|Overall Study|Ineligibility|0|||
147309631|NCT04986982|531300122|FG000|Overall Study|Adverse Event|4|||
147554100|NCT00669955|532183936|FG000|Overall Study|Adverse Event|3|||
147223317|NCT01923168|530989169|FG001|Overall Study|Progressive disease|3|||
147223318|NCT01923168|530989170|FG002|Overall Study|Progressive disease|7|||
147223319|NCT01923168|530989168|FG000|Overall Study|Death|0|||
147223320|NCT01923168|530989169|FG001|Overall Study|Death|0|||
147223321|NCT01923168|530989170|FG002|Overall Study|Death|1|||
147223322|NCT03882008|530989171|FG000|Overall Study|Withdrawal by Subject|1|||
147223323|NCT03882008|530989171|FG000|Overall Study|Lost to Follow-up|1|||
147223324|NCT00768469|530989173|FG000|Overall Study|Adverse Event|0|||
147223325|NCT00768469|530989174|FG001|Overall Study|Adverse Event|2|||
147223326|NCT00768469|530989173|FG000|Overall Study|Disease Progression|3|||
147223327|NCT00768469|530989174|FG001|Overall Study|Disease Progression|4|||
147223328|NCT00768469|530989173|FG000|Overall Study|Withdrawal by Subject|0|||
147223329|NCT00768469|530989174|FG001|Overall Study|Withdrawal by Subject|1|||
147223330|NCT01582854|530989177|FG000|Overall Study|Death|8|||
147223331|NCT01582854|530989178|FG001|Overall Study|Death|5|||
147223332|NCT01582854|530989177|FG000|Overall Study|Adverse Event|2|||
147223333|NCT01582854|530989178|FG001|Overall Study|Adverse Event|3|||
147223334|NCT01582854|530989177|FG000|Overall Study|Withdrawal by Participant|8|||
147223335|NCT01582854|530989178|FG001|Overall Study|Withdrawal by Participant|11|||
147223336|NCT01582854|530989177|FG000|Overall Study|Lost to Follow-up|1|||
147223337|NCT01582854|530989178|FG001|Overall Study|Lost to Follow-up|2|||
147223338|NCT01582854|530989177|FG000|Overall Study|Physician Decision|0|||
147223339|NCT01582854|530989178|FG001|Overall Study|Physician Decision|1|||
147223340|NCT01582854|530989177|FG000|Overall Study|Recurrent Stroke|13|||
147223341|NCT01582854|530989178|FG001|Overall Study|Recurrent Stroke|8|||
147223342|NCT01582854|530989177|FG000|Overall Study|Disallowed Concomitant Medication|3|||
147223343|NCT01582854|530989178|FG001|Overall Study|Disallowed Concomitant Medication|2|||
147223344|NCT01582854|530989177|FG000|Overall Study|Carotid or Neurosurgery|0|||
147223345|NCT01582854|530989178|FG001|Overall Study|Carotid or Neurosurgery|1|||
147223346|NCT01582854|530989177|FG000|Overall Study|General Anaesthesia|0|||
147223347|NCT01582854|530989178|FG001|Overall Study|General Anaesthesia|1|||
147554101|NCT00669955|532183937|FG001|Overall Study|Adverse Event|5|||
147554102|NCT00669955|532183936|FG000|Overall Study|Death|0|||
147554103|NCT00669955|532183937|FG001|Overall Study|Death|1|||
147554104|NCT00669955|532183936|FG000|Overall Study|Withdrawal by Subject|2|||
147554105|NCT00669955|532183937|FG001|Overall Study|Withdrawal by Subject|3|||
147554106|NCT00669955|532183936|FG000|Overall Study|Lost to Follow-up|5|||
147554107|NCT00669955|532183937|FG001|Overall Study|Lost to Follow-up|7|||
147554108|NCT00669955|532183936|FG000|Overall Study|Protocol Violation|2|||
147554109|NCT00669955|532183937|FG001|Overall Study|Protocol Violation|7|||
147554110|NCT00669955|532183936|FG000|Overall Study|Investigator Sponsor Judgement|0|||
147554111|NCT00669955|532183937|FG001|Overall Study|Investigator Sponsor Judgement|1|||
147554112|NCT00669955|532183936|FG000|Overall Study|not compliant with study drug/visit|2|||
147554113|NCT00669955|532183937|FG001|Overall Study|not compliant with study drug/visit|3|||
147554114|NCT01326026|532183939|FG000|Overall Study|Adverse Event|4|||
147554115|NCT01326026|532183940|FG001|Overall Study|Adverse Event|3|||
147554116|NCT01326026|532183939|FG000|Overall Study|Withdrawal Criteria|5|||
147554117|NCT01326026|532183940|FG001|Overall Study|Withdrawal Criteria|7|||
147223348|NCT01582854|530989177|FG000|Overall Study|Other Miscellaneous Reason|1|||
147223349|NCT01582854|530989178|FG001|Overall Study|Other Miscellaneous Reason|0|||
147223350|NCT04068896|530989179|FG000|Overall Study|Adverse Event|2|||
147223351|NCT04068896|530989180|FG001|Overall Study|Adverse Event|0|||
147223352|NCT04068896|530989181|FG002|Overall Study|Adverse Event|1|||
147223353|NCT04068896|530989182|FG003|Overall Study|Adverse Event|0|||
147223354|NCT04068896|530989183|FG004|Overall Study|Adverse Event|0|||
147223355|NCT04068896|530989184|FG005|Overall Study|Adverse Event|0|||
147223356|NCT04068896|530989179|FG000|Overall Study|Death|3|||
147554118|NCT01326026|532183939|FG000|Overall Study|Other|3|||
147554119|NCT01326026|532183940|FG001|Overall Study|Other|3|||
147554120|NCT04317053|532183950|FG000|Overall Study|Withdrawn (screen failure)|4|||
147223357|NCT04068896|530989180|FG001|Overall Study|Death|1|||
147554121|NCT04317053|532183951|FG001|Overall Study|Withdrawn (screen failure)|2|||
147554122|NCT04274192|532183952|FG000|Overall Study|Protocol Violation|1|||
147554123|NCT04274192|532183953|FG001|Overall Study|Protocol Violation|0|||
147554124|NCT00289458|532183954|FG000|Overall Study|Death|1|||
147554125|NCT00289458|532183955|FG001|Overall Study|Death|0|||
147554126|NCT00289458|532183956|FG002|Overall Study|Death|0|||
147554127|NCT00289458|532183954|FG000|Overall Study|Physician Decision|3|||
147554128|NCT00289458|532183955|FG001|Overall Study|Physician Decision|4|||
147554129|NCT00289458|532183956|FG002|Overall Study|Physician Decision|2|||
147223358|NCT04068896|530989181|FG002|Overall Study|Death|3|||
147223359|NCT04068896|530989182|FG003|Overall Study|Death|19|||
147223360|NCT04068896|530989183|FG004|Overall Study|Death|17|||
147223361|NCT04068896|530989184|FG005|Overall Study|Death|0|||
147223362|NCT04068896|530989179|FG000|Overall Study|Physician Decision|0|||
147223363|NCT04068896|530989180|FG001|Overall Study|Physician Decision|0|||
147223364|NCT04068896|530989181|FG002|Overall Study|Physician Decision|0|||
147223365|NCT04068896|530989182|FG003|Overall Study|Physician Decision|1|||
147223366|NCT04068896|530989183|FG004|Overall Study|Physician Decision|0|||
147223367|NCT04068896|530989184|FG005|Overall Study|Physician Decision|0|||
147223368|NCT04068896|530989179|FG000|Overall Study|progressive disease|3|||
147223369|NCT04068896|530989180|FG001|Overall Study|progressive disease|5|||
147223370|NCT04068896|530989181|FG002|Overall Study|progressive disease|3|||
147223371|NCT04068896|530989182|FG003|Overall Study|progressive disease|2|||
147223372|NCT04068896|530989183|FG004|Overall Study|progressive disease|1|||
147223373|NCT04068896|530989184|FG005|Overall Study|progressive disease|2|||
147223374|NCT04068896|530989179|FG000|Overall Study|Study terminated by sponsor|0|||
147223375|NCT04068896|530989180|FG001|Overall Study|Study terminated by sponsor|0|||
147223376|NCT04068896|530989181|FG002|Overall Study|Study terminated by sponsor|1|||
147223377|NCT04068896|530989182|FG003|Overall Study|Study terminated by sponsor|2|||
147223378|NCT04068896|530989183|FG004|Overall Study|Study terminated by sponsor|1|||
147223379|NCT04068896|530989184|FG005|Overall Study|Study terminated by sponsor|4|||
147223380|NCT04068896|530989179|FG000|Overall Study|Protocol Violation|0|||
147223381|NCT04068896|530989180|FG001|Overall Study|Protocol Violation|0|||
147223382|NCT04068896|530989181|FG002|Overall Study|Protocol Violation|0|||
147223383|NCT04068896|530989182|FG003|Overall Study|Protocol Violation|1|||
147223384|NCT04068896|530989183|FG004|Overall Study|Protocol Violation|0|||
147223385|NCT04068896|530989184|FG005|Overall Study|Protocol Violation|0|||
147223386|NCT04068896|530989179|FG000|Overall Study|Withdrawal by Subject|0|||
147223387|NCT04068896|530989180|FG001|Overall Study|Withdrawal by Subject|3|||
147223388|NCT04068896|530989181|FG002|Overall Study|Withdrawal by Subject|0|||
147223389|NCT04068896|530989182|FG003|Overall Study|Withdrawal by Subject|2|||
147223390|NCT04068896|530989183|FG004|Overall Study|Withdrawal by Subject|1|||
147223391|NCT04068896|530989184|FG005|Overall Study|Withdrawal by Subject|0|||
147223392|NCT04068896|530989179|FG000|Overall Study|Symptomatic deterioration|2|||
147223393|NCT04068896|530989180|FG001|Overall Study|Symptomatic deterioration|0|||
147223394|NCT04068896|530989181|FG002|Overall Study|Symptomatic deterioration|0|||
147223395|NCT04068896|530989182|FG003|Overall Study|Symptomatic deterioration|0|||
147223396|NCT04068896|530989183|FG004|Overall Study|Symptomatic deterioration|0|||
147554130|NCT00289458|532183954|FG000|Overall Study|Withdrawal by Subject|2|||
147554131|NCT00289458|532183955|FG001|Overall Study|Withdrawal by Subject|2|||
147554132|NCT00289458|532183956|FG002|Overall Study|Withdrawal by Subject|4|||
147554133|NCT03507439|532183957|FG000|Overall Study|Other|2|||
147223397|NCT04068896|530989184|FG005|Overall Study|Symptomatic deterioration|0|||
147223398|NCT02953509|530989185|FG000|Overall Study|Death|1|||
147223399|NCT02953509|530989186|FG001|Overall Study|Death|3|||
147223400|NCT02953509|530989187|FG002|Overall Study|Death|3|||
147223401|NCT02953509|530989188|FG003|Overall Study|Death|4|||
147223402|NCT02953509|530989189|FG004|Overall Study|Death|12|||
147223403|NCT02953509|530989190|FG005|Overall Study|Death|3|||
147554134|NCT03507439|532183958|FG001|Overall Study|Other|1|||
147223404|NCT02953509|530989191|FG006|Overall Study|Death|25|||
147223405|NCT02953509|530989192|FG007|Overall Study|Death|10|||
147223406|NCT02953509|530989193|FG008|Overall Study|Death|21|||
147223407|NCT02953509|530989194|FG009|Overall Study|Death|20|||
147554135|NCT03507439|532183957|FG000|Overall Study|Withdrawal by Subject|1|||
147554136|NCT03507439|532183958|FG001|Overall Study|Withdrawal by Subject|0|||
147554137|NCT03507439|532183957|FG000|Overall Study|Death|1|||
147554138|NCT03507439|532183958|FG001|Overall Study|Death|1|||
147223408|NCT02953509|530989185|FG000|Overall Study|Reason Not Specified|0|||
147223409|NCT02953509|530989186|FG001|Overall Study|Reason Not Specified|2|||
147223410|NCT02953509|530989187|FG002|Overall Study|Reason Not Specified|8|||
147223411|NCT02953509|530989188|FG003|Overall Study|Reason Not Specified|2|||
147223412|NCT02953509|530989189|FG004|Overall Study|Reason Not Specified|11|||
147223413|NCT02953509|530989190|FG005|Overall Study|Reason Not Specified|4|||
147223414|NCT02953509|530989191|FG006|Overall Study|Reason Not Specified|12|||
147223415|NCT02953509|530989192|FG007|Overall Study|Reason Not Specified|2|||
147223416|NCT02953509|530989193|FG008|Overall Study|Reason Not Specified|7|||
147223417|NCT02953509|530989194|FG009|Overall Study|Reason Not Specified|2|||
147223418|NCT02953509|530989185|FG000|Overall Study|Consent Withdrawn|1|||
147223419|NCT02953509|530989186|FG001|Overall Study|Consent Withdrawn|1|||
147554139|NCT00874757|532183959|FG000|Overall Study|Baseline laboratories outside of normal limits (screen fails).|4|||
147554140|NCT01073020|532185501|FG000|Overall Study|Withdrawal by Subject|6|||
147223420|NCT02953509|530989187|FG002|Overall Study|Consent Withdrawn|2|||
147223421|NCT02953509|530989188|FG003|Overall Study|Consent Withdrawn|1|||
147223422|NCT02953509|530989189|FG004|Overall Study|Consent Withdrawn|3|||
147223423|NCT02953509|530989190|FG005|Overall Study|Consent Withdrawn|0|||
147223424|NCT02953509|530989191|FG006|Overall Study|Consent Withdrawn|4|||
147223425|NCT02953509|530989192|FG007|Overall Study|Consent Withdrawn|1|||
147223426|NCT02953509|530989193|FG008|Overall Study|Consent Withdrawn|1|||
147223427|NCT02953509|530989194|FG009|Overall Study|Consent Withdrawn|4|||
147223428|NCT02953509|530989185|FG000|Overall Study|Lost to Follow-up|0|||
147223429|NCT02953509|530989186|FG001|Overall Study|Lost to Follow-up|0|||
147223430|NCT02953509|530989187|FG002|Overall Study|Lost to Follow-up|0|||
147223431|NCT02953509|530989188|FG003|Overall Study|Lost to Follow-up|0|||
147223432|NCT02953509|530989189|FG004|Overall Study|Lost to Follow-up|0|||
147223433|NCT02953509|530989190|FG005|Overall Study|Lost to Follow-up|0|||
147223434|NCT02953509|530989191|FG006|Overall Study|Lost to Follow-up|1|||
147223435|NCT02953509|530989192|FG007|Overall Study|Lost to Follow-up|1|||
147223436|NCT02953509|530989193|FG008|Overall Study|Lost to Follow-up|1|||
147223437|NCT02953509|530989194|FG009|Overall Study|Lost to Follow-up|1|||
147223438|NCT02953509|530989185|FG000|Overall Study|Study terminated by sponsor|1|||
147223439|NCT02953509|530989186|FG001|Overall Study|Study terminated by sponsor|0|||
147223440|NCT02953509|530989187|FG002|Overall Study|Study terminated by sponsor|0|||
147223441|NCT02953509|530989188|FG003|Overall Study|Study terminated by sponsor|0|||
147223442|NCT02953509|530989189|FG004|Overall Study|Study terminated by sponsor|0|||
147223443|NCT02953509|530989190|FG005|Overall Study|Study terminated by sponsor|0|||
147223444|NCT02953509|530989191|FG006|Overall Study|Study terminated by sponsor|1|||
147223445|NCT02953509|530989192|FG007|Overall Study|Study terminated by sponsor|0|||
147223446|NCT02953509|530989193|FG008|Overall Study|Study terminated by sponsor|1|||
147223447|NCT02953509|530989194|FG009|Overall Study|Study terminated by sponsor|1|||
147223448|NCT00484185|530989197|FG000|Overall Study|Lost to Follow-up|44|||
147223449|NCT00484185|530989197|FG000|Overall Study|Other|20|||
147223450|NCT00484185|530989197|FG000|Overall Study|Randomized but not treated|5|||
147223451|NCT00484185|530989197|FG000|Overall Study|Death|2|||
147223452|NCT00459056|530989198|FG000|First Intervention (First Three Months)|Lost to Follow-up|1|||
147223453|NCT00459056|530989199|FG001|First Intervention (First Three Months)|Lost to Follow-up|1|||
147223454|NCT02522871|530989200|FG000|Overall Study|Protocol Violation|1|||
147223455|NCT02522871|530989201|FG001|Overall Study|Protocol Violation|4|||
147223456|NCT02522871|530989200|FG000|Overall Study|Treated without randomization|1|||
147223457|NCT02522871|530989201|FG001|Overall Study|Treated without randomization|0|||
147223458|NCT02522871|530989200|FG000|Overall Study|Death|9|||
147223459|NCT02522871|530989201|FG001|Overall Study|Death|9|||
147223460|NCT02522871|530989200|FG000|Overall Study|Died in operating room prior to transplant|0|||
147223461|NCT02522871|530989201|FG001|Overall Study|Died in operating room prior to transplant|1|||
147223462|NCT01222403|530989204|FG000|Overall Study|Inappropriate enrollment|0|||
147223463|NCT01222403|530989205|FG001|Overall Study|Inappropriate enrollment|2|||
147223464|NCT00725842|530989206|FG000|Overall Study|Lost to Follow-up|19|||
147223465|NCT00725842|530989206|FG000|Overall Study|Death|1|||
147223466|NCT00725842|530989206|FG000|Overall Study|Positive HCV-RNA at Visit 2|13|||
147223467|NCT00725842|530989206|FG000|Overall Study|Consent date prior to study start date|5|||
147223468|NCT00725842|530989206|FG000|Overall Study|Inclusion criterion not met|1|||
147223469|NCT00725842|530989206|FG000|Overall Study|No Visit 1 data|1|||
147223470|NCT02793622|530989210|FG000|Overall Study|Lost to Follow-up|31|||
147223471|NCT02793622|530989211|FG001|Overall Study|Lost to Follow-up|19|||
147223472|NCT02793622|530989210|FG000|Overall Study|Withdrawal by Subject|21|||
147223473|NCT02793622|530989211|FG001|Overall Study|Withdrawal by Subject|17|||
147223474|NCT02793622|530989210|FG000|Overall Study|Adverse Event|0|||
147223475|NCT02793622|530989211|FG001|Overall Study|Adverse Event|1|||
147223476|NCT02793622|530989210|FG000|Overall Study|Protocol Violation|1|||
147223477|NCT02793622|530989211|FG001|Overall Study|Protocol Violation|5|||
147223478|NCT01075191|530989213|FG000|Overall Study|Death|1|||
147223479|NCT01075191|530989213|FG000|Overall Study|Intensification|3|||
147223480|NCT01075191|530989213|FG000|Overall Study|Co-morbidities|1|||
147223481|NCT01075191|530989213|FG000|Overall Study|Adverse Event|4|||
147223482|NCT01075191|530989213|FG000|Overall Study|Noncompliance|3|||
147223483|NCT01075191|530989213|FG000|Overall Study|Therapy Break|3|||
147223484|NCT01075191|530989213|FG000|Overall Study|Patient's Wish|2|||
147223485|NCT01075191|530989213|FG000|Overall Study|Unknown Reasons|1|||
147223486|NCT00718237|530989218|FG000|Overall Study|Adverse Event|1|||
147223487|NCT00718237|530989219|FG001|Overall Study|Adverse Event|3|||
147223488|NCT00718237|530989218|FG000|Overall Study|Lost to Follow-up|2|||
147223489|NCT00718237|530989219|FG001|Overall Study|Lost to Follow-up|2|||
147223490|NCT00718237|530989218|FG000|Overall Study|Physician Decision|1|||
147223491|NCT00718237|530989219|FG001|Overall Study|Physician Decision|0|||
147223492|NCT00718237|530989218|FG000|Overall Study|Withdrawal by Subject|9|||
147223493|NCT00718237|530989219|FG001|Overall Study|Withdrawal by Subject|10|||
147223494|NCT02068768|530989220|FG000|Overall Study|Lost to Follow-up|5|||
147223495|NCT02068768|530989220|FG000|Overall Study|Early Termination by Sponsor|2|||
147223496|NCT00555425|530989221|FG000|Overall Study|Missed Medication > 1 wk|34|||
147223497|NCT00555425|530989222|FG001|Overall Study|Missed Medication > 1 wk|15|||
147223498|NCT00555425|530989221|FG000|Overall Study|Missed 3 physician management visits|1|||
147223499|NCT00555425|530989222|FG001|Overall Study|Missed 3 physician management visits|0|||
147223500|NCT00555425|530989221|FG000|Overall Study|Met criteria for protective transfer|16|||
147223501|NCT00555425|530989222|FG001|Overall Study|Met criteria for protective transfer|3|||
147223502|NCT00555425|530989221|FG000|Overall Study|Became pregnant and transferred care|0|||
147223503|NCT00555425|530989222|FG001|Overall Study|Became pregnant and transferred care|1|||
147223504|NCT01262352|530989223|FG000|Period 1|Illness after randomization|1|||
147223505|NCT01262352|530989224|FG001|Period 1|Illness after randomization|0|||
147223506|NCT01262352|530989223|FG000|Washout|Adverse Event|1|||
147223507|NCT01262352|530989224|FG001|Washout|Adverse Event|1|||
147223508|NCT01262352|530989223|FG000|Washout|Extended Washout|0|||
147223509|NCT01262352|530989224|FG001|Washout|Extended Washout|1|||
147223510|NCT01185834|530989225|FG000|Overall Study|Lost to Follow-up|2|||
147223511|NCT01185834|530989225|FG000|Overall Study|Discomfort|4|||
147223512|NCT01185834|530989225|FG000|Overall Study|Biomicroscopy|4|||
147223513|NCT01185834|530989225|FG000|Overall Study|Time/Job Conflict|2|||
147223514|NCT01185834|530989225|FG000|Overall Study|Early exit - Site error|2|||
147223515|NCT01683019|530990586|FG000|Overall Study|Withdrawal by Subject|2|||
147223516|NCT01683019|530990587|FG001|Overall Study|Withdrawal by Subject|1|||
147223517|NCT01683019|530990588|FG002|Overall Study|Withdrawal by Subject|4|||
147223518|NCT00543855|530990593|FG000|Overall Study|Adverse Event|3|||
147223519|NCT00543855|530990594|FG001|Overall Study|Adverse Event|1|||
147223520|NCT00543855|530990595|FG002|Overall Study|Adverse Event|3|||
147223521|NCT00543855|530990596|FG003|Overall Study|Adverse Event|4|||
147223522|NCT00543855|530990593|FG000|Overall Study|Lost to Follow-up|0|||
147223523|NCT00543855|530990594|FG001|Overall Study|Lost to Follow-up|0|||
147223524|NCT00543855|530990595|FG002|Overall Study|Lost to Follow-up|1|||
147223525|NCT00543855|530990596|FG003|Overall Study|Lost to Follow-up|0|||
147223526|NCT00543855|530990593|FG000|Overall Study|Withdrawal by Subject|0|||
147223527|NCT00543855|530990594|FG001|Overall Study|Withdrawal by Subject|1|||
147223528|NCT00543855|530990595|FG002|Overall Study|Withdrawal by Subject|2|||
147223529|NCT00543855|530990596|FG003|Overall Study|Withdrawal by Subject|0|||
147223530|NCT00543855|530990593|FG000|Overall Study|Protocol Violation|1|||
147223531|NCT00543855|530990594|FG001|Overall Study|Protocol Violation|0|||
147223532|NCT00543855|530990595|FG002|Overall Study|Protocol Violation|0|||
147223533|NCT00543855|530990596|FG003|Overall Study|Protocol Violation|0|||
147223534|NCT04285580|530990597|FG000|Overall Study|Protocol Violation|0|||
147223535|NCT04285580|530990598|FG001|Overall Study|Protocol Violation|1|||
147223536|NCT02582255|530990599|FG000|Overall Study|Protocol Violation|0|||
147223537|NCT02582255|530990600|FG001|Overall Study|Protocol Violation|3|||
147223538|NCT04050371|530990603|FG000|Overall Study|Withdrawal by Subject|1|||
147223539|NCT04050371|530990604|FG001|Overall Study|Withdrawal by Subject|0|||
147223540|NCT01547780|530990605|FG000|Baseline PET Scan|Physician Decision|1|||
147223541|NCT01547780|530990606|FG001|Baseline PET Scan|Physician Decision|0|||
147223542|NCT01547780|530990607|FG002|Baseline PET Scan|Physician Decision|1|||
147223543|NCT01547780|530990608|FG003|Baseline PET Scan|Physician Decision|0|||
147223544|NCT01547780|530990605|FG000|Baseline PET Scan|Withdrawal by Subject|2|||
147223545|NCT01547780|530990606|FG001|Baseline PET Scan|Withdrawal by Subject|0|||
147223546|NCT01547780|530990607|FG002|Baseline PET Scan|Withdrawal by Subject|1|||
147223547|NCT01547780|530990608|FG003|Baseline PET Scan|Withdrawal by Subject|0|||
147223548|NCT01736657|530990610|FG000|Overall Study|insufficient vascular access|1|||
147223549|NCT04123665|530990619|FG000|Overall Study|Withdrawal by Subject|7|||
147223550|NCT04123665|530990620|FG001|Overall Study|Withdrawal by Subject|0|||
147223551|NCT04123665|530990619|FG000|Overall Study|Lost to Follow-up|1|||
147223552|NCT04123665|530990620|FG001|Overall Study|Lost to Follow-up|0|||
147223553|NCT01711879|530990625|FG000|Overall Study|Death|1|||
147223554|NCT01711879|530990626|FG001|Overall Study|Death|0|||
147223555|NCT00958789|530990627|FG000|Overall Study|Death|5|||
147223556|NCT00958789|530990627|FG000|Overall Study|Lost to Follow-up|14|||
147223557|NCT00958789|530990627|FG000|Overall Study|Withdrawal by Subject|17|||
147223558|NCT00958789|530990627|FG000|Overall Study|No 2 yr. Knee Society Score data|4|||
147223559|NCT00958789|530990627|FG000|Overall Study|2 yr. Knee Society Score not calculable|1|||
147223560|NCT00958789|530990627|FG000|Overall Study|Subject terminated|2|||
147223561|NCT00958789|530990627|FG000|Overall Study|Revision|7|||
147223562|NCT00478881|530990630|FG000|Overall Study|Adverse Event|31|||
147223563|NCT00478881|530990631|FG001|Overall Study|Adverse Event|12|||
147223564|NCT00478881|530990630|FG000|Overall Study|Lack of Efficacy|0|||
147223565|NCT00478881|530990631|FG001|Overall Study|Lack of Efficacy|3|||
147223566|NCT00478881|530990630|FG000|Overall Study|Lost to Follow-up|0|||
147223567|NCT00478881|530990631|FG001|Overall Study|Lost to Follow-up|1|||
147223568|NCT00478881|530990630|FG000|Overall Study|Protocol Violation|2|||
147309632|NCT04986982|531300123|FG001|Overall Study|Adverse Event|4|||
147223569|NCT00478881|530990631|FG001|Overall Study|Protocol Violation|2|||
147223570|NCT00478881|530990630|FG000|Overall Study|Withdrawal by Subject|6|||
147223571|NCT00478881|530990631|FG001|Overall Study|Withdrawal by Subject|2|||
147223572|NCT00478881|530990630|FG000|Overall Study|Non-Compliance with Study Medication|0|||
147223573|NCT00478881|530990631|FG001|Overall Study|Non-Compliance with Study Medication|2|||
147223574|NCT01466179|530990632|FG000|Overall Study|Ongoing in core study|2|||
147223575|NCT01466179|530990632|FG000|Overall Study|Physician Decision|46|||
147223576|NCT01466179|530990632|FG000|Overall Study|Progressive disease|43|||
147223577|NCT01466179|530990632|FG000|Overall Study|Adverse Event|32|||
147223578|NCT01466179|530990632|FG000|Overall Study|Disease relapse|23|||
147223579|NCT01466179|530990632|FG000|Overall Study|Lack of Efficacy|14|||
147223580|NCT01466179|530990632|FG000|Overall Study|Death|7|||
147223581|NCT01466179|530990632|FG000|Overall Study|Withdrawal by Subject|7|||
147223582|NCT01466179|530990632|FG000|Overall Study|Protocol Violation|2|||
147223583|NCT01466179|530990632|FG000|Overall Study|Other|3|||
147223584|NCT01083173|530990635|FG000|Main Surveillance: Safety Group|Violation of inclusion/exclusion crit.|14|||
147223585|NCT01083173|530990636|FG001|Main Surveillance: Safety Group|Violation of inclusion/exclusion crit.|0|||
147223586|NCT01083173|530990635|FG000|Main Surveillance: Safety Group|Violation of the use/dosage|1|||
147223587|NCT01083173|530990636|FG001|Main Surveillance: Safety Group|Violation of the use/dosage|0|||
147223588|NCT01083173|530990635|FG000|Main Surveillance: Effectiveness Group|No follow-up at 24 ±4 wks|201|||
147223589|NCT01083173|530990636|FG001|Main Surveillance: Effectiveness Group|No follow-up at 24 ±4 wks|0|||
147223590|NCT01083173|530990635|FG000|Main Surveillance: Effectiveness Group|No viral load data at 24 ±4 wks|168|||
147223591|NCT01083173|530990636|FG001|Main Surveillance: Effectiveness Group|No viral load data at 24 ±4 wks|0|||
147223592|NCT01083173|530990635|FG000|Main Surveillance: Effectiveness Group|Administration of Kaletra <24 wks|13|||
147223593|NCT01083173|530990636|FG001|Main Surveillance: Effectiveness Group|Administration of Kaletra <24 wks|0|||
147223594|NCT01083173|530990635|FG000|Long-term Surveillance: Safety Group|Violation of inclusion/exclusion crit.|0|||
147223595|NCT01083173|530990636|FG001|Long-term Surveillance: Safety Group|Violation of inclusion/exclusion crit.|14|||
147223596|NCT01083173|530990635|FG000|Long-term Surveillance: Safety Group|Violation of the dosage|0|||
147223597|NCT01083173|530990636|FG001|Long-term Surveillance: Safety Group|Violation of the dosage|1|||
147223598|NCT01083173|530990635|FG000|Long-term Surveillance: Safety Group|Administration of Kaletra <20 wks|0|||
147223599|NCT01083173|530990636|FG001|Long-term Surveillance: Safety Group|Administration of Kaletra <20 wks|101|||
147223600|NCT01083173|530990635|FG000|Long-term Surveillance: Effectiveness Gr|No follow-up at 48 ±4 wks|0|||
147223601|NCT01083173|530990636|FG001|Long-term Surveillance: Effectiveness Gr|No follow-up at 48 ±4 wks|195|||
147223602|NCT01083173|530990635|FG000|Long-term Surveillance: Effectiveness Gr|No viral load data at 48 ±4 wks|0|||
147223603|NCT01083173|530990636|FG001|Long-term Surveillance: Effectiveness Gr|No viral load data at 48 ±4 wks|136|||
147223604|NCT01083173|530990635|FG000|Long-term Surveillance: Effectiveness Gr|Administration of Kaletra <48 wks|0|||
147223605|NCT01083173|530990636|FG001|Long-term Surveillance: Effectiveness Gr|Administration of Kaletra <48 wks|46|||
147223606|NCT03139604|530990639|FG000|Overall Study|Other|7|||
147223607|NCT03139604|530990640|FG001|Overall Study|Other|3|||
147223608|NCT03139604|530990639|FG000|Overall Study|Withdrawal by Subject|16|||
147223609|NCT03139604|530990640|FG001|Overall Study|Withdrawal by Subject|17|||
147223610|NCT03139604|530990639|FG000|Overall Study|Physician Decision|1|||
147443604|NCT04712110|531788729|FG000|Overall Study|Lost to Follow-up|0|||
147443605|NCT04712110|531788730|FG001|Overall Study|Lost to Follow-up|1|||
147443606|NCT04712110|531788729|FG000|Overall Study|Withdrawal by Subject|0|||
147443607|NCT04712110|531788730|FG001|Overall Study|Withdrawal by Subject|4|||
147443608|NCT04712110|531788729|FG000|Overall Study|Chose Publicly Available SARS-CoV-2 Vaccine|46|||
147443609|NCT04712110|531788730|FG001|Overall Study|Chose Publicly Available SARS-CoV-2 Vaccine|14|||
147443610|NCT00271596|531788736|FG000|Overall Study|Protocol Violation|1|||
147443611|NCT00271596|531788737|FG001|Overall Study|Protocol Violation|0|||
147443612|NCT00271596|531788736|FG000|Overall Study|Withdrawal by Subject|0|||
147443613|NCT00271596|531788737|FG001|Overall Study|Withdrawal by Subject|1|||
147443614|NCT04707157|531788738|FG000|Overall Study|Adverse Event|12|||
147443615|NCT04707157|531788739|FG001|Overall Study|Adverse Event|3|||
147443616|NCT04707157|531788738|FG000|Overall Study|Lost to Follow-up|2|||
147554141|NCT01073020|532185502|FG001|Overall Study|Withdrawal by Subject|4|||
147554142|NCT01073020|532185503|FG002|Overall Study|Withdrawal by Subject|1|||
147554143|NCT01073020|532185504|FG003|Overall Study|Withdrawal by Subject|2|||
147554144|NCT01073020|532185501|FG000|Overall Study|Physician Decision|1|||
147554145|NCT01073020|532185502|FG001|Overall Study|Physician Decision|0|||
147554146|NCT01073020|532185503|FG002|Overall Study|Physician Decision|2|||
147554147|NCT01073020|532185504|FG003|Overall Study|Physician Decision|0|||
147554148|NCT01073020|532185501|FG000|Overall Study|Death|0|||
147554149|NCT01073020|532185502|FG001|Overall Study|Death|1|||
147554150|NCT01073020|532185503|FG002|Overall Study|Death|0|||
147554151|NCT01073020|532185504|FG003|Overall Study|Death|0|||
147554152|NCT01644890|532185505|FG000|Overall Study|Adverse Event|7|||
147554153|NCT01644890|532185506|FG001|Overall Study|Adverse Event|20|||
147554154|NCT01644890|532185505|FG000|Overall Study|Death|1|||
147554155|NCT01644890|532185506|FG001|Overall Study|Death|3|||
147554156|NCT01644890|532185505|FG000|Overall Study|Physician Decision|3|||
147554157|NCT01644890|532185506|FG001|Overall Study|Physician Decision|9|||
147554158|NCT01644890|532185505|FG000|Overall Study|Protocol Violation|6|||
147554159|NCT01644890|532185506|FG001|Overall Study|Protocol Violation|7|||
147554160|NCT01644890|532185505|FG000|Overall Study|Withdrawal by Subject|19|||
147554161|NCT01644890|532185506|FG001|Overall Study|Withdrawal by Subject|27|||
147554162|NCT01644890|532185505|FG000|Overall Study|Progression Disease|160|||
147554163|NCT01644890|532185506|FG001|Overall Study|Progression Disease|131|||
147554164|NCT01644890|532185505|FG000|Overall Study|Clinical Progression|6|||
147554165|NCT01644890|532185506|FG001|Overall Study|Clinical Progression|6|||
147554166|NCT01644890|532185505|FG000|Overall Study|> 28 days since last dose of study drug|6|||
147554167|NCT01644890|532185506|FG001|Overall Study|> 28 days since last dose of study drug|3|||
147554168|NCT01644890|532185505|FG000|Overall Study|Other|8|||
147554169|NCT01644890|532185506|FG001|Overall Study|Other|9|||
147554170|NCT03031899|532185511|FG000|Overall Study|Protocol Violation|1|||
147554171|NCT03031899|532185511|FG000|Overall Study|lesion disappeared after stopping habit|1|||
147554172|NCT01060670|532185512|FG000|Run In|screen failure|0|||
147554173|NCT01060670|532185513|FG001|Run In|screen failure|238|||
147554174|NCT00094302|532185514|FG000|Overall Study|Lost to Follow-up|43|||
147554175|NCT00094302|532185515|FG001|Overall Study|Lost to Follow-up|41|||
147554176|NCT00094302|532185514|FG000|Overall Study|Physician Decision|5|||
147554177|NCT00094302|532185515|FG001|Overall Study|Physician Decision|8|||
147554178|NCT00094302|532185514|FG000|Overall Study|Withdrawal by Subject|103|||
147554179|NCT00094302|532185515|FG001|Overall Study|Withdrawal by Subject|111|||
147554180|NCT00094302|532185514|FG000|Overall Study|Death|266|||
147554181|NCT00094302|532185515|FG001|Overall Study|Death|246|||
147554182|NCT03705351|532185521|FG000|Overall Study|Study termination|3|||
147554183|NCT03705351|532185521|FG000|Overall Study|Death|1|||
147554184|NCT03705351|532185521|FG000|Overall Study|Lack of Efficacy|2|||
147554185|NCT03705351|532185521|FG000|Overall Study|Withdrawal by Subject|1|||
147554186|NCT02180061|532185526|FG000|Overall Study|Adverse Event|4|||
147554187|NCT02180061|532185527|FG001|Overall Study|Adverse Event|2|||
147554188|NCT02180061|532185526|FG000|Overall Study|Clinical Progression|5|||
147443617|NCT04707157|531788739|FG001|Overall Study|Lost to Follow-up|0|||
147443618|NCT04707157|531788738|FG000|Overall Study|Sponsor's decision|1|||
147443619|NCT04707157|531788739|FG001|Overall Study|Sponsor's decision|0|||
147554189|NCT02180061|532185527|FG001|Overall Study|Clinical Progression|1|||
147554190|NCT02180061|532185526|FG000|Overall Study|Progressive Disease|15|||
147554191|NCT02180061|532185527|FG001|Overall Study|Progressive Disease|5|||
147554192|NCT02180061|532185526|FG000|Overall Study|Physician Decision|1|||
147554193|NCT02180061|532185527|FG001|Overall Study|Physician Decision|0|||
147554194|NCT00056160|532185530|FG000|Up to Unblinding (07 Jun 2005)|Adverse Event|35|||
147554195|NCT00056160|532185531|FG001|Up to Unblinding (07 Jun 2005)|Adverse Event|18|||
147554196|NCT00056160|532185530|FG000|Up to Unblinding (07 Jun 2005)|Progression of disease|57|||
147554197|NCT00056160|532185531|FG001|Up to Unblinding (07 Jun 2005)|Progression of disease|124|||
147554198|NCT00056160|532185530|FG000|Up to Unblinding (07 Jun 2005)|Lack of Efficacy|3|||
147554199|NCT00056160|532185531|FG001|Up to Unblinding (07 Jun 2005)|Lack of Efficacy|5|||
147554200|NCT00056160|532185530|FG000|Up to Unblinding (07 Jun 2005)|Withdrawal by Subject|8|||
147554201|NCT00056160|532185531|FG001|Up to Unblinding (07 Jun 2005)|Withdrawal by Subject|8|||
147554202|NCT00056160|532185530|FG000|Up to Unblinding (07 Jun 2005)|Death|2|||
147554203|NCT00056160|532185531|FG001|Up to Unblinding (07 Jun 2005)|Death|1|||
147554204|NCT00056160|532185530|FG000|Up to Unblinding (07 Jun 2005)|Other|8|||
147554205|NCT00056160|532185531|FG001|Up to Unblinding (07 Jun 2005)|Other|7|||
147554206|NCT00056160|532185530|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Adverse Event|44|||
147223611|NCT03139604|530990640|FG001|Overall Study|Physician Decision|2|||
147223612|NCT03139604|530990639|FG000|Overall Study|Lost to Follow-up|3|||
147223613|NCT03139604|530990640|FG001|Overall Study|Lost to Follow-up|1|||
147223614|NCT03139604|530990639|FG000|Overall Study|Death|65|||
147223615|NCT03139604|530990640|FG001|Overall Study|Death|67|||
147223616|NCT03139604|530990639|FG000|Overall Study|Study Terminated by Sponsor|122|||
147223617|NCT03139604|530990640|FG001|Overall Study|Study Terminated by Sponsor|127|||
147223618|NCT03139604|530990639|FG000|Overall Study|Final EOS data missing due to COVID-19 restrictions that affected on-site monitoring|5|||
147223619|NCT03139604|530990640|FG001|Overall Study|Final EOS data missing due to COVID-19 restrictions that affected on-site monitoring|3|||
147223620|NCT00740246|530990644|FG000|Overall Study|Received Blood Transfusion|0|||
147223621|NCT00740246|530990645|FG001|Overall Study|Received Blood Transfusion|1|||
147223622|NCT00740246|530990644|FG000|Overall Study|Adverse Event|1|||
147223623|NCT00740246|530990645|FG001|Overall Study|Adverse Event|2|||
147223624|NCT00740246|530990644|FG000|Overall Study|Selection Criteria/Study Compliance|2|||
147223625|NCT00740246|530990645|FG001|Overall Study|Selection Criteria/Study Compliance|0|||
147223626|NCT00740246|530990644|FG000|Overall Study|Lost to Follow-up|2|||
147223627|NCT00740246|530990645|FG001|Overall Study|Lost to Follow-up|2|||
147223628|NCT00740246|530990644|FG000|Overall Study|Withdrawal by Subject|4|||
147223629|NCT00740246|530990645|FG001|Overall Study|Withdrawal by Subject|3|||
147223630|NCT00740246|530990644|FG000|Overall Study|Withdrawn By Site Due To non-compliance|1|||
147223631|NCT00740246|530990645|FG001|Overall Study|Withdrawn By Site Due To non-compliance|0|||
147223632|NCT00740246|530990644|FG000|Overall Study|Discontinued Due To Hurricane Related Issue|1|||
147223633|NCT00740246|530990645|FG001|Overall Study|Discontinued Due To Hurricane Related Issue|1|||
147223634|NCT00740246|530990644|FG000|Overall Study|Unable To Perform Venipuncture For Day 7, Day 14 Labs, and Day 7 Infusion|1|||
147223635|NCT00740246|530990645|FG001|Overall Study|Unable To Perform Venipuncture For Day 7, Day 14 Labs, and Day 7 Infusion|0|||
147223636|NCT00740246|530990644|FG000|Overall Study|Unable To Comply With Study Visits|2|||
147223637|NCT00740246|530990645|FG001|Overall Study|Unable To Comply With Study Visits|0|||
147223638|NCT00740246|530990644|FG000|Overall Study|Unable to Access Vein|0|||
147223639|NCT00740246|530990645|FG001|Overall Study|Unable to Access Vein|2|||
147223640|NCT00740246|530990644|FG000|Overall Study|Early Term - Patient could not return for second infusion due to Thanksgiving Holiday|0|||
147223641|NCT00740246|530990645|FG001|Overall Study|Early Term - Patient could not return for second infusion due to Thanksgiving Holiday|1|||
147223642|NCT00662532|530990649|FG000|Overall Study|Adverse Event|0|||
147223643|NCT00662532|530990650|FG001|Overall Study|Adverse Event|1|||
147223644|NCT00662532|530990649|FG000|Overall Study|Lost to Follow-up|0|||
147223645|NCT00662532|530990650|FG001|Overall Study|Lost to Follow-up|1|||
147223646|NCT00366340|530990651|FG000|Infant Series|Protocol Violation|3|||
147223647|NCT00366340|530990652|FG001|Infant Series|Protocol Violation|4|||
147223648|NCT00366340|530990651|FG000|Infant Series|Withdrawal by Subject|3|||
147223649|NCT00366340|530990652|FG001|Infant Series|Withdrawal by Subject|3|||
147223650|NCT00366340|530990651|FG000|Infant Series|Adverse Event|0|||
147223651|NCT00366340|530990652|FG001|Infant Series|Adverse Event|2|||
147223652|NCT00366340|530990651|FG000|Infant Series|Lost to Follow-up|1|||
147223653|NCT00366340|530990652|FG001|Infant Series|Lost to Follow-up|1|||
147223654|NCT00366340|530990651|FG000|Infant Series|Failure to return|1|||
147223655|NCT00366340|530990652|FG001|Infant Series|Failure to return|0|||
147223656|NCT00366340|530990651|FG000|After the Infant Series|Parent/legal guardian request|1|||
147223657|NCT00366340|530990652|FG001|After the Infant Series|Parent/legal guardian request|1|||
147223658|NCT00366340|530990651|FG000|After the Infant Series|Failed to return|0|||
147223659|NCT00366340|530990652|FG001|After the Infant Series|Failed to return|1|||
147223660|NCT00366340|530990651|FG000|After the Infant Series|Protocol Violation|2|||
147223661|NCT00366340|530990652|FG001|After the Infant Series|Protocol Violation|2|||
147223662|NCT00366340|530990651|FG000|After the Infant Series|Adverse Event|0|||
147223663|NCT00366340|530990652|FG001|After the Infant Series|Adverse Event|1|||
147223664|NCT00366340|530990651|FG000|After the Infant Series|Lost to Follow-up|0|||
147223665|NCT00366340|530990652|FG001|After the Infant Series|Lost to Follow-up|1|||
147223666|NCT00366340|530990651|FG000|Toddler Dose|Failed to return|1|||
147223667|NCT00366340|530990652|FG001|Toddler Dose|Failed to return|0|||
147223668|NCT00366340|530990651|FG000|Toddler Dose|Parent/legal guardian request|0|||
147554207|NCT00056160|532185531|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Adverse Event|0|||
147309633|NCT04986982|531300122|FG000|Overall Study|Lost to Follow-up|0|||
147309634|NCT04986982|531300123|FG001|Overall Study|Lost to Follow-up|1|||
147309635|NCT04986982|531300122|FG000|Overall Study|Sponsor's discretion|1|||
147309636|NCT04986982|531300123|FG001|Overall Study|Sponsor's discretion|0|||
147223669|NCT00366340|530990652|FG001|Toddler Dose|Parent/legal guardian request|1|||
147223670|NCT00442468|530990653|FG000|Overall Study|Adverse Event|4|||
147223671|NCT00442468|530990653|FG000|Overall Study|Withdrawal by Subject|91|||
147223672|NCT00442468|530990653|FG000|Overall Study|Did not complete all study procedures|88|||
147223673|NCT00589784|530990654|FG000|Overall Study|Withdrawal by Subject|0|||
147223674|NCT00589784|530990655|FG001|Overall Study|Withdrawal by Subject|6|||
147223675|NCT00589784|530990654|FG000|Overall Study|Patient inevaluable|1|||
147223676|NCT00589784|530990655|FG001|Overall Study|Patient inevaluable|0|||
147223677|NCT00589784|530990654|FG000|Overall Study|Adverse Event|0|||
147223678|NCT00589784|530990655|FG001|Overall Study|Adverse Event|4|||
147223679|NCT03823378|530990656|FG000|Overall Study|Adverse Event|2|||
147223680|NCT03823378|530990657|FG001|Overall Study|Adverse Event|2|||
147223681|NCT03823378|530990658|FG002|Overall Study|Adverse Event|0|||
147223682|NCT03823378|530990659|FG003|Overall Study|Adverse Event|0|||
147223683|NCT03823378|530990660|FG004|Overall Study|Adverse Event|0|||
147223684|NCT03823378|530990661|FG005|Overall Study|Adverse Event|0|||
147223685|NCT03823378|530990656|FG000|Overall Study|Lost to Follow-up|0|||
147223686|NCT03823378|530990657|FG001|Overall Study|Lost to Follow-up|1|||
147223687|NCT03823378|530990658|FG002|Overall Study|Lost to Follow-up|0|||
147223688|NCT03823378|530990659|FG003|Overall Study|Lost to Follow-up|0|||
147223689|NCT03823378|530990660|FG004|Overall Study|Lost to Follow-up|1|||
147223690|NCT03823378|530990661|FG005|Overall Study|Lost to Follow-up|0|||
147223691|NCT03823378|530990656|FG000|Overall Study|Withdrawal by Subject|0|||
147223692|NCT03823378|530990657|FG001|Overall Study|Withdrawal by Subject|1|||
147223693|NCT03823378|530990658|FG002|Overall Study|Withdrawal by Subject|4|||
147223694|NCT03823378|530990659|FG003|Overall Study|Withdrawal by Subject|2|||
147223695|NCT03823378|530990660|FG004|Overall Study|Withdrawal by Subject|0|||
147223696|NCT03823378|530990661|FG005|Overall Study|Withdrawal by Subject|1|||
147223697|NCT03823378|530990656|FG000|Overall Study|Other, not specified|19|||
147223698|NCT03823378|530990657|FG001|Overall Study|Other, not specified|12|||
147223699|NCT03823378|530990658|FG002|Overall Study|Other, not specified|6|||
147223700|NCT03823378|530990659|FG003|Overall Study|Other, not specified|8|||
147223701|NCT03823378|530990660|FG004|Overall Study|Other, not specified|17|||
147223702|NCT03823378|530990661|FG005|Overall Study|Other, not specified|7|||
147223703|NCT01606254|530990662|FG000|Overall Study|Withdrawal by Subject|1|||
147223704|NCT01606254|530990663|FG001|Overall Study|Withdrawal by Subject|3|||
147223705|NCT01606254|530990664|FG002|Overall Study|Withdrawal by Subject|0|||
147223706|NCT01606254|530990665|FG003|Overall Study|Withdrawal by Subject|2|||
147223707|NCT01606254|530990662|FG000|Overall Study|Adverse Event|1|||
147223708|NCT01606254|530990663|FG001|Overall Study|Adverse Event|1|||
147223709|NCT01606254|530990664|FG002|Overall Study|Adverse Event|0|||
147223710|NCT01606254|530990665|FG003|Overall Study|Adverse Event|1|||
147223711|NCT01056380|530990666|FG000|Overall Study|Lost to Follow-up|2|||
147223712|NCT01056380|530990667|FG001|Overall Study|Lost to Follow-up|3|||
147223713|NCT03189381|530990668|FG000|Overall Study|Death|1|||
147223714|NCT03189381|530990669|FG001|Overall Study|Death|0|||
147223715|NCT01975831|530990670|FG000|Overall Study|Adverse Event|1|||
147223716|NCT01975831|530990671|FG001|Overall Study|Adverse Event|2|||
147223717|NCT01975831|530990672|FG002|Overall Study|Adverse Event|2|||
147223718|NCT01975831|530990673|FG003|Overall Study|Adverse Event|0|||
147223719|NCT01975831|530990674|FG004|Overall Study|Adverse Event|1|||
147223720|NCT01975831|530990675|FG005|Overall Study|Adverse Event|1|||
147223721|NCT01975831|530990676|FG006|Overall Study|Adverse Event|3|||
147223722|NCT01975831|530990677|FG007|Overall Study|Adverse Event|4|||
147223723|NCT01975831|530990678|FG008|Overall Study|Adverse Event|1|||
147223724|NCT01975831|530990670|FG000|Overall Study|Death|1|||
147223725|NCT01975831|530990671|FG001|Overall Study|Death|1|||
147223726|NCT01975831|530990672|FG002|Overall Study|Death|0|||
147223727|NCT01975831|530990673|FG003|Overall Study|Death|0|||
147223728|NCT01975831|530990674|FG004|Overall Study|Death|1|||
147223729|NCT01975831|530990675|FG005|Overall Study|Death|0|||
147223730|NCT01975831|530990676|FG006|Overall Study|Death|1|||
147223731|NCT01975831|530990677|FG007|Overall Study|Death|0|||
147223732|NCT01975831|530990678|FG008|Overall Study|Death|0|||
147223733|NCT01975831|530990670|FG000|Overall Study|Progressive Disease|1|||
147223734|NCT01975831|530990671|FG001|Overall Study|Progressive Disease|3|||
147223735|NCT01975831|530990672|FG002|Overall Study|Progressive Disease|2|||
147223736|NCT01975831|530990673|FG003|Overall Study|Progressive Disease|4|||
147223737|NCT01975831|530990674|FG004|Overall Study|Progressive Disease|13|||
147223738|NCT01975831|530990675|FG005|Overall Study|Progressive Disease|9|||
147223739|NCT01975831|530990676|FG006|Overall Study|Progressive Disease|10|||
147223740|NCT01975831|530990677|FG007|Overall Study|Progressive Disease|8|||
147223741|NCT01975831|530990678|FG008|Overall Study|Progressive Disease|10|||
147223742|NCT01975831|530990670|FG000|Overall Study|Withdrawal by Subject|0|||
147223743|NCT01975831|530990671|FG001|Overall Study|Withdrawal by Subject|3|||
147309637|NCT03679767|531300124|FG000|Overall Study|Death|16|||
147554208|NCT00056160|532185530|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Progression of disease|87|||
147223744|NCT01975831|530990672|FG002|Overall Study|Withdrawal by Subject|0|||
147223745|NCT01975831|530990673|FG003|Overall Study|Withdrawal by Subject|0|||
147223746|NCT01975831|530990674|FG004|Overall Study|Withdrawal by Subject|3|||
147554209|NCT00056160|532185531|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Progression of disease|0|||
147554210|NCT00056160|532185530|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Lack of Efficacy|3|||
147554211|NCT00056160|532185531|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Lack of Efficacy|0|||
147554212|NCT00056160|532185530|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Withdrawal by Subject|11|||
147554213|NCT00056160|532185531|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Withdrawal by Subject|0|||
147554214|NCT00056160|532185530|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Death|5|||
147223747|NCT01975831|530990675|FG005|Overall Study|Withdrawal by Subject|1|||
147223748|NCT01975831|530990676|FG006|Overall Study|Withdrawal by Subject|1|||
147223749|NCT01975831|530990677|FG007|Overall Study|Withdrawal by Subject|0|||
147223750|NCT01975831|530990678|FG008|Overall Study|Withdrawal by Subject|0|||
147223751|NCT01975831|530990670|FG000|Overall Study|Physician Decision|0|||
147223752|NCT01975831|530990671|FG001|Overall Study|Physician Decision|0|||
147223753|NCT01975831|530990672|FG002|Overall Study|Physician Decision|0|||
147223754|NCT01975831|530990673|FG003|Overall Study|Physician Decision|0|||
147223755|NCT01975831|530990674|FG004|Overall Study|Physician Decision|0|||
147223756|NCT01975831|530990675|FG005|Overall Study|Physician Decision|1|||
147223757|NCT01975831|530990676|FG006|Overall Study|Physician Decision|0|||
147223758|NCT01975831|530990677|FG007|Overall Study|Physician Decision|1|||
147223759|NCT01975831|530990678|FG008|Overall Study|Physician Decision|0|||
147223760|NCT01975831|530990670|FG000|Overall Study|Initiation of Subsequent Therapy|0|||
147223761|NCT01975831|530990671|FG001|Overall Study|Initiation of Subsequent Therapy|0|||
147223762|NCT01975831|530990672|FG002|Overall Study|Initiation of Subsequent Therapy|0|||
147223763|NCT01975831|530990673|FG003|Overall Study|Initiation of Subsequent Therapy|0|||
147223764|NCT01975831|530990674|FG004|Overall Study|Initiation of Subsequent Therapy|0|||
147223765|NCT01975831|530990675|FG005|Overall Study|Initiation of Subsequent Therapy|1|||
147223766|NCT01975831|530990676|FG006|Overall Study|Initiation of Subsequent Therapy|0|||
147223767|NCT01975831|530990677|FG007|Overall Study|Initiation of Subsequent Therapy|2|||
147223768|NCT01975831|530990678|FG008|Overall Study|Initiation of Subsequent Therapy|0|||
147223769|NCT01975831|530990670|FG000|Overall Study|Entered Hospice|0|||
147223770|NCT01975831|530990671|FG001|Overall Study|Entered Hospice|0|||
147223771|NCT01975831|530990672|FG002|Overall Study|Entered Hospice|0|||
147223772|NCT01975831|530990673|FG003|Overall Study|Entered Hospice|0|||
147223773|NCT01975831|530990674|FG004|Overall Study|Entered Hospice|0|||
147223774|NCT01975831|530990675|FG005|Overall Study|Entered Hospice|1|||
147223775|NCT01975831|530990676|FG006|Overall Study|Entered Hospice|0|||
147223776|NCT01975831|530990677|FG007|Overall Study|Entered Hospice|0|||
147223777|NCT01975831|530990678|FG008|Overall Study|Entered Hospice|0|||
147223778|NCT01975831|530990670|FG000|Overall Study|Unable to Treat Within Protocol Windows|0|||
147223779|NCT01975831|530990671|FG001|Overall Study|Unable to Treat Within Protocol Windows|0|||
147223780|NCT01975831|530990672|FG002|Overall Study|Unable to Treat Within Protocol Windows|0|||
147223781|NCT01975831|530990673|FG003|Overall Study|Unable to Treat Within Protocol Windows|0|||
147223782|NCT01975831|530990674|FG004|Overall Study|Unable to Treat Within Protocol Windows|0|||
147223783|NCT01975831|530990675|FG005|Overall Study|Unable to Treat Within Protocol Windows|0|||
147223784|NCT01975831|530990676|FG006|Overall Study|Unable to Treat Within Protocol Windows|1|||
147223785|NCT01975831|530990677|FG007|Overall Study|Unable to Treat Within Protocol Windows|0|||
147223786|NCT01975831|530990678|FG008|Overall Study|Unable to Treat Within Protocol Windows|1|||
147223787|NCT01401959|530990679|FG000|Enrolled|Withdrawal by Subject|1|||
147223788|NCT01401959|530990680|FG001|Enrolled|Withdrawal by Subject|0|||
147223789|NCT01401959|530990681|FG002|Enrolled|Withdrawal by Subject|0|||
147223790|NCT01401959|530990679|FG000|Treated|Disease Progression|2|||
147223791|NCT01401959|530990680|FG001|Treated|Disease Progression|2|||
147223792|NCT01401959|530990681|FG002|Treated|Disease Progression|1|||
147223793|NCT01401959|530990679|FG000|Treated|Adverse Event|4|||
147223794|NCT01401959|530990680|FG001|Treated|Adverse Event|3|||
147223795|NCT01401959|530990681|FG002|Treated|Adverse Event|2|||
147223796|NCT01401959|530990679|FG000|Treated|Withdrawal by Subject|1|||
147223797|NCT01401959|530990680|FG001|Treated|Withdrawal by Subject|2|||
147223798|NCT01401959|530990681|FG002|Treated|Withdrawal by Subject|2|||
147223799|NCT01401959|530990679|FG000|Treated|Protocol Violation|0|||
147223800|NCT01401959|530990680|FG001|Treated|Protocol Violation|1|||
147223801|NCT01401959|530990681|FG002|Treated|Protocol Violation|0|||
147223802|NCT00251004|530990682|FG000|Overall Study|Withdrawal by Subject|23|||
147223803|NCT00251004|530990683|FG001|Overall Study|Withdrawal by Subject|16|||
147223804|NCT00251004|530990684|FG002|Overall Study|Withdrawal by Subject|14|||
147223805|NCT00251004|530990682|FG000|Overall Study|Death|9|||
147223806|NCT00251004|530990683|FG001|Overall Study|Death|10|||
147223807|NCT00251004|530990684|FG002|Overall Study|Death|8|||
147223808|NCT00251004|530990682|FG000|Overall Study|Lost to Follow-up|1|||
147223809|NCT00251004|530990683|FG001|Overall Study|Lost to Follow-up|2|||
147223810|NCT00251004|530990684|FG002|Overall Study|Lost to Follow-up|1|||
147223811|NCT00251004|530990682|FG000|Overall Study|Graft Loss|12|||
147223812|NCT00251004|530990683|FG001|Overall Study|Graft Loss|13|||
147223813|NCT00251004|530990684|FG002|Overall Study|Graft Loss|8|||
147223814|NCT02694718|530990689|FG000|Overall Study|Death|1|||
147223815|NCT02694718|530990689|FG000|Overall Study|Withdrawal by Subject|1|||
147223816|NCT02925793|530990690|FG000|Overall Study|Adverse Event|3|||
147223817|NCT02925793|530990691|FG001|Overall Study|Adverse Event|3|||
147223818|NCT02925793|530990692|FG002|Overall Study|Adverse Event|6|||
147223819|NCT02925793|530990690|FG000|Overall Study|Withdrawal by Subject|16|||
147223820|NCT02925793|530990691|FG001|Overall Study|Withdrawal by Subject|15|||
147223821|NCT02925793|530990692|FG002|Overall Study|Withdrawal by Subject|13|||
147223822|NCT02925793|530990690|FG000|Overall Study|Investigator Discretion|0|||
147223823|NCT02925793|530990691|FG001|Overall Study|Investigator Discretion|1|||
147223824|NCT02925793|530990692|FG002|Overall Study|Investigator Discretion|1|||
147223825|NCT02925793|530990690|FG000|Overall Study|Lost to Follow-up|2|||
147223826|NCT02925793|530990691|FG001|Overall Study|Lost to Follow-up|3|||
147223827|NCT02925793|530990692|FG002|Overall Study|Lost to Follow-up|1|||
147223828|NCT02925793|530990690|FG000|Overall Study|Lack of Efficacy|2|||
147223829|NCT02925793|530990691|FG001|Overall Study|Lack of Efficacy|6|||
147223830|NCT02925793|530990692|FG002|Overall Study|Lack of Efficacy|4|||
147223831|NCT02925793|530990690|FG000|Overall Study|Other:|2|||
147223832|NCT02925793|530990691|FG001|Overall Study|Other:|1|||
147223833|NCT02925793|530990692|FG002|Overall Study|Other:|3|||
147223834|NCT01244490|530990693|FG000|Overall Study|Lack of Efficacy|14|||
147223835|NCT01244490|530990694|FG001|Overall Study|Lack of Efficacy|5|||
147223836|NCT01244490|530990695|FG002|Overall Study|Lack of Efficacy|5|||
147223837|NCT01244490|530990693|FG000|Overall Study|Withdrawal by Subject|4|||
147223838|NCT01244490|530990694|FG001|Overall Study|Withdrawal by Subject|4|||
147223839|NCT01244490|530990695|FG002|Overall Study|Withdrawal by Subject|9|||
147223840|NCT01244490|530990693|FG000|Overall Study|Adverse Event|1|||
147223841|NCT01244490|530990694|FG001|Overall Study|Adverse Event|9|||
147223842|NCT01244490|530990695|FG002|Overall Study|Adverse Event|5|||
147223843|NCT01244490|530990693|FG000|Overall Study|Lost to Follow-up|0|||
147223844|NCT01244490|530990694|FG001|Overall Study|Lost to Follow-up|6|||
147223845|NCT01244490|530990695|FG002|Overall Study|Lost to Follow-up|3|||
147223846|NCT01244490|530990693|FG000|Overall Study|Other|0|||
147223847|NCT01244490|530990694|FG001|Overall Study|Other|0|||
147223848|NCT01244490|530990695|FG002|Overall Study|Other|1|||
147223849|NCT00393042|530990696|FG000|First Intervention|Withdrawal by Subject|1|||
147223850|NCT00393042|530990697|FG001|First Intervention|Withdrawal by Subject|2|||
147223851|NCT00393042|530990696|FG000|First Intervention|Lost to Follow-up|3|||
147223852|NCT00393042|530990697|FG001|First Intervention|Lost to Follow-up|3|||
147223853|NCT00393042|530990696|FG000|First Intervention|Protocol Violation|1|||
147223854|NCT00393042|530990697|FG001|First Intervention|Protocol Violation|0|||
147223855|NCT00393042|530990696|FG000|First Intervention|Adverse Event|0|||
147223856|NCT00393042|530990697|FG001|First Intervention|Adverse Event|1|||
147223857|NCT00393042|530990696|FG000|Second Intervetion|Adverse Event|0|||
147223858|NCT00393042|530990697|FG001|Second Intervetion|Adverse Event|3|||
147223859|NCT00393042|530990696|FG000|Second Intervetion|Withdrawal by Subject|0|||
147223860|NCT00393042|530990697|FG001|Second Intervetion|Withdrawal by Subject|2|||
147223861|NCT00393042|530990696|FG000|Second Intervetion|Lack of Efficacy|1|||
147223862|NCT00393042|530990697|FG001|Second Intervetion|Lack of Efficacy|0|||
147223863|NCT00393042|530990696|FG000|Second Intervetion|Lost to Follow-up|0|||
147223864|NCT00393042|530990697|FG001|Second Intervetion|Lost to Follow-up|2|||
147223865|NCT00393042|530990696|FG000|Second Intervetion|Protocol Violation|1|||
147223866|NCT00393042|530990697|FG001|Second Intervetion|Protocol Violation|1|||
147223867|NCT03324581|530990703|FG000|Overall Study|Adverse Event|18|||
147223868|NCT03324581|530990704|FG001|Overall Study|Adverse Event|11|||
147223869|NCT03324581|530990705|FG002|Overall Study|Adverse Event|7|||
147223870|NCT03324581|530990703|FG000|Overall Study|Lack of Efficacy|0|||
147223871|NCT03324581|530990704|FG001|Overall Study|Lack of Efficacy|1|||
147223872|NCT03324581|530990705|FG002|Overall Study|Lack of Efficacy|0|||
147223873|NCT03324581|530990703|FG000|Overall Study|Lost to Follow-up|5|||
147223874|NCT03324581|530990704|FG001|Overall Study|Lost to Follow-up|3|||
147223875|NCT03324581|530990705|FG002|Overall Study|Lost to Follow-up|6|||
147223876|NCT03324581|530990703|FG000|Overall Study|Non-Compliance With Investigational Medicinal Product (IMP)|2|||
147223877|NCT03324581|530990704|FG001|Overall Study|Non-Compliance With Investigational Medicinal Product (IMP)|2|||
147223878|NCT03324581|530990705|FG002|Overall Study|Non-Compliance With Investigational Medicinal Product (IMP)|0|||
147223879|NCT03324581|530990703|FG000|Overall Study|Physician Decision|0|||
147223880|NCT03324581|530990704|FG001|Overall Study|Physician Decision|1|||
147223881|NCT03324581|530990705|FG002|Overall Study|Physician Decision|2|||
147223882|NCT03324581|530990703|FG000|Overall Study|Protocol Deviation|8|||
147223883|NCT03324581|530990704|FG001|Overall Study|Protocol Deviation|9|||
147443620|NCT04707157|531788738|FG000|Overall Study|Physician Decision|8|||
147223884|NCT03324581|530990705|FG002|Overall Study|Protocol Deviation|4|||
147223885|NCT03324581|530990703|FG000|Overall Study|Withdrawal by Subject|6|||
147223886|NCT03324581|530990704|FG001|Overall Study|Withdrawal by Subject|8|||
147223887|NCT03324581|530990705|FG002|Overall Study|Withdrawal by Subject|6|||
147223888|NCT03324581|530990703|FG000|Overall Study|Day 56 Visit was 15 Days Out of the Visit Window|0|||
147223889|NCT03324581|530990704|FG001|Overall Study|Day 56 Visit was 15 Days Out of the Visit Window|1|||
147223890|NCT03324581|530990705|FG002|Overall Study|Day 56 Visit was 15 Days Out of the Visit Window|0|||
147223891|NCT00321893|530990707|FG000|Overall Study|Non-Compliance/Refusal|16|||
147223892|NCT00321893|530990708|FG001|Overall Study|Non-Compliance/Refusal|10|||
147223893|NCT00321893|530990707|FG000|Overall Study|Lost to Follow-up|2|||
147223894|NCT00321893|530990708|FG001|Overall Study|Lost to Follow-up|1|||
147223895|NCT00321893|530990707|FG000|Overall Study|Adverse Event|6|||
147223896|NCT00321893|530990708|FG001|Overall Study|Adverse Event|3|||
147223897|NCT03455764|530990709|FG000|Overall Study|Adverse Event|1|||
147223898|NCT03455764|530990710|FG001|Overall Study|Adverse Event|0|||
147223899|NCT03455764|530990711|FG002|Overall Study|Adverse Event|0|||
147223900|NCT03455764|530990712|FG003|Overall Study|Adverse Event|0|||
147223901|NCT03455764|530990713|FG004|Overall Study|Adverse Event|0|||
147223902|NCT03455764|530990709|FG000|Overall Study|Disease Progression|4|||
147223903|NCT03455764|530990710|FG001|Overall Study|Disease Progression|0|||
147223904|NCT03455764|530990711|FG002|Overall Study|Disease Progression|0|||
147223905|NCT03455764|530990712|FG003|Overall Study|Disease Progression|0|||
147223906|NCT03455764|530990713|FG004|Overall Study|Disease Progression|0|||
147554215|NCT00056160|532185531|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Death|0|||
147223907|NCT03455764|530990709|FG000|Overall Study|On Treatment|1|||
147223908|NCT03455764|530990710|FG001|Overall Study|On Treatment|0|||
147223909|NCT03455764|530990711|FG002|Overall Study|On Treatment|0|||
147223910|NCT03455764|530990712|FG003|Overall Study|On Treatment|0|||
147554216|NCT00056160|532185530|FG000|Extended Follow-up Cutoff (23 Jul 2008)|Other|21|||
147554217|NCT00056160|532185531|FG001|Extended Follow-up Cutoff (23 Jul 2008)|Other|0|||
147554218|NCT00056160|532185530|FG000|Final Follow-up|Transferred into expanded access study.|3|||
147554219|NCT00056160|532185531|FG001|Final Follow-up|Transferred into expanded access study.|0|||
147554220|NCT00056160|532185530|FG000|Final Follow-up|Transferred into RevAssist Program|2|||
147554221|NCT00056160|532185531|FG001|Final Follow-up|Transferred into RevAssist Program|0|||
147554222|NCT00056160|532185530|FG000|Final Follow-up|Adverse Event|1|||
147554223|NCT00056160|532185531|FG001|Final Follow-up|Adverse Event|0|||
147554224|NCT01469364|532185533|FG000|Overall Study|Adverse Event|1|||
147554225|NCT01469364|532185533|FG000|Overall Study|Withdrawal by Subject|1|||
147223911|NCT03455764|530990713|FG004|Overall Study|On Treatment|0|||
147223912|NCT03523000|530990714|FG000|Overall Study|Withdrawal by Subject|3|||
147223913|NCT03523000|530990715|FG001|Overall Study|Withdrawal by Subject|0|||
147223914|NCT03523000|530990714|FG000|Overall Study|Unsuccessful trial|2|||
147223915|NCT03523000|530990715|FG001|Overall Study|Unsuccessful trial|0|||
147223916|NCT00495131|530990716|FG000|Overall Study|Adverse Event|6|||
147223917|NCT00495131|530990717|FG001|Overall Study|Adverse Event|2|||
147223918|NCT00495131|530990716|FG000|Overall Study|Lack of Efficacy|0|||
147223919|NCT00495131|530990717|FG001|Overall Study|Lack of Efficacy|2|||
147223920|NCT00495131|530990716|FG000|Overall Study|Lost to Follow-up|0|||
147223921|NCT00495131|530990717|FG001|Overall Study|Lost to Follow-up|2|||
147223922|NCT00495131|530990716|FG000|Overall Study|Withdrawal by Subject|1|||
147223923|NCT00495131|530990717|FG001|Overall Study|Withdrawal by Subject|0|||
147223924|NCT00727532|530990718|FG000|Overall Study|Adverse Event|1|||
147223925|NCT00727532|530990718|FG000|Overall Study|Withdrawal by Subject|1|||
147223926|NCT00829933|530990719|FG000|Overall Study|Adverse Event|2|||
147223927|NCT00829933|530990720|FG001|Overall Study|Adverse Event|3|||
147223928|NCT00829933|530990721|FG002|Overall Study|Adverse Event|2|||
147223929|NCT00829933|530990722|FG003|Overall Study|Adverse Event|1|||
147223930|NCT00829933|530990719|FG000|Overall Study|Death|0|||
147223931|NCT00829933|530990720|FG001|Overall Study|Death|0|||
147223932|NCT00829933|530990721|FG002|Overall Study|Death|1|||
147223933|NCT00829933|530990722|FG003|Overall Study|Death|1|||
147223934|NCT00829933|530990719|FG000|Overall Study|Lack of Efficacy|0|||
147223935|NCT00829933|530990720|FG001|Overall Study|Lack of Efficacy|1|||
147223936|NCT00829933|530990721|FG002|Overall Study|Lack of Efficacy|0|||
147223937|NCT00829933|530990722|FG003|Overall Study|Lack of Efficacy|0|||
147223938|NCT00829933|530990719|FG000|Overall Study|Physician Decision|5|||
147223939|NCT00829933|530990720|FG001|Overall Study|Physician Decision|7|||
147223940|NCT00829933|530990721|FG002|Overall Study|Physician Decision|8|||
147223941|NCT00829933|530990722|FG003|Overall Study|Physician Decision|1|||
147223942|NCT00829933|530990719|FG000|Overall Study|Pregnancy|0|||
147223943|NCT00829933|530990720|FG001|Overall Study|Pregnancy|0|||
147223944|NCT00829933|530990721|FG002|Overall Study|Pregnancy|0|||
147223945|NCT00829933|530990722|FG003|Overall Study|Pregnancy|2|||
147223946|NCT00829933|530990719|FG000|Overall Study|Protocol Violation|2|||
147223947|NCT00829933|530990720|FG001|Overall Study|Protocol Violation|1|||
147223948|NCT00829933|530990721|FG002|Overall Study|Protocol Violation|0|||
147223949|NCT00829933|530990722|FG003|Overall Study|Protocol Violation|0|||
147223950|NCT00829933|530990719|FG000|Overall Study|withdrew before treatment started|5|||
147223951|NCT00829933|530990720|FG001|Overall Study|withdrew before treatment started|1|||
147554226|NCT02742090|532185534|FG000|Overall Study|Adverse Event|10|||
147554227|NCT02742090|532185534|FG000|Overall Study|Death|3|||
147554228|NCT02742090|532185534|FG000|Overall Study|Disease Progression|25|||
147554229|NCT02742090|532185534|FG000|Overall Study|Investigator's Decision|1|||
147554230|NCT02742090|532185534|FG000|Overall Study|Lost to Follow-up|1|||
147223952|NCT00829933|530990721|FG002|Overall Study|withdrew before treatment started|2|||
147223953|NCT00829933|530990722|FG003|Overall Study|withdrew before treatment started|9|||
147223954|NCT00523367|530990723|FG000|Overall Study|19 screen failures|19|||
147223955|NCT00523367|530990723|FG000|Overall Study|4 Withdrawn by PI|4|||
147223956|NCT00076024|530993007|FG000|Phase 1, Lead-in|Lack of Efficacy|4|||
147223957|NCT00076024|530993008|FG001|Phase 1, Lead-in|Lack of Efficacy|0|||
147223958|NCT00076024|530993009|FG002|Phase 1, Lead-in|Lack of Efficacy|0|||
147223959|NCT00076024|530993010|FG003|Phase 1, Lead-in|Lack of Efficacy|0|||
147223960|NCT00076024|530993007|FG000|Phase 1, Lead-in|Adverse Event|1|||
147223961|NCT00076024|530993008|FG001|Phase 1, Lead-in|Adverse Event|0|||
147223962|NCT00076024|530993009|FG002|Phase 1, Lead-in|Adverse Event|0|||
147223963|NCT00076024|530993010|FG003|Phase 1, Lead-in|Adverse Event|0|||
147223964|NCT00076024|530993007|FG000|Phase 1, Lead-in|Clinical progression|1|||
147223965|NCT00076024|530993008|FG001|Phase 1, Lead-in|Clinical progression|0|||
147223966|NCT00076024|530993009|FG002|Phase 1, Lead-in|Clinical progression|0|||
147223967|NCT00076024|530993010|FG003|Phase 1, Lead-in|Clinical progression|0|||
147223968|NCT00076024|530993007|FG000|Phase 2, Double-blind|Lack of Efficacy|0|||
147223969|NCT00076024|530993008|FG001|Phase 2, Double-blind|Lack of Efficacy|59|||
147223970|NCT00076024|530993009|FG002|Phase 2, Double-blind|Lack of Efficacy|40|||
147223971|NCT00076024|530993010|FG003|Phase 2, Double-blind|Lack of Efficacy|0|||
147554231|NCT02742090|532185534|FG000|Overall Study|Non-compliance with Study|1|||
147554232|NCT02742090|532185534|FG000|Overall Study|Sponsor Discontinuation of the Study|5|||
147554233|NCT02742090|532185534|FG000|Overall Study|Withdrawal by Subject|4|||
147223972|NCT00076024|530993007|FG000|Phase 2, Double-blind|Withdrawal by Subject|0|||
147223973|NCT00076024|530993008|FG001|Phase 2, Double-blind|Withdrawal by Subject|13|||
147554234|NCT02742090|532185534|FG000|Overall Study|Reason Not Specified|1|||
147554235|NCT01767597|532185535|FG000|Overall Study|Incomplete intervention|3|||
147554236|NCT01767597|532185536|FG001|Overall Study|Incomplete intervention|1|||
147554237|NCT01767597|532185535|FG000|Overall Study|Withdrawal by Subject|1|||
147554238|NCT01767597|532185536|FG001|Overall Study|Withdrawal by Subject|0|||
147554239|NCT03355742|532185537|FG000|Overall Study|Lost to Follow-up|4|||
147554240|NCT03355742|532185537|FG000|Overall Study|Withdrawal by Subject|29|||
147554241|NCT03355742|532185537|FG000|Overall Study|Physician Decision|6|||
147554242|NCT03355742|532185537|FG000|Overall Study|Death|55|||
147554243|NCT03355742|532185537|FG000|Overall Study|Administrative Closure of the Study, Other Status Change Reason, Missed Visit, Protocol Violation|5|||
147554244|NCT00836927|532185540|FG000|Overall Study|Progressive disease|2|||
147554245|NCT00836927|532185541|FG001|Overall Study|Progressive disease|0|||
147554246|NCT00836927|532185542|FG002|Overall Study|Progressive disease|0|||
147554247|NCT00836927|532185543|FG003|Overall Study|Progressive disease|1|||
147554248|NCT00836927|532185544|FG004|Overall Study|Progressive disease|1|||
147554249|NCT00836927|532185540|FG000|Overall Study|Withdrawal by Subject|1|||
147554250|NCT00836927|532185541|FG001|Overall Study|Withdrawal by Subject|0|||
147554251|NCT00836927|532185542|FG002|Overall Study|Withdrawal by Subject|0|||
147554252|NCT00836927|532185543|FG003|Overall Study|Withdrawal by Subject|0|||
147554253|NCT00836927|532185544|FG004|Overall Study|Withdrawal by Subject|0|||
147554254|NCT00614055|532185548|FG000|Overall Study|Adverse Event|1|||
147554255|NCT00614055|532185549|FG001|Overall Study|Adverse Event|0|||
147554256|NCT00614055|532185550|FG002|Overall Study|Adverse Event|0|||
147554257|NCT00614055|532185548|FG000|Overall Study|Protocol Violation|2|||
147554258|NCT00614055|532185549|FG001|Overall Study|Protocol Violation|2|||
147554259|NCT00614055|532185550|FG002|Overall Study|Protocol Violation|1|||
147554260|NCT00614055|532185548|FG000|Overall Study|Lack of Efficacy|0|||
147554261|NCT00614055|532185549|FG001|Overall Study|Lack of Efficacy|0|||
147554262|NCT00614055|532185550|FG002|Overall Study|Lack of Efficacy|2|||
147554263|NCT00614055|532185548|FG000|Overall Study|Unclassified|1|||
147554264|NCT00614055|532185549|FG001|Overall Study|Unclassified|4|||
147554265|NCT00614055|532185550|FG002|Overall Study|Unclassified|2|||
147554266|NCT02710071|532185551|FG000|First Intervention (6 Weeks).|Withdrawal by Subject|3|||
147554267|NCT02710071|532185552|FG001|First Intervention (6 Weeks).|Withdrawal by Subject|4|||
147554268|NCT02710071|532185551|FG000|Second Intervention (6 Weeks).|Withdrawal by Subject|1|||
147554269|NCT02710071|532185552|FG001|Second Intervention (6 Weeks).|Withdrawal by Subject|2|||
147554270|NCT02637557|532185553|FG000|Overall Study|Adverse Event|3|||
147554271|NCT02637557|532185554|FG001|Overall Study|Adverse Event|1|||
147554272|NCT02637557|532185555|FG002|Overall Study|Adverse Event|3|||
147554273|NCT02637557|532185556|FG003|Overall Study|Adverse Event|3|||
147554274|NCT02637557|532185553|FG000|Overall Study|Lost to Follow-up|1|||
147223974|NCT00076024|530993009|FG002|Phase 2, Double-blind|Withdrawal by Subject|4|||
147223975|NCT00076024|530993010|FG003|Phase 2, Double-blind|Withdrawal by Subject|0|||
147223976|NCT00076024|530993007|FG000|Phase 2, Double-blind|Adverse Event|0|||
147223977|NCT00076024|530993008|FG001|Phase 2, Double-blind|Adverse Event|25|||
147223978|NCT00076024|530993009|FG002|Phase 2, Double-blind|Adverse Event|6|||
147223979|NCT00076024|530993010|FG003|Phase 2, Double-blind|Adverse Event|0|||
147223980|NCT00076024|530993007|FG000|Phase 2, Double-blind|Un-specified|0|||
147223981|NCT00076024|530993008|FG001|Phase 2, Double-blind|Un-specified|14|||
147223982|NCT00076024|530993009|FG002|Phase 2, Double-blind|Un-specified|6|||
147223983|NCT00076024|530993010|FG003|Phase 2, Double-blind|Un-specified|0|||
147223984|NCT00076024|530993007|FG000|Phase 2, Double-blind|Randomized but not treated|0|||
147223985|NCT00076024|530993008|FG001|Phase 2, Double-blind|Randomized but not treated|1|||
147223986|NCT00076024|530993009|FG002|Phase 2, Double-blind|Randomized but not treated|0|||
147223987|NCT00076024|530993010|FG003|Phase 2, Double-blind|Randomized but not treated|0|||
147223988|NCT00076024|530993007|FG000|Phase 2, Open-label|Adverse Event|0|||
147223989|NCT00076024|530993008|FG001|Phase 2, Open-label|Adverse Event|0|||
147223990|NCT00076024|530993009|FG002|Phase 2, Open-label|Adverse Event|0|||
147223991|NCT00076024|530993010|FG003|Phase 2, Open-label|Adverse Event|2|||
147223992|NCT00076024|530993007|FG000|Phase 2, Open-label|Lack of Efficacy|0|||
147223993|NCT00076024|530993008|FG001|Phase 2, Open-label|Lack of Efficacy|0|||
147223994|NCT00076024|530993009|FG002|Phase 2, Open-label|Lack of Efficacy|0|||
147223995|NCT00076024|530993010|FG003|Phase 2, Open-label|Lack of Efficacy|11|||
147223996|NCT00076024|530993007|FG000|Phase 2, Open-label|Withdrawal by Subject|0|||
147223997|NCT00076024|530993008|FG001|Phase 2, Open-label|Withdrawal by Subject|0|||
147309638|NCT03679767|531300125|FG001|Overall Study|Death|11|||
147554275|NCT02637557|532185554|FG001|Overall Study|Lost to Follow-up|1|||
147554276|NCT02637557|532185555|FG002|Overall Study|Lost to Follow-up|0|||
147554277|NCT02637557|532185556|FG003|Overall Study|Lost to Follow-up|1|||
147554278|NCT02637557|532185553|FG000|Overall Study|Physician Decision|1|||
147554279|NCT02637557|532185554|FG001|Overall Study|Physician Decision|0|||
147554280|NCT02637557|532185555|FG002|Overall Study|Physician Decision|0|||
147554281|NCT02637557|532185556|FG003|Overall Study|Physician Decision|0|||
147554282|NCT02637557|532185553|FG000|Overall Study|Protocol Violation|2|||
147554283|NCT02637557|532185554|FG001|Overall Study|Protocol Violation|0|||
147554284|NCT02637557|532185555|FG002|Overall Study|Protocol Violation|2|||
147554285|NCT02637557|532185556|FG003|Overall Study|Protocol Violation|1|||
147223998|NCT00076024|530993009|FG002|Phase 2, Open-label|Withdrawal by Subject|0|||
147223999|NCT00076024|530993010|FG003|Phase 2, Open-label|Withdrawal by Subject|1|||
147224000|NCT00076024|530993007|FG000|Phase 2, Open-label|Other|0|||
147224001|NCT00076024|530993008|FG001|Phase 2, Open-label|Other|0|||
147224002|NCT00076024|530993009|FG002|Phase 2, Open-label|Other|0|||
147224003|NCT00076024|530993010|FG003|Phase 2, Open-label|Other|2|||
147224004|NCT00301821|530993017|FG000|Overall Study|Ineligible|25|||
147224005|NCT00301821|530993017|FG000|Overall Study|Cancel|1|||
147224006|NCT02294773|530993018|FG000|Overall Study|Withdrawal by Subject|0|||
147224007|NCT02294773|530993019|FG001|Overall Study|Withdrawal by Subject|2|||
147224008|NCT03052764|530993020|FG000|Double-Blind Treatment Period|Adverse Event|2|||
147224009|NCT03052764|530993021|FG001|Double-Blind Treatment Period|Adverse Event|0|||
147224010|NCT03052764|530993020|FG000|Double-Blind Treatment Period|Lack of Efficacy|1|||
147104456|NCT01401322|530548415|FG000|Overall Study|Withdrawal by Subject|1|||
147104457|NCT01401322|530548415|FG000|Overall Study|Physician Decision|1|||
147104458|NCT00486044|530548416|FG000|Overall Study|Withdrawal by Subject|2|||
147104459|NCT00486044|530548417|FG001|Overall Study|Withdrawal by Subject|1|||
147104460|NCT00486044|530548416|FG000|Overall Study|Adverse Event|0|||
147104461|NCT00486044|530548417|FG001|Overall Study|Adverse Event|1|||
147224011|NCT03052764|530993021|FG001|Double-Blind Treatment Period|Lack of Efficacy|0|||
147224012|NCT03052764|530993020|FG000|Double-Blind Treatment Period|Protocol Violation|2|||
147224013|NCT03052764|530993021|FG001|Double-Blind Treatment Period|Protocol Violation|1|||
147104462|NCT00486044|530548416|FG000|Overall Study|Lost to Follow-up|0|||
147104463|NCT00486044|530548417|FG001|Overall Study|Lost to Follow-up|1|||
147104464|NCT00997893|530548418|FG000|Overall Study|Adverse Event|1|||
147104465|NCT00997893|530548419|FG001|Overall Study|Adverse Event|0|||
147104466|NCT00997893|530548420|FG002|Overall Study|Adverse Event|0|||
147104467|NCT00997893|530548418|FG000|Overall Study|Unable to meet study timelines|1|||
147104468|NCT00997893|530548419|FG001|Overall Study|Unable to meet study timelines|0|||
147104469|NCT00997893|530548420|FG002|Overall Study|Unable to meet study timelines|0|||
147104470|NCT00997893|530548418|FG000|Overall Study|Pain/pain meds during Visit 4|0|||
147104471|NCT00997893|530548419|FG001|Overall Study|Pain/pain meds during Visit 4|1|||
147104472|NCT00997893|530548420|FG002|Overall Study|Pain/pain meds during Visit 4|0|||
147104473|NCT00226655|530548421|FG000|Overall Study|Death|13|||
147104474|NCT00226655|530548421|FG000|Overall Study|Withdrawal by Subject|15|||
147104475|NCT00226655|530548421|FG000|Overall Study|Adverse Event|35|||
147104476|NCT00226655|530548421|FG000|Overall Study|Physician Decision|6|||
147104477|NCT00226655|530548421|FG000|Overall Study|Clinical deterioration|10|||
147104478|NCT00701363|530548422|FG000|Screening (Pre-assignment) Phase|Does not meet entry Criteria|4|||
147104479|NCT00701363|530548423|FG001|Screening (Pre-assignment) Phase|Does not meet entry Criteria|0|||
147104480|NCT00701363|530548424|FG002|Screening (Pre-assignment) Phase|Does not meet entry Criteria|0|||
147104481|NCT00701363|530548425|FG003|Screening (Pre-assignment) Phase|Does not meet entry Criteria|0|||
147104482|NCT00701363|530548422|FG000|Treatment Phase 1|Does not meet entry Criteria|1|||
147104483|NCT00701363|530548423|FG001|Treatment Phase 1|Does not meet entry Criteria|0|||
147104484|NCT00701363|530548424|FG002|Treatment Phase 1|Does not meet entry Criteria|0|||
147104485|NCT00701363|530548425|FG003|Treatment Phase 1|Does not meet entry Criteria|0|||
147104486|NCT00701363|530548422|FG000|Treatment Phase 1|Adverse Event|7|||
147104487|NCT00701363|530548423|FG001|Treatment Phase 1|Adverse Event|0|||
147104488|NCT00701363|530548424|FG002|Treatment Phase 1|Adverse Event|0|||
147104489|NCT00701363|530548425|FG003|Treatment Phase 1|Adverse Event|0|||
147104490|NCT00701363|530548422|FG000|Treatment Phase 1|Protocol Violation|1|||
147104491|NCT00701363|530548423|FG001|Treatment Phase 1|Protocol Violation|0|||
147104492|NCT00701363|530548424|FG002|Treatment Phase 1|Protocol Violation|0|||
147104493|NCT00701363|530548425|FG003|Treatment Phase 1|Protocol Violation|0|||
147104494|NCT00701363|530548422|FG000|Treatment Phase 1|Withdrawal by Subject|5|||
147104495|NCT00701363|530548423|FG001|Treatment Phase 1|Withdrawal by Subject|0|||
147104496|NCT00701363|530548424|FG002|Treatment Phase 1|Withdrawal by Subject|0|||
147104497|NCT00701363|530548425|FG003|Treatment Phase 1|Withdrawal by Subject|0|||
147104498|NCT00701363|530548422|FG000|Treatment Phase 1|Lack of Efficacy|1|||
147104499|NCT00701363|530548423|FG001|Treatment Phase 1|Lack of Efficacy|0|||
147104500|NCT00701363|530548424|FG002|Treatment Phase 1|Lack of Efficacy|0|||
147104501|NCT00701363|530548425|FG003|Treatment Phase 1|Lack of Efficacy|0|||
147104502|NCT00701363|530548422|FG000|Treatment Phase 2|Adverse Event|0|||
147104503|NCT00701363|530548423|FG001|Treatment Phase 2|Adverse Event|0|||
147104504|NCT00701363|530548424|FG002|Treatment Phase 2|Adverse Event|1|||
147104505|NCT00701363|530548425|FG003|Treatment Phase 2|Adverse Event|0|||
147104506|NCT00701363|530548422|FG000|Treatment Phase 2|Withdrawal by Subject|0|||
147104507|NCT00701363|530548423|FG001|Treatment Phase 2|Withdrawal by Subject|0|||
147104508|NCT00701363|530548424|FG002|Treatment Phase 2|Withdrawal by Subject|1|||
147104509|NCT00701363|530548425|FG003|Treatment Phase 2|Withdrawal by Subject|0|||
147104510|NCT04759131|530548426|FG000|Overall Study|Investigator's discretion|1|||
147104511|NCT04759131|530548427|FG001|Overall Study|Investigator's discretion|0|||
147104512|NCT04759131|530548426|FG000|Overall Study|Subject withdrawal|1|||
147104513|NCT04759131|530548427|FG001|Overall Study|Subject withdrawal|0|||
147224014|NCT03052764|530993020|FG000|Double-Blind Treatment Period|Withdrawal by Subject|3|||
147224015|NCT03052764|530993021|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
147224016|NCT03052764|530993020|FG000|Double-Blind Treatment Period|Reason not Specified|2|||
147224017|NCT03052764|530993021|FG001|Double-Blind Treatment Period|Reason not Specified|1|||
147224018|NCT03150485|530993022|FG000|Overall Study|Unsatisfactory Lens Fitting|0|||
147224019|NCT03150485|530993023|FG001|Overall Study|Unsatisfactory Lens Fitting|1|||
147224020|NCT03150485|530993024|FG002|Overall Study|Unsatisfactory Lens Fitting|0|||
147224021|NCT03150485|530993025|FG003|Overall Study|Unsatisfactory Lens Fitting|0|||
147224022|NCT03150485|530993026|FG004|Overall Study|Unsatisfactory Lens Fitting|0|||
147224023|NCT03150485|530993027|FG005|Overall Study|Unsatisfactory Lens Fitting|0|||
147104514|NCT05144945|530548428|FG000|Overall Study|Withdrawal by Subject|1|||
147104515|NCT05144945|530548429|FG001|Overall Study|Withdrawal by Subject|0|||
147104516|NCT05853120|530548430|FG000|Overall Study|Lost to Follow-up|4|||
147224024|NCT05828095|530993029|FG000|Overall Study|Lost to Follow-up|1|||
147224025|NCT05828095|530993030|FG001|Overall Study|Lost to Follow-up|0|||
147224026|NCT05828095|530993029|FG000|Overall Study|Reactogenicity symptom|0|||
147224027|NCT05828095|530993030|FG001|Overall Study|Reactogenicity symptom|1|||
147224028|NCT03206073|530993033|FG000|Overall Study|Participant Noncompliance|0|||
147224029|NCT03206073|530993034|FG001|Overall Study|Participant Noncompliance|1|||
147443621|NCT04707157|531788739|FG001|Overall Study|Physician Decision|5|||
147104517|NCT05853120|530548431|FG001|Overall Study|Lost to Follow-up|4|||
147104518|NCT05853120|530548430|FG000|Overall Study|Physician Decision|3|||
147224030|NCT03206073|530993035|FG002|Overall Study|Participant Noncompliance|0|||
147224031|NCT03206073|530993036|FG003|Overall Study|Participant Noncompliance|0|||
147224032|NCT03206073|530993033|FG000|Overall Study|Unable to complete the dose limiting toxicity period|1|||
147104519|NCT05853120|530548431|FG001|Overall Study|Physician Decision|0|||
147104520|NCT05853120|530548430|FG000|Overall Study|Withdrawal by Subject|5|||
147104521|NCT05853120|530548431|FG001|Overall Study|Withdrawal by Subject|2|||
147104522|NCT02592824|530548433|FG000|Overall Study|Protocol Violation|5|||
147104523|NCT02592824|530548434|FG001|Overall Study|Protocol Violation|3|||
147104524|NCT02592824|530548433|FG000|Overall Study|Lost to Follow-up|2|||
147104525|NCT02592824|530548434|FG001|Overall Study|Lost to Follow-up|1|||
147104526|NCT00465517|530548435|FG000|Overall Study|Adverse Event|7|||
147104527|NCT00465517|530548436|FG001|Overall Study|Adverse Event|3|||
147104528|NCT00465517|530548435|FG000|Overall Study|Lost to Follow-up|1|||
147104529|NCT00465517|530548436|FG001|Overall Study|Lost to Follow-up|0|||
147104530|NCT00465517|530548435|FG000|Overall Study|Withdrawal by Subject|4|||
147104531|NCT00465517|530548436|FG001|Overall Study|Withdrawal by Subject|1|||
147104532|NCT00289276|530548439|FG000|Second Part of FAST Study (Expansion)|Death|0|||
147104533|NCT00289276|530548440|FG001|Second Part of FAST Study (Expansion)|Death|2|||
147104534|NCT00289276|530548439|FG000|Second Part of FAST Study (Expansion)|Lost to Follow-up|0|||
147104535|NCT00289276|530548440|FG001|Second Part of FAST Study (Expansion)|Lost to Follow-up|1|||
147104536|NCT00869960|530548441|FG000|Overall Study|Lost to Follow-up|2|||
147104537|NCT00726609|530548442|FG000|Overall Study|Adverse Event|10|||
147104538|NCT00726609|530548442|FG000|Overall Study|Withdrawal by Subject|2|||
147104539|NCT00726609|530548442|FG000|Overall Study|Lack of Efficacy|25|||
147104540|NCT00726609|530548442|FG000|Overall Study|Other|16|||
147104541|NCT00726609|530548442|FG000|Overall Study|Missing|42|||
147104542|NCT00726609|530548442|FG000|Overall Study|Other|3|||
147104543|NCT00746551|530548448|FG000|At Gestational Age of 36 Weeks|Lost to Follow-up|2|||
147104544|NCT00746551|530548449|FG001|At Gestational Age of 36 Weeks|Lost to Follow-up|4|||
147104545|NCT00746551|530548448|FG000|At Delivery (GA of 39 Weeks)|Lost to Follow-up|9|||
147104546|NCT00746551|530548449|FG001|At Delivery (GA of 39 Weeks)|Lost to Follow-up|7|||
147104547|NCT00746551|530548448|FG000|At Delivery (GA of 39 Weeks)|preterm delivery, delivery elesewhere|6|||
147104548|NCT00746551|530548449|FG001|At Delivery (GA of 39 Weeks)|preterm delivery, delivery elesewhere|8|||
147104549|NCT02029417|530548450|FG000|Overall Study|Death|1|||
147104550|NCT02029417|530548450|FG000|Overall Study|Adverse Event|1|||
147104551|NCT00465179|530548453|FG000|Overall Study|Adverse Event|4|||
147104552|NCT00465179|530548453|FG000|Overall Study|Withdrawal by Subject|2|||
147104553|NCT00465179|530548453|FG000|Overall Study|Progression of Disease|47|||
147104554|NCT05219162|530548457|FG000|Overall Study|Meet exclusion criterion or did not meet inclusion criteria|6|||
147104555|NCT05219162|530548457|FG000|Overall Study|Withdrawal by Subject|23|||
147104556|NCT00171249|530548460|FG000|Overall Study|Withdrawal by Subject|2|||
147104557|NCT00171249|530548461|FG001|Overall Study|Withdrawal by Subject|0|||
147104558|NCT00171249|530548462|FG002|Overall Study|Withdrawal by Subject|0|||
147104559|NCT00171249|530548463|FG003|Overall Study|Withdrawal by Subject|6|||
147104560|NCT00171249|530548464|FG004|Overall Study|Withdrawal by Subject|0|||
147104561|NCT00171249|530548465|FG005|Overall Study|Withdrawal by Subject|0|||
147104562|NCT00171249|530548466|FG006|Overall Study|Withdrawal by Subject|0|||
147224033|NCT03206073|530993034|FG001|Overall Study|Unable to complete the dose limiting toxicity period|0|||
147224034|NCT03206073|530993035|FG002|Overall Study|Unable to complete the dose limiting toxicity period|0|||
147224035|NCT03206073|530993036|FG003|Overall Study|Unable to complete the dose limiting toxicity period|0|||
147224036|NCT03206073|530993033|FG000|Overall Study|Death|0|||
147104563|NCT00171249|530548460|FG000|Overall Study|Unsatisfactory Therapeutic Effect|44|||
147224037|NCT03206073|530993034|FG001|Overall Study|Death|0|||
147224038|NCT03206073|530993035|FG002|Overall Study|Death|1|||
147224039|NCT03206073|530993036|FG003|Overall Study|Death|0|||
147224040|NCT03206073|530993033|FG000|Overall Study|Taken off active treatment|0|||
147224041|NCT03206073|530993034|FG001|Overall Study|Taken off active treatment|0|||
147224042|NCT03206073|530993035|FG002|Overall Study|Taken off active treatment|3|||
147224043|NCT03206073|530993036|FG003|Overall Study|Taken off active treatment|0|||
147309639|NCT03679767|531300126|FG002|Overall Study|Death|17|||
147104564|NCT00171249|530548461|FG001|Overall Study|Unsatisfactory Therapeutic Effect|3|||
147104565|NCT00171249|530548462|FG002|Overall Study|Unsatisfactory Therapeutic Effect|5|||
147104566|NCT00171249|530548463|FG003|Overall Study|Unsatisfactory Therapeutic Effect|70|||
147104567|NCT00171249|530548464|FG004|Overall Study|Unsatisfactory Therapeutic Effect|3|||
147104568|NCT00171249|530548465|FG005|Overall Study|Unsatisfactory Therapeutic Effect|31|||
147104569|NCT00171249|530548466|FG006|Overall Study|Unsatisfactory Therapeutic Effect|1|||
147224044|NCT03332771|530993038|FG000|Overall Study|Adverse Event|6|||
147224045|NCT03332771|530993039|FG001|Overall Study|Adverse Event|4|||
147224046|NCT03332771|530993040|FG002|Overall Study|Adverse Event|1|||
147309640|NCT03679767|531300127|FG003|Overall Study|Death|10|||
147104570|NCT00171249|530548460|FG000|Overall Study|Death|7|||
147104571|NCT00171249|530548461|FG001|Overall Study|Death|1|||
147104572|NCT00171249|530548462|FG002|Overall Study|Death|0|||
147104573|NCT00171249|530548463|FG003|Overall Study|Death|4|||
147104574|NCT00171249|530548464|FG004|Overall Study|Death|0|||
147104575|NCT00171249|530548465|FG005|Overall Study|Death|3|||
147104576|NCT00171249|530548466|FG006|Overall Study|Death|1|||
147104577|NCT00171249|530548460|FG000|Overall Study|Other|10|||
147104578|NCT00171249|530548461|FG001|Overall Study|Other|0|||
147104579|NCT00171249|530548462|FG002|Overall Study|Other|0|||
147104580|NCT00171249|530548463|FG003|Overall Study|Other|43|||
147104581|NCT00171249|530548464|FG004|Overall Study|Other|0|||
147104582|NCT00171249|530548465|FG005|Overall Study|Other|2|||
147104583|NCT00171249|530548466|FG006|Overall Study|Other|0|||
147104584|NCT00171249|530548460|FG000|Overall Study|No Longer Requires Study Drug|4|||
147104585|NCT00171249|530548461|FG001|Overall Study|No Longer Requires Study Drug|0|||
147104586|NCT00171249|530548462|FG002|Overall Study|No Longer Requires Study Drug|0|||
147104587|NCT00171249|530548463|FG003|Overall Study|No Longer Requires Study Drug|3|||
147104588|NCT00171249|530548464|FG004|Overall Study|No Longer Requires Study Drug|0|||
147104589|NCT00171249|530548465|FG005|Overall Study|No Longer Requires Study Drug|5|||
147104590|NCT00171249|530548466|FG006|Overall Study|No Longer Requires Study Drug|0|||
147104591|NCT00171249|530548460|FG000|Overall Study|Administrative Problems|1|||
147104592|NCT00171249|530548461|FG001|Overall Study|Administrative Problems|0|||
147104593|NCT00171249|530548462|FG002|Overall Study|Administrative Problems|0|||
147104594|NCT00171249|530548463|FG003|Overall Study|Administrative Problems|2|||
147104595|NCT00171249|530548464|FG004|Overall Study|Administrative Problems|0|||
147104596|NCT00171249|530548465|FG005|Overall Study|Administrative Problems|0|||
147104597|NCT00171249|530548466|FG006|Overall Study|Administrative Problems|0|||
147104598|NCT00171249|530548460|FG000|Overall Study|Adverse Event|3|||
147104599|NCT00171249|530548461|FG001|Overall Study|Adverse Event|1|||
147104600|NCT00171249|530548462|FG002|Overall Study|Adverse Event|0|||
147104601|NCT00171249|530548463|FG003|Overall Study|Adverse Event|15|||
147104602|NCT00171249|530548464|FG004|Overall Study|Adverse Event|0|||
147104603|NCT00171249|530548465|FG005|Overall Study|Adverse Event|2|||
147104604|NCT00171249|530548466|FG006|Overall Study|Adverse Event|0|||
147104605|NCT00171249|530548460|FG000|Overall Study|Lost to Follow-up|5|||
147104606|NCT00171249|530548461|FG001|Overall Study|Lost to Follow-up|0|||
147104607|NCT00171249|530548462|FG002|Overall Study|Lost to Follow-up|0|||
147104608|NCT00171249|530548463|FG003|Overall Study|Lost to Follow-up|9|||
147104609|NCT00171249|530548464|FG004|Overall Study|Lost to Follow-up|0|||
147104610|NCT00171249|530548465|FG005|Overall Study|Lost to Follow-up|0|||
147104611|NCT00171249|530548466|FG006|Overall Study|Lost to Follow-up|0|||
147104612|NCT00471497|530548467|FG000|Core Treatment Phase|Abnormal Laboratory Values|3|||
147104613|NCT00471497|530548468|FG001|Core Treatment Phase|Abnormal Laboratory Values|9|||
147104614|NCT00471497|530548469|FG002|Core Treatment Phase|Abnormal Laboratory Values|9|||
147104615|NCT00471497|530548467|FG000|Core Treatment Phase|Abnormal Test Procedures|1|||
147104616|NCT00471497|530548468|FG001|Core Treatment Phase|Abnormal Test Procedures|0|||
147104617|NCT00471497|530548469|FG002|Core Treatment Phase|Abnormal Test Procedures|1|||
147104618|NCT00471497|530548467|FG000|Core Treatment Phase|Condition no longer requires study drug|0|||
147104619|NCT00471497|530548468|FG001|Core Treatment Phase|Condition no longer requires study drug|1|||
147104620|NCT00471497|530548469|FG002|Core Treatment Phase|Condition no longer requires study drug|0|||
147104621|NCT00471497|530548467|FG000|Core Treatment Phase|Withdrawal by Subject|31|||
147224047|NCT03332771|530993041|FG003|Overall Study|Adverse Event|3|||
147224048|NCT03332771|530993038|FG000|Overall Study|Poor Compliance to Protocol|0|||
147224049|NCT03332771|530993039|FG001|Overall Study|Poor Compliance to Protocol|1|||
147224050|NCT03332771|530993040|FG002|Overall Study|Poor Compliance to Protocol|0|||
147224051|NCT03332771|530993041|FG003|Overall Study|Poor Compliance to Protocol|1|||
147224052|NCT03332771|530993038|FG000|Overall Study|Lost to Follow-up|2|||
147224053|NCT03332771|530993039|FG001|Overall Study|Lost to Follow-up|2|||
147224054|NCT03332771|530993040|FG002|Overall Study|Lost to Follow-up|1|||
147224055|NCT03332771|530993041|FG003|Overall Study|Lost to Follow-up|2|||
147224056|NCT03332771|530993038|FG000|Overall Study|At the Participant's own request|20|||
147224057|NCT03332771|530993039|FG001|Overall Study|At the Participant's own request|26|||
147224058|NCT03332771|530993040|FG002|Overall Study|At the Participant's own request|14|||
147224059|NCT03332771|530993041|FG003|Overall Study|At the Participant's own request|23|||
147224060|NCT03332771|530993038|FG000|Overall Study|Reason Not Specified|6|||
147224061|NCT03332771|530993039|FG001|Overall Study|Reason Not Specified|18|||
147224062|NCT03332771|530993040|FG002|Overall Study|Reason Not Specified|16|||
147224063|NCT03332771|530993041|FG003|Overall Study|Reason Not Specified|19|||
147224064|NCT00096954|530993044|FG000|Overall Study|Adverse Event|3|||
147224065|NCT00096954|530993045|FG001|Overall Study|Adverse Event|1|||
147224066|NCT00096954|530993044|FG000|Overall Study|Withdrawal by Subject|9|||
147224067|NCT00096954|530993045|FG001|Overall Study|Withdrawal by Subject|8|||
147224068|NCT00096954|530993044|FG000|Overall Study|Physician Decision|1|||
147224069|NCT00096954|530993045|FG001|Overall Study|Physician Decision|1|||
147224070|NCT00096954|530993044|FG000|Overall Study|Sponsors Decision|1|||
147224071|NCT00096954|530993045|FG001|Overall Study|Sponsors Decision|1|||
147104622|NCT00471497|530548468|FG001|Core Treatment Phase|Withdrawal by Subject|29|||
147224072|NCT00096954|530993044|FG000|Overall Study|Pregnancy|1|||
147224073|NCT00096954|530993045|FG001|Overall Study|Pregnancy|1|||
147224074|NCT00096954|530993044|FG000|Overall Study|Initiation of immunotherapy|1|||
147224075|NCT00096954|530993045|FG001|Overall Study|Initiation of immunotherapy|0|||
147224076|NCT00096954|530993044|FG000|Overall Study|Non-compliance|0|||
147104623|NCT00471497|530548469|FG002|Core Treatment Phase|Withdrawal by Subject|34|||
147104624|NCT00471497|530548467|FG000|Core Treatment Phase|Lost to Follow-up|6|||
147104625|NCT00471497|530548468|FG001|Core Treatment Phase|Lost to Follow-up|6|||
147104626|NCT00471497|530548469|FG002|Core Treatment Phase|Lost to Follow-up|3|||
147104627|NCT00471497|530548467|FG000|Core Treatment Phase|Death|3|||
147104628|NCT00471497|530548468|FG001|Core Treatment Phase|Death|9|||
147104629|NCT00471497|530548469|FG002|Core Treatment Phase|Death|3|||
147104630|NCT00471497|530548467|FG000|Core Treatment Phase|Disease Progression|10|||
147104631|NCT00471497|530548468|FG001|Core Treatment Phase|Disease Progression|2|||
147104632|NCT00471497|530548469|FG002|Core Treatment Phase|Disease Progression|4|||
147104633|NCT00471497|530548467|FG000|Core Treatment Phase|Protocol Violation|6|||
147104634|NCT00471497|530548468|FG001|Core Treatment Phase|Protocol Violation|15|||
147104635|NCT00471497|530548469|FG002|Core Treatment Phase|Protocol Violation|11|||
147104636|NCT00471497|530548467|FG000|Core Treatment Phase|Sub optimal response or treat. failure|19|||
147104637|NCT00471497|530548468|FG001|Core Treatment Phase|Sub optimal response or treat. failure|11|||
147104638|NCT00471497|530548469|FG002|Core Treatment Phase|Sub optimal response or treat. failure|13|||
147104639|NCT00471497|530548467|FG000|Core Treatment Phase|Administrative problems|14|||
147104640|NCT00471497|530548468|FG001|Core Treatment Phase|Administrative problems|14|||
147104641|NCT00471497|530548469|FG002|Core Treatment Phase|Administrative problems|12|||
147104642|NCT00471497|530548467|FG000|Core Treatment Phase|Adverse Event|43|||
147104643|NCT00471497|530548468|FG001|Core Treatment Phase|Adverse Event|53|||
147104644|NCT00471497|530548469|FG002|Core Treatment Phase|Adverse Event|89|||
147104645|NCT00471497|530548467|FG000|Core Treatment Phase|Disc. Core/Entered Ext. - DP progression|2|||
147104646|NCT00471497|530548468|FG001|Core Treatment Phase|Disc. Core/Entered Ext. - DP progression|0|||
147104647|NCT00471497|530548469|FG002|Core Treatment Phase|Disc. Core/Entered Ext. - DP progression|0|||
147104648|NCT00471497|530548467|FG000|Core Treatment Phase|Disc. Core/Entered Ext.- SOR/TF|46|||
147104649|NCT00471497|530548468|FG001|Core Treatment Phase|Disc. Core/Entered Ext.- SOR/TF|26|||
147104650|NCT00471497|530548469|FG002|Core Treatment Phase|Disc. Core/Entered Ext.- SOR/TF|3|||
147104651|NCT00471497|530548467|FG000|Extension Phase|Adverse Event|9|||
147104652|NCT00471497|530548468|FG001|Extension Phase|Adverse Event|5|||
147104653|NCT00471497|530548469|FG002|Extension Phase|Adverse Event|1|||
147104654|NCT00471497|530548467|FG000|Extension Phase|Unsatisfactory therapeutic effect|8|||
147104655|NCT00471497|530548468|FG001|Extension Phase|Unsatisfactory therapeutic effect|6|||
147104656|NCT00471497|530548469|FG002|Extension Phase|Unsatisfactory therapeutic effect|0|||
147104657|NCT00471497|530548467|FG000|Extension Phase|Withdrawal by Subject|3|||
147104658|NCT00471497|530548468|FG001|Extension Phase|Withdrawal by Subject|1|||
147104659|NCT00471497|530548469|FG002|Extension Phase|Withdrawal by Subject|0|||
147104660|NCT00471497|530548467|FG000|Extension Phase|Lost to Follow-up|2|||
147104661|NCT00471497|530548468|FG001|Extension Phase|Lost to Follow-up|0|||
147104662|NCT00471497|530548469|FG002|Extension Phase|Lost to Follow-up|0|||
147104663|NCT00471497|530548467|FG000|Extension Phase|Death|1|||
147104664|NCT00471497|530548468|FG001|Extension Phase|Death|0|||
147104665|NCT00471497|530548469|FG002|Extension Phase|Death|0|||
147104666|NCT00471497|530548467|FG000|Extension Phase|Disease progression|2|||
147104667|NCT00471497|530548468|FG001|Extension Phase|Disease progression|0|||
147104668|NCT00471497|530548469|FG002|Extension Phase|Disease progression|0|||
147104669|NCT00471497|530548467|FG000|Extension Phase|Protocol Violation|2|||
147104670|NCT00471497|530548468|FG001|Extension Phase|Protocol Violation|2|||
147104671|NCT00471497|530548469|FG002|Extension Phase|Protocol Violation|0|||
147104672|NCT00392223|530548470|FG000|Overall Study|Adverse Event|5|||
147224077|NCT00096954|530993045|FG001|Overall Study|Non-compliance|3|||
147224078|NCT00096954|530993044|FG000|Overall Study|Lost to Follow-up|8|||
147224079|NCT00096954|530993045|FG001|Overall Study|Lost to Follow-up|5|||
147224080|NCT03442764|530993047|FG000|Overall Study|Adverse Event|1|||
147224081|NCT03442764|530993048|FG001|Overall Study|Adverse Event|0|||
147224082|NCT03442764|530993049|FG002|Overall Study|Adverse Event|0|||
147104673|NCT00392223|530548471|FG001|Overall Study|Adverse Event|4|||
147104674|NCT00392223|530548470|FG000|Overall Study|Lost to Follow-up|1|||
147104675|NCT00392223|530548471|FG001|Overall Study|Lost to Follow-up|4|||
147104676|NCT00392223|530548470|FG000|Overall Study|Protocol Violation|0|||
147104677|NCT00392223|530548471|FG001|Overall Study|Protocol Violation|3|||
147104678|NCT00392223|530548470|FG000|Overall Study|Withdrawal by Subject|3|||
147224083|NCT04478123|530993050|FG000|Overall Study|Pt withdrawal or refusal before begin prot txt|2|||
147224084|NCT04478123|530993050|FG000|Overall Study|NE|1|||
147443622|NCT04707157|531788738|FG000|Overall Study|Protocol Deviation|1|||
147443623|NCT04707157|531788739|FG001|Overall Study|Protocol Deviation|0|||
147443624|NCT04707157|531788738|FG000|Overall Study|Withdrawal by Subject|1|||
147443625|NCT04707157|531788739|FG001|Overall Study|Withdrawal by Subject|1|||
147443626|NCT03625687|531788747|FG000|Overall Study|Death|1|||
147443627|NCT04206605|531788748|FG000|Overall Study|Adverse Event|0|||
147443628|NCT04206605|531788749|FG001|Overall Study|Adverse Event|1|||
147443629|NCT04206605|531788748|FG000|Overall Study|Withdrawal by Subject|1|||
147443630|NCT04206605|531788749|FG001|Overall Study|Withdrawal by Subject|0|||
147443631|NCT05879107|531788754|FG000|Overall Study|Withdrawal by participant, not due to an adverse event|5|||
147104679|NCT00392223|530548471|FG001|Overall Study|Withdrawal by Subject|2|||
147104680|NCT01420536|530548473|FG000|Period 1 (30 Days)|Withdrawal by Subject|3|||
147104681|NCT01420536|530548474|FG001|Period 1 (30 Days)|Withdrawal by Subject|0|||
147104682|NCT00764790|530548475|FG000|Overall Study|Protocol Violation|0|||
147104683|NCT00764790|530548476|FG001|Overall Study|Protocol Violation|0|||
147104684|NCT00764790|530548477|FG002|Overall Study|Protocol Violation|1|||
147104685|NCT00764790|530548475|FG000|Overall Study|Withdrawal by Subject|10|||
147104686|NCT00764790|530548476|FG001|Overall Study|Withdrawal by Subject|12|||
147104687|NCT00764790|530548477|FG002|Overall Study|Withdrawal by Subject|6|||
147104688|NCT00764790|530548475|FG000|Overall Study|Lost to Follow-up|28|||
147104689|NCT00764790|530548476|FG001|Overall Study|Lost to Follow-up|29|||
147104690|NCT00764790|530548477|FG002|Overall Study|Lost to Follow-up|23|||
147104691|NCT03533751|530548478|FG000|Overall Study|Withdrawal by Subject|12|||
147104692|NCT03533751|530548479|FG001|Overall Study|Withdrawal by Subject|6|||
147104693|NCT03533751|530548480|FG002|Overall Study|Withdrawal by Subject|11|||
147104694|NCT03533751|530548481|FG003|Overall Study|Withdrawal by Subject|9|||
147104695|NCT03533751|530548482|FG004|Overall Study|Withdrawal by Subject|10|||
147104696|NCT03533751|530548478|FG000|Overall Study|Adverse Event|4|||
147104697|NCT03533751|530548479|FG001|Overall Study|Adverse Event|7|||
147104698|NCT03533751|530548480|FG002|Overall Study|Adverse Event|2|||
147104699|NCT03533751|530548481|FG003|Overall Study|Adverse Event|4|||
147104700|NCT03533751|530548482|FG004|Overall Study|Adverse Event|5|||
147104701|NCT03533751|530548478|FG000|Overall Study|Physician Decision|0|||
147104702|NCT03533751|530548479|FG001|Overall Study|Physician Decision|2|||
147104703|NCT03533751|530548480|FG002|Overall Study|Physician Decision|1|||
147104704|NCT03533751|530548481|FG003|Overall Study|Physician Decision|2|||
147104705|NCT03533751|530548482|FG004|Overall Study|Physician Decision|1|||
147104706|NCT03533751|530548478|FG000|Overall Study|Sponsor Decision|0|||
147104707|NCT03533751|530548479|FG001|Overall Study|Sponsor Decision|0|||
147104708|NCT03533751|530548480|FG002|Overall Study|Sponsor Decision|1|||
147104709|NCT03533751|530548481|FG003|Overall Study|Sponsor Decision|1|||
147104710|NCT03533751|530548482|FG004|Overall Study|Sponsor Decision|0|||
147104711|NCT03533751|530548478|FG000|Overall Study|Lost to Follow-up|3|||
147104712|NCT03533751|530548479|FG001|Overall Study|Lost to Follow-up|7|||
147104713|NCT03533751|530548480|FG002|Overall Study|Lost to Follow-up|6|||
147104714|NCT03533751|530548481|FG003|Overall Study|Lost to Follow-up|4|||
147104715|NCT03533751|530548482|FG004|Overall Study|Lost to Follow-up|3|||
147104716|NCT03533751|530548478|FG000|Overall Study|Use of any excluded/prohibited medications|0|||
147104717|NCT03533751|530548479|FG001|Overall Study|Use of any excluded/prohibited medications|1|||
147104718|NCT03533751|530548480|FG002|Overall Study|Use of any excluded/prohibited medications|0|||
147104719|NCT03533751|530548481|FG003|Overall Study|Use of any excluded/prohibited medications|0|||
147104720|NCT03533751|530548482|FG004|Overall Study|Use of any excluded/prohibited medications|1|||
147104721|NCT03533751|530548478|FG000|Overall Study|Other|0|||
147104722|NCT03533751|530548479|FG001|Overall Study|Other|2|||
147104723|NCT03533751|530548480|FG002|Overall Study|Other|1|||
147104724|NCT03533751|530548481|FG003|Overall Study|Other|0|||
147443632|NCT05879107|531788755|FG001|Overall Study|Withdrawal by participant, not due to an adverse event|7|||
147443633|NCT05879107|531788754|FG000|Overall Study|Migrated / moved from the study area|1|||
147443634|NCT05879107|531788755|FG001|Overall Study|Migrated / moved from the study area|1|||
147443635|NCT05879107|531788754|FG000|Overall Study|Lost to Follow-up|8|||
147443636|NCT05879107|531788755|FG001|Overall Study|Lost to Follow-up|13|||
147443637|NCT05879107|531788754|FG000|Overall Study|Death|0|||
147443638|NCT05879107|531788755|FG001|Overall Study|Death|2|||
147443639|NCT05879107|531788754|FG000|Overall Study|Other|0|||
147443640|NCT05879107|531788755|FG001|Overall Study|Other|3|||
147443641|NCT00589420|531788756|FG000|Overall Study|screen failure|1|||
147443642|NCT00450723|531788761|FG000|Overall Study|Physician Decision|5|||
147443643|NCT01987960|531788762|FG000|Period 1|Adverse Event|24|||
147443644|NCT01987960|531788763|FG001|Period 1|Adverse Event|0|||
147443645|NCT01987960|531788764|FG002|Period 1|Adverse Event|0|||
147443646|NCT01987960|531788765|FG003|Period 1|Adverse Event|0|||
147443647|NCT01987960|531788762|FG000|Period 1|Lack of Efficacy|4|||
147443648|NCT01987960|531788763|FG001|Period 1|Lack of Efficacy|0|||
147443649|NCT01987960|531788764|FG002|Period 1|Lack of Efficacy|0|||
147443650|NCT01987960|531788765|FG003|Period 1|Lack of Efficacy|0|||
147443651|NCT01987960|531788762|FG000|Period 1|Non-compliance with IMP|6|||
147443652|NCT01987960|531788763|FG001|Period 1|Non-compliance with IMP|0|||
147309641|NCT03679767|531300124|FG000|Overall Study|Lost to Follow-up|1|||
147104725|NCT03533751|530548482|FG004|Overall Study|Other|3|||
147104726|NCT03082729|530548485|FG000|Overall Study|Lost to Follow-up|7|||
147104727|NCT03082729|530548485|FG000|Overall Study|Physician Decision|2|||
147104728|NCT03082729|530548485|FG000|Overall Study|Withdrawal by Subject|1|||
147104729|NCT03082729|530548485|FG000|Overall Study|Lack of Efficacy|9|||
147104730|NCT03082729|530548485|FG000|Overall Study|Adverse Event|4|||
147104731|NCT03082729|530548485|FG000|Overall Study|Protocol Violation|6|||
147104732|NCT03082729|530548485|FG000|Overall Study|Fear of study procedure|1|||
147443653|NCT01987960|531788764|FG002|Period 1|Non-compliance with IMP|0|||
147443654|NCT01987960|531788765|FG003|Period 1|Non-compliance with IMP|0|||
147443655|NCT01987960|531788762|FG000|Period 1|Protocol Violation|12|||
147554286|NCT02637557|532185553|FG000|Overall Study|Withdrawal by Subject|1|||
147554287|NCT02637557|532185554|FG001|Overall Study|Withdrawal by Subject|3|||
147554288|NCT02637557|532185555|FG002|Overall Study|Withdrawal by Subject|4|||
147554289|NCT02637557|532185556|FG003|Overall Study|Withdrawal by Subject|2|||
147554290|NCT01673009|532185557|FG000|Overall Study|Physician Decision|5|||
147554291|NCT01673009|532185557|FG000|Overall Study|Withdrawal by Subject|8|||
147554292|NCT00952484|532185561|FG000|Overall Study|Withdrawal by Subject|0|||
147554293|NCT00952484|532185562|FG001|Overall Study|Withdrawal by Subject|1|||
147554294|NCT00952484|532185563|FG002|Overall Study|Withdrawal by Subject|0|||
147554295|NCT02750306|532185564|FG000|Overall Study|Withdrawal by Subject|5|||
147554296|NCT02750306|532185565|FG001|Overall Study|Withdrawal by Subject|2|||
147554297|NCT02750306|532185564|FG000|Overall Study|Protocol Violation|1|||
147554298|NCT02750306|532185565|FG001|Overall Study|Protocol Violation|0|||
147554299|NCT01829477|532185567|FG000|Overall Study|Study Terminated by Sponsor|15|||
147554300|NCT01829477|532185568|FG001|Overall Study|Study Terminated by Sponsor|15|||
147554301|NCT01829477|532185567|FG000|Overall Study|Withdrawal by Subject|1|||
147554302|NCT01829477|532185568|FG001|Overall Study|Withdrawal by Subject|0|||
147554303|NCT03361423|532185569|FG000|Overall Study|Withdrawal by Subject|4|||
147554304|NCT03361423|532185570|FG001|Overall Study|Withdrawal by Subject|3|||
147554305|NCT03361423|532185569|FG000|Overall Study|Did not treat|19|||
147554306|NCT03361423|532185570|FG001|Overall Study|Did not treat|18|||
147554307|NCT03361423|532185569|FG000|Overall Study|Started >60 minutes from migraine onset|0|||
147104733|NCT03082729|530548485|FG000|Overall Study|Scheduling conflict|1|||
147104734|NCT00548327|530550400|FG000|Overall Study|Adverse Event|0|||
147104735|NCT00548327|530550401|FG001|Overall Study|Adverse Event|1|||
147104736|NCT01673386|530550402|FG000|Overall Study|Study terminated by sponsor|16|||
147104737|NCT01673386|530550403|FG001|Overall Study|Study terminated by sponsor|22|||
147104738|NCT01673386|530550402|FG000|Overall Study|Adverse Event|5|||
147554308|NCT03361423|532185570|FG001|Overall Study|Started >60 minutes from migraine onset|1|||
147554309|NCT03361423|532185569|FG000|Overall Study|Missing data|4|||
147554310|NCT03361423|532185570|FG001|Overall Study|Missing data|1|||
147554311|NCT00299156|532185571|FG000|Period 2 (Randomized)|Screen Failure|0|||
147554312|NCT00299156|532185572|FG001|Period 2 (Randomized)|Screen Failure|1|||
147554313|NCT00299156|532185573|FG002|Period 2 (Randomized)|Screen Failure|0|||
147554314|NCT01725451|532185574|FG000|Period 1|Withdrawal by Subject|1|||
147104739|NCT01673386|530550403|FG001|Overall Study|Adverse Event|2|||
147104740|NCT01673386|530550402|FG000|Overall Study|Progressive disease|4|||
147104741|NCT01673386|530550403|FG001|Overall Study|Progressive disease|1|||
147104742|NCT01673386|530550402|FG000|Overall Study|Withdrawal by Subject|0|||
147104743|NCT01673386|530550403|FG001|Overall Study|Withdrawal by Subject|2|||
147104744|NCT00109343|530550404|FG000|Overall Study|Adverse Event|1|||
147104745|NCT00109343|530550405|FG001|Overall Study|Adverse Event|0|||
147104746|NCT00109343|530550406|FG002|Overall Study|Adverse Event|2|||
147104747|NCT00109343|530550404|FG000|Overall Study|Lack of Efficacy|1|||
147104748|NCT00109343|530550405|FG001|Overall Study|Lack of Efficacy|0|||
147104749|NCT00109343|530550406|FG002|Overall Study|Lack of Efficacy|0|||
147104750|NCT00109343|530550404|FG000|Overall Study|Lost to Follow-up|35|||
147104751|NCT00109343|530550405|FG001|Overall Study|Lost to Follow-up|20|||
147104752|NCT00109343|530550406|FG002|Overall Study|Lost to Follow-up|14|||
147104753|NCT00109343|530550404|FG000|Overall Study|Protocol Violation|1|||
147104754|NCT00109343|530550405|FG001|Overall Study|Protocol Violation|2|||
147104755|NCT00109343|530550406|FG002|Overall Study|Protocol Violation|2|||
147104756|NCT00109343|530550404|FG000|Overall Study|Withdrawal by Subject|15|||
147104757|NCT00109343|530550405|FG001|Overall Study|Withdrawal by Subject|11|||
147104758|NCT00109343|530550406|FG002|Overall Study|Withdrawal by Subject|10|||
147104759|NCT00109343|530550404|FG000|Overall Study|Subject Moved|6|||
147104760|NCT00109343|530550405|FG001|Overall Study|Subject Moved|2|||
147104761|NCT00109343|530550406|FG002|Overall Study|Subject Moved|1|||
147104762|NCT00109343|530550404|FG000|Overall Study|Other|5|||
147104763|NCT00109343|530550405|FG001|Overall Study|Other|2|||
147104764|NCT00109343|530550406|FG002|Overall Study|Other|1|||
147104765|NCT01721798|530550407|FG000|Overall Study|Death|0|||
147104766|NCT01721798|530550408|FG001|Overall Study|Death|0|||
147104767|NCT01721798|530550409|FG002|Overall Study|Death|1|||
147104768|NCT01721798|530550410|FG003|Overall Study|Death|1|||
147104769|NCT01721798|530550407|FG000|Overall Study|Lost to Follow-up|2|||
147104770|NCT01721798|530550408|FG001|Overall Study|Lost to Follow-up|2|||
147104771|NCT01721798|530550409|FG002|Overall Study|Lost to Follow-up|9|||
147104772|NCT01721798|530550410|FG003|Overall Study|Lost to Follow-up|9|||
147104773|NCT01721798|530550407|FG000|Overall Study|Pregnancy|0|||
147104774|NCT01721798|530550408|FG001|Overall Study|Pregnancy|0|||
147104775|NCT01721798|530550409|FG002|Overall Study|Pregnancy|1|||
147104776|NCT01721798|530550410|FG003|Overall Study|Pregnancy|1|||
147104777|NCT01721798|530550407|FG000|Overall Study|Withdrawal by Subject|1|||
147554315|NCT01725451|532185575|FG001|Period 1|Withdrawal by Subject|0|||
147554316|NCT01725451|532185576|FG002|Period 1|Withdrawal by Subject|0|||
147104778|NCT01721798|530550408|FG001|Overall Study|Withdrawal by Subject|0|||
147104779|NCT01721798|530550409|FG002|Overall Study|Withdrawal by Subject|2|||
147104780|NCT01721798|530550410|FG003|Overall Study|Withdrawal by Subject|1|||
147104781|NCT01721798|530550407|FG000|Overall Study|Not eligible for 24 month visit|1|||
147104782|NCT01721798|530550408|FG001|Overall Study|Not eligible for 24 month visit|0|||
147104783|NCT01721798|530550409|FG002|Overall Study|Not eligible for 24 month visit|8|||
147104784|NCT01721798|530550410|FG003|Overall Study|Not eligible for 24 month visit|7|||
147104785|NCT01649765|530550411|FG000|Overall Study|Adverse Event|5|||
147104786|NCT01649765|530550412|FG001|Overall Study|Adverse Event|3|||
147104787|NCT01649765|530550411|FG000|Overall Study|Lack of Efficacy|1|||
147104788|NCT01649765|530550412|FG001|Overall Study|Lack of Efficacy|1|||
147104789|NCT01649765|530550411|FG000|Overall Study|Physician Decision|0|||
147104790|NCT01649765|530550412|FG001|Overall Study|Physician Decision|3|||
147104791|NCT01649765|530550411|FG000|Overall Study|Protocol Violation|1|||
147104792|NCT01649765|530550412|FG001|Overall Study|Protocol Violation|0|||
147104793|NCT01649765|530550411|FG000|Overall Study|Withdrawal by Subject|2|||
147104794|NCT01649765|530550412|FG001|Overall Study|Withdrawal by Subject|1|||
147104795|NCT02194465|530550413|FG000|Overall Study|Adverse Event|6|||
147104796|NCT02194465|530550414|FG001|Overall Study|Adverse Event|1|||
147104797|NCT02194465|530550415|FG002|Overall Study|Adverse Event|4|||
147104798|NCT02194465|530550416|FG003|Overall Study|Adverse Event|4|||
147104799|NCT02194465|530550417|FG004|Overall Study|Adverse Event|4|||
147104800|NCT02194465|530550418|FG005|Overall Study|Adverse Event|2|||
147104801|NCT02194465|530550419|FG006|Overall Study|Adverse Event|0|||
147104802|NCT02194465|530550413|FG000|Overall Study|Lost to Follow-up|0|||
147104803|NCT02194465|530550414|FG001|Overall Study|Lost to Follow-up|0|||
147104804|NCT02194465|530550415|FG002|Overall Study|Lost to Follow-up|0|||
147104805|NCT02194465|530550416|FG003|Overall Study|Lost to Follow-up|1|||
147104806|NCT02194465|530550417|FG004|Overall Study|Lost to Follow-up|0|||
147104807|NCT02194465|530550418|FG005|Overall Study|Lost to Follow-up|1|||
147104808|NCT02194465|530550419|FG006|Overall Study|Lost to Follow-up|0|||
147104809|NCT02194465|530550413|FG000|Overall Study|Physician Decision|1|||
147104810|NCT02194465|530550414|FG001|Overall Study|Physician Decision|0|||
147104811|NCT02194465|530550415|FG002|Overall Study|Physician Decision|0|||
147104812|NCT02194465|530550416|FG003|Overall Study|Physician Decision|0|||
147104813|NCT02194465|530550417|FG004|Overall Study|Physician Decision|0|||
147104814|NCT02194465|530550418|FG005|Overall Study|Physician Decision|0|||
147104815|NCT02194465|530550419|FG006|Overall Study|Physician Decision|0|||
147104816|NCT02194465|530550413|FG000|Overall Study|Protocol Violation|1|||
147104817|NCT02194465|530550414|FG001|Overall Study|Protocol Violation|1|||
147104818|NCT02194465|530550415|FG002|Overall Study|Protocol Violation|2|||
147104819|NCT02194465|530550416|FG003|Overall Study|Protocol Violation|1|||
147104820|NCT02194465|530550417|FG004|Overall Study|Protocol Violation|1|||
147104821|NCT02194465|530550418|FG005|Overall Study|Protocol Violation|0|||
147104822|NCT02194465|530550419|FG006|Overall Study|Protocol Violation|0|||
147104823|NCT02194465|530550413|FG000|Overall Study|Withdrawal by Subject|1|||
147104824|NCT02194465|530550414|FG001|Overall Study|Withdrawal by Subject|3|||
147104825|NCT02194465|530550415|FG002|Overall Study|Withdrawal by Subject|1|||
147104826|NCT02194465|530550416|FG003|Overall Study|Withdrawal by Subject|2|||
147104827|NCT02194465|530550417|FG004|Overall Study|Withdrawal by Subject|2|||
147104828|NCT02194465|530550418|FG005|Overall Study|Withdrawal by Subject|1|||
147104829|NCT02194465|530550419|FG006|Overall Study|Withdrawal by Subject|2|||
147104830|NCT02194465|530550413|FG000|Overall Study|Discontinued follow-up period|0|||
147104831|NCT02194465|530550414|FG001|Overall Study|Discontinued follow-up period|2|||
147104832|NCT02194465|530550415|FG002|Overall Study|Discontinued follow-up period|1|||
147104833|NCT02194465|530550416|FG003|Overall Study|Discontinued follow-up period|0|||
147104834|NCT02194465|530550417|FG004|Overall Study|Discontinued follow-up period|2|||
147104835|NCT02194465|530550418|FG005|Overall Study|Discontinued follow-up period|0|||
147104836|NCT02194465|530550419|FG006|Overall Study|Discontinued follow-up period|0|||
147104837|NCT00961064|530550420|FG000|Initial Treatment (Weeks 1 - 20)|No Response|11|||
147104838|NCT00961064|530550420|FG000|Initial Treatment (Weeks 1 - 20)|Disease Progression|3|||
147104839|NCT00961064|530550420|FG000|Initial Treatment (Weeks 1 - 20)|Death|1|||
147104840|NCT00961064|530550420|FG000|Initial Treatment (Weeks 1 - 20)|Withdrawal by Subject|1|||
147104841|NCT00961064|530550420|FG000|Extended Access: Week 20 to Up to Year 5|Disease Progression|3|||
147443656|NCT01987960|531788763|FG001|Period 1|Protocol Violation|0|||
147443657|NCT01987960|531788764|FG002|Period 1|Protocol Violation|0|||
147443658|NCT01987960|531788765|FG003|Period 1|Protocol Violation|0|||
147443659|NCT01987960|531788762|FG000|Period 1|Withdrawal by Subject|21|||
147443660|NCT01987960|531788763|FG001|Period 1|Withdrawal by Subject|0|||
147443661|NCT01987960|531788764|FG002|Period 1|Withdrawal by Subject|0|||
147443662|NCT01987960|531788765|FG003|Period 1|Withdrawal by Subject|0|||
147104842|NCT00961064|530550420|FG000|Extended Access: Week 20 to Up to Year 5|Lost Response|1|||
147104843|NCT00961064|530550420|FG000|Extended Access: Week 20 to Up to Year 5|Non-compliant|1|||
147104844|NCT00961064|530550420|FG000|Extended Access: Week 20 to Up to Year 5|Withdrawal by Subject|2|||
147104845|NCT01408641|530550421|FG000|Overall Study|Physician Decision|1|||
147104846|NCT01408641|530550422|FG001|Overall Study|Physician Decision|0|||
147104847|NCT01648764|530550423|FG000|Overall Study|Progressive Disease|0|||
147104848|NCT01648764|530550424|FG001|Overall Study|Progressive Disease|1|||
147104849|NCT01648764|530550425|FG002|Overall Study|Progressive Disease|0|||
147443663|NCT01987960|531788762|FG000|Period 1|Lost to Follow-up|40|||
147104850|NCT01648764|530550426|FG003|Overall Study|Progressive Disease|0|||
147104851|NCT01648764|530550427|FG004|Overall Study|Progressive Disease|0|||
147104852|NCT01648764|530550428|FG005|Overall Study|Progressive Disease|1|||
147104853|NCT01648764|530550429|FG006|Overall Study|Progressive Disease|1|||
147104854|NCT01648764|530550430|FG007|Overall Study|Progressive Disease|0|||
147104855|NCT01648764|530550431|FG008|Overall Study|Progressive Disease|0|||
147104856|NCT01648764|530550432|FG009|Overall Study|Progressive Disease|2|||
147104857|NCT01648764|530550433|FG010|Overall Study|Progressive Disease|0|||
147104858|NCT01648764|530550434|FG011|Overall Study|Progressive Disease|1|||
147104859|NCT01648764|530550435|FG012|Overall Study|Progressive Disease|2|||
147104860|NCT01648764|530550436|FG013|Overall Study|Progressive Disease|1|||
147104861|NCT01648764|530550423|FG000|Overall Study|Adverse Event|0|||
147104862|NCT01648764|530550424|FG001|Overall Study|Adverse Event|0|||
147104863|NCT01648764|530550425|FG002|Overall Study|Adverse Event|0|||
147104864|NCT01648764|530550426|FG003|Overall Study|Adverse Event|0|||
147104865|NCT01648764|530550427|FG004|Overall Study|Adverse Event|0|||
147104866|NCT01648764|530550428|FG005|Overall Study|Adverse Event|1|||
147104867|NCT01648764|530550429|FG006|Overall Study|Adverse Event|0|||
147104868|NCT01648764|530550430|FG007|Overall Study|Adverse Event|0|||
147104869|NCT01648764|530550431|FG008|Overall Study|Adverse Event|0|||
147104870|NCT01648764|530550432|FG009|Overall Study|Adverse Event|1|||
147104871|NCT01648764|530550433|FG010|Overall Study|Adverse Event|0|||
147104872|NCT01648764|530550434|FG011|Overall Study|Adverse Event|3|||
147104873|NCT01648764|530550435|FG012|Overall Study|Adverse Event|1|||
147104874|NCT01648764|530550436|FG013|Overall Study|Adverse Event|1|||
147104875|NCT01648764|530550423|FG000|Overall Study|Death|0|||
147104876|NCT01648764|530550424|FG001|Overall Study|Death|0|||
147104877|NCT01648764|530550425|FG002|Overall Study|Death|0|||
147104878|NCT01648764|530550426|FG003|Overall Study|Death|0|||
147104879|NCT01648764|530550427|FG004|Overall Study|Death|0|||
147104880|NCT01648764|530550428|FG005|Overall Study|Death|0|||
147104881|NCT01648764|530550429|FG006|Overall Study|Death|1|||
147104882|NCT01648764|530550430|FG007|Overall Study|Death|0|||
147104883|NCT01648764|530550431|FG008|Overall Study|Death|0|||
147104884|NCT01648764|530550432|FG009|Overall Study|Death|0|||
147104885|NCT01648764|530550433|FG010|Overall Study|Death|0|||
147104886|NCT01648764|530550434|FG011|Overall Study|Death|0|||
147104887|NCT01648764|530550435|FG012|Overall Study|Death|0|||
147104888|NCT01648764|530550436|FG013|Overall Study|Death|1|||
147104889|NCT01648764|530550423|FG000|Overall Study|Withdrawal by Subject|0|||
147104890|NCT01648764|530550424|FG001|Overall Study|Withdrawal by Subject|0|||
147104891|NCT01648764|530550425|FG002|Overall Study|Withdrawal by Subject|0|||
147104892|NCT01648764|530550426|FG003|Overall Study|Withdrawal by Subject|0|||
147104893|NCT01648764|530550427|FG004|Overall Study|Withdrawal by Subject|0|||
147104894|NCT01648764|530550428|FG005|Overall Study|Withdrawal by Subject|0|||
147104895|NCT01648764|530550429|FG006|Overall Study|Withdrawal by Subject|2|||
147104896|NCT01648764|530550430|FG007|Overall Study|Withdrawal by Subject|0|||
147104897|NCT01648764|530550431|FG008|Overall Study|Withdrawal by Subject|0|||
147104898|NCT01648764|530550432|FG009|Overall Study|Withdrawal by Subject|0|||
147104899|NCT01648764|530550433|FG010|Overall Study|Withdrawal by Subject|0|||
147104900|NCT01648764|530550434|FG011|Overall Study|Withdrawal by Subject|0|||
147104901|NCT01648764|530550435|FG012|Overall Study|Withdrawal by Subject|1|||
147104902|NCT01648764|530550436|FG013|Overall Study|Withdrawal by Subject|0|||
147104903|NCT01648764|530550423|FG000|Overall Study|Investigator Decision|0|||
147104904|NCT01648764|530550424|FG001|Overall Study|Investigator Decision|0|||
147104905|NCT01648764|530550425|FG002|Overall Study|Investigator Decision|0|||
147104906|NCT01648764|530550426|FG003|Overall Study|Investigator Decision|0|||
147104907|NCT01648764|530550427|FG004|Overall Study|Investigator Decision|0|||
147104908|NCT01648764|530550428|FG005|Overall Study|Investigator Decision|0|||
147104909|NCT01648764|530550429|FG006|Overall Study|Investigator Decision|1|||
147104910|NCT01648764|530550430|FG007|Overall Study|Investigator Decision|0|||
147104911|NCT01648764|530550431|FG008|Overall Study|Investigator Decision|0|||
147104912|NCT01648764|530550432|FG009|Overall Study|Investigator Decision|0|||
147104913|NCT01648764|530550433|FG010|Overall Study|Investigator Decision|0|||
147104914|NCT01648764|530550434|FG011|Overall Study|Investigator Decision|1|||
147104915|NCT01648764|530550435|FG012|Overall Study|Investigator Decision|0|||
147104916|NCT01648764|530550436|FG013|Overall Study|Investigator Decision|0|||
147104917|NCT00715208|530550437|FG000|Overall Study|Withdrawal by Subject|1|||
147104918|NCT00715208|530550438|FG001|Overall Study|Withdrawal by Subject|1|||
147104919|NCT00715208|530550437|FG000|Overall Study|Adverse Event|0|||
147104920|NCT00715208|530550438|FG001|Overall Study|Adverse Event|6|||
147104921|NCT00715208|530550437|FG000|Overall Study|Lack of Efficacy|0|||
147104922|NCT00715208|530550438|FG001|Overall Study|Lack of Efficacy|2|||
147104923|NCT00076570|530550439|FG000|Overall Study|Drug intolerance|8|||
147104924|NCT00076570|530550440|FG001|Overall Study|Drug intolerance|8|||
147104925|NCT01294046|530550441|FG000|Overall Study|Infection and surgical explant|1|||
147104926|NCT01294046|530550441|FG000|Overall Study|Eligibility criteria expanded|1|||
147104927|NCT01294046|530550441|FG000|Overall Study|Stimulation response inadqequate|1|||
147104928|NCT00420745|530550442|FG000|Overall Study|Adverse Event|2|||
147104929|NCT00420745|530550443|FG001|Overall Study|Adverse Event|2|||
147104930|NCT00420745|530550442|FG000|Overall Study|Lost to Follow-up|10|||
147104931|NCT00420745|530550443|FG001|Overall Study|Lost to Follow-up|2|||
147104932|NCT00420745|530550442|FG000|Overall Study|Protocol Violation|1|||
147104933|NCT00420745|530550443|FG001|Overall Study|Protocol Violation|0|||
147104934|NCT00420745|530550442|FG000|Overall Study|Physician Decision|1|||
147104935|NCT00420745|530550443|FG001|Overall Study|Physician Decision|1|||
147104936|NCT00420745|530550442|FG000|Overall Study|Recurrent pneumonia & bronchitis|0|||
147104937|NCT00420745|530550443|FG001|Overall Study|Recurrent pneumonia & bronchitis|1|||
147104938|NCT00420745|530550442|FG000|Overall Study|Age limit exceeded for Dose 2|1|||
147104939|NCT00420745|530550443|FG001|Overall Study|Age limit exceeded for Dose 2|0|||
147104940|NCT01588509|530550444|FG000|Overall Study|Lost to Follow-up|1|||
147104941|NCT01588509|530550445|FG001|Overall Study|Lost to Follow-up|0|||
147104942|NCT01454284|530550446|FG000|Overall Study|Adverse Event|20|||
147104943|NCT01454284|530550447|FG001|Overall Study|Adverse Event|7|||
147443664|NCT01987960|531788763|FG001|Period 1|Lost to Follow-up|0|||
147443665|NCT01987960|531788764|FG002|Period 1|Lost to Follow-up|0|||
147224120|NCT02395016|530993056|FG000|Overall Study|Adverse Event|4|||
147224121|NCT02395016|530993057|FG001|Overall Study|Adverse Event|3|||
147224122|NCT02395016|530993056|FG000|Overall Study|Withdrawal by Subject|9|||
147224123|NCT02395016|530993057|FG001|Overall Study|Withdrawal by Subject|6|||
147224124|NCT02395016|530993056|FG000|Overall Study|Protocol Violation|2|||
147224125|NCT02395016|530993057|FG001|Overall Study|Protocol Violation|3|||
147224126|NCT04444895|530993058|FG000|Overall Study|Adverse Event|2|||
147224127|NCT04444895|530993058|FG000|Overall Study|Lost to Follow-up|2|||
147224128|NCT04444895|530993058|FG000|Overall Study|Withdrawal by Subject|5|||
147224129|NCT00719264|530993059|FG000|Overall Study|Adverse Event|41|||
147224130|NCT00719264|530993060|FG001|Overall Study|Adverse Event|49|||
147224131|NCT00719264|530993059|FG000|Overall Study|Death|13|||
147224132|NCT00719264|530993060|FG001|Overall Study|Death|10|||
147224133|NCT00719264|530993059|FG000|Overall Study|Administrative Problems|6|||
147224134|NCT00719264|530993060|FG001|Overall Study|Administrative Problems|4|||
147224135|NCT00719264|530993059|FG000|Overall Study|Lost to Follow-up|1|||
147224136|NCT00719264|530993060|FG001|Overall Study|Lost to Follow-up|1|||
147224137|NCT00719264|530993059|FG000|Overall Study|Withdrawal by Subject|12|||
147224138|NCT00719264|530993060|FG001|Overall Study|Withdrawal by Subject|7|||
147224139|NCT00719264|530993059|FG000|Overall Study|Protocol Deviation|1|||
147224140|NCT00719264|530993060|FG001|Overall Study|Protocol Deviation|3|||
147224141|NCT00719264|530993059|FG000|Overall Study|New Cancer Therapy|4|||
147224142|NCT00719264|530993060|FG001|Overall Study|New Cancer Therapy|2|||
147224143|NCT00719264|530993059|FG000|Overall Study|Disease Progression|104|||
147224144|NCT00719264|530993060|FG001|Overall Study|Disease Progression|107|||
147224145|NCT00814879|530993061|FG000|By Week 24|Cancer Diagnosis|1|||
147224146|NCT00814879|530993062|FG001|By Week 24|Cancer Diagnosis|0|||
147224147|NCT00814879|530993061|FG000|By Week 24|Incarceration|0|||
147224148|NCT00814879|530993062|FG001|By Week 24|Incarceration|1|||
147224149|NCT00814879|530993061|FG000|By Week 48|Lost to Follow-up|2|||
147224150|NCT00814879|530993062|FG001|By Week 48|Lost to Follow-up|2|||
147224151|NCT00814879|530993061|FG000|By Week 48|Death|0|||
147224152|NCT00814879|530993062|FG001|By Week 48|Death|1|||
147224153|NCT01277042|530993063|FG000|Overall Study|Adverse Event|4|||
147224154|NCT01277042|530993064|FG001|Overall Study|Adverse Event|3|||
147224155|NCT01277042|530993063|FG000|Overall Study|Lost to Follow-up|2|||
147224156|NCT01277042|530993064|FG001|Overall Study|Lost to Follow-up|2|||
147224157|NCT01277042|530993063|FG000|Overall Study|Withdrawal by Subject|2|||
147224158|NCT01277042|530993064|FG001|Overall Study|Withdrawal by Subject|0|||
147224159|NCT00588952|530993065|FG000|Overall Study|Adverse Event|0|||
147224160|NCT00588952|530993066|FG001|Overall Study|Adverse Event|2|||
147224161|NCT00588952|530993065|FG000|Overall Study|Withdrawal by Subject|3|||
147224162|NCT00588952|530993066|FG001|Overall Study|Withdrawal by Subject|5|||
147104944|NCT01454284|530550446|FG000|Overall Study|Death|0|||
147104945|NCT01454284|530550447|FG001|Overall Study|Death|3|||
147104946|NCT01454284|530550446|FG000|Overall Study|Lost to Follow-up|13|||
147104947|NCT01454284|530550447|FG001|Overall Study|Lost to Follow-up|8|||
147224163|NCT01461057|530993067|FG000|Overall Study|Death|10|||
147224164|NCT01461057|530993068|FG001|Overall Study|Death|9|||
147224165|NCT01461057|530993067|FG000|Overall Study|Withdrawal by Subject|2|||
147224166|NCT01461057|530993068|FG001|Overall Study|Withdrawal by Subject|3|||
147224167|NCT01461057|530993067|FG000|Overall Study|Physician Decision|0|||
147224168|NCT01461057|530993068|FG001|Overall Study|Physician Decision|2|||
147224169|NCT01461057|530993067|FG000|Overall Study|Adverse Event|0|||
147104948|NCT01454284|530550446|FG000|Overall Study|Protocol Violation|9|||
147104949|NCT01454284|530550447|FG001|Overall Study|Protocol Violation|6|||
147104950|NCT01454284|530550446|FG000|Overall Study|Withdrawal by Subject|58|||
147224170|NCT01461057|530993068|FG001|Overall Study|Adverse Event|1|||
147224171|NCT01461057|530993067|FG000|Overall Study|Progression of Disease|1|||
147443666|NCT01987960|531788765|FG003|Period 1|Lost to Follow-up|0|||
147443667|NCT01987960|531788762|FG000|Period 1|administrative or other reason|75|||
147443668|NCT01987960|531788763|FG001|Period 1|administrative or other reason|0|||
147443669|NCT01987960|531788764|FG002|Period 1|administrative or other reason|0|||
147309642|NCT03679767|531300125|FG001|Overall Study|Lost to Follow-up|1|||
147309643|NCT03679767|531300126|FG002|Overall Study|Lost to Follow-up|1|||
147309644|NCT03679767|531300127|FG003|Overall Study|Lost to Follow-up|1|||
147309645|NCT03679767|531300124|FG000|Overall Study|Withdrawal by Subject|0|||
147309646|NCT03679767|531300125|FG001|Overall Study|Withdrawal by Subject|0|||
147309647|NCT03679767|531300126|FG002|Overall Study|Withdrawal by Subject|0|||
147309648|NCT03679767|531300127|FG003|Overall Study|Withdrawal by Subject|1|||
147309649|NCT03679767|531300124|FG000|Overall Study|Follow-up Completed|18|||
147554317|NCT01725451|532185577|FG003|Period 1|Withdrawal by Subject|0|||
147554318|NCT01725451|532185574|FG000|Washout From Period 3|Protocol Violation|0|||
147309650|NCT03679767|531300125|FG001|Overall Study|Follow-up Completed|11|||
147309651|NCT03679767|531300126|FG002|Overall Study|Follow-up Completed|11|||
147309652|NCT03679767|531300127|FG003|Overall Study|Follow-up Completed|20|||
147309653|NCT03679767|531300124|FG000|Overall Study|Entered Hospice Care|0|||
147309654|NCT03679767|531300125|FG001|Overall Study|Entered Hospice Care|0|||
147309655|NCT03679767|531300126|FG002|Overall Study|Entered Hospice Care|0|||
147309656|NCT03679767|531300127|FG003|Overall Study|Entered Hospice Care|1|||
147309657|NCT03679767|531300124|FG000|Overall Study|Progressive Disease|0|||
147309658|NCT03679767|531300125|FG001|Overall Study|Progressive Disease|0|||
147309659|NCT03679767|531300126|FG002|Overall Study|Progressive Disease|0|||
147309660|NCT03679767|531300127|FG003|Overall Study|Progressive Disease|1|||
147309661|NCT05229653|531300128|FG000|Overall Study|Lost to Follow-up|1|||
147309662|NCT05229653|531300129|FG001|Overall Study|Lost to Follow-up|0|||
147309663|NCT01845974|531300130|FG000|Overall Study|screen failure|1|||
147309664|NCT01845974|531300131|FG001|Overall Study|screen failure|0|||
147309665|NCT05408468|531300132|FG000|Overall Study|Lost to Follow-up|3|||
147309666|NCT05408468|531300133|FG001|Overall Study|Lost to Follow-up|1|||
147309667|NCT05408468|531300132|FG000|Overall Study|Physician Decision|1|||
147309668|NCT05408468|531300133|FG001|Overall Study|Physician Decision|0|||
147309669|NCT05408468|531300132|FG000|Overall Study|Overwhelmed by clinical situation|3|||
147309670|NCT05408468|531300133|FG001|Overall Study|Overwhelmed by clinical situation|0|||
147309671|NCT05408468|531300132|FG000|Overall Study|Personal illness precluding participation|1|||
147309672|NCT05408468|531300133|FG001|Overall Study|Personal illness precluding participation|0|||
147309673|NCT05408468|531300132|FG000|Overall Study|Withdrawn due to death patient death (unrelated to LAR participation in trial)|2|||
147309674|NCT05408468|531300133|FG001|Overall Study|Withdrawn due to death patient death (unrelated to LAR participation in trial)|2|||
147309675|NCT00663117|531302083|FG000|Overall Study|Lack of Efficacy|1|||
147309676|NCT00663117|531302084|FG001|Overall Study|Lack of Efficacy|0|||
147309677|NCT01158378|531302085|FG000|Overall Study|Death|4|||
147309678|NCT01158378|531302086|FG001|Overall Study|Death|5|||
147309679|NCT01158378|531302085|FG000|Overall Study|Lost to Follow-up|2|||
147309680|NCT01158378|531302086|FG001|Overall Study|Lost to Follow-up|4|||
147309681|NCT01158378|531302085|FG000|Overall Study|Withdrawal by Subject|4|||
147309682|NCT01158378|531302086|FG001|Overall Study|Withdrawal by Subject|0|||
147309683|NCT02769065|531302087|FG000|Overall Study|Voluntary Withdrawal|1|||
147309684|NCT02769065|531302088|FG001|Overall Study|Voluntary Withdrawal|0|||
147309685|NCT02769065|531302089|FG002|Overall Study|Voluntary Withdrawal|0|||
147309686|NCT02769065|531302090|FG003|Overall Study|Voluntary Withdrawal|0|||
147309687|NCT02769065|531302091|FG004|Overall Study|Voluntary Withdrawal|0|||
147309688|NCT02769065|531302092|FG005|Overall Study|Voluntary Withdrawal|0|||
147309689|NCT02769065|531302093|FG006|Overall Study|Voluntary Withdrawal|0|||
147309690|NCT02769065|531302094|FG007|Overall Study|Voluntary Withdrawal|0|||
147309691|NCT02769065|531302095|FG008|Overall Study|Voluntary Withdrawal|0|||
147309692|NCT02769065|531302096|FG009|Overall Study|Voluntary Withdrawal|0|||
147309693|NCT02769065|531302097|FG010|Overall Study|Voluntary Withdrawal|0|||
147309694|NCT02769065|531302098|FG011|Overall Study|Voluntary Withdrawal|0|||
147309695|NCT02769065|531302099|FG012|Overall Study|Voluntary Withdrawal|0|||
147309696|NCT02769065|531302100|FG013|Overall Study|Voluntary Withdrawal|0|||
147309697|NCT02769065|531302101|FG014|Overall Study|Voluntary Withdrawal|0|||
147309698|NCT02769065|531302102|FG015|Overall Study|Voluntary Withdrawal|0|||
147309699|NCT02769065|531302103|FG016|Overall Study|Voluntary Withdrawal|0|||
147309700|NCT02769065|531302104|FG017|Overall Study|Voluntary Withdrawal|0|||
147309701|NCT02769065|531302105|FG018|Overall Study|Voluntary Withdrawal|0|||
147309702|NCT02769065|531302106|FG019|Overall Study|Voluntary Withdrawal|0|||
147309703|NCT02769065|531302107|FG020|Overall Study|Voluntary Withdrawal|0|||
147309704|NCT02769065|531302108|FG021|Overall Study|Voluntary Withdrawal|0|||
147309705|NCT02769065|531302109|FG022|Overall Study|Voluntary Withdrawal|0|||
147309706|NCT02769065|531302110|FG023|Overall Study|Voluntary Withdrawal|0|||
147309707|NCT02769065|531302111|FG024|Overall Study|Voluntary Withdrawal|0|||
147309708|NCT02769065|531302112|FG025|Overall Study|Voluntary Withdrawal|0|||
147309709|NCT02769065|531302113|FG026|Overall Study|Voluntary Withdrawal|0|||
147309710|NCT02769065|531302114|FG027|Overall Study|Voluntary Withdrawal|0|||
147309711|NCT02769065|531302115|FG028|Overall Study|Voluntary Withdrawal|0|||
147309712|NCT02769065|531302116|FG029|Overall Study|Voluntary Withdrawal|0|||
147309713|NCT02769065|531302087|FG000|Overall Study|Reason Not Specified|0|||
147309714|NCT02769065|531302088|FG001|Overall Study|Reason Not Specified|0|||
147309715|NCT02769065|531302089|FG002|Overall Study|Reason Not Specified|0|||
147104951|NCT01454284|530550447|FG001|Overall Study|Withdrawal by Subject|36|||
147104952|NCT01454284|530550446|FG000|Overall Study|Physician Decision|16|||
147104953|NCT01454284|530550447|FG001|Overall Study|Physician Decision|11|||
147104954|NCT01454284|530550446|FG000|Overall Study|Sponsor Decision|0|||
147104955|NCT01454284|530550447|FG001|Overall Study|Sponsor Decision|2|||
147104956|NCT00393367|530550448|FG000|Overall Study|Protocol Violation|2|||
147104957|NCT00393367|530550449|FG001|Overall Study|Protocol Violation|5|||
147104958|NCT00393367|530550448|FG000|Overall Study|Withdrawal by Subject|0|||
147104959|NCT00393367|530550449|FG001|Overall Study|Withdrawal by Subject|2|||
147104960|NCT04810962|530550456|FG000|Overall Study|Adverse Event|0|||
147104961|NCT04810962|530550457|FG001|Overall Study|Adverse Event|1|||
147104962|NCT04810962|530550456|FG000|Overall Study|Lost to Follow-up|2|||
147104963|NCT04810962|530550457|FG001|Overall Study|Lost to Follow-up|1|||
147104964|NCT04810962|530550456|FG000|Overall Study|Physician Decision|1|||
147104965|NCT04810962|530550457|FG001|Overall Study|Physician Decision|0|||
147104966|NCT04810962|530550456|FG000|Overall Study|Withdrawal by Subject|1|||
147104967|NCT04810962|530550457|FG001|Overall Study|Withdrawal by Subject|3|||
147104968|NCT04810962|530550456|FG000|Overall Study|IP NOT AVAILABLE; REMAINED OUT OF THE COUNTRY; NON STUDY EYE NOT ELIGIBLE ON ENDOTHELIAL CELL COUNT|2|||
147104969|NCT04810962|530550457|FG001|Overall Study|IP NOT AVAILABLE; REMAINED OUT OF THE COUNTRY; NON STUDY EYE NOT ELIGIBLE ON ENDOTHELIAL CELL COUNT|1|||
147104970|NCT02412657|530550458|FG000|Overall Study|Lost to Follow-up|1|||
147104971|NCT02412657|530550459|FG001|Overall Study|Lost to Follow-up|0|||
147104972|NCT02412657|530550460|FG002|Overall Study|Lost to Follow-up|0|||
147104973|NCT02412657|530550458|FG000|Overall Study|Protocol Violation|0|||
147104974|NCT02412657|530550459|FG001|Overall Study|Protocol Violation|2|||
147104975|NCT02412657|530550460|FG002|Overall Study|Protocol Violation|3|||
147104976|NCT01281306|530550461|FG000|Overall Study|Lack of Efficacy|0|||
147104977|NCT01281306|530550462|FG001|Overall Study|Lack of Efficacy|1|||
147104978|NCT01281306|530550463|FG002|Overall Study|Lack of Efficacy|3|||
147104979|NCT01281306|530550464|FG003|Overall Study|Lack of Efficacy|0|||
147104980|NCT01281306|530550465|FG004|Overall Study|Lack of Efficacy|2|||
147104981|NCT01281306|530550466|FG005|Overall Study|Lack of Efficacy|0|||
147104982|NCT01281306|530550467|FG006|Overall Study|Lack of Efficacy|1|||
147104983|NCT01281306|530550461|FG000|Overall Study|Withdrawal by Subject|1|||
147104984|NCT01281306|530550462|FG001|Overall Study|Withdrawal by Subject|0|||
147104985|NCT01281306|530550463|FG002|Overall Study|Withdrawal by Subject|2|||
147104986|NCT01281306|530550464|FG003|Overall Study|Withdrawal by Subject|4|||
147104987|NCT01281306|530550465|FG004|Overall Study|Withdrawal by Subject|1|||
147104988|NCT01281306|530550466|FG005|Overall Study|Withdrawal by Subject|3|||
147104989|NCT01281306|530550467|FG006|Overall Study|Withdrawal by Subject|1|||
147104990|NCT01281306|530550461|FG000|Overall Study|Protocol deviation|0|||
147104991|NCT01281306|530550462|FG001|Overall Study|Protocol deviation|1|||
147104992|NCT01281306|530550463|FG002|Overall Study|Protocol deviation|1|||
147104993|NCT01281306|530550464|FG003|Overall Study|Protocol deviation|1|||
147104994|NCT01281306|530550465|FG004|Overall Study|Protocol deviation|1|||
147104995|NCT01281306|530550466|FG005|Overall Study|Protocol deviation|0|||
147104996|NCT01281306|530550467|FG006|Overall Study|Protocol deviation|0|||
147104997|NCT01281306|530550461|FG000|Overall Study|Condition no longer requires study drug|1|||
147104998|NCT01281306|530550462|FG001|Overall Study|Condition no longer requires study drug|0|||
147104999|NCT01281306|530550463|FG002|Overall Study|Condition no longer requires study drug|0|||
147105000|NCT01281306|530550464|FG003|Overall Study|Condition no longer requires study drug|0|||
147105001|NCT01281306|530550465|FG004|Overall Study|Condition no longer requires study drug|0|||
147105002|NCT01281306|530550466|FG005|Overall Study|Condition no longer requires study drug|1|||
147105003|NCT01281306|530550467|FG006|Overall Study|Condition no longer requires study drug|1|||
147105004|NCT01281306|530550461|FG000|Overall Study|Lost to Follow-up|1|||
147105005|NCT01281306|530550462|FG001|Overall Study|Lost to Follow-up|0|||
147105006|NCT01281306|530550463|FG002|Overall Study|Lost to Follow-up|0|||
147105007|NCT01281306|530550464|FG003|Overall Study|Lost to Follow-up|2|||
147105008|NCT01281306|530550465|FG004|Overall Study|Lost to Follow-up|0|||
147105009|NCT01281306|530550466|FG005|Overall Study|Lost to Follow-up|0|||
147105010|NCT01281306|530550467|FG006|Overall Study|Lost to Follow-up|1|||
147105011|NCT01281306|530550461|FG000|Overall Study|Death|1|||
147105012|NCT01281306|530550462|FG001|Overall Study|Death|0|||
147105013|NCT01281306|530550463|FG002|Overall Study|Death|0|||
147105014|NCT01281306|530550464|FG003|Overall Study|Death|0|||
147105015|NCT01281306|530550465|FG004|Overall Study|Death|0|||
147105016|NCT01281306|530550466|FG005|Overall Study|Death|0|||
147105017|NCT01281306|530550467|FG006|Overall Study|Death|0|||
147105018|NCT01281306|530550461|FG000|Overall Study|Adverse Event|3|||
147105019|NCT01281306|530550462|FG001|Overall Study|Adverse Event|2|||
147105020|NCT01281306|530550463|FG002|Overall Study|Adverse Event|2|||
147105021|NCT01281306|530550464|FG003|Overall Study|Adverse Event|3|||
147105022|NCT01281306|530550465|FG004|Overall Study|Adverse Event|5|||
147105023|NCT01281306|530550466|FG005|Overall Study|Adverse Event|3|||
147105024|NCT01281306|530550467|FG006|Overall Study|Adverse Event|3|||
147105025|NCT01281306|530550461|FG000|Overall Study|Randomized in error|1|||
147105026|NCT01281306|530550462|FG001|Overall Study|Randomized in error|0|||
147105027|NCT01281306|530550463|FG002|Overall Study|Randomized in error|0|||
147105028|NCT01281306|530550464|FG003|Overall Study|Randomized in error|1|||
147105029|NCT01281306|530550465|FG004|Overall Study|Randomized in error|0|||
147105030|NCT01281306|530550466|FG005|Overall Study|Randomized in error|0|||
147105031|NCT01281306|530550467|FG006|Overall Study|Randomized in error|0|||
147105032|NCT02410629|530550468|FG000|Overall Study|Family cannot commit to the study|2|||
147105033|NCT02410629|530550469|FG001|Overall Study|Family cannot commit to the study|1|||
147105034|NCT02410629|530550468|FG000|Overall Study|Subject returned to work|1|||
147554319|NCT01725451|532185575|FG001|Washout From Period 3|Protocol Violation|0|||
147105035|NCT02410629|530550469|FG001|Overall Study|Subject returned to work|0|||
147105036|NCT02410629|530550468|FG000|Overall Study|Subject moved back to home country|0|||
147105037|NCT02410629|530550469|FG001|Overall Study|Subject moved back to home country|1|||
147105038|NCT02410629|530550468|FG000|Overall Study|Subject underwent heart surgery|0|||
147105039|NCT02410629|530550469|FG001|Overall Study|Subject underwent heart surgery|1|||
147105040|NCT01206764|530550470|FG000|Overall Study|Adverse Event|20|||
147105041|NCT01206764|530550470|FG000|Overall Study|Abnormal laboratory value|2|||
147105042|NCT01206764|530550470|FG000|Overall Study|Abnormal test procedure result|1|||
147105043|NCT01206764|530550470|FG000|Overall Study|Patient withdrew consent|5|||
147105044|NCT01206764|530550470|FG000|Overall Study|Lost to Follow-up|6|||
147105045|NCT01206764|530550470|FG000|Overall Study|Death|11|||
147105046|NCT01206764|530550470|FG000|Overall Study|New cancer therapy|2|||
147105047|NCT01206764|530550470|FG000|Overall Study|Disease progression|88|||
147105048|NCT01206764|530550470|FG000|Overall Study|Protocol deviation|3|||
147105049|NCT00961415|530550475|FG000|Induction Treatment Phase|Withdrawal by Subject|11|||
147105050|NCT00961415|530550476|FG001|Induction Treatment Phase|Withdrawal by Subject|0|||
147105051|NCT00961415|530550477|FG002|Induction Treatment Phase|Withdrawal by Subject|0|||
147105052|NCT00961415|530550475|FG000|Induction Treatment Phase|Death|77|||
147105053|NCT00961415|530550476|FG001|Induction Treatment Phase|Death|0|||
147105054|NCT00961415|530550477|FG002|Induction Treatment Phase|Death|0|||
147105055|NCT00961415|530550475|FG000|Induction Treatment Phase|Protocol Violation|1|||
147105056|NCT00961415|530550476|FG001|Induction Treatment Phase|Protocol Violation|0|||
147105057|NCT00961415|530550477|FG002|Induction Treatment Phase|Protocol Violation|0|||
147105058|NCT00961415|530550475|FG000|Induction Treatment Phase|Physician Decision|2|||
147105059|NCT00961415|530550476|FG001|Induction Treatment Phase|Physician Decision|0|||
147105060|NCT00961415|530550477|FG002|Induction Treatment Phase|Physician Decision|0|||
147105061|NCT00961415|530550475|FG000|Induction Treatment Phase|Didn't meet maintenance phase criteria|27|||
147105062|NCT00961415|530550476|FG001|Induction Treatment Phase|Didn't meet maintenance phase criteria|0|||
147105063|NCT00961415|530550477|FG002|Induction Treatment Phase|Didn't meet maintenance phase criteria|0|||
147105064|NCT00961415|530550475|FG000|Induction Treatment Phase|Other Reason|5|||
147105065|NCT00961415|530550476|FG001|Induction Treatment Phase|Other Reason|0|||
147105066|NCT00961415|530550477|FG002|Induction Treatment Phase|Other Reason|0|||
147105067|NCT00961415|530550475|FG000|Maintenance Treatment Phase|Death|0|||
147105068|NCT00961415|530550476|FG001|Maintenance Treatment Phase|Death|42|||
147224172|NCT01461057|530993068|FG001|Overall Study|Progression of Disease|0|||
147224173|NCT01461057|530993067|FG000|Overall Study|Study Terminated by Sponsor|2|||
147224174|NCT01461057|530993068|FG001|Overall Study|Study Terminated by Sponsor|0|||
147224175|NCT03034200|530993069|FG000|Overall Study|Disease progression|8|||
147224176|NCT03034200|530993070|FG001|Overall Study|Disease progression|10|||
147224177|NCT03034200|530993071|FG002|Overall Study|Disease progression|4|||
147224178|NCT03034200|530993069|FG000|Overall Study|Physician Decision|2|||
147224179|NCT03034200|530993070|FG001|Overall Study|Physician Decision|0|||
147224180|NCT03034200|530993071|FG002|Overall Study|Physician Decision|3|||
147224181|NCT03034200|530993069|FG000|Overall Study|Patient off treatment for other complicating disease|0|||
147224182|NCT03034200|530993070|FG001|Overall Study|Patient off treatment for other complicating disease|1|||
147224183|NCT03034200|530993071|FG002|Overall Study|Patient off treatment for other complicating disease|0|||
147224184|NCT03034200|530993069|FG000|Overall Study|Adjuvant Therapy|0|||
147224185|NCT03034200|530993070|FG001|Overall Study|Adjuvant Therapy|0|||
147224186|NCT03034200|530993071|FG002|Overall Study|Adjuvant Therapy|1|||
147224187|NCT01288976|530993072|FG000|Overall Study|Withdrawal by Subject|58|||
147224188|NCT01288976|530993073|FG001|Overall Study|Withdrawal by Subject|12|||
147224189|NCT01288976|530993074|FG002|Overall Study|Withdrawal by Subject|9|||
147224190|NCT01288976|530993072|FG000|Overall Study|Death|98|||
147224191|NCT01288976|530993073|FG001|Overall Study|Death|6|||
147224192|NCT01288976|530993074|FG002|Overall Study|Death|4|||
147224193|NCT01288976|530993072|FG000|Overall Study|Data unavailable|22|||
147224194|NCT01288976|530993073|FG001|Overall Study|Data unavailable|9|||
147224195|NCT01288976|530993074|FG002|Overall Study|Data unavailable|7|||
147224196|NCT05523323|530993081|FG000|Overall Study|Death|26|||
147224197|NCT05523323|530993082|FG001|Overall Study|Death|21|||
147554320|NCT01725451|532185576|FG002|Washout From Period 3|Protocol Violation|1|||
147224198|NCT05523323|530993081|FG000|Overall Study|Ongoing participants|35|||
147224199|NCT05523323|530993082|FG001|Overall Study|Ongoing participants|30|||
147224200|NCT02469038|530993083|FG000|Overall Study|Physician Decision|4|||
147105069|NCT00961415|530550477|FG002|Maintenance Treatment Phase|Death|34|||
147224201|NCT02469038|530993084|FG001|Overall Study|Physician Decision|5|||
147224202|NCT03435640|530993085|FG000|Overall Study|Withdrawal by Subject|0|||
147105070|NCT00961415|530550475|FG000|Maintenance Treatment Phase|Investigators decision|0|||
147105071|NCT00961415|530550476|FG001|Maintenance Treatment Phase|Investigators decision|2|||
147105072|NCT00961415|530550477|FG002|Maintenance Treatment Phase|Investigators decision|0|||
147105073|NCT00961415|530550475|FG000|Maintenance Treatment Phase|Withdrawal by Subject|0|||
147105074|NCT00961415|530550476|FG001|Maintenance Treatment Phase|Withdrawal by Subject|3|||
147105075|NCT00961415|530550477|FG002|Maintenance Treatment Phase|Withdrawal by Subject|8|||
147105076|NCT00961415|530550475|FG000|Maintenance Treatment Phase|Other reason|0|||
147105077|NCT00961415|530550476|FG001|Maintenance Treatment Phase|Other reason|1|||
147105078|NCT00961415|530550477|FG002|Maintenance Treatment Phase|Other reason|3|||
147105079|NCT01311661|530550480|FG000|Overall Study|Adverse Event|2|||
147105080|NCT01311661|530550480|FG000|Overall Study|Protocol Violation|3|||
147105081|NCT01311661|530550480|FG000|Overall Study|Withdrawal by Subject|2|||
147105082|NCT00284856|530550481|FG000|Overall Study|Adverse Event|3|||
147105083|NCT00284856|530550482|FG001|Overall Study|Adverse Event|3|||
147105084|NCT00284856|530550483|FG002|Overall Study|Adverse Event|3|||
147105085|NCT00284856|530550481|FG000|Overall Study|Lack of Efficacy|2|||
147105086|NCT00284856|530550482|FG001|Overall Study|Lack of Efficacy|1|||
147105087|NCT00284856|530550483|FG002|Overall Study|Lack of Efficacy|8|||
147443670|NCT01987960|531788765|FG003|Period 1|administrative or other reason|0|||
147443671|NCT01987960|531788762|FG000|Period 1|Withdrawal of consent before treatment|4|||
147105088|NCT00284856|530550481|FG000|Overall Study|Lost to Follow-up|25|||
147105089|NCT00284856|530550482|FG001|Overall Study|Lost to Follow-up|21|||
147105090|NCT00284856|530550483|FG002|Overall Study|Lost to Follow-up|22|||
147105091|NCT00284856|530550481|FG000|Overall Study|Protocol Violation|5|||
147105092|NCT00284856|530550482|FG001|Overall Study|Protocol Violation|4|||
147105093|NCT00284856|530550483|FG002|Overall Study|Protocol Violation|5|||
147105094|NCT00284856|530550481|FG000|Overall Study|Withdrawal by Subject|12|||
147105095|NCT00284856|530550482|FG001|Overall Study|Withdrawal by Subject|16|||
147105096|NCT00284856|530550483|FG002|Overall Study|Withdrawal by Subject|18|||
147105097|NCT00284856|530550481|FG000|Overall Study|Other|4|||
147105098|NCT00284856|530550482|FG001|Overall Study|Other|5|||
147105099|NCT00284856|530550483|FG002|Overall Study|Other|4|||
147105100|NCT03692949|530550484|FG000|Overall Study|Lost to Follow-up|0|||
147105101|NCT03692949|530550485|FG001|Overall Study|Lost to Follow-up|0|||
147105102|NCT03692949|530550486|FG002|Overall Study|Lost to Follow-up|0|||
147105103|NCT03692949|530550487|FG003|Overall Study|Lost to Follow-up|0|||
147105104|NCT03692949|530550488|FG004|Overall Study|Lost to Follow-up|0|||
147105105|NCT03692949|530550489|FG005|Overall Study|Lost to Follow-up|0|||
147105106|NCT03692949|530550490|FG006|Overall Study|Lost to Follow-up|0|||
147105107|NCT03692949|530550491|FG007|Overall Study|Lost to Follow-up|1|||
147105108|NCT00833755|530550500|FG000|Overall Study|Physician Decision|4|||
147105109|NCT00833755|530550501|FG001|Overall Study|Physician Decision|4|||
147105110|NCT00833755|530550502|FG002|Overall Study|Physician Decision|2|||
147105111|NCT00833755|530550503|FG003|Overall Study|Physician Decision|6|||
147105112|NCT00833755|530550500|FG000|Overall Study|Subject had scheduling issues|0|||
147105113|NCT00833755|530550501|FG001|Overall Study|Subject had scheduling issues|1|||
147224203|NCT03435640|530993086|FG001|Overall Study|Withdrawal by Subject|1|||
147224204|NCT03435640|530993087|FG002|Overall Study|Withdrawal by Subject|0|||
147224205|NCT03435640|530993088|FG003|Overall Study|Withdrawal by Subject|2|||
147224206|NCT03435640|530993089|FG004|Overall Study|Withdrawal by Subject|0|||
147224207|NCT03435640|530993090|FG005|Overall Study|Withdrawal by Subject|0|||
147224208|NCT03435640|530993091|FG006|Overall Study|Withdrawal by Subject|3|||
147224209|NCT03435640|530993092|FG007|Overall Study|Withdrawal by Subject|0|||
147224210|NCT03435640|530993093|FG008|Overall Study|Withdrawal by Subject|0|||
147224211|NCT03435640|530993094|FG009|Overall Study|Withdrawal by Subject|2|||
147224212|NCT03435640|530993095|FG010|Overall Study|Withdrawal by Subject|3|||
147224213|NCT03435640|530993085|FG000|Overall Study|Lost to Follow-up|0|||
147224214|NCT03435640|530993086|FG001|Overall Study|Lost to Follow-up|0|||
147224215|NCT03435640|530993087|FG002|Overall Study|Lost to Follow-up|1|||
147224216|NCT03435640|530993088|FG003|Overall Study|Lost to Follow-up|0|||
147224217|NCT03435640|530993089|FG004|Overall Study|Lost to Follow-up|0|||
147224218|NCT03435640|530993090|FG005|Overall Study|Lost to Follow-up|0|||
147224219|NCT03435640|530993091|FG006|Overall Study|Lost to Follow-up|0|||
147224220|NCT03435640|530993092|FG007|Overall Study|Lost to Follow-up|0|||
147105114|NCT00833755|530550502|FG002|Overall Study|Subject had scheduling issues|0|||
147105115|NCT00833755|530550503|FG003|Overall Study|Subject had scheduling issues|0|||
147224221|NCT03435640|530993093|FG008|Overall Study|Lost to Follow-up|0|||
147224222|NCT03435640|530993094|FG009|Overall Study|Lost to Follow-up|0|||
147224223|NCT03435640|530993095|FG010|Overall Study|Lost to Follow-up|0|||
147105116|NCT00262925|530550504|FG000|Overall Study|Lack of Efficacy|3|||
147105117|NCT00262925|530550504|FG000|Overall Study|Adverse Event|4|||
147105118|NCT00262925|530550504|FG000|Overall Study|Death|2|||
147224224|NCT00636987|530993096|FG000|Overall Study|Death|44|||
147443672|NCT01987960|531788763|FG001|Period 1|Withdrawal of consent before treatment|0|||
147443673|NCT01987960|531788764|FG002|Period 1|Withdrawal of consent before treatment|0|||
147443674|NCT01987960|531788765|FG003|Period 1|Withdrawal of consent before treatment|0|||
147443675|NCT01987960|531788762|FG000|Period 2|Adverse Event|0|||
147443676|NCT01987960|531788763|FG001|Period 2|Adverse Event|0|||
147309716|NCT02769065|531302090|FG003|Overall Study|Reason Not Specified|0|||
147309717|NCT02769065|531302091|FG004|Overall Study|Reason Not Specified|0|||
147309718|NCT02769065|531302092|FG005|Overall Study|Reason Not Specified|0|||
147309719|NCT02769065|531302093|FG006|Overall Study|Reason Not Specified|1|||
147309720|NCT02769065|531302094|FG007|Overall Study|Reason Not Specified|0|||
147309721|NCT02769065|531302095|FG008|Overall Study|Reason Not Specified|0|||
147309722|NCT02769065|531302096|FG009|Overall Study|Reason Not Specified|0|||
147309723|NCT02769065|531302097|FG010|Overall Study|Reason Not Specified|0|||
147309724|NCT02769065|531302098|FG011|Overall Study|Reason Not Specified|0|||
147309725|NCT02769065|531302099|FG012|Overall Study|Reason Not Specified|0|||
147309726|NCT02769065|531302100|FG013|Overall Study|Reason Not Specified|0|||
147309727|NCT02769065|531302101|FG014|Overall Study|Reason Not Specified|0|||
147309728|NCT02769065|531302102|FG015|Overall Study|Reason Not Specified|0|||
147309729|NCT02769065|531302103|FG016|Overall Study|Reason Not Specified|0|||
147309730|NCT02769065|531302104|FG017|Overall Study|Reason Not Specified|0|||
147309731|NCT02769065|531302105|FG018|Overall Study|Reason Not Specified|0|||
147309732|NCT02769065|531302106|FG019|Overall Study|Reason Not Specified|0|||
147309733|NCT02769065|531302107|FG020|Overall Study|Reason Not Specified|0|||
147309734|NCT02769065|531302108|FG021|Overall Study|Reason Not Specified|0|||
147309735|NCT02769065|531302109|FG022|Overall Study|Reason Not Specified|0|||
147105119|NCT00262925|530550504|FG000|Overall Study|alternative therapy|1|||
147105120|NCT00262925|530550504|FG000|Overall Study|Other|1|||
147105121|NCT04682301|530550505|FG000|Overall Study|Participant enrolled in Aim I only.|60|||
147105122|NCT04682301|530550505|FG000|Overall Study|Death|2|||
147105123|NCT00560404|530550506|FG000|Overall Study|Adverse Event|2|||
147105124|NCT00560404|530550507|FG001|Overall Study|Adverse Event|3|||
147105125|NCT00560404|530550506|FG000|Overall Study|Death|3|||
147105126|NCT00560404|530550507|FG001|Overall Study|Death|3|||
147105127|NCT00560404|530550506|FG000|Overall Study|Protocol Violation|12|||
147105128|NCT00560404|530550507|FG001|Overall Study|Protocol Violation|7|||
147105129|NCT00560404|530550506|FG000|Overall Study|Administrative Reasons|1|||
147309736|NCT02769065|531302110|FG023|Overall Study|Reason Not Specified|0|||
147309737|NCT02769065|531302111|FG024|Overall Study|Reason Not Specified|0|||
147309738|NCT02769065|531302112|FG025|Overall Study|Reason Not Specified|0|||
147309739|NCT02769065|531302113|FG026|Overall Study|Reason Not Specified|0|||
147309740|NCT02769065|531302114|FG027|Overall Study|Reason Not Specified|0|||
147309741|NCT02769065|531302115|FG028|Overall Study|Reason Not Specified|0|||
147309742|NCT02769065|531302116|FG029|Overall Study|Reason Not Specified|0|||
147309743|NCT02769065|531302087|FG000|Overall Study|Pre-treatment Event/Adverse Event|0|||
147309744|NCT02769065|531302088|FG001|Overall Study|Pre-treatment Event/Adverse Event|0|||
147309745|NCT02769065|531302089|FG002|Overall Study|Pre-treatment Event/Adverse Event|0|||
147309746|NCT02769065|531302090|FG003|Overall Study|Pre-treatment Event/Adverse Event|0|||
147309747|NCT02769065|531302091|FG004|Overall Study|Pre-treatment Event/Adverse Event|0|||
147309748|NCT02769065|531302092|FG005|Overall Study|Pre-treatment Event/Adverse Event|0|||
147309749|NCT02769065|531302093|FG006|Overall Study|Pre-treatment Event/Adverse Event|0|||
147309750|NCT02769065|531302094|FG007|Overall Study|Pre-treatment Event/Adverse Event|0|||
147309751|NCT02769065|531302095|FG008|Overall Study|Pre-treatment Event/Adverse Event|0|||
147309752|NCT02769065|531302096|FG009|Overall Study|Pre-treatment Event/Adverse Event|0|||
147309753|NCT02769065|531302097|FG010|Overall Study|Pre-treatment Event/Adverse Event|1|||
147309754|NCT02769065|531302098|FG011|Overall Study|Pre-treatment Event/Adverse Event|0|||
147309755|NCT02769065|531302099|FG012|Overall Study|Pre-treatment Event/Adverse Event|0|||
147105130|NCT00560404|530550507|FG001|Overall Study|Administrative Reasons|1|||
147224225|NCT00636987|530993096|FG000|Overall Study|Explanted|13|||
147224226|NCT00636987|530993096|FG000|Overall Study|Lost to Follow-up|63|||
147224227|NCT00636987|530993096|FG000|Overall Study|5 year visit window not complete|69|||
147224228|NCT01251146|530993097|FG000|Overall Study|Lost to Follow-up|3|||
147224229|NCT01251146|530993098|FG001|Overall Study|Lost to Follow-up|10|||
147224230|NCT01739400|530993099|FG000|Overall Study|Physician Decision|3|||
147224231|NCT01739400|530993100|FG001|Overall Study|Physician Decision|0|||
147224232|NCT01739400|530993099|FG000|Overall Study|Lost to Follow-up|2|||
147224233|NCT01739400|530993100|FG001|Overall Study|Lost to Follow-up|0|||
147224234|NCT01739400|530993099|FG000|Overall Study|Death|5|||
147224235|NCT01739400|530993100|FG001|Overall Study|Death|2|||
147224236|NCT01739400|530993099|FG000|Overall Study|Withdrawal by Subject|7|||
147309756|NCT02769065|531302100|FG013|Overall Study|Pre-treatment Event/Adverse Event|0|||
147309757|NCT02769065|531302101|FG014|Overall Study|Pre-treatment Event/Adverse Event|0|||
147309758|NCT02769065|531302102|FG015|Overall Study|Pre-treatment Event/Adverse Event|0|||
147105131|NCT00560404|530550506|FG000|Overall Study|Withdrew Consent|4|||
147224237|NCT01739400|530993100|FG001|Overall Study|Withdrawal by Subject|7|||
147309759|NCT02769065|531302103|FG016|Overall Study|Pre-treatment Event/Adverse Event|0|||
147309760|NCT02769065|531302104|FG017|Overall Study|Pre-treatment Event/Adverse Event|0|||
147105132|NCT00560404|530550507|FG001|Overall Study|Withdrew Consent|0|||
147105133|NCT00560404|530550506|FG000|Overall Study|Failure to return|1|||
147105134|NCT00560404|530550507|FG001|Overall Study|Failure to return|2|||
147309761|NCT02769065|531302105|FG018|Overall Study|Pre-treatment Event/Adverse Event|0|||
147309762|NCT02769065|531302106|FG019|Overall Study|Pre-treatment Event/Adverse Event|0|||
147309763|NCT02769065|531302107|FG020|Overall Study|Pre-treatment Event/Adverse Event|0|||
147309764|NCT02769065|531302108|FG021|Overall Study|Pre-treatment Event/Adverse Event|0|||
147309765|NCT02769065|531302109|FG022|Overall Study|Pre-treatment Event/Adverse Event|0|||
147309766|NCT02769065|531302110|FG023|Overall Study|Pre-treatment Event/Adverse Event|0|||
147309767|NCT02769065|531302111|FG024|Overall Study|Pre-treatment Event/Adverse Event|0|||
147309768|NCT02769065|531302112|FG025|Overall Study|Pre-treatment Event/Adverse Event|0|||
147309769|NCT02769065|531302113|FG026|Overall Study|Pre-treatment Event/Adverse Event|0|||
147309770|NCT02769065|531302114|FG027|Overall Study|Pre-treatment Event/Adverse Event|0|||
147309771|NCT02769065|531302115|FG028|Overall Study|Pre-treatment Event/Adverse Event|0|||
147309772|NCT02769065|531302116|FG029|Overall Study|Pre-treatment Event/Adverse Event|0|||
147309773|NCT03017235|531302117|FG000|Overall Study|Withdrawal by Subject|4|||
147309774|NCT03017235|531302118|FG001|Overall Study|Withdrawal by Subject|3|||
147105135|NCT00560404|530550506|FG000|Overall Study|Other withdrawal reason|13|||
147105136|NCT00560404|530550507|FG001|Overall Study|Other withdrawal reason|5|||
147105137|NCT02187783|530550514|FG000|Overall Study|Adverse Event|8|||
147105138|NCT02187783|530550514|FG000|Overall Study|Death|3|||
147105139|NCT02187783|530550514|FG000|Overall Study|Progressive disease|80|||
147105140|NCT02187783|530550514|FG000|Overall Study|Protocol Violation|3|||
147105141|NCT02187783|530550514|FG000|Overall Study|Physician Decision|2|||
147105142|NCT02187783|530550514|FG000|Overall Study|Withdrawal by Subject|9|||
147105143|NCT02187783|530550514|FG000|Overall Study|Study terminated by sponsor|1|||
147224238|NCT03350984|530993101|FG000|Overall Study|Death|1|||
147309775|NCT03017235|531302117|FG000|Overall Study|Lost to Follow-up|2|||
147309776|NCT03017235|531302118|FG001|Overall Study|Lost to Follow-up|7|||
147309777|NCT03017235|531302117|FG000|Overall Study|Adverse Event|0|||
147309778|NCT03017235|531302118|FG001|Overall Study|Adverse Event|1|||
147309779|NCT03017235|531302117|FG000|Overall Study|Protocol Violation|2|||
147309780|NCT03017235|531302118|FG001|Overall Study|Protocol Violation|1|||
147309781|NCT03017235|531302117|FG000|Overall Study|Cancer, emergency, allergy, active UTI|4|||
147309782|NCT03017235|531302118|FG001|Overall Study|Cancer, emergency, allergy, active UTI|2|||
147309783|NCT00437125|531302119|FG000|Overall Study|Adverse Event|12|||
147309784|NCT00437125|531302119|FG000|Overall Study|Death|1|||
147309785|NCT00437125|531302119|FG000|Overall Study|Clinical Relapse|1|||
147309786|NCT00437125|531302119|FG000|Overall Study|Lack of Efficacy|1|||
147309787|NCT00437125|531302119|FG000|Overall Study|Lost to Follow-up|1|||
147309788|NCT00437125|531302119|FG000|Overall Study|Withdrawal by Subject|13|||
147309789|NCT00437125|531302119|FG000|Overall Study|Withdrawal by Caregiver|2|||
147309790|NCT00437125|531302119|FG000|Overall Study|Physician Decision|1|||
147309791|NCT02248961|531302120|FG000|Overall Study|Adverse Event|1|||
147309792|NCT02248961|531302121|FG001|Overall Study|Adverse Event|0|||
147309793|NCT02248961|531302120|FG000|Overall Study|Withdrawal by Subject|1|||
147309794|NCT02248961|531302121|FG001|Overall Study|Withdrawal by Subject|2|||
147309795|NCT02248961|531302120|FG000|Overall Study|Unmet inclusion/exclusion criteria|1|||
147309796|NCT02248961|531302121|FG001|Overall Study|Unmet inclusion/exclusion criteria|0|||
147309797|NCT03518658|531302122|FG000|Overall Study|Other|51|||
147309798|NCT03518658|531302123|FG001|Overall Study|Other|0|||
147309799|NCT02531295|531302124|FG000|Overall Study|The study was terminated (Halted Prematurely).|0|||
147309800|NCT02531295|531302125|FG001|Overall Study|The study was terminated (Halted Prematurely).|0|||
147309801|NCT02531295|531302126|FG002|Overall Study|The study was terminated (Halted Prematurely).|0|||
147309802|NCT02531295|531302127|FG003|Overall Study|The study was terminated (Halted Prematurely).|0|||
147309803|NCT02531295|531302128|FG004|Overall Study|The study was terminated (Halted Prematurely).|0|||
147309804|NCT02531295|531302129|FG005|Overall Study|The study was terminated (Halted Prematurely).|1|||
147224239|NCT03350984|530993102|FG001|Overall Study|Death|0|||
147224240|NCT03350984|530993101|FG000|Overall Study|Lost to Follow-up|5|||
147224241|NCT03350984|530993102|FG001|Overall Study|Lost to Follow-up|6|||
147224242|NCT03350984|530993101|FG000|Overall Study|Protocol Violation|1|||
147224243|NCT03350984|530993102|FG001|Overall Study|Protocol Violation|2|||
147224244|NCT03350984|530993101|FG000|Overall Study|Physician Decision|1|||
147224245|NCT03350984|530993102|FG001|Overall Study|Physician Decision|0|||
147224246|NCT00642473|530993103|FG000|Overall Study|Withdrawal by Subject|0|||
147224247|NCT00642473|530993104|FG001|Overall Study|Withdrawal by Subject|5|||
147224248|NCT00642473|530993103|FG000|Overall Study|Progression or death|2|||
147309805|NCT00649389|531302130|FG000|Overall Study|Adverse Event|22|||
147105144|NCT03344757|530550515|FG000|Overall Study|Withdrawal by Subject|18|||
147105145|NCT03344757|530550516|FG001|Overall Study|Withdrawal by Subject|16|||
147224249|NCT00642473|530993104|FG001|Overall Study|Progression or death|4|||
147224250|NCT00642473|530993103|FG000|Overall Study|Other|2|||
147224251|NCT00642473|530993104|FG001|Overall Study|Other|2|||
147309806|NCT00649389|531302131|FG001|Overall Study|Adverse Event|46|||
147309807|NCT00649389|531302132|FG002|Overall Study|Adverse Event|38|||
147309808|NCT00649389|531302133|FG003|Overall Study|Adverse Event|48|||
147309809|NCT00649389|531302130|FG000|Overall Study|Lost to Follow-up|15|||
147105146|NCT03344757|530550515|FG000|Overall Study|Lost to Follow-up|0|||
147224252|NCT01347307|530993105|FG000|Overall Study|Death|0|||
147224253|NCT01347307|530993106|FG001|Overall Study|Death|4|||
147224254|NCT01347307|530993105|FG000|Overall Study|Physician Decision|0|||
147443677|NCT01987960|531788764|FG002|Period 2|Adverse Event|1|||
147443678|NCT01987960|531788765|FG003|Period 2|Adverse Event|0|||
147105147|NCT03344757|530550516|FG001|Overall Study|Lost to Follow-up|2|||
147105148|NCT00269152|530550517|FG000|Overall Study|Adverse Event|9|||
147105149|NCT00269152|530550518|FG001|Overall Study|Adverse Event|3|||
147224255|NCT01347307|530993106|FG001|Overall Study|Physician Decision|1|||
147224256|NCT00920829|530993108|FG000|Allocation|No post randomization data|3|||
147224257|NCT00920829|530993109|FG001|Allocation|No post randomization data|1|||
147224258|NCT00920829|530993110|FG002|Allocation|No post randomization data|0|||
147224259|NCT00920829|530993111|FG003|Allocation|No post randomization data|2|||
147224260|NCT00920829|530993108|FG000|Available for Analysis|Withdrawal by Subject|6|||
147224261|NCT00920829|530993109|FG001|Available for Analysis|Withdrawal by Subject|6|||
147224262|NCT00920829|530993110|FG002|Available for Analysis|Withdrawal by Subject|6|||
147224263|NCT00920829|530993111|FG003|Available for Analysis|Withdrawal by Subject|10|||
147224264|NCT00920829|530993108|FG000|Available for Analysis|Required Medical Treatment|0|||
147224265|NCT00920829|530993109|FG001|Available for Analysis|Required Medical Treatment|1|||
147224266|NCT00920829|530993110|FG002|Available for Analysis|Required Medical Treatment|2|||
147224267|NCT00920829|530993111|FG003|Available for Analysis|Required Medical Treatment|0|||
147224268|NCT00920829|530993108|FG000|Available for Analysis|Adverse Event|1|||
147224269|NCT00920829|530993109|FG001|Available for Analysis|Adverse Event|2|||
147224270|NCT00920829|530993110|FG002|Available for Analysis|Adverse Event|1|||
147224271|NCT00920829|530993111|FG003|Available for Analysis|Adverse Event|0|||
147224272|NCT00920829|530993108|FG000|Available for Analysis|Death|1|||
147224273|NCT00920829|530993109|FG001|Available for Analysis|Death|0|||
147224274|NCT00920829|530993110|FG002|Available for Analysis|Death|0|||
147224275|NCT00920829|530993111|FG003|Available for Analysis|Death|0|||
147224276|NCT00920829|530993108|FG000|Available for Analysis|Protocol Violation|0|||
147224277|NCT00920829|530993109|FG001|Available for Analysis|Protocol Violation|0|||
147224278|NCT00920829|530993110|FG002|Available for Analysis|Protocol Violation|1|||
147224279|NCT00920829|530993111|FG003|Available for Analysis|Protocol Violation|0|||
147224280|NCT00920829|530993108|FG000|Available for Analysis|Required more treatment|0|||
147224281|NCT00920829|530993109|FG001|Available for Analysis|Required more treatment|2|||
147224282|NCT00920829|530993110|FG002|Available for Analysis|Required more treatment|0|||
147224283|NCT00920829|530993111|FG003|Available for Analysis|Required more treatment|1|||
147224284|NCT04533880|530993112|FG000|Overall Study|Lost to Follow-up|0|||
147224285|NCT04533880|530993113|FG001|Overall Study|Lost to Follow-up|1|||
147224286|NCT04533880|530993114|FG002|Overall Study|Lost to Follow-up|1|||
147224287|NCT02284178|530993117|FG000|Overall Study|Met exclusion criteria|49|||
147224288|NCT02284178|530993118|FG001|Overall Study|Met exclusion criteria|54|||
147224289|NCT01483690|530993121|FG000|Overall Study|Adverse Event|1|||
147224290|NCT01483690|530993122|FG001|Overall Study|Adverse Event|2|||
147224291|NCT01483690|530993121|FG000|Overall Study|clinical deterioration|1|||
147224292|NCT01483690|530993122|FG001|Overall Study|clinical deterioration|0|||
147224293|NCT01483690|530993121|FG000|Overall Study|Physician Decision|0|||
147224294|NCT01483690|530993122|FG001|Overall Study|Physician Decision|2|||
147224295|NCT01483690|530993121|FG000|Overall Study|exclusionary procedure|0|||
147224296|NCT01483690|530993122|FG001|Overall Study|exclusionary procedure|1|||
147224297|NCT02239224|530993131|FG000|Overall Study|Administrative|0|||
147224298|NCT02239224|530993132|FG001|Overall Study|Administrative|0|||
147224299|NCT02239224|530993133|FG002|Overall Study|Administrative|3|||
147224300|NCT02239224|530993134|FG003|Overall Study|Administrative|1|||
147224301|NCT00737464|530993136|FG000|Overall Study|Adverse Event|1|||
147224302|NCT00737464|530993136|FG000|Overall Study|Death|6|||
147224303|NCT00737464|530993136|FG000|Overall Study|Other - Failure to Return|1|||
147224304|NCT00737464|530993136|FG000|Overall Study|Refused Treatment / Withdrew Consent|6|||
147224305|NCT00737464|530993136|FG000|Overall Study|Other reasons|4|||
147224306|NCT03190369|530993139|FG000|Overall Study|Poor compliance to protocol|0|||
147224307|NCT03190369|530993140|FG001|Overall Study|Poor compliance to protocol|1|||
147224308|NCT03190369|530993139|FG000|Overall Study|Withdraw before treatment|1|||
147224309|NCT03190369|530993140|FG001|Overall Study|Withdraw before treatment|5|||
147224310|NCT03190369|530993139|FG000|Overall Study|Randomized but not treated|0|||
147224311|NCT03190369|530993140|FG001|Overall Study|Randomized but not treated|2|||
147224312|NCT04543409|530993141|FG000|Double-Blind Treatment Period|Withdrawal by Subject|1|||
147224313|NCT04543409|530993142|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
147224314|NCT04543409|530993141|FG000|Double-Blind Treatment Period|Subject perceives the IP to be ineffective.|1|||
147224315|NCT04543409|530993142|FG001|Double-Blind Treatment Period|Subject perceives the IP to be ineffective.|0|||
147224316|NCT04543409|530993141|FG000|Open-Label Treatment Period|Lost to Follow-up|0|||
147224317|NCT04543409|530993142|FG001|Open-Label Treatment Period|Lost to Follow-up|1|||
147224318|NCT04543409|530993141|FG000|Open-Label Treatment Period|Study terminated by sponsor|17|||
147224319|NCT04543409|530993142|FG001|Open-Label Treatment Period|Study terminated by sponsor|19|||
147224320|NCT04543409|530993141|FG000|Open-Label Treatment Period|Withdrawal by Subject|4|||
147224321|NCT04543409|530993142|FG001|Open-Label Treatment Period|Withdrawal by Subject|3|||
147224322|NCT04543409|530993141|FG000|Open-Label Extension Treatment Period|Adverse Event|0|||
147105150|NCT00269152|530550517|FG000|Overall Study|Withdrawal by Subject|7|||
147554321|NCT01725451|532185577|FG003|Washout From Period 3|Protocol Violation|0|||
147554322|NCT01725451|532185574|FG000|Washout From Period 3|Adverse Event|0|||
147554323|NCT01725451|532185575|FG001|Washout From Period 3|Adverse Event|1|||
147554324|NCT01725451|532185576|FG002|Washout From Period 3|Adverse Event|0|||
147554325|NCT01725451|532185577|FG003|Washout From Period 3|Adverse Event|0|||
147554326|NCT01725451|532185574|FG000|Period 4|Adverse Event|0|||
147554327|NCT01725451|532185575|FG001|Period 4|Adverse Event|0|||
147554328|NCT01725451|532185576|FG002|Period 4|Adverse Event|1|||
147554329|NCT01725451|532185577|FG003|Period 4|Adverse Event|0|||
147554330|NCT02015793|532185582|FG000|Overall Study|Adverse Event|3|||
147554331|NCT02015793|532185583|FG001|Overall Study|Adverse Event|3|||
147554332|NCT02015793|532185582|FG000|Overall Study|Withdrawal by Subject|1|||
147554333|NCT02015793|532185583|FG001|Overall Study|Withdrawal by Subject|1|||
147554334|NCT00320593|532185584|FG000|Overall Study|Lost to Follow-up|3|||
147554335|NCT00320593|532185585|FG001|Overall Study|Lost to Follow-up|0|||
147554336|NCT00320593|532185584|FG000|Overall Study|Moved to another state|1|||
147554337|NCT00320593|532185585|FG001|Overall Study|Moved to another state|0|||
147554338|NCT00320593|532185584|FG000|Overall Study|Withdrawal by Subject|2|||
147554339|NCT00320593|532185585|FG001|Overall Study|Withdrawal by Subject|1|||
147554340|NCT00320593|532185584|FG000|Overall Study|Withdrawal by clinical center|1|||
147554341|NCT00320593|532185585|FG001|Overall Study|Withdrawal by clinical center|0|||
147554342|NCT00283686|532185586|FG000|Overall Study|Death|1|||
147554343|NCT00283686|532185587|FG001|Overall Study|Death|1|||
147554344|NCT00283686|532185588|FG002|Overall Study|Death|1|||
147554345|NCT00283686|532185589|FG003|Overall Study|Death|0|||
147554346|NCT00283686|532185586|FG000|Overall Study|Lost to Follow-up|21|||
147554347|NCT00283686|532185587|FG001|Overall Study|Lost to Follow-up|31|||
147554348|NCT00283686|532185588|FG002|Overall Study|Lost to Follow-up|26|||
147554349|NCT00283686|532185589|FG003|Overall Study|Lost to Follow-up|20|||
147554350|NCT00283686|532185586|FG000|Overall Study|Less than full participation|7|||
147554351|NCT00283686|532185587|FG001|Overall Study|Less than full participation|9|||
147554352|NCT00283686|532185588|FG002|Overall Study|Less than full participation|6|||
147554353|NCT00283686|532185589|FG003|Overall Study|Less than full participation|12|||
147224323|NCT04543409|530993142|FG001|Open-Label Extension Treatment Period|Adverse Event|1|||
147224324|NCT04543409|530993141|FG000|Open-Label Extension Treatment Period|Lost to Follow-up|1|||
147224325|NCT04543409|530993142|FG001|Open-Label Extension Treatment Period|Lost to Follow-up|0|||
147224326|NCT04543409|530993141|FG000|Open-Label Extension Treatment Period|Study terminated by sponsor|44|||
147224327|NCT04543409|530993142|FG001|Open-Label Extension Treatment Period|Study terminated by sponsor|44|||
147224328|NCT04543409|530993141|FG000|Open-Label Extension Treatment Period|Withdrawal by Subject|0|||
147224329|NCT04543409|530993142|FG001|Open-Label Extension Treatment Period|Withdrawal by Subject|1|||
147224330|NCT04543409|530993141|FG000|Open-Label Extension Treatment Period|Unable to schedule gastroscopy|0|||
147224331|NCT04543409|530993142|FG001|Open-Label Extension Treatment Period|Unable to schedule gastroscopy|1|||
147224332|NCT04543409|530993141|FG000|Open-Label Extension Treatment Period|No study/treatment discontinuation information|0|||
147224333|NCT04543409|530993142|FG001|Open-Label Extension Treatment Period|No study/treatment discontinuation information|1|||
147224334|NCT01289782|530993143|FG000|Overall Study|Lost to Follow-up|14|||
147224335|NCT01289782|530993144|FG001|Overall Study|Lost to Follow-up|7|||
147224336|NCT01289782|530993143|FG000|Overall Study|Protocol Violation|1|||
147224337|NCT01289782|530993144|FG001|Overall Study|Protocol Violation|1|||
147224338|NCT01289782|530993143|FG000|Overall Study|Withdrawal by Subject|8|||
147224339|NCT01289782|530993144|FG001|Overall Study|Withdrawal by Subject|2|||
147224340|NCT01289782|530993143|FG000|Overall Study|Sponsor's Decision|1|||
147224341|NCT01289782|530993144|FG001|Overall Study|Sponsor's Decision|0|||
147224342|NCT01289782|530993143|FG000|Overall Study|Reason not specified|1|||
147224343|NCT01289782|530993144|FG001|Overall Study|Reason not specified|2|||
147224344|NCT02131532|530993145|FG000|Overall Study|Withdrawal by Subject|1|||
147224345|NCT02131532|530993145|FG000|Overall Study|Physician Decision|1|||
147224346|NCT02131532|530993145|FG000|Overall Study|Other health conditions|2|||
147224347|NCT02093026|530993146|FG000|Overall Study|Adverse Event|26|||
147224348|NCT02093026|530993146|FG000|Overall Study|Death|10|||
147554354|NCT00481247|532185590|FG000|Overall Study|Death|0|||
147554355|NCT00481247|532185591|FG001|Overall Study|Death|1|||
147554356|NCT00481247|532185590|FG000|Overall Study|Disease progression|18|||
147224349|NCT02093026|530993146|FG000|Overall Study|Other|157|||
147224350|NCT02195011|530993162|FG000|Overall Study|Adverse Event|4|||
147224351|NCT02195011|530993163|FG001|Overall Study|Adverse Event|0|||
147224352|NCT02195011|530993162|FG000|Overall Study|Progressive Disease|18|||
147224353|NCT02195011|530993163|FG001|Overall Study|Progressive Disease|1|||
147224354|NCT02195011|530993162|FG000|Overall Study|Withdrawal by Subject|3|||
147554357|NCT00481247|532185591|FG001|Overall Study|Disease progression|22|||
147554358|NCT00481247|532185590|FG000|Overall Study|Intolerance|42|||
147554359|NCT00481247|532185591|FG001|Overall Study|Intolerance|17|||
147554360|NCT00481247|532185590|FG000|Overall Study|Treatment failure|10|||
147554361|NCT00481247|532185591|FG001|Overall Study|Treatment failure|14|||
147554362|NCT00481247|532185590|FG000|Overall Study|AE unrelated to study drug|13|||
147554363|NCT00481247|532185591|FG001|Overall Study|AE unrelated to study drug|4|||
147554364|NCT00481247|532185590|FG000|Overall Study|Withdrawal by Subject|8|||
147105151|NCT00269152|530550518|FG001|Overall Study|Withdrawal by Subject|3|||
147105152|NCT00269152|530550517|FG000|Overall Study|Physician Decision|2|||
147105153|NCT00269152|530550518|FG001|Overall Study|Physician Decision|3|||
147105154|NCT00269152|530550517|FG000|Overall Study|Protocol Violation|0|||
147105155|NCT00269152|530550518|FG001|Overall Study|Protocol Violation|1|||
147105156|NCT00671788|530550521|FG000|Overall Study|Adverse Event|8|||
147105157|NCT00671788|530550521|FG000|Overall Study|Refused further treatment|3|||
147105158|NCT00671788|530550521|FG000|Overall Study|Ineligible|1|||
147105159|NCT00671788|530550521|FG000|Overall Study|MD Decision|1|||
147105160|NCT00671788|530550521|FG000|Overall Study|Other|1|||
147105161|NCT02792504|530550524|FG000|Overall Study|Lost to Follow-up|24|||
147105162|NCT02792504|530550524|FG000|Overall Study|Violated inclusion/exclusion criteria|6|||
147105163|NCT01035138|530550531|FG000|Overall Study|Adverse Event|4|||
147224355|NCT02195011|530993163|FG001|Overall Study|Withdrawal by Subject|0|||
147224356|NCT00174291|530993167|FG000|Overall Study|Lost to Follow-up|1|||
147224357|NCT00174291|530993168|FG001|Overall Study|Lost to Follow-up|1|||
147224358|NCT00174291|530993167|FG000|Overall Study|Protocol Violation|0|||
147224359|NCT00174291|530993168|FG001|Overall Study|Protocol Violation|2|||
147224360|NCT00174291|530993167|FG000|Overall Study|Study terminated by sponsor|1|||
147224361|NCT00174291|530993168|FG001|Overall Study|Study terminated by sponsor|0|||
147224362|NCT00174291|530993167|FG000|Overall Study|Withdrawal by Subject|3|||
147224363|NCT00174291|530993168|FG001|Overall Study|Withdrawal by Subject|3|||
147224364|NCT00450112|530993169|FG000|Overall Study|Other Treatment Required|5|||
147224365|NCT00450112|530993170|FG001|Overall Study|Other Treatment Required|1|||
147224366|NCT00450112|530993169|FG000|Overall Study|Withdrawal by Subject|4|||
147224367|NCT00450112|530993170|FG001|Overall Study|Withdrawal by Subject|1|||
147224368|NCT00450112|530993169|FG000|Overall Study|Lost to Follow-up|2|||
147224369|NCT00450112|530993170|FG001|Overall Study|Lost to Follow-up|1|||
147224370|NCT00450112|530993169|FG000|Overall Study|Others|2|||
147224371|NCT00450112|530993170|FG001|Overall Study|Others|3|||
147224372|NCT01642407|530993171|FG000|Part 1 (Screening Till Week 16)|Insufficient clinical response|3|||
147224373|NCT01642407|530993171|FG000|Part 2(Week17 to Maximum of 119.6 Weeks)|Coil Embolization|1|||
147224374|NCT01642407|530993171|FG000|Part 2(Week17 to Maximum of 119.6 Weeks)|Change of treatment plan|1|||
147224375|NCT02045303|530993172|FG000|Overall Study|Protocol Violation|2|||
147224376|NCT02045303|530993173|FG001|Overall Study|Protocol Violation|1|||
147224377|NCT02045303|530993174|FG002|Overall Study|Protocol Violation|0|||
147224378|NCT02045303|530993172|FG000|Overall Study|Withdrawal by Subject|0|||
147224379|NCT02045303|530993173|FG001|Overall Study|Withdrawal by Subject|2|||
147224380|NCT02045303|530993174|FG002|Overall Study|Withdrawal by Subject|0|||
147224381|NCT01856023|530993175|FG000|Overall Study|Death|1|||
147224382|NCT01856023|530993176|FG001|Overall Study|Death|2|||
147224383|NCT01856023|530993175|FG000|Overall Study|Adverse Event|2|||
147224384|NCT01856023|530993176|FG001|Overall Study|Adverse Event|1|||
147224385|NCT01856023|530993175|FG000|Overall Study|Lack of Efficacy|5|||
147224386|NCT01856023|530993176|FG001|Overall Study|Lack of Efficacy|5|||
147224387|NCT01856023|530993175|FG000|Overall Study|non compliance, study closure|1|||
147224388|NCT01856023|530993176|FG001|Overall Study|non compliance, study closure|3|||
147224389|NCT01856023|530993175|FG000|Overall Study|Withdrawal by Subject|1|||
147224390|NCT01856023|530993176|FG001|Overall Study|Withdrawal by Subject|1|||
147224391|NCT00829283|530993177|FG000|Overall Study|Lost to Follow-up|7|||
147224392|NCT00829283|530993178|FG001|Overall Study|Lost to Follow-up|25|||
147224393|NCT00424255|530993179|FG000|Overall Study|Death|115|||
147224394|NCT00424255|530993180|FG001|Overall Study|Death|111|||
147224395|NCT00424255|530993179|FG000|Overall Study|Lost to Follow-up|26|||
147224396|NCT00424255|530993180|FG001|Overall Study|Lost to Follow-up|20|||
147224397|NCT00424255|530993179|FG000|Overall Study|Protocol Violation|0|||
147224398|NCT00424255|530993180|FG001|Overall Study|Protocol Violation|1|||
147224399|NCT00424255|530993179|FG000|Overall Study|Withdrawal by Subject|34|||
147224400|NCT00424255|530993180|FG001|Overall Study|Withdrawal by Subject|38|||
147224401|NCT00424255|530993179|FG000|Overall Study|Physician Decision|3|||
147224402|NCT00424255|530993180|FG001|Overall Study|Physician Decision|7|||
147443679|NCT01987960|531788762|FG000|Period 2|Withdrawal by Subject|0|||
147443680|NCT01987960|531788763|FG001|Period 2|Withdrawal by Subject|0|||
147443681|NCT01987960|531788764|FG002|Period 2|Withdrawal by Subject|1|||
147105164|NCT01035138|530550532|FG001|Overall Study|Adverse Event|0|||
147105165|NCT01035138|530550533|FG002|Overall Study|Adverse Event|2|||
147105166|NCT01035138|530550531|FG000|Overall Study|Caregiver Decision|2|||
147105167|NCT01035138|530550532|FG001|Overall Study|Caregiver Decision|0|||
147224403|NCT00424255|530993179|FG000|Overall Study|Cognitive Disturbance|1|||
147224404|NCT00424255|530993180|FG001|Overall Study|Cognitive Disturbance|0|||
147224405|NCT00424255|530993179|FG000|Overall Study|Non-compliance by Participants|1|||
147224406|NCT00424255|530993180|FG001|Overall Study|Non-compliance by Participants|0|||
147224407|NCT00424255|530993179|FG000|Overall Study|Fatigue|1|||
147224408|NCT00424255|530993180|FG001|Overall Study|Fatigue|0|||
147224409|NCT00424255|530993179|FG000|Overall Study|Disease Progression|0|||
147224410|NCT00424255|530993180|FG001|Overall Study|Disease Progression|2|||
147224411|NCT00424255|530993179|FG000|Overall Study|Sponsor Terminated Study|161|||
147224412|NCT00424255|530993180|FG001|Overall Study|Sponsor Terminated Study|167|||
147309810|NCT00649389|531302131|FG001|Overall Study|Lost to Follow-up|17|||
147309811|NCT00649389|531302132|FG002|Overall Study|Lost to Follow-up|21|||
147309812|NCT00649389|531302133|FG003|Overall Study|Lost to Follow-up|26|||
147309813|NCT00649389|531302130|FG000|Overall Study|Protocol Violation|11|||
147309814|NCT00649389|531302131|FG001|Overall Study|Protocol Violation|13|||
147309815|NCT00649389|531302132|FG002|Overall Study|Protocol Violation|9|||
147309816|NCT00649389|531302133|FG003|Overall Study|Protocol Violation|8|||
147309817|NCT00649389|531302130|FG000|Overall Study|Withdrawal by Subject|20|||
147309818|NCT00649389|531302131|FG001|Overall Study|Withdrawal by Subject|21|||
147309819|NCT00649389|531302132|FG002|Overall Study|Withdrawal by Subject|19|||
147309820|NCT00649389|531302133|FG003|Overall Study|Withdrawal by Subject|23|||
147309821|NCT00649389|531302130|FG000|Overall Study|Other|3|||
147309822|NCT00649389|531302131|FG001|Overall Study|Other|9|||
147309823|NCT00649389|531302132|FG002|Overall Study|Other|1|||
147309824|NCT00649389|531302133|FG003|Overall Study|Other|6|||
147309825|NCT00453310|531302136|FG000|Overall Study|Progression of Disease|10|||
147309826|NCT00244374|531302139|FG000|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|105|||
147309827|NCT00244374|531302140|FG001|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0|||
147309828|NCT00244374|531302141|FG002|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0|||
147309829|NCT00244374|531302142|FG003|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0|||
147309830|NCT00244374|531302143|FG004|Pre-Randomization Cross-sectional Study|Did not complete baseline procedures|0|||
147309831|NCT00244374|531302139|FG000|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|17|||
147309832|NCT00244374|531302140|FG001|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0|||
147309833|NCT00244374|531302141|FG002|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0|||
147309834|NCT00244374|531302142|FG003|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0|||
147309835|NCT00244374|531302143|FG004|Pre-Randomization Cross-sectional Study|Technical difficulty loss of data|0|||
147309836|NCT00244374|531302139|FG000|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|14|||
147309837|NCT00244374|531302140|FG001|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0|||
147309838|NCT00244374|531302141|FG002|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0|||
147309839|NCT00244374|531302142|FG003|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0|||
147309840|NCT00244374|531302143|FG004|Pre-Randomization Cross-sectional Study|Did not respond to willingness questions|0|||
147309841|NCT00244374|531302139|FG000|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|1|||
147309842|NCT00244374|531302140|FG001|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0|||
147309843|NCT00244374|531302141|FG002|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0|||
147309844|NCT00244374|531302142|FG003|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0|||
147309845|NCT00244374|531302143|FG004|Pre-Randomization Cross-sectional Study|Interviewer lack confidence in responses|0|||
147309846|NCT00244374|531302139|FG000|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|172|||
147309847|NCT00244374|531302140|FG001|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0|||
147309848|NCT00244374|531302141|FG002|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0|||
147309849|NCT00244374|531302142|FG003|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0|||
147309850|NCT00244374|531302143|FG004|Evaluation for Vaccine Adherence Cohort|Evidence of hepatitis B immunization|0|||
147309851|NCT00244374|531302139|FG000|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|51|||
147309852|NCT00244374|531302140|FG001|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0|||
147309853|NCT00244374|531302141|FG002|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0|||
147309854|NCT00244374|531302142|FG003|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0|||
147554365|NCT00481247|532185591|FG001|Overall Study|Withdrawal by Subject|13|||
147554366|NCT00481247|532185590|FG000|Overall Study|Pregnancy|2|||
147554367|NCT00481247|532185591|FG001|Overall Study|Pregnancy|1|||
147554368|NCT00481247|532185590|FG000|Overall Study|Lost to Follow-up|1|||
147554369|NCT00481247|532185591|FG001|Overall Study|Lost to Follow-up|2|||
147554370|NCT00481247|532185590|FG000|Overall Study|Poor compliance/noncompliance|1|||
147554371|NCT00481247|532185591|FG001|Overall Study|Poor compliance/noncompliance|7|||
147554372|NCT00481247|532185590|FG000|Overall Study|Administrative reason by sponsor|157|||
147554373|NCT00481247|532185591|FG001|Overall Study|Administrative reason by sponsor|162|||
147554374|NCT00481247|532185590|FG000|Overall Study|Varied|6|||
147554375|NCT00481247|532185591|FG001|Overall Study|Varied|15|||
147554376|NCT00481247|532185590|FG000|Overall Study|Did not receive treatment|1|||
147554377|NCT00481247|532185591|FG001|Overall Study|Did not receive treatment|2|||
147554378|NCT01716754|532185592|FG000|Overall Study|Death|0|||
147105168|NCT01035138|530550533|FG002|Overall Study|Caregiver Decision|1|||
147105169|NCT01035138|530550531|FG000|Overall Study|Withdrawal by Subject|1|||
147105170|NCT01035138|530550532|FG001|Overall Study|Withdrawal by Subject|0|||
147554379|NCT01716754|532185593|FG001|Overall Study|Death|0|||
147554380|NCT01716754|532185594|FG002|Overall Study|Death|0|||
147554381|NCT01716754|532185595|FG003|Overall Study|Death|1|||
147554382|NCT01716754|532185592|FG000|Overall Study|Protocol deviation|0|||
147554383|NCT01716754|532185593|FG001|Overall Study|Protocol deviation|2|||
147105171|NCT01035138|530550533|FG002|Overall Study|Withdrawal by Subject|0|||
147105172|NCT01035138|530550531|FG000|Overall Study|Physician Decision|0|||
147224413|NCT00256282|530993181|FG000|Overall Study|Disease progression, relapse during acti|12|||
147224414|NCT00256282|530993181|FG000|Overall Study|Adverse Event|3|||
147224415|NCT00256282|530993181|FG000|Overall Study|Physician Decision|1|||
147224416|NCT02431247|530993182|FG000|BL to EOE-Test and BL to Switch- Control|Other|11|||
147224417|NCT02431247|530993183|FG001|BL to EOE-Test and BL to Switch- Control|Other|2|||
147224418|NCT02431247|530993184|FG002|BL to EOE-Test and BL to Switch- Control|Other|0|||
147224419|NCT02431247|530993182|FG000|BL to EOE-Test and BL to Switch- Control|Lost to Follow-up|17|||
147224420|NCT02431247|530993183|FG001|BL to EOE-Test and BL to Switch- Control|Lost to Follow-up|8|||
147224421|NCT02431247|530993184|FG002|BL to EOE-Test and BL to Switch- Control|Lost to Follow-up|0|||
147224422|NCT02431247|530993182|FG000|BL to EOE-Test and BL to Switch- Control|Physician Decision|9|||
147224423|NCT02431247|530993183|FG001|BL to EOE-Test and BL to Switch- Control|Physician Decision|4|||
147224424|NCT02431247|530993184|FG002|BL to EOE-Test and BL to Switch- Control|Physician Decision|0|||
147224425|NCT02431247|530993182|FG000|BL to EOE-Test and BL to Switch- Control|Pregnancy|1|||
147224426|NCT02431247|530993183|FG001|BL to EOE-Test and BL to Switch- Control|Pregnancy|1|||
147224427|NCT02431247|530993184|FG002|BL to EOE-Test and BL to Switch- Control|Pregnancy|0|||
147224428|NCT02431247|530993182|FG000|BL to EOE-Test and BL to Switch- Control|Adverse Event|12|||
147224429|NCT02431247|530993183|FG001|BL to EOE-Test and BL to Switch- Control|Adverse Event|16|||
147224430|NCT02431247|530993184|FG002|BL to EOE-Test and BL to Switch- Control|Adverse Event|0|||
147224431|NCT02431247|530993182|FG000|BL to EOE-Test and BL to Switch- Control|Death|0|||
147224432|NCT02431247|530993183|FG001|BL to EOE-Test and BL to Switch- Control|Death|1|||
147224433|NCT02431247|530993184|FG002|BL to EOE-Test and BL to Switch- Control|Death|0|||
147224434|NCT02431247|530993182|FG000|BL to EOE-Test and BL to Switch- Control|Withdrawal by Subject|14|||
147224435|NCT02431247|530993183|FG001|BL to EOE-Test and BL to Switch- Control|Withdrawal by Subject|9|||
147224436|NCT02431247|530993184|FG002|BL to EOE-Test and BL to Switch- Control|Withdrawal by Subject|0|||
147224437|NCT02431247|530993182|FG000|BL to EOE-Test and BL to Switch- Control|Subject non-compliant|2|||
147224438|NCT02431247|530993183|FG001|BL to EOE-Test and BL to Switch- Control|Subject non-compliant|0|||
147105173|NCT01035138|530550532|FG001|Overall Study|Physician Decision|0|||
147105174|NCT01035138|530550533|FG002|Overall Study|Physician Decision|1|||
147105175|NCT01035138|530550531|FG000|Overall Study|Sponsor Decision|66|||
147105176|NCT01035138|530550532|FG001|Overall Study|Sponsor Decision|60|||
147224439|NCT02431247|530993184|FG002|BL to EOE-Test and BL to Switch- Control|Subject non-compliant|0|||
147224440|NCT02431247|530993182|FG000|Switch to D/C/F/TAF (Until EOE)|Other|0|||
147224441|NCT02431247|530993183|FG001|Switch to D/C/F/TAF (Until EOE)|Other|0|||
147224442|NCT02431247|530993184|FG002|Switch to D/C/F/TAF (Until EOE)|Other|4|||
147224443|NCT02431247|530993182|FG000|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|0|||
147224444|NCT02431247|530993183|FG001|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|0|||
147224445|NCT02431247|530993184|FG002|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|12|||
147224446|NCT02431247|530993182|FG000|Switch to D/C/F/TAF (Until EOE)|Physician Decision|0|||
147224447|NCT02431247|530993183|FG001|Switch to D/C/F/TAF (Until EOE)|Physician Decision|0|||
147224448|NCT02431247|530993184|FG002|Switch to D/C/F/TAF (Until EOE)|Physician Decision|1|||
147224449|NCT02431247|530993182|FG000|Switch to D/C/F/TAF (Until EOE)|Adverse Event|0|||
147224450|NCT02431247|530993183|FG001|Switch to D/C/F/TAF (Until EOE)|Adverse Event|0|||
147224451|NCT02431247|530993184|FG002|Switch to D/C/F/TAF (Until EOE)|Adverse Event|5|||
147224452|NCT02431247|530993182|FG000|Switch to D/C/F/TAF (Until EOE)|Death|0|||
147224453|NCT02431247|530993183|FG001|Switch to D/C/F/TAF (Until EOE)|Death|0|||
147224454|NCT02431247|530993184|FG002|Switch to D/C/F/TAF (Until EOE)|Death|1|||
147224455|NCT02431247|530993182|FG000|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|0|||
147224456|NCT02431247|530993183|FG001|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|0|||
147224457|NCT02431247|530993184|FG002|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|10|||
147224458|NCT00667446|530993185|FG000|Treatment Period (36 Months)|Ready to enter puberty based on age|13|||
147224459|NCT00667446|530993186|FG001|Treatment Period (36 Months)|Ready to enter puberty based on age|15|||
147224460|NCT00667446|530993185|FG000|Treatment Period (36 Months)|Other|2|||
147224461|NCT00667446|530993186|FG001|Treatment Period (36 Months)|Other|2|||
147224462|NCT00667446|530993185|FG000|Treatment Period (36 Months)|Personal reasons|2|||
147224463|NCT00667446|530993186|FG001|Treatment Period (36 Months)|Personal reasons|2|||
147224464|NCT00667446|530993185|FG000|Treatment Period (36 Months)|Withdrawal by Subject|0|||
147224465|NCT00667446|530993186|FG001|Treatment Period (36 Months)|Withdrawal by Subject|4|||
147309855|NCT00244374|531302143|FG004|Evaluation for Vaccine Adherence Cohort|Unable/unwilling to complete enrollment|0|||
147331193|NCT04771273|531377598|FG003|Maintenance Period|Perceived lack of efficacy|1|||
147554384|NCT01716754|532185594|FG002|Overall Study|Protocol deviation|7|||
147554385|NCT01716754|532185595|FG003|Overall Study|Protocol deviation|2|||
147224466|NCT00667446|530993185|FG000|Treatment Period (36 Months)|Not Adequately Suppressed on Therapy|3|||
147224467|NCT00667446|530993186|FG001|Treatment Period (36 Months)|Not Adequately Suppressed on Therapy|0|||
147554386|NCT01716754|532185592|FG000|Overall Study|Non-compliance with study treatment|0|||
147105177|NCT01035138|530550533|FG002|Overall Study|Sponsor Decision|42|||
147105178|NCT01035138|530550531|FG000|Overall Study|Lost to Follow-up|0|||
147105179|NCT01035138|530550532|FG001|Overall Study|Lost to Follow-up|0|||
147105180|NCT01035138|530550533|FG002|Overall Study|Lost to Follow-up|1|||
147105181|NCT00848497|530550534|FG000|Overall Study|Screen failure|2|||
147105182|NCT00848497|530550535|FG001|Overall Study|Screen failure|0|||
147105183|NCT00848497|530550534|FG000|Overall Study|Withdrawal by Subject|0|||
147105184|NCT00848497|530550535|FG001|Overall Study|Withdrawal by Subject|1|||
147105185|NCT01832766|530550536|FG000|Washout|Lost to Follow-up|0|||
147105186|NCT01832766|530550537|FG001|Washout|Lost to Follow-up|1|||
147105187|NCT01114724|530550540|FG000|Overall Study|Death|8|||
147105188|NCT01114724|530550540|FG000|Overall Study|Lost to Follow-up|1|||
147105189|NCT01114724|530550540|FG000|Overall Study|Withdrawal by Subject|1|||
147105190|NCT02966834|530550541|FG000|Main Study Period (Up to 12 Weeks)|Adverse Event|0|||
147105191|NCT02966834|530550542|FG001|Main Study Period (Up to 12 Weeks)|Adverse Event|0|||
147105192|NCT02966834|530550543|FG002|Main Study Period (Up to 12 Weeks)|Adverse Event|0|||
147105193|NCT02966834|530550544|FG003|Main Study Period (Up to 12 Weeks)|Adverse Event|0|||
147105194|NCT02966834|530550545|FG004|Main Study Period (Up to 12 Weeks)|Adverse Event|1|||
147105195|NCT02966834|530550546|FG005|Main Study Period (Up to 12 Weeks)|Adverse Event|0|||
147105196|NCT02966834|530550541|FG000|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|1|||
147105197|NCT02966834|530550542|FG001|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0|||
147105198|NCT02966834|530550543|FG002|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0|||
147105199|NCT02966834|530550544|FG003|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0|||
147105200|NCT02966834|530550545|FG004|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0|||
147105201|NCT02966834|530550546|FG005|Main Study Period (Up to 12 Weeks)|Lack of Efficacy|0|||
147105202|NCT02966834|530550541|FG000|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|0|||
147105203|NCT02966834|530550542|FG001|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|0|||
147105204|NCT02966834|530550543|FG002|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|4|||
147105205|NCT02966834|530550544|FG003|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|8|||
147309856|NCT00244374|531302139|FG000|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|34|||
147105206|NCT02966834|530550545|FG004|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|0|||
147224468|NCT00667446|530993185|FG000|Treatment Period (36 Months)|Lost to Follow-up|1|||
147224469|NCT00667446|530993186|FG001|Treatment Period (36 Months)|Lost to Follow-up|0|||
147224470|NCT00667446|530993185|FG000|Treatment Period (36 Months)|Protocol Violation|1|||
147224471|NCT00667446|530993186|FG001|Treatment Period (36 Months)|Protocol Violation|1|||
147224472|NCT00667446|530993185|FG000|Treatment Period (36 Months)|Therapeutic Failure|1|||
147224473|NCT00667446|530993186|FG001|Treatment Period (36 Months)|Therapeutic Failure|1|||
147224474|NCT00667446|530993185|FG000|Safety Follow-up Period (12 Weeks)|No Longer Needed Treatment|0|||
147224475|NCT00667446|530993186|FG001|Safety Follow-up Period (12 Weeks)|No Longer Needed Treatment|1|||
147224476|NCT00322153|530993189|FG000|Overall Study|Adverse Event|21|||
147224477|NCT00322153|530993190|FG001|Overall Study|Adverse Event|34|||
147224478|NCT00322153|530993189|FG000|Overall Study|Protocol Violation|6|||
147224479|NCT00322153|530993190|FG001|Overall Study|Protocol Violation|14|||
147224480|NCT00322153|530993189|FG000|Overall Study|Withdrawal by Subject|18|||
147224481|NCT00322153|530993190|FG001|Overall Study|Withdrawal by Subject|10|||
147224482|NCT00322153|530993189|FG000|Overall Study|Lack of Efficacy|8|||
147224483|NCT00322153|530993190|FG001|Overall Study|Lack of Efficacy|3|||
147224484|NCT00322153|530993189|FG000|Overall Study|Lost to Follow-up|5|||
147224485|NCT00322153|530993190|FG001|Overall Study|Lost to Follow-up|4|||
147224486|NCT00322153|530993189|FG000|Overall Study|Withdrawn for other reasons|5|||
147224487|NCT00322153|530993190|FG001|Overall Study|Withdrawn for other reasons|4|||
147224488|NCT02414139|530993192|FG000|Treatment Period|Adverse Event|11|||
147224489|NCT02414139|530993193|FG001|Treatment Period|Adverse Event|6|||
147224490|NCT02414139|530993194|FG002|Treatment Period|Adverse Event|8|||
147224491|NCT02414139|530993195|FG003|Treatment Period|Adverse Event|5|||
147224492|NCT02414139|530993196|FG004|Treatment Period|Adverse Event|14|||
147224493|NCT02414139|530993197|FG005|Treatment Period|Adverse Event|3|||
147224494|NCT02414139|530993198|FG006|Treatment Period|Adverse Event|6|||
147224495|NCT02414139|530993199|FG007|Treatment Period|Adverse Event|1|||
147224496|NCT02414139|530993200|FG008|Treatment Period|Adverse Event|6|||
147224497|NCT02414139|530993201|FG009|Treatment Period|Adverse Event|8|||
147224498|NCT02414139|530993192|FG000|Treatment Period|Death|0|||
147224499|NCT02414139|530993193|FG001|Treatment Period|Death|0|||
147224500|NCT02414139|530993194|FG002|Treatment Period|Death|1|||
147224501|NCT02414139|530993195|FG003|Treatment Period|Death|1|||
147224502|NCT02414139|530993196|FG004|Treatment Period|Death|0|||
147224503|NCT02414139|530993197|FG005|Treatment Period|Death|0|||
147224504|NCT02414139|530993198|FG006|Treatment Period|Death|0|||
147224505|NCT02414139|530993199|FG007|Treatment Period|Death|0|||
147224506|NCT02414139|530993200|FG008|Treatment Period|Death|0|||
147224507|NCT02414139|530993201|FG009|Treatment Period|Death|1|||
147224508|NCT02414139|530993192|FG000|Treatment Period|Physician Decision|5|||
147224509|NCT02414139|530993193|FG001|Treatment Period|Physician Decision|4|||
147224510|NCT02414139|530993194|FG002|Treatment Period|Physician Decision|6|||
147443682|NCT01987960|531788765|FG003|Period 2|Withdrawal by Subject|0|||
147224511|NCT02414139|530993195|FG003|Treatment Period|Physician Decision|1|||
147224512|NCT02414139|530993196|FG004|Treatment Period|Physician Decision|4|||
147554387|NCT01716754|532185593|FG001|Overall Study|Non-compliance with study treatment|0|||
147554388|NCT01716754|532185594|FG002|Overall Study|Non-compliance with study treatment|1|||
147554389|NCT01716754|532185595|FG003|Overall Study|Non-compliance with study treatment|0|||
147554390|NCT01716754|532185592|FG000|Overall Study|Physician Decision|1|||
147554391|NCT01716754|532185593|FG001|Overall Study|Physician Decision|0|||
147554392|NCT01716754|532185594|FG002|Overall Study|Physician Decision|0|||
147105207|NCT02966834|530550546|FG005|Main Study Period (Up to 12 Weeks)|Discontinued study treatment and entered follow-up|5|||
147105208|NCT02966834|530550541|FG000|Follow-up (Up to 4 Weeks)|Adverse Event|0|||
147105209|NCT02966834|530550542|FG001|Follow-up (Up to 4 Weeks)|Adverse Event|0|||
147105210|NCT02966834|530550543|FG002|Follow-up (Up to 4 Weeks)|Adverse Event|1|||
147105211|NCT02966834|530550544|FG003|Follow-up (Up to 4 Weeks)|Adverse Event|2|||
147105212|NCT02966834|530550545|FG004|Follow-up (Up to 4 Weeks)|Adverse Event|0|||
147105213|NCT02966834|530550546|FG005|Follow-up (Up to 4 Weeks)|Adverse Event|1|||
147105214|NCT02966834|530550541|FG000|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0|||
147105215|NCT02966834|530550542|FG001|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0|||
147105216|NCT02966834|530550543|FG002|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0|||
147105217|NCT02966834|530550544|FG003|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|2|||
147105218|NCT02966834|530550545|FG004|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0|||
147105219|NCT02966834|530550546|FG005|Follow-up (Up to 4 Weeks)|Withdrawal by Subject|0|||
147105220|NCT02966834|530550541|FG000|Follow-up (Up to 4 Weeks)|Protocol Violation|0|||
147105221|NCT02966834|530550542|FG001|Follow-up (Up to 4 Weeks)|Protocol Violation|0|||
147105222|NCT02966834|530550543|FG002|Follow-up (Up to 4 Weeks)|Protocol Violation|0|||
147105223|NCT02966834|530550544|FG003|Follow-up (Up to 4 Weeks)|Protocol Violation|1|||
147105224|NCT02966834|530550545|FG004|Follow-up (Up to 4 Weeks)|Protocol Violation|0|||
147105225|NCT02966834|530550546|FG005|Follow-up (Up to 4 Weeks)|Protocol Violation|0|||
147105226|NCT02814526|530550549|FG000|Overall Study|Adverse Event|4|||
147105227|NCT02814526|530550550|FG001|Overall Study|Adverse Event|3|||
147105228|NCT02814526|530550549|FG000|Overall Study|Death|1|||
147105229|NCT02814526|530550550|FG001|Overall Study|Death|1|||
147105230|NCT02814526|530550549|FG000|Overall Study|Lost to Follow-up|3|||
147105231|NCT02814526|530550550|FG001|Overall Study|Lost to Follow-up|4|||
147105232|NCT02814526|530550549|FG000|Overall Study|non site physician decision|1|||
147105233|NCT02814526|530550550|FG001|Overall Study|non site physician decision|0|||
147105234|NCT02814526|530550549|FG000|Overall Study|participant noncompliance|1|||
147105235|NCT02814526|530550550|FG001|Overall Study|participant noncompliance|1|||
147105236|NCT02814526|530550549|FG000|Overall Study|Withdrawal by Subject|20|||
147105237|NCT02814526|530550550|FG001|Overall Study|Withdrawal by Subject|14|||
147105238|NCT02814526|530550549|FG000|Overall Study|safety risk|2|||
147105239|NCT02814526|530550550|FG001|Overall Study|safety risk|1|||
147105240|NCT02814526|530550549|FG000|Overall Study|early termination-study terminated|1|||
147105241|NCT02814526|530550550|FG001|Overall Study|early termination-study terminated|2|||
147105242|NCT02814526|530550549|FG000|Overall Study|Other|0|||
147105243|NCT02814526|530550550|FG001|Overall Study|Other|4|||
147105244|NCT04711005|530550558|FG000|Overall Study|Withdrawal by Subject|0|||
147105245|NCT04711005|530550559|FG001|Overall Study|Withdrawal by Subject|0|||
147105246|NCT04711005|530550560|FG002|Overall Study|Withdrawal by Subject|0|||
147105247|NCT04711005|530550561|FG003|Overall Study|Withdrawal by Subject|0|||
147105248|NCT04711005|530550562|FG004|Overall Study|Withdrawal by Subject|0|||
147105249|NCT04711005|530550563|FG005|Overall Study|Withdrawal by Subject|0|||
147105250|NCT04711005|530550564|FG006|Overall Study|Withdrawal by Subject|0|||
147105251|NCT04711005|530550565|FG007|Overall Study|Withdrawal by Subject|1|||
147105252|NCT04711005|530550566|FG008|Overall Study|Withdrawal by Subject|0|||
147105253|NCT04711005|530550567|FG009|Overall Study|Withdrawal by Subject|0|||
147105254|NCT04711005|530550558|FG000|Overall Study|Physician Decision|0|||
147105255|NCT04711005|530550559|FG001|Overall Study|Physician Decision|0|||
147105256|NCT04711005|530550560|FG002|Overall Study|Physician Decision|0|||
147105257|NCT04711005|530550561|FG003|Overall Study|Physician Decision|0|||
147105258|NCT04711005|530550562|FG004|Overall Study|Physician Decision|0|||
147105259|NCT04711005|530550563|FG005|Overall Study|Physician Decision|0|||
147105260|NCT04711005|530550564|FG006|Overall Study|Physician Decision|0|||
147105261|NCT04711005|530550565|FG007|Overall Study|Physician Decision|2|||
147105262|NCT04711005|530550566|FG008|Overall Study|Physician Decision|1|||
147105263|NCT04711005|530550567|FG009|Overall Study|Physician Decision|0|||
147105264|NCT04530630|530552116|FG000|Overall Study|Physician Decision|1|||
147105265|NCT03675308|530552119|FG000|Overall Study|Adverse Event|3|||
147105266|NCT03675308|530552120|FG001|Overall Study|Adverse Event|2|||
147105267|NCT03675308|530552119|FG000|Overall Study|Withdrawal by Subject|6|||
147105268|NCT03675308|530552120|FG001|Overall Study|Withdrawal by Subject|4|||
147105269|NCT03675308|530552119|FG000|Overall Study|Lost to Follow-up|3|||
147105270|NCT03675308|530552120|FG001|Overall Study|Lost to Follow-up|0|||
147105271|NCT03675308|530552119|FG000|Overall Study|Lack of Efficacy|1|||
147105272|NCT03675308|530552120|FG001|Overall Study|Lack of Efficacy|1|||
147105273|NCT03675308|530552119|FG000|Overall Study|Coronavirus Disease-2019 (COVID-19) Logistical Restrictions|1|||
147105274|NCT03675308|530552120|FG001|Overall Study|Coronavirus Disease-2019 (COVID-19) Logistical Restrictions|2|||
147105275|NCT03675308|530552119|FG000|Overall Study|Other|0|||
147554393|NCT01716754|532185595|FG003|Overall Study|Physician Decision|0|||
147309857|NCT00244374|531302140|FG001|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0|||
147309858|NCT00244374|531302141|FG002|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0|||
147309859|NCT00244374|531302142|FG003|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0|||
147309860|NCT00244374|531302143|FG004|Evaluation for Vaccine Adherence Cohort|Did not return for screening test result|0|||
147309861|NCT00244374|531302139|FG000|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|4|||
147309862|NCT00244374|531302140|FG001|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0|||
147309863|NCT00244374|531302141|FG002|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0|||
147309864|NCT00244374|531302142|FG003|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0|||
147309865|NCT00244374|531302143|FG004|Evaluation for Vaccine Adherence Cohort|Returned for results after enroll window|0|||
147309866|NCT00244374|531302139|FG000|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|12|||
147309867|NCT00244374|531302140|FG001|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0|||
147309868|NCT00244374|531302141|FG002|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0|||
147309869|NCT00244374|531302142|FG003|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0|||
147309870|NCT00244374|531302143|FG004|Evaluation for Vaccine Adherence Cohort|Declined to participate in cohort|0|||
147309871|NCT00603265|531302144|FG000|Overall Study|Adverse Event|2|||
147309872|NCT00603265|531302145|FG001|Overall Study|Adverse Event|11|||
147309873|NCT00603265|531302146|FG002|Overall Study|Adverse Event|1|||
147309874|NCT00603265|531302144|FG000|Overall Study|Withdrawal by Subject|1|||
147309875|NCT00603265|531302145|FG001|Overall Study|Withdrawal by Subject|2|||
147309876|NCT00603265|531302146|FG002|Overall Study|Withdrawal by Subject|1|||
147309877|NCT00603265|531302144|FG000|Overall Study|Lack of Efficacy|3|||
147309878|NCT00603265|531302145|FG001|Overall Study|Lack of Efficacy|0|||
147309879|NCT00603265|531302146|FG002|Overall Study|Lack of Efficacy|3|||
147309880|NCT00603265|531302144|FG000|Overall Study|Lost to Follow-up|0|||
147309881|NCT00603265|531302145|FG001|Overall Study|Lost to Follow-up|1|||
147309882|NCT00603265|531302146|FG002|Overall Study|Lost to Follow-up|0|||
147309883|NCT00603265|531302144|FG000|Overall Study|Out of Town, Ran Out of Study Drug|0|||
147309884|NCT00603265|531302145|FG001|Overall Study|Out of Town, Ran Out of Study Drug|1|||
147309885|NCT00603265|531302146|FG002|Overall Study|Out of Town, Ran Out of Study Drug|0|||
147309886|NCT00603265|531302144|FG000|Overall Study|Participant Left Country, No Responses|0|||
147309887|NCT00603265|531302145|FG001|Overall Study|Participant Left Country, No Responses|1|||
147309888|NCT00603265|531302146|FG002|Overall Study|Participant Left Country, No Responses|0|||
147309889|NCT00603265|531302144|FG000|Overall Study|Protocol Violation|1|||
147309890|NCT00603265|531302145|FG001|Overall Study|Protocol Violation|0|||
147309891|NCT00603265|531302146|FG002|Overall Study|Protocol Violation|0|||
147309892|NCT04399551|531302148|FG000|Overall Study|Adverse Event|15|||
147309893|NCT04399551|531302148|FG000|Overall Study|Withdrawal by Subject|6|||
147309894|NCT04399551|531302148|FG000|Overall Study|Physician Decision|3|||
147309895|NCT04399551|531302148|FG000|Overall Study|Lost to Follow-up|2|||
147309896|NCT04399551|531302148|FG000|Overall Study|Protocol Deviation|2|||
147309897|NCT01112514|531302162|FG000|Overall Study|Lost to Follow-up|1|||
147309898|NCT01118455|531302163|FG000|Baseline [Visits 1 & 2]|Adverse Event|1|||
147309899|NCT01118455|531302164|FG001|Baseline [Visits 1 & 2]|Adverse Event|0|||
147309900|NCT01973491|531302165|FG000|Baseline Control Period (8 Weeks)|Did not meet Eligibility Criteria|17|||
147309901|NCT01973491|531302165|FG000|Baseline Control Period (8 Weeks)|Withdrawal by Subject|1|||
147105276|NCT03675308|530552120|FG001|Overall Study|Other|1|||
147105277|NCT04006457|530552125|FG000|Main Study: Treatment Period 1|Adverse Event|26|||
147105278|NCT04006457|530552126|FG001|Main Study: Treatment Period 1|Adverse Event|36|||
147105279|NCT04006457|530552127|FG002|Main Study: Treatment Period 1|Adverse Event|0|||
147105280|NCT04006457|530552125|FG000|Main Study: Treatment Period 1|Death|1|||
147105281|NCT04006457|530552126|FG001|Main Study: Treatment Period 1|Death|1|||
147105282|NCT04006457|530552127|FG002|Main Study: Treatment Period 1|Death|0|||
147309902|NCT01973491|531302165|FG000|Treatment Period (16 Weeks)|Adverse Event|1|||
147309903|NCT01863043|531302167|FG000|Overall Study|Death|6|||
147309904|NCT01863043|531302168|FG001|Overall Study|Death|1|||
147309905|NCT01863043|531302167|FG000|Overall Study|Withdrawal by Subject|0|||
147309906|NCT01863043|531302168|FG001|Overall Study|Withdrawal by Subject|2|||
147309907|NCT01863043|531302167|FG000|Overall Study|Adverse Event|7|||
147309908|NCT01863043|531302168|FG001|Overall Study|Adverse Event|8|||
147443683|NCT01987960|531788762|FG000|Period 2|Administrative or other reason|0|||
147105283|NCT04006457|530552125|FG000|Main Study: Treatment Period 1|Lack of Efficacy|27|||
147105284|NCT04006457|530552126|FG001|Main Study: Treatment Period 1|Lack of Efficacy|79|||
147105285|NCT04006457|530552127|FG002|Main Study: Treatment Period 1|Lack of Efficacy|0|||
147105286|NCT04006457|530552125|FG000|Main Study: Treatment Period 1|Lost to Follow-up|22|||
147105287|NCT04006457|530552126|FG001|Main Study: Treatment Period 1|Lost to Follow-up|17|||
147105288|NCT04006457|530552127|FG002|Main Study: Treatment Period 1|Lost to Follow-up|0|||
147309909|NCT01863043|531302167|FG000|Overall Study|exclusion criteria found after enrollment|0|||
147309910|NCT01863043|531302168|FG001|Overall Study|exclusion criteria found after enrollment|1|||
147309911|NCT03377790|531302169|FG000|Overall Study|Withdrawal by Subject|1|||
147309912|NCT03377790|531302170|FG001|Overall Study|Withdrawal by Subject|0|||
147105289|NCT04006457|530552125|FG000|Main Study: Treatment Period 1|Non-Compliance with Study Drug|4|||
147105290|NCT04006457|530552126|FG001|Main Study: Treatment Period 1|Non-Compliance with Study Drug|1|||
147105291|NCT04006457|530552127|FG002|Main Study: Treatment Period 1|Non-Compliance with Study Drug|0|||
147105292|NCT04006457|530552125|FG000|Main Study: Treatment Period 1|Physician Decision|3|||
147105293|NCT04006457|530552126|FG001|Main Study: Treatment Period 1|Physician Decision|0|||
147105294|NCT04006457|530552127|FG002|Main Study: Treatment Period 1|Physician Decision|0|||
147105295|NCT04006457|530552125|FG000|Main Study: Treatment Period 1|Pregnancy|8|||
147105296|NCT04006457|530552126|FG001|Main Study: Treatment Period 1|Pregnancy|8|||
147105297|NCT04006457|530552127|FG002|Main Study: Treatment Period 1|Pregnancy|0|||
147105298|NCT04006457|530552125|FG000|Main Study: Treatment Period 1|Withdrawal by Subject|41|||
147105299|NCT04006457|530552126|FG001|Main Study: Treatment Period 1|Withdrawal by Subject|57|||
147105300|NCT04006457|530552127|FG002|Main Study: Treatment Period 1|Withdrawal by Subject|0|||
147105301|NCT04006457|530552125|FG000|Main Study: Treatment Period 1|No Longer Met Eligibility Criteria (for adolescents)|14|||
147105302|NCT04006457|530552126|FG001|Main Study: Treatment Period 1|No Longer Met Eligibility Criteria (for adolescents)|29|||
147105303|NCT04006457|530552127|FG002|Main Study: Treatment Period 1|No Longer Met Eligibility Criteria (for adolescents)|0|||
147105304|NCT04006457|530552125|FG000|Main Study: Treatment Period 1|No Longer Met Eligibility Criteria (for adults)|4|||
147224513|NCT02414139|530993197|FG005|Treatment Period|Physician Decision|0|||
147224514|NCT02414139|530993198|FG006|Treatment Period|Physician Decision|2|||
147224515|NCT02414139|530993199|FG007|Treatment Period|Physician Decision|0|||
147224516|NCT02414139|530993200|FG008|Treatment Period|Physician Decision|1|||
147309913|NCT03377790|531302169|FG000|Overall Study|Adverse Event|1|||
147309914|NCT03377790|531302170|FG001|Overall Study|Adverse Event|0|||
147309915|NCT03377790|531302169|FG000|Overall Study|Lost to Follow-up|0|||
147309916|NCT03377790|531302170|FG001|Overall Study|Lost to Follow-up|2|||
147224517|NCT02414139|530993201|FG009|Treatment Period|Physician Decision|4|||
147224518|NCT02414139|530993192|FG000|Treatment Period|Progressive disease|48|||
147224519|NCT02414139|530993193|FG001|Treatment Period|Progressive disease|31|||
147224520|NCT02414139|530993194|FG002|Treatment Period|Progressive disease|37|||
147224521|NCT02414139|530993195|FG003|Treatment Period|Progressive disease|21|||
147224522|NCT02414139|530993196|FG004|Treatment Period|Progressive disease|43|||
147224523|NCT02414139|530993197|FG005|Treatment Period|Progressive disease|12|||
147224524|NCT02414139|530993198|FG006|Treatment Period|Progressive disease|16|||
147224525|NCT02414139|530993199|FG007|Treatment Period|Progressive disease|2|||
147224526|NCT02414139|530993200|FG008|Treatment Period|Progressive disease|20|||
147224527|NCT02414139|530993201|FG009|Treatment Period|Progressive disease|14|||
147224528|NCT02414139|530993192|FG000|Treatment Period|Protocol deviation|0|||
147224529|NCT02414139|530993193|FG001|Treatment Period|Protocol deviation|0|||
147224530|NCT02414139|530993194|FG002|Treatment Period|Protocol deviation|1|||
147224531|NCT02414139|530993195|FG003|Treatment Period|Protocol deviation|0|||
147224532|NCT02414139|530993196|FG004|Treatment Period|Protocol deviation|0|||
147224533|NCT02414139|530993197|FG005|Treatment Period|Protocol deviation|0|||
147224534|NCT02414139|530993198|FG006|Treatment Period|Protocol deviation|0|||
147224535|NCT02414139|530993199|FG007|Treatment Period|Protocol deviation|0|||
147224536|NCT02414139|530993200|FG008|Treatment Period|Protocol deviation|0|||
147224537|NCT02414139|530993201|FG009|Treatment Period|Protocol deviation|0|||
147224538|NCT02414139|530993192|FG000|Treatment Period|Subject/Guardian decision|5|||
147224539|NCT02414139|530993193|FG001|Treatment Period|Subject/Guardian decision|1|||
147224540|NCT02414139|530993194|FG002|Treatment Period|Subject/Guardian decision|1|||
147224541|NCT02414139|530993195|FG003|Treatment Period|Subject/Guardian decision|2|||
147224542|NCT02414139|530993196|FG004|Treatment Period|Subject/Guardian decision|5|||
147224543|NCT02414139|530993197|FG005|Treatment Period|Subject/Guardian decision|0|||
147224544|NCT02414139|530993198|FG006|Treatment Period|Subject/Guardian decision|2|||
147224545|NCT02414139|530993199|FG007|Treatment Period|Subject/Guardian decision|0|||
147224546|NCT02414139|530993200|FG008|Treatment Period|Subject/Guardian decision|1|||
147224547|NCT02414139|530993201|FG009|Treatment Period|Subject/Guardian decision|1|||
147224548|NCT02414139|530993192|FG000|Treatment Period|Study terminated (as per protocol) by Sponsor|0|||
147224549|NCT02414139|530993193|FG001|Treatment Period|Study terminated (as per protocol) by Sponsor|0|||
147224550|NCT02414139|530993194|FG002|Treatment Period|Study terminated (as per protocol) by Sponsor|0|||
147224551|NCT02414139|530993195|FG003|Treatment Period|Study terminated (as per protocol) by Sponsor|0|||
147224552|NCT02414139|530993196|FG004|Treatment Period|Study terminated (as per protocol) by Sponsor|3|||
147224553|NCT02414139|530993197|FG005|Treatment Period|Study terminated (as per protocol) by Sponsor|0|||
147224554|NCT02414139|530993198|FG006|Treatment Period|Study terminated (as per protocol) by Sponsor|2|||
147224555|NCT02414139|530993199|FG007|Treatment Period|Study terminated (as per protocol) by Sponsor|0|||
147309917|NCT03377790|531302169|FG000|Overall Study|Randomized but not treated|1|||
147105305|NCT04006457|530552126|FG001|Main Study: Treatment Period 1|No Longer Met Eligibility Criteria (for adults)|2|||
147224556|NCT02414139|530993200|FG008|Treatment Period|Study terminated (as per protocol) by Sponsor|3|||
147224557|NCT02414139|530993201|FG009|Treatment Period|Study terminated (as per protocol) by Sponsor|4|||
147224558|NCT02414139|530993192|FG000|Post-treatment Efficacy Follow-up|Adverse Event|1|||
147309918|NCT03377790|531302170|FG001|Overall Study|Randomized but not treated|0|||
147309919|NCT03377790|531302169|FG000|Overall Study|Withdrawn by Parent/Guardian|7|||
147309920|NCT03377790|531302170|FG001|Overall Study|Withdrawn by Parent/Guardian|4|||
147309921|NCT01987596|531302171|FG000|Overall Study|Physician Decision|1|||
147309922|NCT01987596|531302172|FG001|Overall Study|Physician Decision|0|||
147309923|NCT01987596|531302171|FG000|Overall Study|Progressive Disease; missing all period|0|||
147309924|NCT01987596|531302172|FG001|Overall Study|Progressive Disease; missing all period|1|||
147309925|NCT01928225|531302173|FG000|Overall Study|Pregnancy|1|||
147309926|NCT01928225|531302174|FG001|Overall Study|Pregnancy|0|||
147309927|NCT01928225|531302173|FG000|Overall Study|basaloid cervical cancer|1|||
147309928|NCT01928225|531302174|FG001|Overall Study|basaloid cervical cancer|0|||
147309929|NCT01928225|531302173|FG000|Overall Study|Lost to Follow-up|1|||
147309930|NCT01928225|531302174|FG001|Overall Study|Lost to Follow-up|3|||
147309931|NCT00854295|531302175|FG000|Overall Study|Death|7|||
147309932|NCT00854295|531302176|FG001|Overall Study|Death|0|||
147309933|NCT00854295|531302177|FG002|Overall Study|Death|1|||
147309934|NCT00854295|531302178|FG003|Overall Study|Death|1|||
147309935|NCT00854295|531302175|FG000|Overall Study|Adverse Event|6|||
147309936|NCT00854295|531302176|FG001|Overall Study|Adverse Event|1|||
147309937|NCT00854295|531302177|FG002|Overall Study|Adverse Event|1|||
147309938|NCT00854295|531302178|FG003|Overall Study|Adverse Event|3|||
147309939|NCT00854295|531302175|FG000|Overall Study|Lost to Follow-up|18|||
147309940|NCT00854295|531302176|FG001|Overall Study|Lost to Follow-up|5|||
147309941|NCT00854295|531302177|FG002|Overall Study|Lost to Follow-up|21|||
147309942|NCT00854295|531302178|FG003|Overall Study|Lost to Follow-up|21|||
147309943|NCT00854295|531302175|FG000|Overall Study|Physician Decision|10|||
147309944|NCT00854295|531302176|FG001|Overall Study|Physician Decision|0|||
147309945|NCT00854295|531302177|FG002|Overall Study|Physician Decision|0|||
147309946|NCT00854295|531302178|FG003|Overall Study|Physician Decision|0|||
147309947|NCT00709592|531302179|FG000|Overall Study|Unable to proceed to transplant|0|||
147309948|NCT00709592|531302180|FG001|Overall Study|Unable to proceed to transplant|1|||
147309949|NCT02440594|531302184|FG000|Overall Study|Lost to Follow-up|34|||
147309950|NCT02440594|531302185|FG001|Overall Study|Lost to Follow-up|33|||
147309951|NCT02440594|531302186|FG002|Overall Study|Lost to Follow-up|54|||
147309952|NCT02440594|531302187|FG003|Overall Study|Lost to Follow-up|47|||
147309953|NCT02440594|531302188|FG004|Overall Study|Lost to Follow-up|5|||
147309954|NCT02440594|531302189|FG005|Overall Study|Lost to Follow-up|4|||
147309955|NCT02440594|531302190|FG006|Overall Study|Lost to Follow-up|28|||
147309956|NCT02440594|531302191|FG007|Overall Study|Lost to Follow-up|48|||
147309957|NCT02440594|531302184|FG000|Overall Study|Cognitive Impairment/Communication Issue|14|||
147309958|NCT02440594|531302185|FG001|Overall Study|Cognitive Impairment/Communication Issue|6|||
147309959|NCT02440594|531302186|FG002|Overall Study|Cognitive Impairment/Communication Issue|4|||
147309960|NCT02440594|531302187|FG003|Overall Study|Cognitive Impairment/Communication Issue|4|||
147309961|NCT02440594|531302188|FG004|Overall Study|Cognitive Impairment/Communication Issue|2|||
147309962|NCT02440594|531302189|FG005|Overall Study|Cognitive Impairment/Communication Issue|1|||
147309963|NCT02440594|531302190|FG006|Overall Study|Cognitive Impairment/Communication Issue|0|||
147309964|NCT02440594|531302191|FG007|Overall Study|Cognitive Impairment/Communication Issue|0|||
147309965|NCT02440594|531302184|FG000|Overall Study|Withdrawal by Subject|81|||
147309966|NCT02440594|531302185|FG001|Overall Study|Withdrawal by Subject|67|||
147309967|NCT02440594|531302186|FG002|Overall Study|Withdrawal by Subject|59|||
147309968|NCT02440594|531302187|FG003|Overall Study|Withdrawal by Subject|38|||
147309969|NCT02440594|531302188|FG004|Overall Study|Withdrawal by Subject|2|||
147309970|NCT02440594|531302189|FG005|Overall Study|Withdrawal by Subject|2|||
147309971|NCT02440594|531302190|FG006|Overall Study|Withdrawal by Subject|7|||
147309972|NCT02440594|531302191|FG007|Overall Study|Withdrawal by Subject|7|||
147309973|NCT02440594|531302184|FG000|Overall Study|Administratively w/drawn|3|||
147309974|NCT02440594|531302185|FG001|Overall Study|Administratively w/drawn|2|||
147309975|NCT02440594|531302186|FG002|Overall Study|Administratively w/drawn|0|||
147309976|NCT02440594|531302187|FG003|Overall Study|Administratively w/drawn|0|||
147309977|NCT02440594|531302188|FG004|Overall Study|Administratively w/drawn|0|||
147309978|NCT02440594|531302189|FG005|Overall Study|Administratively w/drawn|0|||
147309979|NCT02440594|531302190|FG006|Overall Study|Administratively w/drawn|2|||
147309980|NCT02440594|531302191|FG007|Overall Study|Administratively w/drawn|1|||
147309981|NCT03154359|531302192|FG000|Overall Study|Adverse Event|1|||
147309982|NCT03154359|531302192|FG000|Overall Study|Lack of Efficacy|2|||
147309983|NCT03154359|531302192|FG000|Overall Study|Lost to Follow-up|3|||
147309984|NCT03154359|531302192|FG000|Overall Study|Physician Decision|3|||
147309985|NCT03154359|531302192|FG000|Overall Study|Protocol Violation|4|||
147309986|NCT03154359|531302192|FG000|Overall Study|Withdrawal by Subject|5|||
147309987|NCT03154359|531302192|FG000|Overall Study|Disruption of study due to COVID-19|4|||
147309988|NCT00152763|531302193|FG000|Overall Study|Death|4|||
147309989|NCT00152763|531302194|FG001|Overall Study|Death|1|||
147309990|NCT00152763|531302195|FG002|Overall Study|Death|2|||
147309991|NCT00152763|531302196|FG003|Overall Study|Death|1|||
147309992|NCT00152763|531302193|FG000|Overall Study|Lost to Follow-up|6|||
147309993|NCT00152763|531302194|FG001|Overall Study|Lost to Follow-up|4|||
147443684|NCT01987960|531788763|FG001|Period 2|Administrative or other reason|5|||
147309994|NCT00152763|531302195|FG002|Overall Study|Lost to Follow-up|2|||
147309995|NCT00152763|531302196|FG003|Overall Study|Lost to Follow-up|13|||
147309996|NCT00474175|531302204|FG000|Overall Study|Lack of Efficacy|0|||
147309997|NCT00474175|531302205|FG001|Overall Study|Lack of Efficacy|0|||
147309998|NCT00474175|531302206|FG002|Overall Study|Lack of Efficacy|1|||
147309999|NCT00474175|531302204|FG000|Overall Study|Withdrawal by Subject|0|||
147310000|NCT00474175|531302205|FG001|Overall Study|Withdrawal by Subject|1|||
147310001|NCT00474175|531302206|FG002|Overall Study|Withdrawal by Subject|1|||
147310002|NCT00474175|531302204|FG000|Overall Study|Ineligible|1|||
147310003|NCT00474175|531302205|FG001|Overall Study|Ineligible|3|||
147310004|NCT00474175|531302206|FG002|Overall Study|Ineligible|1|||
147310005|NCT00474175|531302204|FG000|Overall Study|Protocol Violation|0|||
147310006|NCT00474175|531302205|FG001|Overall Study|Protocol Violation|2|||
147310007|NCT00474175|531302206|FG002|Overall Study|Protocol Violation|1|||
147310008|NCT00474175|531302204|FG000|Overall Study|Administrative|0|||
147310009|NCT00474175|531302205|FG001|Overall Study|Administrative|1|||
147310010|NCT00474175|531302206|FG002|Overall Study|Administrative|0|||
147310011|NCT00467142|531302207|FG000|Overall Study|Withdrawal by Subject|1|||
147310012|NCT00467142|531302207|FG000|Overall Study|Adverse Event|1|||
147310013|NCT00467142|531302207|FG000|Overall Study|Protocol Violation|1|||
147310014|NCT01619787|531302208|FG000|Overall Study|Lost to Follow-up|5|||
147310015|NCT03321006|531302211|FG000|Overall Study|Death|1|||
147310016|NCT03321006|531302212|FG001|Overall Study|Death|0|||
147310017|NCT03321006|531302211|FG000|Overall Study|Lack of Efficacy|1|||
147310018|NCT03321006|531302212|FG001|Overall Study|Lack of Efficacy|0|||
147310019|NCT01737996|531302221|FG000|Overall Study|Adverse Event|0|||
147310020|NCT01737996|531302222|FG001|Overall Study|Adverse Event|1|||
147310021|NCT01737996|531302223|FG002|Overall Study|Adverse Event|1|||
147310022|NCT01737996|531302221|FG000|Overall Study|Withdrawal by Subject|0|||
147310023|NCT01737996|531302222|FG001|Overall Study|Withdrawal by Subject|0|||
147105306|NCT04006457|530552127|FG002|Main Study: Treatment Period 1|No Longer Met Eligibility Criteria (for adults)|0|||
147105307|NCT04006457|530552125|FG000|Main Study: Treatment Period 1|Other|10|||
147105308|NCT04006457|530552126|FG001|Main Study: Treatment Period 1|Other|4|||
147105309|NCT04006457|530552127|FG002|Main Study: Treatment Period 1|Other|0|||
147310024|NCT01737996|531302223|FG002|Overall Study|Withdrawal by Subject|1|||
147310025|NCT02693834|531302227|FG000|Baseline Measurement|Withdrawal by Subject|1|||
147310026|NCT02693834|531302228|FG001|Baseline Measurement|Withdrawal by Subject|0|||
147310027|NCT02693834|531302227|FG000|Baseline Measurement|Adverse Event|1|||
147310028|NCT02693834|531302228|FG001|Baseline Measurement|Adverse Event|0|||
147554394|NCT01716754|532185592|FG000|Overall Study|Lost to Follow-up|1|||
147554395|NCT01716754|532185593|FG001|Overall Study|Lost to Follow-up|0|||
147554396|NCT01716754|532185594|FG002|Overall Study|Lost to Follow-up|0|||
147554397|NCT01716754|532185595|FG003|Overall Study|Lost to Follow-up|1|||
147554398|NCT01716754|532185592|FG000|Overall Study|Adverse Event|4|||
147554399|NCT01716754|532185593|FG001|Overall Study|Adverse Event|2|||
147554400|NCT01716754|532185594|FG002|Overall Study|Adverse Event|2|||
147554401|NCT01716754|532185595|FG003|Overall Study|Adverse Event|1|||
147554402|NCT01716754|532185592|FG000|Overall Study|Withdrawal by Subject|5|||
147554403|NCT01716754|532185593|FG001|Overall Study|Withdrawal by Subject|0|||
147554404|NCT01716754|532185594|FG002|Overall Study|Withdrawal by Subject|4|||
147554405|NCT01716754|532185595|FG003|Overall Study|Withdrawal by Subject|3|||
147554406|NCT04317781|532185596|FG000|Overall Study|Adverse Event|1|||
147554407|NCT04317781|532185596|FG000|Overall Study|Disease relapse|1|||
147554408|NCT04317781|532185596|FG000|Overall Study|Withdrawal by Subject|1|||
147554409|NCT01211769|532185616|FG000|Overall Study|Lost to Follow-up|7|||
147554410|NCT01211769|532185617|FG001|Overall Study|Lost to Follow-up|9|||
147105310|NCT04006457|530552125|FG000|Main Study: Treatment Period 1|Approved Drug Available For Indication|0|||
147105311|NCT04006457|530552126|FG001|Main Study: Treatment Period 1|Approved Drug Available For Indication|37|||
147105312|NCT04006457|530552127|FG002|Main Study: Treatment Period 1|Approved Drug Available For Indication|0|||
147105313|NCT04006457|530552125|FG000|Main Study: Treatment Period 2|Adverse Event|2|||
147105314|NCT04006457|530552126|FG001|Main Study: Treatment Period 2|Adverse Event|2|||
147105315|NCT04006457|530552127|FG002|Main Study: Treatment Period 2|Adverse Event|0|||
147105316|NCT04006457|530552125|FG000|Main Study: Treatment Period 2|Lack of Efficacy|7|||
147310029|NCT02693834|531302227|FG000|Week 2 Practice|Adverse Event|0|||
147310030|NCT02693834|531302228|FG001|Week 2 Practice|Adverse Event|1|||
147310031|NCT01468922|531302229|FG000|Overall Study|Screening failure|0|||
147310032|NCT01468922|531302230|FG001|Overall Study|Screening failure|0|||
147310033|NCT01468922|531302231|FG002|Overall Study|Screening failure|0|||
147310034|NCT01468922|531302232|FG003|Overall Study|Screening failure|0|||
147310035|NCT01468922|531302233|FG004|Overall Study|Screening failure|0|||
147310036|NCT01468922|531302234|FG005|Overall Study|Screening failure|0|||
147310037|NCT01468922|531302235|FG006|Overall Study|Screening failure|0|||
147310038|NCT01468922|531302236|FG007|Overall Study|Screening failure|0|||
147310039|NCT01468922|531302237|FG008|Overall Study|Screening failure|1|||
147554411|NCT01211769|532185618|FG002|Overall Study|Lost to Follow-up|5|||
147554412|NCT01211769|532185619|FG003|Overall Study|Lost to Follow-up|9|||
147554413|NCT01211769|532185616|FG000|Overall Study|Physician Decision|2|||
147554414|NCT01211769|532185617|FG001|Overall Study|Physician Decision|0|||
147554415|NCT01211769|532185618|FG002|Overall Study|Physician Decision|2|||
147310040|NCT01468922|531302229|FG000|Overall Study|Per patient choice|1|||
147310041|NCT01468922|531302230|FG001|Overall Study|Per patient choice|0|||
147310042|NCT01468922|531302231|FG002|Overall Study|Per patient choice|0|||
147310043|NCT01468922|531302232|FG003|Overall Study|Per patient choice|0|||
147310044|NCT01468922|531302233|FG004|Overall Study|Per patient choice|0|||
147310045|NCT01468922|531302234|FG005|Overall Study|Per patient choice|0|||
147310046|NCT01468922|531302235|FG006|Overall Study|Per patient choice|0|||
147310047|NCT01468922|531302236|FG007|Overall Study|Per patient choice|0|||
147310048|NCT01468922|531302237|FG008|Overall Study|Per patient choice|0|||
147310049|NCT01468922|531302229|FG000|Overall Study|Switched to alternative treatment|1|||
147310050|NCT01468922|531302230|FG001|Overall Study|Switched to alternative treatment|0|||
147310051|NCT01468922|531302231|FG002|Overall Study|Switched to alternative treatment|0|||
147310052|NCT01468922|531302232|FG003|Overall Study|Switched to alternative treatment|0|||
147310053|NCT01468922|531302233|FG004|Overall Study|Switched to alternative treatment|1|||
147310054|NCT01468922|531302234|FG005|Overall Study|Switched to alternative treatment|0|||
147310055|NCT01468922|531302235|FG006|Overall Study|Switched to alternative treatment|0|||
147310056|NCT01468922|531302236|FG007|Overall Study|Switched to alternative treatment|0|||
147310057|NCT01468922|531302237|FG008|Overall Study|Switched to alternative treatment|0|||
147310058|NCT01468922|531302229|FG000|Overall Study|Enrolled on new protocol|0|||
147310059|NCT01468922|531302230|FG001|Overall Study|Enrolled on new protocol|0|||
147310060|NCT01468922|531302231|FG002|Overall Study|Enrolled on new protocol|0|||
147310061|NCT01468922|531302232|FG003|Overall Study|Enrolled on new protocol|0|||
147310062|NCT01468922|531302233|FG004|Overall Study|Enrolled on new protocol|1|||
147310063|NCT01468922|531302234|FG005|Overall Study|Enrolled on new protocol|0|||
147310064|NCT01468922|531302235|FG006|Overall Study|Enrolled on new protocol|0|||
147310065|NCT01468922|531302236|FG007|Overall Study|Enrolled on new protocol|0|||
147310066|NCT01468922|531302237|FG008|Overall Study|Enrolled on new protocol|0|||
147310067|NCT01468922|531302229|FG000|Overall Study|Adverse Event|0|||
147310068|NCT01468922|531302230|FG001|Overall Study|Adverse Event|0|||
147310069|NCT01468922|531302231|FG002|Overall Study|Adverse Event|0|||
147310070|NCT01468922|531302232|FG003|Overall Study|Adverse Event|0|||
147310071|NCT01468922|531302233|FG004|Overall Study|Adverse Event|0|||
147310072|NCT01468922|531302234|FG005|Overall Study|Adverse Event|0|||
147310073|NCT01468922|531302235|FG006|Overall Study|Adverse Event|0|||
147310074|NCT01468922|531302236|FG007|Overall Study|Adverse Event|1|||
147310075|NCT01468922|531302237|FG008|Overall Study|Adverse Event|0|||
147310076|NCT01468922|531302229|FG000|Overall Study|Infection of blood|0|||
147310077|NCT01468922|531302230|FG001|Overall Study|Infection of blood|0|||
147310078|NCT01468922|531302231|FG002|Overall Study|Infection of blood|0|||
147310079|NCT01468922|531302232|FG003|Overall Study|Infection of blood|0|||
147310080|NCT01468922|531302233|FG004|Overall Study|Infection of blood|0|||
147310081|NCT01468922|531302234|FG005|Overall Study|Infection of blood|0|||
147310082|NCT01468922|531302235|FG006|Overall Study|Infection of blood|0|||
147310083|NCT01468922|531302236|FG007|Overall Study|Infection of blood|1|||
147310084|NCT01468922|531302237|FG008|Overall Study|Infection of blood|0|||
147310085|NCT01468922|531302229|FG000|Overall Study|Patient choice - surgery|0|||
147310086|NCT01468922|531302230|FG001|Overall Study|Patient choice - surgery|0|||
147310087|NCT01468922|531302231|FG002|Overall Study|Patient choice - surgery|0|||
147310088|NCT01468922|531302232|FG003|Overall Study|Patient choice - surgery|0|||
147310089|NCT01468922|531302233|FG004|Overall Study|Patient choice - surgery|0|||
147310090|NCT01468922|531302234|FG005|Overall Study|Patient choice - surgery|0|||
147310091|NCT01468922|531302235|FG006|Overall Study|Patient choice - surgery|0|||
147310092|NCT01468922|531302236|FG007|Overall Study|Patient choice - surgery|1|||
147310093|NCT01468922|531302237|FG008|Overall Study|Patient choice - surgery|0|||
147310094|NCT01468922|531302229|FG000|Overall Study|Refused further treatment|0|||
147310095|NCT01468922|531302230|FG001|Overall Study|Refused further treatment|0|||
147310096|NCT01468922|531302231|FG002|Overall Study|Refused further treatment|0|||
147310097|NCT01468922|531302232|FG003|Overall Study|Refused further treatment|0|||
147554416|NCT01211769|532185619|FG003|Overall Study|Physician Decision|1|||
147554417|NCT01211769|532185616|FG000|Overall Study|Adverse Event|0|||
147554418|NCT01211769|532185617|FG001|Overall Study|Adverse Event|1|||
147554419|NCT01211769|532185618|FG002|Overall Study|Adverse Event|1|||
147224559|NCT02414139|530993193|FG001|Post-treatment Efficacy Follow-up|Adverse Event|0|||
147310098|NCT01468922|531302233|FG004|Overall Study|Refused further treatment|0|||
147310099|NCT01468922|531302234|FG005|Overall Study|Refused further treatment|0|||
147310100|NCT01468922|531302235|FG006|Overall Study|Refused further treatment|0|||
147310101|NCT01468922|531302236|FG007|Overall Study|Refused further treatment|1|||
147224560|NCT02414139|530993194|FG002|Post-treatment Efficacy Follow-up|Adverse Event|0|||
147224561|NCT02414139|530993195|FG003|Post-treatment Efficacy Follow-up|Adverse Event|0|||
147224562|NCT02414139|530993196|FG004|Post-treatment Efficacy Follow-up|Adverse Event|2|||
147224563|NCT02414139|530993197|FG005|Post-treatment Efficacy Follow-up|Adverse Event|0|||
147224564|NCT02414139|530993198|FG006|Post-treatment Efficacy Follow-up|Adverse Event|0|||
147224565|NCT02414139|530993199|FG007|Post-treatment Efficacy Follow-up|Adverse Event|0|||
147224566|NCT02414139|530993200|FG008|Post-treatment Efficacy Follow-up|Adverse Event|0|||
147224567|NCT02414139|530993201|FG009|Post-treatment Efficacy Follow-up|Adverse Event|0|||
147554420|NCT01211769|532185619|FG003|Overall Study|Adverse Event|1|||
147554421|NCT01214330|532185620|FG000|Overall Study|Withdrawal by Subject|2|||
147554422|NCT01214330|532185620|FG000|Overall Study|Withdrawal by Subject|2|||
147554423|NCT00947427|532185621|FG000|Overall Study|Withdrawal by Subject|1|||
147554424|NCT00947427|532185622|FG001|Overall Study|Withdrawal by Subject|3|||
147554425|NCT00947427|532185621|FG000|Overall Study|Protocol Violation|0|||
147554426|NCT00947427|532185622|FG001|Overall Study|Protocol Violation|1|||
147554427|NCT03402893|532185623|FG000|Overall Study|Withdrawal by Subject|1|||
147554428|NCT00686036|532185628|FG000|Overall Study|Adverse Event|3|||
147554429|NCT00686036|532185629|FG001|Overall Study|Adverse Event|0|||
147554430|NCT00686036|532185628|FG000|Overall Study|Withdrawal by Subject|3|||
147554431|NCT00686036|532185629|FG001|Overall Study|Withdrawal by Subject|1|||
147554432|NCT00686036|532185628|FG000|Overall Study|Study terminated by AstraZeneca|2|||
147554433|NCT00686036|532185629|FG001|Overall Study|Study terminated by AstraZeneca|1|||
147554434|NCT00686036|532185628|FG000|Overall Study|PSA ≥ 10ng/mL|1|||
147554435|NCT00686036|532185629|FG001|Overall Study|PSA ≥ 10ng/mL|0|||
147554436|NCT00686036|532185628|FG000|Overall Study|Other reasons not identified|0|||
147554437|NCT00686036|532185629|FG001|Overall Study|Other reasons not identified|4|||
147554438|NCT01411995|532185630|FG000|Overall Study|Failed IUD insertion|0|||
147554439|NCT01411995|532185631|FG001|Overall Study|Failed IUD insertion|1|||
147554440|NCT01754259|532185640|FG000|Overall Study|Withdrawal by Subject|2|||
147554441|NCT01754259|532185641|FG001|Overall Study|Withdrawal by Subject|4|||
147554442|NCT01754259|532185640|FG000|Overall Study|Adverse Event|3|||
147554443|NCT01754259|532185641|FG001|Overall Study|Adverse Event|1|||
147554444|NCT01754259|532185640|FG000|Overall Study|Lost to Follow-up|0|||
147554445|NCT01754259|532185641|FG001|Overall Study|Lost to Follow-up|1|||
147554446|NCT01364870|532185646|FG000|Overall Study|Withdrawal by Subject|13|||
147554447|NCT01364870|532185647|FG001|Overall Study|Withdrawal by Subject|24|||
147554448|NCT01364870|532185648|FG002|Overall Study|Withdrawal by Subject|10|||
147554449|NCT01364870|532185646|FG000|Overall Study|Adverse Event|8|||
147554450|NCT01364870|532185647|FG001|Overall Study|Adverse Event|6|||
147554451|NCT01364870|532185648|FG002|Overall Study|Adverse Event|4|||
147554452|NCT01364870|532185646|FG000|Overall Study|Protocol Violation|1|||
147554453|NCT01364870|532185647|FG001|Overall Study|Protocol Violation|0|||
147554454|NCT01364870|532185648|FG002|Overall Study|Protocol Violation|0|||
147554455|NCT02102490|532185651|FG000|Overall Study|Death|6|||
147554456|NCT02102490|532185651|FG000|Overall Study|Lost to Follow-up|1|||
147224568|NCT02414139|530993192|FG000|Post-treatment Efficacy Follow-up|Death|0|||
147224569|NCT02414139|530993193|FG001|Post-treatment Efficacy Follow-up|Death|1|||
147224570|NCT02414139|530993194|FG002|Post-treatment Efficacy Follow-up|Death|0|||
147224571|NCT02414139|530993195|FG003|Post-treatment Efficacy Follow-up|Death|0|||
147224572|NCT02414139|530993196|FG004|Post-treatment Efficacy Follow-up|Death|1|||
147224573|NCT02414139|530993197|FG005|Post-treatment Efficacy Follow-up|Death|0|||
147224574|NCT02414139|530993198|FG006|Post-treatment Efficacy Follow-up|Death|0|||
147224575|NCT02414139|530993199|FG007|Post-treatment Efficacy Follow-up|Death|0|||
147224576|NCT02414139|530993200|FG008|Post-treatment Efficacy Follow-up|Death|0|||
147224577|NCT02414139|530993201|FG009|Post-treatment Efficacy Follow-up|Death|1|||
147224578|NCT02414139|530993192|FG000|Post-treatment Efficacy Follow-up|Lost to Follow-up|1|||
147224579|NCT02414139|530993193|FG001|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
147224580|NCT02414139|530993194|FG002|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
147224581|NCT02414139|530993195|FG003|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
147224582|NCT02414139|530993196|FG004|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
147224583|NCT02414139|530993197|FG005|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
147224584|NCT02414139|530993198|FG006|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
147224585|NCT02414139|530993199|FG007|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
147224586|NCT02414139|530993200|FG008|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
147224587|NCT02414139|530993201|FG009|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
147224588|NCT02414139|530993192|FG000|Post-treatment Efficacy Follow-up|Physician Decision|4|||
147224589|NCT02414139|530993193|FG001|Post-treatment Efficacy Follow-up|Physician Decision|2|||
147224590|NCT02414139|530993194|FG002|Post-treatment Efficacy Follow-up|Physician Decision|4|||
147224591|NCT02414139|530993195|FG003|Post-treatment Efficacy Follow-up|Physician Decision|2|||
147224592|NCT02414139|530993196|FG004|Post-treatment Efficacy Follow-up|Physician Decision|4|||
147554457|NCT00095199|532185654|FG000|Overall Study|Adverse Event|40|||
147554458|NCT00095199|532185655|FG001|Overall Study|Adverse Event|22|||
147554459|NCT00095199|532185656|FG002|Overall Study|Adverse Event|26|||
147554460|NCT00095199|532185657|FG003|Overall Study|Adverse Event|11|||
147554461|NCT00095199|532185654|FG000|Overall Study|Progressive disease|213|||
147554462|NCT00095199|532185655|FG001|Overall Study|Progressive disease|179|||
147554463|NCT00095199|532185656|FG002|Overall Study|Progressive disease|105|||
147554464|NCT00095199|532185657|FG003|Overall Study|Progressive disease|98|||
147554465|NCT00095199|532185654|FG000|Overall Study|Death|10|||
147554466|NCT00095199|532185655|FG001|Overall Study|Death|6|||
147554467|NCT00095199|532185656|FG002|Overall Study|Death|11|||
147554468|NCT00095199|532185657|FG003|Overall Study|Death|9|||
147554469|NCT00095199|532185654|FG000|Overall Study|Withdrawal by Subject|21|||
147554470|NCT00095199|532185655|FG001|Overall Study|Withdrawal by Subject|16|||
147105317|NCT04006457|530552126|FG001|Main Study: Treatment Period 2|Lack of Efficacy|0|||
147105318|NCT04006457|530552127|FG002|Main Study: Treatment Period 2|Lack of Efficacy|0|||
147105319|NCT04006457|530552125|FG000|Main Study: Treatment Period 2|Lost to Follow-up|2|||
147105320|NCT04006457|530552126|FG001|Main Study: Treatment Period 2|Lost to Follow-up|1|||
147105321|NCT04006457|530552127|FG002|Main Study: Treatment Period 2|Lost to Follow-up|0|||
147105322|NCT04006457|530552125|FG000|Main Study: Treatment Period 2|Protocol Violation|3|||
147105323|NCT04006457|530552126|FG001|Main Study: Treatment Period 2|Protocol Violation|1|||
147105324|NCT04006457|530552127|FG002|Main Study: Treatment Period 2|Protocol Violation|0|||
147105325|NCT04006457|530552125|FG000|Main Study: Treatment Period 2|Withdrawal by Subject|8|||
147105326|NCT04006457|530552126|FG001|Main Study: Treatment Period 2|Withdrawal by Subject|7|||
147105327|NCT04006457|530552127|FG002|Main Study: Treatment Period 2|Withdrawal by Subject|0|||
147105328|NCT04006457|530552125|FG000|Main Study: Treatment Period 2|Other|2|||
147105329|NCT04006457|530552126|FG001|Main Study: Treatment Period 2|Other|3|||
147105330|NCT04006457|530552127|FG002|Main Study: Treatment Period 2|Other|0|||
147105331|NCT04006457|530552125|FG000|Main Study: Treatment Period 2|Approved Drug Available For Indication|179|||
147105332|NCT04006457|530552126|FG001|Main Study: Treatment Period 2|Approved Drug Available For Indication|222|||
147105333|NCT04006457|530552127|FG002|Main Study: Treatment Period 2|Approved Drug Available For Indication|0|||
147105334|NCT04006457|530552125|FG000|Main Study: Treatment Period 2|Ongoing|86|||
147105335|NCT04006457|530552126|FG001|Main Study: Treatment Period 2|Ongoing|96|||
147105336|NCT04006457|530552127|FG002|Main Study: Treatment Period 2|Ongoing|0|||
147105337|NCT04006457|530552125|FG000|Main Study Observation Period|Adverse Event|1|||
147105338|NCT04006457|530552126|FG001|Main Study Observation Period|Adverse Event|1|||
147105339|NCT04006457|530552127|FG002|Main Study Observation Period|Adverse Event|0|||
147105340|NCT04006457|530552125|FG000|Main Study Observation Period|Lost to Follow-up|0|||
147105341|NCT04006457|530552126|FG001|Main Study Observation Period|Lost to Follow-up|1|||
147224593|NCT02414139|530993197|FG005|Post-treatment Efficacy Follow-up|Physician Decision|0|||
147224594|NCT02414139|530993198|FG006|Post-treatment Efficacy Follow-up|Physician Decision|1|||
147224595|NCT02414139|530993199|FG007|Post-treatment Efficacy Follow-up|Physician Decision|0|||
147224596|NCT02414139|530993200|FG008|Post-treatment Efficacy Follow-up|Physician Decision|0|||
147224597|NCT02414139|530993201|FG009|Post-treatment Efficacy Follow-up|Physician Decision|1|||
147224598|NCT02414139|530993192|FG000|Post-treatment Efficacy Follow-up|Progressive disease|6|||
147224599|NCT02414139|530993193|FG001|Post-treatment Efficacy Follow-up|Progressive disease|5|||
147224600|NCT02414139|530993194|FG002|Post-treatment Efficacy Follow-up|Progressive disease|9|||
147224601|NCT02414139|530993195|FG003|Post-treatment Efficacy Follow-up|Progressive disease|5|||
147224602|NCT02414139|530993196|FG004|Post-treatment Efficacy Follow-up|Progressive disease|15|||
147224603|NCT02414139|530993197|FG005|Post-treatment Efficacy Follow-up|Progressive disease|4|||
147224604|NCT02414139|530993198|FG006|Post-treatment Efficacy Follow-up|Progressive disease|5|||
147224605|NCT02414139|530993199|FG007|Post-treatment Efficacy Follow-up|Progressive disease|1|||
147224606|NCT02414139|530993200|FG008|Post-treatment Efficacy Follow-up|Progressive disease|3|||
147224607|NCT02414139|530993201|FG009|Post-treatment Efficacy Follow-up|Progressive disease|3|||
147224608|NCT02414139|530993192|FG000|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
147224609|NCT02414139|530993193|FG001|Post-treatment Efficacy Follow-up|Study terminated by sponsor|1|||
147224610|NCT02414139|530993194|FG002|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
147224611|NCT02414139|530993195|FG003|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
147224612|NCT02414139|530993196|FG004|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
147224613|NCT02414139|530993197|FG005|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
147224614|NCT02414139|530993198|FG006|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
147224615|NCT02414139|530993199|FG007|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
147224616|NCT02414139|530993200|FG008|Post-treatment Efficacy Follow-up|Study terminated by sponsor|0|||
147224617|NCT02414139|530993201|FG009|Post-treatment Efficacy Follow-up|Study terminated by sponsor|1|||
147224618|NCT02414139|530993192|FG000|Post-treatment Efficacy Follow-up|Subject/guardian decision|4|||
147224619|NCT02414139|530993193|FG001|Post-treatment Efficacy Follow-up|Subject/guardian decision|2|||
147224620|NCT02414139|530993194|FG002|Post-treatment Efficacy Follow-up|Subject/guardian decision|3|||
147224621|NCT02414139|530993195|FG003|Post-treatment Efficacy Follow-up|Subject/guardian decision|1|||
147224622|NCT02414139|530993196|FG004|Post-treatment Efficacy Follow-up|Subject/guardian decision|1|||
147224623|NCT02414139|530993197|FG005|Post-treatment Efficacy Follow-up|Subject/guardian decision|1|||
147224624|NCT02414139|530993198|FG006|Post-treatment Efficacy Follow-up|Subject/guardian decision|0|||
147224625|NCT02414139|530993199|FG007|Post-treatment Efficacy Follow-up|Subject/guardian decision|0|||
147224626|NCT02414139|530993200|FG008|Post-treatment Efficacy Follow-up|Subject/guardian decision|0|||
147224627|NCT02414139|530993201|FG009|Post-treatment Efficacy Follow-up|Subject/guardian decision|2|||
147224628|NCT00591578|530993202|FG000|Double-Blind Treatment Phase|Adverse Event|20|||
147224629|NCT00591578|530993203|FG001|Double-Blind Treatment Phase|Adverse Event|26|||
147224630|NCT00591578|530993204|FG002|Double-Blind Treatment Phase|Adverse Event|19|||
147105342|NCT04006457|530552127|FG002|Main Study Observation Period|Lost to Follow-up|0|||
147310102|NCT01468922|531302237|FG008|Overall Study|Refused further treatment|0|||
147105343|NCT04006457|530552125|FG000|Main Study Observation Period|Pregnancy|1|||
147105344|NCT04006457|530552126|FG001|Main Study Observation Period|Pregnancy|0|||
147105345|NCT04006457|530552127|FG002|Main Study Observation Period|Pregnancy|0|||
147105346|NCT04006457|530552125|FG000|Main Study Observation Period|Withdrawal by Subject|10|||
147105347|NCT04006457|530552126|FG001|Main Study Observation Period|Withdrawal by Subject|14|||
147105348|NCT04006457|530552127|FG002|Main Study Observation Period|Withdrawal by Subject|0|||
147105349|NCT04006457|530552125|FG000|Main Study Observation Period|Other|8|||
147105350|NCT04006457|530552126|FG001|Main Study Observation Period|Other|16|||
147105351|NCT04006457|530552127|FG002|Main Study Observation Period|Other|0|||
147105352|NCT04006457|530552125|FG000|Main Study Observation Period|Approved Drug Available For Indication|6|||
147105353|NCT04006457|530552126|FG001|Main Study Observation Period|Approved Drug Available For Indication|9|||
147105354|NCT04006457|530552127|FG002|Main Study Observation Period|Approved Drug Available For Indication|0|||
147105355|NCT04006457|530552125|FG000|Main Study Observation Period|Ongoing|2|||
147105356|NCT04006457|530552126|FG001|Main Study Observation Period|Ongoing|1|||
147105357|NCT04006457|530552127|FG002|Main Study Observation Period|Ongoing|0|||
147105358|NCT04006457|530552125|FG000|Vaccine Sub Study|Withdrawal by Subject|0|||
147105359|NCT04006457|530552126|FG001|Vaccine Sub Study|Withdrawal by Subject|0|||
147105360|NCT04006457|530552127|FG002|Vaccine Sub Study|Withdrawal by Subject|1|||
147105361|NCT03729362|530552128|FG000|Overall Study|Withdrawal by Subject|2|||
147105362|NCT03729362|530552129|FG001|Overall Study|Withdrawal by Subject|0|||
147554471|NCT00095199|532185656|FG002|Overall Study|Withdrawal by Subject|13|||
147554472|NCT00095199|532185657|FG003|Overall Study|Withdrawal by Subject|22|||
147554473|NCT00095199|532185654|FG000|Overall Study|Protocol Violation|4|||
147554474|NCT00095199|532185655|FG001|Overall Study|Protocol Violation|4|||
147554475|NCT00095199|532185656|FG002|Overall Study|Protocol Violation|2|||
147554476|NCT00095199|532185657|FG003|Overall Study|Protocol Violation|0|||
147554477|NCT00095199|532185654|FG000|Overall Study|Liver function test results elevated|0|||
147554478|NCT00095199|532185655|FG001|Overall Study|Liver function test results elevated|0|||
147554479|NCT00095199|532185656|FG002|Overall Study|Liver function test results elevated|1|||
147554480|NCT00095199|532185657|FG003|Overall Study|Liver function test results elevated|1|||
147554481|NCT00095199|532185654|FG000|Overall Study|Surgery needed could not start in 7 days|0|||
147554482|NCT00095199|532185655|FG001|Overall Study|Surgery needed could not start in 7 days|0|||
147105363|NCT03729362|530552128|FG000|Overall Study|Physician Decision|1|||
147105364|NCT03729362|530552129|FG001|Overall Study|Physician Decision|0|||
147105365|NCT03729362|530552128|FG000|Overall Study|COVID-19 Pandemic|1|||
147105366|NCT03729362|530552129|FG001|Overall Study|COVID-19 Pandemic|0|||
147105367|NCT03729362|530552128|FG000|Overall Study|Discontinued due to COVID-19 related pneumonia|1|||
147105368|NCT03729362|530552129|FG001|Overall Study|Discontinued due to COVID-19 related pneumonia|0|||
147105369|NCT03729362|530552128|FG000|Overall Study|Adverse Event|0|||
147105370|NCT03729362|530552129|FG001|Overall Study|Adverse Event|1|||
147105371|NCT03729362|530552128|FG000|Overall Study|Genotyping did not confirm diagnosis of Pompe disease|0|||
147554483|NCT00095199|532185656|FG002|Overall Study|Surgery needed could not start in 7 days|1|||
147554484|NCT00095199|532185657|FG003|Overall Study|Surgery needed could not start in 7 days|0|||
147554485|NCT00095199|532185654|FG000|Overall Study|Physician Decision|5|||
147554486|NCT00095199|532185655|FG001|Overall Study|Physician Decision|6|||
147554487|NCT00095199|532185656|FG002|Overall Study|Physician Decision|1|||
147554488|NCT00095199|532185657|FG003|Overall Study|Physician Decision|1|||
147554489|NCT00095199|532185654|FG000|Overall Study|Not eligible|1|||
147554490|NCT00095199|532185655|FG001|Overall Study|Not eligible|7|||
147554491|NCT00095199|532185656|FG002|Overall Study|Not eligible|0|||
147554492|NCT00095199|532185657|FG003|Overall Study|Not eligible|1|||
147554493|NCT00095199|532185654|FG000|Overall Study|Started Palliative Radiotherapy|1|||
147554494|NCT00095199|532185655|FG001|Overall Study|Started Palliative Radiotherapy|0|||
147554495|NCT00095199|532185656|FG002|Overall Study|Started Palliative Radiotherapy|0|||
147554496|NCT00095199|532185657|FG003|Overall Study|Started Palliative Radiotherapy|0|||
147554497|NCT00095199|532185654|FG000|Overall Study|Started radiotherapy regimen|0|||
147554498|NCT00095199|532185655|FG001|Overall Study|Started radiotherapy regimen|1|||
147554499|NCT00095199|532185656|FG002|Overall Study|Started radiotherapy regimen|0|||
147105372|NCT03729362|530552129|FG001|Overall Study|Genotyping did not confirm diagnosis of Pompe disease|2|||
147105373|NCT02807259|530552130|FG000|Baseline (3 Months)|migration, refusal, not available|77|||
147105374|NCT02807259|530552131|FG001|Baseline (3 Months)|migration, refusal, not available|112|||
147554500|NCT00095199|532185657|FG003|Overall Study|Started radiotherapy regimen|0|||
147554501|NCT00095199|532185654|FG000|Overall Study|Primary tumor removed in other surgery|0|||
147554502|NCT00095199|532185655|FG001|Overall Study|Primary tumor removed in other surgery|1|||
147105375|NCT02807259|530552130|FG000|Midline (3 Months)|migration, refusal, not available|30|||
147105376|NCT02807259|530552131|FG001|Midline (3 Months)|migration, refusal, not available|34|||
147310103|NCT01923389|531302238|FG000|Overall Study|Protocol Violation|1|||
147554503|NCT00095199|532185656|FG002|Overall Study|Primary tumor removed in other surgery|0|||
147554504|NCT00095199|532185657|FG003|Overall Study|Primary tumor removed in other surgery|0|||
147554505|NCT00095199|532185654|FG000|Overall Study|Data inadvertently lost by site|1|||
147554506|NCT00095199|532185655|FG001|Overall Study|Data inadvertently lost by site|0|||
147554507|NCT00095199|532185656|FG002|Overall Study|Data inadvertently lost by site|0|||
147554508|NCT00095199|532185657|FG003|Overall Study|Data inadvertently lost by site|0|||
147554509|NCT03896490|532185692|FG000|Overall Study|Withdrawal by Subject|1|||
147554510|NCT03896490|532185693|FG001|Overall Study|Withdrawal by Subject|1|||
147554511|NCT01736553|532185698|FG000|Overall Study|Death|12|||
147554512|NCT01736553|532185699|FG001|Overall Study|Death|0|||
147554513|NCT01736553|532185698|FG000|Overall Study|Withdrawal by Subject|5|||
147554514|NCT01736553|532185699|FG001|Overall Study|Withdrawal by Subject|2|||
147554515|NCT01736553|532185698|FG000|Overall Study|Lost to Follow-up|2|||
147554516|NCT01736553|532185699|FG001|Overall Study|Lost to Follow-up|2|||
147554517|NCT01896297|532185700|FG000|Overall Study|Died in post treatment phase|1|||
147554518|NCT00003782|532185701|FG000|Overall Study|No follow up data|30|||
147554519|NCT00003782|532185702|FG001|Overall Study|No follow up data|31|||
147554520|NCT00003782|532185703|FG002|Overall Study|No follow up data|26|||
147554521|NCT01890707|532185704|FG000|Overall Study|Lost to Follow-up|1|||
147554522|NCT01890707|532185705|FG001|Overall Study|Lost to Follow-up|1|||
147554523|NCT00385541|532185707|FG000|Overall Study|severe pain, clinician requested unblind|0|||
147554524|NCT00385541|532185708|FG001|Overall Study|severe pain, clinician requested unblind|1|||
147554525|NCT00929708|532185709|FG000|Overall Study|Protocol Violation|2|||
147554526|NCT00929708|532185710|FG001|Overall Study|Protocol Violation|1|||
147224631|NCT00591578|530993202|FG000|Double-Blind Treatment Phase|Protocol Violation|3|||
147224632|NCT00591578|530993203|FG001|Double-Blind Treatment Phase|Protocol Violation|2|||
147224633|NCT00591578|530993204|FG002|Double-Blind Treatment Phase|Protocol Violation|3|||
147224634|NCT00591578|530993202|FG000|Double-Blind Treatment Phase|Lost to Follow-up|12|||
147224635|NCT00591578|530993203|FG001|Double-Blind Treatment Phase|Lost to Follow-up|12|||
147224636|NCT00591578|530993204|FG002|Double-Blind Treatment Phase|Lost to Follow-up|11|||
147224637|NCT00591578|530993202|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|22|||
147224638|NCT00591578|530993203|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|22|||
147224639|NCT00591578|530993204|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|22|||
147224640|NCT00591578|530993202|FG000|Double-Blind Treatment Phase|Pregnancy|1|||
147224641|NCT00591578|530993203|FG001|Double-Blind Treatment Phase|Pregnancy|0|||
147224642|NCT00591578|530993204|FG002|Double-Blind Treatment Phase|Pregnancy|0|||
147224643|NCT00591578|530993202|FG000|Double-Blind Treatment Phase|Lack of Efficacy|16|||
147224644|NCT00591578|530993203|FG001|Double-Blind Treatment Phase|Lack of Efficacy|9|||
147224645|NCT00591578|530993204|FG002|Double-Blind Treatment Phase|Lack of Efficacy|25|||
147224646|NCT00591578|530993202|FG000|Double-Blind Treatment Phase|Other|4|||
147224647|NCT00591578|530993203|FG001|Double-Blind Treatment Phase|Other|9|||
147224648|NCT00591578|530993204|FG002|Double-Blind Treatment Phase|Other|4|||
147224649|NCT00591578|530993202|FG000|Open-Label Extension Phase|Adverse Event|3|||
147224650|NCT00591578|530993203|FG001|Open-Label Extension Phase|Adverse Event|5|||
147224651|NCT00591578|530993204|FG002|Open-Label Extension Phase|Adverse Event|0|||
147224652|NCT00591578|530993202|FG000|Open-Label Extension Phase|Lost to Follow-up|1|||
147224653|NCT00591578|530993203|FG001|Open-Label Extension Phase|Lost to Follow-up|4|||
147224654|NCT00591578|530993204|FG002|Open-Label Extension Phase|Lost to Follow-up|0|||
147224655|NCT00591578|530993202|FG000|Open-Label Extension Phase|Withdrawal by Subject|1|||
147224656|NCT00591578|530993203|FG001|Open-Label Extension Phase|Withdrawal by Subject|1|||
147224657|NCT00591578|530993204|FG002|Open-Label Extension Phase|Withdrawal by Subject|0|||
147224658|NCT00591578|530993202|FG000|Open-Label Extension Phase|Other|1|||
147224659|NCT00591578|530993203|FG001|Open-Label Extension Phase|Other|0|||
147224660|NCT00591578|530993204|FG002|Open-Label Extension Phase|Other|0|||
147224661|NCT00356122|530993216|FG000|TREATMENT|Lack of Efficacy|26|||
147224662|NCT00356122|530993216|FG000|TREATMENT|Adverse Event|10|||
147224663|NCT00356122|530993216|FG000|TREATMENT|Subject's request|4|||
147224664|NCT00356122|530993216|FG000|TREATMENT|Other|4|||
147224665|NCT00356122|530993216|FG000|TREATMENT|Did not receive study medication|1|||
147224666|NCT00356122|530993216|FG000|FOLLOW-UP|Death|37|||
147224667|NCT00356122|530993216|FG000|FOLLOW-UP|Lost to Follow-up|2|||
147224668|NCT00356122|530993216|FG000|FOLLOW-UP|Other|2|||
147224669|NCT00491556|530993217|FG000|Entry-Week (WK) 48: EXP/Standard Care|Lost to Follow-up|1|||
147224670|NCT00491556|530993218|FG001|Entry-Week (WK) 48: EXP/Standard Care|Lost to Follow-up|0|||
147554527|NCT00929708|532185711|FG002|Overall Study|Protocol Violation|1|||
147224671|NCT00491556|530993217|FG000|Entry-Week (WK) 48: EXP/Standard Care|Physician Decision|1|||
147224672|NCT00491556|530993218|FG001|Entry-Week (WK) 48: EXP/Standard Care|Physician Decision|0|||
147224673|NCT00491556|530993217|FG000|Entry-Week (WK) 48: EXP/Standard Care|Withdrawal by Subject|1|||
147224674|NCT00491556|530993218|FG001|Entry-Week (WK) 48: EXP/Standard Care|Withdrawal by Subject|0|||
147224675|NCT00491556|530993217|FG000|Entry-Week (WK) 48: EXP/Standard Care|Moved Out of Area|2|||
147554528|NCT00929708|532185712|FG003|Overall Study|Protocol Violation|1|||
147554529|NCT00929708|532185713|FG004|Overall Study|Protocol Violation|1|||
147224676|NCT00491556|530993218|FG001|Entry-Week (WK) 48: EXP/Standard Care|Moved Out of Area|0|||
147224677|NCT00491556|530993217|FG000|Entry-Week (WK) 48: EXP/Standard Care|Failure to Suppress VL at Week 24|11|||
147224678|NCT00491556|530993218|FG001|Entry-Week (WK) 48: EXP/Standard Care|Failure to Suppress VL at Week 24|0|||
147224679|NCT00491556|530993217|FG000|Entry-Week (WK) 48: EXP/Standard Care|VL Failure at Week 24|2|||
147224680|NCT00491556|530993218|FG001|Entry-Week (WK) 48: EXP/Standard Care|VL Failure at Week 24|0|||
147554530|NCT00929708|532185709|FG000|Overall Study|Withdrawal by Subject|2|||
147554531|NCT00929708|532185710|FG001|Overall Study|Withdrawal by Subject|0|||
147554532|NCT00929708|532185711|FG002|Overall Study|Withdrawal by Subject|0|||
147554533|NCT00929708|532185712|FG003|Overall Study|Withdrawal by Subject|2|||
147554534|NCT00929708|532185713|FG004|Overall Study|Withdrawal by Subject|1|||
147554535|NCT00929708|532185709|FG000|Overall Study|Adverse Event|0|||
147554536|NCT00929708|532185710|FG001|Overall Study|Adverse Event|0|||
147554537|NCT00929708|532185711|FG002|Overall Study|Adverse Event|0|||
147554538|NCT00929708|532185712|FG003|Overall Study|Adverse Event|0|||
147554539|NCT00929708|532185713|FG004|Overall Study|Adverse Event|3|||
147105377|NCT02807259|530552130|FG000|Endline (3 Months)|migration, refusal, not available|35|||
147105378|NCT02807259|530552131|FG001|Endline (3 Months)|migration, refusal, not available|87|||
147105379|NCT00849056|530552132|FG000|Treatment Period (TP) (156 Weeks)|Adverse Event|13|||
147105380|NCT00849056|530552133|FG001|Treatment Period (TP) (156 Weeks)|Adverse Event|11|||
147105381|NCT00849056|530552132|FG000|Treatment Period (TP) (156 Weeks)|Protocol Violation|3|||
147105382|NCT00849056|530552133|FG001|Treatment Period (TP) (156 Weeks)|Protocol Violation|6|||
147105383|NCT00849056|530552132|FG000|Treatment Period (TP) (156 Weeks)|Noncompliance|3|||
147105384|NCT00849056|530552133|FG001|Treatment Period (TP) (156 Weeks)|Noncompliance|3|||
147105385|NCT00849056|530552132|FG000|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|7|||
147105386|NCT00849056|530552133|FG001|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|5|||
147105387|NCT00849056|530552132|FG000|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|31|||
147105388|NCT00849056|530552133|FG001|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|18|||
147105389|NCT00849056|530552132|FG000|Treatment Period (TP) (156 Weeks)|Physician Decision|3|||
147105390|NCT00849056|530552133|FG001|Treatment Period (TP) (156 Weeks)|Physician Decision|3|||
147105391|NCT00849056|530552132|FG000|Treatment Period (TP) (156 Weeks)|Termination of Study/Site by GSK|1|||
147105392|NCT00849056|530552133|FG001|Treatment Period (TP) (156 Weeks)|Termination of Study/Site by GSK|4|||
147105393|NCT00849056|530552132|FG000|Treatment Period (TP) (156 Weeks)|Calcitonin Out of Range|1|||
147105394|NCT00849056|530552133|FG001|Treatment Period (TP) (156 Weeks)|Calcitonin Out of Range|0|||
147105395|NCT00849056|530552132|FG000|Treatment Period (TP) (156 Weeks)|Pregnancy|1|||
147105396|NCT00849056|530552133|FG001|Treatment Period (TP) (156 Weeks)|Pregnancy|0|||
147105397|NCT00849056|530552132|FG000|Follow-up Period (FUP) (8 Weeks)|Adverse Event|1|||
147105398|NCT00849056|530552133|FG001|Follow-up Period (FUP) (8 Weeks)|Adverse Event|3|||
147105399|NCT00849056|530552132|FG000|Follow-up Period (FUP) (8 Weeks)|Noncompliance|0|||
147105400|NCT00849056|530552133|FG001|Follow-up Period (FUP) (8 Weeks)|Noncompliance|1|||
147105401|NCT00849056|530552132|FG000|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|14|||
147105402|NCT00849056|530552133|FG001|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|9|||
147105403|NCT00849056|530552132|FG000|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|9|||
147105404|NCT00849056|530552133|FG001|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|7|||
147105405|NCT00849056|530552132|FG000|Follow-up Period (FUP) (8 Weeks)|Physician Decision|1|||
147105406|NCT00849056|530552133|FG001|Follow-up Period (FUP) (8 Weeks)|Physician Decision|1|||
147105407|NCT00849056|530552132|FG000|Follow-up Period (FUP) (8 Weeks)|Termination of Study/Site by GSK|1|||
147105408|NCT00849056|530552133|FG001|Follow-up Period (FUP) (8 Weeks)|Termination of Study/Site by GSK|4|||
147105409|NCT00849056|530552132|FG000|Follow-up Period (FUP) (8 Weeks)|Early Termination|1|||
147105410|NCT00849056|530552133|FG001|Follow-up Period (FUP) (8 Weeks)|Early Termination|0|||
147105411|NCT00274456|530552134|FG000|Overall Study|Still on treatment|2|||
147105412|NCT00274456|530552135|FG001|Overall Study|Still on treatment|3|||
147105413|NCT00274456|530552136|FG002|Overall Study|Still on treatment|5|||
147105414|NCT00274456|530552137|FG003|Overall Study|Still on treatment|1|||
147105415|NCT00274456|530552134|FG000|Overall Study|Unacceptable toxicity|10|||
147105416|NCT00274456|530552135|FG001|Overall Study|Unacceptable toxicity|5|||
147105417|NCT00274456|530552136|FG002|Overall Study|Unacceptable toxicity|12|||
147105418|NCT00274456|530552137|FG003|Overall Study|Unacceptable toxicity|16|||
147105419|NCT00274456|530552134|FG000|Overall Study|Adverse Event|0|||
147105420|NCT00274456|530552135|FG001|Overall Study|Adverse Event|1|||
147105421|NCT00274456|530552136|FG002|Overall Study|Adverse Event|2|||
147105422|NCT00274456|530552137|FG003|Overall Study|Adverse Event|2|||
147105423|NCT00274456|530552134|FG000|Overall Study|Physician Decision|7|||
147105424|NCT00274456|530552135|FG001|Overall Study|Physician Decision|5|||
147105425|NCT00274456|530552136|FG002|Overall Study|Physician Decision|6|||
147310104|NCT01923389|531302239|FG001|Overall Study|Protocol Violation|0|||
147310105|NCT02761629|531302244|FG000|Overall Study|Adverse Event/Intercurrent Illness|7|||
147310106|NCT02761629|531302245|FG001|Overall Study|Adverse Event/Intercurrent Illness|5|||
147310107|NCT02761629|531302244|FG000|Overall Study|Insufficient Therapeutic Response|2|||
147554540|NCT00929708|532185709|FG000|Overall Study|Physician Decision|0|||
147554541|NCT00929708|532185710|FG001|Overall Study|Physician Decision|2|||
147554542|NCT00929708|532185711|FG002|Overall Study|Physician Decision|2|||
147105426|NCT00274456|530552137|FG003|Overall Study|Physician Decision|13|||
147105427|NCT00274456|530552134|FG000|Overall Study|Lost to Follow-up|0|||
147105428|NCT00274456|530552135|FG001|Overall Study|Lost to Follow-up|0|||
147105429|NCT00274456|530552136|FG002|Overall Study|Lost to Follow-up|1|||
147105430|NCT00274456|530552137|FG003|Overall Study|Lost to Follow-up|0|||
147554543|NCT00929708|532185712|FG003|Overall Study|Physician Decision|2|||
147554544|NCT00929708|532185713|FG004|Overall Study|Physician Decision|1|||
147105431|NCT00274456|530552134|FG000|Overall Study|Withdrawal by Subject|18|||
147105432|NCT00274456|530552135|FG001|Overall Study|Withdrawal by Subject|13|||
147105433|NCT00274456|530552136|FG002|Overall Study|Withdrawal by Subject|9|||
147105434|NCT00274456|530552137|FG003|Overall Study|Withdrawal by Subject|13|||
147105435|NCT00375752|530552141|FG000|Overall Study|Lack of Efficacy|4|||
147105436|NCT00375752|530552142|FG001|Overall Study|Lack of Efficacy|4|||
147105437|NCT00375752|530552141|FG000|Overall Study|Adverse Event|1|||
147105438|NCT00375752|530552142|FG001|Overall Study|Adverse Event|6|||
147105439|NCT00375752|530552141|FG000|Overall Study|Withdrawal by Subject|6|||
147105440|NCT00375752|530552142|FG001|Overall Study|Withdrawal by Subject|1|||
147105441|NCT00375752|530552141|FG000|Overall Study|Abnormal Laboratory Value(s)|1|||
147105442|NCT00375752|530552142|FG001|Overall Study|Abnormal Laboratory Value(s)|1|||
147105443|NCT00375752|530552141|FG000|Overall Study|Protocol Violation|0|||
147105444|NCT00375752|530552142|FG001|Overall Study|Protocol Violation|2|||
147105445|NCT00375752|530552141|FG000|Overall Study|Administrative Problems|0|||
147105446|NCT00375752|530552142|FG001|Overall Study|Administrative Problems|1|||
147105447|NCT01140906|530552149|FG000|Overall Study|Adverse Event|7|||
147105448|NCT01140906|530552150|FG001|Overall Study|Adverse Event|10|||
147105449|NCT01140906|530552151|FG002|Overall Study|Adverse Event|17|||
147105450|NCT01140906|530552152|FG003|Overall Study|Adverse Event|7|||
147105451|NCT01140906|530552149|FG000|Overall Study|Lack of Efficacy|6|||
147105452|NCT01140906|530552150|FG001|Overall Study|Lack of Efficacy|8|||
147105453|NCT01140906|530552151|FG002|Overall Study|Lack of Efficacy|2|||
147105454|NCT01140906|530552152|FG003|Overall Study|Lack of Efficacy|1|||
147105455|NCT01140906|530552149|FG000|Overall Study|Non-compliance|0|||
147105456|NCT01140906|530552150|FG001|Overall Study|Non-compliance|1|||
147105457|NCT01140906|530552151|FG002|Overall Study|Non-compliance|0|||
147105458|NCT01140906|530552152|FG003|Overall Study|Non-compliance|1|||
147105459|NCT01140906|530552149|FG000|Overall Study|Protocol Violation|5|||
147105460|NCT01140906|530552150|FG001|Overall Study|Protocol Violation|3|||
147105461|NCT01140906|530552151|FG002|Overall Study|Protocol Violation|2|||
147105462|NCT01140906|530552152|FG003|Overall Study|Protocol Violation|1|||
147105463|NCT01140906|530552149|FG000|Overall Study|Withdrawal of consent|6|||
147105464|NCT01140906|530552150|FG001|Overall Study|Withdrawal of consent|6|||
147105465|NCT01140906|530552151|FG002|Overall Study|Withdrawal of consent|2|||
147105466|NCT01140906|530552152|FG003|Overall Study|Withdrawal of consent|2|||
147105467|NCT01140906|530552149|FG000|Overall Study|Lost to Follow-up|1|||
147105468|NCT01140906|530552150|FG001|Overall Study|Lost to Follow-up|1|||
147105469|NCT01140906|530552151|FG002|Overall Study|Lost to Follow-up|0|||
147105470|NCT01140906|530552152|FG003|Overall Study|Lost to Follow-up|2|||
147105471|NCT01140906|530552149|FG000|Overall Study|Administrative or other reason|0|||
147105472|NCT01140906|530552150|FG001|Overall Study|Administrative or other reason|5|||
147105473|NCT01140906|530552151|FG002|Overall Study|Administrative or other reason|3|||
147105474|NCT01140906|530552152|FG003|Overall Study|Administrative or other reason|2|||
147105475|NCT00336544|530552153|FG000|Overall Study|Lack of Efficacy|8|||
147105476|NCT00336544|530552154|FG001|Overall Study|Lack of Efficacy|5|||
147105477|NCT00336544|530552153|FG000|Overall Study|Adverse Event|4|||
147105478|NCT00336544|530552154|FG001|Overall Study|Adverse Event|9|||
147105479|NCT00336544|530552153|FG000|Overall Study|Withdrawal by Subject|4|||
147105480|NCT00336544|530552154|FG001|Overall Study|Withdrawal by Subject|3|||
147105481|NCT00336544|530552153|FG000|Overall Study|Other|3|||
147105482|NCT00336544|530552154|FG001|Overall Study|Other|5|||
147105483|NCT01316614|530552155|FG000|Overall Study|No solid lesion and FNA not indicated|25|||
147105484|NCT01316614|530552155|FG000|Overall Study|Cytology slides not available for review|4|||
147105485|NCT01316614|530552155|FG000|Overall Study|Cystic lesion|5|||
147105486|NCT01316614|530552155|FG000|Overall Study|Inadequate number of passes|2|||
147105487|NCT01316614|530552155|FG000|Overall Study|Medically unstable|1|||
147554545|NCT00929708|532185709|FG000|Overall Study|Lost to Follow-up|0|||
147554546|NCT00929708|532185710|FG001|Overall Study|Lost to Follow-up|0|||
147554547|NCT00929708|532185711|FG002|Overall Study|Lost to Follow-up|0|||
147554548|NCT00929708|532185712|FG003|Overall Study|Lost to Follow-up|1|||
147554549|NCT00929708|532185713|FG004|Overall Study|Lost to Follow-up|0|||
147554550|NCT01893138|532185714|FG000|Double-Blind Period|Withdrawal by Subject|1|||
147554551|NCT01893138|532185715|FG001|Double-Blind Period|Withdrawal by Subject|1|||
147105488|NCT03427411|530552156|FG000|Overall Study|Screen failure - platelets too low|0|||
147105489|NCT03427411|530552157|FG001|Overall Study|Screen failure - platelets too low|1|||
147105490|NCT00089648|530552158|FG000|Overall Study|Adverse Event|7|||
147105491|NCT00089648|530552158|FG000|Overall Study|Withdrawal by Subject|1|||
147105492|NCT00089648|530552158|FG000|Overall Study|Lack of Efficacy|33|||
147105493|NCT00423605|530552159|FG000|Overall Study|Adverse Event|129|||
147105494|NCT00423605|530552159|FG000|Overall Study|Withdrawal by Subject|36|||
147105495|NCT00423605|530552159|FG000|Overall Study|Lost to Follow-up|15|||
147105496|NCT00423605|530552159|FG000|Overall Study|Lack of Efficacy|38|||
147105497|NCT00423605|530552159|FG000|Overall Study|Sponsor Decision|3|||
147105498|NCT00423605|530552159|FG000|Overall Study|Physician Decision|8|||
147105499|NCT00423605|530552159|FG000|Overall Study|Protocol Violation|7|||
147105500|NCT00423605|530552159|FG000|Overall Study|Not one of the pre-specified options|5|||
147105501|NCT03183908|530552160|FG000|Overall Study|Missing Symptom Diary Data|0|||
147105502|NCT03183908|530552161|FG001|Overall Study|Missing Symptom Diary Data|2|||
147105503|NCT03738696|530552165|FG000|Overall Study|Withdrawal by Subject|0|||
147105504|NCT03738696|530552166|FG001|Overall Study|Withdrawal by Subject|1|||
147105505|NCT03738696|530552165|FG000|Overall Study|Lost to Follow-up|8|||
147105506|NCT03738696|530552166|FG001|Overall Study|Lost to Follow-up|14|||
147105507|NCT01983930|530552169|FG000|Overall Study|Withdrawal by Subject|9|||
147105508|NCT01983930|530552170|FG001|Overall Study|Withdrawal by Subject|8|||
147105509|NCT01983930|530552169|FG000|Overall Study|Adverse Event|0|||
147105510|NCT01983930|530552170|FG001|Overall Study|Adverse Event|1|||
147105511|NCT00091819|530552171|FG000|Overall Study|Adverse Event|1|||
147105512|NCT00091819|530552172|FG001|Overall Study|Adverse Event|1|||
147105513|NCT00091819|530552171|FG000|Overall Study|Death|4|||
147105514|NCT00091819|530552172|FG001|Overall Study|Death|5|||
147105515|NCT00091819|530552171|FG000|Overall Study|Lost to Follow-up|26|||
147105516|NCT00091819|530552172|FG001|Overall Study|Lost to Follow-up|23|||
147105517|NCT00091819|530552171|FG000|Overall Study|Withdrawal by Subject|5|||
147105518|NCT00091819|530552172|FG001|Overall Study|Withdrawal by Subject|8|||
147105519|NCT00091819|530552171|FG000|Overall Study|Protocol Violation|1|||
147105520|NCT00091819|530552172|FG001|Overall Study|Protocol Violation|2|||
147105521|NCT00091819|530552171|FG000|Overall Study|Other|2|||
147105522|NCT00091819|530552172|FG001|Overall Study|Other|3|||
147105523|NCT00091819|530552171|FG000|Overall Study|Never received study treatment|3|||
147105524|NCT00091819|530552172|FG001|Overall Study|Never received study treatment|4|||
147105525|NCT05001620|530552173|FG000|Overall Study|Didn't complete the telehealth Palliative Care Consultation|1|||
147105526|NCT05001620|530552174|FG001|Overall Study|Didn't complete the telehealth Palliative Care Consultation|0|||
147105527|NCT00819039|530552175|FG000|Overall Study|Physician Decision|1|||
147105528|NCT00819039|530552176|FG001|Overall Study|Physician Decision|0|||
147105529|NCT00819039|530552177|FG002|Overall Study|Physician Decision|1|||
147105530|NCT00819039|530552175|FG000|Overall Study|Protocol Violation|1|||
147105531|NCT00819039|530552176|FG001|Overall Study|Protocol Violation|0|||
147105532|NCT00819039|530552177|FG002|Overall Study|Protocol Violation|0|||
147105533|NCT04796415|530552178|FG000|Overall Study|not interested|12|||
147105534|NCT04796415|530552178|FG000|Overall Study|health issue|8|||
147105535|NCT04796415|530552178|FG000|Overall Study|Other|4|||
147105536|NCT04796415|530552178|FG000|Overall Study|discharged from home health service|3|||
147105537|NCT04796415|530552178|FG000|Overall Study|re-hospitalization|2|||
147105538|NCT04796415|530552178|FG000|Overall Study|moving to nursing home|1|||
147105539|NCT04796415|530552178|FG000|Overall Study|lost contact|1|||
147105540|NCT03185208|530552182|FG000|Overall Study|Did not start study medication|0|||
147105541|NCT03185208|530552183|FG001|Overall Study|Did not start study medication|3|||
147105542|NCT03834350|530552184|FG000|Overall Study|Withdrawal by Subject|1|||
147105543|NCT02701634|530552185|FG000|Overall Study|Adverse Event|2|||
147105544|NCT02701634|530552186|FG001|Overall Study|Adverse Event|3|||
147105545|NCT02701634|530552185|FG000|Overall Study|Death|1|||
147105546|NCT02701634|530552186|FG001|Overall Study|Death|0|||
147105547|NCT02701634|530552185|FG000|Overall Study|Investigator's Discretion|7|||
147105548|NCT02701634|530552186|FG001|Overall Study|Investigator's Discretion|4|||
147105549|NCT02701634|530552185|FG000|Overall Study|Study terminated by Sponsor|15|||
147105550|NCT02701634|530552186|FG001|Overall Study|Study terminated by Sponsor|17|||
147105551|NCT02701634|530552185|FG000|Overall Study|Withdrew Consent|6|||
147105552|NCT02701634|530552186|FG001|Overall Study|Withdrew Consent|7|||
147105553|NCT02701634|530552185|FG000|Overall Study|Randomized but not treated|1|||
147105554|NCT02701634|530552186|FG001|Overall Study|Randomized but not treated|0|||
147105555|NCT03620162|530552187|FG000|Overall Study|Physician Decision|4|||
147105556|NCT03620162|530552188|FG001|Overall Study|Physician Decision|0|||
147105557|NCT03620162|530552189|FG002|Overall Study|Physician Decision|1|||
147105558|NCT03620162|530552190|FG003|Overall Study|Physician Decision|0|||
147105559|NCT03620162|530552191|FG004|Overall Study|Physician Decision|2|||
147105560|NCT03620162|530552187|FG000|Overall Study|Lost to Follow-up|2|||
147105561|NCT03620162|530552188|FG001|Overall Study|Lost to Follow-up|6|||
147105562|NCT03620162|530552189|FG002|Overall Study|Lost to Follow-up|7|||
147224681|NCT00491556|530993217|FG000|Entry-Week (WK) 48: EXP/Standard Care|Adherence Issues|2|||
147105563|NCT03620162|530552190|FG003|Overall Study|Lost to Follow-up|3|||
147105564|NCT03620162|530552191|FG004|Overall Study|Lost to Follow-up|2|||
147105565|NCT03620162|530552187|FG000|Overall Study|Consent withdrawn by parent/guardian|9|||
147105566|NCT03620162|530552188|FG001|Overall Study|Consent withdrawn by parent/guardian|8|||
147105567|NCT03620162|530552189|FG002|Overall Study|Consent withdrawn by parent/guardian|25|||
147105568|NCT03620162|530552190|FG003|Overall Study|Consent withdrawn by parent/guardian|17|||
147105569|NCT03620162|530552191|FG004|Overall Study|Consent withdrawn by parent/guardian|9|||
147105570|NCT04009837|530552193|FG000|Overall Study|Withdrawal by Subject|5|||
147105571|NCT04009837|530552194|FG001|Overall Study|Withdrawal by Subject|4|||
147105572|NCT04009837|530552193|FG000|Overall Study|Did not complete any aspect of of 8-week assessment|3|||
147105573|NCT04009837|530552194|FG001|Overall Study|Did not complete any aspect of of 8-week assessment|7|||
147331194|NCT04771273|531377595|FG000|Maintenance Period|Adverse Event|4|||
147331195|NCT04771273|531377596|FG001|Maintenance Period|Adverse Event|5|||
147331196|NCT04771273|531377597|FG002|Maintenance Period|Adverse Event|5|||
147105574|NCT03426878|530552196|FG000|Overall Study|Did not return saliva sample to laboratory|126|||
147105575|NCT03426878|530552196|FG000|Overall Study|DNA extraction and sequencing was not successful|14|||
147105576|NCT03426878|530552196|FG000|Overall Study|Declined to receive results|3|||
147105577|NCT03426878|530552196|FG000|Overall Study|Received negative results by mailed letter|65|||
147105578|NCT03426878|530552196|FG000|Overall Study|Lost to Follow-up|177|||
147105579|NCT02855268|530552197|FG000|DB Period (up to 48 Weeks)|Withdrawal by Subject|1|||
147105580|NCT02855268|530552198|FG001|DB Period (up to 48 Weeks)|Withdrawal by Subject|1|||
147105581|NCT02855268|530552197|FG000|DB Period (up to 48 Weeks)|Adverse Event|0|||
147105582|NCT02855268|530552198|FG001|DB Period (up to 48 Weeks)|Adverse Event|2|||
147105583|NCT02855268|530552197|FG000|DB Period (up to 48 Weeks)|Sponsor Decision|4|||
147105584|NCT02855268|530552198|FG001|DB Period (up to 48 Weeks)|Sponsor Decision|7|||
147105585|NCT02855268|530552197|FG000|OLE Period (up to 96 Weeks)|Adverse Event|0|||
147105586|NCT02855268|530552198|FG001|OLE Period (up to 96 Weeks)|Adverse Event|2|||
147105587|NCT02855268|530552197|FG000|OLE Period (up to 96 Weeks)|Withdrawal by Subject|1|||
147105588|NCT02855268|530552198|FG001|OLE Period (up to 96 Weeks)|Withdrawal by Subject|1|||
147105589|NCT02855268|530552197|FG000|OLE Period (up to 96 Weeks)|Early study termination by sponsor|7|||
147105590|NCT02855268|530552198|FG001|OLE Period (up to 96 Weeks)|Early study termination by sponsor|16|||
147105591|NCT00071981|530552203|FG000|Overall Study|Lack of Efficacy|37|||
147105592|NCT00071981|530552204|FG001|Overall Study|Lack of Efficacy|29|||
147105593|NCT00071981|530552205|FG002|Overall Study|Lack of Efficacy|30|||
147105594|NCT00071981|530552206|FG003|Overall Study|Lack of Efficacy|43|||
147105595|NCT00071981|530552203|FG000|Overall Study|Adverse Event|4|||
147105596|NCT00071981|530552204|FG001|Overall Study|Adverse Event|4|||
147105597|NCT00071981|530552205|FG002|Overall Study|Adverse Event|3|||
147105598|NCT00071981|530552206|FG003|Overall Study|Adverse Event|1|||
147105599|NCT00071981|530552203|FG000|Overall Study|Death|0|||
147105600|NCT00071981|530552204|FG001|Overall Study|Death|0|||
147105601|NCT00071981|530552205|FG002|Overall Study|Death|1|||
147105602|NCT00071981|530552206|FG003|Overall Study|Death|1|||
147105603|NCT00071981|530552203|FG000|Overall Study|Withdrawal by Subject|3|||
147105604|NCT00071981|530552204|FG001|Overall Study|Withdrawal by Subject|1|||
147105605|NCT00071981|530552205|FG002|Overall Study|Withdrawal by Subject|0|||
147105606|NCT00071981|530552206|FG003|Overall Study|Withdrawal by Subject|0|||
147105607|NCT00071981|530552203|FG000|Overall Study|No protocol therapy|2|||
147105608|NCT00071981|530552204|FG001|Overall Study|No protocol therapy|5|||
147105609|NCT00071981|530552205|FG002|Overall Study|No protocol therapy|1|||
147105610|NCT00071981|530552206|FG003|Overall Study|No protocol therapy|0|||
147105611|NCT00071981|530552203|FG000|Overall Study|others (not specified in the study)|0|||
147105612|NCT00071981|530552204|FG001|Overall Study|others (not specified in the study)|2|||
147105613|NCT00071981|530552205|FG002|Overall Study|others (not specified in the study)|2|||
147105614|NCT00071981|530552206|FG003|Overall Study|others (not specified in the study)|0|||
147105615|NCT01933594|530552208|FG000|Overall Study|Lost to Follow-up|1|||
147105616|NCT01933594|530552209|FG001|Overall Study|Lost to Follow-up|0|||
147105617|NCT01933594|530552210|FG002|Overall Study|Lost to Follow-up|0|||
147105618|NCT01933594|530552211|FG003|Overall Study|Lost to Follow-up|0|||
147105619|NCT01933594|530552212|FG004|Overall Study|Lost to Follow-up|1|||
147105620|NCT01933594|530552213|FG005|Overall Study|Lost to Follow-up|0|||
147105621|NCT01933594|530552208|FG000|Overall Study|Ineligible for subsequent study step|0|||
147105622|NCT01933594|530552209|FG001|Overall Study|Ineligible for subsequent study step|0|||
147105623|NCT01933594|530552210|FG002|Overall Study|Ineligible for subsequent study step|0|||
147105624|NCT01933594|530552211|FG003|Overall Study|Ineligible for subsequent study step|0|||
147105625|NCT01933594|530552212|FG004|Overall Study|Ineligible for subsequent study step|1|||
147105626|NCT01933594|530552213|FG005|Overall Study|Ineligible for subsequent study step|0|||
147105627|NCT01316575|530552214|FG000|Overall Study|Withdrawal by Subject|2|||
147105628|NCT01316575|530552215|FG001|Overall Study|Withdrawal by Subject|0|||
147105629|NCT01316575|530552214|FG000|Overall Study|Required alternate treatment|0|||
147105630|NCT01316575|530552215|FG001|Overall Study|Required alternate treatment|1|||
147105631|NCT00402831|530552216|FG000|Overall Study|Lost to Follow-up|1|||
147105632|NCT00402831|530552217|FG001|Overall Study|Lost to Follow-up|2|||
147105633|NCT00402831|530552216|FG000|Overall Study|Non-compliance with protocol|0|||
147105634|NCT00402831|530552217|FG001|Overall Study|Non-compliance with protocol|1|||
147105635|NCT04585893|530552220|FG000|Overall Study|Death|1|||
147105636|NCT04585893|530552221|FG001|Overall Study|Death|0|||
147105637|NCT03415178|530552228|FG000|Parallel-Arm Period (up to Week 4)|Randomized but not treated|0|||
147105638|NCT03415178|530552229|FG001|Parallel-Arm Period (up to Week 4)|Randomized but not treated|2|||
147105639|NCT03415178|530552228|FG000|Single Arm Period (up to Week 16)|Adverse Event|0|||
147105640|NCT03415178|530552229|FG001|Single Arm Period (up to Week 16)|Adverse Event|1|||
147105641|NCT01366092|530552230|FG000|Overall Study|Progressive cGVHD|2|||
147105642|NCT01366092|530552230|FG000|Overall Study|Physician Decision|1|||
147105643|NCT01366092|530552230|FG000|Overall Study|Withdrawal by Subject|1|||
147105644|NCT01093846|530552231|FG000|Overall Study|Adverse Event|0|||
147105645|NCT01093846|530552232|FG001|Overall Study|Adverse Event|0|||
147105646|NCT01093846|530552233|FG002|Overall Study|Adverse Event|1|||
147105647|NCT01093846|530552231|FG000|Overall Study|Lack of Efficacy|0|||
147105648|NCT01093846|530552232|FG001|Overall Study|Lack of Efficacy|0|||
147105649|NCT01093846|530552233|FG002|Overall Study|Lack of Efficacy|4|||
147105650|NCT01093846|530552231|FG000|Overall Study|Condition no longer required study drug|1|||
147105651|NCT01093846|530552232|FG001|Overall Study|Condition no longer required study drug|1|||
147105652|NCT01093846|530552233|FG002|Overall Study|Condition no longer required study drug|1|||
147105653|NCT01093846|530552231|FG000|Overall Study|Administrative Problems|18|||
147105654|NCT01093846|530552232|FG001|Overall Study|Administrative Problems|17|||
147105655|NCT01093846|530552233|FG002|Overall Study|Administrative Problems|15|||
147105656|NCT02781324|530552238|FG000|Overall Study|Withdrawal by Subject|1|||
147105657|NCT02781324|530552239|FG001|Overall Study|Withdrawal by Subject|0|||
147105658|NCT02781324|530552238|FG000|Overall Study|Physician Decision|1|||
147105659|NCT02781324|530552239|FG001|Overall Study|Physician Decision|2|||
147105660|NCT00834041|530552240|FG000|Overall Study|Withdrawal by Subject|1|||
147105661|NCT00834041|530552241|FG001|Overall Study|Withdrawal by Subject|0|||
147105662|NCT00834041|530552240|FG000|Overall Study|Lost to Follow-up|0|||
147105663|NCT00834041|530552241|FG001|Overall Study|Lost to Follow-up|1|||
147105664|NCT03074500|530552242|FG000|Overall Study|Lost to Follow-up|1|||
147105665|NCT03074500|530552243|FG001|Overall Study|Lost to Follow-up|0|||
147105666|NCT03074500|530552244|FG002|Overall Study|Lost to Follow-up|0|||
147105667|NCT03074500|530552242|FG000|Overall Study|Lack of Efficacy|0|||
147105668|NCT03074500|530552243|FG001|Overall Study|Lack of Efficacy|1|||
147105669|NCT03074500|530552244|FG002|Overall Study|Lack of Efficacy|0|||
147105670|NCT03074500|530552242|FG000|Overall Study|Adverse Event|0|||
147105671|NCT03074500|530552243|FG001|Overall Study|Adverse Event|0|||
147105672|NCT03074500|530552244|FG002|Overall Study|Adverse Event|1|||
147105673|NCT03321721|530552245|FG000|Overall Study|Lost to Follow-up|4|||
147105674|NCT03321721|530552246|FG001|Overall Study|Lost to Follow-up|8|||
147105675|NCT03321721|530552247|FG002|Overall Study|Lost to Follow-up|11|||
147105676|NCT01416571|530552250|FG000|Overall Study|Lost to Follow-up|2|||
147105677|NCT03608163|530552251|FG000|2nd Intervention (2 Days)|Physician Decision|0|||
147105678|NCT03608163|530552252|FG001|2nd Intervention (2 Days)|Physician Decision|1|||
147105679|NCT03353220|530552253|FG000|Third Intervention (6 Months) - Phase 2|Study was stopped due to unavailable study drug supply|4|||
147105680|NCT03353220|530552254|FG001|Third Intervention (6 Months) - Phase 2|Study was stopped due to unavailable study drug supply|7|||
147105681|NCT00661388|530552257|FG000|Overall Study|Adverse Event|14|||
147105682|NCT00661388|530552257|FG000|Overall Study|Protocol Violation|7|||
147105683|NCT00661388|530552257|FG000|Overall Study|Renal transplantation|1|||
147105684|NCT00661388|530552257|FG000|Overall Study|Dialysis initiation|1|||
147105685|NCT00661388|530552257|FG000|Overall Study|Administrative reasons|1|||
147105686|NCT03454555|530553647|FG000|Overall Study|Death|6|||
147105687|NCT03454555|530553648|FG001|Overall Study|Death|6|||
147105688|NCT03454555|530553647|FG000|Overall Study|Lost to Follow-up|31|||
147105689|NCT03454555|530553648|FG001|Overall Study|Lost to Follow-up|12|||
147105690|NCT03454555|530553647|FG000|Overall Study|Physician Decision|2|||
147105691|NCT03454555|530553648|FG001|Overall Study|Physician Decision|6|||
147105692|NCT03454555|530553647|FG000|Overall Study|Withdrawal by Subject|34|||
147105693|NCT03454555|530553648|FG001|Overall Study|Withdrawal by Subject|5|||
147105694|NCT03454555|530553647|FG000|Overall Study|Ineligible|1|||
147310108|NCT02761629|531302245|FG001|Overall Study|Insufficient Therapeutic Response|7|||
147310109|NCT02761629|531302244|FG000|Overall Study|Failure to Return|2|||
147310110|NCT02761629|531302245|FG001|Overall Study|Failure to Return|4|||
147310111|NCT02761629|531302244|FG000|Overall Study|Did not Cooperate/Refused Treatment|2|||
147105695|NCT03454555|530553648|FG001|Overall Study|Ineligible|5|||
147105696|NCT01288430|530553652|FG000|Part 1|Progressive disease|2|||
147105697|NCT01288430|530553653|FG001|Part 1|Progressive disease|1|||
147105698|NCT01288430|530553654|FG002|Part 1|Progressive disease|1|||
147105699|NCT01288430|530553655|FG003|Part 1|Progressive disease|6|||
147105700|NCT01288430|530553656|FG004|Part 1|Progressive disease|2|||
147105701|NCT01288430|530553657|FG005|Part 1|Progressive disease|4|||
147105702|NCT01288430|530553658|FG006|Part 1|Progressive disease|2|||
147105703|NCT01288430|530553659|FG007|Part 1|Progressive disease|0|||
147105704|NCT01288430|530553660|FG008|Part 1|Progressive disease|0|||
147105705|NCT01288430|530553661|FG009|Part 1|Progressive disease|0|||
147105706|NCT01288430|530553652|FG000|Part 1|Clinical disease progression|0|||
147105707|NCT01288430|530553653|FG001|Part 1|Clinical disease progression|0|||
147105708|NCT01288430|530553654|FG002|Part 1|Clinical disease progression|1|||
147310112|NCT02761629|531302245|FG001|Overall Study|Did not Cooperate/Refused Treatment|4|||
147310113|NCT02761629|531302244|FG000|Overall Study|Protocol Violation|2|||
147310114|NCT02761629|531302245|FG001|Overall Study|Protocol Violation|2|||
147105709|NCT01288430|530553655|FG003|Part 1|Clinical disease progression|0|||
147310115|NCT02761629|531302244|FG000|Overall Study|Withdrawal by Subject|0|||
147310116|NCT02761629|531302245|FG001|Overall Study|Withdrawal by Subject|3|||
147310117|NCT02761629|531302244|FG000|Overall Study|Other|0|||
147105710|NCT01288430|530553656|FG004|Part 1|Clinical disease progression|0|||
147105711|NCT01288430|530553657|FG005|Part 1|Clinical disease progression|2|||
147105712|NCT01288430|530553658|FG006|Part 1|Clinical disease progression|2|||
147105713|NCT01288430|530553659|FG007|Part 1|Clinical disease progression|0|||
147105714|NCT01288430|530553660|FG008|Part 1|Clinical disease progression|0|||
147310118|NCT02761629|531302245|FG001|Overall Study|Other|2|||
147105715|NCT01288430|530553661|FG009|Part 1|Clinical disease progression|0|||
147105716|NCT01288430|530553652|FG000|Part 1|Death due to disease progression|0|||
147105717|NCT01288430|530553653|FG001|Part 1|Death due to disease progression|0|||
147105718|NCT01288430|530553654|FG002|Part 1|Death due to disease progression|0|||
147105719|NCT01288430|530553655|FG003|Part 1|Death due to disease progression|0|||
147105720|NCT01288430|530553656|FG004|Part 1|Death due to disease progression|1|||
147105721|NCT01288430|530553657|FG005|Part 1|Death due to disease progression|0|||
147105722|NCT01288430|530553658|FG006|Part 1|Death due to disease progression|0|||
147105723|NCT01288430|530553659|FG007|Part 1|Death due to disease progression|0|||
147105724|NCT01288430|530553660|FG008|Part 1|Death due to disease progression|0|||
147105725|NCT01288430|530553661|FG009|Part 1|Death due to disease progression|0|||
147105726|NCT01288430|530553652|FG000|Part 1|Adverse Event|0|||
147105727|NCT01288430|530553653|FG001|Part 1|Adverse Event|0|||
147105728|NCT01288430|530553654|FG002|Part 1|Adverse Event|3|||
147105729|NCT01288430|530553655|FG003|Part 1|Adverse Event|1|||
147105730|NCT01288430|530553656|FG004|Part 1|Adverse Event|0|||
147105731|NCT01288430|530553657|FG005|Part 1|Adverse Event|0|||
147105732|NCT01288430|530553658|FG006|Part 1|Adverse Event|2|||
147105733|NCT01288430|530553659|FG007|Part 1|Adverse Event|0|||
147105734|NCT01288430|530553660|FG008|Part 1|Adverse Event|0|||
147105735|NCT01288430|530553661|FG009|Part 1|Adverse Event|0|||
147105736|NCT01288430|530553652|FG000|Part 1|Other|0|||
147105737|NCT01288430|530553653|FG001|Part 1|Other|2|||
147105738|NCT01288430|530553654|FG002|Part 1|Other|0|||
147105739|NCT01288430|530553655|FG003|Part 1|Other|0|||
147105740|NCT01288430|530553656|FG004|Part 1|Other|0|||
147105741|NCT01288430|530553657|FG005|Part 1|Other|0|||
147105742|NCT01288430|530553658|FG006|Part 1|Other|1|||
147105743|NCT01288430|530553659|FG007|Part 1|Other|0|||
147105744|NCT01288430|530553660|FG008|Part 1|Other|0|||
147105745|NCT01288430|530553661|FG009|Part 1|Other|0|||
147105746|NCT01288430|530553652|FG000|Part 2|Progressive disease|0|||
147105747|NCT01288430|530553653|FG001|Part 2|Progressive disease|0|||
147105748|NCT01288430|530553654|FG002|Part 2|Progressive disease|0|||
147105749|NCT01288430|530553655|FG003|Part 2|Progressive disease|0|||
147105750|NCT01288430|530553656|FG004|Part 2|Progressive disease|0|||
147105751|NCT01288430|530553657|FG005|Part 2|Progressive disease|0|||
147105752|NCT01288430|530553658|FG006|Part 2|Progressive disease|0|||
147105753|NCT01288430|530553659|FG007|Part 2|Progressive disease|8|||
147105754|NCT01288430|530553660|FG008|Part 2|Progressive disease|7|||
147105755|NCT01288430|530553661|FG009|Part 2|Progressive disease|2|||
147105756|NCT01288430|530553652|FG000|Part 2|Clinical disease progression|0|||
147105757|NCT01288430|530553653|FG001|Part 2|Clinical disease progression|0|||
147105758|NCT01288430|530553654|FG002|Part 2|Clinical disease progression|0|||
147105759|NCT01288430|530553655|FG003|Part 2|Clinical disease progression|0|||
147105760|NCT01288430|530553656|FG004|Part 2|Clinical disease progression|0|||
147105761|NCT01288430|530553657|FG005|Part 2|Clinical disease progression|0|||
147105762|NCT01288430|530553658|FG006|Part 2|Clinical disease progression|0|||
147105763|NCT01288430|530553659|FG007|Part 2|Clinical disease progression|2|||
147310119|NCT02761629|531302244|FG000|Overall Study|Lost to Follow-up|4|||
147310120|NCT02761629|531302245|FG001|Overall Study|Lost to Follow-up|1|||
147310121|NCT02761629|531302244|FG000|Overall Study|Randomized But Not Treated|8|||
147310122|NCT02761629|531302245|FG001|Overall Study|Randomized But Not Treated|4|||
147310123|NCT00562978|531302246|FG000|Overall Study|Patient had imaging dose only|1|||
147310124|NCT00562978|531302247|FG001|Overall Study|Patient had imaging dose only|11|||
147310125|NCT00936221|531302251|FG000|Overall Study|Withdrawal by Subject|1|||
147310126|NCT00936221|531302252|FG001|Overall Study|Withdrawal by Subject|1|||
147310127|NCT01348776|531302253|FG000|Overall Study|Lost to Follow-up|3|||
147310128|NCT04362137|531302257|FG000|Overall Study|Death|9|||
147310129|NCT04362137|531302258|FG001|Overall Study|Death|3|||
147105764|NCT01288430|530553660|FG008|Part 2|Clinical disease progression|0|||
147105765|NCT01288430|530553661|FG009|Part 2|Clinical disease progression|0|||
147105766|NCT01288430|530553652|FG000|Part 2|Withdrawal by Subject|0|||
147105767|NCT01288430|530553653|FG001|Part 2|Withdrawal by Subject|0|||
147105768|NCT01288430|530553654|FG002|Part 2|Withdrawal by Subject|0|||
147105769|NCT01288430|530553655|FG003|Part 2|Withdrawal by Subject|0|||
147105770|NCT01288430|530553656|FG004|Part 2|Withdrawal by Subject|0|||
147105771|NCT01288430|530553657|FG005|Part 2|Withdrawal by Subject|0|||
147105772|NCT01288430|530553658|FG006|Part 2|Withdrawal by Subject|0|||
147105773|NCT01288430|530553659|FG007|Part 2|Withdrawal by Subject|1|||
147105774|NCT01288430|530553660|FG008|Part 2|Withdrawal by Subject|4|||
147105775|NCT01288430|530553661|FG009|Part 2|Withdrawal by Subject|0|||
147105776|NCT01288430|530553652|FG000|Part 2|Adverse Event|0|||
147105777|NCT01288430|530553653|FG001|Part 2|Adverse Event|0|||
147105778|NCT01288430|530553654|FG002|Part 2|Adverse Event|0|||
147105779|NCT01288430|530553655|FG003|Part 2|Adverse Event|0|||
147105780|NCT01288430|530553656|FG004|Part 2|Adverse Event|0|||
147105781|NCT01288430|530553657|FG005|Part 2|Adverse Event|0|||
147105782|NCT01288430|530553658|FG006|Part 2|Adverse Event|0|||
147105783|NCT01288430|530553659|FG007|Part 2|Adverse Event|1|||
147310130|NCT04362137|531302257|FG000|Overall Study|Patient decision|6|||
147310131|NCT04362137|531302258|FG001|Overall Study|Patient decision|3|||
147554552|NCT01893138|532185714|FG000|Open Label - Unblinded Period|Lack of Efficacy|9|||
147554553|NCT01893138|532185715|FG001|Open Label - Unblinded Period|Lack of Efficacy|0|||
147554554|NCT01893138|532185714|FG000|Open Label - Unblinded Period|Lost to Follow-up|4|||
147554555|NCT01893138|532185715|FG001|Open Label - Unblinded Period|Lost to Follow-up|3|||
147554556|NCT01893138|532185714|FG000|Open Label - Unblinded Period|Withdrawal by Subject|18|||
147554557|NCT01893138|532185715|FG001|Open Label - Unblinded Period|Withdrawal by Subject|7|||
147554558|NCT01893138|532185714|FG000|Open Label - Unblinded Period|Adverse Event|1|||
147554559|NCT01893138|532185715|FG001|Open Label - Unblinded Period|Adverse Event|0|||
147554560|NCT02154529|532185716|FG000|Overall Study|Death|1|||
147554561|NCT02154529|532185717|FG001|Overall Study|Death|1|||
147554562|NCT02154529|532185718|FG002|Overall Study|Death|5|||
147554563|NCT02154529|532185719|FG003|Overall Study|Death|1|||
147554564|NCT02154529|532185716|FG000|Overall Study|Termination of study by sponsor|2|||
147554565|NCT02154529|532185717|FG001|Overall Study|Termination of study by sponsor|2|||
147554566|NCT02154529|532185718|FG002|Overall Study|Termination of study by sponsor|3|||
147554567|NCT02154529|532185719|FG003|Overall Study|Termination of study by sponsor|1|||
147554568|NCT02154529|532185716|FG000|Overall Study|Lost to Follow-up|1|||
147554569|NCT02154529|532185717|FG001|Overall Study|Lost to Follow-up|0|||
147554570|NCT02154529|532185718|FG002|Overall Study|Lost to Follow-up|0|||
147554571|NCT02154529|532185719|FG003|Overall Study|Lost to Follow-up|0|||
147554572|NCT02761980|532187733|FG000|Overall Study|Adverse Event|4|||
147554573|NCT02761980|532187734|FG001|Overall Study|Adverse Event|6|||
147554574|NCT02761980|532187735|FG002|Overall Study|Adverse Event|5|||
147554575|NCT02761980|532187736|FG003|Overall Study|Adverse Event|6|||
147554576|NCT02761980|532187733|FG000|Overall Study|Withdrawal by Subject|0|||
147554577|NCT02761980|532187734|FG001|Overall Study|Withdrawal by Subject|1|||
147554578|NCT02761980|532187735|FG002|Overall Study|Withdrawal by Subject|0|||
147554579|NCT02761980|532187736|FG003|Overall Study|Withdrawal by Subject|0|||
147554580|NCT02761980|532187733|FG000|Overall Study|Other|0|||
147554581|NCT02761980|532187734|FG001|Overall Study|Other|0|||
147554582|NCT02761980|532187735|FG002|Overall Study|Other|1|||
147554583|NCT02761980|532187736|FG003|Overall Study|Other|0|||
147554584|NCT01907087|532187737|FG000|Overall Study|Withdrawal by Subject|1|||
147554585|NCT02192905|532187738|FG000|Overall Study|Lost to Follow-up|1|||
147554586|NCT04820842|532187739|FG000|Active Drug Extension Period (8 Weeks)|Adverse Event|0|||
147554587|NCT04820842|532187740|FG001|Active Drug Extension Period (8 Weeks)|Adverse Event|1|||
147554588|NCT04820842|532187741|FG002|Active Drug Extension Period (8 Weeks)|Adverse Event|2|||
147554589|NCT04820842|532187742|FG003|Active Drug Extension Period (8 Weeks)|Adverse Event|0|||
147554590|NCT04820842|532187743|FG004|Active Drug Extension Period (8 Weeks)|Adverse Event|0|||
147554591|NCT04820842|532187744|FG005|Active Drug Extension Period (8 Weeks)|Adverse Event|0|||
147554592|NCT04820842|532187745|FG006|Active Drug Extension Period (8 Weeks)|Adverse Event|0|||
147554593|NCT04820842|532187739|FG000|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|3|||
147554594|NCT04820842|532187740|FG001|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|6|||
147554595|NCT04820842|532187741|FG002|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|5|||
147554596|NCT04820842|532187742|FG003|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
147554597|NCT04820842|532187743|FG004|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
147554598|NCT04820842|532187744|FG005|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
147554599|NCT04820842|532187745|FG006|Active Drug Extension Period (8 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
147554600|NCT04820842|532187739|FG000|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|0|||
147554601|NCT04820842|532187740|FG001|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|1|||
147554602|NCT04820842|532187741|FG002|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|0|||
147554603|NCT04820842|532187742|FG003|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|0|||
147554604|NCT04820842|532187743|FG004|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|0|||
147554605|NCT04820842|532187744|FG005|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|0|||
147554606|NCT04820842|532187745|FG006|Active Drug Extension Period (8 Weeks)|Withdrawal by Subject|0|||
147554607|NCT04820842|532187739|FG000|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
147554608|NCT04820842|532187740|FG001|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
147554609|NCT04820842|532187741|FG002|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
147554610|NCT04820842|532187742|FG003|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|2|||
147554611|NCT04820842|532187743|FG004|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
147554612|NCT04820842|532187744|FG005|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|0|||
147554613|NCT04820842|532187745|FG006|Randomized Withdrawal Period (4 Weeks)|Study Terminated by Sponsor (ongoing participants in this period were discontinued)|1|||
147105784|NCT01288430|530553660|FG008|Part 2|Adverse Event|1|||
147105785|NCT01288430|530553661|FG009|Part 2|Adverse Event|0|||
147105786|NCT01288430|530553652|FG000|Part 2|Other|0|||
147105787|NCT01288430|530553653|FG001|Part 2|Other|0|||
147105788|NCT01288430|530553654|FG002|Part 2|Other|0|||
147105789|NCT01288430|530553655|FG003|Part 2|Other|0|||
147105790|NCT01288430|530553656|FG004|Part 2|Other|0|||
147105791|NCT01288430|530553657|FG005|Part 2|Other|0|||
147105792|NCT01288430|530553658|FG006|Part 2|Other|0|||
147105793|NCT01288430|530553659|FG007|Part 2|Other|0|||
147105794|NCT01288430|530553660|FG008|Part 2|Other|0|||
147105795|NCT01288430|530553661|FG009|Part 2|Other|1|||
147105796|NCT06125964|530553662|FG000|Overall Study|Lost to Follow-up|0|||
147105797|NCT06125964|530553663|FG001|Overall Study|Lost to Follow-up|1|||
147105798|NCT06125964|530553664|FG002|Overall Study|Lost to Follow-up|0|||
147105799|NCT06125964|530553665|FG003|Overall Study|Lost to Follow-up|0|||
147105800|NCT03405870|530553666|FG000|Overall Study|Withdrawal|1|||
147105801|NCT03405870|530553667|FG001|Overall Study|Withdrawal|0|||
147105802|NCT03405870|530553668|FG002|Overall Study|Withdrawal|1|||
147105803|NCT03405870|530553669|FG003|Overall Study|Withdrawal|0|||
147105804|NCT03405870|530553670|FG004|Overall Study|Withdrawal|0|||
147105805|NCT03405870|530553671|FG005|Overall Study|Withdrawal|0|||
147105806|NCT03405870|530553672|FG006|Overall Study|Withdrawal|1|||
147105807|NCT03405870|530553673|FG007|Overall Study|Withdrawal|0|||
147105808|NCT05172609|530553674|FG000|Time 3|Elected not to continue with study due to time constraints|1|||
147105809|NCT05172609|530553675|FG001|Time 3|Elected not to continue with study due to time constraints|1|||
147105810|NCT05172609|530553674|FG000|Time 4|Elected not to continue with study due to personal reasons unrelated to the study|1|||
147105811|NCT05172609|530553675|FG001|Time 4|Elected not to continue with study due to personal reasons unrelated to the study|0|||
147105812|NCT05172609|530553674|FG000|Time 4|Elected not to continue with study due to time constraints|0|||
147105813|NCT05172609|530553675|FG001|Time 4|Elected not to continue with study due to time constraints|1|||
147105814|NCT03737994|530553676|FG000|Overall Study|Withdrawal by Subject|0|||
147105815|NCT03737994|530553677|FG001|Overall Study|Withdrawal by Subject|0|||
147105816|NCT03737994|530553678|FG002|Overall Study|Withdrawal by Subject|0|||
147105817|NCT03737994|530553679|FG003|Overall Study|Withdrawal by Subject|0|||
147105818|NCT03737994|530553680|FG004|Overall Study|Withdrawal by Subject|0|||
147105819|NCT03737994|530553681|FG005|Overall Study|Withdrawal by Subject|0|||
147105820|NCT03737994|530553682|FG006|Overall Study|Withdrawal by Subject|1|||
147105821|NCT00576758|530553691|FG000|Induction Treatment Period|Adverse event or Intercurrent illness|3|||
147105822|NCT00576758|530553692|FG001|Induction Treatment Period|Adverse event or Intercurrent illness|3|||
147105823|NCT00576758|530553691|FG000|Induction Treatment Period|Insufficient therapeutic response|2|||
147105824|NCT00576758|530553692|FG001|Induction Treatment Period|Insufficient therapeutic response|0|||
147105825|NCT00576758|530553691|FG000|Induction Treatment Period|Violation of selection criteria at entry|1|||
147105826|NCT00576758|530553692|FG001|Induction Treatment Period|Violation of selection criteria at entry|1|||
147105827|NCT00576758|530553691|FG000|Induction Treatment Period|Death|1|||
147105828|NCT00576758|530553692|FG001|Induction Treatment Period|Death|0|||
147105829|NCT00576758|530553691|FG000|Induction Treatment Period|Refused treatment/ Did not Cooperate|0|||
147105830|NCT00576758|530553692|FG001|Induction Treatment Period|Refused treatment/ Did not Cooperate|1|||
147105831|NCT00576758|530553691|FG000|Induction Treatment Period|Withdrew consent|1|||
147105832|NCT00576758|530553692|FG001|Induction Treatment Period|Withdrew consent|0|||
147105833|NCT00576758|530553691|FG000|Extension Treatment Period|Adverse event or Intercurrent illness|6|||
147105834|NCT00576758|530553692|FG001|Extension Treatment Period|Adverse event or Intercurrent illness|7|||
147224682|NCT00491556|530993218|FG001|Entry-Week (WK) 48: EXP/Standard Care|Adherence Issues|0|||
147224683|NCT00491556|530993217|FG000|Entry-Week (WK) 48: EXP/Standard Care|Toxicity|3|||
147224684|NCT00491556|530993218|FG001|Entry-Week (WK) 48: EXP/Standard Care|Toxicity|0|||
147224685|NCT00491556|530993217|FG000|Entry-Week (WK) 48: EXP/Standard Care|Other|3|||
147224686|NCT00491556|530993218|FG001|Entry-Week (WK) 48: EXP/Standard Care|Other|0|||
147224687|NCT00491556|530993217|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Lost to Follow-up|2|||
147224688|NCT00491556|530993218|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Lost to Follow-up|2|||
147224689|NCT00491556|530993217|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Pregnancy|2|||
147224690|NCT00491556|530993218|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Pregnancy|0|||
147105835|NCT00576758|530553691|FG000|Extension Treatment Period|Death|1|||
147105836|NCT00576758|530553692|FG001|Extension Treatment Period|Death|1|||
147105837|NCT00576758|530553691|FG000|Extension Treatment Period|Refused treatment/did not cooperate|2|||
147105838|NCT00576758|530553692|FG001|Extension Treatment Period|Refused treatment/did not cooperate|1|||
147105839|NCT00576758|530553691|FG000|Extension Treatment Period|Insufficient therapeutic response|30|||
147224691|NCT00491556|530993217|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Moved Out of Area|2|||
147105840|NCT00576758|530553692|FG001|Extension Treatment Period|Insufficient therapeutic response|33|||
147105841|NCT00576758|530553691|FG000|Extension Treatment Period|Administrative/Other|3|||
147105842|NCT00576758|530553692|FG001|Extension Treatment Period|Administrative/Other|1|||
147105843|NCT00576758|530553691|FG000|Follow-up Period|Administrative/Other|6|||
147105844|NCT00576758|530553692|FG001|Follow-up Period|Administrative/Other|8|||
147105845|NCT00576758|530553691|FG000|Follow-up Period|Death|3|||
147105846|NCT00576758|530553692|FG001|Follow-up Period|Death|3|||
147105847|NCT00576758|530553691|FG000|Follow-up Period|Insufficient therapeutic response|16|||
147105848|NCT00576758|530553692|FG001|Follow-up Period|Insufficient therapeutic response|5|||
147105849|NCT00576758|530553691|FG000|Follow-up Period|Withdrew consent|2|||
147105850|NCT00576758|530553692|FG001|Follow-up Period|Withdrew consent|1|||
147105851|NCT00903968|530553693|FG000|Overall Study|Adverse Event|0|||
147105852|NCT00903968|530553694|FG001|Overall Study|Adverse Event|0|||
147105853|NCT00903968|530553695|FG002|Overall Study|Adverse Event|0|||
147105854|NCT00903968|530553696|FG003|Overall Study|Adverse Event|0|||
147105855|NCT00903968|530553697|FG004|Overall Study|Adverse Event|0|||
147105856|NCT00903968|530553698|FG005|Overall Study|Adverse Event|0|||
147105857|NCT00903968|530553699|FG006|Overall Study|Adverse Event|1|||
147105858|NCT00903968|530553700|FG007|Overall Study|Adverse Event|8|||
147105859|NCT00903968|530553693|FG000|Overall Study|DLT|0|||
147105860|NCT00903968|530553694|FG001|Overall Study|DLT|0|||
147105861|NCT00903968|530553695|FG002|Overall Study|DLT|0|||
147105862|NCT00903968|530553696|FG003|Overall Study|DLT|0|||
147105863|NCT00903968|530553697|FG004|Overall Study|DLT|0|||
147105864|NCT00903968|530553698|FG005|Overall Study|DLT|0|||
147105865|NCT00903968|530553699|FG006|Overall Study|DLT|2|||
147105866|NCT00903968|530553700|FG007|Overall Study|DLT|0|||
147105867|NCT00903968|530553693|FG000|Overall Study|Withdrawal by Subject|1|||
147105868|NCT00903968|530553694|FG001|Overall Study|Withdrawal by Subject|0|||
147105869|NCT00903968|530553695|FG002|Overall Study|Withdrawal by Subject|1|||
147105870|NCT00903968|530553696|FG003|Overall Study|Withdrawal by Subject|0|||
147105871|NCT00903968|530553697|FG004|Overall Study|Withdrawal by Subject|1|||
147105872|NCT00903968|530553698|FG005|Overall Study|Withdrawal by Subject|1|||
147105873|NCT00903968|530553699|FG006|Overall Study|Withdrawal by Subject|0|||
147105874|NCT00903968|530553700|FG007|Overall Study|Withdrawal by Subject|4|||
147105875|NCT00903968|530553693|FG000|Overall Study|Non-Compliance|0|||
147105876|NCT00903968|530553694|FG001|Overall Study|Non-Compliance|0|||
147105877|NCT00903968|530553695|FG002|Overall Study|Non-Compliance|0|||
147105878|NCT00903968|530553696|FG003|Overall Study|Non-Compliance|0|||
147105879|NCT00903968|530553697|FG004|Overall Study|Non-Compliance|0|||
147105880|NCT00903968|530553698|FG005|Overall Study|Non-Compliance|1|||
147105881|NCT00903968|530553699|FG006|Overall Study|Non-Compliance|0|||
147105882|NCT00903968|530553700|FG007|Overall Study|Non-Compliance|0|||
147105883|NCT00903968|530553693|FG000|Overall Study|Physician Decision|0|||
147105884|NCT00903968|530553694|FG001|Overall Study|Physician Decision|0|||
147105885|NCT00903968|530553695|FG002|Overall Study|Physician Decision|0|||
147105886|NCT00903968|530553696|FG003|Overall Study|Physician Decision|0|||
147105887|NCT00903968|530553697|FG004|Overall Study|Physician Decision|0|||
147105888|NCT00903968|530553698|FG005|Overall Study|Physician Decision|1|||
147105889|NCT00903968|530553699|FG006|Overall Study|Physician Decision|0|||
147105890|NCT00903968|530553700|FG007|Overall Study|Physician Decision|0|||
147105891|NCT00903968|530553693|FG000|Overall Study|Progressive Disease|2|||
147105892|NCT00903968|530553694|FG001|Overall Study|Progressive Disease|3|||
147105893|NCT00903968|530553695|FG002|Overall Study|Progressive Disease|2|||
147105894|NCT00903968|530553696|FG003|Overall Study|Progressive Disease|3|||
147105895|NCT00903968|530553697|FG004|Overall Study|Progressive Disease|3|||
147105896|NCT00903968|530553698|FG005|Overall Study|Progressive Disease|3|||
147105897|NCT00903968|530553699|FG006|Overall Study|Progressive Disease|0|||
147105898|NCT00903968|530553700|FG007|Overall Study|Progressive Disease|18|||
147105899|NCT00903968|530553693|FG000|Overall Study|Lack of Efficacy|0|||
147105900|NCT00903968|530553694|FG001|Overall Study|Lack of Efficacy|0|||
147105901|NCT00903968|530553695|FG002|Overall Study|Lack of Efficacy|0|||
147105902|NCT00903968|530553696|FG003|Overall Study|Lack of Efficacy|0|||
147105903|NCT00903968|530553697|FG004|Overall Study|Lack of Efficacy|0|||
147224692|NCT00491556|530993218|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Moved Out of Area|1|||
147105904|NCT00903968|530553698|FG005|Overall Study|Lack of Efficacy|0|||
147105905|NCT00903968|530553699|FG006|Overall Study|Lack of Efficacy|0|||
147105906|NCT00903968|530553700|FG007|Overall Study|Lack of Efficacy|3|||
147443685|NCT01987960|531788764|FG002|Period 2|Administrative or other reason|7|||
147105907|NCT03979313|530553701|FG000|Primary Cohort (Data Cut Off 11/3/2021)|Lost to Follow-up|3|||
147105908|NCT03979313|530553702|FG001|Primary Cohort (Data Cut Off 11/3/2021)|Lost to Follow-up|9|||
147105909|NCT03979313|530553701|FG000|Primary Cohort (Data Cut Off 11/3/2021)|Any Other Reason|3|||
147105910|NCT03979313|530553702|FG001|Primary Cohort (Data Cut Off 11/3/2021)|Any Other Reason|4|||
147105911|NCT03979313|530553701|FG000|Primary Cohort (Data Cut Off 11/3/2021)|Death|0|||
147105912|NCT03979313|530553702|FG001|Primary Cohort (Data Cut Off 11/3/2021)|Death|4|||
147105913|NCT03979313|530553701|FG000|Primary Cohort (Data Cut Off 11/3/2021)|Withdrawal by Subject|14|||
147105914|NCT03979313|530553702|FG001|Primary Cohort (Data Cut Off 11/3/2021)|Withdrawal by Subject|20|||
147443686|NCT01987960|531788765|FG003|Period 2|Administrative or other reason|0|||
147443687|NCT01987960|531788762|FG000|Period 3|Adverse Event|0|||
147443688|NCT01987960|531788763|FG001|Period 3|Adverse Event|0|||
147443689|NCT01987960|531788764|FG002|Period 3|Adverse Event|0|||
147443690|NCT01987960|531788765|FG003|Period 3|Adverse Event|7|||
147443691|NCT01987960|531788762|FG000|Period 3|Non-compliance with IMP|0|||
147443692|NCT01987960|531788763|FG001|Period 3|Non-compliance with IMP|0|||
147105915|NCT03979313|530553701|FG000|Primary Cohort (Data Cut Off 11/3/2021)|Covid-19 pandemic|1|||
147443693|NCT01987960|531788764|FG002|Period 3|Non-compliance with IMP|0|||
147105916|NCT03979313|530553702|FG001|Primary Cohort (Data Cut Off 11/3/2021)|Covid-19 pandemic|3|||
147105917|NCT03979313|530553701|FG000|Primary Cohort (Data Cut Off 11/3/2021)|Ongoing at the DCO date|432|||
147105918|NCT03979313|530553702|FG001|Primary Cohort (Data Cut Off 11/3/2021)|Ongoing at the DCO date|865|||
147105919|NCT03979313|530553701|FG000|All Subjects|Any Other Reason|16|||
147105920|NCT03979313|530553702|FG001|All Subjects|Any Other Reason|23|||
147105921|NCT03979313|530553701|FG000|All Subjects|Covid-19|1|||
147105922|NCT03979313|530553702|FG001|All Subjects|Covid-19|3|||
147105923|NCT03979313|530553701|FG000|All Subjects|Withdrawal by Subject|35|||
147105924|NCT03979313|530553702|FG001|All Subjects|Withdrawal by Subject|44|||
147105925|NCT03979313|530553701|FG000|All Subjects|Death|0|||
147105926|NCT03979313|530553702|FG001|All Subjects|Death|5|||
147105927|NCT03979313|530553701|FG000|All Subjects|Lost to Follow-up|28|||
147105928|NCT03979313|530553702|FG001|All Subjects|Lost to Follow-up|61|||
147105929|NCT04889040|530553703|FG000|Overall Study|Withdrawal by Subject|3|||
147105930|NCT04889040|530553704|FG001|Overall Study|Withdrawal by Subject|3|||
147105931|NCT04889040|530553703|FG000|Overall Study|Lost to Follow-up|0|||
147105932|NCT04889040|530553704|FG001|Overall Study|Lost to Follow-up|1|||
147105933|NCT04889040|530553703|FG000|Overall Study|Adverse Event|2|||
147105934|NCT04889040|530553704|FG001|Overall Study|Adverse Event|1|||
147105935|NCT00726453|530553709|FG000|Primary Enrollment Group|Death|18|||
147105936|NCT00726453|530553710|FG001|Primary Enrollment Group|Death|0|||
147105937|NCT00726453|530553709|FG000|Primary Enrollment Group|Withdrawal by Subject|13|||
147105938|NCT00726453|530553710|FG001|Primary Enrollment Group|Withdrawal by Subject|0|||
147105939|NCT00726453|530553709|FG000|38 mm Length Group|Death|0|||
147105940|NCT00726453|530553710|FG001|38 mm Length Group|Death|3|||
147105941|NCT02690727|530553711|FG000|Overall Study|Adverse Event|2|||
147105942|NCT02690727|530553712|FG001|Overall Study|Adverse Event|2|||
147105943|NCT00656617|530553713|FG000|Overall Study|Adverse Event|1|||
147105944|NCT00656617|530553713|FG000|Overall Study|Death|2|||
147105945|NCT00656617|530553713|FG000|Overall Study|Insurance Issues|2|||
147105946|NCT00656617|530553713|FG000|Overall Study|Move to different clinical trial|2|||
147105947|NCT02030600|530553714|FG000|Treatment Period 1|Adverse Event|5|||
147105948|NCT02030600|530553715|FG001|Treatment Period 1|Adverse Event|7|||
147105949|NCT02030600|530553714|FG000|Treatment Period 1|Lack of Efficacy|0|||
147105950|NCT02030600|530553715|FG001|Treatment Period 1|Lack of Efficacy|1|||
147105951|NCT02030600|530553714|FG000|Treatment Period 1|Lost to Follow-up|11|||
147105952|NCT02030600|530553715|FG001|Treatment Period 1|Lost to Follow-up|3|||
147105953|NCT02030600|530553714|FG000|Treatment Period 1|Protocol Violation|22|||
147105954|NCT02030600|530553715|FG001|Treatment Period 1|Protocol Violation|17|||
147105955|NCT02030600|530553714|FG000|Treatment Period 1|Withdrawal by Subject|13|||
147105956|NCT02030600|530553715|FG001|Treatment Period 1|Withdrawal by Subject|17|||
147105957|NCT02030600|530553714|FG000|Treatment Period 1|Casebook Unsigned|1|||
147105958|NCT02030600|530553715|FG001|Treatment Period 1|Casebook Unsigned|0|||
147105959|NCT02030600|530553714|FG000|Treatment Period 1|Unclassified|1|||
147105960|NCT02030600|530553715|FG001|Treatment Period 1|Unclassified|0|||
147105961|NCT02030600|530553714|FG000|Treatment Period 2|Adverse Event|4|||
147105962|NCT02030600|530553715|FG001|Treatment Period 2|Adverse Event|4|||
147105963|NCT02030600|530553714|FG000|Treatment Period 2|Lack of Efficacy|2|||
147105964|NCT02030600|530553715|FG001|Treatment Period 2|Lack of Efficacy|1|||
147105965|NCT02030600|530553714|FG000|Treatment Period 2|Lost to Follow-up|4|||
147105966|NCT02030600|530553715|FG001|Treatment Period 2|Lost to Follow-up|2|||
147105967|NCT02030600|530553714|FG000|Treatment Period 2|Protocol Violation|1|||
147105968|NCT02030600|530553715|FG001|Treatment Period 2|Protocol Violation|2|||
147105969|NCT02030600|530553714|FG000|Treatment Period 2|Withdrawal by Subject|13|||
147105970|NCT02030600|530553715|FG001|Treatment Period 2|Withdrawal by Subject|9|||
147105971|NCT02030600|530553714|FG000|Treatment Period 2|Unclassified|1|||
147224693|NCT00491556|530993217|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|VL Failure After Week 48|5|||
147224694|NCT00491556|530993218|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|VL Failure After Week 48|0|||
147224695|NCT00491556|530993217|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|CD4 Failure|2|||
147224696|NCT00491556|530993218|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|CD4 Failure|0|||
147224697|NCT00491556|530993217|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Adherence Issues|5|||
147554614|NCT01296932|532187746|FG000|Overall Study|Dose limiting toxicity|0|||
147224698|NCT00491556|530993218|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Adherence Issues|0|||
147554615|NCT01296932|532187747|FG001|Overall Study|Dose limiting toxicity|0|||
147105972|NCT02030600|530553715|FG001|Treatment Period 2|Unclassified|0|||
147105973|NCT02736617|530553716|FG000|Treatment|Adverse Event|1|||
147554616|NCT01296932|532187748|FG002|Overall Study|Dose limiting toxicity|0|||
147105974|NCT02736617|530553716|FG000|Treatment|Lack of Efficacy|1|||
147105975|NCT02736617|530553716|FG000|Treatment|Withdrawal by Subject|1|||
147105976|NCT02736617|530553716|FG000|Maintenance|Lack of Efficacy|4|||
147105977|NCT02736617|530553716|FG000|Maintenance|Physician Decision|1|||
147105978|NCT00481676|530553719|FG000|Overall Study|Adverse Event|0|||
147105979|NCT00481676|530553720|FG001|Overall Study|Adverse Event|1|||
147105980|NCT00481676|530553719|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
147105981|NCT00481676|530553720|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
147105982|NCT00481676|530553719|FG000|Overall Study|Administrative problem|1|||
147554617|NCT01296932|532187749|FG003|Overall Study|Dose limiting toxicity|0|||
147554618|NCT01296932|532187750|FG004|Overall Study|Dose limiting toxicity|0|||
147554619|NCT01296932|532187751|FG005|Overall Study|Dose limiting toxicity|0|||
147554620|NCT01296932|532187752|FG006|Overall Study|Dose limiting toxicity|1|||
147554621|NCT01296932|532187753|FG007|Overall Study|Dose limiting toxicity|0|||
147554622|NCT01296932|532187754|FG008|Overall Study|Dose limiting toxicity|1|||
147554623|NCT01296932|532187746|FG000|Overall Study|Progressive disease|2|||
147554624|NCT01296932|532187747|FG001|Overall Study|Progressive disease|0|||
147554625|NCT01296932|532187748|FG002|Overall Study|Progressive disease|1|||
147554626|NCT01296932|532187749|FG003|Overall Study|Progressive disease|1|||
147554627|NCT01296932|532187750|FG004|Overall Study|Progressive disease|2|||
147554628|NCT01296932|532187751|FG005|Overall Study|Progressive disease|3|||
147554629|NCT01296932|532187752|FG006|Overall Study|Progressive disease|1|||
147554630|NCT01296932|532187753|FG007|Overall Study|Progressive disease|0|||
147554631|NCT01296932|532187754|FG008|Overall Study|Progressive disease|0|||
147105983|NCT00481676|530553720|FG001|Overall Study|Administrative problem|0|||
147224699|NCT00491556|530993217|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Toxicity|2|||
147224700|NCT00491556|530993218|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Toxicity|0|||
147554632|NCT01296932|532187746|FG000|Overall Study|Withdrawal by Subject|0|||
147554633|NCT01296932|532187747|FG001|Overall Study|Withdrawal by Subject|0|||
147554634|NCT01296932|532187748|FG002|Overall Study|Withdrawal by Subject|1|||
147554635|NCT01296932|532187749|FG003|Overall Study|Withdrawal by Subject|1|||
147554636|NCT01296932|532187750|FG004|Overall Study|Withdrawal by Subject|0|||
147554637|NCT01296932|532187751|FG005|Overall Study|Withdrawal by Subject|0|||
147554638|NCT01296932|532187752|FG006|Overall Study|Withdrawal by Subject|3|||
147554639|NCT01296932|532187753|FG007|Overall Study|Withdrawal by Subject|0|||
147554640|NCT01296932|532187754|FG008|Overall Study|Withdrawal by Subject|0|||
147554641|NCT01296932|532187746|FG000|Overall Study|Adverse Event|1|||
147554642|NCT01296932|532187747|FG001|Overall Study|Adverse Event|1|||
147554643|NCT01296932|532187748|FG002|Overall Study|Adverse Event|1|||
147554644|NCT01296932|532187749|FG003|Overall Study|Adverse Event|2|||
147554645|NCT01296932|532187750|FG004|Overall Study|Adverse Event|1|||
147554646|NCT01296932|532187751|FG005|Overall Study|Adverse Event|0|||
147554647|NCT01296932|532187752|FG006|Overall Study|Adverse Event|0|||
147554648|NCT01296932|532187753|FG007|Overall Study|Adverse Event|0|||
147554649|NCT01296932|532187754|FG008|Overall Study|Adverse Event|1|||
147554650|NCT01296932|532187746|FG000|Overall Study|Investigator decision|0|||
147554651|NCT01296932|532187747|FG001|Overall Study|Investigator decision|1|||
147554652|NCT01296932|532187748|FG002|Overall Study|Investigator decision|0|||
147554653|NCT01296932|532187749|FG003|Overall Study|Investigator decision|1|||
147554654|NCT01296932|532187750|FG004|Overall Study|Investigator decision|0|||
147554655|NCT01296932|532187751|FG005|Overall Study|Investigator decision|0|||
147554656|NCT01296932|532187752|FG006|Overall Study|Investigator decision|1|||
147554657|NCT01296932|532187753|FG007|Overall Study|Investigator decision|0|||
147554658|NCT01296932|532187754|FG008|Overall Study|Investigator decision|1|||
147554659|NCT01296932|532187746|FG000|Overall Study|No clinical benefit anymore|0|||
147554660|NCT01296932|532187747|FG001|Overall Study|No clinical benefit anymore|1|||
147554661|NCT01296932|532187748|FG002|Overall Study|No clinical benefit anymore|0|||
147554662|NCT01296932|532187749|FG003|Overall Study|No clinical benefit anymore|0|||
147554663|NCT01296932|532187750|FG004|Overall Study|No clinical benefit anymore|0|||
147554664|NCT01296932|532187751|FG005|Overall Study|No clinical benefit anymore|0|||
147554665|NCT01296932|532187752|FG006|Overall Study|No clinical benefit anymore|0|||
147554666|NCT01296932|532187753|FG007|Overall Study|No clinical benefit anymore|0|||
147554667|NCT01296932|532187754|FG008|Overall Study|No clinical benefit anymore|0|||
147554668|NCT01296932|532187746|FG000|Overall Study|Physician Decision|0|||
147554669|NCT01296932|532187747|FG001|Overall Study|Physician Decision|0|||
147554670|NCT01296932|532187748|FG002|Overall Study|Physician Decision|1|||
147224701|NCT00491556|530993217|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|End of Funding|2|||
147224702|NCT00491556|530993218|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|End of Funding|0|||
147224703|NCT00491556|530993217|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Other|2|||
147224704|NCT00491556|530993218|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Other|0|||
147224705|NCT00491556|530993217|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Incarceration|0|||
147224706|NCT00491556|530993218|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Incarceration|1|||
147105984|NCT02911116|530553721|FG000|Overall Study|Insufficient Therapeutic Response|1|||
147105985|NCT02911116|530553722|FG001|Overall Study|Insufficient Therapeutic Response|0|||
147224707|NCT00491556|530993217|FG000|Wk 48-152: EXP (On De-Int)/Standard Care|Death of Participant|0|||
147224708|NCT00491556|530993218|FG001|Wk 48-152: EXP (On De-Int)/Standard Care|Death of Participant|1|||
147224709|NCT00782795|530993219|FG000|Overall Study|Withdrawal by Subject|1|||
147554671|NCT01296932|532187749|FG003|Overall Study|Physician Decision|0|||
147554672|NCT01296932|532187750|FG004|Overall Study|Physician Decision|0|||
147554673|NCT01296932|532187751|FG005|Overall Study|Physician Decision|0|||
147554674|NCT01296932|532187752|FG006|Overall Study|Physician Decision|0|||
147554675|NCT01296932|532187753|FG007|Overall Study|Physician Decision|0|||
147554676|NCT01296932|532187754|FG008|Overall Study|Physician Decision|0|||
147554677|NCT01296932|532187746|FG000|Overall Study|IV problems, administration not possible|0|||
147554678|NCT01296932|532187747|FG001|Overall Study|IV problems, administration not possible|0|||
147554679|NCT01296932|532187748|FG002|Overall Study|IV problems, administration not possible|1|||
147554680|NCT01296932|532187749|FG003|Overall Study|IV problems, administration not possible|0|||
147554681|NCT01296932|532187750|FG004|Overall Study|IV problems, administration not possible|0|||
147554682|NCT01296932|532187751|FG005|Overall Study|IV problems, administration not possible|0|||
147554683|NCT01296932|532187752|FG006|Overall Study|IV problems, administration not possible|0|||
147554684|NCT01296932|532187753|FG007|Overall Study|IV problems, administration not possible|0|||
147554685|NCT01296932|532187754|FG008|Overall Study|IV problems, administration not possible|0|||
147554686|NCT01296932|532187746|FG000|Overall Study|per protocol|0|||
147554687|NCT01296932|532187747|FG001|Overall Study|per protocol|0|||
147554688|NCT01296932|532187748|FG002|Overall Study|per protocol|1|||
147554689|NCT01296932|532187749|FG003|Overall Study|per protocol|1|||
147554690|NCT01296932|532187750|FG004|Overall Study|per protocol|0|||
147554691|NCT01296932|532187751|FG005|Overall Study|per protocol|0|||
147554692|NCT01296932|532187752|FG006|Overall Study|per protocol|0|||
147554693|NCT01296932|532187753|FG007|Overall Study|per protocol|0|||
147554694|NCT01296932|532187754|FG008|Overall Study|per protocol|0|||
147554695|NCT01296932|532187746|FG000|Overall Study|Low benefit and too many side effects|0|||
147554696|NCT01296932|532187747|FG001|Overall Study|Low benefit and too many side effects|0|||
147554697|NCT01296932|532187748|FG002|Overall Study|Low benefit and too many side effects|0|||
147554698|NCT01296932|532187749|FG003|Overall Study|Low benefit and too many side effects|0|||
147554699|NCT01296932|532187750|FG004|Overall Study|Low benefit and too many side effects|0|||
147554700|NCT01296932|532187751|FG005|Overall Study|Low benefit and too many side effects|0|||
147554701|NCT01296932|532187752|FG006|Overall Study|Low benefit and too many side effects|0|||
147554702|NCT01296932|532187753|FG007|Overall Study|Low benefit and too many side effects|1|||
147554703|NCT01296932|532187754|FG008|Overall Study|Low benefit and too many side effects|0|||
147554704|NCT01296932|532187746|FG000|Overall Study|No adequate treatment response|0|||
147554705|NCT01296932|532187747|FG001|Overall Study|No adequate treatment response|0|||
147554706|NCT01296932|532187748|FG002|Overall Study|No adequate treatment response|0|||
147554707|NCT01296932|532187749|FG003|Overall Study|No adequate treatment response|0|||
147554708|NCT01296932|532187750|FG004|Overall Study|No adequate treatment response|0|||
147554709|NCT01296932|532187751|FG005|Overall Study|No adequate treatment response|0|||
147554710|NCT01296932|532187752|FG006|Overall Study|No adequate treatment response|0|||
147554711|NCT01296932|532187753|FG007|Overall Study|No adequate treatment response|1|||
147554712|NCT01296932|532187754|FG008|Overall Study|No adequate treatment response|0|||
147554713|NCT01296932|532187746|FG000|Overall Study|Dosage already reduced, AE still present|0|||
147554714|NCT01296932|532187747|FG001|Overall Study|Dosage already reduced, AE still present|0|||
147554715|NCT01296932|532187748|FG002|Overall Study|Dosage already reduced, AE still present|0|||
147554716|NCT01296932|532187749|FG003|Overall Study|Dosage already reduced, AE still present|0|||
147554717|NCT01296932|532187750|FG004|Overall Study|Dosage already reduced, AE still present|0|||
147554718|NCT01296932|532187751|FG005|Overall Study|Dosage already reduced, AE still present|0|||
147554719|NCT01296932|532187752|FG006|Overall Study|Dosage already reduced, AE still present|0|||
147554720|NCT01296932|532187753|FG007|Overall Study|Dosage already reduced, AE still present|0|||
147554721|NCT01296932|532187754|FG008|Overall Study|Dosage already reduced, AE still present|1|||
147554722|NCT04161144|532187759|FG000|Overall Study|Withdrawal by Subject|0|||
147554723|NCT04161144|532187760|FG001|Overall Study|Withdrawal by Subject|1|||
147554724|NCT04161144|532187759|FG000|Overall Study|Protocol Violation|1|||
147554725|NCT04161144|532187760|FG001|Overall Study|Protocol Violation|0|||
147554726|NCT00634907|532187763|FG000|Overall Study|Withdrawal by Subject|3|||
147554727|NCT00634907|532187764|FG001|Overall Study|Withdrawal by Subject|0|||
147554728|NCT00634907|532187763|FG000|Overall Study|Physician Decision|3|||
147554729|NCT00634907|532187764|FG001|Overall Study|Physician Decision|9|||
147554730|NCT00634907|532187763|FG000|Overall Study|Withdrawal by Subject|11|||
147554731|NCT00634907|532187764|FG001|Overall Study|Withdrawal by Subject|8|||
147554732|NCT04041570|532187765|FG000|Overall Study|Moved from Area|0|||
147554733|NCT04041570|532187766|FG001|Overall Study|Moved from Area|2|||
147554734|NCT01338636|532187767|FG000|Overall Study|Withdrawn due to lack of improvement|8|||
147554735|NCT02385526|532187768|FG000|Overall Study|Withdrawal by Subject|0|||
147554736|NCT02385526|532187769|FG001|Overall Study|Withdrawal by Subject|2|||
147554737|NCT02385526|532187770|FG002|Overall Study|Withdrawal by Subject|0|||
147554738|NCT02385526|532187768|FG000|Overall Study|Lost to Follow-up|0|||
147554739|NCT02385526|532187769|FG001|Overall Study|Lost to Follow-up|1|||
147554740|NCT02385526|532187770|FG002|Overall Study|Lost to Follow-up|0|||
147554741|NCT02385526|532187768|FG000|Overall Study|Physician Decision|1|||
147554742|NCT02385526|532187769|FG001|Overall Study|Physician Decision|0|||
147554743|NCT02385526|532187770|FG002|Overall Study|Physician Decision|0|||
147554744|NCT02385526|532187768|FG000|Overall Study|Protocol Violation|1|||
147554745|NCT02385526|532187769|FG001|Overall Study|Protocol Violation|0|||
147554746|NCT02385526|532187770|FG002|Overall Study|Protocol Violation|0|||
147554747|NCT03532009|532187773|FG000|Overall Study|Other|1|||
147554748|NCT03532009|532187774|FG001|Overall Study|Other|1|||
147554749|NCT03532009|532187773|FG000|Overall Study|Death|1|||
147554750|NCT03532009|532187774|FG001|Overall Study|Death|1|||
147554751|NCT03532009|532187773|FG000|Overall Study|Withdrawal by Patient|0|||
147554752|NCT03532009|532187774|FG001|Overall Study|Withdrawal by Patient|2|||
147554753|NCT02866175|532187779|FG000|Overall Study|Adverse Event|56|||
147554754|NCT02866175|532187780|FG001|Overall Study|Adverse Event|54|||
147554755|NCT02866175|532187779|FG000|Overall Study|Withdrawal by Subject|31|||
147554756|NCT02866175|532187780|FG001|Overall Study|Withdrawal by Subject|52|||
147554757|NCT02866175|532187779|FG000|Overall Study|Death|30|||
147554758|NCT02866175|532187780|FG001|Overall Study|Death|23|||
147554759|NCT02866175|532187779|FG000|Overall Study|Other|7|||
147554760|NCT02866175|532187780|FG001|Overall Study|Other|14|||
147554761|NCT02866175|532187779|FG000|Overall Study|Progressive disease|1|||
147554762|NCT02866175|532187780|FG001|Overall Study|Progressive disease|1|||
147554763|NCT02866175|532187779|FG000|Overall Study|Lost to Follow-up|2|||
147554764|NCT02866175|532187780|FG001|Overall Study|Lost to Follow-up|0|||
147554765|NCT02866175|532187779|FG000|Overall Study|Lack of Efficacy|0|||
147554766|NCT02866175|532187780|FG001|Overall Study|Lack of Efficacy|1|||
147554767|NCT02866175|532187779|FG000|Overall Study|Physician Decision|3|||
147554768|NCT02866175|532187780|FG001|Overall Study|Physician Decision|15|||
147554769|NCT02866175|532187779|FG000|Overall Study|Did not receive treatment|5|||
147554770|NCT02866175|532187780|FG001|Overall Study|Did not receive treatment|15|||
147554771|NCT01694485|532187781|FG000|Overall Study|Withdrawal by Subject|20|||
147554772|NCT01694485|532187782|FG001|Overall Study|Withdrawal by Subject|6|||
147554773|NCT01694485|532187783|FG002|Overall Study|Withdrawal by Subject|7|||
147554774|NCT01694485|532187784|FG003|Overall Study|Withdrawal by Subject|25|||
147554775|NCT01694485|532187785|FG004|Overall Study|Withdrawal by Subject|18|||
147554776|NCT01694485|532187781|FG000|Overall Study|Sponsor Decision|3|||
147554777|NCT01694485|532187782|FG001|Overall Study|Sponsor Decision|0|||
147554778|NCT01694485|532187783|FG002|Overall Study|Sponsor Decision|0|||
147554779|NCT01694485|532187784|FG003|Overall Study|Sponsor Decision|2|||
147554780|NCT01694485|532187785|FG004|Overall Study|Sponsor Decision|0|||
147554781|NCT01694485|532187781|FG000|Overall Study|Lost to Follow-up|9|||
147554782|NCT01694485|532187782|FG001|Overall Study|Lost to Follow-up|1|||
147554783|NCT01694485|532187783|FG002|Overall Study|Lost to Follow-up|6|||
147554784|NCT01694485|532187784|FG003|Overall Study|Lost to Follow-up|10|||
147554785|NCT01694485|532187785|FG004|Overall Study|Lost to Follow-up|7|||
147554786|NCT01694485|532187781|FG000|Overall Study|Death|1|||
147554787|NCT01694485|532187782|FG001|Overall Study|Death|0|||
147554788|NCT01694485|532187783|FG002|Overall Study|Death|0|||
147554789|NCT01694485|532187784|FG003|Overall Study|Death|1|||
147554790|NCT01694485|532187785|FG004|Overall Study|Death|0|||
147554791|NCT02907203|532187786|FG000|Overall Study|Death|1|||
147554792|NCT02907203|532187786|FG000|Overall Study|Lost to Follow-up|3|||
147554793|NCT02907203|532187786|FG000|Overall Study|Withdrawal by Subject|3|||
147554794|NCT02907203|532187786|FG000|Overall Study|Surgical bypass|1|||
147554795|NCT00681863|532187788|FG000|Overall Study|Adverse Event|1|||
147554796|NCT00681863|532187788|FG000|Overall Study|Lost to Follow-up|2|||
147554797|NCT00681863|532187788|FG000|Overall Study|Lack of Efficacy|2|||
147554798|NCT00681863|532187788|FG000|Overall Study|Other|18|||
147554799|NCT00384033|532187798|FG000|Overall Study|Adverse Event|10|||
147554800|NCT00384033|532187799|FG001|Overall Study|Adverse Event|8|||
147224710|NCT00782795|530993220|FG001|Overall Study|Withdrawal by Subject|2|||
147224711|NCT04480424|530993221|FG000|Overall Study|Withdrawal by Subject|0|||
147224712|NCT04480424|530993222|FG001|Overall Study|Withdrawal by Subject|2|||
147224713|NCT04480424|530993221|FG000|Overall Study|Lost to Follow-up|3|||
147224714|NCT04480424|530993222|FG001|Overall Study|Lost to Follow-up|3|||
147224715|NCT04480424|530993221|FG000|Overall Study|Death|14|||
147224716|NCT04480424|530993222|FG001|Overall Study|Death|16|||
147224717|NCT04480424|530993221|FG000|Overall Study|Reason not Specified|5|||
147224718|NCT04480424|530993222|FG001|Overall Study|Reason not Specified|5|||
147224719|NCT01909453|530993224|FG000|Overall Study|Ongoing|118|||
147224720|NCT01909453|530993225|FG001|Overall Study|Ongoing|103|||
147224721|NCT01909453|530993226|FG002|Overall Study|Ongoing|83|||
147224722|NCT01909453|530993227|FG003|Overall Study|Ongoing|164|||
147224723|NCT01909453|530993228|FG004|Overall Study|Ongoing|50|||
147554801|NCT00384033|532187800|FG002|Overall Study|Adverse Event|11|||
147554802|NCT00384033|532187801|FG003|Overall Study|Adverse Event|20|||
147554803|NCT00384033|532187798|FG000|Overall Study|Failed to return|1|||
147554804|NCT00384033|532187799|FG001|Overall Study|Failed to return|3|||
147554805|NCT00384033|532187800|FG002|Overall Study|Failed to return|2|||
147554806|NCT00384033|532187801|FG003|Overall Study|Failed to return|2|||
147554807|NCT00384033|532187798|FG000|Overall Study|Physician Decision|1|||
147554808|NCT00384033|532187799|FG001|Overall Study|Physician Decision|0|||
147554809|NCT00384033|532187800|FG002|Overall Study|Physician Decision|0|||
147554810|NCT00384033|532187801|FG003|Overall Study|Physician Decision|0|||
147224724|NCT01909453|530993224|FG000|Overall Study|Death|69|||
147554811|NCT00384033|532187798|FG000|Overall Study|Lost to Follow-up|6|||
147224725|NCT01909453|530993225|FG001|Overall Study|Death|74|||
147554812|NCT00384033|532187799|FG001|Overall Study|Lost to Follow-up|12|||
147554813|NCT00384033|532187800|FG002|Overall Study|Lost to Follow-up|7|||
147554814|NCT00384033|532187801|FG003|Overall Study|Lost to Follow-up|7|||
147554815|NCT00384033|532187798|FG000|Overall Study|Other|2|||
147554816|NCT00384033|532187799|FG001|Overall Study|Other|0|||
147105986|NCT02911116|530553721|FG000|Overall Study|Lost to Follow-up|0|||
147105987|NCT02911116|530553722|FG001|Overall Study|Lost to Follow-up|1|||
147105988|NCT01240694|530553723|FG000|Overall Study|Adverse Event|9|||
147105989|NCT01240694|530553723|FG000|Overall Study|Lack of Efficacy|6|||
147105990|NCT01240694|530553723|FG000|Overall Study|Withdrawal by Subject|6|||
147105991|NCT01240694|530553723|FG000|Overall Study|Protocol Violation|2|||
147443694|NCT01987960|531788765|FG003|Period 3|Non-compliance with IMP|1|||
147443695|NCT01987960|531788762|FG000|Period 3|Protocol Violation|0|||
147443696|NCT01987960|531788763|FG001|Period 3|Protocol Violation|0|||
147443697|NCT01987960|531788764|FG002|Period 3|Protocol Violation|0|||
147443698|NCT01987960|531788765|FG003|Period 3|Protocol Violation|6|||
147443699|NCT01987960|531788762|FG000|Period 3|Withdrawal by Subject|0|||
147443700|NCT01987960|531788763|FG001|Period 3|Withdrawal by Subject|0|||
147443701|NCT01987960|531788764|FG002|Period 3|Withdrawal by Subject|0|||
147443702|NCT01987960|531788765|FG003|Period 3|Withdrawal by Subject|9|||
147443703|NCT01987960|531788762|FG000|Period 3|Lost to Follow-up|0|||
147443704|NCT01987960|531788763|FG001|Period 3|Lost to Follow-up|0|||
147443705|NCT01987960|531788764|FG002|Period 3|Lost to Follow-up|0|||
147443706|NCT01987960|531788765|FG003|Period 3|Lost to Follow-up|5|||
147443707|NCT01987960|531788762|FG000|Period 3|Administrative or other reason|0|||
147443708|NCT01987960|531788763|FG001|Period 3|Administrative or other reason|0|||
147443709|NCT01987960|531788764|FG002|Period 3|Administrative or other reason|0|||
147443710|NCT01987960|531788765|FG003|Period 3|Administrative or other reason|43|||
147443711|NCT01279850|531788766|FG000|Overall Study|Protocol Violation|50|||
147443712|NCT01279850|531788766|FG000|Overall Study|No Drug Administration Information|7|||
147443713|NCT01279850|531788766|FG000|Overall Study|No Visit After Treatment|34|||
147443714|NCT01131520|531788767|FG000|Overall Study|Computer problem|1|||
147443715|NCT01131520|531788768|FG001|Overall Study|Computer problem|0|||
147443716|NCT01131520|531788767|FG000|Overall Study|Counselor not available|0|||
147443717|NCT01131520|531788768|FG001|Overall Study|Counselor not available|3|||
147443718|NCT01131520|531788767|FG000|Overall Study|Subject changed history after enrollment|0|||
147443719|NCT01131520|531788768|FG001|Overall Study|Subject changed history after enrollment|1|||
147443720|NCT01436084|531788771|FG000|Overall Study|Disease Progression|2|||
147443721|NCT01436084|531788771|FG000|Overall Study|Withdrawal by Subject|1|||
147443722|NCT01436084|531788771|FG000|Overall Study|Early Closure of Study|1|||
147443723|NCT05419128|531788772|FG000|Overall Study|Withdrawal by Subject|1|||
147443724|NCT05419128|531788773|FG001|Overall Study|Withdrawal by Subject|1|||
147443725|NCT05419128|531788774|FG002|Overall Study|Withdrawal by Subject|0|||
147443726|NCT05419128|531788775|FG003|Overall Study|Withdrawal by Subject|1|||
147443727|NCT05419128|531788776|FG004|Overall Study|Withdrawal by Subject|1|||
147443728|NCT05419128|531788777|FG005|Overall Study|Withdrawal by Subject|0|||
147443729|NCT05419128|531788772|FG000|Overall Study|Lost to Follow-up|0|||
147443730|NCT05419128|531788773|FG001|Overall Study|Lost to Follow-up|0|||
147443731|NCT05419128|531788774|FG002|Overall Study|Lost to Follow-up|1|||
147443732|NCT05419128|531788775|FG003|Overall Study|Lost to Follow-up|0|||
147443733|NCT05419128|531788776|FG004|Overall Study|Lost to Follow-up|0|||
147443734|NCT05419128|531788777|FG005|Overall Study|Lost to Follow-up|1|||
147443735|NCT04506086|531788778|FG000|Overall Study|Withdrawal by Subject|2|||
147443736|NCT02321930|531788784|FG000|Overall Study|Lost to Follow-up|1|||
147443737|NCT01293968|531788785|FG000|Overall Study|non-cooperation|3|||
147443738|NCT01293968|531788786|FG001|Overall Study|non-cooperation|3|||
147443739|NCT03996876|531788789|FG000|Overall Study|Incomplete Data|2|||
147443740|NCT03996876|531788790|FG001|Overall Study|Incomplete Data|4|||
147443741|NCT00597753|531788795|FG000|Overall Study|Adverse Event|6|||
147443742|NCT00597753|531788796|FG001|Overall Study|Adverse Event|2|||
147443743|NCT00597753|531788795|FG000|Overall Study|Death|55|||
147443744|NCT00597753|531788796|FG001|Overall Study|Death|29|||
147443745|NCT00597753|531788795|FG000|Overall Study|Lack of Efficacy|2|||
147443746|NCT00597753|531788796|FG001|Overall Study|Lack of Efficacy|0|||
147443747|NCT00597753|531788795|FG000|Overall Study|Lost to Follow-up|10|||
147443748|NCT00597753|531788796|FG001|Overall Study|Lost to Follow-up|3|||
147443749|NCT00597753|531788795|FG000|Overall Study|Physician Decision|5|||
147443750|NCT00597753|531788796|FG001|Overall Study|Physician Decision|1|||
147443751|NCT00597753|531788795|FG000|Overall Study|Pregnancy|1|||
147443752|NCT00597753|531788796|FG001|Overall Study|Pregnancy|0|||
147443753|NCT00597753|531788795|FG000|Overall Study|Withdrawal by Subject|35|||
147443754|NCT00597753|531788796|FG001|Overall Study|Withdrawal by Subject|12|||
147443755|NCT00597753|531788795|FG000|Overall Study|Discontinued Dialysis|0|||
147443756|NCT00597753|531788796|FG001|Overall Study|Discontinued Dialysis|1|||
147443757|NCT00597753|531788795|FG000|Overall Study|Never dosed|2|||
147443758|NCT00597753|531788796|FG001|Overall Study|Never dosed|0|||
147443759|NCT00597753|531788795|FG000|Overall Study|Noncompliance|2|||
147443760|NCT00597753|531788796|FG001|Overall Study|Noncompliance|1|||
147443761|NCT00597753|531788795|FG000|Overall Study|Relocation|17|||
147443762|NCT00597753|531788796|FG001|Overall Study|Relocation|6|||
147443763|NCT00597753|531788795|FG000|Overall Study|Renal transplant|10|||
147443764|NCT00597753|531788796|FG001|Overall Study|Renal transplant|3|||
147443765|NCT00597753|531788795|FG000|Overall Study|Site closed by sponsor|19|||
147443766|NCT00597753|531788796|FG001|Overall Study|Site closed by sponsor|7|||
147443767|NCT00597753|531788795|FG000|Overall Study|Site elected to close|2|||
147443768|NCT00597753|531788796|FG001|Overall Study|Site elected to close|4|||
147443769|NCT00388973|531790383|FG000|Overall Study|Adverse Event|16|||
147443770|NCT00388973|531790384|FG001|Overall Study|Adverse Event|6|||
147443771|NCT00388973|531790383|FG000|Overall Study|Lack of Efficacy|1|||
147443772|NCT00388973|531790384|FG001|Overall Study|Lack of Efficacy|12|||
147443773|NCT00388973|531790383|FG000|Overall Study|Protocol Violation|3|||
147443774|NCT00388973|531790384|FG001|Overall Study|Protocol Violation|0|||
147443775|NCT00388973|531790383|FG000|Overall Study|Withdrawal by Subject|14|||
147443776|NCT00388973|531790384|FG001|Overall Study|Withdrawal by Subject|17|||
147443777|NCT00388973|531790383|FG000|Overall Study|Study specific Discontinuation Criteria|0|||
147443778|NCT00388973|531790384|FG001|Overall Study|Study specific Discontinuation Criteria|1|||
147443779|NCT00388973|531790383|FG000|Overall Study|Did not complete 61 days of treatment|5|||
147443780|NCT00388973|531790384|FG001|Overall Study|Did not complete 61 days of treatment|4|||
147443781|NCT00388973|531790383|FG000|Overall Study|Left region|0|||
147443782|NCT00388973|531790384|FG001|Overall Study|Left region|1|||
147443783|NCT00388973|531790383|FG000|Overall Study|Did not complete 2-week follow-up visit|17|||
147443784|NCT00388973|531790384|FG001|Overall Study|Did not complete 2-week follow-up visit|17|||
147443785|NCT00075023|531790389|FG000|Pilot Study|Physician Decision|1|||
147443786|NCT00075023|531790390|FG001|Pilot Study|Physician Decision|2|||
147443787|NCT00075023|531790389|FG000|Pilot Study|Withdrawal by Subject|1|||
147443788|NCT00075023|531790390|FG001|Pilot Study|Withdrawal by Subject|0|||
147443789|NCT02982954|531790392|FG000|Overall Study|Death|55|||
147443790|NCT02982954|531790393|FG001|Overall Study|Death|29|||
147443791|NCT02982954|531790394|FG002|Overall Study|Death|15|||
147443792|NCT02982954|531790395|FG003|Overall Study|Death|20|||
147443793|NCT02982954|531790392|FG000|Overall Study|Lost to Follow-up|2|||
147443794|NCT02982954|531790393|FG001|Overall Study|Lost to Follow-up|1|||
147443795|NCT02982954|531790394|FG002|Overall Study|Lost to Follow-up|0|||
147443796|NCT02982954|531790395|FG003|Overall Study|Lost to Follow-up|0|||
147443797|NCT02982954|531790392|FG000|Overall Study|Participant withdrew consent|7|||
147443798|NCT02982954|531790393|FG001|Overall Study|Participant withdrew consent|5|||
147443799|NCT02982954|531790394|FG002|Overall Study|Participant withdrew consent|1|||
147443800|NCT02982954|531790395|FG003|Overall Study|Participant withdrew consent|1|||
147443801|NCT02982954|531790392|FG000|Overall Study|Other reasons|42|||
147443802|NCT02982954|531790393|FG001|Overall Study|Other reasons|17|||
147443803|NCT02982954|531790394|FG002|Overall Study|Other reasons|12|||
147443804|NCT02982954|531790395|FG003|Overall Study|Other reasons|3|||
147443805|NCT02982954|531790392|FG000|Overall Study|Premature site closure|0|||
147443806|NCT02982954|531790393|FG001|Overall Study|Premature site closure|0|||
147443807|NCT02982954|531790394|FG002|Overall Study|Premature site closure|0|||
147443808|NCT02982954|531790395|FG003|Overall Study|Premature site closure|1|||
147443809|NCT00747643|531790399|FG000|Overall Study|Withdrawal by Subject|36|||
147443810|NCT00747643|531790400|FG001|Overall Study|Withdrawal by Subject|27|||
147443811|NCT00516048|531790401|FG000|Overall Study|Death|0|||
147443812|NCT00516048|531790402|FG001|Overall Study|Death|0|||
147443813|NCT00516048|531790403|FG002|Overall Study|Death|1|||
147443814|NCT00516048|531790401|FG000|Overall Study|Subject Decision|0|||
147443815|NCT00516048|531790402|FG001|Overall Study|Subject Decision|2|||
147443816|NCT00516048|531790403|FG002|Overall Study|Subject Decision|0|||
147443817|NCT02263079|531790404|FG000|Overall Study|Physician Decision|1|||
147443818|NCT02263079|531790405|FG001|Overall Study|Physician Decision|0|||
147443819|NCT02263079|531790406|FG002|Overall Study|Physician Decision|0|||
147443820|NCT02263079|531790404|FG000|Overall Study|Withdrawal by Subject|2|||
147443821|NCT02263079|531790405|FG001|Overall Study|Withdrawal by Subject|8|||
147443822|NCT02263079|531790406|FG002|Overall Study|Withdrawal by Subject|0|||
147443823|NCT03557281|531790407|FG000|Overall Study|Investigator discretion|0|||
147443824|NCT03557281|531790408|FG001|Overall Study|Investigator discretion|0|||
147554817|NCT00384033|532187800|FG002|Overall Study|Other|0|||
147554818|NCT00384033|532187801|FG003|Overall Study|Other|0|||
147554819|NCT00384033|532187798|FG000|Overall Study|Protocol Violation|5|||
147224726|NCT01909453|530993226|FG002|Overall Study|Death|88|||
147443825|NCT03557281|531790409|FG002|Overall Study|Investigator discretion|1|||
147443826|NCT03557281|531790410|FG003|Overall Study|Investigator discretion|0|||
147443827|NCT03557281|531790411|FG004|Overall Study|Investigator discretion|0|||
147443828|NCT03557281|531790407|FG000|Overall Study|Withdrawal by Subject|0|||
147443829|NCT03557281|531790408|FG001|Overall Study|Withdrawal by Subject|1|||
147443830|NCT03557281|531790409|FG002|Overall Study|Withdrawal by Subject|1|||
147443831|NCT03557281|531790410|FG003|Overall Study|Withdrawal by Subject|1|||
147443832|NCT03557281|531790411|FG004|Overall Study|Withdrawal by Subject|2|||
147443833|NCT03557281|531790407|FG000|Overall Study|Randomized, but did not receive treatment|0|||
147443834|NCT03557281|531790408|FG001|Overall Study|Randomized, but did not receive treatment|0|||
147443835|NCT03557281|531790409|FG002|Overall Study|Randomized, but did not receive treatment|0|||
147224727|NCT01909453|530993227|FG003|Overall Study|Death|86|||
147224728|NCT01909453|530993228|FG004|Overall Study|Death|29|||
147443836|NCT03557281|531790410|FG003|Overall Study|Randomized, but did not receive treatment|0|||
147554820|NCT00384033|532187799|FG001|Overall Study|Protocol Violation|0|||
147554821|NCT00384033|532187800|FG002|Overall Study|Protocol Violation|5|||
147554822|NCT00384033|532187801|FG003|Overall Study|Protocol Violation|6|||
147554823|NCT00384033|532187798|FG000|Overall Study|Withdrawal by Subject|6|||
147554824|NCT00384033|532187799|FG001|Overall Study|Withdrawal by Subject|2|||
147554825|NCT00384033|532187800|FG002|Overall Study|Withdrawal by Subject|5|||
147554826|NCT00384033|532187801|FG003|Overall Study|Withdrawal by Subject|2|||
147554827|NCT00384033|532187798|FG000|Overall Study|Lack of Efficacy|7|||
147554828|NCT00384033|532187799|FG001|Overall Study|Lack of Efficacy|3|||
147554829|NCT00384033|532187800|FG002|Overall Study|Lack of Efficacy|3|||
147554830|NCT00384033|532187801|FG003|Overall Study|Lack of Efficacy|1|||
147554831|NCT00384033|532187798|FG000|Overall Study|Randomized but not treated|3|||
147554832|NCT00384033|532187799|FG001|Overall Study|Randomized but not treated|7|||
147554833|NCT00384033|532187800|FG002|Overall Study|Randomized but not treated|10|||
147554834|NCT00384033|532187801|FG003|Overall Study|Randomized but not treated|2|||
147554835|NCT01006707|532187802|FG000|Study Session 1|Lost to Follow-up|2|||
147554836|NCT01006707|532187803|FG001|Study Session 1|Lost to Follow-up|0|||
147554837|NCT01006707|532187804|FG002|Study Session 1|Lost to Follow-up|0|||
147554838|NCT01006707|532187802|FG000|Study Session 1|Could not tolerate withdrawal in scanner|3|||
147554839|NCT01006707|532187803|FG001|Study Session 1|Could not tolerate withdrawal in scanner|0|||
147554840|NCT01006707|532187804|FG002|Study Session 1|Could not tolerate withdrawal in scanner|0|||
147554841|NCT00760383|532187806|FG000|Overall Study|moved away; withdrew; medical reasons|5|||
147554842|NCT00760383|532187807|FG001|Overall Study|moved away; withdrew; medical reasons|7|||
147554843|NCT00192296|532187808|FG000|Overall Study|Withdrawal by Subject|0|||
147554844|NCT00192296|532187809|FG001|Overall Study|Withdrawal by Subject|1|||
147554845|NCT00192296|532187810|FG002|Overall Study|Withdrawal by Subject|0|||
147554846|NCT00192296|532187811|FG003|Overall Study|Withdrawal by Subject|0|||
147554847|NCT01842958|532187812|FG000|Overall Study|Lost to Follow-up|1|||
147554848|NCT01842958|532187813|FG001|Overall Study|Lost to Follow-up|1|||
147554849|NCT03465891|532187815|FG000|Overall Study|Withdrawal by Subject|0|||
147554850|NCT03465891|532187816|FG001|Overall Study|Withdrawal by Subject|1|||
147554851|NCT03465891|532187815|FG000|Overall Study|Disease progression|1|||
147554852|NCT03465891|532187816|FG001|Overall Study|Disease progression|0|||
147554853|NCT02737306|532187818|FG000|Overall Study|Adverse Event|3|||
147554854|NCT02737306|532187819|FG001|Overall Study|Adverse Event|0|||
147554855|NCT02737306|532187818|FG000|Overall Study|Enrolment and treatment halted by sponsor.|1|||
147554856|NCT02737306|532187819|FG001|Overall Study|Enrolment and treatment halted by sponsor.|0|||
147554857|NCT05034731|532187820|FG000|Overall Study|Screen fail|1|||
147554858|NCT05034731|532187821|FG001|Overall Study|Screen fail|1|||
147554859|NCT00622908|532187822|FG000|Overall Study|Protocol Violation|1|||
147554860|NCT00622908|532187823|FG001|Overall Study|Protocol Violation|0|||
147554861|NCT00622908|532187822|FG000|Overall Study|Adverse Event|0|||
147554862|NCT00622908|532187823|FG001|Overall Study|Adverse Event|1|||
147554863|NCT00622908|532187822|FG000|Overall Study|Lack of Efficacy|1|||
147554864|NCT00622908|532187823|FG001|Overall Study|Lack of Efficacy|7|||
147554865|NCT00622908|532187822|FG000|Overall Study|Lost to Follow-up|1|||
147554866|NCT00622908|532187823|FG001|Overall Study|Lost to Follow-up|0|||
147554867|NCT00622908|532187822|FG000|Overall Study|Refusal|0|||
147554868|NCT00622908|532187823|FG001|Overall Study|Refusal|1|||
147554869|NCT00622908|532187822|FG000|Overall Study|Termination by study sponser|0|||
147554870|NCT00622908|532187823|FG001|Overall Study|Termination by study sponser|1|||
147554871|NCT03937466|532187824|FG000|Overall Study|not eligbile after the 2-week diary|9|||
147554872|NCT03937466|532187824|FG000|Overall Study|never returned their diary|6|||
147554873|NCT03937466|532187824|FG000|Overall Study|dropped out of study before getting Chilipad|5|||
147554874|NCT03937466|532187824|FG000|Overall Study|3 did not complete follow-up questionnaire.|3|||
147554875|NCT03305055|532187825|FG000|Overall Study|Withdrawal by Subject|0|||
147554876|NCT03305055|532187826|FG001|Overall Study|Withdrawal by Subject|1|||
147554877|NCT03305055|532187825|FG000|Overall Study|Adverse Event|1|||
147554878|NCT03305055|532187826|FG001|Overall Study|Adverse Event|1|||
147224729|NCT01909453|530993224|FG000|Overall Study|Lost to Follow-up|3|||
147224730|NCT01909453|530993225|FG001|Overall Study|Lost to Follow-up|4|||
147224731|NCT01909453|530993226|FG002|Overall Study|Lost to Follow-up|4|||
147224732|NCT01909453|530993227|FG003|Overall Study|Lost to Follow-up|3|||
147224733|NCT01909453|530993228|FG004|Overall Study|Lost to Follow-up|3|||
147224734|NCT01909453|530993224|FG000|Overall Study|Withdrawal by Subject|2|||
147224735|NCT01909453|530993225|FG001|Overall Study|Withdrawal by Subject|13|||
147224736|NCT01909453|530993226|FG002|Overall Study|Withdrawal by Subject|16|||
147224737|NCT01909453|530993227|FG003|Overall Study|Withdrawal by Subject|5|||
147224738|NCT01909453|530993228|FG004|Overall Study|Withdrawal by Subject|4|||
147224739|NCT03437512|530994782|FG000|Randomized|Withdrawal by Subject|0|||
147224740|NCT03437512|530994783|FG001|Randomized|Withdrawal by Subject|2|||
147554879|NCT03213210|532187827|FG000|Overall Study|Lost to Follow-up|2|||
147224741|NCT03437512|530994782|FG000|Completed Study Follow up|Could not complete study due to COVID-19 research pause|2|||
147554880|NCT03213210|532187827|FG000|Overall Study|Study termination|3|||
147554881|NCT02540356|532187828|FG000|Overall Study|Terminated due to disease progression|1|||
147224742|NCT03437512|530994783|FG001|Completed Study Follow up|Could not complete study due to COVID-19 research pause|1|||
147554882|NCT02540356|532187829|FG001|Overall Study|Terminated due to disease progression|0|||
147554883|NCT01166568|532187835|FG000|Deferred Implantation- Randomized|Withdrawal by Subject|0|||
147554884|NCT01166568|532187836|FG001|Deferred Implantation- Randomized|Withdrawal by Subject|0|||
147554885|NCT01166568|532187837|FG002|Deferred Implantation- Randomized|Withdrawal by Subject|1|||
147554886|NCT01166568|532187835|FG000|Implantation- Nonrandomized & Randomized|Lost to Follow-up|7|||
147554887|NCT01166568|532187836|FG001|Implantation- Nonrandomized & Randomized|Lost to Follow-up|1|||
147554888|NCT01166568|532187837|FG002|Implantation- Nonrandomized & Randomized|Lost to Follow-up|0|||
147554889|NCT01166568|532187835|FG000|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|7|||
147554890|NCT01166568|532187836|FG001|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|0|||
147554891|NCT01166568|532187837|FG002|Implantation- Nonrandomized & Randomized|Withdrawal by Subject|1|||
147554892|NCT03335371|532187838|FG000|Overall Study|Lost to Follow-up|0|||
147554893|NCT03335371|532187839|FG001|Overall Study|Lost to Follow-up|0|||
147554894|NCT03335371|532187840|FG002|Overall Study|Lost to Follow-up|0|||
147554895|NCT03335371|532187841|FG003|Overall Study|Lost to Follow-up|0|||
147554896|NCT03335371|532187842|FG004|Overall Study|Lost to Follow-up|1|||
147554897|NCT03335371|532187838|FG000|Overall Study|Withdrawal by Subject|0|||
147554898|NCT03335371|532187839|FG001|Overall Study|Withdrawal by Subject|0|||
147554899|NCT03335371|532187840|FG002|Overall Study|Withdrawal by Subject|0|||
147554900|NCT03335371|532187841|FG003|Overall Study|Withdrawal by Subject|0|||
147554901|NCT03335371|532187842|FG004|Overall Study|Withdrawal by Subject|1|||
147554902|NCT03335371|532187838|FG000|Overall Study|Randomization Error|0|||
147554903|NCT03335371|532187839|FG001|Overall Study|Randomization Error|0|||
147554904|NCT03335371|532187840|FG002|Overall Study|Randomization Error|1|||
147554905|NCT03335371|532187841|FG003|Overall Study|Randomization Error|0|||
147554906|NCT03335371|532187842|FG004|Overall Study|Randomization Error|0|||
147554907|NCT00684671|532187843|FG000|Overall Study|Adverse Event|1|||
147554908|NCT00684671|532187844|FG001|Overall Study|Adverse Event|0|||
147554909|NCT00684671|532187845|FG002|Overall Study|Adverse Event|0|||
147554910|NCT00684671|532187843|FG000|Overall Study|Lost to Follow-up|1|||
147554911|NCT00684671|532187844|FG001|Overall Study|Lost to Follow-up|0|||
147554912|NCT00684671|532187845|FG002|Overall Study|Lost to Follow-up|0|||
147554913|NCT00684671|532187843|FG000|Overall Study|Alcoholic dependance|1|||
147554914|NCT00684671|532187844|FG001|Overall Study|Alcoholic dependance|0|||
147554915|NCT00684671|532187845|FG002|Overall Study|Alcoholic dependance|0|||
147554916|NCT02649231|532187848|FG000|Overall Study|Adverse Event|0|||
147554917|NCT02649231|532187849|FG001|Overall Study|Adverse Event|0|||
147554918|NCT02649231|532187850|FG002|Overall Study|Adverse Event|0|||
147554919|NCT02649231|532187851|FG003|Overall Study|Adverse Event|1|||
147554920|NCT02649231|532187848|FG000|Overall Study|Lost to Follow-up|2|||
147554921|NCT02649231|532187849|FG001|Overall Study|Lost to Follow-up|1|||
147554922|NCT02649231|532187850|FG002|Overall Study|Lost to Follow-up|1|||
147554923|NCT02649231|532187851|FG003|Overall Study|Lost to Follow-up|0|||
147554924|NCT02649231|532187848|FG000|Overall Study|Withdrawal by Subject|0|||
147554925|NCT02649231|532187849|FG001|Overall Study|Withdrawal by Subject|1|||
147554926|NCT02649231|532187850|FG002|Overall Study|Withdrawal by Subject|0|||
147554927|NCT02649231|532187851|FG003|Overall Study|Withdrawal by Subject|1|||
147554928|NCT02649231|532187848|FG000|Overall Study|Protocol Violation|2|||
147554929|NCT02649231|532187849|FG001|Overall Study|Protocol Violation|1|||
147554930|NCT02649231|532187850|FG002|Overall Study|Protocol Violation|1|||
147554931|NCT02649231|532187851|FG003|Overall Study|Protocol Violation|0|||
147554932|NCT00437281|532187852|FG000|Overall Study|Adverse Event|0|||
147554933|NCT00437281|532187853|FG001|Overall Study|Adverse Event|0|||
147554934|NCT00437281|532187854|FG002|Overall Study|Adverse Event|0|||
147554935|NCT00437281|532187855|FG003|Overall Study|Adverse Event|1|||
147554936|NCT00437281|532187856|FG004|Overall Study|Adverse Event|0|||
147554937|NCT00437281|532187857|FG005|Overall Study|Adverse Event|1|||
147554938|NCT00437281|532187858|FG006|Overall Study|Adverse Event|0|||
147554939|NCT00437281|532187859|FG007|Overall Study|Adverse Event|0|||
147554940|NCT00437281|532187860|FG008|Overall Study|Adverse Event|0|||
147554941|NCT00437281|532187861|FG009|Overall Study|Adverse Event|1|||
147554942|NCT00437281|532187862|FG010|Overall Study|Adverse Event|0|||
147105992|NCT01240694|530553723|FG000|Overall Study|Lost to Follow-up|2|||
147105993|NCT01240694|530553723|FG000|Overall Study|Other than specified|3|||
147224743|NCT01897714|530994784|FG000|Phase I (Dose Escalation)|Disease progression|3|||
147224744|NCT01897714|530994785|FG001|Phase I (Dose Escalation)|Disease progression|5|||
147554943|NCT00437281|532187863|FG011|Overall Study|Adverse Event|0|||
147554944|NCT00437281|532187864|FG012|Overall Study|Adverse Event|0|||
147554945|NCT00437281|532187865|FG013|Overall Study|Adverse Event|1|||
147554946|NCT00437281|532187866|FG014|Overall Study|Adverse Event|1|||
147554947|NCT00437281|532187867|FG015|Overall Study|Adverse Event|0|||
147554948|NCT00437281|532187868|FG016|Overall Study|Adverse Event|0|||
147554949|NCT00437281|532187869|FG017|Overall Study|Adverse Event|0|||
147554950|NCT00437281|532187870|FG018|Overall Study|Adverse Event|1|||
147554951|NCT00437281|532187871|FG019|Overall Study|Adverse Event|0|||
147554952|NCT00437281|532187852|FG000|Overall Study|Lost to Follow-up|0|||
147554953|NCT00437281|532187853|FG001|Overall Study|Lost to Follow-up|0|||
147554954|NCT00437281|532187854|FG002|Overall Study|Lost to Follow-up|0|||
147554955|NCT00437281|532187855|FG003|Overall Study|Lost to Follow-up|0|||
147554956|NCT00437281|532187856|FG004|Overall Study|Lost to Follow-up|0|||
147554957|NCT00437281|532187857|FG005|Overall Study|Lost to Follow-up|0|||
147554958|NCT00437281|532187858|FG006|Overall Study|Lost to Follow-up|0|||
147554959|NCT00437281|532187859|FG007|Overall Study|Lost to Follow-up|0|||
147554960|NCT00437281|532187860|FG008|Overall Study|Lost to Follow-up|0|||
147554961|NCT00437281|532187861|FG009|Overall Study|Lost to Follow-up|0|||
147554962|NCT00437281|532187862|FG010|Overall Study|Lost to Follow-up|0|||
147554963|NCT00437281|532187863|FG011|Overall Study|Lost to Follow-up|0|||
147554964|NCT00437281|532187864|FG012|Overall Study|Lost to Follow-up|0|||
147554965|NCT00437281|532187865|FG013|Overall Study|Lost to Follow-up|0|||
147554966|NCT00437281|532187866|FG014|Overall Study|Lost to Follow-up|0|||
147554967|NCT00437281|532187867|FG015|Overall Study|Lost to Follow-up|0|||
147554968|NCT00437281|532187868|FG016|Overall Study|Lost to Follow-up|0|||
147554969|NCT00437281|532187869|FG017|Overall Study|Lost to Follow-up|0|||
147554970|NCT00437281|532187870|FG018|Overall Study|Lost to Follow-up|0|||
147554971|NCT00437281|532187871|FG019|Overall Study|Lost to Follow-up|1|||
147554972|NCT00249821|532187874|FG000|Overall Study|Technical problem|0|||
147554973|NCT00249821|532187875|FG001|Overall Study|Technical problem|1|||
147554974|NCT01348542|532187879|FG000|Overall Study|Withdrawal by Subject|3|||
147554975|NCT01348542|532187880|FG001|Overall Study|Withdrawal by Subject|0|||
147554976|NCT00467584|532187881|FG000|Overall Study|Withdrawal by Subject|4|||
147554977|NCT00467584|532187882|FG001|Overall Study|Withdrawal by Subject|5|||
147554978|NCT00467584|532187883|FG002|Overall Study|Withdrawal by Subject|1|||
147554979|NCT00926289|532187884|FG000|Overall Study|Adverse Event|9|||
147554980|NCT00926289|532187885|FG001|Overall Study|Adverse Event|11|||
147554981|NCT00926289|532187884|FG000|Overall Study|Protocol Violation|8|||
147554982|NCT00926289|532187885|FG001|Overall Study|Protocol Violation|12|||
147554983|NCT00926289|532187884|FG000|Overall Study|Lost to Follow-up|3|||
147554984|NCT00926289|532187885|FG001|Overall Study|Lost to Follow-up|6|||
147554985|NCT00926289|532187884|FG000|Overall Study|Withdrawal by Subject|4|||
147554986|NCT00926289|532187885|FG001|Overall Study|Withdrawal by Subject|4|||
147554987|NCT00926289|532187884|FG000|Overall Study|Other|1|||
147554988|NCT00926289|532187885|FG001|Overall Study|Other|3|||
147554989|NCT00319956|532187886|FG000|Overall Study|Death|20|||
147554990|NCT00319956|532187887|FG001|Overall Study|Death|24|||
147554991|NCT01202747|532187888|FG000|Overall Study|Withdrawal by Subject|1|||
147554992|NCT01446913|532187889|FG000|Overall Study|Significant illness|1|||
147554993|NCT01446913|532187890|FG001|Overall Study|Significant illness|1|||
147554994|NCT01446913|532187891|FG002|Overall Study|Significant illness|1|||
147554995|NCT01446913|532187889|FG000|Overall Study|Withdrawal by Subject|5|||
147554996|NCT01446913|532187890|FG001|Overall Study|Withdrawal by Subject|3|||
147554997|NCT01446913|532187891|FG002|Overall Study|Withdrawal by Subject|5|||
147554998|NCT01446913|532187889|FG000|Overall Study|Physician Decision|0|||
147554999|NCT01446913|532187890|FG001|Overall Study|Physician Decision|0|||
147555000|NCT01446913|532187891|FG002|Overall Study|Physician Decision|2|||
147555001|NCT01446913|532187889|FG000|Overall Study|Lost to Follow-up|3|||
147555002|NCT01446913|532187890|FG001|Overall Study|Lost to Follow-up|5|||
147555003|NCT01446913|532187891|FG002|Overall Study|Lost to Follow-up|3|||
147555004|NCT04000009|532187892|FG000|Overall Study|Adverse Event|13|||
147105994|NCT01240694|530553723|FG000|Overall Study|Withdrawn due to early study termination|107|||
147105995|NCT01513590|530553724|FG000|Overall Study|Adverse Event|2|||
147105996|NCT01513590|530553725|FG001|Overall Study|Adverse Event|3|||
147105997|NCT01513590|530553724|FG000|Overall Study|Withdrawal Criteria|3|||
147443837|NCT03557281|531790411|FG004|Overall Study|Randomized, but did not receive treatment|1|||
147443838|NCT01999465|531790412|FG000|Overall Study|Lost to Follow-up|0|||
147443839|NCT01999465|531790413|FG001|Overall Study|Lost to Follow-up|2|||
147443840|NCT01999465|531790412|FG000|Overall Study|Protocol Violation|0|||
147443841|NCT01999465|531790413|FG001|Overall Study|Protocol Violation|1|||
147443842|NCT01549275|531790417|FG000|Overall Study|Lost to Follow-up|1|||
147443843|NCT01549275|531790418|FG001|Overall Study|Lost to Follow-up|0|||
147443844|NCT01040351|531790419|FG000|Overall Study|poor ovarian response|1|||
147443845|NCT01040351|531790420|FG001|Overall Study|poor ovarian response|2|||
147443846|NCT04773106|531790426|FG000|Overall Study|Withdrawal by Subject|3|||
147443847|NCT04773106|531790426|FG000|Overall Study|Death|1|||
147443848|NCT00122681|531790431|FG000|Overall Study|Adverse Event|20|||
147443849|NCT00122681|531790432|FG001|Overall Study|Adverse Event|16|||
147443850|NCT00122681|531790431|FG000|Overall Study|Lost to Follow-up|1080|||
147443851|NCT00122681|531790432|FG001|Overall Study|Lost to Follow-up|1097|||
147443852|NCT00122681|531790431|FG000|Overall Study|Protocol Violation|7|||
147443853|NCT00122681|531790432|FG001|Overall Study|Protocol Violation|10|||
147443854|NCT00122681|531790431|FG000|Overall Study|Withdrawal by Subject|257|||
147443855|NCT00122681|531790432|FG001|Overall Study|Withdrawal by Subject|251|||
147555005|NCT04000009|532187892|FG000|Overall Study|Lack of Efficacy|7|||
147555006|NCT04000009|532187892|FG000|Overall Study|Lost to Follow-up|8|||
147555007|NCT04000009|532187892|FG000|Overall Study|Noncompliance with study drug|4|||
147555008|NCT04000009|532187892|FG000|Overall Study|Physician Decision|1|||
147555009|NCT04000009|532187892|FG000|Overall Study|Use of prohibited medication|3|||
147555010|NCT04000009|532187892|FG000|Overall Study|Pregnancy|1|||
147555011|NCT04000009|532187892|FG000|Overall Study|Withdrawal by Subject|22|||
147105998|NCT01513590|530553725|FG001|Overall Study|Withdrawal Criteria|0|||
147105999|NCT01513590|530553724|FG000|Overall Study|Unclassified|5|||
147106000|NCT01513590|530553725|FG001|Overall Study|Unclassified|10|||
147106001|NCT01056276|530553726|FG000|Treatment Period-Cycles 1-8|Toxicity|2|||
147106002|NCT01056276|530553727|FG001|Treatment Period-Cycles 1-8|Toxicity|1|||
147106003|NCT01056276|530553726|FG000|Treatment Period-Cycles 1-8|Withdrawal by Subject|1|||
147106004|NCT01056276|530553727|FG001|Treatment Period-Cycles 1-8|Withdrawal by Subject|2|||
147106005|NCT01056276|530553726|FG000|Treatment Period-Cycles 1-8|Disease Progression|2|||
147224745|NCT01897714|530994786|FG002|Phase I (Dose Escalation)|Disease progression|1|||
147443856|NCT00122681|531790431|FG000|Overall Study|Personal reasons|150|||
147443857|NCT00122681|531790432|FG001|Overall Study|Personal reasons|147|||
147443858|NCT02819635|531790437|FG000|Substudy 1 and Substudy 2, Part 1|Adverse Event|3|||
147443859|NCT02819635|531790438|FG001|Substudy 1 and Substudy 2, Part 1|Adverse Event|1|||
147443860|NCT02819635|531790439|FG002|Substudy 1 and Substudy 2, Part 1|Adverse Event|3|||
147443861|NCT02819635|531790440|FG003|Substudy 1 and Substudy 2, Part 1|Adverse Event|5|||
147443862|NCT02819635|531790441|FG004|Substudy 1 and Substudy 2, Part 1|Adverse Event|4|||
147443863|NCT02819635|531790442|FG005|Substudy 1 and Substudy 2, Part 1|Adverse Event|9|||
147443864|NCT02819635|531790443|FG006|Substudy 1 and Substudy 2, Part 1|Adverse Event|6|||
147443865|NCT02819635|531790444|FG007|Substudy 1 and Substudy 2, Part 1|Adverse Event|0|||
147443866|NCT02819635|531790445|FG008|Substudy 1 and Substudy 2, Part 1|Adverse Event|0|||
147443867|NCT02819635|531790446|FG009|Substudy 1 and Substudy 2, Part 1|Adverse Event|0|||
147443868|NCT02819635|531790447|FG010|Substudy 1 and Substudy 2, Part 1|Adverse Event|0|||
147443869|NCT02819635|531790448|FG011|Substudy 1 and Substudy 2, Part 1|Adverse Event|0|||
147443870|NCT02819635|531790437|FG000|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
147443871|NCT02819635|531790438|FG001|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
147443872|NCT02819635|531790439|FG002|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
147443873|NCT02819635|531790440|FG003|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
147443874|NCT02819635|531790441|FG004|Substudy 1 and Substudy 2, Part 1|Withdrew consent|1|||
147443875|NCT02819635|531790442|FG005|Substudy 1 and Substudy 2, Part 1|Withdrew consent|3|||
147443876|NCT02819635|531790443|FG006|Substudy 1 and Substudy 2, Part 1|Withdrew consent|2|||
147443877|NCT02819635|531790444|FG007|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
147443878|NCT02819635|531790445|FG008|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
147443879|NCT02819635|531790446|FG009|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
147443880|NCT02819635|531790447|FG010|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
147443881|NCT02819635|531790448|FG011|Substudy 1 and Substudy 2, Part 1|Withdrew consent|0|||
147443882|NCT02819635|531790437|FG000|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
147443883|NCT02819635|531790438|FG001|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
147443884|NCT02819635|531790439|FG002|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
147443885|NCT02819635|531790440|FG003|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
147443886|NCT02819635|531790441|FG004|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
147443887|NCT02819635|531790442|FG005|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|1|||
147443888|NCT02819635|531790443|FG006|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|1|||
147443889|NCT02819635|531790444|FG007|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
147443890|NCT02819635|531790445|FG008|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
147443891|NCT02819635|531790446|FG009|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
147443892|NCT02819635|531790447|FG010|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
147443893|NCT02819635|531790448|FG011|Substudy 1 and Substudy 2, Part 1|Lost to Follow-up|0|||
147443894|NCT02819635|531790437|FG000|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
147443895|NCT02819635|531790438|FG001|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
147443896|NCT02819635|531790439|FG002|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
147443897|NCT02819635|531790440|FG003|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
147443898|NCT02819635|531790441|FG004|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
147443899|NCT02819635|531790442|FG005|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
147443900|NCT02819635|531790443|FG006|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|1|||
147443901|NCT02819635|531790444|FG007|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
147443902|NCT02819635|531790445|FG008|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
147443903|NCT02819635|531790446|FG009|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
147443904|NCT02819635|531790447|FG010|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
147443905|NCT02819635|531790448|FG011|Substudy 1 and Substudy 2, Part 1|COVID-19 Logistical Restrictions|0|||
147443906|NCT02819635|531790437|FG000|Substudy 1 and Substudy 2, Part 1|Other, not specified|2|||
147443907|NCT02819635|531790438|FG001|Substudy 1 and Substudy 2, Part 1|Other, not specified|1|||
147443908|NCT02819635|531790439|FG002|Substudy 1 and Substudy 2, Part 1|Other, not specified|1|||
147443909|NCT02819635|531790440|FG003|Substudy 1 and Substudy 2, Part 1|Other, not specified|7|||
147443910|NCT02819635|531790441|FG004|Substudy 1 and Substudy 2, Part 1|Other, not specified|5|||
147443911|NCT02819635|531790442|FG005|Substudy 1 and Substudy 2, Part 1|Other, not specified|7|||
147443912|NCT02819635|531790443|FG006|Substudy 1 and Substudy 2, Part 1|Other, not specified|3|||
147310132|NCT04362137|531302257|FG000|Overall Study|Adverse Event|1|||
147310133|NCT04362137|531302258|FG001|Overall Study|Adverse Event|0|||
147310134|NCT04362137|531302257|FG000|Overall Study|Lost to Follow-up|1|||
147310135|NCT04362137|531302258|FG001|Overall Study|Lost to Follow-up|0|||
147310136|NCT04362137|531302257|FG000|Overall Study|Protocol deviation|1|||
147310137|NCT04362137|531302258|FG001|Overall Study|Protocol deviation|0|||
147310138|NCT01121484|531302262|FG000|Overall Study|Adverse Event|12|||
147310139|NCT01121484|531302263|FG001|Overall Study|Adverse Event|5|||
147310140|NCT01121484|531302262|FG000|Overall Study|Lack of Efficacy|3|||
147310141|NCT01121484|531302263|FG001|Overall Study|Lack of Efficacy|11|||
147310142|NCT01121484|531302262|FG000|Overall Study|Lost to Follow-up|5|||
147310143|NCT01121484|531302263|FG001|Overall Study|Lost to Follow-up|9|||
147310144|NCT01121484|531302262|FG000|Overall Study|Physician Decision|0|||
147310145|NCT01121484|531302263|FG001|Overall Study|Physician Decision|3|||
147310146|NCT01121484|531302262|FG000|Overall Study|Protocol Violation|1|||
147310147|NCT01121484|531302263|FG001|Overall Study|Protocol Violation|0|||
147310148|NCT01121484|531302262|FG000|Overall Study|Withdrawal by Subject|8|||
147310149|NCT01121484|531302263|FG001|Overall Study|Withdrawal by Subject|7|||
147310150|NCT01121484|531302262|FG000|Overall Study|Discontinuation of study by sponsor|0|||
147310151|NCT01121484|531302263|FG001|Overall Study|Discontinuation of study by sponsor|1|||
147310152|NCT01121484|531302262|FG000|Overall Study|Other|3|||
147310153|NCT01121484|531302263|FG001|Overall Study|Other|3|||
147310154|NCT01121484|531302262|FG000|Overall Study|Randomized, not treated|1|||
147310155|NCT01121484|531302263|FG001|Overall Study|Randomized, not treated|4|||
147310156|NCT02204579|531302267|FG000|Overall Study|Screen failures|2|||
147310157|NCT00539279|531302268|FG000|Treatment|Withdrawal by Subject|10|||
147310158|NCT00539279|531302269|FG001|Treatment|Withdrawal by Subject|8|||
147310159|NCT00539279|531302268|FG000|Treatment|Death|1|||
147310160|NCT00539279|531302269|FG001|Treatment|Death|0|||
147310161|NCT00539279|531302268|FG000|Post-Treatment Assessment|Lost to Follow-up|12|||
147310162|NCT00539279|531302269|FG001|Post-Treatment Assessment|Lost to Follow-up|9|||
147310163|NCT00539279|531302268|FG000|6-Month Follow-Up Assessment|Lost to Follow-up|1|||
147310164|NCT00539279|531302269|FG001|6-Month Follow-Up Assessment|Lost to Follow-up|7|||
147310165|NCT02906683|531303803|FG000|Overall Study|Adverse Event|0|||
147310166|NCT02906683|531303804|FG001|Overall Study|Adverse Event|1|||
147310167|NCT02906683|531303805|FG002|Overall Study|Adverse Event|0|||
147310168|NCT02906683|531303803|FG000|Overall Study|Physician Decision|0|||
147310169|NCT02906683|531303804|FG001|Overall Study|Physician Decision|1|||
147555012|NCT04000009|532187892|FG000|Overall Study|Study terminated by sponsor|98|||
147106006|NCT01056276|530553727|FG001|Treatment Period-Cycles 1-8|Disease Progression|2|||
147106007|NCT01056276|530553726|FG000|Treatment Period-Cycles 1-8|Intercurrent Illness|1|||
147106008|NCT01056276|530553727|FG001|Treatment Period-Cycles 1-8|Intercurrent Illness|2|||
147310170|NCT02906683|531303805|FG002|Overall Study|Physician Decision|1|||
147310171|NCT02906683|531303803|FG000|Overall Study|Withdrawal by Subject|0|||
147310172|NCT02906683|531303804|FG001|Overall Study|Withdrawal by Subject|2|||
147310173|NCT02906683|531303805|FG002|Overall Study|Withdrawal by Subject|1|||
147310174|NCT02906683|531303803|FG000|Overall Study|Patient did not meet the eligibility criteria for the study|1|||
147555013|NCT04000009|532187892|FG000|Overall Study|Not further specified|8|||
147555014|NCT02292238|532187893|FG000|Overall Study|Protocol Violation|1|||
147555015|NCT02292238|532187894|FG001|Overall Study|Protocol Violation|2|||
147555016|NCT02292238|532187893|FG000|Overall Study|Withdrawal by Subject|2|||
147555017|NCT02292238|532187894|FG001|Overall Study|Withdrawal by Subject|1|||
147555018|NCT02292238|532187893|FG000|Overall Study|Lost to Follow-up|1|||
147555019|NCT02292238|532187894|FG001|Overall Study|Lost to Follow-up|0|||
147555020|NCT02292238|532187893|FG000|Overall Study|Physician Decision|0|||
147555021|NCT02292238|532187894|FG001|Overall Study|Physician Decision|1|||
147555022|NCT02041702|532187897|FG000|Overall Study|Lost to Follow-up|1|||
147555023|NCT02041702|532187898|FG001|Overall Study|Lost to Follow-up|6|||
147555024|NCT02041702|532187897|FG000|Overall Study|Death|4|||
147555025|NCT02041702|532187898|FG001|Overall Study|Death|0|||
147555026|NCT02041702|532187897|FG000|Overall Study|Withdrawal by Subject|4|||
147555027|NCT02041702|532187898|FG001|Overall Study|Withdrawal by Subject|3|||
147555028|NCT02041702|532187897|FG000|Overall Study|Patient not confirmed as MRI compatible|1|||
147555029|NCT02041702|532187898|FG001|Overall Study|Patient not confirmed as MRI compatible|0|||
147555030|NCT02041702|532187897|FG000|Overall Study|Cardiac Resynchronization Therapy|1|||
147555031|NCT02041702|532187898|FG001|Overall Study|Cardiac Resynchronization Therapy|0|||
147555032|NCT00203307|532187899|FG000|First Intervention|Adverse Event|2|||
147555033|NCT00203307|532187900|FG001|First Intervention|Adverse Event|0|||
147106009|NCT01056276|530553726|FG000|Treatment Period-Cycles 1-8|Physician Decision|3|||
147106010|NCT01056276|530553727|FG001|Treatment Period-Cycles 1-8|Physician Decision|0|||
147310175|NCT02906683|531303804|FG001|Overall Study|Patient did not meet the eligibility criteria for the study|0|||
147310176|NCT02906683|531303805|FG002|Overall Study|Patient did not meet the eligibility criteria for the study|0|||
147555034|NCT01618305|532187901|FG000|Overall Study|Death|0|||
147555035|NCT01618305|532187902|FG001|Overall Study|Death|1|||
147555036|NCT01618305|532187901|FG000|Overall Study|Lost to Follow-up|11|||
147310177|NCT02906683|531303803|FG000|Overall Study|Study treatment becomes impossible due to changing hospital or other reasons|0|||
147331197|NCT04771273|531377598|FG003|Maintenance Period|Adverse Event|0|||
147555037|NCT01618305|532187902|FG001|Overall Study|Lost to Follow-up|7|||
147555038|NCT01618305|532187901|FG000|Overall Study|Protocol Violation|1|||
147555039|NCT01618305|532187902|FG001|Overall Study|Protocol Violation|0|||
147555040|NCT01618305|532187901|FG000|Overall Study|Withdrawal by Subject|3|||
147555041|NCT01618305|532187902|FG001|Overall Study|Withdrawal by Subject|2|||
147555042|NCT01960816|532187903|FG000|Overall Study|Lost to Follow-up|1|||
147555043|NCT01309919|532187919|FG000|Overall Study|Did not receive a postpartum IUD|17|||
147555044|NCT01309919|532187920|FG001|Overall Study|Did not receive a postpartum IUD|48|||
147555045|NCT04583579|532189501|FG000|Overall Study|Lost to Follow-up|4|||
147555046|NCT01691508|532189502|FG000|Overall Study|Adverse Event|3|||
147555047|NCT01691508|532189503|FG001|Overall Study|Adverse Event|3|||
147555048|NCT01691508|532189502|FG000|Overall Study|Withdrawal by Subject|1|||
147555049|NCT01691508|532189503|FG001|Overall Study|Withdrawal by Subject|0|||
147555050|NCT03731182|532189506|FG000|Overall Study|Lost to Follow-up|2|||
147555051|NCT03731182|532189507|FG001|Overall Study|Lost to Follow-up|0|||
147555052|NCT03731182|532189506|FG000|Overall Study|Physician Decision|1|||
147555053|NCT03731182|532189507|FG001|Overall Study|Physician Decision|0|||
147555054|NCT03731182|532189506|FG000|Overall Study|Withdrawal By Parent/Guardian|2|||
147555055|NCT03731182|532189507|FG001|Overall Study|Withdrawal By Parent/Guardian|0|||
147555056|NCT02006706|532189508|FG000|Overall Study|Lost to Follow-up|1|||
147555057|NCT02207621|532189510|FG000|Overall Study|Adverse Event|71|||
147555058|NCT02207621|532189511|FG001|Overall Study|Adverse Event|15|||
147555059|NCT02207621|532189512|FG002|Overall Study|Adverse Event|132|||
147555060|NCT02207621|532189510|FG000|Overall Study|Withdrawal by Subject|9|||
147555061|NCT02207621|532189511|FG001|Overall Study|Withdrawal by Subject|9|||
147555062|NCT02207621|532189512|FG002|Overall Study|Withdrawal by Subject|13|||
147555063|NCT02207621|532189510|FG000|Overall Study|Non-Compliant|3|||
147555064|NCT02207621|532189511|FG001|Overall Study|Non-Compliant|3|||
147555065|NCT02207621|532189512|FG002|Overall Study|Non-Compliant|1|||
147555066|NCT02207621|532189510|FG000|Overall Study|Lost to Follow-up|1|||
147555067|NCT02207621|532189511|FG001|Overall Study|Lost to Follow-up|0|||
147555068|NCT02207621|532189512|FG002|Overall Study|Lost to Follow-up|3|||
147555069|NCT02207621|532189510|FG000|Overall Study|Lack of Efficacy|10|||
147555070|NCT02207621|532189511|FG001|Overall Study|Lack of Efficacy|2|||
147555071|NCT02207621|532189512|FG002|Overall Study|Lack of Efficacy|4|||
147555072|NCT02207621|532189510|FG000|Overall Study|Disallowed Concurrent Medication|2|||
147555073|NCT02207621|532189511|FG001|Overall Study|Disallowed Concurrent Medication|5|||
147555074|NCT02207621|532189512|FG002|Overall Study|Disallowed Concurrent Medication|2|||
147555075|NCT02207621|532189510|FG000|Overall Study|Physician Decision|1|||
147555076|NCT02207621|532189511|FG001|Overall Study|Physician Decision|2|||
147555077|NCT02207621|532189512|FG002|Overall Study|Physician Decision|2|||
147555078|NCT02207621|532189510|FG000|Overall Study|Protocol Violation|4|||
147555079|NCT02207621|532189511|FG001|Overall Study|Protocol Violation|10|||
147555080|NCT02207621|532189512|FG002|Overall Study|Protocol Violation|6|||
147555081|NCT02207621|532189510|FG000|Overall Study|Death|2|||
147555082|NCT02207621|532189511|FG001|Overall Study|Death|0|||
147555083|NCT02207621|532189512|FG002|Overall Study|Death|0|||
147555084|NCT02207621|532189510|FG000|Overall Study|Other(Site,Sponsor and Subject request)|2|||
147555085|NCT02207621|532189511|FG001|Overall Study|Other(Site,Sponsor and Subject request)|1|||
147310178|NCT02906683|531303804|FG001|Overall Study|Study treatment becomes impossible due to changing hospital or other reasons|1|||
147310179|NCT02906683|531303805|FG002|Overall Study|Study treatment becomes impossible due to changing hospital or other reasons|1|||
147310180|NCT02781506|531303806|FG000|Overall Study|Adverse Event|5|||
147310181|NCT01340482|531303808|FG000|Overall Study|Adverse Event|2|||
147310182|NCT01340482|531303809|FG001|Overall Study|Adverse Event|0|||
147310183|NCT01340482|531303810|FG002|Overall Study|Adverse Event|0|||
147310184|NCT02593539|531303811|FG000|Overall Study|Adverse Event|1|||
147310185|NCT02791490|531303815|FG000|Overall Study|Lost to Follow-up|1|||
147443913|NCT02819635|531790444|FG007|Substudy 1 and Substudy 2, Part 1|Other, not specified|0|||
147443914|NCT02819635|531790445|FG008|Substudy 1 and Substudy 2, Part 1|Other, not specified|0|||
147555086|NCT02207621|532189512|FG002|Overall Study|Other(Site,Sponsor and Subject request)|5|||
147555087|NCT00958256|532189514|FG000|Overall Study|Adverse Event|3|||
147555088|NCT03036579|532189517|FG000|2 Years|Lost to Follow-up|1|||
147555089|NCT03036579|532189518|FG001|2 Years|Lost to Follow-up|0|||
147555090|NCT03036579|532189517|FG000|3 Years|Lost to Follow-up|0|||
147555091|NCT03036579|532189518|FG001|3 Years|Lost to Follow-up|1|||
147443915|NCT02819635|531790446|FG009|Substudy 1 and Substudy 2, Part 1|Other, not specified|0|||
147443916|NCT02819635|531790447|FG010|Substudy 1 and Substudy 2, Part 1|Other, not specified|0|||
147443917|NCT02819635|531790448|FG011|Substudy 1 and Substudy 2, Part 1|Other, not specified|0|||
147443918|NCT02819635|531790437|FG000|Substudy 2, Part 2|Adverse Event|0|||
147443919|NCT02819635|531790438|FG001|Substudy 2, Part 2|Adverse Event|0|||
147443920|NCT02819635|531790439|FG002|Substudy 2, Part 2|Adverse Event|0|||
147443921|NCT02819635|531790440|FG003|Substudy 2, Part 2|Adverse Event|0|||
147443922|NCT02819635|531790441|FG004|Substudy 2, Part 2|Adverse Event|0|||
147443923|NCT02819635|531790442|FG005|Substudy 2, Part 2|Adverse Event|4|||
147443924|NCT02819635|531790443|FG006|Substudy 2, Part 2|Adverse Event|0|||
147443925|NCT02819635|531790444|FG007|Substudy 2, Part 2|Adverse Event|0|||
147555092|NCT02848599|532189519|FG000|Overall Study|Protocol Violation|7|||
147555093|NCT02848599|532189520|FG001|Overall Study|Protocol Violation|9|||
147555094|NCT05431153|532189521|FG000|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
147555095|NCT05431153|532189522|FG001|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
147555096|NCT05431153|532189523|FG002|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
147555097|NCT05431153|532189524|FG003|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
147555098|NCT05431153|532189525|FG004|Treatment Period 1 (Day 1)|Withdrawal by Subject|1|||
147555099|NCT05431153|532189526|FG005|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
147555100|NCT04828161|532189527|FG000|Overall Study|Withdrawal by Subject|0|||
147555101|NCT04828161|532189528|FG001|Overall Study|Withdrawal by Subject|3|||
147555102|NCT04828161|532189529|FG002|Overall Study|Withdrawal by Subject|3|||
147555103|NCT04828161|532189530|FG003|Overall Study|Withdrawal by Subject|4|||
147555104|NCT04828161|532189527|FG000|Overall Study|Lost to Follow-up|1|||
147555105|NCT04828161|532189528|FG001|Overall Study|Lost to Follow-up|4|||
147555106|NCT04828161|532189529|FG002|Overall Study|Lost to Follow-up|2|||
147555107|NCT04828161|532189530|FG003|Overall Study|Lost to Follow-up|2|||
147555108|NCT04828161|532189527|FG000|Overall Study|Other|2|||
147555109|NCT04828161|532189528|FG001|Overall Study|Other|0|||
147555110|NCT04828161|532189529|FG002|Overall Study|Other|2|||
147555111|NCT04828161|532189530|FG003|Overall Study|Other|0|||
147555112|NCT04828161|532189527|FG000|Overall Study|Death|0|||
147555113|NCT04828161|532189528|FG001|Overall Study|Death|0|||
147555114|NCT04828161|532189529|FG002|Overall Study|Death|0|||
147555115|NCT04828161|532189530|FG003|Overall Study|Death|2|||
147555116|NCT02352337|532189531|FG000|Overall Study|Patients never treated|4|||
147555117|NCT02352337|532189532|FG001|Overall Study|Patients never treated|1|||
147106011|NCT01056276|530553726|FG000|Treatment Period-Cycles 1-8|Death|3|||
147106012|NCT01056276|530553727|FG001|Treatment Period-Cycles 1-8|Death|1|||
147106013|NCT01056276|530553726|FG000|Treatment Period-Cycles 1-8|Lost to Follow-up|1|||
147106014|NCT01056276|530553727|FG001|Treatment Period-Cycles 1-8|Lost to Follow-up|0|||
147224746|NCT01897714|530994787|FG003|Phase I (Dose Escalation)|Disease progression|3|||
147224747|NCT01897714|530994788|FG004|Phase I (Dose Escalation)|Disease progression|0|||
147224748|NCT01897714|530994789|FG005|Phase I (Dose Escalation)|Disease progression|0|||
147224749|NCT01897714|530994784|FG000|Phase I (Dose Escalation)|Adverse Event|0|||
147224750|NCT01897714|530994785|FG001|Phase I (Dose Escalation)|Adverse Event|1|||
147224751|NCT01897714|530994786|FG002|Phase I (Dose Escalation)|Adverse Event|4|||
147224752|NCT01897714|530994787|FG003|Phase I (Dose Escalation)|Adverse Event|3|||
147224753|NCT01897714|530994788|FG004|Phase I (Dose Escalation)|Adverse Event|0|||
147224754|NCT01897714|530994789|FG005|Phase I (Dose Escalation)|Adverse Event|0|||
147224755|NCT01897714|530994784|FG000|Phase I (Dose Escalation)|Other|0|||
147224756|NCT01897714|530994785|FG001|Phase I (Dose Escalation)|Other|1|||
147224757|NCT01897714|530994786|FG002|Phase I (Dose Escalation)|Other|0|||
147224758|NCT01897714|530994787|FG003|Phase I (Dose Escalation)|Other|0|||
147224759|NCT01897714|530994788|FG004|Phase I (Dose Escalation)|Other|0|||
147224760|NCT01897714|530994789|FG005|Phase I (Dose Escalation)|Other|0|||
147224761|NCT01897714|530994784|FG000|Phase II (MTD)|Withdrawal by Subject|0|||
147224762|NCT01897714|530994785|FG001|Phase II (MTD)|Withdrawal by Subject|0|||
147224763|NCT01897714|530994786|FG002|Phase II (MTD)|Withdrawal by Subject|0|||
147224764|NCT01897714|530994787|FG003|Phase II (MTD)|Withdrawal by Subject|0|||
147224765|NCT01897714|530994788|FG004|Phase II (MTD)|Withdrawal by Subject|0|||
147224766|NCT01897714|530994789|FG005|Phase II (MTD)|Withdrawal by Subject|1|||
147224767|NCT01897714|530994784|FG000|Phase II (MTD)|Lost to Follow-up|0|||
147224768|NCT01897714|530994785|FG001|Phase II (MTD)|Lost to Follow-up|0|||
147224769|NCT01897714|530994786|FG002|Phase II (MTD)|Lost to Follow-up|0|||
147224770|NCT01897714|530994787|FG003|Phase II (MTD)|Lost to Follow-up|0|||
147443926|NCT02819635|531790445|FG008|Substudy 2, Part 2|Adverse Event|0|||
147443927|NCT02819635|531790446|FG009|Substudy 2, Part 2|Adverse Event|0|||
147443928|NCT02819635|531790447|FG010|Substudy 2, Part 2|Adverse Event|0|||
147443929|NCT02819635|531790448|FG011|Substudy 2, Part 2|Adverse Event|0|||
147443930|NCT02819635|531790437|FG000|Substudy 2, Part 2|Withdrew consent|0|||
147443931|NCT02819635|531790438|FG001|Substudy 2, Part 2|Withdrew consent|0|||
147555118|NCT02352337|532189533|FG002|Overall Study|Patients never treated|2|||
147555119|NCT02458638|532189534|FG000|Overall Study|Death|309|||
147106015|NCT01056276|530553726|FG000|Maintenance Therapy|Toxicity|0|||
147224771|NCT01897714|530994788|FG004|Phase II (MTD)|Lost to Follow-up|1|||
147224772|NCT01897714|530994789|FG005|Phase II (MTD)|Lost to Follow-up|0|||
147224773|NCT01897714|530994784|FG000|Phase II (MTD)|Death|0|||
147224774|NCT01897714|530994785|FG001|Phase II (MTD)|Death|0|||
147224775|NCT01897714|530994786|FG002|Phase II (MTD)|Death|0|||
147443932|NCT02819635|531790439|FG002|Substudy 2, Part 2|Withdrew consent|0|||
147224776|NCT01897714|530994787|FG003|Phase II (MTD)|Death|0|||
147443933|NCT02819635|531790440|FG003|Substudy 2, Part 2|Withdrew consent|0|||
147555120|NCT02458638|532189534|FG000|Overall Study|End of Cohort/End of Study|67|||
147555121|NCT02458638|532189534|FG000|Overall Study|Lost to Follow-up|31|||
147224777|NCT01897714|530994788|FG004|Phase II (MTD)|Death|25|||
147224778|NCT01897714|530994789|FG005|Phase II (MTD)|Death|10|||
147555122|NCT02458638|532189534|FG000|Overall Study|Other Reasons|4|||
147224779|NCT01897714|530994784|FG000|Phase II (MTD)|Study terminated with patient alive|0|||
147106016|NCT01056276|530553727|FG001|Maintenance Therapy|Toxicity|2|||
147555123|NCT02458638|532189534|FG000|Overall Study|Physician Decision|1|||
147555124|NCT02458638|532189534|FG000|Overall Study|Withdrawal by Subject|47|||
147555125|NCT00135707|532189545|FG000|Overall Study|Lost to Follow-up|94|||
147555126|NCT00135707|532189546|FG001|Overall Study|Lost to Follow-up|89|||
147555127|NCT00135707|532189545|FG000|Overall Study|Withdrawal by Subject|0|||
147555128|NCT00135707|532189546|FG001|Overall Study|Withdrawal by Subject|1|||
147555129|NCT00135707|532189545|FG000|Overall Study|Institutional review board request|1|||
147555130|NCT00135707|532189546|FG001|Overall Study|Institutional review board request|0|||
147555131|NCT03093454|532189549|FG000|Overall Study|Withdrawal by Subject|1|||
147555132|NCT03093454|532189550|FG001|Overall Study|Withdrawal by Subject|1|||
147555133|NCT03093454|532189549|FG000|Overall Study|Scheduling conflict|3|||
147555134|NCT03093454|532189550|FG001|Overall Study|Scheduling conflict|1|||
147555135|NCT03093454|532189549|FG000|Overall Study|Physician Decision|2|||
147555136|NCT03093454|532189550|FG001|Overall Study|Physician Decision|1|||
147555137|NCT04540497|532189551|FG000|Overall Study|Adverse Event|0|||
147555138|NCT04540497|532189552|FG001|Overall Study|Adverse Event|2|||
147555139|NCT04540497|532189551|FG000|Overall Study|Lost to Follow-up|1|||
147555140|NCT04540497|532189552|FG001|Overall Study|Lost to Follow-up|0|||
147555141|NCT04540497|532189551|FG000|Overall Study|Withdrawal by Subject|1|||
147555142|NCT04540497|532189552|FG001|Overall Study|Withdrawal by Subject|1|||
147555143|NCT04540497|532189551|FG000|Overall Study|Miscellaneous|2|||
147555144|NCT04540497|532189552|FG001|Overall Study|Miscellaneous|1|||
147555145|NCT00421174|532189554|FG000|Overall Study|Withdrawal by Subject|0|||
147555146|NCT00421174|532189555|FG001|Overall Study|Withdrawal by Subject|1|||
147555147|NCT00421174|532189554|FG000|Overall Study|Ineligible due to infection|2|||
147555148|NCT00421174|532189555|FG001|Overall Study|Ineligible due to infection|0|||
147555149|NCT01829464|532189559|FG000|Overall Study|Adverse Event|1|||
147555150|NCT01829464|532189560|FG001|Overall Study|Adverse Event|0|||
147555151|NCT01829464|532189561|FG002|Overall Study|Adverse Event|0|||
147555152|NCT01829464|532189559|FG000|Overall Study|Lost to Follow-up|0|||
147555153|NCT01829464|532189560|FG001|Overall Study|Lost to Follow-up|0|||
147555154|NCT01829464|532189561|FG002|Overall Study|Lost to Follow-up|1|||
147555155|NCT01829464|532189559|FG000|Overall Study|Withdrawal by Subject|2|||
147555156|NCT01829464|532189560|FG001|Overall Study|Withdrawal by Subject|0|||
147555157|NCT01829464|532189561|FG002|Overall Study|Withdrawal by Subject|0|||
147555158|NCT01829464|532189559|FG000|Overall Study|Study terminated by sponsor|25|||
147555159|NCT01829464|532189560|FG001|Overall Study|Study terminated by sponsor|28|||
147555160|NCT01829464|532189561|FG002|Overall Study|Study terminated by sponsor|25|||
147555161|NCT01829464|532189559|FG000|Overall Study|Lack of Efficacy|0|||
147555162|NCT01829464|532189560|FG001|Overall Study|Lack of Efficacy|1|||
147310186|NCT02791490|531303816|FG001|Overall Study|Lost to Follow-up|2|||
147310187|NCT02791490|531303815|FG000|Overall Study|Withdrawal by Subject|2|||
147310188|NCT02791490|531303816|FG001|Overall Study|Withdrawal by Subject|6|||
147310189|NCT01189890|531303817|FG000|Overall Study|Adverse Event|3|||
147555163|NCT01829464|532189561|FG002|Overall Study|Lack of Efficacy|0|||
147555164|NCT00992407|532189564|FG000|Overall Study|Protocol Violation|2|||
147555165|NCT00992407|532189565|FG001|Overall Study|Protocol Violation|1|||
147555166|NCT00992407|532189564|FG000|Overall Study|Lost to Follow-up|3|||
147310190|NCT01189890|531303818|FG001|Overall Study|Adverse Event|4|||
147310191|NCT01189890|531303817|FG000|Overall Study|Lack of Efficacy|7|||
147310192|NCT01189890|531303818|FG001|Overall Study|Lack of Efficacy|2|||
147310193|NCT01189890|531303817|FG000|Overall Study|Lost to Follow-up|1|||
147310194|NCT01189890|531303818|FG001|Overall Study|Lost to Follow-up|7|||
147310195|NCT01189890|531303817|FG000|Overall Study|Protocol Violation|1|||
147310196|NCT01189890|531303818|FG001|Overall Study|Protocol Violation|5|||
147310197|NCT01189890|531303817|FG000|Overall Study|Withdrawal by Subject|15|||
147310198|NCT01189890|531303818|FG001|Overall Study|Withdrawal by Subject|11|||
147310199|NCT01189890|531303817|FG000|Overall Study|Non Compliance|0|||
147310200|NCT01189890|531303818|FG001|Overall Study|Non Compliance|1|||
147555167|NCT00992407|532189565|FG001|Overall Study|Lost to Follow-up|3|||
147555168|NCT00992407|532189564|FG000|Overall Study|Adverse Event|3|||
147555169|NCT00992407|532189565|FG001|Overall Study|Adverse Event|2|||
147555170|NCT00992407|532189564|FG000|Overall Study|protocol Violation & Adverse events|2|||
147555171|NCT00992407|532189565|FG001|Overall Study|protocol Violation & Adverse events|4|||
147555172|NCT00992407|532189564|FG000|Overall Study|Other|2|||
147555173|NCT00992407|532189565|FG001|Overall Study|Other|0|||
147555174|NCT00992407|532189564|FG000|Overall Study|Loss of follow-up & Adverse events|2|||
147555175|NCT00992407|532189565|FG001|Overall Study|Loss of follow-up & Adverse events|1|||
147310201|NCT01189890|531303817|FG000|Overall Study|Physician Decision|5|||
147310202|NCT01189890|531303818|FG001|Overall Study|Physician Decision|4|||
147555176|NCT00992407|532189564|FG000|Overall Study|Study medication not administered|17|||
147555177|NCT00992407|532189565|FG001|Overall Study|Study medication not administered|13|||
147555178|NCT04700449|532189570|FG000|Stage 1: Double-Blind Period|Adverse Event|5|||
147310203|NCT01189890|531303817|FG000|Overall Study|Hyperglycemia Discontinuation Criteria|5|||
147310204|NCT01189890|531303818|FG001|Overall Study|Hyperglycemia Discontinuation Criteria|5|||
147555179|NCT04700449|532189571|FG001|Stage 1: Double-Blind Period|Adverse Event|0|||
147310205|NCT00077636|531303819|FG000|Overall Study|Refused Treatment|9|||
147555180|NCT04700449|532189572|FG002|Stage 1: Double-Blind Period|Adverse Event|1|||
147555181|NCT04700449|532189573|FG003|Stage 1: Double-Blind Period|Adverse Event|0|||
147555182|NCT04700449|532189570|FG000|Stage 1: Double-Blind Period|Protocol Violation|0|||
147555183|NCT04700449|532189571|FG001|Stage 1: Double-Blind Period|Protocol Violation|1|||
147555184|NCT04700449|532189572|FG002|Stage 1: Double-Blind Period|Protocol Violation|0|||
147555185|NCT04700449|532189573|FG003|Stage 1: Double-Blind Period|Protocol Violation|0|||
147555186|NCT04700449|532189570|FG000|Stage 1: Double-Blind Period|Withdrawal by Subject|2|||
147555187|NCT04700449|532189571|FG001|Stage 1: Double-Blind Period|Withdrawal by Subject|2|||
147555188|NCT04700449|532189572|FG002|Stage 1: Double-Blind Period|Withdrawal by Subject|2|||
147555189|NCT04700449|532189573|FG003|Stage 1: Double-Blind Period|Withdrawal by Subject|0|||
147555190|NCT04700449|532189570|FG000|Stage 1: Double-Blind Period|Lack of Efficacy|1|||
147555191|NCT04700449|532189571|FG001|Stage 1: Double-Blind Period|Lack of Efficacy|0|||
147555192|NCT04700449|532189572|FG002|Stage 1: Double-Blind Period|Lack of Efficacy|0|||
147555193|NCT04700449|532189573|FG003|Stage 1: Double-Blind Period|Lack of Efficacy|0|||
147555194|NCT04700449|532189570|FG000|Stage 1: Double-Blind Period|COVID-19 Restriction|3|||
147555195|NCT04700449|532189571|FG001|Stage 1: Double-Blind Period|COVID-19 Restriction|0|||
147555196|NCT04700449|532189572|FG002|Stage 1: Double-Blind Period|COVID-19 Restriction|1|||
147555197|NCT04700449|532189573|FG003|Stage 1: Double-Blind Period|COVID-19 Restriction|0|||
147555198|NCT04700449|532189570|FG000|Stage 1: Double-Blind Period|Other|0|||
147555199|NCT04700449|532189571|FG001|Stage 1: Double-Blind Period|Other|0|||
147555200|NCT04700449|532189572|FG002|Stage 1: Double-Blind Period|Other|1|||
147555201|NCT04700449|532189573|FG003|Stage 1: Double-Blind Period|Other|0|||
147555202|NCT04700449|532189570|FG000|Stage 2 Sub-study 1|Adverse Event|0|||
147555203|NCT04700449|532189571|FG001|Stage 2 Sub-study 1|Adverse Event|1|||
147555204|NCT04700449|532189572|FG002|Stage 2 Sub-study 1|Adverse Event|0|||
147555205|NCT04700449|532189573|FG003|Stage 2 Sub-study 1|Adverse Event|0|||
147555206|NCT04700449|532189570|FG000|Stage 2 Sub-study 1|Withdrawal by Subject|1|||
147555207|NCT04700449|532189571|FG001|Stage 2 Sub-study 1|Withdrawal by Subject|1|||
147555208|NCT04700449|532189572|FG002|Stage 2 Sub-study 1|Withdrawal by Subject|1|||
147555209|NCT04700449|532189573|FG003|Stage 2 Sub-study 1|Withdrawal by Subject|0|||
147555210|NCT04700449|532189570|FG000|Stage 2 Sub-study 1|Lack of Efficacy|0|||
147555211|NCT04700449|532189571|FG001|Stage 2 Sub-study 1|Lack of Efficacy|0|||
147555212|NCT04700449|532189572|FG002|Stage 2 Sub-study 1|Lack of Efficacy|2|||
147555213|NCT04700449|532189573|FG003|Stage 2 Sub-study 1|Lack of Efficacy|0|||
147555214|NCT04700449|532189570|FG000|Stage 2 Sub-study 1|COVID-19 Restriction|0|||
147555215|NCT04700449|532189571|FG001|Stage 2 Sub-study 1|COVID-19 Restriction|0|||
147555216|NCT04700449|532189572|FG002|Stage 2 Sub-study 1|COVID-19 Restriction|1|||
147555217|NCT04700449|532189573|FG003|Stage 2 Sub-study 1|COVID-19 Restriction|0|||
147555218|NCT04700449|532189570|FG000|Stage 2 Sub-study 1|Other|1|||
147555219|NCT04700449|532189571|FG001|Stage 2 Sub-study 1|Other|2|||
147555220|NCT04700449|532189572|FG002|Stage 2 Sub-study 1|Other|0|||
147555221|NCT04700449|532189573|FG003|Stage 2 Sub-study 1|Other|0|||
147555222|NCT04700449|532189570|FG000|Stage 2 Sub-study 2|Adverse Event|0|||
147555223|NCT04700449|532189571|FG001|Stage 2 Sub-study 2|Adverse Event|0|||
147310206|NCT00077636|531303820|FG001|Overall Study|Refused Treatment|31|||
147310207|NCT00077636|531303819|FG000|Overall Study|Admin|3|||
147310208|NCT00077636|531303820|FG001|Overall Study|Admin|3|||
147555224|NCT04700449|532189572|FG002|Stage 2 Sub-study 2|Adverse Event|0|||
147555225|NCT04700449|532189573|FG003|Stage 2 Sub-study 2|Adverse Event|7|||
147555226|NCT04700449|532189570|FG000|Stage 2 Sub-study 2|Lost to Follow-up|0|||
147555227|NCT04700449|532189571|FG001|Stage 2 Sub-study 2|Lost to Follow-up|0|||
147555228|NCT04700449|532189572|FG002|Stage 2 Sub-study 2|Lost to Follow-up|0|||
147555229|NCT04700449|532189573|FG003|Stage 2 Sub-study 2|Lost to Follow-up|1|||
147555230|NCT04700449|532189570|FG000|Stage 2 Sub-study 2|Lack of Efficacy|0|||
147555231|NCT04700449|532189571|FG001|Stage 2 Sub-study 2|Lack of Efficacy|0|||
147555232|NCT04700449|532189572|FG002|Stage 2 Sub-study 2|Lack of Efficacy|0|||
147555233|NCT04700449|532189573|FG003|Stage 2 Sub-study 2|Lack of Efficacy|9|||
147555234|NCT04700449|532189570|FG000|Stage 2 Sub-study 2|COVID-19 Restriction|0|||
147555235|NCT04700449|532189571|FG001|Stage 2 Sub-study 2|COVID-19 Restriction|0|||
147224780|NCT01897714|530994785|FG001|Phase II (MTD)|Study terminated with patient alive|0|||
147224781|NCT01897714|530994786|FG002|Phase II (MTD)|Study terminated with patient alive|0|||
147224782|NCT01897714|530994787|FG003|Phase II (MTD)|Study terminated with patient alive|0|||
147224783|NCT01897714|530994788|FG004|Phase II (MTD)|Study terminated with patient alive|1|||
147224784|NCT01897714|530994789|FG005|Phase II (MTD)|Study terminated with patient alive|0|||
147224785|NCT01897714|530994784|FG000|Phase II (MTD)|Other|0|||
147224786|NCT01897714|530994785|FG001|Phase II (MTD)|Other|0|||
147224787|NCT01897714|530994786|FG002|Phase II (MTD)|Other|0|||
147224788|NCT01897714|530994787|FG003|Phase II (MTD)|Other|0|||
147224789|NCT01897714|530994788|FG004|Phase II (MTD)|Other|3|||
147224790|NCT01897714|530994789|FG005|Phase II (MTD)|Other|0|||
147224791|NCT01994590|530994790|FG000|Overall Study|Adverse Event|1|||
147310209|NCT00077636|531303819|FG000|Overall Study|Withdrawal by Subject|2|||
147555236|NCT04700449|532189572|FG002|Stage 2 Sub-study 2|COVID-19 Restriction|0|||
147555237|NCT04700449|532189573|FG003|Stage 2 Sub-study 2|COVID-19 Restriction|1|||
147310210|NCT00077636|531303820|FG001|Overall Study|Withdrawal by Subject|2|||
147555238|NCT04700449|532189570|FG000|Stage 2 Sub-study 2|Other|0|||
147555239|NCT04700449|532189571|FG001|Stage 2 Sub-study 2|Other|0|||
147555240|NCT04700449|532189572|FG002|Stage 2 Sub-study 2|Other|0|||
147555241|NCT04700449|532189573|FG003|Stage 2 Sub-study 2|Other|5|||
147555242|NCT03738332|532189574|FG000|Overall Study|Withdrawal by Subject|1|||
147555243|NCT02336737|532189575|FG000|Overall Study|Withdrawal by Subject|5|||
147555244|NCT02336737|532189575|FG000|Overall Study|Physician Decision|8|||
147555245|NCT02396381|532189576|FG000|Overall Study|Adverse Event|3|||
147555246|NCT02396381|532189577|FG001|Overall Study|Adverse Event|2|||
147555247|NCT02396381|532189576|FG000|Overall Study|Withdrawal by Subject|33|||
147555248|NCT02396381|532189577|FG001|Overall Study|Withdrawal by Subject|24|||
147555249|NCT02396381|532189576|FG000|Overall Study|Lost to Follow-up|49|||
147555250|NCT02396381|532189577|FG001|Overall Study|Lost to Follow-up|31|||
147555251|NCT02396381|532189576|FG000|Overall Study|Protocol Violation|1|||
147555252|NCT02396381|532189577|FG001|Overall Study|Protocol Violation|0|||
147555253|NCT02396381|532189576|FG000|Overall Study|Site terminated by sponsor|7|||
147555254|NCT02396381|532189577|FG001|Overall Study|Site terminated by sponsor|8|||
147555255|NCT02396381|532189576|FG000|Overall Study|Physician Decision|5|||
147555256|NCT02396381|532189577|FG001|Overall Study|Physician Decision|5|||
147555257|NCT02396381|532189576|FG000|Overall Study|Pregnancy|2|||
147555258|NCT02396381|532189577|FG001|Overall Study|Pregnancy|0|||
147555259|NCT02396381|532189576|FG000|Overall Study|Non-compliance with study procedures|1|||
147555260|NCT02396381|532189577|FG001|Overall Study|Non-compliance with study procedures|0|||
147224792|NCT01994590|530994790|FG000|Overall Study|Trial Terminated|1|||
147224793|NCT01801072|530994791|FG000|Overall Study|Lost to Follow-up|17|||
147224794|NCT01801072|530994792|FG001|Overall Study|Lost to Follow-up|14|||
147224795|NCT01801072|530994791|FG000|Overall Study|Physician Decision|2|||
147224796|NCT01801072|530994792|FG001|Overall Study|Physician Decision|3|||
147224797|NCT01801072|530994791|FG000|Overall Study|Withdrawal by Subject|1|||
147224798|NCT01801072|530994792|FG001|Overall Study|Withdrawal by Subject|0|||
147224799|NCT01801072|530994791|FG000|Overall Study|Protocol Violation|2|||
147224800|NCT01801072|530994792|FG001|Overall Study|Protocol Violation|0|||
147224801|NCT01801072|530994791|FG000|Overall Study|Death|7|||
147224802|NCT01801072|530994792|FG001|Overall Study|Death|8|||
147224803|NCT03693170|530994793|FG000|Overall Study|Disease Progression|48|||
147224804|NCT03693170|530994793|FG000|Overall Study|Adverse Event|16|||
147224805|NCT03693170|530994793|FG000|Overall Study|Physician Decision|6|||
147224806|NCT03693170|530994793|FG000|Overall Study|Protocol Violation|2|||
147224807|NCT03693170|530994793|FG000|Overall Study|Death|1|||
147224808|NCT03693170|530994793|FG000|Overall Study|Non compliance with study drug|1|||
147224809|NCT03693170|530994793|FG000|Overall Study|Withdrawal by Subject|1|||
147224810|NCT00053365|530994794|FG000|Overall Study|Incorrect cell type|1|||
147224811|NCT00053365|530994794|FG000|Overall Study|Platinum-sensitive interval >12 months|1|||
147224812|NCT00053365|530994794|FG000|Overall Study|Never treated|4|||
147224813|NCT03183778|530994797|FG000|Overall Study|Withdrawn by Investigator (potassium in normal range)|1|||
147224814|NCT00721123|530994799|FG000|Overall Study|Adverse Event|96|||
147224815|NCT00721123|530994799|FG000|Overall Study|Death|10|||
147224816|NCT00721123|530994799|FG000|Overall Study|Insufficient Therapeutic Response|21|||
147224817|NCT00721123|530994799|FG000|Overall Study|Protocol Violation|1|||
147224818|NCT00721123|530994799|FG000|Overall Study|Refused Treatment|41|||
147224819|NCT00721123|530994799|FG000|Overall Study|Failure to Return|9|||
147224820|NCT00721123|530994799|FG000|Overall Study|Withdrawal by Subject|5|||
147224821|NCT03228420|530994812|FG000|Overall Study|Lost to Follow-up|5|||
147224822|NCT03228420|530994813|FG001|Overall Study|Lost to Follow-up|3|||
147224823|NCT03228420|530994812|FG000|Overall Study|Withdrawal by Subject|10|||
147224824|NCT03228420|530994813|FG001|Overall Study|Withdrawal by Subject|0|||
147224825|NCT03228420|530994812|FG000|Overall Study|Adverse Event|5|||
147224826|NCT03228420|530994813|FG001|Overall Study|Adverse Event|2|||
147224827|NCT03954041|530994816|FG000|Overall Study|Lost to Follow-up|3|||
147224828|NCT03954041|530994817|FG001|Overall Study|Lost to Follow-up|3|||
147224829|NCT03954041|530994818|FG002|Overall Study|Lost to Follow-up|6|||
147224830|NCT03954041|530994816|FG000|Overall Study|Death|4|||
147224831|NCT03954041|530994817|FG001|Overall Study|Death|0|||
147224832|NCT03954041|530994818|FG002|Overall Study|Death|1|||
147224833|NCT03954041|530994816|FG000|Overall Study|Death by neurologic criteria|0|||
147224834|NCT03954041|530994817|FG001|Overall Study|Death by neurologic criteria|0|||
147224835|NCT03954041|530994818|FG002|Overall Study|Death by neurologic criteria|1|||
147224836|NCT03954041|530994816|FG000|Overall Study|Reason not specified|7|||
147224837|NCT03954041|530994817|FG001|Overall Study|Reason not specified|4|||
147224838|NCT03954041|530994818|FG002|Overall Study|Reason not specified|2|||
147224839|NCT03954041|530994816|FG000|Overall Study|Withdrew prior to dosing|4|||
147224840|NCT03954041|530994817|FG001|Overall Study|Withdrew prior to dosing|2|||
147224841|NCT03954041|530994818|FG002|Overall Study|Withdrew prior to dosing|0|||
147224842|NCT03868124|530994821|FG000|Overall Study|Withdrawal by Subject|4|||
147224843|NCT03868124|530994822|FG001|Overall Study|Withdrawal by Subject|0|||
147224844|NCT03868124|530994823|FG002|Overall Study|Withdrawal by Subject|1|||
147224845|NCT03868124|530994821|FG000|Overall Study|Physician Decision|1|||
147224846|NCT03868124|530994822|FG001|Overall Study|Physician Decision|0|||
147555261|NCT02396381|532189576|FG000|Overall Study|Moved out of town/state|1|||
147555262|NCT02396381|532189577|FG001|Overall Study|Moved out of town/state|3|||
147555263|NCT02396381|532189576|FG000|Overall Study|Could not complete visit|1|||
147555264|NCT02396381|532189577|FG001|Overall Study|Could not complete visit|0|||
147555265|NCT02396381|532189576|FG000|Overall Study|Possible conflict of interest|1|||
147555266|NCT02396381|532189577|FG001|Overall Study|Possible conflict of interest|0|||
147555267|NCT02396381|532189576|FG000|Overall Study|Randomization/Screening Error|3|||
147555268|NCT02396381|532189577|FG001|Overall Study|Randomization/Screening Error|1|||
147555269|NCT00356200|532189579|FG000|Cohort 1: 10 ug/ml|Lack of Efficacy|1|||
147555270|NCT00356200|532189580|FG001|Cohort 1: 10 ug/ml|Lack of Efficacy|0|||
147555271|NCT00356200|532189579|FG000|Cohort 2: 100 ug/ml (New Patients)|Lack of Efficacy|0|||
147555272|NCT00356200|532189580|FG001|Cohort 2: 100 ug/ml (New Patients)|Lack of Efficacy|2|||
147555273|NCT00635778|532189581|FG000|Overall Study|Adverse Event|1|||
147555274|NCT00635778|532189582|FG001|Overall Study|Adverse Event|0|||
147555275|NCT00635778|532189583|FG002|Overall Study|Adverse Event|0|||
147555276|NCT00635778|532189584|FG003|Overall Study|Adverse Event|3|||
147555277|NCT00635778|532189585|FG004|Overall Study|Adverse Event|3|||
147555278|NCT00635778|532189586|FG005|Overall Study|Adverse Event|6|||
147555279|NCT00635778|532189587|FG006|Overall Study|Adverse Event|1|||
147555280|NCT00635778|532189581|FG000|Overall Study|Withdrawal by Subject|0|||
147555281|NCT00635778|532189582|FG001|Overall Study|Withdrawal by Subject|0|||
147555282|NCT00635778|532189583|FG002|Overall Study|Withdrawal by Subject|0|||
147555283|NCT00635778|532189584|FG003|Overall Study|Withdrawal by Subject|1|||
147555284|NCT00635778|532189585|FG004|Overall Study|Withdrawal by Subject|0|||
147555285|NCT00635778|532189586|FG005|Overall Study|Withdrawal by Subject|1|||
147555286|NCT00635778|532189587|FG006|Overall Study|Withdrawal by Subject|1|||
147555287|NCT00635778|532189581|FG000|Overall Study|Progressive disease|0|||
147555288|NCT00635778|532189582|FG001|Overall Study|Progressive disease|3|||
147555289|NCT00635778|532189583|FG002|Overall Study|Progressive disease|3|||
147555290|NCT00635778|532189584|FG003|Overall Study|Progressive disease|4|||
147555291|NCT00635778|532189585|FG004|Overall Study|Progressive disease|5|||
147555292|NCT00635778|532189586|FG005|Overall Study|Progressive disease|14|||
147555293|NCT00635778|532189587|FG006|Overall Study|Progressive disease|4|||
147555294|NCT01000337|532189593|FG000|Overall Study|Lost to Follow-up|4|||
147555295|NCT01000337|532189594|FG001|Overall Study|Lost to Follow-up|3|||
147555296|NCT02227862|532189595|FG000|Overall Study|Protocol Violation|7|||
147555297|NCT02227862|532189596|FG001|Overall Study|Protocol Violation|9|||
147555298|NCT02227862|532189595|FG000|Overall Study|Other|0|||
147555299|NCT02227862|532189596|FG001|Overall Study|Other|2|||
147555300|NCT02227862|532189595|FG000|Overall Study|Adverse Event|4|||
147555301|NCT02227862|532189596|FG001|Overall Study|Adverse Event|3|||
147555302|NCT02227862|532189595|FG000|Overall Study|Withdrawal by Subject|7|||
147555303|NCT02227862|532189596|FG001|Overall Study|Withdrawal by Subject|6|||
147555304|NCT02227862|532189595|FG000|Overall Study|Lost to Follow-up|1|||
147555305|NCT02227862|532189596|FG001|Overall Study|Lost to Follow-up|2|||
147555306|NCT01612000|532189598|FG000|Overall Study|Lost to Follow-up|6|||
147555307|NCT01612000|532189599|FG001|Overall Study|Lost to Follow-up|4|||
147555308|NCT01612000|532189600|FG002|Overall Study|Lost to Follow-up|4|||
147555309|NCT01612000|532189601|FG003|Overall Study|Lost to Follow-up|8|||
147555310|NCT01612000|532189598|FG000|Overall Study|Physician Decision|0|||
147555311|NCT01612000|532189599|FG001|Overall Study|Physician Decision|0|||
147555312|NCT01612000|532189600|FG002|Overall Study|Physician Decision|1|||
147555313|NCT01612000|532189601|FG003|Overall Study|Physician Decision|0|||
147555314|NCT01612000|532189598|FG000|Overall Study|Withdrawal by Subject|3|||
147555315|NCT01612000|532189599|FG001|Overall Study|Withdrawal by Subject|1|||
147555316|NCT01612000|532189600|FG002|Overall Study|Withdrawal by Subject|2|||
147555317|NCT01612000|532189601|FG003|Overall Study|Withdrawal by Subject|2|||
147555318|NCT02173704|532189602|FG000|Overall Study|Adverse Event|1|||
147555319|NCT02173704|532189603|FG001|Overall Study|Adverse Event|0|||
147555320|NCT02173704|532189602|FG000|Overall Study|Lost to Follow-up|1|||
147555321|NCT02173704|532189603|FG001|Overall Study|Lost to Follow-up|0|||
147555322|NCT02173704|532189602|FG000|Overall Study|Other|1|||
147555323|NCT02173704|532189603|FG001|Overall Study|Other|0|||
147555324|NCT02173704|532189602|FG000|Overall Study|Protocol Violation|1|||
147555325|NCT02173704|532189603|FG001|Overall Study|Protocol Violation|0|||
147555326|NCT02173704|532189602|FG000|Overall Study|Withdrawal by Subject|9|||
147555327|NCT02173704|532189603|FG001|Overall Study|Withdrawal by Subject|4|||
147555328|NCT00419926|532189604|FG000|Overall Study|Withdrawal by Subject|7|||
147555329|NCT00419926|532189605|FG001|Overall Study|Withdrawal by Subject|3|||
147555330|NCT00419926|532189604|FG000|Overall Study|Administrative Problem|4|||
147555331|NCT00419926|532189605|FG001|Overall Study|Administrative Problem|4|||
147555332|NCT00419926|532189604|FG000|Overall Study|Lost to Follow-up|1|||
147224847|NCT03868124|530994823|FG002|Overall Study|Physician Decision|1|||
147224848|NCT03868124|530994821|FG000|Overall Study|Lost to Follow-up|1|||
147555333|NCT00419926|532189605|FG001|Overall Study|Lost to Follow-up|2|||
147555334|NCT00419926|532189604|FG000|Overall Study|Death|2|||
147555335|NCT00419926|532189605|FG001|Overall Study|Death|1|||
147555336|NCT01180244|532189616|FG000|Overall Study|Lack of Efficacy|0|||
147555337|NCT01180244|532189617|FG001|Overall Study|Lack of Efficacy|7|||
147555338|NCT01180244|532189616|FG000|Overall Study|Physician Decision|3|||
147555339|NCT01180244|532189617|FG001|Overall Study|Physician Decision|0|||
147555340|NCT01180244|532189616|FG000|Overall Study|Adverse Event|1|||
147555341|NCT01180244|532189617|FG001|Overall Study|Adverse Event|0|||
147555342|NCT01180244|532189616|FG000|Overall Study|Withdrawal by Subject|0|||
147555343|NCT01180244|532189617|FG001|Overall Study|Withdrawal by Subject|1|||
147555344|NCT01180244|532189616|FG000|Overall Study|Protocol Violation|1|||
147555345|NCT01180244|532189617|FG001|Overall Study|Protocol Violation|0|||
147555346|NCT01180244|532189616|FG000|Overall Study|Lost to Follow-up|1|||
147555347|NCT01180244|532189617|FG001|Overall Study|Lost to Follow-up|0|||
147555348|NCT00620763|532189620|FG000|Period: First Intervention|Withdrawal by Subject|0|||
147555349|NCT00620763|532189621|FG001|Period: First Intervention|Withdrawal by Subject|2|||
147555350|NCT00620763|532189620|FG000|Period: First Intervention|Protocol Violation|0|||
147555351|NCT00620763|532189621|FG001|Period: First Intervention|Protocol Violation|3|||
147555352|NCT00620763|532189620|FG000|Period: Second Intervention|Withdrawal by Subject|1|||
147555353|NCT00620763|532189621|FG001|Period: Second Intervention|Withdrawal by Subject|0|||
147555354|NCT01595009|532189622|FG000|Core|Patients completed per protocol|85|||
147555355|NCT01595009|532189623|FG001|Core|Patients completed per protocol|44|||
147555356|NCT01595009|532189624|FG002|Core|Patients completed per protocol|0|||
147555357|NCT01595009|532189625|FG003|Core|Patients completed per protocol|0|||
147555358|NCT01595009|532189622|FG000|Core|Adverse Event|19|||
147555359|NCT01595009|532189623|FG001|Core|Adverse Event|23|||
147555360|NCT01595009|532189624|FG002|Core|Adverse Event|0|||
147555361|NCT01595009|532189625|FG003|Core|Adverse Event|0|||
147555362|NCT01595009|532189622|FG000|Core|Disease progression|14|||
147555363|NCT01595009|532189623|FG001|Core|Disease progression|26|||
147555364|NCT01595009|532189624|FG002|Core|Disease progression|0|||
147555365|NCT01595009|532189625|FG003|Core|Disease progression|0|||
147555366|NCT01595009|532189622|FG000|Core|Withdrawal by Subject|4|||
147555367|NCT01595009|532189623|FG001|Core|Withdrawal by Subject|17|||
147555368|NCT01595009|532189624|FG002|Core|Withdrawal by Subject|0|||
147555369|NCT01595009|532189625|FG003|Core|Withdrawal by Subject|0|||
147555370|NCT01595009|532189622|FG000|Core|Death|3|||
147555371|NCT01595009|532189623|FG001|Core|Death|6|||
147555372|NCT01595009|532189624|FG002|Core|Death|0|||
147555373|NCT01595009|532189625|FG003|Core|Death|0|||
147555374|NCT01595009|532189622|FG000|Core|Lost to Follow-up|1|||
147555375|NCT01595009|532189623|FG001|Core|Lost to Follow-up|2|||
147555376|NCT01595009|532189624|FG002|Core|Lost to Follow-up|0|||
147555377|NCT01595009|532189625|FG003|Core|Lost to Follow-up|0|||
147555378|NCT01595009|532189622|FG000|Core|Protocol deviation|0|||
147555379|NCT01595009|532189623|FG001|Core|Protocol deviation|1|||
147555380|NCT01595009|532189624|FG002|Core|Protocol deviation|0|||
147555381|NCT01595009|532189625|FG003|Core|Protocol deviation|0|||
147555382|NCT01595009|532189622|FG000|Core|Administrative problems|0|||
147555383|NCT01595009|532189623|FG001|Core|Administrative problems|1|||
147555384|NCT01595009|532189624|FG002|Core|Administrative problems|0|||
147555385|NCT01595009|532189625|FG003|Core|Administrative problems|0|||
147555386|NCT01595009|532189622|FG000|Extension|Administrative problems|0|||
147555387|NCT01595009|532189623|FG001|Extension|Administrative problems|0|||
147555388|NCT01595009|532189624|FG002|Extension|Administrative problems|0|||
147555389|NCT01595009|532189625|FG003|Extension|Administrative problems|1|||
147555390|NCT01595009|532189622|FG000|Extension|Patients completed per protocol|0|||
147555391|NCT01595009|532189623|FG001|Extension|Patients completed per protocol|0|||
147555392|NCT01595009|532189624|FG002|Extension|Patients completed per protocol|0|||
147555393|NCT01595009|532189625|FG003|Extension|Patients completed per protocol|2|||
147555394|NCT01595009|532189622|FG000|Extension|Disease progression|0|||
147555395|NCT01595009|532189623|FG001|Extension|Disease progression|0|||
147555396|NCT01595009|532189624|FG002|Extension|Disease progression|4|||
147555397|NCT01595009|532189625|FG003|Extension|Disease progression|7|||
147555398|NCT01595009|532189622|FG000|Extension|Adverse Event|0|||
147555399|NCT01595009|532189623|FG001|Extension|Adverse Event|0|||
147555400|NCT01595009|532189624|FG002|Extension|Adverse Event|0|||
147224849|NCT03868124|530994822|FG001|Overall Study|Lost to Follow-up|1|||
147224850|NCT03868124|530994823|FG002|Overall Study|Lost to Follow-up|2|||
147224851|NCT03868124|530994821|FG000|Overall Study|Death|1|||
147224852|NCT03868124|530994822|FG001|Overall Study|Death|1|||
147224853|NCT03868124|530994823|FG002|Overall Study|Death|2|||
147224854|NCT03868124|530994821|FG000|Overall Study|Adverse Event|0|||
147224855|NCT03868124|530994822|FG001|Overall Study|Adverse Event|0|||
147555401|NCT01595009|532189625|FG003|Extension|Adverse Event|1|||
147555402|NCT04956666|532189626|FG000|Overall Study|Adverse Event|18|||
147555403|NCT04956666|532189626|FG000|Overall Study|Physician Decision|5|||
147555404|NCT00783796|532189628|FG000|Overall Study|Did not receive any stent|4|||
147555405|NCT00783796|532189628|FG000|Overall Study|Received non-XIENCE V stent|1|||
147555406|NCT00783796|532189628|FG000|Overall Study|Received commercial XIENCE V stent|1|||
147555407|NCT00626925|532189633|FG000|Overall Study|Lost to Follow-up|1|||
147555408|NCT00626925|532189634|FG001|Overall Study|Lost to Follow-up|2|||
147555409|NCT00626925|532189633|FG000|Overall Study|relapse|1|||
147555410|NCT00626925|532189634|FG001|Overall Study|relapse|0|||
147555411|NCT00626925|532189633|FG000|Overall Study|Adverse effect|6|||
147555412|NCT00626925|532189634|FG001|Overall Study|Adverse effect|2|||
147555413|NCT00626925|532189633|FG000|Overall Study|Lack of Efficacy|1|||
147555414|NCT00626925|532189634|FG001|Overall Study|Lack of Efficacy|4|||
147555415|NCT00626925|532189633|FG000|Overall Study|Time constraints|3|||
147555416|NCT00626925|532189634|FG001|Overall Study|Time constraints|1|||
147555417|NCT01215942|532189635|FG000|Treatment Period|Adverse Event|15|||
147555418|NCT01215942|532189636|FG001|Treatment Period|Adverse Event|26|||
147555419|NCT01215942|532189635|FG000|Treatment Period|Death|2|||
147224856|NCT03868124|530994823|FG002|Overall Study|Adverse Event|3|||
147224857|NCT03868124|530994821|FG000|Overall Study|Explanted|2|||
147224858|NCT03868124|530994822|FG001|Overall Study|Explanted|1|||
147224859|NCT03868124|530994823|FG002|Overall Study|Explanted|0|||
147224860|NCT03868124|530994821|FG000|Overall Study|Ongoing in study|176|||
147224861|NCT03868124|530994822|FG001|Overall Study|Ongoing in study|180|||
147224862|NCT03868124|530994823|FG002|Overall Study|Ongoing in study|183|||
147224863|NCT04177355|530994824|FG000|Overall Study|Lost to Follow-up|0|||
147224864|NCT04177355|530994825|FG001|Overall Study|Lost to Follow-up|2|||
147224865|NCT04177355|530994826|FG002|Overall Study|Lost to Follow-up|0|||
147224866|NCT04177355|530994827|FG003|Overall Study|Lost to Follow-up|1|||
147224867|NCT04177355|530994828|FG004|Overall Study|Lost to Follow-up|2|||
147224868|NCT04177355|530994829|FG005|Overall Study|Lost to Follow-up|0|||
147224869|NCT04177355|530994830|FG006|Overall Study|Lost to Follow-up|1|||
147224870|NCT04177355|530994831|FG007|Overall Study|Lost to Follow-up|0|||
147224871|NCT04177355|530994832|FG008|Overall Study|Lost to Follow-up|0|||
147224872|NCT04177355|530994833|FG009|Overall Study|Lost to Follow-up|0|||
147224873|NCT04177355|530994834|FG010|Overall Study|Lost to Follow-up|0|||
147224874|NCT04177355|530994824|FG000|Overall Study|Withdrawal by Subject|0|||
147224875|NCT04177355|530994825|FG001|Overall Study|Withdrawal by Subject|0|||
147224876|NCT04177355|530994826|FG002|Overall Study|Withdrawal by Subject|0|||
147224877|NCT04177355|530994827|FG003|Overall Study|Withdrawal by Subject|1|||
147224878|NCT04177355|530994828|FG004|Overall Study|Withdrawal by Subject|1|||
147224879|NCT04177355|530994829|FG005|Overall Study|Withdrawal by Subject|0|||
147224880|NCT04177355|530994830|FG006|Overall Study|Withdrawal by Subject|0|||
147224881|NCT04177355|530994831|FG007|Overall Study|Withdrawal by Subject|0|||
147224882|NCT04177355|530994832|FG008|Overall Study|Withdrawal by Subject|1|||
147224883|NCT04177355|530994833|FG009|Overall Study|Withdrawal by Subject|0|||
147224884|NCT04177355|530994834|FG010|Overall Study|Withdrawal by Subject|0|||
147224885|NCT03981822|530994835|FG000|Overall Study|Lost to Follow-up|0|||
147224886|NCT03981822|530994836|FG001|Overall Study|Lost to Follow-up|1|||
147224887|NCT03981822|530994837|FG002|Overall Study|Lost to Follow-up|1|||
147224888|NCT03981822|530994838|FG003|Overall Study|Lost to Follow-up|0|||
147224889|NCT03981822|530994839|FG004|Overall Study|Lost to Follow-up|6|||
147224890|NCT03981822|530994840|FG005|Overall Study|Lost to Follow-up|4|||
147224891|NCT03981822|530994841|FG006|Overall Study|Lost to Follow-up|4|||
147224892|NCT03981822|530994842|FG007|Overall Study|Lost to Follow-up|2|||
147224893|NCT03981822|530994835|FG000|Overall Study|Withdrawal by Subject|0|||
147224894|NCT03981822|530994836|FG001|Overall Study|Withdrawal by Subject|1|||
147224895|NCT03981822|530994837|FG002|Overall Study|Withdrawal by Subject|0|||
147224896|NCT03981822|530994838|FG003|Overall Study|Withdrawal by Subject|0|||
147224897|NCT03981822|530994839|FG004|Overall Study|Withdrawal by Subject|0|||
147224898|NCT03981822|530994840|FG005|Overall Study|Withdrawal by Subject|1|||
147224899|NCT03981822|530994841|FG006|Overall Study|Withdrawal by Subject|0|||
147224900|NCT03981822|530994842|FG007|Overall Study|Withdrawal by Subject|2|||
147224901|NCT03981822|530994835|FG000|Overall Study|COVID-19 Related|0|||
147224902|NCT03981822|530994836|FG001|Overall Study|COVID-19 Related|0|||
147224903|NCT03981822|530994837|FG002|Overall Study|COVID-19 Related|0|||
147224904|NCT03981822|530994838|FG003|Overall Study|COVID-19 Related|0|||
147224905|NCT03981822|530994839|FG004|Overall Study|COVID-19 Related|2|||
147224906|NCT03981822|530994840|FG005|Overall Study|COVID-19 Related|1|||
147224907|NCT03981822|530994841|FG006|Overall Study|COVID-19 Related|2|||
147224908|NCT03981822|530994842|FG007|Overall Study|COVID-19 Related|1|||
147224909|NCT02742246|530994843|FG000|Overall Study|Never initiated treatment|5|||
147224910|NCT02742246|530994844|FG001|Overall Study|Never initiated treatment|3|||
147224911|NCT02742246|530994845|FG002|Overall Study|Never initiated treatment|1|||
147224912|NCT02742246|530994843|FG000|Overall Study|dropped out during treatment|7|||
147224913|NCT02742246|530994844|FG001|Overall Study|dropped out during treatment|13|||
147224914|NCT02742246|530994845|FG002|Overall Study|dropped out during treatment|10|||
147224915|NCT02742246|530994843|FG000|Overall Study|Death|1|||
147224916|NCT02742246|530994844|FG001|Overall Study|Death|0|||
147224917|NCT02742246|530994845|FG002|Overall Study|Death|0|||
147224918|NCT03489551|530994846|FG000|Overall Study|Withdrawal by Subject|2|||
147224919|NCT00054717|530994848|FG000|Overall Study|Randomized but not treated|2|||
147224920|NCT00054717|530994849|FG001|Overall Study|Randomized but not treated|8|||
147224921|NCT00054717|530994848|FG000|Overall Study|Adverse Event|70|||
147224922|NCT00054717|530994849|FG001|Overall Study|Adverse Event|22|||
147224923|NCT00054717|530994848|FG000|Overall Study|Protocol Violation|18|||
147224924|NCT00054717|530994849|FG001|Overall Study|Protocol Violation|19|||
147224925|NCT00054717|530994848|FG000|Overall Study|Lost to Follow-up|23|||
147224926|NCT00054717|530994849|FG001|Overall Study|Lost to Follow-up|13|||
147224927|NCT00054717|530994848|FG000|Overall Study|Withdrawal by Subject|32|||
147555420|NCT01215942|532189636|FG001|Treatment Period|Death|4|||
147310211|NCT00077636|531303819|FG000|Overall Study|Adverse Event|17|||
147310212|NCT00077636|531303820|FG001|Overall Study|Adverse Event|34|||
147310213|NCT00077636|531303819|FG000|Overall Study|Protocol Violation|0|||
147310214|NCT00077636|531303820|FG001|Overall Study|Protocol Violation|2|||
147310215|NCT00077636|531303819|FG000|Overall Study|Lost to Follow-up|10|||
147310216|NCT00077636|531303820|FG001|Overall Study|Lost to Follow-up|18|||
147310217|NCT00077636|531303819|FG000|Overall Study|Abnormality Of Laboratory Test|3|||
147310218|NCT00077636|531303820|FG001|Overall Study|Abnormality Of Laboratory Test|2|||
147310219|NCT00592319|531303821|FG000|Overall Study|Lost to Follow-up|0|||
147310220|NCT00592319|531303822|FG001|Overall Study|Lost to Follow-up|3|||
147310221|NCT01017120|531303825|FG000|Overall Study|Adverse Event|9|||
147310222|NCT01017120|531303826|FG001|Overall Study|Adverse Event|0|||
147310223|NCT01017120|531303825|FG000|Overall Study|Lost to Follow-up|13|||
147310224|NCT01017120|531303826|FG001|Overall Study|Lost to Follow-up|11|||
147310225|NCT01017120|531303825|FG000|Overall Study|Lack of Efficacy|1|||
147310226|NCT01017120|531303826|FG001|Overall Study|Lack of Efficacy|0|||
147310227|NCT01017120|531303825|FG000|Overall Study|Withdrawal by Subject|39|||
147310228|NCT01017120|531303826|FG001|Overall Study|Withdrawal by Subject|21|||
147310229|NCT01017120|531303825|FG000|Overall Study|Pregnancy|1|||
147310230|NCT01017120|531303826|FG001|Overall Study|Pregnancy|1|||
147310231|NCT01017120|531303825|FG000|Overall Study|Did Not Meet Eligibility Criteria|1|||
147310232|NCT01017120|531303826|FG001|Overall Study|Did Not Meet Eligibility Criteria|0|||
147310233|NCT01017120|531303825|FG000|Overall Study|Relocated Out of Town|0|||
147310234|NCT01017120|531303826|FG001|Overall Study|Relocated Out of Town|2|||
147310235|NCT01017120|531303825|FG000|Overall Study|Protocol Violation|1|||
147310236|NCT01017120|531303826|FG001|Overall Study|Protocol Violation|0|||
147310237|NCT01017120|531303825|FG000|Overall Study|Parent Unable to Provide Transportation|1|||
147310238|NCT01017120|531303826|FG001|Overall Study|Parent Unable to Provide Transportation|0|||
147310239|NCT01642602|531303831|FG000|Overall Study|Adverse Event|2|||
147310240|NCT02961881|531303832|FG000|Overall Study|Adverse Event|1|||
147310241|NCT02961881|531303833|FG001|Overall Study|Adverse Event|2|||
147310242|NCT02961881|531303834|FG002|Overall Study|Adverse Event|2|||
147310243|NCT02961881|531303835|FG003|Overall Study|Adverse Event|0|||
147310244|NCT02961881|531303836|FG004|Overall Study|Adverse Event|1|||
147310245|NCT02961881|531303832|FG000|Overall Study|Participant request|0|||
147310246|NCT02961881|531303833|FG001|Overall Study|Participant request|2|||
147310247|NCT02961881|531303834|FG002|Overall Study|Participant request|0|||
147310248|NCT02961881|531303835|FG003|Overall Study|Participant request|0|||
147310249|NCT02961881|531303836|FG004|Overall Study|Participant request|0|||
147310250|NCT02961881|531303832|FG000|Overall Study|Disease progression|1|||
147310251|NCT02961881|531303833|FG001|Overall Study|Disease progression|0|||
147310252|NCT02961881|531303834|FG002|Overall Study|Disease progression|1|||
147310253|NCT02961881|531303835|FG003|Overall Study|Disease progression|0|||
147310254|NCT02961881|531303836|FG004|Overall Study|Disease progression|0|||
147310255|NCT00569803|531303837|FG000|Overall Study|Lost to Follow-up|1|||
147310256|NCT00569803|531303838|FG001|Overall Study|Lost to Follow-up|0|||
147310257|NCT00569803|531303839|FG002|Overall Study|Lost to Follow-up|0|||
147310258|NCT00569803|531303840|FG003|Overall Study|Lost to Follow-up|0|||
147310259|NCT00569803|531303841|FG004|Overall Study|Lost to Follow-up|0|||
147310260|NCT00569803|531303842|FG005|Overall Study|Lost to Follow-up|0|||
147310261|NCT00569803|531303843|FG006|Overall Study|Lost to Follow-up|0|||
147310262|NCT00569803|531303844|FG007|Overall Study|Lost to Follow-up|0|||
147310263|NCT00569803|531303837|FG000|Overall Study|injection syringe leaked during dosing|0|||
147310264|NCT00569803|531303838|FG001|Overall Study|injection syringe leaked during dosing|0|||
147310265|NCT00569803|531303839|FG002|Overall Study|injection syringe leaked during dosing|0|||
147310266|NCT00569803|531303840|FG003|Overall Study|injection syringe leaked during dosing|1|||
147310267|NCT00569803|531303841|FG004|Overall Study|injection syringe leaked during dosing|0|||
147310268|NCT00569803|531303842|FG005|Overall Study|injection syringe leaked during dosing|0|||
147310269|NCT00569803|531303843|FG006|Overall Study|injection syringe leaked during dosing|0|||
147310270|NCT00569803|531303844|FG007|Overall Study|injection syringe leaked during dosing|0|||
147310271|NCT00569803|531303837|FG000|Overall Study|Withdrawal by Subject|0|||
147310272|NCT00569803|531303838|FG001|Overall Study|Withdrawal by Subject|0|||
147310273|NCT00569803|531303839|FG002|Overall Study|Withdrawal by Subject|0|||
147310274|NCT00569803|531303840|FG003|Overall Study|Withdrawal by Subject|0|||
147310275|NCT00569803|531303841|FG004|Overall Study|Withdrawal by Subject|0|||
147310276|NCT00569803|531303842|FG005|Overall Study|Withdrawal by Subject|0|||
147310277|NCT00569803|531303843|FG006|Overall Study|Withdrawal by Subject|0|||
147310278|NCT00569803|531303844|FG007|Overall Study|Withdrawal by Subject|1|||
147310279|NCT01993823|531303845|FG000|Overall Study|Requested by the patient|6|||
147310280|NCT01993823|531303846|FG001|Overall Study|Requested by the patient|11|||
147310281|NCT01993823|531303845|FG000|Overall Study|Protocol Violation|0|||
147310282|NCT01993823|531303846|FG001|Overall Study|Protocol Violation|1|||
147310283|NCT01993823|531303845|FG000|Overall Study|Lost to Follow-up|1|||
147310284|NCT01993823|531303846|FG001|Overall Study|Lost to Follow-up|4|||
147310285|NCT05033743|531303848|FG000|Overall Study|Lost to Follow-up|1|||
147310286|NCT05033743|531303848|FG000|Overall Study|Protocol Violation|2|||
147310287|NCT05033743|531303848|FG000|Overall Study|Withdrawal by Subject|1|||
147106017|NCT01056276|530553726|FG000|Maintenance Therapy|Progressive Disease|0|||
147310288|NCT01622348|531303849|FG000|Overall Study|Withdrawal by Subject|1|||
147310289|NCT01622348|531303850|FG001|Overall Study|Withdrawal by Subject|0|||
147310290|NCT01622348|531303851|FG002|Overall Study|Withdrawal by Subject|1|||
147310291|NCT00791921|531303852|FG000|Overall Study|Protocol planed|24|||
147310292|NCT00791921|531303853|FG001|Overall Study|Protocol planed|88|||
147310293|NCT00791921|531303852|FG000|Overall Study|Withdrawal by Subject|1|||
147310294|NCT00791921|531303853|FG001|Overall Study|Withdrawal by Subject|2|||
147310295|NCT00791921|531303852|FG000|Overall Study|Adverse Event|8|||
147310296|NCT00791921|531303853|FG001|Overall Study|Adverse Event|2|||
147310297|NCT00791921|531303852|FG000|Overall Study|Lack of Efficacy|0|||
147310298|NCT00791921|531303853|FG001|Overall Study|Lack of Efficacy|2|||
147310299|NCT00791921|531303852|FG000|Overall Study|Lack of study drug administration|1|||
147310300|NCT00791921|531303853|FG001|Overall Study|Lack of study drug administration|1|||
147310301|NCT00791921|531303852|FG000|Overall Study|Reason other than those above|0|||
147310302|NCT00791921|531303853|FG001|Overall Study|Reason other than those above|1|||
147310303|NCT01592695|531303856|FG000|Overall Study|Lost to Follow-up|8|||
147310304|NCT01592695|531303857|FG001|Overall Study|Lost to Follow-up|4|||
147310305|NCT00422799|531303858|FG000|Overall Study|Withdrawal by Subject|6|||
147310306|NCT00422799|531303858|FG000|Overall Study|Adverse Event|7|||
147310307|NCT01965158|531303859|FG000|Overall Study|Adverse Event|14|||
147310308|NCT01965158|531303860|FG001|Overall Study|Adverse Event|5|||
147310309|NCT01965158|531303859|FG000|Overall Study|Withdrawal by Subject|16|||
147310310|NCT01965158|531303860|FG001|Overall Study|Withdrawal by Subject|24|||
147310311|NCT01965158|531303859|FG000|Overall Study|Lost to Follow-up|7|||
147310312|NCT01965158|531303860|FG001|Overall Study|Lost to Follow-up|5|||
147443934|NCT02819635|531790441|FG004|Substudy 2, Part 2|Withdrew consent|0|||
147443935|NCT02819635|531790442|FG005|Substudy 2, Part 2|Withdrew consent|3|||
147443936|NCT02819635|531790443|FG006|Substudy 2, Part 2|Withdrew consent|1|||
147443937|NCT02819635|531790444|FG007|Substudy 2, Part 2|Withdrew consent|0|||
147443938|NCT02819635|531790445|FG008|Substudy 2, Part 2|Withdrew consent|0|||
147443939|NCT02819635|531790446|FG009|Substudy 2, Part 2|Withdrew consent|0|||
147443940|NCT02819635|531790447|FG010|Substudy 2, Part 2|Withdrew consent|0|||
147443941|NCT02819635|531790448|FG011|Substudy 2, Part 2|Withdrew consent|0|||
147443942|NCT02819635|531790437|FG000|Substudy 2, Part 2|Lost to Follow-up|0|||
147443943|NCT02819635|531790438|FG001|Substudy 2, Part 2|Lost to Follow-up|0|||
147443944|NCT02819635|531790439|FG002|Substudy 2, Part 2|Lost to Follow-up|0|||
147443945|NCT02819635|531790440|FG003|Substudy 2, Part 2|Lost to Follow-up|0|||
147443946|NCT02819635|531790441|FG004|Substudy 2, Part 2|Lost to Follow-up|0|||
147443947|NCT02819635|531790442|FG005|Substudy 2, Part 2|Lost to Follow-up|0|||
147443948|NCT02819635|531790443|FG006|Substudy 2, Part 2|Lost to Follow-up|1|||
147443949|NCT02819635|531790444|FG007|Substudy 2, Part 2|Lost to Follow-up|0|||
147443950|NCT02819635|531790445|FG008|Substudy 2, Part 2|Lost to Follow-up|0|||
147443951|NCT02819635|531790446|FG009|Substudy 2, Part 2|Lost to Follow-up|0|||
147443952|NCT02819635|531790447|FG010|Substudy 2, Part 2|Lost to Follow-up|0|||
147443953|NCT02819635|531790448|FG011|Substudy 2, Part 2|Lost to Follow-up|0|||
147443954|NCT02819635|531790437|FG000|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
147443955|NCT02819635|531790438|FG001|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
147443956|NCT02819635|531790439|FG002|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
147443957|NCT02819635|531790440|FG003|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
147443958|NCT02819635|531790441|FG004|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
147443959|NCT02819635|531790442|FG005|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
147443960|NCT02819635|531790443|FG006|Substudy 2, Part 2|COVID-19 Logistical Restrictions|2|||
147443961|NCT02819635|531790444|FG007|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
147443962|NCT02819635|531790445|FG008|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
147443963|NCT02819635|531790446|FG009|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
147443964|NCT02819635|531790447|FG010|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
147443965|NCT02819635|531790448|FG011|Substudy 2, Part 2|COVID-19 Logistical Restrictions|0|||
147443966|NCT02819635|531790437|FG000|Substudy 2, Part 2|Other, not specified|0|||
147443967|NCT02819635|531790438|FG001|Substudy 2, Part 2|Other, not specified|0|||
147443968|NCT02819635|531790439|FG002|Substudy 2, Part 2|Other, not specified|0|||
147443969|NCT02819635|531790440|FG003|Substudy 2, Part 2|Other, not specified|0|||
147443970|NCT02819635|531790441|FG004|Substudy 2, Part 2|Other, not specified|0|||
147443971|NCT02819635|531790442|FG005|Substudy 2, Part 2|Other, not specified|4|||
147443972|NCT02819635|531790443|FG006|Substudy 2, Part 2|Other, not specified|8|||
147443973|NCT02819635|531790444|FG007|Substudy 2, Part 2|Other, not specified|0|||
147443974|NCT02819635|531790445|FG008|Substudy 2, Part 2|Other, not specified|0|||
147443975|NCT02819635|531790446|FG009|Substudy 2, Part 2|Other, not specified|0|||
147443976|NCT02819635|531790447|FG010|Substudy 2, Part 2|Other, not specified|0|||
147443977|NCT02819635|531790448|FG011|Substudy 2, Part 2|Other, not specified|0|||
147443978|NCT02819635|531790437|FG000|Substudy 3|Adverse Event|0|||
147443979|NCT02819635|531790438|FG001|Substudy 3|Adverse Event|0|||
147443980|NCT02819635|531790439|FG002|Substudy 3|Adverse Event|0|||
147443981|NCT02819635|531790440|FG003|Substudy 3|Adverse Event|0|||
147443982|NCT02819635|531790441|FG004|Substudy 3|Adverse Event|0|||
147555421|NCT01215942|532189635|FG000|Treatment Period|Lack of Efficacy|23|||
147555422|NCT01215942|532189636|FG001|Treatment Period|Lack of Efficacy|62|||
147555423|NCT01215942|532189635|FG000|Treatment Period|Lost to Follow-up|3|||
147555424|NCT01215942|532189636|FG001|Treatment Period|Lost to Follow-up|4|||
147555425|NCT01215942|532189635|FG000|Treatment Period|Withdrawal by Subject|17|||
147555426|NCT01215942|532189636|FG001|Treatment Period|Withdrawal by Subject|40|||
147555427|NCT01215942|532189635|FG000|Treatment Period|Physician Decision|5|||
147555428|NCT01215942|532189636|FG001|Treatment Period|Physician Decision|5|||
147555429|NCT01215942|532189635|FG000|Treatment Period|Protocol Violation|0|||
147555430|NCT01215942|532189636|FG001|Treatment Period|Protocol Violation|1|||
147555431|NCT01215942|532189635|FG000|Treatment Period|Sponsor Decision|349|||
147555432|NCT01215942|532189636|FG001|Treatment Period|Sponsor Decision|530|||
147555433|NCT01215942|532189635|FG000|Post-Treatment Follow-Up Period|Death|0|||
147555434|NCT01215942|532189636|FG001|Post-Treatment Follow-Up Period|Death|1|||
147555435|NCT01215942|532189635|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|13|||
147555436|NCT01215942|532189636|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|13|||
147555437|NCT01215942|532189635|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|43|||
147555438|NCT01215942|532189636|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|69|||
147555439|NCT01215942|532189635|FG000|Post-Treatment Follow-Up Period|Physician Decision|1|||
147555440|NCT01215942|532189636|FG001|Post-Treatment Follow-Up Period|Physician Decision|2|||
147555441|NCT01215942|532189635|FG000|Post-Treatment Follow-Up Period|Sponsor Decision|28|||
147555442|NCT01215942|532189636|FG001|Post-Treatment Follow-Up Period|Sponsor Decision|61|||
147555443|NCT00753714|532189637|FG000|Overall Study|Lack of Efficacy|21|||
147555444|NCT00753714|532189638|FG001|Overall Study|Lack of Efficacy|34|||
147555445|NCT00753714|532189637|FG000|Overall Study|Adverse Event|26|||
147555446|NCT00753714|532189638|FG001|Overall Study|Adverse Event|18|||
147555447|NCT00753714|532189637|FG000|Overall Study|Protocol Violation|1|||
147555448|NCT00753714|532189638|FG001|Overall Study|Protocol Violation|0|||
147555449|NCT00753714|532189637|FG000|Overall Study|Lost to Follow-up|0|||
147555450|NCT00753714|532189638|FG001|Overall Study|Lost to Follow-up|1|||
147555451|NCT00753714|532189637|FG000|Overall Study|Withdrawal by Subject|2|||
147555452|NCT00753714|532189638|FG001|Overall Study|Withdrawal by Subject|1|||
147555453|NCT00753714|532189637|FG000|Overall Study|Death|3|||
147555454|NCT00753714|532189638|FG001|Overall Study|Death|3|||
147555455|NCT00753714|532189637|FG000|Overall Study|Other|7|||
147555456|NCT00753714|532189638|FG001|Overall Study|Other|5|||
147555457|NCT00313703|532191390|FG000|Overall Study|Lost to Follow-up|11|||
147555458|NCT00313703|532191391|FG001|Overall Study|Lost to Follow-up|2|||
147555459|NCT00313703|532191392|FG002|Overall Study|Lost to Follow-up|5|||
147555460|NCT00313703|532191393|FG003|Overall Study|Lost to Follow-up|12|||
147555461|NCT03329027|532191396|FG000|Overall Study|Lost to Follow-up|1|||
147555462|NCT03329027|532191397|FG001|Overall Study|Lost to Follow-up|0|||
147555463|NCT03329027|532191398|FG002|Overall Study|Lost to Follow-up|1|||
147555464|NCT03329027|532191396|FG000|Overall Study|Protocol Violation|9|||
147555465|NCT03329027|532191397|FG001|Overall Study|Protocol Violation|5|||
147555466|NCT03329027|532191398|FG002|Overall Study|Protocol Violation|7|||
147555467|NCT04849988|532191399|FG000|Overall Study|Lack of Efficacy|3|||
147555468|NCT04849988|532191400|FG001|Overall Study|Lack of Efficacy|4|||
147555469|NCT04849988|532191401|FG002|Overall Study|Lack of Efficacy|1|||
147555470|NCT04849988|532191402|FG003|Overall Study|Lack of Efficacy|4|||
147555471|NCT04849988|532191399|FG000|Overall Study|Other reasons|1|||
147555472|NCT04849988|532191400|FG001|Overall Study|Other reasons|2|||
147555473|NCT04849988|532191401|FG002|Overall Study|Other reasons|2|||
147555474|NCT04849988|532191402|FG003|Overall Study|Other reasons|1|||
147555475|NCT02146430|532191407|FG000|Overall Study|Protocol Violation|5|||
147555476|NCT02146430|532191408|FG001|Overall Study|Protocol Violation|4|||
147555477|NCT02146430|532191409|FG002|Overall Study|Protocol Violation|8|||
147555478|NCT02146430|532191410|FG003|Overall Study|Protocol Violation|6|||
147555479|NCT02146430|532191407|FG000|Overall Study|Lack of Efficacy|13|||
147555480|NCT02146430|532191408|FG001|Overall Study|Lack of Efficacy|11|||
147555481|NCT02146430|532191409|FG002|Overall Study|Lack of Efficacy|8|||
147555482|NCT02146430|532191410|FG003|Overall Study|Lack of Efficacy|5|||
147555483|NCT02146430|532191407|FG000|Overall Study|Adverse Event|20|||
147555484|NCT02146430|532191408|FG001|Overall Study|Adverse Event|40|||
147555485|NCT02146430|532191409|FG002|Overall Study|Adverse Event|32|||
147555486|NCT02146430|532191410|FG003|Overall Study|Adverse Event|49|||
147555487|NCT02146430|532191407|FG000|Overall Study|Reason missing or not reported|2|||
147555488|NCT02146430|532191408|FG001|Overall Study|Reason missing or not reported|3|||
147555489|NCT02146430|532191409|FG002|Overall Study|Reason missing or not reported|4|||
147555490|NCT02146430|532191410|FG003|Overall Study|Reason missing or not reported|5|||
147555491|NCT02146430|532191407|FG000|Overall Study|Withdrawal by Subject|27|||
147555492|NCT02146430|532191408|FG001|Overall Study|Withdrawal by Subject|29|||
147555493|NCT02146430|532191409|FG002|Overall Study|Withdrawal by Subject|30|||
147555494|NCT02146430|532191410|FG003|Overall Study|Withdrawal by Subject|34|||
147555495|NCT03312530|532191411|FG000|Overall Study|Death|5|||
147555496|NCT03312530|532191412|FG001|Overall Study|Death|5|||
147555497|NCT03312530|532191413|FG002|Overall Study|Death|4|||
147555498|NCT03312530|532191414|FG003|Overall Study|Death|10|||
147555499|NCT03312530|532191415|FG004|Overall Study|Death|8|||
147555500|NCT03312530|532191411|FG000|Overall Study|Lost to Follow-up|0|||
147555501|NCT03312530|532191412|FG001|Overall Study|Lost to Follow-up|0|||
147555502|NCT03312530|532191413|FG002|Overall Study|Lost to Follow-up|0|||
147555503|NCT03312530|532191414|FG003|Overall Study|Lost to Follow-up|1|||
147555504|NCT03312530|532191415|FG004|Overall Study|Lost to Follow-up|0|||
147555505|NCT03312530|532191411|FG000|Overall Study|Participant in another sponsor study.|0|||
147555506|NCT03312530|532191412|FG001|Overall Study|Participant in another sponsor study.|0|||
147555507|NCT03312530|532191413|FG002|Overall Study|Participant in another sponsor study.|0|||
147555508|NCT03312530|532191414|FG003|Overall Study|Participant in another sponsor study.|1|||
147555509|NCT03312530|532191415|FG004|Overall Study|Participant in another sponsor study.|0|||
147555510|NCT03312530|532191411|FG000|Overall Study|Study terminated by sponsor|1|||
147555511|NCT03312530|532191412|FG001|Overall Study|Study terminated by sponsor|0|||
147555512|NCT03312530|532191413|FG002|Overall Study|Study terminated by sponsor|2|||
147555513|NCT03312530|532191414|FG003|Overall Study|Study terminated by sponsor|3|||
147555514|NCT03312530|532191415|FG004|Overall Study|Study terminated by sponsor|7|||
147555515|NCT03312530|532191411|FG000|Overall Study|Withdrawal by Subject|0|||
147555516|NCT03312530|532191412|FG001|Overall Study|Withdrawal by Subject|1|||
147555517|NCT03312530|532191413|FG002|Overall Study|Withdrawal by Subject|0|||
147555518|NCT03312530|532191414|FG003|Overall Study|Withdrawal by Subject|0|||
147555519|NCT03312530|532191415|FG004|Overall Study|Withdrawal by Subject|0|||
147555520|NCT03312530|532191411|FG000|Overall Study|Participant summarized as 'ongoing' due to missing data entry for Long-term Follow Up period on eCRF|0|||
147555521|NCT03312530|532191412|FG001|Overall Study|Participant summarized as 'ongoing' due to missing data entry for Long-term Follow Up period on eCRF|0|||
147555522|NCT03312530|532191413|FG002|Overall Study|Participant summarized as 'ongoing' due to missing data entry for Long-term Follow Up period on eCRF|0|||
147555523|NCT03312530|532191414|FG003|Overall Study|Participant summarized as 'ongoing' due to missing data entry for Long-term Follow Up period on eCRF|1|||
147555524|NCT03312530|532191415|FG004|Overall Study|Participant summarized as 'ongoing' due to missing data entry for Long-term Follow Up period on eCRF|0|||
147555525|NCT02524379|532191429|FG000|Overall Study|Death|1|||
147555526|NCT00812253|532191432|FG000|Overall Study|Withdrawal by Subject|3|||
147555527|NCT00812253|532191433|FG001|Overall Study|Withdrawal by Subject|2|||
147555528|NCT00812253|532191432|FG000|Overall Study|Protocol Violation|1|||
147555529|NCT00812253|532191433|FG001|Overall Study|Protocol Violation|1|||
147555530|NCT00812253|532191432|FG000|Overall Study|Lost to Follow-up|2|||
147555531|NCT00812253|532191433|FG001|Overall Study|Lost to Follow-up|0|||
147555532|NCT01884025|532191434|FG000|Overall Study|Lost to Follow-up|3|||
147555533|NCT01884025|532191435|FG001|Overall Study|Lost to Follow-up|4|||
147555534|NCT02655237|532191436|FG000|Overall Study|Adverse Event|10|||
147555535|NCT02655237|532191437|FG001|Overall Study|Adverse Event|7|||
147555536|NCT02655237|532191436|FG000|Overall Study|Protocol Deviation|2|||
147555537|NCT02655237|532191437|FG001|Overall Study|Protocol Deviation|0|||
147555538|NCT02655237|532191436|FG000|Overall Study|Withdrawal by Participant|1|||
147555539|NCT02655237|532191437|FG001|Overall Study|Withdrawal by Participant|2|||
147555540|NCT02655237|532191436|FG000|Overall Study|Lack of Efficacy|0|||
147555541|NCT02655237|532191437|FG001|Overall Study|Lack of Efficacy|1|||
147555542|NCT02655237|532191436|FG000|Overall Study|Recovery Leading to Surgery|2|||
147555543|NCT02655237|532191437|FG001|Overall Study|Recovery Leading to Surgery|1|||
147555544|NCT02655237|532191436|FG000|Overall Study|Reduction of Hemoglobin Concentration|1|||
147555545|NCT02655237|532191437|FG001|Overall Study|Reduction of Hemoglobin Concentration|0|||
147555546|NCT02655237|532191436|FG000|Overall Study|Randomized but Not Treated|1|||
147555547|NCT02655237|532191437|FG001|Overall Study|Randomized but Not Treated|0|||
147555548|NCT03679741|532191438|FG000|Period 1|No longer meet eligibility criteria|1|||
147555549|NCT03679741|532191439|FG001|Period 1|No longer meet eligibility criteria|0|||
147555550|NCT03679741|532191438|FG000|Period 1|Lost to Follow-up|0|||
147555551|NCT03679741|532191439|FG001|Period 1|Lost to Follow-up|1|||
147555552|NCT03679741|532191438|FG000|Period 1|Adverse Event|1|||
147555553|NCT03679741|532191439|FG001|Period 1|Adverse Event|1|||
147555554|NCT03679741|532191438|FG000|Period 1|Withdrawal by Subject|0|||
147555555|NCT03679741|532191439|FG001|Period 1|Withdrawal by Subject|1|||
147555556|NCT03679741|532191438|FG000|Period 2|Adverse Event|2|||
147555557|NCT03679741|532191439|FG001|Period 2|Adverse Event|1|||
147555558|NCT03679741|532191438|FG000|Period 2|Withdrawal by Subject|1|||
147555559|NCT03679741|532191439|FG001|Period 2|Withdrawal by Subject|1|||
147555560|NCT02750761|532191444|FG000|Overall Study|Lost to Follow-up|0|||
147555561|NCT02750761|532191445|FG001|Overall Study|Lost to Follow-up|0|||
147555562|NCT02750761|532191446|FG002|Overall Study|Lost to Follow-up|1|||
147555563|NCT02750761|532191447|FG003|Overall Study|Lost to Follow-up|0|||
147555564|NCT02750761|532191448|FG004|Overall Study|Lost to Follow-up|0|||
147555565|NCT02750761|532191449|FG005|Overall Study|Lost to Follow-up|0|||
147555566|NCT00729859|532191450|FG000|Overall Study|Adverse Event|0|||
147555567|NCT00729859|532191451|FG001|Overall Study|Adverse Event|1|||
147555568|NCT00729859|532191452|FG002|Overall Study|Adverse Event|0|||
147555569|NCT00729859|532191450|FG000|Overall Study|Withdrawal by Subject|0|||
147555570|NCT00729859|532191451|FG001|Overall Study|Withdrawal by Subject|1|||
147555571|NCT00729859|532191452|FG002|Overall Study|Withdrawal by Subject|0|||
147555572|NCT02623829|532191459|FG000|Overall Study|Lost to Follow-up|1|||
147555573|NCT02623829|532191460|FG001|Overall Study|Lost to Follow-up|1|||
147555574|NCT00662025|532191461|FG000|Overall Study|Objective progression or relapse|51|||
147555575|NCT00662025|532191461|FG000|Overall Study|Adverse Event|7|||
147555576|NCT00662025|532191461|FG000|Overall Study|Withdrawal by Subject|1|||
147555577|NCT00662025|532191461|FG000|Overall Study|Results of other clinical study|2|||
147555578|NCT00662025|532191461|FG000|Overall Study|Target lesion cannot be evaluated|1|||
147555579|NCT00662025|532191461|FG000|Overall Study|Domestic circumstances|1|||
147555580|NCT01700621|532191462|FG000|Analyzed for Immunogenicity|Lost to Follow-up|7|||
147555581|NCT01700621|532191463|FG001|Analyzed for Immunogenicity|Lost to Follow-up|4|||
147555582|NCT01700621|532191462|FG000|Analyzed for Immunogenicity|Protocol Violation|5|||
147555583|NCT01700621|532191463|FG001|Analyzed for Immunogenicity|Protocol Violation|1|||
147555584|NCT01700621|532191462|FG000|Analyzed for Immunogenicity|Baseline measles measure high|1|||
147555585|NCT01700621|532191463|FG001|Analyzed for Immunogenicity|Baseline measles measure high|2|||
147555586|NCT02035137|532191466|FG000|Overall Study|Physician Decision|0|||
147555587|NCT02035137|532191467|FG001|Overall Study|Physician Decision|0|||
147555588|NCT02035137|532191468|FG002|Overall Study|Physician Decision|1|||
147555589|NCT02035137|532191466|FG000|Overall Study|Withdrawal by Subject|0|||
147555590|NCT02035137|532191467|FG001|Overall Study|Withdrawal by Subject|1|||
147555591|NCT02035137|532191468|FG002|Overall Study|Withdrawal by Subject|2|||
147555592|NCT02035137|532191466|FG000|Overall Study|Ineligible|0|||
147555593|NCT02035137|532191467|FG001|Overall Study|Ineligible|1|||
147555594|NCT02035137|532191468|FG002|Overall Study|Ineligible|2|||
147555595|NCT02035137|532191466|FG000|Overall Study|Disease progression prior to treatment start|2|||
147555596|NCT02035137|532191467|FG001|Overall Study|Disease progression prior to treatment start|0|||
147555597|NCT02035137|532191468|FG002|Overall Study|Disease progression prior to treatment start|0|||
147555598|NCT03349333|532191475|FG000|Overall Study|Progression of Disease|36|||
147555599|NCT03349333|532191475|FG000|Overall Study|Adverse Event|11|||
147555600|NCT03349333|532191475|FG000|Overall Study|Other|6|||
147555601|NCT03349333|532191475|FG000|Overall Study|Withdrawal by Subject|5|||
147555602|NCT03349333|532191475|FG000|Overall Study|Conditions interfere with participation|2|||
147555603|NCT03349333|532191475|FG000|Overall Study|Physician Decision|2|||
147555604|NCT03349333|532191475|FG000|Overall Study|3-week lapse between pralatrexate doses|1|||
147555605|NCT03349333|532191475|FG000|Overall Study|Patients in treatment less than 24 month|8|||
147555606|NCT00290745|532191476|FG000|Overall Study|Withdrawal by Subject|4|||
147555607|NCT00290745|532191476|FG000|Overall Study|Physician Decision|2|||
147555608|NCT00290745|532191476|FG000|Overall Study|Surgery after 3 months for progression|3|||
147555609|NCT00290745|532191476|FG000|Overall Study|Baseline MRI not available|3|||
147555610|NCT02985151|532191477|FG000|Original Randomization|Withdrawal by Subject|0|||
147555611|NCT02985151|532191478|FG001|Original Randomization|Withdrawal by Subject|1|||
147555612|NCT00113490|532191484|FG000|Overall Study|Withdrawal by Subject|1|||
147555613|NCT00113490|532191485|FG001|Overall Study|Withdrawal by Subject|3|||
147555614|NCT00113490|532191484|FG000|Overall Study|Lost to Follow-up|1|||
147555615|NCT00113490|532191485|FG001|Overall Study|Lost to Follow-up|0|||
147555616|NCT00819247|532191486|FG000|Overall Study|Adverse Event|0|||
147555617|NCT00819247|532191487|FG001|Overall Study|Adverse Event|5|||
147555618|NCT00819247|532191488|FG002|Overall Study|Adverse Event|3|||
147555619|NCT00819247|532191486|FG000|Overall Study|Insufficient testosterone response|5|||
147555620|NCT00819247|532191487|FG001|Overall Study|Insufficient testosterone response|8|||
147555621|NCT00819247|532191488|FG002|Overall Study|Insufficient testosterone response|10|||
147555622|NCT00819247|532191486|FG000|Overall Study|Withdrawal by Subject|1|||
147555623|NCT00819247|532191487|FG001|Overall Study|Withdrawal by Subject|0|||
147555624|NCT00819247|532191488|FG002|Overall Study|Withdrawal by Subject|0|||
147555625|NCT00819247|532191486|FG000|Overall Study|Protocol Violation|1|||
147555626|NCT00819247|532191487|FG001|Overall Study|Protocol Violation|0|||
147555627|NCT00819247|532191488|FG002|Overall Study|Protocol Violation|1|||
147555628|NCT00819247|532191486|FG000|Overall Study|Mistakenly withdrawn|0|||
147555629|NCT00819247|532191487|FG001|Overall Study|Mistakenly withdrawn|1|||
147106018|NCT01056276|530553727|FG001|Maintenance Therapy|Progressive Disease|9|||
147106019|NCT01056276|530553726|FG000|Maintenance Therapy|Physician Decision|0|||
147106020|NCT01056276|530553727|FG001|Maintenance Therapy|Physician Decision|1|||
147224928|NCT00054717|530994849|FG001|Overall Study|Withdrawal by Subject|20|||
147555630|NCT00819247|532191488|FG002|Overall Study|Mistakenly withdrawn|0|||
147555631|NCT00819247|532191486|FG000|Overall Study|Bad prostate-specific antigen response|3|||
147555632|NCT00819247|532191487|FG001|Overall Study|Bad prostate-specific antigen response|2|||
147555633|NCT00819247|532191488|FG002|Overall Study|Bad prostate-specific antigen response|0|||
147555634|NCT00819247|532191486|FG000|Overall Study|Other|1|||
147224929|NCT00054717|530994848|FG000|Overall Study|Other reason not defined above|117|||
147555635|NCT00819247|532191487|FG001|Overall Study|Other|0|||
147555636|NCT00819247|532191488|FG002|Overall Study|Other|0|||
147555637|NCT02162758|532191489|FG000|Overall Study|Study termination|0|||
147555638|NCT02162758|532191490|FG001|Overall Study|Study termination|1|||
147555639|NCT04471935|532191491|FG000|Overall Study|Withdrawal by Subject|1|||
147555640|NCT04471935|532191491|FG000|Overall Study|Deemed ineligible to participate|1|||
147224930|NCT00054717|530994849|FG001|Overall Study|Other reason not defined above|217|||
147555641|NCT01766921|532191494|FG000|Overall Study|Administrative Reason|5|||
147555642|NCT01766921|532191495|FG001|Overall Study|Administrative Reason|5|||
147555643|NCT01766921|532191494|FG000|Overall Study|Death|1|||
147555644|NCT01766921|532191495|FG001|Overall Study|Death|1|||
147555645|NCT01766921|532191494|FG000|Overall Study|Lost to Follow-up|1|||
147555646|NCT01766921|532191495|FG001|Overall Study|Lost to Follow-up|3|||
147310313|NCT01965158|531303859|FG000|Overall Study|Protocol Violation|1|||
147310314|NCT01965158|531303860|FG001|Overall Study|Protocol Violation|1|||
147310315|NCT01965158|531303859|FG000|Overall Study|Other - Miscellaneous|3|||
147310316|NCT01965158|531303860|FG001|Overall Study|Other - Miscellaneous|0|||
147310317|NCT04537897|531303864|FG000|Overall Study|Other than listed|0|||
147310318|NCT04537897|531303865|FG001|Overall Study|Other than listed|0|||
147555647|NCT01766921|532191494|FG000|Overall Study|Unclassified|2|||
147555648|NCT01766921|532191495|FG001|Overall Study|Unclassified|2|||
147555649|NCT01766921|532191494|FG000|Overall Study|Protocol Violation|1|||
147555650|NCT01766921|532191495|FG001|Overall Study|Protocol Violation|1|||
147555651|NCT01766921|532191494|FG000|Overall Study|Withdrawal by Subject|14|||
147555652|NCT01766921|532191495|FG001|Overall Study|Withdrawal by Subject|5|||
147555653|NCT00708422|532191498|FG000|Overall Study|Adverse Event|3|||
147555654|NCT00708422|532191499|FG001|Overall Study|Adverse Event|1|||
147555655|NCT00708422|532191498|FG000|Overall Study|Withdrawal by Subject|1|||
147555656|NCT00708422|532191499|FG001|Overall Study|Withdrawal by Subject|0|||
147555657|NCT05476679|532191503|FG000|Overall Study|Withdrawal by Subject|0|||
147555658|NCT05476679|532191504|FG001|Overall Study|Withdrawal by Subject|0|||
147555659|NCT05476679|532191505|FG002|Overall Study|Withdrawal by Subject|0|||
147555660|NCT05476679|532191506|FG003|Overall Study|Withdrawal by Subject|1|||
147555661|NCT05476679|532191507|FG004|Overall Study|Withdrawal by Subject|0|||
147555662|NCT05476679|532191503|FG000|Overall Study|Lost to Follow-up|0|||
147555663|NCT05476679|532191504|FG001|Overall Study|Lost to Follow-up|0|||
147555664|NCT05476679|532191505|FG002|Overall Study|Lost to Follow-up|0|||
147555665|NCT05476679|532191506|FG003|Overall Study|Lost to Follow-up|1|||
147555666|NCT05476679|532191507|FG004|Overall Study|Lost to Follow-up|0|||
147555667|NCT00601354|532191508|FG000|Overall Study|Lost to Follow-up|4|||
147310319|NCT04537897|531303866|FG002|Overall Study|Other than listed|0|||
147310320|NCT04537897|531303867|FG003|Overall Study|Other than listed|0|||
147310321|NCT04537897|531303868|FG004|Overall Study|Other than listed|0|||
147310322|NCT04537897|531303869|FG005|Overall Study|Other than listed|0|||
147310323|NCT04537897|531303870|FG006|Overall Study|Other than listed|1|||
147310324|NCT04537897|531303871|FG007|Overall Study|Other than listed|0|||
147310325|NCT04537897|531303872|FG008|Overall Study|Other than listed|0|||
147310326|NCT04537897|531303864|FG000|Overall Study|Adverse Event|0|||
147310327|NCT04537897|531303865|FG001|Overall Study|Adverse Event|0|||
147310328|NCT04537897|531303866|FG002|Overall Study|Adverse Event|0|||
147310329|NCT04537897|531303867|FG003|Overall Study|Adverse Event|1|||
147310330|NCT04537897|531303868|FG004|Overall Study|Adverse Event|0|||
147310331|NCT04537897|531303869|FG005|Overall Study|Adverse Event|0|||
147310332|NCT04537897|531303870|FG006|Overall Study|Adverse Event|0|||
147310333|NCT04537897|531303871|FG007|Overall Study|Adverse Event|0|||
147310334|NCT04537897|531303872|FG008|Overall Study|Adverse Event|0|||
147310335|NCT04537897|531303864|FG000|Overall Study|Withdrawal by Subject|0|||
147310336|NCT04537897|531303865|FG001|Overall Study|Withdrawal by Subject|1|||
147310337|NCT04537897|531303866|FG002|Overall Study|Withdrawal by Subject|0|||
147310338|NCT04537897|531303867|FG003|Overall Study|Withdrawal by Subject|0|||
147310339|NCT04537897|531303868|FG004|Overall Study|Withdrawal by Subject|0|||
147310340|NCT04537897|531303869|FG005|Overall Study|Withdrawal by Subject|0|||
147310341|NCT04537897|531303870|FG006|Overall Study|Withdrawal by Subject|0|||
147555668|NCT00601354|532191509|FG001|Overall Study|Lost to Follow-up|5|||
147555669|NCT00278512|532191511|FG000|Overall Study|Death|1|||
147555670|NCT00278512|532191512|FG001|Overall Study|Death|0|||
147555671|NCT01620177|532191513|FG000|Overall Study|Failure at Screening Visit|43|||
147310342|NCT04537897|531303871|FG007|Overall Study|Withdrawal by Subject|0|||
147310343|NCT04537897|531303872|FG008|Overall Study|Withdrawal by Subject|0|||
147310344|NCT00919893|531303873|FG000|Overall Study|Protocol Violation|19|||
147555672|NCT01620177|532191513|FG000|Overall Study|Withdrawal by Subject|26|||
147555673|NCT01620177|532191513|FG000|Overall Study|Lost to Follow-up|7|||
147555674|NCT01620177|532191513|FG000|Overall Study|Physician Decision|2|||
147555675|NCT01620177|532191513|FG000|Overall Study|Randomized, Not Active due to Scheduling|1|||
147555676|NCT01789320|532191517|FG000|Overall Study|Re-enrolled into study|1|||
147310345|NCT00919893|531303874|FG001|Overall Study|Protocol Violation|9|||
147310346|NCT03029780|531303882|FG000|Overall Study|Disease Progression|20|||
147310347|NCT03029780|531303883|FG001|Overall Study|Disease Progression|22|||
147310348|NCT03029780|531303882|FG000|Overall Study|Study Drug Toxicity|15|||
147310349|NCT03029780|531303883|FG001|Overall Study|Study Drug Toxicity|11|||
147310350|NCT03029780|531303882|FG000|Overall Study|Adverse Event Unrelated to Study Drug|2|||
147310351|NCT03029780|531303883|FG001|Overall Study|Adverse Event Unrelated to Study Drug|3|||
147310352|NCT03029780|531303882|FG000|Overall Study|Participant request to discontinue study treatment|4|||
147555677|NCT01789320|532191517|FG000|Overall Study|Lost to Follow-up|1|||
147555678|NCT00619385|532191522|FG000|Overall Study|Adverse Event|0|||
147106021|NCT01056276|530553726|FG000|Maintenance Therapy|Withdrawal by Subject|0|||
147310353|NCT03029780|531303883|FG001|Overall Study|Participant request to discontinue study treatment|1|||
147310354|NCT03029780|531303882|FG000|Overall Study|Maximum clinical benefit|1|||
147310355|NCT03029780|531303883|FG001|Overall Study|Maximum clinical benefit|0|||
147310356|NCT03029780|531303882|FG000|Overall Study|Participant no longer meets study criteria|0|||
147310357|NCT03029780|531303883|FG001|Overall Study|Participant no longer meets study criteria|1|||
147310358|NCT03029780|531303882|FG000|Overall Study|Other reasons|6|||
147310359|NCT03029780|531303883|FG001|Overall Study|Other reasons|6|||
147310360|NCT03029780|531303882|FG000|Overall Study|Not reported|1|||
147310361|NCT03029780|531303883|FG001|Overall Study|Not reported|1|||
147310362|NCT03029780|531303882|FG000|Overall Study|Death|2|||
147310363|NCT03029780|531303883|FG001|Overall Study|Death|6|||
147310364|NCT00197028|531303884|FG000|Overall Study|Adverse Event|2|||
147310365|NCT00197028|531303885|FG001|Overall Study|Adverse Event|2|||
147310366|NCT00197028|531303884|FG000|Overall Study|Protocol Violation|2|||
147310367|NCT00197028|531303885|FG001|Overall Study|Protocol Violation|1|||
147310368|NCT00197028|531303884|FG000|Overall Study|Withdrawal by Subject|8|||
147310369|NCT00197028|531303885|FG001|Overall Study|Withdrawal by Subject|12|||
147310370|NCT00197028|531303884|FG000|Overall Study|Lost to Follow-up|1|||
147310371|NCT00197028|531303885|FG001|Overall Study|Lost to Follow-up|0|||
147310372|NCT00197028|531303884|FG000|Overall Study|Other|3|||
147310373|NCT00197028|531303885|FG001|Overall Study|Other|6|||
147310374|NCT00178256|531303886|FG000|Overall Study|Adverse Event|2|||
147310375|NCT00178256|531303887|FG001|Overall Study|Adverse Event|0|||
147310376|NCT00178256|531303888|FG002|Overall Study|Adverse Event|0|||
147310377|NCT00178256|531303889|FG003|Overall Study|Adverse Event|0|||
147310378|NCT00178256|531303886|FG000|Overall Study|Death|0|||
147310379|NCT00178256|531303887|FG001|Overall Study|Death|1|||
147310380|NCT00178256|531303888|FG002|Overall Study|Death|0|||
147310381|NCT00178256|531303889|FG003|Overall Study|Death|1|||
147310382|NCT00178256|531303886|FG000|Overall Study|Cancer progression|2|||
147310383|NCT00178256|531303887|FG001|Overall Study|Cancer progression|0|||
147310384|NCT00178256|531303888|FG002|Overall Study|Cancer progression|0|||
147310385|NCT00178256|531303889|FG003|Overall Study|Cancer progression|1|||
147310386|NCT03066622|531303892|FG000|Overall Study|Lost to Follow-up|24|||
147310387|NCT03066622|531303893|FG001|Overall Study|Lost to Follow-up|25|||
147310388|NCT03066622|531303892|FG000|Overall Study|Withdrawal by Subject|2|||
147310389|NCT03066622|531303893|FG001|Overall Study|Withdrawal by Subject|1|||
147310390|NCT01763788|531303894|FG000|Overall Study|Lost to Follow-up|0|||
147555679|NCT00619385|532191523|FG001|Overall Study|Adverse Event|0|||
147555680|NCT00619385|532191524|FG002|Overall Study|Adverse Event|3|||
147555681|NCT00619385|532191522|FG000|Overall Study|Other|1|||
147555682|NCT00619385|532191523|FG001|Overall Study|Other|2|||
147555683|NCT00619385|532191524|FG002|Overall Study|Other|1|||
147555684|NCT03730103|532191525|FG000|Overall Study|Did not meet inclusion criteria|0|||
147106022|NCT01056276|530553727|FG001|Maintenance Therapy|Withdrawal by Subject|1|||
147106023|NCT01056276|530553726|FG000|Maintenance Therapy|Intercurrent Illness|0|||
147310391|NCT01763788|531303895|FG001|Overall Study|Lost to Follow-up|0|||
147310392|NCT01763788|531303896|FG002|Overall Study|Lost to Follow-up|1|||
147310393|NCT01763788|531303897|FG003|Overall Study|Lost to Follow-up|0|||
147310394|NCT00641719|531303898|FG000|Overall Study|Lack of Efficacy|1|||
147310395|NCT00641719|531303899|FG001|Overall Study|Lack of Efficacy|2|||
147310396|NCT00641719|531303898|FG000|Overall Study|Adverse Event|24|||
147310397|NCT00641719|531303899|FG001|Overall Study|Adverse Event|29|||
147310398|NCT00641719|531303898|FG000|Overall Study|Withdrawal by Subject|4|||
147310399|NCT00641719|531303899|FG001|Overall Study|Withdrawal by Subject|4|||
147310400|NCT00641719|531303898|FG000|Overall Study|Reason Not Specified|1|||
147555685|NCT03730103|532191526|FG001|Overall Study|Did not meet inclusion criteria|5|||
147555686|NCT02626949|532191527|FG000|Randomization, Pre-Enrollment|did not attend the baseline interview|15|||
147555687|NCT02626949|532191528|FG001|Randomization, Pre-Enrollment|did not attend the baseline interview|11|||
147555688|NCT02626949|532191527|FG000|Randomization, Pre-Enrollment|did not meet inclusion criteria post-randomization|1|||
147106024|NCT01056276|530553727|FG001|Maintenance Therapy|Intercurrent Illness|1|||
147310401|NCT00641719|531303899|FG001|Overall Study|Reason Not Specified|2|||
147310402|NCT03303469|531303900|FG000|Overall Study|Lost to Follow-up|2|||
147310403|NCT00885352|531303905|FG000|Overall Study|Adverse Event|2|||
147106025|NCT01056276|530553726|FG000|Maintenance Therapy|Continuing maintenance therapy|0|||
147310404|NCT00885352|531303906|FG001|Overall Study|Adverse Event|3|||
147310405|NCT00885352|531303905|FG000|Overall Study|Lost to Follow-up|2|||
147310406|NCT00885352|531303906|FG001|Overall Study|Lost to Follow-up|2|||
147310407|NCT00885352|531303905|FG000|Overall Study|Physician Decision|0|||
147310408|NCT00885352|531303906|FG001|Overall Study|Physician Decision|3|||
147310409|NCT00885352|531303905|FG000|Overall Study|Protocol Violation|0|||
147310410|NCT00885352|531303906|FG001|Overall Study|Protocol Violation|2|||
147310411|NCT00885352|531303905|FG000|Overall Study|Withdrawal by Subject|1|||
147310412|NCT00885352|531303906|FG001|Overall Study|Withdrawal by Subject|5|||
147310413|NCT00885352|531303905|FG000|Overall Study|Contradiction to study medication|0|||
147310414|NCT00885352|531303906|FG001|Overall Study|Contradiction to study medication|2|||
147555689|NCT02626949|532191528|FG001|Randomization, Pre-Enrollment|did not meet inclusion criteria post-randomization|3|||
147555690|NCT02626949|532191527|FG000|Enrolled|Lost to Follow-up|7|||
147555691|NCT02626949|532191528|FG001|Enrolled|Lost to Follow-up|6|||
147555692|NCT02626949|532191527|FG000|Enrolled|Withdrawal by Subject|3|||
147555693|NCT02626949|532191528|FG001|Enrolled|Withdrawal by Subject|2|||
147555694|NCT02789111|532191529|FG000|Overall Study|Withdrawal by Subject|1|||
147555695|NCT02789111|532191530|FG001|Overall Study|Withdrawal by Subject|4|||
147555696|NCT01488578|532191531|FG000|Overall Study|Protocol Violation|1836|||
147555697|NCT02308111|532191532|FG000|Overall Study|Adverse Event|31|||
147555698|NCT02308111|532191533|FG001|Overall Study|Adverse Event|19|||
147555699|NCT02308111|532191532|FG000|Overall Study|Death|9|||
147555700|NCT02308111|532191533|FG001|Overall Study|Death|6|||
147555701|NCT02308111|532191532|FG000|Overall Study|Lost to Follow-up|2|||
147555702|NCT02308111|532191533|FG001|Overall Study|Lost to Follow-up|7|||
147106026|NCT01056276|530553727|FG001|Maintenance Therapy|Continuing maintenance therapy|14|||
147106027|NCT01881425|530553728|FG000|Overall Study|Death|5|||
147106028|NCT01881425|530553729|FG001|Overall Study|Death|1|||
147106029|NCT01881425|530553728|FG000|Overall Study|Withdrawal by Subject|8|||
147555703|NCT02308111|532191532|FG000|Overall Study|Physician Decision|6|||
147555704|NCT02308111|532191533|FG001|Overall Study|Physician Decision|17|||
147555705|NCT02308111|532191532|FG000|Overall Study|Protocol Violation|0|||
147555706|NCT02308111|532191533|FG001|Overall Study|Protocol Violation|1|||
147555707|NCT02308111|532191532|FG000|Overall Study|Withdrawal by Subject|28|||
147555708|NCT02308111|532191533|FG001|Overall Study|Withdrawal by Subject|38|||
147555709|NCT02308111|532191532|FG000|Overall Study|Study Terminated by Sponsor|72|||
147555710|NCT02308111|532191533|FG001|Overall Study|Study Terminated by Sponsor|61|||
147555711|NCT02308111|532191532|FG000|Overall Study|Initiated Commercial OCALIVA|6|||
147555712|NCT02308111|532191533|FG001|Overall Study|Initiated Commercial OCALIVA|8|||
147555713|NCT02308111|532191532|FG000|Overall Study|Site Closure|3|||
147555714|NCT02308111|532191533|FG001|Overall Study|Site Closure|3|||
147555715|NCT02308111|532191532|FG000|Overall Study|Non-compliance with Study Drug|3|||
147555716|NCT02308111|532191533|FG001|Overall Study|Non-compliance with Study Drug|1|||
147555717|NCT02308111|532191532|FG000|Overall Study|COVID-19 Pandemic Limitation|2|||
147555718|NCT02308111|532191533|FG001|Overall Study|COVID-19 Pandemic Limitation|0|||
147555719|NCT02308111|532191532|FG000|Overall Study|Liver Transplant|3|||
147555720|NCT02308111|532191533|FG001|Overall Study|Liver Transplant|3|||
147555721|NCT02308111|532191532|FG000|Overall Study|Liver Transplant Waitlist|2|||
147555722|NCT02308111|532191533|FG001|Overall Study|Liver Transplant Waitlist|2|||
147555723|NCT02308111|532191532|FG000|Overall Study|Early Termination As Subject Was Randomized Without Meeting All Eligibility Criteria|1|||
147555724|NCT02308111|532191533|FG001|Overall Study|Early Termination As Subject Was Randomized Without Meeting All Eligibility Criteria|0|||
147555725|NCT03271528|532191535|FG000|Medication Dispense/Exposure Period 1|Adverse Event|1|||
147555726|NCT03271528|532191536|FG001|Medication Dispense/Exposure Period 1|Adverse Event|0|||
147555727|NCT03271528|532191535|FG000|Medication Dispense/Exposure Period 1|Protocol Violation|1|||
147555728|NCT03271528|532191536|FG001|Medication Dispense/Exposure Period 1|Protocol Violation|0|||
147555729|NCT03271528|532191535|FG000|Medication Dispense/Exposure Period 1|Lost to Follow-up|0|||
147555730|NCT03271528|532191536|FG001|Medication Dispense/Exposure Period 1|Lost to Follow-up|1|||
147555731|NCT03271528|532191535|FG000|Medication Dispense/Exposure Period 1|Participation discontinued due to COVID-19 research pause|0|||
147555732|NCT03271528|532191536|FG001|Medication Dispense/Exposure Period 1|Participation discontinued due to COVID-19 research pause|1|||
147555733|NCT03271528|532191535|FG000|Alcohol Trial 1, Washout Period 1|Lost to Follow-up|1|||
147555734|NCT03271528|532191536|FG001|Alcohol Trial 1, Washout Period 1|Lost to Follow-up|1|||
147555735|NCT03271528|532191535|FG000|Alcohol Trial 1, Washout Period 1|Failed urine drug screen at time of Alcohol Trial 1|1|||
147555736|NCT03271528|532191536|FG001|Alcohol Trial 1, Washout Period 1|Failed urine drug screen at time of Alcohol Trial 1|0|||
147555737|NCT03271528|532191535|FG000|Medication Dispense/Exposure Period 2|Lost to Follow-up|1|||
147555738|NCT03271528|532191536|FG001|Medication Dispense/Exposure Period 2|Lost to Follow-up|0|||
147555739|NCT00673790|532191537|FG000|Overall Study|Adverse Event|23|||
147555740|NCT00673790|532191538|FG001|Overall Study|Adverse Event|14|||
147555741|NCT00673790|532191539|FG002|Overall Study|Adverse Event|2|||
147555742|NCT00673790|532191537|FG000|Overall Study|Lack of Efficacy|2|||
147555743|NCT00673790|532191538|FG001|Overall Study|Lack of Efficacy|2|||
147555744|NCT00673790|532191539|FG002|Overall Study|Lack of Efficacy|2|||
147555745|NCT00673790|532191537|FG000|Overall Study|Protocol Violation|6|||
147555746|NCT00673790|532191538|FG001|Overall Study|Protocol Violation|9|||
147106030|NCT01881425|530553729|FG001|Overall Study|Withdrawal by Subject|3|||
147555747|NCT00673790|532191539|FG002|Overall Study|Protocol Violation|1|||
147555748|NCT00673790|532191537|FG000|Overall Study|Withdrawal by Subject|7|||
147555749|NCT00673790|532191538|FG001|Overall Study|Withdrawal by Subject|4|||
147555750|NCT00673790|532191539|FG002|Overall Study|Withdrawal by Subject|1|||
147555751|NCT00673790|532191537|FG000|Overall Study|Lost to Follow-up|6|||
147555752|NCT00673790|532191538|FG001|Overall Study|Lost to Follow-up|6|||
147555753|NCT00673790|532191539|FG002|Overall Study|Lost to Follow-up|5|||
147555754|NCT00673790|532191537|FG000|Overall Study|Sponsor Terminated due to PI oversight|0|||
147106031|NCT01881425|530553728|FG000|Overall Study|Physician Decision|2|||
147555755|NCT00673790|532191538|FG001|Overall Study|Sponsor Terminated due to PI oversight|1|||
147555756|NCT00673790|532191539|FG002|Overall Study|Sponsor Terminated due to PI oversight|0|||
147555757|NCT00673790|532191537|FG000|Overall Study|Poor compliance|1|||
147555758|NCT00673790|532191538|FG001|Overall Study|Poor compliance|0|||
147555759|NCT00673790|532191539|FG002|Overall Study|Poor compliance|0|||
147555760|NCT00673790|532191537|FG000|Overall Study|Participated in two Nebivolol studies|0|||
147555761|NCT00673790|532191538|FG001|Overall Study|Participated in two Nebivolol studies|0|||
147555762|NCT00673790|532191539|FG002|Overall Study|Participated in two Nebivolol studies|1|||
147555763|NCT00673790|532191537|FG000|Overall Study|Unconfirmed pregnancy|0|||
147555764|NCT00673790|532191538|FG001|Overall Study|Unconfirmed pregnancy|1|||
147555765|NCT00673790|532191539|FG002|Overall Study|Unconfirmed pregnancy|0|||
147555766|NCT00673790|532191537|FG000|Overall Study|Randomization criteria not met|0|||
147555767|NCT00673790|532191538|FG001|Overall Study|Randomization criteria not met|1|||
147555768|NCT00673790|532191539|FG002|Overall Study|Randomization criteria not met|0|||
147555769|NCT00306384|532191540|FG000|Overall Study|Adverse Event|103|||
147555770|NCT00306384|532191541|FG001|Overall Study|Adverse Event|87|||
147555771|NCT00306384|532191542|FG002|Overall Study|Adverse Event|40|||
147555772|NCT00306384|532191540|FG000|Overall Study|Major protocol deviation|43|||
147555773|NCT00306384|532191541|FG001|Overall Study|Major protocol deviation|51|||
147555774|NCT00306384|532191542|FG002|Overall Study|Major protocol deviation|18|||
147555775|NCT00306384|532191540|FG000|Overall Study|Lost to Follow-up|57|||
147555776|NCT00306384|532191541|FG001|Overall Study|Lost to Follow-up|41|||
147555777|NCT00306384|532191542|FG002|Overall Study|Lost to Follow-up|35|||
147555778|NCT00306384|532191540|FG000|Overall Study|Voluntary withdrawal|199|||
147555779|NCT00306384|532191541|FG001|Overall Study|Voluntary withdrawal|187|||
147555780|NCT00306384|532191542|FG002|Overall Study|Voluntary withdrawal|91|||
147555781|NCT00306384|532191540|FG000|Overall Study|Study termination|1|||
147555782|NCT00306384|532191541|FG001|Overall Study|Study termination|0|||
147555783|NCT00306384|532191542|FG002|Overall Study|Study termination|1|||
147555784|NCT00306384|532191540|FG000|Overall Study|Pregnancy|3|||
147555785|NCT00306384|532191541|FG001|Overall Study|Pregnancy|1|||
147555786|NCT00306384|532191542|FG002|Overall Study|Pregnancy|1|||
147555787|NCT00306384|532191540|FG000|Overall Study|Lack of Efficacy|26|||
147555788|NCT00306384|532191541|FG001|Overall Study|Lack of Efficacy|40|||
147555789|NCT00306384|532191542|FG002|Overall Study|Lack of Efficacy|38|||
147555790|NCT00306384|532191540|FG000|Overall Study|Investigator discretion|28|||
147555791|NCT00306384|532191541|FG001|Overall Study|Investigator discretion|31|||
147555792|NCT00306384|532191542|FG002|Overall Study|Investigator discretion|21|||
147555793|NCT00306384|532191540|FG000|Overall Study|Other|80|||
147555794|NCT00306384|532191541|FG001|Overall Study|Other|70|||
147555795|NCT00306384|532191542|FG002|Overall Study|Other|32|||
147555796|NCT00306384|532191540|FG000|Overall Study|Site closure|2|||
147555797|NCT00306384|532191541|FG001|Overall Study|Site closure|0|||
147555798|NCT00306384|532191542|FG002|Overall Study|Site closure|0|||
147555799|NCT00717756|532191543|FG000|Overall Study|Withdrawal by Subject|1|||
147555800|NCT01873859|532191548|FG000|Overall Study|Withdrawal by Subject|0|||
147555801|NCT01873859|532191549|FG001|Overall Study|Withdrawal by Subject|4|||
147555802|NCT00601484|532191551|FG000|Overall Study|Adverse Event|0|||
147555803|NCT00601484|532191552|FG001|Overall Study|Adverse Event|1|||
147555804|NCT00601484|532191551|FG000|Overall Study|Lost to Follow-up|4|||
147555805|NCT00601484|532191552|FG001|Overall Study|Lost to Follow-up|3|||
147555806|NCT00601484|532191551|FG000|Overall Study|Lack of Efficacy|0|||
147555807|NCT00601484|532191552|FG001|Overall Study|Lack of Efficacy|2|||
147555808|NCT00601484|532191551|FG000|Overall Study|Withdrawal by Subject|1|||
147555809|NCT00601484|532191552|FG001|Overall Study|Withdrawal by Subject|1|||
147555810|NCT00601484|532191551|FG000|Overall Study|Randomized, but not treated|0|||
147555811|NCT00601484|532191552|FG001|Overall Study|Randomized, but not treated|1|||
147555812|NCT03977584|532191553|FG000|Overall Study|Reason not disclosed to prevent genetic unblinding|2|||
147555813|NCT03977584|532191554|FG001|Overall Study|Reason not disclosed to prevent genetic unblinding|0|||
147555814|NCT03977584|532191555|FG002|Overall Study|Reason not disclosed to prevent genetic unblinding|4|||
147555815|NCT03504852|532191559|FG000|Overall Study|Withdrawal of informed consent|2|||
147555816|NCT03504852|532191560|FG001|Overall Study|Withdrawal of informed consent|1|||
147555817|NCT03504852|532191561|FG002|Overall Study|Withdrawal of informed consent|0|||
147555818|NCT03504852|532191559|FG000|Overall Study|Withdrawal by Subject|5|||
147555819|NCT03504852|532191560|FG001|Overall Study|Withdrawal by Subject|5|||
147555820|NCT03504852|532191561|FG002|Overall Study|Withdrawal by Subject|1|||
147555821|NCT03504852|532191559|FG000|Overall Study|Lost to Follow-up|4|||
147555822|NCT03504852|532191560|FG001|Overall Study|Lost to Follow-up|1|||
147555823|NCT03504852|532191561|FG002|Overall Study|Lost to Follow-up|0|||
147555824|NCT03504852|532191559|FG000|Overall Study|New therapy for study indication|1|||
147555825|NCT03504852|532191560|FG001|Overall Study|New therapy for study indication|0|||
147555826|NCT03504852|532191561|FG002|Overall Study|New therapy for study indication|0|||
147555827|NCT03504852|532191559|FG000|Overall Study|Lack of Efficacy|1|||
147555828|NCT03504852|532191560|FG001|Overall Study|Lack of Efficacy|2|||
147555829|NCT03504852|532191561|FG002|Overall Study|Lack of Efficacy|0|||
147106032|NCT01881425|530553729|FG001|Overall Study|Physician Decision|1|||
147555830|NCT03504852|532191559|FG000|Overall Study|Death|0|||
147555831|NCT03504852|532191560|FG001|Overall Study|Death|1|||
147555832|NCT03504852|532191561|FG002|Overall Study|Death|0|||
147555833|NCT03504852|532191559|FG000|Overall Study|Adverse Event|4|||
147555834|NCT03504852|532191560|FG001|Overall Study|Adverse Event|8|||
147224931|NCT00206076|530994852|FG000|Overall Study|Physician Decision|2|||
147224932|NCT00206076|530994853|FG001|Overall Study|Physician Decision|0|||
147224933|NCT00206076|530994852|FG000|Overall Study|Withdrawal by Subject|1|||
147224934|NCT00206076|530994853|FG001|Overall Study|Withdrawal by Subject|1|||
147224935|NCT03418571|530994857|FG000|Overall Study|Consent withdrawn by legal guardian|1|||
147224936|NCT03418571|530994858|FG001|Overall Study|Consent withdrawn by legal guardian|0|||
147224937|NCT00586326|530994859|FG000|Enrollment to Device Placement-Enrolled|Skin Distance|6|||
147224938|NCT00586326|530994859|FG000|Enrollment to Device Placement-Enrolled|Cavity Conformance|4|||
147224939|NCT00586326|530994859|FG000|Enrollment to Device Placement-Enrolled|Microinvasion|2|||
147224940|NCT00586326|530994859|FG000|Enrollment to Device Placement-Enrolled|Physician Decision|1|||
147224941|NCT00586326|530994859|FG000|Enrollment to Device Placement-Enrolled|Withdrawal by Subject|1|||
147224942|NCT00586326|530994859|FG000|Enrollment to Device Placement-Enrolled|Other|1|||
147224943|NCT00586326|530994859|FG000|Device Placed toTreatment-ITT|Skin Distance|7|||
147224944|NCT00586326|530994859|FG000|Device Placed toTreatment-ITT|Cavity Conformance|6|||
147224945|NCT00586326|530994859|FG000|Device Placed toTreatment-ITT|Microinvasion|1|||
147224946|NCT00586326|530994859|FG000|Device Placed toTreatment-ITT|Positive Margins|3|||
147224947|NCT00586326|530994859|FG000|Device Placed toTreatment-ITT|Physician Decision|1|||
147224948|NCT00586326|530994859|FG000|Treated Through 5-yr Follow Up-Treated|Clinical Reason|1|||
147224949|NCT00586326|530994859|FG000|Treated Through 5-yr Follow Up-Treated|Death|2|||
147224950|NCT00586326|530994859|FG000|Treated Through 5-yr Follow Up-Treated|Medical Reason|2|||
147224951|NCT00586326|530994859|FG000|Treated Through 5-yr Follow Up-Treated|Withdrawal by Subject|5|||
147224952|NCT00586326|530994859|FG000|Treated Through 5-yr Follow Up-Treated|Lost to Follow-up|14|||
147224953|NCT00586326|530994859|FG000|Treated Through 5-yr Follow Up-Treated|Other|2|||
147224954|NCT03595774|530994860|FG000|Overall Study|Adverse Event|1|||
147224955|NCT03595774|530994861|FG001|Overall Study|Adverse Event|0|||
147224956|NCT03595774|530994862|FG002|Overall Study|Adverse Event|1|||
147224957|NCT03595774|530994863|FG003|Overall Study|Adverse Event|0|||
147224958|NCT03595774|530994860|FG000|Overall Study|screen failure|0|||
147224959|NCT03595774|530994861|FG001|Overall Study|screen failure|1|||
147224960|NCT03595774|530994862|FG002|Overall Study|screen failure|0|||
147224961|NCT03595774|530994863|FG003|Overall Study|screen failure|1|||
147443983|NCT02819635|531790442|FG005|Substudy 3|Adverse Event|0|||
147443984|NCT02819635|531790443|FG006|Substudy 3|Adverse Event|0|||
147443985|NCT02819635|531790444|FG007|Substudy 3|Adverse Event|0|||
147443986|NCT02819635|531790445|FG008|Substudy 3|Adverse Event|32|||
147443987|NCT02819635|531790446|FG009|Substudy 3|Adverse Event|3|||
147443988|NCT02819635|531790447|FG010|Substudy 3|Adverse Event|12|||
147443989|NCT02819635|531790448|FG011|Substudy 3|Adverse Event|18|||
147443990|NCT02819635|531790437|FG000|Substudy 3|Withdrew consent|0|||
147443991|NCT02819635|531790438|FG001|Substudy 3|Withdrew consent|0|||
147443992|NCT02819635|531790439|FG002|Substudy 3|Withdrew consent|0|||
147443993|NCT02819635|531790440|FG003|Substudy 3|Withdrew consent|0|||
147443994|NCT02819635|531790441|FG004|Substudy 3|Withdrew consent|0|||
147443995|NCT02819635|531790442|FG005|Substudy 3|Withdrew consent|0|||
147443996|NCT02819635|531790443|FG006|Substudy 3|Withdrew consent|0|||
147443997|NCT02819635|531790444|FG007|Substudy 3|Withdrew consent|0|||
147443998|NCT02819635|531790445|FG008|Substudy 3|Withdrew consent|11|||
147443999|NCT02819635|531790446|FG009|Substudy 3|Withdrew consent|1|||
147444000|NCT02819635|531790447|FG010|Substudy 3|Withdrew consent|4|||
147444001|NCT02819635|531790448|FG011|Substudy 3|Withdrew consent|9|||
147444002|NCT02819635|531790437|FG000|Substudy 3|Lost to Follow-up|0|||
147444003|NCT02819635|531790438|FG001|Substudy 3|Lost to Follow-up|0|||
147444004|NCT02819635|531790439|FG002|Substudy 3|Lost to Follow-up|0|||
147444005|NCT02819635|531790440|FG003|Substudy 3|Lost to Follow-up|0|||
147444006|NCT02819635|531790441|FG004|Substudy 3|Lost to Follow-up|0|||
147444007|NCT02819635|531790442|FG005|Substudy 3|Lost to Follow-up|0|||
147444008|NCT02819635|531790443|FG006|Substudy 3|Lost to Follow-up|0|||
147444009|NCT02819635|531790444|FG007|Substudy 3|Lost to Follow-up|0|||
147444010|NCT02819635|531790445|FG008|Substudy 3|Lost to Follow-up|1|||
147444011|NCT02819635|531790446|FG009|Substudy 3|Lost to Follow-up|0|||
147444012|NCT02819635|531790447|FG010|Substudy 3|Lost to Follow-up|1|||
147444013|NCT02819635|531790448|FG011|Substudy 3|Lost to Follow-up|1|||
147444014|NCT02819635|531790437|FG000|Substudy 3|COVID-19 Logistical Restrictions|0|||
147444015|NCT02819635|531790438|FG001|Substudy 3|COVID-19 Logistical Restrictions|0|||
147444016|NCT02819635|531790439|FG002|Substudy 3|COVID-19 Logistical Restrictions|0|||
147444017|NCT02819635|531790440|FG003|Substudy 3|COVID-19 Logistical Restrictions|0|||
147444018|NCT02819635|531790441|FG004|Substudy 3|COVID-19 Logistical Restrictions|0|||
147444019|NCT02819635|531790442|FG005|Substudy 3|COVID-19 Logistical Restrictions|0|||
147444020|NCT02819635|531790443|FG006|Substudy 3|COVID-19 Logistical Restrictions|0|||
147444021|NCT02819635|531790444|FG007|Substudy 3|COVID-19 Logistical Restrictions|0|||
147555835|NCT03504852|532191561|FG002|Overall Study|Adverse Event|2|||
147106033|NCT01881425|530553728|FG000|Overall Study|Adverse Event|3|||
147106034|NCT01881425|530553729|FG001|Overall Study|Adverse Event|0|||
147555836|NCT00745251|532191562|FG000|Overall Study|Adverse Event|1|||
147555837|NCT00745251|532191563|FG001|Overall Study|Adverse Event|2|||
147555838|NCT00745251|532191562|FG000|Overall Study|Withdrawal by Subject|1|||
147555839|NCT00745251|532191563|FG001|Overall Study|Withdrawal by Subject|1|||
147555840|NCT02928848|532191564|FG000|Arm 2|Withdrawal by Subject|1|||
147555841|NCT02928848|532191565|FG001|Arm 2|Withdrawal by Subject|0|||
147555842|NCT03850509|532191566|FG000|Overall Study|Study Terminated by the Sponsor (Due to COVID-19 Situation)|2|||
147555843|NCT03850509|532191567|FG001|Overall Study|Study Terminated by the Sponsor (Due to COVID-19 Situation)|1|||
147555844|NCT00969332|532191568|FG000|Overall Study|Physician Decision|8|||
147555845|NCT00969332|532191568|FG000|Overall Study|Withdrawal by Subject|3|||
147555846|NCT02666430|532191569|FG000|Period 1|Lost to Follow-up|1|||
147555847|NCT02666430|532191570|FG001|Period 1|Lost to Follow-up|0|||
147555848|NCT02666430|532191569|FG000|Period 1|Adverse Event|0|||
147555849|NCT02666430|532191570|FG001|Period 1|Adverse Event|1|||
147555850|NCT02666430|532191569|FG000|Period 2|Withdrawal by Subject|1|||
147555851|NCT02666430|532191570|FG001|Period 2|Withdrawal by Subject|4|||
147555852|NCT02666430|532191569|FG000|Period 3|Lost to Follow-up|1|||
147555853|NCT02666430|532191570|FG001|Period 3|Lost to Follow-up|0|||
147555854|NCT03828461|532191571|FG000|Overall Study|Lost to Follow-up|1|||
147555855|NCT03828461|532191571|FG000|Overall Study|Withdrawal by Subject|3|||
147555856|NCT00576199|532191572|FG000|Overall Study|Adverse Event|12|||
147555857|NCT00576199|532191572|FG000|Overall Study|Insufficient Therapeutic Response|14|||
147555858|NCT00576199|532191572|FG000|Overall Study|Refused Treatment|2|||
147555859|NCT00576199|532191572|FG000|Overall Study|Reason Unspecified|2|||
147555860|NCT05328375|532193283|FG000|Overall Study|Withdrawal by Subject|0|||
147555861|NCT05328375|532193284|FG001|Overall Study|Withdrawal by Subject|1|||
147555862|NCT02178709|532193286|FG000|Overall Study|Adverse Event|5|||
147555863|NCT02178709|532193286|FG000|Overall Study|Death|2|||
147555864|NCT02178709|532193286|FG000|Overall Study|Withdrawal by Subject|2|||
147555865|NCT02178709|532193286|FG000|Overall Study|Physician Decision|2|||
147555866|NCT02178709|532193286|FG000|Overall Study|Disease Progression|5|||
147555867|NCT02946385|532193287|FG000|Overall Study|Lost to Follow-up|0|||
147555868|NCT02946385|532193288|FG001|Overall Study|Lost to Follow-up|0|||
147555869|NCT02946385|532193289|FG002|Overall Study|Lost to Follow-up|3|||
147555870|NCT02946385|532193290|FG003|Overall Study|Lost to Follow-up|0|||
147555871|NCT02946385|532193291|FG004|Overall Study|Lost to Follow-up|2|||
147555872|NCT02946385|532193292|FG005|Overall Study|Lost to Follow-up|1|||
147555873|NCT00101582|532193297|FG000|Overall Study|Ineligibility determined|0|||
147555874|NCT00101582|532193298|FG001|Overall Study|Ineligibility determined|1|||
147555875|NCT00101582|532193297|FG000|Overall Study|Adverse Event|1|||
147555876|NCT00101582|532193298|FG001|Overall Study|Adverse Event|4|||
147555877|NCT00101582|532193297|FG000|Overall Study|Withdrawal by Subject|6|||
147555878|NCT00101582|532193298|FG001|Overall Study|Withdrawal by Subject|4|||
147555879|NCT00101582|532193297|FG000|Overall Study|Physician Decision|1|||
147555880|NCT00101582|532193298|FG001|Overall Study|Physician Decision|0|||
147555881|NCT00101582|532193297|FG000|Overall Study|Death|3|||
147555882|NCT00101582|532193298|FG001|Overall Study|Death|5|||
147555883|NCT00101582|532193297|FG000|Overall Study|Other|0|||
147555884|NCT00101582|532193298|FG001|Overall Study|Other|1|||
147555885|NCT01919190|532193299|FG000|Overall Study|Intra-op findings, etc.|3|||
147555886|NCT01919190|532193300|FG001|Overall Study|Intra-op findings, etc.|0|||
147555887|NCT01893905|532193301|FG000|Overall Study|Withdrawal by Subject|1|||
147555888|NCT01893905|532193302|FG001|Overall Study|Withdrawal by Subject|0|||
147555889|NCT01893905|532193301|FG000|Overall Study|Adverse Event|9|||
147555890|NCT01893905|532193302|FG001|Overall Study|Adverse Event|3|||
147555891|NCT01893905|532193301|FG000|Overall Study|Lack of Efficacy|5|||
147555892|NCT01893905|532193302|FG001|Overall Study|Lack of Efficacy|7|||
147555893|NCT01893905|532193301|FG000|Overall Study|Lost to Follow-up|1|||
147555894|NCT01893905|532193302|FG001|Overall Study|Lost to Follow-up|0|||
147555895|NCT01893905|532193301|FG000|Overall Study|Protocol Violation|6|||
147106035|NCT01881425|530553728|FG000|Overall Study|General Anesthesia panic attack|0|||
147106036|NCT01881425|530553729|FG001|Overall Study|General Anesthesia panic attack|1|||
147224962|NCT03519386|530994864|FG000|Overall Study|Withdrawal by Subject|4|||
147224963|NCT03519386|530994865|FG001|Overall Study|Withdrawal by Subject|1|||
147224964|NCT03519386|530994866|FG002|Overall Study|Withdrawal by Subject|2|||
147224965|NCT03519386|530994864|FG000|Overall Study|Physician Decision|1|||
147224966|NCT03519386|530994865|FG001|Overall Study|Physician Decision|1|||
147224967|NCT03519386|530994866|FG002|Overall Study|Physician Decision|1|||
147555896|NCT01893905|532193302|FG001|Overall Study|Protocol Violation|1|||
147555897|NCT01893905|532193301|FG000|Overall Study|Lack of adherence to treatment|2|||
147555898|NCT01893905|532193302|FG001|Overall Study|Lack of adherence to treatment|0|||
147555899|NCT01893905|532193301|FG000|Overall Study|Other reason|1|||
147555900|NCT01893905|532193302|FG001|Overall Study|Other reason|3|||
147555901|NCT01768858|532193303|FG000|Overall Study|Lost to Follow-up|9|||
147555902|NCT01768858|532193303|FG000|Overall Study|Lack of Efficacy|8|||
147555903|NCT01768858|532193303|FG000|Overall Study|Serious Adverse Event|1|||
147224968|NCT03519386|530994864|FG000|Overall Study|Lost to Follow-up|0|||
147224969|NCT03519386|530994865|FG001|Overall Study|Lost to Follow-up|1|||
147224970|NCT03519386|530994866|FG002|Overall Study|Lost to Follow-up|1|||
147224971|NCT03519386|530994864|FG000|Overall Study|Death|1|||
147224972|NCT03519386|530994865|FG001|Overall Study|Death|0|||
147224973|NCT03519386|530994866|FG002|Overall Study|Death|4|||
147224974|NCT03519386|530994864|FG000|Overall Study|Adverse Event|2|||
147224975|NCT03519386|530994865|FG001|Overall Study|Adverse Event|1|||
147224976|NCT03519386|530994866|FG002|Overall Study|Adverse Event|2|||
147224977|NCT03519386|530994864|FG000|Overall Study|Explanted|2|||
147224978|NCT03519386|530994865|FG001|Overall Study|Explanted|1|||
147224979|NCT03519386|530994866|FG002|Overall Study|Explanted|0|||
147224980|NCT03519386|530994864|FG000|Overall Study|Ongoing in study|190|||
147224981|NCT03519386|530994865|FG001|Overall Study|Ongoing in study|192|||
147224982|NCT03519386|530994866|FG002|Overall Study|Ongoing in study|183|||
147224983|NCT03101267|530994868|FG000|Primary Study Period|Withdrawal by Subject|1|||
147224984|NCT03101267|530994869|FG001|Primary Study Period|Withdrawal by Subject|2|||
147224985|NCT03101267|530994870|FG002|Primary Study Period|Withdrawal by Subject|3|||
147224986|NCT03101267|530994868|FG000|Primary Study Period|Miscellaneous|2|||
147224987|NCT03101267|530994869|FG001|Primary Study Period|Miscellaneous|0|||
147224988|NCT03101267|530994870|FG002|Primary Study Period|Miscellaneous|0|||
147224989|NCT00107952|530994871|FG000|Overall Study|Death|75|||
147224990|NCT00107952|530994872|FG001|Overall Study|Death|61|||
147224991|NCT00107952|530994871|FG000|Overall Study|Lost to Follow-up|0|||
147224992|NCT00107952|530994872|FG001|Overall Study|Lost to Follow-up|3|||
147224993|NCT00107952|530994871|FG000|Overall Study|Withdrawal by Subject|9|||
147224994|NCT00107952|530994872|FG001|Overall Study|Withdrawal by Subject|6|||
147224995|NCT00107952|530994871|FG000|Overall Study|Other|2|||
147224996|NCT00107952|530994872|FG001|Overall Study|Other|5|||
147224997|NCT00107952|530994871|FG000|Overall Study|Never received study treatment|9|||
147224998|NCT00107952|530994872|FG001|Overall Study|Never received study treatment|6|||
147224999|NCT03063203|530994880|FG000|Overall Study|Chose alternative therapy|3|||
147225000|NCT03063203|530994880|FG000|Overall Study|Death|2|||
147225001|NCT03063203|530994880|FG000|Overall Study|Disease progression|4|||
147225002|NCT03063203|530994880|FG000|Overall Study|Physician Decision|5|||
147225003|NCT02632838|530994881|FG000|Overall Study|Withdrawal by Subject|3|||
147225004|NCT02632838|530994882|FG001|Overall Study|Withdrawal by Subject|0|||
147225005|NCT02632838|530994881|FG000|Overall Study|Lost to Follow-up|0|||
147225006|NCT02632838|530994882|FG001|Overall Study|Lost to Follow-up|2|||
147225007|NCT03945175|530994883|FG000|Overall Study|Did not meet inclusion criteria|31|||
147225008|NCT03945175|530994883|FG000|Overall Study|Withdrew consent|2|||
147225009|NCT03945175|530994883|FG000|Overall Study|Responded to Placebo Treatment and was not Allocated to Mydayis|1|||
147225010|NCT03945175|530994883|FG000|Overall Study|Early termination during Mydayis treatment|1|||
147225011|NCT00769483|530994888|FG000|Overall Study|Withdrawal by Subject|0|||
147225012|NCT00769483|530994889|FG001|Overall Study|Withdrawal by Subject|1|||
147225013|NCT00769483|530994890|FG002|Overall Study|Withdrawal by Subject|0|||
147225014|NCT00769483|530994891|FG003|Overall Study|Withdrawal by Subject|0|||
147225015|NCT00769483|530994892|FG004|Overall Study|Withdrawal by Subject|1|||
147225016|NCT00769483|530994893|FG005|Overall Study|Withdrawal by Subject|0|||
147225017|NCT01306877|530994894|FG000|Overall Study|Lost to Follow-up|3|||
147225018|NCT01306877|530994895|FG001|Overall Study|Lost to Follow-up|3|||
147225019|NCT01306877|530994894|FG000|Overall Study|Physician Decision|0|||
147225020|NCT01306877|530994895|FG001|Overall Study|Physician Decision|1|||
147225021|NCT00006389|530994896|FG000|Overall Study|Adverse Event|1|||
147225022|NCT00999921|530994900|FG000|Overall Study|Lost to Follow-up|10|||
147225023|NCT00999921|530994901|FG001|Overall Study|Lost to Follow-up|19|||
147225024|NCT00772070|530994908|FG000|Overall Study|Lost to Follow-up|0|||
147225025|NCT00772070|530994909|FG001|Overall Study|Lost to Follow-up|8|||
147225026|NCT00772070|530994908|FG000|Overall Study|Withdrawal by Subject|0|||
147225027|NCT00772070|530994909|FG001|Overall Study|Withdrawal by Subject|2|||
147225028|NCT00772070|530994908|FG000|Overall Study|Vaccination error-wrong dose/expired lot|2|||
147225029|NCT00772070|530994909|FG001|Overall Study|Vaccination error-wrong dose/expired lot|0|||
147225030|NCT01309308|530994910|FG000|Overall Study|Lost to Follow-up|6|||
147225031|NCT01309308|530994911|FG001|Overall Study|Lost to Follow-up|4|||
147225032|NCT01307020|530994913|FG000|Overall Study|Lost to Follow-up|0|||
147225033|NCT01307020|530994914|FG001|Overall Study|Lost to Follow-up|0|||
147225034|NCT01307020|530994915|FG002|Overall Study|Lost to Follow-up|1|||
147225035|NCT01307020|530994916|FG003|Overall Study|Lost to Follow-up|1|||
147225036|NCT01307020|530994917|FG004|Overall Study|Lost to Follow-up|0|||
147225037|NCT01307020|530994918|FG005|Overall Study|Lost to Follow-up|0|||
147225038|NCT01307020|530994919|FG006|Overall Study|Lost to Follow-up|1|||
147225039|NCT01307020|530994920|FG007|Overall Study|Lost to Follow-up|0|||
147225040|NCT01307020|530994921|FG008|Overall Study|Lost to Follow-up|0|||
147225041|NCT01307020|530994922|FG009|Overall Study|Lost to Follow-up|0|||
147225042|NCT01307020|530994913|FG000|Overall Study|Electronic data capture failure|0|||
147225043|NCT01307020|530994914|FG001|Overall Study|Electronic data capture failure|1|||
147225044|NCT01307020|530994915|FG002|Overall Study|Electronic data capture failure|0|||
147225045|NCT01307020|530994916|FG003|Overall Study|Electronic data capture failure|0|||
147310415|NCT00885352|531303905|FG000|Overall Study|Excluded medication|2|||
147310416|NCT00885352|531303906|FG001|Overall Study|Excluded medication|2|||
147310417|NCT00885352|531303905|FG000|Overall Study|Lab abnormalities|1|||
147310418|NCT00885352|531303906|FG001|Overall Study|Lab abnormalities|1|||
147310419|NCT00365378|531303907|FG000|Vaccination (Day 1 to Month 7)|Randomized Not Vaccinated|11|||
147310420|NCT00365378|531303908|FG001|Vaccination (Day 1 to Month 7)|Randomized Not Vaccinated|7|||
147310421|NCT00365378|531303909|FG002|Vaccination (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
147310422|NCT00365378|531303907|FG000|Vaccination (Day 1 to Month 7)|Adverse Event|4|||
147310423|NCT00365378|531303908|FG001|Vaccination (Day 1 to Month 7)|Adverse Event|5|||
147310424|NCT00365378|531303909|FG002|Vaccination (Day 1 to Month 7)|Adverse Event|0|||
147310425|NCT00365378|531303907|FG000|Vaccination (Day 1 to Month 7)|Lost to Follow-up|88|||
147310426|NCT00365378|531303908|FG001|Vaccination (Day 1 to Month 7)|Lost to Follow-up|75|||
147106037|NCT01881425|530553728|FG000|Overall Study|Subject randomized after study treatment cut off|0|||
147106038|NCT01881425|530553729|FG001|Overall Study|Subject randomized after study treatment cut off|1|||
147106039|NCT01881425|530553728|FG000|Overall Study|Lost to Follow-up|7|||
147106040|NCT01881425|530553729|FG001|Overall Study|Lost to Follow-up|2|||
147310427|NCT00365378|531303909|FG002|Vaccination (Day 1 to Month 7)|Lost to Follow-up|0|||
147310428|NCT00365378|531303907|FG000|Vaccination (Day 1 to Month 7)|Pregnancy|19|||
147310429|NCT00365378|531303908|FG001|Vaccination (Day 1 to Month 7)|Pregnancy|14|||
147444022|NCT02819635|531790445|FG008|Substudy 3|COVID-19 Logistical Restrictions|0|||
147444023|NCT02819635|531790446|FG009|Substudy 3|COVID-19 Logistical Restrictions|0|||
147444024|NCT02819635|531790447|FG010|Substudy 3|COVID-19 Logistical Restrictions|0|||
147444025|NCT02819635|531790448|FG011|Substudy 3|COVID-19 Logistical Restrictions|1|||
147444026|NCT02819635|531790437|FG000|Substudy 3|Other, not specified|0|||
147444027|NCT02819635|531790438|FG001|Substudy 3|Other, not specified|0|||
147444028|NCT02819635|531790439|FG002|Substudy 3|Other, not specified|0|||
147444029|NCT02819635|531790440|FG003|Substudy 3|Other, not specified|0|||
147444030|NCT02819635|531790441|FG004|Substudy 3|Other, not specified|0|||
147444031|NCT02819635|531790442|FG005|Substudy 3|Other, not specified|0|||
147444032|NCT02819635|531790443|FG006|Substudy 3|Other, not specified|0|||
147444033|NCT02819635|531790444|FG007|Substudy 3|Other, not specified|0|||
147444034|NCT02819635|531790445|FG008|Substudy 3|Other, not specified|202|||
147444035|NCT02819635|531790446|FG009|Substudy 3|Other, not specified|5|||
147444036|NCT02819635|531790447|FG010|Substudy 3|Other, not specified|89|||
147444037|NCT02819635|531790448|FG011|Substudy 3|Other, not specified|39|||
147444038|NCT03179891|531790452|FG000|First Intervention|Withdrawal by Subject|1|||
147444039|NCT03179891|531790453|FG001|First Intervention|Withdrawal by Subject|1|||
147444040|NCT03179891|531790452|FG000|First Intervention|Unspecified reason|1|||
147444041|NCT03179891|531790453|FG001|First Intervention|Unspecified reason|0|||
147444042|NCT03179891|531790452|FG000|First Intervention|Protocol Violation|0|||
147444043|NCT03179891|531790453|FG001|First Intervention|Protocol Violation|1|||
147444044|NCT02969187|531790455|FG000|Overall Study|Physician Decision|12|||
147444045|NCT02969187|531790456|FG001|Overall Study|Physician Decision|13|||
147444046|NCT03719690|531790459|FG000|Overall Study|Withdrawal by Subject|5|||
147444047|NCT03719690|531790460|FG001|Overall Study|Withdrawal by Subject|10|||
147444048|NCT03719690|531790459|FG000|Overall Study|Death|40|||
147444049|NCT03719690|531790460|FG001|Overall Study|Death|149|||
147444050|NCT03719690|531790459|FG000|Overall Study|Miscellaneous|12|||
147444051|NCT03719690|531790460|FG001|Overall Study|Miscellaneous|56|||
147444052|NCT03719690|531790459|FG000|Overall Study|Lost to Follow-up|2|||
147444053|NCT03719690|531790460|FG001|Overall Study|Lost to Follow-up|18|||
147444054|NCT03719690|531790459|FG000|Overall Study|Unwilling or unable to comply with study requirements|0|||
147444055|NCT03719690|531790460|FG001|Overall Study|Unwilling or unable to comply with study requirements|4|||
147444056|NCT01471015|531790461|FG000|Overall Study|Death|0|||
147444057|NCT01471015|531790462|FG001|Overall Study|Death|1|||
147444058|NCT01471015|531790463|FG002|Overall Study|Death|1|||
147444059|NCT00928889|531790468|FG000|Overall Study|Lost to Follow-up|3|||
147444060|NCT00928889|531790469|FG001|Overall Study|Lost to Follow-up|1|||
147444061|NCT00928889|531790468|FG000|Overall Study|Protocol Violation|0|||
147444062|NCT00928889|531790469|FG001|Overall Study|Protocol Violation|1|||
147444063|NCT00928889|531790468|FG000|Overall Study|Adverse Event|1|||
147444064|NCT00928889|531790469|FG001|Overall Study|Adverse Event|0|||
147444065|NCT00928889|531790468|FG000|Overall Study|Other|1|||
147444066|NCT00928889|531790469|FG001|Overall Study|Other|0|||
147444067|NCT02375724|531790478|FG000|Overall Study|Lack of Efficacy|1|||
147444068|NCT02375724|531790479|FG001|Overall Study|Lack of Efficacy|1|||
147444069|NCT02375724|531790478|FG000|Overall Study|Withdrawal by Subject|1|||
147444070|NCT02375724|531790479|FG001|Overall Study|Withdrawal by Subject|1|||
147444071|NCT02375724|531790478|FG000|Overall Study|Lost to Follow-up|1|||
147444072|NCT02375724|531790479|FG001|Overall Study|Lost to Follow-up|0|||
147444073|NCT02375724|531790478|FG000|Overall Study|Protocol Violation|1|||
147444074|NCT02375724|531790479|FG001|Overall Study|Protocol Violation|0|||
147444075|NCT02375724|531790478|FG000|Overall Study|Adverse Event|2|||
147444076|NCT02375724|531790479|FG001|Overall Study|Adverse Event|4|||
147444077|NCT01197521|531790482|FG000|Overall Study|Not reported|24|||
147444078|NCT01197521|531790483|FG001|Overall Study|Not reported|25|||
147444079|NCT01197521|531790484|FG002|Overall Study|Not reported|21|||
147555904|NCT01768858|532193303|FG000|Overall Study|Participant moved to Germany|1|||
147555905|NCT01768858|532193303|FG000|Overall Study|Aggravation of NY Heart Assoc 3 status|1|||
147555906|NCT01768858|532193303|FG000|Overall Study|Exanthema|1|||
147555907|NCT01768858|532193303|FG000|Overall Study|Withdrawal by Subject|1|||
147555908|NCT03093324|532193305|FG000|Overall Study|Adverse Event|4|||
147555909|NCT03093324|532193306|FG001|Overall Study|Adverse Event|15|||
147555910|NCT03093324|532193305|FG000|Overall Study|Lost to Follow-up|1|||
147555911|NCT03093324|532193306|FG001|Overall Study|Lost to Follow-up|0|||
147555912|NCT03093324|532193305|FG000|Overall Study|Protocol Deviation|2|||
147106041|NCT04154956|530553730|FG000|Overall Study|Death|109|||
147106042|NCT04154956|530553731|FG001|Overall Study|Death|110|||
147106043|NCT04154956|530553730|FG000|Overall Study|Not related to Coronavirus disease 2019|0|||
147106044|NCT04154956|530553731|FG001|Overall Study|Not related to Coronavirus disease 2019|1|||
147106045|NCT04154956|530553730|FG000|Overall Study|Withdrawal by Subject|1|||
147106046|NCT04154956|530553731|FG001|Overall Study|Withdrawal by Subject|7|||
147106047|NCT04154956|530553730|FG000|Overall Study|Ongoing study treatment at the time of primary analysis|36|||
147106048|NCT04154956|530553731|FG001|Overall Study|Ongoing study treatment at the time of primary analysis|25|||
147555913|NCT03093324|532193306|FG001|Overall Study|Protocol Deviation|2|||
147555914|NCT03093324|532193305|FG000|Overall Study|Withdrawal by Subject|2|||
147555915|NCT03093324|532193306|FG001|Overall Study|Withdrawal by Subject|2|||
147555916|NCT01691859|532193309|FG000|Overall Study|Adverse Event|19|||
147555917|NCT01691859|532193309|FG000|Overall Study|Lack of Efficacy|11|||
147555918|NCT01691859|532193309|FG000|Overall Study|Protocol Violation|4|||
147555919|NCT01691859|532193309|FG000|Overall Study|Product commercially available|221|||
147555920|NCT01691859|532193309|FG000|Overall Study|Study closed/terminated|50|||
147555921|NCT01691859|532193309|FG000|Overall Study|Lost to Follow-up|5|||
147555922|NCT01691859|532193309|FG000|Overall Study|Physician Decision|6|||
147555923|NCT01691859|532193309|FG000|Overall Study|Withdrawal by Subject|31|||
147555924|NCT02688400|532193314|FG000|Overall Study|Protocol Violation|2|||
147555925|NCT02688400|532193315|FG001|Overall Study|Protocol Violation|5|||
147555926|NCT02688400|532193314|FG000|Overall Study|Lack of Efficacy|7|||
147555927|NCT02688400|532193315|FG001|Overall Study|Lack of Efficacy|7|||
147555928|NCT02688400|532193314|FG000|Overall Study|Adverse Event|21|||
147555929|NCT02688400|532193315|FG001|Overall Study|Adverse Event|12|||
147555930|NCT02688400|532193314|FG000|Overall Study|Withdrawal by Subject|15|||
147555931|NCT02688400|532193315|FG001|Overall Study|Withdrawal by Subject|13|||
147555932|NCT02688400|532193314|FG000|Overall Study|No study medication intake|1|||
147555933|NCT02688400|532193315|FG001|Overall Study|No study medication intake|4|||
147555934|NCT02688400|532193314|FG000|Overall Study|Lost to Follow-up|0|||
147555935|NCT02688400|532193315|FG001|Overall Study|Lost to Follow-up|3|||
147555936|NCT03519256|532193322|FG000|Overall Study|Disease recurrence|4|||
147555937|NCT03519256|532193323|FG001|Overall Study|Disease recurrence|4|||
147555938|NCT03519256|532193324|FG002|Overall Study|Disease recurrence|5|||
147555939|NCT03519256|532193325|FG003|Overall Study|Disease recurrence|2|||
147555940|NCT03519256|532193322|FG000|Overall Study|Study drug toxicity|0|||
147555941|NCT03519256|532193323|FG001|Overall Study|Study drug toxicity|2|||
147555942|NCT03519256|532193324|FG002|Overall Study|Study drug toxicity|5|||
147555943|NCT03519256|532193325|FG003|Overall Study|Study drug toxicity|2|||
147555944|NCT03519256|532193322|FG000|Overall Study|Adverse event unrelated to study drug|0|||
147555945|NCT03519256|532193323|FG001|Overall Study|Adverse event unrelated to study drug|1|||
147555946|NCT03519256|532193324|FG002|Overall Study|Adverse event unrelated to study drug|1|||
147555947|NCT03519256|532193325|FG003|Overall Study|Adverse event unrelated to study drug|0|||
147555948|NCT03519256|532193322|FG000|Overall Study|Participant request to discontinue study treatment|0|||
147555949|NCT03519256|532193323|FG001|Overall Study|Participant request to discontinue study treatment|0|||
147555950|NCT03519256|532193324|FG002|Overall Study|Participant request to discontinue study treatment|0|||
147555951|NCT03519256|532193325|FG003|Overall Study|Participant request to discontinue study treatment|2|||
147555952|NCT03519256|532193322|FG000|Overall Study|Other reasons|0|||
147555953|NCT03519256|532193323|FG001|Overall Study|Other reasons|0|||
147555954|NCT03519256|532193324|FG002|Overall Study|Other reasons|2|||
147555955|NCT03519256|532193325|FG003|Overall Study|Other reasons|0|||
147555956|NCT03519256|532193322|FG000|Overall Study|Disease progression|6|||
147106049|NCT04424901|530553732|FG000|Overall Study|patients were discharged prior to Hospital Day 9|17|||
147106050|NCT04424901|530553733|FG001|Overall Study|patients were discharged prior to Hospital Day 9|16|||
147555957|NCT03519256|532193323|FG001|Overall Study|Disease progression|3|||
147555958|NCT03519256|532193324|FG002|Overall Study|Disease progression|2|||
147225046|NCT01307020|530994917|FG004|Overall Study|Electronic data capture failure|0|||
147555959|NCT03519256|532193325|FG003|Overall Study|Disease progression|1|||
147106051|NCT00147238|530553734|FG000|Overall Study|Inevaluable|8|||
147106052|NCT01348269|530553735|FG000|Follow-up (Until Week 12)|Surgical intervention - not study related|1|||
147555960|NCT03519256|532193322|FG000|Overall Study|Lost to Follow-up|0|||
147225047|NCT01307020|530994918|FG005|Overall Study|Electronic data capture failure|0|||
147555961|NCT03519256|532193323|FG001|Overall Study|Lost to Follow-up|1|||
147555962|NCT03519256|532193324|FG002|Overall Study|Lost to Follow-up|0|||
147555963|NCT03519256|532193325|FG003|Overall Study|Lost to Follow-up|0|||
147555964|NCT00275002|532193326|FG000|Overall Study|Death|1|||
147310430|NCT00365378|531303909|FG002|Vaccination (Day 1 to Month 7)|Pregnancy|0|||
147310431|NCT00365378|531303907|FG000|Vaccination (Day 1 to Month 7)|Protocol Violation|22|||
147310432|NCT00365378|531303908|FG001|Vaccination (Day 1 to Month 7)|Protocol Violation|13|||
147310433|NCT00365378|531303909|FG002|Vaccination (Day 1 to Month 7)|Protocol Violation|0|||
147310434|NCT00365378|531303907|FG000|Vaccination (Day 1 to Month 7)|Withdrawal by Subject|50|||
147310435|NCT00365378|531303908|FG001|Vaccination (Day 1 to Month 7)|Withdrawal by Subject|44|||
147310436|NCT00365378|531303909|FG002|Vaccination (Day 1 to Month 7)|Withdrawal by Subject|0|||
147310437|NCT00365378|531303907|FG000|Vaccination (Day 1 to Month 7)|Other|17|||
147310438|NCT00365378|531303908|FG001|Vaccination (Day 1 to Month 7)|Other|9|||
147310439|NCT00365378|531303909|FG002|Vaccination (Day 1 to Month 7)|Other|0|||
147310440|NCT00365378|531303907|FG000|Follow-up (Month 7 Though Month 48)|Moved|6|||
147310441|NCT00365378|531303908|FG001|Follow-up (Month 7 Though Month 48)|Moved|5|||
147310442|NCT00365378|531303909|FG002|Follow-up (Month 7 Though Month 48)|Moved|0|||
147310443|NCT00365378|531303907|FG000|Follow-up (Month 7 Though Month 48)|Lost to Follow-up|67|||
147310444|NCT00365378|531303908|FG001|Follow-up (Month 7 Though Month 48)|Lost to Follow-up|69|||
147310445|NCT00365378|531303909|FG002|Follow-up (Month 7 Though Month 48)|Lost to Follow-up|0|||
147310446|NCT00365378|531303907|FG000|Follow-up (Month 7 Though Month 48)|Pregnancy|0|||
147310447|NCT00365378|531303908|FG001|Follow-up (Month 7 Though Month 48)|Pregnancy|1|||
147310448|NCT00365378|531303909|FG002|Follow-up (Month 7 Though Month 48)|Pregnancy|0|||
147310449|NCT00365378|531303907|FG000|Follow-up (Month 7 Though Month 48)|Protocol Violation|1|||
147310450|NCT00365378|531303908|FG001|Follow-up (Month 7 Though Month 48)|Protocol Violation|2|||
147310451|NCT00365378|531303909|FG002|Follow-up (Month 7 Though Month 48)|Protocol Violation|0|||
147310452|NCT00365378|531303907|FG000|Follow-up (Month 7 Though Month 48)|Withdrawal by Subject|73|||
147310453|NCT00365378|531303908|FG001|Follow-up (Month 7 Though Month 48)|Withdrawal by Subject|104|||
147310454|NCT00365378|531303909|FG002|Follow-up (Month 7 Though Month 48)|Withdrawal by Subject|0|||
147310455|NCT00365378|531303907|FG000|Follow-up (Month 7 Though Month 48)|Other|11|||
147310456|NCT00365378|531303908|FG001|Follow-up (Month 7 Though Month 48)|Other|21|||
147310457|NCT00365378|531303909|FG002|Follow-up (Month 7 Though Month 48)|Other|0|||
147310458|NCT00365378|531303907|FG000|Extension|Adverse Event|0|||
147310459|NCT00365378|531303908|FG001|Extension|Adverse Event|0|||
147310460|NCT00365378|531303909|FG002|Extension|Adverse Event|1|||
147310461|NCT00365378|531303907|FG000|Extension|Moved|0|||
147310462|NCT00365378|531303908|FG001|Extension|Moved|0|||
147310463|NCT00365378|531303909|FG002|Extension|Moved|8|||
147310464|NCT00365378|531303907|FG000|Extension|Lost to Follow-up|0|||
147310465|NCT00365378|531303908|FG001|Extension|Lost to Follow-up|0|||
147310466|NCT00365378|531303909|FG002|Extension|Lost to Follow-up|57|||
147310467|NCT00365378|531303907|FG000|Extension|Protocol Violation|0|||
147310468|NCT00365378|531303908|FG001|Extension|Protocol Violation|0|||
147310469|NCT00365378|531303909|FG002|Extension|Protocol Violation|2|||
147310470|NCT00365378|531303907|FG000|Extension|Withdrawal by Subject|0|||
147310471|NCT00365378|531303908|FG001|Extension|Withdrawal by Subject|0|||
147310472|NCT00365378|531303909|FG002|Extension|Withdrawal by Subject|98|||
147310473|NCT00365378|531303907|FG000|Extension|Other|0|||
147310474|NCT00365378|531303908|FG001|Extension|Other|0|||
147310475|NCT00365378|531303909|FG002|Extension|Other|31|||
147310476|NCT03560258|531303912|FG000|Overall Study|Lost to Follow-up|3|||
147310477|NCT03560258|531303913|FG001|Overall Study|Lost to Follow-up|0|||
147310478|NCT03560258|531303914|FG002|Overall Study|Lost to Follow-up|0|||
147310479|NCT03560258|531303912|FG000|Overall Study|Protocol Violation|0|||
147310480|NCT03560258|531303913|FG001|Overall Study|Protocol Violation|1|||
147310481|NCT03560258|531303914|FG002|Overall Study|Protocol Violation|0|||
147310482|NCT03560258|531303912|FG000|Overall Study|Withdrawal by Subject|0|||
147310483|NCT03560258|531303913|FG001|Overall Study|Withdrawal by Subject|0|||
147310484|NCT03560258|531303914|FG002|Overall Study|Withdrawal by Subject|1|||
147310485|NCT01460160|531303915|FG000|Treatment Phase|Lack of Efficacy|3|||
147310486|NCT01460160|531303915|FG000|Treatment Phase|Study Drug Toxicity|2|||
147310487|NCT01460160|531303915|FG000|Treatment Phase|Adverse Event|8|||
147310488|NCT01460160|531303915|FG000|Treatment Phase|Withdrawal by Subject|4|||
147310489|NCT01460160|531303915|FG000|Treatment Phase|Death|2|||
147444080|NCT01197521|531790482|FG000|Overall Study|Enrolment in long term extension|42|||
147310490|NCT01460160|531303915|FG000|Treatment Phase|Other reasons|9|||
147310491|NCT01460160|531303915|FG000|Follow-up Phase|Withdrawal by Subject|4|||
147310492|NCT01460160|531303915|FG000|Follow-up Phase|Death|14|||
147310493|NCT01460160|531303915|FG000|Follow-up Phase|Lost to Follow-up|7|||
147310494|NCT01460160|531303915|FG000|Follow-up Phase|Follow-up no longer required per protocol|70|||
147444081|NCT01197521|531790483|FG001|Overall Study|Enrolment in long term extension|36|||
147444082|NCT01197521|531790484|FG002|Overall Study|Enrolment in long term extension|87|||
147444083|NCT01197521|531790482|FG000|Overall Study|Severe non-compliance to protocol|1|||
147444084|NCT01197521|531790483|FG001|Overall Study|Severe non-compliance to protocol|3|||
147444085|NCT01197521|531790484|FG002|Overall Study|Severe non-compliance to protocol|3|||
147444086|NCT01197521|531790482|FG000|Overall Study|Lack of therapeutic response|2|||
147444087|NCT01197521|531790483|FG001|Overall Study|Lack of therapeutic response|3|||
147444088|NCT01197521|531790484|FG002|Overall Study|Lack of therapeutic response|4|||
147444089|NCT01197521|531790482|FG000|Overall Study|Dev. of study specific discont. criteria|6|||
147555965|NCT00275002|532193327|FG001|Overall Study|Death|0|||
147225048|NCT01307020|530994919|FG006|Overall Study|Electronic data capture failure|0|||
147555966|NCT00275002|532193326|FG000|Overall Study|Disease progression|21|||
147555967|NCT00275002|532193327|FG001|Overall Study|Disease progression|15|||
147555968|NCT00275002|532193326|FG000|Overall Study|Adverse Event|0|||
147555969|NCT00275002|532193327|FG001|Overall Study|Adverse Event|1|||
147555970|NCT05456529|532193328|FG000|8-week Continuous Treatment (CT) Period|Lost to Follow-up|5|||
147555971|NCT05456529|532193328|FG000|8-week Continuous Treatment (CT) Period|Lack of Efficacy|2|||
147555972|NCT05456529|532193328|FG000|8-week Continuous Treatment (CT) Period|Protocol-specified Withdrawal Criterion Met|1|||
147555973|NCT05456529|532193328|FG000|8-week Continuous Treatment (CT) Period|Withdrawal by Subject|3|||
147555974|NCT05456529|532193328|FG000|44-week Long-term Safety Period|Lost to Follow-up|12|||
147555975|NCT05456529|532193328|FG000|44-week Long-term Safety Period|Lack of Efficacy|1|||
147555976|NCT05456529|532193328|FG000|44-week Long-term Safety Period|Physician Decision|2|||
147555977|NCT05456529|532193328|FG000|44-week Long-term Safety Period|Protocol-specified Withdrawal Criterion Met|1|||
147555978|NCT05456529|532193328|FG000|44-week Long-term Safety Period|Withdrawal by Subject|12|||
147555979|NCT05456529|532193328|FG000|44-week Long-term Safety Period|Withdrawal by Sponsor|2|||
147555980|NCT05456529|532193328|FG000|44-week Long-term Safety Period|Unable to Attend the Follow-up Visit|1|||
147555981|NCT02374918|532193329|FG000|Overall Study|Protocol Violation|2|||
147555982|NCT02374918|532193330|FG001|Overall Study|Protocol Violation|0|||
147555983|NCT02374918|532193331|FG002|Overall Study|Protocol Violation|2|||
147555984|NCT02374918|532193332|FG003|Overall Study|Protocol Violation|1|||
147555985|NCT02374918|532193329|FG000|Overall Study|Withdrawal by Subject|1|||
147555986|NCT02374918|532193330|FG001|Overall Study|Withdrawal by Subject|1|||
147555987|NCT02374918|532193331|FG002|Overall Study|Withdrawal by Subject|1|||
147555988|NCT02374918|532193332|FG003|Overall Study|Withdrawal by Subject|0|||
147555989|NCT02374918|532193329|FG000|Overall Study|Lack of Efficacy|0|||
147555990|NCT02374918|532193330|FG001|Overall Study|Lack of Efficacy|0|||
147555991|NCT02374918|532193331|FG002|Overall Study|Lack of Efficacy|1|||
147555992|NCT02374918|532193332|FG003|Overall Study|Lack of Efficacy|1|||
147555993|NCT01506947|532193333|FG000|Overall Study|Lost to Follow-up|7|||
147555994|NCT01506947|532193333|FG000|Overall Study|Adverse Event|5|||
147555995|NCT01506947|532193333|FG000|Overall Study|Death|1|||
147555996|NCT01506947|532193333|FG000|Overall Study|Did Not Meet Eligibility Criteria|3|||
147555997|NCT02752776|532193336|FG000|Overall Study|Adverse Event|15|||
147555998|NCT02752776|532193337|FG001|Overall Study|Adverse Event|23|||
147555999|NCT02752776|532193338|FG002|Overall Study|Adverse Event|11|||
147556000|NCT02752776|532193336|FG000|Overall Study|Lack of Efficacy|2|||
147556001|NCT02752776|532193337|FG001|Overall Study|Lack of Efficacy|6|||
147556002|NCT02752776|532193338|FG002|Overall Study|Lack of Efficacy|14|||
147556003|NCT02752776|532193336|FG000|Overall Study|Lost to Follow-up|11|||
147556004|NCT02752776|532193337|FG001|Overall Study|Lost to Follow-up|12|||
147225049|NCT01307020|530994920|FG007|Overall Study|Electronic data capture failure|0|||
147225050|NCT01307020|530994921|FG008|Overall Study|Electronic data capture failure|0|||
147225051|NCT01307020|530994922|FG009|Overall Study|Electronic data capture failure|0|||
147225052|NCT02380690|530994923|FG000|Overall Study|Lost to Follow-up|14|||
147225053|NCT02380690|530994924|FG001|Overall Study|Lost to Follow-up|4|||
147225054|NCT02380690|530994923|FG000|Overall Study|Withdrawal by Subject|20|||
147225055|NCT02380690|530994924|FG001|Overall Study|Withdrawal by Subject|8|||
147225056|NCT00266864|530994925|FG000|Overall Study|Lost to Follow-up|4|||
147225057|NCT00266864|530994926|FG001|Overall Study|Lost to Follow-up|1|||
147225058|NCT00266864|530994925|FG000|Overall Study|Withdrawal by Subject|1|||
147225059|NCT00266864|530994926|FG001|Overall Study|Withdrawal by Subject|1|||
147225060|NCT03687970|530994934|FG000|Overall Study|visit scheduling conflicts|2|||
147225061|NCT03687970|530994935|FG001|Overall Study|visit scheduling conflicts|0|||
147225062|NCT03119701|530994936|FG000|6-day Dosing|Death|4|||
147225063|NCT03119701|530994937|FG001|6-day Dosing|Death|1|||
147225064|NCT03119701|530994936|FG000|6-day Dosing|Adverse Event|3|||
147225065|NCT03119701|530994937|FG001|6-day Dosing|Adverse Event|0|||
147225066|NCT03119701|530994936|FG000|6-day Dosing|Physician Decision|0|||
147225067|NCT03119701|530994937|FG001|6-day Dosing|Physician Decision|1|||
147225068|NCT03119701|530994936|FG000|6-day Dosing|Withdrawal by Subject|0|||
147225069|NCT03119701|530994937|FG001|6-day Dosing|Withdrawal by Subject|1|||
147225070|NCT03119701|530994936|FG000|Mid-term (Final) Follow-up at D90|Death|3|||
147225071|NCT03119701|530994937|FG001|Mid-term (Final) Follow-up at D90|Death|1|||
147225072|NCT00596362|530994939|FG000|Overall Study|Progressive Disease|1|||
147225073|NCT02793128|530994940|FG000|Overall Study|Death|4|||
147225074|NCT02793128|530994940|FG000|Overall Study|Withdrawal by Subject|2|||
147556005|NCT02752776|532193338|FG002|Overall Study|Lost to Follow-up|4|||
147556006|NCT02752776|532193336|FG000|Overall Study|Non-compliance with study treatment|0|||
147225075|NCT02793128|530994940|FG000|Overall Study|Physician Decision|1|||
147225076|NCT02793128|530994940|FG000|Overall Study|Comorbid conditions and noncompliance|1|||
147225077|NCT02793128|530994940|FG000|Overall Study|Patient elected nephroureterectomy|1|||
147225078|NCT00427960|530996536|FG000|Overall Study|Adverse Event|2|||
147225079|NCT00427960|530996537|FG001|Overall Study|Adverse Event|0|||
147225080|NCT00427960|530996536|FG000|Overall Study|Withdrawal by Subject|0|||
147225081|NCT00427960|530996537|FG001|Overall Study|Withdrawal by Subject|3|||
147556007|NCT02752776|532193337|FG001|Overall Study|Non-compliance with study treatment|0|||
147556008|NCT02752776|532193338|FG002|Overall Study|Non-compliance with study treatment|1|||
147556009|NCT02752776|532193336|FG000|Overall Study|Physician Decision|2|||
147556010|NCT02752776|532193337|FG001|Overall Study|Physician Decision|6|||
147556011|NCT02752776|532193338|FG002|Overall Study|Physician Decision|2|||
147556012|NCT02752776|532193336|FG000|Overall Study|Pregnancy|1|||
147556013|NCT02752776|532193337|FG001|Overall Study|Pregnancy|6|||
147556014|NCT02752776|532193338|FG002|Overall Study|Pregnancy|3|||
147556015|NCT02752776|532193336|FG000|Overall Study|Protocol Violation|10|||
147556016|NCT02752776|532193337|FG001|Overall Study|Protocol Violation|13|||
147556017|NCT02752776|532193338|FG002|Overall Study|Protocol Violation|6|||
147556018|NCT02752776|532193336|FG000|Overall Study|Subject/guardian decision|8|||
147556019|NCT02752776|532193337|FG001|Overall Study|Subject/guardian decision|6|||
147556020|NCT02752776|532193338|FG002|Overall Study|Subject/guardian decision|4|||
147556021|NCT02752776|532193336|FG000|Overall Study|Death|0|||
147556022|NCT02752776|532193337|FG001|Overall Study|Death|0|||
147556023|NCT02752776|532193338|FG002|Overall Study|Death|1|||
147225082|NCT00427960|530996536|FG000|Overall Study|Other|0|||
147556024|NCT02752776|532193336|FG000|Overall Study|Withdrawal by Subject|3|||
147556025|NCT02752776|532193337|FG001|Overall Study|Withdrawal by Subject|4|||
147556026|NCT02752776|532193338|FG002|Overall Study|Withdrawal by Subject|2|||
147556027|NCT01816477|532193339|FG000|Overall Study|Withdrawal by Subject|13|||
147556028|NCT01816477|532193340|FG001|Overall Study|Withdrawal by Subject|1|||
147556029|NCT01816477|532193339|FG000|Overall Study|Unable to tolerate catheter placement|3|||
147556030|NCT01816477|532193340|FG001|Overall Study|Unable to tolerate catheter placement|0|||
147556031|NCT00108732|532193341|FG000|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Adverse Event|1|||
147556032|NCT00108732|532193341|FG000|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Withdrawal by Subject|2|||
147556033|NCT00108732|532193341|FG000|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Ineligible|10|||
147556034|NCT00108732|532193341|FG000|Step 1 (Vaccinia/Fowlpox/GM-CSF)|Non-compliance|1|||
147556035|NCT00108732|532193341|FG000|Step 2 (Androgen Ablation and Vaccine)|Adverse Event|3|||
147556036|NCT00108732|532193341|FG000|Step 2 (Androgen Ablation and Vaccine)|Withdrawal by Subject|1|||
147556037|NCT00108732|532193341|FG000|Step 2 (Androgen Ablation and Vaccine)|Other|1|||
147556038|NCT02116803|532193343|FG000|Overall Study|Adverse Event|2|||
147556039|NCT02116803|532193344|FG001|Overall Study|Adverse Event|1|||
147556040|NCT02116803|532193343|FG000|Overall Study|Physician Decision|1|||
147556041|NCT02116803|532193344|FG001|Overall Study|Physician Decision|0|||
147225083|NCT00427960|530996537|FG001|Overall Study|Other|1|||
147225084|NCT01142128|530996538|FG000|Overall Study|Physician Decision|1|||
147225085|NCT01142128|530996538|FG000|Overall Study|Lost to Follow-up|1|||
147225086|NCT01142128|530996538|FG000|Overall Study|Withdrawal by Subject|2|||
147225087|NCT03355664|530996539|FG000|Overall Study|Adverse Event|1|||
147225088|NCT03355664|530996540|FG001|Overall Study|Adverse Event|2|||
147225089|NCT03355664|530996539|FG000|Overall Study|Lost to Follow-up|11|||
147225090|NCT03355664|530996540|FG001|Overall Study|Lost to Follow-up|7|||
147225091|NCT03355664|530996539|FG000|Overall Study|Protocol Violation|1|||
147225092|NCT03355664|530996540|FG001|Overall Study|Protocol Violation|2|||
147225093|NCT03355664|530996539|FG000|Overall Study|Withdrawal by Subject|2|||
147225094|NCT03355664|530996540|FG001|Overall Study|Withdrawal by Subject|1|||
147225095|NCT00423670|530996546|FG000|Treatment Period|Switched to Arm 8 at TW 24|36|||
147225096|NCT00423670|530996547|FG001|Treatment Period|Switched to Arm 8 at TW 24|0|||
147225097|NCT00423670|530996548|FG002|Treatment Period|Switched to Arm 8 at TW 24|0|||
147225098|NCT00423670|530996549|FG003|Treatment Period|Switched to Arm 8 at TW 24|0|||
147225099|NCT00423670|530996550|FG004|Treatment Period|Switched to Arm 8 at TW 24|0|||
147225100|NCT00423670|530996551|FG005|Treatment Period|Switched to Arm 8 at TW 24|0|||
147225101|NCT00423670|530996552|FG006|Treatment Period|Switched to Arm 8 at TW 24|0|||
147225102|NCT00423670|530996553|FG007|Treatment Period|Switched to Arm 8 at TW 24|0|||
147225103|NCT00423670|530996546|FG000|Treatment Period|Adverse Event|8|||
147225104|NCT00423670|530996547|FG001|Treatment Period|Adverse Event|12|||
147225105|NCT00423670|530996548|FG002|Treatment Period|Adverse Event|15|||
147556042|NCT02116803|532193343|FG000|Overall Study|Progressive disease|4|||
147556043|NCT02116803|532193344|FG001|Overall Study|Progressive disease|0|||
147225106|NCT00423670|530996549|FG003|Treatment Period|Adverse Event|20|||
147225107|NCT00423670|530996550|FG004|Treatment Period|Adverse Event|9|||
147225108|NCT00423670|530996551|FG005|Treatment Period|Adverse Event|4|||
147556044|NCT02116803|532193343|FG000|Overall Study|Study terminated by sponsor|2|||
147556045|NCT02116803|532193344|FG001|Overall Study|Study terminated by sponsor|1|||
147556046|NCT02116803|532193343|FG000|Overall Study|Death|1|||
147556047|NCT02116803|532193344|FG001|Overall Study|Death|0|||
147225109|NCT00423670|530996552|FG006|Treatment Period|Adverse Event|7|||
147225110|NCT00423670|530996553|FG007|Treatment Period|Adverse Event|2|||
147225111|NCT00423670|530996546|FG000|Treatment Period|Protocol-defined clinical event|0|||
147225112|NCT00423670|530996547|FG001|Treatment Period|Protocol-defined clinical event|7|||
147225113|NCT00423670|530996548|FG002|Treatment Period|Protocol-defined clinical event|4|||
147225114|NCT00423670|530996549|FG003|Treatment Period|Protocol-defined clinical event|12|||
147225115|NCT00423670|530996550|FG004|Treatment Period|Protocol-defined clinical event|5|||
147225116|NCT00423670|530996551|FG005|Treatment Period|Protocol-defined clinical event|4|||
147225117|NCT00423670|530996552|FG006|Treatment Period|Protocol-defined clinical event|16|||
147556048|NCT01946165|532193345|FG000|Overall Study|Physician Decision|2|||
147556049|NCT01946165|532193346|FG001|Overall Study|Physician Decision|0|||
147556050|NCT01946165|532193345|FG000|Overall Study|Withdrawal by Subject|0|||
147556051|NCT01946165|532193346|FG001|Overall Study|Withdrawal by Subject|2|||
147556052|NCT01901055|532193347|FG000|Randomization But Not Titrated|Did not come to titration study|1|||
147556053|NCT01901055|532193348|FG001|Randomization But Not Titrated|Did not come to titration study|1|||
147556054|NCT01901055|532193347|FG000|Randomization But Not Titrated|Physician Decision|0|||
147556055|NCT01901055|532193348|FG001|Randomization But Not Titrated|Physician Decision|1|||
147556056|NCT01901055|532193347|FG000|Started Protocol to Week 6|Physician Decision|2|||
147556057|NCT01901055|532193348|FG001|Started Protocol to Week 6|Physician Decision|1|||
147556058|NCT01901055|532193347|FG000|Started Protocol to Week 6|complains of difficulty with wearing mask|0|||
147556059|NCT01901055|532193348|FG001|Started Protocol to Week 6|complains of difficulty with wearing mask|2|||
147556060|NCT01901055|532193347|FG000|Started Protocol to Week 6|Participant had not disclosed that they had been previously been on CPAP|1|||
147556061|NCT01901055|532193348|FG001|Started Protocol to Week 6|Participant had not disclosed that they had been previously been on CPAP|0|||
147556062|NCT01901055|532193347|FG000|Started Protocol to Week 6|Withdrawal by Subject|0|||
147556063|NCT01901055|532193348|FG001|Started Protocol to Week 6|Withdrawal by Subject|1|||
147556064|NCT01901055|532193347|FG000|Week 12 Assessment|Medical procedure that may interfere with wearing CPAPP mask|1|||
147556065|NCT01901055|532193348|FG001|Week 12 Assessment|Medical procedure that may interfere with wearing CPAPP mask|0|||
147556066|NCT01901055|532193347|FG000|Week 12 Assessment|Withdrawal by Subject|0|||
147556067|NCT01901055|532193348|FG001|Week 12 Assessment|Withdrawal by Subject|4|||
147556068|NCT01901055|532193347|FG000|Week 24|Withdrawal by Subject|13|||
147556069|NCT01901055|532193348|FG001|Week 24|Withdrawal by Subject|19|||
147556070|NCT01901055|532193347|FG000|Week 24|Physician Decision|1|||
147556071|NCT01901055|532193348|FG001|Week 24|Physician Decision|0|||
147556072|NCT01901055|532193347|FG000|Week 36|Withdrawal by Subject|0|||
147556073|NCT01901055|532193348|FG001|Week 36|Withdrawal by Subject|5|||
147556074|NCT03019965|532193351|FG000|Overall Study|Withdrawal by Subject|1|||
147556075|NCT03019965|532193352|FG001|Overall Study|Withdrawal by Subject|0|||
147556076|NCT03019965|532193351|FG000|Overall Study|Protocol Violation|1|||
147556077|NCT03019965|532193352|FG001|Overall Study|Protocol Violation|3|||
147556078|NCT03019965|532193351|FG000|Overall Study|viral or fungal infection|3|||
147556079|NCT03019965|532193352|FG001|Overall Study|viral or fungal infection|4|||
147556080|NCT03019965|532193351|FG000|Overall Study|acute liver failure in the first 24 hours of randomization|4|||
147556081|NCT03019965|532193352|FG001|Overall Study|acute liver failure in the first 24 hours of randomization|5|||
147556082|NCT03019965|532193351|FG000|Overall Study|Physician Decision|1|||
147556083|NCT03019965|532193352|FG001|Overall Study|Physician Decision|1|||
147556084|NCT01659567|532193353|FG000|Overall Study|Lack of Efficacy|22|||
147556085|NCT01659567|532193353|FG000|Overall Study|Switched to Pegferon|6|||
147556086|NCT01659567|532193353|FG000|Overall Study|Adverse Event|12|||
147556087|NCT01659567|532193353|FG000|Overall Study|Good result at early stage of treatment|5|||
147556088|NCT01659567|532193353|FG000|Overall Study|Withdrawal by Subject|64|||
147556089|NCT01659567|532193353|FG000|Overall Study|Progression of the main disease|1|||
147556090|NCT01659567|532193353|FG000|Overall Study|Other|13|||
147556091|NCT01915732|532193361|FG000|Overall Study|Withdrawal by Subject|18|||
147556092|NCT01915732|532193362|FG001|Overall Study|Withdrawal by Subject|18|||
147556093|NCT01915732|532193361|FG000|Overall Study|Failure to Meet Randomization Criteria|1|||
147556094|NCT01915732|532193362|FG001|Overall Study|Failure to Meet Randomization Criteria|0|||
147556095|NCT01915732|532193361|FG000|Overall Study|Adverse Event|12|||
147556096|NCT01915732|532193362|FG001|Overall Study|Adverse Event|4|||
147556097|NCT01915732|532193361|FG000|Overall Study|Protocol Violation|5|||
147556098|NCT01915732|532193362|FG001|Overall Study|Protocol Violation|5|||
147556099|NCT01915732|532193361|FG000|Overall Study|Lack of Efficacy|6|||
147556100|NCT01915732|532193362|FG001|Overall Study|Lack of Efficacy|11|||
147556101|NCT01915732|532193361|FG000|Overall Study|Lost to Follow-up|22|||
147556102|NCT01915732|532193362|FG001|Overall Study|Lost to Follow-up|26|||
147556103|NCT01915732|532193361|FG000|Overall Study|Par. Improved, Voluntary (Vol) exit|1|||
147556104|NCT01915732|532193362|FG001|Overall Study|Par. Improved, Voluntary (Vol) exit|0|||
147556105|NCT01915732|532193361|FG000|Overall Study|Par. Conscious Ineffective Vol Exit|1|||
147556106|NCT01915732|532193362|FG001|Overall Study|Par. Conscious Ineffective Vol Exit|0|||
147556107|NCT01915732|532193361|FG000|Overall Study|Drug Release Error|1|||
147556108|NCT01915732|532193362|FG001|Overall Study|Drug Release Error|0|||
147556109|NCT01915732|532193361|FG000|Overall Study|Recovered|1|||
147556110|NCT01915732|532193362|FG001|Overall Study|Recovered|0|||
147556111|NCT01915732|532193361|FG000|Overall Study|Pregnancy|1|||
147556112|NCT01915732|532193362|FG001|Overall Study|Pregnancy|0|||
147556113|NCT01915732|532193361|FG000|Overall Study|Poor Perceived Efficacy|1|||
147556114|NCT01915732|532193362|FG001|Overall Study|Poor Perceived Efficacy|0|||
147556115|NCT01915732|532193361|FG000|Overall Study|Par. Unable to Come to the Hospital|0|||
147556116|NCT01915732|532193362|FG001|Overall Study|Par. Unable to Come to the Hospital|1|||
147556117|NCT01915732|532193361|FG000|Overall Study|Got Well|0|||
147225118|NCT00423670|530996553|FG007|Treatment Period|Protocol-defined clinical event|15|||
147225119|NCT00423670|530996546|FG000|Treatment Period|Lost to Follow-up|2|||
147556118|NCT01915732|532193362|FG001|Overall Study|Got Well|1|||
147556119|NCT01915732|532193361|FG000|Overall Study|Par. not Willing to Continue Treatment|0|||
147556120|NCT01915732|532193362|FG001|Overall Study|Par. not Willing to Continue Treatment|1|||
147556121|NCT01915732|532193361|FG000|Overall Study|Par. Refused to Hospital Visits|0|||
147556122|NCT01915732|532193362|FG001|Overall Study|Par. Refused to Hospital Visits|1|||
147556123|NCT01915732|532193361|FG000|Overall Study|Job Transfer|0|||
147556124|NCT01915732|532193362|FG001|Overall Study|Job Transfer|1|||
147556125|NCT01915732|532193361|FG000|Overall Study|Improper Facial Procedure|0|||
147556126|NCT01915732|532193362|FG001|Overall Study|Improper Facial Procedure|1|||
147556127|NCT01915732|532193361|FG000|Overall Study|Poor Conscious Effect|0|||
147556128|NCT01915732|532193362|FG001|Overall Study|Poor Conscious Effect|1|||
147556129|NCT01325207|532193363|FG000|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0|||
147556130|NCT01325207|532193364|FG001|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0|||
147556131|NCT01325207|532193365|FG002|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0|||
147556132|NCT01325207|532193366|FG003|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0|||
147556133|NCT01325207|532193367|FG004|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|2|||
147556134|NCT01325207|532193368|FG005|Completed 4 Weeks/1 Cycle of Treatment|Adverse Event|0|||
147556135|NCT01325207|532193363|FG000|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|1|||
147556136|NCT01325207|532193364|FG001|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|1|||
147556137|NCT01325207|532193365|FG002|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|0|||
147556138|NCT01325207|532193366|FG003|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|0|||
147556139|NCT01325207|532193367|FG004|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|2|||
147556140|NCT01325207|532193368|FG005|Completed 8 Weeks/2 Cycles of Treatment|Progressive Disease|5|||
147556141|NCT01325207|532193363|FG000|Started 9th Week/Cycle 3 of Treatment|Progressive disease|1|||
147556142|NCT01325207|532193364|FG001|Started 9th Week/Cycle 3 of Treatment|Progressive disease|1|||
147556143|NCT01325207|532193365|FG002|Started 9th Week/Cycle 3 of Treatment|Progressive disease|1|||
147556144|NCT01325207|532193366|FG003|Started 9th Week/Cycle 3 of Treatment|Progressive disease|1|||
147556145|NCT01325207|532193367|FG004|Started 9th Week/Cycle 3 of Treatment|Progressive disease|0|||
147556146|NCT01325207|532193368|FG005|Started 9th Week/Cycle 3 of Treatment|Progressive disease|4|||
147556147|NCT01325207|532193363|FG000|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0|||
147556148|NCT01325207|532193364|FG001|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|1|||
147556149|NCT01325207|532193365|FG002|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0|||
147556150|NCT01325207|532193366|FG003|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0|||
147556151|NCT01325207|532193367|FG004|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0|||
147556152|NCT01325207|532193368|FG005|Started 9th Week/Cycle 3 of Treatment|Withdrawal by Subject|0|||
147556153|NCT01325207|532193363|FG000|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0|||
147556154|NCT01325207|532193364|FG001|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0|||
147556155|NCT01325207|532193365|FG002|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0|||
147556156|NCT01325207|532193366|FG003|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0|||
147556157|NCT01325207|532193367|FG004|Started 9th Week/Cycle 3 of Treatment|Adverse Event|0|||
147556158|NCT01325207|532193368|FG005|Started 9th Week/Cycle 3 of Treatment|Adverse Event|1|||
147556159|NCT01325207|532193363|FG000|Follow-up Every 3 Months Until Death|Lost to Follow-up|0|||
147556160|NCT01325207|532193364|FG001|Follow-up Every 3 Months Until Death|Lost to Follow-up|0|||
147556161|NCT01325207|532193365|FG002|Follow-up Every 3 Months Until Death|Lost to Follow-up|0|||
147556162|NCT01325207|532193366|FG003|Follow-up Every 3 Months Until Death|Lost to Follow-up|0|||
147556163|NCT01325207|532193367|FG004|Follow-up Every 3 Months Until Death|Lost to Follow-up|0|||
147556164|NCT01325207|532193368|FG005|Follow-up Every 3 Months Until Death|Lost to Follow-up|1|||
147556165|NCT01325207|532193363|FG000|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0|||
147556166|NCT01325207|532193364|FG001|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0|||
147556167|NCT01325207|532193365|FG002|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0|||
147556168|NCT01325207|532193366|FG003|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0|||
147556169|NCT01325207|532193367|FG004|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|1|||
147225120|NCT00423670|530996547|FG001|Treatment Period|Lost to Follow-up|1|||
147225121|NCT00423670|530996548|FG002|Treatment Period|Lost to Follow-up|3|||
147225122|NCT00423670|530996549|FG003|Treatment Period|Lost to Follow-up|1|||
147225123|NCT00423670|530996550|FG004|Treatment Period|Lost to Follow-up|6|||
147225124|NCT00423670|530996551|FG005|Treatment Period|Lost to Follow-up|0|||
147225125|NCT00423670|530996552|FG006|Treatment Period|Lost to Follow-up|3|||
147225126|NCT00423670|530996553|FG007|Treatment Period|Lost to Follow-up|1|||
147225127|NCT00423670|530996546|FG000|Treatment Period|Subject withdrew (not treatment related)|3|||
147225128|NCT00423670|530996547|FG001|Treatment Period|Subject withdrew (not treatment related)|9|||
147225129|NCT00423670|530996548|FG002|Treatment Period|Subject withdrew (not treatment related)|4|||
147225130|NCT00423670|530996549|FG003|Treatment Period|Subject withdrew (not treatment related)|4|||
147225131|NCT00423670|530996550|FG004|Treatment Period|Subject withdrew (not treatment related)|5|||
147225132|NCT00423670|530996551|FG005|Treatment Period|Subject withdrew (not treatment related)|0|||
147225133|NCT00423670|530996552|FG006|Treatment Period|Subject withdrew (not treatment related)|3|||
147556170|NCT01325207|532193368|FG005|Follow-up Every 3 Months Until Death|Follow-up Considered Complete|0|||
147556171|NCT01974895|532193376|FG000|Overall Study|Protocol Violation|1|||
147556172|NCT01974895|532193377|FG001|Overall Study|Protocol Violation|0|||
147556173|NCT01974895|532193376|FG000|Overall Study|Lost to Follow-up|4|||
147556174|NCT01974895|532193377|FG001|Overall Study|Lost to Follow-up|6|||
147556175|NCT01974895|532193376|FG000|Overall Study|Withdrawal by Subject|0|||
147556176|NCT01974895|532193377|FG001|Overall Study|Withdrawal by Subject|1|||
147556177|NCT01974895|532193376|FG000|Overall Study|Other (Missed Visit)|1|||
147556178|NCT01974895|532193377|FG001|Overall Study|Other (Missed Visit)|0|||
147556179|NCT01974895|532193376|FG000|Overall Study|Other (Reason unknown)|9|||
147556180|NCT01974895|532193377|FG001|Overall Study|Other (Reason unknown)|8|||
147556181|NCT01399736|532193378|FG000|Overall Study|Withdrawal by Subject|4|||
147556182|NCT01399736|532193379|FG001|Overall Study|Withdrawal by Subject|2|||
147556183|NCT01399736|532193378|FG000|Overall Study|Lost to Follow-up|0|||
147556184|NCT01399736|532193379|FG001|Overall Study|Lost to Follow-up|2|||
147556185|NCT04652453|532193383|FG000|Overall Study|Death|8|||
147556186|NCT04652453|532193384|FG001|Overall Study|Death|2|||
147556187|NCT04652453|532193385|FG002|Overall Study|Death|0|||
147556188|NCT04652453|532193383|FG000|Overall Study|Hospice|5|||
147556189|NCT04652453|532193384|FG001|Overall Study|Hospice|5|||
147556190|NCT04652453|532193385|FG002|Overall Study|Hospice|0|||
147556191|NCT04652453|532193383|FG000|Overall Study|Withdrawal by Subject|2|||
147556192|NCT04652453|532193384|FG001|Overall Study|Withdrawal by Subject|0|||
147556193|NCT04652453|532193385|FG002|Overall Study|Withdrawal by Subject|0|||
147556194|NCT04543136|532193386|FG000|Overall Study|Withdrawal by Subject|0|||
147556195|NCT04543136|532193387|FG001|Overall Study|Withdrawal by Subject|1|||
147556196|NCT04543136|532193388|FG002|Overall Study|Withdrawal by Subject|0|||
147556197|NCT04543136|532193389|FG003|Overall Study|Withdrawal by Subject|1|||
147556198|NCT04543136|532193390|FG004|Overall Study|Withdrawal by Subject|0|||
147556199|NCT04543136|532193391|FG005|Overall Study|Withdrawal by Subject|0|||
147556200|NCT02192099|532193392|FG000|Overall Study|Adverse Event|1|||
147556201|NCT02192099|532193392|FG000|Overall Study|Lost to Follow-up|2|||
147556202|NCT02192099|532193392|FG000|Overall Study|Physician Decision|1|||
147556203|NCT02192099|532193392|FG000|Overall Study|Pregnancy|1|||
147556204|NCT02192099|532193392|FG000|Overall Study|Protocol Violation|8|||
147556205|NCT02192099|532193392|FG000|Overall Study|Study Terminated by Sponsor|32|||
147556206|NCT02192099|532193392|FG000|Overall Study|Withdrawal by Subject|11|||
147556207|NCT02192099|532193392|FG000|Overall Study|Miscellaneous Reasons|5|||
147556208|NCT00386009|532193393|FG000|Overall Study|Adverse Event|0|||
147556209|NCT00386009|532193394|FG001|Overall Study|Adverse Event|2|||
147556210|NCT00386009|532193393|FG000|Overall Study|Death|1|||
147556211|NCT00386009|532193394|FG001|Overall Study|Death|0|||
147556212|NCT00386009|532193393|FG000|Overall Study|Entry Criteria Not Met|0|||
147556213|NCT00386009|532193394|FG001|Overall Study|Entry Criteria Not Met|2|||
147556214|NCT00386009|532193393|FG000|Overall Study|Lost to Follow-up|1|||
147556215|NCT00386009|532193394|FG001|Overall Study|Lost to Follow-up|1|||
147556216|NCT00386009|532193393|FG000|Overall Study|Protocol Violation|1|||
147556217|NCT00386009|532193394|FG001|Overall Study|Protocol Violation|0|||
147556218|NCT00386009|532193393|FG000|Overall Study|Sponsor Decision|1|||
147556219|NCT00386009|532193394|FG001|Overall Study|Sponsor Decision|1|||
147556220|NCT00386009|532193393|FG000|Overall Study|Withdrawal by Subject|5|||
147556221|NCT00386009|532193394|FG001|Overall Study|Withdrawal by Subject|4|||
147556222|NCT01862328|532193405|FG000|Overall Study|Progressive Disease|3|||
147556223|NCT01862328|532193406|FG001|Overall Study|Progressive Disease|11|||
147556224|NCT01862328|532193407|FG002|Overall Study|Progressive Disease|5|||
147556225|NCT01862328|532193408|FG003|Overall Study|Progressive Disease|6|||
147556226|NCT01862328|532193409|FG004|Overall Study|Progressive Disease|7|||
147556227|NCT01862328|532193410|FG005|Overall Study|Progressive Disease|4|||
147556228|NCT01862328|532193411|FG006|Overall Study|Progressive Disease|3|||
147556229|NCT01862328|532193405|FG000|Overall Study|Adverse Event|0|||
147556230|NCT01862328|532193406|FG001|Overall Study|Adverse Event|4|||
147556231|NCT01862328|532193407|FG002|Overall Study|Adverse Event|0|||
147556232|NCT01862328|532193408|FG003|Overall Study|Adverse Event|1|||
147556233|NCT01862328|532193409|FG004|Overall Study|Adverse Event|0|||
147556234|NCT01862328|532193410|FG005|Overall Study|Adverse Event|2|||
147556235|NCT01862328|532193411|FG006|Overall Study|Adverse Event|4|||
147556236|NCT01862328|532193405|FG000|Overall Study|Other|0|||
147556237|NCT01862328|532193406|FG001|Overall Study|Other|2|||
147556238|NCT01862328|532193407|FG002|Overall Study|Other|1|||
147556239|NCT01862328|532193408|FG003|Overall Study|Other|0|||
147556240|NCT01862328|532193409|FG004|Overall Study|Other|4|||
147556241|NCT01862328|532193410|FG005|Overall Study|Other|0|||
147556242|NCT01862328|532193411|FG006|Overall Study|Other|1|||
147556243|NCT01862328|532193405|FG000|Overall Study|Withdrawal by Subject|1|||
147225134|NCT00423670|530996553|FG007|Treatment Period|Subject withdrew (not treatment related)|0|||
147225135|NCT00423670|530996546|FG000|Treatment Period|Investigator decision|0|||
147556244|NCT01862328|532193406|FG001|Overall Study|Withdrawal by Subject|1|||
147556245|NCT01862328|532193407|FG002|Overall Study|Withdrawal by Subject|0|||
147556246|NCT01862328|532193408|FG003|Overall Study|Withdrawal by Subject|0|||
147556247|NCT01862328|532193409|FG004|Overall Study|Withdrawal by Subject|1|||
147556248|NCT01862328|532193410|FG005|Overall Study|Withdrawal by Subject|1|||
147556249|NCT01862328|532193411|FG006|Overall Study|Withdrawal by Subject|1|||
147556250|NCT01862328|532193405|FG000|Overall Study|Symptomatic Deterioration|0|||
147556251|NCT01862328|532193406|FG001|Overall Study|Symptomatic Deterioration|0|||
147556252|NCT01862328|532193407|FG002|Overall Study|Symptomatic Deterioration|0|||
147556253|NCT01862328|532193408|FG003|Overall Study|Symptomatic Deterioration|0|||
147556254|NCT01862328|532193409|FG004|Overall Study|Symptomatic Deterioration|0|||
147556255|NCT01862328|532193410|FG005|Overall Study|Symptomatic Deterioration|0|||
147556256|NCT01862328|532193411|FG006|Overall Study|Symptomatic Deterioration|1|||
147556257|NCT00936975|532193412|FG000|Overall Study|Withdrawal by Subject|1|||
147556258|NCT00936975|532193412|FG000|Overall Study|Disease progression|3|||
147556259|NCT00936975|532193412|FG000|Overall Study|Post-Tx scan uninterpretable|2|||
147556260|NCT02482571|532193413|FG000|Overall Study|Adverse Event|1|||
147556261|NCT02482571|532193413|FG000|Overall Study|Scanner or Respiract failure|3|||
147556262|NCT02482571|532193413|FG000|Overall Study|Withdrawal by Subject|4|||
147556263|NCT03922477|532193414|FG000|Overall Study|Death|9|||
147556264|NCT03922477|532193414|FG000|Overall Study|Fall leading to death prior to treatment initiation.|1|||
147556265|NCT03922477|532193414|FG000|Overall Study|Physician Decision|1|||
147556266|NCT03922477|532193414|FG000|Overall Study|Withdrawal by Subject|2|||
147556267|NCT01498484|532193415|FG000|Overall Study|Death|6|||
147556268|NCT01498484|532193416|FG001|Overall Study|Death|3|||
147556269|NCT01498484|532193417|FG002|Overall Study|Death|1|||
147556270|NCT01498484|532193418|FG003|Overall Study|Death|1|||
147556271|NCT01498484|532193419|FG004|Overall Study|Death|0|||
147556272|NCT01498484|532193420|FG005|Overall Study|Death|0|||
147556273|NCT01498484|532193421|FG006|Overall Study|Death|10|||
147556274|NCT01498484|532193422|FG007|Overall Study|Death|1|||
147556275|NCT01498484|532193423|FG008|Overall Study|Death|0|||
147556276|NCT01498484|532193415|FG000|Overall Study|Physician Decision|3|||
147556277|NCT01498484|532193416|FG001|Overall Study|Physician Decision|2|||
147556278|NCT01498484|532193417|FG002|Overall Study|Physician Decision|1|||
147556279|NCT01498484|532193418|FG003|Overall Study|Physician Decision|1|||
147556280|NCT01498484|532193419|FG004|Overall Study|Physician Decision|0|||
147556281|NCT01498484|532193420|FG005|Overall Study|Physician Decision|0|||
147556282|NCT01498484|532193421|FG006|Overall Study|Physician Decision|8|||
147556283|NCT01498484|532193422|FG007|Overall Study|Physician Decision|13|||
147556284|NCT01498484|532193423|FG008|Overall Study|Physician Decision|1|||
147556285|NCT01498484|532193415|FG000|Overall Study|Adverse Event|0|||
147556286|NCT01498484|532193416|FG001|Overall Study|Adverse Event|0|||
147556287|NCT01498484|532193417|FG002|Overall Study|Adverse Event|0|||
147556288|NCT01498484|532193418|FG003|Overall Study|Adverse Event|0|||
147556289|NCT01498484|532193419|FG004|Overall Study|Adverse Event|0|||
147556290|NCT01498484|532193420|FG005|Overall Study|Adverse Event|1|||
147556291|NCT01498484|532193421|FG006|Overall Study|Adverse Event|0|||
147556292|NCT01498484|532193422|FG007|Overall Study|Adverse Event|0|||
147556293|NCT01498484|532193423|FG008|Overall Study|Adverse Event|0|||
147556294|NCT01498484|532193415|FG000|Overall Study|Withdrawal by Subject|0|||
147556295|NCT01498484|532193416|FG001|Overall Study|Withdrawal by Subject|0|||
147556296|NCT01498484|532193417|FG002|Overall Study|Withdrawal by Subject|0|||
147556297|NCT01498484|532193418|FG003|Overall Study|Withdrawal by Subject|1|||
147556298|NCT01498484|532193419|FG004|Overall Study|Withdrawal by Subject|0|||
147556299|NCT01498484|532193420|FG005|Overall Study|Withdrawal by Subject|0|||
147556300|NCT01498484|532193421|FG006|Overall Study|Withdrawal by Subject|1|||
147556301|NCT01498484|532193422|FG007|Overall Study|Withdrawal by Subject|0|||
147556302|NCT01498484|532193423|FG008|Overall Study|Withdrawal by Subject|0|||
147556303|NCT01498484|532193415|FG000|Overall Study|Other|5|||
147556304|NCT01498484|532193416|FG001|Overall Study|Other|2|||
147556305|NCT01498484|532193417|FG002|Overall Study|Other|0|||
147556306|NCT01498484|532193418|FG003|Overall Study|Other|0|||
147556307|NCT01498484|532193419|FG004|Overall Study|Other|1|||
147556308|NCT01498484|532193420|FG005|Overall Study|Other|0|||
147556309|NCT01498484|532193421|FG006|Overall Study|Other|3|||
147556310|NCT01498484|532193422|FG007|Overall Study|Other|0|||
147556311|NCT01498484|532193423|FG008|Overall Study|Other|1|||
147556312|NCT02486796|532193424|FG000|Overall Study|Withdrawal by Subject|1|||
147556313|NCT02486796|532193425|FG001|Overall Study|Withdrawal by Subject|1|||
147556314|NCT02486796|532193424|FG000|Overall Study|Physician Decision|1|||
147556315|NCT02486796|532193425|FG001|Overall Study|Physician Decision|0|||
147556316|NCT03387098|532193426|FG000|Overall Study|progressive disease|1|||
147556317|NCT03387098|532193426|FG000|Overall Study|Withdrawal by Subject|2|||
147556318|NCT03387098|532193426|FG000|Overall Study|study terminated by sponsor|1|||
147556319|NCT02974153|532193427|FG000|Overall Study|Adverse Event|6|||
147556320|NCT02974153|532193428|FG001|Overall Study|Adverse Event|0|||
147556321|NCT02974153|532193429|FG002|Overall Study|Adverse Event|1|||
147556322|NCT02974153|532193427|FG000|Overall Study|Lack of Efficacy|6|||
147556323|NCT02974153|532193428|FG001|Overall Study|Lack of Efficacy|5|||
147556324|NCT02974153|532193429|FG002|Overall Study|Lack of Efficacy|10|||
147556325|NCT02974153|532193427|FG000|Overall Study|Lost to Follow-up|9|||
147556326|NCT02974153|532193428|FG001|Overall Study|Lost to Follow-up|10|||
147556327|NCT02974153|532193429|FG002|Overall Study|Lost to Follow-up|17|||
147556328|NCT02974153|532193427|FG000|Overall Study|Physician Decision|0|||
147556329|NCT02974153|532193428|FG001|Overall Study|Physician Decision|2|||
147556330|NCT02974153|532193429|FG002|Overall Study|Physician Decision|1|||
147556331|NCT02974153|532193427|FG000|Overall Study|Withdrawal by Subject|9|||
147556332|NCT02974153|532193428|FG001|Overall Study|Withdrawal by Subject|16|||
147556333|NCT02974153|532193429|FG002|Overall Study|Withdrawal by Subject|11|||
147556334|NCT02974153|532193427|FG000|Overall Study|Study Burden|8|||
147556335|NCT02974153|532193428|FG001|Overall Study|Study Burden|7|||
147556336|NCT02974153|532193429|FG002|Overall Study|Study Burden|3|||
147556337|NCT02974153|532193427|FG000|Overall Study|Other|14|||
147556338|NCT02974153|532193428|FG001|Overall Study|Other|8|||
147556339|NCT02974153|532193429|FG002|Overall Study|Other|7|||
147556340|NCT00423800|532193430|FG000|Overall Study|Protocol Violation|0|||
147556341|NCT00423800|532193431|FG001|Overall Study|Protocol Violation|1|||
147556342|NCT00679783|532193433|FG000|Overall Study|Adverse Event|0|||
147556343|NCT00679783|532193434|FG001|Overall Study|Adverse Event|0|||
147556344|NCT00679783|532193435|FG002|Overall Study|Adverse Event|0|||
147556345|NCT00679783|532193436|FG003|Overall Study|Adverse Event|3|||
147556346|NCT00679783|532193437|FG004|Overall Study|Adverse Event|0|||
147556347|NCT00679783|532193438|FG005|Overall Study|Adverse Event|0|||
147556348|NCT00679783|532193439|FG006|Overall Study|Adverse Event|1|||
147556349|NCT00679783|532193433|FG000|Overall Study|Lack of Efficacy|0|||
147556350|NCT00679783|532193434|FG001|Overall Study|Lack of Efficacy|1|||
147556351|NCT00679783|532193435|FG002|Overall Study|Lack of Efficacy|0|||
147556352|NCT00679783|532193436|FG003|Overall Study|Lack of Efficacy|2|||
147556353|NCT00679783|532193437|FG004|Overall Study|Lack of Efficacy|0|||
147556354|NCT00679783|532193438|FG005|Overall Study|Lack of Efficacy|0|||
147556355|NCT00679783|532193439|FG006|Overall Study|Lack of Efficacy|0|||
147556356|NCT00679783|532193433|FG000|Overall Study|Withdrawal by Subject|0|||
147556357|NCT00679783|532193434|FG001|Overall Study|Withdrawal by Subject|0|||
147556358|NCT00679783|532193435|FG002|Overall Study|Withdrawal by Subject|1|||
147556359|NCT00679783|532193436|FG003|Overall Study|Withdrawal by Subject|1|||
147556360|NCT00679783|532193437|FG004|Overall Study|Withdrawal by Subject|0|||
147556361|NCT00679783|532193438|FG005|Overall Study|Withdrawal by Subject|0|||
147556362|NCT00679783|532193439|FG006|Overall Study|Withdrawal by Subject|0|||
147556363|NCT00679783|532193433|FG000|Overall Study|Not Captured|0|||
147556364|NCT00679783|532193434|FG001|Overall Study|Not Captured|0|||
147556365|NCT00679783|532193435|FG002|Overall Study|Not Captured|0|||
147556366|NCT00679783|532193436|FG003|Overall Study|Not Captured|5|||
147556367|NCT00679783|532193437|FG004|Overall Study|Not Captured|0|||
147556368|NCT00679783|532193438|FG005|Overall Study|Not Captured|0|||
147556369|NCT00679783|532193439|FG006|Overall Study|Not Captured|0|||
147556370|NCT00679783|532193433|FG000|Overall Study|Ongoing at data cut-off|2|||
147556371|NCT00679783|532193434|FG001|Overall Study|Ongoing at data cut-off|2|||
147556372|NCT00679783|532193435|FG002|Overall Study|Ongoing at data cut-off|0|||
147556373|NCT00679783|532193436|FG003|Overall Study|Ongoing at data cut-off|9|||
147556374|NCT00679783|532193437|FG004|Overall Study|Ongoing at data cut-off|1|||
147556375|NCT00679783|532193438|FG005|Overall Study|Ongoing at data cut-off|0|||
147556376|NCT00679783|532193439|FG006|Overall Study|Ongoing at data cut-off|0|||
147556377|NCT00814320|532193440|FG000|Epoch 1 (IV Treatment)|Withdrawal by Subject|1|||
147556378|NCT00814320|532193441|FG001|Epoch 1 (IV Treatment)|Withdrawal by Subject|0|||
147556379|NCT00814320|532193440|FG000|Epoch 1 (IV Treatment)|Participant missed 2 consecutive doses|0|||
147556380|NCT00814320|532193441|FG001|Epoch 1 (IV Treatment)|Participant missed 2 consecutive doses|2|||
147556381|NCT00814320|532193440|FG000|Between Epoch 1 (IV) and Epoch 2 Ramp-up|Withdrawal by Subject|0|||
147556382|NCT00814320|532193441|FG001|Between Epoch 1 (IV) and Epoch 2 Ramp-up|Withdrawal by Subject|1|||
147556383|NCT00814320|532193440|FG000|"Epoch 2 Ramp-up (Ramp-up)"|Adverse Event|1|||
147556384|NCT00814320|532193441|FG001|"Epoch 2 Ramp-up (Ramp-up)"|Adverse Event|0|||
147556385|NCT00814320|532193440|FG000|"Epoch 2 Ramp-up (Ramp-up)"|Geographic Factor|1|||
147556386|NCT00814320|532193441|FG001|"Epoch 2 Ramp-up (Ramp-up)"|Geographic Factor|0|||
147225136|NCT00423670|530996547|FG001|Treatment Period|Investigator decision|0|||
147225137|NCT00423670|530996548|FG002|Treatment Period|Investigator decision|0|||
147556387|NCT00814320|532193440|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Adverse Event|1|||
147556388|NCT00814320|532193441|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Adverse Event|4|||
147556389|NCT00814320|532193440|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Withdrawal by Subject|2|||
147556390|NCT00814320|532193441|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Withdrawal by Subject|1|||
147556391|NCT00814320|532193440|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Lost to Follow-up|0|||
147556392|NCT00814320|532193441|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Lost to Follow-up|1|||
147556393|NCT00814320|532193440|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Subject Felt Increased Infections on SC|0|||
147556394|NCT00814320|532193441|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Subject Felt Increased Infections on SC|1|||
147556395|NCT00814320|532193440|FG000|Epoch 2 After Ramp-up (SC/rHuPH20)|Switched to safety follow-up|0|||
147556396|NCT00814320|532193441|FG001|Epoch 2 After Ramp-up (SC/rHuPH20)|Switched to safety follow-up|3|||
147556397|NCT00491504|532193442|FG000|Overall Study|Adverse Event|0|||
147556398|NCT00491504|532193443|FG001|Overall Study|Adverse Event|1|||
147556399|NCT00491504|532193444|FG002|Overall Study|Adverse Event|0|||
147444090|NCT01197521|531790483|FG001|Overall Study|Dev. of study specific discont. criteria|16|||
147444091|NCT01197521|531790484|FG002|Overall Study|Dev. of study specific discont. criteria|2|||
147444092|NCT01197521|531790482|FG000|Overall Study|Lost to Follow-up|3|||
147444093|NCT01197521|531790483|FG001|Overall Study|Lost to Follow-up|2|||
147444094|NCT01197521|531790484|FG002|Overall Study|Lost to Follow-up|2|||
147444095|NCT01197521|531790482|FG000|Overall Study|Adverse Event|25|||
147444096|NCT01197521|531790483|FG001|Overall Study|Adverse Event|28|||
147444097|NCT01197521|531790484|FG002|Overall Study|Adverse Event|24|||
147444098|NCT01517893|531790485|FG000|Overall Study|Withdrawal by Subject|3|||
147444099|NCT01517893|531790486|FG001|Overall Study|Withdrawal by Subject|0|||
147556400|NCT00491504|532193445|FG003|Overall Study|Adverse Event|0|||
147556401|NCT00491504|532193442|FG000|Overall Study|Withdrawal by Subject|0|||
147556402|NCT00491504|532193443|FG001|Overall Study|Withdrawal by Subject|0|||
147556403|NCT00491504|532193444|FG002|Overall Study|Withdrawal by Subject|1|||
147556404|NCT00491504|532193445|FG003|Overall Study|Withdrawal by Subject|2|||
147556405|NCT00491504|532193442|FG000|Overall Study|Protocol Violation|0|||
147556406|NCT00491504|532193443|FG001|Overall Study|Protocol Violation|0|||
147556407|NCT00491504|532193444|FG002|Overall Study|Protocol Violation|3|||
147556408|NCT00491504|532193445|FG003|Overall Study|Protocol Violation|2|||
147556409|NCT03111147|532193448|FG000|Overall Study|Lost to Follow-up|2|||
147556410|NCT03111147|532193449|FG001|Overall Study|Lost to Follow-up|5|||
147556411|NCT03111147|532193448|FG000|Overall Study|Withdrawal by Subject|4|||
147556412|NCT03111147|532193449|FG001|Overall Study|Withdrawal by Subject|3|||
147556413|NCT03111147|532193448|FG000|Overall Study|Protocol Violation|2|||
147556414|NCT03111147|532193449|FG001|Overall Study|Protocol Violation|1|||
147556415|NCT03111147|532193448|FG000|Overall Study|Death|1|||
147556416|NCT03111147|532193449|FG001|Overall Study|Death|1|||
147556417|NCT01463683|532193450|FG000|Overall Study|Adverse Event|2|||
147556418|NCT01463683|532193451|FG001|Overall Study|Adverse Event|0|||
147556419|NCT01463683|532193452|FG002|Overall Study|Adverse Event|0|||
147556420|NCT01463683|532193450|FG000|Overall Study|Lost to Follow-up|10|||
147556421|NCT01463683|532193451|FG001|Overall Study|Lost to Follow-up|9|||
147556422|NCT01463683|532193452|FG002|Overall Study|Lost to Follow-up|7|||
147556423|NCT01463683|532193450|FG000|Overall Study|Physician Decision|0|||
147556424|NCT01463683|532193451|FG001|Overall Study|Physician Decision|3|||
147556425|NCT01463683|532193452|FG002|Overall Study|Physician Decision|1|||
147556426|NCT01463683|532193450|FG000|Overall Study|Pregnancy|2|||
147556427|NCT01463683|532193451|FG001|Overall Study|Pregnancy|2|||
147556428|NCT01463683|532193452|FG002|Overall Study|Pregnancy|1|||
147556429|NCT01463683|532193450|FG000|Overall Study|Withdrawal by Subject|5|||
147556430|NCT01463683|532193451|FG001|Overall Study|Withdrawal by Subject|17|||
147556431|NCT01463683|532193452|FG002|Overall Study|Withdrawal by Subject|2|||
147225138|NCT00423670|530996549|FG003|Treatment Period|Investigator decision|0|||
147225139|NCT00423670|530996550|FG004|Treatment Period|Investigator decision|0|||
147225140|NCT00423670|530996551|FG005|Treatment Period|Investigator decision|0|||
147225141|NCT00423670|530996552|FG006|Treatment Period|Investigator decision|0|||
147225142|NCT00423670|530996553|FG007|Treatment Period|Investigator decision|1|||
147225143|NCT00423670|530996546|FG000|Treatment Period|Non-compliance with protocol|3|||
147444100|NCT03462576|531790487|FG000|Overall Study|Protocol Violation|5|||
147444101|NCT03462576|531790488|FG001|Overall Study|Protocol Violation|11|||
147444102|NCT03462576|531790489|FG002|Overall Study|Protocol Violation|7|||
147444103|NCT03462576|531790487|FG000|Overall Study|Device Malfunction|0|||
147444104|NCT03462576|531790488|FG001|Overall Study|Device Malfunction|0|||
147444105|NCT03462576|531790489|FG002|Overall Study|Device Malfunction|1|||
147444106|NCT01543828|531790494|FG000|Treatment 2|Lost to Follow-up|1|||
147444107|NCT01543828|531790495|FG001|Treatment 2|Lost to Follow-up|0|||
147444108|NCT01069172|531790498|FG000|Overall Study|Withdrawal by Subject|1|||
147444109|NCT01069172|531790499|FG001|Overall Study|Withdrawal by Subject|0|||
147444110|NCT00711425|531790501|FG000|Overall Study|Protocol Violation|1|||
147444111|NCT00711425|531790501|FG000|Overall Study|Death|2|||
147444112|NCT00711425|531790501|FG000|Overall Study|Lost to Follow-up|1|||
147444113|NCT03901079|531790504|FG000|Overall Study|8 of the 20 subjects already enrolled were unable to complete the the 12-month follow-up|8|||
147444114|NCT03710486|531790509|FG000|Overall Study|Lost to Follow-up (at least 12 months)|13|||
147444115|NCT03710486|531790510|FG001|Overall Study|Lost to Follow-up (at least 12 months)|10|||
147444116|NCT03710486|531790509|FG000|Overall Study|Missing|0|||
147444117|NCT03710486|531790510|FG001|Overall Study|Missing|2|||
147444118|NCT01744665|531790524|FG000|Monitoring Phase|Adverse Event|4|||
147444119|NCT01744665|531790524|FG000|Monitoring Phase|Abnormal laboratory value(s)|1|||
147444120|NCT01744665|531790524|FG000|Monitoring Phase|Unsatisfactory therapeutic effect|7|||
147444121|NCT01744665|531790524|FG000|Monitoring Phase|Withdrawal by Subject|5|||
147444122|NCT01744665|531790524|FG000|Monitoring Phase|Did not achieve MR4.5|1|||
147444123|NCT01744665|531790524|FG000|Consolidation Phase|Adverse Event|2|||
147444124|NCT01744665|531790524|FG000|Consolidation Phase|Unsatisfactory therapeutic effect|4|||
147444125|NCT01744665|531790524|FG000|Consolidation Phase|Withdrawal by Subject|4|||
147444126|NCT01744665|531790524|FG000|Consolidation Phase|Administrative problems|9|||
147444127|NCT01744665|531790524|FG000|Re-initiation Phase|Administrative problems|10|||
147444128|NCT01744665|531790524|FG000|Re-initiation Phase|Adverse Event|1|||
147556432|NCT01565083|532193453|FG000|Overall Study|Withdrawal by Subject|6|||
147556433|NCT01565083|532193454|FG001|Overall Study|Withdrawal by Subject|4|||
147556434|NCT01565083|532193453|FG000|Overall Study|Lost to Follow-up|2|||
147556435|NCT01565083|532193454|FG001|Overall Study|Lost to Follow-up|7|||
147556436|NCT01565083|532193453|FG000|Overall Study|Death|22|||
147556437|NCT01565083|532193454|FG001|Overall Study|Death|23|||
147556438|NCT01565083|532193453|FG000|Overall Study|Other|3|||
147556439|NCT01565083|532193454|FG001|Overall Study|Other|5|||
147556440|NCT01118728|532193455|FG000|Overall Study|Adverse Event|17|||
147556441|NCT01118728|532193455|FG000|Overall Study|Lack of Efficacy|27|||
147556442|NCT01118728|532193455|FG000|Overall Study|Sponsor's decision to discontinue study|172|||
147556443|NCT01118728|532193455|FG000|Overall Study|Withdrawal by Subject|3|||
147556444|NCT01118728|532193455|FG000|Overall Study|Lost to Follow-up|4|||
147556445|NCT00266409|532195203|FG000|Overall Study|Lack of Efficacy|2|||
147556446|NCT00266409|532195204|FG001|Overall Study|Lack of Efficacy|6|||
147556447|NCT00266409|532195205|FG002|Overall Study|Lack of Efficacy|1|||
147556448|NCT00266409|532195206|FG003|Overall Study|Lack of Efficacy|2|||
147556449|NCT00266409|532195203|FG000|Overall Study|Adverse Event|7|||
147556450|NCT00266409|532195204|FG001|Overall Study|Adverse Event|2|||
147556451|NCT00266409|532195205|FG002|Overall Study|Adverse Event|1|||
147556452|NCT00266409|532195206|FG003|Overall Study|Adverse Event|1|||
147556453|NCT00266409|532195203|FG000|Overall Study|Lost to Follow-up|18|||
147556454|NCT00266409|532195204|FG001|Overall Study|Lost to Follow-up|21|||
147556455|NCT00266409|532195205|FG002|Overall Study|Lost to Follow-up|6|||
147556456|NCT00266409|532195206|FG003|Overall Study|Lost to Follow-up|8|||
147556457|NCT00266409|532195203|FG000|Overall Study|Withdrawal by Subject|6|||
147556458|NCT00266409|532195204|FG001|Overall Study|Withdrawal by Subject|10|||
147556459|NCT00266409|532195205|FG002|Overall Study|Withdrawal by Subject|3|||
147556460|NCT00266409|532195206|FG003|Overall Study|Withdrawal by Subject|9|||
147556461|NCT00266409|532195203|FG000|Overall Study|Protocol Violation|5|||
147556462|NCT00266409|532195204|FG001|Overall Study|Protocol Violation|3|||
147556463|NCT00266409|532195205|FG002|Overall Study|Protocol Violation|4|||
147556464|NCT00266409|532195206|FG003|Overall Study|Protocol Violation|2|||
147556465|NCT00266409|532195203|FG000|Overall Study|Other|7|||
147556466|NCT00266409|532195204|FG001|Overall Study|Other|4|||
147556467|NCT00266409|532195205|FG002|Overall Study|Other|2|||
147556468|NCT00266409|532195206|FG003|Overall Study|Other|0|||
147556469|NCT00712010|532195207|FG000|Washout (7 Days)|Withdrawal by Subject|1|||
147556470|NCT01179919|532195208|FG000|Overall Study|Protocol Violation|1|||
147556471|NCT01179919|532195208|FG000|Overall Study|Adverse Event|1|||
147556472|NCT00698685|532195212|FG000|Overall Study|Sister withdrew as donor|1|||
147556473|NCT00698685|532195212|FG000|Overall Study|Off study pre transplant by clinic MD|1|||
147556474|NCT01254409|532195213|FG000|Overall Study|Adverse Event|0|||
147556475|NCT01254409|532195214|FG001|Overall Study|Adverse Event|1|||
147556476|NCT01254409|532195215|FG002|Overall Study|Adverse Event|0|||
147556477|NCT01254409|532195216|FG003|Overall Study|Adverse Event|0|||
147556478|NCT00635154|532195218|FG000|Overall Study|Alternative Treatment|8|||
147556479|NCT00635154|532195218|FG000|Overall Study|Other|4|||
147556480|NCT00635154|532195218|FG000|Overall Study|Still on treatment|21|||
147556481|NCT01513148|532195219|FG000|Overall Study|Protocol Violation|2|||
147556482|NCT01513148|532195220|FG001|Overall Study|Protocol Violation|2|||
147556483|NCT03500484|532195221|FG000|Overall Study|Adverse Event|2|||
147556484|NCT03500484|532195222|FG001|Overall Study|Adverse Event|0|||
147556485|NCT03500484|532195221|FG000|Overall Study|Physician Decision|1|||
147556486|NCT03500484|532195222|FG001|Overall Study|Physician Decision|0|||
147556487|NCT03500484|532195221|FG000|Overall Study|Could not be scanned or followed up due to COVID|1|||
147556488|NCT03500484|532195222|FG001|Overall Study|Could not be scanned or followed up due to COVID|0|||
147556489|NCT02795104|532195223|FG000|Overall Study|Determined to be Ineligible with Exit Data|7|||
147556490|NCT02795104|532195224|FG001|Overall Study|Determined to be Ineligible with Exit Data|5|||
147556491|NCT02795104|532195225|FG002|Overall Study|Determined to be Ineligible with Exit Data|7|||
147556492|NCT02795104|532195223|FG000|Overall Study|Withdrawal by Subject|0|||
147556493|NCT02795104|532195224|FG001|Overall Study|Withdrawal by Subject|2|||
147556494|NCT02795104|532195225|FG002|Overall Study|Withdrawal by Subject|0|||
147556495|NCT02795104|532195223|FG000|Overall Study|Lost to Follow-up|0|||
147556496|NCT02795104|532195224|FG001|Overall Study|Lost to Follow-up|0|||
147556497|NCT02795104|532195225|FG002|Overall Study|Lost to Follow-up|1|||
147556498|NCT01654380|532195226|FG000|Part B, Period 1|Physician Decision|0|||
147556499|NCT01654380|532195227|FG001|Part B, Period 1|Physician Decision|0|||
147556500|NCT01654380|532195228|FG002|Part B, Period 1|Physician Decision|1|||
147556501|NCT01654380|532195229|FG003|Part B, Period 1|Physician Decision|0|||
147556502|NCT04128007|532195232|FG000|Overall Study|Withdrawal by Subject|9|||
147556503|NCT04128007|532195233|FG001|Overall Study|Withdrawal by Subject|6|||
147556504|NCT04128007|532195232|FG000|Overall Study|Protocol Violation|1|||
147556505|NCT04128007|532195233|FG001|Overall Study|Protocol Violation|0|||
147556506|NCT04128007|532195232|FG000|Overall Study|Lost to Follow-up|8|||
147556507|NCT04128007|532195233|FG001|Overall Study|Lost to Follow-up|7|||
147556508|NCT04128007|532195232|FG000|Overall Study|Adverse Event|5|||
147556509|NCT04128007|532195233|FG001|Overall Study|Adverse Event|2|||
147556510|NCT04128007|532195232|FG000|Overall Study|Not reported|0|||
147556511|NCT04128007|532195233|FG001|Overall Study|Not reported|2|||
147556512|NCT00429923|532195240|FG000|Overall Study|Adverse Event|0|||
147556513|NCT00429923|532195241|FG001|Overall Study|Adverse Event|2|||
147556514|NCT00429923|532195242|FG002|Overall Study|Adverse Event|3|||
147556515|NCT00429923|532195240|FG000|Overall Study|Lack of Efficacy|4|||
147556516|NCT00429923|532195241|FG001|Overall Study|Lack of Efficacy|1|||
147556517|NCT00429923|532195242|FG002|Overall Study|Lack of Efficacy|33|||
147556518|NCT00429923|532195240|FG000|Overall Study|Lost to Follow-up|0|||
147556519|NCT00429923|532195241|FG001|Overall Study|Lost to Follow-up|0|||
147556520|NCT00429923|532195242|FG002|Overall Study|Lost to Follow-up|2|||
147556521|NCT00429923|532195240|FG000|Overall Study|Withdrew Consent|1|||
147556522|NCT00429923|532195241|FG001|Overall Study|Withdrew Consent|0|||
147556523|NCT00429923|532195242|FG002|Overall Study|Withdrew Consent|1|||
147556524|NCT00429923|532195240|FG000|Overall Study|Early Termination|0|||
147556525|NCT00429923|532195241|FG001|Overall Study|Early Termination|1|||
147556526|NCT00429923|532195242|FG002|Overall Study|Early Termination|0|||
147556527|NCT01265784|532195243|FG000|Overall Study|Lost to Follow-up|5|||
147556528|NCT01265784|532195244|FG001|Overall Study|Lost to Follow-up|3|||
147556529|NCT01265784|532195245|FG002|Overall Study|Lost to Follow-up|2|||
147556530|NCT01265784|532195243|FG000|Overall Study|Withdrawal by Subject|0|||
147556531|NCT01265784|532195244|FG001|Overall Study|Withdrawal by Subject|5|||
147556532|NCT01265784|532195245|FG002|Overall Study|Withdrawal by Subject|0|||
147556533|NCT01265784|532195243|FG000|Overall Study|Physician Decision|1|||
147556534|NCT01265784|532195244|FG001|Overall Study|Physician Decision|0|||
147556535|NCT01265784|532195245|FG002|Overall Study|Physician Decision|1|||
147556536|NCT01265784|532195243|FG000|Overall Study|Adverse Event|1|||
147556537|NCT01265784|532195244|FG001|Overall Study|Adverse Event|0|||
147556538|NCT01265784|532195245|FG002|Overall Study|Adverse Event|0|||
147556539|NCT01265784|532195243|FG000|Overall Study|Death|3|||
147556540|NCT01265784|532195244|FG001|Overall Study|Death|0|||
147556541|NCT01265784|532195245|FG002|Overall Study|Death|0|||
147556542|NCT01265784|532195243|FG000|Overall Study|Protocol Violation|2|||
147556543|NCT01265784|532195244|FG001|Overall Study|Protocol Violation|0|||
147556544|NCT01265784|532195245|FG002|Overall Study|Protocol Violation|0|||
147556545|NCT01265784|532195243|FG000|Overall Study|Incorrectly Randomized|0|||
147556546|NCT01265784|532195244|FG001|Overall Study|Incorrectly Randomized|0|||
147556547|NCT01265784|532195245|FG002|Overall Study|Incorrectly Randomized|1|||
147556548|NCT01937364|532195246|FG000|Overall Study|Adverse Event|2|||
147556549|NCT01937364|532195247|FG001|Overall Study|Adverse Event|1|||
147556550|NCT04799158|532195248|FG000|Run-In Period|Adverse Event|6|||
147556551|NCT04799158|532195249|FG001|Run-In Period|Adverse Event|0|||
147556552|NCT04799158|532195250|FG002|Run-In Period|Adverse Event|0|||
147556553|NCT04799158|532195251|FG003|Run-In Period|Adverse Event|0|||
147556554|NCT04799158|532195252|FG004|Run-In Period|Adverse Event|0|||
147556555|NCT04799158|532195248|FG000|Run-In Period|Lost to Follow-up|4|||
147556556|NCT04799158|532195249|FG001|Run-In Period|Lost to Follow-up|0|||
147556557|NCT04799158|532195250|FG002|Run-In Period|Lost to Follow-up|0|||
147556558|NCT04799158|532195251|FG003|Run-In Period|Lost to Follow-up|0|||
147556559|NCT04799158|532195252|FG004|Run-In Period|Lost to Follow-up|0|||
147556560|NCT04799158|532195248|FG000|Run-In Period|Significant Protocol Deviation|1|||
147556561|NCT04799158|532195249|FG001|Run-In Period|Significant Protocol Deviation|0|||
147556562|NCT04799158|532195250|FG002|Run-In Period|Significant Protocol Deviation|0|||
147556563|NCT04799158|532195251|FG003|Run-In Period|Significant Protocol Deviation|0|||
147556564|NCT04799158|532195252|FG004|Run-In Period|Significant Protocol Deviation|0|||
147556565|NCT04799158|532195248|FG000|Run-In Period|Withdrawal by Subject|11|||
147556566|NCT04799158|532195249|FG001|Run-In Period|Withdrawal by Subject|0|||
147556567|NCT04799158|532195250|FG002|Run-In Period|Withdrawal by Subject|0|||
147556568|NCT04799158|532195251|FG003|Run-In Period|Withdrawal by Subject|0|||
147556569|NCT04799158|532195252|FG004|Run-In Period|Withdrawal by Subject|0|||
147556570|NCT04799158|532195248|FG000|Run-In Period|Miscellaneous|3|||
147556571|NCT04799158|532195249|FG001|Run-In Period|Miscellaneous|0|||
147556572|NCT04799158|532195250|FG002|Run-In Period|Miscellaneous|0|||
147556573|NCT04799158|532195251|FG003|Run-In Period|Miscellaneous|0|||
147556574|NCT04799158|532195252|FG004|Run-In Period|Miscellaneous|0|||
147556575|NCT04799158|532195248|FG000|Run-In Period|Did not meet On-Demand Eligibility Criteria|226|||
147556576|NCT04799158|532195249|FG001|Run-In Period|Did not meet On-Demand Eligibility Criteria|0|||
147556577|NCT04799158|532195250|FG002|Run-In Period|Did not meet On-Demand Eligibility Criteria|0|||
147556578|NCT04799158|532195251|FG003|Run-In Period|Did not meet On-Demand Eligibility Criteria|0|||
147556579|NCT04799158|532195252|FG004|Run-In Period|Did not meet On-Demand Eligibility Criteria|0|||
147556580|NCT04799158|532195248|FG000|On-Demand Treatment Period|Adverse Event|0|||
147556581|NCT04799158|532195249|FG001|On-Demand Treatment Period|Adverse Event|1|||
147556582|NCT04799158|532195250|FG002|On-Demand Treatment Period|Adverse Event|0|||
147556583|NCT04799158|532195251|FG003|On-Demand Treatment Period|Adverse Event|0|||
147556584|NCT04799158|532195252|FG004|On-Demand Treatment Period|Adverse Event|1|||
147556585|NCT04799158|532195248|FG000|On-Demand Treatment Period|Lost to Follow-up|0|||
147556586|NCT04799158|532195249|FG001|On-Demand Treatment Period|Lost to Follow-up|0|||
147556587|NCT04799158|532195250|FG002|On-Demand Treatment Period|Lost to Follow-up|0|||
147556588|NCT04799158|532195251|FG003|On-Demand Treatment Period|Lost to Follow-up|0|||
147556589|NCT04799158|532195252|FG004|On-Demand Treatment Period|Lost to Follow-up|1|||
147556590|NCT04799158|532195248|FG000|On-Demand Treatment Period|Significant Protocol Deviation|0|||
147556591|NCT04799158|532195249|FG001|On-Demand Treatment Period|Significant Protocol Deviation|0|||
147556592|NCT04799158|532195250|FG002|On-Demand Treatment Period|Significant Protocol Deviation|0|||
147556593|NCT04799158|532195251|FG003|On-Demand Treatment Period|Significant Protocol Deviation|1|||
147106053|NCT01348269|530553736|FG001|Follow-up (Until Week 12)|Surgical intervention - not study related|0|||
147106054|NCT01348269|530553735|FG000|Follow-up (Until Week 12)|Subsequent follow-up treatment required|0|||
147556594|NCT04799158|532195252|FG004|On-Demand Treatment Period|Significant Protocol Deviation|0|||
147556595|NCT04799158|532195248|FG000|On-Demand Treatment Period|Withdrawal by Subject|0|||
147556596|NCT04799158|532195249|FG001|On-Demand Treatment Period|Withdrawal by Subject|0|||
147556597|NCT04799158|532195250|FG002|On-Demand Treatment Period|Withdrawal by Subject|0|||
147556598|NCT04799158|532195251|FG003|On-Demand Treatment Period|Withdrawal by Subject|1|||
147556599|NCT04799158|532195252|FG004|On-Demand Treatment Period|Withdrawal by Subject|0|||
147556600|NCT04799158|532195248|FG000|On-Demand Treatment Period|Lack of Efficacy|0|||
147556601|NCT04799158|532195249|FG001|On-Demand Treatment Period|Lack of Efficacy|0|||
147556602|NCT04799158|532195250|FG002|On-Demand Treatment Period|Lack of Efficacy|0|||
147556603|NCT04799158|532195251|FG003|On-Demand Treatment Period|Lack of Efficacy|0|||
147556604|NCT04799158|532195252|FG004|On-Demand Treatment Period|Lack of Efficacy|1|||
147556605|NCT04799158|532195248|FG000|On-Demand Treatment Period|Miscellaneous|0|||
147556606|NCT04799158|532195249|FG001|On-Demand Treatment Period|Miscellaneous|0|||
147556607|NCT04799158|532195250|FG002|On-Demand Treatment Period|Miscellaneous|0|||
147556608|NCT04799158|532195251|FG003|On-Demand Treatment Period|Miscellaneous|0|||
147556609|NCT04799158|532195252|FG004|On-Demand Treatment Period|Miscellaneous|1|||
147556610|NCT04104646|532195256|FG000|Overall Study|Withdrawal by Subject|1|||
147556611|NCT04104646|532195257|FG001|Overall Study|Withdrawal by Subject|1|||
147556612|NCT04104646|532195256|FG000|Overall Study|Lost to Follow-up|1|||
147556613|NCT04104646|532195257|FG001|Overall Study|Lost to Follow-up|0|||
147556614|NCT04104646|532195256|FG000|Overall Study|Physician Decision|2|||
147556615|NCT04104646|532195257|FG001|Overall Study|Physician Decision|0|||
147556616|NCT01199601|532195258|FG000|Overall Study|Lost to Follow-up|47|||
147556617|NCT01199601|532195259|FG001|Overall Study|Lost to Follow-up|66|||
147556618|NCT01199601|532195258|FG000|Overall Study|Withdrawal by Subject|15|||
147556619|NCT01199601|532195259|FG001|Overall Study|Withdrawal by Subject|3|||
147556620|NCT01199601|532195258|FG000|Overall Study|Insecurity prevented staff interviewing.|7|||
147556621|NCT01199601|532195259|FG001|Overall Study|Insecurity prevented staff interviewing.|9|||
147556622|NCT02607800|532195260|FG000|Overall Study|Lost to Follow-up|7|||
147556623|NCT02607800|532195261|FG001|Overall Study|Lost to Follow-up|10|||
147556624|NCT02607800|532195260|FG000|Overall Study|Withdrew Consent|2|||
147556625|NCT02607800|532195261|FG001|Overall Study|Withdrew Consent|0|||
147556626|NCT02607800|532195260|FG000|Overall Study|Randomized/Enrolled but Not Treated|1|||
147556627|NCT02607800|532195261|FG001|Overall Study|Randomized/Enrolled but Not Treated|1|||
147556628|NCT01656889|532195262|FG000|Treatment Period, 12 Weeks|Adverse Event|10|||
147556629|NCT01656889|532195263|FG001|Treatment Period, 12 Weeks|Adverse Event|4|||
147556630|NCT01656889|532195262|FG000|Treatment Period, 12 Weeks|Death|0|||
147556631|NCT01656889|532195263|FG001|Treatment Period, 12 Weeks|Death|1|||
147556632|NCT01656889|532195262|FG000|Treatment Period, 12 Weeks|Lost to Follow-up|1|||
147556633|NCT01656889|532195263|FG001|Treatment Period, 12 Weeks|Lost to Follow-up|1|||
147556634|NCT01656889|532195262|FG000|Treatment Period, 12 Weeks|Withdrawal by Subject|1|||
147556635|NCT01656889|532195263|FG001|Treatment Period, 12 Weeks|Withdrawal by Subject|2|||
147556636|NCT01656889|532195262|FG000|Treatment Period, 12 Weeks|Protocol Violation|0|||
147556637|NCT01656889|532195263|FG001|Treatment Period, 12 Weeks|Protocol Violation|1|||
147556638|NCT01656889|532195262|FG000|Treatment Period, 12 Weeks|Moved out of the area|0|||
147556639|NCT01656889|532195263|FG001|Treatment Period, 12 Weeks|Moved out of the area|2|||
147556640|NCT01656889|532195262|FG000|Post Treatment Follow-Up, 3 Months|Death|1|||
147556641|NCT01656889|532195263|FG001|Post Treatment Follow-Up, 3 Months|Death|5|||
147556642|NCT01656889|532195262|FG000|Post Treatment Follow-Up, 3 Months|Lost to Follow-up|1|||
147556643|NCT01656889|532195263|FG001|Post Treatment Follow-Up, 3 Months|Lost to Follow-up|2|||
147556644|NCT01656889|532195262|FG000|Post Treatment Follow-Up, 3 Months|Withdrawal by Subject|2|||
147556645|NCT01656889|532195263|FG001|Post Treatment Follow-Up, 3 Months|Withdrawal by Subject|1|||
147106055|NCT01348269|530553736|FG001|Follow-up (Until Week 12)|Subsequent follow-up treatment required|1|||
147106056|NCT01348269|530553735|FG000|Follow-up (Until Week 12)|Adverse Event|1|||
147556646|NCT01656889|532195262|FG000|Post Treatment Follow-Up, 3 Months|Site Closure|0|||
147556647|NCT01656889|532195263|FG001|Post Treatment Follow-Up, 3 Months|Site Closure|1|||
147556648|NCT02521948|532195264|FG000|Overall Study|Adverse Event|2|||
147556649|NCT02521948|532195264|FG000|Overall Study|Death|4|||
147556650|NCT02521948|532195264|FG000|Overall Study|Lost to Follow-up|1|||
147556651|NCT02521948|532195264|FG000|Overall Study|Did not attend one or both follow-ups|6|||
147556652|NCT02568384|532195267|FG000|Overall Study|Mobile devices incompatible with App|2|||
147556653|NCT01485536|532195269|FG000|Overall Study|Withdrawal by Subject|3|||
147556654|NCT01485536|532195269|FG000|Overall Study|Adverse Event|1|||
147556655|NCT00329602|532195270|FG000|26-Week Double-Blind Treatment Phase|Did not complete phase; reason unknown|119|||
147225144|NCT00423670|530996547|FG001|Treatment Period|Non-compliance with protocol|1|||
147556656|NCT00329602|532195271|FG001|26-Week Double-Blind Treatment Phase|Did not complete phase; reason unknown|99|||
147556657|NCT00329602|532195272|FG002|26-Week Double-Blind Treatment Phase|Did not complete phase; reason unknown|0|||
147556658|NCT00329602|532195270|FG000|40-Week Open-Label Treatment Phase|Adverse Event|0|||
147556659|NCT00329602|532195271|FG001|40-Week Open-Label Treatment Phase|Adverse Event|0|||
147556660|NCT00329602|532195272|FG002|40-Week Open-Label Treatment Phase|Adverse Event|20|||
147556661|NCT00329602|532195270|FG000|40-Week Open-Label Treatment Phase|Lost to Follow-up|0|||
147556662|NCT00329602|532195271|FG001|40-Week Open-Label Treatment Phase|Lost to Follow-up|0|||
147556663|NCT00329602|532195272|FG002|40-Week Open-Label Treatment Phase|Lost to Follow-up|1|||
147556664|NCT00329602|532195270|FG000|40-Week Open-Label Treatment Phase|Protocol Violation|0|||
147556665|NCT00329602|532195271|FG001|40-Week Open-Label Treatment Phase|Protocol Violation|0|||
147556666|NCT00329602|532195272|FG002|40-Week Open-Label Treatment Phase|Protocol Violation|2|||
147556667|NCT00329602|532195270|FG000|40-Week Open-Label Treatment Phase|Lack of Efficacy|0|||
147106057|NCT01348269|530553736|FG001|Follow-up (Until Week 12)|Adverse Event|0|||
147106058|NCT00805532|530553737|FG000|Overall Study|invalid data|0|||
147106059|NCT00805532|530553738|FG001|Overall Study|invalid data|1|||
147225145|NCT00423670|530996548|FG002|Treatment Period|Non-compliance with protocol|1|||
147225146|NCT00423670|530996549|FG003|Treatment Period|Non-compliance with protocol|3|||
147225147|NCT00423670|530996550|FG004|Treatment Period|Non-compliance with protocol|2|||
147225148|NCT00423670|530996551|FG005|Treatment Period|Non-compliance with protocol|0|||
147225149|NCT00423670|530996552|FG006|Treatment Period|Non-compliance with protocol|2|||
147225150|NCT00423670|530996553|FG007|Treatment Period|Non-compliance with protocol|2|||
147225151|NCT00423670|530996546|FG000|Follow-up Period|Lost to Follow-up|0|||
147225152|NCT00423670|530996547|FG001|Follow-up Period|Lost to Follow-up|12|||
147225153|NCT00423670|530996548|FG002|Follow-up Period|Lost to Follow-up|8|||
147225154|NCT00423670|530996549|FG003|Follow-up Period|Lost to Follow-up|3|||
147225155|NCT00423670|530996550|FG004|Follow-up Period|Lost to Follow-up|1|||
147225156|NCT00423670|530996551|FG005|Follow-up Period|Lost to Follow-up|0|||
147225157|NCT00423670|530996552|FG006|Follow-up Period|Lost to Follow-up|5|||
147225158|NCT00423670|530996553|FG007|Follow-up Period|Lost to Follow-up|0|||
147225159|NCT00423670|530996546|FG000|Follow-up Period|Subject withdrew (not treatment related)|1|||
147225160|NCT00423670|530996547|FG001|Follow-up Period|Subject withdrew (not treatment related)|4|||
147225161|NCT00423670|530996548|FG002|Follow-up Period|Subject withdrew (not treatment related)|2|||
147225162|NCT00423670|530996549|FG003|Follow-up Period|Subject withdrew (not treatment related)|1|||
147225163|NCT00423670|530996550|FG004|Follow-up Period|Subject withdrew (not treatment related)|1|||
147225164|NCT00423670|530996551|FG005|Follow-up Period|Subject withdrew (not treatment related)|0|||
147225165|NCT00423670|530996552|FG006|Follow-up Period|Subject withdrew (not treatment related)|1|||
147225166|NCT00423670|530996553|FG007|Follow-up Period|Subject withdrew (not treatment related)|1|||
147225167|NCT00423670|530996546|FG000|Follow-up Period|Non-compliance with protocol|2|||
147225168|NCT00423670|530996547|FG001|Follow-up Period|Non-compliance with protocol|0|||
147225169|NCT00423670|530996548|FG002|Follow-up Period|Non-compliance with protocol|1|||
147225170|NCT00423670|530996549|FG003|Follow-up Period|Non-compliance with protocol|1|||
147225171|NCT00423670|530996550|FG004|Follow-up Period|Non-compliance with protocol|0|||
147225172|NCT00423670|530996551|FG005|Follow-up Period|Non-compliance with protocol|0|||
147225173|NCT00423670|530996552|FG006|Follow-up Period|Non-compliance with protocol|3|||
147225174|NCT00423670|530996553|FG007|Follow-up Period|Non-compliance with protocol|2|||
147225175|NCT04163718|530996554|FG000|Overall Study|Study terminated|12|||
147225176|NCT01466595|530996555|FG000|Overall Study|Withdrawal by Subject|0|||
147225177|NCT01466595|530996556|FG001|Overall Study|Withdrawal by Subject|1|||
147225178|NCT02376829|530996559|FG000|Overall Study|Withdrawal by Subject|27|||
147225179|NCT02376829|530996560|FG001|Overall Study|Withdrawal by Subject|44|||
147225180|NCT03631355|530996561|FG000|Overall Study|Lost to Follow-up|1|||
147225181|NCT03631355|530996562|FG001|Overall Study|Lost to Follow-up|2|||
147225182|NCT02810340|530996563|FG000|Overall Study|Withdrawal by Subject|1|||
147225183|NCT02810340|530996564|FG001|Overall Study|Withdrawal by Subject|0|||
147225184|NCT02810340|530996565|FG002|Overall Study|Withdrawal by Subject|0|||
147225185|NCT02810340|530996563|FG000|Overall Study|Incarceration|0|||
147225186|NCT02810340|530996564|FG001|Overall Study|Incarceration|1|||
147225187|NCT02810340|530996565|FG002|Overall Study|Incarceration|0|||
147225188|NCT02810340|530996563|FG000|Overall Study|Lost to Follow-up|0|||
147225189|NCT02810340|530996564|FG001|Overall Study|Lost to Follow-up|0|||
147225190|NCT02810340|530996565|FG002|Overall Study|Lost to Follow-up|1|||
147225191|NCT00870233|530996568|FG000|Overall Study|Withdrawal by Subject|18|||
147225192|NCT00870233|530996568|FG000|Overall Study|Did not undergo laparotomy|3|||
147225193|NCT00870233|530996568|FG000|Overall Study|Incompatible internet browser|2|||
147225194|NCT00870233|530996568|FG000|Overall Study|Death|1|||
147225195|NCT01962922|530996578|FG000|PK Portion Day 7|Withdrawal by Subject|3|||
147225196|NCT01962922|530996579|FG001|PK Portion Day 7|Withdrawal by Subject|0|||
147225197|NCT01962922|530996578|FG000|PK Portion Day 7|non-compliance|1|||
147225198|NCT01962922|530996579|FG001|PK Portion Day 7|non-compliance|0|||
147225199|NCT01962922|530996578|FG000|Extendion Portion (up to Month 6)|no longer wished to participate in study|4|||
147556668|NCT00329602|532195271|FG001|40-Week Open-Label Treatment Phase|Lack of Efficacy|0|||
147556669|NCT00329602|532195272|FG002|40-Week Open-Label Treatment Phase|Lack of Efficacy|9|||
147556670|NCT00329602|532195270|FG000|40-Week Open-Label Treatment Phase|Captured as Other|0|||
147556671|NCT00329602|532195271|FG001|40-Week Open-Label Treatment Phase|Captured as Other|0|||
147556672|NCT00329602|532195272|FG002|40-Week Open-Label Treatment Phase|Captured as Other|4|||
147556673|NCT00510510|532195273|FG000|Overall Study|Adverse Event|4|||
147556674|NCT00510510|532195274|FG001|Overall Study|Adverse Event|3|||
147556675|NCT00510510|532195275|FG002|Overall Study|Adverse Event|6|||
147556676|NCT00510510|532195273|FG000|Overall Study|Lack of Efficacy|0|||
147556677|NCT00510510|532195274|FG001|Overall Study|Lack of Efficacy|1|||
147556678|NCT00510510|532195275|FG002|Overall Study|Lack of Efficacy|1|||
147556679|NCT00510510|532195273|FG000|Overall Study|Subjects no longer requires study drug|0|||
147556680|NCT00510510|532195274|FG001|Overall Study|Subjects no longer requires study drug|0|||
147556681|NCT00510510|532195275|FG002|Overall Study|Subjects no longer requires study drug|2|||
147556682|NCT00510510|532195273|FG000|Overall Study|Withdrawal by Subject|1|||
147556683|NCT00510510|532195274|FG001|Overall Study|Withdrawal by Subject|2|||
147556684|NCT00510510|532195275|FG002|Overall Study|Withdrawal by Subject|3|||
147556685|NCT00510510|532195273|FG000|Overall Study|Lost to Follow-up|0|||
147556686|NCT00510510|532195274|FG001|Overall Study|Lost to Follow-up|0|||
147556687|NCT00510510|532195275|FG002|Overall Study|Lost to Follow-up|1|||
147556688|NCT00510510|532195273|FG000|Overall Study|Protocol Violation|0|||
147556689|NCT00510510|532195274|FG001|Overall Study|Protocol Violation|3|||
147556690|NCT00510510|532195275|FG002|Overall Study|Protocol Violation|4|||
147556691|NCT01066052|532195276|FG000|Overall Study|Enrolled But Not Treated|3|||
147556692|NCT01066052|532195277|FG001|Overall Study|Enrolled But Not Treated|0|||
147556693|NCT01200394|532195278|FG000|Overall Study|Adverse Event|0|||
147556694|NCT01200394|532195279|FG001|Overall Study|Adverse Event|14|||
147556695|NCT01200394|532195278|FG000|Overall Study|Death|1|||
147556696|NCT01200394|532195279|FG001|Overall Study|Death|0|||
147556697|NCT01200394|532195278|FG000|Overall Study|Lost to Follow-up|0|||
147556698|NCT01200394|532195279|FG001|Overall Study|Lost to Follow-up|1|||
147556699|NCT01200394|532195278|FG000|Overall Study|Did Not Meet Entrance Criteria|1|||
147556700|NCT01200394|532195279|FG001|Overall Study|Did Not Meet Entrance Criteria|4|||
147556701|NCT01200394|532195278|FG000|Overall Study|Protocol Violation|0|||
147556702|NCT01200394|532195279|FG001|Overall Study|Protocol Violation|3|||
147556703|NCT01200394|532195278|FG000|Overall Study|Withdrawal by Subject|0|||
147556704|NCT01200394|532195279|FG001|Overall Study|Withdrawal by Subject|5|||
147556705|NCT01200394|532195278|FG000|Overall Study|Other|0|||
147556706|NCT01200394|532195279|FG001|Overall Study|Other|1|||
147556707|NCT02729896|532195284|FG000|Overall Study|Death|0|||
147556708|NCT02729896|532195285|FG001|Overall Study|Death|2|||
147556709|NCT02729896|532195286|FG002|Overall Study|Death|13|||
147556710|NCT02729896|532195284|FG000|Overall Study|Lost to Follow-up|0|||
147556711|NCT02729896|532195285|FG001|Overall Study|Lost to Follow-up|2|||
147556712|NCT02729896|532195286|FG002|Overall Study|Lost to Follow-up|3|||
147556713|NCT02729896|532195284|FG000|Overall Study|Other|0|||
147556714|NCT02729896|532195285|FG001|Overall Study|Other|2|||
147556715|NCT02729896|532195286|FG002|Overall Study|Other|0|||
147556716|NCT02729896|532195284|FG000|Overall Study|Physician Decision|1|||
147556717|NCT02729896|532195285|FG001|Overall Study|Physician Decision|2|||
147556718|NCT02729896|532195286|FG002|Overall Study|Physician Decision|3|||
147556719|NCT02729896|532195284|FG000|Overall Study|Progressive Disease|0|||
147556720|NCT02729896|532195285|FG001|Overall Study|Progressive Disease|1|||
147556721|NCT02729896|532195286|FG002|Overall Study|Progressive Disease|0|||
147556722|NCT02729896|532195284|FG000|Overall Study|Withdrawal by Subject|1|||
147556723|NCT02729896|532195285|FG001|Overall Study|Withdrawal by Subject|0|||
147556724|NCT02729896|532195286|FG002|Overall Study|Withdrawal by Subject|3|||
147556725|NCT01835145|532195287|FG000|Overall Study|Ineligible prior to treatment|1|||
147556726|NCT01835145|532195288|FG001|Overall Study|Ineligible prior to treatment|0|||
147556727|NCT00582309|532195289|FG000|Overall Study|Protocol Violation|0|||
147556728|NCT00582309|532195290|FG001|Overall Study|Protocol Violation|0|||
147556729|NCT00582309|532195291|FG002|Overall Study|Protocol Violation|2|||
147225200|NCT01962922|530996579|FG001|Extendion Portion (up to Month 6)|no longer wished to participate in study|3|||
147225201|NCT01962922|530996578|FG000|Extendion Portion (up to Month 6)|Physician Decision|1|||
147225202|NCT01962922|530996579|FG001|Extendion Portion (up to Month 6)|Physician Decision|0|||
147556730|NCT04094870|532195295|FG000|Overall Study|Lost to Follow-up|1|||
147556731|NCT04094870|532195296|FG001|Overall Study|Lost to Follow-up|1|||
147556732|NCT02708277|532195298|FG000|Overall Study|Lost to Follow-up|7|||
147556733|NCT02708277|532195299|FG001|Overall Study|Lost to Follow-up|4|||
147556734|NCT01058421|532195300|FG000|1 Month Outcomes|Death|10|||
147556735|NCT01058421|532195301|FG001|1 Month Outcomes|Death|6|||
147556736|NCT01058421|532195300|FG000|1 Month Outcomes|Lost to Follow-up|8|||
147556737|NCT01058421|532195301|FG001|1 Month Outcomes|Lost to Follow-up|7|||
147556738|NCT01058421|532195300|FG000|1 Month Outcomes|Remained in Hospital|5|||
147556739|NCT01058421|532195301|FG001|1 Month Outcomes|Remained in Hospital|12|||
147556740|NCT01058421|532195300|FG000|1 Month Outcomes|Remained in Other Facility|16|||
147556741|NCT01058421|532195301|FG001|1 Month Outcomes|Remained in Other Facility|17|||
147556742|NCT01058421|532195300|FG000|3 Month Outcomes|Death|3|||
147556743|NCT01058421|532195301|FG001|3 Month Outcomes|Death|5|||
147556744|NCT01058421|532195300|FG000|3 Month Outcomes|Lost to Follow-up|12|||
147556745|NCT01058421|532195301|FG001|3 Month Outcomes|Lost to Follow-up|11|||
147556746|NCT01058421|532195300|FG000|3 Month Outcomes|Remained in Hospital|0|||
147556747|NCT01058421|532195301|FG001|3 Month Outcomes|Remained in Hospital|2|||
147556748|NCT01058421|532195300|FG000|3 Month Outcomes|Remained in Other Facility|5|||
147556749|NCT01058421|532195301|FG001|3 Month Outcomes|Remained in Other Facility|8|||
147556750|NCT01058421|532195300|FG000|6 Month Outcomes|Death|2|||
147556751|NCT01058421|532195301|FG001|6 Month Outcomes|Death|2|||
147556752|NCT01058421|532195300|FG000|6 Month Outcomes|Lost to Follow-up|16|||
147556753|NCT01058421|532195301|FG001|6 Month Outcomes|Lost to Follow-up|21|||
147556754|NCT01058421|532195300|FG000|6 Month Outcomes|Remained in Other Facility|1|||
147556755|NCT01058421|532195301|FG001|6 Month Outcomes|Remained in Other Facility|3|||
147556756|NCT02984683|532195304|FG000|Overall Study|Adverse Event|3|||
147556757|NCT02984683|532195305|FG001|Overall Study|Adverse Event|3|||
147556758|NCT02984683|532195304|FG000|Overall Study|Withdrawal by Subject|1|||
147556759|NCT02984683|532195305|FG001|Overall Study|Withdrawal by Subject|0|||
147556760|NCT02984683|532195304|FG000|Overall Study|Disease progression|7|||
147556761|NCT02984683|532195305|FG001|Overall Study|Disease progression|9|||
147556762|NCT02415959|532195310|FG000|Overall Study|Adverse Event|0|||
147556763|NCT02415959|532195311|FG001|Overall Study|Adverse Event|1|||
147556764|NCT02415959|532195312|FG002|Overall Study|Adverse Event|0|||
147556765|NCT02415959|532195313|FG003|Overall Study|Adverse Event|0|||
147556766|NCT02415959|532195314|FG004|Overall Study|Adverse Event|0|||
147556767|NCT02415959|532195310|FG000|Overall Study|Protocol Violation|0|||
147556768|NCT02415959|532195311|FG001|Overall Study|Protocol Violation|0|||
147556769|NCT02415959|532195312|FG002|Overall Study|Protocol Violation|0|||
147556770|NCT02415959|532195313|FG003|Overall Study|Protocol Violation|1|||
147556771|NCT02415959|532195314|FG004|Overall Study|Protocol Violation|0|||
147556772|NCT01048333|532195317|FG000|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0|||
147556773|NCT01048333|532195318|FG001|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|1|||
147556774|NCT01048333|532195319|FG002|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0|||
147556775|NCT01048333|532195320|FG003|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0|||
147556776|NCT01048333|532195321|FG004|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0|||
147556777|NCT01048333|532195322|FG005|Wash-Out Period 2 of 2 - 7 Days|Adverse Event|0|||
147556778|NCT03008460|532195325|FG000|Overall Study|Protocol deviation|0|||
147556779|NCT03008460|532195326|FG001|Overall Study|Protocol deviation|2|||
147556780|NCT03008460|532195325|FG000|Overall Study|Study drug not dispensed|0|||
147556781|NCT03008460|532195326|FG001|Overall Study|Study drug not dispensed|1|||
147556782|NCT03008460|532195325|FG000|Overall Study|Adverse Event|0|||
147556783|NCT03008460|532195326|FG001|Overall Study|Adverse Event|1|||
147556784|NCT03008460|532195325|FG000|Overall Study|Withdrawal by Subject|5|||
147556785|NCT03008460|532195326|FG001|Overall Study|Withdrawal by Subject|6|||
147556786|NCT03008460|532195325|FG000|Overall Study|COVID-19 pandemic - consent withdrawn|1|||
147556787|NCT03008460|532195326|FG001|Overall Study|COVID-19 pandemic - consent withdrawn|0|||
147556788|NCT03008460|532195325|FG000|Overall Study|End of study visit outside permitted time window|0|||
147556789|NCT03008460|532195326|FG001|Overall Study|End of study visit outside permitted time window|1|||
147556790|NCT03008460|532195325|FG000|Overall Study|Lost to Follow-up|1|||
147556791|NCT03008460|532195326|FG001|Overall Study|Lost to Follow-up|3|||
147556792|NCT03131999|532195331|FG000|Overall Study|Withdrawal by Subject|0|||
147556793|NCT03131999|532195332|FG001|Overall Study|Withdrawal by Subject|1|||
147556794|NCT02260492|532195333|FG000|Overall Study|Adverse Event|6|||
147556795|NCT02260492|532195334|FG001|Overall Study|Adverse Event|1|||
147556796|NCT02260492|532195335|FG002|Overall Study|Adverse Event|2|||
147556797|NCT02260492|532195333|FG000|Overall Study|Death|0|||
147556798|NCT02260492|532195334|FG001|Overall Study|Death|1|||
147556799|NCT02260492|532195335|FG002|Overall Study|Death|0|||
147556800|NCT02260492|532195333|FG000|Overall Study|Lost to Follow-up|12|||
147556801|NCT02260492|532195334|FG001|Overall Study|Lost to Follow-up|9|||
147556802|NCT02260492|532195335|FG002|Overall Study|Lost to Follow-up|0|||
147556803|NCT02260492|532195333|FG000|Overall Study|Physician Decision|2|||
147225203|NCT00744471|530996580|FG000|Overall Study|Randomized but not treated|1|||
147556804|NCT02260492|532195334|FG001|Overall Study|Physician Decision|0|||
147556805|NCT02260492|532195335|FG002|Overall Study|Physician Decision|1|||
147556806|NCT02260492|532195333|FG000|Overall Study|Withdrawal by Subject|3|||
147556807|NCT02260492|532195334|FG001|Overall Study|Withdrawal by Subject|2|||
147556808|NCT02260492|532195335|FG002|Overall Study|Withdrawal by Subject|2|||
147444129|NCT01744665|531790524|FG000|Re-initiation Phase|No longer required treatment|1|||
147106060|NCT01859741|530553739|FG000|Overall Study|Death|3|||
147444130|NCT01744665|531790524|FG000|Re-initiation Phase|Withdrawal by Subject|1|||
147444131|NCT02090413|531790528|FG000|Overall Study|Adverse Event|11|||
147444132|NCT02090413|531790529|FG001|Overall Study|Adverse Event|15|||
147556809|NCT03495869|532195336|FG000|Overall Study|Lost to Follow-up|4|||
147556810|NCT03495869|532195337|FG001|Overall Study|Lost to Follow-up|17|||
147556811|NCT03495869|532195338|FG002|Overall Study|Lost to Follow-up|8|||
147556812|NCT03495869|532195339|FG003|Overall Study|Lost to Follow-up|14|||
147556813|NCT03495869|532195336|FG000|Overall Study|Withdrawal by Subject|0|||
147556814|NCT03495869|532195337|FG001|Overall Study|Withdrawal by Subject|3|||
147556815|NCT03495869|532195338|FG002|Overall Study|Withdrawal by Subject|0|||
147556816|NCT03495869|532195339|FG003|Overall Study|Withdrawal by Subject|3|||
147556817|NCT03495869|532195336|FG000|Overall Study|Dropped from study|0|||
147556818|NCT03495869|532195337|FG001|Overall Study|Dropped from study|7|||
147556819|NCT03495869|532195338|FG002|Overall Study|Dropped from study|2|||
147556820|NCT03495869|532195339|FG003|Overall Study|Dropped from study|4|||
147556821|NCT04634409|532195342|FG000|Overall Study|Death|0|||
147556822|NCT04634409|532195343|FG001|Overall Study|Death|0|||
147556823|NCT04634409|532195344|FG002|Overall Study|Death|0|||
147556824|NCT04634409|532195345|FG003|Overall Study|Death|0|||
147556825|NCT04634409|532195346|FG004|Overall Study|Death|0|||
147556826|NCT04634409|532195347|FG005|Overall Study|Death|0|||
147556827|NCT04634409|532195348|FG006|Overall Study|Death|0|||
147556828|NCT04634409|532195349|FG007|Overall Study|Death|0|||
147556829|NCT04634409|532195350|FG008|Overall Study|Death|0|||
147556830|NCT04634409|532195351|FG009|Overall Study|Death|0|||
147556831|NCT04634409|532195352|FG010|Overall Study|Death|1|||
147556832|NCT04634409|532195353|FG011|Overall Study|Death|0|||
147556833|NCT04634409|532195354|FG012|Overall Study|Death|1|||
147556834|NCT04634409|532195355|FG013|Overall Study|Death|0|||
147556835|NCT04634409|532195356|FG014|Overall Study|Death|0|||
147556836|NCT04634409|532195357|FG015|Overall Study|Death|0|||
147556837|NCT04634409|532195358|FG016|Overall Study|Death|0|||
147556838|NCT04634409|532195359|FG017|Overall Study|Death|0|||
147556839|NCT04634409|532195360|FG018|Overall Study|Death|0|||
147556840|NCT04634409|532195361|FG019|Overall Study|Death|0|||
147556841|NCT04634409|532195362|FG020|Overall Study|Death|0|||
147556842|NCT04634409|532195363|FG021|Overall Study|Death|0|||
147556843|NCT04634409|532195364|FG022|Overall Study|Death|0|||
147556844|NCT04634409|532195365|FG023|Overall Study|Death|0|||
147556845|NCT04634409|532195366|FG024|Overall Study|Death|0|||
147556846|NCT04634409|532195367|FG025|Overall Study|Death|0|||
147556847|NCT04634409|532195368|FG026|Overall Study|Death|0|||
147556848|NCT04634409|532195342|FG000|Overall Study|Adverse Event|0|||
147556849|NCT04634409|532195343|FG001|Overall Study|Adverse Event|0|||
147556850|NCT04634409|532195344|FG002|Overall Study|Adverse Event|1|||
147556851|NCT04634409|532195345|FG003|Overall Study|Adverse Event|0|||
147556852|NCT04634409|532195346|FG004|Overall Study|Adverse Event|0|||
147556853|NCT04634409|532195347|FG005|Overall Study|Adverse Event|1|||
147556854|NCT04634409|532195348|FG006|Overall Study|Adverse Event|0|||
147556855|NCT04634409|532195349|FG007|Overall Study|Adverse Event|0|||
147556856|NCT04634409|532195350|FG008|Overall Study|Adverse Event|0|||
147556857|NCT04634409|532195351|FG009|Overall Study|Adverse Event|0|||
147556858|NCT04634409|532195352|FG010|Overall Study|Adverse Event|0|||
147225204|NCT00744471|530996581|FG001|Overall Study|Randomized but not treated|1|||
147225205|NCT00744471|530996582|FG002|Overall Study|Randomized but not treated|4|||
147225206|NCT00744471|530996583|FG003|Overall Study|Randomized but not treated|0|||
147225207|NCT00744471|530996580|FG000|Overall Study|Death|0|||
147225208|NCT00744471|530996581|FG001|Overall Study|Death|0|||
147225209|NCT00744471|530996582|FG002|Overall Study|Death|0|||
147225210|NCT00744471|530996583|FG003|Overall Study|Death|1|||
147225211|NCT00744471|530996580|FG000|Overall Study|Adverse Event|6|||
147225212|NCT00744471|530996581|FG001|Overall Study|Adverse Event|7|||
147225213|NCT00744471|530996582|FG002|Overall Study|Adverse Event|5|||
147225214|NCT00744471|530996583|FG003|Overall Study|Adverse Event|9|||
147225215|NCT00744471|530996580|FG000|Overall Study|Withdrawal by Subject|9|||
147225216|NCT00744471|530996581|FG001|Overall Study|Withdrawal by Subject|9|||
147225217|NCT00744471|530996582|FG002|Overall Study|Withdrawal by Subject|15|||
147225218|NCT00744471|530996583|FG003|Overall Study|Withdrawal by Subject|12|||
147556859|NCT04634409|532195353|FG011|Overall Study|Adverse Event|0|||
147225219|NCT00744471|530996580|FG000|Overall Study|Protocol Violation|1|||
147225220|NCT00744471|530996581|FG001|Overall Study|Protocol Violation|4|||
147225221|NCT00744471|530996582|FG002|Overall Study|Protocol Violation|1|||
147556860|NCT04634409|532195354|FG012|Overall Study|Adverse Event|0|||
147556861|NCT04634409|532195355|FG013|Overall Study|Adverse Event|0|||
147556862|NCT04634409|532195356|FG014|Overall Study|Adverse Event|0|||
147556863|NCT04634409|532195357|FG015|Overall Study|Adverse Event|0|||
147556864|NCT04634409|532195358|FG016|Overall Study|Adverse Event|0|||
147556865|NCT04634409|532195359|FG017|Overall Study|Adverse Event|0|||
147556866|NCT04634409|532195360|FG018|Overall Study|Adverse Event|0|||
147556867|NCT04634409|532195361|FG019|Overall Study|Adverse Event|0|||
147556868|NCT04634409|532195362|FG020|Overall Study|Adverse Event|0|||
147225222|NCT00744471|530996583|FG003|Overall Study|Protocol Violation|2|||
147225223|NCT00744471|530996580|FG000|Overall Study|Entered extension study|41|||
147556869|NCT04634409|532195363|FG021|Overall Study|Adverse Event|0|||
147556870|NCT04634409|532195364|FG022|Overall Study|Adverse Event|0|||
147556871|NCT04634409|532195365|FG023|Overall Study|Adverse Event|0|||
147556872|NCT04634409|532195366|FG024|Overall Study|Adverse Event|0|||
147556873|NCT04634409|532195367|FG025|Overall Study|Adverse Event|0|||
147556874|NCT04634409|532195368|FG026|Overall Study|Adverse Event|0|||
147556875|NCT04634409|532195342|FG000|Overall Study|Lost to Follow-up|3|||
147556876|NCT04634409|532195343|FG001|Overall Study|Lost to Follow-up|1|||
147556877|NCT04634409|532195344|FG002|Overall Study|Lost to Follow-up|1|||
147556878|NCT04634409|532195345|FG003|Overall Study|Lost to Follow-up|3|||
147556879|NCT04634409|532195346|FG004|Overall Study|Lost to Follow-up|1|||
147556880|NCT04634409|532195347|FG005|Overall Study|Lost to Follow-up|1|||
147556881|NCT04634409|532195348|FG006|Overall Study|Lost to Follow-up|1|||
147556882|NCT04634409|532195349|FG007|Overall Study|Lost to Follow-up|3|||
147556883|NCT04634409|532195350|FG008|Overall Study|Lost to Follow-up|3|||
147556884|NCT04634409|532195351|FG009|Overall Study|Lost to Follow-up|11|||
147556885|NCT04634409|532195352|FG010|Overall Study|Lost to Follow-up|8|||
147556886|NCT04634409|532195353|FG011|Overall Study|Lost to Follow-up|15|||
147556887|NCT04634409|532195354|FG012|Overall Study|Lost to Follow-up|3|||
147556888|NCT04634409|532195355|FG013|Overall Study|Lost to Follow-up|2|||
147556889|NCT04634409|532195356|FG014|Overall Study|Lost to Follow-up|7|||
147556890|NCT04634409|532195357|FG015|Overall Study|Lost to Follow-up|0|||
147556891|NCT04634409|532195358|FG016|Overall Study|Lost to Follow-up|0|||
147556892|NCT04634409|532195359|FG017|Overall Study|Lost to Follow-up|0|||
147556893|NCT04634409|532195360|FG018|Overall Study|Lost to Follow-up|0|||
147556894|NCT04634409|532195361|FG019|Overall Study|Lost to Follow-up|0|||
147556895|NCT04634409|532195362|FG020|Overall Study|Lost to Follow-up|0|||
147556896|NCT04634409|532195363|FG021|Overall Study|Lost to Follow-up|0|||
147556897|NCT04634409|532195364|FG022|Overall Study|Lost to Follow-up|0|||
147556898|NCT04634409|532195365|FG023|Overall Study|Lost to Follow-up|0|||
147556899|NCT04634409|532195366|FG024|Overall Study|Lost to Follow-up|0|||
147556900|NCT04634409|532195367|FG025|Overall Study|Lost to Follow-up|0|||
147556901|NCT04634409|532195368|FG026|Overall Study|Lost to Follow-up|0|||
147556902|NCT04634409|532195342|FG000|Overall Study|Withdrawal by Subject|3|||
147556903|NCT04634409|532195343|FG001|Overall Study|Withdrawal by Subject|1|||
147556904|NCT04634409|532195344|FG002|Overall Study|Withdrawal by Subject|6|||
147556905|NCT04634409|532195345|FG003|Overall Study|Withdrawal by Subject|4|||
147556906|NCT04634409|532195346|FG004|Overall Study|Withdrawal by Subject|2|||
147556907|NCT04634409|532195347|FG005|Overall Study|Withdrawal by Subject|0|||
147556908|NCT04634409|532195348|FG006|Overall Study|Withdrawal by Subject|0|||
147556909|NCT04634409|532195349|FG007|Overall Study|Withdrawal by Subject|2|||
147556910|NCT04634409|532195350|FG008|Overall Study|Withdrawal by Subject|3|||
147556911|NCT04634409|532195351|FG009|Overall Study|Withdrawal by Subject|2|||
147556912|NCT04634409|532195352|FG010|Overall Study|Withdrawal by Subject|3|||
147556913|NCT04634409|532195353|FG011|Overall Study|Withdrawal by Subject|2|||
147556914|NCT04634409|532195354|FG012|Overall Study|Withdrawal by Subject|2|||
147556915|NCT04634409|532195355|FG013|Overall Study|Withdrawal by Subject|1|||
147556916|NCT04634409|532195356|FG014|Overall Study|Withdrawal by Subject|5|||
147556917|NCT04634409|532195357|FG015|Overall Study|Withdrawal by Subject|0|||
147556918|NCT04634409|532195358|FG016|Overall Study|Withdrawal by Subject|0|||
147556919|NCT04634409|532195359|FG017|Overall Study|Withdrawal by Subject|1|||
147556920|NCT04634409|532195360|FG018|Overall Study|Withdrawal by Subject|0|||
147556921|NCT04634409|532195361|FG019|Overall Study|Withdrawal by Subject|0|||
147556922|NCT04634409|532195362|FG020|Overall Study|Withdrawal by Subject|0|||
147556923|NCT04634409|532195363|FG021|Overall Study|Withdrawal by Subject|0|||
147556924|NCT04634409|532195364|FG022|Overall Study|Withdrawal by Subject|0|||
147556925|NCT04634409|532195365|FG023|Overall Study|Withdrawal by Subject|1|||
147556926|NCT04634409|532195366|FG024|Overall Study|Withdrawal by Subject|0|||
147556927|NCT04634409|532195367|FG025|Overall Study|Withdrawal by Subject|0|||
147556928|NCT04634409|532195368|FG026|Overall Study|Withdrawal by Subject|0|||
147556929|NCT04634409|532195342|FG000|Overall Study|Other - As reported by Investigator|1|||
147556930|NCT04634409|532195343|FG001|Overall Study|Other - As reported by Investigator|0|||
147556931|NCT04634409|532195344|FG002|Overall Study|Other - As reported by Investigator|0|||
147556932|NCT04634409|532195345|FG003|Overall Study|Other - As reported by Investigator|0|||
147556933|NCT04634409|532195346|FG004|Overall Study|Other - As reported by Investigator|0|||
147556934|NCT04634409|532195347|FG005|Overall Study|Other - As reported by Investigator|0|||
147556935|NCT04634409|532195348|FG006|Overall Study|Other - As reported by Investigator|0|||
147556936|NCT04634409|532195349|FG007|Overall Study|Other - As reported by Investigator|6|||
147556937|NCT04634409|532195350|FG008|Overall Study|Other - As reported by Investigator|4|||
147556938|NCT04634409|532195351|FG009|Overall Study|Other - As reported by Investigator|0|||
147556939|NCT04634409|532195352|FG010|Overall Study|Other - As reported by Investigator|1|||
147556940|NCT04634409|532195353|FG011|Overall Study|Other - As reported by Investigator|2|||
147556941|NCT04634409|532195354|FG012|Overall Study|Other - As reported by Investigator|2|||
147556942|NCT04634409|532195355|FG013|Overall Study|Other - As reported by Investigator|1|||
147556943|NCT04634409|532195356|FG014|Overall Study|Other - As reported by Investigator|0|||
147556944|NCT04634409|532195357|FG015|Overall Study|Other - As reported by Investigator|0|||
147556945|NCT04634409|532195358|FG016|Overall Study|Other - As reported by Investigator|0|||
147556946|NCT04634409|532195359|FG017|Overall Study|Other - As reported by Investigator|0|||
147556947|NCT04634409|532195360|FG018|Overall Study|Other - As reported by Investigator|0|||
147556948|NCT04634409|532195361|FG019|Overall Study|Other - As reported by Investigator|0|||
147556949|NCT04634409|532195362|FG020|Overall Study|Other - As reported by Investigator|0|||
147556950|NCT04634409|532195363|FG021|Overall Study|Other - As reported by Investigator|0|||
147556951|NCT04634409|532195364|FG022|Overall Study|Other - As reported by Investigator|0|||
147556952|NCT04634409|532195365|FG023|Overall Study|Other - As reported by Investigator|0|||
147556953|NCT04634409|532195366|FG024|Overall Study|Other - As reported by Investigator|0|||
147556954|NCT04634409|532195367|FG025|Overall Study|Other - As reported by Investigator|0|||
147556955|NCT04634409|532195368|FG026|Overall Study|Other - As reported by Investigator|0|||
147556956|NCT01497938|532195369|FG000|Overall Study|Adverse Event|0|||
147556957|NCT01497938|532195370|FG001|Overall Study|Adverse Event|1|||
147556958|NCT01497938|532195369|FG000|Overall Study|Physician Decision|0|||
147556959|NCT01497938|532195370|FG001|Overall Study|Physician Decision|1|||
147556960|NCT01497938|532195369|FG000|Overall Study|Withdrawal by Subject|4|||
147556961|NCT01497938|532195370|FG001|Overall Study|Withdrawal by Subject|0|||
147556962|NCT01497938|532195369|FG000|Overall Study|Device Violation|1|||
147556963|NCT01497938|532195370|FG001|Overall Study|Device Violation|0|||
147556964|NCT00365352|532195371|FG000|Overall Study|Adverse Event|6|||
147556965|NCT00365352|532195372|FG001|Overall Study|Adverse Event|7|||
147556966|NCT00365352|532195373|FG002|Overall Study|Adverse Event|8|||
147556967|NCT00365352|532195371|FG000|Overall Study|Participant Withdrew Consent|8|||
147556968|NCT00365352|532195372|FG001|Overall Study|Participant Withdrew Consent|3|||
147556969|NCT00365352|532195373|FG002|Overall Study|Participant Withdrew Consent|4|||
147556970|NCT00365352|532195371|FG000|Overall Study|Lack of Efficacy|3|||
147556971|NCT00365352|532195372|FG001|Overall Study|Lack of Efficacy|0|||
147556972|NCT00365352|532195373|FG002|Overall Study|Lack of Efficacy|0|||
147556973|NCT00365352|532195371|FG000|Overall Study|Ineligible (Did Not Meet Entry Criteria)|0|||
147556974|NCT00365352|532195372|FG001|Overall Study|Ineligible (Did Not Meet Entry Criteria)|0|||
147556975|NCT00365352|532195373|FG002|Overall Study|Ineligible (Did Not Meet Entry Criteria)|2|||
147556976|NCT00365352|532195371|FG000|Overall Study|Non-Compliance (after Randomization)|1|||
147556977|NCT00365352|532195372|FG001|Overall Study|Non-Compliance (after Randomization)|0|||
147556978|NCT00365352|532195373|FG002|Overall Study|Non-Compliance (after Randomization)|1|||
147556979|NCT00365352|532195371|FG000|Overall Study|Lost to Follow-up|1|||
147556980|NCT00365352|532195372|FG001|Overall Study|Lost to Follow-up|1|||
147556981|NCT00365352|532195373|FG002|Overall Study|Lost to Follow-up|0|||
147556982|NCT00365352|532195371|FG000|Overall Study|Withdrawal of Participant by Sponsor|1|||
147556983|NCT00365352|532195372|FG001|Overall Study|Withdrawal of Participant by Sponsor|0|||
147556984|NCT00365352|532195373|FG002|Overall Study|Withdrawal of Participant by Sponsor|0|||
147556985|NCT02448771|532195380|FG000|Overall Study|Disease Progression|30|||
147556986|NCT02448771|532195380|FG000|Overall Study|Unacceptable Toxicity|1|||
147556987|NCT02448771|532195380|FG000|Overall Study|Physician Decision|3|||
147556988|NCT02448771|532195380|FG000|Overall Study|Started new therapy|2|||
147556989|NCT02683187|532195382|FG000|Overall Study|Failed IV access|3|||
147556990|NCT02683187|532195382|FG000|Overall Study|Withdrawal by Subject|5|||
147556991|NCT05514119|532197226|FG000|Overall Study|Ineligible due to disease progression|1|||
147556992|NCT00278200|532197227|FG000|Overall Study|Death|1|||
147556993|NCT00278200|532197228|FG001|Overall Study|Death|3|||
147556994|NCT00278200|532197227|FG000|Overall Study|Physician Decision|0|||
147556995|NCT00278200|532197228|FG001|Overall Study|Physician Decision|1|||
147556996|NCT01290263|532197229|FG000|Overall Study|Adverse Event|0|||
147556997|NCT01290263|532197230|FG001|Overall Study|Adverse Event|0|||
147556998|NCT01290263|532197231|FG002|Overall Study|Adverse Event|0|||
147556999|NCT01290263|532197232|FG003|Overall Study|Adverse Event|1|||
147557000|NCT01290263|532197233|FG004|Overall Study|Adverse Event|1|||
147557001|NCT01290263|532197229|FG000|Overall Study|Lack of Efficacy|8|||
147557002|NCT01290263|532197230|FG001|Overall Study|Lack of Efficacy|2|||
147557003|NCT01290263|532197231|FG002|Overall Study|Lack of Efficacy|7|||
147557004|NCT01290263|532197232|FG003|Overall Study|Lack of Efficacy|24|||
147557005|NCT01290263|532197233|FG004|Overall Study|Lack of Efficacy|33|||
147557006|NCT01290263|532197229|FG000|Overall Study|Withdrawal by Subject|3|||
147557007|NCT01290263|532197230|FG001|Overall Study|Withdrawal by Subject|1|||
147557008|NCT01290263|532197231|FG002|Overall Study|Withdrawal by Subject|0|||
147557009|NCT01290263|532197232|FG003|Overall Study|Withdrawal by Subject|1|||
147557010|NCT01290263|532197233|FG004|Overall Study|Withdrawal by Subject|2|||
147557011|NCT01290263|532197229|FG000|Overall Study|Participant Non-Compliance|0|||
147557012|NCT01290263|532197230|FG001|Overall Study|Participant Non-Compliance|0|||
147557013|NCT01290263|532197231|FG002|Overall Study|Participant Non-Compliance|0|||
147557014|NCT01290263|532197232|FG003|Overall Study|Participant Non-Compliance|1|||
147557015|NCT01290263|532197233|FG004|Overall Study|Participant Non-Compliance|1|||
147557016|NCT01521559|532197234|FG000|Overall Study|Adverse Event|0|||
147557017|NCT01521559|532197235|FG001|Overall Study|Adverse Event|4|||
147557018|NCT01521559|532197234|FG000|Overall Study|Death|1|||
147557019|NCT01521559|532197235|FG001|Overall Study|Death|0|||
147557020|NCT01521559|532197234|FG000|Overall Study|Withdrawal by Subject|9|||
147557021|NCT01521559|532197235|FG001|Overall Study|Withdrawal by Subject|11|||
147557022|NCT01521559|532197234|FG000|Overall Study|Lost to Follow-up|3|||
147557023|NCT01521559|532197235|FG001|Overall Study|Lost to Follow-up|1|||
147557024|NCT01521559|532197234|FG000|Overall Study|Protocol Violation|1|||
147557025|NCT01521559|532197235|FG001|Overall Study|Protocol Violation|0|||
147557026|NCT01521559|532197234|FG000|Overall Study|Other|1|||
147557027|NCT01521559|532197235|FG001|Overall Study|Other|2|||
147557028|NCT02228382|532197236|FG000|Overall Study|Death|5|||
147557029|NCT02228382|532197237|FG001|Overall Study|Death|7|||
147557030|NCT02228382|532197238|FG002|Overall Study|Death|5|||
147557031|NCT02228382|532197239|FG003|Overall Study|Death|0|||
147557032|NCT02228382|532197240|FG004|Overall Study|Death|2|||
147557033|NCT02228382|532197236|FG000|Overall Study|Participant refused further follow-up|0|||
147557034|NCT02228382|532197237|FG001|Overall Study|Participant refused further follow-up|0|||
147557035|NCT02228382|532197238|FG002|Overall Study|Participant refused further follow-up|1|||
147557036|NCT02228382|532197239|FG003|Overall Study|Participant refused further follow-up|0|||
147557037|NCT02228382|532197240|FG004|Overall Study|Participant refused further follow-up|0|||
147557038|NCT02228382|532197236|FG000|Overall Study|Study terminated by sponsor|3|||
147557039|NCT02228382|532197237|FG001|Overall Study|Study terminated by sponsor|5|||
147557040|NCT02228382|532197238|FG002|Overall Study|Study terminated by sponsor|7|||
147557041|NCT02228382|532197239|FG003|Overall Study|Study terminated by sponsor|0|||
147557042|NCT02228382|532197240|FG004|Overall Study|Study terminated by sponsor|0|||
147557043|NCT02228382|532197236|FG000|Overall Study|Lost to Follow-up|0|||
147557044|NCT02228382|532197237|FG001|Overall Study|Lost to Follow-up|0|||
147557045|NCT02228382|532197238|FG002|Overall Study|Lost to Follow-up|3|||
147557046|NCT02228382|532197239|FG003|Overall Study|Lost to Follow-up|1|||
147557047|NCT02228382|532197240|FG004|Overall Study|Lost to Follow-up|0|||
147557048|NCT02228382|532197236|FG000|Overall Study|Withdrawal by Subject|0|||
147557049|NCT02228382|532197237|FG001|Overall Study|Withdrawal by Subject|3|||
147557050|NCT02228382|532197238|FG002|Overall Study|Withdrawal by Subject|2|||
147557051|NCT02228382|532197239|FG003|Overall Study|Withdrawal by Subject|1|||
147557052|NCT02228382|532197240|FG004|Overall Study|Withdrawal by Subject|0|||
147557053|NCT02228382|532197236|FG000|Overall Study|Other|2|||
147557054|NCT02228382|532197237|FG001|Overall Study|Other|3|||
147557055|NCT02228382|532197238|FG002|Overall Study|Other|3|||
147557056|NCT02228382|532197239|FG003|Overall Study|Other|0|||
147557057|NCT02228382|532197240|FG004|Overall Study|Other|0|||
147557058|NCT02918162|532197242|FG000|Overall Study|Withdrawal by Subject|1|||
147557059|NCT02918162|532197242|FG000|Overall Study|Omental Disease|1|||
147557060|NCT00395226|532197243|FG000|Overall Study|Adverse Event|4|||
147557061|NCT00395226|532197244|FG001|Overall Study|Adverse Event|3|||
147557062|NCT00395226|532197243|FG000|Overall Study|Withdrawal by Subject|0|||
147557063|NCT00395226|532197244|FG001|Overall Study|Withdrawal by Subject|1|||
147557064|NCT00395226|532197243|FG000|Overall Study|Lost to Follow-up|0|||
147557065|NCT00395226|532197244|FG001|Overall Study|Lost to Follow-up|1|||
147557066|NCT00576381|532197245|FG000|Overall Study|Reoperation|3|||
147557067|NCT00576381|532197245|FG000|Overall Study|Adverse Event|4|||
147557068|NCT01031537|532197249|FG000|Overall Study|medical reasons not related to study|3|||
147557069|NCT01031537|532197249|FG000|Overall Study|Lack of Efficacy|1|||
147557070|NCT01031537|532197249|FG000|Overall Study|retired from NIH, met exclusion criteria|1|||
147557071|NCT01031537|532197249|FG000|Overall Study|moved, met exclusion criteria|10|||
147557072|NCT01031537|532197249|FG000|Overall Study|Withdrawal by Subject|5|||
147557073|NCT01031537|532197249|FG000|Overall Study|PI removal, no longer met eligibility|12|||
147557074|NCT02492958|532197257|FG000|Overall Study|Withdrawal by Subject|0|||
147557075|NCT02492958|532197258|FG001|Overall Study|Withdrawal by Subject|0|||
147557076|NCT02492958|532197259|FG002|Overall Study|Withdrawal by Subject|1|||
147557077|NCT02492958|532197260|FG003|Overall Study|Withdrawal by Subject|0|||
147557078|NCT02492958|532197257|FG000|Overall Study|Adverse Event|1|||
147557079|NCT02492958|532197258|FG001|Overall Study|Adverse Event|0|||
147557080|NCT02492958|532197259|FG002|Overall Study|Adverse Event|1|||
147557081|NCT02492958|532197260|FG003|Overall Study|Adverse Event|0|||
147557082|NCT03522948|532197261|FG000|Overall Study|Lost to Follow-up|1|||
147557083|NCT02187042|532197264|FG000|Overall Study|Death|1|||
147557084|NCT02187042|532197265|FG001|Overall Study|Death|1|||
147557085|NCT02187042|532197264|FG000|Overall Study|Toxicity|6|||
147557086|NCT02187042|532197265|FG001|Overall Study|Toxicity|5|||
147106061|NCT01859741|530553740|FG001|Overall Study|Death|2|||
147557087|NCT02187042|532197264|FG000|Overall Study|Participant choice|1|||
147557088|NCT02187042|532197265|FG001|Overall Study|Participant choice|0|||
147557089|NCT02187042|532197264|FG000|Overall Study|Doctor choice|1|||
147557090|NCT02187042|532197265|FG001|Overall Study|Doctor choice|0|||
147557091|NCT02187042|532197264|FG000|Overall Study|Progressive disease|4|||
147557092|NCT02187042|532197265|FG001|Overall Study|Progressive disease|8|||
147557093|NCT00337571|532197269|FG000|Overall Study|Lack of Efficacy|3|||
147557094|NCT00337571|532197270|FG001|Overall Study|Lack of Efficacy|0|||
147557095|NCT00337571|532197271|FG002|Overall Study|Lack of Efficacy|0|||
147557096|NCT00337571|532197272|FG003|Overall Study|Lack of Efficacy|0|||
147557097|NCT00337571|532197269|FG000|Overall Study|Adverse Event|4|||
147557098|NCT00337571|532197270|FG001|Overall Study|Adverse Event|5|||
147106062|NCT01859741|530553741|FG002|Overall Study|Death|4|||
147557099|NCT00337571|532197271|FG002|Overall Study|Adverse Event|8|||
147557100|NCT00337571|532197272|FG003|Overall Study|Adverse Event|4|||
147557101|NCT00337571|532197269|FG000|Overall Study|Withdrawal by Subject|2|||
147557102|NCT00337571|532197270|FG001|Overall Study|Withdrawal by Subject|2|||
147557103|NCT00337571|532197271|FG002|Overall Study|Withdrawal by Subject|1|||
147106063|NCT01859741|530553742|FG003|Overall Study|Death|3|||
147310495|NCT01460160|531303915|FG000|Follow-up Phase|Other and not reported reasons|5|||
147310496|NCT03893825|531303916|FG000|Overall Study|Death|2|||
147310497|NCT03893825|531303917|FG001|Overall Study|Death|1|||
147310498|NCT03893825|531303916|FG000|Overall Study|Adverse Event|0|||
147310499|NCT03893825|531303917|FG001|Overall Study|Adverse Event|2|||
147310500|NCT03893825|531303916|FG000|Overall Study|Withdrawal by Subject|19|||
147310501|NCT03893825|531303917|FG001|Overall Study|Withdrawal by Subject|21|||
147310502|NCT03893825|531303916|FG000|Overall Study|Protocol deviation|1|||
147310503|NCT03893825|531303917|FG001|Overall Study|Protocol deviation|0|||
147310504|NCT03893825|531303916|FG000|Overall Study|Lost to Follow-up|10|||
147310505|NCT03893825|531303917|FG001|Overall Study|Lost to Follow-up|10|||
147310506|NCT03893825|531303916|FG000|Overall Study|Other than specified|7|||
147310507|NCT03893825|531303917|FG001|Overall Study|Other than specified|6|||
147310508|NCT04161807|531303921|FG000|Overall Study|Withdrawal by Subject|2|||
147310509|NCT04161807|531303921|FG000|Overall Study|Performed only 1 treatment|2|||
147310510|NCT02006121|531303922|FG000|Double Blind Phase|Adverse Event|6|||
147310511|NCT02006121|531303923|FG001|Double Blind Phase|Adverse Event|0|||
147310512|NCT02006121|531303922|FG000|Double Blind Phase|Lack of Efficacy|1|||
147310513|NCT02006121|531303923|FG001|Double Blind Phase|Lack of Efficacy|16|||
147310514|NCT02006121|531303922|FG000|Double Blind Phase|Withdrawal by Subject|3|||
147310515|NCT02006121|531303923|FG001|Double Blind Phase|Withdrawal by Subject|4|||
147557104|NCT00337571|532197272|FG003|Overall Study|Withdrawal by Subject|0|||
147557105|NCT00337571|532197269|FG000|Overall Study|Lost to Follow-up|3|||
147557106|NCT00337571|532197270|FG001|Overall Study|Lost to Follow-up|1|||
147557107|NCT00337571|532197271|FG002|Overall Study|Lost to Follow-up|0|||
147557108|NCT00337571|532197272|FG003|Overall Study|Lost to Follow-up|1|||
147557109|NCT00337571|532197269|FG000|Overall Study|Poor/noncompliance|1|||
147557110|NCT00337571|532197270|FG001|Overall Study|Poor/noncompliance|1|||
147557111|NCT00337571|532197271|FG002|Overall Study|Poor/noncompliance|1|||
147557112|NCT00337571|532197272|FG003|Overall Study|Poor/noncompliance|1|||
147557113|NCT00337571|532197269|FG000|Overall Study|No longer met study criteria|1|||
147557114|NCT00337571|532197270|FG001|Overall Study|No longer met study criteria|0|||
147557115|NCT00337571|532197271|FG002|Overall Study|No longer met study criteria|0|||
147557116|NCT00337571|532197272|FG003|Overall Study|No longer met study criteria|0|||
147557117|NCT00337571|532197269|FG000|Overall Study|High Potassium level|0|||
147557118|NCT00337571|532197270|FG001|Overall Study|High Potassium level|0|||
147557119|NCT00337571|532197271|FG002|Overall Study|High Potassium level|0|||
147557120|NCT00337571|532197272|FG003|Overall Study|High Potassium level|1|||
147557121|NCT00948675|532197273|FG000|Overall Study|Lost to Follow-up|1|||
147557122|NCT00948675|532197274|FG001|Overall Study|Lost to Follow-up|0|||
147557123|NCT03552757|532197275|FG000|Overall Study|Withdrawal by Subject|10|||
147557124|NCT03552757|532197276|FG001|Overall Study|Withdrawal by Subject|5|||
147557125|NCT03552757|532197277|FG002|Overall Study|Withdrawal by Subject|12|||
147557126|NCT03552757|532197275|FG000|Overall Study|Lost to Follow-up|2|||
147557127|NCT03552757|532197276|FG001|Overall Study|Lost to Follow-up|7|||
147557128|NCT03552757|532197277|FG002|Overall Study|Lost to Follow-up|7|||
147557129|NCT03552757|532197275|FG000|Overall Study|Death|1|||
147557130|NCT03552757|532197276|FG001|Overall Study|Death|1|||
147557131|NCT03552757|532197277|FG002|Overall Study|Death|1|||
147557132|NCT00449150|532197278|FG000|Overall Study|Adverse Event|11|||
147557133|NCT00449150|532197279|FG001|Overall Study|Adverse Event|18|||
147557134|NCT00449150|532197280|FG002|Overall Study|Adverse Event|9|||
147557135|NCT00449150|532197278|FG000|Overall Study|Lack of Efficacy|1|||
147557136|NCT00449150|532197279|FG001|Overall Study|Lack of Efficacy|2|||
147557137|NCT00449150|532197280|FG002|Overall Study|Lack of Efficacy|2|||
147557138|NCT00449150|532197278|FG000|Overall Study|Other|16|||
147557139|NCT00449150|532197279|FG001|Overall Study|Other|13|||
147557140|NCT00449150|532197280|FG002|Overall Study|Other|14|||
147557141|NCT00449150|532197278|FG000|Overall Study|Withdrawal by Subject|17|||
147557142|NCT00449150|532197279|FG001|Overall Study|Withdrawal by Subject|18|||
147310516|NCT02006121|531303922|FG000|Double Blind Phase|Non-compliance with study drug|1|||
147444133|NCT02090413|531790530|FG002|Overall Study|Adverse Event|20|||
147557143|NCT00449150|532197280|FG002|Overall Study|Withdrawal by Subject|21|||
147557144|NCT00449150|532197278|FG000|Overall Study|Protocol Violation|1|||
147557145|NCT00449150|532197279|FG001|Overall Study|Protocol Violation|2|||
147557146|NCT00449150|532197280|FG002|Overall Study|Protocol Violation|1|||
147557147|NCT06331156|532197281|FG000|Overall Study|Adverse Event|1|||
147310517|NCT02006121|531303923|FG001|Double Blind Phase|Non-compliance with study drug|3|||
147310518|NCT02006121|531303922|FG000|Double Blind Phase|Minimum infusion rate poorly tolerated|1|||
147310519|NCT02006121|531303923|FG001|Double Blind Phase|Minimum infusion rate poorly tolerated|0|||
147557148|NCT06331156|532197282|FG001|Overall Study|Adverse Event|0|||
147557149|NCT06331156|532197281|FG000|Overall Study|Lost to Follow-up|1|||
147557150|NCT06331156|532197282|FG001|Overall Study|Lost to Follow-up|0|||
147557151|NCT06331156|532197281|FG000|Overall Study|Migrated / Moved from the study area|4|||
147557152|NCT06331156|532197282|FG001|Overall Study|Migrated / Moved from the study area|3|||
147557153|NCT06331156|532197281|FG000|Overall Study|Other|7|||
147557154|NCT06331156|532197282|FG001|Overall Study|Other|0|||
147557155|NCT06331156|532197281|FG000|Overall Study|Adverse event requiring expedited reporting|0|||
147557156|NCT06331156|532197282|FG001|Overall Study|Adverse event requiring expedited reporting|1|||
147557157|NCT02978326|532197283|FG000|Part B (Up to 45 Days)|Adverse Event|0|||
147557158|NCT02978326|532197284|FG001|Part B (Up to 45 Days)|Adverse Event|0|||
147557159|NCT02978326|532197285|FG002|Part B (Up to 45 Days)|Adverse Event|1|||
147557160|NCT02978326|532197283|FG000|Part B (Up to 45 Days)|Lost to Follow-up|0|||
147557161|NCT02978326|532197284|FG001|Part B (Up to 45 Days)|Lost to Follow-up|3|||
147557162|NCT02978326|532197285|FG002|Part B (Up to 45 Days)|Lost to Follow-up|0|||
147557163|NCT02978326|532197283|FG000|Part B (Up to 45 Days)|Non-compliance|0|||
147557164|NCT02978326|532197284|FG001|Part B (Up to 45 Days)|Non-compliance|2|||
147557165|NCT02978326|532197285|FG002|Part B (Up to 45 Days)|Non-compliance|0|||
147557166|NCT02978326|532197283|FG000|Part B (Up to 45 Days)|Withdrawal by Subject|0|||
147557167|NCT02978326|532197284|FG001|Part B (Up to 45 Days)|Withdrawal by Subject|2|||
147557168|NCT02978326|532197285|FG002|Part B (Up to 45 Days)|Withdrawal by Subject|3|||
147557169|NCT00865709|532197293|FG000|Treatment|Adverse Event|9|||
147557170|NCT00865709|532197294|FG001|Treatment|Adverse Event|6|||
147557171|NCT00865709|532197293|FG000|Treatment|Withdrawal by Subject|10|||
147557172|NCT00865709|532197294|FG001|Treatment|Withdrawal by Subject|7|||
147557173|NCT00865709|532197293|FG000|Treatment|Physician Decision|3|||
147557174|NCT00865709|532197294|FG001|Treatment|Physician Decision|2|||
147557175|NCT00865709|532197293|FG000|Treatment|Surgery|8|||
147557176|NCT00865709|532197294|FG001|Treatment|Surgery|3|||
147557177|NCT00662129|532197295|FG000|Overall Study|Protocol Violation|1|||
147557178|NCT00662129|532197295|FG000|Overall Study|Cancel prior to beginning treatment|1|||
147557179|NCT00662129|532197295|FG000|Overall Study|Ineligible|1|||
147557180|NCT03276975|532197296|FG000|Overall Study|Withdrawal by Subject|1|||
147557181|NCT03276975|532197297|FG001|Overall Study|Withdrawal by Subject|0|||
147557182|NCT02153736|532197302|FG000|Overall Study|Lost to Follow-up|1|||
147557183|NCT02153736|532197303|FG001|Overall Study|Lost to Follow-up|0|||
147557184|NCT02153736|532197302|FG000|Overall Study|Medical status change made ineligible|1|||
147557185|NCT02153736|532197303|FG001|Overall Study|Medical status change made ineligible|0|||
147557186|NCT02153736|532197302|FG000|Overall Study|Death|0|||
147557187|NCT02153736|532197303|FG001|Overall Study|Death|1|||
147557188|NCT02153736|532197302|FG000|Overall Study|Withdrawal by Subject|0|||
147557189|NCT02153736|532197303|FG001|Overall Study|Withdrawal by Subject|1|||
147557190|NCT00796510|532197312|FG000|Overall Study|Death|1|||
147557191|NCT00796510|532197313|FG001|Overall Study|Death|0|||
147557192|NCT00796510|532197312|FG000|Overall Study|Study Terminated|2|||
147557193|NCT00796510|532197313|FG001|Overall Study|Study Terminated|0|||
147557194|NCT01734772|532197314|FG000|Overall Study|Adverse Event|1|||
147557195|NCT01734772|532197315|FG001|Overall Study|Adverse Event|2|||
147557196|NCT01734772|532197314|FG000|Overall Study|Withdrawal by Subject|0|||
147557197|NCT01734772|532197315|FG001|Overall Study|Withdrawal by Subject|1|||
147557198|NCT05030753|532197316|FG000|9-week|Lost to Follow-up|10|||
147557199|NCT05030753|532197317|FG001|9-week|Lost to Follow-up|7|||
147557200|NCT05030753|532197316|FG000|9-week|Withdrawal by Subject|1|||
147557201|NCT05030753|532197317|FG001|9-week|Withdrawal by Subject|0|||
147557202|NCT05030753|532197316|FG000|9-week|Excluded from analysis due to missing covariates|2|||
147557203|NCT05030753|532197317|FG001|9-week|Excluded from analysis due to missing covariates|1|||
147557204|NCT05030753|532197316|FG000|6-month post intervention|Lost to Follow-up|5|||
147557205|NCT05030753|532197317|FG001|6-month post intervention|Lost to Follow-up|4|||
147557206|NCT05030753|532197316|FG000|6-month post intervention|Withdrawal by Subject|4|||
147557207|NCT05030753|532197317|FG001|6-month post intervention|Withdrawal by Subject|0|||
147557208|NCT05030753|532197316|FG000|18-month post intervention|Lost to Follow-up|3|||
147557209|NCT05030753|532197317|FG001|18-month post intervention|Lost to Follow-up|1|||
147557210|NCT00720122|532197326|FG000|Overall Study|Lost to Follow-up|1|||
147557211|NCT00720122|532197326|FG000|Overall Study|Physician Decision|1|||
147557212|NCT00720122|532197326|FG000|Overall Study|Withdrawal by Subject|7|||
147557213|NCT03072459|532197327|FG000|Overall Study|Device revised/removed|1|||
147557214|NCT03072459|532197327|FG000|Overall Study|Subject not able to return|1|||
147557215|NCT02275364|532197328|FG000|Period 1|Withdrawal by Subject|1|||
147557216|NCT02275364|532197329|FG001|Period 1|Withdrawal by Subject|0|||
147557217|NCT02275364|532197328|FG000|Period 1|Other reason|1|||
147557218|NCT02275364|532197329|FG001|Period 1|Other reason|0|||
147557219|NCT03595657|532197334|FG000|Overall Study|Adverse Event|14|||
147557220|NCT03595657|532197334|FG000|Overall Study|Death|1|||
147106064|NCT01859741|530553743|FG004|Overall Study|Death|5|||
147557221|NCT03595657|532197334|FG000|Overall Study|Lack of Efficacy|40|||
147557222|NCT03595657|532197334|FG000|Overall Study|Withdrawal by Subject|10|||
147557223|NCT03595657|532197334|FG000|Overall Study|Dosing delayed over 9 weeks|1|||
147557224|NCT03595657|532197334|FG000|Overall Study|Achieved CR and completed 2 years of treatment|1|||
147106065|NCT01859741|530553744|FG005|Overall Study|Death|4|||
147557225|NCT00663871|532197335|FG000|Overall Study|Lost to Follow-up|5|||
147557226|NCT00663871|532197336|FG001|Overall Study|Lost to Follow-up|5|||
147557227|NCT00663871|532197335|FG000|Overall Study|Withdrawal by Subject|5|||
147557228|NCT00663871|532197336|FG001|Overall Study|Withdrawal by Subject|2|||
147557229|NCT03384745|532197339|FG000|Placebo Controlled Induction (W0 - W12)|Adverse Event|0|||
147557230|NCT03384745|532197340|FG001|Placebo Controlled Induction (W0 - W12)|Adverse Event|0|||
147310520|NCT02006121|531303922|FG000|Double Blind Phase|Inconvenience of infusion system|0|||
147310521|NCT02006121|531303923|FG001|Double Blind Phase|Inconvenience of infusion system|1|||
147310522|NCT02006121|531303922|FG000|Open Label Phase|Adverse Event|15|||
147310523|NCT02006121|531303923|FG001|Open Label Phase|Adverse Event|0|||
147310524|NCT02006121|531303922|FG000|Open Label Phase|Lack of Efficacy|2|||
147310525|NCT02006121|531303923|FG001|Open Label Phase|Lack of Efficacy|0|||
147310526|NCT02006121|531303922|FG000|Open Label Phase|Protocol Violation|2|||
147310527|NCT02006121|531303923|FG001|Open Label Phase|Protocol Violation|0|||
147310528|NCT02006121|531303922|FG000|Open Label Phase|Withdrawal by Subject|3|||
147310529|NCT02006121|531303923|FG001|Open Label Phase|Withdrawal by Subject|0|||
147310530|NCT02006121|531303922|FG000|Open Label Phase|Non-compliance with study drug|3|||
147310531|NCT02006121|531303923|FG001|Open Label Phase|Non-compliance with study drug|0|||
147310532|NCT02340520|531303931|FG000|Overall Study|Lost to Follow-up|1|||
147310533|NCT02340520|531303931|FG000|Overall Study|Patient did not take drug as specified|1|||
147310534|NCT02340520|531303931|FG000|Overall Study|Withdrawal by Subject|1|||
147310535|NCT03176238|531303935|FG000|Overall Study|Unacceptable AEs|15|||
147310536|NCT03176238|531303936|FG001|Overall Study|Unacceptable AEs|8|||
147310537|NCT03176238|531303935|FG000|Overall Study|Abnormal lab value(s)|2|||
147310538|NCT03176238|531303936|FG001|Overall Study|Abnormal lab value(s)|0|||
147310539|NCT03176238|531303935|FG000|Overall Study|Inter-current illness|0|||
147310540|NCT03176238|531303936|FG001|Overall Study|Inter-current illness|1|||
147310541|NCT03176238|531303935|FG000|Overall Study|Consent withdrawal|14|||
147310542|NCT03176238|531303936|FG001|Overall Study|Consent withdrawal|2|||
147310543|NCT03176238|531303935|FG000|Overall Study|Lost to Follow-up|3|||
147310544|NCT03176238|531303936|FG001|Overall Study|Lost to Follow-up|0|||
147310545|NCT03176238|531303935|FG000|Overall Study|Administrative problems|1|||
147310546|NCT03176238|531303936|FG001|Overall Study|Administrative problems|0|||
147310547|NCT03176238|531303935|FG000|Overall Study|Death|3|||
147310548|NCT03176238|531303936|FG001|Overall Study|Death|0|||
147310549|NCT03176238|531303935|FG000|Overall Study|Disease Progression|133|||
147310550|NCT03176238|531303936|FG001|Overall Study|Disease Progression|22|||
147310551|NCT03176238|531303935|FG000|Overall Study|Tx duration completed per EAP|0|||
147310552|NCT03176238|531303936|FG001|Overall Study|Tx duration completed per EAP|1|||
147310553|NCT03176238|531303935|FG000|Overall Study|Patient is switched to commercial drug|16|||
147310554|NCT03176238|531303936|FG001|Overall Study|Patient is switched to commercial drug|1|||
147310555|NCT03176238|531303935|FG000|Overall Study|Protocol Violation|1|||
147310556|NCT03176238|531303936|FG001|Overall Study|Protocol Violation|0|||
147310557|NCT03176238|531303935|FG000|Overall Study|Changes in the patient's condition|2|||
147310558|NCT03176238|531303936|FG001|Overall Study|Changes in the patient's condition|1|||
147310559|NCT03176238|531303935|FG000|Overall Study|Everolimus dose interrupt > 4 wks|9|||
147310560|NCT03176238|531303936|FG001|Overall Study|Everolimus dose interrupt > 4 wks|0|||
147310561|NCT03556358|531303937|FG000|Overall Study|Subjects Randomized that did not Treat|3|||
147310562|NCT03556358|531303938|FG001|Overall Study|Subjects Randomized that did not Treat|0|||
147310563|NCT03556358|531303937|FG000|Overall Study|Subjects who Randomized and Treated but Drop prior to Cycle 5|7|||
147310564|NCT03556358|531303938|FG001|Overall Study|Subjects who Randomized and Treated but Drop prior to Cycle 5|5|||
147310565|NCT03556358|531303937|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to Adverse Event|0|||
147310566|NCT03556358|531303938|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to Adverse Event|1|||
147310567|NCT03556358|531303937|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to Death|0|||
147310568|NCT03556358|531303938|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to Death|1|||
147310569|NCT03556358|531303937|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to Consent Withdrawn|0|||
147310570|NCT03556358|531303938|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to Consent Withdrawn|2|||
147557231|NCT03384745|532197341|FG002|Placebo Controlled Induction (W0 - W12)|Adverse Event|1|||
147557232|NCT03384745|532197342|FG003|Placebo Controlled Induction (W0 - W12)|Adverse Event|2|||
147557233|NCT03384745|532197343|FG004|Placebo Controlled Induction (W0 - W12)|Adverse Event|0|||
147557234|NCT03384745|532197344|FG005|Placebo Controlled Induction (W0 - W12)|Adverse Event|0|||
147557235|NCT03384745|532197339|FG000|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|0|||
147557236|NCT03384745|532197340|FG001|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|0|||
147310571|NCT03556358|531303937|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to COVID-19|0|||
147310572|NCT03556358|531303938|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to COVID-19|1|||
147310573|NCT03556358|531303937|FG000|Overall Study|Discontinued Treatment after Cycle 5 due to Other (Subject Decision)|1|||
147310574|NCT03556358|531303938|FG001|Overall Study|Discontinued Treatment after Cycle 5 due to Other (Subject Decision)|2|||
147310575|NCT01351025|531303940|FG000|Week 0 - 20|Lost to Follow-up|2|||
147310576|NCT01351025|531303941|FG001|Week 0 - 20|Lost to Follow-up|1|||
147310577|NCT01351025|531303940|FG000|Week 0 - 20|Withdrawal by Subject|1|||
147310578|NCT01351025|531303941|FG001|Week 0 - 20|Withdrawal by Subject|0|||
147310579|NCT01351025|531303940|FG000|Week 24 - 44|Lost to Follow-up|0|||
147310580|NCT01351025|531303941|FG001|Week 24 - 44|Lost to Follow-up|2|||
147310581|NCT01351025|531303940|FG000|Week 24 - 44|Site closed|0|||
147310582|NCT01351025|531303941|FG001|Week 24 - 44|Site closed|1|||
147310583|NCT01351025|531303940|FG000|Week 24 - 44|unable to get to clinic|1|||
147557237|NCT03384745|532197341|FG002|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|0|||
147557238|NCT03384745|532197342|FG003|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|0|||
147557239|NCT03384745|532197343|FG004|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|3|||
147557240|NCT03384745|532197344|FG005|Placebo Controlled Induction (W0 - W12)|Withdrawal by Subject|1|||
147557241|NCT03384745|532197339|FG000|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|0|||
147557242|NCT03384745|532197340|FG001|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|1|||
147557243|NCT03384745|532197341|FG002|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|1|||
147557244|NCT03384745|532197342|FG003|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|0|||
147557245|NCT03384745|532197343|FG004|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|0|||
147557246|NCT03384745|532197344|FG005|Placebo Controlled Induction (W0 - W12)|Lost to Follow-up|1|||
147557247|NCT03384745|532197339|FG000|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0|||
147557248|NCT03384745|532197340|FG001|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0|||
147557249|NCT03384745|532197341|FG002|Placebo Controlled Induction (W0 - W12)|Protocol Violation|1|||
147557250|NCT03384745|532197342|FG003|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0|||
147557251|NCT03384745|532197343|FG004|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0|||
147557252|NCT03384745|532197344|FG005|Placebo Controlled Induction (W0 - W12)|Protocol Violation|0|||
147557253|NCT03384745|532197339|FG000|Maintenance/Escalation (W12-W24)|Adverse Event|0|||
147557254|NCT03384745|532197340|FG001|Maintenance/Escalation (W12-W24)|Adverse Event|0|||
147557255|NCT03384745|532197341|FG002|Maintenance/Escalation (W12-W24)|Adverse Event|0|||
147557256|NCT03384745|532197342|FG003|Maintenance/Escalation (W12-W24)|Adverse Event|1|||
147557257|NCT03384745|532197343|FG004|Maintenance/Escalation (W12-W24)|Adverse Event|1|||
147557258|NCT03384745|532197344|FG005|Maintenance/Escalation (W12-W24)|Adverse Event|0|||
147557259|NCT03384745|532197339|FG000|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0|||
147557260|NCT03384745|532197340|FG001|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0|||
147557261|NCT03384745|532197341|FG002|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0|||
147557262|NCT03384745|532197342|FG003|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0|||
147557263|NCT03384745|532197343|FG004|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|1|||
147557264|NCT03384745|532197344|FG005|Maintenance/Escalation (W12-W24)|Withdrawal by Subject|0|||
147557265|NCT03384745|532197339|FG000|Maintenance/Escalation (W12-W24)|Lack of Efficacy|0|||
147557266|NCT03384745|532197340|FG001|Maintenance/Escalation (W12-W24)|Lack of Efficacy|0|||
147557267|NCT03384745|532197341|FG002|Maintenance/Escalation (W12-W24)|Lack of Efficacy|1|||
147557268|NCT03384745|532197342|FG003|Maintenance/Escalation (W12-W24)|Lack of Efficacy|1|||
147557269|NCT03384745|532197343|FG004|Maintenance/Escalation (W12-W24)|Lack of Efficacy|0|||
147557270|NCT03384745|532197344|FG005|Maintenance/Escalation (W12-W24)|Lack of Efficacy|0|||
147557271|NCT03384745|532197339|FG000|Response Assess/Dose Hold (W24-W48)|Adverse Event|1|||
147557272|NCT03384745|532197340|FG001|Response Assess/Dose Hold (W24-W48)|Adverse Event|1|||
147557273|NCT03384745|532197341|FG002|Response Assess/Dose Hold (W24-W48)|Adverse Event|3|||
147557274|NCT03384745|532197342|FG003|Response Assess/Dose Hold (W24-W48)|Adverse Event|0|||
147557275|NCT03384745|532197343|FG004|Response Assess/Dose Hold (W24-W48)|Adverse Event|1|||
147557276|NCT03384745|532197344|FG005|Response Assess/Dose Hold (W24-W48)|Adverse Event|0|||
147557277|NCT03384745|532197339|FG000|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|0|||
147557278|NCT03384745|532197340|FG001|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|1|||
147557279|NCT03384745|532197341|FG002|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|1|||
147557280|NCT03384745|532197342|FG003|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|2|||
147557281|NCT03384745|532197343|FG004|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|0|||
147557282|NCT03384745|532197344|FG005|Response Assess/Dose Hold (W24-W48)|Withdrawal by Subject|2|||
147557283|NCT03384745|532197339|FG000|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0|||
147557284|NCT03384745|532197340|FG001|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0|||
147557285|NCT03384745|532197341|FG002|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0|||
147557286|NCT03384745|532197342|FG003|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|2|||
147557287|NCT03384745|532197343|FG004|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0|||
147557288|NCT03384745|532197344|FG005|Response Assess/Dose Hold (W24-W48)|Lost to Follow-up|0|||
147557289|NCT03384745|532197339|FG000|Response Assess/Dose Hold (W24-W48)|Death|0|||
147557290|NCT03384745|532197340|FG001|Response Assess/Dose Hold (W24-W48)|Death|1|||
147557291|NCT03384745|532197341|FG002|Response Assess/Dose Hold (W24-W48)|Death|0|||
147557292|NCT03384745|532197342|FG003|Response Assess/Dose Hold (W24-W48)|Death|0|||
147557293|NCT03384745|532197343|FG004|Response Assess/Dose Hold (W24-W48)|Death|0|||
147557294|NCT03384745|532197344|FG005|Response Assess/Dose Hold (W24-W48)|Death|0|||
147557295|NCT01592370|532197345|FG000|Overall Study|Disease Progression|62|||
147557296|NCT01592370|532197346|FG001|Overall Study|Disease Progression|16|||
147557297|NCT01592370|532197347|FG002|Overall Study|Disease Progression|52|||
147557298|NCT01592370|532197348|FG003|Overall Study|Disease Progression|3|||
147557299|NCT01592370|532197349|FG004|Overall Study|Disease Progression|3|||
147557300|NCT01592370|532197350|FG005|Overall Study|Disease Progression|31|||
147557301|NCT01592370|532197351|FG006|Overall Study|Disease Progression|14|||
147557302|NCT01592370|532197345|FG000|Overall Study|Study Drug Toxicity|14|||
147557303|NCT01592370|532197346|FG001|Overall Study|Study Drug Toxicity|3|||
147557304|NCT01592370|532197347|FG002|Overall Study|Study Drug Toxicity|0|||
147557305|NCT01592370|532197348|FG003|Overall Study|Study Drug Toxicity|0|||
147106066|NCT01859741|530553745|FG006|Overall Study|Death|51|||
147106067|NCT01859741|530553746|FG007|Overall Study|Death|51|||
147557306|NCT01592370|532197349|FG004|Overall Study|Study Drug Toxicity|0|||
147557307|NCT01592370|532197350|FG005|Overall Study|Study Drug Toxicity|0|||
147557308|NCT01592370|532197351|FG006|Overall Study|Study Drug Toxicity|1|||
147557309|NCT01592370|532197345|FG000|Overall Study|AE unrelated to study drug|4|||
147557310|NCT01592370|532197346|FG001|Overall Study|AE unrelated to study drug|3|||
147557311|NCT01592370|532197347|FG002|Overall Study|AE unrelated to study drug|0|||
147557312|NCT01592370|532197348|FG003|Overall Study|AE unrelated to study drug|0|||
147557313|NCT01592370|532197349|FG004|Overall Study|AE unrelated to study drug|0|||
147557314|NCT01592370|532197350|FG005|Overall Study|AE unrelated to study drug|0|||
147557315|NCT01592370|532197351|FG006|Overall Study|AE unrelated to study drug|1|||
147557316|NCT01592370|532197345|FG000|Overall Study|Request to discontinue study treatment|5|||
147557317|NCT01592370|532197346|FG001|Overall Study|Request to discontinue study treatment|0|||
147557318|NCT01592370|532197347|FG002|Overall Study|Request to discontinue study treatment|2|||
147557319|NCT01592370|532197348|FG003|Overall Study|Request to discontinue study treatment|0|||
147557320|NCT01592370|532197349|FG004|Overall Study|Request to discontinue study treatment|1|||
147557321|NCT01592370|532197350|FG005|Overall Study|Request to discontinue study treatment|2|||
147557322|NCT01592370|532197351|FG006|Overall Study|Request to discontinue study treatment|0|||
147557323|NCT01592370|532197345|FG000|Overall Study|Withdrew consent|1|||
147557324|NCT01592370|532197346|FG001|Overall Study|Withdrew consent|2|||
147557325|NCT01592370|532197347|FG002|Overall Study|Withdrew consent|1|||
147557326|NCT01592370|532197348|FG003|Overall Study|Withdrew consent|1|||
147557327|NCT01592370|532197349|FG004|Overall Study|Withdrew consent|0|||
147557328|NCT01592370|532197350|FG005|Overall Study|Withdrew consent|0|||
147557329|NCT01592370|532197351|FG006|Overall Study|Withdrew consent|0|||
147557330|NCT01592370|532197345|FG000|Overall Study|Maximum clinical benefit|11|||
147557331|NCT01592370|532197346|FG001|Overall Study|Maximum clinical benefit|1|||
147557332|NCT01592370|532197347|FG002|Overall Study|Maximum clinical benefit|7|||
147557333|NCT01592370|532197348|FG003|Overall Study|Maximum clinical benefit|1|||
147557334|NCT01592370|532197349|FG004|Overall Study|Maximum clinical benefit|0|||
147557335|NCT01592370|532197350|FG005|Overall Study|Maximum clinical benefit|0|||
147557336|NCT01592370|532197351|FG006|Overall Study|Maximum clinical benefit|0|||
147557337|NCT01592370|532197345|FG000|Overall Study|No longer meets study criteria|1|||
147557338|NCT01592370|532197346|FG001|Overall Study|No longer meets study criteria|0|||
147557339|NCT01592370|532197347|FG002|Overall Study|No longer meets study criteria|0|||
147557340|NCT01592370|532197348|FG003|Overall Study|No longer meets study criteria|0|||
147557341|NCT01592370|532197349|FG004|Overall Study|No longer meets study criteria|0|||
147557342|NCT01592370|532197350|FG005|Overall Study|No longer meets study criteria|0|||
147557343|NCT01592370|532197351|FG006|Overall Study|No longer meets study criteria|0|||
147557344|NCT01592370|532197345|FG000|Overall Study|Other Reasons|6|||
147557345|NCT01592370|532197346|FG001|Overall Study|Other Reasons|0|||
147557346|NCT01592370|532197347|FG002|Overall Study|Other Reasons|10|||
147557347|NCT01592370|532197348|FG003|Overall Study|Other Reasons|0|||
147557348|NCT01592370|532197349|FG004|Overall Study|Other Reasons|0|||
147557349|NCT01592370|532197350|FG005|Overall Study|Other Reasons|1|||
147557350|NCT01592370|532197351|FG006|Overall Study|Other Reasons|0|||
147557351|NCT01592370|532197345|FG000|Overall Study|Not Treated|0|||
147557352|NCT01592370|532197346|FG001|Overall Study|Not Treated|0|||
147557353|NCT01592370|532197347|FG002|Overall Study|Not Treated|0|||
147557354|NCT01592370|532197348|FG003|Overall Study|Not Treated|0|||
147557355|NCT01592370|532197349|FG004|Overall Study|Not Treated|2|||
147557356|NCT01592370|532197350|FG005|Overall Study|Not Treated|2|||
147557357|NCT01592370|532197351|FG006|Overall Study|Not Treated|0|||
147557358|NCT00319449|532197354|FG000|Overall Study|Subject did not wish to continue|1|||
147557359|NCT00319449|532197355|FG001|Overall Study|Subject did not wish to continue|0|||
147557360|NCT00319449|532197354|FG000|Overall Study|Noncompliance with the protocol|1|||
147557361|NCT00319449|532197355|FG001|Overall Study|Noncompliance with the protocol|0|||
147557362|NCT00455533|532197356|FG000|Period One: Initial Chemotherapy|Adverse Event Not Related to Study Drug|1|||
147557363|NCT00455533|532197357|FG001|Period One: Initial Chemotherapy|Adverse Event Not Related to Study Drug|0|||
147557364|NCT00455533|532197358|FG002|Period One: Initial Chemotherapy|Adverse Event Not Related to Study Drug|0|||
147557365|NCT00455533|532197356|FG000|Period One: Initial Chemotherapy|Disease Progression|5|||
147225224|NCT00744471|530996581|FG001|Overall Study|Entered extension study|84|||
147557366|NCT00455533|532197357|FG001|Period One: Initial Chemotherapy|Disease Progression|0|||
147557367|NCT00455533|532197358|FG002|Period One: Initial Chemotherapy|Disease Progression|0|||
147557368|NCT00455533|532197356|FG000|Period One: Initial Chemotherapy|Lost to Follow-up|2|||
147557369|NCT00455533|532197357|FG001|Period One: Initial Chemotherapy|Lost to Follow-up|0|||
147557370|NCT00455533|532197358|FG002|Period One: Initial Chemotherapy|Lost to Follow-up|0|||
147557371|NCT00455533|532197356|FG000|Period One: Initial Chemotherapy|Not Reported|1|||
147557372|NCT00455533|532197357|FG001|Period One: Initial Chemotherapy|Not Reported|0|||
147557373|NCT00455533|532197358|FG002|Period One: Initial Chemotherapy|Not Reported|0|||
147106068|NCT01859741|530553739|FG000|Overall Study|Lost to Follow-up|0|||
147225225|NCT00744471|530996582|FG002|Overall Study|Entered extension study|100|||
147557374|NCT00455533|532197356|FG000|Period One: Initial Chemotherapy|Other--Need Reasons|2|||
147106069|NCT01859741|530553740|FG001|Overall Study|Lost to Follow-up|0|||
147106070|NCT01859741|530553741|FG002|Overall Study|Lost to Follow-up|0|||
147106071|NCT01859741|530553742|FG003|Overall Study|Lost to Follow-up|0|||
147106072|NCT01859741|530553743|FG004|Overall Study|Lost to Follow-up|0|||
147106073|NCT01859741|530553744|FG005|Overall Study|Lost to Follow-up|1|||
147106074|NCT01859741|530553745|FG006|Overall Study|Lost to Follow-up|0|||
147106075|NCT01859741|530553746|FG007|Overall Study|Lost to Follow-up|4|||
147106076|NCT01859741|530553739|FG000|Overall Study|Withdrawal by Subject|0|||
147106077|NCT01859741|530553740|FG001|Overall Study|Withdrawal by Subject|1|||
147106078|NCT01859741|530553741|FG002|Overall Study|Withdrawal by Subject|2|||
147106079|NCT01859741|530553742|FG003|Overall Study|Withdrawal by Subject|0|||
147106080|NCT01859741|530553743|FG004|Overall Study|Withdrawal by Subject|0|||
147106081|NCT01859741|530553744|FG005|Overall Study|Withdrawal by Subject|1|||
147106082|NCT01859741|530553745|FG006|Overall Study|Withdrawal by Subject|1|||
147106083|NCT01859741|530553746|FG007|Overall Study|Withdrawal by Subject|1|||
147106084|NCT01859741|530553739|FG000|Overall Study|Study Terminated by Sponsor|0|||
147106085|NCT01859741|530553740|FG001|Overall Study|Study Terminated by Sponsor|0|||
147106086|NCT01859741|530553741|FG002|Overall Study|Study Terminated by Sponsor|0|||
147106087|NCT01859741|530553742|FG003|Overall Study|Study Terminated by Sponsor|0|||
147106088|NCT01859741|530553743|FG004|Overall Study|Study Terminated by Sponsor|1|||
147106089|NCT01859741|530553744|FG005|Overall Study|Study Terminated by Sponsor|0|||
147106090|NCT01859741|530553745|FG006|Overall Study|Study Terminated by Sponsor|16|||
147106091|NCT01859741|530553746|FG007|Overall Study|Study Terminated by Sponsor|14|||
147106092|NCT01859741|530553739|FG000|Overall Study|Other|0|||
147106093|NCT01859741|530553740|FG001|Overall Study|Other|0|||
147106094|NCT01859741|530553741|FG002|Overall Study|Other|0|||
147557375|NCT00455533|532197357|FG001|Period One: Initial Chemotherapy|Other--Need Reasons|0|||
147557376|NCT00455533|532197358|FG002|Period One: Initial Chemotherapy|Other--Need Reasons|0|||
147557377|NCT00455533|532197356|FG000|Period One: Initial Chemotherapy|Study Drug Toxicity|2|||
147557378|NCT00455533|532197357|FG001|Period One: Initial Chemotherapy|Study Drug Toxicity|0|||
147557379|NCT00455533|532197358|FG002|Period One: Initial Chemotherapy|Study Drug Toxicity|0|||
147106095|NCT01859741|530553742|FG003|Overall Study|Other|0|||
147106096|NCT01859741|530553743|FG004|Overall Study|Other|0|||
147106097|NCT01859741|530553744|FG005|Overall Study|Other|0|||
147106098|NCT01859741|530553745|FG006|Overall Study|Other|2|||
147106099|NCT01859741|530553746|FG007|Overall Study|Other|0|||
147106100|NCT02606253|530553750|FG000|Overall Study|Adverse Event|2|||
147106101|NCT02606253|530553751|FG001|Overall Study|Adverse Event|0|||
147106102|NCT02606253|530553752|FG002|Overall Study|Adverse Event|0|||
147106103|NCT02606253|530553750|FG000|Overall Study|Protocol Violation|2|||
147106104|NCT02606253|530553751|FG001|Overall Study|Protocol Violation|1|||
147106105|NCT02606253|530553752|FG002|Overall Study|Protocol Violation|0|||
147557380|NCT00455533|532197356|FG000|Period One: Initial Chemotherapy|Subject Request to Discontinue Study|1|||
147557381|NCT00455533|532197357|FG001|Period One: Initial Chemotherapy|Subject Request to Discontinue Study|0|||
147557382|NCT00455533|532197358|FG002|Period One: Initial Chemotherapy|Subject Request to Discontinue Study|0|||
147557383|NCT00455533|532197356|FG000|Period One: Initial Chemotherapy|Subject No Longer Meets Study Criteria|2|||
147557384|NCT00455533|532197357|FG001|Period One: Initial Chemotherapy|Subject No Longer Meets Study Criteria|0|||
147557385|NCT00455533|532197358|FG002|Period One: Initial Chemotherapy|Subject No Longer Meets Study Criteria|0|||
147557386|NCT00455533|532197356|FG000|Period One: Initial Chemotherapy|Subject Withdrew Consent|2|||
147557387|NCT00455533|532197357|FG001|Period One: Initial Chemotherapy|Subject Withdrew Consent|0|||
147557388|NCT00455533|532197358|FG002|Period One: Initial Chemotherapy|Subject Withdrew Consent|0|||
147557389|NCT00455533|532197356|FG000|Period Two: Randomized Period|Death|0|||
147557390|NCT00455533|532197357|FG001|Period Two: Randomized Period|Death|0|||
147557391|NCT00455533|532197358|FG002|Period Two: Randomized Period|Death|3|||
147557392|NCT00455533|532197356|FG000|Period Two: Randomized Period|Disease Progression|0|||
147557393|NCT00455533|532197357|FG001|Period Two: Randomized Period|Disease Progression|1|||
147557394|NCT00455533|532197358|FG002|Period Two: Randomized Period|Disease Progression|1|||
147557395|NCT00455533|532197356|FG000|Period Two: Randomized Period|Lost to Follow-up|0|||
147557396|NCT00455533|532197357|FG001|Period Two: Randomized Period|Lost to Follow-up|0|||
147557397|NCT00455533|532197358|FG002|Period Two: Randomized Period|Lost to Follow-up|1|||
147557398|NCT00455533|532197356|FG000|Period Two: Randomized Period|Other - need reasons|0|||
147557399|NCT00455533|532197357|FG001|Period Two: Randomized Period|Other - need reasons|1|||
147106106|NCT02606253|530553750|FG000|Overall Study|Physician Decision|1|||
147106107|NCT02606253|530553751|FG001|Overall Study|Physician Decision|1|||
147106108|NCT02606253|530553752|FG002|Overall Study|Physician Decision|0|||
147106109|NCT02765165|530553755|FG000|Treatment Period|Progressive disease|3|||
147106110|NCT02765165|530553756|FG001|Treatment Period|Progressive disease|2|||
147106111|NCT02765165|530553757|FG002|Treatment Period|Progressive disease|3|||
147106112|NCT02765165|530553758|FG003|Treatment Period|Progressive disease|3|||
147106113|NCT02765165|530553759|FG004|Treatment Period|Progressive disease|4|||
147106114|NCT02765165|530553760|FG005|Treatment Period|Progressive disease|2|||
147106115|NCT02765165|530553761|FG006|Treatment Period|Progressive disease|2|||
147106116|NCT02765165|530553755|FG000|Treatment Period|Physician Decision|0|||
147106117|NCT02765165|530553756|FG001|Treatment Period|Physician Decision|1|||
147106118|NCT02765165|530553757|FG002|Treatment Period|Physician Decision|0|||
147106119|NCT02765165|530553758|FG003|Treatment Period|Physician Decision|0|||
147106120|NCT02765165|530553759|FG004|Treatment Period|Physician Decision|0|||
147106121|NCT02765165|530553760|FG005|Treatment Period|Physician Decision|0|||
147106122|NCT02765165|530553761|FG006|Treatment Period|Physician Decision|0|||
147106123|NCT02765165|530553755|FG000|Treatment Period|Adverse Event|0|||
147106124|NCT02765165|530553756|FG001|Treatment Period|Adverse Event|1|||
147106125|NCT02765165|530553757|FG002|Treatment Period|Adverse Event|0|||
147106126|NCT02765165|530553758|FG003|Treatment Period|Adverse Event|0|||
147106127|NCT02765165|530553759|FG004|Treatment Period|Adverse Event|0|||
147106128|NCT02765165|530553760|FG005|Treatment Period|Adverse Event|0|||
147106129|NCT02765165|530553761|FG006|Treatment Period|Adverse Event|0|||
147106130|NCT02765165|530553755|FG000|Treatment Period|Withdrawal by Subject|0|||
147106131|NCT02765165|530553756|FG001|Treatment Period|Withdrawal by Subject|0|||
147106132|NCT02765165|530553757|FG002|Treatment Period|Withdrawal by Subject|0|||
147106133|NCT02765165|530553758|FG003|Treatment Period|Withdrawal by Subject|0|||
147106134|NCT02765165|530553759|FG004|Treatment Period|Withdrawal by Subject|2|||
147106135|NCT02765165|530553760|FG005|Treatment Period|Withdrawal by Subject|0|||
147106136|NCT02765165|530553761|FG006|Treatment Period|Withdrawal by Subject|0|||
147106137|NCT02765165|530553755|FG000|Treatment Period|Study terminated|0|||
147106138|NCT02765165|530553756|FG001|Treatment Period|Study terminated|0|||
147106139|NCT02765165|530553757|FG002|Treatment Period|Study terminated|0|||
147106140|NCT02765165|530553758|FG003|Treatment Period|Study terminated|0|||
147106141|NCT02765165|530553759|FG004|Treatment Period|Study terminated|0|||
147106142|NCT02765165|530553760|FG005|Treatment Period|Study terminated|1|||
147106143|NCT02765165|530553761|FG006|Treatment Period|Study terminated|2|||
147106144|NCT02765165|530553755|FG000|Post-treatment Follow-up|Death|1|||
147106145|NCT02765165|530553756|FG001|Post-treatment Follow-up|Death|2|||
147106146|NCT02765165|530553757|FG002|Post-treatment Follow-up|Death|1|||
147106147|NCT02765165|530553758|FG003|Post-treatment Follow-up|Death|1|||
147106148|NCT02765165|530553759|FG004|Post-treatment Follow-up|Death|1|||
147106149|NCT02765165|530553760|FG005|Post-treatment Follow-up|Death|1|||
147106150|NCT02765165|530553761|FG006|Post-treatment Follow-up|Death|0|||
147106151|NCT02765165|530553755|FG000|Post-treatment Follow-up|Lost to Follow-up|0|||
147106152|NCT02765165|530553756|FG001|Post-treatment Follow-up|Lost to Follow-up|0|||
147225226|NCT00744471|530996583|FG003|Overall Study|Entered extension study|91|||
147225227|NCT00744471|530996580|FG000|Overall Study|Other|2|||
147557400|NCT00455533|532197358|FG002|Period Two: Randomized Period|Other - need reasons|0|||
147106153|NCT02765165|530553757|FG002|Post-treatment Follow-up|Lost to Follow-up|0|||
147106154|NCT02765165|530553758|FG003|Post-treatment Follow-up|Lost to Follow-up|1|||
147106155|NCT02765165|530553759|FG004|Post-treatment Follow-up|Lost to Follow-up|0|||
147225228|NCT00744471|530996581|FG001|Overall Study|Other|3|||
147225229|NCT00744471|530996582|FG002|Overall Study|Other|6|||
147557401|NCT00455533|532197356|FG000|Period Two: Randomized Period|Study Drug Toxicity|0|||
147557402|NCT00455533|532197357|FG001|Period Two: Randomized Period|Study Drug Toxicity|2|||
147557403|NCT00455533|532197358|FG002|Period Two: Randomized Period|Study Drug Toxicity|0|||
147557404|NCT00455533|532197356|FG000|Period Two: Randomized Period|Subject Withdrew Consent|0|||
147557405|NCT00455533|532197357|FG001|Period Two: Randomized Period|Subject Withdrew Consent|2|||
147557406|NCT00455533|532197358|FG002|Period Two: Randomized Period|Subject Withdrew Consent|1|||
147557407|NCT02739984|532197359|FG000|Overall Study|Sponsor Decision|1|||
147557408|NCT02739984|532197360|FG001|Overall Study|Sponsor Decision|0|||
147557409|NCT02739984|532197359|FG000|Overall Study|Withdrawal by Subject|1|||
147557410|NCT02739984|532197360|FG001|Overall Study|Withdrawal by Subject|1|||
147557411|NCT02739984|532197359|FG000|Overall Study|Death|0|||
147557412|NCT02739984|532197360|FG001|Overall Study|Death|1|||
147557413|NCT02739984|532197359|FG000|Overall Study|Lost to Follow-up|3|||
147557414|NCT02739984|532197360|FG001|Overall Study|Lost to Follow-up|0|||
147557415|NCT00767325|532197362|FG000|Overall Study|Lack of Efficacy|2|||
147557416|NCT00767325|532197362|FG000|Overall Study|Adverse Event|7|||
147557417|NCT00767325|532197362|FG000|Overall Study|Lost to Follow-up|3|||
147557418|NCT00767325|532197362|FG000|Overall Study|No longer met study criteria|2|||
147557419|NCT00767325|532197362|FG000|Overall Study|Missed visit due to family reasons|1|||
147557420|NCT03538756|532197363|FG000|Long-Term Follow-up|Adverse Event|0|||
147557421|NCT03538756|532197364|FG001|Long-Term Follow-up|Adverse Event|0|||
147557422|NCT03538756|532197365|FG002|Long-Term Follow-up|Adverse Event|6|||
147106156|NCT02765165|530553760|FG005|Post-treatment Follow-up|Lost to Follow-up|0|||
147106157|NCT02765165|530553761|FG006|Post-treatment Follow-up|Lost to Follow-up|0|||
147225230|NCT00744471|530996583|FG003|Overall Study|Other|2|||
147225231|NCT00744471|530996580|FG000|Overall Study|Lack of Efficacy|83|||
147557423|NCT03538756|532197363|FG000|Long-Term Follow-up|Death|0|||
147557424|NCT03538756|532197364|FG001|Long-Term Follow-up|Death|0|||
147557425|NCT03538756|532197365|FG002|Long-Term Follow-up|Death|1|||
147557426|NCT03538756|532197363|FG000|Long-Term Follow-up|Withdrawal by Subject|0|||
147106158|NCT02765165|530553755|FG000|Post-treatment Follow-up|Site terminated by sponsor|0|||
147106159|NCT02765165|530553756|FG001|Post-treatment Follow-up|Site terminated by sponsor|0|||
147106160|NCT02765165|530553757|FG002|Post-treatment Follow-up|Site terminated by sponsor|1|||
147225232|NCT00744471|530996581|FG001|Overall Study|Lack of Efficacy|37|||
147106161|NCT02765165|530553758|FG003|Post-treatment Follow-up|Site terminated by sponsor|0|||
147106162|NCT02765165|530553759|FG004|Post-treatment Follow-up|Site terminated by sponsor|0|||
147106163|NCT02765165|530553760|FG005|Post-treatment Follow-up|Site terminated by sponsor|0|||
147106164|NCT02765165|530553761|FG006|Post-treatment Follow-up|Site terminated by sponsor|0|||
147106165|NCT02765165|530553755|FG000|Post-treatment Follow-up|Initiation of subsequent treatment|0|||
147106166|NCT02765165|530553756|FG001|Post-treatment Follow-up|Initiation of subsequent treatment|0|||
147106167|NCT02765165|530553757|FG002|Post-treatment Follow-up|Initiation of subsequent treatment|1|||
147106168|NCT02765165|530553758|FG003|Post-treatment Follow-up|Initiation of subsequent treatment|1|||
147106169|NCT02765165|530553759|FG004|Post-treatment Follow-up|Initiation of subsequent treatment|0|||
147106170|NCT02765165|530553760|FG005|Post-treatment Follow-up|Initiation of subsequent treatment|0|||
147106171|NCT02765165|530553761|FG006|Post-treatment Follow-up|Initiation of subsequent treatment|0|||
147106172|NCT02765165|530553755|FG000|Post-treatment Follow-up|Withdrawal by Subject|0|||
147106173|NCT02765165|530553756|FG001|Post-treatment Follow-up|Withdrawal by Subject|1|||
147106174|NCT02765165|530553757|FG002|Post-treatment Follow-up|Withdrawal by Subject|0|||
147106175|NCT02765165|530553758|FG003|Post-treatment Follow-up|Withdrawal by Subject|0|||
147106176|NCT02765165|530553759|FG004|Post-treatment Follow-up|Withdrawal by Subject|0|||
147106177|NCT02765165|530553760|FG005|Post-treatment Follow-up|Withdrawal by Subject|0|||
147106178|NCT02765165|530553761|FG006|Post-treatment Follow-up|Withdrawal by Subject|0|||
147106179|NCT02765165|530553755|FG000|Post-treatment Follow-up|Study terminated by the sponsor|0|||
147106180|NCT02765165|530553756|FG001|Post-treatment Follow-up|Study terminated by the sponsor|0|||
147106181|NCT02765165|530553757|FG002|Post-treatment Follow-up|Study terminated by the sponsor|0|||
147106182|NCT02765165|530553758|FG003|Post-treatment Follow-up|Study terminated by the sponsor|0|||
147106183|NCT02765165|530553759|FG004|Post-treatment Follow-up|Study terminated by the sponsor|2|||
147106184|NCT02765165|530553760|FG005|Post-treatment Follow-up|Study terminated by the sponsor|2|||
147106185|NCT02765165|530553761|FG006|Post-treatment Follow-up|Study terminated by the sponsor|1|||
147557427|NCT03538756|532197364|FG001|Long-Term Follow-up|Withdrawal by Subject|0|||
147557428|NCT03538756|532197365|FG002|Long-Term Follow-up|Withdrawal by Subject|5|||
147557429|NCT03538756|532197363|FG000|Long-Term Follow-up|COVID-19 Disruptions at Sites|0|||
147557430|NCT03538756|532197364|FG001|Long-Term Follow-up|COVID-19 Disruptions at Sites|0|||
147557431|NCT03538756|532197365|FG002|Long-Term Follow-up|COVID-19 Disruptions at Sites|13|||
147557432|NCT03538756|532197363|FG000|Long-Term Follow-up|Device Dissatisfaction|0|||
147557433|NCT03538756|532197364|FG001|Long-Term Follow-up|Device Dissatisfaction|0|||
147557434|NCT03538756|532197365|FG002|Long-Term Follow-up|Device Dissatisfaction|8|||
147557435|NCT00752856|532197366|FG000|Overall Study|randomized but did not do viral kinetics|0|||
147557436|NCT00752856|532197367|FG001|Overall Study|randomized but did not do viral kinetics|1|||
147557437|NCT00996736|532197368|FG000|Overall Study|Death|1|||
147557438|NCT00996736|532197369|FG001|Overall Study|Death|1|||
147557439|NCT00996736|532197368|FG000|Overall Study|Lost to Follow-up|15|||
147106186|NCT02567188|530553762|FG000|Overall Study|Death|10|||
147106187|NCT02567188|530553762|FG000|Overall Study|Terminated Mircera Treatment|9|||
147106188|NCT02567188|530553762|FG000|Overall Study|Lost to Follow-up|5|||
147106189|NCT02567188|530553762|FG000|Overall Study|Adverse Event|1|||
147106190|NCT02567188|530553762|FG000|Overall Study|Withdrawal by Subject|1|||
147106191|NCT02567188|530553762|FG000|Overall Study|Refused Treatment/ Did not Cooperate|1|||
147106192|NCT02567188|530553762|FG000|Overall Study|Moved and Changed Clinic|1|||
147106193|NCT02567188|530553762|FG000|Overall Study|Started Hemodialysis|2|||
147106194|NCT02567188|530553762|FG000|Overall Study|Protocol Violation|5|||
147225233|NCT00744471|530996582|FG002|Overall Study|Lack of Efficacy|19|||
147225234|NCT00744471|530996583|FG003|Overall Study|Lack of Efficacy|31|||
147225235|NCT00744471|530996580|FG000|Overall Study|Lost to Follow-up|0|||
147225236|NCT00744471|530996581|FG001|Overall Study|Lost to Follow-up|0|||
147225237|NCT00744471|530996582|FG002|Overall Study|Lost to Follow-up|2|||
147225238|NCT00744471|530996583|FG003|Overall Study|Lost to Follow-up|0|||
147225239|NCT03224546|530996584|FG000|Overall Study|Lost to Follow-up|9|||
147225240|NCT03224546|530996585|FG001|Overall Study|Lost to Follow-up|8|||
147225241|NCT03224546|530996586|FG002|Overall Study|Lost to Follow-up|3|||
147225242|NCT03224546|530996584|FG000|Overall Study|Withdrawal by Subject|7|||
147225243|NCT03224546|530996585|FG001|Overall Study|Withdrawal by Subject|14|||
147225244|NCT03224546|530996586|FG002|Overall Study|Withdrawal by Subject|12|||
147225245|NCT04706416|530996587|FG000|Overall Study|Lost to Follow-up|2|||
147225246|NCT04706416|530996588|FG001|Overall Study|Lost to Follow-up|0|||
147225247|NCT00976573|530996596|FG000|Overall Study|Ineligible|0|||
147225248|NCT00976573|530996597|FG001|Overall Study|Ineligible|1|||
147225249|NCT00976573|530996596|FG000|Overall Study|Cancel prior to receiving treatment|4|||
147225250|NCT00976573|530996597|FG001|Overall Study|Cancel prior to receiving treatment|2|||
147225251|NCT02117427|530996598|FG000|Overall Study|Permanent need for exogenous EPO Tx|2|||
147225252|NCT02117427|530996599|FG001|Overall Study|Permanent need for exogenous EPO Tx|0|||
147225253|NCT02117427|530996600|FG002|Overall Study|Permanent need for exogenous EPO Tx|0|||
147225254|NCT02117427|530996598|FG000|Overall Study|Permanent need for exogenous ESA Tx|3|||
147225255|NCT02117427|530996599|FG001|Overall Study|Permanent need for exogenous ESA Tx|1|||
147557440|NCT00996736|532197369|FG001|Overall Study|Lost to Follow-up|14|||
147557441|NCT00996736|532197368|FG000|Overall Study|Visit not within 3-month window|5|||
147106195|NCT01189266|530553767|FG000|Overall Study|Adverse Event|1|||
147106196|NCT01189266|530553768|FG001|Overall Study|Adverse Event|0|||
147106197|NCT01189266|530553769|FG002|Overall Study|Adverse Event|5|||
147106198|NCT01189266|530553767|FG000|Overall Study|Death|0|||
147106199|NCT01189266|530553768|FG001|Overall Study|Death|0|||
147106200|NCT01189266|530553769|FG002|Overall Study|Death|5|||
147106201|NCT01189266|530553767|FG000|Overall Study|Lack of Efficacy|4|||
147106202|NCT01189266|530553768|FG001|Overall Study|Lack of Efficacy|5|||
147106203|NCT01189266|530553769|FG002|Overall Study|Lack of Efficacy|44|||
147106204|NCT01189266|530553767|FG000|Overall Study|Physician Decision|0|||
147106205|NCT01189266|530553768|FG001|Overall Study|Physician Decision|0|||
147106206|NCT01189266|530553769|FG002|Overall Study|Physician Decision|1|||
147106207|NCT01189266|530553767|FG000|Overall Study|Protocol Violation|0|||
147106208|NCT01189266|530553768|FG001|Overall Study|Protocol Violation|1|||
147106209|NCT01189266|530553769|FG002|Overall Study|Protocol Violation|1|||
147106210|NCT01189266|530553767|FG000|Overall Study|Withdrawal by Subject|0|||
147106211|NCT01189266|530553768|FG001|Overall Study|Withdrawal by Subject|0|||
147106212|NCT01189266|530553769|FG002|Overall Study|Withdrawal by Subject|1|||
147106213|NCT01189266|530553767|FG000|Overall Study|Patient refuses further therapy|1|||
147106214|NCT01189266|530553768|FG001|Overall Study|Patient refuses further therapy|0|||
147106215|NCT01189266|530553769|FG002|Overall Study|Patient refuses further therapy|7|||
147106216|NCT01189266|530553767|FG000|Overall Study|No treatment|0|||
147106217|NCT01189266|530553768|FG001|Overall Study|No treatment|0|||
147106218|NCT01189266|530553769|FG002|Overall Study|No treatment|1|||
147106219|NCT00537277|530553770|FG000|Overall Study|Adverse Event|1|||
147106220|NCT00537277|530553770|FG000|Overall Study|Lack of Efficacy|2|||
147106221|NCT00537277|530553770|FG000|Overall Study|Lost to Follow-up|12|||
147106222|NCT00537277|530553770|FG000|Overall Study|Protocol Violation|11|||
147106223|NCT00537277|530553770|FG000|Overall Study|Unclassified|4|||
147106224|NCT00537277|530553770|FG000|Overall Study|Inability to tolerate trial medication|4|||
147106225|NCT00537277|530553770|FG000|Overall Study|Non-compliance with trial procedures|15|||
147106226|NCT00410163|530553773|FG000|Treatment and Follow-up Phase (2 Years)|Adverse Event|4|||
147106227|NCT00410163|530553774|FG001|Treatment and Follow-up Phase (2 Years)|Adverse Event|2|||
147106228|NCT00410163|530553773|FG000|Treatment and Follow-up Phase (2 Years)|Death|1|||
147106229|NCT00410163|530553774|FG001|Treatment and Follow-up Phase (2 Years)|Death|1|||
147106230|NCT00410163|530553773|FG000|Treatment and Follow-up Phase (2 Years)|Withdrawal by Subject|2|||
147557442|NCT00996736|532197369|FG001|Overall Study|Visit not within 3-month window|3|||
147557443|NCT02688608|532197370|FG000|Overall Study|Lost to Follow-up|1|||
147557444|NCT02346201|532197372|FG000|Overall Study|Adverse Event|3|||
147557445|NCT02346201|532197373|FG001|Overall Study|Adverse Event|2|||
147557446|NCT02346201|532197372|FG000|Overall Study|Lost to Follow-up|1|||
147557447|NCT02346201|532197373|FG001|Overall Study|Lost to Follow-up|0|||
147557448|NCT02346201|532197372|FG000|Overall Study|Withdrawal by Subject|6|||
147557449|NCT02346201|532197373|FG001|Overall Study|Withdrawal by Subject|3|||
147557450|NCT02346201|532197372|FG000|Overall Study|Unavailable for future follow-up|0|||
147557451|NCT02346201|532197373|FG001|Overall Study|Unavailable for future follow-up|1|||
147557452|NCT02346201|532197372|FG000|Overall Study|Physician Decision|0|||
147557453|NCT02346201|532197373|FG001|Overall Study|Physician Decision|1|||
147557454|NCT02346201|532197372|FG000|Overall Study|Missed final visit|0|||
147557455|NCT02346201|532197373|FG001|Overall Study|Missed final visit|2|||
147557456|NCT03708211|532197375|FG000|Overall Study|Progressive Disease|10|||
147557457|NCT03708211|532197376|FG001|Overall Study|Progressive Disease|7|||
147557458|NCT03708211|532197375|FG000|Overall Study|Withdrawal by Subject|0|||
147557459|NCT03708211|532197376|FG001|Overall Study|Withdrawal by Subject|1|||
147557460|NCT03708211|532197375|FG000|Overall Study|Other|2|||
147557461|NCT03708211|532197376|FG001|Overall Study|Other|0|||
147557462|NCT00462982|532197377|FG000|Overall Study|Adverse Event|1|||
147557463|NCT00462982|532197377|FG000|Overall Study|Patient Not Treated|2|||
147557464|NCT05200858|532197380|FG000|Blinded Phase (4 Weeks)|Lost to Follow-up|3|||
147557465|NCT05200858|532197381|FG001|Blinded Phase (4 Weeks)|Lost to Follow-up|2|||
147557466|NCT05200858|532197382|FG002|Blinded Phase (4 Weeks)|Lost to Follow-up|0|||
147557467|NCT05200858|532197383|FG003|Blinded Phase (4 Weeks)|Lost to Follow-up|0|||
147557468|NCT02109133|532197384|FG000|Overall Study|Lost to Follow-up|1|||
147106231|NCT00410163|530553774|FG001|Treatment and Follow-up Phase (2 Years)|Withdrawal by Subject|1|||
147106232|NCT00410163|530553773|FG000|Treatment and Follow-up Phase (2 Years)|Lack of Efficacy|0|||
147106233|NCT00410163|530553774|FG001|Treatment and Follow-up Phase (2 Years)|Lack of Efficacy|4|||
147557469|NCT02109133|532197385|FG001|Overall Study|Lost to Follow-up|0|||
147106234|NCT00410163|530553773|FG000|Treatment and Follow-up Phase (2 Years)|Participant Had No Response|2|||
147106235|NCT00410163|530553774|FG001|Treatment and Follow-up Phase (2 Years)|Participant Had No Response|1|||
147106236|NCT00410163|530553773|FG000|Treatment and Follow-up Phase (2 Years)|Participant Had Stable Disease|1|||
147106237|NCT00410163|530553774|FG001|Treatment and Follow-up Phase (2 Years)|Participant Had Stable Disease|0|||
147106238|NCT00410163|530553773|FG000|Treatment and Follow-up Phase (2 Years)|Participant Received New Therapy|1|||
147557470|NCT00409578|532197386|FG000|Overall Study|Adverse Event|27|||
147557471|NCT00409578|532197387|FG001|Overall Study|Adverse Event|37|||
147557472|NCT00409578|532197388|FG002|Overall Study|Adverse Event|25|||
147557473|NCT00409578|532197389|FG003|Overall Study|Adverse Event|33|||
147557474|NCT00409578|532197386|FG000|Overall Study|Abnormal laboratory value(s)|2|||
147557475|NCT00409578|532197387|FG001|Overall Study|Abnormal laboratory value(s)|2|||
147557476|NCT00409578|532197388|FG002|Overall Study|Abnormal laboratory value(s)|2|||
147557477|NCT00409578|532197389|FG003|Overall Study|Abnormal laboratory value(s)|4|||
147557478|NCT00409578|532197386|FG000|Overall Study|Lack of Efficacy|0|||
147557479|NCT00409578|532197387|FG001|Overall Study|Lack of Efficacy|0|||
147557480|NCT00409578|532197388|FG002|Overall Study|Lack of Efficacy|0|||
147557481|NCT00409578|532197389|FG003|Overall Study|Lack of Efficacy|2|||
147557482|NCT00409578|532197386|FG000|Overall Study|Subject no longer requires study drug|0|||
147557483|NCT00409578|532197387|FG001|Overall Study|Subject no longer requires study drug|0|||
147557484|NCT00409578|532197388|FG002|Overall Study|Subject no longer requires study drug|0|||
147557485|NCT00409578|532197389|FG003|Overall Study|Subject no longer requires study drug|1|||
147557486|NCT00409578|532197386|FG000|Overall Study|Withdrawal by Subject|8|||
147557487|NCT00409578|532197387|FG001|Overall Study|Withdrawal by Subject|15|||
147557488|NCT00409578|532197388|FG002|Overall Study|Withdrawal by Subject|16|||
147557489|NCT00409578|532197389|FG003|Overall Study|Withdrawal by Subject|17|||
147557490|NCT00409578|532197386|FG000|Overall Study|Lost to Follow-up|2|||
147557491|NCT00409578|532197387|FG001|Overall Study|Lost to Follow-up|0|||
147557492|NCT00409578|532197388|FG002|Overall Study|Lost to Follow-up|2|||
147557493|NCT00409578|532197389|FG003|Overall Study|Lost to Follow-up|2|||
147557494|NCT00409578|532197386|FG000|Overall Study|Administrative problems|8|||
147557495|NCT00409578|532197387|FG001|Overall Study|Administrative problems|9|||
147557496|NCT00409578|532197388|FG002|Overall Study|Administrative problems|2|||
147557497|NCT00409578|532197389|FG003|Overall Study|Administrative problems|4|||
147557498|NCT00409578|532197386|FG000|Overall Study|Death|2|||
147557499|NCT00409578|532197387|FG001|Overall Study|Death|4|||
147557500|NCT00409578|532197388|FG002|Overall Study|Death|4|||
147557501|NCT00409578|532197389|FG003|Overall Study|Death|2|||
147557502|NCT00409578|532197386|FG000|Overall Study|Protocol Violation|3|||
147557503|NCT00409578|532197387|FG001|Overall Study|Protocol Violation|2|||
147557504|NCT00409578|532197388|FG002|Overall Study|Protocol Violation|3|||
147557505|NCT00409578|532197389|FG003|Overall Study|Protocol Violation|1|||
147557506|NCT00409578|532197386|FG000|Overall Study|Missing|0|||
147557507|NCT00409578|532197387|FG001|Overall Study|Missing|1|||
147557508|NCT00409578|532197388|FG002|Overall Study|Missing|0|||
147557509|NCT00409578|532197389|FG003|Overall Study|Missing|1|||
147557510|NCT00770315|532197390|FG000|Overall Study|Adverse Event|11|||
147557511|NCT00770315|532197391|FG001|Overall Study|Adverse Event|17|||
147557512|NCT00770315|532197392|FG002|Overall Study|Adverse Event|16|||
147557513|NCT00770315|532197393|FG003|Overall Study|Adverse Event|6|||
147557514|NCT00770315|532197390|FG000|Overall Study|Lost to Follow-up|9|||
147557515|NCT00770315|532197391|FG001|Overall Study|Lost to Follow-up|5|||
147557516|NCT00770315|532197392|FG002|Overall Study|Lost to Follow-up|10|||
147557517|NCT00770315|532197393|FG003|Overall Study|Lost to Follow-up|3|||
147557518|NCT00770315|532197390|FG000|Overall Study|Withdrawal by Subject|13|||
147557519|NCT00770315|532197391|FG001|Overall Study|Withdrawal by Subject|17|||
147557520|NCT00770315|532197392|FG002|Overall Study|Withdrawal by Subject|24|||
147557521|NCT00770315|532197393|FG003|Overall Study|Withdrawal by Subject|20|||
147557522|NCT00770315|532197390|FG000|Overall Study|Noncompliance with Protocol|7|||
147557523|NCT00770315|532197391|FG001|Overall Study|Noncompliance with Protocol|4|||
147557524|NCT00770315|532197392|FG002|Overall Study|Noncompliance with Protocol|7|||
147557525|NCT00770315|532197393|FG003|Overall Study|Noncompliance with Protocol|9|||
147557526|NCT04256421|532197394|FG000|Overall Study|Death|171|||
147557527|NCT04256421|532197395|FG001|Overall Study|Death|180|||
147557528|NCT04256421|532197394|FG000|Overall Study|Lost to Follow-up|1|||
147557529|NCT04256421|532197395|FG001|Overall Study|Lost to Follow-up|1|||
147225256|NCT02117427|530996600|FG002|Overall Study|Permanent need for exogenous ESA Tx|0|||
147225257|NCT02117427|530996598|FG000|Overall Study|Physician Decision|0|||
147225258|NCT02117427|530996599|FG001|Overall Study|Physician Decision|2|||
147225259|NCT02117427|530996600|FG002|Overall Study|Physician Decision|0|||
147225260|NCT02117427|530996598|FG000|Overall Study|No longer meets inclusion criteria|0|||
147557530|NCT04256421|532197394|FG000|Overall Study|Withdrawal by Subject|9|||
147557531|NCT04256421|532197395|FG001|Overall Study|Withdrawal by Subject|10|||
147557532|NCT04256421|532197394|FG000|Overall Study|Ongoing in Study|66|||
147557533|NCT04256421|532197395|FG001|Overall Study|Ongoing in Study|52|||
147557534|NCT01052116|532198758|FG000|Overall Study|Lost to Follow-up|11|||
147557535|NCT01052116|532198759|FG001|Overall Study|Lost to Follow-up|17|||
147557536|NCT01052116|532198758|FG000|Overall Study|Withdrawal by Subject|3|||
147557537|NCT01052116|532198759|FG001|Overall Study|Withdrawal by Subject|6|||
147557538|NCT01052116|532198758|FG000|Overall Study|Spirometry not performed|0|||
147557539|NCT01052116|532198759|FG001|Overall Study|Spirometry not performed|4|||
147557540|NCT01739790|532198760|FG000|Overall Study|Early Trial Termination|2|||
147557541|NCT01739790|532198761|FG001|Overall Study|Early Trial Termination|4|||
147557542|NCT05568225|532198763|FG000|Primary Treatment Period|Termination of the study by the Sponsor|0|||
147557543|NCT05568225|532198764|FG001|Primary Treatment Period|Termination of the study by the Sponsor|0|||
147557544|NCT05568225|532198765|FG002|Primary Treatment Period|Termination of the study by the Sponsor|1|||
147106239|NCT00410163|530553774|FG001|Treatment and Follow-up Phase (2 Years)|Participant Received New Therapy|1|||
147106240|NCT00410163|530553773|FG000|Treatment and Follow-up Phase (2 Years)|Participant Had Bone Marrow Transplant|1|||
147106241|NCT00410163|530553774|FG001|Treatment and Follow-up Phase (2 Years)|Participant Had Bone Marrow Transplant|0|||
147106242|NCT00410163|530553773|FG000|Treatment and Follow-up Phase (2 Years)|Investigator Decision|0|||
147106243|NCT00410163|530553774|FG001|Treatment and Follow-up Phase (2 Years)|Investigator Decision|1|||
147106244|NCT00410163|530553773|FG000|Extended Follow-up (FU) Phase (2-5 Years|Lost to Follow-up|3|||
147106245|NCT00410163|530553774|FG001|Extended Follow-up (FU) Phase (2-5 Years|Lost to Follow-up|1|||
147106246|NCT00410163|530553773|FG000|Extended Follow-up (FU) Phase (2-5 Years|Death|1|||
147106247|NCT00410163|530553774|FG001|Extended Follow-up (FU) Phase (2-5 Years|Death|1|||
147106248|NCT00410163|530553773|FG000|Extended Follow-up (FU) Phase (2-5 Years|Medical Reasons|1|||
147106249|NCT00410163|530553774|FG001|Extended Follow-up (FU) Phase (2-5 Years|Medical Reasons|0|||
147106250|NCT00410163|530553773|FG000|Extended Follow-up (FU) Phase (2-5 Years|New Anti-CLL Treatment|4|||
147106251|NCT00410163|530553774|FG001|Extended Follow-up (FU) Phase (2-5 Years|New Anti-CLL Treatment|8|||
147106252|NCT00410163|530553773|FG000|Extended Follow-up (FU) Phase (2-5 Years|Secondary Acute Myeloid Leukemia|1|||
147557545|NCT05568225|532198763|FG000|Primary Treatment Period|Physician Decision|0|||
147557546|NCT05568225|532198764|FG001|Primary Treatment Period|Physician Decision|1|||
147557547|NCT05568225|532198765|FG002|Primary Treatment Period|Physician Decision|0|||
147557548|NCT05568225|532198763|FG000|Primary Treatment Period|Disease progression|0|||
147557549|NCT05568225|532198764|FG001|Primary Treatment Period|Disease progression|1|||
147557550|NCT05568225|532198765|FG002|Primary Treatment Period|Disease progression|0|||
147557551|NCT05568225|532198763|FG000|Primary Treatment Period|Lack of Efficacy|0|||
147557552|NCT05568225|532198764|FG001|Primary Treatment Period|Lack of Efficacy|1|||
147557553|NCT05568225|532198765|FG002|Primary Treatment Period|Lack of Efficacy|0|||
147557554|NCT05568225|532198763|FG000|Primary Treatment Period|Withdrawal of conset|1|||
147557555|NCT05568225|532198764|FG001|Primary Treatment Period|Withdrawal of conset|0|||
147557556|NCT05568225|532198765|FG002|Primary Treatment Period|Withdrawal of conset|4|||
147557557|NCT05568225|532198763|FG000|Primary Treatment Period|Adverse Event|1|||
147557558|NCT05568225|532198764|FG001|Primary Treatment Period|Adverse Event|0|||
147557559|NCT05568225|532198765|FG002|Primary Treatment Period|Adverse Event|0|||
147557560|NCT05568225|532198763|FG000|Extension Treatment Period|Termination of the study by the Sponsor|0|||
147557561|NCT05568225|532198764|FG001|Extension Treatment Period|Termination of the study by the Sponsor|0|||
147557562|NCT05568225|532198765|FG002|Extension Treatment Period|Termination of the study by the Sponsor|1|||
147557563|NCT05568225|532198763|FG000|Extension Treatment Period|Protocol Violation|0|||
147557564|NCT05568225|532198764|FG001|Extension Treatment Period|Protocol Violation|0|||
147557565|NCT05568225|532198765|FG002|Extension Treatment Period|Protocol Violation|1|||
147557566|NCT05568225|532198763|FG000|Extension Treatment Period|Lack of Efficacy|0|||
147557567|NCT05568225|532198764|FG001|Extension Treatment Period|Lack of Efficacy|0|||
147557568|NCT05568225|532198765|FG002|Extension Treatment Period|Lack of Efficacy|1|||
147557569|NCT02309099|532198768|FG000|Overall Study|Adverse Event|2|||
147557570|NCT02309099|532198769|FG001|Overall Study|Adverse Event|0|||
147557571|NCT02819362|532198771|FG000|Overall Study|On-site MRI could not be performed|70|||
147557572|NCT05301751|532198772|FG000|Overall Study|Withdrawal by Subject|0|||
147557573|NCT05301751|532198773|FG001|Overall Study|Withdrawal by Subject|0|||
147557574|NCT05301751|532198774|FG002|Overall Study|Withdrawal by Subject|1|||
147557575|NCT05301751|532198775|FG003|Overall Study|Withdrawal by Subject|0|||
147557576|NCT02324465|532198779|FG000|Overall Study|device failure|0|||
147557577|NCT02324465|532198780|FG001|Overall Study|device failure|1|||
147557578|NCT02132247|532198781|FG000|Overall Study|Protocol Violation|1|||
147557579|NCT02132247|532198782|FG001|Overall Study|Protocol Violation|0|||
147557580|NCT00520741|532198789|FG000|Overall Study|Adverse Event|16|||
147557581|NCT00520741|532198790|FG001|Overall Study|Adverse Event|56|||
147557582|NCT00520741|532198789|FG000|Overall Study|Lack of Efficacy|11|||
147557583|NCT00520741|532198790|FG001|Overall Study|Lack of Efficacy|30|||
147557584|NCT00520741|532198789|FG000|Overall Study|Withdrawal by Subject|0|||
147557585|NCT00520741|532198790|FG001|Overall Study|Withdrawal by Subject|11|||
147557586|NCT00520741|532198789|FG000|Overall Study|Protocol Violation|2|||
147557587|NCT00520741|532198790|FG001|Overall Study|Protocol Violation|15|||
147557588|NCT00520741|532198789|FG000|Overall Study|Unsatisfactory compliance of subject|4|||
147557589|NCT00520741|532198790|FG001|Overall Study|Unsatisfactory compliance of subject|3|||
147557590|NCT00520741|532198789|FG000|Overall Study|Lost to Follow-up|4|||
147557591|NCT00520741|532198790|FG001|Overall Study|Lost to Follow-up|4|||
147557592|NCT00520741|532198789|FG000|Overall Study|Other reasons for premature termination|0|||
147557593|NCT00520741|532198790|FG001|Overall Study|Other reasons for premature termination|6|||
147106253|NCT00410163|530553774|FG001|Extended Follow-up (FU) Phase (2-5 Years|Secondary Acute Myeloid Leukemia|0|||
147106254|NCT04513366|530553775|FG000|Treatment Phase|Withdrawal by Subject|6|||
147557594|NCT03702621|532198791|FG000|Overall Study|Physician Decision|6|||
147557595|NCT03702621|532198792|FG001|Overall Study|Physician Decision|6|||
147557596|NCT01860976|532198799|FG000|Blinded Treatment|Adverse Event|1|||
147557597|NCT01860976|532198800|FG001|Blinded Treatment|Adverse Event|3|||
147557598|NCT01860976|532198799|FG000|Blinded Treatment|Lack of Efficacy|5|||
147106255|NCT04513366|530553776|FG001|Treatment Phase|Withdrawal by Subject|8|||
147106256|NCT04513366|530553777|FG002|Treatment Phase|Withdrawal by Subject|3|||
147106257|NCT04513366|530553775|FG000|Treatment Phase|Lost to Follow-up|1|||
147106258|NCT04513366|530553776|FG001|Treatment Phase|Lost to Follow-up|2|||
147106259|NCT04513366|530553777|FG002|Treatment Phase|Lost to Follow-up|5|||
147106260|NCT04513366|530553775|FG000|Treatment Phase|Other than Specified|1|||
147106261|NCT04513366|530553776|FG001|Treatment Phase|Other than Specified|0|||
147106262|NCT04513366|530553777|FG002|Treatment Phase|Other than Specified|2|||
147106263|NCT04513366|530553775|FG000|Treatment Phase|Physician Decision|2|||
147106264|NCT04513366|530553776|FG001|Treatment Phase|Physician Decision|0|||
147106265|NCT04513366|530553777|FG002|Treatment Phase|Physician Decision|0|||
147106266|NCT04513366|530553775|FG000|Treatment Phase|Adverse Event|0|||
147106267|NCT04513366|530553776|FG001|Treatment Phase|Adverse Event|1|||
147106268|NCT04513366|530553777|FG002|Treatment Phase|Adverse Event|1|||
147106269|NCT04513366|530553775|FG000|Extension Phase|Withdrawal by Subject|3|||
147106270|NCT04513366|530553776|FG001|Extension Phase|Withdrawal by Subject|1|||
147106271|NCT04513366|530553777|FG002|Extension Phase|Withdrawal by Subject|1|||
147106272|NCT04513366|530553775|FG000|Extension Phase|Other than Specified|4|||
147106273|NCT04513366|530553776|FG001|Extension Phase|Other than Specified|0|||
147106274|NCT04513366|530553777|FG002|Extension Phase|Other than Specified|1|||
147106275|NCT04513366|530553775|FG000|Extension Phase|Lost to Follow-up|1|||
147106276|NCT04513366|530553776|FG001|Extension Phase|Lost to Follow-up|1|||
147106277|NCT04513366|530553777|FG002|Extension Phase|Lost to Follow-up|1|||
147106278|NCT04513366|530553775|FG000|Extension Phase|Sponsor Decision|0|||
147106279|NCT04513366|530553776|FG001|Extension Phase|Sponsor Decision|1|||
147106280|NCT04513366|530553777|FG002|Extension Phase|Sponsor Decision|0|||
147106281|NCT04513366|530553775|FG000|Extension Phase|Death|0|||
147106282|NCT04513366|530553776|FG001|Extension Phase|Death|1|||
147106283|NCT04513366|530553777|FG002|Extension Phase|Death|0|||
147106284|NCT04513366|530553775|FG000|Extension Phase|Adverse Event|0|||
147106285|NCT04513366|530553776|FG001|Extension Phase|Adverse Event|0|||
147106286|NCT04513366|530553777|FG002|Extension Phase|Adverse Event|1|||
147106287|NCT00655889|530553781|FG000|Overall Study|Inadequate cell growth|1|||
147310584|NCT01351025|531303941|FG001|Week 24 - 44|unable to get to clinic|1|||
147310585|NCT05067933|531303945|FG000|Overall Study|Withdrawal by Subject|2|||
147310586|NCT05067933|531303946|FG001|Overall Study|Withdrawal by Subject|0|||
147310587|NCT05067933|531303947|FG002|Overall Study|Withdrawal by Subject|0|||
147310588|NCT05067933|531303948|FG003|Overall Study|Withdrawal by Subject|0|||
147310589|NCT05067933|531303949|FG004|Overall Study|Withdrawal by Subject|0|||
147310590|NCT05067933|531303950|FG005|Overall Study|Withdrawal by Subject|0|||
147310591|NCT05067933|531303945|FG000|Overall Study|Lost to Follow-up|1|||
147310592|NCT05067933|531303946|FG001|Overall Study|Lost to Follow-up|1|||
147310593|NCT05067933|531303947|FG002|Overall Study|Lost to Follow-up|1|||
147310594|NCT05067933|531303948|FG003|Overall Study|Lost to Follow-up|2|||
147310595|NCT05067933|531303949|FG004|Overall Study|Lost to Follow-up|1|||
147310596|NCT05067933|531303950|FG005|Overall Study|Lost to Follow-up|0|||
147310597|NCT05067933|531303945|FG000|Overall Study|Miscellaneous|1|||
147310598|NCT05067933|531303946|FG001|Overall Study|Miscellaneous|0|||
147310599|NCT05067933|531303947|FG002|Overall Study|Miscellaneous|0|||
147310600|NCT05067933|531303948|FG003|Overall Study|Miscellaneous|0|||
147310601|NCT05067933|531303949|FG004|Overall Study|Miscellaneous|0|||
147310602|NCT05067933|531303950|FG005|Overall Study|Miscellaneous|0|||
147310603|NCT05067933|531303945|FG000|Overall Study|Death|0|||
147310604|NCT05067933|531303946|FG001|Overall Study|Death|0|||
147310605|NCT05067933|531303947|FG002|Overall Study|Death|0|||
147310606|NCT05067933|531303948|FG003|Overall Study|Death|1|||
147310607|NCT05067933|531303949|FG004|Overall Study|Death|0|||
147310608|NCT05067933|531303950|FG005|Overall Study|Death|0|||
147310609|NCT01065350|531303951|FG000|Overall Study|Received incorrect drug allocation|0|||
147310610|NCT01065350|531303952|FG001|Overall Study|Received incorrect drug allocation|1|||
147310611|NCT02875834|531303955|FG000|Open-label Phase|Withdrawal by Subject|3|||
147106288|NCT00655889|530553781|FG000|Overall Study|Protocol Violation|1|||
147106289|NCT03573297|530553782|FG000|Open Label Treatment Period|Adverse Event|67|||
147106290|NCT03573297|530553783|FG001|Open Label Treatment Period|Adverse Event|0|||
147106291|NCT03573297|530553784|FG002|Open Label Treatment Period|Adverse Event|0|||
147310612|NCT02875834|531303956|FG001|Open-label Phase|Withdrawal by Subject|0|||
147310613|NCT02875834|531303957|FG002|Open-label Phase|Withdrawal by Subject|0|||
147106292|NCT03573297|530553785|FG003|Open Label Treatment Period|Adverse Event|0|||
147106293|NCT03573297|530553782|FG000|Open Label Treatment Period|Lack of Efficacy|35|||
147106294|NCT03573297|530553783|FG001|Open Label Treatment Period|Lack of Efficacy|0|||
147106295|NCT03573297|530553784|FG002|Open Label Treatment Period|Lack of Efficacy|0|||
147106296|NCT03573297|530553785|FG003|Open Label Treatment Period|Lack of Efficacy|0|||
147106297|NCT03573297|530553782|FG000|Open Label Treatment Period|Withdrawal by Subject|104|||
147310614|NCT02875834|531303958|FG003|Open-label Phase|Withdrawal by Subject|0|||
147310615|NCT02875834|531303955|FG000|Open-label Phase|(Not collected)|4|||
147310616|NCT02875834|531303956|FG001|Open-label Phase|(Not collected)|0|||
147310617|NCT02875834|531303957|FG002|Open-label Phase|(Not collected)|0|||
147310618|NCT02875834|531303958|FG003|Open-label Phase|(Not collected)|0|||
147106298|NCT03573297|530553783|FG001|Open Label Treatment Period|Withdrawal by Subject|0|||
147106299|NCT03573297|530553784|FG002|Open Label Treatment Period|Withdrawal by Subject|0|||
147106300|NCT03573297|530553785|FG003|Open Label Treatment Period|Withdrawal by Subject|0|||
147106301|NCT03573297|530553782|FG000|Open Label Treatment Period|Lost to Follow-up|55|||
147557599|NCT01860976|532198800|FG001|Blinded Treatment|Lack of Efficacy|12|||
147106302|NCT03573297|530553783|FG001|Open Label Treatment Period|Lost to Follow-up|0|||
147106303|NCT03573297|530553784|FG002|Open Label Treatment Period|Lost to Follow-up|0|||
147106304|NCT03573297|530553785|FG003|Open Label Treatment Period|Lost to Follow-up|0|||
147106305|NCT03573297|530553782|FG000|Open Label Treatment Period|Pregnancy|1|||
147106306|NCT03573297|530553783|FG001|Open Label Treatment Period|Pregnancy|0|||
147106307|NCT03573297|530553784|FG002|Open Label Treatment Period|Pregnancy|0|||
147106308|NCT03573297|530553785|FG003|Open Label Treatment Period|Pregnancy|0|||
147106309|NCT03573297|530553782|FG000|Open Label Treatment Period|Protocol Violation|17|||
147106310|NCT03573297|530553783|FG001|Open Label Treatment Period|Protocol Violation|0|||
147106311|NCT03573297|530553784|FG002|Open Label Treatment Period|Protocol Violation|0|||
147106312|NCT03573297|530553785|FG003|Open Label Treatment Period|Protocol Violation|0|||
147106313|NCT03573297|530553782|FG000|Open Label Treatment Period|Non-Compliance With Study Drug|25|||
147106314|NCT03573297|530553783|FG001|Open Label Treatment Period|Non-Compliance With Study Drug|0|||
147106315|NCT03573297|530553784|FG002|Open Label Treatment Period|Non-Compliance With Study Drug|0|||
147106316|NCT03573297|530553785|FG003|Open Label Treatment Period|Non-Compliance With Study Drug|0|||
147106317|NCT03573297|530553782|FG000|Open Label Treatment Period|Study Terminated by Sponsor|2|||
147106318|NCT03573297|530553783|FG001|Open Label Treatment Period|Study Terminated by Sponsor|0|||
147106319|NCT03573297|530553784|FG002|Open Label Treatment Period|Study Terminated by Sponsor|0|||
147106320|NCT03573297|530553785|FG003|Open Label Treatment Period|Study Terminated by Sponsor|0|||
147106321|NCT03573297|530553782|FG000|Open Label Treatment Period|Failure to Meet Randomization Criteria|143|||
147106322|NCT03573297|530553783|FG001|Open Label Treatment Period|Failure to Meet Randomization Criteria|0|||
147106323|NCT03573297|530553784|FG002|Open Label Treatment Period|Failure to Meet Randomization Criteria|0|||
147106324|NCT03573297|530553785|FG003|Open Label Treatment Period|Failure to Meet Randomization Criteria|0|||
147106325|NCT03573297|530553782|FG000|Open Label Treatment Period|Other, Not Specified|7|||
147106326|NCT03573297|530553783|FG001|Open Label Treatment Period|Other, Not Specified|0|||
147106327|NCT03573297|530553784|FG002|Open Label Treatment Period|Other, Not Specified|0|||
147106328|NCT03573297|530553785|FG003|Open Label Treatment Period|Other, Not Specified|0|||
147106329|NCT03573297|530553782|FG000|Double-Blind Treatment Period|Relapse Event during Double-blind Treatment Period|0|||
147557600|NCT01860976|532198799|FG000|Blinded Treatment|Subject request to discontinue treatment|2|||
147557601|NCT01860976|532198800|FG001|Blinded Treatment|Subject request to discontinue treatment|3|||
147557602|NCT01860976|532198799|FG000|Blinded Treatment|Withdrawal by Subject|3|||
147557603|NCT01860976|532198800|FG001|Blinded Treatment|Withdrawal by Subject|5|||
147557604|NCT01860976|532198799|FG000|Blinded Treatment|Subject no longer met criteria|1|||
147557605|NCT01860976|532198800|FG001|Blinded Treatment|Subject no longer met criteria|0|||
147557606|NCT01860976|532198799|FG000|Blinded Treatment|Entered Open-Label in error|0|||
147557607|NCT01860976|532198800|FG001|Blinded Treatment|Entered Open-Label in error|1|||
147557608|NCT01860976|532198799|FG000|Blinded Treatment|Early Escape: Transitioned to OL period|76|||
147557609|NCT01860976|532198800|FG001|Blinded Treatment|Early Escape: Transitioned to OL period|89|||
147557610|NCT01860976|532198799|FG000|Open-Label|Adverse Event|2|||
147557611|NCT01860976|532198800|FG001|Open-Label|Adverse Event|4|||
147557612|NCT01860976|532198799|FG000|Open-Label|Lack of Efficacy|16|||
147557613|NCT01860976|532198800|FG001|Open-Label|Lack of Efficacy|8|||
147557614|NCT01860976|532198799|FG000|Open-Label|Lost to Follow-up|1|||
147557615|NCT01860976|532198800|FG001|Open-Label|Lost to Follow-up|2|||
147557616|NCT01860976|532198799|FG000|Open-Label|Subject request discontinue treatment|4|||
147557617|NCT01860976|532198800|FG001|Open-Label|Subject request discontinue treatment|3|||
147557618|NCT01860976|532198799|FG000|Open-Label|Withdrawal by Subject|4|||
147557619|NCT01860976|532198800|FG001|Open-Label|Withdrawal by Subject|1|||
147557620|NCT01860976|532198799|FG000|Open-Label|Other Reasons|1|||
147557621|NCT01860976|532198800|FG001|Open-Label|Other Reasons|1|||
147557622|NCT01860976|532198799|FG000|Long Term Extension|Adverse Event|4|||
147557623|NCT01860976|532198800|FG001|Long Term Extension|Adverse Event|0|||
147557624|NCT01860976|532198799|FG000|Long Term Extension|Lack of Efficacy|2|||
147557625|NCT01860976|532198800|FG001|Long Term Extension|Lack of Efficacy|0|||
147557626|NCT01860976|532198799|FG000|Long Term Extension|Subject request to discontinue treatment|10|||
147557627|NCT01860976|532198800|FG001|Long Term Extension|Subject request to discontinue treatment|0|||
147225261|NCT02117427|530996599|FG001|Overall Study|No longer meets inclusion criteria|1|||
147225262|NCT02117427|530996600|FG002|Overall Study|No longer meets inclusion criteria|0|||
147444134|NCT02090413|531790528|FG000|Overall Study|Flushing event|2|||
147557628|NCT01860976|532198799|FG000|Long Term Extension|Lost to Follow-up|2|||
147557629|NCT01860976|532198800|FG001|Long Term Extension|Lost to Follow-up|0|||
147557630|NCT01860976|532198799|FG000|Long Term Extension|subject withdrew consent|7|||
147557631|NCT01860976|532198800|FG001|Long Term Extension|subject withdrew consent|0|||
147557632|NCT02354586|532198803|FG000|Overall Study|Death|230|||
147557633|NCT02354586|532198803|FG000|Overall Study|Withdrawal by Subject|59|||
147557634|NCT02354586|532198803|FG000|Overall Study|Lost to Follow-up|11|||
147310619|NCT02875834|531303955|FG000|Randomized Treatment Phase|Withdrawal by Subject|0|||
147310620|NCT02875834|531303956|FG001|Randomized Treatment Phase|Withdrawal by Subject|3|||
147310621|NCT02875834|531303957|FG002|Randomized Treatment Phase|Withdrawal by Subject|1|||
147310622|NCT02875834|531303958|FG003|Randomized Treatment Phase|Withdrawal by Subject|0|||
147310623|NCT02875834|531303955|FG000|Randomized Treatment Phase|Protocol Violation|0|||
147310624|NCT02875834|531303956|FG001|Randomized Treatment Phase|Protocol Violation|2|||
147310625|NCT02875834|531303957|FG002|Randomized Treatment Phase|Protocol Violation|0|||
147310626|NCT02875834|531303958|FG003|Randomized Treatment Phase|Protocol Violation|0|||
147310627|NCT02875834|531303955|FG000|Randomized Treatment Phase|(Not collected)|0|||
147310628|NCT02875834|531303956|FG001|Randomized Treatment Phase|(Not collected)|9|||
147310629|NCT02875834|531303957|FG002|Randomized Treatment Phase|(Not collected)|10|||
147310630|NCT02875834|531303958|FG003|Randomized Treatment Phase|(Not collected)|9|||
147310631|NCT05200936|531303960|FG000|Overall Study|Withdrawal by Subject|2|||
147310632|NCT05200936|531303961|FG001|Overall Study|Withdrawal by Subject|2|||
147310633|NCT05200936|531303960|FG000|Overall Study|Lost to Follow-up|2|||
147557635|NCT02354586|532198803|FG000|Overall Study|Sponsor decision|51|||
147557636|NCT02354586|532198803|FG000|Overall Study|Site closure|2|||
147557637|NCT02354586|532198803|FG000|Overall Study|Intercurrent illness|1|||
147557638|NCT02354586|532198803|FG000|Overall Study|Protocol Violation|3|||
147557639|NCT02354586|532198803|FG000|Overall Study|Physician Decision|13|||
147557640|NCT02354586|532198803|FG000|Overall Study|Lack of Efficacy|86|||
147557641|NCT02354586|532198803|FG000|Overall Study|Adverse Event|7|||
147557642|NCT02402166|532198805|FG000|Overall Study|Adverse Event|2|||
147557643|NCT02402166|532198805|FG000|Overall Study|Withdrawal by Subject|2|||
147557644|NCT02402166|532198805|FG000|Overall Study|Lost to Follow-up|1|||
147557645|NCT02204371|532198806|FG000|Overall Study|Adverse Event|1|||
147557646|NCT03803943|532198815|FG000|Overall Study|Withdrawal by Subject|2|||
147557647|NCT03803943|532198816|FG001|Overall Study|Withdrawal by Subject|2|||
147557648|NCT03803943|532198817|FG002|Overall Study|Withdrawal by Subject|2|||
147557649|NCT03803943|532198818|FG003|Overall Study|Withdrawal by Subject|2|||
147557650|NCT01574248|532198819|FG000|Overall Study|Withdrawal by Subject|2|||
147557651|NCT01574248|532198820|FG001|Overall Study|Withdrawal by Subject|0|||
147557652|NCT01574248|532198819|FG000|Overall Study|Missing primary endpoint data|1|||
147557653|NCT01574248|532198820|FG001|Overall Study|Missing primary endpoint data|0|||
147557654|NCT01781286|532198823|FG000|Overall Study|Lost to Follow-up|0|||
147557655|NCT01781286|532198824|FG001|Overall Study|Lost to Follow-up|0|||
147557656|NCT01781286|532198825|FG002|Overall Study|Lost to Follow-up|0|||
147557657|NCT01781286|532198826|FG003|Overall Study|Lost to Follow-up|0|||
147557658|NCT01781286|532198827|FG004|Overall Study|Lost to Follow-up|0|||
147557659|NCT01781286|532198828|FG005|Overall Study|Lost to Follow-up|1|||
147557660|NCT01781286|532198823|FG000|Overall Study|Time Constraints|2|||
147557661|NCT01781286|532198824|FG001|Overall Study|Time Constraints|0|||
147557662|NCT01781286|532198825|FG002|Overall Study|Time Constraints|2|||
147557663|NCT01781286|532198826|FG003|Overall Study|Time Constraints|0|||
147557664|NCT01781286|532198827|FG004|Overall Study|Time Constraints|0|||
147557665|NCT01781286|532198828|FG005|Overall Study|Time Constraints|0|||
147557666|NCT01781286|532198823|FG000|Overall Study|Noncompliance|0|||
147557667|NCT01781286|532198824|FG001|Overall Study|Noncompliance|0|||
147557668|NCT01781286|532198825|FG002|Overall Study|Noncompliance|0|||
147557669|NCT01781286|532198826|FG003|Overall Study|Noncompliance|1|||
147557670|NCT01781286|532198827|FG004|Overall Study|Noncompliance|0|||
147557671|NCT01781286|532198828|FG005|Overall Study|Noncompliance|0|||
147557672|NCT00995410|532198829|FG000|Overall Study|Adverse Event|51|||
147557673|NCT00995410|532198829|FG000|Overall Study|Withdrawal by Subject|7|||
147557674|NCT00995410|532198829|FG000|Overall Study|Lost to Follow-up|2|||
147557675|NCT00995410|532198829|FG000|Overall Study|Misc|28|||
147557676|NCT03594123|532198830|FG000|Overall Study|Lost to Follow-up|0|||
147557677|NCT03594123|532198831|FG001|Overall Study|Lost to Follow-up|1|||
147557678|NCT03594123|532198830|FG000|Overall Study|Adverse Event|8|||
147557679|NCT03594123|532198831|FG001|Overall Study|Adverse Event|5|||
147557680|NCT03594123|532198830|FG000|Overall Study|Site Terminated by Sponsor|4|||
147557681|NCT03594123|532198831|FG001|Overall Study|Site Terminated by Sponsor|1|||
147557682|NCT03594123|532198830|FG000|Overall Study|Subject Withdrew Consent to Participate|7|||
147557683|NCT03594123|532198831|FG001|Overall Study|Subject Withdrew Consent to Participate|1|||
147557684|NCT03594123|532198830|FG000|Overall Study|Lack of Efficacy|1|||
147557685|NCT03594123|532198831|FG001|Overall Study|Lack of Efficacy|0|||
147557686|NCT03594123|532198830|FG000|Overall Study|Other (Not Related to COVID-19)|1|||
147557687|NCT03594123|532198831|FG001|Overall Study|Other (Not Related to COVID-19)|1|||
147557688|NCT03365375|532198832|FG000|Overall Study|Withdrawal by Subject|0|||
147557689|NCT03365375|532198833|FG001|Overall Study|Withdrawal by Subject|1|||
147557690|NCT03365375|532198832|FG000|Overall Study|Lost to Follow-up|0|||
147557691|NCT03365375|532198833|FG001|Overall Study|Lost to Follow-up|4|||
147557692|NCT02483975|532198834|FG000|Overall Study|Adverse Event|0|||
147310634|NCT05200936|531303961|FG001|Overall Study|Lost to Follow-up|0|||
147310635|NCT05200936|531303960|FG000|Overall Study|Pregnancy|0|||
147310636|NCT05200936|531303961|FG001|Overall Study|Pregnancy|1|||
147557693|NCT02483975|532198835|FG001|Overall Study|Adverse Event|1|||
147106330|NCT03573297|530553783|FG001|Double-Blind Treatment Period|Relapse Event during Double-blind Treatment Period|29|||
147106331|NCT03573297|530553784|FG002|Double-Blind Treatment Period|Relapse Event during Double-blind Treatment Period|25|||
147106332|NCT03573297|530553785|FG003|Double-Blind Treatment Period|Relapse Event during Double-blind Treatment Period|26|||
147106333|NCT03573297|530553782|FG000|Double-Blind Treatment Period|Adverse Event|0|||
147106334|NCT03573297|530553783|FG001|Double-Blind Treatment Period|Adverse Event|1|||
147106335|NCT03573297|530553784|FG002|Double-Blind Treatment Period|Adverse Event|5|||
147106336|NCT03573297|530553785|FG003|Double-Blind Treatment Period|Adverse Event|1|||
147106337|NCT03573297|530553782|FG000|Double-Blind Treatment Period|Lack of Efficacy|0|||
147106338|NCT03573297|530553783|FG001|Double-Blind Treatment Period|Lack of Efficacy|1|||
147106339|NCT03573297|530553784|FG002|Double-Blind Treatment Period|Lack of Efficacy|0|||
147106340|NCT03573297|530553785|FG003|Double-Blind Treatment Period|Lack of Efficacy|0|||
147106341|NCT03573297|530553782|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
147106342|NCT03573297|530553783|FG001|Double-Blind Treatment Period|Withdrawal by Subject|23|||
147557694|NCT02483975|532198834|FG000|Overall Study|Lost to Follow-up|0|||
147106343|NCT03573297|530553784|FG002|Double-Blind Treatment Period|Withdrawal by Subject|11|||
147106344|NCT03573297|530553785|FG003|Double-Blind Treatment Period|Withdrawal by Subject|14|||
147106345|NCT03573297|530553782|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
147106346|NCT03573297|530553783|FG001|Double-Blind Treatment Period|Lost to Follow-up|4|||
147106347|NCT03573297|530553784|FG002|Double-Blind Treatment Period|Lost to Follow-up|4|||
147557695|NCT02483975|532198835|FG001|Overall Study|Lost to Follow-up|1|||
147557696|NCT02483975|532198834|FG000|Overall Study|Physician Decision|2|||
147557697|NCT02483975|532198835|FG001|Overall Study|Physician Decision|0|||
147557698|NCT02166697|532198836|FG000|Overall Study|Protocol Violation|347|||
147557699|NCT01505530|532198840|FG000|Overall Study|Progressive Disease|19|||
147557700|NCT01505530|532198841|FG001|Overall Study|Progressive Disease|17|||
147557701|NCT01505530|532198842|FG002|Overall Study|Progressive Disease|18|||
147557702|NCT01505530|532198840|FG000|Overall Study|Adverse Event|1|||
147557703|NCT01505530|532198841|FG001|Overall Study|Adverse Event|1|||
147557704|NCT01505530|532198842|FG002|Overall Study|Adverse Event|0|||
147557705|NCT01505530|532198840|FG000|Overall Study|Withdrawal by Subject|7|||
147557706|NCT01505530|532198841|FG001|Overall Study|Withdrawal by Subject|8|||
147557707|NCT01505530|532198842|FG002|Overall Study|Withdrawal by Subject|6|||
147557708|NCT01505530|532198840|FG000|Overall Study|Physician Decision|6|||
147557709|NCT01505530|532198841|FG001|Overall Study|Physician Decision|2|||
147557710|NCT01505530|532198842|FG002|Overall Study|Physician Decision|5|||
147106348|NCT03573297|530553785|FG003|Double-Blind Treatment Period|Lost to Follow-up|9|||
147106349|NCT03573297|530553782|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
147106350|NCT03573297|530553783|FG001|Double-Blind Treatment Period|Protocol Violation|3|||
147106351|NCT03573297|530553784|FG002|Double-Blind Treatment Period|Protocol Violation|8|||
147106352|NCT03573297|530553785|FG003|Double-Blind Treatment Period|Protocol Violation|4|||
147225263|NCT02117427|530996598|FG000|Overall Study|Death|0|||
147225264|NCT02117427|530996599|FG001|Overall Study|Death|1|||
147225265|NCT02117427|530996600|FG002|Overall Study|Death|0|||
147225266|NCT02730208|530996601|FG000|Overall Study|Withdrawal of consent (not due to AE)|0|||
147225267|NCT02730208|530996602|FG001|Overall Study|Withdrawal of consent (not due to AE)|1|||
147225268|NCT00995865|530996603|FG000|Overall Study|Protocol Violation|2|||
147225269|NCT00995865|530996604|FG001|Overall Study|Protocol Violation|0|||
147225270|NCT00995865|530996605|FG002|Overall Study|Protocol Violation|0|||
147225271|NCT00995865|530996603|FG000|Overall Study|Lost to Follow-up|0|||
147225272|NCT00995865|530996604|FG001|Overall Study|Lost to Follow-up|0|||
147225273|NCT00995865|530996605|FG002|Overall Study|Lost to Follow-up|1|||
147225274|NCT00410202|530996607|FG000|On-Treatment|Continuing treatment|69|||
147225275|NCT00410202|530996608|FG001|On-Treatment|Continuing treatment|71|||
147225276|NCT00410202|530996609|FG002|On-Treatment|Continuing treatment|66|||
147225277|NCT00410202|530996607|FG000|On-Treatment|Adverse Event|1|||
147225278|NCT00410202|530996608|FG001|On-Treatment|Adverse Event|3|||
147225279|NCT00410202|530996609|FG002|On-Treatment|Adverse Event|2|||
147225280|NCT00410202|530996607|FG000|On-Treatment|Death|1|||
147225281|NCT00410202|530996608|FG001|On-Treatment|Death|0|||
147225282|NCT00410202|530996609|FG002|On-Treatment|Death|0|||
147225283|NCT00410202|530996607|FG000|On-Treatment|Lost to Follow-up|1|||
147225284|NCT00410202|530996608|FG001|On-Treatment|Lost to Follow-up|0|||
147225285|NCT00410202|530996609|FG002|On-Treatment|Lost to Follow-up|1|||
147225286|NCT00410202|530996607|FG000|On-Treatment|Lack of Efficacy|1|||
147225287|NCT00410202|530996608|FG001|On-Treatment|Lack of Efficacy|4|||
147225288|NCT00410202|530996609|FG002|On-Treatment|Lack of Efficacy|0|||
147225289|NCT00410202|530996607|FG000|On-Treatment|Withdrawal by Subject|2|||
147225290|NCT00410202|530996608|FG001|On-Treatment|Withdrawal by Subject|1|||
147225291|NCT00410202|530996609|FG002|On-Treatment|Withdrawal by Subject|1|||
147225292|NCT00410202|530996607|FG000|On-Treatment|Other Reason|0|||
147225293|NCT00410202|530996608|FG001|On-Treatment|Other Reason|0|||
147557711|NCT01505530|532198840|FG000|Overall Study|Sponsor Decision|1|||
147557712|NCT01505530|532198841|FG001|Overall Study|Sponsor Decision|8|||
147557713|NCT01505530|532198842|FG002|Overall Study|Sponsor Decision|7|||
147557714|NCT01505530|532198840|FG000|Overall Study|Death|7|||
147557715|NCT01505530|532198841|FG001|Overall Study|Death|6|||
147106353|NCT03573297|530553782|FG000|Double-Blind Treatment Period|Non-Compliance With Study Drug|0|||
147106354|NCT03573297|530553783|FG001|Double-Blind Treatment Period|Non-Compliance With Study Drug|0|||
147106355|NCT03573297|530553784|FG002|Double-Blind Treatment Period|Non-Compliance With Study Drug|4|||
147106356|NCT03573297|530553785|FG003|Double-Blind Treatment Period|Non-Compliance With Study Drug|4|||
147106357|NCT03573297|530553782|FG000|Double-Blind Treatment Period|Other, Not Specified|0|||
147106358|NCT03573297|530553783|FG001|Double-Blind Treatment Period|Other, Not Specified|5|||
147106359|NCT03573297|530553784|FG002|Double-Blind Treatment Period|Other, Not Specified|8|||
147106360|NCT03573297|530553785|FG003|Double-Blind Treatment Period|Other, Not Specified|6|||
147106361|NCT02273167|530553788|FG000|Overall Study|Adverse Event|1|||
147106362|NCT02273167|530553789|FG001|Overall Study|Adverse Event|0|||
147106363|NCT02273167|530553790|FG002|Overall Study|Adverse Event|0|||
147106364|NCT02273167|530553788|FG000|Overall Study|Protocol Violation|3|||
147106365|NCT02273167|530553789|FG001|Overall Study|Protocol Violation|1|||
147106366|NCT02273167|530553790|FG002|Overall Study|Protocol Violation|1|||
147106367|NCT02273167|530553788|FG000|Overall Study|Lost to Follow-up|0|||
147106368|NCT02273167|530553789|FG001|Overall Study|Lost to Follow-up|1|||
147106369|NCT02273167|530553790|FG002|Overall Study|Lost to Follow-up|1|||
147106370|NCT02273167|530553788|FG000|Overall Study|Withdrawal by Subject|10|||
147106371|NCT02273167|530553789|FG001|Overall Study|Withdrawal by Subject|12|||
147106372|NCT02273167|530553790|FG002|Overall Study|Withdrawal by Subject|11|||
147106373|NCT02273167|530553788|FG000|Overall Study|Various|10|||
147106374|NCT02273167|530553789|FG001|Overall Study|Various|9|||
147106375|NCT02273167|530553790|FG002|Overall Study|Various|8|||
147225294|NCT00410202|530996609|FG002|On-Treatment|Other Reason|1|||
147225295|NCT00410202|530996607|FG000|Off-treatment Follow up|Continuing off-treatment follow up|10|||
147225296|NCT00410202|530996608|FG001|Off-treatment Follow up|Continuing off-treatment follow up|8|||
147225297|NCT00410202|530996609|FG002|Off-treatment Follow up|Continuing off-treatment follow up|11|||
147225298|NCT00410202|530996607|FG000|Off-treatment Follow up|Follow up not required per protocol|3|||
147225299|NCT00410202|530996608|FG001|Off-treatment Follow up|Follow up not required per protocol|0|||
147225300|NCT00410202|530996609|FG002|Off-treatment Follow up|Follow up not required per protocol|1|||
147225301|NCT00410202|530996607|FG000|Off-treatment Follow up|Lost to Follow-up|1|||
147225302|NCT00410202|530996608|FG001|Off-treatment Follow up|Lost to Follow-up|0|||
147225303|NCT00410202|530996609|FG002|Off-treatment Follow up|Lost to Follow-up|0|||
147225304|NCT00144027|530996610|FG000|Overall Study|Lost to Follow-up|1|||
147225305|NCT00144027|530996611|FG001|Overall Study|Lost to Follow-up|3|||
147225306|NCT00144027|530996610|FG000|Overall Study|Withdrawal by Subject|2|||
147225307|NCT00144027|530996611|FG001|Overall Study|Withdrawal by Subject|2|||
147225308|NCT00144027|530996610|FG000|Overall Study|did not complete baseline assessment|0|||
147225309|NCT00144027|530996611|FG001|Overall Study|did not complete baseline assessment|6|||
147225310|NCT05080660|530996612|FG000|Overall Study|Adverse Event|4|||
147225311|NCT05080660|530996613|FG001|Overall Study|Adverse Event|0|||
147225312|NCT05080660|530996612|FG000|Overall Study|Non-compliance With Study Drug and Procedures|1|||
147225313|NCT05080660|530996613|FG001|Overall Study|Non-compliance With Study Drug and Procedures|0|||
147310637|NCT01282476|531305022|FG000|Overall Study|Death|11|||
147310638|NCT04424290|531305029|FG000|Overall Study|Not treated|0|||
147310639|NCT04424290|531305030|FG001|Overall Study|Not treated|0|||
147310640|NCT04424290|531305031|FG002|Overall Study|Not treated|1|||
147444135|NCT02090413|531790529|FG001|Overall Study|Flushing event|0|||
147444136|NCT02090413|531790530|FG002|Overall Study|Flushing event|1|||
147557716|NCT01505530|532198842|FG002|Overall Study|Death|5|||
147557717|NCT01505530|532198840|FG000|Overall Study|entry criteria not met|0|||
147557718|NCT01505530|532198841|FG001|Overall Study|entry criteria not met|1|||
147557719|NCT01505530|532198842|FG002|Overall Study|entry criteria not met|0|||
147557720|NCT02720510|532198848|FG000|Overall Study|Study Terminated by the sponsor|2|||
147557721|NCT02720510|532198849|FG001|Overall Study|Study Terminated by the sponsor|0|||
147557722|NCT02720510|532198848|FG000|Overall Study|Adverse Event|0|||
147225314|NCT05080660|530996612|FG000|Overall Study|Physician Decision|1|||
147225315|NCT05080660|530996613|FG001|Overall Study|Physician Decision|0|||
147225316|NCT05080660|530996612|FG000|Overall Study|Protocol Deviation|2|||
147225317|NCT05080660|530996613|FG001|Overall Study|Protocol Deviation|0|||
147225318|NCT05080660|530996612|FG000|Overall Study|Withdrawal by Subject|5|||
147225319|NCT05080660|530996613|FG001|Overall Study|Withdrawal by Subject|2|||
147225320|NCT04221230|530996618|FG000|Overall Study|Lost to Follow-up|12|||
147225321|NCT04221230|530996619|FG001|Overall Study|Lost to Follow-up|12|||
147225322|NCT04221230|530996618|FG000|Overall Study|Protocol Violation|2|||
147225323|NCT04221230|530996619|FG001|Overall Study|Protocol Violation|2|||
147225324|NCT04221230|530996618|FG000|Overall Study|Adverse Event|0|||
147225325|NCT04221230|530996619|FG001|Overall Study|Adverse Event|8|||
147557723|NCT02720510|532198849|FG001|Overall Study|Adverse Event|1|||
147557724|NCT02720510|532198848|FG000|Overall Study|Physician Decision|1|||
147225326|NCT04221230|530996618|FG000|Overall Study|Physician Decision|1|||
147310641|NCT04424290|531305032|FG003|Overall Study|Not treated|0|||
147310642|NCT04424290|531305033|FG004|Overall Study|Not treated|1|||
147557725|NCT02720510|532198849|FG001|Overall Study|Physician Decision|2|||
147557726|NCT01618266|532198858|FG000|Overall Study|Lost to Follow-up|9|||
147557727|NCT01618266|532198858|FG000|Overall Study|Treatment satisfaction|10|||
147557728|NCT01618266|532198858|FG000|Overall Study|Other reasons|11|||
147557729|NCT01618266|532198858|FG000|Overall Study|Lack of Efficacy|23|||
147557730|NCT01618266|532198858|FG000|Overall Study|Protocol Violation|43|||
147557731|NCT01966042|532198859|FG000|Overall Study|Death|2|||
147557732|NCT00625807|532198860|FG000|Overall Study|schedule conflict|2|||
147557733|NCT00625807|532198861|FG001|Overall Study|schedule conflict|8|||
147557734|NCT03267264|532198862|FG000|Overall Study|Withdrawal by Subject|1|||
147557735|NCT03267264|532198863|FG001|Overall Study|Withdrawal by Subject|0|||
147557736|NCT03267264|532198864|FG002|Overall Study|Withdrawal by Subject|2|||
147557737|NCT03267264|532198865|FG003|Overall Study|Withdrawal by Subject|4|||
147557738|NCT02224391|532198866|FG000|Overall Study|Lost to Follow-up|26|||
147557739|NCT02224391|532198867|FG001|Overall Study|Lost to Follow-up|19|||
147557740|NCT02224391|532198866|FG000|Overall Study|Withdrawal by Subject|6|||
147557741|NCT02224391|532198867|FG001|Overall Study|Withdrawal by Subject|5|||
147557742|NCT00084084|532198868|FG000|Phase 1 (Treatment With Replagal RB)|Lost to Follow-up|1|||
147557743|NCT00084084|532198868|FG000|Phase 2 (Transition to Replagal AF)|Failure to visit clinic as scheduled|1|||
147557744|NCT01802879|532198869|FG000|Overall Study|Administrative problems|2|||
147557745|NCT01802879|532198869|FG000|Overall Study|Disease progression|6|||
147557746|NCT00454636|532198870|FG000|Overall Study|Adverse Event|10|||
147557747|NCT00454636|532198871|FG001|Overall Study|Adverse Event|6|||
147557748|NCT00454636|532198872|FG002|Overall Study|Adverse Event|9|||
147557749|NCT00454636|532198873|FG003|Overall Study|Adverse Event|15|||
147557750|NCT00454636|532198870|FG000|Overall Study|Disease Progression|11|||
147557751|NCT00454636|532198871|FG001|Overall Study|Disease Progression|12|||
147557752|NCT00454636|532198872|FG002|Overall Study|Disease Progression|4|||
147557753|NCT00454636|532198873|FG003|Overall Study|Disease Progression|11|||
147557754|NCT00454636|532198870|FG000|Overall Study|Protocol Violation|3|||
147557755|NCT00454636|532198871|FG001|Overall Study|Protocol Violation|2|||
147557756|NCT00454636|532198872|FG002|Overall Study|Protocol Violation|3|||
147557757|NCT00454636|532198873|FG003|Overall Study|Protocol Violation|3|||
147557758|NCT00454636|532198870|FG000|Overall Study|Death|6|||
147557759|NCT00454636|532198871|FG001|Overall Study|Death|1|||
147557760|NCT00454636|532198872|FG002|Overall Study|Death|1|||
147557761|NCT00454636|532198873|FG003|Overall Study|Death|1|||
147557762|NCT00454636|532198870|FG000|Overall Study|Patient refusal|1|||
147557763|NCT00454636|532198871|FG001|Overall Study|Patient refusal|1|||
147557764|NCT00454636|532198872|FG002|Overall Study|Patient refusal|3|||
147557765|NCT00454636|532198873|FG003|Overall Study|Patient refusal|2|||
147557766|NCT00454636|532198870|FG000|Overall Study|Lost to Follow-up|0|||
147557767|NCT00454636|532198871|FG001|Overall Study|Lost to Follow-up|1|||
147557768|NCT00454636|532198872|FG002|Overall Study|Lost to Follow-up|0|||
147557769|NCT00454636|532198873|FG003|Overall Study|Lost to Follow-up|0|||
147557770|NCT01400113|532198874|FG000|Overall Study|Withdrawal by Subject|1|||
147557771|NCT01400113|532198875|FG001|Overall Study|Withdrawal by Subject|1|||
147557772|NCT00282256|532198876|FG000|Pharmacokinetic Treatment Period|Poor venous access|1|||
147557773|NCT00282256|532198876|FG000|Extension Treatment Period|Adverse Event|2|||
147557774|NCT01890915|532198881|FG000|Overall Study|Adverse Event|1|||
147557775|NCT01890915|532198882|FG001|Overall Study|Adverse Event|0|||
147557776|NCT01890915|532198881|FG000|Overall Study|Protocol Violation|2|||
147557777|NCT01890915|532198882|FG001|Overall Study|Protocol Violation|0|||
147557778|NCT01890915|532198881|FG000|Overall Study|Equipment Malfunction|0|||
147557779|NCT01890915|532198882|FG001|Overall Study|Equipment Malfunction|1|||
147557780|NCT02114697|532198883|FG000|Overall Study|Study terminated|5|||
147557781|NCT02114697|532198884|FG001|Overall Study|Study terminated|4|||
147557782|NCT01984242|532198885|FG000|Overall Study|Death|52|||
147225327|NCT04221230|530996619|FG001|Overall Study|Physician Decision|0|||
147225328|NCT04221230|530996618|FG000|Overall Study|Withdrawal by Subject|13|||
147225329|NCT04221230|530996619|FG001|Overall Study|Withdrawal by Subject|11|||
147225330|NCT04221230|530996618|FG000|Overall Study|Non-Compliance with Study Drug|1|||
147225331|NCT04221230|530996619|FG001|Overall Study|Non-Compliance with Study Drug|1|||
147225332|NCT04221230|530996618|FG000|Overall Study|Unsatisfactory Therapeutic Effect|0|||
147225333|NCT04221230|530996619|FG001|Overall Study|Unsatisfactory Therapeutic Effect|1|||
147225334|NCT04221230|530996618|FG000|Overall Study|Pregnancy|0|||
147225335|NCT04221230|530996619|FG001|Overall Study|Pregnancy|1|||
147225336|NCT04221230|530996618|FG000|Overall Study|Other|1|||
147225337|NCT04221230|530996619|FG001|Overall Study|Other|2|||
147225338|NCT00817479|530996623|FG000|Overall Study|Physician Decision|1|||
147310643|NCT04424290|531305029|FG000|Overall Study|Adverse Event|0|||
147557783|NCT01984242|532198886|FG001|Overall Study|Death|50|||
147557784|NCT01984242|532198887|FG002|Overall Study|Death|52|||
147557785|NCT01984242|532198885|FG000|Overall Study|Withdrawal by Subject|5|||
147557786|NCT01984242|532198886|FG001|Overall Study|Withdrawal by Subject|3|||
147557787|NCT01984242|532198887|FG002|Overall Study|Withdrawal by Subject|10|||
147557788|NCT01984242|532198885|FG000|Overall Study|Physician Decision|0|||
147310644|NCT04424290|531305030|FG001|Overall Study|Adverse Event|0|||
147557789|NCT01984242|532198886|FG001|Overall Study|Physician Decision|0|||
147557790|NCT01984242|532198887|FG002|Overall Study|Physician Decision|1|||
147557791|NCT01984242|532198885|FG000|Overall Study|Lost to Follow-up|4|||
147106376|NCT05493111|530555721|FG000|Overall Study|Adverse Event|3|||
147106377|NCT05493111|530555722|FG001|Overall Study|Adverse Event|4|||
147106378|NCT05493111|530555721|FG000|Overall Study|Withdrawal of Consent|19|||
147106379|NCT05493111|530555722|FG001|Overall Study|Withdrawal of Consent|10|||
147106380|NCT05493111|530555721|FG000|Overall Study|Non-compliance|1|||
147106381|NCT05493111|530555722|FG001|Overall Study|Non-compliance|1|||
147106382|NCT05493111|530555721|FG000|Overall Study|Lost to Follow-up|8|||
147106383|NCT05493111|530555722|FG001|Overall Study|Lost to Follow-up|1|||
147106384|NCT05493111|530555721|FG000|Overall Study|Disallowed Concurrent Treatment|1|||
147106385|NCT05493111|530555722|FG001|Overall Study|Disallowed Concurrent Treatment|0|||
147106386|NCT05493111|530555721|FG000|Overall Study|Withdrawal by Subject|1|||
147106387|NCT05493111|530555722|FG001|Overall Study|Withdrawal by Subject|1|||
147106388|NCT03836053|530555723|FG000|Overall Study|Protocol-specified criteria|0|||
147106389|NCT03836053|530555724|FG001|Overall Study|Protocol-specified criteria|2|||
147106390|NCT03836053|530555725|FG002|Overall Study|Protocol-specified criteria|1|||
147106391|NCT03836053|530555723|FG000|Overall Study|Death|1|||
147106392|NCT03836053|530555724|FG001|Overall Study|Death|6|||
147106393|NCT03836053|530555725|FG002|Overall Study|Death|4|||
147106394|NCT03836053|530555723|FG000|Overall Study|Withdrawal of consent from study|0|||
147106395|NCT03836053|530555724|FG001|Overall Study|Withdrawal of consent from study|0|||
147106396|NCT03836053|530555725|FG002|Overall Study|Withdrawal of consent from study|1|||
147106397|NCT03836053|530555723|FG000|Overall Study|Decision by sponsor|0|||
147106398|NCT03836053|530555724|FG001|Overall Study|Decision by sponsor|2|||
147106399|NCT03836053|530555725|FG002|Overall Study|Decision by sponsor|4|||
147106400|NCT00788671|530555726|FG000|Overall Study|Death|2|||
147106401|NCT00788671|530555726|FG000|Overall Study|Unable to biopsy|1|||
147106402|NCT00788671|530555726|FG000|Overall Study|Withdrawal by Subject|4|||
147106403|NCT00788671|530555726|FG000|Overall Study|IUD expulsed|1|||
147106404|NCT00788671|530555726|FG000|Overall Study|Lost to follow up|2|||
147106405|NCT04486716|530555727|FG000|Core Phase|Subject decision|6|||
147106406|NCT04486716|530555727|FG000|Core Phase|Adverse Event|5|||
147106407|NCT04486716|530555727|FG000|Core Phase|Lost to Follow-up|1|||
147106408|NCT04486716|530555727|FG000|Core Phase|Physician Decision|1|||
147106409|NCT04486716|530555727|FG000|Core Phase|Enrolled subjects not treated|9|||
147106410|NCT03846479|530555728|FG000|Overall Study|Death|8|||
147106411|NCT03846479|530555728|FG000|Overall Study|Lost to Follow-up|1|||
147106412|NCT02332707|530555729|FG000|Overall Study|Adverse Event|0|||
147106413|NCT02332707|530555730|FG001|Overall Study|Adverse Event|0|||
147106414|NCT02332707|530555731|FG002|Overall Study|Adverse Event|0|||
147106415|NCT02332707|530555732|FG003|Overall Study|Adverse Event|0|||
147106416|NCT02332707|530555733|FG004|Overall Study|Adverse Event|0|||
147106417|NCT02332707|530555734|FG005|Overall Study|Adverse Event|0|||
147106418|NCT02332707|530555735|FG006|Overall Study|Adverse Event|0|||
147106419|NCT02332707|530555736|FG007|Overall Study|Adverse Event|0|||
147106420|NCT02332707|530555737|FG008|Overall Study|Adverse Event|0|||
147106421|NCT02332707|530555738|FG009|Overall Study|Adverse Event|0|||
147106422|NCT02332707|530555739|FG010|Overall Study|Adverse Event|0|||
147106423|NCT02332707|530555740|FG011|Overall Study|Adverse Event|0|||
147106424|NCT02332707|530555741|FG012|Overall Study|Adverse Event|1|||
147106425|NCT02332707|530555742|FG013|Overall Study|Adverse Event|0|||
147106426|NCT02332707|530555743|FG014|Overall Study|Adverse Event|0|||
147106427|NCT02332707|530555744|FG015|Overall Study|Adverse Event|0|||
147106428|NCT02332707|530555745|FG016|Overall Study|Adverse Event|0|||
147106429|NCT02332707|530555746|FG017|Overall Study|Adverse Event|0|||
147106430|NCT02332707|530555729|FG000|Overall Study|Lost to Follow-up|0|||
147106431|NCT02332707|530555730|FG001|Overall Study|Lost to Follow-up|0|||
147106432|NCT02332707|530555731|FG002|Overall Study|Lost to Follow-up|0|||
147106433|NCT02332707|530555732|FG003|Overall Study|Lost to Follow-up|0|||
147106434|NCT02332707|530555733|FG004|Overall Study|Lost to Follow-up|0|||
147106435|NCT02332707|530555734|FG005|Overall Study|Lost to Follow-up|1|||
147106436|NCT02332707|530555735|FG006|Overall Study|Lost to Follow-up|0|||
147106437|NCT02332707|530555736|FG007|Overall Study|Lost to Follow-up|0|||
147106438|NCT02332707|530555737|FG008|Overall Study|Lost to Follow-up|0|||
147444137|NCT02090413|531790528|FG000|Overall Study|Withdrawal by Subject|2|||
147106439|NCT02332707|530555738|FG009|Overall Study|Lost to Follow-up|0|||
147106440|NCT02332707|530555739|FG010|Overall Study|Lost to Follow-up|2|||
147106441|NCT02332707|530555740|FG011|Overall Study|Lost to Follow-up|0|||
147106442|NCT02332707|530555741|FG012|Overall Study|Lost to Follow-up|3|||
147106443|NCT02332707|530555742|FG013|Overall Study|Lost to Follow-up|0|||
147106444|NCT02332707|530555743|FG014|Overall Study|Lost to Follow-up|0|||
147106445|NCT02332707|530555744|FG015|Overall Study|Lost to Follow-up|0|||
147106446|NCT02332707|530555745|FG016|Overall Study|Lost to Follow-up|0|||
147106447|NCT02332707|530555746|FG017|Overall Study|Lost to Follow-up|0|||
147106448|NCT02332707|530555729|FG000|Overall Study|Physician Decision|0|||
147106449|NCT02332707|530555730|FG001|Overall Study|Physician Decision|0|||
147106450|NCT02332707|530555731|FG002|Overall Study|Physician Decision|0|||
147106451|NCT02332707|530555732|FG003|Overall Study|Physician Decision|1|||
147106452|NCT02332707|530555733|FG004|Overall Study|Physician Decision|0|||
147106453|NCT02332707|530555734|FG005|Overall Study|Physician Decision|0|||
147106454|NCT02332707|530555735|FG006|Overall Study|Physician Decision|0|||
147557792|NCT01984242|532198886|FG001|Overall Study|Lost to Follow-up|0|||
147557793|NCT01984242|532198887|FG002|Overall Study|Lost to Follow-up|3|||
147557794|NCT01984242|532198885|FG000|Overall Study|Sponsor Decision|1|||
147557795|NCT01984242|532198886|FG001|Overall Study|Sponsor Decision|0|||
147557796|NCT01984242|532198887|FG002|Overall Study|Sponsor Decision|0|||
147557797|NCT01984242|532198885|FG000|Overall Study|Non-Compliance|1|||
147557798|NCT01984242|532198886|FG001|Overall Study|Non-Compliance|0|||
147557799|NCT01984242|532198887|FG002|Overall Study|Non-Compliance|0|||
147557800|NCT01984242|532198885|FG000|Overall Study|Study terminated by Sponsor|38|||
147557801|NCT01984242|532198886|FG001|Overall Study|Study terminated by Sponsor|50|||
147557802|NCT01984242|532198887|FG002|Overall Study|Study terminated by Sponsor|34|||
147557803|NCT01984242|532198885|FG000|Overall Study|Disease Progression|0|||
147557804|NCT01984242|532198886|FG001|Overall Study|Disease Progression|0|||
147557805|NCT01984242|532198887|FG002|Overall Study|Disease Progression|1|||
147557806|NCT02246478|532198890|FG000|Multiple-dose Phase|Protocol Violation|1|||
147557807|NCT02246478|532198891|FG001|Multiple-dose Phase|Protocol Violation|0|||
147557808|NCT02246478|532198892|FG002|Multiple-dose Phase|Protocol Violation|0|||
147557809|NCT02246478|532198893|FG003|Multiple-dose Phase|Protocol Violation|1|||
147557810|NCT01457053|532198902|FG000|Overall Study|Unable to undergo selected treatment|1|||
147557811|NCT01457053|532198903|FG001|Overall Study|Unable to undergo selected treatment|1|||
147557812|NCT00984295|532198904|FG000|Overall Study|Lost to Follow-up|31|||
147557813|NCT00984295|532198905|FG001|Overall Study|Lost to Follow-up|12|||
147557814|NCT00984295|532198906|FG002|Overall Study|Lost to Follow-up|13|||
147557815|NCT00984295|532198904|FG000|Overall Study|Protocol Violation|2|||
147557816|NCT00984295|532198905|FG001|Overall Study|Protocol Violation|1|||
147557817|NCT00984295|532198906|FG002|Overall Study|Protocol Violation|4|||
147557818|NCT00984295|532198904|FG000|Overall Study|Withdrawal by Subject|18|||
147557819|NCT00984295|532198905|FG001|Overall Study|Withdrawal by Subject|9|||
147557820|NCT00984295|532198906|FG002|Overall Study|Withdrawal by Subject|12|||
147557821|NCT00984295|532198904|FG000|Overall Study|CAE - discontinued test vaccine|0|||
147557822|NCT00984295|532198905|FG001|Overall Study|CAE - discontinued test vaccine|1|||
147557823|NCT00984295|532198906|FG002|Overall Study|CAE - discontinued test vaccine|3|||
147557824|NCT00984295|532198904|FG000|Overall Study|Missed one or more blood samplings|3|||
147557825|NCT00984295|532198905|FG001|Overall Study|Missed one or more blood samplings|7|||
147557826|NCT00984295|532198906|FG002|Overall Study|Missed one or more blood samplings|2|||
147557827|NCT00984295|532198904|FG000|Overall Study|Incomplete safety follow-up|11|||
147557828|NCT00984295|532198905|FG001|Overall Study|Incomplete safety follow-up|2|||
147557829|NCT00984295|532198906|FG002|Overall Study|Incomplete safety follow-up|3|||
147557830|NCT00979628|532198907|FG000|Overall Study|received regimen < 24 hours|7|||
147557831|NCT00979628|532198908|FG001|Overall Study|received regimen < 24 hours|6|||
147557832|NCT00979628|532198909|FG002|Overall Study|received regimen < 24 hours|5|||
147557833|NCT00979628|532198907|FG000|Overall Study|received steroids|1|||
147557834|NCT00979628|532198908|FG001|Overall Study|received steroids|1|||
147557835|NCT00979628|532198909|FG002|Overall Study|received steroids|0|||
147557836|NCT00979628|532198907|FG000|Overall Study|transferred to ICU|1|||
147557837|NCT00979628|532198908|FG001|Overall Study|transferred to ICU|2|||
147557838|NCT00979628|532198909|FG002|Overall Study|transferred to ICU|1|||
147557839|NCT00911859|532198910|FG000|Treatment Period|Adverse Event|3|||
147557840|NCT00911859|532198911|FG001|Treatment Period|Adverse Event|3|||
147557841|NCT00911859|532198912|FG002|Treatment Period|Adverse Event|7|||
147557842|NCT00911859|532198910|FG000|Treatment Period|Death|1|||
147557843|NCT00911859|532198911|FG001|Treatment Period|Death|3|||
147557844|NCT00911859|532198912|FG002|Treatment Period|Death|5|||
147557845|NCT00911859|532198910|FG000|Treatment Period|Lack of Efficacy|1|||
147557846|NCT00911859|532198911|FG001|Treatment Period|Lack of Efficacy|7|||
147557847|NCT00911859|532198912|FG002|Treatment Period|Lack of Efficacy|5|||
147557848|NCT00911859|532198910|FG000|Treatment Period|Physician Decision|3|||
147557849|NCT00911859|532198911|FG001|Treatment Period|Physician Decision|3|||
147557850|NCT00911859|532198912|FG002|Treatment Period|Physician Decision|3|||
147557851|NCT00911859|532198910|FG000|Treatment Period|Withdrawal by Subject|0|||
147557852|NCT00911859|532198911|FG001|Treatment Period|Withdrawal by Subject|4|||
147557853|NCT00911859|532198912|FG002|Treatment Period|Withdrawal by Subject|5|||
147557854|NCT00911859|532198910|FG000|Treatment Period|Did not receive study treatment|0|||
147557855|NCT00911859|532198911|FG001|Treatment Period|Did not receive study treatment|1|||
147557856|NCT00911859|532198912|FG002|Treatment Period|Did not receive study treatment|0|||
147557857|NCT00911859|532198910|FG000|Maintainance Period|Lack of Efficacy|0|||
147557858|NCT00911859|532198911|FG001|Maintainance Period|Lack of Efficacy|0|||
147106455|NCT02332707|530555736|FG007|Overall Study|Physician Decision|0|||
147557859|NCT00911859|532198912|FG002|Maintainance Period|Lack of Efficacy|9|||
147557860|NCT00911859|532198910|FG000|Maintainance Period|Physician Decision|0|||
147557861|NCT00911859|532198911|FG001|Maintainance Period|Physician Decision|0|||
147557862|NCT00911859|532198912|FG002|Maintainance Period|Physician Decision|9|||
147557863|NCT00911859|532198910|FG000|Maintainance Period|Withdrawal by Subject|0|||
147557864|NCT00911859|532198911|FG001|Maintainance Period|Withdrawal by Subject|0|||
147557865|NCT00911859|532198912|FG002|Maintainance Period|Withdrawal by Subject|3|||
147557866|NCT00911859|532198910|FG000|Follow-up Period|Death|5|||
147106456|NCT02332707|530555737|FG008|Overall Study|Physician Decision|0|||
147106457|NCT02332707|530555738|FG009|Overall Study|Physician Decision|0|||
147106458|NCT02332707|530555739|FG010|Overall Study|Physician Decision|0|||
147106459|NCT02332707|530555740|FG011|Overall Study|Physician Decision|0|||
147106460|NCT02332707|530555741|FG012|Overall Study|Physician Decision|1|||
147106461|NCT02332707|530555742|FG013|Overall Study|Physician Decision|0|||
147106462|NCT02332707|530555743|FG014|Overall Study|Physician Decision|0|||
147106463|NCT02332707|530555744|FG015|Overall Study|Physician Decision|0|||
147106464|NCT02332707|530555745|FG016|Overall Study|Physician Decision|0|||
147106465|NCT02332707|530555746|FG017|Overall Study|Physician Decision|0|||
147106466|NCT02332707|530555729|FG000|Overall Study|Withdrawal by Subject|0|||
147106467|NCT02332707|530555730|FG001|Overall Study|Withdrawal by Subject|0|||
147106468|NCT02332707|530555731|FG002|Overall Study|Withdrawal by Subject|1|||
147106469|NCT02332707|530555732|FG003|Overall Study|Withdrawal by Subject|0|||
147106470|NCT02332707|530555733|FG004|Overall Study|Withdrawal by Subject|0|||
147106471|NCT02332707|530555734|FG005|Overall Study|Withdrawal by Subject|0|||
147106472|NCT02332707|530555735|FG006|Overall Study|Withdrawal by Subject|0|||
147106473|NCT02332707|530555736|FG007|Overall Study|Withdrawal by Subject|0|||
147106474|NCT02332707|530555737|FG008|Overall Study|Withdrawal by Subject|0|||
147106475|NCT02332707|530555738|FG009|Overall Study|Withdrawal by Subject|3|||
147106476|NCT02332707|530555739|FG010|Overall Study|Withdrawal by Subject|0|||
147106477|NCT02332707|530555740|FG011|Overall Study|Withdrawal by Subject|0|||
147106478|NCT02332707|530555741|FG012|Overall Study|Withdrawal by Subject|0|||
147106479|NCT02332707|530555742|FG013|Overall Study|Withdrawal by Subject|0|||
147106480|NCT02332707|530555743|FG014|Overall Study|Withdrawal by Subject|0|||
147106481|NCT02332707|530555744|FG015|Overall Study|Withdrawal by Subject|0|||
147106482|NCT02332707|530555745|FG016|Overall Study|Withdrawal by Subject|0|||
147106483|NCT02332707|530555746|FG017|Overall Study|Withdrawal by Subject|0|||
147106484|NCT01473134|530555747|FG000|Overall Study|Lost to Follow-up|21|||
147106485|NCT01473134|530555748|FG001|Overall Study|Lost to Follow-up|13|||
147106486|NCT01473134|530555747|FG000|Overall Study|Protocol Violation|32|||
147106487|NCT01473134|530555748|FG001|Overall Study|Protocol Violation|19|||
147106488|NCT01473134|530555747|FG000|Overall Study|Withdrawal by Subject|1|||
147106489|NCT01473134|530555748|FG001|Overall Study|Withdrawal by Subject|2|||
147106490|NCT01473134|530555747|FG000|Overall Study|Death|0|||
147106491|NCT01473134|530555748|FG001|Overall Study|Death|1|||
147106492|NCT01473134|530555747|FG000|Overall Study|ELK1078R: bilateral subject randomized to investigational, 2nd knee was cemented.|1|||
147106493|NCT01473134|530555748|FG001|Overall Study|ELK1078R: bilateral subject randomized to investigational, 2nd knee was cemented.|0|||
147106494|NCT04761822|530555749|FG000|Overall Study|Adverse Event|3|||
147106495|NCT04761822|530555750|FG001|Overall Study|Adverse Event|1|||
147106496|NCT04761822|530555751|FG002|Overall Study|Adverse Event|1|||
147106497|NCT04761822|530555752|FG003|Overall Study|Adverse Event|3|||
147106498|NCT04761822|530555749|FG000|Overall Study|Lost to Follow-up|1|||
147106499|NCT04761822|530555750|FG001|Overall Study|Lost to Follow-up|0|||
147106500|NCT04761822|530555751|FG002|Overall Study|Lost to Follow-up|2|||
147106501|NCT04761822|530555752|FG003|Overall Study|Lost to Follow-up|3|||
147106502|NCT04761822|530555749|FG000|Overall Study|Physician Decision|0|||
147106503|NCT04761822|530555750|FG001|Overall Study|Physician Decision|1|||
147106504|NCT04761822|530555751|FG002|Overall Study|Physician Decision|0|||
147106505|NCT04761822|530555752|FG003|Overall Study|Physician Decision|0|||
147106506|NCT04761822|530555749|FG000|Overall Study|Withdrawal by Subject|3|||
147106507|NCT04761822|530555750|FG001|Overall Study|Withdrawal by Subject|8|||
147106508|NCT04761822|530555751|FG002|Overall Study|Withdrawal by Subject|1|||
147106509|NCT04761822|530555752|FG003|Overall Study|Withdrawal by Subject|11|||
147106510|NCT04761822|530555749|FG000|Overall Study|Previously rec'd COVID-19 vaccine|1|||
147106511|NCT04761822|530555750|FG001|Overall Study|Previously rec'd COVID-19 vaccine|0|||
147106512|NCT04761822|530555751|FG002|Overall Study|Previously rec'd COVID-19 vaccine|0|||
147106513|NCT04761822|530555752|FG003|Overall Study|Previously rec'd COVID-19 vaccine|0|||
147106514|NCT04761822|530555749|FG000|Overall Study|Participant requested unblinding|0|||
147106515|NCT04761822|530555750|FG001|Overall Study|Participant requested unblinding|0|||
147557867|NCT00911859|532198911|FG001|Follow-up Period|Death|8|||
147557868|NCT00911859|532198912|FG002|Follow-up Period|Death|10|||
147557869|NCT00911859|532198910|FG000|Follow-up Period|Lost to Follow-up|1|||
147310645|NCT04424290|531305031|FG002|Overall Study|Adverse Event|0|||
147310646|NCT04424290|531305032|FG003|Overall Study|Adverse Event|2|||
147557870|NCT00911859|532198911|FG001|Follow-up Period|Lost to Follow-up|1|||
147557871|NCT00911859|532198912|FG002|Follow-up Period|Lost to Follow-up|0|||
147557872|NCT00911859|532198910|FG000|Follow-up Period|Withdrawal by Subject|0|||
147106516|NCT04761822|530555751|FG002|Overall Study|Participant requested unblinding|0|||
147557873|NCT00911859|532198911|FG001|Follow-up Period|Withdrawal by Subject|4|||
147106517|NCT04761822|530555752|FG003|Overall Study|Participant requested unblinding|1|||
147106518|NCT00362232|530555753|FG000|Treatment (12 +/- 2 Days)|Adverse Event|62|||
147106519|NCT00362232|530555754|FG001|Treatment (12 +/- 2 Days)|Adverse Event|56|||
147106520|NCT00362232|530555753|FG000|Treatment (12 +/- 2 Days)|Death|1|||
147106521|NCT00362232|530555754|FG001|Treatment (12 +/- 2 Days)|Death|3|||
147557874|NCT00911859|532198912|FG002|Follow-up Period|Withdrawal by Subject|4|||
147106522|NCT00362232|530555753|FG000|Treatment (12 +/- 2 Days)|Lost to Follow-up|3|||
147106523|NCT00362232|530555754|FG001|Treatment (12 +/- 2 Days)|Lost to Follow-up|1|||
147106524|NCT00362232|530555753|FG000|Treatment (12 +/- 2 Days)|Physician Decision|2|||
147106525|NCT00362232|530555754|FG001|Treatment (12 +/- 2 Days)|Physician Decision|5|||
147106526|NCT00362232|530555753|FG000|Treatment (12 +/- 2 Days)|Protocol Violation|22|||
147106527|NCT00362232|530555754|FG001|Treatment (12 +/- 2 Days)|Protocol Violation|21|||
147106528|NCT00362232|530555753|FG000|Treatment (12 +/- 2 Days)|Withdrawal by Subject|49|||
147106529|NCT00362232|530555754|FG001|Treatment (12 +/- 2 Days)|Withdrawal by Subject|47|||
147106530|NCT00362232|530555753|FG000|Treatment (12 +/- 2 Days)|Noncompliance to Study Drug|9|||
147106531|NCT00362232|530555754|FG001|Treatment (12 +/- 2 Days)|Noncompliance to Study Drug|0|||
147106532|NCT00362232|530555753|FG000|Treatment (12 +/- 2 Days)|Technical Problems|1|||
147106533|NCT00362232|530555754|FG001|Treatment (12 +/- 2 Days)|Technical Problems|0|||
147106534|NCT00362232|530555753|FG000|Treatment (12 +/- 2 Days)|Clinical Endpoint Reached|10|||
147106535|NCT00362232|530555754|FG001|Treatment (12 +/- 2 Days)|Clinical Endpoint Reached|18|||
147106536|NCT00362232|530555753|FG000|Follow-up (30 (+ 5) Days)|Adverse Event|2|||
147106537|NCT00362232|530555754|FG001|Follow-up (30 (+ 5) Days)|Adverse Event|3|||
147106538|NCT00362232|530555753|FG000|Follow-up (30 (+ 5) Days)|Death|1|||
147106539|NCT00362232|530555754|FG001|Follow-up (30 (+ 5) Days)|Death|1|||
147106540|NCT00362232|530555753|FG000|Follow-up (30 (+ 5) Days)|Lost to Follow-up|27|||
147106541|NCT00362232|530555754|FG001|Follow-up (30 (+ 5) Days)|Lost to Follow-up|28|||
147106542|NCT00362232|530555753|FG000|Follow-up (30 (+ 5) Days)|Withdrawal by Subject|8|||
147106543|NCT00362232|530555754|FG001|Follow-up (30 (+ 5) Days)|Withdrawal by Subject|7|||
147106544|NCT05020015|530555761|FG000|Overall Study|Ongoing on study|1|||
147106545|NCT05020015|530555762|FG001|Overall Study|Ongoing on study|3|||
147106546|NCT05020015|530555763|FG002|Overall Study|Ongoing on study|4|||
147106547|NCT05020015|530555764|FG003|Overall Study|Ongoing on study|7|||
147557875|NCT00911859|532198910|FG000|Follow-up Period|Study terminated by sponsor|5|||
147557876|NCT00911859|532198911|FG001|Follow-up Period|Study terminated by sponsor|33|||
147557877|NCT00911859|532198912|FG002|Follow-up Period|Study terminated by sponsor|27|||
147557878|NCT02785913|532201245|FG000|Overall Study|Adverse Event|5|||
147557879|NCT02785913|532201245|FG000|Overall Study|Death|2|||
147557880|NCT02785913|532201245|FG000|Overall Study|Progression|18|||
147557881|NCT02785913|532201245|FG000|Overall Study|Not protocol specified|1|||
147557882|NCT02841709|532201246|FG000|5th Intervention|Adverse Event|2|||
147557883|NCT02841709|532201247|FG001|5th Intervention|Adverse Event|0|||
147557884|NCT02841709|532201248|FG002|5th Intervention|Adverse Event|0|||
147557885|NCT02841709|532201249|FG003|5th Intervention|Adverse Event|0|||
147557886|NCT02841709|532201250|FG004|5th Intervention|Adverse Event|2|||
147557887|NCT01929109|532201251|FG000|Period 1 (All Groups)|Deviation from protocol|0|||
147557888|NCT01929109|532201252|FG001|Period 1 (All Groups)|Deviation from protocol|0|||
147557889|NCT01929109|532201253|FG002|Period 1 (All Groups)|Deviation from protocol|1|||
147557890|NCT01929109|532201254|FG003|Period 1 (All Groups)|Deviation from protocol|0|||
147557891|NCT01929109|532201255|FG004|Period 1 (All Groups)|Deviation from protocol|0|||
147557892|NCT01402908|532201256|FG000|Overall Study|Withdrawal by Subject|30|||
147557893|NCT01402908|532201257|FG001|Overall Study|Withdrawal by Subject|17|||
147557894|NCT01402908|532201256|FG000|Overall Study|Lost to Follow-up|3|||
147557895|NCT01402908|532201257|FG001|Overall Study|Lost to Follow-up|1|||
147557896|NCT01402908|532201256|FG000|Overall Study|Physician Decision|1|||
147557897|NCT01402908|532201257|FG001|Overall Study|Physician Decision|0|||
147557898|NCT02581345|532201258|FG000|Part 1: up to Week 16|Adverse Event|3|||
147557899|NCT02581345|532201259|FG001|Part 1: up to Week 16|Adverse Event|8|||
147557900|NCT02581345|532201260|FG002|Part 1: up to Week 16|Adverse Event|0|||
147557901|NCT02581345|532201261|FG003|Part 1: up to Week 16|Adverse Event|0|||
147557902|NCT02581345|532201258|FG000|Part 1: up to Week 16|Physician Decision|2|||
147557903|NCT02581345|532201259|FG001|Part 1: up to Week 16|Physician Decision|4|||
147106548|NCT05020015|530555761|FG000|Overall Study|Death|2|||
147106549|NCT05020015|530555762|FG001|Overall Study|Death|3|||
147106550|NCT05020015|530555763|FG002|Overall Study|Death|4|||
147106551|NCT05020015|530555764|FG003|Overall Study|Death|0|||
147106552|NCT05020015|530555761|FG000|Overall Study|Withdrawal by Subject|0|||
147225339|NCT00817479|530996624|FG001|Overall Study|Physician Decision|1|||
147225340|NCT02359851|530996630|FG000|Overall Study|Death|1|||
147225341|NCT02359851|530996630|FG000|Overall Study|Disease progression|1|||
147557904|NCT02581345|532201260|FG002|Part 1: up to Week 16|Physician Decision|0|||
147557905|NCT02581345|532201261|FG003|Part 1: up to Week 16|Physician Decision|0|||
147557906|NCT02581345|532201258|FG000|Part 1: up to Week 16|Withdrawal by Subject|4|||
147557907|NCT02581345|532201259|FG001|Part 1: up to Week 16|Withdrawal by Subject|7|||
147557908|NCT02581345|532201260|FG002|Part 1: up to Week 16|Withdrawal by Subject|0|||
147557909|NCT02581345|532201261|FG003|Part 1: up to Week 16|Withdrawal by Subject|0|||
147557910|NCT02581345|532201258|FG000|Part 1: up to Week 16|Lost to Follow-up|2|||
147106553|NCT05020015|530555762|FG001|Overall Study|Withdrawal by Subject|0|||
147106554|NCT05020015|530555763|FG002|Overall Study|Withdrawal by Subject|1|||
147106555|NCT05020015|530555764|FG003|Overall Study|Withdrawal by Subject|0|||
147225342|NCT00055471|530996631|FG000|Period 1: Dose Escalation Period|Adverse Event|0|||
147310647|NCT04424290|531305033|FG004|Overall Study|Adverse Event|0|||
147557911|NCT02581345|532201259|FG001|Part 1: up to Week 16|Lost to Follow-up|0|||
147106556|NCT05020015|530555761|FG000|Overall Study|Reason Not Specified|0|||
147106557|NCT05020015|530555762|FG001|Overall Study|Reason Not Specified|0|||
147106558|NCT05020015|530555763|FG002|Overall Study|Reason Not Specified|2|||
147106559|NCT05020015|530555764|FG003|Overall Study|Reason Not Specified|0|||
147106560|NCT02233413|530555765|FG000|Overall Study|Lost to Follow-up|7|||
147106561|NCT02233413|530555766|FG001|Overall Study|Lost to Follow-up|9|||
147106562|NCT02233413|530555765|FG000|Overall Study|Withdrawal by Subject|4|||
147106563|NCT02233413|530555766|FG001|Overall Study|Withdrawal by Subject|5|||
147106564|NCT00090103|530555767|FG000|Four-Year Double-Blind Treatment Period|Adverse Event|211|||
147106565|NCT00090103|530555768|FG001|Four-Year Double-Blind Treatment Period|Adverse Event|185|||
147106566|NCT00090103|530555769|FG002|Four-Year Double-Blind Treatment Period|Adverse Event|210|||
147106567|NCT00090103|530555767|FG000|Four-Year Double-Blind Treatment Period|Withdrawal by Subject|114|||
147106568|NCT00090103|530555768|FG001|Four-Year Double-Blind Treatment Period|Withdrawal by Subject|160|||
147310648|NCT04424290|531305029|FG000|Overall Study|Withdrawal by Subject|0|||
147557912|NCT02581345|532201260|FG002|Part 1: up to Week 16|Lost to Follow-up|0|||
147557913|NCT02581345|532201261|FG003|Part 1: up to Week 16|Lost to Follow-up|0|||
147557914|NCT02581345|532201258|FG000|Part 1: up to Week 16|Unspecified Reason|3|||
147557915|NCT02581345|532201259|FG001|Part 1: up to Week 16|Unspecified Reason|3|||
147557916|NCT02581345|532201260|FG002|Part 1: up to Week 16|Unspecified Reason|0|||
147557917|NCT02581345|532201261|FG003|Part 1: up to Week 16|Unspecified Reason|0|||
147557918|NCT02581345|532201258|FG000|Part 1: up to Week 16|Did Not Receive Treatment|1|||
147557919|NCT02581345|532201259|FG001|Part 1: up to Week 16|Did Not Receive Treatment|1|||
147557920|NCT02581345|532201260|FG002|Part 1: up to Week 16|Did Not Receive Treatment|0|||
147557921|NCT02581345|532201261|FG003|Part 1: up to Week 16|Did Not Receive Treatment|0|||
147557922|NCT02581345|532201258|FG000|Part 2: Week 17 to Week 47|Adverse Event|5|||
147557923|NCT02581345|532201259|FG001|Part 2: Week 17 to Week 47|Adverse Event|0|||
147557924|NCT02581345|532201260|FG002|Part 2: Week 17 to Week 47|Adverse Event|2|||
147557925|NCT02581345|532201261|FG003|Part 2: Week 17 to Week 47|Adverse Event|2|||
147557926|NCT02581345|532201258|FG000|Part 2: Week 17 to Week 47|Physician Decision|3|||
147557927|NCT02581345|532201259|FG001|Part 2: Week 17 to Week 47|Physician Decision|0|||
147557928|NCT02581345|532201260|FG002|Part 2: Week 17 to Week 47|Physician Decision|2|||
147557929|NCT02581345|532201261|FG003|Part 2: Week 17 to Week 47|Physician Decision|1|||
147557930|NCT02581345|532201258|FG000|Part 2: Week 17 to Week 47|Withdrawal by Subject|9|||
147557931|NCT02581345|532201259|FG001|Part 2: Week 17 to Week 47|Withdrawal by Subject|0|||
147557932|NCT02581345|532201260|FG002|Part 2: Week 17 to Week 47|Withdrawal by Subject|7|||
147557933|NCT02581345|532201261|FG003|Part 2: Week 17 to Week 47|Withdrawal by Subject|5|||
147557934|NCT02581345|532201258|FG000|Part 2: Week 17 to Week 47|Failure to Achieve at Least a PASI 50|8|||
147557935|NCT02581345|532201259|FG001|Part 2: Week 17 to Week 47|Failure to Achieve at Least a PASI 50|0|||
147557936|NCT02581345|532201260|FG002|Part 2: Week 17 to Week 47|Failure to Achieve at Least a PASI 50|3|||
147557937|NCT02581345|532201261|FG003|Part 2: Week 17 to Week 47|Failure to Achieve at Least a PASI 50|2|||
147557938|NCT02581345|532201258|FG000|Part 2: Week 17 to Week 47|Lost to Follow-up|2|||
147557939|NCT02581345|532201259|FG001|Part 2: Week 17 to Week 47|Lost to Follow-up|0|||
147557940|NCT02581345|532201260|FG002|Part 2: Week 17 to Week 47|Lost to Follow-up|0|||
147557941|NCT02581345|532201261|FG003|Part 2: Week 17 to Week 47|Lost to Follow-up|1|||
147557942|NCT02581345|532201258|FG000|Part 2: Week 17 to Week 47|Unspecified Reason|2|||
147557943|NCT02581345|532201259|FG001|Part 2: Week 17 to Week 47|Unspecified Reason|0|||
147557944|NCT02581345|532201260|FG002|Part 2: Week 17 to Week 47|Unspecified Reason|1|||
147557945|NCT02581345|532201261|FG003|Part 2: Week 17 to Week 47|Unspecified Reason|1|||
147557946|NCT03471078|532201268|FG000|Overall Study|Withdrawal by Subject|9|||
147557947|NCT03471078|532201269|FG001|Overall Study|Withdrawal by Subject|1|||
147557948|NCT03471078|532201268|FG000|Overall Study|Adverse Event|4|||
147557949|NCT03471078|532201269|FG001|Overall Study|Adverse Event|1|||
147557950|NCT03471078|532201268|FG000|Overall Study|Physician Decision|3|||
147557951|NCT03471078|532201269|FG001|Overall Study|Physician Decision|2|||
147557952|NCT03471078|532201268|FG000|Overall Study|Death|2|||
147557953|NCT03471078|532201269|FG001|Overall Study|Death|0|||
147557954|NCT03471078|532201268|FG000|Overall Study|Other|3|||
147557955|NCT03471078|532201269|FG001|Overall Study|Other|2|||
147557956|NCT00862979|532201275|FG000|Overall Study|Adverse Event|6|||
147557957|NCT00862979|532201276|FG001|Overall Study|Adverse Event|3|||
147557958|NCT00862979|532201275|FG000|Overall Study|Protocol Violation|0|||
147557959|NCT00862979|532201276|FG001|Overall Study|Protocol Violation|1|||
147557960|NCT00862979|532201275|FG000|Overall Study|Patient withdrew consent|2|||
147557961|NCT00862979|532201276|FG001|Overall Study|Patient withdrew consent|1|||
147106569|NCT00090103|530555769|FG002|Four-Year Double-Blind Treatment Period|Withdrawal by Subject|148|||
147557962|NCT00862979|532201275|FG000|Overall Study|Administrative problems|0|||
147557963|NCT00862979|532201276|FG001|Overall Study|Administrative problems|1|||
147557964|NCT00862979|532201275|FG000|Overall Study|Death|0|||
147557965|NCT00862979|532201276|FG001|Overall Study|Death|1|||
147557966|NCT01027143|532201279|FG000|Overall Study|Lost to Follow-up|9|||
147557967|NCT01027143|532201280|FG001|Overall Study|Lost to Follow-up|4|||
147557968|NCT00797108|532201289|FG000|Overall Study|Adverse Event|1|||
147557969|NCT00797108|532201290|FG001|Overall Study|Adverse Event|0|||
147557970|NCT00797108|532201291|FG002|Overall Study|Adverse Event|3|||
147106570|NCT00090103|530555767|FG000|Four-Year Double-Blind Treatment Period|Lost to Follow-up|53|||
147106571|NCT00090103|530555768|FG001|Four-Year Double-Blind Treatment Period|Lost to Follow-up|48|||
147106572|NCT00090103|530555769|FG002|Four-Year Double-Blind Treatment Period|Lost to Follow-up|58|||
147106573|NCT00090103|530555767|FG000|Four-Year Double-Blind Treatment Period|Protocol Violation|29|||
147106574|NCT00090103|530555768|FG001|Four-Year Double-Blind Treatment Period|Protocol Violation|29|||
147106575|NCT00090103|530555769|FG002|Four-Year Double-Blind Treatment Period|Protocol Violation|34|||
147106576|NCT00090103|530555767|FG000|Four-Year Double-Blind Treatment Period|Lack of Efficacy|53|||
147106577|NCT00090103|530555768|FG001|Four-Year Double-Blind Treatment Period|Lack of Efficacy|71|||
147106578|NCT00090103|530555769|FG002|Four-Year Double-Blind Treatment Period|Lack of Efficacy|104|||
147106579|NCT00090103|530555767|FG000|Four-Year Double-Blind Treatment Period|Participant Relocated|7|||
147106580|NCT00090103|530555768|FG001|Four-Year Double-Blind Treatment Period|Participant Relocated|2|||
147106581|NCT00090103|530555769|FG002|Four-Year Double-Blind Treatment Period|Participant Relocated|8|||
147106582|NCT00090103|530555767|FG000|Four-Year Double-Blind Treatment Period|Site Closed/Sponsor Termination|7|||
147106583|NCT00090103|530555768|FG001|Four-Year Double-Blind Treatment Period|Site Closed/Sponsor Termination|7|||
147106584|NCT00090103|530555769|FG002|Four-Year Double-Blind Treatment Period|Site Closed/Sponsor Termination|4|||
147106585|NCT00090103|530555767|FG000|Four-Year Double-Blind Treatment Period|Non-compliant/Medication Interruption|6|||
147106586|NCT00090103|530555768|FG001|Four-Year Double-Blind Treatment Period|Non-compliant/Medication Interruption|4|||
147106587|NCT00090103|530555769|FG002|Four-Year Double-Blind Treatment Period|Non-compliant/Medication Interruption|7|||
147106588|NCT00090103|530555767|FG000|Four-Year Double-Blind Treatment Period|Prostate Surgery/TURP/Alt. Therapy|3|||
147106589|NCT00090103|530555768|FG001|Four-Year Double-Blind Treatment Period|Prostate Surgery/TURP/Alt. Therapy|7|||
147106590|NCT00090103|530555769|FG002|Four-Year Double-Blind Treatment Period|Prostate Surgery/TURP/Alt. Therapy|19|||
147106591|NCT00090103|530555767|FG000|Four-Year Double-Blind Treatment Period|Participant Decision/Withdrawn|2|||
147106592|NCT00090103|530555768|FG001|Four-Year Double-Blind Treatment Period|Participant Decision/Withdrawn|0|||
147106593|NCT00090103|530555769|FG002|Four-Year Double-Blind Treatment Period|Participant Decision/Withdrawn|4|||
147106594|NCT00090103|530555767|FG000|Four-Year Double-Blind Treatment Period|Acute Urinary Retention (AUR)|2|||
147106595|NCT00090103|530555768|FG001|Four-Year Double-Blind Treatment Period|Acute Urinary Retention (AUR)|3|||
147106596|NCT00090103|530555769|FG002|Four-Year Double-Blind Treatment Period|Acute Urinary Retention (AUR)|6|||
147106597|NCT00090103|530555767|FG000|Four-Year Double-Blind Treatment Period|Prohibited Medication|2|||
147106598|NCT00090103|530555768|FG001|Four-Year Double-Blind Treatment Period|Prohibited Medication|2|||
147106599|NCT00090103|530555769|FG002|Four-Year Double-Blind Treatment Period|Prohibited Medication|8|||
147106600|NCT00090103|530555767|FG000|Four-Year Double-Blind Treatment Period|Investigator Departure|2|||
147106601|NCT00090103|530555768|FG001|Four-Year Double-Blind Treatment Period|Investigator Departure|0|||
147106602|NCT00090103|530555769|FG002|Four-Year Double-Blind Treatment Period|Investigator Departure|0|||
147106603|NCT00090103|530555767|FG000|Four-Year Double-Blind Treatment Period|Alcohol Dependent|1|||
147106604|NCT00090103|530555768|FG001|Four-Year Double-Blind Treatment Period|Alcohol Dependent|0|||
147106605|NCT00090103|530555769|FG002|Four-Year Double-Blind Treatment Period|Alcohol Dependent|0|||
147106606|NCT00090103|530555767|FG000|Four-Year Double-Blind Treatment Period|Screen Failure|1|||
147106607|NCT00090103|530555768|FG001|Four-Year Double-Blind Treatment Period|Screen Failure|0|||
147106608|NCT00090103|530555769|FG002|Four-Year Double-Blind Treatment Period|Screen Failure|0|||
147106609|NCT00090103|530555767|FG000|Four-Year Double-Blind Treatment Period|No Improvement|1|||
147106610|NCT00090103|530555768|FG001|Four-Year Double-Blind Treatment Period|No Improvement|0|||
147310649|NCT04424290|531305030|FG001|Overall Study|Withdrawal by Subject|0|||
147310650|NCT04424290|531305031|FG002|Overall Study|Withdrawal by Subject|0|||
147310651|NCT04424290|531305032|FG003|Overall Study|Withdrawal by Subject|0|||
147310652|NCT04424290|531305033|FG004|Overall Study|Withdrawal by Subject|1|||
147310653|NCT04424290|531305029|FG000|Overall Study|Other than listed|0|||
147310654|NCT04424290|531305030|FG001|Overall Study|Other than listed|0|||
147310655|NCT04424290|531305031|FG002|Overall Study|Other than listed|0|||
147310656|NCT04424290|531305032|FG003|Overall Study|Other than listed|1|||
147310657|NCT04424290|531305033|FG004|Overall Study|Other than listed|0|||
147310658|NCT02936037|531305034|FG000|Double-Blind Treatment Period|Protocol Violation|1|||
147310659|NCT02936037|531305035|FG001|Double-Blind Treatment Period|Protocol Violation|4|||
147310660|NCT02936037|531305034|FG000|Double-Blind Treatment Period|Suicidal risk, etc.|2|||
147310661|NCT02936037|531305035|FG001|Double-Blind Treatment Period|Suicidal risk, etc.|8|||
147310662|NCT02936037|531305034|FG000|Double-Blind Treatment Period|Lack of Efficacy|4|||
147557971|NCT00797108|532201289|FG000|Overall Study|Did Not Meet Entrance Criteria|0|||
147557972|NCT00797108|532201290|FG001|Overall Study|Did Not Meet Entrance Criteria|1|||
147557973|NCT00797108|532201291|FG002|Overall Study|Did Not Meet Entrance Criteria|0|||
147557974|NCT00797108|532201289|FG000|Overall Study|Global Deterioration of Health Status|0|||
147557975|NCT00797108|532201290|FG001|Overall Study|Global Deterioration of Health Status|1|||
147557976|NCT00797108|532201291|FG002|Overall Study|Global Deterioration of Health Status|0|||
147557977|NCT00797108|532201289|FG000|Overall Study|Lack of Efficacy|1|||
147557978|NCT00797108|532201290|FG001|Overall Study|Lack of Efficacy|0|||
147557979|NCT00797108|532201291|FG002|Overall Study|Lack of Efficacy|1|||
147557980|NCT00797108|532201289|FG000|Overall Study|Other|0|||
147557981|NCT00797108|532201290|FG001|Overall Study|Other|0|||
147557982|NCT00797108|532201291|FG002|Overall Study|Other|2|||
147557983|NCT00797108|532201289|FG000|Overall Study|Randomized but not Treated|2|||
147557984|NCT00797108|532201290|FG001|Overall Study|Randomized but not Treated|0|||
147557985|NCT00797108|532201291|FG002|Overall Study|Randomized but not Treated|0|||
147557986|NCT02518113|532201292|FG000|Overall Study|Adverse Event|1|||
147557987|NCT02518113|532201293|FG001|Overall Study|Adverse Event|0|||
147557988|NCT02518113|532201294|FG002|Overall Study|Adverse Event|1|||
147557989|NCT02518113|532201295|FG003|Overall Study|Adverse Event|0|||
147557990|NCT02518113|532201292|FG000|Overall Study|Death|1|||
147557991|NCT02518113|532201293|FG001|Overall Study|Death|2|||
147557992|NCT02518113|532201294|FG002|Overall Study|Death|0|||
147557993|NCT02518113|532201295|FG003|Overall Study|Death|0|||
147557994|NCT02518113|532201292|FG000|Overall Study|Physician Decision|0|||
147557995|NCT02518113|532201293|FG001|Overall Study|Physician Decision|1|||
147557996|NCT02518113|532201294|FG002|Overall Study|Physician Decision|0|||
147557997|NCT02518113|532201295|FG003|Overall Study|Physician Decision|0|||
147557998|NCT02518113|532201292|FG000|Overall Study|Progressive Disease|1|||
147557999|NCT02518113|532201293|FG001|Overall Study|Progressive Disease|2|||
147558000|NCT02518113|532201294|FG002|Overall Study|Progressive Disease|3|||
147558001|NCT02518113|532201295|FG003|Overall Study|Progressive Disease|0|||
147558002|NCT00287118|532201296|FG000|Overall Study|Adverse Event|30|||
147558003|NCT00287118|532201296|FG000|Overall Study|Death|1|||
147558004|NCT00287118|532201296|FG000|Overall Study|Lack of Efficacy|11|||
147558005|NCT00287118|532201296|FG000|Overall Study|Lost to Follow-up|1|||
147558006|NCT00287118|532201296|FG000|Overall Study|Protocol Violation|2|||
147558007|NCT00287118|532201296|FG000|Overall Study|Other|7|||
147558008|NCT01631864|532201297|FG000|Overall Study|Withdrawal by Subject|0|||
147558009|NCT01631864|532201298|FG001|Overall Study|Withdrawal by Subject|1|||
147558010|NCT01631864|532201297|FG000|Overall Study|Adverse Event|2|||
147558011|NCT01631864|532201298|FG001|Overall Study|Adverse Event|3|||
147558012|NCT04471207|532201303|FG000|Overall Study|Lost to Follow-up|4|||
147558013|NCT04471207|532201304|FG001|Overall Study|Lost to Follow-up|1|||
147558014|NCT04471207|532201303|FG000|Overall Study|Medication Contraindication|0|||
147558015|NCT04471207|532201304|FG001|Overall Study|Medication Contraindication|1|||
147558016|NCT04471207|532201303|FG000|Overall Study|Loss of Interest|2|||
147558017|NCT04471207|532201304|FG001|Overall Study|Loss of Interest|1|||
147558018|NCT04471207|532201303|FG000|Overall Study|Unwilling to Discuss Trauma|1|||
147558019|NCT04471207|532201304|FG001|Overall Study|Unwilling to Discuss Trauma|1|||
147558020|NCT04471207|532201303|FG000|Overall Study|Scheduling Conflicts|3|||
147558021|NCT04471207|532201304|FG001|Overall Study|Scheduling Conflicts|1|||
147558022|NCT04471207|532201303|FG000|Overall Study|Physician Decision|1|||
147558023|NCT04471207|532201304|FG001|Overall Study|Physician Decision|0|||
147558024|NCT04471207|532201303|FG000|Overall Study|Unwilling to Use System|0|||
147558025|NCT04471207|532201304|FG001|Overall Study|Unwilling to Use System|1|||
147558026|NCT00561730|532201307|FG000|Overall Study|Adverse Event|2|||
147558027|NCT00561730|532201307|FG000|Overall Study|Handling of the drug|1|||
147558028|NCT00561730|532201307|FG000|Overall Study|Lost to Follow-up|5|||
147558029|NCT00561730|532201307|FG000|Overall Study|Not specified reasons|1|||
147558030|NCT04373434|532201324|FG000|Overall Study|Lost to Follow-up|37|||
147558031|NCT04373434|532201325|FG001|Overall Study|Lost to Follow-up|32|||
147558032|NCT04373434|532201324|FG000|Overall Study|Refused at 9 months|1|||
147558033|NCT04373434|532201325|FG001|Overall Study|Refused at 9 months|2|||
147558034|NCT04373434|532201324|FG000|Overall Study|Refused at 4 months|7|||
147558035|NCT04373434|532201325|FG001|Overall Study|Refused at 4 months|3|||
147558036|NCT04373434|532201324|FG000|Overall Study|Excluded|2|||
147558037|NCT04373434|532201325|FG001|Overall Study|Excluded|0|||
147558038|NCT00527423|532201326|FG000|Overall Study|Protocol Violation|1|||
147558039|NCT00527423|532201326|FG000|Overall Study|Adverse Event|5|||
147558040|NCT00527423|532201326|FG000|Overall Study|Physician Decision|4|||
147558041|NCT00527423|532201326|FG000|Overall Study|Withdrawal by Subject|10|||
147558042|NCT00527423|532201326|FG000|Overall Study|Lost to Follow-up|4|||
147558043|NCT00527423|532201326|FG000|Overall Study|OTHER|4|||
147558044|NCT00527423|532201326|FG000|Overall Study|Death|9|||
147558045|NCT03194464|532201330|FG000|Overall Study|data not usable|2|||
147558046|NCT02153398|532201331|FG000|Overall Study|Withdrawal by Subject|1|||
147310663|NCT02936037|531305035|FG001|Double-Blind Treatment Period|Lack of Efficacy|12|||
147310664|NCT02936037|531305034|FG000|Double-Blind Treatment Period|Death|0|||
147310665|NCT02936037|531305035|FG001|Double-Blind Treatment Period|Death|1|||
147558047|NCT02153398|532201332|FG001|Overall Study|Withdrawal by Subject|0|||
147558048|NCT02153398|532201333|FG002|Overall Study|Withdrawal by Subject|0|||
147558049|NCT02153398|532201334|FG003|Overall Study|Withdrawal by Subject|0|||
147558050|NCT02153398|532201335|FG004|Overall Study|Withdrawal by Subject|0|||
147558051|NCT02153398|532201331|FG000|Overall Study|Adverse Event|0|||
147558052|NCT02153398|532201332|FG001|Overall Study|Adverse Event|0|||
147558053|NCT02153398|532201333|FG002|Overall Study|Adverse Event|1|||
147558054|NCT02153398|532201334|FG003|Overall Study|Adverse Event|1|||
147558055|NCT02153398|532201335|FG004|Overall Study|Adverse Event|0|||
147558056|NCT01400425|532201336|FG000|Overall Study|Withdrawal by Subject|10|||
147558057|NCT00818883|532201337|FG000|Overall Study|Adverse Event|28|||
147558058|NCT00818883|532201338|FG001|Overall Study|Adverse Event|19|||
147558059|NCT00818883|532201337|FG000|Overall Study|Protocol Violation|2|||
147558060|NCT00818883|532201338|FG001|Overall Study|Protocol Violation|2|||
147106611|NCT00090103|530555769|FG002|Four-Year Double-Blind Treatment Period|No Improvement|0|||
147106612|NCT00090103|530555767|FG000|Four-Year Double-Blind Treatment Period|BPH/BPH symptoms worse/urinary incont.|1|||
147106613|NCT00090103|530555768|FG001|Four-Year Double-Blind Treatment Period|BPH/BPH symptoms worse/urinary incont.|0|||
147106614|NCT00090103|530555769|FG002|Four-Year Double-Blind Treatment Period|BPH/BPH symptoms worse/urinary incont.|5|||
147106615|NCT00090103|530555767|FG000|Four-Year Double-Blind Treatment Period|Financial Problems|1|||
147106616|NCT00090103|530555768|FG001|Four-Year Double-Blind Treatment Period|Financial Problems|0|||
147106617|NCT00090103|530555769|FG002|Four-Year Double-Blind Treatment Period|Financial Problems|0|||
147106618|NCT00090103|530555767|FG000|Four-Year Double-Blind Treatment Period|Loss of Libido|1|||
147106619|NCT00090103|530555768|FG001|Four-Year Double-Blind Treatment Period|Loss of Libido|0|||
147106620|NCT00090103|530555769|FG002|Four-Year Double-Blind Treatment Period|Loss of Libido|0|||
147106621|NCT00090103|530555767|FG000|Four-Year Double-Blind Treatment Period|Angina Pectoris|0|||
147106622|NCT00090103|530555768|FG001|Four-Year Double-Blind Treatment Period|Angina Pectoris|2|||
147106623|NCT00090103|530555769|FG002|Four-Year Double-Blind Treatment Period|Angina Pectoris|0|||
147106624|NCT00090103|530555767|FG000|Four-Year Double-Blind Treatment Period|Loss of Contact|0|||
147106625|NCT00090103|530555768|FG001|Four-Year Double-Blind Treatment Period|Loss of Contact|1|||
147106626|NCT00090103|530555769|FG002|Four-Year Double-Blind Treatment Period|Loss of Contact|0|||
147106627|NCT00090103|530555767|FG000|Four-Year Double-Blind Treatment Period|Neoplasm of Bladder/Prostate|0|||
147106628|NCT00090103|530555768|FG001|Four-Year Double-Blind Treatment Period|Neoplasm of Bladder/Prostate|1|||
147106629|NCT00090103|530555769|FG002|Four-Year Double-Blind Treatment Period|Neoplasm of Bladder/Prostate|1|||
147106630|NCT00090103|530555767|FG000|Four-Year Double-Blind Treatment Period|Cardiologist/Neurologist Decision|0|||
147106631|NCT00090103|530555768|FG001|Four-Year Double-Blind Treatment Period|Cardiologist/Neurologist Decision|2|||
147106632|NCT00090103|530555769|FG002|Four-Year Double-Blind Treatment Period|Cardiologist/Neurologist Decision|0|||
147106633|NCT00090103|530555767|FG000|Four-Year Double-Blind Treatment Period|Renal Insufficiency|0|||
147106634|NCT00090103|530555768|FG001|Four-Year Double-Blind Treatment Period|Renal Insufficiency|1|||
147106635|NCT00090103|530555769|FG002|Four-Year Double-Blind Treatment Period|Renal Insufficiency|0|||
147106636|NCT00090103|530555767|FG000|Four-Year Double-Blind Treatment Period|Back Pain|0|||
147106637|NCT00090103|530555768|FG001|Four-Year Double-Blind Treatment Period|Back Pain|1|||
147106638|NCT00090103|530555769|FG002|Four-Year Double-Blind Treatment Period|Back Pain|0|||
147106639|NCT00090103|530555767|FG000|Four-Year Double-Blind Treatment Period|Scheduling Issues|0|||
147106640|NCT00090103|530555768|FG001|Four-Year Double-Blind Treatment Period|Scheduling Issues|1|||
147106641|NCT00090103|530555769|FG002|Four-Year Double-Blind Treatment Period|Scheduling Issues|0|||
147106642|NCT00090103|530555767|FG000|Four-Year Double-Blind Treatment Period|Any Appreciable Improvement|0|||
147106643|NCT00090103|530555768|FG001|Four-Year Double-Blind Treatment Period|Any Appreciable Improvement|1|||
147106644|NCT00090103|530555769|FG002|Four-Year Double-Blind Treatment Period|Any Appreciable Improvement|0|||
147106645|NCT00090103|530555767|FG000|Four-Year Double-Blind Treatment Period|Investigator Decision|0|||
147106646|NCT00090103|530555768|FG001|Four-Year Double-Blind Treatment Period|Investigator Decision|1|||
147106647|NCT00090103|530555769|FG002|Four-Year Double-Blind Treatment Period|Investigator Decision|3|||
147106648|NCT00090103|530555767|FG000|Four-Year Double-Blind Treatment Period|Enrollment Error|0|||
147106649|NCT00090103|530555768|FG001|Four-Year Double-Blind Treatment Period|Enrollment Error|0|||
147106650|NCT00090103|530555769|FG002|Four-Year Double-Blind Treatment Period|Enrollment Error|2|||
147106651|NCT00090103|530555767|FG000|Four-Year Double-Blind Treatment Period|Urinary Tract Infection (UTI)|0|||
147106652|NCT00090103|530555768|FG001|Four-Year Double-Blind Treatment Period|Urinary Tract Infection (UTI)|0|||
147106653|NCT00090103|530555769|FG002|Four-Year Double-Blind Treatment Period|Urinary Tract Infection (UTI)|1|||
147106654|NCT00090103|530555767|FG000|Four-Year Double-Blind Treatment Period|Prostate Specific Antigen Rising|0|||
147106655|NCT00090103|530555768|FG001|Four-Year Double-Blind Treatment Period|Prostate Specific Antigen Rising|1|||
147106656|NCT00090103|530555769|FG002|Four-Year Double-Blind Treatment Period|Prostate Specific Antigen Rising|0|||
147106657|NCT00090103|530555767|FG000|16-Week Safety Follow-up Period|Adverse Event|34|||
147106658|NCT00090103|530555768|FG001|16-Week Safety Follow-up Period|Adverse Event|39|||
147106659|NCT00090103|530555769|FG002|16-Week Safety Follow-up Period|Adverse Event|44|||
147106660|NCT00090103|530555767|FG000|16-Week Safety Follow-up Period|Withdrawal by Subject|185|||
147225343|NCT00055471|530996632|FG001|Period 1: Dose Escalation Period|Adverse Event|1|||
147225344|NCT00055471|530996633|FG002|Period 1: Dose Escalation Period|Adverse Event|2|||
147225345|NCT00055471|530996631|FG000|Period 1: Dose Escalation Period|Erroneously reported discont. criteria|0|||
147225346|NCT00055471|530996632|FG001|Period 1: Dose Escalation Period|Erroneously reported discont. criteria|0|||
147225347|NCT00055471|530996633|FG002|Period 1: Dose Escalation Period|Erroneously reported discont. criteria|1|||
147106661|NCT00090103|530555768|FG001|16-Week Safety Follow-up Period|Withdrawal by Subject|212|||
147106662|NCT00090103|530555769|FG002|16-Week Safety Follow-up Period|Withdrawal by Subject|229|||
147106663|NCT00090103|530555767|FG000|16-Week Safety Follow-up Period|Lost to Follow-up|101|||
147225348|NCT00055471|530996631|FG000|Period 1: Dose Escalation Period|Disease progression|0|||
147558061|NCT00818883|532201337|FG000|Overall Study|Lost to Follow-up|3|||
147106664|NCT00090103|530555768|FG001|16-Week Safety Follow-up Period|Lost to Follow-up|97|||
147106665|NCT00090103|530555769|FG002|16-Week Safety Follow-up Period|Lost to Follow-up|111|||
147106666|NCT00090103|530555767|FG000|16-Week Safety Follow-up Period|Protocol Violation|18|||
147106667|NCT00090103|530555768|FG001|16-Week Safety Follow-up Period|Protocol Violation|18|||
147106668|NCT00090103|530555769|FG002|16-Week Safety Follow-up Period|Protocol Violation|17|||
147106669|NCT00090103|530555767|FG000|16-Week Safety Follow-up Period|Site Closed/Sponsor Termination|8|||
147106670|NCT00090103|530555768|FG001|16-Week Safety Follow-up Period|Site Closed/Sponsor Termination|5|||
147106671|NCT00090103|530555769|FG002|16-Week Safety Follow-up Period|Site Closed/Sponsor Termination|4|||
147106672|NCT00090103|530555767|FG000|16-Week Safety Follow-up Period|Non-compliant/Medication Interruption|8|||
147106673|NCT00090103|530555768|FG001|16-Week Safety Follow-up Period|Non-compliant/Medication Interruption|6|||
147106674|NCT00090103|530555769|FG002|16-Week Safety Follow-up Period|Non-compliant/Medication Interruption|4|||
147106675|NCT00090103|530555767|FG000|16-Week Safety Follow-up Period|Loss of Contact|4|||
147106676|NCT00090103|530555768|FG001|16-Week Safety Follow-up Period|Loss of Contact|0|||
147106677|NCT00090103|530555769|FG002|16-Week Safety Follow-up Period|Loss of Contact|2|||
147106678|NCT00090103|530555767|FG000|16-Week Safety Follow-up Period|Disease Progression/Treatment Failure|3|||
147106679|NCT00090103|530555768|FG001|16-Week Safety Follow-up Period|Disease Progression/Treatment Failure|1|||
147106680|NCT00090103|530555769|FG002|16-Week Safety Follow-up Period|Disease Progression/Treatment Failure|1|||
147106681|NCT00090103|530555767|FG000|16-Week Safety Follow-up Period|Participant relocated|2|||
147106682|NCT00090103|530555768|FG001|16-Week Safety Follow-up Period|Participant relocated|3|||
147106683|NCT00090103|530555769|FG002|16-Week Safety Follow-up Period|Participant relocated|1|||
147106684|NCT00090103|530555767|FG000|16-Week Safety Follow-up Period|Participant Decision/Withdrawn|2|||
147106685|NCT00090103|530555768|FG001|16-Week Safety Follow-up Period|Participant Decision/Withdrawn|1|||
147106686|NCT00090103|530555769|FG002|16-Week Safety Follow-up Period|Participant Decision/Withdrawn|2|||
147106687|NCT00090103|530555767|FG000|16-Week Safety Follow-up Period|Prohibited Medication|2|||
147106688|NCT00090103|530555768|FG001|16-Week Safety Follow-up Period|Prohibited Medication|3|||
147106689|NCT00090103|530555769|FG002|16-Week Safety Follow-up Period|Prohibited Medication|5|||
147106690|NCT00090103|530555767|FG000|16-Week Safety Follow-up Period|Alcohol Dependent|1|||
147106691|NCT00090103|530555768|FG001|16-Week Safety Follow-up Period|Alcohol Dependent|0|||
147106692|NCT00090103|530555769|FG002|16-Week Safety Follow-up Period|Alcohol Dependent|1|||
147106693|NCT00090103|530555767|FG000|16-Week Safety Follow-up Period|Prostate surgery/TURP/Alt. therapy|1|||
147106694|NCT00090103|530555768|FG001|16-Week Safety Follow-up Period|Prostate surgery/TURP/Alt. therapy|5|||
147106695|NCT00090103|530555769|FG002|16-Week Safety Follow-up Period|Prostate surgery/TURP/Alt. therapy|13|||
147106696|NCT00090103|530555767|FG000|16-Week Safety Follow-up Period|Loss of Libido|1|||
147106697|NCT00090103|530555768|FG001|16-Week Safety Follow-up Period|Loss of Libido|0|||
147106698|NCT00090103|530555769|FG002|16-Week Safety Follow-up Period|Loss of Libido|0|||
147106699|NCT00090103|530555767|FG000|16-Week Safety Follow-up Period|Enrollment Error|1|||
147106700|NCT00090103|530555768|FG001|16-Week Safety Follow-up Period|Enrollment Error|0|||
147106701|NCT00090103|530555769|FG002|16-Week Safety Follow-up Period|Enrollment Error|2|||
147106702|NCT00090103|530555767|FG000|16-Week Safety Follow-up Period|Neoplasm of Bladder/Prostate Cancer|1|||
147106703|NCT00090103|530555768|FG001|16-Week Safety Follow-up Period|Neoplasm of Bladder/Prostate Cancer|3|||
147106704|NCT00090103|530555769|FG002|16-Week Safety Follow-up Period|Neoplasm of Bladder/Prostate Cancer|6|||
147106705|NCT00090103|530555767|FG000|16-Week Safety Follow-up Period|Death|1|||
147106706|NCT00090103|530555768|FG001|16-Week Safety Follow-up Period|Death|0|||
147106707|NCT00090103|530555769|FG002|16-Week Safety Follow-up Period|Death|1|||
147106708|NCT00090103|530555767|FG000|16-Week Safety Follow-up Period|Gyneomastia|1|||
147106709|NCT00090103|530555768|FG001|16-Week Safety Follow-up Period|Gyneomastia|0|||
147106710|NCT00090103|530555769|FG002|16-Week Safety Follow-up Period|Gyneomastia|0|||
147106711|NCT00090103|530555767|FG000|16-Week Safety Follow-up Period|Acute Urinary Retention (AUR)|0|||
147106712|NCT00090103|530555768|FG001|16-Week Safety Follow-up Period|Acute Urinary Retention (AUR)|5|||
147106713|NCT00090103|530555769|FG002|16-Week Safety Follow-up Period|Acute Urinary Retention (AUR)|4|||
147106714|NCT00090103|530555767|FG000|16-Week Safety Follow-up Period|BPH/BPH symptoms worse/urinary incont.|0|||
147106715|NCT00090103|530555768|FG001|16-Week Safety Follow-up Period|BPH/BPH symptoms worse/urinary incont.|2|||
147106716|NCT00090103|530555769|FG002|16-Week Safety Follow-up Period|BPH/BPH symptoms worse/urinary incont.|3|||
147310666|NCT02936037|531305034|FG000|Double-Blind Treatment Period|Adverse Event|11|||
147558062|NCT00818883|532201338|FG001|Overall Study|Lost to Follow-up|2|||
147558063|NCT00818883|532201337|FG000|Overall Study|Withdrawal by Subject|16|||
147558064|NCT00818883|532201338|FG001|Overall Study|Withdrawal by Subject|14|||
147558065|NCT00818883|532201337|FG000|Overall Study|Lack of Efficacy|0|||
147558066|NCT00818883|532201338|FG001|Overall Study|Lack of Efficacy|2|||
147558067|NCT00818883|532201337|FG000|Overall Study|Other|2|||
147558068|NCT00818883|532201338|FG001|Overall Study|Other|7|||
147558069|NCT00973700|532201339|FG000|Overall Study|Withdrawal by Subject|2|||
147310667|NCT02936037|531305035|FG001|Double-Blind Treatment Period|Adverse Event|11|||
147310668|NCT02936037|531305034|FG000|Double-Blind Treatment Period|Withdrawal by Subject|31|||
147310669|NCT02936037|531305035|FG001|Double-Blind Treatment Period|Withdrawal by Subject|28|||
147558070|NCT00973700|532201340|FG001|Overall Study|Withdrawal by Subject|2|||
147106717|NCT00090103|530555767|FG000|16-Week Safety Follow-up Period|Angina Pectoris|0|||
147106718|NCT00090103|530555768|FG001|16-Week Safety Follow-up Period|Angina Pectoris|1|||
147106719|NCT00090103|530555769|FG002|16-Week Safety Follow-up Period|Angina Pectoris|0|||
147106720|NCT00090103|530555767|FG000|16-Week Safety Follow-up Period|Back Pain|0|||
147106721|NCT00090103|530555768|FG001|16-Week Safety Follow-up Period|Back Pain|1|||
147106722|NCT00090103|530555769|FG002|16-Week Safety Follow-up Period|Back Pain|0|||
147106723|NCT00090103|530555767|FG000|16-Week Safety Follow-up Period|Scheduling Issues|0|||
147106724|NCT00090103|530555768|FG001|16-Week Safety Follow-up Period|Scheduling Issues|2|||
147106725|NCT00090103|530555769|FG002|16-Week Safety Follow-up Period|Scheduling Issues|4|||
147106726|NCT00090103|530555767|FG000|16-Week Safety Follow-up Period|Investigator/Sponsor Decision|0|||
147106727|NCT00090103|530555768|FG001|16-Week Safety Follow-up Period|Investigator/Sponsor Decision|2|||
147106728|NCT00090103|530555769|FG002|16-Week Safety Follow-up Period|Investigator/Sponsor Decision|3|||
147106729|NCT00090103|530555767|FG000|16-Week Safety Follow-up Period|Depression|0|||
147106730|NCT00090103|530555768|FG001|16-Week Safety Follow-up Period|Depression|1|||
147106731|NCT00090103|530555769|FG002|16-Week Safety Follow-up Period|Depression|0|||
147106732|NCT00090103|530555767|FG000|16-Week Safety Follow-up Period|Diabetes Uncontrolled|0|||
147106733|NCT00090103|530555768|FG001|16-Week Safety Follow-up Period|Diabetes Uncontrolled|1|||
147106734|NCT00090103|530555769|FG002|16-Week Safety Follow-up Period|Diabetes Uncontrolled|0|||
147106735|NCT00090103|530555767|FG000|16-Week Safety Follow-up Period|Jailed|0|||
147106736|NCT00090103|530555768|FG001|16-Week Safety Follow-up Period|Jailed|1|||
147106737|NCT00090103|530555769|FG002|16-Week Safety Follow-up Period|Jailed|0|||
147106738|NCT00090103|530555767|FG000|16-Week Safety Follow-up Period|Other|0|||
147106739|NCT00090103|530555768|FG001|16-Week Safety Follow-up Period|Other|1|||
147106740|NCT00090103|530555769|FG002|16-Week Safety Follow-up Period|Other|0|||
147106741|NCT01799889|530555772|FG000|Overall Study|Adverse Event|4|||
147106742|NCT01799889|530555773|FG001|Overall Study|Adverse Event|4|||
147558071|NCT00973700|532201341|FG002|Overall Study|Withdrawal by Subject|8|||
147558072|NCT00973700|532201342|FG003|Overall Study|Withdrawal by Subject|4|||
147558073|NCT00973700|532201343|FG004|Overall Study|Withdrawal by Subject|4|||
147558074|NCT00973700|532201339|FG000|Overall Study|Lost to Follow-up|5|||
147558075|NCT00973700|532201340|FG001|Overall Study|Lost to Follow-up|0|||
147558076|NCT00973700|532201341|FG002|Overall Study|Lost to Follow-up|1|||
147558077|NCT00973700|532201342|FG003|Overall Study|Lost to Follow-up|8|||
147558078|NCT00973700|532201343|FG004|Overall Study|Lost to Follow-up|5|||
147558079|NCT00973700|532201339|FG000|Overall Study|Inappropriate enrolment|0|||
147558080|NCT00973700|532201340|FG001|Overall Study|Inappropriate enrolment|0|||
147558081|NCT00973700|532201341|FG002|Overall Study|Inappropriate enrolment|0|||
147558082|NCT00973700|532201342|FG003|Overall Study|Inappropriate enrolment|4|||
147558083|NCT00973700|532201343|FG004|Overall Study|Inappropriate enrolment|0|||
147558084|NCT00973700|532201339|FG000|Overall Study|Unable to Classify|0|||
147558085|NCT00973700|532201340|FG001|Overall Study|Unable to Classify|0|||
147558086|NCT00973700|532201341|FG002|Overall Study|Unable to Classify|1|||
147558087|NCT00973700|532201342|FG003|Overall Study|Unable to Classify|2|||
147558088|NCT00973700|532201343|FG004|Overall Study|Unable to Classify|1|||
147558089|NCT01047345|532201349|FG000|Base Study|Adverse Event|3|||
147558090|NCT01047345|532201350|FG001|Base Study|Adverse Event|0|||
147558091|NCT01047345|532201351|FG002|Base Study|Adverse Event|0|||
147558092|NCT01047345|532201349|FG000|Base Study|Lost to Follow-up|4|||
147558093|NCT01047345|532201350|FG001|Base Study|Lost to Follow-up|1|||
147558094|NCT01047345|532201351|FG002|Base Study|Lost to Follow-up|0|||
147558095|NCT01047345|532201349|FG000|Base Study|Protocol Violation|3|||
147106743|NCT01799889|530555774|FG002|Overall Study|Adverse Event|5|||
147106744|NCT01799889|530555775|FG003|Overall Study|Adverse Event|1|||
147558096|NCT01047345|532201350|FG001|Base Study|Protocol Violation|1|||
147558097|NCT01047345|532201351|FG002|Base Study|Protocol Violation|0|||
147558098|NCT01047345|532201349|FG000|Base Study|Withdrawal by Subject|12|||
147558099|NCT01047345|532201350|FG001|Base Study|Withdrawal by Subject|4|||
147558100|NCT01047345|532201351|FG002|Base Study|Withdrawal by Subject|0|||
147558101|NCT01047345|532201349|FG000|Extension|Withdrawal by Subject|0|||
147558102|NCT01047345|532201350|FG001|Extension|Withdrawal by Subject|0|||
147558103|NCT01047345|532201351|FG002|Extension|Withdrawal by Subject|1|||
147558104|NCT01047345|532201349|FG000|Extension|Lost to Follow-up|0|||
147558105|NCT01047345|532201350|FG001|Extension|Lost to Follow-up|0|||
147558106|NCT01047345|532201351|FG002|Extension|Lost to Follow-up|5|||
147558107|NCT00806156|532201352|FG000|Overall Study|Death|35|||
147558108|NCT00806156|532201353|FG001|Overall Study|Death|95|||
147558109|NCT00806156|532201352|FG000|Overall Study|Did not meet eligibility criteria|1|||
147558110|NCT00806156|532201353|FG001|Overall Study|Did not meet eligibility criteria|0|||
147558111|NCT00806156|532201352|FG000|Overall Study|Study terminated by Sponsor|2|||
147558112|NCT00806156|532201353|FG001|Overall Study|Study terminated by Sponsor|40|||
147558113|NCT00806156|532201352|FG000|Overall Study|Consent withdrawn by subject|1|||
147558114|NCT00806156|532201353|FG001|Overall Study|Consent withdrawn by subject|3|||
147106745|NCT01799889|530555776|FG004|Overall Study|Adverse Event|11|||
147106746|NCT01799889|530555777|FG005|Overall Study|Adverse Event|1|||
147106747|NCT01799889|530555778|FG006|Overall Study|Adverse Event|5|||
147106748|NCT01799889|530555779|FG007|Overall Study|Adverse Event|2|||
147106749|NCT01799889|530555780|FG008|Overall Study|Adverse Event|3|||
147106750|NCT01799889|530555781|FG009|Overall Study|Adverse Event|1|||
147106751|NCT01799889|530555782|FG010|Overall Study|Adverse Event|1|||
147106752|NCT01799889|530555783|FG011|Overall Study|Adverse Event|0|||
147106753|NCT01799889|530555772|FG000|Overall Study|Death|1|||
147106754|NCT01799889|530555773|FG001|Overall Study|Death|0|||
147106755|NCT01799889|530555774|FG002|Overall Study|Death|5|||
147106756|NCT01799889|530555775|FG003|Overall Study|Death|3|||
147106757|NCT01799889|530555776|FG004|Overall Study|Death|1|||
147106758|NCT01799889|530555777|FG005|Overall Study|Death|0|||
147106759|NCT01799889|530555778|FG006|Overall Study|Death|0|||
147106760|NCT01799889|530555779|FG007|Overall Study|Death|0|||
147106761|NCT01799889|530555780|FG008|Overall Study|Death|1|||
147106762|NCT01799889|530555781|FG009|Overall Study|Death|0|||
147106763|NCT01799889|530555782|FG010|Overall Study|Death|1|||
147106764|NCT01799889|530555783|FG011|Overall Study|Death|0|||
147106765|NCT01799889|530555772|FG000|Overall Study|Lack of Efficacy|1|||
147106766|NCT01799889|530555773|FG001|Overall Study|Lack of Efficacy|1|||
147106767|NCT01799889|530555774|FG002|Overall Study|Lack of Efficacy|0|||
147106768|NCT01799889|530555775|FG003|Overall Study|Lack of Efficacy|1|||
147106769|NCT01799889|530555776|FG004|Overall Study|Lack of Efficacy|2|||
147106770|NCT01799889|530555777|FG005|Overall Study|Lack of Efficacy|2|||
147106771|NCT01799889|530555778|FG006|Overall Study|Lack of Efficacy|0|||
147106772|NCT01799889|530555779|FG007|Overall Study|Lack of Efficacy|0|||
147106773|NCT01799889|530555780|FG008|Overall Study|Lack of Efficacy|2|||
147106774|NCT01799889|530555781|FG009|Overall Study|Lack of Efficacy|0|||
147106775|NCT01799889|530555782|FG010|Overall Study|Lack of Efficacy|1|||
147106776|NCT01799889|530555783|FG011|Overall Study|Lack of Efficacy|0|||
147106777|NCT01799889|530555772|FG000|Overall Study|Lost to Follow-up|0|||
147106778|NCT01799889|530555773|FG001|Overall Study|Lost to Follow-up|1|||
147106779|NCT01799889|530555774|FG002|Overall Study|Lost to Follow-up|0|||
147106780|NCT01799889|530555775|FG003|Overall Study|Lost to Follow-up|0|||
147106781|NCT01799889|530555776|FG004|Overall Study|Lost to Follow-up|0|||
147106782|NCT01799889|530555777|FG005|Overall Study|Lost to Follow-up|0|||
147106783|NCT01799889|530555778|FG006|Overall Study|Lost to Follow-up|0|||
147106784|NCT01799889|530555779|FG007|Overall Study|Lost to Follow-up|0|||
147106785|NCT01799889|530555780|FG008|Overall Study|Lost to Follow-up|0|||
147106786|NCT01799889|530555781|FG009|Overall Study|Lost to Follow-up|0|||
147106787|NCT01799889|530555782|FG010|Overall Study|Lost to Follow-up|0|||
147106788|NCT01799889|530555783|FG011|Overall Study|Lost to Follow-up|0|||
147106789|NCT01799889|530555772|FG000|Overall Study|Physician Decision|3|||
147106790|NCT01799889|530555773|FG001|Overall Study|Physician Decision|2|||
147106791|NCT01799889|530555774|FG002|Overall Study|Physician Decision|4|||
147106792|NCT01799889|530555775|FG003|Overall Study|Physician Decision|4|||
147106793|NCT01799889|530555776|FG004|Overall Study|Physician Decision|5|||
147106794|NCT01799889|530555777|FG005|Overall Study|Physician Decision|5|||
147106795|NCT01799889|530555778|FG006|Overall Study|Physician Decision|5|||
147106796|NCT01799889|530555779|FG007|Overall Study|Physician Decision|2|||
147106797|NCT01799889|530555780|FG008|Overall Study|Physician Decision|6|||
147106798|NCT01799889|530555781|FG009|Overall Study|Physician Decision|0|||
147106799|NCT01799889|530555782|FG010|Overall Study|Physician Decision|0|||
147106800|NCT01799889|530555783|FG011|Overall Study|Physician Decision|1|||
147106801|NCT01799889|530555772|FG000|Overall Study|Progressive Disease|30|||
147106802|NCT01799889|530555773|FG001|Overall Study|Progressive Disease|26|||
147106803|NCT01799889|530555774|FG002|Overall Study|Progressive Disease|25|||
147225349|NCT00055471|530996632|FG001|Period 1: Dose Escalation Period|Disease progression|1|||
147225350|NCT00055471|530996633|FG002|Period 1: Dose Escalation Period|Disease progression|0|||
147225351|NCT01854944|530996634|FG000|Overall Study|Withdrawal by Subject|0|||
147225352|NCT01854944|530996635|FG001|Overall Study|Withdrawal by Subject|0|||
147225353|NCT01854944|530996636|FG002|Overall Study|Withdrawal by Subject|1|||
147106804|NCT01799889|530555775|FG003|Overall Study|Progressive Disease|30|||
147106805|NCT01799889|530555776|FG004|Overall Study|Progressive Disease|23|||
147106806|NCT01799889|530555777|FG005|Overall Study|Progressive Disease|9|||
147106807|NCT01799889|530555778|FG006|Overall Study|Progressive Disease|8|||
147106808|NCT01799889|530555779|FG007|Overall Study|Progressive Disease|13|||
147106809|NCT01799889|530555780|FG008|Overall Study|Progressive Disease|18|||
147225354|NCT00282347|530996639|FG000|Treatment Period|Death|2|||
147225355|NCT00282347|530996640|FG001|Treatment Period|Death|0|||
147106810|NCT01799889|530555781|FG009|Overall Study|Progressive Disease|5|||
147106811|NCT01799889|530555782|FG010|Overall Study|Progressive Disease|3|||
147106812|NCT01799889|530555783|FG011|Overall Study|Progressive Disease|1|||
147106813|NCT01799889|530555772|FG000|Overall Study|Specified Criteria for Withdrawal|0|||
147106814|NCT01799889|530555773|FG001|Overall Study|Specified Criteria for Withdrawal|1|||
147106815|NCT01799889|530555774|FG002|Overall Study|Specified Criteria for Withdrawal|1|||
147106816|NCT01799889|530555775|FG003|Overall Study|Specified Criteria for Withdrawal|0|||
147106817|NCT01799889|530555776|FG004|Overall Study|Specified Criteria for Withdrawal|0|||
147106818|NCT01799889|530555777|FG005|Overall Study|Specified Criteria for Withdrawal|0|||
147106819|NCT01799889|530555778|FG006|Overall Study|Specified Criteria for Withdrawal|0|||
147106820|NCT01799889|530555779|FG007|Overall Study|Specified Criteria for Withdrawal|0|||
147106821|NCT01799889|530555780|FG008|Overall Study|Specified Criteria for Withdrawal|0|||
147106822|NCT01799889|530555781|FG009|Overall Study|Specified Criteria for Withdrawal|0|||
147106823|NCT01799889|530555782|FG010|Overall Study|Specified Criteria for Withdrawal|0|||
147106824|NCT01799889|530555783|FG011|Overall Study|Specified Criteria for Withdrawal|0|||
147106825|NCT01799889|530555772|FG000|Overall Study|Study Terminated By Sponsor|1|||
147106826|NCT01799889|530555773|FG001|Overall Study|Study Terminated By Sponsor|0|||
147106827|NCT01799889|530555774|FG002|Overall Study|Study Terminated By Sponsor|0|||
147106828|NCT01799889|530555775|FG003|Overall Study|Study Terminated By Sponsor|0|||
147106829|NCT01799889|530555776|FG004|Overall Study|Study Terminated By Sponsor|2|||
147106830|NCT01799889|530555777|FG005|Overall Study|Study Terminated By Sponsor|1|||
147106831|NCT01799889|530555778|FG006|Overall Study|Study Terminated By Sponsor|0|||
147106832|NCT01799889|530555779|FG007|Overall Study|Study Terminated By Sponsor|2|||
147106833|NCT01799889|530555780|FG008|Overall Study|Study Terminated By Sponsor|1|||
147106834|NCT01799889|530555781|FG009|Overall Study|Study Terminated By Sponsor|1|||
147106835|NCT01799889|530555782|FG010|Overall Study|Study Terminated By Sponsor|0|||
147106836|NCT01799889|530555783|FG011|Overall Study|Study Terminated By Sponsor|0|||
147106837|NCT01799889|530555772|FG000|Overall Study|Withdrawal by Subject|1|||
147106838|NCT01799889|530555773|FG001|Overall Study|Withdrawal by Subject|6|||
147106839|NCT01799889|530555774|FG002|Overall Study|Withdrawal by Subject|4|||
147106840|NCT01799889|530555775|FG003|Overall Study|Withdrawal by Subject|0|||
147106841|NCT01799889|530555776|FG004|Overall Study|Withdrawal by Subject|5|||
147106842|NCT01799889|530555777|FG005|Overall Study|Withdrawal by Subject|1|||
147106843|NCT01799889|530555778|FG006|Overall Study|Withdrawal by Subject|3|||
147106844|NCT01799889|530555779|FG007|Overall Study|Withdrawal by Subject|1|||
147106845|NCT01799889|530555780|FG008|Overall Study|Withdrawal by Subject|2|||
147106846|NCT01799889|530555781|FG009|Overall Study|Withdrawal by Subject|1|||
147106847|NCT01799889|530555782|FG010|Overall Study|Withdrawal by Subject|1|||
147106848|NCT01799889|530555783|FG011|Overall Study|Withdrawal by Subject|1|||
147106849|NCT01799889|530555772|FG000|Overall Study|Non-Compliance With Study Drug|0|||
147106850|NCT01799889|530555773|FG001|Overall Study|Non-Compliance With Study Drug|0|||
147106851|NCT01799889|530555774|FG002|Overall Study|Non-Compliance With Study Drug|0|||
147106852|NCT01799889|530555775|FG003|Overall Study|Non-Compliance With Study Drug|0|||
147106853|NCT01799889|530555776|FG004|Overall Study|Non-Compliance With Study Drug|0|||
147106854|NCT01799889|530555777|FG005|Overall Study|Non-Compliance With Study Drug|1|||
147106855|NCT01799889|530555778|FG006|Overall Study|Non-Compliance With Study Drug|0|||
147106856|NCT01799889|530555779|FG007|Overall Study|Non-Compliance With Study Drug|0|||
147106857|NCT01799889|530555780|FG008|Overall Study|Non-Compliance With Study Drug|0|||
147106858|NCT01799889|530555781|FG009|Overall Study|Non-Compliance With Study Drug|0|||
147106859|NCT01799889|530555782|FG010|Overall Study|Non-Compliance With Study Drug|0|||
147106860|NCT01799889|530555783|FG011|Overall Study|Non-Compliance With Study Drug|0|||
147106861|NCT04476043|530555786|FG000|Overall Study|Withdrawal by Subject|1|||
147106862|NCT04476043|530555787|FG001|Overall Study|Withdrawal by Subject|3|||
147106863|NCT04476043|530555788|FG002|Overall Study|Withdrawal by Subject|4|||
147106864|NCT04476043|530555789|FG003|Overall Study|Withdrawal by Subject|1|||
147106865|NCT04476043|530555786|FG000|Overall Study|Lost to Follow-up|1|||
147106866|NCT04476043|530555787|FG001|Overall Study|Lost to Follow-up|1|||
147106867|NCT04476043|530555788|FG002|Overall Study|Lost to Follow-up|2|||
147106868|NCT04476043|530555789|FG003|Overall Study|Lost to Follow-up|1|||
147106869|NCT04476043|530555786|FG000|Overall Study|Adverse Event|2|||
147106870|NCT04476043|530555787|FG001|Overall Study|Adverse Event|0|||
147106871|NCT04476043|530555788|FG002|Overall Study|Adverse Event|1|||
147106872|NCT04476043|530555789|FG003|Overall Study|Adverse Event|0|||
147106873|NCT04476043|530555786|FG000|Overall Study|Protocol Violation|0|||
147106874|NCT04476043|530555787|FG001|Overall Study|Protocol Violation|1|||
147106875|NCT04476043|530555788|FG002|Overall Study|Protocol Violation|0|||
147106876|NCT04476043|530555789|FG003|Overall Study|Protocol Violation|0|||
147106877|NCT06217380|530555790|FG000|Overall Study|Death: Unrelated to the device. The subject was enrolled but did not start any study activities|1|||
147106878|NCT06217380|530555790|FG000|Overall Study|Physician Decision|1|||
147106879|NCT06217380|530555790|FG000|Overall Study|Withdrawal by Subject|2|||
147106880|NCT06633965|530555791|FG000|Overall Study|Withdrawal by Subject|0|||
147106881|NCT06633965|530555792|FG001|Overall Study|Withdrawal by Subject|1|||
147558115|NCT00806156|532201352|FG000|Overall Study|Lost to Follow-up|0|||
147558116|NCT00806156|532201353|FG001|Overall Study|Lost to Follow-up|1|||
147558117|NCT00424489|532201357|FG000|Overall Study|Death|3|||
147558118|NCT00770510|532201360|FG000|Overall Study|Lost to Follow-up|2|||
147558119|NCT00770510|532201360|FG000|Overall Study|Pregnancy|1|||
147106882|NCT02469233|530555797|FG000|Overall Study|Death|1|||
147106883|NCT02469233|530555798|FG001|Overall Study|Death|1|||
147106884|NCT02469233|530555797|FG000|Overall Study|Lost to post or 6 month follow up|7|||
147106885|NCT02469233|530555798|FG001|Overall Study|Lost to post or 6 month follow up|2|||
147106886|NCT00947544|530555799|FG000|Safety-Extension Period (12 Months)|Withdrawal by Subject|1|||
147106887|NCT00947544|530555800|FG001|Safety-Extension Period (12 Months)|Withdrawal by Subject|0|||
147106888|NCT00300053|530555801|FG000|Overall Study|Patient/Caregiver Preference|2|||
147106889|NCT00300053|530555802|FG001|Overall Study|Patient/Caregiver Preference|2|||
147558120|NCT00770510|532201360|FG000|Overall Study|Withdrawal by Subject|2|||
147558121|NCT00536575|532201363|FG000|Overall Study|Withdrawal by Subject|1|||
147106890|NCT00300053|530555803|FG002|Overall Study|Patient/Caregiver Preference|3|||
147106891|NCT00300053|530555801|FG000|Overall Study|Death|0|||
147106892|NCT00300053|530555802|FG001|Overall Study|Death|0|||
147106893|NCT00300053|530555803|FG002|Overall Study|Death|3|||
147106894|NCT00300053|530555801|FG000|Overall Study|Lost to Follow-up|0|||
147106895|NCT00300053|530555802|FG001|Overall Study|Lost to Follow-up|1|||
147106896|NCT00300053|530555803|FG002|Overall Study|Lost to Follow-up|0|||
147106897|NCT02566005|530555809|FG000|Overall Study|vaginal bleeding|0|||
147106898|NCT02566005|530555810|FG001|Overall Study|vaginal bleeding|1|||
147106899|NCT02566005|530555809|FG000|Overall Study|received foley|8|||
147106900|NCT02566005|530555810|FG001|Overall Study|received foley|0|||
147106901|NCT02566005|530555809|FG000|Overall Study|did not receive foley|0|||
147106902|NCT02566005|530555810|FG001|Overall Study|did not receive foley|1|||
147106903|NCT02566005|530555809|FG000|Overall Study|labor after randomization|0|||
147106904|NCT02566005|530555810|FG001|Overall Study|labor after randomization|4|||
147106905|NCT01963611|530555811|FG000|Overall Study|Adverse Event|1|||
147106906|NCT01963611|530555812|FG001|Overall Study|Adverse Event|1|||
147106907|NCT01963611|530555813|FG002|Overall Study|Adverse Event|3|||
147106908|NCT01963611|530555814|FG003|Overall Study|Adverse Event|4|||
147106909|NCT01963611|530555815|FG004|Overall Study|Adverse Event|3|||
147106910|NCT01963611|530555811|FG000|Overall Study|Protocol Violation|0|||
147106911|NCT01963611|530555812|FG001|Overall Study|Protocol Violation|0|||
147106912|NCT01963611|530555813|FG002|Overall Study|Protocol Violation|0|||
147106913|NCT01963611|530555814|FG003|Overall Study|Protocol Violation|1|||
147106914|NCT01963611|530555815|FG004|Overall Study|Protocol Violation|0|||
147106915|NCT01963611|530555811|FG000|Overall Study|Lack of Efficacy|0|||
147106916|NCT01963611|530555812|FG001|Overall Study|Lack of Efficacy|0|||
147106917|NCT01963611|530555813|FG002|Overall Study|Lack of Efficacy|0|||
147106918|NCT01963611|530555814|FG003|Overall Study|Lack of Efficacy|1|||
147106919|NCT01963611|530555815|FG004|Overall Study|Lack of Efficacy|0|||
147106920|NCT01963611|530555811|FG000|Overall Study|Withdrawal by Subject|3|||
147106921|NCT01963611|530555812|FG001|Overall Study|Withdrawal by Subject|2|||
147106922|NCT01963611|530555813|FG002|Overall Study|Withdrawal by Subject|1|||
147106923|NCT01963611|530555814|FG003|Overall Study|Withdrawal by Subject|1|||
147106924|NCT01963611|530555815|FG004|Overall Study|Withdrawal by Subject|3|||
147106925|NCT01963611|530555811|FG000|Overall Study|Other|47|||
147106926|NCT01963611|530555812|FG001|Overall Study|Other|46|||
147106927|NCT01963611|530555813|FG002|Overall Study|Other|48|||
147106928|NCT01963611|530555814|FG003|Overall Study|Other|45|||
147106929|NCT01963611|530555815|FG004|Overall Study|Other|45|||
147106930|NCT03801252|530555816|FG000|Overall Study|Protocol Violation|1|||
147106931|NCT03801252|530555817|FG001|Overall Study|Protocol Violation|2|||
147106932|NCT02471183|530555818|FG000|Main Treatment Period|Adverse Event|1|||
147106933|NCT02471183|530555818|FG000|Main Treatment Period|Withdrawal by Subject|1|||
147106934|NCT02471183|530555818|FG000|Extended Treatment Period|Lack of Efficacy|1|||
147106935|NCT02328105|530555822|FG000|Overall Study|Death|6|||
147106936|NCT02328105|530555822|FG000|Overall Study|Withdrawal by Subject|1|||
147106937|NCT02328105|530555822|FG000|Overall Study|Still On Study in Follow-Up|4|||
147106938|NCT00614393|530555823|FG000|Overall Study|Adverse Event|20|||
147106939|NCT00614393|530555824|FG001|Overall Study|Adverse Event|2|||
147106940|NCT00614393|530555825|FG002|Overall Study|Adverse Event|3|||
147106941|NCT00614393|530555826|FG003|Overall Study|Adverse Event|13|||
147106942|NCT00614393|530555827|FG004|Overall Study|Adverse Event|21|||
147310670|NCT02936037|531305034|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
147310671|NCT02936037|531305035|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
147310672|NCT02936037|531305034|FG000|Open Label Extension|Adverse Event|0|||
147310673|NCT02936037|531305035|FG001|Open Label Extension|Adverse Event|3|||
147310674|NCT02936037|531305034|FG000|Open Label Extension|Other|0|||
147310675|NCT02936037|531305035|FG001|Open Label Extension|Other|3|||
147310676|NCT02936037|531305034|FG000|Open Label Extension|Withdrawal by Subject|0|||
147310677|NCT02936037|531305035|FG001|Open Label Extension|Withdrawal by Subject|4|||
147310678|NCT01087723|531305040|FG000|Overall Study|1 Year Visit Too Early (<335 days)|0|||
147310679|NCT01087723|531305041|FG001|Overall Study|1 Year Visit Too Early (<335 days)|1|||
147310680|NCT01087723|531305040|FG000|Overall Study|Withdrawal by Subject|10|||
147444138|NCT02090413|531790529|FG001|Overall Study|Withdrawal by Subject|2|||
147558122|NCT00536575|532201363|FG000|Overall Study|Death|1|||
147106943|NCT00614393|530555823|FG000|Overall Study|Lost to Follow-up|0|||
147106944|NCT00614393|530555824|FG001|Overall Study|Lost to Follow-up|0|||
147106945|NCT00614393|530555825|FG002|Overall Study|Lost to Follow-up|0|||
147310681|NCT01087723|531305041|FG001|Overall Study|Withdrawal by Subject|13|||
147444139|NCT02090413|531790530|FG002|Overall Study|Withdrawal by Subject|2|||
147444140|NCT02090413|531790528|FG000|Overall Study|Investigator Decision|1|||
147106946|NCT00614393|530555826|FG003|Overall Study|Lost to Follow-up|1|||
147106947|NCT00614393|530555827|FG004|Overall Study|Lost to Follow-up|2|||
147106948|NCT00614393|530555823|FG000|Overall Study|Physician Decision|17|||
147106949|NCT00614393|530555824|FG001|Overall Study|Physician Decision|0|||
147106950|NCT00614393|530555825|FG002|Overall Study|Physician Decision|1|||
147106951|NCT00614393|530555826|FG003|Overall Study|Physician Decision|8|||
147106952|NCT00614393|530555827|FG004|Overall Study|Physician Decision|9|||
147106953|NCT00614393|530555823|FG000|Overall Study|Progressive Disease|118|||
147106954|NCT00614393|530555824|FG001|Overall Study|Progressive Disease|5|||
147106955|NCT00614393|530555825|FG002|Overall Study|Progressive Disease|5|||
147106956|NCT00614393|530555826|FG003|Overall Study|Progressive Disease|138|||
147106957|NCT00614393|530555827|FG004|Overall Study|Progressive Disease|130|||
147106958|NCT00614393|530555823|FG000|Overall Study|Protocol Violation|1|||
147106959|NCT00614393|530555824|FG001|Overall Study|Protocol Violation|0|||
147106960|NCT00614393|530555825|FG002|Overall Study|Protocol Violation|0|||
147106961|NCT00614393|530555826|FG003|Overall Study|Protocol Violation|0|||
147106962|NCT00614393|530555827|FG004|Overall Study|Protocol Violation|0|||
147106963|NCT00614393|530555823|FG000|Overall Study|Terminated by Sponsor|0|||
147106964|NCT00614393|530555824|FG001|Overall Study|Terminated by Sponsor|0|||
147106965|NCT00614393|530555825|FG002|Overall Study|Terminated by Sponsor|0|||
147106966|NCT00614393|530555826|FG003|Overall Study|Terminated by Sponsor|0|||
147106967|NCT00614393|530555827|FG004|Overall Study|Terminated by Sponsor|1|||
147106968|NCT00614393|530555823|FG000|Overall Study|Withdrawal by Subject|20|||
147106969|NCT00614393|530555824|FG001|Overall Study|Withdrawal by Subject|1|||
147106970|NCT00614393|530555825|FG002|Overall Study|Withdrawal by Subject|1|||
147106971|NCT00614393|530555826|FG003|Overall Study|Withdrawal by Subject|16|||
147106972|NCT00614393|530555827|FG004|Overall Study|Withdrawal by Subject|13|||
147106973|NCT00614393|530555823|FG000|Overall Study|Other|4|||
147106974|NCT00614393|530555824|FG001|Overall Study|Other|0|||
147106975|NCT00614393|530555825|FG002|Overall Study|Other|0|||
147106976|NCT00614393|530555826|FG003|Overall Study|Other|4|||
147106977|NCT00614393|530555827|FG004|Overall Study|Other|2|||
147106978|NCT00614393|530555823|FG000|Overall Study|Not Treated|0|||
147106979|NCT00614393|530555824|FG001|Overall Study|Not Treated|0|||
147106980|NCT00614393|530555825|FG002|Overall Study|Not Treated|0|||
147106981|NCT00614393|530555826|FG003|Overall Study|Not Treated|0|||
147106982|NCT00614393|530555827|FG004|Overall Study|Not Treated|2|||
147106983|NCT00855582|530555828|FG000|Overall Study|Adverse Event|2|||
147106984|NCT00855582|530555829|FG001|Overall Study|Adverse Event|6|||
147106985|NCT00855582|530555830|FG002|Overall Study|Adverse Event|3|||
147106986|NCT00855582|530555828|FG000|Overall Study|Death|1|||
147106987|NCT00855582|530555829|FG001|Overall Study|Death|0|||
147106988|NCT00855582|530555830|FG002|Overall Study|Death|0|||
147106989|NCT00855582|530555828|FG000|Overall Study|Lack of Efficacy|1|||
147106990|NCT00855582|530555829|FG001|Overall Study|Lack of Efficacy|3|||
147106991|NCT00855582|530555830|FG002|Overall Study|Lack of Efficacy|8|||
147106992|NCT00855582|530555828|FG000|Overall Study|Lost to Follow-up|1|||
147106993|NCT00855582|530555829|FG001|Overall Study|Lost to Follow-up|3|||
147106994|NCT00855582|530555830|FG002|Overall Study|Lost to Follow-up|1|||
147106995|NCT00855582|530555828|FG000|Overall Study|Physician Decision|0|||
147106996|NCT00855582|530555829|FG001|Overall Study|Physician Decision|0|||
147106997|NCT00855582|530555830|FG002|Overall Study|Physician Decision|1|||
147106998|NCT00855582|530555828|FG000|Overall Study|Protocol Violation|6|||
147106999|NCT00855582|530555829|FG001|Overall Study|Protocol Violation|2|||
147107000|NCT00855582|530555830|FG002|Overall Study|Protocol Violation|6|||
147107001|NCT00855582|530555828|FG000|Overall Study|Entry Criteria Not Met|8|||
147107002|NCT00855582|530555829|FG001|Overall Study|Entry Criteria Not Met|6|||
147107003|NCT00855582|530555830|FG002|Overall Study|Entry Criteria Not Met|3|||
147107004|NCT00855582|530555828|FG000|Overall Study|Withdrawal by Subject|7|||
147107005|NCT00855582|530555829|FG001|Overall Study|Withdrawal by Subject|4|||
147107006|NCT00855582|530555830|FG002|Overall Study|Withdrawal by Subject|8|||
147107007|NCT03345004|530555834|FG000|Overall Study|Physician Decision|1|||
147107008|NCT03345004|530555835|FG001|Overall Study|Physician Decision|0|||
147107009|NCT03345004|530555834|FG000|Overall Study|Withdrawal by Subject|0|||
147107010|NCT03345004|530555835|FG001|Overall Study|Withdrawal by Subject|1|||
147107011|NCT01013753|530555840|FG000|Overall Study|Adverse Event|8|||
147107012|NCT01013753|530555840|FG000|Overall Study|Protocol Violation|3|||
147107013|NCT01013753|530555840|FG000|Overall Study|Lost to Follow-up|1|||
147107014|NCT01013753|530555840|FG000|Overall Study|Withdrawal by Subject|2|||
147107015|NCT01013753|530555840|FG000|Overall Study|Other|2|||
147107016|NCT03286504|530555844|FG000|Overall Study|Lost to Follow-up|19|||
147107017|NCT03286504|530555845|FG001|Overall Study|Lost to Follow-up|16|||
147107018|NCT00851591|530555852|FG000|Overall Study|Withdrawal by Subject|2|||
147107019|NCT00851591|530555853|FG001|Overall Study|Withdrawal by Subject|0|||
147107020|NCT00634504|530555854|FG000|Overall Study|Protocol Violation|1|||
147107021|NCT00634504|530555855|FG001|Overall Study|Protocol Violation|0|||
147107022|NCT02110693|530555856|FG000|Overall Study|Withdrawal by Subject|6|||
147107023|NCT02110693|530555857|FG001|Overall Study|Withdrawal by Subject|7|||
147107024|NCT02110693|530555856|FG000|Overall Study|skipped assessment|15|||
147107025|NCT02110693|530555857|FG001|Overall Study|skipped assessment|18|||
147107026|NCT02110693|530555856|FG000|Overall Study|technical difficulties|6|||
147107027|NCT02110693|530555857|FG001|Overall Study|technical difficulties|4|||
147107028|NCT02110693|530555856|FG000|Overall Study|Other|1|||
147107029|NCT02110693|530555857|FG001|Overall Study|Other|0|||
147107030|NCT01186770|530555860|FG000|Overall Study|Ineligibility|0|||
147107031|NCT01186770|530555861|FG001|Overall Study|Ineligibility|0|||
147107032|NCT01186770|530555862|FG002|Overall Study|Ineligibility|2|||
147107033|NCT01186770|530555863|FG003|Overall Study|Ineligibility|0|||
147107034|NCT01186770|530555860|FG000|Overall Study|Protocol Violation|7|||
147107035|NCT01186770|530555861|FG001|Overall Study|Protocol Violation|9|||
147107036|NCT01186770|530555862|FG002|Overall Study|Protocol Violation|12|||
147107037|NCT01186770|530555863|FG003|Overall Study|Protocol Violation|14|||
147107038|NCT01186770|530555860|FG000|Overall Study|Adverse Event|2|||
147107039|NCT01186770|530555861|FG001|Overall Study|Adverse Event|9|||
147107040|NCT01186770|530555862|FG002|Overall Study|Adverse Event|7|||
147107041|NCT01186770|530555863|FG003|Overall Study|Adverse Event|9|||
147107042|NCT01186770|530555860|FG000|Overall Study|Withdrawal by Subject|15|||
147107043|NCT01186770|530555861|FG001|Overall Study|Withdrawal by Subject|13|||
147107044|NCT01186770|530555862|FG002|Overall Study|Withdrawal by Subject|11|||
147107045|NCT01186770|530555863|FG003|Overall Study|Withdrawal by Subject|17|||
147107046|NCT01186770|530555860|FG000|Overall Study|Lost to Follow-up|10|||
147107047|NCT01186770|530555861|FG001|Overall Study|Lost to Follow-up|6|||
147107048|NCT01186770|530555862|FG002|Overall Study|Lost to Follow-up|14|||
147107049|NCT01186770|530555863|FG003|Overall Study|Lost to Follow-up|9|||
147107050|NCT01186770|530555860|FG000|Overall Study|Insufficient response to treatment|7|||
147107051|NCT01186770|530555861|FG001|Overall Study|Insufficient response to treatment|8|||
147107052|NCT01186770|530555862|FG002|Overall Study|Insufficient response to treatment|5|||
147107053|NCT01186770|530555863|FG003|Overall Study|Insufficient response to treatment|7|||
147107054|NCT01186770|530555860|FG000|Overall Study|Other than specified|0|||
147107055|NCT01186770|530555861|FG001|Overall Study|Other than specified|1|||
147107056|NCT01186770|530555862|FG002|Overall Study|Other than specified|1|||
147107057|NCT01186770|530555863|FG003|Overall Study|Other than specified|2|||
147107058|NCT01394276|530555864|FG000|Overall Study|Related Adverse event (AEs)|15|||
147107059|NCT01394276|530555864|FG000|Overall Study|Not related AEs|9|||
147107060|NCT01394276|530555864|FG000|Overall Study|Remission of disease|2|||
147107061|NCT01394276|530555864|FG000|Overall Study|Insufficient therapeutic effect|17|||
147107062|NCT01394276|530555864|FG000|Overall Study|Insufficient compliance|9|||
147107063|NCT01394276|530555864|FG000|Overall Study|Lost to Follow-up|5|||
147107064|NCT01394276|530555864|FG000|Overall Study|Participant moved to another site|1|||
147107065|NCT01394276|530555864|FG000|Overall Study|Pregnancy|1|||
147107066|NCT01394276|530555864|FG000|Overall Study|unavailability of drug at the Hospital|2|||
147107067|NCT01394276|530555864|FG000|Overall Study|Symptoms of concurrent diseases|1|||
147107068|NCT02696798|530555865|FG000|Blinded Treatment Dosing Period|Adverse Event|2|||
147107069|NCT02696798|530555866|FG001|Blinded Treatment Dosing Period|Adverse Event|9|||
147107070|NCT02696798|530555867|FG002|Blinded Treatment Dosing Period|Adverse Event|2|||
147107071|NCT02696798|530555865|FG000|Blinded Treatment Dosing Period|Death|0|||
147107072|NCT02696798|530555866|FG001|Blinded Treatment Dosing Period|Death|0|||
147107073|NCT02696798|530555867|FG002|Blinded Treatment Dosing Period|Death|1|||
147107074|NCT02696798|530555865|FG000|Blinded Treatment Dosing Period|Lack of Efficacy|2|||
147107075|NCT02696798|530555866|FG001|Blinded Treatment Dosing Period|Lack of Efficacy|1|||
147107076|NCT02696798|530555867|FG002|Blinded Treatment Dosing Period|Lack of Efficacy|1|||
147107077|NCT02696798|530555865|FG000|Blinded Treatment Dosing Period|Lost to Follow-up|0|||
147107078|NCT02696798|530555866|FG001|Blinded Treatment Dosing Period|Lost to Follow-up|1|||
147107079|NCT02696798|530555867|FG002|Blinded Treatment Dosing Period|Lost to Follow-up|0|||
147107080|NCT02696798|530555865|FG000|Blinded Treatment Dosing Period|Physician Decision|0|||
147107081|NCT02696798|530555866|FG001|Blinded Treatment Dosing Period|Physician Decision|1|||
147107082|NCT02696798|530555867|FG002|Blinded Treatment Dosing Period|Physician Decision|0|||
147107083|NCT02696798|530555865|FG000|Blinded Treatment Dosing Period|Withdrawal by Subject|7|||
147107084|NCT02696798|530555866|FG001|Blinded Treatment Dosing Period|Withdrawal by Subject|3|||
147107085|NCT02696798|530555867|FG002|Blinded Treatment Dosing Period|Withdrawal by Subject|4|||
147558123|NCT01089647|532201364|FG000|Overall Study|Lost to Follow-up|2|||
147558124|NCT01089647|532201365|FG001|Overall Study|Lost to Follow-up|2|||
147558125|NCT01089647|532201364|FG000|Overall Study|Withdrawal by Subject|2|||
147558126|NCT01089647|532201365|FG001|Overall Study|Withdrawal by Subject|1|||
147558127|NCT01089647|532201364|FG000|Overall Study|Adverse Event|0|||
147558128|NCT01089647|532201365|FG001|Overall Study|Adverse Event|1|||
147558129|NCT00927810|532201366|FG000|Overall Study|Withdrawal by Subject|0|||
147107086|NCT02696798|530555865|FG000|Extended Treatment Period|Adverse Event|1|||
147107087|NCT02696798|530555866|FG001|Extended Treatment Period|Adverse Event|4|||
147107088|NCT02696798|530555867|FG002|Extended Treatment Period|Adverse Event|5|||
147107089|NCT02696798|530555865|FG000|Extended Treatment Period|Lack of Efficacy|7|||
147107090|NCT02696798|530555866|FG001|Extended Treatment Period|Lack of Efficacy|2|||
147107091|NCT02696798|530555867|FG002|Extended Treatment Period|Lack of Efficacy|2|||
147107092|NCT02696798|530555865|FG000|Extended Treatment Period|Lost to Follow-up|1|||
147107093|NCT02696798|530555866|FG001|Extended Treatment Period|Lost to Follow-up|0|||
147107094|NCT02696798|530555867|FG002|Extended Treatment Period|Lost to Follow-up|0|||
147107095|NCT02696798|530555865|FG000|Extended Treatment Period|Physician Decision|0|||
147107096|NCT02696798|530555866|FG001|Extended Treatment Period|Physician Decision|1|||
147558130|NCT00927810|532201367|FG001|Overall Study|Withdrawal by Subject|3|||
147558131|NCT00927810|532201368|FG002|Overall Study|Withdrawal by Subject|0|||
147558132|NCT00927810|532201369|FG003|Overall Study|Withdrawal by Subject|1|||
147107097|NCT02696798|530555867|FG002|Extended Treatment Period|Physician Decision|0|||
147107098|NCT02696798|530555865|FG000|Extended Treatment Period|Withdrawal by Subject|3|||
147107099|NCT02696798|530555866|FG001|Extended Treatment Period|Withdrawal by Subject|2|||
147107100|NCT02696798|530555867|FG002|Extended Treatment Period|Withdrawal by Subject|3|||
147107101|NCT02696798|530555865|FG000|Post-treatment Follow-up Period|Adverse Event|2|||
147107102|NCT02696798|530555866|FG001|Post-treatment Follow-up Period|Adverse Event|12|||
147107103|NCT02696798|530555867|FG002|Post-treatment Follow-up Period|Adverse Event|6|||
147107104|NCT02696798|530555865|FG000|Post-treatment Follow-up Period|Lost to Follow-up|0|||
147107105|NCT02696798|530555866|FG001|Post-treatment Follow-up Period|Lost to Follow-up|1|||
147107106|NCT02696798|530555867|FG002|Post-treatment Follow-up Period|Lost to Follow-up|1|||
147107107|NCT02696798|530555865|FG000|Post-treatment Follow-up Period|Lack of Efficacy|1|||
147107108|NCT02696798|530555866|FG001|Post-treatment Follow-up Period|Lack of Efficacy|2|||
147107109|NCT02696798|530555867|FG002|Post-treatment Follow-up Period|Lack of Efficacy|0|||
147107110|NCT02696798|530555865|FG000|Post-treatment Follow-up Period|Withdrawal by Subject|2|||
147107111|NCT02696798|530555866|FG001|Post-treatment Follow-up Period|Withdrawal by Subject|8|||
147107112|NCT02696798|530555867|FG002|Post-treatment Follow-up Period|Withdrawal by Subject|12|||
147107113|NCT02696798|530555865|FG000|Post-treatment Follow-up Period|Physician Decision|0|||
147107114|NCT02696798|530555866|FG001|Post-treatment Follow-up Period|Physician Decision|2|||
147107115|NCT02696798|530555867|FG002|Post-treatment Follow-up Period|Physician Decision|0|||
147107116|NCT02696798|530555865|FG000|Post-treatment Follow-up Period|No progressive improvement|0|||
147107117|NCT02696798|530555866|FG001|Post-treatment Follow-up Period|No progressive improvement|1|||
147107118|NCT02696798|530555867|FG002|Post-treatment Follow-up Period|No progressive improvement|0|||
147107119|NCT01277861|530555868|FG000|Overall Study|Physician Decision|2|||
147107120|NCT01277861|530555869|FG001|Overall Study|Physician Decision|2|||
147107121|NCT01157845|530555872|FG000|Overall Study|Lost to Follow-up|5|||
147107122|NCT01157845|530555872|FG000|Overall Study|Withdrawal by Subject|12|||
147107123|NCT01157845|530555872|FG000|Overall Study|Physician Decision|3|||
147107124|NCT01157845|530555872|FG000|Overall Study|Protocol Violation|13|||
147107125|NCT01157845|530555872|FG000|Overall Study|Study was ended|1|||
147107126|NCT01157845|530555872|FG000|Overall Study|Device malfunction|1|||
147107127|NCT03311555|530555873|FG000|Overall Study|Adverse Event|1|||
147107128|NCT02394275|530557518|FG000|Overall Study|Adverse Event|22|||
147107129|NCT02394275|530557518|FG000|Overall Study|Lost to Follow-up|7|||
147107130|NCT00782067|530557519|FG000|Overall Study|Adverse Event|35|||
147107131|NCT00782067|530557519|FG000|Overall Study|Subject withdrew consent|11|||
147107132|NCT00782067|530557519|FG000|Overall Study|Lost to Follow-up|2|||
147107133|NCT00782067|530557519|FG000|Overall Study|Administrative problems|14|||
147107134|NCT00782067|530557519|FG000|Overall Study|Death|9|||
147107135|NCT00782067|530557519|FG000|Overall Study|Disease progression|43|||
147107136|NCT00782067|530557519|FG000|Overall Study|Protocol deviation|2|||
147107137|NCT04757636|530557520|FG000|Overall Study|Adverse Event|25|||
147107138|NCT04757636|530557521|FG001|Overall Study|Adverse Event|8|||
147107139|NCT04757636|530557522|FG002|Overall Study|Adverse Event|11|||
147107140|NCT04757636|530557520|FG000|Overall Study|Death|9|||
147107141|NCT04757636|530557521|FG001|Overall Study|Death|12|||
147107142|NCT04757636|530557522|FG002|Overall Study|Death|6|||
147107143|NCT04757636|530557520|FG000|Overall Study|Lack of Efficacy|2|||
147107144|NCT04757636|530557521|FG001|Overall Study|Lack of Efficacy|0|||
147107145|NCT04757636|530557522|FG002|Overall Study|Lack of Efficacy|0|||
147107146|NCT04757636|530557520|FG000|Overall Study|Lost to Follow-up|1|||
147558133|NCT00927810|532201366|FG000|Overall Study|Lost to Follow-up|0|||
147558134|NCT00927810|532201367|FG001|Overall Study|Lost to Follow-up|2|||
147558135|NCT00927810|532201368|FG002|Overall Study|Lost to Follow-up|1|||
147558136|NCT00927810|532201369|FG003|Overall Study|Lost to Follow-up|1|||
147558137|NCT00927810|532201366|FG000|Overall Study|Death|0|||
147558138|NCT00927810|532201367|FG001|Overall Study|Death|2|||
147107147|NCT04757636|530557521|FG001|Overall Study|Lost to Follow-up|6|||
147107148|NCT04757636|530557522|FG002|Overall Study|Lost to Follow-up|7|||
147107149|NCT04757636|530557520|FG000|Overall Study|Physician Decision|1|||
147107150|NCT04757636|530557521|FG001|Overall Study|Physician Decision|3|||
147107151|NCT04757636|530557522|FG002|Overall Study|Physician Decision|4|||
147107152|NCT04757636|530557520|FG000|Overall Study|Withdrawal by Subject|20|||
147107153|NCT04757636|530557521|FG001|Overall Study|Withdrawal by Subject|23|||
147107154|NCT04757636|530557522|FG002|Overall Study|Withdrawal by Subject|18|||
147107155|NCT04757636|530557520|FG000|Overall Study|Discontinued Study Treatment at or prior to Week 52|0|||
147107156|NCT04757636|530557521|FG001|Overall Study|Discontinued Study Treatment at or prior to Week 52|1|||
147107157|NCT04757636|530557522|FG002|Overall Study|Discontinued Study Treatment at or prior to Week 52|0|||
147558139|NCT00927810|532201368|FG002|Overall Study|Death|0|||
147107158|NCT04757636|530557520|FG000|Overall Study|Study Terminated by Sponsor|103|||
147107159|NCT04757636|530557521|FG001|Overall Study|Study Terminated by Sponsor|104|||
147107160|NCT04757636|530557522|FG002|Overall Study|Study Terminated by Sponsor|114|||
147107161|NCT04757636|530557520|FG000|Overall Study|Sponsor Decision|0|||
147107162|NCT04757636|530557521|FG001|Overall Study|Sponsor Decision|0|||
147558140|NCT00927810|532201369|FG003|Overall Study|Death|0|||
147558141|NCT00927810|532201366|FG000|Overall Study|Abnormal laboratory value(s)|0|||
147107163|NCT04757636|530557522|FG002|Overall Study|Sponsor Decision|1|||
147107164|NCT04757636|530557520|FG000|Overall Study|Randomized in Error|0|||
147107165|NCT04757636|530557521|FG001|Overall Study|Randomized in Error|0|||
147107166|NCT04757636|530557522|FG002|Overall Study|Randomized in Error|2|||
147107167|NCT00141921|530557524|FG000|Overall Study|Remain on Study|28|||
147558142|NCT00927810|532201367|FG001|Overall Study|Abnormal laboratory value(s)|1|||
147558143|NCT00927810|532201368|FG002|Overall Study|Abnormal laboratory value(s)|0|||
147558144|NCT00927810|532201369|FG003|Overall Study|Abnormal laboratory value(s)|0|||
147558145|NCT00198029|532201370|FG000|Overall Study|Withdrawal by Subject|4|||
147558146|NCT02465567|532201371|FG000|Overall Study|Adverse Event|118|||
147558147|NCT02465567|532201372|FG001|Overall Study|Adverse Event|113|||
147558148|NCT02465567|532201373|FG002|Overall Study|Adverse Event|147|||
147558149|NCT02465567|532201374|FG003|Overall Study|Adverse Event|138|||
147558150|NCT02465567|532201371|FG000|Overall Study|Lack of Efficacy|103|||
147558151|NCT02465567|532201372|FG001|Overall Study|Lack of Efficacy|102|||
147558152|NCT02465567|532201373|FG002|Overall Study|Lack of Efficacy|171|||
147107168|NCT00141921|530557524|FG000|Overall Study|Withdrawal by Subject|42|||
147107169|NCT00141921|530557524|FG000|Overall Study|Lost to Follow-up|19|||
147107170|NCT00141921|530557524|FG000|Overall Study|Noncompliance|17|||
147107171|NCT00141921|530557524|FG000|Overall Study|Disease Progression|7|||
147107172|NCT00141921|530557524|FG000|Overall Study|Protocol Deviation|7|||
147107173|NCT00141921|530557524|FG000|Overall Study|Adverse Event|5|||
147107174|NCT00141921|530557524|FG000|Overall Study|Administrative Decision|2|||
147107175|NCT00141921|530557524|FG000|Overall Study|Pregnancy|4|||
147107176|NCT00141921|530557524|FG000|Overall Study|Ineligibility Determined|2|||
147107177|NCT00141921|530557524|FG000|Overall Study|Other|8|||
147107178|NCT03813654|530557527|FG000|Overall Study|Protocol Violation|0|||
147107179|NCT03813654|530557528|FG001|Overall Study|Protocol Violation|1|||
147107180|NCT03813654|530557529|FG002|Overall Study|Protocol Violation|2|||
147107181|NCT03813654|530557527|FG000|Overall Study|Withdrawal by Subject|1|||
147107182|NCT03813654|530557528|FG001|Overall Study|Withdrawal by Subject|0|||
147107183|NCT03813654|530557529|FG002|Overall Study|Withdrawal by Subject|0|||
147107184|NCT01732692|530557530|FG000|Overall Study|Adverse Event|0|||
147107185|NCT01732692|530557531|FG001|Overall Study|Adverse Event|1|||
147107186|NCT01155323|530557532|FG000|First Intervention|exclusion criteria|1|||
147107187|NCT01155323|530557533|FG001|First Intervention|exclusion criteria|1|||
147107188|NCT01155323|530557532|FG000|Second Intervention|Lost to Follow-up|1|||
147107189|NCT01155323|530557533|FG001|Second Intervention|Lost to Follow-up|1|||
147107190|NCT01208051|530557549|FG000|Total Enrollment|Withdrawal by Subject|0|||
147107191|NCT01208051|530557550|FG001|Total Enrollment|Withdrawal by Subject|1|||
147107192|NCT01208051|530557551|FG002|Total Enrollment|Withdrawal by Subject|0|||
147107193|NCT01208051|530557552|FG003|Total Enrollment|Withdrawal by Subject|0|||
147107194|NCT01208051|530557553|FG004|Total Enrollment|Withdrawal by Subject|2|||
147107195|NCT01208051|530557549|FG000|Total Enrollment|Brain metastases|0|||
147107196|NCT01208051|530557550|FG001|Total Enrollment|Brain metastases|0|||
147107197|NCT01208051|530557551|FG002|Total Enrollment|Brain metastases|1|||
147107198|NCT01208051|530557552|FG003|Total Enrollment|Brain metastases|0|||
147107199|NCT01208051|530557553|FG004|Total Enrollment|Brain metastases|0|||
147107200|NCT02349386|530557555|FG000|24-Week Double-Blind Main Study|Adverse Event|0|||
147107201|NCT02349386|530557556|FG001|24-Week Double-Blind Main Study|Adverse Event|0|||
147107202|NCT02349386|530557557|FG002|24-Week Double-Blind Main Study|Adverse Event|1|||
147107203|NCT02349386|530557558|FG003|24-Week Double-Blind Main Study|Adverse Event|1|||
147107204|NCT02349386|530557555|FG000|24-Week Double-Blind Main Study|Lack of Efficacy|6|||
147107205|NCT02349386|530557556|FG001|24-Week Double-Blind Main Study|Lack of Efficacy|6|||
147107206|NCT02349386|530557557|FG002|24-Week Double-Blind Main Study|Lack of Efficacy|2|||
147107207|NCT02349386|530557558|FG003|24-Week Double-Blind Main Study|Lack of Efficacy|7|||
147107208|NCT02349386|530557555|FG000|24-Week Double-Blind Main Study|Withdrawal by Subject|0|||
147225356|NCT00282347|530996639|FG000|Treatment Period|Lost to Follow-up|2|||
147225357|NCT00282347|530996640|FG001|Treatment Period|Lost to Follow-up|5|||
147558153|NCT02465567|532201374|FG003|Overall Study|Lack of Efficacy|135|||
147558154|NCT02465567|532201371|FG000|Overall Study|Withdrawal by Subject|104|||
147107209|NCT02349386|530557556|FG001|24-Week Double-Blind Main Study|Withdrawal by Subject|0|||
147107210|NCT02349386|530557557|FG002|24-Week Double-Blind Main Study|Withdrawal by Subject|1|||
147225358|NCT00282347|530996639|FG000|Treatment Period|Withdrawal by Subject|1|||
147225359|NCT00282347|530996640|FG001|Treatment Period|Withdrawal by Subject|3|||
147558155|NCT02465567|532201372|FG001|Overall Study|Withdrawal by Subject|94|||
147107211|NCT02349386|530557558|FG003|24-Week Double-Blind Main Study|Withdrawal by Subject|0|||
147107212|NCT02349386|530557555|FG000|24-Week Double-Blind Main Study|Patient underwent transurethral resection of prostate (exclusionary procedure)|0|||
147107213|NCT02349386|530557556|FG001|24-Week Double-Blind Main Study|Patient underwent transurethral resection of prostate (exclusionary procedure)|0|||
147107214|NCT02349386|530557557|FG002|24-Week Double-Blind Main Study|Patient underwent transurethral resection of prostate (exclusionary procedure)|1|||
147225360|NCT00282347|530996639|FG000|Treatment Period|Physician Decision|0|||
147107215|NCT02349386|530557558|FG003|24-Week Double-Blind Main Study|Patient underwent transurethral resection of prostate (exclusionary procedure)|0|||
147310682|NCT01087723|531305040|FG000|Overall Study|Physician Decision|2|||
147558156|NCT02465567|532201373|FG002|Overall Study|Withdrawal by Subject|123|||
147107216|NCT02349386|530557555|FG000|28-Week Double-Blind Optional Extension|Lack of Efficacy|2|||
147107217|NCT02349386|530557556|FG001|28-Week Double-Blind Optional Extension|Lack of Efficacy|0|||
147107218|NCT02349386|530557557|FG002|28-Week Double-Blind Optional Extension|Lack of Efficacy|2|||
147107219|NCT02349386|530557558|FG003|28-Week Double-Blind Optional Extension|Lack of Efficacy|0|||
147107220|NCT02349386|530557555|FG000|28-Week Double-Blind Optional Extension|Withdrawal by Subject|0|||
147107221|NCT02349386|530557556|FG001|28-Week Double-Blind Optional Extension|Withdrawal by Subject|0|||
147107222|NCT02349386|530557557|FG002|28-Week Double-Blind Optional Extension|Withdrawal by Subject|1|||
147107223|NCT02349386|530557558|FG003|28-Week Double-Blind Optional Extension|Withdrawal by Subject|0|||
147107224|NCT00973973|530557559|FG000|Double-blind Treatment Phase (Weeks 1-8)|Adverse Event|1|||
147107225|NCT00973973|530557560|FG001|Double-blind Treatment Phase (Weeks 1-8)|Adverse Event|3|||
147107226|NCT00973973|530557559|FG000|Double-blind Treatment Phase (Weeks 1-8)|Protocol Deviation|1|||
147107227|NCT00973973|530557560|FG001|Double-blind Treatment Phase (Weeks 1-8)|Protocol Deviation|0|||
147107228|NCT00973973|530557559|FG000|Double-blind Treatment Phase (Weeks 1-8)|Withdrawal by Subject|1|||
147107229|NCT00973973|530557560|FG001|Double-blind Treatment Phase (Weeks 1-8)|Withdrawal by Subject|3|||
147107230|NCT00973973|530557559|FG000|Double-blind Treatment Phase (Weeks 1-8)|Lack of Efficacy|1|||
147107231|NCT00973973|530557560|FG001|Double-blind Treatment Phase (Weeks 1-8)|Lack of Efficacy|0|||
147107232|NCT00973973|530557559|FG000|Double-blind Treatment Phase (Weeks 1-8)|Lost to Follow-up|1|||
147107233|NCT00973973|530557560|FG001|Double-blind Treatment Phase (Weeks 1-8)|Lost to Follow-up|1|||
147107234|NCT00973973|530557559|FG000|Double-blind Treatment Phase (Weeks 1-8)|Sponsor/Investigator Decision|1|||
147107235|NCT00973973|530557560|FG001|Double-blind Treatment Phase (Weeks 1-8)|Sponsor/Investigator Decision|1|||
147107236|NCT00973973|530557559|FG000|Open-label Treatment Phase (Weeks 8-24)|Adverse Event|1|||
147107237|NCT00973973|530557560|FG001|Open-label Treatment Phase (Weeks 8-24)|Adverse Event|2|||
147107238|NCT00973973|530557559|FG000|Open-label Treatment Phase (Weeks 8-24)|Protocol Deviation|1|||
147107239|NCT00973973|530557560|FG001|Open-label Treatment Phase (Weeks 8-24)|Protocol Deviation|0|||
147107240|NCT00973973|530557559|FG000|Open-label Treatment Phase (Weeks 8-24)|Noncompliance|1|||
147107241|NCT00973973|530557560|FG001|Open-label Treatment Phase (Weeks 8-24)|Noncompliance|0|||
147107242|NCT00973973|530557559|FG000|Open-label Treatment Phase (Weeks 8-24)|Withdrawal by Subject|1|||
147107243|NCT00973973|530557560|FG001|Open-label Treatment Phase (Weeks 8-24)|Withdrawal by Subject|3|||
147107244|NCT00973973|530557559|FG000|Open-label Treatment Phase (Weeks 8-24)|Lost to Follow-up|1|||
147107245|NCT00973973|530557560|FG001|Open-label Treatment Phase (Weeks 8-24)|Lost to Follow-up|0|||
147107246|NCT00973973|530557559|FG000|Open-label Treatment Phase (Weeks 8-24)|Sponsor/Investigator Decision|1|||
147107247|NCT00973973|530557560|FG001|Open-label Treatment Phase (Weeks 8-24)|Sponsor/Investigator Decision|0|||
147107248|NCT02471339|530557561|FG000|Overall Study|Did not provide follow-up data|2|||
147107249|NCT02471339|530557562|FG001|Overall Study|Did not provide follow-up data|0|||
147107250|NCT00984867|530557563|FG000|Overall Study|Adverse Event|3|||
147107251|NCT00984867|530557564|FG001|Overall Study|Adverse Event|7|||
147107252|NCT00984867|530557563|FG000|Overall Study|Death|1|||
147107253|NCT00984867|530557564|FG001|Overall Study|Death|0|||
147107254|NCT00984867|530557563|FG000|Overall Study|Withdrawal by Subject|13|||
147107255|NCT00984867|530557564|FG001|Overall Study|Withdrawal by Subject|4|||
147107256|NCT00984867|530557563|FG000|Overall Study|Lost to Follow-up|3|||
147107257|NCT00984867|530557564|FG001|Overall Study|Lost to Follow-up|4|||
147107258|NCT00984867|530557563|FG000|Overall Study|Poor/non-compliance|0|||
147107259|NCT00984867|530557564|FG001|Overall Study|Poor/non-compliance|1|||
147107260|NCT00984867|530557563|FG000|Overall Study|Subject no longer meets study criteria|1|||
147107261|NCT00984867|530557564|FG001|Overall Study|Subject no longer meets study criteria|1|||
147107262|NCT00984867|530557563|FG000|Overall Study|site closing|1|||
147107263|NCT00984867|530557564|FG001|Overall Study|site closing|0|||
147107264|NCT00984867|530557563|FG000|Overall Study|lack of efficacy and subject compliance|1|||
147107265|NCT00984867|530557564|FG001|Overall Study|lack of efficacy and subject compliance|0|||
147107266|NCT06057064|530557565|FG000|Overall Study|Death|2|||
147107267|NCT06057064|530557566|FG001|Overall Study|Death|0|||
147107268|NCT06057064|530557565|FG000|Overall Study|Physician Decision|1|||
147107269|NCT06057064|530557566|FG001|Overall Study|Physician Decision|0|||
147107270|NCT06057064|530557565|FG000|Overall Study|Withdrawal by Subject|1|||
147107271|NCT06057064|530557566|FG001|Overall Study|Withdrawal by Subject|1|||
147558157|NCT02465567|532201374|FG003|Overall Study|Withdrawal by Subject|130|||
147558158|NCT02465567|532201371|FG000|Overall Study|Physician Decision|23|||
147558159|NCT02465567|532201372|FG001|Overall Study|Physician Decision|33|||
147558160|NCT02465567|532201373|FG002|Overall Study|Physician Decision|38|||
147558161|NCT02465567|532201374|FG003|Overall Study|Physician Decision|28|||
147558162|NCT02465567|532201371|FG000|Overall Study|Major Protocol Deviation|24|||
147107272|NCT01541748|530557567|FG000|Overall Study|Lost to Follow-up|17|||
147107273|NCT01541748|530557567|FG000|Overall Study|Moved out of state|1|||
147107274|NCT01541748|530557567|FG000|Overall Study|Withdrawal by Subject|7|||
147107275|NCT01541748|530557567|FG000|Overall Study|Screen failure|5|||
147107276|NCT01541748|530557567|FG000|Overall Study|Did not receive study device|1|||
147558163|NCT02465567|532201372|FG001|Overall Study|Major Protocol Deviation|26|||
147558164|NCT02465567|532201373|FG002|Overall Study|Major Protocol Deviation|22|||
147558165|NCT02465567|532201374|FG003|Overall Study|Major Protocol Deviation|25|||
147558166|NCT02465567|532201371|FG000|Overall Study|Lost to Follow-up|25|||
147107277|NCT00626639|530557575|FG000|Overall Study|Occurrence of grade 3 oral mucositis|2|||
147107278|NCT00626639|530557576|FG001|Overall Study|Occurrence of grade 3 oral mucositis|2|||
147107279|NCT01461551|530557577|FG000|Overall Study|Physician Decision|2|||
147107280|NCT01461551|530557578|FG001|Overall Study|Physician Decision|1|||
147107281|NCT01461551|530557579|FG002|Overall Study|Physician Decision|2|||
147107282|NCT01155141|530557580|FG000|Overall Study|Withdrawal by Subject|1|||
147107283|NCT01155141|530557580|FG000|Overall Study|Screen Failure|1|||
147107284|NCT03473197|530557582|FG000|Overall Study|Adverse Event|4|||
147107285|NCT03473197|530557582|FG000|Overall Study|Lost to Follow-up|1|||
147107286|NCT03473197|530557582|FG000|Overall Study|Withdrawal by Subject|5|||
147107287|NCT00785629|530557583|FG000|Overall Study|Adverse Event|2|||
147107288|NCT00785629|530557584|FG001|Overall Study|Adverse Event|1|||
147107289|NCT00785629|530557585|FG002|Overall Study|Adverse Event|1|||
147107290|NCT00785629|530557586|FG003|Overall Study|Adverse Event|5|||
147107291|NCT00785629|530557583|FG000|Overall Study|Protocol Violation|1|||
147107292|NCT00785629|530557584|FG001|Overall Study|Protocol Violation|2|||
147107293|NCT00785629|530557585|FG002|Overall Study|Protocol Violation|4|||
147107294|NCT00785629|530557586|FG003|Overall Study|Protocol Violation|5|||
147107295|NCT00785629|530557583|FG000|Overall Study|administrative decision|5|||
147107296|NCT00785629|530557584|FG001|Overall Study|administrative decision|1|||
147107297|NCT00785629|530557585|FG002|Overall Study|administrative decision|3|||
147107298|NCT00785629|530557586|FG003|Overall Study|administrative decision|4|||
147107299|NCT00785629|530557583|FG000|Overall Study|Withdrawal by Subject|0|||
147107300|NCT00785629|530557584|FG001|Overall Study|Withdrawal by Subject|1|||
147107301|NCT00785629|530557585|FG002|Overall Study|Withdrawal by Subject|2|||
147107302|NCT00785629|530557586|FG003|Overall Study|Withdrawal by Subject|2|||
147107303|NCT02326883|530557590|FG000|Overall Study|Disenrolled or died prior to first follow-up day - not included in outcome or adverse event counts|84|||
147107304|NCT02326883|530557591|FG001|Overall Study|Disenrolled or died prior to first follow-up day - not included in outcome or adverse event counts|85|||
147107305|NCT02326883|530557592|FG002|Overall Study|Disenrolled or died prior to first follow-up day - not included in outcome or adverse event counts|69|||
147107306|NCT02107898|530557596|FG000|Overall Study|Adverse Event|4|||
147107307|NCT02107898|530557597|FG001|Overall Study|Adverse Event|7|||
147107308|NCT02107898|530557596|FG000|Overall Study|Poor compliance to protocol|0|||
147107309|NCT02107898|530557597|FG001|Overall Study|Poor compliance to protocol|1|||
147107310|NCT02107898|530557596|FG000|Overall Study|Participant moved|0|||
147107311|NCT02107898|530557597|FG001|Overall Study|Participant moved|2|||
147107312|NCT02107898|530557596|FG000|Overall Study|Consent withdrawn by participant|2|||
147107313|NCT02107898|530557597|FG001|Overall Study|Consent withdrawn by participant|1|||
147107314|NCT02107898|530557596|FG000|Overall Study|Randomized but not treated|0|||
147107315|NCT02107898|530557597|FG001|Overall Study|Randomized but not treated|1|||
147107316|NCT03329989|530557598|FG000|Overall Study|Withdrawal by Subject|9|||
147107317|NCT03329989|530557598|FG000|Overall Study|Lost to Follow-up|8|||
147107318|NCT03329989|530557598|FG000|Overall Study|Adverse Event|5|||
147107319|NCT03329989|530557598|FG000|Overall Study|Protocol Violation|1|||
147107320|NCT01283386|530557599|FG000|Overall Study|Death|2|||
147107321|NCT01283386|530557600|FG001|Overall Study|Death|0|||
147107322|NCT01283386|530557599|FG000|Overall Study|Withdrawal by Subject|2|||
147107323|NCT01283386|530557600|FG001|Overall Study|Withdrawal by Subject|1|||
147107324|NCT01283386|530557599|FG000|Overall Study|Relapse of underlying disease|1|||
147107325|NCT01283386|530557600|FG001|Overall Study|Relapse of underlying disease|3|||
147107326|NCT01283386|530557599|FG000|Overall Study|Progression of underlying disease|2|||
147107327|NCT01283386|530557600|FG001|Overall Study|Progression of underlying disease|7|||
147107328|NCT01283386|530557599|FG000|Overall Study|Reason not specified|1|||
147107329|NCT01283386|530557600|FG001|Overall Study|Reason not specified|0|||
147107330|NCT01283386|530557599|FG000|Overall Study|Protocol Violation|0|||
147107331|NCT01283386|530557600|FG001|Overall Study|Protocol Violation|1|||
147107332|NCT02469857|530557601|FG000|Overall Study|Death|24|||
147225361|NCT00282347|530996640|FG001|Treatment Period|Physician Decision|1|||
147225362|NCT00282347|530996639|FG000|Safety Follow-up Period|Lost to Follow-up|0|||
147225363|NCT00282347|530996640|FG001|Safety Follow-up Period|Lost to Follow-up|2|||
147225364|NCT00282347|530996639|FG000|Safety Follow-up Period|Withdrawal by Subject|2|||
147225365|NCT00282347|530996640|FG001|Safety Follow-up Period|Withdrawal by Subject|1|||
147225366|NCT00282347|530996639|FG000|Safety Follow-up Period|Physician Decision|1|||
147225367|NCT00282347|530996640|FG001|Safety Follow-up Period|Physician Decision|1|||
147225368|NCT00282347|530996639|FG000|Safety Follow-up Period|Protocol Deviation|0|||
147310683|NCT01087723|531305041|FG001|Overall Study|Physician Decision|0|||
147107333|NCT02469857|530557602|FG001|Overall Study|Death|29|||
147225369|NCT00282347|530996640|FG001|Safety Follow-up Period|Protocol Deviation|2|||
147310684|NCT01087723|531305040|FG000|Overall Study|Lost to Follow-up|1|||
147310685|NCT01087723|531305041|FG001|Overall Study|Lost to Follow-up|4|||
147310686|NCT01087723|531305040|FG000|Overall Study|Reason Not Specified|1|||
147107334|NCT02469857|530557601|FG000|Overall Study|Discontinuation|1|||
147107335|NCT02469857|530557602|FG001|Overall Study|Discontinuation|3|||
147107336|NCT00937950|530557603|FG000|Overall Study|Withdrawal by Subject|23|||
147107337|NCT00937950|530557603|FG000|Overall Study|Migrated/moved from study area|27|||
147107338|NCT00937950|530557603|FG000|Overall Study|Lost to Follow-up|144|||
147107339|NCT00937950|530557603|FG000|Overall Study|Missing confirmed|4|||
147107340|NCT00937950|530557603|FG000|Overall Study|Other|18|||
147107341|NCT03483103|530557606|FG000|Pre-Treatment Phase|Other reasons|1|||
147107342|NCT03483103|530557606|FG000|Pre-Treatment Phase|No longer meets eligibility criteria|4|||
147107343|NCT03483103|530557606|FG000|Pre-Treatment Phase|Disease-related complications|1|||
147107344|NCT03483103|530557606|FG000|Pre-Treatment Phase|Death|5|||
147107345|NCT03483103|530557606|FG000|Treatment Phase|Withdrawal by Subject|7|||
147107346|NCT03483103|530557606|FG000|Treatment Phase|Other reasons|1|||
147107347|NCT03483103|530557606|FG000|Treatment Phase|Death|23|||
147107348|NCT03483103|530557606|FG000|Treatment Phase|Did not receive either JAR017 or nonconforming product|1|||
147107349|NCT03483103|530557606|FG000|Treatment Phase|Received nonconforming product|1|||
147107350|NCT02378181|530557607|FG000|Overall Study|Lost to Follow-up|2|||
147107351|NCT02378181|530557608|FG001|Overall Study|Lost to Follow-up|5|||
147107352|NCT02378181|530557607|FG000|Overall Study|Withdrawal by Subject|1|||
147107353|NCT02378181|530557608|FG001|Overall Study|Withdrawal by Subject|1|||
147107354|NCT02378181|530557607|FG000|Overall Study|Incarcerated|0|||
147107355|NCT02378181|530557608|FG001|Overall Study|Incarcerated|1|||
147107356|NCT00297167|530557609|FG000|Open-label Dose Normalization Period 1|Withdrawal by Subject|0|||
147107357|NCT00297167|530557610|FG001|Open-label Dose Normalization Period 1|Withdrawal by Subject|0|||
147107358|NCT00297167|530557611|FG002|Open-label Dose Normalization Period 1|Withdrawal by Subject|1|||
147107359|NCT00297167|530557609|FG000|Second Double-blind Intervention Period|Protocol Violation|1|||
147107360|NCT00297167|530557610|FG001|Second Double-blind Intervention Period|Protocol Violation|0|||
147107361|NCT00297167|530557611|FG002|Second Double-blind Intervention Period|Protocol Violation|0|||
147107362|NCT01898130|530557613|FG000|Treatment|Withdrawal by Subject|2|||
147107363|NCT01898130|530557613|FG000|Treatment|Progressive Disease|4|||
147107364|NCT01898130|530557613|FG000|Follow up Until PD or Death|Lost to Follow-up|1|||
147107365|NCT00920816|530557614|FG000|Overall Study|Death|116|||
147107366|NCT00920816|530557615|FG001|Overall Study|Death|63|||
147107367|NCT00920816|530557616|FG002|Overall Study|Death|8|||
147107368|NCT00920816|530557617|FG003|Overall Study|Death|3|||
147107369|NCT00920816|530557614|FG000|Overall Study|Participant refused continued treatment for reason other than adverse events|11|||
147107370|NCT00920816|530557615|FG001|Overall Study|Participant refused continued treatment for reason other than adverse events|5|||
147107371|NCT00920816|530557616|FG002|Overall Study|Participant refused continued treatment for reason other than adverse events|1|||
147107372|NCT00920816|530557617|FG003|Overall Study|Participant refused continued treatment for reason other than adverse events|0|||
147107373|NCT00920816|530557614|FG000|Overall Study|Global deterioration of health status|2|||
147107374|NCT00920816|530557615|FG001|Overall Study|Global deterioration of health status|0|||
147107375|NCT00920816|530557616|FG002|Overall Study|Global deterioration of health status|0|||
147107376|NCT00920816|530557617|FG003|Overall Study|Global deterioration of health status|0|||
147107377|NCT00920816|530557614|FG000|Overall Study|Objective progression or relapse|6|||
147107378|NCT00920816|530557615|FG001|Overall Study|Objective progression or relapse|2|||
147107379|NCT00920816|530557616|FG002|Overall Study|Objective progression or relapse|0|||
147107380|NCT00920816|530557617|FG003|Overall Study|Objective progression or relapse|0|||
147107381|NCT00920816|530557614|FG000|Overall Study|Other|26|||
147107382|NCT00920816|530557615|FG001|Overall Study|Other|15|||
147107383|NCT00920816|530557616|FG002|Overall Study|Other|1|||
147107384|NCT00920816|530557617|FG003|Overall Study|Other|2|||
147107385|NCT00920816|530557614|FG000|Overall Study|Lost to Follow-up|11|||
147558167|NCT02465567|532201372|FG001|Overall Study|Lost to Follow-up|21|||
147558168|NCT02465567|532201373|FG002|Overall Study|Lost to Follow-up|19|||
147558169|NCT02465567|532201374|FG003|Overall Study|Lost to Follow-up|15|||
147558170|NCT02465567|532201371|FG000|Overall Study|Protocol Specified Criteria|20|||
147558171|NCT02465567|532201372|FG001|Overall Study|Protocol Specified Criteria|10|||
147558172|NCT02465567|532201373|FG002|Overall Study|Protocol Specified Criteria|9|||
147558173|NCT02465567|532201374|FG003|Overall Study|Protocol Specified Criteria|12|||
147558174|NCT02465567|532201371|FG000|Overall Study|Administrative Reasons|12|||
147558175|NCT02465567|532201372|FG001|Overall Study|Administrative Reasons|9|||
147558176|NCT02465567|532201373|FG002|Overall Study|Administrative Reasons|11|||
147558177|NCT02465567|532201374|FG003|Overall Study|Administrative Reasons|5|||
147558178|NCT02465567|532201371|FG000|Overall Study|Randomized but not treated|1|||
147558179|NCT02465567|532201372|FG001|Overall Study|Randomized but not treated|5|||
147558180|NCT02465567|532201373|FG002|Overall Study|Randomized but not treated|4|||
147558181|NCT02465567|532201374|FG003|Overall Study|Randomized but not treated|5|||
147558182|NCT02465567|532201371|FG000|Overall Study|enrolled in >1 studies|18|||
147558183|NCT02465567|532201372|FG001|Overall Study|enrolled in >1 studies|11|||
147558184|NCT02465567|532201373|FG002|Overall Study|enrolled in >1 studies|19|||
147558185|NCT02465567|532201374|FG003|Overall Study|enrolled in >1 studies|15|||
147558186|NCT02465567|532201371|FG000|Overall Study|missing PI Signature|1|||
147558187|NCT02465567|532201372|FG001|Overall Study|missing PI Signature|0|||
147558188|NCT02465567|532201373|FG002|Overall Study|missing PI Signature|0|||
147107386|NCT00920816|530557615|FG001|Overall Study|Lost to Follow-up|2|||
147107387|NCT00920816|530557616|FG002|Overall Study|Lost to Follow-up|0|||
147107388|NCT00920816|530557617|FG003|Overall Study|Lost to Follow-up|0|||
147107389|NCT00920816|530557614|FG000|Overall Study|Adverse Event|1|||
147107390|NCT00920816|530557615|FG001|Overall Study|Adverse Event|1|||
147107391|NCT00920816|530557616|FG002|Overall Study|Adverse Event|1|||
147107392|NCT00920816|530557617|FG003|Overall Study|Adverse Event|0|||
147107393|NCT00920816|530557614|FG000|Overall Study|Data not disclosed due to lack of HGRAC filings|16|||
147107394|NCT00920816|530557615|FG001|Overall Study|Data not disclosed due to lack of HGRAC filings|8|||
147107395|NCT00920816|530557616|FG002|Overall Study|Data not disclosed due to lack of HGRAC filings|124|||
147107396|NCT00920816|530557617|FG003|Overall Study|Data not disclosed due to lack of HGRAC filings|64|||
147107397|NCT00920816|530557614|FG000|Overall Study|Randomized but not treated|3|||
147107398|NCT00920816|530557615|FG001|Overall Study|Randomized but not treated|0|||
147107399|NCT00920816|530557616|FG002|Overall Study|Randomized but not treated|0|||
147107400|NCT00920816|530557617|FG003|Overall Study|Randomized but not treated|0|||
147107401|NCT04167462|530557620|FG000|Overall Study|Other reasons|3|||
147107402|NCT04167462|530557621|FG001|Overall Study|Other reasons|2|||
147107403|NCT04167462|530557620|FG000|Overall Study|Withdrawal by Subject|6|||
147107404|NCT04167462|530557621|FG001|Overall Study|Withdrawal by Subject|7|||
147107405|NCT04167462|530557620|FG000|Overall Study|Adverse Event|4|||
147107406|NCT04167462|530557621|FG001|Overall Study|Adverse Event|0|||
147107407|NCT04167462|530557620|FG000|Overall Study|Pregnancy|1|||
147107408|NCT04167462|530557621|FG001|Overall Study|Pregnancy|0|||
147107409|NCT04167462|530557620|FG000|Overall Study|Lack of Efficacy|0|||
147107410|NCT04167462|530557621|FG001|Overall Study|Lack of Efficacy|1|||
147107411|NCT03331562|530557622|FG000|Overall Study|Adverse Event|2|||
147107412|NCT03331562|530557623|FG001|Overall Study|Adverse Event|0|||
147107413|NCT03331562|530557622|FG000|Overall Study|Death|1|||
147310687|NCT01087723|531305041|FG001|Overall Study|Reason Not Specified|2|||
147310688|NCT01868035|531305042|FG000|Overall Study|Lost to Follow-up|3|||
147310689|NCT01868035|531305042|FG000|Overall Study|Withdrawal by Subject|1|||
147310690|NCT01868035|531305042|FG000|Overall Study|Progressive Disease|2|||
147310691|NCT01868035|531305042|FG000|Overall Study|Non-compliance|1|||
147310692|NCT01912222|531305047|FG000|Part A: Pharmacokinetic Period|Not evaluable for PK analyses|1|||
147310693|NCT01912222|531305048|FG001|Part A: Pharmacokinetic Period|Not evaluable for PK analyses|2|||
147310694|NCT01912222|531305049|FG002|Part A: Pharmacokinetic Period|Not evaluable for PK analyses|2|||
147310695|NCT01912222|531305047|FG000|Part B: Treatment Period|Progressive disease|10|||
147310696|NCT01912222|531305048|FG001|Part B: Treatment Period|Progressive disease|12|||
147310697|NCT01912222|531305049|FG002|Part B: Treatment Period|Progressive disease|15|||
147310698|NCT01912222|531305047|FG000|Part B: Treatment Period|Adverse Event|1|||
147310699|NCT01912222|531305048|FG001|Part B: Treatment Period|Adverse Event|2|||
147310700|NCT01912222|531305049|FG002|Part B: Treatment Period|Adverse Event|3|||
147310701|NCT01912222|531305047|FG000|Part B: Treatment Period|Withdrawal by Subject|2|||
147310702|NCT01912222|531305048|FG001|Part B: Treatment Period|Withdrawal by Subject|1|||
147310703|NCT01912222|531305049|FG002|Part B: Treatment Period|Withdrawal by Subject|2|||
147310704|NCT00451217|531305060|FG000|Overall Study|Lost to Follow-up|0|||
147310705|NCT00451217|531305061|FG001|Overall Study|Lost to Follow-up|1|||
147310706|NCT00451217|531305062|FG002|Overall Study|Lost to Follow-up|1|||
147310707|NCT00451217|531305063|FG003|Overall Study|Lost to Follow-up|1|||
147310708|NCT00451217|531305060|FG000|Overall Study|Withdrawal by Subject|1|||
147310709|NCT00451217|531305061|FG001|Overall Study|Withdrawal by Subject|0|||
147310710|NCT00451217|531305062|FG002|Overall Study|Withdrawal by Subject|0|||
147310711|NCT00451217|531305063|FG003|Overall Study|Withdrawal by Subject|0|||
147310712|NCT00451217|531305060|FG000|Overall Study|Not Treated|1|||
147310713|NCT00451217|531305061|FG001|Overall Study|Not Treated|1|||
147310714|NCT00451217|531305062|FG002|Overall Study|Not Treated|3|||
147310715|NCT00451217|531305063|FG003|Overall Study|Not Treated|4|||
147310716|NCT01129336|531305064|FG000|Overall Study|Protocol Violation|1|||
147310717|NCT01129336|531305065|FG001|Overall Study|Protocol Violation|0|||
147310718|NCT01129336|531305064|FG000|Overall Study|Disease Progression|1|||
147107414|NCT03331562|530557623|FG001|Overall Study|Death|0|||
147107415|NCT00505921|530557624|FG000|Overall Study|Ineligible|1|||
147107416|NCT00505921|530557624|FG000|Overall Study|Failed to Mobilize|8|||
147310719|NCT01129336|531305065|FG001|Overall Study|Disease Progression|4|||
147310720|NCT01129336|531305064|FG000|Overall Study|Lost to Follow-up|1|||
147310721|NCT01129336|531305065|FG001|Overall Study|Lost to Follow-up|0|||
147310722|NCT01129336|531305064|FG000|Overall Study|Withdrawal by Subject|7|||
147310723|NCT01129336|531305065|FG001|Overall Study|Withdrawal by Subject|4|||
147310724|NCT01129336|531305064|FG000|Overall Study|Adverse Event|0|||
147310725|NCT01129336|531305065|FG001|Overall Study|Adverse Event|1|||
147310726|NCT01129336|531305064|FG000|Overall Study|Missing Study Completion Status|2|||
147310727|NCT01129336|531305065|FG001|Overall Study|Missing Study Completion Status|3|||
147310728|NCT01129336|531305064|FG000|Overall Study|Death|0|||
147107417|NCT01033136|530557625|FG000|Follow-Up (3 Month)|Lost to Follow-up|2|||
147107418|NCT01033136|530557626|FG001|Follow-Up (3 Month)|Lost to Follow-up|2|||
147107419|NCT00142415|530557627|FG000|Overall Study|Physician Decision|0|||
147107420|NCT00142415|530557628|FG001|Overall Study|Physician Decision|0|||
147107421|NCT00142415|530557629|FG002|Overall Study|Physician Decision|0|||
147107422|NCT00142415|530557630|FG003|Overall Study|Physician Decision|0|||
147107423|NCT00142415|530557631|FG004|Overall Study|Physician Decision|1|||
147107424|NCT00142415|530557632|FG005|Overall Study|Physician Decision|2|||
147107425|NCT01572792|530557635|FG000|Lead-in Study|Lost to Follow-up|5|||
147107426|NCT01572792|530557636|FG001|Lead-in Study|Lost to Follow-up|9|||
147107427|NCT01572792|530557637|FG002|Lead-in Study|Lost to Follow-up|4|||
147107428|NCT01572792|530557638|FG003|Lead-in Study|Lost to Follow-up|2|||
147107429|NCT01572792|530557639|FG004|Lead-in Study|Lost to Follow-up|4|||
147107430|NCT01572792|530557635|FG000|Lead-in Study|Withdrawal by Subject|22|||
147107431|NCT01572792|530557636|FG001|Lead-in Study|Withdrawal by Subject|11|||
147107432|NCT01572792|530557637|FG002|Lead-in Study|Withdrawal by Subject|12|||
147107433|NCT01572792|530557638|FG003|Lead-in Study|Withdrawal by Subject|24|||
147107434|NCT01572792|530557639|FG004|Lead-in Study|Withdrawal by Subject|11|||
147107435|NCT01572792|530557635|FG000|Lead-in Study|Protocol Violation|19|||
147107436|NCT01572792|530557636|FG001|Lead-in Study|Protocol Violation|10|||
147107437|NCT01572792|530557637|FG002|Lead-in Study|Protocol Violation|12|||
147107438|NCT01572792|530557638|FG003|Lead-in Study|Protocol Violation|13|||
147107439|NCT01572792|530557639|FG004|Lead-in Study|Protocol Violation|21|||
147107440|NCT01572792|530557635|FG000|Lead-in Study|Lack of Efficacy|20|||
147107441|NCT01572792|530557636|FG001|Lead-in Study|Lack of Efficacy|5|||
147107442|NCT01572792|530557637|FG002|Lead-in Study|Lack of Efficacy|4|||
147107443|NCT01572792|530557638|FG003|Lead-in Study|Lack of Efficacy|8|||
147107444|NCT01572792|530557639|FG004|Lead-in Study|Lack of Efficacy|10|||
147107445|NCT01572792|530557635|FG000|Lead-in Study|Adverse Event|21|||
147558189|NCT02465567|532201374|FG003|Overall Study|missing PI Signature|0|||
147558190|NCT02001558|532201375|FG000|Overall Study|Lost to Follow-up|8|||
147558191|NCT02001558|532201376|FG001|Overall Study|Lost to Follow-up|14|||
147558192|NCT04117607|532201377|FG000|Overall Study|Early Termination|0|||
147558193|NCT04117607|532201378|FG001|Overall Study|Early Termination|1|||
147558194|NCT04117607|532201379|FG002|Overall Study|Early Termination|0|||
147558195|NCT04117607|532201380|FG003|Overall Study|Early Termination|0|||
147558196|NCT04117607|532201381|FG004|Overall Study|Early Termination|0|||
147558197|NCT04117607|532201382|FG005|Overall Study|Early Termination|0|||
147558198|NCT04117607|532201383|FG006|Overall Study|Early Termination|1|||
147558199|NCT04117607|532201384|FG007|Overall Study|Early Termination|0|||
147558200|NCT04117607|532201385|FG008|Overall Study|Early Termination|0|||
147558201|NCT04117607|532201386|FG009|Overall Study|Early Termination|0|||
147558202|NCT04117607|532201387|FG010|Overall Study|Early Termination|0|||
147558203|NCT04117607|532201388|FG011|Overall Study|Early Termination|0|||
147558204|NCT04117607|532201389|FG012|Overall Study|Early Termination|0|||
147558205|NCT04117607|532201390|FG013|Overall Study|Early Termination|0|||
147558206|NCT02780687|532201393|FG000|Overall Study|Adverse Event|1|||
147558207|NCT02780687|532201394|FG001|Overall Study|Adverse Event|1|||
147558208|NCT02780687|532201393|FG000|Overall Study|Withdrawal by Subject|2|||
147558209|NCT02780687|532201394|FG001|Overall Study|Withdrawal by Subject|1|||
147558210|NCT02780687|532201393|FG000|Overall Study|Switched to commercial program (in CTP)|2|||
147558211|NCT02780687|532201394|FG001|Overall Study|Switched to commercial program (in CTP)|0|||
147558212|NCT02780687|532201393|FG000|Overall Study|progressive disease|29|||
147558213|NCT02780687|532201394|FG001|Overall Study|progressive disease|6|||
147558214|NCT02430870|532201395|FG000|Part 2|Voluntary Withdrawal|0|||
147558215|NCT02430870|532201396|FG001|Part 2|Voluntary Withdrawal|0|||
147558216|NCT02430870|532201397|FG002|Part 2|Voluntary Withdrawal|0|||
147558217|NCT02430870|532201398|FG003|Part 2|Voluntary Withdrawal|0|||
147558218|NCT02430870|532201399|FG004|Part 2|Voluntary Withdrawal|0|||
147558219|NCT02430870|532201400|FG005|Part 2|Voluntary Withdrawal|0|||
147558220|NCT02430870|532201401|FG006|Part 2|Voluntary Withdrawal|1|||
147558221|NCT02430870|532201402|FG007|Part 2|Voluntary Withdrawal|0|||
147558222|NCT02430870|532201395|FG000|Part 2|Other Reason Not Specified|0|||
147558223|NCT02430870|532201396|FG001|Part 2|Other Reason Not Specified|0|||
147558224|NCT02430870|532201397|FG002|Part 2|Other Reason Not Specified|0|||
147558225|NCT02430870|532201398|FG003|Part 2|Other Reason Not Specified|0|||
147558226|NCT02430870|532201399|FG004|Part 2|Other Reason Not Specified|0|||
147558227|NCT02430870|532201400|FG005|Part 2|Other Reason Not Specified|0|||
147558228|NCT02430870|532201401|FG006|Part 2|Other Reason Not Specified|0|||
147558229|NCT02430870|532201402|FG007|Part 2|Other Reason Not Specified|1|||
147558230|NCT03982433|532201403|FG000|Overall Study|Lost to Follow-up|1|||
147558231|NCT04257929|532201406|FG000|Overall Study|Adverse Event|1|||
147107446|NCT01572792|530557636|FG001|Lead-in Study|Adverse Event|21|||
147107447|NCT01572792|530557637|FG002|Lead-in Study|Adverse Event|22|||
147558232|NCT04257929|532201407|FG001|Overall Study|Adverse Event|0|||
147558233|NCT04257929|532201408|FG002|Overall Study|Adverse Event|1|||
147558234|NCT04257929|532201406|FG000|Overall Study|Withdrawal by Subject|1|||
147558235|NCT04257929|532201407|FG001|Overall Study|Withdrawal by Subject|0|||
147558236|NCT04257929|532201408|FG002|Overall Study|Withdrawal by Subject|0|||
147558237|NCT04257929|532201406|FG000|Overall Study|COVID-19|0|||
147107448|NCT01572792|530557638|FG003|Lead-in Study|Adverse Event|16|||
147107449|NCT01572792|530557639|FG004|Lead-in Study|Adverse Event|14|||
147107450|NCT01572792|530557635|FG000|Lead-in Study|Site termination/COPD exacerbation/other|14|||
147107451|NCT01572792|530557636|FG001|Lead-in Study|Site termination/COPD exacerbation/other|10|||
147310729|NCT01129336|531305065|FG001|Overall Study|Death|4|||
147558238|NCT04257929|532201407|FG001|Overall Study|COVID-19|1|||
147558239|NCT04257929|532201408|FG002|Overall Study|COVID-19|1|||
147558240|NCT04257929|532201406|FG000|Overall Study|Lost to Follow-up|0|||
147558241|NCT04257929|532201407|FG001|Overall Study|Lost to Follow-up|0|||
147558242|NCT04257929|532201408|FG002|Overall Study|Lost to Follow-up|1|||
147558243|NCT05049460|532201409|FG000|Overall Study|Withdrawal by Subject|2|||
147558244|NCT05049460|532201410|FG001|Overall Study|Withdrawal by Subject|2|||
147558245|NCT05049460|532201409|FG000|Overall Study|Lost to Follow-up|2|||
147558246|NCT05049460|532201410|FG001|Overall Study|Lost to Follow-up|2|||
147558247|NCT04333095|532201415|FG000|Overall Study|Protocol Violation|4|||
147558248|NCT04333095|532201416|FG001|Overall Study|Protocol Violation|0|||
147558249|NCT04333095|532201415|FG000|Overall Study|Unblinded anesthesiologist unavailable to give block at the time of surgery|1|||
147558250|NCT04333095|532201416|FG001|Overall Study|Unblinded anesthesiologist unavailable to give block at the time of surgery|4|||
147558251|NCT04333095|532201415|FG000|Overall Study|Mini Sternotomy|4|||
147558252|NCT04333095|532201416|FG001|Overall Study|Mini Sternotomy|5|||
147558253|NCT03740165|532201417|FG000|Overall Study|Death|232|||
147558254|NCT03740165|532201418|FG001|Overall Study|Death|242|||
147558255|NCT03740165|532201419|FG002|Overall Study|Death|229|||
147558256|NCT03740165|532201417|FG000|Overall Study|Lost to Follow-up|0|||
147558257|NCT03740165|532201418|FG001|Overall Study|Lost to Follow-up|0|||
147558258|NCT03740165|532201419|FG002|Overall Study|Lost to Follow-up|1|||
147558259|NCT03740165|532201417|FG000|Overall Study|Withdrawal by Subject|7|||
147558260|NCT03740165|532201418|FG001|Overall Study|Withdrawal by Subject|4|||
147558261|NCT03740165|532201419|FG002|Overall Study|Withdrawal by Subject|3|||
147558262|NCT03740165|532201417|FG000|Overall Study|Ongoing in Study|216|||
147558263|NCT03740165|532201418|FG001|Overall Study|Ongoing in Study|212|||
147558264|NCT03740165|532201419|FG002|Overall Study|Ongoing in Study|221|||
147558265|NCT03049618|532201420|FG000|Overall Study|Death|1|||
147558266|NCT03049618|532201421|FG001|Overall Study|Death|0|||
147558267|NCT03049618|532201420|FG000|Overall Study|Lack of Efficacy|1|||
147558268|NCT03049618|532201421|FG001|Overall Study|Lack of Efficacy|2|||
147558269|NCT04582539|532201422|FG000|Overall Study|Death|1|||
147558270|NCT04582539|532201423|FG001|Overall Study|Death|1|||
147558271|NCT04582539|532201424|FG002|Overall Study|Death|0|||
147558272|NCT04582539|532201425|FG003|Overall Study|Death|1|||
147558273|NCT04582539|532201426|FG004|Overall Study|Death|0|||
147558274|NCT04582539|532201422|FG000|Overall Study|Lost to Follow-up|1|||
147558275|NCT04582539|532201423|FG001|Overall Study|Lost to Follow-up|0|||
147558276|NCT04582539|532201424|FG002|Overall Study|Lost to Follow-up|0|||
147558277|NCT04582539|532201425|FG003|Overall Study|Lost to Follow-up|0|||
147558278|NCT04582539|532201426|FG004|Overall Study|Lost to Follow-up|0|||
147558279|NCT04582539|532201422|FG000|Overall Study|Study Terminated by Sponsor|1|||
147558280|NCT04582539|532201423|FG001|Overall Study|Study Terminated by Sponsor|3|||
147558281|NCT04582539|532201424|FG002|Overall Study|Study Terminated by Sponsor|2|||
147558282|NCT04582539|532201425|FG003|Overall Study|Study Terminated by Sponsor|2|||
147558283|NCT04582539|532201426|FG004|Overall Study|Study Terminated by Sponsor|3|||
147558284|NCT04582539|532201422|FG000|Overall Study|Physician Decision|0|||
147558285|NCT04582539|532201423|FG001|Overall Study|Physician Decision|1|||
147558286|NCT04582539|532201424|FG002|Overall Study|Physician Decision|0|||
147558287|NCT04582539|532201425|FG003|Overall Study|Physician Decision|0|||
147558288|NCT04582539|532201426|FG004|Overall Study|Physician Decision|0|||
147558289|NCT04582539|532201422|FG000|Overall Study|Withdrawal by Subject|1|||
147558290|NCT04582539|532201423|FG001|Overall Study|Withdrawal by Subject|0|||
147558291|NCT04582539|532201424|FG002|Overall Study|Withdrawal by Subject|2|||
147558292|NCT04582539|532201425|FG003|Overall Study|Withdrawal by Subject|1|||
147558293|NCT04582539|532201426|FG004|Overall Study|Withdrawal by Subject|0|||
147558294|NCT04582539|532201422|FG000|Overall Study|Participant Started New Therapy; Did Not Return to Clinic|0|||
147558295|NCT04582539|532201423|FG001|Overall Study|Participant Started New Therapy; Did Not Return to Clinic|0|||
147558296|NCT04582539|532201424|FG002|Overall Study|Participant Started New Therapy; Did Not Return to Clinic|0|||
147558297|NCT04582539|532201425|FG003|Overall Study|Participant Started New Therapy; Did Not Return to Clinic|1|||
147558298|NCT04582539|532201426|FG004|Overall Study|Participant Started New Therapy; Did Not Return to Clinic|0|||
147558299|NCT00788957|532201435|FG000|Part 1|Death|8|||
147558300|NCT00788957|532201436|FG001|Part 1|Death|0|||
147558301|NCT00788957|532201437|FG002|Part 1|Death|0|||
147558302|NCT00788957|532201438|FG003|Part 1|Death|0|||
147558303|NCT00788957|532201439|FG004|Part 1|Death|0|||
147558304|NCT00788957|532201440|FG005|Part 1|Death|0|||
147558305|NCT00788957|532201435|FG000|Part 1|Lost to Follow-up|1|||
147558306|NCT00788957|532201436|FG001|Part 1|Lost to Follow-up|0|||
147558307|NCT00788957|532201437|FG002|Part 1|Lost to Follow-up|0|||
147558308|NCT00788957|532201438|FG003|Part 1|Lost to Follow-up|0|||
147558309|NCT00788957|532201439|FG004|Part 1|Lost to Follow-up|0|||
147558310|NCT00788957|532201440|FG005|Part 1|Lost to Follow-up|0|||
147558311|NCT00788957|532201435|FG000|Part 2|Withdrawal by Subject|0|||
147558312|NCT00788957|532201436|FG001|Part 2|Withdrawal by Subject|9|||
147558313|NCT00788957|532201437|FG002|Part 2|Withdrawal by Subject|5|||
147558314|NCT00788957|532201438|FG003|Part 2|Withdrawal by Subject|3|||
147558315|NCT00788957|532201439|FG004|Part 2|Withdrawal by Subject|0|||
147558316|NCT00788957|532201440|FG005|Part 2|Withdrawal by Subject|0|||
147558317|NCT00788957|532201435|FG000|Part 2|Death|0|||
147558318|NCT00788957|532201436|FG001|Part 2|Death|32|||
147558319|NCT00788957|532201437|FG002|Part 2|Death|35|||
147558320|NCT00788957|532201438|FG003|Part 2|Death|37|||
147558321|NCT00788957|532201439|FG004|Part 2|Death|0|||
147558322|NCT00788957|532201440|FG005|Part 2|Death|0|||
147558323|NCT00788957|532201435|FG000|Part 2|Lost to Follow-up|0|||
147558324|NCT00788957|532201436|FG001|Part 2|Lost to Follow-up|0|||
147558325|NCT00788957|532201437|FG002|Part 2|Lost to Follow-up|3|||
147558326|NCT00788957|532201438|FG003|Part 2|Lost to Follow-up|0|||
147558327|NCT00788957|532201439|FG004|Part 2|Lost to Follow-up|0|||
147558328|NCT00788957|532201440|FG005|Part 2|Lost to Follow-up|0|||
147558329|NCT00788957|532201435|FG000|Part 2|On-study at time of data cut-off|0|||
147558330|NCT00788957|532201436|FG001|Part 2|On-study at time of data cut-off|1|||
147558331|NCT00788957|532201437|FG002|Part 2|On-study at time of data cut-off|1|||
147558332|NCT00788957|532201438|FG003|Part 2|On-study at time of data cut-off|1|||
147558333|NCT00788957|532201439|FG004|Part 2|On-study at time of data cut-off|0|||
147558334|NCT00788957|532201440|FG005|Part 2|On-study at time of data cut-off|0|||
147558335|NCT00788957|532201435|FG000|Part 3|Withdrawal by Subject|0|||
147558336|NCT00788957|532201436|FG001|Part 3|Withdrawal by Subject|0|||
147558337|NCT00788957|532201437|FG002|Part 3|Withdrawal by Subject|0|||
147558338|NCT00788957|532201438|FG003|Part 3|Withdrawal by Subject|0|||
147558339|NCT00788957|532201439|FG004|Part 3|Withdrawal by Subject|0|||
147558340|NCT00788957|532201440|FG005|Part 3|Withdrawal by Subject|2|||
147558341|NCT00788957|532201435|FG000|Part 3|Death|0|||
147558342|NCT00788957|532201436|FG001|Part 3|Death|0|||
147558343|NCT00788957|532201437|FG002|Part 3|Death|0|||
147558344|NCT00788957|532201438|FG003|Part 3|Death|0|||
147558345|NCT00788957|532201439|FG004|Part 3|Death|8|||
147558346|NCT00788957|532201440|FG005|Part 3|Death|8|||
147558347|NCT00788957|532201435|FG000|Part 3|On-study at time of data cut-off|0|||
147558348|NCT00788957|532201436|FG001|Part 3|On-study at time of data cut-off|0|||
147558349|NCT00788957|532201437|FG002|Part 3|On-study at time of data cut-off|0|||
147558350|NCT00788957|532201438|FG003|Part 3|On-study at time of data cut-off|0|||
147558351|NCT00788957|532201439|FG004|Part 3|On-study at time of data cut-off|1|||
147558352|NCT00788957|532201440|FG005|Part 3|On-study at time of data cut-off|0|||
147558353|NCT02579096|532201443|FG000|Phase 1, Weeks 0 - 24|Side effects with study medications|10|||
147558354|NCT02579096|532201444|FG001|Phase 1, Weeks 0 - 24|Side effects with study medications|6|||
147558355|NCT02579096|532201443|FG000|Phase 1, Weeks 0 - 24|Physician Decision|2|||
147558356|NCT02579096|532201444|FG001|Phase 1, Weeks 0 - 24|Physician Decision|1|||
147558357|NCT02579096|532201443|FG000|Phase 1, Weeks 0 - 24|Withdrawal by Subject|32|||
147558358|NCT02579096|532201444|FG001|Phase 1, Weeks 0 - 24|Withdrawal by Subject|36|||
147558359|NCT02579096|532201443|FG000|Phase 1, Weeks 0 - 24|Lost to Follow-up|9|||
147558360|NCT02579096|532201444|FG001|Phase 1, Weeks 0 - 24|Lost to Follow-up|4|||
147558361|NCT02579096|532201443|FG000|Phase 1, Weeks 0 - 24|Other reasons|4|||
147558362|NCT02579096|532201444|FG001|Phase 1, Weeks 0 - 24|Other reasons|3|||
147558363|NCT02579096|532201443|FG000|Phase 2, Weeks 25 - 48|Death|2|||
147558364|NCT02579096|532201444|FG001|Phase 2, Weeks 25 - 48|Death|4|||
147558365|NCT02579096|532201443|FG000|Phase 2, Weeks 25 - 48|Side effects with study medications|3|||
147558366|NCT02579096|532201444|FG001|Phase 2, Weeks 25 - 48|Side effects with study medications|1|||
147558367|NCT02579096|532201443|FG000|Phase 2, Weeks 25 - 48|Physician Decision|4|||
147558368|NCT02579096|532201444|FG001|Phase 2, Weeks 25 - 48|Physician Decision|0|||
147558369|NCT02579096|532201443|FG000|Phase 2, Weeks 25 - 48|Withdrawal by Subject|9|||
147558370|NCT02579096|532201444|FG001|Phase 2, Weeks 25 - 48|Withdrawal by Subject|12|||
147558371|NCT02579096|532201443|FG000|Phase 2, Weeks 25 - 48|Lost to Follow-up|4|||
147558372|NCT02579096|532201444|FG001|Phase 2, Weeks 25 - 48|Lost to Follow-up|9|||
147558373|NCT02579096|532201443|FG000|Phase 2, Weeks 25 - 48|Other reasons|0|||
147558374|NCT02579096|532201444|FG001|Phase 2, Weeks 25 - 48|Other reasons|5|||
147558375|NCT02579096|532201443|FG000|Phase 3, Weeks 49 - 72|Death|3|||
147107452|NCT01572792|530557637|FG002|Lead-in Study|Site termination/COPD exacerbation/other|8|||
147558376|NCT02579096|532201444|FG001|Phase 3, Weeks 49 - 72|Death|2|||
147558377|NCT02579096|532201443|FG000|Phase 3, Weeks 49 - 72|Side effects with study medications|0|||
147558378|NCT02579096|532201444|FG001|Phase 3, Weeks 49 - 72|Side effects with study medications|1|||
147558379|NCT02579096|532201443|FG000|Phase 3, Weeks 49 - 72|Physician Decision|0|||
147558380|NCT02579096|532201444|FG001|Phase 3, Weeks 49 - 72|Physician Decision|5|||
147444141|NCT02090413|531790529|FG001|Overall Study|Investigator Decision|1|||
147558381|NCT02579096|532201443|FG000|Phase 3, Weeks 49 - 72|Withdrawal by Subject|6|||
147558382|NCT02579096|532201444|FG001|Phase 3, Weeks 49 - 72|Withdrawal by Subject|4|||
147558383|NCT02579096|532201443|FG000|Phase 3, Weeks 49 - 72|Lost to Follow-up|10|||
147558384|NCT02579096|532201444|FG001|Phase 3, Weeks 49 - 72|Lost to Follow-up|5|||
147558385|NCT02579096|532201443|FG000|Phase 3, Weeks 49 - 72|Participant required to take exclusion medication on a regular basis|0|||
147558386|NCT02579096|532201444|FG001|Phase 3, Weeks 49 - 72|Participant required to take exclusion medication on a regular basis|1|||
147558387|NCT02579096|532201443|FG000|Phase 3, Weeks 49 - 72|Other reasons|3|||
147558388|NCT02579096|532201444|FG001|Phase 3, Weeks 49 - 72|Other reasons|0|||
147558389|NCT02097121|532201445|FG000|Overall Study|Other, not specified|4|||
147558390|NCT02097121|532201446|FG001|Overall Study|Other, not specified|2|||
147558391|NCT02097121|532201447|FG002|Overall Study|Other, not specified|3|||
147558392|NCT02097121|532201445|FG000|Overall Study|Lack of Efficacy|2|||
147558393|NCT02097121|532201446|FG001|Overall Study|Lack of Efficacy|1|||
147558394|NCT02097121|532201447|FG002|Overall Study|Lack of Efficacy|3|||
147558395|NCT02097121|532201445|FG000|Overall Study|Withdrawal by Subject|0|||
147558396|NCT02097121|532201446|FG001|Overall Study|Withdrawal by Subject|1|||
147558397|NCT02097121|532201447|FG002|Overall Study|Withdrawal by Subject|2|||
147558398|NCT02097121|532201445|FG000|Overall Study|Adverse Event|0|||
147558399|NCT02097121|532201446|FG001|Overall Study|Adverse Event|1|||
147558400|NCT02097121|532201447|FG002|Overall Study|Adverse Event|0|||
147558401|NCT02097121|532201445|FG000|Overall Study|Lost to Follow-up|1|||
147558402|NCT02097121|532201446|FG001|Overall Study|Lost to Follow-up|1|||
147558403|NCT02097121|532201447|FG002|Overall Study|Lost to Follow-up|2|||
147558404|NCT03066999|532201448|FG000|Overall Study|abnormal urethraBladder neck contracture|0|||
147558405|NCT03066999|532201449|FG001|Overall Study|abnormal urethraBladder neck contracture|2|||
147558406|NCT00661999|532201450|FG000|Overall Study|Adverse Event|11|||
147558407|NCT00661999|532201451|FG001|Overall Study|Adverse Event|5|||
147558408|NCT00661999|532201452|FG002|Overall Study|Adverse Event|8|||
147558409|NCT00661999|532201450|FG000|Overall Study|Death|8|||
147558410|NCT00661999|532201451|FG001|Overall Study|Death|6|||
147558411|NCT00661999|532201452|FG002|Overall Study|Death|3|||
147558412|NCT00661999|532201450|FG000|Overall Study|Other Reasons|5|||
147558413|NCT00661999|532201451|FG001|Overall Study|Other Reasons|12|||
147558414|NCT00661999|532201452|FG002|Overall Study|Other Reasons|23|||
147558415|NCT00661999|532201450|FG000|Overall Study|Withdrawal by Subject|30|||
147558416|NCT00661999|532201451|FG001|Overall Study|Withdrawal by Subject|23|||
147558417|NCT00661999|532201452|FG002|Overall Study|Withdrawal by Subject|14|||
147558418|NCT00661999|532201450|FG000|Overall Study|Alternative Treatment|1|||
147558419|NCT00661999|532201451|FG001|Overall Study|Alternative Treatment|0|||
147558420|NCT00661999|532201452|FG002|Overall Study|Alternative Treatment|0|||
147558421|NCT00661999|532201450|FG000|Overall Study|Other Medical Problems|4|||
147558422|NCT00661999|532201451|FG001|Overall Study|Other Medical Problems|4|||
147558423|NCT00661999|532201452|FG002|Overall Study|Other Medical Problems|9|||
147558424|NCT01790568|532201453|FG000|Overall Study|Progression prior to transplant|0|||
147558425|NCT01790568|532201454|FG001|Overall Study|Progression prior to transplant|1|||
147558426|NCT01361126|532201455|FG000|Overall Study|Sponsor decision|0|||
147558427|NCT01361126|532201456|FG001|Overall Study|Sponsor decision|2|||
147107453|NCT01572792|530557638|FG003|Lead-in Study|Site termination/COPD exacerbation/other|9|||
147107454|NCT01572792|530557639|FG004|Lead-in Study|Site termination/COPD exacerbation/other|9|||
147107455|NCT01572792|530557635|FG000|Extension Study|Lost to Follow-up|6|||
147107456|NCT01572792|530557636|FG001|Extension Study|Lost to Follow-up|2|||
147107457|NCT01572792|530557637|FG002|Extension Study|Lost to Follow-up|0|||
147107458|NCT01572792|530557638|FG003|Extension Study|Lost to Follow-up|3|||
147107459|NCT01572792|530557639|FG004|Extension Study|Lost to Follow-up|3|||
147107460|NCT01572792|530557635|FG000|Extension Study|Withdrawal by Subject|7|||
147107461|NCT01572792|530557636|FG001|Extension Study|Withdrawal by Subject|6|||
147107462|NCT01572792|530557637|FG002|Extension Study|Withdrawal by Subject|11|||
147107463|NCT01572792|530557638|FG003|Extension Study|Withdrawal by Subject|8|||
147107464|NCT01572792|530557639|FG004|Extension Study|Withdrawal by Subject|14|||
147107465|NCT01572792|530557635|FG000|Extension Study|Protocol Violation|0|||
147107466|NCT01572792|530557636|FG001|Extension Study|Protocol Violation|4|||
147107467|NCT01572792|530557637|FG002|Extension Study|Protocol Violation|3|||
147107468|NCT01572792|530557638|FG003|Extension Study|Protocol Violation|4|||
147107469|NCT01572792|530557639|FG004|Extension Study|Protocol Violation|3|||
147107470|NCT01572792|530557635|FG000|Extension Study|Lack of Efficacy|2|||
147107471|NCT01572792|530557636|FG001|Extension Study|Lack of Efficacy|3|||
147107472|NCT01572792|530557637|FG002|Extension Study|Lack of Efficacy|3|||
147107473|NCT01572792|530557638|FG003|Extension Study|Lack of Efficacy|2|||
147107474|NCT01572792|530557639|FG004|Extension Study|Lack of Efficacy|2|||
147107475|NCT01572792|530557635|FG000|Extension Study|Adverse Event|7|||
147107476|NCT01572792|530557636|FG001|Extension Study|Adverse Event|6|||
147107477|NCT01572792|530557637|FG002|Extension Study|Adverse Event|5|||
147107478|NCT01572792|530557638|FG003|Extension Study|Adverse Event|6|||
147107479|NCT01572792|530557639|FG004|Extension Study|Adverse Event|4|||
147107480|NCT01572792|530557635|FG000|Extension Study|Site termination/COPD exacerbation/other|3|||
147107481|NCT01572792|530557636|FG001|Extension Study|Site termination/COPD exacerbation/other|8|||
147107482|NCT01572792|530557637|FG002|Extension Study|Site termination/COPD exacerbation/other|4|||
147107483|NCT01572792|530557638|FG003|Extension Study|Site termination/COPD exacerbation/other|6|||
147107484|NCT01572792|530557639|FG004|Extension Study|Site termination/COPD exacerbation/other|6|||
147558428|NCT02994056|532201457|FG000|Overall Study|Death|8|||
147558429|NCT02994056|532201457|FG000|Overall Study|Withdrew Consent|1|||
147558430|NCT02742181|532201458|FG000|Overall Study|Physician Decision|1|||
147558431|NCT02742181|532201459|FG001|Overall Study|Physician Decision|0|||
147558432|NCT01346410|532201460|FG000|Overall Study|Death|1|||
147107485|NCT03530696|530557641|FG000|Overall Study|Excluded for not meeting eligibility criteria upon further review|1|||
147107486|NCT03530696|530557642|FG001|Overall Study|Excluded for not meeting eligibility criteria upon further review|2|||
147107487|NCT02472353|530557643|FG000|Overall Study|Lost to Follow-up|1|||
147107488|NCT02472353|530557644|FG001|Overall Study|Lost to Follow-up|1|||
147107489|NCT02472353|530557643|FG000|Overall Study|Withdrawal by Subject|2|||
147107490|NCT02472353|530557644|FG001|Overall Study|Withdrawal by Subject|1|||
147107491|NCT02472353|530557643|FG000|Overall Study|Study Termination|1|||
147107492|NCT02472353|530557644|FG001|Overall Study|Study Termination|4|||
147107493|NCT00797563|530557645|FG000|Overall Study|Adverse Event|1|||
147107494|NCT03416179|530557646|FG000|Overall Study|Death|90|||
147107495|NCT03416179|530557647|FG001|Overall Study|Death|87|||
147107496|NCT03416179|530557648|FG002|Overall Study|Death|117|||
147107497|NCT03416179|530557649|FG003|Overall Study|Death|113|||
147107498|NCT03416179|530557646|FG000|Overall Study|Withdrawal by Subject|15|||
147107499|NCT03416179|530557647|FG001|Overall Study|Withdrawal by Subject|20|||
147107500|NCT03416179|530557648|FG002|Overall Study|Withdrawal by Subject|6|||
147107501|NCT03416179|530557649|FG003|Overall Study|Withdrawal by Subject|9|||
147107502|NCT03416179|530557646|FG000|Overall Study|Lost to Follow-up|1|||
147107503|NCT03416179|530557647|FG001|Overall Study|Lost to Follow-up|1|||
147107504|NCT03416179|530557648|FG002|Overall Study|Lost to Follow-up|0|||
147107505|NCT03416179|530557649|FG003|Overall Study|Lost to Follow-up|3|||
147107506|NCT03416179|530557646|FG000|Overall Study|Study participation terminated by Sponsor|93|||
147107507|NCT03416179|530557647|FG001|Overall Study|Study participation terminated by Sponsor|91|||
147107508|NCT03416179|530557648|FG002|Overall Study|Study participation terminated by Sponsor|26|||
147107509|NCT03416179|530557649|FG003|Overall Study|Study participation terminated by Sponsor|31|||
147107510|NCT03416179|530557646|FG000|Overall Study|Other|2|||
147107511|NCT03416179|530557647|FG001|Overall Study|Other|3|||
147107512|NCT03416179|530557648|FG002|Overall Study|Other|1|||
147107513|NCT03416179|530557649|FG003|Overall Study|Other|0|||
147107514|NCT00688597|530557651|FG000|Overall Study|Adverse Event|2|||
147107515|NCT00688597|530557652|FG001|Overall Study|Adverse Event|0|||
147107516|NCT00688597|530557653|FG002|Overall Study|Adverse Event|0|||
147107517|NCT00688597|530557651|FG000|Overall Study|Physician Decision|1|||
147107518|NCT00688597|530557652|FG001|Overall Study|Physician Decision|0|||
147107519|NCT00688597|530557653|FG002|Overall Study|Physician Decision|0|||
147107520|NCT06438601|530557654|FG000|Period 1: Lens A (15 Minutes)|Withdrawal by Subject|1|||
147107521|NCT06438601|530557655|FG001|Period 1: Lens A (15 Minutes)|Withdrawal by Subject|0|||
147107522|NCT06438601|530557654|FG000|Period 1: Lens A (15 Minutes)|Use of eye drops between study visits|1|||
147107523|NCT06438601|530557655|FG001|Period 1: Lens A (15 Minutes)|Use of eye drops between study visits|0|||
147107524|NCT05233761|530557658|FG000|Treatment Period A|Withdrawal by Subject|12|||
147107525|NCT05233761|530557659|FG001|Treatment Period A|Withdrawal by Subject|10|||
147107526|NCT05233761|530557658|FG000|Treatment Period A|Lost to Follow-up|6|||
147107527|NCT05233761|530557659|FG001|Treatment Period A|Lost to Follow-up|12|||
147107528|NCT05233761|530557658|FG000|Treatment Period A|Protocol Violation|8|||
147107529|NCT05233761|530557659|FG001|Treatment Period A|Protocol Violation|15|||
147107530|NCT04058717|530557664|FG000|Randomization Period|Lost to Follow-up|2|||
147107531|NCT04058717|530557665|FG001|Randomization Period|Lost to Follow-up|3|||
147107532|NCT04058717|530557666|FG002|Randomization Period|Lost to Follow-up|4|||
147107533|NCT04058717|530557667|FG003|Randomization Period|Lost to Follow-up|4|||
147107534|NCT04058717|530557664|FG000|Randomization Period|Withdrawal by Subject|1|||
147107535|NCT04058717|530557665|FG001|Randomization Period|Withdrawal by Subject|3|||
147107536|NCT04058717|530557666|FG002|Randomization Period|Withdrawal by Subject|3|||
147107537|NCT04058717|530557667|FG003|Randomization Period|Withdrawal by Subject|3|||
147107538|NCT04058717|530557664|FG000|Randomization Period|PI decision|0|||
147107539|NCT04058717|530557665|FG001|Randomization Period|PI decision|1|||
147107540|NCT04058717|530557666|FG002|Randomization Period|PI decision|0|||
147107541|NCT04058717|530557667|FG003|Randomization Period|PI decision|0|||
147107542|NCT00846365|530557668|FG000|Overall Study|Adverse Event|20|||
147107543|NCT00846365|530557669|FG001|Overall Study|Adverse Event|30|||
147107544|NCT00846365|530557670|FG002|Overall Study|Adverse Event|11|||
147107545|NCT00846365|530557668|FG000|Overall Study|Protocol Violation|5|||
147107546|NCT00846365|530557669|FG001|Overall Study|Protocol Violation|4|||
147107547|NCT00846365|530557670|FG002|Overall Study|Protocol Violation|0|||
147107548|NCT00846365|530557668|FG000|Overall Study|Lost to Follow-up|8|||
147107549|NCT00846365|530557669|FG001|Overall Study|Lost to Follow-up|2|||
147107550|NCT00846365|530557670|FG002|Overall Study|Lost to Follow-up|5|||
147107551|NCT00846365|530557668|FG000|Overall Study|Withdrawal by Subject|11|||
147444142|NCT02090413|531790530|FG002|Overall Study|Investigator Decision|0|||
147107552|NCT00846365|530557669|FG001|Overall Study|Withdrawal by Subject|11|||
147107553|NCT00846365|530557670|FG002|Overall Study|Withdrawal by Subject|9|||
147107554|NCT00846365|530557668|FG000|Overall Study|Pregnancy|1|||
147107555|NCT00846365|530557669|FG001|Overall Study|Pregnancy|0|||
147107556|NCT00846365|530557670|FG002|Overall Study|Pregnancy|0|||
147107557|NCT00846365|530557668|FG000|Overall Study|Lack of Efficacy|1|||
147107558|NCT00846365|530557669|FG001|Overall Study|Lack of Efficacy|1|||
147107559|NCT00846365|530557670|FG002|Overall Study|Lack of Efficacy|2|||
147107560|NCT00846365|530557668|FG000|Overall Study|Other|9|||
147107561|NCT00846365|530557669|FG001|Overall Study|Other|1|||
147107562|NCT00846365|530557670|FG002|Overall Study|Other|6|||
147107563|NCT01925417|530557671|FG000|Overall Study|Withdrawal by Subject|2|||
147107564|NCT01925417|530557671|FG000|Overall Study|Death|1|||
147107565|NCT01047319|530557676|FG000|Overall Study|Teva requested participant withdrawal|3|||
147444143|NCT02090413|531790528|FG000|Overall Study|Other|2|||
147107566|NCT01047319|530557677|FG001|Overall Study|Teva requested participant withdrawal|0|||
147107567|NCT01047319|530557678|FG002|Overall Study|Teva requested participant withdrawal|1|||
147558433|NCT02576990|532201461|FG000|Overall Study|Death|29|||
147558434|NCT02576990|532201462|FG001|Overall Study|Death|18|||
147558435|NCT02576990|532201461|FG000|Overall Study|Physician Decision|1|||
147558436|NCT02576990|532201462|FG001|Overall Study|Physician Decision|0|||
147107568|NCT01047319|530557676|FG000|Overall Study|Protocol Violation|3|||
147107569|NCT01047319|530557677|FG001|Overall Study|Protocol Violation|2|||
147107570|NCT01047319|530557678|FG002|Overall Study|Protocol Violation|4|||
147107571|NCT01047319|530557676|FG000|Overall Study|Lack of Efficacy|4|||
147107572|NCT01047319|530557677|FG001|Overall Study|Lack of Efficacy|3|||
147107573|NCT01047319|530557678|FG002|Overall Study|Lack of Efficacy|3|||
147107574|NCT01047319|530557676|FG000|Overall Study|Death|5|||
147107575|NCT01047319|530557677|FG001|Overall Study|Death|1|||
147107576|NCT01047319|530557678|FG002|Overall Study|Death|5|||
147107577|NCT01047319|530557676|FG000|Overall Study|Pregnancy|13|||
147107578|NCT01047319|530557677|FG001|Overall Study|Pregnancy|8|||
147107579|NCT01047319|530557678|FG002|Overall Study|Pregnancy|8|||
147107580|NCT01047319|530557676|FG000|Overall Study|Physician Decision|12|||
147107581|NCT01047319|530557677|FG001|Overall Study|Physician Decision|9|||
147107582|NCT01047319|530557678|FG002|Overall Study|Physician Decision|10|||
147107583|NCT01047319|530557676|FG000|Overall Study|Lost to Follow-up|14|||
147107584|NCT01047319|530557677|FG001|Overall Study|Lost to Follow-up|10|||
147107585|NCT01047319|530557678|FG002|Overall Study|Lost to Follow-up|10|||
147107586|NCT01047319|530557676|FG000|Overall Study|Adverse Event|16|||
147107587|NCT01047319|530557677|FG001|Overall Study|Adverse Event|27|||
147107588|NCT01047319|530557678|FG002|Overall Study|Adverse Event|21|||
147107589|NCT01047319|530557676|FG000|Overall Study|Withdrawal by Subject|77|||
147107590|NCT01047319|530557677|FG001|Overall Study|Withdrawal by Subject|75|||
147107591|NCT01047319|530557678|FG002|Overall Study|Withdrawal by Subject|87|||
147107592|NCT01047319|530557676|FG000|Overall Study|Study terminated by Sponsor|198|||
147107593|NCT01047319|530557677|FG001|Overall Study|Study terminated by Sponsor|215|||
147107594|NCT01047319|530557678|FG002|Overall Study|Study terminated by Sponsor|203|||
147107595|NCT03095287|530559393|FG000|Overall Study|Treatment Failure|1|||
147107596|NCT03095287|530559393|FG000|Overall Study|Adverse Event|1|||
147107597|NCT01294514|530559396|FG000|Overall Study|Excluded due to Arrhythmia|1|||
147107598|NCT00671060|530559399|FG000|Overall Study|Protocol Violation|1|||
147107599|NCT00671060|530559400|FG001|Overall Study|Protocol Violation|0|||
147107600|NCT00671060|530559399|FG000|Overall Study|Physician Decision|0|||
147107601|NCT00671060|530559400|FG001|Overall Study|Physician Decision|1|||
147107602|NCT00303186|530559401|FG000|Overall Study|Other|52|||
147107603|NCT02020941|530559402|FG000|Overall Study|Adverse Event|1|||
147107604|NCT02020941|530559402|FG000|Overall Study|Physician Decision|2|||
147107605|NCT02020941|530559402|FG000|Overall Study|Withdrawal by Subject|1|||
147107606|NCT02020941|530559402|FG000|Overall Study|Disease Progression|4|||
147107607|NCT02832037|530559403|FG000|Overall Study|Administrative reasons|0|||
147107608|NCT02832037|530559404|FG001|Overall Study|Administrative reasons|0|||
147107609|NCT02832037|530559405|FG002|Overall Study|Administrative reasons|1|||
147107610|NCT02832037|530559406|FG003|Overall Study|Administrative reasons|0|||
147107611|NCT02832037|530559407|FG004|Overall Study|Administrative reasons|0|||
147107612|NCT02832037|530559403|FG000|Overall Study|Protocol Violation|3|||
147107613|NCT02832037|530559404|FG001|Overall Study|Protocol Violation|0|||
147107614|NCT02832037|530559405|FG002|Overall Study|Protocol Violation|4|||
147107615|NCT02832037|530559406|FG003|Overall Study|Protocol Violation|1|||
147225370|NCT00282347|530996639|FG000|B Cell Follow-up Period|Withdrawal by Subject|2|||
147225371|NCT00282347|530996640|FG001|B Cell Follow-up Period|Withdrawal by Subject|0|||
147225372|NCT00282347|530996639|FG000|B Cell Follow-up Period|Physician Decision|1|||
147225373|NCT00282347|530996640|FG001|B Cell Follow-up Period|Physician Decision|0|||
147225374|NCT00282347|530996639|FG000|B Cell Follow-up Period|Reason Not Specified|2|||
147225375|NCT00282347|530996640|FG001|B Cell Follow-up Period|Reason Not Specified|0|||
147225376|NCT02101112|530996641|FG000|Overall Study|Adverse Event|0|||
147225377|NCT02101112|530996642|FG001|Overall Study|Adverse Event|0|||
147225378|NCT02101112|530996643|FG002|Overall Study|Adverse Event|1|||
147225379|NCT02101112|530996644|FG003|Overall Study|Adverse Event|0|||
147225380|NCT02101112|530996645|FG004|Overall Study|Adverse Event|0|||
147107616|NCT02832037|530559407|FG004|Overall Study|Protocol Violation|2|||
147107617|NCT02832037|530559403|FG000|Overall Study|Lost to Follow-up|2|||
147107618|NCT02832037|530559404|FG001|Overall Study|Lost to Follow-up|0|||
147107619|NCT02832037|530559405|FG002|Overall Study|Lost to Follow-up|3|||
147107620|NCT02832037|530559406|FG003|Overall Study|Lost to Follow-up|0|||
147107621|NCT02832037|530559407|FG004|Overall Study|Lost to Follow-up|5|||
147107622|NCT02832037|530559403|FG000|Overall Study|Withdrawal by Subject|9|||
147225381|NCT02101112|530996646|FG005|Overall Study|Adverse Event|0|||
147225382|NCT02101112|530996641|FG000|Overall Study|Withdrawal by Subject|0|||
147558437|NCT02576990|532201461|FG000|Overall Study|Screen failure|2|||
147107623|NCT02832037|530559404|FG001|Overall Study|Withdrawal by Subject|8|||
147107624|NCT02832037|530559405|FG002|Overall Study|Withdrawal by Subject|0|||
147107625|NCT02832037|530559406|FG003|Overall Study|Withdrawal by Subject|4|||
147225383|NCT02101112|530996642|FG001|Overall Study|Withdrawal by Subject|0|||
147558438|NCT02576990|532201462|FG001|Overall Study|Screen failure|0|||
147558439|NCT02576990|532201461|FG000|Overall Study|Sponsor's decision|24|||
147558440|NCT02576990|532201462|FG001|Overall Study|Sponsor's decision|4|||
147558441|NCT02576990|532201461|FG000|Overall Study|Withdrawal by Subject|0|||
147558442|NCT02576990|532201462|FG001|Overall Study|Withdrawal by Subject|2|||
147558443|NCT01508936|532201464|FG000|Overall Study|Adverse Event|11|||
147558444|NCT01508936|532201465|FG001|Overall Study|Adverse Event|32|||
147558445|NCT01508936|532201464|FG000|Overall Study|Lack of Efficacy|0|||
147558446|NCT01508936|532201465|FG001|Overall Study|Lack of Efficacy|1|||
147558447|NCT01508936|532201464|FG000|Overall Study|Withdrawal by Subject|4|||
147558448|NCT01508936|532201465|FG001|Overall Study|Withdrawal by Subject|18|||
147558449|NCT01508936|532201464|FG000|Overall Study|Protocol Violation|2|||
147558450|NCT01508936|532201465|FG001|Overall Study|Protocol Violation|3|||
147558451|NCT01508936|532201464|FG000|Overall Study|Lost to Follow-up|2|||
147558452|NCT01508936|532201465|FG001|Overall Study|Lost to Follow-up|9|||
147558453|NCT01508936|532201464|FG000|Overall Study|Other|0|||
147558454|NCT01508936|532201465|FG001|Overall Study|Other|5|||
147558455|NCT01508936|532201464|FG000|Overall Study|Data from 2 sites deemed invalid|4|||
147558456|NCT01508936|532201465|FG001|Overall Study|Data from 2 sites deemed invalid|11|||
147558457|NCT00679367|532201466|FG000|Overall Study|Adverse Event|7|||
147558458|NCT00679367|532201466|FG000|Overall Study|inability to swallow oral drugs|1|||
147558459|NCT00679367|532201466|FG000|Overall Study|Lack of Efficacy|3|||
147558460|NCT00679367|532201466|FG000|Overall Study|Withdrawal by Subject|1|||
147558461|NCT03365947|532201467|FG000|Overall Study|Lost to Follow-up|0|||
147558462|NCT03365947|532201468|FG001|Overall Study|Lost to Follow-up|0|||
147558463|NCT03365947|532201469|FG002|Overall Study|Lost to Follow-up|0|||
147558464|NCT03365947|532201470|FG003|Overall Study|Lost to Follow-up|0|||
147558465|NCT03365947|532201471|FG004|Overall Study|Lost to Follow-up|0|||
147558466|NCT03365947|532201472|FG005|Overall Study|Lost to Follow-up|1|||
147558467|NCT03365947|532201473|FG006|Overall Study|Lost to Follow-up|0|||
147558468|NCT03365947|532201474|FG007|Overall Study|Lost to Follow-up|0|||
147558469|NCT03365947|532201475|FG008|Overall Study|Lost to Follow-up|0|||
147558470|NCT03365947|532201476|FG009|Overall Study|Lost to Follow-up|0|||
147558471|NCT03365947|532201477|FG010|Overall Study|Lost to Follow-up|0|||
147558472|NCT03365947|532201478|FG011|Overall Study|Lost to Follow-up|0|||
147558473|NCT03365947|532201479|FG012|Overall Study|Lost to Follow-up|0|||
147558474|NCT03365947|532201480|FG013|Overall Study|Lost to Follow-up|0|||
147558475|NCT03365947|532201481|FG014|Overall Study|Lost to Follow-up|0|||
147558476|NCT03365947|532201482|FG015|Overall Study|Lost to Follow-up|0|||
147558477|NCT03365947|532201483|FG016|Overall Study|Lost to Follow-up|0|||
147558478|NCT03365947|532201484|FG017|Overall Study|Lost to Follow-up|0|||
147558479|NCT03365947|532201485|FG018|Overall Study|Lost to Follow-up|0|||
147558480|NCT02518685|532201486|FG000|Overall Study|Adverse Event|29|||
147558481|NCT02518685|532201487|FG001|Overall Study|Adverse Event|1|||
147558482|NCT02518685|532201486|FG000|Overall Study|Withdrawal by Subject|10|||
147558483|NCT02518685|532201487|FG001|Overall Study|Withdrawal by Subject|3|||
147558484|NCT02518685|532201486|FG000|Overall Study|relocation, study fatigue|7|||
147558485|NCT02518685|532201487|FG001|Overall Study|relocation, study fatigue|2|||
147558486|NCT02518685|532201486|FG000|Overall Study|Pregnancy|1|||
147558487|NCT02518685|532201487|FG001|Overall Study|Pregnancy|0|||
147558488|NCT02518685|532201486|FG000|Overall Study|Physician Decision|1|||
147558489|NCT02518685|532201487|FG001|Overall Study|Physician Decision|0|||
147558490|NCT02518685|532201486|FG000|Overall Study|Lost to Follow-up|1|||
147558491|NCT02518685|532201487|FG001|Overall Study|Lost to Follow-up|4|||
147558492|NCT05665595|532203832|FG000|Overall Study|Ongoing|692|||
147558493|NCT05665595|532203833|FG001|Overall Study|Ongoing|698|||
147558494|NCT05665595|532203832|FG000|Overall Study|Withdrawal by Subject|2|||
147558495|NCT05665595|532203833|FG001|Overall Study|Withdrawal by Subject|2|||
147558496|NCT05665595|532203832|FG000|Overall Study|Lost to Follow-up|1|||
147558497|NCT05665595|532203833|FG001|Overall Study|Lost to Follow-up|0|||
147558498|NCT05665595|532203832|FG000|Overall Study|Death|6|||
147558499|NCT05665595|532203833|FG001|Overall Study|Death|1|||
147558500|NCT05771428|532203834|FG000|Overall Study|Adverse Event|0|||
147558501|NCT05771428|532203835|FG001|Overall Study|Adverse Event|1|||
147558502|NCT05771428|532203836|FG002|Overall Study|Adverse Event|1|||
147558503|NCT05771428|532203837|FG003|Overall Study|Adverse Event|1|||
147558504|NCT05771428|532203834|FG000|Overall Study|Withdrawal by Subject|3|||
147558505|NCT05771428|532203835|FG001|Overall Study|Withdrawal by Subject|2|||
147558506|NCT05771428|532203836|FG002|Overall Study|Withdrawal by Subject|1|||
147107626|NCT02832037|530559407|FG004|Overall Study|Withdrawal by Subject|8|||
147107627|NCT02832037|530559403|FG000|Overall Study|Adverse Event|5|||
147558507|NCT05771428|532203837|FG003|Overall Study|Withdrawal by Subject|4|||
147558508|NCT05771428|532203834|FG000|Overall Study|Other|0|||
147558509|NCT05771428|532203835|FG001|Overall Study|Other|1|||
147558510|NCT05771428|532203836|FG002|Overall Study|Other|2|||
147558511|NCT05771428|532203837|FG003|Overall Study|Other|1|||
147558512|NCT05771428|532203834|FG000|Overall Study|Randomized but Not Treated|0|||
147558513|NCT05771428|532203835|FG001|Overall Study|Randomized but Not Treated|0|||
147558514|NCT05771428|532203836|FG002|Overall Study|Randomized but Not Treated|1|||
147558515|NCT05771428|532203837|FG003|Overall Study|Randomized but Not Treated|0|||
147107628|NCT02832037|530559404|FG001|Overall Study|Adverse Event|4|||
147107629|NCT02832037|530559405|FG002|Overall Study|Adverse Event|0|||
147107630|NCT02832037|530559406|FG003|Overall Study|Adverse Event|2|||
147107631|NCT02832037|530559407|FG004|Overall Study|Adverse Event|4|||
147107632|NCT01531153|530559414|FG000|Overall Study|Withdrawal by Subject|10|||
147107633|NCT01531153|530559415|FG001|Overall Study|Withdrawal by Subject|9|||
147107634|NCT01531153|530559416|FG002|Overall Study|Withdrawal by Subject|15|||
147107635|NCT00435942|530559417|FG000|Overall Study|Death|17|||
147107636|NCT00435942|530559418|FG001|Overall Study|Death|10|||
147107637|NCT00435942|530559417|FG000|Overall Study|Withdrawal by Subject|2|||
147107638|NCT00435942|530559418|FG001|Overall Study|Withdrawal by Subject|0|||
147107639|NCT00435942|530559417|FG000|Overall Study|Lost to Follow-up|0|||
147107640|NCT00435942|530559418|FG001|Overall Study|Lost to Follow-up|16|||
147107641|NCT00435942|530559417|FG000|Overall Study|Conversion to Open Repair|1|||
147107642|NCT00435942|530559418|FG001|Overall Study|Conversion to Open Repair|0|||
147107643|NCT00435942|530559417|FG000|Overall Study|Technical Failure|3|||
147107644|NCT00435942|530559418|FG001|Overall Study|Technical Failure|0|||
147107645|NCT00435942|530559417|FG000|Overall Study|Other|0|||
147107646|NCT00435942|530559418|FG001|Overall Study|Other|1|||
147107647|NCT01180777|530559419|FG000|Overall Study|Protocol Violation|6|||
147107648|NCT01180777|530559419|FG000|Overall Study|Poor lens fit|4|||
147107649|NCT01180777|530559419|FG000|Overall Study|Lost to Follow-up|1|||
147107650|NCT01180777|530559419|FG000|Overall Study|Adverse Event|1|||
147107651|NCT04491994|530559420|FG000|Overall Study|Withdrawal by Subject|10|||
147107652|NCT04491994|530559421|FG001|Overall Study|Withdrawal by Subject|5|||
147107653|NCT04491994|530559420|FG000|Overall Study|developed fever > 3 days|4|||
147107654|NCT04491994|530559421|FG001|Overall Study|developed fever > 3 days|1|||
147107655|NCT04491994|530559420|FG000|Overall Study|Protocol Violation|11|||
147107656|NCT04491994|530559421|FG001|Overall Study|Protocol Violation|2|||
147107657|NCT04491994|530559420|FG000|Overall Study|Lost to Follow-up|4|||
147107658|NCT04491994|530559421|FG001|Overall Study|Lost to Follow-up|3|||
147107659|NCT02475213|530559424|FG000|Overall Study|Adverse Event|2|||
147107660|NCT02475213|530559425|FG001|Overall Study|Adverse Event|0|||
147107661|NCT02475213|530559426|FG002|Overall Study|Adverse Event|0|||
147107662|NCT02475213|530559427|FG003|Overall Study|Adverse Event|1|||
147107663|NCT02475213|530559428|FG004|Overall Study|Adverse Event|1|||
147107664|NCT02475213|530559429|FG005|Overall Study|Adverse Event|4|||
147107665|NCT02475213|530559430|FG006|Overall Study|Adverse Event|6|||
147107666|NCT02475213|530559431|FG007|Overall Study|Adverse Event|2|||
147107667|NCT02475213|530559424|FG000|Overall Study|Physician Decision|1|||
147310730|NCT04668989|531305069|FG000|First Intervention|Covid-19 related self-isolation|0|||
147107668|NCT02475213|530559425|FG001|Overall Study|Physician Decision|1|||
147107669|NCT02475213|530559426|FG002|Overall Study|Physician Decision|1|||
147107670|NCT02475213|530559427|FG003|Overall Study|Physician Decision|0|||
147107671|NCT02475213|530559428|FG004|Overall Study|Physician Decision|0|||
147107672|NCT02475213|530559429|FG005|Overall Study|Physician Decision|1|||
147107673|NCT02475213|530559430|FG006|Overall Study|Physician Decision|4|||
147107674|NCT02475213|530559431|FG007|Overall Study|Physician Decision|0|||
147107675|NCT02475213|530559424|FG000|Overall Study|Progressive Disease|3|||
147107676|NCT02475213|530559425|FG001|Overall Study|Progressive Disease|2|||
147107677|NCT02475213|530559426|FG002|Overall Study|Progressive Disease|2|||
147107678|NCT02475213|530559427|FG003|Overall Study|Progressive Disease|13|||
147107679|NCT02475213|530559428|FG004|Overall Study|Progressive Disease|15|||
147107680|NCT02475213|530559429|FG005|Overall Study|Progressive Disease|25|||
147310731|NCT04668989|531305070|FG001|First Intervention|Covid-19 related self-isolation|1|||
147310732|NCT04668989|531305069|FG000|Second Intervention|Adverse Event|0|||
147310733|NCT04668989|531305070|FG001|Second Intervention|Adverse Event|1|||
147310734|NCT01235975|531305074|FG000|Overall Study|Serious Adverse Event|0|||
147310735|NCT01235975|531305075|FG001|Overall Study|Serious Adverse Event|1|||
147107681|NCT02475213|530559430|FG006|Overall Study|Progressive Disease|30|||
147107682|NCT02475213|530559431|FG007|Overall Study|Progressive Disease|10|||
147107683|NCT02475213|530559424|FG000|Overall Study|Death|0|||
147107684|NCT02475213|530559425|FG001|Overall Study|Death|0|||
147107685|NCT02475213|530559426|FG002|Overall Study|Death|0|||
147107686|NCT02475213|530559427|FG003|Overall Study|Death|0|||
147107687|NCT02475213|530559428|FG004|Overall Study|Death|0|||
147310736|NCT01235975|531305074|FG000|Overall Study|Withdrawal by Subject|8|||
147310737|NCT01235975|531305075|FG001|Overall Study|Withdrawal by Subject|2|||
147558516|NCT04025229|532203838|FG000|Overall Study|Adverse Event|1|||
147558517|NCT04025229|532203839|FG001|Overall Study|Adverse Event|0|||
147107688|NCT02475213|530559429|FG005|Overall Study|Death|4|||
147107689|NCT02475213|530559430|FG006|Overall Study|Death|1|||
147107690|NCT02475213|530559431|FG007|Overall Study|Death|0|||
147107691|NCT02475213|530559424|FG000|Overall Study|Protocol Violation|0|||
147558518|NCT04025229|532203838|FG000|Overall Study|Withdrawal by Subject|0|||
147107692|NCT02475213|530559425|FG001|Overall Study|Protocol Violation|0|||
147107693|NCT02475213|530559426|FG002|Overall Study|Protocol Violation|0|||
147107694|NCT02475213|530559427|FG003|Overall Study|Protocol Violation|0|||
147107695|NCT02475213|530559428|FG004|Overall Study|Protocol Violation|1|||
147107696|NCT02475213|530559429|FG005|Overall Study|Protocol Violation|0|||
147107697|NCT02475213|530559430|FG006|Overall Study|Protocol Violation|0|||
147107698|NCT02475213|530559431|FG007|Overall Study|Protocol Violation|0|||
147107699|NCT02475213|530559424|FG000|Overall Study|Withdrawal by Subject|0|||
147107700|NCT02475213|530559425|FG001|Overall Study|Withdrawal by Subject|0|||
147107701|NCT02475213|530559426|FG002|Overall Study|Withdrawal by Subject|0|||
147107702|NCT02475213|530559427|FG003|Overall Study|Withdrawal by Subject|1|||
147107703|NCT02475213|530559428|FG004|Overall Study|Withdrawal by Subject|0|||
147107704|NCT02475213|530559429|FG005|Overall Study|Withdrawal by Subject|2|||
147310738|NCT01235975|531305074|FG000|Overall Study|Migrated/moved from study area|2|||
147310739|NCT01235975|531305075|FG001|Overall Study|Migrated/moved from study area|1|||
147310740|NCT01235975|531305074|FG000|Overall Study|Lost to Follow-up|7|||
147310741|NCT01235975|531305075|FG001|Overall Study|Lost to Follow-up|3|||
147310742|NCT00708305|531305084|FG000|Period 1|Protocol Violation|1|||
147310743|NCT00708305|531305085|FG001|Period 1|Protocol Violation|0|||
147310744|NCT00708305|531305086|FG002|Period 1|Protocol Violation|1|||
147310745|NCT00708305|531305087|FG003|Period 1|Protocol Violation|0|||
147310746|NCT00708305|531305084|FG000|Period 1|Other Reason|0|||
147310747|NCT00708305|531305085|FG001|Period 1|Other Reason|0|||
147310748|NCT00708305|531305086|FG002|Period 1|Other Reason|0|||
147310749|NCT00708305|531305087|FG003|Period 1|Other Reason|2|||
147310750|NCT00708305|531305084|FG000|Period 2|Lost to Follow-up|0|||
147310751|NCT00708305|531305085|FG001|Period 2|Lost to Follow-up|1|||
147310752|NCT00708305|531305086|FG002|Period 2|Lost to Follow-up|0|||
147310753|NCT00708305|531305087|FG003|Period 2|Lost to Follow-up|0|||
147310754|NCT00708305|531305084|FG000|Period 2|Protocol Violation|0|||
147310755|NCT00708305|531305085|FG001|Period 2|Protocol Violation|1|||
147310756|NCT00708305|531305086|FG002|Period 2|Protocol Violation|0|||
147310757|NCT00708305|531305087|FG003|Period 2|Protocol Violation|0|||
147310758|NCT00708305|531305084|FG000|Period 2|Other Reason|1|||
147310759|NCT00708305|531305085|FG001|Period 2|Other Reason|0|||
147310760|NCT00708305|531305086|FG002|Period 2|Other Reason|0|||
147310761|NCT00708305|531305087|FG003|Period 2|Other Reason|1|||
147310762|NCT00708305|531305084|FG000|Period 3|Protocol Violation|0|||
147310763|NCT00708305|531305085|FG001|Period 3|Protocol Violation|2|||
147310764|NCT00708305|531305086|FG002|Period 3|Protocol Violation|0|||
147310765|NCT00708305|531305087|FG003|Period 3|Protocol Violation|0|||
147310766|NCT00708305|531305084|FG000|Period 3|Other Reason|1|||
147310767|NCT00708305|531305085|FG001|Period 3|Other Reason|0|||
147310768|NCT00708305|531305086|FG002|Period 3|Other Reason|0|||
147310769|NCT00708305|531305087|FG003|Period 3|Other Reason|0|||
147310770|NCT00192023|531305094|FG000|Period III - Double-Blind|Adverse Event|3|||
147310771|NCT00192023|531305095|FG001|Period III - Double-Blind|Adverse Event|0|||
147310772|NCT00192023|531305094|FG000|Period III - Double-Blind|Physician Decision|2|||
147310773|NCT00192023|531305095|FG001|Period III - Double-Blind|Physician Decision|0|||
147310774|NCT00192023|531305094|FG000|Period III - Double-Blind|Parent/Caregiver Decision|2|||
147310775|NCT00192023|531305095|FG001|Period III - Double-Blind|Parent/Caregiver Decision|0|||
147310776|NCT00192023|531305094|FG000|Period IV - Optional Open-Label|Adverse Event|6|||
147310777|NCT00192023|531305095|FG001|Period IV - Optional Open-Label|Adverse Event|0|||
147107705|NCT02475213|530559430|FG006|Overall Study|Withdrawal by Subject|2|||
147107706|NCT02475213|530559431|FG007|Overall Study|Withdrawal by Subject|0|||
147225384|NCT02101112|530996643|FG002|Overall Study|Withdrawal by Subject|0|||
147225385|NCT02101112|530996644|FG003|Overall Study|Withdrawal by Subject|0|||
147225386|NCT02101112|530996645|FG004|Overall Study|Withdrawal by Subject|1|||
147225387|NCT02101112|530996646|FG005|Overall Study|Withdrawal by Subject|0|||
147225388|NCT02125604|530996647|FG000|Overall Study|Other|4|||
147225389|NCT02125604|530996647|FG000|Overall Study|Investigator Decision|1|||
147225390|NCT02125604|530996647|FG000|Overall Study|Lost to Follow-up|2|||
147225391|NCT02125604|530996647|FG000|Overall Study|Consent Withdrawn|4|||
147225392|NCT02125604|530996647|FG000|Overall Study|Adverse Event|20|||
147225393|NCT04340063|530996648|FG000|Overall Study|Withdrawal by Subject|1|||
147225394|NCT04340063|530996649|FG001|Overall Study|Withdrawal by Subject|2|||
147225395|NCT04340063|530996648|FG000|Overall Study|Lost to Follow-up|3|||
147225396|NCT04340063|530996649|FG001|Overall Study|Lost to Follow-up|1|||
147225397|NCT04340063|530996648|FG000|Overall Study|Protocol Violation|0|||
147225398|NCT04340063|530996649|FG001|Overall Study|Protocol Violation|1|||
147444144|NCT02090413|531790529|FG001|Overall Study|Other|1|||
147310778|NCT00192023|531305094|FG000|Period IV - Optional Open-Label|Lack of Efficacy|7|||
147310779|NCT00192023|531305095|FG001|Period IV - Optional Open-Label|Lack of Efficacy|0|||
147310780|NCT00192023|531305094|FG000|Period IV - Optional Open-Label|Patient/Caregiver Decision|46|||
147310781|NCT00192023|531305095|FG001|Period IV - Optional Open-Label|Patient/Caregiver Decision|0|||
147310782|NCT00192023|531305094|FG000|Period IV - Optional Open-Label|Lost to Follow-up|2|||
147310783|NCT00192023|531305095|FG001|Period IV - Optional Open-Label|Lost to Follow-up|0|||
147444145|NCT02090413|531790530|FG002|Overall Study|Other|0|||
147107707|NCT02475213|530559424|FG000|Overall Study|Other|0|||
147225399|NCT02782923|530996652|FG000|Overall Study|Lost to Follow-up|15|||
147225400|NCT02418156|530996653|FG000|Overall Study|Lost to Follow-up|12|||
147225401|NCT02418156|530996653|FG000|Overall Study|Death|2|||
147225402|NCT02418156|530996653|FG000|Overall Study|Physician Decision|1|||
147107708|NCT02475213|530559425|FG001|Overall Study|Other|0|||
147107709|NCT02475213|530559426|FG002|Overall Study|Other|0|||
147107710|NCT02475213|530559427|FG003|Overall Study|Other|1|||
147107711|NCT02475213|530559428|FG004|Overall Study|Other|3|||
147107712|NCT02475213|530559429|FG005|Overall Study|Other|1|||
147107713|NCT02475213|530559430|FG006|Overall Study|Other|0|||
147107714|NCT02475213|530559431|FG007|Overall Study|Other|0|||
147107715|NCT02441283|530559432|FG000|Overall Study|Withdrew consent|15|||
147107716|NCT02441283|530559432|FG000|Overall Study|Lost to Follow-up|42|||
147107717|NCT02441283|530559432|FG000|Overall Study|Death|1|||
147107718|NCT02441283|530559432|FG000|Overall Study|Other, not specified|32|||
147107719|NCT00630292|530559433|FG000|Overall Study|Withdrawal by Subject|1|||
147107720|NCT02382939|530559434|FG000|Overall Study|Adverse Event|1|||
147107721|NCT02382939|530559435|FG001|Overall Study|Adverse Event|1|||
147107722|NCT02382939|530559434|FG000|Overall Study|Withdrawal by Subject|2|||
147107723|NCT02382939|530559435|FG001|Overall Study|Withdrawal by Subject|2|||
147107724|NCT01553851|530559438|FG000|Overall Study|Adverse Event|2|||
147107725|NCT01553851|530559438|FG000|Overall Study|constipation|1|||
147107726|NCT02101294|530559439|FG000|Overall Study|Withdrawal by Subject|5|||
147107727|NCT02101294|530559439|FG000|Overall Study|Lost to Follow-up|6|||
147107728|NCT01129128|530559440|FG000|Overall Study|Lost to Follow-up|2|||
147107729|NCT01129128|530559441|FG001|Overall Study|Lost to Follow-up|2|||
147107730|NCT01129128|530559442|FG002|Overall Study|Lost to Follow-up|1|||
147107731|NCT01129128|530559440|FG000|Overall Study|Protocol Violation|0|||
147107732|NCT01129128|530559441|FG001|Overall Study|Protocol Violation|1|||
147107733|NCT01129128|530559442|FG002|Overall Study|Protocol Violation|0|||
147107734|NCT01129128|530559440|FG000|Overall Study|Withdrawal by Subject|0|||
147107735|NCT01129128|530559441|FG001|Overall Study|Withdrawal by Subject|1|||
147107736|NCT01129128|530559442|FG002|Overall Study|Withdrawal by Subject|3|||
147107737|NCT01129128|530559440|FG000|Overall Study|Physician Decision|1|||
147107738|NCT01129128|530559441|FG001|Overall Study|Physician Decision|0|||
147107739|NCT01129128|530559442|FG002|Overall Study|Physician Decision|0|||
147107740|NCT00844519|530559443|FG000|Overall Study|Withdrawal by Subject|1|||
147107741|NCT00844519|530559444|FG001|Overall Study|Withdrawal by Subject|1|||
147107742|NCT00844519|530559443|FG000|Overall Study|Adverse Event|1|||
147107743|NCT00844519|530559444|FG001|Overall Study|Adverse Event|0|||
147107744|NCT02709369|530559445|FG000|Overall Study|Lost to Follow-up|15|||
147107745|NCT02709369|530559445|FG000|Overall Study|Withdrawal by Subject|10|||
147107746|NCT02709369|530559445|FG000|Overall Study|Did not received intervention|2|||
147107747|NCT01900314|530559446|FG000|Overall Study|Lost to Follow-up|1|||
147107748|NCT01900314|530559447|FG001|Overall Study|Lost to Follow-up|0|||
147107749|NCT01900314|530559446|FG000|Overall Study|Protocol Violation|0|||
147107750|NCT01900314|530559447|FG001|Overall Study|Protocol Violation|1|||
147107751|NCT01900314|530559446|FG000|Overall Study|Withdrawal by Subject|3|||
147107752|NCT01900314|530559447|FG001|Overall Study|Withdrawal by Subject|3|||
147107753|NCT03282097|530559449|FG000|Randomized and Completed Baseline|Randomized no Baseline|1|||
147107754|NCT03282097|530559450|FG001|Randomized and Completed Baseline|Randomized no Baseline|1|||
147107755|NCT03282097|530559449|FG000|Intervention Visit Complete|Patient Death|13|||
147107756|NCT03282097|530559450|FG001|Intervention Visit Complete|Patient Death|15|||
147107757|NCT03282097|530559449|FG000|Intervention Visit Complete|Caregiver Death|0|||
147107758|NCT03282097|530559450|FG001|Intervention Visit Complete|Caregiver Death|3|||
147107759|NCT03282097|530559449|FG000|Intervention Visit Complete|Withdrawal by Subject|14|||
147107760|NCT03282097|530559450|FG001|Intervention Visit Complete|Withdrawal by Subject|13|||
147107761|NCT03282097|530559449|FG000|Intervention Visit Complete|Became Ineligible before PCP Index visit|12|||
147107762|NCT03282097|530559450|FG001|Intervention Visit Complete|Became Ineligible before PCP Index visit|21|||
147107763|NCT03282097|530559449|FG000|Intervention Visit Complete|PCP Index Visit Not Completed|3|||
147107764|NCT03282097|530559450|FG001|Intervention Visit Complete|PCP Index Visit Not Completed|7|||
147107765|NCT03282097|530559449|FG000|Primary Outcome Data Collection Complete|Missing|2|||
147107766|NCT03282097|530559450|FG001|Primary Outcome Data Collection Complete|Missing|3|||
147107767|NCT03282097|530559449|FG000|Primary Outcome Data Collection Complete|Withdrawal by Subject|1|||
147107768|NCT03282097|530559450|FG001|Primary Outcome Data Collection Complete|Withdrawal by Subject|0|||
147107769|NCT03282097|530559449|FG000|15 Month Follow-up Complete|Withdrawal by Subject|0|||
147107770|NCT03282097|530559450|FG001|15 Month Follow-up Complete|Withdrawal by Subject|1|||
147107771|NCT03282097|530559449|FG000|15 Month Follow-up Complete|Lost to Follow-up|6|||
147107772|NCT03282097|530559450|FG001|15 Month Follow-up Complete|Lost to Follow-up|8|||
147107773|NCT01056536|530559453|FG000|Overall Study|Lost to Follow-up|202|||
147107774|NCT01056536|530559454|FG001|Overall Study|Lost to Follow-up|116|||
147107775|NCT01056536|530559455|FG002|Overall Study|Lost to Follow-up|248|||
147107776|NCT01551173|530559460|FG000|Overall Study|Withdrawal by Subject|11|||
147107777|NCT01551173|530559461|FG001|Overall Study|Withdrawal by Subject|16|||
147107778|NCT01551173|530559460|FG000|Overall Study|Adverse Event|7|||
147107779|NCT01551173|530559461|FG001|Overall Study|Adverse Event|6|||
147107780|NCT01551173|530559460|FG000|Overall Study|Lost to Follow-up|5|||
147107781|NCT01551173|530559461|FG001|Overall Study|Lost to Follow-up|7|||
147107782|NCT01551173|530559460|FG000|Overall Study|Other|5|||
147107783|NCT01551173|530559461|FG001|Overall Study|Other|3|||
147107784|NCT04530344|530559462|FG000|Overall Study|Lost to Follow-up|3|||
147107785|NCT04530344|530559463|FG001|Overall Study|Lost to Follow-up|3|||
147107786|NCT04530344|530559464|FG002|Overall Study|Lost to Follow-up|3|||
147107787|NCT04530344|530559465|FG003|Overall Study|Lost to Follow-up|10|||
147107788|NCT04530344|530559462|FG000|Overall Study|Withdrawal by Subject|14|||
147107789|NCT04530344|530559463|FG001|Overall Study|Withdrawal by Subject|5|||
147107790|NCT04530344|530559464|FG002|Overall Study|Withdrawal by Subject|18|||
147107791|NCT04530344|530559465|FG003|Overall Study|Withdrawal by Subject|33|||
147107792|NCT04530344|530559462|FG000|Overall Study|Adverse Event|0|||
147107793|NCT04530344|530559463|FG001|Overall Study|Adverse Event|0|||
147107794|NCT04530344|530559464|FG002|Overall Study|Adverse Event|0|||
147107795|NCT04530344|530559465|FG003|Overall Study|Adverse Event|1|||
147107796|NCT04530344|530559462|FG000|Overall Study|Lack of Efficacy|0|||
147107797|NCT04530344|530559463|FG001|Overall Study|Lack of Efficacy|0|||
147107798|NCT04530344|530559464|FG002|Overall Study|Lack of Efficacy|0|||
147107799|NCT04530344|530559465|FG003|Overall Study|Lack of Efficacy|1|||
147107800|NCT04530344|530559462|FG000|Overall Study|Physician Decision|0|||
147107801|NCT04530344|530559463|FG001|Overall Study|Physician Decision|0|||
147107802|NCT04530344|530559464|FG002|Overall Study|Physician Decision|1|||
147107803|NCT04530344|530559465|FG003|Overall Study|Physician Decision|1|||
147107804|NCT04530344|530559462|FG000|Overall Study|Pregnancy|0|||
147107805|NCT04530344|530559463|FG001|Overall Study|Pregnancy|0|||
147107806|NCT04530344|530559464|FG002|Overall Study|Pregnancy|2|||
147107807|NCT04530344|530559465|FG003|Overall Study|Pregnancy|1|||
147107808|NCT04530344|530559462|FG000|Overall Study|Protocol Violation|0|||
147107809|NCT04530344|530559463|FG001|Overall Study|Protocol Violation|0|||
147107810|NCT04530344|530559464|FG002|Overall Study|Protocol Violation|0|||
147107811|NCT04530344|530559465|FG003|Overall Study|Protocol Violation|1|||
147107812|NCT04530344|530559462|FG000|Overall Study|Site Closed Due to Noncompliance|0|||
147107813|NCT04530344|530559463|FG001|Overall Study|Site Closed Due to Noncompliance|0|||
147107814|NCT04530344|530559464|FG002|Overall Study|Site Closed Due to Noncompliance|0|||
147107815|NCT04530344|530559465|FG003|Overall Study|Site Closed Due to Noncompliance|1|||
147107816|NCT04530344|530559462|FG000|Overall Study|Discontinued due to COVID-19 Pandemic|0|||
147107817|NCT04530344|530559463|FG001|Overall Study|Discontinued due to COVID-19 Pandemic|0|||
147107818|NCT04530344|530559464|FG002|Overall Study|Discontinued due to COVID-19 Pandemic|1|||
147107819|NCT04530344|530559465|FG003|Overall Study|Discontinued due to COVID-19 Pandemic|0|||
147107820|NCT04530344|530559462|FG000|Overall Study|Missed Safety Follow-up Visit|0|||
147107821|NCT04530344|530559463|FG001|Overall Study|Missed Safety Follow-up Visit|0|||
147107822|NCT04530344|530559464|FG002|Overall Study|Missed Safety Follow-up Visit|1|||
147107823|NCT04530344|530559465|FG003|Overall Study|Missed Safety Follow-up Visit|0|||
147107824|NCT04530344|530559462|FG000|Overall Study|Personal Reasons|0|||
147107825|NCT04530344|530559463|FG001|Overall Study|Personal Reasons|0|||
147107826|NCT04530344|530559464|FG002|Overall Study|Personal Reasons|0|||
147107827|NCT04530344|530559465|FG003|Overall Study|Personal Reasons|1|||
147107828|NCT04530344|530559462|FG000|Overall Study|Not Compliant with Protocol-specific Visit Window|0|||
147107829|NCT04530344|530559463|FG001|Overall Study|Not Compliant with Protocol-specific Visit Window|0|||
147107830|NCT04530344|530559464|FG002|Overall Study|Not Compliant with Protocol-specific Visit Window|0|||
147107831|NCT04530344|530559465|FG003|Overall Study|Not Compliant with Protocol-specific Visit Window|1|||
147107832|NCT05352399|530559474|FG000|Overall Study|Discontinued intervention|6|||
147107833|NCT01654276|530559475|FG000|Overall Study|Lack of Efficacy|1|||
147225403|NCT02418156|530996653|FG000|Overall Study|Withdrawal by Subject|1|||
147225404|NCT02418156|530996653|FG000|Overall Study|Subject refused to return|1|||
147558519|NCT04025229|532203839|FG001|Overall Study|Withdrawal by Subject|2|||
147558520|NCT04025229|532203838|FG000|Overall Study|Death|0|||
147225405|NCT00993044|530996656|FG000|Irinotecan 50 mg|Physician Decision|1|||
147558521|NCT04025229|532203839|FG001|Overall Study|Death|1|||
147558522|NCT04025229|532203838|FG000|Overall Study|Physician Decision|0|||
147558523|NCT04025229|532203839|FG001|Overall Study|Physician Decision|1|||
147558524|NCT03815942|532203840|FG000|Overall Study|Withdrawal by Subject|0|||
147558525|NCT03815942|532203841|FG001|Overall Study|Withdrawal by Subject|17|||
147558526|NCT01298570|532203842|FG000|Overall Study|Disease progression, relapse during acti|64|||
147558527|NCT01298570|532203843|FG001|Overall Study|Disease progression, relapse during acti|40|||
147558528|NCT01298570|532203842|FG000|Overall Study|Adverse Event|20|||
147558529|NCT01298570|532203843|FG001|Overall Study|Adverse Event|2|||
147558530|NCT01298570|532203842|FG000|Overall Study|Withdrawal by Subject|21|||
147107834|NCT01654276|530559475|FG000|Overall Study|Lost to Follow-up|4|||
147107835|NCT01654276|530559475|FG000|Overall Study|Withdrawal by Subject|1|||
147107836|NCT02657551|530559476|FG000|Overall Study|Adverse Event|2|||
147107837|NCT02657551|530559476|FG000|Overall Study|Withdrawal by Subject|1|||
147107838|NCT02657551|530559476|FG000|Overall Study|Non-Compliance|1|||
147107839|NCT02657551|530559476|FG000|Overall Study|Progression / Relapse|4|||
147107840|NCT04478266|530559477|FG000|Overall Study|Adverse Event|20|||
147107841|NCT04478266|530559478|FG001|Overall Study|Adverse Event|21|||
147107842|NCT04478266|530559477|FG000|Overall Study|Progressive disease|146|||
147107843|NCT04478266|530559478|FG001|Overall Study|Progressive disease|168|||
147225406|NCT00734747|530996658|FG000|SRS Procedure|No staples placed|3|||
147107844|NCT04478266|530559477|FG000|Overall Study|Poor compliance to protocol|1|||
147107845|NCT04478266|530559478|FG001|Overall Study|Poor compliance to protocol|0|||
147107846|NCT04478266|530559477|FG000|Overall Study|Withdrawal by Subject|19|||
147107847|NCT04478266|530559478|FG001|Overall Study|Withdrawal by Subject|16|||
147107848|NCT04478266|530559477|FG000|Overall Study|Data Monitoring Committee recommendation due to negative interim analysis|309|||
147107849|NCT04478266|530559478|FG001|Overall Study|Data Monitoring Committee recommendation due to negative interim analysis|286|||
147107850|NCT04478266|530559477|FG000|Overall Study|Study terminated by sponsor|33|||
147107851|NCT04478266|530559478|FG001|Overall Study|Study terminated by sponsor|35|||
147107852|NCT04478266|530559477|FG000|Overall Study|Other: unspecified|5|||
147107853|NCT04478266|530559478|FG001|Overall Study|Other: unspecified|7|||
147107854|NCT04478266|530559477|FG000|Overall Study|Randomized but not treated|1|||
147107855|NCT04478266|530559478|FG001|Overall Study|Randomized but not treated|1|||
147107856|NCT01977846|530559481|FG000|Total Study - Prospective|Death|0|||
147107857|NCT01977846|530559482|FG001|Total Study - Prospective|Death|1|||
147107858|NCT01977846|530559481|FG000|Total Study - Prospective|Lost to Follow-up|0|||
147107859|NCT01977846|530559482|FG001|Total Study - Prospective|Lost to Follow-up|8|||
147107860|NCT01977846|530559481|FG000|Total Study - Prospective|Withdrawal by Subject|0|||
147107861|NCT01977846|530559482|FG001|Total Study - Prospective|Withdrawal by Subject|13|||
147107862|NCT01977846|530559481|FG000|Total Study - Prospective|Not available at time of visit|0|||
147107863|NCT01977846|530559482|FG001|Total Study - Prospective|Not available at time of visit|5|||
147107864|NCT01977846|530559481|FG000|Total Study - Prospective|No show|0|||
147107865|NCT01977846|530559482|FG001|Total Study - Prospective|No show|1|||
147107866|NCT01977846|530559481|FG000|Total Study - Prospective|Protocol Violation|0|||
147107867|NCT01977846|530559482|FG001|Total Study - Prospective|Protocol Violation|1|||
147107868|NCT00296517|530559483|FG000|Dose Level 2 - Week 2|Adverse Event|1|||
147107869|NCT00296517|530559484|FG001|Dose Level 2 - Week 2|Adverse Event|5|||
147107870|NCT00296517|530559483|FG000|Dose Level 2 - Week 2|Withdrawal by Subject|1|||
147107871|NCT00296517|530559484|FG001|Dose Level 2 - Week 2|Withdrawal by Subject|0|||
147107872|NCT00296517|530559483|FG000|Dose Level 3 - Weeks 3-12|Adverse Event|30|||
147107873|NCT00296517|530559484|FG001|Dose Level 3 - Weeks 3-12|Adverse Event|34|||
147558531|NCT01298570|532203843|FG001|Overall Study|Withdrawal by Subject|6|||
147558532|NCT01298570|532203842|FG000|Overall Study|Treatment delay > 4 weeks|4|||
147558533|NCT01298570|532203843|FG001|Overall Study|Treatment delay > 4 weeks|5|||
147558534|NCT01298570|532203842|FG000|Overall Study|Physician Decision|4|||
147558535|NCT01298570|532203843|FG001|Overall Study|Physician Decision|2|||
147558536|NCT01298570|532203842|FG000|Overall Study|Other complicating disease|2|||
147558537|NCT01298570|532203843|FG001|Overall Study|Other complicating disease|1|||
147558538|NCT01298570|532203842|FG000|Overall Study|Surgery|2|||
147558539|NCT01298570|532203843|FG001|Overall Study|Surgery|1|||
147558540|NCT01298570|532203842|FG000|Overall Study|Symptomatic progression/deterioration|3|||
147558541|NCT01298570|532203843|FG001|Overall Study|Symptomatic progression/deterioration|2|||
147558542|NCT01298570|532203842|FG000|Overall Study|Death|0|||
147558543|NCT01298570|532203843|FG001|Overall Study|Death|1|||
147558544|NCT01298570|532203842|FG000|Overall Study|Ineligibility|0|||
147558545|NCT01298570|532203843|FG001|Overall Study|Ineligibility|1|||
147558546|NCT00076102|532203844|FG000|Overall Study|Clinical progression|1|||
147558547|NCT00076102|532203844|FG000|Overall Study|Progression in pre-existing brain tumor|1|||
147558548|NCT00076102|532203844|FG000|Overall Study|plexiform neurofibroma surgery|1|||
147558549|NCT00076102|532203844|FG000|Overall Study|refusal of further therapy|2|||
147558550|NCT02207231|532203846|FG000|Placebo Controlled Period: Week 0 - 16|Adverse Event|2|||
147558551|NCT02207231|532203847|FG001|Placebo Controlled Period: Week 0 - 16|Adverse Event|4|||
147558552|NCT02207231|532203848|FG002|Placebo Controlled Period: Week 0 - 16|Adverse Event|2|||
147558553|NCT02207231|532203849|FG003|Placebo Controlled Period: Week 0 - 16|Adverse Event|0|||
147558554|NCT02207231|532203846|FG000|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|2|||
147558555|NCT02207231|532203847|FG001|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|0|||
147558556|NCT02207231|532203848|FG002|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|1|||
147558557|NCT02207231|532203849|FG003|Placebo Controlled Period: Week 0 - 16|Lack of Efficacy|0|||
147558558|NCT02207231|532203846|FG000|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|1|||
147558559|NCT02207231|532203847|FG001|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|1|||
147107874|NCT00296517|530559483|FG000|Dose Level 3 - Weeks 3-12|Lack of Efficacy|3|||
147107875|NCT00296517|530559484|FG001|Dose Level 3 - Weeks 3-12|Lack of Efficacy|6|||
147107876|NCT00296517|530559483|FG000|Dose Level 3 - Weeks 3-12|Lost to Follow-up|3|||
147107877|NCT00296517|530559484|FG001|Dose Level 3 - Weeks 3-12|Lost to Follow-up|2|||
147107878|NCT00296517|530559483|FG000|Dose Level 3 - Weeks 3-12|Protocol Violation|1|||
147107879|NCT00296517|530559484|FG001|Dose Level 3 - Weeks 3-12|Protocol Violation|0|||
147558560|NCT02207231|532203848|FG002|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|1|||
147107880|NCT00296517|530559483|FG000|Dose Level 3 - Weeks 3-12|Withdrawal by Subject|7|||
147107881|NCT00296517|530559484|FG001|Dose Level 3 - Weeks 3-12|Withdrawal by Subject|18|||
147107882|NCT00296517|530559483|FG000|Dose Level 3 - Weeks 3-12|Non - Compliance|1|||
147107883|NCT00296517|530559484|FG001|Dose Level 3 - Weeks 3-12|Non - Compliance|0|||
147558561|NCT02207231|532203849|FG003|Placebo Controlled Period: Week 0 - 16|Lost to Follow-up|0|||
147107884|NCT00296517|530559483|FG000|Dose Level 3 - Weeks 3-12|Other|0|||
147107885|NCT00296517|530559484|FG001|Dose Level 3 - Weeks 3-12|Other|2|||
147107886|NCT00596635|530559491|FG000|Overall Study|Lost to Follow-up|0|||
147107887|NCT00596635|530559492|FG001|Overall Study|Lost to Follow-up|2|||
147107888|NCT00596635|530559493|FG002|Overall Study|Lost to Follow-up|0|||
147107889|NCT00596635|530559491|FG000|Overall Study|Treatment for symptomatic UTI|4|||
147107890|NCT00596635|530559492|FG001|Overall Study|Treatment for symptomatic UTI|6|||
147107891|NCT00596635|530559493|FG002|Overall Study|Treatment for symptomatic UTI|3|||
147107892|NCT00596635|530559491|FG000|Overall Study|Hip fracture|2|||
147107893|NCT00596635|530559492|FG001|Overall Study|Hip fracture|3|||
147107894|NCT00596635|530559493|FG002|Overall Study|Hip fracture|3|||
147107895|NCT00596635|530559491|FG000|Overall Study|Could not provide urine specimen|1|||
147107896|NCT00596635|530559492|FG001|Overall Study|Could not provide urine specimen|2|||
147107897|NCT00596635|530559493|FG002|Overall Study|Could not provide urine specimen|2|||
147107898|NCT01143324|530559496|FG000|Overall Study|Lost to Follow-up|11|||
147107899|NCT01143324|530559496|FG000|Overall Study|Withdrawal by Subject|4|||
147107900|NCT01143324|530559496|FG000|Overall Study|Explant of the device|4|||
147107901|NCT01101178|530559499|FG000|Period 1|Withdrawal by Subject|1|||
147107902|NCT01101178|530559500|FG001|Period 1|Withdrawal by Subject|2|||
147107903|NCT01101178|530559499|FG000|Period 1|Positive drug screen|1|||
147107904|NCT01101178|530559500|FG001|Period 1|Positive drug screen|1|||
147107905|NCT01101178|530559499|FG000|Period 1|Adverse Event|2|||
147107906|NCT01101178|530559500|FG001|Period 1|Adverse Event|1|||
147107907|NCT01101178|530559499|FG000|Period 2|Withdrawal by Subject|0|||
147107908|NCT01101178|530559500|FG001|Period 2|Withdrawal by Subject|1|||
147558562|NCT02207231|532203846|FG000|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|2|||
147558563|NCT02207231|532203847|FG001|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|0|||
147107909|NCT01850641|530559501|FG000|Overall Study|Physician Decision|1|||
147558564|NCT02207231|532203848|FG002|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|4|||
147107910|NCT01850641|530559501|FG000|Overall Study|Decrease in serum phosphorus|1|||
147107911|NCT01850641|530559501|FG000|Overall Study|Decrease in serum calcium|2|||
147107912|NCT01850641|530559501|FG000|Overall Study|Increase in serum ferritin|1|||
147107913|NCT00127803|530559502|FG000|Overall Study|Adverse Event|2|||
147107914|NCT00127803|530559503|FG001|Overall Study|Adverse Event|0|||
147107915|NCT00127803|530559504|FG002|Overall Study|Adverse Event|0|||
147107916|NCT00127803|530559505|FG003|Overall Study|Adverse Event|0|||
147107917|NCT00127803|530559502|FG000|Overall Study|Withdrawal by Subject|1|||
147558565|NCT02207231|532203849|FG003|Placebo Controlled Period: Week 0 - 16|Withdrawal by Subject|0|||
147558566|NCT02207231|532203846|FG000|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0|||
147558567|NCT02207231|532203847|FG001|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0|||
147558568|NCT02207231|532203848|FG002|Placebo Controlled Period: Week 0 - 16|Protocol Violation|1|||
147558569|NCT02207231|532203849|FG003|Placebo Controlled Period: Week 0 - 16|Protocol Violation|0|||
147558570|NCT02207231|532203846|FG000|Placebo Controlled Period: Week 0 - 16|Noncompliance|0|||
147558571|NCT02207231|532203847|FG001|Placebo Controlled Period: Week 0 - 16|Noncompliance|2|||
147558572|NCT02207231|532203848|FG002|Placebo Controlled Period: Week 0 - 16|Noncompliance|1|||
147558573|NCT02207231|532203849|FG003|Placebo Controlled Period: Week 0 - 16|Noncompliance|0|||
147558574|NCT02207231|532203846|FG000|Active Controlled Period: Week 16 - 48|Adverse Event|1|||
147107918|NCT00127803|530559503|FG001|Overall Study|Withdrawal by Subject|0|||
147107919|NCT00127803|530559504|FG002|Overall Study|Withdrawal by Subject|0|||
147107920|NCT00127803|530559505|FG003|Overall Study|Withdrawal by Subject|0|||
147107921|NCT00127803|530559502|FG000|Overall Study|Lost to Follow-up|0|||
147107922|NCT00127803|530559503|FG001|Overall Study|Lost to Follow-up|0|||
147107923|NCT00127803|530559504|FG002|Overall Study|Lost to Follow-up|0|||
147107924|NCT00127803|530559505|FG003|Overall Study|Lost to Follow-up|1|||
147107925|NCT01020123|530559510|FG000|Main Period|Withdrawal by Subject|6|||
147107926|NCT01020123|530559511|FG001|Main Period|Withdrawal by Subject|5|||
147107927|NCT01020123|530559512|FG002|Main Period|Withdrawal by Subject|3|||
147107928|NCT01020123|530559513|FG003|Main Period|Withdrawal by Subject|1|||
147107929|NCT01020123|530559514|FG004|Main Period|Withdrawal by Subject|6|||
147107930|NCT01020123|530559515|FG005|Main Period|Withdrawal by Subject|3|||
147107931|NCT01020123|530559516|FG006|Main Period|Withdrawal by Subject|2|||
147558575|NCT02207231|532203847|FG001|Active Controlled Period: Week 16 - 48|Adverse Event|6|||
147558576|NCT02207231|532203848|FG002|Active Controlled Period: Week 16 - 48|Adverse Event|10|||
147558577|NCT02207231|532203849|FG003|Active Controlled Period: Week 16 - 48|Adverse Event|0|||
147107932|NCT01020123|530559510|FG000|Main Period|Eligibility Criteria not fullfilled|0|||
147107933|NCT01020123|530559511|FG001|Main Period|Eligibility Criteria not fullfilled|1|||
147107934|NCT01020123|530559512|FG002|Main Period|Eligibility Criteria not fullfilled|0|||
147107935|NCT01020123|530559513|FG003|Main Period|Eligibility Criteria not fullfilled|0|||
147225407|NCT00734747|530996658|FG000|6 Month Follow-up|Did not meet inclusion criteria|3|||
147444146|NCT02090413|531790528|FG000|Overall Study|Lost to Follow-up|1|||
147107936|NCT01020123|530559514|FG004|Main Period|Eligibility Criteria not fullfilled|1|||
147107937|NCT01020123|530559515|FG005|Main Period|Eligibility Criteria not fullfilled|0|||
147107938|NCT01020123|530559516|FG006|Main Period|Eligibility Criteria not fullfilled|0|||
147107939|NCT01020123|530559510|FG000|Main Period|Adverse Event|5|||
147107940|NCT01020123|530559511|FG001|Main Period|Adverse Event|2|||
147107941|NCT01020123|530559512|FG002|Main Period|Adverse Event|2|||
147107942|NCT01020123|530559513|FG003|Main Period|Adverse Event|1|||
147107943|NCT01020123|530559514|FG004|Main Period|Adverse Event|1|||
147107944|NCT01020123|530559515|FG005|Main Period|Adverse Event|2|||
147107945|NCT01020123|530559516|FG006|Main Period|Adverse Event|1|||
147107946|NCT01020123|530559510|FG000|Main Period|Protocol Violation|4|||
147107947|NCT01020123|530559511|FG001|Main Period|Protocol Violation|4|||
147107948|NCT01020123|530559512|FG002|Main Period|Protocol Violation|2|||
147107949|NCT01020123|530559513|FG003|Main Period|Protocol Violation|5|||
147107950|NCT01020123|530559514|FG004|Main Period|Protocol Violation|2|||
147107951|NCT01020123|530559515|FG005|Main Period|Protocol Violation|3|||
147107952|NCT01020123|530559516|FG006|Main Period|Protocol Violation|2|||
147107953|NCT01020123|530559510|FG000|Main Period|Lost to Follow-up|0|||
147107954|NCT01020123|530559511|FG001|Main Period|Lost to Follow-up|2|||
147107955|NCT01020123|530559512|FG002|Main Period|Lost to Follow-up|0|||
147107956|NCT01020123|530559513|FG003|Main Period|Lost to Follow-up|0|||
147107957|NCT01020123|530559514|FG004|Main Period|Lost to Follow-up|0|||
147558578|NCT02207231|532203846|FG000|Active Controlled Period: Week 16 - 48|Pregnancy|0|||
147558579|NCT02207231|532203847|FG001|Active Controlled Period: Week 16 - 48|Pregnancy|0|||
147107958|NCT01020123|530559515|FG005|Main Period|Lost to Follow-up|0|||
147107959|NCT01020123|530559516|FG006|Main Period|Lost to Follow-up|0|||
147107960|NCT01020123|530559510|FG000|Main Period|Unclasified|2|||
147107961|NCT01020123|530559511|FG001|Main Period|Unclasified|0|||
147107962|NCT01020123|530559512|FG002|Main Period|Unclasified|1|||
147107963|NCT01020123|530559513|FG003|Main Period|Unclasified|0|||
147107964|NCT01020123|530559514|FG004|Main Period|Unclasified|1|||
147107965|NCT01020123|530559515|FG005|Main Period|Unclasified|3|||
147107966|NCT01020123|530559516|FG006|Main Period|Unclasified|6|||
147107967|NCT01020123|530559510|FG000|Extention Period|Withdrawal by Subject|2|||
147107968|NCT01020123|530559511|FG001|Extention Period|Withdrawal by Subject|1|||
147107969|NCT01020123|530559512|FG002|Extention Period|Withdrawal by Subject|1|||
147107970|NCT01020123|530559513|FG003|Extention Period|Withdrawal by Subject|0|||
147107971|NCT01020123|530559514|FG004|Extention Period|Withdrawal by Subject|0|||
147107972|NCT01020123|530559515|FG005|Extention Period|Withdrawal by Subject|0|||
147107973|NCT01020123|530559516|FG006|Extention Period|Withdrawal by Subject|0|||
147107974|NCT01020123|530559510|FG000|Extention Period|Adverse Event|0|||
147107975|NCT01020123|530559511|FG001|Extention Period|Adverse Event|0|||
147107976|NCT01020123|530559512|FG002|Extention Period|Adverse Event|0|||
147107977|NCT01020123|530559513|FG003|Extention Period|Adverse Event|1|||
147107978|NCT01020123|530559514|FG004|Extention Period|Adverse Event|0|||
147107979|NCT01020123|530559515|FG005|Extention Period|Adverse Event|0|||
147107980|NCT01020123|530559516|FG006|Extention Period|Adverse Event|0|||
147225408|NCT05063318|530996664|FG000|Overall Study|Progressive disease|2|||
147558580|NCT02207231|532203848|FG002|Active Controlled Period: Week 16 - 48|Pregnancy|1|||
147558581|NCT02207231|532203849|FG003|Active Controlled Period: Week 16 - 48|Pregnancy|0|||
147558582|NCT02207231|532203846|FG000|Active Controlled Period: Week 16 - 48|Lack of Efficacy|0|||
147558583|NCT02207231|532203847|FG001|Active Controlled Period: Week 16 - 48|Lack of Efficacy|3|||
147558584|NCT02207231|532203848|FG002|Active Controlled Period: Week 16 - 48|Lack of Efficacy|11|||
147558585|NCT02207231|532203849|FG003|Active Controlled Period: Week 16 - 48|Lack of Efficacy|0|||
147558586|NCT02207231|532203846|FG000|Active Controlled Period: Week 16 - 48|Lost to Follow-up|1|||
147558587|NCT02207231|532203847|FG001|Active Controlled Period: Week 16 - 48|Lost to Follow-up|2|||
147558588|NCT02207231|532203848|FG002|Active Controlled Period: Week 16 - 48|Lost to Follow-up|5|||
147558589|NCT02207231|532203849|FG003|Active Controlled Period: Week 16 - 48|Lost to Follow-up|0|||
147558590|NCT02207231|532203846|FG000|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|1|||
147558591|NCT02207231|532203847|FG001|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|4|||
147558592|NCT02207231|532203848|FG002|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|10|||
147558593|NCT02207231|532203849|FG003|Active Controlled Period: Week 16 - 48|Withdrawal by Subject|0|||
147558594|NCT02207231|532203846|FG000|Active Controlled Period: Week 16 - 48|Protocol Violation|0|||
147558595|NCT02207231|532203847|FG001|Active Controlled Period: Week 16 - 48|Protocol Violation|1|||
147558596|NCT02207231|532203848|FG002|Active Controlled Period: Week 16 - 48|Protocol Violation|0|||
147107981|NCT01020123|530559510|FG000|Extention Period|Protocol Violation|1|||
147107982|NCT01020123|530559511|FG001|Extention Period|Protocol Violation|1|||
147107983|NCT01020123|530559512|FG002|Extention Period|Protocol Violation|1|||
147107984|NCT01020123|530559513|FG003|Extention Period|Protocol Violation|0|||
147107985|NCT01020123|530559514|FG004|Extention Period|Protocol Violation|0|||
147107986|NCT01020123|530559515|FG005|Extention Period|Protocol Violation|0|||
147225409|NCT05063318|530996665|FG001|Overall Study|Progressive disease|0|||
147107987|NCT01020123|530559516|FG006|Extention Period|Protocol Violation|1|||
147444147|NCT02090413|531790529|FG001|Overall Study|Lost to Follow-up|1|||
147107988|NCT01020123|530559510|FG000|Extention Period|Lost to Follow-up|0|||
147107989|NCT01020123|530559511|FG001|Extention Period|Lost to Follow-up|0|||
147107990|NCT01020123|530559512|FG002|Extention Period|Lost to Follow-up|0|||
147107991|NCT01020123|530559513|FG003|Extention Period|Lost to Follow-up|0|||
147558597|NCT02207231|532203849|FG003|Active Controlled Period: Week 16 - 48|Protocol Violation|0|||
147558598|NCT02207231|532203846|FG000|Active Controlled Period: Week 16 - 48|Noncompliance|0|||
147107992|NCT01020123|530559514|FG004|Extention Period|Lost to Follow-up|0|||
147107993|NCT01020123|530559515|FG005|Extention Period|Lost to Follow-up|2|||
147107994|NCT01020123|530559516|FG006|Extention Period|Lost to Follow-up|0|||
147107995|NCT03479905|530559534|FG000|Overall Study|Other airway method used|4|||
147107996|NCT03479905|530559535|FG001|Overall Study|Other airway method used|5|||
147107997|NCT03479905|530559536|FG002|Overall Study|Other airway method used|5|||
147107998|NCT00862992|530559537|FG000|Overall Study|Adverse Event|2|||
147107999|NCT00862992|530559538|FG001|Overall Study|Adverse Event|1|||
147108000|NCT00862992|530559539|FG002|Overall Study|Adverse Event|1|||
147108001|NCT00862992|530559537|FG000|Overall Study|Physician Decision|1|||
147108002|NCT00862992|530559538|FG001|Overall Study|Physician Decision|0|||
147108003|NCT00862992|530559539|FG002|Overall Study|Physician Decision|0|||
147108004|NCT00862992|530559537|FG000|Overall Study|Withdrawal by Subject|0|||
147108005|NCT00862992|530559538|FG001|Overall Study|Withdrawal by Subject|0|||
147108006|NCT00862992|530559539|FG002|Overall Study|Withdrawal by Subject|2|||
147108007|NCT00720759|530559540|FG000|Overall Study|Lost to Follow-up|0|||
147108008|NCT00720759|530559541|FG001|Overall Study|Lost to Follow-up|1|||
147108009|NCT00720759|530559542|FG002|Overall Study|Lost to Follow-up|1|||
147108010|NCT00720759|530559543|FG003|Overall Study|Lost to Follow-up|0|||
147108011|NCT02318940|530559544|FG000|Overall Study|lost the record|1|||
147108012|NCT02318940|530559545|FG001|Overall Study|lost the record|0|||
147108013|NCT05032196|530559558|FG000|Period 1 (Single Ascending Dose)|Withdrawal by Subject|0|||
147108014|NCT05032196|530559559|FG001|Period 1 (Single Ascending Dose)|Withdrawal by Subject|1|||
147108015|NCT05032196|530559560|FG002|Period 1 (Single Ascending Dose)|Withdrawal by Subject|0|||
147108016|NCT05032196|530559561|FG003|Period 1 (Single Ascending Dose)|Withdrawal by Subject|0|||
147108017|NCT05032196|530559562|FG004|Period 1 (Single Ascending Dose)|Withdrawal by Subject|0|||
147108018|NCT05032196|530559563|FG005|Period 1 (Single Ascending Dose)|Withdrawal by Subject|0|||
147108019|NCT05032196|530559558|FG000|Period 1 (Single Ascending Dose)|Adverse Event|0|||
147108020|NCT05032196|530559559|FG001|Period 1 (Single Ascending Dose)|Adverse Event|0|||
147108021|NCT05032196|530559560|FG002|Period 1 (Single Ascending Dose)|Adverse Event|0|||
147108022|NCT05032196|530559561|FG003|Period 1 (Single Ascending Dose)|Adverse Event|1|||
147108023|NCT05032196|530559562|FG004|Period 1 (Single Ascending Dose)|Adverse Event|0|||
147108024|NCT05032196|530559563|FG005|Period 1 (Single Ascending Dose)|Adverse Event|0|||
147108025|NCT05032196|530559558|FG000|Period 2 (Multidose)|Physician Decision|0|||
147108026|NCT05032196|530559559|FG001|Period 2 (Multidose)|Physician Decision|0|||
147108027|NCT05032196|530559560|FG002|Period 2 (Multidose)|Physician Decision|0|||
147108028|NCT05032196|530559561|FG003|Period 2 (Multidose)|Physician Decision|0|||
147108029|NCT05032196|530559562|FG004|Period 2 (Multidose)|Physician Decision|1|||
147108030|NCT05032196|530559563|FG005|Period 2 (Multidose)|Physician Decision|0|||
147108031|NCT00857389|530559564|FG000|Overall Study|Did not proceed to transplant|2|||
147108032|NCT05260008|530559565|FG000|Overall Study|Physician Decision|0|||
147108033|NCT05260008|530559566|FG001|Overall Study|Physician Decision|1|||
147108034|NCT05260008|530559567|FG002|Overall Study|Physician Decision|0|||
147108035|NCT05260008|530559568|FG003|Overall Study|Physician Decision|0|||
147108036|NCT04584788|530559570|FG000|Overall Study|Physician Decision|8|||
147108037|NCT04584788|530559570|FG000|Overall Study|Withdrawal by Subject|1|||
147108038|NCT04584788|530559570|FG000|Overall Study|Adverse Event|3|||
147108039|NCT05350423|530561067|FG000|Overall Study|Lost to Follow-up|3|||
147108040|NCT05350423|530561068|FG001|Overall Study|Lost to Follow-up|3|||
147108041|NCT05350423|530561067|FG000|Overall Study|screen failure|5|||
147108042|NCT05350423|530561068|FG001|Overall Study|screen failure|6|||
147108043|NCT02097277|530561070|FG000|Overall Study|Subject no longer meets study criteria|0|||
147108044|NCT02097277|530561071|FG001|Overall Study|Subject no longer meets study criteria|1|||
147108045|NCT02097277|530561072|FG002|Overall Study|Subject no longer meets study criteria|0|||
147108046|NCT02097277|530561073|FG003|Overall Study|Subject no longer meets study criteria|1|||
147108047|NCT02097277|530561074|FG004|Overall Study|Subject no longer meets study criteria|0|||
147108048|NCT02097277|530561070|FG000|Overall Study|Subject request to discontinue treatment|0|||
147108049|NCT02097277|530561071|FG001|Overall Study|Subject request to discontinue treatment|0|||
147108050|NCT02097277|530561072|FG002|Overall Study|Subject request to discontinue treatment|0|||
147558599|NCT02207231|532203847|FG001|Active Controlled Period: Week 16 - 48|Noncompliance|3|||
147558600|NCT02207231|532203848|FG002|Active Controlled Period: Week 16 - 48|Noncompliance|3|||
147558601|NCT02207231|532203849|FG003|Active Controlled Period: Week 16 - 48|Noncompliance|0|||
147558602|NCT02207231|532203846|FG000|Active Controlled Period: Week 16 - 48|Other|0|||
147558603|NCT02207231|532203847|FG001|Active Controlled Period: Week 16 - 48|Other|2|||
147108051|NCT02097277|530561073|FG003|Overall Study|Subject request to discontinue treatment|0|||
147108052|NCT02097277|530561074|FG004|Overall Study|Subject request to discontinue treatment|1|||
147108053|NCT02097277|530561070|FG000|Overall Study|Lost to Follow-up|0|||
147108054|NCT02097277|530561071|FG001|Overall Study|Lost to Follow-up|1|||
147108055|NCT02097277|530561072|FG002|Overall Study|Lost to Follow-up|1|||
147108056|NCT02097277|530561073|FG003|Overall Study|Lost to Follow-up|0|||
147108057|NCT02097277|530561074|FG004|Overall Study|Lost to Follow-up|0|||
147108058|NCT02097277|530561070|FG000|Overall Study|Withdrawal by Subject|2|||
147108059|NCT02097277|530561071|FG001|Overall Study|Withdrawal by Subject|1|||
147558604|NCT02207231|532203848|FG002|Active Controlled Period: Week 16 - 48|Other|3|||
147108060|NCT02097277|530561072|FG002|Overall Study|Withdrawal by Subject|0|||
147108061|NCT02097277|530561073|FG003|Overall Study|Withdrawal by Subject|1|||
147108062|NCT02097277|530561074|FG004|Overall Study|Withdrawal by Subject|0|||
147108063|NCT02097277|530561070|FG000|Overall Study|Adverse Event|0|||
147108064|NCT02097277|530561071|FG001|Overall Study|Adverse Event|0|||
147108065|NCT02097277|530561072|FG002|Overall Study|Adverse Event|1|||
147108066|NCT02097277|530561073|FG003|Overall Study|Adverse Event|2|||
147108067|NCT02097277|530561074|FG004|Overall Study|Adverse Event|0|||
147108068|NCT01091259|530561077|FG000|Overall Study|Adverse Event|3|||
147108069|NCT01091259|530561077|FG000|Overall Study|Lack of Efficacy|2|||
147108070|NCT03320369|530561078|FG000|Overall Study|Adverse Event|1|||
147108071|NCT03320369|530561078|FG000|Overall Study|Withdrawal by Subject|2|||
147108072|NCT04727749|530561081|FG000|Overall Study|Lost to Follow-up|10|||
147108073|NCT04727749|530561082|FG001|Overall Study|Lost to Follow-up|3|||
147108074|NCT02320396|530561083|FG000|Overall Study|Adverse Event|2|||
147108075|NCT02320396|530561084|FG001|Overall Study|Adverse Event|2|||
147108076|NCT02320396|530561083|FG000|Overall Study|Pregnancy|0|||
147108077|NCT02320396|530561084|FG001|Overall Study|Pregnancy|1|||
147108078|NCT02320396|530561083|FG000|Overall Study|Protocol Violation|0|||
147108079|NCT02320396|530561084|FG001|Overall Study|Protocol Violation|1|||
147108080|NCT02320396|530561083|FG000|Overall Study|Withdrawal by Subject|2|||
147108081|NCT02320396|530561084|FG001|Overall Study|Withdrawal by Subject|0|||
147108082|NCT03718000|530561085|FG000|Overall Study|Relocation|2|||
147108083|NCT03718000|530561086|FG001|Overall Study|Relocation|4|||
147108084|NCT03718000|530561085|FG000|Overall Study|Pregnancy|0|||
147108085|NCT03718000|530561086|FG001|Overall Study|Pregnancy|1|||
147108086|NCT05383209|530561087|FG000|Overall Study|Adverse Event: Non-ocular|0|||
147108087|NCT05383209|530561088|FG001|Overall Study|Adverse Event: Non-ocular|1|||
147108088|NCT05383209|530561089|FG002|Overall Study|Adverse Event: Non-ocular|0|||
147108089|NCT05383209|530561087|FG000|Overall Study|Lost to Follow-up|2|||
147108090|NCT05383209|530561088|FG001|Overall Study|Lost to Follow-up|1|||
147108091|NCT05383209|530561089|FG002|Overall Study|Lost to Follow-up|4|||
147108092|NCT05383209|530561087|FG000|Overall Study|Withdrawal by Subject|2|||
147108093|NCT05383209|530561088|FG001|Overall Study|Withdrawal by Subject|0|||
147108094|NCT05383209|530561089|FG002|Overall Study|Withdrawal by Subject|1|||
147108095|NCT05383209|530561087|FG000|Overall Study|Death|1|||
147108096|NCT05383209|530561088|FG001|Overall Study|Death|0|||
147108097|NCT05383209|530561089|FG002|Overall Study|Death|0|||
147108098|NCT05383209|530561087|FG000|Overall Study|Other|0|||
147108099|NCT05383209|530561088|FG001|Overall Study|Other|1|||
147108100|NCT05383209|530561089|FG002|Overall Study|Other|0|||
147108101|NCT00321763|530561091|FG000|Overall Study|Adverse Event|1|||
147108102|NCT00321763|530561092|FG001|Overall Study|Adverse Event|1|||
147108103|NCT00321763|530561093|FG002|Overall Study|Adverse Event|0|||
147108104|NCT00321763|530561094|FG003|Overall Study|Adverse Event|1|||
147108105|NCT00321763|530561091|FG000|Overall Study|Withdrawal by Subject|2|||
147108106|NCT00321763|530561092|FG001|Overall Study|Withdrawal by Subject|0|||
147108107|NCT00321763|530561093|FG002|Overall Study|Withdrawal by Subject|1|||
147108108|NCT00321763|530561094|FG003|Overall Study|Withdrawal by Subject|0|||
147108109|NCT00321763|530561091|FG000|Overall Study|Lost to Follow-up|3|||
147108110|NCT00321763|530561092|FG001|Overall Study|Lost to Follow-up|1|||
147108111|NCT00321763|530561093|FG002|Overall Study|Lost to Follow-up|5|||
147108112|NCT00321763|530561094|FG003|Overall Study|Lost to Follow-up|4|||
147108113|NCT00717886|530561095|FG000|Overall Study|Withdrawal by Subject|3|||
147108114|NCT00717886|530561095|FG000|Overall Study|Treatment Failure|1|||
147108115|NCT00716417|530561096|FG000|Overall Study|Adverse Event|0|||
147108116|NCT00716417|530561097|FG001|Overall Study|Adverse Event|0|||
147108117|NCT00716417|530561098|FG002|Overall Study|Adverse Event|2|||
147108118|NCT00716417|530561099|FG003|Overall Study|Adverse Event|1|||
147108119|NCT00716417|530561100|FG004|Overall Study|Adverse Event|0|||
147108120|NCT00716417|530561101|FG005|Overall Study|Adverse Event|0|||
147108121|NCT00716417|530561102|FG006|Overall Study|Adverse Event|3|||
147108122|NCT00716417|530561103|FG007|Overall Study|Adverse Event|1|||
147108123|NCT00716417|530561104|FG008|Overall Study|Adverse Event|0|||
147558605|NCT02207231|532203849|FG003|Active Controlled Period: Week 16 - 48|Other|0|||
147558606|NCT02207231|532203846|FG000|Open-label Guselkumab: Week 48 - 264|Adverse Event|0|||
147558607|NCT02207231|532203847|FG001|Open-label Guselkumab: Week 48 - 264|Adverse Event|0|||
147108124|NCT00716417|530561105|FG009|Overall Study|Adverse Event|3|||
147108125|NCT00716417|530561096|FG000|Overall Study|Withdrawal by Subject|0|||
147108126|NCT00716417|530561097|FG001|Overall Study|Withdrawal by Subject|1|||
147108127|NCT00716417|530561098|FG002|Overall Study|Withdrawal by Subject|0|||
147108128|NCT00716417|530561099|FG003|Overall Study|Withdrawal by Subject|2|||
147108129|NCT00716417|530561100|FG004|Overall Study|Withdrawal by Subject|0|||
147108130|NCT00716417|530561101|FG005|Overall Study|Withdrawal by Subject|0|||
147108131|NCT00716417|530561102|FG006|Overall Study|Withdrawal by Subject|1|||
147108132|NCT00716417|530561103|FG007|Overall Study|Withdrawal by Subject|0|||
147108133|NCT00716417|530561104|FG008|Overall Study|Withdrawal by Subject|0|||
147444148|NCT02090413|531790530|FG002|Overall Study|Lost to Follow-up|0|||
147108134|NCT00716417|530561105|FG009|Overall Study|Withdrawal by Subject|0|||
147444149|NCT01045798|531790531|FG000|Overall Study|Changed to Open-Label Caspofungin|1|||
147558608|NCT02207231|532203848|FG002|Open-label Guselkumab: Week 48 - 264|Adverse Event|12|||
147558609|NCT02207231|532203849|FG003|Open-label Guselkumab: Week 48 - 264|Adverse Event|19|||
147558610|NCT02207231|532203846|FG000|Open-label Guselkumab: Week 48 - 264|Death|0|||
147558611|NCT02207231|532203847|FG001|Open-label Guselkumab: Week 48 - 264|Death|0|||
147558612|NCT02207231|532203848|FG002|Open-label Guselkumab: Week 48 - 264|Death|1|||
147558613|NCT02207231|532203849|FG003|Open-label Guselkumab: Week 48 - 264|Death|3|||
147558614|NCT02207231|532203846|FG000|Open-label Guselkumab: Week 48 - 264|Pregnancy|0|||
147558615|NCT02207231|532203847|FG001|Open-label Guselkumab: Week 48 - 264|Pregnancy|0|||
147558616|NCT02207231|532203848|FG002|Open-label Guselkumab: Week 48 - 264|Pregnancy|3|||
147558617|NCT02207231|532203849|FG003|Open-label Guselkumab: Week 48 - 264|Pregnancy|7|||
147558618|NCT02207231|532203846|FG000|Open-label Guselkumab: Week 48 - 264|Lack of Efficacy|0|||
147558619|NCT02207231|532203847|FG001|Open-label Guselkumab: Week 48 - 264|Lack of Efficacy|0|||
147558620|NCT02207231|532203848|FG002|Open-label Guselkumab: Week 48 - 264|Lack of Efficacy|2|||
147558621|NCT02207231|532203849|FG003|Open-label Guselkumab: Week 48 - 264|Lack of Efficacy|4|||
147558622|NCT02207231|532203846|FG000|Open-label Guselkumab: Week 48 - 264|Lost to Follow-up|0|||
147558623|NCT02207231|532203847|FG001|Open-label Guselkumab: Week 48 - 264|Lost to Follow-up|0|||
147558624|NCT02207231|532203848|FG002|Open-label Guselkumab: Week 48 - 264|Lost to Follow-up|6|||
147558625|NCT02207231|532203849|FG003|Open-label Guselkumab: Week 48 - 264|Lost to Follow-up|11|||
147558626|NCT02207231|532203846|FG000|Open-label Guselkumab: Week 48 - 264|Withdrawal by Subject|0|||
147558627|NCT02207231|532203847|FG001|Open-label Guselkumab: Week 48 - 264|Withdrawal by Subject|0|||
147558628|NCT02207231|532203848|FG002|Open-label Guselkumab: Week 48 - 264|Withdrawal by Subject|10|||
147558629|NCT02207231|532203849|FG003|Open-label Guselkumab: Week 48 - 264|Withdrawal by Subject|28|||
147558630|NCT02207231|532203846|FG000|Open-label Guselkumab: Week 48 - 264|Other|0|||
147558631|NCT02207231|532203847|FG001|Open-label Guselkumab: Week 48 - 264|Other|0|||
147558632|NCT02207231|532203848|FG002|Open-label Guselkumab: Week 48 - 264|Other|4|||
147558633|NCT02207231|532203849|FG003|Open-label Guselkumab: Week 48 - 264|Other|11|||
147558634|NCT00502775|532203853|FG000|Overall Study|Adverse Event|1|||
147558635|NCT00502775|532203854|FG001|Overall Study|Adverse Event|2|||
147558636|NCT00502775|532203855|FG002|Overall Study|Adverse Event|1|||
147558637|NCT00502775|532203853|FG000|Overall Study|Protocol Violation|1|||
147558638|NCT00502775|532203854|FG001|Overall Study|Protocol Violation|5|||
147558639|NCT00502775|532203855|FG002|Overall Study|Protocol Violation|2|||
147558640|NCT00502775|532203853|FG000|Overall Study|Withdrawal by Subject|1|||
147558641|NCT00502775|532203854|FG001|Overall Study|Withdrawal by Subject|1|||
147558642|NCT00502775|532203855|FG002|Overall Study|Withdrawal by Subject|2|||
147558643|NCT00502775|532203853|FG000|Overall Study|Sponsor Terminated Study|1|||
147558644|NCT00502775|532203854|FG001|Overall Study|Sponsor Terminated Study|0|||
147558645|NCT00502775|532203855|FG002|Overall Study|Sponsor Terminated Study|1|||
147558646|NCT00502775|532203853|FG000|Overall Study|Non-compliance with eDiary|4|||
147558647|NCT00502775|532203854|FG001|Overall Study|Non-compliance with eDiary|1|||
147558648|NCT00502775|532203855|FG002|Overall Study|Non-compliance with eDiary|1|||
147558649|NCT00502775|532203853|FG000|Overall Study|Subject unable to swallow capsule|1|||
147558650|NCT00502775|532203854|FG001|Overall Study|Subject unable to swallow capsule|0|||
147558651|NCT00502775|532203855|FG002|Overall Study|Subject unable to swallow capsule|1|||
147558652|NCT00502775|532203853|FG000|Overall Study|Logpad compliance <80%|1|||
147558653|NCT00502775|532203854|FG001|Overall Study|Logpad compliance <80%|0|||
147558654|NCT00502775|532203855|FG002|Overall Study|Logpad compliance <80%|0|||
147558655|NCT00502775|532203853|FG000|Overall Study|Randomized in error|0|||
147558656|NCT00502775|532203854|FG001|Overall Study|Randomized in error|1|||
147558657|NCT00502775|532203855|FG002|Overall Study|Randomized in error|1|||
147558658|NCT00502775|532203853|FG000|Overall Study|Non-compliance|0|||
147558659|NCT00502775|532203854|FG001|Overall Study|Non-compliance|2|||
147558660|NCT00502775|532203855|FG002|Overall Study|Non-compliance|2|||
147558661|NCT00502775|532203853|FG000|Overall Study|Outside pollen area more than 48 hours|0|||
147558662|NCT00502775|532203854|FG001|Overall Study|Outside pollen area more than 48 hours|1|||
147558663|NCT00502775|532203855|FG002|Overall Study|Outside pollen area more than 48 hours|0|||
147558664|NCT00502775|532203853|FG000|Overall Study|Declining pollen counts|0|||
147225410|NCT05063318|530996666|FG002|Overall Study|Progressive disease|3|||
147225411|NCT05063318|530996664|FG000|Overall Study|Compassionate use|1|||
147225412|NCT05063318|530996665|FG001|Overall Study|Compassionate use|3|||
147225413|NCT05063318|530996666|FG002|Overall Study|Compassionate use|3|||
147225414|NCT05063318|530996664|FG000|Overall Study|Adverse Event|0|||
147225415|NCT05063318|530996665|FG001|Overall Study|Adverse Event|1|||
147225416|NCT05063318|530996666|FG002|Overall Study|Adverse Event|0|||
147225417|NCT05063318|530996664|FG000|Overall Study|Withdrawal by Subject|0|||
147225418|NCT05063318|530996665|FG001|Overall Study|Withdrawal by Subject|1|||
147225419|NCT05063318|530996666|FG002|Overall Study|Withdrawal by Subject|0|||
147558665|NCT00502775|532203854|FG001|Overall Study|Declining pollen counts|1|||
147558666|NCT00502775|532203855|FG002|Overall Study|Declining pollen counts|1|||
147558667|NCT00502775|532203853|FG000|Overall Study|Subject in jail|0|||
147558668|NCT00502775|532203854|FG001|Overall Study|Subject in jail|1|||
147558669|NCT00502775|532203855|FG002|Overall Study|Subject in jail|0|||
147108135|NCT00716417|530561096|FG000|Overall Study|Progressive disease|3|||
147108136|NCT00716417|530561097|FG001|Overall Study|Progressive disease|5|||
147108137|NCT00716417|530561098|FG002|Overall Study|Progressive disease|3|||
147108138|NCT00716417|530561099|FG003|Overall Study|Progressive disease|8|||
147108139|NCT00716417|530561100|FG004|Overall Study|Progressive disease|0|||
147108140|NCT00716417|530561101|FG005|Overall Study|Progressive disease|3|||
147108141|NCT00716417|530561102|FG006|Overall Study|Progressive disease|3|||
147108142|NCT00716417|530561103|FG007|Overall Study|Progressive disease|1|||
147108143|NCT00716417|530561104|FG008|Overall Study|Progressive disease|5|||
147108144|NCT00716417|530561105|FG009|Overall Study|Progressive disease|0|||
147108145|NCT00716417|530561096|FG000|Overall Study|Dose limiting toxicity (DLT)|0|||
147108146|NCT00716417|530561097|FG001|Overall Study|Dose limiting toxicity (DLT)|0|||
147108147|NCT00716417|530561098|FG002|Overall Study|Dose limiting toxicity (DLT)|0|||
147108148|NCT00716417|530561099|FG003|Overall Study|Dose limiting toxicity (DLT)|0|||
147108149|NCT00716417|530561100|FG004|Overall Study|Dose limiting toxicity (DLT)|1|||
147108150|NCT00716417|530561101|FG005|Overall Study|Dose limiting toxicity (DLT)|0|||
147108151|NCT00716417|530561102|FG006|Overall Study|Dose limiting toxicity (DLT)|0|||
147108152|NCT00716417|530561103|FG007|Overall Study|Dose limiting toxicity (DLT)|0|||
147108153|NCT00716417|530561104|FG008|Overall Study|Dose limiting toxicity (DLT)|0|||
147108154|NCT00716417|530561105|FG009|Overall Study|Dose limiting toxicity (DLT)|0|||
147108155|NCT00716417|530561096|FG000|Overall Study|On patient request due to toxicities|0|||
147108156|NCT00716417|530561097|FG001|Overall Study|On patient request due to toxicities|0|||
147108157|NCT00716417|530561098|FG002|Overall Study|On patient request due to toxicities|0|||
147108158|NCT00716417|530561099|FG003|Overall Study|On patient request due to toxicities|0|||
147108159|NCT00716417|530561100|FG004|Overall Study|On patient request due to toxicities|0|||
147108160|NCT00716417|530561101|FG005|Overall Study|On patient request due to toxicities|0|||
147108161|NCT00716417|530561102|FG006|Overall Study|On patient request due to toxicities|0|||
147108162|NCT00716417|530561103|FG007|Overall Study|On patient request due to toxicities|1|||
147108163|NCT00716417|530561104|FG008|Overall Study|On patient request due to toxicities|0|||
147108164|NCT00716417|530561105|FG009|Overall Study|On patient request due to toxicities|0|||
147108165|NCT03822416|530561108|FG000|Overall Study|Lost to Follow-up|1|||
147108166|NCT03822416|530561109|FG001|Overall Study|Lost to Follow-up|0|||
147108167|NCT03822416|530561108|FG000|Overall Study|Withdrawal by Subject|0|||
147108168|NCT03822416|530561109|FG001|Overall Study|Withdrawal by Subject|1|||
147108169|NCT01303419|530561110|FG000|Overall Study|Discontinuation of study|60|||
147108170|NCT01303419|530561110|FG000|Overall Study|Did not complete both imaging methods|5|||
147108171|NCT01303419|530561110|FG000|Overall Study|Did not meet all I/E after screening|31|||
147108172|NCT01104766|530561112|FG000|Overall Study|Did not meet inc/exc criteria|1|||
147108173|NCT01104766|530561113|FG001|Overall Study|Did not meet inc/exc criteria|0|||
147108174|NCT01104766|530561114|FG002|Overall Study|Did not meet inc/exc criteria|0|||
147108175|NCT01104766|530561115|FG003|Overall Study|Did not meet inc/exc criteria|0|||
147108176|NCT01104766|530561112|FG000|Overall Study|Adverse Event|17|||
147108177|NCT01104766|530561113|FG001|Overall Study|Adverse Event|15|||
147108178|NCT01104766|530561114|FG002|Overall Study|Adverse Event|20|||
147108179|NCT01104766|530561115|FG003|Overall Study|Adverse Event|14|||
147108180|NCT01104766|530561112|FG000|Overall Study|Lack of Efficacy|20|||
147108181|NCT01104766|530561113|FG001|Overall Study|Lack of Efficacy|15|||
147108182|NCT01104766|530561114|FG002|Overall Study|Lack of Efficacy|14|||
147108183|NCT01104766|530561115|FG003|Overall Study|Lack of Efficacy|8|||
147108184|NCT01104766|530561112|FG000|Overall Study|Protocol Violation|2|||
147108185|NCT01104766|530561113|FG001|Overall Study|Protocol Violation|0|||
147108186|NCT01104766|530561114|FG002|Overall Study|Protocol Violation|0|||
147108187|NCT01104766|530561115|FG003|Overall Study|Protocol Violation|0|||
147108188|NCT01104766|530561112|FG000|Overall Study|Withdrawal by Subject|17|||
147108189|NCT01104766|530561113|FG001|Overall Study|Withdrawal by Subject|19|||
147108190|NCT01104766|530561114|FG002|Overall Study|Withdrawal by Subject|25|||
147310784|NCT00192023|531305094|FG000|Period IV - Optional Open-Label|Protocol Violation|1|||
147310785|NCT00192023|531305095|FG001|Period IV - Optional Open-Label|Protocol Violation|0|||
147310786|NCT00192023|531305094|FG000|Period IV - Optional Open-Label|Withdrawal by Subject|4|||
147310787|NCT00192023|531305095|FG001|Period IV - Optional Open-Label|Withdrawal by Subject|0|||
147444150|NCT01045798|531790532|FG001|Overall Study|Changed to Open-Label Caspofungin|0|||
147444151|NCT01045798|531790531|FG000|Overall Study|Invasive Fungal Infection at Baseline|0|||
147558670|NCT00502775|532203853|FG000|Overall Study|Subject took disallowed drug|0|||
147558671|NCT00502775|532203854|FG001|Overall Study|Subject took disallowed drug|0|||
147108191|NCT01104766|530561115|FG003|Overall Study|Withdrawal by Subject|15|||
147108192|NCT01104766|530561112|FG000|Overall Study|Lost to Follow-up|1|||
147108193|NCT01104766|530561113|FG001|Overall Study|Lost to Follow-up|2|||
147108194|NCT01104766|530561114|FG002|Overall Study|Lost to Follow-up|1|||
147108195|NCT01104766|530561115|FG003|Overall Study|Lost to Follow-up|1|||
147108196|NCT01136915|530561116|FG000|Overall Study|Lost to Follow-up|2|||
147108197|NCT01136915|530561117|FG001|Overall Study|Lost to Follow-up|0|||
147108198|NCT01136915|530561116|FG000|Overall Study|Exclusion criterion met|0|||
147310788|NCT00192023|531305094|FG000|Period IV - Optional Open-Label|Physician Decision|9|||
147108199|NCT01136915|530561117|FG001|Overall Study|Exclusion criterion met|1|||
147108200|NCT02755090|530561121|FG000|Overall Study|equipment malfunction|1|||
147108201|NCT02755090|530561122|FG001|Overall Study|equipment malfunction|0|||
147108202|NCT01564407|530561126|FG000|Overall Study|Lost to Follow-up|0|||
147108203|NCT01564407|530561127|FG001|Overall Study|Lost to Follow-up|1|||
147108204|NCT01564407|530561128|FG002|Overall Study|Lost to Follow-up|0|||
147108205|NCT01564407|530561129|FG003|Overall Study|Lost to Follow-up|0|||
147108206|NCT01564407|530561130|FG004|Overall Study|Lost to Follow-up|0|||
147108207|NCT01564407|530561126|FG000|Overall Study|Withdrawal by Subject|0|||
147108208|NCT01564407|530561127|FG001|Overall Study|Withdrawal by Subject|1|||
147108209|NCT01564407|530561128|FG002|Overall Study|Withdrawal by Subject|0|||
147108210|NCT01564407|530561129|FG003|Overall Study|Withdrawal by Subject|0|||
147108211|NCT01564407|530561130|FG004|Overall Study|Withdrawal by Subject|0|||
147108212|NCT01564407|530561126|FG000|Overall Study|funding lost, study ended|0|||
147108213|NCT01564407|530561127|FG001|Overall Study|funding lost, study ended|0|||
147108214|NCT01564407|530561128|FG002|Overall Study|funding lost, study ended|0|||
147108215|NCT01564407|530561129|FG003|Overall Study|funding lost, study ended|1|||
147108216|NCT01564407|530561130|FG004|Overall Study|funding lost, study ended|0|||
147108217|NCT00879658|530561133|FG000|Overall Study|Abnormal laboratory value(s)|3|||
147108218|NCT00879658|530561134|FG001|Overall Study|Abnormal laboratory value(s)|0|||
147108219|NCT00879658|530561135|FG002|Overall Study|Abnormal laboratory value(s)|0|||
147108220|NCT00879658|530561136|FG003|Overall Study|Abnormal laboratory value(s)|1|||
147108221|NCT00879658|530561137|FG004|Overall Study|Abnormal laboratory value(s)|0|||
147108222|NCT00879658|530561138|FG005|Overall Study|Abnormal laboratory value(s)|0|||
147108223|NCT00879658|530561139|FG006|Overall Study|Abnormal laboratory value(s)|0|||
147108224|NCT00879658|530561133|FG000|Overall Study|Administrative problems|2|||
147108225|NCT00879658|530561134|FG001|Overall Study|Administrative problems|1|||
147225420|NCT03287635|530996667|FG000|Overall Study|Lost to Follow-up|5|||
147225421|NCT03287635|530996667|FG000|Overall Study|Withdrawal by Subject|1|||
147225422|NCT03287635|530996667|FG000|Overall Study|Physician Decision|1|||
147225423|NCT03670836|530996668|FG000|Intent-to-treat Population (ITT)|Withdrawal by Subject|1|||
147225424|NCT03670836|530996669|FG001|Intent-to-treat Population (ITT)|Withdrawal by Subject|3|||
147225425|NCT03670836|530996668|FG000|Per Protocol Population (PP)|Physician Decision|9|||
147225426|NCT03670836|530996669|FG001|Per Protocol Population (PP)|Physician Decision|10|||
147225427|NCT03670836|530996668|FG000|Per Protocol Population (PP)|Physician Decision|4|||
147225428|NCT03670836|530996669|FG001|Per Protocol Population (PP)|Physician Decision|6|||
147225429|NCT03670836|530996668|FG000|Per Protocol Population (PP)|Incorrect stratification / inability to insert Dilapan|1|||
147225430|NCT03670836|530996669|FG001|Per Protocol Population (PP)|Incorrect stratification / inability to insert Dilapan|1|||
147225431|NCT00323869|530996672|FG000|Overall Study|Death|1|||
147225432|NCT01052844|530998222|FG000|Overall Study|Adverse Event|0|||
147225433|NCT01052844|530998223|FG001|Overall Study|Adverse Event|1|||
147225434|NCT01241240|530998224|FG000|Overall Study|Adverse Event|5|||
147225435|NCT01241240|530998225|FG001|Overall Study|Adverse Event|4|||
147225436|NCT01241240|530998224|FG000|Overall Study|Lost to Follow-up|2|||
147225437|NCT01241240|530998225|FG001|Overall Study|Lost to Follow-up|4|||
147225438|NCT01241240|530998224|FG000|Overall Study|Personal Reasons|1|||
147225439|NCT01241240|530998225|FG001|Overall Study|Personal Reasons|1|||
147225440|NCT01439347|530998226|FG000|Overall Study|Death|10|||
147225441|NCT01439347|530998227|FG001|Overall Study|Death|9|||
147225442|NCT01439347|530998226|FG000|Overall Study|Withdrawal by Subject|0|||
147225443|NCT01439347|530998227|FG001|Overall Study|Withdrawal by Subject|1|||
147225444|NCT01439347|530998226|FG000|Overall Study|Physician Decision|1|||
147225445|NCT01439347|530998227|FG001|Overall Study|Physician Decision|0|||
147225446|NCT01439347|530998226|FG000|Overall Study|Sponsor Terminated Study|2|||
147225447|NCT01439347|530998227|FG001|Overall Study|Sponsor Terminated Study|3|||
147225448|NCT00542451|530998228|FG000|Overall Study|Adverse Event|31|||
147225449|NCT00542451|530998228|FG000|Overall Study|Withdrawal by Subject|30|||
147225450|NCT00542451|530998228|FG000|Overall Study|Physician Decision|4|||
147225451|NCT00542451|530998228|FG000|Overall Study|Recurrent disease|1|||
147225452|NCT00542451|530998228|FG000|Overall Study|unknown reason|1|||
147225453|NCT00542451|530998228|FG000|Overall Study|Death|2|||
147225454|NCT00542451|530998228|FG000|Overall Study|Lost to Follow-up|10|||
147225455|NCT02788474|530998229|FG000|Double Blind Treatment Period|Not treated|1|||
147225456|NCT02788474|530998230|FG001|Double Blind Treatment Period|Not treated|0|||
147225457|NCT02788474|530998229|FG000|Double Blind Treatment Period|Patient's refusal|3|||
147225458|NCT02788474|530998230|FG001|Double Blind Treatment Period|Patient's refusal|0|||
147444152|NCT01045798|531790532|FG001|Overall Study|Invasive Fungal Infection at Baseline|1|||
147108226|NCT00879658|530561135|FG002|Overall Study|Administrative problems|0|||
147108227|NCT00879658|530561136|FG003|Overall Study|Administrative problems|1|||
147108228|NCT00879658|530561137|FG004|Overall Study|Administrative problems|0|||
147225459|NCT02788474|530998229|FG000|Double Blind Treatment Period|Adverse Event|6|||
147225460|NCT02788474|530998230|FG001|Double Blind Treatment Period|Adverse Event|4|||
147225461|NCT02788474|530998229|FG000|Open Label Treatment Period|Adverse Event|29|||
147225462|NCT02788474|530998230|FG001|Open Label Treatment Period|Adverse Event|9|||
147225463|NCT02788474|530998229|FG000|Open Label Treatment Period|Other than reason specified|1|||
147108229|NCT00879658|530561138|FG005|Overall Study|Administrative problems|0|||
147108230|NCT00879658|530561139|FG006|Overall Study|Administrative problems|0|||
147108231|NCT00879658|530561133|FG000|Overall Study|Adverse Event|6|||
147108232|NCT00879658|530561134|FG001|Overall Study|Adverse Event|4|||
147108233|NCT00879658|530561135|FG002|Overall Study|Adverse Event|3|||
147108234|NCT00879658|530561136|FG003|Overall Study|Adverse Event|1|||
147108235|NCT00879658|530561137|FG004|Overall Study|Adverse Event|2|||
147108236|NCT00879658|530561138|FG005|Overall Study|Adverse Event|0|||
147108237|NCT00879658|530561139|FG006|Overall Study|Adverse Event|0|||
147108238|NCT00879658|530561133|FG000|Overall Study|Protocol Violation|1|||
147108239|NCT00879658|530561134|FG001|Overall Study|Protocol Violation|0|||
147108240|NCT00879658|530561135|FG002|Overall Study|Protocol Violation|0|||
147108241|NCT00879658|530561136|FG003|Overall Study|Protocol Violation|0|||
147108242|NCT00879658|530561137|FG004|Overall Study|Protocol Violation|0|||
147108243|NCT00879658|530561138|FG005|Overall Study|Protocol Violation|0|||
147108244|NCT00879658|530561139|FG006|Overall Study|Protocol Violation|0|||
147108245|NCT00879658|530561133|FG000|Overall Study|Withdrawal by Subject|3|||
147108246|NCT00879658|530561134|FG001|Overall Study|Withdrawal by Subject|0|||
147108247|NCT00879658|530561135|FG002|Overall Study|Withdrawal by Subject|2|||
147108248|NCT00879658|530561136|FG003|Overall Study|Withdrawal by Subject|0|||
147108249|NCT00879658|530561137|FG004|Overall Study|Withdrawal by Subject|0|||
147108250|NCT00879658|530561138|FG005|Overall Study|Withdrawal by Subject|1|||
147108251|NCT00879658|530561139|FG006|Overall Study|Withdrawal by Subject|0|||
147108252|NCT00879658|530561133|FG000|Overall Study|Lack of Efficacy|0|||
147108253|NCT00879658|530561134|FG001|Overall Study|Lack of Efficacy|0|||
147108254|NCT00879658|530561135|FG002|Overall Study|Lack of Efficacy|2|||
147108255|NCT00879658|530561136|FG003|Overall Study|Lack of Efficacy|0|||
147108256|NCT00879658|530561137|FG004|Overall Study|Lack of Efficacy|0|||
147108257|NCT00879658|530561138|FG005|Overall Study|Lack of Efficacy|0|||
147108258|NCT00879658|530561139|FG006|Overall Study|Lack of Efficacy|0|||
147108259|NCT00879658|530561133|FG000|Overall Study|misrandomized (never received study med)|0|||
147108260|NCT00879658|530561134|FG001|Overall Study|misrandomized (never received study med)|0|||
147108261|NCT00879658|530561135|FG002|Overall Study|misrandomized (never received study med)|0|||
147108262|NCT00879658|530561136|FG003|Overall Study|misrandomized (never received study med)|1|||
147108263|NCT00879658|530561137|FG004|Overall Study|misrandomized (never received study med)|0|||
147108264|NCT00879658|530561138|FG005|Overall Study|misrandomized (never received study med)|0|||
147108265|NCT00879658|530561139|FG006|Overall Study|misrandomized (never received study med)|0|||
147108266|NCT00639509|530561140|FG000|Overall Study|Death|1|||
147108267|NCT00294658|530561141|FG000|Overall Study|Death|0|||
147108268|NCT00294658|530561142|FG001|Overall Study|Death|1|||
147108269|NCT00294658|530561141|FG000|Overall Study|Lost to Follow-up|4|||
147108270|NCT00294658|530561142|FG001|Overall Study|Lost to Follow-up|0|||
147108271|NCT00294658|530561141|FG000|Overall Study|Physician Decision|1|||
147108272|NCT00294658|530561142|FG001|Overall Study|Physician Decision|2|||
147108273|NCT00294658|530561141|FG000|Overall Study|Pregnancy|0|||
147108274|NCT00294658|530561142|FG001|Overall Study|Pregnancy|1|||
147108275|NCT00294658|530561141|FG000|Overall Study|Withdrawal by Subject|0|||
147108276|NCT00294658|530561142|FG001|Overall Study|Withdrawal by Subject|4|||
147108277|NCT00294658|530561141|FG000|Overall Study|Found to have invasive thymoma|1|||
147108278|NCT00294658|530561142|FG001|Overall Study|Found to have invasive thymoma|0|||
147108279|NCT00294658|530561141|FG000|Overall Study|Patient and family were not satisfied|0|||
147108280|NCT00294658|530561142|FG001|Overall Study|Patient and family were not satisfied|1|||
147108281|NCT01402700|530561143|FG000|Overall Study|Death|3|||
147108282|NCT01402700|530561143|FG000|Overall Study|Withdrawal by Subject|3|||
147558672|NCT00502775|532203855|FG002|Overall Study|Subject took disallowed drug|1|||
147558673|NCT02016300|532203863|FG000|Overall Study|Lost to Follow-up|0|||
147558674|NCT02016300|532203864|FG001|Overall Study|Lost to Follow-up|3|||
147558675|NCT06165744|532203867|FG000|Overall Study|Non device-related adverse event|1|||
147558676|NCT01545076|532203868|FG000|IgPro10 Restabilization Period|Adverse Event|4|||
147558677|NCT01545076|532203869|FG001|IgPro10 Restabilization Period|Adverse Event|0|||
147558678|NCT01545076|532203870|FG002|IgPro10 Restabilization Period|Adverse Event|0|||
147558679|NCT01545076|532203871|FG003|IgPro10 Restabilization Period|Adverse Event|0|||
147558680|NCT01545076|532203872|FG004|IgPro10 Restabilization Period|Adverse Event|0|||
147558681|NCT01545076|532203868|FG000|IgPro10 Restabilization Period|Physician Decision|2|||
147558682|NCT01545076|532203869|FG001|IgPro10 Restabilization Period|Physician Decision|0|||
147108283|NCT01402700|530561143|FG000|Overall Study|Missed Visit|1|||
147108284|NCT03507790|530561144|FG000|Overall Study|Adverse Event|0|||
147108285|NCT03507790|530561145|FG001|Overall Study|Adverse Event|11|||
147108286|NCT03507790|530561146|FG002|Overall Study|Adverse Event|3|||
147108287|NCT03507790|530561144|FG000|Overall Study|Withdrawal by Subject|2|||
147108288|NCT03507790|530561145|FG001|Overall Study|Withdrawal by Subject|0|||
147108289|NCT03507790|530561146|FG002|Overall Study|Withdrawal by Subject|0|||
147108290|NCT03507790|530561144|FG000|Overall Study|Subject moved to another location|1|||
147108291|NCT03507790|530561145|FG001|Overall Study|Subject moved to another location|2|||
147558683|NCT01545076|532203870|FG002|IgPro10 Restabilization Period|Physician Decision|0|||
147108292|NCT03507790|530561146|FG002|Overall Study|Subject moved to another location|0|||
147108293|NCT03507790|530561144|FG000|Overall Study|Non-compliance with study drug|0|||
147108294|NCT03507790|530561145|FG001|Overall Study|Non-compliance with study drug|0|||
147108295|NCT03507790|530561146|FG002|Overall Study|Non-compliance with study drug|1|||
147108296|NCT03507790|530561144|FG000|Overall Study|COVID 19 Pandemic|0|||
147108297|NCT03507790|530561145|FG001|Overall Study|COVID 19 Pandemic|1|||
147108298|NCT03507790|530561146|FG002|Overall Study|COVID 19 Pandemic|0|||
147108299|NCT03507790|530561144|FG000|Overall Study|Lost to Follow-up|0|||
147108300|NCT03507790|530561145|FG001|Overall Study|Lost to Follow-up|1|||
147108301|NCT03507790|530561146|FG002|Overall Study|Lost to Follow-up|0|||
147108302|NCT03507790|530561144|FG000|Overall Study|Discontinuation of the trial at the site|1|||
147108303|NCT03507790|530561145|FG001|Overall Study|Discontinuation of the trial at the site|1|||
147108304|NCT03507790|530561146|FG002|Overall Study|Discontinuation of the trial at the site|0|||
147108305|NCT03507790|530561144|FG000|Overall Study|Randomized in error|0|||
147108306|NCT03507790|530561145|FG001|Overall Study|Randomized in error|0|||
147108307|NCT03507790|530561146|FG002|Overall Study|Randomized in error|1|||
147108308|NCT00157755|530561148|FG000|Overall Study|Death|2|||
147108309|NCT00157755|530561149|FG001|Overall Study|Death|3|||
147108310|NCT00157755|530561150|FG002|Overall Study|Death|3|||
147108311|NCT00157755|530561151|FG003|Overall Study|Death|2|||
147108312|NCT00157755|530561152|FG004|Overall Study|Death|0|||
147108313|NCT00157755|530561153|FG005|Overall Study|Death|0|||
147108314|NCT00157755|530561148|FG000|Overall Study|Lost to Follow-up|0|||
147108315|NCT00157755|530561149|FG001|Overall Study|Lost to Follow-up|0|||
147108316|NCT00157755|530561150|FG002|Overall Study|Lost to Follow-up|1|||
147108317|NCT00157755|530561151|FG003|Overall Study|Lost to Follow-up|0|||
147108318|NCT00157755|530561152|FG004|Overall Study|Lost to Follow-up|0|||
147108319|NCT00157755|530561153|FG005|Overall Study|Lost to Follow-up|0|||
147108320|NCT00157755|530561148|FG000|Overall Study|Withdrawal by Subject|0|||
147108321|NCT00157755|530561149|FG001|Overall Study|Withdrawal by Subject|0|||
147108322|NCT00157755|530561150|FG002|Overall Study|Withdrawal by Subject|1|||
147108323|NCT00157755|530561151|FG003|Overall Study|Withdrawal by Subject|1|||
147108324|NCT00157755|530561152|FG004|Overall Study|Withdrawal by Subject|1|||
147108325|NCT00157755|530561153|FG005|Overall Study|Withdrawal by Subject|2|||
147108326|NCT00157755|530561148|FG000|Overall Study|Explant due to infection|0|||
147108327|NCT00157755|530561149|FG001|Overall Study|Explant due to infection|0|||
147108328|NCT00157755|530561150|FG002|Overall Study|Explant due to infection|1|||
147108329|NCT00157755|530561151|FG003|Overall Study|Explant due to infection|0|||
147108330|NCT00157755|530561152|FG004|Overall Study|Explant due to infection|0|||
147108331|NCT00157755|530561153|FG005|Overall Study|Explant due to infection|0|||
147108332|NCT00157755|530561148|FG000|Overall Study|Medical reason|0|||
147108333|NCT00157755|530561149|FG001|Overall Study|Medical reason|0|||
147108334|NCT00157755|530561150|FG002|Overall Study|Medical reason|1|||
147108335|NCT00157755|530561151|FG003|Overall Study|Medical reason|1|||
147108336|NCT00157755|530561152|FG004|Overall Study|Medical reason|0|||
147108337|NCT00157755|530561153|FG005|Overall Study|Medical reason|0|||
147108338|NCT00157755|530561148|FG000|Overall Study|Study site closure|0|||
147108339|NCT00157755|530561149|FG001|Overall Study|Study site closure|1|||
147108340|NCT00157755|530561150|FG002|Overall Study|Study site closure|0|||
147108341|NCT00157755|530561151|FG003|Overall Study|Study site closure|0|||
147108342|NCT00157755|530561152|FG004|Overall Study|Study site closure|0|||
147108343|NCT00157755|530561153|FG005|Overall Study|Study site closure|0|||
147108344|NCT00157755|530561148|FG000|Overall Study|Subject non-compliance|0|||
147108345|NCT00157755|530561149|FG001|Overall Study|Subject non-compliance|0|||
147108346|NCT00157755|530561150|FG002|Overall Study|Subject non-compliance|0|||
147108347|NCT00157755|530561151|FG003|Overall Study|Subject non-compliance|0|||
147108348|NCT00157755|530561152|FG004|Overall Study|Subject non-compliance|0|||
147108349|NCT00157755|530561153|FG005|Overall Study|Subject non-compliance|1|||
147108350|NCT00157755|530561148|FG000|Overall Study|Study completion|0|||
147558684|NCT01545076|532203871|FG003|IgPro10 Restabilization Period|Physician Decision|0|||
147558685|NCT01545076|532203872|FG004|IgPro10 Restabilization Period|Physician Decision|0|||
147558686|NCT01545076|532203868|FG000|IgPro10 Restabilization Period|Protocol Violation|1|||
147558687|NCT01545076|532203869|FG001|IgPro10 Restabilization Period|Protocol Violation|0|||
147108351|NCT00157755|530561149|FG001|Overall Study|Study completion|0|||
147108352|NCT00157755|530561150|FG002|Overall Study|Study completion|0|||
147108353|NCT00157755|530561151|FG003|Overall Study|Study completion|0|||
147108354|NCT00157755|530561152|FG004|Overall Study|Study completion|1|||
147108355|NCT00157755|530561153|FG005|Overall Study|Study completion|2|||
147108356|NCT05049122|530561161|FG000|Overall Study|Adverse event not related to Coronavirus Diesease-2019|1|||
147108357|NCT05049122|530561161|FG000|Overall Study|Participant moved|1|||
147108358|NCT05049122|530561161|FG000|Overall Study|At the direction of the doctor|1|||
147108359|NCT03314935|530561162|FG000|Phase 1|Death|4|||
147108360|NCT03314935|530561163|FG001|Phase 1|Death|2|||
147108361|NCT03314935|530561164|FG002|Phase 1|Death|5|||
147108362|NCT03314935|530561165|FG003|Phase 1|Death|4|||
147108363|NCT03314935|530561166|FG004|Phase 1|Death|3|||
147310789|NCT00192023|531305095|FG001|Period IV - Optional Open-Label|Physician Decision|0|||
147558688|NCT01545076|532203870|FG002|IgPro10 Restabilization Period|Protocol Violation|0|||
147108364|NCT03314935|530561167|FG005|Phase 1|Death|4|||
147108365|NCT03314935|530561168|FG006|Phase 1|Death|5|||
147108366|NCT03314935|530561169|FG007|Phase 1|Death|4|||
147108367|NCT03314935|530561170|FG008|Phase 1|Death|3|||
147108368|NCT03314935|530561171|FG009|Phase 1|Death|0|||
147108369|NCT03314935|530561172|FG010|Phase 1|Death|0|||
147108370|NCT03314935|530561173|FG011|Phase 1|Death|0|||
147108371|NCT03314935|530561174|FG012|Phase 1|Death|0|||
147108372|NCT03314935|530561175|FG013|Phase 1|Death|0|||
147108373|NCT03314935|530561176|FG014|Phase 1|Death|0|||
147108374|NCT03314935|530561162|FG000|Phase 1|Withdrawal by Subject|2|||
147108375|NCT03314935|530561163|FG001|Phase 1|Withdrawal by Subject|1|||
147108376|NCT03314935|530561164|FG002|Phase 1|Withdrawal by Subject|1|||
147108377|NCT03314935|530561165|FG003|Phase 1|Withdrawal by Subject|2|||
147108378|NCT03314935|530561166|FG004|Phase 1|Withdrawal by Subject|1|||
147108379|NCT03314935|530561167|FG005|Phase 1|Withdrawal by Subject|0|||
147108380|NCT03314935|530561168|FG006|Phase 1|Withdrawal by Subject|1|||
147108381|NCT03314935|530561169|FG007|Phase 1|Withdrawal by Subject|0|||
147108382|NCT03314935|530561170|FG008|Phase 1|Withdrawal by Subject|1|||
147108383|NCT03314935|530561171|FG009|Phase 1|Withdrawal by Subject|0|||
147108384|NCT03314935|530561172|FG010|Phase 1|Withdrawal by Subject|0|||
147108385|NCT03314935|530561173|FG011|Phase 1|Withdrawal by Subject|0|||
147108386|NCT03314935|530561174|FG012|Phase 1|Withdrawal by Subject|0|||
147108387|NCT03314935|530561175|FG013|Phase 1|Withdrawal by Subject|0|||
147108388|NCT03314935|530561176|FG014|Phase 1|Withdrawal by Subject|0|||
147108389|NCT03314935|530561162|FG000|Phase 1|Progressive Disease|2|||
147108390|NCT03314935|530561163|FG001|Phase 1|Progressive Disease|0|||
147108391|NCT03314935|530561164|FG002|Phase 1|Progressive Disease|0|||
147108392|NCT03314935|530561165|FG003|Phase 1|Progressive Disease|1|||
147108393|NCT03314935|530561166|FG004|Phase 1|Progressive Disease|0|||
147108394|NCT03314935|530561167|FG005|Phase 1|Progressive Disease|0|||
147108395|NCT03314935|530561168|FG006|Phase 1|Progressive Disease|0|||
147108396|NCT03314935|530561169|FG007|Phase 1|Progressive Disease|0|||
147108397|NCT03314935|530561170|FG008|Phase 1|Progressive Disease|0|||
147108398|NCT03314935|530561171|FG009|Phase 1|Progressive Disease|0|||
147108399|NCT03314935|530561172|FG010|Phase 1|Progressive Disease|0|||
147108400|NCT03314935|530561173|FG011|Phase 1|Progressive Disease|0|||
147108401|NCT03314935|530561174|FG012|Phase 1|Progressive Disease|0|||
147108402|NCT03314935|530561175|FG013|Phase 1|Progressive Disease|0|||
147108403|NCT03314935|530561176|FG014|Phase 1|Progressive Disease|0|||
147108404|NCT03314935|530561162|FG000|Phase 1|Study Terminated by Sponsor|0|||
147108405|NCT03314935|530561163|FG001|Phase 1|Study Terminated by Sponsor|1|||
147108406|NCT03314935|530561164|FG002|Phase 1|Study Terminated by Sponsor|0|||
147108407|NCT03314935|530561165|FG003|Phase 1|Study Terminated by Sponsor|0|||
147108408|NCT03314935|530561166|FG004|Phase 1|Study Terminated by Sponsor|0|||
147108409|NCT03314935|530561167|FG005|Phase 1|Study Terminated by Sponsor|0|||
147108410|NCT03314935|530561168|FG006|Phase 1|Study Terminated by Sponsor|0|||
147108411|NCT03314935|530561169|FG007|Phase 1|Study Terminated by Sponsor|0|||
147108412|NCT03314935|530561170|FG008|Phase 1|Study Terminated by Sponsor|1|||
147108413|NCT03314935|530561171|FG009|Phase 1|Study Terminated by Sponsor|0|||
147108414|NCT03314935|530561172|FG010|Phase 1|Study Terminated by Sponsor|0|||
147108415|NCT03314935|530561173|FG011|Phase 1|Study Terminated by Sponsor|0|||
147108416|NCT03314935|530561174|FG012|Phase 1|Study Terminated by Sponsor|0|||
147108417|NCT03314935|530561175|FG013|Phase 1|Study Terminated by Sponsor|0|||
147108418|NCT03314935|530561176|FG014|Phase 1|Study Terminated by Sponsor|0|||
147108419|NCT03314935|530561162|FG000|Phase 1|"Captured as Other in Database"|0|||
147108420|NCT03314935|530561163|FG001|Phase 1|"Captured as Other in Database"|2|||
147108421|NCT03314935|530561164|FG002|Phase 1|"Captured as Other in Database"|0|||
147108422|NCT03314935|530561165|FG003|Phase 1|"Captured as Other in Database"|0|||
147108423|NCT03314935|530561166|FG004|Phase 1|"Captured as Other in Database"|0|||
147108424|NCT03314935|530561167|FG005|Phase 1|"Captured as Other in Database"|0|||
147108425|NCT03314935|530561168|FG006|Phase 1|"Captured as Other in Database"|1|||
147108426|NCT03314935|530561169|FG007|Phase 1|"Captured as Other in Database"|1|||
147108427|NCT03314935|530561170|FG008|Phase 1|"Captured as Other in Database"|1|||
147108428|NCT03314935|530561171|FG009|Phase 1|"Captured as Other in Database"|0|||
147558689|NCT01545076|532203871|FG003|IgPro10 Restabilization Period|Protocol Violation|0|||
147558690|NCT01545076|532203872|FG004|IgPro10 Restabilization Period|Protocol Violation|0|||
147108429|NCT03314935|530561172|FG010|Phase 1|"Captured as Other in Database"|0|||
147108430|NCT03314935|530561173|FG011|Phase 1|"Captured as Other in Database"|0|||
147108431|NCT03314935|530561174|FG012|Phase 1|"Captured as Other in Database"|0|||
147108432|NCT03314935|530561175|FG013|Phase 1|"Captured as Other in Database"|0|||
147108433|NCT03314935|530561176|FG014|Phase 1|"Captured as Other in Database"|0|||
147108434|NCT03314935|530561162|FG000|Phase 1|Lost to Follow-up|0|||
147108435|NCT03314935|530561163|FG001|Phase 1|Lost to Follow-up|0|||
147108436|NCT03314935|530561164|FG002|Phase 1|Lost to Follow-up|0|||
147108437|NCT03314935|530561165|FG003|Phase 1|Lost to Follow-up|0|||
147108438|NCT03314935|530561166|FG004|Phase 1|Lost to Follow-up|0|||
147108439|NCT03314935|530561167|FG005|Phase 1|Lost to Follow-up|0|||
147108440|NCT03314935|530561168|FG006|Phase 1|Lost to Follow-up|0|||
147108441|NCT03314935|530561169|FG007|Phase 1|Lost to Follow-up|0|||
147108442|NCT03314935|530561170|FG008|Phase 1|Lost to Follow-up|1|||
147108443|NCT03314935|530561171|FG009|Phase 1|Lost to Follow-up|0|||
147108444|NCT03314935|530561172|FG010|Phase 1|Lost to Follow-up|0|||
147108445|NCT03314935|530561173|FG011|Phase 1|Lost to Follow-up|0|||
147108446|NCT03314935|530561174|FG012|Phase 1|Lost to Follow-up|0|||
147108447|NCT03314935|530561175|FG013|Phase 1|Lost to Follow-up|0|||
147108448|NCT03314935|530561176|FG014|Phase 1|Lost to Follow-up|0|||
147108449|NCT03314935|530561162|FG000|Phase 2|Death|0|||
147108450|NCT03314935|530561163|FG001|Phase 2|Death|0|||
147108451|NCT03314935|530561164|FG002|Phase 2|Death|0|||
147108452|NCT03314935|530561165|FG003|Phase 2|Death|0|||
147108453|NCT03314935|530561166|FG004|Phase 2|Death|0|||
147108454|NCT03314935|530561167|FG005|Phase 2|Death|0|||
147108455|NCT03314935|530561168|FG006|Phase 2|Death|0|||
147108456|NCT03314935|530561169|FG007|Phase 2|Death|0|||
147108457|NCT03314935|530561170|FG008|Phase 2|Death|0|||
147108458|NCT03314935|530561171|FG009|Phase 2|Death|5|||
147108459|NCT03314935|530561172|FG010|Phase 2|Death|20|||
147108460|NCT03314935|530561173|FG011|Phase 2|Death|6|||
147108461|NCT03314935|530561174|FG012|Phase 2|Death|7|||
147108462|NCT03314935|530561175|FG013|Phase 2|Death|6|||
147108463|NCT03314935|530561176|FG014|Phase 2|Death|17|||
147108464|NCT03314935|530561162|FG000|Phase 2|Withdrawal by Subject|0|||
147108465|NCT03314935|530561163|FG001|Phase 2|Withdrawal by Subject|0|||
147108466|NCT03314935|530561164|FG002|Phase 2|Withdrawal by Subject|0|||
147108467|NCT03314935|530561165|FG003|Phase 2|Withdrawal by Subject|0|||
147108468|NCT03314935|530561166|FG004|Phase 2|Withdrawal by Subject|0|||
147108469|NCT03314935|530561167|FG005|Phase 2|Withdrawal by Subject|0|||
147310790|NCT00251927|531305097|FG000|Overall Study|Adverse Event|3|||
147310791|NCT00251927|531305098|FG001|Overall Study|Adverse Event|15|||
147310792|NCT00251927|531305097|FG000|Overall Study|Lack of Efficacy|22|||
147310793|NCT00251927|531305098|FG001|Overall Study|Lack of Efficacy|16|||
147310794|NCT00251927|531305097|FG000|Overall Study|Lost to Follow-up|22|||
147310795|NCT00251927|531305098|FG001|Overall Study|Lost to Follow-up|8|||
147310796|NCT00251927|531305097|FG000|Overall Study|Protocol Violation|1|||
147310797|NCT00251927|531305098|FG001|Overall Study|Protocol Violation|2|||
147310798|NCT00251927|531305097|FG000|Overall Study|Pregnancy|2|||
147310799|NCT00251927|531305098|FG001|Overall Study|Pregnancy|0|||
147310800|NCT00251927|531305097|FG000|Overall Study|Withdrawal by Subject|40|||
147310801|NCT00251927|531305098|FG001|Overall Study|Withdrawal by Subject|25|||
147310802|NCT00251927|531305097|FG000|Overall Study|Study-specific discont. achieved|13|||
147310803|NCT00251927|531305098|FG001|Overall Study|Study-specific discont. achieved|2|||
147310804|NCT00251927|531305097|FG000|Overall Study|Study procedure non-compliance|5|||
147310805|NCT00251927|531305098|FG001|Overall Study|Study procedure non-compliance|6|||
147310806|NCT00452413|531305102|FG000|Overall Study|Progressive Disease|4|||
147310807|NCT00452413|531305103|FG001|Overall Study|Progressive Disease|11|||
147310808|NCT00452413|531305104|FG002|Overall Study|Progressive Disease|30|||
147310809|NCT00452413|531305102|FG000|Overall Study|Withdrawal by Subject|0|||
147310810|NCT00452413|531305103|FG001|Overall Study|Withdrawal by Subject|1|||
147310811|NCT00452413|531305104|FG002|Overall Study|Withdrawal by Subject|4|||
147310812|NCT00452413|531305102|FG000|Overall Study|Adverse Event|0|||
147310813|NCT00452413|531305103|FG001|Overall Study|Adverse Event|0|||
147310814|NCT00452413|531305104|FG002|Overall Study|Adverse Event|5|||
147310815|NCT00452413|531305102|FG000|Overall Study|Physician Decision|0|||
147310816|NCT00452413|531305103|FG001|Overall Study|Physician Decision|0|||
147310817|NCT00452413|531305104|FG002|Overall Study|Physician Decision|4|||
147310818|NCT00452413|531305102|FG000|Overall Study|Death due to study disease|0|||
147310819|NCT00452413|531305103|FG001|Overall Study|Death due to study disease|0|||
147558691|NCT01545076|532203868|FG000|IgPro10 Restabilization Period|Failure to meet randomization criteria|22|||
147108470|NCT03314935|530561168|FG006|Phase 2|Withdrawal by Subject|0|||
147310820|NCT00452413|531305104|FG002|Overall Study|Death due to study disease|2|||
147310821|NCT00452413|531305102|FG000|Overall Study|Death due to adverse event (AE)|0|||
147310822|NCT00452413|531305103|FG001|Overall Study|Death due to adverse event (AE)|0|||
147310823|NCT00452413|531305104|FG002|Overall Study|Death due to adverse event (AE)|1|||
147310824|NCT00452413|531305102|FG000|Overall Study|On treatment|0|||
147310825|NCT00452413|531305103|FG001|Overall Study|On treatment|0|||
147558692|NCT01545076|532203869|FG001|IgPro10 Restabilization Period|Failure to meet randomization criteria|0|||
147558693|NCT01545076|532203870|FG002|IgPro10 Restabilization Period|Failure to meet randomization criteria|0|||
147310826|NCT00452413|531305104|FG002|Overall Study|On treatment|3|||
147558694|NCT01545076|532203871|FG003|IgPro10 Restabilization Period|Failure to meet randomization criteria|0|||
147310827|NCT02765490|531305110|FG000|Overall Study|Lost to Follow-up|1|||
147310828|NCT02765490|531305111|FG001|Overall Study|Lost to Follow-up|1|||
147310829|NCT02765490|531305110|FG000|Overall Study|Other|0|||
147108471|NCT03314935|530561169|FG007|Phase 2|Withdrawal by Subject|0|||
147108472|NCT03314935|530561170|FG008|Phase 2|Withdrawal by Subject|0|||
147108473|NCT03314935|530561171|FG009|Phase 2|Withdrawal by Subject|1|||
147108474|NCT03314935|530561172|FG010|Phase 2|Withdrawal by Subject|4|||
147108475|NCT03314935|530561173|FG011|Phase 2|Withdrawal by Subject|0|||
147108476|NCT03314935|530561174|FG012|Phase 2|Withdrawal by Subject|1|||
147108477|NCT03314935|530561175|FG013|Phase 2|Withdrawal by Subject|0|||
147310830|NCT02765490|531305111|FG001|Overall Study|Other|1|||
147310831|NCT02765490|531305110|FG000|Overall Study|Death|0|||
147225464|NCT02788474|530998230|FG001|Open Label Treatment Period|Other than reason specified|0|||
147225465|NCT02788474|530998229|FG000|Open Label Treatment Period|Patient's refusal|1|||
147225466|NCT02788474|530998230|FG001|Open Label Treatment Period|Patient's refusal|3|||
147225467|NCT02788474|530998229|FG000|Open Label Treatment Period|Non-compliance|1|||
147225468|NCT02788474|530998230|FG001|Open Label Treatment Period|Non-compliance|0|||
147225469|NCT00048061|530998231|FG000|Overall Study|Adverse Event|41|||
147225470|NCT00048061|530998232|FG001|Overall Study|Adverse Event|32|||
147225471|NCT00048061|530998233|FG002|Overall Study|Adverse Event|44|||
147225472|NCT00048061|530998234|FG003|Overall Study|Adverse Event|37|||
147225473|NCT00048061|530998231|FG000|Overall Study|Lost to Follow-up|3|||
147225474|NCT00048061|530998232|FG001|Overall Study|Lost to Follow-up|2|||
147225475|NCT00048061|530998233|FG002|Overall Study|Lost to Follow-up|4|||
147225476|NCT00048061|530998234|FG003|Overall Study|Lost to Follow-up|5|||
147225477|NCT00048061|530998231|FG000|Overall Study|Withdrawal by Subject|20|||
147225478|NCT00048061|530998232|FG001|Overall Study|Withdrawal by Subject|29|||
147225479|NCT00048061|530998233|FG002|Overall Study|Withdrawal by Subject|29|||
147225480|NCT00048061|530998234|FG003|Overall Study|Withdrawal by Subject|32|||
147225481|NCT00048061|530998231|FG000|Overall Study|Did not follow-up|5|||
147225482|NCT00048061|530998232|FG001|Overall Study|Did not follow-up|5|||
147225483|NCT00048061|530998233|FG002|Overall Study|Did not follow-up|4|||
147225484|NCT00048061|530998234|FG003|Overall Study|Did not follow-up|5|||
147225485|NCT00048061|530998231|FG000|Overall Study|Early improvement|6|||
147225486|NCT00048061|530998232|FG001|Overall Study|Early improvement|5|||
147225487|NCT00048061|530998233|FG002|Overall Study|Early improvement|3|||
147225488|NCT00048061|530998234|FG003|Overall Study|Early improvement|0|||
147225489|NCT02325791|530998238|FG000|Overall Study|Adverse Event|0|||
147225490|NCT02325791|530998239|FG001|Overall Study|Adverse Event|1|||
147225491|NCT02325791|530998240|FG002|Overall Study|Adverse Event|1|||
147225492|NCT02325791|530998241|FG003|Overall Study|Adverse Event|0|||
147225493|NCT02325791|530998238|FG000|Overall Study|Death|0|||
147225494|NCT02325791|530998239|FG001|Overall Study|Death|3|||
147225495|NCT02325791|530998240|FG002|Overall Study|Death|0|||
147225496|NCT02325791|530998241|FG003|Overall Study|Death|1|||
147225497|NCT02325791|530998238|FG000|Overall Study|Lost to Follow-up|0|||
147225498|NCT02325791|530998239|FG001|Overall Study|Lost to Follow-up|15|||
147225499|NCT02325791|530998240|FG002|Overall Study|Lost to Follow-up|14|||
147225500|NCT02325791|530998241|FG003|Overall Study|Lost to Follow-up|9|||
147225501|NCT02325791|530998238|FG000|Overall Study|Physician Decision|0|||
147225502|NCT02325791|530998239|FG001|Overall Study|Physician Decision|1|||
147225503|NCT02325791|530998240|FG002|Overall Study|Physician Decision|1|||
147225504|NCT02325791|530998241|FG003|Overall Study|Physician Decision|0|||
147225505|NCT02325791|530998238|FG000|Overall Study|Protocol Violation|0|||
147225506|NCT02325791|530998239|FG001|Overall Study|Protocol Violation|0|||
147225507|NCT02325791|530998240|FG002|Overall Study|Protocol Violation|1|||
147225508|NCT02325791|530998241|FG003|Overall Study|Protocol Violation|0|||
147225509|NCT02325791|530998238|FG000|Overall Study|Withdrawal by Subject|0|||
147225510|NCT02325791|530998239|FG001|Overall Study|Withdrawal by Subject|5|||
147225511|NCT02325791|530998240|FG002|Overall Study|Withdrawal by Subject|8|||
147225512|NCT02325791|530998241|FG003|Overall Study|Withdrawal by Subject|16|||
147225513|NCT01028378|530998242|FG000|Overall Study|Lost to Follow-up|12|||
147225514|NCT01028378|530998242|FG000|Overall Study|Withdrawal by Subject|1|||
147225515|NCT01028378|530998242|FG000|Overall Study|Adminstrative Reasons|4|||
147225516|NCT01298193|530998243|FG000|Observational Phase (First Cycle)|Withdrawal by Subject|2|||
147225517|NCT01298193|530998243|FG000|Observational Phase (First Cycle)|Received TC at a different dose|16|||
147225518|NCT01298193|530998243|FG000|Observational Phase (First Cycle)|previous emetogenic chemotherapy|9|||
147225519|NCT01298193|530998243|FG000|Efficacy Phase (Second Cycle)|Death|1|||
147225520|NCT01569464|530998244|FG000|Overall Study|Adverse Event|4|||
147225521|NCT01569464|530998245|FG001|Overall Study|Adverse Event|0|||
147225522|NCT01569464|530998244|FG000|Overall Study|Lack of Efficacy|1|||
147225523|NCT01569464|530998245|FG001|Overall Study|Lack of Efficacy|0|||
147225524|NCT01569464|530998244|FG000|Overall Study|Protocol Violation|1|||
147225525|NCT01569464|530998245|FG001|Overall Study|Protocol Violation|0|||
147225526|NCT01569464|530998244|FG000|Overall Study|Lost to Follow-up|2|||
147225527|NCT01569464|530998245|FG001|Overall Study|Lost to Follow-up|3|||
147225528|NCT01569464|530998244|FG000|Overall Study|Withdrawal by Subject|1|||
147225529|NCT01569464|530998245|FG001|Overall Study|Withdrawal by Subject|1|||
147225530|NCT01569464|530998244|FG000|Overall Study|Other|1|||
147225531|NCT01569464|530998245|FG001|Overall Study|Other|1|||
147108478|NCT03314935|530561176|FG014|Phase 2|Withdrawal by Subject|1|||
147225532|NCT03475875|530998246|FG000|Period 1|Lost to Follow-up|1|||
147225533|NCT03475875|530998247|FG001|Period 1|Lost to Follow-up|0|||
147225534|NCT03475875|530998246|FG000|Period 1|Adverse Event|2|||
147225535|NCT03475875|530998247|FG001|Period 1|Adverse Event|1|||
147225536|NCT03475875|530998246|FG000|Period 2|Adverse Event|3|||
147225537|NCT03475875|530998247|FG001|Period 2|Adverse Event|0|||
147225538|NCT03475875|530998246|FG000|Period 2|Protocol Violation|0|||
147225539|NCT03475875|530998247|FG001|Period 2|Protocol Violation|1|||
147225540|NCT01390220|530998248|FG000|Test Dose Phase|Adverse Event|17|||
147225541|NCT01390220|530998249|FG001|Test Dose Phase|Adverse Event|0|||
147558695|NCT01545076|532203872|FG004|IgPro10 Restabilization Period|Failure to meet randomization criteria|0|||
147558696|NCT01545076|532203868|FG000|IgPro10 Restabilization Period|Withdrawal by Subject|7|||
147558697|NCT01545076|532203869|FG001|IgPro10 Restabilization Period|Withdrawal by Subject|0|||
147558698|NCT01545076|532203870|FG002|IgPro10 Restabilization Period|Withdrawal by Subject|0|||
147558699|NCT01545076|532203871|FG003|IgPro10 Restabilization Period|Withdrawal by Subject|0|||
147558700|NCT01545076|532203872|FG004|IgPro10 Restabilization Period|Withdrawal by Subject|0|||
147558701|NCT01545076|532203868|FG000|IgPro20 Subcutaneous Treatment Period|Physician Decision|0|||
147558702|NCT01545076|532203869|FG001|IgPro20 Subcutaneous Treatment Period|Physician Decision|0|||
147558703|NCT01545076|532203870|FG002|IgPro20 Subcutaneous Treatment Period|Physician Decision|0|||
147558704|NCT01545076|532203871|FG003|IgPro20 Subcutaneous Treatment Period|Physician Decision|1|||
147558705|NCT01545076|532203872|FG004|IgPro20 Subcutaneous Treatment Period|Physician Decision|0|||
147558706|NCT01545076|532203868|FG000|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|0|||
147558707|NCT01545076|532203869|FG001|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|10|||
147558708|NCT01545076|532203870|FG002|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|18|||
147558709|NCT01545076|532203871|FG003|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|32|||
147558710|NCT01545076|532203872|FG004|IgPro20 Subcutaneous Treatment Period|Lack of Efficacy|0|||
147558711|NCT01545076|532203868|FG000|IgPro20 Subcutaneous Treatment Period|Adverse Event|0|||
147558712|NCT01545076|532203869|FG001|IgPro20 Subcutaneous Treatment Period|Adverse Event|1|||
147558713|NCT01545076|532203870|FG002|IgPro20 Subcutaneous Treatment Period|Adverse Event|1|||
147558714|NCT01545076|532203871|FG003|IgPro20 Subcutaneous Treatment Period|Adverse Event|0|||
147558715|NCT01545076|532203872|FG004|IgPro20 Subcutaneous Treatment Period|Adverse Event|0|||
147558716|NCT01545076|532203868|FG000|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|0|||
147558717|NCT01545076|532203869|FG001|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|8|||
147558718|NCT01545076|532203870|FG002|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|2|||
147558719|NCT01545076|532203871|FG003|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|3|||
147558720|NCT01545076|532203872|FG004|IgPro20 Subcutaneous Treatment Period|Withdrawal by Subject|0|||
147558721|NCT01546987|532203873|FG000|Overall Study|Protocol Violation|3|||
147558722|NCT01546987|532203874|FG001|Overall Study|Protocol Violation|4|||
147558723|NCT02270736|532203875|FG000|Main Period (MP) (up to 16 Weeks)|Adverse Event|0|||
147558724|NCT02270736|532203876|FG001|Main Period (MP) (up to 16 Weeks)|Adverse Event|1|||
147558725|NCT02270736|532203877|FG002|Main Period (MP) (up to 16 Weeks)|Adverse Event|0|||
147558726|NCT02270736|532203878|FG003|Main Period (MP) (up to 16 Weeks)|Adverse Event|0|||
147558727|NCT02270736|532203879|FG004|Main Period (MP) (up to 16 Weeks)|Adverse Event|0|||
147558728|NCT02270736|532203875|FG000|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|2|||
147558729|NCT02270736|532203876|FG001|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|0|||
147558730|NCT02270736|532203877|FG002|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|1|||
147558731|NCT02270736|532203878|FG003|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|0|||
147558732|NCT02270736|532203879|FG004|Main Period (MP) (up to 16 Weeks)|Withdrawal by Subject|0|||
147558733|NCT02270736|532203875|FG000|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|0|||
147558734|NCT02270736|532203876|FG001|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|1|||
147558735|NCT02270736|532203877|FG002|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|0|||
147558736|NCT02270736|532203878|FG003|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|0|||
147558737|NCT02270736|532203879|FG004|Main Period (MP) (up to 16 Weeks)|Lost to Follow-up|0|||
147558738|NCT02270736|532203875|FG000|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|0|||
147558739|NCT02270736|532203876|FG001|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|0|||
147558740|NCT02270736|532203877|FG002|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|1|||
147558741|NCT02270736|532203878|FG003|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|0|||
147558742|NCT02270736|532203879|FG004|Main Period (MP) (up to 16 Weeks)|Randomized, not Treated|0|||
147558743|NCT02270736|532203875|FG000|OLEX Period (up to 48 Weeks)|Physician Decision|0|||
147558744|NCT02270736|532203876|FG001|OLEX Period (up to 48 Weeks)|Physician Decision|0|||
147558745|NCT02270736|532203877|FG002|OLEX Period (up to 48 Weeks)|Physician Decision|0|||
147558746|NCT02270736|532203878|FG003|OLEX Period (up to 48 Weeks)|Physician Decision|1|||
147108479|NCT03314935|530561162|FG000|Phase 2|Progressive Disease|0|||
147108480|NCT03314935|530561163|FG001|Phase 2|Progressive Disease|0|||
147558747|NCT02270736|532203879|FG004|OLEX Period (up to 48 Weeks)|Physician Decision|0|||
147558748|NCT02270736|532203875|FG000|OLEX Period (up to 48 Weeks)|Lack of Efficacy|0|||
147558749|NCT02270736|532203876|FG001|OLEX Period (up to 48 Weeks)|Lack of Efficacy|0|||
147558750|NCT02270736|532203877|FG002|OLEX Period (up to 48 Weeks)|Lack of Efficacy|0|||
147558751|NCT02270736|532203878|FG003|OLEX Period (up to 48 Weeks)|Lack of Efficacy|2|||
147558752|NCT02270736|532203879|FG004|OLEX Period (up to 48 Weeks)|Lack of Efficacy|0|||
147558753|NCT02270736|532203875|FG000|OLEX Period (up to 48 Weeks)|Adverse Event|0|||
147558754|NCT02270736|532203876|FG001|OLEX Period (up to 48 Weeks)|Adverse Event|0|||
147558755|NCT02270736|532203877|FG002|OLEX Period (up to 48 Weeks)|Adverse Event|0|||
147558756|NCT02270736|532203878|FG003|OLEX Period (up to 48 Weeks)|Adverse Event|4|||
147558757|NCT02270736|532203879|FG004|OLEX Period (up to 48 Weeks)|Adverse Event|0|||
147558758|NCT02270736|532203875|FG000|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|0|||
147108481|NCT03314935|530561164|FG002|Phase 2|Progressive Disease|0|||
147108482|NCT03314935|530561165|FG003|Phase 2|Progressive Disease|0|||
147108483|NCT03314935|530561166|FG004|Phase 2|Progressive Disease|0|||
147108484|NCT03314935|530561167|FG005|Phase 2|Progressive Disease|0|||
147108485|NCT03314935|530561168|FG006|Phase 2|Progressive Disease|0|||
147108486|NCT03314935|530561169|FG007|Phase 2|Progressive Disease|0|||
147108487|NCT03314935|530561170|FG008|Phase 2|Progressive Disease|0|||
147108488|NCT03314935|530561171|FG009|Phase 2|Progressive Disease|1|||
147108489|NCT03314935|530561172|FG010|Phase 2|Progressive Disease|1|||
147108490|NCT03314935|530561173|FG011|Phase 2|Progressive Disease|1|||
147108491|NCT03314935|530561174|FG012|Phase 2|Progressive Disease|2|||
147108492|NCT03314935|530561175|FG013|Phase 2|Progressive Disease|0|||
147108493|NCT03314935|530561176|FG014|Phase 2|Progressive Disease|1|||
147108494|NCT03314935|530561162|FG000|Phase 2|Study Terminated by Sponsor|0|||
147108495|NCT03314935|530561163|FG001|Phase 2|Study Terminated by Sponsor|0|||
147108496|NCT03314935|530561164|FG002|Phase 2|Study Terminated by Sponsor|0|||
147108497|NCT03314935|530561165|FG003|Phase 2|Study Terminated by Sponsor|0|||
147108498|NCT03314935|530561166|FG004|Phase 2|Study Terminated by Sponsor|0|||
147108499|NCT03314935|530561167|FG005|Phase 2|Study Terminated by Sponsor|0|||
147108500|NCT03314935|530561168|FG006|Phase 2|Study Terminated by Sponsor|0|||
147108501|NCT03314935|530561169|FG007|Phase 2|Study Terminated by Sponsor|0|||
147108502|NCT03314935|530561170|FG008|Phase 2|Study Terminated by Sponsor|0|||
147108503|NCT03314935|530561171|FG009|Phase 2|Study Terminated by Sponsor|0|||
147108504|NCT03314935|530561172|FG010|Phase 2|Study Terminated by Sponsor|7|||
147108505|NCT03314935|530561173|FG011|Phase 2|Study Terminated by Sponsor|2|||
147108506|NCT03314935|530561174|FG012|Phase 2|Study Terminated by Sponsor|1|||
147108507|NCT03314935|530561175|FG013|Phase 2|Study Terminated by Sponsor|4|||
147108508|NCT03314935|530561176|FG014|Phase 2|Study Terminated by Sponsor|4|||
147108509|NCT03314935|530561162|FG000|Phase 2|Lost to Follow-up|0|||
147108510|NCT03314935|530561163|FG001|Phase 2|Lost to Follow-up|0|||
147108511|NCT03314935|530561164|FG002|Phase 2|Lost to Follow-up|0|||
147108512|NCT03314935|530561165|FG003|Phase 2|Lost to Follow-up|0|||
147108513|NCT03314935|530561166|FG004|Phase 2|Lost to Follow-up|0|||
147108514|NCT03314935|530561167|FG005|Phase 2|Lost to Follow-up|0|||
147108515|NCT03314935|530561168|FG006|Phase 2|Lost to Follow-up|0|||
147108516|NCT03314935|530561169|FG007|Phase 2|Lost to Follow-up|0|||
147108517|NCT03314935|530561170|FG008|Phase 2|Lost to Follow-up|0|||
147108518|NCT03314935|530561171|FG009|Phase 2|Lost to Follow-up|1|||
147108519|NCT03314935|530561172|FG010|Phase 2|Lost to Follow-up|0|||
147108520|NCT03314935|530561173|FG011|Phase 2|Lost to Follow-up|0|||
147108521|NCT03314935|530561174|FG012|Phase 2|Lost to Follow-up|0|||
147108522|NCT03314935|530561175|FG013|Phase 2|Lost to Follow-up|0|||
147108523|NCT03314935|530561176|FG014|Phase 2|Lost to Follow-up|1|||
147108524|NCT03314935|530561162|FG000|Phase 2|Physician Decision|0|||
147108525|NCT03314935|530561163|FG001|Phase 2|Physician Decision|0|||
147108526|NCT03314935|530561164|FG002|Phase 2|Physician Decision|0|||
147108527|NCT03314935|530561165|FG003|Phase 2|Physician Decision|0|||
147108528|NCT03314935|530561166|FG004|Phase 2|Physician Decision|0|||
147108529|NCT03314935|530561167|FG005|Phase 2|Physician Decision|0|||
147108530|NCT03314935|530561168|FG006|Phase 2|Physician Decision|0|||
147108531|NCT03314935|530561169|FG007|Phase 2|Physician Decision|0|||
147108532|NCT03314935|530561170|FG008|Phase 2|Physician Decision|0|||
147108533|NCT03314935|530561171|FG009|Phase 2|Physician Decision|0|||
147108534|NCT03314935|530561172|FG010|Phase 2|Physician Decision|1|||
147108535|NCT03314935|530561173|FG011|Phase 2|Physician Decision|0|||
147108536|NCT03314935|530561174|FG012|Phase 2|Physician Decision|0|||
147225542|NCT01390220|530998250|FG002|Test Dose Phase|Adverse Event|0|||
147225543|NCT01390220|530998248|FG000|Test Dose Phase|Withdrawal by Subject|8|||
147225544|NCT01390220|530998249|FG001|Test Dose Phase|Withdrawal by Subject|0|||
147225545|NCT01390220|530998250|FG002|Test Dose Phase|Withdrawal by Subject|0|||
147558759|NCT02270736|532203876|FG001|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|0|||
147558760|NCT02270736|532203877|FG002|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|0|||
147558761|NCT02270736|532203878|FG003|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|16|||
147558762|NCT02270736|532203879|FG004|OLEX Period (up to 48 Weeks)|Withdrawal by Subject|0|||
147558763|NCT02270736|532203875|FG000|OLEX Period (up to 48 Weeks)|Lost to Follow-up|0|||
147558764|NCT02270736|532203876|FG001|OLEX Period (up to 48 Weeks)|Lost to Follow-up|0|||
147108537|NCT03314935|530561175|FG013|Phase 2|Physician Decision|0|||
147108538|NCT03314935|530561176|FG014|Phase 2|Physician Decision|0|||
147108539|NCT03636477|530561180|FG000|Overall Study|Adverse Event|0|||
147108540|NCT03636477|530561181|FG001|Overall Study|Adverse Event|0|||
147108541|NCT03636477|530561182|FG002|Overall Study|Adverse Event|1|||
147108542|NCT05168800|530561183|FG000|Time 1 Survey|Did not start T1 survey|182|||
147108543|NCT05168800|530561184|FG001|Time 1 Survey|Did not start T1 survey|150|||
147108544|NCT05168800|530561185|FG002|Time 1 Survey|Did not start T1 survey|140|||
147108545|NCT05168800|530561183|FG000|Time 1 Survey|Completed T1 survey outside window|18|||
147108546|NCT05168800|530561184|FG001|Time 1 Survey|Completed T1 survey outside window|21|||
147108547|NCT05168800|530561185|FG002|Time 1 Survey|Completed T1 survey outside window|13|||
147225546|NCT01390220|530998248|FG000|Test Dose Phase|Lost to Follow-up|2|||
147108548|NCT05168800|530561183|FG000|Time 1 Survey|Missing primary outcome data at Time 0 or Time 1|1|||
147108549|NCT05168800|530561184|FG001|Time 1 Survey|Missing primary outcome data at Time 0 or Time 1|6|||
147108550|NCT05168800|530561185|FG002|Time 1 Survey|Missing primary outcome data at Time 0 or Time 1|1|||
147108551|NCT05168800|530561183|FG000|Time 1 Survey|Failed verification, did not start Time 1 survey|221|||
147108552|NCT05168800|530561184|FG001|Time 1 Survey|Failed verification, did not start Time 1 survey|200|||
147108553|NCT05168800|530561185|FG002|Time 1 Survey|Failed verification, did not start Time 1 survey|220|||
147108554|NCT05168800|530561183|FG000|Time 1 Survey|Failed verification, did complete time 1 survey|23|||
147108555|NCT05168800|530561184|FG001|Time 1 Survey|Failed verification, did complete time 1 survey|24|||
147108556|NCT05168800|530561185|FG002|Time 1 Survey|Failed verification, did complete time 1 survey|16|||
147108557|NCT05168800|530561183|FG000|Time 1 Survey|Withdrawal by Subject|6|||
147108558|NCT05168800|530561184|FG001|Time 1 Survey|Withdrawal by Subject|3|||
147108559|NCT05168800|530561185|FG002|Time 1 Survey|Withdrawal by Subject|2|||
147108560|NCT05168800|530561183|FG000|Time 2 Survey|Already excluded at Time 1|228|||
147108561|NCT05168800|530561184|FG001|Time 2 Survey|Already excluded at Time 1|202|||
147108562|NCT05168800|530561185|FG002|Time 2 Survey|Already excluded at Time 1|173|||
147108563|NCT05168800|530561183|FG000|Time 2 Survey|Did not start Time 2 survey|31|||
147108564|NCT05168800|530561184|FG001|Time 2 Survey|Did not start Time 2 survey|26|||
147108565|NCT05168800|530561185|FG002|Time 2 Survey|Did not start Time 2 survey|45|||
147108566|NCT05168800|530561183|FG000|Time 2 Survey|Completed Time 2 survey outside window|10|||
147108567|NCT05168800|530561184|FG001|Time 2 Survey|Completed Time 2 survey outside window|15|||
147108568|NCT05168800|530561185|FG002|Time 2 Survey|Completed Time 2 survey outside window|9|||
147108569|NCT05168800|530561183|FG000|Time 2 Survey|Missing primary outcome data at Time 2|0|||
147108570|NCT05168800|530561184|FG001|Time 2 Survey|Missing primary outcome data at Time 2|1|||
147108571|NCT05168800|530561185|FG002|Time 2 Survey|Missing primary outcome data at Time 2|1|||
147108572|NCT05168800|530561183|FG000|Time 2 Survey|Withdrawal by Subject|1|||
147108573|NCT05168800|530561184|FG001|Time 2 Survey|Withdrawal by Subject|0|||
147108574|NCT05168800|530561185|FG002|Time 2 Survey|Withdrawal by Subject|1|||
147108575|NCT05168800|530561183|FG000|Time 3 Survey|Already excluded at Time 1|228|||
147108576|NCT05168800|530561184|FG001|Time 3 Survey|Already excluded at Time 1|200|||
147108577|NCT05168800|530561185|FG002|Time 3 Survey|Already excluded at Time 1|173|||
147108578|NCT05168800|530561183|FG000|Time 3 Survey|Did not start Time 3 survey|48|||
147108579|NCT05168800|530561184|FG001|Time 3 Survey|Did not start Time 3 survey|48|||
147108580|NCT05168800|530561185|FG002|Time 3 Survey|Did not start Time 3 survey|51|||
147108581|NCT05168800|530561183|FG000|Time 3 Survey|Completed Time 3 survey outside window|1|||
147108582|NCT05168800|530561184|FG001|Time 3 Survey|Completed Time 3 survey outside window|6|||
147108583|NCT05168800|530561185|FG002|Time 3 Survey|Completed Time 3 survey outside window|8|||
147108584|NCT05168800|530561183|FG000|Time 3 Survey|Missing primary outcome data at Time 3|0|||
147108585|NCT05168800|530561184|FG001|Time 3 Survey|Missing primary outcome data at Time 3|1|||
147108586|NCT05168800|530561185|FG002|Time 3 Survey|Missing primary outcome data at Time 3|0|||
147108587|NCT04958707|530561186|FG000|Post Intervention|Withdrawal by Subject|1|||
147108588|NCT04958707|530561187|FG001|Post Intervention|Withdrawal by Subject|0|||
147108589|NCT04958707|530561188|FG002|Post Intervention|Withdrawal by Subject|0|||
147108590|NCT04958707|530561186|FG000|3 Months Follow- up|Lost to Follow-up|0|||
147108591|NCT04958707|530561187|FG001|3 Months Follow- up|Lost to Follow-up|3|||
147108592|NCT04958707|530561188|FG002|3 Months Follow- up|Lost to Follow-up|0|||
147108593|NCT04958707|530561186|FG000|3 Months Follow- up|Withdrawal by Subject|2|||
147108594|NCT04958707|530561187|FG001|3 Months Follow- up|Withdrawal by Subject|0|||
147108595|NCT04958707|530561188|FG002|3 Months Follow- up|Withdrawal by Subject|0|||
147108596|NCT05722015|530561194|FG000|Overall Study|Death|57|||
147108597|NCT05722015|530561195|FG001|Overall Study|Death|37|||
147108598|NCT05722015|530561194|FG000|Overall Study|Lost to Follow-up|1|||
147108599|NCT05722015|530561195|FG001|Overall Study|Lost to Follow-up|0|||
147108600|NCT05722015|530561194|FG000|Overall Study|Withdrawal by Subject|5|||
147108601|NCT05722015|530561195|FG001|Overall Study|Withdrawal by Subject|1|||
147108602|NCT05722015|530561194|FG000|Overall Study|Participants Ongoing|188|||
147108603|NCT05722015|530561195|FG001|Overall Study|Participants Ongoing|88|||
147108604|NCT05523297|530561196|FG000|Overall Study|Death|7|||
147108605|NCT05523297|530561197|FG001|Overall Study|Death|8|||
147310832|NCT02765490|531305111|FG001|Overall Study|Death|1|||
147310833|NCT03237013|531305112|FG000|Immediate Post-treatment to 1-mo F/u|Lost to Follow-up|43|||
147310834|NCT03237013|531305113|FG001|Immediate Post-treatment to 1-mo F/u|Lost to Follow-up|30|||
147558765|NCT02270736|532203877|FG002|OLEX Period (up to 48 Weeks)|Lost to Follow-up|0|||
147558766|NCT02270736|532203878|FG003|OLEX Period (up to 48 Weeks)|Lost to Follow-up|2|||
147558767|NCT02270736|532203879|FG004|OLEX Period (up to 48 Weeks)|Lost to Follow-up|0|||
147310835|NCT03237013|531305114|FG002|Immediate Post-treatment to 1-mo F/u|Lost to Follow-up|37|||
147310836|NCT00258440|531305119|FG000|Overall Study|Withdrawal by Subject|0|||
147310837|NCT00258440|531305120|FG001|Overall Study|Withdrawal by Subject|0|||
147108606|NCT05523297|530561196|FG000|Overall Study|Lost to Follow-up|2|||
147108607|NCT05523297|530561197|FG001|Overall Study|Lost to Follow-up|1|||
147108608|NCT02340949|530561200|FG000|Overall Study|Adverse Event|4|||
147108609|NCT02340949|530561201|FG001|Overall Study|Adverse Event|2|||
147108610|NCT02340949|530561200|FG000|Overall Study|Withdrawal by Subject|2|||
147108611|NCT02340949|530561201|FG001|Overall Study|Withdrawal by Subject|0|||
147108612|NCT02340949|530561200|FG000|Overall Study|Progression disease|6|||
147108613|NCT02340949|530561201|FG001|Overall Study|Progression disease|2|||
147108614|NCT02340949|530561200|FG000|Overall Study|Death|3|||
147108615|NCT02340949|530561201|FG001|Overall Study|Death|0|||
147108616|NCT02340949|530561200|FG000|Overall Study|Physician Decision|1|||
147108617|NCT02340949|530561201|FG001|Overall Study|Physician Decision|0|||
147108618|NCT01192178|530561202|FG000|Overall Study|Withdrawal by Subject|6|||
147108619|NCT01192178|530561203|FG001|Overall Study|Withdrawal by Subject|10|||
147108620|NCT01192178|530561202|FG000|Overall Study|Protocol Violation|10|||
147108621|NCT01192178|530561203|FG001|Overall Study|Protocol Violation|3|||
147108622|NCT01192178|530561202|FG000|Overall Study|Physician Decision|2|||
147108623|NCT01192178|530561203|FG001|Overall Study|Physician Decision|4|||
147108624|NCT01192178|530561202|FG000|Overall Study|Lost to Follow-up|3|||
147108625|NCT01192178|530561203|FG001|Overall Study|Lost to Follow-up|3|||
147108626|NCT01192178|530561202|FG000|Overall Study|Adverse Event|2|||
147108627|NCT01192178|530561203|FG001|Overall Study|Adverse Event|1|||
147108628|NCT01192178|530561202|FG000|Overall Study|Lack of Efficacy|1|||
147108629|NCT01192178|530561203|FG001|Overall Study|Lack of Efficacy|2|||
147108630|NCT02460289|530561204|FG000|Overall Study|Adverse Event|1|||
147108631|NCT02460289|530561204|FG000|Overall Study|Withdrawal by Subject|8|||
147108632|NCT02460289|530561204|FG000|Overall Study|Lost to Follow-up|1|||
147108633|NCT01155570|530561205|FG000|Overall Study|Adverse Event|39|||
147108634|NCT01155570|530561205|FG000|Overall Study|Lack of Efficacy|46|||
147108635|NCT01155570|530561205|FG000|Overall Study|Participant's Economic Reasons|17|||
147558768|NCT02710123|532203880|FG000|Overall Study|Lost to Follow-up|3|||
147558769|NCT02710123|532203881|FG001|Overall Study|Lost to Follow-up|4|||
147558770|NCT02710123|532203880|FG000|Overall Study|Withdrawal by Subject|1|||
147558771|NCT02710123|532203881|FG001|Overall Study|Withdrawal by Subject|1|||
147558772|NCT02710123|532203880|FG000|Overall Study|Illness unrelated to study intervention|1|||
147558773|NCT02710123|532203881|FG001|Overall Study|Illness unrelated to study intervention|0|||
147108636|NCT01155570|530561205|FG000|Overall Study|No Hospital Visits|7|||
147108637|NCT01155570|530561205|FG000|Overall Study|Adverse Event + Lack of Efficacy|2|||
147108638|NCT01155570|530561205|FG000|Overall Study|Adverse Event + Other Reasons|7|||
147108639|NCT01155570|530561205|FG000|Overall Study|Participant's Economic Reasons + Other|1|||
147108640|NCT01155570|530561205|FG000|Overall Study|Other Reasons|23|||
147108641|NCT02164916|530561206|FG000|Overall Study|Adverse Event|3|||
147108642|NCT02164916|530561207|FG001|Overall Study|Adverse Event|8|||
147108643|NCT02164916|530561206|FG000|Overall Study|Death|1|||
147108644|NCT02164916|530561207|FG001|Overall Study|Death|1|||
147108645|NCT02164916|530561206|FG000|Overall Study|Refusal unrelated to adverse event|3|||
147108646|NCT02164916|530561207|FG001|Overall Study|Refusal unrelated to adverse event|7|||
147108647|NCT02164916|530561206|FG000|Overall Study|Progression|37|||
147108648|NCT02164916|530561207|FG001|Overall Study|Progression|26|||
147108649|NCT02164916|530561206|FG000|Overall Study|Not protocol specified|5|||
147108650|NCT02164916|530561207|FG001|Overall Study|Not protocol specified|1|||
147108651|NCT02164916|530561206|FG000|Overall Study|Reason under review|1|||
147108652|NCT02164916|530561207|FG001|Overall Study|Reason under review|6|||
147108653|NCT02164916|530561206|FG000|Overall Study|Not eligible|2|||
147108654|NCT02164916|530561207|FG001|Overall Study|Not eligible|5|||
147108655|NCT00964782|530561210|FG000|Overall Study|Lost to Follow-up|1|||
147108656|NCT00964782|530561211|FG001|Overall Study|Lost to Follow-up|0|||
147108657|NCT00141817|530561212|FG000|Overall Study|Protocol Violation|0|||
147108658|NCT00141817|530561213|FG001|Overall Study|Protocol Violation|0|||
147108659|NCT00141817|530561214|FG002|Overall Study|Protocol Violation|1|||
147558774|NCT05381948|532203882|FG000|Overall Study|Adverse Event: Ocular - Study Eye|0|||
147558775|NCT05381948|532203883|FG001|Overall Study|Adverse Event: Ocular - Study Eye|1|||
147558776|NCT05381948|532203884|FG002|Overall Study|Adverse Event: Ocular - Study Eye|0|||
147108660|NCT00141817|530561215|FG003|Overall Study|Protocol Violation|0|||
147108661|NCT00141817|530561212|FG000|Overall Study|Parent request|1|||
147108662|NCT00141817|530561213|FG001|Overall Study|Parent request|0|||
147108663|NCT00141817|530561214|FG002|Overall Study|Parent request|0|||
147108664|NCT00141817|530561215|FG003|Overall Study|Parent request|0|||
147558777|NCT05381948|532203882|FG000|Overall Study|Adverse Event: Non-ocular|0|||
147558778|NCT05381948|532203883|FG001|Overall Study|Adverse Event: Non-ocular|1|||
147108665|NCT02472405|530563754|FG000|Overall Study|Lost to Follow-up|9|||
147225547|NCT01390220|530998249|FG001|Test Dose Phase|Lost to Follow-up|0|||
147225548|NCT01390220|530998250|FG002|Test Dose Phase|Lost to Follow-up|0|||
147225549|NCT01390220|530998248|FG000|Test Dose Phase|Protocol Violation|8|||
147108666|NCT02472405|530563754|FG000|Overall Study|Adverse Event|1|||
147108667|NCT01134042|530563755|FG000|Overall Study|Adverse Event|3|||
147108668|NCT01134042|530563756|FG001|Overall Study|Adverse Event|7|||
147558779|NCT05381948|532203884|FG002|Overall Study|Adverse Event: Non-ocular|0|||
147108669|NCT01134042|530563757|FG002|Overall Study|Adverse Event|2|||
147225550|NCT01390220|530998249|FG001|Test Dose Phase|Protocol Violation|0|||
147558780|NCT05381948|532203882|FG000|Overall Study|Lost to Follow-up|1|||
147108670|NCT01134042|530563755|FG000|Overall Study|Lack of Efficacy|21|||
147108671|NCT01134042|530563756|FG001|Overall Study|Lack of Efficacy|6|||
147108672|NCT01134042|530563757|FG002|Overall Study|Lack of Efficacy|18|||
147108673|NCT01134042|530563755|FG000|Overall Study|Protocol Violation|5|||
147108674|NCT01134042|530563756|FG001|Overall Study|Protocol Violation|3|||
147108675|NCT01134042|530563757|FG002|Overall Study|Protocol Violation|5|||
147108676|NCT01134042|530563755|FG000|Overall Study|Lost to Follow-up|2|||
147108677|NCT01134042|530563756|FG001|Overall Study|Lost to Follow-up|0|||
147108678|NCT01134042|530563757|FG002|Overall Study|Lost to Follow-up|1|||
147108679|NCT01134042|530563755|FG000|Overall Study|Physician Decision|4|||
147108680|NCT01134042|530563756|FG001|Overall Study|Physician Decision|8|||
147108681|NCT01134042|530563757|FG002|Overall Study|Physician Decision|1|||
147108682|NCT01134042|530563755|FG000|Overall Study|Withdrawal by Subject|13|||
147108683|NCT01134042|530563756|FG001|Overall Study|Withdrawal by Subject|4|||
147108684|NCT01134042|530563757|FG002|Overall Study|Withdrawal by Subject|7|||
147108685|NCT01137786|530563764|FG000|Overall Study|Lost to Follow-up|0|||
147108686|NCT01137786|530563765|FG001|Overall Study|Lost to Follow-up|2|||
147108687|NCT01137786|530563764|FG000|Overall Study|Withdrawal by Subject|1|||
147108688|NCT01137786|530563765|FG001|Overall Study|Withdrawal by Subject|1|||
147108689|NCT00770367|530563766|FG000|First Intervention|Withdrawal by Subject|0|||
147108690|NCT00770367|530563767|FG001|First Intervention|Withdrawal by Subject|2|||
147108691|NCT00770367|530563766|FG000|Washout Period of 4 Weeks|Withdrawal by Subject|0|||
147108692|NCT00770367|530563767|FG001|Washout Period of 4 Weeks|Withdrawal by Subject|1|||
147108693|NCT00770367|530563766|FG000|Second Intervention|Lost to Follow-up|2|||
147108694|NCT00770367|530563767|FG001|Second Intervention|Lost to Follow-up|0|||
147108695|NCT03881371|530563771|FG000|Overall Study|Adverse Event|8|||
147108696|NCT03881371|530563772|FG001|Overall Study|Adverse Event|9|||
147108697|NCT03881371|530563771|FG000|Overall Study|Death|1|||
147108698|NCT03881371|530563772|FG001|Overall Study|Death|0|||
147108699|NCT03881371|530563771|FG000|Overall Study|Lost to Follow-up|1|||
147108700|NCT03881371|530563772|FG001|Overall Study|Lost to Follow-up|0|||
147108701|NCT03881371|530563771|FG000|Overall Study|Non-Compliance with Study Drug|0|||
147108702|NCT03881371|530563772|FG001|Overall Study|Non-Compliance with Study Drug|2|||
147108703|NCT03881371|530563771|FG000|Overall Study|Physician Decision|3|||
147108704|NCT03881371|530563772|FG001|Overall Study|Physician Decision|3|||
147108705|NCT03881371|530563771|FG000|Overall Study|Withdrawal by Subject|2|||
147108706|NCT03881371|530563772|FG001|Overall Study|Withdrawal by Subject|10|||
147108707|NCT03881371|530563771|FG000|Overall Study|Discontinuation from Study|1|||
147108708|NCT03881371|530563772|FG001|Overall Study|Discontinuation from Study|0|||
147108709|NCT01138046|530563779|FG000|Overall Study|Withdrawal due to death|6|||
147108710|NCT02178956|530563780|FG000|Overall Study|Lost to Follow-up|4|||
147108711|NCT02178956|530563781|FG001|Overall Study|Lost to Follow-up|4|||
147108712|NCT02178956|530563780|FG000|Overall Study|Sponsor terminated study|49|||
147108713|NCT02178956|530563781|FG001|Overall Study|Sponsor terminated study|58|||
147108714|NCT02178956|530563780|FG000|Overall Study|Withdrawal by Subject|15|||
147108715|NCT02178956|530563781|FG001|Overall Study|Withdrawal by Subject|11|||
147108716|NCT02178956|530563780|FG000|Overall Study|Various Reasons|3|||
147108717|NCT02178956|530563781|FG001|Overall Study|Various Reasons|5|||
147108718|NCT03323502|530563782|FG000|Overall Study|Resident could not be linked to CMS data|594|||
147108719|NCT03323502|530563783|FG001|Overall Study|Resident could not be linked to CMS data|435|||
147108720|NCT03323502|530563782|FG000|Overall Study|Resident cognitive status could not be determined from CMS data|6551|||
147108721|NCT03323502|530563783|FG001|Overall Study|Resident cognitive status could not be determined from CMS data|6426|||
147108722|NCT03323502|530563782|FG000|Overall Study|Resident was enrolled in hospice care at study start (exclusion criteria)|247|||
147108723|NCT03323502|530563783|FG001|Overall Study|Resident was enrolled in hospice care at study start (exclusion criteria)|260|||
147108724|NCT03323502|530563782|FG000|Overall Study|Resident did not reside in facility for at least one day of study period (exclusion criteria)|896|||
147108725|NCT03323502|530563783|FG001|Overall Study|Resident did not reside in facility for at least one day of study period (exclusion criteria)|573|||
147108726|NCT03323502|530563782|FG000|Overall Study|Resident did not have ADRD as defined by study (exclusion criteria)|8386|||
147108727|NCT03323502|530563783|FG001|Overall Study|Resident did not have ADRD as defined by study (exclusion criteria)|8196|||
147108728|NCT02327078|530563784|FG000|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|0|||
147225551|NCT01390220|530998250|FG002|Test Dose Phase|Protocol Violation|0|||
147558781|NCT05381948|532203883|FG001|Overall Study|Lost to Follow-up|0|||
147558782|NCT05381948|532203884|FG002|Overall Study|Lost to Follow-up|0|||
147558783|NCT05381948|532203882|FG000|Overall Study|Protocol Deviation|0|||
147558784|NCT05381948|532203883|FG001|Overall Study|Protocol Deviation|2|||
147558785|NCT05381948|532203884|FG002|Overall Study|Protocol Deviation|0|||
147558786|NCT05381948|532203882|FG000|Overall Study|Withdrawal by Subject|1|||
147558787|NCT05381948|532203883|FG001|Overall Study|Withdrawal by Subject|0|||
147558788|NCT05381948|532203884|FG002|Overall Study|Withdrawal by Subject|1|||
147108729|NCT02327078|530563785|FG001|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|1|||
147108730|NCT02327078|530563786|FG002|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|2|||
147108731|NCT02327078|530563787|FG003|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|1|||
147225552|NCT01390220|530998248|FG000|Test Dose Phase|No treated seizure cluster episode|37|||
147558789|NCT05381948|532203882|FG000|Overall Study|Death|0|||
147558790|NCT05381948|532203883|FG001|Overall Study|Death|2|||
147558791|NCT05381948|532203884|FG002|Overall Study|Death|0|||
147558792|NCT05381948|532203882|FG000|Overall Study|Discontinued study without receiving study drug|0|||
147108732|NCT02327078|530563788|FG004|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|1|||
147108733|NCT02327078|530563789|FG005|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|0|||
147108734|NCT02327078|530563790|FG006|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|0|||
147108735|NCT02327078|530563791|FG007|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|11|||
147108736|NCT02327078|530563792|FG008|Overall Study|Participants Decision: Consent Withdrawal from Study and Follow-up|25|||
147108737|NCT02327078|530563784|FG000|Overall Study|Death|2|||
147108738|NCT02327078|530563785|FG001|Overall Study|Death|4|||
147108739|NCT02327078|530563786|FG002|Overall Study|Death|10|||
147108740|NCT02327078|530563787|FG003|Overall Study|Death|6|||
147108741|NCT02327078|530563788|FG004|Overall Study|Death|4|||
147108742|NCT02327078|530563789|FG005|Overall Study|Death|3|||
147108743|NCT02327078|530563790|FG006|Overall Study|Death|2|||
147108744|NCT02327078|530563791|FG007|Overall Study|Death|51|||
147108745|NCT02327078|530563792|FG008|Overall Study|Death|97|||
147108746|NCT02327078|530563784|FG000|Overall Study|Lost to Follow-up|0|||
147108747|NCT02327078|530563785|FG001|Overall Study|Lost to Follow-up|1|||
147108748|NCT02327078|530563786|FG002|Overall Study|Lost to Follow-up|1|||
147108749|NCT02327078|530563787|FG003|Overall Study|Lost to Follow-up|0|||
147108750|NCT02327078|530563788|FG004|Overall Study|Lost to Follow-up|0|||
147108751|NCT02327078|530563789|FG005|Overall Study|Lost to Follow-up|0|||
147108752|NCT02327078|530563790|FG006|Overall Study|Lost to Follow-up|0|||
147108753|NCT02327078|530563791|FG007|Overall Study|Lost to Follow-up|2|||
147108754|NCT02327078|530563792|FG008|Overall Study|Lost to Follow-up|5|||
147108755|NCT02327078|530563784|FG000|Overall Study|Site Terminated by Sponsor|1|||
147108756|NCT02327078|530563785|FG001|Overall Study|Site Terminated by Sponsor|0|||
147108757|NCT02327078|530563786|FG002|Overall Study|Site Terminated by Sponsor|1|||
147108758|NCT02327078|530563787|FG003|Overall Study|Site Terminated by Sponsor|4|||
147108759|NCT02327078|530563788|FG004|Overall Study|Site Terminated by Sponsor|0|||
147108760|NCT02327078|530563789|FG005|Overall Study|Site Terminated by Sponsor|0|||
147108761|NCT02327078|530563790|FG006|Overall Study|Site Terminated by Sponsor|0|||
147108762|NCT02327078|530563791|FG007|Overall Study|Site Terminated by Sponsor|11|||
147108763|NCT02327078|530563792|FG008|Overall Study|Site Terminated by Sponsor|25|||
147108764|NCT02327078|530563784|FG000|Overall Study|Physician Decision|0|||
147108765|NCT02327078|530563785|FG001|Overall Study|Physician Decision|0|||
147108766|NCT02327078|530563786|FG002|Overall Study|Physician Decision|0|||
147108767|NCT02327078|530563787|FG003|Overall Study|Physician Decision|1|||
147108768|NCT02327078|530563788|FG004|Overall Study|Physician Decision|0|||
147108769|NCT02327078|530563789|FG005|Overall Study|Physician Decision|0|||
147108770|NCT02327078|530563790|FG006|Overall Study|Physician Decision|0|||
147108771|NCT02327078|530563791|FG007|Overall Study|Physician Decision|0|||
147558793|NCT05381948|532203883|FG001|Overall Study|Discontinued study without receiving study drug|0|||
147558794|NCT05381948|532203884|FG002|Overall Study|Discontinued study without receiving study drug|1|||
147558795|NCT02446132|532203887|FG000|Overall Study|Adverse Event|10|||
147558796|NCT02446132|532203888|FG001|Overall Study|Adverse Event|27|||
147558797|NCT02446132|532203889|FG002|Overall Study|Adverse Event|27|||
147558798|NCT02446132|532203887|FG000|Overall Study|Death|2|||
147558799|NCT02446132|532203888|FG001|Overall Study|Death|13|||
147558800|NCT02446132|532203889|FG002|Overall Study|Death|10|||
147558801|NCT02446132|532203887|FG000|Overall Study|Lack of Efficacy|1|||
147558802|NCT02446132|532203888|FG001|Overall Study|Lack of Efficacy|10|||
147225553|NCT01390220|530998249|FG001|Test Dose Phase|No treated seizure cluster episode|0|||
147444153|NCT01045798|531790531|FG000|Overall Study|Changed to Other Antifungal Therapy|1|||
147558803|NCT02446132|532203889|FG002|Overall Study|Lack of Efficacy|6|||
147558804|NCT02446132|532203887|FG000|Overall Study|Lost to Follow-up|2|||
147558805|NCT02446132|532203888|FG001|Overall Study|Lost to Follow-up|4|||
147558806|NCT02446132|532203889|FG002|Overall Study|Lost to Follow-up|5|||
147558807|NCT02446132|532203887|FG000|Overall Study|Non-compliance With Study Drug|2|||
147558808|NCT02446132|532203888|FG001|Overall Study|Non-compliance With Study Drug|2|||
147558809|NCT02446132|532203889|FG002|Overall Study|Non-compliance With Study Drug|3|||
147558810|NCT02446132|532203887|FG000|Overall Study|Physician Decision|1|||
147558811|NCT02446132|532203888|FG001|Overall Study|Physician Decision|8|||
147558812|NCT02446132|532203889|FG002|Overall Study|Physician Decision|13|||
147558813|NCT02446132|532203887|FG000|Overall Study|Protocol Deviation|0|||
147558814|NCT02446132|532203888|FG001|Overall Study|Protocol Deviation|0|||
147558815|NCT02446132|532203889|FG002|Overall Study|Protocol Deviation|1|||
147108772|NCT02327078|530563792|FG008|Overall Study|Physician Decision|1|||
147108773|NCT02327078|530563784|FG000|Overall Study|Completed 100 Day Safety Follow-up Period|0|||
147108774|NCT02327078|530563785|FG001|Overall Study|Completed 100 Day Safety Follow-up Period|0|||
147108775|NCT02327078|530563786|FG002|Overall Study|Completed 100 Day Safety Follow-up Period|0|||
147444154|NCT01045798|531790532|FG001|Overall Study|Changed to Other Antifungal Therapy|2|||
147558816|NCT02446132|532203887|FG000|Overall Study|Study Subject Withdrawal by Parent or Guardian|14|||
147558817|NCT02446132|532203888|FG001|Overall Study|Study Subject Withdrawal by Parent or Guardian|36|||
147108776|NCT02327078|530563787|FG003|Overall Study|Completed 100 Day Safety Follow-up Period|1|||
147558818|NCT02446132|532203889|FG002|Overall Study|Study Subject Withdrawal by Parent or Guardian|22|||
147108777|NCT02327078|530563788|FG004|Overall Study|Completed 100 Day Safety Follow-up Period|1|||
147108778|NCT02327078|530563789|FG005|Overall Study|Completed 100 Day Safety Follow-up Period|0|||
147108779|NCT02327078|530563790|FG006|Overall Study|Completed 100 Day Safety Follow-up Period|1|||
147108780|NCT02327078|530563791|FG007|Overall Study|Completed 100 Day Safety Follow-up Period|3|||
147108781|NCT02327078|530563792|FG008|Overall Study|Completed 100 Day Safety Follow-up Period|11|||
147108782|NCT02327078|530563784|FG000|Overall Study|Reason not Specified|0|||
147108783|NCT02327078|530563785|FG001|Overall Study|Reason not Specified|0|||
147108784|NCT02327078|530563786|FG002|Overall Study|Reason not Specified|0|||
147108785|NCT02327078|530563787|FG003|Overall Study|Reason not Specified|0|||
147108786|NCT02327078|530563788|FG004|Overall Study|Reason not Specified|0|||
147108787|NCT02327078|530563789|FG005|Overall Study|Reason not Specified|0|||
147108788|NCT02327078|530563790|FG006|Overall Study|Reason not Specified|0|||
147108789|NCT02327078|530563791|FG007|Overall Study|Reason not Specified|5|||
147108790|NCT02327078|530563792|FG008|Overall Study|Reason not Specified|12|||
147108791|NCT04797169|530563795|FG000|Overall Study|Lost to Follow-up|84|||
147108792|NCT04797169|530563796|FG001|Overall Study|Lost to Follow-up|67|||
147108793|NCT04797169|530563795|FG000|Overall Study|Pregnancy|1|||
147108794|NCT04797169|530563796|FG001|Overall Study|Pregnancy|3|||
147108795|NCT04797169|530563795|FG000|Overall Study|Withdrawal by Subject|27|||
147108796|NCT04797169|530563796|FG001|Overall Study|Withdrawal by Subject|35|||
147108797|NCT02337829|530563797|FG000|Overall Study|Death|0|||
147108798|NCT02337829|530563798|FG001|Overall Study|Death|1|||
147108799|NCT02337829|530563799|FG002|Overall Study|Death|0|||
147108800|NCT02337829|530563800|FG003|Overall Study|Death|0|||
147108801|NCT02337829|530563797|FG000|Overall Study|Study terminated by sponsor|12|||
147108802|NCT02337829|530563798|FG001|Overall Study|Study terminated by sponsor|10|||
147108803|NCT02337829|530563799|FG002|Overall Study|Study terminated by sponsor|5|||
147108804|NCT02337829|530563800|FG003|Overall Study|Study terminated by sponsor|6|||
147108805|NCT02337829|530563797|FG000|Overall Study|discontinued for other reasons|6|||
147108806|NCT02337829|530563798|FG001|Overall Study|discontinued for other reasons|3|||
147108807|NCT02337829|530563799|FG002|Overall Study|discontinued for other reasons|1|||
147108808|NCT02337829|530563800|FG003|Overall Study|discontinued for other reasons|4|||
147108809|NCT03839641|530563802|FG000|Overall Study|Withdrawal by Subject|1|||
147108810|NCT03839641|530563803|FG001|Overall Study|Withdrawal by Subject|1|||
147108811|NCT04221490|530563805|FG000|At 30 Days Follow-up|Death|7|||
147108812|NCT04221490|530563805|FG000|At 30 Days Follow-up|Missed Visit|4|||
147108813|NCT04221490|530563805|FG000|At 30 Days Follow-up|Exited for Other Reasons|1|||
147108814|NCT04221490|530563805|FG000|At 6 Months Follow-up|Death|9|||
147108815|NCT04221490|530563805|FG000|At 6 Months Follow-up|Physician Decision|1|||
147108816|NCT04221490|530563805|FG000|At 6 Months Follow-up|Missed Visit|8|||
147108817|NCT04221490|530563805|FG000|At 6 Months Follow-up|Exited for Other Reasons|8|||
147108818|NCT03765073|530563806|FG000|Stage 1|Lost to Follow-up|1|||
147108819|NCT03765073|530563807|FG001|Stage 1|Lost to Follow-up|0|||
147108820|NCT03765073|530563808|FG002|Stage 1|Lost to Follow-up|0|||
147108821|NCT03765073|530563809|FG003|Stage 1|Lost to Follow-up|0|||
147108822|NCT03765073|530563810|FG004|Stage 1|Lost to Follow-up|0|||
147108823|NCT03765073|530563811|FG005|Stage 1|Lost to Follow-up|0|||
147108824|NCT03765073|530563812|FG006|Stage 1|Lost to Follow-up|0|||
147108825|NCT03765073|530563813|FG007|Stage 1|Lost to Follow-up|0|||
147108826|NCT03765073|530563814|FG008|Stage 1|Lost to Follow-up|0|||
147108827|NCT03765073|530563815|FG009|Stage 1|Lost to Follow-up|0|||
147108828|NCT03765073|530563816|FG010|Stage 1|Lost to Follow-up|0|||
147108829|NCT03765073|530563817|FG011|Stage 1|Lost to Follow-up|0|||
147558819|NCT02446132|532203887|FG000|Overall Study|Study Terminated by Sponsor|4|||
147558820|NCT02446132|532203888|FG001|Overall Study|Study Terminated by Sponsor|35|||
147108830|NCT03765073|530563818|FG012|Stage 1|Lost to Follow-up|0|||
147108831|NCT03765073|530563819|FG013|Stage 1|Lost to Follow-up|0|||
147558821|NCT02446132|532203889|FG002|Overall Study|Study Terminated by Sponsor|58|||
147558822|NCT02446132|532203887|FG000|Overall Study|Trial Site Terminated by Sponsor|6|||
147108832|NCT03765073|530563820|FG014|Stage 1|Lost to Follow-up|0|||
147108833|NCT03765073|530563821|FG015|Stage 1|Lost to Follow-up|0|||
147108834|NCT03765073|530563822|FG016|Stage 1|Lost to Follow-up|0|||
147108835|NCT03765073|530563823|FG017|Stage 1|Lost to Follow-up|0|||
147108836|NCT03765073|530563824|FG018|Stage 1|Lost to Follow-up|0|||
147108837|NCT03765073|530563825|FG019|Stage 1|Lost to Follow-up|0|||
147108838|NCT03765073|530563826|FG020|Stage 1|Lost to Follow-up|0|||
147108839|NCT03765073|530563806|FG000|Stage 1|Withdrawal by participant|0|||
147108840|NCT03765073|530563807|FG001|Stage 1|Withdrawal by participant|1|||
147108841|NCT03765073|530563808|FG002|Stage 1|Withdrawal by participant|0|||
147108842|NCT03765073|530563809|FG003|Stage 1|Withdrawal by participant|0|||
147108843|NCT03765073|530563810|FG004|Stage 1|Withdrawal by participant|0|||
147108844|NCT03765073|530563811|FG005|Stage 1|Withdrawal by participant|0|||
147225554|NCT01390220|530998250|FG002|Test Dose Phase|No treated seizure cluster episode|0|||
147108845|NCT03765073|530563812|FG006|Stage 1|Withdrawal by participant|0|||
147108846|NCT03765073|530563813|FG007|Stage 1|Withdrawal by participant|0|||
147108847|NCT03765073|530563814|FG008|Stage 1|Withdrawal by participant|0|||
147108848|NCT03765073|530563815|FG009|Stage 1|Withdrawal by participant|0|||
147108849|NCT03765073|530563816|FG010|Stage 1|Withdrawal by participant|0|||
147108850|NCT03765073|530563817|FG011|Stage 1|Withdrawal by participant|0|||
147108851|NCT03765073|530563818|FG012|Stage 1|Withdrawal by participant|0|||
147108852|NCT03765073|530563819|FG013|Stage 1|Withdrawal by participant|0|||
147108853|NCT03765073|530563820|FG014|Stage 1|Withdrawal by participant|0|||
147108854|NCT03765073|530563821|FG015|Stage 1|Withdrawal by participant|0|||
147108855|NCT03765073|530563822|FG016|Stage 1|Withdrawal by participant|0|||
147108856|NCT03765073|530563823|FG017|Stage 1|Withdrawal by participant|0|||
147108857|NCT03765073|530563824|FG018|Stage 1|Withdrawal by participant|0|||
147108858|NCT03765073|530563825|FG019|Stage 1|Withdrawal by participant|0|||
147108859|NCT03765073|530563826|FG020|Stage 1|Withdrawal by participant|0|||
147108860|NCT03765073|530563806|FG000|Stage 2|Death|0|||
147108861|NCT03765073|530563807|FG001|Stage 2|Death|0|||
147108862|NCT03765073|530563808|FG002|Stage 2|Death|0|||
147108863|NCT03765073|530563809|FG003|Stage 2|Death|0|||
147108864|NCT03765073|530563810|FG004|Stage 2|Death|0|||
147108865|NCT03765073|530563811|FG005|Stage 2|Death|0|||
147108866|NCT03765073|530563812|FG006|Stage 2|Death|0|||
147108867|NCT03765073|530563813|FG007|Stage 2|Death|0|||
147108868|NCT03765073|530563814|FG008|Stage 2|Death|0|||
147108869|NCT03765073|530563815|FG009|Stage 2|Death|1|||
147108870|NCT03765073|530563816|FG010|Stage 2|Death|0|||
147108871|NCT03765073|530563817|FG011|Stage 2|Death|1|||
147108872|NCT03765073|530563818|FG012|Stage 2|Death|0|||
147108873|NCT03765073|530563819|FG013|Stage 2|Death|0|||
147108874|NCT03765073|530563820|FG014|Stage 2|Death|0|||
147108875|NCT03765073|530563821|FG015|Stage 2|Death|0|||
147108876|NCT03765073|530563822|FG016|Stage 2|Death|2|||
147108877|NCT03765073|530563823|FG017|Stage 2|Death|0|||
147108878|NCT03765073|530563824|FG018|Stage 2|Death|0|||
147108879|NCT03765073|530563825|FG019|Stage 2|Death|0|||
147108880|NCT03765073|530563826|FG020|Stage 2|Death|0|||
147108881|NCT03765073|530563806|FG000|Stage 2|Lost to Follow-up|0|||
147108882|NCT03765073|530563807|FG001|Stage 2|Lost to Follow-up|0|||
147108883|NCT03765073|530563808|FG002|Stage 2|Lost to Follow-up|0|||
147108884|NCT03765073|530563809|FG003|Stage 2|Lost to Follow-up|5|||
147108885|NCT03765073|530563810|FG004|Stage 2|Lost to Follow-up|1|||
147108886|NCT03765073|530563811|FG005|Stage 2|Lost to Follow-up|0|||
147558823|NCT02446132|532203888|FG001|Overall Study|Trial Site Terminated by Sponsor|4|||
147558824|NCT02446132|532203889|FG002|Overall Study|Trial Site Terminated by Sponsor|5|||
147558825|NCT02446132|532203887|FG000|Overall Study|Withdrawal by Subject|11|||
147558826|NCT02446132|532203888|FG001|Overall Study|Withdrawal by Subject|29|||
147558827|NCT02446132|532203889|FG002|Overall Study|Withdrawal by Subject|25|||
147558828|NCT02446132|532203887|FG000|Overall Study|Reason not Specified|4|||
147558829|NCT02446132|532203888|FG001|Overall Study|Reason not Specified|16|||
147558830|NCT02446132|532203889|FG002|Overall Study|Reason not Specified|10|||
147558831|NCT02446132|532203887|FG000|Overall Study|Enrolled Participants Who Did Not Receive Study Medications|0|||
147558832|NCT02446132|532203888|FG001|Overall Study|Enrolled Participants Who Did Not Receive Study Medications|1|||
147558833|NCT02446132|532203889|FG002|Overall Study|Enrolled Participants Who Did Not Receive Study Medications|5|||
147558834|NCT05526248|532203890|FG000|Overall Study|Lost to Follow-up|1|||
147558835|NCT05526248|532203890|FG000|Overall Study|Adverse Event|2|||
147558836|NCT05526248|532203890|FG000|Overall Study|Withdrawal by Subject|1|||
147558837|NCT03444038|532203891|FG000|Overall Study|Adverse Event|12|||
147558838|NCT03444038|532203891|FG000|Overall Study|Withdrawal by Subject|7|||
147558839|NCT03444038|532203891|FG000|Overall Study|Lost to Follow-up|1|||
147558840|NCT03444038|532203891|FG000|Overall Study|Physician Decision|2|||
147558841|NCT03444038|532203891|FG000|Overall Study|Lack of Efficacy|7|||
147558842|NCT01957488|532203894|FG000|Test Period 1 (2 Weeks)|Lost to Follow-up|2|||
147558843|NCT01957488|532203895|FG001|Test Period 1 (2 Weeks)|Lost to Follow-up|0|||
147558844|NCT01957488|532203896|FG002|Test Period 1 (2 Weeks)|Lost to Follow-up|1|||
147558845|NCT01957488|532203897|FG003|Test Period 1 (2 Weeks)|Lost to Follow-up|1|||
147558846|NCT01957488|532203898|FG004|Test Period 1 (2 Weeks)|Lost to Follow-up|0|||
147108887|NCT03765073|530563812|FG006|Stage 2|Lost to Follow-up|3|||
147558847|NCT01957488|532203899|FG005|Test Period 1 (2 Weeks)|Lost to Follow-up|0|||
147108888|NCT03765073|530563813|FG007|Stage 2|Lost to Follow-up|3|||
147108889|NCT03765073|530563814|FG008|Stage 2|Lost to Follow-up|1|||
147108890|NCT03765073|530563815|FG009|Stage 2|Lost to Follow-up|6|||
147108891|NCT03765073|530563816|FG010|Stage 2|Lost to Follow-up|5|||
147108892|NCT03765073|530563817|FG011|Stage 2|Lost to Follow-up|1|||
147108893|NCT03765073|530563818|FG012|Stage 2|Lost to Follow-up|1|||
147108894|NCT03765073|530563819|FG013|Stage 2|Lost to Follow-up|3|||
147558848|NCT01957488|532203894|FG000|Test Period 1 (2 Weeks)|Protocol Violation|1|||
147558849|NCT01957488|532203895|FG001|Test Period 1 (2 Weeks)|Protocol Violation|2|||
147558850|NCT01957488|532203896|FG002|Test Period 1 (2 Weeks)|Protocol Violation|2|||
147558851|NCT01957488|532203897|FG003|Test Period 1 (2 Weeks)|Protocol Violation|1|||
147108895|NCT03765073|530563820|FG014|Stage 2|Lost to Follow-up|3|||
147108896|NCT03765073|530563821|FG015|Stage 2|Lost to Follow-up|1|||
147108897|NCT03765073|530563822|FG016|Stage 2|Lost to Follow-up|6|||
147108898|NCT03765073|530563823|FG017|Stage 2|Lost to Follow-up|0|||
147108899|NCT03765073|530563824|FG018|Stage 2|Lost to Follow-up|0|||
147108900|NCT03765073|530563825|FG019|Stage 2|Lost to Follow-up|0|||
147108901|NCT03765073|530563826|FG020|Stage 2|Lost to Follow-up|0|||
147108902|NCT03765073|530563806|FG000|Stage 2|Other|0|||
147108903|NCT03765073|530563807|FG001|Stage 2|Other|0|||
147108904|NCT03765073|530563808|FG002|Stage 2|Other|0|||
147108905|NCT03765073|530563809|FG003|Stage 2|Other|0|||
147108906|NCT03765073|530563810|FG004|Stage 2|Other|0|||
147108907|NCT03765073|530563811|FG005|Stage 2|Other|0|||
147108908|NCT03765073|530563812|FG006|Stage 2|Other|0|||
147108909|NCT03765073|530563813|FG007|Stage 2|Other|1|||
147108910|NCT03765073|530563814|FG008|Stage 2|Other|1|||
147108911|NCT03765073|530563815|FG009|Stage 2|Other|3|||
147108912|NCT03765073|530563816|FG010|Stage 2|Other|0|||
147108913|NCT03765073|530563817|FG011|Stage 2|Other|0|||
147108914|NCT03765073|530563818|FG012|Stage 2|Other|0|||
147108915|NCT03765073|530563819|FG013|Stage 2|Other|0|||
147108916|NCT03765073|530563820|FG014|Stage 2|Other|0|||
147108917|NCT03765073|530563821|FG015|Stage 2|Other|1|||
147108918|NCT03765073|530563822|FG016|Stage 2|Other|2|||
147108919|NCT03765073|530563823|FG017|Stage 2|Other|0|||
147108920|NCT03765073|530563824|FG018|Stage 2|Other|0|||
147108921|NCT03765073|530563825|FG019|Stage 2|Other|0|||
147108922|NCT03765073|530563826|FG020|Stage 2|Other|0|||
147108923|NCT03765073|530563806|FG000|Stage 2|Withdrawal by parent/guardian|0|||
147108924|NCT03765073|530563807|FG001|Stage 2|Withdrawal by parent/guardian|0|||
147108925|NCT03765073|530563808|FG002|Stage 2|Withdrawal by parent/guardian|0|||
147108926|NCT03765073|530563809|FG003|Stage 2|Withdrawal by parent/guardian|0|||
147108927|NCT03765073|530563810|FG004|Stage 2|Withdrawal by parent/guardian|0|||
147108928|NCT03765073|530563811|FG005|Stage 2|Withdrawal by parent/guardian|0|||
147108929|NCT03765073|530563812|FG006|Stage 2|Withdrawal by parent/guardian|0|||
147108930|NCT03765073|530563813|FG007|Stage 2|Withdrawal by parent/guardian|0|||
147108931|NCT03765073|530563814|FG008|Stage 2|Withdrawal by parent/guardian|0|||
147444155|NCT01045798|531790531|FG000|Overall Study|Received Systemic Antifungal Prestudy|0|||
147108932|NCT03765073|530563815|FG009|Stage 2|Withdrawal by parent/guardian|0|||
147108933|NCT03765073|530563816|FG010|Stage 2|Withdrawal by parent/guardian|3|||
147108934|NCT03765073|530563817|FG011|Stage 2|Withdrawal by parent/guardian|3|||
147108935|NCT03765073|530563818|FG012|Stage 2|Withdrawal by parent/guardian|3|||
147108936|NCT03765073|530563819|FG013|Stage 2|Withdrawal by parent/guardian|1|||
147108937|NCT03765073|530563820|FG014|Stage 2|Withdrawal by parent/guardian|1|||
147108938|NCT03765073|530563821|FG015|Stage 2|Withdrawal by parent/guardian|0|||
147108939|NCT03765073|530563822|FG016|Stage 2|Withdrawal by parent/guardian|3|||
147225555|NCT01390220|530998248|FG000|Test Dose Phase|Study/Site closure|6|||
147225556|NCT01390220|530998249|FG001|Test Dose Phase|Study/Site closure|0|||
147225557|NCT01390220|530998250|FG002|Test Dose Phase|Study/Site closure|0|||
147225558|NCT01390220|530998248|FG000|Test Dose Phase|Caregiver no longer available|5|||
147225559|NCT01390220|530998249|FG001|Test Dose Phase|Caregiver no longer available|0|||
147225560|NCT01390220|530998250|FG002|Test Dose Phase|Caregiver no longer available|0|||
147225561|NCT01390220|530998248|FG000|Test Dose Phase|Noncompliance|2|||
147225562|NCT01390220|530998249|FG001|Test Dose Phase|Noncompliance|0|||
147225563|NCT01390220|530998250|FG002|Test Dose Phase|Noncompliance|0|||
147225564|NCT01390220|530998248|FG000|Test Dose Phase|Logistical|6|||
147225565|NCT01390220|530998249|FG001|Test Dose Phase|Logistical|0|||
147225566|NCT01390220|530998250|FG002|Test Dose Phase|Logistical|0|||
147225567|NCT01390220|530998248|FG000|Comparative Phase|Withdrawal by Subject|0|||
147225568|NCT01390220|530998249|FG001|Comparative Phase|Withdrawal by Subject|1|||
147225569|NCT01390220|530998250|FG002|Comparative Phase|Withdrawal by Subject|0|||
147225570|NCT04025710|530998251|FG000|Overall Study|Death|3|||
147225571|NCT04025710|530998251|FG000|Overall Study|Lost to Follow-up|5|||
147225572|NCT04025710|530998251|FG000|Overall Study|Withdrawal by Subject|1|||
147225573|NCT04025710|530998251|FG000|Overall Study|Patient unable or unwilling to attend required visits|8|||
147225574|NCT04025710|530998251|FG000|Overall Study|Drop-out according to protocol|34|||
147225575|NCT00245583|530998254|FG000|Overall Study|Lost to Follow-up|1|||
147225576|NCT00245583|530998255|FG001|Overall Study|Lost to Follow-up|5|||
147225577|NCT00245583|530998254|FG000|Overall Study|Adverse Event|2|||
147225578|NCT00245583|530998255|FG001|Overall Study|Adverse Event|1|||
147225579|NCT00245583|530998254|FG000|Overall Study|Lack of Efficacy|1|||
147225580|NCT00245583|530998255|FG001|Overall Study|Lack of Efficacy|0|||
147225581|NCT00245583|530998254|FG000|Overall Study|Withdrawal by Subject|2|||
147225582|NCT00245583|530998255|FG001|Overall Study|Withdrawal by Subject|3|||
147225583|NCT02273739|530998256|FG000|Overall Study|Progression of Disease|3|||
147225584|NCT02273739|530998257|FG001|Overall Study|Progression of Disease|4|||
147225585|NCT02273739|530998258|FG002|Overall Study|Progression of Disease|5|||
147225586|NCT02273739|530998259|FG003|Overall Study|Progression of Disease|2|||
147225587|NCT02273739|530998256|FG000|Overall Study|Death|0|||
147225588|NCT02273739|530998257|FG001|Overall Study|Death|0|||
147225589|NCT02273739|530998258|FG002|Overall Study|Death|0|||
147225590|NCT02273739|530998259|FG003|Overall Study|Death|2|||
147225591|NCT02273739|530998256|FG000|Overall Study|Adverse Event|0|||
147225592|NCT02273739|530998257|FG001|Overall Study|Adverse Event|0|||
147225593|NCT02273739|530998258|FG002|Overall Study|Adverse Event|0|||
147225594|NCT02273739|530998259|FG003|Overall Study|Adverse Event|1|||
147444156|NCT01045798|531790532|FG001|Overall Study|Received Systemic Antifungal Prestudy|1|||
147108940|NCT03765073|530563823|FG017|Stage 2|Withdrawal by parent/guardian|0|||
147108941|NCT03765073|530563824|FG018|Stage 2|Withdrawal by parent/guardian|0|||
147225595|NCT02273739|530998256|FG000|Overall Study|Withdrawal by Subject|0|||
147225596|NCT02273739|530998257|FG001|Overall Study|Withdrawal by Subject|0|||
147310838|NCT00258440|531305121|FG002|Overall Study|Withdrawal by Subject|1|||
147310839|NCT00737061|531305122|FG000|Waiting Period|Lost to Follow-up|6|||
147310840|NCT00737061|531305122|FG000|Waiting Period|Withdrawal by Subject|1|||
147310841|NCT00737061|531305122|FG000|Waiting Period|Bilateral placement failure|34|||
147310842|NCT00737061|531305122|FG000|Waiting Period|Deemed patent following HSG|26|||
147310843|NCT00737061|531305122|FG000|Waiting Period|Alternative contraception failure|3|||
147310844|NCT00737061|531305122|FG000|Waiting Period|Elected surgical tubal ligation|5|||
147310845|NCT00737061|531305122|FG000|1 Year Wearing Period|Lost to Follow-up|11|||
147310846|NCT00737061|531305122|FG000|1 Year Wearing Period|Withdrawal by Subject|2|||
147310847|NCT00737061|531305122|FG000|1 Year Wearing Period|Discontinued reilance|3|||
147310848|NCT00737061|531305122|FG000|1 Year Wearing Period|Terminated for protocol non-compliance|1|||
147310849|NCT00734214|531305129|FG000|Overall Study|Withdrawal by Subject|3|||
147310850|NCT00734214|531305130|FG001|Overall Study|Withdrawal by Subject|4|||
147310851|NCT00734214|531305129|FG000|Overall Study|MD withdrawal|1|||
147310852|NCT00734214|531305130|FG001|Overall Study|MD withdrawal|0|||
147310853|NCT00447954|531305131|FG000|Overall Study|Adverse Event|0|||
147310854|NCT00447954|531305132|FG001|Overall Study|Adverse Event|2|||
147310855|NCT00447954|531305133|FG002|Overall Study|Adverse Event|0|||
147108942|NCT03765073|530563825|FG019|Stage 2|Withdrawal by parent/guardian|0|||
147108943|NCT03765073|530563826|FG020|Stage 2|Withdrawal by parent/guardian|0|||
147108944|NCT03765073|530563806|FG000|Stage 2|Withdrawal by Subject|0|||
147108945|NCT03765073|530563807|FG001|Stage 2|Withdrawal by Subject|0|||
147108946|NCT03765073|530563808|FG002|Stage 2|Withdrawal by Subject|0|||
147108947|NCT03765073|530563809|FG003|Stage 2|Withdrawal by Subject|3|||
147108948|NCT03765073|530563810|FG004|Stage 2|Withdrawal by Subject|3|||
147108949|NCT03765073|530563811|FG005|Stage 2|Withdrawal by Subject|3|||
147108950|NCT03765073|530563812|FG006|Stage 2|Withdrawal by Subject|0|||
147108951|NCT03765073|530563813|FG007|Stage 2|Withdrawal by Subject|1|||
147108952|NCT03765073|530563814|FG008|Stage 2|Withdrawal by Subject|0|||
147108953|NCT03765073|530563815|FG009|Stage 2|Withdrawal by Subject|5|||
147108954|NCT03765073|530563816|FG010|Stage 2|Withdrawal by Subject|0|||
147108955|NCT03765073|530563817|FG011|Stage 2|Withdrawal by Subject|0|||
147108956|NCT03765073|530563818|FG012|Stage 2|Withdrawal by Subject|0|||
147108957|NCT03765073|530563819|FG013|Stage 2|Withdrawal by Subject|0|||
147108958|NCT03765073|530563820|FG014|Stage 2|Withdrawal by Subject|0|||
147310856|NCT00447954|531305131|FG000|Overall Study|Withdrawal by Subject|0|||
147310857|NCT00447954|531305132|FG001|Overall Study|Withdrawal by Subject|1|||
147310858|NCT00447954|531305133|FG002|Overall Study|Withdrawal by Subject|1|||
147310859|NCT00447954|531305131|FG000|Overall Study|Lost to Follow-up|0|||
147310860|NCT00447954|531305132|FG001|Overall Study|Lost to Follow-up|1|||
147310861|NCT00447954|531305133|FG002|Overall Study|Lost to Follow-up|0|||
147310862|NCT00447954|531305131|FG000|Overall Study|Exclusionary event prior to implant procedure|1|||
147310863|NCT00447954|531305132|FG001|Overall Study|Exclusionary event prior to implant procedure|0|||
147310864|NCT00447954|531305133|FG002|Overall Study|Exclusionary event prior to implant procedure|0|||
147310865|NCT00621296|531305144|FG000|Overall Study|Adverse Event|2|||
147310866|NCT00621296|531305144|FG000|Overall Study|Lack of Efficacy|1|||
147310867|NCT00621296|531305144|FG000|Overall Study|Physician Decision|7|||
147310868|NCT00621296|531305144|FG000|Overall Study|Unmatch Criteria|1|||
147310869|NCT00621296|531305144|FG000|Overall Study|Stopping Criteria|3|||
147310870|NCT00384059|531305146|FG000|Infant Series|Not consented|2|||
147310871|NCT00384059|531305147|FG001|Infant Series|Not consented|6|||
147310872|NCT00384059|531305146|FG000|Infant Series|Withdrawal by Subject|2|||
147310873|NCT00384059|531305147|FG001|Infant Series|Withdrawal by Subject|2|||
147310874|NCT00384059|531305146|FG000|Infant Series|Adverse Event|1|||
147310875|NCT00384059|531305147|FG001|Infant Series|Adverse Event|2|||
147310876|NCT00384059|531305146|FG000|Infant Series|Protocol Violation|1|||
147310877|NCT00384059|531305147|FG001|Infant Series|Protocol Violation|2|||
147310878|NCT00384059|531305146|FG000|Infant Series|Lost to Follow-up|0|||
147310879|NCT00384059|531305147|FG001|Infant Series|Lost to Follow-up|1|||
147558852|NCT01957488|532203898|FG004|Test Period 1 (2 Weeks)|Protocol Violation|0|||
147558853|NCT01957488|532203899|FG005|Test Period 1 (2 Weeks)|Protocol Violation|3|||
147310880|NCT00384059|531305146|FG000|After Infant Series|Protocol Violation|2|||
147310881|NCT00384059|531305147|FG001|After Infant Series|Protocol Violation|3|||
147558854|NCT01957488|532203894|FG000|Test Period 1 (2 Weeks)|Adverse Event|0|||
147310882|NCT00384059|531305146|FG000|After Infant Series|Withdrawal by Subject|2|||
147558855|NCT01957488|532203895|FG001|Test Period 1 (2 Weeks)|Adverse Event|1|||
147108959|NCT03765073|530563821|FG015|Stage 2|Withdrawal by Subject|0|||
147108960|NCT03765073|530563822|FG016|Stage 2|Withdrawal by Subject|0|||
147108961|NCT03765073|530563823|FG017|Stage 2|Withdrawal by Subject|0|||
147108962|NCT03765073|530563824|FG018|Stage 2|Withdrawal by Subject|0|||
147310883|NCT00384059|531305147|FG001|After Infant Series|Withdrawal by Subject|2|||
147444157|NCT01652885|531792504|FG000|Overall Study|Adverse Event|1|||
147108963|NCT03765073|530563825|FG019|Stage 2|Withdrawal by Subject|0|||
147108964|NCT03765073|530563826|FG020|Stage 2|Withdrawal by Subject|0|||
147108965|NCT03765073|530563806|FG000|Stage 3|Adverse Event|0|||
147108966|NCT03765073|530563807|FG001|Stage 3|Adverse Event|0|||
147444158|NCT00075400|531792505|FG000|Overall Study|Ineligible: wrong primary|1|||
147108967|NCT03765073|530563808|FG002|Stage 3|Adverse Event|0|||
147108968|NCT03765073|530563809|FG003|Stage 3|Adverse Event|0|||
147108969|NCT03765073|530563810|FG004|Stage 3|Adverse Event|0|||
147108970|NCT03765073|530563811|FG005|Stage 3|Adverse Event|0|||
147108971|NCT03765073|530563812|FG006|Stage 3|Adverse Event|0|||
147108972|NCT03765073|530563813|FG007|Stage 3|Adverse Event|0|||
147108973|NCT03765073|530563814|FG008|Stage 3|Adverse Event|0|||
147108974|NCT03765073|530563815|FG009|Stage 3|Adverse Event|0|||
147108975|NCT03765073|530563816|FG010|Stage 3|Adverse Event|0|||
147108976|NCT03765073|530563817|FG011|Stage 3|Adverse Event|0|||
147108977|NCT03765073|530563818|FG012|Stage 3|Adverse Event|0|||
147108978|NCT03765073|530563819|FG013|Stage 3|Adverse Event|0|||
147108979|NCT03765073|530563820|FG014|Stage 3|Adverse Event|0|||
147108980|NCT03765073|530563821|FG015|Stage 3|Adverse Event|0|||
147108981|NCT03765073|530563822|FG016|Stage 3|Adverse Event|0|||
147108982|NCT03765073|530563823|FG017|Stage 3|Adverse Event|0|||
147108983|NCT03765073|530563824|FG018|Stage 3|Adverse Event|1|||
147108984|NCT03765073|530563825|FG019|Stage 3|Adverse Event|0|||
147108985|NCT03765073|530563826|FG020|Stage 3|Adverse Event|0|||
147108986|NCT03765073|530563806|FG000|Stage 3|Death|0|||
147108987|NCT03765073|530563807|FG001|Stage 3|Death|0|||
147108988|NCT03765073|530563808|FG002|Stage 3|Death|0|||
147108989|NCT03765073|530563809|FG003|Stage 3|Death|0|||
147108990|NCT03765073|530563810|FG004|Stage 3|Death|0|||
147108991|NCT03765073|530563811|FG005|Stage 3|Death|0|||
147108992|NCT03765073|530563812|FG006|Stage 3|Death|0|||
147108993|NCT03765073|530563813|FG007|Stage 3|Death|0|||
147108994|NCT03765073|530563814|FG008|Stage 3|Death|0|||
147108995|NCT03765073|530563815|FG009|Stage 3|Death|0|||
147108996|NCT03765073|530563816|FG010|Stage 3|Death|0|||
147108997|NCT03765073|530563817|FG011|Stage 3|Death|0|||
147108998|NCT03765073|530563818|FG012|Stage 3|Death|0|||
147108999|NCT03765073|530563819|FG013|Stage 3|Death|0|||
147109000|NCT03765073|530563820|FG014|Stage 3|Death|0|||
147109001|NCT03765073|530563821|FG015|Stage 3|Death|0|||
147109002|NCT03765073|530563822|FG016|Stage 3|Death|0|||
147109003|NCT03765073|530563823|FG017|Stage 3|Death|0|||
147109004|NCT03765073|530563824|FG018|Stage 3|Death|0|||
147109005|NCT03765073|530563825|FG019|Stage 3|Death|3|||
147109006|NCT03765073|530563826|FG020|Stage 3|Death|2|||
147109007|NCT03765073|530563806|FG000|Stage 3|Lost to Follow-up|0|||
147109008|NCT03765073|530563807|FG001|Stage 3|Lost to Follow-up|0|||
147109009|NCT03765073|530563808|FG002|Stage 3|Lost to Follow-up|0|||
147109010|NCT03765073|530563809|FG003|Stage 3|Lost to Follow-up|0|||
147109011|NCT03765073|530563810|FG004|Stage 3|Lost to Follow-up|0|||
147109012|NCT03765073|530563811|FG005|Stage 3|Lost to Follow-up|0|||
147109013|NCT03765073|530563812|FG006|Stage 3|Lost to Follow-up|0|||
147109014|NCT03765073|530563813|FG007|Stage 3|Lost to Follow-up|0|||
147109015|NCT03765073|530563814|FG008|Stage 3|Lost to Follow-up|0|||
147109016|NCT03765073|530563815|FG009|Stage 3|Lost to Follow-up|0|||
147109017|NCT03765073|530563816|FG010|Stage 3|Lost to Follow-up|0|||
147109018|NCT03765073|530563817|FG011|Stage 3|Lost to Follow-up|0|||
147109019|NCT03765073|530563818|FG012|Stage 3|Lost to Follow-up|0|||
147109020|NCT03765073|530563819|FG013|Stage 3|Lost to Follow-up|0|||
147109021|NCT03765073|530563820|FG014|Stage 3|Lost to Follow-up|0|||
147109022|NCT03765073|530563821|FG015|Stage 3|Lost to Follow-up|0|||
147109023|NCT03765073|530563822|FG016|Stage 3|Lost to Follow-up|0|||
147109024|NCT03765073|530563823|FG017|Stage 3|Lost to Follow-up|8|||
147558856|NCT01957488|532203896|FG002|Test Period 1 (2 Weeks)|Adverse Event|1|||
147558857|NCT01957488|532203897|FG003|Test Period 1 (2 Weeks)|Adverse Event|0|||
147109025|NCT03765073|530563824|FG018|Stage 3|Lost to Follow-up|5|||
147109026|NCT03765073|530563825|FG019|Stage 3|Lost to Follow-up|7|||
147109027|NCT03765073|530563826|FG020|Stage 3|Lost to Follow-up|4|||
147109028|NCT03765073|530563806|FG000|Stage 3|No longer meets eligibility criteria|0|||
147109029|NCT03765073|530563807|FG001|Stage 3|No longer meets eligibility criteria|0|||
147109030|NCT03765073|530563808|FG002|Stage 3|No longer meets eligibility criteria|0|||
147109031|NCT03765073|530563809|FG003|Stage 3|No longer meets eligibility criteria|0|||
147109032|NCT03765073|530563810|FG004|Stage 3|No longer meets eligibility criteria|0|||
147109033|NCT03765073|530563811|FG005|Stage 3|No longer meets eligibility criteria|0|||
147109034|NCT03765073|530563812|FG006|Stage 3|No longer meets eligibility criteria|0|||
147109035|NCT03765073|530563813|FG007|Stage 3|No longer meets eligibility criteria|0|||
147109036|NCT03765073|530563814|FG008|Stage 3|No longer meets eligibility criteria|0|||
147109037|NCT03765073|530563815|FG009|Stage 3|No longer meets eligibility criteria|0|||
147109038|NCT03765073|530563816|FG010|Stage 3|No longer meets eligibility criteria|0|||
147109039|NCT03765073|530563817|FG011|Stage 3|No longer meets eligibility criteria|0|||
147109040|NCT03765073|530563818|FG012|Stage 3|No longer meets eligibility criteria|0|||
147109041|NCT03765073|530563819|FG013|Stage 3|No longer meets eligibility criteria|0|||
147109042|NCT03765073|530563820|FG014|Stage 3|No longer meets eligibility criteria|0|||
147109043|NCT03765073|530563821|FG015|Stage 3|No longer meets eligibility criteria|0|||
147109044|NCT03765073|530563822|FG016|Stage 3|No longer meets eligibility criteria|0|||
147109045|NCT03765073|530563823|FG017|Stage 3|No longer meets eligibility criteria|0|||
147109046|NCT03765073|530563824|FG018|Stage 3|No longer meets eligibility criteria|1|||
147109047|NCT03765073|530563825|FG019|Stage 3|No longer meets eligibility criteria|0|||
147109048|NCT03765073|530563826|FG020|Stage 3|No longer meets eligibility criteria|1|||
147558858|NCT01957488|532203898|FG004|Test Period 1 (2 Weeks)|Adverse Event|1|||
147558859|NCT01957488|532203899|FG005|Test Period 1 (2 Weeks)|Adverse Event|0|||
147558860|NCT01957488|532203894|FG000|Test Period 1 (2 Weeks)|Withdrawal by Subject|0|||
147558861|NCT01957488|532203895|FG001|Test Period 1 (2 Weeks)|Withdrawal by Subject|0|||
147558862|NCT01957488|532203896|FG002|Test Period 1 (2 Weeks)|Withdrawal by Subject|0|||
147558863|NCT01957488|532203897|FG003|Test Period 1 (2 Weeks)|Withdrawal by Subject|1|||
147558864|NCT01957488|532203898|FG004|Test Period 1 (2 Weeks)|Withdrawal by Subject|1|||
147558865|NCT01957488|532203899|FG005|Test Period 1 (2 Weeks)|Withdrawal by Subject|2|||
147558866|NCT01957488|532203894|FG000|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0|||
147558867|NCT01957488|532203895|FG001|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0|||
147558868|NCT01957488|532203896|FG002|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0|||
147558869|NCT01957488|532203897|FG003|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0|||
147558870|NCT01957488|532203898|FG004|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|1|||
147558871|NCT01957488|532203899|FG005|Test Period 1 (2 Weeks)|subject did not want to wait for cut bag|0|||
147558872|NCT01957488|532203894|FG000|Test Period 1 (2 Weeks)|screen failure|0|||
147558873|NCT01957488|532203895|FG001|Test Period 1 (2 Weeks)|screen failure|0|||
147558874|NCT01957488|532203896|FG002|Test Period 1 (2 Weeks)|screen failure|0|||
147558875|NCT01957488|532203897|FG003|Test Period 1 (2 Weeks)|screen failure|0|||
147558876|NCT01957488|532203898|FG004|Test Period 1 (2 Weeks)|screen failure|0|||
147558877|NCT01957488|532203899|FG005|Test Period 1 (2 Weeks)|screen failure|1|||
147558878|NCT01957488|532203894|FG000|Test Period 2 (2 Weeks)|Protocol Violation|2|||
147558879|NCT01957488|532203895|FG001|Test Period 2 (2 Weeks)|Protocol Violation|0|||
147558880|NCT01957488|532203896|FG002|Test Period 2 (2 Weeks)|Protocol Violation|1|||
147558881|NCT01957488|532203897|FG003|Test Period 2 (2 Weeks)|Protocol Violation|1|||
147558882|NCT01957488|532203898|FG004|Test Period 2 (2 Weeks)|Protocol Violation|0|||
147558883|NCT01957488|532203899|FG005|Test Period 2 (2 Weeks)|Protocol Violation|0|||
147558884|NCT01957488|532203894|FG000|Test Period 2 (2 Weeks)|Other|1|||
147558885|NCT01957488|532203895|FG001|Test Period 2 (2 Weeks)|Other|0|||
147558886|NCT01957488|532203896|FG002|Test Period 2 (2 Weeks)|Other|0|||
147558887|NCT01957488|532203897|FG003|Test Period 2 (2 Weeks)|Other|0|||
147558888|NCT01957488|532203898|FG004|Test Period 2 (2 Weeks)|Other|0|||
147558889|NCT01957488|532203899|FG005|Test Period 2 (2 Weeks)|Other|0|||
147558890|NCT01957488|532203894|FG000|Test Period 2 (2 Weeks)|Withdrawal by Subject|0|||
147558891|NCT01957488|532203895|FG001|Test Period 2 (2 Weeks)|Withdrawal by Subject|1|||
147558892|NCT01957488|532203896|FG002|Test Period 2 (2 Weeks)|Withdrawal by Subject|0|||
147558893|NCT01957488|532203897|FG003|Test Period 2 (2 Weeks)|Withdrawal by Subject|0|||
147558894|NCT01957488|532203898|FG004|Test Period 2 (2 Weeks)|Withdrawal by Subject|0|||
147558895|NCT01957488|532203899|FG005|Test Period 2 (2 Weeks)|Withdrawal by Subject|0|||
147558896|NCT01957488|532203894|FG000|Test Period 2 (2 Weeks)|Adverse Event|0|||
147558897|NCT01957488|532203895|FG001|Test Period 2 (2 Weeks)|Adverse Event|0|||
147558898|NCT01957488|532203896|FG002|Test Period 2 (2 Weeks)|Adverse Event|0|||
147558899|NCT01957488|532203897|FG003|Test Period 2 (2 Weeks)|Adverse Event|0|||
147558900|NCT01957488|532203898|FG004|Test Period 2 (2 Weeks)|Adverse Event|2|||
147558901|NCT01957488|532203899|FG005|Test Period 2 (2 Weeks)|Adverse Event|0|||
147558902|NCT01957488|532203894|FG000|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0|||
147558903|NCT01957488|532203895|FG001|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0|||
147558904|NCT01957488|532203896|FG002|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0|||
147558905|NCT01957488|532203897|FG003|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0|||
147558906|NCT01957488|532203898|FG004|Test Period 2 (2 Weeks)|Discontinue due to personal problems|0|||
147558907|NCT01957488|532203899|FG005|Test Period 2 (2 Weeks)|Discontinue due to personal problems|1|||
147558908|NCT01957488|532203894|FG000|Test Period 3 (2 Weeks)|Withdrawal by Subject|1|||
147558909|NCT01957488|532203895|FG001|Test Period 3 (2 Weeks)|Withdrawal by Subject|0|||
147558910|NCT01957488|532203896|FG002|Test Period 3 (2 Weeks)|Withdrawal by Subject|0|||
147558911|NCT01957488|532203897|FG003|Test Period 3 (2 Weeks)|Withdrawal by Subject|0|||
147558912|NCT01957488|532203898|FG004|Test Period 3 (2 Weeks)|Withdrawal by Subject|0|||
147558913|NCT01957488|532203899|FG005|Test Period 3 (2 Weeks)|Withdrawal by Subject|0|||
147558914|NCT01957488|532203894|FG000|Test Period 3 (2 Weeks)|Lack of Efficacy|0|||
147558915|NCT01957488|532203895|FG001|Test Period 3 (2 Weeks)|Lack of Efficacy|1|||
147558916|NCT01957488|532203896|FG002|Test Period 3 (2 Weeks)|Lack of Efficacy|0|||
147558917|NCT01957488|532203897|FG003|Test Period 3 (2 Weeks)|Lack of Efficacy|0|||
147558918|NCT01957488|532203898|FG004|Test Period 3 (2 Weeks)|Lack of Efficacy|0|||
147558919|NCT01957488|532203899|FG005|Test Period 3 (2 Weeks)|Lack of Efficacy|0|||
147109049|NCT03765073|530563806|FG000|Stage 3|Other|0|||
147109050|NCT03765073|530563807|FG001|Stage 3|Other|0|||
147109051|NCT03765073|530563808|FG002|Stage 3|Other|0|||
147109052|NCT03765073|530563809|FG003|Stage 3|Other|0|||
147109053|NCT03765073|530563810|FG004|Stage 3|Other|0|||
147109054|NCT03765073|530563811|FG005|Stage 3|Other|0|||
147109055|NCT03765073|530563812|FG006|Stage 3|Other|0|||
147109056|NCT03765073|530563813|FG007|Stage 3|Other|0|||
147109057|NCT03765073|530563814|FG008|Stage 3|Other|0|||
147109058|NCT03765073|530563815|FG009|Stage 3|Other|0|||
147109059|NCT03765073|530563816|FG010|Stage 3|Other|0|||
147109060|NCT03765073|530563817|FG011|Stage 3|Other|0|||
147109061|NCT03765073|530563818|FG012|Stage 3|Other|0|||
147109062|NCT03765073|530563819|FG013|Stage 3|Other|0|||
147109063|NCT03765073|530563820|FG014|Stage 3|Other|0|||
147109064|NCT03765073|530563821|FG015|Stage 3|Other|0|||
147109065|NCT03765073|530563822|FG016|Stage 3|Other|0|||
147109066|NCT03765073|530563823|FG017|Stage 3|Other|1|||
147109067|NCT03765073|530563824|FG018|Stage 3|Other|2|||
147109068|NCT03765073|530563825|FG019|Stage 3|Other|2|||
147109069|NCT03765073|530563826|FG020|Stage 3|Other|2|||
147109070|NCT03765073|530563806|FG000|Stage 3|Withdrawal by parent/guardian|0|||
147109071|NCT03765073|530563807|FG001|Stage 3|Withdrawal by parent/guardian|0|||
147109072|NCT03765073|530563808|FG002|Stage 3|Withdrawal by parent/guardian|0|||
147109073|NCT03765073|530563809|FG003|Stage 3|Withdrawal by parent/guardian|0|||
147109074|NCT03765073|530563810|FG004|Stage 3|Withdrawal by parent/guardian|0|||
147109075|NCT03765073|530563811|FG005|Stage 3|Withdrawal by parent/guardian|0|||
147109076|NCT03765073|530563812|FG006|Stage 3|Withdrawal by parent/guardian|0|||
147109077|NCT03765073|530563813|FG007|Stage 3|Withdrawal by parent/guardian|0|||
147109078|NCT03765073|530563814|FG008|Stage 3|Withdrawal by parent/guardian|0|||
147109079|NCT03765073|530563815|FG009|Stage 3|Withdrawal by parent/guardian|0|||
147109080|NCT03765073|530563816|FG010|Stage 3|Withdrawal by parent/guardian|0|||
147109081|NCT03765073|530563817|FG011|Stage 3|Withdrawal by parent/guardian|0|||
147109082|NCT03765073|530563818|FG012|Stage 3|Withdrawal by parent/guardian|0|||
147109083|NCT03765073|530563819|FG013|Stage 3|Withdrawal by parent/guardian|0|||
147109084|NCT03765073|530563820|FG014|Stage 3|Withdrawal by parent/guardian|0|||
147109085|NCT03765073|530563821|FG015|Stage 3|Withdrawal by parent/guardian|0|||
147109086|NCT03765073|530563822|FG016|Stage 3|Withdrawal by parent/guardian|0|||
147109087|NCT03765073|530563823|FG017|Stage 3|Withdrawal by parent/guardian|0|||
147109088|NCT03765073|530563824|FG018|Stage 3|Withdrawal by parent/guardian|0|||
147109089|NCT03765073|530563825|FG019|Stage 3|Withdrawal by parent/guardian|6|||
147109090|NCT03765073|530563826|FG020|Stage 3|Withdrawal by parent/guardian|9|||
147109091|NCT03765073|530563806|FG000|Stage 3|Withdrawal by Subject|0|||
147109092|NCT03765073|530563807|FG001|Stage 3|Withdrawal by Subject|0|||
147109093|NCT03765073|530563808|FG002|Stage 3|Withdrawal by Subject|0|||
147109094|NCT03765073|530563809|FG003|Stage 3|Withdrawal by Subject|0|||
147109095|NCT03765073|530563810|FG004|Stage 3|Withdrawal by Subject|0|||
147109096|NCT03765073|530563811|FG005|Stage 3|Withdrawal by Subject|0|||
147109097|NCT03765073|530563812|FG006|Stage 3|Withdrawal by Subject|0|||
147109098|NCT03765073|530563813|FG007|Stage 3|Withdrawal by Subject|0|||
147109099|NCT03765073|530563814|FG008|Stage 3|Withdrawal by Subject|0|||
147109100|NCT03765073|530563815|FG009|Stage 3|Withdrawal by Subject|0|||
147109101|NCT03765073|530563816|FG010|Stage 3|Withdrawal by Subject|0|||
147109102|NCT03765073|530563817|FG011|Stage 3|Withdrawal by Subject|0|||
147109103|NCT03765073|530563818|FG012|Stage 3|Withdrawal by Subject|0|||
147109104|NCT03765073|530563819|FG013|Stage 3|Withdrawal by Subject|0|||
147109105|NCT03765073|530563820|FG014|Stage 3|Withdrawal by Subject|0|||
147109106|NCT03765073|530563821|FG015|Stage 3|Withdrawal by Subject|0|||
147109107|NCT03765073|530563822|FG016|Stage 3|Withdrawal by Subject|0|||
147109108|NCT03765073|530563823|FG017|Stage 3|Withdrawal by Subject|8|||
147109109|NCT03765073|530563824|FG018|Stage 3|Withdrawal by Subject|11|||
147109110|NCT03765073|530563825|FG019|Stage 3|Withdrawal by Subject|0|||
147109111|NCT03765073|530563826|FG020|Stage 3|Withdrawal by Subject|0|||
147109112|NCT03188822|530563834|FG000|Overall Study|Subjects chose not to attend the SOC 12 month follow up visit|6|||
147109113|NCT03188822|530563834|FG000|Overall Study|Clinic was closed due to COVID-19 for 12 month follow up visit|1|||
147109114|NCT04537299|530563835|FG000|Overall Study|Withdrawal by Subject|2|||
147109115|NCT04537299|530563836|FG001|Overall Study|Withdrawal by Subject|0|||
147109116|NCT04537299|530563835|FG000|Overall Study|Protocol Violation|1|||
147109117|NCT04537299|530563836|FG001|Overall Study|Protocol Violation|1|||
147109118|NCT03034967|530563841|FG000|Overall Study|Withdrawal by Subject|9|||
147109119|NCT03034967|530563842|FG001|Overall Study|Withdrawal by Subject|2|||
147109120|NCT03034967|530563843|FG002|Overall Study|Withdrawal by Subject|6|||
147444159|NCT00075400|531792505|FG000|Overall Study|Never treated|2|||
147109121|NCT03034967|530563844|FG003|Overall Study|Withdrawal by Subject|6|||
147109122|NCT03034967|530563845|FG004|Overall Study|Withdrawal by Subject|9|||
147109123|NCT03034967|530563846|FG005|Overall Study|Withdrawal by Subject|2|||
147109124|NCT03034967|530563841|FG000|Overall Study|Physician Decision|1|||
147109125|NCT03034967|530563842|FG001|Overall Study|Physician Decision|0|||
147109126|NCT03034967|530563843|FG002|Overall Study|Physician Decision|1|||
147109127|NCT03034967|530563844|FG003|Overall Study|Physician Decision|1|||
147109128|NCT03034967|530563845|FG004|Overall Study|Physician Decision|1|||
147109129|NCT03034967|530563846|FG005|Overall Study|Physician Decision|0|||
147109130|NCT03034967|530563841|FG000|Overall Study|Lost to Follow-up|0|||
147109131|NCT03034967|530563842|FG001|Overall Study|Lost to Follow-up|0|||
147109132|NCT03034967|530563843|FG002|Overall Study|Lost to Follow-up|0|||
147109133|NCT03034967|530563844|FG003|Overall Study|Lost to Follow-up|1|||
147109134|NCT03034967|530563845|FG004|Overall Study|Lost to Follow-up|0|||
147109135|NCT03034967|530563846|FG005|Overall Study|Lost to Follow-up|2|||
147109136|NCT03034967|530563841|FG000|Overall Study|Liver function test abnormality|0|||
147109137|NCT03034967|530563842|FG001|Overall Study|Liver function test abnormality|0|||
147109138|NCT03034967|530563843|FG002|Overall Study|Liver function test abnormality|1|||
147109139|NCT03034967|530563844|FG003|Overall Study|Liver function test abnormality|0|||
147109140|NCT03034967|530563845|FG004|Overall Study|Liver function test abnormality|0|||
147109141|NCT03034967|530563846|FG005|Overall Study|Liver function test abnormality|0|||
147109142|NCT03034967|530563841|FG000|Overall Study|Protocol Violation|1|||
147109143|NCT03034967|530563842|FG001|Overall Study|Protocol Violation|0|||
147109144|NCT03034967|530563843|FG002|Overall Study|Protocol Violation|0|||
147109145|NCT03034967|530563844|FG003|Overall Study|Protocol Violation|0|||
147109146|NCT03034967|530563845|FG004|Overall Study|Protocol Violation|0|||
147109147|NCT03034967|530563846|FG005|Overall Study|Protocol Violation|2|||
147109148|NCT03034967|530563841|FG000|Overall Study|Lack of Efficacy|0|||
147109149|NCT03034967|530563842|FG001|Overall Study|Lack of Efficacy|1|||
147109150|NCT03034967|530563843|FG002|Overall Study|Lack of Efficacy|2|||
147109151|NCT03034967|530563844|FG003|Overall Study|Lack of Efficacy|1|||
147109152|NCT03034967|530563845|FG004|Overall Study|Lack of Efficacy|1|||
147109153|NCT03034967|530563846|FG005|Overall Study|Lack of Efficacy|0|||
147109154|NCT03034967|530563841|FG000|Overall Study|Adverse Event, non-fatal|3|||
147109155|NCT03034967|530563842|FG001|Overall Study|Adverse Event, non-fatal|1|||
147109156|NCT03034967|530563843|FG002|Overall Study|Adverse Event, non-fatal|2|||
147109157|NCT03034967|530563844|FG003|Overall Study|Adverse Event, non-fatal|0|||
147109158|NCT03034967|530563845|FG004|Overall Study|Adverse Event, non-fatal|2|||
147109159|NCT03034967|530563846|FG005|Overall Study|Adverse Event, non-fatal|8|||
147109160|NCT03034967|530563841|FG000|Overall Study|Adverse Event, Serious Fatal|0|||
147109161|NCT03034967|530563842|FG001|Overall Study|Adverse Event, Serious Fatal|1|||
147109162|NCT03034967|530563843|FG002|Overall Study|Adverse Event, Serious Fatal|1|||
147558920|NCT00721409|532203900|FG000|Overall Study|Global deterioration of health status|2|||
147558921|NCT00721409|532203901|FG001|Overall Study|Global deterioration of health status|6|||
147109163|NCT03034967|530563844|FG003|Overall Study|Adverse Event, Serious Fatal|2|||
147109164|NCT03034967|530563845|FG004|Overall Study|Adverse Event, Serious Fatal|1|||
147109165|NCT03034967|530563846|FG005|Overall Study|Adverse Event, Serious Fatal|1|||
147109166|NCT03806296|530563847|FG000|T1: Laboratory: 1 Week|Withdrawal by Subject|6|||
147109167|NCT03806296|530563848|FG001|T1: Laboratory: 1 Week|Withdrawal by Subject|1|||
147109168|NCT03806296|530563849|FG002|T1: Laboratory: 1 Week|Withdrawal by Subject|3|||
147109169|NCT03806296|530563847|FG000|T1: Laboratory: 1 Week|Lost to Follow-up|7|||
147109170|NCT03806296|530563848|FG001|T1: Laboratory: 1 Week|Lost to Follow-up|1|||
147109171|NCT03806296|530563849|FG002|T1: Laboratory: 1 Week|Lost to Follow-up|1|||
147109172|NCT03806296|530563847|FG000|T1: Laboratory: 1 Week|Investigator withdrawn due to ineligibility learned post-enrollment.|1|||
147109173|NCT03806296|530563848|FG001|T1: Laboratory: 1 Week|Investigator withdrawn due to ineligibility learned post-enrollment.|0|||
147109174|NCT03806296|530563849|FG002|T1: Laboratory: 1 Week|Investigator withdrawn due to ineligibility learned post-enrollment.|0|||
147109175|NCT02550795|530563868|FG000|Overall Study|Physician Decision|0|||
147109176|NCT02550795|530563869|FG001|Overall Study|Physician Decision|1|||
147109177|NCT02550795|530563870|FG002|Overall Study|Physician Decision|0|||
147109178|NCT02802228|530563871|FG000|Overall Study|Withdrawal by Subject|2|||
147109179|NCT02802228|530563872|FG001|Overall Study|Withdrawal by Subject|0|||
147109180|NCT02802228|530563871|FG000|Overall Study|Lost to Follow-up|1|||
147109181|NCT02802228|530563872|FG001|Overall Study|Lost to Follow-up|0|||
147109182|NCT02802228|530563871|FG000|Overall Study|Adverse Event|1|||
147109183|NCT02802228|530563872|FG001|Overall Study|Adverse Event|0|||
147109184|NCT02802228|530563871|FG000|Overall Study|Physician Decision|1|||
147109185|NCT02802228|530563872|FG001|Overall Study|Physician Decision|0|||
147109186|NCT00695019|530563875|FG000|Overall Study|Withdrawal by Subject|8|||
147109187|NCT00695019|530563876|FG001|Overall Study|Withdrawal by Subject|6|||
147109188|NCT00695019|530563877|FG002|Overall Study|Withdrawal by Subject|4|||
147109189|NCT00695019|530563875|FG000|Overall Study|Protocol Violation|1|||
147109190|NCT00695019|530563876|FG001|Overall Study|Protocol Violation|3|||
147109191|NCT00695019|530563877|FG002|Overall Study|Protocol Violation|1|||
147109192|NCT00695019|530563875|FG000|Overall Study|Lack of Efficacy|0|||
147109193|NCT00695019|530563876|FG001|Overall Study|Lack of Efficacy|0|||
147109194|NCT00695019|530563877|FG002|Overall Study|Lack of Efficacy|1|||
147109195|NCT00695019|530563875|FG000|Overall Study|Various|4|||
147109196|NCT00695019|530563876|FG001|Overall Study|Various|5|||
147109197|NCT00695019|530563877|FG002|Overall Study|Various|4|||
147558922|NCT00721409|532203902|FG002|Overall Study|Global deterioration of health status|3|||
147109198|NCT02763566|530563878|FG000|Overall Study|Lost to Follow-up|1|||
147109199|NCT02763566|530563879|FG001|Overall Study|Lost to Follow-up|4|||
147558923|NCT00721409|532203900|FG000|Overall Study|Death|0|||
147558924|NCT00721409|532203901|FG001|Overall Study|Death|1|||
147558925|NCT00721409|532203902|FG002|Overall Study|Death|0|||
147109200|NCT02763566|530563880|FG002|Overall Study|Lost to Follow-up|0|||
147109201|NCT02763566|530563881|FG003|Overall Study|Lost to Follow-up|1|||
147109202|NCT02763566|530563878|FG000|Overall Study|On study treatment at study conclusion|114|||
147109203|NCT02763566|530563879|FG001|Overall Study|On study treatment at study conclusion|34|||
147109204|NCT02763566|530563880|FG002|Overall Study|On study treatment at study conclusion|54|||
147558926|NCT00721409|532203900|FG000|Overall Study|Randomized not Treated|0|||
147558927|NCT00721409|532203901|FG001|Overall Study|Randomized not Treated|1|||
147109205|NCT02763566|530563881|FG003|Overall Study|On study treatment at study conclusion|13|||
147109206|NCT02763566|530563878|FG000|Overall Study|Withdrawal by Subject|3|||
147109207|NCT02763566|530563879|FG001|Overall Study|Withdrawal by Subject|1|||
147109208|NCT02763566|530563880|FG002|Overall Study|Withdrawal by Subject|0|||
147109209|NCT02763566|530563881|FG003|Overall Study|Withdrawal by Subject|0|||
147109210|NCT04896385|530563882|FG000|24-Week Double-Blind Period|Lost to Follow-up|2|||
147109211|NCT04896385|530563883|FG001|24-Week Double-Blind Period|Lost to Follow-up|3|||
147109212|NCT04896385|530563884|FG002|24-Week Double-Blind Period|Lost to Follow-up|0|||
147109213|NCT04896385|530563885|FG003|24-Week Double-Blind Period|Lost to Follow-up|0|||
147109214|NCT04896385|530563882|FG000|24-Week Double-Blind Period|Withdrawal by Subject|2|||
147109215|NCT04896385|530563883|FG001|24-Week Double-Blind Period|Withdrawal by Subject|2|||
147109216|NCT04896385|530563884|FG002|24-Week Double-Blind Period|Withdrawal by Subject|0|||
147109217|NCT04896385|530563885|FG003|24-Week Double-Blind Period|Withdrawal by Subject|0|||
147109218|NCT04896385|530563882|FG000|28-Week Treatment-Extension Period|Lost to Follow-up|0|||
147109219|NCT04896385|530563883|FG001|28-Week Treatment-Extension Period|Lost to Follow-up|0|||
147109220|NCT04896385|530563884|FG002|28-Week Treatment-Extension Period|Lost to Follow-up|5|||
147109221|NCT04896385|530563885|FG003|28-Week Treatment-Extension Period|Lost to Follow-up|2|||
147109222|NCT04896385|530563882|FG000|28-Week Treatment-Extension Period|Withdrawal by Subject|0|||
147109223|NCT04896385|530563883|FG001|28-Week Treatment-Extension Period|Withdrawal by Subject|0|||
147109224|NCT04896385|530563884|FG002|28-Week Treatment-Extension Period|Withdrawal by Subject|1|||
147109225|NCT04896385|530563885|FG003|28-Week Treatment-Extension Period|Withdrawal by Subject|1|||
147109226|NCT04896385|530563882|FG000|28-Week Treatment-Extension Period|Participant Refused Safety Follow-up|0|||
147109227|NCT04896385|530563883|FG001|28-Week Treatment-Extension Period|Participant Refused Safety Follow-up|0|||
147109228|NCT04896385|530563884|FG002|28-Week Treatment-Extension Period|Participant Refused Safety Follow-up|3|||
147109229|NCT04896385|530563885|FG003|28-Week Treatment-Extension Period|Participant Refused Safety Follow-up|2|||
147109230|NCT04896385|530563882|FG000|28-Week Treatment-Extension Period|Pregnancy|0|||
147109231|NCT04896385|530563883|FG001|28-Week Treatment-Extension Period|Pregnancy|0|||
147109232|NCT04896385|530563884|FG002|28-Week Treatment-Extension Period|Pregnancy|1|||
147109233|NCT04896385|530563885|FG003|28-Week Treatment-Extension Period|Pregnancy|0|||
147109234|NCT01925794|530563887|FG000|180 Days|Death|2|||
147109235|NCT01925794|530563887|FG000|180 Days|Withdrawal by Subject|2|||
147109236|NCT01925794|530563887|FG000|270 Days|Death|2|||
147109237|NCT01925794|530563887|FG000|270 Days|Protocol Violation|3|||
147109238|NCT01901562|530563888|FG000|Overall Study|Protocol Violation|5|||
147109239|NCT01901562|530563888|FG000|Overall Study|Excluded intraoperatively|4|||
147109240|NCT00790036|530563889|FG000|Overall Study|Abnormal lab values|3|||
147109241|NCT00790036|530563890|FG001|Overall Study|Abnormal lab values|2|||
147109242|NCT00790036|530563889|FG000|Overall Study|Administrative problems|5|||
147109243|NCT00790036|530563890|FG001|Overall Study|Administrative problems|9|||
147109244|NCT00790036|530563889|FG000|Overall Study|Adverse Event|113|||
147109245|NCT00790036|530563890|FG001|Overall Study|Adverse Event|44|||
147109246|NCT00790036|530563889|FG000|Overall Study|Death|1|||
147109247|NCT00790036|530563890|FG001|Overall Study|Death|0|||
147109248|NCT00790036|530563889|FG000|Overall Study|Disease progression|24|||
147109249|NCT00790036|530563890|FG001|Overall Study|Disease progression|48|||
147109250|NCT00790036|530563889|FG000|Overall Study|Lost to Follow-up|1|||
147109251|NCT00790036|530563890|FG001|Overall Study|Lost to Follow-up|2|||
147109252|NCT00790036|530563889|FG000|Overall Study|Protocol Violation|10|||
147109253|NCT00790036|530563890|FG001|Overall Study|Protocol Violation|2|||
147109254|NCT00790036|530563889|FG000|Overall Study|Withdrawal by Subject|18|||
147109255|NCT00790036|530563890|FG001|Overall Study|Withdrawal by Subject|7|||
147109256|NCT00790036|530563889|FG000|Overall Study|Subject/guardian decision|20|||
147109257|NCT00790036|530563890|FG001|Overall Study|Subject/guardian decision|7|||
147310884|NCT00384059|531305146|FG000|After Infant Series|Failed to Return|0|||
147558928|NCT00721409|532203902|FG002|Overall Study|Randomized not Treated|4|||
147558929|NCT00721409|532203900|FG000|Overall Study|Reason not specified|1|||
147558930|NCT00721409|532203901|FG001|Overall Study|Reason not specified|0|||
147558931|NCT00721409|532203902|FG002|Overall Study|Reason not specified|2|||
147558932|NCT00721409|532203900|FG000|Overall Study|Adverse Event|0|||
147558933|NCT00721409|532203901|FG001|Overall Study|Adverse Event|13|||
147558934|NCT00721409|532203902|FG002|Overall Study|Adverse Event|2|||
147558935|NCT00721409|532203900|FG000|Overall Study|Lost to Follow-up|0|||
147558936|NCT00721409|532203901|FG001|Overall Study|Lost to Follow-up|0|||
147558937|NCT00721409|532203902|FG002|Overall Study|Lost to Follow-up|1|||
147109258|NCT02612155|530563891|FG000|Overall Study|Death|1|||
147109259|NCT02612155|530563892|FG001|Overall Study|Death|1|||
147109260|NCT02612155|530563891|FG000|Overall Study|Lost to Follow-up|2|||
147109261|NCT02612155|530563892|FG001|Overall Study|Lost to Follow-up|2|||
147109262|NCT03197129|530563893|FG000|Overall Study|did not answer the VPT: shyness|4|||
147109263|NCT03197129|530563894|FG001|Overall Study|did not answer the VPT: shyness|5|||
147109264|NCT02442349|530563898|FG000|Overall Study|Death|95|||
147109265|NCT02442349|530563898|FG000|Overall Study|Withdrawal by Subject|27|||
147109266|NCT02442349|530563898|FG000|Overall Study|poor compliance after treatment discontinuation|2|||
147109267|NCT02442349|530563898|FG000|Overall Study|Lost to Follow-up|1|||
147310885|NCT00384059|531305147|FG001|After Infant Series|Failed to Return|2|||
147310886|NCT00384059|531305146|FG000|After Infant Series|Adverse Event|0|||
147310887|NCT00384059|531305147|FG001|After Infant Series|Adverse Event|1|||
147310888|NCT00384059|531305146|FG000|After Infant Series|Physician Decision|0|||
147310889|NCT00384059|531305147|FG001|After Infant Series|Physician Decision|1|||
147310890|NCT00384059|531305146|FG000|After Infant Series|Lost to Follow-up|0|||
147310891|NCT00384059|531305147|FG001|After Infant Series|Lost to Follow-up|1|||
147310892|NCT00384059|531305146|FG000|Toddler Dose|Lost to Follow-up|1|||
147310893|NCT00384059|531305147|FG001|Toddler Dose|Lost to Follow-up|1|||
147310894|NCT00384059|531305146|FG000|Toddler Dose|Failed to return|0|||
147310895|NCT00384059|531305147|FG001|Toddler Dose|Failed to return|1|||
147310896|NCT00381641|531305150|FG000|Overall Study|Withdrawal by Subject|0|||
147310897|NCT00381641|531305151|FG001|Overall Study|Withdrawal by Subject|2|||
147310898|NCT04921969|531305152|FG000|VC Period (Day 1 to Week 8)|Adverse Event|0|||
147310899|NCT04921969|531305153|FG001|VC Period (Day 1 to Week 8)|Adverse Event|1|||
147310900|NCT04921969|531305154|FG002|VC Period (Day 1 to Week 8)|Adverse Event|1|||
147310901|NCT04921969|531305155|FG003|VC Period (Day 1 to Week 8)|Adverse Event|0|||
147310902|NCT04921969|531305156|FG004|VC Period (Day 1 to Week 8)|Adverse Event|0|||
147310903|NCT04921969|531305157|FG005|VC Period (Day 1 to Week 8)|Adverse Event|0|||
147310904|NCT04921969|531305158|FG006|VC Period (Day 1 to Week 8)|Adverse Event|0|||
147310905|NCT04921969|531305152|FG000|VC Period (Day 1 to Week 8)|Lack of Efficacy|2|||
147310906|NCT04921969|531305153|FG001|VC Period (Day 1 to Week 8)|Lack of Efficacy|0|||
147310907|NCT04921969|531305154|FG002|VC Period (Day 1 to Week 8)|Lack of Efficacy|0|||
147310908|NCT04921969|531305155|FG003|VC Period (Day 1 to Week 8)|Lack of Efficacy|0|||
147310909|NCT04921969|531305156|FG004|VC Period (Day 1 to Week 8)|Lack of Efficacy|0|||
147310910|NCT04921969|531305157|FG005|VC Period (Day 1 to Week 8)|Lack of Efficacy|0|||
147310911|NCT04921969|531305158|FG006|VC Period (Day 1 to Week 8)|Lack of Efficacy|0|||
147310912|NCT04921969|531305152|FG000|VC Period (Day 1 to Week 8)|Lost to Follow-up|2|||
147310913|NCT04921969|531305153|FG001|VC Period (Day 1 to Week 8)|Lost to Follow-up|5|||
147310914|NCT04921969|531305154|FG002|VC Period (Day 1 to Week 8)|Lost to Follow-up|5|||
147310915|NCT04921969|531305155|FG003|VC Period (Day 1 to Week 8)|Lost to Follow-up|0|||
147310916|NCT04921969|531305156|FG004|VC Period (Day 1 to Week 8)|Lost to Follow-up|0|||
147310917|NCT04921969|531305157|FG005|VC Period (Day 1 to Week 8)|Lost to Follow-up|0|||
147310918|NCT04921969|531305158|FG006|VC Period (Day 1 to Week 8)|Lost to Follow-up|0|||
147310919|NCT04921969|531305152|FG000|VC Period (Day 1 to Week 8)|Physician Decision|0|||
147310920|NCT04921969|531305153|FG001|VC Period (Day 1 to Week 8)|Physician Decision|1|||
147310921|NCT04921969|531305154|FG002|VC Period (Day 1 to Week 8)|Physician Decision|1|||
147310922|NCT04921969|531305155|FG003|VC Period (Day 1 to Week 8)|Physician Decision|0|||
147310923|NCT04921969|531305156|FG004|VC Period (Day 1 to Week 8)|Physician Decision|0|||
147310924|NCT04921969|531305157|FG005|VC Period (Day 1 to Week 8)|Physician Decision|0|||
147310925|NCT04921969|531305158|FG006|VC Period (Day 1 to Week 8)|Physician Decision|0|||
147310926|NCT04921969|531305152|FG000|VC Period (Day 1 to Week 8)|Protocol Violation|0|||
147310927|NCT04921969|531305153|FG001|VC Period (Day 1 to Week 8)|Protocol Violation|0|||
147310928|NCT04921969|531305154|FG002|VC Period (Day 1 to Week 8)|Protocol Violation|1|||
147310929|NCT04921969|531305155|FG003|VC Period (Day 1 to Week 8)|Protocol Violation|0|||
147310930|NCT04921969|531305156|FG004|VC Period (Day 1 to Week 8)|Protocol Violation|0|||
147310931|NCT04921969|531305157|FG005|VC Period (Day 1 to Week 8)|Protocol Violation|0|||
147310932|NCT04921969|531305158|FG006|VC Period (Day 1 to Week 8)|Protocol Violation|0|||
147310933|NCT04921969|531305152|FG000|VC Period (Day 1 to Week 8)|Withdrawal by Subject|9|||
147310934|NCT04921969|531305153|FG001|VC Period (Day 1 to Week 8)|Withdrawal by Subject|5|||
147310935|NCT04921969|531305154|FG002|VC Period (Day 1 to Week 8)|Withdrawal by Subject|8|||
147310936|NCT04921969|531305155|FG003|VC Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
147310937|NCT04921969|531305156|FG004|VC Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
147310938|NCT04921969|531305157|FG005|VC Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
147310939|NCT04921969|531305158|FG006|VC Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
147310940|NCT04921969|531305152|FG000|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|3|||
147310941|NCT04921969|531305153|FG001|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|2|||
147310942|NCT04921969|531305154|FG002|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|0|||
147310943|NCT04921969|531305155|FG003|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|0|||
147310944|NCT04921969|531305156|FG004|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|0|||
147310945|NCT04921969|531305157|FG005|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|0|||
147310946|NCT04921969|531305158|FG006|VC Period (Day 1 to Week 8)|Protocol-specified Withdrawal Criterion Met|0|||
147310947|NCT04921969|531305152|FG000|LTS Period (Weeks 8 to 52)|Adverse Event|0|||
147310948|NCT04921969|531305153|FG001|LTS Period (Weeks 8 to 52)|Adverse Event|0|||
147310949|NCT04921969|531305154|FG002|LTS Period (Weeks 8 to 52)|Adverse Event|0|||
147310950|NCT04921969|531305155|FG003|LTS Period (Weeks 8 to 52)|Adverse Event|0|||
147310951|NCT04921969|531305156|FG004|LTS Period (Weeks 8 to 52)|Adverse Event|0|||
147310952|NCT04921969|531305157|FG005|LTS Period (Weeks 8 to 52)|Adverse Event|0|||
147310953|NCT04921969|531305158|FG006|LTS Period (Weeks 8 to 52)|Adverse Event|1|||
147310954|NCT04921969|531305152|FG000|LTS Period (Weeks 8 to 52)|Lack of Efficacy|0|||
147310955|NCT04921969|531305153|FG001|LTS Period (Weeks 8 to 52)|Lack of Efficacy|0|||
147109268|NCT03126110|530563899|FG000|Phase 1|Death|2|||
147109269|NCT03126110|530563900|FG001|Phase 1|Death|2|||
147109270|NCT03126110|530563901|FG002|Phase 1|Death|4|||
147109271|NCT03126110|530563902|FG003|Phase 1|Death|3|||
147109272|NCT03126110|530563903|FG004|Phase 1|Death|4|||
147109273|NCT03126110|530563904|FG005|Phase 1|Death|4|||
147109274|NCT03126110|530563905|FG006|Phase 1|Death|3|||
147109275|NCT03126110|530563906|FG007|Phase 1|Death|4|||
147109276|NCT03126110|530563907|FG008|Phase 1|Death|5|||
147109277|NCT03126110|530563908|FG009|Phase 1|Death|2|||
147109278|NCT03126110|530563909|FG010|Phase 1|Death|6|||
147109279|NCT03126110|530563910|FG011|Phase 1|Death|0|||
147109280|NCT03126110|530563911|FG012|Phase 1|Death|0|||
147109281|NCT03126110|530563912|FG013|Phase 1|Death|0|||
147109282|NCT03126110|530563913|FG014|Phase 1|Death|0|||
147109283|NCT03126110|530563914|FG015|Phase 1|Death|0|||
147109284|NCT03126110|530563915|FG016|Phase 1|Death|0|||
147109285|NCT03126110|530563899|FG000|Phase 1|Lost to Follow-up|0|||
147109286|NCT03126110|530563900|FG001|Phase 1|Lost to Follow-up|1|||
147109287|NCT03126110|530563901|FG002|Phase 1|Lost to Follow-up|0|||
147109288|NCT03126110|530563902|FG003|Phase 1|Lost to Follow-up|0|||
147109289|NCT03126110|530563903|FG004|Phase 1|Lost to Follow-up|0|||
147109290|NCT03126110|530563904|FG005|Phase 1|Lost to Follow-up|0|||
147109291|NCT03126110|530563905|FG006|Phase 1|Lost to Follow-up|0|||
147109292|NCT03126110|530563906|FG007|Phase 1|Lost to Follow-up|0|||
147109293|NCT03126110|530563907|FG008|Phase 1|Lost to Follow-up|1|||
147109294|NCT03126110|530563908|FG009|Phase 1|Lost to Follow-up|0|||
147109295|NCT03126110|530563909|FG010|Phase 1|Lost to Follow-up|0|||
147109296|NCT03126110|530563910|FG011|Phase 1|Lost to Follow-up|0|||
147109297|NCT03126110|530563911|FG012|Phase 1|Lost to Follow-up|0|||
147109298|NCT03126110|530563912|FG013|Phase 1|Lost to Follow-up|0|||
147109299|NCT03126110|530563913|FG014|Phase 1|Lost to Follow-up|0|||
147109300|NCT03126110|530563914|FG015|Phase 1|Lost to Follow-up|0|||
147109301|NCT03126110|530563915|FG016|Phase 1|Lost to Follow-up|0|||
147109302|NCT03126110|530563899|FG000|Phase 1|Withdrawal by Subject|1|||
147109303|NCT03126110|530563900|FG001|Phase 1|Withdrawal by Subject|0|||
147109304|NCT03126110|530563901|FG002|Phase 1|Withdrawal by Subject|0|||
147109305|NCT03126110|530563902|FG003|Phase 1|Withdrawal by Subject|1|||
147109306|NCT03126110|530563903|FG004|Phase 1|Withdrawal by Subject|1|||
147109307|NCT03126110|530563904|FG005|Phase 1|Withdrawal by Subject|0|||
147109308|NCT03126110|530563905|FG006|Phase 1|Withdrawal by Subject|0|||
147109309|NCT03126110|530563906|FG007|Phase 1|Withdrawal by Subject|0|||
147109310|NCT03126110|530563907|FG008|Phase 1|Withdrawal by Subject|2|||
147109311|NCT03126110|530563908|FG009|Phase 1|Withdrawal by Subject|1|||
147109312|NCT03126110|530563909|FG010|Phase 1|Withdrawal by Subject|0|||
147109313|NCT03126110|530563910|FG011|Phase 1|Withdrawal by Subject|0|||
147109314|NCT03126110|530563911|FG012|Phase 1|Withdrawal by Subject|0|||
147109315|NCT03126110|530563912|FG013|Phase 1|Withdrawal by Subject|0|||
147109316|NCT03126110|530563913|FG014|Phase 1|Withdrawal by Subject|0|||
147109317|NCT03126110|530563914|FG015|Phase 1|Withdrawal by Subject|0|||
147109318|NCT03126110|530563915|FG016|Phase 1|Withdrawal by Subject|0|||
147109319|NCT03126110|530563899|FG000|Phase 1|Safety follow-up no longer necessary|1|||
147109320|NCT03126110|530563900|FG001|Phase 1|Safety follow-up no longer necessary|0|||
147109321|NCT03126110|530563901|FG002|Phase 1|Safety follow-up no longer necessary|0|||
147109322|NCT03126110|530563902|FG003|Phase 1|Safety follow-up no longer necessary|0|||
147225597|NCT02273739|530998258|FG002|Overall Study|Withdrawal by Subject|2|||
147225598|NCT02273739|530998259|FG003|Overall Study|Withdrawal by Subject|1|||
147225599|NCT02273739|530998256|FG000|Overall Study|Physician Decision|0|||
147225600|NCT02273739|530998257|FG001|Overall Study|Physician Decision|0|||
147109323|NCT03126110|530563903|FG004|Phase 1|Safety follow-up no longer necessary|0|||
147109324|NCT03126110|530563904|FG005|Phase 1|Safety follow-up no longer necessary|0|||
147109325|NCT03126110|530563905|FG006|Phase 1|Safety follow-up no longer necessary|0|||
147109326|NCT03126110|530563906|FG007|Phase 1|Safety follow-up no longer necessary|0|||
147109327|NCT03126110|530563907|FG008|Phase 1|Safety follow-up no longer necessary|0|||
147109328|NCT03126110|530563908|FG009|Phase 1|Safety follow-up no longer necessary|0|||
147109329|NCT03126110|530563909|FG010|Phase 1|Safety follow-up no longer necessary|0|||
147109330|NCT03126110|530563910|FG011|Phase 1|Safety follow-up no longer necessary|0|||
147109331|NCT03126110|530563911|FG012|Phase 1|Safety follow-up no longer necessary|0|||
147109332|NCT03126110|530563912|FG013|Phase 1|Safety follow-up no longer necessary|0|||
147109333|NCT03126110|530563913|FG014|Phase 1|Safety follow-up no longer necessary|0|||
147109334|NCT03126110|530563914|FG015|Phase 1|Safety follow-up no longer necessary|0|||
147109335|NCT03126110|530563915|FG016|Phase 1|Safety follow-up no longer necessary|0|||
147109336|NCT03126110|530563899|FG000|Phase 1|Survival follow-up no longer necessary|0|||
147225601|NCT02273739|530998258|FG002|Overall Study|Physician Decision|0|||
147109337|NCT03126110|530563900|FG001|Phase 1|Survival follow-up no longer necessary|0|||
147109338|NCT03126110|530563901|FG002|Phase 1|Survival follow-up no longer necessary|1|||
147109339|NCT03126110|530563902|FG003|Phase 1|Survival follow-up no longer necessary|0|||
147109340|NCT03126110|530563903|FG004|Phase 1|Survival follow-up no longer necessary|0|||
147109341|NCT03126110|530563904|FG005|Phase 1|Survival follow-up no longer necessary|0|||
147109342|NCT03126110|530563905|FG006|Phase 1|Survival follow-up no longer necessary|0|||
147109343|NCT03126110|530563906|FG007|Phase 1|Survival follow-up no longer necessary|0|||
147109344|NCT03126110|530563907|FG008|Phase 1|Survival follow-up no longer necessary|0|||
147558938|NCT00721409|532203900|FG000|Overall Study|Withdrawal by Subject|1|||
147558939|NCT00721409|532203901|FG001|Overall Study|Withdrawal by Subject|6|||
147558940|NCT00721409|532203902|FG002|Overall Study|Withdrawal by Subject|5|||
147109345|NCT03126110|530563908|FG009|Phase 1|Survival follow-up no longer necessary|0|||
147109346|NCT03126110|530563909|FG010|Phase 1|Survival follow-up no longer necessary|0|||
147109347|NCT03126110|530563910|FG011|Phase 1|Survival follow-up no longer necessary|0|||
147558941|NCT00721409|532203900|FG000|Overall Study|Objective progression or relapse|8|||
147558942|NCT00721409|532203901|FG001|Overall Study|Objective progression or relapse|55|||
147558943|NCT00721409|532203902|FG002|Overall Study|Objective progression or relapse|62|||
147558944|NCT00810368|532203904|FG000|Overall Study|Lost to Follow-up|4|||
147558945|NCT00810368|532203905|FG001|Overall Study|Lost to Follow-up|2|||
147558946|NCT00810368|532203904|FG000|Overall Study|Lack of Efficacy|2|||
147558947|NCT00810368|532203905|FG001|Overall Study|Lack of Efficacy|0|||
147558948|NCT00623103|532203906|FG000|Overall Study|Adverse Event|70|||
147558949|NCT00623103|532203907|FG001|Overall Study|Adverse Event|60|||
147558950|NCT00623103|532203906|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
147558951|NCT00623103|532203907|FG001|Overall Study|Unsatisfactory therapeutic effect|12|||
147558952|NCT00623103|532203906|FG000|Overall Study|Withdrawal by Subject|18|||
147558953|NCT00623103|532203907|FG001|Overall Study|Withdrawal by Subject|24|||
147558954|NCT00623103|532203906|FG000|Overall Study|Lost to Follow-up|4|||
147558955|NCT00623103|532203907|FG001|Overall Study|Lost to Follow-up|1|||
147558956|NCT00623103|532203906|FG000|Overall Study|Administrative problems|2|||
147558957|NCT00623103|532203907|FG001|Overall Study|Administrative problems|4|||
147558958|NCT00623103|532203906|FG000|Overall Study|Death|11|||
147558959|NCT00623103|532203907|FG001|Overall Study|Death|11|||
147558960|NCT00623103|532203906|FG000|Overall Study|Protocol deviation|2|||
147558961|NCT00623103|532203907|FG001|Overall Study|Protocol deviation|1|||
147558962|NCT00442936|532203911|FG000|Overall Study|Protocol Violation|1|||
147558963|NCT00442936|532203912|FG001|Overall Study|Protocol Violation|0|||
147558964|NCT00442936|532203913|FG002|Overall Study|Protocol Violation|1|||
147558965|NCT00442936|532203914|FG003|Overall Study|Protocol Violation|1|||
147558966|NCT00524459|532203916|FG000|Overall Study|Withdrawal by Subject|1|||
147558967|NCT00524459|532203916|FG000|Overall Study|Other|1|||
147558968|NCT02428699|532203917|FG000|Washout Period 1|Screen Failure|1|||
147558969|NCT02428699|532203918|FG001|Washout Period 1|Screen Failure|2|||
147558970|NCT02433678|532203919|FG000|Overall Study|Lost to Follow-up|1|||
147558971|NCT02433678|532203920|FG001|Overall Study|Lost to Follow-up|2|||
147558972|NCT04424407|532203921|FG000|Overall Study|Withdrawal by Subject|2|||
147558973|NCT04424407|532203921|FG000|Overall Study|Lost to Follow-up|1|||
147558974|NCT01424722|532203924|FG000|Overall Study|Sponsor terminated investigation|2258|||
147558975|NCT02684578|532203925|FG000|Overall Study|Withdrawal by Subject|10|||
147558976|NCT02684578|532203926|FG001|Overall Study|Withdrawal by Subject|7|||
147558977|NCT02684578|532203925|FG000|Overall Study|Lost to Follow-up|0|||
147558978|NCT02684578|532203926|FG001|Overall Study|Lost to Follow-up|3|||
147558979|NCT02684578|532203925|FG000|Overall Study|Ineligible after reviewing baseline imaging|1|||
147558980|NCT02684578|532203926|FG001|Overall Study|Ineligible after reviewing baseline imaging|0|||
147558981|NCT02684578|532203925|FG000|Overall Study|Missing follow-up data|0|||
147558982|NCT02684578|532203926|FG001|Overall Study|Missing follow-up data|1|||
147558983|NCT01153984|532203927|FG000|Overall Study|Withdrawal by Subject|1|||
147558984|NCT01153984|532203927|FG000|Overall Study|Adverse Event|1|||
147558985|NCT02460159|532203928|FG000|Overall Study|Adverse Event|4|||
147558986|NCT02460159|532203929|FG001|Overall Study|Adverse Event|1|||
147558987|NCT02460159|532203928|FG000|Overall Study|Withdrawal by Subject|2|||
147558988|NCT02460159|532203929|FG001|Overall Study|Withdrawal by Subject|0|||
147558989|NCT03499964|532203930|FG000|Overall Study|Lack of Efficacy|6|||
147558990|NCT03499964|532203931|FG001|Overall Study|Lack of Efficacy|26|||
147558991|NCT03499964|532203930|FG000|Overall Study|Adverse Event|1|||
147558992|NCT03499964|532203931|FG001|Overall Study|Adverse Event|0|||
147558993|NCT03499964|532203930|FG000|Overall Study|Death|1|||
147558994|NCT03499964|532203931|FG001|Overall Study|Death|0|||
147558995|NCT03499964|532203930|FG000|Overall Study|Withdrawal by Subject|2|||
147558996|NCT03499964|532203931|FG001|Overall Study|Withdrawal by Subject|1|||
147109348|NCT03126110|530563911|FG012|Phase 1|Survival follow-up no longer necessary|0|||
147109349|NCT03126110|530563912|FG013|Phase 1|Survival follow-up no longer necessary|0|||
147109350|NCT03126110|530563913|FG014|Phase 1|Survival follow-up no longer necessary|0|||
147558997|NCT03499964|532203930|FG000|Overall Study|Lost to Follow-up|1|||
147109351|NCT03126110|530563914|FG015|Phase 1|Survival follow-up no longer necessary|0|||
147558998|NCT03499964|532203931|FG001|Overall Study|Lost to Follow-up|0|||
147558999|NCT01193608|532203932|FG000|Overall Study|Other|0|||
147559000|NCT01193608|532203933|FG001|Overall Study|Other|1|||
147559001|NCT01193608|532203934|FG002|Overall Study|Other|0|||
147559002|NCT01193608|532203935|FG003|Overall Study|Other|0|||
147559003|NCT01193608|532203936|FG004|Overall Study|Other|0|||
147559004|NCT01193608|532203937|FG005|Overall Study|Other|0|||
147559005|NCT01193608|532203932|FG000|Overall Study|Withdrawal by Subject|0|||
147559006|NCT01193608|532203933|FG001|Overall Study|Withdrawal by Subject|1|||
147559007|NCT01193608|532203934|FG002|Overall Study|Withdrawal by Subject|2|||
147109352|NCT03126110|530563915|FG016|Phase 1|Survival follow-up no longer necessary|0|||
147109353|NCT03126110|530563899|FG000|Phase 2|Study terminated by the sponsor|0|||
147109354|NCT03126110|530563900|FG001|Phase 2|Study terminated by the sponsor|0|||
147109355|NCT03126110|530563901|FG002|Phase 2|Study terminated by the sponsor|0|||
147109356|NCT03126110|530563902|FG003|Phase 2|Study terminated by the sponsor|0|||
147109357|NCT03126110|530563903|FG004|Phase 2|Study terminated by the sponsor|0|||
147109358|NCT03126110|530563904|FG005|Phase 2|Study terminated by the sponsor|0|||
147109359|NCT03126110|530563905|FG006|Phase 2|Study terminated by the sponsor|0|||
147109360|NCT03126110|530563906|FG007|Phase 2|Study terminated by the sponsor|0|||
147109361|NCT03126110|530563907|FG008|Phase 2|Study terminated by the sponsor|0|||
147109362|NCT03126110|530563908|FG009|Phase 2|Study terminated by the sponsor|0|||
147109363|NCT03126110|530563909|FG010|Phase 2|Study terminated by the sponsor|0|||
147109364|NCT03126110|530563910|FG011|Phase 2|Study terminated by the sponsor|0|||
147109365|NCT03126110|530563911|FG012|Phase 2|Study terminated by the sponsor|0|||
147109366|NCT03126110|530563912|FG013|Phase 2|Study terminated by the sponsor|4|||
147109367|NCT03126110|530563913|FG014|Phase 2|Study terminated by the sponsor|0|||
147109368|NCT03126110|530563914|FG015|Phase 2|Study terminated by the sponsor|0|||
147109369|NCT03126110|530563915|FG016|Phase 2|Study terminated by the sponsor|0|||
147109370|NCT03126110|530563899|FG000|Phase 2|Withdrawal by Subject|0|||
147109371|NCT03126110|530563900|FG001|Phase 2|Withdrawal by Subject|0|||
147109372|NCT03126110|530563901|FG002|Phase 2|Withdrawal by Subject|0|||
147109373|NCT03126110|530563902|FG003|Phase 2|Withdrawal by Subject|0|||
147109374|NCT03126110|530563903|FG004|Phase 2|Withdrawal by Subject|0|||
147109375|NCT03126110|530563904|FG005|Phase 2|Withdrawal by Subject|0|||
147109376|NCT03126110|530563905|FG006|Phase 2|Withdrawal by Subject|0|||
147109377|NCT03126110|530563906|FG007|Phase 2|Withdrawal by Subject|0|||
147109378|NCT03126110|530563907|FG008|Phase 2|Withdrawal by Subject|0|||
147109379|NCT03126110|530563908|FG009|Phase 2|Withdrawal by Subject|0|||
147109380|NCT03126110|530563909|FG010|Phase 2|Withdrawal by Subject|0|||
147109381|NCT03126110|530563910|FG011|Phase 2|Withdrawal by Subject|1|||
147109382|NCT03126110|530563911|FG012|Phase 2|Withdrawal by Subject|3|||
147109383|NCT03126110|530563912|FG013|Phase 2|Withdrawal by Subject|3|||
147109384|NCT03126110|530563913|FG014|Phase 2|Withdrawal by Subject|2|||
147109385|NCT03126110|530563914|FG015|Phase 2|Withdrawal by Subject|1|||
147109386|NCT03126110|530563915|FG016|Phase 2|Withdrawal by Subject|0|||
147109387|NCT03126110|530563899|FG000|Phase 2|Lost to Follow-up|0|||
147109388|NCT03126110|530563900|FG001|Phase 2|Lost to Follow-up|0|||
147109389|NCT03126110|530563901|FG002|Phase 2|Lost to Follow-up|0|||
147109390|NCT03126110|530563902|FG003|Phase 2|Lost to Follow-up|0|||
147109391|NCT03126110|530563903|FG004|Phase 2|Lost to Follow-up|0|||
147109392|NCT03126110|530563904|FG005|Phase 2|Lost to Follow-up|0|||
147109393|NCT03126110|530563905|FG006|Phase 2|Lost to Follow-up|0|||
147109394|NCT03126110|530563906|FG007|Phase 2|Lost to Follow-up|0|||
147559008|NCT01193608|532203935|FG003|Overall Study|Withdrawal by Subject|3|||
147559009|NCT01193608|532203936|FG004|Overall Study|Withdrawal by Subject|3|||
147559010|NCT01193608|532203937|FG005|Overall Study|Withdrawal by Subject|0|||
147559011|NCT01193608|532203932|FG000|Overall Study|Lost to Follow-up|0|||
147559012|NCT01193608|532203933|FG001|Overall Study|Lost to Follow-up|0|||
147559013|NCT01193608|532203934|FG002|Overall Study|Lost to Follow-up|0|||
147559014|NCT01193608|532203935|FG003|Overall Study|Lost to Follow-up|0|||
147559015|NCT01193608|532203936|FG004|Overall Study|Lost to Follow-up|1|||
147559016|NCT01193608|532203937|FG005|Overall Study|Lost to Follow-up|2|||
147559017|NCT01193608|532203932|FG000|Overall Study|Adverse Event|0|||
147559018|NCT01193608|532203933|FG001|Overall Study|Adverse Event|0|||
147559019|NCT01193608|532203934|FG002|Overall Study|Adverse Event|0|||
147559020|NCT01193608|532203935|FG003|Overall Study|Adverse Event|0|||
147559021|NCT01193608|532203936|FG004|Overall Study|Adverse Event|1|||
147559022|NCT01193608|532203937|FG005|Overall Study|Adverse Event|0|||
147559023|NCT01025037|532203941|FG000|Overall Study|Adverse Event|3|||
147559024|NCT01025037|532203941|FG000|Overall Study|Lost to Follow-up|7|||
147109395|NCT03126110|530563907|FG008|Phase 2|Lost to Follow-up|0|||
147109396|NCT03126110|530563908|FG009|Phase 2|Lost to Follow-up|0|||
147109397|NCT03126110|530563909|FG010|Phase 2|Lost to Follow-up|0|||
147109398|NCT03126110|530563910|FG011|Phase 2|Lost to Follow-up|1|||
147109399|NCT03126110|530563911|FG012|Phase 2|Lost to Follow-up|1|||
147109400|NCT03126110|530563912|FG013|Phase 2|Lost to Follow-up|1|||
147109401|NCT03126110|530563913|FG014|Phase 2|Lost to Follow-up|2|||
147109402|NCT03126110|530563914|FG015|Phase 2|Lost to Follow-up|0|||
147109403|NCT03126110|530563915|FG016|Phase 2|Lost to Follow-up|0|||
147109404|NCT03126110|530563899|FG000|Phase 2|Death|0|||
147109405|NCT03126110|530563900|FG001|Phase 2|Death|0|||
147559025|NCT01025037|532203941|FG000|Overall Study|Withdrawal by Subject|1|||
147559026|NCT02674334|532203944|FG000|Overall Study|Lost to Follow-up|5|||
147559027|NCT02674334|532203945|FG001|Overall Study|Lost to Follow-up|3|||
147109406|NCT03126110|530563901|FG002|Phase 2|Death|0|||
147109407|NCT03126110|530563902|FG003|Phase 2|Death|0|||
147109408|NCT03126110|530563903|FG004|Phase 2|Death|0|||
147109409|NCT03126110|530563904|FG005|Phase 2|Death|0|||
147109410|NCT03126110|530563905|FG006|Phase 2|Death|0|||
147109411|NCT03126110|530563906|FG007|Phase 2|Death|0|||
147559028|NCT02674334|532203944|FG000|Overall Study|participant difficulty breathing|1|||
147559029|NCT02674334|532203945|FG001|Overall Study|participant difficulty breathing|0|||
147559030|NCT02674334|532203944|FG000|Overall Study|NIRS not recording|1|||
147559031|NCT02674334|532203945|FG001|Overall Study|NIRS not recording|0|||
147559032|NCT02660242|532203951|FG000|Glucose Tabs|Lost to Follow-up|1|||
147559033|NCT02660242|532203951|FG000|Glucagon Injection|Lost to Follow-up|1|||
147559034|NCT02796664|532203953|FG000|Overall Study|Withdrawal by Subject|0|||
147559035|NCT02796664|532203954|FG001|Overall Study|Withdrawal by Subject|3|||
147559036|NCT02796664|532203953|FG000|Overall Study|Noncompliance|1|||
147559037|NCT02796664|532203954|FG001|Overall Study|Noncompliance|1|||
147559038|NCT02796664|532203953|FG000|Overall Study|Death|0|||
147559039|NCT02796664|532203954|FG001|Overall Study|Death|1|||
147559040|NCT00995553|532203955|FG000|Overall Study|Withdrawal by Subject|2|||
147559041|NCT00995553|532203956|FG001|Overall Study|Withdrawal by Subject|6|||
147225602|NCT02273739|530998259|FG003|Overall Study|Physician Decision|1|||
147225603|NCT04718103|530998260|FG000|Overall Study|Adverse Event|1|||
147225604|NCT04718103|530998261|FG001|Overall Study|Adverse Event|1|||
147225605|NCT04718103|530998260|FG000|Overall Study|Lack of Efficacy|4|||
147225606|NCT04718103|530998261|FG001|Overall Study|Lack of Efficacy|1|||
147225607|NCT04718103|530998260|FG000|Overall Study|Lost to Follow-up|2|||
147225608|NCT04718103|530998261|FG001|Overall Study|Lost to Follow-up|2|||
147225609|NCT04718103|530998260|FG000|Overall Study|Physician Decision|2|||
147225610|NCT04718103|530998261|FG001|Overall Study|Physician Decision|0|||
147225611|NCT04718103|530998260|FG000|Overall Study|Pregnancy|0|||
147225612|NCT04718103|530998261|FG001|Overall Study|Pregnancy|1|||
147225613|NCT04718103|530998260|FG000|Overall Study|Withdrawal by Subject|10|||
147225614|NCT04718103|530998261|FG001|Overall Study|Withdrawal by Subject|6|||
147225615|NCT04718103|530998260|FG000|Overall Study|Randomized, not treated|4|||
147225616|NCT04718103|530998261|FG001|Overall Study|Randomized, not treated|1|||
147225617|NCT04718103|530998260|FG000|Overall Study|GCP violations|7|||
147225618|NCT04718103|530998261|FG001|Overall Study|GCP violations|5|||
147225619|NCT01309893|530998262|FG000|Week 2 - Crossover Intervention|Lost to Follow-up|1|||
147225620|NCT01309893|530998263|FG001|Week 2 - Crossover Intervention|Lost to Follow-up|0|||
147225621|NCT01309893|530998262|FG000|Week 2 - Crossover Intervention|Missed crossover visit|0|||
147225622|NCT01309893|530998263|FG001|Week 2 - Crossover Intervention|Missed crossover visit|1|||
147225623|NCT01343901|530998265|FG000|Overall Study|Death|85|||
147225624|NCT01343901|530998265|FG000|Overall Study|Physician Decision|4|||
147225625|NCT01343901|530998265|FG000|Overall Study|Lost to Follow-up|12|||
147225626|NCT01343901|530998265|FG000|Overall Study|Management by another medical team|11|||
147225627|NCT01343901|530998265|FG000|Overall Study|Participant decision|1|||
147225628|NCT01369485|530998266|FG000|Randomized Phase (Day 0 to Week 12)|Adverse Event|7|||
147225629|NCT01369485|530998267|FG001|Randomized Phase (Day 0 to Week 12)|Adverse Event|5|||
147225630|NCT01369485|530998266|FG000|Randomized Phase (Day 0 to Week 12)|Withdrawal by Subject|12|||
147225631|NCT01369485|530998267|FG001|Randomized Phase (Day 0 to Week 12)|Withdrawal by Subject|8|||
147225632|NCT01369485|530998266|FG000|Randomized Phase (Day 0 to Week 12)|Lost to Follow-up|2|||
147225633|NCT01369485|530998267|FG001|Randomized Phase (Day 0 to Week 12)|Lost to Follow-up|4|||
147225634|NCT01369485|530998266|FG000|Randomized Phase (Day 0 to Week 12)|expired patches|2|||
147225635|NCT01369485|530998267|FG001|Randomized Phase (Day 0 to Week 12)|expired patches|0|||
147225636|NCT01369485|530998266|FG000|Open Label Phase (Week 12 to Month 12)|Adverse Event|11|||
147225637|NCT01369485|530998267|FG001|Open Label Phase (Week 12 to Month 12)|Adverse Event|9|||
147225638|NCT01369485|530998266|FG000|Open Label Phase (Week 12 to Month 12)|Lost to Follow-up|2|||
147225639|NCT01369485|530998267|FG001|Open Label Phase (Week 12 to Month 12)|Lost to Follow-up|3|||
147225640|NCT01369485|530998266|FG000|Open Label Phase (Week 12 to Month 12)|Physician Decision|3|||
147225641|NCT01369485|530998267|FG001|Open Label Phase (Week 12 to Month 12)|Physician Decision|4|||
147225642|NCT01369485|530998266|FG000|Open Label Phase (Week 12 to Month 12)|Withdrawal by Subject|17|||
147225643|NCT01369485|530998267|FG001|Open Label Phase (Week 12 to Month 12)|Withdrawal by Subject|20|||
147225644|NCT01369485|530998266|FG000|Open Label Phase (Week 12 to Month 12)|Death|0|||
147225645|NCT01369485|530998267|FG001|Open Label Phase (Week 12 to Month 12)|Death|1|||
147225646|NCT01369485|530998266|FG000|Open Label Phase (Week 12 to Month 12)|1 pacemaker, 1 noncompliance, 1 hospice|0|||
147225647|NCT01369485|530998267|FG001|Open Label Phase (Week 12 to Month 12)|1 pacemaker, 1 noncompliance, 1 hospice|3|||
147225648|NCT03370289|530998269|FG000|Overall Study|Screen Failure|1|||
147559042|NCT01531205|532203957|FG000|Overall Study|Did not proceed to surgery|1|||
147559043|NCT01626079|532203960|FG000|Overall Study|Death|167|||
147225649|NCT03370289|530998269|FG000|Overall Study|Sample Size Sufficient|4|||
147225650|NCT00873860|530998271|FG000|Overall Study|Lost to Follow-up|1|||
147225651|NCT00873860|530998272|FG001|Overall Study|Lost to Follow-up|0|||
147225652|NCT00873860|530998273|FG002|Overall Study|Lost to Follow-up|0|||
147225653|NCT00873860|530998274|FG003|Overall Study|Lost to Follow-up|1|||
147225654|NCT00873860|530998271|FG000|Overall Study|Withdrawal by Subject|1|||
147225655|NCT00873860|530998272|FG001|Overall Study|Withdrawal by Subject|0|||
147225656|NCT00873860|530998273|FG002|Overall Study|Withdrawal by Subject|2|||
147225657|NCT00873860|530998274|FG003|Overall Study|Withdrawal by Subject|0|||
147225658|NCT00873860|530998271|FG000|Overall Study|Death|1|||
147559044|NCT01626079|532203961|FG001|Overall Study|Death|192|||
147559045|NCT01626079|532203962|FG002|Overall Study|Death|39|||
147559046|NCT01626079|532203960|FG000|Overall Study|Withdrawal by Subject|23|||
147559047|NCT01626079|532203961|FG001|Overall Study|Withdrawal by Subject|37|||
147559048|NCT01626079|532203962|FG002|Overall Study|Withdrawal by Subject|5|||
147559049|NCT01626079|532203960|FG000|Overall Study|Lost to Follow-up|7|||
147559050|NCT01626079|532203961|FG001|Overall Study|Lost to Follow-up|4|||
147559051|NCT01626079|532203962|FG002|Overall Study|Lost to Follow-up|2|||
147559052|NCT01626079|532203960|FG000|Overall Study|Missed Visits|1|||
147559053|NCT01626079|532203961|FG001|Overall Study|Missed Visits|4|||
147559054|NCT01626079|532203962|FG002|Overall Study|Missed Visits|6|||
147559055|NCT00814463|532203963|FG000|Overall Study|Lost to Follow-up|1|||
147559056|NCT04803357|532203965|FG000|Overall Study|Withdrawal by Subject|31|||
147559057|NCT04803357|532203966|FG001|Overall Study|Withdrawal by Subject|5|||
147559058|NCT05905783|532203968|FG000|Overall Study|Lost to Follow-up|12|||
147559059|NCT05905783|532203969|FG001|Overall Study|Lost to Follow-up|18|||
147559060|NCT05905783|532203968|FG000|Overall Study|Withdrawal by Subject|29|||
147559061|NCT05905783|532203969|FG001|Overall Study|Withdrawal by Subject|37|||
147559062|NCT05905783|532203968|FG000|Overall Study|Decision by sponsor|69|||
147559063|NCT05905783|532203969|FG001|Overall Study|Decision by sponsor|65|||
147559064|NCT03968224|532203970|FG000|Overall Study|Lost to Follow-up|11|||
147559065|NCT03968224|532203971|FG001|Overall Study|Lost to Follow-up|18|||
147559066|NCT03717064|532205315|FG000|Period 2|Adverse Event|1|||
147559067|NCT00262600|532205316|FG000|Overall Study|Lost to Follow-up|17|||
147559068|NCT00262600|532205317|FG001|Overall Study|Lost to Follow-up|31|||
147559069|NCT00262600|532205318|FG002|Overall Study|Lost to Follow-up|41|||
147559070|NCT00262600|532205316|FG000|Overall Study|Withdrawal by Subject|128|||
147559071|NCT00262600|532205317|FG001|Overall Study|Withdrawal by Subject|145|||
147559072|NCT00262600|532205318|FG002|Overall Study|Withdrawal by Subject|139|||
147559073|NCT00262600|532205316|FG000|Overall Study|Not Treated|32|||
147559074|NCT00262600|532205317|FG001|Overall Study|Not Treated|17|||
147559075|NCT00262600|532205318|FG002|Overall Study|Not Treated|24|||
147559076|NCT00262600|532205316|FG000|Overall Study|Other|58|||
147559077|NCT00262600|532205317|FG001|Overall Study|Other|59|||
147559078|NCT00262600|532205318|FG002|Overall Study|Other|62|||
147559079|NCT03103100|532205319|FG000|Overall Study|Adverse Event|1|||
147559080|NCT03103100|532205320|FG001|Overall Study|Adverse Event|0|||
147559081|NCT03103100|532205321|FG002|Overall Study|Adverse Event|0|||
147559082|NCT03103100|532205319|FG000|Overall Study|Physician Decision|1|||
147559083|NCT03103100|532205320|FG001|Overall Study|Physician Decision|0|||
147559084|NCT03103100|532205321|FG002|Overall Study|Physician Decision|2|||
147559085|NCT00977106|532205323|FG000|Overall Study|Adverse Event|5|||
147559086|NCT00977106|532205324|FG001|Overall Study|Adverse Event|6|||
147559087|NCT00977106|532205323|FG000|Overall Study|Withdrawal by Subject|2|||
147559088|NCT00977106|532205324|FG001|Overall Study|Withdrawal by Subject|2|||
147559089|NCT00977106|532205323|FG000|Overall Study|Lack of Efficacy|2|||
147559090|NCT00977106|532205324|FG001|Overall Study|Lack of Efficacy|2|||
147559091|NCT00977106|532205323|FG000|Overall Study|Protocol Violation|0|||
147559092|NCT00977106|532205324|FG001|Overall Study|Protocol Violation|1|||
147559093|NCT00977106|532205323|FG000|Overall Study|Other|1|||
147559094|NCT00977106|532205324|FG001|Overall Study|Other|0|||
147559095|NCT00436007|532205325|FG000|Overall Study|Withdrawal by Subject|5|||
147559096|NCT00436007|532205326|FG001|Overall Study|Withdrawal by Subject|3|||
147559097|NCT00436007|532205327|FG002|Overall Study|Withdrawal by Subject|4|||
147225659|NCT00873860|530998272|FG001|Overall Study|Death|0|||
147225660|NCT00873860|530998273|FG002|Overall Study|Death|0|||
147225661|NCT00873860|530998274|FG003|Overall Study|Death|0|||
147225662|NCT00873860|530998271|FG000|Overall Study|Other|1|||
147225663|NCT00873860|530998272|FG001|Overall Study|Other|0|||
147225664|NCT00873860|530998273|FG002|Overall Study|Other|1|||
147225665|NCT00873860|530998274|FG003|Overall Study|Other|0|||
147225666|NCT02764190|530998275|FG000|Overall Study|Lost to Follow-up|17|||
147225667|NCT02764190|530998276|FG001|Overall Study|Lost to Follow-up|13|||
147225668|NCT01484938|530998281|FG000|Overall Study|Adverse Event|2|||
147225669|NCT01484938|530998281|FG000|Overall Study|Lost to Follow-up|1|||
147225670|NCT01484938|530998281|FG000|Overall Study|Noncompliance|1|||
147225671|NCT02140775|530998283|FG000|Overall Study|Withdrawal by Subject|30|||
147225672|NCT02140775|530998284|FG001|Overall Study|Withdrawal by Subject|7|||
147225673|NCT02942576|530998286|FG000|Overall Study|Adverse Event|28|||
147225674|NCT02942576|530998287|FG001|Overall Study|Adverse Event|6|||
147559098|NCT00436007|532205325|FG000|Overall Study|Lost to Follow-up|14|||
147559099|NCT00436007|532205326|FG001|Overall Study|Lost to Follow-up|10|||
147559100|NCT00436007|532205327|FG002|Overall Study|Lost to Follow-up|13|||
147559101|NCT00436007|532205325|FG000|Overall Study|Physician Decision|0|||
147559102|NCT00436007|532205326|FG001|Overall Study|Physician Decision|0|||
147559103|NCT00436007|532205327|FG002|Overall Study|Physician Decision|2|||
147559104|NCT00436007|532205325|FG000|Overall Study|Death|0|||
147559105|NCT00436007|532205326|FG001|Overall Study|Death|1|||
147559106|NCT00436007|532205327|FG002|Overall Study|Death|3|||
147559107|NCT00436007|532205325|FG000|Overall Study|Other|0|||
147559108|NCT00436007|532205326|FG001|Overall Study|Other|0|||
147225675|NCT02942576|530998286|FG000|Overall Study|Withdrawal by Subject|7|||
147559109|NCT00436007|532205327|FG002|Overall Study|Other|1|||
147559110|NCT02419313|532205328|FG000|First Intervention|Lost to Follow-up|2|||
147109412|NCT03126110|530563907|FG008|Phase 2|Death|0|||
147109413|NCT03126110|530563908|FG009|Phase 2|Death|0|||
147109414|NCT03126110|530563909|FG010|Phase 2|Death|0|||
147109415|NCT03126110|530563910|FG011|Phase 2|Death|6|||
147109416|NCT03126110|530563911|FG012|Phase 2|Death|12|||
147109417|NCT03126110|530563912|FG013|Phase 2|Death|25|||
147109418|NCT03126110|530563913|FG014|Phase 2|Death|11|||
147109419|NCT03126110|530563914|FG015|Phase 2|Death|3|||
147109420|NCT03126110|530563915|FG016|Phase 2|Death|2|||
147109421|NCT03126110|530563899|FG000|Phase 2|Progressive Disease|0|||
147109422|NCT03126110|530563900|FG001|Phase 2|Progressive Disease|0|||
147109423|NCT03126110|530563901|FG002|Phase 2|Progressive Disease|0|||
147109424|NCT03126110|530563902|FG003|Phase 2|Progressive Disease|0|||
147109425|NCT03126110|530563903|FG004|Phase 2|Progressive Disease|0|||
147109426|NCT03126110|530563904|FG005|Phase 2|Progressive Disease|0|||
147109427|NCT03126110|530563905|FG006|Phase 2|Progressive Disease|0|||
147109428|NCT03126110|530563906|FG007|Phase 2|Progressive Disease|0|||
147109429|NCT03126110|530563907|FG008|Phase 2|Progressive Disease|0|||
147109430|NCT03126110|530563908|FG009|Phase 2|Progressive Disease|0|||
147109431|NCT03126110|530563909|FG010|Phase 2|Progressive Disease|0|||
147109432|NCT03126110|530563910|FG011|Phase 2|Progressive Disease|0|||
147109433|NCT03126110|530563911|FG012|Phase 2|Progressive Disease|0|||
147109434|NCT03126110|530563912|FG013|Phase 2|Progressive Disease|1|||
147109435|NCT03126110|530563913|FG014|Phase 2|Progressive Disease|0|||
147109436|NCT03126110|530563914|FG015|Phase 2|Progressive Disease|0|||
147109437|NCT03126110|530563915|FG016|Phase 2|Progressive Disease|0|||
147225676|NCT02942576|530998287|FG001|Overall Study|Withdrawal by Subject|5|||
147559111|NCT02419313|532205329|FG001|First Intervention|Lost to Follow-up|0|||
147559112|NCT02419313|532205328|FG000|Second Intervention|Lost to Follow-up|1|||
147559113|NCT02419313|532205329|FG001|Second Intervention|Lost to Follow-up|0|||
147559114|NCT00688064|532205331|FG000|Overall Study|Protocol Violation|0|||
147559115|NCT00688064|532205332|FG001|Overall Study|Protocol Violation|1|||
147559116|NCT00688064|532205331|FG000|Overall Study|Adverse Event|2|||
147559117|NCT00688064|532205332|FG001|Overall Study|Adverse Event|4|||
147559118|NCT00688064|532205331|FG000|Overall Study|Withdrawal by Subject|7|||
147559119|NCT00688064|532205332|FG001|Overall Study|Withdrawal by Subject|7|||
147559120|NCT00688064|532205331|FG000|Overall Study|Lost to Follow-up|10|||
147559121|NCT00688064|532205332|FG001|Overall Study|Lost to Follow-up|10|||
147559122|NCT00688064|532205331|FG000|Overall Study|Lack of Efficacy|0|||
147559123|NCT00688064|532205332|FG001|Overall Study|Lack of Efficacy|1|||
147559124|NCT00688064|532205331|FG000|Overall Study|Pregnancy|1|||
147559125|NCT00688064|532205332|FG001|Overall Study|Pregnancy|0|||
147559126|NCT00688064|532205331|FG000|Overall Study|Any other reasons|1|||
147559127|NCT00688064|532205332|FG001|Overall Study|Any other reasons|3|||
147559128|NCT00950807|532205340|FG000|Treatment Period 1|Lack of Efficacy|1|||
147559129|NCT00950807|532205341|FG001|Treatment Period 1|Lack of Efficacy|0|||
147559130|NCT00950807|532205342|FG002|Treatment Period 1|Lack of Efficacy|0|||
147559131|NCT00950807|532205343|FG003|Treatment Period 1|Lack of Efficacy|0|||
147559132|NCT00950807|532205344|FG004|Treatment Period 1|Lack of Efficacy|0|||
147559133|NCT00950807|532205345|FG005|Treatment Period 1|Lack of Efficacy|1|||
147559134|NCT00950807|532205346|FG006|Treatment Period 1|Lack of Efficacy|0|||
147559135|NCT00950807|532205347|FG007|Treatment Period 1|Lack of Efficacy|0|||
147559136|NCT00950807|532205348|FG008|Treatment Period 1|Lack of Efficacy|0|||
147559137|NCT00950807|532205349|FG009|Treatment Period 1|Lack of Efficacy|0|||
147559138|NCT00950807|532205340|FG000|Treatment Period 1|Protocol Violation|1|||
147559139|NCT00950807|532205341|FG001|Treatment Period 1|Protocol Violation|0|||
147559140|NCT00950807|532205342|FG002|Treatment Period 1|Protocol Violation|0|||
147559141|NCT00950807|532205343|FG003|Treatment Period 1|Protocol Violation|0|||
147559142|NCT00950807|532205344|FG004|Treatment Period 1|Protocol Violation|0|||
147109438|NCT03126110|530563899|FG000|Phase 2|Started new treatment|0|||
147109439|NCT03126110|530563900|FG001|Phase 2|Started new treatment|0|||
147225677|NCT02942576|530998286|FG000|Overall Study|Physician Decision|1|||
147225678|NCT02942576|530998287|FG001|Overall Study|Physician Decision|4|||
147109440|NCT03126110|530563901|FG002|Phase 2|Started new treatment|0|||
147109441|NCT03126110|530563902|FG003|Phase 2|Started new treatment|0|||
147109442|NCT03126110|530563903|FG004|Phase 2|Started new treatment|0|||
147109443|NCT03126110|530563904|FG005|Phase 2|Started new treatment|0|||
147109444|NCT03126110|530563905|FG006|Phase 2|Started new treatment|0|||
147109445|NCT03126110|530563906|FG007|Phase 2|Started new treatment|0|||
147109446|NCT03126110|530563907|FG008|Phase 2|Started new treatment|0|||
147225679|NCT02942576|530998286|FG000|Overall Study|Other|10|||
147225680|NCT02942576|530998287|FG001|Overall Study|Other|8|||
147559143|NCT00950807|532205345|FG005|Treatment Period 1|Protocol Violation|0|||
147559144|NCT00950807|532205346|FG006|Treatment Period 1|Protocol Violation|0|||
147559145|NCT00950807|532205347|FG007|Treatment Period 1|Protocol Violation|0|||
147559146|NCT00950807|532205348|FG008|Treatment Period 1|Protocol Violation|0|||
147559147|NCT00950807|532205349|FG009|Treatment Period 1|Protocol Violation|0|||
147109447|NCT03126110|530563908|FG009|Phase 2|Started new treatment|0|||
147109448|NCT03126110|530563909|FG010|Phase 2|Started new treatment|0|||
147109449|NCT03126110|530563910|FG011|Phase 2|Started new treatment|0|||
147109450|NCT03126110|530563911|FG012|Phase 2|Started new treatment|0|||
147310956|NCT04921969|531305154|FG002|LTS Period (Weeks 8 to 52)|Lack of Efficacy|0|||
147310957|NCT04921969|531305155|FG003|LTS Period (Weeks 8 to 52)|Lack of Efficacy|1|||
147310958|NCT04921969|531305156|FG004|LTS Period (Weeks 8 to 52)|Lack of Efficacy|0|||
147310959|NCT04921969|531305157|FG005|LTS Period (Weeks 8 to 52)|Lack of Efficacy|3|||
147310960|NCT04921969|531305158|FG006|LTS Period (Weeks 8 to 52)|Lack of Efficacy|2|||
147310961|NCT04921969|531305152|FG000|LTS Period (Weeks 8 to 52)|Lost to Follow-up|0|||
147310962|NCT04921969|531305153|FG001|LTS Period (Weeks 8 to 52)|Lost to Follow-up|0|||
147310963|NCT04921969|531305154|FG002|LTS Period (Weeks 8 to 52)|Lost to Follow-up|0|||
147310964|NCT04921969|531305155|FG003|LTS Period (Weeks 8 to 52)|Lost to Follow-up|1|||
147310965|NCT04921969|531305156|FG004|LTS Period (Weeks 8 to 52)|Lost to Follow-up|6|||
147310966|NCT04921969|531305157|FG005|LTS Period (Weeks 8 to 52)|Lost to Follow-up|18|||
147310967|NCT04921969|531305158|FG006|LTS Period (Weeks 8 to 52)|Lost to Follow-up|9|||
147310968|NCT04921969|531305152|FG000|LTS Period (Weeks 8 to 52)|Physician Decision|0|||
147310969|NCT04921969|531305153|FG001|LTS Period (Weeks 8 to 52)|Physician Decision|0|||
147310970|NCT04921969|531305154|FG002|LTS Period (Weeks 8 to 52)|Physician Decision|0|||
147310971|NCT04921969|531305155|FG003|LTS Period (Weeks 8 to 52)|Physician Decision|1|||
147310972|NCT04921969|531305156|FG004|LTS Period (Weeks 8 to 52)|Physician Decision|0|||
147310973|NCT04921969|531305157|FG005|LTS Period (Weeks 8 to 52)|Physician Decision|1|||
147310974|NCT04921969|531305158|FG006|LTS Period (Weeks 8 to 52)|Physician Decision|1|||
147310975|NCT04921969|531305152|FG000|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
147310976|NCT04921969|531305153|FG001|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
147310977|NCT04921969|531305154|FG002|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
147310978|NCT04921969|531305155|FG003|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|2|||
147310979|NCT04921969|531305156|FG004|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|3|||
147310980|NCT04921969|531305157|FG005|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|22|||
147310981|NCT04921969|531305158|FG006|LTS Period (Weeks 8 to 52)|Withdrawal by Subject|18|||
147310982|NCT04921969|531305152|FG000|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|0|||
147310983|NCT04921969|531305153|FG001|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|0|||
147310984|NCT04921969|531305154|FG002|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|0|||
147310985|NCT04921969|531305155|FG003|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|1|||
147310986|NCT04921969|531305156|FG004|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|0|||
147310987|NCT04921969|531305157|FG005|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|1|||
147310988|NCT04921969|531305158|FG006|LTS Period (Weeks 8 to 52)|Protocol-specified Withdrawal Criterion Met|2|||
147310989|NCT04921969|531305152|FG000|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|0|||
147310990|NCT04921969|531305153|FG001|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|0|||
147310991|NCT04921969|531305154|FG002|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|0|||
147310992|NCT04921969|531305155|FG003|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|1|||
147310993|NCT04921969|531305156|FG004|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|0|||
147310994|NCT04921969|531305157|FG005|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|0|||
147310995|NCT04921969|531305158|FG006|LTS Period (Weeks 8 to 52)|Non-compliance with Study Drug|1|||
147310996|NCT04921969|531305152|FG000|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|0|||
147310997|NCT04921969|531305153|FG001|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|0|||
147310998|NCT04921969|531305154|FG002|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|0|||
147310999|NCT04921969|531305155|FG003|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|0|||
147311000|NCT04921969|531305156|FG004|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|0|||
147311001|NCT04921969|531305157|FG005|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|3|||
147311002|NCT04921969|531305158|FG006|LTS Period (Weeks 8 to 52)|Follow-up Not Performed per Protocol|3|||
147311003|NCT04287868|531305159|FG000|Overall Study|Screening fail|1|||
147311004|NCT04287868|531305160|FG001|Overall Study|Screening fail|0|||
147311005|NCT01811563|531307063|FG000|Overall Study|Lost to Follow-up|5|||
147311006|NCT01811563|531307064|FG001|Overall Study|Lost to Follow-up|2|||
147311007|NCT01811563|531307063|FG000|Overall Study|Incorrect Randomization procedure|0|||
147559148|NCT00950807|532205340|FG000|Treatment Period 1|Lost to Follow-up|0|||
147559149|NCT00950807|532205341|FG001|Treatment Period 1|Lost to Follow-up|0|||
147559150|NCT00950807|532205342|FG002|Treatment Period 1|Lost to Follow-up|1|||
147559151|NCT00950807|532205343|FG003|Treatment Period 1|Lost to Follow-up|0|||
147559152|NCT00950807|532205344|FG004|Treatment Period 1|Lost to Follow-up|0|||
147559153|NCT00950807|532205345|FG005|Treatment Period 1|Lost to Follow-up|0|||
147311008|NCT01811563|531307064|FG001|Overall Study|Incorrect Randomization procedure|1|||
147311009|NCT01267825|531307065|FG000|Overall Study|study terminated. no data collected.|1|||
147311010|NCT01267825|531307066|FG001|Overall Study|study terminated. no data collected.|0|||
147311011|NCT00806624|531307067|FG000|Overall Study|Adverse Event|2|||
147311012|NCT00806624|531307068|FG001|Overall Study|Adverse Event|8|||
147311013|NCT00806624|531307069|FG002|Overall Study|Adverse Event|0|||
147311014|NCT00806624|531307067|FG000|Overall Study|Death|0|||
147311015|NCT00806624|531307068|FG001|Overall Study|Death|1|||
147559154|NCT00950807|532205346|FG006|Treatment Period 1|Lost to Follow-up|0|||
147311016|NCT00806624|531307069|FG002|Overall Study|Death|1|||
147559155|NCT00950807|532205347|FG007|Treatment Period 1|Lost to Follow-up|0|||
147559156|NCT00950807|532205348|FG008|Treatment Period 1|Lost to Follow-up|0|||
147559157|NCT00950807|532205349|FG009|Treatment Period 1|Lost to Follow-up|0|||
147559158|NCT00950807|532205340|FG000|Treatment Period 1|Withdrawal by Subject|1|||
147559159|NCT00950807|532205341|FG001|Treatment Period 1|Withdrawal by Subject|0|||
147559160|NCT00950807|532205342|FG002|Treatment Period 1|Withdrawal by Subject|0|||
147559161|NCT00950807|532205343|FG003|Treatment Period 1|Withdrawal by Subject|0|||
147559162|NCT00950807|532205344|FG004|Treatment Period 1|Withdrawal by Subject|1|||
147559163|NCT00950807|532205345|FG005|Treatment Period 1|Withdrawal by Subject|0|||
147109451|NCT03126110|530563912|FG013|Phase 2|Started new treatment|0|||
147109452|NCT03126110|530563913|FG014|Phase 2|Started new treatment|1|||
147109453|NCT03126110|530563914|FG015|Phase 2|Started new treatment|0|||
147109454|NCT03126110|530563915|FG016|Phase 2|Started new treatment|0|||
147109455|NCT01285518|530563916|FG000|Overall Study|Lost to Follow-up|0|||
147109456|NCT01285518|530563917|FG001|Overall Study|Lost to Follow-up|0|||
147109457|NCT01285518|530563918|FG002|Overall Study|Lost to Follow-up|0|||
147109458|NCT01285518|530563919|FG003|Overall Study|Lost to Follow-up|0|||
147109459|NCT01285518|530563920|FG004|Overall Study|Lost to Follow-up|0|||
147109460|NCT01285518|530563921|FG005|Overall Study|Lost to Follow-up|1|||
147109461|NCT01285518|530563922|FG006|Overall Study|Lost to Follow-up|0|||
147109462|NCT01285518|530563923|FG007|Overall Study|Lost to Follow-up|0|||
147109463|NCT00580840|530563924|FG000|Run-in|Adverse Event|17|||
147225681|NCT00938964|530998290|FG000|Overall Study|Death|3|||
147225682|NCT00938964|530998291|FG001|Overall Study|Death|3|||
147225683|NCT00938964|530998290|FG000|Overall Study|Lost to Follow-up|2|||
147225684|NCT00938964|530998291|FG001|Overall Study|Lost to Follow-up|3|||
147225685|NCT00938964|530998290|FG000|Overall Study|Withdrawal by Subject|22|||
147225686|NCT00938964|530998291|FG001|Overall Study|Withdrawal by Subject|18|||
147225687|NCT00938964|530998290|FG000|Overall Study|Found to Meet Exclusion Criteria|3|||
147225688|NCT00938964|530998291|FG001|Overall Study|Found to Meet Exclusion Criteria|4|||
147225689|NCT01227564|530998298|FG000|Overall Study|No Longer Willing to Participate|4|||
147225690|NCT01227564|530998299|FG001|Overall Study|No Longer Willing to Participate|2|||
147225691|NCT01227564|530998300|FG002|Overall Study|No Longer Willing to Participate|5|||
147225692|NCT01227564|530998298|FG000|Overall Study|Participant moved to another town|0|||
147225693|NCT01227564|530998299|FG001|Overall Study|Participant moved to another town|0|||
147225694|NCT01227564|530998300|FG002|Overall Study|Participant moved to another town|1|||
147225695|NCT00704808|530998316|FG000|Overall Study|Discontinued prior to starting treatment|14|||
147225696|NCT00704808|530998316|FG000|Overall Study|Death|7|||
147225697|NCT00704808|530998316|FG000|Overall Study|Tumor progression|80|||
147225698|NCT00704808|530998316|FG000|Overall Study|Patient's decision|11|||
147225699|NCT00704808|530998316|FG000|Overall Study|Early therapy discontinuation|16|||
147225700|NCT00704808|530998316|FG000|Overall Study|Adverse Event|1|||
147225701|NCT00704808|530998316|FG000|Overall Study|Lost to Follow-up|1|||
147225702|NCT00704808|530998316|FG000|Overall Study|Treatment change|1|||
147225703|NCT05308290|530998322|FG000|Overall Study|Death|1|||
147225704|NCT05308290|530998323|FG001|Overall Study|Death|0|||
147225705|NCT05308290|530998322|FG000|Overall Study|Lost to Follow-up|2|||
147225706|NCT05308290|530998323|FG001|Overall Study|Lost to Follow-up|1|||
147225707|NCT05308290|530998322|FG000|Overall Study|still in study followup|0|||
147225708|NCT05308290|530998323|FG001|Overall Study|still in study followup|1|||
147225709|NCT00473746|530998324|FG000|Period 1 (Phase 1)|Adverse Event|1|||
147225710|NCT00473746|530998325|FG001|Period 1 (Phase 1)|Adverse Event|0|||
147225711|NCT00473746|530998326|FG002|Period 1 (Phase 1)|Adverse Event|0|||
147225712|NCT00473746|530998327|FG003|Period 1 (Phase 1)|Adverse Event|0|||
147225713|NCT00473746|530998328|FG004|Period 1 (Phase 1)|Adverse Event|0|||
147225714|NCT00473746|530998324|FG000|Period 1 (Phase 1)|Withdrawal by Subject|0|||
147225715|NCT00473746|530998325|FG001|Period 1 (Phase 1)|Withdrawal by Subject|1|||
147225716|NCT00473746|530998326|FG002|Period 1 (Phase 1)|Withdrawal by Subject|0|||
147225717|NCT00473746|530998327|FG003|Period 1 (Phase 1)|Withdrawal by Subject|0|||
147225718|NCT00473746|530998328|FG004|Period 1 (Phase 1)|Withdrawal by Subject|0|||
147225719|NCT00473746|530998324|FG000|Period 1 (Phase 1)|Progressive Disease|5|||
147225720|NCT00473746|530998325|FG001|Period 1 (Phase 1)|Progressive Disease|6|||
147225721|NCT00473746|530998326|FG002|Period 1 (Phase 1)|Progressive Disease|6|||
147225722|NCT00473746|530998327|FG003|Period 1 (Phase 1)|Progressive Disease|10|||
147225723|NCT00473746|530998328|FG004|Period 1 (Phase 1)|Progressive Disease|0|||
147225724|NCT00473746|530998324|FG000|Period 1 (Phase 1)|Symptomatic Deterioration|0|||
147225725|NCT00473746|530998325|FG001|Period 1 (Phase 1)|Symptomatic Deterioration|1|||
147225726|NCT00473746|530998326|FG002|Period 1 (Phase 1)|Symptomatic Deterioration|0|||
147225727|NCT00473746|530998327|FG003|Period 1 (Phase 1)|Symptomatic Deterioration|0|||
147225728|NCT00473746|530998328|FG004|Period 1 (Phase 1)|Symptomatic Deterioration|0|||
147225729|NCT00473746|530998324|FG000|Period 1 (Phase 1)|Reason not specified|0|||
147225730|NCT00473746|530998325|FG001|Period 1 (Phase 1)|Reason not specified|1|||
147225731|NCT00473746|530998326|FG002|Period 1 (Phase 1)|Reason not specified|0|||
147225732|NCT00473746|530998327|FG003|Period 1 (Phase 1)|Reason not specified|0|||
147225733|NCT00473746|530998328|FG004|Period 1 (Phase 1)|Reason not specified|0|||
147559164|NCT00950807|532205346|FG006|Treatment Period 1|Withdrawal by Subject|0|||
147109464|NCT00580840|530563925|FG001|Run-in|Adverse Event|0|||
147109465|NCT00580840|530563926|FG002|Run-in|Adverse Event|0|||
147559165|NCT00950807|532205347|FG007|Treatment Period 1|Withdrawal by Subject|0|||
147559166|NCT00950807|532205348|FG008|Treatment Period 1|Withdrawal by Subject|1|||
147559167|NCT00950807|532205349|FG009|Treatment Period 1|Withdrawal by Subject|0|||
147559168|NCT00950807|532205340|FG000|Treatment Period 1|Adverse Event|0|||
147559169|NCT00950807|532205341|FG001|Treatment Period 1|Adverse Event|0|||
147559170|NCT00950807|532205342|FG002|Treatment Period 1|Adverse Event|0|||
147559171|NCT00950807|532205343|FG003|Treatment Period 1|Adverse Event|0|||
147559172|NCT00950807|532205344|FG004|Treatment Period 1|Adverse Event|0|||
147559173|NCT00950807|532205345|FG005|Treatment Period 1|Adverse Event|1|||
147559174|NCT00950807|532205346|FG006|Treatment Period 1|Adverse Event|0|||
147559175|NCT00950807|532205347|FG007|Treatment Period 1|Adverse Event|0|||
147559176|NCT00950807|532205348|FG008|Treatment Period 1|Adverse Event|0|||
147559177|NCT00950807|532205349|FG009|Treatment Period 1|Adverse Event|0|||
147559178|NCT00950807|532205340|FG000|Washout Period 1|Lack of Efficacy|0|||
147559179|NCT00950807|532205341|FG001|Washout Period 1|Lack of Efficacy|0|||
147559180|NCT00950807|532205342|FG002|Washout Period 1|Lack of Efficacy|0|||
147559181|NCT00950807|532205343|FG003|Washout Period 1|Lack of Efficacy|0|||
147559182|NCT00950807|532205344|FG004|Washout Period 1|Lack of Efficacy|0|||
147559183|NCT00950807|532205345|FG005|Washout Period 1|Lack of Efficacy|0|||
147559184|NCT00950807|532205346|FG006|Washout Period 1|Lack of Efficacy|1|||
147559185|NCT00950807|532205347|FG007|Washout Period 1|Lack of Efficacy|0|||
147559186|NCT00950807|532205348|FG008|Washout Period 1|Lack of Efficacy|0|||
147559187|NCT00950807|532205349|FG009|Washout Period 1|Lack of Efficacy|0|||
147559188|NCT00950807|532205340|FG000|Washout Period 1|Withdrawal by Subject|0|||
147559189|NCT00950807|532205341|FG001|Washout Period 1|Withdrawal by Subject|0|||
147225734|NCT00473746|530998324|FG000|Period 2 (Phase 2)|Adverse Event|0|||
147559190|NCT00950807|532205342|FG002|Washout Period 1|Withdrawal by Subject|0|||
147559191|NCT00950807|532205343|FG003|Washout Period 1|Withdrawal by Subject|0|||
147559192|NCT00950807|532205344|FG004|Washout Period 1|Withdrawal by Subject|0|||
147559193|NCT00950807|532205345|FG005|Washout Period 1|Withdrawal by Subject|0|||
147559194|NCT00950807|532205346|FG006|Washout Period 1|Withdrawal by Subject|0|||
147559195|NCT00950807|532205347|FG007|Washout Period 1|Withdrawal by Subject|0|||
147559196|NCT00950807|532205348|FG008|Washout Period 1|Withdrawal by Subject|1|||
147559197|NCT00950807|532205349|FG009|Washout Period 1|Withdrawal by Subject|0|||
147559198|NCT00950807|532205340|FG000|Washout Period 1|Protocol-defined Stopping Criteria|3|||
147559199|NCT00950807|532205341|FG001|Washout Period 1|Protocol-defined Stopping Criteria|0|||
147559200|NCT00950807|532205342|FG002|Washout Period 1|Protocol-defined Stopping Criteria|0|||
147559201|NCT00950807|532205343|FG003|Washout Period 1|Protocol-defined Stopping Criteria|0|||
147559202|NCT00950807|532205344|FG004|Washout Period 1|Protocol-defined Stopping Criteria|0|||
147559203|NCT00950807|532205345|FG005|Washout Period 1|Protocol-defined Stopping Criteria|0|||
147559204|NCT00950807|532205346|FG006|Washout Period 1|Protocol-defined Stopping Criteria|1|||
147559205|NCT00950807|532205347|FG007|Washout Period 1|Protocol-defined Stopping Criteria|1|||
147559206|NCT00950807|532205348|FG008|Washout Period 1|Protocol-defined Stopping Criteria|0|||
147559207|NCT00950807|532205349|FG009|Washout Period 1|Protocol-defined Stopping Criteria|0|||
147559208|NCT00950807|532205340|FG000|Washout Period 1|Adverse Event|2|||
147559209|NCT00950807|532205341|FG001|Washout Period 1|Adverse Event|0|||
147559210|NCT00950807|532205342|FG002|Washout Period 1|Adverse Event|0|||
147559211|NCT00950807|532205343|FG003|Washout Period 1|Adverse Event|1|||
147559212|NCT00950807|532205344|FG004|Washout Period 1|Adverse Event|1|||
147559213|NCT00950807|532205345|FG005|Washout Period 1|Adverse Event|0|||
147559214|NCT00950807|532205346|FG006|Washout Period 1|Adverse Event|0|||
147559215|NCT00950807|532205347|FG007|Washout Period 1|Adverse Event|0|||
147559216|NCT00950807|532205348|FG008|Washout Period 1|Adverse Event|0|||
147559217|NCT00950807|532205349|FG009|Washout Period 1|Adverse Event|0|||
147559218|NCT00950807|532205340|FG000|Treatment Period 2|Lack of Efficacy|1|||
147559219|NCT00950807|532205341|FG001|Treatment Period 2|Lack of Efficacy|0|||
147559220|NCT00950807|532205342|FG002|Treatment Period 2|Lack of Efficacy|0|||
147559221|NCT00950807|532205343|FG003|Treatment Period 2|Lack of Efficacy|0|||
147559222|NCT00950807|532205344|FG004|Treatment Period 2|Lack of Efficacy|0|||
147559223|NCT00950807|532205345|FG005|Treatment Period 2|Lack of Efficacy|0|||
147225735|NCT00473746|530998325|FG001|Period 2 (Phase 2)|Adverse Event|0|||
147559224|NCT00950807|532205346|FG006|Treatment Period 2|Lack of Efficacy|0|||
147559225|NCT00950807|532205347|FG007|Treatment Period 2|Lack of Efficacy|0|||
147559226|NCT00950807|532205348|FG008|Treatment Period 2|Lack of Efficacy|0|||
147225736|NCT00473746|530998326|FG002|Period 2 (Phase 2)|Adverse Event|0|||
147444160|NCT03723707|531792507|FG000|Overall Study|Death|32|||
147444161|NCT03723707|531792508|FG001|Overall Study|Death|32|||
147559227|NCT00950807|532205349|FG009|Treatment Period 2|Lack of Efficacy|0|||
147559228|NCT00950807|532205340|FG000|Treatment Period 2|Withdrawal by Subject|0|||
147559229|NCT00950807|532205341|FG001|Treatment Period 2|Withdrawal by Subject|0|||
147559230|NCT00950807|532205342|FG002|Treatment Period 2|Withdrawal by Subject|0|||
147559231|NCT00950807|532205343|FG003|Treatment Period 2|Withdrawal by Subject|0|||
147559232|NCT00950807|532205344|FG004|Treatment Period 2|Withdrawal by Subject|0|||
147225737|NCT00473746|530998327|FG003|Period 2 (Phase 2)|Adverse Event|0|||
147225738|NCT00473746|530998328|FG004|Period 2 (Phase 2)|Adverse Event|3|||
147559233|NCT00950807|532205345|FG005|Treatment Period 2|Withdrawal by Subject|0|||
147559234|NCT00950807|532205346|FG006|Treatment Period 2|Withdrawal by Subject|1|||
147559235|NCT00950807|532205347|FG007|Treatment Period 2|Withdrawal by Subject|2|||
147559236|NCT00950807|532205348|FG008|Treatment Period 2|Withdrawal by Subject|0|||
147559237|NCT00950807|532205349|FG009|Treatment Period 2|Withdrawal by Subject|0|||
147559238|NCT00950807|532205340|FG000|Treatment Period 2|Protocol-defined Stopping Criteria|1|||
147559239|NCT00950807|532205341|FG001|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
147559240|NCT00950807|532205342|FG002|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
147559241|NCT00950807|532205343|FG003|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
147559242|NCT00950807|532205344|FG004|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
147559243|NCT00950807|532205345|FG005|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
147559244|NCT00950807|532205346|FG006|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
147559245|NCT00950807|532205347|FG007|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
147559246|NCT00950807|532205348|FG008|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
147559247|NCT00950807|532205349|FG009|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
147559248|NCT00950807|532205340|FG000|Treatment Period 2|Adverse Event|0|||
147559249|NCT00950807|532205341|FG001|Treatment Period 2|Adverse Event|1|||
147559250|NCT00950807|532205342|FG002|Treatment Period 2|Adverse Event|0|||
147559251|NCT00950807|532205343|FG003|Treatment Period 2|Adverse Event|1|||
147559252|NCT00950807|532205344|FG004|Treatment Period 2|Adverse Event|0|||
147559253|NCT00950807|532205345|FG005|Treatment Period 2|Adverse Event|1|||
147559254|NCT00950807|532205346|FG006|Treatment Period 2|Adverse Event|0|||
147559255|NCT00950807|532205347|FG007|Treatment Period 2|Adverse Event|1|||
147559256|NCT00950807|532205348|FG008|Treatment Period 2|Adverse Event|0|||
147559257|NCT00950807|532205349|FG009|Treatment Period 2|Adverse Event|0|||
147559258|NCT00950807|532205340|FG000|Washout Period 2|Lack of Efficacy|1|||
147559259|NCT00950807|532205341|FG001|Washout Period 2|Lack of Efficacy|0|||
147225739|NCT00473746|530998324|FG000|Period 2 (Phase 2)|Death|0|||
147559260|NCT00950807|532205342|FG002|Washout Period 2|Lack of Efficacy|0|||
147559261|NCT00950807|532205343|FG003|Washout Period 2|Lack of Efficacy|0|||
147559262|NCT00950807|532205344|FG004|Washout Period 2|Lack of Efficacy|0|||
147559263|NCT00950807|532205345|FG005|Washout Period 2|Lack of Efficacy|0|||
147559264|NCT00950807|532205346|FG006|Washout Period 2|Lack of Efficacy|0|||
147559265|NCT00950807|532205347|FG007|Washout Period 2|Lack of Efficacy|0|||
147559266|NCT00950807|532205348|FG008|Washout Period 2|Lack of Efficacy|0|||
147559267|NCT00950807|532205349|FG009|Washout Period 2|Lack of Efficacy|0|||
147559268|NCT00950807|532205340|FG000|Washout Period 2|Protocol-defined Stopping Criteria|0|||
147559269|NCT00950807|532205341|FG001|Washout Period 2|Protocol-defined Stopping Criteria|1|||
147559270|NCT00950807|532205342|FG002|Washout Period 2|Protocol-defined Stopping Criteria|0|||
147559271|NCT00950807|532205343|FG003|Washout Period 2|Protocol-defined Stopping Criteria|0|||
147559272|NCT00950807|532205344|FG004|Washout Period 2|Protocol-defined Stopping Criteria|1|||
147559273|NCT00950807|532205345|FG005|Washout Period 2|Protocol-defined Stopping Criteria|0|||
147225740|NCT00473746|530998325|FG001|Period 2 (Phase 2)|Death|0|||
147225741|NCT00473746|530998326|FG002|Period 2 (Phase 2)|Death|0|||
147225742|NCT00473746|530998327|FG003|Period 2 (Phase 2)|Death|0|||
147225743|NCT00473746|530998328|FG004|Period 2 (Phase 2)|Death|1|||
147225744|NCT00473746|530998324|FG000|Period 2 (Phase 2)|Progressive Disease|0|||
147559274|NCT00950807|532205346|FG006|Washout Period 2|Protocol-defined Stopping Criteria|1|||
147559275|NCT00950807|532205347|FG007|Washout Period 2|Protocol-defined Stopping Criteria|1|||
147559276|NCT00950807|532205348|FG008|Washout Period 2|Protocol-defined Stopping Criteria|0|||
147559277|NCT00950807|532205349|FG009|Washout Period 2|Protocol-defined Stopping Criteria|0|||
147559278|NCT00950807|532205340|FG000|Washout Period 2|Adverse Event|3|||
147559279|NCT00950807|532205341|FG001|Washout Period 2|Adverse Event|0|||
147559280|NCT00950807|532205342|FG002|Washout Period 2|Adverse Event|0|||
147559281|NCT00950807|532205343|FG003|Washout Period 2|Adverse Event|1|||
147559282|NCT00950807|532205344|FG004|Washout Period 2|Adverse Event|0|||
147559283|NCT00950807|532205345|FG005|Washout Period 2|Adverse Event|0|||
147559284|NCT00950807|532205346|FG006|Washout Period 2|Adverse Event|0|||
147559285|NCT00950807|532205347|FG007|Washout Period 2|Adverse Event|0|||
147559286|NCT00950807|532205348|FG008|Washout Period 2|Adverse Event|0|||
147559287|NCT00950807|532205349|FG009|Washout Period 2|Adverse Event|0|||
147559288|NCT00950807|532205340|FG000|Treatment Period 3|Withdrawal by Subject|0|||
147559289|NCT00950807|532205341|FG001|Treatment Period 3|Withdrawal by Subject|0|||
147559290|NCT00950807|532205342|FG002|Treatment Period 3|Withdrawal by Subject|0|||
147559291|NCT00950807|532205343|FG003|Treatment Period 3|Withdrawal by Subject|0|||
147559292|NCT00950807|532205344|FG004|Treatment Period 3|Withdrawal by Subject|0|||
147559293|NCT00950807|532205345|FG005|Treatment Period 3|Withdrawal by Subject|0|||
147225745|NCT00473746|530998325|FG001|Period 2 (Phase 2)|Progressive Disease|0|||
147225746|NCT00473746|530998326|FG002|Period 2 (Phase 2)|Progressive Disease|0|||
147559294|NCT00950807|532205346|FG006|Treatment Period 3|Withdrawal by Subject|0|||
147311017|NCT00806624|531307067|FG000|Overall Study|Lost to Follow-up|1|||
147559295|NCT00950807|532205347|FG007|Treatment Period 3|Withdrawal by Subject|0|||
147225747|NCT00473746|530998327|FG003|Period 2 (Phase 2)|Progressive Disease|0|||
147225748|NCT00473746|530998328|FG004|Period 2 (Phase 2)|Progressive Disease|20|||
147559296|NCT00950807|532205348|FG008|Treatment Period 3|Withdrawal by Subject|0|||
147559297|NCT00950807|532205349|FG009|Treatment Period 3|Withdrawal by Subject|1|||
147559298|NCT00950807|532205340|FG000|Treatment Period 3|Protocol-defined Stopping Criteria|1|||
147109466|NCT00580840|530563927|FG003|Run-in|Adverse Event|0|||
147109467|NCT00580840|530563924|FG000|Run-in|Lack of Efficacy|93|||
147109468|NCT00580840|530563925|FG001|Run-in|Lack of Efficacy|0|||
147109469|NCT00580840|530563926|FG002|Run-in|Lack of Efficacy|0|||
147109470|NCT00580840|530563927|FG003|Run-in|Lack of Efficacy|0|||
147109471|NCT00580840|530563924|FG000|Run-in|Loss of Efficacy|1|||
147109472|NCT00580840|530563925|FG001|Run-in|Loss of Efficacy|0|||
147109473|NCT00580840|530563926|FG002|Run-in|Loss of Efficacy|0|||
147109474|NCT00580840|530563927|FG003|Run-in|Loss of Efficacy|0|||
147109475|NCT00580840|530563924|FG000|Run-in|Lost to Follow-up|4|||
147109476|NCT00580840|530563925|FG001|Run-in|Lost to Follow-up|0|||
147109477|NCT00580840|530563926|FG002|Run-in|Lost to Follow-up|0|||
147109478|NCT00580840|530563927|FG003|Run-in|Lost to Follow-up|0|||
147109479|NCT00580840|530563924|FG000|Run-in|Withdrawal by Subject|5|||
147109480|NCT00580840|530563925|FG001|Run-in|Withdrawal by Subject|0|||
147109481|NCT00580840|530563926|FG002|Run-in|Withdrawal by Subject|0|||
147109482|NCT00580840|530563927|FG003|Run-in|Withdrawal by Subject|0|||
147109483|NCT00580840|530563924|FG000|Run-in|Other: Per Sponsor Request|2|||
147109484|NCT00580840|530563925|FG001|Run-in|Other: Per Sponsor Request|0|||
147109485|NCT00580840|530563926|FG002|Run-in|Other: Per Sponsor Request|0|||
147109486|NCT00580840|530563927|FG003|Run-in|Other: Per Sponsor Request|0|||
147109487|NCT00580840|530563924|FG000|Run-in|Other: Did Not Meet Joint Count Criteria|1|||
147109488|NCT00580840|530563925|FG001|Run-in|Other: Did Not Meet Joint Count Criteria|0|||
147109489|NCT00580840|530563926|FG002|Run-in|Other: Did Not Meet Joint Count Criteria|0|||
147109490|NCT00580840|530563927|FG003|Run-in|Other: Did Not Meet Joint Count Criteria|0|||
147109491|NCT00580840|530563924|FG000|Run-in|Other: Exclusionary Lab Value|1|||
147109492|NCT00580840|530563925|FG001|Run-in|Other: Exclusionary Lab Value|0|||
147109493|NCT00580840|530563926|FG002|Run-in|Other: Exclusionary Lab Value|0|||
147109494|NCT00580840|530563927|FG003|Run-in|Other: Exclusionary Lab Value|0|||
147109495|NCT00580840|530563924|FG000|Double-Blind|Adverse Event|0|||
147109496|NCT00580840|530563925|FG001|Double-Blind|Adverse Event|3|||
147109497|NCT00580840|530563926|FG002|Double-Blind|Adverse Event|4|||
147109498|NCT00580840|530563927|FG003|Double-Blind|Adverse Event|1|||
147109499|NCT00580840|530563924|FG000|Double-Blind|Loss of Efficacy|0|||
147109500|NCT00580840|530563925|FG001|Double-Blind|Loss of Efficacy|1|||
147109501|NCT00580840|530563926|FG002|Double-Blind|Loss of Efficacy|2|||
147109502|NCT00580840|530563927|FG003|Double-Blind|Loss of Efficacy|10|||
147109503|NCT00580840|530563924|FG000|Double-Blind|Lost to Follow-up|0|||
147109504|NCT00580840|530563925|FG001|Double-Blind|Lost to Follow-up|1|||
147109505|NCT00580840|530563926|FG002|Double-Blind|Lost to Follow-up|0|||
147109506|NCT00580840|530563927|FG003|Double-Blind|Lost to Follow-up|2|||
147109507|NCT00580840|530563924|FG000|Double-Blind|Withdrawal by Subject|0|||
147109508|NCT00580840|530563925|FG001|Double-Blind|Withdrawal by Subject|1|||
147109509|NCT00580840|530563926|FG002|Double-Blind|Withdrawal by Subject|2|||
147109510|NCT00580840|530563927|FG003|Double-Blind|Withdrawal by Subject|2|||
147109511|NCT00580840|530563924|FG000|Double-Blind|Other: Discontinued Methotrexate|0|||
147109512|NCT00580840|530563925|FG001|Double-Blind|Other: Discontinued Methotrexate|1|||
147109513|NCT00580840|530563926|FG002|Double-Blind|Other: Discontinued Methotrexate|0|||
147109514|NCT00580840|530563927|FG003|Double-Blind|Other: Discontinued Methotrexate|0|||
147109515|NCT00580840|530563924|FG000|Double-Blind|Other: Forbidden Medication|0|||
147109516|NCT00580840|530563925|FG001|Double-Blind|Other: Forbidden Medication|0|||
147109517|NCT00580840|530563926|FG002|Double-Blind|Other: Forbidden Medication|1|||
147109518|NCT00580840|530563927|FG003|Double-Blind|Other: Forbidden Medication|0|||
147109519|NCT01910441|530563929|FG000|Overall Study|Sponsor decision|0|||
147109520|NCT01910441|530563930|FG001|Overall Study|Sponsor decision|2|||
147109521|NCT01910441|530563929|FG000|Overall Study|Lost to Follow-up|6|||
147109522|NCT01910441|530563930|FG001|Overall Study|Lost to Follow-up|5|||
147109523|NCT01910441|530563929|FG000|Overall Study|Withdrawal by Subject|0|||
147109524|NCT01910441|530563930|FG001|Overall Study|Withdrawal by Subject|1|||
147109525|NCT01910441|530563929|FG000|Overall Study|Non-compliance|0|||
147109526|NCT01910441|530563930|FG001|Overall Study|Non-compliance|1|||
147109527|NCT01910441|530563929|FG000|Overall Study|Adverse Event|1|||
147109528|NCT01910441|530563930|FG001|Overall Study|Adverse Event|0|||
147225749|NCT00473746|530998324|FG000|Period 2 (Phase 2)|Reason not specified|0|||
147225750|NCT00473746|530998325|FG001|Period 2 (Phase 2)|Reason not specified|0|||
147225751|NCT00473746|530998326|FG002|Period 2 (Phase 2)|Reason not specified|0|||
147109529|NCT01910441|530563929|FG000|Overall Study|Physician Decision|0|||
147109530|NCT01910441|530563930|FG001|Overall Study|Physician Decision|1|||
147109531|NCT05845619|530563931|FG000|Overall Study|duplicate enrollment|2|||
147109532|NCT05845619|530563932|FG001|Overall Study|duplicate enrollment|2|||
147109533|NCT05845619|530563933|FG002|Overall Study|duplicate enrollment|1|||
147109534|NCT04279522|530563934|FG000|Period 1: Double Blind Phase|Lost to Follow-up|0|||
147109535|NCT04279522|530563935|FG001|Period 1: Double Blind Phase|Lost to Follow-up|1|||
147109536|NCT04279522|530563934|FG000|Period 1: Double Blind Phase|Withdrawal by Subject|10|||
147109537|NCT04279522|530563935|FG001|Period 1: Double Blind Phase|Withdrawal by Subject|8|||
147109538|NCT04279522|530563934|FG000|Period 1: Double Blind Phase|Protocol Violation|1|||
147109539|NCT04279522|530563935|FG001|Period 1: Double Blind Phase|Protocol Violation|0|||
147109540|NCT04279522|530563934|FG000|Period 2: Open Label Phase|Lost to Follow-up|1|||
147109541|NCT04279522|530563935|FG001|Period 2: Open Label Phase|Lost to Follow-up|1|||
147109542|NCT04279522|530563934|FG000|Period 2: Open Label Phase|Withdrawal by Subject|2|||
147109543|NCT04279522|530563935|FG001|Period 2: Open Label Phase|Withdrawal by Subject|2|||
147109544|NCT04279522|530563934|FG000|Period 2: Open Label Phase|Physician Decision|0|||
147109545|NCT04279522|530563935|FG001|Period 2: Open Label Phase|Physician Decision|3|||
147109546|NCT04279522|530563934|FG000|Period 2: Open Label Phase|Adverse Event|0|||
147109547|NCT04279522|530563935|FG001|Period 2: Open Label Phase|Adverse Event|1|||
147109548|NCT04279522|530563934|FG000|Period 2: Open Label Phase|Protocol Violation|1|||
147109549|NCT04279522|530563935|FG001|Period 2: Open Label Phase|Protocol Violation|0|||
147109550|NCT02629159|530563936|FG000|Overall Study|Adverse Event|17|||
147109551|NCT02629159|530563937|FG001|Overall Study|Adverse Event|20|||
147109552|NCT02629159|530563938|FG002|Overall Study|Adverse Event|22|||
147109553|NCT02629159|530563936|FG000|Overall Study|Withdrawal by Subject|22|||
147109554|NCT02629159|530563937|FG001|Overall Study|Withdrawal by Subject|11|||
147109555|NCT02629159|530563938|FG002|Overall Study|Withdrawal by Subject|15|||
147109556|NCT02629159|530563936|FG000|Overall Study|Lost to Follow-up|7|||
147109557|NCT02629159|530563937|FG001|Overall Study|Lost to Follow-up|4|||
147109558|NCT02629159|530563938|FG002|Overall Study|Lost to Follow-up|5|||
147109559|NCT02629159|530563936|FG000|Overall Study|Lack of Efficacy|4|||
147109560|NCT02629159|530563937|FG001|Overall Study|Lack of Efficacy|0|||
147109561|NCT02629159|530563938|FG002|Overall Study|Lack of Efficacy|1|||
147109562|NCT02629159|530563936|FG000|Overall Study|Other|6|||
147109563|NCT02629159|530563937|FG001|Overall Study|Other|4|||
147109564|NCT02629159|530563938|FG002|Overall Study|Other|8|||
147109565|NCT02401230|530563945|FG000|Overall Study|Adverse Event|3|||
147109566|NCT02401230|530563946|FG001|Overall Study|Adverse Event|2|||
147109567|NCT02401230|530563947|FG002|Overall Study|Adverse Event|0|||
147109568|NCT02401230|530563945|FG000|Overall Study|Withdrawal by Subject|2|||
147109569|NCT02401230|530563946|FG001|Overall Study|Withdrawal by Subject|1|||
147109570|NCT02401230|530563947|FG002|Overall Study|Withdrawal by Subject|1|||
147109571|NCT02401230|530563945|FG000|Overall Study|Lost to Follow-up|1|||
147109572|NCT02401230|530563946|FG001|Overall Study|Lost to Follow-up|3|||
147109573|NCT02401230|530563947|FG002|Overall Study|Lost to Follow-up|3|||
147109574|NCT00830765|530563948|FG000|Overall Study|Protocol Violation|3|||
147109575|NCT00830765|530563949|FG001|Overall Study|Protocol Violation|2|||
147109576|NCT01299909|530563950|FG000|Overall Study|Lost to Follow-up|22|||
147109577|NCT01299909|530563951|FG001|Overall Study|Lost to Follow-up|18|||
147109578|NCT01299909|530563952|FG002|Overall Study|Lost to Follow-up|17|||
147109579|NCT02774889|530563953|FG000|Overall Study|Lost to Follow-up|2|||
147109580|NCT02774889|530563954|FG001|Overall Study|Lost to Follow-up|1|||
147109581|NCT01349595|530563957|FG000|Overall Study|Lack of funding|2|||
147109582|NCT01349595|530563958|FG001|Overall Study|Lack of funding|2|||
147109583|NCT04817410|530565545|FG000|Overall Study|Withdrawal by Subject|5|||
147109584|NCT04817410|530565545|FG000|Overall Study|Physician Decision|3|||
147109585|NCT00549055|530565551|FG000|Overall Study|Adverse Event|4|||
147109586|NCT00549055|530565551|FG000|Overall Study|Lack of Efficacy|18|||
147109587|NCT00549055|530565551|FG000|Overall Study|Stabilization|5|||
147109588|NCT00549055|530565551|FG000|Overall Study|Progression to fibrosis|2|||
147109589|NCT00549055|530565551|FG000|Overall Study|Decrease of size|1|||
147109590|NCT00549055|530565551|FG000|Overall Study|Active choroidal neovascula increased|1|||
147109591|NCT00549055|530565551|FG000|Overall Study|Vitreous hemorrhage|1|||
147109592|NCT00549055|530565551|FG000|Overall Study|Growth choroidal neovascularisation|1|||
147109593|NCT00549055|530565551|FG000|Overall Study|Choroidal neovascularization|1|||
147109594|NCT00549055|530565551|FG000|Overall Study|Very low visual acuity (VA)|1|||
147109595|NCT01431976|530565552|FG000|Overall Study|Adverse Event|6|||
147109596|NCT01431976|530565552|FG000|Overall Study|Lack of Efficacy|2|||
147109597|NCT01431976|530565552|FG000|Overall Study|Met Protocol-defined Stopping Criteria|4|||
147109598|NCT01431976|530565552|FG000|Overall Study|Physician Decision|1|||
147109599|NCT01431976|530565552|FG000|Overall Study|Withdrawal by Subject|1|||
147109600|NCT00460798|530565556|FG000|Overall Study|Death|59|||
147109601|NCT00460798|530565556|FG000|Overall Study|Adverse Event|27|||
147109602|NCT00460798|530565556|FG000|Overall Study|Lost to Follow-up|19|||
147109603|NCT00460798|530565556|FG000|Overall Study|Progressive Disease|99|||
147109604|NCT00460798|530565556|FG000|Overall Study|Other|27|||
147109605|NCT00460798|530565556|FG000|Overall Study|Ongoing at Date of Cut-Off|82|||
147109606|NCT00460798|530565556|FG000|Overall Study|Missing/Incomplete Dosing Information|27|||
147225752|NCT00473746|530998327|FG003|Period 2 (Phase 2)|Reason not specified|0|||
147225753|NCT00473746|530998328|FG004|Period 2 (Phase 2)|Reason not specified|3|||
147225754|NCT00667420|530998329|FG000|Overall Study|Adverse Event|2|||
147109607|NCT02313155|530565563|FG000|Overall Study|Lost to Follow-up|0|||
147109608|NCT02313155|530565564|FG001|Overall Study|Lost to Follow-up|1|||
147109609|NCT04666298|530565567|FG000|Overall Study|Subject decision|1|||
147225755|NCT00667420|530998329|FG000|Overall Study|Lack of Efficacy|5|||
147109610|NCT04666298|530565568|FG001|Overall Study|Subject decision|0|||
147109611|NCT04666298|530565569|FG002|Overall Study|Subject decision|0|||
147225756|NCT00667420|530998329|FG000|Overall Study|Physician Decision|1|||
147225757|NCT00667420|530998329|FG000|Overall Study|Withdrawal by Subject|2|||
147109612|NCT04666298|530565570|FG003|Overall Study|Subject decision|2|||
147109613|NCT04666298|530565567|FG000|Overall Study|Death|1|||
147109614|NCT04666298|530565568|FG001|Overall Study|Death|0|||
147109615|NCT04666298|530565569|FG002|Overall Study|Death|0|||
147109616|NCT04666298|530565570|FG003|Overall Study|Death|0|||
147109617|NCT04666298|530565567|FG000|Overall Study|Lost to Follow-up|0|||
147109618|NCT04666298|530565568|FG001|Overall Study|Lost to Follow-up|0|||
147109619|NCT04666298|530565569|FG002|Overall Study|Lost to Follow-up|0|||
147109620|NCT04666298|530565570|FG003|Overall Study|Lost to Follow-up|1|||
147109621|NCT04666298|530565567|FG000|Overall Study|Physician Decision|0|||
147109622|NCT04666298|530565568|FG001|Overall Study|Physician Decision|0|||
147109623|NCT04666298|530565569|FG002|Overall Study|Physician Decision|0|||
147109624|NCT04666298|530565570|FG003|Overall Study|Physician Decision|1|||
147109625|NCT04666298|530565567|FG000|Overall Study|Protocol deviation|0|||
147109626|NCT04666298|530565568|FG001|Overall Study|Protocol deviation|0|||
147109627|NCT04666298|530565569|FG002|Overall Study|Protocol deviation|1|||
147109628|NCT04666298|530565570|FG003|Overall Study|Protocol deviation|0|||
147109629|NCT01995201|530565573|FG000|From Baseline Until Week 24|Adverse Event|4|||
147109630|NCT01995201|530565574|FG001|From Baseline Until Week 24|Adverse Event|15|||
147109631|NCT01995201|530565575|FG002|From Baseline Until Week 24|Adverse Event|0|||
147109632|NCT01995201|530565576|FG003|From Baseline Until Week 24|Adverse Event|0|||
147109633|NCT01995201|530565577|FG004|From Baseline Until Week 24|Adverse Event|0|||
147109634|NCT01995201|530565578|FG005|From Baseline Until Week 24|Adverse Event|0|||
147109635|NCT01995201|530565579|FG006|From Baseline Until Week 24|Adverse Event|0|||
147109636|NCT01995201|530565573|FG000|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
147109637|NCT01995201|530565574|FG001|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|3|||
147109638|NCT01995201|530565575|FG002|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
147109639|NCT01995201|530565576|FG003|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
147109640|NCT01995201|530565577|FG004|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
147109641|NCT01995201|530565578|FG005|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
147109642|NCT01995201|530565579|FG006|From Baseline Until Week 24|Anaphylaxis or hypersensitivity reaction|0|||
147109643|NCT01995201|530565573|FG000|From Baseline Until Week 24|Death|0|||
147109644|NCT01995201|530565574|FG001|From Baseline Until Week 24|Death|1|||
147109645|NCT01995201|530565575|FG002|From Baseline Until Week 24|Death|0|||
147109646|NCT01995201|530565576|FG003|From Baseline Until Week 24|Death|0|||
147109647|NCT01995201|530565577|FG004|From Baseline Until Week 24|Death|0|||
147109648|NCT01995201|530565578|FG005|From Baseline Until Week 24|Death|0|||
147109649|NCT01995201|530565579|FG006|From Baseline Until Week 24|Death|0|||
147109650|NCT01995201|530565573|FG000|From Baseline Until Week 24|Lack of Efficacy|2|||
147109651|NCT01995201|530565574|FG001|From Baseline Until Week 24|Lack of Efficacy|5|||
147109652|NCT01995201|530565575|FG002|From Baseline Until Week 24|Lack of Efficacy|0|||
147109653|NCT01995201|530565576|FG003|From Baseline Until Week 24|Lack of Efficacy|0|||
147109654|NCT01995201|530565577|FG004|From Baseline Until Week 24|Lack of Efficacy|0|||
147109655|NCT01995201|530565578|FG005|From Baseline Until Week 24|Lack of Efficacy|0|||
147109656|NCT01995201|530565579|FG006|From Baseline Until Week 24|Lack of Efficacy|0|||
147109657|NCT01995201|530565573|FG000|From Baseline Until Week 24|Lost to Follow-up|2|||
147109658|NCT01995201|530565574|FG001|From Baseline Until Week 24|Lost to Follow-up|3|||
147225758|NCT01017575|530998330|FG000|Overall Study|Lack of Efficacy|0|||
147225759|NCT01017575|530998331|FG001|Overall Study|Lack of Efficacy|1|||
147559299|NCT00950807|532205341|FG001|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
147559300|NCT00950807|532205342|FG002|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
147559301|NCT00950807|532205343|FG003|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
147559302|NCT00950807|532205344|FG004|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
147559303|NCT00950807|532205345|FG005|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
147559304|NCT00950807|532205346|FG006|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
147225760|NCT01017575|530998332|FG002|Overall Study|Lack of Efficacy|0|||
147225761|NCT01017575|530998333|FG003|Overall Study|Lack of Efficacy|1|||
147225762|NCT01017575|530998334|FG004|Overall Study|Lack of Efficacy|1|||
147225763|NCT01017575|530998330|FG000|Overall Study|Adverse Event|0|||
147225764|NCT01017575|530998331|FG001|Overall Study|Adverse Event|1|||
147225765|NCT01017575|530998332|FG002|Overall Study|Adverse Event|0|||
147225766|NCT01017575|530998333|FG003|Overall Study|Adverse Event|0|||
147225767|NCT01017575|530998334|FG004|Overall Study|Adverse Event|2|||
147225768|NCT01017575|530998330|FG000|Overall Study|Withdrawal by Subject|1|||
147225769|NCT01017575|530998331|FG001|Overall Study|Withdrawal by Subject|0|||
147225770|NCT01017575|530998332|FG002|Overall Study|Withdrawal by Subject|0|||
147311018|NCT00806624|531307068|FG001|Overall Study|Lost to Follow-up|0|||
147559305|NCT00950807|532205347|FG007|Treatment Period 3|Protocol-defined Stopping Criteria|1|||
147109659|NCT01995201|530565575|FG002|From Baseline Until Week 24|Lost to Follow-up|0|||
147109660|NCT01995201|530565576|FG003|From Baseline Until Week 24|Lost to Follow-up|0|||
147109661|NCT01995201|530565577|FG004|From Baseline Until Week 24|Lost to Follow-up|0|||
147109662|NCT01995201|530565578|FG005|From Baseline Until Week 24|Lost to Follow-up|0|||
147109663|NCT01995201|530565579|FG006|From Baseline Until Week 24|Lost to Follow-up|0|||
147225771|NCT01017575|530998333|FG003|Overall Study|Withdrawal by Subject|0|||
147225772|NCT01017575|530998334|FG004|Overall Study|Withdrawal by Subject|0|||
147109664|NCT01995201|530565573|FG000|From Baseline Until Week 24|Withdrawal by Subject|2|||
147109665|NCT01995201|530565574|FG001|From Baseline Until Week 24|Withdrawal by Subject|8|||
147109666|NCT01995201|530565575|FG002|From Baseline Until Week 24|Withdrawal by Subject|0|||
147109667|NCT01995201|530565576|FG003|From Baseline Until Week 24|Withdrawal by Subject|0|||
147109668|NCT01995201|530565577|FG004|From Baseline Until Week 24|Withdrawal by Subject|0|||
147109669|NCT01995201|530565578|FG005|From Baseline Until Week 24|Withdrawal by Subject|0|||
147109670|NCT01995201|530565579|FG006|From Baseline Until Week 24|Withdrawal by Subject|0|||
147109671|NCT01995201|530565573|FG000|From Baseline Until Week 24|Physician Decision|0|||
147109672|NCT01995201|530565574|FG001|From Baseline Until Week 24|Physician Decision|2|||
147109673|NCT01995201|530565575|FG002|From Baseline Until Week 24|Physician Decision|0|||
147109674|NCT01995201|530565576|FG003|From Baseline Until Week 24|Physician Decision|0|||
147109675|NCT01995201|530565577|FG004|From Baseline Until Week 24|Physician Decision|0|||
147109676|NCT01995201|530565578|FG005|From Baseline Until Week 24|Physician Decision|0|||
147109677|NCT01995201|530565579|FG006|From Baseline Until Week 24|Physician Decision|0|||
147109678|NCT01995201|530565573|FG000|From Baseline Until Week 24|Protocol Violation|0|||
147109679|NCT01995201|530565574|FG001|From Baseline Until Week 24|Protocol Violation|9|||
147109680|NCT01995201|530565575|FG002|From Baseline Until Week 24|Protocol Violation|0|||
147109681|NCT01995201|530565576|FG003|From Baseline Until Week 24|Protocol Violation|0|||
147109682|NCT01995201|530565577|FG004|From Baseline Until Week 24|Protocol Violation|0|||
147109683|NCT01995201|530565578|FG005|From Baseline Until Week 24|Protocol Violation|0|||
147109684|NCT01995201|530565579|FG006|From Baseline Until Week 24|Protocol Violation|0|||
147109685|NCT01995201|530565573|FG000|From Week 24 Until Week 48|Adverse Event|0|||
147109686|NCT01995201|530565574|FG001|From Week 24 Until Week 48|Adverse Event|0|||
147109687|NCT01995201|530565575|FG002|From Week 24 Until Week 48|Adverse Event|2|||
147109688|NCT01995201|530565576|FG003|From Week 24 Until Week 48|Adverse Event|1|||
147109689|NCT01995201|530565577|FG004|From Week 24 Until Week 48|Adverse Event|1|||
147109690|NCT01995201|530565578|FG005|From Week 24 Until Week 48|Adverse Event|3|||
147109691|NCT01995201|530565579|FG006|From Week 24 Until Week 48|Adverse Event|1|||
147109692|NCT01995201|530565573|FG000|From Week 24 Until Week 48|Death|0|||
147109693|NCT01995201|530565574|FG001|From Week 24 Until Week 48|Death|0|||
147109694|NCT01995201|530565575|FG002|From Week 24 Until Week 48|Death|0|||
147109695|NCT01995201|530565576|FG003|From Week 24 Until Week 48|Death|0|||
147109696|NCT01995201|530565577|FG004|From Week 24 Until Week 48|Death|0|||
147109697|NCT01995201|530565578|FG005|From Week 24 Until Week 48|Death|2|||
147109698|NCT01995201|530565579|FG006|From Week 24 Until Week 48|Death|0|||
147109699|NCT01995201|530565573|FG000|From Week 24 Until Week 48|Lack of Efficacy|0|||
147109700|NCT01995201|530565574|FG001|From Week 24 Until Week 48|Lack of Efficacy|0|||
147109701|NCT01995201|530565575|FG002|From Week 24 Until Week 48|Lack of Efficacy|1|||
147109702|NCT01995201|530565576|FG003|From Week 24 Until Week 48|Lack of Efficacy|0|||
147109703|NCT01995201|530565577|FG004|From Week 24 Until Week 48|Lack of Efficacy|0|||
147109704|NCT01995201|530565578|FG005|From Week 24 Until Week 48|Lack of Efficacy|2|||
147109705|NCT01995201|530565579|FG006|From Week 24 Until Week 48|Lack of Efficacy|1|||
147109706|NCT01995201|530565573|FG000|From Week 24 Until Week 48|Lost to Follow-up|0|||
147109707|NCT01995201|530565574|FG001|From Week 24 Until Week 48|Lost to Follow-up|0|||
147109708|NCT01995201|530565575|FG002|From Week 24 Until Week 48|Lost to Follow-up|0|||
147109709|NCT01995201|530565576|FG003|From Week 24 Until Week 48|Lost to Follow-up|0|||
147109710|NCT01995201|530565577|FG004|From Week 24 Until Week 48|Lost to Follow-up|1|||
147559306|NCT00950807|532205348|FG008|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
147559307|NCT00950807|532205349|FG009|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
147559308|NCT00950807|532205340|FG000|Treatment Period 3|Adverse Event|0|||
147559309|NCT00950807|532205341|FG001|Treatment Period 3|Adverse Event|0|||
147559310|NCT00950807|532205342|FG002|Treatment Period 3|Adverse Event|0|||
147559311|NCT00950807|532205343|FG003|Treatment Period 3|Adverse Event|0|||
147559312|NCT00950807|532205344|FG004|Treatment Period 3|Adverse Event|0|||
147559313|NCT00950807|532205345|FG005|Treatment Period 3|Adverse Event|0|||
147559314|NCT00950807|532205346|FG006|Treatment Period 3|Adverse Event|1|||
147559315|NCT00950807|532205347|FG007|Treatment Period 3|Adverse Event|0|||
147109711|NCT01995201|530565578|FG005|From Week 24 Until Week 48|Lost to Follow-up|1|||
147109712|NCT01995201|530565579|FG006|From Week 24 Until Week 48|Lost to Follow-up|0|||
147109713|NCT01995201|530565573|FG000|From Week 24 Until Week 48|Withdrawal by Subject|0|||
147559316|NCT00950807|532205348|FG008|Treatment Period 3|Adverse Event|0|||
147559317|NCT00950807|532205349|FG009|Treatment Period 3|Adverse Event|0|||
147559318|NCT00337077|532205350|FG000|Overall Study|Progressive disease|25|||
147109714|NCT01995201|530565574|FG001|From Week 24 Until Week 48|Withdrawal by Subject|0|||
147109715|NCT01995201|530565575|FG002|From Week 24 Until Week 48|Withdrawal by Subject|1|||
147109716|NCT01995201|530565576|FG003|From Week 24 Until Week 48|Withdrawal by Subject|0|||
147109717|NCT01995201|530565577|FG004|From Week 24 Until Week 48|Withdrawal by Subject|1|||
147109718|NCT01995201|530565578|FG005|From Week 24 Until Week 48|Withdrawal by Subject|0|||
147109719|NCT01995201|530565579|FG006|From Week 24 Until Week 48|Withdrawal by Subject|0|||
147109720|NCT01995201|530565573|FG000|From Week 24 Until Week 48|Physician Decision|0|||
147109721|NCT01995201|530565574|FG001|From Week 24 Until Week 48|Physician Decision|0|||
147559319|NCT00337077|532205351|FG001|Overall Study|Progressive disease|37|||
147559320|NCT00337077|532205352|FG002|Overall Study|Progressive disease|19|||
147109722|NCT01995201|530565575|FG002|From Week 24 Until Week 48|Physician Decision|0|||
147109723|NCT01995201|530565576|FG003|From Week 24 Until Week 48|Physician Decision|0|||
147109724|NCT01995201|530565577|FG004|From Week 24 Until Week 48|Physician Decision|1|||
147109725|NCT01995201|530565578|FG005|From Week 24 Until Week 48|Physician Decision|0|||
147109726|NCT01995201|530565579|FG006|From Week 24 Until Week 48|Physician Decision|0|||
147109727|NCT01995201|530565573|FG000|From Week 24 Until Week 48|Protocol Violation|0|||
147109728|NCT01995201|530565574|FG001|From Week 24 Until Week 48|Protocol Violation|0|||
147109729|NCT01995201|530565575|FG002|From Week 24 Until Week 48|Protocol Violation|1|||
147109730|NCT01995201|530565576|FG003|From Week 24 Until Week 48|Protocol Violation|0|||
147109731|NCT01995201|530565577|FG004|From Week 24 Until Week 48|Protocol Violation|2|||
147109732|NCT01995201|530565578|FG005|From Week 24 Until Week 48|Protocol Violation|0|||
147109733|NCT01995201|530565579|FG006|From Week 24 Until Week 48|Protocol Violation|0|||
147109734|NCT03329001|530565580|FG000|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|0|||
147109735|NCT03329001|530565581|FG001|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|0|||
147109736|NCT03329001|530565582|FG002|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|5|||
147109737|NCT03329001|530565583|FG003|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|6|||
147109738|NCT03329001|530565584|FG004|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|0|||
147109739|NCT03329001|530565585|FG005|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|0|||
147109740|NCT03329001|530565586|FG006|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|0|||
147109741|NCT03329001|530565587|FG007|Stage 2: PK Phase-Period 1 (Day 1)|Randomized, but did not receive treatment|0|||
147109742|NCT03329001|530565580|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
147109743|NCT03329001|530565581|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
147109744|NCT03329001|530565582|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
147109745|NCT03329001|530565583|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|1|||
147109746|NCT03329001|530565584|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
147109747|NCT03329001|530565585|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
147109748|NCT03329001|530565586|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
147109749|NCT03329001|530565587|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Deemed unevaluable|0|||
147109750|NCT03329001|530565580|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
147109751|NCT03329001|530565581|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
147109752|NCT03329001|530565582|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
147109753|NCT03329001|530565583|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|1|||
147109754|NCT03329001|530565584|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
147109755|NCT03329001|530565585|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
147109756|NCT03329001|530565586|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
147109757|NCT03329001|530565587|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor discontinued the participant|0|||
147109758|NCT03329001|530565580|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
147109759|NCT03329001|530565581|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
147109760|NCT03329001|530565582|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
147109761|NCT03329001|530565583|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|1|||
147109762|NCT03329001|530565584|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
147109763|NCT03329001|530565585|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
147109764|NCT03329001|530565586|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
147109765|NCT03329001|530565587|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Sponsor and Investigator decision|0|||
147109766|NCT03329001|530565580|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
147109767|NCT03329001|530565581|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
147109768|NCT03329001|530565582|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|1|||
147109769|NCT03329001|530565583|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
147109770|NCT03329001|530565584|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
147109771|NCT03329001|530565585|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
147109772|NCT03329001|530565586|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
147225773|NCT03500679|530998344|FG000|Overall Study|Lost to Follow-up|6|||
147559321|NCT00337077|532205350|FG000|Overall Study|Adverse Event|7|||
147559322|NCT00337077|532205351|FG001|Overall Study|Adverse Event|7|||
147559323|NCT00337077|532205352|FG002|Overall Study|Adverse Event|1|||
147559324|NCT00337077|532205350|FG000|Overall Study|Death|0|||
147559325|NCT00337077|532205351|FG001|Overall Study|Death|1|||
147559326|NCT00337077|532205352|FG002|Overall Study|Death|0|||
147559327|NCT00337077|532205350|FG000|Overall Study|Withdrawal by Subject|7|||
147559328|NCT00337077|532205351|FG001|Overall Study|Withdrawal by Subject|2|||
147559329|NCT00337077|532205352|FG002|Overall Study|Withdrawal by Subject|2|||
147559330|NCT00337077|532205350|FG000|Overall Study|Alternative therapy|1|||
147109773|NCT03329001|530565587|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Participant had incorrectly overdosed and removed from PK phase|0|||
147109774|NCT03329001|530565580|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
147109775|NCT03329001|530565581|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
147109776|NCT03329001|530565582|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|1|||
147109777|NCT03329001|530565583|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
147109778|NCT03329001|530565584|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
147109779|NCT03329001|530565585|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
147109780|NCT03329001|530565586|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
147109781|NCT03329001|530565587|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Participant admitted to emergency room for elevated serum creatinine|0|||
147109782|NCT03329001|530565580|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
147109783|NCT03329001|530565581|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
147109784|NCT03329001|530565582|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|1|||
147109785|NCT03329001|530565583|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
147109786|NCT03329001|530565584|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
147109787|NCT03329001|530565585|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
147109788|NCT03329001|530565586|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
147109789|NCT03329001|530565587|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Participant unable to complete due to Tornado in site area|0|||
147109790|NCT03329001|530565580|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
147109791|NCT03329001|530565581|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
147109792|NCT03329001|530565582|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|1|||
147109793|NCT03329001|530565583|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
147109794|NCT03329001|530565584|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
147109795|NCT03329001|530565585|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
147109796|NCT03329001|530565586|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
147109797|NCT03329001|530565587|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Participant non-compliance|0|||
147109798|NCT03329001|530565580|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|0|||
147109799|NCT03329001|530565581|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|0|||
147109800|NCT03329001|530565582|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|2|||
147109801|NCT03329001|530565583|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|2|||
147109802|NCT03329001|530565584|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|0|||
147109803|NCT03329001|530565585|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|0|||
147109804|NCT03329001|530565586|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|0|||
147109805|NCT03329001|530565587|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Vomiting within protocol-specified hours of dose administration|0|||
147109806|NCT03329001|530565580|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
147109807|NCT03329001|530565581|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
147109808|NCT03329001|530565582|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|1|||
147109809|NCT03329001|530565583|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
147109810|NCT03329001|530565584|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
147109811|NCT03329001|530565585|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
147109812|NCT03329001|530565586|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
147109813|NCT03329001|530565587|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Protocol Violation|0|||
147109814|NCT03329001|530565580|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|0|||
147109815|NCT03329001|530565581|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|0|||
147109816|NCT03329001|530565582|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|3|||
147109817|NCT03329001|530565583|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|3|||
147109818|NCT03329001|530565584|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|0|||
147109819|NCT03329001|530565585|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|0|||
147109820|NCT03329001|530565586|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|0|||
147109821|NCT03329001|530565587|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Disease progression per Investigator Decision|0|||
147109822|NCT03329001|530565580|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|0|||
147109823|NCT03329001|530565581|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|0|||
147109824|NCT03329001|530565582|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|5|||
147109825|NCT03329001|530565583|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|2|||
147109826|NCT03329001|530565584|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|0|||
147109827|NCT03329001|530565585|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|0|||
147109828|NCT03329001|530565586|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|0|||
147109829|NCT03329001|530565587|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Adverse Event|0|||
147109830|NCT03329001|530565580|FG000|Stage 2: PK Phase-W1 (Up to Day 14)|Death|0|||
147109831|NCT03329001|530565581|FG001|Stage 2: PK Phase-W1 (Up to Day 14)|Death|0|||
147109832|NCT03329001|530565582|FG002|Stage 2: PK Phase-W1 (Up to Day 14)|Death|1|||
147109833|NCT03329001|530565583|FG003|Stage 2: PK Phase-W1 (Up to Day 14)|Death|2|||
147109834|NCT03329001|530565584|FG004|Stage 2: PK Phase-W1 (Up to Day 14)|Death|0|||
147109835|NCT03329001|530565585|FG005|Stage 2: PK Phase-W1 (Up to Day 14)|Death|0|||
147109836|NCT03329001|530565586|FG006|Stage 2: PK Phase-W1 (Up to Day 14)|Death|0|||
147109837|NCT03329001|530565587|FG007|Stage 2: PK Phase-W1 (Up to Day 14)|Death|0|||
147109838|NCT03329001|530565580|FG000|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
147109839|NCT03329001|530565581|FG001|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
147109840|NCT03329001|530565582|FG002|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
147311019|NCT00806624|531307069|FG002|Overall Study|Lost to Follow-up|1|||
147559331|NCT00337077|532205351|FG001|Overall Study|Alternative therapy|0|||
147559332|NCT00337077|532205352|FG002|Overall Study|Alternative therapy|0|||
147559333|NCT00337077|532205350|FG000|Overall Study|Physician Decision|1|||
147559334|NCT00337077|532205351|FG001|Overall Study|Physician Decision|4|||
147559335|NCT00337077|532205352|FG002|Overall Study|Physician Decision|2|||
147559336|NCT00337077|532205350|FG000|Overall Study|Never started treatment|1|||
147559337|NCT00337077|532205351|FG001|Overall Study|Never started treatment|1|||
147559338|NCT00337077|532205352|FG002|Overall Study|Never started treatment|0|||
147559339|NCT00337077|532205350|FG000|Overall Study|Ineligible|1|||
147559340|NCT00337077|532205351|FG001|Overall Study|Ineligible|1|||
147559341|NCT00337077|532205352|FG002|Overall Study|Ineligible|1|||
147559342|NCT01492400|532205357|FG000|Overall Study|Miscellaneous Reasons|2|||
147559343|NCT01492400|532205358|FG001|Overall Study|Miscellaneous Reasons|3|||
147559344|NCT01492400|532205357|FG000|Overall Study|Personal Reasons|0|||
147559345|NCT01492400|532205358|FG001|Overall Study|Personal Reasons|5|||
147559346|NCT01492400|532205357|FG000|Overall Study|Lost to Follow-up|3|||
147559347|NCT01492400|532205358|FG001|Overall Study|Lost to Follow-up|1|||
147559348|NCT01492400|532205357|FG000|Overall Study|Pregnancy|0|||
147559349|NCT01492400|532205358|FG001|Overall Study|Pregnancy|1|||
147559350|NCT01492400|532205357|FG000|Overall Study|Lack of Efficacy|1|||
147559351|NCT01492400|532205358|FG001|Overall Study|Lack of Efficacy|1|||
147559352|NCT01492400|532205357|FG000|Overall Study|Adverse Event|10|||
147559353|NCT01492400|532205358|FG001|Overall Study|Adverse Event|5|||
147559354|NCT00659607|532205359|FG000|Overall Study|No blood pressure recorded|147|||
147559355|NCT00659607|532205359|FG000|Overall Study|Unknown measuring date of blood pressure|85|||
147559356|NCT00659607|532205359|FG000|Overall Study|'Unable to evaluate' for the final asses|67|||
147559357|NCT00659607|532205359|FG000|Overall Study|No recorded efficacy data|15|||
147559358|NCT00659607|532205359|FG000|Overall Study|Inconsistent BP measuring date|2|||
147559359|NCT02899338|532205361|FG000|Overall Study|Adverse Event|1|||
147559360|NCT02899338|532205362|FG001|Overall Study|Adverse Event|2|||
147559361|NCT02899338|532205361|FG000|Overall Study|Withdrawal by Subject|2|||
147559362|NCT02899338|532205362|FG001|Overall Study|Withdrawal by Subject|0|||
147559363|NCT06179108|532205363|FG000|Overall Study|Withdrawal by Subject|16|||
147559364|NCT06179108|532205364|FG001|Overall Study|Withdrawal by Subject|19|||
147559365|NCT06179108|532205365|FG002|Overall Study|Withdrawal by Subject|10|||
147109841|NCT03329001|530565583|FG003|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|1|||
147109842|NCT03329001|530565584|FG004|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
147225774|NCT03500679|530998345|FG001|Overall Study|Lost to Follow-up|3|||
147225775|NCT03500679|530998344|FG000|Overall Study|Withdrawal by Subject|3|||
147225776|NCT03500679|530998345|FG001|Overall Study|Withdrawal by Subject|0|||
147225777|NCT00095628|530998346|FG000|Overall Study|Disease progression prior to treatment|1|||
147225778|NCT01484054|530998350|FG000|Period 1|Withdrawal by Subject|0|||
147225779|NCT01484054|530998351|FG001|Period 1|Withdrawal by Subject|1|||
147225780|NCT01539317|530998352|FG000|Overall Study|Screening Error. Deleted from analysis.|1|||
147225781|NCT01539317|530998353|FG001|Overall Study|Screening Error. Deleted from analysis.|0|||
147225782|NCT01674634|530998355|FG000|Overall Study|Withdrawal by Subject|3|||
147225783|NCT01674634|530998355|FG000|Overall Study|Lost to Follow-up|3|||
147225784|NCT02021656|530998371|FG000|Overall Study|Adverse Event|1|||
147225785|NCT02021656|530998371|FG000|Overall Study|Lack of Efficacy|2|||
147225786|NCT02021656|530998371|FG000|Overall Study|Lost to Follow-up|1|||
147225787|NCT02021656|530998371|FG000|Overall Study|Withdrew Consent|2|||
147225788|NCT00510952|530998372|FG000|Overall Study|Adverse Event|1|||
147225789|NCT00510952|530998373|FG001|Overall Study|Adverse Event|0|||
147225790|NCT00510952|530998372|FG000|Overall Study|Entry Criteria Not Met|3|||
147225791|NCT00510952|530998373|FG001|Overall Study|Entry Criteria Not Met|1|||
147225792|NCT00510952|530998372|FG000|Overall Study|Lost to Follow-up|5|||
147225793|NCT00510952|530998373|FG001|Overall Study|Lost to Follow-up|3|||
147559366|NCT06179108|532205366|FG003|Overall Study|Withdrawal by Subject|11|||
147559367|NCT06179108|532205363|FG000|Overall Study|Lost to Follow-up|12|||
147559368|NCT06179108|532205364|FG001|Overall Study|Lost to Follow-up|4|||
147559369|NCT06179108|532205365|FG002|Overall Study|Lost to Follow-up|1|||
147559370|NCT06179108|532205366|FG003|Overall Study|Lost to Follow-up|9|||
147109843|NCT03329001|530565585|FG005|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
147109844|NCT03329001|530565586|FG006|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
147109845|NCT03329001|530565587|FG007|Stage2:PK Phase W2 (Up to Day 7)|Participant had paracentesis|0|||
147109846|NCT03329001|530565580|FG000|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
147109847|NCT03329001|530565581|FG001|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
147109848|NCT03329001|530565582|FG002|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
147109849|NCT03329001|530565583|FG003|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|1|||
147109850|NCT03329001|530565584|FG004|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
147109851|NCT03329001|530565585|FG005|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
147109852|NCT03329001|530565586|FG006|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
147109853|NCT03329001|530565587|FG007|Stage2:PK Phase W2 (Up to Day 7)|Participant forgot appointment|0|||
147109854|NCT03329001|530565580|FG000|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
147109855|NCT03329001|530565581|FG001|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
147109856|NCT03329001|530565582|FG002|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|1|||
147109857|NCT03329001|530565583|FG003|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
147109858|NCT03329001|530565584|FG004|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
147109859|NCT03329001|530565585|FG005|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
147109860|NCT03329001|530565586|FG006|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
147109861|NCT03329001|530565587|FG007|Stage2:PK Phase W2 (Up to Day 7)|Participant missed PK sampling in Period 1 Day 8|0|||
147109862|NCT03329001|530565580|FG000|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|0|||
147109863|NCT03329001|530565581|FG001|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|0|||
147109864|NCT03329001|530565582|FG002|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|1|||
147109865|NCT03329001|530565583|FG003|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|1|||
147109866|NCT03329001|530565584|FG004|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|0|||
147109867|NCT03329001|530565585|FG005|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|0|||
147109868|NCT03329001|530565586|FG006|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|0|||
147109869|NCT03329001|530565587|FG007|Stage2:PK Phase W2 (Up to Day 7)|Deemed unevaluable|0|||
147225794|NCT00510952|530998372|FG000|Overall Study|Physician Decision|1|||
147225795|NCT00510952|530998373|FG001|Overall Study|Physician Decision|1|||
147225796|NCT00510952|530998372|FG000|Overall Study|Protocol Violation|7|||
147225797|NCT00510952|530998373|FG001|Overall Study|Protocol Violation|4|||
147225798|NCT00510952|530998372|FG000|Overall Study|Sponsor Decision|1|||
147225799|NCT00510952|530998373|FG001|Overall Study|Sponsor Decision|0|||
147225800|NCT00510952|530998372|FG000|Overall Study|Withdrawal by Subject|6|||
147225801|NCT00510952|530998373|FG001|Overall Study|Withdrawal by Subject|7|||
147225802|NCT00510952|530998372|FG000|Overall Study|Did Not Receive Study Drug|2|||
147225803|NCT00510952|530998373|FG001|Overall Study|Did Not Receive Study Drug|0|||
147225804|NCT03581786|531000275|FG000|Overall Study|Death|67|||
147225805|NCT03581786|531000276|FG001|Overall Study|Death|47|||
147225806|NCT03581786|531000275|FG000|Overall Study|Withdrawal by Subject|2|||
147225807|NCT03581786|531000276|FG001|Overall Study|Withdrawal by Subject|5|||
147225808|NCT03581786|531000275|FG000|Overall Study|Lost to Follow-up|7|||
147225809|NCT03581786|531000276|FG001|Overall Study|Lost to Follow-up|4|||
147225810|NCT03581786|531000275|FG000|Overall Study|reason other than specified above|0|||
147225811|NCT03581786|531000276|FG001|Overall Study|reason other than specified above|1|||
147225812|NCT00510874|531000277|FG000|Overall Study|Withdrawal by Subject|1|||
147225813|NCT00510874|531000278|FG001|Overall Study|Withdrawal by Subject|1|||
147225814|NCT00510874|531000279|FG002|Overall Study|Withdrawal by Subject|0|||
147225815|NCT00510874|531000280|FG003|Overall Study|Withdrawal by Subject|0|||
147225816|NCT00510874|531000281|FG004|Overall Study|Withdrawal by Subject|3|||
147225817|NCT00510874|531000282|FG005|Overall Study|Withdrawal by Subject|0|||
147225818|NCT00510874|531000283|FG006|Overall Study|Withdrawal by Subject|0|||
147225819|NCT00510874|531000277|FG000|Overall Study|Lost to Follow-up|2|||
147225820|NCT00510874|531000278|FG001|Overall Study|Lost to Follow-up|3|||
147225821|NCT00510874|531000279|FG002|Overall Study|Lost to Follow-up|1|||
147225822|NCT00510874|531000280|FG003|Overall Study|Lost to Follow-up|3|||
147225823|NCT00510874|531000281|FG004|Overall Study|Lost to Follow-up|4|||
147225824|NCT00510874|531000282|FG005|Overall Study|Lost to Follow-up|0|||
147225825|NCT00510874|531000283|FG006|Overall Study|Lost to Follow-up|1|||
147225826|NCT00397943|531000289|FG000|Overall Study|Unspecified reasons|12|||
147225827|NCT00397943|531000290|FG001|Overall Study|Unspecified reasons|9|||
147225828|NCT00397943|531000291|FG002|Overall Study|Unspecified reasons|0|||
147225829|NCT00397943|531000292|FG003|Overall Study|Unspecified reasons|0|||
147225830|NCT00397943|531000293|FG004|Overall Study|Unspecified reasons|0|||
147225831|NCT02806973|531000296|FG000|Period 1|Withdrawal by Subject|0|||
147225832|NCT02806973|531000297|FG001|Period 1|Withdrawal by Subject|2|||
147225833|NCT02806973|531000298|FG002|Period 1|Withdrawal by Subject|1|||
147225834|NCT02806973|531000299|FG003|Period 1|Withdrawal by Subject|1|||
147225835|NCT02806973|531000296|FG000|Period 1|Adverse Event|0|||
147225836|NCT02806973|531000297|FG001|Period 1|Adverse Event|0|||
147225837|NCT02806973|531000298|FG002|Period 1|Adverse Event|0|||
147109870|NCT03329001|530565580|FG000|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
147109871|NCT03329001|530565581|FG001|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
147109872|NCT03329001|530565582|FG002|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|1|||
147109873|NCT03329001|530565583|FG003|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
147109874|NCT03329001|530565584|FG004|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
147109875|NCT03329001|530565585|FG005|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
147109876|NCT03329001|530565586|FG006|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
147109877|NCT03329001|530565587|FG007|Stage2:PK Phase W2 (Up to Day 7)|Participant was not in fasted state and therefore was outside of protocol compliance|0|||
147109878|NCT03329001|530565580|FG000|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
147109879|NCT03329001|530565581|FG001|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
147109880|NCT03329001|530565582|FG002|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|2|||
147109881|NCT03329001|530565583|FG003|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
147109882|NCT03329001|530565584|FG004|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
147109883|NCT03329001|530565585|FG005|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
147109884|NCT03329001|530565586|FG006|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
147109885|NCT03329001|530565587|FG007|Stage2:PK Phase W2 (Up to Day 7)|Disease progression per Investigator Decision|0|||
147109886|NCT03329001|530565580|FG000|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
147109887|NCT03329001|530565581|FG001|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
147109888|NCT03329001|530565582|FG002|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
147109889|NCT03329001|530565583|FG003|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|2|||
147109890|NCT03329001|530565584|FG004|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
147109891|NCT03329001|530565585|FG005|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
147109892|NCT03329001|530565586|FG006|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
147109893|NCT03329001|530565587|FG007|Stage2:PK Phase W2 (Up to Day 7)|Adverse Event|0|||
147109894|NCT03329001|530565580|FG000|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
147109895|NCT03329001|530565581|FG001|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
147109896|NCT03329001|530565582|FG002|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
147109897|NCT03329001|530565583|FG003|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
147109898|NCT03329001|530565584|FG004|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
147109899|NCT03329001|530565585|FG005|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|1|||
147109900|NCT03329001|530565586|FG006|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
147109901|NCT03329001|530565587|FG007|Stage 3: PK Phase- Period 1 (Day 1)|Adverse Event|0|||
147109902|NCT03329001|530565580|FG000|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
147109903|NCT03329001|530565581|FG001|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
147109904|NCT03329001|530565582|FG002|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
147109905|NCT03329001|530565583|FG003|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
147109906|NCT03329001|530565584|FG004|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|1|||
147109907|NCT03329001|530565585|FG005|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
147109908|NCT03329001|530565586|FG006|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
147109909|NCT03329001|530565587|FG007|Stage 3: PK Phase- Period 1 (Day 1)|Clinical progression|0|||
147109910|NCT03329001|530565580|FG000|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|0|||
147109911|NCT03329001|530565581|FG001|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|0|||
147109912|NCT03329001|530565582|FG002|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|0|||
147109913|NCT03329001|530565583|FG003|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|0|||
147109914|NCT03329001|530565584|FG004|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|1|||
147109915|NCT03329001|530565585|FG005|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|1|||
147109916|NCT03329001|530565586|FG006|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|0|||
147109917|NCT03329001|530565587|FG007|Stage 3: PK Phase- Period 1 (Day 1)|Withdrawal by Subject|0|||
147109918|NCT03329001|530565580|FG000|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
147109919|NCT03329001|530565581|FG001|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
147109920|NCT03329001|530565582|FG002|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
147109921|NCT03329001|530565583|FG003|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
147109922|NCT03329001|530565584|FG004|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|1|||
147109923|NCT03329001|530565585|FG005|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
147109924|NCT03329001|530565586|FG006|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
147109925|NCT03329001|530565587|FG007|Stage 3: PK Phase- Period 1 (Day 1)|Progressive Disease|0|||
147109926|NCT03329001|530565580|FG000|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|0|||
147109927|NCT03329001|530565581|FG001|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|0|||
147225838|NCT02806973|531000299|FG003|Period 1|Adverse Event|1|||
147444162|NCT03723707|531792507|FG000|Overall Study|Admitted to long term care|12|||
147559371|NCT06179108|532205363|FG000|Overall Study|Adverse Event|2|||
147109928|NCT03329001|530565582|FG002|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|0|||
147109929|NCT03329001|530565583|FG003|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|0|||
147109930|NCT03329001|530565584|FG004|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|1|||
147109931|NCT03329001|530565585|FG005|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|1|||
147109932|NCT03329001|530565586|FG006|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|0|||
147109933|NCT03329001|530565587|FG007|Stage 3: PK Phase- Period 2 (Day 15)|Vomiting within protocol-specified hours of dose administration|0|||
147109934|NCT03329001|530565580|FG000|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|0|||
147109935|NCT03329001|530565581|FG001|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|0|||
147109936|NCT03329001|530565582|FG002|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|0|||
147109937|NCT03329001|530565583|FG003|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|0|||
147109938|NCT03329001|530565584|FG004|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|0|||
147109939|NCT03329001|530565585|FG005|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|0|||
147109940|NCT03329001|530565586|FG006|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|22|||
147109941|NCT03329001|530565587|FG007|Extension Phase(Approx 5 Years 5 Months)|Withdrawal by Subject|14|||
147109942|NCT03329001|530565580|FG000|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
147109943|NCT03329001|530565581|FG001|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
147109944|NCT03329001|530565582|FG002|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
147109945|NCT03329001|530565583|FG003|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
147109946|NCT03329001|530565584|FG004|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
147109947|NCT03329001|530565585|FG005|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
147109948|NCT03329001|530565586|FG006|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|4|||
147109949|NCT03329001|530565587|FG007|Extension Phase(Approx 5 Years 5 Months)|Lost to Follow-up|0|||
147109950|NCT03329001|530565580|FG000|Extension Phase(Approx 5 Years 5 Months)|Death|0|||
147109951|NCT03329001|530565581|FG001|Extension Phase(Approx 5 Years 5 Months)|Death|0|||
147109952|NCT03329001|530565582|FG002|Extension Phase(Approx 5 Years 5 Months)|Death|0|||
147109953|NCT03329001|530565583|FG003|Extension Phase(Approx 5 Years 5 Months)|Death|0|||
147109954|NCT03329001|530565584|FG004|Extension Phase(Approx 5 Years 5 Months)|Death|0|||
147109955|NCT03329001|530565585|FG005|Extension Phase(Approx 5 Years 5 Months)|Death|0|||
147109956|NCT03329001|530565586|FG006|Extension Phase(Approx 5 Years 5 Months)|Death|15|||
147109957|NCT03329001|530565587|FG007|Extension Phase(Approx 5 Years 5 Months)|Death|3|||
147109958|NCT03329001|530565580|FG000|Extension Phase(Approx 5 Years 5 Months)|Other reasons|0|||
147109959|NCT03329001|530565581|FG001|Extension Phase(Approx 5 Years 5 Months)|Other reasons|0|||
147109960|NCT03329001|530565582|FG002|Extension Phase(Approx 5 Years 5 Months)|Other reasons|0|||
147109961|NCT03329001|530565583|FG003|Extension Phase(Approx 5 Years 5 Months)|Other reasons|0|||
147109962|NCT03329001|530565584|FG004|Extension Phase(Approx 5 Years 5 Months)|Other reasons|0|||
147109963|NCT03329001|530565585|FG005|Extension Phase(Approx 5 Years 5 Months)|Other reasons|0|||
147109964|NCT03329001|530565586|FG006|Extension Phase(Approx 5 Years 5 Months)|Other reasons|30|||
147109965|NCT03329001|530565587|FG007|Extension Phase(Approx 5 Years 5 Months)|Other reasons|13|||
147109966|NCT00963235|530565592|FG000|Overall Study|Withdrawal by Subject|22|||
147109967|NCT00963235|530565592|FG000|Overall Study|Lost to Follow-up|14|||
147109968|NCT00963235|530565592|FG000|Overall Study|Failed to return|9|||
147109969|NCT00963235|530565592|FG000|Overall Study|Protocol Violation|7|||
147109970|NCT00963235|530565592|FG000|Overall Study|Adverse Event|5|||
147109971|NCT00963235|530565592|FG000|Overall Study|Physician Decision|2|||
147109972|NCT00963235|530565592|FG000|Overall Study|Other|1|||
147109973|NCT01756235|530565594|FG000|Overall Study|Adalimumab Treatment was not Documented|2|||
147109974|NCT05376358|530565595|FG000|3 Month Timepoint Data Collection|Dyads who did not complete 3 month due to parent not completing (ONLY ADOLESCENT COMPLETED)|13|||
147109975|NCT05376358|530565596|FG001|3 Month Timepoint Data Collection|Dyads who did not complete 3 month due to parent not completing (ONLY ADOLESCENT COMPLETED)|15|||
147109976|NCT05376358|530565595|FG000|3 Month Timepoint Data Collection|Dyads who did not complete 3 month due to adolescent not completing (ONLY PARENT COMPLETED)|3|||
147109977|NCT05376358|530565596|FG001|3 Month Timepoint Data Collection|Dyads who did not complete 3 month due to adolescent not completing (ONLY PARENT COMPLETED)|3|||
147109978|NCT05376358|530565595|FG000|3 Month Timepoint Data Collection|Lost to Follow-up|3|||
147109979|NCT05376358|530565596|FG001|3 Month Timepoint Data Collection|Lost to Follow-up|5|||
147109980|NCT05376358|530565595|FG000|6 Month Timepoint Data Collection|Dyads who did not complete 6 month due to parent not completing (ONLY ADOLESCENT COMPLETED)|14|||
147225839|NCT02806973|531000296|FG000|Period 3|Withdrawal by Subject|0|||
147225840|NCT02806973|531000297|FG001|Period 3|Withdrawal by Subject|0|||
147225841|NCT02806973|531000298|FG002|Period 3|Withdrawal by Subject|0|||
147225842|NCT02806973|531000299|FG003|Period 3|Withdrawal by Subject|3|||
147225843|NCT02806973|531000296|FG000|Period 3|Adverse Event|0|||
147559372|NCT06179108|532205364|FG001|Overall Study|Adverse Event|3|||
147225844|NCT02806973|531000297|FG001|Period 3|Adverse Event|0|||
147225845|NCT02806973|531000298|FG002|Period 3|Adverse Event|1|||
147225846|NCT02806973|531000299|FG003|Period 3|Adverse Event|0|||
147225847|NCT04209426|531000302|FG000|Overall Study|Lost to Follow-up|3|||
147109981|NCT05376358|530565596|FG001|6 Month Timepoint Data Collection|Dyads who did not complete 6 month due to parent not completing (ONLY ADOLESCENT COMPLETED)|13|||
147109982|NCT05376358|530565595|FG000|6 Month Timepoint Data Collection|Dyads who did not complete 6 month due to parent not completing (ONLY ADOLESCENT COMPLETED)|1|||
147109983|NCT05376358|530565596|FG001|6 Month Timepoint Data Collection|Dyads who did not complete 6 month due to parent not completing (ONLY ADOLESCENT COMPLETED)|5|||
147109984|NCT05376358|530565595|FG000|6 Month Timepoint Data Collection|Lost to Follow-up|8|||
147109985|NCT05376358|530565596|FG001|6 Month Timepoint Data Collection|Lost to Follow-up|6|||
147109986|NCT04225832|530565597|FG000|Overall Study|No longer eligible (e.g., seroconversion)|6|||
147109987|NCT04225832|530565598|FG001|Overall Study|No longer eligible (e.g., seroconversion)|3|||
147109988|NCT04225832|530565597|FG000|Overall Study|Unable to recontact or too busy/not recontacted or unknown reason|36|||
147109989|NCT04225832|530565598|FG001|Overall Study|Unable to recontact or too busy/not recontacted or unknown reason|5|||
147109990|NCT03965923|530565601|FG000|Overall Study|Withdrawal by Subject|1|||
147109991|NCT03965923|530565602|FG001|Overall Study|Withdrawal by Subject|2|||
147109992|NCT03965923|530565603|FG002|Overall Study|Withdrawal by Subject|3|||
147109993|NCT03965923|530565604|FG003|Overall Study|Withdrawal by Subject|1|||
147109994|NCT03965923|530565605|FG004|Overall Study|Withdrawal by Subject|2|||
147109995|NCT03965923|530565606|FG005|Overall Study|Withdrawal by Subject|0|||
147109996|NCT03965923|530565607|FG006|Overall Study|Withdrawal by Subject|4|||
147109997|NCT03965923|530565608|FG007|Overall Study|Withdrawal by Subject|3|||
147109998|NCT03965923|530565609|FG008|Overall Study|Withdrawal by Subject|4|||
147109999|NCT03965923|530565610|FG009|Overall Study|Withdrawal by Subject|0|||
147110000|NCT03965923|530565611|FG010|Overall Study|Withdrawal by Subject|2|||
147110001|NCT03965923|530565612|FG011|Overall Study|Withdrawal by Subject|0|||
147110002|NCT03965923|530565601|FG000|Overall Study|Lost to Follow-up|2|||
147110003|NCT03965923|530565602|FG001|Overall Study|Lost to Follow-up|1|||
147110004|NCT03965923|530565603|FG002|Overall Study|Lost to Follow-up|1|||
147110005|NCT03965923|530565604|FG003|Overall Study|Lost to Follow-up|0|||
147110006|NCT03965923|530565605|FG004|Overall Study|Lost to Follow-up|2|||
147110007|NCT03965923|530565606|FG005|Overall Study|Lost to Follow-up|1|||
147110008|NCT03965923|530565607|FG006|Overall Study|Lost to Follow-up|2|||
147110009|NCT03965923|530565608|FG007|Overall Study|Lost to Follow-up|1|||
147110010|NCT03965923|530565609|FG008|Overall Study|Lost to Follow-up|0|||
147110011|NCT03965923|530565610|FG009|Overall Study|Lost to Follow-up|2|||
147110012|NCT03965923|530565611|FG010|Overall Study|Lost to Follow-up|0|||
147110013|NCT03965923|530565612|FG011|Overall Study|Lost to Follow-up|0|||
147110014|NCT03965923|530565601|FG000|Overall Study|Death|0|||
147110015|NCT03965923|530565602|FG001|Overall Study|Death|0|||
147110016|NCT03965923|530565603|FG002|Overall Study|Death|0|||
147110017|NCT03965923|530565604|FG003|Overall Study|Death|0|||
147225848|NCT04209426|531000303|FG001|Overall Study|Lost to Follow-up|2|||
147225849|NCT01751802|531000311|FG000|Overall Study|Adverse Event|4|||
147225850|NCT01751802|531000312|FG001|Overall Study|Adverse Event|2|||
147559373|NCT06179108|532205365|FG002|Overall Study|Adverse Event|3|||
147225851|NCT00521001|531000314|FG000|Overall Study|Ineligible|1|||
147225852|NCT02821910|531000315|FG000|Overall Study|Withdrawal by Subject|0|||
147225853|NCT02821910|531000316|FG001|Overall Study|Withdrawal by Subject|0|||
147225854|NCT02821910|531000317|FG002|Overall Study|Withdrawal by Subject|1|||
147225855|NCT02821910|531000318|FG003|Overall Study|Withdrawal by Subject|0|||
147225856|NCT02821910|531000319|FG004|Overall Study|Withdrawal by Subject|0|||
147225857|NCT02821910|531000320|FG005|Overall Study|Withdrawal by Subject|1|||
147225858|NCT02821910|531000315|FG000|Overall Study|Other than specified|1|||
147225859|NCT02821910|531000316|FG001|Overall Study|Other than specified|0|||
147225860|NCT02821910|531000317|FG002|Overall Study|Other than specified|1|||
147225861|NCT02821910|531000318|FG003|Overall Study|Other than specified|0|||
147225862|NCT02821910|531000319|FG004|Overall Study|Other than specified|0|||
147225863|NCT02821910|531000320|FG005|Overall Study|Other than specified|0|||
147225864|NCT00900601|531000321|FG000|Overall Study|Physician Decision|1|||
147225865|NCT01082640|531000322|FG000|Overall Study|Adverse Event|9|||
147225866|NCT01082640|531000323|FG001|Overall Study|Adverse Event|5|||
147225867|NCT01082640|531000324|FG002|Overall Study|Adverse Event|3|||
147225868|NCT01082640|531000322|FG000|Overall Study|Withdrawal by Subject|3|||
147559374|NCT06179108|532205366|FG003|Overall Study|Adverse Event|2|||
147559375|NCT06179108|532205363|FG000|Overall Study|Protocol Violation|0|||
147559376|NCT06179108|532205364|FG001|Overall Study|Protocol Violation|1|||
147559377|NCT06179108|532205365|FG002|Overall Study|Protocol Violation|0|||
147559378|NCT06179108|532205366|FG003|Overall Study|Protocol Violation|1|||
147110018|NCT03965923|530565605|FG004|Overall Study|Death|0|||
147110019|NCT03965923|530565606|FG005|Overall Study|Death|0|||
147225869|NCT01082640|531000323|FG001|Overall Study|Withdrawal by Subject|3|||
147225870|NCT01082640|531000324|FG002|Overall Study|Withdrawal by Subject|2|||
147110020|NCT03965923|530565607|FG006|Overall Study|Death|0|||
147110021|NCT03965923|530565608|FG007|Overall Study|Death|1|||
147110022|NCT03965923|530565609|FG008|Overall Study|Death|4|||
147225871|NCT01082640|531000322|FG000|Overall Study|Major protocol deviation|3|||
147559379|NCT06179108|532205363|FG000|Overall Study|Physician Decision|1|||
147559380|NCT06179108|532205364|FG001|Overall Study|Physician Decision|1|||
147559381|NCT06179108|532205365|FG002|Overall Study|Physician Decision|0|||
147559382|NCT06179108|532205366|FG003|Overall Study|Physician Decision|0|||
147559383|NCT06179108|532205363|FG000|Overall Study|Lack of Efficacy|0|||
147559384|NCT06179108|532205364|FG001|Overall Study|Lack of Efficacy|0|||
147559385|NCT06179108|532205365|FG002|Overall Study|Lack of Efficacy|0|||
147559386|NCT06179108|532205366|FG003|Overall Study|Lack of Efficacy|1|||
147559387|NCT06179108|532205363|FG000|Overall Study|Death|0|||
147559388|NCT06179108|532205364|FG001|Overall Study|Death|0|||
147559389|NCT06179108|532205365|FG002|Overall Study|Death|0|||
147559390|NCT06179108|532205366|FG003|Overall Study|Death|1|||
147559391|NCT01370408|532205367|FG000|Overall Study|treatment failure|9|||
147559392|NCT05014412|532205369|FG000|Overall Study|Death|11|||
147559393|NCT05014412|532205370|FG001|Overall Study|Death|7|||
147559394|NCT05014412|532205371|FG002|Overall Study|Death|4|||
147559395|NCT05014412|532205372|FG003|Overall Study|Death|7|||
147559396|NCT05014412|532205369|FG000|Overall Study|Withdrawal by Subject|1|||
147559397|NCT05014412|532205370|FG001|Overall Study|Withdrawal by Subject|1|||
147559398|NCT05014412|532205371|FG002|Overall Study|Withdrawal by Subject|1|||
147559399|NCT05014412|532205372|FG003|Overall Study|Withdrawal by Subject|2|||
147559400|NCT05014412|532205369|FG000|Overall Study|Ongoing|21|||
147559401|NCT05014412|532205370|FG001|Overall Study|Ongoing|4|||
147559402|NCT05014412|532205371|FG002|Overall Study|Ongoing|6|||
147559403|NCT05014412|532205372|FG003|Overall Study|Ongoing|20|||
147559404|NCT02353169|532205373|FG000|Overall Study|QTc > 450 msec|1|||
147444163|NCT03723707|531792508|FG001|Overall Study|Admitted to long term care|12|||
147444164|NCT03723707|531792507|FG000|Overall Study|No longer receiving care at NYU Langone Health|15|||
147444165|NCT03723707|531792508|FG001|Overall Study|No longer receiving care at NYU Langone Health|8|||
147444166|NCT03723707|531792507|FG000|Overall Study|Lost to Follow-up|40|||
147444167|NCT03723707|531792508|FG001|Overall Study|Lost to Follow-up|22|||
147559405|NCT02353169|532205374|FG001|Overall Study|QTc > 450 msec|1|||
147559406|NCT02353169|532205375|FG002|Overall Study|QTc > 450 msec|1|||
147559407|NCT02353169|532205376|FG003|Overall Study|QTc > 450 msec|1|||
147559408|NCT02353169|532205373|FG000|Overall Study|OR team declined|2|||
147559409|NCT02353169|532205374|FG001|Overall Study|OR team declined|0|||
147559410|NCT02353169|532205375|FG002|Overall Study|OR team declined|0|||
147559411|NCT02353169|532205376|FG003|Overall Study|OR team declined|0|||
147559412|NCT02353169|532205373|FG000|Overall Study|Inhalational induction|0|||
147559413|NCT02353169|532205374|FG001|Overall Study|Inhalational induction|2|||
147559414|NCT02353169|532205375|FG002|Overall Study|Inhalational induction|0|||
147559415|NCT02353169|532205376|FG003|Overall Study|Inhalational induction|0|||
147559416|NCT02353169|532205373|FG000|Overall Study|ECG data error|0|||
147559417|NCT02353169|532205374|FG001|Overall Study|ECG data error|3|||
147559418|NCT02353169|532205375|FG002|Overall Study|ECG data error|2|||
147559419|NCT02353169|532205376|FG003|Overall Study|ECG data error|2|||
147559420|NCT02353169|532205373|FG000|Overall Study|Pre-op medication|0|||
147559421|NCT02353169|532205374|FG001|Overall Study|Pre-op medication|0|||
147559422|NCT02353169|532205375|FG002|Overall Study|Pre-op medication|1|||
147559423|NCT02353169|532205376|FG003|Overall Study|Pre-op medication|0|||
147559424|NCT00486837|532205379|FG000|Overall Study|Withdrawal by Subject|1|||
147559425|NCT00486837|532205380|FG001|Overall Study|Withdrawal by Subject|0|||
147559426|NCT00486837|532205379|FG000|Overall Study|Adverse Event|1|||
147559427|NCT00486837|532205380|FG001|Overall Study|Adverse Event|1|||
147559428|NCT00486837|532205379|FG000|Overall Study|Protocol Violation|4|||
147559429|NCT00486837|532205380|FG001|Overall Study|Protocol Violation|2|||
147559430|NCT00486837|532205379|FG000|Overall Study|No sputum, devise issues, exacerbation|3|||
147559431|NCT00486837|532205380|FG001|Overall Study|No sputum, devise issues, exacerbation|4|||
147559432|NCT02468778|532205381|FG000|Overall Study|Death|2|||
147559433|NCT02468778|532205382|FG001|Overall Study|Death|1|||
147110023|NCT03965923|530565610|FG009|Overall Study|Death|0|||
147110024|NCT03965923|530565611|FG010|Overall Study|Death|4|||
147110025|NCT03965923|530565612|FG011|Overall Study|Death|0|||
147225872|NCT01082640|531000323|FG001|Overall Study|Major protocol deviation|3|||
147225873|NCT01082640|531000324|FG002|Overall Study|Major protocol deviation|0|||
147225874|NCT01082640|531000322|FG000|Overall Study|Lost to Follow-up|0|||
147225875|NCT01082640|531000323|FG001|Overall Study|Lost to Follow-up|3|||
147559434|NCT02468778|532205383|FG002|Overall Study|Death|0|||
147559435|NCT02468778|532205381|FG000|Overall Study|Lost to Follow-up|1|||
147559436|NCT02468778|532205382|FG001|Overall Study|Lost to Follow-up|2|||
147559437|NCT02468778|532205383|FG002|Overall Study|Lost to Follow-up|2|||
147559438|NCT02468778|532205381|FG000|Overall Study|Withdrawal by Subject|0|||
147559439|NCT02468778|532205382|FG001|Overall Study|Withdrawal by Subject|1|||
147559440|NCT02468778|532205383|FG002|Overall Study|Withdrawal by Subject|1|||
147110026|NCT03965923|530565601|FG000|Overall Study|Other reason|0|||
147110027|NCT03965923|530565602|FG001|Overall Study|Other reason|0|||
147110028|NCT03965923|530565603|FG002|Overall Study|Other reason|0|||
147559441|NCT00414765|532205384|FG000|Overall Study|Adverse Event|5|||
147559442|NCT00414765|532205385|FG001|Overall Study|Adverse Event|9|||
147559443|NCT00414765|532205384|FG000|Overall Study|Withdrawal by Subject|1|||
147559444|NCT00414765|532205385|FG001|Overall Study|Withdrawal by Subject|1|||
147559445|NCT00414765|532205384|FG000|Overall Study|Disease Progression|0|||
147559446|NCT00414765|532205385|FG001|Overall Study|Disease Progression|1|||
147225876|NCT01082640|531000324|FG002|Overall Study|Lost to Follow-up|0|||
147225877|NCT01082640|531000322|FG000|Overall Study|Other|2|||
147559447|NCT05295953|532205386|FG000|Overall Study|Withdrawal by Subject|0|||
147559448|NCT05295953|532205387|FG001|Overall Study|Withdrawal by Subject|1|||
147559449|NCT05694013|532205389|FG000|Overall Study|Death|6|||
147559450|NCT05694013|532205390|FG001|Overall Study|Death|2|||
147559451|NCT05694013|532205389|FG000|Overall Study|Participant Decision|0|||
147559452|NCT05694013|532205390|FG001|Overall Study|Participant Decision|1|||
147559453|NCT05694013|532205389|FG000|Overall Study|Physician Decision|1|||
147559454|NCT05694013|532205390|FG001|Overall Study|Physician Decision|0|||
147559455|NCT05694013|532205389|FG000|Overall Study|Progressive Disease|0|||
147559456|NCT05694013|532205390|FG001|Overall Study|Progressive Disease|1|||
147559457|NCT05694013|532205389|FG000|Overall Study|Study Terminated by Sponsor|12|||
147559458|NCT05694013|532205390|FG001|Overall Study|Study Terminated by Sponsor|17|||
147559459|NCT05694013|532205389|FG000|Overall Study|Withdrawal by Subject|3|||
147559460|NCT05694013|532205390|FG001|Overall Study|Withdrawal by Subject|0|||
147559461|NCT04817891|532205391|FG000|Overall Study|Did not pass screening after consenting to participate|1|||
147559462|NCT04817891|532205391|FG000|Overall Study|Adverse Event|1|||
147225878|NCT01082640|531000323|FG001|Overall Study|Other|1|||
147225879|NCT01082640|531000324|FG002|Overall Study|Other|3|||
147225880|NCT01025154|531000329|FG000|Overall Study|Lost to Follow-up|1|||
147225881|NCT01025154|531000329|FG000|Overall Study|Withdrawal by Subject|1|||
147225882|NCT01810432|531000330|FG000|Washout|Protocol Violation|0|||
147444168|NCT03723707|531792507|FG000|Overall Study|Discontinued after study closure|24|||
147444169|NCT03723707|531792508|FG001|Overall Study|Discontinued after study closure|12|||
147444170|NCT04342871|531792509|FG000|Overall Study|Death|4|||
147444171|NCT04342871|531792509|FG000|Overall Study|Clinical deterioration/illness progression|2|||
147444172|NCT04342871|531792509|FG000|Overall Study|Did not complete baseline assessments|5|||
147444173|NCT04342871|531792509|FG000|Overall Study|Lost to Follow-up|13|||
147444174|NCT00666458|531792510|FG000|Overall Study|Adverse Event|8|||
147444175|NCT00666458|531792511|FG001|Overall Study|Adverse Event|7|||
147444176|NCT00666458|531792510|FG000|Overall Study|Withdrawal by Subject|5|||
147444177|NCT00666458|531792511|FG001|Overall Study|Withdrawal by Subject|4|||
147444178|NCT00666458|531792510|FG000|Overall Study|Lost to Follow-up|0|||
147444179|NCT00666458|531792511|FG001|Overall Study|Lost to Follow-up|3|||
147444180|NCT00666458|531792510|FG000|Overall Study|Administrative reason by sponsor|1|||
147444181|NCT00666458|531792511|FG001|Overall Study|Administrative reason by sponsor|1|||
147444182|NCT00666458|531792510|FG000|Overall Study|Incorrect enrollment|7|||
147444183|NCT00666458|531792511|FG001|Overall Study|Incorrect enrollment|1|||
147444184|NCT00666458|531792510|FG000|Overall Study|Study specific discontinuation criteria|14|||
147444185|NCT00666458|531792511|FG001|Overall Study|Study specific discontinuation criteria|7|||
147444186|NCT00666458|531792510|FG000|Overall Study|Severe non-compliance to the protocol|1|||
147444187|NCT00666458|531792511|FG001|Overall Study|Severe non-compliance to the protocol|1|||
147444188|NCT00666458|531792510|FG000|Overall Study|Safety reasons|1|||
147444189|NCT00666458|531792511|FG001|Overall Study|Safety reasons|0|||
147444190|NCT00666458|531792510|FG000|Overall Study|Medical history of anemia|1|||
147444191|NCT00666458|531792511|FG001|Overall Study|Medical history of anemia|0|||
147444192|NCT02222207|531792512|FG000|Overall Study|Death|1|||
147444193|NCT02222207|531792512|FG000|Overall Study|Other reasons|2|||
147444194|NCT02222207|531792512|FG000|Overall Study|Adverse Event|1|||
147444195|NCT04682405|531792514|FG000|Overall Study|Adverse Event|0|||
147444196|NCT04682405|531792515|FG001|Overall Study|Adverse Event|1|||
147444197|NCT01429584|531792516|FG000|Overall Study|Withdrawal by Subject|1|||
147444198|NCT01429584|531792517|FG001|Overall Study|Withdrawal by Subject|0|||
147444199|NCT01429584|531792516|FG000|Overall Study|Protocol Violation|0|||
147444200|NCT01429584|531792517|FG001|Overall Study|Protocol Violation|1|||
147444201|NCT00750698|531792518|FG000|Overall Study|Withdrawal by Subject|1|||
147444202|NCT00750698|531792519|FG001|Overall Study|Withdrawal by Subject|0|||
147444203|NCT00750698|531792518|FG000|Overall Study|Progressive disease|5|||
147444204|NCT00750698|531792519|FG001|Overall Study|Progressive disease|2|||
147444205|NCT00390546|531792529|FG000|Overall Study|Renal impairment|1|||
147444206|NCT00390546|531792530|FG001|Overall Study|Renal impairment|0|||
147444207|NCT00390546|531792529|FG000|Overall Study|Physician Decision|5|||
147559463|NCT04817891|532205391|FG000|Overall Study|Withdrawal by Subject|1|||
147559464|NCT04534283|532205392|FG000|Overall Study|Physician Decision|2|||
147559465|NCT04534283|532205392|FG000|Overall Study|Withdrawal by Subject|1|||
147559466|NCT04534283|532205392|FG000|Overall Study|Disease Progression|12|||
147559467|NCT04534283|532205392|FG000|Overall Study|Adverse Event|1|||
147444208|NCT00390546|531792530|FG001|Overall Study|Physician Decision|5|||
147444209|NCT01308008|531792531|FG000|4 Weeks|Illness, disinterest, time|9|||
147559468|NCT03257462|532205395|FG000|Cohort A|Lost to Follow-up|1|||
147559469|NCT03257462|532205396|FG001|Cohort A|Lost to Follow-up|0|||
147559470|NCT03257462|532205397|FG002|Cohort A|Lost to Follow-up|0|||
147225883|NCT01810432|531000331|FG001|Washout|Protocol Violation|1|||
147559471|NCT03257462|532205398|FG003|Cohort A|Lost to Follow-up|0|||
147110029|NCT03965923|530565604|FG003|Overall Study|Other reason|1|||
147559472|NCT03257462|532205395|FG000|Cohort B|Discontinued due to Sponsor decision|0|||
147110030|NCT03965923|530565605|FG004|Overall Study|Other reason|0|||
147110031|NCT03965923|530565606|FG005|Overall Study|Other reason|0|||
147110032|NCT03965923|530565607|FG006|Overall Study|Other reason|0|||
147110033|NCT03965923|530565608|FG007|Overall Study|Other reason|0|||
147110034|NCT03965923|530565609|FG008|Overall Study|Other reason|0|||
147110035|NCT03965923|530565610|FG009|Overall Study|Other reason|0|||
147110036|NCT03965923|530565611|FG010|Overall Study|Other reason|2|||
147110037|NCT03965923|530565612|FG011|Overall Study|Other reason|0|||
147110038|NCT02452190|530565613|FG000|Overall Study|Withdrawal by Sponsor|1|||
147110039|NCT02452190|530565614|FG001|Overall Study|Withdrawal by Sponsor|3|||
147110040|NCT02452190|530565613|FG000|Overall Study|Pregnancy|1|||
147110041|NCT02452190|530565614|FG001|Overall Study|Pregnancy|0|||
147110042|NCT02452190|530565613|FG000|Overall Study|Investigator's Decision|2|||
147110043|NCT02452190|530565614|FG001|Overall Study|Investigator's Decision|0|||
147110044|NCT02452190|530565613|FG000|Overall Study|Lack of Efficacy|3|||
147110045|NCT02452190|530565614|FG001|Overall Study|Lack of Efficacy|1|||
147110046|NCT02452190|530565613|FG000|Overall Study|Lost to Follow-up|4|||
147110047|NCT02452190|530565614|FG001|Overall Study|Lost to Follow-up|3|||
147110048|NCT02452190|530565613|FG000|Overall Study|Adverse Event|2|||
147110049|NCT02452190|530565614|FG001|Overall Study|Adverse Event|5|||
147110050|NCT02452190|530565613|FG000|Overall Study|Withdrawal by Subject|20|||
147110051|NCT02452190|530565614|FG001|Overall Study|Withdrawal by Subject|11|||
147110052|NCT02452190|530565613|FG000|Overall Study|Noncompliance with study drug|1|||
147110053|NCT02452190|530565614|FG001|Overall Study|Noncompliance with study drug|0|||
147110054|NCT02452190|530565613|FG000|Overall Study|Participant traveled abroad|1|||
147444210|NCT01308008|531792532|FG001|4 Weeks|Illness, disinterest, time|2|||
147444211|NCT03357731|531792533|FG000|Overall Study|Withdrew consent due to personal reasons|0|||
147110055|NCT02452190|530565614|FG001|Overall Study|Participant traveled abroad|0|||
147110056|NCT02452190|530565613|FG000|Overall Study|Death|0|||
147110057|NCT02452190|530565614|FG001|Overall Study|Death|1|||
147110058|NCT06001021|530565617|FG000|15 August 2023 to 30 September 2023|Withdrawal by Subject|2|||
147110059|NCT06001021|530565618|FG001|15 August 2023 to 30 September 2023|Withdrawal by Subject|0|||
147110060|NCT06001021|530565619|FG002|15 August 2023 to 30 September 2023|Withdrawal by Subject|0|||
147110061|NCT06001021|530565620|FG003|15 August 2023 to 30 September 2023|Withdrawal by Subject|8|||
147110062|NCT06001021|530565621|FG004|15 August 2023 to 30 September 2023|Withdrawal by Subject|6|||
147110063|NCT06001021|530565622|FG005|15 August 2023 to 30 September 2023|Withdrawal by Subject|2|||
147110064|NCT06001021|530565623|FG006|15 August 2023 to 30 September 2023|Withdrawal by Subject|0|||
147110065|NCT06001021|530565617|FG000|1 October 2023 to 28 October 2023)|Withdrawal by Subject|14|||
147110066|NCT06001021|530565618|FG001|1 October 2023 to 28 October 2023)|Withdrawal by Subject|0|||
147110067|NCT06001021|530565619|FG002|1 October 2023 to 28 October 2023)|Withdrawal by Subject|0|||
147110068|NCT06001021|530565620|FG003|1 October 2023 to 28 October 2023)|Withdrawal by Subject|8|||
147110069|NCT06001021|530565621|FG004|1 October 2023 to 28 October 2023)|Withdrawal by Subject|10|||
147110070|NCT06001021|530565622|FG005|1 October 2023 to 28 October 2023)|Withdrawal by Subject|0|||
147110071|NCT06001021|530565623|FG006|1 October 2023 to 28 October 2023)|Withdrawal by Subject|0|||
147110072|NCT00390013|530565624|FG000|Phase 1|tired|0|||
147110073|NCT00390013|530565625|FG001|Phase 1|tired|0|||
147110074|NCT00390013|530565626|FG002|Phase 1|tired|0|||
147110075|NCT00390013|530565627|FG003|Phase 1|tired|1|||
147110076|NCT00390013|530565624|FG000|Phase 2 First Treatment|tired|1|||
147110077|NCT00390013|530565625|FG001|Phase 2 First Treatment|tired|0|||
147110078|NCT00390013|530565626|FG002|Phase 2 First Treatment|tired|0|||
147110079|NCT00390013|530565627|FG003|Phase 2 First Treatment|tired|0|||
147110080|NCT00390013|530565624|FG000|Phase 2 First Treatment|Withdrawal by Subject|0|||
147110081|NCT00390013|530565625|FG001|Phase 2 First Treatment|Withdrawal by Subject|1|||
147110082|NCT00390013|530565626|FG002|Phase 2 First Treatment|Withdrawal by Subject|0|||
147110083|NCT00390013|530565627|FG003|Phase 2 First Treatment|Withdrawal by Subject|0|||
147110084|NCT02225587|530565628|FG000|Overall Study|Adverse Event|5|||
147110085|NCT02225587|530565629|FG001|Overall Study|Adverse Event|5|||
147110086|NCT02225587|530565628|FG000|Overall Study|Lost to Follow-up|5|||
147110087|NCT02225587|530565629|FG001|Overall Study|Lost to Follow-up|5|||
147225884|NCT01810432|531000330|FG000|Washout|Adverse Event|1|||
147444212|NCT03357731|531792534|FG001|Overall Study|Withdrew consent due to personal reasons|0|||
147444213|NCT03357731|531792535|FG002|Overall Study|Withdrew consent due to personal reasons|0|||
147444214|NCT03357731|531792536|FG003|Overall Study|Withdrew consent due to personal reasons|0|||
147444215|NCT03357731|531792537|FG004|Overall Study|Withdrew consent due to personal reasons|1|||
147559473|NCT03257462|532205396|FG001|Cohort B|Discontinued due to Sponsor decision|1|||
147110088|NCT02225587|530565628|FG000|Overall Study|Non-Compliance With Study Drug|1|||
147110089|NCT02225587|530565629|FG001|Overall Study|Non-Compliance With Study Drug|0|||
147110090|NCT02225587|530565628|FG000|Overall Study|Physician Decision|2|||
147110091|NCT02225587|530565629|FG001|Overall Study|Physician Decision|0|||
147110092|NCT02225587|530565628|FG000|Overall Study|Protocol Violation|1|||
147110093|NCT02225587|530565629|FG001|Overall Study|Protocol Violation|0|||
147110094|NCT02225587|530565628|FG000|Overall Study|Participant Moved|1|||
147110095|NCT02225587|530565629|FG001|Overall Study|Participant Moved|0|||
147225885|NCT01810432|531000331|FG001|Washout|Adverse Event|0|||
147444216|NCT03357731|531792538|FG005|Overall Study|Withdrew consent due to personal reasons|0|||
147444217|NCT03357731|531792533|FG000|Overall Study|Acute bradycardia and hypotension|0|||
147444218|NCT03357731|531792534|FG001|Overall Study|Acute bradycardia and hypotension|0|||
147444219|NCT03357731|531792535|FG002|Overall Study|Acute bradycardia and hypotension|0|||
147444220|NCT03357731|531792536|FG003|Overall Study|Acute bradycardia and hypotension|1|||
147444221|NCT03357731|531792537|FG004|Overall Study|Acute bradycardia and hypotension|0|||
147444222|NCT03357731|531792538|FG005|Overall Study|Acute bradycardia and hypotension|0|||
147444223|NCT03357731|531792533|FG000|Overall Study|Adverse Event|0|||
147444224|NCT03357731|531792534|FG001|Overall Study|Adverse Event|0|||
147444225|NCT03357731|531792535|FG002|Overall Study|Adverse Event|0|||
147444226|NCT03357731|531792536|FG003|Overall Study|Adverse Event|0|||
147444227|NCT03357731|531792537|FG004|Overall Study|Adverse Event|0|||
147444228|NCT03357731|531792538|FG005|Overall Study|Adverse Event|1|||
147444229|NCT03357731|531792533|FG000|Overall Study|Hypotension|0|||
147444230|NCT03357731|531792534|FG001|Overall Study|Hypotension|0|||
147444231|NCT03357731|531792535|FG002|Overall Study|Hypotension|1|||
147444232|NCT03357731|531792536|FG003|Overall Study|Hypotension|1|||
147444233|NCT03357731|531792537|FG004|Overall Study|Hypotension|0|||
147444234|NCT03357731|531792538|FG005|Overall Study|Hypotension|0|||
147444235|NCT03357731|531792533|FG000|Overall Study|Lost to Follow-up|0|||
147444236|NCT03357731|531792534|FG001|Overall Study|Lost to Follow-up|0|||
147444237|NCT03357731|531792535|FG002|Overall Study|Lost to Follow-up|0|||
147444238|NCT03357731|531792536|FG003|Overall Study|Lost to Follow-up|1|||
147444239|NCT03357731|531792537|FG004|Overall Study|Lost to Follow-up|0|||
147444240|NCT03357731|531792538|FG005|Overall Study|Lost to Follow-up|0|||
147444241|NCT01417195|531792539|FG000|Overall Study|Stimulation failure|1|||
147444242|NCT01417195|531792540|FG001|Overall Study|Stimulation failure|0|||
147444243|NCT01417195|531792539|FG000|Overall Study|No embryos for transfer|0|||
147444244|NCT01417195|531792540|FG001|Overall Study|No embryos for transfer|1|||
147444245|NCT01417195|531792539|FG000|Overall Study|No transfer due to risk of OHSS|1|||
147444246|NCT01417195|531792540|FG001|Overall Study|No transfer due to risk of OHSS|0|||
147444247|NCT01417195|531792539|FG000|Overall Study|No transfer due to elevated progesterone|1|||
147444248|NCT01417195|531792540|FG001|Overall Study|No transfer due to elevated progesterone|0|||
147444249|NCT02257372|531792543|FG000|Overall Study|Adverse Event|3|||
147444250|NCT02257372|531792544|FG001|Overall Study|Adverse Event|7|||
147444251|NCT02257372|531792543|FG000|Overall Study|Lack of Efficacy|2|||
147444252|NCT02257372|531792544|FG001|Overall Study|Lack of Efficacy|1|||
147444253|NCT02257372|531792543|FG000|Overall Study|Protocol Violation|1|||
147444254|NCT02257372|531792544|FG001|Overall Study|Protocol Violation|1|||
147444255|NCT02257372|531792543|FG000|Overall Study|Lost to Follow-up|0|||
147444256|NCT02257372|531792544|FG001|Overall Study|Lost to Follow-up|1|||
147444257|NCT02257372|531792543|FG000|Overall Study|Withdrew consent|1|||
147444258|NCT02257372|531792544|FG001|Overall Study|Withdrew consent|0|||
147444259|NCT01849874|531792546|FG000|Overall Study|Death|89|||
147444260|NCT01849874|531792547|FG001|Overall Study|Death|42|||
147444261|NCT01849874|531792546|FG000|Overall Study|Withdrawal by Subject|17|||
147444262|NCT01849874|531792547|FG001|Overall Study|Withdrawal by Subject|16|||
147444263|NCT01849874|531792546|FG000|Overall Study|Lost to Follow-up|3|||
147444264|NCT01849874|531792547|FG001|Overall Study|Lost to Follow-up|2|||
147444265|NCT01849874|531792546|FG000|Overall Study|Study Termination By Sponsor|93|||
147444266|NCT01849874|531792547|FG001|Overall Study|Study Termination By Sponsor|48|||
147110096|NCT02225587|530565628|FG000|Overall Study|Withdrawal by Subject|13|||
147110097|NCT02225587|530565629|FG001|Overall Study|Withdrawal by Subject|28|||
147110098|NCT00924898|530565630|FG000|Overall Study|Withdrawal by Subject|2|||
147110099|NCT05291689|530565636|FG000|Overall Study|Adverse Event|3|||
147110100|NCT05291689|530565636|FG000|Overall Study|Lack of Efficacy|10|||
147110101|NCT05291689|530565636|FG000|Overall Study|Withdrawal by Subject|4|||
147110102|NCT01931098|530565637|FG000|Overall Study|Withdrawal by Subject|0|||
147110103|NCT01931098|530565638|FG001|Overall Study|Withdrawal by Subject|1|||
147110104|NCT01931098|530565637|FG000|Overall Study|Enrolled in different protocol|0|||
147110105|NCT01931098|530565638|FG001|Overall Study|Enrolled in different protocol|1|||
147110106|NCT01931098|530565637|FG000|Overall Study|Unable to begin trmt:active infection|0|||
147225886|NCT01810432|531000330|FG000|Period 2|Withdrawal by Subject|2|||
147444267|NCT01849874|531792546|FG000|Overall Study|Completed as per protocol amendment 6|3|||
147444268|NCT01849874|531792547|FG001|Overall Study|Completed as per protocol amendment 6|0|||
147444269|NCT01849874|531792546|FG000|Overall Study|Physician Decision|7|||
147444270|NCT01849874|531792547|FG001|Overall Study|Physician Decision|1|||
147444271|NCT01849874|531792546|FG000|Overall Study|Other|16|||
147444272|NCT01849874|531792547|FG001|Overall Study|Other|4|||
147444273|NCT02104583|531792548|FG000|Overall Study|New ICD or CRT-D implanted|2|||
147444274|NCT02104583|531792549|FG001|Overall Study|New ICD or CRT-D implanted|0|||
147444275|NCT02104583|531792550|FG002|Overall Study|New ICD or CRT-D implanted|1|||
147444276|NCT02104583|531792551|FG003|Overall Study|New ICD or CRT-D implanted|0|||
147444277|NCT02104583|531792552|FG004|Overall Study|New ICD or CRT-D implanted|0|||
147444278|NCT02104583|531792548|FG000|Overall Study|Death|2|||
147444279|NCT02104583|531792549|FG001|Overall Study|Death|1|||
147110107|NCT01931098|530565638|FG001|Overall Study|Unable to begin trmt:active infection|1|||
147110108|NCT01931098|530565637|FG000|Overall Study|Refused further treatment|0|||
147110109|NCT01931098|530565638|FG001|Overall Study|Refused further treatment|1|||
147110110|NCT02278354|530565642|FG000|Overall Study|Lost to Follow-up|2|||
147110111|NCT02278354|530565643|FG001|Overall Study|Lost to Follow-up|2|||
147110112|NCT02278354|530565642|FG000|Overall Study|Withdrawal by Subject|0|||
147110113|NCT02278354|530565643|FG001|Overall Study|Withdrawal by Subject|1|||
147110114|NCT02278354|530565642|FG000|Overall Study|<10 professional fights|2|||
147110115|NCT02278354|530565643|FG001|Overall Study|<10 professional fights|0|||
147110116|NCT00314145|530565647|FG000|Overall Study|Withdrawal by Subject|8|||
147110117|NCT00314145|530565648|FG001|Overall Study|Withdrawal by Subject|10|||
147110118|NCT00314145|530565647|FG000|Overall Study|Lost to Follow-up|5|||
147110119|NCT00314145|530565648|FG001|Overall Study|Lost to Follow-up|12|||
147110120|NCT00314145|530565647|FG000|Overall Study|Physician Decision|3|||
147110121|NCT00314145|530565648|FG001|Overall Study|Physician Decision|4|||
147110122|NCT00314145|530565647|FG000|Overall Study|Adverse Event|0|||
147110123|NCT00314145|530565648|FG001|Overall Study|Adverse Event|3|||
147110124|NCT00314145|530565647|FG000|Overall Study|Protocol Violation|3|||
147110125|NCT00314145|530565648|FG001|Overall Study|Protocol Violation|0|||
147110126|NCT00314145|530565647|FG000|Overall Study|Sponsor Decision|2|||
147110127|NCT00314145|530565648|FG001|Overall Study|Sponsor Decision|0|||
147110128|NCT02572167|530565651|FG000|Overall Study|Withdrawal by Subject|0|||
147110129|NCT02572167|530565652|FG001|Overall Study|Withdrawal by Subject|3|||
147110130|NCT02572167|530565653|FG002|Overall Study|Withdrawal by Subject|0|||
147110131|NCT02572167|530565651|FG000|Overall Study|Lost to Follow-up|2|||
147110132|NCT02572167|530565652|FG001|Overall Study|Lost to Follow-up|5|||
147110133|NCT02572167|530565653|FG002|Overall Study|Lost to Follow-up|3|||
147110134|NCT02572167|530565651|FG000|Overall Study|Death|0|||
147110135|NCT02572167|530565652|FG001|Overall Study|Death|8|||
147110136|NCT02572167|530565653|FG002|Overall Study|Death|3|||
147110137|NCT02572167|530565651|FG000|Overall Study|Did not meet inclusion criteria|0|||
147110138|NCT02572167|530565652|FG001|Overall Study|Did not meet inclusion criteria|0|||
147110139|NCT02572167|530565653|FG002|Overall Study|Did not meet inclusion criteria|1|||
147110140|NCT02572167|530565651|FG000|Overall Study|Study closure by Sponsor|4|||
147110141|NCT02572167|530565652|FG001|Overall Study|Study closure by Sponsor|40|||
147110142|NCT02572167|530565653|FG002|Overall Study|Study closure by Sponsor|24|||
147110143|NCT00976027|530565654|FG000|Overall Study|Serious Adverse Event|36|||
147110144|NCT00976027|530565655|FG001|Overall Study|Serious Adverse Event|17|||
147110145|NCT00976027|530565654|FG000|Overall Study|Adverse Event|0|||
147110146|NCT00976027|530565655|FG001|Overall Study|Adverse Event|2|||
147110147|NCT00976027|530565654|FG000|Overall Study|Protocol Violation|60|||
147110148|NCT00976027|530565655|FG001|Overall Study|Protocol Violation|27|||
147110149|NCT00976027|530565654|FG000|Overall Study|Lost to Follow-up|208|||
147110150|NCT00976027|530565655|FG001|Overall Study|Lost to Follow-up|103|||
147110151|NCT00976027|530565654|FG000|Overall Study|Withdrawal by Subject|107|||
147225887|NCT01810432|531000331|FG001|Period 2|Withdrawal by Subject|1|||
147225888|NCT01810432|531000330|FG000|Period 2|Physician Decision|1|||
147225889|NCT01810432|531000331|FG001|Period 2|Physician Decision|0|||
147225890|NCT01810432|531000330|FG000|Period 2|Lost to Follow-up|1|||
147225891|NCT01810432|531000331|FG001|Period 2|Lost to Follow-up|1|||
147225892|NCT00057954|531000332|FG000|Overall Study|Death|1|||
147225893|NCT00057954|531000332|FG000|Overall Study|Disease progression|1|||
147225894|NCT00559754|531000333|FG000|Overall Study|Disease progression|1|||
147225895|NCT00559754|531000333|FG000|Overall Study|Adverse Event|5|||
147225896|NCT00559754|531000333|FG000|Overall Study|Protocol Violation|1|||
147225897|NCT00559754|531000333|FG000|Overall Study|Investigator criteria|2|||
147225898|NCT00559754|531000333|FG000|Overall Study|Withdrawal by Subject|2|||
147225899|NCT01264016|531000334|FG000|Overall Study|Withdrawal by Subject|1|||
147225900|NCT01264016|531000334|FG000|Overall Study|Felt faint at sight of blood|1|||
147110152|NCT00976027|530565655|FG001|Overall Study|Withdrawal by Subject|66|||
147110153|NCT04435626|530565658|FG000|Overall Study|Lost to Follow-up|1|||
147110154|NCT04435626|530565659|FG001|Overall Study|Lost to Follow-up|5|||
147110155|NCT04435626|530565658|FG000|Overall Study|Withdrawal by Subject|6|||
147110156|NCT04435626|530565659|FG001|Overall Study|Withdrawal by Subject|7|||
147110157|NCT04435626|530565658|FG000|Overall Study|major GCP violations|8|||
147225901|NCT02117414|531000335|FG000|Overall Study|Death|5|||
147225902|NCT02117414|531000336|FG001|Overall Study|Death|2|||
147225903|NCT02117414|531000335|FG000|Overall Study|Withdrawal by Subject|10|||
147110158|NCT04435626|530565659|FG001|Overall Study|major GCP violations|7|||
147110159|NCT01160614|530565660|FG000|Overall Study|Withdrawal by Subject|0|||
147110160|NCT01160614|530565661|FG001|Overall Study|Withdrawal by Subject|2|||
147110161|NCT03805841|530565662|FG000|Overall Study|Clinical Progression|2|||
147110162|NCT03805841|530565663|FG001|Overall Study|Clinical Progression|0|||
147225904|NCT02117414|531000336|FG001|Overall Study|Withdrawal by Subject|4|||
147225905|NCT01629706|531000337|FG000|Phase 1 PureVision|Screen Failure|4|||
147225906|NCT01629706|531000337|FG000|Phase 1 PureVision|Slit Lamp Finding prior to Dispense|1|||
147225907|NCT01629706|531000337|FG000|Phase 1 PureVision|Inconvenience prior to Dispense|1|||
147225908|NCT01629706|531000337|FG000|Phase 1 PureVision|No Solution-Induced Corneal Staining|3|||
147225909|NCT01629706|531000337|FG000|Phase 2 Habitual|Screen Failure|6|||
147110163|NCT03805841|530565664|FG002|Overall Study|Clinical Progression|0|||
147110164|NCT03805841|530565662|FG000|Overall Study|Death|0|||
147110165|NCT03805841|530565663|FG001|Overall Study|Death|3|||
147110166|NCT03805841|530565664|FG002|Overall Study|Death|1|||
147110167|NCT03805841|530565662|FG000|Overall Study|Lost to Follow-up|0|||
147110168|NCT03805841|530565663|FG001|Overall Study|Lost to Follow-up|0|||
147110169|NCT03805841|530565664|FG002|Overall Study|Lost to Follow-up|1|||
147110170|NCT03805841|530565662|FG000|Overall Study|Withdrawal by Subject|2|||
147110171|NCT03805841|530565663|FG001|Overall Study|Withdrawal by Subject|3|||
147110172|NCT03805841|530565664|FG002|Overall Study|Withdrawal by Subject|0|||
147110173|NCT03805841|530565662|FG000|Overall Study|Progressive disease according to RECIST 1.1 at any time during the study|1|||
147110174|NCT03805841|530565663|FG001|Overall Study|Progressive disease according to RECIST 1.1 at any time during the study|4|||
147110175|NCT03805841|530565664|FG002|Overall Study|Progressive disease according to RECIST 1.1 at any time during the study|1|||
147110176|NCT02382380|530565666|FG000|Overall Study|Withdrawal by Subject|2|||
147110177|NCT02382380|530565667|FG001|Overall Study|Withdrawal by Subject|2|||
147110178|NCT02382380|530565666|FG000|Overall Study|Lost to Follow-up|0|||
147110179|NCT02382380|530565667|FG001|Overall Study|Lost to Follow-up|1|||
147110180|NCT01295944|530565668|FG000|Overall Study|Switched to alternative treatment|1|||
147110181|NCT01295944|530565668|FG000|Overall Study|Ineligible|9|||
147110182|NCT01295944|530565668|FG000|Overall Study|Withdrawal by Subject|1|||
147110183|NCT01295944|530565668|FG000|Overall Study|Participant chose to be treated in Peru|1|||
147110184|NCT01295944|530565668|FG000|Overall Study|Participant wanting a local endoscopy surgery to remove more tumor|1|||
147110185|NCT01295944|530565668|FG000|Overall Study|Physician Decision|1|||
147110186|NCT01295944|530565668|FG000|Overall Study|Participant decided to pursue other treatment before beginning protocol treatment|1|||
147110187|NCT01295944|530565668|FG000|Overall Study|Disease progression|4|||
147110188|NCT01295944|530565668|FG000|Overall Study|Transferred care before starting new treatment|1|||
147110189|NCT01802281|530565669|FG000|Overall Study|Death|1|||
147110190|NCT01802281|530565670|FG001|Overall Study|Death|2|||
147110191|NCT01802281|530565669|FG000|Overall Study|Withdrawal by Subject|2|||
147110192|NCT01802281|530565670|FG001|Overall Study|Withdrawal by Subject|1|||
147110193|NCT01802281|530565669|FG000|Overall Study|Ineligible|5|||
147110194|NCT01802281|530565670|FG001|Overall Study|Ineligible|3|||
147110195|NCT00831844|530565671|FG000|Overall Study|Adverse Event|2|||
147110196|NCT00831844|530565672|FG001|Overall Study|Adverse Event|0|||
147110197|NCT00831844|530565673|FG002|Overall Study|Adverse Event|0|||
147110198|NCT00831844|530565674|FG003|Overall Study|Adverse Event|0|||
147110199|NCT00831844|530565675|FG004|Overall Study|Adverse Event|1|||
147110200|NCT00831844|530565676|FG005|Overall Study|Adverse Event|1|||
147110201|NCT00831844|530565677|FG006|Overall Study|Adverse Event|2|||
147110202|NCT00831844|530565678|FG007|Overall Study|Adverse Event|0|||
147110203|NCT00831844|530565679|FG008|Overall Study|Adverse Event|0|||
147110204|NCT00831844|530565680|FG009|Overall Study|Adverse Event|0|||
147110205|NCT00831844|530565671|FG000|Overall Study|Death|0|||
147110206|NCT00831844|530565672|FG001|Overall Study|Death|0|||
147110207|NCT00831844|530565673|FG002|Overall Study|Death|0|||
147110208|NCT00831844|530565674|FG003|Overall Study|Death|1|||
147110209|NCT00831844|530565675|FG004|Overall Study|Death|0|||
147110210|NCT00831844|530565676|FG005|Overall Study|Death|0|||
147225910|NCT01629706|531000337|FG000|Phase 2 Habitual|Slit Lamp Finding prior to Dispense|1|||
147225911|NCT01629706|531000337|FG000|Phase 2 Habitual|Relocation prior to Dispense|1|||
147225912|NCT01629706|531000337|FG000|Phase 2 Habitual|Lost to Follow Up prior to Dispense|1|||
147225913|NCT01629706|531000337|FG000|Phase 2 Habitual|Lost to Follow Up after Dispense|1|||
147225914|NCT02537574|531000339|FG000|Overall Study|Adverse Event|1|||
147225915|NCT02537574|531000340|FG001|Overall Study|Adverse Event|3|||
147225916|NCT02537574|531000341|FG002|Overall Study|Adverse Event|2|||
147225917|NCT02537574|531000339|FG000|Overall Study|Lost to Follow-up|40|||
147225918|NCT02537574|531000340|FG001|Overall Study|Lost to Follow-up|51|||
147225919|NCT02537574|531000341|FG002|Overall Study|Lost to Follow-up|55|||
147225920|NCT02537574|531000339|FG000|Overall Study|Noncompliance with study drug|0|||
147225921|NCT02537574|531000340|FG001|Overall Study|Noncompliance with study drug|1|||
147225922|NCT02537574|531000341|FG002|Overall Study|Noncompliance with study drug|1|||
147225923|NCT02537574|531000339|FG000|Overall Study|Physician Decision|2|||
147225924|NCT02537574|531000340|FG001|Overall Study|Physician Decision|0|||
147225925|NCT02537574|531000341|FG002|Overall Study|Physician Decision|0|||
147110211|NCT00831844|530565677|FG006|Overall Study|Death|0|||
147110212|NCT00831844|530565678|FG007|Overall Study|Death|0|||
147110213|NCT00831844|530565679|FG008|Overall Study|Death|0|||
147110214|NCT00831844|530565680|FG009|Overall Study|Death|0|||
147110215|NCT00831844|530565671|FG000|Overall Study|Lack of Efficacy|8|||
147110216|NCT00831844|530565672|FG001|Overall Study|Lack of Efficacy|10|||
147110217|NCT00831844|530565673|FG002|Overall Study|Lack of Efficacy|15|||
147110218|NCT00831844|530565674|FG003|Overall Study|Lack of Efficacy|8|||
147110219|NCT00831844|530565675|FG004|Overall Study|Lack of Efficacy|11|||
147225926|NCT02537574|531000339|FG000|Overall Study|Protocol Violation|4|||
147110220|NCT00831844|530565676|FG005|Overall Study|Lack of Efficacy|17|||
147110221|NCT00831844|530565677|FG006|Overall Study|Lack of Efficacy|8|||
147225927|NCT02537574|531000340|FG001|Overall Study|Protocol Violation|2|||
147110222|NCT00831844|530565678|FG007|Overall Study|Lack of Efficacy|9|||
147110223|NCT00831844|530565679|FG008|Overall Study|Lack of Efficacy|7|||
147110224|NCT00831844|530565680|FG009|Overall Study|Lack of Efficacy|0|||
147110225|NCT00831844|530565671|FG000|Overall Study|Physician Decision|0|||
147110226|NCT00831844|530565672|FG001|Overall Study|Physician Decision|1|||
147110227|NCT00831844|530565673|FG002|Overall Study|Physician Decision|3|||
147110228|NCT00831844|530565674|FG003|Overall Study|Physician Decision|1|||
147110229|NCT00831844|530565675|FG004|Overall Study|Physician Decision|1|||
147110230|NCT00831844|530565676|FG005|Overall Study|Physician Decision|1|||
147110231|NCT00831844|530565677|FG006|Overall Study|Physician Decision|0|||
147110232|NCT00831844|530565678|FG007|Overall Study|Physician Decision|0|||
147110233|NCT00831844|530565679|FG008|Overall Study|Physician Decision|1|||
147110234|NCT00831844|530565680|FG009|Overall Study|Physician Decision|0|||
147110235|NCT00831844|530565671|FG000|Overall Study|Withdrawal by Subject|0|||
147110236|NCT00831844|530565672|FG001|Overall Study|Withdrawal by Subject|0|||
147110237|NCT00831844|530565673|FG002|Overall Study|Withdrawal by Subject|1|||
147110238|NCT00831844|530565674|FG003|Overall Study|Withdrawal by Subject|0|||
147110239|NCT00831844|530565675|FG004|Overall Study|Withdrawal by Subject|0|||
147110240|NCT00831844|530565676|FG005|Overall Study|Withdrawal by Subject|0|||
147110241|NCT00831844|530565677|FG006|Overall Study|Withdrawal by Subject|0|||
147110242|NCT00831844|530565678|FG007|Overall Study|Withdrawal by Subject|1|||
147110243|NCT00831844|530565679|FG008|Overall Study|Withdrawal by Subject|1|||
147110244|NCT00831844|530565680|FG009|Overall Study|Withdrawal by Subject|0|||
147110245|NCT00831844|530565671|FG000|Overall Study|Ineligible|0|||
147110246|NCT00831844|530565672|FG001|Overall Study|Ineligible|1|||
147110247|NCT00831844|530565673|FG002|Overall Study|Ineligible|1|||
147110248|NCT00831844|530565674|FG003|Overall Study|Ineligible|0|||
147110249|NCT00831844|530565675|FG004|Overall Study|Ineligible|1|||
147110250|NCT00831844|530565676|FG005|Overall Study|Ineligible|0|||
147110251|NCT00831844|530565677|FG006|Overall Study|Ineligible|0|||
147110252|NCT00831844|530565678|FG007|Overall Study|Ineligible|0|||
147110253|NCT00831844|530565679|FG008|Overall Study|Ineligible|0|||
147110254|NCT00831844|530565680|FG009|Overall Study|Ineligible|0|||
147110255|NCT00315445|530565681|FG000|Overall Study|Adverse Event|7|||
147110256|NCT00315445|530565682|FG001|Overall Study|Adverse Event|12|||
147110257|NCT00315445|530565683|FG002|Overall Study|Adverse Event|15|||
147110258|NCT00315445|530565681|FG000|Overall Study|Lack of Efficacy|16|||
147110259|NCT00315445|530565682|FG001|Overall Study|Lack of Efficacy|1|||
147110260|NCT00315445|530565683|FG002|Overall Study|Lack of Efficacy|7|||
147110261|NCT00315445|530565681|FG000|Overall Study|Lost to Follow-up|1|||
147110262|NCT00315445|530565682|FG001|Overall Study|Lost to Follow-up|0|||
147110263|NCT00315445|530565683|FG002|Overall Study|Lost to Follow-up|1|||
147110264|NCT00315445|530565681|FG000|Overall Study|Protocol Violation|2|||
147110265|NCT00315445|530565682|FG001|Overall Study|Protocol Violation|0|||
147110266|NCT00315445|530565683|FG002|Overall Study|Protocol Violation|1|||
147110267|NCT00315445|530565681|FG000|Overall Study|Other|1|||
147110268|NCT00315445|530565682|FG001|Overall Study|Other|3|||
147110269|NCT00315445|530565683|FG002|Overall Study|Other|0|||
147110270|NCT00858988|530565693|FG000|Analysis|Lactulose unable to be detected in urine|2|||
147110271|NCT00858988|530565694|FG001|Analysis|Lactulose unable to be detected in urine|1|||
147110272|NCT01706328|530565695|FG000|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|140|||
147110273|NCT01706328|530565696|FG001|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
147110274|NCT01706328|530565697|FG002|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
147110275|NCT01706328|530565695|FG000|2-week Run-in Period|Withdrawal by Subject|15|||
147110276|NCT01706328|530565696|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
147110277|NCT01706328|530565697|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
147110278|NCT01706328|530565695|FG000|2-week Run-in Period|Physician Decision|4|||
147110279|NCT01706328|530565696|FG001|2-week Run-in Period|Physician Decision|0|||
147110280|NCT01706328|530565697|FG002|2-week Run-in Period|Physician Decision|0|||
147110281|NCT01706328|530565695|FG000|2-week Run-in Period|Adverse Event|4|||
147110282|NCT01706328|530565696|FG001|2-week Run-in Period|Adverse Event|0|||
147110283|NCT01706328|530565697|FG002|2-week Run-in Period|Adverse Event|0|||
147110284|NCT01706328|530565695|FG000|2-week Run-in Period|Lost to Follow-up|2|||
147110285|NCT01706328|530565696|FG001|2-week Run-in Period|Lost to Follow-up|0|||
147110286|NCT01706328|530565697|FG002|2-week Run-in Period|Lost to Follow-up|0|||
147110287|NCT01706328|530565695|FG000|12-week Double-blind Treatment Period|Adverse Event|0|||
147110288|NCT01706328|530565696|FG001|12-week Double-blind Treatment Period|Adverse Event|14|||
147110289|NCT01706328|530565697|FG002|12-week Double-blind Treatment Period|Adverse Event|16|||
147110290|NCT01706328|530565695|FG000|12-week Double-blind Treatment Period|Lack of Efficacy|0|||
147110291|NCT01706328|530565696|FG001|12-week Double-blind Treatment Period|Lack of Efficacy|4|||
147110292|NCT01706328|530565697|FG002|12-week Double-blind Treatment Period|Lack of Efficacy|4|||
147110293|NCT01706328|530565695|FG000|12-week Double-blind Treatment Period|Protocol Violation|0|||
147311020|NCT00806624|531307067|FG000|Overall Study|Withdrawal by Subject|6|||
147110294|NCT01706328|530565696|FG001|12-week Double-blind Treatment Period|Protocol Violation|4|||
147110295|NCT01706328|530565697|FG002|12-week Double-blind Treatment Period|Protocol Violation|2|||
147110296|NCT01706328|530565695|FG000|12-week Double-blind Treatment Period|Protocol-defined Stopping Criteria Met|0|||
147110297|NCT01706328|530565696|FG001|12-week Double-blind Treatment Period|Protocol-defined Stopping Criteria Met|11|||
147110298|NCT01706328|530565697|FG002|12-week Double-blind Treatment Period|Protocol-defined Stopping Criteria Met|9|||
147110299|NCT01706328|530565695|FG000|12-week Double-blind Treatment Period|Lost to Follow-up|0|||
147110300|NCT01706328|530565696|FG001|12-week Double-blind Treatment Period|Lost to Follow-up|3|||
147110301|NCT01706328|530565697|FG002|12-week Double-blind Treatment Period|Lost to Follow-up|1|||
147110302|NCT01706328|530565695|FG000|12-week Double-blind Treatment Period|Physician Decision|0|||
147110303|NCT01706328|530565696|FG001|12-week Double-blind Treatment Period|Physician Decision|2|||
147110304|NCT01706328|530565697|FG002|12-week Double-blind Treatment Period|Physician Decision|2|||
147110305|NCT01706328|530565695|FG000|12-week Double-blind Treatment Period|Withdrawal by Subject|0|||
147110306|NCT01706328|530565696|FG001|12-week Double-blind Treatment Period|Withdrawal by Subject|8|||
147110307|NCT01706328|530565697|FG002|12-week Double-blind Treatment Period|Withdrawal by Subject|11|||
147110308|NCT04409002|530565698|FG000|Overall Study|Disease progression prior to starting study treatment|3|||
147110309|NCT02924376|530565699|FG000|Overall Study|Progressive Disease|4|||
147110310|NCT02924376|530565700|FG001|Overall Study|Progressive Disease|0|||
147110311|NCT02924376|530565701|FG002|Overall Study|Progressive Disease|1|||
147110312|NCT02924376|530565702|FG003|Overall Study|Progressive Disease|0|||
147110313|NCT02924376|530565699|FG000|Overall Study|Death|73|||
147110314|NCT02924376|530565700|FG001|Overall Study|Death|18|||
147110315|NCT02924376|530565701|FG002|Overall Study|Death|15|||
147110316|NCT02924376|530565702|FG003|Overall Study|Death|2|||
147110317|NCT02924376|530565699|FG000|Overall Study|Lost to Follow-up|3|||
147110318|NCT02924376|530565700|FG001|Overall Study|Lost to Follow-up|0|||
147110319|NCT02924376|530565701|FG002|Overall Study|Lost to Follow-up|0|||
147110320|NCT02924376|530565702|FG003|Overall Study|Lost to Follow-up|0|||
147110321|NCT02924376|530565699|FG000|Overall Study|Study Terminated by Sponsor|19|||
147110322|NCT02924376|530565700|FG001|Overall Study|Study Terminated by Sponsor|0|||
147110323|NCT02924376|530565701|FG002|Overall Study|Study Terminated by Sponsor|0|||
147110324|NCT02924376|530565702|FG003|Overall Study|Study Terminated by Sponsor|0|||
147110325|NCT02924376|530565699|FG000|Overall Study|Physician Decision|1|||
147110326|NCT02924376|530565700|FG001|Overall Study|Physician Decision|0|||
147110327|NCT02924376|530565701|FG002|Overall Study|Physician Decision|0|||
147110328|NCT02924376|530565702|FG003|Overall Study|Physician Decision|0|||
147110329|NCT02924376|530565699|FG000|Overall Study|Withdrawal by Subject|7|||
147110330|NCT02924376|530565700|FG001|Overall Study|Withdrawal by Subject|2|||
147110331|NCT02924376|530565701|FG002|Overall Study|Withdrawal by Subject|1|||
147110332|NCT02924376|530565702|FG003|Overall Study|Withdrawal by Subject|0|||
147110333|NCT02924376|530565699|FG000|Overall Study|Rolled Over to Another Study|1|||
147110334|NCT02924376|530565700|FG001|Overall Study|Rolled Over to Another Study|0|||
147110335|NCT02924376|530565701|FG002|Overall Study|Rolled Over to Another Study|0|||
147110336|NCT02924376|530565702|FG003|Overall Study|Rolled Over to Another Study|0|||
147110337|NCT06481579|530565703|FG000|Overall Study|Death|1|||
147110338|NCT06481579|530565704|FG001|Overall Study|Death|0|||
147110339|NCT06481579|530565703|FG000|Overall Study|Withdrawal by Subject|3|||
147110340|NCT06481579|530565704|FG001|Overall Study|Withdrawal by Subject|0|||
147110341|NCT06481579|530565703|FG000|Overall Study|Other|1|||
147110342|NCT06481579|530565704|FG001|Overall Study|Other|1|||
147110343|NCT03595748|530567461|FG000|Overall Study|Death|11|||
147110344|NCT03595748|530567462|FG001|Overall Study|Death|12|||
147110345|NCT03595748|530567461|FG000|Overall Study|Withdrawal by Subject|28|||
147110346|NCT03595748|530567462|FG001|Overall Study|Withdrawal by Subject|29|||
147110347|NCT03595748|530567461|FG000|Overall Study|Protocol Violation|0|||
147110348|NCT03595748|530567462|FG001|Overall Study|Protocol Violation|1|||
147110349|NCT04809974|530567463|FG000|Lead-in Phase|Withdrawal by Subject|3|||
147110350|NCT04809974|530567464|FG001|Lead-in Phase|Withdrawal by Subject|0|||
147110351|NCT04809974|530567465|FG002|Lead-in Phase|Withdrawal by Subject|0|||
147110352|NCT04809974|530567463|FG000|Lead-in Phase|No longer eligible|11|||
147110353|NCT04809974|530567464|FG001|Lead-in Phase|No longer eligible|0|||
147110354|NCT04809974|530567465|FG002|Lead-in Phase|No longer eligible|0|||
147110355|NCT04809974|530567463|FG000|Randomized Phase|Lost to Follow-up|0|||
147110356|NCT04809974|530567464|FG001|Randomized Phase|Lost to Follow-up|1|||
147110357|NCT04809974|530567465|FG002|Randomized Phase|Lost to Follow-up|5|||
147110358|NCT04809974|530567463|FG000|Randomized Phase|Met an exclusion criteria during the study (e.g., re-infected with COVID-19, started new medication)|0|||
147110359|NCT04809974|530567464|FG001|Randomized Phase|Met an exclusion criteria during the study (e.g., re-infected with COVID-19, started new medication)|2|||
147110360|NCT04809974|530567465|FG002|Randomized Phase|Met an exclusion criteria during the study (e.g., re-infected with COVID-19, started new medication)|8|||
147110361|NCT04809974|530567463|FG000|Randomized Phase|Adverse Event|0|||
147110362|NCT04809974|530567464|FG001|Randomized Phase|Adverse Event|1|||
147110363|NCT04809974|530567465|FG002|Randomized Phase|Adverse Event|4|||
147110364|NCT04809974|530567463|FG000|Randomized Phase|Withdrawal by Subject|0|||
147110365|NCT04809974|530567464|FG001|Randomized Phase|Withdrawal by Subject|0|||
147110366|NCT04809974|530567465|FG002|Randomized Phase|Withdrawal by Subject|5|||
147110367|NCT00770809|530567475|FG000|Overall Study|Adverse Event|9|||
147110368|NCT00770809|530567476|FG001|Overall Study|Adverse Event|1|||
147110369|NCT00770809|530567477|FG002|Overall Study|Adverse Event|12|||
147110370|NCT00770809|530567475|FG000|Overall Study|Death|1|||
147110371|NCT00770809|530567476|FG001|Overall Study|Death|0|||
147110372|NCT00770809|530567477|FG002|Overall Study|Death|0|||
147110373|NCT00770809|530567475|FG000|Overall Study|Withdrawal by Subject|3|||
147110374|NCT00770809|530567476|FG001|Overall Study|Withdrawal by Subject|3|||
147110375|NCT00770809|530567477|FG002|Overall Study|Withdrawal by Subject|7|||
147110376|NCT00770809|530567475|FG000|Overall Study|Progression|2|||
147110377|NCT00770809|530567476|FG001|Overall Study|Progression|2|||
147110378|NCT00770809|530567477|FG002|Overall Study|Progression|0|||
147110379|NCT00770809|530567475|FG000|Overall Study|Complicating illness|0|||
147110380|NCT00770809|530567476|FG001|Overall Study|Complicating illness|0|||
147110381|NCT00770809|530567477|FG002|Overall Study|Complicating illness|1|||
147110382|NCT00770809|530567475|FG000|Overall Study|Other Medical Reasons|2|||
147110383|NCT00770809|530567476|FG001|Overall Study|Other Medical Reasons|4|||
147110384|NCT00770809|530567477|FG002|Overall Study|Other Medical Reasons|3|||
147110385|NCT01787838|530567479|FG000|Overall Study|refused|1413|||
147110386|NCT01240746|530567480|FG000|Overall Study|Adverse Event|2|||
147110387|NCT01240746|530567481|FG001|Overall Study|Adverse Event|0|||
147110388|NCT01240746|530567482|FG002|Overall Study|Adverse Event|10|||
147110389|NCT01240746|530567480|FG000|Overall Study|Lost to Follow-up|23|||
147110390|NCT01240746|530567481|FG001|Overall Study|Lost to Follow-up|20|||
147110391|NCT01240746|530567482|FG002|Overall Study|Lost to Follow-up|102|||
147110392|NCT01240746|530567480|FG000|Overall Study|Protocol Violation|24|||
147110393|NCT01240746|530567481|FG001|Overall Study|Protocol Violation|15|||
147110394|NCT01240746|530567482|FG002|Overall Study|Protocol Violation|72|||
147110395|NCT01240746|530567480|FG000|Overall Study|Withdrawal by Subject|10|||
147110396|NCT01240746|530567481|FG001|Overall Study|Withdrawal by Subject|13|||
147110397|NCT01240746|530567482|FG002|Overall Study|Withdrawal by Subject|59|||
147110398|NCT01126424|530567487|FG000|Overall Study|Adverse Event|0|||
147110399|NCT01126424|530567488|FG001|Overall Study|Adverse Event|0|||
147110400|NCT01126424|530567489|FG002|Overall Study|Adverse Event|0|||
147110401|NCT01126424|530567490|FG003|Overall Study|Adverse Event|0|||
147110402|NCT01126424|530567491|FG004|Overall Study|Adverse Event|1|||
147110403|NCT01126424|530567492|FG005|Overall Study|Adverse Event|0|||
147110404|NCT01126424|530567487|FG000|Overall Study|Withdrawal by Subject|0|||
147110405|NCT01126424|530567488|FG001|Overall Study|Withdrawal by Subject|0|||
147110406|NCT01126424|530567489|FG002|Overall Study|Withdrawal by Subject|1|||
147110407|NCT01126424|530567490|FG003|Overall Study|Withdrawal by Subject|3|||
147110408|NCT01126424|530567491|FG004|Overall Study|Withdrawal by Subject|1|||
147110409|NCT01126424|530567492|FG005|Overall Study|Withdrawal by Subject|0|||
147110410|NCT02127671|530567493|FG000|Overall Study|Death|2|||
147110411|NCT02127671|530567494|FG001|Overall Study|Death|2|||
147110412|NCT02127671|530567493|FG000|Overall Study|Lost to Follow-up|4|||
147110413|NCT02127671|530567494|FG001|Overall Study|Lost to Follow-up|2|||
147110414|NCT02127671|530567493|FG000|Overall Study|Physician Decision|1|||
147110415|NCT02127671|530567494|FG001|Overall Study|Physician Decision|0|||
147110416|NCT02127671|530567493|FG000|Overall Study|incarceration|0|||
147110417|NCT02127671|530567494|FG001|Overall Study|incarceration|1|||
147110418|NCT02127671|530567493|FG000|Overall Study|Did not have full Framingham risk score measured|1|||
147110419|NCT02127671|530567494|FG001|Overall Study|Did not have full Framingham risk score measured|0|||
147110420|NCT00764517|530567498|FG000|Overall Study|Adverse Event|9|||
147110421|NCT00764517|530567499|FG001|Overall Study|Adverse Event|3|||
147110422|NCT00764517|530567498|FG000|Overall Study|Death|3|||
147225928|NCT02537574|531000341|FG002|Overall Study|Protocol Violation|3|||
147225929|NCT02537574|531000339|FG000|Overall Study|Withdrawal by Subject|37|||
147225930|NCT02537574|531000340|FG001|Overall Study|Withdrawal by Subject|27|||
147225931|NCT02537574|531000341|FG002|Overall Study|Withdrawal by Subject|29|||
147225932|NCT02537574|531000339|FG000|Overall Study|Lack of Efficacy|14|||
147225933|NCT02537574|531000340|FG001|Overall Study|Lack of Efficacy|16|||
147225934|NCT02537574|531000341|FG002|Overall Study|Lack of Efficacy|15|||
147225935|NCT02537574|531000339|FG000|Overall Study|Duplicate Patient|1|||
147225936|NCT02537574|531000340|FG001|Overall Study|Duplicate Patient|0|||
147110423|NCT00764517|530567499|FG001|Overall Study|Death|11|||
147225937|NCT02537574|531000341|FG002|Overall Study|Duplicate Patient|0|||
147225938|NCT02537574|531000339|FG000|Overall Study|Patient not Stable|0|||
147225939|NCT02537574|531000340|FG001|Overall Study|Patient not Stable|1|||
147110424|NCT00764517|530567498|FG000|Overall Study|Physician Decision|3|||
147110425|NCT00764517|530567499|FG001|Overall Study|Physician Decision|0|||
147110426|NCT02239328|530567505|FG000|Overall Study|Benign disease noted at time of surgery|6|||
147110427|NCT02239328|530567505|FG000|Overall Study|Equipment or website malfunction|2|||
147110428|NCT04115059|530567508|FG000|Overall Study|Withdrawal by Subject|1|||
147110429|NCT04115059|530567508|FG000|Overall Study|Lack of Efficacy|2|||
147110430|NCT03517137|530567518|FG000|Overall Study|Lack of Efficacy|1|||
147110431|NCT03517137|530567518|FG000|Overall Study|Adverse Event|2|||
147110432|NCT03517137|530567518|FG000|Overall Study|Withdrawal by Subject|2|||
147110433|NCT03517137|530567518|FG000|Overall Study|Poor therapy tolerance, ineligibility, AE, error in treatment administration|4|||
147110434|NCT03575364|530567519|FG000|Overall Study|Death|45|||
147110435|NCT03575364|530567519|FG000|Overall Study|Lost to Follow-up|114|||
147225940|NCT02537574|531000341|FG002|Overall Study|Patient not Stable|0|||
147110436|NCT03575364|530567519|FG000|Overall Study|Withdrawal by Subject|21|||
147110437|NCT03575364|530567519|FG000|Overall Study|Physician Decision|11|||
147110438|NCT03575364|530567519|FG000|Overall Study|Subject Refused Follow-up|13|||
147110439|NCT03575364|530567519|FG000|Overall Study|Hospital Administration decision, Research department closed|6|||
147110440|NCT03575364|530567519|FG000|Overall Study|Patient moved out of the state|1|||
147110441|NCT03575364|530567519|FG000|Overall Study|Patient no longer has insurance, will not return to clinic.|1|||
147110442|NCT03575364|530567519|FG000|Overall Study|Patient is lost to follow up|1|||
147110443|NCT03575364|530567519|FG000|Overall Study|Patient was unable to get to the clinic due to health problems and transportation difficulties|1|||
147110444|NCT05522751|530567521|FG000|Overall Study|Adverse Event|1|||
147110445|NCT06420232|530567522|FG000|Overall Study|Withdrawal by Subject|3|||
147110446|NCT01582451|530567528|FG000|Overall Study|Adverse Event|1|||
147110447|NCT01582451|530567529|FG001|Overall Study|Adverse Event|3|||
147110448|NCT01582451|530567528|FG000|Overall Study|Death|3|||
147110449|NCT01582451|530567529|FG001|Overall Study|Death|3|||
147110450|NCT01582451|530567528|FG000|Overall Study|Lost to Follow-up|0|||
147110451|NCT01582451|530567529|FG001|Overall Study|Lost to Follow-up|2|||
147110452|NCT01582451|530567528|FG000|Overall Study|Protocol Violation|11|||
147110453|NCT01582451|530567529|FG001|Overall Study|Protocol Violation|3|||
147110454|NCT01582451|530567528|FG000|Overall Study|Withdrawal by Subject|13|||
147110455|NCT01582451|530567529|FG001|Overall Study|Withdrawal by Subject|9|||
147110456|NCT01582451|530567528|FG000|Overall Study|Physician Decision|3|||
147110457|NCT01582451|530567529|FG001|Overall Study|Physician Decision|0|||
147110458|NCT01582451|530567528|FG000|Overall Study|Sponsor Decision|1|||
147110459|NCT01582451|530567529|FG001|Overall Study|Sponsor Decision|0|||
147110460|NCT01369433|530567530|FG000|Overall Study|Adverse Event|31|||
147110461|NCT01369433|530567531|FG001|Overall Study|Adverse Event|1|||
147110462|NCT01369433|530567530|FG000|Overall Study|Required significant surgical procedure|1|||
147110463|NCT01369433|530567531|FG001|Overall Study|Required significant surgical procedure|0|||
147110464|NCT01369433|530567530|FG000|Overall Study|Non-compliance|1|||
147110465|NCT01369433|530567531|FG001|Overall Study|Non-compliance|0|||
147110466|NCT01369433|530567530|FG000|Overall Study|Withdrawal by Subject|5|||
147110467|NCT01369433|530567531|FG001|Overall Study|Withdrawal by Subject|2|||
147110468|NCT01369433|530567530|FG000|Overall Study|Study terminated by Sponsor|67|||
147110469|NCT01369433|530567531|FG001|Overall Study|Study terminated by Sponsor|0|||
147110470|NCT01369433|530567530|FG000|Overall Study|Lost to Follow-up|1|||
147110471|NCT01369433|530567531|FG001|Overall Study|Lost to Follow-up|0|||
147110472|NCT01369433|530567530|FG000|Overall Study|Death|5|||
147110473|NCT01369433|530567531|FG001|Overall Study|Death|0|||
147110474|NCT01369433|530567530|FG000|Overall Study|Investigator discretion|6|||
147110475|NCT01369433|530567531|FG001|Overall Study|Investigator discretion|1|||
147110476|NCT01369433|530567530|FG000|Overall Study|Progressive Disease|92|||
147110477|NCT01369433|530567531|FG001|Overall Study|Progressive Disease|12|||
147110478|NCT01838876|530567532|FG000|Overall Study|Adverse Event|49|||
147110479|NCT01838876|530567532|FG000|Overall Study|Insufficient Therapeutic Response|10|||
147110480|NCT01838876|530567532|FG000|Overall Study|Protocol Violation|34|||
147110481|NCT01838876|530567532|FG000|Overall Study|Withdrawal of Consent|33|||
147110482|NCT01838876|530567532|FG000|Overall Study|Lost to Follow-up|21|||
147110483|NCT01838876|530567532|FG000|Overall Study|Study or Site Terminated by Sponsor|1|||
147110484|NCT01838876|530567532|FG000|Overall Study|Reason not Specified|7|||
147110485|NCT01838876|530567532|FG000|Overall Study|Did not meet eligibility criteria|78|||
147110486|NCT00689936|530567533|FG000|Active Treatment Phase|Adverse Event|68|||
147110487|NCT00689936|530567534|FG001|Active Treatment Phase|Adverse Event|71|||
147110488|NCT00689936|530567535|FG002|Active Treatment Phase|Adverse Event|76|||
147110489|NCT00689936|530567533|FG000|Active Treatment Phase|Disease Progression|273|||
147110490|NCT00689936|530567534|FG001|Active Treatment Phase|Disease Progression|362|||
147110491|NCT00689936|530567535|FG002|Active Treatment Phase|Disease Progression|339|||
147110492|NCT00689936|530567533|FG000|Active Treatment Phase|Withdrawal by Subject|16|||
147110493|NCT00689936|530567534|FG001|Active Treatment Phase|Withdrawal by Subject|16|||
147110494|NCT00689936|530567535|FG002|Active Treatment Phase|Withdrawal by Subject|21|||
147110495|NCT00689936|530567533|FG000|Active Treatment Phase|Death|60|||
147110496|NCT00689936|530567534|FG001|Active Treatment Phase|Death|28|||
147110497|NCT00689936|530567535|FG002|Active Treatment Phase|Death|37|||
147110498|NCT00689936|530567533|FG000|Active Treatment Phase|Lost to Follow-up|0|||
147110499|NCT00689936|530567534|FG001|Active Treatment Phase|Lost to Follow-up|2|||
147110500|NCT00689936|530567535|FG002|Active Treatment Phase|Lost to Follow-up|2|||
147110501|NCT00689936|530567533|FG000|Active Treatment Phase|Protocol Violation|2|||
147110502|NCT00689936|530567534|FG001|Active Treatment Phase|Protocol Violation|2|||
147110503|NCT00689936|530567535|FG002|Active Treatment Phase|Protocol Violation|4|||
147110504|NCT00689936|530567533|FG000|Active Treatment Phase|Study Close Out|64|||
147110505|NCT00689936|530567534|FG001|Active Treatment Phase|Study Close Out|26|||
147110506|NCT00689936|530567535|FG002|Active Treatment Phase|Study Close Out|21|||
147110507|NCT00689936|530567533|FG000|Active Treatment Phase|Miscellaneous|52|||
147110508|NCT00689936|530567534|FG001|Active Treatment Phase|Miscellaneous|34|||
147110509|NCT00689936|530567535|FG002|Active Treatment Phase|Miscellaneous|47|||
147110510|NCT00689936|530567533|FG000|Long-Term Follow Up Phase|Continue in Long Term Follow Up|127|||
147110511|NCT00689936|530567534|FG001|Long-Term Follow Up Phase|Continue in Long Term Follow Up|188|||
147110512|NCT00689936|530567535|FG002|Long-Term Follow Up Phase|Continue in Long Term Follow Up|144|||
147110513|NCT01682031|530567536|FG000|Overall Study|Withdrawal by Subject|0|||
147110514|NCT01682031|530567537|FG001|Overall Study|Withdrawal by Subject|1|||
147110515|NCT01682031|530567536|FG000|Overall Study|Adverse Event|0|||
147110516|NCT01682031|530567537|FG001|Overall Study|Adverse Event|2|||
147110517|NCT01682031|530567536|FG000|Overall Study|MRI results indicate increased nodul|0|||
147110518|NCT01682031|530567537|FG001|Overall Study|MRI results indicate increased nodul|1|||
147110519|NCT01682031|530567536|FG000|Overall Study|Patient could not swallow tablets|1|||
147110520|NCT01682031|530567537|FG001|Overall Study|Patient could not swallow tablets|0|||
147110521|NCT01682031|530567536|FG000|Overall Study|Patient stopped selenium on his own|0|||
147110522|NCT01682031|530567537|FG001|Overall Study|Patient stopped selenium on his own|1|||
147110523|NCT00933933|530567542|FG000|General Population From 16 to 89 Years|Did not meet criteria for analysis|0|||
147110524|NCT00933933|530567543|FG001|General Population From 16 to 89 Years|Did not meet criteria for analysis|20|||
147110525|NCT00933933|530567544|FG002|General Population From 16 to 89 Years|Did not meet criteria for analysis|0|||
147110526|NCT00933933|530567542|FG000|Pregnant Females Between 16-44 Years|Specimens classified incorrectly|0|||
147110527|NCT00933933|530567543|FG001|Pregnant Females Between 16-44 Years|Specimens classified incorrectly|2|||
147110528|NCT00933933|530567544|FG002|Pregnant Females Between 16-44 Years|Specimens classified incorrectly|0|||
147110529|NCT01341470|530567545|FG000|Overall Study|Sponsor decision|0|||
147110530|NCT01341470|530567546|FG001|Overall Study|Sponsor decision|0|||
147110531|NCT01341470|530567547|FG002|Overall Study|Sponsor decision|1|||
147110532|NCT01341470|530567548|FG003|Overall Study|Sponsor decision|1|||
147110533|NCT01341470|530567549|FG004|Overall Study|Sponsor decision|0|||
147110534|NCT01341470|530567550|FG005|Overall Study|Sponsor decision|1|||
147110535|NCT00311168|530567554|FG000|First Intervention|Withdrawal by Subject|2|||
147110536|NCT00311168|530567555|FG001|First Intervention|Withdrawal by Subject|2|||
147110537|NCT00311168|530567554|FG000|First Intervention|Lost to Follow-up|1|||
147110538|NCT00311168|530567555|FG001|First Intervention|Lost to Follow-up|1|||
147110539|NCT00311168|530567554|FG000|First Intervention|Protocol Violation|1|||
147110540|NCT00311168|530567555|FG001|First Intervention|Protocol Violation|1|||
147110541|NCT00311168|530567554|FG000|First Intervention|Adverse Event|1|||
147110542|NCT00311168|530567555|FG001|First Intervention|Adverse Event|0|||
147110543|NCT00311168|530567554|FG000|First Intervention|Other|2|||
147110544|NCT00311168|530567555|FG001|First Intervention|Other|2|||
147110545|NCT00311168|530567554|FG000|Second Intervention|Lost to Follow-up|9|||
147110546|NCT00311168|530567555|FG001|Second Intervention|Lost to Follow-up|2|||
147110547|NCT00311168|530567554|FG000|Second Intervention|Withdrawal by Subject|0|||
147110548|NCT00311168|530567555|FG001|Second Intervention|Withdrawal by Subject|1|||
147110549|NCT00311168|530567554|FG000|Second Intervention|Other|1|||
147110550|NCT00311168|530567555|FG001|Second Intervention|Other|1|||
147110551|NCT06001866|530567558|FG000|Overall Study|Withdrawal by Subject|0|||
147110552|NCT06001866|530567559|FG001|Overall Study|Withdrawal by Subject|2|||
147110553|NCT06001866|530567558|FG000|Overall Study|Protocol Violation|0|||
147110554|NCT06001866|530567559|FG001|Overall Study|Protocol Violation|2|||
147110555|NCT03112603|530567562|FG000|End of Randomization Period|Lost to Follow-up|3|||
147110556|NCT03112603|530567563|FG001|End of Randomization Period|Lost to Follow-up|0|||
147110557|NCT03112603|530567564|FG002|End of Randomization Period|Lost to Follow-up|0|||
147110558|NCT03112603|530567562|FG000|End of Randomization Period|Participant/Guardian Decision|7|||
147110559|NCT03112603|530567563|FG001|End of Randomization Period|Participant/Guardian Decision|14|||
147110560|NCT03112603|530567564|FG002|End of Randomization Period|Participant/Guardian Decision|0|||
147110561|NCT03112603|530567562|FG000|End of Randomization Period|Physician Decision|43|||
147110562|NCT03112603|530567563|FG001|End of Randomization Period|Physician Decision|18|||
147110563|NCT03112603|530567564|FG002|End of Randomization Period|Physician Decision|0|||
147110564|NCT03112603|530567562|FG000|End of Randomization Period|Failure to Meet Protocol Continuation Criteria|4|||
147110565|NCT03112603|530567563|FG001|End of Randomization Period|Failure to Meet Protocol Continuation Criteria|5|||
147110566|NCT03112603|530567564|FG002|End of Randomization Period|Failure to Meet Protocol Continuation Criteria|0|||
147110567|NCT03112603|530567562|FG000|End of Randomization Period|Death|10|||
147110568|NCT03112603|530567563|FG001|End of Randomization Period|Death|7|||
147110569|NCT03112603|530567564|FG002|End of Randomization Period|Death|0|||
147110570|NCT03112603|530567562|FG000|End of Randomization Period|Disease Relapse|12|||
147110571|NCT03112603|530567563|FG001|End of Randomization Period|Disease Relapse|7|||
147110572|NCT03112603|530567564|FG002|End of Randomization Period|Disease Relapse|0|||
147110573|NCT03112603|530567562|FG000|End of Randomization Period|Lack of Efficacy|25|||
147110574|NCT03112603|530567563|FG001|End of Randomization Period|Lack of Efficacy|77|||
147110575|NCT03112603|530567564|FG002|End of Randomization Period|Lack of Efficacy|0|||
147110576|NCT03112603|530567562|FG000|End of Randomization Period|Adverse Event|32|||
147110577|NCT03112603|530567563|FG001|End of Randomization Period|Adverse Event|12|||
147110578|NCT03112603|530567564|FG002|End of Randomization Period|Adverse Event|0|||
147110579|NCT03112603|530567562|FG000|End of Cross Over Period|Death|0|||
147110580|NCT03112603|530567563|FG001|End of Cross Over Period|Death|0|||
147110581|NCT03112603|530567564|FG002|End of Cross Over Period|Death|2|||
147110582|NCT03112603|530567562|FG000|End of Cross Over Period|Participant/Guardian Decision|0|||
147110583|NCT03112603|530567563|FG001|End of Cross Over Period|Participant/Guardian Decision|0|||
147110584|NCT03112603|530567564|FG002|End of Cross Over Period|Participant/Guardian Decision|7|||
147110585|NCT03112603|530567562|FG000|End of Cross Over Period|Physician Decision|0|||
147110586|NCT03112603|530567563|FG001|End of Cross Over Period|Physician Decision|0|||
147110587|NCT03112603|530567564|FG002|End of Cross Over Period|Physician Decision|29|||
147110588|NCT03112603|530567562|FG000|End of Cross Over Period|Lack of Efficacy|0|||
147110589|NCT03112603|530567563|FG001|End of Cross Over Period|Lack of Efficacy|0|||
147110590|NCT03112603|530567564|FG002|End of Cross Over Period|Lack of Efficacy|8|||
147110591|NCT03112603|530567562|FG000|End of Cross Over Period|Adverse Event|0|||
147110592|NCT03112603|530567563|FG001|End of Cross Over Period|Adverse Event|0|||
147110593|NCT03112603|530567564|FG002|End of Cross Over Period|Adverse Event|6|||
147110594|NCT03112603|530567562|FG000|End of Cross Over Period|Disease Relapse|0|||
147110595|NCT03112603|530567563|FG001|End of Cross Over Period|Disease Relapse|0|||
147110596|NCT03112603|530567564|FG002|End of Cross Over Period|Disease Relapse|2|||
147110597|NCT00207740|530567565|FG000|Overall Study|Adverse Event|4|||
147110598|NCT00207740|530567566|FG001|Overall Study|Adverse Event|14|||
147110599|NCT00207740|530567567|FG002|Overall Study|Adverse Event|14|||
147110600|NCT00207740|530567568|FG003|Overall Study|Adverse Event|11|||
147110601|NCT00207740|530567565|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
147110602|NCT00207740|530567566|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
147110603|NCT00207740|530567567|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
147110604|NCT00207740|530567568|FG003|Overall Study|Unsatisfactory therapeutic effect|4|||
147110605|NCT00207740|530567565|FG000|Overall Study|Lost to Follow-up|0|||
147110606|NCT00207740|530567566|FG001|Overall Study|Lost to Follow-up|2|||
147110607|NCT00207740|530567567|FG002|Overall Study|Lost to Follow-up|1|||
147110608|NCT00207740|530567568|FG003|Overall Study|Lost to Follow-up|1|||
147110609|NCT00207740|530567565|FG000|Overall Study|Death|0|||
147110610|NCT00207740|530567566|FG001|Overall Study|Death|0|||
147110611|NCT00207740|530567567|FG002|Overall Study|Death|0|||
147110612|NCT00207740|530567568|FG003|Overall Study|Death|1|||
147110613|NCT00207740|530567565|FG000|Overall Study|Sponsor Directive|22|||
147110614|NCT00207740|530567566|FG001|Overall Study|Sponsor Directive|15|||
147110615|NCT00207740|530567567|FG002|Overall Study|Sponsor Directive|16|||
147110616|NCT00207740|530567568|FG003|Overall Study|Sponsor Directive|21|||
147110617|NCT00207740|530567565|FG000|Overall Study|Other|2|||
147110618|NCT00207740|530567566|FG001|Overall Study|Other|10|||
147110619|NCT00207740|530567567|FG002|Overall Study|Other|7|||
147110620|NCT00207740|530567568|FG003|Overall Study|Other|5|||
147110621|NCT03916926|530567569|FG000|26 Week Follow-Up Visit|Missed due to COVID-19/logistical issues|51|||
147110622|NCT03916926|530567570|FG001|26 Week Follow-Up Visit|Missed due to COVID-19/logistical issues|35|||
147110623|NCT03916926|530567569|FG000|26 Week Follow-Up Visit|Withdrawal by Subject|11|||
147110624|NCT03916926|530567570|FG001|26 Week Follow-Up Visit|Withdrawal by Subject|2|||
147110625|NCT03916926|530567569|FG000|52 Week Follow-Up Visit|Missed due to COVID-19 or logistical issues|22|||
147110626|NCT03916926|530567570|FG001|52 Week Follow-Up Visit|Missed due to COVID-19 or logistical issues|13|||
147110627|NCT03916926|530567569|FG000|52 Week Follow-Up Visit|Withdrawal by Subject|22|||
147110628|NCT03916926|530567570|FG001|52 Week Follow-Up Visit|Withdrawal by Subject|12|||
147110629|NCT04725188|530567571|FG000|Overall Study|Death|72|||
147110630|NCT04725188|530567572|FG001|Overall Study|Death|69|||
147110631|NCT04725188|530567573|FG002|Overall Study|Death|76|||
147110632|NCT04725188|530567571|FG000|Overall Study|Lost to Follow-up|1|||
147110633|NCT04725188|530567572|FG001|Overall Study|Lost to Follow-up|0|||
147110634|NCT04725188|530567573|FG002|Overall Study|Lost to Follow-up|1|||
147110635|NCT04725188|530567571|FG000|Overall Study|Withdrawal by Subject|2|||
147110636|NCT04725188|530567572|FG001|Overall Study|Withdrawal by Subject|2|||
147110637|NCT04725188|530567573|FG002|Overall Study|Withdrawal by Subject|1|||
147110638|NCT04725188|530567571|FG000|Overall Study|Sponsor Decision|12|||
147110639|NCT04725188|530567572|FG001|Overall Study|Sponsor Decision|12|||
147444280|NCT02104583|531792550|FG002|Overall Study|Death|3|||
147444281|NCT02104583|531792551|FG003|Overall Study|Death|3|||
147444282|NCT02104583|531792552|FG004|Overall Study|Death|5|||
147444283|NCT02104583|531792548|FG000|Overall Study|Subject required cardiac ablation|6|||
147110640|NCT04725188|530567573|FG002|Overall Study|Sponsor Decision|7|||
147110641|NCT02879695|530567574|FG000|Overall Study|Did not start study treatment|2|||
147110642|NCT02879695|530567575|FG001|Overall Study|Did not start study treatment|0|||
147110643|NCT02879695|530567576|FG002|Overall Study|Did not start study treatment|3|||
147110644|NCT02879695|530567577|FG003|Overall Study|Did not start study treatment|0|||
147444284|NCT02104583|531792549|FG001|Overall Study|Subject required cardiac ablation|4|||
147110645|NCT04235374|530567578|FG000|Overall Study|Death|91|||
147110646|NCT04235374|530567579|FG001|Overall Study|Death|91|||
147110647|NCT04235374|530567578|FG000|Overall Study|Refused|2|||
147110648|NCT04235374|530567579|FG001|Overall Study|Refused|2|||
147110649|NCT04235374|530567578|FG000|Overall Study|Unavailable|12|||
147110650|NCT04235374|530567579|FG001|Overall Study|Unavailable|3|||
147110651|NCT04235374|530567578|FG000|Overall Study|Withdrawal by Subject|0|||
147110652|NCT04235374|530567579|FG001|Overall Study|Withdrawal by Subject|1|||
147110653|NCT04235374|530567578|FG000|Overall Study|Withdrawal by Legally Authorized Representative|10|||
147225941|NCT02537574|531000339|FG000|Overall Study|Incarceration|0|||
147110654|NCT04235374|530567579|FG001|Overall Study|Withdrawal by Legally Authorized Representative|9|||
147110655|NCT01771107|530567587|FG000|Overall Study|Adverse Event|1|||
147110656|NCT01771107|530567588|FG001|Overall Study|Adverse Event|3|||
147110657|NCT01771107|530567587|FG000|Overall Study|Withdrawal by Subject|0|||
147110658|NCT01771107|530567588|FG001|Overall Study|Withdrawal by Subject|2|||
147110659|NCT01771107|530567587|FG000|Overall Study|Lost to Follow-up|0|||
147110660|NCT01771107|530567588|FG001|Overall Study|Lost to Follow-up|1|||
147110661|NCT01771107|530567587|FG000|Overall Study|participant moved|0|||
147110662|NCT01771107|530567588|FG001|Overall Study|participant moved|1|||
147110663|NCT01771107|530567587|FG000|Overall Study|Other|0|||
147110664|NCT01771107|530567588|FG001|Overall Study|Other|1|||
147110665|NCT02296125|530567593|FG000|Overall Study|Withdrawal by Subject|18|||
147110666|NCT02296125|530567594|FG001|Overall Study|Withdrawal by Subject|8|||
147110667|NCT02296125|530567595|FG002|Overall Study|Withdrawal by Subject|6|||
147110668|NCT02296125|530567596|FG003|Overall Study|Withdrawal by Subject|2|||
147110669|NCT02296125|530567593|FG000|Overall Study|Adverse Event|41|||
147110670|NCT02296125|530567594|FG001|Overall Study|Adverse Event|52|||
147110671|NCT02296125|530567595|FG002|Overall Study|Adverse Event|9|||
147110672|NCT02296125|530567596|FG003|Overall Study|Adverse Event|4|||
147110673|NCT02296125|530567593|FG000|Overall Study|Severe non-compliance to protocol|0|||
147110674|NCT02296125|530567594|FG001|Overall Study|Severe non-compliance to protocol|1|||
147110675|NCT02296125|530567595|FG002|Overall Study|Severe non-compliance to protocol|0|||
147110676|NCT02296125|530567596|FG003|Overall Study|Severe non-compliance to protocol|0|||
147110677|NCT02296125|530567593|FG000|Overall Study|Condition under investigation worsened|153|||
147110678|NCT02296125|530567594|FG001|Overall Study|Condition under investigation worsened|199|||
147110679|NCT02296125|530567595|FG002|Overall Study|Condition under investigation worsened|39|||
147110680|NCT02296125|530567596|FG003|Overall Study|Condition under investigation worsened|56|||
147110681|NCT02296125|530567593|FG000|Overall Study|Any reason not specifically recorded|6|||
147110682|NCT02296125|530567594|FG001|Overall Study|Any reason not specifically recorded|4|||
147110683|NCT02296125|530567595|FG002|Overall Study|Any reason not specifically recorded|2|||
147110684|NCT02296125|530567596|FG003|Overall Study|Any reason not specifically recorded|0|||
147110685|NCT05248386|530567597|FG000|Overall Study|Technical problems|0|||
147110686|NCT05248386|530567598|FG001|Overall Study|Technical problems|1|||
147110687|NCT05248386|530567597|FG000|Overall Study|Withdrawal by Subject|15|||
147110688|NCT05248386|530567598|FG001|Overall Study|Withdrawal by Subject|10|||
147110689|NCT05248386|530567597|FG000|Overall Study|Physician Decision|0|||
147110690|NCT05248386|530567598|FG001|Overall Study|Physician Decision|1|||
147110691|NCT05248386|530567597|FG000|Overall Study|Adverse Event|2|||
147110692|NCT05248386|530567598|FG001|Overall Study|Adverse Event|4|||
147110693|NCT05248386|530567597|FG000|Overall Study|Other|1|||
147110694|NCT05248386|530567598|FG001|Overall Study|Other|0|||
147110695|NCT05248386|530567597|FG000|Overall Study|Lack of Efficacy|14|||
147110696|NCT05248386|530567598|FG001|Overall Study|Lack of Efficacy|12|||
147110697|NCT02864992|530567599|FG000|Overall Study|still on treatment|15|||
147110698|NCT02864992|530567600|FG001|Overall Study|still on treatment|1|||
147110699|NCT02864992|530567601|FG002|Overall Study|still on treatment|33|||
147110700|NCT03621592|530567602|FG000|Overall Study|Lost to Follow-up|1|||
147110701|NCT03621592|530567603|FG001|Overall Study|Lost to Follow-up|0|||
147110702|NCT03621592|530567602|FG000|Overall Study|Lack of Improvement|1|||
147110703|NCT03621592|530567603|FG001|Overall Study|Lack of Improvement|0|||
147110704|NCT03621592|530567602|FG000|Overall Study|Preference to receive wound care closer to home|1|||
147110705|NCT03621592|530567603|FG001|Overall Study|Preference to receive wound care closer to home|0|||
147110706|NCT03621592|530567602|FG000|Overall Study|Lack of healing|0|||
147110707|NCT03621592|530567603|FG001|Overall Study|Lack of healing|2|||
147110708|NCT04967222|530567605|FG000|Randomized|Lost to Follow-up|0|||
147110709|NCT04967222|530567606|FG001|Randomized|Lost to Follow-up|1|||
147110710|NCT04967222|530567607|FG002|Randomized|Lost to Follow-up|1|||
147225942|NCT02537574|531000340|FG001|Overall Study|Incarceration|1|||
147225943|NCT02537574|531000341|FG002|Overall Study|Incarceration|0|||
147225944|NCT02537574|531000339|FG000|Overall Study|Failed Naloxone Challenge|0|||
147225945|NCT02537574|531000340|FG001|Overall Study|Failed Naloxone Challenge|1|||
147225946|NCT02537574|531000341|FG002|Overall Study|Failed Naloxone Challenge|0|||
147225947|NCT02537574|531000339|FG000|Overall Study|Transportation Issues|0|||
147110711|NCT04967222|530567605|FG000|Randomized|Physician Decision|0|||
147559474|NCT03257462|532205397|FG002|Cohort B|Discontinued due to Sponsor decision|0|||
147110712|NCT04967222|530567606|FG001|Randomized|Physician Decision|0|||
147110713|NCT04967222|530567607|FG002|Randomized|Physician Decision|1|||
147110714|NCT04967222|530567605|FG000|Randomized|Withdrawal by Subject|0|||
147110715|NCT04967222|530567606|FG001|Randomized|Withdrawal by Subject|0|||
147110716|NCT04967222|530567607|FG002|Randomized|Withdrawal by Subject|2|||
147110717|NCT04967222|530567605|FG000|Randomized|abnormal finding in MRI|0|||
147225948|NCT02537574|531000340|FG001|Overall Study|Transportation Issues|0|||
147110718|NCT04967222|530567606|FG001|Randomized|abnormal finding in MRI|2|||
147110719|NCT04967222|530567607|FG002|Randomized|abnormal finding in MRI|0|||
147110720|NCT03785366|530567615|FG000|Overall Study|Non-Menstrual Pelvic Pain|1|||
147110721|NCT03785366|530567616|FG001|Overall Study|Non-Menstrual Pelvic Pain|0|||
147110722|NCT03785366|530567615|FG000|Overall Study|Lost to Follow-up|1|||
147110723|NCT03785366|530567616|FG001|Overall Study|Lost to Follow-up|0|||
147110724|NCT03785366|530567615|FG000|Overall Study|Partial IUD Expulsion|0|||
147110725|NCT03785366|530567616|FG001|Overall Study|Partial IUD Expulsion|2|||
147110726|NCT03785366|530567615|FG000|Overall Study|Unsuccessful IUD Insertion|0|||
147110727|NCT03785366|530567616|FG001|Overall Study|Unsuccessful IUD Insertion|1|||
147110728|NCT02783274|530567617|FG000|Overall Study|Withdrawal by Subject|16|||
147110729|NCT02783274|530567617|FG000|Overall Study|Physician Decision|6|||
147110730|NCT02783274|530567617|FG000|Overall Study|Death|9|||
147110731|NCT02783274|530567617|FG000|Overall Study|Lost to Follow-up|22|||
147110732|NCT02783274|530567617|FG000|Overall Study|Other|22|||
147110733|NCT06354257|530567619|FG000|Treatment Period 1|Withdrawal by Subject|1|||
147110734|NCT06354257|530567619|FG000|Treatment Period 2|Adverse Event|1|||
147110735|NCT02685735|530567620|FG000|Overall Study|Surgery Cancelled|4|||
147110736|NCT02685735|530567621|FG001|Overall Study|Surgery Cancelled|9|||
147110737|NCT02685735|530567620|FG000|Overall Study|Adverse Event|10|||
147110738|NCT02685735|530567621|FG001|Overall Study|Adverse Event|3|||
147110739|NCT02685735|530567620|FG000|Overall Study|Preop testing found to be incomplete|2|||
147110740|NCT02685735|530567621|FG001|Overall Study|Preop testing found to be incomplete|2|||
147110741|NCT02685735|530567620|FG000|Overall Study|Withdrawal by Subject|1|||
147110742|NCT02685735|530567621|FG001|Overall Study|Withdrawal by Subject|2|||
147110743|NCT02685735|530567620|FG000|Overall Study|Death|1|||
147110744|NCT02685735|530567621|FG001|Overall Study|Death|0|||
147110745|NCT04132050|530567622|FG000|Period I (Double-blind Period)|Adverse Event|3|||
147110746|NCT04132050|530567623|FG001|Period I (Double-blind Period)|Adverse Event|0|||
147110747|NCT04132050|530567622|FG000|Period I (Double-blind Period)|Lack of Efficacy|9|||
147110748|NCT04132050|530567623|FG001|Period I (Double-blind Period)|Lack of Efficacy|8|||
147110749|NCT04132050|530567622|FG000|R788 Treatment Period|Adverse Event|5|||
147110750|NCT04132050|530567623|FG001|R788 Treatment Period|Adverse Event|0|||
147110751|NCT04132050|530567622|FG000|R788 Treatment Period|Lack of Efficacy|5|||
147110752|NCT04132050|530567623|FG001|R788 Treatment Period|Lack of Efficacy|0|||
147110753|NCT04132050|530567622|FG000|R788 Treatment Period|Withdrawal by Subject|1|||
147110754|NCT04132050|530567623|FG001|R788 Treatment Period|Withdrawal by Subject|0|||
147110755|NCT04133909|530567629|FG000|Overall Study|Death|11|||
147110756|NCT04133909|530567630|FG001|Overall Study|Death|11|||
147110757|NCT04133909|530567629|FG000|Overall Study|Adverse Event|4|||
147110758|NCT04133909|530567630|FG001|Overall Study|Adverse Event|5|||
147110759|NCT04133909|530567629|FG000|Overall Study|Lost to Follow-up|3|||
147110760|NCT04133909|530567630|FG001|Overall Study|Lost to Follow-up|5|||
147110761|NCT04133909|530567629|FG000|Overall Study|Physician Decision|4|||
147110762|NCT04133909|530567630|FG001|Overall Study|Physician Decision|7|||
147110763|NCT04133909|530567629|FG000|Overall Study|Withdrawal by Subject|40|||
147110764|NCT04133909|530567630|FG001|Overall Study|Withdrawal by Subject|35|||
147110765|NCT04133909|530567629|FG000|Overall Study|Lack of Efficacy|2|||
147110766|NCT04133909|530567630|FG001|Overall Study|Lack of Efficacy|7|||
147110767|NCT04133909|530567629|FG000|Overall Study|Randomized in error|1|||
147110768|NCT04133909|530567630|FG001|Overall Study|Randomized in error|1|||
147110769|NCT01063114|530567631|FG000|Overall Study|Lost to Follow-up|1|||
147110770|NCT04635423|530567632|FG000|Overall Study|Ongoing|493|||
147110771|NCT04635423|530567633|FG001|Overall Study|Ongoing|501|||
147110772|NCT04635423|530567632|FG000|Overall Study|Withdrawal by Subject|36|||
147110773|NCT04635423|530567633|FG001|Overall Study|Withdrawal by Subject|29|||
147110774|NCT01811238|530567637|FG000|Overall Study|Withdrawal by Subject|42|||
147110775|NCT01811238|530567637|FG000|Overall Study|Adverse Event|25|||
147110776|NCT01811238|530567637|FG000|Overall Study|Protocol Violation|4|||
147110777|NCT01811238|530567637|FG000|Overall Study|Lack of Efficacy|4|||
147110778|NCT01811238|530567637|FG000|Overall Study|subject refused study medication|6|||
147110779|NCT02916927|530567641|FG000|Overall Study|Discharged prior to study drug receipt|0|||
147110780|NCT02916927|530567642|FG001|Overall Study|Discharged prior to study drug receipt|2|||
147110781|NCT02916927|530567641|FG000|Overall Study|At radiology for 45 & 60 min time points|0|||
147110782|NCT02916927|530567642|FG001|Overall Study|At radiology for 45 & 60 min time points|1|||
147110783|NCT02916927|530567641|FG000|Overall Study|Withdrawal before first time point|1|||
147110784|NCT02916927|530567642|FG001|Overall Study|Withdrawal before first time point|0|||
147110785|NCT05759338|530567643|FG000|Overall Study|Withdrawal by Subject|3|||
147110786|NCT04835441|530567645|FG000|Overall Study|Physician Decision|4|||
147110787|NCT04835441|530567646|FG001|Overall Study|Physician Decision|4|||
147110788|NCT04835441|530567645|FG000|Overall Study|Other|1|||
147110789|NCT04835441|530567646|FG001|Overall Study|Other|1|||
147110790|NCT04835441|530567645|FG000|Overall Study|Lost to Follow-up|0|||
147110791|NCT04835441|530567646|FG001|Overall Study|Lost to Follow-up|1|||
147110792|NCT05253807|530567647|FG000|Overall Study|Death|1|||
147110793|NCT05253807|530567648|FG001|Overall Study|Death|4|||
147110794|NCT05253807|530567647|FG000|Overall Study|Withdrawal by Subject|1|||
147110795|NCT05253807|530567648|FG001|Overall Study|Withdrawal by Subject|0|||
147110796|NCT05253807|530567647|FG000|Overall Study|Study Terminated by Sponsor|1|||
147110797|NCT05253807|530567648|FG001|Overall Study|Study Terminated by Sponsor|1|||
147110798|NCT02293499|530568815|FG000|Training - Peer Leaders Only|By design, two treatment groups did not participate; 10 peer leaders were Withdrawn by PI|0|||
147110799|NCT02293499|530568816|FG001|Training - Peer Leaders Only|By design, two treatment groups did not participate; 10 peer leaders were Withdrawn by PI|0|||
147110800|NCT02293499|530568817|FG002|Training - Peer Leaders Only|By design, two treatment groups did not participate; 10 peer leaders were Withdrawn by PI|10|||
147110801|NCT02293499|530568815|FG000|Intervention - Camp|Withdrawal by Subject|3|||
147110802|NCT02293499|530568816|FG001|Intervention - Camp|Withdrawal by Subject|6|||
147110803|NCT02293499|530568817|FG002|Intervention - Camp|Withdrawal by Subject|2|||
147110804|NCT02293499|530568815|FG000|Intervention - Camp|these are those not showing up at camp|24|||
147110805|NCT02293499|530568816|FG001|Intervention - Camp|these are those not showing up at camp|28|||
147110806|NCT02293499|530568817|FG002|Intervention - Camp|these are those not showing up at camp|4|||
147110807|NCT02293499|530568815|FG000|3 Month Follow Up|Withdrawal by Subject|1|||
147110808|NCT02293499|530568816|FG001|3 Month Follow Up|Withdrawal by Subject|0|||
147110809|NCT02293499|530568817|FG002|3 Month Follow Up|Withdrawal by Subject|4|||
147110810|NCT02293499|530568815|FG000|3 Month Follow Up|Lost to Follow-up|14|||
147110811|NCT02293499|530568816|FG001|3 Month Follow Up|Lost to Follow-up|15|||
147110812|NCT02293499|530568817|FG002|3 Month Follow Up|Lost to Follow-up|6|||
147110813|NCT02293499|530568815|FG000|6 Month Follow Up|Lost to Follow-up|17|||
147110814|NCT02293499|530568816|FG001|6 Month Follow Up|Lost to Follow-up|27|||
147110815|NCT02293499|530568817|FG002|6 Month Follow Up|Lost to Follow-up|6|||
147110816|NCT02293499|530568815|FG000|6 Month Follow Up|Withdrawal by Subject|0|||
147110817|NCT02293499|530568816|FG001|6 Month Follow Up|Withdrawal by Subject|0|||
147110818|NCT02293499|530568817|FG002|6 Month Follow Up|Withdrawal by Subject|1|||
147110819|NCT02293499|530568815|FG000|9 Month Follow Up|Withdrawal by Subject|2|||
147110820|NCT02293499|530568816|FG001|9 Month Follow Up|Withdrawal by Subject|0|||
147110821|NCT02293499|530568817|FG002|9 Month Follow Up|Withdrawal by Subject|0|||
147110822|NCT02293499|530568815|FG000|9 Month Follow Up|Lost to Follow-up|24|||
147110823|NCT02293499|530568816|FG001|9 Month Follow Up|Lost to Follow-up|28|||
147110824|NCT02293499|530568817|FG002|9 Month Follow Up|Lost to Follow-up|4|||
147110825|NCT02293499|530568815|FG000|12 Month Follow Up|Lost to Follow-up|26|||
147110826|NCT02293499|530568816|FG001|12 Month Follow Up|Lost to Follow-up|25|||
147110827|NCT02293499|530568817|FG002|12 Month Follow Up|Lost to Follow-up|6|||
147110828|NCT02293499|530568815|FG000|12 Month Follow Up|Withdrawal by Subject|0|||
147110829|NCT02293499|530568816|FG001|12 Month Follow Up|Withdrawal by Subject|1|||
147110830|NCT02293499|530568817|FG002|12 Month Follow Up|Withdrawal by Subject|0|||
147110831|NCT02293499|530568815|FG000|15 Month Follow Up|Lost to Follow-up|22|||
147110832|NCT02293499|530568816|FG001|15 Month Follow Up|Lost to Follow-up|22|||
147110833|NCT02293499|530568817|FG002|15 Month Follow Up|Lost to Follow-up|7|||
147110834|NCT00690898|530568818|FG000|SCREENING|Screen failure|18|||
147110835|NCT00690898|530568818|FG000|TREATMENT|Adverse Event|3|||
147110836|NCT00690898|530568818|FG000|TREATMENT|Lack of Efficacy|18|||
147110837|NCT00690898|530568818|FG000|TREATMENT|Withdrawal by Subject|4|||
147110838|NCT00690898|530568818|FG000|TREATMENT|Other (not otherwise specified)|1|||
147110839|NCT05977868|530568819|FG000|Overall Study|Withdrawal by Subject|1|||
147110840|NCT05977868|530568820|FG001|Overall Study|Withdrawal by Subject|2|||
147110841|NCT05977868|530568819|FG000|Overall Study|Transitioned to comfort care|1|||
147110842|NCT05977868|530568820|FG001|Overall Study|Transitioned to comfort care|0|||
147110843|NCT00620542|530568829|FG000|Part A (Run-in - 2 Weeks)|Adverse Event|12|||
147110844|NCT00620542|530568830|FG001|Part A (Run-in - 2 Weeks)|Adverse Event|15|||
147110845|NCT00620542|530568831|FG002|Part A (Run-in - 2 Weeks)|Adverse Event|0|||
147110846|NCT00620542|530568832|FG003|Part A (Run-in - 2 Weeks)|Adverse Event|0|||
147110847|NCT00620542|530568829|FG000|Part A (Run-in - 2 Weeks)|Protocol Violation|406|||
147110848|NCT00620542|530568830|FG001|Part A (Run-in - 2 Weeks)|Protocol Violation|409|||
147225949|NCT02537574|531000341|FG002|Overall Study|Transportation Issues|1|||
147225950|NCT02537574|531000339|FG000|Overall Study|Subject did not want last Vivitrol Injec|0|||
147225951|NCT02537574|531000340|FG001|Overall Study|Subject did not want last Vivitrol Injec|0|||
147225952|NCT02537574|531000341|FG002|Overall Study|Subject did not want last Vivitrol Injec|1|||
147225953|NCT02537574|531000339|FG000|Overall Study|Noncompliance with Protocol|0|||
147225954|NCT02537574|531000340|FG001|Overall Study|Noncompliance with Protocol|0|||
147225955|NCT02537574|531000341|FG002|Overall Study|Noncompliance with Protocol|1|||
147225956|NCT02663687|531000342|FG000|Overall Study|Adverse Event|1|||
147225957|NCT02663687|531000343|FG001|Overall Study|Adverse Event|0|||
147225958|NCT02663687|531000344|FG002|Overall Study|Adverse Event|0|||
147110849|NCT00620542|530568831|FG002|Part A (Run-in - 2 Weeks)|Protocol Violation|0|||
147110850|NCT00620542|530568832|FG003|Part A (Run-in - 2 Weeks)|Protocol Violation|0|||
147110851|NCT00620542|530568829|FG000|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|43|||
147110852|NCT00620542|530568830|FG001|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|40|||
147110853|NCT00620542|530568831|FG002|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|0|||
147110854|NCT00620542|530568832|FG003|Part A (Run-in - 2 Weeks)|Withdrawal by Subject|0|||
147110855|NCT00620542|530568829|FG000|Part A (Run-in - 2 Weeks)|Lost to Follow-up|7|||
147110856|NCT00620542|530568830|FG001|Part A (Run-in - 2 Weeks)|Lost to Follow-up|6|||
147225959|NCT02663687|531000345|FG003|Overall Study|Adverse Event|0|||
147225960|NCT02663687|531000346|FG004|Overall Study|Adverse Event|0|||
147225961|NCT02663687|531000342|FG000|Overall Study|Other|1|||
147225962|NCT02663687|531000343|FG001|Overall Study|Other|0|||
147225963|NCT02663687|531000344|FG002|Overall Study|Other|1|||
147110857|NCT00620542|530568831|FG002|Part A (Run-in - 2 Weeks)|Lost to Follow-up|0|||
147110858|NCT00620542|530568832|FG003|Part A (Run-in - 2 Weeks)|Lost to Follow-up|0|||
147110859|NCT00620542|530568829|FG000|Part A (Run-in - 2 Weeks)|Protocol Violation|0|||
147110860|NCT00620542|530568830|FG001|Part A (Run-in - 2 Weeks)|Protocol Violation|1|||
147110861|NCT00620542|530568831|FG002|Part A (Run-in - 2 Weeks)|Protocol Violation|0|||
147110862|NCT00620542|530568832|FG003|Part A (Run-in - 2 Weeks)|Protocol Violation|0|||
147444285|NCT02104583|531792550|FG002|Overall Study|Subject required cardiac ablation|4|||
147444286|NCT02104583|531792551|FG003|Overall Study|Subject required cardiac ablation|5|||
147444287|NCT02104583|531792552|FG004|Overall Study|Subject required cardiac ablation|4|||
147444288|NCT02104583|531792548|FG000|Overall Study|Subject required prohibited medication|0|||
147444289|NCT02104583|531792549|FG001|Overall Study|Subject required prohibited medication|1|||
147444290|NCT02104583|531792550|FG002|Overall Study|Subject required prohibited medication|1|||
147444291|NCT02104583|531792551|FG003|Overall Study|Subject required prohibited medication|0|||
147444292|NCT02104583|531792552|FG004|Overall Study|Subject required prohibited medication|1|||
147444293|NCT02104583|531792548|FG000|Overall Study|Withdrew Consent|3|||
147444294|NCT02104583|531792549|FG001|Overall Study|Withdrew Consent|2|||
147444295|NCT02104583|531792550|FG002|Overall Study|Withdrew Consent|0|||
147444296|NCT02104583|531792551|FG003|Overall Study|Withdrew Consent|2|||
147444297|NCT02104583|531792552|FG004|Overall Study|Withdrew Consent|1|||
147444298|NCT02104583|531792548|FG000|Overall Study|Investigator's Discretion|1|||
147444299|NCT02104583|531792549|FG001|Overall Study|Investigator's Discretion|0|||
147444300|NCT02104583|531792550|FG002|Overall Study|Investigator's Discretion|0|||
147110863|NCT00620542|530568829|FG000|Part A (Run-in - 2 Weeks)|Safety reasons|0|||
147110864|NCT00620542|530568830|FG001|Part A (Run-in - 2 Weeks)|Safety reasons|1|||
147444301|NCT02104583|531792551|FG003|Overall Study|Investigator's Discretion|0|||
147444302|NCT02104583|531792552|FG004|Overall Study|Investigator's Discretion|0|||
147444303|NCT02104583|531792548|FG000|Overall Study|Protocol Violation|0|||
147444304|NCT02104583|531792549|FG001|Overall Study|Protocol Violation|0|||
147444305|NCT02104583|531792550|FG002|Overall Study|Protocol Violation|1|||
147559475|NCT03257462|532205398|FG003|Cohort B|Discontinued due to Sponsor decision|0|||
147559476|NCT00368277|532205399|FG000|Overall Study|Adverse Event|33|||
147559477|NCT00368277|532205400|FG001|Overall Study|Adverse Event|49|||
147559478|NCT00368277|532205399|FG000|Overall Study|Death|2|||
147559479|NCT00368277|532205400|FG001|Overall Study|Death|1|||
147110865|NCT00620542|530568831|FG002|Part A (Run-in - 2 Weeks)|Safety reasons|0|||
147110866|NCT00620542|530568832|FG003|Part A (Run-in - 2 Weeks)|Safety reasons|0|||
147110867|NCT00620542|530568829|FG000|Part A (Run-in - 2 Weeks)|IVUS not available|4|||
147110868|NCT00620542|530568830|FG001|Part A (Run-in - 2 Weeks)|IVUS not available|4|||
147110869|NCT00620542|530568831|FG002|Part A (Run-in - 2 Weeks)|IVUS not available|0|||
147110870|NCT00620542|530568832|FG003|Part A (Run-in - 2 Weeks)|IVUS not available|0|||
147559480|NCT00368277|532205399|FG000|Overall Study|Unsatisfactory therapeutic effect|31|||
147559481|NCT00368277|532205400|FG001|Overall Study|Unsatisfactory therapeutic effect|24|||
147110871|NCT00620542|530568829|FG000|Part B (2 Year Core Study)|Adverse Event|0|||
147110872|NCT00620542|530568830|FG001|Part B (2 Year Core Study)|Adverse Event|0|||
147110873|NCT00620542|530568831|FG002|Part B (2 Year Core Study)|Adverse Event|46|||
147110874|NCT00620542|530568832|FG003|Part B (2 Year Core Study)|Adverse Event|49|||
147110875|NCT00620542|530568829|FG000|Part B (2 Year Core Study)|Protocol Violation|0|||
147110876|NCT00620542|530568830|FG001|Part B (2 Year Core Study)|Protocol Violation|0|||
147559482|NCT00368277|532205399|FG000|Overall Study|Protocol deviation|7|||
147110877|NCT00620542|530568831|FG002|Part B (2 Year Core Study)|Protocol Violation|3|||
147110878|NCT00620542|530568832|FG003|Part B (2 Year Core Study)|Protocol Violation|5|||
147559483|NCT00368277|532205400|FG001|Overall Study|Protocol deviation|0|||
147559484|NCT00368277|532205399|FG000|Overall Study|Patient withdrew consent|32|||
147559485|NCT00368277|532205400|FG001|Overall Study|Patient withdrew consent|28|||
147110879|NCT00620542|530568829|FG000|Part B (2 Year Core Study)|Withdrawal by Subject|0|||
147110880|NCT00620542|530568830|FG001|Part B (2 Year Core Study)|Withdrawal by Subject|0|||
147110881|NCT00620542|530568831|FG002|Part B (2 Year Core Study)|Withdrawal by Subject|55|||
147110882|NCT00620542|530568832|FG003|Part B (2 Year Core Study)|Withdrawal by Subject|54|||
147110883|NCT00620542|530568829|FG000|Part B (2 Year Core Study)|Lost to Follow-up|0|||
147110884|NCT00620542|530568830|FG001|Part B (2 Year Core Study)|Lost to Follow-up|0|||
147110885|NCT00620542|530568831|FG002|Part B (2 Year Core Study)|Lost to Follow-up|20|||
147110886|NCT00620542|530568832|FG003|Part B (2 Year Core Study)|Lost to Follow-up|9|||
147559486|NCT00368277|532205399|FG000|Overall Study|Lost to Follow-up|8|||
147559487|NCT00368277|532205400|FG001|Overall Study|Lost to Follow-up|6|||
147559488|NCT04347239|532205401|FG000|Blinded Portion|Pt randomized to study but withdrew consent before treatment with investigational product|6|||
147110887|NCT00620542|530568829|FG000|Part B (2 Year Core Study)|Protocol Violation|0|||
147110888|NCT00620542|530568830|FG001|Part B (2 Year Core Study)|Protocol Violation|0|||
147110889|NCT00620542|530568831|FG002|Part B (2 Year Core Study)|Protocol Violation|13|||
147110890|NCT00620542|530568832|FG003|Part B (2 Year Core Study)|Protocol Violation|16|||
147444306|NCT02104583|531792551|FG003|Overall Study|Protocol Violation|0|||
147444307|NCT02104583|531792552|FG004|Overall Study|Protocol Violation|0|||
147559489|NCT04347239|532205402|FG001|Blinded Portion|Pt randomized to study but withdrew consent before treatment with investigational product|0|||
147110891|NCT00620542|530568829|FG000|Part B (2 Year Core Study)|Safety reasons|0|||
147110892|NCT00620542|530568830|FG001|Part B (2 Year Core Study)|Safety reasons|0|||
147110893|NCT00620542|530568831|FG002|Part B (2 Year Core Study)|Safety reasons|2|||
147110894|NCT00620542|530568832|FG003|Part B (2 Year Core Study)|Safety reasons|3|||
147110895|NCT00620542|530568829|FG000|Part B (2 Year Core Study)|Study specific discontinuation criteris|0|||
147110896|NCT00620542|530568830|FG001|Part B (2 Year Core Study)|Study specific discontinuation criteris|0|||
147110897|NCT00620542|530568831|FG002|Part B (2 Year Core Study)|Study specific discontinuation criteris|6|||
147110898|NCT00620542|530568832|FG003|Part B (2 Year Core Study)|Study specific discontinuation criteris|6|||
147110899|NCT00620542|530568829|FG000|Part B (2 Year Core Study)|IVUS not available|0|||
147110900|NCT00620542|530568830|FG001|Part B (2 Year Core Study)|IVUS not available|0|||
147110901|NCT00620542|530568831|FG002|Part B (2 Year Core Study)|IVUS not available|3|||
147110902|NCT00620542|530568832|FG003|Part B (2 Year Core Study)|IVUS not available|2|||
147110903|NCT01970371|530568833|FG000|Overall Study|Death|8|||
147110904|NCT01970371|530568834|FG001|Overall Study|Death|13|||
147110905|NCT01970371|530568835|FG002|Overall Study|Death|12|||
147110906|NCT01970371|530568833|FG000|Overall Study|Lost to Follow-up|0|||
147110907|NCT01970371|530568834|FG001|Overall Study|Lost to Follow-up|0|||
147110908|NCT01970371|530568835|FG002|Overall Study|Lost to Follow-up|1|||
147110909|NCT01481779|530568836|FG000|Overall Study|Adverse Event|23|||
147110910|NCT01481779|530568837|FG001|Overall Study|Adverse Event|5|||
147110911|NCT01481779|530568836|FG000|Overall Study|Lost to Follow-up|3|||
147110912|NCT01481779|530568837|FG001|Overall Study|Lost to Follow-up|2|||
147110913|NCT01481779|530568836|FG000|Overall Study|Protocol Violation|2|||
147110914|NCT01481779|530568837|FG001|Overall Study|Protocol Violation|3|||
147110915|NCT01481779|530568836|FG000|Overall Study|Withdrawal by Subject|26|||
147110916|NCT01481779|530568837|FG001|Overall Study|Withdrawal by Subject|13|||
147110917|NCT01481779|530568836|FG000|Overall Study|Physician Decision|13|||
147110918|NCT01481779|530568837|FG001|Overall Study|Physician Decision|4|||
147110919|NCT01481779|530568836|FG000|Overall Study|Sponsor Decision|3|||
147110920|NCT01481779|530568837|FG001|Overall Study|Sponsor Decision|1|||
147110921|NCT00487188|530568844|FG000|Induction Phase|Abnormality of Laboratory Test|0|||
147110922|NCT00487188|530568845|FG001|Induction Phase|Abnormality of Laboratory Test|1|||
147110923|NCT00487188|530568846|FG002|Induction Phase|Abnormality of Laboratory Test|0|||
147110924|NCT00487188|530568844|FG000|Induction Phase|Adverse Event|5|||
147110925|NCT00487188|530568845|FG001|Induction Phase|Adverse Event|0|||
147110926|NCT00487188|530568846|FG002|Induction Phase|Adverse Event|0|||
147110927|NCT00487188|530568844|FG000|Induction Phase|Lack of Efficacy|0|||
147110928|NCT00487188|530568845|FG001|Induction Phase|Lack of Efficacy|1|||
147110929|NCT00487188|530568846|FG002|Induction Phase|Lack of Efficacy|0|||
147110930|NCT00487188|530568844|FG000|Induction Phase|Protocol Violation|1|||
147110931|NCT00487188|530568845|FG001|Induction Phase|Protocol Violation|0|||
147110932|NCT00487188|530568846|FG002|Induction Phase|Protocol Violation|0|||
147110933|NCT00487188|530568844|FG000|Induction Phase|Refused Treatment|1|||
147110934|NCT00487188|530568845|FG001|Induction Phase|Refused Treatment|2|||
147110935|NCT00487188|530568846|FG002|Induction Phase|Refused Treatment|0|||
147110936|NCT00487188|530568844|FG000|Induction Phase|Lost to Follow-up|2|||
147110937|NCT00487188|530568845|FG001|Induction Phase|Lost to Follow-up|2|||
147110938|NCT00487188|530568846|FG002|Induction Phase|Lost to Follow-up|0|||
147110939|NCT00487188|530568844|FG000|Induction Phase|Administrative|0|||
147110940|NCT00487188|530568845|FG001|Induction Phase|Administrative|1|||
147110941|NCT00487188|530568846|FG002|Induction Phase|Administrative|0|||
147110942|NCT00487188|530568844|FG000|Maintenance Phase|Adverse Event|1|||
147110943|NCT00487188|530568845|FG001|Maintenance Phase|Adverse Event|0|||
147110944|NCT00487188|530568846|FG002|Maintenance Phase|Adverse Event|0|||
147225964|NCT02663687|531000345|FG003|Overall Study|Other|0|||
147225965|NCT02663687|531000346|FG004|Overall Study|Other|0|||
147225966|NCT01151098|531000347|FG000|Overall Study|Adverse Event|82|||
147225967|NCT01151098|531000347|FG000|Overall Study|Lost to Follow-up|6|||
147225968|NCT01151098|531000347|FG000|Overall Study|Lack of Efficacy|15|||
147225969|NCT01151098|531000347|FG000|Overall Study|Protocol Violation|1|||
147225970|NCT01151098|531000347|FG000|Overall Study|Miscellaneous|13|||
147225971|NCT03343067|531000350|FG000|Double Blind Period: Month 3 to Month 6|Study Terminated by Sponsor|0|||
147225972|NCT03343067|531000351|FG001|Double Blind Period: Month 3 to Month 6|Study Terminated by Sponsor|3|||
147225973|NCT03343067|531000352|FG002|Double Blind Period: Month 3 to Month 6|Study Terminated by Sponsor|1|||
147225974|NCT00116168|531000353|FG000|Overall Study|Lost to Follow-up|6|||
147110945|NCT00487188|530568844|FG000|Maintenance Phase|Death|1|||
147110946|NCT00487188|530568845|FG001|Maintenance Phase|Death|0|||
147110947|NCT00487188|530568846|FG002|Maintenance Phase|Death|0|||
147110948|NCT00487188|530568844|FG000|Maintenance Phase|Lost to Follow-up|1|||
147225975|NCT00116168|531000354|FG001|Overall Study|Lost to Follow-up|5|||
147110949|NCT00487188|530568845|FG001|Maintenance Phase|Lost to Follow-up|0|||
147110950|NCT00487188|530568846|FG002|Maintenance Phase|Lost to Follow-up|0|||
147225976|NCT00116168|531000355|FG002|Overall Study|Lost to Follow-up|0|||
147225977|NCT00116168|531000356|FG003|Overall Study|Lost to Follow-up|0|||
147110951|NCT00487188|530568844|FG000|Maintenance Phase|Administrative|0|||
147110952|NCT00487188|530568845|FG001|Maintenance Phase|Administrative|0|||
147110953|NCT00487188|530568846|FG002|Maintenance Phase|Administrative|1|||
147110954|NCT05696847|530568848|FG000|Overall Study|Withdrawal by Subject|1|||
147110955|NCT05696847|530568849|FG001|Overall Study|Withdrawal by Subject|0|||
147110956|NCT05696847|530568850|FG002|Overall Study|Withdrawal by Subject|0|||
147110957|NCT05696847|530568851|FG003|Overall Study|Withdrawal by Subject|0|||
147110958|NCT05696847|530568852|FG004|Overall Study|Withdrawal by Subject|0|||
147110959|NCT05696847|530568853|FG005|Overall Study|Withdrawal by Subject|0|||
147110960|NCT05696847|530568848|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
147110961|NCT05696847|530568849|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
147110962|NCT05696847|530568850|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
147110963|NCT05696847|530568851|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
147110964|NCT05696847|530568852|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
147110965|NCT05696847|530568853|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
147110966|NCT05696847|530568848|FG000|Overall Study|Adverse Event|0|||
147110967|NCT05696847|530568849|FG001|Overall Study|Adverse Event|0|||
147110968|NCT05696847|530568850|FG002|Overall Study|Adverse Event|0|||
147110969|NCT05696847|530568851|FG003|Overall Study|Adverse Event|0|||
147110970|NCT05696847|530568852|FG004|Overall Study|Adverse Event|0|||
147110971|NCT05696847|530568853|FG005|Overall Study|Adverse Event|1|||
147110972|NCT05696847|530568848|FG000|Overall Study|Sponsor Decision|0|||
147110973|NCT05696847|530568849|FG001|Overall Study|Sponsor Decision|0|||
147110974|NCT05696847|530568850|FG002|Overall Study|Sponsor Decision|0|||
147110975|NCT05696847|530568851|FG003|Overall Study|Sponsor Decision|1|||
147110976|NCT05696847|530568852|FG004|Overall Study|Sponsor Decision|0|||
147110977|NCT05696847|530568853|FG005|Overall Study|Sponsor Decision|0|||
147110978|NCT03330197|530568856|FG000|Overall Study|Adverse Event|0|||
147110979|NCT03330197|530568857|FG001|Overall Study|Adverse Event|1|||
147110980|NCT03330197|530568856|FG000|Overall Study|Withdrawal by Subject|0|||
147110981|NCT03330197|530568857|FG001|Overall Study|Withdrawal by Subject|1|||
147110982|NCT03240874|530568865|FG000|Overall Study|Lost to Follow-up|0|||
147110983|NCT03240874|530568866|FG001|Overall Study|Lost to Follow-up|2|||
147110984|NCT03240874|530568867|FG002|Overall Study|Lost to Follow-up|4|||
147110985|NCT03240874|530568868|FG003|Overall Study|Lost to Follow-up|1|||
147110986|NCT05252702|530568869|FG000|Overall Study|No attempted implant, subjects withdrawn|12|||
147110987|NCT05252702|530568869|FG000|Overall Study|Death|16|||
147110988|NCT05252702|530568869|FG000|Overall Study|System explant|5|||
147110989|NCT05252702|530568869|FG000|Overall Study|Lost to Follow-up|1|||
147110990|NCT05252702|530568869|FG000|Overall Study|Withdrawn by investigator|1|||
147110991|NCT05252702|530568869|FG000|Overall Study|Visit not due|306|||
147110992|NCT05252702|530568869|FG000|Overall Study|Visit within window but not completed|92|||
147110993|NCT05252702|530568869|FG000|Overall Study|Unsuccessful implant|1|||
147110994|NCT04153864|530568870|FG000|Overall Study|Withdrawal by Subject|21|||
147110995|NCT04153864|530568871|FG001|Overall Study|Withdrawal by Subject|7|||
147110996|NCT04153864|530568872|FG002|Overall Study|Withdrawal by Subject|23|||
147110997|NCT04153864|530568873|FG003|Overall Study|Withdrawal by Subject|2|||
147110998|NCT04153864|530568870|FG000|Overall Study|Lost to Follow-up|4|||
147110999|NCT04153864|530568871|FG001|Overall Study|Lost to Follow-up|0|||
147111000|NCT04153864|530568872|FG002|Overall Study|Lost to Follow-up|3|||
147111001|NCT04153864|530568873|FG003|Overall Study|Lost to Follow-up|0|||
147111002|NCT04153864|530568870|FG000|Overall Study|Did not complete 3-month follow-up assessment but continued in the trial|28|||
147111003|NCT04153864|530568871|FG001|Overall Study|Did not complete 3-month follow-up assessment but continued in the trial|10|||
147111004|NCT04153864|530568872|FG002|Overall Study|Did not complete 3-month follow-up assessment but continued in the trial|26|||
147111005|NCT04153864|530568873|FG003|Overall Study|Did not complete 3-month follow-up assessment but continued in the trial|8|||
147111006|NCT03036254|530568875|FG000|Overall Study|Adverse Event|6|||
147111007|NCT03036254|530568876|FG001|Overall Study|Adverse Event|4|||
147111008|NCT03036254|530568875|FG000|Overall Study|Death|3|||
147225978|NCT05153473|531000357|FG000|Overall Study|Death|46|||
147225979|NCT05153473|531000357|FG000|Overall Study|Lost to Follow-up|3|||
147225980|NCT03555435|531000358|FG000|Overall Study|Lost to Follow-up|17|||
147225981|NCT03555435|531000359|FG001|Overall Study|Lost to Follow-up|19|||
147225982|NCT03555435|531000360|FG002|Overall Study|Lost to Follow-up|8|||
147225983|NCT01058265|531000365|FG000|Overall Study|Lost to Follow-up|11|||
147225984|NCT01058265|531000366|FG001|Overall Study|Lost to Follow-up|12|||
147225985|NCT02869438|531000367|FG000|Overall Study|Lost to Follow-up|1|||
147225986|NCT02869438|531000368|FG001|Overall Study|Lost to Follow-up|0|||
147559490|NCT04347239|532205403|FG002|Blinded Portion|Pt randomized to study but withdrew consent before treatment with investigational product|4|||
147111009|NCT03036254|530568876|FG001|Overall Study|Death|1|||
147111010|NCT03036254|530568875|FG000|Overall Study|Lack of Efficacy|5|||
147111011|NCT03036254|530568876|FG001|Overall Study|Lack of Efficacy|1|||
147111012|NCT03036254|530568875|FG000|Overall Study|Withdrawal by Subject|3|||
147111013|NCT03036254|530568876|FG001|Overall Study|Withdrawal by Subject|5|||
147111014|NCT05020743|530568892|FG000|Overall Study|Enrollment in Interventional Study|2|||
147111015|NCT05020743|530568893|FG001|Overall Study|Enrollment in Interventional Study|9|||
147111016|NCT05020743|530568894|FG002|Overall Study|Enrollment in Interventional Study|0|||
147225987|NCT02869438|531000367|FG000|Overall Study|Adverse Event|1|||
147225988|NCT02869438|531000368|FG001|Overall Study|Adverse Event|0|||
147111017|NCT05020743|530568892|FG000|Overall Study|Withdrawal by Subject|0|||
147111018|NCT05020743|530568893|FG001|Overall Study|Withdrawal by Subject|3|||
147111019|NCT05020743|530568894|FG002|Overall Study|Withdrawal by Subject|1|||
147111020|NCT05020743|530568892|FG000|Overall Study|Lost to Follow-up|1|||
147111021|NCT05020743|530568893|FG001|Overall Study|Lost to Follow-up|0|||
147111022|NCT05020743|530568894|FG002|Overall Study|Lost to Follow-up|0|||
147111023|NCT05020743|530568892|FG000|Overall Study|Study Termination by Sponsor|10|||
147111024|NCT05020743|530568893|FG001|Overall Study|Study Termination by Sponsor|11|||
147111025|NCT05020743|530568894|FG002|Overall Study|Study Termination by Sponsor|10|||
147111026|NCT03488524|530568895|FG000|Overall Study|Withdrawal by Subject|51|||
147111027|NCT03488524|530568895|FG000|Overall Study|Death|19|||
147111028|NCT03488524|530568895|FG000|Overall Study|Study Sponsor|11|||
147111029|NCT03488524|530568895|FG000|Overall Study|Physician Decision|4|||
147111030|NCT03488524|530568895|FG000|Overall Study|Lost to Follow-up|3|||
147111031|NCT02390284|530568896|FG000|Overall Study|Physician Decision|0|||
147111032|NCT02390284|530568897|FG001|Overall Study|Physician Decision|0|||
147111033|NCT02390284|530568898|FG002|Overall Study|Physician Decision|9|||
147111034|NCT03980223|530568899|FG000|Overall Study|Lost to Follow-up|3|||
147111035|NCT03980223|530568900|FG001|Overall Study|Lost to Follow-up|7|||
147111036|NCT03980223|530568901|FG002|Overall Study|Lost to Follow-up|10|||
147111037|NCT03980223|530568902|FG003|Overall Study|Lost to Follow-up|8|||
147111038|NCT03980223|530568899|FG000|Overall Study|Withdrawal by Subject|0|||
147111039|NCT03980223|530568900|FG001|Overall Study|Withdrawal by Subject|0|||
147111040|NCT03980223|530568901|FG002|Overall Study|Withdrawal by Subject|1|||
147111041|NCT03980223|530568902|FG003|Overall Study|Withdrawal by Subject|2|||
147111042|NCT03980223|530568899|FG000|Overall Study|Physician Decision|0|||
147111043|NCT03980223|530568900|FG001|Overall Study|Physician Decision|0|||
147111044|NCT03980223|530568901|FG002|Overall Study|Physician Decision|1|||
147111045|NCT03980223|530568902|FG003|Overall Study|Physician Decision|0|||
147111046|NCT03980223|530568899|FG000|Overall Study|Not included because they had not yet reached month 3 visit at time of analysis|72|||
147111047|NCT03980223|530568900|FG001|Overall Study|Not included because they had not yet reached month 3 visit at time of analysis|33|||
147111048|NCT03980223|530568901|FG002|Overall Study|Not included because they had not yet reached month 3 visit at time of analysis|20|||
147111049|NCT03980223|530568902|FG003|Overall Study|Not included because they had not yet reached month 3 visit at time of analysis|11|||
147111050|NCT01922934|530568906|FG000|Eligible Patients|Death|0|||
147111051|NCT01922934|530568907|FG001|Eligible Patients|Death|7|||
147111052|NCT01922934|530568906|FG000|Eligible Patients|Physician Decision|17|||
147111053|NCT01922934|530568907|FG001|Eligible Patients|Physician Decision|0|||
147111054|NCT01922934|530568906|FG000|Eligible Patients|Did not meet inclusion criteria|36|||
147111055|NCT01922934|530568907|FG001|Eligible Patients|Did not meet inclusion criteria|81|||
147111056|NCT01922934|530568906|FG000|Visit 0 - Patient Contacted & Consented|Patient declined to participate|169|||
147111057|NCT01922934|530568907|FG001|Visit 0 - Patient Contacted & Consented|Patient declined to participate|0|||
147111058|NCT01922934|530568906|FG000|Visit 0 - Patient Contacted & Consented|No response or could not reach|66|||
147111059|NCT01922934|530568907|FG001|Visit 0 - Patient Contacted & Consented|No response or could not reach|0|||
147111060|NCT01922934|530568906|FG000|Visit 1- Weight Measured|Did not have weight recorded (visit 1)|21|||
147111061|NCT01922934|530568907|FG001|Visit 1- Weight Measured|Did not have weight recorded (visit 1)|1284|||
147111062|NCT01069939|530568912|FG000|Randomised and Included in the Analyses|Adverse Event|17|||
147111063|NCT01069939|530568913|FG001|Randomised and Included in the Analyses|Adverse Event|22|||
147111064|NCT01069939|530568912|FG000|Randomised and Included in the Analyses|Withdrawal by Subject|15|||
147225989|NCT02869438|531000367|FG000|Overall Study|Withdrawal by Subject|1|||
147225990|NCT02869438|531000368|FG001|Overall Study|Withdrawal by Subject|2|||
147225991|NCT02169284|531000373|FG000|Overall Study|Physician Decision|0|||
147225992|NCT02169284|531000374|FG001|Overall Study|Physician Decision|1|||
147225993|NCT03583073|531000375|FG000|Overall Study|Lost to Follow-up|8|||
147225994|NCT03583073|531000376|FG001|Overall Study|Lost to Follow-up|12|||
147225995|NCT02964507|531000379|FG000|Overall Study|Protocol specified Withdrawal criteria met|0|||
147225996|NCT02964507|531000380|FG001|Overall Study|Protocol specified Withdrawal criteria met|1|||
147225997|NCT02964507|531000381|FG002|Overall Study|Protocol specified Withdrawal criteria met|0|||
147225998|NCT02964507|531000382|FG003|Overall Study|Protocol specified Withdrawal criteria met|0|||
147225999|NCT02964507|531000383|FG004|Overall Study|Protocol specified Withdrawal criteria met|1|||
147226000|NCT02964507|531000384|FG005|Overall Study|Protocol specified Withdrawal criteria met|0|||
147226001|NCT02964507|531000385|FG006|Overall Study|Protocol specified Withdrawal criteria met|0|||
147226002|NCT02964507|531000386|FG007|Overall Study|Protocol specified Withdrawal criteria met|0|||
147226003|NCT02964507|531000379|FG000|Overall Study|Study terminated by Sponsor|9|||
147226004|NCT02964507|531000380|FG001|Overall Study|Study terminated by Sponsor|1|||
147226005|NCT02964507|531000381|FG002|Overall Study|Study terminated by Sponsor|9|||
147226006|NCT02964507|531000382|FG003|Overall Study|Study terminated by Sponsor|3|||
147111065|NCT01069939|530568913|FG001|Randomised and Included in the Analyses|Withdrawal by Subject|12|||
147226007|NCT02964507|531000383|FG004|Overall Study|Study terminated by Sponsor|3|||
147226008|NCT02964507|531000384|FG005|Overall Study|Study terminated by Sponsor|2|||
147444308|NCT02104583|531792548|FG000|Overall Study|Adverse Event|3|||
147111066|NCT01069939|530568912|FG000|Randomised and Included in the Analyses|Lost to Follow-up|1|||
147111067|NCT01069939|530568913|FG001|Randomised and Included in the Analyses|Lost to Follow-up|1|||
147111068|NCT01069939|530568912|FG000|Randomised and Included in the Analyses|Protocol Violation|0|||
147111069|NCT01069939|530568913|FG001|Randomised and Included in the Analyses|Protocol Violation|1|||
147111070|NCT01069939|530568912|FG000|Randomised and Included in the Analyses|Lack of Efficacy|0|||
147111071|NCT01069939|530568913|FG001|Randomised and Included in the Analyses|Lack of Efficacy|1|||
147111072|NCT01069939|530568912|FG000|Randomised and Included in the Analyses|Study-specific withdrawal criteria|7|||
147111073|NCT01069939|530568913|FG001|Randomised and Included in the Analyses|Study-specific withdrawal criteria|33|||
147111074|NCT01069939|530568912|FG000|Randomised and Included in the Analyses|Eligibility criteria not fulfilled|4|||
147111075|NCT01069939|530568913|FG001|Randomised and Included in the Analyses|Eligibility criteria not fulfilled|3|||
147111076|NCT01069939|530568912|FG000|Randomised and Included in the Analyses|Use of prohibited concomitant drug|4|||
147111077|NCT01069939|530568913|FG001|Randomised and Included in the Analyses|Use of prohibited concomitant drug|2|||
147111078|NCT01069939|530568912|FG000|Randomised and Included in the Analyses|Physician Decision|0|||
147111079|NCT01069939|530568913|FG001|Randomised and Included in the Analyses|Physician Decision|2|||
147111080|NCT01069939|530568912|FG000|Randomised and Included in the Analyses|Removal|1|||
147111081|NCT01069939|530568913|FG001|Randomised and Included in the Analyses|Removal|0|||
147111082|NCT00724945|530568914|FG000|Period 1|non-compliance|1|||
147111083|NCT00724945|530568915|FG001|Period 1|non-compliance|0|||
147111084|NCT00724945|530568914|FG000|Period 1|Adverse Event|1|||
147111085|NCT00724945|530568915|FG001|Period 1|Adverse Event|1|||
147111086|NCT00724945|530568914|FG000|Period 1|Lost to Follow-up|1|||
147111087|NCT00724945|530568915|FG001|Period 1|Lost to Follow-up|0|||
147111088|NCT00724945|530568914|FG000|Period 2|lens comfort issue|3|||
147111089|NCT00724945|530568915|FG001|Period 2|lens comfort issue|0|||
147111090|NCT00724945|530568914|FG000|Period 2|lens physiology issue|1|||
147111091|NCT00724945|530568915|FG001|Period 2|lens physiology issue|0|||
147111092|NCT05166876|530568916|FG000|Overall Study|Withdrawal by Subject|1|||
147111093|NCT05166876|530568917|FG001|Overall Study|Withdrawal by Subject|0|||
147111094|NCT05166876|530568918|FG002|Overall Study|Withdrawal by Subject|0|||
147111095|NCT00658528|530568919|FG000|Overall Study|Adverse Event|5|||
147111096|NCT00658528|530568920|FG001|Overall Study|Adverse Event|7|||
147111097|NCT00658528|530568919|FG000|Overall Study|Lost to Follow-up|14|||
147111098|NCT00658528|530568920|FG001|Overall Study|Lost to Follow-up|22|||
147111099|NCT00658528|530568919|FG000|Overall Study|Withdrawal by Subject|8|||
147111100|NCT00658528|530568920|FG001|Overall Study|Withdrawal by Subject|6|||
147111101|NCT00658528|530568919|FG000|Overall Study|Withdrawal of consent|5|||
147111102|NCT00658528|530568920|FG001|Overall Study|Withdrawal of consent|6|||
147111103|NCT00658528|530568919|FG000|Overall Study|Other|8|||
147111104|NCT00658528|530568920|FG001|Overall Study|Other|4|||
147111105|NCT01147458|530568922|FG000|First Intervention|Study terminated by sponsor|8|||
147111106|NCT01147458|530568923|FG001|First Intervention|Study terminated by sponsor|8|||
147111107|NCT01147458|530568924|FG002|First Intervention|Study terminated by sponsor|7|||
147111108|NCT01147458|530568925|FG003|First Intervention|Study terminated by sponsor|8|||
147111109|NCT01147458|530568922|FG000|First Intervention|Protocol Violation|2|||
147111110|NCT01147458|530568923|FG001|First Intervention|Protocol Violation|3|||
147111111|NCT01147458|530568924|FG002|First Intervention|Protocol Violation|2|||
147111112|NCT01147458|530568925|FG003|First Intervention|Protocol Violation|3|||
147111113|NCT01147458|530568922|FG000|First Intervention|Withdrawal by Subject|3|||
147111114|NCT01147458|530568923|FG001|First Intervention|Withdrawal by Subject|0|||
147111115|NCT01147458|530568924|FG002|First Intervention|Withdrawal by Subject|1|||
147111116|NCT01147458|530568925|FG003|First Intervention|Withdrawal by Subject|0|||
147111117|NCT01147458|530568922|FG000|First Intervention|Adverse Event|0|||
147111118|NCT01147458|530568923|FG001|First Intervention|Adverse Event|3|||
147111119|NCT01147458|530568924|FG002|First Intervention|Adverse Event|2|||
147111120|NCT01147458|530568925|FG003|First Intervention|Adverse Event|3|||
147111121|NCT01147458|530568922|FG000|First Intervention|Other|1|||
147111122|NCT01147458|530568923|FG001|First Intervention|Other|2|||
147111123|NCT01147458|530568924|FG002|First Intervention|Other|0|||
147111124|NCT01147458|530568925|FG003|First Intervention|Other|0|||
147111125|NCT01147458|530568922|FG000|Second Intervention|Study terminated by sponsor|7|||
147111126|NCT01147458|530568923|FG001|Second Intervention|Study terminated by sponsor|5|||
147111127|NCT01147458|530568924|FG002|Second Intervention|Study terminated by sponsor|5|||
147111128|NCT01147458|530568925|FG003|Second Intervention|Study terminated by sponsor|3|||
147111129|NCT01147458|530568922|FG000|Second Intervention|Protocol Violation|0|||
147111130|NCT01147458|530568923|FG001|Second Intervention|Protocol Violation|1|||
147111131|NCT01147458|530568924|FG002|Second Intervention|Protocol Violation|1|||
147111132|NCT01147458|530568925|FG003|Second Intervention|Protocol Violation|0|||
147111133|NCT01147458|530568922|FG000|Second Intervention|Withdrawal by Subject|0|||
147111134|NCT01147458|530568923|FG001|Second Intervention|Withdrawal by Subject|1|||
147111135|NCT01147458|530568924|FG002|Second Intervention|Withdrawal by Subject|0|||
147111136|NCT01147458|530568925|FG003|Second Intervention|Withdrawal by Subject|0|||
147226009|NCT02964507|531000385|FG006|Overall Study|Study terminated by Sponsor|0|||
147444309|NCT02104583|531792549|FG001|Overall Study|Adverse Event|3|||
147111137|NCT01147458|530568922|FG000|Second Intervention|Adverse Event|2|||
147111138|NCT01147458|530568923|FG001|Second Intervention|Adverse Event|0|||
147111139|NCT01147458|530568924|FG002|Second Intervention|Adverse Event|1|||
147111140|NCT01147458|530568925|FG003|Second Intervention|Adverse Event|1|||
147111141|NCT01147458|530568922|FG000|Second Intervention|Other|0|||
147111142|NCT01147458|530568923|FG001|Second Intervention|Other|0|||
147111143|NCT01147458|530568924|FG002|Second Intervention|Other|1|||
147111144|NCT01147458|530568925|FG003|Second Intervention|Other|0|||
147111145|NCT00832975|530568933|FG000|Overall Study|Lost to Follow-up|7|||
147111146|NCT00832975|530568933|FG000|Overall Study|Protocol Violation|6|||
147111147|NCT00832975|530568933|FG000|Overall Study|Death|5|||
147111148|NCT00832975|530568933|FG000|Overall Study|Physician Decision|4|||
147111149|NCT00832975|530568933|FG000|Overall Study|Withdrawal by Subject|3|||
147111150|NCT00832975|530568933|FG000|Overall Study|Other reasons|14|||
147111151|NCT02811159|530568941|FG000|Treatment Course 1|Lost to Follow-up|1|||
147111152|NCT04603066|530568943|FG000|Wash-out (3 Weeks)|Protocol Violation|1|||
147111153|NCT04603066|530568944|FG001|Wash-out (3 Weeks)|Protocol Violation|0|||
147111154|NCT06717399|530568945|FG000|Overall Study|Death|1|||
147111155|NCT00177671|530569944|FG000|Overall Study|Withdrawal by Subject|5|||
147111156|NCT00177671|530569945|FG001|Overall Study|Withdrawal by Subject|6|||
147111157|NCT00177671|530569944|FG000|Overall Study|medical complications|2|||
147111158|NCT00177671|530569945|FG001|Overall Study|medical complications|0|||
147111159|NCT00177671|530569944|FG000|Overall Study|Adverse Event|6|||
147111160|NCT00177671|530569945|FG001|Overall Study|Adverse Event|0|||
147111161|NCT00177671|530569944|FG000|Overall Study|Physician Decision|12|||
147111162|NCT00177671|530569945|FG001|Overall Study|Physician Decision|8|||
147111163|NCT01991314|530569950|FG000|Overall Study|Adverse Event|5|||
147111164|NCT01991314|530569951|FG001|Overall Study|Adverse Event|1|||
147111165|NCT01991314|530569950|FG000|Overall Study|Lost to Follow-up|6|||
147111166|NCT01991314|530569951|FG001|Overall Study|Lost to Follow-up|10|||
147111167|NCT01136954|530569952|FG000|Overall Study|Adverse Event|3|||
147111168|NCT01136954|530569953|FG001|Overall Study|Adverse Event|2|||
147111169|NCT01136954|530569952|FG000|Overall Study|Withdrawal by Subject|6|||
147111170|NCT01136954|530569953|FG001|Overall Study|Withdrawal by Subject|2|||
147111171|NCT01136954|530569952|FG000|Overall Study|Lack of Efficacy|14|||
147111172|NCT01136954|530569953|FG001|Overall Study|Lack of Efficacy|13|||
147111173|NCT01136954|530569952|FG000|Overall Study|Physician Decision|0|||
147111174|NCT01136954|530569953|FG001|Overall Study|Physician Decision|1|||
147111175|NCT01136954|530569952|FG000|Overall Study|Other|1|||
147111176|NCT01136954|530569953|FG001|Overall Study|Other|3|||
147111177|NCT03317496|530569954|FG000|Phase 1b Lead-in: Treatment|Adverse Event|3|||
147111178|NCT03317496|530569955|FG001|Phase 1b Lead-in: Treatment|Adverse Event|4|||
147111179|NCT03317496|530569956|FG002|Phase 1b Lead-in: Treatment|Adverse Event|1|||
147111180|NCT03317496|530569957|FG003|Phase 1b Lead-in: Treatment|Adverse Event|1|||
147111181|NCT03317496|530569958|FG004|Phase 1b Lead-in: Treatment|Adverse Event|0|||
147111182|NCT03317496|530569954|FG000|Phase 1b Lead-in: Treatment|Physician Decision|0|||
147111183|NCT03317496|530569955|FG001|Phase 1b Lead-in: Treatment|Physician Decision|1|||
147111184|NCT03317496|530569956|FG002|Phase 1b Lead-in: Treatment|Physician Decision|0|||
147111185|NCT03317496|530569957|FG003|Phase 1b Lead-in: Treatment|Physician Decision|0|||
147226010|NCT02964507|531000386|FG007|Overall Study|Study terminated by Sponsor|0|||
147226011|NCT02964507|531000379|FG000|Overall Study|Other|3|||
147226012|NCT02964507|531000380|FG001|Overall Study|Other|0|||
147226013|NCT02964507|531000381|FG002|Overall Study|Other|0|||
147226014|NCT02964507|531000382|FG003|Overall Study|Other|0|||
147226015|NCT02964507|531000383|FG004|Overall Study|Other|1|||
147226016|NCT02964507|531000384|FG005|Overall Study|Other|0|||
147226017|NCT02964507|531000385|FG006|Overall Study|Other|0|||
147226018|NCT02964507|531000386|FG007|Overall Study|Other|0|||
147226019|NCT02964507|531000379|FG000|Overall Study|Death|11|||
147226020|NCT02964507|531000380|FG001|Overall Study|Death|9|||
147226021|NCT02964507|531000381|FG002|Overall Study|Death|12|||
147111186|NCT03317496|530569958|FG004|Phase 1b Lead-in: Treatment|Physician Decision|0|||
147111187|NCT03317496|530569954|FG000|Phase 1b Lead-in: Treatment|Death|0|||
147111188|NCT03317496|530569955|FG001|Phase 1b Lead-in: Treatment|Death|0|||
147111189|NCT03317496|530569956|FG002|Phase 1b Lead-in: Treatment|Death|1|||
147111190|NCT03317496|530569957|FG003|Phase 1b Lead-in: Treatment|Death|0|||
147559491|NCT04347239|532205401|FG000|Open Label|Pt enrolled but withdrew consent prior to dosing|1|||
147226022|NCT02964507|531000382|FG003|Overall Study|Death|2|||
147226023|NCT02964507|531000383|FG004|Overall Study|Death|10|||
147226024|NCT02964507|531000384|FG005|Overall Study|Death|5|||
147226025|NCT02964507|531000385|FG006|Overall Study|Death|0|||
147111191|NCT03317496|530569958|FG004|Phase 1b Lead-in: Treatment|Death|0|||
147111192|NCT03317496|530569954|FG000|Phase 1b Lead-in: Treatment|Progressive Disease|1|||
147111193|NCT03317496|530569955|FG001|Phase 1b Lead-in: Treatment|Progressive Disease|6|||
147111194|NCT03317496|530569956|FG002|Phase 1b Lead-in: Treatment|Progressive Disease|3|||
147111195|NCT03317496|530569957|FG003|Phase 1b Lead-in: Treatment|Progressive Disease|4|||
147111196|NCT03317496|530569958|FG004|Phase 1b Lead-in: Treatment|Progressive Disease|0|||
147111197|NCT03317496|530569954|FG000|Phase 1b Lead-in: Treatment|Other|2|||
147111198|NCT03317496|530569955|FG001|Phase 1b Lead-in: Treatment|Other|1|||
147111199|NCT03317496|530569956|FG002|Phase 1b Lead-in: Treatment|Other|0|||
147111200|NCT03317496|530569957|FG003|Phase 1b Lead-in: Treatment|Other|0|||
147111201|NCT03317496|530569958|FG004|Phase 1b Lead-in: Treatment|Other|0|||
147111202|NCT03317496|530569954|FG000|Phase 1b Lead-in: Treatment|Global deterioration of health status|0|||
147111203|NCT03317496|530569955|FG001|Phase 1b Lead-in: Treatment|Global deterioration of health status|0|||
147111204|NCT03317496|530569956|FG002|Phase 1b Lead-in: Treatment|Global deterioration of health status|1|||
147111205|NCT03317496|530569957|FG003|Phase 1b Lead-in: Treatment|Global deterioration of health status|0|||
147111206|NCT03317496|530569958|FG004|Phase 1b Lead-in: Treatment|Global deterioration of health status|0|||
147111207|NCT03317496|530569954|FG000|Phase 1b Lead-in: Treatment|Study terminated by sponsor|0|||
147111208|NCT03317496|530569955|FG001|Phase 1b Lead-in: Treatment|Study terminated by sponsor|1|||
147111209|NCT03317496|530569956|FG002|Phase 1b Lead-in: Treatment|Study terminated by sponsor|0|||
147111210|NCT03317496|530569957|FG003|Phase 1b Lead-in: Treatment|Study terminated by sponsor|1|||
147111211|NCT03317496|530569958|FG004|Phase 1b Lead-in: Treatment|Study terminated by sponsor|0|||
147111212|NCT03317496|530569954|FG000|Phase 1b Lead-in: Follow-up|Death|3|||
147111213|NCT03317496|530569955|FG001|Phase 1b Lead-in: Follow-up|Death|8|||
147111214|NCT03317496|530569956|FG002|Phase 1b Lead-in: Follow-up|Death|4|||
147111215|NCT03317496|530569957|FG003|Phase 1b Lead-in: Follow-up|Death|4|||
147111216|NCT03317496|530569958|FG004|Phase 1b Lead-in: Follow-up|Death|0|||
147111217|NCT03317496|530569954|FG000|Phase 1b Lead-in: Follow-up|Lost to Follow-up|1|||
147111218|NCT03317496|530569955|FG001|Phase 1b Lead-in: Follow-up|Lost to Follow-up|0|||
147111219|NCT03317496|530569956|FG002|Phase 1b Lead-in: Follow-up|Lost to Follow-up|0|||
147111220|NCT03317496|530569957|FG003|Phase 1b Lead-in: Follow-up|Lost to Follow-up|0|||
147111221|NCT03317496|530569958|FG004|Phase 1b Lead-in: Follow-up|Lost to Follow-up|0|||
147111222|NCT03317496|530569954|FG000|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|0|||
147111223|NCT03317496|530569955|FG001|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|0|||
147111224|NCT03317496|530569956|FG002|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|1|||
147111225|NCT03317496|530569957|FG003|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|0|||
147111226|NCT03317496|530569958|FG004|Phase 1b Lead-in: Follow-up|Withdrawal by Subject|0|||
147111227|NCT03317496|530569954|FG000|Phase 1b Lead-in: Follow-up|Other|0|||
147111228|NCT03317496|530569955|FG001|Phase 1b Lead-in: Follow-up|Other|1|||
147111229|NCT03317496|530569956|FG002|Phase 1b Lead-in: Follow-up|Other|0|||
147111230|NCT03317496|530569957|FG003|Phase 1b Lead-in: Follow-up|Other|1|||
147111231|NCT03317496|530569958|FG004|Phase 1b Lead-in: Follow-up|Other|0|||
147111232|NCT03317496|530569954|FG000|Phase 1b Lead-in: Follow-up|Study terminated by sponsor|2|||
147111233|NCT03317496|530569955|FG001|Phase 1b Lead-in: Follow-up|Study terminated by sponsor|3|||
147111234|NCT03317496|530569956|FG002|Phase 1b Lead-in: Follow-up|Study terminated by sponsor|0|||
147111235|NCT03317496|530569957|FG003|Phase 1b Lead-in: Follow-up|Study terminated by sponsor|1|||
147111236|NCT03317496|530569958|FG004|Phase 1b Lead-in: Follow-up|Study terminated by sponsor|0|||
147111237|NCT03317496|530569954|FG000|Phase 2: Treatment|Adverse Event|0|||
147111238|NCT03317496|530569955|FG001|Phase 2: Treatment|Adverse Event|0|||
147111239|NCT03317496|530569956|FG002|Phase 2: Treatment|Adverse Event|0|||
147111240|NCT03317496|530569957|FG003|Phase 2: Treatment|Adverse Event|0|||
147111241|NCT03317496|530569958|FG004|Phase 2: Treatment|Adverse Event|6|||
147111242|NCT03317496|530569954|FG000|Phase 2: Treatment|Progressive disease|0|||
147111243|NCT03317496|530569955|FG001|Phase 2: Treatment|Progressive disease|0|||
147111244|NCT03317496|530569956|FG002|Phase 2: Treatment|Progressive disease|0|||
147111245|NCT03317496|530569957|FG003|Phase 2: Treatment|Progressive disease|0|||
147111246|NCT03317496|530569958|FG004|Phase 2: Treatment|Progressive disease|22|||
147111247|NCT03317496|530569954|FG000|Phase 2: Treatment|Other|0|||
147111248|NCT03317496|530569955|FG001|Phase 2: Treatment|Other|0|||
147111249|NCT03317496|530569956|FG002|Phase 2: Treatment|Other|0|||
147111250|NCT03317496|530569957|FG003|Phase 2: Treatment|Other|0|||
147111251|NCT03317496|530569958|FG004|Phase 2: Treatment|Other|4|||
147111252|NCT03317496|530569954|FG000|Phase 2: Treatment|Withdrawal by Subject|0|||
147111253|NCT03317496|530569955|FG001|Phase 2: Treatment|Withdrawal by Subject|0|||
147111254|NCT03317496|530569956|FG002|Phase 2: Treatment|Withdrawal by Subject|0|||
147111255|NCT03317496|530569957|FG003|Phase 2: Treatment|Withdrawal by Subject|0|||
147111256|NCT03317496|530569958|FG004|Phase 2: Treatment|Withdrawal by Subject|1|||
147111257|NCT03317496|530569954|FG000|Phase 2: Treatment|Physician Decision|0|||
147111258|NCT03317496|530569955|FG001|Phase 2: Treatment|Physician Decision|0|||
147111259|NCT03317496|530569956|FG002|Phase 2: Treatment|Physician Decision|0|||
147111260|NCT03317496|530569957|FG003|Phase 2: Treatment|Physician Decision|0|||
147111261|NCT03317496|530569958|FG004|Phase 2: Treatment|Physician Decision|1|||
147111262|NCT03317496|530569954|FG000|Phase 2: Treatment|Death|0|||
147111263|NCT03317496|530569955|FG001|Phase 2: Treatment|Death|0|||
147111264|NCT03317496|530569956|FG002|Phase 2: Treatment|Death|0|||
147111265|NCT03317496|530569957|FG003|Phase 2: Treatment|Death|0|||
147111266|NCT03317496|530569958|FG004|Phase 2: Treatment|Death|1|||
147111267|NCT03317496|530569954|FG000|Phase 2: Follow-up|Death|0|||
147111268|NCT03317496|530569955|FG001|Phase 2: Follow-up|Death|0|||
147111269|NCT03317496|530569956|FG002|Phase 2: Follow-up|Death|0|||
147111270|NCT03317496|530569957|FG003|Phase 2: Follow-up|Death|0|||
147111271|NCT03317496|530569958|FG004|Phase 2: Follow-up|Death|24|||
147111272|NCT03317496|530569954|FG000|Phase 2: Follow-up|Lost to Follow-up|0|||
147111273|NCT03317496|530569955|FG001|Phase 2: Follow-up|Lost to Follow-up|0|||
147111274|NCT03317496|530569956|FG002|Phase 2: Follow-up|Lost to Follow-up|0|||
147111275|NCT03317496|530569957|FG003|Phase 2: Follow-up|Lost to Follow-up|0|||
147111276|NCT03317496|530569958|FG004|Phase 2: Follow-up|Lost to Follow-up|1|||
147111277|NCT03317496|530569954|FG000|Phase 2: Follow-up|Other|0|||
147111278|NCT03317496|530569955|FG001|Phase 2: Follow-up|Other|0|||
147111279|NCT03317496|530569956|FG002|Phase 2: Follow-up|Other|0|||
147111280|NCT03317496|530569957|FG003|Phase 2: Follow-up|Other|0|||
147111281|NCT03317496|530569958|FG004|Phase 2: Follow-up|Other|1|||
147111282|NCT03317496|530569954|FG000|Phase 2: Follow-up|Study terminated by sponsor|0|||
147111283|NCT03317496|530569955|FG001|Phase 2: Follow-up|Study terminated by sponsor|0|||
147111284|NCT03317496|530569956|FG002|Phase 2: Follow-up|Study terminated by sponsor|0|||
147111285|NCT03317496|530569957|FG003|Phase 2: Follow-up|Study terminated by sponsor|0|||
147111286|NCT03317496|530569958|FG004|Phase 2: Follow-up|Study terminated by sponsor|7|||
147111287|NCT02034591|530569969|FG000|Overall Study|Withdrawal by Subject|0|||
147111288|NCT02034591|530569970|FG001|Overall Study|Withdrawal by Subject|0|||
147111289|NCT02034591|530569971|FG002|Overall Study|Withdrawal by Subject|0|||
147111290|NCT02034591|530569972|FG003|Overall Study|Withdrawal by Subject|0|||
147111291|NCT02034591|530569973|FG004|Overall Study|Withdrawal by Subject|1|||
147111292|NCT02034591|530569974|FG005|Overall Study|Withdrawal by Subject|0|||
147111293|NCT00817063|530569975|FG000|Overall Study|Adverse Event|32|||
147111294|NCT00817063|530569976|FG001|Overall Study|Adverse Event|13|||
147111295|NCT00817063|530569975|FG000|Overall Study|Death|1|||
147111296|NCT00817063|530569976|FG001|Overall Study|Death|1|||
147111297|NCT00817063|530569975|FG000|Overall Study|Lack of Efficacy|33|||
147111298|NCT00817063|530569976|FG001|Overall Study|Lack of Efficacy|86|||
147111299|NCT00817063|530569975|FG000|Overall Study|Failure to Return|13|||
147111300|NCT00817063|530569976|FG001|Overall Study|Failure to Return|12|||
147111301|NCT00817063|530569975|FG000|Overall Study|Violation of Selection at Entry|7|||
147111302|NCT00817063|530569976|FG001|Overall Study|Violation of Selection at Entry|4|||
147111303|NCT00817063|530569975|FG000|Overall Study|Protocol Violation|3|||
147111304|NCT00817063|530569976|FG001|Overall Study|Protocol Violation|8|||
147111305|NCT00817063|530569975|FG000|Overall Study|Withdrawal by Subject|17|||
147111306|NCT00817063|530569976|FG001|Overall Study|Withdrawal by Subject|37|||
147111307|NCT00817063|530569975|FG000|Overall Study|Early Improvement|19|||
147111308|NCT00817063|530569976|FG001|Overall Study|Early Improvement|4|||
147111309|NCT00817063|530569975|FG000|Overall Study|Administrative|10|||
147111310|NCT00817063|530569976|FG001|Overall Study|Administrative|4|||
147111311|NCT00817063|530569975|FG000|Overall Study|Abnormality of Laboratory Test|2|||
147111312|NCT00817063|530569976|FG001|Overall Study|Abnormality of Laboratory Test|1|||
147111313|NCT01496456|530569977|FG000|Overall Study|Protocol Violation|1|||
147111314|NCT01496456|530569977|FG000|Overall Study|Lost to Follow-up|7|||
147111315|NCT01697579|530569980|FG000|Base Study-Cycle 1|Adverse Event|1|||
147111316|NCT01697579|530569981|FG001|Base Study-Cycle 1|Adverse Event|0|||
147111317|NCT01697579|530569982|FG002|Base Study-Cycle 1|Adverse Event|0|||
147111318|NCT01697579|530569983|FG003|Base Study-Cycle 1|Adverse Event|0|||
147111319|NCT01697579|530569984|FG004|Base Study-Cycle 1|Adverse Event|0|||
147111320|NCT01697579|530569985|FG005|Base Study-Cycle 1|Adverse Event|0|||
147111321|NCT01697579|530569986|FG006|Base Study-Cycle 1|Adverse Event|0|||
147111322|NCT01697579|530569980|FG000|Base Study-Cycle 1|Withdrawal by Parent/Guardian|1|||
147111323|NCT01697579|530569981|FG001|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
147111324|NCT01697579|530569982|FG002|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
147111325|NCT01697579|530569983|FG003|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
147111326|NCT01697579|530569984|FG004|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
147111327|NCT01697579|530569985|FG005|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
147111328|NCT01697579|530569986|FG006|Base Study-Cycle 1|Withdrawal by Parent/Guardian|0|||
147111329|NCT01697579|530569980|FG000|Base Study-Cycle 1|Protocol Violation|0|||
147111330|NCT01697579|530569981|FG001|Base Study-Cycle 1|Protocol Violation|0|||
147111331|NCT01697579|530569982|FG002|Base Study-Cycle 1|Protocol Violation|0|||
147111332|NCT01697579|530569983|FG003|Base Study-Cycle 1|Protocol Violation|0|||
147111333|NCT01697579|530569984|FG004|Base Study-Cycle 1|Protocol Violation|3|||
147111334|NCT01697579|530569985|FG005|Base Study-Cycle 1|Protocol Violation|0|||
147111335|NCT01697579|530569986|FG006|Base Study-Cycle 1|Protocol Violation|0|||
147111336|NCT01697579|530569980|FG000|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
147111337|NCT01697579|530569981|FG001|Base Study-Cycle 1|Consent Withdrawn by Participant|1|||
147111338|NCT01697579|530569982|FG002|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
147111339|NCT01697579|530569983|FG003|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
147111340|NCT01697579|530569984|FG004|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
147111341|NCT01697579|530569985|FG005|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
147111342|NCT01697579|530569986|FG006|Base Study-Cycle 1|Consent Withdrawn by Participant|0|||
147111343|NCT01697579|530569980|FG000|Base Study-Cycle 1|Technical Problems|0|||
147111344|NCT01697579|530569981|FG001|Base Study-Cycle 1|Technical Problems|0|||
147111345|NCT01697579|530569982|FG002|Base Study-Cycle 1|Technical Problems|1|||
147111346|NCT01697579|530569983|FG003|Base Study-Cycle 1|Technical Problems|1|||
147111347|NCT01697579|530569984|FG004|Base Study-Cycle 1|Technical Problems|0|||
147111348|NCT01697579|530569985|FG005|Base Study-Cycle 1|Technical Problems|0|||
147111349|NCT01697579|530569986|FG006|Base Study-Cycle 1|Technical Problems|0|||
147111350|NCT01697579|530569980|FG000|Optional Extension-Cycles 2-6|Death|0|||
147111351|NCT01697579|530569981|FG001|Optional Extension-Cycles 2-6|Death|0|||
147111352|NCT01697579|530569982|FG002|Optional Extension-Cycles 2-6|Death|0|||
147559492|NCT04347239|532205402|FG001|Open Label|Pt enrolled but withdrew consent prior to dosing|0|||
147559493|NCT04347239|532205403|FG002|Open Label|Pt enrolled but withdrew consent prior to dosing|0|||
147559494|NCT00918567|532205404|FG000|Overall Study|Lack of Efficacy|3|||
147559495|NCT00918567|532205405|FG001|Overall Study|Lack of Efficacy|1|||
147559496|NCT00918567|532205404|FG000|Overall Study|Withdrawal by Subject|1|||
147559497|NCT00918567|532205405|FG001|Overall Study|Withdrawal by Subject|1|||
147559498|NCT00918567|532205404|FG000|Overall Study|Adverse Event|1|||
147559499|NCT00918567|532205405|FG001|Overall Study|Adverse Event|0|||
147559500|NCT03283709|532205415|FG000|Overall Study|trial terminated|0|||
147559501|NCT03283709|532205416|FG001|Overall Study|trial terminated|1|||
147559502|NCT05275998|532205417|FG000|Overall Study|Adverse Event|0|||
147559503|NCT05275998|532205418|FG001|Overall Study|Adverse Event|0|||
147559504|NCT05275998|532205419|FG002|Overall Study|Adverse Event|0|||
147559505|NCT05275998|532205420|FG003|Overall Study|Adverse Event|1|||
147559506|NCT05275998|532205417|FG000|Overall Study|Withdrawal by Subject|0|||
147559507|NCT05275998|532205418|FG001|Overall Study|Withdrawal by Subject|0|||
147559508|NCT05275998|532205419|FG002|Overall Study|Withdrawal by Subject|0|||
147559509|NCT05275998|532205420|FG003|Overall Study|Withdrawal by Subject|1|||
147559510|NCT05275998|532205417|FG000|Overall Study|Physician Decision|0|||
147559511|NCT05275998|532205418|FG001|Overall Study|Physician Decision|0|||
147559512|NCT05275998|532205419|FG002|Overall Study|Physician Decision|0|||
147559513|NCT05275998|532205420|FG003|Overall Study|Physician Decision|1|||
147559514|NCT05275998|532205417|FG000|Overall Study|Protocol Violation|0|||
147559515|NCT05275998|532205418|FG001|Overall Study|Protocol Violation|0|||
147559516|NCT05275998|532205419|FG002|Overall Study|Protocol Violation|1|||
147559517|NCT05275998|532205420|FG003|Overall Study|Protocol Violation|0|||
147559518|NCT01867242|532205425|FG000|Overall Study|Lost to follow-up, personal reasons|24|||
147559519|NCT01867242|532205426|FG001|Overall Study|Lost to follow-up, personal reasons|16|||
147559520|NCT01867242|532205427|FG002|Overall Study|Lost to follow-up, personal reasons|8|||
147559521|NCT00264810|532205430|FG000|Baseline|Withdrawal by Subject|10|||
147559522|NCT00264810|532205431|FG001|Baseline|Withdrawal by Subject|10|||
147559523|NCT00264810|532205430|FG000|Baseline|Physician Decision|7|||
147559524|NCT00264810|532205431|FG001|Baseline|Physician Decision|8|||
147559525|NCT00264810|532205430|FG000|Baseline|Subject Compliance Failure|3|||
147559526|NCT00264810|532205431|FG001|Baseline|Subject Compliance Failure|3|||
147559527|NCT00264810|532205430|FG000|Baseline|Insufficient Seizure Frequency|2|||
147559528|NCT00264810|532205431|FG001|Baseline|Insufficient Seizure Frequency|2|||
147559529|NCT00264810|532205430|FG000|Baseline|Did not Meet/Maintain Study I/E Criteria|1|||
147559530|NCT00264810|532205431|FG001|Baseline|Did not Meet/Maintain Study I/E Criteria|2|||
147559531|NCT00264810|532205430|FG000|Baseline|Other|0|||
147559532|NCT00264810|532205431|FG001|Baseline|Other|1|||
147559533|NCT00264810|532205430|FG000|Stimulation Optimization Period|Withdrawal by Subject|1|||
147559534|NCT00264810|532205431|FG001|Stimulation Optimization Period|Withdrawal by Subject|0|||
147559535|NCT00264810|532205430|FG000|Stimulation Optimization Period|Death|0|||
147559536|NCT00264810|532205431|FG001|Stimulation Optimization Period|Death|1|||
147559537|NCT00264810|532205430|FG000|Blinded Evaluation Period|Explant due to infection|1|||
147559538|NCT00264810|532205431|FG001|Blinded Evaluation Period|Explant due to infection|1|||
147559539|NCT00264810|532205430|FG000|Open Label Evaluation Period|Explant due to infection|1|||
147559540|NCT00264810|532205431|FG001|Open Label Evaluation Period|Explant due to infection|1|||
147559541|NCT00264810|532205430|FG000|Open Label Evaluation Period|Death|3|||
147559542|NCT00264810|532205431|FG001|Open Label Evaluation Period|Death|2|||
147559543|NCT00264810|532205430|FG000|Open Label Evaluation Period|Pursue Other Treatment Options|2|||
147559544|NCT00264810|532205431|FG001|Open Label Evaluation Period|Pursue Other Treatment Options|3|||
147559545|NCT02879643|532205433|FG000|Overall Study|Adverse Event|0|||
147559546|NCT02879643|532205434|FG001|Overall Study|Adverse Event|0|||
147559547|NCT02879643|532205435|FG002|Overall Study|Adverse Event|1|||
147559548|NCT02879643|532205436|FG003|Overall Study|Adverse Event|1|||
147559549|NCT02879643|532205437|FG004|Overall Study|Adverse Event|0|||
147559550|NCT00182091|532205438|FG000|Overall Study|Withdrawal by Subject|1|||
147559551|NCT00182091|532205439|FG001|Overall Study|Withdrawal by Subject|0|||
147559552|NCT00182091|532205440|FG002|Overall Study|Withdrawal by Subject|0|||
147559553|NCT00182091|532205441|FG003|Overall Study|Withdrawal by Subject|0|||
147559554|NCT02199509|532205442|FG000|Overall Study|Suicidal Ideation|0|||
147559555|NCT02199509|532205443|FG001|Overall Study|Suicidal Ideation|1|||
147559556|NCT02199509|532205442|FG000|Overall Study|Misunderstood titration schedule|1|||
147559557|NCT02199509|532205443|FG001|Overall Study|Misunderstood titration schedule|0|||
147559558|NCT02093689|532205445|FG000|Overall Study|Physician Decision|4|||
147559559|NCT02093689|532205446|FG001|Overall Study|Physician Decision|0|||
147559560|NCT02093689|532205447|FG002|Overall Study|Physician Decision|0|||
147559561|NCT00634179|532205451|FG000|Phase II: Maintenance|Diagnosis changed after re-review|1|||
147559562|NCT04947579|532205454|FG000|Week 0 - Week 12 (Placebo-Controlled)|Adverse Event|0|||
147559563|NCT04947579|532205455|FG001|Week 0 - Week 12 (Placebo-Controlled)|Adverse Event|0|||
147559564|NCT04947579|532205456|FG002|Week 0 - Week 12 (Placebo-Controlled)|Adverse Event|0|||
147559565|NCT04947579|532205457|FG003|Week 0 - Week 12 (Placebo-Controlled)|Adverse Event|1|||
147559566|NCT04947579|532205458|FG004|Week 0 - Week 12 (Placebo-Controlled)|Adverse Event|0|||
147111353|NCT01697579|530569983|FG003|Optional Extension-Cycles 2-6|Death|0|||
147111354|NCT01697579|530569984|FG004|Optional Extension-Cycles 2-6|Death|0|||
147111355|NCT01697579|530569985|FG005|Optional Extension-Cycles 2-6|Death|0|||
147111356|NCT01697579|530569986|FG006|Optional Extension-Cycles 2-6|Death|2|||
147111357|NCT01697579|530569980|FG000|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0|||
147111358|NCT01697579|530569981|FG001|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0|||
147111359|NCT01697579|530569982|FG002|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0|||
147111360|NCT01697579|530569983|FG003|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0|||
147111361|NCT01697579|530569984|FG004|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|0|||
147111362|NCT01697579|530569985|FG005|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|1|||
147111363|NCT01697579|530569986|FG006|Optional Extension-Cycles 2-6|Withdrawal by Parent/Guardian|5|||
147111364|NCT01697579|530569980|FG000|Optional Extension-Cycles 2-6|Physician Decision|0|||
147111365|NCT01697579|530569981|FG001|Optional Extension-Cycles 2-6|Physician Decision|0|||
147111366|NCT01697579|530569982|FG002|Optional Extension-Cycles 2-6|Physician Decision|0|||
147111367|NCT01697579|530569983|FG003|Optional Extension-Cycles 2-6|Physician Decision|0|||
147111368|NCT01697579|530569984|FG004|Optional Extension-Cycles 2-6|Physician Decision|0|||
147111369|NCT01697579|530569985|FG005|Optional Extension-Cycles 2-6|Physician Decision|7|||
147111370|NCT01697579|530569986|FG006|Optional Extension-Cycles 2-6|Physician Decision|11|||
147111371|NCT01697579|530569980|FG000|Optional Extension-Cycles 2-6|Protocol Violation|0|||
147111372|NCT01697579|530569981|FG001|Optional Extension-Cycles 2-6|Protocol Violation|0|||
147111373|NCT01697579|530569982|FG002|Optional Extension-Cycles 2-6|Protocol Violation|0|||
147111374|NCT01697579|530569983|FG003|Optional Extension-Cycles 2-6|Protocol Violation|0|||
147111375|NCT01697579|530569984|FG004|Optional Extension-Cycles 2-6|Protocol Violation|0|||
147111376|NCT01697579|530569985|FG005|Optional Extension-Cycles 2-6|Protocol Violation|0|||
147111377|NCT01697579|530569986|FG006|Optional Extension-Cycles 2-6|Protocol Violation|4|||
147111378|NCT01697579|530569980|FG000|Optional Extension-Cycles 2-6|Excluded Medication|0|||
147111379|NCT01697579|530569981|FG001|Optional Extension-Cycles 2-6|Excluded Medication|0|||
147111380|NCT01697579|530569982|FG002|Optional Extension-Cycles 2-6|Excluded Medication|0|||
147111381|NCT01697579|530569983|FG003|Optional Extension-Cycles 2-6|Excluded Medication|0|||
147111382|NCT01697579|530569984|FG004|Optional Extension-Cycles 2-6|Excluded Medication|0|||
147111383|NCT01697579|530569985|FG005|Optional Extension-Cycles 2-6|Excluded Medication|1|||
147111384|NCT01697579|530569986|FG006|Optional Extension-Cycles 2-6|Excluded Medication|2|||
147111385|NCT01697579|530569980|FG000|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
147111386|NCT01697579|530569981|FG001|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
147111387|NCT01697579|530569982|FG002|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
147111388|NCT01697579|530569983|FG003|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
147111389|NCT01697579|530569984|FG004|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
147111390|NCT01697579|530569985|FG005|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|1|||
147111391|NCT01697579|530569986|FG006|Optional Extension-Cycles 2-6|Did Not Respond To Chemotherapy Regimen|0|||
147111392|NCT01697579|530569980|FG000|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0|||
147111393|NCT01697579|530569981|FG001|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0|||
147111394|NCT01697579|530569982|FG002|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0|||
147111395|NCT01697579|530569983|FG003|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0|||
147111396|NCT01697579|530569984|FG004|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|0|||
147111397|NCT01697579|530569985|FG005|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|15|||
147111398|NCT01697579|530569986|FG006|Optional Extension-Cycles 2-6|Completed Chemotherapy Regimen|24|||
147111399|NCT01697579|530569980|FG000|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0|||
147111400|NCT01697579|530569981|FG001|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0|||
147111401|NCT01697579|530569982|FG002|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0|||
147111402|NCT01697579|530569983|FG003|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0|||
147111403|NCT01697579|530569984|FG004|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|0|||
147111404|NCT01697579|530569985|FG005|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|4|||
147111405|NCT01697579|530569986|FG006|Optional Extension-Cycles 2-6|Did Not Meet Cycle Eligibility Criteria|11|||
147111406|NCT01697579|530569980|FG000|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
147226026|NCT02964507|531000386|FG007|Overall Study|Death|0|||
147226027|NCT02964507|531000379|FG000|Overall Study|Withdrawal by Subject|1|||
147226028|NCT02964507|531000380|FG001|Overall Study|Withdrawal by Subject|0|||
147226029|NCT02964507|531000381|FG002|Overall Study|Withdrawal by Subject|1|||
147226030|NCT02964507|531000382|FG003|Overall Study|Withdrawal by Subject|1|||
147226031|NCT02964507|531000383|FG004|Overall Study|Withdrawal by Subject|0|||
147559567|NCT04947579|532205459|FG005|Week 0 - Week 12 (Placebo-Controlled)|Adverse Event|0|||
147559568|NCT04947579|532205454|FG000|Week 0 - Week 12 (Placebo-Controlled)|Other reasons|0|||
147226032|NCT02964507|531000384|FG005|Overall Study|Withdrawal by Subject|1|||
147226033|NCT02964507|531000385|FG006|Overall Study|Withdrawal by Subject|0|||
147226034|NCT02964507|531000386|FG007|Overall Study|Withdrawal by Subject|0|||
147226035|NCT02964507|531000379|FG000|Overall Study|Physician Decision|2|||
147111407|NCT01697579|530569981|FG001|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
147111408|NCT01697579|530569982|FG002|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
147111409|NCT01697579|530569983|FG003|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
147111410|NCT01697579|530569984|FG004|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
147111411|NCT01697579|530569985|FG005|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|0|||
147111412|NCT01697579|530569986|FG006|Optional Extension-Cycles 2-6|Consent Withdrawn by Participant|2|||
147111413|NCT01697579|530569980|FG000|Optional Extension-Cycles 2-6|Technical Problems|0|||
147111414|NCT01697579|530569981|FG001|Optional Extension-Cycles 2-6|Technical Problems|0|||
147111415|NCT01697579|530569982|FG002|Optional Extension-Cycles 2-6|Technical Problems|0|||
147111416|NCT01697579|530569983|FG003|Optional Extension-Cycles 2-6|Technical Problems|0|||
147111417|NCT01697579|530569984|FG004|Optional Extension-Cycles 2-6|Technical Problems|0|||
147111418|NCT01697579|530569985|FG005|Optional Extension-Cycles 2-6|Technical Problems|0|||
147111419|NCT01697579|530569986|FG006|Optional Extension-Cycles 2-6|Technical Problems|1|||
147111420|NCT01697579|530569980|FG000|Optional Extension-Cycles 2-6|Participant Moved|0|||
147111421|NCT01697579|530569981|FG001|Optional Extension-Cycles 2-6|Participant Moved|0|||
147111422|NCT01697579|530569982|FG002|Optional Extension-Cycles 2-6|Participant Moved|0|||
147111423|NCT01697579|530569983|FG003|Optional Extension-Cycles 2-6|Participant Moved|0|||
147111424|NCT01697579|530569984|FG004|Optional Extension-Cycles 2-6|Participant Moved|0|||
147111425|NCT01697579|530569985|FG005|Optional Extension-Cycles 2-6|Participant Moved|0|||
147111426|NCT01697579|530569986|FG006|Optional Extension-Cycles 2-6|Participant Moved|2|||
147111427|NCT01697579|530569980|FG000|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0|||
147111428|NCT01697579|530569981|FG001|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0|||
147111429|NCT01697579|530569982|FG002|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0|||
147111430|NCT01697579|530569983|FG003|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0|||
147111431|NCT01697579|530569984|FG004|Optional Extension-Cycles 2-6|Non-compliance With Protocol|0|||
147111432|NCT01697579|530569985|FG005|Optional Extension-Cycles 2-6|Non-compliance With Protocol|6|||
147111433|NCT01697579|530569986|FG006|Optional Extension-Cycles 2-6|Non-compliance With Protocol|4|||
147111434|NCT01697579|530569980|FG000|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
147111435|NCT01697579|530569981|FG001|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
147111436|NCT01697579|530569982|FG002|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
147111437|NCT01697579|530569983|FG003|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
147111438|NCT01697579|530569984|FG004|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
147111439|NCT01697579|530569985|FG005|Optional Extension-Cycles 2-6|Lost to Follow-up|0|||
147111440|NCT01697579|530569986|FG006|Optional Extension-Cycles 2-6|Lost to Follow-up|1|||
147111441|NCT04092777|530569988|FG000|Overall Study|Lost to Follow-up|28|||
147111442|NCT04092777|530569989|FG001|Overall Study|Lost to Follow-up|46|||
147111443|NCT04092777|530569988|FG000|Overall Study|Withdrawal by Subject|8|||
147111444|NCT04092777|530569989|FG001|Overall Study|Withdrawal by Subject|5|||
147111445|NCT00876343|530569992|FG000|Overall Study|Adverse Event|7|||
147111446|NCT00876343|530569993|FG001|Overall Study|Adverse Event|8|||
147111447|NCT00876343|530569994|FG002|Overall Study|Adverse Event|2|||
147111448|NCT00876343|530569992|FG000|Overall Study|Withdrawal by Subject|4|||
147111449|NCT00876343|530569993|FG001|Overall Study|Withdrawal by Subject|4|||
147111450|NCT00876343|530569994|FG002|Overall Study|Withdrawal by Subject|3|||
147111451|NCT00876343|530569992|FG000|Overall Study|Lack of Efficacy|0|||
147111452|NCT00876343|530569993|FG001|Overall Study|Lack of Efficacy|0|||
147111453|NCT00876343|530569994|FG002|Overall Study|Lack of Efficacy|1|||
147111454|NCT00876343|530569992|FG000|Overall Study|Protocol Violation|4|||
147111455|NCT00876343|530569993|FG001|Overall Study|Protocol Violation|1|||
147111456|NCT00876343|530569994|FG002|Overall Study|Protocol Violation|1|||
147111457|NCT00876343|530569992|FG000|Overall Study|Physician Decision|0|||
147111458|NCT00876343|530569993|FG001|Overall Study|Physician Decision|1|||
147111459|NCT00876343|530569994|FG002|Overall Study|Physician Decision|1|||
147111460|NCT00876343|530569992|FG000|Overall Study|Diabetic glucose level or HbA1C>=6.5%|0|||
147111461|NCT00876343|530569993|FG001|Overall Study|Diabetic glucose level or HbA1C>=6.5%|1|||
147111462|NCT00876343|530569994|FG002|Overall Study|Diabetic glucose level or HbA1C>=6.5%|1|||
147111463|NCT00876343|530569992|FG000|Overall Study|Change of residence or other commitments|2|||
147111464|NCT00876343|530569993|FG001|Overall Study|Change of residence or other commitments|2|||
147226036|NCT02964507|531000380|FG001|Overall Study|Physician Decision|0|||
147559569|NCT04947579|532205455|FG001|Week 0 - Week 12 (Placebo-Controlled)|Other reasons|0|||
147226037|NCT02964507|531000381|FG002|Overall Study|Physician Decision|3|||
147226038|NCT02964507|531000382|FG003|Overall Study|Physician Decision|0|||
147226039|NCT02964507|531000383|FG004|Overall Study|Physician Decision|1|||
147226040|NCT02964507|531000384|FG005|Overall Study|Physician Decision|0|||
147111465|NCT00876343|530569994|FG002|Overall Study|Change of residence or other commitments|3|||
147111466|NCT00088153|530569998|FG000|Overall Study|Physician Decision|3|||
147111467|NCT00088153|530569999|FG001|Overall Study|Physician Decision|3|||
147226041|NCT02964507|531000385|FG006|Overall Study|Physician Decision|0|||
147226042|NCT02964507|531000386|FG007|Overall Study|Physician Decision|0|||
147226043|NCT04341662|531000388|FG000|Overall Study|Did not have source-verified blood loss data|423|||
147226044|NCT04341662|531000389|FG001|Overall Study|Did not have source-verified blood loss data|514|||
147311021|NCT00806624|531307068|FG001|Overall Study|Withdrawal by Subject|3|||
147311022|NCT00806624|531307069|FG002|Overall Study|Withdrawal by Subject|3|||
147311023|NCT00806624|531307067|FG000|Overall Study|discontinued before start of treatment|0|||
147311024|NCT00806624|531307068|FG001|Overall Study|discontinued before start of treatment|0|||
147311025|NCT00806624|531307069|FG002|Overall Study|discontinued before start of treatment|1|||
147311026|NCT01804673|531307070|FG000|Overall Study|Adverse Event|4|||
147311027|NCT01804673|531307070|FG000|Overall Study|Withdrawal by Subject|1|||
147311028|NCT01804673|531307070|FG000|Overall Study|Lack of Efficacy|9|||
147311029|NCT01804673|531307070|FG000|Overall Study|Change to Oral Therapy|37|||
147311030|NCT01804673|531307070|FG000|Overall Study|No Further Therapy Required|84|||
147311031|NCT01804673|531307070|FG000|Overall Study|Use of Prohibited Medication|1|||
147311032|NCT01804673|531307070|FG000|Overall Study|Other|4|||
147311033|NCT01857934|531307071|FG000|Overall Study|Relapse or progression|2|||
147444310|NCT02104583|531792550|FG002|Overall Study|Adverse Event|6|||
147559570|NCT04947579|532205456|FG002|Week 0 - Week 12 (Placebo-Controlled)|Other reasons|1|||
147559571|NCT04947579|532205457|FG003|Week 0 - Week 12 (Placebo-Controlled)|Other reasons|0|||
147559572|NCT04947579|532205458|FG004|Week 0 - Week 12 (Placebo-Controlled)|Other reasons|0|||
147559573|NCT04947579|532205459|FG005|Week 0 - Week 12 (Placebo-Controlled)|Other reasons|0|||
147559574|NCT04947579|532205454|FG000|Week 0 - Week 12 (Placebo-Controlled)|Withdrawal by Subject|1|||
147559575|NCT04947579|532205455|FG001|Week 0 - Week 12 (Placebo-Controlled)|Withdrawal by Subject|1|||
147559576|NCT04947579|532205456|FG002|Week 0 - Week 12 (Placebo-Controlled)|Withdrawal by Subject|2|||
147559577|NCT04947579|532205457|FG003|Week 0 - Week 12 (Placebo-Controlled)|Withdrawal by Subject|0|||
147559578|NCT04947579|532205458|FG004|Week 0 - Week 12 (Placebo-Controlled)|Withdrawal by Subject|2|||
147559579|NCT04947579|532205459|FG005|Week 0 - Week 12 (Placebo-Controlled)|Withdrawal by Subject|0|||
147559580|NCT04947579|532205454|FG000|Week 0 - Week 12 (Placebo-Controlled)|Study terminated by sponsor|5|||
147559581|NCT04947579|532205455|FG001|Week 0 - Week 12 (Placebo-Controlled)|Study terminated by sponsor|6|||
147559582|NCT04947579|532205456|FG002|Week 0 - Week 12 (Placebo-Controlled)|Study terminated by sponsor|7|||
147559583|NCT04947579|532205457|FG003|Week 0 - Week 12 (Placebo-Controlled)|Study terminated by sponsor|1|||
147559584|NCT04947579|532205458|FG004|Week 0 - Week 12 (Placebo-Controlled)|Study terminated by sponsor|0|||
147559585|NCT04947579|532205459|FG005|Week 0 - Week 12 (Placebo-Controlled)|Study terminated by sponsor|1|||
147559586|NCT04947579|532205454|FG000|Week 0 - Week 12 (Placebo-Controlled)|Protocol Deviation|1|||
147559587|NCT04947579|532205455|FG001|Week 0 - Week 12 (Placebo-Controlled)|Protocol Deviation|0|||
147559588|NCT04947579|532205456|FG002|Week 0 - Week 12 (Placebo-Controlled)|Protocol Deviation|0|||
147559589|NCT04947579|532205457|FG003|Week 0 - Week 12 (Placebo-Controlled)|Protocol Deviation|0|||
147559590|NCT04947579|532205458|FG004|Week 0 - Week 12 (Placebo-Controlled)|Protocol Deviation|0|||
147559591|NCT04947579|532205459|FG005|Week 0 - Week 12 (Placebo-Controlled)|Protocol Deviation|0|||
147559592|NCT04947579|532205454|FG000|Week 12 - Week 64 (Long-Term Extension)|Death|0|||
147559593|NCT04947579|532205455|FG001|Week 12 - Week 64 (Long-Term Extension)|Death|0|||
147559594|NCT04947579|532205456|FG002|Week 12 - Week 64 (Long-Term Extension)|Death|1|||
147559595|NCT04947579|532205457|FG003|Week 12 - Week 64 (Long-Term Extension)|Death|0|||
147559596|NCT04947579|532205458|FG004|Week 12 - Week 64 (Long-Term Extension)|Death|0|||
147559597|NCT04947579|532205459|FG005|Week 12 - Week 64 (Long-Term Extension)|Death|0|||
147559598|NCT04947579|532205454|FG000|Week 12 - Week 64 (Long-Term Extension)|Adverse Event|0|||
147559599|NCT04947579|532205455|FG001|Week 12 - Week 64 (Long-Term Extension)|Adverse Event|1|||
147559600|NCT04947579|532205456|FG002|Week 12 - Week 64 (Long-Term Extension)|Adverse Event|0|||
147559601|NCT04947579|532205457|FG003|Week 12 - Week 64 (Long-Term Extension)|Adverse Event|0|||
147559602|NCT04947579|532205458|FG004|Week 12 - Week 64 (Long-Term Extension)|Adverse Event|0|||
147559603|NCT04947579|532205459|FG005|Week 12 - Week 64 (Long-Term Extension)|Adverse Event|1|||
147559604|NCT04947579|532205454|FG000|Week 12 - Week 64 (Long-Term Extension)|Lost to Follow-up|0|||
147559605|NCT04947579|532205455|FG001|Week 12 - Week 64 (Long-Term Extension)|Lost to Follow-up|0|||
147559606|NCT04947579|532205456|FG002|Week 12 - Week 64 (Long-Term Extension)|Lost to Follow-up|1|||
147559607|NCT04947579|532205457|FG003|Week 12 - Week 64 (Long-Term Extension)|Lost to Follow-up|0|||
147559608|NCT04947579|532205458|FG004|Week 12 - Week 64 (Long-Term Extension)|Lost to Follow-up|0|||
147559609|NCT04947579|532205459|FG005|Week 12 - Week 64 (Long-Term Extension)|Lost to Follow-up|0|||
147559610|NCT04947579|532205454|FG000|Week 12 - Week 64 (Long-Term Extension)|Study terminated by sponsor|0|||
147559611|NCT04947579|532205455|FG001|Week 12 - Week 64 (Long-Term Extension)|Study terminated by sponsor|54|||
147559612|NCT04947579|532205456|FG002|Week 12 - Week 64 (Long-Term Extension)|Study terminated by sponsor|46|||
147559613|NCT04947579|532205457|FG003|Week 12 - Week 64 (Long-Term Extension)|Study terminated by sponsor|0|||
147559614|NCT04947579|532205458|FG004|Week 12 - Week 64 (Long-Term Extension)|Study terminated by sponsor|5|||
147559615|NCT04947579|532205459|FG005|Week 12 - Week 64 (Long-Term Extension)|Study terminated by sponsor|4|||
147559616|NCT04947579|532205454|FG000|Week 12 - Week 64 (Long-Term Extension)|Withdrawal by Subject|0|||
147559617|NCT04947579|532205455|FG001|Week 12 - Week 64 (Long-Term Extension)|Withdrawal by Subject|2|||
147559618|NCT04947579|532205456|FG002|Week 12 - Week 64 (Long-Term Extension)|Withdrawal by Subject|4|||
147311034|NCT01857934|531307071|FG000|Overall Study|Unacceptable toxicity|3|||
147444311|NCT02104583|531792551|FG003|Overall Study|Adverse Event|6|||
147111468|NCT00088153|530569998|FG000|Overall Study|Withdrawal by Subject|10|||
147111469|NCT00088153|530569999|FG001|Overall Study|Withdrawal by Subject|10|||
147111470|NCT00088153|530569998|FG000|Overall Study|Lost to Follow-up|11|||
147111471|NCT00088153|530569999|FG001|Overall Study|Lost to Follow-up|12|||
147111472|NCT04717557|530570007|FG000|Overall Study|Withdrawal by Subject|2|||
147111473|NCT04717557|530570008|FG001|Overall Study|Withdrawal by Subject|0|||
147111474|NCT04717557|530570007|FG000|Overall Study|Death|1|||
147111475|NCT04717557|530570008|FG001|Overall Study|Death|0|||
147111476|NCT03168672|530570011|FG000|Overall Study|Withdrawal by Subject|13|||
147111477|NCT03168672|530570011|FG000|Overall Study|Death|3|||
147111478|NCT03168672|530570011|FG000|Overall Study|Investigator's Decision|137|||
147111479|NCT03168672|530570011|FG000|Overall Study|Adverse Event|1|||
147111480|NCT03168672|530570011|FG000|Overall Study|Other|2|||
147111481|NCT03168672|530570011|FG000|Overall Study|Started but not treated with GLOBAL ICON|15|||
147111482|NCT02246777|530570012|FG000|Overall Study|Adverse Event|2|||
147111483|NCT02246777|530570012|FG000|Overall Study|Change of residence|1|||
147111484|NCT00927472|530570018|FG000|Overall Study|Withdrawal by Subject|10|||
147111485|NCT00927472|530570019|FG001|Overall Study|Withdrawal by Subject|11|||
147111486|NCT00927472|530570018|FG000|Overall Study|Lost to Follow-up|1|||
147111487|NCT00927472|530570019|FG001|Overall Study|Lost to Follow-up|6|||
147111488|NCT00927472|530570018|FG000|Overall Study|Protocol Violation|0|||
147111489|NCT00927472|530570019|FG001|Overall Study|Protocol Violation|1|||
147111490|NCT00927472|530570018|FG000|Overall Study|Post treatment Assessment out of window|0|||
147111491|NCT00927472|530570019|FG001|Overall Study|Post treatment Assessment out of window|4|||
147111492|NCT00433537|530570020|FG000|Step 1 - VcR-CVAD Induction|Path ineligible (not having MCL)|1|||
147111493|NCT00433537|530570021|FG001|Step 1 - VcR-CVAD Induction|Path ineligible (not having MCL)|0|||
147111494|NCT00433537|530570022|FG002|Step 1 - VcR-CVAD Induction|Path ineligible (not having MCL)|1|||
147111495|NCT00433537|530570020|FG000|Step 1 - VcR-CVAD Induction|Lack of Efficacy|0|||
147111496|NCT00433537|530570021|FG001|Step 1 - VcR-CVAD Induction|Lack of Efficacy|0|||
147111497|NCT00433537|530570022|FG002|Step 1 - VcR-CVAD Induction|Lack of Efficacy|2|||
147111498|NCT00433537|530570020|FG000|Step 1 - VcR-CVAD Induction|Adverse Event|0|||
147111499|NCT00433537|530570021|FG001|Step 1 - VcR-CVAD Induction|Adverse Event|0|||
147111500|NCT00433537|530570022|FG002|Step 1 - VcR-CVAD Induction|Adverse Event|4|||
147111501|NCT00433537|530570020|FG000|Step 1 - VcR-CVAD Induction|Withdrawal by Subject|0|||
147111502|NCT00433537|530570021|FG001|Step 1 - VcR-CVAD Induction|Withdrawal by Subject|0|||
147111503|NCT00433537|530570022|FG002|Step 1 - VcR-CVAD Induction|Withdrawal by Subject|2|||
147111504|NCT00433537|530570020|FG000|Step 2 - Maintenance Rituximab or ASCT|Path ineligible (not having MCL)|1|||
147111505|NCT00433537|530570021|FG001|Step 2 - Maintenance Rituximab or ASCT|Path ineligible (not having MCL)|0|||
147111506|NCT00433537|530570022|FG002|Step 2 - Maintenance Rituximab or ASCT|Path ineligible (not having MCL)|0|||
147111507|NCT00433537|530570020|FG000|Step 2 - Maintenance Rituximab or ASCT|Lack of Efficacy|8|||
147111508|NCT00433537|530570021|FG001|Step 2 - Maintenance Rituximab or ASCT|Lack of Efficacy|0|||
147111509|NCT00433537|530570022|FG002|Step 2 - Maintenance Rituximab or ASCT|Lack of Efficacy|0|||
147111510|NCT00433537|530570020|FG000|Step 2 - Maintenance Rituximab or ASCT|Adverse Event|2|||
147226045|NCT05323656|531000390|FG000|Overall Study|Still On-Treatment|6|||
147226046|NCT05323656|531000391|FG001|Overall Study|Still On-Treatment|6|||
147226047|NCT05323656|531000390|FG000|Overall Study|Progressive Disease|15|||
147226048|NCT05323656|531000391|FG001|Overall Study|Progressive Disease|14|||
147226049|NCT05323656|531000390|FG000|Overall Study|Adverse Event|2|||
147226050|NCT05323656|531000391|FG001|Overall Study|Adverse Event|3|||
147226051|NCT05323656|531000390|FG000|Overall Study|Death|1|||
147226052|NCT05323656|531000391|FG001|Overall Study|Death|2|||
147226053|NCT05323656|531000390|FG000|Overall Study|Withdrawal by Subject|1|||
147226054|NCT05323656|531000391|FG001|Overall Study|Withdrawal by Subject|0|||
147226055|NCT05323656|531000390|FG000|Overall Study|Clinical disease progression|0|||
147226056|NCT05323656|531000391|FG001|Overall Study|Clinical disease progression|1|||
147226057|NCT05323656|531000390|FG000|Overall Study|Patient and Investigator decision|1|||
147226058|NCT05323656|531000391|FG001|Overall Study|Patient and Investigator decision|0|||
147226059|NCT05323656|531000390|FG000|Overall Study|Physician Decision|0|||
147226060|NCT05323656|531000391|FG001|Overall Study|Physician Decision|1|||
147226061|NCT00064298|531000396|FG000|Overall Study|Withdrawal by Subject|2|||
147226062|NCT00064298|531000397|FG001|Overall Study|Withdrawal by Subject|1|||
147226063|NCT00064298|531000396|FG000|Overall Study|Lost to Follow-up|2|||
147226064|NCT00064298|531000397|FG001|Overall Study|Lost to Follow-up|2|||
147111511|NCT00433537|530570021|FG001|Step 2 - Maintenance Rituximab or ASCT|Adverse Event|0|||
147226065|NCT00064298|531000396|FG000|Overall Study|Death|0|||
147226066|NCT00064298|531000397|FG001|Overall Study|Death|1|||
147226067|NCT00064298|531000396|FG000|Overall Study|Disease Progression|2|||
147226068|NCT00064298|531000397|FG001|Overall Study|Disease Progression|1|||
147226069|NCT03614975|531000398|FG000|Overall Study|Physician Decision|7|||
147226070|NCT03614975|531000399|FG001|Overall Study|Physician Decision|5|||
147226071|NCT03614975|531000398|FG000|Overall Study|Withdrawal by Subject|2|||
147226072|NCT03614975|531000399|FG001|Overall Study|Withdrawal by Subject|2|||
147111512|NCT00433537|530570022|FG002|Step 2 - Maintenance Rituximab or ASCT|Adverse Event|0|||
147111513|NCT00433537|530570020|FG000|Step 2 - Maintenance Rituximab or ASCT|Alternative therapy|4|||
147111514|NCT00433537|530570021|FG001|Step 2 - Maintenance Rituximab or ASCT|Alternative therapy|0|||
147111515|NCT00433537|530570022|FG002|Step 2 - Maintenance Rituximab or ASCT|Alternative therapy|0|||
147111516|NCT00433537|530570020|FG000|Step 2 - Maintenance Rituximab or ASCT|Other|1|||
147111517|NCT00433537|530570021|FG001|Step 2 - Maintenance Rituximab or ASCT|Other|0|||
147111518|NCT00433537|530570022|FG002|Step 2 - Maintenance Rituximab or ASCT|Other|0|||
147111519|NCT05436613|530570023|FG000|Overall Study|Lost to Follow-up|9|||
147111520|NCT05436613|530570023|FG000|Overall Study|Withdrawal by Subject|3|||
147111521|NCT05317546|530570026|FG000|First Wash-Out Period|Withdrawal by Subject|1|||
147111522|NCT05317546|530570027|FG001|First Wash-Out Period|Withdrawal by Subject|2|||
147111523|NCT03331250|530570028|FG000|Overall Study|Withdrawal by Subject|1|||
147111524|NCT04590963|530570029|FG000|Overall Study|Death|118|||
147111525|NCT04590963|530570030|FG001|Overall Study|Death|59|||
147111526|NCT04590963|530570029|FG000|Overall Study|Lost to Follow-up|1|||
147111527|NCT04590963|530570030|FG001|Overall Study|Lost to Follow-up|1|||
147111528|NCT04590963|530570029|FG000|Overall Study|Progressive disease|0|||
147111529|NCT04590963|530570030|FG001|Overall Study|Progressive disease|1|||
147111530|NCT04590963|530570029|FG000|Overall Study|Study terminated by sponsor|103|||
147111531|NCT04590963|530570030|FG001|Overall Study|Study terminated by sponsor|50|||
147111532|NCT04590963|530570029|FG000|Overall Study|Withdrawal by Subject|15|||
147111533|NCT04590963|530570030|FG001|Overall Study|Withdrawal by Subject|8|||
147111534|NCT04590963|530570029|FG000|Overall Study|Ongoing at data cut-off|9|||
147111535|NCT04590963|530570030|FG001|Overall Study|Ongoing at data cut-off|4|||
147111536|NCT04590963|530570029|FG000|Overall Study|Screen failure|1|||
147111537|NCT04590963|530570030|FG001|Overall Study|Screen failure|0|||
147111538|NCT05350202|530570031|FG000|Visit 1 - Baseline|Not-treated|18|||
147111539|NCT05350202|530570032|FG001|Visit 1 - Baseline|Not-treated|0|||
147111540|NCT05350202|530570031|FG000|Visit 1 to Visit 2 - 24 Weeks|Still active/screening failure|25|||
147111541|NCT05350202|530570032|FG001|Visit 1 to Visit 2 - 24 Weeks|Still active/screening failure|0|||
147111542|NCT05350202|530570031|FG000|Visit 1 to Visit 2 - 24 Weeks|Other reason than listed|36|||
147111543|NCT05350202|530570032|FG001|Visit 1 to Visit 2 - 24 Weeks|Other reason than listed|0|||
147111544|NCT05350202|530570031|FG000|Visit 1 to Visit 2 - 24 Weeks|Death|45|||
147111545|NCT05350202|530570032|FG001|Visit 1 to Visit 2 - 24 Weeks|Death|0|||
147111546|NCT05350202|530570031|FG000|Visit 1 to Visit 2 - 24 Weeks|Adverse-drug reaction/heart failure hospitalization|7|||
147111547|NCT05350202|530570032|FG001|Visit 1 to Visit 2 - 24 Weeks|Adverse-drug reaction/heart failure hospitalization|0|||
147111548|NCT05350202|530570031|FG000|Visit 1 to Visit 2 - 24 Weeks|Withdrawal by Subject|6|||
147111549|NCT05350202|530570032|FG001|Visit 1 to Visit 2 - 24 Weeks|Withdrawal by Subject|0|||
147111550|NCT05350202|530570031|FG000|Visit 1 to Visit 2 - 24 Weeks|Lost to Follow-up|38|||
147111551|NCT05350202|530570032|FG001|Visit 1 to Visit 2 - 24 Weeks|Lost to Follow-up|0|||
147111552|NCT05556057|530570045|FG000|Overall Study|Lost to Follow-up|5|||
147111553|NCT05556057|530570046|FG001|Overall Study|Lost to Follow-up|4|||
147111554|NCT05556057|530570045|FG000|Overall Study|Withdrawal by Subject|0|||
147111555|NCT05556057|530570046|FG001|Overall Study|Withdrawal by Subject|2|||
147111556|NCT01525589|530570047|FG000|Overall Study|Non-treatment-related AE|1|||
147111557|NCT01525589|530570048|FG001|Overall Study|Non-treatment-related AE|0|||
147111558|NCT01525589|530570049|FG002|Overall Study|Non-treatment-related AE|0|||
147111559|NCT01525589|530570047|FG000|Overall Study|Progressive disease|48|||
147111560|NCT01525589|530570048|FG001|Overall Study|Progressive disease|15|||
147111561|NCT01525589|530570049|FG002|Overall Study|Progressive disease|29|||
147111562|NCT01525589|530570047|FG000|Overall Study|Never treated|2|||
147111563|NCT01525589|530570048|FG001|Overall Study|Never treated|0|||
147111564|NCT01525589|530570049|FG002|Overall Study|Never treated|0|||
147111565|NCT01525589|530570047|FG000|Overall Study|Physician Decision|4|||
147111566|NCT01525589|530570048|FG001|Overall Study|Physician Decision|2|||
147111567|NCT01525589|530570049|FG002|Overall Study|Physician Decision|2|||
147111568|NCT01525589|530570047|FG000|Overall Study|Death|0|||
147111569|NCT01525589|530570048|FG001|Overall Study|Death|0|||
147111570|NCT01525589|530570049|FG002|Overall Study|Death|2|||
147111571|NCT01525589|530570047|FG000|Overall Study|Treatment-related AE|1|||
147111572|NCT01525589|530570048|FG001|Overall Study|Treatment-related AE|1|||
147111573|NCT01525589|530570049|FG002|Overall Study|Treatment-related AE|2|||
147111574|NCT01525589|530570047|FG000|Overall Study|Other reasons|0|||
147311035|NCT01857934|531307071|FG000|Overall Study|Unwillingness or inability to comply|2|||
147311036|NCT01857934|531307071|FG000|Overall Study|Physician Decision|3|||
147311037|NCT01024959|531307072|FG000|Overall Study|ineligible|12|||
147311038|NCT01024959|531307072|FG000|Overall Study|results not evaluable|12|||
147444312|NCT02104583|531792552|FG004|Overall Study|Adverse Event|1|||
147444313|NCT02104583|531792548|FG000|Overall Study|Lost to Follow-up|1|||
147111575|NCT01525589|530570048|FG001|Overall Study|Other reasons|1|||
147111576|NCT01525589|530570049|FG002|Overall Study|Other reasons|0|||
147111577|NCT01525589|530570047|FG000|Overall Study|Withdrawal by Subject|0|||
147111578|NCT01525589|530570048|FG001|Overall Study|Withdrawal by Subject|1|||
147111579|NCT01525589|530570049|FG002|Overall Study|Withdrawal by Subject|0|||
147111580|NCT04611126|530570050|FG000|Overall Study|TIL expansion unsuccessful|1|||
147111581|NCT04611126|530570051|FG001|Overall Study|TIL expansion unsuccessful|0|||
147444314|NCT02104583|531792549|FG001|Overall Study|Lost to Follow-up|0|||
147444315|NCT02104583|531792550|FG002|Overall Study|Lost to Follow-up|0|||
147444316|NCT02104583|531792551|FG003|Overall Study|Lost to Follow-up|0|||
147444317|NCT02104583|531792552|FG004|Overall Study|Lost to Follow-up|0|||
147444318|NCT02104583|531792548|FG000|Overall Study|Randomized but Never Treated|0|||
147444319|NCT02104583|531792549|FG001|Overall Study|Randomized but Never Treated|0|||
147111588|NCT00143507|530571115|FG000|Overall Study|Death|572|||
147111589|NCT00143507|530571116|FG001|Overall Study|Death|547|||
147111590|NCT00143507|530571115|FG000|Overall Study|Withdrawal by Subject|114|||
147111591|NCT00143507|530571116|FG001|Overall Study|Withdrawal by Subject|102|||
147111592|NCT00143507|530571115|FG000|Overall Study|Lost to Follow-up|1|||
147111593|NCT00143507|530571116|FG001|Overall Study|Lost to Follow-up|0|||
147111594|NCT00143507|530571115|FG000|Overall Study|Withdrawn by sponsor's decision|0|||
147111595|NCT00143507|530571116|FG001|Overall Study|Withdrawn by sponsor's decision|3|||
147111596|NCT00876395|530571117|FG000|Overall Study|Untreated|8|||
147111597|NCT00876395|530571118|FG001|Overall Study|Untreated|1|||
147111598|NCT00876395|530571117|FG000|Overall Study|Adverse Event|63|||
147111599|NCT00876395|530571118|FG001|Overall Study|Adverse Event|11|||
147111600|NCT00876395|530571117|FG000|Overall Study|Abnormal test procedure result(s)|1|||
147111601|NCT00876395|530571118|FG001|Overall Study|Abnormal test procedure result(s)|0|||
147111602|NCT00876395|530571117|FG000|Overall Study|Disease progression|259|||
147111603|NCT00876395|530571118|FG001|Overall Study|Disease progression|162|||
147111604|NCT00876395|530571117|FG000|Overall Study|New cancer therapy|25|||
147111605|NCT00876395|530571118|FG001|Overall Study|New cancer therapy|7|||
147111606|NCT00876395|530571117|FG000|Overall Study|Protocol Violation|5|||
147111607|NCT00876395|530571118|FG001|Overall Study|Protocol Violation|2|||
147111608|NCT00876395|530571117|FG000|Overall Study|Withdrawal by Subject|66|||
147111609|NCT00876395|530571118|FG001|Overall Study|Withdrawal by Subject|33|||
147111610|NCT00876395|530571117|FG000|Overall Study|Lost to Follow-up|2|||
147111611|NCT00876395|530571118|FG001|Overall Study|Lost to Follow-up|0|||
147111612|NCT00876395|530571117|FG000|Overall Study|Administrative problems|39|||
147111613|NCT00876395|530571118|FG001|Overall Study|Administrative problems|23|||
147111614|NCT00876395|530571117|FG000|Overall Study|Death|12|||
147111615|NCT00876395|530571118|FG001|Overall Study|Death|0|||
147111616|NCT04919161|530571119|FG000|Overall Study|Early participant discharge from rehabilitation program after session 4|1|||
147111617|NCT04919161|530571120|FG001|Overall Study|Early participant discharge from rehabilitation program after session 4|0|||
147111618|NCT04919161|530571119|FG000|Overall Study|Flare-up of existing orthopedic condition after session 4|0|||
147111619|NCT04919161|530571120|FG001|Overall Study|Flare-up of existing orthopedic condition after session 4|1|||
147111620|NCT04919161|530571119|FG000|Overall Study|Acute ankle sprain after session 1|0|||
147111621|NCT04919161|530571120|FG001|Overall Study|Acute ankle sprain after session 1|1|||
147111622|NCT02489773|530571121|FG000|Overall Study|Lost to Follow-up|4|||
147111623|NCT02489773|530571122|FG001|Overall Study|Lost to Follow-up|1|||
147111624|NCT02489773|530571121|FG000|Overall Study|Physician Decision|1|||
147111625|NCT02489773|530571122|FG001|Overall Study|Physician Decision|0|||
147559619|NCT04947579|532205457|FG003|Week 12 - Week 64 (Long-Term Extension)|Withdrawal by Subject|0|||
147559620|NCT04947579|532205458|FG004|Week 12 - Week 64 (Long-Term Extension)|Withdrawal by Subject|1|||
147559621|NCT04947579|532205459|FG005|Week 12 - Week 64 (Long-Term Extension)|Withdrawal by Subject|3|||
147559622|NCT04947579|532205454|FG000|Week 12 - Week 64 (Long-Term Extension)|Other reasons|0|||
147559623|NCT04947579|532205455|FG001|Week 12 - Week 64 (Long-Term Extension)|Other reasons|5|||
147559624|NCT04947579|532205456|FG002|Week 12 - Week 64 (Long-Term Extension)|Other reasons|8|||
147559625|NCT04947579|532205457|FG003|Week 12 - Week 64 (Long-Term Extension)|Other reasons|0|||
147559626|NCT04947579|532205458|FG004|Week 12 - Week 64 (Long-Term Extension)|Other reasons|1|||
147559627|NCT04947579|532205459|FG005|Week 12 - Week 64 (Long-Term Extension)|Other reasons|0|||
147559628|NCT04272801|532205460|FG000|Overall Study|Withdrawal by Subject|4|||
147559629|NCT04272801|532205460|FG000|Overall Study|Lost to Follow-up|4|||
147111626|NCT02489773|530571121|FG000|Overall Study|Withdrawal by Subject|1|||
147111627|NCT02489773|530571122|FG001|Overall Study|Withdrawal by Subject|0|||
147111628|NCT02489773|530571121|FG000|Overall Study|Leave the country or the state|1|||
147111629|NCT02489773|530571122|FG001|Overall Study|Leave the country or the state|1|||
147111630|NCT00712920|530571123|FG000|Overall Study|Adverse Event|3|||
147111631|NCT00712920|530571124|FG001|Overall Study|Adverse Event|4|||
147111632|NCT00712920|530571125|FG002|Overall Study|Adverse Event|7|||
147111633|NCT00712920|530571123|FG000|Overall Study|Withdrawal by Subject|4|||
147111634|NCT00712920|530571124|FG001|Overall Study|Withdrawal by Subject|2|||
147111635|NCT00712920|530571125|FG002|Overall Study|Withdrawal by Subject|1|||
147111636|NCT00712920|530571123|FG000|Overall Study|Lost to Follow-up|1|||
147111637|NCT00712920|530571124|FG001|Overall Study|Lost to Follow-up|4|||
147111638|NCT00712920|530571125|FG002|Overall Study|Lost to Follow-up|0|||
147111639|NCT00712920|530571123|FG000|Overall Study|Lack of Efficacy|1|||
147111640|NCT00712920|530571124|FG001|Overall Study|Lack of Efficacy|0|||
147111641|NCT00712920|530571125|FG002|Overall Study|Lack of Efficacy|1|||
147111642|NCT00712920|530571123|FG000|Overall Study|Other|5|||
147111643|NCT00712920|530571124|FG001|Overall Study|Other|7|||
147111644|NCT00712920|530571125|FG002|Overall Study|Other|3|||
147111645|NCT00712920|530571123|FG000|Overall Study|Non-compliance|3|||
147111646|NCT00712920|530571124|FG001|Overall Study|Non-compliance|0|||
147111647|NCT00712920|530571125|FG002|Overall Study|Non-compliance|0|||
147111648|NCT02362451|530571127|FG000|Overall Study|Withdrawal by Subject|0|||
147111649|NCT02362451|530571128|FG001|Overall Study|Withdrawal by Subject|1|||
147111650|NCT02362451|530571127|FG000|Overall Study|Lack of Efficacy|2|||
147111651|NCT02362451|530571128|FG001|Overall Study|Lack of Efficacy|0|||
147111652|NCT02362451|530571127|FG000|Overall Study|Progression|1|||
147111653|NCT02362451|530571128|FG001|Overall Study|Progression|0|||
147111654|NCT02362451|530571127|FG000|Overall Study|Participant chose other therapy.|1|||
147111655|NCT02362451|530571128|FG001|Overall Study|Participant chose other therapy.|0|||
147111656|NCT02696616|530571131|FG000|Overall Study|Adverse Event|0|||
147111657|NCT02696616|530571132|FG001|Overall Study|Adverse Event|1|||
147111658|NCT02696616|530571133|FG002|Overall Study|Adverse Event|0|||
147111659|NCT02696616|530571134|FG003|Overall Study|Adverse Event|0|||
147111660|NCT02696616|530571135|FG004|Overall Study|Adverse Event|0|||
147111661|NCT02696616|530571136|FG005|Overall Study|Adverse Event|0|||
147111662|NCT02696616|530571137|FG006|Overall Study|Adverse Event|0|||
147111663|NCT01732783|530571140|FG000|Overall Study|Discontinued Panitumumab Treatment|106|||
147111664|NCT01732783|530571141|FG001|Overall Study|Discontinued Panitumumab Treatment|25|||
147111665|NCT01732783|530571142|FG002|Overall Study|Discontinued Panitumumab Treatment|7|||
147111666|NCT01732783|530571140|FG000|Overall Study|Death|13|||
147111667|NCT01732783|530571141|FG001|Overall Study|Death|4|||
147111668|NCT01732783|530571142|FG002|Overall Study|Death|1|||
147111669|NCT01732783|530571140|FG000|Overall Study|Lost to Follow-up|7|||
147111670|NCT01732783|530571141|FG001|Overall Study|Lost to Follow-up|1|||
147111671|NCT01732783|530571142|FG002|Overall Study|Lost to Follow-up|1|||
147111672|NCT01732783|530571140|FG000|Overall Study|Administrative Decision|8|||
147111673|NCT01732783|530571141|FG001|Overall Study|Administrative Decision|2|||
147111674|NCT01732783|530571142|FG002|Overall Study|Administrative Decision|1|||
147111675|NCT01732783|530571140|FG000|Overall Study|Withdrawal by Subject|1|||
147111676|NCT01732783|530571141|FG001|Overall Study|Withdrawal by Subject|0|||
147111677|NCT01732783|530571142|FG002|Overall Study|Withdrawal by Subject|0|||
147111678|NCT01500083|530571143|FG000|Overall Study|Adverse Event|4|||
147111679|NCT01500083|530571144|FG001|Overall Study|Adverse Event|17|||
147111680|NCT01500083|530571143|FG000|Overall Study|Death|0|||
147111681|NCT01500083|530571144|FG001|Overall Study|Death|2|||
147111682|NCT01500083|530571143|FG000|Overall Study|Lost to Follow-up|1|||
147111683|NCT01500083|530571144|FG001|Overall Study|Lost to Follow-up|0|||
147111684|NCT01500083|530571143|FG000|Overall Study|Withdrawal of Consent|0|||
147111685|NCT01500083|530571144|FG001|Overall Study|Withdrawal of Consent|1|||
147111686|NCT01500083|530571143|FG000|Overall Study|Disease Progression|2|||
147111687|NCT01500083|530571144|FG001|Overall Study|Disease Progression|10|||
147111688|NCT01500083|530571143|FG000|Overall Study|Investigator Discretion|3|||
147111689|NCT01500083|530571144|FG001|Overall Study|Investigator Discretion|8|||
147111690|NCT01500083|530571143|FG000|Overall Study|Other Reasons|2|||
147111691|NCT01500083|530571144|FG001|Overall Study|Other Reasons|5|||
147111692|NCT01555931|530571145|FG000|Overall Study|Lost to Follow-up|2|||
147111693|NCT01555931|530571146|FG001|Overall Study|Lost to Follow-up|5|||
147111694|NCT03600428|530571149|FG000|Overall Study|Not eligible|0|||
147111695|NCT03600428|530571150|FG001|Overall Study|Not eligible|1|||
147111696|NCT03600428|530571149|FG000|Overall Study|Lost to Follow-up|5|||
147111697|NCT03600428|530571150|FG001|Overall Study|Lost to Follow-up|4|||
147111698|NCT01044498|530571155|FG000|Overall Study|Withdrew consent|1|||
147111699|NCT01044498|530571156|FG001|Overall Study|Withdrew consent|1|||
147111700|NCT01044498|530571155|FG000|Overall Study|Adverse Event|1|||
147111701|NCT01044498|530571156|FG001|Overall Study|Adverse Event|1|||
147111702|NCT01044498|530571155|FG000|Overall Study|Other|1|||
147311039|NCT01024959|531307072|FG000|Overall Study|missing results required for analysis|17|||
147311040|NCT00313911|531307073|FG000|Overall Study|Serious adverse event|6|||
147311041|NCT00313911|531307074|FG001|Overall Study|Serious adverse event|1|||
147311042|NCT00313911|531307073|FG000|Overall Study|Adverse Event|2|||
147311043|NCT00313911|531307074|FG001|Overall Study|Adverse Event|3|||
147311044|NCT00313911|531307073|FG000|Overall Study|Protocol Violation|19|||
147111703|NCT01044498|530571156|FG001|Overall Study|Other|0|||
147311045|NCT00313911|531307074|FG001|Overall Study|Protocol Violation|10|||
147111704|NCT05513950|530571157|FG000|Overall Study|Not treated due to technical reasons|0|||
147111705|NCT05513950|530571158|FG001|Overall Study|Not treated due to technical reasons|0|||
147111706|NCT05513950|530571159|FG002|Overall Study|Not treated due to technical reasons|1|||
147111707|NCT05513950|530571160|FG003|Overall Study|Not treated due to technical reasons|0|||
147111708|NCT02903914|530571161|FG000|Overall Study|Adverse Event|0|||
147111709|NCT02903914|530571162|FG001|Overall Study|Adverse Event|0|||
147111710|NCT02903914|530571163|FG002|Overall Study|Adverse Event|1|||
147111711|NCT02903914|530571164|FG003|Overall Study|Adverse Event|0|||
147111712|NCT02903914|530571165|FG004|Overall Study|Adverse Event|0|||
147111713|NCT02903914|530571166|FG005|Overall Study|Adverse Event|0|||
147111714|NCT02903914|530571167|FG006|Overall Study|Adverse Event|2|||
147111715|NCT02903914|530571168|FG007|Overall Study|Adverse Event|0|||
147111716|NCT02903914|530571161|FG000|Overall Study|Withdrawal by Subject|3|||
147111717|NCT02903914|530571162|FG001|Overall Study|Withdrawal by Subject|1|||
147111718|NCT02903914|530571163|FG002|Overall Study|Withdrawal by Subject|28|||
147111719|NCT02903914|530571164|FG003|Overall Study|Withdrawal by Subject|0|||
147311046|NCT00313911|531307073|FG000|Overall Study|Lost to Follow-up|27|||
147111720|NCT02903914|530571165|FG004|Overall Study|Withdrawal by Subject|1|||
147111721|NCT02903914|530571166|FG005|Overall Study|Withdrawal by Subject|2|||
147111722|NCT02903914|530571167|FG006|Overall Study|Withdrawal by Subject|12|||
147111723|NCT02903914|530571168|FG007|Overall Study|Withdrawal by Subject|0|||
147111724|NCT02903914|530571161|FG000|Overall Study|Progressive Disease|1|||
147111725|NCT02903914|530571162|FG001|Overall Study|Progressive Disease|0|||
147111726|NCT02903914|530571163|FG002|Overall Study|Progressive Disease|4|||
147111727|NCT02903914|530571164|FG003|Overall Study|Progressive Disease|0|||
147111728|NCT02903914|530571165|FG004|Overall Study|Progressive Disease|0|||
147111729|NCT02903914|530571166|FG005|Overall Study|Progressive Disease|0|||
147111730|NCT02903914|530571167|FG006|Overall Study|Progressive Disease|2|||
147111731|NCT02903914|530571168|FG007|Overall Study|Progressive Disease|0|||
147111732|NCT02903914|530571161|FG000|Overall Study|Death|0|||
147111733|NCT02903914|530571162|FG001|Overall Study|Death|0|||
147111734|NCT02903914|530571163|FG002|Overall Study|Death|9|||
147111735|NCT02903914|530571164|FG003|Overall Study|Death|0|||
147111736|NCT02903914|530571165|FG004|Overall Study|Death|1|||
147111737|NCT02903914|530571166|FG005|Overall Study|Death|3|||
147111738|NCT02903914|530571167|FG006|Overall Study|Death|24|||
147111739|NCT02903914|530571168|FG007|Overall Study|Death|2|||
147111740|NCT02903914|530571161|FG000|Overall Study|Lost to Follow-up|0|||
147111741|NCT02903914|530571162|FG001|Overall Study|Lost to Follow-up|1|||
147111742|NCT02903914|530571163|FG002|Overall Study|Lost to Follow-up|0|||
147111743|NCT02903914|530571164|FG003|Overall Study|Lost to Follow-up|0|||
147111744|NCT02903914|530571165|FG004|Overall Study|Lost to Follow-up|2|||
147111745|NCT02903914|530571166|FG005|Overall Study|Lost to Follow-up|0|||
147111746|NCT02903914|530571167|FG006|Overall Study|Lost to Follow-up|1|||
147111747|NCT02903914|530571168|FG007|Overall Study|Lost to Follow-up|0|||
147111748|NCT02903914|530571161|FG000|Overall Study|Physician Decision|0|||
147111749|NCT02903914|530571162|FG001|Overall Study|Physician Decision|0|||
147111750|NCT02903914|530571163|FG002|Overall Study|Physician Decision|1|||
147111751|NCT02903914|530571164|FG003|Overall Study|Physician Decision|0|||
147111752|NCT02903914|530571165|FG004|Overall Study|Physician Decision|0|||
147111753|NCT02903914|530571166|FG005|Overall Study|Physician Decision|0|||
147111754|NCT02903914|530571167|FG006|Overall Study|Physician Decision|1|||
147111755|NCT02903914|530571168|FG007|Overall Study|Physician Decision|0|||
147111756|NCT02903914|530571161|FG000|Overall Study|Symptomatic Deterioration|0|||
147111757|NCT02903914|530571162|FG001|Overall Study|Symptomatic Deterioration|0|||
147111758|NCT02903914|530571163|FG002|Overall Study|Symptomatic Deterioration|1|||
147111759|NCT02903914|530571164|FG003|Overall Study|Symptomatic Deterioration|0|||
147111760|NCT02903914|530571165|FG004|Overall Study|Symptomatic Deterioration|0|||
147111761|NCT02903914|530571166|FG005|Overall Study|Symptomatic Deterioration|0|||
147111762|NCT02903914|530571167|FG006|Overall Study|Symptomatic Deterioration|0|||
147559630|NCT04272801|532205460|FG000|Overall Study|Ineligible|1|||
147559631|NCT00475020|532205461|FG000|Overall Study|Physician Decision|3|||
147559632|NCT00475020|532205461|FG000|Overall Study|Insurance Denial|1|||
147559633|NCT00475020|532205461|FG000|Overall Study|Donor not able to donate the last minute|1|||
147559634|NCT02456909|532205462|FG000|Overall Study|Did not receive allocated intervention|24|||
147559635|NCT02456909|532205463|FG001|Overall Study|Did not receive allocated intervention|26|||
147559636|NCT02456909|532205462|FG000|Overall Study|Did not complete the primary outcome|0|||
147559637|NCT02456909|532205463|FG001|Overall Study|Did not complete the primary outcome|1|||
147559638|NCT03481309|532205464|FG000|Washout (at Least 3 Days)|Withdrawal by Subject|1|||
147559639|NCT03481309|532205465|FG001|Washout (at Least 3 Days)|Withdrawal by Subject|0|||
147559640|NCT03481309|532205466|FG002|Washout (at Least 3 Days)|Withdrawal by Subject|0|||
147111763|NCT02903914|530571168|FG007|Overall Study|Symptomatic Deterioration|0|||
147111764|NCT02903914|530571161|FG000|Overall Study|New Cancer Therapy|2|||
147111765|NCT02903914|530571162|FG001|Overall Study|New Cancer Therapy|2|||
147226073|NCT03614975|531000398|FG000|Overall Study|Specimens not in lab batch shipment|1|||
147226074|NCT03614975|531000399|FG001|Overall Study|Specimens not in lab batch shipment|1|||
147226075|NCT00450385|531000400|FG000|Overall Study|Death|3|||
147226076|NCT00450385|531000400|FG000|Overall Study|Protocol Violation|1|||
147226077|NCT00450385|531000400|FG000|Overall Study|Withdrawal by Subject|2|||
147226078|NCT00450385|531000400|FG000|Overall Study|Lack of Efficacy|2|||
147444320|NCT02104583|531792550|FG002|Overall Study|Randomized but Never Treated|0|||
147444321|NCT02104583|531792551|FG003|Overall Study|Randomized but Never Treated|1|||
147444322|NCT02104583|531792552|FG004|Overall Study|Randomized but Never Treated|0|||
147226079|NCT00450385|531000400|FG000|Overall Study|Adverse Event|1|||
147444323|NCT04640272|531792554|FG000|Overall Study|Subject moved out of area|1|||
147111766|NCT02903914|530571163|FG002|Overall Study|New Cancer Therapy|21|||
147111767|NCT02903914|530571164|FG003|Overall Study|New Cancer Therapy|4|||
147111768|NCT02903914|530571165|FG004|Overall Study|New Cancer Therapy|3|||
147111769|NCT02903914|530571166|FG005|Overall Study|New Cancer Therapy|6|||
147111770|NCT02903914|530571167|FG006|Overall Study|New Cancer Therapy|56|||
147111771|NCT02903914|530571168|FG007|Overall Study|New Cancer Therapy|3|||
147111772|NCT02903914|530571161|FG000|Overall Study|Didn't Return to Site|1|||
147111773|NCT02903914|530571162|FG001|Overall Study|Didn't Return to Site|0|||
147111774|NCT02903914|530571163|FG002|Overall Study|Didn't Return to Site|1|||
147559641|NCT03481309|532205467|FG003|Washout (at Least 3 Days)|Withdrawal by Subject|0|||
147559642|NCT03481309|532205468|FG004|Washout (at Least 3 Days)|Withdrawal by Subject|0|||
147559643|NCT03481309|532205469|FG005|Washout (at Least 3 Days)|Withdrawal by Subject|0|||
147559644|NCT01575054|532205470|FG000|Overall Study|Other Reasons|5|||
147559645|NCT01575054|532205471|FG001|Overall Study|Other Reasons|3|||
147559646|NCT01575054|532205470|FG000|Overall Study|Protocol Violation|2|||
147559647|NCT01575054|532205471|FG001|Overall Study|Protocol Violation|1|||
147559648|NCT01575054|532205470|FG000|Overall Study|Personal Reasons|10|||
147559649|NCT01575054|532205471|FG001|Overall Study|Personal Reasons|11|||
147559650|NCT01575054|532205470|FG000|Overall Study|Lost to Follow-up|3|||
147559651|NCT01575054|532205471|FG001|Overall Study|Lost to Follow-up|3|||
147559652|NCT01575054|532205470|FG000|Overall Study|Adverse Event|9|||
147559653|NCT01575054|532205471|FG001|Overall Study|Adverse Event|8|||
147559654|NCT02768298|532205474|FG000|Overall Study|Adverse Event|1|||
147559655|NCT02768298|532205475|FG001|Overall Study|Adverse Event|4|||
147559656|NCT02768298|532205474|FG000|Overall Study|Death|2|||
147111775|NCT02903914|530571164|FG003|Overall Study|Didn't Return to Site|1|||
147111776|NCT02903914|530571165|FG004|Overall Study|Didn't Return to Site|0|||
147111777|NCT02903914|530571166|FG005|Overall Study|Didn't Return to Site|0|||
147111778|NCT02903914|530571167|FG006|Overall Study|Didn't Return to Site|2|||
147111779|NCT02903914|530571168|FG007|Overall Study|Didn't Return to Site|0|||
147111780|NCT02903914|530571161|FG000|Overall Study|Entered/Referred to Hospice Care|1|||
147559657|NCT02768298|532205475|FG001|Overall Study|Death|1|||
147559658|NCT02768298|532205474|FG000|Overall Study|Non-compliance with study treatment|0|||
147559659|NCT02768298|532205475|FG001|Overall Study|Non-compliance with study treatment|1|||
147559660|NCT02768298|532205474|FG000|Overall Study|Subject/guardian decision|1|||
147559661|NCT02768298|532205475|FG001|Overall Study|Subject/guardian decision|0|||
147559662|NCT02768298|532205474|FG000|Overall Study|Withdrawal of informed consent|0|||
147559663|NCT02768298|532205475|FG001|Overall Study|Withdrawal of informed consent|1|||
147559664|NCT04603937|532205476|FG000|Overall Study|Adverse Event|9|||
147559665|NCT04603937|532205477|FG001|Overall Study|Adverse Event|10|||
147111781|NCT02903914|530571162|FG001|Overall Study|Entered/Referred to Hospice Care|1|||
147111782|NCT02903914|530571163|FG002|Overall Study|Entered/Referred to Hospice Care|8|||
147559666|NCT04603937|532205476|FG000|Overall Study|Withdrawal by Subject|7|||
147559667|NCT04603937|532205477|FG001|Overall Study|Withdrawal by Subject|6|||
147559668|NCT04603937|532205476|FG000|Overall Study|Lost to Follow-up|5|||
147559669|NCT04603937|532205477|FG001|Overall Study|Lost to Follow-up|6|||
147559670|NCT04603937|532205476|FG000|Overall Study|Physician Decision|0|||
147559671|NCT04603937|532205477|FG001|Overall Study|Physician Decision|1|||
147559672|NCT04603937|532205476|FG000|Overall Study|Subject did not meet inclusion criteria 1 so was withdrawn from the study|0|||
147559673|NCT04603937|532205477|FG001|Overall Study|Subject did not meet inclusion criteria 1 so was withdrawn from the study|1|||
147559674|NCT01611090|532205478|FG000|Randomized Period|Lost to Follow-up|8|||
147559675|NCT01611090|532205479|FG001|Randomized Period|Lost to Follow-up|3|||
147559676|NCT01611090|532205480|FG002|Randomized Period|Lost to Follow-up|0|||
147559677|NCT01611090|532205478|FG000|Randomized Period|Withdrawal by Subject|22|||
147559678|NCT01611090|532205479|FG001|Randomized Period|Withdrawal by Subject|26|||
147559679|NCT01611090|532205480|FG002|Randomized Period|Withdrawal by Subject|0|||
147559680|NCT01611090|532205478|FG000|Cross Over (Placebo to Ibrutinib)|Lost to Follow-up|0|||
147559681|NCT01611090|532205479|FG001|Cross Over (Placebo to Ibrutinib)|Lost to Follow-up|0|||
147559682|NCT01611090|532205480|FG002|Cross Over (Placebo to Ibrutinib)|Lost to Follow-up|4|||
147559683|NCT01611090|532205478|FG000|Cross Over (Placebo to Ibrutinib)|Withdrawal by Subject|0|||
147559684|NCT01611090|532205479|FG001|Cross Over (Placebo to Ibrutinib)|Withdrawal by Subject|0|||
147559685|NCT01611090|532205480|FG002|Cross Over (Placebo to Ibrutinib)|Withdrawal by Subject|1|||
147559686|NCT05109234|532205481|FG000|Overall Study|Adverse Event|2|||
147559687|NCT05109234|532205482|FG001|Overall Study|Adverse Event|2|||
147559688|NCT05109234|532205481|FG000|Overall Study|Lack of Efficacy|5|||
147111783|NCT02903914|530571164|FG003|Overall Study|Entered/Referred to Hospice Care|0|||
147111784|NCT02903914|530571165|FG004|Overall Study|Entered/Referred to Hospice Care|0|||
147559689|NCT05109234|532205482|FG001|Overall Study|Lack of Efficacy|0|||
147559690|NCT05109234|532205481|FG000|Overall Study|Consent withdrawn by Participant (not due to AE)|1|||
147111785|NCT02903914|530571166|FG005|Overall Study|Entered/Referred to Hospice Care|0|||
147111786|NCT02903914|530571167|FG006|Overall Study|Entered/Referred to Hospice Care|4|||
147111787|NCT02903914|530571168|FG007|Overall Study|Entered/Referred to Hospice Care|0|||
147111788|NCT02903914|530571161|FG000|Overall Study|Follow-up Did Not Occur|0|||
147111789|NCT02903914|530571162|FG001|Overall Study|Follow-up Did Not Occur|1|||
147111790|NCT02903914|530571163|FG002|Overall Study|Follow-up Did Not Occur|1|||
147111791|NCT02903914|530571164|FG003|Overall Study|Follow-up Did Not Occur|0|||
147111792|NCT02903914|530571165|FG004|Overall Study|Follow-up Did Not Occur|2|||
147111793|NCT02903914|530571166|FG005|Overall Study|Follow-up Did Not Occur|0|||
147111794|NCT02903914|530571167|FG006|Overall Study|Follow-up Did Not Occur|8|||
147111795|NCT02903914|530571168|FG007|Overall Study|Follow-up Did Not Occur|0|||
147559691|NCT05109234|532205482|FG001|Overall Study|Consent withdrawn by Participant (not due to AE)|0|||
147559692|NCT05109234|532205481|FG000|Overall Study|Consent withdrawn by parent/guardian (not AE)|3|||
147559693|NCT05109234|532205482|FG001|Overall Study|Consent withdrawn by parent/guardian (not AE)|4|||
147559694|NCT05109234|532205481|FG000|Overall Study|Evacuated from Ukraine due to the war|2|||
147559695|NCT05109234|532205482|FG001|Overall Study|Evacuated from Ukraine due to the war|0|||
147559696|NCT05109234|532205481|FG000|Overall Study|Missed safety visit; study incomplete per protocol|1|||
147559697|NCT05109234|532205482|FG001|Overall Study|Missed safety visit; study incomplete per protocol|0|||
147559698|NCT00336024|532205484|FG000|Overall Study|Death|2|||
147559699|NCT00336024|532205485|FG001|Overall Study|Death|1|||
147559700|NCT00336024|532205484|FG000|Overall Study|Physician Decision|4|||
147559701|NCT00336024|532205485|FG001|Overall Study|Physician Decision|1|||
147559702|NCT00336024|532205484|FG000|Overall Study|Protocol Violation|1|||
147559703|NCT00336024|532205485|FG001|Overall Study|Protocol Violation|0|||
147559704|NCT00336024|532205484|FG000|Overall Study|Withdrawal by Subject|1|||
147559705|NCT00336024|532205485|FG001|Overall Study|Withdrawal by Subject|2|||
147559706|NCT00336024|532205484|FG000|Overall Study|Failure to fulfill consolidation|1|||
147559707|NCT00336024|532205485|FG001|Overall Study|Failure to fulfill consolidation|1|||
147559708|NCT00336024|532205484|FG000|Overall Study|Progressive Disease|4|||
147559709|NCT00336024|532205485|FG001|Overall Study|Progressive Disease|7|||
147559710|NCT00336024|532205484|FG000|Overall Study|Ineligible|7|||
147559711|NCT00336024|532205485|FG001|Overall Study|Ineligible|7|||
147559712|NCT02585258|532205486|FG000|Overall Study|Adverse Event|28|||
147559713|NCT02585258|532205487|FG001|Overall Study|Adverse Event|29|||
147559714|NCT02585258|532205486|FG000|Overall Study|Death|3|||
147559715|NCT02585258|532205487|FG001|Overall Study|Death|2|||
147559716|NCT02585258|532205486|FG000|Overall Study|Lack of Efficacy|7|||
147559717|NCT02585258|532205487|FG001|Overall Study|Lack of Efficacy|9|||
147559718|NCT02585258|532205486|FG000|Overall Study|includes covid-related access problems|42|||
147111796|NCT02903914|530571161|FG000|Overall Study|Systemic Treatment Options Necessary|0|||
147111797|NCT02903914|530571162|FG001|Overall Study|Systemic Treatment Options Necessary|1|||
147311047|NCT00313911|531307074|FG001|Overall Study|Lost to Follow-up|14|||
147311048|NCT00313911|531307073|FG000|Overall Study|Withdrawal by Subject|39|||
147311049|NCT00313911|531307074|FG001|Overall Study|Withdrawal by Subject|12|||
147311050|NCT00313911|531307073|FG000|Overall Study|Did not meet age criteria|1|||
147311051|NCT00313911|531307074|FG001|Overall Study|Did not meet age criteria|1|||
147311052|NCT00636792|531307077|FG000|Overall Study|Adverse Event|16|||
147311053|NCT00636792|531307077|FG000|Overall Study|Physician Decision|7|||
147311054|NCT00636792|531307077|FG000|Overall Study|Progressive Disease|4|||
147311055|NCT00636792|531307077|FG000|Overall Study|Withdrawal by Subject|3|||
147311056|NCT00636792|531307077|FG000|Overall Study|Other|3|||
147311057|NCT01912781|531307078|FG000|Overall Study|Withdrawal by Subject|2|||
147111798|NCT02903914|530571163|FG002|Overall Study|Systemic Treatment Options Necessary|0|||
147111799|NCT02903914|530571164|FG003|Overall Study|Systemic Treatment Options Necessary|0|||
147111800|NCT02903914|530571165|FG004|Overall Study|Systemic Treatment Options Necessary|0|||
147111801|NCT02903914|530571166|FG005|Overall Study|Systemic Treatment Options Necessary|0|||
147226080|NCT00450385|531000400|FG000|Overall Study|Physician Decision|1|||
147226081|NCT00450385|531000400|FG000|Overall Study|Other|3|||
147226082|NCT03533686|531000401|FG000|Overall Study|Withdrawal by Subject|1|||
147226083|NCT03533686|531000402|FG001|Overall Study|Withdrawal by Subject|0|||
147226084|NCT03533686|531000403|FG002|Overall Study|Withdrawal by Subject|0|||
147226085|NCT03533686|531000404|FG003|Overall Study|Withdrawal by Subject|3|||
147226086|NCT03533686|531000405|FG004|Overall Study|Withdrawal by Subject|5|||
147226087|NCT03533686|531000406|FG005|Overall Study|Withdrawal by Subject|1|||
147226088|NCT03533686|531000401|FG000|Overall Study|Lost to Follow-up|0|||
147226089|NCT03533686|531000402|FG001|Overall Study|Lost to Follow-up|1|||
147226090|NCT03533686|531000403|FG002|Overall Study|Lost to Follow-up|0|||
147226091|NCT03533686|531000404|FG003|Overall Study|Lost to Follow-up|0|||
147226092|NCT03533686|531000405|FG004|Overall Study|Lost to Follow-up|2|||
147226093|NCT03533686|531000406|FG005|Overall Study|Lost to Follow-up|0|||
147226094|NCT03533686|531000401|FG000|Overall Study|Screen Failure|0|||
147226095|NCT03533686|531000402|FG001|Overall Study|Screen Failure|0|||
147226096|NCT03533686|531000403|FG002|Overall Study|Screen Failure|0|||
147311058|NCT01912781|531307079|FG001|Overall Study|Withdrawal by Subject|0|||
147226097|NCT03533686|531000404|FG003|Overall Study|Screen Failure|2|||
147226098|NCT03533686|531000405|FG004|Overall Study|Screen Failure|0|||
147226099|NCT03533686|531000406|FG005|Overall Study|Screen Failure|0|||
147226100|NCT01858636|531000407|FG000|Overall Study|No Device Deployment Attempted|24|||
147226101|NCT01858636|531000407|FG000|Overall Study|Physician Decision|1|||
147226102|NCT01858636|531000407|FG000|Overall Study|Death|1|||
147226103|NCT01858636|531000407|FG000|Overall Study|Lost to Follow-up|1|||
147226104|NCT01858636|531000407|FG000|Overall Study|Withdrawal by Subject|1|||
147559719|NCT02585258|532205487|FG001|Overall Study|includes covid-related access problems|46|||
147559720|NCT02585258|532205486|FG000|Overall Study|Lost to Follow-up|5|||
147226105|NCT01172275|531000408|FG000|Overall Study|Lost to Follow-up|1|||
147311059|NCT04789577|531307081|FG000|Overall Study|Withdrawal by Subject|1|||
147559721|NCT02585258|532205487|FG001|Overall Study|Lost to Follow-up|2|||
147559722|NCT05125952|532205488|FG000|Overall Study|Physician Decision|1|||
147559723|NCT03946449|532205489|FG000|Treatment Extension II|Rolled over to another study|0|||
147559724|NCT03946449|532205490|FG001|Treatment Extension II|Rolled over to another study|0|||
147111802|NCT02903914|530571167|FG006|Overall Study|Systemic Treatment Options Necessary|0|||
147111803|NCT02903914|530571168|FG007|Overall Study|Systemic Treatment Options Necessary|0|||
147111804|NCT02903914|530571161|FG000|Overall Study|Consented to/Considered Other Clinical Study|0|||
147111805|NCT02903914|530571162|FG001|Overall Study|Consented to/Considered Other Clinical Study|0|||
147111806|NCT02903914|530571163|FG002|Overall Study|Consented to/Considered Other Clinical Study|2|||
147111807|NCT02903914|530571164|FG003|Overall Study|Consented to/Considered Other Clinical Study|0|||
147111808|NCT02903914|530571165|FG004|Overall Study|Consented to/Considered Other Clinical Study|0|||
147111809|NCT02903914|530571166|FG005|Overall Study|Consented to/Considered Other Clinical Study|2|||
147111810|NCT02903914|530571167|FG006|Overall Study|Consented to/Considered Other Clinical Study|0|||
147111811|NCT02903914|530571168|FG007|Overall Study|Consented to/Considered Other Clinical Study|0|||
147111812|NCT02903914|530571161|FG000|Overall Study|Clinical Disease Progression|0|||
147111813|NCT02903914|530571162|FG001|Overall Study|Clinical Disease Progression|0|||
147111814|NCT02903914|530571163|FG002|Overall Study|Clinical Disease Progression|2|||
147111815|NCT02903914|530571164|FG003|Overall Study|Clinical Disease Progression|0|||
147111816|NCT02903914|530571165|FG004|Overall Study|Clinical Disease Progression|0|||
147111817|NCT02903914|530571166|FG005|Overall Study|Clinical Disease Progression|0|||
147111818|NCT02903914|530571167|FG006|Overall Study|Clinical Disease Progression|0|||
147111819|NCT02903914|530571168|FG007|Overall Study|Clinical Disease Progression|0|||
147111820|NCT02903914|530571161|FG000|Overall Study|Completed Follow-up Period|0|||
147111821|NCT02903914|530571162|FG001|Overall Study|Completed Follow-up Period|0|||
147111822|NCT02903914|530571163|FG002|Overall Study|Completed Follow-up Period|6|||
147111823|NCT02903914|530571164|FG003|Overall Study|Completed Follow-up Period|2|||
147111824|NCT02903914|530571165|FG004|Overall Study|Completed Follow-up Period|1|||
147111825|NCT02903914|530571166|FG005|Overall Study|Completed Follow-up Period|0|||
147111826|NCT02903914|530571167|FG006|Overall Study|Completed Follow-up Period|9|||
147226106|NCT01172275|531000409|FG001|Overall Study|Lost to Follow-up|0|||
147226107|NCT01172275|531000408|FG000|Overall Study|Protocol Violation|1|||
147226108|NCT01172275|531000409|FG001|Overall Study|Protocol Violation|0|||
147226109|NCT02862600|531000410|FG000|Period 1--Perhexiline-low Target Range|Lack of Efficacy|9|||
147226110|NCT02862600|531000410|FG000|Period 1--Perhexiline-low Target Range|Protocol Violation|3|||
147226111|NCT02862600|531000410|FG000|Period 1--Perhexiline-low Target Range|Withdrawal by Subject|1|||
147226112|NCT02862600|531000410|FG000|Period 2--Perhexiline-high Target Range|Lack of Efficacy|7|||
147226113|NCT04650854|531000411|FG000|Overall Study|Adverse Event|1|||
147226114|NCT04650854|531000412|FG001|Overall Study|Adverse Event|12|||
147226115|NCT04650854|531000413|FG002|Overall Study|Adverse Event|14|||
147226116|NCT04650854|531000411|FG000|Overall Study|Lack of Efficacy|1|||
147226117|NCT04650854|531000412|FG001|Overall Study|Lack of Efficacy|3|||
147226118|NCT04650854|531000413|FG002|Overall Study|Lack of Efficacy|6|||
147226119|NCT04650854|531000411|FG000|Overall Study|Lost to Follow-up|1|||
147226120|NCT04650854|531000412|FG001|Overall Study|Lost to Follow-up|1|||
147226121|NCT04650854|531000413|FG002|Overall Study|Lost to Follow-up|0|||
147226122|NCT04650854|531000411|FG000|Overall Study|Withdrawal by Subject|2|||
147226123|NCT04650854|531000412|FG001|Overall Study|Withdrawal by Subject|17|||
147226124|NCT04650854|531000413|FG002|Overall Study|Withdrawal by Subject|9|||
147226125|NCT04650854|531000411|FG000|Overall Study|Last Treatment Per Sponsor Lplv Timelines|0|||
147226126|NCT04650854|531000412|FG001|Overall Study|Last Treatment Per Sponsor Lplv Timelines|12|||
147226127|NCT04650854|531000413|FG002|Overall Study|Last Treatment Per Sponsor Lplv Timelines|6|||
147226128|NCT04650854|531000411|FG000|Overall Study|Participant Withdrawn After Drug Approved By FDA|0|||
147226129|NCT04650854|531000412|FG001|Overall Study|Participant Withdrawn After Drug Approved By FDA|0|||
147226130|NCT04650854|531000413|FG002|Overall Study|Participant Withdrawn After Drug Approved By FDA|1|||
147226131|NCT04650854|531000411|FG000|Overall Study|Pi Withdrew the Patients From the Study|0|||
147226132|NCT04650854|531000412|FG001|Overall Study|Pi Withdrew the Patients From the Study|0|||
147226133|NCT04650854|531000413|FG002|Overall Study|Pi Withdrew the Patients From the Study|1|||
147226134|NCT04650854|531000411|FG000|Overall Study|Withdraw Per Sponsor's Directive|0|||
147226135|NCT04650854|531000412|FG001|Overall Study|Withdraw Per Sponsor's Directive|1|||
147226136|NCT04650854|531000413|FG002|Overall Study|Withdraw Per Sponsor's Directive|0|||
147226137|NCT04650854|531000411|FG000|Overall Study|Withdrawal Due to Prohibited Treatment|0|||
147226138|NCT04650854|531000412|FG001|Overall Study|Withdrawal Due to Prohibited Treatment|0|||
147226139|NCT04650854|531000413|FG002|Overall Study|Withdrawal Due to Prohibited Treatment|1|||
147226140|NCT04650854|531000411|FG000|Overall Study|Use of Rescue Medication|0|||
147226141|NCT04650854|531000412|FG001|Overall Study|Use of Rescue Medication|0|||
147226142|NCT04650854|531000413|FG002|Overall Study|Use of Rescue Medication|1|||
147226143|NCT04650854|531000411|FG000|Overall Study|Last Treatment Per Sponsor|0|||
147226144|NCT04650854|531000412|FG001|Overall Study|Last Treatment Per Sponsor|0|||
147226145|NCT04650854|531000413|FG002|Overall Study|Last Treatment Per Sponsor|2|||
147559725|NCT03946449|532205491|FG002|Treatment Extension II|Rolled over to another study|2|||
147311060|NCT04789577|531307082|FG001|Overall Study|Withdrawal by Subject|1|||
147559726|NCT03946449|532205489|FG000|Treatment Extension II|Withdrawal by Subject|0|||
147111827|NCT02903914|530571168|FG007|Overall Study|Completed Follow-up Period|1|||
147111828|NCT02903914|530571161|FG000|Overall Study|Taken off Treatment per Protocol|0|||
147559727|NCT03946449|532205490|FG001|Treatment Extension II|Withdrawal by Subject|0|||
147559728|NCT03946449|532205491|FG002|Treatment Extension II|Withdrawal by Subject|1|||
147559729|NCT01210001|532207321|FG000|Overall Study|Not treated|1|||
147559730|NCT01210001|532207322|FG001|Overall Study|Not treated|0|||
147559731|NCT01210001|532207323|FG002|Overall Study|Not treated|0|||
147559732|NCT01210001|532207321|FG000|Overall Study|Adverse Event|4|||
147559733|NCT01210001|532207322|FG001|Overall Study|Adverse Event|2|||
147559734|NCT01210001|532207323|FG002|Overall Study|Adverse Event|5|||
147559735|NCT01210001|532207321|FG000|Overall Study|Non compliant with protocol|2|||
147559736|NCT01210001|532207322|FG001|Overall Study|Non compliant with protocol|2|||
147559737|NCT01210001|532207323|FG002|Overall Study|Non compliant with protocol|3|||
147559738|NCT01210001|532207321|FG000|Overall Study|Lost to Follow-up|4|||
147559739|NCT01210001|532207322|FG001|Overall Study|Lost to Follow-up|3|||
147559740|NCT01210001|532207323|FG002|Overall Study|Lost to Follow-up|2|||
147559741|NCT01210001|532207321|FG000|Overall Study|Patient refusal to continue,not due toAE|6|||
147559742|NCT01210001|532207322|FG001|Overall Study|Patient refusal to continue,not due toAE|2|||
147559743|NCT01210001|532207323|FG002|Overall Study|Patient refusal to continue,not due toAE|1|||
147559744|NCT01210001|532207321|FG000|Overall Study|Other reason not defined above|2|||
147559745|NCT01210001|532207322|FG001|Overall Study|Other reason not defined above|2|||
147559746|NCT01210001|532207323|FG002|Overall Study|Other reason not defined above|1|||
147111829|NCT02903914|530571162|FG001|Overall Study|Taken off Treatment per Protocol|0|||
147111830|NCT02903914|530571163|FG002|Overall Study|Taken off Treatment per Protocol|0|||
147111831|NCT02903914|530571164|FG003|Overall Study|Taken off Treatment per Protocol|0|||
147111832|NCT02903914|530571165|FG004|Overall Study|Taken off Treatment per Protocol|0|||
147111833|NCT02903914|530571166|FG005|Overall Study|Taken off Treatment per Protocol|1|||
147111834|NCT02903914|530571167|FG006|Overall Study|Taken off Treatment per Protocol|0|||
147111835|NCT02903914|530571168|FG007|Overall Study|Taken off Treatment per Protocol|0|||
147111836|NCT02903914|530571161|FG000|Overall Study|Refused Further Treatment/Contact|0|||
147111837|NCT02903914|530571162|FG001|Overall Study|Refused Further Treatment/Contact|0|||
147111838|NCT02903914|530571163|FG002|Overall Study|Refused Further Treatment/Contact|0|||
147559747|NCT00788125|532207324|FG000|Overall Study|Death|6|||
147559748|NCT02180711|532207329|FG000|Overall Study|Death|0|||
147559749|NCT02180711|532207330|FG001|Overall Study|Death|1|||
147559750|NCT02180711|532207331|FG002|Overall Study|Death|0|||
147559751|NCT02180711|532207332|FG003|Overall Study|Death|0|||
147559752|NCT02180711|532207333|FG004|Overall Study|Death|7|||
147559753|NCT02180711|532207334|FG005|Overall Study|Death|0|||
147559754|NCT02180711|532207335|FG006|Overall Study|Death|1|||
147559755|NCT02180711|532207336|FG007|Overall Study|Death|3|||
147559756|NCT02180711|532207329|FG000|Overall Study|Lost to Follow-up|0|||
147559757|NCT02180711|532207330|FG001|Overall Study|Lost to Follow-up|1|||
147559758|NCT02180711|532207331|FG002|Overall Study|Lost to Follow-up|0|||
147559759|NCT02180711|532207332|FG003|Overall Study|Lost to Follow-up|0|||
147559760|NCT02180711|532207333|FG004|Overall Study|Lost to Follow-up|1|||
147559761|NCT02180711|532207334|FG005|Overall Study|Lost to Follow-up|1|||
147559762|NCT02180711|532207335|FG006|Overall Study|Lost to Follow-up|0|||
147559763|NCT02180711|532207336|FG007|Overall Study|Lost to Follow-up|3|||
147559764|NCT02180711|532207329|FG000|Overall Study|Withdrawal by Subject|2|||
147559765|NCT02180711|532207330|FG001|Overall Study|Withdrawal by Subject|1|||
147559766|NCT02180711|532207331|FG002|Overall Study|Withdrawal by Subject|0|||
147111839|NCT02903914|530571164|FG003|Overall Study|Refused Further Treatment/Contact|0|||
147111840|NCT02903914|530571165|FG004|Overall Study|Refused Further Treatment/Contact|0|||
147111841|NCT02903914|530571166|FG005|Overall Study|Refused Further Treatment/Contact|0|||
147111842|NCT02903914|530571167|FG006|Overall Study|Refused Further Treatment/Contact|1|||
147226146|NCT04650854|531000411|FG000|Overall Study|Rescue Medication|0|||
147226147|NCT04650854|531000412|FG001|Overall Study|Rescue Medication|0|||
147226148|NCT04650854|531000413|FG002|Overall Study|Rescue Medication|1|||
147226149|NCT04650854|531000411|FG000|Overall Study|Participant Want to Start a Family|0|||
147226150|NCT04650854|531000412|FG001|Overall Study|Participant Want to Start a Family|0|||
147226151|NCT04650854|531000413|FG002|Overall Study|Participant Want to Start a Family|1|||
147226152|NCT04650854|531000411|FG000|Overall Study|Withdraw Based on Sponsor Decision|0|||
147226153|NCT04650854|531000412|FG001|Overall Study|Withdraw Based on Sponsor Decision|0|||
147226154|NCT04650854|531000413|FG002|Overall Study|Withdraw Based on Sponsor Decision|1|||
147226155|NCT04650854|531000411|FG000|Overall Study|Participant Screened For MG0020|0|||
147226156|NCT04650854|531000412|FG001|Overall Study|Participant Screened For MG0020|2|||
147226157|NCT04650854|531000413|FG002|Overall Study|Participant Screened For MG0020|3|||
147226158|NCT04650854|531000411|FG000|Overall Study|Patient Withdrawn Due To Inappropriate Behavior|0|||
147226159|NCT04650854|531000412|FG001|Overall Study|Patient Withdrawn Due To Inappropriate Behavior|1|||
147226160|NCT04650854|531000413|FG002|Overall Study|Patient Withdrawn Due To Inappropriate Behavior|0|||
147226161|NCT04650854|531000411|FG000|Overall Study|Subject Performed PEOT, Not a Completed Subject|0|||
147226162|NCT04650854|531000412|FG001|Overall Study|Subject Performed PEOT, Not a Completed Subject|1|||
147559767|NCT02180711|532207332|FG003|Overall Study|Withdrawal by Subject|4|||
147559768|NCT02180711|532207333|FG004|Overall Study|Withdrawal by Subject|3|||
147559769|NCT02180711|532207334|FG005|Overall Study|Withdrawal by Subject|0|||
147559770|NCT02180711|532207335|FG006|Overall Study|Withdrawal by Subject|3|||
147111843|NCT02903914|530571168|FG007|Overall Study|Refused Further Treatment/Contact|0|||
147111844|NCT02903914|530571161|FG000|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
147111845|NCT02903914|530571162|FG001|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
147111846|NCT02903914|530571163|FG002|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
147111847|NCT02903914|530571164|FG003|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
147111848|NCT02903914|530571165|FG004|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
147111849|NCT02903914|530571166|FG005|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
147111850|NCT02903914|530571167|FG006|Overall Study|Discontinued per Sponsor/Participant Agreement|1|||
147111851|NCT02903914|530571168|FG007|Overall Study|Discontinued per Sponsor/Participant Agreement|0|||
147111852|NCT04225039|530571173|FG000|Overall Study|Withdrawal by Subject|1|||
147111853|NCT04225039|530571174|FG001|Overall Study|Withdrawal by Subject|0|||
147111854|NCT04225039|530571175|FG002|Overall Study|Withdrawal by Subject|0|||
147111855|NCT04225039|530571176|FG003|Overall Study|Withdrawal by Subject|1|||
147111856|NCT04225039|530571173|FG000|Overall Study|Currently active on study treatment|0|||
147111857|NCT04225039|530571174|FG001|Overall Study|Currently active on study treatment|1|||
147111858|NCT04225039|530571175|FG002|Overall Study|Currently active on study treatment|0|||
147111859|NCT04225039|530571176|FG003|Overall Study|Currently active on study treatment|0|||
147111860|NCT04225039|530571173|FG000|Overall Study|Protocol deviation; data not analyzed for efficacy|2|||
147111861|NCT04225039|530571174|FG001|Overall Study|Protocol deviation; data not analyzed for efficacy|0|||
147559771|NCT02180711|532207336|FG007|Overall Study|Withdrawal by Subject|2|||
147559772|NCT02180711|532207329|FG000|Overall Study|- Disease Progression|0|||
147559773|NCT02180711|532207330|FG001|Overall Study|- Disease Progression|1|||
147559774|NCT02180711|532207331|FG002|Overall Study|- Disease Progression|0|||
147559775|NCT02180711|532207332|FG003|Overall Study|- Disease Progression|0|||
147111862|NCT04225039|530571175|FG002|Overall Study|Protocol deviation; data not analyzed for efficacy|0|||
147111863|NCT04225039|530571176|FG003|Overall Study|Protocol deviation; data not analyzed for efficacy|0|||
147111864|NCT04225039|530571173|FG000|Overall Study|Ineligible for treatment|0|||
147111865|NCT04225039|530571174|FG001|Overall Study|Ineligible for treatment|0|||
147111866|NCT04225039|530571175|FG002|Overall Study|Ineligible for treatment|0|||
147111867|NCT04225039|530571176|FG003|Overall Study|Ineligible for treatment|4|||
147226163|NCT04650854|531000413|FG002|Overall Study|Subject Performed PEOT, Not a Completed Subject|0|||
147226164|NCT04650854|531000411|FG000|Overall Study|Participant to Be Screened for MG0020 Study|0|||
147226165|NCT04650854|531000412|FG001|Overall Study|Participant to Be Screened for MG0020 Study|4|||
147226166|NCT04650854|531000413|FG002|Overall Study|Participant to Be Screened for MG0020 Study|5|||
147226167|NCT04650854|531000411|FG000|Overall Study|End Of Study|0|||
147226168|NCT04650854|531000412|FG001|Overall Study|End Of Study|2|||
147226169|NCT04650854|531000413|FG002|Overall Study|End Of Study|1|||
147226170|NCT04650854|531000411|FG000|Overall Study|Wish To Continue Study IMP in Patient Programme|0|||
147226171|NCT04650854|531000412|FG001|Overall Study|Wish To Continue Study IMP in Patient Programme|1|||
147226172|NCT04650854|531000413|FG002|Overall Study|Wish To Continue Study IMP in Patient Programme|0|||
147226173|NCT04650854|531000411|FG000|Overall Study|Participant Received Rescue Medication|0|||
147226174|NCT04650854|531000412|FG001|Overall Study|Participant Received Rescue Medication|1|||
147226175|NCT04650854|531000413|FG002|Overall Study|Participant Received Rescue Medication|0|||
147226176|NCT04650854|531000411|FG000|Overall Study|Patient Withdrawn; Lack of IMP Shipments|0|||
147226177|NCT04650854|531000412|FG001|Overall Study|Patient Withdrawn; Lack of IMP Shipments|2|||
147226178|NCT04650854|531000413|FG002|Overall Study|Patient Withdrawn; Lack of IMP Shipments|1|||
147226179|NCT04650854|531000411|FG000|Overall Study|Last Treatment Per Lplv, Screened For MG0020|0|||
147226180|NCT04650854|531000412|FG001|Overall Study|Last Treatment Per Lplv, Screened For MG0020|2|||
147226181|NCT04650854|531000413|FG002|Overall Study|Last Treatment Per Lplv, Screened For MG0020|2|||
147226182|NCT04650854|531000411|FG000|Overall Study|Discontinued Due to Chronic Heart Failure|0|||
147226183|NCT04650854|531000412|FG001|Overall Study|Discontinued Due to Chronic Heart Failure|0|||
147226184|NCT04650854|531000413|FG002|Overall Study|Discontinued Due to Chronic Heart Failure|1|||
147226185|NCT04650854|531000411|FG000|Overall Study|Last Treatment Per Sponsor Lplv Timelines- Japan|0|||
147226186|NCT04650854|531000412|FG001|Overall Study|Last Treatment Per Sponsor Lplv Timelines- Japan|3|||
147226187|NCT04650854|531000413|FG002|Overall Study|Last Treatment Per Sponsor Lplv Timelines- Japan|3|||
147226188|NCT04650854|531000411|FG000|Overall Study|Enrollment Cup|0|||
147226189|NCT04650854|531000412|FG001|Overall Study|Enrollment Cup|0|||
147226190|NCT04650854|531000413|FG002|Overall Study|Enrollment Cup|1|||
147226191|NCT00194675|531000422|FG000|Overall Study|Lost to Follow-up|1|||
147226192|NCT00194675|531000423|FG001|Overall Study|Lost to Follow-up|1|||
147226193|NCT00194675|531000422|FG000|Overall Study|lack of interest|1|||
147226194|NCT00194675|531000423|FG001|Overall Study|lack of interest|1|||
147226195|NCT00194675|531000422|FG000|Overall Study|"withdrew due to edgy feeling"|1|||
147226196|NCT00194675|531000423|FG001|Overall Study|"withdrew due to edgy feeling"|0|||
147226197|NCT00194675|531000422|FG000|Overall Study|Protocol Violation|1|||
147559776|NCT02180711|532207333|FG004|Overall Study|- Disease Progression|0|||
147559777|NCT02180711|532207334|FG005|Overall Study|- Disease Progression|0|||
147226198|NCT00194675|531000423|FG001|Overall Study|Protocol Violation|0|||
147559778|NCT02180711|532207335|FG006|Overall Study|- Disease Progression|0|||
147111868|NCT00975923|530571183|FG000|Overall Study|Withdrawal by Subject|0|||
147111869|NCT00975923|530571184|FG001|Overall Study|Withdrawal by Subject|1|||
147111870|NCT00005047|530571186|FG000|Overall Study|Withdrawal by Subject|12|||
147111871|NCT00005047|530571187|FG001|Overall Study|Withdrawal by Subject|0|||
147111872|NCT00005047|530571188|FG002|Overall Study|Withdrawal by Subject|0|||
147111873|NCT00005047|530571189|FG003|Overall Study|Withdrawal by Subject|0|||
147559779|NCT02180711|532207336|FG007|Overall Study|- Disease Progression|0|||
147559780|NCT02180711|532207329|FG000|Overall Study|- Subject Started Alternative Cancer Therapy|7|||
147559781|NCT02180711|532207330|FG001|Overall Study|- Subject Started Alternative Cancer Therapy|6|||
147559782|NCT02180711|532207331|FG002|Overall Study|- Subject Started Alternative Cancer Therapy|2|||
147559783|NCT02180711|532207332|FG003|Overall Study|- Subject Started Alternative Cancer Therapy|2|||
147559784|NCT02180711|532207333|FG004|Overall Study|- Subject Started Alternative Cancer Therapy|0|||
147559785|NCT02180711|532207334|FG005|Overall Study|- Subject Started Alternative Cancer Therapy|0|||
147559786|NCT02180711|532207335|FG006|Overall Study|- Subject Started Alternative Cancer Therapy|0|||
147559787|NCT02180711|532207336|FG007|Overall Study|- Subject Started Alternative Cancer Therapy|0|||
147111874|NCT00005047|530571186|FG000|Overall Study|Adverse Event|5|||
147111875|NCT00005047|530571187|FG001|Overall Study|Adverse Event|0|||
147111876|NCT00005047|530571188|FG002|Overall Study|Adverse Event|0|||
147111877|NCT00005047|530571189|FG003|Overall Study|Adverse Event|0|||
147311061|NCT04789577|531307083|FG002|Overall Study|Withdrawal by Subject|1|||
147311062|NCT04789577|531307084|FG003|Overall Study|Withdrawal by Subject|3|||
147311063|NCT04789577|531307085|FG004|Overall Study|Withdrawal by Subject|1|||
147311064|NCT04789577|531307086|FG005|Overall Study|Withdrawal by Subject|7|||
147311065|NCT04789577|531307087|FG006|Overall Study|Withdrawal by Subject|1|||
147311066|NCT04789577|531307081|FG000|Overall Study|Lost to Follow-up|7|||
147311067|NCT04789577|531307082|FG001|Overall Study|Lost to Follow-up|12|||
147311068|NCT04789577|531307083|FG002|Overall Study|Lost to Follow-up|7|||
147311069|NCT04789577|531307084|FG003|Overall Study|Lost to Follow-up|10|||
147311070|NCT04789577|531307085|FG004|Overall Study|Lost to Follow-up|8|||
147311071|NCT04789577|531307086|FG005|Overall Study|Lost to Follow-up|6|||
147311072|NCT04789577|531307087|FG006|Overall Study|Lost to Follow-up|10|||
147311073|NCT04789577|531307081|FG000|Overall Study|Migrated Or Moved From The Study Area|0|||
147559788|NCT02180711|532207329|FG000|Overall Study|- Study Terminated by Sponsor|2|||
147559789|NCT02180711|532207330|FG001|Overall Study|- Study Terminated by Sponsor|3|||
147111878|NCT00005047|530571186|FG000|Overall Study|Lost to Follow-up|1|||
147111879|NCT00005047|530571187|FG001|Overall Study|Lost to Follow-up|0|||
147226199|NCT00194675|531000422|FG000|Overall Study|Death|1|||
147226200|NCT00194675|531000423|FG001|Overall Study|Death|0|||
147226201|NCT01285960|531000424|FG000|Overall Study|Withdrawal by Subject|2|||
147226202|NCT01285960|531000424|FG000|Overall Study|Lost to Follow-up|2|||
147226203|NCT01285960|531000424|FG000|Overall Study|2 subjects received less 10 sonications|2|||
147226204|NCT04437368|531000427|FG000|Overall Study|Death|3|||
147226205|NCT04437368|531000428|FG001|Overall Study|Death|0|||
147226206|NCT04437368|531000429|FG002|Overall Study|Death|2|||
147226207|NCT04437368|531000427|FG000|Overall Study|Study terminated by sponsor|16|||
147226208|NCT04437368|531000428|FG001|Overall Study|Study terminated by sponsor|1|||
147226209|NCT04437368|531000429|FG002|Overall Study|Study terminated by sponsor|25|||
147226210|NCT04437368|531000427|FG000|Overall Study|Withdrawal by Subject|4|||
147226211|NCT04437368|531000428|FG001|Overall Study|Withdrawal by Subject|0|||
147226212|NCT04437368|531000429|FG002|Overall Study|Withdrawal by Subject|3|||
147226213|NCT04437368|531000427|FG000|Overall Study|Sponsor instructions|23|||
147226214|NCT04437368|531000428|FG001|Overall Study|Sponsor instructions|0|||
147226215|NCT04437368|531000429|FG002|Overall Study|Sponsor instructions|0|||
147226216|NCT04271280|531000430|FG000|Overall Study|Lost to Follow-up|300|||
147226217|NCT04271280|531000430|FG000|Overall Study|Death|153|||
147226218|NCT04271280|531000430|FG000|Overall Study|Withdrawal of consent by patient|59|||
147226219|NCT04271280|531000430|FG000|Overall Study|Other|51|||
147226220|NCT04271280|531000430|FG000|Overall Study|No end of study information|42|||
147226221|NCT01280955|531000433|FG000|Overall Study|Death|2|||
147226222|NCT01280955|531000433|FG000|Overall Study|Withdrawal by Subject|1|||
147226223|NCT00364130|531000434|FG000|Intervention Period|Lost to Follow-up|4|||
147226224|NCT00364130|531000435|FG001|Intervention Period|Lost to Follow-up|3|||
147226225|NCT00364130|531000434|FG000|Intervention Period|Pregnancy|1|||
147226226|NCT00364130|531000435|FG001|Intervention Period|Pregnancy|0|||
147226227|NCT00364130|531000434|FG000|Intervention Period|Withdrawal by Subject|4|||
147226228|NCT00364130|531000435|FG001|Intervention Period|Withdrawal by Subject|5|||
147226229|NCT00364130|531000434|FG000|Post Intervention Follow-up Period|Lost to Follow-up|5|||
147311074|NCT04789577|531307082|FG001|Overall Study|Migrated Or Moved From The Study Area|0|||
147311075|NCT04789577|531307083|FG002|Overall Study|Migrated Or Moved From The Study Area|0|||
147311076|NCT04789577|531307084|FG003|Overall Study|Migrated Or Moved From The Study Area|1|||
147226230|NCT00364130|531000435|FG001|Post Intervention Follow-up Period|Lost to Follow-up|11|||
147226231|NCT00901927|531000436|FG000|Overall Study|Lack of Efficacy|1|||
147226232|NCT00901927|531000436|FG000|Overall Study|Protocol Violation|3|||
147226233|NCT00901927|531000436|FG000|Overall Study|Withdrawal by Subject|2|||
147111880|NCT00005047|530571188|FG002|Overall Study|Lost to Follow-up|0|||
147559790|NCT02180711|532207331|FG002|Overall Study|- Study Terminated by Sponsor|0|||
147559791|NCT02180711|532207332|FG003|Overall Study|- Study Terminated by Sponsor|5|||
147559792|NCT02180711|532207333|FG004|Overall Study|- Study Terminated by Sponsor|32|||
147559793|NCT02180711|532207334|FG005|Overall Study|- Study Terminated by Sponsor|0|||
147559794|NCT02180711|532207335|FG006|Overall Study|- Study Terminated by Sponsor|4|||
147559795|NCT02180711|532207336|FG007|Overall Study|- Study Terminated by Sponsor|13|||
147559796|NCT02180711|532207329|FG000|Overall Study|- Enrolled into Follow-up Study|0|||
147559797|NCT02180711|532207330|FG001|Overall Study|- Enrolled into Follow-up Study|0|||
147559798|NCT02180711|532207331|FG002|Overall Study|- Enrolled into Follow-up Study|0|||
147559799|NCT02180711|532207332|FG003|Overall Study|- Enrolled into Follow-up Study|1|||
147559800|NCT02180711|532207333|FG004|Overall Study|- Enrolled into Follow-up Study|0|||
147559801|NCT02180711|532207334|FG005|Overall Study|- Enrolled into Follow-up Study|0|||
147559802|NCT02180711|532207335|FG006|Overall Study|- Enrolled into Follow-up Study|0|||
147559803|NCT02180711|532207336|FG007|Overall Study|- Enrolled into Follow-up Study|0|||
147559804|NCT02180711|532207329|FG000|Overall Study|- Other|1|||
147559805|NCT02180711|532207330|FG001|Overall Study|- Other|0|||
147559806|NCT02180711|532207331|FG002|Overall Study|- Other|0|||
147559807|NCT02180711|532207332|FG003|Overall Study|- Other|1|||
147559808|NCT02180711|532207333|FG004|Overall Study|- Other|0|||
147559809|NCT02180711|532207334|FG005|Overall Study|- Other|0|||
147559810|NCT02180711|532207335|FG006|Overall Study|- Other|0|||
147559811|NCT02180711|532207336|FG007|Overall Study|- Other|0|||
147559812|NCT02684344|532207344|FG000|Overall Study|Withdrawal by Subject|0|||
147559813|NCT02684344|532207345|FG001|Overall Study|Withdrawal by Subject|1|||
147559814|NCT00863746|532207348|FG000|Treatment|Not treated|4|||
147559815|NCT00863746|532207349|FG001|Treatment|Not treated|2|||
147559816|NCT00863746|532207348|FG000|Treatment|Adverse Event|41|||
147559817|NCT00863746|532207349|FG001|Treatment|Adverse Event|16|||
147559818|NCT00863746|532207348|FG000|Treatment|non-compliant with study medication|4|||
147559819|NCT00863746|532207349|FG001|Treatment|non-compliant with study medication|0|||
147559820|NCT00863746|532207348|FG000|Treatment|Consent withdrawn|15|||
147559821|NCT00863746|532207349|FG001|Treatment|Consent withdrawn|14|||
147559822|NCT00863746|532207348|FG000|Treatment|Lost to Follow-up|1|||
147559823|NCT00863746|532207349|FG001|Treatment|Lost to Follow-up|0|||
147559824|NCT00863746|532207348|FG000|Treatment|Protocol Violation|5|||
147559825|NCT00863746|532207349|FG001|Treatment|Protocol Violation|3|||
147559826|NCT00863746|532207348|FG000|Treatment|Other|1|||
147559827|NCT00863746|532207349|FG001|Treatment|Other|0|||
147559828|NCT00863746|532207348|FG000|Survival Follow up|Death|244|||
147559829|NCT00863746|532207349|FG001|Survival Follow up|Death|271|||
147559830|NCT00863746|532207348|FG000|Survival Follow up|Lost to Follow-up|2|||
147559831|NCT00863746|532207349|FG001|Survival Follow up|Lost to Follow-up|1|||
147559832|NCT00863746|532207348|FG000|Survival Follow up|Consent Withdrawn|7|||
147111881|NCT00005047|530571189|FG003|Overall Study|Lost to Follow-up|0|||
147111882|NCT00005047|530571186|FG000|Overall Study|Lack of Efficacy|1|||
147111883|NCT00005047|530571187|FG001|Overall Study|Lack of Efficacy|0|||
147111884|NCT00005047|530571188|FG002|Overall Study|Lack of Efficacy|0|||
147111885|NCT00005047|530571189|FG003|Overall Study|Lack of Efficacy|0|||
147111886|NCT06455111|530571198|FG000|Overall Study|Withdrawal by Subject|11|||
147111887|NCT06455111|530571199|FG001|Overall Study|Withdrawal by Subject|4|||
147111888|NCT03069989|530571207|FG000|Dosing Period 2 (Up to 16 Days)|Protocol-defined stop criteria reached|1|||
147111889|NCT03069989|530571208|FG001|Dosing Period 2 (Up to 16 Days)|Protocol-defined stop criteria reached|0|||
147111890|NCT02145390|530571209|FG000|Overall Study|Withdrawal by Subject|1|||
147111891|NCT00970944|530572768|FG000|Overall Study|Death|1|||
147111892|NCT00970944|530572769|FG001|Overall Study|Death|0|||
147111893|NCT00970944|530572768|FG000|Overall Study|Physician Decision|0|||
147111894|NCT00970944|530572769|FG001|Overall Study|Physician Decision|2|||
147111895|NCT02008370|530572770|FG000|Overall Study|Lost to Follow-up|7|||
147111896|NCT00662259|530572771|FG000|Overall Study|Adverse Event|2|||
147111897|NCT00662259|530572772|FG001|Overall Study|Adverse Event|0|||
147111898|NCT00972738|530572773|FG000|Overall Study|Adverse Event|7|||
147559833|NCT00863746|532207349|FG001|Survival Follow up|Consent Withdrawn|8|||
147111899|NCT00972738|530572774|FG001|Overall Study|Adverse Event|1|||
147111900|NCT00972738|530572775|FG002|Overall Study|Adverse Event|8|||
147111901|NCT00972738|530572773|FG000|Overall Study|Protocol Violation|2|||
147559834|NCT03292653|532207352|FG000|Overall Study|Adverse Event|0|||
147559835|NCT03292653|532207353|FG001|Overall Study|Adverse Event|0|||
147559836|NCT03292653|532207354|FG002|Overall Study|Adverse Event|1|||
147559837|NCT03292653|532207352|FG000|Overall Study|Did not Receive Treatment|1|||
147559838|NCT03292653|532207353|FG001|Overall Study|Did not Receive Treatment|0|||
147559839|NCT03292653|532207354|FG002|Overall Study|Did not Receive Treatment|0|||
147559840|NCT04720664|532207355|FG000|Overall Study|Adverse Event|2|||
147111902|NCT00972738|530572774|FG001|Overall Study|Protocol Violation|1|||
147111903|NCT00972738|530572775|FG002|Overall Study|Protocol Violation|3|||
147559841|NCT04720664|532207355|FG000|Overall Study|Lack of Efficacy|9|||
147559842|NCT05037097|532207356|FG000|Overall Study|Withdrawal by Subject|0|||
147111904|NCT00972738|530572773|FG000|Overall Study|Lost to Follow-up|1|||
147111905|NCT00972738|530572774|FG001|Overall Study|Lost to Follow-up|0|||
147111906|NCT00972738|530572775|FG002|Overall Study|Lost to Follow-up|1|||
147559843|NCT05037097|532207357|FG001|Overall Study|Withdrawal by Subject|1|||
147559844|NCT05037097|532207358|FG002|Overall Study|Withdrawal by Subject|0|||
147559845|NCT05037097|532207359|FG003|Overall Study|Withdrawal by Subject|1|||
147559846|NCT05037097|532207360|FG004|Overall Study|Withdrawal by Subject|0|||
147559847|NCT05037097|532207361|FG005|Overall Study|Withdrawal by Subject|2|||
147559848|NCT05037097|532207362|FG006|Overall Study|Withdrawal by Subject|0|||
147559849|NCT05037097|532207363|FG007|Overall Study|Withdrawal by Subject|0|||
147559850|NCT05037097|532207356|FG000|Overall Study|Lost to Follow-up|0|||
147559851|NCT05037097|532207357|FG001|Overall Study|Lost to Follow-up|1|||
147559852|NCT05037097|532207358|FG002|Overall Study|Lost to Follow-up|0|||
147559853|NCT05037097|532207359|FG003|Overall Study|Lost to Follow-up|0|||
147559854|NCT05037097|532207360|FG004|Overall Study|Lost to Follow-up|1|||
147559855|NCT05037097|532207361|FG005|Overall Study|Lost to Follow-up|1|||
147559856|NCT05037097|532207362|FG006|Overall Study|Lost to Follow-up|0|||
147559857|NCT05037097|532207363|FG007|Overall Study|Lost to Follow-up|0|||
147559858|NCT02322047|532207364|FG000|Overall Study|Physician Decision|1|||
147559859|NCT02322047|532207365|FG001|Overall Study|Physician Decision|0|||
147559860|NCT02322047|532207366|FG002|Overall Study|Physician Decision|0|||
147559861|NCT02322047|532207367|FG003|Overall Study|Physician Decision|0|||
147559862|NCT02322047|532207364|FG000|Overall Study|Withdrawal by Subject|1|||
147559863|NCT02322047|532207365|FG001|Overall Study|Withdrawal by Subject|0|||
147559864|NCT02322047|532207366|FG002|Overall Study|Withdrawal by Subject|0|||
147559865|NCT02322047|532207367|FG003|Overall Study|Withdrawal by Subject|1|||
147559866|NCT02322047|532207364|FG000|Overall Study|Adverse Event|0|||
147111907|NCT00972738|530572773|FG000|Overall Study|Lack of Efficacy|5|||
147111908|NCT00972738|530572774|FG001|Overall Study|Lack of Efficacy|1|||
147111909|NCT00972738|530572775|FG002|Overall Study|Lack of Efficacy|11|||
147111910|NCT00972738|530572773|FG000|Overall Study|Withdrawal by Subject|5|||
147111911|NCT00972738|530572774|FG001|Overall Study|Withdrawal by Subject|1|||
147111912|NCT00972738|530572775|FG002|Overall Study|Withdrawal by Subject|4|||
147111913|NCT00972738|530572773|FG000|Overall Study|Moved|0|||
147111914|NCT00972738|530572774|FG001|Overall Study|Moved|0|||
147111915|NCT00972738|530572775|FG002|Overall Study|Moved|1|||
147111916|NCT00972738|530572773|FG000|Overall Study|Other|1|||
147559867|NCT02322047|532207365|FG001|Overall Study|Adverse Event|1|||
147559868|NCT02322047|532207366|FG002|Overall Study|Adverse Event|0|||
147559869|NCT02322047|532207367|FG003|Overall Study|Adverse Event|0|||
147559870|NCT02322047|532207364|FG000|Overall Study|Lost to Follow-up|0|||
147559871|NCT02322047|532207365|FG001|Overall Study|Lost to Follow-up|0|||
147559872|NCT02322047|532207366|FG002|Overall Study|Lost to Follow-up|1|||
147559873|NCT02322047|532207367|FG003|Overall Study|Lost to Follow-up|1|||
147111917|NCT00972738|530572774|FG001|Overall Study|Other|2|||
147111918|NCT00972738|530572775|FG002|Overall Study|Other|1|||
147111919|NCT03915067|530572777|FG000|Overall Study|Adverse Event|0|||
147111920|NCT03915067|530572778|FG001|Overall Study|Adverse Event|0|||
147111921|NCT03915067|530572779|FG002|Overall Study|Adverse Event|1|||
147311077|NCT04789577|531307085|FG004|Overall Study|Migrated Or Moved From The Study Area|0|||
147311078|NCT04789577|531307086|FG005|Overall Study|Migrated Or Moved From The Study Area|0|||
147311079|NCT04789577|531307087|FG006|Overall Study|Migrated Or Moved From The Study Area|0|||
147311080|NCT04789577|531307081|FG000|Overall Study|AE Requiring Expedited Reporting|0|||
147311081|NCT04789577|531307082|FG001|Overall Study|AE Requiring Expedited Reporting|0|||
147311082|NCT04789577|531307083|FG002|Overall Study|AE Requiring Expedited Reporting|0|||
147559874|NCT00376220|532207372|FG000|Overall Study|Lost to Follow-up|7|||
147559875|NCT00376220|532207373|FG001|Overall Study|Lost to Follow-up|10|||
147559876|NCT00376220|532207372|FG000|Overall Study|Withdrawal by Subject|3|||
147559877|NCT00376220|532207373|FG001|Overall Study|Withdrawal by Subject|2|||
147559878|NCT03311646|532207374|FG000|Overall Study|Physician Decision|1|||
147559879|NCT03311646|532207374|FG000|Overall Study|Withdrawal by Subject|5|||
147559880|NCT03311646|532207374|FG000|Overall Study|Lost to Follow-up|5|||
147559881|NCT03311646|532207374|FG000|Overall Study|PI Withdrawal for Positive Drug Screen|4|||
147559882|NCT00531206|532207375|FG000|Overall Study|Adverse Event related|5|||
147559883|NCT00531206|532207375|FG000|Overall Study|Lack of Efficacy|2|||
147559884|NCT00531206|532207375|FG000|Overall Study|Lost to Follow-up|5|||
147111922|NCT03915067|530572777|FG000|Overall Study|Withdrawal by Subject|4|||
147111923|NCT03915067|530572778|FG001|Overall Study|Withdrawal by Subject|3|||
147559885|NCT00531206|532207375|FG000|Overall Study|including non-related adverse events|8|||
147559886|NCT02906709|532207376|FG000|Phase A (Week 0 to Week 16)|Adverse Event|1|||
147559887|NCT02906709|532207377|FG001|Phase A (Week 0 to Week 16)|Adverse Event|2|||
147559888|NCT02906709|532207376|FG000|Phase A (Week 0 to Week 16)|Death|0|||
147559889|NCT02906709|532207377|FG001|Phase A (Week 0 to Week 16)|Death|1|||
147559890|NCT02906709|532207376|FG000|Phase B (Extension, Week 17 to Week 52)|Adverse Event|3|||
147559891|NCT02906709|532207377|FG001|Phase B (Extension, Week 17 to Week 52)|Adverse Event|0|||
147311083|NCT04789577|531307084|FG003|Overall Study|AE Requiring Expedited Reporting|0|||
147111924|NCT03915067|530572779|FG002|Overall Study|Withdrawal by Subject|0|||
147111925|NCT03915067|530572777|FG000|Overall Study|Lost to Follow-up|3|||
147111926|NCT03915067|530572778|FG001|Overall Study|Lost to Follow-up|2|||
147559892|NCT02906709|532207376|FG000|Phase B (Extension, Week 17 to Week 52)|Withdrawal by Subject|2|||
147559893|NCT02906709|532207377|FG001|Phase B (Extension, Week 17 to Week 52)|Withdrawal by Subject|0|||
147559894|NCT01439165|532207384|FG000|Overall Study|Protocol Violation|3|||
147559895|NCT01439165|532207385|FG001|Overall Study|Protocol Violation|0|||
147559896|NCT01439165|532207384|FG000|Overall Study|Lost to Follow-up|11|||
147559897|NCT01439165|532207385|FG001|Overall Study|Lost to Follow-up|1|||
147559898|NCT01439165|532207384|FG000|Overall Study|Withdrawal by Subject|7|||
147559899|NCT01439165|532207385|FG001|Overall Study|Withdrawal by Subject|1|||
147559900|NCT03331042|532207386|FG000|Overall Study|Protocol Violation|1|||
147559901|NCT03331042|532207387|FG001|Overall Study|Protocol Violation|0|||
147559902|NCT03331042|532207388|FG002|Overall Study|Protocol Violation|0|||
147559903|NCT03331042|532207389|FG003|Overall Study|Protocol Violation|0|||
147559904|NCT03331042|532207386|FG000|Overall Study|Physician Decision|0|||
147559905|NCT03331042|532207387|FG001|Overall Study|Physician Decision|0|||
147559906|NCT03331042|532207388|FG002|Overall Study|Physician Decision|1|||
147559907|NCT03331042|532207389|FG003|Overall Study|Physician Decision|0|||
147559908|NCT03331042|532207386|FG000|Overall Study|Lost to Follow-up|0|||
147559909|NCT03331042|532207387|FG001|Overall Study|Lost to Follow-up|0|||
147559910|NCT03331042|532207388|FG002|Overall Study|Lost to Follow-up|0|||
147559911|NCT03331042|532207389|FG003|Overall Study|Lost to Follow-up|1|||
147559912|NCT00322491|532207395|FG000|Overall Study|Adverse Event|1|||
147559913|NCT00322491|532207396|FG001|Overall Study|Adverse Event|0|||
147559914|NCT00322491|532207395|FG000|Overall Study|Death|1|||
147559915|NCT00322491|532207396|FG001|Overall Study|Death|2|||
147559916|NCT00048048|532207397|FG000|Core Treatment|Withdrawal by Subject|0|||
147559917|NCT00048048|532207398|FG001|Core Treatment|Withdrawal by Subject|0|||
147559918|NCT00048048|532207399|FG002|Core Treatment|Withdrawal by Subject|1|||
147559919|NCT00048048|532207400|FG003|Core Treatment|Withdrawal by Subject|0|||
147559920|NCT00048048|532207401|FG004|Core Treatment|Withdrawal by Subject|0|||
147559921|NCT00048048|532207402|FG005|Core Treatment|Withdrawal by Subject|0|||
147559922|NCT00048048|532207403|FG006|Core Treatment|Withdrawal by Subject|0|||
147559923|NCT00048048|532207404|FG007|Core Treatment|Withdrawal by Subject|0|||
147559924|NCT00048048|532207405|FG008|Core Treatment|Withdrawal by Subject|0|||
147559925|NCT00048048|532207406|FG009|Core Treatment|Withdrawal by Subject|0|||
147559926|NCT00048048|532207407|FG010|Core Treatment|Withdrawal by Subject|0|||
147559927|NCT00048048|532207408|FG011|Core Treatment|Withdrawal by Subject|0|||
147559928|NCT00048048|532207397|FG000|Core Treatment|Adverse Event|0|||
147559929|NCT00048048|532207398|FG001|Core Treatment|Adverse Event|0|||
147559930|NCT00048048|532207399|FG002|Core Treatment|Adverse Event|0|||
147559931|NCT00048048|532207400|FG003|Core Treatment|Adverse Event|0|||
147559932|NCT00048048|532207401|FG004|Core Treatment|Adverse Event|0|||
147559933|NCT00048048|532207402|FG005|Core Treatment|Adverse Event|0|||
147559934|NCT00048048|532207403|FG006|Core Treatment|Adverse Event|0|||
147559935|NCT00048048|532207404|FG007|Core Treatment|Adverse Event|1|||
147559936|NCT00048048|532207405|FG008|Core Treatment|Adverse Event|0|||
147559937|NCT00048048|532207406|FG009|Core Treatment|Adverse Event|0|||
147559938|NCT00048048|532207407|FG010|Core Treatment|Adverse Event|0|||
147559939|NCT00048048|532207408|FG011|Core Treatment|Adverse Event|0|||
147559940|NCT00048048|532207397|FG000|Extension Year 1|Early withdrawals|0|||
147559941|NCT00048048|532207398|FG001|Extension Year 1|Early withdrawals|0|||
147559942|NCT00048048|532207399|FG002|Extension Year 1|Early withdrawals|0|||
147559943|NCT00048048|532207400|FG003|Extension Year 1|Early withdrawals|0|||
147559944|NCT00048048|532207401|FG004|Extension Year 1|Early withdrawals|0|||
147559945|NCT00048048|532207402|FG005|Extension Year 1|Early withdrawals|0|||
147559946|NCT00048048|532207403|FG006|Extension Year 1|Early withdrawals|0|||
147559947|NCT00048048|532207404|FG007|Extension Year 1|Early withdrawals|0|||
147559948|NCT00048048|532207405|FG008|Extension Year 1|Early withdrawals|0|||
147559949|NCT00048048|532207406|FG009|Extension Year 1|Early withdrawals|2|||
147559950|NCT00048048|532207407|FG010|Extension Year 1|Early withdrawals|2|||
147559951|NCT00048048|532207408|FG011|Extension Year 1|Early withdrawals|4|||
147559952|NCT00048048|532207397|FG000|Extension Year 2|Early withdrawals|0|||
147559953|NCT00048048|532207398|FG001|Extension Year 2|Early withdrawals|0|||
147559954|NCT00048048|532207399|FG002|Extension Year 2|Early withdrawals|0|||
147559955|NCT00048048|532207400|FG003|Extension Year 2|Early withdrawals|0|||
147559956|NCT00048048|532207401|FG004|Extension Year 2|Early withdrawals|0|||
147559957|NCT00048048|532207402|FG005|Extension Year 2|Early withdrawals|0|||
147559958|NCT00048048|532207403|FG006|Extension Year 2|Early withdrawals|0|||
147559959|NCT00048048|532207404|FG007|Extension Year 2|Early withdrawals|0|||
147559960|NCT00048048|532207405|FG008|Extension Year 2|Early withdrawals|0|||
147559961|NCT00048048|532207406|FG009|Extension Year 2|Early withdrawals|0|||
147559962|NCT00048048|532207407|FG010|Extension Year 2|Early withdrawals|4|||
147559963|NCT00048048|532207408|FG011|Extension Year 2|Early withdrawals|2|||
147559964|NCT03992196|532207409|FG000|Enrollment|lost to follow-up prior dosing|1|||
147559965|NCT03992196|532207410|FG001|Enrollment|lost to follow-up prior dosing|0|||
147559966|NCT03992196|532207411|FG002|Enrollment|lost to follow-up prior dosing|0|||
147559967|NCT03992196|532207409|FG000|Treatment|Protocol Violation|0|||
147559968|NCT03992196|532207410|FG001|Treatment|Protocol Violation|0|||
147559969|NCT03992196|532207411|FG002|Treatment|Protocol Violation|1|||
147559970|NCT03992196|532207409|FG000|Treatment|Poor drug compliance withdrawn by team and sponsor|0|||
147559971|NCT03992196|532207410|FG001|Treatment|Poor drug compliance withdrawn by team and sponsor|0|||
147559972|NCT03992196|532207411|FG002|Treatment|Poor drug compliance withdrawn by team and sponsor|1|||
147559973|NCT03992196|532207409|FG000|Treatment|Withdrawal due to non-compliance|0|||
147559974|NCT03992196|532207410|FG001|Treatment|Withdrawal due to non-compliance|0|||
147559975|NCT03992196|532207411|FG002|Treatment|Withdrawal due to non-compliance|1|||
147559976|NCT03992196|532207409|FG000|Treatment|PI's decision due to investigational medicinal product non-compliance|0|||
147559977|NCT03992196|532207410|FG001|Treatment|PI's decision due to investigational medicinal product non-compliance|0|||
147559978|NCT03992196|532207411|FG002|Treatment|PI's decision due to investigational medicinal product non-compliance|1|||
147559979|NCT03992196|532207409|FG000|Treatment|Withdrawal by parent/guardian|0|||
147559980|NCT03992196|532207410|FG001|Treatment|Withdrawal by parent/guardian|0|||
147559981|NCT03992196|532207411|FG002|Treatment|Withdrawal by parent/guardian|2|||
147559982|NCT02388763|532207414|FG000|Habitual, 10 Days of Wear|Withdrawal by Subject|1|||
147559983|NCT02388763|532207415|FG001|Habitual, 10 Days of Wear|Withdrawal by Subject|1|||
147559984|NCT02388763|532207414|FG000|Period 1, 10 Days of Wear|Withdrawal by Subject|1|||
147559985|NCT02388763|532207415|FG001|Period 1, 10 Days of Wear|Withdrawal by Subject|1|||
147559986|NCT05518487|532207416|FG000|Overall Study|Withdrawal by Subject|3|||
147559987|NCT02194998|532207419|FG000|On-HCV Treatment|Did not pick up study medication|0|||
147559988|NCT02194998|532207420|FG001|On-HCV Treatment|Did not pick up study medication|1|||
147559989|NCT02194998|532207421|FG002|On-HCV Treatment|Did not pick up study medication|0|||
147559990|NCT02194998|532207422|FG003|On-HCV Treatment|Did not pick up study medication|0|||
147559991|NCT02194998|532207419|FG000|Post-HCV Treatment Follow-Up|Lost to Follow-up|1|||
147559992|NCT02194998|532207420|FG001|Post-HCV Treatment Follow-Up|Lost to Follow-up|0|||
147559993|NCT02194998|532207421|FG002|Post-HCV Treatment Follow-Up|Lost to Follow-up|1|||
147559994|NCT02194998|532207422|FG003|Post-HCV Treatment Follow-Up|Lost to Follow-up|0|||
147559995|NCT01458405|532207425|FG000|Phase 1 (up to 12 Months)|Other|0|||
147559996|NCT01458405|532207426|FG001|Phase 1 (up to 12 Months)|Other|1|||
147559997|NCT01458405|532207427|FG002|Phase 1 (up to 12 Months)|Other|0|||
147559998|NCT01458405|532207428|FG003|Phase 1 (up to 12 Months)|Other|0|||
147559999|NCT01458405|532207425|FG000|Phase 2 (up to 12 Months)|Study discontinued by Sponsor|0|||
147560000|NCT01458405|532207426|FG001|Phase 2 (up to 12 Months)|Study discontinued by Sponsor|0|||
147560001|NCT01458405|532207427|FG002|Phase 2 (up to 12 Months)|Study discontinued by Sponsor|11|||
147560002|NCT01458405|532207428|FG003|Phase 2 (up to 12 Months)|Study discontinued by Sponsor|20|||
147560003|NCT01458405|532207425|FG000|Phase 2 (up to 12 Months)|Lost to Follow-up|0|||
147560004|NCT01458405|532207426|FG001|Phase 2 (up to 12 Months)|Lost to Follow-up|0|||
147560005|NCT01458405|532207427|FG002|Phase 2 (up to 12 Months)|Lost to Follow-up|0|||
147560006|NCT01458405|532207428|FG003|Phase 2 (up to 12 Months)|Lost to Follow-up|2|||
147560007|NCT01458405|532207425|FG000|Phase 2 (up to 12 Months)|Withdrawal by Subject|0|||
147560008|NCT01458405|532207426|FG001|Phase 2 (up to 12 Months)|Withdrawal by Subject|0|||
147560009|NCT01458405|532207427|FG002|Phase 2 (up to 12 Months)|Withdrawal by Subject|0|||
147560010|NCT01458405|532207428|FG003|Phase 2 (up to 12 Months)|Withdrawal by Subject|1|||
147560011|NCT02497781|532207429|FG000|Overall Study|Withdrawal by Subject|2|||
147560012|NCT02497781|532207430|FG001|Overall Study|Withdrawal by Subject|0|||
147560013|NCT02497781|532207429|FG000|Overall Study|Lack of Efficacy|0|||
147560014|NCT02497781|532207430|FG001|Overall Study|Lack of Efficacy|1|||
147560015|NCT02497781|532207429|FG000|Overall Study|Randomised but not treated|1|||
147560016|NCT02497781|532207430|FG001|Overall Study|Randomised but not treated|1|||
147560017|NCT02497781|532207429|FG000|Overall Study|Lost to Follow-up|1|||
147560018|NCT02497781|532207430|FG001|Overall Study|Lost to Follow-up|1|||
147560019|NCT02236130|532207431|FG000|Overall Study|Lost to Follow-up|7|||
147560020|NCT02236130|532207432|FG001|Overall Study|Lost to Follow-up|12|||
147560021|NCT00525590|532207433|FG000|Overall Study|Adverse Event|3|||
147560022|NCT00525590|532207433|FG000|Overall Study|Physician Decision|3|||
147560023|NCT00525590|532207433|FG000|Overall Study|Withdrawal by Subject|16|||
147560024|NCT00525590|532207433|FG000|Overall Study|Lost to Follow-up|1|||
147560025|NCT00525590|532207433|FG000|Overall Study|Death|9|||
147560026|NCT00525590|532207433|FG000|Overall Study|Other|13|||
147560027|NCT01345019|532207442|FG000|Blinded Treatment Phase|Death|147|||
147560028|NCT01345019|532207443|FG001|Blinded Treatment Phase|Death|137|||
147311084|NCT04789577|531307085|FG004|Overall Study|AE Requiring Expedited Reporting|0|||
147311085|NCT04789577|531307086|FG005|Overall Study|AE Requiring Expedited Reporting|1|||
147560029|NCT01345019|532207442|FG000|Blinded Treatment Phase|Withdrawal by Subject|103|||
147560030|NCT01345019|532207443|FG001|Blinded Treatment Phase|Withdrawal by Subject|112|||
147560031|NCT01345019|532207442|FG000|Blinded Treatment Phase|Completed Survival Follow-up|21|||
147560032|NCT01345019|532207443|FG001|Blinded Treatment Phase|Completed Survival Follow-up|9|||
147560033|NCT01345019|532207442|FG000|Blinded Treatment Phase|Disease Progression|12|||
147560034|NCT01345019|532207443|FG001|Blinded Treatment Phase|Disease Progression|10|||
147560035|NCT01345019|532207442|FG000|Blinded Treatment Phase|Adverse Event|6|||
147560036|NCT01345019|532207443|FG001|Blinded Treatment Phase|Adverse Event|13|||
147560037|NCT01345019|532207442|FG000|Blinded Treatment Phase|Administrative Decision|10|||
147111927|NCT03915067|530572779|FG002|Overall Study|Lost to Follow-up|0|||
147560038|NCT01345019|532207443|FG001|Blinded Treatment Phase|Administrative Decision|8|||
147560039|NCT01345019|532207442|FG000|Blinded Treatment Phase|Noncompliance|5|||
147560040|NCT01345019|532207443|FG001|Blinded Treatment Phase|Noncompliance|3|||
147560041|NCT01345019|532207442|FG000|Blinded Treatment Phase|Ineligibility Determined|1|||
147560042|NCT01345019|532207443|FG001|Blinded Treatment Phase|Ineligibility Determined|6|||
147560043|NCT01345019|532207442|FG000|Blinded Treatment Phase|Protocol Deviation|5|||
147560044|NCT01345019|532207443|FG001|Blinded Treatment Phase|Protocol Deviation|0|||
147560045|NCT01345019|532207442|FG000|Blinded Treatment Phase|Other, Not Specified|2|||
147560046|NCT01345019|532207443|FG001|Blinded Treatment Phase|Other, Not Specified|3|||
147560047|NCT01345019|532207442|FG000|Blinded Treatment Phase|Lost to Follow-up|6|||
147560048|NCT01345019|532207443|FG001|Blinded Treatment Phase|Lost to Follow-up|3|||
147560049|NCT01345019|532207442|FG000|Open Label Treatment Phase|Death|49|||
147560050|NCT01345019|532207443|FG001|Open Label Treatment Phase|Death|48|||
147560051|NCT01345019|532207442|FG000|Open Label Treatment Phase|Withdrawal by Subject|49|||
147560052|NCT01345019|532207443|FG001|Open Label Treatment Phase|Withdrawal by Subject|47|||
147560053|NCT01345019|532207442|FG000|Open Label Treatment Phase|Adverse Event|30|||
147560054|NCT01345019|532207443|FG001|Open Label Treatment Phase|Adverse Event|51|||
147560055|NCT01345019|532207442|FG000|Open Label Treatment Phase|Administrative Decision|30|||
147560056|NCT01345019|532207443|FG001|Open Label Treatment Phase|Administrative Decision|15|||
147226234|NCT00937391|531000442|FG000|Stage 2|Withdrawal by Subject|1|||
147226235|NCT01865084|531002004|FG000|Double Blind Period (DB)|Adverse Event|2|||
147226236|NCT01865084|531002005|FG001|Double Blind Period (DB)|Adverse Event|2|||
147226237|NCT01865084|531002006|FG002|Double Blind Period (DB)|Adverse Event|1|||
147226238|NCT01865084|531002004|FG000|Double Blind Period (DB)|Protocol Violation|0|||
147226239|NCT01865084|531002005|FG001|Double Blind Period (DB)|Protocol Violation|0|||
147226240|NCT01865084|531002006|FG002|Double Blind Period (DB)|Protocol Violation|1|||
147226241|NCT01865084|531002004|FG000|Double Blind Period (DB)|Withdrawal by Parent/Guardian|2|||
147226242|NCT01865084|531002005|FG001|Double Blind Period (DB)|Withdrawal by Parent/Guardian|2|||
147226243|NCT01865084|531002006|FG002|Double Blind Period (DB)|Withdrawal by Parent/Guardian|4|||
147226244|NCT01865084|531002004|FG000|Double Blind Period (DB)|Withdrawal by Subject|1|||
147226245|NCT01865084|531002005|FG001|Double Blind Period (DB)|Withdrawal by Subject|0|||
147226246|NCT01865084|531002006|FG002|Double Blind Period (DB)|Withdrawal by Subject|0|||
147226247|NCT01865084|531002004|FG000|Open Label Extension (OLE) Period|Adverse Event|0|||
147226248|NCT01865084|531002005|FG001|Open Label Extension (OLE) Period|Adverse Event|0|||
147226249|NCT01865084|531002006|FG002|Open Label Extension (OLE) Period|Adverse Event|1|||
147226250|NCT01865084|531002004|FG000|Open Label Extension (OLE) Period|Lack of Efficacy|0|||
147226251|NCT01865084|531002005|FG001|Open Label Extension (OLE) Period|Lack of Efficacy|0|||
147226252|NCT01865084|531002006|FG002|Open Label Extension (OLE) Period|Lack of Efficacy|2|||
147226253|NCT01865084|531002004|FG000|Open Label Extension (OLE) Period|Lost to Follow-up|0|||
147226254|NCT01865084|531002005|FG001|Open Label Extension (OLE) Period|Lost to Follow-up|1|||
147226255|NCT01865084|531002006|FG002|Open Label Extension (OLE) Period|Lost to Follow-up|0|||
147226256|NCT01865084|531002004|FG000|Open Label Extension (OLE) Period|Withdrawal by Parent/Guardian|0|||
147226257|NCT01865084|531002005|FG001|Open Label Extension (OLE) Period|Withdrawal by Parent/Guardian|8|||
147226258|NCT01865084|531002006|FG002|Open Label Extension (OLE) Period|Withdrawal by Parent/Guardian|2|||
147226259|NCT01865084|531002004|FG000|Open Label Extension (OLE) Period|Withdrawal by Subject|0|||
147226260|NCT01865084|531002005|FG001|Open Label Extension (OLE) Period|Withdrawal by Subject|2|||
147226261|NCT01865084|531002006|FG002|Open Label Extension (OLE) Period|Withdrawal by Subject|2|||
147226262|NCT02247531|531002007|FG000|Overall Study|Adverse Event|3|||
147226263|NCT02247531|531002008|FG001|Overall Study|Adverse Event|4|||
147226264|NCT02247531|531002009|FG002|Overall Study|Adverse Event|9|||
147226265|NCT02247531|531002007|FG000|Overall Study|Death|8|||
147226266|NCT02247531|531002008|FG001|Overall Study|Death|9|||
147226267|NCT02247531|531002009|FG002|Overall Study|Death|5|||
147226268|NCT02247531|531002007|FG000|Overall Study|Lost to Follow-up|1|||
147226269|NCT02247531|531002008|FG001|Overall Study|Lost to Follow-up|8|||
147226270|NCT02247531|531002009|FG002|Overall Study|Lost to Follow-up|3|||
147226271|NCT02247531|531002007|FG000|Overall Study|Non-compliance|2|||
147226272|NCT02247531|531002008|FG001|Overall Study|Non-compliance|2|||
147226273|NCT02247531|531002009|FG002|Overall Study|Non-compliance|0|||
147226274|NCT02247531|531002007|FG000|Overall Study|Withdrawal by Subject|26|||
147226275|NCT02247531|531002008|FG001|Overall Study|Withdrawal by Subject|31|||
147226276|NCT02247531|531002009|FG002|Overall Study|Withdrawal by Subject|25|||
147226277|NCT02247531|531002007|FG000|Overall Study|Study Terminated by Sponsor|64|||
147226278|NCT02247531|531002008|FG001|Overall Study|Study Terminated by Sponsor|66|||
147226279|NCT02247531|531002009|FG002|Overall Study|Study Terminated by Sponsor|62|||
147560057|NCT01345019|532207442|FG000|Open Label Treatment Phase|Disease Progression|17|||
147560058|NCT01345019|532207443|FG001|Open Label Treatment Phase|Disease Progression|18|||
147560059|NCT01345019|532207442|FG000|Open Label Treatment Phase|Noncompliance|5|||
147226280|NCT02247531|531002007|FG000|Overall Study|Physician Decision|0|||
147226281|NCT02247531|531002008|FG001|Overall Study|Physician Decision|2|||
147226282|NCT02247531|531002009|FG002|Overall Study|Physician Decision|2|||
147226283|NCT02247531|531002007|FG000|Overall Study|Unspecified Reason|2|||
147226284|NCT02247531|531002008|FG001|Overall Study|Unspecified Reason|3|||
147560060|NCT01345019|532207443|FG001|Open Label Treatment Phase|Noncompliance|4|||
147560061|NCT01345019|532207442|FG000|Open Label Treatment Phase|Lost to Follow-up|1|||
147560062|NCT01345019|532207443|FG001|Open Label Treatment Phase|Lost to Follow-up|2|||
147560063|NCT01345019|532207442|FG000|Open Label Treatment Phase|Pregnancy|1|||
147560064|NCT01345019|532207443|FG001|Open Label Treatment Phase|Pregnancy|0|||
147560065|NCT01345019|532207442|FG000|Open Label Treatment Phase|Other, Not Specified|9|||
147560066|NCT01345019|532207443|FG001|Open Label Treatment Phase|Other, Not Specified|7|||
147560067|NCT01345019|532207442|FG000|Open Label Treatment Phase|Protocol Violation|0|||
147560068|NCT01345019|532207443|FG001|Open Label Treatment Phase|Protocol Violation|1|||
147560069|NCT03830164|532207444|FG000|Overall Study|Adverse Event|0|||
147560070|NCT03830164|532207445|FG001|Overall Study|Adverse Event|2|||
147560071|NCT03830164|532207446|FG002|Overall Study|Adverse Event|0|||
147560072|NCT03830164|532207444|FG000|Overall Study|Lack of Efficacy|1|||
147560073|NCT03830164|532207445|FG001|Overall Study|Lack of Efficacy|5|||
147560074|NCT03830164|532207446|FG002|Overall Study|Lack of Efficacy|0|||
147560075|NCT03830164|532207444|FG000|Overall Study|Lost to Follow-up|0|||
147560076|NCT03830164|532207445|FG001|Overall Study|Lost to Follow-up|1|||
147560077|NCT03830164|532207446|FG002|Overall Study|Lost to Follow-up|0|||
147560078|NCT03830164|532207444|FG000|Overall Study|Withdrawal by Subject|1|||
147560079|NCT03830164|532207445|FG001|Overall Study|Withdrawal by Subject|0|||
147560080|NCT03830164|532207446|FG002|Overall Study|Withdrawal by Subject|0|||
147560081|NCT00320112|532207447|FG000|Overall Study|Lost to Follow-up|3|||
147560082|NCT00320112|532207448|FG001|Overall Study|Lost to Follow-up|4|||
147560083|NCT00320112|532207447|FG000|Overall Study|Withdrawal by Subject|3|||
147560084|NCT00320112|532207448|FG001|Overall Study|Withdrawal by Subject|0|||
147560085|NCT00320112|532207447|FG000|Overall Study|Death|2|||
147560086|NCT00320112|532207448|FG001|Overall Study|Death|1|||
147560087|NCT01199861|532207450|FG000|Overall Study|Administrative problems|1|||
147560088|NCT01199861|532207451|FG001|Overall Study|Administrative problems|0|||
147560089|NCT01199861|532207450|FG000|Overall Study|Adverse Event|1|||
147560090|NCT01199861|532207451|FG001|Overall Study|Adverse Event|0|||
147560091|NCT04981912|532207452|FG000|Overall Study|Physician Decision|2|||
147560092|NCT00661505|532207453|FG000|Overall Study|Adverse Event|3|||
147560093|NCT00661505|532207453|FG000|Overall Study|Protocol Violation|14|||
147560094|NCT00661505|532207453|FG000|Overall Study|Withdrawal by Subject|8|||
147560095|NCT00661505|532207453|FG000|Overall Study|Lost to Follow-up|3|||
147560096|NCT00661505|532207453|FG000|Overall Study|Other|2|||
147560097|NCT05630547|532207454|FG000|Part A (Double-blind Period: 48 Weeks)|Other|0|||
147560098|NCT05630547|532207455|FG001|Part A (Double-blind Period: 48 Weeks)|Other|2|||
147560099|NCT05630547|532207456|FG002|Part A (Double-blind Period: 48 Weeks)|Other|0|||
147560100|NCT05630547|532207457|FG003|Part A (Double-blind Period: 48 Weeks)|Other|0|||
147560101|NCT05630547|532207454|FG000|Part A (Double-blind Period: 48 Weeks)|Withdrawal by Subject|8|||
147560102|NCT05630547|532207455|FG001|Part A (Double-blind Period: 48 Weeks)|Withdrawal by Subject|3|||
147560103|NCT05630547|532207456|FG002|Part A (Double-blind Period: 48 Weeks)|Withdrawal by Subject|0|||
147560104|NCT05630547|532207457|FG003|Part A (Double-blind Period: 48 Weeks)|Withdrawal by Subject|0|||
147560105|NCT05630547|532207454|FG000|Part A (Double-blind Period: 48 Weeks)|Lack of Efficacy|0|||
147560106|NCT05630547|532207455|FG001|Part A (Double-blind Period: 48 Weeks)|Lack of Efficacy|1|||
147560107|NCT05630547|532207456|FG002|Part A (Double-blind Period: 48 Weeks)|Lack of Efficacy|0|||
147560108|NCT05630547|532207457|FG003|Part A (Double-blind Period: 48 Weeks)|Lack of Efficacy|0|||
147560109|NCT05630547|532207454|FG000|Part A (Double-blind Period: 48 Weeks)|Adverse Event|1|||
147560110|NCT05630547|532207455|FG001|Part A (Double-blind Period: 48 Weeks)|Adverse Event|13|||
147560111|NCT05630547|532207456|FG002|Part A (Double-blind Period: 48 Weeks)|Adverse Event|0|||
147560112|NCT05630547|532207457|FG003|Part A (Double-blind Period: 48 Weeks)|Adverse Event|0|||
147560113|NCT05630547|532207454|FG000|Part A (Double-blind Period: 48 Weeks)|Randomized and not treated|0|||
147560114|NCT05630547|532207455|FG001|Part A (Double-blind Period: 48 Weeks)|Randomized and not treated|1|||
147560115|NCT05630547|532207456|FG002|Part A (Double-blind Period: 48 Weeks)|Randomized and not treated|0|||
147560116|NCT05630547|532207457|FG003|Part A (Double-blind Period: 48 Weeks)|Randomized and not treated|0|||
147226285|NCT02247531|531002009|FG002|Overall Study|Unspecified Reason|4|||
147560117|NCT05630547|532207454|FG000|Part B (Open-label Period: 48 Weeks)|Study terminated by sponsor|0|||
147560118|NCT05630547|532207455|FG001|Part B (Open-label Period: 48 Weeks)|Study terminated by sponsor|0|||
147560119|NCT05630547|532207456|FG002|Part B (Open-label Period: 48 Weeks)|Study terminated by sponsor|72|||
147560120|NCT05630547|532207457|FG003|Part B (Open-label Period: 48 Weeks)|Study terminated by sponsor|62|||
147560121|NCT05630547|532207454|FG000|Part B (Open-label Period: 48 Weeks)|Non-compliance with study schedule|0|||
147226286|NCT03875118|531002014|FG000|Overall Study|Withdrawal by Subject|4|||
147226287|NCT03875118|531002015|FG001|Overall Study|Withdrawal by Subject|4|||
147226288|NCT02237911|531002016|FG000|Overall Study|Withdrawal by Subject|4|||
147226289|NCT02237911|531002017|FG001|Overall Study|Withdrawal by Subject|7|||
147226290|NCT02237911|531002018|FG002|Overall Study|Withdrawal by Subject|2|||
147226291|NCT02237911|531002016|FG000|Overall Study|Lost to Follow-up|3|||
147226292|NCT02237911|531002017|FG001|Overall Study|Lost to Follow-up|1|||
147226293|NCT02237911|531002018|FG002|Overall Study|Lost to Follow-up|1|||
147226294|NCT02423109|531002019|FG000|Lens 1|Adverse Event|1|||
147226295|NCT02423109|531002020|FG001|Lens 1|Adverse Event|0|||
147560122|NCT05630547|532207455|FG001|Part B (Open-label Period: 48 Weeks)|Non-compliance with study schedule|0|||
147560123|NCT05630547|532207456|FG002|Part B (Open-label Period: 48 Weeks)|Non-compliance with study schedule|0|||
147560124|NCT05630547|532207457|FG003|Part B (Open-label Period: 48 Weeks)|Non-compliance with study schedule|1|||
147560125|NCT05630547|532207454|FG000|Part B (Open-label Period: 48 Weeks)|Withdrawal by Subject|0|||
147560126|NCT05630547|532207455|FG001|Part B (Open-label Period: 48 Weeks)|Withdrawal by Subject|0|||
147560127|NCT05630547|532207456|FG002|Part B (Open-label Period: 48 Weeks)|Withdrawal by Subject|1|||
147560128|NCT05630547|532207457|FG003|Part B (Open-label Period: 48 Weeks)|Withdrawal by Subject|3|||
147560129|NCT05630547|532207454|FG000|Part B (Open-label Period: 48 Weeks)|Lack of Efficacy|0|||
147560130|NCT05630547|532207455|FG001|Part B (Open-label Period: 48 Weeks)|Lack of Efficacy|0|||
147560131|NCT05630547|532207456|FG002|Part B (Open-label Period: 48 Weeks)|Lack of Efficacy|1|||
147560132|NCT05630547|532207457|FG003|Part B (Open-label Period: 48 Weeks)|Lack of Efficacy|1|||
147560133|NCT05630547|532207454|FG000|Part B (Open-label Period: 48 Weeks)|Adverse Event|0|||
147560134|NCT05630547|532207455|FG001|Part B (Open-label Period: 48 Weeks)|Adverse Event|0|||
147560135|NCT05630547|532207456|FG002|Part B (Open-label Period: 48 Weeks)|Adverse Event|3|||
147560136|NCT05630547|532207457|FG003|Part B (Open-label Period: 48 Weeks)|Adverse Event|1|||
147560137|NCT00977470|532207458|FG000|Overall Study|Lack of Efficacy|32|||
147560138|NCT00977470|532207459|FG001|Overall Study|Lack of Efficacy|30|||
147560139|NCT00977470|532207458|FG000|Overall Study|Physician Decision|2|||
147560140|NCT00977470|532207459|FG001|Overall Study|Physician Decision|0|||
147560141|NCT00977470|532207458|FG000|Overall Study|Adverse Event|1|||
147560142|NCT00977470|532207459|FG001|Overall Study|Adverse Event|2|||
147560143|NCT00977470|532207458|FG000|Overall Study|Protocol Violation|1|||
147560144|NCT00977470|532207459|FG001|Overall Study|Protocol Violation|0|||
147560145|NCT00977470|532207458|FG000|Overall Study|Withdrawal by Subject|0|||
147560146|NCT00977470|532207459|FG001|Overall Study|Withdrawal by Subject|2|||
147560147|NCT00977470|532207458|FG000|Overall Study|Death|0|||
147560148|NCT00977470|532207459|FG001|Overall Study|Death|2|||
147560149|NCT00977470|532207458|FG000|Overall Study|clinical decline|0|||
147560150|NCT00977470|532207459|FG001|Overall Study|clinical decline|1|||
147560151|NCT00977470|532207458|FG000|Overall Study|prolonged recovery post-surgery|0|||
147560152|NCT00977470|532207459|FG001|Overall Study|prolonged recovery post-surgery|1|||
147560153|NCT00977470|532207458|FG000|Overall Study|Still on-study|2|||
147560154|NCT00977470|532207459|FG001|Overall Study|Still on-study|0|||
147560155|NCT00796822|532207460|FG000|Overall Study|Lost to Follow-up|2|||
147560156|NCT00796822|532207461|FG001|Overall Study|Lost to Follow-up|0|||
147560157|NCT00796822|532207460|FG000|Overall Study|Adverse Event|1|||
147560158|NCT00796822|532207461|FG001|Overall Study|Adverse Event|0|||
147560159|NCT02364557|532207462|FG000|Overall Study|Protocol Violation|3|||
147560160|NCT02364557|532207463|FG001|Overall Study|Protocol Violation|1|||
147560161|NCT03978624|532207464|FG000|Overall Study|Protocol Violation|1|||
147560162|NCT03978624|532207465|FG001|Overall Study|Protocol Violation|0|||
147560163|NCT05097989|532207467|FG000|Initial Evaluation Period (26 Weeks)|Physician Decision|0|||
147560164|NCT05097989|532207468|FG001|Initial Evaluation Period (26 Weeks)|Physician Decision|0|||
147560165|NCT05097989|532207469|FG002|Initial Evaluation Period (26 Weeks)|Physician Decision|0|||
147560166|NCT05097989|532207470|FG003|Initial Evaluation Period (26 Weeks)|Physician Decision|0|||
147560167|NCT05097989|532207471|FG004|Initial Evaluation Period (26 Weeks)|Physician Decision|0|||
147560168|NCT05097989|532207472|FG005|Initial Evaluation Period (26 Weeks)|Physician Decision|1|||
147560169|NCT05097989|532207473|FG006|Initial Evaluation Period (26 Weeks)|Physician Decision|0|||
147560170|NCT05097989|532207474|FG007|Initial Evaluation Period (26 Weeks)|Physician Decision|0|||
147560171|NCT05097989|532207475|FG008|Initial Evaluation Period (26 Weeks)|Physician Decision|0|||
147560172|NCT05097989|532207467|FG000|Initial Evaluation Period (26 Weeks)|Death|0|||
147560173|NCT05097989|532207468|FG001|Initial Evaluation Period (26 Weeks)|Death|0|||
147560174|NCT05097989|532207469|FG002|Initial Evaluation Period (26 Weeks)|Death|0|||
147560175|NCT05097989|532207470|FG003|Initial Evaluation Period (26 Weeks)|Death|0|||
147226296|NCT02428608|531002021|FG000|Overall Study|Pregnancy|2|||
147226297|NCT02428608|531002021|FG000|Overall Study|Lost to Follow-up|37|||
147226298|NCT02428608|531002021|FG000|Overall Study|Withdrawal by Subject|2|||
147226299|NCT02428608|531002021|FG000|Overall Study|scheduling conflicts|15|||
147226300|NCT02428608|531002021|FG000|Overall Study|moved away|10|||
147226301|NCT02428608|531002021|FG000|Overall Study|Death|1|||
147226302|NCT02428608|531002021|FG000|Overall Study|various|16|||
147226303|NCT04521777|531002022|FG000|Overall Study|Death|2|||
147226304|NCT04521777|531002022|FG000|Overall Study|Withdrawal by Subject|2|||
147226305|NCT01869725|531002027|FG000|Overall Study|ineligible after registration|1|||
147226306|NCT01869725|531002027|FG000|Overall Study|Death|1|||
147226307|NCT01869725|531002027|FG000|Overall Study|Lost to Follow-up|2|||
147226308|NCT01143207|531002028|FG000|Overall Study|Lost to Follow-up|2|||
147226309|NCT03416374|531002035|FG000|Between Treatment Period I and II|Other|0|||
147226310|NCT03416374|531002036|FG001|Between Treatment Period I and II|Other|9|||
147226311|NCT03416374|531002035|FG000|Treatment Period II|Lack of Efficacy|3|||
147226312|NCT03416374|531002036|FG001|Treatment Period II|Lack of Efficacy|11|||
147226313|NCT03416374|531002035|FG000|Treatment Period II|Adverse Event|1|||
147560176|NCT05097989|532207471|FG004|Initial Evaluation Period (26 Weeks)|Death|0|||
147560177|NCT05097989|532207472|FG005|Initial Evaluation Period (26 Weeks)|Death|0|||
147560178|NCT05097989|532207473|FG006|Initial Evaluation Period (26 Weeks)|Death|1|||
147560179|NCT05097989|532207474|FG007|Initial Evaluation Period (26 Weeks)|Death|0|||
147560180|NCT05097989|532207475|FG008|Initial Evaluation Period (26 Weeks)|Death|0|||
147560181|NCT05097989|532207467|FG000|Initial Evaluation Period (26 Weeks)|Study Terminated by Sponsor|0|||
147560182|NCT05097989|532207468|FG001|Initial Evaluation Period (26 Weeks)|Study Terminated by Sponsor|0|||
147560183|NCT05097989|532207469|FG002|Initial Evaluation Period (26 Weeks)|Study Terminated by Sponsor|0|||
147560184|NCT05097989|532207470|FG003|Initial Evaluation Period (26 Weeks)|Study Terminated by Sponsor|0|||
147560185|NCT05097989|532207471|FG004|Initial Evaluation Period (26 Weeks)|Study Terminated by Sponsor|0|||
147560186|NCT05097989|532207472|FG005|Initial Evaluation Period (26 Weeks)|Study Terminated by Sponsor|2|||
147560187|NCT05097989|532207473|FG006|Initial Evaluation Period (26 Weeks)|Study Terminated by Sponsor|3|||
147560188|NCT05097989|532207474|FG007|Initial Evaluation Period (26 Weeks)|Study Terminated by Sponsor|3|||
147560189|NCT05097989|532207475|FG008|Initial Evaluation Period (26 Weeks)|Study Terminated by Sponsor|0|||
147560190|NCT05097989|532207467|FG000|Initial Evaluation Period (26 Weeks)|Withdrawal by Subject|0|||
147560191|NCT05097989|532207468|FG001|Initial Evaluation Period (26 Weeks)|Withdrawal by Subject|0|||
147560192|NCT05097989|532207469|FG002|Initial Evaluation Period (26 Weeks)|Withdrawal by Subject|1|||
147560193|NCT05097989|532207470|FG003|Initial Evaluation Period (26 Weeks)|Withdrawal by Subject|0|||
147560194|NCT05097989|532207471|FG004|Initial Evaluation Period (26 Weeks)|Withdrawal by Subject|0|||
147560195|NCT05097989|532207472|FG005|Initial Evaluation Period (26 Weeks)|Withdrawal by Subject|1|||
147560196|NCT05097989|532207473|FG006|Initial Evaluation Period (26 Weeks)|Withdrawal by Subject|0|||
147560197|NCT05097989|532207474|FG007|Initial Evaluation Period (26 Weeks)|Withdrawal by Subject|2|||
147560198|NCT05097989|532207475|FG008|Initial Evaluation Period (26 Weeks)|Withdrawal by Subject|0|||
147560199|NCT05097989|532207467|FG000|Initial Evaluation Period (26 Weeks)|Adverse Event|0|||
147560200|NCT05097989|532207468|FG001|Initial Evaluation Period (26 Weeks)|Adverse Event|0|||
147560201|NCT05097989|532207469|FG002|Initial Evaluation Period (26 Weeks)|Adverse Event|1|||
147560202|NCT05097989|532207470|FG003|Initial Evaluation Period (26 Weeks)|Adverse Event|0|||
147560203|NCT05097989|532207471|FG004|Initial Evaluation Period (26 Weeks)|Adverse Event|0|||
147560204|NCT05097989|532207472|FG005|Initial Evaluation Period (26 Weeks)|Adverse Event|0|||
147560205|NCT05097989|532207473|FG006|Initial Evaluation Period (26 Weeks)|Adverse Event|0|||
147560206|NCT05097989|532207474|FG007|Initial Evaluation Period (26 Weeks)|Adverse Event|0|||
147560207|NCT05097989|532207475|FG008|Initial Evaluation Period (26 Weeks)|Adverse Event|0|||
147560208|NCT05097989|532207467|FG000|Extended Treatment Period (24 Weeks)|Pregnancy|0|||
147560209|NCT05097989|532207468|FG001|Extended Treatment Period (24 Weeks)|Pregnancy|1|||
147560210|NCT05097989|532207469|FG002|Extended Treatment Period (24 Weeks)|Pregnancy|0|||
147560211|NCT05097989|532207470|FG003|Extended Treatment Period (24 Weeks)|Pregnancy|0|||
147560212|NCT05097989|532207471|FG004|Extended Treatment Period (24 Weeks)|Pregnancy|0|||
147560213|NCT05097989|532207472|FG005|Extended Treatment Period (24 Weeks)|Pregnancy|0|||
147560214|NCT05097989|532207473|FG006|Extended Treatment Period (24 Weeks)|Pregnancy|0|||
147560215|NCT05097989|532207474|FG007|Extended Treatment Period (24 Weeks)|Pregnancy|0|||
147560216|NCT05097989|532207475|FG008|Extended Treatment Period (24 Weeks)|Pregnancy|0|||
147560217|NCT05097989|532207467|FG000|Extended Treatment Period (24 Weeks)|Lost to Follow-up|0|||
147560218|NCT05097989|532207468|FG001|Extended Treatment Period (24 Weeks)|Lost to Follow-up|0|||
147560219|NCT05097989|532207469|FG002|Extended Treatment Period (24 Weeks)|Lost to Follow-up|0|||
147560220|NCT05097989|532207470|FG003|Extended Treatment Period (24 Weeks)|Lost to Follow-up|0|||
147560221|NCT05097989|532207471|FG004|Extended Treatment Period (24 Weeks)|Lost to Follow-up|1|||
147560222|NCT05097989|532207472|FG005|Extended Treatment Period (24 Weeks)|Lost to Follow-up|0|||
147560223|NCT05097989|532207473|FG006|Extended Treatment Period (24 Weeks)|Lost to Follow-up|0|||
147560224|NCT05097989|532207474|FG007|Extended Treatment Period (24 Weeks)|Lost to Follow-up|0|||
147560225|NCT05097989|532207475|FG008|Extended Treatment Period (24 Weeks)|Lost to Follow-up|0|||
147560226|NCT05097989|532207467|FG000|Extended Treatment Period (24 Weeks)|Adverse Event|0|||
147560227|NCT05097989|532207468|FG001|Extended Treatment Period (24 Weeks)|Adverse Event|0|||
147560228|NCT05097989|532207469|FG002|Extended Treatment Period (24 Weeks)|Adverse Event|0|||
147560229|NCT05097989|532207470|FG003|Extended Treatment Period (24 Weeks)|Adverse Event|0|||
147560230|NCT05097989|532207471|FG004|Extended Treatment Period (24 Weeks)|Adverse Event|1|||
147560231|NCT05097989|532207472|FG005|Extended Treatment Period (24 Weeks)|Adverse Event|0|||
147560232|NCT05097989|532207473|FG006|Extended Treatment Period (24 Weeks)|Adverse Event|0|||
147560233|NCT05097989|532207474|FG007|Extended Treatment Period (24 Weeks)|Adverse Event|0|||
147226314|NCT03416374|531002036|FG001|Treatment Period II|Adverse Event|4|||
147226315|NCT03416374|531002035|FG000|Treatment Period II|Death|0|||
147226316|NCT03416374|531002036|FG001|Treatment Period II|Death|1|||
147226317|NCT03416374|531002035|FG000|Treatment Period II|Other|0|||
147226318|NCT03416374|531002036|FG001|Treatment Period II|Other|2|||
147560234|NCT05097989|532207475|FG008|Extended Treatment Period (24 Weeks)|Adverse Event|0|||
147226319|NCT03463031|531002039|FG000|Overall Study|Withdrawal by Subject|4|||
147226320|NCT03463031|531002040|FG001|Overall Study|Withdrawal by Subject|2|||
147560235|NCT05097989|532207467|FG000|Extended Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
147560236|NCT05097989|532207468|FG001|Extended Treatment Period (24 Weeks)|Withdrawal by Subject|3|||
147560237|NCT05097989|532207469|FG002|Extended Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
147560238|NCT05097989|532207470|FG003|Extended Treatment Period (24 Weeks)|Withdrawal by Subject|3|||
147560239|NCT05097989|532207471|FG004|Extended Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
147560240|NCT05097989|532207472|FG005|Extended Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
147560241|NCT05097989|532207473|FG006|Extended Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
147560242|NCT05097989|532207474|FG007|Extended Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
147560243|NCT05097989|532207475|FG008|Extended Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
147560244|NCT05097989|532207467|FG000|Extended Treatment Period (24 Weeks)|Study Terminated by Sponsor|4|||
147560245|NCT05097989|532207468|FG001|Extended Treatment Period (24 Weeks)|Study Terminated by Sponsor|8|||
147560246|NCT05097989|532207469|FG002|Extended Treatment Period (24 Weeks)|Study Terminated by Sponsor|0|||
147560247|NCT05097989|532207470|FG003|Extended Treatment Period (24 Weeks)|Study Terminated by Sponsor|1|||
147560248|NCT05097989|532207471|FG004|Extended Treatment Period (24 Weeks)|Study Terminated by Sponsor|3|||
147560249|NCT05097989|532207472|FG005|Extended Treatment Period (24 Weeks)|Study Terminated by Sponsor|0|||
147560250|NCT05097989|532207473|FG006|Extended Treatment Period (24 Weeks)|Study Terminated by Sponsor|7|||
147560251|NCT05097989|532207474|FG007|Extended Treatment Period (24 Weeks)|Study Terminated by Sponsor|3|||
147560252|NCT05097989|532207475|FG008|Extended Treatment Period (24 Weeks)|Study Terminated by Sponsor|0|||
147560253|NCT05097989|532207467|FG000|Extended Treatment Period (24 Weeks)|Death|0|||
147560254|NCT05097989|532207468|FG001|Extended Treatment Period (24 Weeks)|Death|0|||
147560255|NCT05097989|532207469|FG002|Extended Treatment Period (24 Weeks)|Death|0|||
147560256|NCT05097989|532207470|FG003|Extended Treatment Period (24 Weeks)|Death|0|||
147226321|NCT03463031|531002039|FG000|Overall Study|Investigator/Sponsor Decision|0|||
147226322|NCT03463031|531002040|FG001|Overall Study|Investigator/Sponsor Decision|1|||
147226323|NCT03463031|531002039|FG000|Overall Study|Lost to Follow-up|1|||
147226324|NCT03463031|531002040|FG001|Overall Study|Lost to Follow-up|1|||
147226325|NCT03463031|531002039|FG000|Overall Study|Adverse Event|4|||
147226326|NCT03463031|531002040|FG001|Overall Study|Adverse Event|1|||
147111928|NCT03915067|530572777|FG000|Overall Study|Protocol Deviation|0|||
147111929|NCT03915067|530572778|FG001|Overall Study|Protocol Deviation|0|||
147226327|NCT03463031|531002039|FG000|Overall Study|Use of prohibited medication by subject|1|||
147226328|NCT03463031|531002040|FG001|Overall Study|Use of prohibited medication by subject|0|||
147226329|NCT01068652|531002041|FG000|Overall Study|Adverse Event|4|||
147226330|NCT01068652|531002042|FG001|Overall Study|Adverse Event|0|||
147226331|NCT01068652|531002041|FG000|Overall Study|Lack of Efficacy|0|||
147226332|NCT01068652|531002042|FG001|Overall Study|Lack of Efficacy|2|||
147226333|NCT01068652|531002041|FG000|Overall Study|Lost to Follow-up|2|||
147226334|NCT01068652|531002042|FG001|Overall Study|Lost to Follow-up|1|||
147226335|NCT01068652|531002041|FG000|Overall Study|Protocol Violation|3|||
147226336|NCT01068652|531002042|FG001|Overall Study|Protocol Violation|6|||
147226337|NCT01068652|531002041|FG000|Overall Study|Withdrawal criteria|1|||
147226338|NCT01068652|531002042|FG001|Overall Study|Withdrawal criteria|2|||
147226339|NCT01068652|531002041|FG000|Overall Study|Patient was not eligible|1|||
147226340|NCT01068652|531002042|FG001|Overall Study|Patient was not eligible|0|||
147226341|NCT01068652|531002041|FG000|Overall Study|Unclassified|7|||
147226342|NCT01068652|531002042|FG001|Overall Study|Unclassified|4|||
147226343|NCT00417482|531002043|FG000|Phase B 1st 16 Weeks|Lack of Efficacy|14|||
147226344|NCT00417482|531002044|FG001|Phase B 1st 16 Weeks|Lack of Efficacy|8|||
147226345|NCT00417482|531002045|FG002|Phase B 1st 16 Weeks|Lack of Efficacy|24|||
147226346|NCT00417482|531002043|FG000|Phase B 1st 16 Weeks|Adverse Event|2|||
147226347|NCT00417482|531002044|FG001|Phase B 1st 16 Weeks|Adverse Event|0|||
147226348|NCT00417482|531002045|FG002|Phase B 1st 16 Weeks|Adverse Event|1|||
147226349|NCT00417482|531002043|FG000|Phase B 1st 16 Weeks|Moved, Unclear reasons|2|||
147226350|NCT00417482|531002044|FG001|Phase B 1st 16 Weeks|Moved, Unclear reasons|3|||
147226351|NCT00417482|531002045|FG002|Phase B 1st 16 Weeks|Moved, Unclear reasons|2|||
147226352|NCT00417482|531002043|FG000|Phase B 1st 16 Weeks|Death|1|||
147226353|NCT00417482|531002044|FG001|Phase B 1st 16 Weeks|Death|0|||
147444324|NCT02535715|531792559|FG000|Overall Study|Withdrawal by Subject|0|||
147560257|NCT05097989|532207471|FG004|Extended Treatment Period (24 Weeks)|Death|0|||
147560258|NCT05097989|532207472|FG005|Extended Treatment Period (24 Weeks)|Death|0|||
147560259|NCT05097989|532207473|FG006|Extended Treatment Period (24 Weeks)|Death|0|||
147560260|NCT05097989|532207474|FG007|Extended Treatment Period (24 Weeks)|Death|1|||
147111930|NCT03915067|530572779|FG002|Overall Study|Protocol Deviation|1|||
147111931|NCT03915067|530572777|FG000|Overall Study|Covid-19 Related Issues|2|||
147111932|NCT03915067|530572778|FG001|Overall Study|Covid-19 Related Issues|4|||
147226354|NCT00417482|531002045|FG002|Phase B 1st 16 Weeks|Death|0|||
147226355|NCT00417482|531002043|FG000|Phase B 2nd 16 Weeks|Lack of Efficacy|1|||
147226356|NCT00417482|531002044|FG001|Phase B 2nd 16 Weeks|Lack of Efficacy|12|||
147226357|NCT00417482|531002045|FG002|Phase B 2nd 16 Weeks|Lack of Efficacy|2|||
147226358|NCT00417482|531002043|FG000|Phase B 2nd 16 Weeks|Adverse Event|0|||
147226359|NCT00417482|531002044|FG001|Phase B 2nd 16 Weeks|Adverse Event|0|||
147560261|NCT05097989|532207475|FG008|Extended Treatment Period (24 Weeks)|Death|0|||
147560262|NCT05097989|532207467|FG000|Open-label Extension Period (2 Years)|Adverse Event|0|||
147560263|NCT05097989|532207468|FG001|Open-label Extension Period (2 Years)|Adverse Event|0|||
147560264|NCT05097989|532207469|FG002|Open-label Extension Period (2 Years)|Adverse Event|0|||
147560265|NCT05097989|532207470|FG003|Open-label Extension Period (2 Years)|Adverse Event|0|||
147560266|NCT05097989|532207471|FG004|Open-label Extension Period (2 Years)|Adverse Event|1|||
147560267|NCT05097989|532207472|FG005|Open-label Extension Period (2 Years)|Adverse Event|0|||
147560268|NCT05097989|532207473|FG006|Open-label Extension Period (2 Years)|Adverse Event|0|||
147560269|NCT05097989|532207474|FG007|Open-label Extension Period (2 Years)|Adverse Event|0|||
147560270|NCT05097989|532207475|FG008|Open-label Extension Period (2 Years)|Adverse Event|0|||
147560271|NCT05097989|532207467|FG000|Open-label Extension Period (2 Years)|Withdrawal by Subject|1|||
147560272|NCT05097989|532207468|FG001|Open-label Extension Period (2 Years)|Withdrawal by Subject|2|||
147560273|NCT05097989|532207469|FG002|Open-label Extension Period (2 Years)|Withdrawal by Subject|0|||
147560274|NCT05097989|532207470|FG003|Open-label Extension Period (2 Years)|Withdrawal by Subject|0|||
147560275|NCT05097989|532207471|FG004|Open-label Extension Period (2 Years)|Withdrawal by Subject|0|||
147560276|NCT05097989|532207472|FG005|Open-label Extension Period (2 Years)|Withdrawal by Subject|0|||
147560277|NCT05097989|532207473|FG006|Open-label Extension Period (2 Years)|Withdrawal by Subject|0|||
147560278|NCT05097989|532207474|FG007|Open-label Extension Period (2 Years)|Withdrawal by Subject|0|||
147111933|NCT03915067|530572779|FG002|Overall Study|Covid-19 Related Issues|4|||
147111934|NCT03915067|530572777|FG000|Overall Study|Randomized With Incorrect C-APPS|1|||
147111935|NCT03915067|530572778|FG001|Overall Study|Randomized With Incorrect C-APPS|0|||
147111936|NCT03915067|530572779|FG002|Overall Study|Randomized With Incorrect C-APPS|0|||
147111937|NCT02693418|530572780|FG000|Overall Study|Lost to Follow-up|1|||
147111938|NCT02693418|530572781|FG001|Overall Study|Lost to Follow-up|2|||
147111939|NCT02693418|530572782|FG002|Overall Study|Lost to Follow-up|0|||
147111940|NCT02693418|530572783|FG003|Overall Study|Lost to Follow-up|0|||
147111941|NCT02693418|530572784|FG004|Overall Study|Lost to Follow-up|0|||
147111942|NCT02693418|530572780|FG000|Overall Study|Menses during study period|0|||
147111943|NCT02693418|530572781|FG001|Overall Study|Menses during study period|0|||
147111944|NCT02693418|530572782|FG002|Overall Study|Menses during study period|2|||
147111945|NCT02693418|530572783|FG003|Overall Study|Menses during study period|0|||
147111946|NCT02693418|530572784|FG004|Overall Study|Menses during study period|0|||
147111947|NCT01750346|530572786|FG000|Overall Study|Adverse Event|1|||
147111948|NCT01750346|530572787|FG001|Overall Study|Adverse Event|0|||
147111949|NCT01750346|530572788|FG002|Overall Study|Adverse Event|0|||
147560279|NCT05097989|532207475|FG008|Open-label Extension Period (2 Years)|Withdrawal by Subject|0|||
147560280|NCT05097989|532207467|FG000|Open-label Extension Period (2 Years)|Study Terminated by Sponsor|4|||
147560281|NCT05097989|532207468|FG001|Open-label Extension Period (2 Years)|Study Terminated by Sponsor|12|||
147560282|NCT05097989|532207469|FG002|Open-label Extension Period (2 Years)|Study Terminated by Sponsor|0|||
147560283|NCT05097989|532207470|FG003|Open-label Extension Period (2 Years)|Study Terminated by Sponsor|8|||
147560284|NCT05097989|532207471|FG004|Open-label Extension Period (2 Years)|Study Terminated by Sponsor|5|||
147560285|NCT05097989|532207472|FG005|Open-label Extension Period (2 Years)|Study Terminated by Sponsor|2|||
147560286|NCT05097989|532207473|FG006|Open-label Extension Period (2 Years)|Study Terminated by Sponsor|5|||
147560287|NCT05097989|532207474|FG007|Open-label Extension Period (2 Years)|Study Terminated by Sponsor|0|||
147560288|NCT05097989|532207475|FG008|Open-label Extension Period (2 Years)|Study Terminated by Sponsor|6|||
147560289|NCT00117949|532207483|FG000|Overall Study|Testosterone >1.0 ng/mL|10|||
147560290|NCT00117949|532207484|FG001|Overall Study|Testosterone >1.0 ng/mL|18|||
147560291|NCT00117949|532207485|FG002|Overall Study|Testosterone >1.0 ng/mL|17|||
147560292|NCT00117949|532207486|FG003|Overall Study|Testosterone >1.0 ng/mL|15|||
147560293|NCT00117949|532207483|FG000|Overall Study|Testosterone 0.5 - 1.0 ng/mL|0|||
147560294|NCT00117949|532207484|FG001|Overall Study|Testosterone 0.5 - 1.0 ng/mL|1|||
147560295|NCT00117949|532207485|FG002|Overall Study|Testosterone 0.5 - 1.0 ng/mL|3|||
147560296|NCT00117949|532207486|FG003|Overall Study|Testosterone 0.5 - 1.0 ng/mL|2|||
147560297|NCT00117949|532207483|FG000|Overall Study|Prostate-specific antigen increase >=25%|0|||
147560298|NCT00117949|532207484|FG001|Overall Study|Prostate-specific antigen increase >=25%|1|||
147560299|NCT00117949|532207485|FG002|Overall Study|Prostate-specific antigen increase >=25%|1|||
147560300|NCT00117949|532207486|FG003|Overall Study|Prostate-specific antigen increase >=25%|2|||
147560301|NCT00117949|532207483|FG000|Overall Study|PSA increase >=10ng/mL|0|||
147560302|NCT00117949|532207484|FG001|Overall Study|PSA increase >=10ng/mL|1|||
147560303|NCT00117949|532207485|FG002|Overall Study|PSA increase >=10ng/mL|1|||
147560304|NCT00117949|532207486|FG003|Overall Study|PSA increase >=10ng/mL|0|||
147560305|NCT00117949|532207483|FG000|Overall Study|PSA reduction <=50%|0|||
147111950|NCT01001104|530572789|FG000|Overall Study|Adverse Event|2|||
147560306|NCT00117949|532207484|FG001|Overall Study|PSA reduction <=50%|2|||
147560307|NCT00117949|532207485|FG002|Overall Study|PSA reduction <=50%|2|||
147111951|NCT01001104|530572790|FG001|Overall Study|Adverse Event|1|||
147111952|NCT01001104|530572791|FG002|Overall Study|Adverse Event|0|||
147226360|NCT00417482|531002045|FG002|Phase B 2nd 16 Weeks|Adverse Event|1|||
147111953|NCT01001104|530572792|FG003|Overall Study|Adverse Event|0|||
147111954|NCT01001104|530572789|FG000|Overall Study|Lost to Follow-up|0|||
147560308|NCT00117949|532207486|FG003|Overall Study|PSA reduction <=50%|4|||
147560309|NCT00117949|532207483|FG000|Overall Study|Hepatic abnormalities|0|||
147560310|NCT00117949|532207484|FG001|Overall Study|Hepatic abnormalities|1|||
147560311|NCT00117949|532207485|FG002|Overall Study|Hepatic abnormalities|0|||
147560312|NCT00117949|532207486|FG003|Overall Study|Hepatic abnormalities|1|||
147560313|NCT01658943|532207489|FG000|Overall Study|Adverse Event|6|||
147560314|NCT01658943|532207490|FG001|Overall Study|Adverse Event|13|||
147560315|NCT01658943|532207489|FG000|Overall Study|Withdrawal by Subject|9|||
147560316|NCT01658943|532207490|FG001|Overall Study|Withdrawal by Subject|2|||
147560317|NCT01658943|532207489|FG000|Overall Study|Progression/Relapse|39|||
147560318|NCT01658943|532207490|FG001|Overall Study|Progression/Relapse|40|||
147560319|NCT01658943|532207489|FG000|Overall Study|Death|4|||
147560320|NCT01658943|532207490|FG001|Overall Study|Death|2|||
147560321|NCT01658943|532207489|FG000|Overall Study|not protocol specified|4|||
147560322|NCT01658943|532207490|FG001|Overall Study|not protocol specified|1|||
147560323|NCT01658943|532207489|FG000|Overall Study|Not eligible|7|||
147560324|NCT01658943|532207490|FG001|Overall Study|Not eligible|9|||
147560325|NCT01658943|532207489|FG000|Overall Study|Withdrew prior to beginning protocol Tx|1|||
147560326|NCT01658943|532207490|FG001|Overall Study|Withdrew prior to beginning protocol Tx|0|||
147560327|NCT03309956|532207491|FG000|Overall Study|Devices worn for <24 hrs or >72 hrs, device failing to record, or devices were lost|47|||
147560328|NCT02130466|532207492|FG000|Overall Study|Death|4|||
147560329|NCT02130466|532207493|FG001|Overall Study|Death|1|||
147560330|NCT02130466|532207494|FG002|Overall Study|Death|1|||
147560331|NCT02130466|532207495|FG003|Overall Study|Death|3|||
147560332|NCT02130466|532207496|FG004|Overall Study|Death|2|||
147560333|NCT02130466|532207497|FG005|Overall Study|Death|30|||
147560334|NCT02130466|532207498|FG006|Overall Study|Death|45|||
147560335|NCT02130466|532207499|FG007|Overall Study|Death|2|||
147560336|NCT02130466|532207500|FG008|Overall Study|Death|3|||
147560337|NCT02130466|532207501|FG009|Overall Study|Death|4|||
147560338|NCT02130466|532207502|FG010|Overall Study|Death|5|||
147560339|NCT02130466|532207503|FG011|Overall Study|Death|3|||
147560340|NCT02130466|532207504|FG012|Overall Study|Death|11|||
147560341|NCT02130466|532207505|FG013|Overall Study|Death|7|||
147560342|NCT02130466|532207492|FG000|Overall Study|Lost to Follow-up|1|||
147560343|NCT02130466|532207493|FG001|Overall Study|Lost to Follow-up|0|||
147560344|NCT02130466|532207494|FG002|Overall Study|Lost to Follow-up|0|||
147560345|NCT02130466|532207495|FG003|Overall Study|Lost to Follow-up|0|||
147560346|NCT02130466|532207496|FG004|Overall Study|Lost to Follow-up|0|||
147560347|NCT02130466|532207497|FG005|Overall Study|Lost to Follow-up|1|||
147560348|NCT02130466|532207498|FG006|Overall Study|Lost to Follow-up|0|||
147560349|NCT02130466|532207499|FG007|Overall Study|Lost to Follow-up|0|||
147560350|NCT02130466|532207500|FG008|Overall Study|Lost to Follow-up|0|||
147560351|NCT02130466|532207501|FG009|Overall Study|Lost to Follow-up|0|||
147560352|NCT02130466|532207502|FG010|Overall Study|Lost to Follow-up|0|||
147560353|NCT02130466|532207503|FG011|Overall Study|Lost to Follow-up|0|||
147560354|NCT02130466|532207504|FG012|Overall Study|Lost to Follow-up|1|||
147560355|NCT02130466|532207505|FG013|Overall Study|Lost to Follow-up|0|||
147560356|NCT02130466|532207492|FG000|Overall Study|Physician Decision|0|||
147560357|NCT02130466|532207493|FG001|Overall Study|Physician Decision|0|||
147560358|NCT02130466|532207494|FG002|Overall Study|Physician Decision|0|||
147560359|NCT02130466|532207495|FG003|Overall Study|Physician Decision|0|||
147560360|NCT02130466|532207496|FG004|Overall Study|Physician Decision|0|||
147560361|NCT02130466|532207497|FG005|Overall Study|Physician Decision|1|||
147560362|NCT02130466|532207498|FG006|Overall Study|Physician Decision|1|||
147560363|NCT02130466|532207499|FG007|Overall Study|Physician Decision|0|||
147560364|NCT02130466|532207500|FG008|Overall Study|Physician Decision|0|||
147560365|NCT02130466|532207501|FG009|Overall Study|Physician Decision|0|||
147560366|NCT02130466|532207502|FG010|Overall Study|Physician Decision|0|||
147560367|NCT02130466|532207503|FG011|Overall Study|Physician Decision|0|||
147560368|NCT02130466|532207504|FG012|Overall Study|Physician Decision|0|||
147560369|NCT02130466|532207505|FG013|Overall Study|Physician Decision|0|||
147560370|NCT02130466|532207492|FG000|Overall Study|Participation in Study Discontinued by Sponsor|1|||
147560371|NCT02130466|532207493|FG001|Overall Study|Participation in Study Discontinued by Sponsor|2|||
147560372|NCT02130466|532207494|FG002|Overall Study|Participation in Study Discontinued by Sponsor|1|||
147560373|NCT02130466|532207495|FG003|Overall Study|Participation in Study Discontinued by Sponsor|5|||
147560374|NCT02130466|532207496|FG004|Overall Study|Participation in Study Discontinued by Sponsor|0|||
147560375|NCT02130466|532207497|FG005|Overall Study|Participation in Study Discontinued by Sponsor|27|||
147560376|NCT02130466|532207498|FG006|Overall Study|Participation in Study Discontinued by Sponsor|14|||
147560377|NCT02130466|532207499|FG007|Overall Study|Participation in Study Discontinued by Sponsor|1|||
147560378|NCT02130466|532207500|FG008|Overall Study|Participation in Study Discontinued by Sponsor|0|||
147560379|NCT02130466|532207501|FG009|Overall Study|Participation in Study Discontinued by Sponsor|1|||
147560380|NCT02130466|532207502|FG010|Overall Study|Participation in Study Discontinued by Sponsor|1|||
147560381|NCT02130466|532207503|FG011|Overall Study|Participation in Study Discontinued by Sponsor|0|||
147560382|NCT02130466|532207504|FG012|Overall Study|Participation in Study Discontinued by Sponsor|0|||
147560383|NCT02130466|532207505|FG013|Overall Study|Participation in Study Discontinued by Sponsor|2|||
147560384|NCT02130466|532207492|FG000|Overall Study|Withdrawal by Subject|1|||
147560385|NCT02130466|532207493|FG001|Overall Study|Withdrawal by Subject|0|||
147560386|NCT02130466|532207494|FG002|Overall Study|Withdrawal by Subject|0|||
147560387|NCT02130466|532207495|FG003|Overall Study|Withdrawal by Subject|0|||
147560388|NCT02130466|532207496|FG004|Overall Study|Withdrawal by Subject|0|||
147560389|NCT02130466|532207497|FG005|Overall Study|Withdrawal by Subject|1|||
147560390|NCT02130466|532207498|FG006|Overall Study|Withdrawal by Subject|0|||
147560391|NCT02130466|532207499|FG007|Overall Study|Withdrawal by Subject|0|||
147560392|NCT02130466|532207500|FG008|Overall Study|Withdrawal by Subject|1|||
147560393|NCT02130466|532207501|FG009|Overall Study|Withdrawal by Subject|0|||
147560394|NCT02130466|532207502|FG010|Overall Study|Withdrawal by Subject|0|||
147560395|NCT02130466|532207503|FG011|Overall Study|Withdrawal by Subject|0|||
147560396|NCT02130466|532207504|FG012|Overall Study|Withdrawal by Subject|0|||
147560397|NCT02130466|532207505|FG013|Overall Study|Withdrawal by Subject|0|||
147560398|NCT04529109|532207506|FG000|Period 1|Unsatisfactory Lens Fitting due to Test Article|0|||
147560399|NCT04529109|532207507|FG001|Period 1|Unsatisfactory Lens Fitting due to Test Article|1|||
147560400|NCT01922349|532207508|FG000|Multiple Rising Dose (MRD) Period|Adverse Event|0|||
147560401|NCT01922349|532207509|FG001|Multiple Rising Dose (MRD) Period|Adverse Event|0|||
147560402|NCT01922349|532207510|FG002|Multiple Rising Dose (MRD) Period|Adverse Event|0|||
147560403|NCT01922349|532207511|FG003|Multiple Rising Dose (MRD) Period|Adverse Event|1|||
147560404|NCT00922779|532207512|FG000|Overall Study|Adverse Event|67|||
147560405|NCT00922779|532207512|FG000|Overall Study|Pregnancy|7|||
147560406|NCT00922779|532207512|FG000|Overall Study|Withdrawal by Subject|308|||
147560407|NCT00922779|532207512|FG000|Overall Study|Lost to Follow-up|44|||
147111955|NCT01001104|530572790|FG001|Overall Study|Lost to Follow-up|0|||
147111956|NCT01001104|530572791|FG002|Overall Study|Lost to Follow-up|1|||
147111957|NCT01001104|530572792|FG003|Overall Study|Lost to Follow-up|0|||
147111958|NCT01001104|530572789|FG000|Overall Study|Entry Criteria Not Met|0|||
147111959|NCT01001104|530572790|FG001|Overall Study|Entry Criteria Not Met|0|||
147111960|NCT01001104|530572791|FG002|Overall Study|Entry Criteria Not Met|0|||
147111961|NCT01001104|530572792|FG003|Overall Study|Entry Criteria Not Met|1|||
147111962|NCT01001104|530572789|FG000|Overall Study|Withdrawal by Subject|0|||
147111963|NCT01001104|530572790|FG001|Overall Study|Withdrawal by Subject|0|||
147111964|NCT01001104|530572791|FG002|Overall Study|Withdrawal by Subject|0|||
147111965|NCT01001104|530572792|FG003|Overall Study|Withdrawal by Subject|2|||
147111966|NCT00599313|530572795|FG000|Overall Study|Adverse Event|19|||
147111967|NCT00599313|530572795|FG000|Overall Study|Disease Progression|12|||
147111968|NCT00599313|530572795|FG000|Overall Study|Patient Request|4|||
147111969|NCT00599313|530572795|FG000|Overall Study|Ineligible|1|||
147111970|NCT01793935|530572796|FG000|Overall Study|Pregnancy|1|||
147111971|NCT01793935|530572797|FG001|Overall Study|Pregnancy|0|||
147111972|NCT01793935|530572796|FG000|Overall Study|Protocol Violation|2|||
147111973|NCT01793935|530572797|FG001|Overall Study|Protocol Violation|1|||
147111974|NCT01793935|530572796|FG000|Overall Study|Adverse Event|2|||
147111975|NCT01793935|530572797|FG001|Overall Study|Adverse Event|0|||
147111976|NCT01793935|530572796|FG000|Overall Study|Patient did not take study medication|1|||
147111977|NCT01793935|530572797|FG001|Overall Study|Patient did not take study medication|1|||
147111978|NCT01793935|530572796|FG000|Overall Study|Lost to Follow-up|0|||
147111979|NCT01793935|530572797|FG001|Overall Study|Lost to Follow-up|1|||
147111980|NCT01121926|530572798|FG000|First Intervention Period|Adverse Event|1|||
147111981|NCT01121926|530572799|FG001|First Intervention Period|Adverse Event|0|||
147111982|NCT01121926|530572798|FG000|Washout Period|Adverse Event|0|||
147111983|NCT01121926|530572799|FG001|Washout Period|Adverse Event|1|||
147226361|NCT00417482|531002043|FG000|Phase B 2nd 16 Weeks|Moved; unclear reason|1|||
147226362|NCT00417482|531002044|FG001|Phase B 2nd 16 Weeks|Moved; unclear reason|0|||
147560408|NCT00922779|532207512|FG000|Overall Study|Other|27|||
147560409|NCT00922779|532207512|FG000|Overall Study|Missing|1874|||
147560410|NCT00993616|532207513|FG000|Overall Study|No tumor at entry|1|||
147560411|NCT00993616|532207513|FG000|Overall Study|Never treated|1|||
147560412|NCT05067504|532207514|FG000|Period 2 (Day 180)|Lost to Follow-up|0|||
147560413|NCT05067504|532207515|FG001|Period 2 (Day 180)|Lost to Follow-up|1|||
147560414|NCT05067504|532207514|FG000|Period 2 (Day 180)|Withdrawal by Subject|1|||
147111984|NCT01121926|530572798|FG000|Washout Period|Positive pregnancy test|0|||
147111985|NCT01121926|530572799|FG001|Washout Period|Positive pregnancy test|1|||
147226363|NCT00417482|531002045|FG002|Phase B 2nd 16 Weeks|Moved; unclear reason|0|||
147226364|NCT00417482|531002043|FG000|Phase B 2nd 16 Weeks|Death|1|||
147226365|NCT00417482|531002044|FG001|Phase B 2nd 16 Weeks|Death|1|||
147560415|NCT05067504|532207515|FG001|Period 2 (Day 180)|Withdrawal by Subject|0|||
147560416|NCT05067504|532207514|FG000|Period 2 (Day 180)|Not reconsented for Period 2|3|||
147560417|NCT05067504|532207515|FG001|Period 2 (Day 180)|Not reconsented for Period 2|0|||
147560418|NCT03805438|532208856|FG000|Overall Study|Lack of Efficacy|1|||
147560419|NCT03805438|532208856|FG000|Overall Study|Protocol Violation|1|||
147560420|NCT01374919|532208857|FG000|Overall Study|Withdrawal by Subject|2|||
147111986|NCT02782468|530572800|FG000|Overall Study|Progressive Disease|2|||
147111987|NCT02782468|530572801|FG001|Overall Study|Progressive Disease|5|||
147111988|NCT02782468|530572802|FG002|Overall Study|Progressive Disease|0|||
147111989|NCT02782468|530572803|FG003|Overall Study|Progressive Disease|4|||
147560421|NCT00366899|532208858|FG000|Infant Series|Withdrawal by Subject|4|||
147560422|NCT00366899|532208859|FG001|Infant Series|Withdrawal by Subject|7|||
147560423|NCT00366899|532208858|FG000|Infant Series|Protocol Violation|2|||
147560424|NCT00366899|532208859|FG001|Infant Series|Protocol Violation|1|||
147560425|NCT00366899|532208858|FG000|Infant Series|Failed to return|1|||
147560426|NCT00366899|532208859|FG001|Infant Series|Failed to return|1|||
147560427|NCT00366899|532208858|FG000|Infant Series|Lost to Follow-up|0|||
147560428|NCT00366899|532208859|FG001|Infant Series|Lost to Follow-up|2|||
147560429|NCT00366899|532208858|FG000|Infant Series|Adverse Event|0|||
147560430|NCT00366899|532208859|FG001|Infant Series|Adverse Event|1|||
147560431|NCT00366899|532208858|FG000|Infant Series|Physician Decision|1|||
147560432|NCT00366899|532208859|FG001|Infant Series|Physician Decision|0|||
147560433|NCT00366899|532208858|FG000|Infant Series|Randomized but not consented|1|||
147560434|NCT00366899|532208859|FG001|Infant Series|Randomized but not consented|0|||
147560435|NCT00366899|532208858|FG000|After Infant Series|Lost to Follow-up|4|||
147560436|NCT00366899|532208859|FG001|After Infant Series|Lost to Follow-up|3|||
147560437|NCT00366899|532208858|FG000|After Infant Series|Withdrawal by Subject|1|||
147560438|NCT00366899|532208859|FG001|After Infant Series|Withdrawal by Subject|4|||
147560439|NCT00366899|532208858|FG000|After Infant Series|Adverse Event|1|||
147560440|NCT00366899|532208859|FG001|After Infant Series|Adverse Event|2|||
147560441|NCT00366899|532208858|FG000|After Infant Series|Protocol Violation|1|||
147560442|NCT00366899|532208859|FG001|After Infant Series|Protocol Violation|0|||
147560443|NCT00366899|532208858|FG000|Toddler Dose|Withdrawal by Subject|1|||
147560444|NCT00366899|532208859|FG001|Toddler Dose|Withdrawal by Subject|1|||
147560445|NCT00366899|532208858|FG000|Toddler Dose|Protocol Violation|1|||
147560446|NCT00366899|532208859|FG001|Toddler Dose|Protocol Violation|0|||
147560447|NCT01619800|532208860|FG000|Overall Study|study terminated|2|||
147560448|NCT01619800|532208861|FG001|Overall Study|study terminated|0|||
147560449|NCT02848326|532208862|FG000|Treatment Period|Adverse Event|5|||
147560450|NCT02848326|532208863|FG001|Treatment Period|Adverse Event|4|||
147560451|NCT02848326|532208864|FG002|Treatment Period|Adverse Event|11|||
147560452|NCT02848326|532208865|FG003|Treatment Period|Adverse Event|6|||
147560453|NCT02848326|532208866|FG004|Treatment Period|Adverse Event|5|||
147560454|NCT02848326|532208867|FG005|Treatment Period|Adverse Event|7|||
147560455|NCT02848326|532208862|FG000|Treatment Period|Withdrawal of Consent|20|||
147560456|NCT02848326|532208863|FG001|Treatment Period|Withdrawal of Consent|6|||
147560457|NCT02848326|532208864|FG002|Treatment Period|Withdrawal of Consent|9|||
147560458|NCT02848326|532208865|FG003|Treatment Period|Withdrawal of Consent|6|||
147560459|NCT02848326|532208866|FG004|Treatment Period|Withdrawal of Consent|9|||
147560460|NCT02848326|532208867|FG005|Treatment Period|Withdrawal of Consent|6|||
147560461|NCT02848326|532208862|FG000|Treatment Period|Lost to Follow-up|5|||
147560462|NCT02848326|532208863|FG001|Treatment Period|Lost to Follow-up|1|||
147560463|NCT02848326|532208864|FG002|Treatment Period|Lost to Follow-up|11|||
147560464|NCT02848326|532208865|FG003|Treatment Period|Lost to Follow-up|7|||
147560465|NCT02848326|532208866|FG004|Treatment Period|Lost to Follow-up|2|||
147560466|NCT02848326|532208867|FG005|Treatment Period|Lost to Follow-up|3|||
147560467|NCT02848326|532208862|FG000|Treatment Period|Pregnancy|0|||
147560468|NCT02848326|532208863|FG001|Treatment Period|Pregnancy|0|||
147560469|NCT02848326|532208864|FG002|Treatment Period|Pregnancy|1|||
147560470|NCT02848326|532208865|FG003|Treatment Period|Pregnancy|1|||
147560471|NCT02848326|532208866|FG004|Treatment Period|Pregnancy|0|||
147560472|NCT02848326|532208867|FG005|Treatment Period|Pregnancy|1|||
147560473|NCT02848326|532208862|FG000|Treatment Period|Protocol Violation|4|||
147560474|NCT02848326|532208863|FG001|Treatment Period|Protocol Violation|3|||
147560475|NCT02848326|532208864|FG002|Treatment Period|Protocol Violation|4|||
147560476|NCT02848326|532208865|FG003|Treatment Period|Protocol Violation|2|||
147560477|NCT02848326|532208866|FG004|Treatment Period|Protocol Violation|3|||
147560478|NCT02848326|532208867|FG005|Treatment Period|Protocol Violation|3|||
147311086|NCT04789577|531307087|FG006|Overall Study|AE Requiring Expedited Reporting|0|||
147311087|NCT01275196|531307088|FG000|Overall Study|Adverse Event|3|||
147560479|NCT02848326|532208862|FG000|Treatment Period|Non-compliance with Study Drug|4|||
147560480|NCT02848326|532208863|FG001|Treatment Period|Non-compliance with Study Drug|0|||
147560481|NCT02848326|532208864|FG002|Treatment Period|Non-compliance with Study Drug|0|||
147560482|NCT02848326|532208865|FG003|Treatment Period|Non-compliance with Study Drug|1|||
147560483|NCT02848326|532208866|FG004|Treatment Period|Non-compliance with Study Drug|0|||
147560484|NCT02848326|532208867|FG005|Treatment Period|Non-compliance with Study Drug|0|||
147560485|NCT02848326|532208862|FG000|Safety Follow-up Period|Withdrawal of Consent|0|||
147560486|NCT02848326|532208863|FG001|Safety Follow-up Period|Withdrawal of Consent|1|||
147560487|NCT02848326|532208864|FG002|Safety Follow-up Period|Withdrawal of Consent|1|||
147560488|NCT02848326|532208865|FG003|Safety Follow-up Period|Withdrawal of Consent|0|||
147560489|NCT02848326|532208866|FG004|Safety Follow-up Period|Withdrawal of Consent|0|||
147560490|NCT02848326|532208867|FG005|Safety Follow-up Period|Withdrawal of Consent|2|||
147560491|NCT02848326|532208862|FG000|Safety Follow-up Period|Lost to Follow-up|4|||
147560492|NCT02848326|532208863|FG001|Safety Follow-up Period|Lost to Follow-up|0|||
147560493|NCT02848326|532208864|FG002|Safety Follow-up Period|Lost to Follow-up|2|||
147560494|NCT02848326|532208865|FG003|Safety Follow-up Period|Lost to Follow-up|0|||
147111990|NCT02782468|530572800|FG000|Overall Study|Adverse Event|0|||
147111991|NCT02782468|530572801|FG001|Overall Study|Adverse Event|2|||
147560495|NCT02848326|532208866|FG004|Safety Follow-up Period|Lost to Follow-up|1|||
147560496|NCT02848326|532208867|FG005|Safety Follow-up Period|Lost to Follow-up|3|||
147111992|NCT02782468|530572802|FG002|Overall Study|Adverse Event|2|||
147111993|NCT02782468|530572803|FG003|Overall Study|Adverse Event|3|||
147111994|NCT02782468|530572800|FG000|Overall Study|Other|0|||
147560497|NCT00414466|532208868|FG000|Overall Study|Adverse Event|0|||
147560498|NCT00414466|532208869|FG001|Overall Study|Adverse Event|0|||
147560499|NCT00414466|532208870|FG002|Overall Study|Adverse Event|1|||
147560500|NCT00414466|532208871|FG003|Overall Study|Adverse Event|1|||
147560501|NCT00414466|532208868|FG000|Overall Study|Lack of Efficacy|1|||
147560502|NCT00414466|532208869|FG001|Overall Study|Lack of Efficacy|0|||
147560503|NCT00414466|532208870|FG002|Overall Study|Lack of Efficacy|0|||
147560504|NCT00414466|532208871|FG003|Overall Study|Lack of Efficacy|0|||
147560505|NCT00414466|532208868|FG000|Overall Study|Withdrawn by Sponsor|1|||
147560506|NCT00414466|532208869|FG001|Overall Study|Withdrawn by Sponsor|0|||
147560507|NCT00414466|532208870|FG002|Overall Study|Withdrawn by Sponsor|0|||
147560508|NCT00414466|532208871|FG003|Overall Study|Withdrawn by Sponsor|0|||
147560509|NCT03480425|532208873|FG000|Overall Study|Force transducer technical failure|1|||
147560510|NCT01451762|532208874|FG000|Overall Study|Lost to Follow-up|3|||
147560511|NCT01451762|532208875|FG001|Overall Study|Lost to Follow-up|6|||
147560512|NCT01451762|532208876|FG002|Overall Study|Lost to Follow-up|6|||
147560513|NCT00630305|532208880|FG000|Overall Study|Withdrawal by Subject|1|||
147560514|NCT00630305|532208880|FG000|Overall Study|Inability to insert contact lens|1|||
147560515|NCT01085045|532208881|FG000|Part A|Withdrawal by Subject|4|||
147560516|NCT01085045|532208881|FG000|Part A|Adverse Event|6|||
147560517|NCT01085045|532208881|FG000|Part A|Protocol Violation|1|||
147560518|NCT01085045|532208881|FG000|Part A|Protocol Specified Criteria|7|||
147560519|NCT01085045|532208881|FG000|Part B|Withdrawal by Subject|2|||
147560520|NCT01085045|532208881|FG000|Part B|Protocol Specified Criteria|6|||
147560521|NCT01085045|532208881|FG000|Part B|Lost to Follow-up|1|||
147560522|NCT01085045|532208881|FG000|Part B|Adverse Event|6|||
147560523|NCT02395822|532208885|FG000|Overall Study|Withdrawal by Subject|1|||
147560524|NCT02395822|532208885|FG000|Overall Study|Death|1|||
147560525|NCT02127281|532208886|FG000|Overall Study|Lost to Follow-up|1|||
147560526|NCT02127281|532208887|FG001|Overall Study|Lost to Follow-up|0|||
147560527|NCT04510857|532208888|FG000|Overall Study|Withdrawal by Subject|1|||
147560528|NCT04510857|532208889|FG001|Overall Study|Withdrawal by Subject|2|||
147560529|NCT02564263|532208892|FG000|Overall Study|Adverse Event|31|||
147560530|NCT02564263|532208893|FG001|Overall Study|Adverse Event|29|||
147560531|NCT02564263|532208892|FG000|Overall Study|Death|270|||
147560532|NCT02564263|532208893|FG001|Overall Study|Death|262|||
147560533|NCT02564263|532208892|FG000|Overall Study|Withdrawal by Subject|4|||
147111995|NCT02782468|530572801|FG001|Overall Study|Other|0|||
147111996|NCT02782468|530572802|FG002|Overall Study|Other|1|||
147111997|NCT02782468|530572803|FG003|Overall Study|Other|1|||
147111998|NCT02782468|530572800|FG000|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|0|||
147111999|NCT02782468|530572801|FG001|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|0|||
147112000|NCT02782468|530572802|FG002|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|0|||
147112001|NCT02782468|530572803|FG003|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|1|||
147112002|NCT02782468|530572800|FG000|Overall Study|Symptomatic Deterioration|0|||
147112003|NCT02782468|530572801|FG001|Overall Study|Symptomatic Deterioration|0|||
147112004|NCT02782468|530572802|FG002|Overall Study|Symptomatic Deterioration|0|||
147112005|NCT02782468|530572803|FG003|Overall Study|Symptomatic Deterioration|1|||
147112006|NCT02782468|530572800|FG000|Overall Study|Withdrawal by Subject|1|||
147112007|NCT02782468|530572801|FG001|Overall Study|Withdrawal by Subject|0|||
147112008|NCT02782468|530572802|FG002|Overall Study|Withdrawal by Subject|0|||
147112009|NCT02782468|530572803|FG003|Overall Study|Withdrawal by Subject|0|||
147112010|NCT00356590|530572810|FG000|Overall Study|Adverse Event|54|||
147112011|NCT00356590|530572810|FG000|Overall Study|Death|10|||
147226366|NCT00417482|531002045|FG002|Phase B 2nd 16 Weeks|Death|0|||
147112012|NCT00356590|530572810|FG000|Overall Study|Lost to Follow-up|35|||
147226367|NCT03739840|531002046|FG000|Treatment Period: Wk0-16|Adverse Event|2|||
147226368|NCT03739840|531002047|FG001|Treatment Period: Wk0-16|Adverse Event|6|||
147112013|NCT00356590|530572810|FG000|Overall Study|Physician Decision|46|||
147112014|NCT00356590|530572810|FG000|Overall Study|Withdrawal by Subject|41|||
147226369|NCT03739840|531002048|FG002|Treatment Period: Wk0-16|Adverse Event|6|||
147560534|NCT02564263|532208893|FG001|Overall Study|Withdrawal by Subject|19|||
147560535|NCT02564263|532208892|FG000|Overall Study|Sponsor's decision|9|||
147560536|NCT02564263|532208893|FG001|Overall Study|Sponsor's decision|4|||
147560537|NCT00920140|532208894|FG000|Phase 1 (Dose Escalation)|Adverse Event|3|||
147560538|NCT00920140|532208895|FG001|Phase 1 (Dose Escalation)|Adverse Event|3|||
147560539|NCT00920140|532208896|FG002|Phase 1 (Dose Escalation)|Adverse Event|0|||
147560540|NCT00920140|532208897|FG003|Phase 1 (Dose Escalation)|Adverse Event|0|||
147560541|NCT00920140|532208898|FG004|Phase 1 (Dose Escalation)|Adverse Event|0|||
147560542|NCT00920140|532208894|FG000|Phase 1 (Dose Escalation)|Lack of Efficacy|2|||
147560543|NCT00920140|532208895|FG001|Phase 1 (Dose Escalation)|Lack of Efficacy|4|||
147560544|NCT00920140|532208896|FG002|Phase 1 (Dose Escalation)|Lack of Efficacy|0|||
147560545|NCT00920140|532208897|FG003|Phase 1 (Dose Escalation)|Lack of Efficacy|0|||
147560546|NCT00920140|532208898|FG004|Phase 1 (Dose Escalation)|Lack of Efficacy|0|||
147560547|NCT00920140|532208894|FG000|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
147560548|NCT00920140|532208895|FG001|Phase 1 (Dose Escalation)|Withdrawal by Subject|2|||
147560549|NCT00920140|532208896|FG002|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
147560550|NCT00920140|532208897|FG003|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
147560551|NCT00920140|532208898|FG004|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
147560552|NCT00920140|532208894|FG000|Phase 2|Adverse Event|0|||
147560553|NCT00920140|532208895|FG001|Phase 2|Adverse Event|0|||
147560554|NCT00920140|532208896|FG002|Phase 2|Adverse Event|14|||
147560555|NCT00920140|532208897|FG003|Phase 2|Adverse Event|2|||
147560556|NCT00920140|532208898|FG004|Phase 2|Adverse Event|3|||
147560557|NCT00920140|532208894|FG000|Phase 2|Lack of Efficacy|0|||
147560558|NCT00920140|532208895|FG001|Phase 2|Lack of Efficacy|0|||
147560559|NCT00920140|532208896|FG002|Phase 2|Lack of Efficacy|29|||
147560560|NCT00920140|532208897|FG003|Phase 2|Lack of Efficacy|14|||
147560561|NCT00920140|532208898|FG004|Phase 2|Lack of Efficacy|5|||
147560562|NCT00920140|532208894|FG000|Phase 2|Lost to Follow-up|0|||
147560563|NCT00920140|532208895|FG001|Phase 2|Lost to Follow-up|0|||
147560564|NCT00920140|532208896|FG002|Phase 2|Lost to Follow-up|0|||
147560565|NCT00920140|532208897|FG003|Phase 2|Lost to Follow-up|1|||
147560566|NCT00920140|532208898|FG004|Phase 2|Lost to Follow-up|0|||
147560567|NCT00920140|532208894|FG000|Phase 2|Physician Decision|0|||
147560568|NCT00920140|532208895|FG001|Phase 2|Physician Decision|0|||
147560569|NCT00920140|532208896|FG002|Phase 2|Physician Decision|3|||
147560570|NCT00920140|532208897|FG003|Phase 2|Physician Decision|3|||
147560571|NCT00920140|532208898|FG004|Phase 2|Physician Decision|2|||
147560572|NCT00920140|532208894|FG000|Phase 2|Withdrawal by Subject|0|||
147560573|NCT00920140|532208895|FG001|Phase 2|Withdrawal by Subject|0|||
147560574|NCT00920140|532208896|FG002|Phase 2|Withdrawal by Subject|4|||
147112015|NCT00356590|530572810|FG000|Overall Study|Completed month 12 only|2|||
147112016|NCT00356590|530572810|FG000|Overall Study|Protocol issues|6|||
147112017|NCT00356590|530572810|FG000|Overall Study|Response status|28|||
147112018|NCT00356590|530572810|FG000|Overall Study|Other|52|||
147112019|NCT03439514|530572817|FG000|Double-Blind Treatment Period|Other|4|||
147112020|NCT03439514|530572818|FG001|Double-Blind Treatment Period|Other|1|||
147112021|NCT03439514|530572817|FG000|Double-Blind Treatment Period|Withdrawal by Subject|4|||
147112022|NCT03439514|530572818|FG001|Double-Blind Treatment Period|Withdrawal by Subject|2|||
147112023|NCT03439514|530572817|FG000|Double-Blind Treatment Period|Study Termination by Sponsor|29|||
147112024|NCT03439514|530572818|FG001|Double-Blind Treatment Period|Study Termination by Sponsor|32|||
147112025|NCT03439514|530572817|FG000|Double-Blind Treatment Period|Lost to Follow-up|2|||
147112026|NCT03439514|530572818|FG001|Double-Blind Treatment Period|Lost to Follow-up|0|||
147112027|NCT03439514|530572817|FG000|Double-Blind Treatment Period|Death|1|||
147112028|NCT03439514|530572818|FG001|Double-Blind Treatment Period|Death|2|||
147112029|NCT02175758|530572819|FG000|Treatment Phase|Lost to Follow-up|0|||
147112030|NCT02175758|530572820|FG001|Treatment Phase|Lost to Follow-up|1|||
147112031|NCT02175758|530572821|FG002|Treatment Phase|Lost to Follow-up|0|||
147112032|NCT02175758|530572822|FG003|Treatment Phase|Lost to Follow-up|0|||
147112033|NCT02175758|530572823|FG004|Treatment Phase|Lost to Follow-up|0|||
147112034|NCT02175758|530572824|FG005|Treatment Phase|Lost to Follow-up|0|||
147112035|NCT02175758|530572819|FG000|Treatment Phase|Adverse Event|0|||
147112036|NCT02175758|530572820|FG001|Treatment Phase|Adverse Event|0|||
147112037|NCT02175758|530572821|FG002|Treatment Phase|Adverse Event|0|||
147112038|NCT02175758|530572822|FG003|Treatment Phase|Adverse Event|0|||
147112039|NCT02175758|530572823|FG004|Treatment Phase|Adverse Event|1|||
147112040|NCT02175758|530572824|FG005|Treatment Phase|Adverse Event|0|||
147112041|NCT02299167|530572825|FG000|Overall Study|patients were excluded from the study|11|||
147112042|NCT04398134|530572826|FG000|Overall Study|Adverse Event|0|||
147560575|NCT00920140|532208897|FG003|Phase 2|Withdrawal by Subject|2|||
147560576|NCT00920140|532208898|FG004|Phase 2|Withdrawal by Subject|1|||
147560577|NCT01124149|532208899|FG000|Acute Phase|Withdrawal by Subject|22|||
147560578|NCT01124149|532208899|FG000|Acute Phase|Adverse Event|21|||
147444325|NCT02535715|531792560|FG001|Overall Study|Withdrawal by Subject|0|||
147560579|NCT01124149|532208899|FG000|Acute Phase|Lack of Efficacy|17|||
147112043|NCT04398134|530572827|FG001|Overall Study|Adverse Event|0|||
147112044|NCT04398134|530572828|FG002|Overall Study|Adverse Event|1|||
147444326|NCT02535715|531792561|FG002|Overall Study|Withdrawal by Subject|1|||
147112045|NCT04398134|530572829|FG003|Overall Study|Adverse Event|0|||
147112046|NCT04398134|530572826|FG000|Overall Study|Withdrawal by Subject|2|||
147311088|NCT01275196|531307089|FG001|Overall Study|Adverse Event|5|||
147560580|NCT01124149|532208899|FG000|Acute Phase|Protocol Violation|14|||
147560581|NCT01124149|532208899|FG000|Acute Phase|Lost to Follow-up|2|||
147560582|NCT01124149|532208899|FG000|Acute Phase|Prolonged antibiotic therapy|1|||
147560583|NCT01124149|532208899|FG000|Acute Phase|Sponsor request|1|||
147560584|NCT01124149|532208899|FG000|Acute Phase|UC symptoms not ameliorated|1|||
147560585|NCT01124149|532208899|FG000|Acute Phase|Non-compliance|1|||
147560586|NCT01124149|532208899|FG000|Acute Phase|Low hemoglobin|1|||
147560587|NCT01124149|532208899|FG000|Acute Phase|Travelling to another country|1|||
147112047|NCT04398134|530572827|FG001|Overall Study|Withdrawal by Subject|0|||
147112048|NCT04398134|530572828|FG002|Overall Study|Withdrawal by Subject|0|||
147112049|NCT04398134|530572829|FG003|Overall Study|Withdrawal by Subject|1|||
147112050|NCT04398134|530572826|FG000|Overall Study|Study Terminated by Sponsor|30|||
147112051|NCT04398134|530572827|FG001|Overall Study|Study Terminated by Sponsor|11|||
147112052|NCT04398134|530572828|FG002|Overall Study|Study Terminated by Sponsor|32|||
147112053|NCT04398134|530572829|FG003|Overall Study|Study Terminated by Sponsor|11|||
147112054|NCT03506477|530572836|FG000|Overall Study|Withdrawal by Subject|1|||
147112055|NCT03506477|530572837|FG001|Overall Study|Withdrawal by Subject|0|||
147112056|NCT03462680|530572838|FG000|Overall Study|Withdrawal by Subject|3|||
147112057|NCT03462680|530572839|FG001|Overall Study|Withdrawal by Subject|5|||
147311089|NCT01275196|531307088|FG000|Overall Study|Withdrawal by Subject|4|||
147311090|NCT01275196|531307089|FG001|Overall Study|Withdrawal by Subject|5|||
147311091|NCT01275196|531307088|FG000|Overall Study|Lost to Follow-up|1|||
147311092|NCT01275196|531307089|FG001|Overall Study|Lost to Follow-up|0|||
147560588|NCT01124149|532208899|FG000|Acute Phase|Sponsor decision|1|||
147560589|NCT01124149|532208899|FG000|Maintenance Phase|Lack of Efficacy|40|||
147560590|NCT01124149|532208899|FG000|Maintenance Phase|Adverse Event|24|||
147560591|NCT01124149|532208899|FG000|Maintenance Phase|Lost to Follow-up|15|||
147560592|NCT01124149|532208899|FG000|Maintenance Phase|Withdrawal by Subject|10|||
147560593|NCT01124149|532208899|FG000|Maintenance Phase|Protocol Violation|5|||
147560594|NCT01124149|532208899|FG000|Maintenance Phase|Coordinator error|1|||
147560595|NCT01124149|532208899|FG000|Maintenance Phase|Non-compliance|1|||
147560596|NCT01644500|532208900|FG000|Overall Study|Adverse Event|6|||
147560597|NCT01644500|532208901|FG001|Overall Study|Adverse Event|1|||
147560598|NCT01644500|532208902|FG002|Overall Study|Adverse Event|2|||
147560599|NCT01644500|532208900|FG000|Overall Study|Death|0|||
147560600|NCT01644500|532208901|FG001|Overall Study|Death|1|||
147311093|NCT01275196|531307088|FG000|Overall Study|Disease Progression|6|||
147444327|NCT00909181|531792562|FG000|Overall Study|Lost to Follow-up|39|||
147560601|NCT01644500|532208902|FG002|Overall Study|Death|0|||
147560602|NCT01644500|532208900|FG000|Overall Study|Lost to Follow-up|3|||
147560603|NCT01644500|532208901|FG001|Overall Study|Lost to Follow-up|8|||
147560604|NCT01644500|532208902|FG002|Overall Study|Lost to Follow-up|0|||
147560605|NCT01644500|532208900|FG000|Overall Study|Protocol Violation|1|||
147560606|NCT01644500|532208901|FG001|Overall Study|Protocol Violation|1|||
147560607|NCT01644500|532208902|FG002|Overall Study|Protocol Violation|0|||
147560608|NCT01644500|532208900|FG000|Overall Study|Withdrawal by Subject|11|||
147560609|NCT01644500|532208901|FG001|Overall Study|Withdrawal by Subject|12|||
147560610|NCT01644500|532208902|FG002|Overall Study|Withdrawal by Subject|12|||
147560611|NCT01644500|532208900|FG000|Overall Study|Physician Decision|1|||
147560612|NCT01644500|532208901|FG001|Overall Study|Physician Decision|1|||
147560613|NCT01644500|532208902|FG002|Overall Study|Physician Decision|1|||
147560614|NCT00720096|532208909|FG000|Overall Study|Withdrawal by Subject|0|||
147560615|NCT00720096|532208910|FG001|Overall Study|Withdrawal by Subject|2|||
147226370|NCT03739840|531002049|FG003|Treatment Period: Wk0-16|Adverse Event|12|||
147226371|NCT03739840|531002046|FG000|Treatment Period: Wk0-16|Lack of Efficacy|0|||
147226372|NCT03739840|531002047|FG001|Treatment Period: Wk0-16|Lack of Efficacy|1|||
147226373|NCT03739840|531002048|FG002|Treatment Period: Wk0-16|Lack of Efficacy|0|||
147226374|NCT03739840|531002049|FG003|Treatment Period: Wk0-16|Lack of Efficacy|3|||
147226375|NCT03739840|531002046|FG000|Treatment Period: Wk0-16|Protocol Violation|0|||
147226376|NCT03739840|531002047|FG001|Treatment Period: Wk0-16|Protocol Violation|0|||
147226377|NCT03739840|531002048|FG002|Treatment Period: Wk0-16|Protocol Violation|1|||
147226378|NCT03739840|531002049|FG003|Treatment Period: Wk0-16|Protocol Violation|0|||
147226379|NCT03739840|531002046|FG000|Treatment Period: Wk0-16|Consent Withdrawn|1|||
147226380|NCT03739840|531002047|FG001|Treatment Period: Wk0-16|Consent Withdrawn|3|||
147226381|NCT03739840|531002048|FG002|Treatment Period: Wk0-16|Consent Withdrawn|1|||
147226382|NCT03739840|531002049|FG003|Treatment Period: Wk0-16|Consent Withdrawn|1|||
147226383|NCT03739840|531002046|FG000|Treatment Period: Wk0-16|Program Termination|3|||
147226384|NCT03739840|531002047|FG001|Treatment Period: Wk0-16|Program Termination|0|||
147226385|NCT03739840|531002048|FG002|Treatment Period: Wk0-16|Program Termination|1|||
147226386|NCT03739840|531002049|FG003|Treatment Period: Wk0-16|Program Termination|1|||
147226387|NCT03739840|531002046|FG000|Treatment Period: Wk0-16|Sponsor Closed Study- Subject Was Discontinued|1|||
147311094|NCT01275196|531307089|FG001|Overall Study|Disease Progression|5|||
147311095|NCT01275196|531307088|FG000|Overall Study|Protocol Violation|1|||
147311096|NCT01275196|531307089|FG001|Overall Study|Protocol Violation|0|||
147311097|NCT01275196|531307088|FG000|Overall Study|Suboptimal response/treatment failure|5|||
147560616|NCT04557124|532208911|FG000|Allocation (Baseline)|Withdrawal by Subject|0|||
147560617|NCT04557124|532208912|FG001|Allocation (Baseline)|Withdrawal by Subject|1|||
147226388|NCT03739840|531002047|FG001|Treatment Period: Wk0-16|Sponsor Closed Study- Subject Was Discontinued|0|||
147226389|NCT03739840|531002048|FG002|Treatment Period: Wk0-16|Sponsor Closed Study- Subject Was Discontinued|0|||
147560618|NCT04557124|532208911|FG000|Mid-point (1 Month)|Missed testing|5|||
147560619|NCT04557124|532208912|FG001|Mid-point (1 Month)|Missed testing|4|||
147560620|NCT04557124|532208911|FG000|Mid-point (1 Month)|Lost to Follow-up|1|||
147560621|NCT04557124|532208912|FG001|Mid-point (1 Month)|Lost to Follow-up|2|||
147560622|NCT04557124|532208911|FG000|Post-testing (2 Months)|Missed testing|1|||
147560623|NCT04557124|532208912|FG001|Post-testing (2 Months)|Missed testing|5|||
147560624|NCT04557124|532208911|FG000|Post-testing (2 Months)|Lost to Follow-up|2|||
147560625|NCT04557124|532208912|FG001|Post-testing (2 Months)|Lost to Follow-up|3|||
147560626|NCT04557124|532208911|FG000|Follow-up (4 Months)|Lost to Follow-up|2|||
147560627|NCT04557124|532208912|FG001|Follow-up (4 Months)|Lost to Follow-up|1|||
147560628|NCT00001849|532208913|FG000|Overall Study|Death|4|||
147560629|NCT00001849|532208913|FG000|Overall Study|Lost to Follow-up|2|||
147560630|NCT00001849|532208913|FG000|Overall Study|Withdrawal by Subject|2|||
147560631|NCT00001849|532208913|FG000|Overall Study|tumor remained occult|6|||
147560632|NCT03127137|532208917|FG000|Overall Study|Requested sedation after consent|1|||
147560633|NCT03127137|532208918|FG001|Overall Study|Requested sedation after consent|0|||
147560634|NCT03127137|532208917|FG000|Overall Study|Malfunction in electronic data collection|1|||
147560635|NCT03127137|532208918|FG001|Overall Study|Malfunction in electronic data collection|0|||
147560636|NCT03127137|532208917|FG000|Overall Study|Post procedure testing could not be obtained|0|||
147560637|NCT03127137|532208918|FG001|Overall Study|Post procedure testing could not be obtained|1|||
147560638|NCT02319148|532208922|FG000|Second Intervention Period|Adverse event (AE) related to study drug|0|||
147560639|NCT02319148|532208923|FG001|Second Intervention Period|Adverse event (AE) related to study drug|0|||
147560640|NCT02319148|532208924|FG002|Second Intervention Period|Adverse event (AE) related to study drug|1|||
147560641|NCT02319148|532208925|FG003|Second Intervention Period|Adverse event (AE) related to study drug|1|||
147560642|NCT02319148|532208922|FG000|Second Intervention Period|No longer willing to participate|0|||
147560643|NCT02319148|532208923|FG001|Second Intervention Period|No longer willing to participate|1|||
147560644|NCT02319148|532208924|FG002|Second Intervention Period|No longer willing to participate|0|||
147560645|NCT02319148|532208925|FG003|Second Intervention Period|No longer willing to participate|0|||
147560646|NCT02319148|532208922|FG000|Second Intervention Period|Other|0|||
147560647|NCT02319148|532208923|FG001|Second Intervention Period|Other|0|||
147560648|NCT02319148|532208924|FG002|Second Intervention Period|Other|0|||
147560649|NCT02319148|532208925|FG003|Second Intervention Period|Other|1|||
147560650|NCT00264797|532208926|FG000|Overall Study|Withdrawal by Subject|11|||
147560651|NCT00264797|532208927|FG001|Overall Study|Withdrawal by Subject|11|||
147560652|NCT00264797|532208926|FG000|Overall Study|Lost to Follow-up|9|||
147560653|NCT00264797|532208927|FG001|Overall Study|Lost to Follow-up|17|||
147560654|NCT00264797|532208926|FG000|Overall Study|Moved from area|3|||
147560655|NCT00264797|532208927|FG001|Overall Study|Moved from area|1|||
147560656|NCT00264797|532208926|FG000|Overall Study|Practical Problems|2|||
147560657|NCT00264797|532208927|FG001|Overall Study|Practical Problems|3|||
147560658|NCT00264797|532208926|FG000|Overall Study|Incarceration|4|||
147560659|NCT00264797|532208927|FG001|Overall Study|Incarceration|5|||
147560660|NCT00264797|532208926|FG000|Overall Study|Pressure/advice from Outsiders|1|||
147560661|NCT00264797|532208927|FG001|Overall Study|Pressure/advice from Outsiders|1|||
147560662|NCT00264797|532208926|FG000|Overall Study|Feels treatment not necessary, not worki|0|||
147560663|NCT00264797|532208927|FG001|Overall Study|Feels treatment not necessary, not worki|1|||
147560664|NCT00264797|532208926|FG000|Overall Study|Other|3|||
147560665|NCT00264797|532208927|FG001|Overall Study|Other|4|||
147560666|NCT01249664|532208928|FG000|Overall Study|Withdrawal by Subject|5|||
147560667|NCT01249664|532208929|FG001|Overall Study|Withdrawal by Subject|0|||
147560668|NCT01249664|532208928|FG000|Overall Study|Adverse Event|1|||
147560669|NCT01249664|532208929|FG001|Overall Study|Adverse Event|0|||
147560670|NCT00762086|532208932|FG000|Overall Study|Adverse Event|2|||
147560671|NCT00762086|532208933|FG001|Overall Study|Adverse Event|0|||
147560672|NCT00762086|532208932|FG000|Overall Study|Lost to Follow-up|0|||
147560673|NCT00762086|532208933|FG001|Overall Study|Lost to Follow-up|2|||
147560674|NCT00762086|532208932|FG000|Overall Study|Non compliance|1|||
147560675|NCT00762086|532208933|FG001|Overall Study|Non compliance|0|||
147560676|NCT00762086|532208932|FG000|Overall Study|Withdrawal by Subject|2|||
147560677|NCT00762086|532208933|FG001|Overall Study|Withdrawal by Subject|2|||
147560678|NCT00762086|532208932|FG000|Overall Study|Ineligible to participate in the study|1|||
147560679|NCT00762086|532208933|FG001|Overall Study|Ineligible to participate in the study|0|||
147560680|NCT00860405|532208934|FG000|Overall Study|Main reason: Follow-up data not complete|5|||
147560681|NCT00860405|532208935|FG001|Overall Study|Main reason: Follow-up data not complete|4|||
147560682|NCT00497796|532208937|FG000|Overall Study|Adverse event (not related)|9|||
147560683|NCT00497796|532208938|FG001|Overall Study|Adverse event (not related)|9|||
147560684|NCT00497796|532208937|FG000|Overall Study|Adverse event (related)|5|||
147560685|NCT00497796|532208938|FG001|Overall Study|Adverse event (related)|4|||
147560686|NCT00497796|532208937|FG000|Overall Study|CMV infection or disease treatment|30|||
147560687|NCT00497796|532208938|FG001|Overall Study|CMV infection or disease treatment|4|||
147560688|NCT00497796|532208937|FG000|Overall Study|Consent withdrawn|10|||
147560689|NCT00497796|532208938|FG001|Overall Study|Consent withdrawn|3|||
147560690|NCT00497796|532208937|FG000|Overall Study|Investigator/sponsor discretion|31|||
147560691|NCT00497796|532208938|FG001|Overall Study|Investigator/sponsor discretion|34|||
147560692|NCT00497796|532208937|FG000|Overall Study|Lost to Follow-up|0|||
147560693|NCT00497796|532208938|FG001|Overall Study|Lost to Follow-up|1|||
147560694|NCT00497796|532208937|FG000|Overall Study|Not applicable (randomized not treated)|0|||
147560695|NCT00497796|532208938|FG001|Overall Study|Not applicable (randomized not treated)|4|||
147560696|NCT01074554|532208939|FG000|Overall Study|Adverse Event|3|||
147560697|NCT01074554|532208940|FG001|Overall Study|Adverse Event|3|||
147560698|NCT01074554|532208939|FG000|Overall Study|Lost to Follow-up|0|||
147560699|NCT01074554|532208940|FG001|Overall Study|Lost to Follow-up|1|||
147560700|NCT04276883|532208941|FG000|Overall Study|Withdrawal by Subject|2|||
147560701|NCT04276883|532208942|FG001|Overall Study|Withdrawal by Subject|3|||
147560702|NCT04276883|532208943|FG002|Overall Study|Withdrawal by Subject|6|||
147560703|NCT04276883|532208941|FG000|Overall Study|Lost to Follow-up|1|||
147560704|NCT04276883|532208942|FG001|Overall Study|Lost to Follow-up|3|||
147560705|NCT04276883|532208943|FG002|Overall Study|Lost to Follow-up|0|||
147560706|NCT04276883|532208941|FG000|Overall Study|Adverse Event|0|||
147560707|NCT04276883|532208942|FG001|Overall Study|Adverse Event|1|||
147560708|NCT04276883|532208943|FG002|Overall Study|Adverse Event|0|||
147560709|NCT04276883|532208941|FG000|Overall Study|Randomized in error - di dnot receive treatment|1|||
147560710|NCT04276883|532208942|FG001|Overall Study|Randomized in error - di dnot receive treatment|1|||
147560711|NCT04276883|532208943|FG002|Overall Study|Randomized in error - di dnot receive treatment|0|||
147560712|NCT02073643|532208946|FG000|Overall Study|Lost to Follow-up|24|||
147560713|NCT01139164|532208952|FG000|Overall Study|Withdrawn prior to study start|0|||
147560714|NCT01139164|532208953|FG001|Overall Study|Withdrawn prior to study start|2|||
147560715|NCT01139164|532208954|FG002|Overall Study|Withdrawn prior to study start|0|||
147560716|NCT00406848|532208955|FG000|Overall Study|Withdrawal by Subject|27|||
147560717|NCT00406848|532208956|FG001|Overall Study|Withdrawal by Subject|22|||
147560718|NCT00406848|532208955|FG000|Overall Study|Adverse Event|38|||
147560719|NCT00406848|532208956|FG001|Overall Study|Adverse Event|7|||
147560720|NCT00406848|532208955|FG000|Overall Study|Lack of Efficacy|9|||
147560721|NCT00406848|532208956|FG001|Overall Study|Lack of Efficacy|14|||
147560722|NCT00406848|532208955|FG000|Overall Study|Protocol Violation|10|||
147560723|NCT00406848|532208956|FG001|Overall Study|Protocol Violation|6|||
147560724|NCT00406848|532208955|FG000|Overall Study|Lost to Follow-up|6|||
147560725|NCT00406848|532208956|FG001|Overall Study|Lost to Follow-up|2|||
147560726|NCT00406848|532208955|FG000|Overall Study|Physician Decision|2|||
147560727|NCT00406848|532208956|FG001|Overall Study|Physician Decision|2|||
147560728|NCT00406848|532208955|FG000|Overall Study|Sponsor Decision|1|||
147560729|NCT00406848|532208956|FG001|Overall Study|Sponsor Decision|1|||
147560730|NCT01355081|532208957|FG000|Overall Study|Pretreatment Event or Adverse Event|3|||
147560731|NCT01355081|532208958|FG001|Overall Study|Pretreatment Event or Adverse Event|4|||
147560732|NCT01355081|532208959|FG002|Overall Study|Pretreatment Event or Adverse Event|6|||
147560733|NCT01355081|532208957|FG000|Overall Study|Major Protocol Deviation|0|||
147560734|NCT01355081|532208958|FG001|Overall Study|Major Protocol Deviation|1|||
147560735|NCT01355081|532208959|FG002|Overall Study|Major Protocol Deviation|0|||
147560736|NCT01355081|532208957|FG000|Overall Study|Lost to Follow-up|0|||
147560737|NCT01355081|532208958|FG001|Overall Study|Lost to Follow-up|0|||
147560738|NCT01355081|532208959|FG002|Overall Study|Lost to Follow-up|1|||
147560739|NCT01355081|532208957|FG000|Overall Study|Withdrawal of Consent|2|||
147560740|NCT01355081|532208958|FG001|Overall Study|Withdrawal of Consent|3|||
147560741|NCT01355081|532208959|FG002|Overall Study|Withdrawal of Consent|3|||
147560742|NCT01355081|532208957|FG000|Overall Study|Lack of Efficacy|2|||
147560743|NCT01355081|532208958|FG001|Overall Study|Lack of Efficacy|1|||
147560744|NCT01355081|532208959|FG002|Overall Study|Lack of Efficacy|1|||
147560745|NCT01355081|532208957|FG000|Overall Study|Non Compliance with Study Medication|0|||
147560746|NCT01355081|532208958|FG001|Overall Study|Non Compliance with Study Medication|1|||
147560747|NCT01355081|532208959|FG002|Overall Study|Non Compliance with Study Medication|0|||
147560748|NCT02719522|532208960|FG000|Overall Study|Implant Failure|4|||
147560749|NCT02719522|532208960|FG000|Overall Study|Death|2|||
147560750|NCT02719522|532208960|FG000|Overall Study|Lost to Follow-up|5|||
147560751|NCT03184441|532208961|FG000|Overall Study|Withdrawal by Subject|1|||
147560752|NCT00860028|532208964|FG000|Placebo Controlled Pretreatment Period|No longer interested in treatment|2|||
147560753|NCT00860028|532208965|FG001|Placebo Controlled Pretreatment Period|No longer interested in treatment|1|||
147560754|NCT00936390|532208966|FG000|Overall Study|Protocol Violation|21|||
147560755|NCT00936390|532208967|FG001|Overall Study|Protocol Violation|25|||
147226390|NCT03739840|531002049|FG003|Treatment Period: Wk0-16|Sponsor Closed Study- Subject Was Discontinued|0|||
147226391|NCT03739840|531002046|FG000|Treatment Period: Wk0-16|Sponsors Decision|3|||
147560756|NCT02514174|532208971|FG000|Overall Study|Patient refused to continue medication|1|||
147560757|NCT02514174|532208971|FG000|Overall Study|Adverse Event|2|||
147560758|NCT02514174|532208971|FG000|Overall Study|Study closed by sponsor|9|||
147560759|NCT02514174|532208971|FG000|Overall Study|Progressive disease|11|||
147560760|NCT02514174|532208971|FG000|Overall Study|Treatment change|1|||
147560761|NCT02514174|532208971|FG000|Overall Study|Treated off study with Afatinib.|1|||
147595947|NCT03096847|532338752|FG001|Overall Study|Non-compliance with study medication|0|||
147595948|NCT03096847|532338753|FG002|Overall Study|Non-compliance with study medication|0|||
147595949|NCT03096847|532338751|FG000|Overall Study|New therapy for study indication|1|||
147595950|NCT03096847|532338752|FG001|Overall Study|New therapy for study indication|0|||
147595951|NCT03096847|532338753|FG002|Overall Study|New therapy for study indication|1|||
147595952|NCT00359632|532338754|FG000|Overall Study|Death|2|||
147560762|NCT00444145|532210715|FG000|Overall Study|Withdrawal by Subject|2|||
147560763|NCT00444145|532210715|FG000|Overall Study|Lost to Follow-up|1|||
147560764|NCT00444145|532210715|FG000|Overall Study|non-compliant|11|||
147560765|NCT00444145|532210715|FG000|Overall Study|Screen Failures|5|||
147560766|NCT00419770|532210716|FG000|Overall Study|Withdrawal by Subject|5|||
147560767|NCT00419770|532210717|FG001|Overall Study|Withdrawal by Subject|1|||
147560768|NCT01781637|532210719|FG000|Overall Study|Adverse Event|1|||
147560769|NCT01781637|532210720|FG001|Overall Study|Adverse Event|0|||
147560770|NCT01781637|532210719|FG000|Overall Study|Lack of Efficacy|2|||
147560771|NCT01781637|532210720|FG001|Overall Study|Lack of Efficacy|6|||
147560772|NCT01781637|532210719|FG000|Overall Study|Withdrawal by Subject|1|||
147560773|NCT01781637|532210720|FG001|Overall Study|Withdrawal by Subject|0|||
147560774|NCT02637232|532210721|FG000|Overall Study|Lost to Follow-up|42|||
147560775|NCT02637232|532210721|FG000|Overall Study|Adverse Event|11|||
147560776|NCT02637232|532210721|FG000|Overall Study|patient 's decision|2|||
147560777|NCT02999178|532210722|FG000|Overall Study|Adverse Event|85|||
147560778|NCT02999178|532210723|FG001|Overall Study|Adverse Event|62|||
147560779|NCT02999178|532210722|FG000|Overall Study|Protocol Violation|1|||
147560780|NCT02999178|532210723|FG001|Overall Study|Protocol Violation|2|||
147560781|NCT02999178|532210722|FG000|Overall Study|Lost to Follow-up|0|||
147560782|NCT02999178|532210723|FG001|Overall Study|Lost to Follow-up|2|||
147560783|NCT02999178|532210722|FG000|Overall Study|Withdrawal by Subject|21|||
147560784|NCT02999178|532210723|FG001|Overall Study|Withdrawal by Subject|21|||
147560785|NCT02999178|532210722|FG000|Overall Study|Other reason not defined above|7|||
147560786|NCT02999178|532210723|FG001|Overall Study|Other reason not defined above|13|||
147560787|NCT00090857|532210724|FG000|Overall Study|Lost to Follow-up|0|||
147560788|NCT00090857|532210725|FG001|Overall Study|Lost to Follow-up|1|||
147560789|NCT00090857|532210724|FG000|Overall Study|Withdrawal by Subject|2|||
147560790|NCT00090857|532210725|FG001|Overall Study|Withdrawal by Subject|0|||
147560791|NCT00090857|532210724|FG000|Overall Study|Adverse Event|2|||
147560792|NCT00090857|532210725|FG001|Overall Study|Adverse Event|2|||
147560793|NCT05097326|532210726|FG000|Overall Study|Spontaneous labor prior to medication administration|1|||
147560794|NCT05097326|532210727|FG001|Overall Study|Spontaneous labor prior to medication administration|0|||
147560795|NCT01244126|532210728|FG000|Overall Study|Protocol Violation|3|||
147560796|NCT01244126|532210729|FG001|Overall Study|Protocol Violation|3|||
147560797|NCT01244126|532210730|FG002|Overall Study|Protocol Violation|9|||
147560798|NCT02424188|532210735|FG000|Overall Study|Death|2|||
147560799|NCT02424188|532210736|FG001|Overall Study|Death|2|||
147560800|NCT02424188|532210735|FG000|Overall Study|Lost to Follow-up|1|||
147560801|NCT02424188|532210736|FG001|Overall Study|Lost to Follow-up|3|||
147560802|NCT02424188|532210735|FG000|Overall Study|Incarceration|1|||
147560803|NCT02424188|532210736|FG001|Overall Study|Incarceration|0|||
147560804|NCT01494506|532210745|FG000|Overall Study|Lack of Efficacy|77|||
147560805|NCT01494506|532210746|FG001|Overall Study|Lack of Efficacy|83|||
147560806|NCT01494506|532210747|FG002|Overall Study|Lack of Efficacy|57|||
147560807|NCT01494506|532210745|FG000|Overall Study|Adverse Event|17|||
147560808|NCT01494506|532210746|FG001|Overall Study|Adverse Event|10|||
147560809|NCT01494506|532210747|FG002|Overall Study|Adverse Event|11|||
147560810|NCT01494506|532210745|FG000|Overall Study|Death|9|||
147560811|NCT01494506|532210746|FG001|Overall Study|Death|5|||
147560812|NCT01494506|532210747|FG002|Overall Study|Death|2|||
147560813|NCT01494506|532210745|FG000|Overall Study|Physician Decision|7|||
147560814|NCT01494506|532210746|FG001|Overall Study|Physician Decision|5|||
147560815|NCT01494506|532210747|FG002|Overall Study|Physician Decision|4|||
147560816|NCT01494506|532210745|FG000|Overall Study|Withdrawal by Subject|17|||
147560817|NCT01494506|532210746|FG001|Overall Study|Withdrawal by Subject|20|||
147112058|NCT01757847|530572840|FG000|Overall Study|Withdrawal by Subject|3|||
147226392|NCT03739840|531002047|FG001|Treatment Period: Wk0-16|Sponsors Decision|2|||
147226393|NCT03739840|531002048|FG002|Treatment Period: Wk0-16|Sponsors Decision|1|||
147226394|NCT03739840|531002049|FG003|Treatment Period: Wk0-16|Sponsors Decision|3|||
147560818|NCT01494506|532210747|FG002|Overall Study|Withdrawal by Subject|14|||
147112059|NCT01757847|530572841|FG001|Overall Study|Withdrawal by Subject|4|||
147112060|NCT04556097|530572842|FG000|Overall Study|Death|0|||
147226395|NCT03739840|531002046|FG000|Treatment Period: Wk0-16|Promotor Decision|0|||
147560819|NCT01494506|532210745|FG000|Overall Study|Clinical Deterioration|21|||
147560820|NCT01494506|532210746|FG001|Overall Study|Clinical Deterioration|17|||
147560821|NCT01494506|532210747|FG002|Overall Study|Clinical Deterioration|13|||
147560822|NCT01494506|532210745|FG000|Overall Study|Sponsor Decision|0|||
147560823|NCT01494506|532210746|FG001|Overall Study|Sponsor Decision|0|||
147560824|NCT01494506|532210747|FG002|Overall Study|Sponsor Decision|1|||
147560825|NCT01494506|532210745|FG000|Overall Study|Other|0|||
147560826|NCT01494506|532210746|FG001|Overall Study|Other|3|||
147226396|NCT03739840|531002047|FG001|Treatment Period: Wk0-16|Promotor Decision|1|||
147560827|NCT01494506|532210747|FG002|Overall Study|Other|1|||
147560828|NCT00755196|532210751|FG000|Overall Study|Lost to Follow-up|1|||
147560829|NCT00755196|532210751|FG000|Overall Study|Lack of Efficiency|1|||
147560830|NCT01604850|532210752|FG000|Overall Study|Enrolled but never treated|0|||
147560831|NCT01604850|532210753|FG001|Overall Study|Enrolled but never treated|1|||
147560832|NCT01604850|532210752|FG000|Overall Study|Efficacy Failure|50|||
147560833|NCT01604850|532210753|FG001|Overall Study|Efficacy Failure|29|||
147560834|NCT01604850|532210752|FG000|Overall Study|Lost to Follow-up|1|||
147560835|NCT01604850|532210753|FG001|Overall Study|Lost to Follow-up|0|||
147560836|NCT01604850|532210752|FG000|Overall Study|Subject withdrew consent|1|||
147560837|NCT01604850|532210753|FG001|Overall Study|Subject withdrew consent|0|||
147560838|NCT01703832|532210754|FG000|Overall Study|Withdrawal by Subject|1|||
147560839|NCT01703832|532210755|FG001|Overall Study|Withdrawal by Subject|0|||
147560840|NCT00243932|532210756|FG000|Stage 1: Dose Selection|Lost to Follow-up|2|||
147311098|NCT01275196|531307089|FG001|Overall Study|Suboptimal response/treatment failure|6|||
147311099|NCT01027364|531307090|FG000|Overall Study|Adverse Event|1|||
147444328|NCT00909181|531792563|FG001|Overall Study|Lost to Follow-up|18|||
147560841|NCT00243932|532210757|FG001|Stage 1: Dose Selection|Lost to Follow-up|0|||
147560842|NCT00243932|532210758|FG002|Stage 1: Dose Selection|Lost to Follow-up|0|||
147560843|NCT00543309|532210759|FG000|Overall Study|Physician Decision|0|||
147560844|NCT00543309|532210760|FG001|Overall Study|Physician Decision|1|||
147560845|NCT00543309|532210761|FG002|Overall Study|Physician Decision|0|||
147560846|NCT04538170|532210773|FG000|Overall Study|Withdrawal by Subject|104|||
147560847|NCT04538170|532210774|FG001|Overall Study|Withdrawal by Subject|210|||
147560848|NCT01682083|532210779|FG000|Overall Study|Lost to Follow-up|11|||
147560849|NCT01682083|532210780|FG001|Overall Study|Lost to Follow-up|18|||
147560850|NCT01682083|532210779|FG000|Overall Study|Withdrawal by Subject|31|||
147560851|NCT01682083|532210780|FG001|Overall Study|Withdrawal by Subject|40|||
147560852|NCT01682083|532210779|FG000|Overall Study|Death|60|||
147560853|NCT01682083|532210780|FG001|Overall Study|Death|93|||
147560854|NCT01682083|532210779|FG000|Overall Study|Physician Decision|5|||
147560855|NCT01682083|532210780|FG001|Overall Study|Physician Decision|4|||
147560856|NCT00864097|532210781|FG000|Overall Study|Death|0|||
147560857|NCT00864097|532210782|FG001|Overall Study|Death|1|||
147560858|NCT00864097|532210783|FG002|Overall Study|Death|0|||
147560859|NCT00864097|532210784|FG003|Overall Study|Death|0|||
147560860|NCT00864097|532210781|FG000|Overall Study|Adverse Event|6|||
147560861|NCT00864097|532210782|FG001|Overall Study|Adverse Event|8|||
147560862|NCT00864097|532210783|FG002|Overall Study|Adverse Event|11|||
147560863|NCT00864097|532210784|FG003|Overall Study|Adverse Event|9|||
147560864|NCT00864097|532210781|FG000|Overall Study|Lack of Efficacy|9|||
147560865|NCT00864097|532210782|FG001|Overall Study|Lack of Efficacy|3|||
147560866|NCT00864097|532210783|FG002|Overall Study|Lack of Efficacy|7|||
147560867|NCT00864097|532210784|FG003|Overall Study|Lack of Efficacy|2|||
147560868|NCT00864097|532210781|FG000|Overall Study|Lost to Follow-up|0|||
147560869|NCT00864097|532210782|FG001|Overall Study|Lost to Follow-up|1|||
147560870|NCT00864097|532210783|FG002|Overall Study|Lost to Follow-up|0|||
147560871|NCT00864097|532210784|FG003|Overall Study|Lost to Follow-up|1|||
147560872|NCT00864097|532210781|FG000|Overall Study|Withdrawal by Subject|15|||
147560873|NCT00864097|532210782|FG001|Overall Study|Withdrawal by Subject|11|||
147560874|NCT00864097|532210783|FG002|Overall Study|Withdrawal by Subject|11|||
147560875|NCT00864097|532210784|FG003|Overall Study|Withdrawal by Subject|12|||
147560876|NCT00864097|532210781|FG000|Overall Study|Protocol Violation|2|||
147560877|NCT00864097|532210782|FG001|Overall Study|Protocol Violation|1|||
147226397|NCT03739840|531002048|FG002|Treatment Period: Wk0-16|Promotor Decision|0|||
147226398|NCT03739840|531002049|FG003|Treatment Period: Wk0-16|Promotor Decision|0|||
147226399|NCT03739840|531002046|FG000|Treatment Period: Wk0-16|Per Sponsor Study Closed|0|||
147226400|NCT03739840|531002047|FG001|Treatment Period: Wk0-16|Per Sponsor Study Closed|1|||
147226401|NCT03739840|531002048|FG002|Treatment Period: Wk0-16|Per Sponsor Study Closed|0|||
147226402|NCT03739840|531002049|FG003|Treatment Period: Wk0-16|Per Sponsor Study Closed|0|||
147226403|NCT03739840|531002046|FG000|Treatment Period: Wk0-16|Premature Program Termination|0|||
147226404|NCT03739840|531002047|FG001|Treatment Period: Wk0-16|Premature Program Termination|1|||
147226405|NCT03739840|531002048|FG002|Treatment Period: Wk0-16|Premature Program Termination|0|||
147226406|NCT03739840|531002049|FG003|Treatment Period: Wk0-16|Premature Program Termination|0|||
147226407|NCT03739840|531002046|FG000|Treatment Period: Wk0-16|Trial Closed By Sponsor|0|||
147226408|NCT03739840|531002047|FG001|Treatment Period: Wk0-16|Trial Closed By Sponsor|1|||
147311100|NCT01027364|531307091|FG001|Overall Study|Adverse Event|0|||
147311101|NCT01027364|531307092|FG002|Overall Study|Adverse Event|1|||
147560878|NCT00864097|532210783|FG002|Overall Study|Protocol Violation|0|||
147560879|NCT00864097|532210784|FG003|Overall Study|Protocol Violation|1|||
147560880|NCT00864097|532210781|FG000|Overall Study|Terminated by sponsor|105|||
147560881|NCT00864097|532210782|FG001|Overall Study|Terminated by sponsor|112|||
147560882|NCT00864097|532210783|FG002|Overall Study|Terminated by sponsor|102|||
147560883|NCT00864097|532210784|FG003|Overall Study|Terminated by sponsor|99|||
147226409|NCT03739840|531002048|FG002|Treatment Period: Wk0-16|Trial Closed By Sponsor|0|||
147560884|NCT00864097|532210781|FG000|Overall Study|Randomized but not treated|2|||
147560885|NCT00864097|532210782|FG001|Overall Study|Randomized but not treated|0|||
147560886|NCT00864097|532210783|FG002|Overall Study|Randomized but not treated|1|||
147560887|NCT00864097|532210784|FG003|Overall Study|Randomized but not treated|0|||
147560888|NCT00864097|532210781|FG000|Overall Study|Other|0|||
147560889|NCT00864097|532210782|FG001|Overall Study|Other|0|||
147560890|NCT00864097|532210783|FG002|Overall Study|Other|0|||
147560891|NCT00864097|532210784|FG003|Overall Study|Other|1|||
147560892|NCT05956665|532210796|FG000|Overall Study|Death|1|||
147560893|NCT05956665|532210796|FG000|Overall Study|Withdrawal by Subject|1|||
147560894|NCT01939197|532210797|FG000|Overall Study|Withdrawal by Subject|1|||
147560895|NCT01939197|532210798|FG001|Overall Study|Withdrawal by Subject|0|||
147560896|NCT01939197|532210799|FG002|Overall Study|Withdrawal by Subject|0|||
147560897|NCT01939197|532210800|FG003|Overall Study|Withdrawal by Subject|0|||
147560898|NCT01939197|532210801|FG004|Overall Study|Withdrawal by Subject|1|||
147560899|NCT01939197|532210802|FG005|Overall Study|Withdrawal by Subject|0|||
147560900|NCT01939197|532210803|FG006|Overall Study|Withdrawal by Subject|0|||
147560901|NCT01939197|532210797|FG000|Overall Study|Lost to Follow-up|0|||
147560902|NCT01939197|532210798|FG001|Overall Study|Lost to Follow-up|1|||
147560903|NCT01939197|532210799|FG002|Overall Study|Lost to Follow-up|0|||
147560904|NCT01939197|532210800|FG003|Overall Study|Lost to Follow-up|1|||
147560905|NCT01939197|532210801|FG004|Overall Study|Lost to Follow-up|3|||
147560906|NCT01939197|532210802|FG005|Overall Study|Lost to Follow-up|1|||
147560907|NCT01939197|532210803|FG006|Overall Study|Lost to Follow-up|2|||
147560908|NCT02545998|532210804|FG000|Overall Study|Lost to Follow-up|12|||
147560909|NCT02545998|532210805|FG001|Overall Study|Lost to Follow-up|3|||
147560910|NCT02545998|532210804|FG000|Overall Study|Withdrawal by Subject|3|||
147560911|NCT02545998|532210805|FG001|Overall Study|Withdrawal by Subject|2|||
147560912|NCT02603952|532210814|FG000|Overall Study|Withdrawal by Subject|1|||
147560913|NCT02603952|532210815|FG001|Overall Study|Withdrawal by Subject|0|||
147560914|NCT02603952|532210816|FG002|Overall Study|Withdrawal by Subject|0|||
147560915|NCT02603952|532210817|FG003|Overall Study|Withdrawal by Subject|0|||
147560916|NCT02603952|532210814|FG000|Overall Study|Received oseltamivir by error|0|||
147560917|NCT02603952|532210815|FG001|Overall Study|Received oseltamivir by error|0|||
147560918|NCT02603952|532210816|FG002|Overall Study|Received oseltamivir by error|0|||
147560919|NCT02603952|532210817|FG003|Overall Study|Received oseltamivir by error|1|||
147560920|NCT00958243|532210830|FG000|Overall Study|Withdrawal by Subject|0|||
147560921|NCT00958243|532210831|FG001|Overall Study|Withdrawal by Subject|1|||
147560922|NCT00958243|532210832|FG002|Overall Study|Withdrawal by Subject|3|||
147560923|NCT00958243|532210833|FG003|Overall Study|Withdrawal by Subject|1|||
147560924|NCT00958243|532210834|FG004|Overall Study|Withdrawal by Subject|1|||
147560925|NCT00958243|532210835|FG005|Overall Study|Withdrawal by Subject|5|||
147560926|NCT00958243|532210830|FG000|Overall Study|Lost to Follow-up|2|||
147560927|NCT00958243|532210831|FG001|Overall Study|Lost to Follow-up|5|||
147560928|NCT00958243|532210832|FG002|Overall Study|Lost to Follow-up|11|||
147560929|NCT00958243|532210833|FG003|Overall Study|Lost to Follow-up|2|||
147560930|NCT00958243|532210834|FG004|Overall Study|Lost to Follow-up|8|||
147560931|NCT00958243|532210835|FG005|Overall Study|Lost to Follow-up|5|||
147560932|NCT04646109|532210836|FG000|Overall Study|Mutation disrupting ivermectin metabolism was found in 6 patients|0|||
147560933|NCT04646109|532210837|FG001|Overall Study|Mutation disrupting ivermectin metabolism was found in 6 patients|6|||
147560934|NCT06176768|532210838|FG000|Overall Study|Adverse Event|1|||
147560935|NCT06176768|532210839|FG001|Overall Study|Adverse Event|0|||
147560936|NCT06176768|532210838|FG000|Overall Study|Assigned treatment by mistake|1|||
147560937|NCT06176768|532210839|FG001|Overall Study|Assigned treatment by mistake|0|||
147560938|NCT06176768|532210838|FG000|Overall Study|Lost to Follow-up|0|||
147560939|NCT06176768|532210839|FG001|Overall Study|Lost to Follow-up|3|||
147560940|NCT06176768|532210838|FG000|Overall Study|Physician Decision|1|||
147560941|NCT06176768|532210839|FG001|Overall Study|Physician Decision|0|||
147560942|NCT06176768|532210838|FG000|Overall Study|Protocol deviation|3|||
147560943|NCT06176768|532210839|FG001|Overall Study|Protocol deviation|1|||
147560944|NCT06176768|532210838|FG000|Overall Study|Other|1|||
147560945|NCT06176768|532210839|FG001|Overall Study|Other|0|||
147560946|NCT06176768|532210838|FG000|Overall Study|Withdrawal by Subject|6|||
147560947|NCT06176768|532210839|FG001|Overall Study|Withdrawal by Subject|9|||
147560948|NCT01226797|532210840|FG000|Overall Study|Adverse Event|1|||
147560949|NCT01226797|532210841|FG001|Overall Study|Adverse Event|0|||
147560950|NCT01226797|532210840|FG000|Overall Study|No longer willing to participate|1|||
147560951|NCT01226797|532210841|FG001|Overall Study|No longer willing to participate|0|||
147560952|NCT01226797|532210840|FG000|Overall Study|Protocol Violation|0|||
147560953|NCT01226797|532210841|FG001|Overall Study|Protocol Violation|1|||
147560954|NCT00577460|532210844|FG000|Overall Study|Adverse Event|11|||
147560955|NCT00577460|532210845|FG001|Overall Study|Adverse Event|7|||
147560956|NCT00577460|532210846|FG002|Overall Study|Adverse Event|14|||
147560957|NCT00577460|532210844|FG000|Overall Study|Protocol Violation|0|||
147560958|NCT00577460|532210845|FG001|Overall Study|Protocol Violation|1|||
147560959|NCT00577460|532210846|FG002|Overall Study|Protocol Violation|1|||
147560960|NCT00577460|532210844|FG000|Overall Study|Lost to Follow-up|0|||
147560961|NCT00577460|532210845|FG001|Overall Study|Lost to Follow-up|3|||
147560962|NCT00577460|532210846|FG002|Overall Study|Lost to Follow-up|4|||
147560963|NCT00577460|532210844|FG000|Overall Study|Withdrawal by Subject|5|||
147560964|NCT00577460|532210845|FG001|Overall Study|Withdrawal by Subject|5|||
147560965|NCT00577460|532210846|FG002|Overall Study|Withdrawal by Subject|6|||
147560966|NCT00577460|532210844|FG000|Overall Study|Other|0|||
147560967|NCT00577460|532210845|FG001|Overall Study|Other|3|||
147560968|NCT00577460|532210846|FG002|Overall Study|Other|2|||
147560969|NCT01318499|532210849|FG000|Overall Study|Adverse Event|16|||
147560970|NCT01318499|532210850|FG001|Overall Study|Adverse Event|11|||
147560971|NCT01318499|532210851|FG002|Overall Study|Adverse Event|6|||
147560972|NCT01318499|532210849|FG000|Overall Study|Pt Decision Unrelated to Adverse Event|1|||
147560973|NCT01318499|532210850|FG001|Overall Study|Pt Decision Unrelated to Adverse Event|1|||
147560974|NCT01318499|532210851|FG002|Overall Study|Pt Decision Unrelated to Adverse Event|2|||
147560975|NCT01318499|532210849|FG000|Overall Study|Noncompliance|2|||
147560976|NCT01318499|532210850|FG001|Overall Study|Noncompliance|3|||
147560977|NCT01318499|532210851|FG002|Overall Study|Noncompliance|0|||
147560978|NCT01318499|532210849|FG000|Overall Study|Treatment Failure|19|||
147560979|NCT01318499|532210850|FG001|Overall Study|Treatment Failure|19|||
147560980|NCT01318499|532210851|FG002|Overall Study|Treatment Failure|101|||
147560981|NCT01318499|532210849|FG000|Overall Study|Protocol Violation|2|||
147560982|NCT01318499|532210850|FG001|Overall Study|Protocol Violation|4|||
147560983|NCT01318499|532210851|FG002|Overall Study|Protocol Violation|2|||
147560984|NCT01318499|532210849|FG000|Overall Study|Patient Did Not Use Study Medication|18|||
147560985|NCT01318499|532210850|FG001|Overall Study|Patient Did Not Use Study Medication|28|||
147560986|NCT01318499|532210851|FG002|Overall Study|Patient Did Not Use Study Medication|14|||
147560987|NCT01318499|532210849|FG000|Overall Study|Other|7|||
147560988|NCT01318499|532210850|FG001|Overall Study|Other|10|||
147560989|NCT01318499|532210851|FG002|Overall Study|Other|22|||
147560990|NCT01974141|532210857|FG000|Overall Study|Other Reasons|28|||
147560991|NCT01974141|532210858|FG001|Overall Study|Other Reasons|18|||
147560992|NCT01974141|532210857|FG000|Overall Study|Protocol Violation|2|||
147560993|NCT01974141|532210858|FG001|Overall Study|Protocol Violation|6|||
147560994|NCT01974141|532210857|FG000|Overall Study|Personal Reasons|21|||
147560995|NCT01974141|532210858|FG001|Overall Study|Personal Reasons|20|||
147560996|NCT01974141|532210857|FG000|Overall Study|Lost to Follow-up|38|||
147560997|NCT01974141|532210858|FG001|Overall Study|Lost to Follow-up|29|||
147560998|NCT01974141|532210857|FG000|Overall Study|Pregnancy|3|||
147560999|NCT01974141|532210858|FG001|Overall Study|Pregnancy|3|||
147561000|NCT01974141|532210857|FG000|Overall Study|Lack of Efficacy|0|||
147561001|NCT01974141|532210858|FG001|Overall Study|Lack of Efficacy|1|||
147561002|NCT01974141|532210857|FG000|Overall Study|Adverse Event|4|||
147561003|NCT01974141|532210858|FG001|Overall Study|Adverse Event|5|||
147561004|NCT04028843|532210861|FG000|Overall Study|Lost to Follow-up|32|||
147561005|NCT04028843|532210862|FG001|Overall Study|Lost to Follow-up|39|||
147561006|NCT04028843|532210861|FG000|Overall Study|Adverse Event|1|||
147561007|NCT04028843|532210862|FG001|Overall Study|Adverse Event|0|||
147112061|NCT04556097|530572843|FG001|Overall Study|Death|5|||
147561008|NCT04028843|532210861|FG000|Overall Study|Non-viable Pregnancy|0|||
147561009|NCT04028843|532210862|FG001|Overall Study|Non-viable Pregnancy|1|||
147561010|NCT04028843|532210861|FG000|Overall Study|Withdrawal by Subject|4|||
147561011|NCT04028843|532210862|FG001|Overall Study|Withdrawal by Subject|2|||
147561012|NCT04977336|532210863|FG000|Overall Study|Withdrawal of Consent (not due to AE)|1|||
147561013|NCT04977336|532210864|FG001|Overall Study|Withdrawal of Consent (not due to AE)|0|||
147561014|NCT04977336|532210865|FG002|Overall Study|Withdrawal of Consent (not due to AE)|0|||
147561015|NCT04977336|532210866|FG003|Overall Study|Withdrawal of Consent (not due to AE)|1|||
147561016|NCT04977336|532210867|FG004|Overall Study|Withdrawal of Consent (not due to AE)|2|||
147561017|NCT04977336|532210863|FG000|Overall Study|Lost to Follow-up|0|||
147561018|NCT04977336|532210864|FG001|Overall Study|Lost to Follow-up|0|||
147561019|NCT04977336|532210865|FG002|Overall Study|Lost to Follow-up|1|||
147561020|NCT04977336|532210866|FG003|Overall Study|Lost to Follow-up|0|||
147112062|NCT04556097|530572844|FG002|Overall Study|Death|0|||
147112063|NCT04556097|530572845|FG003|Overall Study|Death|0|||
147112064|NCT04556097|530572842|FG000|Overall Study|No caregiver|43|||
147112065|NCT04556097|530572843|FG001|Overall Study|No caregiver|53|||
147112066|NCT04556097|530572844|FG002|Overall Study|No caregiver|0|||
147561021|NCT04977336|532210867|FG004|Overall Study|Lost to Follow-up|0|||
147561022|NCT03298451|532210868|FG000|Overall Study|Death|275|||
147112067|NCT04556097|530572845|FG003|Overall Study|No caregiver|0|||
147112068|NCT04556097|530572842|FG000|Overall Study|Ineligible, SNF|2|||
147112069|NCT04556097|530572843|FG001|Overall Study|Ineligible, SNF|2|||
147112070|NCT04556097|530572844|FG002|Overall Study|Ineligible, SNF|0|||
147561023|NCT03298451|532210869|FG001|Overall Study|Death|260|||
147112071|NCT04556097|530572845|FG003|Overall Study|Ineligible, SNF|0|||
147112072|NCT04556097|530572842|FG000|Overall Study|Ineligible, health|3|||
147561024|NCT03298451|532210870|FG002|Overall Study|Death|122|||
147561025|NCT03298451|532210871|FG003|Overall Study|Death|280|||
147561026|NCT03298451|532210868|FG000|Overall Study|Lost to Follow-up|1|||
147561027|NCT03298451|532210869|FG001|Overall Study|Lost to Follow-up|1|||
147561028|NCT03298451|532210870|FG002|Overall Study|Lost to Follow-up|0|||
147561029|NCT03298451|532210871|FG003|Overall Study|Lost to Follow-up|7|||
147561030|NCT03298451|532210868|FG000|Overall Study|Withdrawal by Subject|9|||
147112073|NCT04556097|530572843|FG001|Overall Study|Ineligible, health|4|||
147112074|NCT04556097|530572844|FG002|Overall Study|Ineligible, health|0|||
147561031|NCT03298451|532210869|FG001|Overall Study|Withdrawal by Subject|7|||
147561032|NCT03298451|532210870|FG002|Overall Study|Withdrawal by Subject|1|||
147112075|NCT04556097|530572845|FG003|Overall Study|Ineligible, health|0|||
147561033|NCT03298451|532210871|FG003|Overall Study|Withdrawal by Subject|20|||
147561034|NCT01347710|532210872|FG000|Overall Study|Withdrawal by Subject|2|||
147561035|NCT01347710|532210872|FG000|Overall Study|Adverse Event|4|||
147561036|NCT01347710|532210872|FG000|Overall Study|Angio or SPECT not completed|18|||
147561037|NCT01347710|532210872|FG000|Overall Study|issue with vitals prior to dosing|1|||
147561038|NCT01347710|532210872|FG000|Overall Study|Lost to Follow-up|1|||
147561039|NCT01347710|532210872|FG000|Overall Study|Physician Decision|2|||
147561040|NCT01347710|532210872|FG000|Overall Study|Other|3|||
147561041|NCT04591626|532210874|FG000|Overall Study|Adverse Event|4|||
147561042|NCT04591626|532210875|FG001|Overall Study|Adverse Event|0|||
147561043|NCT04591626|532210874|FG000|Overall Study|Withdrawal by Subject|5|||
147561044|NCT04591626|532210875|FG001|Overall Study|Withdrawal by Subject|3|||
147561045|NCT04591626|532210874|FG000|Overall Study|Physician Decision|0|||
147561046|NCT04591626|532210875|FG001|Overall Study|Physician Decision|1|||
147561047|NCT04591626|532210874|FG000|Overall Study|Death|0|||
147561048|NCT04591626|532210875|FG001|Overall Study|Death|1|||
147561049|NCT04591626|532210874|FG000|Overall Study|Non-Compliance with Study Drug|1|||
147561050|NCT04591626|532210875|FG001|Overall Study|Non-Compliance with Study Drug|0|||
147561051|NCT01004172|532210879|FG000|Overall Study|Progressive Disease in CNS Only|16|||
147561052|NCT01004172|532210879|FG000|Overall Study|Progressive Disease in Non-CNS Only|16|||
147561053|NCT01004172|532210879|FG000|Overall Study|Progressive Disease in CNS and Non-CNS|2|||
147561054|NCT01004172|532210879|FG000|Overall Study|Adverse Event|1|||
147561055|NCT01004172|532210879|FG000|Overall Study|Physician Decision|1|||
147561056|NCT01004172|532210879|FG000|Overall Study|Symptomatic Deterioration|2|||
147561057|NCT00878995|532210883|FG000|Baseline Study - Midpoint Study|Withdrawal by Subject|0|||
147561058|NCT00878995|532210884|FG001|Baseline Study - Midpoint Study|Withdrawal by Subject|2|||
147561059|NCT02480764|532210887|FG000|Overall Study|Pretreatment Event/Adverse Event|3|||
147561060|NCT02480764|532210888|FG001|Overall Study|Pretreatment Event/Adverse Event|6|||
147561061|NCT02480764|532210889|FG002|Overall Study|Pretreatment Event/Adverse Event|3|||
147561062|NCT02480764|532210887|FG000|Overall Study|Major Protocol Deviation|1|||
147561063|NCT02480764|532210888|FG001|Overall Study|Major Protocol Deviation|4|||
147561064|NCT02480764|532210889|FG002|Overall Study|Major Protocol Deviation|3|||
147561065|NCT02480764|532210887|FG000|Overall Study|Lost to Follow-up|0|||
147561066|NCT02480764|532210888|FG001|Overall Study|Lost to Follow-up|1|||
147561067|NCT02480764|532210889|FG002|Overall Study|Lost to Follow-up|2|||
147561068|NCT02480764|532210887|FG000|Overall Study|Voluntary Withdrawal|6|||
147561069|NCT02480764|532210888|FG001|Overall Study|Voluntary Withdrawal|5|||
147561070|NCT02480764|532210889|FG002|Overall Study|Voluntary Withdrawal|10|||
147561071|NCT02480764|532210887|FG000|Overall Study|Lack of Efficacy|0|||
147561072|NCT02480764|532210888|FG001|Overall Study|Lack of Efficacy|3|||
147561073|NCT02480764|532210889|FG002|Overall Study|Lack of Efficacy|3|||
147561074|NCT02480764|532210887|FG000|Overall Study|Reason not Specified|0|||
147561075|NCT02480764|532210888|FG001|Overall Study|Reason not Specified|1|||
147561076|NCT02480764|532210889|FG002|Overall Study|Reason not Specified|0|||
147561077|NCT02457832|532210890|FG000|Training|Lost to Follow-up|10|||
147561078|NCT02457832|532210891|FG001|Training|Lost to Follow-up|6|||
147561079|NCT02457832|532210892|FG002|Training|Lost to Follow-up|3|||
147226410|NCT03739840|531002049|FG003|Treatment Period: Wk0-16|Trial Closed By Sponsor|0|||
147226411|NCT03739840|531002046|FG000|Treatment Period: Wk0-16|Study Early Closure|0|||
147226412|NCT03739840|531002047|FG001|Treatment Period: Wk0-16|Study Early Closure|0|||
147226413|NCT03739840|531002048|FG002|Treatment Period: Wk0-16|Study Early Closure|1|||
147226414|NCT03739840|531002049|FG003|Treatment Period: Wk0-16|Study Early Closure|0|||
147561080|NCT02457832|532210890|FG000|One Month Washout|Lost to Follow-up|0|||
147561081|NCT02457832|532210891|FG001|One Month Washout|Lost to Follow-up|1|||
147561082|NCT02457832|532210892|FG002|One Month Washout|Lost to Follow-up|1|||
147561083|NCT01868009|532210895|FG000|Period 1 (5-9 Days)|Adverse Event|0|||
147561084|NCT01868009|532210896|FG001|Period 1 (5-9 Days)|Adverse Event|2|||
147561085|NCT01868009|532210895|FG000|Period 2 (5-9 Days)|Adverse Event|1|||
147561086|NCT01868009|532210896|FG001|Period 2 (5-9 Days)|Adverse Event|0|||
147561087|NCT01868009|532210895|FG000|Period 2 (5-9 Days)|Protocol-defined Stopping Criteria|1|||
147561088|NCT01868009|532210896|FG001|Period 2 (5-9 Days)|Protocol-defined Stopping Criteria|0|||
147561089|NCT01691248|532210899|FG000|Overall Study|Protocol Violation|43|||
147561090|NCT01691248|532210900|FG001|Overall Study|Protocol Violation|27|||
147561091|NCT01691248|532210899|FG000|Overall Study|Adverse Event|24|||
147561092|NCT01691248|532210900|FG001|Overall Study|Adverse Event|22|||
147561093|NCT01691248|532210899|FG000|Overall Study|Withdrawal by Subject|20|||
147561094|NCT01691248|532210900|FG001|Overall Study|Withdrawal by Subject|18|||
147561095|NCT01691248|532210899|FG000|Overall Study|Confirmed CDAD|14|||
147561096|NCT01691248|532210900|FG001|Overall Study|Confirmed CDAD|31|||
147561097|NCT01691248|532210899|FG000|Overall Study|Lost to Follow-up|2|||
147561098|NCT01691248|532210900|FG001|Overall Study|Lost to Follow-up|5|||
147561099|NCT01691248|532210899|FG000|Overall Study|Reason not provided|4|||
147561100|NCT01691248|532210900|FG001|Overall Study|Reason not provided|4|||
147561101|NCT01691248|532210899|FG000|Overall Study|Not Treated|4|||
147561102|NCT01691248|532210900|FG001|Overall Study|Not Treated|7|||
147226415|NCT03739840|531002046|FG000|Treatment Period: Wk0-16|Premature Study Termination By Sponsor|0|||
147561103|NCT04526210|532212058|FG000|Overall Study|Sponsor decision|7|||
147561104|NCT04526210|532212059|FG001|Overall Study|Sponsor decision|5|||
147561105|NCT04526210|532212058|FG000|Overall Study|Withdrawal by Subject|3|||
147561106|NCT04526210|532212059|FG001|Overall Study|Withdrawal by Subject|2|||
147561107|NCT02924038|532212060|FG000|Overall Study|Excluded from post-surgery vaccines due to high-grade diagnosis of resected tumor|2|||
147561108|NCT02924038|532212061|FG001|Overall Study|Excluded from post-surgery vaccines due to high-grade diagnosis of resected tumor|2|||
147561109|NCT02473640|532212064|FG000|Treatment Period 1|Adverse Event|1|||
147561110|NCT02777528|532212067|FG000|Overall Study|Still in study|24|||
147561111|NCT02777528|532212068|FG001|Overall Study|Still in study|10|||
147561112|NCT02777528|532212069|FG002|Overall Study|Still in study|1|||
147561113|NCT02777528|532212067|FG000|Overall Study|Study Device Explanted|1|||
147112076|NCT04556097|530572842|FG000|Overall Study|Ineligible, language|0|||
147112077|NCT04556097|530572843|FG001|Overall Study|Ineligible, language|1|||
147112078|NCT04556097|530572844|FG002|Overall Study|Ineligible, language|0|||
147112079|NCT04556097|530572845|FG003|Overall Study|Ineligible, language|0|||
147112080|NCT04556097|530572842|FG000|Overall Study|Ineligible, no longer in care management|0|||
147112081|NCT04556097|530572843|FG001|Overall Study|Ineligible, no longer in care management|2|||
147112082|NCT04556097|530572844|FG002|Overall Study|Ineligible, no longer in care management|1|||
147112083|NCT04556097|530572845|FG003|Overall Study|Ineligible, no longer in care management|0|||
147112084|NCT04556097|530572842|FG000|Overall Study|No dementia|13|||
147112085|NCT04556097|530572843|FG001|Overall Study|No dementia|3|||
147112086|NCT04556097|530572844|FG002|Overall Study|No dementia|0|||
147112087|NCT04556097|530572845|FG003|Overall Study|No dementia|0|||
147112088|NCT04556097|530572842|FG000|Overall Study|Missing identifier|2|||
147112089|NCT04556097|530572843|FG001|Overall Study|Missing identifier|4|||
147112090|NCT04556097|530572844|FG002|Overall Study|Missing identifier|0|||
147112091|NCT04556097|530572845|FG003|Overall Study|Missing identifier|0|||
147112092|NCT04556097|530572842|FG000|Overall Study|Did not have at least 1 member month in pre and post period|17|||
147112093|NCT04556097|530572843|FG001|Overall Study|Did not have at least 1 member month in pre and post period|8|||
147112094|NCT04556097|530572844|FG002|Overall Study|Did not have at least 1 member month in pre and post period|0|||
147112095|NCT04556097|530572845|FG003|Overall Study|Did not have at least 1 member month in pre and post period|0|||
147112096|NCT02516241|530572846|FG000|Overall Study|Death|255|||
147112097|NCT02516241|530572847|FG001|Overall Study|Death|262|||
147112098|NCT02516241|530572848|FG002|Overall Study|Death|270|||
147112099|NCT02516241|530572846|FG000|Overall Study|Lost to Follow-up|1|||
147561114|NCT02777528|532212068|FG001|Overall Study|Study Device Explanted|0|||
147561115|NCT02777528|532212069|FG002|Overall Study|Study Device Explanted|0|||
147561116|NCT02777528|532212067|FG000|Overall Study|Death|14|||
147561117|NCT02777528|532212068|FG001|Overall Study|Death|7|||
147561118|NCT02777528|532212069|FG002|Overall Study|Death|1|||
147561119|NCT02777528|532212067|FG000|Overall Study|Withdrawal by Subject|2|||
147561120|NCT02777528|532212068|FG001|Overall Study|Withdrawal by Subject|2|||
147561121|NCT02777528|532212069|FG002|Overall Study|Withdrawal by Subject|1|||
147561122|NCT02777528|532212067|FG000|Overall Study|Physician Decision|2|||
147561123|NCT02777528|532212068|FG001|Overall Study|Physician Decision|1|||
147561124|NCT02777528|532212069|FG002|Overall Study|Physician Decision|0|||
147561125|NCT02777528|532212067|FG000|Overall Study|Lost to Follow-up|2|||
147561126|NCT02777528|532212068|FG001|Overall Study|Lost to Follow-up|0|||
147561127|NCT02777528|532212069|FG002|Overall Study|Lost to Follow-up|0|||
147561128|NCT02777528|532212067|FG000|Overall Study|Discontinued due to Other|1|||
147561129|NCT02777528|532212068|FG001|Overall Study|Discontinued due to Other|0|||
147561130|NCT02777528|532212069|FG002|Overall Study|Discontinued due to Other|0|||
147561131|NCT00453362|532212072|FG000|Overall Study|Adverse Event|5|||
147561132|NCT00453362|532212072|FG000|Overall Study|Death|7|||
147561133|NCT00453362|532212072|FG000|Overall Study|Physician Decision|2|||
147561134|NCT00453362|532212072|FG000|Overall Study|Withdrawal by Subject|3|||
147561135|NCT00453362|532212072|FG000|Overall Study|Progression of disease|56|||
147561136|NCT00453362|532212072|FG000|Overall Study|Screening Failure|14|||
147112100|NCT02516241|530572847|FG001|Overall Study|Lost to Follow-up|1|||
147112101|NCT02516241|530572848|FG002|Overall Study|Lost to Follow-up|3|||
147112102|NCT02516241|530572846|FG000|Overall Study|Withdrawal by Subject|2|||
147112103|NCT02516241|530572847|FG001|Overall Study|Withdrawal by Subject|7|||
147112104|NCT02516241|530572848|FG002|Overall Study|Withdrawal by Subject|12|||
147561137|NCT04885296|532212073|FG000|Period 1|Covid-19 Related|1|||
147561138|NCT04885296|532212074|FG001|Period 1|Covid-19 Related|0|||
147561139|NCT04885296|532212073|FG000|Period 1|Adverse Event|0|||
147561140|NCT04885296|532212074|FG001|Period 1|Adverse Event|1|||
147561141|NCT04885296|532212073|FG000|Period 1|Withdrawal by Subject|1|||
147561142|NCT04885296|532212074|FG001|Period 1|Withdrawal by Subject|1|||
147561143|NCT04885296|532212073|FG000|Period 1|Test Article No Longer Available|1|||
147561144|NCT04885296|532212074|FG001|Period 1|Test Article No Longer Available|0|||
147561145|NCT04885296|532212073|FG000|Period 1|Dispensed Study lens in Error|1|||
147112105|NCT02516241|530572846|FG000|Overall Study|participants ongoing at data cut-off|84|||
147112106|NCT02516241|530572847|FG001|Overall Study|participants ongoing at data cut-off|76|||
147112107|NCT02516241|530572848|FG002|Overall Study|participants ongoing at data cut-off|59|||
147112108|NCT04057365|530572849|FG000|Overall Study|Withdrawal by Subject|2|||
147112109|NCT04057365|530572850|FG001|Overall Study|Withdrawal by Subject|0|||
147112110|NCT04738487|530572851|FG000|Overall Study|Participant Ongoing in Study|298|||
147112111|NCT04738487|530572852|FG001|Overall Study|Participant Ongoing in Study|297|||
147112112|NCT04738487|530572851|FG000|Overall Study|Withdrawal by Subject|7|||
147112113|NCT04738487|530572852|FG001|Overall Study|Withdrawal by Subject|9|||
147112114|NCT04738487|530572851|FG000|Overall Study|Lost to Follow-up|2|||
147112115|NCT04738487|530572852|FG001|Overall Study|Lost to Follow-up|0|||
147112116|NCT04738487|530572851|FG000|Overall Study|Death|287|||
147112117|NCT04738487|530572852|FG001|Overall Study|Death|306|||
147112118|NCT02337686|530572864|FG000|Overall Study|Adverse Event|1|||
147112119|NCT00325416|530573689|FG000|Phase I: Dose Escalation|Pre-transplant screen failure|8|||
147112120|NCT00325416|530573690|FG001|Phase I: Dose Escalation|Pre-transplant screen failure|9|||
147112121|NCT00325416|530573689|FG000|Phase I: Dose Escalation|Denial of insurance coverage|7|||
147112122|NCT00325416|530573690|FG001|Phase I: Dose Escalation|Denial of insurance coverage|4|||
147112123|NCT00325416|530573689|FG000|Phase I: Dose Escalation|Withdrawal by Subject|7|||
147112124|NCT00325416|530573690|FG001|Phase I: Dose Escalation|Withdrawal by Subject|2|||
147112125|NCT00325416|530573689|FG000|Phase I: Dose Escalation|Inability to collect adequate stem cells|0|||
147112126|NCT00325416|530573690|FG001|Phase I: Dose Escalation|Inability to collect adequate stem cells|1|||
147112127|NCT00325416|530573689|FG000|Phase II: Treatment at MTD|denial of insurance coverage|0|||
147112128|NCT00325416|530573690|FG001|Phase II: Treatment at MTD|denial of insurance coverage|1|||
147112129|NCT00325416|530573689|FG000|Phase II: Treatment at MTD|Withdrawal by Subject|0|||
147112130|NCT00325416|530573690|FG001|Phase II: Treatment at MTD|Withdrawal by Subject|1|||
147112131|NCT06239610|530573691|FG000|Overall Study|no usable migration data for minimum of one day|11|||
147112132|NCT02324153|530573694|FG000|Overall Study|Withdrawal by Subject|4|||
147112133|NCT02324153|530573695|FG001|Overall Study|Withdrawal by Subject|1|||
147112134|NCT02324153|530573694|FG000|Overall Study|Surgery postponed after randomization|3|||
147112135|NCT02324153|530573695|FG001|Overall Study|Surgery postponed after randomization|0|||
147112136|NCT02324153|530573694|FG000|Overall Study|Developed delirium preoperatively|1|||
147112137|NCT02324153|530573695|FG001|Overall Study|Developed delirium preoperatively|0|||
147112138|NCT01937299|530573697|FG000|Overall Study|Adverse Event|13|||
147112139|NCT01937299|530573698|FG001|Overall Study|Adverse Event|0|||
147112140|NCT01937299|530573697|FG000|Overall Study|Lack of Efficacy|0|||
147112141|NCT01937299|530573698|FG001|Overall Study|Lack of Efficacy|4|||
147112142|NCT01937299|530573697|FG000|Overall Study|Withdrawal by Subject|1|||
147112143|NCT01937299|530573698|FG001|Overall Study|Withdrawal by Subject|0|||
147112144|NCT01913353|530573699|FG000|Overall Study|Adverse Event|2|||
147112145|NCT01913353|530573700|FG001|Overall Study|Adverse Event|0|||
147112146|NCT01913353|530573699|FG000|Overall Study|Physician Decision|0|||
147112147|NCT01913353|530573700|FG001|Overall Study|Physician Decision|2|||
147112148|NCT01913353|530573699|FG000|Overall Study|Withdrawal by Subject|20|||
147112149|NCT01913353|530573700|FG001|Overall Study|Withdrawal by Subject|6|||
147112150|NCT01913353|530573699|FG000|Overall Study|multiple reasons|10|||
147112151|NCT01913353|530573700|FG001|Overall Study|multiple reasons|7|||
147226416|NCT03739840|531002047|FG001|Treatment Period: Wk0-16|Premature Study Termination By Sponsor|0|||
147226417|NCT03739840|531002048|FG002|Treatment Period: Wk0-16|Premature Study Termination By Sponsor|1|||
147311102|NCT01027364|531307093|FG003|Overall Study|Adverse Event|0|||
147311103|NCT01027364|531307090|FG000|Overall Study|Lost to Follow-up|1|||
147311104|NCT01027364|531307091|FG001|Overall Study|Lost to Follow-up|0|||
147311105|NCT01027364|531307092|FG002|Overall Study|Lost to Follow-up|0|||
147311106|NCT01027364|531307093|FG003|Overall Study|Lost to Follow-up|0|||
147311107|NCT01027364|531307090|FG000|Overall Study|Protocol Violation|1|||
147311108|NCT01027364|531307091|FG001|Overall Study|Protocol Violation|0|||
147561146|NCT04885296|532212074|FG001|Period 1|Dispensed Study lens in Error|0|||
147561147|NCT04885296|532212073|FG000|Period 1|Lost to Follow-up|1|||
147561148|NCT04885296|532212074|FG001|Period 1|Lost to Follow-up|0|||
147226418|NCT03739840|531002049|FG003|Treatment Period: Wk0-16|Premature Study Termination By Sponsor|0|||
147226419|NCT03739840|531002046|FG000|Treatment Period: Wk0-16|Premature Closure Of The Study|0|||
147226420|NCT03739840|531002047|FG001|Treatment Period: Wk0-16|Premature Closure Of The Study|0|||
147226421|NCT03739840|531002048|FG002|Treatment Period: Wk0-16|Premature Closure Of The Study|1|||
147226422|NCT03739840|531002049|FG003|Treatment Period: Wk0-16|Premature Closure Of The Study|0|||
147226423|NCT03739840|531002046|FG000|Treatment Period: Wk0-16|Study Has Been Cancelled By The Sponsor|0|||
147311109|NCT01027364|531307092|FG002|Overall Study|Protocol Violation|0|||
147311110|NCT01027364|531307093|FG003|Overall Study|Protocol Violation|1|||
147311111|NCT01027364|531307090|FG000|Overall Study|Withdrawal by Subject|1|||
147561149|NCT04885296|532212073|FG000|Period 2|Subject No Longer Meets Eligibility Criteria|0|||
147561150|NCT04885296|532212074|FG001|Period 2|Subject No Longer Meets Eligibility Criteria|1|||
147112152|NCT00385840|530573701|FG000|Overall Study|Adverse Event|1|||
147112153|NCT00385840|530573702|FG001|Overall Study|Adverse Event|1|||
147112154|NCT00385840|530573701|FG000|Overall Study|Lost to Follow-up|3|||
147112155|NCT00385840|530573702|FG001|Overall Study|Lost to Follow-up|13|||
147112156|NCT04017962|530573703|FG000|Overall Study|Death|2|||
147112157|NCT04017962|530573704|FG001|Overall Study|Death|0|||
147561151|NCT00433147|532212076|FG000|Overall Study|Adverse Event|0|||
147311112|NCT01027364|531307091|FG001|Overall Study|Withdrawal by Subject|2|||
147112158|NCT04017962|530573703|FG000|Overall Study|Lost to Follow-up|2|||
147112159|NCT04017962|530573704|FG001|Overall Study|Lost to Follow-up|0|||
147112160|NCT04017962|530573703|FG000|Overall Study|Physician Decision|1|||
147112161|NCT04017962|530573704|FG001|Overall Study|Physician Decision|0|||
147112162|NCT04017962|530573703|FG000|Overall Study|Discontinued LTV|5|||
147112163|NCT04017962|530573704|FG001|Overall Study|Discontinued LTV|0|||
147112164|NCT01260948|530573706|FG000|Washout of 28 Days|Withdrawal by Subject|1|||
147112165|NCT01260948|530573707|FG001|Washout of 28 Days|Withdrawal by Subject|3|||
147112166|NCT01260948|530573706|FG000|Second Intervention|Emesis|0|||
147112167|NCT01260948|530573707|FG001|Second Intervention|Emesis|1|||
147112168|NCT00462462|530573708|FG000|Overall Study|Physician Decision|0|||
147112169|NCT00462462|530573709|FG001|Overall Study|Physician Decision|1|||
147112170|NCT02555878|530573710|FG000|Overall Study|Lost to Follow-up|2|||
147112171|NCT02555878|530573711|FG001|Overall Study|Lost to Follow-up|3|||
147112172|NCT02555878|530573710|FG000|Overall Study|Withdrawal by Subject|48|||
147112173|NCT02555878|530573711|FG001|Overall Study|Withdrawal by Subject|48|||
147112174|NCT02555878|530573710|FG000|Overall Study|Adverse Event|12|||
147112175|NCT02555878|530573711|FG001|Overall Study|Adverse Event|8|||
147112176|NCT02555878|530573710|FG000|Overall Study|Death|74|||
147112177|NCT02555878|530573711|FG001|Overall Study|Death|59|||
147112178|NCT02555878|530573710|FG000|Overall Study|Protocol Violation|1|||
147112179|NCT02555878|530573711|FG001|Overall Study|Protocol Violation|2|||
147112180|NCT02555878|530573710|FG000|Overall Study|Physician Decision|12|||
147112181|NCT02555878|530573711|FG001|Overall Study|Physician Decision|13|||
147112182|NCT02555878|530573710|FG000|Overall Study|Other|17|||
147112183|NCT02555878|530573711|FG001|Overall Study|Other|17|||
147112184|NCT00765076|530573712|FG000|Overall Study|Adverse Event|1|||
147112185|NCT00765076|530573713|FG001|Overall Study|Adverse Event|0|||
147112186|NCT00765076|530573714|FG002|Overall Study|Adverse Event|0|||
147226424|NCT03739840|531002047|FG001|Treatment Period: Wk0-16|Study Has Been Cancelled By The Sponsor|0|||
147226425|NCT03739840|531002048|FG002|Treatment Period: Wk0-16|Study Has Been Cancelled By The Sponsor|0|||
147561152|NCT00433147|532212077|FG001|Overall Study|Adverse Event|1|||
147561153|NCT00433147|532212078|FG002|Overall Study|Adverse Event|0|||
147561154|NCT00433147|532212079|FG003|Overall Study|Adverse Event|0|||
147561155|NCT01882647|532212080|FG000|Overall Study|Lost to Follow-up|2|||
147561156|NCT01882647|532212081|FG001|Overall Study|Lost to Follow-up|2|||
147561157|NCT01882647|532212080|FG000|Overall Study|Withdrawal by Subject|0|||
147561158|NCT01882647|532212081|FG001|Overall Study|Withdrawal by Subject|4|||
147561159|NCT02937701|532212082|FG000|Day 1 to Week 22|Adverse Event|11|||
147561160|NCT02937701|532212083|FG001|Day 1 to Week 22|Adverse Event|14|||
147561161|NCT02937701|532212084|FG002|Day 1 to Week 22|Adverse Event|0|||
147561162|NCT02937701|532212085|FG003|Day 1 to Week 22|Adverse Event|0|||
147561163|NCT02937701|532212086|FG004|Day 1 to Week 22|Adverse Event|0|||
147561164|NCT02937701|532212082|FG000|Day 1 to Week 22|Protocol Specified Criteria|7|||
147561165|NCT02937701|532212083|FG001|Day 1 to Week 22|Protocol Specified Criteria|7|||
147561166|NCT02937701|532212084|FG002|Day 1 to Week 22|Protocol Specified Criteria|0|||
147561167|NCT02937701|532212085|FG003|Day 1 to Week 22|Protocol Specified Criteria|0|||
147561168|NCT02937701|532212086|FG004|Day 1 to Week 22|Protocol Specified Criteria|0|||
147561169|NCT02937701|532212082|FG000|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|5|||
147561170|NCT02937701|532212083|FG001|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|9|||
147561171|NCT02937701|532212084|FG002|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|0|||
147561172|NCT02937701|532212085|FG003|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|0|||
147561173|NCT02937701|532212086|FG004|Day 1 to Week 22|Dissatisfied With Treatment Efficacy|0|||
147561174|NCT02937701|532212082|FG000|Day 1 to Week 22|Withdrawal by Subject|6|||
147561175|NCT02937701|532212083|FG001|Day 1 to Week 22|Withdrawal by Subject|6|||
147561176|NCT02937701|532212084|FG002|Day 1 to Week 22|Withdrawal by Subject|0|||
147561177|NCT02937701|532212085|FG003|Day 1 to Week 22|Withdrawal by Subject|0|||
147561178|NCT02937701|532212086|FG004|Day 1 to Week 22|Withdrawal by Subject|0|||
147226426|NCT03739840|531002049|FG003|Treatment Period: Wk0-16|Study Has Been Cancelled By The Sponsor|1|||
147226427|NCT03739840|531002046|FG000|Treatment Period: Wk0-16|Due To Sponsor Instruction|0|||
147226428|NCT03739840|531002047|FG001|Treatment Period: Wk0-16|Due To Sponsor Instruction|0|||
147226429|NCT03739840|531002048|FG002|Treatment Period: Wk0-16|Due To Sponsor Instruction|0|||
147226430|NCT03739840|531002049|FG003|Treatment Period: Wk0-16|Due To Sponsor Instruction|1|||
147226431|NCT03739840|531002046|FG000|Treatment Period: Wk0-16|Trial Was Closed By Sponsor|0|||
147561179|NCT02937701|532212082|FG000|Day 1 to Week 22|Death|1|||
147561180|NCT02937701|532212083|FG001|Day 1 to Week 22|Death|1|||
147561181|NCT02937701|532212084|FG002|Day 1 to Week 22|Death|0|||
147561182|NCT02937701|532212085|FG003|Day 1 to Week 22|Death|0|||
147226432|NCT03739840|531002047|FG001|Treatment Period: Wk0-16|Trial Was Closed By Sponsor|0|||
147226433|NCT03739840|531002048|FG002|Treatment Period: Wk0-16|Trial Was Closed By Sponsor|0|||
147561183|NCT02937701|532212086|FG004|Day 1 to Week 22|Death|0|||
147561184|NCT02937701|532212082|FG000|Day 1 to Week 22|Protocol Violation|1|||
147112187|NCT00765076|530573712|FG000|Overall Study|Withdrawal by Subject|0|||
147112188|NCT00765076|530573713|FG001|Overall Study|Withdrawal by Subject|0|||
147112189|NCT00765076|530573714|FG002|Overall Study|Withdrawal by Subject|1|||
147112190|NCT01163617|530573715|FG000|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
147112191|NCT01163617|530573716|FG001|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|1|||
147112192|NCT01163617|530573717|FG002|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
147112193|NCT01163617|530573718|FG003|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
147112194|NCT01163617|530573719|FG004|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
147112195|NCT01163617|530573720|FG005|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
147112196|NCT01163617|530573721|FG006|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
147112197|NCT01163617|530573722|FG007|Phase A (User Experience), Weeks 0 and 2|Withdrew consent|0|||
147112198|NCT01163617|530573715|FG000|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
147112199|NCT01163617|530573716|FG001|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|1|||
147112200|NCT01163617|530573717|FG002|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
147112201|NCT01163617|530573718|FG003|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
147112202|NCT01163617|530573719|FG004|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
147112203|NCT01163617|530573720|FG005|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
147112204|NCT01163617|530573721|FG006|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
147112205|NCT01163617|530573722|FG007|Phase A (User Experience), Weeks 0 and 2|Failed to meet inclusion criteria|0|||
147112206|NCT01163617|530573715|FG000|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
147112207|NCT01163617|530573716|FG001|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
147112208|NCT01163617|530573717|FG002|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|1|||
147112209|NCT01163617|530573718|FG003|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
147112210|NCT01163617|530573719|FG004|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
147112211|NCT01163617|530573720|FG005|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
147112212|NCT01163617|530573721|FG006|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
147112213|NCT01163617|530573722|FG007|Phase A (User Experience), Weeks 0 and 2|Didn't meet inclusion/exclusion criteria|0|||
147112214|NCT02875080|530573723|FG000|Overall Study|Positive urine test for cotinine on Day 20 or Day 40|2|||
147112215|NCT02875080|530573724|FG001|Overall Study|Positive urine test for cotinine on Day 20 or Day 40|0|||
147112216|NCT02875080|530573725|FG002|Overall Study|Positive urine test for cotinine on Day 20 or Day 40|0|||
147112217|NCT02394756|530573726|FG000|Period 1|Lens Discomfort|0|||
147112218|NCT02394756|530573727|FG001|Period 1|Lens Discomfort|0|||
147112219|NCT02394756|530573728|FG002|Period 1|Lens Discomfort|0|||
147112220|NCT02394756|530573729|FG003|Period 1|Lens Discomfort|0|||
147112221|NCT02394756|530573730|FG004|Period 1|Lens Discomfort|0|||
147112222|NCT02394756|530573731|FG005|Period 1|Lens Discomfort|1|||
147112223|NCT02394756|530573726|FG000|Period 1|Withdrawal by Subject|0|||
147112224|NCT02394756|530573727|FG001|Period 1|Withdrawal by Subject|1|||
147112225|NCT02394756|530573728|FG002|Period 1|Withdrawal by Subject|1|||
147112226|NCT02394756|530573729|FG003|Period 1|Withdrawal by Subject|1|||
147112227|NCT02394756|530573730|FG004|Period 1|Withdrawal by Subject|0|||
147112228|NCT02394756|530573731|FG005|Period 1|Withdrawal by Subject|0|||
147112229|NCT02394756|530573726|FG000|Period 2|Unsatisfactory Visual Response|0|||
147112230|NCT02394756|530573727|FG001|Period 2|Unsatisfactory Visual Response|0|||
147112231|NCT02394756|530573728|FG002|Period 2|Unsatisfactory Visual Response|0|||
147112232|NCT02394756|530573729|FG003|Period 2|Unsatisfactory Visual Response|0|||
147112233|NCT02394756|530573730|FG004|Period 2|Unsatisfactory Visual Response|1|||
147112234|NCT02394756|530573731|FG005|Period 2|Unsatisfactory Visual Response|0|||
147112235|NCT00768053|530573732|FG000|Overall Study|Adverse Event|10|||
147112236|NCT00768053|530573732|FG000|Overall Study|Lost to Follow-up|1|||
147112237|NCT01164475|530573733|FG000|Overall Study|Lack of Efficacy|1|||
147112238|NCT01164475|530573734|FG001|Overall Study|Lack of Efficacy|0|||
147112239|NCT01164475|530573733|FG000|Overall Study|Other|0|||
147112240|NCT01164475|530573734|FG001|Overall Study|Other|1|||
147112241|NCT01164475|530573733|FG000|Overall Study|Progressive disease|0|||
147112242|NCT01164475|530573734|FG001|Overall Study|Progressive disease|1|||
147112243|NCT01164475|530573733|FG000|Overall Study|Protocol Violation|1|||
147112244|NCT01164475|530573734|FG001|Overall Study|Protocol Violation|0|||
147112245|NCT02335944|530573735|FG000|Treatment Phase|Progressive Disease|2|||
147112246|NCT02335944|530573736|FG001|Treatment Phase|Progressive Disease|5|||
147112247|NCT02335944|530573737|FG002|Treatment Phase|Progressive Disease|2|||
147112248|NCT02335944|530573738|FG003|Treatment Phase|Progressive Disease|11|||
147112249|NCT02335944|530573739|FG004|Treatment Phase|Progressive Disease|4|||
147112250|NCT02335944|530573740|FG005|Treatment Phase|Progressive Disease|25|||
147311113|NCT01027364|531307092|FG002|Overall Study|Withdrawal by Subject|0|||
147311114|NCT01027364|531307093|FG003|Overall Study|Withdrawal by Subject|0|||
147112251|NCT02335944|530573741|FG006|Treatment Phase|Progressive Disease|2|||
147112252|NCT02335944|530573742|FG007|Treatment Phase|Progressive Disease|30|||
147112253|NCT02335944|530573743|FG008|Treatment Phase|Progressive Disease|27|||
147112254|NCT02335944|530573744|FG009|Treatment Phase|Progressive Disease|0|||
147112255|NCT02335944|530573735|FG000|Treatment Phase|Adverse Event|2|||
147112256|NCT02335944|530573736|FG001|Treatment Phase|Adverse Event|0|||
147112257|NCT02335944|530573737|FG002|Treatment Phase|Adverse Event|0|||
147112258|NCT02335944|530573738|FG003|Treatment Phase|Adverse Event|2|||
147112259|NCT02335944|530573739|FG004|Treatment Phase|Adverse Event|1|||
147112260|NCT02335944|530573740|FG005|Treatment Phase|Adverse Event|15|||
147112261|NCT02335944|530573741|FG006|Treatment Phase|Adverse Event|0|||
147112262|NCT02335944|530573742|FG007|Treatment Phase|Adverse Event|5|||
147112263|NCT02335944|530573743|FG008|Treatment Phase|Adverse Event|7|||
147112264|NCT02335944|530573744|FG009|Treatment Phase|Adverse Event|0|||
147112265|NCT02335944|530573735|FG000|Treatment Phase|Physician Decision|0|||
147112266|NCT02335944|530573736|FG001|Treatment Phase|Physician Decision|0|||
147112267|NCT02335944|530573737|FG002|Treatment Phase|Physician Decision|0|||
147112268|NCT02335944|530573738|FG003|Treatment Phase|Physician Decision|1|||
147112269|NCT02335944|530573739|FG004|Treatment Phase|Physician Decision|0|||
147112270|NCT02335944|530573740|FG005|Treatment Phase|Physician Decision|6|||
147112271|NCT02335944|530573741|FG006|Treatment Phase|Physician Decision|1|||
147112272|NCT02335944|530573742|FG007|Treatment Phase|Physician Decision|2|||
147112273|NCT02335944|530573743|FG008|Treatment Phase|Physician Decision|1|||
147112274|NCT02335944|530573744|FG009|Treatment Phase|Physician Decision|0|||
147112275|NCT02335944|530573735|FG000|Treatment Phase|Study Terminated By Sponsor|0|||
147112276|NCT02335944|530573736|FG001|Treatment Phase|Study Terminated By Sponsor|0|||
147112277|NCT02335944|530573737|FG002|Treatment Phase|Study Terminated By Sponsor|0|||
147112278|NCT02335944|530573738|FG003|Treatment Phase|Study Terminated By Sponsor|1|||
147112279|NCT02335944|530573739|FG004|Treatment Phase|Study Terminated By Sponsor|0|||
147112280|NCT02335944|530573740|FG005|Treatment Phase|Study Terminated By Sponsor|3|||
147112281|NCT02335944|530573741|FG006|Treatment Phase|Study Terminated By Sponsor|0|||
147112282|NCT02335944|530573742|FG007|Treatment Phase|Study Terminated By Sponsor|1|||
147112283|NCT02335944|530573743|FG008|Treatment Phase|Study Terminated By Sponsor|1|||
147112284|NCT02335944|530573744|FG009|Treatment Phase|Study Terminated By Sponsor|0|||
147112285|NCT02335944|530573735|FG000|Treatment Phase|Subject/Guardian Decision|0|||
147112286|NCT02335944|530573736|FG001|Treatment Phase|Subject/Guardian Decision|0|||
147112287|NCT02335944|530573737|FG002|Treatment Phase|Subject/Guardian Decision|1|||
147112288|NCT02335944|530573738|FG003|Treatment Phase|Subject/Guardian Decision|0|||
147112289|NCT02335944|530573739|FG004|Treatment Phase|Subject/Guardian Decision|0|||
147112290|NCT02335944|530573740|FG005|Treatment Phase|Subject/Guardian Decision|1|||
147112291|NCT02335944|530573741|FG006|Treatment Phase|Subject/Guardian Decision|0|||
147112292|NCT02335944|530573742|FG007|Treatment Phase|Subject/Guardian Decision|4|||
147112293|NCT02335944|530573743|FG008|Treatment Phase|Subject/Guardian Decision|0|||
147112294|NCT02335944|530573744|FG009|Treatment Phase|Subject/Guardian Decision|0|||
147112295|NCT02335944|530573735|FG000|Post-treatment Follow-up|Progressive Disease|0|||
147112296|NCT02335944|530573736|FG001|Post-treatment Follow-up|Progressive Disease|0|||
147112297|NCT02335944|530573737|FG002|Post-treatment Follow-up|Progressive Disease|0|||
147112298|NCT02335944|530573738|FG003|Post-treatment Follow-up|Progressive Disease|1|||
147112299|NCT02335944|530573739|FG004|Post-treatment Follow-up|Progressive Disease|0|||
147112300|NCT02335944|530573740|FG005|Post-treatment Follow-up|Progressive Disease|9|||
147112301|NCT02335944|530573741|FG006|Post-treatment Follow-up|Progressive Disease|0|||
147112302|NCT02335944|530573742|FG007|Post-treatment Follow-up|Progressive Disease|2|||
147112303|NCT02335944|530573743|FG008|Post-treatment Follow-up|Progressive Disease|3|||
147112304|NCT02335944|530573744|FG009|Post-treatment Follow-up|Progressive Disease|0|||
147112305|NCT02335944|530573735|FG000|Post-treatment Follow-up|Subject/Guardian Decision|0|||
147112306|NCT02335944|530573736|FG001|Post-treatment Follow-up|Subject/Guardian Decision|0|||
147112307|NCT02335944|530573737|FG002|Post-treatment Follow-up|Subject/Guardian Decision|0|||
147112308|NCT02335944|530573738|FG003|Post-treatment Follow-up|Subject/Guardian Decision|0|||
147112309|NCT02335944|530573739|FG004|Post-treatment Follow-up|Subject/Guardian Decision|0|||
147112310|NCT02335944|530573740|FG005|Post-treatment Follow-up|Subject/Guardian Decision|2|||
147112311|NCT02335944|530573741|FG006|Post-treatment Follow-up|Subject/Guardian Decision|0|||
147112312|NCT02335944|530573742|FG007|Post-treatment Follow-up|Subject/Guardian Decision|0|||
147112313|NCT02335944|530573743|FG008|Post-treatment Follow-up|Subject/Guardian Decision|0|||
147112314|NCT02335944|530573744|FG009|Post-treatment Follow-up|Subject/Guardian Decision|0|||
147112315|NCT02335944|530573735|FG000|Post-treatment Follow-up|Terminated by Sponsor|0|||
147226434|NCT03739840|531002049|FG003|Treatment Period: Wk0-16|Trial Was Closed By Sponsor|1|||
147226435|NCT03739840|531002046|FG000|Post-Treatment Period: Wk16-23|Adverse Event|3|||
147226436|NCT03739840|531002047|FG001|Post-Treatment Period: Wk16-23|Adverse Event|0|||
147561185|NCT02937701|532212083|FG001|Day 1 to Week 22|Protocol Violation|1|||
147561186|NCT02937701|532212084|FG002|Day 1 to Week 22|Protocol Violation|0|||
147226437|NCT03739840|531002048|FG002|Post-Treatment Period: Wk16-23|Adverse Event|0|||
147226438|NCT03739840|531002049|FG003|Post-Treatment Period: Wk16-23|Adverse Event|0|||
147226439|NCT03739840|531002046|FG000|Post-Treatment Period: Wk16-23|Consent Withdrawn|0|||
147561187|NCT02937701|532212085|FG003|Day 1 to Week 22|Protocol Violation|0|||
147112316|NCT02335944|530573736|FG001|Post-treatment Follow-up|Terminated by Sponsor|0|||
147112317|NCT02335944|530573737|FG002|Post-treatment Follow-up|Terminated by Sponsor|0|||
147112318|NCT02335944|530573738|FG003|Post-treatment Follow-up|Terminated by Sponsor|0|||
147226440|NCT03739840|531002047|FG001|Post-Treatment Period: Wk16-23|Consent Withdrawn|0|||
147311115|NCT03119610|531307094|FG000|Overall Study|Adverse Event|1|||
147311116|NCT03119610|531307095|FG001|Overall Study|Adverse Event|0|||
147112319|NCT02335944|530573739|FG004|Post-treatment Follow-up|Terminated by Sponsor|0|||
147112320|NCT02335944|530573740|FG005|Post-treatment Follow-up|Terminated by Sponsor|0|||
147112321|NCT02335944|530573741|FG006|Post-treatment Follow-up|Terminated by Sponsor|0|||
147112322|NCT02335944|530573742|FG007|Post-treatment Follow-up|Terminated by Sponsor|2|||
147112323|NCT02335944|530573743|FG008|Post-treatment Follow-up|Terminated by Sponsor|0|||
147112324|NCT02335944|530573744|FG009|Post-treatment Follow-up|Terminated by Sponsor|0|||
147112325|NCT02335944|530573735|FG000|Post-treatment Follow-up|Adverse Event|0|||
147112326|NCT02335944|530573736|FG001|Post-treatment Follow-up|Adverse Event|0|||
147112327|NCT02335944|530573737|FG002|Post-treatment Follow-up|Adverse Event|0|||
147112328|NCT02335944|530573738|FG003|Post-treatment Follow-up|Adverse Event|0|||
147112329|NCT02335944|530573739|FG004|Post-treatment Follow-up|Adverse Event|0|||
147112330|NCT02335944|530573740|FG005|Post-treatment Follow-up|Adverse Event|1|||
147112331|NCT02335944|530573741|FG006|Post-treatment Follow-up|Adverse Event|0|||
147112332|NCT02335944|530573742|FG007|Post-treatment Follow-up|Adverse Event|0|||
147112333|NCT02335944|530573743|FG008|Post-treatment Follow-up|Adverse Event|0|||
147112334|NCT02335944|530573744|FG009|Post-treatment Follow-up|Adverse Event|0|||
147112335|NCT02335944|530573735|FG000|Post-treatment Follow-up|Death|0|||
147112336|NCT02335944|530573736|FG001|Post-treatment Follow-up|Death|0|||
147112337|NCT02335944|530573737|FG002|Post-treatment Follow-up|Death|0|||
147112338|NCT02335944|530573738|FG003|Post-treatment Follow-up|Death|1|||
147112339|NCT02335944|530573739|FG004|Post-treatment Follow-up|Death|0|||
147112340|NCT02335944|530573740|FG005|Post-treatment Follow-up|Death|1|||
147112341|NCT02335944|530573741|FG006|Post-treatment Follow-up|Death|0|||
147112342|NCT02335944|530573742|FG007|Post-treatment Follow-up|Death|0|||
147112343|NCT02335944|530573743|FG008|Post-treatment Follow-up|Death|0|||
147112344|NCT02335944|530573744|FG009|Post-treatment Follow-up|Death|0|||
147112345|NCT02335944|530573735|FG000|Post-treatment Follow-up|Physician Decision|1|||
147112346|NCT02335944|530573736|FG001|Post-treatment Follow-up|Physician Decision|0|||
147112347|NCT02335944|530573737|FG002|Post-treatment Follow-up|Physician Decision|0|||
147112348|NCT02335944|530573738|FG003|Post-treatment Follow-up|Physician Decision|0|||
147112349|NCT02335944|530573739|FG004|Post-treatment Follow-up|Physician Decision|0|||
147112350|NCT02335944|530573740|FG005|Post-treatment Follow-up|Physician Decision|0|||
147112351|NCT02335944|530573741|FG006|Post-treatment Follow-up|Physician Decision|0|||
147112352|NCT02335944|530573742|FG007|Post-treatment Follow-up|Physician Decision|1|||
147112353|NCT02335944|530573743|FG008|Post-treatment Follow-up|Physician Decision|0|||
147112354|NCT02335944|530573744|FG009|Post-treatment Follow-up|Physician Decision|0|||
147112355|NCT03018938|530573745|FG000|Overall Study|Death|0|||
147112356|NCT03018938|530573746|FG001|Overall Study|Death|1|||
147112357|NCT03018938|530573745|FG000|Overall Study|Lost to Follow-up|21|||
147112358|NCT03018938|530573746|FG001|Overall Study|Lost to Follow-up|32|||
147112359|NCT03018938|530573745|FG000|Overall Study|Withdrawal by Subject|38|||
147112360|NCT03018938|530573746|FG001|Overall Study|Withdrawal by Subject|45|||
147112361|NCT03018938|530573745|FG000|Overall Study|Physician Decision|3|||
147112362|NCT03018938|530573746|FG001|Overall Study|Physician Decision|2|||
147112363|NCT03018938|530573745|FG000|Overall Study|Sponsor Decision|0|||
147112364|NCT03018938|530573746|FG001|Overall Study|Sponsor Decision|1|||
147112365|NCT03018938|530573745|FG000|Overall Study|Screen failure-After randomization|4|||
147112366|NCT03018938|530573746|FG001|Overall Study|Screen failure-After randomization|2|||
147311117|NCT03119610|531307094|FG000|Overall Study|Lost to Follow-up|0|||
147311118|NCT03119610|531307095|FG001|Overall Study|Lost to Follow-up|1|||
147311119|NCT00114634|531307120|FG000|Overall Study|failure to return forms|3|||
147311120|NCT03283696|531307121|FG000|Overall Study|Physician Decision|5|||
147112367|NCT03018938|530573745|FG000|Overall Study|Not recorded|0|||
147311121|NCT03283696|531307122|FG001|Overall Study|Physician Decision|6|||
147311122|NCT03283696|531307121|FG000|Overall Study|Withdrawal by Subject|2|||
147311123|NCT03283696|531307122|FG001|Overall Study|Withdrawal by Subject|0|||
147311124|NCT00684762|531307125|FG000|Washout Period of 7 Days|Withdrawal by Subject|2|||
147311125|NCT00684762|531307126|FG001|Washout Period of 7 Days|Withdrawal by Subject|2|||
147311126|NCT00439179|531307136|FG000|Overall Study|* 1 pt inelig, 1 pt numb not used|0|||
147311127|NCT00439179|531307137|FG001|Overall Study|* 1 pt inelig, 1 pt numb not used|2|||
147311128|NCT00439179|531307138|FG002|Overall Study|* 1 pt inelig, 1 pt numb not used|0|||
147311129|NCT00439179|531307139|FG003|Overall Study|* 1 pt inelig, 1 pt numb not used|0|||
147311130|NCT06173570|531307142|FG000|Overall Study|Adverse Event|1|||
147112368|NCT03018938|530573746|FG001|Overall Study|Not recorded|2|||
147311131|NCT06173570|531307143|FG001|Overall Study|Adverse Event|0|||
147112369|NCT01202591|530573747|FG000|Overall Study|Adverse Event|2|||
147112370|NCT01202591|530573748|FG001|Overall Study|Adverse Event|1|||
147112371|NCT01202591|530573749|FG002|Overall Study|Adverse Event|4|||
147112372|NCT01202591|530573750|FG003|Overall Study|Adverse Event|4|||
147112373|NCT01202591|530573751|FG004|Overall Study|Adverse Event|0|||
147112374|NCT01202591|530573752|FG005|Overall Study|Adverse Event|0|||
147112375|NCT01202591|530573747|FG000|Overall Study|Other reason as per investigator|3|||
147112376|NCT01202591|530573748|FG001|Overall Study|Other reason as per investigator|4|||
147112377|NCT01202591|530573749|FG002|Overall Study|Other reason as per investigator|7|||
147112378|NCT01202591|530573750|FG003|Overall Study|Other reason as per investigator|3|||
147311132|NCT06173570|531307144|FG002|Overall Study|Adverse Event|0|||
147112379|NCT01202591|530573751|FG004|Overall Study|Other reason as per investigator|1|||
147112380|NCT01202591|530573752|FG005|Overall Study|Other reason as per investigator|3|||
147112381|NCT01202591|530573747|FG000|Overall Study|Withdrawal by Subject|0|||
147112382|NCT01202591|530573748|FG001|Overall Study|Withdrawal by Subject|0|||
147112383|NCT01202591|530573749|FG002|Overall Study|Withdrawal by Subject|0|||
147112384|NCT01202591|530573750|FG003|Overall Study|Withdrawal by Subject|0|||
147112385|NCT01202591|530573751|FG004|Overall Study|Withdrawal by Subject|2|||
147112386|NCT01202591|530573752|FG005|Overall Study|Withdrawal by Subject|1|||
147112387|NCT01202591|530573747|FG000|Overall Study|Objective Disease Progression|0|||
147112388|NCT01202591|530573748|FG001|Overall Study|Objective Disease Progression|0|||
147112389|NCT01202591|530573749|FG002|Overall Study|Objective Disease Progression|0|||
147112390|NCT01202591|530573750|FG003|Overall Study|Objective Disease Progression|0|||
147112391|NCT01202591|530573751|FG004|Overall Study|Objective Disease Progression|2|||
147112392|NCT01202591|530573752|FG005|Overall Study|Objective Disease Progression|0|||
147112393|NCT00191100|530573755|FG000|Overall Study|Adverse Event|18|||
147112394|NCT00191100|530573756|FG001|Overall Study|Adverse Event|1|||
147112395|NCT00191100|530573755|FG000|Overall Study|Lost to Follow-up|2|||
147112396|NCT00191100|530573756|FG001|Overall Study|Lost to Follow-up|0|||
147112397|NCT00191100|530573755|FG000|Overall Study|Patient Moved|0|||
147112398|NCT00191100|530573756|FG001|Overall Study|Patient Moved|1|||
147112399|NCT00191100|530573755|FG000|Overall Study|Withdrawal by Subject|9|||
147112400|NCT00191100|530573756|FG001|Overall Study|Withdrawal by Subject|3|||
147112401|NCT00191100|530573755|FG000|Overall Study|Protocol Entry Criteria Not Met|2|||
147112402|NCT00191100|530573756|FG001|Overall Study|Protocol Entry Criteria Not Met|1|||
147112403|NCT00191100|530573755|FG000|Overall Study|Clinical Relapse|2|||
147112404|NCT00191100|530573756|FG001|Overall Study|Clinical Relapse|1|||
147112405|NCT00191100|530573755|FG000|Overall Study|Lack of Efficacy, Progressive Disease|1|||
147112406|NCT00191100|530573756|FG001|Overall Study|Lack of Efficacy, Progressive Disease|2|||
147112407|NCT00191100|530573755|FG000|Overall Study|Lack of Efficacy, Stable Disease|1|||
147112408|NCT00191100|530573756|FG001|Overall Study|Lack of Efficacy, Stable Disease|0|||
147112409|NCT00191100|530573755|FG000|Overall Study|Physician Decision|3|||
147112410|NCT00191100|530573756|FG001|Overall Study|Physician Decision|1|||
147112411|NCT00191100|530573755|FG000|Overall Study|Death from Study Drug Toxicity|2|||
147112412|NCT00191100|530573756|FG001|Overall Study|Death from Study Drug Toxicity|0|||
147112413|NCT00191100|530573755|FG000|Overall Study|Protocol Violation|1|||
147112414|NCT00191100|530573756|FG001|Overall Study|Protocol Violation|1|||
147112415|NCT00191100|530573755|FG000|Overall Study|Death from Other Cause|1|||
147112416|NCT00191100|530573756|FG001|Overall Study|Death from Other Cause|0|||
147112417|NCT00191100|530573755|FG000|Overall Study|Reason Not Specified|0|||
147112418|NCT00191100|530573756|FG001|Overall Study|Reason Not Specified|1|||
147112419|NCT02406612|530573757|FG000|Overall Study|Screening Failure|3|||
147112420|NCT02406612|530573758|FG001|Overall Study|Screening Failure|0|||
147112421|NCT02406612|530573757|FG000|Overall Study|Intra-procedural Exclusion|1|||
147112422|NCT02406612|530573758|FG001|Overall Study|Intra-procedural Exclusion|3|||
147112423|NCT02406612|530573757|FG000|Overall Study|Guidewire Failure|0|||
147112424|NCT02406612|530573758|FG001|Overall Study|Guidewire Failure|1|||
147112425|NCT02830087|530573763|FG000|Overall Study|No study staff to follow-up patients|4|||
147112426|NCT02830087|530573764|FG001|Overall Study|No study staff to follow-up patients|4|||
147112427|NCT02830087|530573765|FG002|Overall Study|No study staff to follow-up patients|4|||
147112428|NCT02830087|530573766|FG003|Overall Study|No study staff to follow-up patients|3|||
147112429|NCT02830087|530573767|FG004|Overall Study|No study staff to follow-up patients|3|||
147112430|NCT02830087|530573768|FG005|Overall Study|No study staff to follow-up patients|3|||
147112431|NCT02916771|530573769|FG000|Overall Study|Withdrawal by Subject|9|||
147112432|NCT02916771|530573769|FG000|Overall Study|Physician Decision|1|||
147112433|NCT02916771|530573769|FG000|Overall Study|Began treatment for another active malignancy|1|||
147112434|NCT00529035|530574468|FG000|Overall Study|Withdrawal by Subject|1|||
147311133|NCT06173570|531307145|FG003|Overall Study|Adverse Event|2|||
147311134|NCT06173570|531307146|FG004|Overall Study|Adverse Event|0|||
147311135|NCT06173570|531307142|FG000|Overall Study|Lost to Follow-up|1|||
147311136|NCT06173570|531307143|FG001|Overall Study|Lost to Follow-up|0|||
147311137|NCT06173570|531307144|FG002|Overall Study|Lost to Follow-up|0|||
147311138|NCT06173570|531307145|FG003|Overall Study|Lost to Follow-up|0|||
147112435|NCT01879852|530574469|FG000|Overall Study|Withdrawal by Subject|2|||
147112436|NCT01879852|530574470|FG001|Overall Study|Withdrawal by Subject|0|||
147112437|NCT02115386|530574471|FG000|Overall Study|Protocol Violation|1|||
147112438|NCT02115386|530574471|FG000|Overall Study|Administrative - trial was terminated|6|||
147311139|NCT06173570|531307146|FG004|Overall Study|Lost to Follow-up|2|||
147112439|NCT02493855|530574472|FG000|Overall Study|Non-compliance|1|||
147112440|NCT02493855|530574473|FG001|Overall Study|Non-compliance|0|||
147112441|NCT02493855|530574474|FG002|Overall Study|Non-compliance|0|||
147112442|NCT02493855|530574472|FG000|Overall Study|Adverse Event|0|||
147112443|NCT02493855|530574473|FG001|Overall Study|Adverse Event|1|||
147112444|NCT02493855|530574474|FG002|Overall Study|Adverse Event|0|||
147112445|NCT02493855|530574472|FG000|Overall Study|Withdrawal by Subject|1|||
147311140|NCT06173570|531307142|FG000|Overall Study|Protocol Violation|0|||
147311141|NCT06173570|531307143|FG001|Overall Study|Protocol Violation|2|||
147311142|NCT06173570|531307144|FG002|Overall Study|Protocol Violation|0|||
147311143|NCT06173570|531307145|FG003|Overall Study|Protocol Violation|0|||
147311144|NCT06173570|531307146|FG004|Overall Study|Protocol Violation|1|||
147311145|NCT06173570|531307142|FG000|Overall Study|Withdrawal by Subject|0|||
147311146|NCT06173570|531307143|FG001|Overall Study|Withdrawal by Subject|1|||
147311147|NCT06173570|531307144|FG002|Overall Study|Withdrawal by Subject|1|||
147311148|NCT06173570|531307145|FG003|Overall Study|Withdrawal by Subject|1|||
147311149|NCT06173570|531307146|FG004|Overall Study|Withdrawal by Subject|1|||
147311150|NCT06173570|531307142|FG000|Overall Study|Non-compliance with Study Drug|1|||
147311151|NCT06173570|531307143|FG001|Overall Study|Non-compliance with Study Drug|0|||
147311152|NCT06173570|531307144|FG002|Overall Study|Non-compliance with Study Drug|0|||
147311153|NCT06173570|531307145|FG003|Overall Study|Non-compliance with Study Drug|0|||
147311154|NCT06173570|531307146|FG004|Overall Study|Non-compliance with Study Drug|0|||
147311155|NCT06173570|531307142|FG000|Overall Study|Screen Failure|0|||
147311156|NCT06173570|531307143|FG001|Overall Study|Screen Failure|0|||
147112446|NCT02493855|530574473|FG001|Overall Study|Withdrawal by Subject|0|||
147311157|NCT06173570|531307144|FG002|Overall Study|Screen Failure|0|||
147311158|NCT06173570|531307145|FG003|Overall Study|Screen Failure|0|||
147311159|NCT06173570|531307146|FG004|Overall Study|Screen Failure|1|||
147311160|NCT06173570|531307142|FG000|Overall Study|Other|2|||
147311161|NCT06173570|531307143|FG001|Overall Study|Other|1|||
147311162|NCT06173570|531307144|FG002|Overall Study|Other|0|||
147311163|NCT06173570|531307145|FG003|Overall Study|Other|2|||
147311164|NCT06173570|531307146|FG004|Overall Study|Other|0|||
147311165|NCT01844115|531307149|FG000|Overall Study|Adverse Event|4|||
147311166|NCT01844115|531307150|FG001|Overall Study|Adverse Event|22|||
147311167|NCT01844115|531307149|FG000|Overall Study|Lack of Efficacy|1|||
147311168|NCT01844115|531307150|FG001|Overall Study|Lack of Efficacy|4|||
147311169|NCT01844115|531307149|FG000|Overall Study|Protocol Violation|12|||
147311170|NCT01844115|531307150|FG001|Overall Study|Protocol Violation|10|||
147311171|NCT01844115|531307149|FG000|Overall Study|Withdrawal by Subject|11|||
147311172|NCT01844115|531307150|FG001|Overall Study|Withdrawal by Subject|11|||
147311173|NCT01844115|531307149|FG000|Overall Study|Lost to Follow-up|11|||
147311174|NCT01844115|531307150|FG001|Overall Study|Lost to Follow-up|10|||
147311175|NCT01844115|531307149|FG000|Overall Study|Pregnancy|0|||
147311176|NCT01844115|531307150|FG001|Overall Study|Pregnancy|1|||
147561188|NCT02937701|532212086|FG004|Day 1 to Week 22|Protocol Violation|0|||
147112447|NCT02493855|530574474|FG002|Overall Study|Withdrawal by Subject|0|||
147112448|NCT02453048|530574475|FG000|Overall Study|Only part of initial 6 mo. study|0|||
147112449|NCT02453048|530574476|FG001|Overall Study|Only part of initial 6 mo. study|0|||
147112450|NCT02453048|530574477|FG002|Overall Study|Only part of initial 6 mo. study|0|||
147112451|NCT02453048|530574478|FG003|Overall Study|Only part of initial 6 mo. study|0|||
147112452|NCT02453048|530574479|FG004|Overall Study|Only part of initial 6 mo. study|6|||
147112453|NCT02453048|530574475|FG000|Overall Study|Lost to Follow-up|0|||
147112454|NCT02453048|530574476|FG001|Overall Study|Lost to Follow-up|1|||
147112455|NCT02453048|530574477|FG002|Overall Study|Lost to Follow-up|2|||
147112456|NCT02453048|530574478|FG003|Overall Study|Lost to Follow-up|0|||
147112457|NCT02453048|530574479|FG004|Overall Study|Lost to Follow-up|0|||
147112458|NCT00741611|530574481|FG000|Overall Study|Death|0|||
147112459|NCT00741611|530574482|FG001|Overall Study|Death|0|||
147112460|NCT00741611|530574483|FG002|Overall Study|Death|1|||
147112461|NCT00741611|530574481|FG000|Overall Study|Withdrawal by Subject|0|||
147112462|NCT00741611|530574482|FG001|Overall Study|Withdrawal by Subject|2|||
147112463|NCT00741611|530574483|FG002|Overall Study|Withdrawal by Subject|2|||
147112464|NCT04339972|530574488|FG000|Overall Study|Scheduling Issues|3|||
147112465|NCT04339972|530574489|FG001|Overall Study|Scheduling Issues|3|||
147112466|NCT04339972|530574488|FG000|Overall Study|dropout|1|||
147112467|NCT04339972|530574489|FG001|Overall Study|dropout|1|||
147112468|NCT04339972|530574488|FG000|Overall Study|Technical issues|1|||
147112469|NCT04339972|530574489|FG001|Overall Study|Technical issues|0|||
147112470|NCT04339972|530574488|FG000|Overall Study|Claustraphobia|0|||
147311177|NCT00758160|531307151|FG000|Overall Study|No Longer Requires Study Medication|4|||
147311178|NCT00758160|531307151|FG000|Overall Study|Administration Problems|3|||
147561189|NCT02937701|532212082|FG000|Day 1 to Week 22|Lost to Follow-up|1|||
147561190|NCT02937701|532212083|FG001|Day 1 to Week 22|Lost to Follow-up|1|||
147561191|NCT02937701|532212084|FG002|Day 1 to Week 22|Lost to Follow-up|0|||
147311179|NCT00758160|531307151|FG000|Overall Study|Adverse Event|15|||
147311180|NCT00758160|531307151|FG000|Overall Study|Lack of Efficacy|10|||
147311181|NCT00758160|531307151|FG000|Overall Study|Lost to Follow-up|14|||
147311182|NCT00758160|531307151|FG000|Overall Study|Protocol Violation|12|||
147311183|NCT00758160|531307151|FG000|Overall Study|Withdrawal by Subject|8|||
147561192|NCT02937701|532212085|FG003|Day 1 to Week 22|Lost to Follow-up|0|||
147112471|NCT04339972|530574489|FG001|Overall Study|Claustraphobia|1|||
147112472|NCT02403271|530574490|FG000|Period 1|Other varied reasons|1|||
147112473|NCT02403271|530574491|FG001|Period 1|Other varied reasons|0|||
147311184|NCT00545363|531307152|FG000|Overall Study|Adverse Event|6|||
147311185|NCT00545363|531307153|FG001|Overall Study|Adverse Event|7|||
147311186|NCT00545363|531307152|FG000|Overall Study|Withdrawal by Subject|6|||
147112474|NCT02403271|530574490|FG000|Period 2|Withdrawal by Subject|0|||
147112475|NCT02403271|530574491|FG001|Period 2|Withdrawal by Subject|14|||
147112476|NCT02403271|530574490|FG000|Period 2|Death|0|||
147112477|NCT02403271|530574491|FG001|Period 2|Death|84|||
147112478|NCT02403271|530574490|FG000|Period 2|Lost to Follow-up|0|||
147112479|NCT02403271|530574491|FG001|Period 2|Lost to Follow-up|2|||
147112480|NCT02403271|530574490|FG000|Period 2|Study Terminated by Sponsor|0|||
147112481|NCT02403271|530574491|FG001|Period 2|Study Terminated by Sponsor|14|||
147112482|NCT02403271|530574490|FG000|Period 2|Other varied reasons|0|||
147112483|NCT02403271|530574491|FG001|Period 2|Other varied reasons|10|||
147112484|NCT03487445|530574494|FG000|Randomization|Not treated for administrative reasons|1|||
147112485|NCT03487445|530574495|FG001|Randomization|Not treated for administrative reasons|0|||
147112486|NCT00221104|530574496|FG000|Overall Study|Adverse Event|1|||
147112487|NCT00221104|530574497|FG001|Overall Study|Adverse Event|0|||
147112488|NCT00221104|530574496|FG000|Overall Study|Physician Decision|1|||
147112489|NCT00221104|530574497|FG001|Overall Study|Physician Decision|0|||
147112490|NCT00221104|530574496|FG000|Overall Study|Protocol Violation|2|||
147112491|NCT00221104|530574497|FG001|Overall Study|Protocol Violation|0|||
147112492|NCT00221104|530574496|FG000|Overall Study|Withdrawal by Subject|42|||
147112493|NCT00221104|530574497|FG001|Overall Study|Withdrawal by Subject|29|||
147112494|NCT00221104|530574496|FG000|Overall Study|Others|37|||
147112495|NCT00221104|530574497|FG001|Overall Study|Others|47|||
147112496|NCT02989389|530574498|FG000|Period 1|Lost to Follow-up|0|||
147112497|NCT02989389|530574499|FG001|Period 1|Lost to Follow-up|1|||
147112498|NCT02989389|530574500|FG002|Period 1|Lost to Follow-up|0|||
147112499|NCT02989389|530574501|FG003|Period 1|Lost to Follow-up|0|||
147112500|NCT02989389|530574502|FG004|Period 1|Lost to Follow-up|0|||
147112501|NCT02989389|530574503|FG005|Period 1|Lost to Follow-up|0|||
147112502|NCT02989389|530574504|FG006|Period 1|Lost to Follow-up|0|||
147112503|NCT02989389|530574505|FG007|Period 1|Lost to Follow-up|0|||
147112504|NCT02989389|530574506|FG008|Period 1|Lost to Follow-up|0|||
147112505|NCT02989389|530574507|FG009|Period 1|Lost to Follow-up|0|||
147112506|NCT02989389|530574498|FG000|Period 1|Physician Decision|0|||
147112507|NCT02989389|530574499|FG001|Period 1|Physician Decision|0|||
147112508|NCT02989389|530574500|FG002|Period 1|Physician Decision|0|||
147112509|NCT02989389|530574501|FG003|Period 1|Physician Decision|0|||
147226441|NCT03739840|531002048|FG002|Post-Treatment Period: Wk16-23|Consent Withdrawn|0|||
147226442|NCT03739840|531002049|FG003|Post-Treatment Period: Wk16-23|Consent Withdrawn|1|||
147226443|NCT03739840|531002046|FG000|Post-Treatment Period: Wk16-23|Sponsor Decision To Terminate The Study|1|||
147112510|NCT02989389|530574502|FG004|Period 1|Physician Decision|0|||
147112511|NCT02989389|530574503|FG005|Period 1|Physician Decision|0|||
147226444|NCT03739840|531002047|FG001|Post-Treatment Period: Wk16-23|Sponsor Decision To Terminate The Study|0|||
147226445|NCT03739840|531002048|FG002|Post-Treatment Period: Wk16-23|Sponsor Decision To Terminate The Study|0|||
147226446|NCT03739840|531002049|FG003|Post-Treatment Period: Wk16-23|Sponsor Decision To Terminate The Study|0|||
147226447|NCT03739840|531002046|FG000|Post-Treatment Period: Wk16-23|Sponsor's Decision|0|||
147226448|NCT03739840|531002047|FG001|Post-Treatment Period: Wk16-23|Sponsor's Decision|1|||
147226449|NCT03739840|531002048|FG002|Post-Treatment Period: Wk16-23|Sponsor's Decision|0|||
147226450|NCT03739840|531002049|FG003|Post-Treatment Period: Wk16-23|Sponsor's Decision|0|||
147226451|NCT03739840|531002046|FG000|Post-Treatment Period: Wk16-23|Sponsor Closed Study- Subject Was Discontinued|0|||
147226452|NCT03739840|531002047|FG001|Post-Treatment Period: Wk16-23|Sponsor Closed Study- Subject Was Discontinued|1|||
147226453|NCT03739840|531002048|FG002|Post-Treatment Period: Wk16-23|Sponsor Closed Study- Subject Was Discontinued|0|||
147226454|NCT03739840|531002049|FG003|Post-Treatment Period: Wk16-23|Sponsor Closed Study- Subject Was Discontinued|0|||
147226455|NCT03739840|531002046|FG000|Post-Treatment Period: Wk16-23|Sponsor Decision + Subject Refusal|0|||
147226456|NCT03739840|531002047|FG001|Post-Treatment Period: Wk16-23|Sponsor Decision + Subject Refusal|0|||
147226457|NCT03739840|531002048|FG002|Post-Treatment Period: Wk16-23|Sponsor Decision + Subject Refusal|1|||
147226458|NCT03739840|531002049|FG003|Post-Treatment Period: Wk16-23|Sponsor Decision + Subject Refusal|0|||
147226459|NCT03739840|531002046|FG000|Post-Treatment Period: Wk16-23|Early Study Closure|0|||
147226460|NCT03739840|531002047|FG001|Post-Treatment Period: Wk16-23|Early Study Closure|0|||
147226461|NCT03739840|531002048|FG002|Post-Treatment Period: Wk16-23|Early Study Closure|1|||
147311187|NCT00545363|531307153|FG001|Overall Study|Withdrawal by Subject|5|||
147311188|NCT00545363|531307152|FG000|Overall Study|Non-compliance|3|||
147444329|NCT00909181|531792564|FG002|Overall Study|Lost to Follow-up|33|||
147112512|NCT02989389|530574504|FG006|Period 1|Physician Decision|0|||
147112513|NCT02989389|530574505|FG007|Period 1|Physician Decision|0|||
147112514|NCT02989389|530574506|FG008|Period 1|Physician Decision|1|||
147112515|NCT02989389|530574507|FG009|Period 1|Physician Decision|0|||
147112516|NCT01666652|530574508|FG000|Overall Study|Serious Adverse Event|0|||
147112517|NCT01666652|530574509|FG001|Overall Study|Serious Adverse Event|0|||
147112518|NCT01666652|530574510|FG002|Overall Study|Serious Adverse Event|0|||
147444330|NCT04353284|531792565|FG000|Overall Study|Adverse Event|1|||
147112519|NCT01666652|530574511|FG003|Overall Study|Serious Adverse Event|1|||
147112520|NCT01666652|530574512|FG004|Overall Study|Serious Adverse Event|0|||
147112521|NCT01666652|530574508|FG000|Overall Study|Withdrawal by Subject|0|||
147112522|NCT01666652|530574509|FG001|Overall Study|Withdrawal by Subject|0|||
147561193|NCT02937701|532212086|FG004|Day 1 to Week 22|Lost to Follow-up|0|||
147561194|NCT02937701|532212082|FG000|Day 1 to Week 22|Physician Decision|2|||
147561195|NCT02937701|532212083|FG001|Day 1 to Week 22|Physician Decision|0|||
147561196|NCT02937701|532212084|FG002|Day 1 to Week 22|Physician Decision|0|||
147561197|NCT02937701|532212085|FG003|Day 1 to Week 22|Physician Decision|0|||
147561198|NCT02937701|532212086|FG004|Day 1 to Week 22|Physician Decision|0|||
147561199|NCT02937701|532212082|FG000|Day 1 to Week 22|Other|1|||
147561200|NCT02937701|532212083|FG001|Day 1 to Week 22|Other|0|||
147561201|NCT02937701|532212084|FG002|Day 1 to Week 22|Other|0|||
147561202|NCT02937701|532212085|FG003|Day 1 to Week 22|Other|0|||
147561203|NCT02937701|532212086|FG004|Day 1 to Week 22|Other|0|||
147561204|NCT02937701|532212082|FG000|Week 22 to Week 50|Adverse Event|0|||
147561205|NCT02937701|532212083|FG001|Week 22 to Week 50|Adverse Event|0|||
147561206|NCT02937701|532212084|FG002|Week 22 to Week 50|Adverse Event|10|||
147561207|NCT02937701|532212085|FG003|Week 22 to Week 50|Adverse Event|3|||
147561208|NCT02937701|532212086|FG004|Week 22 to Week 50|Adverse Event|3|||
147561209|NCT02937701|532212082|FG000|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|0|||
147561210|NCT02937701|532212083|FG001|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|0|||
147561211|NCT02937701|532212084|FG002|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|10|||
147561212|NCT02937701|532212085|FG003|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|3|||
147561213|NCT02937701|532212086|FG004|Week 22 to Week 50|Dissatisfied with Treatment Efficacy|2|||
147561214|NCT02937701|532212082|FG000|Week 22 to Week 50|Withdrawal by Subject|0|||
147561215|NCT02937701|532212083|FG001|Week 22 to Week 50|Withdrawal by Subject|0|||
147561216|NCT02937701|532212084|FG002|Week 22 to Week 50|Withdrawal by Subject|8|||
147561217|NCT02937701|532212085|FG003|Week 22 to Week 50|Withdrawal by Subject|2|||
147561218|NCT02937701|532212086|FG004|Week 22 to Week 50|Withdrawal by Subject|1|||
147561219|NCT02937701|532212082|FG000|Week 22 to Week 50|Lost to Follow-up|0|||
147561220|NCT02937701|532212083|FG001|Week 22 to Week 50|Lost to Follow-up|0|||
147561221|NCT02937701|532212084|FG002|Week 22 to Week 50|Lost to Follow-up|2|||
147561222|NCT02937701|532212085|FG003|Week 22 to Week 50|Lost to Follow-up|0|||
147561223|NCT02937701|532212086|FG004|Week 22 to Week 50|Lost to Follow-up|1|||
147561224|NCT02937701|532212082|FG000|Week 22 to Week 50|Physician Decision|0|||
147561225|NCT02937701|532212083|FG001|Week 22 to Week 50|Physician Decision|0|||
147561226|NCT02937701|532212084|FG002|Week 22 to Week 50|Physician Decision|2|||
147561227|NCT02937701|532212085|FG003|Week 22 to Week 50|Physician Decision|0|||
147561228|NCT02937701|532212086|FG004|Week 22 to Week 50|Physician Decision|1|||
147561229|NCT02937701|532212082|FG000|Week 22 to Week 50|Other|0|||
147561230|NCT02937701|532212083|FG001|Week 22 to Week 50|Other|0|||
147561231|NCT02937701|532212084|FG002|Week 22 to Week 50|Other|0|||
147561232|NCT02937701|532212085|FG003|Week 22 to Week 50|Other|0|||
147561233|NCT02937701|532212086|FG004|Week 22 to Week 50|Other|1|||
147561234|NCT00416520|532212088|FG000|Open-label Period|Adverse Event|28|||
147561235|NCT00416520|532212089|FG001|Open-label Period|Adverse Event|10|||
147561236|NCT00416520|532212090|FG002|Open-label Period|Adverse Event|0|||
147561237|NCT00416520|532212091|FG003|Open-label Period|Adverse Event|0|||
147561238|NCT00416520|532212088|FG000|Open-label Period|Death|2|||
147561239|NCT00416520|532212089|FG001|Open-label Period|Death|1|||
147561240|NCT00416520|532212090|FG002|Open-label Period|Death|0|||
147561241|NCT00416520|532212091|FG003|Open-label Period|Death|0|||
147561242|NCT00416520|532212088|FG000|Open-label Period|Lack of Efficacy|8|||
147561243|NCT00416520|532212089|FG001|Open-label Period|Lack of Efficacy|1|||
147561244|NCT00416520|532212090|FG002|Open-label Period|Lack of Efficacy|0|||
147561245|NCT00416520|532212091|FG003|Open-label Period|Lack of Efficacy|0|||
147561246|NCT00416520|532212088|FG000|Open-label Period|Protocol Violation|3|||
147561247|NCT00416520|532212089|FG001|Open-label Period|Protocol Violation|3|||
147561248|NCT00416520|532212090|FG002|Open-label Period|Protocol Violation|0|||
147561249|NCT00416520|532212091|FG003|Open-label Period|Protocol Violation|0|||
147226462|NCT03739840|531002049|FG003|Post-Treatment Period: Wk16-23|Early Study Closure|0|||
147226463|NCT03739840|531002046|FG000|Post-Treatment Period: Wk16-23|Trial Closed By Sponsor Decision|0|||
147226464|NCT03739840|531002047|FG001|Post-Treatment Period: Wk16-23|Trial Closed By Sponsor Decision|0|||
147226465|NCT03739840|531002048|FG002|Post-Treatment Period: Wk16-23|Trial Closed By Sponsor Decision|1|||
147561250|NCT00416520|532212088|FG000|Open-label Period|Withdrawal by Subject|16|||
147561251|NCT00416520|532212089|FG001|Open-label Period|Withdrawal by Subject|5|||
147561252|NCT00416520|532212090|FG002|Open-label Period|Withdrawal by Subject|0|||
147561253|NCT00416520|532212091|FG003|Open-label Period|Withdrawal by Subject|0|||
147561254|NCT00416520|532212088|FG000|Open-label Period|Other Reasons|3|||
147561255|NCT00416520|532212089|FG001|Open-label Period|Other Reasons|12|||
147561256|NCT00416520|532212090|FG002|Open-label Period|Other Reasons|0|||
147226466|NCT03739840|531002049|FG003|Post-Treatment Period: Wk16-23|Trial Closed By Sponsor Decision|0|||
147561257|NCT00416520|532212091|FG003|Open-label Period|Other Reasons|0|||
147561258|NCT00416520|532212088|FG000|Placebo-controlled Withdrawal Period|Adverse Event|0|||
147561259|NCT00416520|532212089|FG001|Placebo-controlled Withdrawal Period|Adverse Event|0|||
147561260|NCT00416520|532212090|FG002|Placebo-controlled Withdrawal Period|Adverse Event|0|||
147561261|NCT00416520|532212091|FG003|Placebo-controlled Withdrawal Period|Adverse Event|1|||
147561262|NCT00416520|532212088|FG000|Placebo-controlled Withdrawal Period|Lack of Efficacy|0|||
147561263|NCT00416520|532212089|FG001|Placebo-controlled Withdrawal Period|Lack of Efficacy|0|||
147112523|NCT01666652|530574510|FG002|Overall Study|Withdrawal by Subject|0|||
147112524|NCT01666652|530574511|FG003|Overall Study|Withdrawal by Subject|0|||
147112525|NCT01666652|530574512|FG004|Overall Study|Withdrawal by Subject|1|||
147112526|NCT01666652|530574508|FG000|Overall Study|Moved from study area|1|||
147112527|NCT01666652|530574509|FG001|Overall Study|Moved from study area|0|||
147112528|NCT01666652|530574510|FG002|Overall Study|Moved from study area|0|||
147112529|NCT01666652|530574511|FG003|Overall Study|Moved from study area|2|||
147112530|NCT01666652|530574512|FG004|Overall Study|Moved from study area|0|||
147112531|NCT01666652|530574508|FG000|Overall Study|Lost to Follow-up|1|||
147112532|NCT01666652|530574509|FG001|Overall Study|Lost to Follow-up|1|||
147112533|NCT01666652|530574510|FG002|Overall Study|Lost to Follow-up|1|||
147112534|NCT01666652|530574511|FG003|Overall Study|Lost to Follow-up|1|||
147112535|NCT01666652|530574512|FG004|Overall Study|Lost to Follow-up|0|||
147112536|NCT04470427|530574513|FG000|Part A: Blinded|Discontinued from Study in Part A|831|||
147112537|NCT04470427|530574514|FG001|Part A: Blinded|Discontinued from Study in Part A|548|||
147112538|NCT04470427|530574515|FG002|Part A: Blinded|Discontinued from Study in Part A|0|||
147112539|NCT04470427|530574516|FG003|Part A: Blinded|Discontinued from Study in Part A|0|||
147112540|NCT04470427|530574517|FG004|Part A: Blinded|Discontinued from Study in Part A|0|||
147112541|NCT04470427|530574518|FG005|Part A: Blinded|Discontinued from Study in Part A|0|||
147112542|NCT04470427|530574513|FG000|Part B :Open-label|Other than specified|0|||
147112543|NCT04470427|530574514|FG001|Part B :Open-label|Other than specified|0|||
147112544|NCT04470427|530574515|FG002|Part B :Open-label|Other than specified|788|||
147112545|NCT04470427|530574516|FG003|Part B :Open-label|Other than specified|0|||
147112546|NCT04470427|530574517|FG004|Part B :Open-label|Other than specified|523|||
147112547|NCT04470427|530574518|FG005|Part B :Open-label|Other than specified|0|||
147112548|NCT04470427|530574513|FG000|Part B :Open-label|Discontinued from Study in Part B|0|||
147112549|NCT04470427|530574514|FG001|Part B :Open-label|Discontinued from Study in Part B|0|||
147112550|NCT04470427|530574515|FG002|Part B :Open-label|Discontinued from Study in Part B|1576|||
147112551|NCT04470427|530574516|FG003|Part B :Open-label|Discontinued from Study in Part B|2185|||
147112552|NCT04470427|530574517|FG004|Part B :Open-label|Discontinued from Study in Part B|4490|||
147112553|NCT04470427|530574518|FG005|Part B :Open-label|Discontinued from Study in Part B|0|||
147112554|NCT04470427|530574513|FG000|Part C: Booster|Discontinued from Study in Part C|0|||
147112555|NCT04470427|530574514|FG001|Part C: Booster|Discontinued from Study in Part C|0|||
147112556|NCT04470427|530574515|FG002|Part C: Booster|Discontinued from Study in Part C|0|||
147112557|NCT04470427|530574516|FG003|Part C: Booster|Discontinued from Study in Part C|0|||
147112558|NCT04470427|530574517|FG004|Part C: Booster|Discontinued from Study in Part C|0|||
147112559|NCT04470427|530574518|FG005|Part C: Booster|Discontinued from Study in Part C|2918|||
147112560|NCT01018979|530574519|FG000|Overall Study|Peak CD34+ cell count in PB < 10 cell/uL|3|||
147112561|NCT01018979|530574520|FG001|Overall Study|Peak CD34+ cell count in PB < 10 cell/uL|9|||
147112562|NCT01018979|530574519|FG000|Overall Study|Not received at least one dose|0|||
147112563|NCT01018979|530574520|FG001|Overall Study|Not received at least one dose|1|||
147112564|NCT01695746|530574521|FG000|Overall Study|Adverse Event|1|||
147112565|NCT01695746|530574521|FG000|Overall Study|Non-compliance by the participant|3|||
147112566|NCT01695746|530574521|FG000|Overall Study|Protocol Violation|5|||
147112567|NCT01695746|530574521|FG000|Overall Study|Participant not willing to participate|3|||
147112568|NCT03976375|530574524|FG000|Overall Study|Death|158|||
147112569|NCT03976375|530574525|FG001|Overall Study|Death|160|||
147112570|NCT03976375|530574526|FG002|Overall Study|Death|42|||
147112571|NCT03976375|530574524|FG000|Overall Study|Lost to Follow-up|2|||
147112572|NCT03976375|530574525|FG001|Overall Study|Lost to Follow-up|1|||
147112573|NCT03976375|530574526|FG002|Overall Study|Lost to Follow-up|1|||
147112574|NCT03976375|530574524|FG000|Overall Study|Withdrawal by Subject|5|||
147112575|NCT03976375|530574525|FG001|Overall Study|Withdrawal by Subject|9|||
147112576|NCT03976375|530574526|FG002|Overall Study|Withdrawal by Subject|4|||
147112577|NCT03976375|530574524|FG000|Overall Study|Sponsor decision|20|||
147112578|NCT03976375|530574525|FG001|Overall Study|Sponsor decision|19|||
147112579|NCT03976375|530574526|FG002|Overall Study|Sponsor decision|1|||
147112580|NCT04818112|530574527|FG000|Overall Study|Withdrawal by Subject|54|||
147112581|NCT04818112|530574528|FG001|Overall Study|Withdrawal by Subject|12|||
147112582|NCT04818112|530574527|FG000|Overall Study|Lost to Follow-up|38|||
147112583|NCT04818112|530574528|FG001|Overall Study|Lost to Follow-up|10|||
147226467|NCT01323946|531002050|FG000|Overall Study|Lost to Follow-up|0|||
147226468|NCT01323946|531002051|FG001|Overall Study|Lost to Follow-up|1|||
147226469|NCT01323946|531002052|FG002|Overall Study|Lost to Follow-up|0|||
147226470|NCT01323946|531002050|FG000|Overall Study|Parents refused the last blood draw|1|||
147226471|NCT01323946|531002051|FG001|Overall Study|Parents refused the last blood draw|0|||
147226472|NCT01323946|531002052|FG002|Overall Study|Parents refused the last blood draw|0|||
147226473|NCT01323946|531002050|FG000|Overall Study|Withdrawal by Subject|2|||
147595953|NCT00359632|532338755|FG001|Overall Study|Death|0|||
147112584|NCT00700635|530574531|FG000|Overall Study|Adverse Event|1|||
147112585|NCT00700635|530574532|FG001|Overall Study|Adverse Event|0|||
147112586|NCT00700635|530574533|FG002|Overall Study|Adverse Event|0|||
147112587|NCT00700635|530574531|FG000|Overall Study|Lost to Follow-up|1|||
147226474|NCT01323946|531002051|FG001|Overall Study|Withdrawal by Subject|2|||
147444331|NCT04353284|531792566|FG001|Overall Study|Adverse Event|1|||
147112588|NCT00700635|530574532|FG001|Overall Study|Lost to Follow-up|3|||
147112589|NCT00700635|530574533|FG002|Overall Study|Lost to Follow-up|0|||
147112590|NCT00700635|530574531|FG000|Overall Study|Protocol Violation|2|||
147561264|NCT00416520|532212090|FG002|Placebo-controlled Withdrawal Period|Lack of Efficacy|0|||
147561265|NCT00416520|532212091|FG003|Placebo-controlled Withdrawal Period|Lack of Efficacy|3|||
147561266|NCT00416520|532212088|FG000|Placebo-controlled Withdrawal Period|Protocol Violation|0|||
147561267|NCT00416520|532212089|FG001|Placebo-controlled Withdrawal Period|Protocol Violation|0|||
147561268|NCT00416520|532212090|FG002|Placebo-controlled Withdrawal Period|Protocol Violation|1|||
147561269|NCT00416520|532212091|FG003|Placebo-controlled Withdrawal Period|Protocol Violation|1|||
147561270|NCT03601637|532212093|FG000|Overall Study|Withdrawal of Consent (not due to adverse event)|0|||
147561271|NCT03601637|532212094|FG001|Overall Study|Withdrawal of Consent (not due to adverse event)|1|||
147561272|NCT03601637|532212093|FG000|Overall Study|Adverse Event|1|||
147561273|NCT03601637|532212094|FG001|Overall Study|Adverse Event|1|||
147561274|NCT03601637|532212093|FG000|Overall Study|Other|0|||
147561275|NCT03601637|532212094|FG001|Overall Study|Other|1|||
147561276|NCT01108094|532212098|FG000|Overall Study|Adverse Event|2|||
147561277|NCT01108094|532212099|FG001|Overall Study|Adverse Event|0|||
147561278|NCT01108094|532212100|FG002|Overall Study|Adverse Event|0|||
147561279|NCT01108094|532212101|FG003|Overall Study|Adverse Event|0|||
147561280|NCT01108094|532212098|FG000|Overall Study|Withdrawal by Subject|1|||
147561281|NCT01108094|532212099|FG001|Overall Study|Withdrawal by Subject|0|||
147561282|NCT01108094|532212100|FG002|Overall Study|Withdrawal by Subject|0|||
147561283|NCT01108094|532212101|FG003|Overall Study|Withdrawal by Subject|0|||
147561284|NCT05818137|532212111|FG000|Extension Treatment Period|Withdrawal by Subject|1|||
147561285|NCT05818137|532212111|FG000|Extension Treatment Period|Ongoing participants|44|||
147561286|NCT05346055|532212114|FG000|Overall Study|Withdrawal by Subject|1|||
147561287|NCT05346055|532212114|FG000|Overall Study|Protocol Violation|1|||
147561288|NCT05346055|532212114|FG000|Overall Study|Therapist decision|1|||
147561289|NCT00728949|532212115|FG000|Overall Study|Adverse Event|8|||
147561290|NCT00728949|532212116|FG001|Overall Study|Adverse Event|0|||
147561291|NCT00728949|532212115|FG000|Overall Study|Withdrawal by Subject|2|||
147561292|NCT00728949|532212116|FG001|Overall Study|Withdrawal by Subject|2|||
147561293|NCT00728949|532212115|FG000|Overall Study|Abnormal Lab Results|0|||
147561294|NCT00728949|532212116|FG001|Overall Study|Abnormal Lab Results|2|||
147561295|NCT00728949|532212115|FG000|Overall Study|On treatment at cutoff date|1|||
147561296|NCT00728949|532212116|FG001|Overall Study|On treatment at cutoff date|0|||
147561297|NCT01996033|532212117|FG000|Overall Study|Death|1|||
147561298|NCT01996033|532212117|FG000|Overall Study|Physician Decision|1|||
147561299|NCT01996033|532212117|FG000|Overall Study|Withdrawal by Subject|4|||
147561300|NCT01996033|532212117|FG000|Overall Study|Lost to Follow-up|3|||
147561301|NCT01087970|532212122|FG000|Overall Study|Protocol Violation|2|||
147561302|NCT02143102|532212125|FG000|Overall Study|Lost to Follow-up|11|||
147561303|NCT02143102|532212126|FG001|Overall Study|Lost to Follow-up|0|||
147561304|NCT02636907|532212129|FG000|Autoinjector Assessment Period|Adverse Event|2|||
147561305|NCT02636907|532212129|FG000|Autoinjector Assessment Period|Withdrawal by Subject|2|||
147561306|NCT02636907|532212129|FG000|Extension Phase|Adverse Event|2|||
147561307|NCT02636907|532212129|FG000|Extension Phase|Withdrawal by Subject|4|||
147561308|NCT02636907|532212129|FG000|Extension Phase|Physician Decision|1|||
147561309|NCT02636907|532212129|FG000|Extension Phase|Lost to Follow-up|2|||
147561310|NCT02636907|532212129|FG000|Extension Phase|Lack of Efficacy|1|||
147561311|NCT04099888|532212130|FG000|Overall Study|Study terminated by sponsor|9|||
147561312|NCT04099888|532212131|FG001|Overall Study|Study terminated by sponsor|11|||
147561313|NCT04099888|532212130|FG000|Overall Study|Lost to Follow-up|1|||
147561314|NCT04099888|532212131|FG001|Overall Study|Lost to Follow-up|1|||
147561315|NCT04099888|532212130|FG000|Overall Study|Withdrawal by Subject|5|||
147561316|NCT04099888|532212131|FG001|Overall Study|Withdrawal by Subject|6|||
147561317|NCT04099888|532212130|FG000|Overall Study|Death|5|||
147561318|NCT04099888|532212131|FG001|Overall Study|Death|2|||
147561319|NCT04099888|532212130|FG000|Overall Study|Other|1|||
147561320|NCT04099888|532212131|FG001|Overall Study|Other|0|||
147311189|NCT00545363|531307153|FG001|Overall Study|Non-compliance|1|||
147311190|NCT00545363|531307152|FG000|Overall Study|Did not meet entry criteria|1|||
147561321|NCT01225146|532212136|FG000|Overall Study|Sponsor discontinued making 2mg drug|0|||
147561322|NCT01225146|532212137|FG001|Overall Study|Sponsor discontinued making 2mg drug|2|||
147561323|NCT03661528|532212140|FG000|Overall Study|Death|1|||
147561324|NCT03661528|532212141|FG001|Overall Study|Death|0|||
147561325|NCT03661528|532212140|FG000|Overall Study|Physician Decision|3|||
147561326|NCT03661528|532212141|FG001|Overall Study|Physician Decision|1|||
147444332|NCT04353284|531792565|FG000|Overall Study|Lost to Follow-up|1|||
147561327|NCT03661528|532212140|FG000|Overall Study|Other than Specified|5|||
147561328|NCT03661528|532212141|FG001|Overall Study|Other than Specified|2|||
147561329|NCT03661528|532212140|FG000|Overall Study|Withdrawal by Subject|5|||
147561330|NCT03661528|532212141|FG001|Overall Study|Withdrawal by Subject|3|||
147561331|NCT03661528|532212140|FG000|Overall Study|Disease Progression|8|||
147561332|NCT03661528|532212141|FG001|Overall Study|Disease Progression|13|||
147561333|NCT03661528|532212140|FG000|Overall Study|Adverse Event|61|||
147561334|NCT03661528|532212141|FG001|Overall Study|Adverse Event|55|||
147112591|NCT00700635|530574532|FG001|Overall Study|Protocol Violation|2|||
147112592|NCT00700635|530574533|FG002|Overall Study|Protocol Violation|0|||
147112593|NCT00700635|530574531|FG000|Overall Study|Withdrawal by Subject|7|||
147112594|NCT00700635|530574532|FG001|Overall Study|Withdrawal by Subject|3|||
147112595|NCT00700635|530574533|FG002|Overall Study|Withdrawal by Subject|1|||
147112596|NCT06170827|530574534|FG000|Overall Study|Withdrawal by Subject|1|||
147112597|NCT06170827|530574535|FG001|Overall Study|Withdrawal by Subject|1|||
147112598|NCT00632359|530574541|FG000|Overall Study|Withdrawal by Subject|2|||
147112599|NCT03043573|530574546|FG000|Overall Study|Lost to Follow-up|3|||
147112600|NCT03043573|530574547|FG001|Overall Study|Lost to Follow-up|3|||
147112601|NCT03043573|530574546|FG000|Overall Study|Physician Decision|0|||
147112602|NCT03043573|530574547|FG001|Overall Study|Physician Decision|5|||
147112603|NCT03043573|530574546|FG000|Overall Study|Withdrawal by Subject|0|||
147112604|NCT03043573|530574547|FG001|Overall Study|Withdrawal by Subject|4|||
147112605|NCT05578872|530574550|FG000|Overall Study|Withdrawal by Subject|2|||
147112606|NCT05578872|530574551|FG001|Overall Study|Withdrawal by Subject|1|||
147112607|NCT05578872|530574550|FG000|Overall Study|Adverse Event|1|||
147112608|NCT05578872|530574551|FG001|Overall Study|Adverse Event|1|||
147112609|NCT05578872|530574550|FG000|Overall Study|Physician Decision|1|||
147112610|NCT05578872|530574551|FG001|Overall Study|Physician Decision|2|||
147112611|NCT05578872|530574550|FG000|Overall Study|Progressive disease|10|||
147112612|NCT05578872|530574551|FG001|Overall Study|Progressive disease|9|||
147112613|NCT05578872|530574550|FG000|Overall Study|Sponsor decision|0|||
147112614|NCT05578872|530574551|FG001|Overall Study|Sponsor decision|1|||
147112615|NCT05578872|530574550|FG000|Overall Study|Toxicity and Patient's decision|0|||
147112616|NCT05578872|530574551|FG001|Overall Study|Toxicity and Patient's decision|1|||
147112617|NCT03641924|530576561|FG000|Overall Study|Withdrawal by Subject|26|||
147112618|NCT03641924|530576561|FG000|Overall Study|Lost to Follow-up|16|||
147112619|NCT03641924|530576561|FG000|Overall Study|Protocol Violation|10|||
147112620|NCT04333498|530576562|FG000|Overall Study|Lost to Follow-up|1|||
147112621|NCT04333498|530576563|FG001|Overall Study|Lost to Follow-up|0|||
147112622|NCT04333498|530576562|FG000|Overall Study|Lost to Follow-up|0|||
147112623|NCT04333498|530576563|FG001|Overall Study|Lost to Follow-up|1|||
147112624|NCT00479232|530576564|FG000|Overall Study|Adverse Event|0|||
147112625|NCT00479232|530576565|FG001|Overall Study|Adverse Event|0|||
147112626|NCT00479232|530576566|FG002|Overall Study|Adverse Event|5|||
147112627|NCT00479232|530576567|FG003|Overall Study|Adverse Event|0|||
147112628|NCT00479232|530576568|FG004|Overall Study|Adverse Event|0|||
147112629|NCT00479232|530576569|FG005|Overall Study|Adverse Event|10|||
147112630|NCT00479232|530576564|FG000|Overall Study|Deviation from Protocol|0|||
147112631|NCT00479232|530576565|FG001|Overall Study|Deviation from Protocol|0|||
147112632|NCT00479232|530576566|FG002|Overall Study|Deviation from Protocol|1|||
147112633|NCT00479232|530576567|FG003|Overall Study|Deviation from Protocol|0|||
147112634|NCT00479232|530576568|FG004|Overall Study|Deviation from Protocol|0|||
147112635|NCT00479232|530576569|FG005|Overall Study|Deviation from Protocol|0|||
147112636|NCT00479232|530576564|FG000|Overall Study|Lack of Efficacy|0|||
147112637|NCT00479232|530576565|FG001|Overall Study|Lack of Efficacy|0|||
147112638|NCT00479232|530576566|FG002|Overall Study|Lack of Efficacy|2|||
147112639|NCT00479232|530576567|FG003|Overall Study|Lack of Efficacy|0|||
147112640|NCT00479232|530576568|FG004|Overall Study|Lack of Efficacy|0|||
147112641|NCT00479232|530576569|FG005|Overall Study|Lack of Efficacy|4|||
147112642|NCT00479232|530576564|FG000|Overall Study|Physician Decision|0|||
147112643|NCT00479232|530576565|FG001|Overall Study|Physician Decision|0|||
147112644|NCT00479232|530576566|FG002|Overall Study|Physician Decision|2|||
147112645|NCT00479232|530576567|FG003|Overall Study|Physician Decision|0|||
147112646|NCT00479232|530576568|FG004|Overall Study|Physician Decision|0|||
147112647|NCT00479232|530576569|FG005|Overall Study|Physician Decision|1|||
147112648|NCT00479232|530576564|FG000|Overall Study|Progressive Disease|3|||
147112649|NCT00479232|530576565|FG001|Overall Study|Progressive Disease|1|||
147112650|NCT00479232|530576566|FG002|Overall Study|Progressive Disease|12|||
147112651|NCT00479232|530576567|FG003|Overall Study|Progressive Disease|3|||
147112652|NCT00479232|530576568|FG004|Overall Study|Progressive Disease|3|||
147112653|NCT00479232|530576569|FG005|Overall Study|Progressive Disease|12|||
147112654|NCT00479232|530576564|FG000|Overall Study|Withdrew Consent|0|||
147112655|NCT00479232|530576565|FG001|Overall Study|Withdrew Consent|2|||
147112656|NCT00479232|530576566|FG002|Overall Study|Withdrew Consent|6|||
147112657|NCT00479232|530576567|FG003|Overall Study|Withdrew Consent|0|||
147112658|NCT00479232|530576568|FG004|Overall Study|Withdrew Consent|1|||
147112659|NCT00479232|530576569|FG005|Overall Study|Withdrew Consent|3|||
147112660|NCT05399771|530576570|FG000|Overall Study|Physician Decision|3|||
147112661|NCT05399771|530576570|FG000|Overall Study|Adverse Event|1|||
147112662|NCT00484159|530576572|FG000|Overall Study|Lost to Follow-up|1|||
147112663|NCT00484159|530576573|FG001|Overall Study|Lost to Follow-up|1|||
147112664|NCT00484159|530576574|FG002|Overall Study|Lost to Follow-up|0|||
147112665|NCT04766333|530576575|FG000|Overall Study|Lost to Follow-up|40|||
147112666|NCT04766333|530576576|FG001|Overall Study|Lost to Follow-up|826|||
147112667|NCT01239680|530576579|FG000|Overall Study|Withdrawal by Subject|2|||
147112668|NCT01239680|530576580|FG001|Overall Study|Withdrawal by Subject|0|||
147112669|NCT03033901|530576581|FG000|Overall Study|Ineligible for Polysomnography (PSG)|59|||
147561335|NCT02732210|532212142|FG000|Overall Study|Site Closed|0|||
147112670|NCT03033901|530576581|FG000|Overall Study|Refused PSG|23|||
147112671|NCT03033901|530576581|FG000|Overall Study|Total Sleep Time < 2 hours|12|||
147112672|NCT03033901|530576581|FG000|Overall Study|Missing Oximetry Data|3|||
147112673|NCT01797185|530576582|FG000|Overall Study|Adverse Event|5|||
147112674|NCT01797185|530576583|FG001|Overall Study|Adverse Event|15|||
147112675|NCT01797185|530576584|FG002|Overall Study|Adverse Event|6|||
147112676|NCT01797185|530576582|FG000|Overall Study|Withdrawal by Subject|6|||
147112677|NCT01797185|530576583|FG001|Overall Study|Withdrawal by Subject|9|||
147112678|NCT01797185|530576584|FG002|Overall Study|Withdrawal by Subject|5|||
147112679|NCT01797185|530576582|FG000|Overall Study|Site terminated|8|||
147112680|NCT01797185|530576583|FG001|Overall Study|Site terminated|4|||
147112681|NCT01797185|530576584|FG002|Overall Study|Site terminated|0|||
147112682|NCT01797185|530576582|FG000|Overall Study|Lost to Follow-up|2|||
147112683|NCT01797185|530576583|FG001|Overall Study|Lost to Follow-up|6|||
147112684|NCT01797185|530576584|FG002|Overall Study|Lost to Follow-up|1|||
147112685|NCT01797185|530576582|FG000|Overall Study|Withdrawn per sponsor|5|||
147112686|NCT01797185|530576583|FG001|Overall Study|Withdrawn per sponsor|0|||
147112687|NCT01797185|530576584|FG002|Overall Study|Withdrawn per sponsor|0|||
147112688|NCT01797185|530576582|FG000|Overall Study|Physician Decision|1|||
147112689|NCT01797185|530576583|FG001|Overall Study|Physician Decision|3|||
147112690|NCT01797185|530576584|FG002|Overall Study|Physician Decision|0|||
147112691|NCT01797185|530576582|FG000|Overall Study|Protocol Violation|1|||
147112692|NCT01797185|530576583|FG001|Overall Study|Protocol Violation|1|||
147112693|NCT01797185|530576584|FG002|Overall Study|Protocol Violation|0|||
147112694|NCT00729586|530576585|FG000|Overall Study|Ineligible|0|||
147112695|NCT00729586|530576586|FG001|Overall Study|Ineligible|1|||
147112696|NCT00729586|530576585|FG000|Overall Study|never treated|1|||
147112697|NCT00729586|530576586|FG001|Overall Study|never treated|0|||
147112698|NCT05177094|530576589|FG000|Overall Study|Adverse Event|5|||
147112699|NCT05177094|530576590|FG001|Overall Study|Adverse Event|5|||
147226475|NCT01323946|531002052|FG002|Overall Study|Withdrawal by Subject|0|||
147226476|NCT01243671|531002053|FG000|Overall Study|Adverse Event|3|||
147226477|NCT01243671|531002053|FG000|Overall Study|Anti-adalimumab antibody positive|1|||
147226478|NCT01243671|531002053|FG000|Overall Study|Other|1|||
147226479|NCT02962765|531002054|FG000|Overall Study|Protocol Violation|9|||
147226480|NCT02962765|531002054|FG000|Overall Study|Withdrawal by Subject|3|||
147226481|NCT02962765|531002054|FG000|Overall Study|Lost to Follow-up|1|||
147311191|NCT00545363|531307153|FG001|Overall Study|Did not meet entry criteria|1|||
147311192|NCT00545363|531307152|FG000|Overall Study|Lost to Follow-up|2|||
147561336|NCT02732210|532212143|FG001|Overall Study|Site Closed|11|||
147561337|NCT02732210|532212142|FG000|Overall Study|Study Ended|13|||
147561338|NCT02732210|532212143|FG001|Overall Study|Study Ended|13|||
147561339|NCT02732210|532212142|FG000|Overall Study|Withdrawal by Subject|28|||
147561340|NCT02732210|532212143|FG001|Overall Study|Withdrawal by Subject|87|||
147561341|NCT02732210|532212142|FG000|Overall Study|Lost to Follow-up|5|||
147561342|NCT02732210|532212143|FG001|Overall Study|Lost to Follow-up|57|||
147561343|NCT02732210|532212142|FG000|Overall Study|Death|4|||
147561344|NCT02732210|532212143|FG001|Overall Study|Death|15|||
147561345|NCT02732210|532212142|FG000|Overall Study|Other|35|||
147561346|NCT02732210|532212143|FG001|Overall Study|Other|103|||
147561347|NCT02732210|532212142|FG000|Overall Study|Missing|0|||
147311193|NCT00545363|531307153|FG001|Overall Study|Lost to Follow-up|0|||
147311194|NCT00545363|531307152|FG000|Overall Study|Other|1|||
147561348|NCT02732210|532212143|FG001|Overall Study|Missing|8|||
147561349|NCT01876706|532212144|FG000|Overall Study|BPH Intervention|9|||
147561350|NCT01876706|532212144|FG000|Overall Study|Lost to Follow-up|7|||
147561351|NCT01876706|532212144|FG000|Overall Study|Withdrawals|6|||
147112700|NCT05177094|530576589|FG000|Overall Study|Non-compliance With Study Drug and Procedures|0|||
147112701|NCT05177094|530576590|FG001|Overall Study|Non-compliance With Study Drug and Procedures|1|||
147112702|NCT05177094|530576589|FG000|Overall Study|Protocol Deviation|3|||
147112703|NCT05177094|530576590|FG001|Overall Study|Protocol Deviation|0|||
147112704|NCT05177094|530576589|FG000|Overall Study|Withdrawal by Subject|6|||
147112705|NCT05177094|530576590|FG001|Overall Study|Withdrawal by Subject|3|||
147561352|NCT01876706|532212144|FG000|Overall Study|Death|3|||
147561353|NCT00604500|532212145|FG000|Overall Study|Adverse Event|2|||
147561354|NCT00604500|532212145|FG000|Overall Study|Protocol Violation|2|||
147112706|NCT05177094|530576589|FG000|Overall Study|Participant could not tolerate long study visits|1|||
147112707|NCT05177094|530576590|FG001|Overall Study|Participant could not tolerate long study visits|0|||
147112708|NCT01033942|530576593|FG000|Overall Study|Withdrawal by Subject|1|||
147226482|NCT02962765|531002054|FG000|Overall Study|Death|1|||
147561355|NCT00604500|532212145|FG000|Overall Study|Treatment Failure|1|||
147112709|NCT01033942|530576594|FG001|Overall Study|Withdrawal by Subject|1|||
147112710|NCT01033942|530576595|FG002|Overall Study|Withdrawal by Subject|1|||
147226483|NCT02962765|531002054|FG000|Overall Study|Limited access to study medication|3|||
147311195|NCT00545363|531307153|FG001|Overall Study|Other|1|||
147311196|NCT00366301|531307154|FG000|Overall Study|Lost to Follow-up|4|||
147561356|NCT00604500|532212145|FG000|Overall Study|Withdrawal by Subject|4|||
147561357|NCT00604500|532212145|FG000|Overall Study|Administrative|1|||
147595954|NCT00359632|532338754|FG000|Overall Study|Adverse Event|1|||
147112711|NCT01033942|530576593|FG000|Overall Study|Lost to Follow-up|1|||
147112712|NCT01033942|530576594|FG001|Overall Study|Lost to Follow-up|0|||
147112713|NCT01033942|530576595|FG002|Overall Study|Lost to Follow-up|0|||
147112714|NCT01033942|530576593|FG000|Overall Study|Enrolled in Extension Study|0|||
147112715|NCT01033942|530576594|FG001|Overall Study|Enrolled in Extension Study|3|||
147112716|NCT01033942|530576595|FG002|Overall Study|Enrolled in Extension Study|0|||
147112717|NCT02737618|530576596|FG000|Overall Study|Withdrawal by Subject|9|||
147112718|NCT02513199|530576597|FG000|Treatment|Death|1|||
147112719|NCT02513199|530576597|FG000|Treatment|Lost to Follow-up|1|||
147112720|NCT02513199|530576597|FG000|Follow-Up|Death|11|||
147112721|NCT02260986|530576605|FG000|Overall Study|Adverse Event|24|||
147112722|NCT02260986|530576606|FG001|Overall Study|Adverse Event|0|||
147112723|NCT02260986|530576607|FG002|Overall Study|Adverse Event|11|||
147112724|NCT02260986|530576605|FG000|Overall Study|Lack of Efficacy|27|||
147112725|NCT02260986|530576606|FG001|Overall Study|Lack of Efficacy|3|||
147112726|NCT02260986|530576607|FG002|Overall Study|Lack of Efficacy|0|||
147112727|NCT02260986|530576605|FG000|Overall Study|Protocol Violation|14|||
147112728|NCT02260986|530576606|FG001|Overall Study|Protocol Violation|5|||
147112729|NCT02260986|530576607|FG002|Overall Study|Protocol Violation|16|||
147112730|NCT02260986|530576605|FG000|Overall Study|Car accident|0|||
147112731|NCT02260986|530576606|FG001|Overall Study|Car accident|0|||
147112732|NCT02260986|530576607|FG002|Overall Study|Car accident|1|||
147112733|NCT02260986|530576605|FG000|Overall Study|Withdrawal by Subject|17|||
147112734|NCT02260986|530576606|FG001|Overall Study|Withdrawal by Subject|4|||
147112735|NCT02260986|530576607|FG002|Overall Study|Withdrawal by Subject|9|||
147112736|NCT02260986|530576605|FG000|Overall Study|Incorrect randomization|0|||
147112737|NCT02260986|530576606|FG001|Overall Study|Incorrect randomization|1|||
147112738|NCT02260986|530576607|FG002|Overall Study|Incorrect randomization|0|||
147112739|NCT02260986|530576605|FG000|Overall Study|Lack of investigation product supply|2|||
147112740|NCT02260986|530576606|FG001|Overall Study|Lack of investigation product supply|0|||
147226484|NCT00750880|531002058|FG000|Overall Study|Adverse Event|76|||
147226485|NCT00750880|531002058|FG000|Overall Study|Death|4|||
147561358|NCT00604500|532212145|FG000|Overall Study|Did not meet protocol eligibility|1|||
147226486|NCT00750880|531002058|FG000|Overall Study|Lack of Efficacy|46|||
147226487|NCT00750880|531002058|FG000|Overall Study|Lost to Follow-up|10|||
147226488|NCT00750880|531002058|FG000|Overall Study|Protocol Violation|15|||
147226489|NCT00750880|531002058|FG000|Overall Study|Withdrawal by Subject|33|||
147226490|NCT00750880|531002058|FG000|Overall Study|Physician Decision|20|||
147226491|NCT00750880|531002058|FG000|Overall Study|Administrative|11|||
147226492|NCT02495233|531002061|FG000|Overall Study|Miscellaneous|0|||
147226493|NCT02495233|531002062|FG001|Overall Study|Miscellaneous|1|||
147226494|NCT03880461|531002064|FG000|Overall Study|Determined ineligible after enrollment|45|||
147226495|NCT03880461|531002065|FG001|Overall Study|Determined ineligible after enrollment|44|||
147226496|NCT03880461|531002064|FG000|Overall Study|No weight measurement after enrollment|24|||
147226497|NCT03880461|531002065|FG001|Overall Study|No weight measurement after enrollment|17|||
147226498|NCT01115803|531002067|FG000|Overall Study|Withdrawal by Subject|0|||
147226499|NCT01115803|531002068|FG001|Overall Study|Withdrawal by Subject|0|||
147226500|NCT01115803|531002069|FG002|Overall Study|Withdrawal by Subject|0|||
147226501|NCT01115803|531002070|FG003|Overall Study|Withdrawal by Subject|0|||
147226502|NCT01115803|531002071|FG004|Overall Study|Withdrawal by Subject|0|||
147226503|NCT01115803|531002072|FG005|Overall Study|Withdrawal by Subject|0|||
147226504|NCT01115803|531002073|FG006|Overall Study|Withdrawal by Subject|1|||
147226505|NCT01115803|531002067|FG000|Overall Study|Lost to Follow-up|0|||
147226506|NCT01115803|531002068|FG001|Overall Study|Lost to Follow-up|0|||
147226507|NCT01115803|531002069|FG002|Overall Study|Lost to Follow-up|1|||
147226508|NCT01115803|531002070|FG003|Overall Study|Lost to Follow-up|0|||
147226509|NCT01115803|531002071|FG004|Overall Study|Lost to Follow-up|0|||
147226510|NCT01115803|531002072|FG005|Overall Study|Lost to Follow-up|0|||
147226511|NCT01115803|531002073|FG006|Overall Study|Lost to Follow-up|0|||
147226512|NCT01115803|531002067|FG000|Overall Study|Progressive Disease during Cycle1|0|||
147226513|NCT01115803|531002068|FG001|Overall Study|Progressive Disease during Cycle1|0|||
147226514|NCT01115803|531002069|FG002|Overall Study|Progressive Disease during Cycle1|0|||
147226515|NCT01115803|531002070|FG003|Overall Study|Progressive Disease during Cycle1|0|||
147226516|NCT01115803|531002071|FG004|Overall Study|Progressive Disease during Cycle1|0|||
147226517|NCT01115803|531002072|FG005|Overall Study|Progressive Disease during Cycle1|0|||
147444333|NCT04353284|531792566|FG001|Overall Study|Lost to Follow-up|0|||
147112741|NCT02260986|530576607|FG002|Overall Study|Lack of investigation product supply|1|||
147112742|NCT02260986|530576605|FG000|Overall Study|Lost to Follow-up|4|||
147112743|NCT02260986|530576606|FG001|Overall Study|Lost to Follow-up|0|||
147112744|NCT02260986|530576607|FG002|Overall Study|Lost to Follow-up|3|||
147112745|NCT02260986|530576605|FG000|Overall Study|Pregnancy|2|||
147112746|NCT02260986|530576606|FG001|Overall Study|Pregnancy|0|||
147112747|NCT02260986|530576607|FG002|Overall Study|Pregnancy|0|||
147226518|NCT01115803|531002073|FG006|Overall Study|Progressive Disease during Cycle1|1|||
147226519|NCT00136604|531002074|FG000|Overall Study|Lost to Follow-up|1|||
147226520|NCT00136604|531002075|FG001|Overall Study|Lost to Follow-up|0|||
147226521|NCT00136604|531002076|FG002|Overall Study|Lost to Follow-up|0|||
147112748|NCT02397837|530576609|FG000|Overall Study|Withdrawal by Subject|6|||
147112749|NCT02397837|530576610|FG001|Overall Study|Withdrawal by Subject|5|||
147112750|NCT02397837|530576609|FG000|Overall Study|Physician Decision|1|||
147112751|NCT02397837|530576610|FG001|Overall Study|Physician Decision|1|||
147112752|NCT00313170|530576614|FG000|Overall Study|Death|2|||
147112753|NCT00313170|530576615|FG001|Overall Study|Death|4|||
147112754|NCT00313170|530576616|FG002|Overall Study|Death|2|||
147112755|NCT00313170|530576614|FG000|Overall Study|Adverse Event|1|||
147112756|NCT00313170|530576615|FG001|Overall Study|Adverse Event|2|||
147112757|NCT00313170|530576616|FG002|Overall Study|Adverse Event|0|||
147112758|NCT00313170|530576614|FG000|Overall Study|Disease progression|31|||
147112759|NCT00313170|530576615|FG001|Overall Study|Disease progression|26|||
147112760|NCT00313170|530576616|FG002|Overall Study|Disease progression|27|||
147112761|NCT00313170|530576614|FG000|Overall Study|Withdrawal by Subject|1|||
147112762|NCT00313170|530576615|FG001|Overall Study|Withdrawal by Subject|0|||
147112763|NCT00313170|530576616|FG002|Overall Study|Withdrawal by Subject|1|||
147112764|NCT00313170|530576614|FG000|Overall Study|Incorrect enrollment|0|||
147112765|NCT00313170|530576615|FG001|Overall Study|Incorrect enrollment|2|||
147112766|NCT00313170|530576616|FG002|Overall Study|Incorrect enrollment|1|||
147112767|NCT00313170|530576614|FG000|Overall Study|Lost to Follow-up|0|||
147112768|NCT00313170|530576615|FG001|Overall Study|Lost to Follow-up|0|||
147112769|NCT00313170|530576616|FG002|Overall Study|Lost to Follow-up|1|||
147112770|NCT00313170|530576614|FG000|Overall Study|Progression (investigators opinion)|1|||
147112771|NCT00313170|530576615|FG001|Overall Study|Progression (investigators opinion)|0|||
147112772|NCT00313170|530576616|FG002|Overall Study|Progression (investigators opinion)|0|||
147112773|NCT00407511|530576622|FG000|Overall Study|Adverse Event|9|||
147112774|NCT00407511|530576622|FG000|Overall Study|Lost to Follow-up|4|||
147112775|NCT00407511|530576622|FG000|Overall Study|Other|5|||
147112776|NCT00407511|530576622|FG000|Overall Study|Withdrawal by Subject|4|||
147112777|NCT01482221|530576625|FG000|Overall Study|Lack of Efficacy|1|||
147112778|NCT01482221|530576626|FG001|Overall Study|Lack of Efficacy|0|||
147112779|NCT01482221|530576627|FG002|Overall Study|Lack of Efficacy|1|||
147112780|NCT01482221|530576625|FG000|Overall Study|Lost to Follow-up|3|||
147112781|NCT01482221|530576626|FG001|Overall Study|Lost to Follow-up|2|||
147112782|NCT01482221|530576627|FG002|Overall Study|Lost to Follow-up|1|||
147112783|NCT01482221|530576625|FG000|Overall Study|Study-Specific Withdrawal Criteria|2|||
147112784|NCT01482221|530576626|FG001|Overall Study|Study-Specific Withdrawal Criteria|0|||
147112785|NCT01482221|530576627|FG002|Overall Study|Study-Specific Withdrawal Criteria|1|||
147112786|NCT01482221|530576625|FG000|Overall Study|Condition under Investigation Worsened|3|||
147112787|NCT01482221|530576626|FG001|Overall Study|Condition under Investigation Worsened|2|||
147112788|NCT01482221|530576627|FG002|Overall Study|Condition under Investigation Worsened|4|||
147112789|NCT01482221|530576625|FG000|Overall Study|Severe Non-Compliance to Protocol|1|||
147112790|NCT01482221|530576626|FG001|Overall Study|Severe Non-Compliance to Protocol|0|||
147112791|NCT01482221|530576627|FG002|Overall Study|Severe Non-Compliance to Protocol|1|||
147112792|NCT01482221|530576625|FG000|Overall Study|Adverse Event|1|||
147112793|NCT01482221|530576626|FG001|Overall Study|Adverse Event|7|||
147112794|NCT01482221|530576627|FG002|Overall Study|Adverse Event|3|||
147112795|NCT01482221|530576625|FG000|Overall Study|Withdrawal by Subject|10|||
147112796|NCT01482221|530576626|FG001|Overall Study|Withdrawal by Subject|7|||
147112797|NCT01482221|530576627|FG002|Overall Study|Withdrawal by Subject|12|||
147112798|NCT01482221|530576625|FG000|Overall Study|Incorrect randomization|0|||
147112799|NCT01482221|530576626|FG001|Overall Study|Incorrect randomization|1|||
147112800|NCT01482221|530576627|FG002|Overall Study|Incorrect randomization|0|||
147226522|NCT00136604|531002077|FG003|Overall Study|Lost to Follow-up|0|||
147226523|NCT00136604|531002078|FG004|Overall Study|Lost to Follow-up|1|||
147226524|NCT00136604|531002074|FG000|Overall Study|Migrated/moved from study area|0|||
147226525|NCT00136604|531002075|FG001|Overall Study|Migrated/moved from study area|1|||
147226526|NCT00136604|531002076|FG002|Overall Study|Migrated/moved from study area|0|||
147226527|NCT00136604|531002077|FG003|Overall Study|Migrated/moved from study area|0|||
147226528|NCT00136604|531002078|FG004|Overall Study|Migrated/moved from study area|0|||
147444334|NCT00530894|531792572|FG000|Overall Study|Death|84|||
147444335|NCT00530894|531792573|FG001|Overall Study|Death|89|||
147112801|NCT01482221|530576625|FG000|Overall Study|Physician Decision|0|||
147112802|NCT01482221|530576626|FG001|Overall Study|Physician Decision|1|||
147112803|NCT01482221|530576627|FG002|Overall Study|Physician Decision|0|||
147112804|NCT03086343|530576628|FG000|Period 1|Adverse Event|7|||
147112805|NCT03086343|530576629|FG001|Period 1|Adverse Event|7|||
147112806|NCT03086343|530576630|FG002|Period 1|Adverse Event|0|||
147112807|NCT03086343|530576631|FG003|Period 1|Adverse Event|1|||
147112808|NCT03086343|530576628|FG000|Period 1|Withdrawal by Subject|6|||
147112809|NCT03086343|530576629|FG001|Period 1|Withdrawal by Subject|10|||
147112810|NCT03086343|530576630|FG002|Period 1|Withdrawal by Subject|0|||
147112811|NCT03086343|530576631|FG003|Period 1|Withdrawal by Subject|0|||
147112812|NCT03086343|530576628|FG000|Period 1|Lost to Follow-up|1|||
147112813|NCT03086343|530576629|FG001|Period 1|Lost to Follow-up|3|||
147112814|NCT03086343|530576630|FG002|Period 1|Lost to Follow-up|1|||
147112815|NCT03086343|530576631|FG003|Period 1|Lost to Follow-up|0|||
147226529|NCT02017171|531002079|FG000|Overall Study|Death|10|||
147112816|NCT03086343|530576628|FG000|Period 1|Other, Not Specified|10|||
147112817|NCT03086343|530576629|FG001|Period 1|Other, Not Specified|12|||
147112818|NCT03086343|530576630|FG002|Period 1|Other, Not Specified|2|||
147112819|NCT03086343|530576631|FG003|Period 1|Other, Not Specified|1|||
147112820|NCT03086343|530576628|FG000|Period 1|Missing|1|||
147112821|NCT03086343|530576629|FG001|Period 1|Missing|0|||
147112822|NCT03086343|530576630|FG002|Period 1|Missing|0|||
147112823|NCT03086343|530576631|FG003|Period 1|Missing|0|||
147112824|NCT03086343|530576628|FG000|Period 2|Adverse Event|20|||
147112825|NCT03086343|530576629|FG001|Period 2|Adverse Event|11|||
147112826|NCT03086343|530576630|FG002|Period 2|Adverse Event|1|||
147112827|NCT03086343|530576631|FG003|Period 2|Adverse Event|2|||
147112828|NCT03086343|530576628|FG000|Period 2|Withdrawal by Subject|15|||
147112829|NCT03086343|530576629|FG001|Period 2|Withdrawal by Subject|25|||
147112830|NCT03086343|530576630|FG002|Period 2|Withdrawal by Subject|2|||
147112831|NCT03086343|530576631|FG003|Period 2|Withdrawal by Subject|2|||
147112832|NCT03086343|530576628|FG000|Period 2|Lost to Follow-up|6|||
147112833|NCT03086343|530576629|FG001|Period 2|Lost to Follow-up|11|||
147112834|NCT03086343|530576630|FG002|Period 2|Lost to Follow-up|1|||
147112835|NCT03086343|530576631|FG003|Period 2|Lost to Follow-up|0|||
147112836|NCT03086343|530576628|FG000|Period 2|COVID-19 Infection|5|||
147112837|NCT03086343|530576629|FG001|Period 2|COVID-19 Infection|0|||
147112838|NCT03086343|530576630|FG002|Period 2|COVID-19 Infection|0|||
147112839|NCT03086343|530576631|FG003|Period 2|COVID-19 Infection|0|||
147112840|NCT03086343|530576628|FG000|Period 2|COVID-19 Logistical Restrictions|1|||
147112841|NCT03086343|530576629|FG001|Period 2|COVID-19 Logistical Restrictions|0|||
147112842|NCT03086343|530576630|FG002|Period 2|COVID-19 Logistical Restrictions|0|||
147112843|NCT03086343|530576631|FG003|Period 2|COVID-19 Logistical Restrictions|0|||
147112844|NCT03086343|530576628|FG000|Period 2|Other, Not Specified|23|||
147112845|NCT03086343|530576629|FG001|Period 2|Other, Not Specified|22|||
147112846|NCT03086343|530576630|FG002|Period 2|Other, Not Specified|2|||
147112847|NCT03086343|530576631|FG003|Period 2|Other, Not Specified|4|||
147112848|NCT01047501|530576633|FG000|Overall Study|Adverse Event|7|||
147112849|NCT01047501|530576634|FG001|Overall Study|Adverse Event|8|||
147112850|NCT01047501|530576635|FG002|Overall Study|Adverse Event|5|||
147112851|NCT01047501|530576633|FG000|Overall Study|Withdrew Consent|6|||
147112852|NCT01047501|530576634|FG001|Overall Study|Withdrew Consent|2|||
147112853|NCT01047501|530576635|FG002|Overall Study|Withdrew Consent|4|||
147112854|NCT01047501|530576633|FG000|Overall Study|Lost to Follow-up|0|||
147112855|NCT01047501|530576634|FG001|Overall Study|Lost to Follow-up|1|||
147112856|NCT01047501|530576635|FG002|Overall Study|Lost to Follow-up|1|||
147112857|NCT01047501|530576633|FG000|Overall Study|Triglycerides >800 mg/dL|1|||
147112858|NCT01047501|530576634|FG001|Overall Study|Triglycerides >800 mg/dL|0|||
147112859|NCT01047501|530576635|FG002|Overall Study|Triglycerides >800 mg/dL|0|||
147112860|NCT01047501|530576633|FG000|Overall Study|Death|1|||
147112861|NCT01047501|530576634|FG001|Overall Study|Death|0|||
147112862|NCT01047501|530576635|FG002|Overall Study|Death|0|||
147112863|NCT01047501|530576633|FG000|Overall Study|Other discontinuation|1|||
147112864|NCT01047501|530576634|FG001|Overall Study|Other discontinuation|0|||
147112865|NCT01047501|530576635|FG002|Overall Study|Other discontinuation|1|||
147112866|NCT01047501|530576633|FG000|Overall Study|Investigator judgement|0|||
147112867|NCT01047501|530576634|FG001|Overall Study|Investigator judgement|0|||
147112868|NCT01047501|530576635|FG002|Overall Study|Investigator judgement|1|||
147112869|NCT04602000|530576636|FG000|Overall Study|Withdrawal by Subject|3|||
147444336|NCT00530894|531792574|FG002|Overall Study|Death|55|||
147561359|NCT02191891|532212146|FG000|Overall Study|Withdrawal by Subject|0|||
147561360|NCT02191891|532212147|FG001|Overall Study|Withdrawal by Subject|1|||
147561361|NCT02191891|532212148|FG002|Overall Study|Withdrawal by Subject|0|||
147112870|NCT04602000|530576637|FG001|Overall Study|Withdrawal by Subject|6|||
147112871|NCT04602000|530576638|FG002|Overall Study|Withdrawal by Subject|3|||
147112872|NCT04602000|530576639|FG003|Overall Study|Withdrawal by Subject|27|||
147112873|NCT04602000|530576640|FG004|Overall Study|Withdrawal by Subject|39|||
147112874|NCT04602000|530576636|FG000|Overall Study|Physician Decision|1|||
147112875|NCT04602000|530576637|FG001|Overall Study|Physician Decision|0|||
147112876|NCT04602000|530576638|FG002|Overall Study|Physician Decision|0|||
147112877|NCT04602000|530576639|FG003|Overall Study|Physician Decision|2|||
147112878|NCT04602000|530576640|FG004|Overall Study|Physician Decision|2|||
147112879|NCT04602000|530576636|FG000|Overall Study|Death|0|||
147112880|NCT04602000|530576637|FG001|Overall Study|Death|1|||
147112881|NCT04602000|530576638|FG002|Overall Study|Death|0|||
147112882|NCT04602000|530576639|FG003|Overall Study|Death|1|||
147112883|NCT04602000|530576640|FG004|Overall Study|Death|2|||
147112884|NCT04602000|530576636|FG000|Overall Study|Lost to Follow-up|0|||
147112885|NCT04602000|530576637|FG001|Overall Study|Lost to Follow-up|0|||
147112886|NCT04602000|530576638|FG002|Overall Study|Lost to Follow-up|0|||
147112887|NCT04602000|530576639|FG003|Overall Study|Lost to Follow-up|3|||
147112888|NCT04602000|530576640|FG004|Overall Study|Lost to Follow-up|4|||
147561362|NCT02191891|532212149|FG003|Overall Study|Withdrawal by Subject|0|||
147112889|NCT04602000|530576636|FG000|Overall Study|Other|4|||
147112890|NCT04602000|530576637|FG001|Overall Study|Other|1|||
147112891|NCT04602000|530576638|FG002|Overall Study|Other|2|||
147561363|NCT02191891|532212150|FG004|Overall Study|Withdrawal by Subject|1|||
147561364|NCT02191891|532212146|FG000|Overall Study|Adverse Event|0|||
147561365|NCT02191891|532212147|FG001|Overall Study|Adverse Event|1|||
147561366|NCT02191891|532212148|FG002|Overall Study|Adverse Event|0|||
147561367|NCT02191891|532212149|FG003|Overall Study|Adverse Event|0|||
147561368|NCT02191891|532212150|FG004|Overall Study|Adverse Event|2|||
147561369|NCT02191891|532212146|FG000|Overall Study|Disease Progression|4|||
147561370|NCT02191891|532212147|FG001|Overall Study|Disease Progression|10|||
147561371|NCT02191891|532212148|FG002|Overall Study|Disease Progression|4|||
147561372|NCT02191891|532212149|FG003|Overall Study|Disease Progression|2|||
147561373|NCT02191891|532212150|FG004|Overall Study|Disease Progression|7|||
147561374|NCT03883906|532212155|FG000|Overall Study|Withdrawal by Subject|2|||
147561375|NCT03883906|532212155|FG000|Overall Study|Physician Decision|5|||
147561376|NCT00874237|532212156|FG000|Overall Study|Physician Decision|0|||
147561377|NCT00874237|532212157|FG001|Overall Study|Physician Decision|1|||
147561378|NCT00874237|532212158|FG002|Overall Study|Physician Decision|0|||
147561379|NCT00874237|532212159|FG003|Overall Study|Physician Decision|0|||
147561380|NCT00874237|532212160|FG004|Overall Study|Physician Decision|0|||
147561381|NCT00874237|532212161|FG005|Overall Study|Physician Decision|0|||
147561382|NCT00874237|532212156|FG000|Overall Study|Withdrawal by Subject|0|||
147561383|NCT00874237|532212157|FG001|Overall Study|Withdrawal by Subject|0|||
147561384|NCT00874237|532212158|FG002|Overall Study|Withdrawal by Subject|1|||
147561385|NCT00874237|532212159|FG003|Overall Study|Withdrawal by Subject|0|||
147561386|NCT00874237|532212160|FG004|Overall Study|Withdrawal by Subject|0|||
147561387|NCT00874237|532212161|FG005|Overall Study|Withdrawal by Subject|0|||
147561388|NCT02458469|532212165|FG000|First Intervention (2 Weeks)|Lost to Follow-up|0|||
147561389|NCT02458469|532212166|FG001|First Intervention (2 Weeks)|Lost to Follow-up|0|||
147561390|NCT02458469|532212167|FG002|First Intervention (2 Weeks)|Lost to Follow-up|1|||
147112892|NCT04602000|530576639|FG003|Overall Study|Other|5|||
147112893|NCT04602000|530576640|FG004|Overall Study|Other|4|||
147112894|NCT04602000|530576636|FG000|Overall Study|Completed Treatment Period but not entered into Follow-up Period|0|||
147112895|NCT04602000|530576637|FG001|Overall Study|Completed Treatment Period but not entered into Follow-up Period|0|||
147112896|NCT04602000|530576638|FG002|Overall Study|Completed Treatment Period but not entered into Follow-up Period|1|||
147561391|NCT02458469|532212168|FG003|First Intervention (2 Weeks)|Lost to Follow-up|0|||
147561392|NCT02458469|532212169|FG004|First Intervention (2 Weeks)|Lost to Follow-up|0|||
147561393|NCT02458469|532212170|FG005|First Intervention (2 Weeks)|Lost to Follow-up|0|||
147561394|NCT02458469|532212165|FG000|First Intervention (2 Weeks)|Physician Decision|1|||
147561395|NCT02458469|532212166|FG001|First Intervention (2 Weeks)|Physician Decision|0|||
147561396|NCT02458469|532212167|FG002|First Intervention (2 Weeks)|Physician Decision|0|||
147561397|NCT02458469|532212168|FG003|First Intervention (2 Weeks)|Physician Decision|0|||
147561398|NCT02458469|532212169|FG004|First Intervention (2 Weeks)|Physician Decision|0|||
147561399|NCT02458469|532212170|FG005|First Intervention (2 Weeks)|Physician Decision|0|||
147561400|NCT02458469|532212165|FG000|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
147561401|NCT02458469|532212166|FG001|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
147561402|NCT02458469|532212167|FG002|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
147561403|NCT02458469|532212168|FG003|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
147561404|NCT02458469|532212169|FG004|Second Intervention (2 Weeks)|Withdrawal by Subject|0|||
147561405|NCT02458469|532212170|FG005|Second Intervention (2 Weeks)|Withdrawal by Subject|1|||
147561406|NCT03561883|532212173|FG000|Overall Study|Adverse Event|10|||
147561407|NCT03561883|532212174|FG001|Overall Study|Adverse Event|13|||
147561408|NCT03561883|532212173|FG000|Overall Study|Non-Compliance With Study Drug|1|||
147561409|NCT03561883|532212174|FG001|Overall Study|Non-Compliance With Study Drug|2|||
147561410|NCT03561883|532212173|FG000|Overall Study|Protocol Violation|2|||
147561411|NCT03561883|532212174|FG001|Overall Study|Protocol Violation|3|||
147561412|NCT03561883|532212173|FG000|Overall Study|Withdrawal by Subject|14|||
147561413|NCT03561883|532212174|FG001|Overall Study|Withdrawal by Subject|6|||
147561414|NCT03561883|532212173|FG000|Overall Study|Lost to Follow-up|2|||
147561415|NCT03561883|532212174|FG001|Overall Study|Lost to Follow-up|6|||
147561416|NCT03561883|532212173|FG000|Overall Study|Study Terminated by Sponsor|12|||
147561417|NCT03561883|532212174|FG001|Overall Study|Study Terminated by Sponsor|11|||
147561418|NCT03561883|532212173|FG000|Overall Study|Physician Decision|1|||
147112897|NCT04602000|530576639|FG003|Overall Study|Completed Treatment Period but not entered into Follow-up Period|0|||
147226530|NCT02017171|531002080|FG001|Overall Study|Death|4|||
147226531|NCT02017171|531002079|FG000|Overall Study|Withdrawal by Subject|23|||
147561419|NCT03561883|532212174|FG001|Overall Study|Physician Decision|0|||
147561420|NCT03561883|532212173|FG000|Overall Study|Randomized by Mistake|1|||
147561421|NCT03561883|532212174|FG001|Overall Study|Randomized by Mistake|0|||
147561422|NCT03561883|532212173|FG000|Overall Study|Other, Not Specified|3|||
147561423|NCT03561883|532212174|FG001|Overall Study|Other, Not Specified|2|||
147561424|NCT01471522|532212188|FG000|Overall Study|Withdrawal by Subject|28|||
147561425|NCT01471522|532212189|FG001|Overall Study|Withdrawal by Subject|22|||
147561426|NCT01471522|532212188|FG000|Overall Study|Lost to Follow-up|36|||
147561427|NCT01471522|532212189|FG001|Overall Study|Lost to Follow-up|26|||
147226532|NCT02017171|531002080|FG001|Overall Study|Withdrawal by Subject|17|||
147561428|NCT02863575|532212190|FG000|Overall Study|Participants Unable To Swallow Capsule|1|||
147561429|NCT02863575|532212191|FG001|Overall Study|Participants Unable To Swallow Capsule|0|||
147561430|NCT02863575|532212192|FG002|Overall Study|Participants Unable To Swallow Capsule|0|||
147561431|NCT02863575|532212190|FG000|Overall Study|Withdrawal by Subject|0|||
147561432|NCT02863575|532212191|FG001|Overall Study|Withdrawal by Subject|1|||
147561433|NCT02863575|532212192|FG002|Overall Study|Withdrawal by Subject|1|||
147561434|NCT02863575|532212190|FG000|Overall Study|Adverse Event|0|||
147561435|NCT02863575|532212191|FG001|Overall Study|Adverse Event|1|||
147561436|NCT02863575|532212192|FG002|Overall Study|Adverse Event|0|||
147561437|NCT05628675|532213733|FG000|Overall Study|Lost to Follow-up|2|||
147561438|NCT05628675|532213733|FG000|Overall Study|Withdrawal by Subject|1|||
147561439|NCT02918877|532213736|FG000|Overall Study|Withdrawal by Subject|2|||
147561440|NCT02918877|532213737|FG001|Overall Study|Withdrawal by Subject|2|||
147561441|NCT02918877|532213736|FG000|Overall Study|Surgery cancelled|1|||
147561442|NCT02918877|532213737|FG001|Overall Study|Surgery cancelled|0|||
147561443|NCT02918877|532213736|FG000|Overall Study|Physician Decision|1|||
147561444|NCT02918877|532213737|FG001|Overall Study|Physician Decision|0|||
147561445|NCT02918877|532213736|FG000|Overall Study|Received intraoperative steroids|1|||
147561446|NCT02918877|532213737|FG001|Overall Study|Received intraoperative steroids|0|||
147561447|NCT02918877|532213736|FG000|Overall Study|Unable to obtain lab samples|1|||
147561448|NCT02918877|532213737|FG001|Overall Study|Unable to obtain lab samples|0|||
147561449|NCT02918877|532213736|FG000|Overall Study|Unsafe to perform BAL|0|||
147561450|NCT02918877|532213737|FG001|Overall Study|Unsafe to perform BAL|1|||
147561451|NCT01367275|532213738|FG000|Overall Study|Ineligible|1|||
147561452|NCT01367275|532213738|FG000|Overall Study|Disease Progression|2|||
147561453|NCT01648166|532213739|FG000|Overall Study|inadequate toenail samples|53|||
147561454|NCT01648166|532213740|FG001|Overall Study|inadequate toenail samples|100|||
147561455|NCT00883090|532213741|FG000|Overall Study|Sponsor's decision|1|||
147561456|NCT00883090|532213741|FG000|Overall Study|Withdrawal by Subject|1|||
147561457|NCT02532764|532213742|FG000|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
147561458|NCT02532764|532213743|FG001|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
147561459|NCT02532764|532213744|FG002|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
147561460|NCT02532764|532213745|FG003|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
147561461|NCT02532764|532213746|FG004|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
147561462|NCT02532764|532213747|FG005|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
147561463|NCT02532764|532213748|FG006|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|0|||
147561464|NCT02532764|532213749|FG007|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|1|||
147561465|NCT02532764|532213750|FG008|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|1|||
147561466|NCT02532764|532213751|FG009|Multiple Ascending Dose (MAD) Cohorst|Met stopping criteria|1|||
147561467|NCT01717976|532213752|FG000|Overall Study|Protocol Violation|0|||
147561468|NCT01717976|532213753|FG001|Overall Study|Protocol Violation|1|||
147561469|NCT00262223|532213756|FG000|Treatment Phase|Withdrawal by Subject|3|||
147561470|NCT00262223|532213757|FG001|Treatment Phase|Withdrawal by Subject|6|||
147561471|NCT00262223|532213756|FG000|Treatment Phase|Adverse Event|1|||
147561472|NCT00262223|532213757|FG001|Treatment Phase|Adverse Event|2|||
147561473|NCT00262223|532213756|FG000|1-week Post-treatment Follow-up|Lost to Follow-up|4|||
147561474|NCT00262223|532213757|FG001|1-week Post-treatment Follow-up|Lost to Follow-up|4|||
147561475|NCT00262223|532213756|FG000|6-month Post-treatment Follow-up|Lost to Follow-up|6|||
147561476|NCT00262223|532213757|FG001|6-month Post-treatment Follow-up|Lost to Follow-up|1|||
147561477|NCT00262223|532213756|FG000|12-month Post-treatment Follow-up|Lost to Follow-up|7|||
147561478|NCT00262223|532213757|FG001|12-month Post-treatment Follow-up|Lost to Follow-up|7|||
147561479|NCT00437658|532213758|FG000|Treatment Period (24 Weeks)|Adverse Event|4|||
147561480|NCT00437658|532213759|FG001|Treatment Period (24 Weeks)|Adverse Event|7|||
147561481|NCT00437658|532213760|FG002|Treatment Period (24 Weeks)|Adverse Event|14|||
147561482|NCT00437658|532213758|FG000|Treatment Period (24 Weeks)|Non-compliance|1|||
147561483|NCT00437658|532213759|FG001|Treatment Period (24 Weeks)|Non-compliance|1|||
147561484|NCT00437658|532213760|FG002|Treatment Period (24 Weeks)|Non-compliance|4|||
147561485|NCT00437658|532213758|FG000|Treatment Period (24 Weeks)|Withdrawal by Subject|9|||
147561486|NCT00437658|532213759|FG001|Treatment Period (24 Weeks)|Withdrawal by Subject|7|||
147561487|NCT00437658|532213760|FG002|Treatment Period (24 Weeks)|Withdrawal by Subject|7|||
147561488|NCT00437658|532213758|FG000|Treatment Period (24 Weeks)|Lack of Efficacy|4|||
147561489|NCT00437658|532213759|FG001|Treatment Period (24 Weeks)|Lack of Efficacy|2|||
147561490|NCT00437658|532213760|FG002|Treatment Period (24 Weeks)|Lack of Efficacy|3|||
147561491|NCT00437658|532213758|FG000|Treatment Period (24 Weeks)|Lost to Follow-up|5|||
147561492|NCT00437658|532213759|FG001|Treatment Period (24 Weeks)|Lost to Follow-up|4|||
147561493|NCT00437658|532213760|FG002|Treatment Period (24 Weeks)|Lost to Follow-up|5|||
147561494|NCT00437658|532213758|FG000|Treatment Period (24 Weeks)|Sponsor/Investigator Decision|5|||
147561495|NCT00437658|532213759|FG001|Treatment Period (24 Weeks)|Sponsor/Investigator Decision|1|||
147561496|NCT00437658|532213760|FG002|Treatment Period (24 Weeks)|Sponsor/Investigator Decision|0|||
147561497|NCT00437658|532213758|FG000|Post-treatment Period (24 Weeks)|Adverse Event|1|||
147561498|NCT00437658|532213759|FG001|Post-treatment Period (24 Weeks)|Adverse Event|0|||
147112898|NCT04602000|530576640|FG004|Overall Study|Completed Treatment Period but not entered into Follow-up Period|0|||
147112899|NCT05607043|530576641|FG000|Overall Study|Lost to Follow-up|2|||
147112900|NCT00429299|530576648|FG000|Overall Study|Disease Progression|1|||
147112901|NCT00429299|530576649|FG001|Overall Study|Disease Progression|1|||
147112902|NCT00429299|530576650|FG002|Overall Study|Disease Progression|0|||
147112903|NCT00429299|530576648|FG000|Overall Study|Adverse Event|2|||
147112904|NCT00429299|530576649|FG001|Overall Study|Adverse Event|5|||
147112905|NCT00429299|530576650|FG002|Overall Study|Adverse Event|1|||
147112906|NCT00429299|530576648|FG000|Overall Study|Protocol Violation|1|||
147112907|NCT00429299|530576649|FG001|Overall Study|Protocol Violation|0|||
147112908|NCT00429299|530576650|FG002|Overall Study|Protocol Violation|0|||
147112909|NCT00429299|530576648|FG000|Overall Study|Withdrawal by Subject|0|||
147112910|NCT00429299|530576649|FG001|Overall Study|Withdrawal by Subject|1|||
147112911|NCT00429299|530576650|FG002|Overall Study|Withdrawal by Subject|3|||
147112912|NCT01510756|530576651|FG000|Overall Study|Death|1|||
147112913|NCT01510756|530576651|FG000|Overall Study|Lack of Efficacy|2|||
147112914|NCT01510756|530576651|FG000|Overall Study|Physician Decision|1|||
147112915|NCT02447029|530576652|FG000|Overall Study|Withdrawal by Subject|3|||
147112916|NCT02447029|530576653|FG001|Overall Study|Withdrawal by Subject|2|||
147112917|NCT02202616|530576656|FG000|Overall Study|Screen failed|24|||
147112918|NCT02202616|530576656|FG000|Overall Study|Adverse Event|32|||
147112919|NCT02202616|530576656|FG000|Overall Study|Protocol deviation|18|||
147112920|NCT02202616|530576656|FG000|Overall Study|Patient withdrew consent|12|||
147112921|NCT02202616|530576656|FG000|Overall Study|Lost to Follow-up|6|||
147112922|NCT02202616|530576656|FG000|Overall Study|Administrative problems|6|||
147112923|NCT02202616|530576656|FG000|Overall Study|Abnormal test procedure result|1|||
147112924|NCT02202616|530576656|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
147112925|NCT00776997|530576659|FG000|Overall Study|Adverse Event|2|||
147112926|NCT05221866|530576660|FG000|Overall Study|Withdrawal by Subject|5|||
147112927|NCT05221866|530576661|FG001|Overall Study|Withdrawal by Subject|7|||
147112928|NCT05221866|530576662|FG002|Overall Study|Withdrawal by Subject|6|||
147112929|NCT05221866|530576663|FG003|Overall Study|Withdrawal by Subject|4|||
147112930|NCT05221866|530576660|FG000|Overall Study|Physician Decision|3|||
147112931|NCT05221866|530576661|FG001|Overall Study|Physician Decision|2|||
147112932|NCT05221866|530576662|FG002|Overall Study|Physician Decision|1|||
147112933|NCT05221866|530576663|FG003|Overall Study|Physician Decision|4|||
147112934|NCT05221866|530576660|FG000|Overall Study|Lost to Follow-up|12|||
147112935|NCT05221866|530576661|FG001|Overall Study|Lost to Follow-up|17|||
147112936|NCT05221866|530576662|FG002|Overall Study|Lost to Follow-up|14|||
147112937|NCT05221866|530576663|FG003|Overall Study|Lost to Follow-up|14|||
147112938|NCT05221866|530576660|FG000|Overall Study|Discharge plan revised; app compatibility issue or chronic opioid use discovered post-enrollment.|7|||
147112939|NCT05221866|530576661|FG001|Overall Study|Discharge plan revised; app compatibility issue or chronic opioid use discovered post-enrollment.|5|||
147112940|NCT05221866|530576662|FG002|Overall Study|Discharge plan revised; app compatibility issue or chronic opioid use discovered post-enrollment.|0|||
147112941|NCT05221866|530576663|FG003|Overall Study|Discharge plan revised; app compatibility issue or chronic opioid use discovered post-enrollment.|4|||
147112942|NCT02717611|530576664|FG000|Overall Study|Death|13|||
147112943|NCT02717611|530576664|FG000|Overall Study|Withdrawal by Subject|6|||
147112944|NCT02717611|530576664|FG000|Overall Study|Active, not recruiting|40|||
147112945|NCT02717611|530576664|FG000|Overall Study|Complicating disease|1|||
147112946|NCT04598828|530576665|FG000|Overall Study|Physician Decision|1|||
147112947|NCT04598828|530576666|FG001|Overall Study|Physician Decision|0|||
147112948|NCT04598828|530576665|FG000|Overall Study|Withdrawal by Subject|0|||
147112949|NCT04598828|530576666|FG001|Overall Study|Withdrawal by Subject|1|||
147112950|NCT04598828|530576665|FG000|Overall Study|Withdrawal by Subject|0|||
147112951|NCT04598828|530576666|FG001|Overall Study|Withdrawal by Subject|1|||
147112952|NCT02676973|530576667|FG000|Overall Study|Withdrawal by Subject|9|||
147561499|NCT00437658|532213760|FG002|Post-treatment Period (24 Weeks)|Adverse Event|1|||
147561500|NCT00437658|532213758|FG000|Post-treatment Period (24 Weeks)|Non-compliance|3|||
147112953|NCT02676973|530576668|FG001|Overall Study|Withdrawal by Subject|8|||
147112954|NCT02676973|530576669|FG002|Overall Study|Withdrawal by Subject|11|||
147112955|NCT02676973|530576667|FG000|Overall Study|Lost to Follow-up|8|||
147112956|NCT02676973|530576668|FG001|Overall Study|Lost to Follow-up|12|||
147112957|NCT02676973|530576669|FG002|Overall Study|Lost to Follow-up|8|||
147112958|NCT02676973|530576667|FG000|Overall Study|Death|2|||
147561501|NCT00437658|532213759|FG001|Post-treatment Period (24 Weeks)|Non-compliance|0|||
147561502|NCT00437658|532213760|FG002|Post-treatment Period (24 Weeks)|Non-compliance|1|||
147561503|NCT00437658|532213758|FG000|Post-treatment Period (24 Weeks)|Withdrawal by Subject|12|||
147561504|NCT00437658|532213759|FG001|Post-treatment Period (24 Weeks)|Withdrawal by Subject|6|||
147112959|NCT02676973|530576668|FG001|Overall Study|Death|1|||
147112960|NCT02676973|530576669|FG002|Overall Study|Death|5|||
147112961|NCT01078662|530576671|FG000|Overall Study|Death|41|||
147112962|NCT01078662|530576672|FG001|Overall Study|Death|103|||
147112963|NCT01078662|530576673|FG002|Overall Study|Death|18|||
147112964|NCT01078662|530576674|FG003|Overall Study|Death|5|||
147112965|NCT01078662|530576675|FG004|Overall Study|Death|8|||
147112966|NCT01078662|530576671|FG000|Overall Study|Patients reached data cut-off|12|||
147112967|NCT01078662|530576672|FG001|Overall Study|Patients reached data cut-off|53|||
147112968|NCT01078662|530576673|FG002|Overall Study|Patients reached data cut-off|2|||
147112969|NCT01078662|530576674|FG003|Overall Study|Patients reached data cut-off|2|||
147112970|NCT01078662|530576675|FG004|Overall Study|Patients reached data cut-off|3|||
147112971|NCT01078662|530576671|FG000|Overall Study|Withdrawal by Subject|4|||
147112972|NCT01078662|530576672|FG001|Overall Study|Withdrawal by Subject|11|||
147112973|NCT01078662|530576673|FG002|Overall Study|Withdrawal by Subject|1|||
147112974|NCT01078662|530576674|FG003|Overall Study|Withdrawal by Subject|0|||
147112975|NCT01078662|530576675|FG004|Overall Study|Withdrawal by Subject|0|||
147112976|NCT01078662|530576671|FG000|Overall Study|Protocol Violation|0|||
147112977|NCT01078662|530576672|FG001|Overall Study|Protocol Violation|1|||
147112978|NCT01078662|530576673|FG002|Overall Study|Protocol Violation|0|||
147112979|NCT01078662|530576674|FG003|Overall Study|Protocol Violation|0|||
147112980|NCT01078662|530576675|FG004|Overall Study|Protocol Violation|0|||
147112981|NCT01078662|530576671|FG000|Overall Study|Lost to Follow-up|1|||
147112982|NCT01078662|530576672|FG001|Overall Study|Lost to Follow-up|0|||
147112983|NCT01078662|530576673|FG002|Overall Study|Lost to Follow-up|0|||
147112984|NCT01078662|530576674|FG003|Overall Study|Lost to Follow-up|0|||
147112985|NCT01078662|530576675|FG004|Overall Study|Lost to Follow-up|0|||
147112986|NCT03122106|530576676|FG000|Overall Study|Not enough tissue|1|||
147112987|NCT03122106|530576676|FG000|Overall Study|Disease progression during screening|2|||
147112988|NCT03122106|530576676|FG000|Overall Study|Poor RNA quality for vaccine|1|||
147112989|NCT03244189|530576677|FG000|Overall Study|Death|0|||
147112990|NCT03244189|530576678|FG001|Overall Study|Death|2|||
147112991|NCT03244189|530576677|FG000|Overall Study|Lost to Follow-up|92|||
147112992|NCT03244189|530576678|FG001|Overall Study|Lost to Follow-up|107|||
147112993|NCT03244189|530576677|FG000|Overall Study|Physician Decision|4|||
147112994|NCT03244189|530576678|FG001|Overall Study|Physician Decision|2|||
147112995|NCT03244189|530576677|FG000|Overall Study|Pregnancy|7|||
147112996|NCT03244189|530576678|FG001|Overall Study|Pregnancy|5|||
147112997|NCT03244189|530576677|FG000|Overall Study|Protocol Violation|0|||
147112998|NCT03244189|530576678|FG001|Overall Study|Protocol Violation|2|||
147112999|NCT03244189|530576677|FG000|Overall Study|Withdrawal by Subject|45|||
147113000|NCT03244189|530576678|FG001|Overall Study|Withdrawal by Subject|23|||
147113001|NCT03244189|530576677|FG000|Overall Study|Technical Problems|2|||
147113002|NCT03244189|530576678|FG001|Overall Study|Technical Problems|0|||
147113003|NCT03611946|530576679|FG000|Overall Study|Withdrawal by Subject|0|||
147113004|NCT03611946|530576680|FG001|Overall Study|Withdrawal by Subject|0|||
147113005|NCT03611946|530576681|FG002|Overall Study|Withdrawal by Subject|1|||
147113006|NCT03611946|530576682|FG003|Overall Study|Withdrawal by Subject|0|||
147113007|NCT02872714|530576686|FG000|Overall Study|Progressive Disease|1|||
147113008|NCT02872714|530576687|FG001|Overall Study|Progressive Disease|2|||
147113009|NCT02872714|530576688|FG002|Overall Study|Progressive Disease|0|||
147113010|NCT02872714|530576689|FG003|Overall Study|Progressive Disease|0|||
147113011|NCT02872714|530576690|FG004|Overall Study|Progressive Disease|0|||
147113012|NCT02872714|530576686|FG000|Overall Study|Death|87|||
147113013|NCT02872714|530576687|FG001|Overall Study|Death|36|||
147113014|NCT02872714|530576688|FG002|Overall Study|Death|8|||
147113015|NCT02872714|530576689|FG003|Overall Study|Death|81|||
147113016|NCT02872714|530576690|FG004|Overall Study|Death|2|||
147113017|NCT02872714|530576686|FG000|Overall Study|Lost to Follow-up|2|||
147113018|NCT02872714|530576687|FG001|Overall Study|Lost to Follow-up|1|||
147113019|NCT02872714|530576688|FG002|Overall Study|Lost to Follow-up|0|||
147113020|NCT02872714|530576689|FG003|Overall Study|Lost to Follow-up|3|||
147113021|NCT02872714|530576690|FG004|Overall Study|Lost to Follow-up|0|||
147113022|NCT02872714|530576686|FG000|Overall Study|Physician Decision|0|||
147113023|NCT02872714|530576687|FG001|Overall Study|Physician Decision|0|||
147113024|NCT02872714|530576688|FG002|Overall Study|Physician Decision|0|||
147113025|NCT02872714|530576689|FG003|Overall Study|Physician Decision|1|||
147113026|NCT02872714|530576690|FG004|Overall Study|Physician Decision|0|||
147113027|NCT02872714|530576686|FG000|Overall Study|Withdrawal by Subject|1|||
147113028|NCT02872714|530576687|FG001|Overall Study|Withdrawal by Subject|3|||
147113029|NCT02872714|530576688|FG002|Overall Study|Withdrawal by Subject|0|||
147561505|NCT00437658|532213760|FG002|Post-treatment Period (24 Weeks)|Withdrawal by Subject|8|||
147113030|NCT02872714|530576689|FG003|Overall Study|Withdrawal by Subject|2|||
147113031|NCT02872714|530576690|FG004|Overall Study|Withdrawal by Subject|0|||
147113032|NCT02872714|530576686|FG000|Overall Study|Captured as Other|2|||
147113033|NCT02872714|530576687|FG001|Overall Study|Captured as Other|0|||
147113034|NCT02872714|530576688|FG002|Overall Study|Captured as Other|0|||
147113035|NCT02872714|530576689|FG003|Overall Study|Captured as Other|1|||
147113036|NCT02872714|530576690|FG004|Overall Study|Captured as Other|0|||
147113037|NCT05800145|530576693|FG000|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|7|||
147113038|NCT05800145|530576694|FG001|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
147113039|NCT05800145|530576695|FG002|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
147113040|NCT05800145|530576696|FG003|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|3|||
147561506|NCT00437658|532213758|FG000|Post-treatment Period (24 Weeks)|Lack of Efficacy|0|||
147561507|NCT00437658|532213759|FG001|Post-treatment Period (24 Weeks)|Lack of Efficacy|2|||
147113041|NCT05800145|530576697|FG004|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
147113042|NCT05800145|530576698|FG005|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
147113043|NCT05800145|530576693|FG000|Stage 1 Intervention (Months 1-3)|Withdrawal by Subject|1|||
147113044|NCT05800145|530576694|FG001|Stage 1 Intervention (Months 1-3)|Withdrawal by Subject|0|||
147113045|NCT05800145|530576695|FG002|Stage 1 Intervention (Months 1-3)|Withdrawal by Subject|0|||
147113046|NCT05800145|530576696|FG003|Stage 1 Intervention (Months 1-3)|Withdrawal by Subject|3|||
147113047|NCT05800145|530576697|FG004|Stage 1 Intervention (Months 1-3)|Withdrawal by Subject|0|||
147113048|NCT05800145|530576698|FG005|Stage 1 Intervention (Months 1-3)|Withdrawal by Subject|0|||
147113049|NCT05800145|530576693|FG000|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|1|||
147113050|NCT05800145|530576694|FG001|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|5|||
147113051|NCT05800145|530576695|FG002|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|0|||
147113052|NCT05800145|530576696|FG003|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|3|||
147113053|NCT05800145|530576697|FG004|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|2|||
147113054|NCT05800145|530576698|FG005|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|1|||
147113055|NCT02850406|530576699|FG000|Part B (Up to 28 Weeks)|Adverse Event|0|||
147113056|NCT02850406|530576700|FG001|Part B (Up to 28 Weeks)|Adverse Event|0|||
147113057|NCT02850406|530576701|FG002|Part B (Up to 28 Weeks)|Adverse Event|0|||
147113058|NCT02850406|530576702|FG003|Part B (Up to 28 Weeks)|Adverse Event|1|||
147113059|NCT02850406|530576703|FG004|Part B (Up to 28 Weeks)|Adverse Event|0|||
147113060|NCT02850406|530576704|FG005|Part B (Up to 28 Weeks)|Adverse Event|0|||
147113061|NCT02850406|530576705|FG006|Part B (Up to 28 Weeks)|Adverse Event|0|||
147113062|NCT02850406|530576706|FG007|Part B (Up to 28 Weeks)|Adverse Event|0|||
147113063|NCT02850406|530576699|FG000|Part B (Up to 28 Weeks)|Withdrawal by Subject|0|||
147113064|NCT02850406|530576700|FG001|Part B (Up to 28 Weeks)|Withdrawal by Subject|0|||
147113065|NCT02850406|530576701|FG002|Part B (Up to 28 Weeks)|Withdrawal by Subject|1|||
147113066|NCT02850406|530576702|FG003|Part B (Up to 28 Weeks)|Withdrawal by Subject|2|||
147113067|NCT02850406|530576703|FG004|Part B (Up to 28 Weeks)|Withdrawal by Subject|0|||
147113068|NCT02850406|530576704|FG005|Part B (Up to 28 Weeks)|Withdrawal by Subject|0|||
147113069|NCT02850406|530576705|FG006|Part B (Up to 28 Weeks)|Withdrawal by Subject|0|||
147113070|NCT02850406|530576706|FG007|Part B (Up to 28 Weeks)|Withdrawal by Subject|0|||
147113071|NCT02850406|530576699|FG000|Part B (Up to 28 Weeks)|Lost to Follow-up|0|||
147113072|NCT02850406|530576700|FG001|Part B (Up to 28 Weeks)|Lost to Follow-up|0|||
147113073|NCT02850406|530576701|FG002|Part B (Up to 28 Weeks)|Lost to Follow-up|1|||
147113074|NCT02850406|530576702|FG003|Part B (Up to 28 Weeks)|Lost to Follow-up|0|||
147113075|NCT02850406|530576703|FG004|Part B (Up to 28 Weeks)|Lost to Follow-up|0|||
147113076|NCT02850406|530576704|FG005|Part B (Up to 28 Weeks)|Lost to Follow-up|0|||
147113077|NCT02850406|530576705|FG006|Part B (Up to 28 Weeks)|Lost to Follow-up|0|||
147113078|NCT02850406|530576706|FG007|Part B (Up to 28 Weeks)|Lost to Follow-up|0|||
147113079|NCT02850406|530576699|FG000|Part B (Up to 28 Weeks)|Non compliance|0|||
147113080|NCT02850406|530576700|FG001|Part B (Up to 28 Weeks)|Non compliance|0|||
147113081|NCT02850406|530576701|FG002|Part B (Up to 28 Weeks)|Non compliance|1|||
147113082|NCT02850406|530576702|FG003|Part B (Up to 28 Weeks)|Non compliance|0|||
147113083|NCT02850406|530576703|FG004|Part B (Up to 28 Weeks)|Non compliance|0|||
147113084|NCT02850406|530576704|FG005|Part B (Up to 28 Weeks)|Non compliance|0|||
147113085|NCT02850406|530576705|FG006|Part B (Up to 28 Weeks)|Non compliance|0|||
147113086|NCT02850406|530576706|FG007|Part B (Up to 28 Weeks)|Non compliance|0|||
147113087|NCT02850406|530576699|FG000|Part C (Up to 52 Weeks)|Adverse Event|0|||
147113088|NCT02850406|530576700|FG001|Part C (Up to 52 Weeks)|Adverse Event|0|||
147113089|NCT02850406|530576701|FG002|Part C (Up to 52 Weeks)|Adverse Event|0|||
147113090|NCT02850406|530576702|FG003|Part C (Up to 52 Weeks)|Adverse Event|0|||
147113091|NCT02850406|530576703|FG004|Part C (Up to 52 Weeks)|Adverse Event|4|||
147113092|NCT02850406|530576704|FG005|Part C (Up to 52 Weeks)|Adverse Event|2|||
147113093|NCT02850406|530576705|FG006|Part C (Up to 52 Weeks)|Adverse Event|0|||
147113094|NCT02850406|530576706|FG007|Part C (Up to 52 Weeks)|Adverse Event|0|||
147113095|NCT02850406|530576699|FG000|Part C (Up to 52 Weeks)|Withdrawal by Subject|0|||
147113096|NCT02850406|530576700|FG001|Part C (Up to 52 Weeks)|Withdrawal by Subject|0|||
147561508|NCT00437658|532213760|FG002|Post-treatment Period (24 Weeks)|Lack of Efficacy|2|||
147561509|NCT00437658|532213758|FG000|Post-treatment Period (24 Weeks)|Lost to Follow-up|5|||
147561510|NCT00437658|532213759|FG001|Post-treatment Period (24 Weeks)|Lost to Follow-up|0|||
147561511|NCT00437658|532213760|FG002|Post-treatment Period (24 Weeks)|Lost to Follow-up|1|||
147561512|NCT00437658|532213758|FG000|Post-treatment Period (24 Weeks)|Sponsor/Investigator Decision|3|||
147561513|NCT00437658|532213759|FG001|Post-treatment Period (24 Weeks)|Sponsor/Investigator Decision|0|||
147113097|NCT02850406|530576701|FG002|Part C (Up to 52 Weeks)|Withdrawal by Subject|0|||
147113098|NCT02850406|530576702|FG003|Part C (Up to 52 Weeks)|Withdrawal by Subject|0|||
147113099|NCT02850406|530576703|FG004|Part C (Up to 52 Weeks)|Withdrawal by Subject|6|||
147113100|NCT02850406|530576704|FG005|Part C (Up to 52 Weeks)|Withdrawal by Subject|3|||
147113101|NCT02850406|530576705|FG006|Part C (Up to 52 Weeks)|Withdrawal by Subject|0|||
147113102|NCT02850406|530576706|FG007|Part C (Up to 52 Weeks)|Withdrawal by Subject|0|||
147113103|NCT02850406|530576699|FG000|Part C (Up to 52 Weeks)|Physician Decision|0|||
147113104|NCT02850406|530576700|FG001|Part C (Up to 52 Weeks)|Physician Decision|0|||
147113105|NCT02850406|530576701|FG002|Part C (Up to 52 Weeks)|Physician Decision|0|||
147226533|NCT02017171|531002079|FG000|Overall Study|Lost to Follow-up|21|||
147113106|NCT02850406|530576702|FG003|Part C (Up to 52 Weeks)|Physician Decision|0|||
147113107|NCT02850406|530576703|FG004|Part C (Up to 52 Weeks)|Physician Decision|1|||
147113108|NCT02850406|530576704|FG005|Part C (Up to 52 Weeks)|Physician Decision|0|||
147113109|NCT02850406|530576705|FG006|Part C (Up to 52 Weeks)|Physician Decision|0|||
147113110|NCT02850406|530576706|FG007|Part C (Up to 52 Weeks)|Physician Decision|0|||
147113111|NCT02850406|530576699|FG000|Part C (Up to 52 Weeks)|Other|0|||
147113112|NCT02850406|530576700|FG001|Part C (Up to 52 Weeks)|Other|0|||
147113113|NCT02850406|530576701|FG002|Part C (Up to 52 Weeks)|Other|0|||
147113114|NCT02850406|530576702|FG003|Part C (Up to 52 Weeks)|Other|0|||
147113115|NCT02850406|530576703|FG004|Part C (Up to 52 Weeks)|Other|1|||
147113116|NCT02850406|530576704|FG005|Part C (Up to 52 Weeks)|Other|3|||
147113117|NCT02850406|530576705|FG006|Part C (Up to 52 Weeks)|Other|0|||
147113118|NCT02850406|530576706|FG007|Part C (Up to 52 Weeks)|Other|0|||
147113119|NCT02850406|530576699|FG000|Part D (Up to 52 Weeks)|Adverse Event|0|||
147113120|NCT02850406|530576700|FG001|Part D (Up to 52 Weeks)|Adverse Event|0|||
147113121|NCT02850406|530576701|FG002|Part D (Up to 52 Weeks)|Adverse Event|0|||
147113122|NCT02850406|530576702|FG003|Part D (Up to 52 Weeks)|Adverse Event|0|||
147113123|NCT02850406|530576703|FG004|Part D (Up to 52 Weeks)|Adverse Event|0|||
147113124|NCT02850406|530576704|FG005|Part D (Up to 52 Weeks)|Adverse Event|0|||
147113125|NCT02850406|530576705|FG006|Part D (Up to 52 Weeks)|Adverse Event|1|||
147113126|NCT02850406|530576706|FG007|Part D (Up to 52 Weeks)|Adverse Event|0|||
147113127|NCT02850406|530576699|FG000|Part D (Up to 52 Weeks)|Withdrawal by Subject|0|||
147113128|NCT02850406|530576700|FG001|Part D (Up to 52 Weeks)|Withdrawal by Subject|0|||
147113129|NCT02850406|530576701|FG002|Part D (Up to 52 Weeks)|Withdrawal by Subject|0|||
147113130|NCT02850406|530576702|FG003|Part D (Up to 52 Weeks)|Withdrawal by Subject|0|||
147113131|NCT02850406|530576703|FG004|Part D (Up to 52 Weeks)|Withdrawal by Subject|0|||
147113132|NCT02850406|530576704|FG005|Part D (Up to 52 Weeks)|Withdrawal by Subject|0|||
147113133|NCT02850406|530576705|FG006|Part D (Up to 52 Weeks)|Withdrawal by Subject|0|||
147113134|NCT02850406|530576706|FG007|Part D (Up to 52 Weeks)|Withdrawal by Subject|1|||
147113135|NCT02850406|530576699|FG000|Part D (Up to 52 Weeks)|Physician Decision|0|||
147113136|NCT02850406|530576700|FG001|Part D (Up to 52 Weeks)|Physician Decision|0|||
147113137|NCT02850406|530576701|FG002|Part D (Up to 52 Weeks)|Physician Decision|0|||
147113138|NCT02850406|530576702|FG003|Part D (Up to 52 Weeks)|Physician Decision|0|||
147113139|NCT02850406|530576703|FG004|Part D (Up to 52 Weeks)|Physician Decision|0|||
147113140|NCT02850406|530576704|FG005|Part D (Up to 52 Weeks)|Physician Decision|0|||
147113141|NCT02850406|530576705|FG006|Part D (Up to 52 Weeks)|Physician Decision|1|||
147113142|NCT02850406|530576706|FG007|Part D (Up to 52 Weeks)|Physician Decision|1|||
147113143|NCT02850406|530576699|FG000|Part D (Up to 52 Weeks)|Other|0|||
147113144|NCT02850406|530576700|FG001|Part D (Up to 52 Weeks)|Other|0|||
147113145|NCT02850406|530576701|FG002|Part D (Up to 52 Weeks)|Other|0|||
147113146|NCT02850406|530576702|FG003|Part D (Up to 52 Weeks)|Other|0|||
147113147|NCT02850406|530576703|FG004|Part D (Up to 52 Weeks)|Other|0|||
147113148|NCT02850406|530576704|FG005|Part D (Up to 52 Weeks)|Other|0|||
147113149|NCT02850406|530576705|FG006|Part D (Up to 52 Weeks)|Other|0|||
147113150|NCT02850406|530576706|FG007|Part D (Up to 52 Weeks)|Other|1|||
147113151|NCT01565694|530577547|FG000|Dose-Titration Period|Adverse Event|4|||
147113152|NCT01565694|530577547|FG000|Dose-Titration Period|Protocol Violation|10|||
147113153|NCT01565694|530577547|FG000|Fixed-Dose Assessment Period|Withdrawal by Subject|4|||
147113154|NCT01373229|530577548|FG000|Overall Study|Death|3|||
147113155|NCT01373229|530577548|FG000|Overall Study|Physician Decision|3|||
147113156|NCT03234881|530577550|FG000|Overall Study|Lost to Follow-up|9|||
147113157|NCT03234881|530577551|FG001|Overall Study|Lost to Follow-up|3|||
147113158|NCT03807843|530577552|FG000|Overall Study|Lost to Follow-up|1|||
147113159|NCT03807843|530577553|FG001|Overall Study|Lost to Follow-up|0|||
147113160|NCT01312129|530577554|FG000|Second Intervention (24 Hours)|Lost to Follow-up|0|||
147113161|NCT01312129|530577555|FG001|Second Intervention (24 Hours)|Lost to Follow-up|1|||
147113162|NCT03720847|530577556|FG000|Washout|Physician Decision|1|||
147113163|NCT03720847|530577557|FG001|Washout|Physician Decision|2|||
147311197|NCT00366301|531307155|FG001|Overall Study|Lost to Follow-up|4|||
147311198|NCT00366301|531307156|FG002|Overall Study|Lost to Follow-up|3|||
147444337|NCT00530894|531792575|FG003|Overall Study|Death|89|||
147444338|NCT00530894|531792572|FG000|Overall Study|Lost to Follow-up|1|||
147561514|NCT00437658|532213760|FG002|Post-treatment Period (24 Weeks)|Sponsor/Investigator Decision|1|||
147561515|NCT03952143|532213761|FG000|Lead-In Period|Adverse Event|2|||
147113164|NCT02636283|530577560|FG000|Overall Study|Adverse Event|2|||
147113165|NCT02636283|530577561|FG001|Overall Study|Adverse Event|0|||
147113166|NCT02636283|530577560|FG000|Overall Study|Trial Terminated Prematurely|0|||
147113167|NCT02636283|530577561|FG001|Overall Study|Trial Terminated Prematurely|3|||
147113168|NCT03418675|530577562|FG000|Overall Study|Lost to Follow-up|13|||
147113169|NCT03418675|530577563|FG001|Overall Study|Lost to Follow-up|10|||
147113170|NCT03418675|530577562|FG000|Overall Study|Adverse Event|2|||
147113171|NCT03418675|530577563|FG001|Overall Study|Adverse Event|0|||
147113172|NCT01178411|530577564|FG000|Overall Study|Adverse Event|5|||
147113173|NCT01178411|530577564|FG000|Overall Study|Withdrawal by Subject|4|||
147113174|NCT01178411|530577564|FG000|Overall Study|Protocol Violation|1|||
147444339|NCT00530894|531792573|FG001|Overall Study|Lost to Follow-up|3|||
147113175|NCT01178411|530577564|FG000|Overall Study|Progressive disease per RECIST|32|||
147113176|NCT01178411|530577564|FG000|Overall Study|Progressive disease per clinician|9|||
147113177|NCT01178411|530577564|FG000|Overall Study|Physician Decision|6|||
147561516|NCT03952143|532213762|FG001|Lead-In Period|Adverse Event|0|||
147561517|NCT03952143|532213763|FG002|Lead-In Period|Adverse Event|0|||
147113178|NCT01178411|530577564|FG000|Overall Study|Death|1|||
147113179|NCT01178411|530577564|FG000|Overall Study|No reason provided|1|||
147561518|NCT03952143|532213761|FG000|Lead-In Period|Lack of Efficacy|2|||
147561519|NCT03952143|532213762|FG001|Lead-In Period|Lack of Efficacy|0|||
147561520|NCT03952143|532213763|FG002|Lead-In Period|Lack of Efficacy|0|||
147561521|NCT03952143|532213761|FG000|Lead-In Period|Physician Decision|5|||
147561522|NCT03952143|532213762|FG001|Lead-In Period|Physician Decision|0|||
147561523|NCT03952143|532213763|FG002|Lead-In Period|Physician Decision|0|||
147561524|NCT03952143|532213761|FG000|Lead-In Period|Protocol Violation|5|||
147561525|NCT03952143|532213762|FG001|Lead-In Period|Protocol Violation|0|||
147561526|NCT03952143|532213763|FG002|Lead-In Period|Protocol Violation|0|||
147561527|NCT03952143|532213761|FG000|Lead-In Period|Withdrawal by Subject|19|||
147561528|NCT03952143|532213762|FG001|Lead-In Period|Withdrawal by Subject|0|||
147561529|NCT03952143|532213763|FG002|Lead-In Period|Withdrawal by Subject|0|||
147561530|NCT03952143|532213761|FG000|Treatment Period|Adverse Event|0|||
147561531|NCT03952143|532213762|FG001|Treatment Period|Adverse Event|0|||
147561532|NCT03952143|532213763|FG002|Treatment Period|Adverse Event|1|||
147561533|NCT03952143|532213761|FG000|Treatment Period|Lost to Follow-up|0|||
147561534|NCT03952143|532213762|FG001|Treatment Period|Lost to Follow-up|2|||
147561535|NCT03952143|532213763|FG002|Treatment Period|Lost to Follow-up|0|||
147561536|NCT03952143|532213761|FG000|Treatment Period|Physician Decision|0|||
147561537|NCT03952143|532213762|FG001|Treatment Period|Physician Decision|0|||
147561538|NCT03952143|532213763|FG002|Treatment Period|Physician Decision|2|||
147561539|NCT03952143|532213761|FG000|Treatment Period|Protocol Violation|0|||
147113180|NCT01178411|530577564|FG000|Overall Study|Drug manufacturing ended|1|||
147113181|NCT02383173|530577568|FG000|Overall Study|Palliative Care Team withdrew|0|||
147113182|NCT02383173|530577569|FG001|Overall Study|Palliative Care Team withdrew|2|||
147113183|NCT04900272|530577570|FG000|Overall Study|Lost to Follow-up|2|||
147113184|NCT04900272|530577570|FG000|Overall Study|Withdrawal due to technical difficulties (see above)|3|||
147561540|NCT03952143|532213762|FG001|Treatment Period|Protocol Violation|0|||
147561541|NCT03952143|532213763|FG002|Treatment Period|Protocol Violation|1|||
147113185|NCT04900272|530577570|FG000|Overall Study|Withdrawal by Subject|1|||
147113186|NCT01625182|530577571|FG000|Overall Study|Administrative problems|1|||
147561542|NCT03952143|532213761|FG000|Treatment Period|Withdrawal by Subject|0|||
147561543|NCT03952143|532213762|FG001|Treatment Period|Withdrawal by Subject|5|||
147561544|NCT03952143|532213763|FG002|Treatment Period|Withdrawal by Subject|26|||
147561545|NCT03952143|532213761|FG000|Treatment Period|Due to COVID 19 restrictions|0|||
147561546|NCT03952143|532213762|FG001|Treatment Period|Due to COVID 19 restrictions|2|||
147113187|NCT01625182|530577572|FG001|Overall Study|Administrative problems|0|||
147113188|NCT01625182|530577571|FG000|Overall Study|Protocol deviation|0|||
147113189|NCT01625182|530577572|FG001|Overall Study|Protocol deviation|2|||
147113190|NCT01625182|530577571|FG000|Overall Study|Adverse Event|2|||
147113191|NCT01625182|530577572|FG001|Overall Study|Adverse Event|0|||
147113192|NCT01625182|530577571|FG000|Overall Study|Withdrawal by Subject|5|||
147113193|NCT01625182|530577572|FG001|Overall Study|Withdrawal by Subject|1|||
147113194|NCT01625182|530577571|FG000|Overall Study|Lack of Efficacy|12|||
147113195|NCT01625182|530577572|FG001|Overall Study|Lack of Efficacy|8|||
147113196|NCT00263562|530577573|FG000|Overall Study|Protocol Violation|3|||
147113197|NCT00263562|530577574|FG001|Overall Study|Protocol Violation|0|||
147113198|NCT05059080|530577575|FG000|Overall Study|Withdrawal by Subject|3|||
147113199|NCT05059080|530577575|FG000|Overall Study|Study Terminated by Sponsor|64|||
147113200|NCT01922011|530577576|FG000|Overall Study|Protocol Violation|0|||
147113201|NCT01922011|530577577|FG001|Overall Study|Protocol Violation|1|||
147113202|NCT01922011|530577576|FG000|Overall Study|Physician Decision|0|||
147113203|NCT01922011|530577577|FG001|Overall Study|Physician Decision|1|||
147561547|NCT03952143|532213763|FG002|Treatment Period|Due to COVID 19 restrictions|5|||
147561548|NCT03952143|532213761|FG000|Treatment Period|Participant had taken prohibited concomitant medication|0|||
147113204|NCT01922011|530577576|FG000|Overall Study|Parent/Guardian Decision|3|||
147561549|NCT03952143|532213762|FG001|Treatment Period|Participant had taken prohibited concomitant medication|0|||
147561550|NCT03952143|532213763|FG002|Treatment Period|Participant had taken prohibited concomitant medication|1|||
147561551|NCT01866319|532213764|FG000|Overall Study|Adverse Event|12|||
147561552|NCT01866319|532213765|FG001|Overall Study|Adverse Event|5|||
147561553|NCT01866319|532213766|FG002|Overall Study|Adverse Event|9|||
147561554|NCT01866319|532213764|FG000|Overall Study|Clinical progression|3|||
147561555|NCT01866319|532213765|FG001|Overall Study|Clinical progression|2|||
147561556|NCT01866319|532213766|FG002|Overall Study|Clinical progression|2|||
147561557|NCT01866319|532213764|FG000|Overall Study|Death|153|||
147113205|NCT01922011|530577577|FG001|Overall Study|Parent/Guardian Decision|0|||
147113206|NCT01922011|530577576|FG000|Overall Study|Lost to Follow-up|0|||
147226534|NCT02017171|531002080|FG001|Overall Study|Lost to Follow-up|20|||
147113207|NCT01922011|530577577|FG001|Overall Study|Lost to Follow-up|1|||
147113208|NCT01922011|530577576|FG000|Overall Study|Missed Test-of-Cure Visit|0|||
147113209|NCT01922011|530577577|FG001|Overall Study|Missed Test-of-Cure Visit|2|||
147113210|NCT01922011|530577576|FG000|Overall Study|Not Treated|1|||
147113211|NCT01922011|530577577|FG001|Overall Study|Not Treated|0|||
147113212|NCT01922011|530577576|FG000|Overall Study|Lack of willing home health agency|1|||
147113213|NCT01922011|530577577|FG001|Overall Study|Lack of willing home health agency|0|||
147113214|NCT01922011|530577576|FG000|Overall Study|Randomized in error|1|||
147113215|NCT01922011|530577577|FG001|Overall Study|Randomized in error|0|||
147113216|NCT04871113|530577578|FG000|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
147561558|NCT01866319|532213765|FG001|Overall Study|Death|154|||
147561559|NCT01866319|532213766|FG002|Overall Study|Death|147|||
147561560|NCT01866319|532213764|FG000|Overall Study|Lost to Follow-up|6|||
147561561|NCT01866319|532213765|FG001|Overall Study|Lost to Follow-up|3|||
147561562|NCT01866319|532213766|FG002|Overall Study|Lost to Follow-up|8|||
147561563|NCT01866319|532213764|FG000|Overall Study|Physician Decision|1|||
147561564|NCT01866319|532213765|FG001|Overall Study|Physician Decision|0|||
147113217|NCT04871113|530577579|FG001|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
147113218|NCT04871113|530577580|FG002|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
147113219|NCT04871113|530577581|FG003|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
147113220|NCT04871113|530577582|FG004|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
147113221|NCT04871113|530577583|FG005|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|1|||
147113222|NCT04871113|530577584|FG006|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
147113223|NCT04871113|530577585|FG007|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
147113224|NCT04871113|530577586|FG008|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
147113225|NCT04871113|530577587|FG009|SOC Follow-up (SOC Day 1 to 48 Weeks)|Lost to Follow-up|0|||
147113226|NCT04871113|530577578|FG000|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
147113227|NCT04871113|530577579|FG001|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
147113228|NCT04871113|530577580|FG002|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
147113229|NCT04871113|530577581|FG003|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
147113230|NCT04871113|530577582|FG004|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
147113231|NCT04871113|530577583|FG005|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
147113232|NCT04871113|530577584|FG006|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|1|||
147113233|NCT04871113|530577585|FG007|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|2|||
147561565|NCT01866319|532213766|FG002|Overall Study|Physician Decision|1|||
147561566|NCT01866319|532213764|FG000|Overall Study|Protocol Violation|0|||
147561567|NCT01866319|532213765|FG001|Overall Study|Protocol Violation|0|||
147561568|NCT01866319|532213766|FG002|Overall Study|Protocol Violation|1|||
147561569|NCT01866319|532213764|FG000|Overall Study|Withdrawal by Subject|32|||
147561570|NCT01866319|532213765|FG001|Overall Study|Withdrawal by Subject|14|||
147113234|NCT04871113|530577586|FG008|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
147113235|NCT04871113|530577587|FG009|SOC Follow-up (SOC Day 1 to 48 Weeks)|Withdrawal by Subject|0|||
147113236|NCT01239745|530577588|FG000|Overall Study|Study terminated by sponsor|45|||
147113237|NCT01239745|530577588|FG000|Overall Study|Adverse Event|1|||
147113238|NCT01257542|530577593|FG000|Overall Study|Protocol Violation|3|||
147226535|NCT02017171|531002079|FG000|Overall Study|ESKD|6|||
147226536|NCT02017171|531002080|FG001|Overall Study|ESKD|2|||
147226537|NCT02017171|531002079|FG000|Overall Study|Miscellaneous|2|||
147226538|NCT02017171|531002080|FG001|Overall Study|Miscellaneous|3|||
147226539|NCT01562873|531002081|FG000|Overall Study|Disease Progression per RECIST|10|||
147226540|NCT01562873|531002082|FG001|Overall Study|Disease Progression per RECIST|0|||
147226541|NCT01562873|531002081|FG000|Overall Study|Adverse Event|1|||
147226542|NCT01562873|531002082|FG001|Overall Study|Adverse Event|0|||
147226543|NCT01562873|531002081|FG000|Overall Study|Clinical Disease Progression|9|||
147226544|NCT01562873|531002082|FG001|Overall Study|Clinical Disease Progression|0|||
147226545|NCT01562873|531002081|FG000|Overall Study|Clinical PD and adverse event|1|||
147226546|NCT01562873|531002082|FG001|Overall Study|Clinical PD and adverse event|0|||
147226547|NCT02536833|531002083|FG000|Overall Study|Discontinued Before Treatment|0|||
147561571|NCT01866319|532213766|FG002|Overall Study|Withdrawal by Subject|12|||
147561572|NCT00623779|532213768|FG000|Overall Study|Adverse Event|1|||
147561573|NCT00623779|532213769|FG001|Overall Study|Adverse Event|3|||
147113239|NCT01257542|530577594|FG001|Overall Study|Protocol Violation|5|||
147113240|NCT01257542|530577593|FG000|Overall Study|Withdrawal by Subject|0|||
147226548|NCT02536833|531002084|FG001|Overall Study|Discontinued Before Treatment|0|||
147561574|NCT00623779|532213770|FG002|Overall Study|Adverse Event|0|||
147561575|NCT00623779|532213768|FG000|Overall Study|Criteria from CSR|2|||
147561576|NCT00623779|532213769|FG001|Overall Study|Criteria from CSR|0|||
147561577|NCT00623779|532213770|FG002|Overall Study|Criteria from CSR|1|||
147561578|NCT00832377|532213771|FG000|Overall Study|Protocol Violation|1|||
147226549|NCT02536833|531002085|FG002|Overall Study|Discontinued Before Treatment|1|||
147561579|NCT01273181|532213772|FG000|Phase I, Dose 1|Study termination|1|||
147561580|NCT01273181|532213773|FG001|Phase I, Dose 1|Study termination|0|||
147561581|NCT01273181|532213774|FG002|Phase I, Dose 1|Study termination|0|||
147561582|NCT01273181|532213775|FG003|Phase I, Dose 1|Study termination|0|||
147561583|NCT01273181|532213772|FG000|Phase I, Dose 2|Death during treatment|0|||
147113241|NCT01257542|530577594|FG001|Overall Study|Withdrawal by Subject|2|||
147113242|NCT00081458|530577595|FG000|Overall Study|Adverse Event|1|||
147113243|NCT00081458|530577596|FG001|Overall Study|Adverse Event|5|||
147113244|NCT00081458|530577597|FG002|Overall Study|Adverse Event|2|||
147113245|NCT00081458|530577595|FG000|Overall Study|Withdrawal by Subject|0|||
147113246|NCT00081458|530577596|FG001|Overall Study|Withdrawal by Subject|3|||
147113247|NCT00081458|530577597|FG002|Overall Study|Withdrawal by Subject|1|||
147113248|NCT00081458|530577595|FG000|Overall Study|Randomized but not dosed|0|||
147113249|NCT00081458|530577596|FG001|Overall Study|Randomized but not dosed|0|||
147113250|NCT00081458|530577597|FG002|Overall Study|Randomized but not dosed|1|||
147113251|NCT00549328|530577601|FG000|Overall Study|Adverse Event|2|||
147113252|NCT00549328|530577601|FG000|Overall Study|Disease Progression|10|||
147113253|NCT00549328|530577601|FG000|Overall Study|Death|1|||
147113254|NCT00549328|530577601|FG000|Overall Study|Use of Prohibited Medication|1|||
147113255|NCT00770484|530577602|FG000|Overall Study|Withdrawal by Subject|1|||
147113256|NCT00770484|530577603|FG001|Overall Study|Withdrawal by Subject|0|||
147113257|NCT03097315|530577608|FG000|Overall Study|Withdrawal by Subject|1|||
147113258|NCT01946802|530577609|FG000|Overall Study|Death|1|||
147113259|NCT01946802|530577609|FG000|Overall Study|Withdrawal by Subject|2|||
147113260|NCT01946802|530577609|FG000|Overall Study|Combined septic shock|1|||
147113261|NCT01946802|530577609|FG000|Overall Study|Protocol Violation|1|||
147113262|NCT00153920|530577610|FG000|Overall Study|Adverse Event|9|||
147113263|NCT00153920|530577610|FG000|Overall Study|Progressive Disease|9|||
147113264|NCT00153920|530577610|FG000|Overall Study|Physician Decision|3|||
147113265|NCT00153920|530577610|FG000|Overall Study|Lack of Response|3|||
147113266|NCT00153920|530577610|FG000|Overall Study|Death|2|||
147113267|NCT00153920|530577610|FG000|Overall Study|Withdrawal by Subject|1|||
147113268|NCT00153920|530577610|FG000|Overall Study|Non-Protocol Therapy|1|||
147113269|NCT00153920|530577610|FG000|Overall Study|Withdrawal of Consent before Trt|1|||
147113270|NCT00153920|530577610|FG000|Overall Study|Progressive Disease before Trt|1|||
147113271|NCT00195429|530577611|FG000|Overall Study|Adverse Event|2|||
147113272|NCT00195429|530577612|FG001|Overall Study|Adverse Event|4|||
147113273|NCT00195429|530577611|FG000|Overall Study|Lack of Efficacy|2|||
147113274|NCT00195429|530577612|FG001|Overall Study|Lack of Efficacy|1|||
147113275|NCT00195429|530577611|FG000|Overall Study|Lost to Follow-up|1|||
147113276|NCT00195429|530577612|FG001|Overall Study|Lost to Follow-up|0|||
147113277|NCT02143778|530577613|FG000|Overall Study|Withdrawal by Subject|2|||
147113278|NCT02143778|530577613|FG000|Overall Study|Device malfunction|1|||
147113279|NCT03384966|530577617|FG000|Randomized at End of Screening Period|Physician decision due to adverse event|1|||
147113280|NCT03384966|530577618|FG001|Randomized at End of Screening Period|Physician decision due to adverse event|0|||
147113281|NCT03384966|530577619|FG002|Randomized at End of Screening Period|Physician decision due to adverse event|0|||
147113282|NCT03384966|530577617|FG000|Follow-up Period|Adverse Event|1|||
147561584|NCT01273181|532213773|FG001|Phase I, Dose 2|Death during treatment|1|||
147561585|NCT01273181|532213774|FG002|Phase I, Dose 2|Death during treatment|0|||
147561586|NCT01273181|532213775|FG003|Phase I, Dose 2|Death during treatment|0|||
147561587|NCT01273181|532213772|FG000|Phase 2, Dose 1|Study termination|0|||
147561588|NCT01273181|532213773|FG001|Phase 2, Dose 1|Study termination|0|||
147561589|NCT01273181|532213774|FG002|Phase 2, Dose 1|Study termination|1|||
147561590|NCT01273181|532213775|FG003|Phase 2, Dose 1|Study termination|0|||
147561591|NCT01273181|532213772|FG000|Phase 2, Dose 2|Death during treatment|0|||
147113283|NCT03384966|530577618|FG001|Follow-up Period|Adverse Event|0|||
147113284|NCT03384966|530577619|FG002|Follow-up Period|Adverse Event|0|||
147113285|NCT00367458|530577620|FG000|First Intervention - 8 Weeks|Adverse Event|2|||
147113286|NCT00367458|530577621|FG001|First Intervention - 8 Weeks|Adverse Event|0|||
147113287|NCT01334515|530577624|FG000|Overall Study|Adverse Event|1|||
147113288|NCT01334515|530577625|FG001|Overall Study|Adverse Event|6|||
147113289|NCT01334515|530577624|FG000|Overall Study|Death|1|||
147113290|NCT01334515|530577625|FG001|Overall Study|Death|0|||
147113291|NCT01334515|530577624|FG000|Overall Study|Lack of Efficacy|8|||
147113292|NCT01334515|530577625|FG001|Overall Study|Lack of Efficacy|21|||
147113293|NCT01334515|530577624|FG000|Overall Study|Physician Decision|1|||
147113294|NCT01334515|530577625|FG001|Overall Study|Physician Decision|1|||
147113295|NCT01334515|530577624|FG000|Overall Study|Withdrawal by Subject|1|||
147113296|NCT01334515|530577625|FG001|Overall Study|Withdrawal by Subject|1|||
147113297|NCT04327271|530577626|FG000|Overall Study|Death|1|||
147113298|NCT04327271|530577627|FG001|Overall Study|Death|0|||
147113299|NCT04327271|530577626|FG000|Overall Study|Withdrawal by Subject|1|||
147561592|NCT01273181|532213773|FG001|Phase 2, Dose 2|Death during treatment|0|||
147561593|NCT01273181|532213774|FG002|Phase 2, Dose 2|Death during treatment|0|||
147561594|NCT01273181|532213775|FG003|Phase 2, Dose 2|Death during treatment|1|||
147561595|NCT00944697|532213776|FG000|Overall Study|Withdrawal by Subject|1|||
147561596|NCT00944697|532213777|FG001|Overall Study|Withdrawal by Subject|1|||
147561597|NCT00944697|532213776|FG000|Overall Study|Adverse Event|0|||
147113300|NCT04327271|530577627|FG001|Overall Study|Withdrawal by Subject|0|||
147113301|NCT04327271|530577626|FG000|Overall Study|randomization error (data capture)|4|||
147113302|NCT04327271|530577627|FG001|Overall Study|randomization error (data capture)|3|||
147113303|NCT03599713|530577628|FG000|Overall Study|Death|38|||
147113304|NCT03599713|530577629|FG001|Overall Study|Death|3|||
147113305|NCT03599713|530577628|FG000|Overall Study|Withdrawal by Subject|17|||
147113306|NCT03599713|530577629|FG001|Overall Study|Withdrawal by Subject|0|||
147113307|NCT03599713|530577628|FG000|Overall Study|Lost to Follow-up|4|||
147113308|NCT03599713|530577629|FG001|Overall Study|Lost to Follow-up|0|||
147113309|NCT03599713|530577628|FG000|Overall Study|Discontinued Due to End of Study|42|||
147113310|NCT03599713|530577629|FG001|Overall Study|Discontinued Due to End of Study|3|||
147113311|NCT03580928|530577634|FG000|Overall Study|Death|0|||
147113312|NCT03580928|530577635|FG001|Overall Study|Death|3|||
147113313|NCT03580928|530577634|FG000|Overall Study|Withdrawal by Subject|2|||
147113314|NCT03580928|530577635|FG001|Overall Study|Withdrawal by Subject|1|||
147113315|NCT03580928|530577634|FG000|Overall Study|Lost to Follow-up|2|||
147113316|NCT03580928|530577635|FG001|Overall Study|Lost to Follow-up|0|||
147113317|NCT03580928|530577634|FG000|Overall Study|Progressive Disease|0|||
147113318|NCT03580928|530577635|FG001|Overall Study|Progressive Disease|1|||
147113319|NCT00587457|530578717|FG000|Overall Study|Adverse Event|1|||
147113320|NCT00587457|530578718|FG001|Overall Study|Adverse Event|2|||
147113321|NCT00587457|530578719|FG002|Overall Study|Adverse Event|1|||
147113322|NCT00587457|530578717|FG000|Overall Study|Disease progression|2|||
147113323|NCT00587457|530578718|FG001|Overall Study|Disease progression|0|||
147113324|NCT00587457|530578719|FG002|Overall Study|Disease progression|2|||
147113325|NCT00587457|530578717|FG000|Overall Study|Initiation of alternative therapy|0|||
147113326|NCT00587457|530578718|FG001|Overall Study|Initiation of alternative therapy|1|||
147113327|NCT00587457|530578719|FG002|Overall Study|Initiation of alternative therapy|0|||
147113328|NCT00587457|530578717|FG000|Overall Study|Undefined|0|||
147113329|NCT00587457|530578718|FG001|Overall Study|Undefined|0|||
147113330|NCT00587457|530578719|FG002|Overall Study|Undefined|1|||
147113331|NCT00587457|530578717|FG000|Overall Study|Development of neutralizing Abs|0|||
147113332|NCT00587457|530578718|FG001|Overall Study|Development of neutralizing Abs|0|||
147113333|NCT00587457|530578719|FG002|Overall Study|Development of neutralizing Abs|1|||
147113334|NCT00541229|530578720|FG000|Treatment Period I (Week 1)|Physician Decision|0|||
147113335|NCT00541229|530578721|FG001|Treatment Period I (Week 1)|Physician Decision|0|||
147113336|NCT00541229|530578722|FG002|Treatment Period I (Week 1)|Physician Decision|1|||
147113337|NCT00541229|530578723|FG003|Treatment Period I (Week 1)|Physician Decision|0|||
147113338|NCT00541229|530578724|FG004|Treatment Period I (Week 1)|Physician Decision|0|||
147113339|NCT00541229|530578725|FG005|Treatment Period I (Week 1)|Physician Decision|0|||
147113340|NCT00541229|530578720|FG000|Treatment Period I (Week 1)|Withdrawal by Subject|0|||
147113341|NCT00541229|530578721|FG001|Treatment Period I (Week 1)|Withdrawal by Subject|0|||
147113342|NCT00541229|530578722|FG002|Treatment Period I (Week 1)|Withdrawal by Subject|0|||
147113343|NCT00541229|530578723|FG003|Treatment Period I (Week 1)|Withdrawal by Subject|0|||
147113344|NCT00541229|530578724|FG004|Treatment Period I (Week 1)|Withdrawal by Subject|0|||
147113345|NCT00541229|530578725|FG005|Treatment Period I (Week 1)|Withdrawal by Subject|1|||
147113346|NCT00541229|530578720|FG000|Treatment Period I (Week 1)|Protocol Specified Criteria|0|||
147113347|NCT00541229|530578721|FG001|Treatment Period I (Week 1)|Protocol Specified Criteria|0|||
147113348|NCT00541229|530578722|FG002|Treatment Period I (Week 1)|Protocol Specified Criteria|0|||
147113349|NCT00541229|530578723|FG003|Treatment Period I (Week 1)|Protocol Specified Criteria|0|||
147113350|NCT00541229|530578724|FG004|Treatment Period I (Week 1)|Protocol Specified Criteria|0|||
147113351|NCT00541229|530578725|FG005|Treatment Period I (Week 1)|Protocol Specified Criteria|1|||
147113352|NCT00541229|530578720|FG000|Treatment Period I (Week 1)|Study Terminated by Sponsor|0|||
147113353|NCT00541229|530578721|FG001|Treatment Period I (Week 1)|Study Terminated by Sponsor|1|||
147226550|NCT02536833|531002086|FG003|Overall Study|Discontinued Before Treatment|2|||
147226551|NCT02536833|531002083|FG000|Overall Study|Adverse Event|1|||
147226552|NCT02536833|531002084|FG001|Overall Study|Adverse Event|3|||
147226553|NCT02536833|531002085|FG002|Overall Study|Adverse Event|4|||
147113354|NCT00541229|530578722|FG002|Treatment Period I (Week 1)|Study Terminated by Sponsor|2|||
147226554|NCT02536833|531002086|FG003|Overall Study|Adverse Event|1|||
147226555|NCT02536833|531002083|FG000|Overall Study|Lost to Follow-up|2|||
147226556|NCT02536833|531002084|FG001|Overall Study|Lost to Follow-up|1|||
147226557|NCT02536833|531002085|FG002|Overall Study|Lost to Follow-up|2|||
147561598|NCT00944697|532213777|FG001|Overall Study|Adverse Event|3|||
147561599|NCT00944697|532213776|FG000|Overall Study|Administrative|1|||
147561600|NCT00944697|532213777|FG001|Overall Study|Administrative|1|||
147561601|NCT01062256|532213782|FG000|Overall Study|Adverse Event|1|||
147561602|NCT01062256|532213783|FG001|Overall Study|Adverse Event|0|||
147113355|NCT00541229|530578723|FG003|Treatment Period I (Week 1)|Study Terminated by Sponsor|1|||
147113356|NCT00541229|530578724|FG004|Treatment Period I (Week 1)|Study Terminated by Sponsor|0|||
147226558|NCT02536833|531002086|FG003|Overall Study|Lost to Follow-up|2|||
147226559|NCT02536833|531002083|FG000|Overall Study|Physician Decision|0|||
147113357|NCT00541229|530578725|FG005|Treatment Period I (Week 1)|Study Terminated by Sponsor|0|||
147113358|NCT00541229|530578720|FG000|Washout Period I (Week 2-5)|Adverse Event|1|||
147113359|NCT00541229|530578721|FG001|Washout Period I (Week 2-5)|Adverse Event|0|||
147226560|NCT02536833|531002084|FG001|Overall Study|Physician Decision|0|||
147226561|NCT02536833|531002085|FG002|Overall Study|Physician Decision|0|||
147226562|NCT02536833|531002086|FG003|Overall Study|Physician Decision|1|||
147311199|NCT00366301|531307157|FG003|Overall Study|Lost to Follow-up|7|||
147113360|NCT00541229|530578722|FG002|Washout Period I (Week 2-5)|Adverse Event|1|||
147113361|NCT00541229|530578723|FG003|Washout Period I (Week 2-5)|Adverse Event|0|||
147113362|NCT00541229|530578724|FG004|Washout Period I (Week 2-5)|Adverse Event|0|||
147113363|NCT00541229|530578725|FG005|Washout Period I (Week 2-5)|Adverse Event|0|||
147113364|NCT00541229|530578720|FG000|Washout Period I (Week 2-5)|Physician Decision|0|||
147113365|NCT00541229|530578721|FG001|Washout Period I (Week 2-5)|Physician Decision|0|||
147113366|NCT00541229|530578722|FG002|Washout Period I (Week 2-5)|Physician Decision|0|||
147113367|NCT00541229|530578723|FG003|Washout Period I (Week 2-5)|Physician Decision|1|||
147113368|NCT00541229|530578724|FG004|Washout Period I (Week 2-5)|Physician Decision|0|||
147113369|NCT00541229|530578725|FG005|Washout Period I (Week 2-5)|Physician Decision|0|||
147113370|NCT00541229|530578720|FG000|Washout Period I (Week 2-5)|Protocol Violation|0|||
147113371|NCT00541229|530578721|FG001|Washout Period I (Week 2-5)|Protocol Violation|0|||
147113372|NCT00541229|530578722|FG002|Washout Period I (Week 2-5)|Protocol Violation|0|||
147113373|NCT00541229|530578723|FG003|Washout Period I (Week 2-5)|Protocol Violation|0|||
147113374|NCT00541229|530578724|FG004|Washout Period I (Week 2-5)|Protocol Violation|0|||
147113375|NCT00541229|530578725|FG005|Washout Period I (Week 2-5)|Protocol Violation|1|||
147113376|NCT00541229|530578720|FG000|Washout Period I (Week 2-5)|Study Terminated by Sponsor|3|||
147113377|NCT00541229|530578721|FG001|Washout Period I (Week 2-5)|Study Terminated by Sponsor|2|||
147113378|NCT00541229|530578722|FG002|Washout Period I (Week 2-5)|Study Terminated by Sponsor|3|||
147113379|NCT00541229|530578723|FG003|Washout Period I (Week 2-5)|Study Terminated by Sponsor|3|||
147113380|NCT00541229|530578724|FG004|Washout Period I (Week 2-5)|Study Terminated by Sponsor|1|||
147113381|NCT00541229|530578725|FG005|Washout Period I (Week 2-5)|Study Terminated by Sponsor|4|||
147113382|NCT00541229|530578720|FG000|Treatment Period II (Week 6)|Protocol Violation|0|||
147113383|NCT00541229|530578721|FG001|Treatment Period II (Week 6)|Protocol Violation|0|||
147113384|NCT00541229|530578722|FG002|Treatment Period II (Week 6)|Protocol Violation|0|||
147113385|NCT00541229|530578723|FG003|Treatment Period II (Week 6)|Protocol Violation|0|||
147113386|NCT00541229|530578724|FG004|Treatment Period II (Week 6)|Protocol Violation|1|||
147113387|NCT00541229|530578725|FG005|Treatment Period II (Week 6)|Protocol Violation|1|||
147113388|NCT00541229|530578720|FG000|Treatment Period II (Week 6)|Study Terminated by Sponsor|2|||
147113389|NCT00541229|530578721|FG001|Treatment Period II (Week 6)|Study Terminated by Sponsor|1|||
147113390|NCT00541229|530578722|FG002|Treatment Period II (Week 6)|Study Terminated by Sponsor|1|||
147113391|NCT00541229|530578723|FG003|Treatment Period II (Week 6)|Study Terminated by Sponsor|1|||
147113392|NCT00541229|530578724|FG004|Treatment Period II (Week 6)|Study Terminated by Sponsor|1|||
147113393|NCT00541229|530578725|FG005|Treatment Period II (Week 6)|Study Terminated by Sponsor|2|||
147113394|NCT00541229|530578720|FG000|Washout Period II (Week 7-10)|Protocol Violation|1|||
147113395|NCT00541229|530578721|FG001|Washout Period II (Week 7-10)|Protocol Violation|0|||
147113396|NCT00541229|530578722|FG002|Washout Period II (Week 7-10)|Protocol Violation|0|||
147113397|NCT00541229|530578723|FG003|Washout Period II (Week 7-10)|Protocol Violation|0|||
147113398|NCT00541229|530578724|FG004|Washout Period II (Week 7-10)|Protocol Violation|0|||
147113399|NCT00541229|530578725|FG005|Washout Period II (Week 7-10)|Protocol Violation|0|||
147113400|NCT00541229|530578720|FG000|Washout Period II (Week 7-10)|Withdrawal by Subject|0|||
147113401|NCT00541229|530578721|FG001|Washout Period II (Week 7-10)|Withdrawal by Subject|0|||
147113402|NCT00541229|530578722|FG002|Washout Period II (Week 7-10)|Withdrawal by Subject|0|||
147113403|NCT00541229|530578723|FG003|Washout Period II (Week 7-10)|Withdrawal by Subject|0|||
147113404|NCT00541229|530578724|FG004|Washout Period II (Week 7-10)|Withdrawal by Subject|1|||
147113405|NCT00541229|530578725|FG005|Washout Period II (Week 7-10)|Withdrawal by Subject|0|||
147113406|NCT00541229|530578720|FG000|Washout Period II (Week 7-10)|Study Terminated by Sponsor|3|||
147113407|NCT00541229|530578721|FG001|Washout Period II (Week 7-10)|Study Terminated by Sponsor|4|||
147113408|NCT00541229|530578722|FG002|Washout Period II (Week 7-10)|Study Terminated by Sponsor|2|||
147113409|NCT00541229|530578723|FG003|Washout Period II (Week 7-10)|Study Terminated by Sponsor|4|||
147113410|NCT00541229|530578724|FG004|Washout Period II (Week 7-10)|Study Terminated by Sponsor|3|||
147113411|NCT00541229|530578725|FG005|Washout Period II (Week 7-10)|Study Terminated by Sponsor|3|||
147113412|NCT00541229|530578720|FG000|Treatment Period III (Week 11)|Adverse Event|0|||
147113413|NCT00541229|530578721|FG001|Treatment Period III (Week 11)|Adverse Event|0|||
147113414|NCT00541229|530578722|FG002|Treatment Period III (Week 11)|Adverse Event|0|||
147113415|NCT00541229|530578723|FG003|Treatment Period III (Week 11)|Adverse Event|0|||
147113416|NCT00541229|530578724|FG004|Treatment Period III (Week 11)|Adverse Event|1|||
147113417|NCT00541229|530578725|FG005|Treatment Period III (Week 11)|Adverse Event|0|||
147113418|NCT00541229|530578720|FG000|Treatment Period III (Week 11)|Protocol Specified Criteria|0|||
147113419|NCT00541229|530578721|FG001|Treatment Period III (Week 11)|Protocol Specified Criteria|0|||
147113420|NCT00541229|530578722|FG002|Treatment Period III (Week 11)|Protocol Specified Criteria|0|||
147113421|NCT00541229|530578723|FG003|Treatment Period III (Week 11)|Protocol Specified Criteria|0|||
147113422|NCT00541229|530578724|FG004|Treatment Period III (Week 11)|Protocol Specified Criteria|0|||
147113423|NCT00541229|530578725|FG005|Treatment Period III (Week 11)|Protocol Specified Criteria|1|||
147113424|NCT00541229|530578720|FG000|Treatment Period III (Week 11)|Study Terminated by Sponsor|0|||
147113425|NCT00541229|530578721|FG001|Treatment Period III (Week 11)|Study Terminated by Sponsor|0|||
147113426|NCT00541229|530578722|FG002|Treatment Period III (Week 11)|Study Terminated by Sponsor|1|||
147113427|NCT00541229|530578723|FG003|Treatment Period III (Week 11)|Study Terminated by Sponsor|0|||
147113428|NCT00541229|530578724|FG004|Treatment Period III (Week 11)|Study Terminated by Sponsor|0|||
147113429|NCT00541229|530578725|FG005|Treatment Period III (Week 11)|Study Terminated by Sponsor|0|||
147113430|NCT00924651|530578726|FG000|Overall Study|Chemo started too soon|2|||
147113431|NCT00924651|530578727|FG001|Overall Study|Chemo started too soon|3|||
147113432|NCT00924651|530578726|FG000|Overall Study|No Reason|3|||
147113433|NCT00924651|530578727|FG001|Overall Study|No Reason|7|||
147113434|NCT00924651|530578726|FG000|Overall Study|Overwhelmed|6|||
147113435|NCT00924651|530578727|FG001|Overall Study|Overwhelmed|6|||
147113436|NCT00924651|530578726|FG000|Overall Study|Noncompliant|1|||
147113437|NCT00924651|530578727|FG001|Overall Study|Noncompliant|4|||
147113438|NCT00924651|530578726|FG000|Overall Study|Medical|1|||
147113439|NCT00924651|530578727|FG001|Overall Study|Medical|3|||
147113440|NCT00924651|530578726|FG000|Overall Study|Changed Mind|10|||
147113441|NCT00924651|530578727|FG001|Overall Study|Changed Mind|1|||
147113442|NCT00924651|530578726|FG000|Overall Study|Incomplete Form|2|||
147113443|NCT00924651|530578727|FG001|Overall Study|Incomplete Form|1|||
147113444|NCT02506036|530578728|FG000|First Intervention (4-6 Weeks)|Death|1|||
147113445|NCT02506036|530578729|FG001|First Intervention (4-6 Weeks)|Death|0|||
147113446|NCT02506036|530578728|FG000|First Intervention (4-6 Weeks)|Lost to Follow-up|0|||
147113447|NCT02506036|530578729|FG001|First Intervention (4-6 Weeks)|Lost to Follow-up|1|||
147113448|NCT02506036|530578728|FG000|First Intervention (4-6 Weeks)|Withdrawal by Subject|0|||
147113449|NCT02506036|530578729|FG001|First Intervention (4-6 Weeks)|Withdrawal by Subject|1|||
147113450|NCT05276804|530578731|FG000|Overall Study|screen failure|23|||
147113451|NCT05276804|530578732|FG001|Overall Study|screen failure|0|||
147113452|NCT02827708|530578733|FG000|Overall Study|Lost to Follow-up|3|||
147113453|NCT02827708|530578734|FG001|Overall Study|Lost to Follow-up|1|||
147113454|NCT02827708|530578733|FG000|Overall Study|Withdrawal by Subject|1|||
147113455|NCT02827708|530578734|FG001|Overall Study|Withdrawal by Subject|2|||
147113456|NCT02827708|530578733|FG000|Overall Study|Death|1|||
147113457|NCT02827708|530578734|FG001|Overall Study|Death|2|||
147113458|NCT00898807|530578735|FG000|Overall Study|Withdrawal by Subject|5|||
147113459|NCT00898807|530578736|FG001|Overall Study|Withdrawal by Subject|3|||
147113460|NCT00898807|530578735|FG000|Overall Study|Family pressure to discontinue|2|||
147113461|NCT00898807|530578736|FG001|Overall Study|Family pressure to discontinue|2|||
147113462|NCT00898807|530578735|FG000|Overall Study|Lost to Follow-up|1|||
147113463|NCT00898807|530578736|FG001|Overall Study|Lost to Follow-up|3|||
147113464|NCT00898807|530578735|FG000|Overall Study|Death|0|||
147113465|NCT00898807|530578736|FG001|Overall Study|Death|1|||
147113466|NCT01521364|530578739|FG000|Linezolid + 250mg Claritromycin (wk 2&3)|Protocol Violation|1|||
147113467|NCT01521364|530578739|FG000|Linezolid + 500mg Claritromycin (wk 4&5)|Withdrawal by Subject|1|||
147113468|NCT03637374|530578740|FG000|Overall Study|Death|2|||
147113469|NCT03637374|530578741|FG001|Overall Study|Death|0|||
147113470|NCT01479530|530578746|FG000|Overall Study|Adverse Event|5|||
147113471|NCT01479530|530578747|FG001|Overall Study|Adverse Event|6|||
147113472|NCT01479530|530578746|FG000|Overall Study|Lack of Efficacy|0|||
147113473|NCT01479530|530578747|FG001|Overall Study|Lack of Efficacy|1|||
147113474|NCT01479530|530578746|FG000|Overall Study|Protocol Violation|2|||
147113475|NCT01479530|530578747|FG001|Overall Study|Protocol Violation|3|||
147113476|NCT01479530|530578746|FG000|Overall Study|Withdrawal of Consent|3|||
147113477|NCT01479530|530578747|FG001|Overall Study|Withdrawal of Consent|2|||
147113478|NCT04795323|530578748|FG000|Overall Study|Did not interact with TARA|1|||
147113479|NCT04795323|530578749|FG001|Overall Study|Did not interact with TARA|0|||
147113480|NCT00303628|530578752|FG000|Overall Study|Disease progression|0|||
147113481|NCT00303628|530578753|FG001|Overall Study|Disease progression|1|||
147226563|NCT02536833|531002083|FG000|Overall Study|Site Terminated by Sponsor|2|||
147226564|NCT02536833|531002084|FG001|Overall Study|Site Terminated by Sponsor|2|||
147226565|NCT02536833|531002085|FG002|Overall Study|Site Terminated by Sponsor|2|||
147226566|NCT02536833|531002086|FG003|Overall Study|Site Terminated by Sponsor|2|||
147226567|NCT02536833|531002083|FG000|Overall Study|Subject Non-Compliance|0|||
147226568|NCT02536833|531002084|FG001|Overall Study|Subject Non-Compliance|1|||
147226569|NCT02536833|531002085|FG002|Overall Study|Subject Non-Compliance|1|||
147226570|NCT02536833|531002086|FG003|Overall Study|Subject Non-Compliance|0|||
147561603|NCT01062256|532213784|FG002|Overall Study|Adverse Event|0|||
147113482|NCT00303628|530578752|FG000|Overall Study|Adverse Event|26|||
147113483|NCT00303628|530578753|FG001|Overall Study|Adverse Event|36|||
147113484|NCT00303628|530578752|FG000|Overall Study|Death|0|||
147113485|NCT00303628|530578753|FG001|Overall Study|Death|1|||
147113486|NCT00303628|530578752|FG000|Overall Study|Withdrawal by Subject|11|||
147113487|NCT00303628|530578753|FG001|Overall Study|Withdrawal by Subject|20|||
147113488|NCT00303628|530578752|FG000|Overall Study|Alternative therapy|2|||
147113489|NCT00303628|530578753|FG001|Overall Study|Alternative therapy|0|||
147113490|NCT00303628|530578752|FG000|Overall Study|Other complicating disease|0|||
147113491|NCT00303628|530578753|FG001|Overall Study|Other complicating disease|1|||
147113492|NCT00303628|530578752|FG000|Overall Study|Not start protocol therapy|3|||
147113493|NCT00303628|530578753|FG001|Overall Study|Not start protocol therapy|5|||
147226571|NCT02536833|531002083|FG000|Overall Study|Withdrawal by Subject|4|||
147561604|NCT01062256|532213782|FG000|Overall Study|Withdrawal by Subject|1|||
147561605|NCT01062256|532213783|FG001|Overall Study|Withdrawal by Subject|1|||
147113494|NCT00303628|530578752|FG000|Overall Study|Other|8|||
147113495|NCT00303628|530578753|FG001|Overall Study|Other|9|||
147113496|NCT00376506|530578754|FG000|Overall Study|Death|0|||
147113497|NCT00376506|530578755|FG001|Overall Study|Death|2|||
147113498|NCT04925934|530578756|FG000|Overall Study|Adverse Event|1|||
147113499|NCT04925934|530578757|FG001|Overall Study|Adverse Event|0|||
147113500|NCT04925934|530578758|FG002|Overall Study|Adverse Event|0|||
147113501|NCT04925934|530578756|FG000|Overall Study|Lost to Follow-up|2|||
147113502|NCT04925934|530578757|FG001|Overall Study|Lost to Follow-up|0|||
147113503|NCT04925934|530578758|FG002|Overall Study|Lost to Follow-up|1|||
147113504|NCT04925934|530578756|FG000|Overall Study|Death|0|||
147113505|NCT04925934|530578757|FG001|Overall Study|Death|1|||
147113506|NCT04925934|530578758|FG002|Overall Study|Death|0|||
147113507|NCT04925934|530578756|FG000|Overall Study|Withdrawal by Subject|8|||
147113508|NCT04925934|530578757|FG001|Overall Study|Withdrawal by Subject|5|||
147113509|NCT04925934|530578758|FG002|Overall Study|Withdrawal by Subject|9|||
147113510|NCT04925934|530578756|FG000|Overall Study|Other|2|||
147113511|NCT04925934|530578757|FG001|Overall Study|Other|2|||
147113512|NCT04925934|530578758|FG002|Overall Study|Other|2|||
147113513|NCT04925934|530578756|FG000|Overall Study|Eastern European Conflict|7|||
147113514|NCT04925934|530578757|FG001|Overall Study|Eastern European Conflict|3|||
147113515|NCT04925934|530578758|FG002|Overall Study|Eastern European Conflict|2|||
147113516|NCT03158688|530578759|FG000|Overall Study|Withdrawal by Subject|14|||
147113517|NCT03158688|530578760|FG001|Overall Study|Withdrawal by Subject|28|||
147113518|NCT03158688|530578759|FG000|Overall Study|Decision by sponsor|13|||
147226572|NCT02536833|531002084|FG001|Overall Study|Withdrawal by Subject|3|||
147226573|NCT02536833|531002085|FG002|Overall Study|Withdrawal by Subject|5|||
147311200|NCT00366301|531307154|FG000|Overall Study|Withdrawal by Subject|4|||
147311201|NCT00366301|531307155|FG001|Overall Study|Withdrawal by Subject|2|||
147561606|NCT01062256|532213784|FG002|Overall Study|Withdrawal by Subject|1|||
147226574|NCT02536833|531002086|FG003|Overall Study|Withdrawal by Subject|11|||
147226575|NCT02220998|531002087|FG000|Overall Study|Randomized but Never Treated|1|||
147226576|NCT02220998|531002088|FG001|Overall Study|Randomized but Never Treated|2|||
147226577|NCT02220998|531002087|FG000|Overall Study|Death|2|||
147226578|NCT02220998|531002088|FG001|Overall Study|Death|0|||
147226579|NCT02220998|531002087|FG000|Overall Study|Lack of Efficacy|0|||
147226580|NCT02220998|531002088|FG001|Overall Study|Lack of Efficacy|5|||
147226581|NCT02220998|531002087|FG000|Overall Study|Lost to Follow-up|4|||
147226582|NCT02220998|531002088|FG001|Overall Study|Lost to Follow-up|4|||
147226583|NCT02280473|531002090|FG000|Overall Study|Adverse Event|1|||
147226584|NCT02280473|531002091|FG001|Overall Study|Adverse Event|1|||
147226585|NCT02280473|531002090|FG000|Overall Study|Lack of Efficacy|0|||
147226586|NCT02280473|531002091|FG001|Overall Study|Lack of Efficacy|1|||
147226587|NCT02280473|531002090|FG000|Overall Study|Lost to Follow-up|0|||
147226588|NCT02280473|531002091|FG001|Overall Study|Lost to Follow-up|1|||
147226589|NCT04223232|531002096|FG000|Overall Study|Withdrawal by Subject|1|||
147226590|NCT05281601|531002104|FG000|Overall Study|Physician Decision|2|||
147226591|NCT05281601|531002105|FG001|Overall Study|Physician Decision|0|||
147226592|NCT05281601|531002104|FG000|Overall Study|Lost to Follow-up|2|||
147226593|NCT05281601|531002105|FG001|Overall Study|Lost to Follow-up|0|||
147226594|NCT05281601|531002104|FG000|Overall Study|Death|1|||
147226595|NCT05281601|531002105|FG001|Overall Study|Death|0|||
147226596|NCT05281601|531002104|FG000|Overall Study|Withdrawal by parent/guardian|2|||
147226597|NCT05281601|531002105|FG001|Overall Study|Withdrawal by parent/guardian|1|||
147226598|NCT00191646|531002107|FG000|Overall Study|Toxicity|26|||
147226599|NCT00191646|531002108|FG001|Overall Study|Toxicity|37|||
147226600|NCT00191646|531002107|FG000|Overall Study|Disease Progression|5|||
147226601|NCT00191646|531002108|FG001|Overall Study|Disease Progression|6|||
147226602|NCT00191646|531002107|FG000|Overall Study|Physician Decision|20|||
147226603|NCT00191646|531002108|FG001|Overall Study|Physician Decision|11|||
147226604|NCT00191646|531002107|FG000|Overall Study|Withdrawal by Subject|58|||
147113519|NCT03158688|530578760|FG001|Overall Study|Decision by sponsor|37|||
147113520|NCT03158688|530578759|FG000|Overall Study|Lost to Follow-up|4|||
147113521|NCT03158688|530578760|FG001|Overall Study|Lost to Follow-up|3|||
147113522|NCT03158688|530578759|FG000|Overall Study|Death|74|||
147113523|NCT03158688|530578760|FG001|Overall Study|Death|142|||
147113524|NCT02948400|530578767|FG000|Overall Study|Withdrawal by Subject|17|||
147226605|NCT00191646|531002108|FG001|Overall Study|Withdrawal by Subject|39|||
147226606|NCT00191646|531002107|FG000|Overall Study|Protocol Violation|5|||
147226607|NCT00191646|531002108|FG001|Overall Study|Protocol Violation|7|||
147226608|NCT00191646|531002107|FG000|Overall Study|Death|6|||
147226609|NCT00191646|531002108|FG001|Overall Study|Death|8|||
147226610|NCT00191646|531002107|FG000|Overall Study|Other|33|||
147226611|NCT00191646|531002108|FG001|Overall Study|Other|34|||
147226612|NCT00191646|531002107|FG000|Overall Study|Missing Data|18|||
147226613|NCT00191646|531002108|FG001|Overall Study|Missing Data|11|||
147113525|NCT02948400|530578768|FG001|Overall Study|Withdrawal by Subject|10|||
147113526|NCT02948400|530578767|FG000|Overall Study|failed to attend appointments|47|||
147561607|NCT01062256|532213782|FG000|Overall Study|Ineligible|1|||
147113527|NCT02948400|530578768|FG001|Overall Study|failed to attend appointments|34|||
147113528|NCT02948400|530578767|FG000|Overall Study|COVID-related closure|6|||
147113529|NCT02948400|530578768|FG001|Overall Study|COVID-related closure|2|||
147113530|NCT02948400|530578767|FG000|Overall Study|sibling discovered to be in study so participant ineligible|1|||
147113531|NCT02948400|530578768|FG001|Overall Study|sibling discovered to be in study so participant ineligible|0|||
147113532|NCT02948400|530578767|FG000|Overall Study|motion sickness in virtual reality|2|||
147113533|NCT02948400|530578768|FG001|Overall Study|motion sickness in virtual reality|0|||
147113534|NCT01716156|530578769|FG000|Overall Study|Protocol Violation|1|||
147113535|NCT01716156|530578770|FG001|Overall Study|Protocol Violation|0|||
147113536|NCT01716156|530578771|FG002|Overall Study|Protocol Violation|0|||
147113537|NCT01716156|530578769|FG000|Overall Study|Withdrawal by Subject|0|||
147113538|NCT01716156|530578770|FG001|Overall Study|Withdrawal by Subject|1|||
147113539|NCT01716156|530578771|FG002|Overall Study|Withdrawal by Subject|2|||
147113540|NCT01716156|530578769|FG000|Overall Study|Lost to Follow-up|1|||
147113541|NCT01716156|530578770|FG001|Overall Study|Lost to Follow-up|0|||
147113542|NCT01716156|530578771|FG002|Overall Study|Lost to Follow-up|0|||
147113543|NCT05561140|530578772|FG000|Randomized Treatment Period|Adverse Event|1|||
147113544|NCT05561140|530578773|FG001|Randomized Treatment Period|Adverse Event|0|||
147113545|NCT05561140|530578772|FG000|Randomized Treatment Period|Withdrawal by Subject|1|||
147113546|NCT05561140|530578773|FG001|Randomized Treatment Period|Withdrawal by Subject|0|||
147113547|NCT05561140|530578772|FG000|Open Label Treatment Period|Adverse Event|6|||
147113548|NCT05561140|530578773|FG001|Open Label Treatment Period|Adverse Event|4|||
147113549|NCT05561140|530578772|FG000|Open Label Treatment Period|Lost to Follow-up|1|||
147113550|NCT05561140|530578773|FG001|Open Label Treatment Period|Lost to Follow-up|1|||
147113551|NCT05561140|530578772|FG000|Open Label Treatment Period|Physician Decision|0|||
147113552|NCT05561140|530578773|FG001|Open Label Treatment Period|Physician Decision|1|||
147113553|NCT05561140|530578772|FG000|Open Label Treatment Period|Pregnancy|1|||
147113554|NCT05561140|530578773|FG001|Open Label Treatment Period|Pregnancy|0|||
147113555|NCT05561140|530578772|FG000|Open Label Treatment Period|Study terminated by sponsor|29|||
147113556|NCT05561140|530578773|FG001|Open Label Treatment Period|Study terminated by sponsor|30|||
147113557|NCT05561140|530578772|FG000|Open Label Treatment Period|Withdrawal by Subject|0|||
147113558|NCT05561140|530578773|FG001|Open Label Treatment Period|Withdrawal by Subject|1|||
147113559|NCT05561140|530578772|FG000|Open Label Treatment Period|Other|1|||
147113560|NCT05561140|530578773|FG001|Open Label Treatment Period|Other|0|||
147113561|NCT03301714|530578777|FG000|Overall Study|Lost to Follow-up|10|||
147113562|NCT03301714|530578778|FG001|Overall Study|Lost to Follow-up|4|||
147113563|NCT03301714|530578779|FG002|Overall Study|Lost to Follow-up|4|||
147113564|NCT03301714|530578777|FG000|Overall Study|Did not receive allocated intervention|0|||
147113565|NCT03301714|530578778|FG001|Overall Study|Did not receive allocated intervention|2|||
147113566|NCT03301714|530578779|FG002|Overall Study|Did not receive allocated intervention|3|||
147113567|NCT02112552|530578782|FG000|Overall Study|Withdrawal by Subject|1|||
147113568|NCT02112552|530578782|FG000|Overall Study|Adverse Event|1|||
147113569|NCT03349515|530578788|FG000|Overall Study|Lack of Efficacy|2|||
147113570|NCT03349515|530578789|FG001|Overall Study|Lack of Efficacy|0|||
147561608|NCT01062256|532213783|FG001|Overall Study|Ineligible|4|||
147561609|NCT01062256|532213784|FG002|Overall Study|Ineligible|3|||
147113571|NCT03349515|530578788|FG000|Overall Study|Physician Decision|3|||
147113572|NCT03349515|530578789|FG001|Overall Study|Physician Decision|1|||
147113573|NCT01132755|530578790|FG000|Overall Study|Procedure not done due to medical reason|23|||
147113574|NCT01132755|530578790|FG000|Overall Study|Protocol Violation|15|||
147113575|NCT01132755|530578790|FG000|Overall Study|Withdrawal by Subject|4|||
147113576|NCT02393755|530578791|FG000|Overall Study|Withdrawal by Subject|0|||
147113577|NCT02393755|530578792|FG001|Overall Study|Withdrawal by Subject|3|||
147113578|NCT02393755|530578791|FG000|Overall Study|Adverse Event|0|||
147113579|NCT02393755|530578792|FG001|Overall Study|Adverse Event|2|||
147113580|NCT02393755|530578791|FG000|Overall Study|Physician Decision|0|||
147113581|NCT02393755|530578792|FG001|Overall Study|Physician Decision|2|||
147113582|NCT02949934|530578795|FG000|Natural Drinking Period|Adverse Event|1|||
147113583|NCT02949934|530578796|FG001|Natural Drinking Period|Adverse Event|0|||
147226614|NCT03194490|531002110|FG000|Overall Study|Lost to Follow-up|1|||
147561610|NCT01062256|532213782|FG000|Overall Study|Administrative|0|||
147561611|NCT01062256|532213783|FG001|Overall Study|Administrative|2|||
147561612|NCT01062256|532213784|FG002|Overall Study|Administrative|0|||
147561613|NCT03049488|532213785|FG000|Overall Study|Lost to Follow-up|1|||
147226615|NCT03194490|531002111|FG001|Overall Study|Lost to Follow-up|3|||
147561614|NCT03049488|532213786|FG001|Overall Study|Lost to Follow-up|1|||
147561615|NCT03049488|532213787|FG002|Overall Study|Lost to Follow-up|0|||
147113584|NCT02949934|530578797|FG002|Natural Drinking Period|Adverse Event|0|||
147113585|NCT02949934|530578798|FG003|Natural Drinking Period|Adverse Event|1|||
147113586|NCT02949934|530578799|FG004|Natural Drinking Period|Adverse Event|0|||
147113587|NCT02949934|530578800|FG005|Natural Drinking Period|Adverse Event|0|||
147113588|NCT02949934|530578795|FG000|Natural Drinking Period|Lost to Follow-up|0|||
147113589|NCT02949934|530578796|FG001|Natural Drinking Period|Lost to Follow-up|0|||
147226616|NCT03194490|531002110|FG000|Overall Study|participant developed specific neck pain|1|||
147561616|NCT03049488|532213788|FG003|Overall Study|Lost to Follow-up|0|||
147561617|NCT03049488|532213789|FG004|Overall Study|Lost to Follow-up|0|||
147561618|NCT03049488|532213790|FG005|Overall Study|Lost to Follow-up|0|||
147561619|NCT03049488|532213785|FG000|Overall Study|Moved from Area|1|||
147561620|NCT03049488|532213786|FG001|Overall Study|Moved from Area|0|||
147561621|NCT03049488|532213787|FG002|Overall Study|Moved from Area|0|||
147561622|NCT03049488|532213788|FG003|Overall Study|Moved from Area|1|||
147561623|NCT03049488|532213789|FG004|Overall Study|Moved from Area|1|||
147113590|NCT02949934|530578797|FG002|Natural Drinking Period|Lost to Follow-up|0|||
147113591|NCT02949934|530578798|FG003|Natural Drinking Period|Lost to Follow-up|0|||
147113592|NCT02949934|530578799|FG004|Natural Drinking Period|Lost to Follow-up|1|||
147113593|NCT02949934|530578800|FG005|Natural Drinking Period|Lost to Follow-up|0|||
147113594|NCT02949934|530578795|FG000|Neuroimaging|Protocol Violation|2|||
147113595|NCT02949934|530578796|FG001|Neuroimaging|Protocol Violation|0|||
147113596|NCT02949934|530578797|FG002|Neuroimaging|Protocol Violation|0|||
147113597|NCT02949934|530578798|FG003|Neuroimaging|Protocol Violation|0|||
147113598|NCT02949934|530578799|FG004|Neuroimaging|Protocol Violation|1|||
147113599|NCT02949934|530578800|FG005|Neuroimaging|Protocol Violation|0|||
147113600|NCT02949934|530578795|FG000|Neuroimaging|Motion artifacts in imaging data|1|||
147113601|NCT02949934|530578796|FG001|Neuroimaging|Motion artifacts in imaging data|0|||
147113602|NCT02949934|530578797|FG002|Neuroimaging|Motion artifacts in imaging data|1|||
147113603|NCT02949934|530578798|FG003|Neuroimaging|Motion artifacts in imaging data|0|||
147113604|NCT02949934|530578799|FG004|Neuroimaging|Motion artifacts in imaging data|1|||
147113605|NCT02949934|530578800|FG005|Neuroimaging|Motion artifacts in imaging data|0|||
147113606|NCT02949934|530578795|FG000|Neuroimaging|Not scanned|0|||
147113607|NCT02949934|530578796|FG001|Neuroimaging|Not scanned|0|||
147113608|NCT02949934|530578797|FG002|Neuroimaging|Not scanned|1|||
147113609|NCT02949934|530578798|FG003|Neuroimaging|Not scanned|0|||
147113610|NCT02949934|530578799|FG004|Neuroimaging|Not scanned|0|||
147113611|NCT02949934|530578800|FG005|Neuroimaging|Not scanned|2|||
147113612|NCT02949934|530578795|FG000|Bar Laboratory|Procedure not done due to COVID-19 pandemic|0|||
147113613|NCT02949934|530578796|FG001|Bar Laboratory|Procedure not done due to COVID-19 pandemic|5|||
147113614|NCT02949934|530578797|FG002|Bar Laboratory|Procedure not done due to COVID-19 pandemic|5|||
147113615|NCT02949934|530578798|FG003|Bar Laboratory|Procedure not done due to COVID-19 pandemic|3|||
147113616|NCT02949934|530578799|FG004|Bar Laboratory|Procedure not done due to COVID-19 pandemic|5|||
147113617|NCT02949934|530578800|FG005|Bar Laboratory|Procedure not done due to COVID-19 pandemic|1|||
147113618|NCT02949934|530578795|FG000|Bar Laboratory|Adverse Event|1|||
147113619|NCT02949934|530578796|FG001|Bar Laboratory|Adverse Event|0|||
147113620|NCT02949934|530578797|FG002|Bar Laboratory|Adverse Event|2|||
147113621|NCT02949934|530578798|FG003|Bar Laboratory|Adverse Event|0|||
147113622|NCT02949934|530578799|FG004|Bar Laboratory|Adverse Event|1|||
147113623|NCT02949934|530578800|FG005|Bar Laboratory|Adverse Event|0|||
147113624|NCT02949934|530578795|FG000|Bar Laboratory|Protocol Violation|0|||
147113625|NCT02949934|530578796|FG001|Bar Laboratory|Protocol Violation|0|||
147113626|NCT02949934|530578797|FG002|Bar Laboratory|Protocol Violation|0|||
147113627|NCT02949934|530578798|FG003|Bar Laboratory|Protocol Violation|1|||
147113628|NCT02949934|530578799|FG004|Bar Laboratory|Protocol Violation|0|||
147113629|NCT02949934|530578800|FG005|Bar Laboratory|Protocol Violation|0|||
147113630|NCT04069520|530578804|FG000|Overall Study|Lost to Follow-up|0|||
147113631|NCT04069520|530578805|FG001|Overall Study|Lost to Follow-up|2|||
147113632|NCT04069520|530578804|FG000|Overall Study|Withdrawal by Subject|0|||
147113633|NCT04069520|530578805|FG001|Overall Study|Withdrawal by Subject|1|||
147113634|NCT04069520|530578804|FG000|Overall Study|Prior Injury|1|||
147113635|NCT04069520|530578805|FG001|Overall Study|Prior Injury|0|||
147113636|NCT04069520|530578804|FG000|Overall Study|Orthodontia|1|||
147113637|NCT04069520|530578805|FG001|Overall Study|Orthodontia|0|||
147113638|NCT04069520|530578804|FG000|Overall Study|Cut from team|0|||
147113639|NCT04069520|530578805|FG001|Overall Study|Cut from team|2|||
147113640|NCT00849472|530578806|FG000|Doxorubicin and Cyclophosphamide (AC)|Disease Progression|2|||
147113641|NCT00849472|530578806|FG000|Doxorubicin and Cyclophosphamide (AC)|Adverse Event|1|||
147113642|NCT00849472|530578806|FG000|Doxorubicin and Cyclophosphamide (AC)|Withdrawal by Subject|1|||
147561624|NCT03049488|532213790|FG005|Overall Study|Moved from Area|0|||
147561625|NCT03049488|532213785|FG000|Overall Study|Physician Decision|0|||
147561626|NCT03049488|532213786|FG001|Overall Study|Physician Decision|1|||
147561627|NCT03049488|532213787|FG002|Overall Study|Physician Decision|0|||
147113643|NCT00849472|530578806|FG000|Doxorubicin and Cyclophosphamide (AC)|Physician Decision|1|||
147113644|NCT00849472|530578806|FG000|Doxorubicin and Cyclophosphamide (AC)|Participant Moved|1|||
147113645|NCT00849472|530578806|FG000|Weekly Paclitaxel|Disease Progression|1|||
147113646|NCT00849472|530578806|FG000|Weekly Paclitaxel|Adverse Event|11|||
147113647|NCT00849472|530578806|FG000|Weekly Paclitaxel|Withdrawal by Subject|1|||
147226617|NCT03194490|531002111|FG001|Overall Study|participant developed specific neck pain|0|||
147226618|NCT01505647|531002112|FG000|Day 1 Through Day 42 Follow-up|Lost to Follow-up|1|||
147226619|NCT01505647|531002113|FG001|Day 1 Through Day 42 Follow-up|Lost to Follow-up|0|||
147226620|NCT01505647|531002112|FG000|Day 1 Through Day 42 Follow-up|Physician Decision|1|||
147561628|NCT03049488|532213788|FG003|Overall Study|Physician Decision|0|||
147561629|NCT03049488|532213789|FG004|Overall Study|Physician Decision|0|||
147561630|NCT03049488|532213790|FG005|Overall Study|Physician Decision|0|||
147113648|NCT00849472|530578806|FG000|Weekly Paclitaxel|Physician Decision|3|||
147113649|NCT00849472|530578806|FG000|Pazopanib Presurgery Treatment (PPT)|Adverse Event|52|||
147561631|NCT03049488|532213785|FG000|Overall Study|Withdrawal by Subject|0|||
147561632|NCT03049488|532213786|FG001|Overall Study|Withdrawal by Subject|0|||
147561633|NCT03049488|532213787|FG002|Overall Study|Withdrawal by Subject|0|||
147561634|NCT03049488|532213788|FG003|Overall Study|Withdrawal by Subject|1|||
147561635|NCT03049488|532213789|FG004|Overall Study|Withdrawal by Subject|1|||
147561636|NCT03049488|532213790|FG005|Overall Study|Withdrawal by Subject|0|||
147113650|NCT00849472|530578806|FG000|Pazopanib Presurgery Treatment (PPT)|Withdrawal by Subject|4|||
147113651|NCT00849472|530578806|FG000|Pazopanib Presurgery Treatment (PPT)|Physician Decision|1|||
147113652|NCT00849472|530578806|FG000|Pazopanib Presurgery Treatment (PPT)|Never Started Pre-operative Pazopanib|1|||
147113653|NCT00849472|530578806|FG000|Pazopanib Postsurgery Treatment|Adverse Event|19|||
147113654|NCT00849472|530578806|FG000|Pazopanib Postsurgery Treatment|Withdrawal by Subject|5|||
147113655|NCT00849472|530578806|FG000|Pazopanib Postsurgery Treatment|Moved|1|||
147113656|NCT00849472|530578806|FG000|Pazopanib Postsurgery Treatment|Site Thought Treatment Was Completed|1|||
147113657|NCT00825175|530578807|FG000|Overall Study|Withdrawal by Subject|0|||
147113658|NCT00825175|530578808|FG001|Overall Study|Withdrawal by Subject|5|||
147113659|NCT04822194|530578809|FG000|Overall Study|Withdrawal by Subject|5|||
147113660|NCT04822194|530578810|FG001|Overall Study|Withdrawal by Subject|4|||
147113661|NCT04822194|530578809|FG000|Overall Study|Technical issues with MR scanner|1|||
147113662|NCT04822194|530578810|FG001|Overall Study|Technical issues with MR scanner|0|||
147113663|NCT04822194|530578809|FG000|Overall Study|Lost to Follow-up|5|||
147113664|NCT04822194|530578810|FG001|Overall Study|Lost to Follow-up|7|||
147113665|NCT04615507|530578811|FG000|Period 1|Covid-19 exposure|2|||
147113666|NCT04615507|530578812|FG001|Period 1|Covid-19 exposure|1|||
147113667|NCT04615507|530578811|FG000|Period 2|Covid-19 exposure|0|||
147113668|NCT04615507|530578812|FG001|Period 2|Covid-19 exposure|1|||
147561637|NCT00891293|532213792|FG000|Overall Study|Adverse Event|2|||
147561638|NCT00891293|532213792|FG000|Overall Study|Protocol Violation|2|||
147561639|NCT00891293|532213792|FG000|Overall Study|Laboratory abnormality|4|||
147561640|NCT00891293|532213792|FG000|Overall Study|Lost to Follow-up|7|||
147561641|NCT00891293|532213792|FG000|Overall Study|Subject withdrew consent|7|||
147561642|NCT00891293|532213792|FG000|Overall Study|Sponsor termination|62|||
147561643|NCT01448057|532213793|FG000|Overall Study|Protocol Violation|3|||
147561644|NCT01448057|532213794|FG001|Overall Study|Protocol Violation|2|||
147561645|NCT01448057|532213793|FG000|Overall Study|Lost to Follow-up|3|||
147561646|NCT01448057|532213794|FG001|Overall Study|Lost to Follow-up|0|||
147113669|NCT04615507|530578811|FG000|Period 2|Protocol Violation|1|||
147561647|NCT01448057|532213793|FG000|Overall Study|Adverse Event|0|||
147113670|NCT04615507|530578812|FG001|Period 2|Protocol Violation|0|||
147113671|NCT04615507|530578811|FG000|Period 2|Withdrawal by Subject|1|||
147113672|NCT04615507|530578812|FG001|Period 2|Withdrawal by Subject|0|||
147113673|NCT04615507|530578811|FG000|Period 2|Adverse Event|0|||
147113674|NCT04615507|530578812|FG001|Period 2|Adverse Event|1|||
147226621|NCT01505647|531002113|FG001|Day 1 Through Day 42 Follow-up|Physician Decision|0|||
147226622|NCT01505647|531002112|FG000|Day 1 Through Day 42 Follow-up|Withdrawal by Subject|1|||
147226623|NCT01505647|531002113|FG001|Day 1 Through Day 42 Follow-up|Withdrawal by Subject|0|||
147226624|NCT01505647|531002112|FG000|Day 43 Through Day 182 Follow-up|Death|0|||
147226625|NCT01505647|531002113|FG001|Day 43 Through Day 182 Follow-up|Death|1|||
147561648|NCT01448057|532213794|FG001|Overall Study|Adverse Event|2|||
147561649|NCT01448057|532213793|FG000|Overall Study|Withdrawal by Subject|2|||
147561650|NCT01448057|532213794|FG001|Overall Study|Withdrawal by Subject|0|||
147561651|NCT03912337|532213810|FG000|Overall Study|Withdrawal of Consent From Study|1|||
147561652|NCT03912337|532213811|FG001|Overall Study|Withdrawal of Consent From Study|0|||
147561653|NCT03912337|532213810|FG000|Overall Study|Lost to Follow-up|1|||
147561654|NCT03912337|532213811|FG001|Overall Study|Lost to Follow-up|1|||
147561655|NCT00537030|532213812|FG000|Overall Study|Physician Decision|2|||
147561656|NCT00537030|532213812|FG000|Overall Study|Withdrawal by Subject|2|||
147226626|NCT01505647|531002112|FG000|Day 43 Through Day 182 Follow-up|Lost to Follow-up|1|||
147226627|NCT01505647|531002113|FG001|Day 43 Through Day 182 Follow-up|Lost to Follow-up|2|||
147226628|NCT01574079|531002114|FG000|Overall Study|Physician Decision|0|||
147226629|NCT01574079|531002115|FG001|Overall Study|Physician Decision|2|||
147561657|NCT00537030|532213812|FG000|Overall Study|≥ Grade 2 allergy|7|||
147561658|NCT00537030|532213812|FG000|Overall Study|Disease progression/ relapse during Tx|1|||
147561659|NCT00537030|532213812|FG000|Overall Study|Ineligible|2|||
147561660|NCT00537030|532213812|FG000|Overall Study|Inevaluable|2|||
147561661|NCT01496183|532213814|FG000|Overall Study|Physician Decision|3|||
147561662|NCT01496183|532213815|FG001|Overall Study|Physician Decision|1|||
147113675|NCT04615507|530578811|FG000|Period 3|Covid-19 exposure|0|||
147113676|NCT04615507|530578812|FG001|Period 3|Covid-19 exposure|1|||
147113677|NCT00118287|530578815|FG000|Overall Study|Intracranial haemorrhage|1|||
147113678|NCT00118287|530578815|FG000|Overall Study|Muscle pain|1|||
147113679|NCT03091439|530578820|FG000|Overall Study|Study Terminated by the Sponsor|1|||
147226630|NCT01574079|531002114|FG000|Overall Study|Lost to Follow-up|1|||
147226631|NCT01574079|531002115|FG001|Overall Study|Lost to Follow-up|0|||
147561663|NCT01496183|532213814|FG000|Overall Study|Withdrawal by Subject|0|||
147113680|NCT03091439|530578821|FG001|Overall Study|Study Terminated by the Sponsor|0|||
147113681|NCT05172570|530578822|FG000|Overall Study|withdrawn-unable to take postop required study meds due to being NPO|0|||
147113682|NCT05172570|530578823|FG001|Overall Study|withdrawn-unable to take postop required study meds due to being NPO|1|||
147113683|NCT05172570|530578824|FG002|Overall Study|withdrawn-unable to take postop required study meds due to being NPO|0|||
147113684|NCT05172570|530578822|FG000|Overall Study|PI Decision due to equipment shortages|0|||
147113685|NCT05172570|530578823|FG001|Overall Study|PI Decision due to equipment shortages|0|||
147113686|NCT05172570|530578824|FG002|Overall Study|PI Decision due to equipment shortages|1|||
147113687|NCT03550209|530578826|FG000|Overall Study|Lost to Follow-up|1|||
147113688|NCT03550209|530578827|FG001|Overall Study|Lost to Follow-up|0|||
147113689|NCT03550209|530578828|FG002|Overall Study|Lost to Follow-up|1|||
147113690|NCT03550209|530578829|FG003|Overall Study|Lost to Follow-up|0|||
147113691|NCT03550209|530578826|FG000|Overall Study|Withdrawal by Subject|0|||
147113692|NCT03550209|530578827|FG001|Overall Study|Withdrawal by Subject|3|||
147113693|NCT03550209|530578828|FG002|Overall Study|Withdrawal by Subject|1|||
147561664|NCT01496183|532213815|FG001|Overall Study|Withdrawal by Subject|1|||
147561665|NCT03130699|532213816|FG000|Overall Study|Lost to Follow-up|34|||
147113694|NCT03550209|530578829|FG003|Overall Study|Withdrawal by Subject|2|||
147113695|NCT03550209|530578826|FG000|Overall Study|Excluded due to ineligibility after randomization|0|||
147113696|NCT03550209|530578827|FG001|Overall Study|Excluded due to ineligibility after randomization|0|||
147113697|NCT03550209|530578828|FG002|Overall Study|Excluded due to ineligibility after randomization|0|||
147226632|NCT00406718|531002116|FG000|Overall Study|Withdrawal by Subject|2|||
147226633|NCT00406718|531002117|FG001|Overall Study|Withdrawal by Subject|9|||
147226634|NCT00406718|531002118|FG002|Overall Study|Withdrawal by Subject|4|||
147226635|NCT00406718|531002116|FG000|Overall Study|Lost to Follow-up|2|||
147226636|NCT00406718|531002117|FG001|Overall Study|Lost to Follow-up|5|||
147226637|NCT00406718|531002118|FG002|Overall Study|Lost to Follow-up|4|||
147226638|NCT03640559|531002119|FG000|Overall Study|Physician Decision|1|||
147226639|NCT03640559|531002120|FG001|Overall Study|Physician Decision|1|||
147226640|NCT03640559|531002119|FG000|Overall Study|Withdrawal by Subject|1|||
147226641|NCT03640559|531002120|FG001|Overall Study|Withdrawal by Subject|0|||
147226642|NCT01436162|531002121|FG000|Single-blind Lead-in Phase|Adverse Event|26|||
147226643|NCT01436162|531002122|FG001|Single-blind Lead-in Phase|Adverse Event|0|||
147226644|NCT01436162|531002123|FG002|Single-blind Lead-in Phase|Adverse Event|0|||
147226645|NCT01436162|531002121|FG000|Single-blind Lead-in Phase|Protocol Violation|24|||
147226646|NCT01436162|531002122|FG001|Single-blind Lead-in Phase|Protocol Violation|0|||
147226647|NCT01436162|531002123|FG002|Single-blind Lead-in Phase|Protocol Violation|0|||
147226648|NCT01436162|531002121|FG000|Single-blind Lead-in Phase|Withdrawal by Subject|69|||
147226649|NCT01436162|531002122|FG001|Single-blind Lead-in Phase|Withdrawal by Subject|0|||
147226650|NCT01436162|531002123|FG002|Single-blind Lead-in Phase|Withdrawal by Subject|0|||
147226651|NCT01436162|531002121|FG000|Single-blind Lead-in Phase|Lost to Follow-up|43|||
147226652|NCT01436162|531002122|FG001|Single-blind Lead-in Phase|Lost to Follow-up|0|||
147226653|NCT01436162|531002123|FG002|Single-blind Lead-in Phase|Lost to Follow-up|0|||
147226654|NCT01436162|531002121|FG000|Single-blind Lead-in Phase|Met BP or Pulse Withdrawal Criteria|13|||
147226655|NCT01436162|531002122|FG001|Single-blind Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
147226656|NCT01436162|531002123|FG002|Single-blind Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
147226657|NCT01436162|531002121|FG000|Single-blind Lead-in Phase|Other|107|||
147226658|NCT01436162|531002122|FG001|Single-blind Lead-in Phase|Other|0|||
147226659|NCT01436162|531002123|FG002|Single-blind Lead-in Phase|Other|0|||
147226660|NCT01436162|531002121|FG000|Randomized Phase|Adverse Event|1|||
147226661|NCT01436162|531002122|FG001|Randomized Phase|Adverse Event|5|||
147226662|NCT01436162|531002123|FG002|Randomized Phase|Adverse Event|6|||
147226663|NCT01436162|531002121|FG000|Randomized Phase|Protocol Violation|4|||
147226664|NCT01436162|531002122|FG001|Randomized Phase|Protocol Violation|4|||
147226665|NCT01436162|531002123|FG002|Randomized Phase|Protocol Violation|2|||
147226666|NCT01436162|531002121|FG000|Randomized Phase|Withdrawal by Subject|16|||
147226667|NCT01436162|531002122|FG001|Randomized Phase|Withdrawal by Subject|9|||
147226668|NCT01436162|531002123|FG002|Randomized Phase|Withdrawal by Subject|8|||
147226669|NCT01436162|531002121|FG000|Randomized Phase|Lost to Follow-up|17|||
147226670|NCT01436162|531002122|FG001|Randomized Phase|Lost to Follow-up|5|||
147226671|NCT01436162|531002123|FG002|Randomized Phase|Lost to Follow-up|4|||
147226672|NCT01436162|531002121|FG000|Randomized Phase|Lack of Efficacy|0|||
147561666|NCT03130699|532213817|FG001|Overall Study|Lost to Follow-up|37|||
147561667|NCT03130699|532213818|FG002|Overall Study|Lost to Follow-up|26|||
147561668|NCT03130699|532213816|FG000|Overall Study|Withdrawal by Subject|5|||
147561669|NCT03130699|532213817|FG001|Overall Study|Withdrawal by Subject|1|||
147561670|NCT03130699|532213818|FG002|Overall Study|Withdrawal by Subject|0|||
147226673|NCT01436162|531002122|FG001|Randomized Phase|Lack of Efficacy|1|||
147226674|NCT01436162|531002123|FG002|Randomized Phase|Lack of Efficacy|1|||
147226675|NCT01436162|531002121|FG000|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|4|||
147226676|NCT01436162|531002122|FG001|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|2|||
147226677|NCT01436162|531002123|FG002|Randomized Phase|Met BP Or Pulse Withdrawal Criteria|0|||
147226678|NCT01436162|531002121|FG000|Randomized Phase|Other|2|||
147226679|NCT01436162|531002122|FG001|Randomized Phase|Other|5|||
147113698|NCT03550209|530578829|FG003|Overall Study|Excluded due to ineligibility after randomization|2|||
147113699|NCT02347787|530578832|FG000|6 Month Follow-Up|Lost to Follow-up|63|||
147113700|NCT02347787|530578833|FG001|6 Month Follow-Up|Lost to Follow-up|47|||
147113701|NCT02347787|530578832|FG000|6 Month Follow-Up|Withdrawal by Subject|3|||
147113702|NCT02347787|530578833|FG001|6 Month Follow-Up|Withdrawal by Subject|9|||
147113703|NCT02347787|530578832|FG000|9 Month Follow-Up|Lost to Follow-up|52|||
147113704|NCT02347787|530578833|FG001|9 Month Follow-Up|Lost to Follow-up|59|||
147113705|NCT02347787|530578832|FG000|9 Month Follow-Up|Withdrawal by Subject|9|||
147113706|NCT02347787|530578833|FG001|9 Month Follow-Up|Withdrawal by Subject|12|||
147113707|NCT05643794|530579892|FG000|Treatment Period 1 (12 Weeks)|Adverse Event|2|||
147113708|NCT05643794|530579893|FG001|Treatment Period 1 (12 Weeks)|Adverse Event|0|||
147113709|NCT05643794|530579894|FG002|Treatment Period 1 (12 Weeks)|Adverse Event|1|||
147561671|NCT03130699|532213816|FG000|Overall Study|Withdrawal by PI|1|||
147561672|NCT03130699|532213817|FG001|Overall Study|Withdrawal by PI|2|||
147561673|NCT03130699|532213818|FG002|Overall Study|Withdrawal by PI|5|||
147561674|NCT03130699|532213816|FG000|Overall Study|Death|0|||
147561675|NCT03130699|532213817|FG001|Overall Study|Death|0|||
147561676|NCT03130699|532213818|FG002|Overall Study|Death|1|||
147561677|NCT00669864|532213821|FG000|Overall Study|Lost to Follow-up|2|||
147561678|NCT00669864|532213821|FG000|Overall Study|Protocol Violation|2|||
147561679|NCT00669864|532213821|FG000|Overall Study|Withdrawal by Subject|3|||
147561680|NCT00669864|532213821|FG000|Overall Study|Other|2|||
147561681|NCT06354270|532213824|FG000|Overall Study|Withdrawal by Subject|1|||
147561682|NCT06354270|532213825|FG001|Overall Study|Withdrawal by Subject|0|||
147561683|NCT00680121|532213826|FG000|Overall Study|Lost to Follow-up|27|||
147561684|NCT00680121|532213827|FG001|Overall Study|Lost to Follow-up|23|||
147561685|NCT00162123|532213828|FG000|Overall Study|Disease progression|27|||
147561686|NCT00162123|532213829|FG001|Overall Study|Disease progression|19|||
147561687|NCT00162123|532213830|FG002|Overall Study|Disease progression|10|||
147561688|NCT00162123|532213831|FG003|Overall Study|Disease progression|4|||
147561689|NCT00162123|532213832|FG004|Overall Study|Disease progression|8|||
147561690|NCT00162123|532213833|FG005|Overall Study|Disease progression|3|||
147561691|NCT00162123|532213834|FG006|Overall Study|Disease progression|1|||
147561692|NCT00162123|532213835|FG007|Overall Study|Disease progression|0|||
147561693|NCT00162123|532213828|FG000|Overall Study|Study drug toxicity|6|||
147561694|NCT00162123|532213829|FG001|Overall Study|Study drug toxicity|1|||
147561695|NCT00162123|532213830|FG002|Overall Study|Study drug toxicity|5|||
147561696|NCT00162123|532213831|FG003|Overall Study|Study drug toxicity|0|||
147561697|NCT00162123|532213832|FG004|Overall Study|Study drug toxicity|4|||
147561698|NCT00162123|532213833|FG005|Overall Study|Study drug toxicity|1|||
147561699|NCT00162123|532213834|FG006|Overall Study|Study drug toxicity|1|||
147561700|NCT00162123|532213835|FG007|Overall Study|Study drug toxicity|0|||
147561701|NCT00162123|532213828|FG000|Overall Study|Death|3|||
147561702|NCT00162123|532213829|FG001|Overall Study|Death|3|||
147561703|NCT00162123|532213830|FG002|Overall Study|Death|1|||
147561704|NCT00162123|532213831|FG003|Overall Study|Death|1|||
147561705|NCT00162123|532213832|FG004|Overall Study|Death|1|||
147113710|NCT05643794|530579892|FG000|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
147113711|NCT05643794|530579893|FG001|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
147113712|NCT05643794|530579894|FG002|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
147113713|NCT05643794|530579892|FG000|Treatment Period 1 (12 Weeks)|Consent Withdrawn by Study Participant (Not Due to Adverse Event)|0|||
147113714|NCT05643794|530579893|FG001|Treatment Period 1 (12 Weeks)|Consent Withdrawn by Study Participant (Not Due to Adverse Event)|1|||
147113715|NCT05643794|530579894|FG002|Treatment Period 1 (12 Weeks)|Consent Withdrawn by Study Participant (Not Due to Adverse Event)|0|||
147113716|NCT05643794|530579892|FG000|Treatment Period 2 (12 Weeks)|Lack of Efficacy|0|||
147113717|NCT05643794|530579893|FG001|Treatment Period 2 (12 Weeks)|Lack of Efficacy|1|||
147113718|NCT05643794|530579894|FG002|Treatment Period 2 (12 Weeks)|Lack of Efficacy|0|||
147113719|NCT05643794|530579892|FG000|Treatment Period 2 (12 Weeks)|Consent Withdrawn by Study Participant (Not Due to Adverse Event)|1|||
147113720|NCT05643794|530579893|FG001|Treatment Period 2 (12 Weeks)|Consent Withdrawn by Study Participant (Not Due to Adverse Event)|0|||
147113721|NCT05643794|530579894|FG002|Treatment Period 2 (12 Weeks)|Consent Withdrawn by Study Participant (Not Due to Adverse Event)|0|||
147113722|NCT05643794|530579892|FG000|Treatment Period 2 (12 Weeks)|New Work Commitments|1|||
147113723|NCT05643794|530579893|FG001|Treatment Period 2 (12 Weeks)|New Work Commitments|0|||
147113724|NCT05643794|530579894|FG002|Treatment Period 2 (12 Weeks)|New Work Commitments|0|||
147113725|NCT04167670|530579897|FG000|Overall Study|Pretreatment Event, Adverse Event, or Serious Adverse Event|1|||
147113726|NCT04167670|530579898|FG001|Overall Study|Pretreatment Event, Adverse Event, or Serious Adverse Event|7|||
147113727|NCT04167670|530579899|FG002|Overall Study|Pretreatment Event, Adverse Event, or Serious Adverse Event|4|||
147113728|NCT04167670|530579897|FG000|Overall Study|Significant protocol deviation|3|||
147561706|NCT00162123|532213833|FG005|Overall Study|Death|1|||
147113729|NCT04167670|530579898|FG001|Overall Study|Significant protocol deviation|1|||
147561707|NCT00162123|532213834|FG006|Overall Study|Death|0|||
147561708|NCT00162123|532213835|FG007|Overall Study|Death|0|||
147561709|NCT00162123|532213828|FG000|Overall Study|Withdrawal by Subject|2|||
147561710|NCT00162123|532213829|FG001|Overall Study|Withdrawal by Subject|0|||
147561711|NCT00162123|532213830|FG002|Overall Study|Withdrawal by Subject|2|||
147113730|NCT04167670|530579899|FG002|Overall Study|Significant protocol deviation|0|||
147113731|NCT04167670|530579897|FG000|Overall Study|Lost to Follow-up|0|||
147113732|NCT04167670|530579898|FG001|Overall Study|Lost to Follow-up|3|||
147113733|NCT04167670|530579899|FG002|Overall Study|Lost to Follow-up|3|||
147113734|NCT04167670|530579897|FG000|Overall Study|Voluntary Withdrawal|0|||
147113735|NCT04167670|530579898|FG001|Overall Study|Voluntary Withdrawal|1|||
147113736|NCT04167670|530579899|FG002|Overall Study|Voluntary Withdrawal|1|||
147113737|NCT04167670|530579897|FG000|Overall Study|Withdrawal of Consent|4|||
147113738|NCT04167670|530579898|FG001|Overall Study|Withdrawal of Consent|1|||
147113739|NCT04167670|530579899|FG002|Overall Study|Withdrawal of Consent|3|||
147561712|NCT00162123|532213831|FG003|Overall Study|Withdrawal by Subject|1|||
147561713|NCT00162123|532213832|FG004|Overall Study|Withdrawal by Subject|1|||
147561714|NCT00162123|532213833|FG005|Overall Study|Withdrawal by Subject|2|||
147561715|NCT00162123|532213834|FG006|Overall Study|Withdrawal by Subject|1|||
147561716|NCT00162123|532213835|FG007|Overall Study|Withdrawal by Subject|0|||
147561717|NCT00162123|532213828|FG000|Overall Study|Deterioration without progression|2|||
147561718|NCT00162123|532213829|FG001|Overall Study|Deterioration without progression|2|||
147561719|NCT00162123|532213830|FG002|Overall Study|Deterioration without progression|3|||
147561720|NCT00162123|532213831|FG003|Overall Study|Deterioration without progression|0|||
147561721|NCT00162123|532213832|FG004|Overall Study|Deterioration without progression|1|||
147561722|NCT00162123|532213833|FG005|Overall Study|Deterioration without progression|0|||
147113740|NCT04167670|530579897|FG000|Overall Study|Miscellaneous|7|||
147113741|NCT04167670|530579898|FG001|Overall Study|Miscellaneous|5|||
147113742|NCT04167670|530579899|FG002|Overall Study|Miscellaneous|3|||
147113743|NCT01127061|530579900|FG000|Overall Study|Lost to Follow-up|7|||
147226680|NCT01436162|531002123|FG002|Randomized Phase|Other|4|||
147226681|NCT01888003|531002124|FG000|Overall Study|Study Terminated|5|||
147226682|NCT01888003|531002125|FG001|Overall Study|Study Terminated|6|||
147226683|NCT01888003|531002126|FG002|Overall Study|Study Terminated|40|||
147226684|NCT01931202|531002130|FG000|Overall Study|Withdrawal by Subject|0|||
147226685|NCT01931202|531002131|FG001|Overall Study|Withdrawal by Subject|0|||
147226686|NCT01931202|531002132|FG002|Overall Study|Withdrawal by Subject|2|||
147226687|NCT01931202|531002130|FG000|Overall Study|Lost to Follow-up|0|||
147226688|NCT01931202|531002131|FG001|Overall Study|Lost to Follow-up|5|||
147226689|NCT01931202|531002132|FG002|Overall Study|Lost to Follow-up|2|||
147226690|NCT04597918|531002133|FG000|Overall Study|Withdrawal by Subject|6|||
147226691|NCT04597918|531002133|FG000|Overall Study|Lost to Follow-up|3|||
147226692|NCT04597918|531002133|FG000|Overall Study|Death|1|||
147226693|NCT05140382|531002136|FG000|Overall Study|Death|3|||
147226694|NCT05140382|531002137|FG001|Overall Study|Death|0|||
147226695|NCT05140382|531002138|FG002|Overall Study|Death|0|||
147226696|NCT05140382|531002136|FG000|Overall Study|Investigator decision|1|||
147226697|NCT05140382|531002137|FG001|Overall Study|Investigator decision|0|||
147226698|NCT05140382|531002138|FG002|Overall Study|Investigator decision|0|||
147226699|NCT05140382|531002136|FG000|Overall Study|Other|4|||
147226700|NCT05140382|531002137|FG001|Overall Study|Other|0|||
147226701|NCT05140382|531002138|FG002|Overall Study|Other|1|||
147226702|NCT05140382|531002136|FG000|Overall Study|Progressive disease|20|||
147226703|NCT05140382|531002137|FG001|Overall Study|Progressive disease|1|||
147226704|NCT05140382|531002138|FG002|Overall Study|Progressive disease|12|||
147226705|NCT05140382|531002136|FG000|Overall Study|Subjective disease progression|2|||
147226706|NCT05140382|531002137|FG001|Overall Study|Subjective disease progression|1|||
147226707|NCT05140382|531002138|FG002|Overall Study|Subjective disease progression|0|||
147226708|NCT05140382|531002136|FG000|Overall Study|Unknown at data cut-off|0|||
147226709|NCT05140382|531002137|FG001|Overall Study|Unknown at data cut-off|0|||
147226710|NCT05140382|531002138|FG002|Overall Study|Unknown at data cut-off|1|||
147226711|NCT05140382|531002136|FG000|Overall Study|Withdrawal by Subject|1|||
147226712|NCT05140382|531002137|FG001|Overall Study|Withdrawal by Subject|0|||
147226713|NCT05140382|531002138|FG002|Overall Study|Withdrawal by Subject|4|||
147226714|NCT05140382|531002136|FG000|Overall Study|Withdrawal of consent|0|||
147444340|NCT00530894|531792574|FG002|Overall Study|Lost to Follow-up|0|||
147444341|NCT00530894|531792575|FG003|Overall Study|Lost to Follow-up|0|||
147561723|NCT00162123|532213834|FG006|Overall Study|Deterioration without progression|0|||
147561724|NCT00162123|532213835|FG007|Overall Study|Deterioration without progression|0|||
147561725|NCT00162123|532213828|FG000|Overall Study|Adverse Event|1|||
147113744|NCT01127061|530579901|FG001|Overall Study|Lost to Follow-up|10|||
147113745|NCT01127061|530579900|FG000|Overall Study|Physician Decision|3|||
147113746|NCT01127061|530579901|FG001|Overall Study|Physician Decision|3|||
147226715|NCT05140382|531002137|FG001|Overall Study|Withdrawal of consent|0|||
147226716|NCT05140382|531002138|FG002|Overall Study|Withdrawal of consent|1|||
147226717|NCT03172910|531003624|FG000|Overall Study|Adverse Event|0|||
147226718|NCT03172910|531003625|FG001|Overall Study|Adverse Event|0|||
147226719|NCT03172910|531003626|FG002|Overall Study|Adverse Event|0|||
147226720|NCT03172910|531003627|FG003|Overall Study|Adverse Event|0|||
147226721|NCT03172910|531003628|FG004|Overall Study|Adverse Event|1|||
147226722|NCT00451451|531003637|FG000|Overall Study|Adverse Event|11|||
147226723|NCT00451451|531003638|FG001|Overall Study|Adverse Event|21|||
147444342|NCT00530894|531792572|FG000|Overall Study|Withdrawal by Subject|1|||
147561726|NCT00162123|532213829|FG001|Overall Study|Adverse Event|2|||
147561727|NCT00162123|532213830|FG002|Overall Study|Adverse Event|0|||
147561728|NCT00162123|532213831|FG003|Overall Study|Adverse Event|2|||
147561729|NCT00162123|532213832|FG004|Overall Study|Adverse Event|1|||
147561730|NCT00162123|532213833|FG005|Overall Study|Adverse Event|0|||
147561731|NCT00162123|532213834|FG006|Overall Study|Adverse Event|0|||
147561732|NCT00162123|532213835|FG007|Overall Study|Adverse Event|0|||
147561733|NCT00162123|532213828|FG000|Overall Study|Not specified (before treatment)|2|||
147561734|NCT00162123|532213829|FG001|Overall Study|Not specified (before treatment)|0|||
147561735|NCT00162123|532213830|FG002|Overall Study|Not specified (before treatment)|0|||
147561736|NCT00162123|532213831|FG003|Overall Study|Not specified (before treatment)|0|||
147561737|NCT00162123|532213832|FG004|Overall Study|Not specified (before treatment)|12|||
147561738|NCT00162123|532213833|FG005|Overall Study|Not specified (before treatment)|1|||
147561739|NCT00162123|532213834|FG006|Overall Study|Not specified (before treatment)|0|||
147561740|NCT00162123|532213835|FG007|Overall Study|Not specified (before treatment)|0|||
147561741|NCT00162123|532213828|FG000|Overall Study|Not specified (after start of treatment)|0|||
147561742|NCT00162123|532213829|FG001|Overall Study|Not specified (after start of treatment)|0|||
147561743|NCT00162123|532213830|FG002|Overall Study|Not specified (after start of treatment)|0|||
147561744|NCT00162123|532213831|FG003|Overall Study|Not specified (after start of treatment)|0|||
147561745|NCT00162123|532213832|FG004|Overall Study|Not specified (after start of treatment)|3|||
147561746|NCT00162123|532213833|FG005|Overall Study|Not specified (after start of treatment)|0|||
147561747|NCT00162123|532213834|FG006|Overall Study|Not specified (after start of treatment)|0|||
147561748|NCT00162123|532213835|FG007|Overall Study|Not specified (after start of treatment)|0|||
147561749|NCT00162123|532213828|FG000|Overall Study|Physician Decision|1|||
147561750|NCT00162123|532213829|FG001|Overall Study|Physician Decision|2|||
147561751|NCT00162123|532213830|FG002|Overall Study|Physician Decision|0|||
147561752|NCT00162123|532213831|FG003|Overall Study|Physician Decision|0|||
147561753|NCT00162123|532213832|FG004|Overall Study|Physician Decision|0|||
147561754|NCT00162123|532213833|FG005|Overall Study|Physician Decision|1|||
147561755|NCT00162123|532213834|FG006|Overall Study|Physician Decision|1|||
147561756|NCT00162123|532213835|FG007|Overall Study|Physician Decision|0|||
147561757|NCT00162123|532213828|FG000|Overall Study|Tumor assessment only (not treated)|0|||
147561758|NCT00162123|532213829|FG001|Overall Study|Tumor assessment only (not treated)|0|||
147561759|NCT00162123|532213830|FG002|Overall Study|Tumor assessment only (not treated)|0|||
147561760|NCT00162123|532213831|FG003|Overall Study|Tumor assessment only (not treated)|0|||
147561761|NCT00162123|532213832|FG004|Overall Study|Tumor assessment only (not treated)|0|||
147561762|NCT00162123|532213833|FG005|Overall Study|Tumor assessment only (not treated)|0|||
147561763|NCT00162123|532213834|FG006|Overall Study|Tumor assessment only (not treated)|0|||
147561764|NCT00162123|532213835|FG007|Overall Study|Tumor assessment only (not treated)|1|||
147561765|NCT00162123|532213828|FG000|Overall Study|Follow-up only (not treated or assessed)|0|||
147561766|NCT00162123|532213829|FG001|Overall Study|Follow-up only (not treated or assessed)|0|||
147561767|NCT00162123|532213830|FG002|Overall Study|Follow-up only (not treated or assessed)|0|||
147561768|NCT00162123|532213831|FG003|Overall Study|Follow-up only (not treated or assessed)|0|||
147561769|NCT00162123|532213832|FG004|Overall Study|Follow-up only (not treated or assessed)|0|||
147561770|NCT00162123|532213833|FG005|Overall Study|Follow-up only (not treated or assessed)|0|||
147561771|NCT00162123|532213834|FG006|Overall Study|Follow-up only (not treated or assessed)|0|||
147561772|NCT00162123|532213835|FG007|Overall Study|Follow-up only (not treated or assessed)|57|||
147561773|NCT02016170|532213836|FG000|Overall Study|Adverse Event|1|||
147561774|NCT02016170|532213837|FG001|Overall Study|Adverse Event|1|||
147561775|NCT02016170|532213838|FG002|Overall Study|Adverse Event|0|||
147561776|NCT02016170|532213836|FG000|Overall Study|Protocol Violation|1|||
147561777|NCT02016170|532213837|FG001|Overall Study|Protocol Violation|0|||
147113747|NCT04827446|530579904|FG000|Overall Study|Lost to Follow-up|1|||
147113748|NCT04827446|530579905|FG001|Overall Study|Lost to Follow-up|1|||
147113749|NCT04827446|530579904|FG000|Overall Study|Death|2|||
147113750|NCT04827446|530579905|FG001|Overall Study|Death|0|||
147113751|NCT04827446|530579904|FG000|Overall Study|Withdrawal by Subject|2|||
147113752|NCT04827446|530579905|FG001|Overall Study|Withdrawal by Subject|2|||
147113753|NCT03921541|530579908|FG000|Double Blind Treatment Period|Withdrawal by Subject|1|||
147226724|NCT00451451|531003639|FG002|Overall Study|Adverse Event|26|||
147226725|NCT00451451|531003640|FG003|Overall Study|Adverse Event|10|||
147226726|NCT00451451|531003637|FG000|Overall Study|Lost to Follow-up|11|||
147226727|NCT00451451|531003638|FG001|Overall Study|Lost to Follow-up|9|||
147561778|NCT02016170|532213838|FG002|Overall Study|Protocol Violation|0|||
147561779|NCT01936948|532213842|FG000|Overall Study|no 30-day follow-up data|0|||
147561780|NCT01936948|532213843|FG001|Overall Study|no 30-day follow-up data|3|||
147113754|NCT03921541|530579909|FG001|Double Blind Treatment Period|Withdrawal by Subject|0|||
147561781|NCT01936948|532213844|FG002|Overall Study|no 30-day follow-up data|3|||
147561782|NCT01936948|532213845|FG003|Overall Study|no 30-day follow-up data|3|||
147561783|NCT02365207|532213846|FG000|Overall Study|Withdrawal by Subject|1|||
147561784|NCT02365207|532213846|FG000|Overall Study|Physician Decision|1|||
147113755|NCT05399485|530579910|FG000|DBT Phase|Other|6|||
147113756|NCT05399485|530579911|FG001|DBT Phase|Other|5|||
147226728|NCT00451451|531003639|FG002|Overall Study|Lost to Follow-up|8|||
147113757|NCT05399485|530579910|FG000|DBT Phase|Protocol-specified withdrawal criterion met|1|||
147113758|NCT05399485|530579911|FG001|DBT Phase|Protocol-specified withdrawal criterion met|1|||
147113759|NCT05399485|530579910|FG000|DBT Phase|Withdrawal by Subject|3|||
147113760|NCT05399485|530579911|FG001|DBT Phase|Withdrawal by Subject|2|||
147113761|NCT05399485|530579910|FG000|DBT Phase|Protocol Violation|2|||
147113762|NCT05399485|530579911|FG001|DBT Phase|Protocol Violation|1|||
147113763|NCT05399485|530579910|FG000|DBT Phase|Physician Decision|0|||
147113764|NCT05399485|530579911|FG001|DBT Phase|Physician Decision|1|||
147113765|NCT05399485|530579910|FG000|DBT Phase|Adverse Event|2|||
147113766|NCT05399485|530579911|FG001|DBT Phase|Adverse Event|1|||
147113767|NCT05399485|530579910|FG000|OLE Phase|Protocol deviation|1|||
147113768|NCT05399485|530579911|FG001|OLE Phase|Protocol deviation|0|||
147226729|NCT00451451|531003640|FG003|Overall Study|Lost to Follow-up|11|||
147226730|NCT00451451|531003637|FG000|Overall Study|Consent Withdrawn|14|||
147226731|NCT00451451|531003638|FG001|Overall Study|Consent Withdrawn|9|||
147226732|NCT00451451|531003639|FG002|Overall Study|Consent Withdrawn|17|||
147226733|NCT00451451|531003640|FG003|Overall Study|Consent Withdrawn|17|||
147226734|NCT00451451|531003637|FG000|Overall Study|Investigator Decision|6|||
147226735|NCT00451451|531003638|FG001|Overall Study|Investigator Decision|2|||
147226736|NCT00451451|531003639|FG002|Overall Study|Investigator Decision|1|||
147226737|NCT00451451|531003640|FG003|Overall Study|Investigator Decision|2|||
147226738|NCT00451451|531003637|FG000|Overall Study|Subject Non-Compliance|8|||
147226739|NCT00451451|531003638|FG001|Overall Study|Subject Non-Compliance|4|||
147226740|NCT00451451|531003639|FG002|Overall Study|Subject Non-Compliance|3|||
147226741|NCT00451451|531003640|FG003|Overall Study|Subject Non-Compliance|3|||
147226742|NCT00451451|531003637|FG000|Overall Study|Death|1|||
147226743|NCT00451451|531003638|FG001|Overall Study|Death|0|||
147226744|NCT00451451|531003639|FG002|Overall Study|Death|0|||
147226745|NCT00451451|531003640|FG003|Overall Study|Death|1|||
147226746|NCT00451451|531003637|FG000|Overall Study|Other Reasons for Not Completing Study|34|||
147226747|NCT00451451|531003638|FG001|Overall Study|Other Reasons for Not Completing Study|30|||
147226748|NCT00451451|531003639|FG002|Overall Study|Other Reasons for Not Completing Study|17|||
147226749|NCT00451451|531003640|FG003|Overall Study|Other Reasons for Not Completing Study|14|||
147226750|NCT00122278|531003641|FG000|Overall Study|Lost to Follow-up|2|||
147226751|NCT00122278|531003642|FG001|Overall Study|Lost to Follow-up|0|||
147226752|NCT01002482|531003643|FG000|Overall Study|Withdrawal by Subject|14|||
147226753|NCT01002482|531003644|FG001|Overall Study|Withdrawal by Subject|21|||
147226754|NCT01002482|531003643|FG000|Overall Study|Included twice|1|||
147226755|NCT01002482|531003644|FG001|Overall Study|Included twice|0|||
147226756|NCT03468985|531003648|FG000|Overall Study|Adverse Event|0|||
147226757|NCT03468985|531003649|FG001|Overall Study|Adverse Event|2|||
147226758|NCT03468985|531003650|FG002|Overall Study|Adverse Event|0|||
147226759|NCT03468985|531003651|FG003|Overall Study|Adverse Event|0|||
147226760|NCT03468985|531003648|FG000|Overall Study|Withdrawal by Subject|0|||
147226761|NCT03468985|531003649|FG001|Overall Study|Withdrawal by Subject|0|||
147226762|NCT03468985|531003650|FG002|Overall Study|Withdrawal by Subject|0|||
147226763|NCT03468985|531003651|FG003|Overall Study|Withdrawal by Subject|1|||
147226764|NCT04060862|531003652|FG000|Overall Study|Symptomatic Deterioration|1|||
147226765|NCT04060862|531003652|FG000|Overall Study|Un-specified|6|||
147226766|NCT04060862|531003652|FG000|Overall Study|Progressive disease|12|||
147226767|NCT04060862|531003652|FG000|Overall Study|Physician Decision|1|||
147226768|NCT01367119|531003657|FG000|Overall Study|Adverse Event|1|||
147226769|NCT01367119|531003658|FG001|Overall Study|Adverse Event|0|||
147226770|NCT01367119|531003657|FG000|Overall Study|Withdrawal by Subject|1|||
147226771|NCT01367119|531003658|FG001|Overall Study|Withdrawal by Subject|1|||
147226772|NCT05342532|531003659|FG000|Overall Study|Adverse Event|5|||
147444343|NCT00530894|531792573|FG001|Overall Study|Withdrawal by Subject|23|||
147444344|NCT00530894|531792574|FG002|Overall Study|Withdrawal by Subject|0|||
147444345|NCT00530894|531792575|FG003|Overall Study|Withdrawal by Subject|5|||
147444346|NCT00530894|531792572|FG000|Overall Study|Alive and censored prior to 1 year|2|||
147113769|NCT05399485|530579910|FG000|OLE Phase|Other|5|||
147113770|NCT05399485|530579911|FG001|OLE Phase|Other|5|||
147113771|NCT05399485|530579910|FG000|OLE Phase|Withdrawal by Subject|12|||
147113772|NCT05399485|530579911|FG001|OLE Phase|Withdrawal by Subject|7|||
147113773|NCT05399485|530579910|FG000|OLE Phase|Pregnancy|0|||
147113774|NCT05399485|530579911|FG001|OLE Phase|Pregnancy|2|||
147113775|NCT05399485|530579910|FG000|OLE Phase|Physician Decision|3|||
147226773|NCT05342532|531003660|FG001|Overall Study|Adverse Event|20|||
147226774|NCT05342532|531003659|FG000|Overall Study|Lost to Follow-up|10|||
147226775|NCT05342532|531003660|FG001|Overall Study|Lost to Follow-up|15|||
147226776|NCT02675231|531003661|FG000|Overall Study|Withdrawal by Subject|2|||
147226777|NCT02675231|531003662|FG001|Overall Study|Withdrawal by Subject|4|||
147226778|NCT02675231|531003663|FG002|Overall Study|Withdrawal by Subject|2|||
147113776|NCT05399485|530579911|FG001|OLE Phase|Physician Decision|0|||
147226779|NCT02675231|531003661|FG000|Overall Study|Lost to Follow-up|3|||
147226780|NCT02675231|531003662|FG001|Overall Study|Lost to Follow-up|4|||
147226781|NCT02675231|531003663|FG002|Overall Study|Lost to Follow-up|3|||
147226782|NCT02652767|531003664|FG000|Overall Study|Death|2|||
147226783|NCT02652767|531003664|FG000|Overall Study|Lost to Follow-up|1|||
147561785|NCT01395030|532213847|FG000|Overall Study|Did not complete FCH PET/CT|7|||
147561786|NCT01606306|532213850|FG000|Overall Study|Lack of Efficacy|2|||
147561787|NCT01606306|532213851|FG001|Overall Study|Lack of Efficacy|1|||
147561788|NCT01606306|532213852|FG002|Overall Study|Lack of Efficacy|4|||
147561789|NCT01606306|532213853|FG003|Overall Study|Lack of Efficacy|4|||
147561790|NCT01606306|532213854|FG004|Overall Study|Lack of Efficacy|1|||
147561791|NCT01606306|532213855|FG005|Overall Study|Lack of Efficacy|2|||
147561792|NCT01606306|532213850|FG000|Overall Study|Adverse Event|1|||
147561793|NCT01606306|532213851|FG001|Overall Study|Adverse Event|0|||
147561794|NCT01606306|532213852|FG002|Overall Study|Adverse Event|1|||
147561795|NCT01606306|532213853|FG003|Overall Study|Adverse Event|1|||
147561796|NCT01606306|532213854|FG004|Overall Study|Adverse Event|2|||
147561797|NCT01606306|532213855|FG005|Overall Study|Adverse Event|0|||
147561798|NCT01606306|532213850|FG000|Overall Study|Lost to Follow-up|7|||
147561799|NCT01606306|532213851|FG001|Overall Study|Lost to Follow-up|4|||
147561800|NCT01606306|532213852|FG002|Overall Study|Lost to Follow-up|5|||
147113777|NCT05399485|530579910|FG000|OLE Phase|Adverse Event|2|||
147113778|NCT05399485|530579911|FG001|OLE Phase|Adverse Event|2|||
147113779|NCT01363076|530579914|FG000|Overall Study|Withdrawal by Subject|0|||
147113780|NCT01363076|530579915|FG001|Overall Study|Withdrawal by Subject|1|||
147561801|NCT01606306|532213853|FG003|Overall Study|Lost to Follow-up|4|||
147561802|NCT01606306|532213854|FG004|Overall Study|Lost to Follow-up|3|||
147561803|NCT01606306|532213855|FG005|Overall Study|Lost to Follow-up|5|||
147561804|NCT01606306|532213850|FG000|Overall Study|Withdrawal by Subject|4|||
147561805|NCT01606306|532213851|FG001|Overall Study|Withdrawal by Subject|3|||
147561806|NCT01606306|532213852|FG002|Overall Study|Withdrawal by Subject|4|||
147561807|NCT01606306|532213853|FG003|Overall Study|Withdrawal by Subject|4|||
147561808|NCT01606306|532213854|FG004|Overall Study|Withdrawal by Subject|5|||
147561809|NCT01606306|532213855|FG005|Overall Study|Withdrawal by Subject|4|||
147561810|NCT01606306|532213850|FG000|Overall Study|Physician Decision|1|||
147561811|NCT01606306|532213851|FG001|Overall Study|Physician Decision|2|||
147561812|NCT01606306|532213852|FG002|Overall Study|Physician Decision|0|||
147561813|NCT01606306|532213853|FG003|Overall Study|Physician Decision|0|||
147561814|NCT01606306|532213854|FG004|Overall Study|Physician Decision|0|||
147561815|NCT01606306|532213855|FG005|Overall Study|Physician Decision|0|||
147561816|NCT00950872|532213858|FG000|Overall Study|Withdrawal by Subject|1|||
147561817|NCT00950872|532213858|FG000|Overall Study|Did not have surgery|2|||
147561818|NCT00408902|532213861|FG000|Overall Study|Lack of Efficacy|7|||
147561819|NCT00408902|532213861|FG000|Overall Study|Adverse Event|3|||
147561820|NCT00970281|532213862|FG000|Overall Study|Lack of Efficacy|1|||
147561821|NCT00970281|532213863|FG001|Overall Study|Lack of Efficacy|14|||
147561822|NCT00970281|532213862|FG000|Overall Study|Withdrawal by Subject|0|||
147561823|NCT00970281|532213863|FG001|Overall Study|Withdrawal by Subject|1|||
147561824|NCT00970281|532213862|FG000|Overall Study|Physician Decision|1|||
147561825|NCT00970281|532213863|FG001|Overall Study|Physician Decision|1|||
147561826|NCT01759290|532213864|FG000|Overall Study|Subjects withdrawn consent|5|||
147561827|NCT01759290|532213864|FG000|Overall Study|Physician Decision|2|||
147561828|NCT01759290|532213864|FG000|Overall Study|Death|17|||
147561829|NCT01759290|532213864|FG000|Overall Study|Lost to Follow-up|53|||
147561830|NCT01759290|532213864|FG000|Overall Study|Unknown reason|4|||
147561831|NCT00841100|532213865|FG000|Phase 1 (28 Days)|Adverse Event|1|||
147561832|NCT00841100|532213865|FG000|Phase 1 (28 Days)|Participant non-compliance|2|||
147561833|NCT03338972|532213866|FG000|Overall Study|Death|1|||
147561834|NCT03338972|532213867|FG001|Overall Study|Death|1|||
147113781|NCT04706403|530579916|FG000|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|0|||
147113782|NCT04706403|530579917|FG001|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|0|||
147226784|NCT02652767|531003664|FG000|Overall Study|Withdrawal by Subject|1|||
147226785|NCT03953183|531003665|FG000|Overall Study|Physician Decision|0|||
147561835|NCT03338972|532213868|FG002|Overall Study|Death|0|||
147561836|NCT03338972|532213869|FG003|Overall Study|Death|0|||
147561837|NCT03338972|532213866|FG000|Overall Study|Withdrawal by Subject|1|||
147561838|NCT03338972|532213867|FG001|Overall Study|Withdrawal by Subject|0|||
147561839|NCT03338972|532213868|FG002|Overall Study|Withdrawal by Subject|0|||
147561840|NCT03338972|532213869|FG003|Overall Study|Withdrawal by Subject|0|||
147561841|NCT03629249|532213870|FG000|Overall Study|Study terminated by sponsor|197|||
147561842|NCT03629249|532213871|FG001|Overall Study|Study terminated by sponsor|197|||
147561843|NCT03629249|532213872|FG002|Overall Study|Study terminated by sponsor|194|||
147561844|NCT03629249|532213870|FG000|Overall Study|Protocol deviation|0|||
147561845|NCT03629249|532213871|FG001|Overall Study|Protocol deviation|2|||
147561846|NCT03629249|532213872|FG002|Overall Study|Protocol deviation|5|||
147226786|NCT03953183|531003666|FG001|Overall Study|Physician Decision|1|||
147561847|NCT03629249|532213870|FG000|Overall Study|Subject decision|1|||
147561848|NCT03629249|532213871|FG001|Overall Study|Subject decision|1|||
147561849|NCT03629249|532213872|FG002|Overall Study|Subject decision|3|||
147561850|NCT03629249|532213870|FG000|Overall Study|Adverse Event|1|||
147561851|NCT03629249|532213871|FG001|Overall Study|Adverse Event|1|||
147561852|NCT03629249|532213872|FG002|Overall Study|Adverse Event|0|||
147561853|NCT03629249|532213870|FG000|Overall Study|Death|1|||
147561854|NCT03629249|532213871|FG001|Overall Study|Death|0|||
147113783|NCT04706403|530579918|FG002|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|1|||
147113784|NCT04706403|530579919|FG003|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|1|||
147113785|NCT04706403|530579920|FG004|Overall Study|Participants did not provide respond to the question re-assessing vaccination intent|2|||
147113786|NCT00182637|530579921|FG000|Overall Study|Adverse Event|2|||
147113787|NCT00182637|530579921|FG000|Overall Study|Disease Progression|1|||
147113788|NCT02642679|530579922|FG000|Overall Study|Withdrawal by Subject|1|||
147226787|NCT03953183|531003665|FG000|Overall Study|Withdrawal by Subject|0|||
147226788|NCT03953183|531003666|FG001|Overall Study|Withdrawal by Subject|1|||
147561855|NCT03629249|532213872|FG002|Overall Study|Death|0|||
147561856|NCT03629249|532213870|FG000|Overall Study|Physician Decision|1|||
147561857|NCT03629249|532213871|FG001|Overall Study|Physician Decision|0|||
147561858|NCT03629249|532213872|FG002|Overall Study|Physician Decision|0|||
147561859|NCT00352690|532213873|FG000|Overall Study|Determined to be ineligible|2|||
147561860|NCT00352690|532213874|FG001|Overall Study|Determined to be ineligible|0|||
147561861|NCT03633721|532213879|FG000|Washout (From 1 Day to 212 Days)|Withdrawal by Subject|2|||
147561862|NCT03633721|532213880|FG001|Washout (From 1 Day to 212 Days)|Withdrawal by Subject|1|||
147561863|NCT03633721|532213881|FG002|Washout (From 1 Day to 212 Days)|Withdrawal by Subject|0|||
147561864|NCT03633721|532213882|FG003|Washout (From 1 Day to 212 Days)|Withdrawal by Subject|1|||
147561865|NCT01475474|532213886|FG000|Baseline Period - 4 Weeks|Did not meet eligibility for treatment|4|||
147561866|NCT01475474|532213886|FG000|Baseline Period - 4 Weeks|Withdrawal by Subject|2|||
147561867|NCT05277389|532213887|FG000|Overall Study|Lost to Follow-up|1|||
147561868|NCT05277389|532213888|FG001|Overall Study|Lost to Follow-up|4|||
147561869|NCT03069937|532213889|FG000|Overall Study|Second primary malignancy noted|1|||
147561870|NCT06096168|532213890|FG000|Overall Study|Death|30|||
147561871|NCT06096168|532213890|FG000|Overall Study|Revision|2|||
147561872|NCT01046253|532213891|FG000|Second Intervention|Adverse Event|0|||
147561873|NCT01046253|532213892|FG001|Second Intervention|Adverse Event|1|||
147561874|NCT01046253|532213891|FG000|Second Intervention|Protocol Violation|0|||
147561875|NCT01046253|532213892|FG001|Second Intervention|Protocol Violation|1|||
147561876|NCT02339909|532213895|FG000|Overall Study|Became ineligible after randomisation|89|||
147561877|NCT02339909|532213896|FG001|Overall Study|Became ineligible after randomisation|63|||
147561878|NCT02339909|532213897|FG002|Overall Study|Became ineligible after randomisation|71|||
147561879|NCT01766778|532213902|FG000|Overall Study|Adverse Event|4|||
147226789|NCT00887744|531003675|FG000|Overall Study|Adverse Event|3|||
147226790|NCT00887744|531003675|FG000|Overall Study|Death|1|||
147226791|NCT00887744|531003675|FG000|Overall Study|Lost to Follow-up|3|||
147226792|NCT00887744|531003675|FG000|Overall Study|Withdrawal by Subject|18|||
147226793|NCT00887744|531003675|FG000|Overall Study|Various reasons|9|||
147226794|NCT00089674|531003679|FG000|Overall Study|Physician Decision|4|||
147226795|NCT00089674|531003680|FG001|Overall Study|Physician Decision|2|||
147226796|NCT00089674|531003679|FG000|Overall Study|Adverse Event|23|||
147226797|NCT00089674|531003680|FG001|Overall Study|Adverse Event|29|||
147226798|NCT00089674|531003679|FG000|Overall Study|Withdrawal by Subject|143|||
147226799|NCT00089674|531003680|FG001|Overall Study|Withdrawal by Subject|127|||
147226800|NCT00089674|531003679|FG000|Overall Study|Death|43|||
147226801|NCT00089674|531003680|FG001|Overall Study|Death|43|||
147226802|NCT00089674|531003679|FG000|Overall Study|Disease progression|21|||
147226803|NCT00089674|531003680|FG001|Overall Study|Disease progression|23|||
147226804|NCT00089674|531003679|FG000|Overall Study|Ineligibility determined|8|||
147226805|NCT00089674|531003680|FG001|Overall Study|Ineligibility determined|10|||
147226806|NCT00089674|531003679|FG000|Overall Study|Lost to Follow-up|21|||
147226807|NCT00089674|531003680|FG001|Overall Study|Lost to Follow-up|17|||
147226808|NCT00089674|531003679|FG000|Overall Study|Noncompliance|7|||
147226809|NCT00089674|531003680|FG001|Overall Study|Noncompliance|3|||
147226810|NCT00089674|531003679|FG000|Overall Study|Other|5|||
147226811|NCT00089674|531003680|FG001|Overall Study|Other|9|||
147226812|NCT00089674|531003679|FG000|Overall Study|Requirement for alternative therapy|14|||
147226813|NCT00089674|531003680|FG001|Overall Study|Requirement for alternative therapy|4|||
147226814|NCT01528215|531003681|FG000|Enrollment to 1 Year Follow-up|Adverse Event|4|||
147561880|NCT01766778|532213903|FG001|Overall Study|Adverse Event|4|||
147561881|NCT01766778|532213902|FG000|Overall Study|Withdrawal by Subject|1|||
147226815|NCT01528215|531003682|FG001|Enrollment to 1 Year Follow-up|Adverse Event|1|||
147226816|NCT01528215|531003681|FG000|1 Year Follow-up to 5 Year Follow-up|Adverse Event|2|||
147226817|NCT01528215|531003682|FG001|1 Year Follow-up to 5 Year Follow-up|Adverse Event|2|||
147561882|NCT01766778|532213903|FG001|Overall Study|Withdrawal by Subject|0|||
147561883|NCT01411332|532213904|FG000|Enrollment|Protocol Violation|0|||
147561884|NCT01411332|532213905|FG001|Enrollment|Protocol Violation|1|||
147561885|NCT01411332|532213904|FG000|Enrollment|Withdrawal by Subject|0|||
147561886|NCT01411332|532213905|FG001|Enrollment|Withdrawal by Subject|1|||
147561887|NCT01411332|532213904|FG000|Treatment|Lost to Follow-up|1|||
147561888|NCT01411332|532213905|FG001|Treatment|Lost to Follow-up|0|||
147226818|NCT01528215|531003681|FG000|1 Year Follow-up to 5 Year Follow-up|Lost to Follow-up|10|||
147226819|NCT01528215|531003682|FG001|1 Year Follow-up to 5 Year Follow-up|Lost to Follow-up|13|||
147226820|NCT01528215|531003681|FG000|1 Year Follow-up to 5 Year Follow-up|Withdrawal by Subject|3|||
147226821|NCT01528215|531003682|FG001|1 Year Follow-up to 5 Year Follow-up|Withdrawal by Subject|0|||
147226822|NCT01610271|531003683|FG000|Overall Study|Surgery not complete|0|||
147226823|NCT01610271|531003684|FG001|Overall Study|Surgery not complete|1|||
147226824|NCT01610271|531003683|FG000|Overall Study|Prosthesis not implanted|2|||
147226825|NCT01610271|531003684|FG001|Overall Study|Prosthesis not implanted|3|||
147226826|NCT02961218|531003686|FG000|Overall Study|Lost to Follow-up|0|||
147226827|NCT02961218|531003687|FG001|Overall Study|Lost to Follow-up|2|||
147226828|NCT02961218|531003686|FG000|Overall Study|Physician Decision|0|||
147226829|NCT02961218|531003687|FG001|Overall Study|Physician Decision|2|||
147226830|NCT02961218|531003686|FG000|Overall Study|Subject/Guardian Decision|3|||
147226831|NCT02961218|531003687|FG001|Overall Study|Subject/Guardian Decision|1|||
147226832|NCT01462227|531003688|FG000|Second Assignment|Lost to Follow-up|1|||
147226833|NCT01462227|531003689|FG001|Second Assignment|Lost to Follow-up|0|||
147226834|NCT01462227|531003690|FG002|Second Assignment|Lost to Follow-up|0|||
147226835|NCT01462227|531003691|FG003|Second Assignment|Lost to Follow-up|0|||
147226836|NCT01462227|531003688|FG000|Second Assignment|Protocol Violation|0|||
147226837|NCT01462227|531003689|FG001|Second Assignment|Protocol Violation|1|||
147226838|NCT01462227|531003690|FG002|Second Assignment|Protocol Violation|1|||
147226839|NCT01462227|531003691|FG003|Second Assignment|Protocol Violation|0|||
147226840|NCT00591266|531003692|FG000|Overall Study|Adverse Event|2|||
147226841|NCT00591266|531003693|FG001|Overall Study|Adverse Event|2|||
147226842|NCT00591266|531003694|FG002|Overall Study|Adverse Event|3|||
147226843|NCT00591266|531003692|FG000|Overall Study|Lost to Follow-up|0|||
147226844|NCT00591266|531003693|FG001|Overall Study|Lost to Follow-up|1|||
147226845|NCT00591266|531003694|FG002|Overall Study|Lost to Follow-up|0|||
147226846|NCT00591266|531003692|FG000|Overall Study|Protocol Violation|0|||
147226847|NCT00591266|531003693|FG001|Overall Study|Protocol Violation|0|||
147226848|NCT00591266|531003694|FG002|Overall Study|Protocol Violation|1|||
147226849|NCT00591266|531003692|FG000|Overall Study|Withdrawal by Subject|6|||
147226850|NCT00591266|531003693|FG001|Overall Study|Withdrawal by Subject|2|||
147226851|NCT00591266|531003694|FG002|Overall Study|Withdrawal by Subject|5|||
147226852|NCT00591266|531003692|FG000|Overall Study|Lack of Efficacy|0|||
147226853|NCT00591266|531003693|FG001|Overall Study|Lack of Efficacy|2|||
147226854|NCT00591266|531003694|FG002|Overall Study|Lack of Efficacy|0|||
147226855|NCT00591266|531003692|FG000|Overall Study|Other|1|||
147226856|NCT00591266|531003693|FG001|Overall Study|Other|4|||
147226857|NCT00591266|531003694|FG002|Overall Study|Other|5|||
147226858|NCT00586846|531003697|FG000|Overall Study|Physician Decision|1|||
147226859|NCT00586846|531003697|FG000|Overall Study|Death|1|||
147226860|NCT00586846|531003697|FG000|Overall Study|Evaluable for Toxicity Only|4|||
147226861|NCT05298306|531003700|FG000|Overall Study|Physician Decision|0|||
147226862|NCT05298306|531003701|FG001|Overall Study|Physician Decision|0|||
147226863|NCT05298306|531003702|FG002|Overall Study|Physician Decision|0|||
147226864|NCT05298306|531003703|FG003|Overall Study|Physician Decision|1|||
147226865|NCT05298306|531003704|FG004|Overall Study|Physician Decision|0|||
147226866|NCT05298306|531003705|FG005|Overall Study|Physician Decision|0|||
147226867|NCT01178073|531003711|FG000|Overall Study|Adverse Event|34|||
147226868|NCT01178073|531003712|FG001|Overall Study|Adverse Event|27|||
147226869|NCT01178073|531003713|FG002|Overall Study|Adverse Event|24|||
147226870|NCT01178073|531003711|FG000|Overall Study|Protocol Violation|1|||
147226871|NCT01178073|531003712|FG001|Overall Study|Protocol Violation|1|||
147226872|NCT01178073|531003713|FG002|Overall Study|Protocol Violation|1|||
147226873|NCT01178073|531003711|FG000|Overall Study|Lost to Follow-up|2|||
147226874|NCT01178073|531003712|FG001|Overall Study|Lost to Follow-up|0|||
147226875|NCT01178073|531003713|FG002|Overall Study|Lost to Follow-up|3|||
147226876|NCT01178073|531003711|FG000|Overall Study|Physician Decision|14|||
147226877|NCT01178073|531003712|FG001|Overall Study|Physician Decision|10|||
147226878|NCT01178073|531003713|FG002|Overall Study|Physician Decision|10|||
147226879|NCT01178073|531003711|FG000|Overall Study|Withdrawal by Subject|10|||
147226880|NCT01178073|531003712|FG001|Overall Study|Withdrawal by Subject|6|||
147311202|NCT00366301|531307156|FG002|Overall Study|Withdrawal by Subject|1|||
147311203|NCT00366301|531307157|FG003|Overall Study|Withdrawal by Subject|1|||
147311204|NCT01372605|531307158|FG000|Overall Study|Death|1|||
147226881|NCT01178073|531003713|FG002|Overall Study|Withdrawal by Subject|8|||
147226882|NCT01178073|531003711|FG000|Overall Study|Missing Completion Status|1|||
147226883|NCT01178073|531003712|FG001|Overall Study|Missing Completion Status|0|||
147226884|NCT01178073|531003713|FG002|Overall Study|Missing Completion Status|0|||
147226885|NCT03497676|531003714|FG000|Cohort 1 Treatment Initiation to Week 16|Adverse Event|0|||
147226886|NCT03497676|531003715|FG001|Cohort 1 Treatment Initiation to Week 16|Adverse Event|1|||
147226887|NCT03497676|531003716|FG002|Cohort 1 Treatment Initiation to Week 16|Adverse Event|0|||
147226888|NCT03497676|531003717|FG003|Cohort 1 Treatment Initiation to Week 16|Adverse Event|0|||
147226889|NCT03497676|531003714|FG000|Cohort 1 Treatment Initiation to Week 16|Withdrawal by Subject|1|||
147226890|NCT03497676|531003715|FG001|Cohort 1 Treatment Initiation to Week 16|Withdrawal by Subject|1|||
147226891|NCT03497676|531003716|FG002|Cohort 1 Treatment Initiation to Week 16|Withdrawal by Subject|0|||
147226892|NCT03497676|531003717|FG003|Cohort 1 Treatment Initiation to Week 16|Withdrawal by Subject|0|||
147226893|NCT03497676|531003714|FG000|Cohort 1 Week 16 Through End of Cohort 1|Lost to Follow-up|1|||
147311205|NCT01372605|531307159|FG001|Overall Study|Death|2|||
147113789|NCT02642679|530579922|FG000|Overall Study|Physician Decision|1|||
147113790|NCT02642679|530579922|FG000|Overall Study|Physician Decision|1|||
147113791|NCT01112267|530579923|FG000|Overall Study|Adverse Event|24|||
147113792|NCT01112267|530579924|FG001|Overall Study|Adverse Event|6|||
147226894|NCT03497676|531003715|FG001|Cohort 1 Week 16 Through End of Cohort 1|Lost to Follow-up|1|||
147311206|NCT01372605|531307158|FG000|Overall Study|Lost to Follow-up|2|||
147311207|NCT01372605|531307159|FG001|Overall Study|Lost to Follow-up|1|||
147311208|NCT01372605|531307158|FG000|Overall Study|Withdrawal by Subject|4|||
147311209|NCT01372605|531307159|FG001|Overall Study|Withdrawal by Subject|7|||
147311210|NCT01372605|531307158|FG000|Overall Study|Moved|3|||
147311211|NCT01372605|531307159|FG001|Overall Study|Moved|0|||
147113793|NCT01112267|530579923|FG000|Overall Study|Withdrawal by Subject|3|||
147226895|NCT03497676|531003716|FG002|Cohort 1 Week 16 Through End of Cohort 1|Lost to Follow-up|0|||
147226896|NCT03497676|531003717|FG003|Cohort 1 Week 16 Through End of Cohort 1|Lost to Follow-up|0|||
147226897|NCT03497676|531003714|FG000|Cohort 1 Week 16 Through End of Cohort 1|Withdrawal by Subject|0|||
147226898|NCT03497676|531003715|FG001|Cohort 1 Week 16 Through End of Cohort 1|Withdrawal by Subject|1|||
147226899|NCT03497676|531003716|FG002|Cohort 1 Week 16 Through End of Cohort 1|Withdrawal by Subject|0|||
147226900|NCT03497676|531003717|FG003|Cohort 1 Week 16 Through End of Cohort 1|Withdrawal by Subject|0|||
147226901|NCT03497676|531003714|FG000|Cohort 2 Treatment Initiation to Week 24|Pregnancy|0|||
147226902|NCT03497676|531003715|FG001|Cohort 2 Treatment Initiation to Week 24|Pregnancy|0|||
147226903|NCT03497676|531003716|FG002|Cohort 2 Treatment Initiation to Week 24|Pregnancy|1|||
147226904|NCT03497676|531003717|FG003|Cohort 2 Treatment Initiation to Week 24|Pregnancy|0|||
147226905|NCT03497676|531003714|FG000|Cohort 2 Treatment Initiation to Week 24|Protocol Violation|0|||
147226906|NCT03497676|531003715|FG001|Cohort 2 Treatment Initiation to Week 24|Protocol Violation|0|||
147226907|NCT03497676|531003716|FG002|Cohort 2 Treatment Initiation to Week 24|Protocol Violation|1|||
147226908|NCT03497676|531003717|FG003|Cohort 2 Treatment Initiation to Week 24|Protocol Violation|0|||
147226909|NCT03497676|531003714|FG000|Cohort 2 Treatment Initiation to Week 24|Non-compliance with study treatment|0|||
147226910|NCT03497676|531003715|FG001|Cohort 2 Treatment Initiation to Week 24|Non-compliance with study treatment|0|||
147226911|NCT03497676|531003716|FG002|Cohort 2 Treatment Initiation to Week 24|Non-compliance with study treatment|1|||
147226912|NCT03497676|531003717|FG003|Cohort 2 Treatment Initiation to Week 24|Non-compliance with study treatment|0|||
147226913|NCT03497676|531003714|FG000|Cohort 2 Week 24 to Week 48|Lost to Follow-up|0|||
147226914|NCT03497676|531003715|FG001|Cohort 2 Week 24 to Week 48|Lost to Follow-up|0|||
147226915|NCT03497676|531003716|FG002|Cohort 2 Week 24 to Week 48|Lost to Follow-up|1|||
147226916|NCT03497676|531003717|FG003|Cohort 2 Week 24 to Week 48|Lost to Follow-up|0|||
147226917|NCT01226043|531003727|FG000|4-week Crossover Phase - Period 1|Protocol Violation|1|||
147226918|NCT01226043|531003728|FG001|4-week Crossover Phase - Period 1|Protocol Violation|2|||
147226919|NCT01226043|531003729|FG002|4-week Crossover Phase - Period 1|Protocol Violation|0|||
147226920|NCT01226043|531003730|FG003|4-week Crossover Phase - Period 1|Protocol Violation|0|||
147226921|NCT01226043|531003727|FG000|4-week Crossover Phase - Period 1|Lost to Follow-up|0|||
147226922|NCT01226043|531003728|FG001|4-week Crossover Phase - Period 1|Lost to Follow-up|1|||
147226923|NCT01226043|531003729|FG002|4-week Crossover Phase - Period 1|Lost to Follow-up|0|||
147226924|NCT01226043|531003730|FG003|4-week Crossover Phase - Period 1|Lost to Follow-up|0|||
147226925|NCT01226043|531003727|FG000|4-week Crossover Phase - Period 1|Withdrawal by Subject|2|||
147226926|NCT01226043|531003728|FG001|4-week Crossover Phase - Period 1|Withdrawal by Subject|0|||
147226927|NCT01226043|531003729|FG002|4-week Crossover Phase - Period 1|Withdrawal by Subject|0|||
147226928|NCT01226043|531003730|FG003|4-week Crossover Phase - Period 1|Withdrawal by Subject|0|||
147226929|NCT01226043|531003727|FG000|4-week Crossover Phase - Period 1|Physician Decision|0|||
147226930|NCT01226043|531003728|FG001|4-week Crossover Phase - Period 1|Physician Decision|6|||
147226931|NCT01226043|531003729|FG002|4-week Crossover Phase - Period 1|Physician Decision|0|||
147226932|NCT01226043|531003730|FG003|4-week Crossover Phase - Period 1|Physician Decision|0|||
147226933|NCT01226043|531003727|FG000|4-week Crossover Phase - Period 2|Withdrawal by Subject|0|||
147226934|NCT01226043|531003728|FG001|4-week Crossover Phase - Period 2|Withdrawal by Subject|1|||
147226935|NCT01226043|531003729|FG002|4-week Crossover Phase - Period 2|Withdrawal by Subject|0|||
147226936|NCT01226043|531003730|FG003|4-week Crossover Phase - Period 2|Withdrawal by Subject|0|||
147226937|NCT01226043|531003727|FG000|4-week Crossover Phase - Period 2|Physician Decision|4|||
147226938|NCT01226043|531003728|FG001|4-week Crossover Phase - Period 2|Physician Decision|5|||
147226939|NCT01226043|531003729|FG002|4-week Crossover Phase - Period 2|Physician Decision|0|||
147226940|NCT01226043|531003730|FG003|4-week Crossover Phase - Period 2|Physician Decision|0|||
147226941|NCT01226043|531003727|FG000|6-week Re-randomization Phase|Adverse Event|0|||
147311212|NCT01372605|531307158|FG000|Overall Study|Changed medical home|2|||
147311213|NCT01372605|531307159|FG001|Overall Study|Changed medical home|0|||
147311214|NCT01108510|531307160|FG000|Overall Study|Randomized but Not Treated|5|||
147311215|NCT01108510|531307161|FG001|Overall Study|Randomized but Not Treated|1|||
147561889|NCT02079532|532213906|FG000|Overall Study|Adverse Event|7|||
147226942|NCT01226043|531003728|FG001|6-week Re-randomization Phase|Adverse Event|0|||
147226943|NCT01226043|531003729|FG002|6-week Re-randomization Phase|Adverse Event|1|||
147311216|NCT01108510|531307160|FG000|Overall Study|Joined Another Gilead-sponsored Study|186|||
147113794|NCT01112267|530579924|FG001|Overall Study|Withdrawal by Subject|5|||
147226944|NCT01226043|531003730|FG003|6-week Re-randomization Phase|Adverse Event|1|||
147561890|NCT02079532|532213906|FG000|Overall Study|Additional or changed therapy|2|||
147561891|NCT02079532|532213906|FG000|Overall Study|Lack of Efficacy|9|||
147561892|NCT02079532|532213906|FG000|Overall Study|Protocol Violation|3|||
147561893|NCT02079532|532213906|FG000|Overall Study|Withdrawal by Subject|1|||
147561894|NCT02079532|532213906|FG000|Overall Study|Administrative problems|1|||
147226945|NCT01226043|531003727|FG000|6-week Re-randomization Phase|Protocol Violation|0|||
147226946|NCT01226043|531003728|FG001|6-week Re-randomization Phase|Protocol Violation|0|||
147226947|NCT01226043|531003729|FG002|6-week Re-randomization Phase|Protocol Violation|1|||
147226948|NCT01226043|531003730|FG003|6-week Re-randomization Phase|Protocol Violation|1|||
147226949|NCT01226043|531003727|FG000|6-week Re-randomization Phase|Lost to Follow-up|0|||
147226950|NCT01226043|531003728|FG001|6-week Re-randomization Phase|Lost to Follow-up|0|||
147226951|NCT01226043|531003729|FG002|6-week Re-randomization Phase|Lost to Follow-up|1|||
147226952|NCT01226043|531003730|FG003|6-week Re-randomization Phase|Lost to Follow-up|3|||
147113795|NCT01112267|530579923|FG000|Overall Study|Protocol Violation|5|||
147113796|NCT01112267|530579924|FG001|Overall Study|Protocol Violation|3|||
147113797|NCT01112267|530579923|FG000|Overall Study|Participants not compliant|1|||
147113798|NCT01112267|530579924|FG001|Overall Study|Participants not compliant|2|||
147113799|NCT01112267|530579923|FG000|Overall Study|Participants not receive any study drug|1|||
147113800|NCT01112267|530579924|FG001|Overall Study|Participants not receive any study drug|2|||
147113801|NCT00003456|530579925|FG000|Overall Study|Not evaluable|8|||
147113802|NCT00134719|530579933|FG000|Primary Vaccination Phase|Adverse Event|4|||
147113803|NCT00134719|530579934|FG001|Primary Vaccination Phase|Adverse Event|0|||
147113804|NCT00134719|530579935|FG002|Primary Vaccination Phase|Adverse Event|0|||
147113805|NCT00134719|530579933|FG000|Primary Vaccination Phase|Protocol Violation|1|||
147226953|NCT01226043|531003727|FG000|6-week Re-randomization Phase|Withdrawal by Subject|0|||
147226954|NCT01226043|531003728|FG001|6-week Re-randomization Phase|Withdrawal by Subject|0|||
147226955|NCT01226043|531003729|FG002|6-week Re-randomization Phase|Withdrawal by Subject|1|||
147226956|NCT01226043|531003730|FG003|6-week Re-randomization Phase|Withdrawal by Subject|3|||
147226957|NCT01226043|531003727|FG000|6-week Re-randomization Phase|Physician Decision|0|||
147226958|NCT01226043|531003728|FG001|6-week Re-randomization Phase|Physician Decision|0|||
147226959|NCT01226043|531003729|FG002|6-week Re-randomization Phase|Physician Decision|3|||
147226960|NCT01226043|531003730|FG003|6-week Re-randomization Phase|Physician Decision|2|||
147226961|NCT01226043|531003727|FG000|6-week Re-randomization Phase|completed in error|0|||
147226962|NCT01226043|531003728|FG001|6-week Re-randomization Phase|completed in error|0|||
147226963|NCT01226043|531003729|FG002|6-week Re-randomization Phase|completed in error|0|||
147226964|NCT01226043|531003730|FG003|6-week Re-randomization Phase|completed in error|1|||
147226965|NCT01226043|531003727|FG000|30-week Observational Phase|Adverse Event|0|||
147226966|NCT01226043|531003728|FG001|30-week Observational Phase|Adverse Event|0|||
147226967|NCT01226043|531003729|FG002|30-week Observational Phase|Adverse Event|1|||
147226968|NCT01226043|531003730|FG003|30-week Observational Phase|Adverse Event|1|||
147226969|NCT01226043|531003727|FG000|30-week Observational Phase|Protocol Violation|0|||
147226970|NCT01226043|531003728|FG001|30-week Observational Phase|Protocol Violation|0|||
147226971|NCT01226043|531003729|FG002|30-week Observational Phase|Protocol Violation|0|||
147226972|NCT01226043|531003730|FG003|30-week Observational Phase|Protocol Violation|1|||
147226973|NCT01226043|531003727|FG000|30-week Observational Phase|Lost to Follow-up|0|||
147226974|NCT01226043|531003728|FG001|30-week Observational Phase|Lost to Follow-up|0|||
147226975|NCT01226043|531003729|FG002|30-week Observational Phase|Lost to Follow-up|2|||
147226976|NCT01226043|531003730|FG003|30-week Observational Phase|Lost to Follow-up|2|||
147226977|NCT01226043|531003727|FG000|30-week Observational Phase|Withdrawal by Subject|0|||
147226978|NCT01226043|531003728|FG001|30-week Observational Phase|Withdrawal by Subject|0|||
147226979|NCT01226043|531003729|FG002|30-week Observational Phase|Withdrawal by Subject|1|||
147226980|NCT01226043|531003730|FG003|30-week Observational Phase|Withdrawal by Subject|7|||
147226981|NCT01226043|531003727|FG000|30-week Observational Phase|Physician Decision|0|||
147226982|NCT01226043|531003728|FG001|30-week Observational Phase|Physician Decision|0|||
147226983|NCT01226043|531003729|FG002|30-week Observational Phase|Physician Decision|2|||
147226984|NCT01226043|531003730|FG003|30-week Observational Phase|Physician Decision|2|||
147226985|NCT02204007|531003731|FG000|Overall Study|Surgery Canceled|1|||
147226986|NCT02204007|531003732|FG001|Overall Study|Surgery Canceled|1|||
147226987|NCT01702571|531003733|FG000|Overall Study|Death|1067|||
147226988|NCT01702571|531003734|FG001|Overall Study|Death|76|||
147226989|NCT01702571|531003733|FG000|Overall Study|Lost to Follow-up|144|||
147226990|NCT01702571|531003734|FG001|Overall Study|Lost to Follow-up|10|||
147561895|NCT02079532|532213906|FG000|Overall Study|Inclusion into ReFIRST|3|||
147561896|NCT02079532|532213906|FG000|Overall Study|Other|3|||
147113806|NCT00134719|530579934|FG001|Primary Vaccination Phase|Protocol Violation|0|||
147226991|NCT01702571|531003733|FG000|Overall Study|Adverse Event/Unacceptable Toxicity|4|||
147226992|NCT01702571|531003734|FG001|Overall Study|Adverse Event/Unacceptable Toxicity|0|||
147226993|NCT01702571|531003733|FG000|Overall Study|Investigator Decision|5|||
147226994|NCT01702571|531003734|FG001|Overall Study|Investigator Decision|0|||
147561897|NCT01432171|532213907|FG000|Overall Study|Death|1|||
147561898|NCT01432171|532213908|FG001|Overall Study|Death|2|||
147561899|NCT01432171|532213907|FG000|Overall Study|Lost to Follow-up|6|||
147561900|NCT01432171|532213908|FG001|Overall Study|Lost to Follow-up|5|||
147561901|NCT01432171|532213907|FG000|Overall Study|Withdrawal by Subject|3|||
147561902|NCT01432171|532213908|FG001|Overall Study|Withdrawal by Subject|1|||
147561903|NCT01432171|532213907|FG000|Overall Study|Noncompliance|2|||
147561904|NCT01432171|532213908|FG001|Overall Study|Noncompliance|3|||
147561905|NCT01432171|532213907|FG000|Overall Study|Insurance denial trial coverage|1|||
147561906|NCT01432171|532213908|FG001|Overall Study|Insurance denial trial coverage|0|||
147561907|NCT01432171|532213907|FG000|Overall Study|Patient moved to palliative care|1|||
147561908|NCT01432171|532213908|FG001|Overall Study|Patient moved to palliative care|0|||
147113807|NCT00134719|530579935|FG002|Primary Vaccination Phase|Protocol Violation|0|||
147113808|NCT00134719|530579933|FG000|Primary Vaccination Phase|Withdrawal by Subject|2|||
147113809|NCT00134719|530579934|FG001|Primary Vaccination Phase|Withdrawal by Subject|3|||
147113810|NCT00134719|530579935|FG002|Primary Vaccination Phase|Withdrawal by Subject|2|||
147113811|NCT00134719|530579933|FG000|Primary Vaccination Phase|Lost to Follow-up|7|||
147113812|NCT00134719|530579934|FG001|Primary Vaccination Phase|Lost to Follow-up|3|||
147113813|NCT00134719|530579935|FG002|Primary Vaccination Phase|Lost to Follow-up|3|||
147226995|NCT01702571|531003733|FG000|Overall Study|Not Classifiable|1|||
147226996|NCT01702571|531003734|FG001|Overall Study|Not Classifiable|0|||
147226997|NCT01702571|531003733|FG000|Overall Study|On Study Treatment At Lplv/Cohort 1|93|||
147226998|NCT01702571|531003734|FG001|Overall Study|On Study Treatment At Lplv/Cohort 1|0|||
147226999|NCT01702571|531003733|FG000|Overall Study|On Study Treatment At Lplv/Cohort 2|0|||
147227000|NCT01702571|531003734|FG001|Overall Study|On Study Treatment At Lplv/Cohort 2|1|||
147227001|NCT01702571|531003733|FG000|Overall Study|Progressive Disease|3|||
147227002|NCT01702571|531003734|FG001|Overall Study|Progressive Disease|0|||
147227003|NCT01702571|531003733|FG000|Overall Study|Protocol Violation|2|||
147227004|NCT01702571|531003734|FG001|Overall Study|Protocol Violation|0|||
147227005|NCT01702571|531003733|FG000|Overall Study|Safety FU Done < 3 Months Prior To CCOD|9|||
147227006|NCT01702571|531003734|FG001|Overall Study|Safety FU Done < 3 Months Prior To CCOD|1|||
147227007|NCT01702571|531003733|FG000|Overall Study|Termination By Sponsor|4|||
147227008|NCT01702571|531003734|FG001|Overall Study|Termination By Sponsor|0|||
147227009|NCT01702571|531003733|FG000|Overall Study|Withdrawal by Subject|177|||
147227010|NCT01702571|531003734|FG001|Overall Study|Withdrawal by Subject|29|||
147227011|NCT00910988|531003735|FG000|Overall Study|Lost to Follow-up|2|||
147227012|NCT00910988|531003736|FG001|Overall Study|Lost to Follow-up|4|||
147227013|NCT00910988|531003737|FG002|Overall Study|Lost to Follow-up|3|||
147227014|NCT00910988|531003738|FG003|Overall Study|Lost to Follow-up|0|||
147227015|NCT01977937|531003741|FG000|Overall Study|Withdrawal by Subject|2|||
147227016|NCT01977937|531003742|FG001|Overall Study|Withdrawal by Subject|1|||
147227017|NCT01977937|531003741|FG000|Overall Study|Adverse Event|1|||
147227018|NCT01977937|531003742|FG001|Overall Study|Adverse Event|0|||
147227019|NCT01977937|531003741|FG000|Overall Study|Physician Decision|0|||
147227020|NCT01977937|531003742|FG001|Overall Study|Physician Decision|1|||
147227021|NCT03004443|531003743|FG000|Overall Study|Pregnancy|0|||
147227022|NCT03004443|531003744|FG001|Overall Study|Pregnancy|1|||
147227023|NCT00828854|531003748|FG000|Overall Study|Disease Progression|17|||
147227024|NCT00828854|531003748|FG000|Overall Study|Adverse Event|9|||
147227025|NCT00828854|531003748|FG000|Overall Study|Reason not Specified|1|||
147227026|NCT00915356|531003749|FG000|Overall Study|Withdrawal by Subject|1|||
147227027|NCT00915356|531003750|FG001|Overall Study|Withdrawal by Subject|0|||
147227028|NCT00915356|531003751|FG002|Overall Study|Withdrawal by Subject|0|||
147227029|NCT00915356|531003752|FG003|Overall Study|Withdrawal by Subject|0|||
147227030|NCT00915356|531003753|FG004|Overall Study|Withdrawal by Subject|0|||
147227031|NCT03911843|531003764|FG000|Overall Study|Adverse Event|2|||
147227032|NCT03911843|531003765|FG001|Overall Study|Adverse Event|0|||
147227033|NCT03911843|531003764|FG000|Overall Study|Protocol Violation|2|||
147311217|NCT01108510|531307161|FG001|Overall Study|Joined Another Gilead-sponsored Study|195|||
147311218|NCT01108510|531307160|FG000|Overall Study|Adverse Event|26|||
147311219|NCT01108510|531307161|FG001|Overall Study|Adverse Event|19|||
147311220|NCT01108510|531307160|FG000|Overall Study|Lost to Follow-up|20|||
147561909|NCT01519661|532215566|FG000|Overall Study|Protocol deviation|6|||
147561910|NCT01519661|532215566|FG000|Overall Study|Lost to Follow-up|3|||
147561911|NCT01519661|532215566|FG000|Overall Study|Withdrawal by Subject|17|||
147113814|NCT00134719|530579933|FG000|Fourth Dose Vaccination Phase|Lost to Follow-up|1|||
147227034|NCT03911843|531003765|FG001|Overall Study|Protocol Violation|0|||
147561912|NCT01519661|532215566|FG000|Overall Study|Lack of Efficacy|6|||
147561913|NCT01519661|532215566|FG000|Overall Study|Adverse Event|29|||
147561914|NCT01139047|532215567|FG000|Overall Study|Withdrawal by Subject|1|||
147561915|NCT00420303|532215568|FG000|Overall Study|Serious Adverse Event|1|||
147561916|NCT00420303|532215569|FG001|Overall Study|Serious Adverse Event|0|||
147561917|NCT00420303|532215568|FG000|Overall Study|Lack of Efficacy|0|||
147561918|NCT00420303|532215569|FG001|Overall Study|Lack of Efficacy|3|||
147227035|NCT03911843|531003764|FG000|Overall Study|Lost to Follow-up|0|||
147227036|NCT03911843|531003765|FG001|Overall Study|Lost to Follow-up|1|||
147227037|NCT02819518|531003766|FG000|Overall Study|Death|9|||
147227038|NCT02819518|531003767|FG001|Overall Study|Death|12|||
147227039|NCT02819518|531003768|FG002|Overall Study|Death|9|||
147113815|NCT00134719|530579934|FG001|Fourth Dose Vaccination Phase|Lost to Follow-up|3|||
147113816|NCT00134719|530579935|FG002|Fourth Dose Vaccination Phase|Lost to Follow-up|1|||
147113817|NCT00134719|530579933|FG000|Fourth Dose Vaccination Phase|Mother just delivered a new baby|1|||
147113818|NCT00134719|530579934|FG001|Fourth Dose Vaccination Phase|Mother just delivered a new baby|0|||
147113819|NCT00134719|530579935|FG002|Fourth Dose Vaccination Phase|Mother just delivered a new baby|0|||
147113820|NCT01807520|530579936|FG000|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0|||
147113821|NCT01807520|530579937|FG001|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|1|||
147113822|NCT01807520|530579938|FG002|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|3|||
147113823|NCT01807520|530579939|FG003|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0|||
147113824|NCT01807520|530579940|FG004|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0|||
147113825|NCT01807520|530579941|FG005|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0|||
147113826|NCT01807520|530579942|FG006|Treatment Period 1 (0-16 Weeks)|Withdrawal by Subject|0|||
147113827|NCT01807520|530579936|FG000|Treatment Period 1 (0-16 Weeks)|Protocol deviation|1|||
147113828|NCT01807520|530579937|FG001|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0|||
147113829|NCT01807520|530579938|FG002|Treatment Period 1 (0-16 Weeks)|Protocol deviation|1|||
147113830|NCT01807520|530579939|FG003|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0|||
147113831|NCT01807520|530579940|FG004|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0|||
147113832|NCT01807520|530579941|FG005|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0|||
147113833|NCT01807520|530579942|FG006|Treatment Period 1 (0-16 Weeks)|Protocol deviation|0|||
147113834|NCT01807520|530579936|FG000|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
147113835|NCT01807520|530579937|FG001|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
147113836|NCT01807520|530579938|FG002|Treatment Period 1 (0-16 Weeks)|Physician Decision|1|||
147113837|NCT01807520|530579939|FG003|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
147113838|NCT01807520|530579940|FG004|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
147113839|NCT01807520|530579941|FG005|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
147113840|NCT01807520|530579942|FG006|Treatment Period 1 (0-16 Weeks)|Physician Decision|0|||
147113841|NCT01807520|530579936|FG000|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|1|||
147113842|NCT01807520|530579937|FG001|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
147113843|NCT01807520|530579938|FG002|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
147113844|NCT01807520|530579939|FG003|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
147113845|NCT01807520|530579940|FG004|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
147113846|NCT01807520|530579941|FG005|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
147227040|NCT02819518|531003769|FG003|Overall Study|Death|475|||
147227041|NCT02819518|531003770|FG004|Overall Study|Death|244|||
147227042|NCT02819518|531003766|FG000|Overall Study|Withdrawal by Subject|0|||
147227043|NCT02819518|531003767|FG001|Overall Study|Withdrawal by Subject|0|||
147227044|NCT02819518|531003768|FG002|Overall Study|Withdrawal by Subject|0|||
147227045|NCT02819518|531003769|FG003|Overall Study|Withdrawal by Subject|25|||
147561919|NCT00420303|532215568|FG000|Overall Study|Physician Decision|0|||
147561920|NCT00420303|532215569|FG001|Overall Study|Physician Decision|1|||
147561921|NCT00745420|532215570|FG000|Overall Study|Ineligible|1|||
147561922|NCT01941095|532215571|FG000|Overall Study|Insufficient therapeutic response|13|||
147561923|NCT01941095|532215571|FG000|Overall Study|Anaphylaxis or serious hypersensitivity|2|||
147561924|NCT01941095|532215571|FG000|Overall Study|Adverse Event|11|||
147561925|NCT01941095|532215571|FG000|Overall Study|Physician Decision|3|||
147561926|NCT01941095|532215571|FG000|Overall Study|Withdrawal by Subject|17|||
147227046|NCT02819518|531003770|FG004|Overall Study|Withdrawal by Subject|8|||
147227047|NCT02819518|531003766|FG000|Overall Study|Lost to Follow-up|0|||
147227048|NCT02819518|531003767|FG001|Overall Study|Lost to Follow-up|0|||
147227049|NCT02819518|531003768|FG002|Overall Study|Lost to Follow-up|0|||
147227050|NCT02819518|531003769|FG003|Overall Study|Lost to Follow-up|0|||
147227051|NCT02819518|531003770|FG004|Overall Study|Lost to Follow-up|1|||
147227052|NCT02819518|531003766|FG000|Overall Study|Sponsor Decision|1|||
147227053|NCT02819518|531003767|FG001|Overall Study|Sponsor Decision|1|||
147227054|NCT02819518|531003768|FG002|Overall Study|Sponsor Decision|0|||
147227055|NCT02819518|531003769|FG003|Overall Study|Sponsor Decision|34|||
147227056|NCT02819518|531003770|FG004|Overall Study|Sponsor Decision|17|||
147227057|NCT02819518|531003766|FG000|Overall Study|Transferred to extension study|1|||
147227058|NCT02819518|531003767|FG001|Overall Study|Transferred to extension study|1|||
147561927|NCT01941095|532215571|FG000|Overall Study|Lost to Follow-up|10|||
147561928|NCT00088829|532215579|FG000|Overall Study|PI left institution and study was close|22|||
147561929|NCT01475838|532215583|FG000|Randomized Phase|Randomized but Not Treated|0|||
147113847|NCT01807520|530579942|FG006|Treatment Period 1 (0-16 Weeks)|Lost to Follow-up|0|||
147113848|NCT01807520|530579936|FG000|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
147227059|NCT02819518|531003768|FG002|Overall Study|Transferred to extension study|1|||
147561930|NCT01475838|532215584|FG001|Randomized Phase|Randomized but Not Treated|5|||
147561931|NCT01475838|532215583|FG000|Randomized Phase|Adverse Event|6|||
147227060|NCT02819518|531003769|FG003|Overall Study|Transferred to extension study|32|||
147444347|NCT00530894|531792573|FG001|Overall Study|Alive and censored prior to 1 year|0|||
147561932|NCT01475838|532215584|FG001|Randomized Phase|Adverse Event|1|||
147561933|NCT01475838|532215583|FG000|Randomized Phase|Pregnancy|0|||
147561934|NCT01475838|532215584|FG001|Randomized Phase|Pregnancy|1|||
147113849|NCT01807520|530579937|FG001|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
147113850|NCT01807520|530579938|FG002|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|2|||
147113851|NCT01807520|530579939|FG003|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
147113852|NCT01807520|530579940|FG004|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
147113853|NCT01807520|530579941|FG005|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
147561935|NCT01475838|532215583|FG000|Randomized Phase|Investigators Discretion|1|||
147561936|NCT01475838|532215584|FG001|Randomized Phase|Investigators Discretion|2|||
147561937|NCT01475838|532215583|FG000|Randomized Phase|Withdrew Consent|10|||
147561938|NCT01475838|532215584|FG001|Randomized Phase|Withdrew Consent|14|||
147561939|NCT01475838|532215583|FG000|Randomized Phase|Lost to Follow-up|3|||
147561940|NCT01475838|532215584|FG001|Randomized Phase|Lost to Follow-up|4|||
147561941|NCT01475838|532215583|FG000|Randomized Phase|Participant Noncompliance|1|||
147561942|NCT01475838|532215584|FG001|Randomized Phase|Participant Noncompliance|5|||
147561943|NCT01475838|532215583|FG000|Randomized Phase|Protocol Violation|9|||
147561944|NCT01475838|532215584|FG001|Randomized Phase|Protocol Violation|4|||
147561945|NCT01475838|532215583|FG000|Extension Phase|Participant Noncompliance|1|||
147561946|NCT01475838|532215584|FG001|Extension Phase|Participant Noncompliance|0|||
147561947|NCT00048568|532215590|FG000|Double-Blind Period Days 1 to 169|Adverse Event|11|||
147561948|NCT00048568|532215591|FG001|Double-Blind Period Days 1 to 169|Adverse Event|3|||
147561949|NCT00048568|532215592|FG002|Double-Blind Period Days 1 to 169|Adverse Event|0|||
147561950|NCT00048568|532215590|FG000|Double-Blind Period Days 1 to 169|Lack of Efficacy|11|||
147561951|NCT00048568|532215591|FG001|Double-Blind Period Days 1 to 169|Lack of Efficacy|33|||
147561952|NCT00048568|532215592|FG002|Double-Blind Period Days 1 to 169|Lack of Efficacy|0|||
147561953|NCT00048568|532215590|FG000|Double-Blind Period Days 1 to 169|Lost to Follow-up|1|||
147561954|NCT00048568|532215591|FG001|Double-Blind Period Days 1 to 169|Lost to Follow-up|1|||
147561955|NCT00048568|532215592|FG002|Double-Blind Period Days 1 to 169|Lost to Follow-up|0|||
147561956|NCT00048568|532215590|FG000|Double-Blind Period Days 1 to 169|Withdrawal by Subject|7|||
147561957|NCT00048568|532215591|FG001|Double-Blind Period Days 1 to 169|Withdrawal by Subject|4|||
147113854|NCT01807520|530579942|FG006|Treatment Period 1 (0-16 Weeks)|Lack of Efficacy|0|||
147113855|NCT01807520|530579936|FG000|Treatment Period 1 (0-16 Weeks)|Adverse Event|2|||
147113856|NCT01807520|530579937|FG001|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
147227061|NCT02819518|531003770|FG004|Overall Study|Transferred to extension study|11|||
147227062|NCT00880165|531003771|FG000|Overall Study|Withdrawal by Subject|27|||
147227063|NCT00880165|531003772|FG001|Overall Study|Withdrawal by Subject|23|||
147227064|NCT00880165|531003771|FG000|Overall Study|Not diagnosed with OSA|14|||
147227065|NCT00880165|531003772|FG001|Overall Study|Not diagnosed with OSA|8|||
147227066|NCT00880165|531003771|FG000|Overall Study|Required BIPAP or oxygen treatment|12|||
147227067|NCT00880165|531003772|FG001|Overall Study|Required BIPAP or oxygen treatment|4|||
147227068|NCT00880165|531003771|FG000|Overall Study|Lost to follow|9|||
147227069|NCT00880165|531003772|FG001|Overall Study|Lost to follow|15|||
147227070|NCT01907100|531003773|FG000|Overall Study|PD based on modified RECIST criteria|31|||
147227071|NCT01907100|531003774|FG001|Overall Study|PD based on modified RECIST criteria|32|||
147227072|NCT01907100|531003775|FG002|Overall Study|PD based on modified RECIST criteria|95|||
147227073|NCT01907100|531003776|FG003|Overall Study|PD based on modified RECIST criteria|92|||
147227074|NCT01907100|531003773|FG000|Overall Study|Withdrawal by Subject|2|||
147227075|NCT01907100|531003774|FG001|Overall Study|Withdrawal by Subject|5|||
147227076|NCT01907100|531003775|FG002|Overall Study|Withdrawal by Subject|10|||
147227077|NCT01907100|531003776|FG003|Overall Study|Withdrawal by Subject|13|||
147227078|NCT01907100|531003773|FG000|Overall Study|Protocol Violation|0|||
147227079|NCT01907100|531003774|FG001|Overall Study|Protocol Violation|0|||
147227080|NCT01907100|531003775|FG002|Overall Study|Protocol Violation|1|||
147227081|NCT01907100|531003776|FG003|Overall Study|Protocol Violation|1|||
147227082|NCT01907100|531003773|FG000|Overall Study|Lost to Follow-up|0|||
147227083|NCT01907100|531003774|FG001|Overall Study|Lost to Follow-up|0|||
147227084|NCT01907100|531003775|FG002|Overall Study|Lost to Follow-up|0|||
147227085|NCT01907100|531003776|FG003|Overall Study|Lost to Follow-up|1|||
147227086|NCT01907100|531003773|FG000|Overall Study|Not treated|2|||
147561958|NCT00048568|532215592|FG002|Double-Blind Period Days 1 to 169|Withdrawal by Subject|0|||
147561959|NCT00048568|532215590|FG000|Double-Blind Period Days 1 to 169|Unknown Reasons|2|||
147561960|NCT00048568|532215591|FG001|Double-Blind Period Days 1 to 169|Unknown Reasons|4|||
147561961|NCT00048568|532215592|FG002|Double-Blind Period Days 1 to 169|Unknown Reasons|0|||
147561962|NCT00048568|532215590|FG000|Double-Blind Period Days 170 to 365|Death|1|||
147561963|NCT00048568|532215591|FG001|Double-Blind Period Days 170 to 365|Death|1|||
147561964|NCT00048568|532215592|FG002|Double-Blind Period Days 170 to 365|Death|0|||
147561965|NCT00048568|532215590|FG000|Double-Blind Period Days 170 to 365|Adverse Event|7|||
147561966|NCT00048568|532215591|FG001|Double-Blind Period Days 170 to 365|Adverse Event|1|||
147113857|NCT01807520|530579938|FG002|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
147227087|NCT01907100|531003774|FG001|Overall Study|Not treated|0|||
147227088|NCT01907100|531003775|FG002|Overall Study|Not treated|1|||
147227089|NCT01907100|531003776|FG003|Overall Study|Not treated|2|||
147311221|NCT01108510|531307161|FG001|Overall Study|Lost to Follow-up|17|||
147561967|NCT00048568|532215592|FG002|Double-Blind Period Days 170 to 365|Adverse Event|0|||
147561968|NCT00048568|532215590|FG000|Double-Blind Period Days 170 to 365|Lack of Efficacy|2|||
147311222|NCT01108510|531307160|FG000|Overall Study|Withdrew Consent|21|||
147311223|NCT01108510|531307161|FG001|Overall Study|Withdrew Consent|15|||
147311224|NCT01108510|531307160|FG000|Overall Study|Investigator's Discretion|12|||
147311225|NCT01108510|531307161|FG001|Overall Study|Investigator's Discretion|10|||
147311226|NCT01108510|531307160|FG000|Overall Study|Participant Noncompliance|5|||
147311227|NCT01108510|531307161|FG001|Overall Study|Participant Noncompliance|7|||
147311228|NCT01108510|531307160|FG000|Overall Study|Lack of Efficacy|3|||
147311229|NCT01108510|531307161|FG001|Overall Study|Lack of Efficacy|0|||
147311230|NCT01108510|531307160|FG000|Overall Study|Pregnancy|0|||
147311231|NCT01108510|531307161|FG001|Overall Study|Pregnancy|3|||
147311232|NCT01108510|531307160|FG000|Overall Study|Death|1|||
147311233|NCT01108510|531307161|FG001|Overall Study|Death|1|||
147311234|NCT00210119|531307162|FG000|Overall Study|Protocol Violation|1|||
147311235|NCT00210119|531307162|FG000|Overall Study|Withdrawal by Subject|1|||
147311236|NCT00951509|531307163|FG000|Overall Study|Withdrawal by Subject|2|||
147311237|NCT01830881|531307165|FG000|Overall Study|Changed decision to have an abortion|0|||
147561969|NCT00048568|532215591|FG001|Double-Blind Period Days 170 to 365|Lack of Efficacy|7|||
147561970|NCT00048568|532215592|FG002|Double-Blind Period Days 170 to 365|Lack of Efficacy|0|||
147561971|NCT00048568|532215590|FG000|Double-Blind Period Days 170 to 365|Withdrawal by Subject|3|||
147113858|NCT01807520|530579939|FG003|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
147113859|NCT01807520|530579940|FG004|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
147113860|NCT01807520|530579941|FG005|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
147113861|NCT01807520|530579942|FG006|Treatment Period 1 (0-16 Weeks)|Adverse Event|0|||
147113862|NCT01807520|530579936|FG000|Treatment Period 2 (16-132 Weeks)|Study terminated|7|||
147227090|NCT01907100|531003773|FG000|Overall Study|Other than reasons specified|1|||
147227091|NCT01907100|531003774|FG001|Overall Study|Other than reasons specified|0|||
147227092|NCT01907100|531003775|FG002|Overall Study|Other than reasons specified|10|||
147227093|NCT01907100|531003776|FG003|Overall Study|Other than reasons specified|6|||
147227094|NCT01907100|531003773|FG000|Overall Study|Adverse event (AE)|6|||
147227095|NCT01907100|531003774|FG001|Overall Study|Adverse event (AE)|3|||
147227096|NCT01907100|531003775|FG002|Overall Study|Adverse event (AE)|22|||
147311238|NCT01830881|531307166|FG001|Overall Study|Changed decision to have an abortion|1|||
147311239|NCT03125941|531307167|FG000|Overall Study|did not receive intervention|1|||
147311240|NCT03125941|531307168|FG001|Overall Study|did not receive intervention|2|||
147311241|NCT00582491|531307169|FG000|Overall Study|Withdrawal by Subject|1|||
147311242|NCT00582491|531307170|FG001|Overall Study|Withdrawal by Subject|0|||
147311243|NCT01193582|531307171|FG000|Vaccination Series|Withdrawal by Subject|11|||
147311244|NCT01193582|531307172|FG001|Vaccination Series|Withdrawal by Subject|13|||
147311245|NCT01193582|531307173|FG002|Vaccination Series|Withdrawal by Subject|8|||
147311246|NCT01193582|531307174|FG003|Vaccination Series|Withdrawal by Subject|3|||
147311247|NCT01193582|531307171|FG000|12 Month Follow-up|Death|0|||
147311248|NCT01193582|531307172|FG001|12 Month Follow-up|Death|0|||
147311249|NCT01193582|531307173|FG002|12 Month Follow-up|Death|1|||
147311250|NCT01193582|531307174|FG003|12 Month Follow-up|Death|0|||
147311251|NCT01193582|531307171|FG000|12 Month Follow-up|Withdrawal by Subject|6|||
147311252|NCT01193582|531307172|FG001|12 Month Follow-up|Withdrawal by Subject|0|||
147311253|NCT01193582|531307173|FG002|12 Month Follow-up|Withdrawal by Subject|3|||
147311254|NCT01193582|531307174|FG003|12 Month Follow-up|Withdrawal by Subject|11|||
147311255|NCT01425632|531307175|FG000|Overall Study|Adverse Event|0|||
147311256|NCT01425632|531307176|FG001|Overall Study|Adverse Event|1|||
147311257|NCT01425632|531307177|FG002|Overall Study|Adverse Event|1|||
147311258|NCT01425632|531307175|FG000|Overall Study|Physician Decision|1|||
147311259|NCT01425632|531307176|FG001|Overall Study|Physician Decision|0|||
147561972|NCT00048568|532215591|FG001|Double-Blind Period Days 170 to 365|Withdrawal by Subject|1|||
147561973|NCT00048568|532215592|FG002|Double-Blind Period Days 170 to 365|Withdrawal by Subject|0|||
147561974|NCT00048568|532215590|FG000|Double-Blind Period Days 170 to 365|Poor/Non-Compliance|0|||
147227097|NCT01907100|531003776|FG003|Overall Study|Adverse event (AE)|23|||
147227098|NCT01907100|531003773|FG000|Overall Study|Worsening/AE underlying cancer disease|0|||
147227099|NCT01907100|531003774|FG001|Overall Study|Worsening/AE underlying cancer disease|0|||
147227100|NCT01907100|531003775|FG002|Overall Study|Worsening/AE underlying cancer disease|8|||
147227101|NCT01907100|531003776|FG003|Overall Study|Worsening/AE underlying cancer disease|8|||
147227102|NCT01758289|531003777|FG000|Overall Study|Premature Study Termination|44|||
147227103|NCT01758289|531003777|FG000|Overall Study|Adverse Event|9|||
147227104|NCT00667602|531003780|FG000|Overall Study|Withdrawal by Subject|4|||
147227105|NCT00667602|531003781|FG001|Overall Study|Withdrawal by Subject|9|||
147227106|NCT00667602|531003782|FG002|Overall Study|Withdrawal by Subject|10|||
147227107|NCT00667602|531003780|FG000|Overall Study|Lost to Follow-up|4|||
147227108|NCT00667602|531003781|FG001|Overall Study|Lost to Follow-up|5|||
147227109|NCT00667602|531003782|FG002|Overall Study|Lost to Follow-up|6|||
147311260|NCT01425632|531307177|FG002|Overall Study|Physician Decision|0|||
147227110|NCT00667602|531003780|FG000|Overall Study|Administrative reason|0|||
147311261|NCT01425632|531307175|FG000|Overall Study|Protocol Violation|0|||
147311262|NCT01425632|531307176|FG001|Overall Study|Protocol Violation|0|||
147311263|NCT01425632|531307177|FG002|Overall Study|Protocol Violation|2|||
147311264|NCT01425632|531307175|FG000|Overall Study|Withdrawal by Subject|0|||
147561975|NCT00048568|532215591|FG001|Double-Blind Period Days 170 to 365|Poor/Non-Compliance|1|||
147561976|NCT00048568|532215592|FG002|Double-Blind Period Days 170 to 365|Poor/Non-Compliance|0|||
147561977|NCT00048568|532215590|FG000|Double-Blind Period Days 170 to 365|Pregnancy|2|||
147561978|NCT00048568|532215591|FG001|Double-Blind Period Days 170 to 365|Pregnancy|0|||
147561979|NCT00048568|532215592|FG002|Double-Blind Period Days 170 to 365|Pregnancy|0|||
147561980|NCT00048568|532215590|FG000|Double-Blind Period Days 170 to 365|No Longer Met Study Criteria|1|||
147561981|NCT00048568|532215591|FG001|Double-Blind Period Days 170 to 365|No Longer Met Study Criteria|1|||
147561982|NCT00048568|532215592|FG002|Double-Blind Period Days 170 to 365|No Longer Met Study Criteria|0|||
147561983|NCT00048568|532215590|FG000|Open-Label Period|Death|0|||
147561984|NCT00048568|532215591|FG001|Open-Label Period|Death|0|||
147561985|NCT00048568|532215592|FG002|Open-Label Period|Death|13|||
147561986|NCT00048568|532215590|FG000|Open-Label Period|Adverse Event|0|||
147561987|NCT00048568|532215591|FG001|Open-Label Period|Adverse Event|0|||
147561988|NCT00048568|532215592|FG002|Open-Label Period|Adverse Event|49|||
147561989|NCT00048568|532215590|FG000|Open-Label Period|Lack of Efficacy|0|||
147561990|NCT00048568|532215591|FG001|Open-Label Period|Lack of Efficacy|0|||
147561991|NCT00048568|532215592|FG002|Open-Label Period|Lack of Efficacy|32|||
147561992|NCT00048568|532215590|FG000|Open-Label Period|Withdrawal by Subject|0|||
147561993|NCT00048568|532215591|FG001|Open-Label Period|Withdrawal by Subject|0|||
147561994|NCT00048568|532215592|FG002|Open-Label Period|Withdrawal by Subject|26|||
147561995|NCT00048568|532215590|FG000|Open-Label Period|Pregnancy|0|||
147561996|NCT00048568|532215591|FG001|Open-Label Period|Pregnancy|0|||
147113863|NCT01807520|530579937|FG001|Treatment Period 2 (16-132 Weeks)|Study terminated|4|||
147113864|NCT01807520|530579938|FG002|Treatment Period 2 (16-132 Weeks)|Study terminated|0|||
147227111|NCT00667602|531003781|FG001|Overall Study|Administrative reason|0|||
147561997|NCT00048568|532215592|FG002|Open-Label Period|Pregnancy|5|||
147561998|NCT00048568|532215590|FG000|Open-Label Period|No Longer Met Study Criteria|0|||
147561999|NCT00048568|532215591|FG001|Open-Label Period|No Longer Met Study Criteria|0|||
147562000|NCT00048568|532215592|FG002|Open-Label Period|No Longer Met Study Criteria|2|||
147562001|NCT00048568|532215590|FG000|Open-Label Period|Administrative Decision By Sponsor|0|||
147562002|NCT00048568|532215591|FG001|Open-Label Period|Administrative Decision By Sponsor|0|||
147562003|NCT00048568|532215592|FG002|Open-Label Period|Administrative Decision By Sponsor|1|||
147562004|NCT00048568|532215590|FG000|Open-Label Period|Unknown Reasons|0|||
147562005|NCT00048568|532215591|FG001|Open-Label Period|Unknown Reasons|0|||
147562006|NCT00048568|532215592|FG002|Open-Label Period|Unknown Reasons|25|||
147562007|NCT00048568|532215590|FG000|Open-Label Period|Lost to Follow-up|0|||
147562008|NCT00048568|532215591|FG001|Open-Label Period|Lost to Follow-up|0|||
147562009|NCT00048568|532215592|FG002|Open-Label Period|Lost to Follow-up|7|||
147562010|NCT03831048|532215593|FG000|Overall Study|Protocol Violation|9|||
147562011|NCT03831048|532215594|FG001|Overall Study|Protocol Violation|3|||
147562012|NCT03831048|532215593|FG000|Overall Study|Death|4|||
147562013|NCT03831048|532215594|FG001|Overall Study|Death|9|||
147562014|NCT03831048|532215593|FG000|Overall Study|Re-transplant|0|||
147562015|NCT03831048|532215594|FG001|Overall Study|Re-transplant|2|||
147227112|NCT00667602|531003782|FG002|Overall Study|Administrative reason|2|||
147227113|NCT00667602|531003780|FG000|Overall Study|Protocol Violation|0|||
147227114|NCT00667602|531003781|FG001|Overall Study|Protocol Violation|1|||
147227115|NCT00667602|531003782|FG002|Overall Study|Protocol Violation|0|||
147227116|NCT03187756|531003787|FG000|Overall Study|Termination of study|4|||
147227117|NCT01876810|531003790|FG000|Overall Study|Physician Decision|0|||
147227118|NCT01876810|531003791|FG001|Overall Study|Physician Decision|1|||
147227119|NCT01659658|531005696|FG000|Overall Study|Withdrawal by Patient|18|||
147227120|NCT01659658|531005697|FG001|Overall Study|Withdrawal by Patient|4|||
147227121|NCT01659658|531005698|FG002|Overall Study|Withdrawal by Patient|2|||
147227122|NCT01659658|531005699|FG003|Overall Study|Withdrawal by Patient|0|||
147227123|NCT01659658|531005700|FG004|Overall Study|Withdrawal by Patient|11|||
147227124|NCT01659658|531005696|FG000|Overall Study|Study Terminated by Sponsor|9|||
147227125|NCT01659658|531005697|FG001|Overall Study|Study Terminated by Sponsor|7|||
147227126|NCT01659658|531005698|FG002|Overall Study|Study Terminated by Sponsor|0|||
147227127|NCT01659658|531005699|FG003|Overall Study|Study Terminated by Sponsor|1|||
147227128|NCT01659658|531005700|FG004|Overall Study|Study Terminated by Sponsor|4|||
147311265|NCT01425632|531307176|FG001|Overall Study|Withdrawal by Subject|0|||
147562016|NCT03831048|532215593|FG000|Overall Study|Protocol violation and death|1|||
147562017|NCT03831048|532215594|FG001|Overall Study|Protocol violation and death|1|||
147562018|NCT01315249|532215599|FG000|Overall Study|Adverse Event|22|||
147562019|NCT01315249|532215600|FG001|Overall Study|Adverse Event|26|||
147562020|NCT01315249|532215599|FG000|Overall Study|Withdrawal by Subject|11|||
147227129|NCT01659658|531005696|FG000|Overall Study|Reason not Specified|61|||
147227130|NCT01659658|531005697|FG001|Overall Study|Reason not Specified|15|||
147227131|NCT01659658|531005698|FG002|Overall Study|Reason not Specified|8|||
147562021|NCT01315249|532215600|FG001|Overall Study|Withdrawal by Subject|10|||
147562022|NCT01315249|532215599|FG000|Overall Study|Protocol Violation|8|||
147562023|NCT01315249|532215600|FG001|Overall Study|Protocol Violation|5|||
147562024|NCT01315249|532215599|FG000|Overall Study|Abnormal test results|1|||
147562025|NCT01315249|532215600|FG001|Overall Study|Abnormal test results|2|||
147562026|NCT01315249|532215599|FG000|Overall Study|Administrative problems|1|||
147562027|NCT01315249|532215600|FG001|Overall Study|Administrative problems|0|||
147311266|NCT01425632|531307177|FG002|Overall Study|Withdrawal by Subject|1|||
147311267|NCT00406419|531307184|FG000|Overall Study|Death|3|||
147311268|NCT00406419|531307185|FG001|Overall Study|Death|1|||
147311269|NCT00406419|531307186|FG002|Overall Study|Death|4|||
147311270|NCT00406419|531307184|FG000|Overall Study|Protocol Violation|6|||
147311271|NCT00406419|531307185|FG001|Overall Study|Protocol Violation|2|||
147311272|NCT00406419|531307186|FG002|Overall Study|Protocol Violation|5|||
147311273|NCT00406419|531307184|FG000|Overall Study|Study Terminated by Sponsor|260|||
147311274|NCT00406419|531307185|FG001|Overall Study|Study Terminated by Sponsor|288|||
147311275|NCT00406419|531307186|FG002|Overall Study|Study Terminated by Sponsor|282|||
147311276|NCT00406419|531307184|FG000|Overall Study|Withdrawal by Subject|17|||
147311277|NCT00406419|531307185|FG001|Overall Study|Withdrawal by Subject|24|||
147311278|NCT00406419|531307186|FG002|Overall Study|Withdrawal by Subject|26|||
147311279|NCT00406419|531307184|FG000|Overall Study|Lack of Efficacy|12|||
147311280|NCT00406419|531307185|FG001|Overall Study|Lack of Efficacy|1|||
147311281|NCT00406419|531307186|FG002|Overall Study|Lack of Efficacy|6|||
147311282|NCT00406419|531307184|FG000|Overall Study|Non-Compliance with Study Drug|5|||
147311283|NCT00406419|531307185|FG001|Overall Study|Non-Compliance with Study Drug|6|||
147311284|NCT00406419|531307186|FG002|Overall Study|Non-Compliance with Study Drug|3|||
147311285|NCT00406419|531307184|FG000|Overall Study|Adverse Event|10|||
147311286|NCT00406419|531307185|FG001|Overall Study|Adverse Event|12|||
147311287|NCT00406419|531307186|FG002|Overall Study|Adverse Event|16|||
147311288|NCT00406419|531307184|FG000|Overall Study|Lost to Follow-up|11|||
147311289|NCT00406419|531307185|FG001|Overall Study|Lost to Follow-up|10|||
147311290|NCT00406419|531307186|FG002|Overall Study|Lost to Follow-up|5|||
147311291|NCT01775930|531307187|FG000|Overall Study|Futility stopping boundary met|1|||
147311292|NCT03915951|531307190|FG000|Overall Study|As of the PCD data-cut, 33 participants remained on-treatment.|25|||
147311293|NCT03915951|531307191|FG001|Overall Study|As of the PCD data-cut, 33 participants remained on-treatment.|8|||
147311294|NCT03915951|531307190|FG000|Overall Study|Adverse Event|12|||
147311295|NCT03915951|531307191|FG001|Overall Study|Adverse Event|6|||
147311296|NCT03915951|531307190|FG000|Overall Study|Disease progression (radiological)|17|||
147311297|NCT03915951|531307191|FG001|Overall Study|Disease progression (radiological)|15|||
147311298|NCT03915951|531307190|FG000|Overall Study|Disease progression (clinical)|4|||
147311299|NCT03915951|531307191|FG001|Overall Study|Disease progression (clinical)|1|||
147311300|NCT03915951|531307190|FG000|Overall Study|Patient decision|0|||
147562028|NCT01315249|532215599|FG000|Overall Study|inability to use device|1|||
147562029|NCT01315249|532215600|FG001|Overall Study|inability to use device|0|||
147562030|NCT01315249|532215599|FG000|Overall Study|Lack of Efficacy|0|||
147227132|NCT01659658|531005699|FG003|Overall Study|Reason not Specified|1|||
147227133|NCT01659658|531005700|FG004|Overall Study|Reason not Specified|34|||
147227134|NCT01659658|531005696|FG000|Overall Study|Lost to Follow-up|2|||
147227135|NCT01659658|531005697|FG001|Overall Study|Lost to Follow-up|0|||
147227136|NCT01659658|531005698|FG002|Overall Study|Lost to Follow-up|0|||
147227137|NCT01659658|531005699|FG003|Overall Study|Lost to Follow-up|0|||
147227138|NCT01659658|531005700|FG004|Overall Study|Lost to Follow-up|0|||
147227139|NCT01927341|531005702|FG000|Phase 1b|Lost to Follow-up|1|||
147227140|NCT01927341|531005703|FG001|Phase 1b|Lost to Follow-up|0|||
147227141|NCT01927341|531005704|FG002|Phase 1b|Lost to Follow-up|0|||
147227142|NCT01927341|531005705|FG003|Phase 1b|Lost to Follow-up|0|||
147227143|NCT01927341|531005706|FG004|Phase 1b|Lost to Follow-up|0|||
147227144|NCT01927341|531005702|FG000|Phase 1b|Death|2|||
147227145|NCT01927341|531005703|FG001|Phase 1b|Death|0|||
147227146|NCT01927341|531005704|FG002|Phase 1b|Death|0|||
147227147|NCT01927341|531005705|FG003|Phase 1b|Death|0|||
147227148|NCT01927341|531005706|FG004|Phase 1b|Death|0|||
147227149|NCT01927341|531005702|FG000|Phase 1b|Follow-up completed|7|||
147227150|NCT01927341|531005703|FG001|Phase 1b|Follow-up completed|0|||
147227151|NCT01927341|531005704|FG002|Phase 1b|Follow-up completed|0|||
147227152|NCT01927341|531005705|FG003|Phase 1b|Follow-up completed|0|||
147311301|NCT03915951|531307191|FG001|Overall Study|Patient decision|4|||
147311302|NCT03915951|531307190|FG000|Overall Study|Investigator decision|0|||
147311303|NCT03915951|531307191|FG001|Overall Study|Investigator decision|1|||
147227153|NCT01927341|531005706|FG004|Phase 1b|Follow-up completed|0|||
147311304|NCT03915951|531307190|FG000|Overall Study|Consent withdrawn|1|||
147311305|NCT03915951|531307191|FG001|Overall Study|Consent withdrawn|1|||
147311306|NCT03915951|531307190|FG000|Overall Study|Death|0|||
147227154|NCT01927341|531005702|FG000|Phase 2|Lost to Follow-up|0|||
147227155|NCT01927341|531005703|FG001|Phase 2|Lost to Follow-up|1|||
147227156|NCT01927341|531005704|FG002|Phase 2|Lost to Follow-up|0|||
147227157|NCT01927341|531005705|FG003|Phase 2|Lost to Follow-up|0|||
147227158|NCT01927341|531005706|FG004|Phase 2|Lost to Follow-up|0|||
147227159|NCT01927341|531005702|FG000|Phase 2|Participant withdrew consent|0|||
147311307|NCT03915951|531307191|FG001|Overall Study|Death|3|||
147311308|NCT05064735|531307192|FG000|Overall Study|Withdrawal by Subject|7|||
147311309|NCT05064735|531307193|FG001|Overall Study|Withdrawal by Subject|8|||
147311310|NCT05064735|531307192|FG000|Overall Study|Lost to Follow-up|7|||
147311311|NCT05064735|531307193|FG001|Overall Study|Lost to Follow-up|2|||
147562031|NCT01315249|532215600|FG001|Overall Study|Lack of Efficacy|1|||
147562032|NCT01315249|532215599|FG000|Overall Study|Lost to Follow-up|0|||
147562033|NCT01315249|532215600|FG001|Overall Study|Lost to Follow-up|2|||
147562034|NCT01315249|532215599|FG000|Overall Study|Death|0|||
147562035|NCT01315249|532215600|FG001|Overall Study|Death|1|||
147562036|NCT03227445|532215601|FG000|Period 1 (28 Days)|Adverse Event|1|||
147562037|NCT03227445|532215602|FG001|Period 1 (28 Days)|Adverse Event|2|||
147562038|NCT03227445|532215603|FG002|Period 1 (28 Days)|Adverse Event|0|||
147562039|NCT03227445|532215604|FG003|Period 1 (28 Days)|Adverse Event|1|||
147562040|NCT03227445|532215601|FG000|Period 1 (28 Days)|Protocol Violation|1|||
147562041|NCT03227445|532215602|FG001|Period 1 (28 Days)|Protocol Violation|0|||
147562042|NCT03227445|532215603|FG002|Period 1 (28 Days)|Protocol Violation|0|||
147562043|NCT03227445|532215604|FG003|Period 1 (28 Days)|Protocol Violation|0|||
147562044|NCT03227445|532215601|FG000|Period 1 (28 Days)|Withdrawal by Subject|0|||
147562045|NCT03227445|532215602|FG001|Period 1 (28 Days)|Withdrawal by Subject|0|||
147562046|NCT03227445|532215603|FG002|Period 1 (28 Days)|Withdrawal by Subject|1|||
147113865|NCT01807520|530579939|FG003|Treatment Period 2 (16-132 Weeks)|Study terminated|0|||
147562047|NCT03227445|532215604|FG003|Period 1 (28 Days)|Withdrawal by Subject|1|||
147562048|NCT03227445|532215601|FG000|Period 2 (28 Days)|Adverse Event|1|||
147113866|NCT01807520|530579940|FG004|Treatment Period 2 (16-132 Weeks)|Study terminated|2|||
147113867|NCT01807520|530579941|FG005|Treatment Period 2 (16-132 Weeks)|Study terminated|0|||
147113868|NCT01807520|530579942|FG006|Treatment Period 2 (16-132 Weeks)|Study terminated|0|||
147113869|NCT01807520|530579936|FG000|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
147113870|NCT01807520|530579937|FG001|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
147113871|NCT01807520|530579938|FG002|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
147113872|NCT01807520|530579939|FG003|Treatment Period 2 (16-132 Weeks)|Protocol deviation|1|||
147113873|NCT01807520|530579940|FG004|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
147113874|NCT01807520|530579941|FG005|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
147113875|NCT01807520|530579942|FG006|Treatment Period 2 (16-132 Weeks)|Protocol deviation|0|||
147113876|NCT01807520|530579936|FG000|Treatment Period 2 (16-132 Weeks)|Pregnancy|1|||
147113877|NCT01807520|530579937|FG001|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
147113878|NCT01807520|530579938|FG002|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
147113879|NCT01807520|530579939|FG003|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
147113880|NCT01807520|530579940|FG004|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
147113881|NCT01807520|530579941|FG005|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
147562049|NCT03227445|532215602|FG001|Period 2 (28 Days)|Adverse Event|0|||
147562050|NCT03227445|532215603|FG002|Period 2 (28 Days)|Adverse Event|2|||
147562051|NCT03227445|532215604|FG003|Period 2 (28 Days)|Adverse Event|1|||
147227160|NCT01927341|531005703|FG001|Phase 2|Participant withdrew consent|2|||
147227161|NCT01927341|531005704|FG002|Phase 2|Participant withdrew consent|1|||
147227162|NCT01927341|531005705|FG003|Phase 2|Participant withdrew consent|2|||
147227163|NCT01927341|531005706|FG004|Phase 2|Participant withdrew consent|3|||
147227164|NCT01927341|531005702|FG000|Phase 2|Death|0|||
147227165|NCT01927341|531005703|FG001|Phase 2|Death|4|||
147227166|NCT01927341|531005704|FG002|Phase 2|Death|0|||
147227167|NCT01927341|531005705|FG003|Phase 2|Death|3|||
147227168|NCT01927341|531005706|FG004|Phase 2|Death|2|||
147227169|NCT01927341|531005702|FG000|Phase 2|New cancer therapy|0|||
147227170|NCT01927341|531005703|FG001|Phase 2|New cancer therapy|1|||
147227171|NCT01927341|531005704|FG002|Phase 2|New cancer therapy|0|||
147227172|NCT01927341|531005705|FG003|Phase 2|New cancer therapy|4|||
147227173|NCT01927341|531005706|FG004|Phase 2|New cancer therapy|1|||
147227174|NCT01927341|531005702|FG000|Phase 2|Disease progression|0|||
147227175|NCT01927341|531005703|FG001|Phase 2|Disease progression|1|||
147227176|NCT01927341|531005704|FG002|Phase 2|Disease progression|1|||
147227177|NCT01927341|531005705|FG003|Phase 2|Disease progression|1|||
147227178|NCT01927341|531005706|FG004|Phase 2|Disease progression|0|||
147227179|NCT01927341|531005702|FG000|Phase 2|Follow-up completed|0|||
147227180|NCT01927341|531005703|FG001|Phase 2|Follow-up completed|6|||
147227181|NCT01927341|531005704|FG002|Phase 2|Follow-up completed|3|||
147227182|NCT01927341|531005705|FG003|Phase 2|Follow-up completed|5|||
147227183|NCT01927341|531005706|FG004|Phase 2|Follow-up completed|2|||
147227184|NCT01397201|531005707|FG000|Overall Study|Not treated|0|||
147562052|NCT03227445|532215601|FG000|Period 2 (28 Days)|Protocol Violation|0|||
147227185|NCT01397201|531005708|FG001|Overall Study|Not treated|0|||
147227186|NCT01397201|531005709|FG002|Overall Study|Not treated|1|||
147227187|NCT01397201|531005710|FG003|Overall Study|Not treated|0|||
147227188|NCT01397201|531005711|FG004|Overall Study|Not treated|0|||
147227189|NCT01397201|531005707|FG000|Overall Study|Not yet defined|3|||
147227190|NCT01397201|531005708|FG001|Overall Study|Not yet defined|6|||
147227191|NCT01397201|531005709|FG002|Overall Study|Not yet defined|5|||
147227192|NCT01397201|531005710|FG003|Overall Study|Not yet defined|5|||
147227193|NCT01397201|531005711|FG004|Overall Study|Not yet defined|4|||
147562053|NCT03227445|532215602|FG001|Period 2 (28 Days)|Protocol Violation|0|||
147562054|NCT03227445|532215603|FG002|Period 2 (28 Days)|Protocol Violation|0|||
147562055|NCT03227445|532215604|FG003|Period 2 (28 Days)|Protocol Violation|1|||
147562056|NCT03227445|532215601|FG000|Period 2 (28 Days)|Withdrawal by Subject|0|||
147562057|NCT03227445|532215602|FG001|Period 2 (28 Days)|Withdrawal by Subject|1|||
147227194|NCT01397201|531005707|FG000|Overall Study|Adverse Event|2|||
147227195|NCT01397201|531005708|FG001|Overall Study|Adverse Event|0|||
147227196|NCT01397201|531005709|FG002|Overall Study|Adverse Event|0|||
147227197|NCT01397201|531005710|FG003|Overall Study|Adverse Event|0|||
147227198|NCT01397201|531005711|FG004|Overall Study|Adverse Event|0|||
147227199|NCT01442038|531005720|FG000|Overall Study|Death|35|||
147444348|NCT00530894|531792574|FG002|Overall Study|Alive and censored prior to 1 year|0|||
147562058|NCT03227445|532215603|FG002|Period 2 (28 Days)|Withdrawal by Subject|0|||
147562059|NCT03227445|532215604|FG003|Period 2 (28 Days)|Withdrawal by Subject|1|||
147562060|NCT00365300|532215607|FG000|Open-label Phase|Adverse Event|4|||
147562061|NCT00365300|532215608|FG001|Open-label Phase|Adverse Event|0|||
147562062|NCT00365300|532215607|FG000|Open-label Phase|Failed to Return|1|||
147562063|NCT00365300|532215608|FG001|Open-label Phase|Failed to Return|0|||
147562064|NCT00365300|532215607|FG000|Open-label Phase|Physician Decision|1|||
147562065|NCT00365300|532215608|FG001|Open-label Phase|Physician Decision|0|||
147562066|NCT00365300|532215607|FG000|Open-label Phase|Noncompliance|9|||
147562067|NCT00365300|532215608|FG001|Open-label Phase|Noncompliance|0|||
147562068|NCT00365300|532215607|FG000|Open-label Phase|Parent/Legal Guardian Request|4|||
147562069|NCT00365300|532215608|FG001|Open-label Phase|Parent/Legal Guardian Request|0|||
147562070|NCT00365300|532215607|FG000|Open-label Phase|Protocol Violation|1|||
147562071|NCT00365300|532215608|FG001|Open-label Phase|Protocol Violation|0|||
147227200|NCT01442038|531005721|FG001|Overall Study|Death|29|||
147227201|NCT01442038|531005720|FG000|Overall Study|Investigator-Initiated Early Closure|44|||
147227202|NCT01442038|531005721|FG001|Overall Study|Investigator-Initiated Early Closure|43|||
147227203|NCT01442038|531005720|FG000|Overall Study|Participant Withdrew Consent|137|||
147227204|NCT01442038|531005721|FG001|Overall Study|Participant Withdrew Consent|102|||
147227205|NCT01442038|531005720|FG000|Overall Study|Lost to Follow-up|37|||
147227206|NCT01442038|531005721|FG001|Overall Study|Lost to Follow-up|51|||
147227207|NCT01442038|531005720|FG000|Overall Study|Adverse Event|26|||
147227208|NCT01442038|531005721|FG001|Overall Study|Adverse Event|15|||
147227209|NCT01442038|531005720|FG000|Overall Study|Protocol Deviation|9|||
147227210|NCT01442038|531005721|FG001|Overall Study|Protocol Deviation|20|||
147227211|NCT01442038|531005720|FG000|Overall Study|Investigator's Discretion|13|||
147227212|NCT01442038|531005721|FG001|Overall Study|Investigator's Discretion|16|||
147227213|NCT01442038|531005720|FG000|Overall Study|Study Terminated By Sponsor|2|||
147227214|NCT01442038|531005721|FG001|Overall Study|Study Terminated By Sponsor|3|||
147227215|NCT00089284|531005722|FG000|Overall Study|Adverse event before starting treatment|0|||
147227216|NCT00089284|531005723|FG001|Overall Study|Adverse event before starting treatment|0|||
147227217|NCT00089284|531005724|FG002|Overall Study|Adverse event before starting treatment|0|||
147227218|NCT00089284|531005725|FG003|Overall Study|Adverse event before starting treatment|0|||
147227219|NCT00089284|531005726|FG004|Overall Study|Adverse event before starting treatment|0|||
147227220|NCT00089284|531005727|FG005|Overall Study|Adverse event before starting treatment|0|||
147227221|NCT00089284|531005728|FG006|Overall Study|Adverse event before starting treatment|1|||
147227222|NCT03956056|531005731|FG000|Overall Study|Cannot make vaccine due to lack of tissue variants|2|||
147227223|NCT03956056|531005731|FG000|Overall Study|Lack of Efficacy|1|||
147227224|NCT03347188|531005732|FG000|Double-blind (DB) Period (12 Weeks)|Protocol Violation|2|||
147227225|NCT03347188|531005733|FG001|Double-blind (DB) Period (12 Weeks)|Protocol Violation|2|||
147227226|NCT03347188|531005732|FG000|Double-blind (DB) Period (12 Weeks)|Withdrawal by Subject|4|||
147227227|NCT03347188|531005733|FG001|Double-blind (DB) Period (12 Weeks)|Withdrawal by Subject|8|||
147227228|NCT03347188|531005732|FG000|Double-blind (DB) Period (12 Weeks)|Lost to Follow-up|7|||
147227229|NCT03347188|531005733|FG001|Double-blind (DB) Period (12 Weeks)|Lost to Follow-up|4|||
147227230|NCT03347188|531005732|FG000|Double-blind (DB) Period (12 Weeks)|Adverse Event|1|||
147227231|NCT03347188|531005733|FG001|Double-blind (DB) Period (12 Weeks)|Adverse Event|1|||
147227232|NCT03347188|531005732|FG000|Double-blind (DB) Period (12 Weeks)|Other than specified|1|||
147227233|NCT03347188|531005733|FG001|Double-blind (DB) Period (12 Weeks)|Other than specified|2|||
147227234|NCT03347188|531005732|FG000|Open-label (OL) Period (12 Weeks)|Entered for ADA assessment only, not treated|26|||
147227235|NCT03347188|531005733|FG001|Open-label (OL) Period (12 Weeks)|Entered for ADA assessment only, not treated|28|||
147227236|NCT03347188|531005732|FG000|Open-label (OL) Period (12 Weeks)|Withdrawal by Subject|1|||
147227237|NCT03347188|531005733|FG001|Open-label (OL) Period (12 Weeks)|Withdrawal by Subject|0|||
147227238|NCT03347188|531005732|FG000|Open-label (OL) Period (12 Weeks)|Other than specified|0|||
147227239|NCT03347188|531005733|FG001|Open-label (OL) Period (12 Weeks)|Other than specified|1|||
147227240|NCT01298531|531005737|FG000|Overall Study|Lack of Efficacy|0|||
147227241|NCT01298531|531005738|FG001|Overall Study|Lack of Efficacy|1|||
147227242|NCT01298531|531005737|FG000|Overall Study|Lost to Follow-up|2|||
147227243|NCT01298531|531005738|FG001|Overall Study|Lost to Follow-up|0|||
147227244|NCT01298531|531005737|FG000|Overall Study|Protocol Violation|1|||
147227245|NCT01298531|531005738|FG001|Overall Study|Protocol Violation|1|||
147227246|NCT01298531|531005737|FG000|Overall Study|Adverse Event|4|||
147227247|NCT01298531|531005738|FG001|Overall Study|Adverse Event|3|||
147227248|NCT01298531|531005737|FG000|Overall Study|Does not meet entrance criteria|0|||
147562072|NCT00365300|532215607|FG000|Open-label Phase|Lack of Efficacy|1|||
147562073|NCT00365300|532215608|FG001|Open-label Phase|Lack of Efficacy|0|||
147562074|NCT00365300|532215607|FG000|Open-label Phase|Patient skipped open label phase|1|||
147562075|NCT00365300|532215608|FG001|Open-label Phase|Patient skipped open label phase|0|||
147562076|NCT00365300|532215607|FG000|Double-blind Phase|Failed to return|1|||
147562077|NCT00365300|532215608|FG001|Double-blind Phase|Failed to return|0|||
147562078|NCT00365300|532215607|FG000|Double-blind Phase|Noncompliance|1|||
147562079|NCT00365300|532215608|FG001|Double-blind Phase|Noncompliance|1|||
147562080|NCT00365300|532215607|FG000|Double-blind Phase|Withdrawal by Subject|0|||
147562081|NCT00365300|532215608|FG001|Double-blind Phase|Withdrawal by Subject|1|||
147562082|NCT00365300|532215607|FG000|Double-blind Phase|Protocol Violation|3|||
147562083|NCT00365300|532215608|FG001|Double-blind Phase|Protocol Violation|1|||
147227249|NCT01298531|531005738|FG001|Overall Study|Does not meet entrance criteria|1|||
147562084|NCT00365300|532215607|FG000|Double-blind Phase|Lack of Efficacy|6|||
147562085|NCT00365300|532215608|FG001|Double-blind Phase|Lack of Efficacy|6|||
147562086|NCT01991470|532215609|FG000|Enlite 1 Period|Withdrawal by Subject|18|||
147562087|NCT01991470|532215609|FG000|Enlite 1 Period|Adverse Event|1|||
147562088|NCT01991470|532215609|FG000|Enlite 1 Period|Inclusion/Exclusion not met|1|||
147562089|NCT01991470|532215609|FG000|Enlite 3 Period|Lost to Follow-up|1|||
147562090|NCT01991470|532215609|FG000|Enlite 3 Period|Physician Decision|2|||
147562091|NCT01991470|532215609|FG000|Enlite 3 Period|Physician Decision|8|||
147562092|NCT01991470|532215609|FG000|Enlite 3 Period|DUE TO MULTIPLE SENSOR ISSUES|1|||
147562093|NCT02896361|532215626|FG000|Third Intervention (2 Weeks)|Protocol Violation|1|||
147562094|NCT02896361|532215627|FG001|Third Intervention (2 Weeks)|Protocol Violation|0|||
147562095|NCT02896361|532215628|FG002|Third Intervention (2 Weeks)|Protocol Violation|0|||
147562096|NCT02896361|532215626|FG000|Third Intervention (2 Weeks)|emergenge of several new painful regions|0|||
147562097|NCT02896361|532215627|FG001|Third Intervention (2 Weeks)|emergenge of several new painful regions|1|||
147562098|NCT02896361|532215628|FG002|Third Intervention (2 Weeks)|emergenge of several new painful regions|0|||
147562099|NCT03164772|532215630|FG000|Overall Study|Death|4|||
147562100|NCT03164772|532215631|FG001|Overall Study|Death|2|||
147562101|NCT03164772|532215630|FG000|Overall Study|Adverse Event|1|||
147562102|NCT03164772|532215631|FG001|Overall Study|Adverse Event|4|||
147562103|NCT03164772|532215630|FG000|Overall Study|Progressive Disease|11|||
147562104|NCT03164772|532215631|FG001|Overall Study|Progressive Disease|21|||
147562105|NCT03164772|532215630|FG000|Overall Study|Physician Decision|2|||
147562106|NCT03164772|532215631|FG001|Overall Study|Physician Decision|0|||
147562107|NCT03164772|532215630|FG000|Overall Study|Withdrawal by Subject|0|||
147562108|NCT03164772|532215631|FG001|Overall Study|Withdrawal by Subject|4|||
147227250|NCT01298531|531005737|FG000|Overall Study|Other|2|||
147227251|NCT01298531|531005738|FG001|Overall Study|Other|1|||
147227252|NCT01092507|531005739|FG000|Overall Study|Withdrawal by Subject|2|||
147227253|NCT01092507|531005740|FG001|Overall Study|Withdrawal by Subject|0|||
147227254|NCT03646643|531005741|FG000|Overall Study|Not yet achieved 6 months study follow-up at the time of analysis|2|||
147227255|NCT03646643|531005742|FG001|Overall Study|Not yet achieved 6 months study follow-up at the time of analysis|2|||
147227256|NCT03646643|531005741|FG000|Overall Study|Lost to Follow-up|0|||
147227257|NCT03646643|531005742|FG001|Overall Study|Lost to Follow-up|1|||
147227258|NCT05314478|531005745|FG000|Overall Study|Physician Decision|1|||
147227259|NCT02007512|531005746|FG000|Double Blind Treatment Period|Adverse Event|4|||
147227260|NCT02007512|531005747|FG001|Double Blind Treatment Period|Adverse Event|6|||
147227261|NCT02007512|531005748|FG002|Double Blind Treatment Period|Adverse Event|2|||
147227262|NCT02007512|531005749|FG003|Double Blind Treatment Period|Adverse Event|2|||
147227263|NCT02007512|531005746|FG000|Double Blind Treatment Period|Death|1|||
147227264|NCT02007512|531005747|FG001|Double Blind Treatment Period|Death|0|||
147227265|NCT02007512|531005748|FG002|Double Blind Treatment Period|Death|0|||
147227266|NCT02007512|531005749|FG003|Double Blind Treatment Period|Death|0|||
147227267|NCT02007512|531005746|FG000|Double Blind Treatment Period|Disease progression|51|||
147227268|NCT02007512|531005747|FG001|Double Blind Treatment Period|Disease progression|50|||
147227269|NCT02007512|531005748|FG002|Double Blind Treatment Period|Disease progression|57|||
147227270|NCT02007512|531005749|FG003|Double Blind Treatment Period|Disease progression|52|||
147227271|NCT02007512|531005746|FG000|Double Blind Treatment Period|Withdrawal by Subject|3|||
147227272|NCT02007512|531005747|FG001|Double Blind Treatment Period|Withdrawal by Subject|3|||
147227273|NCT02007512|531005748|FG002|Double Blind Treatment Period|Withdrawal by Subject|3|||
147227274|NCT02007512|531005749|FG003|Double Blind Treatment Period|Withdrawal by Subject|3|||
147227275|NCT02007512|531005746|FG000|Double Blind Treatment Period|Protocol Violation|1|||
147227276|NCT02007512|531005747|FG001|Double Blind Treatment Period|Protocol Violation|0|||
147227277|NCT02007512|531005748|FG002|Double Blind Treatment Period|Protocol Violation|0|||
147227278|NCT02007512|531005749|FG003|Double Blind Treatment Period|Protocol Violation|1|||
147311312|NCT05064735|531307192|FG000|Overall Study|Physician Decision|2|||
147311313|NCT05064735|531307193|FG001|Overall Study|Physician Decision|1|||
147311314|NCT05064735|531307192|FG000|Overall Study|Failing to Meet Randomization Requirements|2|||
147562109|NCT01029353|532215632|FG000|Overall Study|Lost to Follow-up|4|||
147562110|NCT01029353|532215633|FG001|Overall Study|Lost to Follow-up|5|||
147562111|NCT01029353|532215634|FG002|Overall Study|Lost to Follow-up|5|||
147562112|NCT01029353|532215635|FG003|Overall Study|Lost to Follow-up|4|||
147562113|NCT01029353|532215632|FG000|Overall Study|Consent Withdrawn|2|||
147562114|NCT01029353|532215633|FG001|Overall Study|Consent Withdrawn|0|||
147562115|NCT01029353|532215634|FG002|Overall Study|Consent Withdrawn|0|||
147227279|NCT02007512|531005746|FG000|Double Blind Treatment Period|Other|2|||
147227280|NCT02007512|531005747|FG001|Double Blind Treatment Period|Other|1|||
147227281|NCT02007512|531005748|FG002|Double Blind Treatment Period|Other|1|||
147227282|NCT02007512|531005749|FG003|Double Blind Treatment Period|Other|2|||
147227283|NCT02007512|531005746|FG000|Double Blind Treatment Period|Randomized but not treated|1|||
147227284|NCT02007512|531005747|FG001|Double Blind Treatment Period|Randomized but not treated|0|||
147227285|NCT02007512|531005748|FG002|Double Blind Treatment Period|Randomized but not treated|1|||
147227286|NCT02007512|531005749|FG003|Double Blind Treatment Period|Randomized but not treated|0|||
147227287|NCT02007512|531005746|FG000|Open Label Treatment Period|Adverse Event|1|||
147227288|NCT02007512|531005747|FG001|Open Label Treatment Period|Adverse Event|0|||
147311315|NCT05064735|531307193|FG001|Overall Study|Failing to Meet Randomization Requirements|1|||
147311316|NCT05064735|531307192|FG000|Overall Study|Site Closure|7|||
147311317|NCT05064735|531307193|FG001|Overall Study|Site Closure|2|||
147311318|NCT01396395|531307194|FG000|Overall Study|Withdrawal by Subject|10|||
147311319|NCT01396395|531307195|FG001|Overall Study|Withdrawal by Subject|12|||
147311320|NCT01396395|531307194|FG000|Overall Study|Protocol Violation|3|||
147311321|NCT01396395|531307195|FG001|Overall Study|Protocol Violation|1|||
147311322|NCT01396395|531307194|FG000|Overall Study|Adverse Event|10|||
147311323|NCT01396395|531307195|FG001|Overall Study|Adverse Event|2|||
147311324|NCT01396395|531307194|FG000|Overall Study|Lost to Follow-up|17|||
147311325|NCT01396395|531307195|FG001|Overall Study|Lost to Follow-up|11|||
147311326|NCT01396395|531307194|FG000|Overall Study|Other|0|||
147311327|NCT01396395|531307195|FG001|Overall Study|Other|1|||
147311328|NCT03691948|531307196|FG000|Overall Study|Lost to Follow-up|1|||
147311329|NCT03691948|531307197|FG001|Overall Study|Lost to Follow-up|3|||
147311330|NCT01370005|531307198|FG000|Overall Study|Not treated|1|||
147311331|NCT01370005|531307199|FG001|Overall Study|Not treated|0|||
147311332|NCT01370005|531307200|FG002|Overall Study|Not treated|0|||
147311333|NCT01370005|531307198|FG000|Overall Study|Adverse Event|5|||
147311334|NCT01370005|531307199|FG001|Overall Study|Adverse Event|5|||
147227289|NCT02007512|531005748|FG002|Open Label Treatment Period|Adverse Event|0|||
147227290|NCT02007512|531005749|FG003|Open Label Treatment Period|Adverse Event|0|||
147227291|NCT02007512|531005746|FG000|Open Label Treatment Period|Other|1|||
147227292|NCT02007512|531005747|FG001|Open Label Treatment Period|Other|1|||
147227293|NCT02007512|531005748|FG002|Open Label Treatment Period|Other|0|||
147227294|NCT02007512|531005749|FG003|Open Label Treatment Period|Other|0|||
147311335|NCT01370005|531307200|FG002|Overall Study|Adverse Event|6|||
147311336|NCT01370005|531307198|FG000|Overall Study|Lack of Efficacy|1|||
147311337|NCT01370005|531307199|FG001|Overall Study|Lack of Efficacy|0|||
147311338|NCT01370005|531307200|FG002|Overall Study|Lack of Efficacy|0|||
147311339|NCT01370005|531307198|FG000|Overall Study|Non compliant with protocol|0|||
147311340|NCT01370005|531307199|FG001|Overall Study|Non compliant with protocol|1|||
147311341|NCT01370005|531307200|FG002|Overall Study|Non compliant with protocol|2|||
147311342|NCT01370005|531307198|FG000|Overall Study|Lost to Follow-up|1|||
147444349|NCT00530894|531792575|FG003|Overall Study|Alive and censored prior to 1 year|0|||
147562116|NCT01029353|532215635|FG003|Overall Study|Consent Withdrawn|0|||
147562117|NCT01029353|532215632|FG000|Overall Study|Primary Outcome Indeterminate|1|||
147562118|NCT01029353|532215633|FG001|Overall Study|Primary Outcome Indeterminate|3|||
147562119|NCT01029353|532215634|FG002|Overall Study|Primary Outcome Indeterminate|2|||
147444350|NCT01349465|531792576|FG000|Overall Study|Adverse Event|1|||
147562120|NCT01029353|532215635|FG003|Overall Study|Primary Outcome Indeterminate|0|||
147562121|NCT02932878|532215638|FG000|Overall Study|Due to Lab Results|2|||
147562122|NCT02932878|532215639|FG001|Overall Study|Due to Lab Results|1|||
147562123|NCT00849901|532215640|FG000|Acute Treatment Phase|Adverse Event|9|||
147562124|NCT00849901|532215641|FG001|Acute Treatment Phase|Adverse Event|1|||
147562125|NCT00849901|532215642|FG002|Acute Treatment Phase|Adverse Event|3|||
147562126|NCT00849901|532215640|FG000|Acute Treatment Phase|Lost to Follow-up|2|||
147562127|NCT00849901|532215641|FG001|Acute Treatment Phase|Lost to Follow-up|4|||
147562128|NCT00849901|532215642|FG002|Acute Treatment Phase|Lost to Follow-up|1|||
147562129|NCT00849901|532215640|FG000|Acute Treatment Phase|Protocol Violation|0|||
147562130|NCT00849901|532215641|FG001|Acute Treatment Phase|Protocol Violation|2|||
147562131|NCT00849901|532215642|FG002|Acute Treatment Phase|Protocol Violation|1|||
147562132|NCT00849901|532215640|FG000|Acute Treatment Phase|Withdrawal by Subject|4|||
147562133|NCT00849901|532215641|FG001|Acute Treatment Phase|Withdrawal by Subject|10|||
147227295|NCT02007512|531005746|FG000|Open Label Treatment Period|Disease progression|23|||
147562134|NCT00849901|532215642|FG002|Acute Treatment Phase|Withdrawal by Subject|4|||
147227296|NCT02007512|531005747|FG001|Open Label Treatment Period|Disease progression|11|||
147227297|NCT02007512|531005748|FG002|Open Label Treatment Period|Disease progression|0|||
147311343|NCT01370005|531307199|FG001|Overall Study|Lost to Follow-up|1|||
147311344|NCT01370005|531307200|FG002|Overall Study|Lost to Follow-up|1|||
147311345|NCT01370005|531307198|FG000|Overall Study|Patient refusal to continue,not due toAE|5|||
147311346|NCT01370005|531307199|FG001|Overall Study|Patient refusal to continue,not due toAE|4|||
147311347|NCT01370005|531307200|FG002|Overall Study|Patient refusal to continue,not due toAE|0|||
147311348|NCT01370005|531307198|FG000|Overall Study|Other reason not defined above|3|||
147311349|NCT01370005|531307199|FG001|Overall Study|Other reason not defined above|0|||
147444351|NCT01349465|531792577|FG001|Overall Study|Adverse Event|0|||
147311350|NCT01370005|531307200|FG002|Overall Study|Other reason not defined above|2|||
147311351|NCT02009696|531307201|FG000|Overall Study|Withdrawal by Subject|2|||
147311352|NCT02120664|531307202|FG000|Overall Study|Withdrawal by Subject|0|||
147311353|NCT02120664|531307203|FG001|Overall Study|Withdrawal by Subject|0|||
147311354|NCT02120664|531307204|FG002|Overall Study|Withdrawal by Subject|0|||
147311355|NCT02120664|531307205|FG003|Overall Study|Withdrawal by Subject|1|||
147311356|NCT02120664|531307206|FG004|Overall Study|Withdrawal by Subject|0|||
147311357|NCT03916744|531307207|FG000|Overall Study|Withdrawal by Subject|0|||
147311358|NCT03916744|531307208|FG001|Overall Study|Withdrawal by Subject|1|||
147311359|NCT03916744|531307209|FG002|Overall Study|Withdrawal by Subject|2|||
147311360|NCT02460263|531307210|FG000|Transition Period|Withdrawal by Subject|1|||
147311361|NCT02460263|531307210|FG000|Transition Period|Death|1|||
147311362|NCT04524598|531307211|FG000|Phase I - Feasibility|Lost to Follow-up|2|||
147311363|NCT04524598|531307212|FG001|Phase I - Feasibility|Lost to Follow-up|4|||
147311364|NCT04524598|531307213|FG002|Phase I - Feasibility|Lost to Follow-up|0|||
147311365|NCT04524598|531307214|FG003|Phase I - Feasibility|Lost to Follow-up|0|||
147311366|NCT04524598|531307215|FG004|Phase I - Feasibility|Lost to Follow-up|0|||
147311367|NCT04524598|531307211|FG000|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|2|||
147311368|NCT04524598|531307212|FG001|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|1|||
147311369|NCT04524598|531307213|FG002|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|0|||
147311370|NCT04524598|531307214|FG003|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|0|||
147311371|NCT04524598|531307215|FG004|Phase I - Feasibility|Dropped for missing two consecutive weekly safety check-ins.|0|||
147311372|NCT04524598|531307211|FG000|Phase II - Outcomes|Lost to Follow-up|0|||
147311373|NCT04524598|531307212|FG001|Phase II - Outcomes|Lost to Follow-up|0|||
147311374|NCT04524598|531307213|FG002|Phase II - Outcomes|Lost to Follow-up|16|||
147311375|NCT04524598|531307214|FG003|Phase II - Outcomes|Lost to Follow-up|8|||
147311376|NCT04524598|531307215|FG004|Phase II - Outcomes|Lost to Follow-up|0|||
147311377|NCT04524598|531307211|FG000|Phase II - Outcomes|Withdrawal by Subject|0|||
147311378|NCT04524598|531307212|FG001|Phase II - Outcomes|Withdrawal by Subject|0|||
147311379|NCT04524598|531307213|FG002|Phase II - Outcomes|Withdrawal by Subject|2|||
147311380|NCT04524598|531307214|FG003|Phase II - Outcomes|Withdrawal by Subject|0|||
147311381|NCT04524598|531307215|FG004|Phase II - Outcomes|Withdrawal by Subject|0|||
147311382|NCT04524598|531307211|FG000|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|0|||
147311383|NCT04524598|531307212|FG001|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|0|||
147311384|NCT04524598|531307213|FG002|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|8|||
147311385|NCT04524598|531307214|FG003|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|5|||
147311386|NCT04524598|531307215|FG004|Phase II - Outcomes|Dropped for missing two consecutive weekly safety check-ins.|0|||
147311387|NCT04524598|531307211|FG000|Phase II - Control Extension|Lost to Follow-up|0|||
147311388|NCT04524598|531307212|FG001|Phase II - Control Extension|Lost to Follow-up|0|||
147311389|NCT04524598|531307213|FG002|Phase II - Control Extension|Lost to Follow-up|0|||
147311390|NCT04524598|531307214|FG003|Phase II - Control Extension|Lost to Follow-up|0|||
147311391|NCT04524598|531307215|FG004|Phase II - Control Extension|Lost to Follow-up|6|||
147311392|NCT04524598|531307211|FG000|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|0|||
147311393|NCT04524598|531307212|FG001|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|0|||
147311394|NCT04524598|531307213|FG002|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|0|||
147311395|NCT04524598|531307214|FG003|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|0|||
147311396|NCT04524598|531307215|FG004|Phase II - Control Extension|Dropped for missing two consecutive weekly safety check-ins.|6|||
147311397|NCT02301156|531307216|FG000|Overall Study|Adverse Event|13|||
147311398|NCT02301156|531307217|FG001|Overall Study|Adverse Event|14|||
147311399|NCT02301156|531307216|FG000|Overall Study|Death|1|||
147311400|NCT02301156|531307217|FG001|Overall Study|Death|5|||
147311401|NCT02301156|531307216|FG000|Overall Study|Investigator Decision (includes non-compliance with study drug, investigator determined suitability)|2|||
147311402|NCT02301156|531307217|FG001|Overall Study|Investigator Decision (includes non-compliance with study drug, investigator determined suitability)|2|||
147311403|NCT02301156|531307216|FG000|Overall Study|Site Terminated by Sponsor at the End of Study|27|||
147311404|NCT02301156|531307217|FG001|Overall Study|Site Terminated by Sponsor at the End of Study|16|||
147311405|NCT02301156|531307216|FG000|Overall Study|Withdrawal of Consent by Subject|4|||
147311406|NCT02301156|531307217|FG001|Overall Study|Withdrawal of Consent by Subject|12|||
147311407|NCT02301156|531307216|FG000|Overall Study|Reason not Specified|6|||
147311408|NCT02301156|531307217|FG001|Overall Study|Reason not Specified|3|||
147562135|NCT00849901|532215640|FG000|Acute Treatment Phase|Parent or Caregiver Decision|11|||
147562136|NCT00849901|532215641|FG001|Acute Treatment Phase|Parent or Caregiver Decision|5|||
147562137|NCT00849901|532215642|FG002|Acute Treatment Phase|Parent or Caregiver Decision|4|||
147562138|NCT00849901|532215640|FG000|Acute Treatment Phase|Physician Decision|1|||
147562139|NCT00849901|532215641|FG001|Acute Treatment Phase|Physician Decision|1|||
147562140|NCT00849901|532215642|FG002|Acute Treatment Phase|Physician Decision|1|||
147562141|NCT00849901|532215640|FG000|Acute Treatment Phase|Sponsor Decision|1|||
147595955|NCT00359632|532338755|FG001|Overall Study|Adverse Event|0|||
147562142|NCT00849901|532215641|FG001|Acute Treatment Phase|Sponsor Decision|0|||
147562143|NCT00849901|532215642|FG002|Acute Treatment Phase|Sponsor Decision|0|||
147562144|NCT00849901|532215640|FG000|Acute Treatment Phase|Lack of Efficacy|2|||
147227298|NCT02007512|531005749|FG003|Open Label Treatment Period|Disease progression|0|||
147227299|NCT04629508|531005750|FG000|Overall Study|Adverse Event|1|||
147562145|NCT00849901|532215641|FG001|Acute Treatment Phase|Lack of Efficacy|3|||
147562146|NCT00849901|532215642|FG002|Acute Treatment Phase|Lack of Efficacy|2|||
147227300|NCT04629508|531005750|FG000|Overall Study|Death|2|||
147227301|NCT04629508|531005750|FG000|Overall Study|Protocol-specified withdrawal criterion met|1|||
147227302|NCT04073368|531005755|FG000|Overall Study|Adverse Event|2|||
147227303|NCT04073368|531005756|FG001|Overall Study|Adverse Event|0|||
147227304|NCT04073368|531005757|FG002|Overall Study|Adverse Event|1|||
147227305|NCT04073368|531005758|FG003|Overall Study|Adverse Event|1|||
147227306|NCT04073368|531005755|FG000|Overall Study|Withdrawal by Subject|2|||
147227307|NCT04073368|531005756|FG001|Overall Study|Withdrawal by Subject|2|||
147227308|NCT04073368|531005757|FG002|Overall Study|Withdrawal by Subject|1|||
147227309|NCT04073368|531005758|FG003|Overall Study|Withdrawal by Subject|1|||
147227310|NCT04073368|531005755|FG000|Overall Study|Lost to Follow-up|1|||
147227311|NCT04073368|531005756|FG001|Overall Study|Lost to Follow-up|1|||
147227312|NCT04073368|531005757|FG002|Overall Study|Lost to Follow-up|1|||
147227313|NCT04073368|531005758|FG003|Overall Study|Lost to Follow-up|0|||
147227314|NCT04073368|531005755|FG000|Overall Study|Protocol Violation|0|||
147227315|NCT04073368|531005756|FG001|Overall Study|Protocol Violation|1|||
147227316|NCT04073368|531005757|FG002|Overall Study|Protocol Violation|0|||
147227317|NCT04073368|531005758|FG003|Overall Study|Protocol Violation|0|||
147227318|NCT04073368|531005755|FG000|Overall Study|Subject noncompliance|7|||
147227319|NCT04073368|531005756|FG001|Overall Study|Subject noncompliance|4|||
147227320|NCT04073368|531005757|FG002|Overall Study|Subject noncompliance|0|||
147227321|NCT04073368|531005758|FG003|Overall Study|Subject noncompliance|0|||
147227322|NCT00145600|531005759|FG000|Overall Study|Death|1|||
147227323|NCT00145600|531005760|FG001|Overall Study|Death|2|||
147227324|NCT00145600|531005761|FG002|Overall Study|Death|2|||
147227325|NCT00145600|531005762|FG003|Overall Study|Death|6|||
147227326|NCT00145600|531005759|FG000|Overall Study|Ineligible|3|||
147227327|NCT00145600|531005760|FG001|Overall Study|Ineligible|0|||
147227328|NCT00145600|531005761|FG002|Overall Study|Ineligible|1|||
147227329|NCT00145600|531005762|FG003|Overall Study|Ineligible|5|||
147227330|NCT00145600|531005759|FG000|Overall Study|Lost to Follow-up|2|||
147227331|NCT00145600|531005760|FG001|Overall Study|Lost to Follow-up|6|||
147227332|NCT00145600|531005761|FG002|Overall Study|Lost to Follow-up|2|||
147227333|NCT00145600|531005762|FG003|Overall Study|Lost to Follow-up|4|||
147227334|NCT00145600|531005759|FG000|Overall Study|Noncompliance|1|||
147227335|NCT00145600|531005760|FG001|Overall Study|Noncompliance|0|||
147227336|NCT00145600|531005761|FG002|Overall Study|Noncompliance|0|||
147227337|NCT00145600|531005762|FG003|Overall Study|Noncompliance|0|||
147227338|NCT00145600|531005759|FG000|Overall Study|Withdrawal by Subject|1|||
147227339|NCT00145600|531005760|FG001|Overall Study|Withdrawal by Subject|2|||
147227340|NCT00145600|531005761|FG002|Overall Study|Withdrawal by Subject|0|||
147227341|NCT00145600|531005762|FG003|Overall Study|Withdrawal by Subject|1|||
147227342|NCT01229397|531005763|FG000|Overall Study|Withdrawal by Subject|3|||
147227343|NCT01229397|531005764|FG001|Overall Study|Withdrawal by Subject|3|||
147227344|NCT01229397|531005763|FG000|Overall Study|Lost to Follow-up|7|||
147227345|NCT01229397|531005764|FG001|Overall Study|Lost to Follow-up|6|||
147227346|NCT01229397|531005763|FG000|Overall Study|Migrated/moved from study area|1|||
147227347|NCT01229397|531005764|FG001|Overall Study|Migrated/moved from study area|0|||
147227348|NCT00608543|531005765|FG000|Overall Study|Adverse Event|4|||
147227349|NCT01251744|531005770|FG000|Overall Study|Lost to Follow-up|1|||
147227350|NCT01251744|531005771|FG001|Overall Study|Lost to Follow-up|0|||
147227351|NCT00214500|531005772|FG000|Treatment Period|Adverse Event|1|||
147227352|NCT00214500|531005772|FG000|Extension Period|Withdrawal by Subject|2|||
147444352|NCT01349465|531792576|FG000|Overall Study|Death|3|||
147562147|NCT00849901|532215640|FG000|Extension Phase|Adverse Event|2|||
147562148|NCT00849901|532215641|FG001|Extension Phase|Adverse Event|8|||
147562149|NCT00849901|532215642|FG002|Extension Phase|Adverse Event|4|||
147562150|NCT00849901|532215640|FG000|Extension Phase|Lost to Follow-up|3|||
147562151|NCT00849901|532215641|FG001|Extension Phase|Lost to Follow-up|0|||
147562152|NCT00849901|532215642|FG002|Extension Phase|Lost to Follow-up|1|||
147562153|NCT00849901|532215640|FG000|Extension Phase|Protocol Violation|2|||
147562154|NCT00849901|532215641|FG001|Extension Phase|Protocol Violation|2|||
147562155|NCT00849901|532215642|FG002|Extension Phase|Protocol Violation|4|||
147227353|NCT02147184|531005773|FG000|Overall Study|Lost to Follow-up|28|||
147227354|NCT02147184|531005774|FG001|Overall Study|Lost to Follow-up|15|||
147227355|NCT02147184|531005773|FG000|Overall Study|Study Burden|11|||
147227356|NCT02147184|531005774|FG001|Overall Study|Study Burden|7|||
147227357|NCT02147184|531005773|FG000|Overall Study|Pregnancy|6|||
147227358|NCT02147184|531005774|FG001|Overall Study|Pregnancy|0|||
147227359|NCT02147184|531005773|FG000|Overall Study|Moved out of state|3|||
147227360|NCT02147184|531005774|FG001|Overall Study|Moved out of state|3|||
147227361|NCT02147184|531005773|FG000|Overall Study|Physician Decision|0|||
147227362|NCT02147184|531005774|FG001|Overall Study|Physician Decision|2|||
147562156|NCT00849901|532215640|FG000|Extension Phase|Withdrawal by Subject|7|||
147562157|NCT00849901|532215641|FG001|Extension Phase|Withdrawal by Subject|6|||
147562158|NCT00849901|532215642|FG002|Extension Phase|Withdrawal by Subject|3|||
147562159|NCT00849901|532215640|FG000|Extension Phase|Parent or Caregiver Decision|10|||
147562160|NCT00849901|532215641|FG001|Extension Phase|Parent or Caregiver Decision|4|||
147562161|NCT00849901|532215642|FG002|Extension Phase|Parent or Caregiver Decision|4|||
147562162|NCT00849901|532215640|FG000|Extension Phase|Physician Decision|1|||
147562163|NCT00849901|532215641|FG001|Extension Phase|Physician Decision|2|||
147562164|NCT00849901|532215642|FG002|Extension Phase|Physician Decision|0|||
147562165|NCT00849901|532215640|FG000|Extension Phase|Lack of Efficacy|2|||
147562166|NCT00849901|532215641|FG001|Extension Phase|Lack of Efficacy|4|||
147562167|NCT00849901|532215642|FG002|Extension Phase|Lack of Efficacy|1|||
147562168|NCT02152566|532215645|FG000|Overall Study|Lost to Follow-up|1|||
147311409|NCT02638623|531307219|FG000|Overall Study|Surgery timing|5|||
147311410|NCT02638623|531307220|FG001|Overall Study|Surgery timing|6|||
147311411|NCT02638623|531307219|FG000|Overall Study|Not given intervention|2|||
147311412|NCT02638623|531307220|FG001|Overall Study|Not given intervention|0|||
147311413|NCT00180713|531307221|FG000|Overall Study|Withdrawal by Subject|2|||
147311414|NCT00180713|531307222|FG001|Overall Study|Withdrawal by Subject|0|||
147311415|NCT00180713|531307221|FG000|Overall Study|Adverse Event|3|||
147311416|NCT00180713|531307222|FG001|Overall Study|Adverse Event|3|||
147311417|NCT05295732|531307227|FG000|Phase 3: Double-blind / MUsT: Treatment|Various reasons|14|||
147311418|NCT05295732|531307228|FG001|Phase 3: Double-blind / MUsT: Treatment|Various reasons|4|||
147311419|NCT05295732|531307229|FG002|Phase 3: Double-blind / MUsT: Treatment|Various reasons|0|||
147311420|NCT05295732|531307230|FG003|Phase 3: Double-blind / MUsT: Treatment|Various reasons|0|||
147311421|NCT05295732|531307231|FG004|Phase 3: Double-blind / MUsT: Treatment|Various reasons|2|||
147311422|NCT05295732|531307227|FG000|Phase 3: Open-label / MUsT: Maintenance|Various reasons|0|||
147562169|NCT02152566|532215645|FG000|Overall Study|Withdrawal by Subject|2|||
147562170|NCT02731157|532215646|FG000|First Rejuvenated RCE|Withdrawal by Subject|1|||
147311423|NCT05295732|531307228|FG001|Phase 3: Open-label / MUsT: Maintenance|Various reasons|0|||
147311424|NCT05295732|531307229|FG002|Phase 3: Open-label / MUsT: Maintenance|Various reasons|0|||
147311425|NCT05295732|531307230|FG003|Phase 3: Open-label / MUsT: Maintenance|Various reasons|1|||
147311426|NCT05295732|531307231|FG004|Phase 3: Open-label / MUsT: Maintenance|Various reasons|1|||
147311427|NCT00550550|531307232|FG000|Overall Study|Adverse Event|13|||
147311428|NCT00550550|531307233|FG001|Overall Study|Adverse Event|5|||
147311429|NCT00550550|531307232|FG000|Overall Study|Treatment Failure|0|||
147311430|NCT00550550|531307233|FG001|Overall Study|Treatment Failure|1|||
147311431|NCT00550550|531307232|FG000|Overall Study|Lost to Follow-up|4|||
147311432|NCT00550550|531307233|FG001|Overall Study|Lost to Follow-up|0|||
147311433|NCT00550550|531307232|FG000|Overall Study|Withdrawal by Subject|10|||
147311434|NCT00550550|531307233|FG001|Overall Study|Withdrawal by Subject|8|||
147311435|NCT00550550|531307232|FG000|Overall Study|Protocol Violation|5|||
147311436|NCT00550550|531307233|FG001|Overall Study|Protocol Violation|14|||
147311437|NCT00550550|531307232|FG000|Overall Study|Did Not Meet Protocol Eligibility|1|||
147311438|NCT00550550|531307233|FG001|Overall Study|Did Not Meet Protocol Eligibility|1|||
147311439|NCT00550550|531307232|FG000|Overall Study|Randomized But Not Treated|1|||
147311440|NCT00550550|531307233|FG001|Overall Study|Randomized But Not Treated|0|||
147311441|NCT03311230|531307237|FG000|Overall Study|Withdrawal by Subject|1|||
147311442|NCT03311230|531307238|FG001|Overall Study|Withdrawal by Subject|4|||
147311443|NCT03311230|531307239|FG002|Overall Study|Withdrawal by Subject|2|||
147311444|NCT03311230|531307240|FG003|Overall Study|Withdrawal by Subject|7|||
147311445|NCT03311230|531307237|FG000|Overall Study|Unrelated injury|0|||
147311446|NCT03311230|531307238|FG001|Overall Study|Unrelated injury|1|||
147311447|NCT03311230|531307239|FG002|Overall Study|Unrelated injury|0|||
147311448|NCT03311230|531307240|FG003|Overall Study|Unrelated injury|0|||
147311449|NCT01302938|531307241|FG000|Overall Study|Withdrawal by Subject|1|||
147562171|NCT01856309|532215647|FG000|Overall Study|Death|4|||
147562172|NCT01856309|532215648|FG001|Overall Study|Death|6|||
147562173|NCT01856309|532215649|FG002|Overall Study|Death|11|||
147562174|NCT01856309|532215650|FG003|Overall Study|Death|6|||
147562175|NCT01856309|532215647|FG000|Overall Study|Lost to Follow-up|6|||
147562176|NCT01856309|532215648|FG001|Overall Study|Lost to Follow-up|2|||
147562177|NCT01856309|532215649|FG002|Overall Study|Lost to Follow-up|4|||
147562178|NCT01856309|532215650|FG003|Overall Study|Lost to Follow-up|8|||
147562179|NCT01856309|532215647|FG000|Overall Study|Withdrawal by Subject|11|||
147562180|NCT01856309|532215648|FG001|Overall Study|Withdrawal by Subject|13|||
147311450|NCT01302938|531307242|FG001|Overall Study|Withdrawal by Subject|0|||
147311451|NCT01302938|531307241|FG000|Overall Study|Adverse Event|1|||
147311452|NCT01302938|531307242|FG001|Overall Study|Adverse Event|0|||
147311453|NCT00171873|531307243|FG000|Overall Study|Withdrawal by Subject|4|||
147311454|NCT00171873|531307244|FG001|Overall Study|Withdrawal by Subject|2|||
147311455|NCT00171873|531307243|FG000|Overall Study|Adverse Event|5|||
147311456|NCT00171873|531307244|FG001|Overall Study|Adverse Event|0|||
147311457|NCT00171873|531307243|FG000|Overall Study|Switched to Octreotide|0|||
147562181|NCT01856309|532215649|FG002|Overall Study|Withdrawal by Subject|28|||
147562182|NCT01856309|532215650|FG003|Overall Study|Withdrawal by Subject|26|||
147562183|NCT01856309|532215647|FG000|Overall Study|Other|227|||
147562184|NCT01856309|532215648|FG001|Overall Study|Other|225|||
147311458|NCT00171873|531307244|FG001|Overall Study|Switched to Octreotide|1|||
147311459|NCT01518946|531307257|FG000|Open-label Phase|Other|4|||
147311460|NCT01518946|531307258|FG001|Open-label Phase|Other|0|||
147311461|NCT01518946|531307259|FG002|Open-label Phase|Other|0|||
147311462|NCT01518946|531307257|FG000|Randomized Phase (First Intervention)|Other|0|||
147311463|NCT01518946|531307258|FG001|Randomized Phase (First Intervention)|Other|1|||
147311464|NCT01518946|531307259|FG002|Randomized Phase (First Intervention)|Other|0|||
147311465|NCT03857841|531307260|FG000|Overall Study|Death|1|||
147311466|NCT03857841|531307261|FG001|Overall Study|Death|0|||
147311467|NCT03857841|531307262|FG002|Overall Study|Death|0|||
147311468|NCT03857841|531307263|FG003|Overall Study|Death|0|||
147311469|NCT03857841|531307260|FG000|Overall Study|Study Terminated by Sponsor|1|||
147311470|NCT03857841|531307261|FG001|Overall Study|Study Terminated by Sponsor|0|||
147311471|NCT03857841|531307262|FG002|Overall Study|Study Terminated by Sponsor|0|||
147311472|NCT03857841|531307263|FG003|Overall Study|Study Terminated by Sponsor|0|||
147311473|NCT04249336|531309115|FG000|Overall Study|Lost to Follow-up|3|||
147311474|NCT04249336|531309116|FG001|Overall Study|Lost to Follow-up|3|||
147311475|NCT04249336|531309117|FG002|Overall Study|Lost to Follow-up|3|||
147311476|NCT04249336|531309118|FG003|Overall Study|Lost to Follow-up|3|||
147311477|NCT01242176|531309119|FG000|Washout Period of 7 Days|Adverse Event|0|||
147311478|NCT01242176|531309120|FG001|Washout Period of 7 Days|Adverse Event|2|||
147311479|NCT01242176|531309119|FG000|Washout Period of 7 Days|Non-compliant with protocol|1|||
147311480|NCT01242176|531309120|FG001|Washout Period of 7 Days|Non-compliant with protocol|0|||
147311481|NCT00871351|531309121|FG000|Overall Study|Withdrawal by Subject|1|||
147311482|NCT00871351|531309122|FG001|Overall Study|Withdrawal by Subject|0|||
147311483|NCT00871351|531309123|FG002|Overall Study|Withdrawal by Subject|0|||
147311484|NCT00871351|531309121|FG000|Overall Study|Adverse Event|3|||
147311485|NCT00871351|531309122|FG001|Overall Study|Adverse Event|1|||
147311486|NCT00871351|531309123|FG002|Overall Study|Adverse Event|0|||
147311487|NCT02291289|531309125|FG000|Induction Treatment|Withdrawal by Subject|0|||
147311488|NCT02291289|531309126|FG001|Induction Treatment|Withdrawal by Subject|0|||
147311489|NCT02291289|531309127|FG002|Induction Treatment|Withdrawal by Subject|0|||
147311490|NCT02291289|531309128|FG003|Induction Treatment|Withdrawal by Subject|24|||
147311491|NCT02291289|531309129|FG004|Induction Treatment|Withdrawal by Subject|0|||
147311492|NCT02291289|531309130|FG005|Induction Treatment|Withdrawal by Subject|0|||
147311493|NCT02291289|531309131|FG006|Induction Treatment|Withdrawal by Subject|0|||
147311494|NCT02291289|531309132|FG007|Induction Treatment|Withdrawal by Subject|0|||
147311495|NCT02291289|531309133|FG008|Induction Treatment|Withdrawal by Subject|0|||
147311496|NCT02291289|531309134|FG009|Induction Treatment|Withdrawal by Subject|18|||
147311497|NCT02291289|531309135|FG010|Induction Treatment|Withdrawal by Subject|0|||
147311498|NCT02291289|531309136|FG011|Induction Treatment|Withdrawal by Subject|0|||
147311499|NCT02291289|531309137|FG012|Induction Treatment|Withdrawal by Subject|0|||
147311500|NCT02291289|531309125|FG000|Induction Treatment|Adverse Event|0|||
147311501|NCT02291289|531309126|FG001|Induction Treatment|Adverse Event|0|||
147311502|NCT02291289|531309127|FG002|Induction Treatment|Adverse Event|0|||
147311503|NCT02291289|531309128|FG003|Induction Treatment|Adverse Event|3|||
147311504|NCT02291289|531309129|FG004|Induction Treatment|Adverse Event|0|||
147311505|NCT02291289|531309130|FG005|Induction Treatment|Adverse Event|0|||
147311506|NCT02291289|531309131|FG006|Induction Treatment|Adverse Event|0|||
147311507|NCT02291289|531309132|FG007|Induction Treatment|Adverse Event|0|||
147311508|NCT02291289|531309133|FG008|Induction Treatment|Adverse Event|0|||
147311509|NCT02291289|531309134|FG009|Induction Treatment|Adverse Event|1|||
147562185|NCT01856309|532215649|FG002|Overall Study|Other|447|||
147562186|NCT01856309|532215650|FG003|Overall Study|Other|469|||
147562187|NCT01856309|532215647|FG000|Overall Study|Lack of Efficacy|14|||
147311510|NCT02291289|531309135|FG010|Induction Treatment|Adverse Event|0|||
147311511|NCT02291289|531309136|FG011|Induction Treatment|Adverse Event|0|||
147311512|NCT02291289|531309137|FG012|Induction Treatment|Adverse Event|0|||
147311513|NCT02291289|531309125|FG000|Induction Treatment|Death|25|||
147311514|NCT02291289|531309126|FG001|Induction Treatment|Death|0|||
147562188|NCT01856309|532215648|FG001|Overall Study|Lack of Efficacy|9|||
147311515|NCT02291289|531309127|FG002|Induction Treatment|Death|0|||
147311516|NCT02291289|531309128|FG003|Induction Treatment|Death|111|||
147311517|NCT02291289|531309129|FG004|Induction Treatment|Death|0|||
147311518|NCT02291289|531309130|FG005|Induction Treatment|Death|0|||
147311519|NCT02291289|531309131|FG006|Induction Treatment|Death|1|||
147311520|NCT02291289|531309132|FG007|Induction Treatment|Death|0|||
147311521|NCT02291289|531309133|FG008|Induction Treatment|Death|0|||
147311522|NCT02291289|531309134|FG009|Induction Treatment|Death|82|||
147311523|NCT02291289|531309135|FG010|Induction Treatment|Death|0|||
147311524|NCT02291289|531309136|FG011|Induction Treatment|Death|0|||
147311525|NCT02291289|531309137|FG012|Induction Treatment|Death|0|||
147311526|NCT02291289|531309125|FG000|Induction Treatment|Lost to Follow-up|1|||
147311527|NCT02291289|531309126|FG001|Induction Treatment|Lost to Follow-up|0|||
147311528|NCT02291289|531309127|FG002|Induction Treatment|Lost to Follow-up|0|||
147311529|NCT02291289|531309128|FG003|Induction Treatment|Lost to Follow-up|12|||
147562189|NCT01856309|532215649|FG002|Overall Study|Lack of Efficacy|40|||
147562190|NCT01856309|532215650|FG003|Overall Study|Lack of Efficacy|25|||
147311530|NCT02291289|531309129|FG004|Induction Treatment|Lost to Follow-up|0|||
147311531|NCT02291289|531309130|FG005|Induction Treatment|Lost to Follow-up|0|||
147311532|NCT02291289|531309131|FG006|Induction Treatment|Lost to Follow-up|0|||
147311533|NCT02291289|531309132|FG007|Induction Treatment|Lost to Follow-up|0|||
147311534|NCT02291289|531309133|FG008|Induction Treatment|Lost to Follow-up|0|||
147311535|NCT02291289|531309134|FG009|Induction Treatment|Lost to Follow-up|9|||
147311536|NCT02291289|531309135|FG010|Induction Treatment|Lost to Follow-up|0|||
147311537|NCT02291289|531309136|FG011|Induction Treatment|Lost to Follow-up|0|||
147311538|NCT02291289|531309137|FG012|Induction Treatment|Lost to Follow-up|0|||
147311539|NCT02291289|531309125|FG000|Induction Treatment|Non-Compliance|0|||
147311540|NCT02291289|531309126|FG001|Induction Treatment|Non-Compliance|0|||
147311541|NCT02291289|531309127|FG002|Induction Treatment|Non-Compliance|0|||
147311542|NCT02291289|531309128|FG003|Induction Treatment|Non-Compliance|1|||
147311543|NCT02291289|531309129|FG004|Induction Treatment|Non-Compliance|0|||
147311544|NCT02291289|531309130|FG005|Induction Treatment|Non-Compliance|0|||
147311545|NCT02291289|531309131|FG006|Induction Treatment|Non-Compliance|0|||
147311546|NCT02291289|531309132|FG007|Induction Treatment|Non-Compliance|0|||
147311547|NCT02291289|531309133|FG008|Induction Treatment|Non-Compliance|0|||
147311548|NCT02291289|531309134|FG009|Induction Treatment|Non-Compliance|1|||
147311549|NCT02291289|531309135|FG010|Induction Treatment|Non-Compliance|0|||
147311550|NCT02291289|531309136|FG011|Induction Treatment|Non-Compliance|0|||
147311551|NCT02291289|531309137|FG012|Induction Treatment|Non-Compliance|0|||
147311552|NCT02291289|531309125|FG000|Induction Treatment|Reason Not Specified|0|||
147311553|NCT02291289|531309126|FG001|Induction Treatment|Reason Not Specified|0|||
147311554|NCT02291289|531309127|FG002|Induction Treatment|Reason Not Specified|0|||
147311555|NCT02291289|531309128|FG003|Induction Treatment|Reason Not Specified|4|||
147311556|NCT02291289|531309129|FG004|Induction Treatment|Reason Not Specified|0|||
147311557|NCT02291289|531309130|FG005|Induction Treatment|Reason Not Specified|0|||
147311558|NCT02291289|531309131|FG006|Induction Treatment|Reason Not Specified|0|||
147311559|NCT02291289|531309132|FG007|Induction Treatment|Reason Not Specified|0|||
147311560|NCT02291289|531309133|FG008|Induction Treatment|Reason Not Specified|0|||
147311561|NCT02291289|531309134|FG009|Induction Treatment|Reason Not Specified|7|||
147311562|NCT02291289|531309135|FG010|Induction Treatment|Reason Not Specified|0|||
147311563|NCT02291289|531309136|FG011|Induction Treatment|Reason Not Specified|0|||
147311564|NCT02291289|531309137|FG012|Induction Treatment|Reason Not Specified|0|||
147311565|NCT02291289|531309125|FG000|Induction Treatment|Physician Decision|0|||
147311566|NCT02291289|531309126|FG001|Induction Treatment|Physician Decision|0|||
147311567|NCT02291289|531309127|FG002|Induction Treatment|Physician Decision|0|||
147227363|NCT02147184|531005773|FG000|Overall Study|Other|1|||
147227364|NCT02147184|531005774|FG001|Overall Study|Other|0|||
147227365|NCT06400979|531005775|FG000|Overall Study|Lost to Follow-up|29|||
147227366|NCT06400979|531005775|FG000|Overall Study|Withdrawal by Subject|1|||
147227367|NCT00117286|531005778|FG000|Overall Study|Adverse Event|12|||
147227368|NCT00117286|531005779|FG001|Overall Study|Adverse Event|6|||
147227369|NCT00117286|531005778|FG000|Overall Study|Lost to Follow-up|2|||
147227370|NCT00117286|531005779|FG001|Overall Study|Lost to Follow-up|0|||
147311568|NCT02291289|531309128|FG003|Induction Treatment|Physician Decision|3|||
147311569|NCT02291289|531309129|FG004|Induction Treatment|Physician Decision|0|||
147562191|NCT01856309|532215647|FG000|Overall Study|Adverse Event|31|||
147562192|NCT01856309|532215648|FG001|Overall Study|Adverse Event|31|||
147562193|NCT01856309|532215649|FG002|Overall Study|Adverse Event|55|||
147562194|NCT01856309|532215650|FG003|Overall Study|Adverse Event|65|||
147562195|NCT01856309|532215647|FG000|Overall Study|Pregnancy|0|||
147562196|NCT01856309|532215648|FG001|Overall Study|Pregnancy|0|||
147562197|NCT01856309|532215649|FG002|Overall Study|Pregnancy|0|||
147562198|NCT01856309|532215650|FG003|Overall Study|Pregnancy|1|||
147562199|NCT01856309|532215647|FG000|Overall Study|Physician Decision|6|||
147562200|NCT01856309|532215648|FG001|Overall Study|Physician Decision|1|||
147562201|NCT01856309|532215649|FG002|Overall Study|Physician Decision|6|||
147562202|NCT01856309|532215650|FG003|Overall Study|Physician Decision|8|||
147562203|NCT01856309|532215647|FG000|Overall Study|Noncompliance With Study Drug|0|||
147311570|NCT02291289|531309130|FG005|Induction Treatment|Physician Decision|0|||
147311571|NCT02291289|531309131|FG006|Induction Treatment|Physician Decision|0|||
147311572|NCT02291289|531309132|FG007|Induction Treatment|Physician Decision|0|||
147311573|NCT02291289|531309133|FG008|Induction Treatment|Physician Decision|0|||
147311574|NCT02291289|531309134|FG009|Induction Treatment|Physician Decision|1|||
147311575|NCT02291289|531309135|FG010|Induction Treatment|Physician Decision|0|||
147311576|NCT02291289|531309136|FG011|Induction Treatment|Physician Decision|0|||
147311577|NCT02291289|531309137|FG012|Induction Treatment|Physician Decision|0|||
147311578|NCT02291289|531309125|FG000|Induction Treatment|Protocol Violation|0|||
147311579|NCT02291289|531309126|FG001|Induction Treatment|Protocol Violation|0|||
147227371|NCT00117286|531005778|FG000|Overall Study|Protocol Violation|3|||
147311580|NCT02291289|531309127|FG002|Induction Treatment|Protocol Violation|0|||
147562204|NCT01856309|532215648|FG001|Overall Study|Noncompliance With Study Drug|1|||
147227372|NCT00117286|531005779|FG001|Overall Study|Protocol Violation|3|||
147562205|NCT01856309|532215649|FG002|Overall Study|Noncompliance With Study Drug|4|||
147562206|NCT01856309|532215650|FG003|Overall Study|Noncompliance With Study Drug|1|||
147562207|NCT00220337|532215651|FG000|Overall Study|Adverse Event|70|||
147562208|NCT00220337|532215651|FG000|Overall Study|Lack of Efficacy|17|||
147562209|NCT00220337|532215651|FG000|Overall Study|Withdrawal by Subject|68|||
147562210|NCT00220337|532215651|FG000|Overall Study|Protocol Violation|2|||
147227373|NCT00117286|531005778|FG000|Overall Study|Withdrawal by Subject|6|||
147227374|NCT00117286|531005779|FG001|Overall Study|Withdrawal by Subject|2|||
147227375|NCT00117286|531005778|FG000|Overall Study|Physician Decision|3|||
147227376|NCT00117286|531005779|FG001|Overall Study|Physician Decision|7|||
147227377|NCT00117286|531005778|FG000|Overall Study|Lack of Efficacy|2|||
147227378|NCT00117286|531005779|FG001|Overall Study|Lack of Efficacy|1|||
147227379|NCT00117286|531005778|FG000|Overall Study|Research site closing|0|||
147227380|NCT00117286|531005779|FG001|Overall Study|Research site closing|2|||
147227381|NCT01272661|531005780|FG000|Overall Study|lost to followup/case closed/ no birth|126|||
147227382|NCT01272661|531005781|FG001|Overall Study|lost to followup/case closed/ no birth|209|||
147227383|NCT01272661|531005782|FG002|Overall Study|lost to followup/case closed/ no birth|72|||
147227384|NCT02314143|531005783|FG000|Overall Study|Adverse Event|0|||
147227385|NCT02314143|531005784|FG001|Overall Study|Adverse Event|6|||
147227386|NCT02314143|531005785|FG002|Overall Study|Adverse Event|4|||
147227387|NCT02314143|531005783|FG000|Overall Study|Other (Study Closed/Terminated)|5|||
147227388|NCT02314143|531005784|FG001|Overall Study|Other (Study Closed/Terminated)|3|||
147227389|NCT02314143|531005785|FG002|Overall Study|Other (Study Closed/Terminated)|4|||
147227390|NCT02314143|531005783|FG000|Overall Study|Physician Decision|2|||
147227391|NCT02314143|531005784|FG001|Overall Study|Physician Decision|1|||
147227392|NCT02314143|531005785|FG002|Overall Study|Physician Decision|0|||
147227393|NCT02314143|531005783|FG000|Overall Study|Withdrawal by Subject|1|||
147227394|NCT02314143|531005784|FG001|Overall Study|Withdrawal by Subject|0|||
147227395|NCT02314143|531005785|FG002|Overall Study|Withdrawal by Subject|1|||
147227396|NCT03963401|531005786|FG000|Initial Period (Day 1 - Week 16)|Adverse Event|1|||
147227397|NCT03963401|531005787|FG001|Initial Period (Day 1 - Week 16)|Adverse Event|2|||
147227398|NCT03963401|531005788|FG002|Initial Period (Day 1 - Week 16)|Adverse Event|0|||
147227399|NCT03963401|531005789|FG003|Initial Period (Day 1 - Week 16)|Adverse Event|0|||
147227400|NCT03963401|531005790|FG004|Initial Period (Day 1 - Week 16)|Adverse Event|1|||
147227401|NCT03963401|531005791|FG005|Initial Period (Day 1 - Week 16)|Adverse Event|2|||
147227402|NCT03963401|531005786|FG000|Initial Period (Day 1 - Week 16)|Lack of Efficacy|0|||
147227403|NCT03963401|531005787|FG001|Initial Period (Day 1 - Week 16)|Lack of Efficacy|0|||
147227404|NCT03963401|531005788|FG002|Initial Period (Day 1 - Week 16)|Lack of Efficacy|1|||
147227405|NCT03963401|531005789|FG003|Initial Period (Day 1 - Week 16)|Lack of Efficacy|1|||
147227406|NCT03963401|531005790|FG004|Initial Period (Day 1 - Week 16)|Lack of Efficacy|0|||
147227407|NCT03963401|531005791|FG005|Initial Period (Day 1 - Week 16)|Lack of Efficacy|0|||
147227408|NCT03963401|531005786|FG000|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|2|||
147227409|NCT03963401|531005787|FG001|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|1|||
147227410|NCT03963401|531005788|FG002|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|1|||
147227411|NCT03963401|531005789|FG003|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|1|||
147227412|NCT03963401|531005790|FG004|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|2|||
147227413|NCT03963401|531005791|FG005|Initial Period (Day 1 - Week 16)|Withdrawal by Subject|0|||
147227414|NCT03963401|531005786|FG000|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0|||
147227415|NCT03963401|531005787|FG001|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|1|||
147227416|NCT03963401|531005788|FG002|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0|||
147227417|NCT03963401|531005789|FG003|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0|||
147227418|NCT03963401|531005790|FG004|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0|||
147227419|NCT03963401|531005791|FG005|Initial Period (Day 1 - Week 16)|Randomized but Not Treated|0|||
147227420|NCT03963401|531005786|FG000|Extension Period (Week 17 - Week 52)|Adverse Event|6|||
147227421|NCT03963401|531005787|FG001|Extension Period (Week 17 - Week 52)|Adverse Event|3|||
147227422|NCT03963401|531005788|FG002|Extension Period (Week 17 - Week 52)|Adverse Event|2|||
147227423|NCT03963401|531005789|FG003|Extension Period (Week 17 - Week 52)|Adverse Event|0|||
147227424|NCT03963401|531005790|FG004|Extension Period (Week 17 - Week 52)|Adverse Event|4|||
147227425|NCT03963401|531005791|FG005|Extension Period (Week 17 - Week 52)|Adverse Event|3|||
147311581|NCT02291289|531309128|FG003|Induction Treatment|Protocol Violation|3|||
147311582|NCT02291289|531309129|FG004|Induction Treatment|Protocol Violation|0|||
147311583|NCT02291289|531309130|FG005|Induction Treatment|Protocol Violation|0|||
147562211|NCT00220337|532215651|FG000|Overall Study|Lost to Follow-up|5|||
147562212|NCT00220337|532215651|FG000|Overall Study|Other|12|||
147227426|NCT03963401|531005786|FG000|Extension Period (Week 17 - Week 52)|Lack of Efficacy|1|||
147227427|NCT03963401|531005787|FG001|Extension Period (Week 17 - Week 52)|Lack of Efficacy|0|||
147311584|NCT02291289|531309131|FG006|Induction Treatment|Protocol Violation|0|||
147311585|NCT02291289|531309132|FG007|Induction Treatment|Protocol Violation|0|||
147227428|NCT03963401|531005788|FG002|Extension Period (Week 17 - Week 52)|Lack of Efficacy|1|||
147227429|NCT03963401|531005789|FG003|Extension Period (Week 17 - Week 52)|Lack of Efficacy|0|||
147227430|NCT03963401|531005790|FG004|Extension Period (Week 17 - Week 52)|Lack of Efficacy|0|||
147562213|NCT00220337|532215651|FG000|Overall Study|Unsatisfactory compliance|5|||
147562214|NCT02327130|532215652|FG000|Overall Study|Discharged in less than 5 days|5|||
147562215|NCT02327130|532215652|FG000|Overall Study|Physician Decision|2|||
147562216|NCT02327130|532215652|FG000|Overall Study|Unable to provide breath sample|1|||
147562217|NCT02327130|532215652|FG000|Overall Study|Incorrectly place ventilator adaptor|1|||
147562218|NCT02327130|532215652|FG000|Overall Study|Met exclusion criteria|3|||
147562219|NCT05214560|532215654|FG000|Overall Study|Screening Failure|1|||
147562220|NCT05214560|532215654|FG000|Overall Study|Physician Decision|4|||
147562221|NCT05214560|532215654|FG000|Overall Study|Withdrawal by Subject|1|||
147562222|NCT05214560|532215654|FG000|Overall Study|Lost to Follow-up|2|||
147562223|NCT05214560|532215654|FG000|Overall Study|General anesthesia at the request of the surgeon|2|||
147562224|NCT05214560|532215654|FG000|Overall Study|Study physician not available for the anesthesia|3|||
147562225|NCT05214560|532215654|FG000|Overall Study|Anesthesia rejected by the patient on the day of surgery|1|||
147562226|NCT05214560|532215654|FG000|Overall Study|Device not listed in the study was used for the procedure|1|||
147562227|NCT05214560|532215654|FG000|Overall Study|Surgery not performed|3|||
147562228|NCT02672553|532215655|FG000|Overall Study|Death|3|||
147227431|NCT03963401|531005791|FG005|Extension Period (Week 17 - Week 52)|Lack of Efficacy|0|||
147227432|NCT03963401|531005786|FG000|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0|||
147227433|NCT03963401|531005787|FG001|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0|||
147227434|NCT03963401|531005788|FG002|Extension Period (Week 17 - Week 52)|Lost to Follow-up|1|||
147227435|NCT03963401|531005789|FG003|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0|||
147227436|NCT03963401|531005790|FG004|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0|||
147227437|NCT03963401|531005791|FG005|Extension Period (Week 17 - Week 52)|Lost to Follow-up|0|||
147227438|NCT03963401|531005786|FG000|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|1|||
147227439|NCT03963401|531005787|FG001|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0|||
147227440|NCT03963401|531005788|FG002|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0|||
147227441|NCT03963401|531005789|FG003|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0|||
147227442|NCT03963401|531005790|FG004|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0|||
147227443|NCT03963401|531005791|FG005|Extension Period (Week 17 - Week 52)|Non-Compliance With Study Drug|0|||
147227444|NCT03963401|531005786|FG000|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|4|||
147227445|NCT03963401|531005787|FG001|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|1|||
147227446|NCT03963401|531005788|FG002|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|0|||
147227447|NCT03963401|531005789|FG003|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|0|||
147227448|NCT03963401|531005790|FG004|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|1|||
147227449|NCT03963401|531005791|FG005|Extension Period (Week 17 - Week 52)|Withdrawal by Subject|1|||
147227450|NCT03963401|531005786|FG000|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|1|||
147227451|NCT03963401|531005787|FG001|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0|||
147227452|NCT03963401|531005788|FG002|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0|||
147227453|NCT03963401|531005789|FG003|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0|||
147227454|NCT03963401|531005790|FG004|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0|||
147227455|NCT03963401|531005791|FG005|Extension Period (Week 17 - Week 52)|No Longer Meets Eligibility Criteria|0|||
147227456|NCT03963401|531005786|FG000|Extension Period (Week 17 - Week 52)|Other|1|||
147227457|NCT03963401|531005787|FG001|Extension Period (Week 17 - Week 52)|Other|1|||
147227458|NCT03963401|531005788|FG002|Extension Period (Week 17 - Week 52)|Other|0|||
147227459|NCT03963401|531005789|FG003|Extension Period (Week 17 - Week 52)|Other|1|||
147227460|NCT03963401|531005790|FG004|Extension Period (Week 17 - Week 52)|Other|1|||
147227461|NCT03963401|531005791|FG005|Extension Period (Week 17 - Week 52)|Other|1|||
147227462|NCT01982331|531005792|FG000|Received Vaccination 2|Adverse Event|1|||
147227463|NCT01982331|531005793|FG001|Received Vaccination 2|Adverse Event|2|||
147227464|NCT01982331|531005792|FG000|Received Vaccination 2|Withdrawal by Subject|0|||
147227465|NCT01982331|531005793|FG001|Received Vaccination 2|Withdrawal by Subject|1|||
147227466|NCT01982331|531005792|FG000|Completed Study (Day 112)|Withdrawal by Subject|2|||
147227467|NCT01982331|531005793|FG001|Completed Study (Day 112)|Withdrawal by Subject|0|||
147227468|NCT00237185|531005794|FG000|Core|Adverse Event|3|||
147227469|NCT00237185|531005795|FG001|Core|Adverse Event|4|||
147227470|NCT00237185|531005794|FG000|Core|Abnormal laboratory value|0|||
147227471|NCT00237185|531005795|FG001|Core|Abnormal laboratory value|4|||
147227472|NCT00237185|531005794|FG000|Core|Abnormal test procedure results|1|||
147227473|NCT00237185|531005795|FG001|Core|Abnormal test procedure results|0|||
147227474|NCT00237185|531005794|FG000|Core|Lack of Efficacy|30|||
147227475|NCT00237185|531005795|FG001|Core|Lack of Efficacy|23|||
147227476|NCT00237185|531005794|FG000|Core|Protocol Violation|1|||
147227477|NCT00237185|531005795|FG001|Core|Protocol Violation|1|||
147227478|NCT00237185|531005794|FG000|Core|Withdrawal by Subject|4|||
147227479|NCT00237185|531005795|FG001|Core|Withdrawal by Subject|4|||
147227480|NCT00237185|531005794|FG000|Core|Administrative problems|0|||
147227481|NCT00237185|531005795|FG001|Core|Administrative problems|1|||
147227482|NCT00237185|531005794|FG000|Core|Death|4|||
147227483|NCT00237185|531005795|FG001|Core|Death|0|||
147227484|NCT00237185|531005794|FG000|Core|Determined ineligible post randomization|1|||
147444353|NCT01349465|531792577|FG001|Overall Study|Death|0|||
147562229|NCT02672553|532215656|FG001|Overall Study|Death|5|||
147562230|NCT02672553|532215655|FG000|Overall Study|Valve Explant|1|||
147227485|NCT00237185|531005795|FG001|Core|Determined ineligible post randomization|0|||
147227486|NCT00237185|531005794|FG000|Extension|Adverse Event|1|||
147227487|NCT00237185|531005795|FG001|Extension|Adverse Event|0|||
147227488|NCT00237185|531005794|FG000|Extension|Abnormal laboratory value|0|||
147227489|NCT00237185|531005795|FG001|Extension|Abnormal laboratory value|1|||
147227490|NCT00237185|531005794|FG000|Extension|Lack of Efficacy|9|||
147227491|NCT00237185|531005795|FG001|Extension|Lack of Efficacy|14|||
147227492|NCT00237185|531005794|FG000|Extension|Condition no longer required study drug|0|||
147227493|NCT00237185|531005795|FG001|Extension|Condition no longer required study drug|1|||
147227494|NCT00237185|531005794|FG000|Extension|Withdrawal by Subject|3|||
147227495|NCT00237185|531005795|FG001|Extension|Withdrawal by Subject|2|||
147227496|NCT00237185|531005794|FG000|Extension|Lost to Follow-up|1|||
147227497|NCT00237185|531005795|FG001|Extension|Lost to Follow-up|0|||
147227498|NCT00237185|531005794|FG000|Extension|Administrative problems|1|||
147227499|NCT00237185|531005795|FG001|Extension|Administrative problems|0|||
147227500|NCT00237185|531005794|FG000|Extension|Death|1|||
147227501|NCT00237185|531005795|FG001|Extension|Death|1|||
147227502|NCT05211284|531005797|FG000|Overall Study|Study Terminated|3|||
147227503|NCT05211284|531005798|FG001|Overall Study|Study Terminated|1|||
147227504|NCT02750943|531005805|FG000|Overall Study|Lost to Follow-up|1|||
147227505|NCT02750943|531005806|FG001|Overall Study|Lost to Follow-up|2|||
147227506|NCT02750943|531005805|FG000|Overall Study|Withdrawal by Subject|5|||
147227507|NCT02750943|531005806|FG001|Overall Study|Withdrawal by Subject|7|||
147227508|NCT00395538|531005807|FG000|Overall Study|Did not re-consent to revised protocol|1|||
147227509|NCT00395538|531005808|FG001|Overall Study|Did not re-consent to revised protocol|10|||
147227510|NCT00395538|531005809|FG002|Overall Study|Did not re-consent to revised protocol|0|||
147227511|NCT00395538|531005807|FG000|Overall Study|FDA partial hold on PTH|0|||
147227512|NCT00395538|531005808|FG001|Overall Study|FDA partial hold on PTH|0|||
147227513|NCT00395538|531005809|FG002|Overall Study|FDA partial hold on PTH|11|||
147227514|NCT00395538|531005807|FG000|Overall Study|Failed screening|0|||
147227515|NCT00395538|531005808|FG001|Overall Study|Failed screening|0|||
147227516|NCT00395538|531005809|FG002|Overall Study|Failed screening|4|||
147227517|NCT00395538|531005807|FG000|Overall Study|Switch to Natpara|0|||
147227518|NCT00395538|531005808|FG001|Overall Study|Switch to Natpara|0|||
147227519|NCT00395538|531005809|FG002|Overall Study|Switch to Natpara|3|||
147227520|NCT00395538|531005807|FG000|Overall Study|Adverse Event|1|||
147227521|NCT00395538|531005808|FG001|Overall Study|Adverse Event|0|||
147227522|NCT00395538|531005809|FG002|Overall Study|Adverse Event|2|||
147227523|NCT00395538|531005807|FG000|Overall Study|DXA or QCT z-score or t-score<-2|0|||
147444354|NCT01349465|531792576|FG000|Overall Study|Lost to Follow-up|10|||
147444355|NCT01349465|531792577|FG001|Overall Study|Lost to Follow-up|1|||
147444356|NCT01349465|531792576|FG000|Overall Study|Withdrawal by Subject|4|||
147444357|NCT01349465|531792577|FG001|Overall Study|Withdrawal by Subject|2|||
147444358|NCT01349465|531792576|FG000|Overall Study|Subject Ineligible To Continue The Trial|0|||
147444359|NCT01349465|531792577|FG001|Overall Study|Subject Ineligible To Continue The Trial|19|||
147444360|NCT04329702|531792584|FG000|Overall Study|illness|3|||
147444361|NCT04329702|531792585|FG001|Overall Study|illness|4|||
147444362|NCT04329702|531792586|FG002|Overall Study|illness|0|||
147444363|NCT04329702|531792584|FG000|Overall Study|Lost to Follow-up|0|||
147444364|NCT04329702|531792585|FG001|Overall Study|Lost to Follow-up|0|||
147444365|NCT04329702|531792586|FG002|Overall Study|Lost to Follow-up|2|||
147444366|NCT04329702|531792584|FG000|Overall Study|Death|0|||
147444367|NCT04329702|531792585|FG001|Overall Study|Death|2|||
147444368|NCT04329702|531792586|FG002|Overall Study|Death|0|||
147444369|NCT01438489|531792587|FG000|Overall Study|Lost to Follow-up|4|||
147444370|NCT01438489|531792588|FG001|Overall Study|Lost to Follow-up|2|||
147444371|NCT01438489|531792589|FG002|Overall Study|Lost to Follow-up|2|||
147444372|NCT01438489|531792587|FG000|Overall Study|Withdrawal by Subject|11|||
147444373|NCT01438489|531792588|FG001|Overall Study|Withdrawal by Subject|3|||
147444374|NCT01438489|531792589|FG002|Overall Study|Withdrawal by Subject|8|||
147444375|NCT01438489|531792587|FG000|Overall Study|Death|0|||
147562231|NCT02672553|532215656|FG001|Overall Study|Valve Explant|0|||
147562232|NCT02672553|532215655|FG000|Overall Study|Conversion to Commercial Valve|3|||
147562233|NCT02672553|532215656|FG001|Overall Study|Conversion to Commercial Valve|0|||
147562234|NCT02672553|532215655|FG000|Overall Study|Withdrawal by Subject|3|||
147227524|NCT00395538|531005808|FG001|Overall Study|DXA or QCT z-score or t-score<-2|2|||
147227525|NCT00395538|531005809|FG002|Overall Study|DXA or QCT z-score or t-score<-2|0|||
147227526|NCT00395538|531005807|FG000|Overall Study|Non-compliance with study protocol|0|||
147227527|NCT00395538|531005808|FG001|Overall Study|Non-compliance with study protocol|1|||
147227528|NCT00395538|531005809|FG002|Overall Study|Non-compliance with study protocol|0|||
147227529|NCT00395538|531005807|FG000|Overall Study|PTH resistance|0|||
147444376|NCT01438489|531792588|FG001|Overall Study|Death|0|||
147444377|NCT01438489|531792589|FG002|Overall Study|Death|1|||
147227530|NCT00395538|531005808|FG001|Overall Study|PTH resistance|0|||
147444378|NCT01438489|531792587|FG000|Overall Study|Sponsor decision|4|||
147227531|NCT00395538|531005809|FG002|Overall Study|PTH resistance|1|||
147227532|NCT00395538|531005807|FG000|Overall Study|Pregnancy|1|||
147311586|NCT02291289|531309133|FG008|Induction Treatment|Protocol Violation|0|||
147311587|NCT02291289|531309134|FG009|Induction Treatment|Protocol Violation|2|||
147311588|NCT02291289|531309135|FG010|Induction Treatment|Protocol Violation|0|||
147311589|NCT02291289|531309136|FG011|Induction Treatment|Protocol Violation|0|||
147311590|NCT02291289|531309137|FG012|Induction Treatment|Protocol Violation|0|||
147311591|NCT02291289|531309125|FG000|Induction Treatment|Missing|4|||
147311592|NCT02291289|531309126|FG001|Induction Treatment|Missing|0|||
147311593|NCT02291289|531309127|FG002|Induction Treatment|Missing|0|||
147311594|NCT02291289|531309128|FG003|Induction Treatment|Missing|14|||
147311595|NCT02291289|531309129|FG004|Induction Treatment|Missing|0|||
147311596|NCT02291289|531309130|FG005|Induction Treatment|Missing|0|||
147311597|NCT02291289|531309131|FG006|Induction Treatment|Missing|0|||
147311598|NCT02291289|531309132|FG007|Induction Treatment|Missing|0|||
147311599|NCT02291289|531309133|FG008|Induction Treatment|Missing|0|||
147311600|NCT02291289|531309134|FG009|Induction Treatment|Missing|54|||
147311601|NCT02291289|531309135|FG010|Induction Treatment|Missing|0|||
147311602|NCT02291289|531309136|FG011|Induction Treatment|Missing|0|||
147562235|NCT02672553|532215656|FG001|Overall Study|Withdrawal by Subject|3|||
147562236|NCT02672553|532215655|FG000|Overall Study|Intraoperative screen failure|2|||
147562237|NCT02672553|532215656|FG001|Overall Study|Intraoperative screen failure|0|||
147311603|NCT02291289|531309137|FG012|Induction Treatment|Missing|0|||
147311604|NCT02291289|531309125|FG000|Maintenance Treatment Phase|Withdrawal by Subject|0|||
147311605|NCT02291289|531309126|FG001|Maintenance Treatment Phase|Withdrawal by Subject|0|||
147562238|NCT02003183|532215657|FG000|Overall Study|Lost to Follow-up|0|||
147562239|NCT02003183|532215658|FG001|Overall Study|Lost to Follow-up|2|||
147562240|NCT02343120|532215661|FG000|Part 1: Dose Escalation|Sponsor decision|1|||
147562241|NCT02343120|532215662|FG001|Part 1: Dose Escalation|Sponsor decision|2|||
147562242|NCT02343120|532215663|FG002|Part 1: Dose Escalation|Sponsor decision|3|||
147562243|NCT02343120|532215664|FG003|Part 1: Dose Escalation|Sponsor decision|2|||
147562244|NCT02343120|532215665|FG004|Part 1: Dose Escalation|Sponsor decision|0|||
147562245|NCT02343120|532215661|FG000|Part 1: Dose Escalation|Death|1|||
147562246|NCT02343120|532215662|FG001|Part 1: Dose Escalation|Death|2|||
147562247|NCT02343120|532215663|FG002|Part 1: Dose Escalation|Death|2|||
147562248|NCT02343120|532215664|FG003|Part 1: Dose Escalation|Death|2|||
147562249|NCT02343120|532215665|FG004|Part 1: Dose Escalation|Death|1|||
147562250|NCT02343120|532215661|FG000|Part 1: Dose Escalation|Lost to Follow-up|1|||
147562251|NCT02343120|532215662|FG001|Part 1: Dose Escalation|Lost to Follow-up|0|||
147562252|NCT02343120|532215663|FG002|Part 1: Dose Escalation|Lost to Follow-up|0|||
147562253|NCT02343120|532215664|FG003|Part 1: Dose Escalation|Lost to Follow-up|0|||
147562254|NCT02343120|532215665|FG004|Part 1: Dose Escalation|Lost to Follow-up|0|||
147562255|NCT02343120|532215661|FG000|Part 2: Expansion|Sponsor decision|0|||
147562256|NCT02343120|532215662|FG001|Part 2: Expansion|Sponsor decision|0|||
147562257|NCT02343120|532215663|FG002|Part 2: Expansion|Sponsor decision|0|||
147562258|NCT02343120|532215664|FG003|Part 2: Expansion|Sponsor decision|165|||
147562259|NCT02343120|532215665|FG004|Part 2: Expansion|Sponsor decision|67|||
147562260|NCT02343120|532215661|FG000|Part 2: Expansion|Death|0|||
147562261|NCT02343120|532215662|FG001|Part 2: Expansion|Death|0|||
147562262|NCT02343120|532215663|FG002|Part 2: Expansion|Death|0|||
147562263|NCT02343120|532215664|FG003|Part 2: Expansion|Death|74|||
147562264|NCT02343120|532215665|FG004|Part 2: Expansion|Death|17|||
147562265|NCT02343120|532215661|FG000|Part 2: Expansion|Withdrawal by Subject|0|||
147562266|NCT02343120|532215662|FG001|Part 2: Expansion|Withdrawal by Subject|0|||
147562267|NCT02343120|532215663|FG002|Part 2: Expansion|Withdrawal by Subject|0|||
147562268|NCT02343120|532215664|FG003|Part 2: Expansion|Withdrawal by Subject|28|||
147562269|NCT02343120|532215665|FG004|Part 2: Expansion|Withdrawal by Subject|2|||
147562270|NCT02343120|532215661|FG000|Part 2: Expansion|Lost to Follow-up|0|||
147562271|NCT02343120|532215662|FG001|Part 2: Expansion|Lost to Follow-up|0|||
147562272|NCT02343120|532215663|FG002|Part 2: Expansion|Lost to Follow-up|0|||
147562273|NCT02343120|532215664|FG003|Part 2: Expansion|Lost to Follow-up|5|||
147562274|NCT02343120|532215665|FG004|Part 2: Expansion|Lost to Follow-up|2|||
147311606|NCT02291289|531309127|FG002|Maintenance Treatment Phase|Withdrawal by Subject|0|||
147562275|NCT02343120|532215661|FG000|Part 2: Expansion|Other|0|||
147562276|NCT02343120|532215662|FG001|Part 2: Expansion|Other|0|||
147562277|NCT02343120|532215663|FG002|Part 2: Expansion|Other|0|||
147562278|NCT02343120|532215664|FG003|Part 2: Expansion|Other|1|||
147562279|NCT02343120|532215665|FG004|Part 2: Expansion|Other|5|||
147562280|NCT02343120|532215661|FG000|Part 2: Expansion|Adverse Event|0|||
147311607|NCT02291289|531309128|FG003|Maintenance Treatment Phase|Withdrawal by Subject|0|||
147311608|NCT02291289|531309129|FG004|Maintenance Treatment Phase|Withdrawal by Subject|15|||
147562281|NCT02343120|532215662|FG001|Part 2: Expansion|Adverse Event|0|||
147562282|NCT02343120|532215663|FG002|Part 2: Expansion|Adverse Event|0|||
147562283|NCT02343120|532215664|FG003|Part 2: Expansion|Adverse Event|1|||
147562284|NCT02343120|532215665|FG004|Part 2: Expansion|Adverse Event|1|||
147562285|NCT02534493|532215668|FG000|Overall Study|Lost to Follow-up|1|||
147562286|NCT02534493|532215668|FG000|Overall Study|Withdrawal by Subject|1|||
147562287|NCT01054599|532215674|FG000|Overall Study|Dizziness due to phenytoin toxicity|1|||
147562288|NCT01054599|532215675|FG001|Overall Study|Dizziness due to phenytoin toxicity|0|||
147562289|NCT01054599|532215674|FG000|Overall Study|Protocol Violation|1|||
147562290|NCT01054599|532215675|FG001|Overall Study|Protocol Violation|0|||
147562291|NCT01054599|532215674|FG000|Overall Study|Spells/seizure-like episodes|1|||
147562292|NCT01054599|532215675|FG001|Overall Study|Spells/seizure-like episodes|1|||
147562293|NCT01054599|532215674|FG000|Overall Study|Timing/scheduling difficulties|1|||
147562294|NCT01054599|532215675|FG001|Overall Study|Timing/scheduling difficulties|1|||
147562295|NCT01054599|532215674|FG000|Overall Study|Visual impairment, WTAR <80|0|||
147562296|NCT01054599|532215675|FG001|Overall Study|Visual impairment, WTAR <80|1|||
147562297|NCT01054599|532215674|FG000|Overall Study|Lost to Follow-up|0|||
147562298|NCT01054599|532215675|FG001|Overall Study|Lost to Follow-up|2|||
147562299|NCT01054599|532215674|FG000|Overall Study|Adverse Event|0|||
147562300|NCT01054599|532215675|FG001|Overall Study|Adverse Event|1|||
147562301|NCT01054599|532215674|FG000|Overall Study|Withdrawal by Subject|0|||
147562302|NCT01054599|532215675|FG001|Overall Study|Withdrawal by Subject|1|||
147562303|NCT01104662|532215676|FG000|Overall Study|Adverse Event|2|||
147562304|NCT01104662|532215677|FG001|Overall Study|Adverse Event|2|||
147562305|NCT01104662|532215678|FG002|Overall Study|Adverse Event|0|||
147562306|NCT01104662|532215679|FG003|Overall Study|Adverse Event|1|||
147562307|NCT01104662|532215680|FG004|Overall Study|Adverse Event|1|||
147562308|NCT01104662|532215681|FG005|Overall Study|Adverse Event|1|||
147562309|NCT01104662|532215682|FG006|Overall Study|Adverse Event|0|||
147562310|NCT01104662|532215683|FG007|Overall Study|Adverse Event|0|||
147562311|NCT01104662|532215676|FG000|Overall Study|Clinical Failure|1|||
147562312|NCT01104662|532215677|FG001|Overall Study|Clinical Failure|0|||
147562313|NCT01104662|532215678|FG002|Overall Study|Clinical Failure|0|||
147562314|NCT01104662|532215679|FG003|Overall Study|Clinical Failure|0|||
147562315|NCT01104662|532215680|FG004|Overall Study|Clinical Failure|0|||
147562316|NCT01104662|532215681|FG005|Overall Study|Clinical Failure|1|||
147562317|NCT01104662|532215682|FG006|Overall Study|Clinical Failure|0|||
147562318|NCT01104662|532215683|FG007|Overall Study|Clinical Failure|0|||
147562319|NCT01104662|532215676|FG000|Overall Study|Participant left investigator's care|1|||
147562320|NCT01104662|532215677|FG001|Overall Study|Participant left investigator's care|1|||
147562321|NCT01104662|532215678|FG002|Overall Study|Participant left investigator's care|0|||
147562322|NCT01104662|532215679|FG003|Overall Study|Participant left investigator's care|0|||
147562323|NCT01104662|532215680|FG004|Overall Study|Participant left investigator's care|0|||
147562324|NCT01104662|532215681|FG005|Overall Study|Participant left investigator's care|0|||
147562325|NCT01104662|532215682|FG006|Overall Study|Participant left investigator's care|0|||
147562326|NCT01104662|532215683|FG007|Overall Study|Participant left investigator's care|0|||
147562327|NCT01104662|532215676|FG000|Overall Study|Reason not specified|3|||
147562328|NCT01104662|532215677|FG001|Overall Study|Reason not specified|3|||
147562329|NCT01104662|532215678|FG002|Overall Study|Reason not specified|0|||
147562330|NCT01104662|532215679|FG003|Overall Study|Reason not specified|0|||
147562331|NCT01104662|532215680|FG004|Overall Study|Reason not specified|0|||
147562332|NCT01104662|532215681|FG005|Overall Study|Reason not specified|1|||
147562333|NCT01104662|532215682|FG006|Overall Study|Reason not specified|0|||
147562334|NCT01104662|532215683|FG007|Overall Study|Reason not specified|0|||
147562335|NCT01104662|532215676|FG000|Overall Study|Randomized but not treated|3|||
147562336|NCT01104662|532215677|FG001|Overall Study|Randomized but not treated|4|||
147562337|NCT01104662|532215678|FG002|Overall Study|Randomized but not treated|1|||
147562338|NCT01104662|532215679|FG003|Overall Study|Randomized but not treated|0|||
147562339|NCT01104662|532215680|FG004|Overall Study|Randomized but not treated|0|||
147562340|NCT01104662|532215681|FG005|Overall Study|Randomized but not treated|1|||
147562341|NCT01104662|532215682|FG006|Overall Study|Randomized but not treated|0|||
147562342|NCT01104662|532215683|FG007|Overall Study|Randomized but not treated|0|||
147562343|NCT00743197|532215684|FG000|Overall Study|Study terminated due to departure of PI.|1|||
147562344|NCT00743197|532215685|FG001|Overall Study|Study terminated due to departure of PI.|2|||
147562345|NCT01478620|532215686|FG000|Overall Study|Lost to Follow-up|6|||
147562346|NCT02170688|532215691|FG000|Overall Study|Exclusion Criteria: Fatty Liver|4|||
147562347|NCT02170688|532215692|FG001|Overall Study|Exclusion Criteria: Fatty Liver|2|||
147562348|NCT02170688|532215693|FG002|Overall Study|Exclusion Criteria: Fatty Liver|3|||
147562349|NCT02170688|532215694|FG003|Overall Study|Exclusion Criteria: Fatty Liver|2|||
147562350|NCT02170688|532215695|FG004|Overall Study|Exclusion Criteria: Fatty Liver|0|||
147562351|NCT02170688|532215691|FG000|Overall Study|Full dose not received|0|||
147562352|NCT02170688|532215692|FG001|Overall Study|Full dose not received|1|||
147562353|NCT02170688|532215693|FG002|Overall Study|Full dose not received|0|||
147227533|NCT00395538|531005808|FG001|Overall Study|Pregnancy|0|||
147562354|NCT02170688|532215694|FG003|Overall Study|Full dose not received|0|||
147562355|NCT02170688|532215695|FG004|Overall Study|Full dose not received|0|||
147562356|NCT02170688|532215691|FG000|Overall Study|Physician Decision|0|||
147562357|NCT02170688|532215692|FG001|Overall Study|Physician Decision|0|||
147562358|NCT02170688|532215693|FG002|Overall Study|Physician Decision|1|||
147562359|NCT02170688|532215694|FG003|Overall Study|Physician Decision|0|||
147562360|NCT02170688|532215695|FG004|Overall Study|Physician Decision|0|||
147562361|NCT01402947|532215698|FG000|First Intervention|Adverse Event|0|||
147562362|NCT01402947|532215699|FG001|First Intervention|Adverse Event|1|||
147227534|NCT00395538|531005809|FG002|Overall Study|Pregnancy|0|||
147562363|NCT01706926|532215703|FG000|Overall Study|Lost to Follow-up|0|||
147562364|NCT01706926|532215704|FG001|Overall Study|Lost to Follow-up|0|||
147562365|NCT01706926|532215705|FG002|Overall Study|Lost to Follow-up|1|||
147562366|NCT01706926|532215706|FG003|Overall Study|Lost to Follow-up|0|||
147562367|NCT01706926|532215703|FG000|Overall Study|Withdrawal by Subject|2|||
147562368|NCT01706926|532215704|FG001|Overall Study|Withdrawal by Subject|0|||
147562369|NCT01706926|532215705|FG002|Overall Study|Withdrawal by Subject|1|||
147562370|NCT01706926|532215706|FG003|Overall Study|Withdrawal by Subject|2|||
147562371|NCT01706926|532215703|FG000|Overall Study|Other|4|||
147562372|NCT01706926|532215704|FG001|Overall Study|Other|4|||
147562373|NCT01706926|532215705|FG002|Overall Study|Other|4|||
147562374|NCT01706926|532215706|FG003|Overall Study|Other|3|||
147562375|NCT04349917|532217552|FG000|First Intervention (2-4 Hours)|Withdrawal by Subject|0|||
147562376|NCT04349917|532217553|FG001|First Intervention (2-4 Hours)|Withdrawal by Subject|1|||
147562377|NCT04349917|532217552|FG000|First Intervention (2-4 Hours)|Unable to Swallow Pill|0|||
147562378|NCT04349917|532217553|FG001|First Intervention (2-4 Hours)|Unable to Swallow Pill|1|||
147562379|NCT04188106|532217560|FG000|Overall Study|Lost to Follow-up|5|||
147562380|NCT04188106|532217560|FG000|Overall Study|Non-Compliance|1|||
147562381|NCT00441467|532217561|FG000|Overall Study|Adverse Event|6|||
147562382|NCT00441467|532217561|FG000|Overall Study|Withdrawal by Subject|3|||
147562383|NCT00441467|532217561|FG000|Overall Study|Progressive disease|9|||
147562384|NCT02289963|532217562|FG000|Overall Study|Adverse Event|1|||
147562385|NCT02289963|532217563|FG001|Overall Study|Adverse Event|2|||
147562386|NCT02289963|532217562|FG000|Overall Study|Poor compliance to protocol|1|||
147562387|NCT02289963|532217563|FG001|Overall Study|Poor compliance to protocol|0|||
147562388|NCT02289963|532217562|FG000|Overall Study|Withdrawal by Subject|1|||
147562389|NCT02289963|532217563|FG001|Overall Study|Withdrawal by Subject|0|||
147562390|NCT02289963|532217562|FG000|Overall Study|Last injection missed|2|||
147562391|NCT02289963|532217563|FG001|Overall Study|Last injection missed|2|||
147562392|NCT02289963|532217562|FG000|Overall Study|End treatment visit outside visit window|0|||
147562393|NCT02289963|532217563|FG001|Overall Study|End treatment visit outside visit window|4|||
147562394|NCT02289963|532217562|FG000|Overall Study|Other than specified above|0|||
147562395|NCT02289963|532217563|FG001|Overall Study|Other than specified above|2|||
147562396|NCT01042522|532217565|FG000|Overall Study|Adverse Event|1|||
147562397|NCT01042522|532217566|FG001|Overall Study|Adverse Event|2|||
147562398|NCT01042522|532217565|FG000|Overall Study|Disease Progression|5|||
147562399|NCT01042522|532217566|FG001|Overall Study|Disease Progression|0|||
147562400|NCT01042522|532217565|FG000|Overall Study|Death|1|||
147562401|NCT01042522|532217566|FG001|Overall Study|Death|0|||
147562402|NCT01042522|532217565|FG000|Overall Study|Patient Refused|0|||
147562403|NCT01042522|532217566|FG001|Overall Study|Patient Refused|3|||
147562404|NCT01042522|532217565|FG000|Overall Study|Withdrawal by Subject|1|||
147562405|NCT01042522|532217566|FG001|Overall Study|Withdrawal by Subject|1|||
147562406|NCT01746017|532217569|FG000|Period 1|Withdrawal by Subject|0|||
147562407|NCT01746017|532217570|FG001|Period 1|Withdrawal by Subject|0|||
147562408|NCT01746017|532217571|FG002|Period 1|Withdrawal by Subject|0|||
147562409|NCT01746017|532217572|FG003|Period 1|Withdrawal by Subject|0|||
147562410|NCT01746017|532217573|FG004|Period 1|Withdrawal by Subject|0|||
147562411|NCT01746017|532217574|FG005|Period 1|Withdrawal by Subject|0|||
147562412|NCT01746017|532217575|FG006|Period 1|Withdrawal by Subject|1|||
147562413|NCT01746017|532217576|FG007|Period 1|Withdrawal by Subject|0|||
147562414|NCT01746017|532217577|FG008|Period 1|Withdrawal by Subject|0|||
147562415|NCT01746017|532217578|FG009|Period 1|Withdrawal by Subject|0|||
147562416|NCT01746017|532217579|FG010|Period 1|Withdrawal by Subject|0|||
147562417|NCT01746017|532217569|FG000|Period 3|Withdrawal by Subject|0|||
147562418|NCT01746017|532217570|FG001|Period 3|Withdrawal by Subject|0|||
147562419|NCT01746017|532217571|FG002|Period 3|Withdrawal by Subject|0|||
147227535|NCT00395538|531005807|FG000|Overall Study|Partial recovery of parathyroid function|0|||
147227536|NCT00395538|531005808|FG001|Overall Study|Partial recovery of parathyroid function|0|||
147227537|NCT00395538|531005809|FG002|Overall Study|Partial recovery of parathyroid function|1|||
147227538|NCT00395538|531005807|FG000|Overall Study|Participant elected to discontinue|0|||
147227539|NCT00395538|531005808|FG001|Overall Study|Participant elected to discontinue|0|||
147227540|NCT00395538|531005809|FG002|Overall Study|Participant elected to discontinue|1|||
147227541|NCT01857583|531005810|FG000|Overall Study|Adverse Event|0|||
147227542|NCT01857583|531005811|FG001|Overall Study|Adverse Event|0|||
147562420|NCT01746017|532217572|FG003|Period 3|Withdrawal by Subject|0|||
147562421|NCT01746017|532217573|FG004|Period 3|Withdrawal by Subject|0|||
147562422|NCT01746017|532217574|FG005|Period 3|Withdrawal by Subject|1|||
147227543|NCT01857583|531005812|FG002|Overall Study|Adverse Event|1|||
147562423|NCT01746017|532217575|FG006|Period 3|Withdrawal by Subject|0|||
147562424|NCT01746017|532217576|FG007|Period 3|Withdrawal by Subject|0|||
147562425|NCT01746017|532217577|FG008|Period 3|Withdrawal by Subject|0|||
147562426|NCT01746017|532217578|FG009|Period 3|Withdrawal by Subject|0|||
147562427|NCT01746017|532217579|FG010|Period 3|Withdrawal by Subject|0|||
147562428|NCT01507051|532217580|FG000|Overall Study|Withdrawal by Subject|1|||
147562429|NCT01507051|532217581|FG001|Overall Study|Withdrawal by Subject|3|||
147562430|NCT01507051|532217582|FG002|Overall Study|Withdrawal by Subject|1|||
147562431|NCT01507051|532217583|FG003|Overall Study|Withdrawal by Subject|6|||
147562432|NCT01507051|532217580|FG000|Overall Study|Physician Decision|0|||
147562433|NCT01507051|532217581|FG001|Overall Study|Physician Decision|0|||
147562434|NCT01507051|532217582|FG002|Overall Study|Physician Decision|0|||
147562435|NCT01507051|532217583|FG003|Overall Study|Physician Decision|1|||
147562436|NCT01507051|532217580|FG000|Overall Study|Adverse Event|1|||
147562437|NCT01507051|532217581|FG001|Overall Study|Adverse Event|0|||
147562438|NCT01507051|532217582|FG002|Overall Study|Adverse Event|0|||
147562439|NCT01507051|532217583|FG003|Overall Study|Adverse Event|0|||
147562440|NCT01675622|532217584|FG000|Overall Study|Withdrawal by Subject|2|||
147562441|NCT01675622|532217585|FG001|Overall Study|Withdrawal by Subject|2|||
147562442|NCT01675622|532217584|FG000|Overall Study|Adverse Event|12|||
147562443|NCT01675622|532217585|FG001|Overall Study|Adverse Event|10|||
147562444|NCT01675622|532217584|FG000|Overall Study|Protocol Violation|4|||
147562445|NCT01675622|532217585|FG001|Overall Study|Protocol Violation|1|||
147562446|NCT01675622|532217584|FG000|Overall Study|Lack of Efficacy|2|||
147562447|NCT01675622|532217585|FG001|Overall Study|Lack of Efficacy|4|||
147562448|NCT01675622|532217584|FG000|Overall Study|Lost to Follow-up|1|||
147562449|NCT01675622|532217585|FG001|Overall Study|Lost to Follow-up|3|||
147562450|NCT01675622|532217584|FG000|Overall Study|Other|5|||
147562451|NCT01675622|532217585|FG001|Overall Study|Other|4|||
147562452|NCT01101022|532217586|FG000|Overall Study|Adverse Event|6|||
147227544|NCT01857583|531005813|FG003|Overall Study|Adverse Event|1|||
147227545|NCT01857583|531005810|FG000|Overall Study|Death|0|||
147227546|NCT01857583|531005811|FG001|Overall Study|Death|1|||
147227547|NCT01857583|531005812|FG002|Overall Study|Death|1|||
147227548|NCT01857583|531005813|FG003|Overall Study|Death|0|||
147227549|NCT01857583|531005810|FG000|Overall Study|Physician Decision|0|||
147227550|NCT01857583|531005811|FG001|Overall Study|Physician Decision|0|||
147227551|NCT01857583|531005812|FG002|Overall Study|Physician Decision|0|||
147227552|NCT01857583|531005813|FG003|Overall Study|Physician Decision|1|||
147227553|NCT01857583|531005810|FG000|Overall Study|Withdrawal by Subject|1|||
147227554|NCT01857583|531005811|FG001|Overall Study|Withdrawal by Subject|0|||
147227555|NCT01857583|531005812|FG002|Overall Study|Withdrawal by Subject|1|||
147227556|NCT01857583|531005813|FG003|Overall Study|Withdrawal by Subject|2|||
147227557|NCT02211638|531005814|FG000|Overall Study|Case Report Forms Uncollected|291|||
147227558|NCT02211638|531005814|FG000|Overall Study|Protocol Violation|692|||
147227559|NCT04382755|531005815|FG000|Overall Study|Withdrawal by Subject|1|||
147227560|NCT04382755|531005816|FG001|Overall Study|Withdrawal by Subject|0|||
147227561|NCT04382755|531005815|FG000|Overall Study|did not receive allocated intervention due to clinical error|0|||
147227562|NCT04382755|531005816|FG001|Overall Study|did not receive allocated intervention due to clinical error|1|||
147227563|NCT04382755|531005815|FG000|Overall Study|did not meet inclusion criteria but was randomized without receiving the allocated intervention|0|||
147227564|NCT04382755|531005816|FG001|Overall Study|did not meet inclusion criteria but was randomized without receiving the allocated intervention|1|||
147227565|NCT02775903|531005821|FG000|Overall Study|Death|7|||
147227566|NCT02775903|531005822|FG001|Overall Study|Death|11|||
147227567|NCT02775903|531005823|FG002|Overall Study|Death|12|||
147227568|NCT02775903|531005824|FG003|Overall Study|Death|11|||
147227569|NCT02775903|531005821|FG000|Overall Study|Adverse Event|0|||
147227570|NCT02775903|531005822|FG001|Overall Study|Adverse Event|1|||
147227571|NCT02775903|531005823|FG002|Overall Study|Adverse Event|12|||
147227572|NCT02775903|531005824|FG003|Overall Study|Adverse Event|3|||
147227573|NCT02775903|531005821|FG000|Overall Study|Progressive disease|15|||
147227574|NCT02775903|531005822|FG001|Overall Study|Progressive disease|14|||
147227575|NCT02775903|531005823|FG002|Overall Study|Progressive disease|30|||
147227576|NCT02775903|531005824|FG003|Overall Study|Progressive disease|20|||
147227577|NCT02775903|531005821|FG000|Overall Study|Lack of Efficacy|2|||
147227578|NCT02775903|531005822|FG001|Overall Study|Lack of Efficacy|2|||
147227579|NCT02775903|531005823|FG002|Overall Study|Lack of Efficacy|2|||
147227580|NCT02775903|531005824|FG003|Overall Study|Lack of Efficacy|6|||
147227581|NCT02775903|531005821|FG000|Overall Study|Withdrawal by Subject|7|||
147227582|NCT02775903|531005822|FG001|Overall Study|Withdrawal by Subject|5|||
147227583|NCT02775903|531005823|FG002|Overall Study|Withdrawal by Subject|5|||
147227584|NCT02775903|531005824|FG003|Overall Study|Withdrawal by Subject|8|||
147227585|NCT02775903|531005821|FG000|Overall Study|Other reasons|7|||
147227586|NCT02775903|531005822|FG001|Overall Study|Other reasons|8|||
147311609|NCT02291289|531309130|FG005|Maintenance Treatment Phase|Withdrawal by Subject|12|||
147227587|NCT02775903|531005823|FG002|Overall Study|Other reasons|2|||
147227588|NCT02775903|531005824|FG003|Overall Study|Other reasons|12|||
147227589|NCT04041700|531005825|FG000|Overall Study|Pregnancy|1|||
147311610|NCT02291289|531309131|FG006|Maintenance Treatment Phase|Withdrawal by Subject|0|||
147562453|NCT01101022|532217587|FG001|Overall Study|Adverse Event|2|||
147562454|NCT01101022|532217586|FG000|Overall Study|Protocol Violation|4|||
147562455|NCT01101022|532217587|FG001|Overall Study|Protocol Violation|3|||
147562456|NCT01101022|532217586|FG000|Overall Study|Withdrawal by Subject|3|||
147227590|NCT04041700|531005825|FG000|Overall Study|Unable to visit the site due to the Covid-19 travel restrictions|1|||
147227591|NCT00458536|531005828|FG000|Overall Study|Disease progression prior to treatment|7|||
147227592|NCT00458536|531005828|FG000|Overall Study|Unable to make vaccine|3|||
147562457|NCT01101022|532217587|FG001|Overall Study|Withdrawal by Subject|8|||
147311611|NCT02291289|531309132|FG007|Maintenance Treatment Phase|Withdrawal by Subject|0|||
147311612|NCT02291289|531309133|FG008|Maintenance Treatment Phase|Withdrawal by Subject|0|||
147311613|NCT02291289|531309134|FG009|Maintenance Treatment Phase|Withdrawal by Subject|0|||
147311614|NCT02291289|531309135|FG010|Maintenance Treatment Phase|Withdrawal by Subject|2|||
147311615|NCT02291289|531309136|FG011|Maintenance Treatment Phase|Withdrawal by Subject|3|||
147311616|NCT02291289|531309137|FG012|Maintenance Treatment Phase|Withdrawal by Subject|0|||
147311617|NCT02291289|531309125|FG000|Maintenance Treatment Phase|Death|0|||
147562458|NCT01101022|532217586|FG000|Overall Study|Lost to Follow-up|1|||
147562459|NCT01101022|532217587|FG001|Overall Study|Lost to Follow-up|4|||
147562460|NCT01101022|532217586|FG000|Overall Study|Lack of Efficacy|0|||
147562461|NCT01101022|532217587|FG001|Overall Study|Lack of Efficacy|7|||
147562462|NCT01101022|532217586|FG000|Overall Study|Sponsor decision|1|||
147562463|NCT01101022|532217587|FG001|Overall Study|Sponsor decision|1|||
147227593|NCT00458536|531005828|FG000|Overall Study|No measurable disease after surgery|2|||
147227594|NCT00458536|531005828|FG000|Overall Study|Did not have renal cell carcinoma|2|||
147227595|NCT00458536|531005828|FG000|Overall Study|Patient did not have surgery|1|||
147227596|NCT00458536|531005828|FG000|Overall Study|Ineligible due to toxicity|1|||
147227597|NCT00458536|531005828|FG000|Overall Study|Withdrawal by Subject|1|||
147227598|NCT00458536|531005828|FG000|Overall Study|Progressive disease during treatment|2|||
147227599|NCT00285207|531005831|FG000|Overall Study|Lost to Follow-up|3|||
147227600|NCT00285207|531005832|FG001|Overall Study|Lost to Follow-up|2|||
147227601|NCT00285207|531005831|FG000|Overall Study|Withdrawal by Subject|5|||
147227602|NCT00285207|531005832|FG001|Overall Study|Withdrawal by Subject|2|||
147227603|NCT00285207|531005831|FG000|Overall Study|Pregnancy|1|||
147227604|NCT00285207|531005832|FG001|Overall Study|Pregnancy|1|||
147227605|NCT00285207|531005831|FG000|Overall Study|non-compliance|0|||
147227606|NCT00285207|531005832|FG001|Overall Study|non-compliance|1|||
147227607|NCT03552965|531005834|FG000|Overall Study|Death|1|||
147227608|NCT03552965|531005835|FG001|Overall Study|Death|1|||
147227609|NCT03552965|531005834|FG000|Overall Study|Lost to Follow-up|1|||
147227610|NCT03552965|531005835|FG001|Overall Study|Lost to Follow-up|1|||
147227611|NCT03552965|531005834|FG000|Overall Study|Physician Decision|1|||
147227612|NCT03552965|531005835|FG001|Overall Study|Physician Decision|1|||
147227613|NCT03552965|531005834|FG000|Overall Study|Withdrawal by Subject|0|||
147227614|NCT03552965|531005835|FG001|Overall Study|Withdrawal by Subject|2|||
147227615|NCT03552965|531005834|FG000|Overall Study|Continuation not in patient best interest|1|||
147227616|NCT03552965|531005835|FG001|Overall Study|Continuation not in patient best interest|0|||
147227617|NCT03552965|531005834|FG000|Overall Study|Patient opted to be treated elsewhere|1|||
147227618|NCT03552965|531005835|FG001|Overall Study|Patient opted to be treated elsewhere|0|||
147227619|NCT03120624|531005836|FG000|Overall Study|Withdrawal by Subject|0|||
147227620|NCT03120624|531005837|FG001|Overall Study|Withdrawal by Subject|1|||
147227621|NCT03120624|531005838|FG002|Overall Study|Withdrawal by Subject|0|||
147227622|NCT03120624|531005839|FG003|Overall Study|Withdrawal by Subject|0|||
147227623|NCT03120624|531005840|FG004|Overall Study|Withdrawal by Subject|0|||
147227624|NCT03120624|531005841|FG005|Overall Study|Withdrawal by Subject|0|||
147227625|NCT03120624|531005842|FG006|Overall Study|Withdrawal by Subject|0|||
147227626|NCT03120624|531005843|FG007|Overall Study|Withdrawal by Subject|0|||
147227627|NCT04571515|531005844|FG000|Overall Study|Physician Decision|0|||
147227628|NCT04571515|531005845|FG001|Overall Study|Physician Decision|0|||
147227629|NCT04571515|531005846|FG002|Overall Study|Physician Decision|0|||
147227630|NCT04571515|531005847|FG003|Overall Study|Physician Decision|0|||
147227631|NCT04571515|531005848|FG004|Overall Study|Physician Decision|1|||
147227632|NCT04571515|531005844|FG000|Overall Study|Withdrawal by Subject|0|||
147227633|NCT04571515|531005845|FG001|Overall Study|Withdrawal by Subject|0|||
147227634|NCT04571515|531005846|FG002|Overall Study|Withdrawal by Subject|0|||
147227635|NCT04571515|531005847|FG003|Overall Study|Withdrawal by Subject|0|||
147227636|NCT04571515|531005848|FG004|Overall Study|Withdrawal by Subject|1|||
147227637|NCT04571515|531005844|FG000|Overall Study|insufficient pain|1|||
147227638|NCT04571515|531005845|FG001|Overall Study|insufficient pain|0|||
147227639|NCT04571515|531005846|FG002|Overall Study|insufficient pain|0|||
147227640|NCT04571515|531005847|FG003|Overall Study|insufficient pain|0|||
147311618|NCT02291289|531309126|FG001|Maintenance Treatment Phase|Death|29|||
147311619|NCT02291289|531309127|FG002|Maintenance Treatment Phase|Death|16|||
147227641|NCT04571515|531005848|FG004|Overall Study|insufficient pain|1|||
147227642|NCT01104701|531007071|FG000|Overall Study|Withdrawal by Subject|0|||
147227643|NCT01104701|531007072|FG001|Overall Study|Withdrawal by Subject|1|||
147227644|NCT01104701|531007073|FG002|Overall Study|Withdrawal by Subject|2|||
147227645|NCT01104701|531007074|FG003|Overall Study|Withdrawal by Subject|1|||
147227646|NCT01104701|531007071|FG000|Overall Study|Adverse Event|0|||
147227647|NCT01104701|531007072|FG001|Overall Study|Adverse Event|0|||
147227648|NCT01104701|531007073|FG002|Overall Study|Adverse Event|0|||
147227649|NCT01104701|531007074|FG003|Overall Study|Adverse Event|1|||
147227650|NCT01104701|531007071|FG000|Overall Study|Physician Decision|0|||
147311620|NCT02291289|531309128|FG003|Maintenance Treatment Phase|Death|0|||
147311621|NCT02291289|531309129|FG004|Maintenance Treatment Phase|Death|188|||
147227651|NCT01104701|531007072|FG001|Overall Study|Physician Decision|2|||
147562464|NCT01101022|532217586|FG000|Overall Study|Non-compliance|1|||
147227652|NCT01104701|531007073|FG002|Overall Study|Physician Decision|0|||
147562465|NCT01101022|532217587|FG001|Overall Study|Non-compliance|0|||
147562466|NCT01101022|532217586|FG000|Overall Study|Work schedule|1|||
147562467|NCT01101022|532217587|FG001|Overall Study|Work schedule|1|||
147227653|NCT01104701|531007074|FG003|Overall Study|Physician Decision|0|||
147227654|NCT02171065|531007077|FG000|Overall Study|Withdrawal by Subject|1|||
147227655|NCT02171065|531007078|FG001|Overall Study|Withdrawal by Subject|0|||
147227656|NCT02171065|531007079|FG002|Overall Study|Withdrawal by Subject|0|||
147227657|NCT02171065|531007077|FG000|Overall Study|Lost to Follow-up|0|||
147227658|NCT02171065|531007078|FG001|Overall Study|Lost to Follow-up|0|||
147227659|NCT02171065|531007079|FG002|Overall Study|Lost to Follow-up|1|||
147227660|NCT00084838|531007080|FG000|Overall Study|Death|1|||
147227661|NCT00084838|531007080|FG000|Overall Study|Adverse Event|2|||
147227662|NCT00084838|531007080|FG000|Overall Study|Withdrawal by Subject|1|||
147227663|NCT00084838|531007080|FG000|Overall Study|Progressive Disease|4|||
147227664|NCT00084838|531007080|FG000|Overall Study|Pt Non-Compliance|1|||
147227665|NCT00084838|531007080|FG000|Overall Study|Ineligible|4|||
147227666|NCT00518687|531007081|FG000|Overall Study|Adverse Event|201|||
147227667|NCT00518687|531007082|FG001|Overall Study|Adverse Event|177|||
147227668|NCT00518687|531007081|FG000|Overall Study|Lost to Follow-up|144|||
147227669|NCT00518687|531007082|FG001|Overall Study|Lost to Follow-up|155|||
147227670|NCT00518687|531007081|FG000|Overall Study|Physician Decision|42|||
147227671|NCT00518687|531007082|FG001|Overall Study|Physician Decision|48|||
147227672|NCT00518687|531007081|FG000|Overall Study|Progressive disease|2|||
147227673|NCT00518687|531007082|FG001|Overall Study|Progressive disease|2|||
147227674|NCT00518687|531007081|FG000|Overall Study|Protocol Violation|8|||
147227675|NCT00518687|531007082|FG001|Overall Study|Protocol Violation|10|||
147227676|NCT00518687|531007081|FG000|Overall Study|Study terminated by sponsor|930|||
147227677|NCT00518687|531007082|FG001|Overall Study|Study terminated by sponsor|918|||
147227678|NCT00518687|531007081|FG000|Overall Study|Withdrawal by Subject|110|||
147227679|NCT00518687|531007082|FG001|Overall Study|Withdrawal by Subject|110|||
147227680|NCT02598960|531007083|FG000|Treatment Period|Disease Progression|4|||
147227681|NCT02598960|531007084|FG001|Treatment Period|Disease Progression|4|||
147227682|NCT02598960|531007085|FG002|Treatment Period|Disease Progression|4|||
147227683|NCT02598960|531007086|FG003|Treatment Period|Disease Progression|6|||
147227684|NCT02598960|531007087|FG004|Treatment Period|Disease Progression|8|||
147227685|NCT02598960|531007088|FG005|Treatment Period|Disease Progression|2|||
147227686|NCT02598960|531007089|FG006|Treatment Period|Disease Progression|2|||
147227687|NCT02598960|531007090|FG007|Treatment Period|Disease Progression|3|||
147227688|NCT02598960|531007091|FG008|Treatment Period|Disease Progression|7|||
147227689|NCT02598960|531007092|FG009|Treatment Period|Disease Progression|9|||
147227690|NCT02598960|531007093|FG010|Treatment Period|Disease Progression|7|||
147227691|NCT02598960|531007094|FG011|Treatment Period|Disease Progression|143|||
147227692|NCT02598960|531007095|FG012|Treatment Period|Disease Progression|23|||
147227693|NCT02598960|531007083|FG000|Treatment Period|Study drug toxicity|0|||
147227694|NCT02598960|531007084|FG001|Treatment Period|Study drug toxicity|0|||
147227695|NCT02598960|531007085|FG002|Treatment Period|Study drug toxicity|0|||
147227696|NCT02598960|531007086|FG003|Treatment Period|Study drug toxicity|0|||
147227697|NCT02598960|531007087|FG004|Treatment Period|Study drug toxicity|0|||
147227698|NCT02598960|531007088|FG005|Treatment Period|Study drug toxicity|0|||
147227699|NCT02598960|531007089|FG006|Treatment Period|Study drug toxicity|0|||
147227700|NCT02598960|531007090|FG007|Treatment Period|Study drug toxicity|0|||
147227701|NCT02598960|531007091|FG008|Treatment Period|Study drug toxicity|0|||
147227702|NCT02598960|531007092|FG009|Treatment Period|Study drug toxicity|1|||
147227703|NCT02598960|531007093|FG010|Treatment Period|Study drug toxicity|0|||
147227704|NCT02598960|531007094|FG011|Treatment Period|Study drug toxicity|3|||
147227705|NCT02598960|531007095|FG012|Treatment Period|Study drug toxicity|0|||
147227706|NCT02598960|531007083|FG000|Treatment Period|Adverse Event unrelated to study drug|0|||
147227707|NCT02598960|531007084|FG001|Treatment Period|Adverse Event unrelated to study drug|1|||
147227708|NCT02598960|531007085|FG002|Treatment Period|Adverse Event unrelated to study drug|0|||
147227709|NCT02598960|531007086|FG003|Treatment Period|Adverse Event unrelated to study drug|0|||
147227710|NCT02598960|531007087|FG004|Treatment Period|Adverse Event unrelated to study drug|0|||
147227711|NCT02598960|531007088|FG005|Treatment Period|Adverse Event unrelated to study drug|0|||
147562468|NCT01101022|532217586|FG000|Overall Study|Vacation|0|||
147562469|NCT01101022|532217587|FG001|Overall Study|Vacation|1|||
147227712|NCT02598960|531007089|FG006|Treatment Period|Adverse Event unrelated to study drug|0|||
147227713|NCT02598960|531007090|FG007|Treatment Period|Adverse Event unrelated to study drug|0|||
147227714|NCT02598960|531007091|FG008|Treatment Period|Adverse Event unrelated to study drug|0|||
147227715|NCT02598960|531007092|FG009|Treatment Period|Adverse Event unrelated to study drug|1|||
147227716|NCT02598960|531007093|FG010|Treatment Period|Adverse Event unrelated to study drug|0|||
147227717|NCT02598960|531007094|FG011|Treatment Period|Adverse Event unrelated to study drug|11|||
147227718|NCT02598960|531007095|FG012|Treatment Period|Adverse Event unrelated to study drug|2|||
147227719|NCT02598960|531007083|FG000|Treatment Period|participant request to discontinue|0|||
147227720|NCT02598960|531007084|FG001|Treatment Period|participant request to discontinue|1|||
147562470|NCT02311361|532217588|FG000|Overall Study|Did not receive treatment|0|||
147227721|NCT02598960|531007085|FG002|Treatment Period|participant request to discontinue|0|||
147227722|NCT02598960|531007086|FG003|Treatment Period|participant request to discontinue|0|||
147227723|NCT02598960|531007087|FG004|Treatment Period|participant request to discontinue|1|||
147227724|NCT02598960|531007088|FG005|Treatment Period|participant request to discontinue|0|||
147227725|NCT02598960|531007089|FG006|Treatment Period|participant request to discontinue|0|||
147227726|NCT02598960|531007090|FG007|Treatment Period|participant request to discontinue|0|||
147227727|NCT02598960|531007091|FG008|Treatment Period|participant request to discontinue|0|||
147227728|NCT02598960|531007092|FG009|Treatment Period|participant request to discontinue|0|||
147227729|NCT02598960|531007093|FG010|Treatment Period|participant request to discontinue|1|||
147227730|NCT02598960|531007094|FG011|Treatment Period|participant request to discontinue|4|||
147227731|NCT02598960|531007095|FG012|Treatment Period|participant request to discontinue|0|||
147227732|NCT02598960|531007083|FG000|Treatment Period|participant withdrew consent|0|||
147227733|NCT02598960|531007084|FG001|Treatment Period|participant withdrew consent|0|||
147227734|NCT02598960|531007085|FG002|Treatment Period|participant withdrew consent|0|||
147227735|NCT02598960|531007086|FG003|Treatment Period|participant withdrew consent|0|||
147227736|NCT02598960|531007087|FG004|Treatment Period|participant withdrew consent|0|||
147227737|NCT02598960|531007088|FG005|Treatment Period|participant withdrew consent|0|||
147227738|NCT02598960|531007089|FG006|Treatment Period|participant withdrew consent|0|||
147227739|NCT02598960|531007090|FG007|Treatment Period|participant withdrew consent|0|||
147227740|NCT02598960|531007091|FG008|Treatment Period|participant withdrew consent|0|||
147227741|NCT02598960|531007092|FG009|Treatment Period|participant withdrew consent|0|||
147227742|NCT02598960|531007093|FG010|Treatment Period|participant withdrew consent|0|||
147227743|NCT02598960|531007094|FG011|Treatment Period|participant withdrew consent|3|||
147227744|NCT02598960|531007095|FG012|Treatment Period|participant withdrew consent|0|||
147227745|NCT02598960|531007083|FG000|Treatment Period|No longer meets study criteria|0|||
147227746|NCT02598960|531007084|FG001|Treatment Period|No longer meets study criteria|0|||
147227747|NCT02598960|531007085|FG002|Treatment Period|No longer meets study criteria|0|||
147227748|NCT02598960|531007086|FG003|Treatment Period|No longer meets study criteria|0|||
147227749|NCT02598960|531007087|FG004|Treatment Period|No longer meets study criteria|0|||
147227750|NCT02598960|531007088|FG005|Treatment Period|No longer meets study criteria|0|||
147227751|NCT02598960|531007089|FG006|Treatment Period|No longer meets study criteria|0|||
147227752|NCT02598960|531007090|FG007|Treatment Period|No longer meets study criteria|0|||
147227753|NCT02598960|531007091|FG008|Treatment Period|No longer meets study criteria|0|||
147227754|NCT02598960|531007092|FG009|Treatment Period|No longer meets study criteria|0|||
147227755|NCT02598960|531007093|FG010|Treatment Period|No longer meets study criteria|0|||
147227756|NCT02598960|531007094|FG011|Treatment Period|No longer meets study criteria|1|||
147227757|NCT02598960|531007095|FG012|Treatment Period|No longer meets study criteria|0|||
147227758|NCT02598960|531007083|FG000|Treatment Period|Other Reasons|0|||
147227759|NCT02598960|531007084|FG001|Treatment Period|Other Reasons|0|||
147227760|NCT02598960|531007085|FG002|Treatment Period|Other Reasons|0|||
147227761|NCT02598960|531007086|FG003|Treatment Period|Other Reasons|0|||
147562471|NCT02311361|532217589|FG001|Overall Study|Did not receive treatment|1|||
147562472|NCT02311361|532217590|FG002|Overall Study|Did not receive treatment|0|||
147562473|NCT02311361|532217591|FG003|Overall Study|Did not receive treatment|1|||
147562474|NCT04455633|532217593|FG000|Double-Blind Period (Up to Week 6)|Adverse Event|4|||
147562475|NCT04455633|532217594|FG001|Double-Blind Period (Up to Week 6)|Adverse Event|17|||
147562476|NCT04455633|532217595|FG002|Double-Blind Period (Up to Week 6)|Adverse Event|28|||
147562477|NCT04455633|532217593|FG000|Double-Blind Period (Up to Week 6)|Subject Choice Unrelated to Adverse Event/Serious Adverse Event|2|||
147562478|NCT04455633|532217594|FG001|Double-Blind Period (Up to Week 6)|Subject Choice Unrelated to Adverse Event/Serious Adverse Event|2|||
147562479|NCT04455633|532217595|FG002|Double-Blind Period (Up to Week 6)|Subject Choice Unrelated to Adverse Event/Serious Adverse Event|6|||
147562480|NCT04455633|532217593|FG000|Double-Blind Period (Up to Week 6)|Other, not specified|0|||
147562481|NCT04455633|532217594|FG001|Double-Blind Period (Up to Week 6)|Other, not specified|2|||
147562482|NCT04455633|532217595|FG002|Double-Blind Period (Up to Week 6)|Other, not specified|2|||
147562483|NCT04455633|532217593|FG000|Follow up Period (Weeks 7 to 11)|Other, not specified|1|||
147562484|NCT04455633|532217594|FG001|Follow up Period (Weeks 7 to 11)|Other, not specified|0|||
147562485|NCT04455633|532217595|FG002|Follow up Period (Weeks 7 to 11)|Other, not specified|0|||
147562486|NCT03527745|532217596|FG000|Overall Study|Lost to Follow-up|3|||
147562487|NCT03527745|532217597|FG001|Overall Study|Lost to Follow-up|6|||
147562488|NCT03527745|532217598|FG002|Overall Study|Lost to Follow-up|7|||
147562489|NCT03527745|532217599|FG003|Overall Study|Lost to Follow-up|9|||
147562490|NCT03527745|532217600|FG004|Overall Study|Lost to Follow-up|0|||
147562491|NCT03527745|532217601|FG005|Overall Study|Lost to Follow-up|2|||
147562492|NCT03527745|532217602|FG006|Overall Study|Lost to Follow-up|3|||
147562493|NCT03527745|532217603|FG007|Overall Study|Lost to Follow-up|2|||
147562494|NCT03527745|532217604|FG008|Overall Study|Lost to Follow-up|3|||
147562495|NCT03527745|532217605|FG009|Overall Study|Lost to Follow-up|2|||
147562496|NCT03527745|532217606|FG010|Overall Study|Lost to Follow-up|1|||
147311622|NCT02291289|531309130|FG005|Maintenance Treatment Phase|Death|107|||
147562497|NCT03527745|532217607|FG011|Overall Study|Lost to Follow-up|1|||
147562498|NCT03527745|532217608|FG012|Overall Study|Lost to Follow-up|0|||
147562499|NCT03527745|532217609|FG013|Overall Study|Lost to Follow-up|0|||
147562500|NCT03527745|532217610|FG014|Overall Study|Lost to Follow-up|0|||
147227762|NCT02598960|531007087|FG004|Treatment Period|Other Reasons|0|||
147227763|NCT02598960|531007088|FG005|Treatment Period|Other Reasons|0|||
147227764|NCT02598960|531007089|FG006|Treatment Period|Other Reasons|0|||
147227765|NCT02598960|531007090|FG007|Treatment Period|Other Reasons|0|||
147227766|NCT02598960|531007091|FG008|Treatment Period|Other Reasons|0|||
147227767|NCT02598960|531007092|FG009|Treatment Period|Other Reasons|0|||
147227768|NCT02598960|531007093|FG010|Treatment Period|Other Reasons|0|||
147227769|NCT02598960|531007094|FG011|Treatment Period|Other Reasons|0|||
147227770|NCT02598960|531007095|FG012|Treatment Period|Other Reasons|1|||
147227771|NCT02598960|531007083|FG000|Participants Entering Follow Up Period|Death|1|||
147227772|NCT02598960|531007084|FG001|Participants Entering Follow Up Period|Death|0|||
147227773|NCT02598960|531007085|FG002|Participants Entering Follow Up Period|Death|0|||
147227774|NCT02598960|531007086|FG003|Participants Entering Follow Up Period|Death|0|||
147227775|NCT02598960|531007087|FG004|Participants Entering Follow Up Period|Death|0|||
147227776|NCT02598960|531007088|FG005|Participants Entering Follow Up Period|Death|0|||
147227777|NCT02598960|531007089|FG006|Participants Entering Follow Up Period|Death|0|||
147227778|NCT02598960|531007090|FG007|Participants Entering Follow Up Period|Death|0|||
147227779|NCT02598960|531007091|FG008|Participants Entering Follow Up Period|Death|0|||
147227780|NCT02598960|531007092|FG009|Participants Entering Follow Up Period|Death|1|||
147227781|NCT02598960|531007093|FG010|Participants Entering Follow Up Period|Death|0|||
147227782|NCT02598960|531007094|FG011|Participants Entering Follow Up Period|Death|11|||
147227783|NCT02598960|531007095|FG012|Participants Entering Follow Up Period|Death|2|||
147227784|NCT02598960|531007083|FG000|Participants Entering Follow Up Period|participant withdrew consent|0|||
147227785|NCT02598960|531007084|FG001|Participants Entering Follow Up Period|participant withdrew consent|0|||
147227786|NCT02598960|531007085|FG002|Participants Entering Follow Up Period|participant withdrew consent|0|||
147227787|NCT02598960|531007086|FG003|Participants Entering Follow Up Period|participant withdrew consent|0|||
147227788|NCT02598960|531007087|FG004|Participants Entering Follow Up Period|participant withdrew consent|0|||
147227789|NCT02598960|531007088|FG005|Participants Entering Follow Up Period|participant withdrew consent|0|||
147227790|NCT02598960|531007089|FG006|Participants Entering Follow Up Period|participant withdrew consent|0|||
147227791|NCT02598960|531007090|FG007|Participants Entering Follow Up Period|participant withdrew consent|0|||
147227792|NCT02598960|531007091|FG008|Participants Entering Follow Up Period|participant withdrew consent|0|||
147227793|NCT02598960|531007092|FG009|Participants Entering Follow Up Period|participant withdrew consent|0|||
147227794|NCT02598960|531007093|FG010|Participants Entering Follow Up Period|participant withdrew consent|0|||
147227795|NCT02598960|531007094|FG011|Participants Entering Follow Up Period|participant withdrew consent|7|||
147227796|NCT02598960|531007095|FG012|Participants Entering Follow Up Period|participant withdrew consent|0|||
147227797|NCT02598960|531007083|FG000|Participants Entering Follow Up Period|lost to follow up|0|||
147227798|NCT02598960|531007084|FG001|Participants Entering Follow Up Period|lost to follow up|0|||
147227799|NCT02598960|531007085|FG002|Participants Entering Follow Up Period|lost to follow up|0|||
147227800|NCT02598960|531007086|FG003|Participants Entering Follow Up Period|lost to follow up|0|||
147227801|NCT02598960|531007087|FG004|Participants Entering Follow Up Period|lost to follow up|0|||
147227802|NCT02598960|531007088|FG005|Participants Entering Follow Up Period|lost to follow up|0|||
147227803|NCT02598960|531007089|FG006|Participants Entering Follow Up Period|lost to follow up|0|||
147227804|NCT02598960|531007090|FG007|Participants Entering Follow Up Period|lost to follow up|0|||
147311623|NCT02291289|531309131|FG006|Maintenance Treatment Phase|Death|0|||
147311624|NCT02291289|531309132|FG007|Maintenance Treatment Phase|Death|1|||
147562501|NCT03527745|532217611|FG015|Overall Study|Lost to Follow-up|0|||
147562502|NCT03527745|532217612|FG016|Overall Study|Lost to Follow-up|1|||
147562503|NCT03527745|532217613|FG017|Overall Study|Lost to Follow-up|0|||
147562504|NCT03527745|532217614|FG018|Overall Study|Lost to Follow-up|0|||
147562505|NCT03527745|532217615|FG019|Overall Study|Lost to Follow-up|1|||
147562506|NCT03527745|532217616|FG020|Overall Study|Lost to Follow-up|1|||
147562507|NCT03527745|532217617|FG021|Overall Study|Lost to Follow-up|5|||
147562508|NCT03527745|532217618|FG022|Overall Study|Lost to Follow-up|6|||
147562509|NCT03527745|532217619|FG023|Overall Study|Lost to Follow-up|8|||
147562510|NCT03527745|532217620|FG024|Overall Study|Lost to Follow-up|1|||
147562511|NCT03527745|532217621|FG025|Overall Study|Lost to Follow-up|3|||
147562512|NCT02942264|532217626|FG000|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
147562513|NCT02942264|532217627|FG001|Phase 1 MTD Finding Stage|Withdrawal of consent|1|||
147562514|NCT02942264|532217628|FG002|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
147562515|NCT02942264|532217629|FG003|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
147562516|NCT02942264|532217630|FG004|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
147562517|NCT02942264|532217631|FG005|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
147562518|NCT02942264|532217632|FG006|Phase 1 MTD Finding Stage|Withdrawal of consent|1|||
147562519|NCT02942264|532217633|FG007|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
147562520|NCT02942264|532217634|FG008|Phase 1 MTD Finding Stage|Withdrawal of consent|0|||
147562521|NCT02942264|532217626|FG000|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
147562522|NCT02942264|532217627|FG001|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
147562523|NCT02942264|532217628|FG002|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
147562524|NCT02942264|532217629|FG003|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
147562525|NCT02942264|532217630|FG004|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
147562526|NCT02942264|532217631|FG005|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
147562527|NCT02942264|532217632|FG006|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
147562528|NCT02942264|532217633|FG007|Phase 1 Cohort Expansion Stage|Withdrawal of consent|0|||
147562529|NCT02942264|532217634|FG008|Phase 1 Cohort Expansion Stage|Withdrawal of consent|1|||
147562530|NCT01328093|532217635|FG000|Double-Blind Phase|Adverse Event|78|||
147562531|NCT01328093|532217636|FG001|Double-Blind Phase|Adverse Event|15|||
147562532|NCT01328093|532217635|FG000|Double-Blind Phase|Withdrawal by Subject|42|||
147113882|NCT01807520|530579942|FG006|Treatment Period 2 (16-132 Weeks)|Pregnancy|0|||
147113883|NCT01807520|530579936|FG000|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
147113884|NCT01807520|530579937|FG001|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|2|||
147113885|NCT01807520|530579938|FG002|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
147227805|NCT02598960|531007091|FG008|Participants Entering Follow Up Period|lost to follow up|0|||
147227806|NCT02598960|531007092|FG009|Participants Entering Follow Up Period|lost to follow up|0|||
147227807|NCT02598960|531007093|FG010|Participants Entering Follow Up Period|lost to follow up|0|||
147227808|NCT02598960|531007094|FG011|Participants Entering Follow Up Period|lost to follow up|3|||
147227809|NCT02598960|531007095|FG012|Participants Entering Follow Up Period|lost to follow up|0|||
147227810|NCT02598960|531007083|FG000|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
147227811|NCT02598960|531007084|FG001|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
147227812|NCT02598960|531007085|FG002|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
147227813|NCT02598960|531007086|FG003|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
147227814|NCT02598960|531007087|FG004|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
147227815|NCT02598960|531007088|FG005|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
147227816|NCT02598960|531007089|FG006|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
147227817|NCT02598960|531007090|FG007|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
147227818|NCT02598960|531007091|FG008|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
147227819|NCT02598960|531007092|FG009|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
147227820|NCT02598960|531007093|FG010|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
147227821|NCT02598960|531007094|FG011|Participants Entering Follow Up Period|follow up no longer required per protocol|2|||
147227822|NCT02598960|531007095|FG012|Participants Entering Follow Up Period|follow up no longer required per protocol|0|||
147227823|NCT02598960|531007083|FG000|Participants Entering Follow Up Period|Other Reasons|0|||
147227824|NCT02598960|531007084|FG001|Participants Entering Follow Up Period|Other Reasons|0|||
147227825|NCT02598960|531007085|FG002|Participants Entering Follow Up Period|Other Reasons|0|||
147227826|NCT02598960|531007086|FG003|Participants Entering Follow Up Period|Other Reasons|0|||
147227827|NCT02598960|531007087|FG004|Participants Entering Follow Up Period|Other Reasons|0|||
147227828|NCT02598960|531007088|FG005|Participants Entering Follow Up Period|Other Reasons|0|||
147227829|NCT02598960|531007089|FG006|Participants Entering Follow Up Period|Other Reasons|0|||
147227830|NCT02598960|531007090|FG007|Participants Entering Follow Up Period|Other Reasons|0|||
147227831|NCT02598960|531007091|FG008|Participants Entering Follow Up Period|Other Reasons|0|||
147227832|NCT02598960|531007092|FG009|Participants Entering Follow Up Period|Other Reasons|0|||
147227833|NCT02598960|531007093|FG010|Participants Entering Follow Up Period|Other Reasons|1|||
147227834|NCT02598960|531007094|FG011|Participants Entering Follow Up Period|Other Reasons|6|||
147227835|NCT02598960|531007095|FG012|Participants Entering Follow Up Period|Other Reasons|3|||
147227836|NCT01846104|531007096|FG000|Overall Study|Withdrawal by Subject|1|||
147227837|NCT00851630|531007097|FG000|Overall Study|Death|2|||
147227838|NCT00851630|531007098|FG001|Overall Study|Death|1|||
147227839|NCT00851630|531007097|FG000|Overall Study|Clinical failure|0|||
147227840|NCT00851630|531007098|FG001|Overall Study|Clinical failure|1|||
147227841|NCT00398411|531007099|FG000|Overall Study|Death|0|||
147227842|NCT00398411|531007100|FG001|Overall Study|Death|1|||
147227843|NCT01397162|531007101|FG000|Overall Study|Adverse Event|4|||
147227844|NCT01397162|531007102|FG001|Overall Study|Adverse Event|0|||
147227845|NCT01397162|531007103|FG002|Overall Study|Adverse Event|0|||
147227846|NCT01397162|531007104|FG003|Overall Study|Adverse Event|0|||
147227847|NCT01397162|531007105|FG004|Overall Study|Adverse Event|0|||
147227848|NCT01397162|531007101|FG000|Overall Study|Not yet defined|3|||
147227849|NCT01397162|531007102|FG001|Overall Study|Not yet defined|4|||
147227850|NCT01397162|531007103|FG002|Overall Study|Not yet defined|3|||
147227851|NCT01397162|531007104|FG003|Overall Study|Not yet defined|5|||
147227852|NCT01397162|531007105|FG004|Overall Study|Not yet defined|3|||
147227853|NCT00401531|531007108|FG000|Overall Study|Adverse Event|2|||
147227854|NCT00401531|531007109|FG001|Overall Study|Adverse Event|0|||
147562533|NCT01328093|532217636|FG001|Double-Blind Phase|Withdrawal by Subject|14|||
147562534|NCT01328093|532217635|FG000|Double-Blind Phase|Lost to Follow-up|39|||
147113886|NCT01807520|530579939|FG003|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
147113887|NCT01807520|530579940|FG004|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
147562535|NCT01328093|532217636|FG001|Double-Blind Phase|Lost to Follow-up|14|||
147562536|NCT01328093|532217635|FG000|Double-Blind Phase|Protocol Violation|30|||
147562537|NCT01328093|532217636|FG001|Double-Blind Phase|Protocol Violation|10|||
147562538|NCT01328093|532217635|FG000|Double-Blind Phase|Lack of Efficacy|55|||
147562539|NCT01328093|532217636|FG001|Double-Blind Phase|Lack of Efficacy|13|||
147562540|NCT01328093|532217635|FG000|Double-Blind Phase|Sponsor Decision|17|||
147562541|NCT01328093|532217636|FG001|Double-Blind Phase|Sponsor Decision|3|||
147227855|NCT00401531|531007108|FG000|Overall Study|Protocol Violation|3|||
147227856|NCT00401531|531007109|FG001|Overall Study|Protocol Violation|7|||
147227857|NCT00401531|531007108|FG000|Overall Study|Lost to Follow-up|1|||
147227858|NCT00401531|531007109|FG001|Overall Study|Lost to Follow-up|1|||
147227859|NCT00401531|531007108|FG000|Overall Study|Withdrawal by Subject|3|||
147227860|NCT00401531|531007109|FG001|Overall Study|Withdrawal by Subject|2|||
147227861|NCT01614600|531007110|FG000|Overall Study|Unacceptable fit|1|||
147227862|NCT01614600|531007110|FG000|Overall Study|Discomfort|1|||
147227863|NCT01614600|531007110|FG000|Overall Study|Unable to remove lens at the end of day|1|||
147227864|NCT01614600|531007110|FG000|Overall Study|Protocol deviation|1|||
147227865|NCT02437513|531007111|FG000|Overall Study|Withdrawal by Subject|2|||
147227866|NCT03403374|531007112|FG000|Overall Study|Lost to Follow-up|1|||
147227867|NCT04879225|531007113|FG000|Mint, Menthol, Tobacco|Lost to Follow-up|1|||
147227868|NCT04879225|531007113|FG000|Menthol and Tobacco|Lost to Follow-up|1|||
147227869|NCT00736957|531007116|FG000|Overall Study|Adverse Event|43|||
147227870|NCT00736957|531007116|FG000|Overall Study|Withdrawal by Subject|49|||
147227871|NCT00736957|531007116|FG000|Overall Study|violation of eligibility criteria|2|||
147227872|NCT00736957|531007116|FG000|Overall Study|did not attend hospital appointments|1|||
147227873|NCT00736957|531007116|FG000|Overall Study|not eligible for Treatment Period I|22|||
147227874|NCT00736957|531007116|FG000|Overall Study|Physician Decision|5|||
147227875|NCT01409434|531007117|FG000|Overall Study|Protocol Violation|4|||
147227876|NCT02213042|531007118|FG000|Overall Study|Disease progression (incl. death due to disease progression)|14|||
147227877|NCT02213042|531007119|FG001|Overall Study|Disease progression (incl. death due to disease progression)|13|||
147227878|NCT02213042|531007120|FG002|Overall Study|Disease progression (incl. death due to disease progression)|8|||
147227879|NCT02213042|531007118|FG000|Overall Study|Adverse Event|2|||
147227880|NCT02213042|531007119|FG001|Overall Study|Adverse Event|1|||
147227881|NCT02213042|531007120|FG002|Overall Study|Adverse Event|0|||
147227882|NCT02213042|531007118|FG000|Overall Study|Withdrawal by Subject|0|||
147227883|NCT02213042|531007119|FG001|Overall Study|Withdrawal by Subject|1|||
147227884|NCT02213042|531007120|FG002|Overall Study|Withdrawal by Subject|1|||
147227885|NCT02213042|531007118|FG000|Overall Study|Protocol Violation|1|||
147227886|NCT02213042|531007119|FG001|Overall Study|Protocol Violation|0|||
147227887|NCT02213042|531007120|FG002|Overall Study|Protocol Violation|0|||
147227888|NCT02213042|531007118|FG000|Overall Study|Investigator discretion|0|||
147227889|NCT02213042|531007119|FG001|Overall Study|Investigator discretion|0|||
147227890|NCT02213042|531007120|FG002|Overall Study|Investigator discretion|1|||
147227891|NCT04622735|531007121|FG000|Overall Study|Lost to Follow-up|1|||
147227892|NCT04622735|531007122|FG001|Overall Study|Lost to Follow-up|2|||
147227893|NCT04622735|531007123|FG002|Overall Study|Lost to Follow-up|1|||
147227894|NCT04622735|531007121|FG000|Overall Study|Adverse Event|0|||
147227895|NCT04622735|531007122|FG001|Overall Study|Adverse Event|0|||
147227896|NCT04622735|531007123|FG002|Overall Study|Adverse Event|1|||
147227897|NCT04622735|531007121|FG000|Overall Study|Protocol Violation|1|||
147227898|NCT04622735|531007122|FG001|Overall Study|Protocol Violation|0|||
147227899|NCT04622735|531007123|FG002|Overall Study|Protocol Violation|0|||
147227900|NCT04087213|531007124|FG000|In-Facility Introduction|Withdrawal by Subject|1|||
147227901|NCT04087213|531007124|FG000|In-Facility Introduction|Adverse Event|1|||
147227902|NCT04087213|531007124|FG000|Assisted Evaluable Period|Withdrawal by Subject|2|||
147227903|NCT04087213|531007124|FG000|Assisted Evaluable Period|Personal reasons|3|||
147227904|NCT04087213|531007124|FG000|Transition Period B|Renal Transplantation|1|||
147227905|NCT01134315|531007125|FG000|Overall Study|Adverse Event|1|||
147227906|NCT01134315|531007126|FG001|Overall Study|Adverse Event|2|||
147227907|NCT01134315|531007125|FG000|Overall Study|Other Reason|8|||
147227908|NCT01134315|531007126|FG001|Overall Study|Other Reason|17|||
147227909|NCT02545075|531007130|FG000|Randomization|Lost to Follow-up|0|||
147227910|NCT02545075|531007131|FG001|Randomization|Lost to Follow-up|1|||
147227911|NCT02545075|531007130|FG000|Randomization|Withdrawal by Subject|0|||
147227912|NCT02545075|531007131|FG001|Randomization|Withdrawal by Subject|6|||
147227913|NCT02545075|531007130|FG000|Treatment|Disease progression|71|||
147227914|NCT02545075|531007131|FG001|Treatment|Disease progression|32|||
147227915|NCT02545075|531007130|FG000|Treatment|Participant dicontinued study treatment|7|||
147227916|NCT02545075|531007131|FG001|Treatment|Participant dicontinued study treatment|9|||
147562542|NCT01328093|532217635|FG000|Double-Blind Phase|Entry Criteria Not Met|7|||
147227917|NCT02545075|531007130|FG000|Treatment|Withdrawal by Subject|1|||
147227918|NCT02545075|531007131|FG001|Treatment|Withdrawal by Subject|0|||
147227919|NCT02545075|531007130|FG000|Treatment|Adverse event not related to study drug|1|||
147227920|NCT02545075|531007131|FG001|Treatment|Adverse event not related to study drug|0|||
147227921|NCT02545075|531007130|FG000|Treatment|Death|1|||
147562543|NCT01328093|532217636|FG001|Double-Blind Phase|Entry Criteria Not Met|5|||
147227922|NCT02545075|531007131|FG001|Treatment|Death|0|||
147227923|NCT02545075|531007130|FG000|Treatment|Participant drug toxicity|1|||
147227924|NCT02545075|531007131|FG001|Treatment|Participant drug toxicity|0|||
147227925|NCT02545075|531007130|FG000|Treatment|Completed treatment|40|||
147227926|NCT02545075|531007131|FG001|Treatment|Completed treatment|12|||
147227927|NCT05246397|531007135|FG000|Overall Study|3 were excluded due to protocol deviation|3|||
147227928|NCT00735254|531007136|FG000|Overall Study|Protocol Violation|1|||
147227929|NCT00735254|531007137|FG001|Overall Study|Protocol Violation|1|||
147227930|NCT00735254|531007138|FG002|Overall Study|Protocol Violation|1|||
147227931|NCT00735254|531007139|FG003|Overall Study|Protocol Violation|0|||
147227932|NCT00147251|531007147|FG000|Recruitment and Enrollment|change in treatment guidelines|24|||
147227933|NCT00147251|531007148|FG001|Recruitment and Enrollment|change in treatment guidelines|25|||
147227934|NCT00751621|531007149|FG000|Overall Study|Adverse Event|1|||
147227935|NCT00751621|531007149|FG000|Overall Study|Withdrawal by Subject|1|||
147227936|NCT00751621|531007149|FG000|Overall Study|Subject moved to another country|1|||
147227937|NCT00751621|531007149|FG000|Overall Study|Poor adherence to asthma treatment|1|||
147227938|NCT02694523|531007155|FG000|Part A|Adverse Event|7|||
147227939|NCT02694523|531007156|FG001|Part A|Adverse Event|3|||
147227940|NCT02694523|531007157|FG002|Part A|Adverse Event|0|||
147227941|NCT02694523|531007158|FG003|Part A|Adverse Event|0|||
147227942|NCT02694523|531007159|FG004|Part A|Adverse Event|0|||
147227943|NCT02694523|531007160|FG005|Part A|Adverse Event|0|||
147227944|NCT02694523|531007161|FG006|Part A|Adverse Event|0|||
147227945|NCT02694523|531007155|FG000|Part A|Protocol Violation|1|||
147227946|NCT02694523|531007156|FG001|Part A|Protocol Violation|0|||
147227947|NCT02694523|531007157|FG002|Part A|Protocol Violation|0|||
147227948|NCT02694523|531007158|FG003|Part A|Protocol Violation|0|||
147227949|NCT02694523|531007159|FG004|Part A|Protocol Violation|0|||
147227950|NCT02694523|531007160|FG005|Part A|Protocol Violation|0|||
147227951|NCT02694523|531007161|FG006|Part A|Protocol Violation|0|||
147227952|NCT02694523|531007155|FG000|Part A|Lost to Follow-up|1|||
147227953|NCT02694523|531007156|FG001|Part A|Lost to Follow-up|2|||
147227954|NCT02694523|531007157|FG002|Part A|Lost to Follow-up|0|||
147227955|NCT02694523|531007158|FG003|Part A|Lost to Follow-up|0|||
147227956|NCT02694523|531007159|FG004|Part A|Lost to Follow-up|0|||
147227957|NCT02694523|531007160|FG005|Part A|Lost to Follow-up|0|||
147227958|NCT02694523|531007161|FG006|Part A|Lost to Follow-up|0|||
147227959|NCT02694523|531007155|FG000|Part A|Withdrawal by Subject|3|||
147227960|NCT02694523|531007156|FG001|Part A|Withdrawal by Subject|1|||
147227961|NCT02694523|531007157|FG002|Part A|Withdrawal by Subject|0|||
147227962|NCT02694523|531007158|FG003|Part A|Withdrawal by Subject|0|||
147227963|NCT02694523|531007159|FG004|Part A|Withdrawal by Subject|0|||
147227964|NCT02694523|531007160|FG005|Part A|Withdrawal by Subject|0|||
147227965|NCT02694523|531007161|FG006|Part A|Withdrawal by Subject|0|||
147227966|NCT02694523|531007155|FG000|Part A|Other|1|||
147227967|NCT02694523|531007156|FG001|Part A|Other|1|||
147227968|NCT02694523|531007157|FG002|Part A|Other|0|||
147227969|NCT02694523|531007158|FG003|Part A|Other|0|||
147227970|NCT02694523|531007159|FG004|Part A|Other|0|||
147227971|NCT02694523|531007160|FG005|Part A|Other|0|||
147227972|NCT02694523|531007161|FG006|Part A|Other|0|||
147227973|NCT02694523|531007155|FG000|Part B|Adverse Event|0|||
147227974|NCT02694523|531007156|FG001|Part B|Adverse Event|0|||
147227975|NCT02694523|531007157|FG002|Part B|Adverse Event|7|||
147227976|NCT02694523|531007158|FG003|Part B|Adverse Event|1|||
147227977|NCT02694523|531007159|FG004|Part B|Adverse Event|1|||
147227978|NCT02694523|531007160|FG005|Part B|Adverse Event|2|||
147227979|NCT02694523|531007161|FG006|Part B|Adverse Event|0|||
147227980|NCT02694523|531007155|FG000|Part B|Protocol Violation|0|||
147227981|NCT02694523|531007156|FG001|Part B|Protocol Violation|0|||
147227982|NCT02694523|531007157|FG002|Part B|Protocol Violation|1|||
147227983|NCT02694523|531007158|FG003|Part B|Protocol Violation|0|||
147227984|NCT02694523|531007159|FG004|Part B|Protocol Violation|0|||
147227985|NCT02694523|531007160|FG005|Part B|Protocol Violation|0|||
147311625|NCT02291289|531309133|FG008|Maintenance Treatment Phase|Death|1|||
147227986|NCT02694523|531007161|FG006|Part B|Protocol Violation|0|||
147227987|NCT02694523|531007155|FG000|Part B|Lost to Follow-up|0|||
147311626|NCT02291289|531309134|FG009|Maintenance Treatment Phase|Death|0|||
147227988|NCT02694523|531007156|FG001|Part B|Lost to Follow-up|0|||
147227989|NCT02694523|531007157|FG002|Part B|Lost to Follow-up|2|||
147227990|NCT02694523|531007158|FG003|Part B|Lost to Follow-up|3|||
147227991|NCT02694523|531007159|FG004|Part B|Lost to Follow-up|2|||
147227992|NCT02694523|531007160|FG005|Part B|Lost to Follow-up|0|||
147227993|NCT02694523|531007161|FG006|Part B|Lost to Follow-up|1|||
147227994|NCT02694523|531007155|FG000|Part B|Withdrawal by Subject|0|||
147311627|NCT02291289|531309135|FG010|Maintenance Treatment Phase|Death|46|||
147227995|NCT02694523|531007156|FG001|Part B|Withdrawal by Subject|0|||
147227996|NCT02694523|531007157|FG002|Part B|Withdrawal by Subject|9|||
147227997|NCT02694523|531007158|FG003|Part B|Withdrawal by Subject|0|||
147227998|NCT02694523|531007159|FG004|Part B|Withdrawal by Subject|1|||
147227999|NCT02694523|531007160|FG005|Part B|Withdrawal by Subject|3|||
147228000|NCT02694523|531007161|FG006|Part B|Withdrawal by Subject|0|||
147228001|NCT02694523|531007155|FG000|Part B|Other|0|||
147228002|NCT02694523|531007156|FG001|Part B|Other|0|||
147228003|NCT02694523|531007157|FG002|Part B|Other|1|||
147311628|NCT02291289|531309136|FG011|Maintenance Treatment Phase|Death|19|||
147311629|NCT02291289|531309137|FG012|Maintenance Treatment Phase|Death|0|||
147311630|NCT02291289|531309125|FG000|Maintenance Treatment Phase|Adverse Event|0|||
147311631|NCT02291289|531309126|FG001|Maintenance Treatment Phase|Adverse Event|0|||
147311632|NCT02291289|531309127|FG002|Maintenance Treatment Phase|Adverse Event|0|||
147311633|NCT02291289|531309128|FG003|Maintenance Treatment Phase|Adverse Event|0|||
147311634|NCT02291289|531309129|FG004|Maintenance Treatment Phase|Adverse Event|1|||
147311635|NCT02291289|531309130|FG005|Maintenance Treatment Phase|Adverse Event|1|||
147311636|NCT02291289|531309131|FG006|Maintenance Treatment Phase|Adverse Event|0|||
147311637|NCT02291289|531309132|FG007|Maintenance Treatment Phase|Adverse Event|0|||
147311638|NCT02291289|531309133|FG008|Maintenance Treatment Phase|Adverse Event|0|||
147311639|NCT02291289|531309134|FG009|Maintenance Treatment Phase|Adverse Event|0|||
147311640|NCT02291289|531309135|FG010|Maintenance Treatment Phase|Adverse Event|0|||
147311641|NCT02291289|531309136|FG011|Maintenance Treatment Phase|Adverse Event|0|||
147311642|NCT02291289|531309137|FG012|Maintenance Treatment Phase|Adverse Event|0|||
147311643|NCT02291289|531309125|FG000|Maintenance Treatment Phase|Lost to Follow-up|0|||
147311644|NCT02291289|531309126|FG001|Maintenance Treatment Phase|Lost to Follow-up|1|||
147311645|NCT02291289|531309127|FG002|Maintenance Treatment Phase|Lost to Follow-up|0|||
147311646|NCT02291289|531309128|FG003|Maintenance Treatment Phase|Lost to Follow-up|0|||
147311647|NCT02291289|531309129|FG004|Maintenance Treatment Phase|Lost to Follow-up|15|||
147311648|NCT02291289|531309130|FG005|Maintenance Treatment Phase|Lost to Follow-up|4|||
147311649|NCT02291289|531309131|FG006|Maintenance Treatment Phase|Lost to Follow-up|0|||
147311650|NCT02291289|531309132|FG007|Maintenance Treatment Phase|Lost to Follow-up|1|||
147311651|NCT02291289|531309133|FG008|Maintenance Treatment Phase|Lost to Follow-up|0|||
147311652|NCT02291289|531309134|FG009|Maintenance Treatment Phase|Lost to Follow-up|0|||
147311653|NCT02291289|531309135|FG010|Maintenance Treatment Phase|Lost to Follow-up|3|||
147311654|NCT02291289|531309136|FG011|Maintenance Treatment Phase|Lost to Follow-up|3|||
147311655|NCT02291289|531309137|FG012|Maintenance Treatment Phase|Lost to Follow-up|0|||
147311656|NCT02291289|531309125|FG000|Maintenance Treatment Phase|Reason Not Specified|0|||
147311657|NCT02291289|531309126|FG001|Maintenance Treatment Phase|Reason Not Specified|0|||
147311658|NCT02291289|531309127|FG002|Maintenance Treatment Phase|Reason Not Specified|0|||
147311659|NCT02291289|531309128|FG003|Maintenance Treatment Phase|Reason Not Specified|0|||
147311660|NCT02291289|531309129|FG004|Maintenance Treatment Phase|Reason Not Specified|7|||
147311661|NCT02291289|531309130|FG005|Maintenance Treatment Phase|Reason Not Specified|2|||
147311662|NCT02291289|531309131|FG006|Maintenance Treatment Phase|Reason Not Specified|0|||
147311663|NCT02291289|531309132|FG007|Maintenance Treatment Phase|Reason Not Specified|1|||
147311664|NCT02291289|531309133|FG008|Maintenance Treatment Phase|Reason Not Specified|0|||
147311665|NCT02291289|531309134|FG009|Maintenance Treatment Phase|Reason Not Specified|0|||
147311666|NCT02291289|531309135|FG010|Maintenance Treatment Phase|Reason Not Specified|1|||
147311667|NCT02291289|531309136|FG011|Maintenance Treatment Phase|Reason Not Specified|0|||
147311668|NCT02291289|531309137|FG012|Maintenance Treatment Phase|Reason Not Specified|0|||
147311669|NCT02291289|531309125|FG000|Maintenance Treatment Phase|Physician Decision|0|||
147311670|NCT02291289|531309126|FG001|Maintenance Treatment Phase|Physician Decision|2|||
147311671|NCT02291289|531309127|FG002|Maintenance Treatment Phase|Physician Decision|0|||
147311672|NCT02291289|531309128|FG003|Maintenance Treatment Phase|Physician Decision|0|||
147311673|NCT02291289|531309129|FG004|Maintenance Treatment Phase|Physician Decision|3|||
147311674|NCT02291289|531309130|FG005|Maintenance Treatment Phase|Physician Decision|0|||
147311675|NCT02291289|531309131|FG006|Maintenance Treatment Phase|Physician Decision|0|||
147311676|NCT02291289|531309132|FG007|Maintenance Treatment Phase|Physician Decision|0|||
147311677|NCT02291289|531309133|FG008|Maintenance Treatment Phase|Physician Decision|0|||
147311678|NCT02291289|531309134|FG009|Maintenance Treatment Phase|Physician Decision|0|||
147311679|NCT02291289|531309135|FG010|Maintenance Treatment Phase|Physician Decision|1|||
147311680|NCT02291289|531309136|FG011|Maintenance Treatment Phase|Physician Decision|3|||
147311681|NCT02291289|531309137|FG012|Maintenance Treatment Phase|Physician Decision|0|||
147311682|NCT02291289|531309125|FG000|Maintenance Treatment Phase|Not Treated|0|||
147311683|NCT02291289|531309126|FG001|Maintenance Treatment Phase|Not Treated|0|||
147311684|NCT02291289|531309127|FG002|Maintenance Treatment Phase|Not Treated|2|||
147311685|NCT02291289|531309128|FG003|Maintenance Treatment Phase|Not Treated|0|||
147311686|NCT02291289|531309129|FG004|Maintenance Treatment Phase|Not Treated|0|||
147311687|NCT02291289|531309130|FG005|Maintenance Treatment Phase|Not Treated|0|||
147311688|NCT02291289|531309131|FG006|Maintenance Treatment Phase|Not Treated|0|||
147311689|NCT02291289|531309132|FG007|Maintenance Treatment Phase|Not Treated|0|||
147311690|NCT02291289|531309133|FG008|Maintenance Treatment Phase|Not Treated|0|||
147311691|NCT02291289|531309134|FG009|Maintenance Treatment Phase|Not Treated|0|||
147311692|NCT02291289|531309135|FG010|Maintenance Treatment Phase|Not Treated|0|||
147311693|NCT02291289|531309136|FG011|Maintenance Treatment Phase|Not Treated|0|||
147311694|NCT02291289|531309137|FG012|Maintenance Treatment Phase|Not Treated|0|||
147311695|NCT02291289|531309125|FG000|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
147311696|NCT02291289|531309126|FG001|Maintenance Treatment Phase|Study Ended by Sponsor|1|||
147444379|NCT01438489|531792588|FG001|Overall Study|Sponsor decision|1|||
147444380|NCT01438489|531792589|FG002|Overall Study|Sponsor decision|4|||
147311697|NCT02291289|531309127|FG002|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
147311698|NCT02291289|531309128|FG003|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
147311699|NCT02291289|531309129|FG004|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
147311700|NCT02291289|531309130|FG005|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
147311701|NCT02291289|531309131|FG006|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
147311702|NCT02291289|531309132|FG007|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
147311703|NCT02291289|531309133|FG008|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
147311704|NCT02291289|531309134|FG009|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
147311705|NCT02291289|531309135|FG010|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
147311706|NCT02291289|531309136|FG011|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
147311707|NCT02291289|531309137|FG012|Maintenance Treatment Phase|Study Ended by Sponsor|0|||
147311708|NCT02291289|531309125|FG000|Maintenance Treatment Phase|Non-Compliance|0|||
147311709|NCT02291289|531309126|FG001|Maintenance Treatment Phase|Non-Compliance|1|||
147311710|NCT02291289|531309127|FG002|Maintenance Treatment Phase|Non-Compliance|0|||
147311711|NCT02291289|531309128|FG003|Maintenance Treatment Phase|Non-Compliance|0|||
147311712|NCT02291289|531309129|FG004|Maintenance Treatment Phase|Non-Compliance|2|||
147311713|NCT02291289|531309130|FG005|Maintenance Treatment Phase|Non-Compliance|1|||
147311714|NCT02291289|531309131|FG006|Maintenance Treatment Phase|Non-Compliance|0|||
147311715|NCT02291289|531309132|FG007|Maintenance Treatment Phase|Non-Compliance|0|||
147311716|NCT02291289|531309133|FG008|Maintenance Treatment Phase|Non-Compliance|0|||
147311717|NCT02291289|531309134|FG009|Maintenance Treatment Phase|Non-Compliance|0|||
147311718|NCT02291289|531309135|FG010|Maintenance Treatment Phase|Non-Compliance|0|||
147311719|NCT02291289|531309136|FG011|Maintenance Treatment Phase|Non-Compliance|0|||
147311720|NCT02291289|531309137|FG012|Maintenance Treatment Phase|Non-Compliance|0|||
147311721|NCT02291289|531309125|FG000|Early Disease Progression|Death|0|||
147311722|NCT02291289|531309126|FG001|Early Disease Progression|Death|0|||
147311723|NCT02291289|531309127|FG002|Early Disease Progression|Death|0|||
147311724|NCT02291289|531309128|FG003|Early Disease Progression|Death|0|||
147311725|NCT02291289|531309129|FG004|Early Disease Progression|Death|0|||
147311726|NCT02291289|531309130|FG005|Early Disease Progression|Death|0|||
147311727|NCT02291289|531309131|FG006|Early Disease Progression|Death|0|||
147311728|NCT02291289|531309132|FG007|Early Disease Progression|Death|0|||
147311729|NCT02291289|531309133|FG008|Early Disease Progression|Death|0|||
147311730|NCT02291289|531309134|FG009|Early Disease Progression|Death|0|||
147311731|NCT02291289|531309135|FG010|Early Disease Progression|Death|0|||
147311732|NCT02291289|531309136|FG011|Early Disease Progression|Death|0|||
147311733|NCT02291289|531309137|FG012|Early Disease Progression|Death|10|||
147311734|NCT02291289|531309125|FG000|Early Disease Progression|Lost to Follow-up|0|||
147311735|NCT02291289|531309126|FG001|Early Disease Progression|Lost to Follow-up|0|||
147311736|NCT02291289|531309127|FG002|Early Disease Progression|Lost to Follow-up|0|||
147311737|NCT02291289|531309128|FG003|Early Disease Progression|Lost to Follow-up|0|||
147311738|NCT02291289|531309129|FG004|Early Disease Progression|Lost to Follow-up|0|||
147311739|NCT02291289|531309130|FG005|Early Disease Progression|Lost to Follow-up|0|||
147311740|NCT02291289|531309131|FG006|Early Disease Progression|Lost to Follow-up|0|||
147311741|NCT02291289|531309132|FG007|Early Disease Progression|Lost to Follow-up|0|||
147311742|NCT02291289|531309133|FG008|Early Disease Progression|Lost to Follow-up|0|||
147311743|NCT02291289|531309134|FG009|Early Disease Progression|Lost to Follow-up|0|||
147311744|NCT02291289|531309135|FG010|Early Disease Progression|Lost to Follow-up|0|||
147311745|NCT02291289|531309136|FG011|Early Disease Progression|Lost to Follow-up|0|||
147311746|NCT02291289|531309137|FG012|Early Disease Progression|Lost to Follow-up|1|||
147311747|NCT00154063|531309138|FG000|Overall Study|Adverse Event|4|||
147311748|NCT00154063|531309139|FG001|Overall Study|Adverse Event|8|||
147311749|NCT00154063|531309138|FG000|Overall Study|Protocol Violation|1|||
147311750|NCT00154063|531309139|FG001|Overall Study|Protocol Violation|1|||
147311751|NCT00154063|531309138|FG000|Overall Study|Investigator or Sponsor Request|0|||
147311752|NCT00154063|531309139|FG001|Overall Study|Investigator or Sponsor Request|1|||
147311753|NCT00154063|531309138|FG000|Overall Study|Withdrawal by Subject|4|||
147311754|NCT00154063|531309139|FG001|Overall Study|Withdrawal by Subject|9|||
147311755|NCT00154063|531309138|FG000|Overall Study|Other|3|||
147311756|NCT00154063|531309139|FG001|Overall Study|Other|3|||
147113888|NCT01807520|530579941|FG005|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
147113889|NCT01807520|530579942|FG006|Treatment Period 2 (16-132 Weeks)|Non-compliant with study treatment|0|||
147311757|NCT01258660|531309147|FG000|Overall Study|Adverse Event|2|||
147311758|NCT01258660|531309148|FG001|Overall Study|Adverse Event|4|||
147311759|NCT01258660|531309147|FG000|Overall Study|Withdrawal by Subject|3|||
147311760|NCT01258660|531309148|FG001|Overall Study|Withdrawal by Subject|0|||
147311761|NCT01258660|531309147|FG000|Overall Study|due to relocation|2|||
147311762|NCT01258660|531309148|FG001|Overall Study|due to relocation|0|||
147311763|NCT01258660|531309147|FG000|Overall Study|Protocol Violation|0|||
147311764|NCT01258660|531309148|FG001|Overall Study|Protocol Violation|1|||
147113890|NCT01807520|530579936|FG000|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|4|||
147113891|NCT01807520|530579937|FG001|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0|||
147311765|NCT01258660|531309147|FG000|Overall Study|Invalid for primary analysis data set|4|||
147311766|NCT01258660|531309148|FG001|Overall Study|Invalid for primary analysis data set|6|||
147311767|NCT04192630|531309151|FG000|Overall Study|Discontinued before surgery|2|||
147311768|NCT04192630|531309152|FG001|Overall Study|Discontinued before surgery|0|||
147311769|NCT04192630|531309151|FG000|Overall Study|Discontinued after surgery|5|||
147311770|NCT04192630|531309152|FG001|Overall Study|Discontinued after surgery|3|||
147311771|NCT01208415|531309153|FG000|Overall Study|Death|1|||
147311772|NCT01208415|531309153|FG000|Overall Study|Lost to Follow-up|2|||
147311773|NCT01208415|531309153|FG000|Overall Study|Withdrawal by Subject|3|||
147311774|NCT01208415|531309153|FG000|Overall Study|Device not placed|1|||
147311775|NCT01208415|531309153|FG000|Overall Study|Still be eligible for follow-up|33|||
147311776|NCT01115491|531309154|FG000|Overall Study|Death|22|||
147311777|NCT01115491|531309154|FG000|Overall Study|Adverse Event|3|||
147311778|NCT01115491|531309154|FG000|Overall Study|Lost to Follow-up|3|||
147311779|NCT01115491|531309154|FG000|Overall Study|Withdrawal by Subject|1|||
147311780|NCT01115491|531309154|FG000|Overall Study|Physician Decision|1|||
147311781|NCT03856996|531309155|FG000|Overall Study|Withdrawal by Subject|1|||
147311782|NCT03856996|531309156|FG001|Overall Study|Withdrawal by Subject|0|||
147311783|NCT03856996|531309155|FG000|Overall Study|Lost to Follow-up|0|||
147311784|NCT03856996|531309156|FG001|Overall Study|Lost to Follow-up|1|||
147311785|NCT03856996|531309155|FG000|Overall Study|Adverse Event|1|||
147311786|NCT03856996|531309156|FG001|Overall Study|Adverse Event|1|||
147311787|NCT03856996|531309155|FG000|Overall Study|Other|1|||
147311788|NCT03856996|531309156|FG001|Overall Study|Other|0|||
147311789|NCT01586338|531309158|FG000|Overall Study|Adverse Event|3|||
147311790|NCT01586338|531309158|FG000|Overall Study|Lost to Follow-up|1|||
147311791|NCT01586338|531309158|FG000|Overall Study|Withdrawal by participant|3|||
147311792|NCT01586338|531309158|FG000|Overall Study|Other|1|||
147311793|NCT03306043|531309161|FG000|Overall Study|Adverse Event|1|||
147311794|NCT03306043|531309161|FG000|Overall Study|Lost to Follow-up|1|||
147311795|NCT03306043|531309161|FG000|Overall Study|Withdrawal by Subject|2|||
147311796|NCT01544491|531309162|FG000|Overall Study|Withdrawal by Subject|3|||
147311797|NCT01544491|531309163|FG001|Overall Study|Withdrawal by Subject|2|||
147311798|NCT01544491|531309162|FG000|Overall Study|Lost to Follow-up|0|||
147311799|NCT01544491|531309163|FG001|Overall Study|Lost to Follow-up|1|||
147311800|NCT01544491|531309162|FG000|Overall Study|administrative problems|2|||
147311801|NCT01544491|531309163|FG001|Overall Study|administrative problems|0|||
147311802|NCT01799720|531309164|FG000|Overall Study|Withdrawal by Subject|3|||
147311803|NCT01799720|531309165|FG001|Overall Study|Withdrawal by Subject|0|||
147311804|NCT01799720|531309166|FG002|Overall Study|Withdrawal by Subject|0|||
147311805|NCT01799720|531309164|FG000|Overall Study|Protocol Violation|0|||
147311806|NCT01799720|531309165|FG001|Overall Study|Protocol Violation|1|||
147311807|NCT01799720|531309166|FG002|Overall Study|Protocol Violation|0|||
147311808|NCT01799720|531309164|FG000|Overall Study|Pregnancy|0|||
147311809|NCT01799720|531309165|FG001|Overall Study|Pregnancy|0|||
147311810|NCT01799720|531309166|FG002|Overall Study|Pregnancy|1|||
147311811|NCT02733042|531309174|FG000|Overall Study|Adverse Event|1|||
147311812|NCT02733042|531309175|FG001|Overall Study|Adverse Event|0|||
147311813|NCT02733042|531309176|FG002|Overall Study|Adverse Event|1|||
147311814|NCT02733042|531309177|FG003|Overall Study|Adverse Event|1|||
147311815|NCT02733042|531309178|FG004|Overall Study|Adverse Event|0|||
147311816|NCT02733042|531309179|FG005|Overall Study|Adverse Event|0|||
147311817|NCT02733042|531309180|FG006|Overall Study|Adverse Event|0|||
147311818|NCT02733042|531309181|FG007|Overall Study|Adverse Event|0|||
147311819|NCT02733042|531309182|FG008|Overall Study|Adverse Event|0|||
147311820|NCT02733042|531309183|FG009|Overall Study|Adverse Event|0|||
147311821|NCT02733042|531309184|FG010|Overall Study|Adverse Event|2|||
147311822|NCT02733042|531309185|FG011|Overall Study|Adverse Event|2|||
147311823|NCT02733042|531309186|FG012|Overall Study|Adverse Event|0|||
147311824|NCT02733042|531309187|FG013|Overall Study|Adverse Event|2|||
147311825|NCT02733042|531309188|FG014|Overall Study|Adverse Event|0|||
147311826|NCT02733042|531309189|FG015|Overall Study|Adverse Event|0|||
147311827|NCT02733042|531309190|FG016|Overall Study|Adverse Event|0|||
147444381|NCT01438489|531792587|FG000|Overall Study|Subject choice/Subject moved|2|||
147311828|NCT02733042|531309191|FG017|Overall Study|Adverse Event|1|||
147311829|NCT02733042|531309192|FG018|Overall Study|Adverse Event|0|||
147311830|NCT02733042|531309174|FG000|Overall Study|Progressive Disease|2|||
147311831|NCT02733042|531309175|FG001|Overall Study|Progressive Disease|1|||
147311832|NCT02733042|531309176|FG002|Overall Study|Progressive Disease|3|||
147311833|NCT02733042|531309177|FG003|Overall Study|Progressive Disease|1|||
147444382|NCT01438489|531792588|FG001|Overall Study|Subject choice/Subject moved|1|||
147311834|NCT02733042|531309178|FG004|Overall Study|Progressive Disease|2|||
147311835|NCT02733042|531309179|FG005|Overall Study|Progressive Disease|3|||
147311836|NCT02733042|531309180|FG006|Overall Study|Progressive Disease|0|||
147311837|NCT02733042|531309181|FG007|Overall Study|Progressive Disease|3|||
147311838|NCT02733042|531309182|FG008|Overall Study|Progressive Disease|3|||
147311839|NCT02733042|531309183|FG009|Overall Study|Progressive Disease|2|||
147311840|NCT02733042|531309184|FG010|Overall Study|Progressive Disease|2|||
147311841|NCT02733042|531309185|FG011|Overall Study|Progressive Disease|2|||
147311842|NCT02733042|531309186|FG012|Overall Study|Progressive Disease|8|||
147311843|NCT02733042|531309187|FG013|Overall Study|Progressive Disease|1|||
147228004|NCT02694523|531007158|FG003|Part B|Other|0|||
147228005|NCT02694523|531007159|FG004|Part B|Other|0|||
147228006|NCT02694523|531007160|FG005|Part B|Other|0|||
147228007|NCT02694523|531007161|FG006|Part B|Other|1|||
147228008|NCT01086423|531007162|FG000|Overall Study|Protocol Violation|0|||
147228009|NCT01086423|531007163|FG001|Overall Study|Protocol Violation|0|||
147228010|NCT01086423|531007164|FG002|Overall Study|Protocol Violation|1|||
147228011|NCT01086423|531007162|FG000|Overall Study|Migrated/moved from study area|2|||
147228012|NCT01086423|531007163|FG001|Overall Study|Migrated/moved from study area|0|||
147228013|NCT01086423|531007164|FG002|Overall Study|Migrated/moved from study area|4|||
147228014|NCT01086423|531007162|FG000|Overall Study|Adverse event, fatal|1|||
147228015|NCT01086423|531007163|FG001|Overall Study|Adverse event, fatal|1|||
147228016|NCT01086423|531007164|FG002|Overall Study|Adverse event, fatal|0|||
147228017|NCT01086423|531007162|FG000|Overall Study|Adverse event, non-fatal|2|||
147228018|NCT01086423|531007163|FG001|Overall Study|Adverse event, non-fatal|1|||
147228019|NCT01086423|531007164|FG002|Overall Study|Adverse event, non-fatal|0|||
147228020|NCT01086423|531007162|FG000|Overall Study|Withdrawal by Subject|5|||
147228021|NCT01086423|531007163|FG001|Overall Study|Withdrawal by Subject|1|||
147228022|NCT01086423|531007164|FG002|Overall Study|Withdrawal by Subject|3|||
147228023|NCT01086423|531007162|FG000|Overall Study|Lost to Follow-up|0|||
147228024|NCT01086423|531007163|FG001|Overall Study|Lost to Follow-up|0|||
147228025|NCT01086423|531007164|FG002|Overall Study|Lost to Follow-up|1|||
147228026|NCT00984568|531007166|FG000|Overall Study|Withdrawal by Subject|1|||
147228027|NCT00984568|531007167|FG001|Overall Study|Withdrawal by Subject|2|||
147228028|NCT00984568|531007166|FG000|Overall Study|Lack of Efficacy|2|||
147228029|NCT00984568|531007167|FG001|Overall Study|Lack of Efficacy|0|||
147228030|NCT00984568|531007166|FG000|Overall Study|Adverse Event|2|||
147228031|NCT00984568|531007167|FG001|Overall Study|Adverse Event|0|||
147228032|NCT00984568|531007166|FG000|Overall Study|Did Not Meet Randomization Criteria|1|||
147228033|NCT00984568|531007167|FG001|Overall Study|Did Not Meet Randomization Criteria|0|||
147228034|NCT00984568|531007166|FG000|Overall Study|Lost to Follow-up|0|||
147228035|NCT00984568|531007167|FG001|Overall Study|Lost to Follow-up|1|||
147228036|NCT00984568|531007166|FG000|Overall Study|Opportunistic Infection|1|||
147228037|NCT00984568|531007167|FG001|Overall Study|Opportunistic Infection|0|||
147228038|NCT00984568|531007166|FG000|Overall Study|Unknown Reason|1|||
147228039|NCT00984568|531007167|FG001|Overall Study|Unknown Reason|3|||
147228040|NCT04505540|531007168|FG000|Baseline|Protocol Violation|10|||
147228041|NCT04505540|531007168|FG000|1 Week Eligible to Self-report|Incarcerated/Institutionalized|1|||
147228042|NCT04505540|531007168|FG000|1 Week Contacted for Self-report|Lost to Follow-up|27|||
147228043|NCT04505540|531007168|FG000|1 Week Eligible for Urinanalysis|COVID disruption of urine sampling|52|||
147228044|NCT04505540|531007168|FG000|1 Week Eligible for Urinanalysis|Incarcerated/Institutionalized|1|||
147228045|NCT04505540|531007168|FG000|1 Week Urine Sample Provided|Lost to Follow-up|13|||
147228046|NCT04505540|531007168|FG000|3 Months Eligible to Self-report|Incarcerated/Institutionalized|7|||
147228047|NCT04505540|531007168|FG000|3 Months Contacted for Self-report|Lost to Follow-up|22|||
147228048|NCT04505540|531007168|FG000|3 Months Eligible for Urinanalysis|COVID disruption of urine sampling|70|||
147228049|NCT04505540|531007168|FG000|3 Months Urine Sample Provided|Lost to Follow-up|13|||
147228050|NCT04505540|531007168|FG000|6 Months Eligible to Self-report|Incarcerated/Institutionalized|9|||
147228051|NCT04505540|531007168|FG000|6 Months Contacted for Self-report|Lost to Follow-up|17|||
147228052|NCT04505540|531007168|FG000|6 Months Eligible for Urinanalysis|COVID disruption of urine sampling|91|||
147228053|NCT02057393|531007171|FG000|Overall Study|Withdrawal by Subject|1|||
147228054|NCT02057393|531007171|FG000|Overall Study|Patient did not meet criteria|1|||
147228055|NCT03180684|531007172|FG000|Overall Study|Withdrawal by Subject (Not Related to AE)|5|||
147228056|NCT03180684|531007173|FG001|Overall Study|Withdrawal by Subject (Not Related to AE)|0|||
147228057|NCT03180684|531007172|FG000|Overall Study|Physician Decision|1|||
147228058|NCT03180684|531007173|FG001|Overall Study|Physician Decision|0|||
147228059|NCT03180684|531007172|FG000|Overall Study|Lost to Follow-up|1|||
147228060|NCT03180684|531007173|FG001|Overall Study|Lost to Follow-up|0|||
147228061|NCT03180684|531007172|FG000|Overall Study|Progressive Disease|1|||
147228062|NCT03180684|531007173|FG001|Overall Study|Progressive Disease|0|||
147228063|NCT03091777|531007174|FG000|Overall Study|Pregnancy|2|||
147228064|NCT03091777|531007175|FG001|Overall Study|Pregnancy|1|||
147228065|NCT03091777|531007176|FG002|Overall Study|Pregnancy|0|||
147228066|NCT03091777|531007174|FG000|Overall Study|Adverse Event|2|||
147228067|NCT03091777|531007175|FG001|Overall Study|Adverse Event|1|||
147228068|NCT03091777|531007176|FG002|Overall Study|Adverse Event|4|||
147228069|NCT03091777|531007174|FG000|Overall Study|Withdrawal by Subject|4|||
147228070|NCT03091777|531007175|FG001|Overall Study|Withdrawal by Subject|2|||
147228071|NCT03091777|531007176|FG002|Overall Study|Withdrawal by Subject|6|||
147228072|NCT03091777|531007174|FG000|Overall Study|Protocol Violation|2|||
147228073|NCT03091777|531007175|FG001|Overall Study|Protocol Violation|1|||
147228074|NCT03091777|531007176|FG002|Overall Study|Protocol Violation|1|||
147228075|NCT03091777|531007174|FG000|Overall Study|Lost to Follow-up|12|||
147228076|NCT03091777|531007175|FG001|Overall Study|Lost to Follow-up|14|||
147228077|NCT03091777|531007176|FG002|Overall Study|Lost to Follow-up|7|||
147228078|NCT03091777|531007174|FG000|Overall Study|Lack of Efficacy|0|||
147228079|NCT03091777|531007175|FG001|Overall Study|Lack of Efficacy|0|||
147311844|NCT02733042|531309188|FG014|Overall Study|Progressive Disease|4|||
147311845|NCT02733042|531309189|FG015|Overall Study|Progressive Disease|7|||
147311846|NCT02733042|531309190|FG016|Overall Study|Progressive Disease|2|||
147311847|NCT02733042|531309191|FG017|Overall Study|Progressive Disease|3|||
147311848|NCT02733042|531309192|FG018|Overall Study|Progressive Disease|4|||
147311849|NCT02733042|531309174|FG000|Overall Study|Withdrawal by Subject|0|||
147311850|NCT02733042|531309175|FG001|Overall Study|Withdrawal by Subject|1|||
147311851|NCT02733042|531309176|FG002|Overall Study|Withdrawal by Subject|2|||
147311852|NCT02733042|531309177|FG003|Overall Study|Withdrawal by Subject|1|||
147311853|NCT02733042|531309178|FG004|Overall Study|Withdrawal by Subject|1|||
147311854|NCT02733042|531309179|FG005|Overall Study|Withdrawal by Subject|0|||
147311855|NCT02733042|531309180|FG006|Overall Study|Withdrawal by Subject|0|||
147311856|NCT02733042|531309181|FG007|Overall Study|Withdrawal by Subject|0|||
147311857|NCT02733042|531309182|FG008|Overall Study|Withdrawal by Subject|1|||
147311858|NCT02733042|531309183|FG009|Overall Study|Withdrawal by Subject|1|||
147311859|NCT02733042|531309184|FG010|Overall Study|Withdrawal by Subject|0|||
147311860|NCT02733042|531309185|FG011|Overall Study|Withdrawal by Subject|2|||
147311861|NCT02733042|531309186|FG012|Overall Study|Withdrawal by Subject|1|||
147311862|NCT02733042|531309187|FG013|Overall Study|Withdrawal by Subject|1|||
147311863|NCT02733042|531309188|FG014|Overall Study|Withdrawal by Subject|0|||
147311864|NCT02733042|531309189|FG015|Overall Study|Withdrawal by Subject|0|||
147311865|NCT02733042|531309190|FG016|Overall Study|Withdrawal by Subject|0|||
147311866|NCT02733042|531309191|FG017|Overall Study|Withdrawal by Subject|0|||
147311867|NCT02733042|531309192|FG018|Overall Study|Withdrawal by Subject|0|||
147311868|NCT02733042|531309174|FG000|Overall Study|Other Reasons|0|||
147311869|NCT02733042|531309175|FG001|Overall Study|Other Reasons|0|||
147311870|NCT02733042|531309176|FG002|Overall Study|Other Reasons|1|||
147311871|NCT02733042|531309177|FG003|Overall Study|Other Reasons|0|||
147311872|NCT02733042|531309178|FG004|Overall Study|Other Reasons|0|||
147311873|NCT02733042|531309179|FG005|Overall Study|Other Reasons|0|||
147311874|NCT02733042|531309180|FG006|Overall Study|Other Reasons|0|||
147311875|NCT02733042|531309181|FG007|Overall Study|Other Reasons|0|||
147311876|NCT02733042|531309182|FG008|Overall Study|Other Reasons|0|||
147311877|NCT02733042|531309183|FG009|Overall Study|Other Reasons|1|||
147311878|NCT02733042|531309184|FG010|Overall Study|Other Reasons|1|||
147311879|NCT02733042|531309185|FG011|Overall Study|Other Reasons|0|||
147311880|NCT02733042|531309186|FG012|Overall Study|Other Reasons|0|||
147311881|NCT02733042|531309187|FG013|Overall Study|Other Reasons|0|||
147311882|NCT02733042|531309188|FG014|Overall Study|Other Reasons|0|||
147311883|NCT02733042|531309189|FG015|Overall Study|Other Reasons|1|||
147311884|NCT02733042|531309190|FG016|Overall Study|Other Reasons|0|||
147311885|NCT02733042|531309191|FG017|Overall Study|Other Reasons|1|||
147311886|NCT02733042|531309192|FG018|Overall Study|Other Reasons|0|||
147311887|NCT02733042|531309174|FG000|Overall Study|Death|0|||
147311888|NCT02733042|531309175|FG001|Overall Study|Death|0|||
147311889|NCT02733042|531309176|FG002|Overall Study|Death|0|||
147311890|NCT02733042|531309177|FG003|Overall Study|Death|0|||
147311891|NCT02733042|531309178|FG004|Overall Study|Death|0|||
147113892|NCT01807520|530579938|FG002|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0|||
147311892|NCT02733042|531309179|FG005|Overall Study|Death|0|||
147311893|NCT02733042|531309180|FG006|Overall Study|Death|1|||
147311894|NCT02733042|531309181|FG007|Overall Study|Death|0|||
147311895|NCT02733042|531309182|FG008|Overall Study|Death|1|||
147311896|NCT02733042|531309183|FG009|Overall Study|Death|0|||
147311897|NCT02733042|531309184|FG010|Overall Study|Death|1|||
147311898|NCT02733042|531309185|FG011|Overall Study|Death|0|||
147311899|NCT02733042|531309186|FG012|Overall Study|Death|0|||
147311900|NCT02733042|531309187|FG013|Overall Study|Death|0|||
147311901|NCT02733042|531309188|FG014|Overall Study|Death|1|||
147311902|NCT02733042|531309189|FG015|Overall Study|Death|2|||
147311903|NCT02733042|531309190|FG016|Overall Study|Death|0|||
147311904|NCT02733042|531309191|FG017|Overall Study|Death|0|||
147311905|NCT02733042|531309192|FG018|Overall Study|Death|0|||
147311906|NCT02838628|531309193|FG000|Recurrence Follow-up Period|AK Recurrence|18|||
147311907|NCT02838628|531309194|FG001|Recurrence Follow-up Period|AK Recurrence|13|||
147311908|NCT02838628|531309193|FG000|Recurrence Follow-up Period|Adverse Event|1|||
147311909|NCT02838628|531309194|FG001|Recurrence Follow-up Period|Adverse Event|0|||
147311910|NCT02838628|531309193|FG000|Recurrence Follow-up Period|Non-compliance|0|||
147311911|NCT02838628|531309194|FG001|Recurrence Follow-up Period|Non-compliance|1|||
147311912|NCT02838628|531309193|FG000|Recurrence Follow-up Period|Withdrawal by Subject|0|||
147311913|NCT02838628|531309194|FG001|Recurrence Follow-up Period|Withdrawal by Subject|2|||
147311914|NCT02838628|531309193|FG000|Recurrence Follow-up Period|Other un-specified|1|||
147311915|NCT02838628|531309194|FG001|Recurrence Follow-up Period|Other un-specified|1|||
147311916|NCT01018563|531309197|FG000|Overall Study|Termination of the study by Sponsor|2|||
147311917|NCT01018563|531309198|FG001|Overall Study|Termination of the study by Sponsor|1|||
147311918|NCT02344537|531309199|FG000|Overall Study|Protocol Violation|1|||
147311919|NCT02344537|531309200|FG001|Overall Study|Protocol Violation|1|||
147311920|NCT02344537|531309199|FG000|Overall Study|Subject started another treatment after wk 6|1|||
147311921|NCT02344537|531309200|FG001|Overall Study|Subject started another treatment after wk 6|0|||
147311922|NCT02344537|531309199|FG000|Overall Study|Participants completed the treatment but the week 8 data not available.|2|||
147311923|NCT02344537|531309200|FG001|Overall Study|Participants completed the treatment but the week 8 data not available.|1|||
147311924|NCT00960752|531309209|FG000|Overall Study|Adverse Event|0|||
147311925|NCT00960752|531309210|FG001|Overall Study|Adverse Event|0|||
147311926|NCT00960752|531309211|FG002|Overall Study|Adverse Event|1|||
147311927|NCT00960752|531309209|FG000|Overall Study|Progression|0|||
147311928|NCT00960752|531309210|FG001|Overall Study|Progression|0|||
147311929|NCT00960752|531309211|FG002|Overall Study|Progression|1|||
147311930|NCT04844970|531309212|FG000|Overall Study|Adverse Event|0|||
147311931|NCT04844970|531309213|FG001|Overall Study|Adverse Event|1|||
147311932|NCT04844970|531309212|FG000|Overall Study|Withdrawal by Subject|2|||
147311933|NCT04844970|531309213|FG001|Overall Study|Withdrawal by Subject|0|||
147311934|NCT05490329|531309214|FG000|2-Arm Randomized Control Trial|Lost to Follow-up|8|||
147311935|NCT05490329|531309215|FG001|2-Arm Randomized Control Trial|Lost to Follow-up|25|||
147311936|NCT05490329|531309214|FG000|2-Arm Randomized Control Trial|Withdrawal by Subject|0|||
147311937|NCT05490329|531309215|FG001|2-Arm Randomized Control Trial|Withdrawal by Subject|1|||
147311938|NCT05490329|531309214|FG000|Standard of Care - App Access Crossover|Lost to Follow-up|9|||
147311939|NCT05490329|531309215|FG001|Standard of Care - App Access Crossover|Lost to Follow-up|0|||
147311940|NCT03169881|531309216|FG000|Overall Study|Incomplete Follow-up|10|||
147311941|NCT03169881|531309217|FG001|Overall Study|Incomplete Follow-up|15|||
147311942|NCT03169881|531309216|FG000|Overall Study|Lost to Follow-up|18|||
147311943|NCT03169881|531309217|FG001|Overall Study|Lost to Follow-up|20|||
147311944|NCT03169881|531309216|FG000|Overall Study|Data withdrawn prior to hospital discharge|3|||
147311945|NCT03169881|531309217|FG001|Overall Study|Data withdrawn prior to hospital discharge|1|||
147311946|NCT00856661|531309218|FG000|Overall Study|Death|15|||
147311947|NCT00856661|531309219|FG001|Overall Study|Death|18|||
147311948|NCT00856661|531309218|FG000|Overall Study|Protocol Violation|2|||
147311949|NCT00856661|531309219|FG001|Overall Study|Protocol Violation|1|||
147311950|NCT00856661|531309218|FG000|Overall Study|Withdrawal by Subject|1|||
147311951|NCT00856661|531309219|FG001|Overall Study|Withdrawal by Subject|2|||
147311952|NCT00856661|531309218|FG000|Overall Study|Lost to Follow-up|1|||
147311953|NCT00856661|531309219|FG001|Overall Study|Lost to Follow-up|3|||
147311954|NCT00856661|531309218|FG000|Overall Study|Physician Judgement|8|||
147311955|NCT00856661|531309219|FG001|Overall Study|Physician Judgement|5|||
147311956|NCT03936777|531309220|FG000|Overall Study|Adverse Event|3|||
147311957|NCT03936777|531309220|FG000|Overall Study|Death|3|||
147311958|NCT03936777|531309220|FG000|Overall Study|Lack of Efficacy|24|||
147311959|NCT03936777|531309220|FG000|Overall Study|Lost to Follow-up|3|||
147311960|NCT03936777|531309220|FG000|Overall Study|Physician Decision|1|||
147311961|NCT03936777|531309220|FG000|Overall Study|Withdrawal by Subject|11|||
147311962|NCT03936777|531309220|FG000|Overall Study|Subjected Weaned of ZX008|1|||
147311963|NCT03936777|531309220|FG000|Overall Study|Missing|6|||
147311964|NCT02306122|531309221|FG000|Initial Physician Randomization|Physician Decision|0|||
147311965|NCT02306122|531309222|FG001|Initial Physician Randomization|Physician Decision|0|||
147311966|NCT02306122|531309223|FG002|Initial Physician Randomization|Physician Decision|0|||
147311967|NCT02306122|531309224|FG003|Initial Physician Randomization|Physician Decision|0|||
147311968|NCT02306122|531309225|FG004|Initial Physician Randomization|Physician Decision|0|||
147311969|NCT02306122|531309226|FG005|Initial Physician Randomization|Physician Decision|0|||
147311970|NCT02306122|531309227|FG006|Initial Physician Randomization|Physician Decision|0|||
147311971|NCT02306122|531309228|FG007|Initial Physician Randomization|Physician Decision|0|||
147311972|NCT02306122|531309229|FG008|Initial Physician Randomization|Physician Decision|1|||
147311973|NCT02306122|531309230|FG009|Initial Physician Randomization|Physician Decision|0|||
147311974|NCT02306122|531309231|FG010|Initial Physician Randomization|Physician Decision|0|||
147311975|NCT03734991|531309235|FG000|Overall Study|Adverse Event|4|||
147444383|NCT01438489|531792589|FG002|Overall Study|Subject choice/Subject moved|1|||
147562544|NCT01328093|532217635|FG000|Double-Blind Phase|Scheduling conflict|8|||
147562545|NCT01328093|532217636|FG001|Double-Blind Phase|Scheduling conflict|3|||
147562546|NCT01328093|532217635|FG000|Double-Blind Phase|Subject is moving or has moved|8|||
147562547|NCT01328093|532217636|FG001|Double-Blind Phase|Subject is moving or has moved|1|||
147562548|NCT01328093|532217635|FG000|Double-Blind Phase|Death|1|||
147562549|NCT01328093|532217636|FG001|Double-Blind Phase|Death|0|||
147562550|NCT01328093|532217635|FG000|Open-Label Phase|Sponsor Decision|98|||
147113893|NCT01807520|530579939|FG003|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|1|||
147113894|NCT01807520|530579940|FG004|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0|||
147311976|NCT03734991|531309236|FG001|Overall Study|Adverse Event|0|||
147311977|NCT03734991|531309235|FG000|Overall Study|Lost to Follow-up|4|||
147311978|NCT03734991|531309236|FG001|Overall Study|Lost to Follow-up|0|||
147311979|NCT03734991|531309235|FG000|Overall Study|Physician Decision|0|||
147311980|NCT03734991|531309236|FG001|Overall Study|Physician Decision|1|||
147311981|NCT03734991|531309235|FG000|Overall Study|Pregnancy|1|||
147311982|NCT03734991|531309236|FG001|Overall Study|Pregnancy|0|||
147311983|NCT03734991|531309235|FG000|Overall Study|Withdrawal by Subject|6|||
147311984|NCT03734991|531309236|FG001|Overall Study|Withdrawal by Subject|3|||
147562551|NCT01328093|532217636|FG001|Open-Label Phase|Sponsor Decision|34|||
147562552|NCT01328093|532217635|FG000|Open-Label Phase|Protocol Violation|8|||
147228080|NCT03091777|531007176|FG002|Overall Study|Lack of Efficacy|5|||
147228081|NCT03091777|531007174|FG000|Overall Study|Noncompliance with study drug|2|||
147228082|NCT03091777|531007175|FG001|Overall Study|Noncompliance with study drug|3|||
147228083|NCT03091777|531007176|FG002|Overall Study|Noncompliance with study drug|1|||
147228084|NCT03091777|531007174|FG000|Overall Study|Physician Decision|1|||
147228085|NCT03091777|531007175|FG001|Overall Study|Physician Decision|0|||
147228086|NCT03091777|531007176|FG002|Overall Study|Physician Decision|1|||
147228087|NCT03091777|531007174|FG000|Overall Study|Abnormal Laboratory Value|7|||
147228088|NCT03091777|531007175|FG001|Overall Study|Abnormal Laboratory Value|11|||
147228089|NCT03091777|531007176|FG002|Overall Study|Abnormal Laboratory Value|12|||
147228090|NCT01437878|531007177|FG000|Overall Study|Withdrawal by Subject|1|||
147228091|NCT01437878|531007178|FG001|Overall Study|Withdrawal by Subject|0|||
147228092|NCT01070043|531007179|FG000|Run-In Phase|Did not Meet Inclusion Criteria|18|||
147228093|NCT01070043|531007180|FG001|Run-In Phase|Did not Meet Inclusion Criteria|0|||
147228094|NCT01070043|531007181|FG002|Run-In Phase|Did not Meet Inclusion Criteria|0|||
147228095|NCT01070043|531007179|FG000|Double-Blind Treatment|Adverse Event|0|||
147228096|NCT01070043|531007180|FG001|Double-Blind Treatment|Adverse Event|0|||
147228097|NCT01070043|531007181|FG002|Double-Blind Treatment|Adverse Event|2|||
147228098|NCT01476644|531007186|FG000|Overall Study|Death|5|||
147228099|NCT01476644|531007186|FG000|Overall Study|moved to another state|2|||
147228100|NCT01476644|531007186|FG000|Overall Study|Lost to Follow-up|19|||
147228101|NCT01476644|531007186|FG000|Overall Study|Withdrawal by Subject|13|||
147228102|NCT02393690|531007187|FG000|Overall Study|Ineligible|0|||
147228103|NCT02393690|531007188|FG001|Overall Study|Ineligible|1|||
147228104|NCT03488927|531007189|FG000|Overall Study|Withdrawal by Subject|44|||
147228105|NCT03488927|531007190|FG001|Overall Study|Withdrawal by Subject|118|||
147228106|NCT03488927|531007191|FG002|Overall Study|Withdrawal by Subject|217|||
147228107|NCT00586066|531007192|FG000|Overall Study|Lost to Follow-up|6|||
147228108|NCT00586066|531007193|FG001|Overall Study|Lost to Follow-up|3|||
147228109|NCT00586066|531007192|FG000|Overall Study|Lack of Efficacy|5|||
147228110|NCT00586066|531007193|FG001|Overall Study|Lack of Efficacy|3|||
147228111|NCT00586066|531007192|FG000|Overall Study|Adverse Event|2|||
147228112|NCT00586066|531007193|FG001|Overall Study|Adverse Event|2|||
147228113|NCT00586066|531007192|FG000|Overall Study|Physician Decision|1|||
147228114|NCT00586066|531007193|FG001|Overall Study|Physician Decision|0|||
147228115|NCT00586066|531007192|FG000|Overall Study|Withdrawal of consent|4|||
147228116|NCT00586066|531007193|FG001|Overall Study|Withdrawal of consent|2|||
147228117|NCT02676466|531007194|FG000|Overall Study|Death|0|||
147228118|NCT02676466|531007195|FG001|Overall Study|Death|2|||
147228119|NCT02676466|531007196|FG002|Overall Study|Death|1|||
147228120|NCT02676466|531007197|FG003|Overall Study|Death|0|||
147562553|NCT01328093|532217636|FG001|Open-Label Phase|Protocol Violation|3|||
147562554|NCT01328093|532217635|FG000|Open-Label Phase|Lost to Follow-up|10|||
147228121|NCT02676466|531007198|FG004|Overall Study|Death|0|||
147228122|NCT02676466|531007199|FG005|Overall Study|Death|0|||
147228123|NCT02676466|531007200|FG006|Overall Study|Death|0|||
147228124|NCT02676466|531007201|FG007|Overall Study|Death|0|||
147228125|NCT02676466|531007194|FG000|Overall Study|Withdrawal by Subject|4|||
147228126|NCT02676466|531007195|FG001|Overall Study|Withdrawal by Subject|3|||
147228127|NCT02676466|531007196|FG002|Overall Study|Withdrawal by Subject|1|||
147228128|NCT02676466|531007197|FG003|Overall Study|Withdrawal by Subject|0|||
147228129|NCT02676466|531007198|FG004|Overall Study|Withdrawal by Subject|3|||
147228130|NCT02676466|531007199|FG005|Overall Study|Withdrawal by Subject|1|||
147228131|NCT02676466|531007200|FG006|Overall Study|Withdrawal by Subject|1|||
147228132|NCT02676466|531007201|FG007|Overall Study|Withdrawal by Subject|1|||
147228133|NCT02059005|531007202|FG000|Overall Study|Death|1|||
147228134|NCT02059005|531007203|FG001|Overall Study|Death|3|||
147228135|NCT02059005|531007202|FG000|Overall Study|Lost to Follow-up|19|||
147228136|NCT02059005|531007203|FG001|Overall Study|Lost to Follow-up|19|||
147228137|NCT02059005|531007202|FG000|Overall Study|Incarceration|0|||
147228138|NCT02059005|531007203|FG001|Overall Study|Incarceration|1|||
147228139|NCT02059005|531007202|FG000|Overall Study|Inpatient|0|||
147228140|NCT02059005|531007203|FG001|Overall Study|Inpatient|1|||
147228141|NCT00760084|531007204|FG000|Overall Study|Physician Decision|5|||
147228142|NCT00760084|531007204|FG000|Overall Study|Withdrawal by Subject|2|||
147228143|NCT00760084|531007204|FG000|Overall Study|Progressive Disease|3|||
147228144|NCT02231918|531008695|FG000|Overall Study|Withdrawal by Subject|0|||
147228145|NCT02231918|531008696|FG001|Overall Study|Withdrawal by Subject|1|||
147228146|NCT02231918|531008697|FG002|Overall Study|Withdrawal by Subject|0|||
147228147|NCT02231918|531008695|FG000|Overall Study|Adverse Event|0|||
147228148|NCT02231918|531008696|FG001|Overall Study|Adverse Event|0|||
147228149|NCT02231918|531008697|FG002|Overall Study|Adverse Event|1|||
147228150|NCT00137631|531008705|FG000|Overall Study|Lost to Follow-up|37|||
147228151|NCT00137631|531008706|FG001|Overall Study|Lost to Follow-up|41|||
147228152|NCT02611960|531008707|FG000|Overall Study|Adverse Event|7|||
147228153|NCT02611960|531008708|FG001|Overall Study|Adverse Event|8|||
147228154|NCT02611960|531008707|FG000|Overall Study|Death|98|||
147228155|NCT02611960|531008708|FG001|Overall Study|Death|92|||
147228156|NCT02611960|531008707|FG000|Overall Study|Withdrawal by Subject|1|||
147113895|NCT01807520|530579941|FG005|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0|||
147113896|NCT01807520|530579942|FG006|Treatment Period 2 (16-132 Weeks)|Lost to Follow-up|0|||
147113897|NCT01807520|530579936|FG000|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|5|||
147113898|NCT01807520|530579937|FG001|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|3|||
147113899|NCT01807520|530579938|FG002|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0|||
147113900|NCT01807520|530579939|FG003|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0|||
147113901|NCT01807520|530579940|FG004|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|1|||
147113902|NCT01807520|530579941|FG005|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0|||
147113903|NCT01807520|530579942|FG006|Treatment Period 2 (16-132 Weeks)|Lack of Efficacy|0|||
147113904|NCT01807520|530579936|FG000|Treatment Period 2 (16-132 Weeks)|Adverse Event|3|||
147113905|NCT01807520|530579937|FG001|Treatment Period 2 (16-132 Weeks)|Adverse Event|3|||
147228157|NCT02611960|531008708|FG001|Overall Study|Withdrawal by Subject|5|||
147228158|NCT02611960|531008707|FG000|Overall Study|Sponsor Decision|11|||
147228159|NCT02611960|531008708|FG001|Overall Study|Sponsor Decision|11|||
147228160|NCT00085709|531008709|FG000|Overall Study|Adverse Event|8|||
147228161|NCT00085709|531008710|FG001|Overall Study|Adverse Event|0|||
147562555|NCT01328093|532217636|FG001|Open-Label Phase|Lost to Follow-up|1|||
147562556|NCT01328093|532217635|FG000|Open-Label Phase|Adverse Event|10|||
147113906|NCT01807520|530579938|FG002|Treatment Period 2 (16-132 Weeks)|Adverse Event|0|||
147228162|NCT00085709|531008709|FG000|Overall Study|Death|8|||
147228163|NCT00085709|531008710|FG001|Overall Study|Death|2|||
147228164|NCT00085709|531008709|FG000|Overall Study|Refusal unrelated to adverse events|1|||
147228165|NCT00085709|531008710|FG001|Overall Study|Refusal unrelated to adverse events|2|||
147228166|NCT00085709|531008709|FG000|Overall Study|Progression|3|||
147562557|NCT01328093|532217636|FG001|Open-Label Phase|Adverse Event|4|||
147562558|NCT01328093|532217635|FG000|Open-Label Phase|Lack of Efficacy|5|||
147228167|NCT00085709|531008710|FG001|Overall Study|Progression|4|||
147228168|NCT00085709|531008709|FG000|Overall Study|Not protocol specified|12|||
147228169|NCT00085709|531008710|FG001|Overall Study|Not protocol specified|22|||
147228170|NCT00085709|531008709|FG000|Overall Study|Not eligible|19|||
147228171|NCT00085709|531008710|FG001|Overall Study|Not eligible|19|||
147228172|NCT00085709|531008709|FG000|Overall Study|Withdrawal by Subject|2|||
147228173|NCT00085709|531008710|FG001|Overall Study|Withdrawal by Subject|1|||
147228174|NCT00293215|531008711|FG000|Overall Study|Progressive disease|3|||
147228175|NCT00293215|531008712|FG001|Overall Study|Progressive disease|1|||
147228176|NCT00293215|531008711|FG000|Overall Study|Adverse Event|2|||
147228177|NCT00293215|531008712|FG001|Overall Study|Adverse Event|2|||
147228178|NCT03026088|531008713|FG000|Overall Study|Study termination|20|||
147228179|NCT03611010|531008714|FG000|Period 2: 15 Day Treatment|Inaccessible veins|1|||
147228180|NCT03611010|531008715|FG001|Period 2: 15 Day Treatment|Inaccessible veins|0|||
147228181|NCT03611010|531008716|FG002|Period 2: 15 Day Treatment|Inaccessible veins|0|||
147228182|NCT03611010|531008717|FG003|Period 2: 15 Day Treatment|Inaccessible veins|0|||
147228183|NCT00760214|531008726|FG000|Overall Study|Adverse Event|8|||
147228184|NCT00760214|531008727|FG001|Overall Study|Adverse Event|9|||
147228185|NCT00760214|531008728|FG002|Overall Study|Adverse Event|12|||
147228186|NCT00760214|531008726|FG000|Overall Study|Protocol Violation|3|||
147228187|NCT00760214|531008727|FG001|Overall Study|Protocol Violation|0|||
147228188|NCT00760214|531008728|FG002|Overall Study|Protocol Violation|3|||
147228189|NCT00760214|531008726|FG000|Overall Study|Lost to Follow-up|0|||
147228190|NCT00760214|531008727|FG001|Overall Study|Lost to Follow-up|0|||
147228191|NCT00760214|531008728|FG002|Overall Study|Lost to Follow-up|1|||
147228192|NCT00760214|531008726|FG000|Overall Study|Withdrawal by Subject|12|||
147228193|NCT00760214|531008727|FG001|Overall Study|Withdrawal by Subject|14|||
147228194|NCT00760214|531008728|FG002|Overall Study|Withdrawal by Subject|13|||
147228195|NCT00760214|531008726|FG000|Overall Study|Lack of Efficacy|3|||
147228196|NCT00760214|531008727|FG001|Overall Study|Lack of Efficacy|2|||
147228197|NCT00760214|531008728|FG002|Overall Study|Lack of Efficacy|4|||
147228198|NCT00760214|531008726|FG000|Overall Study|Pregnancy|0|||
147228199|NCT00760214|531008727|FG001|Overall Study|Pregnancy|0|||
147228200|NCT00760214|531008728|FG002|Overall Study|Pregnancy|1|||
147228201|NCT00760214|531008726|FG000|Overall Study|Physician Decision|1|||
147228202|NCT00760214|531008727|FG001|Overall Study|Physician Decision|1|||
147444384|NCT01438489|531792587|FG000|Overall Study|Investigator decision|0|||
147444385|NCT01438489|531792588|FG001|Overall Study|Investigator decision|1|||
147562559|NCT01328093|532217636|FG001|Open-Label Phase|Lack of Efficacy|6|||
147113907|NCT01807520|530579939|FG003|Treatment Period 2 (16-132 Weeks)|Adverse Event|3|||
147113908|NCT01807520|530579940|FG004|Treatment Period 2 (16-132 Weeks)|Adverse Event|0|||
147113909|NCT01807520|530579941|FG005|Treatment Period 2 (16-132 Weeks)|Adverse Event|0|||
147228203|NCT00760214|531008728|FG002|Overall Study|Physician Decision|1|||
147228204|NCT00760214|531008726|FG000|Overall Study|Other|3|||
147228205|NCT00760214|531008727|FG001|Overall Study|Other|4|||
147228206|NCT00760214|531008728|FG002|Overall Study|Other|6|||
147228207|NCT03960554|531008732|FG000|Overall Study|Due to the pandemic, this study was terminated early|4|||
147228208|NCT03960554|531008733|FG001|Overall Study|Due to the pandemic, this study was terminated early|4|||
147228209|NCT00736879|531008734|FG000|Double Blind Treatment Period|Lack of Efficacy|1|||
147228210|NCT00736879|531008735|FG001|Double Blind Treatment Period|Lack of Efficacy|0|||
147562560|NCT01328093|532217635|FG000|Open-Label Phase|Withdrawal by Subject|4|||
147562561|NCT01328093|532217636|FG001|Open-Label Phase|Withdrawal by Subject|1|||
147562562|NCT01328093|532217635|FG000|Open-Label Phase|Scheduling conflict|2|||
147562563|NCT01328093|532217636|FG001|Open-Label Phase|Scheduling conflict|1|||
147562564|NCT01328093|532217635|FG000|Open-Label Phase|Subject is moving or has moved|2|||
147562565|NCT01328093|532217636|FG001|Open-Label Phase|Subject is moving or has moved|0|||
147562566|NCT01328093|532217635|FG000|Open-Label Phase|Entry Criteria Not Met|1|||
147562567|NCT01328093|532217636|FG001|Open-Label Phase|Entry Criteria Not Met|0|||
147562568|NCT03980483|532217639|FG000|Overall Study|Adverse Event|13|||
147562569|NCT03980483|532217640|FG001|Overall Study|Adverse Event|29|||
147562570|NCT03980483|532217641|FG002|Overall Study|Adverse Event|11|||
147562571|NCT03980483|532217642|FG003|Overall Study|Adverse Event|2|||
147562572|NCT03980483|532217643|FG004|Overall Study|Adverse Event|2|||
147562573|NCT03980483|532217644|FG005|Overall Study|Adverse Event|2|||
147562574|NCT03980483|532217639|FG000|Overall Study|Lack of Efficacy|7|||
147562575|NCT03980483|532217640|FG001|Overall Study|Lack of Efficacy|6|||
147562576|NCT03980483|532217641|FG002|Overall Study|Lack of Efficacy|0|||
147562577|NCT03980483|532217642|FG003|Overall Study|Lack of Efficacy|3|||
147562578|NCT03980483|532217643|FG004|Overall Study|Lack of Efficacy|1|||
147562579|NCT03980483|532217644|FG005|Overall Study|Lack of Efficacy|1|||
147562580|NCT03980483|532217639|FG000|Overall Study|Lost to Follow-up|2|||
147562581|NCT03980483|532217640|FG001|Overall Study|Lost to Follow-up|4|||
147562582|NCT03980483|532217641|FG002|Overall Study|Lost to Follow-up|2|||
147562583|NCT03980483|532217642|FG003|Overall Study|Lost to Follow-up|1|||
147562584|NCT03980483|532217643|FG004|Overall Study|Lost to Follow-up|2|||
147562585|NCT03980483|532217644|FG005|Overall Study|Lost to Follow-up|0|||
147562586|NCT03980483|532217639|FG000|Overall Study|Protocol Violation|4|||
147562587|NCT03980483|532217640|FG001|Overall Study|Protocol Violation|2|||
147562588|NCT03980483|532217641|FG002|Overall Study|Protocol Violation|1|||
147562589|NCT03980483|532217642|FG003|Overall Study|Protocol Violation|1|||
147562590|NCT03980483|532217643|FG004|Overall Study|Protocol Violation|0|||
147562591|NCT03980483|532217644|FG005|Overall Study|Protocol Violation|0|||
147562592|NCT03980483|532217639|FG000|Overall Study|Physician Decision|14|||
147562593|NCT03980483|532217640|FG001|Overall Study|Physician Decision|10|||
147562594|NCT03980483|532217641|FG002|Overall Study|Physician Decision|7|||
147562595|NCT03980483|532217642|FG003|Overall Study|Physician Decision|4|||
147562596|NCT03980483|532217643|FG004|Overall Study|Physician Decision|4|||
147562597|NCT03980483|532217644|FG005|Overall Study|Physician Decision|2|||
147562598|NCT03980483|532217639|FG000|Overall Study|Withdrawal by Subject|38|||
147562599|NCT03980483|532217640|FG001|Overall Study|Withdrawal by Subject|21|||
147562600|NCT03980483|532217641|FG002|Overall Study|Withdrawal by Subject|15|||
147562601|NCT03980483|532217642|FG003|Overall Study|Withdrawal by Subject|5|||
147562602|NCT03980483|532217643|FG004|Overall Study|Withdrawal by Subject|3|||
147562603|NCT03980483|532217644|FG005|Overall Study|Withdrawal by Subject|4|||
147562604|NCT03980483|532217639|FG000|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|4|||
147562605|NCT03980483|532217640|FG001|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|0|||
147562606|NCT03980483|532217641|FG002|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
147562607|NCT03980483|532217642|FG003|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|0|||
147562608|NCT03980483|532217643|FG004|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
147562609|NCT03980483|532217644|FG005|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
147562610|NCT03980483|532217639|FG000|Overall Study|INVESTIGATOR SITE CLOSED|0|||
147562611|NCT03980483|532217640|FG001|Overall Study|INVESTIGATOR SITE CLOSED|1|||
147562612|NCT03980483|532217641|FG002|Overall Study|INVESTIGATOR SITE CLOSED|0|||
147562613|NCT03980483|532217642|FG003|Overall Study|INVESTIGATOR SITE CLOSED|0|||
147562614|NCT03980483|532217643|FG004|Overall Study|INVESTIGATOR SITE CLOSED|0|||
147562615|NCT03980483|532217644|FG005|Overall Study|INVESTIGATOR SITE CLOSED|0|||
147562616|NCT03980483|532217639|FG000|Overall Study|Other|0|||
147562617|NCT03980483|532217640|FG001|Overall Study|Other|1|||
147562618|NCT03980483|532217641|FG002|Overall Study|Other|0|||
147562619|NCT03980483|532217642|FG003|Overall Study|Other|0|||
147562620|NCT03980483|532217643|FG004|Overall Study|Other|0|||
147562621|NCT03980483|532217644|FG005|Overall Study|Other|0|||
147562622|NCT00760266|532217647|FG000|Overall Study|Adverse Event|13|||
147562623|NCT00760266|532217648|FG001|Overall Study|Adverse Event|7|||
147562624|NCT00760266|532217647|FG000|Overall Study|Abnormal laboratory value(s)|1|||
147562625|NCT00760266|532217648|FG001|Overall Study|Abnormal laboratory value(s)|0|||
147562626|NCT00760266|532217647|FG000|Overall Study|Abnormal test procedure result(s)|1|||
147562627|NCT00760266|532217648|FG001|Overall Study|Abnormal test procedure result(s)|0|||
147562628|NCT00760266|532217647|FG000|Overall Study|Lack of Efficacy|2|||
147562629|NCT00760266|532217648|FG001|Overall Study|Lack of Efficacy|2|||
147562630|NCT00760266|532217647|FG000|Overall Study|Protocol deviation|2|||
147562631|NCT00760266|532217648|FG001|Overall Study|Protocol deviation|4|||
147562632|NCT00760266|532217647|FG000|Overall Study|Patient withdrew consent|3|||
147562633|NCT00760266|532217648|FG001|Overall Study|Patient withdrew consent|3|||
147562634|NCT00760266|532217647|FG000|Overall Study|Lost to Follow-up|2|||
147562635|NCT00760266|532217648|FG001|Overall Study|Lost to Follow-up|1|||
147562636|NCT00760266|532217647|FG000|Overall Study|Administrative Problems|0|||
147562637|NCT00760266|532217648|FG001|Overall Study|Administrative Problems|1|||
147113910|NCT01807520|530579942|FG006|Treatment Period 2 (16-132 Weeks)|Adverse Event|0|||
147113911|NCT01807520|530579936|FG000|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|5|||
147113912|NCT01807520|530579937|FG001|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|6|||
147113913|NCT01807520|530579938|FG002|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|0|||
147113914|NCT01807520|530579939|FG003|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|2|||
147113915|NCT01807520|530579940|FG004|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|2|||
147113916|NCT01807520|530579941|FG005|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|0|||
147113917|NCT01807520|530579942|FG006|Treatment Period 2 (16-132 Weeks)|Withdrawal by Subject|0|||
147113918|NCT01807520|530579936|FG000|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
147113919|NCT01807520|530579937|FG001|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
147113920|NCT01807520|530579938|FG002|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
147113921|NCT01807520|530579939|FG003|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
147113922|NCT01807520|530579940|FG004|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
147113923|NCT01807520|530579941|FG005|Follow-up Period (132-140 Weeks)|Lack of Efficacy|1|||
147113924|NCT01807520|530579942|FG006|Follow-up Period (132-140 Weeks)|Lack of Efficacy|0|||
147113925|NCT01807520|530579936|FG000|Follow-up Period (132-140 Weeks)|Study terminated|0|||
147113926|NCT01807520|530579937|FG001|Follow-up Period (132-140 Weeks)|Study terminated|0|||
147311985|NCT03734991|531309235|FG000|Overall Study|Lack of efficacy and or/use of antifungal therapy|49|||
147311986|NCT03734991|531309236|FG001|Overall Study|Lack of efficacy and or/use of antifungal therapy|41|||
147311987|NCT03734991|531309235|FG000|Overall Study|Other|2|||
147311988|NCT03734991|531309236|FG001|Overall Study|Other|2|||
147311989|NCT02322814|531309237|FG000|Overall Study|Death|7|||
147311990|NCT02322814|531309238|FG001|Overall Study|Death|29|||
147311991|NCT02322814|531309239|FG002|Overall Study|Death|32|||
147311992|NCT02322814|531309240|FG003|Overall Study|Death|23|||
147311993|NCT02322814|531309241|FG004|Overall Study|Death|14|||
147311994|NCT02322814|531309237|FG000|Overall Study|Lost to Follow-up|1|||
147311995|NCT02322814|531309238|FG001|Overall Study|Lost to Follow-up|3|||
147311996|NCT02322814|531309239|FG002|Overall Study|Lost to Follow-up|3|||
147311997|NCT02322814|531309240|FG003|Overall Study|Lost to Follow-up|1|||
147311998|NCT02322814|531309241|FG004|Overall Study|Lost to Follow-up|0|||
147311999|NCT02322814|531309237|FG000|Overall Study|Various Reasons|2|||
147312000|NCT02322814|531309238|FG001|Overall Study|Various Reasons|0|||
147312001|NCT02322814|531309239|FG002|Overall Study|Various Reasons|1|||
147312002|NCT02322814|531309240|FG003|Overall Study|Various Reasons|1|||
147312003|NCT02322814|531309241|FG004|Overall Study|Various Reasons|0|||
147312004|NCT02322814|531309237|FG000|Overall Study|Progressive Disease|0|||
147312005|NCT02322814|531309238|FG001|Overall Study|Progressive Disease|0|||
147312006|NCT02322814|531309239|FG002|Overall Study|Progressive Disease|0|||
147312007|NCT02322814|531309240|FG003|Overall Study|Progressive Disease|1|||
147312008|NCT02322814|531309241|FG004|Overall Study|Progressive Disease|1|||
147312009|NCT02322814|531309237|FG000|Overall Study|Protocol Violation|1|||
147312010|NCT02322814|531309238|FG001|Overall Study|Protocol Violation|0|||
147312011|NCT02322814|531309239|FG002|Overall Study|Protocol Violation|0|||
147312012|NCT02322814|531309240|FG003|Overall Study|Protocol Violation|0|||
147312013|NCT02322814|531309241|FG004|Overall Study|Protocol Violation|0|||
147312014|NCT02322814|531309237|FG000|Overall Study|Study Terminated by Sponsor|0|||
147312015|NCT02322814|531309238|FG001|Overall Study|Study Terminated by Sponsor|7|||
147312016|NCT02322814|531309239|FG002|Overall Study|Study Terminated by Sponsor|9|||
147312017|NCT02322814|531309240|FG003|Overall Study|Study Terminated by Sponsor|5|||
147312018|NCT02322814|531309241|FG004|Overall Study|Study Terminated by Sponsor|13|||
147312019|NCT02322814|531309237|FG000|Overall Study|Withdrawal by Subject|5|||
147312020|NCT02322814|531309238|FG001|Overall Study|Withdrawal by Subject|4|||
147312021|NCT02322814|531309239|FG002|Overall Study|Withdrawal by Subject|2|||
147562638|NCT01239121|532217649|FG000|Overall Study|Withdrawal by Subject|2|||
147562639|NCT01239121|532217650|FG001|Overall Study|Withdrawal by Subject|4|||
147562640|NCT01239121|532217651|FG002|Overall Study|Withdrawal by Subject|0|||
147562641|NCT03657160|532217652|FG000|Overall Study|Adverse Event|5|||
147562642|NCT03657160|532217653|FG001|Overall Study|Adverse Event|6|||
147113927|NCT01807520|530579938|FG002|Follow-up Period (132-140 Weeks)|Study terminated|0|||
147113928|NCT01807520|530579939|FG003|Follow-up Period (132-140 Weeks)|Study terminated|0|||
147113929|NCT01807520|530579940|FG004|Follow-up Period (132-140 Weeks)|Study terminated|0|||
147113930|NCT01807520|530579941|FG005|Follow-up Period (132-140 Weeks)|Study terminated|1|||
147113931|NCT01807520|530579942|FG006|Follow-up Period (132-140 Weeks)|Study terminated|0|||
147113932|NCT01807520|530579936|FG000|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0|||
147312022|NCT02322814|531309240|FG003|Overall Study|Withdrawal by Subject|1|||
147312023|NCT02322814|531309241|FG004|Overall Study|Withdrawal by Subject|3|||
147312024|NCT03012061|531309242|FG000|Overall Study|Withdrawal by Subject|1|||
147312025|NCT03012061|531309243|FG001|Overall Study|Withdrawal by Subject|5|||
147312026|NCT03012061|531309244|FG002|Overall Study|Withdrawal by Subject|4|||
147312027|NCT03012061|531309242|FG000|Overall Study|Investigator Site Closed|1|||
147312028|NCT03012061|531309243|FG001|Overall Study|Investigator Site Closed|2|||
147312029|NCT03012061|531309244|FG002|Overall Study|Investigator Site Closed|0|||
147312030|NCT03012061|531309242|FG000|Overall Study|Lost to Follow-up|2|||
147312031|NCT03012061|531309243|FG001|Overall Study|Lost to Follow-up|1|||
147113933|NCT01807520|530579937|FG001|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0|||
147113934|NCT01807520|530579938|FG002|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0|||
147113935|NCT01807520|530579939|FG003|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0|||
147113936|NCT01807520|530579940|FG004|Follow-up Period (132-140 Weeks)|Lost to Follow-up|0|||
147113937|NCT01807520|530579941|FG005|Follow-up Period (132-140 Weeks)|Lost to Follow-up|2|||
147562643|NCT03657160|532217652|FG000|Overall Study|Protocol Deviation|3|||
147562644|NCT03657160|532217653|FG001|Overall Study|Protocol Deviation|0|||
147113938|NCT01807520|530579942|FG006|Follow-up Period (132-140 Weeks)|Lost to Follow-up|1|||
147113939|NCT01500096|530579943|FG000|Overall Study|Lost to Follow-up|1|||
147562645|NCT03657160|532217652|FG000|Overall Study|Withdrawal by Subject|18|||
147562646|NCT03657160|532217653|FG001|Overall Study|Withdrawal by Subject|16|||
147562647|NCT03657160|532217652|FG000|Overall Study|Site Termination|1|||
147562648|NCT03657160|532217653|FG001|Overall Study|Site Termination|0|||
147562649|NCT03657160|532217652|FG000|Overall Study|Unsatisfactory Therapeutic Response|5|||
147562650|NCT03657160|532217653|FG001|Overall Study|Unsatisfactory Therapeutic Response|3|||
147562651|NCT03657160|532217652|FG000|Overall Study|Death|33|||
147562652|NCT03657160|532217653|FG001|Overall Study|Death|26|||
147562653|NCT03657160|532217652|FG000|Overall Study|Death (COVID-19-Related)|1|||
147562654|NCT03657160|532217653|FG001|Overall Study|Death (COVID-19-Related)|0|||
147562655|NCT03657160|532217652|FG000|Overall Study|Reason Not Specified|5|||
147562656|NCT03657160|532217653|FG001|Overall Study|Reason Not Specified|5|||
147562657|NCT03657160|532217652|FG000|Overall Study|Other (COVID-19-Related)|0|||
147562658|NCT03657160|532217653|FG001|Overall Study|Other (COVID-19-Related)|1|||
147562659|NCT00686959|532217655|FG000|Overall Study|Participants censored (no death events)|124|||
147562660|NCT00686959|532217656|FG001|Overall Study|Participants censored (no death events)|117|||
147562661|NCT01449630|532217657|FG000|Period 1|Physician Decision|1|||
147562662|NCT01449630|532217658|FG001|Period 1|Physician Decision|0|||
147562663|NCT01449630|532217659|FG002|Period 1|Physician Decision|0|||
147562664|NCT01449630|532217660|FG003|Period 1|Physician Decision|1|||
147562665|NCT01449630|532217661|FG004|Period 1|Physician Decision|0|||
147562666|NCT01449630|532217662|FG005|Period 1|Physician Decision|0|||
147562667|NCT01449630|532217663|FG006|Period 1|Physician Decision|0|||
147562668|NCT01449630|532217664|FG007|Period 1|Physician Decision|0|||
147562669|NCT01449630|532217665|FG008|Period 1|Physician Decision|0|||
147562670|NCT01449630|532217657|FG000|Period 1|Sponsor Decision|0|||
147562671|NCT01449630|532217658|FG001|Period 1|Sponsor Decision|0|||
147562672|NCT01449630|532217659|FG002|Period 1|Sponsor Decision|0|||
147562673|NCT01449630|532217660|FG003|Period 1|Sponsor Decision|0|||
147562674|NCT01449630|532217661|FG004|Period 1|Sponsor Decision|0|||
147562675|NCT01449630|532217662|FG005|Period 1|Sponsor Decision|1|||
147562676|NCT01449630|532217663|FG006|Period 1|Sponsor Decision|0|||
147562677|NCT01449630|532217664|FG007|Period 1|Sponsor Decision|0|||
147562678|NCT01449630|532217665|FG008|Period 1|Sponsor Decision|0|||
147562679|NCT01449630|532217657|FG000|Period 2|Sponsor Decision|0|||
147562680|NCT01449630|532217658|FG001|Period 2|Sponsor Decision|0|||
147562681|NCT01449630|532217659|FG002|Period 2|Sponsor Decision|0|||
147562682|NCT01449630|532217660|FG003|Period 2|Sponsor Decision|0|||
147562683|NCT01449630|532217661|FG004|Period 2|Sponsor Decision|0|||
147562684|NCT01449630|532217662|FG005|Period 2|Sponsor Decision|0|||
147562685|NCT01449630|532217663|FG006|Period 2|Sponsor Decision|1|||
147562686|NCT01449630|532217664|FG007|Period 2|Sponsor Decision|0|||
147562687|NCT01449630|532217665|FG008|Period 2|Sponsor Decision|0|||
147562688|NCT01735630|532217667|FG000|Overall Study|Adverse Event|8|||
147562689|NCT01735630|532217668|FG001|Overall Study|Adverse Event|7|||
147562690|NCT01735630|532217667|FG000|Overall Study|Lost to Follow-up|1|||
147562691|NCT01735630|532217668|FG001|Overall Study|Lost to Follow-up|0|||
147562692|NCT01735630|532217667|FG000|Overall Study|Physician Decision|0|||
147562693|NCT01735630|532217668|FG001|Overall Study|Physician Decision|1|||
147562694|NCT01735630|532217667|FG000|Overall Study|Sponsor Decision|2|||
147562695|NCT01735630|532217668|FG001|Overall Study|Sponsor Decision|1|||
147562696|NCT01735630|532217667|FG000|Overall Study|Withdrawal by Subject|7|||
147113940|NCT01500096|530579944|FG001|Overall Study|Lost to Follow-up|0|||
147113941|NCT01500096|530579945|FG002|Overall Study|Lost to Follow-up|0|||
147562697|NCT01735630|532217668|FG001|Overall Study|Withdrawal by Subject|9|||
147562698|NCT01572948|532217669|FG000|Overall Study|Lost to Follow-up|1|||
147113942|NCT01500096|530579946|FG003|Overall Study|Lost to Follow-up|2|||
147113943|NCT00639379|530579947|FG000|Period 1 - 2 Weeks|Lost to Follow-up|2|||
147562699|NCT01572948|532217670|FG001|Overall Study|Lost to Follow-up|0|||
147113944|NCT00639379|530579948|FG001|Period 1 - 2 Weeks|Lost to Follow-up|0|||
147113945|NCT00639379|530579947|FG000|Period 1 - 2 Weeks|lens issue|3|||
147562700|NCT01572948|532217669|FG000|Overall Study|unable to contact|0|||
147562701|NCT01572948|532217670|FG001|Overall Study|unable to contact|1|||
147562702|NCT01126736|532217676|FG000|Overall Study|Death|2|||
147562703|NCT01126736|532217677|FG001|Overall Study|Death|2|||
147562704|NCT01126736|532217678|FG002|Overall Study|Death|1|||
147562705|NCT01126736|532217679|FG003|Overall Study|Death|19|||
147562706|NCT01126736|532217680|FG004|Overall Study|Death|19|||
147562707|NCT01126736|532217676|FG000|Overall Study|Completed 1 Year Follow-Up Per Protocol|0|||
147562708|NCT01126736|532217677|FG001|Overall Study|Completed 1 Year Follow-Up Per Protocol|0|||
147562709|NCT01126736|532217678|FG002|Overall Study|Completed 1 Year Follow-Up Per Protocol|0|||
147562710|NCT01126736|532217679|FG003|Overall Study|Completed 1 Year Follow-Up Per Protocol|3|||
147562711|NCT01126736|532217680|FG004|Overall Study|Completed 1 Year Follow-Up Per Protocol|3|||
147113946|NCT00639379|530579948|FG001|Period 1 - 2 Weeks|lens issue|0|||
147113947|NCT03298061|530579951|FG000|Overall Study|Adverse Event|3|||
147113948|NCT03298061|530579951|FG000|Overall Study|Lack of Efficacy|6|||
147113949|NCT03298061|530579951|FG000|Overall Study|Protocol Violation|1|||
147113950|NCT03298061|530579951|FG000|Overall Study|Physician Decision|7|||
147562712|NCT01126736|532217676|FG000|Overall Study|Lost to Follow-up|0|||
147562713|NCT01126736|532217677|FG001|Overall Study|Lost to Follow-up|0|||
147113951|NCT03298061|530579951|FG000|Overall Study|Withdrawal by Subject|10|||
147113952|NCT00992836|530579955|FG000|Overall Study|Lost to Follow-up|1|||
147113953|NCT00992836|530579955|FG000|Overall Study|Withdrawal by Subject|2|||
147113954|NCT00992836|530579955|FG000|Overall Study|Protocol Violation|2|||
147113955|NCT01410604|530579957|FG000|Overall Study|Adverse Event|2|||
147113956|NCT01410604|530579958|FG001|Overall Study|Adverse Event|1|||
147562714|NCT01126736|532217678|FG002|Overall Study|Lost to Follow-up|0|||
147562715|NCT01126736|532217679|FG003|Overall Study|Lost to Follow-up|1|||
147113957|NCT01410604|530579957|FG000|Overall Study|Lost to Follow-up|1|||
147113958|NCT01410604|530579958|FG001|Overall Study|Lost to Follow-up|0|||
147113959|NCT01410604|530579957|FG000|Overall Study|Physician Decision|0|||
147113960|NCT01410604|530579958|FG001|Overall Study|Physician Decision|1|||
147562716|NCT01126736|532217680|FG004|Overall Study|Lost to Follow-up|1|||
147562717|NCT01126736|532217676|FG000|Overall Study|Administrative reasons|0|||
147562718|NCT01126736|532217677|FG001|Overall Study|Administrative reasons|0|||
147562719|NCT01126736|532217678|FG002|Overall Study|Administrative reasons|0|||
147562720|NCT01126736|532217679|FG003|Overall Study|Administrative reasons|0|||
147562721|NCT01126736|532217680|FG004|Overall Study|Administrative reasons|1|||
147562722|NCT01126736|532217676|FG000|Overall Study|Progressive disease|0|||
147562723|NCT01126736|532217677|FG001|Overall Study|Progressive disease|0|||
147113961|NCT05427916|530579959|FG000|Overall Study|Adverse Event|3|||
147113962|NCT05427916|530579960|FG001|Overall Study|Adverse Event|0|||
147562724|NCT01126736|532217678|FG002|Overall Study|Progressive disease|0|||
147562725|NCT01126736|532217679|FG003|Overall Study|Progressive disease|2|||
147562726|NCT01126736|532217680|FG004|Overall Study|Progressive disease|1|||
147562727|NCT01126736|532217676|FG000|Overall Study|Withdrawal by Subject|0|||
147562728|NCT01126736|532217677|FG001|Overall Study|Withdrawal by Subject|0|||
147562729|NCT01126736|532217678|FG002|Overall Study|Withdrawal by Subject|0|||
147562730|NCT01126736|532217679|FG003|Overall Study|Withdrawal by Subject|1|||
147562731|NCT01126736|532217680|FG004|Overall Study|Withdrawal by Subject|1|||
147562732|NCT01126736|532217676|FG000|Overall Study|Other|2|||
147562733|NCT01126736|532217677|FG001|Overall Study|Other|4|||
147562734|NCT01126736|532217678|FG002|Overall Study|Other|4|||
147562735|NCT01126736|532217679|FG003|Overall Study|Other|16|||
147562736|NCT01126736|532217680|FG004|Overall Study|Other|15|||
147562737|NCT01720264|532217685|FG000|Transplant With Sitagliptin for 15 Days|Adverse Event|1|||
147562738|NCT01720264|532217685|FG000|Post-transplant (Day 16) to 1 Year|Death|8|||
147562739|NCT01720264|532217685|FG000|Post-transplant (Day 16) to 1 Year|Disease Progression|4|||
147562740|NCT03018249|532217697|FG000|Overall Study|Withdrawal by Subject|2|||
147562741|NCT03018249|532217698|FG001|Overall Study|Withdrawal by Subject|2|||
147562742|NCT01030965|532217700|FG000|Overall Study|Lack of Efficacy|3|||
147562743|NCT01030965|532217701|FG001|Overall Study|Lack of Efficacy|2|||
147562744|NCT01030965|532217702|FG002|Overall Study|Lack of Efficacy|0|||
147562745|NCT01030965|532217703|FG003|Overall Study|Lack of Efficacy|3|||
147562746|NCT01030965|532217700|FG000|Overall Study|Protocol Violation|1|||
147562747|NCT01030965|532217701|FG001|Overall Study|Protocol Violation|1|||
147562748|NCT01030965|532217702|FG002|Overall Study|Protocol Violation|1|||
147562749|NCT01030965|532217703|FG003|Overall Study|Protocol Violation|1|||
147562750|NCT01030965|532217700|FG000|Overall Study|Adverse Event|0|||
147312032|NCT03012061|531309244|FG002|Overall Study|Lost to Follow-up|0|||
147562751|NCT01030965|532217701|FG001|Overall Study|Adverse Event|1|||
147562752|NCT01030965|532217702|FG002|Overall Study|Adverse Event|2|||
147562753|NCT01030965|532217703|FG003|Overall Study|Adverse Event|1|||
147562754|NCT01030965|532217700|FG000|Overall Study|Protocol-defined Stopping Criteria|0|||
147562755|NCT01030965|532217701|FG001|Overall Study|Protocol-defined Stopping Criteria|1|||
147562756|NCT01030965|532217702|FG002|Overall Study|Protocol-defined Stopping Criteria|1|||
147562757|NCT01030965|532217703|FG003|Overall Study|Protocol-defined Stopping Criteria|0|||
147562758|NCT01030965|532217700|FG000|Overall Study|Withdrawal by Subject|0|||
147562759|NCT01030965|532217701|FG001|Overall Study|Withdrawal by Subject|1|||
147562760|NCT01030965|532217702|FG002|Overall Study|Withdrawal by Subject|0|||
147562761|NCT01030965|532217703|FG003|Overall Study|Withdrawal by Subject|2|||
147562762|NCT02097290|532217704|FG000|Overall Study|Death|6|||
147562763|NCT02097290|532217704|FG000|Overall Study|Total Withdrawals|3|||
147562764|NCT02097290|532217704|FG000|Overall Study|Attempt|8|||
147562765|NCT00824265|532217705|FG000|Treatment Phase|Adverse Event,non-fatal|50|||
147562766|NCT00824265|532217706|FG001|Treatment Phase|Adverse Event,non-fatal|52|||
147562767|NCT00824265|532217705|FG000|Treatment Phase|Protocol Violation|1|||
147113963|NCT05427916|530579959|FG000|Overall Study|Lack of Efficacy|6|||
147562768|NCT00824265|532217706|FG001|Treatment Phase|Protocol Violation|0|||
147562769|NCT00824265|532217705|FG000|Treatment Phase|Lost to Follow-up|1|||
147562770|NCT00824265|532217706|FG001|Treatment Phase|Lost to Follow-up|1|||
147562771|NCT00824265|532217705|FG000|Treatment Phase|Physician Decision|6|||
147562772|NCT00824265|532217706|FG001|Treatment Phase|Physician Decision|12|||
147562773|NCT00824265|532217705|FG000|Treatment Phase|Withdrawal by Subject|6|||
147562774|NCT00824265|532217706|FG001|Treatment Phase|Withdrawal by Subject|15|||
147562775|NCT00824265|532217705|FG000|Follow-up Phase|w/drew consent, no f/u, or MD choice|18|||
147562776|NCT00824265|532217706|FG001|Follow-up Phase|w/drew consent, no f/u, or MD choice|31|||
147562777|NCT00824265|532217705|FG000|Survival Follow-up Phase|w/drew consent, no f/u, or MD choice|9|||
147562778|NCT00824265|532217706|FG001|Survival Follow-up Phase|w/drew consent, no f/u, or MD choice|16|||
147562779|NCT02888171|532217707|FG000|Overall Study|Lost to Follow-up|2|||
147562780|NCT02888171|532217708|FG001|Overall Study|Lost to Follow-up|1|||
147562781|NCT02888171|532217707|FG000|Overall Study|Withdrawal by Subject|3|||
147562782|NCT02888171|532217708|FG001|Overall Study|Withdrawal by Subject|2|||
147562783|NCT02888171|532217707|FG000|Overall Study|Adverse Event|0|||
147562784|NCT02888171|532217708|FG001|Overall Study|Adverse Event|1|||
147562785|NCT02920996|532217709|FG000|Overall Study|Adverse Event|8|||
147562786|NCT02920996|532217710|FG001|Overall Study|Adverse Event|0|||
147562787|NCT02920996|532217709|FG000|Overall Study|Physician Decision|1|||
147562788|NCT02920996|532217710|FG001|Overall Study|Physician Decision|0|||
147562789|NCT02920996|532217709|FG000|Overall Study|Death|1|||
147562790|NCT02920996|532217710|FG001|Overall Study|Death|0|||
147562791|NCT02920996|532217709|FG000|Overall Study|Missing|1|||
147562792|NCT02920996|532217710|FG001|Overall Study|Missing|0|||
147562793|NCT02920996|532217709|FG000|Overall Study|Subject Non-Compliance|1|||
147562794|NCT02920996|532217710|FG001|Overall Study|Subject Non-Compliance|0|||
147562795|NCT00591630|532217711|FG000|Overall Study|Death|0|||
147562796|NCT00591630|532217712|FG001|Overall Study|Death|0|||
147562797|NCT00591630|532217713|FG002|Overall Study|Death|1|||
147562798|NCT00591630|532217714|FG003|Overall Study|Death|0|||
147562799|NCT00485472|532219393|FG000|Overall Study|Adverse Event|8|||
147562800|NCT00485472|532219394|FG001|Overall Study|Adverse Event|5|||
147562801|NCT00485472|532219393|FG000|Overall Study|Lack of Efficacy|5|||
147562802|NCT00485472|532219394|FG001|Overall Study|Lack of Efficacy|4|||
147562803|NCT00485472|532219393|FG000|Overall Study|Withdrawal by Subject|1|||
147562804|NCT00485472|532219394|FG001|Overall Study|Withdrawal by Subject|0|||
147562805|NCT00485472|532219393|FG000|Overall Study|Protocol Violation|0|||
147562806|NCT00485472|532219394|FG001|Overall Study|Protocol Violation|1|||
147562807|NCT00485472|532219393|FG000|Overall Study|Other|2|||
147562808|NCT00485472|532219394|FG001|Overall Study|Other|1|||
147562809|NCT00485472|532219393|FG000|Overall Study|Lost to Follow-up|0|||
147562810|NCT00485472|532219394|FG001|Overall Study|Lost to Follow-up|1|||
147562811|NCT01492361|532219395|FG000|Overall Study|Withdrawal by Subject|281|||
147562812|NCT01492361|532219396|FG001|Overall Study|Withdrawal by Subject|297|||
147562813|NCT01492361|532219395|FG000|Overall Study|Physician Decision|12|||
147562814|NCT01492361|532219396|FG001|Overall Study|Physician Decision|12|||
147562815|NCT01492361|532219395|FG000|Overall Study|Lost to Follow-up|6|||
147562816|NCT01492361|532219396|FG001|Overall Study|Lost to Follow-up|13|||
147562817|NCT01492361|532219395|FG000|Overall Study|Other than specified above|106|||
147228211|NCT00736879|531008736|FG002|Double Blind Treatment Period|Lack of Efficacy|0|||
147228212|NCT00736879|531008737|FG003|Double Blind Treatment Period|Lack of Efficacy|0|||
147228213|NCT00736879|531008734|FG000|Double Blind Treatment Period|Adverse Event|0|||
147228214|NCT00736879|531008735|FG001|Double Blind Treatment Period|Adverse Event|1|||
147228215|NCT00736879|531008736|FG002|Double Blind Treatment Period|Adverse Event|1|||
147228216|NCT00736879|531008737|FG003|Double Blind Treatment Period|Adverse Event|0|||
147228217|NCT00736879|531008734|FG000|Double Blind Treatment Period|Withdrawal by Subject|2|||
147228218|NCT00736879|531008735|FG001|Double Blind Treatment Period|Withdrawal by Subject|1|||
147228219|NCT00736879|531008736|FG002|Double Blind Treatment Period|Withdrawal by Subject|3|||
147228220|NCT00736879|531008737|FG003|Double Blind Treatment Period|Withdrawal by Subject|3|||
147228221|NCT00736879|531008734|FG000|Double Blind Treatment Period|Lost to Follow-up|0|||
147228222|NCT00736879|531008735|FG001|Double Blind Treatment Period|Lost to Follow-up|0|||
147562818|NCT01492361|532219396|FG001|Overall Study|Other than specified above|138|||
147562819|NCT04015232|532219397|FG000|Overall Study|Withdrawal by Subject|7|||
147562820|NCT04015232|532219398|FG001|Overall Study|Withdrawal by Subject|4|||
147562821|NCT04015232|532219397|FG000|Overall Study|Protocol Violation|1|||
147562822|NCT04015232|532219398|FG001|Overall Study|Protocol Violation|0|||
147562823|NCT04015232|532219397|FG000|Overall Study|Medical Grounds|3|||
147562824|NCT04015232|532219398|FG001|Overall Study|Medical Grounds|3|||
147562825|NCT05150964|532219403|FG000|Overall Study|Lost to Follow-up|2|||
147562826|NCT01434693|532219406|FG000|Overall Study|Adverse Event|1|||
147562827|NCT01434693|532219407|FG001|Overall Study|Adverse Event|0|||
147562828|NCT01434693|532219408|FG002|Overall Study|Adverse Event|0|||
147562829|NCT01434693|532219409|FG003|Overall Study|Adverse Event|0|||
147562830|NCT01434693|532219406|FG000|Overall Study|Withdrawal by Subject|1|||
147562831|NCT01434693|532219407|FG001|Overall Study|Withdrawal by Subject|0|||
147113964|NCT05427916|530579960|FG001|Overall Study|Lack of Efficacy|0|||
147562832|NCT01434693|532219408|FG002|Overall Study|Withdrawal by Subject|1|||
147562833|NCT01434693|532219409|FG003|Overall Study|Withdrawal by Subject|1|||
147562834|NCT01434693|532219406|FG000|Overall Study|Lost to Follow-up|1|||
147562835|NCT01434693|532219407|FG001|Overall Study|Lost to Follow-up|0|||
147562836|NCT01434693|532219408|FG002|Overall Study|Lost to Follow-up|0|||
147562837|NCT01434693|532219409|FG003|Overall Study|Lost to Follow-up|0|||
147562838|NCT04006171|532219410|FG000|Overall Study|Withdrawal by Subject|8|||
147562839|NCT04006171|532219411|FG001|Overall Study|Withdrawal by Subject|7|||
147562840|NCT04006171|532219410|FG000|Overall Study|missing serum samples|2|||
147562841|NCT04006171|532219411|FG001|Overall Study|missing serum samples|2|||
147562842|NCT04006171|532219410|FG000|Overall Study|insufficient sample volume|2|||
147562843|NCT04006171|532219411|FG001|Overall Study|insufficient sample volume|3|||
147562844|NCT00912288|532219412|FG000|Overall Study|Death|0|||
147562845|NCT00912288|532219413|FG001|Overall Study|Death|1|||
147562846|NCT00912288|532219412|FG000|Overall Study|Adverse Event|1|||
147562847|NCT00912288|532219413|FG001|Overall Study|Adverse Event|1|||
147562848|NCT00912288|532219412|FG000|Overall Study|Lost to Follow-up|1|||
147562849|NCT00912288|532219413|FG001|Overall Study|Lost to Follow-up|0|||
147562850|NCT00912288|532219412|FG000|Overall Study|Protocol Violation|1|||
147562851|NCT00912288|532219413|FG001|Overall Study|Protocol Violation|0|||
147562852|NCT00912288|532219412|FG000|Overall Study|Withdrawal by Subject|3|||
147562853|NCT00912288|532219413|FG001|Overall Study|Withdrawal by Subject|3|||
147562854|NCT00912288|532219412|FG000|Overall Study|Study terminated by sponsor|34|||
147562855|NCT00912288|532219413|FG001|Overall Study|Study terminated by sponsor|35|||
147562856|NCT00912288|532219412|FG000|Overall Study|Other|1|||
147562857|NCT00912288|532219413|FG001|Overall Study|Other|0|||
147562858|NCT02087904|532219420|FG000|Overall Study|Did Not Receive Study Drug|0|||
147562859|NCT02087904|532219421|FG001|Overall Study|Did Not Receive Study Drug|0|||
147562860|NCT02087904|532219422|FG002|Overall Study|Did Not Receive Study Drug|2|||
147562861|NCT02087904|532219423|FG003|Overall Study|Did Not Receive Study Drug|1|||
147562862|NCT02087904|532219420|FG000|Overall Study|Adverse Event|8|||
147562863|NCT02087904|532219421|FG001|Overall Study|Adverse Event|4|||
147562864|NCT02087904|532219422|FG002|Overall Study|Adverse Event|4|||
147562865|NCT02087904|532219423|FG003|Overall Study|Adverse Event|12|||
147562866|NCT02087904|532219420|FG000|Overall Study|Lack of Efficacy|3|||
147562867|NCT02087904|532219421|FG001|Overall Study|Lack of Efficacy|6|||
147562868|NCT02087904|532219422|FG002|Overall Study|Lack of Efficacy|3|||
147562869|NCT02087904|532219423|FG003|Overall Study|Lack of Efficacy|2|||
147562870|NCT02087904|532219420|FG000|Overall Study|Other|6|||
147562871|NCT02087904|532219421|FG001|Overall Study|Other|2|||
147562872|NCT02087904|532219422|FG002|Overall Study|Other|4|||
147562873|NCT02087904|532219423|FG003|Overall Study|Other|4|||
147562874|NCT02087904|532219420|FG000|Overall Study|Withdrawal by Subject|8|||
147562875|NCT02087904|532219421|FG001|Overall Study|Withdrawal by Subject|3|||
147562876|NCT02087904|532219422|FG002|Overall Study|Withdrawal by Subject|7|||
147113965|NCT05427916|530579959|FG000|Overall Study|Active arm terminated; trial was ended.|3|||
147113966|NCT05427916|530579960|FG001|Overall Study|Active arm terminated; trial was ended.|8|||
147113967|NCT00800540|530579961|FG000|Period One: 6 Weeks|Noncompliance|1|||
147113968|NCT00800540|530579962|FG001|Period One: 6 Weeks|Noncompliance|0|||
147113969|NCT00800540|530579961|FG000|Period One: 6 Weeks|Pt Decision Unrelated to Adverse Event|0|||
147113970|NCT00800540|530579962|FG001|Period One: 6 Weeks|Pt Decision Unrelated to Adverse Event|1|||
147228223|NCT00736879|531008736|FG002|Double Blind Treatment Period|Lost to Follow-up|2|||
147228224|NCT00736879|531008737|FG003|Double Blind Treatment Period|Lost to Follow-up|1|||
147228225|NCT00736879|531008734|FG000|Double Blind Treatment Period|Poor non-compliance|0|||
147562877|NCT02087904|532219423|FG003|Overall Study|Withdrawal by Subject|4|||
147562878|NCT02087904|532219420|FG000|Overall Study|Lost to Follow-up|0|||
147562879|NCT02087904|532219421|FG001|Overall Study|Lost to Follow-up|4|||
147562880|NCT02087904|532219422|FG002|Overall Study|Lost to Follow-up|2|||
147444386|NCT01438489|531792589|FG002|Overall Study|Investigator decision|0|||
147444387|NCT01438489|531792587|FG000|Overall Study|AE/SAEs|2|||
147562881|NCT02087904|532219423|FG003|Overall Study|Lost to Follow-up|2|||
147562882|NCT01196052|532219424|FG000|Overall Study|Adverse Event|9|||
147562883|NCT01196052|532219424|FG000|Overall Study|Lost to Follow-up|1|||
147562884|NCT01196052|532219424|FG000|Overall Study|Noncompliance to Protocol Requirements|2|||
147562885|NCT01196052|532219424|FG000|Overall Study|Reason not Specified|5|||
147562886|NCT01196052|532219424|FG000|Overall Study|Withdrawal by Subject|6|||
147562887|NCT02178722|532219425|FG000|Overall Study|Withdrawal by Subject|0|||
147562888|NCT02178722|532219426|FG001|Overall Study|Withdrawal by Subject|0|||
147562889|NCT02178722|532219427|FG002|Overall Study|Withdrawal by Subject|0|||
147562890|NCT02178722|532219428|FG003|Overall Study|Withdrawal by Subject|2|||
147562891|NCT02178722|532219429|FG004|Overall Study|Withdrawal by Subject|33|||
147562892|NCT02178722|532219425|FG000|Overall Study|Death|2|||
147113971|NCT00800540|530579961|FG000|Period 2: 6 Weeks|Adverse Event|0|||
147562893|NCT02178722|532219426|FG001|Overall Study|Death|13|||
147562894|NCT02178722|532219427|FG002|Overall Study|Death|12|||
147562895|NCT02178722|532219428|FG003|Overall Study|Death|12|||
147562896|NCT02178722|532219429|FG004|Overall Study|Death|205|||
147562897|NCT02178722|532219425|FG000|Overall Study|Lost to Follow-up|0|||
147562898|NCT02178722|532219426|FG001|Overall Study|Lost to Follow-up|0|||
147562899|NCT02178722|532219427|FG002|Overall Study|Lost to Follow-up|0|||
147562900|NCT02178722|532219428|FG003|Overall Study|Lost to Follow-up|2|||
147562901|NCT02178722|532219429|FG004|Overall Study|Lost to Follow-up|11|||
147562902|NCT02178722|532219425|FG000|Overall Study|Study terminated by Sponsor|2|||
147562903|NCT02178722|532219426|FG001|Overall Study|Study terminated by Sponsor|7|||
147562904|NCT02178722|532219427|FG002|Overall Study|Study terminated by Sponsor|6|||
147562905|NCT02178722|532219428|FG003|Overall Study|Study terminated by Sponsor|4|||
147562906|NCT02178722|532219429|FG004|Overall Study|Study terminated by Sponsor|128|||
147562907|NCT02178722|532219425|FG000|Overall Study|Physician Decision|0|||
147562908|NCT02178722|532219426|FG001|Overall Study|Physician Decision|0|||
147562909|NCT02178722|532219427|FG002|Overall Study|Physician Decision|0|||
147562910|NCT02178722|532219428|FG003|Overall Study|Physician Decision|0|||
147562911|NCT02178722|532219429|FG004|Overall Study|Physician Decision|3|||
147562912|NCT02178722|532219425|FG000|Overall Study|Other|0|||
147562913|NCT02178722|532219426|FG001|Overall Study|Other|0|||
147562914|NCT02178722|532219427|FG002|Overall Study|Other|0|||
147562915|NCT02178722|532219428|FG003|Overall Study|Other|0|||
147562916|NCT02178722|532219429|FG004|Overall Study|Other|2|||
147562917|NCT03340727|532219430|FG000|Overall Study|Death|1|||
147562918|NCT03340727|532219431|FG001|Overall Study|Death|0|||
147562919|NCT03340727|532219430|FG000|Overall Study|Lost to Follow-up|31|||
147562920|NCT03340727|532219431|FG001|Overall Study|Lost to Follow-up|35|||
147562921|NCT03340727|532219430|FG000|Overall Study|Still in hospital at 48 0/7 wks Post-menstrual Age (PMA)|1|||
147562922|NCT03340727|532219431|FG001|Overall Study|Still in hospital at 48 0/7 wks Post-menstrual Age (PMA)|1|||
147562923|NCT03340727|532219430|FG000|Overall Study|Transferred to another facility|10|||
147562924|NCT03340727|532219431|FG001|Overall Study|Transferred to another facility|7|||
147562925|NCT03340727|532219430|FG000|Overall Study|Withdrawal by Subject|28|||
147562926|NCT03340727|532219431|FG001|Overall Study|Withdrawal by Subject|17|||
147562927|NCT00440557|532219432|FG000|Overall Study|Withdrawal by Subject|10|||
147562928|NCT00440557|532219433|FG001|Overall Study|Withdrawal by Subject|5|||
147562929|NCT00440557|532219434|FG002|Overall Study|Withdrawal by Subject|11|||
147562930|NCT00440557|532219432|FG000|Overall Study|Lost to Follow-up|1|||
147562931|NCT00440557|532219433|FG001|Overall Study|Lost to Follow-up|2|||
147562932|NCT00440557|532219434|FG002|Overall Study|Lost to Follow-up|6|||
147562933|NCT00440557|532219432|FG000|Overall Study|Adverse Event|3|||
147562934|NCT00440557|532219433|FG001|Overall Study|Adverse Event|3|||
147562935|NCT00440557|532219434|FG002|Overall Study|Adverse Event|5|||
147562936|NCT00440557|532219432|FG000|Overall Study|Death|2|||
147562937|NCT00440557|532219433|FG001|Overall Study|Death|6|||
147562938|NCT00440557|532219434|FG002|Overall Study|Death|3|||
147562939|NCT00440557|532219432|FG000|Overall Study|Began Dialysis|4|||
147312033|NCT03012061|531309242|FG000|Overall Study|Study closed/ Terminated|0|||
147312034|NCT03012061|531309243|FG001|Overall Study|Study closed/ Terminated|0|||
147312035|NCT03012061|531309244|FG002|Overall Study|Study closed/ Terminated|1|||
147312036|NCT03012061|531309242|FG000|Overall Study|Met Protocol Withdrawal Criterion|0|||
147312037|NCT03012061|531309243|FG001|Overall Study|Met Protocol Withdrawal Criterion|0|||
147312038|NCT03012061|531309244|FG002|Overall Study|Met Protocol Withdrawal Criterion|1|||
147312039|NCT03012061|531309242|FG000|Overall Study|Protocol Violation|0|||
147562940|NCT00440557|532219433|FG001|Overall Study|Began Dialysis|1|||
147562941|NCT00440557|532219434|FG002|Overall Study|Began Dialysis|4|||
147562942|NCT00440557|532219432|FG000|Overall Study|Principal Investigator decision|0|||
147562943|NCT00440557|532219433|FG001|Overall Study|Principal Investigator decision|3|||
147562944|NCT00440557|532219434|FG002|Overall Study|Principal Investigator decision|1|||
147562945|NCT00440557|532219432|FG000|Overall Study|Patient moved|1|||
147562946|NCT00440557|532219433|FG001|Overall Study|Patient moved|2|||
147562947|NCT00440557|532219434|FG002|Overall Study|Patient moved|1|||
147562948|NCT00440557|532219432|FG000|Overall Study|Principal Investigator's office closed|3|||
147312040|NCT03012061|531309243|FG001|Overall Study|Protocol Violation|0|||
147312041|NCT03012061|531309244|FG002|Overall Study|Protocol Violation|2|||
147562949|NCT00440557|532219433|FG001|Overall Study|Principal Investigator's office closed|6|||
147562950|NCT00440557|532219434|FG002|Overall Study|Principal Investigator's office closed|4|||
147562951|NCT00440557|532219432|FG000|Overall Study|Patient transferred to nursing home|0|||
147562952|NCT00440557|532219433|FG001|Overall Study|Patient transferred to nursing home|1|||
147562953|NCT00440557|532219434|FG002|Overall Study|Patient transferred to nursing home|0|||
147562954|NCT00440557|532219432|FG000|Overall Study|Patient had surgery|1|||
147562955|NCT00440557|532219433|FG001|Overall Study|Patient had surgery|0|||
147562956|NCT00440557|532219434|FG002|Overall Study|Patient had surgery|0|||
147562957|NCT00669942|532219435|FG000|Parts 2 and 3|Adverse Event|0|||
147562958|NCT00669942|532219436|FG001|Parts 2 and 3|Adverse Event|0|||
147562959|NCT00669942|532219437|FG002|Parts 2 and 3|Adverse Event|0|||
147562960|NCT00669942|532219438|FG003|Parts 2 and 3|Adverse Event|0|||
147562961|NCT00669942|532219439|FG004|Parts 2 and 3|Adverse Event|0|||
147562962|NCT00669942|532219440|FG005|Parts 2 and 3|Adverse Event|0|||
147312042|NCT03012061|531309242|FG000|Overall Study|Lack of Efficacy|0|||
147312043|NCT03012061|531309243|FG001|Overall Study|Lack of Efficacy|1|||
147562963|NCT00669942|532219441|FG006|Parts 2 and 3|Adverse Event|0|||
147562964|NCT00669942|532219442|FG007|Parts 2 and 3|Adverse Event|2|||
147562965|NCT00669942|532219443|FG008|Parts 2 and 3|Adverse Event|1|||
147562966|NCT00669942|532219444|FG009|Parts 2 and 3|Adverse Event|0|||
147562967|NCT00669942|532219445|FG010|Parts 2 and 3|Adverse Event|0|||
147562968|NCT00669942|532219446|FG011|Parts 2 and 3|Adverse Event|0|||
147562969|NCT00669942|532219435|FG000|Parts 2 and 3|Withdrawal by Subject|0|||
147562970|NCT00669942|532219436|FG001|Parts 2 and 3|Withdrawal by Subject|0|||
147562971|NCT00669942|532219437|FG002|Parts 2 and 3|Withdrawal by Subject|0|||
147562972|NCT00669942|532219438|FG003|Parts 2 and 3|Withdrawal by Subject|0|||
147562973|NCT00669942|532219439|FG004|Parts 2 and 3|Withdrawal by Subject|0|||
147562974|NCT00669942|532219440|FG005|Parts 2 and 3|Withdrawal by Subject|1|||
147562975|NCT00669942|532219441|FG006|Parts 2 and 3|Withdrawal by Subject|0|||
147562976|NCT00669942|532219442|FG007|Parts 2 and 3|Withdrawal by Subject|0|||
147562977|NCT00669942|532219443|FG008|Parts 2 and 3|Withdrawal by Subject|2|||
147562978|NCT00669942|532219444|FG009|Parts 2 and 3|Withdrawal by Subject|0|||
147562979|NCT00669942|532219445|FG010|Parts 2 and 3|Withdrawal by Subject|0|||
147562980|NCT00669942|532219446|FG011|Parts 2 and 3|Withdrawal by Subject|0|||
147562981|NCT00669942|532219435|FG000|Parts 2 and 3|Protocol Violation|0|||
147562982|NCT00669942|532219436|FG001|Parts 2 and 3|Protocol Violation|0|||
147562983|NCT00669942|532219437|FG002|Parts 2 and 3|Protocol Violation|0|||
147562984|NCT00669942|532219438|FG003|Parts 2 and 3|Protocol Violation|0|||
147562985|NCT00669942|532219439|FG004|Parts 2 and 3|Protocol Violation|0|||
147562986|NCT00669942|532219440|FG005|Parts 2 and 3|Protocol Violation|1|||
147562987|NCT00669942|532219441|FG006|Parts 2 and 3|Protocol Violation|0|||
147562988|NCT00669942|532219442|FG007|Parts 2 and 3|Protocol Violation|0|||
147562989|NCT00669942|532219443|FG008|Parts 2 and 3|Protocol Violation|0|||
147562990|NCT00669942|532219444|FG009|Parts 2 and 3|Protocol Violation|0|||
147562991|NCT00669942|532219445|FG010|Parts 2 and 3|Protocol Violation|0|||
147562992|NCT00669942|532219446|FG011|Parts 2 and 3|Protocol Violation|0|||
147562993|NCT02107092|532219447|FG000|Overall Study|Miscellaneous|3|||
147562994|NCT02107092|532219447|FG000|Overall Study|Subject compliance|3|||
147562995|NCT02107092|532219447|FG000|Overall Study|Hypo-or hyperkalemia|2|||
147562996|NCT02107092|532219447|FG000|Overall Study|Met ECG withdrawal criteria|3|||
147562997|NCT02107092|532219447|FG000|Overall Study|Physician Decision|3|||
147562998|NCT02107092|532219447|FG000|Overall Study|Lost to Follow-up|2|||
147562999|NCT02107092|532219447|FG000|Overall Study|Withdrawal by Subject|9|||
147563000|NCT02107092|532219447|FG000|Overall Study|Adverse Event|7|||
147563001|NCT02107092|532219447|FG000|Overall Study|Expected progression of CKD|12|||
147563002|NCT04213326|532219452|FG000|Overall Study|Consent withdrawn|51|||
147563003|NCT04213326|532219453|FG001|Overall Study|Consent withdrawn|241|||
147563004|NCT04213326|532219452|FG000|Overall Study|Lost to Follow-up|50|||
147563005|NCT04213326|532219453|FG001|Overall Study|Lost to Follow-up|902|||
147563006|NCT04213326|532219452|FG000|Overall Study|Protocol Violation|3|||
147563007|NCT04213326|532219453|FG001|Overall Study|Protocol Violation|25|||
147563008|NCT04213326|532219452|FG000|Overall Study|Participant eligibility changed|106|||
147113972|NCT00800540|530579962|FG001|Period 2: 6 Weeks|Adverse Event|1|||
147113973|NCT03927157|530579966|FG000|Overall Study|Adverse Event|1|||
147113974|NCT03927157|530579967|FG001|Overall Study|Adverse Event|3|||
147113975|NCT03927157|530579966|FG000|Overall Study|Protocol Violation|1|||
147563009|NCT04213326|532219453|FG001|Overall Study|Participant eligibility changed|19|||
147563010|NCT04213326|532219452|FG000|Overall Study|SCRI confirmed to be withdrawal|0|||
147563011|NCT04213326|532219453|FG001|Overall Study|SCRI confirmed to be withdrawal|16|||
147563012|NCT04213326|532219452|FG000|Overall Study|Incomplete study visit|0|||
147228226|NCT00736879|531008735|FG001|Double Blind Treatment Period|Poor non-compliance|0|||
147228227|NCT00736879|531008736|FG002|Double Blind Treatment Period|Poor non-compliance|1|||
147228228|NCT00736879|531008737|FG003|Double Blind Treatment Period|Poor non-compliance|1|||
147228229|NCT00736879|531008734|FG000|Double Blind Treatment Period|No longer met criteria|0|||
147228230|NCT00736879|531008735|FG001|Double Blind Treatment Period|No longer met criteria|1|||
147228231|NCT00736879|531008736|FG002|Double Blind Treatment Period|No longer met criteria|0|||
147228232|NCT00736879|531008737|FG003|Double Blind Treatment Period|No longer met criteria|0|||
147228233|NCT00736879|531008734|FG000|Double Blind Treatment Period|non-specified|0|||
147228234|NCT00736879|531008735|FG001|Double Blind Treatment Period|non-specified|1|||
147228235|NCT00736879|531008736|FG002|Double Blind Treatment Period|non-specified|0|||
147563013|NCT04213326|532219453|FG001|Overall Study|Incomplete study visit|367|||
147563014|NCT02549092|532219454|FG000|Treatment Period|Adverse Event|2|||
147563015|NCT02549092|532219455|FG001|Treatment Period|Adverse Event|2|||
147563016|NCT02549092|532219454|FG000|Treatment Period|Withdrawal by Subject|1|||
147563017|NCT02549092|532219455|FG001|Treatment Period|Withdrawal by Subject|3|||
147563018|NCT02549092|532219454|FG000|Treatment Period|Lack of Efficacy|0|||
147563019|NCT02549092|532219455|FG001|Treatment Period|Lack of Efficacy|2|||
147563020|NCT02549092|532219454|FG000|Extension/Transition Period|Adverse Event|1|||
147563021|NCT02549092|532219455|FG001|Extension/Transition Period|Adverse Event|1|||
147563022|NCT02549092|532219454|FG000|Extension/Transition Period|Withdrawal by Subject|0|||
147563023|NCT02549092|532219455|FG001|Extension/Transition Period|Withdrawal by Subject|1|||
147113976|NCT03927157|530579967|FG001|Overall Study|Protocol Violation|2|||
147563024|NCT02549092|532219454|FG000|Extension/Transition Period|Other, Not Specified|4|||
147563025|NCT02549092|532219455|FG001|Extension/Transition Period|Other, Not Specified|2|||
147563026|NCT03002077|532219462|FG000|Overall Study|Non-compliance with Study Drug|4|||
147563027|NCT03002077|532219462|FG000|Overall Study|Non-compliance w/Background ADT|1|||
147563028|NCT03002077|532219462|FG000|Overall Study|Study Terminated by Sponsor|257|||
147563029|NCT03002077|532219462|FG000|Overall Study|Site Terminated by Sponsor|5|||
147563030|NCT03002077|532219462|FG000|Overall Study|Miscellaneous Reasons|10|||
147563031|NCT03002077|532219462|FG000|Overall Study|Adverse Event|23|||
147563032|NCT03002077|532219462|FG000|Overall Study|Lack of Efficacy|20|||
147563033|NCT03002077|532219462|FG000|Overall Study|Withdrawal by Subject|72|||
147563034|NCT03002077|532219462|FG000|Overall Study|Lost to Follow-up|21|||
147563035|NCT03002077|532219462|FG000|Overall Study|Pregnancy|4|||
147563036|NCT03002077|532219462|FG000|Overall Study|Protocol Violation|21|||
147563037|NCT04625114|532219473|FG000|Overall Study|Adverse Event|3|||
147563038|NCT04625114|532219474|FG001|Overall Study|Adverse Event|1|||
147563039|NCT04625114|532219473|FG000|Overall Study|Withdrawal by Subject|2|||
147563040|NCT04625114|532219474|FG001|Overall Study|Withdrawal by Subject|0|||
147563041|NCT01629381|532219475|FG000|Overall Study|Withdrawal by Subject|2|||
147563042|NCT01629381|532219476|FG001|Overall Study|Withdrawal by Subject|5|||
147563043|NCT00906347|532219479|FG000|Received Study Drug|8 cm prior to initiation of study drug|18|||
147563044|NCT00906347|532219480|FG001|Received Study Drug|8 cm prior to initiation of study drug|30|||
147563045|NCT00906347|532219479|FG000|Received Study Drug|Nonreassuring fetal heart rate|13|||
147563046|NCT00906347|532219480|FG001|Received Study Drug|Nonreassuring fetal heart rate|1|||
147563047|NCT00906347|532219479|FG000|Received Study Drug|Refused study drug|1|||
147563048|NCT00906347|532219480|FG001|Received Study Drug|Refused study drug|0|||
147563049|NCT00906347|532219479|FG000|Received Study Drug|Uterine tachysystole or hypertonus|8|||
147563050|NCT00906347|532219480|FG001|Received Study Drug|Uterine tachysystole or hypertonus|0|||
147563051|NCT02849652|532219488|FG000|Overall Study|Lost to Follow-up|104|||
147563052|NCT02849652|532219489|FG001|Overall Study|Lost to Follow-up|35|||
147563053|NCT02849652|532219490|FG002|Overall Study|Lost to Follow-up|116|||
147563054|NCT02849652|532219491|FG003|Overall Study|Lost to Follow-up|22|||
147563055|NCT02849652|532219488|FG000|Overall Study|Withdrawal by Subject|10|||
147563056|NCT02849652|532219489|FG001|Overall Study|Withdrawal by Subject|2|||
147563057|NCT02849652|532219490|FG002|Overall Study|Withdrawal by Subject|8|||
147312044|NCT03012061|531309244|FG002|Overall Study|Lack of Efficacy|0|||
147312045|NCT03012061|531309242|FG000|Overall Study|Adverse Event|2|||
147312046|NCT03012061|531309243|FG001|Overall Study|Adverse Event|0|||
147312047|NCT03012061|531309244|FG002|Overall Study|Adverse Event|0|||
147312048|NCT04152343|531309245|FG000|Overall Study|Transplanted|5|||
147312049|NCT04152343|531309245|FG000|Overall Study|Death|20|||
147312050|NCT04152343|531309245|FG000|Overall Study|Lost to Follow-up|3|||
147312051|NCT00118092|531309246|FG000|Overall Study|Withdrawal by Subject|1|||
147312052|NCT00118092|531309246|FG000|Overall Study|Protocol Violation|1|||
147312053|NCT00591864|531309247|FG000|Overall Study|Incomplete Imaging|5|||
147312054|NCT02459093|531309248|FG000|Overall Study|Protocol Violation|6|||
147444388|NCT01438489|531792588|FG001|Overall Study|AE/SAEs|1|||
147563058|NCT02849652|532219491|FG003|Overall Study|Withdrawal by Subject|4|||
147563059|NCT00472290|532219492|FG000|Overall Study|Progression of Therapy-Related MDS|1|||
147563060|NCT00472290|532219492|FG000|Overall Study|Protocol Specified Criteria|7|||
147563061|NCT00472290|532219492|FG000|Overall Study|Administrative Decision|37|||
147563062|NCT00472290|532219492|FG000|Overall Study|Death|3|||
147563063|NCT00472290|532219492|FG000|Overall Study|Lost to Follow-up|1|||
147563064|NCT00472290|532219492|FG000|Overall Study|Lack of Efficacy|1|||
147563065|NCT00472290|532219492|FG000|Overall Study|Disease Progression|4|||
147563066|NCT00472290|532219492|FG000|Overall Study|Withdrawal by Subject|5|||
147563067|NCT00472290|532219492|FG000|Overall Study|Adverse Event|6|||
147563068|NCT00472290|532219492|FG000|Overall Study|Requirement for alternative therapy|7|||
147563069|NCT00777829|532219493|FG000|Overall Study|Withdrawal by Subject|0|||
147563070|NCT00777829|532219494|FG001|Overall Study|Withdrawal by Subject|2|||
147228236|NCT00736879|531008737|FG003|Double Blind Treatment Period|non-specified|0|||
147228237|NCT00736879|531008734|FG000|Follow up Period - No Drug Treatment|Withdrawal by Subject|0|||
147228238|NCT00736879|531008735|FG001|Follow up Period - No Drug Treatment|Withdrawal by Subject|1|||
147228239|NCT00736879|531008736|FG002|Follow up Period - No Drug Treatment|Withdrawal by Subject|0|||
147228240|NCT00736879|531008737|FG003|Follow up Period - No Drug Treatment|Withdrawal by Subject|0|||
147228241|NCT00736879|531008734|FG000|Follow up Period - No Drug Treatment|non-specified|1|||
147228242|NCT00736879|531008735|FG001|Follow up Period - No Drug Treatment|non-specified|2|||
147228243|NCT00736879|531008736|FG002|Follow up Period - No Drug Treatment|non-specified|0|||
147228244|NCT00736879|531008737|FG003|Follow up Period - No Drug Treatment|non-specified|0|||
147228245|NCT02360111|531008738|FG000|Overall Study|Death|2|||
147312055|NCT02459093|531309249|FG001|Overall Study|Protocol Violation|11|||
147312056|NCT02459093|531309248|FG000|Overall Study|Lost to Follow-up|6|||
147312057|NCT02459093|531309249|FG001|Overall Study|Lost to Follow-up|7|||
147312058|NCT01164228|531309254|FG000|Overall Study|Progression|24|||
147563071|NCT00854308|532219503|FG000|Overall Study|Disease progression|42|||
147312059|NCT01164228|531309255|FG001|Overall Study|Progression|25|||
147563072|NCT00854308|532219504|FG001|Overall Study|Disease progression|50|||
147563073|NCT00854308|532219503|FG000|Overall Study|Adverse Event|8|||
147563074|NCT00854308|532219504|FG001|Overall Study|Adverse Event|3|||
147563075|NCT00854308|532219503|FG000|Overall Study|Death|2|||
147563076|NCT00854308|532219504|FG001|Overall Study|Death|5|||
147563077|NCT00854308|532219503|FG000|Overall Study|Physician Decision|6|||
147563078|NCT00854308|532219504|FG001|Overall Study|Physician Decision|6|||
147563079|NCT00854308|532219503|FG000|Overall Study|Withdrawal by Subject|4|||
147563080|NCT00854308|532219504|FG001|Overall Study|Withdrawal by Subject|2|||
147563081|NCT00854308|532219503|FG000|Overall Study|Sponsor's decision to terminate study|0|||
147563082|NCT00854308|532219504|FG001|Overall Study|Sponsor's decision to terminate study|1|||
147563083|NCT01390844|532219505|FG000|Treatment Phase|Adverse Event|12|||
147563084|NCT01390844|532219506|FG001|Treatment Phase|Adverse Event|2|||
147563085|NCT01390844|532219507|FG002|Treatment Phase|Adverse Event|3|||
147563086|NCT01390844|532219508|FG003|Treatment Phase|Adverse Event|2|||
147563087|NCT01390844|532219505|FG000|Treatment Phase|Treatment Failure|23|||
147563088|NCT01390844|532219506|FG001|Treatment Phase|Treatment Failure|25|||
147563089|NCT01390844|532219507|FG002|Treatment Phase|Treatment Failure|10|||
147563090|NCT01390844|532219508|FG003|Treatment Phase|Treatment Failure|13|||
147563091|NCT01390844|532219505|FG000|Treatment Phase|Non-Medical Reasons|5|||
147563092|NCT01390844|532219506|FG001|Treatment Phase|Non-Medical Reasons|1|||
147563093|NCT01390844|532219507|FG002|Treatment Phase|Non-Medical Reasons|8|||
147563094|NCT01390844|532219508|FG003|Treatment Phase|Non-Medical Reasons|1|||
147563095|NCT01390844|532219505|FG000|Treatment Phase|Non-GCP Compliant|0|||
147563096|NCT01390844|532219506|FG001|Treatment Phase|Non-GCP Compliant|0|||
147563097|NCT01390844|532219507|FG002|Treatment Phase|Non-GCP Compliant|10|||
147563098|NCT01390844|532219508|FG003|Treatment Phase|Non-GCP Compliant|3|||
147563099|NCT01390844|532219505|FG000|Follow-Up Phase|Non-Medical Reasons|1|||
147563100|NCT01390844|532219506|FG001|Follow-Up Phase|Non-Medical Reasons|1|||
147563101|NCT01390844|532219507|FG002|Follow-Up Phase|Non-Medical Reasons|1|||
147563102|NCT01390844|532219508|FG003|Follow-Up Phase|Non-Medical Reasons|0|||
147563103|NCT00745095|532219509|FG000|Overall Study|Declined to participate|1|||
147563104|NCT00745095|532219510|FG001|Overall Study|Declined to participate|0|||
147563105|NCT00745095|532219511|FG002|Overall Study|Declined to participate|0|||
147563106|NCT00745095|532219512|FG003|Overall Study|Declined to participate|0|||
147563107|NCT00745095|532219513|FG004|Overall Study|Declined to participate|92|||
147563108|NCT00745095|532219514|FG005|Overall Study|Declined to participate|95|||
147563109|NCT00745095|532219509|FG000|Overall Study|Ineligible due to GFR criteria|0|||
147563110|NCT00745095|532219510|FG001|Overall Study|Ineligible due to GFR criteria|2|||
147563111|NCT00745095|532219511|FG002|Overall Study|Ineligible due to GFR criteria|3|||
147563112|NCT00745095|532219512|FG003|Overall Study|Ineligible due to GFR criteria|3|||
147228246|NCT01933217|531008743|FG000|Randomization (4 Weeks)|Withdrawal by Subject|1|||
147228247|NCT01933217|531008744|FG001|Randomization (4 Weeks)|Withdrawal by Subject|3|||
147228248|NCT01933217|531008743|FG000|Randomization (4 Weeks)|Lost to Follow-up|1|||
147228249|NCT01933217|531008744|FG001|Randomization (4 Weeks)|Lost to Follow-up|1|||
147228250|NCT03923738|531008747|FG000|Period 1|Adverse Event|1|||
147228251|NCT03923738|531008747|FG000|Period 1|Withdrawal by Subject|1|||
147228252|NCT03583164|531008751|FG000|Overall Study|Death in Main Phase|35|||
147228253|NCT03583164|531008751|FG000|Overall Study|Lost to Follow up in Main Phase|1|||
147228254|NCT03583164|531008751|FG000|Overall Study|Lost to follow up in Extended Phase|3|||
147228255|NCT03583164|531008751|FG000|Overall Study|Clinically significant lab value in Main Phase|2|||
147228256|NCT03583164|531008751|FG000|Overall Study|Clinically significant lab value in Extended Phase|4|||
147228257|NCT03583164|531008751|FG000|Overall Study|Physician decision in Main Phase|1|||
147228258|NCT03583164|531008751|FG000|Overall Study|Physician decision in Extended Phase|2|||
147228259|NCT03583164|531008751|FG000|Overall Study|Death in Extended Phase|13|||
147228260|NCT03583164|531008751|FG000|Overall Study|Intolerable adverse event in Main Phase|3|||
147228261|NCT03583164|531008751|FG000|Overall Study|Intolerable adverse event in Extended Phase|1|||
147228262|NCT03583164|531008751|FG000|Overall Study|Lack of compliance in Extended Phase|2|||
147228263|NCT03583164|531008751|FG000|Overall Study|Treatment failure in Main Phase|2|||
147228264|NCT03583164|531008751|FG000|Overall Study|Treatment failure in Extended Phase|4|||
147228265|NCT03583164|531008751|FG000|Overall Study|Withdrawal of consent in Extended Phase|2|||
147563113|NCT00745095|532219513|FG004|Overall Study|Ineligible due to GFR criteria|30|||
147563114|NCT00745095|532219514|FG005|Overall Study|Ineligible due to GFR criteria|28|||
147228266|NCT03583164|531008751|FG000|Overall Study|Other not specified reason in Main Phase|2|||
147228267|NCT01031381|531008752|FG000|Overall Study|Physician Decision|3|||
147228268|NCT01031381|531008752|FG000|Overall Study|Withdrawal by Subject|6|||
147228269|NCT00573248|531008754|FG000|Overall Study|scheduling conflicts|15|||
147563115|NCT01479439|532219515|FG000|Overall Study|Adverse Event|1|||
147563116|NCT01479439|532219516|FG001|Overall Study|Adverse Event|0|||
147563117|NCT01479439|532219517|FG002|Overall Study|Adverse Event|0|||
147228270|NCT00573248|531008755|FG001|Overall Study|scheduling conflicts|11|||
147228271|NCT02791594|531008758|FG000|Overall Study|Physician Decision|2|||
147228272|NCT04950166|531008764|FG000|Overall Study|Withdrawal by Subject|1|||
147563118|NCT01479439|532219515|FG000|Overall Study|Lost to Follow-up|0|||
147563119|NCT01479439|532219516|FG001|Overall Study|Lost to Follow-up|1|||
147563120|NCT01479439|532219517|FG002|Overall Study|Lost to Follow-up|0|||
147563121|NCT01479439|532219515|FG000|Overall Study|Protocol Violation|0|||
147563122|NCT01479439|532219516|FG001|Overall Study|Protocol Violation|0|||
147563123|NCT01479439|532219517|FG002|Overall Study|Protocol Violation|2|||
147563124|NCT02079766|532219518|FG000|Overall Study|Physician Decision|1|||
147563125|NCT02079766|532219519|FG001|Overall Study|Physician Decision|0|||
147563126|NCT02079766|532219518|FG000|Overall Study|Withdrawal by Subject|1|||
147563127|NCT02079766|532219519|FG001|Overall Study|Withdrawal by Subject|0|||
147563128|NCT00304083|532219522|FG000|Overall Study|Withdrawal by Subject|4|||
147563129|NCT00304083|532219523|FG001|Overall Study|Withdrawal by Subject|2|||
147563130|NCT00304083|532219522|FG000|Overall Study|Physician Decision|8|||
147563131|NCT00304083|532219523|FG001|Overall Study|Physician Decision|3|||
147563132|NCT00304083|532219522|FG000|Overall Study|Disease Progression|5|||
147563133|NCT00304083|532219523|FG001|Overall Study|Disease Progression|1|||
147563134|NCT00304083|532219522|FG000|Overall Study|Other|5|||
147563135|NCT00304083|532219523|FG001|Overall Study|Other|2|||
147563136|NCT01044732|532219524|FG000|Overall Study|Lost to Follow-up|2|||
147563137|NCT01044732|532219525|FG001|Overall Study|Lost to Follow-up|1|||
147563138|NCT01044732|532219524|FG000|Overall Study|Physician Decision|5|||
147563139|NCT01044732|532219525|FG001|Overall Study|Physician Decision|3|||
147563140|NCT01044732|532219524|FG000|Overall Study|Protocol Violation|11|||
147563141|NCT01044732|532219525|FG001|Overall Study|Protocol Violation|12|||
147563142|NCT01044732|532219524|FG000|Overall Study|Withdrawal by Subject|0|||
147563143|NCT01044732|532219525|FG001|Overall Study|Withdrawal by Subject|1|||
147563144|NCT01044732|532219524|FG000|Overall Study|Inadequate bowel preparation|11|||
147563145|NCT01044732|532219525|FG001|Overall Study|Inadequate bowel preparation|17|||
147563146|NCT01044732|532219524|FG000|Overall Study|Inability to reach cecum|5|||
147563147|NCT01044732|532219525|FG001|Overall Study|Inability to reach cecum|2|||
147563148|NCT01044732|532219524|FG000|Overall Study|Technical error or malfunction|15|||
147563149|NCT01044732|532219525|FG001|Overall Study|Technical error or malfunction|14|||
147563150|NCT03991494|532219528|FG000|Overall Study|Progressive Disease|4|||
147563151|NCT03144687|532219535|FG000|Overall Study|Death|0|||
147563152|NCT03144687|532219536|FG001|Overall Study|Death|2|||
147563153|NCT03144687|532219535|FG000|Overall Study|Lost to Follow-up|0|||
147563154|NCT03144687|532219536|FG001|Overall Study|Lost to Follow-up|1|||
147563155|NCT03144687|532219535|FG000|Overall Study|Physician Decision|0|||
147563156|NCT03144687|532219536|FG001|Overall Study|Physician Decision|1|||
147563157|NCT03144687|532219535|FG000|Overall Study|Withdrawal by Subject|1|||
147563158|NCT03144687|532219536|FG001|Overall Study|Withdrawal by Subject|3|||
147563159|NCT03144687|532219535|FG000|Overall Study|Not Reported|2|||
147563160|NCT03144687|532219536|FG001|Overall Study|Not Reported|0|||
147563161|NCT00683293|532219539|FG000|Overall Study|Withdrawal by Subject|2|||
147563162|NCT00683293|532219540|FG001|Overall Study|Withdrawal by Subject|3|||
147563163|NCT02507375|532219545|FG000|Overall Study|Progressive Disease|4|||
147563164|NCT02507375|532219546|FG001|Overall Study|Progressive Disease|5|||
147563165|NCT02507375|532219545|FG000|Overall Study|Death|0|||
147563166|NCT02507375|532219546|FG001|Overall Study|Death|1|||
147563167|NCT02507375|532219545|FG000|Overall Study|Refused treatment|0|||
147228273|NCT05896748|531008765|FG000|Screening Phase (Week -4 up to Day 1)|Passed away due to unknown reasons|1|||
147228274|NCT05896748|531008765|FG000|SC Injection Phase (Day 1 up to Week 12)|Adverse Event|2|||
147228275|NCT05896748|531008765|FG000|SC Injection Phase (Day 1 up to Week 12)|Protocol Violation|1|||
147563168|NCT02507375|532219546|FG001|Overall Study|Refused treatment|1|||
147563169|NCT02507375|532219545|FG000|Overall Study|Adverse Event|0|||
147563170|NCT02507375|532219546|FG001|Overall Study|Adverse Event|1|||
147563171|NCT02158936|532219547|FG000|Overall Study|Study closed/ terminated|57|||
147563172|NCT02158936|532219548|FG001|Overall Study|Study closed/ terminated|77|||
147563173|NCT02158936|532219547|FG000|Overall Study|Azacitidine tx discontinued|53|||
147563174|NCT02158936|532219548|FG001|Overall Study|Azacitidine tx discontinued|46|||
147563175|NCT02158936|532219547|FG000|Overall Study|Adverse Event|39|||
147563176|NCT02158936|532219548|FG001|Overall Study|Adverse Event|24|||
147563177|NCT02158936|532219547|FG000|Overall Study|Withdrawal by Subject|15|||
147563178|NCT02158936|532219548|FG001|Overall Study|Withdrawal by Subject|16|||
147563179|NCT02158936|532219547|FG000|Overall Study|Physician Decision|15|||
147563180|NCT02158936|532219548|FG001|Overall Study|Physician Decision|13|||
147563181|NCT02158936|532219547|FG000|Overall Study|Lost to Follow-up|0|||
147563182|NCT02158936|532219548|FG001|Overall Study|Lost to Follow-up|1|||
147563183|NCT00522457|532219549|FG000|Overall Study|Due to disease progression|16|||
147563184|NCT00522457|532219549|FG000|Overall Study|Adverse Event|2|||
147563185|NCT01387737|532220901|FG000|Overall Study|Adverse Event|20|||
147563186|NCT01387737|532220902|FG001|Overall Study|Adverse Event|30|||
147563187|NCT01387737|532220901|FG000|Overall Study|Lack of Efficacy|1|||
147563188|NCT01387737|532220902|FG001|Overall Study|Lack of Efficacy|0|||
147563189|NCT01387737|532220901|FG000|Overall Study|Physician Decision|3|||
147563190|NCT01387737|532220902|FG001|Overall Study|Physician Decision|10|||
147563191|NCT01387737|532220901|FG000|Overall Study|Withdrawal by Subject|27|||
147563192|NCT01387737|532220902|FG001|Overall Study|Withdrawal by Subject|31|||
147563193|NCT01387737|532220901|FG000|Overall Study|Clearly not eligible for the study|1|||
147563194|NCT01387737|532220902|FG001|Overall Study|Clearly not eligible for the study|3|||
147563195|NCT01248247|532220904|FG000|Overall Study|Adverse Event|2|||
147563196|NCT01248247|532220905|FG001|Overall Study|Adverse Event|4|||
147563197|NCT01248247|532220906|FG002|Overall Study|Adverse Event|4|||
147563198|NCT01248247|532220907|FG003|Overall Study|Adverse Event|2|||
147563199|NCT01248247|532220904|FG000|Overall Study|Death|0|||
147563200|NCT01248247|532220905|FG001|Overall Study|Death|1|||
147563201|NCT01248247|532220906|FG002|Overall Study|Death|4|||
147563202|NCT01248247|532220907|FG003|Overall Study|Death|7|||
147563203|NCT01248247|532220904|FG000|Overall Study|Lost to Follow-up|0|||
147563204|NCT01248247|532220905|FG001|Overall Study|Lost to Follow-up|1|||
147563205|NCT01248247|532220906|FG002|Overall Study|Lost to Follow-up|1|||
147563206|NCT01248247|532220907|FG003|Overall Study|Lost to Follow-up|0|||
147563207|NCT01248247|532220904|FG000|Overall Study|Alternative treatment|0|||
147563208|NCT01248247|532220905|FG001|Overall Study|Alternative treatment|1|||
147563209|NCT01248247|532220906|FG002|Overall Study|Alternative treatment|0|||
147563210|NCT01248247|532220907|FG003|Overall Study|Alternative treatment|0|||
147563211|NCT01248247|532220904|FG000|Overall Study|Other|2|||
147563212|NCT01248247|532220905|FG001|Overall Study|Other|8|||
147563213|NCT01248247|532220906|FG002|Overall Study|Other|8|||
147563214|NCT01248247|532220907|FG003|Overall Study|Other|5|||
147563215|NCT01248247|532220904|FG000|Overall Study|Progression|18|||
147563216|NCT01248247|532220905|FG001|Overall Study|Progression|27|||
147563217|NCT01248247|532220906|FG002|Overall Study|Progression|56|||
147563218|NCT01248247|532220907|FG003|Overall Study|Progression|44|||
147563219|NCT01248247|532220904|FG000|Overall Study|Refuse further treatment|0|||
147563220|NCT01248247|532220905|FG001|Overall Study|Refuse further treatment|0|||
147113977|NCT03927157|530579966|FG000|Overall Study|Withdrawal by Subject|8|||
147113978|NCT03927157|530579967|FG001|Overall Study|Withdrawal by Subject|21|||
147113979|NCT03927157|530579966|FG000|Overall Study|Due to COVID-19 pandemic|5|||
147113980|NCT03927157|530579967|FG001|Overall Study|Due to COVID-19 pandemic|2|||
147113981|NCT03927157|530579966|FG000|Overall Study|Protocol-specified withdrawal criterion met|0|||
147113982|NCT03927157|530579967|FG001|Overall Study|Protocol-specified withdrawal criterion met|2|||
147113983|NCT03927157|530579966|FG000|Overall Study|Other than above|0|||
147113984|NCT03927157|530579967|FG001|Overall Study|Other than above|1|||
147113985|NCT00726557|530579968|FG000|Overall Study|Screening failure|4|||
147113986|NCT00726557|530579968|FG000|Overall Study|No end of treatment documentation|37|||
147113987|NCT00726557|530579968|FG000|Overall Study|No follow-up documentation available|55|||
147113988|NCT00726557|530579968|FG000|Overall Study|Treatment less than 3 months|17|||
147113989|NCT00726557|530579968|FG000|Overall Study|Inclusion criteria not met|15|||
147113990|NCT05630755|530579969|FG000|Overall Study|Lost to Follow-up|7|||
147563221|NCT01248247|532220906|FG002|Overall Study|Refuse further treatment|1|||
147563222|NCT01248247|532220907|FG003|Overall Study|Refuse further treatment|2|||
147563223|NCT01248247|532220904|FG000|Overall Study|Complicating disease|0|||
147563224|NCT01248247|532220905|FG001|Overall Study|Complicating disease|0|||
147563225|NCT01248247|532220906|FG002|Overall Study|Complicating disease|1|||
147563226|NCT01248247|532220907|FG003|Overall Study|Complicating disease|1|||
147563227|NCT00705536|532220908|FG000|Start Period 1|Withdrawal by Subject|0|||
147113991|NCT05630755|530579970|FG001|Overall Study|Lost to Follow-up|0|||
147113992|NCT05630755|530579969|FG000|Overall Study|Randomized by Mistake Without Study Treatment|1|||
147113993|NCT05630755|530579970|FG001|Overall Study|Randomized by Mistake Without Study Treatment|0|||
147113994|NCT05630755|530579969|FG000|Overall Study|Withdrawal by Subject|9|||
147113995|NCT05630755|530579970|FG001|Overall Study|Withdrawal by Subject|3|||
147113996|NCT05630755|530579969|FG000|Overall Study|Participant moved away from trial site|0|||
147563228|NCT00705536|532220909|FG001|Start Period 1|Withdrawal by Subject|0|||
147563229|NCT00705536|532220910|FG002|Start Period 1|Withdrawal by Subject|0|||
147563230|NCT00705536|532220911|FG003|Start Period 1|Withdrawal by Subject|1|||
147563231|NCT00549718|532220912|FG000|Overall Study|Insufficient clinical response|20|||
147563232|NCT00549718|532220913|FG001|Overall Study|Insufficient clinical response|7|||
147563233|NCT00549718|532220914|FG002|Overall Study|Insufficient clinical response|18|||
147113997|NCT05630755|530579970|FG001|Overall Study|Participant moved away from trial site|1|||
147113998|NCT05630755|530579969|FG000|Overall Study|Status not Recorded|316|||
147113999|NCT05630755|530579970|FG001|Overall Study|Status not Recorded|161|||
147114000|NCT04868682|530579971|FG000|Post-treatment|Lost to Follow-up|1|||
147114001|NCT04868682|530579972|FG001|Post-treatment|Lost to Follow-up|1|||
147312060|NCT01164228|531309254|FG000|Overall Study|Adverse Event|13|||
147563234|NCT00549718|532220915|FG003|Overall Study|Insufficient clinical response|32|||
147563235|NCT00549718|532220912|FG000|Overall Study|Adverse Event|6|||
147563236|NCT00549718|532220913|FG001|Overall Study|Adverse Event|8|||
147563237|NCT00549718|532220914|FG002|Overall Study|Adverse Event|7|||
147563238|NCT00549718|532220915|FG003|Overall Study|Adverse Event|3|||
147563239|NCT00549718|532220912|FG000|Overall Study|Lost to Follow-up|4|||
147563240|NCT00549718|532220913|FG001|Overall Study|Lost to Follow-up|2|||
147563241|NCT00549718|532220914|FG002|Overall Study|Lost to Follow-up|0|||
147563242|NCT00549718|532220915|FG003|Overall Study|Lost to Follow-up|6|||
147563243|NCT00549718|532220912|FG000|Overall Study|Withdrawal by Subject|9|||
147563244|NCT00549718|532220913|FG001|Overall Study|Withdrawal by Subject|18|||
147563245|NCT00549718|532220914|FG002|Overall Study|Withdrawal by Subject|12|||
147563246|NCT00549718|532220915|FG003|Overall Study|Withdrawal by Subject|13|||
147563247|NCT00549718|532220912|FG000|Overall Study|Administrative|2|||
147563248|NCT00549718|532220913|FG001|Overall Study|Administrative|2|||
147563249|NCT00549718|532220914|FG002|Overall Study|Administrative|2|||
147563250|NCT00549718|532220915|FG003|Overall Study|Administrative|1|||
147563251|NCT04032977|532220916|FG000|Overall Study|Withdrawal by Subject|6|||
147563252|NCT04032977|532220917|FG001|Overall Study|Withdrawal by Subject|1|||
147563253|NCT04032977|532220916|FG000|Overall Study|Lost to Follow-up|2|||
147563254|NCT04032977|532220917|FG001|Overall Study|Lost to Follow-up|7|||
147563255|NCT04032977|532220916|FG000|Overall Study|Pregnancy|1|||
147563256|NCT04032977|532220917|FG001|Overall Study|Pregnancy|0|||
147563257|NCT03075761|532220919|FG000|Overall Study|Lost to Follow-up|1|||
147563258|NCT03075761|532220920|FG001|Overall Study|Lost to Follow-up|6|||
147563259|NCT02880761|532220921|FG000|Overall Study|Death|6|||
147563260|NCT02880761|532220922|FG001|Overall Study|Death|8|||
147563261|NCT02880761|532220921|FG000|Overall Study|Withdrawal by Subject|3|||
147563262|NCT02880761|532220922|FG001|Overall Study|Withdrawal by Subject|6|||
147563263|NCT02880761|532220921|FG000|Overall Study|Protocol Violation|4|||
147563264|NCT02880761|532220922|FG001|Overall Study|Protocol Violation|3|||
147563265|NCT02880761|532220921|FG000|Overall Study|Lost to Follow-up|3|||
147563266|NCT02880761|532220922|FG001|Overall Study|Lost to Follow-up|4|||
147563267|NCT03597256|532220923|FG000|Overall Study|Lost to Follow-up|3|||
147563268|NCT03597256|532220924|FG001|Overall Study|Lost to Follow-up|1|||
147563269|NCT03597256|532220923|FG000|Overall Study|Withdrawal by Subject|0|||
147563270|NCT03597256|532220924|FG001|Overall Study|Withdrawal by Subject|1|||
147563271|NCT03597256|532220923|FG000|Overall Study|Could not return for treatment|0|||
147563272|NCT03597256|532220924|FG001|Overall Study|Could not return for treatment|1|||
147563273|NCT03597256|532220923|FG000|Overall Study|Moved from location|0|||
147563274|NCT03597256|532220924|FG001|Overall Study|Moved from location|1|||
147563275|NCT03597256|532220923|FG000|Overall Study|Not accepted the treatment|0|||
147563276|NCT03597256|532220924|FG001|Overall Study|Not accepted the treatment|1|||
147563277|NCT02106156|532220925|FG000|Overall Study|Patient Died|19|||
147563278|NCT02106156|532220926|FG001|Overall Study|Patient Died|0|||
147563279|NCT02106156|532220927|FG002|Overall Study|Patient Died|0|||
147563280|NCT02106156|532220925|FG000|Overall Study|Lack of Tolerability|305|||
147563281|NCT02106156|532220926|FG001|Overall Study|Lack of Tolerability|3|||
147563282|NCT02106156|532220927|FG002|Overall Study|Lack of Tolerability|0|||
147563283|NCT02106156|532220925|FG000|Overall Study|Lack of Virological Response|1044|||
147563284|NCT02106156|532220926|FG001|Overall Study|Lack of Virological Response|8|||
147563285|NCT02106156|532220927|FG002|Overall Study|Lack of Virological Response|0|||
147563286|NCT02106156|532220925|FG000|Overall Study|Concomitant Disease|74|||
147563287|NCT02106156|532220926|FG001|Overall Study|Concomitant Disease|2|||
147563288|NCT02106156|532220927|FG002|Overall Study|Concomitant Disease|0|||
147563289|NCT02106156|532220925|FG000|Overall Study|Lack of Compliance|211|||
147563290|NCT02106156|532220926|FG001|Overall Study|Lack of Compliance|7|||
147563291|NCT02106156|532220927|FG002|Overall Study|Lack of Compliance|0|||
147563292|NCT02106156|532220925|FG000|Overall Study|Patients Request|307|||
147563293|NCT02106156|532220926|FG001|Overall Study|Patients Request|9|||
147563294|NCT02106156|532220927|FG002|Overall Study|Patients Request|0|||
147563295|NCT02106156|532220925|FG000|Overall Study|Lost to Follow-up|451|||
147228276|NCT05896748|531008765|FG000|SC Injection Phase (Day 1 up to Week 12)|Withdrawal by Subject|3|||
147228277|NCT05896748|531008765|FG000|Return to IM Glu Inj Phase(Week12-Week20|Protocol Violation|1|||
147228278|NCT00857415|531008774|FG000|Overall Study|Image acquisition failure|2|||
147228279|NCT00857415|531008775|FG001|Overall Study|Image acquisition failure|0|||
147228280|NCT00857415|531008774|FG000|Overall Study|Invalid image or not imaged|3|||
147228281|NCT00857415|531008775|FG001|Overall Study|Invalid image or not imaged|0|||
147228282|NCT00857415|531008774|FG000|Overall Study|Subject still living at end of study|110|||
147228283|NCT00857415|531008775|FG001|Overall Study|Subject still living at end of study|0|||
147228284|NCT00857415|531008774|FG000|Overall Study|Deceased with no autopsy|2|||
147228285|NCT00857415|531008775|FG001|Overall Study|Deceased with no autopsy|0|||
147228286|NCT04508140|531008776|FG000|Overall Study|Adverse Event|2|||
147228287|NCT04508140|531008777|FG001|Overall Study|Adverse Event|2|||
147228288|NCT04508140|531008776|FG000|Overall Study|Withdrawal by Subject|0|||
147228289|NCT04508140|531008777|FG001|Overall Study|Withdrawal by Subject|2|||
147228290|NCT04508140|531008776|FG000|Overall Study|progressive disease|9|||
147228291|NCT04508140|531008777|FG001|Overall Study|progressive disease|3|||
147563296|NCT02106156|532220926|FG001|Overall Study|Lost to Follow-up|8|||
147563297|NCT02106156|532220927|FG002|Overall Study|Lost to Follow-up|0|||
147563298|NCT02106156|532220925|FG000|Overall Study|Unplanned Event|82|||
147563299|NCT02106156|532220926|FG001|Overall Study|Unplanned Event|2|||
147563300|NCT02106156|532220927|FG002|Overall Study|Unplanned Event|0|||
147563301|NCT02106156|532220925|FG000|Overall Study|Change of Laboratory Parameter|10|||
147563302|NCT02106156|532220926|FG001|Overall Study|Change of Laboratory Parameter|0|||
147228292|NCT01130103|531008778|FG000|Randomized Treatment|Adverse Event|1|||
147228293|NCT01130103|531008779|FG001|Randomized Treatment|Adverse Event|1|||
147228294|NCT01130103|531008778|FG000|Randomized Treatment|Lost to Follow-up|1|||
147228295|NCT01130103|531008779|FG001|Randomized Treatment|Lost to Follow-up|0|||
147228296|NCT01130103|531008778|FG000|Randomized Treatment|Protocol Violation|3|||
147563303|NCT02106156|532220927|FG002|Overall Study|Change of Laboratory Parameter|0|||
147563304|NCT02106156|532220925|FG000|Overall Study|Hospitalization/Surgical Intervention|6|||
147563305|NCT02106156|532220926|FG001|Overall Study|Hospitalization/Surgical Intervention|0|||
147563306|NCT02106156|532220927|FG002|Overall Study|Hospitalization/Surgical Intervention|0|||
147563307|NCT02106156|532220925|FG000|Overall Study|Relocation/Change of Physician|40|||
147563308|NCT02106156|532220926|FG001|Overall Study|Relocation/Change of Physician|1|||
147563309|NCT02106156|532220927|FG002|Overall Study|Relocation/Change of Physician|0|||
147563310|NCT00560235|532220937|FG000|Phase 1|Discontinued|8|||
147563311|NCT00560235|532220938|FG001|Phase 1|Discontinued|0|||
147563312|NCT00560235|532220939|FG002|Phase 1|Discontinued|0|||
147563313|NCT00560235|532220937|FG000|Phase 1B|Discontinued|0|||
147563314|NCT00560235|532220938|FG001|Phase 1B|Discontinued|19|||
147563315|NCT00560235|532220939|FG002|Phase 1B|Discontinued|0|||
147563316|NCT00560235|532220937|FG000|Phase 2|Discontinued|0|||
147563317|NCT00560235|532220938|FG001|Phase 2|Discontinued|0|||
147563318|NCT00560235|532220939|FG002|Phase 2|Discontinued|96|||
147563319|NCT00560235|532220937|FG000|Phase 2|Ongoing at Date of Cut-Off|0|||
147114002|NCT04868682|530579971|FG000|Post-treatment|1 refused assessment; 1 in residing in a nursing home; 1 assessment was missed by staff|1|||
147114003|NCT04868682|530579972|FG001|Post-treatment|1 refused assessment; 1 in residing in a nursing home; 1 assessment was missed by staff|2|||
147114004|NCT04868682|530579971|FG000|Six-month Assessment|Lost to Follow-up|1|||
147563320|NCT00560235|532220938|FG001|Phase 2|Ongoing at Date of Cut-Off|0|||
147114005|NCT04868682|530579972|FG001|Six-month Assessment|Lost to Follow-up|0|||
147563321|NCT00560235|532220939|FG002|Phase 2|Ongoing at Date of Cut-Off|1|||
147563322|NCT03247556|532220941|FG000|Overall Study|Adverse Event|1|||
147563323|NCT03247556|532220942|FG001|Overall Study|Adverse Event|4|||
147563324|NCT03247556|532220943|FG002|Overall Study|Adverse Event|5|||
147563325|NCT03247556|532220941|FG000|Overall Study|Lost to Follow-up|5|||
147563326|NCT03247556|532220942|FG001|Overall Study|Lost to Follow-up|5|||
147563327|NCT03247556|532220943|FG002|Overall Study|Lost to Follow-up|4|||
147563328|NCT03247556|532220941|FG000|Overall Study|Consent Withdrawn by Caregiver|4|||
147563329|NCT03247556|532220942|FG001|Overall Study|Consent Withdrawn by Caregiver|1|||
147563330|NCT03247556|532220943|FG002|Overall Study|Consent Withdrawn by Caregiver|5|||
147563331|NCT03247556|532220941|FG000|Overall Study|Assent/consent Withdrawn by Subject|0|||
147563332|NCT03247556|532220942|FG001|Overall Study|Assent/consent Withdrawn by Subject|2|||
147563333|NCT03247556|532220943|FG002|Overall Study|Assent/consent Withdrawn by Subject|2|||
147563334|NCT03247556|532220941|FG000|Overall Study|Protocol Violation|2|||
147563335|NCT03247556|532220942|FG001|Overall Study|Protocol Violation|0|||
147563336|NCT03247556|532220943|FG002|Overall Study|Protocol Violation|1|||
147563337|NCT03247556|532220941|FG000|Overall Study|Subject did not meet inclusion criteria|0|||
147563338|NCT03247556|532220942|FG001|Overall Study|Subject did not meet inclusion criteria|0|||
147563339|NCT03247556|532220943|FG002|Overall Study|Subject did not meet inclusion criteria|1|||
147563340|NCT00051025|532220947|FG000|Overall Study|Progressive Disease|1|||
147563341|NCT00051025|532220948|FG001|Overall Study|Progressive Disease|1|||
147563342|NCT00051025|532220947|FG000|Overall Study|Adverse Event|1|||
147563343|NCT00051025|532220948|FG001|Overall Study|Adverse Event|1|||
147563344|NCT00051025|532220947|FG000|Overall Study|Withdrawal by Subject|0|||
147563345|NCT00051025|532220948|FG001|Overall Study|Withdrawal by Subject|1|||
147563346|NCT00051025|532220947|FG000|Overall Study|Death|0|||
147563347|NCT00051025|532220948|FG001|Overall Study|Death|1|||
147563348|NCT00274937|532220949|FG000|Overall Study|Physician Decision|10|||
147563349|NCT00274937|532220949|FG000|Overall Study|Withdrawal by Subject|6|||
147563350|NCT00274937|532220949|FG000|Overall Study|Progressive Disease|4|||
147563351|NCT02189941|532220950|FG000|Overall Study|Non-compliance|0|||
147563352|NCT02189941|532220951|FG001|Overall Study|Non-compliance|0|||
147563353|NCT02189941|532220952|FG002|Overall Study|Non-compliance|1|||
147563354|NCT00445003|532220953|FG000|Overall Study|Death|1|||
147563355|NCT00445003|532220954|FG001|Overall Study|Death|2|||
147563356|NCT00445003|532220955|FG002|Overall Study|Death|1|||
147114006|NCT04868682|530579971|FG000|Six-month Assessment|Death|1|||
147114007|NCT04868682|530579972|FG001|Six-month Assessment|Death|0|||
147114008|NCT04868682|530579971|FG000|Six-month Assessment|Refused|0|||
147114009|NCT04868682|530579972|FG001|Six-month Assessment|Refused|1|||
147114010|NCT04868682|530579971|FG000|12-month Assessment|Lost to Follow-up|2|||
147114011|NCT04868682|530579972|FG001|12-month Assessment|Lost to Follow-up|1|||
147114012|NCT04868682|530579971|FG000|12-month Assessment|Death|0|||
147114013|NCT04868682|530579972|FG001|12-month Assessment|Death|1|||
147114014|NCT02541903|530579973|FG000|Overall Study|Death|1|||
147114015|NCT03880565|530579974|FG000|Overall Study|Withdrawal by Subject|1|||
147228297|NCT01130103|531008779|FG001|Randomized Treatment|Protocol Violation|2|||
147114016|NCT03880565|530579975|FG001|Overall Study|Withdrawal by Subject|0|||
147114017|NCT05073315|530579983|FG000|Period 1 (Lead-in Period)|Adverse Event|6|||
147228298|NCT01130103|531008778|FG000|Randomized Treatment|Withdrawal by Subject|1|||
147563357|NCT00445003|532220953|FG000|Overall Study|Missed Visit|3|||
147563358|NCT00445003|532220954|FG001|Overall Study|Missed Visit|5|||
147563359|NCT00445003|532220955|FG002|Overall Study|Missed Visit|1|||
147563360|NCT00445003|532220953|FG000|Overall Study|Dropped|1|||
147563361|NCT00445003|532220954|FG001|Overall Study|Dropped|3|||
147563362|NCT00445003|532220955|FG002|Overall Study|Dropped|2|||
147563363|NCT00528606|532220956|FG000|Overall Study|Withdrew consent|4|||
147228299|NCT01130103|531008779|FG001|Randomized Treatment|Withdrawal by Subject|2|||
147228300|NCT01130103|531008778|FG000|Maintenance Treatment|Lack of Efficacy|0|||
147228301|NCT01130103|531008779|FG001|Maintenance Treatment|Lack of Efficacy|1|||
147228302|NCT01130103|531008778|FG000|Maintenance Treatment|Lost to Follow-up|1|||
147228303|NCT01130103|531008779|FG001|Maintenance Treatment|Lost to Follow-up|1|||
147228304|NCT01130103|531008778|FG000|Maintenance Treatment|Withdrawal by Subject|1|||
147228305|NCT01130103|531008779|FG001|Maintenance Treatment|Withdrawal by Subject|0|||
147228306|NCT01822678|531008782|FG000|Overall Study|Withdrawal by Subject|5|||
147228307|NCT01822678|531008783|FG001|Overall Study|Withdrawal by Subject|4|||
147228308|NCT01822678|531008784|FG002|Overall Study|Withdrawal by Subject|4|||
147228309|NCT01822678|531008782|FG000|Overall Study|Adverse Event|4|||
147228310|NCT01822678|531008783|FG001|Overall Study|Adverse Event|3|||
147228311|NCT01822678|531008784|FG002|Overall Study|Adverse Event|1|||
147228312|NCT01822678|531008782|FG000|Overall Study|Lack of Efficacy|3|||
147228313|NCT01822678|531008783|FG001|Overall Study|Lack of Efficacy|6|||
147228314|NCT01822678|531008784|FG002|Overall Study|Lack of Efficacy|5|||
147228315|NCT01822678|531008782|FG000|Overall Study|Lost to Follow-up|0|||
147228316|NCT01822678|531008783|FG001|Overall Study|Lost to Follow-up|2|||
147228317|NCT01822678|531008784|FG002|Overall Study|Lost to Follow-up|1|||
147228318|NCT00249288|531008790|FG000|Overall Study|Lost to Follow-up|3|||
147228319|NCT00249288|531008791|FG001|Overall Study|Lost to Follow-up|3|||
147228320|NCT00249288|531008790|FG000|Overall Study|Withdrawal by Subject|2|||
147228321|NCT00249288|531008791|FG001|Overall Study|Withdrawal by Subject|2|||
147228322|NCT03059446|531008792|FG000|Overall Study|Adverse Event|11|||
147228323|NCT03059446|531008792|FG000|Overall Study|Withdrawal of Consent|16|||
147228324|NCT03059446|531008792|FG000|Overall Study|Lost to Follow-up|3|||
147228325|NCT03059446|531008792|FG000|Overall Study|Protocol Violation|1|||
147228326|NCT03059446|531008792|FG000|Overall Study|Study Terminated by Sponsor|131|||
147563364|NCT00528606|532220957|FG001|Overall Study|Withdrew consent|3|||
147563365|NCT00528606|532220956|FG000|Overall Study|Lost to Follow-up|4|||
147563366|NCT00528606|532220957|FG001|Overall Study|Lost to Follow-up|1|||
147563367|NCT00528606|532220956|FG000|Overall Study|Adverse Event|3|||
147563368|NCT00528606|532220957|FG001|Overall Study|Adverse Event|0|||
147563369|NCT00528606|532220956|FG000|Overall Study|Other|2|||
147563370|NCT00528606|532220957|FG001|Overall Study|Other|0|||
147563371|NCT01918397|532220959|FG000|Overall Study|Never started treatment|2|||
147563372|NCT01918397|532220960|FG001|Overall Study|Never started treatment|1|||
147563373|NCT01918397|532220961|FG002|Overall Study|Never started treatment|0|||
147114018|NCT05073315|530579984|FG001|Period 1 (Lead-in Period)|Adverse Event|0|||
147114019|NCT05073315|530579985|FG002|Period 1 (Lead-in Period)|Adverse Event|0|||
147114020|NCT05073315|530579983|FG000|Period 1 (Lead-in Period)|Death|1|||
147114021|NCT05073315|530579984|FG001|Period 1 (Lead-in Period)|Death|0|||
147114022|NCT05073315|530579985|FG002|Period 1 (Lead-in Period)|Death|0|||
147114023|NCT05073315|530579983|FG000|Period 1 (Lead-in Period)|Withdrawal by Subject|6|||
147114024|NCT05073315|530579984|FG001|Period 1 (Lead-in Period)|Withdrawal by Subject|0|||
147114025|NCT05073315|530579985|FG002|Period 1 (Lead-in Period)|Withdrawal by Subject|0|||
147563374|NCT01918397|532220962|FG003|Overall Study|Never started treatment|0|||
147563375|NCT01918397|532220959|FG000|Overall Study|Adverse Event|1|||
147563376|NCT01918397|532220960|FG001|Overall Study|Adverse Event|1|||
147563377|NCT01918397|532220961|FG002|Overall Study|Adverse Event|1|||
147563378|NCT01918397|532220962|FG003|Overall Study|Adverse Event|0|||
147563379|NCT01918397|532220959|FG000|Overall Study|Lack of compliance|2|||
147563380|NCT01918397|532220960|FG001|Overall Study|Lack of compliance|2|||
147563381|NCT01918397|532220961|FG002|Overall Study|Lack of compliance|3|||
147563382|NCT01918397|532220962|FG003|Overall Study|Lack of compliance|0|||
147563383|NCT01918397|532220959|FG000|Overall Study|Pregnancy|0|||
147563384|NCT01918397|532220960|FG001|Overall Study|Pregnancy|1|||
147563385|NCT01918397|532220961|FG002|Overall Study|Pregnancy|0|||
147563386|NCT01918397|532220962|FG003|Overall Study|Pregnancy|0|||
147228327|NCT03059446|531008792|FG000|Overall Study|Reason not Specified|5|||
147228328|NCT04795622|531008793|FG000|Overall Study|Adverse Event|1|||
147228329|NCT04795622|531008794|FG001|Overall Study|Adverse Event|0|||
147228330|NCT04795622|531008793|FG000|Overall Study|Withdrawal by Subject|3|||
147228331|NCT04795622|531008794|FG001|Overall Study|Withdrawal by Subject|3|||
147228332|NCT04795622|531008793|FG000|Overall Study|Protocol Violation|0|||
147228333|NCT04795622|531008794|FG001|Overall Study|Protocol Violation|2|||
147228334|NCT04795622|531008793|FG000|Overall Study|Lost to Follow-up|2|||
147228335|NCT04795622|531008794|FG001|Overall Study|Lost to Follow-up|3|||
147563387|NCT01918397|532220959|FG000|Overall Study|Rifampin susceptible|0|||
147563388|NCT01918397|532220960|FG001|Overall Study|Rifampin susceptible|0|||
147563389|NCT01918397|532220961|FG002|Overall Study|Rifampin susceptible|0|||
147563390|NCT01918397|532220962|FG003|Overall Study|Rifampin susceptible|2|||
147563391|NCT01918397|532220959|FG000|Overall Study|Treatment failure|0|||
147563392|NCT01918397|532220960|FG001|Overall Study|Treatment failure|0|||
147563393|NCT01918397|532220961|FG002|Overall Study|Treatment failure|0|||
147563394|NCT01918397|532220962|FG003|Overall Study|Treatment failure|1|||
147563395|NCT01918397|532220959|FG000|Overall Study|Withdrawal by Subject|3|||
147563396|NCT01918397|532220960|FG001|Overall Study|Withdrawal by Subject|2|||
147563397|NCT01918397|532220961|FG002|Overall Study|Withdrawal by Subject|1|||
147563398|NCT01918397|532220962|FG003|Overall Study|Withdrawal by Subject|1|||
147563399|NCT01918397|532220959|FG000|Overall Study|XDR at baseline|0|||
147563400|NCT01918397|532220960|FG001|Overall Study|XDR at baseline|0|||
147563401|NCT01918397|532220961|FG002|Overall Study|XDR at baseline|1|||
147563402|NCT01918397|532220962|FG003|Overall Study|XDR at baseline|0|||
147563403|NCT01918397|532220959|FG000|Overall Study|Lost to Follow-up|2|||
147563404|NCT01918397|532220960|FG001|Overall Study|Lost to Follow-up|1|||
147563405|NCT01918397|532220961|FG002|Overall Study|Lost to Follow-up|1|||
147563406|NCT01918397|532220962|FG003|Overall Study|Lost to Follow-up|1|||
147563407|NCT01918397|532220959|FG000|Overall Study|Increased QTc|1|||
147563408|NCT01918397|532220960|FG001|Overall Study|Increased QTc|0|||
147563409|NCT01918397|532220961|FG002|Overall Study|Increased QTc|0|||
147563410|NCT01918397|532220962|FG003|Overall Study|Increased QTc|1|||
147563411|NCT01918397|532220959|FG000|Overall Study|Death|0|||
147563412|NCT01918397|532220960|FG001|Overall Study|Death|0|||
147563413|NCT01918397|532220961|FG002|Overall Study|Death|1|||
147563414|NCT01918397|532220962|FG003|Overall Study|Death|0|||
147563415|NCT01918397|532220959|FG000|Overall Study|Involved in another investigative trial|0|||
147563416|NCT01918397|532220960|FG001|Overall Study|Involved in another investigative trial|0|||
147563417|NCT01918397|532220961|FG002|Overall Study|Involved in another investigative trial|0|||
147563418|NCT01918397|532220962|FG003|Overall Study|Involved in another investigative trial|1|||
147563419|NCT00880568|532220963|FG000|Overall Study|Disease progression|3|||
147563420|NCT00880568|532220964|FG001|Overall Study|Disease progression|3|||
147563421|NCT00880568|532220965|FG002|Overall Study|Disease progression|3|||
147563422|NCT00880568|532220966|FG003|Overall Study|Disease progression|1|||
147563423|NCT00880568|532220967|FG004|Overall Study|Disease progression|3|||
147563424|NCT00880568|532220968|FG005|Overall Study|Disease progression|3|||
147563425|NCT00880568|532220969|FG006|Overall Study|Disease progression|5|||
147563426|NCT00880568|532220970|FG007|Overall Study|Disease progression|0|||
147563427|NCT00880568|532220971|FG008|Overall Study|Disease progression|3|||
147563428|NCT00880568|532220963|FG000|Overall Study|Adverse Event|0|||
147563429|NCT00880568|532220964|FG001|Overall Study|Adverse Event|0|||
147563430|NCT00880568|532220965|FG002|Overall Study|Adverse Event|0|||
147563431|NCT00880568|532220966|FG003|Overall Study|Adverse Event|0|||
147563432|NCT00880568|532220967|FG004|Overall Study|Adverse Event|0|||
147563433|NCT00880568|532220968|FG005|Overall Study|Adverse Event|0|||
147563434|NCT00880568|532220969|FG006|Overall Study|Adverse Event|1|||
147563435|NCT00880568|532220970|FG007|Overall Study|Adverse Event|1|||
147563436|NCT00880568|532220971|FG008|Overall Study|Adverse Event|0|||
147563437|NCT00880568|532220963|FG000|Overall Study|Withdrawal by Subject|0|||
147563438|NCT00880568|532220964|FG001|Overall Study|Withdrawal by Subject|0|||
147563439|NCT00880568|532220965|FG002|Overall Study|Withdrawal by Subject|0|||
147563440|NCT00880568|532220966|FG003|Overall Study|Withdrawal by Subject|0|||
147563441|NCT00880568|532220967|FG004|Overall Study|Withdrawal by Subject|0|||
147563442|NCT00880568|532220968|FG005|Overall Study|Withdrawal by Subject|0|||
147563443|NCT00880568|532220969|FG006|Overall Study|Withdrawal by Subject|0|||
147563444|NCT00880568|532220970|FG007|Overall Study|Withdrawal by Subject|1|||
147563445|NCT00880568|532220971|FG008|Overall Study|Withdrawal by Subject|0|||
147563446|NCT00620022|532220972|FG000|Treatment Period 1|Adverse Event|4|||
147563447|NCT00620022|532220973|FG001|Treatment Period 1|Adverse Event|6|||
147563448|NCT00620022|532220972|FG000|Treatment Period 1|Subject withdrew consent|1|||
147563449|NCT00620022|532220973|FG001|Treatment Period 1|Subject withdrew consent|0|||
147563450|NCT00620022|532220972|FG000|Treatment Period 2|Adverse Event|2|||
147563451|NCT00620022|532220973|FG001|Treatment Period 2|Adverse Event|2|||
147563452|NCT00496964|532220980|FG000|Overall Study|Withdrawal by Subject|0|||
147563453|NCT00496964|532220981|FG001|Overall Study|Withdrawal by Subject|1|||
147563454|NCT02017964|532220985|FG000|Overall Study|Patient deemed ineligible|1|||
147563455|NCT00150462|532220989|FG000|Overall Study|Disease Progression or Relapse|3|||
147563456|NCT00150462|532220990|FG001|Overall Study|Disease Progression or Relapse|1|||
147563457|NCT00150462|532220991|FG002|Overall Study|Disease Progression or Relapse|2|||
147563458|NCT00150462|532220992|FG003|Overall Study|Disease Progression or Relapse|1|||
147563459|NCT00150462|532220993|FG004|Overall Study|Disease Progression or Relapse|2|||
147563460|NCT00150462|532220994|FG005|Overall Study|Disease Progression or Relapse|2|||
147563461|NCT00150462|532220995|FG006|Overall Study|Disease Progression or Relapse|3|||
147563462|NCT00150462|532220996|FG007|Overall Study|Disease Progression or Relapse|5|||
147563463|NCT00150462|532220997|FG008|Overall Study|Disease Progression or Relapse|5|||
147563464|NCT00150462|532220998|FG009|Overall Study|Disease Progression or Relapse|3|||
147563465|NCT00150462|532220999|FG010|Overall Study|Disease Progression or Relapse|2|||
147563466|NCT00150462|532220989|FG000|Overall Study|Withdrawal by Subject|0|||
147228336|NCT04795622|531008793|FG000|Overall Study|Other|7|||
147563467|NCT00150462|532220990|FG001|Overall Study|Withdrawal by Subject|1|||
147563468|NCT00150462|532220991|FG002|Overall Study|Withdrawal by Subject|1|||
147563469|NCT00150462|532220992|FG003|Overall Study|Withdrawal by Subject|0|||
147563470|NCT00150462|532220993|FG004|Overall Study|Withdrawal by Subject|1|||
147563471|NCT00150462|532220994|FG005|Overall Study|Withdrawal by Subject|2|||
147563472|NCT00150462|532220995|FG006|Overall Study|Withdrawal by Subject|0|||
147563473|NCT00150462|532220996|FG007|Overall Study|Withdrawal by Subject|1|||
147563474|NCT00150462|532220997|FG008|Overall Study|Withdrawal by Subject|0|||
147563475|NCT00150462|532220998|FG009|Overall Study|Withdrawal by Subject|1|||
147563476|NCT00150462|532220999|FG010|Overall Study|Withdrawal by Subject|0|||
147563477|NCT00150462|532220989|FG000|Overall Study|Death|0|||
147563478|NCT00150462|532220990|FG001|Overall Study|Death|1|||
147563479|NCT00150462|532220991|FG002|Overall Study|Death|0|||
147563480|NCT00150462|532220992|FG003|Overall Study|Death|0|||
147563481|NCT00150462|532220993|FG004|Overall Study|Death|0|||
147563482|NCT00150462|532220994|FG005|Overall Study|Death|0|||
147563483|NCT00150462|532220995|FG006|Overall Study|Death|0|||
147563484|NCT00150462|532220996|FG007|Overall Study|Death|0|||
147563485|NCT00150462|532220997|FG008|Overall Study|Death|1|||
147563486|NCT00150462|532220998|FG009|Overall Study|Death|0|||
147563487|NCT00150462|532220999|FG010|Overall Study|Death|0|||
147563488|NCT00150462|532220989|FG000|Overall Study|Adverse Event|0|||
147563489|NCT00150462|532220990|FG001|Overall Study|Adverse Event|0|||
147563490|NCT00150462|532220991|FG002|Overall Study|Adverse Event|0|||
147563491|NCT00150462|532220992|FG003|Overall Study|Adverse Event|1|||
147563492|NCT00150462|532220993|FG004|Overall Study|Adverse Event|0|||
147563493|NCT00150462|532220994|FG005|Overall Study|Adverse Event|0|||
147563494|NCT00150462|532220995|FG006|Overall Study|Adverse Event|0|||
147228337|NCT04795622|531008794|FG001|Overall Study|Other|8|||
147228338|NCT03309046|531008795|FG000|Overall Study|Withdrawal by Subject|4|||
147228339|NCT03309046|531008796|FG001|Overall Study|Withdrawal by Subject|17|||
147228340|NCT01369615|531008803|FG000|Overall Study|Withdrawal by Subject|0|||
147228341|NCT01369615|531008804|FG001|Overall Study|Withdrawal by Subject|1|||
147228342|NCT01369615|531008803|FG000|Overall Study|Lost to Follow-up|0|||
147228343|NCT01369615|531008804|FG001|Overall Study|Lost to Follow-up|1|||
147228344|NCT04263454|531008805|FG000|Overall Study|Adverse Event|0|||
147228345|NCT04263454|531008806|FG001|Overall Study|Adverse Event|2|||
147228346|NCT04263454|531008805|FG000|Overall Study|Physician Decision|3|||
147228347|NCT04263454|531008806|FG001|Overall Study|Physician Decision|5|||
147228348|NCT04263454|531008805|FG000|Overall Study|Poor Data Quality|0|||
147228349|NCT04263454|531008806|FG001|Overall Study|Poor Data Quality|1|||
147228350|NCT00986479|531008808|FG000|Period 1|Improved mood|1|||
147228351|NCT00986479|531008809|FG001|Period 1|Improved mood|0|||
147228352|NCT00986479|531008808|FG000|Period 1|Administrative reasons|1|||
147228353|NCT00986479|531008809|FG001|Period 1|Administrative reasons|0|||
147228354|NCT01721070|531008810|FG000|Ketoconazole 400 mg and SUF NT 15 mcg|Withdrawal by Subject|1|||
147228355|NCT01090973|531008815|FG000|Overall Study|Disease progression|1|||
147228356|NCT00908011|531008816|FG000|Overall Study|Withdrawal by Subject|2|||
147228357|NCT00908011|531008817|FG001|Overall Study|Withdrawal by Subject|2|||
147228358|NCT00739596|531008822|FG000|Overall Study|Adverse Event|12|||
147228359|NCT00739596|531008823|FG001|Overall Study|Adverse Event|6|||
147228360|NCT00739596|531008822|FG000|Overall Study|Unsatisfactory Therapeutic Effect|4|||
147228361|NCT00739596|531008823|FG001|Overall Study|Unsatisfactory Therapeutic Effect|0|||
147228362|NCT00739596|531008822|FG000|Overall Study|Patient Withdrew Consent|8|||
147228363|NCT00739596|531008823|FG001|Overall Study|Patient Withdrew Consent|8|||
147228364|NCT00739596|531008822|FG000|Overall Study|Lost to Follow-up|0|||
147228365|NCT00739596|531008823|FG001|Overall Study|Lost to Follow-up|2|||
147228366|NCT00739596|531008822|FG000|Overall Study|Protocol Deviation|1|||
147228367|NCT00739596|531008823|FG001|Overall Study|Protocol Deviation|1|||
147228368|NCT02567552|531008827|FG000|Overall Study|Adverse Event|0|||
147228369|NCT02567552|531008828|FG001|Overall Study|Adverse Event|1|||
147228370|NCT02301988|531008829|FG000|Overall Study|Withdrawal by Subject|2|||
147228371|NCT02301988|531008830|FG001|Overall Study|Withdrawal by Subject|1|||
147228372|NCT02301988|531008829|FG000|Overall Study|Physician Decision|2|||
147228373|NCT02301988|531008830|FG001|Overall Study|Physician Decision|2|||
147228374|NCT02301988|531008829|FG000|Overall Study|Unknown Reason|1|||
147228375|NCT02301988|531008830|FG001|Overall Study|Unknown Reason|3|||
147228376|NCT02301988|531008829|FG000|Overall Study|Lack of Efficacy|3|||
147228377|NCT02301988|531008830|FG001|Overall Study|Lack of Efficacy|2|||
147228378|NCT02301988|531008829|FG000|Overall Study|Death|1|||
147228379|NCT02301988|531008830|FG001|Overall Study|Death|0|||
147228380|NCT02301988|531008829|FG000|Overall Study|Adverse Event|1|||
147228381|NCT02301988|531008830|FG001|Overall Study|Adverse Event|1|||
147228382|NCT02891161|531008831|FG000|Study Treatment|Disease Progression|2|||
147228383|NCT02891161|531008832|FG001|Study Treatment|Disease Progression|4|||
147228384|NCT02891161|531008831|FG000|Study Treatment|AE/Side Effects/Complications|1|||
147228385|NCT02891161|531008832|FG001|Study Treatment|AE/Side Effects/Complications|5|||
147228386|NCT02891161|531008831|FG000|Study Treatment|Patient withdrawal After Therapy Start|1|||
147228387|NCT02891161|531008832|FG001|Study Treatment|Patient withdrawal After Therapy Start|4|||
147228388|NCT02891161|531008831|FG000|Follow up|Death|4|||
147228389|NCT02891161|531008832|FG001|Follow up|Death|8|||
147228390|NCT02891161|531008831|FG000|Follow up|Refused to Follow up|0|||
147228391|NCT02891161|531008832|FG001|Follow up|Refused to Follow up|2|||
147228392|NCT02891161|531008831|FG000|Follow up|Symptomatic deterioration|0|||
147228393|NCT02891161|531008832|FG001|Follow up|Symptomatic deterioration|1|||
147563495|NCT00150462|532220996|FG007|Overall Study|Adverse Event|2|||
147563496|NCT00150462|532220997|FG008|Overall Study|Adverse Event|0|||
147563497|NCT00150462|532220998|FG009|Overall Study|Adverse Event|1|||
147563498|NCT00150462|532220999|FG010|Overall Study|Adverse Event|0|||
147563499|NCT00150462|532220989|FG000|Overall Study|Physician Decision|0|||
147563500|NCT00150462|532220990|FG001|Overall Study|Physician Decision|0|||
147563501|NCT00150462|532220991|FG002|Overall Study|Physician Decision|1|||
147563502|NCT00150462|532220992|FG003|Overall Study|Physician Decision|1|||
147563503|NCT00150462|532220993|FG004|Overall Study|Physician Decision|0|||
147563504|NCT00150462|532220994|FG005|Overall Study|Physician Decision|0|||
147563505|NCT00150462|532220995|FG006|Overall Study|Physician Decision|0|||
147563506|NCT00150462|532220996|FG007|Overall Study|Physician Decision|0|||
147563507|NCT00150462|532220997|FG008|Overall Study|Physician Decision|0|||
147563508|NCT00150462|532220998|FG009|Overall Study|Physician Decision|0|||
147563509|NCT00150462|532220999|FG010|Overall Study|Physician Decision|0|||
147563510|NCT00150462|532220989|FG000|Overall Study|Other|0|||
147563511|NCT00150462|532220990|FG001|Overall Study|Other|0|||
147563512|NCT00150462|532220991|FG002|Overall Study|Other|0|||
147563513|NCT00150462|532220992|FG003|Overall Study|Other|0|||
147563514|NCT00150462|532220993|FG004|Overall Study|Other|0|||
147563515|NCT00150462|532220994|FG005|Overall Study|Other|0|||
147563516|NCT00150462|532220995|FG006|Overall Study|Other|0|||
147563517|NCT00150462|532220996|FG007|Overall Study|Other|0|||
147563518|NCT00150462|532220997|FG008|Overall Study|Other|0|||
147563519|NCT00150462|532220998|FG009|Overall Study|Other|1|||
147563520|NCT00150462|532220999|FG010|Overall Study|Other|1|||
147563521|NCT00569374|532221000|FG000|Overall Study|Withdrawal by Subject|4|||
147563522|NCT04638153|532221003|FG000|Overall Study|Withdrawal by parent/guardian|0|||
147563523|NCT04638153|532221004|FG001|Overall Study|Withdrawal by parent/guardian|0|||
147563524|NCT04638153|532221005|FG002|Overall Study|Withdrawal by parent/guardian|1|||
147563525|NCT04638153|532221003|FG000|Overall Study|Study terminated by sponsor|4|||
147563526|NCT04638153|532221004|FG001|Overall Study|Study terminated by sponsor|2|||
147563527|NCT04638153|532221005|FG002|Overall Study|Study terminated by sponsor|14|||
147563528|NCT01440283|532221008|FG000|Overall Study|Death|3|||
147563529|NCT01440283|532221008|FG000|Overall Study|Withdrawal by Subject|4|||
147563530|NCT01440283|532221008|FG000|Overall Study|Physician Decision|3|||
147563531|NCT03099538|532221012|FG000|Overall Study|Lack of Efficacy|3|||
147563532|NCT02015390|532221013|FG000|Overall Study|Lost to Follow-up|1|||
147563533|NCT02015390|532221014|FG001|Overall Study|Lost to Follow-up|0|||
147563534|NCT02015390|532221013|FG000|Overall Study|Adverse Event|0|||
147563535|NCT02015390|532221014|FG001|Overall Study|Adverse Event|3|||
147563536|NCT02015390|532221013|FG000|Overall Study|Physician Decision|0|||
147563537|NCT02015390|532221014|FG001|Overall Study|Physician Decision|1|||
147563538|NCT01661686|532221020|FG000|Overall Study|Lost to Follow-up|2|||
147563539|NCT01661686|532221021|FG001|Overall Study|Lost to Follow-up|1|||
147563540|NCT01661686|532221020|FG000|Overall Study|did not receive allocated intervention|0|||
147563541|NCT01661686|532221021|FG001|Overall Study|did not receive allocated intervention|1|||
147563542|NCT00877032|532221024|FG000|Overall Study|Did not meet entrance criteria|0|||
147563543|NCT00877032|532221025|FG001|Overall Study|Did not meet entrance criteria|0|||
147563544|NCT00877032|532221026|FG002|Overall Study|Did not meet entrance criteria|0|||
147563545|NCT00877032|532221027|FG003|Overall Study|Did not meet entrance criteria|1|||
147563546|NCT00877032|532221028|FG004|Overall Study|Did not meet entrance criteria|0|||
147563547|NCT00877032|532221029|FG005|Overall Study|Did not meet entrance criteria|0|||
147563548|NCT00877032|532221030|FG006|Overall Study|Did not meet entrance criteria|2|||
147563549|NCT03752528|532221031|FG000|Part A|Lost to Follow-up|1|||
147563550|NCT03752528|532221031|FG000|Part A|Protocol Violation|1|||
147563551|NCT03752528|532221031|FG000|Part B|Protocol Violation|1|||
147563552|NCT03752528|532221031|FG000|Part B|Study terminated by sponsor|3|||
147563553|NCT00259012|532221033|FG000|Overall Study|Adverse Event|0|||
147563554|NCT00259012|532221034|FG001|Overall Study|Adverse Event|1|||
147563555|NCT00259012|532221033|FG000|Overall Study|Withdrawal by Subject|1|||
147563556|NCT00259012|532221034|FG001|Overall Study|Withdrawal by Subject|0|||
147563557|NCT00259012|532221033|FG000|Overall Study|Physician Decision|0|||
147563558|NCT00259012|532221034|FG001|Overall Study|Physician Decision|1|||
147563559|NCT00259012|532221033|FG000|Overall Study|Lost to Follow-up|0|||
147563560|NCT00259012|532221034|FG001|Overall Study|Lost to Follow-up|1|||
147563561|NCT00259012|532221033|FG000|Overall Study|Protocol Violation|1|||
147563562|NCT00259012|532221034|FG001|Overall Study|Protocol Violation|1|||
147563563|NCT02781727|532221037|FG000|Pre-dosing Period|Withdrawal by Subject|1|||
147563564|NCT02781727|532221038|FG001|Pre-dosing Period|Withdrawal by Subject|0|||
147563565|NCT02781727|532221037|FG000|Treatment Period|Withdrawal by Subject|1|||
147563566|NCT02781727|532221038|FG001|Treatment Period|Withdrawal by Subject|0|||
147563567|NCT02781727|532221037|FG000|Treatment Period|Lost to Follow-up|0|||
147563568|NCT02781727|532221038|FG001|Treatment Period|Lost to Follow-up|1|||
147563569|NCT01378975|532221040|FG000|Overall Study|Death|77|||
147563570|NCT01378975|532221041|FG001|Overall Study|Death|46|||
147563571|NCT01378975|532221040|FG000|Overall Study|Investigator Request|1|||
147563572|NCT01378975|532221041|FG001|Overall Study|Investigator Request|0|||
147563573|NCT01378975|532221040|FG000|Overall Study|Lost to Follow-up|4|||
147563574|NCT01378975|532221041|FG001|Overall Study|Lost to Follow-up|1|||
147563575|NCT01378975|532221040|FG000|Overall Study|Withdrew Consent|4|||
147563576|NCT01378975|532221041|FG001|Overall Study|Withdrew Consent|3|||
147563577|NCT00694551|532221046|FG000|Overall Study|Disease Progression|1|||
147563578|NCT00694551|532221047|FG001|Overall Study|Disease Progression|0|||
147563579|NCT00694551|532221048|FG002|Overall Study|Disease Progression|1|||
147563580|NCT01937390|532221052|FG000|Overall Study|Death|2|||
147563581|NCT01937390|532221052|FG000|Overall Study|Lost to Follow-up|7|||
147563582|NCT01937390|532221052|FG000|Overall Study|Withdrawal by Subject|5|||
147563583|NCT01937390|532221052|FG000|Overall Study|Fail to return|21|||
147563584|NCT02817841|532222577|FG000|Overall Study|Lost to Follow-up|287|||
147563585|NCT02817841|532222577|FG000|Overall Study|Withdrawal by Subject|183|||
147563586|NCT02817841|532222577|FG000|Overall Study|Adverse event not related to bleeding|131|||
147563587|NCT02817841|532222577|FG000|Overall Study|Adverse event related to bleeding|51|||
147563588|NCT02817841|532222577|FG000|Overall Study|Pregnancy|32|||
147563589|NCT02817841|532222577|FG000|Overall Study|Pregnancy wish|17|||
147563590|NCT02817841|532222577|FG000|Overall Study|Other reasons|53|||
147563591|NCT02817841|532222577|FG000|Overall Study|Protocol Violation|94|||
147563592|NCT00397488|532222580|FG000|Overall Study|Withdrawal by Subject|3|||
147563593|NCT00397488|532222580|FG000|Overall Study|Adverse Event|3|||
147563594|NCT00397488|532222580|FG000|Overall Study|Death|1|||
147563595|NCT02424097|532222581|FG000|Overall Study|Lost to Follow-up|1|||
147563596|NCT02424097|532222582|FG001|Overall Study|Lost to Follow-up|2|||
147563597|NCT01215981|532222585|FG000|Overall Study|Physician Decision|0|||
147563598|NCT01215981|532222586|FG001|Overall Study|Physician Decision|1|||
147563599|NCT01215981|532222585|FG000|Overall Study|Protocol Violation|1|||
147563600|NCT01215981|532222586|FG001|Overall Study|Protocol Violation|0|||
147563601|NCT01215981|532222585|FG000|Overall Study|Withdrawal by Subject|1|||
147563602|NCT01215981|532222586|FG001|Overall Study|Withdrawal by Subject|0|||
147563603|NCT02943447|532222587|FG000|Blinded Study Phase|Withdrew Consent|1|||
147563604|NCT02943447|532222588|FG001|Blinded Study Phase|Withdrew Consent|2|||
147563605|NCT02943447|532222589|FG002|Blinded Study Phase|Withdrew Consent|1|||
147563606|NCT02943447|532222587|FG000|Blinded Study Phase|Adverse Event|3|||
147563607|NCT02943447|532222588|FG001|Blinded Study Phase|Adverse Event|0|||
147563608|NCT02943447|532222589|FG002|Blinded Study Phase|Adverse Event|0|||
147563609|NCT02943447|532222587|FG000|Blinded Study Phase|Investigator's discretion|1|||
147563610|NCT02943447|532222588|FG001|Blinded Study Phase|Investigator's discretion|0|||
147563611|NCT02943447|532222589|FG002|Blinded Study Phase|Investigator's discretion|0|||
147563612|NCT02943447|532222587|FG000|Open-Label Extension Phase|Study terminated by sponsor|10|||
147563613|NCT02943447|532222588|FG001|Open-Label Extension Phase|Study terminated by sponsor|12|||
147563614|NCT02943447|532222589|FG002|Open-Label Extension Phase|Study terminated by sponsor|6|||
147563615|NCT02943447|532222587|FG000|Open-Label Extension Phase|Adverse Event|4|||
147563616|NCT02943447|532222588|FG001|Open-Label Extension Phase|Adverse Event|7|||
147563617|NCT02943447|532222589|FG002|Open-Label Extension Phase|Adverse Event|3|||
147563618|NCT02943447|532222587|FG000|Open-Label Extension Phase|Lack of Efficacy|3|||
147563619|NCT02943447|532222588|FG001|Open-Label Extension Phase|Lack of Efficacy|4|||
147563620|NCT02943447|532222589|FG002|Open-Label Extension Phase|Lack of Efficacy|0|||
147563621|NCT02943447|532222587|FG000|Open-Label Extension Phase|Withdrew consent|1|||
147563622|NCT02943447|532222588|FG001|Open-Label Extension Phase|Withdrew consent|1|||
147563623|NCT02943447|532222589|FG002|Open-Label Extension Phase|Withdrew consent|1|||
147563624|NCT02943447|532222587|FG000|Open-Label Extension Phase|Lost to Follow-up|0|||
147563625|NCT02943447|532222588|FG001|Open-Label Extension Phase|Lost to Follow-up|1|||
147563626|NCT02943447|532222589|FG002|Open-Label Extension Phase|Lost to Follow-up|0|||
147563627|NCT00840632|532222591|FG000|First Intervention|Withdrawal by Subject|0|||
147563628|NCT00840632|532222592|FG001|First Intervention|Withdrawal by Subject|1|||
147563629|NCT00840632|532222591|FG000|Washout|Withdrawal by Subject|1|||
147563630|NCT00840632|532222592|FG001|Washout|Withdrawal by Subject|1|||
147563631|NCT01136382|532222595|FG000|Overall Study|Other|8|||
147563632|NCT01136382|532222596|FG001|Overall Study|Other|3|||
147563633|NCT01136382|532222595|FG000|Overall Study|Study-Specific Withdrawal Criteria|48|||
147563634|NCT01136382|532222596|FG001|Overall Study|Study-Specific Withdrawal Criteria|25|||
147563635|NCT01136382|532222595|FG000|Overall Study|Severe Non-Compliance to Protocol|0|||
147563636|NCT01136382|532222596|FG001|Overall Study|Severe Non-Compliance to Protocol|2|||
147563637|NCT01136382|532222595|FG000|Overall Study|Withdrawal by Subject|4|||
147563638|NCT01136382|532222596|FG001|Overall Study|Withdrawal by Subject|1|||
147563639|NCT01725529|532222602|FG000|Overall Study|Adverse Event|1|||
147563640|NCT01725529|532222603|FG001|Overall Study|Adverse Event|0|||
147563641|NCT01725529|532222604|FG002|Overall Study|Adverse Event|0|||
147563642|NCT01725529|532222602|FG000|Overall Study|Lost to Follow-up|2|||
147563643|NCT01725529|532222603|FG001|Overall Study|Lost to Follow-up|1|||
147563644|NCT01725529|532222604|FG002|Overall Study|Lost to Follow-up|1|||
147563645|NCT01725529|532222602|FG000|Overall Study|Protocol Violation|0|||
147563646|NCT01725529|532222603|FG001|Overall Study|Protocol Violation|1|||
147563647|NCT01725529|532222604|FG002|Overall Study|Protocol Violation|1|||
147563648|NCT01725529|532222602|FG000|Overall Study|Withdrawal by Subject|12|||
147563649|NCT01725529|532222603|FG001|Overall Study|Withdrawal by Subject|14|||
147563650|NCT01725529|532222604|FG002|Overall Study|Withdrawal by Subject|8|||
147563651|NCT02653664|532222610|FG000|Post-Treatment|Withdrawal by Subject|6|||
147563652|NCT02653664|532222611|FG001|Post-Treatment|Withdrawal by Subject|5|||
147563653|NCT02653664|532222612|FG002|Post-Treatment|Withdrawal by Subject|7|||
147563654|NCT02653664|532222610|FG000|Post-Treatment|Lost to Follow-up|8|||
147563655|NCT02653664|532222611|FG001|Post-Treatment|Lost to Follow-up|1|||
147563656|NCT02653664|532222612|FG002|Post-Treatment|Lost to Follow-up|7|||
147563657|NCT02653664|532222610|FG000|3 Month Follow-Up|Withdrawal by Subject|9|||
147563658|NCT02653664|532222611|FG001|3 Month Follow-Up|Withdrawal by Subject|5|||
147563659|NCT02653664|532222612|FG002|3 Month Follow-Up|Withdrawal by Subject|9|||
147563660|NCT02653664|532222610|FG000|3 Month Follow-Up|Lost to Follow-up|9|||
147563661|NCT02653664|532222611|FG001|3 Month Follow-Up|Lost to Follow-up|8|||
147563662|NCT02653664|532222612|FG002|3 Month Follow-Up|Lost to Follow-up|16|||
147563663|NCT02653664|532222610|FG000|3 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|0|||
147563664|NCT02653664|532222611|FG001|3 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|2|||
147563665|NCT02653664|532222612|FG002|3 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|0|||
147563666|NCT02653664|532222610|FG000|3 Month Follow-Up|Subject Declined Assessment Period, Remained Enrolled in Trial|3|||
147563667|NCT02653664|532222611|FG001|3 Month Follow-Up|Subject Declined Assessment Period, Remained Enrolled in Trial|0|||
147563668|NCT02653664|532222612|FG002|3 Month Follow-Up|Subject Declined Assessment Period, Remained Enrolled in Trial|0|||
147563669|NCT02653664|532222610|FG000|6 Month Follow-Up|Withdrawal by Subject|13|||
147563670|NCT02653664|532222611|FG001|6 Month Follow-Up|Withdrawal by Subject|7|||
147563671|NCT02653664|532222612|FG002|6 Month Follow-Up|Withdrawal by Subject|14|||
147563672|NCT02653664|532222610|FG000|6 Month Follow-Up|Lost to Follow-up|10|||
147563673|NCT02653664|532222611|FG001|6 Month Follow-Up|Lost to Follow-up|11|||
147563674|NCT02653664|532222612|FG002|6 Month Follow-Up|Lost to Follow-up|9|||
147563675|NCT02653664|532222610|FG000|6 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|0|||
147563676|NCT02653664|532222611|FG001|6 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|2|||
147563677|NCT02653664|532222612|FG002|6 Month Follow-Up|Investigator Withdrawn, Behavioral Issues|0|||
147563678|NCT02653664|532222610|FG000|6 Month Follow-Up|Subject Declined Assessment Period|0|||
147563679|NCT02653664|532222611|FG001|6 Month Follow-Up|Subject Declined Assessment Period|1|||
147563680|NCT02653664|532222612|FG002|6 Month Follow-Up|Subject Declined Assessment Period|0|||
147563681|NCT04657770|532222613|FG000|Overall Study|Withdrawal by Subject|3|||
147563682|NCT04657770|532222613|FG000|Overall Study|Completed training but withdrew before follow-up testing due to change in medical status|1|||
147563683|NCT00746798|532222614|FG000|Overall Study|Protocol Violation|0|||
147563684|NCT00746798|532222615|FG001|Overall Study|Protocol Violation|1|||
147563685|NCT00746798|532222616|FG002|Overall Study|Protocol Violation|0|||
147563686|NCT00746798|532222617|FG003|Overall Study|Protocol Violation|0|||
147563687|NCT00746798|532222614|FG000|Overall Study|Withdrawal by Subject|0|||
147563688|NCT00746798|532222615|FG001|Overall Study|Withdrawal by Subject|1|||
147563689|NCT00746798|532222616|FG002|Overall Study|Withdrawal by Subject|1|||
147563690|NCT00746798|532222617|FG003|Overall Study|Withdrawal by Subject|0|||
147228394|NCT02891161|531008831|FG000|Follow up|Study terminated|0|||
147228395|NCT02891161|531008832|FG001|Follow up|Study terminated|6|||
147228396|NCT01074047|531008839|FG000|Treatment Phase|Adverse Event|89|||
147228397|NCT01074047|531008840|FG001|Treatment Phase|Adverse Event|66|||
147228398|NCT01074047|531008839|FG000|Treatment Phase|Disease Progression|16|||
147228399|NCT01074047|531008840|FG001|Treatment Phase|Disease Progression|21|||
147563691|NCT00746798|532222614|FG000|Overall Study|Death|0|||
147563692|NCT00746798|532222615|FG001|Overall Study|Death|0|||
147563693|NCT00746798|532222616|FG002|Overall Study|Death|2|||
147563694|NCT00746798|532222617|FG003|Overall Study|Death|0|||
147563695|NCT00746798|532222614|FG000|Overall Study|Participant unable to return for visit|1|||
147228400|NCT01074047|531008839|FG000|Treatment Phase|Withdrawal by Subject|27|||
147228401|NCT01074047|531008840|FG001|Treatment Phase|Withdrawal by Subject|48|||
147228402|NCT01074047|531008839|FG000|Treatment Phase|Death|53|||
147228403|NCT01074047|531008840|FG001|Treatment Phase|Death|58|||
147228404|NCT01074047|531008839|FG000|Treatment Phase|Lost to Follow-up|0|||
147228405|NCT01074047|531008840|FG001|Treatment Phase|Lost to Follow-up|1|||
147228406|NCT01074047|531008839|FG000|Treatment Phase|Protocol Violation|0|||
147228407|NCT01074047|531008840|FG001|Treatment Phase|Protocol Violation|1|||
147228408|NCT01074047|531008839|FG000|Treatment Phase|Miscellaneous|32|||
147228409|NCT01074047|531008840|FG001|Treatment Phase|Miscellaneous|39|||
147228410|NCT01074047|531008839|FG000|Survival Follow-Up Phase|Withdrawal by Subject|5|||
147563696|NCT00746798|532222615|FG001|Overall Study|Participant unable to return for visit|0|||
147563697|NCT00746798|532222616|FG002|Overall Study|Participant unable to return for visit|0|||
147563698|NCT00746798|532222617|FG003|Overall Study|Participant unable to return for visit|0|||
147114026|NCT05073315|530579983|FG000|Period 1 (Lead-in Period)|Lost to Follow-up|3|||
147228411|NCT01074047|531008840|FG001|Survival Follow-Up Phase|Withdrawal by Subject|8|||
147228412|NCT01074047|531008839|FG000|Survival Follow-Up Phase|Lost to Follow-up|2|||
147228413|NCT01074047|531008840|FG001|Survival Follow-Up Phase|Lost to Follow-up|1|||
147563699|NCT00633594|532222620|FG000|Overall Study|Adverse Event|0|||
147563700|NCT00633594|532222621|FG001|Overall Study|Adverse Event|4|||
147563701|NCT00633594|532222622|FG002|Overall Study|Adverse Event|7|||
147563702|NCT00633594|532222620|FG000|Overall Study|Death|0|||
147563703|NCT00633594|532222621|FG001|Overall Study|Death|1|||
147563704|NCT00633594|532222622|FG002|Overall Study|Death|2|||
147563705|NCT00633594|532222620|FG000|Overall Study|Disease Progression|0|||
147563706|NCT00633594|532222621|FG001|Overall Study|Disease Progression|0|||
147563707|NCT00633594|532222622|FG002|Overall Study|Disease Progression|1|||
147563708|NCT00727571|532222624|FG000|Overall Study|Ineligibility determined|1|||
147563709|NCT00727571|532222625|FG001|Overall Study|Ineligibility determined|1|||
147563710|NCT00727571|532222626|FG002|Overall Study|Ineligibility determined|1|||
147563711|NCT00727571|532222627|FG003|Overall Study|Ineligibility determined|0|||
147563712|NCT00727571|532222624|FG000|Overall Study|Death|0|||
147563713|NCT00727571|532222625|FG001|Overall Study|Death|19|||
147563714|NCT00727571|532222626|FG002|Overall Study|Death|5|||
147563715|NCT00727571|532222627|FG003|Overall Study|Death|1|||
147563716|NCT00727571|532222624|FG000|Overall Study|Physician Decision|0|||
147563717|NCT00727571|532222625|FG001|Overall Study|Physician Decision|5|||
147563718|NCT00727571|532222626|FG002|Overall Study|Physician Decision|0|||
147228414|NCT01074047|531008839|FG000|Survival Follow-Up Phase|Death|116|||
147228415|NCT01074047|531008840|FG001|Survival Follow-Up Phase|Death|124|||
147228416|NCT01074047|531008839|FG000|Survival Follow-Up Phase|Alive at study closure|1|||
147228417|NCT01074047|531008840|FG001|Survival Follow-Up Phase|Alive at study closure|3|||
147228418|NCT01074047|531008839|FG000|Extension Phase|Physician Decision|1|||
147228419|NCT01074047|531008840|FG001|Extension Phase|Physician Decision|0|||
147228420|NCT01074047|531008839|FG000|Extension Phase|Adverse Event|5|||
147228421|NCT01074047|531008840|FG001|Extension Phase|Adverse Event|0|||
147228422|NCT01074047|531008839|FG000|Extension Phase|Disease Progression|9|||
147228423|NCT01074047|531008840|FG001|Extension Phase|Disease Progression|0|||
147228424|NCT01074047|531008839|FG000|Extension Phase|Withdrawal by Subject|2|||
147228425|NCT01074047|531008840|FG001|Extension Phase|Withdrawal by Subject|0|||
147228426|NCT01074047|531008839|FG000|Extension Phase|Death|5|||
147228427|NCT01074047|531008840|FG001|Extension Phase|Death|0|||
147228428|NCT04669535|531008841|FG000|Overall Study|Death|1|||
147228429|NCT04669535|531008842|FG001|Overall Study|Death|1|||
147228430|NCT04669535|531008843|FG002|Overall Study|Death|0|||
147228431|NCT04669535|531008844|FG003|Overall Study|Death|0|||
147228432|NCT05169567|531008846|FG000|Overall Study|On study treatment|116|||
147228433|NCT05169567|531008847|FG001|Overall Study|On study treatment|128|||
147228434|NCT05169567|531008846|FG000|Overall Study|Lost to Follow-up|1|||
147228435|NCT05169567|531008847|FG001|Overall Study|Lost to Follow-up|0|||
147228436|NCT05169567|531008846|FG000|Overall Study|Withdrawal by Subject|25|||
147228437|NCT05169567|531008847|FG001|Overall Study|Withdrawal by Subject|21|||
147228438|NCT05419908|531008850|FG000|Overall Study|Participant Did not Fulfill all Inclusion/Exclusion Criteria|1|||
147228439|NCT05419908|531008851|FG001|Overall Study|Participant Did not Fulfill all Inclusion/Exclusion Criteria|0|||
147228440|NCT05419908|531008850|FG000|Overall Study|Serious Adverse Event|0|||
147228441|NCT05419908|531008851|FG001|Overall Study|Serious Adverse Event|2|||
147228442|NCT05419908|531008850|FG000|Overall Study|Withdrawal by Subject|2|||
147228443|NCT05419908|531008851|FG001|Overall Study|Withdrawal by Subject|0|||
147228444|NCT05419908|531008850|FG000|Overall Study|Miscellaneous|1|||
147228445|NCT05419908|531008851|FG001|Overall Study|Miscellaneous|1|||
147228446|NCT05069259|531008855|FG000|Overall Study|Withdrawal by Subject|1|||
147228447|NCT05069259|531008855|FG000|Overall Study|Sponsor decision|1|||
147228448|NCT01828320|531008857|FG000|Overall Study|Lost to Follow-up|1|||
147228449|NCT01828320|531008858|FG001|Overall Study|Lost to Follow-up|3|||
147228450|NCT01828320|531008857|FG000|Overall Study|Withdrawal by Subject|7|||
147228451|NCT01828320|531008858|FG001|Overall Study|Withdrawal by Subject|2|||
147228452|NCT02160782|531010403|FG000|Open-label Period: Maralixibat|Adverse Event|2|||
147228453|NCT02160782|531010404|FG001|Open-label Period: Maralixibat|Adverse Event|0|||
147228454|NCT02160782|531010405|FG002|Open-label Period: Maralixibat|Adverse Event|0|||
147228455|NCT02160782|531010406|FG003|Open-label Period: Maralixibat|Adverse Event|0|||
147228456|NCT02160782|531010407|FG004|Open-label Period: Maralixibat|Adverse Event|0|||
147228457|NCT02160782|531010403|FG000|After Randomized Withdrawal: Maralixibat|Adverse Event|0|||
147228458|NCT02160782|531010404|FG001|After Randomized Withdrawal: Maralixibat|Adverse Event|0|||
147228459|NCT02160782|531010405|FG002|After Randomized Withdrawal: Maralixibat|Adverse Event|0|||
147228460|NCT02160782|531010406|FG003|After Randomized Withdrawal: Maralixibat|Adverse Event|1|||
147228461|NCT02160782|531010407|FG004|After Randomized Withdrawal: Maralixibat|Adverse Event|0|||
147228462|NCT02160782|531010403|FG000|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|0|||
147228463|NCT02160782|531010404|FG001|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|0|||
147228464|NCT02160782|531010405|FG002|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|0|||
147228465|NCT02160782|531010406|FG003|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|5|||
147228466|NCT02160782|531010407|FG004|After Randomized Withdrawal: Maralixibat|Did not consent to protocol amendment for long term extension|0|||
147228467|NCT02160782|531010403|FG000|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|0|||
147563719|NCT00727571|532222627|FG003|Overall Study|Physician Decision|0|||
147563720|NCT00727571|532222624|FG000|Overall Study|Withdrawal by Subject|0|||
147563721|NCT00727571|532222625|FG001|Overall Study|Withdrawal by Subject|10|||
147563722|NCT00727571|532222626|FG002|Overall Study|Withdrawal by Subject|11|||
147563723|NCT00727571|532222627|FG003|Overall Study|Withdrawal by Subject|0|||
147563724|NCT00727571|532222624|FG000|Overall Study|Subject Non Compliance|0|||
147563725|NCT00727571|532222625|FG001|Overall Study|Subject Non Compliance|6|||
147563726|NCT00727571|532222626|FG002|Overall Study|Subject Non Compliance|0|||
147563727|NCT00727571|532222627|FG003|Overall Study|Subject Non Compliance|4|||
147563728|NCT00727571|532222624|FG000|Overall Study|Dismissed from nursing home|0|||
147563729|NCT00727571|532222625|FG001|Overall Study|Dismissed from nursing home|9|||
147563730|NCT00727571|532222626|FG002|Overall Study|Dismissed from nursing home|5|||
147563731|NCT00727571|532222627|FG003|Overall Study|Dismissed from nursing home|0|||
147563732|NCT00727571|532222624|FG000|Overall Study|Hospitalization|0|||
147563733|NCT00727571|532222625|FG001|Overall Study|Hospitalization|1|||
147563734|NCT00727571|532222626|FG002|Overall Study|Hospitalization|0|||
147563735|NCT00727571|532222627|FG003|Overall Study|Hospitalization|1|||
147563736|NCT00727571|532222624|FG000|Overall Study|AE not leading to hospitalization|0|||
147563737|NCT00727571|532222625|FG001|Overall Study|AE not leading to hospitalization|0|||
147563738|NCT00727571|532222626|FG002|Overall Study|AE not leading to hospitalization|2|||
147563739|NCT00727571|532222627|FG003|Overall Study|AE not leading to hospitalization|0|||
147563740|NCT00727571|532222624|FG000|Overall Study|Other|0|||
147563741|NCT00727571|532222625|FG001|Overall Study|Other|4|||
147563742|NCT00727571|532222626|FG002|Overall Study|Other|6|||
147563743|NCT00727571|532222627|FG003|Overall Study|Other|0|||
147563744|NCT01287013|532222628|FG000|Overall Study|Non-evaluable|3|||
147563745|NCT01287013|532222629|FG001|Overall Study|Non-evaluable|5|||
147563746|NCT01287013|532222630|FG002|Overall Study|Non-evaluable|21|||
147563747|NCT01900730|532222631|FG000|Overall Study|Withdrawal by Subject|1|||
147563748|NCT01900730|532222632|FG001|Overall Study|Withdrawal by Subject|0|||
147563749|NCT01900730|532222631|FG000|Overall Study|Screen Failure|1|||
147563750|NCT01900730|532222632|FG001|Overall Study|Screen Failure|0|||
147563751|NCT01179048|532222633|FG000|Overall Study|Withdrawn - does not allow contact|4|||
147563752|NCT01179048|532222634|FG001|Overall Study|Withdrawn - does not allow contact|8|||
147563753|NCT01179048|532222633|FG000|Overall Study|Lost to Follow-up|8|||
147563754|NCT01179048|532222634|FG001|Overall Study|Lost to Follow-up|9|||
147563755|NCT01179048|532222633|FG000|Overall Study|Alive|127|||
147563756|NCT01179048|532222634|FG001|Overall Study|Alive|142|||
147563757|NCT02109042|532222635|FG000|Overall Study|Sponsor Decision|15|||
147563758|NCT03203447|532222640|FG000|Overall Study|Withdrawal by Subject|2|||
147563759|NCT03203447|532222641|FG001|Overall Study|Withdrawal by Subject|1|||
147563760|NCT03203447|532222640|FG000|Overall Study|Lost to Follow-up|1|||
147563761|NCT03203447|532222641|FG001|Overall Study|Lost to Follow-up|10|||
147563762|NCT03203447|532222640|FG000|Overall Study|Includes premature discontinuation due to study termination and unknown|159|||
147563763|NCT03203447|532222641|FG001|Overall Study|Includes premature discontinuation due to study termination and unknown|152|||
147563764|NCT00324168|532222642|FG000|Overall Study|Lost to Follow-up|19|||
147563765|NCT00324168|532222643|FG001|Overall Study|Lost to Follow-up|18|||
147563766|NCT00324168|532222642|FG000|Overall Study|Death|3|||
147563767|NCT00324168|532222643|FG001|Overall Study|Death|3|||
147563768|NCT00324168|532222642|FG000|Overall Study|Patient did not visit in f/u window|6|||
147563769|NCT00324168|532222643|FG001|Overall Study|Patient did not visit in f/u window|9|||
147563770|NCT01203878|532222644|FG000|Overall Study|Withdrawal by Subject|0|||
147563771|NCT01203878|532222645|FG001|Overall Study|Withdrawal by Subject|0|||
147563772|NCT01203878|532222646|FG002|Overall Study|Withdrawal by Subject|1|||
147563773|NCT01203878|532222644|FG000|Overall Study|Adverse Event|0|||
147563774|NCT01203878|532222645|FG001|Overall Study|Adverse Event|0|||
147563775|NCT01203878|532222646|FG002|Overall Study|Adverse Event|2|||
147563776|NCT01471093|532222647|FG000|Overall Study|Adverse Event|1|||
147563777|NCT01471093|532222648|FG001|Overall Study|Adverse Event|0|||
147563778|NCT01471093|532222649|FG002|Overall Study|Adverse Event|0|||
147563779|NCT01471093|532222650|FG003|Overall Study|Adverse Event|0|||
147563780|NCT02475954|532222651|FG000|Overall Study|Withdrawal by Subject|2|||
147563781|NCT02475954|532222652|FG001|Overall Study|Withdrawal by Subject|2|||
147563782|NCT02475954|532222651|FG000|Overall Study|Lost to Follow-up|11|||
147563783|NCT02475954|532222652|FG001|Overall Study|Lost to Follow-up|9|||
147563784|NCT02475954|532222651|FG000|Overall Study|Death|1|||
147563785|NCT02475954|532222652|FG001|Overall Study|Death|1|||
147563786|NCT00358449|532222656|FG000|Overall Study|Adverse Event|1|||
147563787|NCT00358449|532222657|FG001|Overall Study|Adverse Event|0|||
147563788|NCT00358449|532222658|FG002|Overall Study|Adverse Event|1|||
147563789|NCT00358449|532222656|FG000|Overall Study|Lost to Follow-up|1|||
147563790|NCT00358449|532222657|FG001|Overall Study|Lost to Follow-up|0|||
147563791|NCT00358449|532222658|FG002|Overall Study|Lost to Follow-up|0|||
147563792|NCT00358449|532222656|FG000|Overall Study|Withdrawal by Subject|2|||
147563793|NCT00358449|532222657|FG001|Overall Study|Withdrawal by Subject|0|||
147563794|NCT00358449|532222658|FG002|Overall Study|Withdrawal by Subject|0|||
147563795|NCT00358449|532222656|FG000|Overall Study|Lack of Efficacy|0|||
147563796|NCT00358449|532222657|FG001|Overall Study|Lack of Efficacy|1|||
147563797|NCT00358449|532222658|FG002|Overall Study|Lack of Efficacy|0|||
147563798|NCT00358449|532222656|FG000|Overall Study|Steriod Inhaler was Increased|0|||
147563799|NCT00358449|532222657|FG001|Overall Study|Steriod Inhaler was Increased|0|||
147563800|NCT00358449|532222658|FG002|Overall Study|Steriod Inhaler was Increased|1|||
147563801|NCT01804270|532222659|FG000|Overall Study|Withdrawal by Subject|1|||
147563802|NCT01804270|532222660|FG001|Overall Study|Withdrawal by Subject|1|||
147563803|NCT04407806|532222665|FG000|Overall Study|Withdrawal by Subject|1|||
147563804|NCT04407806|532222666|FG001|Overall Study|Withdrawal by Subject|2|||
147563805|NCT03478397|532222669|FG000|Overall Study|Refused to participate|31|||
147563806|NCT03478397|532222670|FG001|Overall Study|Refused to participate|7|||
147563807|NCT05327491|532222671|FG000|Periods 1 & 2|Miscellaneous|0|||
147563808|NCT05327491|532222672|FG001|Periods 1 & 2|Miscellaneous|1|||
147563809|NCT05327491|532222673|FG002|Periods 1 & 2|Miscellaneous|0|||
147563810|NCT05327491|532222674|FG003|Periods 1 & 2|Miscellaneous|0|||
147563811|NCT05327491|532222671|FG000|Periods 1 & 2|Withdrawal by Subject|1|||
147563812|NCT05327491|532222672|FG001|Periods 1 & 2|Withdrawal by Subject|0|||
147563813|NCT05327491|532222673|FG002|Periods 1 & 2|Withdrawal by Subject|0|||
147563814|NCT05327491|532222674|FG003|Periods 1 & 2|Withdrawal by Subject|0|||
147563815|NCT04869787|532222675|FG000|Screening|Physician Decision|1|||
147563816|NCT04869787|532222675|FG000|SCD Treatment Period (up to 10 Days)|Death|1|||
147563817|NCT00813293|532222676|FG000|Overall Study|Intercurrent illness|1|||
147563818|NCT00813293|532222677|FG001|Overall Study|Intercurrent illness|0|||
147563819|NCT00813293|532222676|FG000|Overall Study|Adverse Event|0|||
147563820|NCT00813293|532222677|FG001|Overall Study|Adverse Event|1|||
147563821|NCT00533273|532222678|FG000|Double-blind|Withdrew consent|0|||
147563822|NCT00533273|532222679|FG001|Double-blind|Withdrew consent|2|||
147563823|NCT00533273|532222678|FG000|Open-label|Withdrawal by Subject|6|||
147563824|NCT00533273|532222679|FG001|Open-label|Withdrawal by Subject|0|||
147563825|NCT02794974|532222680|FG000|Overall Study|Physician Decision|0|||
147563826|NCT02794974|532222681|FG001|Overall Study|Physician Decision|1|||
147563827|NCT01873586|532222683|FG000|Overall Study|Lost to Follow-up|3|||
147563828|NCT02202850|532222684|FG000|Overall Study|Other|2|||
147563829|NCT02202850|532222685|FG001|Overall Study|Other|2|||
147563830|NCT02202850|532222684|FG000|Overall Study|Enbrel treatment discontinued|15|||
147563831|NCT02202850|532222685|FG001|Overall Study|Enbrel treatment discontinued|3|||
147563832|NCT02202850|532222684|FG000|Overall Study|Lost to Follow-up|7|||
147563833|NCT02202850|532222685|FG001|Overall Study|Lost to Follow-up|1|||
147563834|NCT00615069|532222686|FG000|Overall Study|Death|10|||
147228468|NCT02160782|531010404|FG001|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|0|||
147228469|NCT02160782|531010405|FG002|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|0|||
147228470|NCT02160782|531010406|FG003|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|0|||
147228471|NCT02160782|531010407|FG004|Long-term Extension Period: Maralixibat|Did not consent to protocol amendment|4|||
147228472|NCT02160782|531010403|FG000|Long-term Extension Period: Maralixibat|Physician Decision|0|||
147228473|NCT02160782|531010404|FG001|Long-term Extension Period: Maralixibat|Physician Decision|0|||
147228474|NCT02160782|531010405|FG002|Long-term Extension Period: Maralixibat|Physician Decision|0|||
147228475|NCT02160782|531010406|FG003|Long-term Extension Period: Maralixibat|Physician Decision|0|||
147228476|NCT02160782|531010407|FG004|Long-term Extension Period: Maralixibat|Physician Decision|1|||
147228477|NCT02160782|531010403|FG000|Long-term Extension Period: Maralixibat|Adverse Event|0|||
147228478|NCT02160782|531010404|FG001|Long-term Extension Period: Maralixibat|Adverse Event|0|||
147228479|NCT02160782|531010405|FG002|Long-term Extension Period: Maralixibat|Adverse Event|0|||
147228480|NCT02160782|531010406|FG003|Long-term Extension Period: Maralixibat|Adverse Event|0|||
147228481|NCT02160782|531010407|FG004|Long-term Extension Period: Maralixibat|Adverse Event|3|||
147228482|NCT02160782|531010403|FG000|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|0|||
147228483|NCT02160782|531010404|FG001|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|0|||
147228484|NCT02160782|531010405|FG002|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|0|||
147228485|NCT02160782|531010406|FG003|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|0|||
147228486|NCT02160782|531010407|FG004|Long-term Extension Period: Maralixibat|Withdrawal by caregiver|1|||
147228487|NCT00891462|531010410|FG000|Overall Study|Withdrawal by Subject|9|||
147228488|NCT00891462|531010411|FG001|Overall Study|Withdrawal by Subject|6|||
147228489|NCT00891462|531010412|FG002|Overall Study|Withdrawal by Subject|7|||
147228490|NCT00891462|531010410|FG000|Overall Study|Adverse Event|7|||
147228491|NCT00891462|531010411|FG001|Overall Study|Adverse Event|8|||
147228492|NCT00891462|531010412|FG002|Overall Study|Adverse Event|7|||
147563835|NCT00615069|532222686|FG000|Overall Study|Physician Decision|2|||
147563836|NCT00615069|532222686|FG000|Overall Study|Withdrawal by Subject|4|||
147563837|NCT00454909|532222687|FG000|Overall Study|Withdrawal by Subject|1|||
147563838|NCT00454909|532222688|FG001|Overall Study|Withdrawal by Subject|0|||
147563839|NCT00454909|532222689|FG002|Overall Study|Withdrawal by Subject|0|||
147563840|NCT00454909|532222687|FG000|Overall Study|Migrated/moved from study area|0|||
147563841|NCT00454909|532222688|FG001|Overall Study|Migrated/moved from study area|0|||
147563842|NCT00454909|532222689|FG002|Overall Study|Migrated/moved from study area|1|||
147563843|NCT00454909|532222687|FG000|Overall Study|Lost to follow-up (complete vaccination)|5|||
147563844|NCT00454909|532222688|FG001|Overall Study|Lost to follow-up (complete vaccination)|3|||
147563845|NCT00454909|532222689|FG002|Overall Study|Lost to follow-up (complete vaccination)|1|||
147563846|NCT00454909|532222687|FG000|Overall Study|Others|1|||
147563847|NCT00454909|532222688|FG001|Overall Study|Others|0|||
147563848|NCT00454909|532222689|FG002|Overall Study|Others|0|||
147563849|NCT02996682|532222690|FG000|Overall Study|Death|0|||
147563850|NCT02996682|532222691|FG001|Overall Study|Death|3|||
147563851|NCT01981720|532222692|FG000|Overall Study|Adverse Event|1|||
147563852|NCT01981720|532222692|FG000|Overall Study|Withdrawal by Subject|3|||
147563853|NCT01981720|532222692|FG000|Overall Study|Pregnancy|1|||
147563854|NCT00282048|532222693|FG000|Overall Study|Lack of Efficacy|30|||
147563855|NCT00282048|532222693|FG000|Overall Study|Adverse Event|22|||
147563856|NCT00282048|532222693|FG000|Overall Study|Withdrawal by Subject|1|||
147563857|NCT00282048|532222693|FG000|Overall Study|Other|8|||
147563858|NCT00282048|532222693|FG000|Overall Study|Ongoing|1|||
147563859|NCT03048500|532222697|FG000|2 Cycles of Treatment|Withdrawal by Subject|1|||
147563860|NCT03048500|532222697|FG000|Reached 1st Response/Continued Treatment|Progressive Disease|4|||
147563861|NCT03048500|532222697|FG000|Reached 1st Response/Continued Treatment|Death|1|||
147563862|NCT03048500|532222697|FG000|Reached 1st Response/Continued Treatment|Withdrawal by Subject|1|||
147563863|NCT03048500|532222697|FG000|Reached 1st Response/Continued Treatment|Physician decision, Patient PS declining|1|||
147563864|NCT03048500|532222697|FG000|Follow up for 3 Years|Currently in Follow-up|4|||
147563865|NCT03048500|532222697|FG000|Follow up for 3 Years|Death|12|||
147563866|NCT01941030|532222698|FG000|Overall Study|Death|3|||
147563867|NCT01941030|532222699|FG001|Overall Study|Death|2|||
147563868|NCT01941030|532222698|FG000|Overall Study|Lost to Follow-up|6|||
147563869|NCT01941030|532222699|FG001|Overall Study|Lost to Follow-up|5|||
147563870|NCT01941030|532222698|FG000|Overall Study|Withdrawal by Subject|4|||
147563871|NCT01941030|532222699|FG001|Overall Study|Withdrawal by Subject|6|||
147563872|NCT00870870|532222702|FG000|Overall Study|Withdrawal by Subject|0|||
147563873|NCT00870870|532222703|FG001|Overall Study|Withdrawal by Subject|1|||
147563874|NCT00870870|532222704|FG002|Overall Study|Withdrawal by Subject|1|||
147563875|NCT00870870|532222705|FG003|Overall Study|Withdrawal by Subject|3|||
147563876|NCT00870870|532222702|FG000|Overall Study|Adverse Event|0|||
147563877|NCT00870870|532222703|FG001|Overall Study|Adverse Event|0|||
147563878|NCT00870870|532222704|FG002|Overall Study|Adverse Event|2|||
147563879|NCT00870870|532222705|FG003|Overall Study|Adverse Event|2|||
147563880|NCT03639311|532222710|FG000|Maintenance Phase|Lost to Follow-up|1|||
147563881|NCT03639311|532222711|FG001|Maintenance Phase|Lost to Follow-up|0|||
147563882|NCT03639311|532222712|FG002|Maintenance Phase|Lost to Follow-up|0|||
147563883|NCT03639311|532222710|FG000|Maintenance Phase|Adverse Event|1|||
147563884|NCT03639311|532222711|FG001|Maintenance Phase|Adverse Event|0|||
147563885|NCT03639311|532222712|FG002|Maintenance Phase|Adverse Event|0|||
147563886|NCT03639311|532222710|FG000|Maintenance Phase|DECISION BY SUBJECT OR PROXY|7|||
147563887|NCT03639311|532222711|FG001|Maintenance Phase|DECISION BY SUBJECT OR PROXY|0|||
147563888|NCT03639311|532222712|FG002|Maintenance Phase|DECISION BY SUBJECT OR PROXY|0|||
147563889|NCT03639311|532222710|FG000|Maintenance Phase|STUDY SITE TERMINATED BY SPONSOR|3|||
147228493|NCT00891462|531010410|FG000|Overall Study|Lack of Efficacy|10|||
147228494|NCT00891462|531010411|FG001|Overall Study|Lack of Efficacy|5|||
147228495|NCT00891462|531010412|FG002|Overall Study|Lack of Efficacy|1|||
147228496|NCT00891462|531010410|FG000|Overall Study|COPD exacerbation|7|||
147228497|NCT00891462|531010411|FG001|Overall Study|COPD exacerbation|4|||
147228498|NCT00891462|531010412|FG002|Overall Study|COPD exacerbation|1|||
147228499|NCT00891462|531010410|FG000|Overall Study|Other Reason|2|||
147228500|NCT00891462|531010411|FG001|Overall Study|Other Reason|5|||
147228501|NCT00891462|531010412|FG002|Overall Study|Other Reason|3|||
147563890|NCT03639311|532222711|FG001|Maintenance Phase|STUDY SITE TERMINATED BY SPONSOR|0|||
147563891|NCT03639311|532222712|FG002|Maintenance Phase|STUDY SITE TERMINATED BY SPONSOR|0|||
147563892|NCT03639311|532222710|FG000|Maintenance Phase|SUBJECT REACHED PROTOCOL-DEFINED STOPPING CRITERIA|1|||
147563893|NCT03639311|532222711|FG001|Maintenance Phase|SUBJECT REACHED PROTOCOL-DEFINED STOPPING CRITERIA|0|||
147563894|NCT03639311|532222712|FG002|Maintenance Phase|SUBJECT REACHED PROTOCOL-DEFINED STOPPING CRITERIA|0|||
147563895|NCT03639311|532222710|FG000|Maintenance Phase|Lack of Efficacy|1|||
147563896|NCT03639311|532222711|FG001|Maintenance Phase|Lack of Efficacy|0|||
147563897|NCT03639311|532222712|FG002|Maintenance Phase|Lack of Efficacy|0|||
147563898|NCT00822926|532222713|FG000|Second Injection Visit|Lost to Follow-up|1|||
147563899|NCT00822926|532222714|FG001|Second Injection Visit|Lost to Follow-up|0|||
147563900|NCT00822926|532222713|FG000|Second Injection Visit|Withdrawal by Subject|0|||
147563901|NCT00822926|532222714|FG001|Second Injection Visit|Withdrawal by Subject|1|||
147563902|NCT03125200|532222716|FG000|Overall Study|Study Termination|0|||
147563903|NCT03125200|532222717|FG001|Overall Study|Study Termination|0|||
147563904|NCT03125200|532222718|FG002|Overall Study|Study Termination|0|||
147228502|NCT00891462|531010410|FG000|Overall Study|Protocol Violation|2|||
147228503|NCT00891462|531010411|FG001|Overall Study|Protocol Violation|1|||
147228504|NCT00891462|531010412|FG002|Overall Study|Protocol Violation|3|||
147228505|NCT00891462|531010410|FG000|Overall Study|Inclusion/exclusion criteria|0|||
147228506|NCT00891462|531010411|FG001|Overall Study|Inclusion/exclusion criteria|2|||
147312061|NCT01164228|531309255|FG001|Overall Study|Adverse Event|7|||
147563905|NCT03125200|532222719|FG003|Overall Study|Study Termination|1|||
147563906|NCT03125200|532222720|FG004|Overall Study|Study Termination|1|||
147563907|NCT03125200|532222721|FG005|Overall Study|Study Termination|2|||
147563908|NCT03125200|532222722|FG006|Overall Study|Study Termination|1|||
147563909|NCT03125200|532222716|FG000|Overall Study|Clinical Progression|0|||
147563910|NCT03125200|532222717|FG001|Overall Study|Clinical Progression|0|||
147563911|NCT03125200|532222718|FG002|Overall Study|Clinical Progression|0|||
147563912|NCT03125200|532222719|FG003|Overall Study|Clinical Progression|1|||
147563913|NCT03125200|532222720|FG004|Overall Study|Clinical Progression|0|||
147563914|NCT03125200|532222721|FG005|Overall Study|Clinical Progression|1|||
147563915|NCT03125200|532222722|FG006|Overall Study|Clinical Progression|0|||
147563916|NCT03125200|532222716|FG000|Overall Study|Progressive Disease|2|||
147563917|NCT03125200|532222717|FG001|Overall Study|Progressive Disease|1|||
147563918|NCT03125200|532222718|FG002|Overall Study|Progressive Disease|2|||
147563919|NCT03125200|532222719|FG003|Overall Study|Progressive Disease|1|||
147563920|NCT03125200|532222720|FG004|Overall Study|Progressive Disease|2|||
147563921|NCT03125200|532222721|FG005|Overall Study|Progressive Disease|0|||
147563922|NCT03125200|532222722|FG006|Overall Study|Progressive Disease|1|||
147563923|NCT03125200|532222716|FG000|Overall Study|Lack of Efficacy|0|||
147563924|NCT03125200|532222717|FG001|Overall Study|Lack of Efficacy|0|||
147563925|NCT03125200|532222718|FG002|Overall Study|Lack of Efficacy|0|||
147563926|NCT03125200|532222719|FG003|Overall Study|Lack of Efficacy|1|||
147563927|NCT03125200|532222720|FG004|Overall Study|Lack of Efficacy|0|||
147563928|NCT03125200|532222721|FG005|Overall Study|Lack of Efficacy|0|||
147563929|NCT03125200|532222722|FG006|Overall Study|Lack of Efficacy|0|||
147563930|NCT03125200|532222716|FG000|Overall Study|Toxicity|0|||
147563931|NCT03125200|532222717|FG001|Overall Study|Toxicity|0|||
147563932|NCT03125200|532222718|FG002|Overall Study|Toxicity|0|||
147563933|NCT03125200|532222719|FG003|Overall Study|Toxicity|1|||
147563934|NCT03125200|532222720|FG004|Overall Study|Toxicity|0|||
147563935|NCT03125200|532222721|FG005|Overall Study|Toxicity|0|||
147563936|NCT03125200|532222722|FG006|Overall Study|Toxicity|0|||
147563937|NCT03125200|532222716|FG000|Overall Study|Consent Withdrawn by Subject|0|||
147563938|NCT03125200|532222717|FG001|Overall Study|Consent Withdrawn by Subject|1|||
147563939|NCT03125200|532222718|FG002|Overall Study|Consent Withdrawn by Subject|0|||
147563940|NCT03125200|532222719|FG003|Overall Study|Consent Withdrawn by Subject|0|||
147563941|NCT03125200|532222720|FG004|Overall Study|Consent Withdrawn by Subject|1|||
147563942|NCT03125200|532222721|FG005|Overall Study|Consent Withdrawn by Subject|0|||
147563943|NCT03125200|532222722|FG006|Overall Study|Consent Withdrawn by Subject|1|||
147563944|NCT03544138|532222725|FG000|Overall Study|Lost to Follow-up|29|||
147563945|NCT05017480|532224213|FG000|Stage 1 Study|Withdrawal by Subject|8|||
147563946|NCT05017480|532224214|FG001|Stage 1 Study|Withdrawal by Subject|6|||
147563947|NCT05017480|532224215|FG002|Stage 1 Study|Withdrawal by Subject|0|||
147563948|NCT05017480|532224216|FG003|Stage 1 Study|Withdrawal by Subject|0|||
147563949|NCT05017480|532224217|FG004|Stage 1 Study|Withdrawal by Subject|0|||
147563950|NCT05017480|532224213|FG000|Stage 1 Study|Adverse Event|1|||
147563951|NCT05017480|532224214|FG001|Stage 1 Study|Adverse Event|1|||
147563952|NCT05017480|532224215|FG002|Stage 1 Study|Adverse Event|0|||
147563953|NCT05017480|532224216|FG003|Stage 1 Study|Adverse Event|0|||
147563954|NCT05017480|532224217|FG004|Stage 1 Study|Adverse Event|0|||
147563955|NCT05017480|532224213|FG000|Stage 1 Study|Poor Compliance|1|||
147563956|NCT05017480|532224214|FG001|Stage 1 Study|Poor Compliance|1|||
147563957|NCT05017480|532224215|FG002|Stage 1 Study|Poor Compliance|0|||
147563958|NCT05017480|532224216|FG003|Stage 1 Study|Poor Compliance|0|||
147563959|NCT05017480|532224217|FG004|Stage 1 Study|Poor Compliance|0|||
147228507|NCT00891462|531010412|FG002|Overall Study|Inclusion/exclusion criteria|2|||
147228508|NCT00891462|531010410|FG000|Overall Study|Lost to Follow-up|0|||
147228509|NCT00891462|531010411|FG001|Overall Study|Lost to Follow-up|2|||
147228510|NCT00891462|531010412|FG002|Overall Study|Lost to Follow-up|0|||
147563960|NCT05017480|532224213|FG000|Stage 1 Study|Physician Decision|0|||
147563961|NCT05017480|532224214|FG001|Stage 1 Study|Physician Decision|1|||
147563962|NCT05017480|532224215|FG002|Stage 1 Study|Physician Decision|0|||
147563963|NCT05017480|532224216|FG003|Stage 1 Study|Physician Decision|0|||
147563964|NCT05017480|532224217|FG004|Stage 1 Study|Physician Decision|0|||
147563965|NCT05017480|532224213|FG000|Stage 2 Study|Withdrawal by Subject|0|||
147563966|NCT05017480|532224214|FG001|Stage 2 Study|Withdrawal by Subject|0|||
147563967|NCT05017480|532224215|FG002|Stage 2 Study|Withdrawal by Subject|6|||
147563968|NCT05017480|532224216|FG003|Stage 2 Study|Withdrawal by Subject|9|||
147563969|NCT05017480|532224217|FG004|Stage 2 Study|Withdrawal by Subject|11|||
147563970|NCT05017480|532224213|FG000|Stage 2 Study|Lost to Follow-up|0|||
147563971|NCT05017480|532224214|FG001|Stage 2 Study|Lost to Follow-up|0|||
147228511|NCT00423722|531010416|FG000|Overall Study|Death|4|||
147228512|NCT00423722|531010417|FG001|Overall Study|Death|4|||
147228513|NCT00423722|531010416|FG000|Overall Study|Declined to participate|2|||
147228514|NCT00423722|531010417|FG001|Overall Study|Declined to participate|3|||
147228515|NCT00423722|531010416|FG000|Overall Study|Unable to complete questionnaires|4|||
147563972|NCT05017480|532224215|FG002|Stage 2 Study|Lost to Follow-up|0|||
147563973|NCT05017480|532224216|FG003|Stage 2 Study|Lost to Follow-up|2|||
147563974|NCT05017480|532224217|FG004|Stage 2 Study|Lost to Follow-up|1|||
147563975|NCT05017480|532224213|FG000|Stage 2 Study|Adverse Event|0|||
147563976|NCT05017480|532224214|FG001|Stage 2 Study|Adverse Event|0|||
147563977|NCT05017480|532224215|FG002|Stage 2 Study|Adverse Event|0|||
147563978|NCT05017480|532224216|FG003|Stage 2 Study|Adverse Event|1|||
147563979|NCT05017480|532224217|FG004|Stage 2 Study|Adverse Event|0|||
147563980|NCT05017480|532224213|FG000|Stage 2 Study|COVID-19|0|||
147563981|NCT05017480|532224214|FG001|Stage 2 Study|COVID-19|0|||
147563982|NCT05017480|532224215|FG002|Stage 2 Study|COVID-19|0|||
147563983|NCT05017480|532224216|FG003|Stage 2 Study|COVID-19|1|||
147563984|NCT05017480|532224217|FG004|Stage 2 Study|COVID-19|0|||
147563985|NCT05017480|532224213|FG000|Stage 2 Study|Pregnancy|0|||
147563986|NCT05017480|532224214|FG001|Stage 2 Study|Pregnancy|0|||
147563987|NCT05017480|532224215|FG002|Stage 2 Study|Pregnancy|0|||
147563988|NCT05017480|532224216|FG003|Stage 2 Study|Pregnancy|0|||
147563989|NCT05017480|532224217|FG004|Stage 2 Study|Pregnancy|1|||
147563990|NCT02028715|532224220|FG000|Overall Study|Adverse Event|2|||
147563991|NCT02028715|532224221|FG001|Overall Study|Adverse Event|2|||
147563992|NCT02028715|532224220|FG000|Overall Study|Physician Decision|1|||
147563993|NCT02028715|532224221|FG001|Overall Study|Physician Decision|0|||
147563994|NCT02028715|532224220|FG000|Overall Study|Did not complete satisfaction surveys|2|||
147563995|NCT02028715|532224221|FG001|Overall Study|Did not complete satisfaction surveys|2|||
147563996|NCT01710657|532224222|FG000|Overall Study|Lost to Follow-up|2|||
147563997|NCT01710657|532224223|FG001|Overall Study|Lost to Follow-up|0|||
147563998|NCT01710657|532224224|FG002|Overall Study|Lost to Follow-up|1|||
147563999|NCT01710657|532224222|FG000|Overall Study|Protocol Violation|2|||
147564000|NCT01710657|532224223|FG001|Overall Study|Protocol Violation|2|||
147564001|NCT01710657|532224224|FG002|Overall Study|Protocol Violation|0|||
147564002|NCT01710657|532224222|FG000|Overall Study|Adverse Event|14|||
147564003|NCT01710657|532224223|FG001|Overall Study|Adverse Event|8|||
147564004|NCT01710657|532224224|FG002|Overall Study|Adverse Event|28|||
147564005|NCT01710657|532224222|FG000|Overall Study|Withdrawal by Subject|0|||
147564006|NCT01710657|532224223|FG001|Overall Study|Withdrawal by Subject|1|||
147564007|NCT01710657|532224224|FG002|Overall Study|Withdrawal by Subject|2|||
147564008|NCT01710657|532224222|FG000|Overall Study|Lack of Efficacy|0|||
147564009|NCT01710657|532224223|FG001|Overall Study|Lack of Efficacy|1|||
147564010|NCT01710657|532224224|FG002|Overall Study|Lack of Efficacy|1|||
147564011|NCT02188303|532224227|FG000|Overall Study|Adverse Event|0|||
147564012|NCT02188303|532224228|FG001|Overall Study|Adverse Event|0|||
147564013|NCT02188303|532224229|FG002|Overall Study|Adverse Event|0|||
147564014|NCT02188303|532224230|FG003|Overall Study|Adverse Event|0|||
147564015|NCT02188303|532224231|FG004|Overall Study|Adverse Event|0|||
147564016|NCT02188303|532224232|FG005|Overall Study|Adverse Event|2|||
147564017|NCT02188303|532224233|FG006|Overall Study|Adverse Event|0|||
147564018|NCT02188303|532224234|FG007|Overall Study|Adverse Event|2|||
147564019|NCT02188303|532224227|FG000|Overall Study|Dose Termination Criteria Met|0|||
147564020|NCT02188303|532224228|FG001|Overall Study|Dose Termination Criteria Met|0|||
147564021|NCT02188303|532224229|FG002|Overall Study|Dose Termination Criteria Met|0|||
147564022|NCT02188303|532224230|FG003|Overall Study|Dose Termination Criteria Met|0|||
147564023|NCT02188303|532224231|FG004|Overall Study|Dose Termination Criteria Met|0|||
147564024|NCT02188303|532224232|FG005|Overall Study|Dose Termination Criteria Met|0|||
147564025|NCT02188303|532224233|FG006|Overall Study|Dose Termination Criteria Met|2|||
147228516|NCT00423722|531010417|FG001|Overall Study|Unable to complete questionnaires|4|||
147228517|NCT00423722|531010416|FG000|Overall Study|Withdrawal by Subject|4|||
147228518|NCT00423722|531010417|FG001|Overall Study|Withdrawal by Subject|2|||
147228519|NCT00215683|531010418|FG000|Overall Study|Adverse Event|15|||
147228520|NCT00215683|531010419|FG001|Overall Study|Adverse Event|16|||
147228521|NCT00215683|531010420|FG002|Overall Study|Adverse Event|15|||
147228522|NCT00215683|531010418|FG000|Overall Study|Lack of Efficacy|5|||
147228523|NCT00215683|531010419|FG001|Overall Study|Lack of Efficacy|1|||
147228524|NCT00215683|531010420|FG002|Overall Study|Lack of Efficacy|2|||
147228525|NCT00215683|531010418|FG000|Overall Study|Lost to Follow-up|0|||
147228526|NCT00215683|531010419|FG001|Overall Study|Lost to Follow-up|2|||
147228527|NCT00215683|531010420|FG002|Overall Study|Lost to Follow-up|1|||
147564026|NCT02188303|532224234|FG007|Overall Study|Dose Termination Criteria Met|4|||
147564027|NCT04206332|532224236|FG000|Part A|Lost to Follow-up|0|||
147564028|NCT04206332|532224237|FG001|Part A|Lost to Follow-up|1|||
147564029|NCT04206332|532224238|FG002|Part A|Lost to Follow-up|0|||
147564030|NCT04206332|532224239|FG003|Part A|Lost to Follow-up|0|||
147564031|NCT04206332|532224240|FG004|Part A|Lost to Follow-up|0|||
147564032|NCT04206332|532224241|FG005|Part A|Lost to Follow-up|0|||
147564033|NCT04206332|532224242|FG006|Part A|Lost to Follow-up|0|||
147564034|NCT04206332|532224243|FG007|Part A|Lost to Follow-up|0|||
147564035|NCT04206332|532224244|FG008|Part A|Lost to Follow-up|0|||
147564036|NCT04206332|532224245|FG009|Part A|Lost to Follow-up|0|||
147228528|NCT00215683|531010418|FG000|Overall Study|Withdrawal by Subject|9|||
147228529|NCT00215683|531010419|FG001|Overall Study|Withdrawal by Subject|4|||
147228530|NCT00215683|531010420|FG002|Overall Study|Withdrawal by Subject|13|||
147564037|NCT04206332|532224246|FG010|Part A|Lost to Follow-up|0|||
147564038|NCT04206332|532224247|FG011|Part A|Lost to Follow-up|0|||
147228531|NCT00215683|531010418|FG000|Overall Study|Physician Decision|0|||
147564039|NCT04206332|532224248|FG012|Part A|Lost to Follow-up|0|||
147564040|NCT04206332|532224249|FG013|Part A|Lost to Follow-up|0|||
147564041|NCT04206332|532224250|FG014|Part A|Lost to Follow-up|0|||
147564042|NCT04206332|532224251|FG015|Part A|Lost to Follow-up|0|||
147564043|NCT04206332|532224252|FG016|Part A|Lost to Follow-up|0|||
147564044|NCT04206332|532224236|FG000|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
147564045|NCT04206332|532224237|FG001|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
147564046|NCT04206332|532224238|FG002|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
147564047|NCT04206332|532224239|FG003|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
147564048|NCT04206332|532224240|FG004|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
147564049|NCT04206332|532224241|FG005|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|8|||
147564050|NCT04206332|532224242|FG006|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
147564051|NCT04206332|532224243|FG007|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
147564052|NCT04206332|532224244|FG008|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
147564053|NCT04206332|532224245|FG009|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
147564054|NCT04206332|532224246|FG010|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
147564055|NCT04206332|532224247|FG011|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
147564056|NCT04206332|532224248|FG012|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
147564057|NCT04206332|532224249|FG013|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
147564058|NCT04206332|532224250|FG014|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
147564059|NCT04206332|532224251|FG015|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
147564060|NCT04206332|532224252|FG016|Part A|CHMI canceled because of restrictions related to coronavirus disease 2019 (COVID-19)|0|||
147564061|NCT04206332|532224236|FG000|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
147564062|NCT04206332|532224237|FG001|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
147564063|NCT04206332|532224238|FG002|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
147564064|NCT04206332|532224239|FG003|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
147564065|NCT04206332|532224240|FG004|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
147564066|NCT04206332|532224241|FG005|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
147564067|NCT04206332|532224242|FG006|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
147564068|NCT04206332|532224243|FG007|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|3|||
147564069|NCT04206332|532224244|FG008|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
147564070|NCT04206332|532224245|FG009|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
147564071|NCT04206332|532224246|FG010|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|2|||
147564072|NCT04206332|532224247|FG011|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
147564073|NCT04206332|532224248|FG012|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
147564074|NCT04206332|532224249|FG013|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
147564075|NCT04206332|532224250|FG014|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
147564076|NCT04206332|532224251|FG015|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
147564077|NCT04206332|532224252|FG016|Part B|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
147564078|NCT04206332|532224236|FG000|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
147564079|NCT04206332|532224237|FG001|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
147564080|NCT04206332|532224238|FG002|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
147564081|NCT04206332|532224239|FG003|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
147564082|NCT04206332|532224240|FG004|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
147564083|NCT04206332|532224241|FG005|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
147564084|NCT04206332|532224242|FG006|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
147564085|NCT04206332|532224243|FG007|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
147228532|NCT00215683|531010419|FG001|Overall Study|Physician Decision|0|||
147228533|NCT00215683|531010420|FG002|Overall Study|Physician Decision|1|||
147228534|NCT00215683|531010418|FG000|Overall Study|Difficult to attend visits|0|||
147228535|NCT00215683|531010419|FG001|Overall Study|Difficult to attend visits|1|||
147228536|NCT00215683|531010420|FG002|Overall Study|Difficult to attend visits|0|||
147228537|NCT00215683|531010418|FG000|Overall Study|No study drug available|0|||
147228538|NCT00215683|531010419|FG001|Overall Study|No study drug available|1|||
147228539|NCT00215683|531010420|FG002|Overall Study|No study drug available|0|||
147228540|NCT00215683|531010418|FG000|Overall Study|Intermittent therapy required|0|||
147228541|NCT00215683|531010419|FG001|Overall Study|Intermittent therapy required|1|||
147564086|NCT04206332|532224244|FG008|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
147564087|NCT04206332|532224245|FG009|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
147564088|NCT04206332|532224246|FG010|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
147564089|NCT04206332|532224247|FG011|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
147564090|NCT04206332|532224248|FG012|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
147564091|NCT04206332|532224249|FG013|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
147564092|NCT04206332|532224250|FG014|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
147564093|NCT04206332|532224251|FG015|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|0|||
147564094|NCT04206332|532224252|FG016|Part C|Back up participants who did not receive CIS43LS or CHMI because they were not needed|2|||
147564095|NCT04206332|532224236|FG000|Part C|Withdrawal by Subject|0|||
147564096|NCT04206332|532224237|FG001|Part C|Withdrawal by Subject|0|||
147564097|NCT04206332|532224238|FG002|Part C|Withdrawal by Subject|0|||
147564098|NCT04206332|532224239|FG003|Part C|Withdrawal by Subject|0|||
147564099|NCT04206332|532224240|FG004|Part C|Withdrawal by Subject|0|||
147564100|NCT04206332|532224241|FG005|Part C|Withdrawal by Subject|0|||
147564101|NCT04206332|532224242|FG006|Part C|Withdrawal by Subject|0|||
147564102|NCT04206332|532224243|FG007|Part C|Withdrawal by Subject|0|||
147564103|NCT04206332|532224244|FG008|Part C|Withdrawal by Subject|0|||
147564104|NCT04206332|532224245|FG009|Part C|Withdrawal by Subject|0|||
147564105|NCT04206332|532224246|FG010|Part C|Withdrawal by Subject|0|||
147564106|NCT04206332|532224247|FG011|Part C|Withdrawal by Subject|0|||
147564107|NCT04206332|532224248|FG012|Part C|Withdrawal by Subject|0|||
147564108|NCT04206332|532224249|FG013|Part C|Withdrawal by Subject|0|||
147564109|NCT04206332|532224250|FG014|Part C|Withdrawal by Subject|2|||
147564110|NCT04206332|532224251|FG015|Part C|Withdrawal by Subject|0|||
147228542|NCT00215683|531010420|FG002|Overall Study|Intermittent therapy required|0|||
147228543|NCT01083485|531010421|FG000|Overall Study|Adverse Event|0|||
147228544|NCT01083485|531010422|FG001|Overall Study|Adverse Event|1|||
147228545|NCT01083485|531010421|FG000|Overall Study|Protocol Violation|1|||
147228546|NCT01083485|531010422|FG001|Overall Study|Protocol Violation|0|||
147228547|NCT01083485|531010421|FG000|Overall Study|Withdrawal by Subject|5|||
147228548|NCT01083485|531010422|FG001|Overall Study|Withdrawal by Subject|2|||
147228549|NCT01083485|531010421|FG000|Overall Study|Other|1|||
147228550|NCT01083485|531010422|FG001|Overall Study|Other|0|||
147228551|NCT04493333|531010423|FG000|Overall Study|Withdrawal by Subject|1|||
147228552|NCT04493333|531010424|FG001|Overall Study|Withdrawal by Subject|1|||
147228553|NCT04493333|531010423|FG000|Overall Study|Ineligible|0|||
147228554|NCT04493333|531010424|FG001|Overall Study|Ineligible|1|||
147228555|NCT04493333|531010423|FG000|Overall Study|Noncompliance|2|||
147228556|NCT04493333|531010424|FG001|Overall Study|Noncompliance|1|||
147228557|NCT00674973|531010427|FG000|Overall Study|Insufficient Therapeutic Response|77|||
147228558|NCT00674973|531010428|FG001|Overall Study|Insufficient Therapeutic Response|72|||
147228559|NCT00674973|531010427|FG000|Overall Study|Refused Treatment|1|||
147228560|NCT00674973|531010428|FG001|Overall Study|Refused Treatment|5|||
147228561|NCT00674973|531010427|FG000|Overall Study|Failure to Return|1|||
147228562|NCT00674973|531010428|FG001|Overall Study|Failure to Return|0|||
147228563|NCT00674973|531010427|FG000|Overall Study|Adverse Event|2|||
147228564|NCT00674973|531010428|FG001|Overall Study|Adverse Event|9|||
147228565|NCT00674973|531010427|FG000|Overall Study|Death|19|||
147228566|NCT00674973|531010428|FG001|Overall Study|Death|15|||
147228567|NCT00674973|531010427|FG000|Overall Study|Protocol Violation|0|||
147228568|NCT00674973|531010428|FG001|Overall Study|Protocol Violation|1|||
147228569|NCT05108922|531010432|FG000|Overall Study|Adverse Event|2|||
147228570|NCT05108922|531010433|FG001|Overall Study|Adverse Event|3|||
147228571|NCT05108922|531010432|FG000|Overall Study|Lost to Follow-up|2|||
147228572|NCT05108922|531010433|FG001|Overall Study|Lost to Follow-up|1|||
147228573|NCT05108922|531010432|FG000|Overall Study|Inadvertent enrollment|0|||
147228574|NCT05108922|531010433|FG001|Overall Study|Inadvertent enrollment|1|||
147228575|NCT05108922|531010432|FG000|Overall Study|Physician Decision|2|||
147228576|NCT05108922|531010433|FG001|Overall Study|Physician Decision|3|||
147228577|NCT05108922|531010432|FG000|Overall Study|Protocol deviation|1|||
147228578|NCT05108922|531010433|FG001|Overall Study|Protocol deviation|0|||
147228579|NCT05108922|531010432|FG000|Overall Study|Screen failure|1|||
147228580|NCT05108922|531010433|FG001|Overall Study|Screen failure|0|||
147228581|NCT05108922|531010432|FG000|Overall Study|Withdrawal by Subject|11|||
147228582|NCT05108922|531010433|FG001|Overall Study|Withdrawal by Subject|8|||
147228583|NCT05036369|531010435|FG000|Overall Study|Run In non compliance|1|||
147228584|NCT05036369|531010436|FG001|Overall Study|Run In non compliance|2|||
147228585|NCT05036369|531010435|FG000|Overall Study|Change in eligibility criteria|0|||
147228586|NCT05036369|531010436|FG001|Overall Study|Change in eligibility criteria|1|||
147228587|NCT02349061|531010441|FG000|Main Study: PCP (Up to Week 24)|Adverse Event|4|||
147228588|NCT02349061|531010442|FG001|Main Study: PCP (Up to Week 24)|Adverse Event|3|||
147228589|NCT02349061|531010443|FG002|Main Study: PCP (Up to Week 24)|Adverse Event|0|||
147312062|NCT01164228|531309254|FG000|Overall Study|Death|1|||
147564111|NCT04206332|532224252|FG016|Part C|Withdrawal by Subject|0|||
147564112|NCT02334722|532224253|FG000|Overall Study|Lost to Follow-up|4|||
147564113|NCT02334722|532224254|FG001|Overall Study|Lost to Follow-up|0|||
147564114|NCT02334722|532224253|FG000|Overall Study|6 week questionnaire not completed|2|||
147564115|NCT02334722|532224254|FG001|Overall Study|6 week questionnaire not completed|0|||
147564116|NCT02334722|532224253|FG000|Overall Study|Unable to obtain medication|1|||
147564117|NCT02334722|532224254|FG001|Overall Study|Unable to obtain medication|1|||
147564118|NCT02334722|532224253|FG000|Overall Study|Withdrawal by Subject|0|||
147564119|NCT02334722|532224254|FG001|Overall Study|Withdrawal by Subject|3|||
147564120|NCT02334722|532224253|FG000|Overall Study|Adverse Event|0|||
147564121|NCT02334722|532224254|FG001|Overall Study|Adverse Event|2|||
147564122|NCT02334722|532224253|FG000|Overall Study|Physician Decision|0|||
147564123|NCT02334722|532224254|FG001|Overall Study|Physician Decision|1|||
147564124|NCT05612724|532224256|FG000|Overall Study|Lost to Follow-up|4|||
147564125|NCT04000815|532224263|FG000|Overall Study|Lost to Follow-up|9|||
147564126|NCT04000815|532224264|FG001|Overall Study|Lost to Follow-up|2|||
147564127|NCT04000815|532224265|FG002|Overall Study|Lost to Follow-up|3|||
147564128|NCT04000815|532224263|FG000|Overall Study|Withdrawal by Subject|4|||
147564129|NCT04000815|532224264|FG001|Overall Study|Withdrawal by Subject|3|||
147564130|NCT04000815|532224265|FG002|Overall Study|Withdrawal by Subject|2|||
147564131|NCT04000815|532224263|FG000|Overall Study|Right ovarian cyst occured|1|||
147564132|NCT04000815|532224264|FG001|Overall Study|Right ovarian cyst occured|0|||
147564133|NCT04000815|532224265|FG002|Overall Study|Right ovarian cyst occured|0|||
147564134|NCT04000815|532224263|FG000|Overall Study|Hypertension occured on follow up|0|||
147564135|NCT04000815|532224264|FG001|Overall Study|Hypertension occured on follow up|0|||
147564136|NCT04000815|532224265|FG002|Overall Study|Hypertension occured on follow up|2|||
147564137|NCT00239577|532224266|FG000|Primary Phase|Adverse Event|0|||
147564138|NCT00239577|532224267|FG001|Primary Phase|Adverse Event|0|||
147564139|NCT00239577|532224268|FG002|Primary Phase|Adverse Event|1|||
147564140|NCT00239577|532224269|FG003|Primary Phase|Adverse Event|0|||
147564141|NCT00239577|532224266|FG000|Primary Phase|Other|5|||
147564142|NCT00239577|532224267|FG001|Primary Phase|Other|3|||
147564143|NCT00239577|532224268|FG002|Primary Phase|Other|2|||
147564144|NCT00239577|532224269|FG003|Primary Phase|Other|0|||
147564145|NCT02422264|532224272|FG000|Overall Study|Serious Adverse Event|1|||
147564146|NCT02422264|532224273|FG001|Overall Study|Serious Adverse Event|0|||
147564147|NCT02422264|532224272|FG000|Overall Study|Withdrawal by Subject|1|||
147564148|NCT02422264|532224273|FG001|Overall Study|Withdrawal by Subject|2|||
147564149|NCT02422264|532224272|FG000|Overall Study|Migrated/moved from study area|3|||
147564150|NCT02422264|532224273|FG001|Overall Study|Migrated/moved from study area|1|||
147564151|NCT02422264|532224272|FG000|Overall Study|Subject vaccinated outside of the study|0|||
147564152|NCT02422264|532224273|FG001|Overall Study|Subject vaccinated outside of the study|1|||
147564153|NCT03021018|532224274|FG000|Overall Study|Adverse Event|1|||
147564154|NCT03021018|532224275|FG001|Overall Study|Adverse Event|0|||
147564155|NCT03021018|532224276|FG002|Overall Study|Adverse Event|0|||
147564156|NCT03021018|532224274|FG000|Overall Study|Fall with subsequent nasal fracture|1|||
147564157|NCT03021018|532224275|FG001|Overall Study|Fall with subsequent nasal fracture|0|||
147564158|NCT03021018|532224276|FG002|Overall Study|Fall with subsequent nasal fracture|0|||
147564159|NCT00856388|532224279|FG000|Overall Study|Other|1|||
147564160|NCT01617668|532224281|FG000|Overall Study|Adverse Event|7|||
147564161|NCT01617668|532224282|FG001|Overall Study|Adverse Event|0|||
147564162|NCT01617668|532224283|FG002|Overall Study|Adverse Event|12|||
147564163|NCT01617668|532224284|FG003|Overall Study|Adverse Event|5|||
147564164|NCT01617668|532224281|FG000|Overall Study|Physician Decision|1|||
147564165|NCT01617668|532224282|FG001|Overall Study|Physician Decision|2|||
147564166|NCT01617668|532224283|FG002|Overall Study|Physician Decision|3|||
147564167|NCT01617668|532224284|FG003|Overall Study|Physician Decision|0|||
147564168|NCT01617668|532224281|FG000|Overall Study|Progressive Disease|4|||
147564169|NCT01617668|532224282|FG001|Overall Study|Progressive Disease|4|||
147564170|NCT01617668|532224283|FG002|Overall Study|Progressive Disease|6|||
147564171|NCT01617668|532224284|FG003|Overall Study|Progressive Disease|9|||
147564172|NCT01617668|532224281|FG000|Overall Study|Subject/guardian decision|1|||
147564173|NCT01617668|532224282|FG001|Overall Study|Subject/guardian decision|3|||
147564174|NCT01617668|532224283|FG002|Overall Study|Subject/guardian decision|2|||
147564175|NCT01617668|532224284|FG003|Overall Study|Subject/guardian decision|1|||
147564176|NCT00925769|532224285|FG000|Overall Study|Major toxicity|1|||
147564177|NCT00925769|532224286|FG001|Overall Study|Major toxicity|0|||
147564178|NCT00925769|532224287|FG002|Overall Study|Major toxicity|1|||
147564179|NCT00925769|532224288|FG003|Overall Study|Major toxicity|1|||
147564180|NCT00925769|532224289|FG004|Overall Study|Major toxicity|0|||
147564181|NCT00925769|532224290|FG005|Overall Study|Major toxicity|0|||
147564182|NCT00925769|532224285|FG000|Overall Study|Disease progression|4|||
147564183|NCT00925769|532224286|FG001|Overall Study|Disease progression|5|||
147564184|NCT00925769|532224287|FG002|Overall Study|Disease progression|3|||
147564185|NCT00925769|532224288|FG003|Overall Study|Disease progression|4|||
147564186|NCT00925769|532224289|FG004|Overall Study|Disease progression|2|||
147564187|NCT00925769|532224290|FG005|Overall Study|Disease progression|3|||
147564188|NCT00925769|532224285|FG000|Overall Study|Death|0|||
147564189|NCT00925769|532224286|FG001|Overall Study|Death|0|||
147564190|NCT00925769|532224287|FG002|Overall Study|Death|1|||
147564191|NCT00925769|532224288|FG003|Overall Study|Death|0|||
147564192|NCT00925769|532224289|FG004|Overall Study|Death|0|||
147650871|NCT02757352|532544540|FG003|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
147650872|NCT02757352|532544541|FG004|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
147650873|NCT02757352|532544542|FG005|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
147564193|NCT00925769|532224290|FG005|Overall Study|Death|0|||
147564194|NCT00925769|532224285|FG000|Overall Study|Physician Decision|1|||
147564195|NCT00925769|532224286|FG001|Overall Study|Physician Decision|0|||
147564196|NCT00925769|532224287|FG002|Overall Study|Physician Decision|0|||
147564197|NCT00925769|532224288|FG003|Overall Study|Physician Decision|0|||
147564198|NCT00925769|532224289|FG004|Overall Study|Physician Decision|0|||
147564199|NCT00925769|532224290|FG005|Overall Study|Physician Decision|0|||
147564200|NCT00925769|532224285|FG000|Overall Study|Missing documentation|0|||
147564201|NCT00925769|532224286|FG001|Overall Study|Missing documentation|1|||
147564202|NCT00925769|532224287|FG002|Overall Study|Missing documentation|0|||
147564203|NCT00925769|532224288|FG003|Overall Study|Missing documentation|0|||
147564204|NCT00925769|532224289|FG004|Overall Study|Missing documentation|0|||
147564205|NCT00925769|532224290|FG005|Overall Study|Missing documentation|0|||
147564206|NCT00925769|532224285|FG000|Overall Study|End of study visit not done|0|||
147564207|NCT00925769|532224286|FG001|Overall Study|End of study visit not done|0|||
147564208|NCT00925769|532224287|FG002|Overall Study|End of study visit not done|1|||
147564209|NCT00925769|532224288|FG003|Overall Study|End of study visit not done|0|||
147564210|NCT00925769|532224289|FG004|Overall Study|End of study visit not done|0|||
147564211|NCT00925769|532224290|FG005|Overall Study|End of study visit not done|0|||
147564212|NCT00925769|532224285|FG000|Overall Study|Participant is unable to swallow drug|0|||
147564213|NCT00925769|532224286|FG001|Overall Study|Participant is unable to swallow drug|0|||
147564214|NCT00925769|532224287|FG002|Overall Study|Participant is unable to swallow drug|0|||
147564215|NCT00925769|532224288|FG003|Overall Study|Participant is unable to swallow drug|1|||
147564216|NCT00925769|532224289|FG004|Overall Study|Participant is unable to swallow drug|0|||
147564217|NCT00925769|532224290|FG005|Overall Study|Participant is unable to swallow drug|0|||
147564218|NCT00925769|532224285|FG000|Overall Study|Adverse Event|0|||
147564219|NCT00925769|532224286|FG001|Overall Study|Adverse Event|0|||
147564220|NCT00925769|532224287|FG002|Overall Study|Adverse Event|0|||
147564221|NCT00925769|532224288|FG003|Overall Study|Adverse Event|0|||
147564222|NCT00925769|532224289|FG004|Overall Study|Adverse Event|1|||
147564223|NCT00925769|532224290|FG005|Overall Study|Adverse Event|0|||
147564224|NCT01038856|532224293|FG000|Overall Study|Adverse Event|2|||
147564225|NCT02300103|532224294|FG000|Overall Study|Lack of Efficacy|3|||
147564226|NCT02300103|532224294|FG000|Overall Study|Protocol Violation|1|||
147564227|NCT02300103|532224294|FG000|Overall Study|Withdrew Consent|2|||
147564228|NCT04091971|532224295|FG000|Overall Study|Withdrawal by Subject|1|||
147564229|NCT04091971|532224295|FG000|Overall Study|No longer met eligibility criteria after enrollment.|2|||
147564230|NCT04091971|532224295|FG000|Overall Study|Panic attack during MRI; no MRI or PET but completed ketamine and other procedures|1|||
147564231|NCT01666730|532224296|FG000|Overall Study|Adverse Event|16|||
147564232|NCT01666730|532224296|FG000|Overall Study|Death|2|||
147564233|NCT01666730|532224296|FG000|Overall Study|Physician Decision|5|||
147564234|NCT01666730|532224296|FG000|Overall Study|Withdrawal by Subject|9|||
147564235|NCT01666730|532224296|FG000|Overall Study|Disease progression/relapse|18|||
147564236|NCT03553823|532224297|FG000|Overall Study|Physician Decision|0|||
147564237|NCT03553823|532224298|FG001|Overall Study|Physician Decision|1|||
147564238|NCT03603314|532224299|FG000|Overall Study|Lost to Follow-up|0|||
147564239|NCT03603314|532224300|FG001|Overall Study|Lost to Follow-up|3|||
147564240|NCT03603314|532224301|FG002|Overall Study|Lost to Follow-up|0|||
147564241|NCT03603314|532224299|FG000|Overall Study|Protocol Violation|0|||
147564242|NCT03603314|532224300|FG001|Overall Study|Protocol Violation|1|||
147564243|NCT03603314|532224301|FG002|Overall Study|Protocol Violation|0|||
147312063|NCT01164228|531309255|FG001|Overall Study|Death|1|||
147312064|NCT01164228|531309254|FG000|Overall Study|Withdrawal by Subject|2|||
147312065|NCT01164228|531309255|FG001|Overall Study|Withdrawal by Subject|0|||
147312066|NCT01164228|531309254|FG000|Overall Study|Physician Decision|1|||
147564244|NCT03603314|532224299|FG000|Overall Study|Adverse Event|2|||
147312067|NCT01164228|531309255|FG001|Overall Study|Physician Decision|2|||
147564245|NCT03603314|532224300|FG001|Overall Study|Adverse Event|0|||
147564246|NCT03603314|532224301|FG002|Overall Study|Adverse Event|0|||
147312068|NCT01164228|531309254|FG000|Overall Study|Symptomatic deterioration|1|||
147312069|NCT01164228|531309255|FG001|Overall Study|Symptomatic deterioration|0|||
147312070|NCT01164228|531309254|FG000|Overall Study|Never started treatment|1|||
147564247|NCT03603314|532224299|FG000|Overall Study|Physician Decision|1|||
147564248|NCT03603314|532224300|FG001|Overall Study|Physician Decision|1|||
147564249|NCT03603314|532224301|FG002|Overall Study|Physician Decision|0|||
147564250|NCT03603314|532224299|FG000|Overall Study|Withdrawal by Subject|4|||
147564251|NCT03603314|532224300|FG001|Overall Study|Withdrawal by Subject|5|||
147564252|NCT03603314|532224301|FG002|Overall Study|Withdrawal by Subject|3|||
147564253|NCT03603314|532224299|FG000|Overall Study|Other|0|||
147564254|NCT03603314|532224300|FG001|Overall Study|Other|1|||
147564255|NCT03603314|532224301|FG002|Overall Study|Other|0|||
147564256|NCT01389102|532224302|FG000|Overall Study|Adverse Event|1|||
147564257|NCT01389102|532224303|FG001|Overall Study|Adverse Event|3|||
147564258|NCT01389102|532224304|FG002|Overall Study|Adverse Event|2|||
147564259|NCT01389102|532224305|FG003|Overall Study|Adverse Event|2|||
147564260|NCT01389102|532224306|FG004|Overall Study|Adverse Event|2|||
147564261|NCT01389102|532224307|FG005|Overall Study|Adverse Event|2|||
147564262|NCT01389102|532224302|FG000|Overall Study|Hurricane Katrina|4|||
147564263|NCT01389102|532224303|FG001|Overall Study|Hurricane Katrina|2|||
147564264|NCT01389102|532224304|FG002|Overall Study|Hurricane Katrina|3|||
147564265|NCT01389102|532224305|FG003|Overall Study|Hurricane Katrina|0|||
147564266|NCT01389102|532224306|FG004|Overall Study|Hurricane Katrina|3|||
147564267|NCT01389102|532224307|FG005|Overall Study|Hurricane Katrina|1|||
147564268|NCT01389102|532224302|FG000|Overall Study|Lost to Follow-up|4|||
147564269|NCT01389102|532224303|FG001|Overall Study|Lost to Follow-up|1|||
147564270|NCT01389102|532224304|FG002|Overall Study|Lost to Follow-up|1|||
147564271|NCT01389102|532224305|FG003|Overall Study|Lost to Follow-up|2|||
147564272|NCT01389102|532224306|FG004|Overall Study|Lost to Follow-up|4|||
147564273|NCT01389102|532224307|FG005|Overall Study|Lost to Follow-up|1|||
147564274|NCT01389102|532224302|FG000|Overall Study|Protocol Violation|0|||
147564275|NCT01389102|532224303|FG001|Overall Study|Protocol Violation|0|||
147564276|NCT01389102|532224304|FG002|Overall Study|Protocol Violation|3|||
147564277|NCT01389102|532224305|FG003|Overall Study|Protocol Violation|0|||
147564278|NCT01389102|532224306|FG004|Overall Study|Protocol Violation|1|||
147564279|NCT01389102|532224307|FG005|Overall Study|Protocol Violation|1|||
147564280|NCT01389102|532224302|FG000|Overall Study|Withdrawal by Subject|7|||
147564281|NCT01389102|532224303|FG001|Overall Study|Withdrawal by Subject|4|||
147564282|NCT01389102|532224304|FG002|Overall Study|Withdrawal by Subject|9|||
147564283|NCT01389102|532224305|FG003|Overall Study|Withdrawal by Subject|2|||
147564284|NCT01389102|532224306|FG004|Overall Study|Withdrawal by Subject|3|||
147564285|NCT01389102|532224307|FG005|Overall Study|Withdrawal by Subject|3|||
147564286|NCT01389102|532224302|FG000|Overall Study|Subject Traveling Out of Country|0|||
147564287|NCT01389102|532224303|FG001|Overall Study|Subject Traveling Out of Country|0|||
147564288|NCT01389102|532224304|FG002|Overall Study|Subject Traveling Out of Country|0|||
147564289|NCT01389102|532224305|FG003|Overall Study|Subject Traveling Out of Country|1|||
147564290|NCT01389102|532224306|FG004|Overall Study|Subject Traveling Out of Country|0|||
147564291|NCT01389102|532224307|FG005|Overall Study|Subject Traveling Out of Country|0|||
147564292|NCT01389102|532224302|FG000|Overall Study|Subject Moved|2|||
147564293|NCT01389102|532224303|FG001|Overall Study|Subject Moved|0|||
147564294|NCT01389102|532224304|FG002|Overall Study|Subject Moved|1|||
147564295|NCT01389102|532224305|FG003|Overall Study|Subject Moved|0|||
147564296|NCT01389102|532224306|FG004|Overall Study|Subject Moved|0|||
147564297|NCT01389102|532224307|FG005|Overall Study|Subject Moved|0|||
147564298|NCT01389102|532224302|FG000|Overall Study|Unavailable due to husband's illness|0|||
147564299|NCT01389102|532224303|FG001|Overall Study|Unavailable due to husband's illness|1|||
147564300|NCT01389102|532224304|FG002|Overall Study|Unavailable due to husband's illness|0|||
147564301|NCT01389102|532224305|FG003|Overall Study|Unavailable due to husband's illness|0|||
147564302|NCT01389102|532224306|FG004|Overall Study|Unavailable due to husband's illness|0|||
147564303|NCT01389102|532224307|FG005|Overall Study|Unavailable due to husband's illness|0|||
147564304|NCT01389102|532224302|FG000|Overall Study|Investigator Judgement|0|||
147564305|NCT01389102|532224303|FG001|Overall Study|Investigator Judgement|1|||
147114027|NCT05073315|530579984|FG001|Period 1 (Lead-in Period)|Lost to Follow-up|0|||
147114028|NCT05073315|530579985|FG002|Period 1 (Lead-in Period)|Lost to Follow-up|0|||
147564306|NCT01389102|532224304|FG002|Overall Study|Investigator Judgement|0|||
147564307|NCT01389102|532224305|FG003|Overall Study|Investigator Judgement|0|||
147564308|NCT01389102|532224306|FG004|Overall Study|Investigator Judgement|0|||
147564309|NCT01389102|532224307|FG005|Overall Study|Investigator Judgement|0|||
147564310|NCT03450070|532224308|FG000|Overall Study|Withdrawal by Subject|8|||
147564311|NCT00050778|532224309|FG000|Overall Study|Adverse Event|13|||
147564312|NCT00050778|532224310|FG001|Overall Study|Adverse Event|3|||
147564313|NCT00050778|532224311|FG002|Overall Study|Adverse Event|2|||
147564314|NCT00050778|532224309|FG000|Overall Study|Death|0|||
147564315|NCT00050778|532224310|FG001|Overall Study|Death|1|||
147114029|NCT05073315|530579983|FG000|Period 1 (Lead-in Period)|Protocol Violation|5|||
147114030|NCT05073315|530579984|FG001|Period 1 (Lead-in Period)|Protocol Violation|0|||
147114031|NCT05073315|530579985|FG002|Period 1 (Lead-in Period)|Protocol Violation|0|||
147114032|NCT05073315|530579983|FG000|Period 1 (Lead-in Period)|Did not Meet PASI 50 at Week 12|23|||
147114033|NCT05073315|530579984|FG001|Period 1 (Lead-in Period)|Did not Meet PASI 50 at Week 12|0|||
147114034|NCT05073315|530579985|FG002|Period 1 (Lead-in Period)|Did not Meet PASI 50 at Week 12|0|||
147564316|NCT00050778|532224311|FG002|Overall Study|Death|1|||
147564317|NCT00050778|532224309|FG000|Overall Study|Lack of Efficacy|16|||
147564318|NCT00050778|532224310|FG001|Overall Study|Lack of Efficacy|2|||
147564319|NCT00050778|532224311|FG002|Overall Study|Lack of Efficacy|2|||
147564320|NCT00050778|532224309|FG000|Overall Study|Lost to Follow-up|0|||
147564321|NCT00050778|532224310|FG001|Overall Study|Lost to Follow-up|2|||
147564322|NCT00050778|532224311|FG002|Overall Study|Lost to Follow-up|4|||
147114035|NCT05073315|530579983|FG000|Period 1 (Lead-in Period)|Lack of Efficacy|1|||
147114036|NCT05073315|530579984|FG001|Period 1 (Lead-in Period)|Lack of Efficacy|0|||
147114037|NCT05073315|530579985|FG002|Period 1 (Lead-in Period)|Lack of Efficacy|0|||
147114038|NCT05073315|530579983|FG000|Period 2|Adverse Event|0|||
147114039|NCT05073315|530579984|FG001|Period 2|Adverse Event|3|||
147114040|NCT05073315|530579985|FG002|Period 2|Adverse Event|6|||
147114041|NCT05073315|530579983|FG000|Period 2|Lost to Follow-up|0|||
147114042|NCT05073315|530579984|FG001|Period 2|Lost to Follow-up|5|||
147114043|NCT05073315|530579985|FG002|Period 2|Lost to Follow-up|5|||
147114044|NCT05073315|530579983|FG000|Period 2|Withdrawal by Subject|0|||
147228590|NCT02349061|531010441|FG000|Main Study: PCP (Up to Week 24)|Lack of Efficacy|1|||
147564323|NCT00050778|532224309|FG000|Overall Study|Physician Decision|3|||
147564324|NCT00050778|532224310|FG001|Overall Study|Physician Decision|0|||
147564325|NCT00050778|532224311|FG002|Overall Study|Physician Decision|2|||
147564326|NCT00050778|532224309|FG000|Overall Study|Protocol Violation|2|||
147564327|NCT00050778|532224310|FG001|Overall Study|Protocol Violation|0|||
147564328|NCT00050778|532224311|FG002|Overall Study|Protocol Violation|1|||
147564329|NCT00050778|532224309|FG000|Overall Study|Withdrawal by Subject|6|||
147564330|NCT00050778|532224310|FG001|Overall Study|Withdrawal by Subject|8|||
147564331|NCT00050778|532224311|FG002|Overall Study|Withdrawal by Subject|4|||
147564332|NCT00050778|532224309|FG000|Overall Study|Randomized but not treated|4|||
147564333|NCT00050778|532224310|FG001|Overall Study|Randomized but not treated|5|||
147564334|NCT00050778|532224311|FG002|Overall Study|Randomized but not treated|2|||
147564335|NCT00050778|532224309|FG000|Overall Study|Familial and personal reasons|1|||
147564336|NCT00050778|532224310|FG001|Overall Study|Familial and personal reasons|0|||
147564337|NCT00050778|532224311|FG002|Overall Study|Familial and personal reasons|0|||
147564338|NCT02910037|532224314|FG000|Overall Study|Withdrawal by Subject|4|||
147564339|NCT02910037|532224314|FG000|Overall Study|Lost to Follow-up|6|||
147564340|NCT00436553|532224315|FG000|Overall Study|Adverse Event|4|||
147564341|NCT00436553|532224316|FG001|Overall Study|Adverse Event|3|||
147564342|NCT00436553|532224317|FG002|Overall Study|Adverse Event|4|||
147564343|NCT00436553|532224315|FG000|Overall Study|Death|3|||
147564344|NCT00436553|532224316|FG001|Overall Study|Death|1|||
147564345|NCT00436553|532224317|FG002|Overall Study|Death|3|||
147564346|NCT00436553|532224315|FG000|Overall Study|Lost to Follow-up|0|||
147564347|NCT00436553|532224316|FG001|Overall Study|Lost to Follow-up|2|||
147564348|NCT00436553|532224317|FG002|Overall Study|Lost to Follow-up|0|||
147564349|NCT00436553|532224315|FG000|Overall Study|Protocol Violation|1|||
147564350|NCT00436553|532224316|FG001|Overall Study|Protocol Violation|0|||
147564351|NCT00436553|532224317|FG002|Overall Study|Protocol Violation|0|||
147564352|NCT00436553|532224315|FG000|Overall Study|Withdrawal by Subject|5|||
147564353|NCT00436553|532224316|FG001|Overall Study|Withdrawal by Subject|6|||
147564354|NCT00436553|532224317|FG002|Overall Study|Withdrawal by Subject|3|||
147564355|NCT01035060|532224318|FG000|Overall Study|Lost to Follow-up|0|||
147564356|NCT01035060|532224319|FG001|Overall Study|Lost to Follow-up|7|||
147564357|NCT01035060|532224318|FG000|Overall Study|Did not quality after 2nd screening|14|||
147564358|NCT01035060|532224319|FG001|Overall Study|Did not quality after 2nd screening|1|||
147564359|NCT01035060|532224318|FG000|Overall Study|Withdrawal by Subject|8|||
147564360|NCT01035060|532224319|FG001|Overall Study|Withdrawal by Subject|6|||
147564361|NCT01035060|532224318|FG000|Overall Study|Physician Decision|2|||
147564362|NCT01035060|532224319|FG001|Overall Study|Physician Decision|0|||
147564363|NCT00064753|532224321|FG000|Overall Study|Death|251|||
147228591|NCT02349061|531010442|FG001|Main Study: PCP (Up to Week 24)|Lack of Efficacy|0|||
147564364|NCT00064753|532224322|FG001|Overall Study|Death|242|||
147564365|NCT00064753|532224321|FG000|Overall Study|Withdrawal by Subject|198|||
147564366|NCT00064753|532224322|FG001|Overall Study|Withdrawal by Subject|171|||
147564367|NCT00064753|532224321|FG000|Overall Study|Lost to Follow-up|225|||
147564368|NCT00064753|532224322|FG001|Overall Study|Lost to Follow-up|235|||
147564369|NCT02193880|532224325|FG000|Overall Study|patients did not collect enough HPC|3|||
147564370|NCT03522675|532224326|FG000|Overall Study|Screen fail|1|||
147564371|NCT03522675|532224326|FG000|Overall Study|Non-reactive to histamine|1|||
147564372|NCT00707161|532224327|FG000|Overall Study|Physician Decision|6|||
147564373|NCT02674477|532224328|FG000|Overall Study|Protocol Violation|8|||
147564374|NCT02674477|532224329|FG001|Overall Study|Protocol Violation|2|||
147564375|NCT00296647|532224330|FG000|Overall Study|Death|4|||
147228592|NCT02349061|531010443|FG002|Main Study: PCP (Up to Week 24)|Lack of Efficacy|0|||
147564376|NCT00296647|532224331|FG001|Overall Study|Death|1|||
147564377|NCT00296647|532224332|FG002|Overall Study|Death|2|||
147564378|NCT00296647|532224333|FG003|Overall Study|Death|1|||
147564379|NCT00296647|532224334|FG004|Overall Study|Death|1|||
147564380|NCT00296647|532224330|FG000|Overall Study|Withdrawal by Subject|28|||
147228593|NCT02349061|531010441|FG000|Main Study: PCP (Up to Week 24)|Physician Decision|1|||
147564381|NCT00296647|532224331|FG001|Overall Study|Withdrawal by Subject|27|||
147564382|NCT00296647|532224332|FG002|Overall Study|Withdrawal by Subject|32|||
147228594|NCT02349061|531010442|FG001|Main Study: PCP (Up to Week 24)|Physician Decision|0|||
147564383|NCT00296647|532224333|FG003|Overall Study|Withdrawal by Subject|16|||
147564384|NCT00296647|532224334|FG004|Overall Study|Withdrawal by Subject|19|||
147564385|NCT00565448|532224335|FG000|Overall Study|Adverse Event|1|||
147564386|NCT00565448|532224336|FG001|Overall Study|Adverse Event|2|||
147564387|NCT00565448|532224335|FG000|Overall Study|Disease progression|1|||
147564388|NCT00565448|532224336|FG001|Overall Study|Disease progression|0|||
147564389|NCT00565448|532224335|FG000|Overall Study|Withdrawal by Subject|1|||
147564390|NCT00565448|532224336|FG001|Overall Study|Withdrawal by Subject|0|||
147564391|NCT01863745|532224337|FG000|Overall Study|Disease Progression|9|||
147564392|NCT01863745|532224337|FG000|Overall Study|Adverse Event|2|||
147564393|NCT01863745|532224337|FG000|Overall Study|Death|1|||
147564394|NCT01863745|532224337|FG000|Overall Study|Withdrawal by Subject|1|||
147564395|NCT00193609|532224338|FG000|Overall Study|Lack of Efficacy|2|||
147564396|NCT00193609|532224338|FG000|Overall Study|Adverse Event|2|||
147564397|NCT00735904|532224340|FG000|Overall Study|Adverse Event|3|||
147564398|NCT00735904|532224340|FG000|Overall Study|Death|20|||
147564399|NCT00735904|532224340|FG000|Overall Study|Protocol Violation|1|||
147564400|NCT00735904|532224340|FG000|Overall Study|Withdrawal by Subject|1|||
147564401|NCT00735904|532224340|FG000|Overall Study|Study Terminated by Sponsor|5|||
147564402|NCT00735904|532224340|FG000|Overall Study|Other|8|||
147564403|NCT03361228|532224344|FG000|Overall Study|Other|1|||
147564404|NCT03361228|532224345|FG001|Overall Study|Other|1|||
147564405|NCT03361228|532224344|FG000|Overall Study|Death|3|||
147564406|NCT03361228|532224345|FG001|Overall Study|Death|0|||
147564407|NCT03693430|532224353|FG000|Overall Study|Lost to Follow-up|3|||
147564408|NCT03693430|532224354|FG001|Overall Study|Lost to Follow-up|14|||
147564409|NCT03693430|532224353|FG000|Overall Study|Death|1|||
147564410|NCT03693430|532224354|FG001|Overall Study|Death|0|||
147564411|NCT03693430|532224353|FG000|Overall Study|Withdrawal by Subject|0|||
147564412|NCT03693430|532224354|FG001|Overall Study|Withdrawal by Subject|4|||
147564413|NCT00585689|532224355|FG000|Overall Study|Received different ABI-007 schedule|3|||
147564414|NCT00585689|532224355|FG000|Overall Study|Adverse Event|1|||
147564415|NCT00585689|532224355|FG000|Overall Study|Patient Declined Surgery|1|||
147564416|NCT00585689|532224355|FG000|Overall Study|Patient had unresectable disease|1|||
147564417|NCT00585689|532224355|FG000|Overall Study|Death|1|||
147564418|NCT02930005|532224356|FG000|Overall Study|Lost to Follow-up|1|||
147564419|NCT02930005|532224357|FG001|Overall Study|Lost to Follow-up|5|||
147564420|NCT02373098|532224358|FG000|Overall Study|Lost to Follow-up|1|||
147564421|NCT02373098|532224359|FG001|Overall Study|Lost to Follow-up|0|||
147564422|NCT02373098|532224358|FG000|Overall Study|Protocol Violation|3|||
147564423|NCT02373098|532224359|FG001|Overall Study|Protocol Violation|0|||
147564424|NCT02373098|532224358|FG000|Overall Study|Withdrawal by Subject|5|||
147564425|NCT02373098|532224359|FG001|Overall Study|Withdrawal by Subject|0|||
147564426|NCT02373098|532224358|FG000|Overall Study|Adverse Event|3|||
147564427|NCT02373098|532224359|FG001|Overall Study|Adverse Event|0|||
147564428|NCT00855738|532224366|FG000|Overall Study|Lost to Follow-up|2|||
147564429|NCT00855738|532224366|FG000|Overall Study|Adverse Event|1|||
147564430|NCT00855738|532224366|FG000|Overall Study|Subject Defaulted|1|||
147564431|NCT00855738|532224366|FG000|Overall Study|Death|1|||
147564432|NCT00319735|532224379|FG000|Overall Study|Death|2|||
147564433|NCT00119379|532224385|FG000|Overall Study|Adverse Event|4|||
147564434|NCT00119379|532224386|FG001|Overall Study|Adverse Event|1|||
147564435|NCT00154102|532224387|FG000|Overall Study|investigational study phase ongoing|7|||
147564436|NCT00154102|532224388|FG001|Overall Study|investigational study phase ongoing|2|||
147564437|NCT01811953|532225916|FG000|Overall Study|Adverse Event|0|||
147564438|NCT01811953|532225917|FG001|Overall Study|Adverse Event|0|||
147564439|NCT01811953|532225918|FG002|Overall Study|Adverse Event|0|||
147564440|NCT01811953|532225919|FG003|Overall Study|Adverse Event|1|||
147564441|NCT01811953|532225920|FG004|Overall Study|Adverse Event|0|||
147564442|NCT01811953|532225921|FG005|Overall Study|Adverse Event|1|||
147564443|NCT01811953|532225916|FG000|Overall Study|Protocol Violation|0|||
147564444|NCT01811953|532225917|FG001|Overall Study|Protocol Violation|0|||
147564445|NCT01811953|532225918|FG002|Overall Study|Protocol Violation|0|||
147564446|NCT01811953|532225919|FG003|Overall Study|Protocol Violation|0|||
147564447|NCT01811953|532225920|FG004|Overall Study|Protocol Violation|1|||
147564448|NCT01811953|532225921|FG005|Overall Study|Protocol Violation|0|||
147564449|NCT02533258|532225926|FG000|Overall Study|Adverse Event|1|||
147564450|NCT02533258|532225926|FG000|Overall Study|Death|2|||
147564451|NCT02533258|532225926|FG000|Overall Study|Other|1|||
147564452|NCT02533258|532225926|FG000|Overall Study|Economic factor|1|||
147564453|NCT02533258|532225926|FG000|Overall Study|Progression of pleural effusion|1|||
147564454|NCT02533258|532225926|FG000|Overall Study|Lack of Efficacy|2|||
147564455|NCT03655106|532225927|FG000|Overall Study|Withdrawal by Subject|3|||
147564456|NCT03655106|532225928|FG001|Overall Study|Withdrawal by Subject|2|||
147564457|NCT03655106|532225927|FG000|Overall Study|Lost to Follow-up|2|||
147564458|NCT03655106|532225928|FG001|Overall Study|Lost to Follow-up|1|||
147564459|NCT03655106|532225927|FG000|Overall Study|Duplicate Enrollment|1|||
147564460|NCT03655106|532225928|FG001|Overall Study|Duplicate Enrollment|1|||
147564461|NCT03655106|532225927|FG000|Overall Study|Protocol Violation|3|||
147564462|NCT03655106|532225928|FG001|Overall Study|Protocol Violation|0|||
147564463|NCT01049334|532225930|FG000|Overall Study|Withdrawal by Subject|5|||
147564464|NCT01049334|532225931|FG001|Overall Study|Withdrawal by Subject|3|||
147564465|NCT01049334|532225930|FG000|Overall Study|Adverse Event|2|||
147564466|NCT01049334|532225931|FG001|Overall Study|Adverse Event|3|||
147564467|NCT01049334|532225930|FG000|Overall Study|Physician Decision|2|||
147564468|NCT01049334|532225931|FG001|Overall Study|Physician Decision|0|||
147564469|NCT01049334|532225930|FG000|Overall Study|Protocol Violation|0|||
147564470|NCT01049334|532225931|FG001|Overall Study|Protocol Violation|1|||
147564471|NCT01367457|532225934|FG000|Overall Study|Death|2|||
147564472|NCT01367457|532225935|FG001|Overall Study|Death|0|||
147564473|NCT01367457|532225936|FG002|Overall Study|Death|0|||
147564474|NCT01367457|532225934|FG000|Overall Study|Investigator's decision|2|||
147564475|NCT01367457|532225935|FG001|Overall Study|Investigator's decision|0|||
147564476|NCT01367457|532225936|FG002|Overall Study|Investigator's decision|0|||
147564477|NCT01367457|532225934|FG000|Overall Study|Clinical decline (CD)|2|||
147564478|NCT01367457|532225935|FG001|Overall Study|Clinical decline (CD)|0|||
147564479|NCT01367457|532225936|FG002|Overall Study|Clinical decline (CD)|0|||
147564480|NCT01367457|532225934|FG000|Overall Study|Progression and death|8|||
147564481|NCT01367457|532225935|FG001|Overall Study|Progression and death|0|||
147564482|NCT01367457|532225936|FG002|Overall Study|Progression and death|0|||
147564483|NCT01367457|532225934|FG000|Overall Study|Toxicity|16|||
147564484|NCT01367457|532225935|FG001|Overall Study|Toxicity|0|||
147564485|NCT01367457|532225936|FG002|Overall Study|Toxicity|0|||
147564486|NCT01367457|532225934|FG000|Overall Study|Progression|137|||
147564487|NCT01367457|532225935|FG001|Overall Study|Progression|0|||
147564488|NCT01367457|532225936|FG002|Overall Study|Progression|0|||
147564489|NCT01367457|532225934|FG000|Overall Study|Patient asks for rest + slow progression|1|||
147564490|NCT01367457|532225935|FG001|Overall Study|Patient asks for rest + slow progression|0|||
147564491|NCT01367457|532225936|FG002|Overall Study|Patient asks for rest + slow progression|0|||
147564492|NCT01367457|532225934|FG000|Overall Study|Investigator's opinion, stable disease|1|||
147228595|NCT02349061|531010443|FG002|Main Study: PCP (Up to Week 24)|Physician Decision|0|||
147228596|NCT02349061|531010441|FG000|Main Study: PCP (Up to Week 24)|Other|1|||
147228597|NCT02349061|531010442|FG001|Main Study: PCP (Up to Week 24)|Other|1|||
147228598|NCT02349061|531010443|FG002|Main Study: PCP (Up to Week 24)|Other|0|||
147228599|NCT02349061|531010441|FG000|Main Study: PCP (Up to Week 24)|Withdrawal by Subject|2|||
147228600|NCT02349061|531010442|FG001|Main Study: PCP (Up to Week 24)|Withdrawal by Subject|0|||
147228601|NCT02349061|531010443|FG002|Main Study: PCP (Up to Week 24)|Withdrawal by Subject|0|||
147228602|NCT02349061|531010441|FG000|Main Study: Week 24 to 56|Adverse Event|0|||
147228603|NCT02349061|531010442|FG001|Main Study: Week 24 to 56|Adverse Event|2|||
147228604|NCT02349061|531010443|FG002|Main Study: Week 24 to 56|Adverse Event|1|||
147228605|NCT02349061|531010441|FG000|Main Study: Week 24 to 56|Lack of Efficacy|0|||
147228606|NCT02349061|531010442|FG001|Main Study: Week 24 to 56|Lack of Efficacy|1|||
147228607|NCT02349061|531010443|FG002|Main Study: Week 24 to 56|Lack of Efficacy|0|||
147228608|NCT02349061|531010441|FG000|Main Study: Week 24 to 56|Withdrawal by Subject|0|||
147228609|NCT02349061|531010442|FG001|Main Study: Week 24 to 56|Withdrawal by Subject|0|||
147228610|NCT02349061|531010443|FG002|Main Study: Week 24 to 56|Withdrawal by Subject|1|||
147228611|NCT02349061|531010441|FG000|Main Study: Week 24 to 56|Physician Decision|0|||
147228612|NCT02349061|531010442|FG001|Main Study: Week 24 to 56|Physician Decision|0|||
147228613|NCT02349061|531010443|FG002|Main Study: Week 24 to 56|Physician Decision|1|||
147228614|NCT02349061|531010441|FG000|Study Extension (Week 56 to Week 120)|Adverse Event|0|||
147228615|NCT02349061|531010442|FG001|Study Extension (Week 56 to Week 120)|Adverse Event|3|||
147228616|NCT02349061|531010443|FG002|Study Extension (Week 56 to Week 120)|Adverse Event|0|||
147228617|NCT02349061|531010441|FG000|Study Extension (Week 56 to Week 120)|Lack of Efficacy|0|||
147228618|NCT02349061|531010442|FG001|Study Extension (Week 56 to Week 120)|Lack of Efficacy|0|||
147228619|NCT02349061|531010443|FG002|Study Extension (Week 56 to Week 120)|Lack of Efficacy|1|||
147228620|NCT02349061|531010441|FG000|Study Extension (Week 56 to Week 120)|Withdrawal by Subject|0|||
147228621|NCT02349061|531010442|FG001|Study Extension (Week 56 to Week 120)|Withdrawal by Subject|2|||
147228622|NCT02349061|531010443|FG002|Study Extension (Week 56 to Week 120)|Withdrawal by Subject|1|||
147228623|NCT02349061|531010441|FG000|Study Extension (Week 56 to Week 120)|Physician Decision|0|||
147228624|NCT02349061|531010442|FG001|Study Extension (Week 56 to Week 120)|Physician Decision|0|||
147228625|NCT02349061|531010443|FG002|Study Extension (Week 56 to Week 120)|Physician Decision|1|||
147228626|NCT02095223|531010446|FG000|Overall Study|Withdrawal by Subject|1|||
147228627|NCT02095223|531010447|FG001|Overall Study|Withdrawal by Subject|0|||
147228628|NCT01507298|531010448|FG000|Overall Study|Protocol Violation|0|||
147564493|NCT01367457|532225935|FG001|Overall Study|Investigator's opinion, stable disease|0|||
147564494|NCT01367457|532225936|FG002|Overall Study|Investigator's opinion, stable disease|0|||
147564495|NCT01367457|532225934|FG000|Overall Study|Bleeding from cavernous haemangioma|1|||
147564496|NCT01367457|532225935|FG001|Overall Study|Bleeding from cavernous haemangioma|0|||
147564497|NCT01367457|532225936|FG002|Overall Study|Bleeding from cavernous haemangioma|0|||
147228629|NCT01507298|531010449|FG001|Overall Study|Protocol Violation|6|||
147564498|NCT01367457|532225934|FG000|Overall Study|3 yr Temsirolimus treatment (no disease)|1|||
147564499|NCT01367457|532225935|FG001|Overall Study|3 yr Temsirolimus treatment (no disease)|0|||
147564500|NCT01367457|532225936|FG002|Overall Study|3 yr Temsirolimus treatment (no disease)|0|||
147228630|NCT03906461|531010450|FG000|Completed 12-month Follow-up|Withdrawal by Subject|4|||
147228631|NCT03906461|531010450|FG000|Completed 12-month Follow-up|Missed Visit|6|||
147564501|NCT01367457|532225934|FG000|Overall Study|low grade toxicities + stable disease|1|||
147564502|NCT01367457|532225935|FG001|Overall Study|low grade toxicities + stable disease|0|||
147564503|NCT01367457|532225936|FG002|Overall Study|low grade toxicities + stable disease|0|||
147564504|NCT01367457|532225934|FG000|Overall Study|Choledocolithiasis and pancreatitis|1|||
147564505|NCT01367457|532225935|FG001|Overall Study|Choledocolithiasis and pancreatitis|0|||
147564506|NCT01367457|532225936|FG002|Overall Study|Choledocolithiasis and pancreatitis|0|||
147564507|NCT01367457|532225934|FG000|Overall Study|Withdrawal by Subject|1|||
147564508|NCT01367457|532225935|FG001|Overall Study|Withdrawal by Subject|0|||
147564509|NCT01367457|532225936|FG002|Overall Study|Withdrawal by Subject|0|||
147564510|NCT01367457|532225934|FG000|Overall Study|CD, associated leukaemia|1|||
147564511|NCT01367457|532225935|FG001|Overall Study|CD, associated leukaemia|0|||
147564512|NCT01367457|532225936|FG002|Overall Study|CD, associated leukaemia|0|||
147564513|NCT01367457|532225934|FG000|Overall Study|Uncontrolled pain|1|||
147564514|NCT01367457|532225935|FG001|Overall Study|Uncontrolled pain|0|||
147564515|NCT01367457|532225936|FG002|Overall Study|Uncontrolled pain|0|||
147564516|NCT01367457|532225934|FG000|Overall Study|Overall status worsens to grade 4|1|||
147564517|NCT01367457|532225935|FG001|Overall Study|Overall status worsens to grade 4|0|||
147564518|NCT01367457|532225936|FG002|Overall Study|Overall status worsens to grade 4|0|||
147564519|NCT01367457|532225934|FG000|Overall Study|Stabilisation + frequent infections|1|||
147564520|NCT01367457|532225935|FG001|Overall Study|Stabilisation + frequent infections|0|||
147564521|NCT01367457|532225936|FG002|Overall Study|Stabilisation + frequent infections|0|||
147564522|NCT01367457|532225934|FG000|Overall Study|No clinical benefit|1|||
147564523|NCT01367457|532225935|FG001|Overall Study|No clinical benefit|0|||
147564524|NCT01367457|532225936|FG002|Overall Study|No clinical benefit|0|||
147564525|NCT01367457|532225934|FG000|Overall Study|Intestinal obstruction with necrosis|1|||
147564526|NCT01367457|532225935|FG001|Overall Study|Intestinal obstruction with necrosis|0|||
147564527|NCT01367457|532225936|FG002|Overall Study|Intestinal obstruction with necrosis|0|||
147564528|NCT01367457|532225934|FG000|Overall Study|Overall decline|1|||
147564529|NCT01367457|532225935|FG001|Overall Study|Overall decline|0|||
147564530|NCT01367457|532225936|FG002|Overall Study|Overall decline|0|||
147564531|NCT01367457|532225934|FG000|Overall Study|Rejection of treatment|1|||
147564532|NCT01367457|532225935|FG001|Overall Study|Rejection of treatment|0|||
147564533|NCT01367457|532225936|FG002|Overall Study|Rejection of treatment|0|||
147564534|NCT01367457|532225934|FG000|Overall Study|Lost to Follow-up|1|||
147564535|NCT01367457|532225935|FG001|Overall Study|Lost to Follow-up|0|||
147564536|NCT01367457|532225936|FG002|Overall Study|Lost to Follow-up|0|||
147564537|NCT01367457|532225934|FG000|Overall Study|Death from septic shock|1|||
147564538|NCT01367457|532225935|FG001|Overall Study|Death from septic shock|0|||
147564539|NCT01367457|532225936|FG002|Overall Study|Death from septic shock|0|||
147564540|NCT01367457|532225934|FG000|Overall Study|CD, Suspected disease progression (DP)|1|||
147564541|NCT01367457|532225935|FG001|Overall Study|CD, Suspected disease progression (DP)|0|||
147564542|NCT01367457|532225936|FG002|Overall Study|CD, Suspected disease progression (DP)|0|||
147564543|NCT01367457|532225934|FG000|Overall Study|Patient's Wish|1|||
147564544|NCT01367457|532225935|FG001|Overall Study|Patient's Wish|0|||
147564545|NCT01367457|532225936|FG002|Overall Study|Patient's Wish|0|||
147564546|NCT01367457|532225934|FG000|Overall Study|Palliative. Overall decline|1|||
147564547|NCT01367457|532225935|FG001|Overall Study|Palliative. Overall decline|0|||
147564548|NCT01367457|532225936|FG002|Overall Study|Palliative. Overall decline|0|||
147564549|NCT01367457|532225934|FG000|Overall Study|Suspected DP/suspected active infection|1|||
147564550|NCT01367457|532225935|FG001|Overall Study|Suspected DP/suspected active infection|0|||
147564551|NCT01367457|532225936|FG002|Overall Study|Suspected DP/suspected active infection|0|||
147564552|NCT03447262|532225937|FG000|Overall Study|Adverse Event|7|||
147564553|NCT03447262|532225937|FG000|Overall Study|Withdrawal of Consent (not due to AE)|2|||
147564554|NCT03447262|532225937|FG000|Overall Study|Commercial Drug is Available for Participant|9|||
147564555|NCT03447262|532225937|FG000|Overall Study|Death|2|||
147564556|NCT03447262|532225937|FG000|Overall Study|Study Termination by Sponsor|455|||
147564557|NCT03447262|532225937|FG000|Overall Study|Other|4|||
147564558|NCT02058498|532225938|FG000|Overall Study|Withdrawal by Subject|4|||
147564559|NCT03988803|532225939|FG000|Period 2|Prematurely discontinued from medication|2|||
147564560|NCT03988803|532225939|FG000|Period 2|Adverse Event|1|||
147564561|NCT05038293|532225949|FG000|Overall Study|device was not operating properly for one subject.|1|||
147564562|NCT05038293|532225950|FG001|Overall Study|device was not operating properly for one subject.|0|||
147564563|NCT05038293|532225949|FG000|Overall Study|one subject was dropped due to a behavioral issue|1|||
147564564|NCT05038293|532225950|FG001|Overall Study|one subject was dropped due to a behavioral issue|0|||
147564565|NCT01171989|532225951|FG000|Overall Study|Lost to Follow-up|0|||
147564566|NCT01171989|532225952|FG001|Overall Study|Lost to Follow-up|0|||
147564567|NCT01171989|532225953|FG002|Overall Study|Lost to Follow-up|1|||
147564568|NCT02822235|532225954|FG000|Cross-sectional Phase (Day 1)|Not Eligible for Prospective Follow-up|144|||
147564569|NCT02822235|532225955|FG001|Cross-sectional Phase (Day 1)|Not Eligible for Prospective Follow-up|107|||
147564570|NCT02822235|532225954|FG000|Cross-sectional Phase (Day 1)|Reason Not Specified|2|||
147564571|NCT02822235|532225955|FG001|Cross-sectional Phase (Day 1)|Reason Not Specified|0|||
147650874|NCT02757352|532544543|FG006|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
147228632|NCT00426231|531010453|FG000|Overall Study|Withdrawal by Subject|9|||
147564572|NCT02822235|532225954|FG000|Prospective Phase (Day 1 up to Month 12)|Withdrawal of Consent|0|||
147564573|NCT02822235|532225955|FG001|Prospective Phase (Day 1 up to Month 12)|Withdrawal of Consent|1|||
147564574|NCT02822235|532225954|FG000|Prospective Phase (Day 1 up to Month 12)|Lost to Follow-up|4|||
147228633|NCT00426231|531010454|FG001|Overall Study|Withdrawal by Subject|12|||
147228634|NCT01795638|531010455|FG000|Overall Study|Death|0|||
147228635|NCT01795638|531010456|FG001|Overall Study|Death|3|||
147564575|NCT02822235|532225955|FG001|Prospective Phase (Day 1 up to Month 12)|Lost to Follow-up|0|||
147564576|NCT02822235|532225954|FG000|Prospective Phase (Day 1 up to Month 12)|Death|1|||
147564577|NCT02822235|532225955|FG001|Prospective Phase (Day 1 up to Month 12)|Death|0|||
147564578|NCT02822235|532225954|FG000|Prospective Phase (Day 1 up to Month 12)|Reason Not Specified|6|||
147564579|NCT02822235|532225955|FG001|Prospective Phase (Day 1 up to Month 12)|Reason Not Specified|1|||
147564580|NCT00627016|532225956|FG000|Overall Study|Adverse Event|1|||
147564581|NCT00627016|532225957|FG001|Overall Study|Adverse Event|1|||
147564582|NCT00627016|532225956|FG000|Overall Study|Protocol Violation|0|||
147564583|NCT00627016|532225957|FG001|Overall Study|Protocol Violation|2|||
147564584|NCT00627016|532225956|FG000|Overall Study|Lost to Follow-up|0|||
147564585|NCT00627016|532225957|FG001|Overall Study|Lost to Follow-up|1|||
147564586|NCT00627016|532225956|FG000|Overall Study|Withdrawal by Subject|2|||
147564587|NCT00627016|532225957|FG001|Overall Study|Withdrawal by Subject|1|||
147564588|NCT00627016|532225956|FG000|Overall Study|Failed Inclusion/Exclusion Criteria|0|||
147564589|NCT00627016|532225957|FG001|Overall Study|Failed Inclusion/Exclusion Criteria|1|||
147564590|NCT00627016|532225956|FG000|Overall Study|Lack of Efficacy|1|||
147564591|NCT00627016|532225957|FG001|Overall Study|Lack of Efficacy|0|||
147564592|NCT00627016|532225956|FG000|Overall Study|Placed on Excluded Drugs|1|||
147564593|NCT00627016|532225957|FG001|Overall Study|Placed on Excluded Drugs|0|||
147564594|NCT00627016|532225956|FG000|Overall Study|Pregnancy|1|||
147564595|NCT00627016|532225957|FG001|Overall Study|Pregnancy|0|||
147564596|NCT00829530|532225958|FG000|First Intervention|Adverse Event|0|||
147564597|NCT00829530|532225959|FG001|First Intervention|Adverse Event|1|||
147564598|NCT00829530|532225958|FG000|First Intervention|Intolerance to Venopuncture|0|||
147564599|NCT00829530|532225959|FG001|First Intervention|Intolerance to Venopuncture|1|||
147564600|NCT00829530|532225958|FG000|Second Intervention|Intolerance to Venopuncture|1|||
147564601|NCT00829530|532225959|FG001|Second Intervention|Intolerance to Venopuncture|0|||
147564602|NCT04466111|532225961|FG000|Prior to Trial Phase|Physician Decision|1|||
147564603|NCT02511782|532225970|FG000|Overall Study|Withdrawal by Subject|1|||
147564604|NCT02511782|532225971|FG001|Overall Study|Withdrawal by Subject|0|||
147564605|NCT02511782|532225972|FG002|Overall Study|Withdrawal by Subject|0|||
147564606|NCT00112463|532225973|FG000|Overall Study|Physician Decision|1|||
147564607|NCT00112463|532225973|FG000|Overall Study|Progression|30|||
147564608|NCT00112463|532225973|FG000|Overall Study|Second Primary|1|||
147564609|NCT00112463|532225973|FG000|Overall Study|Toxicity|3|||
147564610|NCT00112463|532225973|FG000|Overall Study|Withdrawal by Subject|2|||
147564611|NCT00112463|532225973|FG000|Overall Study|Never started treatment|2|||
147564612|NCT01171963|532225974|FG000|Overall Study|Adverse Event|10|||
147564613|NCT01171963|532225975|FG001|Overall Study|Adverse Event|15|||
147564614|NCT01171963|532225974|FG000|Overall Study|Lost to Follow-up|23|||
147564615|NCT01171963|532225975|FG001|Overall Study|Lost to Follow-up|24|||
147564616|NCT01171963|532225974|FG000|Overall Study|Other - diarrhoea|1|||
147564617|NCT01171963|532225975|FG001|Overall Study|Other - diarrhoea|0|||
147564618|NCT01171963|532225974|FG000|Overall Study|Withdrawal by Subject|114|||
147564619|NCT01171963|532225975|FG001|Overall Study|Withdrawal by Subject|129|||
147564620|NCT05093205|532225976|FG000|Part A Period 2 - Treatment|Physician Decision|0|||
147564621|NCT05093205|532225977|FG001|Part A Period 2 - Treatment|Physician Decision|1|||
147564622|NCT05093205|532225978|FG002|Part A Period 2 - Treatment|Physician Decision|0|||
147564623|NCT05093205|532225979|FG003|Part A Period 2 - Treatment|Physician Decision|0|||
147564624|NCT05093205|532225980|FG004|Part A Period 2 - Treatment|Physician Decision|0|||
147564625|NCT05093205|532225981|FG005|Part A Period 2 - Treatment|Physician Decision|0|||
147564626|NCT05093205|532225982|FG006|Part A Period 2 - Treatment|Physician Decision|0|||
147564627|NCT05093205|532225983|FG007|Part A Period 2 - Treatment|Physician Decision|0|||
147564628|NCT05093205|532225984|FG008|Part A Period 2 - Treatment|Physician Decision|0|||
147564629|NCT05093205|532225985|FG009|Part A Period 2 - Treatment|Physician Decision|0|||
147228636|NCT01795638|531010455|FG000|Overall Study|transferred to quaternary hospital|2|||
147564630|NCT05093205|532225986|FG010|Part A Period 2 - Treatment|Physician Decision|0|||
147564631|NCT05093205|532225987|FG011|Part A Period 2 - Treatment|Physician Decision|0|||
147564632|NCT05093205|532225988|FG012|Part A Period 2 - Treatment|Physician Decision|0|||
147564633|NCT05093205|532225976|FG000|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
147228637|NCT01795638|531010456|FG001|Overall Study|transferred to quaternary hospital|3|||
147228638|NCT01795638|531010455|FG000|Overall Study|Protocol Violation|3|||
147564634|NCT05093205|532225977|FG001|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
147564635|NCT05093205|532225978|FG002|Part A Period 3 - Treatment|Withdrawal by Subject|1|||
147564636|NCT05093205|532225979|FG003|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
147564637|NCT05093205|532225980|FG004|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
147650875|NCT02757352|532544544|FG007|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
147564638|NCT05093205|532225981|FG005|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
147564639|NCT05093205|532225982|FG006|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
147564640|NCT05093205|532225983|FG007|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
147564641|NCT05093205|532225984|FG008|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
147564642|NCT05093205|532225985|FG009|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
147564643|NCT05093205|532225986|FG010|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
147564644|NCT05093205|532225987|FG011|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
147564645|NCT05093205|532225988|FG012|Part A Period 3 - Treatment|Withdrawal by Subject|0|||
147564646|NCT05093205|532225976|FG000|Part A Period 3 - Treatment|Physician Decision|0|||
147564647|NCT05093205|532225977|FG001|Part A Period 3 - Treatment|Physician Decision|0|||
147564648|NCT05093205|532225978|FG002|Part A Period 3 - Treatment|Physician Decision|1|||
147564649|NCT05093205|532225979|FG003|Part A Period 3 - Treatment|Physician Decision|0|||
147564650|NCT05093205|532225980|FG004|Part A Period 3 - Treatment|Physician Decision|0|||
147564651|NCT05093205|532225981|FG005|Part A Period 3 - Treatment|Physician Decision|0|||
147564652|NCT05093205|532225982|FG006|Part A Period 3 - Treatment|Physician Decision|0|||
147564653|NCT05093205|532225983|FG007|Part A Period 3 - Treatment|Physician Decision|0|||
147564654|NCT05093205|532225984|FG008|Part A Period 3 - Treatment|Physician Decision|0|||
147228639|NCT01795638|531010456|FG001|Overall Study|Protocol Violation|0|||
147228640|NCT01795638|531010455|FG000|Overall Study|discharged from hospital|7|||
147228641|NCT01795638|531010456|FG001|Overall Study|discharged from hospital|5|||
147228642|NCT01795638|531010455|FG000|Overall Study|Withdrawal by Subject|1|||
147228643|NCT01795638|531010456|FG001|Overall Study|Withdrawal by Subject|0|||
147228644|NCT03061097|531010457|FG000|Overall Study|Withdrawal by Subject|0|||
147228645|NCT03061097|531010458|FG001|Overall Study|Withdrawal by Subject|3|||
147228646|NCT00595465|531010465|FG000|Overall Study|Adverse Event|4|||
147228647|NCT00595465|531010466|FG001|Overall Study|Adverse Event|3|||
147564655|NCT05093205|532225985|FG009|Part A Period 3 - Treatment|Physician Decision|0|||
147564656|NCT05093205|532225986|FG010|Part A Period 3 - Treatment|Physician Decision|0|||
147564657|NCT05093205|532225987|FG011|Part A Period 3 - Treatment|Physician Decision|0|||
147564658|NCT05093205|532225988|FG012|Part A Period 3 - Treatment|Physician Decision|0|||
147564659|NCT05093205|532225976|FG000|Part A Period 3 - Treatment|Adverse Event|0|||
147564660|NCT05093205|532225977|FG001|Part A Period 3 - Treatment|Adverse Event|0|||
147564661|NCT05093205|532225978|FG002|Part A Period 3 - Treatment|Adverse Event|2|||
147564662|NCT05093205|532225979|FG003|Part A Period 3 - Treatment|Adverse Event|0|||
147564663|NCT05093205|532225980|FG004|Part A Period 3 - Treatment|Adverse Event|0|||
147564664|NCT05093205|532225981|FG005|Part A Period 3 - Treatment|Adverse Event|0|||
147564665|NCT05093205|532225982|FG006|Part A Period 3 - Treatment|Adverse Event|0|||
147564666|NCT05093205|532225983|FG007|Part A Period 3 - Treatment|Adverse Event|0|||
147564667|NCT05093205|532225984|FG008|Part A Period 3 - Treatment|Adverse Event|0|||
147564668|NCT05093205|532225985|FG009|Part A Period 3 - Treatment|Adverse Event|0|||
147564669|NCT05093205|532225986|FG010|Part A Period 3 - Treatment|Adverse Event|0|||
147564670|NCT05093205|532225987|FG011|Part A Period 3 - Treatment|Adverse Event|0|||
147564671|NCT05093205|532225988|FG012|Part A Period 3 - Treatment|Adverse Event|0|||
147564672|NCT05093205|532225976|FG000|Part A Period 6 - Treatment|Adverse Event|0|||
147564673|NCT05093205|532225977|FG001|Part A Period 6 - Treatment|Adverse Event|0|||
147564674|NCT05093205|532225978|FG002|Part A Period 6 - Treatment|Adverse Event|0|||
147564675|NCT05093205|532225979|FG003|Part A Period 6 - Treatment|Adverse Event|0|||
147564676|NCT05093205|532225980|FG004|Part A Period 6 - Treatment|Adverse Event|0|||
147564677|NCT05093205|532225981|FG005|Part A Period 6 - Treatment|Adverse Event|7|||
147564678|NCT05093205|532225982|FG006|Part A Period 6 - Treatment|Adverse Event|0|||
147564679|NCT05093205|532225983|FG007|Part A Period 6 - Treatment|Adverse Event|0|||
147564680|NCT05093205|532225984|FG008|Part A Period 6 - Treatment|Adverse Event|0|||
147564681|NCT05093205|532225985|FG009|Part A Period 6 - Treatment|Adverse Event|0|||
147564682|NCT05093205|532225986|FG010|Part A Period 6 - Treatment|Adverse Event|0|||
147564683|NCT05093205|532225987|FG011|Part A Period 6 - Treatment|Adverse Event|0|||
147564684|NCT05093205|532225988|FG012|Part A Period 6 - Treatment|Adverse Event|0|||
147564685|NCT05093205|532225976|FG000|Part A Period 8 - Treatment|Adverse Event|0|||
147228648|NCT00595465|531010467|FG002|Overall Study|Adverse Event|3|||
147228649|NCT00595465|531010465|FG000|Overall Study|Pregnancy|0|||
147228650|NCT00595465|531010466|FG001|Overall Study|Pregnancy|0|||
147228651|NCT00595465|531010467|FG002|Overall Study|Pregnancy|1|||
147564686|NCT05093205|532225977|FG001|Part A Period 8 - Treatment|Adverse Event|0|||
147564687|NCT05093205|532225978|FG002|Part A Period 8 - Treatment|Adverse Event|0|||
147564688|NCT05093205|532225979|FG003|Part A Period 8 - Treatment|Adverse Event|0|||
147564689|NCT05093205|532225980|FG004|Part A Period 8 - Treatment|Adverse Event|0|||
147564690|NCT05093205|532225981|FG005|Part A Period 8 - Treatment|Adverse Event|0|||
147564691|NCT05093205|532225982|FG006|Part A Period 8 - Treatment|Adverse Event|0|||
147564692|NCT05093205|532225983|FG007|Part A Period 8 - Treatment|Adverse Event|1|||
147564693|NCT05093205|532225984|FG008|Part A Period 8 - Treatment|Adverse Event|0|||
147564694|NCT05093205|532225985|FG009|Part A Period 8 - Treatment|Adverse Event|0|||
147564695|NCT05093205|532225986|FG010|Part A Period 8 - Treatment|Adverse Event|0|||
147564696|NCT05093205|532225987|FG011|Part A Period 8 - Treatment|Adverse Event|0|||
147564697|NCT05093205|532225988|FG012|Part A Period 8 - Treatment|Adverse Event|0|||
147564698|NCT05093205|532225976|FG000|Part B Period 1 - Treatment|Protocol Violation|0|||
147564699|NCT05093205|532225977|FG001|Part B Period 1 - Treatment|Protocol Violation|0|||
147564700|NCT05093205|532225978|FG002|Part B Period 1 - Treatment|Protocol Violation|0|||
147564701|NCT05093205|532225979|FG003|Part B Period 1 - Treatment|Protocol Violation|0|||
147564702|NCT05093205|532225980|FG004|Part B Period 1 - Treatment|Protocol Violation|0|||
147564703|NCT05093205|532225981|FG005|Part B Period 1 - Treatment|Protocol Violation|0|||
147564704|NCT05093205|532225982|FG006|Part B Period 1 - Treatment|Protocol Violation|0|||
147564705|NCT05093205|532225983|FG007|Part B Period 1 - Treatment|Protocol Violation|0|||
147564706|NCT05093205|532225984|FG008|Part B Period 1 - Treatment|Protocol Violation|1|||
147564707|NCT05093205|532225985|FG009|Part B Period 1 - Treatment|Protocol Violation|0|||
147564708|NCT05093205|532225986|FG010|Part B Period 1 - Treatment|Protocol Violation|0|||
147564709|NCT05093205|532225987|FG011|Part B Period 1 - Treatment|Protocol Violation|0|||
147564710|NCT05093205|532225988|FG012|Part B Period 1 - Treatment|Protocol Violation|0|||
147564711|NCT05093205|532225976|FG000|Part B Period 2 - Treatment|Adverse Event|0|||
147564712|NCT05093205|532225977|FG001|Part B Period 2 - Treatment|Adverse Event|0|||
147564713|NCT05093205|532225978|FG002|Part B Period 2 - Treatment|Adverse Event|0|||
147564714|NCT05093205|532225979|FG003|Part B Period 2 - Treatment|Adverse Event|0|||
147564715|NCT05093205|532225980|FG004|Part B Period 2 - Treatment|Adverse Event|0|||
147564716|NCT05093205|532225981|FG005|Part B Period 2 - Treatment|Adverse Event|0|||
147564717|NCT05093205|532225982|FG006|Part B Period 2 - Treatment|Adverse Event|0|||
147564718|NCT05093205|532225983|FG007|Part B Period 2 - Treatment|Adverse Event|0|||
147564719|NCT05093205|532225984|FG008|Part B Period 2 - Treatment|Adverse Event|0|||
147564720|NCT05093205|532225985|FG009|Part B Period 2 - Treatment|Adverse Event|2|||
147564721|NCT05093205|532225986|FG010|Part B Period 2 - Treatment|Adverse Event|0|||
147564722|NCT05093205|532225987|FG011|Part B Period 2 - Treatment|Adverse Event|0|||
147564723|NCT05093205|532225988|FG012|Part B Period 2 - Treatment|Adverse Event|0|||
147564724|NCT05093205|532225976|FG000|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
147564725|NCT05093205|532225977|FG001|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
147564726|NCT05093205|532225978|FG002|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
147564727|NCT05093205|532225979|FG003|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
147564728|NCT05093205|532225980|FG004|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
147564729|NCT05093205|532225981|FG005|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
147564730|NCT05093205|532225982|FG006|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
147564731|NCT05093205|532225983|FG007|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
147564732|NCT05093205|532225984|FG008|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
147564733|NCT05093205|532225985|FG009|Part B Period 2 - Follow-Up|Withdrawal by Subject|1|||
147564734|NCT05093205|532225986|FG010|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
147564735|NCT05093205|532225987|FG011|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
147564736|NCT05093205|532225988|FG012|Part B Period 2 - Follow-Up|Withdrawal by Subject|0|||
147564737|NCT05093205|532225976|FG000|Part B Period 3 - Treatment|Adverse Event|0|||
147564738|NCT05093205|532225977|FG001|Part B Period 3 - Treatment|Adverse Event|0|||
147564739|NCT05093205|532225978|FG002|Part B Period 3 - Treatment|Adverse Event|0|||
147564740|NCT05093205|532225979|FG003|Part B Period 3 - Treatment|Adverse Event|0|||
147564741|NCT05093205|532225980|FG004|Part B Period 3 - Treatment|Adverse Event|0|||
147564742|NCT05093205|532225981|FG005|Part B Period 3 - Treatment|Adverse Event|0|||
147564743|NCT05093205|532225982|FG006|Part B Period 3 - Treatment|Adverse Event|0|||
147564744|NCT05093205|532225983|FG007|Part B Period 3 - Treatment|Adverse Event|0|||
147564745|NCT05093205|532225984|FG008|Part B Period 3 - Treatment|Adverse Event|0|||
147564746|NCT05093205|532225985|FG009|Part B Period 3 - Treatment|Adverse Event|0|||
147564747|NCT05093205|532225986|FG010|Part B Period 3 - Treatment|Adverse Event|2|||
147564748|NCT05093205|532225987|FG011|Part B Period 3 - Treatment|Adverse Event|0|||
147564749|NCT05093205|532225988|FG012|Part B Period 3 - Treatment|Adverse Event|0|||
147564750|NCT05093205|532225976|FG000|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
147564751|NCT05093205|532225977|FG001|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
147564752|NCT05093205|532225978|FG002|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
147564753|NCT05093205|532225979|FG003|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
147564754|NCT05093205|532225980|FG004|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
147564755|NCT05093205|532225981|FG005|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
147564756|NCT05093205|532225982|FG006|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
147564757|NCT05093205|532225983|FG007|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
147564758|NCT05093205|532225984|FG008|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
147564759|NCT05093205|532225985|FG009|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
147564760|NCT05093205|532225986|FG010|Part B Period 3 - Follow-Up|Withdrawal by Subject|2|||
147564761|NCT05093205|532225987|FG011|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
147564762|NCT05093205|532225988|FG012|Part B Period 3 - Follow-Up|Withdrawal by Subject|0|||
147564763|NCT05093205|532225976|FG000|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
147564764|NCT05093205|532225977|FG001|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
147564765|NCT05093205|532225978|FG002|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
147564766|NCT05093205|532225979|FG003|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
147564767|NCT05093205|532225980|FG004|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
147564768|NCT05093205|532225981|FG005|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
147564769|NCT05093205|532225982|FG006|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
147564770|NCT05093205|532225983|FG007|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
147312071|NCT01164228|531309255|FG001|Overall Study|Never started treatment|3|||
147564771|NCT05093205|532225984|FG008|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
147564772|NCT05093205|532225985|FG009|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
147564773|NCT05093205|532225986|FG010|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
147564774|NCT05093205|532225987|FG011|Part B Period 4 - Treatment|Withdrawal by Subject|1|||
147564775|NCT05093205|532225988|FG012|Part B Period 4 - Treatment|Withdrawal by Subject|0|||
147564776|NCT05093205|532225976|FG000|Part B Period 4 - Treatment|Adverse Event|0|||
147564777|NCT05093205|532225977|FG001|Part B Period 4 - Treatment|Adverse Event|0|||
147564778|NCT05093205|532225978|FG002|Part B Period 4 - Treatment|Adverse Event|0|||
147564779|NCT05093205|532225979|FG003|Part B Period 4 - Treatment|Adverse Event|0|||
147564780|NCT05093205|532225980|FG004|Part B Period 4 - Treatment|Adverse Event|0|||
147564781|NCT05093205|532225981|FG005|Part B Period 4 - Treatment|Adverse Event|0|||
147564782|NCT05093205|532225982|FG006|Part B Period 4 - Treatment|Adverse Event|0|||
147564783|NCT05093205|532225983|FG007|Part B Period 4 - Treatment|Adverse Event|0|||
147564784|NCT05093205|532225984|FG008|Part B Period 4 - Treatment|Adverse Event|0|||
147564785|NCT05093205|532225985|FG009|Part B Period 4 - Treatment|Adverse Event|0|||
147564786|NCT05093205|532225986|FG010|Part B Period 4 - Treatment|Adverse Event|0|||
147564787|NCT05093205|532225987|FG011|Part B Period 4 - Treatment|Adverse Event|2|||
147564788|NCT05093205|532225988|FG012|Part B Period 4 - Treatment|Adverse Event|0|||
147564789|NCT05093205|532225976|FG000|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
147564790|NCT05093205|532225977|FG001|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
147564791|NCT05093205|532225978|FG002|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
147564792|NCT05093205|532225979|FG003|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
147564793|NCT05093205|532225980|FG004|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
147564794|NCT05093205|532225981|FG005|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
147564795|NCT05093205|532225982|FG006|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
147564796|NCT05093205|532225983|FG007|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
147564797|NCT05093205|532225984|FG008|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
147564798|NCT05093205|532225985|FG009|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
147564799|NCT05093205|532225986|FG010|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
147564800|NCT05093205|532225987|FG011|Part B Period 4 - Follow-Up|Withdrawal by Subject|1|||
147564801|NCT05093205|532225988|FG012|Part B Period 4 - Follow-Up|Withdrawal by Subject|0|||
147564802|NCT02979353|532225993|FG000|Overall Study|Hospital Discharge to Non-Partner PAC or Non- PAC Location|24|||
147564803|NCT02979353|532225994|FG001|Overall Study|Hospital Discharge to Non-Partner PAC or Non- PAC Location|29|||
147564804|NCT02979353|532225993|FG000|Overall Study|Withdrawal by Subject|16|||
147564805|NCT02979353|532225994|FG001|Overall Study|Withdrawal by Subject|12|||
147564806|NCT02979353|532225993|FG000|Overall Study|Death|10|||
147564807|NCT02979353|532225994|FG001|Overall Study|Death|11|||
147564808|NCT02979353|532225993|FG000|Overall Study|Transfer to Hospice Care|19|||
147564809|NCT02979353|532225994|FG001|Overall Study|Transfer to Hospice Care|14|||
147564810|NCT02979353|532225993|FG000|Overall Study|Lost to Follow-up|1|||
147564811|NCT02979353|532225994|FG001|Overall Study|Lost to Follow-up|5|||
147564812|NCT01722877|532225997|FG000|Overall Study|Death|1|||
147564813|NCT01722877|532225997|FG000|Overall Study|Lost to Follow-up|1|||
147564814|NCT05067647|532226000|FG000|Overall Study|Lost to Follow-up|1|||
147564815|NCT03897088|532226001|FG000|Overall Study|Withdrawal by Subject|12|||
147564816|NCT03897088|532226002|FG001|Overall Study|Withdrawal by Subject|12|||
147564817|NCT03897088|532226001|FG000|Overall Study|Lost to Follow-up|7|||
147564818|NCT03897088|532226002|FG001|Overall Study|Lost to Follow-up|15|||
147564819|NCT03897088|532226001|FG000|Overall Study|Sponsor Decision|1|||
147564820|NCT03897088|532226002|FG001|Overall Study|Sponsor Decision|2|||
147564821|NCT03897088|532226001|FG000|Overall Study|COVID-19|2|||
147564822|NCT03897088|532226002|FG001|Overall Study|COVID-19|0|||
147564823|NCT03897088|532226001|FG000|Overall Study|Other|3|||
147564824|NCT03897088|532226002|FG001|Overall Study|Other|0|||
147312072|NCT01164228|531309254|FG000|Overall Study|Ineligible|1|||
147312073|NCT01164228|531309255|FG001|Overall Study|Ineligible|0|||
147312074|NCT02090634|531309256|FG000|Overall Study|Lost to Follow-up|0|||
147312075|NCT02090634|531309257|FG001|Overall Study|Lost to Follow-up|1|||
147312076|NCT02090634|531309256|FG000|Overall Study|Death|0|||
147312077|NCT02090634|531309257|FG001|Overall Study|Death|1|||
147312078|NCT02090634|531309256|FG000|Overall Study|Protocol Violation|3|||
147312079|NCT02090634|531309257|FG001|Overall Study|Protocol Violation|1|||
147564825|NCT03897088|532226001|FG000|Overall Study|Non-compliance with Study Drug|1|||
147564826|NCT03897088|532226002|FG001|Overall Study|Non-compliance with Study Drug|1|||
147564827|NCT03897088|532226001|FG000|Overall Study|Pregnancy|0|||
147564828|NCT03897088|532226002|FG001|Overall Study|Pregnancy|1|||
147312080|NCT02090634|531309256|FG000|Overall Study|Adverse Event|2|||
147312081|NCT02090634|531309257|FG001|Overall Study|Adverse Event|0|||
147564829|NCT04320849|532226007|FG000|Overall Study|Withdrawal by Subject|4|||
147564830|NCT04320849|532226007|FG000|Overall Study|Imaging data unavailable|2|||
147564831|NCT04320849|532226007|FG000|Overall Study|Incomplete imaging|2|||
147564832|NCT03929393|532226010|FG000|Overall Study|Death|1|||
147564833|NCT03929393|532226011|FG001|Overall Study|Death|0|||
147564834|NCT03929393|532226010|FG000|Overall Study|Time Commitment|2|||
147564835|NCT03929393|532226011|FG001|Overall Study|Time Commitment|5|||
147564836|NCT03929393|532226010|FG000|Overall Study|Motor Vehicle Accident|0|||
147564837|NCT03929393|532226011|FG001|Overall Study|Motor Vehicle Accident|1|||
147564838|NCT03929393|532226010|FG000|Overall Study|Difficulty Using Videoconferencing Technology|0|||
147564839|NCT03929393|532226011|FG001|Overall Study|Difficulty Using Videoconferencing Technology|1|||
147564840|NCT03929393|532226010|FG000|Overall Study|Other|1|||
147564841|NCT03929393|532226011|FG001|Overall Study|Other|3|||
147564842|NCT01569152|532226018|FG000|Phase IIa, Period 1|Early Escape|5|||
147564843|NCT01569152|532226019|FG001|Phase IIa, Period 1|Early Escape|22|||
147564844|NCT01569152|532226020|FG002|Phase IIa, Period 1|Early Escape|0|||
147564845|NCT01569152|532226018|FG000|Phase IIa, Period 1|Adverse Event|4|||
147564846|NCT01569152|532226019|FG001|Phase IIa, Period 1|Adverse Event|0|||
147564847|NCT01569152|532226020|FG002|Phase IIa, Period 1|Adverse Event|0|||
147564848|NCT01569152|532226018|FG000|Phase IIa, Period 1|Lost to Follow-up|1|||
147564849|NCT01569152|532226019|FG001|Phase IIa, Period 1|Lost to Follow-up|0|||
147564850|NCT01569152|532226020|FG002|Phase IIa, Period 1|Lost to Follow-up|0|||
147564851|NCT01569152|532226018|FG000|Phase IIa, Period 1|Study Terminated by Sponsor|9|||
147564852|NCT01569152|532226019|FG001|Phase IIa, Period 1|Study Terminated by Sponsor|8|||
147564853|NCT01569152|532226020|FG002|Phase IIa, Period 1|Study Terminated by Sponsor|0|||
147564854|NCT01569152|532226018|FG000|Phase IIa, Period 1|Protocol Violation|0|||
147564855|NCT01569152|532226019|FG001|Phase IIa, Period 1|Protocol Violation|1|||
147564856|NCT01569152|532226020|FG002|Phase IIa, Period 1|Protocol Violation|0|||
147564857|NCT01569152|532226018|FG000|Phase IIa, Period 1|Withdrawal by Subject|2|||
147564858|NCT01569152|532226019|FG001|Phase IIa, Period 1|Withdrawal by Subject|1|||
147564859|NCT01569152|532226020|FG002|Phase IIa, Period 1|Withdrawal by Subject|0|||
147564860|NCT01569152|532226018|FG000|Safety Extension, Period 3|Adverse Event|0|||
147564861|NCT01569152|532226019|FG001|Safety Extension, Period 3|Adverse Event|0|||
147564862|NCT01569152|532226020|FG002|Safety Extension, Period 3|Adverse Event|4|||
147564863|NCT01569152|532226018|FG000|Safety Extension, Period 3|Withdrawal by Subject|0|||
147564864|NCT01569152|532226019|FG001|Safety Extension, Period 3|Withdrawal by Subject|0|||
147564865|NCT01569152|532226020|FG002|Safety Extension, Period 3|Withdrawal by Subject|2|||
147564866|NCT01569152|532226018|FG000|Safety Extension, Period 3|Physician Decision|0|||
147564867|NCT01569152|532226019|FG001|Safety Extension, Period 3|Physician Decision|0|||
147564868|NCT01569152|532226020|FG002|Safety Extension, Period 3|Physician Decision|2|||
147564869|NCT01569152|532226018|FG000|Safety Extension, Period 3|Study terminated by Sponsor|0|||
147564870|NCT01569152|532226019|FG001|Safety Extension, Period 3|Study terminated by Sponsor|0|||
147564871|NCT01569152|532226020|FG002|Safety Extension, Period 3|Study terminated by Sponsor|47|||
147564872|NCT01706536|532226021|FG000|Overall Study|Withdrawal by Subject|1|||
147564873|NCT01706536|532226022|FG001|Overall Study|Withdrawal by Subject|0|||
147564874|NCT01706536|532226023|FG002|Overall Study|Withdrawal by Subject|1|||
147564875|NCT01706536|532226024|FG003|Overall Study|Withdrawal by Subject|0|||
147564876|NCT01706536|532226025|FG004|Overall Study|Withdrawal by Subject|0|||
147564877|NCT01706536|532226021|FG000|Overall Study|Adverse Event|2|||
147564878|NCT01706536|532226022|FG001|Overall Study|Adverse Event|3|||
147564879|NCT01706536|532226023|FG002|Overall Study|Adverse Event|4|||
147564880|NCT01706536|532226024|FG003|Overall Study|Adverse Event|3|||
147564881|NCT01706536|532226025|FG004|Overall Study|Adverse Event|2|||
147564882|NCT01706536|532226021|FG000|Overall Study|Lack of Efficacy|1|||
147564883|NCT01706536|532226022|FG001|Overall Study|Lack of Efficacy|0|||
147564884|NCT01706536|532226023|FG002|Overall Study|Lack of Efficacy|0|||
147564885|NCT01706536|532226024|FG003|Overall Study|Lack of Efficacy|1|||
147564886|NCT01706536|532226025|FG004|Overall Study|Lack of Efficacy|0|||
147564887|NCT01706536|532226021|FG000|Overall Study|non compliance|0|||
147444389|NCT01438489|531792589|FG002|Overall Study|AE/SAEs|1|||
147564888|NCT01706536|532226022|FG001|Overall Study|non compliance|1|||
147564889|NCT01706536|532226023|FG002|Overall Study|non compliance|0|||
147564890|NCT01706536|532226024|FG003|Overall Study|non compliance|0|||
147564891|NCT01706536|532226025|FG004|Overall Study|non compliance|0|||
147564892|NCT03262012|532226026|FG000|Overall Study|Withdrawal by Subject|15|||
147564893|NCT03262012|532226027|FG001|Overall Study|Withdrawal by Subject|13|||
147564894|NCT03262012|532226028|FG002|Overall Study|Withdrawal by Subject|8|||
147564895|NCT03262012|532226029|FG003|Overall Study|Withdrawal by Subject|7|||
147228652|NCT00595465|531010465|FG000|Overall Study|Protocol Violation|2|||
147228653|NCT00595465|531010466|FG001|Overall Study|Protocol Violation|1|||
147228654|NCT00595465|531010467|FG002|Overall Study|Protocol Violation|0|||
147228655|NCT00595465|531010465|FG000|Overall Study|Lost to Follow-up|0|||
147444390|NCT01438489|531792587|FG000|Overall Study|Received prohibited medication|1|||
147564896|NCT03262012|532226026|FG000|Overall Study|Adverse Event|10|||
147564897|NCT03262012|532226027|FG001|Overall Study|Adverse Event|12|||
147564898|NCT03262012|532226028|FG002|Overall Study|Adverse Event|4|||
147564899|NCT03262012|532226029|FG003|Overall Study|Adverse Event|6|||
147564900|NCT03262012|532226026|FG000|Overall Study|Physician Decision|2|||
147564901|NCT03262012|532226027|FG001|Overall Study|Physician Decision|5|||
147564902|NCT03262012|532226028|FG002|Overall Study|Physician Decision|1|||
147564903|NCT03262012|532226029|FG003|Overall Study|Physician Decision|0|||
147564904|NCT03262012|532226026|FG000|Overall Study|Lack of Efficacy|0|||
147564905|NCT03262012|532226027|FG001|Overall Study|Lack of Efficacy|5|||
147564906|NCT03262012|532226028|FG002|Overall Study|Lack of Efficacy|1|||
147564907|NCT03262012|532226029|FG003|Overall Study|Lack of Efficacy|2|||
147564908|NCT03262012|532226026|FG000|Overall Study|Protocol Discontinuation Criteria|0|||
147564909|NCT03262012|532226027|FG001|Overall Study|Protocol Discontinuation Criteria|1|||
147564910|NCT03262012|532226028|FG002|Overall Study|Protocol Discontinuation Criteria|0|||
147564911|NCT03262012|532226029|FG003|Overall Study|Protocol Discontinuation Criteria|0|||
147564912|NCT01469546|532226032|FG000|Received 5 mg Dose|Adverse Event|13|||
147564913|NCT01469546|532226032|FG000|Received 5 mg Dose|Death|2|||
147564914|NCT01469546|532226032|FG000|Received 5 mg Dose|Protocol Violation|2|||
147564915|NCT01469546|532226032|FG000|Received 5 mg Dose|Progressive Disease|3|||
147564916|NCT01469546|532226032|FG000|Received 5 mg Dose|Physician Decision|3|||
147564917|NCT00385684|532226035|FG000|FIRST INTERVENTION OF PHASE A|Death|1|||
147564918|NCT00385684|532226036|FG001|FIRST INTERVENTION OF PHASE A|Death|0|||
147564919|NCT00385684|532226035|FG000|SECOND INTERVENTION OF PHASE A|Adverse Event|0|||
147564920|NCT00385684|532226036|FG001|SECOND INTERVENTION OF PHASE A|Adverse Event|1|||
147564921|NCT00385684|532226035|FG000|SECOND INTERVENTION OF PHASE A|study drug recall|0|||
147564922|NCT00385684|532226036|FG001|SECOND INTERVENTION OF PHASE A|study drug recall|1|||
147564923|NCT02801877|532226037|FG000|Overall Study|Lost to Follow-up|1|||
147564924|NCT02801877|532226038|FG001|Overall Study|Lost to Follow-up|1|||
147564925|NCT02801877|532226039|FG002|Overall Study|Lost to Follow-up|2|||
147564926|NCT02801877|532226040|FG003|Overall Study|Lost to Follow-up|0|||
147564927|NCT02801877|532226037|FG000|Overall Study|Never Started Treatment|2|||
147564928|NCT02801877|532226038|FG001|Overall Study|Never Started Treatment|0|||
147564929|NCT02801877|532226039|FG002|Overall Study|Never Started Treatment|4|||
147564930|NCT02801877|532226040|FG003|Overall Study|Never Started Treatment|0|||
147564931|NCT00463606|532226041|FG000|Overall Study|Adverse Event|21|||
147650876|NCT02757352|532544545|FG008|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
147114045|NCT05073315|530579984|FG001|Period 2|Withdrawal by Subject|4|||
147114046|NCT05073315|530579985|FG002|Period 2|Withdrawal by Subject|9|||
147114047|NCT05073315|530579983|FG000|Period 2|Protocol Violation|0|||
147114048|NCT05073315|530579984|FG001|Period 2|Protocol Violation|0|||
147114049|NCT05073315|530579985|FG002|Period 2|Protocol Violation|1|||
147114050|NCT00303953|530579986|FG000|Overall Study|Ineligible|1|||
147114051|NCT00303953|530579986|FG000|Overall Study|Death|1|||
147114052|NCT00303953|530579986|FG000|Overall Study|Adverse Event|4|||
147114053|NCT00303953|530579986|FG000|Overall Study|Lack of Efficacy|12|||
147114054|NCT00303953|530579986|FG000|Overall Study|Physician Decision|1|||
147114055|NCT03010501|530579989|FG000|Study Week 1|Withdrawal by Subject|2|||
147114056|NCT03010501|530579990|FG001|Study Week 1|Withdrawal by Subject|1|||
147114057|NCT03010501|530579991|FG002|Study Week 1|Withdrawal by Subject|0|||
147114058|NCT03010501|530579992|FG003|Study Week 1|Withdrawal by Subject|2|||
147114059|NCT03010501|530579993|FG004|Study Week 1|Withdrawal by Subject|0|||
147114060|NCT03010501|530579994|FG005|Study Week 1|Withdrawal by Subject|0|||
147114061|NCT03010501|530579989|FG000|Study Week 3|Withdrawal by Subject|0|||
147114062|NCT03010501|530579990|FG001|Study Week 3|Withdrawal by Subject|0|||
147114063|NCT03010501|530579991|FG002|Study Week 3|Withdrawal by Subject|0|||
147114064|NCT03010501|530579992|FG003|Study Week 3|Withdrawal by Subject|1|||
147114065|NCT03010501|530579993|FG004|Study Week 3|Withdrawal by Subject|0|||
147114066|NCT03010501|530579994|FG005|Study Week 3|Withdrawal by Subject|0|||
147114067|NCT00640289|530579997|FG000|Overall Study|Death|3|||
147114068|NCT00640289|530579997|FG000|Overall Study|Withdrawal by Subject|1|||
147114069|NCT00640289|530579997|FG000|Overall Study|Lost to Follow-up|1|||
147114070|NCT00640289|530579997|FG000|Overall Study|Data collected under different amendment|2|||
147114071|NCT00640289|530579997|FG000|Overall Study|Transferred to another center|1|||
147114072|NCT00640289|530579997|FG000|Overall Study|Missing status|5|||
147114073|NCT02207608|530580007|FG000|Overall Study|Adverse Event|1|||
147114074|NCT02207608|530580008|FG001|Overall Study|Adverse Event|0|||
147114075|NCT04941898|530580957|FG000|Overall Study|Protocol Violation|1|||
147114076|NCT01653262|530580958|FG000|Overall Study|Lack of Efficacy|1|||
147114077|NCT01653262|530580958|FG000|Overall Study|SAE, non-fatal|1|||
147114078|NCT01653262|530580958|FG000|Overall Study|AE, non-serious non-fatal|1|||
147114079|NCT00420407|530580960|FG000|Overall Study|Lost to Follow-up|0|||
147114080|NCT00420407|530580961|FG001|Overall Study|Lost to Follow-up|3|||
147114081|NCT00420407|530580960|FG000|Overall Study|Physician Decision|2|||
147114082|NCT00420407|530580961|FG001|Overall Study|Physician Decision|1|||
147114083|NCT00420407|530580960|FG000|Overall Study|subject identified as detainee|1|||
147228656|NCT00595465|531010466|FG001|Overall Study|Lost to Follow-up|0|||
147228657|NCT00595465|531010467|FG002|Overall Study|Lost to Follow-up|2|||
147228658|NCT00595465|531010465|FG000|Overall Study|administrative reason|0|||
147228659|NCT00595465|531010466|FG001|Overall Study|administrative reason|0|||
147228660|NCT00595465|531010467|FG002|Overall Study|administrative reason|1|||
147564932|NCT00463606|532226042|FG001|Overall Study|Adverse Event|18|||
147114084|NCT00420407|530580961|FG001|Overall Study|subject identified as detainee|0|||
147114085|NCT00420407|530580960|FG000|Overall Study|subject identified as Jehovah's witness|1|||
147114086|NCT00420407|530580961|FG001|Overall Study|subject identified as Jehovah's witness|0|||
147564933|NCT00463606|532226043|FG002|Overall Study|Adverse Event|11|||
147564934|NCT00463606|532226041|FG000|Overall Study|Withdrawal by Subject|11|||
147114087|NCT00420407|530580960|FG000|Overall Study|Withdrawal by Subject|0|||
147114088|NCT00420407|530580961|FG001|Overall Study|Withdrawal by Subject|2|||
147114089|NCT04633447|530580964|FG000|Main Study (From Week 0 up to Week 60)|Adverse Event|8|||
147114090|NCT04633447|530580965|FG001|Main Study (From Week 0 up to Week 60)|Adverse Event|2|||
147114091|NCT04633447|530580964|FG000|Main Study (From Week 0 up to Week 60)|Study terminated by sponsor|3|||
147114092|NCT04633447|530580965|FG001|Main Study (From Week 0 up to Week 60)|Study terminated by sponsor|3|||
147114093|NCT04633447|530580964|FG000|Main Study (From Week 0 up to Week 60)|Physician Decision|0|||
147114094|NCT04633447|530580965|FG001|Main Study (From Week 0 up to Week 60)|Physician Decision|1|||
147114095|NCT04633447|530580964|FG000|Main Study (From Week 0 up to Week 60)|Withdrawal by Subject|2|||
147114096|NCT04633447|530580965|FG001|Main Study (From Week 0 up to Week 60)|Withdrawal by Subject|0|||
147114097|NCT04633447|530580964|FG000|LTE Period (Week 52 up to Week 112)|Study Terminated by Sponsor|3|||
147564935|NCT00463606|532226042|FG001|Overall Study|Withdrawal by Subject|11|||
147564936|NCT00463606|532226043|FG002|Overall Study|Withdrawal by Subject|5|||
147564937|NCT00463606|532226041|FG000|Overall Study|Lost to Follow-up|2|||
147564938|NCT00463606|532226042|FG001|Overall Study|Lost to Follow-up|2|||
147564939|NCT00463606|532226043|FG002|Overall Study|Lost to Follow-up|3|||
147564940|NCT00463606|532226041|FG000|Overall Study|Subject noncompliance|1|||
147564941|NCT00463606|532226042|FG001|Overall Study|Subject noncompliance|1|||
147564942|NCT00463606|532226043|FG002|Overall Study|Subject noncompliance|0|||
147564943|NCT00463606|532226041|FG000|Overall Study|Subject moved out of town|1|||
147564944|NCT00463606|532226042|FG001|Overall Study|Subject moved out of town|0|||
147564945|NCT00463606|532226043|FG002|Overall Study|Subject moved out of town|0|||
147564946|NCT00463606|532226041|FG000|Overall Study|Physician Decision|0|||
147564947|NCT00463606|532226042|FG001|Overall Study|Physician Decision|1|||
147564948|NCT00463606|532226043|FG002|Overall Study|Physician Decision|0|||
147564949|NCT00463606|532226041|FG000|Overall Study|Sponsor request|0|||
147564950|NCT00463606|532226042|FG001|Overall Study|Sponsor request|1|||
147564951|NCT00463606|532226043|FG002|Overall Study|Sponsor request|0|||
147564952|NCT00463606|532226041|FG000|Overall Study|Exclusion criteria violation|2|||
147564953|NCT00463606|532226042|FG001|Overall Study|Exclusion criteria violation|0|||
147564954|NCT00463606|532226043|FG002|Overall Study|Exclusion criteria violation|0|||
147564955|NCT00463606|532226041|FG000|Overall Study|Coordinator error|1|||
147564956|NCT00463606|532226042|FG001|Overall Study|Coordinator error|0|||
147564957|NCT00463606|532226043|FG002|Overall Study|Coordinator error|0|||
147564958|NCT00463606|532226041|FG000|Overall Study|Patient randomized in error|1|||
147564959|NCT00463606|532226042|FG001|Overall Study|Patient randomized in error|0|||
147564960|NCT00463606|532226043|FG002|Overall Study|Patient randomized in error|0|||
147564961|NCT00463606|532226041|FG000|Overall Study|Participation in another ABT-335 trial|1|||
147564962|NCT00463606|532226042|FG001|Overall Study|Participation in another ABT-335 trial|0|||
147564963|NCT00463606|532226043|FG002|Overall Study|Participation in another ABT-335 trial|0|||
147564964|NCT00463606|532226041|FG000|Overall Study|Protocol Violation|0|||
147564965|NCT00463606|532226042|FG001|Overall Study|Protocol Violation|0|||
147564966|NCT00463606|532226043|FG002|Overall Study|Protocol Violation|1|||
147564967|NCT01223365|532226044|FG000|Open-label Titration Period|Enrolled but not treated|1|||
147564968|NCT01223365|532226044|FG000|Open-label Titration Period|Adverse Event|23|||
147114098|NCT04633447|530580965|FG001|LTE Period (Week 52 up to Week 112)|Study Terminated by Sponsor|2|||
147114099|NCT04633447|530580964|FG000|LTE Period (Week 52 up to Week 112)|Adverse Event|1|||
147114100|NCT04633447|530580965|FG001|LTE Period (Week 52 up to Week 112)|Adverse Event|1|||
147564969|NCT01223365|532226044|FG000|Open-label Titration Period|Lack of Efficacy|3|||
147564970|NCT01223365|532226044|FG000|Open-label Titration Period|Withdrawal by Subject|5|||
147114101|NCT05417113|530580966|FG000|Overall Study|Lost to Follow-up|2|||
147114102|NCT05417113|530580967|FG001|Overall Study|Lost to Follow-up|2|||
147114103|NCT01022580|530580968|FG000|Overall Study|Death|18|||
147114104|NCT01022580|530580969|FG001|Overall Study|Death|22|||
147114105|NCT03439839|530580970|FG000|Overall Study|Death|3|||
147114106|NCT03439839|530580971|FG001|Overall Study|Death|0|||
147114107|NCT00723944|530580977|FG000|Permanent Prosthesis Placement|Adverse Event|1|||
147114108|NCT00723944|530580978|FG001|Permanent Prosthesis Placement|Adverse Event|7|||
147114109|NCT00723944|530580977|FG000|Permanent Prosthesis Placement|Lost to Follow-up|2|||
147114110|NCT00723944|530580978|FG001|Permanent Prosthesis Placement|Lost to Follow-up|2|||
147114111|NCT00723944|530580977|FG000|One Year Post Placement Follow-up|Lost to Follow-up|1|||
147228661|NCT00107783|531010468|FG000|Overall Study|Adverse Event|0|||
147228662|NCT00107783|531010469|FG001|Overall Study|Adverse Event|2|||
147228663|NCT00107783|531010468|FG000|Overall Study|Death|0|||
147228664|NCT00107783|531010469|FG001|Overall Study|Death|1|||
147564971|NCT01223365|532226044|FG000|Open-label Titration Period|Protocol Violation|1|||
147564972|NCT01223365|532226044|FG000|Open-label Titration Period|Lost to Follow-up|2|||
147564973|NCT01223365|532226044|FG000|Open-label Titration Period|Noncompliance with study drug admin|1|||
147564974|NCT01223365|532226044|FG000|Open-label Titration Period|Noncompliance with study procedures|2|||
147564975|NCT01223365|532226044|FG000|Open-label Titration Period|Starting physical therapy|1|||
147564976|NCT01223365|532226044|FG000|Open-label Treatment Period|Adverse Event|39|||
147564977|NCT01223365|532226044|FG000|Open-label Treatment Period|Lack of Efficacy|2|||
147564978|NCT01223365|532226044|FG000|Open-label Treatment Period|Withdrawal by Subject|19|||
147114112|NCT00723944|530580978|FG001|One Year Post Placement Follow-up|Lost to Follow-up|4|||
147114113|NCT02582632|530580979|FG000|Overall Study|Other|1|||
147114114|NCT01771913|530580982|FG000|Overall Study|Withdrawal by Subject|1|||
147114115|NCT01771913|530580983|FG001|Overall Study|Withdrawal by Subject|0|||
147114116|NCT04307394|530580984|FG000|Overall Study|Lost to Follow-up|3|||
147114117|NCT04307394|530580984|FG000|Overall Study|Withdrawal by Subject|2|||
147114118|NCT01617967|530580989|FG000|Overall Study|Protocol Violation|0|||
147114119|NCT01617967|530580990|FG001|Overall Study|Protocol Violation|0|||
147114120|NCT01617967|530580991|FG002|Overall Study|Protocol Violation|0|||
147114121|NCT01617967|530580992|FG003|Overall Study|Protocol Violation|1|||
147114122|NCT01617967|530580993|FG004|Overall Study|Protocol Violation|0|||
147114123|NCT01617967|530580994|FG005|Overall Study|Protocol Violation|0|||
147114124|NCT01617967|530580989|FG000|Overall Study|Withdrawal by Subject|0|||
147564979|NCT01223365|532226044|FG000|Open-label Treatment Period|Protocol Violation|15|||
147564980|NCT01223365|532226044|FG000|Open-label Treatment Period|Lost to Follow-up|7|||
147564981|NCT01223365|532226044|FG000|Open-label Treatment Period|Noncompliance with study drug admin|7|||
147564982|NCT01223365|532226044|FG000|Open-label Treatment Period|Noncompliance with study procedures|6|||
147564983|NCT01223365|532226044|FG000|Open-label Treatment Period|Moved out of area|2|||
147564984|NCT01223365|532226044|FG000|Open-label Treatment Period|Negative urine drug screen when on treat|1|||
147564985|NCT01223365|532226044|FG000|Open-label Treatment Period|"Out of window"|1|||
147564986|NCT01223365|532226044|FG000|Open-label Treatment Period|Starting physical therapy|1|||
147564987|NCT01223365|532226044|FG000|Open-label Treatment Period|Physician Decision|2|||
147564988|NCT02682602|532226045|FG000|Pre-operative Diseased & Normal Hips|Unusable images|1|||
147564989|NCT02682602|532226046|FG001|Pre-operative Diseased & Normal Hips|Unusable images|0|||
147564990|NCT02682602|532226045|FG000|Post-operative Fluoroscopy for Implanted|Lost to Follow-up|3|||
147114125|NCT01617967|530580990|FG001|Overall Study|Withdrawal by Subject|0|||
147114126|NCT01617967|530580991|FG002|Overall Study|Withdrawal by Subject|0|||
147114127|NCT01617967|530580992|FG003|Overall Study|Withdrawal by Subject|0|||
147114128|NCT01617967|530580993|FG004|Overall Study|Withdrawal by Subject|0|||
147114129|NCT01617967|530580994|FG005|Overall Study|Withdrawal by Subject|1|||
147114130|NCT01617967|530580989|FG000|Overall Study|Dosing Suspended by Sponsor|1|||
147564991|NCT02682602|532226046|FG001|Post-operative Fluoroscopy for Implanted|Lost to Follow-up|0|||
147564992|NCT02140060|532226047|FG000|Overall Study|Adverse Event|0|||
147564993|NCT02140060|532226048|FG001|Overall Study|Adverse Event|0|||
147564994|NCT02140060|532226049|FG002|Overall Study|Adverse Event|0|||
147312082|NCT01965938|531309258|FG000|Overall Study|Withdrawal by Subject|1|||
147312083|NCT01965938|531309259|FG001|Overall Study|Withdrawal by Subject|0|||
147312084|NCT03757234|531309260|FG000|Overall Study|Adverse Event|0|||
147312085|NCT03757234|531309261|FG001|Overall Study|Adverse Event|0|||
147114131|NCT01617967|530580990|FG001|Overall Study|Dosing Suspended by Sponsor|0|||
147312086|NCT03757234|531309262|FG002|Overall Study|Adverse Event|0|||
147312087|NCT03757234|531309263|FG003|Overall Study|Adverse Event|0|||
147564995|NCT02140060|532226050|FG003|Overall Study|Adverse Event|1|||
147564996|NCT02140060|532226051|FG004|Overall Study|Adverse Event|1|||
147564997|NCT02140060|532226052|FG005|Overall Study|Adverse Event|1|||
147564998|NCT02140060|532226047|FG000|Overall Study|Lack of Efficacy|0|||
147564999|NCT02140060|532226048|FG001|Overall Study|Lack of Efficacy|0|||
147312088|NCT03757234|531309264|FG004|Overall Study|Adverse Event|1|||
147312089|NCT03757234|531309260|FG000|Overall Study|Lost to Follow-up|1|||
147312090|NCT03757234|531309261|FG001|Overall Study|Lost to Follow-up|0|||
147312091|NCT03757234|531309262|FG002|Overall Study|Lost to Follow-up|0|||
147312092|NCT03757234|531309263|FG003|Overall Study|Lost to Follow-up|0|||
147312093|NCT03757234|531309264|FG004|Overall Study|Lost to Follow-up|1|||
147312094|NCT03757234|531309260|FG000|Overall Study|Withdrawal by Subject|1|||
147312095|NCT03757234|531309261|FG001|Overall Study|Withdrawal by Subject|1|||
147312096|NCT03757234|531309262|FG002|Overall Study|Withdrawal by Subject|0|||
147312097|NCT03757234|531309263|FG003|Overall Study|Withdrawal by Subject|1|||
147312098|NCT03757234|531309264|FG004|Overall Study|Withdrawal by Subject|2|||
147312099|NCT03757234|531309260|FG000|Overall Study|Other|1|||
147565000|NCT02140060|532226049|FG002|Overall Study|Lack of Efficacy|0|||
147565001|NCT02140060|532226050|FG003|Overall Study|Lack of Efficacy|1|||
147565002|NCT02140060|532226051|FG004|Overall Study|Lack of Efficacy|0|||
147565003|NCT02140060|532226052|FG005|Overall Study|Lack of Efficacy|0|||
147565004|NCT00520130|532228202|FG000|Overall Study|Disease progression on study|4|||
147565005|NCT00520130|532228203|FG001|Overall Study|Disease progression on study|0|||
147565006|NCT00520130|532228202|FG000|Overall Study|Physician Decision|1|||
147565007|NCT00520130|532228203|FG001|Overall Study|Physician Decision|1|||
147114132|NCT01617967|530580991|FG002|Overall Study|Dosing Suspended by Sponsor|0|||
147312100|NCT03757234|531309261|FG001|Overall Study|Other|1|||
147312101|NCT03757234|531309262|FG002|Overall Study|Other|0|||
147114133|NCT01617967|530580992|FG003|Overall Study|Dosing Suspended by Sponsor|0|||
147114134|NCT01617967|530580993|FG004|Overall Study|Dosing Suspended by Sponsor|0|||
147312102|NCT03757234|531309263|FG003|Overall Study|Other|0|||
147312103|NCT03757234|531309264|FG004|Overall Study|Other|0|||
147444391|NCT01438489|531792588|FG001|Overall Study|Received prohibited medication|0|||
147312104|NCT02736968|531309270|FG000|Overall Study|Lost to Follow-up|0|||
147565008|NCT04915755|532228204|FG000|Overall Study|Physician Decision|3|||
147565009|NCT04915755|532228205|FG001|Overall Study|Physician Decision|2|||
147565010|NCT04915755|532228204|FG000|Overall Study|Withdrawal by Subject|1|||
147565011|NCT04915755|532228205|FG001|Overall Study|Withdrawal by Subject|1|||
147565012|NCT04915755|532228204|FG000|Overall Study|Ongoing for PACT|3|||
147565013|NCT04915755|532228205|FG001|Overall Study|Ongoing for PACT|2|||
147565014|NCT04915755|532228204|FG000|Overall Study|Other|7|||
147565015|NCT04915755|532228205|FG001|Overall Study|Other|11|||
147565016|NCT01993030|532228209|FG000|Overall Study|Adverse Event|0|||
147565017|NCT01993030|532228210|FG001|Overall Study|Adverse Event|4|||
147565018|NCT02736721|532228211|FG000|Overall Study|Adverse Event|8|||
147565019|NCT02736721|532228211|FG000|Overall Study|Lost to Follow-up|3|||
147565020|NCT02736721|532228211|FG000|Overall Study|Other|5|||
147565021|NCT01838941|532228212|FG000|Overall Study|Adverse Event|1|||
147114135|NCT01617967|530580994|FG005|Overall Study|Dosing Suspended by Sponsor|0|||
147114136|NCT02536794|530580995|FG000|Reached 1st Response Assessment|Adverse Event|2|||
147565022|NCT01838941|532228212|FG000|Overall Study|Withdrawal by Subject|1|||
147565023|NCT01034358|532228213|FG000|Overall Study|Withdrawal by Subject|1|||
147565024|NCT01034358|532228213|FG000|Overall Study|Protocol Violation|1|||
147565025|NCT01534663|532228216|FG000|Overall Study|Lost to Follow-up|0|||
147565026|NCT01534663|532228217|FG001|Overall Study|Lost to Follow-up|2|||
147565027|NCT01534663|532228216|FG000|Overall Study|Adverse Event|2|||
147565028|NCT01534663|532228217|FG001|Overall Study|Adverse Event|1|||
147565029|NCT04088760|532228220|FG000|Overall Study|Physician Decision|1|||
147565030|NCT00377260|532228221|FG000|Overall Study|Lost to Follow-up|0|||
147565031|NCT00377260|532228222|FG001|Overall Study|Lost to Follow-up|1|||
147565032|NCT00377260|532228221|FG000|Overall Study|Withdrawal by Subject|2|||
147565033|NCT00377260|532228222|FG001|Overall Study|Withdrawal by Subject|4|||
147565034|NCT01391793|532228223|FG000|Overall Study|Ineligible|3|||
147565035|NCT01391793|532228224|FG001|Overall Study|Ineligible|0|||
147565036|NCT01391793|532228223|FG000|Overall Study|Urine Culture Negative or Indeterminate|71|||
147565037|NCT01391793|532228224|FG001|Overall Study|Urine Culture Negative or Indeterminate|87|||
147565038|NCT01391793|532228223|FG000|Overall Study|No DMSA|73|||
147565039|NCT01391793|532228224|FG001|Overall Study|No DMSA|57|||
147565040|NCT01015625|532228225|FG000|Overall Study|Lost to Follow-up|3|||
147565041|NCT01015625|532228226|FG001|Overall Study|Lost to Follow-up|1|||
147565042|NCT01015625|532228225|FG000|Overall Study|Withdrawal by Subject|2|||
147565043|NCT01015625|532228226|FG001|Overall Study|Withdrawal by Subject|3|||
147565044|NCT01015625|532228225|FG000|Overall Study|Physician Decision|2|||
147565045|NCT01015625|532228226|FG001|Overall Study|Physician Decision|0|||
147565046|NCT01015625|532228225|FG000|Overall Study|Death|30|||
147565047|NCT01015625|532228226|FG001|Overall Study|Death|22|||
147565048|NCT03136380|532228228|FG000|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
147565049|NCT03136380|532228229|FG001|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|1|||
147565050|NCT03136380|532228230|FG002|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
147565051|NCT03136380|532228231|FG003|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
147565052|NCT03136380|532228232|FG004|Part 1, Washout Period 2 (7 Days)|Withdrawal by Subject|0|||
147565053|NCT02419937|532228236|FG000|Overall Study|Lost to Follow-up|1|||
147565054|NCT02419937|532228237|FG001|Overall Study|Lost to Follow-up|0|||
147565055|NCT02457520|532228238|FG000|Active Treatment Phase|Adverse Event|10|||
147565056|NCT02457520|532228238|FG000|Active Treatment Phase|Lost to Follow-up|8|||
147565057|NCT02457520|532228238|FG000|Active Treatment Phase|Non-compliance with Study Treatment|3|||
147565058|NCT02457520|532228238|FG000|Active Treatment Phase|other|4|||
147565059|NCT02457520|532228238|FG000|Active Treatment Phase|Physician Decision|1|||
147565060|NCT02457520|532228238|FG000|Active Treatment Phase|Protocol Violation|1|||
147565061|NCT02457520|532228238|FG000|Active Treatment Phase|Withdrawal by Subject|7|||
147565062|NCT02457520|532228238|FG000|Post-treatment Period|Other: Retreatment Required|7|||
147565063|NCT02457520|532228238|FG000|Post-treatment Period|Lost to Follow-up|23|||
147565064|NCT02457520|532228238|FG000|Post-treatment Period|Other|3|||
147565065|NCT02457520|532228238|FG000|Post-treatment Period|Physician Decision|1|||
147565066|NCT02457520|532228238|FG000|Post-treatment Period|Withdrawal by Subject|14|||
147565067|NCT00286754|532228239|FG000|Overall Study|Adverse Event|2|||
147565068|NCT00286754|532228240|FG001|Overall Study|Adverse Event|2|||
147565069|NCT00286754|532228241|FG002|Overall Study|Adverse Event|3|||
147565070|NCT00286754|532228239|FG000|Overall Study|Withdrawal by Subject|6|||
147312105|NCT02736968|531309271|FG001|Overall Study|Lost to Follow-up|0|||
147565071|NCT00286754|532228240|FG001|Overall Study|Withdrawal by Subject|2|||
147444392|NCT01438489|531792589|FG002|Overall Study|Received prohibited medication|0|||
147565072|NCT00286754|532228241|FG002|Overall Study|Withdrawal by Subject|0|||
147565073|NCT00286754|532228239|FG000|Overall Study|Lost to Follow-up|12|||
147565074|NCT00286754|532228240|FG001|Overall Study|Lost to Follow-up|14|||
147565075|NCT00286754|532228241|FG002|Overall Study|Lost to Follow-up|6|||
147565076|NCT00286754|532228239|FG000|Overall Study|Moved out of state|0|||
147565077|NCT00286754|532228240|FG001|Overall Study|Moved out of state|0|||
147565078|NCT00286754|532228241|FG002|Overall Study|Moved out of state|1|||
147565079|NCT02661295|532228242|FG000|Overall Study|Death|1|||
147565080|NCT02661295|532228242|FG000|Overall Study|Transferred Out|1|||
147565081|NCT02661295|532228242|FG000|Overall Study|Kidney Transplant|1|||
147565082|NCT02661295|532228242|FG000|Overall Study|Withdrawn due to side effects|8|||
147565083|NCT02661295|532228242|FG000|Overall Study|Withdrawn due to access type|1|||
147565084|NCT02661295|532228242|FG000|Overall Study|Withdrawn due to allergies|1|||
147565085|NCT02661295|532228242|FG000|Overall Study|Withdrawn due to non-compliance|1|||
147565086|NCT02661295|532228242|FG000|Overall Study|Withdrawal by Subject|3|||
147565087|NCT02661295|532228242|FG000|Overall Study|Failed screening|2|||
147565088|NCT00910663|532228243|FG000|Period 1|Withdrawal by Subject|0|||
147565089|NCT00910663|532228244|FG001|Period 1|Withdrawal by Subject|1|||
147565090|NCT02726581|532228245|FG000|Pre-Treatment Period|Participant request to discontinue study treatment|0|||
147565091|NCT02726581|532228246|FG001|Pre-Treatment Period|Participant request to discontinue study treatment|1|||
147565092|NCT02726581|532228247|FG002|Pre-Treatment Period|Participant request to discontinue study treatment|0|||
147565093|NCT02726581|532228245|FG000|Pre-Treatment Period|Administrative reason by sponsor|2|||
147565094|NCT02726581|532228246|FG001|Pre-Treatment Period|Administrative reason by sponsor|0|||
147565095|NCT02726581|532228247|FG002|Pre-Treatment Period|Administrative reason by sponsor|0|||
147565096|NCT02726581|532228245|FG000|Pre-Treatment Period|Participant no longer meets study criteria|1|||
147565097|NCT02726581|532228246|FG001|Pre-Treatment Period|Participant no longer meets study criteria|0|||
147565098|NCT02726581|532228247|FG002|Pre-Treatment Period|Participant no longer meets study criteria|0|||
147565099|NCT02726581|532228245|FG000|Treatment Period|Disease progression|47|||
147565100|NCT02726581|532228246|FG001|Treatment Period|Disease progression|50|||
147565101|NCT02726581|532228247|FG002|Treatment Period|Disease progression|16|||
147565102|NCT02726581|532228245|FG000|Treatment Period|Other reasons|9|||
147565103|NCT02726581|532228246|FG001|Treatment Period|Other reasons|8|||
147565104|NCT02726581|532228247|FG002|Treatment Period|Other reasons|2|||
147565105|NCT02726581|532228245|FG000|Treatment Period|Study drug toxicity|6|||
147565106|NCT02726581|532228246|FG001|Treatment Period|Study drug toxicity|3|||
147565107|NCT02726581|532228247|FG002|Treatment Period|Study drug toxicity|2|||
147565108|NCT02726581|532228245|FG000|Treatment Period|Adverse event unrelated to study drug|4|||
147565109|NCT02726581|532228246|FG001|Treatment Period|Adverse event unrelated to study drug|4|||
147565110|NCT02726581|532228247|FG002|Treatment Period|Adverse event unrelated to study drug|2|||
147565111|NCT02726581|532228245|FG000|Treatment Period|Participant withdrew consent|3|||
147565112|NCT02726581|532228246|FG001|Treatment Period|Participant withdrew consent|1|||
147565113|NCT02726581|532228247|FG002|Treatment Period|Participant withdrew consent|1|||
147565114|NCT02726581|532228245|FG000|Treatment Period|Participant request to discontinue study treatment|1|||
147565115|NCT02726581|532228246|FG001|Treatment Period|Participant request to discontinue study treatment|1|||
147565116|NCT02726581|532228247|FG002|Treatment Period|Participant request to discontinue study treatment|1|||
147565117|NCT02726581|532228245|FG000|Treatment Period|Maximum clinical benefit|0|||
147565118|NCT02726581|532228246|FG001|Treatment Period|Maximum clinical benefit|2|||
147565119|NCT02726581|532228247|FG002|Treatment Period|Maximum clinical benefit|0|||
147565120|NCT02726581|532228245|FG000|Treatment Period|Death|1|||
147565121|NCT02726581|532228246|FG001|Treatment Period|Death|0|||
147565122|NCT02726581|532228247|FG002|Treatment Period|Death|0|||
147565123|NCT02726581|532228245|FG000|Treatment Period|Poor/non-compliance|1|||
147659417|NCT01064414|532576181|FG000|Core Period: Baseline to Week 26|Protocol Violation|1|||
147114137|NCT02536794|530580995|FG000|Reached 1st Response Assessment|Progressive Disease|2|||
147114138|NCT02536794|530580995|FG000|Reached 1st Response Assessment|Withdrawal by Subject|1|||
147114139|NCT02536794|530580995|FG000|Reached 1st Response Assessment|Protocol Violation|1|||
147114140|NCT02536794|530580995|FG000|Continued Treatment After 1st Response|Progressive disease|7|||
147114141|NCT02536794|530580995|FG000|Continued Treatment After 1st Response|Adverse Event|1|||
147114142|NCT00416949|530580996|FG000|Overall Study|Patients refused to participate|5|||
147114143|NCT01471574|530581001|FG000|Treatment Period|Lack of Efficacy|12|||
147114144|NCT01471574|530581002|FG001|Treatment Period|Lack of Efficacy|4|||
147114145|NCT01471574|530581003|FG002|Treatment Period|Lack of Efficacy|14|||
147114146|NCT01471574|530581004|FG003|Treatment Period|Lack of Efficacy|1|||
147114147|NCT01471574|530581001|FG000|Treatment Period|Adverse Event|7|||
147312106|NCT02736968|531309272|FG002|Overall Study|Lost to Follow-up|0|||
147312107|NCT02736968|531309273|FG003|Overall Study|Lost to Follow-up|0|||
147312108|NCT02736968|531309274|FG004|Overall Study|Lost to Follow-up|0|||
147312109|NCT02736968|531309275|FG005|Overall Study|Lost to Follow-up|0|||
147312110|NCT02736968|531309276|FG006|Overall Study|Lost to Follow-up|5|||
147312111|NCT02736968|531309277|FG007|Overall Study|Lost to Follow-up|2|||
147312112|NCT02736968|531309270|FG000|Overall Study|COVID-19 Pandemic|0|||
147312113|NCT02736968|531309271|FG001|Overall Study|COVID-19 Pandemic|0|||
147312114|NCT02736968|531309272|FG002|Overall Study|COVID-19 Pandemic|0|||
147114148|NCT01471574|530581002|FG001|Treatment Period|Adverse Event|3|||
147114149|NCT01471574|530581003|FG002|Treatment Period|Adverse Event|6|||
147114150|NCT01471574|530581004|FG003|Treatment Period|Adverse Event|1|||
147114151|NCT01471574|530581001|FG000|Treatment Period|Withdrawal by Subject|5|||
147114152|NCT01471574|530581002|FG001|Treatment Period|Withdrawal by Subject|1|||
147114153|NCT01471574|530581003|FG002|Treatment Period|Withdrawal by Subject|1|||
147114154|NCT01471574|530581004|FG003|Treatment Period|Withdrawal by Subject|0|||
147312115|NCT02736968|531309273|FG003|Overall Study|COVID-19 Pandemic|0|||
147312116|NCT02736968|531309274|FG004|Overall Study|COVID-19 Pandemic|0|||
147312117|NCT02736968|531309275|FG005|Overall Study|COVID-19 Pandemic|0|||
147565124|NCT02726581|532228246|FG001|Treatment Period|Poor/non-compliance|0|||
147565125|NCT02726581|532228247|FG002|Treatment Period|Poor/non-compliance|0|||
147565126|NCT02726581|532228245|FG000|Treatment Period|Participant no longer meets study criteria|0|||
147114155|NCT01471574|530581001|FG000|Treatment Period|Patient Requested Discontinue Study drug|4|||
147114156|NCT01471574|530581002|FG001|Treatment Period|Patient Requested Discontinue Study drug|0|||
147114157|NCT01471574|530581003|FG002|Treatment Period|Patient Requested Discontinue Study drug|1|||
147114158|NCT01471574|530581004|FG003|Treatment Period|Patient Requested Discontinue Study drug|1|||
147114159|NCT01471574|530581001|FG000|Treatment Period|Lost to Follow-up|1|||
147114160|NCT01471574|530581002|FG001|Treatment Period|Lost to Follow-up|2|||
147114161|NCT01471574|530581003|FG002|Treatment Period|Lost to Follow-up|2|||
147114162|NCT01471574|530581004|FG003|Treatment Period|Lost to Follow-up|0|||
147114163|NCT01471574|530581001|FG000|Treatment Period|Patient no Longer Meets Study Criteria|1|||
147114164|NCT01471574|530581002|FG001|Treatment Period|Patient no Longer Meets Study Criteria|0|||
147114165|NCT01471574|530581003|FG002|Treatment Period|Patient no Longer Meets Study Criteria|0|||
147114166|NCT01471574|530581004|FG003|Treatment Period|Patient no Longer Meets Study Criteria|0|||
147114167|NCT01471574|530581001|FG000|Treatment Period|Other|1|||
147114168|NCT01471574|530581002|FG001|Treatment Period|Other|0|||
147114169|NCT01471574|530581003|FG002|Treatment Period|Other|0|||
147114170|NCT01471574|530581004|FG003|Treatment Period|Other|0|||
147114171|NCT01471574|530581001|FG000|Follow-up Period|Withdrawal by Subject|3|||
147114172|NCT01471574|530581002|FG001|Follow-up Period|Withdrawal by Subject|0|||
147114173|NCT01471574|530581003|FG002|Follow-up Period|Withdrawal by Subject|3|||
147114174|NCT01471574|530581004|FG003|Follow-up Period|Withdrawal by Subject|1|||
147114175|NCT01471574|530581001|FG000|Follow-up Period|Lost to Follow-up|4|||
147114176|NCT01471574|530581002|FG001|Follow-up Period|Lost to Follow-up|1|||
147114177|NCT01471574|530581003|FG002|Follow-up Period|Lost to Follow-up|3|||
147114178|NCT01471574|530581004|FG003|Follow-up Period|Lost to Follow-up|2|||
147114179|NCT01471574|530581001|FG000|Follow-up Period|Death|0|||
147228665|NCT00107783|531010468|FG000|Overall Study|Withdrawal by Subject|2|||
147228666|NCT00107783|531010469|FG001|Overall Study|Withdrawal by Subject|0|||
147565127|NCT02726581|532228246|FG001|Treatment Period|Participant no longer meets study criteria|1|||
147565128|NCT02726581|532228247|FG002|Treatment Period|Participant no longer meets study criteria|0|||
147565129|NCT02865850|532228248|FG000|Overall Study|Death|15|||
147565130|NCT02865850|532228249|FG001|Overall Study|Death|19|||
147565131|NCT02865850|532228248|FG000|Overall Study|Withdrawal by Subject|3|||
147565132|NCT02865850|532228249|FG001|Overall Study|Withdrawal by Subject|2|||
147565133|NCT02865850|532228248|FG000|Overall Study|Lost to Follow-up|3|||
147565134|NCT02865850|532228249|FG001|Overall Study|Lost to Follow-up|2|||
147565135|NCT01844375|532228253|FG000|Overall Study|Protocol Violation|1|||
147565136|NCT01844375|532228254|FG001|Overall Study|Protocol Violation|1|||
147565137|NCT01772537|532228256|FG000|Overall Study|unsuccessful lumbar drain placement|1|||
147565138|NCT01772537|532228257|FG001|Overall Study|unsuccessful lumbar drain placement|0|||
147565139|NCT01772537|532228258|FG002|Overall Study|unsuccessful lumbar drain placement|0|||
147565140|NCT03627091|532228259|FG000|Overall Study|Adverse Event|0|||
147565141|NCT03627091|532228260|FG001|Overall Study|Adverse Event|0|||
147565142|NCT03627091|532228261|FG002|Overall Study|Adverse Event|2|||
147565143|NCT03627091|532228259|FG000|Overall Study|Withdrawal by Subject|2|||
147565144|NCT03627091|532228260|FG001|Overall Study|Withdrawal by Subject|0|||
147565145|NCT03627091|532228261|FG002|Overall Study|Withdrawal by Subject|2|||
147565146|NCT03627091|532228259|FG000|Overall Study|Physician Decision|2|||
147565147|NCT03627091|532228260|FG001|Overall Study|Physician Decision|0|||
147565148|NCT03627091|532228261|FG002|Overall Study|Physician Decision|0|||
147565149|NCT03627091|532228259|FG000|Overall Study|Site terminated by sponsor|0|||
147565150|NCT03627091|532228260|FG001|Overall Study|Site terminated by sponsor|1|||
147565151|NCT03627091|532228261|FG002|Overall Study|Site terminated by sponsor|0|||
147565152|NCT03627091|532228259|FG000|Overall Study|Disease relapse|7|||
147565153|NCT03627091|532228260|FG001|Overall Study|Disease relapse|5|||
147565154|NCT03627091|532228261|FG002|Overall Study|Disease relapse|1|||
147565155|NCT03627091|532228259|FG000|Overall Study|Other|1|||
147565156|NCT03627091|532228260|FG001|Overall Study|Other|0|||
147565157|NCT03627091|532228261|FG002|Overall Study|Other|0|||
147565158|NCT00450190|532228262|FG000|Overall Study|Withdrawal by Subject|2|||
147565159|NCT01536574|532228263|FG000|Overall Study|Adverse Event|4|||
147565160|NCT01536574|532228264|FG001|Overall Study|Adverse Event|5|||
147565161|NCT01536574|532228263|FG000|Overall Study|Withdrawal by Subject|1|||
147565162|NCT01536574|532228264|FG001|Overall Study|Withdrawal by Subject|2|||
147565163|NCT01536574|532228263|FG000|Overall Study|Lack of Efficacy|1|||
147565164|NCT01536574|532228264|FG001|Overall Study|Lack of Efficacy|0|||
147565165|NCT01376167|532228265|FG000|Overall Study|Lost to Follow-up|2|||
147228667|NCT00107783|531010468|FG000|Overall Study|Second hip replacement|1|||
147565166|NCT01376167|532228266|FG001|Overall Study|Lost to Follow-up|4|||
147565167|NCT01376167|532228267|FG002|Overall Study|Lost to Follow-up|2|||
147565168|NCT01376167|532228265|FG000|Overall Study|Physician Decision|1|||
147565169|NCT01376167|532228266|FG001|Overall Study|Physician Decision|1|||
147565170|NCT01376167|532228267|FG002|Overall Study|Physician Decision|0|||
147565171|NCT01376167|532228265|FG000|Overall Study|Withdrawal by Subject|1|||
147565172|NCT01376167|532228266|FG001|Overall Study|Withdrawal by Subject|5|||
147565173|NCT01376167|532228267|FG002|Overall Study|Withdrawal by Subject|4|||
147565174|NCT00834756|532228268|FG000|First Intervention|Adverse Event|1|||
147565175|NCT00834756|532228269|FG001|First Intervention|Adverse Event|0|||
147565176|NCT00834756|532228268|FG000|Washout: 21 Days|Withdrawal by Subject|1|||
147565177|NCT00834756|532228269|FG001|Washout: 21 Days|Withdrawal by Subject|0|||
147565178|NCT02193165|532228272|FG000|4 Week Product Use|Lost to Follow-up|1|||
147565179|NCT02193165|532228273|FG001|4 Week Product Use|Lost to Follow-up|1|||
147565180|NCT02193165|532228274|FG002|4 Week Product Use|Lost to Follow-up|1|||
147565181|NCT02193165|532228272|FG000|6 Week Product Use|Lost to Follow-up|0|||
147565182|NCT02193165|532228273|FG001|6 Week Product Use|Lost to Follow-up|1|||
147565183|NCT02193165|532228274|FG002|6 Week Product Use|Lost to Follow-up|0|||
147565184|NCT04239872|532228275|FG000|Overall Study|Lost to Follow-up|0|||
147565185|NCT04239872|532228276|FG001|Overall Study|Lost to Follow-up|1|||
147565186|NCT01498120|532228280|FG000|Overall Study|Lost to Follow-up|1|||
147565187|NCT01498120|532228280|FG000|Overall Study|Withdrawal by Subject|5|||
147565188|NCT01498120|532228280|FG000|Overall Study|AE, non-serious non-fatal|3|||
147565189|NCT01498120|532228280|FG000|Overall Study|Other|4|||
147565190|NCT01173692|532228281|FG000|Overall Study|Adverse Event|1|||
147565191|NCT01173692|532228282|FG001|Overall Study|Adverse Event|2|||
147565192|NCT01173692|532228281|FG000|Overall Study|Withdrawal by Subject|1|||
147565193|NCT01173692|532228282|FG001|Overall Study|Withdrawal by Subject|3|||
147565194|NCT01472341|532228283|FG000|Overall Study|Started insulin therapy|55|||
147565195|NCT01472341|532228283|FG000|Overall Study|Started therapy with a DPP-IV/GLP-1|92|||
147565196|NCT01472341|532228283|FG000|Overall Study|Withdrawal by Subject|39|||
147565197|NCT01472341|532228283|FG000|Overall Study|Lost to Follow-up|52|||
147565198|NCT01472341|532228283|FG000|Overall Study|Laboratory parameters unavailable|25|||
147565199|NCT01472341|532228283|FG000|Overall Study|Death|9|||
147565200|NCT00579670|532228284|FG000|Overall Study|Death|1|||
147565201|NCT00579670|532228285|FG001|Overall Study|Death|0|||
147565202|NCT00579670|532228286|FG002|Overall Study|Death|0|||
147565203|NCT00579670|532228287|FG003|Overall Study|Death|0|||
147565204|NCT00579670|532228288|FG004|Overall Study|Death|0|||
147565205|NCT00579670|532228284|FG000|Overall Study|Adverse Event|1|||
147565206|NCT00579670|532228285|FG001|Overall Study|Adverse Event|0|||
147565207|NCT00579670|532228286|FG002|Overall Study|Adverse Event|1|||
147565208|NCT00579670|532228287|FG003|Overall Study|Adverse Event|2|||
147565209|NCT00579670|532228288|FG004|Overall Study|Adverse Event|0|||
147565210|NCT00579670|532228284|FG000|Overall Study|Lack of Efficacy|0|||
147565211|NCT00579670|532228285|FG001|Overall Study|Lack of Efficacy|0|||
147565212|NCT00579670|532228286|FG002|Overall Study|Lack of Efficacy|1|||
147565213|NCT00579670|532228287|FG003|Overall Study|Lack of Efficacy|14|||
147565214|NCT00579670|532228288|FG004|Overall Study|Lack of Efficacy|0|||
147228668|NCT00107783|531010469|FG001|Overall Study|Second hip replacement|1|||
147228669|NCT00422097|531010470|FG000|Dose Level 2|Still on treatment|0|||
147228670|NCT00422097|531010471|FG001|Dose Level 2|Still on treatment|1|||
147565215|NCT00579670|532228284|FG000|Overall Study|Lost to Follow-up|0|||
147565216|NCT00579670|532228285|FG001|Overall Study|Lost to Follow-up|1|||
147565217|NCT00579670|532228286|FG002|Overall Study|Lost to Follow-up|0|||
147565218|NCT00579670|532228287|FG003|Overall Study|Lost to Follow-up|4|||
147565219|NCT00579670|532228288|FG004|Overall Study|Lost to Follow-up|0|||
147565220|NCT00579670|532228284|FG000|Overall Study|Other|0|||
147565221|NCT00579670|532228285|FG001|Overall Study|Other|0|||
147565222|NCT00579670|532228286|FG002|Overall Study|Other|1|||
147565223|NCT00579670|532228287|FG003|Overall Study|Other|2|||
147565224|NCT00579670|532228288|FG004|Overall Study|Other|0|||
147565225|NCT00579670|532228284|FG000|Overall Study|Withdrawal by Subject|0|||
147565226|NCT00579670|532228285|FG001|Overall Study|Withdrawal by Subject|0|||
147565227|NCT00579670|532228286|FG002|Overall Study|Withdrawal by Subject|1|||
147228671|NCT00422097|531010472|FG002|Dose Level 2|Still on treatment|0|||
147565228|NCT00579670|532228287|FG003|Overall Study|Withdrawal by Subject|0|||
147565229|NCT00579670|532228288|FG004|Overall Study|Withdrawal by Subject|0|||
147565230|NCT01118312|532228294|FG000|Overall Study|Lost to Follow-up|33|||
147565231|NCT01118312|532228295|FG001|Overall Study|Lost to Follow-up|32|||
147565232|NCT01118312|532228294|FG000|Overall Study|Withdrawal by Subject|1|||
147565233|NCT01118312|532228295|FG001|Overall Study|Withdrawal by Subject|3|||
147565234|NCT00678639|532228296|FG000|Overall Study|Lost to Follow-up at 30 days|2|||
147565235|NCT00678639|532228297|FG001|Overall Study|Lost to Follow-up at 30 days|0|||
147565236|NCT01546545|532228300|FG000|Overall Study|Withdrawal by Subject|1|||
147565237|NCT04060147|532228301|FG000|Overall Study|Withdrew consent|1|||
147228672|NCT00422097|531010473|FG003|Dose Level 2|Still on treatment|0|||
147565238|NCT00986245|532228302|FG000|First Intervention|Poor compliance|8|||
147565239|NCT00986245|532228303|FG001|First Intervention|Poor compliance|4|||
147565240|NCT00986245|532228302|FG000|First Intervention|Lack of Efficacy|1|||
147565241|NCT00986245|532228303|FG001|First Intervention|Lack of Efficacy|2|||
147565242|NCT00986245|532228302|FG000|First Intervention|Withdrawal by Subject|0|||
147565243|NCT00986245|532228303|FG001|First Intervention|Withdrawal by Subject|1|||
147565244|NCT00986245|532228302|FG000|First Intervention|Protocol Violation|0|||
147565245|NCT00986245|532228303|FG001|First Intervention|Protocol Violation|1|||
147565246|NCT00986245|532228302|FG000|First Intervention|Out of indication|1|||
147565247|NCT00986245|532228303|FG001|First Intervention|Out of indication|0|||
147565248|NCT00986245|532228302|FG000|Second Intervention|Poor compliance|1|||
147565249|NCT00986245|532228303|FG001|Second Intervention|Poor compliance|0|||
147565250|NCT00986245|532228302|FG000|Second Intervention|Lost to Follow-up|1|||
147565251|NCT00986245|532228303|FG001|Second Intervention|Lost to Follow-up|0|||
147565252|NCT00986245|532228302|FG000|Second Intervention|Protocol Violation|0|||
147565253|NCT00986245|532228303|FG001|Second Intervention|Protocol Violation|1|||
147565254|NCT01214850|532228304|FG000|Overall Study|Withdrawal by Subject|38|||
147565255|NCT01214850|532228305|FG001|Overall Study|Withdrawal by Subject|31|||
147565256|NCT01214850|532228306|FG002|Overall Study|Withdrawal by Subject|28|||
147565257|NCT01214850|532228304|FG000|Overall Study|Lost to Follow-up|124|||
147565258|NCT01214850|532228305|FG001|Overall Study|Lost to Follow-up|98|||
147565259|NCT01214850|532228306|FG002|Overall Study|Lost to Follow-up|123|||
147565260|NCT01214850|532228304|FG000|Overall Study|Protocol Violation|5|||
147565261|NCT01214850|532228305|FG001|Overall Study|Protocol Violation|5|||
147565262|NCT01214850|532228306|FG002|Overall Study|Protocol Violation|6|||
147565263|NCT01214850|532228304|FG000|Overall Study|Adverse event or death|11|||
147565264|NCT01214850|532228305|FG001|Overall Study|Adverse event or death|8|||
147565265|NCT01214850|532228306|FG002|Overall Study|Adverse event or death|3|||
147565266|NCT01214850|532228304|FG000|Overall Study|Inappropriate enrollment|2|||
147565267|NCT01214850|532228305|FG001|Overall Study|Inappropriate enrollment|1|||
147565268|NCT01214850|532228306|FG002|Overall Study|Inappropriate enrollment|0|||
147565269|NCT01214850|532228304|FG000|Overall Study|Administrative reason|1|||
147565270|NCT01214850|532228305|FG001|Overall Study|Administrative reason|0|||
147565271|NCT01214850|532228306|FG002|Overall Study|Administrative reason|0|||
147565272|NCT01214850|532228304|FG000|Overall Study|Unable to classify|2|||
147565273|NCT01214850|532228305|FG001|Overall Study|Unable to classify|1|||
147565274|NCT01214850|532228306|FG002|Overall Study|Unable to classify|1|||
147565275|NCT00610363|532228307|FG000|Overall Study|Non-compliance with protocol|0|||
147565276|NCT00610363|532228308|FG001|Overall Study|Non-compliance with protocol|1|||
147565277|NCT00610363|532228307|FG000|Overall Study|Adverse Event|3|||
147565278|NCT00610363|532228308|FG001|Overall Study|Adverse Event|1|||
147565279|NCT00610363|532228307|FG000|Overall Study|Lack of Efficacy|2|||
147565280|NCT00610363|532228308|FG001|Overall Study|Lack of Efficacy|0|||
147565281|NCT00610363|532228307|FG000|Overall Study|Lost to Follow-up|4|||
147565282|NCT00610363|532228308|FG001|Overall Study|Lost to Follow-up|0|||
147565283|NCT00610363|532228307|FG000|Overall Study|Withdrawal by Subject|1|||
147565284|NCT00610363|532228308|FG001|Overall Study|Withdrawal by Subject|0|||
147565285|NCT00610363|532228307|FG000|Overall Study|Other than specified above|1|||
147565286|NCT00610363|532228308|FG001|Overall Study|Other than specified above|1|||
147565287|NCT03204539|532228309|FG000|Overall Study|Loss of funding|0|||
147565288|NCT03204539|532228310|FG001|Overall Study|Loss of funding|1|||
147565289|NCT00302952|532228324|FG000|Overall Study|Physician Decision|1|||
147565290|NCT00302952|532228325|FG001|Overall Study|Physician Decision|1|||
147565291|NCT00302952|532228324|FG000|Overall Study|Withdrawal by Subject|2|||
147565292|NCT00302952|532228325|FG001|Overall Study|Withdrawal by Subject|3|||
147565293|NCT00302952|532228324|FG000|Overall Study|Elevated SGOT (AST) lab value|0|||
147565294|NCT00302952|532228325|FG001|Overall Study|Elevated SGOT (AST) lab value|1|||
147565295|NCT00336479|532228326|FG000|Overall Study|Adverse Event|8|||
147565296|NCT00336479|532228327|FG001|Overall Study|Adverse Event|11|||
147565297|NCT00336479|532228328|FG002|Overall Study|Adverse Event|18|||
147565298|NCT00336479|532228329|FG003|Overall Study|Adverse Event|4|||
147114180|NCT01471574|530581002|FG001|Follow-up Period|Death|0|||
147114181|NCT01471574|530581003|FG002|Follow-up Period|Death|1|||
147565299|NCT00336479|532228326|FG000|Overall Study|Noncompliant|1|||
147565300|NCT00336479|532228327|FG001|Overall Study|Noncompliant|7|||
147565301|NCT00336479|532228328|FG002|Overall Study|Noncompliant|3|||
147565302|NCT00336479|532228329|FG003|Overall Study|Noncompliant|0|||
147565303|NCT00336479|532228326|FG000|Overall Study|Physician Decision|2|||
147114182|NCT01471574|530581004|FG003|Follow-up Period|Death|0|||
147114183|NCT01471574|530581001|FG000|Follow-up Period|Follow-up no longer required|0|||
147114184|NCT01471574|530581002|FG001|Follow-up Period|Follow-up no longer required|1|||
147228673|NCT00422097|531010474|FG004|Dose Level 2|Still on treatment|0|||
147228674|NCT00422097|531010475|FG005|Dose Level 2|Still on treatment|0|||
147228675|NCT00422097|531010476|FG006|Dose Level 2|Still on treatment|0|||
147228676|NCT00422097|531010477|FG007|Dose Level 2|Still on treatment|0|||
147228677|NCT02572388|531010478|FG000|Overall Study|Withdrawal by Subject|1|||
147114185|NCT01471574|530581003|FG002|Follow-up Period|Follow-up no longer required|0|||
147228678|NCT02572388|531010479|FG001|Overall Study|Withdrawal by Subject|1|||
147565304|NCT00336479|532228327|FG001|Overall Study|Physician Decision|3|||
147114186|NCT01471574|530581004|FG003|Follow-up Period|Follow-up no longer required|0|||
147565305|NCT00336479|532228328|FG002|Overall Study|Physician Decision|1|||
147565306|NCT00336479|532228329|FG003|Overall Study|Physician Decision|0|||
147114187|NCT01177410|530581005|FG000|Overall Study|Adverse Event|0|||
147565307|NCT00336479|532228326|FG000|Overall Study|Lost to Follow-up|3|||
147114188|NCT01177410|530581006|FG001|Overall Study|Adverse Event|2|||
147565308|NCT00336479|532228327|FG001|Overall Study|Lost to Follow-up|2|||
147114189|NCT01177410|530581007|FG002|Overall Study|Adverse Event|2|||
147114190|NCT01177410|530581005|FG000|Overall Study|Withdrawal by Subject|1|||
147114191|NCT01177410|530581006|FG001|Overall Study|Withdrawal by Subject|4|||
147114192|NCT01177410|530581007|FG002|Overall Study|Withdrawal by Subject|3|||
147114193|NCT01177410|530581005|FG000|Overall Study|Lost to Follow-up|0|||
147565309|NCT00336479|532228328|FG002|Overall Study|Lost to Follow-up|0|||
147565310|NCT00336479|532228329|FG003|Overall Study|Lost to Follow-up|0|||
147565311|NCT00336479|532228326|FG000|Overall Study|Withdrawal by Subject|3|||
147565312|NCT00336479|532228327|FG001|Overall Study|Withdrawal by Subject|2|||
147565313|NCT00336479|532228328|FG002|Overall Study|Withdrawal by Subject|3|||
147565314|NCT00336479|532228329|FG003|Overall Study|Withdrawal by Subject|0|||
147565315|NCT00336479|532228326|FG000|Overall Study|Other|0|||
147565316|NCT00336479|532228327|FG001|Overall Study|Other|0|||
147565317|NCT00336479|532228328|FG002|Overall Study|Other|1|||
147565318|NCT00336479|532228329|FG003|Overall Study|Other|0|||
147565319|NCT00336479|532228326|FG000|Overall Study|Virologic Stopping Rule|20|||
147565320|NCT00336479|532228327|FG001|Overall Study|Virologic Stopping Rule|0|||
147565321|NCT00336479|532228328|FG002|Overall Study|Virologic Stopping Rule|0|||
147565322|NCT00336479|532228329|FG003|Overall Study|Virologic Stopping Rule|0|||
147565323|NCT00550537|532228330|FG000|Overall Study|Death|18|||
147565324|NCT00550537|532228330|FG000|Overall Study|Adverse Event|20|||
147565325|NCT00550537|532228330|FG000|Overall Study|Disease progression before|46|||
147565326|NCT00550537|532228330|FG000|Overall Study|Withdrawal by Subject|7|||
147565327|NCT00550537|532228330|FG000|Overall Study|Change in treatment plan|4|||
147565328|NCT00550537|532228330|FG000|Overall Study|Other complicating ilness|3|||
147565329|NCT00550537|532228330|FG000|Overall Study|Declining performance status|2|||
147565330|NCT00550537|532228330|FG000|Overall Study|Treated closer to home|4|||
147565331|NCT02008565|532228331|FG000|Overall Study|Protocol Violation|1|||
147565332|NCT02008565|532228332|FG001|Overall Study|Protocol Violation|1|||
147565333|NCT02008565|532228333|FG002|Overall Study|Protocol Violation|2|||
147565334|NCT02008565|532228334|FG003|Overall Study|Protocol Violation|0|||
147565335|NCT00268905|532228335|FG000|Overall Study|Adverse Event|3|||
147565336|NCT00268905|532228336|FG001|Overall Study|Adverse Event|0|||
147565337|NCT00268905|532228337|FG002|Overall Study|Adverse Event|4|||
147565338|NCT00268905|532228335|FG000|Overall Study|Lost to Follow-up|0|||
147565339|NCT00268905|532228336|FG001|Overall Study|Lost to Follow-up|1|||
147565340|NCT00268905|532228337|FG002|Overall Study|Lost to Follow-up|0|||
147565341|NCT00268905|532228335|FG000|Overall Study|Withdrawal by Subject|0|||
147565342|NCT00268905|532228336|FG001|Overall Study|Withdrawal by Subject|0|||
147565343|NCT00268905|532228337|FG002|Overall Study|Withdrawal by Subject|3|||
147114194|NCT01177410|530581006|FG001|Overall Study|Lost to Follow-up|1|||
147114195|NCT01177410|530581007|FG002|Overall Study|Lost to Follow-up|0|||
147114196|NCT02836769|530581009|FG000|Overall Study|Lost to Follow-up|10|||
147114197|NCT02836769|530581009|FG000|Overall Study|Medical withdrawal|2|||
147114198|NCT02836769|530581009|FG000|Overall Study|Withdrawal by Subject|3|||
147114199|NCT02503865|530581010|FG000|Overall Study|Moved out of area|1|||
147114200|NCT02503865|530581011|FG001|Overall Study|Moved out of area|8|||
147114201|NCT02503865|530581012|FG002|Overall Study|Moved out of area|0|||
147114202|NCT02503865|530581010|FG000|Overall Study|Refused treatment|4|||
147114203|NCT02503865|530581011|FG001|Overall Study|Refused treatment|39|||
147114204|NCT02503865|530581012|FG002|Overall Study|Refused treatment|2|||
147228679|NCT02572388|531010480|FG002|Overall Study|Withdrawal by Subject|2|||
147114205|NCT01529268|530581013|FG000|Overall Study|Lost to Follow-up|9|||
147114206|NCT01529268|530581014|FG001|Overall Study|Lost to Follow-up|3|||
147114207|NCT01529268|530581013|FG000|Overall Study|Moved|3|||
147114208|NCT01529268|530581014|FG001|Overall Study|Moved|0|||
147114209|NCT00021255|530581015|FG000|Overall Study|Death|1|||
147114210|NCT00021255|530581016|FG001|Overall Study|Death|0|||
147114211|NCT00021255|530581017|FG002|Overall Study|Death|2|||
147114212|NCT00021255|530581015|FG000|Overall Study|Breast cancer relapse|5|||
147114213|NCT00021255|530581016|FG001|Overall Study|Breast cancer relapse|18|||
147114214|NCT00021255|530581017|FG002|Overall Study|Breast cancer relapse|11|||
147114215|NCT00021255|530581015|FG000|Overall Study|Second primary malignancy|0|||
147114216|NCT00021255|530581016|FG001|Overall Study|Second primary malignancy|4|||
147114217|NCT00021255|530581017|FG002|Overall Study|Second primary malignancy|1|||
147114218|NCT00021255|530581015|FG000|Overall Study|Withdrawal by Subject|41|||
147114219|NCT00021255|530581016|FG001|Overall Study|Withdrawal by Subject|64|||
147114220|NCT00021255|530581017|FG002|Overall Study|Withdrawal by Subject|26|||
147114221|NCT00021255|530581015|FG000|Overall Study|Lost to Follow-up|0|||
147114222|NCT00021255|530581016|FG001|Overall Study|Lost to Follow-up|2|||
147114223|NCT00021255|530581017|FG002|Overall Study|Lost to Follow-up|3|||
147114224|NCT00021255|530581015|FG000|Overall Study|Cardiac toxicity|0|||
147114225|NCT00021255|530581016|FG001|Overall Study|Cardiac toxicity|61|||
147114226|NCT00021255|530581017|FG002|Overall Study|Cardiac toxicity|32|||
147114227|NCT00021255|530581015|FG000|Overall Study|Herceptin toxicity|0|||
147114228|NCT00021255|530581016|FG001|Overall Study|Herceptin toxicity|22|||
147114229|NCT00021255|530581017|FG002|Overall Study|Herceptin toxicity|6|||
147114230|NCT00021255|530581015|FG000|Overall Study|Adverse Event|46|||
147228680|NCT02572388|531010481|FG003|Overall Study|Withdrawal by Subject|2|||
147114231|NCT00021255|530581016|FG001|Overall Study|Adverse Event|30|||
147114232|NCT00021255|530581017|FG002|Overall Study|Adverse Event|18|||
147565344|NCT00268905|532228335|FG000|Overall Study|Progressive Disease|28|||
147565345|NCT00268905|532228336|FG001|Overall Study|Progressive Disease|4|||
147565346|NCT00268905|532228337|FG002|Overall Study|Progressive Disease|3|||
147565347|NCT00268905|532228335|FG000|Overall Study|Physician Decision|3|||
147565348|NCT00268905|532228336|FG001|Overall Study|Physician Decision|0|||
147565349|NCT00268905|532228337|FG002|Overall Study|Physician Decision|1|||
147114233|NCT00021255|530581015|FG000|Overall Study|Protocol Violation|0|||
147114234|NCT00021255|530581016|FG001|Overall Study|Protocol Violation|2|||
147114235|NCT00021255|530581017|FG002|Overall Study|Protocol Violation|0|||
147114236|NCT00021255|530581015|FG000|Overall Study|Other than specified above|0|||
147114237|NCT00021255|530581016|FG001|Overall Study|Other than specified above|38|||
147114238|NCT00021255|530581017|FG002|Overall Study|Other than specified above|19|||
147114239|NCT00021255|530581015|FG000|Overall Study|Missing|0|||
147114240|NCT00021255|530581016|FG001|Overall Study|Missing|27|||
147114241|NCT00021255|530581017|FG002|Overall Study|Missing|13|||
147114242|NCT00021255|530581015|FG000|Overall Study|Randomized but not treated|28|||
147114243|NCT00021255|530581016|FG001|Overall Study|Randomized but not treated|2|||
147114244|NCT00021255|530581017|FG002|Overall Study|Randomized but not treated|18|||
147114245|NCT02232698|530581018|FG000|Overall Study|Pregnancy|1|||
147114246|NCT02232698|530581019|FG001|Overall Study|Pregnancy|1|||
147114247|NCT02232698|530581018|FG000|Overall Study|Met exclusion criteria|1|||
147114248|NCT02232698|530581019|FG001|Overall Study|Met exclusion criteria|1|||
147114249|NCT02232698|530581018|FG000|Overall Study|Had device-associated symptoms|7|||
147114250|NCT02232698|530581019|FG001|Overall Study|Had device-associated symptoms|0|||
147114251|NCT02232698|530581018|FG000|Overall Study|Non-compliance with study device|1|||
147114252|NCT02232698|530581019|FG001|Overall Study|Non-compliance with study device|4|||
147114253|NCT02232698|530581018|FG000|Overall Study|Allocated to control group|0|||
147114254|NCT02232698|530581019|FG001|Overall Study|Allocated to control group|3|||
147114255|NCT02232698|530581018|FG000|Overall Study|Withdrawal by Subject|0|||
147114256|NCT02232698|530581019|FG001|Overall Study|Withdrawal by Subject|11|||
147114257|NCT05324371|530581021|FG000|Overall Study|Withdrawal by Subject|1|||
147114258|NCT05324371|530581021|FG000|Overall Study|Death|1|||
147114259|NCT01131585|530581022|FG000|Overall Study|Adverse Event|0|||
147114260|NCT01131585|530581023|FG001|Overall Study|Adverse Event|2|||
147114261|NCT01131585|530581022|FG000|Overall Study|Abnormal laboratory value|1|||
147114262|NCT01131585|530581023|FG001|Overall Study|Abnormal laboratory value|0|||
147114263|NCT01131585|530581022|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
147114264|NCT01131585|530581023|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
147114265|NCT01131585|530581022|FG000|Overall Study|Protocol Violation|2|||
147114266|NCT01131585|530581023|FG001|Overall Study|Protocol Violation|1|||
147114267|NCT01131585|530581022|FG000|Overall Study|Withdrawal by Subject|3|||
147114268|NCT01131585|530581023|FG001|Overall Study|Withdrawal by Subject|3|||
147114269|NCT01131585|530581022|FG000|Overall Study|Lost to Follow-up|0|||
147114270|NCT01131585|530581023|FG001|Overall Study|Lost to Follow-up|1|||
147114271|NCT01131585|530581022|FG000|Overall Study|Administrative problems|1|||
147114272|NCT01131585|530581023|FG001|Overall Study|Administrative problems|1|||
147114273|NCT01131585|530581022|FG000|Overall Study|Study termination|78|||
147114274|NCT01131585|530581023|FG001|Overall Study|Study termination|32|||
147114275|NCT01786109|530581024|FG000|Overall Study|fail manometry barostat tube placement|1|||
147114276|NCT01786109|530581025|FG001|Overall Study|fail manometry barostat tube placement|0|||
147114277|NCT01786109|530581026|FG002|Overall Study|fail manometry barostat tube placement|0|||
147114278|NCT01786109|530581024|FG000|Overall Study|unrelated illness|0|||
147114279|NCT01786109|530581025|FG001|Overall Study|unrelated illness|0|||
147114280|NCT01786109|530581026|FG002|Overall Study|unrelated illness|1|||
147114281|NCT01786109|530581024|FG000|Overall Study|adverse effects colon preparation|0|||
147114282|NCT01786109|530581025|FG001|Overall Study|adverse effects colon preparation|0|||
147114283|NCT01786109|530581026|FG002|Overall Study|adverse effects colon preparation|1|||
147114284|NCT01068912|530581031|FG000|Overall Study|Adverse Event|2|||
147114285|NCT01068912|530581032|FG001|Overall Study|Adverse Event|3|||
147114286|NCT01068912|530581033|FG002|Overall Study|Adverse Event|2|||
147114287|NCT01068912|530581031|FG000|Overall Study|Withdrawal by Subject|5|||
147114288|NCT01068912|530581032|FG001|Overall Study|Withdrawal by Subject|6|||
147114289|NCT01068912|530581033|FG002|Overall Study|Withdrawal by Subject|6|||
147114290|NCT01068912|530581031|FG000|Overall Study|Lost to Follow-up|3|||
147228681|NCT02360995|531010482|FG000|Overall Study|Lost to Follow-up|2|||
147228682|NCT02360995|531010483|FG001|Overall Study|Lost to Follow-up|0|||
147565350|NCT00268905|532228335|FG000|Overall Study|Clinical Progression|9|||
147565351|NCT00268905|532228336|FG001|Overall Study|Clinical Progression|4|||
147114291|NCT01068912|530581032|FG001|Overall Study|Lost to Follow-up|7|||
147114292|NCT01068912|530581033|FG002|Overall Study|Lost to Follow-up|3|||
147114293|NCT01068912|530581031|FG000|Overall Study|Protocol Violation|0|||
147114294|NCT01068912|530581032|FG001|Overall Study|Protocol Violation|2|||
147114295|NCT01068912|530581033|FG002|Overall Study|Protocol Violation|0|||
147114296|NCT01068912|530581031|FG000|Overall Study|aggravation influenza|1|||
147228683|NCT02360995|531010484|FG002|Overall Study|Lost to Follow-up|2|||
147114297|NCT01068912|530581032|FG001|Overall Study|aggravation influenza|1|||
147114298|NCT01068912|530581033|FG002|Overall Study|aggravation influenza|1|||
147114299|NCT01068912|530581031|FG000|Overall Study|other underlying illness|0|||
147114300|NCT01068912|530581032|FG001|Overall Study|other underlying illness|3|||
147114301|NCT01068912|530581033|FG002|Overall Study|other underlying illness|3|||
147114302|NCT02762604|530581034|FG000|Overall Study|Lost to Follow-up|2|||
147114303|NCT02762604|530581035|FG001|Overall Study|Lost to Follow-up|7|||
147114304|NCT02762604|530581034|FG000|Overall Study|Study Suspension due to COVID pandemic|1|||
147114305|NCT02762604|530581035|FG001|Overall Study|Study Suspension due to COVID pandemic|3|||
147114306|NCT03442569|530581044|FG000|Overall Study|Subject was ineligible after enrollment|1|||
147114307|NCT00544882|530581050|FG000|Cycle 1: Run-in Cycle|Withdrawal by Subject|2|||
147114308|NCT00544882|530581051|FG001|Cycle 1: Run-in Cycle|Withdrawal by Subject|0|||
147114309|NCT00544882|530581052|FG002|Cycle 1: Run-in Cycle|Withdrawal by Subject|0|||
147114310|NCT00544882|530581050|FG000|Cycle 1: Run-in Cycle|Adverse Event|1|||
147114311|NCT00544882|530581051|FG001|Cycle 1: Run-in Cycle|Adverse Event|0|||
147114312|NCT00544882|530581052|FG002|Cycle 1: Run-in Cycle|Adverse Event|0|||
147114313|NCT00544882|530581050|FG000|Cycle 2: Randomized Treatment Cycle|Withdrawal by Subject|0|||
147114314|NCT00544882|530581051|FG001|Cycle 2: Randomized Treatment Cycle|Withdrawal by Subject|1|||
147114315|NCT00544882|530581052|FG002|Cycle 2: Randomized Treatment Cycle|Withdrawal by Subject|0|||
147114316|NCT00544882|530581050|FG000|Cycle 2: Randomized Treatment Cycle|Noncompliance|0|||
147114317|NCT00544882|530581051|FG001|Cycle 2: Randomized Treatment Cycle|Noncompliance|0|||
147114318|NCT00544882|530581052|FG002|Cycle 2: Randomized Treatment Cycle|Noncompliance|1|||
147114319|NCT00544882|530581050|FG000|Cycle 3: Follow-up|Noncompliance|0|||
147114320|NCT00544882|530581051|FG001|Cycle 3: Follow-up|Noncompliance|1|||
147114321|NCT00544882|530581052|FG002|Cycle 3: Follow-up|Noncompliance|0|||
147114322|NCT00544882|530581050|FG000|Cycle 3: Follow-up|Pregnancy|0|||
147114323|NCT00544882|530581051|FG001|Cycle 3: Follow-up|Pregnancy|1|||
147114324|NCT00544882|530581052|FG002|Cycle 3: Follow-up|Pregnancy|0|||
147114325|NCT00308685|530581053|FG000|Overall Study|Lost to Follow-up|1|||
147114326|NCT00308685|530581054|FG001|Overall Study|Lost to Follow-up|0|||
147114327|NCT00308685|530581053|FG000|Overall Study|Need to administer prohibited medication|1|||
147114328|NCT00308685|530581054|FG001|Overall Study|Need to administer prohibited medication|2|||
147114329|NCT00308685|530581053|FG000|Overall Study|Other than specified|1|||
147114330|NCT00308685|530581054|FG001|Overall Study|Other than specified|3|||
147114331|NCT03770455|530581055|FG000|Overall Study|Screen failures|3|||
147114332|NCT04937387|530581056|FG000|Overall Study|Adverse Event|1|||
147114333|NCT04937387|530581057|FG001|Overall Study|Adverse Event|0|||
147114334|NCT04937387|530581058|FG002|Overall Study|Adverse Event|2|||
147114335|NCT04937387|530581059|FG003|Overall Study|Adverse Event|0|||
147114336|NCT04937387|530581056|FG000|Overall Study|Lack of Efficacy|1|||
147114337|NCT04937387|530581057|FG001|Overall Study|Lack of Efficacy|0|||
147114338|NCT04937387|530581058|FG002|Overall Study|Lack of Efficacy|0|||
147114339|NCT04937387|530581059|FG003|Overall Study|Lack of Efficacy|1|||
147114340|NCT04937387|530581056|FG000|Overall Study|Withdrawal by Subject|1|||
147114341|NCT04937387|530581057|FG001|Overall Study|Withdrawal by Subject|0|||
147114342|NCT04937387|530581058|FG002|Overall Study|Withdrawal by Subject|1|||
147114343|NCT04937387|530581059|FG003|Overall Study|Withdrawal by Subject|1|||
147114344|NCT04937387|530581056|FG000|Overall Study|Randomized in error|0|||
147114345|NCT04937387|530581057|FG001|Overall Study|Randomized in error|0|||
147114346|NCT04937387|530581058|FG002|Overall Study|Randomized in error|0|||
147114347|NCT04937387|530581059|FG003|Overall Study|Randomized in error|1|||
147114348|NCT02583269|530581060|FG000|Overall Study|Patient hospitalized prior to start|1|||
147114349|NCT02583269|530581061|FG001|Overall Study|Patient hospitalized prior to start|0|||
147114350|NCT02583269|530581062|FG002|Overall Study|Patient hospitalized prior to start|0|||
147114351|NCT02583269|530581063|FG003|Overall Study|Patient hospitalized prior to start|0|||
147114352|NCT02583269|530581064|FG004|Overall Study|Patient hospitalized prior to start|0|||
147114353|NCT01039675|530581067|FG000|Overall Study|Adverse Event|0|||
147114354|NCT01039675|530581068|FG001|Overall Study|Adverse Event|2|||
147114355|NCT01039675|530581067|FG000|Overall Study|Lack of Efficacy|0|||
147114356|NCT01039675|530581068|FG001|Overall Study|Lack of Efficacy|2|||
147114357|NCT01039675|530581067|FG000|Overall Study|Withdrawal by Subject|0|||
147114358|NCT01039675|530581068|FG001|Overall Study|Withdrawal by Subject|1|||
147114359|NCT01039675|530581067|FG000|Overall Study|Lost to Follow-up|0|||
147114360|NCT01039675|530581068|FG001|Overall Study|Lost to Follow-up|1|||
147114361|NCT01039675|530581067|FG000|Overall Study|Physician Decision|0|||
147114362|NCT01039675|530581068|FG001|Overall Study|Physician Decision|1|||
147114363|NCT01847209|530582094|FG000|Overall Study|Withdrawal by Subject|1|||
147114364|NCT01847209|530582094|FG000|Overall Study|No lung nodule found on intraop CT scan|1|||
147114365|NCT03600350|530582097|FG000|Overall Study|Death|1|||
147114366|NCT03600350|530582097|FG000|Overall Study|On Follow Up|18|||
147114367|NCT04575324|530582098|FG000|Overall Study|Lost to Follow-up|29|||
147114368|NCT04575324|530582099|FG001|Overall Study|Lost to Follow-up|25|||
147228684|NCT02360995|531010482|FG000|Overall Study|Withdrawal by Subject|0|||
147228685|NCT02360995|531010483|FG001|Overall Study|Withdrawal by Subject|1|||
147114369|NCT04575324|530582098|FG000|Overall Study|Death|1|||
147114370|NCT04575324|530582099|FG001|Overall Study|Death|2|||
147114371|NCT04575324|530582098|FG000|Overall Study|Withdrawn: Did not meet eligibility criteria|0|||
147114372|NCT04575324|530582099|FG001|Overall Study|Withdrawn: Did not meet eligibility criteria|1|||
147114373|NCT01137812|530582107|FG000|Overall Study|Adverse Event|21|||
147114374|NCT01137812|530582108|FG001|Overall Study|Adverse Event|14|||
147114375|NCT01137812|530582107|FG000|Overall Study|Lost to Follow-up|6|||
147114376|NCT01137812|530582108|FG001|Overall Study|Lost to Follow-up|8|||
147114377|NCT01137812|530582107|FG000|Overall Study|Physician Decision|25|||
147114378|NCT01137812|530582108|FG001|Overall Study|Physician Decision|17|||
147114379|NCT01137812|530582107|FG000|Overall Study|Protocol Violation|5|||
147114380|NCT01137812|530582108|FG001|Overall Study|Protocol Violation|4|||
147114381|NCT01137812|530582107|FG000|Overall Study|Withdrawal by Subject|5|||
147114382|NCT01137812|530582108|FG001|Overall Study|Withdrawal by Subject|13|||
147114383|NCT01137812|530582107|FG000|Overall Study|Death|2|||
147114384|NCT01137812|530582108|FG001|Overall Study|Death|0|||
147114385|NCT01137812|530582107|FG000|Overall Study|Patient met glycemic withdrawal criteria|40|||
147114386|NCT01137812|530582108|FG001|Overall Study|Patient met glycemic withdrawal criteria|85|||
147114387|NCT01137812|530582107|FG000|Overall Study|Other|19|||
147114388|NCT01137812|530582108|FG001|Overall Study|Other|27|||
147114389|NCT00845182|530582109|FG000|Overall Study|Lost to Follow-up|3|||
147114390|NCT00845182|530582110|FG001|Overall Study|Lost to Follow-up|3|||
147114391|NCT00845182|530582111|FG002|Overall Study|Lost to Follow-up|4|||
147114392|NCT00845182|530582109|FG000|Overall Study|Adverse Event|0|||
147114393|NCT00845182|530582110|FG001|Overall Study|Adverse Event|1|||
147114394|NCT00845182|530582111|FG002|Overall Study|Adverse Event|1|||
147114395|NCT00845182|530582109|FG000|Overall Study|Physician Decision|0|||
147114396|NCT00845182|530582110|FG001|Overall Study|Physician Decision|0|||
147114397|NCT00845182|530582111|FG002|Overall Study|Physician Decision|1|||
147114398|NCT04621760|530582112|FG000|Overall Study|Lost to Follow-up|2|||
147114399|NCT04621760|530582113|FG001|Overall Study|Lost to Follow-up|4|||
147114400|NCT04621760|530582112|FG000|Overall Study|Withdrawal by Subject|1|||
147114401|NCT04621760|530582113|FG001|Overall Study|Withdrawal by Subject|0|||
147114402|NCT00447278|530582116|FG000|Period II (6 Month Open-Label)|Adverse Event|7|||
147114403|NCT00447278|530582117|FG001|Period II (6 Month Open-Label)|Adverse Event|3|||
147312118|NCT02736968|531309276|FG006|Overall Study|COVID-19 Pandemic|2|||
147312119|NCT02736968|531309277|FG007|Overall Study|COVID-19 Pandemic|0|||
147312120|NCT02736968|531309270|FG000|Overall Study|Withdrawal by Subject|0|||
147312121|NCT02736968|531309271|FG001|Overall Study|Withdrawal by Subject|0|||
147312122|NCT02736968|531309272|FG002|Overall Study|Withdrawal by Subject|0|||
147114404|NCT00447278|530582116|FG000|Period II (6 Month Open-Label)|Lost to Follow-up|0|||
147312123|NCT02736968|531309273|FG003|Overall Study|Withdrawal by Subject|0|||
147312124|NCT02736968|531309274|FG004|Overall Study|Withdrawal by Subject|0|||
147312125|NCT02736968|531309275|FG005|Overall Study|Withdrawal by Subject|0|||
147312126|NCT02736968|531309276|FG006|Overall Study|Withdrawal by Subject|1|||
147312127|NCT02736968|531309277|FG007|Overall Study|Withdrawal by Subject|0|||
147312128|NCT03342053|531309280|FG000|Overall Study|Adverse Event|2|||
147312129|NCT03342053|531309281|FG001|Overall Study|Adverse Event|0|||
147312130|NCT03342053|531309280|FG000|Overall Study|Withdrawal by Subject|0|||
147312131|NCT03342053|531309281|FG001|Overall Study|Withdrawal by Subject|1|||
147312132|NCT02961374|531309282|FG000|Overall Study|Adverse Event|4|||
147312133|NCT00735644|531309283|FG000|Overall Study|Did not receive study vaccine|0|||
147312134|NCT00735644|531309284|FG001|Overall Study|Did not receive study vaccine|1|||
147312135|NCT00735644|531309285|FG002|Overall Study|Did not receive study vaccine|0|||
147312136|NCT00735644|531309286|FG003|Overall Study|Did not receive study vaccine|0|||
147312137|NCT00735644|531309287|FG004|Overall Study|Did not receive study vaccine|0|||
147312138|NCT00735644|531309283|FG000|Overall Study|Withdrawal by Subject|0|||
147312139|NCT00735644|531309284|FG001|Overall Study|Withdrawal by Subject|1|||
147312140|NCT00735644|531309285|FG002|Overall Study|Withdrawal by Subject|1|||
147565352|NCT00268905|532228337|FG002|Overall Study|Clinical Progression|1|||
147565353|NCT00617305|532228338|FG000|Overall Study|Adverse Event|4|||
147565354|NCT00617305|532228339|FG001|Overall Study|Adverse Event|0|||
147114405|NCT00447278|530582117|FG001|Period II (6 Month Open-Label)|Lost to Follow-up|4|||
147114406|NCT00447278|530582116|FG000|Period II (6 Month Open-Label)|Protocol Violation|10|||
147114407|NCT00447278|530582117|FG001|Period II (6 Month Open-Label)|Protocol Violation|7|||
147114408|NCT00447278|530582116|FG000|Period II (6 Month Open-Label)|Withdrawal by Subject|1|||
147114409|NCT00447278|530582117|FG001|Period II (6 Month Open-Label)|Withdrawal by Subject|3|||
147114410|NCT00447278|530582116|FG000|Period II (6 Month Open-Label)|Physician Decision|4|||
147114411|NCT00447278|530582117|FG001|Period II (6 Month Open-Label)|Physician Decision|1|||
147114412|NCT00447278|530582116|FG000|Period II (6 Month Open-Label)|Lack of Efficacy|11|||
147114413|NCT00447278|530582117|FG001|Period II (6 Month Open-Label)|Lack of Efficacy|1|||
147114414|NCT00447278|530582116|FG000|Period II (6 Month Open-Label)|Parent/Guardian Decision|9|||
147114415|NCT00447278|530582117|FG001|Period II (6 Month Open-Label)|Parent/Guardian Decision|10|||
147312141|NCT00735644|531309286|FG003|Overall Study|Withdrawal by Subject|1|||
147312142|NCT00735644|531309287|FG004|Overall Study|Withdrawal by Subject|0|||
147312143|NCT02041923|531309290|FG000|Overall Study|Lost to Follow-up|26|||
147312144|NCT02041923|531309291|FG001|Overall Study|Lost to Follow-up|30|||
147114416|NCT00447278|530582116|FG000|Period III (Optional 6 Month Extension)|Adverse Event|2|||
147114417|NCT00447278|530582117|FG001|Period III (Optional 6 Month Extension)|Adverse Event|2|||
147114418|NCT00447278|530582116|FG000|Period III (Optional 6 Month Extension)|Lost to Follow-up|2|||
147114419|NCT00447278|530582117|FG001|Period III (Optional 6 Month Extension)|Lost to Follow-up|2|||
147114420|NCT00447278|530582116|FG000|Period III (Optional 6 Month Extension)|Protocol Violation|6|||
147114421|NCT00447278|530582117|FG001|Period III (Optional 6 Month Extension)|Protocol Violation|1|||
147114422|NCT00447278|530582116|FG000|Period III (Optional 6 Month Extension)|Withdrawal by Subject|4|||
147114423|NCT00447278|530582117|FG001|Period III (Optional 6 Month Extension)|Withdrawal by Subject|1|||
147114424|NCT00447278|530582116|FG000|Period III (Optional 6 Month Extension)|Physician Decision|1|||
147114425|NCT00447278|530582117|FG001|Period III (Optional 6 Month Extension)|Physician Decision|1|||
147114426|NCT00447278|530582116|FG000|Period III (Optional 6 Month Extension)|Lack of Efficacy|4|||
147114427|NCT00447278|530582117|FG001|Period III (Optional 6 Month Extension)|Lack of Efficacy|0|||
147114428|NCT00447278|530582116|FG000|Period III (Optional 6 Month Extension)|Parent/Guardian Decision|11|||
147114429|NCT00447278|530582117|FG001|Period III (Optional 6 Month Extension)|Parent/Guardian Decision|8|||
147114430|NCT03677401|530582118|FG000|Overall Study|Adverse Event|4|||
147114431|NCT03677401|530582119|FG001|Overall Study|Adverse Event|14|||
147114432|NCT03677401|530582118|FG000|Overall Study|Lack of Efficacy|3|||
147114433|NCT03677401|530582119|FG001|Overall Study|Lack of Efficacy|1|||
147114434|NCT03677401|530582118|FG000|Overall Study|Withdrawal by Subject|2|||
147114435|NCT03677401|530582119|FG001|Overall Study|Withdrawal by Subject|2|||
147114436|NCT03677401|530582118|FG000|Overall Study|Sponsor decision|0|||
147114437|NCT03677401|530582119|FG001|Overall Study|Sponsor decision|1|||
147114438|NCT03677401|530582118|FG000|Overall Study|Reason Unspecified|1|||
147114439|NCT03677401|530582119|FG001|Overall Study|Reason Unspecified|0|||
147114440|NCT00471354|530582122|FG000|Overall Study|Protocol Entry Criteria Not Met|1|||
147114441|NCT00471354|530582122|FG000|Overall Study|Adverse Event|13|||
147114442|NCT00471354|530582122|FG000|Overall Study|Protocol Violation|12|||
147114443|NCT00471354|530582122|FG000|Overall Study|Withdrawal by Subject|1|||
147114444|NCT00471354|530582122|FG000|Overall Study|Physician Decision|4|||
147114445|NCT00471354|530582122|FG000|Overall Study|Sponsor Decision|1|||
147114446|NCT00471354|530582122|FG000|Overall Study|Lost to Follow-up|3|||
147114447|NCT00471354|530582122|FG000|Overall Study|Lack of Efficacy|5|||
147114448|NCT00471354|530582122|FG000|Overall Study|Patient/Caregiver Decision|12|||
147114449|NCT05950906|530582123|FG000|Overall Study|Adverse Event|0|||
147114450|NCT05950906|530582124|FG001|Overall Study|Adverse Event|0|||
147114451|NCT05950906|530582125|FG002|Overall Study|Adverse Event|0|||
147114452|NCT05950906|530582126|FG003|Overall Study|Adverse Event|0|||
147114453|NCT05950906|530582127|FG004|Overall Study|Adverse Event|0|||
147114454|NCT05950906|530582128|FG005|Overall Study|Adverse Event|0|||
147114455|NCT05950906|530582129|FG006|Overall Study|Adverse Event|0|||
147114456|NCT05950906|530582130|FG007|Overall Study|Adverse Event|0|||
147114457|NCT05950906|530582131|FG008|Overall Study|Adverse Event|0|||
147114458|NCT05950906|530582132|FG009|Overall Study|Adverse Event|0|||
147565355|NCT00617305|532228340|FG002|Overall Study|Adverse Event|0|||
147565356|NCT00617305|532228338|FG000|Overall Study|Death|1|||
147565357|NCT00617305|532228339|FG001|Overall Study|Death|0|||
147565358|NCT00617305|532228340|FG002|Overall Study|Death|0|||
147565359|NCT00617305|532228338|FG000|Overall Study|Physician Decision|1|||
147565360|NCT00617305|532228339|FG001|Overall Study|Physician Decision|0|||
147565361|NCT00617305|532228340|FG002|Overall Study|Physician Decision|0|||
147565362|NCT00617305|532228338|FG000|Overall Study|Protocol Violation|1|||
147565363|NCT00617305|532228339|FG001|Overall Study|Protocol Violation|0|||
147565364|NCT00617305|532228340|FG002|Overall Study|Protocol Violation|1|||
147565365|NCT00617305|532228338|FG000|Overall Study|Withdrawal by Subject|1|||
147565366|NCT00617305|532228339|FG001|Overall Study|Withdrawal by Subject|0|||
147565367|NCT00617305|532228340|FG002|Overall Study|Withdrawal by Subject|0|||
147565368|NCT02193178|532228341|FG000|Overall Study|Lost to Follow-up|1|||
147565369|NCT02193178|532228341|FG000|Overall Study|Dry eyes|1|||
147565370|NCT03435081|532228342|FG000|Week 0 to Week 16|Lack of Efficacy|6|||
147565371|NCT03435081|532228343|FG001|Week 0 to Week 16|Lack of Efficacy|5|||
147565372|NCT03435081|532228344|FG002|Week 0 to Week 16|Lack of Efficacy|0|||
147565373|NCT03435081|532228342|FG000|Week 0 to Week 16|Adverse Event|2|||
147565374|NCT03435081|532228343|FG001|Week 0 to Week 16|Adverse Event|2|||
147565375|NCT03435081|532228344|FG002|Week 0 to Week 16|Adverse Event|2|||
147565376|NCT03435081|532228342|FG000|Week 0 to Week 16|Withdrawal by Subject|8|||
147565377|NCT03435081|532228343|FG001|Week 0 to Week 16|Withdrawal by Subject|7|||
147565378|NCT03435081|532228344|FG002|Week 0 to Week 16|Withdrawal by Subject|10|||
147565379|NCT03435081|532228342|FG000|Week 0 to Week 16|Lost to Follow-up|3|||
147114459|NCT05950906|530582133|FG010|Overall Study|Adverse Event|0|||
147114460|NCT05950906|530582134|FG011|Overall Study|Adverse Event|0|||
147565380|NCT03435081|532228343|FG001|Week 0 to Week 16|Lost to Follow-up|1|||
147565381|NCT03435081|532228344|FG002|Week 0 to Week 16|Lost to Follow-up|4|||
147565382|NCT03435081|532228342|FG000|Week 0 to Week 16|Pregnancy|1|||
147659418|NCT01064414|532576182|FG001|Core Period: Baseline to Week 26|Protocol Violation|0|||
147565383|NCT03435081|532228343|FG001|Week 0 to Week 16|Pregnancy|0|||
147565384|NCT03435081|532228344|FG002|Week 0 to Week 16|Pregnancy|0|||
147114461|NCT05950906|530582135|FG012|Overall Study|Adverse Event|1|||
147114462|NCT05950906|530582136|FG013|Overall Study|Adverse Event|0|||
147114463|NCT05950906|530582123|FG000|Overall Study|Physician Decision|0|||
147114464|NCT05950906|530582124|FG001|Overall Study|Physician Decision|0|||
147114465|NCT05950906|530582125|FG002|Overall Study|Physician Decision|0|||
147114466|NCT05950906|530582126|FG003|Overall Study|Physician Decision|0|||
147114467|NCT05950906|530582127|FG004|Overall Study|Physician Decision|0|||
147114468|NCT05950906|530582128|FG005|Overall Study|Physician Decision|0|||
147114469|NCT05950906|530582129|FG006|Overall Study|Physician Decision|0|||
147114470|NCT05950906|530582130|FG007|Overall Study|Physician Decision|0|||
147114471|NCT05950906|530582131|FG008|Overall Study|Physician Decision|0|||
147114472|NCT05950906|530582132|FG009|Overall Study|Physician Decision|0|||
147114473|NCT05950906|530582133|FG010|Overall Study|Physician Decision|0|||
147114474|NCT05950906|530582134|FG011|Overall Study|Physician Decision|0|||
147114475|NCT05950906|530582135|FG012|Overall Study|Physician Decision|1|||
147114476|NCT05950906|530582136|FG013|Overall Study|Physician Decision|0|||
147114477|NCT03142750|530582142|FG000|Overall Study|Lost to Follow-up|4|||
147114478|NCT03142750|530582143|FG001|Overall Study|Lost to Follow-up|1|||
147114479|NCT02942407|530582144|FG000|Overall Study|Lost to Follow-up|3|||
147114480|NCT02942407|530582145|FG001|Overall Study|Lost to Follow-up|2|||
147114481|NCT02942407|530582144|FG000|Overall Study|Withdrawal by Subject|7|||
147114482|NCT02942407|530582145|FG001|Overall Study|Withdrawal by Subject|9|||
147114483|NCT02942407|530582144|FG000|Overall Study|Death|16|||
147114484|NCT02942407|530582145|FG001|Overall Study|Death|13|||
147114485|NCT00933166|530582146|FG000|Overall Study|Lost to Follow-up|4|||
147114486|NCT00933166|530582146|FG000|Overall Study|Lack of Efficacy|9|||
147114487|NCT00933166|530582146|FG000|Overall Study|Unavailable|4|||
147114488|NCT00933166|530582146|FG000|Overall Study|Withdrawal by Subject|1|||
147114489|NCT04618471|530582147|FG000|Overall Study|Screen Failure|62|||
147114490|NCT04618471|530582147|FG000|Overall Study|Withdrawal by Subject|6|||
147114491|NCT04618471|530582147|FG000|Overall Study|Physician Decision|2|||
147114492|NCT04618471|530582147|FG000|Overall Study|Lost to Follow-up|1|||
147114493|NCT04618471|530582147|FG000|Overall Study|Various other reasons|2|||
147114494|NCT04618471|530582147|FG000|Overall Study|Pending study evaluation and completion of 3-Month post activation visit|84|||
147114495|NCT05774977|530582150|FG000|Overall Study|Withdrawal by Subject|2|||
147114496|NCT00374868|530582151|FG000|Overall Study|Adverse Event|12|||
147114497|NCT00374868|530582151|FG000|Overall Study|Progressive Disease|7|||
147114498|NCT00374868|530582151|FG000|Overall Study|Physician Decision|13|||
147114499|NCT00374868|530582151|FG000|Overall Study|Lost to Follow-up|1|||
147114500|NCT00374868|530582151|FG000|Overall Study|Death|2|||
147114501|NCT00374868|530582151|FG000|Overall Study|Other - Not Specified|1|||
147114502|NCT03325439|530582152|FG000|Overall Study|Ineligibility|3|||
147114503|NCT03188185|530582153|FG000|Stage 1|Adverse Event|4|||
147114504|NCT03188185|530582154|FG001|Stage 1|Adverse Event|12|||
147114505|NCT03188185|530582155|FG002|Stage 1|Adverse Event|0|||
147114506|NCT03188185|530582156|FG003|Stage 1|Adverse Event|0|||
147114507|NCT03188185|530582153|FG000|Stage 1|Lack of Efficacy|0|||
147114508|NCT03188185|530582154|FG001|Stage 1|Lack of Efficacy|2|||
147114509|NCT03188185|530582155|FG002|Stage 1|Lack of Efficacy|0|||
147114510|NCT03188185|530582156|FG003|Stage 1|Lack of Efficacy|0|||
147114511|NCT03188185|530582153|FG000|Stage 1|Lost to Follow-up|6|||
147114512|NCT03188185|530582154|FG001|Stage 1|Lost to Follow-up|1|||
147114513|NCT03188185|530582155|FG002|Stage 1|Lost to Follow-up|0|||
147114514|NCT03188185|530582156|FG003|Stage 1|Lost to Follow-up|0|||
147114515|NCT03188185|530582153|FG000|Stage 1|Withdrawal by Subject|9|||
147114516|NCT03188185|530582154|FG001|Stage 1|Withdrawal by Subject|0|||
147114517|NCT03188185|530582155|FG002|Stage 1|Withdrawal by Subject|0|||
147114518|NCT03188185|530582156|FG003|Stage 1|Withdrawal by Subject|0|||
147114519|NCT03188185|530582153|FG000|Stage 1|Identified as a professional patient|0|||
147114520|NCT03188185|530582154|FG001|Stage 1|Identified as a professional patient|1|||
147114521|NCT03188185|530582155|FG002|Stage 1|Identified as a professional patient|0|||
147114522|NCT03188185|530582156|FG003|Stage 1|Identified as a professional patient|0|||
147114523|NCT03188185|530582153|FG000|Stage 2|Adverse Event|0|||
147114524|NCT03188185|530582154|FG001|Stage 2|Adverse Event|0|||
147114525|NCT03188185|530582155|FG002|Stage 2|Adverse Event|2|||
147114526|NCT03188185|530582156|FG003|Stage 2|Adverse Event|4|||
147114527|NCT03188185|530582153|FG000|Stage 2|Lack of Efficacy|0|||
147114528|NCT03188185|530582154|FG001|Stage 2|Lack of Efficacy|0|||
147114529|NCT03188185|530582155|FG002|Stage 2|Lack of Efficacy|3|||
147114530|NCT03188185|530582156|FG003|Stage 2|Lack of Efficacy|0|||
147228686|NCT02360995|531010484|FG002|Overall Study|Withdrawal by Subject|0|||
147228687|NCT00810108|531010485|FG000|Overall Study|Withdrawal by Subject|1|||
147228688|NCT00810108|531010486|FG001|Overall Study|Withdrawal by Subject|0|||
147114531|NCT03188185|530582153|FG000|Stage 2|Lost to Follow-up|0|||
147114532|NCT03188185|530582154|FG001|Stage 2|Lost to Follow-up|0|||
147114533|NCT03188185|530582155|FG002|Stage 2|Lost to Follow-up|1|||
147114534|NCT03188185|530582156|FG003|Stage 2|Lost to Follow-up|0|||
147114535|NCT03188185|530582153|FG000|Stage 2|Physician Decision|0|||
147114536|NCT03188185|530582154|FG001|Stage 2|Physician Decision|0|||
147114537|NCT03188185|530582155|FG002|Stage 2|Physician Decision|0|||
147114538|NCT03188185|530582156|FG003|Stage 2|Physician Decision|1|||
147114539|NCT03188185|530582153|FG000|Stage 2|Withdrawal by Subject|0|||
147114540|NCT03188185|530582154|FG001|Stage 2|Withdrawal by Subject|0|||
147114541|NCT03188185|530582155|FG002|Stage 2|Withdrawal by Subject|3|||
147114542|NCT03188185|530582156|FG003|Stage 2|Withdrawal by Subject|1|||
147114543|NCT00774748|530582157|FG000|Overall Study|Lost to Follow-up|3|||
147114544|NCT03412890|530582160|FG000|Overall Study|Adverse Event|5|||
147114545|NCT03412890|530582161|FG001|Overall Study|Adverse Event|5|||
147114546|NCT03412890|530582162|FG002|Overall Study|Adverse Event|9|||
147114547|NCT03412890|530582160|FG000|Overall Study|Protocol deviation|2|||
147114548|NCT03412890|530582161|FG001|Overall Study|Protocol deviation|1|||
147114549|NCT03412890|530582162|FG002|Overall Study|Protocol deviation|2|||
147114550|NCT03412890|530582160|FG000|Overall Study|Lost to Follow-up|7|||
147114551|NCT03412890|530582161|FG001|Overall Study|Lost to Follow-up|10|||
147114552|NCT03412890|530582162|FG002|Overall Study|Lost to Follow-up|10|||
147114553|NCT03412890|530582160|FG000|Overall Study|Withdrawal by Subject|9|||
147114554|NCT03412890|530582161|FG001|Overall Study|Withdrawal by Subject|12|||
147114555|NCT03412890|530582162|FG002|Overall Study|Withdrawal by Subject|11|||
147114556|NCT03412890|530582160|FG000|Overall Study|Lack of Efficacy|2|||
147114557|NCT03412890|530582161|FG001|Overall Study|Lack of Efficacy|7|||
147114558|NCT03412890|530582162|FG002|Overall Study|Lack of Efficacy|5|||
147114559|NCT03412890|530582160|FG000|Overall Study|Other|5|||
147114560|NCT03412890|530582161|FG001|Overall Study|Other|6|||
147114561|NCT03412890|530582162|FG002|Overall Study|Other|5|||
147114562|NCT03412890|530582160|FG000|Overall Study|Participants who did not receive any study drug|0|||
147114563|NCT03412890|530582161|FG001|Overall Study|Participants who did not receive any study drug|1|||
147114564|NCT03412890|530582162|FG002|Overall Study|Participants who did not receive any study drug|0|||
147114565|NCT02315625|530582163|FG000|First Intervention|Disease Progression|1|||
147114566|NCT02315625|530582164|FG001|First Intervention|Disease Progression|0|||
147114567|NCT02315625|530582163|FG000|Second Intervention|Physician Decision|2|||
147114568|NCT02315625|530582164|FG001|Second Intervention|Physician Decision|1|||
147114569|NCT02315625|530582163|FG000|Second Intervention|Study closure|1|||
147114570|NCT02315625|530582164|FG001|Second Intervention|Study closure|0|||
147228689|NCT01051466|531010487|FG000|Overall Study|Adverse Event|1|||
147228690|NCT01051466|531010488|FG001|Overall Study|Adverse Event|0|||
147228691|NCT01051466|531010487|FG000|Overall Study|Lost to Follow-up|1|||
147228692|NCT01051466|531010488|FG001|Overall Study|Lost to Follow-up|1|||
147228693|NCT01051466|531010487|FG000|Overall Study|Withdrawal by Subject|5|||
147228694|NCT01051466|531010488|FG001|Overall Study|Withdrawal by Subject|1|||
147228695|NCT01051466|531010487|FG000|Overall Study|Entry Criteria Not Met|0|||
147565385|NCT03435081|532228342|FG000|Week 0 to Week 16|Non-compliance|1|||
147565386|NCT03435081|532228343|FG001|Week 0 to Week 16|Non-compliance|0|||
147565387|NCT03435081|532228344|FG002|Week 0 to Week 16|Non-compliance|2|||
147565388|NCT03435081|532228342|FG000|Week 0 to Week 16|Inadequate Response|0|||
147565389|NCT03435081|532228343|FG001|Week 0 to Week 16|Inadequate Response|1|||
147565390|NCT03435081|532228344|FG002|Week 0 to Week 16|Inadequate Response|0|||
147565391|NCT03435081|532228342|FG000|Week 0 to Week 16|Withdrawal Due to Caregiver Circumstance|0|||
147565392|NCT03435081|532228343|FG001|Week 0 to Week 16|Withdrawal Due to Caregiver Circumstance|0|||
147565393|NCT03435081|532228344|FG002|Week 0 to Week 16|Withdrawal Due to Caregiver Circumstance|1|||
147565394|NCT03435081|532228342|FG000|Week 16 to Week 104|Lack of Efficacy|2|||
147565395|NCT03435081|532228343|FG001|Week 16 to Week 104|Lack of Efficacy|11|||
147565396|NCT03435081|532228344|FG002|Week 16 to Week 104|Lack of Efficacy|10|||
147565397|NCT03435081|532228342|FG000|Week 16 to Week 104|Adverse Event|1|||
147565398|NCT03435081|532228343|FG001|Week 16 to Week 104|Adverse Event|0|||
147650877|NCT02757352|532544546|FG009|Double-Blind Period (Week 16 - Week 52)|Classified as Inadequate Responders (IR)|0|||
147114571|NCT02315625|530582163|FG000|Second Intervention|Disease Progression|1|||
147114572|NCT02315625|530582164|FG001|Second Intervention|Disease Progression|0|||
147114573|NCT02337946|530582165|FG000|Protocol Treatment 1 Period|Adverse Event|7|||
147114574|NCT02337946|530582166|FG001|Protocol Treatment 1 Period|Adverse Event|0|||
147114575|NCT02337946|530582167|FG002|Protocol Treatment 1 Period|Adverse Event|0|||
147114576|NCT02337946|530582165|FG000|Protocol Treatment 1 Period|Major Protocol Deviation|1|||
147114577|NCT02337946|530582166|FG001|Protocol Treatment 1 Period|Major Protocol Deviation|0|||
147114578|NCT02337946|530582167|FG002|Protocol Treatment 1 Period|Major Protocol Deviation|0|||
147114579|NCT02337946|530582165|FG000|Protocol Treatment 1 Period|Voluntary Withdrawal|6|||
147228696|NCT01051466|531010488|FG001|Overall Study|Entry Criteria Not Met|3|||
147228697|NCT01051466|531010487|FG000|Overall Study|Physician Decision|1|||
147228698|NCT01051466|531010488|FG001|Overall Study|Physician Decision|0|||
147228699|NCT00331864|531010489|FG000|Overall Study|Adverse Event|30|||
147114580|NCT02337946|530582166|FG001|Protocol Treatment 1 Period|Voluntary Withdrawal|0|||
147114581|NCT02337946|530582167|FG002|Protocol Treatment 1 Period|Voluntary Withdrawal|0|||
147114582|NCT02337946|530582165|FG000|Protocol Treatment 1 Period|Lack of Efficacy|15|||
147114583|NCT02337946|530582166|FG001|Protocol Treatment 1 Period|Lack of Efficacy|0|||
147114584|NCT02337946|530582167|FG002|Protocol Treatment 1 Period|Lack of Efficacy|0|||
147114585|NCT02337946|530582165|FG000|Protocol Treatment 1 Period|Death During Protocol Treatment|3|||
147114586|NCT02337946|530582166|FG001|Protocol Treatment 1 Period|Death During Protocol Treatment|0|||
147565399|NCT03435081|532228344|FG002|Week 16 to Week 104|Adverse Event|2|||
147114587|NCT02337946|530582167|FG002|Protocol Treatment 1 Period|Death During Protocol Treatment|0|||
147114588|NCT02337946|530582165|FG000|Protocol Treatment 1 Period|Surgery Aimed at Curative Resection|9|||
147114589|NCT02337946|530582166|FG001|Protocol Treatment 1 Period|Surgery Aimed at Curative Resection|0|||
147114590|NCT02337946|530582167|FG002|Protocol Treatment 1 Period|Surgery Aimed at Curative Resection|0|||
147114591|NCT02337946|530582165|FG000|Protocol Treatment 1 Period|Did not Meet Entrance Criteria|1|||
147114592|NCT02337946|530582166|FG001|Protocol Treatment 1 Period|Did not Meet Entrance Criteria|0|||
147114593|NCT02337946|530582167|FG002|Protocol Treatment 1 Period|Did not Meet Entrance Criteria|0|||
147114594|NCT02337946|530582165|FG000|Protocol Treatment 1 Period|Reason not specified|8|||
147114595|NCT02337946|530582166|FG001|Protocol Treatment 1 Period|Reason not specified|0|||
147114596|NCT02337946|530582167|FG002|Protocol Treatment 1 Period|Reason not specified|0|||
147565400|NCT03435081|532228342|FG000|Week 16 to Week 104|Withdrawal by Subject|0|||
147565401|NCT03435081|532228343|FG001|Week 16 to Week 104|Withdrawal by Subject|1|||
147565402|NCT03435081|532228344|FG002|Week 16 to Week 104|Withdrawal by Subject|2|||
147114597|NCT02337946|530582165|FG000|In-between Period|Without Informed Consent|1|||
147114598|NCT02337946|530582166|FG001|In-between Period|Without Informed Consent|0|||
147114599|NCT02337946|530582167|FG002|In-between Period|Without Informed Consent|0|||
147114600|NCT02337946|530582165|FG000|Protocol Treatment 2 Period|Adverse Event|0|||
147114601|NCT02337946|530582166|FG001|Protocol Treatment 2 Period|Adverse Event|9|||
147114602|NCT02337946|530582167|FG002|Protocol Treatment 2 Period|Adverse Event|9|||
147114603|NCT02337946|530582165|FG000|Protocol Treatment 2 Period|Voluntary Withdrawal|0|||
147114604|NCT02337946|530582166|FG001|Protocol Treatment 2 Period|Voluntary Withdrawal|3|||
147114605|NCT02337946|530582167|FG002|Protocol Treatment 2 Period|Voluntary Withdrawal|1|||
147114606|NCT02337946|530582165|FG000|Protocol Treatment 2 Period|Lack of Efficacy|0|||
147114607|NCT02337946|530582166|FG001|Protocol Treatment 2 Period|Lack of Efficacy|29|||
147114608|NCT02337946|530582167|FG002|Protocol Treatment 2 Period|Lack of Efficacy|29|||
147114609|NCT02337946|530582165|FG000|Protocol Treatment 2 Period|Death During Protocol Treatment|0|||
147114610|NCT02337946|530582166|FG001|Protocol Treatment 2 Period|Death During Protocol Treatment|1|||
147114611|NCT02337946|530582167|FG002|Protocol Treatment 2 Period|Death During Protocol Treatment|0|||
147114612|NCT02337946|530582165|FG000|Protocol Treatment 2 Period|Surgery Aimed at Curative Resection|0|||
147114613|NCT02337946|530582166|FG001|Protocol Treatment 2 Period|Surgery Aimed at Curative Resection|5|||
147114614|NCT02337946|530582167|FG002|Protocol Treatment 2 Period|Surgery Aimed at Curative Resection|7|||
147114615|NCT02337946|530582165|FG000|Protocol Treatment 2 Period|Reason not specified|0|||
147114616|NCT02337946|530582166|FG001|Protocol Treatment 2 Period|Reason not specified|4|||
147114617|NCT02337946|530582167|FG002|Protocol Treatment 2 Period|Reason not specified|4|||
147114618|NCT00927082|530582168|FG000|Overall Study|Lost to Follow-up|9|||
147114619|NCT00927082|530582169|FG001|Overall Study|Lost to Follow-up|8|||
147114620|NCT00927082|530582170|FG002|Overall Study|Lost to Follow-up|12|||
147114621|NCT00927082|530582171|FG003|Overall Study|Lost to Follow-up|16|||
147114622|NCT00927082|530582168|FG000|Overall Study|Withdrawal by Subject|3|||
147114623|NCT00927082|530582169|FG001|Overall Study|Withdrawal by Subject|2|||
147114624|NCT00927082|530582170|FG002|Overall Study|Withdrawal by Subject|7|||
147114625|NCT00927082|530582171|FG003|Overall Study|Withdrawal by Subject|2|||
147114626|NCT00927082|530582168|FG000|Overall Study|Death|0|||
147114627|NCT00927082|530582169|FG001|Overall Study|Death|0|||
147114628|NCT00927082|530582170|FG002|Overall Study|Death|1|||
147114629|NCT00927082|530582171|FG003|Overall Study|Death|0|||
147114630|NCT00927082|530582168|FG000|Overall Study|Screen fail,Participant migrated,Unknown|0|||
147114631|NCT00927082|530582169|FG001|Overall Study|Screen fail,Participant migrated,Unknown|0|||
147114632|NCT00927082|530582170|FG002|Overall Study|Screen fail,Participant migrated,Unknown|2|||
147114633|NCT00927082|530582171|FG003|Overall Study|Screen fail,Participant migrated,Unknown|1|||
147114634|NCT02369458|530582172|FG000|Overall Study|Determined to be not eligible|1|||
147114635|NCT02369458|530582173|FG001|Overall Study|Determined to be not eligible|0|||
147114636|NCT03853798|530582174|FG000|Overall Study|Death|0|||
147114637|NCT03853798|530582175|FG001|Overall Study|Death|0|||
147114638|NCT03853798|530582176|FG002|Overall Study|Death|0|||
147114639|NCT03853798|530582177|FG003|Overall Study|Death|0|||
147114640|NCT03853798|530582178|FG004|Overall Study|Death|0|||
147114641|NCT03853798|530582179|FG005|Overall Study|Death|1|||
147228700|NCT00331864|531010490|FG001|Overall Study|Adverse Event|1|||
147114642|NCT03853798|530582180|FG006|Overall Study|Death|0|||
147114643|NCT03853798|530582181|FG007|Overall Study|Death|0|||
147228701|NCT00331864|531010489|FG000|Overall Study|Lack of Efficacy|4|||
147228702|NCT00331864|531010490|FG001|Overall Study|Lack of Efficacy|0|||
147228703|NCT00331864|531010489|FG000|Overall Study|Protocol Violation|3|||
147228704|NCT00331864|531010490|FG001|Overall Study|Protocol Violation|0|||
147228705|NCT00331864|531010489|FG000|Overall Study|Withdrawal by Subject|10|||
147228706|NCT00331864|531010490|FG001|Overall Study|Withdrawal by Subject|0|||
147228707|NCT00331864|531010489|FG000|Overall Study|Lost to Follow-up|4|||
147228708|NCT00331864|531010490|FG001|Overall Study|Lost to Follow-up|3|||
147114644|NCT03853798|530582182|FG008|Overall Study|Death|0|||
147114645|NCT03853798|530582174|FG000|Overall Study|Adverse Event|0|||
147114646|NCT03853798|530582175|FG001|Overall Study|Adverse Event|0|||
147228709|NCT00331864|531010489|FG000|Overall Study|Administrative Problems|1|||
147114647|NCT03853798|530582176|FG002|Overall Study|Adverse Event|2|||
147114648|NCT03853798|530582177|FG003|Overall Study|Adverse Event|0|||
147114649|NCT03853798|530582178|FG004|Overall Study|Adverse Event|0|||
147114650|NCT03853798|530582179|FG005|Overall Study|Adverse Event|0|||
147114651|NCT03853798|530582180|FG006|Overall Study|Adverse Event|0|||
147114652|NCT03853798|530582181|FG007|Overall Study|Adverse Event|0|||
147114653|NCT03853798|530582182|FG008|Overall Study|Adverse Event|0|||
147114654|NCT03853798|530582174|FG000|Overall Study|Withdrawal by Subject|0|||
147114655|NCT03853798|530582175|FG001|Overall Study|Withdrawal by Subject|1|||
147114656|NCT03853798|530582176|FG002|Overall Study|Withdrawal by Subject|4|||
147114657|NCT03853798|530582177|FG003|Overall Study|Withdrawal by Subject|0|||
147114658|NCT03853798|530582178|FG004|Overall Study|Withdrawal by Subject|0|||
147114659|NCT03853798|530582179|FG005|Overall Study|Withdrawal by Subject|5|||
147114660|NCT03853798|530582180|FG006|Overall Study|Withdrawal by Subject|0|||
147114661|NCT03853798|530582181|FG007|Overall Study|Withdrawal by Subject|0|||
147114662|NCT03853798|530582182|FG008|Overall Study|Withdrawal by Subject|4|||
147114663|NCT03853798|530582174|FG000|Overall Study|Physician Decision|1|||
147114664|NCT03853798|530582175|FG001|Overall Study|Physician Decision|0|||
147114665|NCT03853798|530582176|FG002|Overall Study|Physician Decision|0|||
147114666|NCT03853798|530582177|FG003|Overall Study|Physician Decision|0|||
147114667|NCT03853798|530582178|FG004|Overall Study|Physician Decision|0|||
147114668|NCT03853798|530582179|FG005|Overall Study|Physician Decision|0|||
147114669|NCT03853798|530582180|FG006|Overall Study|Physician Decision|0|||
147114670|NCT03853798|530582181|FG007|Overall Study|Physician Decision|0|||
147114671|NCT03853798|530582182|FG008|Overall Study|Physician Decision|1|||
147114672|NCT03853798|530582174|FG000|Overall Study|Lack of Efficacy|0|||
147114673|NCT03853798|530582175|FG001|Overall Study|Lack of Efficacy|0|||
147114674|NCT03853798|530582176|FG002|Overall Study|Lack of Efficacy|2|||
147114675|NCT03853798|530582177|FG003|Overall Study|Lack of Efficacy|0|||
147114676|NCT03853798|530582178|FG004|Overall Study|Lack of Efficacy|0|||
147114677|NCT03853798|530582179|FG005|Overall Study|Lack of Efficacy|0|||
147114678|NCT03853798|530582180|FG006|Overall Study|Lack of Efficacy|0|||
147114679|NCT03853798|530582181|FG007|Overall Study|Lack of Efficacy|0|||
147114680|NCT03853798|530582182|FG008|Overall Study|Lack of Efficacy|1|||
147114681|NCT03853798|530582174|FG000|Overall Study|Approved Drug Available for Indication|0|||
147114682|NCT03853798|530582175|FG001|Overall Study|Approved Drug Available for Indication|0|||
147114683|NCT03853798|530582176|FG002|Overall Study|Approved Drug Available for Indication|1|||
147114684|NCT03853798|530582177|FG003|Overall Study|Approved Drug Available for Indication|0|||
147114685|NCT03853798|530582178|FG004|Overall Study|Approved Drug Available for Indication|0|||
147114686|NCT03853798|530582179|FG005|Overall Study|Approved Drug Available for Indication|1|||
147114687|NCT03853798|530582180|FG006|Overall Study|Approved Drug Available for Indication|0|||
147114688|NCT03853798|530582181|FG007|Overall Study|Approved Drug Available for Indication|0|||
147114689|NCT03853798|530582182|FG008|Overall Study|Approved Drug Available for Indication|0|||
147114690|NCT03853798|530582174|FG000|Overall Study|Other un-specified|0|||
147114691|NCT03853798|530582175|FG001|Overall Study|Other un-specified|0|||
147114692|NCT03853798|530582176|FG002|Overall Study|Other un-specified|2|||
147114693|NCT03853798|530582177|FG003|Overall Study|Other un-specified|0|||
147114694|NCT03853798|530582178|FG004|Overall Study|Other un-specified|0|||
147114695|NCT03853798|530582179|FG005|Overall Study|Other un-specified|1|||
147114696|NCT03853798|530582180|FG006|Overall Study|Other un-specified|0|||
147114697|NCT03853798|530582181|FG007|Overall Study|Other un-specified|0|||
147114698|NCT03853798|530582182|FG008|Overall Study|Other un-specified|0|||
147114699|NCT02743494|530582183|FG000|Pre-treatment Period|Participant request to discontinue treatment|0|||
147114700|NCT02743494|530582184|FG001|Pre-treatment Period|Participant request to discontinue treatment|1|||
147114701|NCT02743494|530582183|FG000|Pre-treatment Period|Participant no longer meeting study criteria|0|||
147114702|NCT02743494|530582184|FG001|Pre-treatment Period|Participant no longer meeting study criteria|1|||
147114703|NCT02743494|530582183|FG000|Treatment Period|Disease recurrence|152|||
147114704|NCT02743494|530582184|FG001|Treatment Period|Disease recurrence|115|||
147114705|NCT02743494|530582183|FG000|Treatment Period|Study drug toxicity|56|||
147114706|NCT02743494|530582184|FG001|Treatment Period|Study drug toxicity|8|||
147114707|NCT02743494|530582183|FG000|Treatment Period|Death|1|||
147114708|NCT02743494|530582184|FG001|Treatment Period|Death|1|||
147114709|NCT02743494|530582183|FG000|Treatment Period|Adverse event unrelated to study drug|15|||
147228710|NCT00331864|531010490|FG001|Overall Study|Administrative Problems|0|||
147228711|NCT00331864|531010489|FG000|Overall Study|Death|6|||
147228712|NCT00331864|531010490|FG001|Overall Study|Death|0|||
147114710|NCT02743494|530582184|FG001|Treatment Period|Adverse event unrelated to study drug|9|||
147114711|NCT02743494|530582183|FG000|Treatment Period|Participant request to discontinue treatment|31|||
147114712|NCT02743494|530582184|FG001|Treatment Period|Participant request to discontinue treatment|5|||
147114713|NCT02743494|530582183|FG000|Treatment Period|Participant withdrew consent|11|||
147114714|NCT02743494|530582184|FG001|Treatment Period|Participant withdrew consent|4|||
147114715|NCT02743494|530582183|FG000|Treatment Period|Lost to Follow-up|0|||
147114716|NCT02743494|530582184|FG001|Treatment Period|Lost to Follow-up|1|||
147114717|NCT02743494|530582183|FG000|Treatment Period|Poor/Non-compliance|2|||
147114718|NCT02743494|530582184|FG001|Treatment Period|Poor/Non-compliance|0|||
147114719|NCT02743494|530582183|FG000|Treatment Period|Other reasons|4|||
147114720|NCT02743494|530582184|FG001|Treatment Period|Other reasons|1|||
147114721|NCT02068794|530583443|FG000|Overall Study|Withdrawal by Subject|0|||
147114722|NCT02068794|530583444|FG001|Overall Study|Withdrawal by Subject|1|||
147114723|NCT02068794|530583445|FG002|Overall Study|Withdrawal by Subject|2|||
147114724|NCT02068794|530583443|FG000|Overall Study|Early Progression|1|||
147114725|NCT02068794|530583444|FG001|Overall Study|Early Progression|0|||
147114726|NCT02068794|530583445|FG002|Overall Study|Early Progression|1|||
147114727|NCT02068794|530583443|FG000|Overall Study|Ineligible|0|||
147114728|NCT02068794|530583444|FG001|Overall Study|Ineligible|0|||
147114729|NCT02068794|530583445|FG002|Overall Study|Ineligible|1|||
147114730|NCT04439175|530583446|FG000|Overall Study|Never started treatment|4|||
147114731|NCT04439175|530583446|FG000|Overall Study|Ineligible|5|||
147114732|NCT04439175|530583446|FG000|Overall Study|Adverse Event|6|||
147114733|NCT04439175|530583446|FG000|Overall Study|Death|4|||
147114734|NCT04439175|530583446|FG000|Overall Study|Disease progression|44|||
147114735|NCT04439175|530583446|FG000|Overall Study|Withdrawal by Subject|4|||
147114736|NCT04439175|530583446|FG000|Overall Study|Alternative Therapy|1|||
147114737|NCT04439175|530583446|FG000|Overall Study|Other|2|||
147114738|NCT01631188|530583447|FG000|Overall Study|Physician Decision|75|||
147114739|NCT06262607|530583453|FG000|Overall Study|Physician Decision|0|||
147114740|NCT06262607|530583454|FG001|Overall Study|Physician Decision|1|||
147114741|NCT06262607|530583453|FG000|Overall Study|Withdrawal by Subject|2|||
147114742|NCT06262607|530583454|FG001|Overall Study|Withdrawal by Subject|0|||
147114743|NCT02639559|530583455|FG000|Overall Study|Mobilization failure|0|||
147114744|NCT02639559|530583456|FG001|Overall Study|Mobilization failure|3|||
147114745|NCT02639559|530583455|FG000|Overall Study|Issues with vascular acess|1|||
147114746|NCT02639559|530583456|FG001|Overall Study|Issues with vascular acess|0|||
147114747|NCT02969018|530583461|FG000|Overall Study|Adverse Event|2|||
147114748|NCT02969018|530583462|FG001|Overall Study|Adverse Event|4|||
147114749|NCT02969018|530583463|FG002|Overall Study|Adverse Event|1|||
147114750|NCT02969018|530583464|FG003|Overall Study|Adverse Event|2|||
147114751|NCT02969018|530583465|FG004|Overall Study|Adverse Event|0|||
147114752|NCT02969018|530583466|FG005|Overall Study|Adverse Event|1|||
147114753|NCT02969018|530583467|FG006|Overall Study|Adverse Event|2|||
147114754|NCT02969018|530583468|FG007|Overall Study|Adverse Event|0|||
147114755|NCT02969018|530583461|FG000|Overall Study|Lack of Efficacy|0|||
147312145|NCT02023879|531309297|FG000|Period 1: 24-Week Double-blind Treatment|Adverse Event|2|||
147312146|NCT02023879|531309298|FG001|Period 1: 24-Week Double-blind Treatment|Adverse Event|2|||
147312147|NCT02023879|531309299|FG002|Period 1: 24-Week Double-blind Treatment|Adverse Event|5|||
147312148|NCT02023879|531309297|FG000|Period 1: 24-Week Double-blind Treatment|Poor compliance to protocol|0|||
147312149|NCT02023879|531309298|FG001|Period 1: 24-Week Double-blind Treatment|Poor compliance to protocol|2|||
147312150|NCT02023879|531309299|FG002|Period 1: 24-Week Double-blind Treatment|Poor compliance to protocol|1|||
147312151|NCT02023879|531309297|FG000|Period 1: 24-Week Double-blind Treatment|Physician Decision|0|||
147312152|NCT02023879|531309298|FG001|Period 1: 24-Week Double-blind Treatment|Physician Decision|1|||
147312153|NCT02023879|531309299|FG002|Period 1: 24-Week Double-blind Treatment|Physician Decision|0|||
147114756|NCT02969018|530583462|FG001|Overall Study|Lack of Efficacy|1|||
147114757|NCT02969018|530583463|FG002|Overall Study|Lack of Efficacy|0|||
147114758|NCT02969018|530583464|FG003|Overall Study|Lack of Efficacy|0|||
147312154|NCT02023879|531309297|FG000|Period 1: 24-Week Double-blind Treatment|Consent withdrawn by participant|1|||
147312155|NCT02023879|531309298|FG001|Period 1: 24-Week Double-blind Treatment|Consent withdrawn by participant|0|||
147312156|NCT02023879|531309299|FG002|Period 1: 24-Week Double-blind Treatment|Consent withdrawn by participant|1|||
147312157|NCT02023879|531309297|FG000|Period 1: 24-Week Double-blind Treatment|Randomized but not treated|0|||
147114759|NCT02969018|530583465|FG004|Overall Study|Lack of Efficacy|1|||
147114760|NCT02969018|530583466|FG005|Overall Study|Lack of Efficacy|1|||
147114761|NCT02969018|530583467|FG006|Overall Study|Lack of Efficacy|1|||
147114762|NCT02969018|530583468|FG007|Overall Study|Lack of Efficacy|1|||
147114763|NCT02969018|530583461|FG000|Overall Study|Lost to Follow-up|1|||
147312158|NCT02023879|531309298|FG001|Period 1: 24-Week Double-blind Treatment|Randomized but not treated|1|||
147312159|NCT02023879|531309299|FG002|Period 1: 24-Week Double-blind Treatment|Randomized but not treated|1|||
147312160|NCT02023879|531309297|FG000|Period 1: 24-Week Double-blind Treatment|Other than specified above|1|||
147312161|NCT02023879|531309298|FG001|Period 1: 24-Week Double-blind Treatment|Other than specified above|3|||
147565403|NCT03435081|532228342|FG000|Week 16 to Week 104|Lost to Follow-up|0|||
147565404|NCT03435081|532228343|FG001|Week 16 to Week 104|Lost to Follow-up|1|||
147114764|NCT02969018|530583462|FG001|Overall Study|Lost to Follow-up|2|||
147114765|NCT02969018|530583463|FG002|Overall Study|Lost to Follow-up|2|||
147114766|NCT02969018|530583464|FG003|Overall Study|Lost to Follow-up|0|||
147114767|NCT02969018|530583465|FG004|Overall Study|Lost to Follow-up|1|||
147114768|NCT02969018|530583466|FG005|Overall Study|Lost to Follow-up|1|||
147114769|NCT02969018|530583467|FG006|Overall Study|Lost to Follow-up|0|||
147114770|NCT02969018|530583468|FG007|Overall Study|Lost to Follow-up|1|||
147114771|NCT02969018|530583461|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
147114772|NCT02969018|530583462|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
147114773|NCT02969018|530583463|FG002|Overall Study|No Longer Meets Eligibility Criteria|0|||
147114774|NCT02969018|530583464|FG003|Overall Study|No Longer Meets Eligibility Criteria|0|||
147114775|NCT02969018|530583465|FG004|Overall Study|No Longer Meets Eligibility Criteria|0|||
147114776|NCT02969018|530583466|FG005|Overall Study|No Longer Meets Eligibility Criteria|0|||
147114777|NCT02969018|530583467|FG006|Overall Study|No Longer Meets Eligibility Criteria|1|||
147114778|NCT02969018|530583468|FG007|Overall Study|No Longer Meets Eligibility Criteria|0|||
147114779|NCT02969018|530583461|FG000|Overall Study|Non-Compliance With Study Drug|1|||
147114780|NCT02969018|530583462|FG001|Overall Study|Non-Compliance With Study Drug|0|||
147114781|NCT02969018|530583463|FG002|Overall Study|Non-Compliance With Study Drug|0|||
147114782|NCT02969018|530583464|FG003|Overall Study|Non-Compliance With Study Drug|0|||
147114783|NCT02969018|530583465|FG004|Overall Study|Non-Compliance With Study Drug|0|||
147114784|NCT02969018|530583466|FG005|Overall Study|Non-Compliance With Study Drug|0|||
147114785|NCT02969018|530583467|FG006|Overall Study|Non-Compliance With Study Drug|0|||
147114786|NCT02969018|530583468|FG007|Overall Study|Non-Compliance With Study Drug|0|||
147114787|NCT02969018|530583461|FG000|Overall Study|Other|0|||
147114788|NCT02969018|530583462|FG001|Overall Study|Other|0|||
147114789|NCT02969018|530583463|FG002|Overall Study|Other|0|||
147114790|NCT02969018|530583464|FG003|Overall Study|Other|1|||
147114791|NCT02969018|530583465|FG004|Overall Study|Other|0|||
147114792|NCT02969018|530583466|FG005|Overall Study|Other|0|||
147114793|NCT02969018|530583467|FG006|Overall Study|Other|0|||
147114794|NCT02969018|530583468|FG007|Overall Study|Other|2|||
147114795|NCT02969018|530583461|FG000|Overall Study|Pregnancy|0|||
147114796|NCT02969018|530583462|FG001|Overall Study|Pregnancy|0|||
147114797|NCT02969018|530583463|FG002|Overall Study|Pregnancy|0|||
147114798|NCT02969018|530583464|FG003|Overall Study|Pregnancy|0|||
147114799|NCT02969018|530583465|FG004|Overall Study|Pregnancy|0|||
147114800|NCT02969018|530583466|FG005|Overall Study|Pregnancy|1|||
147114801|NCT02969018|530583467|FG006|Overall Study|Pregnancy|0|||
147114802|NCT02969018|530583468|FG007|Overall Study|Pregnancy|0|||
147114803|NCT02969018|530583461|FG000|Overall Study|Protocol Violation|0|||
147114804|NCT02969018|530583462|FG001|Overall Study|Protocol Violation|0|||
147114805|NCT02969018|530583463|FG002|Overall Study|Protocol Violation|1|||
147114806|NCT02969018|530583464|FG003|Overall Study|Protocol Violation|1|||
147114807|NCT02969018|530583465|FG004|Overall Study|Protocol Violation|0|||
147114808|NCT02969018|530583466|FG005|Overall Study|Protocol Violation|0|||
147114809|NCT02969018|530583467|FG006|Overall Study|Protocol Violation|0|||
147114810|NCT02969018|530583468|FG007|Overall Study|Protocol Violation|0|||
147114811|NCT02969018|530583461|FG000|Overall Study|Withdrawal by Subject|0|||
147114812|NCT02969018|530583462|FG001|Overall Study|Withdrawal by Subject|1|||
147114813|NCT02969018|530583463|FG002|Overall Study|Withdrawal by Subject|2|||
147114814|NCT02969018|530583464|FG003|Overall Study|Withdrawal by Subject|1|||
147114815|NCT02969018|530583465|FG004|Overall Study|Withdrawal by Subject|0|||
147114816|NCT02969018|530583466|FG005|Overall Study|Withdrawal by Subject|4|||
147114817|NCT02969018|530583467|FG006|Overall Study|Withdrawal by Subject|4|||
147114818|NCT02969018|530583468|FG007|Overall Study|Withdrawal by Subject|3|||
147114819|NCT04999020|530583469|FG000|Randomized Controlled Period (RCP)|Withdrawal by Subject|1|||
147114820|NCT04999020|530583470|FG001|Randomized Controlled Period (RCP)|Withdrawal by Subject|2|||
147114821|NCT04999020|530583471|FG002|Randomized Controlled Period (RCP)|Withdrawal by Subject|0|||
147114822|NCT04999020|530583472|FG003|Randomized Controlled Period (RCP)|Withdrawal by Subject|0|||
147114823|NCT04999020|530583469|FG000|Randomized Controlled Period (RCP)|Physician Decision|1|||
147114824|NCT04999020|530583470|FG001|Randomized Controlled Period (RCP)|Physician Decision|1|||
147114825|NCT04999020|530583471|FG002|Randomized Controlled Period (RCP)|Physician Decision|0|||
147114826|NCT04999020|530583472|FG003|Randomized Controlled Period (RCP)|Physician Decision|0|||
147114827|NCT04999020|530583469|FG000|Randomized Controlled Period (RCP)|Adverse Event|2|||
147114828|NCT04999020|530583470|FG001|Randomized Controlled Period (RCP)|Adverse Event|0|||
147114829|NCT04999020|530583471|FG002|Randomized Controlled Period (RCP)|Adverse Event|0|||
147114830|NCT04999020|530583472|FG003|Randomized Controlled Period (RCP)|Adverse Event|0|||
147114831|NCT04999020|530583469|FG000|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
147114832|NCT04999020|530583470|FG001|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
147114833|NCT04999020|530583471|FG002|Open-Label Extension (OLE) Period|Withdrawal by Subject|3|||
147114834|NCT04999020|530583472|FG003|Open-Label Extension (OLE) Period|Withdrawal by Subject|3|||
147114835|NCT04999020|530583469|FG000|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|0|||
147114836|NCT04999020|530583470|FG001|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|0|||
147114837|NCT04999020|530583471|FG002|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|17|||
147114838|NCT04999020|530583472|FG003|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|4|||
147114839|NCT04999020|530583469|FG000|Open-Label Extension (OLE) Period|Physician Decision|0|||
147114840|NCT04999020|530583470|FG001|Open-Label Extension (OLE) Period|Physician Decision|0|||
147114841|NCT04999020|530583471|FG002|Open-Label Extension (OLE) Period|Physician Decision|1|||
147114842|NCT04999020|530583472|FG003|Open-Label Extension (OLE) Period|Physician Decision|0|||
147114843|NCT04999020|530583469|FG000|Open-Label Extension (OLE) Period|Lost to Follow-up|0|||
147114844|NCT04999020|530583470|FG001|Open-Label Extension (OLE) Period|Lost to Follow-up|0|||
147228713|NCT02395666|531010491|FG000|Overall Study|Physician Decision|3|||
147565405|NCT03435081|532228344|FG002|Week 16 to Week 104|Lost to Follow-up|4|||
147114845|NCT04999020|530583471|FG002|Open-Label Extension (OLE) Period|Lost to Follow-up|1|||
147114846|NCT04999020|530583472|FG003|Open-Label Extension (OLE) Period|Lost to Follow-up|0|||
147114847|NCT04999020|530583469|FG000|Open-Label Extension (OLE) Period|Adverse Event|0|||
147114848|NCT04999020|530583470|FG001|Open-Label Extension (OLE) Period|Adverse Event|0|||
147114849|NCT04999020|530583471|FG002|Open-Label Extension (OLE) Period|Adverse Event|0|||
147114850|NCT04999020|530583472|FG003|Open-Label Extension (OLE) Period|Adverse Event|2|||
147114851|NCT02691663|530583475|FG000|Overall Study|Screen failure after baseline|2|||
147114852|NCT02691663|530583476|FG001|Overall Study|Screen failure after baseline|2|||
147114853|NCT02691663|530583475|FG000|Overall Study|withdrawn after Follow up 1 visit|2|||
147114854|NCT02691663|530583476|FG001|Overall Study|withdrawn after Follow up 1 visit|2|||
147114855|NCT02691663|530583475|FG000|Overall Study|Withdrawn after Follow up 2|1|||
147114856|NCT02691663|530583476|FG001|Overall Study|Withdrawn after Follow up 2|1|||
147114857|NCT02691663|530583475|FG000|Overall Study|Lost to Follow-up|3|||
147114858|NCT02691663|530583476|FG001|Overall Study|Lost to Follow-up|2|||
147114859|NCT04425018|530583479|FG000|Overall Study|Withdrawal by Subject|1|||
147114860|NCT04425018|530583480|FG001|Overall Study|Withdrawal by Subject|2|||
147114861|NCT01944774|530583481|FG000|Overall Study|Withdrawal by Subject|2|||
147114862|NCT01944774|530583482|FG001|Overall Study|Withdrawal by Subject|3|||
147114863|NCT01944774|530583483|FG002|Overall Study|Withdrawal by Subject|3|||
147114864|NCT01944774|530583481|FG000|Overall Study|Adverse Event|3|||
147114865|NCT01944774|530583482|FG001|Overall Study|Adverse Event|2|||
147114866|NCT01944774|530583483|FG002|Overall Study|Adverse Event|3|||
147114867|NCT01944774|530583481|FG000|Overall Study|Lack of Efficacy|1|||
147114868|NCT01944774|530583482|FG001|Overall Study|Lack of Efficacy|2|||
147114869|NCT01944774|530583483|FG002|Overall Study|Lack of Efficacy|2|||
147114870|NCT01944774|530583481|FG000|Overall Study|Lost to Follow-up|0|||
147114871|NCT01944774|530583482|FG001|Overall Study|Lost to Follow-up|1|||
147114872|NCT01944774|530583483|FG002|Overall Study|Lost to Follow-up|0|||
147114873|NCT00866320|530583486|FG000|Overall Study|Withdrawal by Subject|4|||
147114874|NCT00866320|530583486|FG000|Overall Study|Death|2|||
147114875|NCT00387127|530583487|FG000|Overall Study|Lost to Follow-up|0|||
147114876|NCT00387127|530583488|FG001|Overall Study|Lost to Follow-up|4|||
147114877|NCT00387127|530583487|FG000|Overall Study|Death|16|||
147114878|NCT00387127|530583488|FG001|Overall Study|Death|16|||
147114879|NCT00387127|530583487|FG000|Overall Study|Physician Decision|0|||
147565406|NCT03435081|532228342|FG000|Week 16 to Week 104|Non--Compliance|0|||
147565407|NCT03435081|532228343|FG001|Week 16 to Week 104|Non--Compliance|0|||
147565408|NCT03435081|532228344|FG002|Week 16 to Week 104|Non--Compliance|1|||
147565409|NCT00420238|532228345|FG000|12 Week Double-Blind Treatment Period 1|Adverse Event|1|||
147565410|NCT00420238|532228346|FG001|12 Week Double-Blind Treatment Period 1|Adverse Event|0|||
147565411|NCT00420238|532228345|FG000|12 Week Double-Blind Treatment Period 1|Lack of Efficacy|0|||
147565412|NCT00420238|532228346|FG001|12 Week Double-Blind Treatment Period 1|Lack of Efficacy|2|||
147565413|NCT00420238|532228345|FG000|12 Week Double-Blind Treatment Period 1|Lost to Follow-up|0|||
147565414|NCT00420238|532228346|FG001|12 Week Double-Blind Treatment Period 1|Lost to Follow-up|1|||
147565415|NCT00420238|532228345|FG000|12 Week Double-Blind Treatment Period 1|Withdrawal of Consent|0|||
147565416|NCT00420238|532228346|FG001|12 Week Double-Blind Treatment Period 1|Withdrawal of Consent|1|||
147114880|NCT00387127|530583488|FG001|Overall Study|Physician Decision|1|||
147114881|NCT00387127|530583487|FG000|Overall Study|Withdrawal by Subject|3|||
147114882|NCT00387127|530583488|FG001|Overall Study|Withdrawal by Subject|2|||
147114883|NCT00387127|530583487|FG000|Overall Study|Required by Protocol Amendment #4|12|||
147114884|NCT00387127|530583488|FG001|Overall Study|Required by Protocol Amendment #4|10|||
147114885|NCT00387127|530583487|FG000|Overall Study|Serious Adverse Event|1|||
147114886|NCT00387127|530583488|FG001|Overall Study|Serious Adverse Event|1|||
147114887|NCT00387127|530583487|FG000|Overall Study|Sponsor Unblinded|1|||
147114888|NCT00387127|530583488|FG001|Overall Study|Sponsor Unblinded|0|||
147114889|NCT05101317|530583489|FG000|Week1-13|Adverse Event|0|||
147228714|NCT02395666|531010492|FG001|Overall Study|Physician Decision|0|||
147228715|NCT02395666|531010491|FG000|Overall Study|Lost to Follow-up|1|||
147228716|NCT02395666|531010492|FG001|Overall Study|Lost to Follow-up|0|||
147228717|NCT02395666|531010491|FG000|Overall Study|Withdrawal by Subject|2|||
147228718|NCT02395666|531010492|FG001|Overall Study|Withdrawal by Subject|1|||
147228719|NCT04131556|531010505|FG000|Overall Study|Adverse Event|1|||
147228720|NCT04131556|531010505|FG000|Overall Study|Withdrawal by Subject|1|||
147228721|NCT01229371|531010508|FG000|Overall Study|Withdrawal by Subject|0|||
147228722|NCT01229371|531010509|FG001|Overall Study|Withdrawal by Subject|1|||
147228723|NCT01229371|531010510|FG002|Overall Study|Withdrawal by Subject|0|||
147228724|NCT01229371|531010511|FG003|Overall Study|Withdrawal by Subject|0|||
147228725|NCT00761579|531010515|FG000|Overall Study|Adverse Event|10|||
147228726|NCT00761579|531010515|FG000|Overall Study|Death|2|||
147228727|NCT00761579|531010515|FG000|Overall Study|Lack of Efficacy|21|||
147228728|NCT00761579|531010515|FG000|Overall Study|Lost to Follow-up|16|||
147228729|NCT00761579|531010515|FG000|Overall Study|Pregnancy|1|||
147228730|NCT00761579|531010515|FG000|Overall Study|Withdrawal by Subject|34|||
147228731|NCT00761579|531010515|FG000|Overall Study|Lack of compliance|2|||
147228732|NCT00761579|531010515|FG000|Overall Study|Protocol deviation|1|||
147228733|NCT00761579|531010515|FG000|Overall Study|Drug overdose|1|||
147114890|NCT05101317|530583490|FG001|Week1-13|Adverse Event|1|||
147114891|NCT05101317|530583491|FG002|Week1-13|Adverse Event|0|||
147114892|NCT05101317|530583492|FG003|Week1-13|Adverse Event|0|||
147114893|NCT05101317|530583489|FG000|Week1-13|Withdrawal by Subject|0|||
147114894|NCT05101317|530583490|FG001|Week1-13|Withdrawal by Subject|2|||
147114895|NCT05101317|530583491|FG002|Week1-13|Withdrawal by Subject|0|||
147114896|NCT05101317|530583492|FG003|Week1-13|Withdrawal by Subject|0|||
147114897|NCT05101317|530583489|FG000|Week1-13|Early Withdrawl|0|||
147114898|NCT05101317|530583490|FG001|Week1-13|Early Withdrawl|0|||
147114899|NCT05101317|530583491|FG002|Week1-13|Early Withdrawl|0|||
147114900|NCT05101317|530583492|FG003|Week1-13|Early Withdrawl|1|||
147114901|NCT05101317|530583489|FG000|Week 13-25|Lost to Follow-up|0|||
147114902|NCT05101317|530583490|FG001|Week 13-25|Lost to Follow-up|0|||
147114903|NCT05101317|530583491|FG002|Week 13-25|Lost to Follow-up|1|||
147114904|NCT05101317|530583492|FG003|Week 13-25|Lost to Follow-up|0|||
147114905|NCT05101317|530583489|FG000|Week 13-25|Withdrawal by Subject|1|||
147114906|NCT05101317|530583490|FG001|Week 13-25|Withdrawal by Subject|1|||
147114907|NCT05101317|530583491|FG002|Week 13-25|Withdrawal by Subject|0|||
147114908|NCT05101317|530583492|FG003|Week 13-25|Withdrawal by Subject|0|||
147114909|NCT05101317|530583489|FG000|Week 13-25|Patient decide to have oral contraception/refuse to come back|0|||
147114910|NCT05101317|530583490|FG001|Week 13-25|Patient decide to have oral contraception/refuse to come back|2|||
147312162|NCT02023879|531309299|FG002|Period 1: 24-Week Double-blind Treatment|Other than specified above|1|||
147312163|NCT02023879|531309297|FG000|Extension Open Label Treatment|Adverse Event|1|||
147312164|NCT02023879|531309298|FG001|Extension Open Label Treatment|Adverse Event|7|||
147312165|NCT02023879|531309299|FG002|Extension Open Label Treatment|Adverse Event|3|||
147312166|NCT02023879|531309297|FG000|Extension Open Label Treatment|Poor compliance to protocol|1|||
147312167|NCT02023879|531309298|FG001|Extension Open Label Treatment|Poor compliance to protocol|1|||
147312168|NCT02023879|531309299|FG002|Extension Open Label Treatment|Poor compliance to protocol|0|||
147312169|NCT02023879|531309297|FG000|Extension Open Label Treatment|Participant moved|1|||
147114911|NCT05101317|530583491|FG002|Week 13-25|Patient decide to have oral contraception/refuse to come back|1|||
147114912|NCT05101317|530583492|FG003|Week 13-25|Patient decide to have oral contraception/refuse to come back|0|||
147114913|NCT01327703|530583493|FG000|Second Treatment Period|Adverse Event|1|||
147114914|NCT01327703|530583494|FG001|Second Treatment Period|Adverse Event|1|||
147114915|NCT01327703|530583493|FG000|Second Treatment Period|Protocol Violation|0|||
147114916|NCT01327703|530583494|FG001|Second Treatment Period|Protocol Violation|1|||
147114917|NCT00812097|530583495|FG000|Overall Study|Death|3|||
147114918|NCT00812097|530583496|FG001|Overall Study|Death|10|||
147114919|NCT00812097|530583497|FG002|Overall Study|Death|3|||
147114920|NCT00812097|530583498|FG003|Overall Study|Death|3|||
147114921|NCT00812097|530583495|FG000|Overall Study|Withdrawal by Subject|14|||
147114922|NCT00812097|530583496|FG001|Overall Study|Withdrawal by Subject|12|||
147114923|NCT00812097|530583497|FG002|Overall Study|Withdrawal by Subject|8|||
147114924|NCT00812097|530583498|FG003|Overall Study|Withdrawal by Subject|2|||
147114925|NCT00812097|530583495|FG000|Overall Study|Lost to Follow-up|90|||
147114926|NCT00812097|530583496|FG001|Overall Study|Lost to Follow-up|14|||
147114927|NCT00812097|530583497|FG002|Overall Study|Lost to Follow-up|17|||
147114928|NCT00812097|530583498|FG003|Overall Study|Lost to Follow-up|5|||
147114929|NCT00812097|530583495|FG000|Overall Study|Explantation of study device(s)|27|||
147114930|NCT00812097|530583496|FG001|Overall Study|Explantation of study device(s)|29|||
147114931|NCT00812097|530583497|FG002|Overall Study|Explantation of study device(s)|14|||
147114932|NCT00812097|530583498|FG003|Overall Study|Explantation of study device(s)|20|||
147114933|NCT00812097|530583495|FG000|Overall Study|Unknown reasons and patient/doctor moves|111|||
147114934|NCT00812097|530583496|FG001|Overall Study|Unknown reasons and patient/doctor moves|24|||
147114935|NCT00812097|530583497|FG002|Overall Study|Unknown reasons and patient/doctor moves|15|||
147114936|NCT00812097|530583498|FG003|Overall Study|Unknown reasons and patient/doctor moves|5|||
147114937|NCT02513563|530583502|FG000|Overall Study|Death|4|||
147114938|NCT02513563|530583502|FG000|Overall Study|Withdrawal by Subject|4|||
147114939|NCT02513563|530583502|FG000|Overall Study|Physician Decision|1|||
147114940|NCT03674411|530583505|FG000|Overall Study|Non-treatment|4|||
147114941|NCT06038643|530583509|FG000|Overall Study|Withdrawal by Subject|9|||
147114942|NCT06038643|530583510|FG001|Overall Study|Withdrawal by Subject|4|||
147114943|NCT06038643|530583509|FG000|Overall Study|Excluded (not longer fulfilled enrollment criteria)|1|||
147114944|NCT06038643|530583510|FG001|Overall Study|Excluded (not longer fulfilled enrollment criteria)|0|||
147312170|NCT02023879|531309298|FG001|Extension Open Label Treatment|Participant moved|2|||
147565417|NCT00420238|532228345|FG000|12 Week Open-Label Treatment Period 2|Lost to Follow-up|1|||
147114945|NCT02227199|530583511|FG000|Overall Study|Physician Decision|0|||
147114946|NCT02227199|530583512|FG001|Overall Study|Physician Decision|0|||
147114947|NCT02227199|530583513|FG002|Overall Study|Physician Decision|1|||
147114948|NCT02227199|530583511|FG000|Overall Study|Adverse Event|0|||
147114949|NCT02227199|530583512|FG001|Overall Study|Adverse Event|0|||
147114950|NCT02227199|530583513|FG002|Overall Study|Adverse Event|3|||
147114951|NCT03998462|530583515|FG000|Overall Study|Withdrawal by Subject|10|||
147114952|NCT03998462|530583516|FG001|Overall Study|Withdrawal by Subject|4|||
147114953|NCT03998462|530583515|FG000|Overall Study|Lost to Follow-up|1|||
147114954|NCT03998462|530583516|FG001|Overall Study|Lost to Follow-up|0|||
147114955|NCT03998462|530583515|FG000|Overall Study|Technical Difficulties|1|||
147114956|NCT03998462|530583516|FG001|Overall Study|Technical Difficulties|2|||
147114957|NCT05710224|530583517|FG000|Overall Study|Death|1|||
147114958|NCT05710224|530583518|FG001|Overall Study|Death|0|||
147114959|NCT05710224|530583517|FG000|Overall Study|Lost to Follow-up|16|||
147114960|NCT05710224|530583518|FG001|Overall Study|Lost to Follow-up|7|||
147114961|NCT05710224|530583517|FG000|Overall Study|Withdrawal by Subject|4|||
147114962|NCT05710224|530583518|FG001|Overall Study|Withdrawal by Subject|6|||
147114963|NCT05710224|530583517|FG000|Overall Study|Randomized By Mistake Without Study Treatment|1|||
147114964|NCT05710224|530583518|FG001|Overall Study|Randomized By Mistake Without Study Treatment|2|||
147114965|NCT05710224|530583517|FG000|Overall Study|Participants Left The City|0|||
147114966|NCT05710224|530583518|FG001|Overall Study|Participants Left The City|2|||
147114967|NCT03369223|530583519|FG000|Overall Study|Lost to Follow-up|0|||
147114968|NCT03369223|530583520|FG001|Overall Study|Lost to Follow-up|0|||
147114969|NCT03369223|530583521|FG002|Overall Study|Lost to Follow-up|0|||
147114970|NCT03369223|530583522|FG003|Overall Study|Lost to Follow-up|0|||
147114971|NCT03369223|530583523|FG004|Overall Study|Lost to Follow-up|0|||
147114972|NCT03369223|530583524|FG005|Overall Study|Lost to Follow-up|0|||
147114973|NCT03369223|530583525|FG006|Overall Study|Lost to Follow-up|0|||
147114974|NCT03369223|530583526|FG007|Overall Study|Lost to Follow-up|0|||
147114975|NCT03369223|530583527|FG008|Overall Study|Lost to Follow-up|0|||
147114976|NCT03369223|530583528|FG009|Overall Study|Lost to Follow-up|0|||
147114977|NCT03369223|530583529|FG010|Overall Study|Lost to Follow-up|0|||
147114978|NCT03369223|530583530|FG011|Overall Study|Lost to Follow-up|0|||
147114979|NCT03369223|530583531|FG012|Overall Study|Lost to Follow-up|0|||
147114980|NCT03369223|530583532|FG013|Overall Study|Lost to Follow-up|0|||
147114981|NCT03369223|530583533|FG014|Overall Study|Lost to Follow-up|0|||
147114982|NCT03369223|530583534|FG015|Overall Study|Lost to Follow-up|0|||
147114983|NCT03369223|530583535|FG016|Overall Study|Lost to Follow-up|0|||
147114984|NCT03369223|530583536|FG017|Overall Study|Lost to Follow-up|0|||
147114985|NCT03369223|530583537|FG018|Overall Study|Lost to Follow-up|2|||
147114986|NCT03369223|530583538|FG019|Overall Study|Lost to Follow-up|1|||
147114987|NCT03369223|530583519|FG000|Overall Study|Participant no longer meets study criteria|0|||
147114988|NCT03369223|530583520|FG001|Overall Study|Participant no longer meets study criteria|0|||
147114989|NCT03369223|530583521|FG002|Overall Study|Participant no longer meets study criteria|0|||
147114990|NCT03369223|530583522|FG003|Overall Study|Participant no longer meets study criteria|0|||
147114991|NCT03369223|530583523|FG004|Overall Study|Participant no longer meets study criteria|0|||
147114992|NCT03369223|530583524|FG005|Overall Study|Participant no longer meets study criteria|0|||
147114993|NCT03369223|530583525|FG006|Overall Study|Participant no longer meets study criteria|0|||
147114994|NCT03369223|530583526|FG007|Overall Study|Participant no longer meets study criteria|0|||
147114995|NCT03369223|530583527|FG008|Overall Study|Participant no longer meets study criteria|0|||
147114996|NCT03369223|530583528|FG009|Overall Study|Participant no longer meets study criteria|0|||
147114997|NCT03369223|530583529|FG010|Overall Study|Participant no longer meets study criteria|0|||
147114998|NCT03369223|530583530|FG011|Overall Study|Participant no longer meets study criteria|0|||
147114999|NCT03369223|530583531|FG012|Overall Study|Participant no longer meets study criteria|0|||
147115000|NCT03369223|530583532|FG013|Overall Study|Participant no longer meets study criteria|0|||
147115001|NCT03369223|530583533|FG014|Overall Study|Participant no longer meets study criteria|2|||
147115002|NCT03369223|530583534|FG015|Overall Study|Participant no longer meets study criteria|0|||
147115003|NCT03369223|530583535|FG016|Overall Study|Participant no longer meets study criteria|2|||
147115004|NCT03369223|530583536|FG017|Overall Study|Participant no longer meets study criteria|0|||
147115005|NCT03369223|530583537|FG018|Overall Study|Participant no longer meets study criteria|0|||
147115006|NCT03369223|530583538|FG019|Overall Study|Participant no longer meets study criteria|0|||
147115007|NCT03369223|530583519|FG000|Overall Study|Other reasons|0|||
147115008|NCT03369223|530583520|FG001|Overall Study|Other reasons|0|||
147115009|NCT03369223|530583521|FG002|Overall Study|Other reasons|0|||
147115010|NCT03369223|530583522|FG003|Overall Study|Other reasons|0|||
147115011|NCT03369223|530583523|FG004|Overall Study|Other reasons|0|||
147115012|NCT03369223|530583524|FG005|Overall Study|Other reasons|0|||
147115013|NCT03369223|530583525|FG006|Overall Study|Other reasons|0|||
147115014|NCT03369223|530583526|FG007|Overall Study|Other reasons|0|||
147115015|NCT03369223|530583527|FG008|Overall Study|Other reasons|0|||
147115016|NCT03369223|530583528|FG009|Overall Study|Other reasons|0|||
147115017|NCT03369223|530583529|FG010|Overall Study|Other reasons|0|||
147115018|NCT03369223|530583530|FG011|Overall Study|Other reasons|0|||
147115019|NCT03369223|530583531|FG012|Overall Study|Other reasons|0|||
147115020|NCT03369223|530583532|FG013|Overall Study|Other reasons|1|||
147115021|NCT03369223|530583533|FG014|Overall Study|Other reasons|2|||
147115022|NCT03369223|530583534|FG015|Overall Study|Other reasons|0|||
147115023|NCT03369223|530583535|FG016|Overall Study|Other reasons|1|||
147115024|NCT03369223|530583536|FG017|Overall Study|Other reasons|0|||
147115025|NCT03369223|530583537|FG018|Overall Study|Other reasons|0|||
147115026|NCT03369223|530583538|FG019|Overall Study|Other reasons|2|||
147115027|NCT03369223|530583519|FG000|Overall Study|Death|0|||
147115028|NCT03369223|530583520|FG001|Overall Study|Death|0|||
147115029|NCT03369223|530583521|FG002|Overall Study|Death|0|||
147115030|NCT03369223|530583522|FG003|Overall Study|Death|0|||
147115031|NCT03369223|530583523|FG004|Overall Study|Death|0|||
147115032|NCT03369223|530583524|FG005|Overall Study|Death|0|||
147115033|NCT03369223|530583525|FG006|Overall Study|Death|0|||
147115034|NCT03369223|530583526|FG007|Overall Study|Death|0|||
147115035|NCT03369223|530583527|FG008|Overall Study|Death|0|||
147115036|NCT03369223|530583528|FG009|Overall Study|Death|0|||
147115037|NCT03369223|530583529|FG010|Overall Study|Death|0|||
147115038|NCT03369223|530583530|FG011|Overall Study|Death|0|||
147115039|NCT03369223|530583531|FG012|Overall Study|Death|0|||
147115040|NCT03369223|530583532|FG013|Overall Study|Death|1|||
147115041|NCT03369223|530583533|FG014|Overall Study|Death|0|||
147115042|NCT03369223|530583534|FG015|Overall Study|Death|0|||
147115043|NCT03369223|530583535|FG016|Overall Study|Death|0|||
147115044|NCT03369223|530583536|FG017|Overall Study|Death|0|||
147115045|NCT03369223|530583537|FG018|Overall Study|Death|1|||
147115046|NCT03369223|530583538|FG019|Overall Study|Death|0|||
147115047|NCT03369223|530583519|FG000|Overall Study|Adverse event unrelated to study drug|0|||
147115048|NCT03369223|530583520|FG001|Overall Study|Adverse event unrelated to study drug|0|||
147115049|NCT03369223|530583521|FG002|Overall Study|Adverse event unrelated to study drug|0|||
147115050|NCT03369223|530583522|FG003|Overall Study|Adverse event unrelated to study drug|0|||
147115051|NCT03369223|530583523|FG004|Overall Study|Adverse event unrelated to study drug|0|||
147115052|NCT03369223|530583524|FG005|Overall Study|Adverse event unrelated to study drug|0|||
147115053|NCT03369223|530583525|FG006|Overall Study|Adverse event unrelated to study drug|1|||
147115054|NCT03369223|530583526|FG007|Overall Study|Adverse event unrelated to study drug|0|||
147115055|NCT03369223|530583527|FG008|Overall Study|Adverse event unrelated to study drug|0|||
147115056|NCT03369223|530583528|FG009|Overall Study|Adverse event unrelated to study drug|1|||
147115057|NCT03369223|530583529|FG010|Overall Study|Adverse event unrelated to study drug|0|||
147115058|NCT03369223|530583530|FG011|Overall Study|Adverse event unrelated to study drug|0|||
147115059|NCT03369223|530583531|FG012|Overall Study|Adverse event unrelated to study drug|0|||
147115060|NCT03369223|530583532|FG013|Overall Study|Adverse event unrelated to study drug|4|||
147115061|NCT03369223|530583533|FG014|Overall Study|Adverse event unrelated to study drug|2|||
147115062|NCT03369223|530583534|FG015|Overall Study|Adverse event unrelated to study drug|0|||
147115063|NCT03369223|530583535|FG016|Overall Study|Adverse event unrelated to study drug|2|||
147115064|NCT03369223|530583536|FG017|Overall Study|Adverse event unrelated to study drug|1|||
147115065|NCT03369223|530583537|FG018|Overall Study|Adverse event unrelated to study drug|3|||
147115066|NCT03369223|530583538|FG019|Overall Study|Adverse event unrelated to study drug|2|||
147115067|NCT03369223|530583519|FG000|Overall Study|Disease progression|6|||
147115068|NCT03369223|530583520|FG001|Overall Study|Disease progression|8|||
147115069|NCT03369223|530583521|FG002|Overall Study|Disease progression|5|||
147115070|NCT03369223|530583522|FG003|Overall Study|Disease progression|1|||
147115071|NCT03369223|530583523|FG004|Overall Study|Disease progression|9|||
147115072|NCT03369223|530583524|FG005|Overall Study|Disease progression|9|||
147115073|NCT03369223|530583525|FG006|Overall Study|Disease progression|4|||
147115074|NCT03369223|530583526|FG007|Overall Study|Disease progression|6|||
147115075|NCT03369223|530583527|FG008|Overall Study|Disease progression|10|||
147115076|NCT03369223|530583528|FG009|Overall Study|Disease progression|7|||
147115077|NCT03369223|530583529|FG010|Overall Study|Disease progression|4|||
147115078|NCT03369223|530583530|FG011|Overall Study|Disease progression|1|||
147115079|NCT03369223|530583531|FG012|Overall Study|Disease progression|1|||
147115080|NCT03369223|530583532|FG013|Overall Study|Disease progression|25|||
147312171|NCT02023879|531309299|FG002|Extension Open Label Treatment|Participant moved|0|||
147312172|NCT02023879|531309297|FG000|Extension Open Label Treatment|Other than specified above|2|||
147565418|NCT00420238|532228346|FG001|12 Week Open-Label Treatment Period 2|Lost to Follow-up|0|||
147565419|NCT00420238|532228345|FG000|12 Week Open-Label Treatment Period 2|Withdrawal of Consent|1|||
147565420|NCT00420238|532228346|FG001|12 Week Open-Label Treatment Period 2|Withdrawal of Consent|1|||
147565421|NCT00048581|532228347|FG000|Double-Blind Period|Adverse Event|9|||
147565422|NCT00048581|532228348|FG001|Double-Blind Period|Adverse Event|5|||
147565423|NCT00048581|532228349|FG002|Double-Blind Period|Adverse Event|0|||
147565424|NCT00048581|532228347|FG000|Double-Blind Period|Lack of Efficacy|14|||
147115081|NCT03369223|530583533|FG014|Overall Study|Disease progression|22|||
147115082|NCT03369223|530583534|FG015|Overall Study|Disease progression|2|||
147115083|NCT03369223|530583535|FG016|Overall Study|Disease progression|10|||
147115084|NCT03369223|530583536|FG017|Overall Study|Disease progression|1|||
147115085|NCT03369223|530583537|FG018|Overall Study|Disease progression|18|||
147115086|NCT03369223|530583538|FG019|Overall Study|Disease progression|28|||
147115087|NCT03369223|530583519|FG000|Overall Study|Study drug toxicity|0|||
147115088|NCT03369223|530583520|FG001|Overall Study|Study drug toxicity|1|||
147115089|NCT03369223|530583521|FG002|Overall Study|Study drug toxicity|4|||
147115090|NCT03369223|530583522|FG003|Overall Study|Study drug toxicity|0|||
147115091|NCT03369223|530583523|FG004|Overall Study|Study drug toxicity|1|||
147115092|NCT03369223|530583524|FG005|Overall Study|Study drug toxicity|2|||
147115093|NCT03369223|530583525|FG006|Overall Study|Study drug toxicity|4|||
147115094|NCT03369223|530583526|FG007|Overall Study|Study drug toxicity|2|||
147115095|NCT03369223|530583527|FG008|Overall Study|Study drug toxicity|2|||
147115096|NCT03369223|530583528|FG009|Overall Study|Study drug toxicity|0|||
147115097|NCT03369223|530583529|FG010|Overall Study|Study drug toxicity|6|||
147115098|NCT03369223|530583530|FG011|Overall Study|Study drug toxicity|1|||
147115099|NCT03369223|530583531|FG012|Overall Study|Study drug toxicity|2|||
147115100|NCT03369223|530583532|FG013|Overall Study|Study drug toxicity|19|||
147115101|NCT03369223|530583533|FG014|Overall Study|Study drug toxicity|19|||
147115102|NCT03369223|530583534|FG015|Overall Study|Study drug toxicity|0|||
147115103|NCT03369223|530583535|FG016|Overall Study|Study drug toxicity|18|||
147115104|NCT03369223|530583536|FG017|Overall Study|Study drug toxicity|3|||
147115105|NCT03369223|530583537|FG018|Overall Study|Study drug toxicity|11|||
147115106|NCT03369223|530583538|FG019|Overall Study|Study drug toxicity|7|||
147115107|NCT03369223|530583519|FG000|Overall Study|Participant request to discontinue study treatment|0|||
147115108|NCT03369223|530583520|FG001|Overall Study|Participant request to discontinue study treatment|1|||
147115109|NCT03369223|530583521|FG002|Overall Study|Participant request to discontinue study treatment|0|||
147115110|NCT03369223|530583522|FG003|Overall Study|Participant request to discontinue study treatment|0|||
147115111|NCT03369223|530583523|FG004|Overall Study|Participant request to discontinue study treatment|1|||
147115112|NCT03369223|530583524|FG005|Overall Study|Participant request to discontinue study treatment|1|||
147115113|NCT03369223|530583525|FG006|Overall Study|Participant request to discontinue study treatment|1|||
147115114|NCT03369223|530583526|FG007|Overall Study|Participant request to discontinue study treatment|0|||
147115115|NCT03369223|530583527|FG008|Overall Study|Participant request to discontinue study treatment|0|||
147115116|NCT03369223|530583528|FG009|Overall Study|Participant request to discontinue study treatment|0|||
147115117|NCT03369223|530583529|FG010|Overall Study|Participant request to discontinue study treatment|0|||
147115118|NCT03369223|530583530|FG011|Overall Study|Participant request to discontinue study treatment|0|||
147115119|NCT03369223|530583531|FG012|Overall Study|Participant request to discontinue study treatment|0|||
147115120|NCT03369223|530583532|FG013|Overall Study|Participant request to discontinue study treatment|1|||
147115121|NCT03369223|530583533|FG014|Overall Study|Participant request to discontinue study treatment|1|||
147115122|NCT03369223|530583534|FG015|Overall Study|Participant request to discontinue study treatment|0|||
147115123|NCT03369223|530583535|FG016|Overall Study|Participant request to discontinue study treatment|0|||
147115124|NCT03369223|530583536|FG017|Overall Study|Participant request to discontinue study treatment|0|||
147115125|NCT03369223|530583537|FG018|Overall Study|Participant request to discontinue study treatment|1|||
147115126|NCT03369223|530583538|FG019|Overall Study|Participant request to discontinue study treatment|0|||
147115127|NCT03369223|530583519|FG000|Overall Study|Participant withdrew consent|0|||
147115128|NCT03369223|530583520|FG001|Overall Study|Participant withdrew consent|1|||
147115129|NCT03369223|530583521|FG002|Overall Study|Participant withdrew consent|1|||
147115130|NCT03369223|530583522|FG003|Overall Study|Participant withdrew consent|0|||
147115131|NCT03369223|530583523|FG004|Overall Study|Participant withdrew consent|0|||
147115132|NCT03369223|530583524|FG005|Overall Study|Participant withdrew consent|0|||
147115133|NCT03369223|530583525|FG006|Overall Study|Participant withdrew consent|1|||
147115134|NCT03369223|530583526|FG007|Overall Study|Participant withdrew consent|1|||
147115135|NCT03369223|530583527|FG008|Overall Study|Participant withdrew consent|1|||
147115136|NCT03369223|530583528|FG009|Overall Study|Participant withdrew consent|0|||
147115137|NCT03369223|530583529|FG010|Overall Study|Participant withdrew consent|0|||
147115138|NCT03369223|530583530|FG011|Overall Study|Participant withdrew consent|1|||
147115139|NCT03369223|530583531|FG012|Overall Study|Participant withdrew consent|0|||
147115140|NCT03369223|530583532|FG013|Overall Study|Participant withdrew consent|0|||
147115141|NCT03369223|530583533|FG014|Overall Study|Participant withdrew consent|3|||
147115142|NCT03369223|530583534|FG015|Overall Study|Participant withdrew consent|0|||
147115143|NCT03369223|530583535|FG016|Overall Study|Participant withdrew consent|1|||
147115144|NCT03369223|530583536|FG017|Overall Study|Participant withdrew consent|0|||
147115145|NCT03369223|530583537|FG018|Overall Study|Participant withdrew consent|4|||
147115146|NCT03369223|530583538|FG019|Overall Study|Participant withdrew consent|2|||
147115147|NCT03369223|530583519|FG000|Overall Study|Randomized but not treated|0|||
147115148|NCT03369223|530583520|FG001|Overall Study|Randomized but not treated|0|||
147115149|NCT03369223|530583521|FG002|Overall Study|Randomized but not treated|0|||
147565425|NCT00048581|532228348|FG001|Double-Blind Period|Lack of Efficacy|27|||
147115150|NCT03369223|530583522|FG003|Overall Study|Randomized but not treated|0|||
147228734|NCT00761579|531010515|FG000|Overall Study|Aggravation of depression|1|||
147228735|NCT00761579|531010515|FG000|Overall Study|Aggravation of symptoms by changing drug|1|||
147228736|NCT00761579|531010515|FG000|Overall Study|Lost survey form|1|||
147228737|NCT00761579|531010515|FG000|Overall Study|Intake of prohibited concomitant drug|1|||
147228738|NCT00950911|531010516|FG000|Overall Study|Adverse Event|0|||
147228739|NCT00950911|531010517|FG001|Overall Study|Adverse Event|2|||
147228740|NCT00950911|531010516|FG000|Overall Study|Death|4|||
147228741|NCT00950911|531010517|FG001|Overall Study|Death|6|||
147228742|NCT00950911|531010516|FG000|Overall Study|Disease progression|2|||
147228743|NCT00950911|531010517|FG001|Overall Study|Disease progression|2|||
147565426|NCT00048581|532228349|FG002|Double-Blind Period|Lack of Efficacy|0|||
147565427|NCT00048581|532228347|FG000|Double-Blind Period|Lost to Follow-up|5|||
147565428|NCT00048581|532228348|FG001|Double-Blind Period|Lost to Follow-up|0|||
147228744|NCT00950911|531010516|FG000|Overall Study|Consent withdrawn|1|||
147565429|NCT00048581|532228349|FG002|Double-Blind Period|Lost to Follow-up|0|||
147115151|NCT03369223|530583523|FG004|Overall Study|Randomized but not treated|0|||
147115152|NCT03369223|530583524|FG005|Overall Study|Randomized but not treated|0|||
147115153|NCT03369223|530583525|FG006|Overall Study|Randomized but not treated|0|||
147115154|NCT03369223|530583526|FG007|Overall Study|Randomized but not treated|0|||
147115155|NCT03369223|530583527|FG008|Overall Study|Randomized but not treated|0|||
147115156|NCT03369223|530583528|FG009|Overall Study|Randomized but not treated|0|||
147115157|NCT03369223|530583529|FG010|Overall Study|Randomized but not treated|0|||
147115158|NCT03369223|530583530|FG011|Overall Study|Randomized but not treated|0|||
147115159|NCT03369223|530583531|FG012|Overall Study|Randomized but not treated|0|||
147115160|NCT03369223|530583532|FG013|Overall Study|Randomized but not treated|1|||
147115161|NCT03369223|530583533|FG014|Overall Study|Randomized but not treated|1|||
147115162|NCT03369223|530583534|FG015|Overall Study|Randomized but not treated|0|||
147115163|NCT03369223|530583535|FG016|Overall Study|Randomized but not treated|0|||
147115164|NCT03369223|530583536|FG017|Overall Study|Randomized but not treated|0|||
147115165|NCT03369223|530583537|FG018|Overall Study|Randomized but not treated|0|||
147115166|NCT03369223|530583538|FG019|Overall Study|Randomized but not treated|0|||
147115167|NCT03573882|530583539|FG000|Overall Study|Study Terminated by Sponsor|22|||
147115168|NCT03573882|530583540|FG001|Overall Study|Study Terminated by Sponsor|17|||
147115169|NCT03573882|530583541|FG002|Overall Study|Study Terminated by Sponsor|18|||
147115170|NCT03573882|530583539|FG000|Overall Study|Withdrawal by Subject|6|||
147115171|NCT03573882|530583540|FG001|Overall Study|Withdrawal by Subject|11|||
147115172|NCT03573882|530583541|FG002|Overall Study|Withdrawal by Subject|7|||
147115173|NCT03573882|530583539|FG000|Overall Study|Adverse Event|7|||
147115174|NCT03573882|530583540|FG001|Overall Study|Adverse Event|5|||
147115175|NCT03573882|530583541|FG002|Overall Study|Adverse Event|6|||
147115176|NCT03573882|530583539|FG000|Overall Study|Lost to Follow-up|2|||
147115177|NCT03573882|530583540|FG001|Overall Study|Lost to Follow-up|5|||
147115178|NCT03573882|530583541|FG002|Overall Study|Lost to Follow-up|3|||
147115179|NCT03573882|530583539|FG000|Overall Study|Physician Decision|4|||
147115180|NCT03573882|530583540|FG001|Overall Study|Physician Decision|3|||
147115181|NCT03573882|530583541|FG002|Overall Study|Physician Decision|2|||
147115182|NCT03573882|530583539|FG000|Overall Study|Participant is Noncompliant with Study Drug|1|||
147115183|NCT03573882|530583540|FG001|Overall Study|Participant is Noncompliant with Study Drug|2|||
147115184|NCT03573882|530583541|FG002|Overall Study|Participant is Noncompliant with Study Drug|1|||
147115185|NCT03573882|530583539|FG000|Overall Study|Pregnancy|1|||
147115186|NCT03573882|530583540|FG001|Overall Study|Pregnancy|2|||
147115187|NCT03573882|530583541|FG002|Overall Study|Pregnancy|0|||
147115188|NCT03573882|530583539|FG000|Overall Study|Other|4|||
147115189|NCT03573882|530583540|FG001|Overall Study|Other|2|||
147115190|NCT03573882|530583541|FG002|Overall Study|Other|2|||
147115191|NCT02965833|530583542|FG000|Period 1, First 30 Days of Wear|Adverse Event|0|||
147115192|NCT02965833|530583543|FG001|Period 1, First 30 Days of Wear|Adverse Event|1|||
147115193|NCT02965833|530583542|FG000|Period 1, First 30 Days of Wear|Lost to Follow-up|1|||
147115194|NCT02965833|530583543|FG001|Period 1, First 30 Days of Wear|Lost to Follow-up|1|||
147115195|NCT02965833|530583542|FG000|Period 1, First 30 Days of Wear|Protocol Violation|1|||
147115196|NCT02965833|530583543|FG001|Period 1, First 30 Days of Wear|Protocol Violation|0|||
147115197|NCT02965833|530583542|FG000|Period 1, First 30 Days of Wear|Withdrawal by Subject|1|||
147115198|NCT02965833|530583543|FG001|Period 1, First 30 Days of Wear|Withdrawal by Subject|0|||
147115199|NCT02965833|530583542|FG000|Period 2, Second 30 Days of Wear|Protocol Violation|2|||
147115200|NCT02965833|530583543|FG001|Period 2, Second 30 Days of Wear|Protocol Violation|0|||
147115201|NCT03370302|530583548|FG000|Dose Escalation Phase|Other|0|||
147115202|NCT03370302|530583549|FG001|Dose Escalation Phase|Other|1|||
147115203|NCT03370302|530583550|FG002|Dose Escalation Phase|Other|1|||
147115204|NCT03370302|530583551|FG003|Dose Escalation Phase|Other|0|||
147115205|NCT03370302|530583552|FG004|Dose Escalation Phase|Other|0|||
147115206|NCT03370302|530583553|FG005|Dose Escalation Phase|Other|0|||
147115207|NCT03370302|530583548|FG000|Dose Escalation Phase|Withdrawal by Subject|0|||
147115208|NCT03370302|530583549|FG001|Dose Escalation Phase|Withdrawal by Subject|1|||
147115209|NCT03370302|530583550|FG002|Dose Escalation Phase|Withdrawal by Subject|2|||
147115210|NCT03370302|530583551|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
147115211|NCT03370302|530583552|FG004|Dose Escalation Phase|Withdrawal by Subject|0|||
147115212|NCT03370302|530583553|FG005|Dose Escalation Phase|Withdrawal by Subject|2|||
147115213|NCT03370302|530583548|FG000|Dose Escalation Phase|Adverse Event|1|||
147115214|NCT03370302|530583549|FG001|Dose Escalation Phase|Adverse Event|0|||
147115215|NCT03370302|530583550|FG002|Dose Escalation Phase|Adverse Event|2|||
147115216|NCT03370302|530583551|FG003|Dose Escalation Phase|Adverse Event|0|||
147115217|NCT03370302|530583552|FG004|Dose Escalation Phase|Adverse Event|0|||
147115218|NCT03370302|530583553|FG005|Dose Escalation Phase|Adverse Event|0|||
147115219|NCT03370302|530583548|FG000|Dose Escalation Phase|Progressive Disease|2|||
147115220|NCT03370302|530583549|FG001|Dose Escalation Phase|Progressive Disease|4|||
147115221|NCT03370302|530583550|FG002|Dose Escalation Phase|Progressive Disease|2|||
147115222|NCT03370302|530583551|FG003|Dose Escalation Phase|Progressive Disease|0|||
147115223|NCT03370302|530583552|FG004|Dose Escalation Phase|Progressive Disease|3|||
147115224|NCT03370302|530583553|FG005|Dose Escalation Phase|Progressive Disease|1|||
147115225|NCT03370302|530583548|FG000|Dose Expansion Phase|Progressive Disease|0|||
147115226|NCT03370302|530583549|FG001|Dose Expansion Phase|Progressive Disease|0|||
147115227|NCT03370302|530583550|FG002|Dose Expansion Phase|Progressive Disease|0|||
147115228|NCT03370302|530583551|FG003|Dose Expansion Phase|Progressive Disease|6|||
147115229|NCT03370302|530583552|FG004|Dose Expansion Phase|Progressive Disease|0|||
147115230|NCT03370302|530583553|FG005|Dose Expansion Phase|Progressive Disease|0|||
147115231|NCT03407482|530583554|FG000|Overall Study|Adverse Event|12|||
147115232|NCT03407482|530583554|FG000|Overall Study|Disease Relapse|1|||
147115233|NCT03407482|530583554|FG000|Overall Study|Lost to Follow-up|1|||
147115234|NCT03407482|530583554|FG000|Overall Study|Non-Compliance With Study Drug|1|||
147115235|NCT03407482|530583554|FG000|Overall Study|Pregnancy|2|||
147115236|NCT03407482|530583554|FG000|Overall Study|Protocol Violation|1|||
147115237|NCT03407482|530583554|FG000|Overall Study|Study Terminated By Sponsor|106|||
147115238|NCT03407482|530583554|FG000|Overall Study|Withdrawal by Subject|6|||
147115239|NCT03407482|530583554|FG000|Overall Study|Data Entry Error|1|||
147115240|NCT06061952|530583555|FG000|Overall Study|Withdrawal by Subject|1|||
147115241|NCT06061952|530583556|FG001|Overall Study|Withdrawal by Subject|2|||
147115242|NCT06061952|530583555|FG000|Overall Study|Lost to Follow-up|2|||
147115243|NCT06061952|530583556|FG001|Overall Study|Lost to Follow-up|2|||
147115244|NCT03659916|530583557|FG000|Treatment Period (72 Weeks)|Adverse Event|2|||
147115245|NCT03659916|530583558|FG001|Treatment Period (72 Weeks)|Adverse Event|1|||
147115246|NCT03659916|530583559|FG002|Treatment Period (72 Weeks)|Adverse Event|6|||
147115247|NCT03659916|530583557|FG000|Treatment Period (72 Weeks)|Withdrawal by Subject|1|||
147115248|NCT03659916|530583558|FG001|Treatment Period (72 Weeks)|Withdrawal by Subject|4|||
147115249|NCT03659916|530583559|FG002|Treatment Period (72 Weeks)|Withdrawal by Subject|4|||
147115250|NCT03659916|530583557|FG000|Treatment Period (72 Weeks)|Physician Decision|0|||
147115251|NCT03659916|530583558|FG001|Treatment Period (72 Weeks)|Physician Decision|1|||
147115252|NCT03659916|530583559|FG002|Treatment Period (72 Weeks)|Physician Decision|0|||
147115253|NCT03659916|530583557|FG000|Treatment Period (72 Weeks)|Lost to Follow-up|0|||
147115254|NCT03659916|530583558|FG001|Treatment Period (72 Weeks)|Lost to Follow-up|0|||
147115255|NCT03659916|530583559|FG002|Treatment Period (72 Weeks)|Lost to Follow-up|1|||
147115256|NCT03659916|530583557|FG000|Treatment Period (72 Weeks)|Other|1|||
147115257|NCT03659916|530583558|FG001|Treatment Period (72 Weeks)|Other|3|||
147115258|NCT03659916|530583559|FG002|Treatment Period (72 Weeks)|Other|9|||
147115259|NCT03659916|530583557|FG000|Optional Extension Treatment (176 Weeks)|Adverse Event|0|||
147115260|NCT03659916|530583558|FG001|Optional Extension Treatment (176 Weeks)|Adverse Event|0|||
147115261|NCT03659916|530583559|FG002|Optional Extension Treatment (176 Weeks)|Adverse Event|1|||
147115262|NCT03659916|530583557|FG000|Optional Extension Treatment (176 Weeks)|Withdrawal by Subject|0|||
147115263|NCT03659916|530583558|FG001|Optional Extension Treatment (176 Weeks)|Withdrawal by Subject|1|||
147115264|NCT03659916|530583559|FG002|Optional Extension Treatment (176 Weeks)|Withdrawal by Subject|0|||
147115265|NCT03659916|530583557|FG000|Optional Extension Treatment (176 Weeks)|Physician Decision|0|||
147115266|NCT03659916|530583558|FG001|Optional Extension Treatment (176 Weeks)|Physician Decision|0|||
147115267|NCT03659916|530583559|FG002|Optional Extension Treatment (176 Weeks)|Physician Decision|1|||
147115268|NCT03659916|530583557|FG000|Optional Extension Treatment (176 Weeks)|Transition to Commercial Drug|5|||
147115269|NCT03659916|530583558|FG001|Optional Extension Treatment (176 Weeks)|Transition to Commercial Drug|17|||
147115270|NCT03659916|530583559|FG002|Optional Extension Treatment (176 Weeks)|Transition to Commercial Drug|11|||
147115271|NCT03659916|530583557|FG000|Optional Extension Treatment (176 Weeks)|Other|4|||
147115272|NCT03659916|530583558|FG001|Optional Extension Treatment (176 Weeks)|Other|0|||
147115273|NCT03659916|530583559|FG002|Optional Extension Treatment (176 Weeks)|Other|3|||
147115274|NCT03659916|530583557|FG000|Optional Extension Treatment (176 Weeks)|Ongoing Optional Extension Period|5|||
147115275|NCT03659916|530583558|FG001|Optional Extension Treatment (176 Weeks)|Ongoing Optional Extension Period|9|||
147115276|NCT03659916|530583559|FG002|Optional Extension Treatment (176 Weeks)|Ongoing Optional Extension Period|17|||
147115277|NCT00504231|530585364|FG000|Overall Study|Discrepant chart documentation re route|0|||
147115278|NCT00504231|530585365|FG001|Overall Study|Discrepant chart documentation re route|0|||
147115279|NCT00504231|530585366|FG002|Overall Study|Discrepant chart documentation re route|1|||
147115280|NCT00504231|530585367|FG003|Overall Study|Discrepant chart documentation re route|0|||
147115281|NCT00835978|530585368|FG000|Overall Study|Death|33|||
147115282|NCT00835978|530585369|FG001|Overall Study|Death|40|||
147115283|NCT00835978|530585370|FG002|Overall Study|Death|49|||
147115284|NCT00835978|530585371|FG003|Overall Study|Death|4|||
147115285|NCT00835978|530585368|FG000|Overall Study|Lost to Follow-up|3|||
147115286|NCT00835978|530585369|FG001|Overall Study|Lost to Follow-up|4|||
147115287|NCT00835978|530585370|FG002|Overall Study|Lost to Follow-up|2|||
147115288|NCT00835978|530585371|FG003|Overall Study|Lost to Follow-up|1|||
147115289|NCT00835978|530585368|FG000|Overall Study|Other|5|||
147115290|NCT00835978|530585369|FG001|Overall Study|Other|1|||
147115291|NCT00835978|530585370|FG002|Overall Study|Other|8|||
147115292|NCT00835978|530585371|FG003|Overall Study|Other|0|||
147115293|NCT00835978|530585368|FG000|Overall Study|Objective progression or relapse|2|||
147115294|NCT00835978|530585369|FG001|Overall Study|Objective progression or relapse|0|||
147115295|NCT00835978|530585370|FG002|Overall Study|Objective progression or relapse|1|||
147115296|NCT00835978|530585371|FG003|Overall Study|Objective progression or relapse|0|||
147115297|NCT00835978|530585368|FG000|Overall Study|Adverse Event|1|||
147115298|NCT00835978|530585369|FG001|Overall Study|Adverse Event|0|||
147115299|NCT00835978|530585370|FG002|Overall Study|Adverse Event|1|||
147115300|NCT00835978|530585371|FG003|Overall Study|Adverse Event|0|||
147115301|NCT00835978|530585368|FG000|Overall Study|Withdrawal by Subject|0|||
147115302|NCT00835978|530585369|FG001|Overall Study|Withdrawal by Subject|3|||
147115303|NCT00835978|530585370|FG002|Overall Study|Withdrawal by Subject|0|||
147115304|NCT00835978|530585371|FG003|Overall Study|Withdrawal by Subject|5|||
147115305|NCT00835978|530585368|FG000|Overall Study|Study terminated by sponsor|12|||
147115306|NCT00835978|530585369|FG001|Overall Study|Study terminated by sponsor|8|||
147115307|NCT00835978|530585370|FG002|Overall Study|Study terminated by sponsor|30|||
147115308|NCT00835978|530585371|FG003|Overall Study|Study terminated by sponsor|0|||
147115309|NCT01002105|530585372|FG000|Overall Study|Lost to Follow-up|10|||
147115310|NCT01002105|530585373|FG001|Overall Study|Lost to Follow-up|16|||
147115311|NCT01002105|530585372|FG000|Overall Study|non compliance|5|||
147115312|NCT01002105|530585373|FG001|Overall Study|non compliance|3|||
147115313|NCT01002105|530585372|FG000|Overall Study|condition worsened|4|||
147115314|NCT01002105|530585373|FG001|Overall Study|condition worsened|2|||
147115315|NCT03695094|530585375|FG000|Overall Study|Adverse Event|1|||
147115316|NCT03695094|530585376|FG001|Overall Study|Adverse Event|1|||
147115317|NCT03695094|530585375|FG000|Overall Study|Withdrawal by Subject|1|||
147115318|NCT03695094|530585376|FG001|Overall Study|Withdrawal by Subject|0|||
147115319|NCT00266812|530585377|FG000|Overall Study|Disease Progression|9|||
147115320|NCT00266812|530585378|FG001|Overall Study|Disease Progression|3|||
147115321|NCT00266812|530585377|FG000|Overall Study|Death|5|||
147115322|NCT00266812|530585378|FG001|Overall Study|Death|4|||
147115323|NCT00266812|530585377|FG000|Overall Study|Adverse Event|3|||
147115324|NCT00266812|530585378|FG001|Overall Study|Adverse Event|1|||
147115325|NCT00266812|530585377|FG000|Overall Study|Protocol Violation|0|||
147115326|NCT00266812|530585378|FG001|Overall Study|Protocol Violation|1|||
147115327|NCT00266812|530585377|FG000|Overall Study|Withdrawal by Subject|0|||
147115328|NCT00266812|530585378|FG001|Overall Study|Withdrawal by Subject|2|||
147115329|NCT00266812|530585377|FG000|Overall Study|Discontinued before starting study drug|4|||
147115330|NCT00266812|530585378|FG001|Overall Study|Discontinued before starting study drug|0|||
147115331|NCT00552058|530585384|FG000|Overall Study|Adverse Event|8|||
147115332|NCT00552058|530585385|FG001|Overall Study|Adverse Event|7|||
147115333|NCT00552058|530585384|FG000|Overall Study|Lack of Efficacy|1|||
147115334|NCT00552058|530585385|FG001|Overall Study|Lack of Efficacy|5|||
147115335|NCT00552058|530585384|FG000|Overall Study|Lost to Follow-up|1|||
147115336|NCT00552058|530585385|FG001|Overall Study|Lost to Follow-up|0|||
147115337|NCT00552058|530585384|FG000|Overall Study|Withdrawal by Subject|4|||
147115338|NCT00552058|530585385|FG001|Overall Study|Withdrawal by Subject|4|||
147115339|NCT00552058|530585384|FG000|Overall Study|Other: Protocol Violation|0|||
147115340|NCT00552058|530585385|FG001|Overall Study|Other: Protocol Violation|1|||
147115341|NCT00552058|530585384|FG000|Overall Study|Other: Non Compliance|1|||
147115342|NCT00552058|530585385|FG001|Overall Study|Other: Non Compliance|2|||
147115343|NCT00552058|530585384|FG000|Overall Study|Other: Crossed Over to a Follow-up Study|0|||
147115344|NCT00552058|530585385|FG001|Overall Study|Other: Crossed Over to a Follow-up Study|1|||
147115345|NCT00552058|530585384|FG000|Overall Study|Other: Low CDAI score, entry violation|0|||
147115346|NCT00552058|530585385|FG001|Overall Study|Other: Low CDAI score, entry violation|1|||
147115347|NCT00552058|530585384|FG000|Overall Study|Other: Positive Stool Result|0|||
147115348|NCT00552058|530585385|FG001|Overall Study|Other: Positive Stool Result|1|||
147115349|NCT00552058|530585384|FG000|Overall Study|Other: Randomized in error|0|||
147115350|NCT00552058|530585385|FG001|Overall Study|Other: Randomized in error|1|||
147115351|NCT00552058|530585384|FG000|Overall Study|Other: Sponsors Decision|0|||
147115352|NCT00552058|530585385|FG001|Overall Study|Other: Sponsors Decision|1|||
147115353|NCT00552058|530585384|FG000|Overall Study|Other: Early Roll Over|1|||
147115354|NCT00552058|530585385|FG001|Overall Study|Other: Early Roll Over|0|||
147115355|NCT03520569|530585386|FG000|Overall Study|Withdrawal by Subject|1|||
147115356|NCT02965716|530585388|FG000|Overall Study|Refusal Unrelated to Adverse Event|1|||
147115357|NCT02965716|530585389|FG001|Overall Study|Refusal Unrelated to Adverse Event|5|||
147115358|NCT02965716|530585388|FG000|Overall Study|Progression/Relapse|8|||
147115359|NCT02965716|530585389|FG001|Overall Study|Progression/Relapse|16|||
147115360|NCT02965716|530585388|FG000|Overall Study|Death|1|||
147228745|NCT00950911|531010517|FG001|Overall Study|Consent withdrawn|3|||
147565430|NCT00048581|532228347|FG000|Double-Blind Period|Withdrawal by Subject|5|||
147115361|NCT02965716|530585389|FG001|Overall Study|Death|0|||
147228746|NCT00950911|531010516|FG000|Overall Study|Administrative decision|3|||
147228747|NCT00950911|531010517|FG001|Overall Study|Administrative decision|1|||
147115362|NCT02965716|530585388|FG000|Overall Study|Not Protocol Specified|1|||
147115363|NCT02965716|530585389|FG001|Overall Study|Not Protocol Specified|3|||
147115364|NCT05558410|530585390|FG000|Overall Study|Adverse Event|1|||
147115365|NCT05558410|530585391|FG001|Overall Study|Adverse Event|2|||
147115366|NCT05558410|530585392|FG002|Overall Study|Adverse Event|0|||
147115367|NCT05558410|530585390|FG000|Overall Study|Withdrawal of consent (not due to AE)|3|||
147115368|NCT05558410|530585391|FG001|Overall Study|Withdrawal of consent (not due to AE)|2|||
147115369|NCT05558410|530585392|FG002|Overall Study|Withdrawal of consent (not due to AE)|2|||
147115370|NCT05558410|530585390|FG000|Overall Study|Lost to Follow-up|10|||
147115371|NCT05558410|530585391|FG001|Overall Study|Lost to Follow-up|17|||
147115372|NCT05558410|530585392|FG002|Overall Study|Lost to Follow-up|19|||
147115373|NCT05558410|530585390|FG000|Overall Study|Death|1|||
147115374|NCT05558410|530585391|FG001|Overall Study|Death|0|||
147115375|NCT05558410|530585392|FG002|Overall Study|Death|0|||
147115376|NCT05558410|530585390|FG000|Overall Study|Other non-compliance|0|||
147115377|NCT05558410|530585391|FG001|Overall Study|Other non-compliance|1|||
147115378|NCT05558410|530585392|FG002|Overall Study|Other non-compliance|2|||
147115379|NCT05558410|530585390|FG000|Overall Study|Sponsor Decision|1|||
147228748|NCT00950911|531010516|FG000|Overall Study|Ineligibility determined|1|||
147228749|NCT00950911|531010517|FG001|Overall Study|Ineligibility determined|0|||
147228750|NCT00950911|531010516|FG000|Overall Study|Noncompliance|1|||
147228751|NCT00950911|531010517|FG001|Overall Study|Noncompliance|0|||
147228752|NCT00950911|531010516|FG000|Overall Study|Poor performance status|0|||
147115380|NCT05558410|530585391|FG001|Overall Study|Sponsor Decision|0|||
147115381|NCT05558410|530585392|FG002|Overall Study|Sponsor Decision|0|||
147115382|NCT05558410|530585390|FG000|Overall Study|Other|1|||
147115383|NCT05558410|530585391|FG001|Overall Study|Other|0|||
147115384|NCT05558410|530585392|FG002|Overall Study|Other|1|||
147115385|NCT02265744|530585395|FG000|Overall Study|Poor/Non-compliance|1|||
147115386|NCT02265744|530585396|FG001|Overall Study|Poor/Non-compliance|1|||
147115387|NCT02265744|530585397|FG002|Overall Study|Poor/Non-compliance|0|||
147115388|NCT02265744|530585398|FG003|Overall Study|Poor/Non-compliance|0|||
147115389|NCT02265744|530585399|FG004|Overall Study|Poor/Non-compliance|2|||
147115390|NCT02265744|530585395|FG000|Overall Study|Lost to Follow-up|0|||
147115391|NCT02265744|530585396|FG001|Overall Study|Lost to Follow-up|0|||
147228753|NCT00950911|531010517|FG001|Overall Study|Poor performance status|1|||
147115392|NCT02265744|530585397|FG002|Overall Study|Lost to Follow-up|0|||
147115393|NCT02265744|530585398|FG003|Overall Study|Lost to Follow-up|1|||
147115394|NCT02265744|530585399|FG004|Overall Study|Lost to Follow-up|0|||
147115395|NCT02265744|530585395|FG000|Overall Study|Death|0|||
147115396|NCT02265744|530585396|FG001|Overall Study|Death|0|||
147115397|NCT02265744|530585397|FG002|Overall Study|Death|0|||
147115398|NCT02265744|530585398|FG003|Overall Study|Death|2|||
147115399|NCT02265744|530585399|FG004|Overall Study|Death|0|||
147115400|NCT02265744|530585395|FG000|Overall Study|Withdrawal by Subject|2|||
147115401|NCT02265744|530585396|FG001|Overall Study|Withdrawal by Subject|0|||
147115402|NCT02265744|530585397|FG002|Overall Study|Withdrawal by Subject|0|||
147115403|NCT02265744|530585398|FG003|Overall Study|Withdrawal by Subject|2|||
147115404|NCT02265744|530585399|FG004|Overall Study|Withdrawal by Subject|0|||
147115405|NCT02265744|530585395|FG000|Overall Study|Participant request to discontinue|2|||
147115406|NCT02265744|530585396|FG001|Overall Study|Participant request to discontinue|2|||
147115407|NCT02265744|530585397|FG002|Overall Study|Participant request to discontinue|2|||
147115408|NCT02265744|530585398|FG003|Overall Study|Participant request to discontinue|0|||
147115409|NCT02265744|530585399|FG004|Overall Study|Participant request to discontinue|0|||
147115410|NCT02265744|530585395|FG000|Overall Study|Adverse Event|8|||
147115411|NCT02265744|530585396|FG001|Overall Study|Adverse Event|4|||
147115412|NCT02265744|530585397|FG002|Overall Study|Adverse Event|9|||
147115413|NCT02265744|530585398|FG003|Overall Study|Adverse Event|8|||
147115414|NCT02265744|530585399|FG004|Overall Study|Adverse Event|2|||
147115415|NCT02265744|530585395|FG000|Overall Study|Lack of Efficacy|2|||
147115416|NCT02265744|530585396|FG001|Overall Study|Lack of Efficacy|4|||
147115417|NCT02265744|530585397|FG002|Overall Study|Lack of Efficacy|3|||
147115418|NCT02265744|530585398|FG003|Overall Study|Lack of Efficacy|4|||
147565431|NCT00048581|532228348|FG001|Double-Blind Period|Withdrawal by Subject|2|||
147565432|NCT00048581|532228349|FG002|Double-Blind Period|Withdrawal by Subject|0|||
147565433|NCT00048581|532228347|FG000|Double-Blind Period|Participant Has History of Lymphopenia|1|||
147565434|NCT00048581|532228348|FG001|Double-Blind Period|Participant Has History of Lymphopenia|0|||
147565435|NCT00048581|532228349|FG002|Double-Blind Period|Participant Has History of Lymphopenia|0|||
147565436|NCT00048581|532228347|FG000|Double-Blind Period|Investigator Decision|1|||
147565437|NCT00048581|532228348|FG001|Double-Blind Period|Investigator Decision|0|||
147565438|NCT00048581|532228349|FG002|Double-Blind Period|Investigator Decision|0|||
147565439|NCT00048581|532228347|FG000|Open-Label Period|Death|0|||
147228754|NCT02476422|531010518|FG000|Overall Study|Subject/guardian decision|0|||
147565440|NCT00048581|532228348|FG001|Open-Label Period|Death|0|||
147115419|NCT02265744|530585399|FG004|Overall Study|Lack of Efficacy|5|||
147115420|NCT02265744|530585395|FG000|Overall Study|Reason not provided by Investigator|1|||
147115421|NCT02265744|530585396|FG001|Overall Study|Reason not provided by Investigator|0|||
147228755|NCT02476422|531010519|FG001|Overall Study|Subject/guardian decision|1|||
147228756|NCT01859143|531010520|FG000|Overall Study|Lost to Follow-up|2|||
147228757|NCT01859143|531010521|FG001|Overall Study|Lost to Follow-up|0|||
147565441|NCT00048581|532228349|FG002|Open-Label Period|Death|4|||
147565442|NCT00048581|532228347|FG000|Open-Label Period|Adverse Event|0|||
147115422|NCT02265744|530585397|FG002|Overall Study|Reason not provided by Investigator|0|||
147115423|NCT02265744|530585398|FG003|Overall Study|Reason not provided by Investigator|2|||
147115424|NCT02265744|530585399|FG004|Overall Study|Reason not provided by Investigator|0|||
147228758|NCT02413372|531010525|FG000|Treatment|Lost to Follow-up|0|||
147115425|NCT02265744|530585395|FG000|Overall Study|Administrative reason by sponsor|3|||
147115426|NCT02265744|530585396|FG001|Overall Study|Administrative reason by sponsor|2|||
147115427|NCT02265744|530585397|FG002|Overall Study|Administrative reason by sponsor|2|||
147115428|NCT02265744|530585398|FG003|Overall Study|Administrative reason by sponsor|3|||
147115429|NCT02265744|530585399|FG004|Overall Study|Administrative reason by sponsor|3|||
147115430|NCT02265744|530585395|FG000|Overall Study|Subject no longer meets study criteria|0|||
147115431|NCT02265744|530585396|FG001|Overall Study|Subject no longer meets study criteria|0|||
147115432|NCT02265744|530585397|FG002|Overall Study|Subject no longer meets study criteria|0|||
147115433|NCT02265744|530585398|FG003|Overall Study|Subject no longer meets study criteria|0|||
147115434|NCT02265744|530585399|FG004|Overall Study|Subject no longer meets study criteria|1|||
147115435|NCT02265744|530585395|FG000|Overall Study|Pregnancy|1|||
147115436|NCT02265744|530585396|FG001|Overall Study|Pregnancy|2|||
147115437|NCT02265744|530585397|FG002|Overall Study|Pregnancy|1|||
147115438|NCT02265744|530585398|FG003|Overall Study|Pregnancy|1|||
147115439|NCT02265744|530585399|FG004|Overall Study|Pregnancy|0|||
147115440|NCT00574951|530585400|FG000|Overall Study|Ineligible - improper prior treatment|1|||
147115441|NCT00923702|530585401|FG000|Overall Study|Ongoing enrollment|0|||
147115442|NCT00923702|530585402|FG001|Overall Study|Ongoing enrollment|0|||
147115443|NCT00923702|530585403|FG002|Overall Study|Ongoing enrollment|0|||
147115444|NCT00923702|530585404|FG003|Overall Study|Ongoing enrollment|0|||
147115445|NCT00923702|530585405|FG004|Overall Study|Ongoing enrollment|354|||
147115446|NCT05161936|530585406|FG000|Overall Study|Study terminated by Sponsor|1|||
147115447|NCT05161936|530585407|FG001|Overall Study|Study terminated by Sponsor|0|||
147115448|NCT05161936|530585408|FG002|Overall Study|Study terminated by Sponsor|0|||
147115449|NCT05161936|530585406|FG000|Overall Study|Withdrawal by Subject|0|||
147115450|NCT05161936|530585407|FG001|Overall Study|Withdrawal by Subject|0|||
147115451|NCT05161936|530585408|FG002|Overall Study|Withdrawal by Subject|1|||
147115452|NCT01158404|530585411|FG000|Overall Study|Withdrawal by Subject|0|||
147115453|NCT01158404|530585412|FG001|Overall Study|Withdrawal by Subject|1|||
147115454|NCT01158404|530585413|FG002|Overall Study|Withdrawal by Subject|0|||
147115455|NCT01158404|530585414|FG003|Overall Study|Withdrawal by Subject|0|||
147115456|NCT01158404|530585415|FG004|Overall Study|Withdrawal by Subject|3|||
147115457|NCT01158404|530585416|FG005|Overall Study|Withdrawal by Subject|1|||
147115458|NCT01158404|530585417|FG006|Overall Study|Withdrawal by Subject|0|||
147115459|NCT01158404|530585418|FG007|Overall Study|Withdrawal by Subject|1|||
147115460|NCT01158404|530585411|FG000|Overall Study|Physician Decision|0|||
147115461|NCT01158404|530585412|FG001|Overall Study|Physician Decision|0|||
147115462|NCT01158404|530585413|FG002|Overall Study|Physician Decision|0|||
147115463|NCT01158404|530585414|FG003|Overall Study|Physician Decision|0|||
147115464|NCT01158404|530585415|FG004|Overall Study|Physician Decision|0|||
147115465|NCT01158404|530585416|FG005|Overall Study|Physician Decision|0|||
147115466|NCT01158404|530585417|FG006|Overall Study|Physician Decision|0|||
147115467|NCT01158404|530585418|FG007|Overall Study|Physician Decision|1|||
147115468|NCT01158404|530585411|FG000|Overall Study|Progressive Disease|0|||
147115469|NCT01158404|530585412|FG001|Overall Study|Progressive Disease|0|||
147115470|NCT01158404|530585413|FG002|Overall Study|Progressive Disease|0|||
147115471|NCT01158404|530585414|FG003|Overall Study|Progressive Disease|0|||
147115472|NCT01158404|530585415|FG004|Overall Study|Progressive Disease|0|||
147115473|NCT01158404|530585416|FG005|Overall Study|Progressive Disease|0|||
147115474|NCT01158404|530585417|FG006|Overall Study|Progressive Disease|1|||
147115475|NCT01158404|530585418|FG007|Overall Study|Progressive Disease|0|||
147115476|NCT05278065|530585419|FG000|Overall Study|Withdrawal by Subject|1|||
147115477|NCT05278065|530585420|FG001|Overall Study|Withdrawal by Subject|0|||
147115478|NCT02029443|530585421|FG000|Overall Study|Completed 30-Day safety follow-up visit|53|||
147115479|NCT02029443|530585422|FG001|Overall Study|Completed 30-Day safety follow-up visit|16|||
147115480|NCT02029443|530585423|FG002|Overall Study|Completed 30-Day safety follow-up visit|12|||
147115481|NCT02029443|530585424|FG003|Overall Study|Completed 30-Day safety follow-up visit|2|||
147115482|NCT02029443|530585425|FG004|Overall Study|Completed 30-Day safety follow-up visit|1|||
147115483|NCT02029443|530585421|FG000|Overall Study|Death|13|||
147115484|NCT02029443|530585422|FG001|Overall Study|Death|2|||
147115485|NCT02029443|530585423|FG002|Overall Study|Death|2|||
147115486|NCT02029443|530585424|FG003|Overall Study|Death|11|||
147115487|NCT02029443|530585425|FG004|Overall Study|Death|2|||
147115488|NCT02029443|530585421|FG000|Overall Study|Lost to Follow-up|1|||
147115489|NCT02029443|530585422|FG001|Overall Study|Lost to Follow-up|0|||
147115490|NCT02029443|530585423|FG002|Overall Study|Lost to Follow-up|1|||
147115491|NCT02029443|530585424|FG003|Overall Study|Lost to Follow-up|1|||
147115492|NCT02029443|530585425|FG004|Overall Study|Lost to Follow-up|0|||
147115493|NCT02029443|530585421|FG000|Overall Study|Started other anti-cancer therapy|17|||
147115494|NCT02029443|530585422|FG001|Overall Study|Started other anti-cancer therapy|4|||
147115495|NCT02029443|530585423|FG002|Overall Study|Started other anti-cancer therapy|7|||
147115496|NCT02029443|530585424|FG003|Overall Study|Started other anti-cancer therapy|9|||
147115497|NCT02029443|530585425|FG004|Overall Study|Started other anti-cancer therapy|3|||
147115498|NCT02029443|530585421|FG000|Overall Study|Withdrawal by Subject|3|||
147115499|NCT02029443|530585422|FG001|Overall Study|Withdrawal by Subject|1|||
147312173|NCT02023879|531309298|FG001|Extension Open Label Treatment|Other than specified above|7|||
147115500|NCT02029443|530585423|FG002|Overall Study|Withdrawal by Subject|1|||
147115501|NCT02029443|530585424|FG003|Overall Study|Withdrawal by Subject|1|||
147115502|NCT02029443|530585425|FG004|Overall Study|Withdrawal by Subject|0|||
147115503|NCT02029443|530585421|FG000|Overall Study|Other|6|||
147115504|NCT02029443|530585422|FG001|Overall Study|Other|6|||
147115505|NCT02029443|530585423|FG002|Overall Study|Other|4|||
147115506|NCT02029443|530585424|FG003|Overall Study|Other|2|||
147115507|NCT02029443|530585425|FG004|Overall Study|Other|0|||
147115508|NCT00827242|530585429|FG000|Overall Study|Withdrawal by Subject|2|||
147115509|NCT00827242|530585430|FG001|Overall Study|Withdrawal by Subject|4|||
147115510|NCT00827242|530585429|FG000|Overall Study|Protocol Violation|1|||
147115511|NCT00827242|530585430|FG001|Overall Study|Protocol Violation|3|||
147115512|NCT00827242|530585429|FG000|Overall Study|Lost to Follow-up|0|||
147115513|NCT00827242|530585430|FG001|Overall Study|Lost to Follow-up|3|||
147115514|NCT00827242|530585429|FG000|Overall Study|Adverse Event Excluding Death|2|||
147115515|NCT00827242|530585430|FG001|Overall Study|Adverse Event Excluding Death|1|||
147115516|NCT00827242|530585429|FG000|Overall Study|Entry Criteria Not Met|4|||
147115517|NCT00827242|530585430|FG001|Overall Study|Entry Criteria Not Met|1|||
147115518|NCT00827242|530585429|FG000|Overall Study|Physician Decision|2|||
147115519|NCT00827242|530585430|FG001|Overall Study|Physician Decision|0|||
147115520|NCT00827242|530585429|FG000|Overall Study|Death|1|||
147115521|NCT00827242|530585430|FG001|Overall Study|Death|0|||
147115522|NCT00827242|530585429|FG000|Overall Study|Lack of Efficacy|1|||
147115523|NCT00827242|530585430|FG001|Overall Study|Lack of Efficacy|0|||
147115524|NCT04790201|530585431|FG000|Overall Study|Lost to Follow-up|0|||
147115525|NCT04790201|530585432|FG001|Overall Study|Lost to Follow-up|0|||
147115526|NCT04790201|530585433|FG002|Overall Study|Lost to Follow-up|2|||
147115527|NCT04790201|530585431|FG000|Overall Study|Death|0|||
147115528|NCT04790201|530585432|FG001|Overall Study|Death|1|||
147115529|NCT04790201|530585433|FG002|Overall Study|Death|0|||
147115530|NCT04790201|530585431|FG000|Overall Study|Protocol Violation|1|||
147115531|NCT04790201|530585432|FG001|Overall Study|Protocol Violation|0|||
147115532|NCT04790201|530585433|FG002|Overall Study|Protocol Violation|1|||
147115533|NCT02609633|530585434|FG000|Overall Study|Consent Withdrawn|0|||
147115534|NCT02609633|530585435|FG001|Overall Study|Consent Withdrawn|1|||
147115535|NCT02609633|530585434|FG000|Overall Study|Protocol Deviation|1|||
147115536|NCT02609633|530585435|FG001|Overall Study|Protocol Deviation|0|||
147115537|NCT02609633|530585434|FG000|Overall Study|Non-Compliant with Study Procedures|2|||
147115538|NCT02609633|530585435|FG001|Overall Study|Non-Compliant with Study Procedures|0|||
147115539|NCT02609633|530585434|FG000|Overall Study|Reason not Specified|2|||
147115540|NCT02609633|530585435|FG001|Overall Study|Reason not Specified|1|||
147115541|NCT05762679|530585438|FG000|Overall Study|Withdrawal by Subject|1|||
147115542|NCT05762679|530585438|FG000|Overall Study|No analyzable imaging data|1|||
147115543|NCT03670628|530585439|FG000|Weekly Therapy Sessions|Enrollment was halted; participants were unable to attend study visits due to COVID-19 restrictions.|8|||
147115544|NCT03670628|530585440|FG001|Weekly Therapy Sessions|Enrollment was halted; participants were unable to attend study visits due to COVID-19 restrictions.|3|||
147115545|NCT03670628|530585439|FG000|Waiting Period|Enrollment was halted; participants were unable to attend study visits due to COVID-19 restrictions.|4|||
147115546|NCT03670628|530585440|FG001|Waiting Period|Enrollment was halted; participants were unable to attend study visits due to COVID-19 restrictions.|6|||
147115547|NCT00997126|530585444|FG000|Overall Study|Physician Decision|7|||
147115548|NCT00997126|530585445|FG001|Overall Study|Physician Decision|11|||
147115549|NCT00471107|530585448|FG000|Overall Study|Technical problems/data loss|3|||
147115550|NCT00471107|530585449|FG001|Overall Study|Technical problems/data loss|1|||
147115551|NCT00471107|530585450|FG002|Overall Study|Technical problems/data loss|3|||
147115552|NCT03925220|530585451|FG000|Overall Study|Withdrawal by Subject|4|||
147115553|NCT03925220|530585452|FG001|Overall Study|Withdrawal by Subject|4|||
147115554|NCT03925220|530585453|FG002|Overall Study|Withdrawal by Subject|4|||
147115555|NCT03925220|530585454|FG003|Overall Study|Withdrawal by Subject|4|||
147115556|NCT03925220|530585451|FG000|Overall Study|Lost to Follow-up|40|||
147115557|NCT03925220|530585452|FG001|Overall Study|Lost to Follow-up|46|||
147115558|NCT03925220|530585453|FG002|Overall Study|Lost to Follow-up|37|||
147115559|NCT03925220|530585454|FG003|Overall Study|Lost to Follow-up|38|||
147115560|NCT04828486|530585455|FG000|Overall Study|Adverse Event|2|||
147115561|NCT04828486|530585455|FG000|Overall Study|Death|1|||
147115562|NCT04828486|530585455|FG000|Overall Study|Disease Progression|8|||
147115563|NCT04828486|530585455|FG000|Overall Study|Other Complicating Disease|1|||
147115564|NCT04828486|530585455|FG000|Overall Study|Withdrawal by Subject|1|||
147115565|NCT02063724|530585456|FG000|Overall Study|Disease progression|1|||
147115566|NCT00896233|530585457|FG000|Overall Study|Claustrophobia during MRI|1|||
147115567|NCT02965456|530585458|FG000|Overall Study|Lost to Follow-up|40|||
147115568|NCT02965456|530585459|FG001|Overall Study|Lost to Follow-up|18|||
147115569|NCT02965456|530585458|FG000|Overall Study|Subject Request|22|||
147115570|NCT02965456|530585459|FG001|Overall Study|Subject Request|13|||
147115571|NCT02965456|530585458|FG000|Overall Study|Withdrawal by Parent or Guardian|3|||
147115572|NCT02965456|530585459|FG001|Overall Study|Withdrawal by Parent or Guardian|6|||
147115573|NCT02965456|530585458|FG000|Overall Study|Adverse Event|3|||
147115574|NCT02965456|530585459|FG001|Overall Study|Adverse Event|0|||
147228759|NCT02413372|531010526|FG001|Treatment|Lost to Follow-up|2|||
147115575|NCT02965456|530585458|FG000|Overall Study|Noncompliance with Study Drug|1|||
147115576|NCT02965456|530585459|FG001|Overall Study|Noncompliance with Study Drug|1|||
147115577|NCT02965456|530585458|FG000|Overall Study|Worsening Condition|0|||
147115578|NCT02965456|530585459|FG001|Overall Study|Worsening Condition|2|||
147115579|NCT02965456|530585458|FG000|Overall Study|Lack of Efficacy|1|||
147115580|NCT02965456|530585459|FG001|Overall Study|Lack of Efficacy|0|||
147115581|NCT02965456|530585458|FG000|Overall Study|Physician Decision|0|||
147115582|NCT02965456|530585459|FG001|Overall Study|Physician Decision|1|||
147115583|NCT02965456|530585458|FG000|Overall Study|Pregnancy|1|||
147115584|NCT02965456|530585459|FG001|Overall Study|Pregnancy|0|||
147115585|NCT02965456|530585458|FG000|Overall Study|Protocol Violation|0|||
147115586|NCT02965456|530585459|FG001|Overall Study|Protocol Violation|1|||
147115587|NCT02965456|530585458|FG000|Overall Study|Participant ran out of study drug|0|||
147115588|NCT02965456|530585459|FG001|Overall Study|Participant ran out of study drug|1|||
147115589|NCT04465955|530585460|FG000|Overall Study|Withdrew consent|6|||
147115590|NCT04465955|530585461|FG001|Overall Study|Withdrew consent|10|||
147115591|NCT04465955|530585462|FG002|Overall Study|Withdrew consent|7|||
147115592|NCT04465955|530585460|FG000|Overall Study|Adverse Event|6|||
147115593|NCT04465955|530585461|FG001|Overall Study|Adverse Event|5|||
147115594|NCT04465955|530585462|FG002|Overall Study|Adverse Event|1|||
147115595|NCT04465955|530585460|FG000|Overall Study|Lost to Follow-up|2|||
147115596|NCT04465955|530585461|FG001|Overall Study|Lost to Follow-up|0|||
147115597|NCT04465955|530585462|FG002|Overall Study|Lost to Follow-up|3|||
147115598|NCT04465955|530585460|FG000|Overall Study|Other|1|||
147115599|NCT04465955|530585461|FG001|Overall Study|Other|1|||
147115600|NCT04465955|530585462|FG002|Overall Study|Other|3|||
147115601|NCT00317369|530585468|FG000|Overall Study|Adverse Event|2|||
147115602|NCT00317369|530585469|FG001|Overall Study|Adverse Event|1|||
147115603|NCT00317369|530585470|FG002|Overall Study|Adverse Event|0|||
147115604|NCT00317369|530585468|FG000|Overall Study|Lack of Efficacy|0|||
147115605|NCT00317369|530585469|FG001|Overall Study|Lack of Efficacy|1|||
147115606|NCT00317369|530585470|FG002|Overall Study|Lack of Efficacy|1|||
147115607|NCT00317369|530585468|FG000|Overall Study|Withdrawal by Subject|0|||
147115608|NCT00317369|530585469|FG001|Overall Study|Withdrawal by Subject|0|||
147115609|NCT00317369|530585470|FG002|Overall Study|Withdrawal by Subject|1|||
147115610|NCT00250718|530585474|FG000|Overall Study|Death|1|||
147115611|NCT00250718|530585474|FG000|Overall Study|Adverse Event|1|||
147115612|NCT00250718|530585474|FG000|Overall Study|Withdrawal by Subject|1|||
147115613|NCT05942040|530585475|FG000|Overall Study|No longer employed at study site.|0|||
147115614|NCT05942040|530585476|FG001|Overall Study|No longer employed at study site.|0|||
147115615|NCT05942040|530585477|FG002|Overall Study|No longer employed at study site.|3|||
147115616|NCT05259033|530585481|FG000|Overall Study|Withdrawal by Subject|10|||
147115617|NCT05259033|530585482|FG001|Overall Study|Withdrawal by Subject|5|||
147115618|NCT05259033|530585481|FG000|Overall Study|Lost to Follow-up|1|||
147115619|NCT05259033|530585482|FG001|Overall Study|Lost to Follow-up|0|||
147115620|NCT05259033|530585481|FG000|Overall Study|Death|2|||
147115621|NCT05259033|530585482|FG001|Overall Study|Death|0|||
147115622|NCT01068249|530585483|FG000|Overall Study|Death|1|||
147115623|NCT01068249|530585483|FG000|Overall Study|Withdrawal by Subject|3|||
147115624|NCT04337021|530585492|FG000|Overall Study|Lost to Follow-up|54|||
147115625|NCT04337021|530585493|FG001|Overall Study|Lost to Follow-up|66|||
147115626|NCT01685437|530585498|FG000|Overall Study|Withdrawal by Subject|22|||
147115627|NCT01685437|530585498|FG000|Overall Study|Lost to Follow-up|3|||
147115628|NCT01685437|530585498|FG000|Overall Study|Adverse Event|1|||
147115629|NCT01685437|530585498|FG000|Overall Study|Protocol Violation|4|||
147115630|NCT01685437|530585498|FG000|Overall Study|Unable to make visits due to work|1|||
147115631|NCT01121575|530585509|FG000|Overall Study|Participant Refused Further Follow-Up|0|||
147115632|NCT01121575|530585510|FG001|Overall Study|Participant Refused Further Follow-Up|0|||
147115633|NCT01121575|530585511|FG002|Overall Study|Participant Refused Further Follow-Up|0|||
147115634|NCT01121575|530585512|FG003|Overall Study|Participant Refused Further Follow-Up|0|||
147115635|NCT01121575|530585513|FG004|Overall Study|Participant Refused Further Follow-Up|5|||
147115636|NCT01121575|530585514|FG005|Overall Study|Participant Refused Further Follow-Up|1|||
147115637|NCT01121575|530585509|FG000|Overall Study|Unspecified Reasons|8|||
147115638|NCT01121575|530585510|FG001|Overall Study|Unspecified Reasons|6|||
147115639|NCT01121575|530585511|FG002|Overall Study|Unspecified Reasons|7|||
147115640|NCT01121575|530585512|FG003|Overall Study|Unspecified Reasons|5|||
147115641|NCT01121575|530585513|FG004|Overall Study|Unspecified Reasons|13|||
147115642|NCT01121575|530585514|FG005|Overall Study|Unspecified Reasons|10|||
147115643|NCT01121575|530585509|FG000|Overall Study|Death|6|||
147115644|NCT01121575|530585510|FG001|Overall Study|Death|0|||
147115645|NCT01121575|530585511|FG002|Overall Study|Death|0|||
147115646|NCT01121575|530585512|FG003|Overall Study|Death|1|||
147115647|NCT01121575|530585513|FG004|Overall Study|Death|7|||
147115648|NCT01121575|530585514|FG005|Overall Study|Death|1|||
147115649|NCT03860584|530585524|FG000|First Intervention (2 Weeks)|Lack of Efficacy|1|||
147115650|NCT03860584|530585525|FG001|First Intervention (2 Weeks)|Lack of Efficacy|0|||
147115651|NCT03860584|530585524|FG000|First Intervention (2 Weeks)|Lost to Follow-up|0|||
147115652|NCT03860584|530585525|FG001|First Intervention (2 Weeks)|Lost to Follow-up|1|||
147115653|NCT03860584|530585524|FG000|Second Intervention (2 Weeks)|Lost to Follow-up|3|||
147115654|NCT03860584|530585525|FG001|Second Intervention (2 Weeks)|Lost to Follow-up|0|||
147115655|NCT03860584|530585524|FG000|Second Intervention (2 Weeks)|Lack of Efficacy|0|||
147115656|NCT03860584|530585525|FG001|Second Intervention (2 Weeks)|Lack of Efficacy|1|||
147115657|NCT02400736|530586732|FG000|Overall Study|Lost to Follow-up|6|||
147115658|NCT02400736|530586733|FG001|Overall Study|Lost to Follow-up|6|||
147115659|NCT02400736|530586732|FG000|Overall Study|Withdrawal by Subject|2|||
147115660|NCT02400736|530586733|FG001|Overall Study|Withdrawal by Subject|1|||
147115661|NCT02400736|530586732|FG000|Overall Study|Moved from the area|3|||
147115662|NCT02400736|530586733|FG001|Overall Study|Moved from the area|1|||
147312174|NCT02023879|531309299|FG002|Extension Open Label Treatment|Other than specified above|2|||
147312175|NCT00874432|531309300|FG000|Overall Study|Withdrawal by Subject|1|||
147312176|NCT00874432|531309301|FG001|Overall Study|Withdrawal by Subject|0|||
147312177|NCT00874432|531309302|FG002|Overall Study|Withdrawal by Subject|0|||
147565443|NCT00048581|532228348|FG001|Open-Label Period|Adverse Event|0|||
147565444|NCT00048581|532228349|FG002|Open-Label Period|Adverse Event|37|||
147565445|NCT00048581|532228347|FG000|Open-Label Period|Lack of Efficacy|0|||
147565446|NCT00048581|532228348|FG001|Open-Label Period|Lack of Efficacy|0|||
147565447|NCT00048581|532228349|FG002|Open-Label Period|Lack of Efficacy|69|||
147565448|NCT00048581|532228347|FG000|Open-Label Period|Lost to Follow-up|0|||
147115663|NCT01105130|530586734|FG000|Overall Study|Withdrawal by Subject|4|||
147115664|NCT01105130|530586735|FG001|Overall Study|Withdrawal by Subject|6|||
147115665|NCT01105130|530586736|FG002|Overall Study|Withdrawal by Subject|2|||
147565449|NCT00048581|532228348|FG001|Open-Label Period|Lost to Follow-up|0|||
147565450|NCT00048581|532228349|FG002|Open-Label Period|Lost to Follow-up|14|||
147565451|NCT00048581|532228347|FG000|Open-Label Period|Withdrawal by Subject|0|||
147115666|NCT01105130|530586734|FG000|Overall Study|Never Started|2|||
147115667|NCT01105130|530586735|FG001|Overall Study|Never Started|2|||
147115668|NCT01105130|530586736|FG002|Overall Study|Never Started|4|||
147115669|NCT01105130|530586734|FG000|Overall Study|Toxicity|1|||
147115670|NCT01105130|530586735|FG001|Overall Study|Toxicity|3|||
147115671|NCT01105130|530586736|FG002|Overall Study|Toxicity|2|||
147115672|NCT01105130|530586734|FG000|Overall Study|Multiple Reasons|3|||
147115673|NCT01105130|530586735|FG001|Overall Study|Multiple Reasons|0|||
147115674|NCT01105130|530586736|FG002|Overall Study|Multiple Reasons|2|||
147115675|NCT02927145|530586738|FG000|Initial Recruitment|Withdrawal by Subject|0|||
147115676|NCT02927145|530586739|FG001|Initial Recruitment|Withdrawal by Subject|1|||
147115677|NCT02927145|530586740|FG002|Initial Recruitment|Withdrawal by Subject|1|||
147115678|NCT02927145|530586741|FG003|Initial Recruitment|Withdrawal by Subject|4|||
147115679|NCT02927145|530586742|FG004|Initial Recruitment|Withdrawal by Subject|1|||
147115680|NCT02927145|530586743|FG005|Initial Recruitment|Withdrawal by Subject|1|||
147115681|NCT02927145|530586744|FG006|Initial Recruitment|Withdrawal by Subject|0|||
147115682|NCT02927145|530586745|FG007|Initial Recruitment|Withdrawal by Subject|0|||
147115683|NCT02927145|530586746|FG008|Initial Recruitment|Withdrawal by Subject|2|||
147115684|NCT02927145|530586738|FG000|Initial Recruitment|Adverse Event|0|||
147115685|NCT02927145|530586739|FG001|Initial Recruitment|Adverse Event|0|||
147115686|NCT02927145|530586740|FG002|Initial Recruitment|Adverse Event|0|||
147115687|NCT02927145|530586741|FG003|Initial Recruitment|Adverse Event|0|||
147115688|NCT02927145|530586742|FG004|Initial Recruitment|Adverse Event|2|||
147115689|NCT02927145|530586743|FG005|Initial Recruitment|Adverse Event|0|||
147115690|NCT02927145|530586744|FG006|Initial Recruitment|Adverse Event|0|||
147115691|NCT02927145|530586745|FG007|Initial Recruitment|Adverse Event|0|||
147115692|NCT02927145|530586746|FG008|Initial Recruitment|Adverse Event|0|||
147115693|NCT02927145|530586738|FG000|Invitation for Additional Challenge|Pregnancy|0|||
147115694|NCT02927145|530586739|FG001|Invitation for Additional Challenge|Pregnancy|0|||
147115695|NCT02927145|530586740|FG002|Invitation for Additional Challenge|Pregnancy|0|||
147115696|NCT02927145|530586741|FG003|Invitation for Additional Challenge|Pregnancy|0|||
147115697|NCT02927145|530586742|FG004|Invitation for Additional Challenge|Pregnancy|0|||
147115698|NCT02927145|530586743|FG005|Invitation for Additional Challenge|Pregnancy|0|||
147115699|NCT02927145|530586744|FG006|Invitation for Additional Challenge|Pregnancy|1|||
147115700|NCT02927145|530586745|FG007|Invitation for Additional Challenge|Pregnancy|0|||
147115701|NCT02927145|530586746|FG008|Invitation for Additional Challenge|Pregnancy|0|||
147115702|NCT00327171|530586747|FG000|Overall Study|Did not receive study medication|3|||
147115703|NCT00327171|530586748|FG001|Overall Study|Did not receive study medication|0|||
147115704|NCT00327171|530586747|FG000|Overall Study|Adverse Event|23|||
147115705|NCT00327171|530586748|FG001|Overall Study|Adverse Event|23|||
147115706|NCT00327171|530586747|FG000|Overall Study|Disease progression/lack of efficacy|68|||
147312178|NCT00874432|531309303|FG003|Overall Study|Withdrawal by Subject|0|||
147312179|NCT00874432|531309300|FG000|Overall Study|Physician Decision|1|||
147650878|NCT02757352|532544537|FG000|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
147115707|NCT00327171|530586748|FG001|Overall Study|Disease progression/lack of efficacy|69|||
147115708|NCT00327171|530586747|FG000|Overall Study|Investigator/participant request|1|||
147115709|NCT00327171|530586748|FG001|Overall Study|Investigator/participant request|8|||
147115710|NCT00327171|530586747|FG000|Overall Study|Clinical progression|12|||
147115711|NCT00327171|530586748|FG001|Overall Study|Clinical progression|8|||
147115712|NCT00327171|530586747|FG000|Overall Study|Undisclosed history of ischemia|0|||
147115713|NCT00327171|530586748|FG001|Overall Study|Undisclosed history of ischemia|1|||
147115714|NCT00327171|530586747|FG000|Overall Study|Other|1|||
147115715|NCT00327171|530586748|FG001|Overall Study|Other|0|||
147115716|NCT01363440|530586749|FG000|Overall Study|Adverse Event|5|||
147115717|NCT01363440|530586750|FG001|Overall Study|Adverse Event|4|||
147115718|NCT01363440|530586751|FG002|Overall Study|Adverse Event|4|||
147115719|NCT01363440|530586749|FG000|Overall Study|Death|3|||
147115720|NCT01363440|530586750|FG001|Overall Study|Death|7|||
147115721|NCT01363440|530586751|FG002|Overall Study|Death|5|||
147115722|NCT01363440|530586749|FG000|Overall Study|Withdrawal by Subject|9|||
147115723|NCT01363440|530586750|FG001|Overall Study|Withdrawal by Subject|11|||
147115724|NCT01363440|530586751|FG002|Overall Study|Withdrawal by Subject|11|||
147115725|NCT01363440|530586749|FG000|Overall Study|Lost to Follow-up|2|||
147115726|NCT01363440|530586750|FG001|Overall Study|Lost to Follow-up|4|||
147115727|NCT01363440|530586751|FG002|Overall Study|Lost to Follow-up|5|||
147115728|NCT01363440|530586749|FG000|Overall Study|Other|4|||
147115729|NCT01363440|530586750|FG001|Overall Study|Other|5|||
147115730|NCT01363440|530586751|FG002|Overall Study|Other|2|||
147115731|NCT02323334|530586753|FG000|Period 3|Lost to Follow-up|0|||
147115732|NCT02323334|530586754|FG001|Period 3|Lost to Follow-up|0|||
147115733|NCT02323334|530586755|FG002|Period 3|Lost to Follow-up|1|||
147115734|NCT02323334|530586756|FG003|Period 3|Lost to Follow-up|0|||
147115735|NCT02323334|530586757|FG004|Period 3|Lost to Follow-up|0|||
147115736|NCT02323334|530586758|FG005|Period 3|Lost to Follow-up|0|||
147115737|NCT02323334|530586759|FG006|Period 3|Lost to Follow-up|0|||
147115738|NCT02323334|530586760|FG007|Period 3|Lost to Follow-up|0|||
147115739|NCT02323334|530586761|FG008|Period 3|Lost to Follow-up|0|||
147115740|NCT02323334|530586762|FG009|Period 3|Lost to Follow-up|0|||
147115741|NCT02323334|530586763|FG010|Period 3|Lost to Follow-up|0|||
147115742|NCT02323334|530586764|FG011|Period 3|Lost to Follow-up|0|||
147115743|NCT02323334|530586765|FG012|Period 3|Lost to Follow-up|0|||
147115744|NCT02323334|530586766|FG013|Period 3|Lost to Follow-up|0|||
147115745|NCT02323334|530586767|FG014|Period 3|Lost to Follow-up|0|||
147115746|NCT02323334|530586768|FG015|Period 3|Lost to Follow-up|0|||
147115747|NCT02323334|530586769|FG016|Period 3|Lost to Follow-up|0|||
147115748|NCT02323334|530586753|FG000|Period 3|Withdrawal by Subject|1|||
147115749|NCT02323334|530586754|FG001|Period 3|Withdrawal by Subject|0|||
147115750|NCT02323334|530586755|FG002|Period 3|Withdrawal by Subject|0|||
147115751|NCT02323334|530586756|FG003|Period 3|Withdrawal by Subject|0|||
147115752|NCT02323334|530586757|FG004|Period 3|Withdrawal by Subject|0|||
147115753|NCT02323334|530586758|FG005|Period 3|Withdrawal by Subject|0|||
147115754|NCT02323334|530586759|FG006|Period 3|Withdrawal by Subject|0|||
147115755|NCT02323334|530586760|FG007|Period 3|Withdrawal by Subject|0|||
147115756|NCT02323334|530586761|FG008|Period 3|Withdrawal by Subject|0|||
147115757|NCT02323334|530586762|FG009|Period 3|Withdrawal by Subject|0|||
147115758|NCT02323334|530586763|FG010|Period 3|Withdrawal by Subject|0|||
147115759|NCT02323334|530586764|FG011|Period 3|Withdrawal by Subject|0|||
147115760|NCT02323334|530586765|FG012|Period 3|Withdrawal by Subject|0|||
147115761|NCT02323334|530586766|FG013|Period 3|Withdrawal by Subject|0|||
147115762|NCT02323334|530586767|FG014|Period 3|Withdrawal by Subject|0|||
147115763|NCT02323334|530586768|FG015|Period 3|Withdrawal by Subject|0|||
147115764|NCT02323334|530586769|FG016|Period 3|Withdrawal by Subject|0|||
147115765|NCT00530075|530586770|FG000|Overall Study|Adverse Event|1|||
147115766|NCT00530075|530586770|FG000|Overall Study|Death|1|||
147565452|NCT00048581|532228348|FG001|Open-Label Period|Withdrawal by Subject|0|||
147565453|NCT00048581|532228349|FG002|Open-Label Period|Withdrawal by Subject|20|||
147565454|NCT00048581|532228347|FG000|Open-Label Period|No Longer Meets Study Criteria|0|||
147565455|NCT00048581|532228348|FG001|Open-Label Period|No Longer Meets Study Criteria|0|||
147228760|NCT02413372|531010527|FG002|Treatment|Lost to Follow-up|1|||
147115767|NCT00530075|530586770|FG000|Overall Study|Lack of Efficacy|3|||
147115768|NCT00530075|530586770|FG000|Overall Study|Protocol Violation|1|||
147228761|NCT02413372|531010525|FG000|Treatment|Withdrawal by Subject|1|||
147228762|NCT02413372|531010526|FG001|Treatment|Withdrawal by Subject|0|||
147115769|NCT00530075|530586770|FG000|Overall Study|Withdrawal by Subject|1|||
147115770|NCT01166945|530586771|FG000|Randomized|diagnosed with Group A strep|4|||
147115771|NCT01166945|530586772|FG001|Randomized|diagnosed with Group A strep|4|||
147115772|NCT01166945|530586771|FG000|Day 10|NonCompliance/Lost to Follow Up|3|||
147115773|NCT01166945|530586772|FG001|Day 10|NonCompliance/Lost to Follow Up|2|||
147115774|NCT01166945|530586771|FG000|Day 15|NonCompliance/Lost to Follow Up|2|||
147228763|NCT02413372|531010527|FG002|Treatment|Withdrawal by Subject|0|||
147115775|NCT01166945|530586772|FG001|Day 15|NonCompliance/Lost to Follow Up|1|||
147115776|NCT01166945|530586771|FG000|Day 30|Lost to Follow-up|4|||
147115777|NCT01166945|530586772|FG001|Day 30|Lost to Follow-up|3|||
147115778|NCT00784927|530586778|FG000|Overall Study|Cancel Prior to Initiating Treatment|1|||
147115779|NCT00784927|530586778|FG000|Overall Study|Protocol Violation|1|||
147115780|NCT00784927|530586778|FG000|Overall Study|Ineligible|1|||
147115781|NCT00422461|530586785|FG000|Overall Study|Adverse Event|1|||
147115782|NCT00422461|530586786|FG001|Overall Study|Adverse Event|2|||
147115783|NCT00422461|530586787|FG002|Overall Study|Adverse Event|1|||
147115784|NCT00422461|530586788|FG003|Overall Study|Adverse Event|1|||
147115785|NCT00422461|530586785|FG000|Overall Study|Other|0|||
147115786|NCT00422461|530586786|FG001|Overall Study|Other|0|||
147115787|NCT00422461|530586787|FG002|Overall Study|Other|0|||
147115788|NCT00422461|530586788|FG003|Overall Study|Other|2|||
147115789|NCT00422461|530586785|FG000|Overall Study|Participants no longer willing to participate in study|1|||
147115790|NCT00422461|530586786|FG001|Overall Study|Participants no longer willing to participate in study|0|||
147115791|NCT00422461|530586787|FG002|Overall Study|Participants no longer willing to participate in study|0|||
147115792|NCT00422461|530586788|FG003|Overall Study|Participants no longer willing to participate in study|0|||
147115793|NCT00422461|530586785|FG000|Overall Study|Randomized but not treated|1|||
147115794|NCT00422461|530586786|FG001|Overall Study|Randomized but not treated|1|||
147115795|NCT00422461|530586787|FG002|Overall Study|Randomized but not treated|0|||
147115796|NCT00422461|530586788|FG003|Overall Study|Randomized but not treated|0|||
147115797|NCT01795937|530586790|FG000|Overall Study|Withdrawal by Subject|1|||
147115798|NCT01795937|530586791|FG001|Overall Study|Withdrawal by Subject|0|||
147115799|NCT01795937|530586792|FG002|Overall Study|Withdrawal by Subject|0|||
147115800|NCT01795937|530586790|FG000|Overall Study|Physician Decision|0|||
147115801|NCT01795937|530586791|FG001|Overall Study|Physician Decision|1|||
147115802|NCT01795937|530586792|FG002|Overall Study|Physician Decision|0|||
147115803|NCT01028053|530586793|FG000|Overall Study|Screen Failure|113|||
147115804|NCT01028053|530586793|FG000|Overall Study|Patient Request|11|||
147115805|NCT01028053|530586793|FG000|Overall Study|Protocol Violation|1|||
147115806|NCT01028053|530586793|FG000|Overall Study|Physician Decision|2|||
147115807|NCT01028053|530586793|FG000|Overall Study|Technical Problem|1|||
147115808|NCT01028053|530586793|FG000|Overall Study|Terminated by Sponsor|1|||
147115809|NCT01028053|530586793|FG000|Overall Study|Various reasons|4|||
147115810|NCT01336972|530586800|FG000|Overall Study|Adverse Event|1|||
147115811|NCT01336972|530586801|FG001|Overall Study|Adverse Event|1|||
147115812|NCT01336972|530586802|FG002|Overall Study|Adverse Event|0|||
147115813|NCT02441114|530586804|FG000|Washout2|Withdrawal by Subject|4|||
147115814|NCT03446573|530586805|FG000|Early Switch Phase (Day 1 to Week 148)|Adverse Event|23|||
147228764|NCT02413372|531010525|FG000|Follow-up|Lost to Follow-up|1|||
147228765|NCT02413372|531010526|FG001|Follow-up|Lost to Follow-up|1|||
147228766|NCT02413372|531010527|FG002|Follow-up|Lost to Follow-up|0|||
147228767|NCT02413372|531010525|FG000|Follow-up|Subject Withdrew Consent|1|||
147228768|NCT02413372|531010526|FG001|Follow-up|Subject Withdrew Consent|0|||
147228769|NCT02413372|531010527|FG002|Follow-up|Subject Withdrew Consent|1|||
147228770|NCT02413372|531010525|FG000|Follow-up|Subject unable to return for visit|0|||
147228771|NCT02413372|531010526|FG001|Follow-up|Subject unable to return for visit|0|||
147228772|NCT02413372|531010527|FG002|Follow-up|Subject unable to return for visit|1|||
147228773|NCT04587271|531010530|FG000|Overall Study|Lost to Follow-up|2|||
147228774|NCT04587271|531010531|FG001|Overall Study|Lost to Follow-up|2|||
147228775|NCT04587271|531010532|FG002|Overall Study|Lost to Follow-up|0|||
147228776|NCT04587271|531010533|FG003|Overall Study|Lost to Follow-up|2|||
147228777|NCT04587271|531010534|FG004|Overall Study|Lost to Follow-up|2|||
147228778|NCT04587271|531010535|FG005|Overall Study|Lost to Follow-up|0|||
147228779|NCT04587271|531010530|FG000|Overall Study|Caregiver brought child to visits|0|||
147228780|NCT04587271|531010531|FG001|Overall Study|Caregiver brought child to visits|0|||
147228781|NCT04587271|531010532|FG002|Overall Study|Caregiver brought child to visits|0|||
147228782|NCT04587271|531010533|FG003|Overall Study|Caregiver brought child to visits|1|||
147115815|NCT03446573|530586806|FG001|Early Switch Phase (Day 1 to Week 148)|Adverse Event|7|||
147115816|NCT03446573|530586805|FG000|Early Switch Phase (Day 1 to Week 148)|Lack of Efficacy|0|||
147115817|NCT03446573|530586806|FG001|Early Switch Phase (Day 1 to Week 148)|Lack of Efficacy|6|||
147115818|NCT03446573|530586805|FG000|Early Switch Phase (Day 1 to Week 148)|Protocol Violation|5|||
147115819|NCT03446573|530586806|FG001|Early Switch Phase (Day 1 to Week 148)|Protocol Violation|6|||
147228783|NCT04587271|531010534|FG004|Overall Study|Caregiver brought child to visits|0|||
147228784|NCT04587271|531010535|FG005|Overall Study|Caregiver brought child to visits|0|||
147228785|NCT02180165|531010536|FG000|Overall Study|Not Treated|0|||
147228786|NCT02180165|531010537|FG001|Overall Study|Not Treated|0|||
147228787|NCT02180165|531010538|FG002|Overall Study|Not Treated|1|||
147228788|NCT02180165|531010539|FG003|Overall Study|Not Treated|0|||
147228789|NCT02180165|531010536|FG000|Overall Study|Adverse Event|7|||
147228790|NCT02180165|531010537|FG001|Overall Study|Adverse Event|0|||
147228791|NCT02180165|531010538|FG002|Overall Study|Adverse Event|18|||
147228792|NCT02180165|531010539|FG003|Overall Study|Adverse Event|3|||
147228793|NCT02180165|531010536|FG000|Overall Study|Lack of Efficacy|0|||
147228794|NCT02180165|531010537|FG001|Overall Study|Lack of Efficacy|1|||
147228795|NCT02180165|531010538|FG002|Overall Study|Lack of Efficacy|3|||
147228796|NCT02180165|531010539|FG003|Overall Study|Lack of Efficacy|2|||
147228797|NCT02180165|531010536|FG000|Overall Study|Physician Decision|1|||
147228798|NCT02180165|531010537|FG001|Overall Study|Physician Decision|0|||
147115820|NCT03446573|530586805|FG000|Early Switch Phase (Day 1 to Week 148)|Lost to Follow-up|4|||
147115821|NCT03446573|530586806|FG001|Early Switch Phase (Day 1 to Week 148)|Lost to Follow-up|10|||
147115822|NCT03446573|530586805|FG000|Early Switch Phase (Day 1 to Week 148)|Physician Decision|2|||
147115823|NCT03446573|530586806|FG001|Early Switch Phase (Day 1 to Week 148)|Physician Decision|11|||
147115824|NCT03446573|530586805|FG000|Early Switch Phase (Day 1 to Week 148)|Withdrawal by Subject|16|||
147115825|NCT03446573|530586806|FG001|Early Switch Phase (Day 1 to Week 148)|Withdrawal by Subject|33|||
147115826|NCT03446573|530586805|FG000|Early Switch Phase (Day 1 to Week 148)|Randomized, but did not receive treatment|2|||
147115827|NCT03446573|530586806|FG001|Early Switch Phase (Day 1 to Week 148)|Randomized, but did not receive treatment|0|||
147115828|NCT03446573|530586805|FG000|Late Switch Phase (Week 148 to Week 196)|Adverse Event|2|||
147115829|NCT03446573|530586806|FG001|Late Switch Phase (Week 148 to Week 196)|Adverse Event|9|||
147312180|NCT00874432|531309301|FG001|Overall Study|Physician Decision|0|||
147115830|NCT03446573|530586805|FG000|Late Switch Phase (Week 148 to Week 196)|Lack of Efficacy|1|||
147115831|NCT03446573|530586806|FG001|Late Switch Phase (Week 148 to Week 196)|Lack of Efficacy|1|||
147312181|NCT00874432|531309302|FG002|Overall Study|Physician Decision|0|||
147312182|NCT00874432|531309303|FG003|Overall Study|Physician Decision|0|||
147312183|NCT00874432|531309300|FG000|Overall Study|Other|1|||
147312184|NCT00874432|531309301|FG001|Overall Study|Other|2|||
147312185|NCT00874432|531309302|FG002|Overall Study|Other|8|||
147312186|NCT00874432|531309303|FG003|Overall Study|Other|3|||
147312187|NCT03713021|531309304|FG000|Overall Study|Did not have CT sim scan available|6|||
147312188|NCT03713021|531309304|FG000|Overall Study|Not eligible|4|||
147312189|NCT03713021|531309304|FG000|Overall Study|Issues with TraceIT markers|5|||
147312190|NCT05256381|531309305|FG000|Overall Study|Withdrawal by Subject|4|||
147312191|NCT05256381|531309306|FG001|Overall Study|Withdrawal by Subject|0|||
147312192|NCT05256381|531309307|FG002|Overall Study|Withdrawal by Subject|2|||
147312193|NCT05256381|531309308|FG003|Overall Study|Withdrawal by Subject|2|||
147312194|NCT05256381|531309309|FG004|Overall Study|Withdrawal by Subject|8|||
147115832|NCT03446573|530586805|FG000|Late Switch Phase (Week 148 to Week 196)|Protocol Violation|0|||
147115833|NCT03446573|530586806|FG001|Late Switch Phase (Week 148 to Week 196)|Protocol Violation|1|||
147115834|NCT03446573|530586805|FG000|Late Switch Phase (Week 148 to Week 196)|Lost to Follow-up|5|||
147115835|NCT03446573|530586806|FG001|Late Switch Phase (Week 148 to Week 196)|Lost to Follow-up|6|||
147228799|NCT02180165|531010538|FG002|Overall Study|Physician Decision|5|||
147228800|NCT02180165|531010539|FG003|Overall Study|Physician Decision|0|||
147228801|NCT02180165|531010536|FG000|Overall Study|Withdrawal by Subject|3|||
147228802|NCT02180165|531010537|FG001|Overall Study|Withdrawal by Subject|0|||
147228803|NCT02180165|531010538|FG002|Overall Study|Withdrawal by Subject|2|||
147228804|NCT02180165|531010539|FG003|Overall Study|Withdrawal by Subject|1|||
147228805|NCT03875768|531010540|FG000|Overall Study|Lost to Follow-up|16|||
147228806|NCT03875768|531010541|FG001|Overall Study|Lost to Follow-up|13|||
147228807|NCT03875768|531010540|FG000|Overall Study|Withdrawal by Subject|10|||
147228808|NCT03875768|531010541|FG001|Overall Study|Withdrawal by Subject|21|||
147228809|NCT03875768|531010540|FG000|Overall Study|Did not complete assessment|21|||
147228810|NCT03875768|531010541|FG001|Overall Study|Did not complete assessment|12|||
147228811|NCT03875768|531010540|FG000|Overall Study|Became ineligible|1|||
147228812|NCT03875768|531010541|FG001|Overall Study|Became ineligible|0|||
147228813|NCT01925274|531010542|FG000|Overall Study|Death|1|||
147228814|NCT01925274|531010543|FG001|Overall Study|Death|0|||
147228815|NCT01925274|531010544|FG002|Overall Study|Death|0|||
147228816|NCT01925274|531010542|FG000|Overall Study|Lost to Follow-up|0|||
147228817|NCT01925274|531010543|FG001|Overall Study|Lost to Follow-up|1|||
147228818|NCT01925274|531010544|FG002|Overall Study|Lost to Follow-up|0|||
147228819|NCT01925274|531010542|FG000|Overall Study|Withdrawal by Subject|1|||
147228820|NCT01925274|531010543|FG001|Overall Study|Withdrawal by Subject|2|||
147228821|NCT01925274|531010544|FG002|Overall Study|Withdrawal by Subject|0|||
147228822|NCT01925274|531010542|FG000|Overall Study|Study terminated by sponsor|4|||
147228823|NCT01925274|531010543|FG001|Overall Study|Study terminated by sponsor|0|||
147228824|NCT01925274|531010544|FG002|Overall Study|Study terminated by sponsor|0|||
147228825|NCT01925274|531010542|FG000|Overall Study|Protocol amendment|1|||
147228826|NCT01925274|531010543|FG001|Overall Study|Protocol amendment|3|||
147228827|NCT01925274|531010544|FG002|Overall Study|Protocol amendment|6|||
147228828|NCT04327674|531010545|FG000|Overall Study|Protocol Violation|19|||
147228829|NCT00723398|531010546|FG000|Overall Study|Withdrawal by Subject|2|||
147228830|NCT00723398|531010547|FG001|Overall Study|Withdrawal by Subject|6|||
147228831|NCT00723398|531010548|FG002|Overall Study|Withdrawal by Subject|4|||
147228832|NCT00723398|531010549|FG003|Overall Study|Withdrawal by Subject|4|||
147228833|NCT00723398|531010550|FG004|Overall Study|Withdrawal by Subject|4|||
147228834|NCT00723398|531010546|FG000|Overall Study|Protocol Violation|2|||
147228835|NCT00723398|531010547|FG001|Overall Study|Protocol Violation|1|||
147228836|NCT00723398|531010548|FG002|Overall Study|Protocol Violation|5|||
147228837|NCT00723398|531010549|FG003|Overall Study|Protocol Violation|0|||
147228838|NCT00723398|531010550|FG004|Overall Study|Protocol Violation|0|||
147228839|NCT00723398|531010546|FG000|Overall Study|Physician Decision|2|||
147228840|NCT00723398|531010547|FG001|Overall Study|Physician Decision|2|||
147228841|NCT00723398|531010548|FG002|Overall Study|Physician Decision|5|||
147228842|NCT00723398|531010549|FG003|Overall Study|Physician Decision|0|||
147228843|NCT00723398|531010550|FG004|Overall Study|Physician Decision|1|||
147228844|NCT00723398|531010546|FG000|Overall Study|Adverse Event|0|||
147228845|NCT00723398|531010547|FG001|Overall Study|Adverse Event|5|||
147115836|NCT03446573|530586805|FG000|Late Switch Phase (Week 148 to Week 196)|Physician Decision|0|||
147115837|NCT03446573|530586806|FG001|Late Switch Phase (Week 148 to Week 196)|Physician Decision|1|||
147115838|NCT03446573|530586805|FG000|Late Switch Phase (Week 148 to Week 196)|Withdrawal by Subject|4|||
147115839|NCT03446573|530586806|FG001|Late Switch Phase (Week 148 to Week 196)|Withdrawal by Subject|6|||
147115840|NCT01769443|530586811|FG000|Overall Study|Study closure|1|||
147115841|NCT01769443|530586812|FG001|Overall Study|Study closure|0|||
147115842|NCT06042855|530586821|FG000|Overall Study|No Receipt of Study Drug|48|||
147115843|NCT06042855|530586822|FG001|Overall Study|No Receipt of Study Drug|57|||
147115844|NCT06042855|530586821|FG000|Overall Study|Administratively Withdrawn|59|||
147115845|NCT06042855|530586822|FG001|Overall Study|Administratively Withdrawn|59|||
147115846|NCT01428128|530586824|FG000|Overall Study|Withdrawal by Subject|4|||
147115847|NCT01428128|530586824|FG000|Overall Study|Screen failure by p53|10|||
147228846|NCT00723398|531010548|FG002|Overall Study|Adverse Event|3|||
147228847|NCT00723398|531010549|FG003|Overall Study|Adverse Event|1|||
147228848|NCT00723398|531010550|FG004|Overall Study|Adverse Event|4|||
147228849|NCT00723398|531010546|FG000|Overall Study|Lost to Follow-up|0|||
147228850|NCT00723398|531010547|FG001|Overall Study|Lost to Follow-up|1|||
147228851|NCT00723398|531010548|FG002|Overall Study|Lost to Follow-up|0|||
147228852|NCT00723398|531010549|FG003|Overall Study|Lost to Follow-up|0|||
147115848|NCT01428128|530586824|FG000|Overall Study|Received Neulasta in one cycle|2|||
147115849|NCT01428128|530586824|FG000|Overall Study|Adverse Event|1|||
147115850|NCT04439123|530586827|FG000|Overall Study|Adverse Event|11|||
147115851|NCT04439123|530586827|FG000|Overall Study|Death|1|||
147115852|NCT04439123|530586827|FG000|Overall Study|Disease progression|19|||
147115853|NCT04439123|530586827|FG000|Overall Study|Withdrawal by Subject|2|||
147115854|NCT04439123|530586827|FG000|Overall Study|Still on treatment|2|||
147228853|NCT00723398|531010550|FG004|Overall Study|Lost to Follow-up|0|||
147228854|NCT00470847|531010551|FG000|Overall Study|Pt still receiving treatment|1|||
147228855|NCT02035475|531010552|FG000|Overall Study|Withdrawal by Subject|4|||
147228856|NCT02035475|531010552|FG000|Overall Study|Physician Decision|1|||
147228857|NCT02035475|531010552|FG000|Overall Study|Equipment Error|1|||
147228858|NCT02047227|531010553|FG000|Overall Study|Adverse Event|2|||
147228859|NCT02047227|531010554|FG001|Overall Study|Adverse Event|4|||
147228860|NCT02047227|531010553|FG000|Overall Study|Lost to Follow-up|0|||
147228861|NCT02047227|531010554|FG001|Overall Study|Lost to Follow-up|3|||
147228862|NCT02047227|531010553|FG000|Overall Study|Protocol Violation|1|||
147228863|NCT02047227|531010554|FG001|Overall Study|Protocol Violation|0|||
147228864|NCT02047227|531010553|FG000|Overall Study|Spontaneous pregnancy|1|||
147228865|NCT02047227|531010554|FG001|Overall Study|Spontaneous pregnancy|0|||
147228866|NCT02047227|531010553|FG000|Overall Study|Lack of ovarian response to stimulation|35|||
147228867|NCT02047227|531010554|FG001|Overall Study|Lack of ovarian response to stimulation|32|||
147228868|NCT02047227|531010553|FG000|Overall Study|No oocytes retrieved|21|||
147228869|NCT02047227|531010554|FG001|Overall Study|No oocytes retrieved|20|||
147228870|NCT02047227|531010553|FG000|Overall Study|No fertilization|61|||
147228871|NCT02047227|531010554|FG001|Overall Study|No fertilization|51|||
147228872|NCT02047227|531010553|FG000|Overall Study|Intention to freeze all embryos|1|||
147228873|NCT02047227|531010554|FG001|Overall Study|Intention to freeze all embryos|0|||
147228874|NCT02047227|531010553|FG000|Overall Study|All embryos discarded|12|||
147228875|NCT02047227|531010554|FG001|Overall Study|All embryos discarded|11|||
147228876|NCT02047227|531010553|FG000|Overall Study|Other|10|||
147228877|NCT02047227|531010554|FG001|Overall Study|Other|9|||
147228878|NCT02766465|531010561|FG000|Overall Study|Withdrawal by Subject|0|||
147228879|NCT02766465|531010562|FG001|Overall Study|Withdrawal by Subject|10|||
147228880|NCT02435069|531010563|FG000|Dose Response - First Intervention|Adverse Event|0|||
147228881|NCT02435069|531010564|FG001|Dose Response - First Intervention|Adverse Event|1|||
147228882|NCT02435069|531010565|FG002|Dose Response - First Intervention|Adverse Event|1|||
147228883|NCT02435069|531010566|FG003|Dose Response - First Intervention|Adverse Event|0|||
147228884|NCT02435069|531010567|FG004|Dose Response - First Intervention|Adverse Event|0|||
147228885|NCT02435069|531010563|FG000|Effectiveness - Second Intervention|Lack of Efficacy|0|||
147228886|NCT02435069|531010564|FG001|Effectiveness - Second Intervention|Lack of Efficacy|0|||
147228887|NCT02435069|531010565|FG002|Effectiveness - Second Intervention|Lack of Efficacy|0|||
147228888|NCT02435069|531010566|FG003|Effectiveness - Second Intervention|Lack of Efficacy|0|||
147228889|NCT02435069|531010567|FG004|Effectiveness - Second Intervention|Lack of Efficacy|1|||
147228890|NCT03112590|531010568|FG000|Overall Study|Adverse Event|0|||
147115855|NCT01405911|530586828|FG000|Overall Study|Pre-treatment lab AE|0|||
147115856|NCT01405911|530586829|FG001|Overall Study|Pre-treatment lab AE|1|||
147228891|NCT03112590|531010569|FG001|Overall Study|Adverse Event|1|||
147228892|NCT03112590|531010570|FG002|Overall Study|Adverse Event|0|||
147228893|NCT02520661|531010573|FG000|Overall Study|Lost to Follow-up|7|||
147228894|NCT02520661|531010574|FG001|Overall Study|Lost to Follow-up|3|||
147228895|NCT02520661|531010573|FG000|Overall Study|Admitted from ED|49|||
147228896|NCT02520661|531010574|FG001|Overall Study|Admitted from ED|48|||
147228897|NCT02520661|531010573|FG000|Overall Study|ED greater than 24 hours|29|||
147228898|NCT02520661|531010574|FG001|Overall Study|ED greater than 24 hours|38|||
147228899|NCT02520661|531010573|FG000|Overall Study|other ineligibility|14|||
147565456|NCT00048581|532228349|FG002|Open-Label Period|No Longer Meets Study Criteria|2|||
147565457|NCT00048581|532228347|FG000|Open-Label Period|Poor/Non-compliance|0|||
147565458|NCT00048581|532228348|FG001|Open-Label Period|Poor/Non-compliance|0|||
147565459|NCT00048581|532228349|FG002|Open-Label Period|Poor/Non-compliance|5|||
147565460|NCT00048581|532228347|FG000|Open-Label Period|Pregnancy|0|||
147115857|NCT01405911|530586830|FG002|Overall Study|Pre-treatment lab AE|0|||
147115858|NCT01405911|530586828|FG000|Overall Study|Lost to Follow-up|0|||
147115859|NCT01405911|530586829|FG001|Overall Study|Lost to Follow-up|1|||
147115860|NCT01405911|530586830|FG002|Overall Study|Lost to Follow-up|0|||
147115861|NCT01405911|530586828|FG000|Overall Study|Protocol Violation|1|||
147115862|NCT01405911|530586829|FG001|Overall Study|Protocol Violation|0|||
147115863|NCT01405911|530586830|FG002|Overall Study|Protocol Violation|0|||
147115864|NCT01405911|530586828|FG000|Overall Study|Withdrawal by Subject|3|||
147115865|NCT01405911|530586829|FG001|Overall Study|Withdrawal by Subject|1|||
147115866|NCT01405911|530586830|FG002|Overall Study|Withdrawal by Subject|1|||
147115867|NCT06375655|530586831|FG000|Overall Study|premature delivery (prior to 35 weeks GA)|2|||
147115868|NCT06375655|530586832|FG001|Overall Study|premature delivery (prior to 35 weeks GA)|1|||
147115869|NCT04124965|530586833|FG000|Overall Study|Adverse event, non-fatal|3|||
147115870|NCT04124965|530586834|FG001|Overall Study|Adverse event, non-fatal|1|||
147115871|NCT04124965|530586833|FG000|Overall Study|Withdrawal by Subject|1|||
147115872|NCT04124965|530586834|FG001|Overall Study|Withdrawal by Subject|1|||
147115873|NCT04124965|530586833|FG000|Overall Study|Rolled Over To MG0007 Study|25|||
147115874|NCT04124965|530586834|FG001|Overall Study|Rolled Over To MG0007 Study|28|||
147115875|NCT04124965|530586833|FG000|Overall Study|Pregnancy|1|||
147115876|NCT04124965|530586834|FG001|Overall Study|Pregnancy|0|||
147115877|NCT04124965|530586833|FG000|Overall Study|Sponsor and participant decision|0|||
147115878|NCT04124965|530586834|FG001|Overall Study|Sponsor and participant decision|1|||
147115879|NCT04124965|530586833|FG000|Overall Study|Personal surgery|0|||
147115880|NCT04124965|530586834|FG001|Overall Study|Personal surgery|1|||
147115881|NCT04124965|530586833|FG000|Overall Study|Physician Decision|0|||
147115882|NCT04124965|530586834|FG001|Overall Study|Physician Decision|1|||
147115883|NCT00002874|530586835|FG000|Overall Study|Withdrawal by Subject|1|||
147115884|NCT00002874|530586836|FG001|Overall Study|Withdrawal by Subject|1|||
147115885|NCT00002874|530586835|FG000|Overall Study|Protocol Violation|44|||
147115886|NCT00002874|530586836|FG001|Overall Study|Protocol Violation|34|||
147115887|NCT03828383|530586839|FG000|Overall Study|Lost to Follow-up|3|||
147115888|NCT03828383|530586840|FG001|Overall Study|Lost to Follow-up|2|||
147115889|NCT03828383|530586839|FG000|Overall Study|Withdrawal by Subject|4|||
147115890|NCT03828383|530586840|FG001|Overall Study|Withdrawal by Subject|5|||
147115891|NCT00504309|530586842|FG000|Overall Study|Death|0|||
147115892|NCT00504309|530586843|FG001|Overall Study|Death|0|||
147115893|NCT00504309|530586844|FG002|Overall Study|Death|0|||
147115894|NCT00504309|530586845|FG003|Overall Study|Death|0|||
147115895|NCT00504309|530586846|FG004|Overall Study|Death|1|||
147115896|NCT00504309|530586847|FG005|Overall Study|Death|0|||
147115897|NCT00504309|530586842|FG000|Overall Study|Withdrawal by Subject|0|||
147115898|NCT00504309|530586843|FG001|Overall Study|Withdrawal by Subject|0|||
147115899|NCT00504309|530586844|FG002|Overall Study|Withdrawal by Subject|1|||
147115900|NCT00504309|530586845|FG003|Overall Study|Withdrawal by Subject|0|||
147115901|NCT00504309|530586846|FG004|Overall Study|Withdrawal by Subject|0|||
147115902|NCT00504309|530586847|FG005|Overall Study|Withdrawal by Subject|0|||
147115903|NCT03345095|530586848|FG000|Overall Study|Lack of Efficacy|184|||
147115904|NCT03345095|530586849|FG001|Overall Study|Lack of Efficacy|156|||
147115905|NCT03345095|530586848|FG000|Overall Study|Adverse Event|36|||
147115906|NCT03345095|530586849|FG001|Overall Study|Adverse Event|118|||
147115907|NCT03345095|530586848|FG000|Overall Study|Withdrawal by Subject|22|||
147115908|NCT03345095|530586849|FG001|Overall Study|Withdrawal by Subject|59|||
147115909|NCT03345095|530586848|FG000|Overall Study|Physician Decision|3|||
147228900|NCT02520661|531010574|FG001|Overall Study|other ineligibility|22|||
147228901|NCT02520661|531010573|FG000|Overall Study|Withdrawal by Subject|7|||
147228902|NCT02520661|531010574|FG001|Overall Study|Withdrawal by Subject|16|||
147228903|NCT00843726|531010575|FG000|Overall Study|Death|1|||
147228904|NCT00843726|531010576|FG001|Overall Study|Death|0|||
147228905|NCT00843726|531010575|FG000|Overall Study|Withdrawal by Subject|0|||
147565461|NCT00048581|532228348|FG001|Open-Label Period|Pregnancy|0|||
147115910|NCT03345095|530586849|FG001|Overall Study|Physician Decision|18|||
147115911|NCT03345095|530586848|FG000|Overall Study|Death|2|||
147115912|NCT03345095|530586849|FG001|Overall Study|Death|4|||
147115913|NCT03345095|530586848|FG000|Overall Study|Other reasons|2|||
147115914|NCT03345095|530586849|FG001|Overall Study|Other reasons|11|||
147115915|NCT03345095|530586848|FG000|Overall Study|Protocol Violation|0|||
147115916|NCT03345095|530586849|FG001|Overall Study|Protocol Violation|1|||
147115917|NCT03158311|530586850|FG000|Overall Study|Subject/Guardian Decision|10|||
147115918|NCT03158311|530586851|FG001|Overall Study|Subject/Guardian Decision|6|||
147115919|NCT03158311|530586852|FG002|Overall Study|Subject/Guardian Decision|11|||
147115920|NCT03158311|530586850|FG000|Overall Study|Adverse Event|5|||
147115921|NCT03158311|530586851|FG001|Overall Study|Adverse Event|3|||
147565462|NCT00048581|532228349|FG002|Open-Label Period|Pregnancy|7|||
147565463|NCT00048581|532228347|FG000|Open-Label Period|Study Site Closure|0|||
147115922|NCT03158311|530586852|FG002|Overall Study|Adverse Event|3|||
147115923|NCT03158311|530586850|FG000|Overall Study|Techinical Problems|3|||
147115924|NCT03158311|530586851|FG001|Overall Study|Techinical Problems|1|||
147115925|NCT03158311|530586852|FG002|Overall Study|Techinical Problems|5|||
147115926|NCT03158311|530586850|FG000|Overall Study|Physician Decision|2|||
147115927|NCT03158311|530586851|FG001|Overall Study|Physician Decision|3|||
147115928|NCT03158311|530586852|FG002|Overall Study|Physician Decision|7|||
147115929|NCT03158311|530586850|FG000|Overall Study|Lost to Follow-up|1|||
147115930|NCT03158311|530586851|FG001|Overall Study|Lost to Follow-up|1|||
147115931|NCT03158311|530586852|FG002|Overall Study|Lost to Follow-up|1|||
147115932|NCT03158311|530586850|FG000|Overall Study|Sponsor decision|1|||
147115933|NCT03158311|530586851|FG001|Overall Study|Sponsor decision|0|||
147115934|NCT03158311|530586852|FG002|Overall Study|Sponsor decision|0|||
147115935|NCT03158311|530586850|FG000|Overall Study|Pregnancy|0|||
147115936|NCT03158311|530586851|FG001|Overall Study|Pregnancy|2|||
147115937|NCT03158311|530586852|FG002|Overall Study|Pregnancy|0|||
147115938|NCT03158311|530586850|FG000|Overall Study|Randomized in error|0|||
147115939|NCT03158311|530586851|FG001|Overall Study|Randomized in error|0|||
147115940|NCT03158311|530586852|FG002|Overall Study|Randomized in error|1|||
147115941|NCT02665455|530586853|FG000|Overall Study|Withdrawal by Subject|6|||
147115942|NCT02665455|530586853|FG000|Overall Study|Lost to Follow-up|1|||
147115943|NCT02665455|530586853|FG000|Overall Study|Adverse Event|1|||
147115944|NCT02665455|530586853|FG000|Overall Study|Protocol Violation|1|||
147115945|NCT03011372|530586857|FG000|Overall Study|Death|16|||
147115946|NCT03011372|530586857|FG000|Overall Study|Lost to Follow-up|2|||
147115947|NCT03011372|530586857|FG000|Overall Study|Sponsor Decision|17|||
147115948|NCT03011372|530586857|FG000|Overall Study|Withdrawal by Subject|7|||
147115949|NCT03011372|530586857|FG000|Overall Study|Moved to Commercial Supply of Investigational Drug|2|||
147228906|NCT00843726|531010576|FG001|Overall Study|Withdrawal by Subject|1|||
147228907|NCT00171054|531010580|FG000|Overall Study|Protocol Violation|1|||
147228908|NCT00171054|531010581|FG001|Overall Study|Protocol Violation|2|||
147228909|NCT00171054|531010580|FG000|Overall Study|Patient withdrew consent|1|||
147228910|NCT00171054|531010581|FG001|Overall Study|Patient withdrew consent|0|||
147228911|NCT00171054|531010580|FG000|Overall Study|Lost to Follow-up|0|||
147228912|NCT00171054|531010581|FG001|Overall Study|Lost to Follow-up|1|||
147228913|NCT00171054|531010580|FG000|Overall Study|Adverse Event|8|||
147228914|NCT00171054|531010581|FG001|Overall Study|Adverse Event|8|||
147228915|NCT00171054|531010580|FG000|Overall Study|Condition no longer required study drug|0|||
147228916|NCT00171054|531010581|FG001|Overall Study|Condition no longer required study drug|1|||
147228917|NCT00598702|531011833|FG000|Overall Study|Other|0|||
147228918|NCT00598702|531011834|FG001|Overall Study|Other|2|||
147228919|NCT00598702|531011835|FG002|Overall Study|Other|0|||
147228920|NCT00598702|531011836|FG003|Overall Study|Other|0|||
147228921|NCT00598702|531011837|FG004|Overall Study|Other|0|||
147115950|NCT03011372|530586857|FG000|Overall Study|Received First Dose of Chemotherapy for Stem Cell Transplant|1|||
147115951|NCT03011372|530586857|FG000|Overall Study|Sponsor's Decision|2|||
147115952|NCT03554473|530588707|FG000|Arm A M7824 Relapsed SCLC|Withdrew for hospice care.|2|||
147115953|NCT03554473|530588708|FG001|Arm A M7824 Relapsed SCLC|Withdrew for hospice care.|0|||
147115954|NCT03554473|530588709|FG002|Arm A M7824 Relapsed SCLC|Withdrew for hospice care.|0|||
147115955|NCT03554473|530588707|FG000|Arm A M7824 Relapsed SCLC|Worsening brain metastases. Did not complete a full cycle or return for restaging.|1|||
147115956|NCT03554473|530588708|FG001|Arm A M7824 Relapsed SCLC|Worsening brain metastases. Did not complete a full cycle or return for restaging.|0|||
147115957|NCT03554473|530588709|FG002|Arm A M7824 Relapsed SCLC|Worsening brain metastases. Did not complete a full cycle or return for restaging.|0|||
147115958|NCT03554473|530588707|FG000|Arm C M7824 + Temozolomide ESCC|Developed progressive disease during Cycle 1. Did not complete a full cycle or return for restaging.|0|||
147115959|NCT03554473|530588708|FG001|Arm C M7824 + Temozolomide ESCC|Developed progressive disease during Cycle 1. Did not complete a full cycle or return for restaging.|0|||
147115960|NCT03554473|530588709|FG002|Arm C M7824 + Temozolomide ESCC|Developed progressive disease during Cycle 1. Did not complete a full cycle or return for restaging.|4|||
147115961|NCT04971837|530588713|FG000|Overall Study|Long Term Illness|1|||
147115962|NCT04971837|530588713|FG000|Overall Study|BMI too low|9|||
147115963|NCT04971837|530588713|FG000|Overall Study|geographic location|1|||
147115964|NCT04971837|530588713|FG000|Overall Study|Discontinued scheduling conflict|1|||
147115965|NCT03735498|530588714|FG000|Overall Study|Withdrawal by Subject|3|||
147115966|NCT03735498|530588714|FG000|Overall Study|Two participants did not complete all 6 sessions|2|||
147115967|NCT00160615|530588715|FG000|Overall Study|Adverse Event|5|||
147115968|NCT00160615|530588716|FG001|Overall Study|Adverse Event|12|||
147115969|NCT00160615|530588715|FG000|Overall Study|Withdrawal by Subject|0|||
147115970|NCT00160615|530588716|FG001|Overall Study|Withdrawal by Subject|2|||
147115971|NCT00160615|530588715|FG000|Overall Study|Lack of Efficacy|11|||
147115972|NCT00160615|530588716|FG001|Overall Study|Lack of Efficacy|23|||
147115973|NCT00160615|530588715|FG000|Overall Study|Patient decision|1|||
147115974|NCT00160615|530588716|FG001|Overall Study|Patient decision|2|||
147115975|NCT00160615|530588715|FG000|Overall Study|Investigator decision|1|||
147115976|NCT00160615|530588716|FG001|Overall Study|Investigator decision|1|||
147115977|NCT00160615|530588715|FG000|Overall Study|AE agents had to be discontinued (exam.)|0|||
147565464|NCT00048581|532228348|FG001|Open-Label Period|Study Site Closure|0|||
147565465|NCT00048581|532228349|FG002|Open-Label Period|Study Site Closure|2|||
147565466|NCT00048581|532228347|FG000|Open-Label Period|Continue ABA With Primary Rheumatologist|0|||
147565467|NCT00048581|532228348|FG001|Open-Label Period|Continue ABA With Primary Rheumatologist|0|||
147565468|NCT00048581|532228349|FG002|Open-Label Period|Continue ABA With Primary Rheumatologist|3|||
147565469|NCT00048581|532228347|FG000|Open-Label Period|Problem With Transportation To Site|0|||
147565470|NCT00048581|532228348|FG001|Open-Label Period|Problem With Transportation To Site|0|||
147565471|NCT00048581|532228349|FG002|Open-Label Period|Problem With Transportation To Site|1|||
147565472|NCT00048581|532228347|FG000|Open-Label Period|Primary Investigator Retired|0|||
147565473|NCT00048581|532228348|FG001|Open-Label Period|Primary Investigator Retired|0|||
147565474|NCT00048581|532228349|FG002|Open-Label Period|Primary Investigator Retired|2|||
147565475|NCT00048581|532228347|FG000|Open-Label Period|Study Ended By Sponsor|0|||
147565476|NCT00048581|532228348|FG001|Open-Label Period|Study Ended By Sponsor|0|||
147565477|NCT00048581|532228349|FG002|Open-Label Period|Study Ended By Sponsor|1|||
147565478|NCT01406795|532228350|FG000|Overall Study|Withdrawal by Subject|1|||
147565479|NCT03966365|532228351|FG000|Overall Study|Protocol Violation|1|||
147565480|NCT03966365|532228352|FG001|Overall Study|Protocol Violation|0|||
147565481|NCT03567174|532228354|FG000|Overall Study|Death|24|||
147565482|NCT03567174|532228355|FG001|Overall Study|Death|31|||
147565483|NCT03567174|532228354|FG000|Overall Study|Lost to Follow-up|165|||
147565484|NCT03567174|532228355|FG001|Overall Study|Lost to Follow-up|174|||
147565485|NCT06358820|532229938|FG000|Overall Study|Adverse Event|11|||
147565486|NCT06358820|532229938|FG000|Overall Study|kidney transplantation|3|||
147565487|NCT06358820|532229938|FG000|Overall Study|patient voluntary withdrawal|6|||
147565488|NCT06358820|532229938|FG000|Overall Study|Physician Decision|1|||
147565489|NCT05376319|532229943|FG000|Overall Study|Funding termination|2|||
147565490|NCT05376319|532229944|FG001|Overall Study|Funding termination|4|||
147565491|NCT01124175|532229945|FG000|Washout of 7 Days|Withdrawal by Subject|0|||
147565492|NCT01124175|532229946|FG001|Washout of 7 Days|Withdrawal by Subject|2|||
147565493|NCT00942968|532229947|FG000|Overall Study|Adverse Event|60|||
147565494|NCT00942968|532229947|FG000|Overall Study|Death|76|||
147565495|NCT00942968|532229947|FG000|Overall Study|Protocol Violation|9|||
147565496|NCT00942968|532229947|FG000|Overall Study|Lost to Follow-up|4|||
147565497|NCT00942968|532229947|FG000|Overall Study|Withdrawal by Subject|44|||
147565498|NCT00942968|532229947|FG000|Overall Study|Sponsor request|5|||
147565499|NCT00942968|532229947|FG000|Overall Study|Physician Decision|11|||
147565500|NCT00942968|532229947|FG000|Overall Study|Progression of disease|12|||
147565501|NCT00942968|532229947|FG000|Overall Study|Inferior vena cava filter placement|4|||
147565502|NCT00942968|532229947|FG000|Overall Study|Pulmonary embolism (PE)|1|||
147565503|NCT00942968|532229947|FG000|Overall Study|Participant required pancreatic biopsy|1|||
147565504|NCT00942968|532229947|FG000|Overall Study|Deep vein thrombosis (DVT)|2|||
147565505|NCT01340495|532229952|FG000|Overall Study|Withdrawal by Subject|1|||
147565506|NCT00070291|532229953|FG000|Step 1|Withdrawal by Subject|1|||
147565507|NCT00070291|532229953|FG000|Step 1|Adverse Event|1|||
147565508|NCT00070291|532229953|FG000|Step 2|Adverse Event|1|||
147565509|NCT02262377|532229954|FG000|Overall Study|Lost to Follow-up|5|||
147565510|NCT02262377|532229955|FG001|Overall Study|Lost to Follow-up|6|||
147565511|NCT02262377|532229954|FG000|Overall Study|Found ineligible after enrollment|3|||
147228922|NCT00598702|531011838|FG005|Overall Study|Other|1|||
147228923|NCT00598702|531011839|FG006|Overall Study|Other|0|||
147565512|NCT02262377|532229955|FG001|Overall Study|Found ineligible after enrollment|0|||
147565513|NCT02262377|532229954|FG000|Overall Study|Withdrawal by Subject|4|||
147565514|NCT02262377|532229955|FG001|Overall Study|Withdrawal by Subject|0|||
147565515|NCT01045096|532229956|FG000|Overall Study|Withdrawal by Subject|2|||
147565516|NCT01045096|532229957|FG001|Overall Study|Withdrawal by Subject|0|||
147565517|NCT01045096|532229958|FG002|Overall Study|Withdrawal by Subject|0|||
147565518|NCT01045096|532229956|FG000|Overall Study|Other|1|||
147565519|NCT01045096|532229957|FG001|Overall Study|Other|0|||
147228924|NCT00598702|531011840|FG007|Overall Study|Other|0|||
147228925|NCT00598702|531011833|FG000|Overall Study|Early discharge from hospital|0|||
147228926|NCT00598702|531011834|FG001|Overall Study|Early discharge from hospital|0|||
147228927|NCT00598702|531011835|FG002|Overall Study|Early discharge from hospital|2|||
147228928|NCT00598702|531011836|FG003|Overall Study|Early discharge from hospital|5|||
147565520|NCT01045096|532229958|FG002|Overall Study|Other|0|||
147565521|NCT01511939|532229960|FG000|Overall Study|Withdrawal by Subject|2|||
147565522|NCT01511939|532229961|FG001|Overall Study|Withdrawal by Subject|1|||
147565523|NCT01511939|532229962|FG002|Overall Study|Withdrawal by Subject|0|||
147565524|NCT03497897|532229965|FG000|Overall Study|Adverse Event|1|||
147565525|NCT03497897|532229966|FG001|Overall Study|Adverse Event|1|||
147565526|NCT03497897|532229967|FG002|Overall Study|Adverse Event|1|||
147565527|NCT03497897|532229965|FG000|Overall Study|Lost to Follow-up|2|||
147228929|NCT00598702|531011837|FG004|Overall Study|Early discharge from hospital|0|||
147565528|NCT03497897|532229966|FG001|Overall Study|Lost to Follow-up|0|||
147565529|NCT03497897|532229967|FG002|Overall Study|Lost to Follow-up|2|||
147565530|NCT03497897|532229965|FG000|Overall Study|Physician Decision|1|||
147228930|NCT00598702|531011838|FG005|Overall Study|Early discharge from hospital|10|||
147115978|NCT00160615|530588716|FG001|Overall Study|AE agents had to be discontinued (exam.)|1|||
147115979|NCT00160615|530588715|FG000|Overall Study|Switch to surgical treatment|0|||
147115980|NCT00160615|530588716|FG001|Overall Study|Switch to surgical treatment|2|||
147115981|NCT00160615|530588715|FG000|Overall Study|Non-compliance was suspected|0|||
147312195|NCT05256381|531309310|FG005|Overall Study|Withdrawal by Subject|6|||
147312196|NCT05256381|531309305|FG000|Overall Study|Physician Decision|0|||
147312197|NCT05256381|531309306|FG001|Overall Study|Physician Decision|0|||
147312198|NCT05256381|531309307|FG002|Overall Study|Physician Decision|1|||
147312199|NCT05256381|531309308|FG003|Overall Study|Physician Decision|0|||
147312200|NCT05256381|531309309|FG004|Overall Study|Physician Decision|2|||
147312201|NCT05256381|531309310|FG005|Overall Study|Physician Decision|0|||
147312202|NCT05256381|531309305|FG000|Overall Study|Death|17|||
147312203|NCT05256381|531309306|FG001|Overall Study|Death|3|||
147312204|NCT05256381|531309307|FG002|Overall Study|Death|4|||
147312205|NCT05256381|531309308|FG003|Overall Study|Death|5|||
147312206|NCT05256381|531309309|FG004|Overall Study|Death|24|||
147312207|NCT05256381|531309310|FG005|Overall Study|Death|21|||
147312208|NCT05256381|531309305|FG000|Overall Study|Other, not specified|0|||
147312209|NCT05256381|531309306|FG001|Overall Study|Other, not specified|0|||
147312210|NCT05256381|531309307|FG002|Overall Study|Other, not specified|0|||
147312211|NCT05256381|531309308|FG003|Overall Study|Other, not specified|0|||
147312212|NCT05256381|531309309|FG004|Overall Study|Other, not specified|2|||
147312213|NCT05256381|531309310|FG005|Overall Study|Other, not specified|1|||
147312214|NCT05256381|531309305|FG000|Overall Study|Study terminated by sponsor|18|||
147312215|NCT05256381|531309306|FG001|Overall Study|Study terminated by sponsor|5|||
147312216|NCT05256381|531309307|FG002|Overall Study|Study terminated by sponsor|5|||
147312217|NCT05256381|531309308|FG003|Overall Study|Study terminated by sponsor|5|||
147312218|NCT05256381|531309309|FG004|Overall Study|Study terminated by sponsor|18|||
147312219|NCT05256381|531309310|FG005|Overall Study|Study terminated by sponsor|11|||
147312220|NCT05256381|531309305|FG000|Overall Study|Lost to Follow-up|1|||
147312221|NCT05256381|531309306|FG001|Overall Study|Lost to Follow-up|0|||
147312222|NCT05256381|531309307|FG002|Overall Study|Lost to Follow-up|0|||
147312223|NCT05256381|531309308|FG003|Overall Study|Lost to Follow-up|0|||
147312224|NCT05256381|531309309|FG004|Overall Study|Lost to Follow-up|1|||
147312225|NCT05256381|531309310|FG005|Overall Study|Lost to Follow-up|0|||
147312226|NCT01702428|531310710|FG000|Overall Study|Adverse Event|2|||
147312227|NCT01702428|531310711|FG001|Overall Study|Adverse Event|0|||
147312228|NCT01702428|531310712|FG002|Overall Study|Adverse Event|0|||
147312229|NCT01702428|531310713|FG003|Overall Study|Adverse Event|0|||
147312230|NCT01702428|531310710|FG000|Overall Study|Lost to Follow-up|33|||
147312231|NCT01702428|531310711|FG001|Overall Study|Lost to Follow-up|41|||
147312232|NCT01702428|531310712|FG002|Overall Study|Lost to Follow-up|37|||
147312233|NCT01702428|531310713|FG003|Overall Study|Lost to Follow-up|44|||
147312234|NCT01702428|531310710|FG000|Overall Study|Parents cannot assist to site|1|||
147312235|NCT01702428|531310711|FG001|Overall Study|Parents cannot assist to site|0|||
147312236|NCT01702428|531310712|FG002|Overall Study|Parents cannot assist to site|1|||
147312237|NCT01702428|531310713|FG003|Overall Study|Parents cannot assist to site|0|||
147312238|NCT01702428|531310710|FG000|Overall Study|Lost Coverage|0|||
147312239|NCT01702428|531310711|FG001|Overall Study|Lost Coverage|0|||
147312240|NCT01702428|531310712|FG002|Overall Study|Lost Coverage|0|||
147312241|NCT01702428|531310713|FG003|Overall Study|Lost Coverage|1|||
147312242|NCT01702428|531310710|FG000|Overall Study|Lost Health Plan|3|||
147312243|NCT01702428|531310711|FG001|Overall Study|Lost Health Plan|5|||
147312244|NCT01702428|531310712|FG002|Overall Study|Lost Health Plan|0|||
147312245|NCT01702428|531310713|FG003|Overall Study|Lost Health Plan|2|||
147312246|NCT01702428|531310710|FG000|Overall Study|Mother transferred care|0|||
147312247|NCT01702428|531310711|FG001|Overall Study|Mother transferred care|1|||
147312248|NCT01702428|531310712|FG002|Overall Study|Mother transferred care|0|||
147444393|NCT01438489|531792587|FG000|Overall Study|Did not complete all 3 follow-up visits|2|||
147444394|NCT01438489|531792588|FG001|Overall Study|Did not complete all 3 follow-up visits|5|||
147444395|NCT01438489|531792589|FG002|Overall Study|Did not complete all 3 follow-up visits|2|||
147565531|NCT03497897|532229966|FG001|Overall Study|Physician Decision|0|||
147565532|NCT03497897|532229967|FG002|Overall Study|Physician Decision|0|||
147565533|NCT03497897|532229965|FG000|Overall Study|Subject/Guardian Decision|2|||
147565534|NCT03497897|532229966|FG001|Overall Study|Subject/Guardian Decision|1|||
147115982|NCT00160615|530588716|FG001|Overall Study|Non-compliance was suspected|1|||
147115983|NCT00160615|530588715|FG000|Overall Study|Poor compliance|0|||
147312249|NCT01702428|531310713|FG003|Overall Study|Mother transferred care|0|||
147312250|NCT01702428|531310710|FG000|Overall Study|Parents too busy|1|||
147312251|NCT01702428|531310711|FG001|Overall Study|Parents too busy|0|||
147565535|NCT03497897|532229967|FG002|Overall Study|Subject/Guardian Decision|3|||
147115984|NCT00160615|530588716|FG001|Overall Study|Poor compliance|1|||
147312252|NCT01702428|531310712|FG002|Overall Study|Parents too busy|0|||
147312253|NCT01702428|531310713|FG003|Overall Study|Parents too busy|0|||
147312254|NCT01702428|531310710|FG000|Overall Study|Protocol Violation|3|||
147312255|NCT01702428|531310711|FG001|Overall Study|Protocol Violation|0|||
147444396|NCT01438489|531792587|FG000|Overall Study|Inadequate venous access|0|||
147115985|NCT03166631|530588717|FG000|Overall Study|Progressive disease|2|||
147565536|NCT00723528|532229971|FG000|Period 1: Controlled Period (CP)|Adverse Event|0|||
147565537|NCT00723528|532229972|FG001|Period 1: Controlled Period (CP)|Adverse Event|0|||
147565538|NCT00723528|532229973|FG002|Period 1: Controlled Period (CP)|Adverse Event|1|||
147565539|NCT00723528|532229974|FG003|Period 1: Controlled Period (CP)|Adverse Event|0|||
147565540|NCT00723528|532229975|FG004|Period 1: Controlled Period (CP)|Adverse Event|0|||
147565541|NCT00723528|532229976|FG005|Period 1: Controlled Period (CP)|Adverse Event|0|||
147565542|NCT00723528|532229977|FG006|Period 1: Controlled Period (CP)|Adverse Event|0|||
147565543|NCT00723528|532229971|FG000|Period 1: Controlled Period (CP)|Withdrawal by Subject|2|||
147565544|NCT00723528|532229972|FG001|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
147565545|NCT00723528|532229973|FG002|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
147565546|NCT00723528|532229974|FG003|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
147565547|NCT00723528|532229975|FG004|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
147565548|NCT00723528|532229976|FG005|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
147565549|NCT00723528|532229977|FG006|Period 1: Controlled Period (CP)|Withdrawal by Subject|0|||
147565550|NCT00723528|532229971|FG000|Period 1: Controlled Period (CP)|Physician Decision|0|||
147565551|NCT00723528|532229972|FG001|Period 1: Controlled Period (CP)|Physician Decision|0|||
147565552|NCT00723528|532229973|FG002|Period 1: Controlled Period (CP)|Physician Decision|1|||
147565553|NCT00723528|532229974|FG003|Period 1: Controlled Period (CP)|Physician Decision|0|||
147565554|NCT00723528|532229975|FG004|Period 1: Controlled Period (CP)|Physician Decision|0|||
147565555|NCT00723528|532229976|FG005|Period 1: Controlled Period (CP)|Physician Decision|0|||
147565556|NCT00723528|532229977|FG006|Period 1: Controlled Period (CP)|Physician Decision|0|||
147565557|NCT00723528|532229971|FG000|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
147565558|NCT00723528|532229972|FG001|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
147565559|NCT00723528|532229973|FG002|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|1|||
147565560|NCT00723528|532229974|FG003|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
147565561|NCT00723528|532229975|FG004|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
147565562|NCT00723528|532229976|FG005|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
147565563|NCT00723528|532229977|FG006|Period 1: Controlled Period (CP)|Onset of Tuberculosis Infection|0|||
147565564|NCT00723528|532229971|FG000|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|2|||
147565565|NCT00723528|532229972|FG001|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0|||
147565566|NCT00723528|532229973|FG002|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|1|||
147565567|NCT00723528|532229974|FG003|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0|||
147565568|NCT00723528|532229975|FG004|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0|||
147565569|NCT00723528|532229976|FG005|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0|||
147565570|NCT00723528|532229977|FG006|Period 1: Controlled Period (CP)|Withdrawal due to worsened symptoms|0|||
147565571|NCT00723528|532229971|FG000|Period 2: After Controlled Period|Withdrawal by Subject|0|||
147565572|NCT00723528|532229972|FG001|Period 2: After Controlled Period|Withdrawal by Subject|0|||
147565573|NCT00723528|532229973|FG002|Period 2: After Controlled Period|Withdrawal by Subject|0|||
147565574|NCT00723528|532229974|FG003|Period 2: After Controlled Period|Withdrawal by Subject|1|||
147565575|NCT00723528|532229975|FG004|Period 2: After Controlled Period|Withdrawal by Subject|0|||
147565576|NCT00723528|532229976|FG005|Period 2: After Controlled Period|Withdrawal by Subject|1|||
147565577|NCT00723528|532229977|FG006|Period 2: After Controlled Period|Withdrawal by Subject|1|||
147565578|NCT00723528|532229971|FG000|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
147565579|NCT00723528|532229972|FG001|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
147565580|NCT00723528|532229973|FG002|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
147565581|NCT00723528|532229974|FG003|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
147565582|NCT00723528|532229975|FG004|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
147565583|NCT00723528|532229976|FG005|Period 2: After Controlled Period|Onset of tuberculosis infection|1|||
147565584|NCT00723528|532229977|FG006|Period 2: After Controlled Period|Onset of tuberculosis infection|0|||
147565585|NCT00723528|532229971|FG000|Period 2: After Controlled Period|Other|0|||
147565586|NCT00723528|532229972|FG001|Period 2: After Controlled Period|Other|0|||
147565587|NCT00723528|532229973|FG002|Period 2: After Controlled Period|Other|0|||
147565588|NCT00723528|532229974|FG003|Period 2: After Controlled Period|Other|0|||
147565589|NCT00723528|532229975|FG004|Period 2: After Controlled Period|Other|1|||
147565590|NCT00723528|532229976|FG005|Period 2: After Controlled Period|Other|4|||
147565591|NCT00723528|532229977|FG006|Period 2: After Controlled Period|Other|0|||
147565592|NCT00723528|532229971|FG000|Period 2: After Controlled Period|Adverse Event|0|||
147565593|NCT00723528|532229972|FG001|Period 2: After Controlled Period|Adverse Event|0|||
147565594|NCT00723528|532229973|FG002|Period 2: After Controlled Period|Adverse Event|0|||
147565595|NCT00723528|532229974|FG003|Period 2: After Controlled Period|Adverse Event|0|||
147565596|NCT00723528|532229975|FG004|Period 2: After Controlled Period|Adverse Event|1|||
147565597|NCT00723528|532229976|FG005|Period 2: After Controlled Period|Adverse Event|0|||
147565598|NCT00723528|532229977|FG006|Period 2: After Controlled Period|Adverse Event|1|||
147115986|NCT03166631|530588718|FG001|Overall Study|Progressive disease|1|||
147115987|NCT03166631|530588719|FG002|Overall Study|Progressive disease|3|||
147565599|NCT00723528|532229971|FG000|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
147565600|NCT00723528|532229972|FG001|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
147565601|NCT00723528|532229973|FG002|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
147565602|NCT00723528|532229974|FG003|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
147565603|NCT00723528|532229975|FG004|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
147565604|NCT00723528|532229976|FG005|Period 2: After Controlled Period|Use of prohibited concomitant medication|0|||
147565605|NCT00723528|532229977|FG006|Period 2: After Controlled Period|Use of prohibited concomitant medication|1|||
147565606|NCT00723528|532229971|FG000|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
147565607|NCT00723528|532229972|FG001|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
147565608|NCT00723528|532229973|FG002|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
147565609|NCT00723528|532229974|FG003|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
147565610|NCT00723528|532229975|FG004|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
147565611|NCT00723528|532229976|FG005|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|0|||
147565612|NCT00723528|532229977|FG006|Period 2: After Controlled Period|Withdrawal due to worsened symptoms|1|||
147565613|NCT01591785|532229982|FG000|Overall Study|worsening condition|1|||
147565614|NCT01591785|532229983|FG001|Overall Study|worsening condition|2|||
147565615|NCT01591785|532229982|FG000|Overall Study|Protocol Violation|2|||
147565616|NCT01591785|532229983|FG001|Overall Study|Protocol Violation|0|||
147565617|NCT01591785|532229982|FG000|Overall Study|Lost to Follow-up|1|||
147565618|NCT01591785|532229983|FG001|Overall Study|Lost to Follow-up|0|||
147565619|NCT00667862|532229984|FG000|Overall Study|Adverse Event|9|||
147565620|NCT00667862|532229984|FG000|Overall Study|Death|1|||
147565621|NCT00667862|532229984|FG000|Overall Study|Disease Progression|22|||
147565622|NCT00667862|532229984|FG000|Overall Study|Withdrawal by Subject|3|||
147565623|NCT02495857|532229991|FG000|Overall Study|Adverse Event|5|||
147565624|NCT02495857|532229992|FG001|Overall Study|Adverse Event|0|||
147565625|NCT02495857|532229993|FG002|Overall Study|Adverse Event|1|||
147565626|NCT02495857|532229991|FG000|Overall Study|Withdrawal by Subject|9|||
147565627|NCT02495857|532229992|FG001|Overall Study|Withdrawal by Subject|6|||
147565628|NCT02495857|532229993|FG002|Overall Study|Withdrawal by Subject|10|||
147565629|NCT02495857|532229991|FG000|Overall Study|Physician Decision|0|||
147565630|NCT02495857|532229992|FG001|Overall Study|Physician Decision|1|||
147565631|NCT02495857|532229993|FG002|Overall Study|Physician Decision|0|||
147565632|NCT02495857|532229991|FG000|Overall Study|Protocol Violation|1|||
147565633|NCT02495857|532229992|FG001|Overall Study|Protocol Violation|1|||
147565634|NCT02495857|532229993|FG002|Overall Study|Protocol Violation|2|||
147565635|NCT02495857|532229991|FG000|Overall Study|Lost to Follow-up|4|||
147565636|NCT02495857|532229992|FG001|Overall Study|Lost to Follow-up|5|||
147565637|NCT02495857|532229993|FG002|Overall Study|Lost to Follow-up|3|||
147565638|NCT02495857|532229991|FG000|Overall Study|Other|3|||
147565639|NCT02495857|532229992|FG001|Overall Study|Other|3|||
147565640|NCT02495857|532229993|FG002|Overall Study|Other|2|||
147565641|NCT02883452|532229995|FG000|Overall Study|Withdrawal by Subject|1|||
147565642|NCT02883452|532229996|FG001|Overall Study|Withdrawal by Subject|1|||
147565643|NCT02883452|532229997|FG002|Overall Study|Withdrawal by Subject|3|||
147565644|NCT02883452|532229998|FG003|Overall Study|Withdrawal by Subject|0|||
147565645|NCT02883452|532229999|FG004|Overall Study|Withdrawal by Subject|2|||
147565646|NCT02883452|532230000|FG005|Overall Study|Withdrawal by Subject|5|||
147565647|NCT02883452|532229995|FG000|Overall Study|Disease progression|1|||
147565648|NCT02883452|532229996|FG001|Overall Study|Disease progression|0|||
147565649|NCT02883452|532229997|FG002|Overall Study|Disease progression|0|||
147565650|NCT02883452|532229998|FG003|Overall Study|Disease progression|1|||
147565651|NCT02883452|532229999|FG004|Overall Study|Disease progression|4|||
147565652|NCT02883452|532230000|FG005|Overall Study|Disease progression|5|||
147565653|NCT02883452|532229995|FG000|Overall Study|Adverse Event|2|||
147565654|NCT02883452|532229996|FG001|Overall Study|Adverse Event|1|||
147565655|NCT02883452|532229997|FG002|Overall Study|Adverse Event|1|||
147115988|NCT03166631|530588720|FG003|Overall Study|Progressive disease|4|||
147115989|NCT03166631|530588721|FG004|Overall Study|Progressive disease|2|||
147115990|NCT03166631|530588722|FG005|Overall Study|Progressive disease|2|||
147115991|NCT03166631|530588723|FG006|Overall Study|Progressive disease|5|||
147115992|NCT03166631|530588724|FG007|Overall Study|Progressive disease|6|||
147115993|NCT03166631|530588725|FG008|Overall Study|Progressive disease|11|||
147115994|NCT03166631|530588726|FG009|Overall Study|Progressive disease|5|||
147565656|NCT02883452|532229998|FG003|Overall Study|Adverse Event|1|||
147565657|NCT02883452|532229999|FG004|Overall Study|Adverse Event|1|||
147565658|NCT02883452|532230000|FG005|Overall Study|Adverse Event|3|||
147565659|NCT02883452|532229995|FG000|Overall Study|Physician Decision|0|||
147565660|NCT02883452|532229996|FG001|Overall Study|Physician Decision|0|||
147565661|NCT02883452|532229997|FG002|Overall Study|Physician Decision|0|||
147565662|NCT02883452|532229998|FG003|Overall Study|Physician Decision|0|||
147565663|NCT02883452|532229999|FG004|Overall Study|Physician Decision|4|||
147115995|NCT03166631|530588727|FG010|Overall Study|Progressive disease|7|||
147115996|NCT03166631|530588717|FG000|Overall Study|Physician Decision|0|||
147228931|NCT00598702|531011839|FG006|Overall Study|Early discharge from hospital|1|||
147228932|NCT00598702|531011840|FG007|Overall Study|Early discharge from hospital|0|||
147228933|NCT00598702|531011833|FG000|Overall Study|Adverse Event|0|||
147228934|NCT00598702|531011834|FG001|Overall Study|Adverse Event|0|||
147228935|NCT00598702|531011835|FG002|Overall Study|Adverse Event|0|||
147312256|NCT01702428|531310712|FG002|Overall Study|Protocol Violation|1|||
147312257|NCT01702428|531310713|FG003|Overall Study|Protocol Violation|0|||
147312258|NCT01702428|531310710|FG000|Overall Study|Withdrawal by Subject|21|||
147312259|NCT01702428|531310711|FG001|Overall Study|Withdrawal by Subject|23|||
147312260|NCT01702428|531310712|FG002|Overall Study|Withdrawal by Subject|14|||
147312261|NCT01702428|531310713|FG003|Overall Study|Withdrawal by Subject|10|||
147312262|NCT02091869|531310716|FG000|Overall Study|Withdrawal by Subject|0|||
147312263|NCT02091869|531310717|FG001|Overall Study|Withdrawal by Subject|3|||
147312264|NCT01533714|531310718|FG000|Overall Study|Adverse Event|0|||
147312265|NCT01533714|531310719|FG001|Overall Study|Adverse Event|1|||
147312266|NCT01533714|531310720|FG002|Overall Study|Adverse Event|2|||
147312267|NCT01533714|531310721|FG003|Overall Study|Adverse Event|2|||
147312268|NCT01533714|531310722|FG004|Overall Study|Adverse Event|2|||
147312269|NCT01533714|531310723|FG005|Overall Study|Adverse Event|1|||
147312270|NCT01533714|531310718|FG000|Overall Study|Lack of Efficacy|0|||
147312271|NCT01533714|531310719|FG001|Overall Study|Lack of Efficacy|0|||
147312272|NCT01533714|531310720|FG002|Overall Study|Lack of Efficacy|0|||
147312273|NCT01533714|531310721|FG003|Overall Study|Lack of Efficacy|0|||
147312274|NCT01533714|531310722|FG004|Overall Study|Lack of Efficacy|0|||
147312275|NCT01533714|531310723|FG005|Overall Study|Lack of Efficacy|1|||
147312276|NCT01533714|531310718|FG000|Overall Study|Withdrawal by Subject|0|||
147312277|NCT01533714|531310719|FG001|Overall Study|Withdrawal by Subject|1|||
147312278|NCT01533714|531310720|FG002|Overall Study|Withdrawal by Subject|0|||
147312279|NCT01533714|531310721|FG003|Overall Study|Withdrawal by Subject|1|||
147565664|NCT02883452|532230000|FG005|Overall Study|Physician Decision|1|||
147115997|NCT03166631|530588718|FG001|Overall Study|Physician Decision|0|||
147115998|NCT03166631|530588719|FG002|Overall Study|Physician Decision|0|||
147115999|NCT03166631|530588720|FG003|Overall Study|Physician Decision|0|||
147116000|NCT03166631|530588721|FG004|Overall Study|Physician Decision|0|||
147116001|NCT03166631|530588722|FG005|Overall Study|Physician Decision|0|||
147116002|NCT03166631|530588723|FG006|Overall Study|Physician Decision|1|||
147116003|NCT03166631|530588724|FG007|Overall Study|Physician Decision|0|||
147116004|NCT03166631|530588725|FG008|Overall Study|Physician Decision|1|||
147116005|NCT03166631|530588726|FG009|Overall Study|Physician Decision|0|||
147116006|NCT03166631|530588727|FG010|Overall Study|Physician Decision|1|||
147116007|NCT03166631|530588717|FG000|Overall Study|Death|0|||
147116008|NCT03166631|530588718|FG001|Overall Study|Death|0|||
147228936|NCT00598702|531011836|FG003|Overall Study|Adverse Event|1|||
147228937|NCT00598702|531011837|FG004|Overall Study|Adverse Event|0|||
147228938|NCT00598702|531011838|FG005|Overall Study|Adverse Event|0|||
147228939|NCT00598702|531011839|FG006|Overall Study|Adverse Event|0|||
147228940|NCT00598702|531011840|FG007|Overall Study|Adverse Event|0|||
147228941|NCT00598702|531011833|FG000|Overall Study|Withdrawal by Subject|0|||
147228942|NCT00598702|531011834|FG001|Overall Study|Withdrawal by Subject|0|||
147228943|NCT00598702|531011835|FG002|Overall Study|Withdrawal by Subject|0|||
147228944|NCT00598702|531011836|FG003|Overall Study|Withdrawal by Subject|1|||
147228945|NCT00598702|531011837|FG004|Overall Study|Withdrawal by Subject|1|||
147228946|NCT00598702|531011838|FG005|Overall Study|Withdrawal by Subject|0|||
147228947|NCT00598702|531011839|FG006|Overall Study|Withdrawal by Subject|0|||
147228948|NCT00598702|531011840|FG007|Overall Study|Withdrawal by Subject|0|||
147312280|NCT01533714|531310722|FG004|Overall Study|Withdrawal by Subject|1|||
147312281|NCT01533714|531310723|FG005|Overall Study|Withdrawal by Subject|0|||
147312282|NCT01533714|531310718|FG000|Overall Study|Exclusion criteria|0|||
147444397|NCT01438489|531792588|FG001|Overall Study|Inadequate venous access|2|||
147444398|NCT01438489|531792589|FG002|Overall Study|Inadequate venous access|0|||
147444399|NCT00766532|531792590|FG000|Overall Study|Protocol Violation|2|||
147444400|NCT01372384|531792597|FG000|Overall Study|Progression of disease|3|||
147444401|NCT01923285|531792601|FG000|Overall Study|Withdrawal by Subject|7|||
147565665|NCT02883452|532229995|FG000|Overall Study|Death|1|||
147565666|NCT02883452|532229996|FG001|Overall Study|Death|0|||
147116009|NCT03166631|530588719|FG002|Overall Study|Death|0|||
147116010|NCT03166631|530588720|FG003|Overall Study|Death|0|||
147116011|NCT03166631|530588721|FG004|Overall Study|Death|1|||
147228949|NCT00598702|531011833|FG000|Overall Study|Physician Decision|0|||
147228950|NCT00598702|531011834|FG001|Overall Study|Physician Decision|0|||
147228951|NCT00598702|531011835|FG002|Overall Study|Physician Decision|0|||
147312283|NCT01533714|531310719|FG001|Overall Study|Exclusion criteria|1|||
147312284|NCT01533714|531310720|FG002|Overall Study|Exclusion criteria|0|||
147312285|NCT01533714|531310721|FG003|Overall Study|Exclusion criteria|0|||
147116012|NCT03166631|530588722|FG005|Overall Study|Death|0|||
147116013|NCT03166631|530588723|FG006|Overall Study|Death|1|||
147116014|NCT03166631|530588724|FG007|Overall Study|Death|0|||
147116015|NCT03166631|530588725|FG008|Overall Study|Death|0|||
147228952|NCT00598702|531011836|FG003|Overall Study|Physician Decision|0|||
147444402|NCT01923285|531792602|FG001|Overall Study|Withdrawal by Subject|6|||
147444403|NCT03374189|531792603|FG000|Overall Study|Lost to Follow-up|1|||
147444404|NCT03374189|531792604|FG001|Overall Study|Lost to Follow-up|0|||
147444405|NCT03962101|531792605|FG000|Overall Study|Adverse Event|1|||
147444406|NCT03962101|531792605|FG000|Overall Study|Physician Decision|2|||
147444407|NCT03962101|531792605|FG000|Overall Study|Not related to medical events|1|||
147444408|NCT03699007|531792606|FG000|Treatment Phase (Baseline to 3-Month FU)|Physician Decision|7|||
147444409|NCT03699007|531792607|FG001|Treatment Phase (Baseline to 3-Month FU)|Physician Decision|2|||
147444410|NCT03699007|531792606|FG000|6-month Follow Up|Lost to Follow-up|2|||
147444411|NCT03699007|531792607|FG001|6-month Follow Up|Lost to Follow-up|3|||
147444412|NCT00843518|531792608|FG000|Period 2 (Double-blind Treatment)|Adverse Event|5|||
147444413|NCT00843518|531792609|FG001|Period 2 (Double-blind Treatment)|Adverse Event|3|||
147444414|NCT00843518|531792608|FG000|Period 2 (Double-blind Treatment)|Death|0|||
147444415|NCT00843518|531792609|FG001|Period 2 (Double-blind Treatment)|Death|1|||
147444416|NCT00843518|531792608|FG000|Period 2 (Double-blind Treatment)|Lost to Follow-up|2|||
147444417|NCT00843518|531792609|FG001|Period 2 (Double-blind Treatment)|Lost to Follow-up|3|||
147444418|NCT00843518|531792608|FG000|Period 2 (Double-blind Treatment)|Physician Decision|2|||
147444419|NCT00843518|531792609|FG001|Period 2 (Double-blind Treatment)|Physician Decision|1|||
147444420|NCT00843518|531792608|FG000|Period 2 (Double-blind Treatment)|Protocol Violation|2|||
147444421|NCT00843518|531792609|FG001|Period 2 (Double-blind Treatment)|Protocol Violation|5|||
147116016|NCT03166631|530588726|FG009|Overall Study|Death|0|||
147116017|NCT03166631|530588727|FG010|Overall Study|Death|0|||
147116018|NCT03166631|530588717|FG000|Overall Study|Adverse Event|1|||
147228953|NCT00598702|531011837|FG004|Overall Study|Physician Decision|1|||
147228954|NCT00598702|531011838|FG005|Overall Study|Physician Decision|0|||
147228955|NCT00598702|531011839|FG006|Overall Study|Physician Decision|0|||
147228956|NCT00598702|531011840|FG007|Overall Study|Physician Decision|0|||
147228957|NCT00598702|531011833|FG000|Overall Study|Dose limiting toxicity|0|||
147228958|NCT00598702|531011834|FG001|Overall Study|Dose limiting toxicity|0|||
147228959|NCT00598702|531011835|FG002|Overall Study|Dose limiting toxicity|0|||
147228960|NCT00598702|531011836|FG003|Overall Study|Dose limiting toxicity|1|||
147228961|NCT00598702|531011837|FG004|Overall Study|Dose limiting toxicity|1|||
147228962|NCT00598702|531011838|FG005|Overall Study|Dose limiting toxicity|1|||
147228963|NCT00598702|531011839|FG006|Overall Study|Dose limiting toxicity|0|||
147228964|NCT00598702|531011840|FG007|Overall Study|Dose limiting toxicity|0|||
147228965|NCT02600351|531011841|FG000|Overall Study|Lack of Efficacy|3|||
147228966|NCT02600351|531011842|FG001|Overall Study|Lack of Efficacy|0|||
147228967|NCT02600351|531011843|FG002|Overall Study|Lack of Efficacy|5|||
147228968|NCT02600351|531011844|FG003|Overall Study|Lack of Efficacy|2|||
147228969|NCT02600351|531011841|FG000|Overall Study|Lost to Follow-up|1|||
147228970|NCT02600351|531011842|FG001|Overall Study|Lost to Follow-up|0|||
147228971|NCT02600351|531011843|FG002|Overall Study|Lost to Follow-up|0|||
147228972|NCT02600351|531011844|FG003|Overall Study|Lost to Follow-up|0|||
147228973|NCT02600351|531011841|FG000|Overall Study|Randomized but Not Treated|1|||
147228974|NCT02600351|531011842|FG001|Overall Study|Randomized but Not Treated|0|||
147228975|NCT02600351|531011843|FG002|Overall Study|Randomized but Not Treated|1|||
147228976|NCT02600351|531011844|FG003|Overall Study|Randomized but Not Treated|3|||
147228977|NCT00567593|531011847|FG000|Overall Study|Adverse Event|1|||
147228978|NCT00567593|531011847|FG000|Overall Study|Physician Decision|1|||
147228979|NCT02106910|531011848|FG000|Overall Study|Lost to Follow-up|1|||
147228980|NCT02106910|531011849|FG001|Overall Study|Lost to Follow-up|1|||
147228981|NCT00700570|531011850|FG000|Overall Study|Adverse Event|2|||
147228982|NCT00700570|531011851|FG001|Overall Study|Adverse Event|6|||
147228983|NCT00700570|531011850|FG000|Overall Study|Discretion of Investigator or Sponsor|0|||
147228984|NCT00700570|531011851|FG001|Overall Study|Discretion of Investigator or Sponsor|3|||
147116019|NCT03166631|530588718|FG001|Overall Study|Adverse Event|0|||
147116020|NCT03166631|530588719|FG002|Overall Study|Adverse Event|0|||
147116021|NCT03166631|530588720|FG003|Overall Study|Adverse Event|0|||
147116022|NCT03166631|530588721|FG004|Overall Study|Adverse Event|0|||
147116023|NCT03166631|530588722|FG005|Overall Study|Adverse Event|1|||
147116024|NCT03166631|530588723|FG006|Overall Study|Adverse Event|1|||
147116025|NCT03166631|530588724|FG007|Overall Study|Adverse Event|0|||
147116026|NCT03166631|530588725|FG008|Overall Study|Adverse Event|1|||
147116027|NCT03166631|530588726|FG009|Overall Study|Adverse Event|2|||
147116028|NCT03166631|530588727|FG010|Overall Study|Adverse Event|1|||
147116029|NCT03166631|530588717|FG000|Overall Study|Withdrawal by Subject|0|||
147116030|NCT03166631|530588718|FG001|Overall Study|Withdrawal by Subject|0|||
147228985|NCT00700570|531011850|FG000|Overall Study|Disease Progression|8|||
147228986|NCT00700570|531011851|FG001|Overall Study|Disease Progression|11|||
147444422|NCT00843518|531792608|FG000|Period 2 (Double-blind Treatment)|Withdrawal by Subject|2|||
147444423|NCT00843518|531792609|FG001|Period 2 (Double-blind Treatment)|Withdrawal by Subject|0|||
147444424|NCT00843518|531792608|FG000|Period 2 (Double-blind Treatment)|Caregiver decision|7|||
147116031|NCT03166631|530588719|FG002|Overall Study|Withdrawal by Subject|0|||
147116032|NCT03166631|530588720|FG003|Overall Study|Withdrawal by Subject|0|||
147116033|NCT03166631|530588721|FG004|Overall Study|Withdrawal by Subject|0|||
147116034|NCT03166631|530588722|FG005|Overall Study|Withdrawal by Subject|0|||
147228987|NCT00700570|531011850|FG000|Overall Study|Withdrawal by Subject|1|||
147565667|NCT02883452|532229997|FG002|Overall Study|Death|1|||
147565668|NCT02883452|532229998|FG003|Overall Study|Death|0|||
147565669|NCT02883452|532229999|FG004|Overall Study|Death|0|||
147565670|NCT02883452|532230000|FG005|Overall Study|Death|0|||
147565671|NCT02883452|532229995|FG000|Overall Study|Other|0|||
147565672|NCT02883452|532229996|FG001|Overall Study|Other|0|||
147565673|NCT02883452|532229997|FG002|Overall Study|Other|0|||
147565674|NCT02883452|532229998|FG003|Overall Study|Other|0|||
147565675|NCT02883452|532229999|FG004|Overall Study|Other|0|||
147565676|NCT02883452|532230000|FG005|Overall Study|Other|1|||
147565677|NCT00667095|532230010|FG000|Overall Study|Withdrawal by Subject|0|||
147565678|NCT00667095|532230011|FG001|Overall Study|Withdrawal by Subject|1|||
147565679|NCT01520909|532230012|FG000|Part 1 (Randomized Period)|Adverse Event|1|||
147565680|NCT01520909|532230013|FG001|Part 1 (Randomized Period)|Adverse Event|2|||
147565681|NCT01520909|532230014|FG002|Part 1 (Randomized Period)|Adverse Event|0|||
147565682|NCT01520909|532230012|FG000|Part 2 (Open-Label Period)-Eltrombopag|Adverse Event|0|||
147565683|NCT01520909|532230013|FG001|Part 2 (Open-Label Period)-Eltrombopag|Adverse Event|0|||
147565684|NCT01520909|532230014|FG002|Part 2 (Open-Label Period)-Eltrombopag|Adverse Event|4|||
147565685|NCT01520909|532230012|FG000|Part 2 (Open-Label Period)-Eltrombopag|Lack of Efficacy|0|||
147116035|NCT03166631|530588723|FG006|Overall Study|Withdrawal by Subject|0|||
147116036|NCT03166631|530588724|FG007|Overall Study|Withdrawal by Subject|0|||
147116037|NCT03166631|530588725|FG008|Overall Study|Withdrawal by Subject|1|||
147116038|NCT03166631|530588726|FG009|Overall Study|Withdrawal by Subject|1|||
147116039|NCT03166631|530588727|FG010|Overall Study|Withdrawal by Subject|0|||
147565686|NCT01520909|532230013|FG001|Part 2 (Open-Label Period)-Eltrombopag|Lack of Efficacy|0|||
147565687|NCT01520909|532230014|FG002|Part 2 (Open-Label Period)-Eltrombopag|Lack of Efficacy|2|||
147565688|NCT01520909|532230012|FG000|Part 2 (Open-Label Period)-Eltrombopag|Withdrawal by parent or guardian|0|||
147565689|NCT01520909|532230013|FG001|Part 2 (Open-Label Period)-Eltrombopag|Withdrawal by parent or guardian|0|||
147565690|NCT01520909|532230014|FG002|Part 2 (Open-Label Period)-Eltrombopag|Withdrawal by parent or guardian|1|||
147565691|NCT01882257|532230016|FG000|Study Origination to Beginning Therapy|Withdrawal by Subject|0|||
147565692|NCT01882257|532230017|FG001|Study Origination to Beginning Therapy|Withdrawal by Subject|2|||
147565693|NCT01882257|532230018|FG002|Study Origination to Beginning Therapy|Withdrawal by Subject|1|||
147565694|NCT01882257|532230016|FG000|Therapy Portion of Study (12 Months)|Withdrawal by Subject|0|||
147565695|NCT01882257|532230017|FG001|Therapy Portion of Study (12 Months)|Withdrawal by Subject|11|||
147565696|NCT01882257|532230018|FG002|Therapy Portion of Study (12 Months)|Withdrawal by Subject|4|||
147565697|NCT00830206|532230019|FG000|Washout: 21 Days|Withdrawal by Subject|1|||
147565698|NCT00830206|532230020|FG001|Washout: 21 Days|Withdrawal by Subject|1|||
147565699|NCT00905346|532230027|FG000|Period 1|Withdrawal by Subject|1|||
147565700|NCT00905346|532230028|FG001|Period 1|Withdrawal by Subject|0|||
147565701|NCT01435265|532230029|FG000|Overall Study|Lost to Follow-up|0|||
147565702|NCT01435265|532230030|FG001|Overall Study|Lost to Follow-up|1|||
147565703|NCT00909610|532230033|FG000|Period: First Intervention|Adverse Event|0|||
147565704|NCT00909610|532230034|FG001|Period: First Intervention|Adverse Event|1|||
147565705|NCT00909610|532230033|FG000|Period: Washout of 28 Days|Withdrawal by Subject|3|||
147565706|NCT00909610|532230034|FG001|Period: Washout of 28 Days|Withdrawal by Subject|6|||
147565707|NCT00909610|532230033|FG000|Period: Second Intervention|Adverse Event|1|||
147565708|NCT00909610|532230034|FG001|Period: Second Intervention|Adverse Event|0|||
147565709|NCT04123548|532230038|FG000|Overall Study|Withdrawal by Subject|1|||
147565710|NCT04123548|532230038|FG000|Overall Study|Lost to Follow-up|8|||
147565711|NCT04123548|532230038|FG000|Overall Study|Death|4|||
147565712|NCT04123548|532230038|FG000|Overall Study|Reason Not Specified|1|||
147565713|NCT04166630|532230040|FG000|Overall Study|Withdrawal by Subject|0|||
147565714|NCT04166630|532230041|FG001|Overall Study|Withdrawal by Subject|1|||
147565715|NCT03107091|532230042|FG000|Overall Study|Physician Decision|1|||
147565716|NCT00105196|532230047|FG000|Overall Study|Lack of Efficacy|2|||
147565717|NCT00105196|532230048|FG001|Overall Study|Lack of Efficacy|3|||
147565718|NCT00105196|532230047|FG000|Overall Study|Adverse Event|11|||
147565719|NCT00105196|532230048|FG001|Overall Study|Adverse Event|3|||
147565720|NCT00105196|532230047|FG000|Overall Study|Withdrawal by Subject|6|||
147565721|NCT00105196|532230048|FG001|Overall Study|Withdrawal by Subject|6|||
147565722|NCT00105196|532230047|FG000|Overall Study|Lost to Follow-up|3|||
147116040|NCT03787212|530588731|FG000|Period 1|Study Termination|2|||
147116041|NCT03787212|530588732|FG001|Period 1|Study Termination|2|||
147565723|NCT00105196|532230048|FG001|Overall Study|Lost to Follow-up|2|||
147565724|NCT00105196|532230047|FG000|Overall Study|Poor/noncompliance|3|||
147565725|NCT00105196|532230048|FG001|Overall Study|Poor/noncompliance|4|||
147565726|NCT00105196|532230047|FG000|Overall Study|Protocol Violation|5|||
147116042|NCT02014103|530588733|FG000|Overall Study|Protocol Violation|7|||
147312286|NCT01533714|531310722|FG004|Overall Study|Exclusion criteria|0|||
147565727|NCT00105196|532230048|FG001|Overall Study|Protocol Violation|2|||
147565728|NCT00105196|532230047|FG000|Overall Study|pending surgery|0|||
147116043|NCT02014103|530588734|FG001|Overall Study|Protocol Violation|7|||
147312287|NCT01533714|531310723|FG005|Overall Study|Exclusion criteria|0|||
147116044|NCT02014103|530588733|FG000|Overall Study|Adverse Event|1|||
147116045|NCT02014103|530588734|FG001|Overall Study|Adverse Event|0|||
147116046|NCT02014103|530588733|FG000|Overall Study|Lost venous access|1|||
147116047|NCT02014103|530588734|FG001|Overall Study|Lost venous access|0|||
147116048|NCT02014103|530588733|FG000|Overall Study|Withdrawal by Subject|0|||
147116049|NCT02014103|530588734|FG001|Overall Study|Withdrawal by Subject|2|||
147228988|NCT00700570|531011851|FG001|Overall Study|Withdrawal by Subject|6|||
147228989|NCT00267189|531011859|FG000|Overall Study|Patient withdrew consent|1|||
147228990|NCT00267189|531011860|FG001|Overall Study|Patient withdrew consent|1|||
147228991|NCT00267189|531011859|FG000|Overall Study|Death|1|||
147228992|NCT00267189|531011860|FG001|Overall Study|Death|0|||
147228993|NCT00267189|531011859|FG000|Overall Study|Missing|3|||
147228994|NCT00267189|531011860|FG001|Overall Study|Missing|0|||
147228995|NCT04137224|531011864|FG000|Treatment Period 1 (Week 1 to Week 16)|Adverse Event|1|||
147228996|NCT04137224|531011865|FG001|Treatment Period 1 (Week 1 to Week 16)|Adverse Event|0|||
147228997|NCT04137224|531011864|FG000|Treatment Period 1 (Week 1 to Week 16)|Withdrawal by Subject|0|||
147228998|NCT04137224|531011865|FG001|Treatment Period 1 (Week 1 to Week 16)|Withdrawal by Subject|1|||
147228999|NCT04137224|531011864|FG000|Treatment Period 2 (Week 17 to Week 32)|Adverse Event|0|||
147229000|NCT04137224|531011865|FG001|Treatment Period 2 (Week 17 to Week 32)|Adverse Event|1|||
147229001|NCT01225887|531011866|FG000|Overall Study|Ineligible:required test not done|2|||
147229002|NCT01225887|531011866|FG000|Overall Study|Ineligible;improper pre-protocol therapy|1|||
147229003|NCT01225887|531011866|FG000|Overall Study|Ineligible:inadequate pathology|2|||
147229004|NCT00566501|531011867|FG000|Overall Study|Adverse Event|68|||
147229005|NCT00566501|531011868|FG001|Overall Study|Adverse Event|59|||
147229006|NCT00566501|531011867|FG000|Overall Study|Medication Non-compliance|5|||
147229007|NCT00566501|531011868|FG001|Overall Study|Medication Non-compliance|0|||
147229008|NCT00566501|531011867|FG000|Overall Study|Protocol Violation|2|||
147229009|NCT00566501|531011868|FG001|Overall Study|Protocol Violation|2|||
147229010|NCT00566501|531011867|FG000|Overall Study|Request of Investigator or Sponsor|6|||
147229011|NCT00566501|531011868|FG001|Overall Study|Request of Investigator or Sponsor|7|||
147229012|NCT00566501|531011867|FG000|Overall Study|Withdrawal by Subject|33|||
147229013|NCT00566501|531011868|FG001|Overall Study|Withdrawal by Subject|30|||
147229014|NCT00566501|531011867|FG000|Overall Study|Lack of Efficacy|8|||
147229015|NCT00566501|531011868|FG001|Overall Study|Lack of Efficacy|3|||
147229016|NCT00566501|531011867|FG000|Overall Study|Other|25|||
147229017|NCT00566501|531011868|FG001|Overall Study|Other|21|||
147229018|NCT00925990|531011869|FG000|Overall Study|Adverse Event|1|||
147229019|NCT00925990|531011870|FG001|Overall Study|Adverse Event|3|||
147229020|NCT00925990|531011869|FG000|Overall Study|Withdrawal by Subject|2|||
147229021|NCT00925990|531011870|FG001|Overall Study|Withdrawal by Subject|2|||
147229022|NCT00925990|531011869|FG000|Overall Study|Lost to Follow-up|1|||
147229023|NCT00925990|531011870|FG001|Overall Study|Lost to Follow-up|3|||
147229024|NCT00925990|531011869|FG000|Overall Study|Physician Decision|1|||
147229025|NCT00925990|531011870|FG001|Overall Study|Physician Decision|1|||
147229026|NCT00925990|531011869|FG000|Overall Study|moved out of state, missed medication|0|||
147229027|NCT00925990|531011870|FG001|Overall Study|moved out of state, missed medication|2|||
147229028|NCT01368432|531011875|FG000|Overall Study|Lost to Follow-up|0|||
147229029|NCT01368432|531011876|FG001|Overall Study|Lost to Follow-up|1|||
147116050|NCT05638737|530588735|FG000|Overall Study|Withdrawal by Subject|4|||
147116051|NCT05638737|530588736|FG001|Overall Study|Withdrawal by Subject|7|||
147116052|NCT00567580|530588737|FG000|Overall Study|Protocol Violation|28|||
147116053|NCT00567580|530588738|FG001|Overall Study|Protocol Violation|24|||
147116054|NCT00567580|530588739|FG002|Overall Study|Protocol Violation|24|||
147116055|NCT03022630|530588741|FG000|Overall Study|Death|9|||
147116056|NCT03022630|530588742|FG001|Overall Study|Death|7|||
147116057|NCT03022630|530588741|FG000|Overall Study|Withdrawal by Subject|0|||
147116058|NCT03022630|530588742|FG001|Overall Study|Withdrawal by Subject|5|||
147116059|NCT00884949|530588743|FG000|Weeks 1-12: 0.1 mg/kg/Week|Adverse Event|1|||
147116060|NCT00884949|530588743|FG000|Weeks 1-12: 0.1 mg/kg/Week|Withdrawal by Subject|1|||
147116061|NCT00382070|530588744|FG000|Overall Study|No follow up data mapped to Other|17|||
147116062|NCT00382070|530588745|FG001|Overall Study|No follow up data mapped to Other|19|||
147116063|NCT00382070|530588744|FG000|Overall Study|Patient not at risk for primary endpoint mapped to Other|7|||
147116064|NCT00382070|530588745|FG001|Overall Study|Patient not at risk for primary endpoint mapped to Other|0|||
147116065|NCT00382070|530588744|FG000|Overall Study|No clinical assessment|9|||
147116066|NCT00382070|530588745|FG001|Overall Study|No clinical assessment|11|||
147116067|NCT03422718|530588746|FG000|12 Month Interventional Trial Period|Lost to Follow-up|26|||
147116068|NCT03422718|530588747|FG001|12 Month Interventional Trial Period|Lost to Follow-up|16|||
147116069|NCT03422718|530588748|FG002|12 Month Interventional Trial Period|Lost to Follow-up|23|||
147116070|NCT03422718|530588749|FG003|12 Month Interventional Trial Period|Lost to Follow-up|27|||
147116071|NCT03422718|530588750|FG004|12 Month Interventional Trial Period|Lost to Follow-up|21|||
147116072|NCT03422718|530588751|FG005|12 Month Interventional Trial Period|Lost to Follow-up|22|||
147116073|NCT03422718|530588752|FG006|12 Month Interventional Trial Period|Lost to Follow-up|36|||
147116074|NCT03422718|530588753|FG007|12 Month Interventional Trial Period|Lost to Follow-up|25|||
147116075|NCT03422718|530588746|FG000|12 Month Interventional Trial Period|Withdrawal by Subject|11|||
147116076|NCT03422718|530588747|FG001|12 Month Interventional Trial Period|Withdrawal by Subject|13|||
147312288|NCT01533714|531310718|FG000|Overall Study|Positive for purified protein derivative|0|||
147312289|NCT01533714|531310719|FG001|Overall Study|Positive for purified protein derivative|0|||
147312290|NCT01533714|531310720|FG002|Overall Study|Positive for purified protein derivative|1|||
147312291|NCT01533714|531310721|FG003|Overall Study|Positive for purified protein derivative|0|||
147312292|NCT01533714|531310722|FG004|Overall Study|Positive for purified protein derivative|1|||
147312293|NCT01533714|531310723|FG005|Overall Study|Positive for purified protein derivative|0|||
147312294|NCT01533714|531310718|FG000|Overall Study|Withdrawal criteria|0|||
147312295|NCT01533714|531310719|FG001|Overall Study|Withdrawal criteria|0|||
147312296|NCT01533714|531310720|FG002|Overall Study|Withdrawal criteria|1|||
147312297|NCT01533714|531310721|FG003|Overall Study|Withdrawal criteria|0|||
147312298|NCT01533714|531310722|FG004|Overall Study|Withdrawal criteria|3|||
147312299|NCT01533714|531310723|FG005|Overall Study|Withdrawal criteria|1|||
147312300|NCT01533714|531310718|FG000|Overall Study|Ineligibility reason|0|||
147312301|NCT01533714|531310719|FG001|Overall Study|Ineligibility reason|0|||
147312302|NCT01533714|531310720|FG002|Overall Study|Ineligibility reason|0|||
147312303|NCT01533714|531310721|FG003|Overall Study|Ineligibility reason|1|||
147312304|NCT01533714|531310722|FG004|Overall Study|Ineligibility reason|0|||
147312305|NCT01533714|531310723|FG005|Overall Study|Ineligibility reason|0|||
147312306|NCT02572817|531310725|FG000|Overall Study|Death|6|||
147312307|NCT02572817|531310726|FG001|Overall Study|Death|3|||
147312308|NCT02572817|531310725|FG000|Overall Study|Lost to Follow-up|3|||
147312309|NCT02572817|531310726|FG001|Overall Study|Lost to Follow-up|3|||
147312310|NCT01234649|531310731|FG000|Overall Study|Withdrawal by Subject|32|||
147312311|NCT01234649|531310732|FG001|Overall Study|Withdrawal by Subject|26|||
147312312|NCT01234649|531310731|FG000|Overall Study|Pregnancy|6|||
147312313|NCT01234649|531310732|FG001|Overall Study|Pregnancy|6|||
147312314|NCT01234649|531310731|FG000|Overall Study|intolerant to side effects|4|||
147312315|NCT01234649|531310732|FG001|Overall Study|intolerant to side effects|3|||
147312316|NCT01234649|531310731|FG000|Overall Study|Allergic reaction|1|||
147312317|NCT01234649|531310732|FG001|Overall Study|Allergic reaction|0|||
147312318|NCT01234649|531310731|FG000|Overall Study|Lack of Efficacy|0|||
147312319|NCT01234649|531310732|FG001|Overall Study|Lack of Efficacy|3|||
147312320|NCT00896454|531310733|FG000|Overall Study|Death|10|||
147312321|NCT00896454|531310733|FG000|Overall Study|Adverse Event|8|||
147312322|NCT00896454|531310733|FG000|Overall Study|Disease Progression|5|||
147312323|NCT00896454|531310733|FG000|Overall Study|Other|4|||
147312324|NCT00896454|531310733|FG000|Overall Study|Requirement for alternative therapy|3|||
147312325|NCT00896454|531310733|FG000|Overall Study|Ongoing in study|2|||
147312326|NCT00896454|531310733|FG000|Overall Study|Withdrawal by Subject|1|||
147312327|NCT01461993|531310737|FG000|Overall Study|Withdrawal by Subject|60|||
147312328|NCT01461993|531310738|FG001|Overall Study|Withdrawal by Subject|53|||
147312329|NCT01461993|531310739|FG002|Overall Study|Withdrawal by Subject|16|||
147312330|NCT01461993|531310737|FG000|Overall Study|Lost to Follow-up|44|||
147312331|NCT01461993|531310738|FG001|Overall Study|Lost to Follow-up|48|||
147312332|NCT01461993|531310739|FG002|Overall Study|Lost to Follow-up|22|||
147312333|NCT01461993|531310737|FG000|Overall Study|Protocol Violation|10|||
147312334|NCT01461993|531310738|FG001|Overall Study|Protocol Violation|9|||
147312335|NCT01461993|531310739|FG002|Overall Study|Protocol Violation|7|||
147312336|NCT01461993|531310737|FG000|Overall Study|Adverse Event|9|||
147312337|NCT01461993|531310738|FG001|Overall Study|Adverse Event|11|||
147312338|NCT01461993|531310739|FG002|Overall Study|Adverse Event|3|||
147312339|NCT01461993|531310737|FG000|Overall Study|No longer met eligibility criteria|13|||
147312340|NCT01461993|531310738|FG001|Overall Study|No longer met eligibility criteria|18|||
147312341|NCT01461993|531310739|FG002|Overall Study|No longer met eligibility criteria|10|||
147312342|NCT01461993|531310737|FG000|Overall Study|Did not meet entrance criteria|2|||
147312343|NCT01461993|531310738|FG001|Overall Study|Did not meet entrance criteria|3|||
147312344|NCT01461993|531310739|FG002|Overall Study|Did not meet entrance criteria|0|||
147312345|NCT01461993|531310737|FG000|Overall Study|Other|13|||
147312346|NCT01461993|531310738|FG001|Overall Study|Other|15|||
147312347|NCT01461993|531310739|FG002|Overall Study|Other|6|||
147312348|NCT00680056|531310741|FG000|First Intervention|Mainly Exacerbation of COPD|1|||
147312349|NCT00680056|531310742|FG001|First Intervention|Mainly Exacerbation of COPD|2|||
147565729|NCT00105196|532230048|FG001|Overall Study|pending surgery|1|||
147565730|NCT00105196|532230047|FG000|Overall Study|marijuana use|0|||
147312350|NCT00680056|531310741|FG000|Second Intervention|Protocol Violation|3|||
147312351|NCT00680056|531310742|FG001|Second Intervention|Protocol Violation|1|||
147312352|NCT01821898|531310744|FG000|Overall Study|Withdrawal by Subject|2|||
147312353|NCT01821898|531310745|FG001|Overall Study|Withdrawal by Subject|1|||
147312354|NCT03904693|531310748|FG000|DB Treatment Period (Week 1 to Week 16)|Death|0|||
147312355|NCT03904693|531310749|FG001|DB Treatment Period (Week 1 to Week 16)|Death|0|||
147312356|NCT03904693|531310750|FG002|DB Treatment Period (Week 1 to Week 16)|Death|3|||
147565731|NCT00105196|532230048|FG001|Overall Study|marijuana use|1|||
147312357|NCT03904693|531310751|FG003|DB Treatment Period (Week 1 to Week 16)|Death|0|||
147312358|NCT03904693|531310752|FG004|DB Treatment Period (Week 1 to Week 16)|Death|0|||
147312359|NCT03904693|531310753|FG005|DB Treatment Period (Week 1 to Week 16)|Death|0|||
147312360|NCT03904693|531310748|FG000|DB Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
147565732|NCT00105196|532230047|FG000|Overall Study|Subject became unblinded|0|||
147565733|NCT00105196|532230048|FG001|Overall Study|Subject became unblinded|1|||
147565734|NCT00893464|532230049|FG000|Overall Study|Did not complete therapy/experience PD|0|||
147565735|NCT00893464|532230050|FG001|Overall Study|Did not complete therapy/experience PD|0|||
147565736|NCT00893464|532230051|FG002|Overall Study|Did not complete therapy/experience PD|0|||
147565737|NCT00893464|532230052|FG003|Overall Study|Did not complete therapy/experience PD|0|||
147565738|NCT00893464|532230053|FG004|Overall Study|Did not complete therapy/experience PD|0|||
147565739|NCT00893464|532230054|FG005|Overall Study|Did not complete therapy/experience PD|0|||
147565740|NCT00893464|532230055|FG006|Overall Study|Did not complete therapy/experience PD|2|||
147565741|NCT00893464|532230056|FG007|Overall Study|Did not complete therapy/experience PD|2|||
147565742|NCT01544127|532230057|FG000|Overall Study|Lost to Follow-up|4|||
147565743|NCT01544127|532230058|FG001|Overall Study|Lost to Follow-up|2|||
147565744|NCT01544127|532230059|FG002|Overall Study|Lost to Follow-up|9|||
147565745|NCT01544127|532230057|FG000|Overall Study|Withdrawal by Subject|2|||
147565746|NCT01544127|532230058|FG001|Overall Study|Withdrawal by Subject|2|||
147565747|NCT01544127|532230059|FG002|Overall Study|Withdrawal by Subject|1|||
147565748|NCT01544127|532230057|FG000|Overall Study|Discharged out of catchment area|1|||
147565749|NCT01544127|532230058|FG001|Overall Study|Discharged out of catchment area|1|||
147565750|NCT01544127|532230059|FG002|Overall Study|Discharged out of catchment area|1|||
147565751|NCT01544127|532230057|FG000|Overall Study|Death|1|||
147565752|NCT01544127|532230058|FG001|Overall Study|Death|0|||
147565753|NCT01544127|532230059|FG002|Overall Study|Death|0|||
147565754|NCT01544127|532230057|FG000|Overall Study|Jail or Prison|1|||
147565755|NCT01544127|532230058|FG001|Overall Study|Jail or Prison|1|||
147565756|NCT01544127|532230059|FG002|Overall Study|Jail or Prison|2|||
147565757|NCT01544127|532230057|FG000|Overall Study|Became Psychotic|1|||
147565758|NCT01544127|532230058|FG001|Overall Study|Became Psychotic|0|||
147565759|NCT01544127|532230059|FG002|Overall Study|Became Psychotic|0|||
147565760|NCT01544127|532230057|FG000|Overall Study|Researcher withdrew|1|||
147565761|NCT01544127|532230058|FG001|Overall Study|Researcher withdrew|0|||
147565762|NCT01544127|532230059|FG002|Overall Study|Researcher withdrew|0|||
147565763|NCT01544127|532230057|FG000|Overall Study|Went active duty|0|||
147565764|NCT01544127|532230058|FG001|Overall Study|Went active duty|0|||
147565765|NCT01544127|532230059|FG002|Overall Study|Went active duty|1|||
147116077|NCT03422718|530588748|FG002|12 Month Interventional Trial Period|Withdrawal by Subject|15|||
147116078|NCT03422718|530588749|FG003|12 Month Interventional Trial Period|Withdrawal by Subject|12|||
147116079|NCT03422718|530588750|FG004|12 Month Interventional Trial Period|Withdrawal by Subject|7|||
147116080|NCT03422718|530588751|FG005|12 Month Interventional Trial Period|Withdrawal by Subject|8|||
147116081|NCT03422718|530588752|FG006|12 Month Interventional Trial Period|Withdrawal by Subject|4|||
147116082|NCT03422718|530588753|FG007|12 Month Interventional Trial Period|Withdrawal by Subject|11|||
147116083|NCT03422718|530588746|FG000|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|8|||
147116084|NCT03422718|530588747|FG001|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|11|||
147116085|NCT03422718|530588748|FG002|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|16|||
147116086|NCT03422718|530588749|FG003|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|14|||
147116087|NCT03422718|530588750|FG004|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|17|||
147116088|NCT03422718|530588751|FG005|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|14|||
147116089|NCT03422718|530588752|FG006|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|14|||
147116090|NCT03422718|530588753|FG007|Optional Six Month Follow-Up Period|Chose Not to start 6 month extension|10|||
147116091|NCT03422718|530588746|FG000|Optional Six Month Follow-Up Period|Withdrawal by Subject|0|||
147116092|NCT03422718|530588747|FG001|Optional Six Month Follow-Up Period|Withdrawal by Subject|3|||
147116093|NCT03422718|530588748|FG002|Optional Six Month Follow-Up Period|Withdrawal by Subject|0|||
147116094|NCT03422718|530588749|FG003|Optional Six Month Follow-Up Period|Withdrawal by Subject|0|||
147116095|NCT03422718|530588750|FG004|Optional Six Month Follow-Up Period|Withdrawal by Subject|1|||
147116096|NCT03422718|530588751|FG005|Optional Six Month Follow-Up Period|Withdrawal by Subject|2|||
147116097|NCT03422718|530588752|FG006|Optional Six Month Follow-Up Period|Withdrawal by Subject|0|||
147116098|NCT03422718|530588753|FG007|Optional Six Month Follow-Up Period|Withdrawal by Subject|0|||
147116099|NCT03422718|530588746|FG000|Optional Six Month Follow-Up Period|ineligible|8|||
147116100|NCT03422718|530588747|FG001|Optional Six Month Follow-Up Period|ineligible|5|||
147116101|NCT03422718|530588748|FG002|Optional Six Month Follow-Up Period|ineligible|2|||
147229030|NCT00437320|531011879|FG000|Overall Study|Participant request|2|||
147229031|NCT00437320|531011880|FG001|Overall Study|Participant request|1|||
147444425|NCT00843518|531792609|FG001|Period 2 (Double-blind Treatment)|Caregiver decision|7|||
147116102|NCT03422718|530588749|FG003|Optional Six Month Follow-Up Period|ineligible|2|||
147229032|NCT00437320|531011881|FG002|Overall Study|Participant request|4|||
147229033|NCT01400815|531011892|FG000|Overall Study|Adverse Event|3|||
147444426|NCT00804570|531792612|FG000|Overall Study|Adverse Event|14|||
147444427|NCT00804570|531792613|FG001|Overall Study|Adverse Event|7|||
147444428|NCT00804570|531792612|FG000|Overall Study|Lack of Efficacy|0|||
147565766|NCT01256684|532230060|FG000|Overall Study|Adverse Event|1|||
147565767|NCT01256684|532230061|FG001|Overall Study|Adverse Event|4|||
147565768|NCT01256684|532230062|FG002|Overall Study|Adverse Event|2|||
147565769|NCT01256684|532230060|FG000|Overall Study|Withdrawal by Subject|4|||
147565770|NCT01256684|532230061|FG001|Overall Study|Withdrawal by Subject|0|||
147565771|NCT01256684|532230062|FG002|Overall Study|Withdrawal by Subject|2|||
147565772|NCT01256684|532230060|FG000|Overall Study|Physician Decision|0|||
147565773|NCT01256684|532230061|FG001|Overall Study|Physician Decision|1|||
147565774|NCT01256684|532230062|FG002|Overall Study|Physician Decision|0|||
147565775|NCT01256684|532230060|FG000|Overall Study|Lack of Efficacy|0|||
147565776|NCT01256684|532230061|FG001|Overall Study|Lack of Efficacy|1|||
147565777|NCT01256684|532230062|FG002|Overall Study|Lack of Efficacy|1|||
147565778|NCT01256684|532230060|FG000|Overall Study|Entry criteria not met/non-compliance|4|||
147565779|NCT01256684|532230061|FG001|Overall Study|Entry criteria not met/non-compliance|7|||
147565780|NCT01256684|532230062|FG002|Overall Study|Entry criteria not met/non-compliance|6|||
147565781|NCT02914600|532230063|FG000|Overall Study|Adverse Event|298|||
147565782|NCT02914600|532230064|FG001|Overall Study|Adverse Event|35|||
147565783|NCT02914600|532230065|FG002|Overall Study|Adverse Event|25|||
147565784|NCT02914600|532230063|FG000|Overall Study|Sponsors decision|287|||
147565785|NCT02914600|532230064|FG001|Overall Study|Sponsors decision|41|||
147565786|NCT02914600|532230065|FG002|Overall Study|Sponsors decision|12|||
147565787|NCT02914600|532230063|FG000|Overall Study|Withdrawal by Subject|158|||
147565788|NCT02914600|532230064|FG001|Overall Study|Withdrawal by Subject|20|||
147565789|NCT02914600|532230065|FG002|Overall Study|Withdrawal by Subject|18|||
147229034|NCT01400815|531011893|FG001|Overall Study|Adverse Event|0|||
147229035|NCT01400815|531011892|FG000|Overall Study|Death|0|||
147229036|NCT01400815|531011893|FG001|Overall Study|Death|1|||
147229037|NCT01400815|531011892|FG000|Overall Study|Lost to Follow-up|18|||
147229038|NCT01400815|531011893|FG001|Overall Study|Lost to Follow-up|11|||
147229039|NCT01400815|531011892|FG000|Overall Study|Protocol Violation|0|||
147229040|NCT01400815|531011893|FG001|Overall Study|Protocol Violation|1|||
147229041|NCT01400815|531011892|FG000|Overall Study|Physician Decision|1|||
147229042|NCT01400815|531011893|FG001|Overall Study|Physician Decision|0|||
147229043|NCT01400815|531011892|FG000|Overall Study|Withdrawal by Subject|15|||
147229044|NCT01400815|531011893|FG001|Overall Study|Withdrawal by Subject|8|||
147229045|NCT01400815|531011892|FG000|Overall Study|Subject in jail|1|||
147229046|NCT01400815|531011893|FG001|Overall Study|Subject in jail|0|||
147229047|NCT01123850|531011894|FG000|Overall Study|Slow enrollment|45|||
147229048|NCT02310321|531011896|FG000|Phase 1(DEv):IP (2 Cycles;42 Days/Cycle)|Miscellaneous|1|||
147229049|NCT02310321|531011897|FG001|Phase 1(DEv):IP (2 Cycles;42 Days/Cycle)|Miscellaneous|0|||
147229050|NCT02310321|531011898|FG002|Phase 1(DEv):IP (2 Cycles;42 Days/Cycle)|Miscellaneous|0|||
147229051|NCT02310321|531011896|FG000|Phase 1(DEv):CP (3 Cycles;28 Days/Cycle)|Miscellaneous|1|||
147229052|NCT02310321|531011897|FG001|Phase 1(DEv):CP (3 Cycles;28 Days/Cycle)|Miscellaneous|0|||
147229053|NCT02310321|531011898|FG002|Phase 1(DEv):CP (3 Cycles;28 Days/Cycle)|Miscellaneous|0|||
147229054|NCT02310321|531011896|FG000|Phase 1(DEv):MP(26 Cycles;28 Days/Cycle)|Miscellaneous|1|||
147229055|NCT02310321|531011897|FG001|Phase 1(DEv):MP(26 Cycles;28 Days/Cycle)|Miscellaneous|0|||
147229056|NCT02310321|531011898|FG002|Phase 1(DEv):MP(26 Cycles;28 Days/Cycle)|Miscellaneous|0|||
147229057|NCT02310321|531011896|FG000|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Adverse Event|0|||
147565790|NCT02914600|532230063|FG000|Overall Study|Investigators discretion|169|||
147565791|NCT02914600|532230064|FG001|Overall Study|Investigators discretion|14|||
147565792|NCT02914600|532230065|FG002|Overall Study|Investigators discretion|13|||
147565793|NCT02914600|532230063|FG000|Overall Study|Lost to Follow-up|10|||
147565794|NCT02914600|532230064|FG001|Overall Study|Lost to Follow-up|4|||
147565795|NCT02914600|532230065|FG002|Overall Study|Lost to Follow-up|0|||
147565796|NCT02914600|532230063|FG000|Overall Study|Pregnancy|8|||
147565797|NCT02914600|532230064|FG001|Overall Study|Pregnancy|0|||
147565798|NCT02914600|532230065|FG002|Overall Study|Pregnancy|0|||
147565799|NCT02914600|532230063|FG000|Overall Study|Protocol Violation|5|||
147565800|NCT02914600|532230064|FG001|Overall Study|Protocol Violation|3|||
147565801|NCT02914600|532230065|FG002|Overall Study|Protocol Violation|0|||
147565802|NCT02914600|532230063|FG000|Overall Study|Non-compliance with study drug|6|||
147565803|NCT02914600|532230064|FG001|Overall Study|Non-compliance with study drug|1|||
147565804|NCT02914600|532230065|FG002|Overall Study|Non-compliance with study drug|0|||
147565805|NCT02914600|532230063|FG000|Overall Study|Death|3|||
147565806|NCT02914600|532230064|FG001|Overall Study|Death|1|||
147565807|NCT02914600|532230065|FG002|Overall Study|Death|1|||
147565808|NCT02914600|532230063|FG000|Overall Study|Current Study Unblinded and participant confirmed on Placebo|0|||
147565809|NCT02914600|532230064|FG001|Overall Study|Current Study Unblinded and participant confirmed on Placebo|0|||
147565810|NCT02914600|532230065|FG002|Overall Study|Current Study Unblinded and participant confirmed on Placebo|55|||
147565811|NCT02914600|532230063|FG000|Overall Study|Enrolled but not treated|1|||
147229058|NCT02310321|531011897|FG001|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Adverse Event|1|||
147229059|NCT02310321|531011898|FG002|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Adverse Event|0|||
147229060|NCT02310321|531011896|FG000|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Miscellaneous|0|||
147229061|NCT02310321|531011897|FG001|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Miscellaneous|4|||
147229062|NCT02310321|531011898|FG002|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Miscellaneous|0|||
147229063|NCT02310321|531011896|FG000|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|There is no CR, CRp, or CRi after 2 Cycles of Therapy|0|||
147444429|NCT00804570|531792613|FG001|Overall Study|Lack of Efficacy|1|||
147565812|NCT02914600|532230064|FG001|Overall Study|Enrolled but not treated|0|||
147565813|NCT02914600|532230065|FG002|Overall Study|Enrolled but not treated|0|||
147565814|NCT01185548|532230066|FG000|Period 2: Tasisulam and Tolbutamide|Sponsor Decision|2|||
147565815|NCT00184600|532230069|FG000|Overall Study|Adverse Event|9|||
147565816|NCT00184600|532230070|FG001|Overall Study|Adverse Event|0|||
147565817|NCT00184600|532230071|FG002|Overall Study|Adverse Event|5|||
147565818|NCT00184600|532230069|FG000|Overall Study|Death|3|||
147565819|NCT00184600|532230070|FG001|Overall Study|Death|9|||
147565820|NCT00184600|532230071|FG002|Overall Study|Death|7|||
147565821|NCT00184600|532230069|FG000|Overall Study|Lack of Efficacy|3|||
147565822|NCT00184600|532230070|FG001|Overall Study|Lack of Efficacy|1|||
147565823|NCT00184600|532230071|FG002|Overall Study|Lack of Efficacy|3|||
147565824|NCT00184600|532230069|FG000|Overall Study|Lost to Follow-up|4|||
147565825|NCT00184600|532230070|FG001|Overall Study|Lost to Follow-up|6|||
147565826|NCT00184600|532230071|FG002|Overall Study|Lost to Follow-up|1|||
147565827|NCT00184600|532230069|FG000|Overall Study|Protocol Violation|2|||
147565828|NCT00184600|532230070|FG001|Overall Study|Protocol Violation|2|||
147565829|NCT00184600|532230071|FG002|Overall Study|Protocol Violation|3|||
147565830|NCT00184600|532230069|FG000|Overall Study|Withdrawal by Subject|20|||
147565831|NCT00184600|532230070|FG001|Overall Study|Withdrawal by Subject|28|||
147565832|NCT00184600|532230071|FG002|Overall Study|Withdrawal by Subject|12|||
147565833|NCT00184600|532230069|FG000|Overall Study|Unclassified|4|||
147565834|NCT00184600|532230070|FG001|Overall Study|Unclassified|5|||
147565835|NCT00184600|532230071|FG002|Overall Study|Unclassified|3|||
147565836|NCT00624065|532230074|FG000|Overall Study|Adverse Event|5|||
147565837|NCT00624065|532230075|FG001|Overall Study|Adverse Event|6|||
147565838|NCT00624065|532230074|FG000|Overall Study|Lost to Follow-up|4|||
147565839|NCT00624065|532230075|FG001|Overall Study|Lost to Follow-up|1|||
147565840|NCT00624065|532230074|FG000|Overall Study|Consent withdrawn|6|||
147565841|NCT00624065|532230075|FG001|Overall Study|Consent withdrawn|5|||
147565842|NCT00624065|532230074|FG000|Overall Study|Lack of Efficacy|0|||
147565843|NCT00624065|532230075|FG001|Overall Study|Lack of Efficacy|3|||
147565844|NCT00624065|532230074|FG000|Overall Study|Met protocol-defined stopping criteria|4|||
147565845|NCT00624065|532230075|FG001|Overall Study|Met protocol-defined stopping criteria|9|||
147565846|NCT00696020|532230076|FG000|Overall Study|Adverse Event|3|||
147565847|NCT00696020|532230077|FG001|Overall Study|Adverse Event|1|||
147565848|NCT00696020|532230078|FG002|Overall Study|Adverse Event|2|||
147565849|NCT00696020|532230079|FG003|Overall Study|Adverse Event|1|||
147565850|NCT00696020|532230076|FG000|Overall Study|Lack of Efficacy|1|||
147565851|NCT00696020|532230077|FG001|Overall Study|Lack of Efficacy|0|||
147565852|NCT00696020|532230078|FG002|Overall Study|Lack of Efficacy|0|||
147565853|NCT00696020|532230079|FG003|Overall Study|Lack of Efficacy|0|||
147565854|NCT00696020|532230076|FG000|Overall Study|Protocol Violation|0|||
147565855|NCT00696020|532230077|FG001|Overall Study|Protocol Violation|0|||
147565856|NCT00696020|532230078|FG002|Overall Study|Protocol Violation|0|||
147565857|NCT00696020|532230079|FG003|Overall Study|Protocol Violation|1|||
147565858|NCT00696020|532230076|FG000|Overall Study|Withdrawal by Subject|0|||
147565859|NCT00696020|532230077|FG001|Overall Study|Withdrawal by Subject|1|||
147116103|NCT03422718|530588750|FG004|Optional Six Month Follow-Up Period|ineligible|1|||
147116104|NCT03422718|530588751|FG005|Optional Six Month Follow-Up Period|ineligible|5|||
147116105|NCT03422718|530588752|FG006|Optional Six Month Follow-Up Period|ineligible|2|||
147116106|NCT03422718|530588753|FG007|Optional Six Month Follow-Up Period|ineligible|4|||
147565860|NCT00696020|532230078|FG002|Overall Study|Withdrawal by Subject|0|||
147116107|NCT03422718|530588746|FG000|Optional Six Month Follow-Up Period|Lost to Follow-up|8|||
147229064|NCT02310321|531011897|FG001|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|There is no CR, CRp, or CRi after 2 Cycles of Therapy|1|||
147229065|NCT02310321|531011898|FG002|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|There is no CR, CRp, or CRi after 2 Cycles of Therapy|0|||
147229066|NCT02310321|531011896|FG000|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Disease Relapse|0|||
147229067|NCT02310321|531011897|FG001|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Disease Relapse|1|||
147229068|NCT02310321|531011898|FG002|Phase 1(DEx):IP (2 Cycles;42 Days/Cycle)|Disease Relapse|0|||
147229069|NCT02310321|531011896|FG000|Phase 1(DEx):MP(26 Cycles;28 Days/Cycle)|Micellaneous|0|||
147565861|NCT00696020|532230079|FG003|Overall Study|Withdrawal by Subject|1|||
147565862|NCT00696020|532230076|FG000|Overall Study|Other not stated above|0|||
147116108|NCT03422718|530588747|FG001|Optional Six Month Follow-Up Period|Lost to Follow-up|11|||
147116109|NCT03422718|530588748|FG002|Optional Six Month Follow-Up Period|Lost to Follow-up|6|||
147565863|NCT00696020|532230077|FG001|Overall Study|Other not stated above|0|||
147565864|NCT00696020|532230078|FG002|Overall Study|Other not stated above|1|||
147565865|NCT00696020|532230079|FG003|Overall Study|Other not stated above|1|||
147565866|NCT01387022|532230081|FG000|Overall Study|Death|1|||
147565867|NCT01387022|532230082|FG001|Overall Study|Death|1|||
147565868|NCT01387022|532230081|FG000|Overall Study|Lost to Follow-up|0|||
147565869|NCT01387022|532230082|FG001|Overall Study|Lost to Follow-up|3|||
147565870|NCT02076022|532230083|FG000|Overall Study|Withdrawal by Subject|2|||
147565871|NCT02076022|532230084|FG001|Overall Study|Withdrawal by Subject|0|||
147565872|NCT00312663|532230087|FG000|Immunization Phase|Adverse Event|0|||
147565873|NCT00312663|532230088|FG001|Immunization Phase|Adverse Event|1|||
147565874|NCT00312663|532230089|FG002|Immunization Phase|Adverse Event|0|||
147116110|NCT03422718|530588749|FG003|Optional Six Month Follow-Up Period|Lost to Follow-up|4|||
147116111|NCT03422718|530588750|FG004|Optional Six Month Follow-Up Period|Lost to Follow-up|9|||
147116112|NCT03422718|530588751|FG005|Optional Six Month Follow-Up Period|Lost to Follow-up|8|||
147116113|NCT03422718|530588752|FG006|Optional Six Month Follow-Up Period|Lost to Follow-up|3|||
147116114|NCT03422718|530588753|FG007|Optional Six Month Follow-Up Period|Lost to Follow-up|6|||
147116115|NCT03309605|530588754|FG000|Overall Study|Adverse Event|0|||
147116116|NCT03309605|530588755|FG001|Overall Study|Adverse Event|0|||
147116117|NCT03309605|530588756|FG002|Overall Study|Adverse Event|0|||
147116118|NCT03309605|530588757|FG003|Overall Study|Adverse Event|1|||
147116119|NCT03309605|530588758|FG004|Overall Study|Adverse Event|0|||
147116120|NCT03309605|530588759|FG005|Overall Study|Adverse Event|0|||
147116121|NCT03309605|530588760|FG006|Overall Study|Adverse Event|2|||
147116122|NCT03309605|530588761|FG007|Overall Study|Adverse Event|1|||
147116123|NCT03309605|530588754|FG000|Overall Study|Withdrawal by Subject|0|||
147116124|NCT03309605|530588755|FG001|Overall Study|Withdrawal by Subject|0|||
147116125|NCT03309605|530588756|FG002|Overall Study|Withdrawal by Subject|0|||
147116126|NCT03309605|530588757|FG003|Overall Study|Withdrawal by Subject|0|||
147116127|NCT03309605|530588758|FG004|Overall Study|Withdrawal by Subject|1|||
147116128|NCT03309605|530588759|FG005|Overall Study|Withdrawal by Subject|0|||
147116129|NCT03309605|530588760|FG006|Overall Study|Withdrawal by Subject|1|||
147116130|NCT03309605|530588761|FG007|Overall Study|Withdrawal by Subject|1|||
147116131|NCT01129284|530588762|FG000|Overall Study|Adverse Event|2|||
147116132|NCT01129284|530588763|FG001|Overall Study|Adverse Event|0|||
147116133|NCT01129284|530588764|FG002|Overall Study|Adverse Event|1|||
147116134|NCT00245570|530588770|FG000|Washout Between Periods III and IV|Adverse Event|0|||
147116135|NCT00245570|530588771|FG001|Washout Between Periods III and IV|Adverse Event|1|||
147116136|NCT00245570|530588772|FG002|Washout Between Periods III and IV|Adverse Event|0|||
147116137|NCT00245570|530588773|FG003|Washout Between Periods III and IV|Adverse Event|0|||
147116138|NCT00245570|530588774|FG004|Washout Between Periods III and IV|Adverse Event|0|||
147116139|NCT00245570|530588775|FG005|Washout Between Periods III and IV|Adverse Event|0|||
147116140|NCT01913470|530588778|FG000|Overall Study|Lost to Follow-up|0|||
147116141|NCT01913470|530588779|FG001|Overall Study|Lost to Follow-up|1|||
147116142|NCT01913470|530588778|FG000|Overall Study|Physician Decision|0|||
147116143|NCT01913470|530588779|FG001|Overall Study|Physician Decision|1|||
147116144|NCT01913470|530588778|FG000|Overall Study|Withdrawal by Subject|0|||
147116145|NCT01913470|530588779|FG001|Overall Study|Withdrawal by Subject|1|||
147116146|NCT02384460|530588805|FG000|Overall Study|Protocol Violation|0|||
147116147|NCT02384460|530588806|FG001|Overall Study|Protocol Violation|1|||
147116148|NCT02384460|530588805|FG000|Overall Study|Returned to previous therapeutic regimen|0|||
147116149|NCT02384460|530588806|FG001|Overall Study|Returned to previous therapeutic regimen|1|||
147116150|NCT02384460|530588805|FG000|Overall Study|Adverse Event|5|||
147116151|NCT02384460|530588806|FG001|Overall Study|Adverse Event|2|||
147116152|NCT02384460|530588805|FG000|Overall Study|Withdrawal by Subject|0|||
147116153|NCT02384460|530588806|FG001|Overall Study|Withdrawal by Subject|3|||
147116154|NCT02384460|530588805|FG000|Overall Study|Elective medical treatment|1|||
147116155|NCT02384460|530588806|FG001|Overall Study|Elective medical treatment|0|||
147116156|NCT02384460|530588805|FG000|Overall Study|Non-compliance|1|||
147116157|NCT02384460|530588806|FG001|Overall Study|Non-compliance|0|||
147116158|NCT02400580|530588807|FG000|Overall Study|Withdrawal by Subject|1|||
147116159|NCT02400580|530588808|FG001|Overall Study|Withdrawal by Subject|1|||
147116160|NCT02400580|530588807|FG000|Overall Study|Adverse Event|1|||
147116161|NCT02400580|530588808|FG001|Overall Study|Adverse Event|0|||
147116162|NCT00965094|530588809|FG000|Overall Study|Adverse Event|5|||
147116163|NCT00965094|530588810|FG001|Overall Study|Adverse Event|0|||
147116164|NCT00965094|530588809|FG000|Overall Study|Lost to Follow-up|0|||
147229070|NCT02310321|531011897|FG001|Phase 1(DEx):MP(26 Cycles;28 Days/Cycle)|Micellaneous|3|||
147229071|NCT02310321|531011898|FG002|Phase 1(DEx):MP(26 Cycles;28 Days/Cycle)|Micellaneous|0|||
147229072|NCT02310321|531011896|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Miscellaneous|0|||
147229073|NCT02310321|531011897|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Miscellaneous|0|||
147229074|NCT02310321|531011898|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Miscellaneous|2|||
147229075|NCT02310321|531011896|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Disease Relapse|0|||
147229076|NCT02310321|531011897|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Disease Relapse|0|||
147229077|NCT02310321|531011898|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Disease Relapse|2|||
147444430|NCT00804570|531792612|FG000|Overall Study|Lost to Follow-up|18|||
147116165|NCT00965094|530588810|FG001|Overall Study|Lost to Follow-up|1|||
147116166|NCT01060111|530588811|FG000|Overall Study|Adverse Event|9|||
147116167|NCT01060111|530588812|FG001|Overall Study|Adverse Event|5|||
147116168|NCT01060111|530588813|FG002|Overall Study|Adverse Event|18|||
147116169|NCT01060111|530588811|FG000|Overall Study|Lack of Efficacy|2|||
147116170|NCT01060111|530588812|FG001|Overall Study|Lack of Efficacy|1|||
147116171|NCT01060111|530588813|FG002|Overall Study|Lack of Efficacy|0|||
147116172|NCT01060111|530588811|FG000|Overall Study|Inappropriate participant|5|||
147116173|NCT01060111|530588812|FG001|Overall Study|Inappropriate participant|4|||
147116174|NCT01060111|530588813|FG002|Overall Study|Inappropriate participant|5|||
147116175|NCT01060111|530588811|FG000|Overall Study|Participants' evasion for hospital visit|0|||
147116176|NCT01060111|530588812|FG001|Overall Study|Participants' evasion for hospital visit|3|||
147116177|NCT01060111|530588813|FG002|Overall Study|Participants' evasion for hospital visit|2|||
147116178|NCT01060111|530588811|FG000|Overall Study|Participants' non-cooperation|8|||
147116179|NCT01060111|530588812|FG001|Overall Study|Participants' non-cooperation|6|||
147116180|NCT01060111|530588813|FG002|Overall Study|Participants' non-cooperation|6|||
147116181|NCT01060111|530588811|FG000|Overall Study|Adverse event and insufficient effect|0|||
147116182|NCT01060111|530588812|FG001|Overall Study|Adverse event and insufficient effect|1|||
147116183|NCT01060111|530588813|FG002|Overall Study|Adverse event and insufficient effect|0|||
147116184|NCT01060111|530588811|FG000|Overall Study|Participants' non-cooperation|1|||
147116185|NCT01060111|530588812|FG001|Overall Study|Participants' non-cooperation|0|||
147116186|NCT01060111|530588813|FG002|Overall Study|Participants' non-cooperation|0|||
147116187|NCT01060111|530588811|FG000|Overall Study|Other|2|||
147116188|NCT01060111|530588812|FG001|Overall Study|Other|3|||
147116189|NCT01060111|530588813|FG002|Overall Study|Other|4|||
147116190|NCT00625378|530588814|FG000|Overall Study|Adverse Event|22|||
147116191|NCT00625378|530588815|FG001|Overall Study|Adverse Event|0|||
147116192|NCT00625378|530588814|FG000|Overall Study|Withdrawal by Subject|16|||
147116193|NCT00625378|530588815|FG001|Overall Study|Withdrawal by Subject|0|||
147116194|NCT00625378|530588814|FG000|Overall Study|Death|38|||
147116195|NCT00625378|530588815|FG001|Overall Study|Death|0|||
147116196|NCT00625378|530588814|FG000|Overall Study|Disease progression, recurrence or relapse|88|||
147116197|NCT00625378|530588815|FG001|Overall Study|Disease progression, recurrence or relapse|0|||
147116198|NCT00625378|530588814|FG000|Overall Study|Lost to Follow-up|17|||
147116199|NCT00625378|530588815|FG001|Overall Study|Lost to Follow-up|0|||
147116200|NCT00625378|530588814|FG000|Overall Study|Non-compliant with study medication|3|||
147116201|NCT00625378|530588815|FG001|Overall Study|Non-compliant with study medication|0|||
147116202|NCT00625378|530588814|FG000|Overall Study|Investigator's judgement (no need to continue treatment)|1|||
147116203|NCT00625378|530588815|FG001|Overall Study|Investigator's judgement (no need to continue treatment)|0|||
147116204|NCT00625378|530588814|FG000|Overall Study|Medical decision|1|||
147116205|NCT00625378|530588815|FG001|Overall Study|Medical decision|0|||
147116206|NCT00625378|530588814|FG000|Overall Study|Multiple toxicities|1|||
147116207|NCT00625378|530588815|FG001|Overall Study|Multiple toxicities|0|||
147116208|NCT00625378|530588814|FG000|Overall Study|New cancer|1|||
147116209|NCT00625378|530588815|FG001|Overall Study|New cancer|0|||
147116210|NCT00625378|530588814|FG000|Overall Study|PTA program|2|||
147116211|NCT00625378|530588815|FG001|Overall Study|PTA program|0|||
147116212|NCT00625378|530588814|FG000|Overall Study|Recurrent rise in amylase and lipase|1|||
147116213|NCT00625378|530588815|FG001|Overall Study|Recurrent rise in amylase and lipase|0|||
147116214|NCT00625378|530588814|FG000|Overall Study|Sponsor decision|1|||
147116215|NCT00625378|530588815|FG001|Overall Study|Sponsor decision|0|||
147116216|NCT00625378|530588814|FG000|Overall Study|Sponsor's decision to stop the trial|1|||
147116217|NCT00625378|530588815|FG001|Overall Study|Sponsor's decision to stop the trial|0|||
147116218|NCT00625378|530588814|FG000|Overall Study|Switch to commercial drug|6|||
147116219|NCT00625378|530588815|FG001|Overall Study|Switch to commercial drug|1|||
147116220|NCT00625378|530588814|FG000|Overall Study|Missing|2|||
147116221|NCT00625378|530588815|FG001|Overall Study|Missing|0|||
147116222|NCT00625378|530588814|FG000|Overall Study|End of treatment not available|2|||
147116223|NCT00625378|530588815|FG001|Overall Study|End of treatment not available|0|||
147116224|NCT00625378|530588814|FG000|Overall Study|Never treated|2|||
147116225|NCT00625378|530588815|FG001|Overall Study|Never treated|0|||
147116226|NCT04270760|530588816|FG000|Overall Study|Withdrawal by Subject|0|||
147116227|NCT04270760|530588817|FG001|Overall Study|Withdrawal by Subject|1|||
147116228|NCT04270760|530588818|FG002|Overall Study|Withdrawal by Subject|3|||
147229078|NCT02310321|531011896|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Physician Decision|0|||
147229079|NCT02310321|531011897|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Physician Decision|0|||
147229080|NCT02310321|531011898|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Physician Decision|6|||
147229081|NCT02310321|531011896|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Withdrawal by Subject|0|||
147229082|NCT02310321|531011897|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Withdrawal by Subject|0|||
147229083|NCT02310321|531011898|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Withdrawal by Subject|4|||
147229084|NCT02310321|531011896|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Lack of Efficacy|0|||
147229085|NCT02310321|531011897|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Lack of Efficacy|0|||
147312361|NCT03904693|531310749|FG001|DB Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
147444431|NCT00804570|531792613|FG001|Overall Study|Lost to Follow-up|21|||
147116229|NCT04270760|530588819|FG003|Overall Study|Withdrawal by Subject|0|||
147116230|NCT04270760|530588820|FG004|Overall Study|Withdrawal by Subject|0|||
147116231|NCT04270760|530588816|FG000|Overall Study|Lost to Follow-up|1|||
147116232|NCT04270760|530588817|FG001|Overall Study|Lost to Follow-up|2|||
147116233|NCT04270760|530588818|FG002|Overall Study|Lost to Follow-up|1|||
147116234|NCT04270760|530588819|FG003|Overall Study|Lost to Follow-up|0|||
147116235|NCT04270760|530588820|FG004|Overall Study|Lost to Follow-up|0|||
147116236|NCT04270760|530588816|FG000|Overall Study|Death|0|||
147116237|NCT04270760|530588817|FG001|Overall Study|Death|0|||
147116238|NCT04270760|530588818|FG002|Overall Study|Death|0|||
147116239|NCT04270760|530588819|FG003|Overall Study|Death|0|||
147116240|NCT04270760|530588820|FG004|Overall Study|Death|1|||
147116241|NCT02070991|530588821|FG000|Overall Study|Death|2|||
147116242|NCT02070991|530588822|FG001|Overall Study|Death|0|||
147116243|NCT02070991|530588821|FG000|Overall Study|Withdrawal by Subject|1|||
147116244|NCT02070991|530588822|FG001|Overall Study|Withdrawal by Subject|0|||
147116245|NCT02448043|530588825|FG000|Overall Study|Withdrawal by Subject|2|||
147116246|NCT02448043|530588826|FG001|Overall Study|Withdrawal by Subject|2|||
147116247|NCT02448043|530588825|FG000|Overall Study|Protocol Violation|1|||
147116248|NCT02448043|530588826|FG001|Overall Study|Protocol Violation|2|||
147116249|NCT04149353|530588834|FG000|Overall Study|Study terminated|1|||
147116250|NCT02068599|530588835|FG000|Overall Study|Adverse Event|4|||
147116251|NCT02068599|530588836|FG001|Overall Study|Adverse Event|1|||
147116252|NCT02068599|530588837|FG002|Overall Study|Adverse Event|1|||
147229086|NCT02310321|531011898|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Lack of Efficacy|3|||
147229087|NCT02310321|531011896|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Death|0|||
147229088|NCT02310321|531011897|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Death|0|||
147229089|NCT02310321|531011898|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Death|3|||
147229090|NCT02310321|531011896|FG000|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Adverse Event|0|||
147229091|NCT02310321|531011897|FG001|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Adverse Event|0|||
147229092|NCT02310321|531011898|FG002|Phase 2:IP(2 Cycles;up to 56 Days/Cycle)|Adverse Event|2|||
147229093|NCT02310321|531011896|FG000|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Miscellaneous|0|||
147229094|NCT02310321|531011897|FG001|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Miscellaneous|0|||
147229095|NCT02310321|531011898|FG002|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Miscellaneous|7|||
147229096|NCT02310321|531011896|FG000|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Disease Relapse|0|||
147229097|NCT02310321|531011897|FG001|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Disease Relapse|0|||
147229098|NCT02310321|531011898|FG002|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Disease Relapse|4|||
147229099|NCT02310321|531011896|FG000|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Physician Decision|0|||
147229100|NCT02310321|531011897|FG001|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Physician Decision|0|||
147229101|NCT02310321|531011898|FG002|Phase 2:CP(4 Cycles;up to 28 Days/Cycle)|Physician Decision|4|||
147229102|NCT02310321|531011896|FG000|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Disease relapse|0|||
147229103|NCT02310321|531011897|FG001|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Disease relapse|0|||
147229104|NCT02310321|531011898|FG002|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Disease relapse|11|||
147229105|NCT02310321|531011896|FG000|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Miscellaneous|0|||
147229106|NCT02310321|531011897|FG001|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Miscellaneous|0|||
147229107|NCT02310321|531011898|FG002|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Miscellaneous|2|||
147229108|NCT02310321|531011896|FG000|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Adverse Event|0|||
147229109|NCT02310321|531011897|FG001|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Adverse Event|0|||
147229110|NCT02310321|531011898|FG002|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Adverse Event|3|||
147229111|NCT02310321|531011896|FG000|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Death|0|||
147229112|NCT02310321|531011897|FG001|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Death|0|||
147229113|NCT02310321|531011898|FG002|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Death|1|||
147229114|NCT02310321|531011896|FG000|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Physician Decision|0|||
147229115|NCT02310321|531011897|FG001|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Physician Decision|0|||
147229116|NCT02310321|531011898|FG002|Phase 2:MP(26 Cycles; 28 Days/Cycle)|Physician Decision|6|||
147229117|NCT01698905|531011899|FG000|Overall Study|Adverse Event|4|||
147229118|NCT01698905|531011899|FG000|Overall Study|Physician Decision|2|||
147229119|NCT01698905|531011899|FG000|Overall Study|Pregnancy|1|||
147229120|NCT01698905|531011899|FG000|Overall Study|Protocol Violation|1|||
147229121|NCT01698905|531011899|FG000|Overall Study|Subject/guardian decision|2|||
147229122|NCT01698905|531011899|FG000|Overall Study|Death|1|||
147229123|NCT00764504|531011901|FG000|Overall Study|Death|12|||
147229124|NCT00764504|531011902|FG001|Overall Study|Death|6|||
147229125|NCT00764504|531011903|FG002|Overall Study|Death|13|||
147229126|NCT00764504|531011901|FG000|Overall Study|Revision of Device|12|||
147229127|NCT00764504|531011902|FG001|Overall Study|Revision of Device|23|||
147229128|NCT00764504|531011903|FG002|Overall Study|Revision of Device|14|||
147229129|NCT00764504|531011901|FG000|Overall Study|Physician Decision|1|||
147229130|NCT00764504|531011902|FG001|Overall Study|Physician Decision|0|||
147565875|NCT02336165|532230093|FG000|Overall Study|Death|3|||
147565876|NCT02336165|532230094|FG001|Overall Study|Death|0|||
147565877|NCT02336165|532230095|FG002|Overall Study|Death|0|||
147565878|NCT02336165|532230096|FG003|Overall Study|Death|0|||
147565879|NCT02336165|532230097|FG004|Overall Study|Death|1|||
147565880|NCT02336165|532230093|FG000|Overall Study|Physician Decision|2|||
147565881|NCT02336165|532230094|FG001|Overall Study|Physician Decision|2|||
147565882|NCT02336165|532230095|FG002|Overall Study|Physician Decision|1|||
147116253|NCT02068599|530588835|FG000|Overall Study|Withdrawal by Subject|2|||
147116254|NCT02068599|530588836|FG001|Overall Study|Withdrawal by Subject|7|||
147229131|NCT00764504|531011903|FG002|Overall Study|Physician Decision|0|||
147116255|NCT02068599|530588837|FG002|Overall Study|Withdrawal by Subject|5|||
147116256|NCT02068599|530588835|FG000|Overall Study|Protocol Violation|4|||
147116257|NCT02068599|530588836|FG001|Overall Study|Protocol Violation|2|||
147116258|NCT02068599|530588837|FG002|Overall Study|Protocol Violation|3|||
147229132|NCT00764504|531011901|FG000|Overall Study|Withdrawal by Subject|1|||
147565883|NCT02336165|532230096|FG003|Overall Study|Physician Decision|1|||
147565884|NCT02336165|532230097|FG004|Overall Study|Physician Decision|0|||
147565885|NCT02336165|532230093|FG000|Overall Study|Withdrawal by Subject|0|||
147565886|NCT02336165|532230094|FG001|Overall Study|Withdrawal by Subject|0|||
147565887|NCT02336165|532230095|FG002|Overall Study|Withdrawal by Subject|1|||
147565888|NCT02336165|532230096|FG003|Overall Study|Withdrawal by Subject|0|||
147565889|NCT02336165|532230097|FG004|Overall Study|Withdrawal by Subject|1|||
147565890|NCT02336165|532230093|FG000|Overall Study|Adverse Event|4|||
147565891|NCT02336165|532230094|FG001|Overall Study|Adverse Event|1|||
147565892|NCT02336165|532230095|FG002|Overall Study|Adverse Event|2|||
147565893|NCT02336165|532230096|FG003|Overall Study|Adverse Event|4|||
147565894|NCT02336165|532230097|FG004|Overall Study|Adverse Event|1|||
147565895|NCT02336165|532230093|FG000|Overall Study|Progressive disease|23|||
147565896|NCT02336165|532230094|FG001|Overall Study|Progressive disease|22|||
147565897|NCT02336165|532230095|FG002|Overall Study|Progressive disease|27|||
147565898|NCT02336165|532230096|FG003|Overall Study|Progressive disease|24|||
147565899|NCT02336165|532230097|FG004|Overall Study|Progressive disease|19|||
147565900|NCT02336165|532230093|FG000|Overall Study|Non-compliance|1|||
147565901|NCT02336165|532230094|FG001|Overall Study|Non-compliance|0|||
147565902|NCT02336165|532230095|FG002|Overall Study|Non-compliance|0|||
147565903|NCT02336165|532230096|FG003|Overall Study|Non-compliance|1|||
147565904|NCT02336165|532230097|FG004|Overall Study|Non-compliance|0|||
147565905|NCT02336165|532230093|FG000|Overall Study|Other|1|||
147565906|NCT02336165|532230094|FG001|Overall Study|Other|0|||
147565907|NCT02336165|532230095|FG002|Overall Study|Other|0|||
147565908|NCT02336165|532230096|FG003|Overall Study|Other|1|||
147565909|NCT02336165|532230097|FG004|Overall Study|Other|0|||
147565910|NCT01010542|532230102|FG000|Overall Study|Adverse Event|0|||
147565911|NCT01010542|532230103|FG001|Overall Study|Adverse Event|1|||
147565912|NCT01010542|532230104|FG002|Overall Study|Adverse Event|0|||
147565913|NCT01010542|532230102|FG000|Overall Study|Lost to Follow-up|0|||
147565914|NCT01010542|532230103|FG001|Overall Study|Lost to Follow-up|1|||
147565915|NCT01010542|532230104|FG002|Overall Study|Lost to Follow-up|0|||
147565916|NCT01010542|532230102|FG000|Overall Study|Withdrawal by Subject|0|||
147565917|NCT01010542|532230103|FG001|Overall Study|Withdrawal by Subject|3|||
147565918|NCT01010542|532230104|FG002|Overall Study|Withdrawal by Subject|2|||
147565919|NCT00857623|532230105|FG000|Overall Study|Adverse Event|5|||
147565920|NCT00857623|532230106|FG001|Overall Study|Adverse Event|2|||
147116259|NCT02068599|530588835|FG000|Overall Study|Lost to Follow-up|1|||
147116260|NCT02068599|530588836|FG001|Overall Study|Lost to Follow-up|0|||
147116261|NCT02068599|530588837|FG002|Overall Study|Lost to Follow-up|0|||
147116262|NCT02068599|530588835|FG000|Overall Study|Lack of Efficacy|0|||
147116263|NCT02068599|530588836|FG001|Overall Study|Lack of Efficacy|0|||
147116264|NCT02068599|530588837|FG002|Overall Study|Lack of Efficacy|3|||
147116265|NCT02068599|530588835|FG000|Overall Study|Noncompliance|0|||
147116266|NCT02068599|530588836|FG001|Overall Study|Noncompliance|0|||
147116267|NCT02068599|530588837|FG002|Overall Study|Noncompliance|1|||
147565921|NCT00857623|532230105|FG000|Overall Study|Study-specific discontinuation criteria|5|||
147565922|NCT00857623|532230106|FG001|Overall Study|Study-specific discontinuation criteria|3|||
147565923|NCT00857623|532230105|FG000|Overall Study|Withdrawal by Subject|2|||
147565924|NCT00857623|532230106|FG001|Overall Study|Withdrawal by Subject|1|||
147565925|NCT00857623|532230105|FG000|Overall Study|Lack of Efficacy|1|||
147565926|NCT00857623|532230106|FG001|Overall Study|Lack of Efficacy|1|||
147565927|NCT00857623|532230105|FG000|Overall Study|Severe non-compliance to protocol|1|||
147565928|NCT00857623|532230106|FG001|Overall Study|Severe non-compliance to protocol|1|||
147565929|NCT00857623|532230105|FG000|Overall Study|Intake of prohibited medication|0|||
147565930|NCT00857623|532230106|FG001|Overall Study|Intake of prohibited medication|1|||
147565931|NCT00857623|532230105|FG000|Overall Study|Positive for HEP C|0|||
147565932|NCT00857623|532230106|FG001|Overall Study|Positive for HEP C|1|||
147565933|NCT04185909|532230107|FG000|Overall Study|Lost to Follow-up|1|||
147565934|NCT04510285|532230110|FG000|Overall Study|Death|1|||
147565935|NCT00626548|532230111|FG000|Overall Study|Adverse Event|164|||
147565936|NCT00626548|532230112|FG001|Overall Study|Adverse Event|44|||
147565937|NCT00626548|532230111|FG000|Overall Study|Withdrawal by Subject|42|||
147565938|NCT00626548|532230112|FG001|Overall Study|Withdrawal by Subject|46|||
147565939|NCT00626548|532230111|FG000|Overall Study|Protocol Violation|4|||
147229133|NCT00764504|531011902|FG001|Overall Study|Withdrawal by Subject|7|||
147229134|NCT00764504|531011903|FG002|Overall Study|Withdrawal by Subject|4|||
147565940|NCT00626548|532230112|FG001|Overall Study|Protocol Violation|11|||
147565941|NCT00626548|532230111|FG000|Overall Study|Lost to Follow-up|2|||
147565942|NCT00626548|532230112|FG001|Overall Study|Lost to Follow-up|2|||
147565943|NCT00626548|532230111|FG000|Overall Study|Other termination reason|493|||
147565944|NCT00626548|532230112|FG001|Overall Study|Other termination reason|613|||
147565945|NCT01066143|532232021|FG000|Overall Study|ineligible for the study|8|||
147565946|NCT01294787|532232022|FG000|Period 1|Adverse Event|0|||
147565947|NCT01294787|532232023|FG001|Period 1|Adverse Event|0|||
147565948|NCT01294787|532232024|FG002|Period 1|Adverse Event|0|||
147116268|NCT01871727|530588838|FG000|Lead-In Part (1 Year 2 Months)|Disease Progression|1|||
147116269|NCT01871727|530588839|FG001|Lead-In Part (1 Year 2 Months)|Disease Progression|4|||
147565949|NCT01294787|532232025|FG003|Period 1|Adverse Event|0|||
147565950|NCT01294787|532232026|FG004|Period 1|Adverse Event|1|||
147565951|NCT01294787|532232027|FG005|Period 1|Adverse Event|0|||
147565952|NCT01294787|532232022|FG000|Period 1|Withdrawal by Subject|0|||
147565953|NCT01294787|532232023|FG001|Period 1|Withdrawal by Subject|0|||
147565954|NCT01294787|532232024|FG002|Period 1|Withdrawal by Subject|0|||
147565955|NCT01294787|532232025|FG003|Period 1|Withdrawal by Subject|1|||
147565956|NCT01294787|532232026|FG004|Period 1|Withdrawal by Subject|1|||
147565957|NCT01294787|532232027|FG005|Period 1|Withdrawal by Subject|1|||
147565958|NCT01294787|532232022|FG000|Period 1|Administrative problem|0|||
147565959|NCT01294787|532232023|FG001|Period 1|Administrative problem|0|||
147565960|NCT01294787|532232024|FG002|Period 1|Administrative problem|1|||
147565961|NCT01294787|532232025|FG003|Period 1|Administrative problem|0|||
147565962|NCT01294787|532232026|FG004|Period 1|Administrative problem|0|||
147565963|NCT01294787|532232027|FG005|Period 1|Administrative problem|1|||
147565964|NCT01294787|532232022|FG000|Period 2|Adverse Event|0|||
147565965|NCT01294787|532232023|FG001|Period 2|Adverse Event|3|||
147116270|NCT01871727|530588840|FG002|Lead-In Part (1 Year 2 Months)|Disease Progression|4|||
147116271|NCT01871727|530588841|FG003|Lead-In Part (1 Year 2 Months)|Disease Progression|0|||
147116272|NCT01871727|530588842|FG004|Lead-In Part (1 Year 2 Months)|Disease Progression|0|||
147116273|NCT01871727|530588838|FG000|Main Study Part (2 Years 4 Months)|Other|0|||
147116274|NCT01871727|530588839|FG001|Main Study Part (2 Years 4 Months)|Other|0|||
147116275|NCT01871727|530588840|FG002|Main Study Part (2 Years 4 Months)|Other|0|||
147116276|NCT01871727|530588841|FG003|Main Study Part (2 Years 4 Months)|Other|0|||
147116277|NCT01871727|530588842|FG004|Main Study Part (2 Years 4 Months)|Other|2|||
147116278|NCT01871727|530588838|FG000|Main Study Part (2 Years 4 Months)|Sponsor Decision|0|||
147116279|NCT01871727|530588839|FG001|Main Study Part (2 Years 4 Months)|Sponsor Decision|0|||
147116280|NCT01871727|530588840|FG002|Main Study Part (2 Years 4 Months)|Sponsor Decision|0|||
147116281|NCT01871727|530588841|FG003|Main Study Part (2 Years 4 Months)|Sponsor Decision|0|||
147116282|NCT01871727|530588842|FG004|Main Study Part (2 Years 4 Months)|Sponsor Decision|11|||
147116283|NCT01871727|530588838|FG000|Main Study Part (2 Years 4 Months)|Withdrawal by Subject|0|||
147116284|NCT01871727|530588839|FG001|Main Study Part (2 Years 4 Months)|Withdrawal by Subject|0|||
147116285|NCT01871727|530588840|FG002|Main Study Part (2 Years 4 Months)|Withdrawal by Subject|0|||
147116286|NCT01871727|530588841|FG003|Main Study Part (2 Years 4 Months)|Withdrawal by Subject|0|||
147116287|NCT01871727|530588842|FG004|Main Study Part (2 Years 4 Months)|Withdrawal by Subject|9|||
147116288|NCT01871727|530588838|FG000|Main Study Part (2 Years 4 Months)|Disease progression|0|||
147116289|NCT01871727|530588839|FG001|Main Study Part (2 Years 4 Months)|Disease progression|0|||
147116290|NCT01871727|530588840|FG002|Main Study Part (2 Years 4 Months)|Disease progression|0|||
147229135|NCT00764504|531011901|FG000|Overall Study|Lost to Follow-up|40|||
147229136|NCT00764504|531011902|FG001|Overall Study|Lost to Follow-up|34|||
147229137|NCT00764504|531011903|FG002|Overall Study|Lost to Follow-up|72|||
147229138|NCT02456103|531011904|FG000|Overall Study|Study Closure|207|||
147229139|NCT02456103|531011904|FG000|Overall Study|Physician Decision|1|||
147229140|NCT02456103|531011904|FG000|Overall Study|Required prohibited medications|5|||
147229141|NCT02456103|531011904|FG000|Overall Study|Protocol Violation|1|||
147229142|NCT02456103|531011904|FG000|Overall Study|Adverse Event|5|||
147229143|NCT02456103|531011904|FG000|Overall Study|Abnormal Laboratory Value|2|||
147229144|NCT02456103|531011904|FG000|Overall Study|Lost to Follow-up|1|||
147229145|NCT02456103|531011904|FG000|Overall Study|Withdrawal by Subject|24|||
147229146|NCT04010539|531011905|FG000|Overall Study|Withdrawal by Subject|4|||
147229147|NCT04010539|531011906|FG001|Overall Study|Withdrawal by Subject|1|||
147229148|NCT04010539|531011905|FG000|Overall Study|Physician Decision|0|||
147229149|NCT04010539|531011906|FG001|Overall Study|Physician Decision|2|||
147229150|NCT04010539|531011905|FG000|Overall Study|Lost to Follow-up|10|||
147229151|NCT04010539|531011906|FG001|Overall Study|Lost to Follow-up|14|||
147229152|NCT04010539|531011905|FG000|Overall Study|Adverse Event|3|||
147229153|NCT04010539|531011906|FG001|Overall Study|Adverse Event|0|||
147229154|NCT04010539|531011905|FG000|Overall Study|Participant Did Not Receive IP|0|||
147229155|NCT04010539|531011906|FG001|Overall Study|Participant Did Not Receive IP|1|||
147229156|NCT04010539|531011905|FG000|Overall Study|Protocol Deviation|0|||
147229157|NCT04010539|531011906|FG001|Overall Study|Protocol Deviation|1|||
147312362|NCT03904693|531310750|FG002|DB Treatment Period (Week 1 to Week 16)|Physician Decision|2|||
147565966|NCT01294787|532232024|FG002|Period 2|Adverse Event|0|||
147565967|NCT01294787|532232025|FG003|Period 2|Adverse Event|1|||
147229158|NCT04010539|531011905|FG000|Overall Study|Randomized in Error/ Mistake|2|||
147229159|NCT04010539|531011906|FG001|Overall Study|Randomized in Error/ Mistake|0|||
147229160|NCT04010539|531011905|FG000|Overall Study|Eligibility Criteria Unable to Evaluate|1|||
147229161|NCT04010539|531011906|FG001|Overall Study|Eligibility Criteria Unable to Evaluate|0|||
147229162|NCT00568685|531011911|FG000|Overall Study|Adverse Event|2|||
147565968|NCT01294787|532232026|FG004|Period 2|Adverse Event|0|||
147565969|NCT01294787|532232027|FG005|Period 2|Adverse Event|0|||
147565970|NCT01294787|532232022|FG000|Period 2|No longer needs study drug|0|||
147116291|NCT01871727|530588841|FG003|Main Study Part (2 Years 4 Months)|Disease progression|0|||
147116292|NCT01871727|530588842|FG004|Main Study Part (2 Years 4 Months)|Disease progression|20|||
147565971|NCT01294787|532232023|FG001|Period 2|No longer needs study drug|0|||
147565972|NCT01294787|532232024|FG002|Period 2|No longer needs study drug|0|||
147565973|NCT01294787|532232025|FG003|Period 2|No longer needs study drug|1|||
147565974|NCT01294787|532232026|FG004|Period 2|No longer needs study drug|0|||
147565975|NCT01294787|532232027|FG005|Period 2|No longer needs study drug|0|||
147565976|NCT01294787|532232022|FG000|Period 3|Adverse Event|0|||
147565977|NCT01294787|532232023|FG001|Period 3|Adverse Event|0|||
147565978|NCT01294787|532232024|FG002|Period 3|Adverse Event|0|||
147565979|NCT01294787|532232025|FG003|Period 3|Adverse Event|0|||
147565980|NCT01294787|532232026|FG004|Period 3|Adverse Event|1|||
147565981|NCT01294787|532232027|FG005|Period 3|Adverse Event|0|||
147565982|NCT03785548|532232028|FG000|Overall Study|age > 80|1|||
147565983|NCT03785548|532232029|FG001|Overall Study|age > 80|0|||
147565984|NCT03785548|532232028|FG000|Overall Study|no Postop queries|1|||
147229163|NCT00568685|531011912|FG001|Overall Study|Adverse Event|3|||
147229164|NCT00568685|531011913|FG002|Overall Study|Adverse Event|3|||
147229165|NCT00568685|531011911|FG000|Overall Study|Withdrawal by Subject|7|||
147229166|NCT00568685|531011912|FG001|Overall Study|Withdrawal by Subject|2|||
147229167|NCT00568685|531011913|FG002|Overall Study|Withdrawal by Subject|2|||
147229168|NCT00568685|531011911|FG000|Overall Study|Protocol Violation|1|||
147229169|NCT00568685|531011912|FG001|Overall Study|Protocol Violation|0|||
147229170|NCT00568685|531011913|FG002|Overall Study|Protocol Violation|0|||
147229171|NCT01638819|531011915|FG000|Overall Study|Lost to Follow-up|1|||
147229172|NCT01638819|531011916|FG001|Overall Study|Lost to Follow-up|0|||
147229173|NCT00471146|531011917|FG000|Overall Study|Adverse Event|32|||
147229174|NCT00471146|531011918|FG001|Overall Study|Adverse Event|33|||
147229175|NCT00471146|531011917|FG000|Overall Study|Withdrawal by Subject|14|||
147229176|NCT00471146|531011918|FG001|Overall Study|Withdrawal by Subject|11|||
147229177|NCT00471146|531011917|FG000|Overall Study|Death|11|||
147229178|NCT00471146|531011918|FG001|Overall Study|Death|12|||
147229179|NCT00471146|531011917|FG000|Overall Study|Lost to Follow-up|4|||
147229180|NCT00471146|531011918|FG001|Overall Study|Lost to Follow-up|2|||
147229181|NCT00471146|531011917|FG000|Overall Study|Protocol Violation|2|||
147565985|NCT03785548|532232029|FG001|Overall Study|no Postop queries|0|||
147565986|NCT00396279|532232030|FG000|Overall Study|Ongoing in study|26|||
147565987|NCT00396279|532232030|FG000|Overall Study|Disease progression|2|||
147565988|NCT00396279|532232030|FG000|Overall Study|Withdrawal by Subject|1|||
147565989|NCT00396279|532232030|FG000|Overall Study|Physician Decision|1|||
147565990|NCT03351335|532232032|FG000|Overall Study|Failure to maintain inclusion/exclusion|0|||
147565991|NCT03351335|532232033|FG001|Overall Study|Failure to maintain inclusion/exclusion|0|||
147565992|NCT03351335|532232034|FG002|Overall Study|Failure to maintain inclusion/exclusion|4|||
147565993|NCT04605094|532232035|FG000|Overall Study|Adverse Event|2|||
147565994|NCT04605094|532232036|FG001|Overall Study|Adverse Event|2|||
147565995|NCT04605094|532232035|FG000|Overall Study|Lost to Follow-up|1|||
147565996|NCT04605094|532232036|FG001|Overall Study|Lost to Follow-up|4|||
147565997|NCT04605094|532232035|FG000|Overall Study|Physician Decision|2|||
147565998|NCT04605094|532232036|FG001|Overall Study|Physician Decision|2|||
147565999|NCT04605094|532232035|FG000|Overall Study|Study terminated by Sponsor|31|||
147566000|NCT04605094|532232036|FG001|Overall Study|Study terminated by Sponsor|33|||
147566001|NCT04605094|532232035|FG000|Overall Study|Withdrawal by Subject|22|||
147566002|NCT04605094|532232036|FG001|Overall Study|Withdrawal by Subject|19|||
147566003|NCT04605094|532232035|FG000|Overall Study|Other|1|||
147566004|NCT04605094|532232036|FG001|Overall Study|Other|1|||
147566005|NCT02724462|532232037|FG000|3 Month Follow-up Survey|Lost to Follow-up|171|||
147566006|NCT02724462|532232038|FG001|3 Month Follow-up Survey|Lost to Follow-up|151|||
147566007|NCT02724462|532232037|FG000|3 Month Follow-up Survey|Excluded as ineligible after randomization|40|||
147566008|NCT02724462|532232038|FG001|3 Month Follow-up Survey|Excluded as ineligible after randomization|48|||
147566009|NCT02724462|532232037|FG000|6 Month Follow-up Survey|Lost to Follow-up|156|||
147566010|NCT02724462|532232038|FG001|6 Month Follow-up Survey|Lost to Follow-up|123|||
147566011|NCT02724462|532232037|FG000|6 Month Follow-up Survey|Excluded as ineligible after randomization|40|||
147566012|NCT02724462|532232038|FG001|6 Month Follow-up Survey|Excluded as ineligible after randomization|48|||
147566013|NCT02724462|532232037|FG000|12 Month Follow-up Survey|Lost to Follow-up|174|||
147566014|NCT02724462|532232038|FG001|12 Month Follow-up Survey|Lost to Follow-up|134|||
147566015|NCT02724462|532232037|FG000|12 Month Follow-up Survey|Excluded as ineligible after randomization|40|||
147566016|NCT02724462|532232038|FG001|12 Month Follow-up Survey|Excluded as ineligible after randomization|48|||
147566017|NCT01900691|532232039|FG000|Overall Study|Death|7|||
147566018|NCT01900691|532232039|FG000|Overall Study|Lost to Follow-up|4|||
147566019|NCT01900691|532232039|FG000|Overall Study|Study Device Not Placed|3|||
147566020|NCT01900691|532232039|FG000|Overall Study|Non study stent placed|2|||
147566021|NCT01900691|532232039|FG000|Overall Study|Six month Follow up completed, stent not removed|2|||
147566022|NCT01900691|532232039|FG000|Overall Study|Complete stent migration through digestive tract|1|||
147566023|NCT00469417|532232040|FG000|Overall Study|Treatment failure all lesions|18|||
147229182|NCT00471146|531011918|FG001|Overall Study|Protocol Violation|2|||
147229183|NCT00471146|531011917|FG000|Overall Study|Objective progression or relapse|84|||
147229184|NCT00471146|531011918|FG001|Overall Study|Objective progression or relapse|87|||
147229185|NCT00471146|531011917|FG000|Overall Study|Global deterioration of health status|12|||
147566024|NCT00469417|532232041|FG001|Overall Study|Treatment failure all lesions|11|||
147566025|NCT00469417|532232040|FG000|Overall Study|Consent withdrawn|1|||
147116293|NCT01871727|530588838|FG000|Main Study Part (2 Years 4 Months)|Lost to Follow-up|0|||
147116294|NCT01871727|530588839|FG001|Main Study Part (2 Years 4 Months)|Lost to Follow-up|0|||
147116295|NCT01871727|530588840|FG002|Main Study Part (2 Years 4 Months)|Lost to Follow-up|0|||
147116296|NCT01871727|530588841|FG003|Main Study Part (2 Years 4 Months)|Lost to Follow-up|0|||
147116297|NCT01871727|530588842|FG004|Main Study Part (2 Years 4 Months)|Lost to Follow-up|2|||
147116298|NCT01871727|530588838|FG000|Main Study Part (2 Years 4 Months)|Not treated|0|||
147116299|NCT01871727|530588839|FG001|Main Study Part (2 Years 4 Months)|Not treated|0|||
147116300|NCT01871727|530588840|FG002|Main Study Part (2 Years 4 Months)|Not treated|0|||
147116301|NCT01871727|530588841|FG003|Main Study Part (2 Years 4 Months)|Not treated|0|||
147116302|NCT01871727|530588842|FG004|Main Study Part (2 Years 4 Months)|Not treated|1|||
147116303|NCT01263028|530588843|FG000|Overall Study|Withdrawal by Subject|1|||
147116304|NCT01263028|530588843|FG000|Overall Study|Adverse Event|1|||
147116305|NCT01263028|530588843|FG000|Overall Study|Study terminated due to low enrollment.|4|||
147116306|NCT02958527|530588846|FG000|Overall Study|Not collected CRFs|12|||
147116307|NCT02691572|530588847|FG000|Overall Study|Withdrawal by Subject|1|||
147116308|NCT02691572|530588848|FG001|Overall Study|Withdrawal by Subject|0|||
147116309|NCT02691572|530588847|FG000|Overall Study|Protocol Violation|0|||
147116310|NCT02691572|530588848|FG001|Overall Study|Protocol Violation|1|||
147116311|NCT01947933|530588849|FG000|Overall Study|Withdrawal by Subject|0|||
147116312|NCT01947933|530588850|FG001|Overall Study|Withdrawal by Subject|0|||
147116313|NCT01947933|530588851|FG002|Overall Study|Withdrawal by Subject|1|||
147116314|NCT01947933|530588852|FG003|Overall Study|Withdrawal by Subject|0|||
147116315|NCT01947933|530588853|FG004|Overall Study|Withdrawal by Subject|0|||
147116316|NCT01947933|530588854|FG005|Overall Study|Withdrawal by Subject|0|||
147116317|NCT01947933|530588855|FG006|Overall Study|Withdrawal by Subject|0|||
147116318|NCT01947933|530588856|FG007|Overall Study|Withdrawal by Subject|0|||
147116319|NCT01947933|530588857|FG008|Overall Study|Withdrawal by Subject|0|||
147116320|NCT01947933|530588849|FG000|Overall Study|Lost to Follow-up|0|||
147116321|NCT01947933|530588850|FG001|Overall Study|Lost to Follow-up|0|||
147116322|NCT01947933|530588851|FG002|Overall Study|Lost to Follow-up|0|||
147116323|NCT01947933|530588852|FG003|Overall Study|Lost to Follow-up|0|||
147116324|NCT01947933|530588853|FG004|Overall Study|Lost to Follow-up|0|||
147116325|NCT01947933|530588854|FG005|Overall Study|Lost to Follow-up|0|||
147116326|NCT01947933|530588855|FG006|Overall Study|Lost to Follow-up|0|||
147116327|NCT01947933|530588856|FG007|Overall Study|Lost to Follow-up|0|||
147116328|NCT01947933|530588857|FG008|Overall Study|Lost to Follow-up|1|||
147116329|NCT00294398|530588858|FG000|Overall Study|Lost to Follow-up|21|||
147116330|NCT00294398|530588859|FG001|Overall Study|Lost to Follow-up|26|||
147116331|NCT00985790|530588860|FG000|Overall Study|Withdrawal by Subject|1|||
147116332|NCT00985790|530588861|FG001|Overall Study|Withdrawal by Subject|1|||
147116333|NCT00985790|530588860|FG000|Overall Study|Lost to Follow-up|6|||
147116334|NCT00985790|530588861|FG001|Overall Study|Lost to Follow-up|7|||
147116335|NCT03753542|530588865|FG000|Overall Study|Lost to Follow-up|9|||
147116336|NCT03753542|530588866|FG001|Overall Study|Lost to Follow-up|14|||
147116337|NCT06100250|530588867|FG000|Overall Study|Lost to Follow-up|5|||
147116338|NCT04180696|530588868|FG000|Overall Study|Death|5|||
147116339|NCT04180696|530588869|FG001|Overall Study|Death|6|||
147116340|NCT04180696|530588868|FG000|Overall Study|Lost to Follow-up|1|||
147116341|NCT04180696|530588869|FG001|Overall Study|Lost to Follow-up|0|||
147116342|NCT04180696|530588868|FG000|Overall Study|Withdrawal by Subject|0|||
147116343|NCT04180696|530588869|FG001|Overall Study|Withdrawal by Subject|1|||
147312363|NCT03904693|531310751|FG003|DB Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
147312364|NCT03904693|531310752|FG004|DB Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
147312365|NCT03904693|531310753|FG005|DB Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
147312366|NCT03904693|531310748|FG000|DB Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|0|||
147312367|NCT03904693|531310749|FG001|DB Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|1|||
147312368|NCT03904693|531310750|FG002|DB Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|4|||
147116344|NCT05537571|530588870|FG000|Overall Study|Withdrawal by Subject|1|||
147116345|NCT05537571|530588871|FG001|Overall Study|Withdrawal by Subject|1|||
147116346|NCT05537571|530588872|FG002|Overall Study|Withdrawal by Subject|0|||
147116347|NCT05537571|530588873|FG003|Overall Study|Withdrawal by Subject|0|||
147312369|NCT03904693|531310751|FG003|DB Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|0|||
147444432|NCT00804570|531792612|FG000|Overall Study|Entry criteria not met|5|||
147116348|NCT05537571|530588874|FG004|Overall Study|Withdrawal by Subject|0|||
147116349|NCT05537571|530588870|FG000|Overall Study|Adverse Event|2|||
147116350|NCT05537571|530588871|FG001|Overall Study|Adverse Event|0|||
147116351|NCT05537571|530588872|FG002|Overall Study|Adverse Event|0|||
147116352|NCT05537571|530588873|FG003|Overall Study|Adverse Event|0|||
147116353|NCT05537571|530588874|FG004|Overall Study|Adverse Event|0|||
147116354|NCT05537571|530588870|FG000|Overall Study|Hepatitis A screening result|2|||
147116355|NCT05537571|530588871|FG001|Overall Study|Hepatitis A screening result|0|||
147116356|NCT05537571|530588872|FG002|Overall Study|Hepatitis A screening result|0|||
147116357|NCT05537571|530588873|FG003|Overall Study|Hepatitis A screening result|0|||
147116358|NCT05537571|530588874|FG004|Overall Study|Hepatitis A screening result|0|||
147116359|NCT05537571|530588870|FG000|Overall Study|Lost to Follow-up|0|||
147116360|NCT05537571|530588871|FG001|Overall Study|Lost to Follow-up|0|||
147116361|NCT05537571|530588872|FG002|Overall Study|Lost to Follow-up|1|||
147116362|NCT05537571|530588873|FG003|Overall Study|Lost to Follow-up|0|||
147116363|NCT05537571|530588874|FG004|Overall Study|Lost to Follow-up|1|||
147116364|NCT04210375|530588875|FG000|Overall Study|Death|0|||
147312370|NCT03904693|531310752|FG004|DB Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|0|||
147312371|NCT03904693|531310753|FG005|DB Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|0|||
147312372|NCT03904693|531310748|FG000|OL Treatment Period (Week 17 to Week189)|Withdrawal by Subject|0|||
147312373|NCT03904693|531310749|FG001|OL Treatment Period (Week 17 to Week189)|Withdrawal by Subject|0|||
147312374|NCT03904693|531310750|FG002|OL Treatment Period (Week 17 to Week189)|Withdrawal by Subject|0|||
147312375|NCT03904693|531310751|FG003|OL Treatment Period (Week 17 to Week189)|Withdrawal by Subject|2|||
147312376|NCT03904693|531310752|FG004|OL Treatment Period (Week 17 to Week189)|Withdrawal by Subject|4|||
147312377|NCT03904693|531310753|FG005|OL Treatment Period (Week 17 to Week189)|Withdrawal by Subject|7|||
147312378|NCT03904693|531310748|FG000|OL Treatment Period (Week 17 to Week189)|Death|0|||
147312379|NCT03904693|531310749|FG001|OL Treatment Period (Week 17 to Week189)|Death|0|||
147312380|NCT03904693|531310750|FG002|OL Treatment Period (Week 17 to Week189)|Death|0|||
147312381|NCT03904693|531310751|FG003|OL Treatment Period (Week 17 to Week189)|Death|0|||
147312382|NCT03904693|531310752|FG004|OL Treatment Period (Week 17 to Week189)|Death|0|||
147312383|NCT03904693|531310753|FG005|OL Treatment Period (Week 17 to Week189)|Death|5|||
147312384|NCT03904693|531310748|FG000|OL Treatment Period (Week 17 to Week189)|Adverse Event|0|||
147312385|NCT03904693|531310749|FG001|OL Treatment Period (Week 17 to Week189)|Adverse Event|0|||
147312386|NCT03904693|531310750|FG002|OL Treatment Period (Week 17 to Week189)|Adverse Event|0|||
147312387|NCT03904693|531310751|FG003|OL Treatment Period (Week 17 to Week189)|Adverse Event|2|||
147312388|NCT03904693|531310752|FG004|OL Treatment Period (Week 17 to Week189)|Adverse Event|0|||
147312389|NCT03904693|531310753|FG005|OL Treatment Period (Week 17 to Week189)|Adverse Event|0|||
147312390|NCT03904693|531310748|FG000|OL Treatment Period (Week 17 to Week189)|Initiated prohibited medication|0|||
147312391|NCT03904693|531310749|FG001|OL Treatment Period (Week 17 to Week189)|Initiated prohibited medication|0|||
147312392|NCT03904693|531310750|FG002|OL Treatment Period (Week 17 to Week189)|Initiated prohibited medication|0|||
147312393|NCT03904693|531310751|FG003|OL Treatment Period (Week 17 to Week189)|Initiated prohibited medication|1|||
147312394|NCT03904693|531310752|FG004|OL Treatment Period (Week 17 to Week189)|Initiated prohibited medication|0|||
147312395|NCT03904693|531310753|FG005|OL Treatment Period (Week 17 to Week189)|Initiated prohibited medication|0|||
147312396|NCT03904693|531310748|FG000|OL Treatment Period (Week 17 to Week189)|Lost to Follow-up|0|||
147312397|NCT03904693|531310749|FG001|OL Treatment Period (Week 17 to Week189)|Lost to Follow-up|0|||
147312398|NCT03904693|531310750|FG002|OL Treatment Period (Week 17 to Week189)|Lost to Follow-up|0|||
147312399|NCT03904693|531310751|FG003|OL Treatment Period (Week 17 to Week189)|Lost to Follow-up|0|||
147312400|NCT03904693|531310752|FG004|OL Treatment Period (Week 17 to Week189)|Lost to Follow-up|0|||
147312401|NCT03904693|531310753|FG005|OL Treatment Period (Week 17 to Week189)|Lost to Follow-up|1|||
147312402|NCT03904693|531310748|FG000|OL Treatment Period (Week 17 to Week189)|Non-compliance with study drug|0|||
147312403|NCT03904693|531310749|FG001|OL Treatment Period (Week 17 to Week189)|Non-compliance with study drug|0|||
147312404|NCT03904693|531310750|FG002|OL Treatment Period (Week 17 to Week189)|Non-compliance with study drug|0|||
147312405|NCT03904693|531310751|FG003|OL Treatment Period (Week 17 to Week189)|Non-compliance with study drug|0|||
147312406|NCT03904693|531310752|FG004|OL Treatment Period (Week 17 to Week189)|Non-compliance with study drug|1|||
147312407|NCT03904693|531310753|FG005|OL Treatment Period (Week 17 to Week189)|Non-compliance with study drug|0|||
147312408|NCT03904693|531310748|FG000|OL Treatment Period (Week 17 to Week189)|Technical problems|0|||
147312409|NCT03904693|531310749|FG001|OL Treatment Period (Week 17 to Week189)|Technical problems|0|||
147312410|NCT03904693|531310750|FG002|OL Treatment Period (Week 17 to Week189)|Technical problems|0|||
147566026|NCT00469417|532232041|FG001|Overall Study|Consent withdrawn|1|||
147566027|NCT00469417|532232040|FG000|Overall Study|Adverse Event|8|||
147566028|NCT00469417|532232041|FG001|Overall Study|Adverse Event|2|||
147566029|NCT00469417|532232040|FG000|Overall Study|Lost to Follow-up|1|||
147566030|NCT00469417|532232041|FG001|Overall Study|Lost to Follow-up|2|||
147566031|NCT00469417|532232040|FG000|Overall Study|Intercurrent disease|0|||
147566032|NCT00469417|532232041|FG001|Overall Study|Intercurrent disease|1|||
147566033|NCT00469417|532232040|FG000|Overall Study|Randomized but not treated|2|||
147116365|NCT04210375|530588876|FG001|Overall Study|Death|1|||
147116366|NCT04210375|530588877|FG002|Overall Study|Death|0|||
147116367|NCT04210375|530588878|FG003|Overall Study|Death|0|||
147116368|NCT00424008|530588879|FG000|Overall Study|Adverse Event|8|||
147116369|NCT00424008|530588880|FG001|Overall Study|Adverse Event|6|||
147116370|NCT00424008|530588879|FG000|Overall Study|Lack of Efficacy|40|||
147116371|NCT00424008|530588880|FG001|Overall Study|Lack of Efficacy|34|||
147116372|NCT00424008|530588879|FG000|Overall Study|Lost to Follow-up|1|||
147116373|NCT00424008|530588880|FG001|Overall Study|Lost to Follow-up|2|||
147116374|NCT00424008|530588879|FG000|Overall Study|Withdrawal by Subject|5|||
147116375|NCT00424008|530588880|FG001|Overall Study|Withdrawal by Subject|8|||
147312411|NCT03904693|531310751|FG003|OL Treatment Period (Week 17 to Week189)|Technical problems|0|||
147312412|NCT03904693|531310752|FG004|OL Treatment Period (Week 17 to Week189)|Technical problems|0|||
147312413|NCT03904693|531310753|FG005|OL Treatment Period (Week 17 to Week189)|Technical problems|1|||
147312414|NCT03904693|531310748|FG000|OL Treatment Period (Week 17 to Week189)|Family problems|0|||
147312415|NCT03904693|531310749|FG001|OL Treatment Period (Week 17 to Week189)|Family problems|0|||
147312416|NCT03904693|531310750|FG002|OL Treatment Period (Week 17 to Week189)|Family problems|0|||
147312417|NCT03904693|531310751|FG003|OL Treatment Period (Week 17 to Week189)|Family problems|0|||
147312418|NCT03904693|531310752|FG004|OL Treatment Period (Week 17 to Week189)|Family problems|0|||
147312419|NCT03904693|531310753|FG005|OL Treatment Period (Week 17 to Week189)|Family problems|1|||
147312420|NCT04654468|531310754|FG000|Overall Study|Death|1|||
147312421|NCT04654468|531310754|FG000|Overall Study|Ongoing in the Study|50|||
147116376|NCT00424008|530588879|FG000|Overall Study|Noncompliance with protocol|13|||
147116377|NCT00424008|530588880|FG001|Overall Study|Noncompliance with protocol|7|||
147116378|NCT00424008|530588879|FG000|Overall Study|Did not meet protocol eligibility|16|||
147116379|NCT00424008|530588880|FG001|Overall Study|Did not meet protocol eligibility|21|||
147116380|NCT00424008|530588879|FG000|Overall Study|Administrative|266|||
147116381|NCT00424008|530588880|FG001|Overall Study|Administrative|257|||
147116382|NCT02593864|530588881|FG000|Overall Study|Withdrawal by Subject|3|||
147116383|NCT02593864|530588881|FG000|Overall Study|Lost to Follow-up|3|||
147312422|NCT06390826|531310755|FG000|Overall Study|Never Start Protocol Therapy|1|||
147312423|NCT06390826|531310755|FG000|Overall Study|Adverse Event|1|||
147312424|NCT06390826|531310755|FG000|Overall Study|Disease Progression|8|||
147312425|NCT01155661|531310756|FG000|Overall Study|Adverse Event|101|||
147312426|NCT01155661|531310756|FG000|Overall Study|Death|1|||
147312427|NCT01155661|531310756|FG000|Overall Study|Lack of Efficacy|32|||
147312428|NCT01155661|531310756|FG000|Overall Study|Lost to Follow-up|22|||
147312429|NCT01155661|531310756|FG000|Overall Study|Physician Decision|3|||
147312430|NCT01155661|531310756|FG000|Overall Study|Protocol Violation|35|||
147312431|NCT01155661|531310756|FG000|Overall Study|Withdrawal by Subject|73|||
147312432|NCT01155661|531310756|FG000|Overall Study|Sponsor Decision|13|||
147312433|NCT05832437|531310768|FG000|Overall Study|time off work|1|||
147312434|NCT05832437|531310769|FG001|Overall Study|time off work|0|||
147312435|NCT05832437|531310770|FG002|Overall Study|time off work|0|||
147312436|NCT05832437|531310771|FG003|Overall Study|time off work|0|||
147312437|NCT04159415|531310772|FG000|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; did not enter OLTP 4 extension|0|||
147312438|NCT04159415|531310773|FG001|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; did not enter OLTP 4 extension|0|||
147312439|NCT04159415|531310774|FG002|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; did not enter OLTP 4 extension|0|||
147312440|NCT04159415|531310775|FG003|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; did not enter OLTP 4 extension|0|||
147312441|NCT04159415|531310776|FG004|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; did not enter OLTP 4 extension|0|||
147312442|NCT04159415|531310777|FG005|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; did not enter OLTP 4 extension|0|||
147312443|NCT04159415|531310778|FG006|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; did not enter OLTP 4 extension|2|||
147312444|NCT04159415|531310779|FG007|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; did not enter OLTP 4 extension|2|||
147312445|NCT04159415|531310780|FG008|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; did not enter OLTP 4 extension|0|||
147312446|NCT04159415|531310781|FG009|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; did not enter OLTP 4 extension|0|||
147312447|NCT04159415|531310772|FG000|Open-Label Treatment Period (OLTP) 4|Lost to follow-up during OLTP 4 extension|0|||
147312448|NCT04159415|531310773|FG001|Open-Label Treatment Period (OLTP) 4|Lost to follow-up during OLTP 4 extension|0|||
147312449|NCT04159415|531310774|FG002|Open-Label Treatment Period (OLTP) 4|Lost to follow-up during OLTP 4 extension|0|||
147312450|NCT04159415|531310775|FG003|Open-Label Treatment Period (OLTP) 4|Lost to follow-up during OLTP 4 extension|0|||
147312451|NCT04159415|531310776|FG004|Open-Label Treatment Period (OLTP) 4|Lost to follow-up during OLTP 4 extension|0|||
147312452|NCT04159415|531310777|FG005|Open-Label Treatment Period (OLTP) 4|Lost to follow-up during OLTP 4 extension|0|||
147312453|NCT04159415|531310778|FG006|Open-Label Treatment Period (OLTP) 4|Lost to follow-up during OLTP 4 extension|0|||
147312454|NCT04159415|531310779|FG007|Open-Label Treatment Period (OLTP) 4|Lost to follow-up during OLTP 4 extension|1|||
147312455|NCT04159415|531310780|FG008|Open-Label Treatment Period (OLTP) 4|Lost to follow-up during OLTP 4 extension|0|||
147312456|NCT04159415|531310781|FG009|Open-Label Treatment Period (OLTP) 4|Lost to follow-up during OLTP 4 extension|0|||
147312457|NCT04159415|531310772|FG000|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; discontinued during OLTP4 Ext. PI/Participant decision|0|||
147312458|NCT04159415|531310773|FG001|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; discontinued during OLTP4 Ext. PI/Participant decision|0|||
147312459|NCT04159415|531310774|FG002|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; discontinued during OLTP4 Ext. PI/Participant decision|0|||
147312460|NCT04159415|531310775|FG003|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; discontinued during OLTP4 Ext. PI/Participant decision|0|||
147566034|NCT00469417|532232041|FG001|Overall Study|Randomized but not treated|0|||
147116384|NCT02184156|530588882|FG000|Phase 2 20 Week Efficacy|Protocol Violation|0|||
147312461|NCT04159415|531310776|FG004|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; discontinued during OLTP4 Ext. PI/Participant decision|0|||
147444433|NCT00804570|531792613|FG001|Overall Study|Entry criteria not met|5|||
147116385|NCT02184156|530588883|FG001|Phase 2 20 Week Efficacy|Protocol Violation|1|||
147566035|NCT01954394|532232044|FG000|Overall Study|Enrolled but not treated|1|||
147566036|NCT01954394|532232045|FG001|Overall Study|Enrolled but not treated|0|||
147566037|NCT01954394|532232044|FG000|Overall Study|Adverse Event|10|||
147566038|NCT01954394|532232045|FG001|Overall Study|Adverse Event|23|||
147566039|NCT01954394|532232044|FG000|Overall Study|Poor compliance to protocol|7|||
147566040|NCT01954394|532232045|FG001|Overall Study|Poor compliance to protocol|7|||
147566041|NCT01954394|532232044|FG000|Overall Study|Participant Moved|0|||
147566042|NCT01954394|532232045|FG001|Overall Study|Participant Moved|4|||
147566043|NCT01954394|532232044|FG000|Overall Study|Related to Study Drug administration|2|||
147566044|NCT01954394|532232045|FG001|Overall Study|Related to Study Drug administration|2|||
147566045|NCT01954394|532232044|FG000|Overall Study|Other than specified above|10|||
147566046|NCT01954394|532232045|FG001|Overall Study|Other than specified above|21|||
147566047|NCT04089735|532232050|FG000|Overall Study|Adverse Event|1|||
147566048|NCT04089735|532232051|FG001|Overall Study|Adverse Event|0|||
147566049|NCT04089735|532232052|FG002|Overall Study|Adverse Event|1|||
147566050|NCT04089735|532232053|FG003|Overall Study|Adverse Event|1|||
147566051|NCT04089735|532232054|FG004|Overall Study|Adverse Event|0|||
147566052|NCT04089735|532232055|FG005|Overall Study|Adverse Event|0|||
147566053|NCT04089735|532232050|FG000|Overall Study|Physician Decision|0|||
147566054|NCT04089735|532232051|FG001|Overall Study|Physician Decision|3|||
147566055|NCT04089735|532232052|FG002|Overall Study|Physician Decision|0|||
147566056|NCT04089735|532232053|FG003|Overall Study|Physician Decision|0|||
147566057|NCT04089735|532232054|FG004|Overall Study|Physician Decision|0|||
147566058|NCT04089735|532232055|FG005|Overall Study|Physician Decision|0|||
147566059|NCT04089735|532232050|FG000|Overall Study|Withdrawal by Subject|0|||
147566060|NCT04089735|532232051|FG001|Overall Study|Withdrawal by Subject|0|||
147566061|NCT04089735|532232052|FG002|Overall Study|Withdrawal by Subject|1|||
147566062|NCT04089735|532232053|FG003|Overall Study|Withdrawal by Subject|0|||
147566063|NCT04089735|532232054|FG004|Overall Study|Withdrawal by Subject|0|||
147566064|NCT04089735|532232055|FG005|Overall Study|Withdrawal by Subject|0|||
147566065|NCT04089735|532232050|FG000|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|0|||
147566066|NCT04089735|532232051|FG001|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|3|||
147566067|NCT04089735|532232052|FG002|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|0|||
147566068|NCT04089735|532232053|FG003|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|5|||
147566069|NCT04089735|532232054|FG004|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|1|||
147566070|NCT04089735|532232055|FG005|Overall Study|Rescue therapy, prohibited medication, withdrawn requiring alternate medication for inflammation|6|||
147566071|NCT02128997|532232057|FG000|Overall Study|Lost to Follow-up|6|||
147566072|NCT02128997|532232058|FG001|Overall Study|Lost to Follow-up|11|||
147566073|NCT00418184|532232065|FG000|Double-blind Phase|Withdrawal by Subject|22|||
147566074|NCT00418184|532232066|FG001|Double-blind Phase|Withdrawal by Subject|9|||
147566075|NCT00418184|532232065|FG000|Double-blind Phase|Adverse Event|2|||
147566076|NCT00418184|532232066|FG001|Double-blind Phase|Adverse Event|1|||
147566077|NCT00418184|532232065|FG000|Double-blind Phase|Poor compliance|3|||
147566078|NCT00418184|532232066|FG001|Double-blind Phase|Poor compliance|1|||
147566079|NCT01247701|532232068|FG000|Overall Study|Death|2|||
147566080|NCT01247701|532232068|FG000|Overall Study|Relapsed|8|||
147566081|NCT00096447|532232069|FG000|Overall Study|Never treated|1|||
147566082|NCT02246166|532232072|FG000|Overall Study|Protocol Violation|1|||
147566083|NCT02246166|532232073|FG001|Overall Study|Protocol Violation|0|||
147566084|NCT00834743|532232074|FG000|Second Intervention|Withdrawal by Subject|1|||
147566085|NCT00834743|532232075|FG001|Second Intervention|Withdrawal by Subject|0|||
147566086|NCT04112823|532232078|FG000|Overall Study|Lost to Follow-up|2|||
147566087|NCT04112823|532232079|FG001|Overall Study|Lost to Follow-up|3|||
147566088|NCT03025880|532232082|FG000|Overall Study|Adverse Event|1|||
147566089|NCT03025880|532232083|FG001|Overall Study|Adverse Event|0|||
147566090|NCT03025880|532232082|FG000|Overall Study|Death|1|||
147566091|NCT03025880|532232083|FG001|Overall Study|Death|1|||
147566092|NCT03025880|532232082|FG000|Overall Study|Withdrawal by Subject|0|||
147566093|NCT03025880|532232083|FG001|Overall Study|Withdrawal by Subject|1|||
147566094|NCT03025880|532232082|FG000|Overall Study|Physician Decision|0|||
147116386|NCT02184156|530588882|FG000|Phase 2 20 Week Efficacy|Withdrawal by Subject|1|||
147566095|NCT03025880|532232083|FG001|Overall Study|Physician Decision|1|||
147566096|NCT03025880|532232082|FG000|Overall Study|Progressive Disease|12|||
147566097|NCT03025880|532232083|FG001|Overall Study|Progressive Disease|19|||
147116387|NCT02184156|530588883|FG001|Phase 2 20 Week Efficacy|Withdrawal by Subject|0|||
147116388|NCT02114684|530588894|FG000|Overall Study|Death|6|||
147566098|NCT00625443|532232085|FG000|Overall Study|Adverse Event|1|||
147566099|NCT00625443|532232086|FG001|Overall Study|Adverse Event|4|||
147566100|NCT00625443|532232087|FG002|Overall Study|Adverse Event|0|||
147566101|NCT00625443|532232085|FG000|Overall Study|Non-compliance with protocol|0|||
147566102|NCT00625443|532232086|FG001|Overall Study|Non-compliance with protocol|1|||
147566103|NCT00625443|532232087|FG002|Overall Study|Non-compliance with protocol|0|||
147566104|NCT00625443|532232085|FG000|Overall Study|Platelet count increase >=500,000/mm3|1|||
147116389|NCT02114684|530588895|FG001|Overall Study|Death|4|||
147312462|NCT04159415|531310777|FG005|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; discontinued during OLTP4 Ext. PI/Participant decision|0|||
147312463|NCT04159415|531310778|FG006|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; discontinued during OLTP4 Ext. PI/Participant decision|0|||
147312464|NCT04159415|531310779|FG007|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; discontinued during OLTP4 Ext. PI/Participant decision|1|||
147312465|NCT04159415|531310780|FG008|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; discontinued during OLTP4 Ext. PI/Participant decision|0|||
147312466|NCT04159415|531310781|FG009|Open-Label Treatment Period (OLTP) 4|Completed Wk 52; discontinued during OLTP4 Ext. PI/Participant decision|0|||
147312467|NCT04159415|531310772|FG000|Open-Label Treatment Period (OLTP) 5|Withdrawal by Subject|0|||
147312468|NCT04159415|531310773|FG001|Open-Label Treatment Period (OLTP) 5|Withdrawal by Subject|0|||
147312469|NCT04159415|531310774|FG002|Open-Label Treatment Period (OLTP) 5|Withdrawal by Subject|0|||
147312470|NCT04159415|531310775|FG003|Open-Label Treatment Period (OLTP) 5|Withdrawal by Subject|0|||
147312471|NCT04159415|531310776|FG004|Open-Label Treatment Period (OLTP) 5|Withdrawal by Subject|0|||
147312472|NCT04159415|531310777|FG005|Open-Label Treatment Period (OLTP) 5|Withdrawal by Subject|0|||
147312473|NCT04159415|531310778|FG006|Open-Label Treatment Period (OLTP) 5|Withdrawal by Subject|0|||
147312474|NCT04159415|531310779|FG007|Open-Label Treatment Period (OLTP) 5|Withdrawal by Subject|0|||
147312475|NCT04159415|531310780|FG008|Open-Label Treatment Period (OLTP) 5|Withdrawal by Subject|0|||
147312476|NCT04159415|531310781|FG009|Open-Label Treatment Period (OLTP) 5|Withdrawal by Subject|1|||
147312477|NCT00337662|531310783|FG000|Study Period II|Lost to Follow-up|0|||
147312478|NCT00337662|531310784|FG001|Study Period II|Lost to Follow-up|0|||
147312479|NCT00337662|531310785|FG002|Study Period II|Lost to Follow-up|0|||
147312480|NCT00337662|531310786|FG003|Study Period II|Lost to Follow-up|35|||
147312481|NCT00337662|531310783|FG000|Study Period II|Withdrawal by Subject|0|||
147312482|NCT00337662|531310784|FG001|Study Period II|Withdrawal by Subject|0|||
147312483|NCT00337662|531310785|FG002|Study Period II|Withdrawal by Subject|0|||
147312484|NCT00337662|531310786|FG003|Study Period II|Withdrawal by Subject|20|||
147312485|NCT00337662|531310783|FG000|Study Period II|Adverse Event|0|||
147312486|NCT00337662|531310784|FG001|Study Period II|Adverse Event|0|||
147312487|NCT00337662|531310785|FG002|Study Period II|Adverse Event|0|||
147312488|NCT00337662|531310786|FG003|Study Period II|Adverse Event|16|||
147312489|NCT00337662|531310783|FG000|Study Period II|Physician Decision|0|||
147312490|NCT00337662|531310784|FG001|Study Period II|Physician Decision|0|||
147312491|NCT00337662|531310785|FG002|Study Period II|Physician Decision|0|||
147312492|NCT00337662|531310786|FG003|Study Period II|Physician Decision|13|||
147312493|NCT00337662|531310783|FG000|Study Period II|Entry Criteria Not Met|0|||
147312494|NCT00337662|531310784|FG001|Study Period II|Entry Criteria Not Met|0|||
147312495|NCT00337662|531310785|FG002|Study Period II|Entry Criteria Not Met|0|||
147312496|NCT00337662|531310786|FG003|Study Period II|Entry Criteria Not Met|6|||
147312497|NCT00337662|531310783|FG000|Study Period II|Protocol Violation|0|||
147312498|NCT00337662|531310784|FG001|Study Period II|Protocol Violation|0|||
147312499|NCT00337662|531310785|FG002|Study Period II|Protocol Violation|0|||
147312500|NCT00337662|531310786|FG003|Study Period II|Protocol Violation|6|||
147312501|NCT00337662|531310783|FG000|Study Period II|Lack of Efficacy|0|||
147312502|NCT00337662|531310784|FG001|Study Period II|Lack of Efficacy|0|||
147312503|NCT00337662|531310785|FG002|Study Period II|Lack of Efficacy|0|||
147312504|NCT00337662|531310786|FG003|Study Period II|Lack of Efficacy|7|||
147312505|NCT00337662|531310783|FG000|Study Period II|Sponsor Decision|0|||
147312506|NCT00337662|531310784|FG001|Study Period II|Sponsor Decision|0|||
147312507|NCT00337662|531310785|FG002|Study Period II|Sponsor Decision|0|||
147312508|NCT00337662|531310786|FG003|Study Period II|Sponsor Decision|2|||
147312509|NCT00337662|531310783|FG000|Study Period II|Parent/Caregiver Decision|0|||
147312510|NCT00337662|531310784|FG001|Study Period II|Parent/Caregiver Decision|0|||
147312511|NCT00337662|531310785|FG002|Study Period II|Parent/Caregiver Decision|0|||
147312512|NCT00337662|531310786|FG003|Study Period II|Parent/Caregiver Decision|1|||
147312513|NCT00337662|531310783|FG000|Study Period III|Lost to Follow-up|14|||
147312514|NCT00337662|531310784|FG001|Study Period III|Lost to Follow-up|16|||
147312515|NCT00337662|531310785|FG002|Study Period III|Lost to Follow-up|14|||
147312516|NCT00337662|531310786|FG003|Study Period III|Lost to Follow-up|0|||
147312517|NCT00337662|531310783|FG000|Study Period III|Withdrawal by Subject|18|||
147312518|NCT00337662|531310784|FG001|Study Period III|Withdrawal by Subject|14|||
147312519|NCT00337662|531310785|FG002|Study Period III|Withdrawal by Subject|12|||
147312520|NCT00337662|531310786|FG003|Study Period III|Withdrawal by Subject|0|||
147312521|NCT00337662|531310783|FG000|Study Period III|Adverse Event|9|||
147312522|NCT00337662|531310784|FG001|Study Period III|Adverse Event|10|||
147312523|NCT00337662|531310785|FG002|Study Period III|Adverse Event|8|||
147312524|NCT00337662|531310786|FG003|Study Period III|Adverse Event|0|||
147312525|NCT00337662|531310783|FG000|Study Period III|Protocol Violation|3|||
147312526|NCT00337662|531310784|FG001|Study Period III|Protocol Violation|8|||
147312527|NCT00337662|531310785|FG002|Study Period III|Protocol Violation|2|||
147312528|NCT00337662|531310786|FG003|Study Period III|Protocol Violation|0|||
147312529|NCT00337662|531310783|FG000|Study Period III|Physician Decision|6|||
147312530|NCT00337662|531310784|FG001|Study Period III|Physician Decision|5|||
147312531|NCT00337662|531310785|FG002|Study Period III|Physician Decision|0|||
147312532|NCT00337662|531310786|FG003|Study Period III|Physician Decision|0|||
147116390|NCT02114684|530588894|FG000|Overall Study|Lost to Follow-up|1|||
147116391|NCT02114684|530588895|FG001|Overall Study|Lost to Follow-up|2|||
147116392|NCT02114684|530588894|FG000|Overall Study|Withdrawal by Subject|1|||
147116393|NCT02114684|530588895|FG001|Overall Study|Withdrawal by Subject|2|||
147116394|NCT02114684|530588894|FG000|Overall Study|Relocation|3|||
147116395|NCT02114684|530588895|FG001|Overall Study|Relocation|1|||
147116396|NCT02114684|530588894|FG000|Overall Study|Rifampicin resistant on culture|0|||
147116397|NCT02114684|530588895|FG001|Overall Study|Rifampicin resistant on culture|1|||
147116398|NCT02114684|530588894|FG000|Overall Study|Patient Incarcerated|1|||
147116399|NCT02114684|530588895|FG001|Overall Study|Patient Incarcerated|0|||
147116400|NCT02530242|530588896|FG000|Overall Study|excluded due to asthma and oxcarbazepine|0|||
147116401|NCT02530242|530588897|FG001|Overall Study|excluded due to asthma and oxcarbazepine|1|||
147116402|NCT00283959|530588898|FG000|Extension Period|Low Compliance|1|||
147116403|NCT01214720|530588899|FG000|Overall Study|Alive and still on treatment|34|||
147116404|NCT01214720|530588900|FG001|Overall Study|Alive and still on treatment|18|||
147116405|NCT01214720|530588899|FG000|Overall Study|Alive and in follow-up|45|||
147116406|NCT01214720|530588900|FG001|Overall Study|Alive and in follow-up|48|||
147116407|NCT01214720|530588899|FG000|Overall Study|Lost to Follow-up|6|||
147444434|NCT00804570|531792612|FG000|Overall Study|Protocol Violation|12|||
147566105|NCT00625443|532232086|FG001|Overall Study|Platelet count increase >=500,000/mm3|0|||
147566106|NCT00625443|532232087|FG002|Overall Study|Platelet count increase >=500,000/mm3|0|||
147566107|NCT00625443|532232085|FG000|Overall Study|Withdrawal by Subject|0|||
147566108|NCT00625443|532232086|FG001|Overall Study|Withdrawal by Subject|1|||
147116408|NCT01214720|530588900|FG001|Overall Study|Lost to Follow-up|2|||
147116409|NCT05591755|530588901|FG000|Overall Study|Screen Failure|1|||
147116410|NCT05591755|530588902|FG001|Overall Study|Screen Failure|0|||
147116411|NCT05591755|530588903|FG002|Overall Study|Screen Failure|0|||
147116412|NCT05591755|530588904|FG003|Overall Study|Screen Failure|0|||
147116413|NCT05591755|530588901|FG000|Overall Study|Protocol Violation|0|||
147116414|NCT05591755|530588902|FG001|Overall Study|Protocol Violation|0|||
147116415|NCT05591755|530588903|FG002|Overall Study|Protocol Violation|2|||
147116416|NCT05591755|530588904|FG003|Overall Study|Protocol Violation|0|||
147116417|NCT05591755|530588901|FG000|Overall Study|Withdrawal by Subject|0|||
147116418|NCT05591755|530588902|FG001|Overall Study|Withdrawal by Subject|1|||
147116419|NCT05591755|530588903|FG002|Overall Study|Withdrawal by Subject|0|||
147116420|NCT05591755|530588904|FG003|Overall Study|Withdrawal by Subject|0|||
147116421|NCT01397747|530588905|FG000|Overall Study|Multitarget DNA test excluded|689|||
147116422|NCT01397747|530588905|FG000|Overall Study|Colonoscopy excluded|304|||
147116423|NCT01397747|530588905|FG000|Overall Study|FIT excluded|34|||
147116424|NCT05865886|530588906|FG000|Overall Study|Serious adverse event|0|||
147116425|NCT05865886|530588907|FG001|Overall Study|Serious adverse event|1|||
147116426|NCT01671059|530588908|FG000|Overall Study|Adverse Event|4|||
147116427|NCT01671059|530588908|FG000|Overall Study|Lack of Efficacy|1|||
147116428|NCT01033071|530588911|FG000|Overall Study|Adverse Event|28|||
147116429|NCT01033071|530588912|FG001|Overall Study|Adverse Event|51|||
147116430|NCT01033071|530588913|FG002|Overall Study|Adverse Event|26|||
147116431|NCT01033071|530588911|FG000|Overall Study|Protocol Violation|0|||
147116432|NCT01033071|530588912|FG001|Overall Study|Protocol Violation|2|||
147116433|NCT01033071|530588913|FG002|Overall Study|Protocol Violation|1|||
147116434|NCT01033071|530588911|FG000|Overall Study|Lost to Follow-up|4|||
147116435|NCT01033071|530588912|FG001|Overall Study|Lost to Follow-up|5|||
147116436|NCT01033071|530588913|FG002|Overall Study|Lost to Follow-up|5|||
147116437|NCT01033071|530588911|FG000|Overall Study|Withdrawal by Subject|17|||
147116438|NCT01033071|530588912|FG001|Overall Study|Withdrawal by Subject|14|||
147116439|NCT01033071|530588913|FG002|Overall Study|Withdrawal by Subject|11|||
147116440|NCT01033071|530588911|FG000|Overall Study|Lack of Efficacy|0|||
147116441|NCT01033071|530588912|FG001|Overall Study|Lack of Efficacy|1|||
147116442|NCT01033071|530588913|FG002|Overall Study|Lack of Efficacy|1|||
147116443|NCT01033071|530588911|FG000|Overall Study|Other|6|||
147116444|NCT01033071|530588912|FG001|Overall Study|Other|4|||
147116445|NCT01033071|530588913|FG002|Overall Study|Other|3|||
147116446|NCT02564978|530588914|FG000|Overall Study|Adverse Event|8|||
147566109|NCT00625443|532232087|FG002|Overall Study|Withdrawal by Subject|2|||
147116447|NCT02564978|530588914|FG000|Overall Study|Death|1|||
147116448|NCT02564978|530588914|FG000|Overall Study|Lost to Follow-up|1|||
147116449|NCT02564978|530588914|FG000|Overall Study|Withdrawal by Subject|15|||
147116450|NCT02564978|530588914|FG000|Overall Study|Early Study Closure|2|||
147116451|NCT02564978|530588914|FG000|Overall Study|Other Reason|5|||
147116452|NCT05206604|530591324|FG000|Overall Study|Non-compliance with study drug|0|||
147116453|NCT05206604|530591325|FG001|Overall Study|Non-compliance with study drug|0|||
147116454|NCT05206604|530591326|FG002|Overall Study|Non-compliance with study drug|0|||
147116455|NCT05206604|530591327|FG003|Overall Study|Non-compliance with study drug|0|||
147116456|NCT05206604|530591328|FG004|Overall Study|Non-compliance with study drug|0|||
147116457|NCT05206604|530591329|FG005|Overall Study|Non-compliance with study drug|1|||
147116458|NCT05206604|530591330|FG006|Overall Study|Non-compliance with study drug|0|||
147116459|NCT05206604|530591331|FG007|Overall Study|Non-compliance with study drug|0|||
147444435|NCT00804570|531792613|FG001|Overall Study|Protocol Violation|16|||
147116460|NCT00456612|530591334|FG000|Overall Study|Withdrawal by Subject|3|||
147116461|NCT02316613|530591337|FG000|Overall Study|Death|63|||
147116462|NCT02316613|530591337|FG000|Overall Study|Lost to Follow-up|9|||
147116463|NCT02316613|530591337|FG000|Overall Study|Lymphoma transformation|2|||
147116464|NCT02316613|530591337|FG000|Overall Study|Participant moved/changed medical team|11|||
147116465|NCT02316613|530591337|FG000|Overall Study|No data and duplicate cases|5|||
147116466|NCT02316613|530591337|FG000|Overall Study|Did not met selection criteria|14|||
147116467|NCT01108796|530591338|FG000|Overall Study|Adverse Event|0|||
147116468|NCT01108796|530591339|FG001|Overall Study|Adverse Event|1|||
147116469|NCT01108796|530591338|FG000|Overall Study|Lost to Follow-up|7|||
147116470|NCT01108796|530591339|FG001|Overall Study|Lost to Follow-up|6|||
147116471|NCT00758043|530591340|FG000|Overall Study|Adverse Event|1|||
147116472|NCT00758043|530591341|FG001|Overall Study|Adverse Event|20|||
147116473|NCT00758043|530591342|FG002|Overall Study|Adverse Event|12|||
147116474|NCT00758043|530591343|FG003|Overall Study|Adverse Event|62|||
147116475|NCT00758043|530591340|FG000|Overall Study|Lack of Efficacy|0|||
147116476|NCT00758043|530591341|FG001|Overall Study|Lack of Efficacy|6|||
147116477|NCT00758043|530591342|FG002|Overall Study|Lack of Efficacy|18|||
147116478|NCT00758043|530591343|FG003|Overall Study|Lack of Efficacy|12|||
147116479|NCT00758043|530591340|FG000|Overall Study|Refused Further Treatment|0|||
147116480|NCT00758043|530591341|FG001|Overall Study|Refused Further Treatment|11|||
147116481|NCT00758043|530591342|FG002|Overall Study|Refused Further Treatment|5|||
147116482|NCT00758043|530591343|FG003|Overall Study|Refused Further Treatment|8|||
147116483|NCT00758043|530591340|FG000|Overall Study|Lost to Follow-up|0|||
147116484|NCT00758043|530591341|FG001|Overall Study|Lost to Follow-up|2|||
147116485|NCT00758043|530591342|FG002|Overall Study|Lost to Follow-up|2|||
147116486|NCT00758043|530591343|FG003|Overall Study|Lost to Follow-up|5|||
147116487|NCT00758043|530591340|FG000|Overall Study|Withdrawal by Subject|0|||
147116488|NCT00758043|530591341|FG001|Overall Study|Withdrawal by Subject|1|||
147116489|NCT00758043|530591342|FG002|Overall Study|Withdrawal by Subject|1|||
147116490|NCT00758043|530591343|FG003|Overall Study|Withdrawal by Subject|4|||
147116491|NCT00758043|530591340|FG000|Overall Study|Required Prohibited Medication|0|||
147116492|NCT00758043|530591341|FG001|Overall Study|Required Prohibited Medication|0|||
147116493|NCT00758043|530591342|FG002|Overall Study|Required Prohibited Medication|1|||
147116494|NCT00758043|530591343|FG003|Overall Study|Required Prohibited Medication|3|||
147116495|NCT00758043|530591340|FG000|Overall Study|Non-Compliant With study Drug|0|||
147116496|NCT00758043|530591341|FG001|Overall Study|Non-Compliant With study Drug|0|||
147116497|NCT00758043|530591342|FG002|Overall Study|Non-Compliant With study Drug|0|||
147116498|NCT00758043|530591343|FG003|Overall Study|Non-Compliant With study Drug|1|||
147116499|NCT00758043|530591340|FG000|Overall Study|Other Reasons|0|||
147116500|NCT00758043|530591341|FG001|Overall Study|Other Reasons|1|||
147116501|NCT00758043|530591342|FG002|Overall Study|Other Reasons|0|||
147116502|NCT00758043|530591343|FG003|Overall Study|Other Reasons|5|||
147116503|NCT05788328|530591349|FG000|Treatment Period 4 (5 Days)|Other|1|||
147229186|NCT00471146|531011918|FG001|Overall Study|Global deterioration of health status|14|||
147229187|NCT00471146|531011917|FG000|Overall Study|Randomized but not treated|9|||
147229188|NCT00471146|531011918|FG001|Overall Study|Randomized but not treated|8|||
147229189|NCT00471146|531011917|FG000|Overall Study|Other|4|||
147229190|NCT00471146|531011918|FG001|Overall Study|Other|5|||
147229191|NCT00467610|531011921|FG000|Overall Study|Withdrawal by Subject|1|||
147229192|NCT01460368|531011922|FG000|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
147229193|NCT01460368|531011923|FG001|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
147229194|NCT01460368|531011924|FG002|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
147229195|NCT01460368|531011925|FG003|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
147229196|NCT01460368|531011926|FG004|Part B: First Intervention (Period 1)|Lost to Follow-up|1|||
147229197|NCT01460368|531011927|FG005|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
147229198|NCT01460368|531011928|FG006|Part B: First Intervention (Period 1)|Lost to Follow-up|0|||
147229199|NCT01460368|531011922|FG000|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0|||
147229200|NCT01460368|531011923|FG001|Part B: Second Intervention (Period 2)|Withdrawal by Subject|1|||
147229201|NCT01460368|531011924|FG002|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0|||
147229202|NCT01460368|531011925|FG003|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0|||
147229203|NCT01460368|531011926|FG004|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0|||
147229204|NCT01460368|531011927|FG005|Part B: Second Intervention (Period 2)|Withdrawal by Subject|0|||
147229205|NCT01460368|531011928|FG006|Part B: Second Intervention (Period 2)|Withdrawal by Subject|1|||
147116504|NCT05788328|530591349|FG000|Treatment Period 8 (4 Days)|Adverse Event|1|||
147116505|NCT00145327|530591353|FG000|Overall Study|Withdrawal by Subject|77|||
147116506|NCT00145327|530591354|FG001|Overall Study|Withdrawal by Subject|72|||
147116507|NCT00145327|530591355|FG002|Overall Study|Withdrawal by Subject|164|||
147116508|NCT00145327|530591353|FG000|Overall Study|Death|26|||
147116509|NCT00145327|530591354|FG001|Overall Study|Death|18|||
147116510|NCT00145327|530591355|FG002|Overall Study|Death|30|||
147116511|NCT00145327|530591353|FG000|Overall Study|Adverse Event|14|||
147116512|NCT00145327|530591354|FG001|Overall Study|Adverse Event|11|||
147116513|NCT00145327|530591355|FG002|Overall Study|Adverse Event|22|||
147116514|NCT00145327|530591353|FG000|Overall Study|Lost to Follow-up|9|||
147116515|NCT00145327|530591354|FG001|Overall Study|Lost to Follow-up|14|||
147116516|NCT00145327|530591355|FG002|Overall Study|Lost to Follow-up|14|||
147116517|NCT00145327|530591353|FG000|Overall Study|Administrative problems|12|||
147116518|NCT00145327|530591354|FG001|Overall Study|Administrative problems|9|||
147116519|NCT00145327|530591355|FG002|Overall Study|Administrative problems|13|||
147116520|NCT00145327|530591353|FG000|Overall Study|Protocol Violation|2|||
147116521|NCT00145327|530591354|FG001|Overall Study|Protocol Violation|0|||
147116522|NCT00145327|530591355|FG002|Overall Study|Protocol Violation|2|||
147116523|NCT00145327|530591353|FG000|Overall Study|Abnormal laboratory value(s)|1|||
147116524|NCT00145327|530591354|FG001|Overall Study|Abnormal laboratory value(s)|0|||
147116525|NCT00145327|530591355|FG002|Overall Study|Abnormal laboratory value(s)|2|||
147116526|NCT00145327|530591353|FG000|Overall Study|Missing - not stated|1|||
147116527|NCT00145327|530591354|FG001|Overall Study|Missing - not stated|0|||
147116528|NCT00145327|530591355|FG002|Overall Study|Missing - not stated|1|||
147116529|NCT04027946|530591356|FG000|Overall Study|Screen failures|3|||
147116530|NCT03315689|530591361|FG000|Double-blind Period = 28 Days|Withdrawal by Subject|1|||
147116531|NCT03315689|530591362|FG001|Double-blind Period = 28 Days|Withdrawal by Subject|0|||
147116532|NCT03315689|530591361|FG000|Open Label Extension = 52 Weeks|Withdrawal by Subject|0|||
147116533|NCT03315689|530591362|FG001|Open Label Extension = 52 Weeks|Withdrawal by Subject|2|||
147116534|NCT03315689|530591361|FG000|Open Label Extension = 52 Weeks|Lost to Follow-up|0|||
147116535|NCT03315689|530591362|FG001|Open Label Extension = 52 Weeks|Lost to Follow-up|1|||
147116536|NCT00864513|530591363|FG000|Overall Study|Withdrawal by Subject|3|||
147116537|NCT03073109|530591364|FG000|Overall Study|Adverse Event|0|||
147116538|NCT03073109|530591365|FG001|Overall Study|Adverse Event|1|||
147116539|NCT03073109|530591364|FG000|Overall Study|Other|2|||
147116540|NCT03073109|530591365|FG001|Overall Study|Other|0|||
147116541|NCT03073109|530591364|FG000|Overall Study|Lost to Follow-up|8|||
147116542|NCT03073109|530591365|FG001|Overall Study|Lost to Follow-up|1|||
147116543|NCT01297244|530591366|FG000|Overall Study|Progressive disease|22|||
147116544|NCT01297244|530591367|FG001|Overall Study|Progressive disease|3|||
147116545|NCT01297244|530591366|FG000|Overall Study|Adverse Event|9|||
147116546|NCT01297244|530591367|FG001|Overall Study|Adverse Event|1|||
147116547|NCT01297244|530591366|FG000|Overall Study|Death|1|||
147116548|NCT01297244|530591367|FG001|Overall Study|Death|1|||
147116549|NCT01297244|530591366|FG000|Overall Study|Clinical progression|1|||
147116550|NCT01297244|530591367|FG001|Overall Study|Clinical progression|1|||
147116551|NCT01297244|530591366|FG000|Overall Study|Withdrawal by Subject|2|||
147116552|NCT01297244|530591367|FG001|Overall Study|Withdrawal by Subject|0|||
147116553|NCT01348698|530591368|FG000|Overall Study|Does not meet lesion size criteria|1|||
147116554|NCT01348698|530591368|FG000|Overall Study|Death|3|||
147116555|NCT01348698|530591368|FG000|Overall Study|PI decision to close study|68|||
147116556|NCT01875237|530591369|FG000|Overall Study|GVDH before DLI|1|||
147116557|NCT01875237|530591370|FG001|Overall Study|GVDH before DLI|0|||
147116558|NCT01875237|530591369|FG000|Overall Study|DLI cells could not be produced|1|||
147116559|NCT01875237|530591370|FG001|Overall Study|DLI cells could not be produced|0|||
147116560|NCT03558672|530591371|FG000|Overall Study|Study Early Termination|10|||
147116561|NCT00983957|530591374|FG000|Overall Study|Adverse Event|1|||
147116562|NCT00983957|530591374|FG000|Overall Study|Personal Reasons|1|||
147116563|NCT03055195|530591375|FG000|Overall Study|Lack of Efficacy|1|||
147116564|NCT03055195|530591376|FG001|Overall Study|Lack of Efficacy|0|||
147116565|NCT03055195|530591375|FG000|Overall Study|Withdrawal by Subject|6|||
147116566|NCT03055195|530591376|FG001|Overall Study|Withdrawal by Subject|7|||
147116567|NCT03055195|530591375|FG000|Overall Study|Study Terminated by Sponsor|2|||
147116568|NCT03055195|530591376|FG001|Overall Study|Study Terminated by Sponsor|6|||
147116569|NCT03055195|530591375|FG000|Overall Study|Protocol Violation|2|||
147116570|NCT03055195|530591376|FG001|Overall Study|Protocol Violation|1|||
147116571|NCT03055195|530591375|FG000|Overall Study|Physician Decision|1|||
147566110|NCT00625443|532232085|FG000|Overall Study|Physician Decision|0|||
147566111|NCT00625443|532232086|FG001|Overall Study|Physician Decision|4|||
147566112|NCT00625443|532232087|FG002|Overall Study|Physician Decision|2|||
147566113|NCT00625443|532232085|FG000|Overall Study|Other|0|||
147566114|NCT00625443|532232086|FG001|Overall Study|Other|1|||
147116572|NCT03055195|530591376|FG001|Overall Study|Physician Decision|0|||
147116573|NCT00986232|530591377|FG000|Overall Study|Adverse Event|1|||
147116574|NCT00986232|530591378|FG001|Overall Study|Adverse Event|2|||
147116575|NCT00986232|530591379|FG002|Overall Study|Adverse Event|3|||
147116576|NCT00986232|530591380|FG003|Overall Study|Adverse Event|0|||
147116577|NCT00986232|530591377|FG000|Overall Study|Lost to Follow-up|19|||
147116578|NCT00986232|530591378|FG001|Overall Study|Lost to Follow-up|12|||
147116579|NCT00986232|530591379|FG002|Overall Study|Lost to Follow-up|12|||
147116580|NCT00986232|530591380|FG003|Overall Study|Lost to Follow-up|7|||
147116581|NCT00986232|530591377|FG000|Overall Study|Protocol Violation|2|||
147116582|NCT00986232|530591378|FG001|Overall Study|Protocol Violation|3|||
147116583|NCT00986232|530591379|FG002|Overall Study|Protocol Violation|0|||
147116584|NCT00986232|530591380|FG003|Overall Study|Protocol Violation|1|||
147116585|NCT00986232|530591377|FG000|Overall Study|Withdrawal by Subject|13|||
147116586|NCT00986232|530591378|FG001|Overall Study|Withdrawal by Subject|16|||
147116587|NCT00986232|530591379|FG002|Overall Study|Withdrawal by Subject|12|||
147116588|NCT00986232|530591380|FG003|Overall Study|Withdrawal by Subject|3|||
147116589|NCT00986232|530591377|FG000|Overall Study|Missed one or more bleeds|13|||
147116590|NCT00986232|530591378|FG001|Overall Study|Missed one or more bleeds|10|||
147116591|NCT00986232|530591379|FG002|Overall Study|Missed one or more bleeds|6|||
147116592|NCT00986232|530591380|FG003|Overall Study|Missed one or more bleeds|7|||
147116593|NCT00986232|530591377|FG000|Overall Study|Incomplete safety follow-up|3|||
147116594|NCT00986232|530591378|FG001|Overall Study|Incomplete safety follow-up|7|||
147116595|NCT00986232|530591379|FG002|Overall Study|Incomplete safety follow-up|2|||
147116596|NCT00986232|530591380|FG003|Overall Study|Incomplete safety follow-up|2|||
147116597|NCT00790933|530591381|FG000|Overall Study|Adverse Event|94|||
147116598|NCT00790933|530591382|FG001|Overall Study|Adverse Event|119|||
147116599|NCT00790933|530591383|FG002|Overall Study|Adverse Event|65|||
147116600|NCT00790933|530591384|FG003|Overall Study|Adverse Event|5|||
147116601|NCT00790933|530591385|FG004|Overall Study|Adverse Event|69|||
147116602|NCT00790933|530591381|FG000|Overall Study|Protocol Violation(s)|8|||
147116603|NCT00790933|530591382|FG001|Overall Study|Protocol Violation(s)|18|||
147116604|NCT00790933|530591383|FG002|Overall Study|Protocol Violation(s)|7|||
147116605|NCT00790933|530591384|FG003|Overall Study|Protocol Violation(s)|0|||
147116606|NCT00790933|530591385|FG004|Overall Study|Protocol Violation(s)|12|||
147116607|NCT00790933|530591381|FG000|Overall Study|Lack of Efficacy|192|||
147116608|NCT00790933|530591382|FG001|Overall Study|Lack of Efficacy|176|||
147116609|NCT00790933|530591383|FG002|Overall Study|Lack of Efficacy|130|||
147116610|NCT00790933|530591384|FG003|Overall Study|Lack of Efficacy|1|||
147116611|NCT00790933|530591385|FG004|Overall Study|Lack of Efficacy|121|||
147116612|NCT00790933|530591381|FG000|Overall Study|Study Terminated by Sponsor|0|||
147116613|NCT00790933|530591382|FG001|Overall Study|Study Terminated by Sponsor|0|||
147116614|NCT00790933|530591383|FG002|Overall Study|Study Terminated by Sponsor|1|||
147116615|NCT00790933|530591384|FG003|Overall Study|Study Terminated by Sponsor|0|||
147116616|NCT00790933|530591385|FG004|Overall Study|Study Terminated by Sponsor|0|||
147116617|NCT00790933|530591381|FG000|Overall Study|Withdrawal by Subject|123|||
147116618|NCT00790933|530591382|FG001|Overall Study|Withdrawal by Subject|120|||
147116619|NCT00790933|530591383|FG002|Overall Study|Withdrawal by Subject|52|||
147116620|NCT00790933|530591384|FG003|Overall Study|Withdrawal by Subject|6|||
147116621|NCT00790933|530591385|FG004|Overall Study|Withdrawal by Subject|50|||
147116622|NCT00790933|530591381|FG000|Overall Study|Lost to Follow-up|13|||
147116623|NCT00790933|530591382|FG001|Overall Study|Lost to Follow-up|31|||
147116624|NCT00790933|530591383|FG002|Overall Study|Lost to Follow-up|10|||
147116625|NCT00790933|530591384|FG003|Overall Study|Lost to Follow-up|1|||
147116626|NCT00790933|530591385|FG004|Overall Study|Lost to Follow-up|15|||
147116627|NCT00790933|530591381|FG000|Overall Study|Reason Not Specified|8|||
147116628|NCT00790933|530591382|FG001|Overall Study|Reason Not Specified|16|||
147116629|NCT00790933|530591383|FG002|Overall Study|Reason Not Specified|4|||
147116630|NCT00790933|530591384|FG003|Overall Study|Reason Not Specified|1|||
147116631|NCT00790933|530591385|FG004|Overall Study|Reason Not Specified|9|||
147116632|NCT00875667|530591386|FG000|Overall Study|Adverse Event|29|||
147116633|NCT00875667|530591387|FG001|Overall Study|Adverse Event|10|||
147116634|NCT00875667|530591386|FG000|Overall Study|Withdrawal by Subject|17|||
147116635|NCT00875667|530591387|FG001|Overall Study|Withdrawal by Subject|5|||
147116636|NCT00875667|530591386|FG000|Overall Study|Death|7|||
147116637|NCT00875667|530591387|FG001|Overall Study|Death|2|||
147116638|NCT00875667|530591386|FG000|Overall Study|Protocol Violation|2|||
147116639|NCT00875667|530591387|FG001|Overall Study|Protocol Violation|0|||
147116640|NCT00875667|530591386|FG000|Overall Study|Disease Progression|100|||
147116641|NCT00875667|530591387|FG001|Overall Study|Disease Progression|49|||
147116642|NCT00875667|530591386|FG000|Overall Study|Miscellaneous|12|||
147116643|NCT00875667|530591387|FG001|Overall Study|Miscellaneous|6|||
147116644|NCT00875667|530591386|FG000|Overall Study|Randomized but no Study Drug Given|3|||
147116645|NCT00875667|530591387|FG001|Overall Study|Randomized but no Study Drug Given|1|||
147116646|NCT00894647|530591390|FG000|Overall Study|Adverse Event|5|||
147229206|NCT01460368|531011922|FG000|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
147116647|NCT00894647|530591391|FG001|Overall Study|Adverse Event|4|||
147116648|NCT00894647|530591390|FG000|Overall Study|Withdrawal by Subject|4|||
147116649|NCT00894647|530591391|FG001|Overall Study|Withdrawal by Subject|4|||
147116650|NCT00894647|530591390|FG000|Overall Study|Lost to Follow-up|0|||
147116651|NCT00894647|530591391|FG001|Overall Study|Lost to Follow-up|2|||
147229207|NCT01460368|531011923|FG001|Part B: Second Intervention (Period 2)|Lost to Follow-up|1|||
147116652|NCT00894647|530591390|FG000|Overall Study|Non-compliance with study procedures|0|||
147116653|NCT00894647|530591391|FG001|Overall Study|Non-compliance with study procedures|2|||
147116654|NCT00894647|530591390|FG000|Overall Study|Other, not due to AE|1|||
147116655|NCT00894647|530591391|FG001|Overall Study|Other, not due to AE|2|||
147116656|NCT01967277|530591392|FG000|Overall Study|Lost to Follow-up|1|||
147116657|NCT01967277|530591393|FG001|Overall Study|Lost to Follow-up|2|||
147116658|NCT01967277|530591392|FG000|Overall Study|Unrelated illness|0|||
147116659|NCT01967277|530591393|FG001|Overall Study|Unrelated illness|1|||
147116660|NCT02573467|530591394|FG000|Double-blind Treatment Epoch|Lack of Efficacy|0|||
147116661|NCT02573467|530591395|FG001|Double-blind Treatment Epoch|Lack of Efficacy|0|||
147312533|NCT00337662|531310783|FG000|Study Period III|Entry Criteria Not Met|4|||
147312534|NCT00337662|531310784|FG001|Study Period III|Entry Criteria Not Met|1|||
147312535|NCT00337662|531310785|FG002|Study Period III|Entry Criteria Not Met|3|||
147312536|NCT00337662|531310786|FG003|Study Period III|Entry Criteria Not Met|0|||
147312537|NCT00337662|531310783|FG000|Study Period III|Lack of Efficacy|4|||
147312538|NCT00337662|531310784|FG001|Study Period III|Lack of Efficacy|4|||
147312539|NCT00337662|531310785|FG002|Study Period III|Lack of Efficacy|2|||
147312540|NCT00337662|531310786|FG003|Study Period III|Lack of Efficacy|0|||
147312541|NCT00337662|531310783|FG000|Study Period III|Parent/Caregiver Decision|0|||
147312542|NCT00337662|531310784|FG001|Study Period III|Parent/Caregiver Decision|0|||
147312543|NCT00337662|531310785|FG002|Study Period III|Parent/Caregiver Decision|2|||
147312544|NCT00337662|531310786|FG003|Study Period III|Parent/Caregiver Decision|0|||
147312545|NCT00337662|531310783|FG000|Study Period III|Sponsor Decision|1|||
147312546|NCT00337662|531310784|FG001|Study Period III|Sponsor Decision|0|||
147444436|NCT00804570|531792612|FG000|Overall Study|Physician Decision|1|||
147444437|NCT00804570|531792613|FG001|Overall Study|Physician Decision|2|||
147444438|NCT00804570|531792612|FG000|Overall Study|Sponsor decision|1|||
147116662|NCT02573467|530591396|FG002|Double-blind Treatment Epoch|Lack of Efficacy|1|||
147116663|NCT02573467|530591397|FG003|Double-blind Treatment Epoch|Lack of Efficacy|0|||
147116664|NCT02573467|530591394|FG000|Double-blind Treatment Epoch|Adverse Event|1|||
147116665|NCT02573467|530591395|FG001|Double-blind Treatment Epoch|Adverse Event|0|||
147116666|NCT02573467|530591396|FG002|Double-blind Treatment Epoch|Adverse Event|1|||
147116667|NCT02573467|530591397|FG003|Double-blind Treatment Epoch|Adverse Event|0|||
147116668|NCT02573467|530591394|FG000|Double-blind Treatment Epoch|Withdrawal by Subject|2|||
147116669|NCT02573467|530591395|FG001|Double-blind Treatment Epoch|Withdrawal by Subject|1|||
147116670|NCT02573467|530591396|FG002|Double-blind Treatment Epoch|Withdrawal by Subject|1|||
147116671|NCT02573467|530591397|FG003|Double-blind Treatment Epoch|Withdrawal by Subject|0|||
147116672|NCT02573467|530591394|FG000|Double-blind Treatment Epoch|Study Terminated by sponsor|50|||
147116673|NCT02573467|530591395|FG001|Double-blind Treatment Epoch|Study Terminated by sponsor|51|||
147116674|NCT02573467|530591396|FG002|Double-blind Treatment Epoch|Study Terminated by sponsor|48|||
147116675|NCT02573467|530591397|FG003|Double-blind Treatment Epoch|Study Terminated by sponsor|55|||
147116676|NCT02573467|530591394|FG000|Post-treatment Follow up Epoch|Death|1|||
147116677|NCT02573467|530591395|FG001|Post-treatment Follow up Epoch|Death|1|||
147116678|NCT02573467|530591396|FG002|Post-treatment Follow up Epoch|Death|0|||
147116679|NCT02573467|530591397|FG003|Post-treatment Follow up Epoch|Death|1|||
147116680|NCT02573467|530591394|FG000|Post-treatment Follow up Epoch|Withdrawal by Subject|5|||
147116681|NCT02573467|530591395|FG001|Post-treatment Follow up Epoch|Withdrawal by Subject|4|||
147116682|NCT02573467|530591396|FG002|Post-treatment Follow up Epoch|Withdrawal by Subject|9|||
147116683|NCT02573467|530591397|FG003|Post-treatment Follow up Epoch|Withdrawal by Subject|2|||
147116684|NCT02573467|530591394|FG000|Post-treatment Follow up Epoch|Technical problems|0|||
147116685|NCT02573467|530591395|FG001|Post-treatment Follow up Epoch|Technical problems|0|||
147116686|NCT02573467|530591396|FG002|Post-treatment Follow up Epoch|Technical problems|1|||
147116687|NCT02573467|530591397|FG003|Post-treatment Follow up Epoch|Technical problems|0|||
147116688|NCT01829165|530591398|FG000|Overall Study|Did not complete intervention|2|||
147116689|NCT01829165|530591399|FG001|Overall Study|Did not complete intervention|0|||
147116690|NCT00710970|530591403|FG000|Overall Study|Never took drug|3|||
147116691|NCT01028560|530591404|FG000|Overall Study|Lack of Efficacy|3|||
147116692|NCT01028560|530591405|FG001|Overall Study|Lack of Efficacy|6|||
147116693|NCT01028560|530591404|FG000|Overall Study|Withdrawal by Subject|7|||
147116694|NCT01028560|530591405|FG001|Overall Study|Withdrawal by Subject|12|||
147116695|NCT02153827|530591406|FG000|Overall Study|Lost to Follow-up|3|||
147116696|NCT02153827|530591407|FG001|Overall Study|Lost to Follow-up|9|||
147116697|NCT01960842|530591410|FG000|Overall Study|Adverse Event|1|||
147116698|NCT01960842|530591410|FG000|Overall Study|Withdrawal by Subject|2|||
147116699|NCT00397930|530591411|FG000|Overall Study|Personal reasons|14|||
147116700|NCT00397930|530591412|FG001|Overall Study|Personal reasons|8|||
147116701|NCT00397930|530591411|FG000|Overall Study|Other medical|9|||
147116702|NCT00397930|530591412|FG001|Overall Study|Other medical|4|||
147116703|NCT00397930|530591411|FG000|Overall Study|Unknown reasons|9|||
147116704|NCT00397930|530591412|FG001|Overall Study|Unknown reasons|14|||
147116705|NCT00397930|530591411|FG000|Overall Study|Noncompliant|3|||
147116706|NCT00397930|530591412|FG001|Overall Study|Noncompliant|2|||
147116707|NCT00397930|530591411|FG000|Overall Study|Too time-consuming|2|||
147116708|NCT00397930|530591412|FG001|Overall Study|Too time-consuming|9|||
147116709|NCT00397930|530591411|FG000|Overall Study|Started own yoga program|1|||
147116710|NCT00397930|530591412|FG001|Overall Study|Started own yoga program|1|||
147312547|NCT00337662|531310785|FG002|Study Period III|Sponsor Decision|1|||
147312548|NCT00337662|531310786|FG003|Study Period III|Sponsor Decision|0|||
147312549|NCT00337662|531310783|FG000|Study Period III|Clinical Relapse|1|||
147312550|NCT00337662|531310784|FG001|Study Period III|Clinical Relapse|0|||
147312551|NCT00337662|531310785|FG002|Study Period III|Clinical Relapse|0|||
147116711|NCT00397930|530591411|FG000|Overall Study|Did not want to be in control group|0|||
147312552|NCT00337662|531310786|FG003|Study Period III|Clinical Relapse|0|||
147116712|NCT00397930|530591412|FG001|Overall Study|Did not want to be in control group|1|||
147116713|NCT00397930|530591411|FG000|Overall Study|Withdrawal by Subject|0|||
147116714|NCT00397930|530591412|FG001|Overall Study|Withdrawal by Subject|8|||
147116715|NCT00397930|530591411|FG000|Overall Study|Missing data|0|||
147116716|NCT00397930|530591412|FG001|Overall Study|Missing data|4|||
147116717|NCT02391584|530591413|FG000|Primary Endpoint (6-weeks)|Lost to Follow-up|1|||
147116718|NCT02391584|530591414|FG001|Primary Endpoint (6-weeks)|Lost to Follow-up|2|||
147116719|NCT02391584|530591413|FG000|Primary Endpoint (6-weeks)|Missed primary endpoint visit|1|||
147116720|NCT02391584|530591414|FG001|Primary Endpoint (6-weeks)|Missed primary endpoint visit|0|||
147116721|NCT02391584|530591413|FG000|3 Month|Lost to Follow-up|1|||
147116722|NCT02391584|530591414|FG001|3 Month|Lost to Follow-up|0|||
147116723|NCT02391584|530591413|FG000|6 Month|Withdrawal by Subject|1|||
147116724|NCT02391584|530591414|FG001|6 Month|Withdrawal by Subject|0|||
147116725|NCT02391584|530591413|FG000|12 Month (End of Study)|Lost to Follow-up|2|||
147116726|NCT02391584|530591414|FG001|12 Month (End of Study)|Lost to Follow-up|0|||
147116727|NCT03019588|530591426|FG000|Overall Study|Death|44|||
147116728|NCT03019588|530591427|FG001|Overall Study|Death|46|||
147116729|NCT03019588|530591426|FG000|Overall Study|Study terminated by Sponsor|3|||
147116730|NCT03019588|530591427|FG001|Overall Study|Study terminated by Sponsor|1|||
147116731|NCT00887588|530591428|FG000|Core Period|Death|1|||
147116732|NCT00887588|530591429|FG001|Core Period|Death|1|||
147116733|NCT00887588|530591428|FG000|Core Period|Lost to Follow-up|3|||
147116734|NCT00887588|530591429|FG001|Core Period|Lost to Follow-up|1|||
147116735|NCT00887588|530591428|FG000|Core Period|Withdrawal by Subject|6|||
147116736|NCT00887588|530591429|FG001|Core Period|Withdrawal by Subject|8|||
147116737|NCT00887588|530591428|FG000|Core Period|Adverse Event|9|||
147116738|NCT00887588|530591429|FG001|Core Period|Adverse Event|11|||
147116739|NCT00887588|530591428|FG000|Extension Period|Adverse Event|4|||
147116740|NCT00887588|530591429|FG001|Extension Period|Adverse Event|4|||
147116741|NCT00887588|530591428|FG000|Extension Period|Death|0|||
147116742|NCT00887588|530591429|FG001|Extension Period|Death|1|||
147116743|NCT00887588|530591428|FG000|Extension Period|Protocol deviation|1|||
147116744|NCT00887588|530591429|FG001|Extension Period|Protocol deviation|0|||
147116745|NCT00887588|530591428|FG000|Extension Period|Lost to Follow-up|1|||
147116746|NCT00887588|530591429|FG001|Extension Period|Lost to Follow-up|0|||
147116747|NCT00366535|530591430|FG000|First Phase: 12 Weeks|Adverse Event|1|||
147116748|NCT00366535|530591431|FG001|First Phase: 12 Weeks|Adverse Event|3|||
147566115|NCT00625443|532232087|FG002|Overall Study|Other|1|||
147566116|NCT02728102|532232088|FG000|Overall Study|Death|3|||
147566117|NCT02728102|532232089|FG001|Overall Study|Death|0|||
147566118|NCT02728102|532232090|FG002|Overall Study|Death|1|||
147566119|NCT02728102|532232088|FG000|Overall Study|Withdrawal by Subject|0|||
147116749|NCT00366535|530591430|FG000|First Phase: 12 Weeks|Withdrawal by Subject|2|||
147116750|NCT00366535|530591431|FG001|First Phase: 12 Weeks|Withdrawal by Subject|5|||
147116751|NCT00366535|530591430|FG000|Second Phase: 12 Weeks|Adverse Event|1|||
147116752|NCT00366535|530591431|FG001|Second Phase: 12 Weeks|Adverse Event|1|||
147116753|NCT00366535|530591430|FG000|Second Phase: 12 Weeks|Withdrawal by Subject|2|||
147116754|NCT00366535|530591431|FG001|Second Phase: 12 Weeks|Withdrawal by Subject|2|||
147116755|NCT00699751|530591436|FG000|Period 1: Without/Before Drug Switch|Investigator Request|27|||
147116756|NCT00699751|530591437|FG001|Period 1: Without/Before Drug Switch|Investigator Request|27|||
147116757|NCT00699751|530591436|FG000|Period 1: Without/Before Drug Switch|Death|28|||
147116758|NCT00699751|530591437|FG001|Period 1: Without/Before Drug Switch|Death|29|||
147116759|NCT00699751|530591436|FG000|Period 1: Without/Before Drug Switch|Subject Request|43|||
147116760|NCT00699751|530591437|FG001|Period 1: Without/Before Drug Switch|Subject Request|23|||
147116761|NCT00699751|530591436|FG000|Period 1: Without/Before Drug Switch|Other|30|||
147116762|NCT00699751|530591437|FG001|Period 1: Without/Before Drug Switch|Other|20|||
147116763|NCT00699751|530591436|FG000|Period 1: Without/Before Drug Switch|Adverse Event|97|||
147116764|NCT00699751|530591437|FG001|Period 1: Without/Before Drug Switch|Adverse Event|63|||
147116765|NCT00699751|530591436|FG000|Period 2:Switched From Placebo to Xofigo|Adverse Event|0|||
147116766|NCT00699751|530591437|FG001|Period 2:Switched From Placebo to Xofigo|Adverse Event|4|||
147116767|NCT00699751|530591436|FG000|Period 2:Switched From Placebo to Xofigo|Investigator Request|0|||
147116768|NCT00699751|530591437|FG001|Period 2:Switched From Placebo to Xofigo|Investigator Request|1|||
147116769|NCT00699751|530591436|FG000|Period 2:Switched From Placebo to Xofigo|Completion page not expected|0|||
147116770|NCT00699751|530591437|FG001|Period 2:Switched From Placebo to Xofigo|Completion page not expected|4|||
147116771|NCT05089357|530591440|FG000|Overall Study|Withdrawal by Subject|23|||
147116772|NCT05089357|530591440|FG000|Overall Study|Lost to Follow-up|6|||
147116773|NCT05089357|530591440|FG000|Overall Study|Medical reason|1|||
147116774|NCT05089357|530591440|FG000|Overall Study|Due to completion of project, participants did not enter the follow-up window period and withdrew|2|||
147116775|NCT05089357|530591440|FG000|Overall Study|Pregnancy|2|||
147116776|NCT05752487|530591441|FG000|Overall Study|Enrolled, not treated|9|||
147116777|NCT05752487|530591441|FG000|Overall Study|Study catheter inserted but did not undergo ablation|1|||
147116778|NCT05752487|530591441|FG000|Overall Study|Withdrawal by Subject|2|||
147116779|NCT01860989|530591442|FG000|Overall Study|Unsatisfactory therapeutic|5|||
147116780|NCT01018953|530591449|FG000|Overall Study|Adverse Event|2|||
147566120|NCT02728102|532232089|FG001|Overall Study|Withdrawal by Subject|2|||
147116781|NCT01018953|530591449|FG000|Overall Study|Withdrawal by Subject|1|||
147116782|NCT01018953|530591449|FG000|Overall Study|Study termination by sponsor|5|||
147566121|NCT02728102|532232090|FG002|Overall Study|Withdrawal by Subject|3|||
147566122|NCT02728102|532232088|FG000|Overall Study|Physician Decision|1|||
147566123|NCT02728102|532232089|FG001|Overall Study|Physician Decision|1|||
147116783|NCT01186419|530591452|FG000|Overall Study|Withdrawal by Subject|5|||
147116784|NCT01186419|530591453|FG001|Overall Study|Withdrawal by Subject|3|||
147116785|NCT01186419|530591452|FG000|Overall Study|Adverse Event|1|||
147116786|NCT01186419|530591453|FG001|Overall Study|Adverse Event|2|||
147116787|NCT01186419|530591452|FG000|Overall Study|Physician Decision|0|||
147116788|NCT01186419|530591453|FG001|Overall Study|Physician Decision|3|||
147116789|NCT01186419|530591452|FG000|Overall Study|Other|1|||
147116790|NCT01186419|530591453|FG001|Overall Study|Other|1|||
147116791|NCT00853047|530591457|FG000|Core Phase|Participant Request|0|||
147566124|NCT02728102|532232090|FG002|Overall Study|Physician Decision|0|||
147566125|NCT02728102|532232088|FG000|Overall Study|Investigational study drug permanently discontinued|3|||
147566126|NCT02728102|532232089|FG001|Overall Study|Investigational study drug permanently discontinued|1|||
147566127|NCT02728102|532232090|FG002|Overall Study|Investigational study drug permanently discontinued|0|||
147566128|NCT02728102|532232088|FG000|Overall Study|Covid|0|||
147566129|NCT02728102|532232089|FG001|Overall Study|Covid|0|||
147566130|NCT02728102|532232090|FG002|Overall Study|Covid|1|||
147566131|NCT02924883|532232092|FG000|Overall Study|Death|39|||
147566132|NCT02924883|532232093|FG001|Overall Study|Death|20|||
147566133|NCT02924883|532232092|FG000|Overall Study|Lost to Follow-up|1|||
147566134|NCT02924883|532232093|FG001|Overall Study|Lost to Follow-up|0|||
147566135|NCT02924883|532232092|FG000|Overall Study|Symptomatic Deterioration/ Clinical Progression|0|||
147566136|NCT02924883|532232093|FG001|Overall Study|Symptomatic Deterioration/ Clinical Progression|1|||
147566137|NCT02924883|532232092|FG000|Overall Study|Protocol Violation|1|||
147566138|NCT02924883|532232093|FG001|Overall Study|Protocol Violation|0|||
147566139|NCT02924883|532232092|FG000|Overall Study|Withdrawal by Subject|22|||
147566140|NCT02924883|532232093|FG001|Overall Study|Withdrawal by Subject|16|||
147566141|NCT02924883|532232092|FG000|Overall Study|Progressive Disease|1|||
147566142|NCT02924883|532232093|FG001|Overall Study|Progressive Disease|0|||
147566143|NCT02924883|532232092|FG000|Overall Study|Study Terminated by Sponsor|69|||
147566144|NCT02924883|532232093|FG001|Overall Study|Study Terminated by Sponsor|32|||
147566145|NCT00553280|532232094|FG000|Overall Study|Adverse Event|19|||
147566146|NCT00553280|532232094|FG000|Overall Study|Lack of Efficacy|3|||
147566147|NCT00553280|532232094|FG000|Overall Study|Withdrawal by Subject|3|||
147566148|NCT00553280|532232094|FG000|Overall Study|Physician Decision|1|||
147566149|NCT01182415|532232095|FG000|Overall Study|Lost to Follow-up|1|||
147566150|NCT02587962|532232100|FG000|Overall Study|Adverse Event|0|||
147566151|NCT02587962|532232101|FG001|Overall Study|Adverse Event|0|||
147566152|NCT02587962|532232102|FG002|Overall Study|Adverse Event|1|||
147566153|NCT02587962|532232103|FG003|Overall Study|Adverse Event|0|||
147566154|NCT02587962|532232104|FG004|Overall Study|Adverse Event|0|||
147566155|NCT02587962|532232100|FG000|Overall Study|Withdrawal by Subject|0|||
147566156|NCT02587962|532232101|FG001|Overall Study|Withdrawal by Subject|0|||
147566157|NCT02587962|532232102|FG002|Overall Study|Withdrawal by Subject|1|||
147566158|NCT02587962|532232103|FG003|Overall Study|Withdrawal by Subject|1|||
147566159|NCT02587962|532232104|FG004|Overall Study|Withdrawal by Subject|4|||
147566160|NCT02587962|532232100|FG000|Overall Study|Radiological progression|2|||
147566161|NCT02587962|532232101|FG001|Overall Study|Radiological progression|2|||
147566162|NCT02587962|532232102|FG002|Overall Study|Radiological progression|2|||
147566163|NCT02587962|532232103|FG003|Overall Study|Radiological progression|5|||
147566164|NCT02587962|532232104|FG004|Overall Study|Radiological progression|10|||
147566165|NCT02587962|532232100|FG000|Overall Study|Clinical progression|0|||
147566166|NCT02587962|532232101|FG001|Overall Study|Clinical progression|1|||
147566167|NCT02587962|532232102|FG002|Overall Study|Clinical progression|2|||
147566168|NCT02587962|532232103|FG003|Overall Study|Clinical progression|0|||
147116792|NCT00853047|530591458|FG001|Core Phase|Participant Request|0|||
147566169|NCT02587962|532232104|FG004|Overall Study|Clinical progression|1|||
147566170|NCT01422538|532232107|FG000|Overall Study|Lost to Follow-up|0|||
147566171|NCT01422538|532232108|FG001|Overall Study|Lost to Follow-up|1|||
147566172|NCT01422538|532232109|FG002|Overall Study|Lost to Follow-up|1|||
147566173|NCT01422538|532232107|FG000|Overall Study|Missed visit|0|||
147566174|NCT01422538|532232108|FG001|Overall Study|Missed visit|1|||
147566175|NCT01422538|532232109|FG002|Overall Study|Missed visit|1|||
147566176|NCT01536405|532232110|FG000|Randomization to Visit 1 (Vaccination 1)|Not vaccinated|8|||
147566177|NCT01536405|532232111|FG001|Randomization to Visit 1 (Vaccination 1)|Not vaccinated|4|||
147566178|NCT01536405|532232110|FG000|Visit 1 (Vaccination 1) to Visit 2|Withdrawal by Subject|12|||
147566179|NCT01536405|532232111|FG001|Visit 1 (Vaccination 1) to Visit 2|Withdrawal by Subject|18|||
147566180|NCT01536405|532232110|FG000|Visit 1 (Vaccination 1) to Visit 2|Lost to Follow-up|20|||
147566181|NCT01536405|532232111|FG001|Visit 1 (Vaccination 1) to Visit 2|Lost to Follow-up|22|||
147566182|NCT01536405|532232110|FG000|Visit 2 to Visit 3 (Vaccination 2)|Withdrawal by Subject|17|||
147116793|NCT00853047|530591459|FG002|Core Phase|Participant Request|0|||
147116794|NCT00853047|530591460|FG003|Core Phase|Participant Request|1|||
147566183|NCT01536405|532232111|FG001|Visit 2 to Visit 3 (Vaccination 2)|Withdrawal by Subject|13|||
147566184|NCT01536405|532232110|FG000|Visit 2 to Visit 3 (Vaccination 2)|Adverse Event|3|||
147566185|NCT01536405|532232111|FG001|Visit 2 to Visit 3 (Vaccination 2)|Adverse Event|3|||
147116795|NCT00853047|530591461|FG004|Core Phase|Participant Request|0|||
147116796|NCT00853047|530591462|FG005|Core Phase|Participant Request|0|||
147116797|NCT00853047|530591457|FG000|Open-Label Extension Phase|Participant Request|0|||
147116798|NCT00853047|530591458|FG001|Open-Label Extension Phase|Participant Request|0|||
147116799|NCT00853047|530591459|FG002|Open-Label Extension Phase|Participant Request|0|||
147116800|NCT00853047|530591460|FG003|Open-Label Extension Phase|Participant Request|0|||
147116801|NCT00853047|530591461|FG004|Open-Label Extension Phase|Participant Request|0|||
147116802|NCT00853047|530591462|FG005|Open-Label Extension Phase|Participant Request|7|||
147116803|NCT00853047|530591457|FG000|Open-Label Extension Phase|Lost to Follow-up|0|||
147116804|NCT00853047|530591458|FG001|Open-Label Extension Phase|Lost to Follow-up|0|||
147116805|NCT00853047|530591459|FG002|Open-Label Extension Phase|Lost to Follow-up|0|||
147116806|NCT00853047|530591460|FG003|Open-Label Extension Phase|Lost to Follow-up|0|||
147116807|NCT00853047|530591461|FG004|Open-Label Extension Phase|Lost to Follow-up|0|||
147116808|NCT00853047|530591462|FG005|Open-Label Extension Phase|Lost to Follow-up|1|||
147116809|NCT00853047|530591457|FG000|Open-Label Extension Phase|Transfer to LX1606-302|0|||
147116810|NCT00853047|530591458|FG001|Open-Label Extension Phase|Transfer to LX1606-302|0|||
147116811|NCT00853047|530591459|FG002|Open-Label Extension Phase|Transfer to LX1606-302|0|||
147116812|NCT00853047|530591460|FG003|Open-Label Extension Phase|Transfer to LX1606-302|0|||
147116813|NCT00853047|530591461|FG004|Open-Label Extension Phase|Transfer to LX1606-302|0|||
147116814|NCT00853047|530591462|FG005|Open-Label Extension Phase|Transfer to LX1606-302|2|||
147116815|NCT00853047|530591457|FG000|Open-Label Extension Phase|Investigator Decision|0|||
147116816|NCT00853047|530591458|FG001|Open-Label Extension Phase|Investigator Decision|0|||
147116817|NCT00853047|530591459|FG002|Open-Label Extension Phase|Investigator Decision|0|||
147116818|NCT00853047|530591460|FG003|Open-Label Extension Phase|Investigator Decision|0|||
147116819|NCT00853047|530591461|FG004|Open-Label Extension Phase|Investigator Decision|0|||
147116820|NCT00853047|530591462|FG005|Open-Label Extension Phase|Investigator Decision|1|||
147116821|NCT00853047|530591457|FG000|Open-Label Extension Phase|Reason Not Specified|0|||
147116822|NCT00853047|530591458|FG001|Open-Label Extension Phase|Reason Not Specified|0|||
147116823|NCT00853047|530591459|FG002|Open-Label Extension Phase|Reason Not Specified|0|||
147116824|NCT00853047|530591460|FG003|Open-Label Extension Phase|Reason Not Specified|0|||
147566186|NCT01536405|532232110|FG000|Visit 2 to Visit 3 (Vaccination 2)|Lost to Follow-up|9|||
147116825|NCT00853047|530591461|FG004|Open-Label Extension Phase|Reason Not Specified|0|||
147116826|NCT00853047|530591462|FG005|Open-Label Extension Phase|Reason Not Specified|6|||
147116827|NCT01695772|530591463|FG000|Overall Study|Withdrawal by Subject|18|||
147229208|NCT01460368|531011924|FG002|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
147229209|NCT01460368|531011925|FG003|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
147229210|NCT01460368|531011926|FG004|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
147229211|NCT01460368|531011927|FG005|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
147229212|NCT01460368|531011928|FG006|Part B: Second Intervention (Period 2)|Lost to Follow-up|0|||
147229213|NCT01460368|531011922|FG000|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
147229214|NCT01460368|531011923|FG001|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
147229215|NCT01460368|531011924|FG002|Part B: Washout (up to 15 Days)|Protocol Violation|1|||
147229216|NCT01460368|531011925|FG003|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
147229217|NCT01460368|531011926|FG004|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
147229218|NCT01460368|531011927|FG005|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
147229219|NCT01460368|531011928|FG006|Part B: Washout (up to 15 Days)|Protocol Violation|0|||
147229220|NCT01460368|531011922|FG000|Part B: Third Interventions (Period 3)|Withdrawal by Subject|0|||
147229221|NCT01460368|531011923|FG001|Part B: Third Interventions (Period 3)|Withdrawal by Subject|0|||
147229222|NCT01460368|531011924|FG002|Part B: Third Interventions (Period 3)|Withdrawal by Subject|1|||
147229223|NCT01460368|531011925|FG003|Part B: Third Interventions (Period 3)|Withdrawal by Subject|1|||
147229224|NCT01460368|531011926|FG004|Part B: Third Interventions (Period 3)|Withdrawal by Subject|0|||
147229225|NCT01460368|531011927|FG005|Part B: Third Interventions (Period 3)|Withdrawal by Subject|1|||
147229226|NCT01460368|531011928|FG006|Part B: Third Interventions (Period 3)|Withdrawal by Subject|0|||
147229227|NCT02322021|531011929|FG000|Core Phase|Adverse Event|1|||
147229228|NCT02322021|531011930|FG001|Core Phase|Adverse Event|3|||
147229229|NCT02322021|531011931|FG002|Core Phase|Adverse Event|4|||
147229230|NCT02322021|531011932|FG003|Core Phase|Adverse Event|2|||
147229231|NCT02322021|531011933|FG004|Core Phase|Adverse Event|0|||
147229232|NCT02322021|531011929|FG000|Core Phase|Participant Choice|4|||
147229233|NCT02322021|531011930|FG001|Core Phase|Participant Choice|5|||
147566187|NCT01536405|532232111|FG001|Visit 2 to Visit 3 (Vaccination 2)|Lost to Follow-up|10|||
147229234|NCT02322021|531011931|FG002|Core Phase|Participant Choice|4|||
147229235|NCT02322021|531011932|FG003|Core Phase|Participant Choice|2|||
147229236|NCT02322021|531011933|FG004|Core Phase|Participant Choice|0|||
147229237|NCT02322021|531011929|FG000|Core Phase|Lost to Follow-up|0|||
147229238|NCT02322021|531011930|FG001|Core Phase|Lost to Follow-up|0|||
147229239|NCT02322021|531011931|FG002|Core Phase|Lost to Follow-up|0|||
147566188|NCT01536405|532232110|FG000|Visit 2 to Visit 3 (Vaccination 2)|Protocol Violation|2|||
147566189|NCT01536405|532232111|FG001|Visit 2 to Visit 3 (Vaccination 2)|Protocol Violation|2|||
147116828|NCT01695772|530591463|FG000|Overall Study|Progressive Disease|8|||
147116829|NCT01695772|530591463|FG000|Overall Study|Investigator Decision|5|||
147116830|NCT01695772|530591463|FG000|Overall Study|Lost to Follow-up|4|||
147116831|NCT01695772|530591463|FG000|Overall Study|Protocol Violation|2|||
147116832|NCT01695772|530591463|FG000|Overall Study|Unspecified Reason|1|||
147116833|NCT00004859|530591466|FG000|Overall Study|Lack of Efficacy|43|||
147116834|NCT00004859|530591467|FG001|Overall Study|Lack of Efficacy|113|||
147116835|NCT00004859|530591466|FG000|Overall Study|Adverse Event|31|||
147116836|NCT00004859|530591467|FG001|Overall Study|Adverse Event|93|||
147116837|NCT00004859|530591466|FG000|Overall Study|Death|5|||
147116838|NCT00004859|530591467|FG001|Overall Study|Death|5|||
147116839|NCT00004859|530591466|FG000|Overall Study|Withdrawal by Subject|7|||
147116840|NCT00004859|530591467|FG001|Overall Study|Withdrawal by Subject|33|||
147116841|NCT00004859|530591466|FG000|Overall Study|Protocol Violation|2|||
147116842|NCT00004859|530591467|FG001|Overall Study|Protocol Violation|2|||
147116843|NCT00004859|530591466|FG000|Overall Study|other disease|0|||
147116844|NCT00004859|530591467|FG001|Overall Study|other disease|3|||
147116845|NCT00004859|530591466|FG000|Overall Study|error|3|||
147116846|NCT00004859|530591467|FG001|Overall Study|error|1|||
147116847|NCT00004859|530591466|FG000|Overall Study|missing data|14|||
147566190|NCT01536405|532232110|FG000|Visit 3 (Vaccination 2) to Visit 4|Withdrawal by Subject|3|||
147116848|NCT00004859|530591467|FG001|Overall Study|missing data|11|||
147116849|NCT00004859|530591466|FG000|Overall Study|Other|13|||
147116850|NCT00004859|530591467|FG001|Overall Study|Other|21|||
147116851|NCT04073407|530591468|FG000|Part 1|Withdrawal by Subject|1|||
147116852|NCT04073407|530591469|FG001|Part 1|Withdrawal by Subject|0|||
147116853|NCT04073407|530591468|FG000|Part 1|Subjects discontinued in response to restrictions on the study due to impact of COVID-19 pandemic|4|||
147116854|NCT04073407|530591469|FG001|Part 1|Subjects discontinued in response to restrictions on the study due to impact of COVID-19 pandemic|1|||
147116855|NCT04073407|530591468|FG000|Part 2|Withdrawal by Subject|0|||
147116856|NCT04073407|530591469|FG001|Part 2|Withdrawal by Subject|1|||
147116857|NCT04289298|530592916|FG000|Overall Study|Lost to Follow-up|5|||
147116858|NCT04289298|530592917|FG001|Overall Study|Lost to Follow-up|0|||
147116859|NCT04289298|530592916|FG000|Overall Study|Withdrawal by Subject|2|||
147116860|NCT04289298|530592917|FG001|Overall Study|Withdrawal by Subject|0|||
147116861|NCT01734928|530592918|FG000|Randomization|Physician Decision|0|||
147116862|NCT01734928|530592919|FG001|Randomization|Physician Decision|1|||
147116863|NCT01734928|530592918|FG000|Randomization|clinical progression|0|||
147116864|NCT01734928|530592919|FG001|Randomization|clinical progression|1|||
147116865|NCT01734928|530592918|FG000|Randomization|progressive disease|0|||
147116866|NCT01734928|530592919|FG001|Randomization|progressive disease|2|||
147116867|NCT01734928|530592918|FG000|Randomization|Withdrew informed consent|0|||
147116868|NCT01734928|530592919|FG001|Randomization|Withdrew informed consent|4|||
147116869|NCT01734928|530592918|FG000|Randomization|Death|1|||
147116870|NCT01734928|530592919|FG001|Randomization|Death|0|||
147116871|NCT01734928|530592918|FG000|Randomization|Randomization error|1|||
147116872|NCT01734928|530592919|FG001|Randomization|Randomization error|0|||
147116873|NCT01734928|530592918|FG000|Randomization|Lost to Follow-up|1|||
147116874|NCT01734928|530592919|FG001|Randomization|Lost to Follow-up|0|||
147116875|NCT01734928|530592918|FG000|Treatment Period|Lost to Follow-up|0|||
147116876|NCT01734928|530592919|FG001|Treatment Period|Lost to Follow-up|2|||
147116877|NCT01734928|530592918|FG000|Treatment Period|Progressive Disease|167|||
147116878|NCT01734928|530592919|FG001|Treatment Period|Progressive Disease|165|||
147116879|NCT01734928|530592918|FG000|Treatment Period|Adverse Event|39|||
147116880|NCT01734928|530592919|FG001|Treatment Period|Adverse Event|52|||
147116881|NCT01734928|530592918|FG000|Treatment Period|Withdrawal of Consent|25|||
147116882|NCT01734928|530592919|FG001|Treatment Period|Withdrawal of Consent|22|||
147116883|NCT01734928|530592918|FG000|Treatment Period|Death|20|||
147116884|NCT01734928|530592919|FG001|Treatment Period|Death|9|||
147116885|NCT01734928|530592918|FG000|Treatment Period|Other Reasons|27|||
147116886|NCT01734928|530592919|FG001|Treatment Period|Other Reasons|19|||
147116887|NCT01734928|530592918|FG000|Treatment Period|Pregnancy|0|||
147116888|NCT01734928|530592919|FG001|Treatment Period|Pregnancy|1|||
147116889|NCT00620035|530592922|FG000|Overall Study|Adverse Event|106|||
147116890|NCT00620035|530592922|FG000|Overall Study|Withdrawal of Informed Consent|1|||
147116891|NCT00620035|530592922|FG000|Overall Study|Other Reason|38|||
147116892|NCT01778985|530592924|FG000|Overall Study|Lost to Follow-up|1|||
147116893|NCT01778985|530592925|FG001|Overall Study|Lost to Follow-up|0|||
147116894|NCT01778985|530592924|FG000|Overall Study|Physician Decision|2|||
147229240|NCT02322021|531011932|FG003|Core Phase|Lost to Follow-up|1|||
147116895|NCT01778985|530592925|FG001|Overall Study|Physician Decision|2|||
147229241|NCT02322021|531011933|FG004|Core Phase|Lost to Follow-up|0|||
147116896|NCT01778985|530592924|FG000|Overall Study|Protocol Violation|4|||
147116897|NCT01778985|530592925|FG001|Overall Study|Protocol Violation|1|||
147116898|NCT01629563|530592926|FG000|Overall Study|Adverse Event|16|||
147116899|NCT01629563|530592927|FG001|Overall Study|Adverse Event|16|||
147229242|NCT02322021|531011929|FG000|Core Phase|Other|0|||
147229243|NCT02322021|531011930|FG001|Core Phase|Other|0|||
147566191|NCT01536405|532232111|FG001|Visit 3 (Vaccination 2) to Visit 4|Withdrawal by Subject|2|||
147566192|NCT01536405|532232110|FG000|Visit 3 (Vaccination 2) to Visit 4|Adverse Event|1|||
147566193|NCT01536405|532232111|FG001|Visit 3 (Vaccination 2) to Visit 4|Adverse Event|0|||
147566194|NCT01536405|532232110|FG000|Visit 3 (Vaccination 2) to Visit 4|Lost to Follow-up|16|||
147566195|NCT01536405|532232111|FG001|Visit 3 (Vaccination 2) to Visit 4|Lost to Follow-up|14|||
147566196|NCT01536405|532232110|FG000|Visit 4 to Extended Study Follow-up|Withdrawal by Subject|0|||
147566197|NCT01536405|532232111|FG001|Visit 4 to Extended Study Follow-up|Withdrawal by Subject|2|||
147566198|NCT01536405|532232110|FG000|Visit 4 to Extended Study Follow-up|Adverse Event|0|||
147566199|NCT01536405|532232111|FG001|Visit 4 to Extended Study Follow-up|Adverse Event|1|||
147566200|NCT01536405|532232110|FG000|Visit 4 to Extended Study Follow-up|Lost to Follow-up|20|||
147566201|NCT01536405|532232111|FG001|Visit 4 to Extended Study Follow-up|Lost to Follow-up|20|||
147566202|NCT01263704|532232114|FG000|Overall Study|Progressive disease|18|||
147566203|NCT01263704|532232114|FG000|Overall Study|Adverse Event|3|||
147566204|NCT01263704|532232114|FG000|Overall Study|Death|2|||
147566205|NCT01263704|532232114|FG000|Overall Study|Patient withdrew consent|2|||
147566206|NCT01263704|532232114|FG000|Overall Study|Eligibility criteria not fulfilled|1|||
147566207|NCT01263704|532232114|FG000|Overall Study|Lost to Follow-up|1|||
147566208|NCT01263704|532232114|FG000|Overall Study|Colon metastases|1|||
147566209|NCT01263704|532232114|FG000|Overall Study|Principal Investigator (PI) decision|1|||
147566210|NCT01061866|532232115|FG000|Overall Study|Adverse Event|2|||
147566211|NCT02255097|532232116|FG000|Overall Study|Death|151|||
147566212|NCT02255097|532232116|FG000|Overall Study|Lost to Follow-up|5|||
147566213|NCT02255097|532232116|FG000|Overall Study|Participation in Study Discontinued by Sponsor|8|||
147566214|NCT02255097|532232116|FG000|Overall Study|Withdrawal by Subject|7|||
147566215|NCT02255097|532232116|FG000|Overall Study|Allocated but not treated|1|||
147566216|NCT02514122|532232117|FG000|Overall Study|Withdrawal by Subject|2|||
147566217|NCT02514122|532232118|FG001|Overall Study|Withdrawal by Subject|0|||
147566218|NCT01675765|532232119|FG000|Overall Study|Progressive disease|4|||
147566219|NCT01675765|532232120|FG001|Overall Study|Progressive disease|4|||
147566220|NCT01675765|532232119|FG000|Overall Study|Adverse Event|1|||
147566221|NCT01675765|532232120|FG001|Overall Study|Adverse Event|2|||
147566222|NCT01675765|532232119|FG000|Overall Study|Withdrawal by Subject|2|||
147566223|NCT01675765|532232120|FG001|Overall Study|Withdrawal by Subject|0|||
147566224|NCT01675765|532232119|FG000|Overall Study|Death|1|||
147229244|NCT02322021|531011931|FG002|Core Phase|Other|1|||
147229245|NCT02322021|531011932|FG003|Core Phase|Other|0|||
147229246|NCT02322021|531011933|FG004|Core Phase|Other|0|||
147229247|NCT02322021|531011929|FG000|Extension Phase|Adverse Event|0|||
147229248|NCT02322021|531011930|FG001|Extension Phase|Adverse Event|0|||
147229249|NCT02322021|531011931|FG002|Extension Phase|Adverse Event|0|||
147229250|NCT02322021|531011932|FG003|Extension Phase|Adverse Event|0|||
147229251|NCT02322021|531011933|FG004|Extension Phase|Adverse Event|3|||
147229252|NCT02322021|531011929|FG000|Extension Phase|Participant Choice|0|||
147229253|NCT02322021|531011930|FG001|Extension Phase|Participant Choice|0|||
147229254|NCT02322021|531011931|FG002|Extension Phase|Participant Choice|0|||
147229255|NCT02322021|531011932|FG003|Extension Phase|Participant Choice|0|||
147229256|NCT02322021|531011933|FG004|Extension Phase|Participant Choice|6|||
147229257|NCT02322021|531011929|FG000|Extension Phase|Other|0|||
147229258|NCT02322021|531011930|FG001|Extension Phase|Other|0|||
147229259|NCT02322021|531011931|FG002|Extension Phase|Other|0|||
147229260|NCT02322021|531011932|FG003|Extension Phase|Other|0|||
147229261|NCT02322021|531011933|FG004|Extension Phase|Other|3|||
147229262|NCT02322021|531011929|FG000|Extension Phase|Lost to Follow-up|0|||
147229263|NCT02322021|531011930|FG001|Extension Phase|Lost to Follow-up|0|||
147229264|NCT02322021|531011931|FG002|Extension Phase|Lost to Follow-up|0|||
147229265|NCT02322021|531011932|FG003|Extension Phase|Lost to Follow-up|0|||
147229266|NCT02322021|531011933|FG004|Extension Phase|Lost to Follow-up|1|||
147229267|NCT02322021|531011929|FG000|Extension Phase|Study terminated by sponsor|0|||
147229268|NCT02322021|531011930|FG001|Extension Phase|Study terminated by sponsor|0|||
147229269|NCT02322021|531011931|FG002|Extension Phase|Study terminated by sponsor|0|||
147229270|NCT02322021|531011932|FG003|Extension Phase|Study terminated by sponsor|0|||
147229271|NCT02322021|531011933|FG004|Extension Phase|Study terminated by sponsor|28|||
147229272|NCT02001181|531011936|FG000|Overall Study|Adverse Event|0|||
147229273|NCT02001181|531011937|FG001|Overall Study|Adverse Event|2|||
147229274|NCT02001181|531011936|FG000|Overall Study|Lost to Follow-up|1|||
147229275|NCT02001181|531011937|FG001|Overall Study|Lost to Follow-up|0|||
147229276|NCT02001181|531011936|FG000|Overall Study|Withdrawal by Subject|0|||
147229277|NCT02001181|531011937|FG001|Overall Study|Withdrawal by Subject|1|||
147229278|NCT00445978|531011938|FG000|Week 0 - Week 4 (2.5 mg/kg/Day)|Adverse Event|1|||
147229279|NCT00445978|531011938|FG000|Week 0 - Week 4 (2.5 mg/kg/Day)|Physician Decision|1|||
147229280|NCT00445978|531011938|FG000|Week 0 - Week 4 (2.5 mg/kg/Day)|Study Compliance|1|||
147566225|NCT01675765|532232120|FG001|Overall Study|Death|0|||
147566226|NCT01675765|532232119|FG000|Overall Study|Clinical progression|3|||
147566227|NCT01675765|532232120|FG001|Overall Study|Clinical progression|2|||
147566228|NCT03965091|532232121|FG000|Overall Study|Adverse Event|0|||
147566229|NCT03965091|532232122|FG001|Overall Study|Adverse Event|2|||
147566230|NCT03965091|532232123|FG002|Overall Study|Adverse Event|3|||
147566231|NCT03965091|532232121|FG000|Overall Study|Withdrawal by Subject|11|||
147566232|NCT03965091|532232122|FG001|Overall Study|Withdrawal by Subject|3|||
147566233|NCT03965091|532232123|FG002|Overall Study|Withdrawal by Subject|5|||
147566234|NCT03965091|532232121|FG000|Overall Study|Non-compliance with study drug|0|||
147566235|NCT03965091|532232122|FG001|Overall Study|Non-compliance with study drug|0|||
147566236|NCT03965091|532232123|FG002|Overall Study|Non-compliance with study drug|1|||
147566237|NCT03965091|532232121|FG000|Overall Study|Lost to Follow-up|1|||
147566238|NCT03965091|532232122|FG001|Overall Study|Lost to Follow-up|1|||
147566239|NCT03965091|532232123|FG002|Overall Study|Lost to Follow-up|1|||
147566240|NCT03965091|532232121|FG000|Overall Study|Lack of Efficacy|2|||
147566241|NCT03965091|532232122|FG001|Overall Study|Lack of Efficacy|0|||
147566242|NCT03965091|532232123|FG002|Overall Study|Lack of Efficacy|0|||
147566243|NCT03965091|532232121|FG000|Overall Study|Other than specified|9|||
147566244|NCT03965091|532232122|FG001|Overall Study|Other than specified|11|||
147566245|NCT03965091|532232123|FG002|Overall Study|Other than specified|8|||
147566246|NCT01534520|532232126|FG000|Overall Study|Adverse Event|0|||
147566247|NCT01534520|532232127|FG001|Overall Study|Adverse Event|1|||
147566248|NCT01417078|532232128|FG000|Overall Study|Withdrawal by Subject|1|||
147566249|NCT01059903|532232130|FG000|Period 1: First Intervention- 24 Hours|Adverse Event|1|||
147566250|NCT01059903|532232131|FG001|Period 1: First Intervention- 24 Hours|Adverse Event|1|||
147566251|NCT03555305|532232132|FG000|Period 1|Physician Decision|0|||
147566252|NCT03555305|532232133|FG001|Period 1|Physician Decision|1|||
147566253|NCT03555305|532232132|FG000|Period 1|Adverse Event|0|||
147566254|NCT03555305|532232133|FG001|Period 1|Adverse Event|1|||
147566255|NCT03135834|532232139|FG000|Stage 1|Adverse Event|1|||
147566256|NCT03135834|532232140|FG001|Stage 1|Adverse Event|2|||
147566257|NCT03135834|532232141|FG002|Stage 1|Adverse Event|2|||
147566258|NCT03135834|532232142|FG003|Stage 1|Adverse Event|1|||
147566259|NCT03135834|532232139|FG000|Stage 1|Death|1|||
147566260|NCT03135834|532232140|FG001|Stage 1|Death|0|||
147566261|NCT03135834|532232141|FG002|Stage 1|Death|0|||
147566262|NCT03135834|532232142|FG003|Stage 1|Death|0|||
147566263|NCT03135834|532232139|FG000|Stage 1|Lost to Follow-up|17|||
147566264|NCT03135834|532232140|FG001|Stage 1|Lost to Follow-up|24|||
147566265|NCT03135834|532232141|FG002|Stage 1|Lost to Follow-up|21|||
147566266|NCT03135834|532232142|FG003|Stage 1|Lost to Follow-up|38|||
147566267|NCT03135834|532232139|FG000|Stage 1|No longer met eligibility criteria|1|||
147566268|NCT03135834|532232140|FG001|Stage 1|No longer met eligibility criteria|6|||
147566269|NCT03135834|532232141|FG002|Stage 1|No longer met eligibility criteria|2|||
147566270|NCT03135834|532232142|FG003|Stage 1|No longer met eligibility criteria|5|||
147566271|NCT03135834|532232139|FG000|Stage 1|Other|0|||
147566272|NCT03135834|532232140|FG001|Stage 1|Other|2|||
147566273|NCT03135834|532232141|FG002|Stage 1|Other|1|||
147566274|NCT03135834|532232142|FG003|Stage 1|Other|0|||
147566275|NCT03135834|532232139|FG000|Stage 1|Physician Decision|0|||
147566276|NCT03135834|532232140|FG001|Stage 1|Physician Decision|1|||
147116900|NCT01629563|530592926|FG000|Overall Study|Death|2|||
147116901|NCT01629563|530592927|FG001|Overall Study|Death|0|||
147116902|NCT01629563|530592926|FG000|Overall Study|Lack of Efficacy|2|||
147116903|NCT01629563|530592927|FG001|Overall Study|Lack of Efficacy|3|||
147116904|NCT01629563|530592926|FG000|Overall Study|Lost to Follow-up|1|||
147116905|NCT01629563|530592927|FG001|Overall Study|Lost to Follow-up|0|||
147116906|NCT01629563|530592926|FG000|Overall Study|Pregnancy|1|||
147116907|NCT01629563|530592927|FG001|Overall Study|Pregnancy|2|||
147116908|NCT01629563|530592926|FG000|Overall Study|Protocol Violation|0|||
147116909|NCT01629563|530592927|FG001|Overall Study|Protocol Violation|1|||
147116910|NCT01629563|530592926|FG000|Overall Study|Withdrawal by Subject|27|||
147116911|NCT01629563|530592927|FG001|Overall Study|Withdrawal by Subject|20|||
147116912|NCT01629563|530592926|FG000|Overall Study|surgery|0|||
147229281|NCT00445978|531011938|FG000|Week 4 - Week 8 (5 mg/kg/Day)|Adverse Event|1|||
147229282|NCT00445978|531011938|FG000|Week 4 - Week 8 (5 mg/kg/Day)|Physician Decision|1|||
147229283|NCT00445978|531011938|FG000|Week 4 - Week 8 (5 mg/kg/Day)|Lost to Follow-up|1|||
147229284|NCT00445978|531011938|FG000|Week 4 - Week 8 (5 mg/kg/Day)|Withdrew Consent|1|||
147566277|NCT03135834|532232141|FG002|Stage 1|Physician Decision|0|||
147566278|NCT03135834|532232142|FG003|Stage 1|Physician Decision|0|||
147566279|NCT03135834|532232139|FG000|Stage 1|Pregnancy|0|||
147566280|NCT03135834|532232140|FG001|Stage 1|Pregnancy|4|||
147566281|NCT03135834|532232141|FG002|Stage 1|Pregnancy|2|||
147566282|NCT03135834|532232142|FG003|Stage 1|Pregnancy|4|||
147566283|NCT03135834|532232139|FG000|Stage 1|Protocol Violation|1|||
147116913|NCT01629563|530592927|FG001|Overall Study|surgery|3|||
147116914|NCT01629563|530592926|FG000|Overall Study|Lack of return of menses|12|||
147116915|NCT01629563|530592927|FG001|Overall Study|Lack of return of menses|7|||
147229285|NCT00445978|531011938|FG000|Week 8 - Week 12 (10 mg/kg/Day)|Pregnancy|1|||
147566284|NCT03135834|532232140|FG001|Stage 1|Protocol Violation|1|||
147566285|NCT03135834|532232141|FG002|Stage 1|Protocol Violation|2|||
147566286|NCT03135834|532232142|FG003|Stage 1|Protocol Violation|1|||
147566287|NCT03135834|532232139|FG000|Stage 1|Withdrawal by parent/guardian|2|||
147566288|NCT03135834|532232140|FG001|Stage 1|Withdrawal by parent/guardian|10|||
147566289|NCT03135834|532232141|FG002|Stage 1|Withdrawal by parent/guardian|2|||
147566290|NCT03135834|532232142|FG003|Stage 1|Withdrawal by parent/guardian|1|||
147566291|NCT03135834|532232139|FG000|Stage 1|Withdrawal by Subject|16|||
147566292|NCT03135834|532232140|FG001|Stage 1|Withdrawal by Subject|22|||
147566293|NCT03135834|532232141|FG002|Stage 1|Withdrawal by Subject|7|||
147566294|NCT03135834|532232142|FG003|Stage 1|Withdrawal by Subject|10|||
147566295|NCT03135834|532232139|FG000|Stage 1|Randomized but not Vaccinated|0|||
147566296|NCT03135834|532232140|FG001|Stage 1|Randomized but not Vaccinated|3|||
147566297|NCT03135834|532232141|FG002|Stage 1|Randomized but not Vaccinated|1|||
147566298|NCT03135834|532232142|FG003|Stage 1|Randomized but not Vaccinated|6|||
147566299|NCT03135834|532232139|FG000|Stage 2|Lost to Follow-up|0|||
147566300|NCT03135834|532232140|FG001|Stage 2|Lost to Follow-up|1|||
147566301|NCT03135834|532232141|FG002|Stage 2|Lost to Follow-up|0|||
147566302|NCT03135834|532232142|FG003|Stage 2|Lost to Follow-up|0|||
147566303|NCT03135834|532232139|FG000|Stage 2|Withdrawal by Subject|0|||
147566304|NCT03135834|532232140|FG001|Stage 2|Withdrawal by Subject|1|||
147566305|NCT03135834|532232141|FG002|Stage 2|Withdrawal by Subject|0|||
147566306|NCT03135834|532232142|FG003|Stage 2|Withdrawal by Subject|0|||
147566307|NCT03135834|532232139|FG000|Stage 2|Withdrawn Before Booster Vaccination|46|||
147566308|NCT03135834|532232140|FG001|Stage 2|Withdrawn Before Booster Vaccination|24|||
147566309|NCT03135834|532232141|FG002|Stage 2|Withdrawn Before Booster Vaccination|24|||
147566310|NCT03135834|532232142|FG003|Stage 2|Withdrawn Before Booster Vaccination|15|||
147566311|NCT03135834|532232139|FG000|Stage 2|Did not receive Booster Vaccination|1|||
147566312|NCT03135834|532232140|FG001|Stage 2|Did not receive Booster Vaccination|1|||
147566313|NCT03135834|532232141|FG002|Stage 2|Did not receive Booster Vaccination|0|||
147566314|NCT03135834|532232142|FG003|Stage 2|Did not receive Booster Vaccination|0|||
147566315|NCT02100228|532232143|FG000|Overall Study|Other|19|||
147116916|NCT01629563|530592926|FG000|Overall Study|Protocol Violation|0|||
147116917|NCT01629563|530592927|FG001|Overall Study|Protocol Violation|1|||
147116918|NCT00088881|530592929|FG000|Step 1 - R-CHOP|Patient ineligible|9|||
147116919|NCT00088881|530592929|FG000|Step 1 - R-CHOP|Adverse Event|1|||
147116920|NCT00088881|530592929|FG000|Step 1 - R-CHOP|Withdrawal by Subject|2|||
147116921|NCT00088881|530592929|FG000|Step 1 - R-CHOP|Physician Decision|1|||
147116922|NCT00088881|530592929|FG000|Step 1 - R-CHOP|Insurance company refused to cover|1|||
147116923|NCT00088881|530592929|FG000|Step 2 - Zevalin™ Radioimmunotherapy|Patient ineligible|8|||
147116924|NCT00088881|530592929|FG000|Step 2 - Zevalin™ Radioimmunotherapy|Other|3|||
147116925|NCT02370394|530592938|FG000|Overall Study|Lost to Follow-up|2|||
147116926|NCT02370394|530592939|FG001|Overall Study|Lost to Follow-up|1|||
147116927|NCT02370394|530592938|FG000|Overall Study|Withdrawal by Subject|0|||
147116928|NCT02370394|530592939|FG001|Overall Study|Withdrawal by Subject|1|||
147116929|NCT03684057|530592940|FG000|Overall Study|Withdrawal by Subject|4|||
147229286|NCT00445978|531011938|FG000|Week 12 - Week 16 (20 mg/kg/Day)|Lost to Follow-up|1|||
147229287|NCT03643159|531011941|FG000|Overall Study|Adverse Event|1|||
147229288|NCT03643159|531011941|FG000|Overall Study|Withdrawal by Subject|1|||
147229289|NCT03438383|531011942|FG000|Overall Study|Protocol Violation|9|||
147229290|NCT03438383|531011943|FG001|Overall Study|Protocol Violation|3|||
147229291|NCT01528033|531011944|FG000|Primary Endpoint Assessment ITT|Withdrawal by Subject|8|||
147229292|NCT01528033|531011945|FG001|Primary Endpoint Assessment ITT|Withdrawal by Subject|7|||
147229293|NCT01528033|531011944|FG000|Primary Endpoint Assessment ITT|No or deliquent informed consent|3|||
147229294|NCT01528033|531011945|FG001|Primary Endpoint Assessment ITT|No or deliquent informed consent|3|||
147229295|NCT01528033|531011944|FG000|Primary Endpoint Assessment ITT|Death|2|||
147229296|NCT01528033|531011945|FG001|Primary Endpoint Assessment ITT|Death|2|||
147229297|NCT01528033|531011944|FG000|Primary Endpoint Assessment ITT|Physician Decision|2|||
147229298|NCT01528033|531011945|FG001|Primary Endpoint Assessment ITT|Physician Decision|1|||
147229299|NCT01528033|531011944|FG000|Primary Endpoint Assessment ITT|No post baseline documentation|2|||
147229300|NCT01528033|531011945|FG001|Primary Endpoint Assessment ITT|No post baseline documentation|2|||
147229301|NCT01528033|531011944|FG000|Follow Up|No data available|46|||
147229302|NCT01528033|531011945|FG001|Follow Up|No data available|44|||
147229303|NCT02898116|531011956|FG000|Overall Study|Adverse Event|1|||
147229304|NCT02898116|531011956|FG000|Overall Study|Progressive disease|1|||
147229305|NCT03635788|531011957|FG000|Step 1|Death|1|||
147229306|NCT03635788|531011958|FG001|Step 1|Death|0|||
147229307|NCT03635788|531011959|FG002|Step 1|Death|0|||
147229308|NCT03635788|531011957|FG000|Step 1|Lost to Follow-up|31|||
147312553|NCT00882921|531310789|FG000|Overall Study|Death|2|||
147566316|NCT02100228|532232144|FG001|Overall Study|Other|19|||
147566317|NCT02100228|532232143|FG000|Overall Study|Administrative reason|0|||
147566318|NCT02100228|532232144|FG001|Overall Study|Administrative reason|1|||
147566319|NCT02100228|532232143|FG000|Overall Study|Inclusion/Exclusion criteria not met|12|||
147116930|NCT03684057|530592941|FG001|Overall Study|Withdrawal by Subject|5|||
147116931|NCT00960856|530592942|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
147229309|NCT03635788|531011958|FG001|Step 1|Lost to Follow-up|0|||
147229310|NCT03635788|531011959|FG002|Step 1|Lost to Follow-up|0|||
147229311|NCT03635788|531011957|FG000|Step 1|Pregnancy|1|||
147229312|NCT03635788|531011958|FG001|Step 1|Pregnancy|0|||
147566320|NCT02100228|532232144|FG001|Overall Study|Inclusion/Exclusion criteria not met|16|||
147116932|NCT00960856|530592943|FG001|Washout Period of 7 Days|Withdrawal by Subject|2|||
147566321|NCT02100228|532232143|FG000|Overall Study|Non-compliance|0|||
147116933|NCT00960856|530592944|FG002|Washout Period of 7 Days|Withdrawal by Subject|0|||
147116934|NCT00960856|530592945|FG003|Washout Period of 7 Days|Withdrawal by Subject|0|||
147116935|NCT00960856|530592942|FG000|Washout Period of 7 Days|Adverse Event|0|||
147116936|NCT00960856|530592943|FG001|Washout Period of 7 Days|Adverse Event|0|||
147116937|NCT00960856|530592944|FG002|Washout Period of 7 Days|Adverse Event|1|||
147116938|NCT00960856|530592945|FG003|Washout Period of 7 Days|Adverse Event|0|||
147116939|NCT05938010|530592947|FG000|Overall Study|Lost to Follow-up|2|||
147116940|NCT01562444|530592953|FG000|Overall Study|Did not meet entry criteria|2|||
147116941|NCT01562444|530592954|FG001|Overall Study|Did not meet entry criteria|0|||
147116942|NCT01562444|530592955|FG002|Overall Study|Did not meet entry criteria|3|||
147116943|NCT01562444|530592953|FG000|Overall Study|Did not comply with blood draw schedule|1|||
147116944|NCT01562444|530592954|FG001|Overall Study|Did not comply with blood draw schedule|0|||
147116945|NCT01562444|530592955|FG002|Overall Study|Did not comply with blood draw schedule|1|||
147116946|NCT01562444|530592953|FG000|Overall Study|Unavailable serological results|0|||
147116947|NCT01562444|530592954|FG001|Overall Study|Unavailable serological results|2|||
147116948|NCT01562444|530592955|FG002|Overall Study|Unavailable serological results|2|||
147116949|NCT01562444|530592953|FG000|Overall Study|Protocol forbidden concomitant vaccine|1|||
147116950|NCT01562444|530592954|FG001|Overall Study|Protocol forbidden concomitant vaccine|0|||
147116951|NCT01562444|530592955|FG002|Overall Study|Protocol forbidden concomitant vaccine|1|||
147116952|NCT01562444|530592953|FG000|Overall Study|Protocol forbidden medication|1|||
147116953|NCT01562444|530592954|FG001|Overall Study|Protocol forbidden medication|0|||
147116954|NCT01562444|530592955|FG002|Overall Study|Protocol forbidden medication|0|||
147116955|NCT04233580|530592963|FG000|Overall Study|Adverse Event|3|||
147116956|NCT04233580|530592964|FG001|Overall Study|Adverse Event|3|||
147229313|NCT03635788|531011959|FG002|Step 1|Pregnancy|0|||
147229314|NCT03635788|531011957|FG000|Step 1|Protocol Violation|8|||
147229315|NCT03635788|531011958|FG001|Step 1|Protocol Violation|0|||
147229316|NCT03635788|531011959|FG002|Step 1|Protocol Violation|0|||
147229317|NCT03635788|531011957|FG000|Step 1|Withdrawal by Subject|13|||
147229318|NCT03635788|531011958|FG001|Step 1|Withdrawal by Subject|0|||
147229319|NCT03635788|531011959|FG002|Step 1|Withdrawal by Subject|0|||
147229320|NCT03635788|531011957|FG000|Step 1|Other reasons|12|||
147229321|NCT03635788|531011958|FG001|Step 1|Other reasons|0|||
147229322|NCT03635788|531011959|FG002|Step 1|Other reasons|0|||
147229323|NCT03635788|531011957|FG000|Step 1|On Step 1 as of February 12, 2024|27|||
147116957|NCT04233580|530592963|FG000|Overall Study|Withdrawal by Subject|2|||
147116958|NCT04233580|530592964|FG001|Overall Study|Withdrawal by Subject|1|||
147116959|NCT01371565|530592965|FG000|Overall Study|Withdrawal by Subject|1|||
147116960|NCT01371565|530592965|FG000|Overall Study|Death|1|||
147116961|NCT01371565|530592965|FG000|Overall Study|Resection of neuroendocrine tumor|1|||
147116962|NCT02061592|530592967|FG000|Period 1|Withdrawal by Subject|1|||
147116963|NCT02061592|530592968|FG001|Period 1|Withdrawal by Subject|0|||
147116964|NCT02061592|530592967|FG000|Period 1|Protocol Violation|1|||
147116965|NCT02061592|530592968|FG001|Period 1|Protocol Violation|0|||
147116966|NCT02061592|530592967|FG000|Period 2|Lost to Follow-up|0|||
147116967|NCT02061592|530592968|FG001|Period 2|Lost to Follow-up|1|||
147116968|NCT04996264|530592969|FG000|Overall Study|Lost to Follow-up|0|||
147116969|NCT04996264|530592970|FG001|Overall Study|Lost to Follow-up|1|||
147116970|NCT04996264|530592969|FG000|Overall Study|Withdrawal by Subject|4|||
147116971|NCT04996264|530592970|FG001|Overall Study|Withdrawal by Subject|3|||
147116972|NCT04996264|530592969|FG000|Overall Study|1 left AMA|0|||
147116973|NCT04996264|530592970|FG001|Overall Study|1 left AMA|1|||
147116974|NCT04996264|530592969|FG000|Overall Study|Subject changed hospitals|0|||
147116975|NCT04996264|530592970|FG001|Overall Study|Subject changed hospitals|1|||
147116976|NCT04996264|530592969|FG000|Overall Study|unable to complete due to work|0|||
147116977|NCT04996264|530592970|FG001|Overall Study|unable to complete due to work|1|||
147116978|NCT04433975|530592971|FG000|1-month Follow Up|Withdrawal by Subject|1|||
147116979|NCT04433975|530592972|FG001|1-month Follow Up|Withdrawal by Subject|1|||
147116980|NCT04433975|530592971|FG000|1-month Follow Up|Lost to Follow-up|21|||
147116981|NCT04433975|530592972|FG001|1-month Follow Up|Lost to Follow-up|25|||
147116982|NCT04433975|530592971|FG000|3-month Follow Up|Lost to Follow-up|20|||
147116983|NCT04433975|530592972|FG001|3-month Follow Up|Lost to Follow-up|24|||
147116984|NCT04433975|530592971|FG000|3-month Follow Up|Death|1|||
147116985|NCT04433975|530592972|FG001|3-month Follow Up|Death|0|||
147116986|NCT04433975|530592971|FG000|3-month Follow Up|Withdrawal by Subject|2|||
147116987|NCT04433975|530592972|FG001|3-month Follow Up|Withdrawal by Subject|0|||
147116988|NCT04433975|530592971|FG000|6-month Follow Up|Lost to Follow-up|23|||
147116989|NCT04433975|530592972|FG001|6-month Follow Up|Lost to Follow-up|28|||
147116990|NCT04433975|530592971|FG000|6-month Follow Up|Withdrawal by Subject|1|||
147116991|NCT04433975|530592972|FG001|6-month Follow Up|Withdrawal by Subject|1|||
147116992|NCT04433975|530592971|FG000|9-month Follow Up|Lost to Follow-up|27|||
147116993|NCT04433975|530592972|FG001|9-month Follow Up|Lost to Follow-up|36|||
147116994|NCT04433975|530592971|FG000|9-month Follow Up|Death|0|||
147229324|NCT03635788|531011958|FG001|Step 1|On Step 1 as of February 12, 2024|0|||
147229325|NCT03635788|531011959|FG002|Step 1|On Step 1 as of February 12, 2024|0|||
147229326|NCT03635788|531011957|FG000|Step 2|Lost to Follow-up|0|||
147229327|NCT03635788|531011958|FG001|Step 2|Lost to Follow-up|8|||
147566322|NCT02100228|532232144|FG001|Overall Study|Non-compliance|3|||
147566323|NCT02100228|532232143|FG000|Overall Study|Lost to Follow-up|0|||
147566324|NCT02100228|532232144|FG001|Overall Study|Lost to Follow-up|1|||
147566325|NCT02100228|532232143|FG000|Overall Study|Withdrawal by Subject|27|||
147566326|NCT02100228|532232144|FG001|Overall Study|Withdrawal by Subject|37|||
147566327|NCT02100228|532232143|FG000|Overall Study|Adverse Event|16|||
147566328|NCT02100228|532232144|FG001|Overall Study|Adverse Event|12|||
147116995|NCT04433975|530592972|FG001|9-month Follow Up|Death|1|||
147116996|NCT04433975|530592971|FG000|12-month Follow Up|Lost to Follow-up|27|||
147116997|NCT04433975|530592972|FG001|12-month Follow Up|Lost to Follow-up|31|||
147116998|NCT00685698|530592973|FG000|Overall Study|Withdrawal by Subject|1|||
147116999|NCT00685698|530592973|FG000|Overall Study|Protocol Violation|6|||
147117000|NCT00685698|530592973|FG000|Overall Study|Adverse Event|3|||
147117001|NCT00685698|530592973|FG000|Overall Study|CULTURE GRAM NEG SPECIES|1|||
147117002|NCT00685698|530592973|FG000|Overall Study|CULTURE RESULTS: GRAM-VE|1|||
147117003|NCT00685698|530592973|FG000|Overall Study|NO GRAM POSITIVE CULTURE GROWN|1|||
147117004|NCT04392635|530592974|FG000|Overall Study|Lost to Follow-up|0|||
147117005|NCT04392635|530592975|FG001|Overall Study|Lost to Follow-up|1|||
147117006|NCT02030418|530592977|FG000|Overall Study|Death|78|||
147117007|NCT02030418|530592977|FG000|Overall Study|Missed 12-Month Visit|9|||
147117008|NCT02030418|530592977|FG000|Overall Study|Withdrawn|57|||
147117009|NCT01179516|530592978|FG000|Overall Study|Pretreatment Event or Adverse Event|6|||
147117010|NCT01179516|530592979|FG001|Overall Study|Pretreatment Event or Adverse Event|8|||
147117011|NCT01179516|530592980|FG002|Overall Study|Pretreatment Event or Adverse Event|12|||
147117012|NCT01179516|530592978|FG000|Overall Study|Lack of Efficacy|4|||
147117013|NCT01179516|530592979|FG001|Overall Study|Lack of Efficacy|2|||
147117014|NCT01179516|530592980|FG002|Overall Study|Lack of Efficacy|0|||
147117015|NCT01179516|530592978|FG000|Overall Study|Noncompliance with Study Drug|2|||
147117016|NCT01179516|530592979|FG001|Overall Study|Noncompliance with Study Drug|0|||
147117017|NCT01179516|530592980|FG002|Overall Study|Noncompliance with Study Drug|1|||
147117018|NCT01179516|530592978|FG000|Overall Study|Protocol Deviations|4|||
147117019|NCT01179516|530592979|FG001|Overall Study|Protocol Deviations|3|||
147117020|NCT01179516|530592980|FG002|Overall Study|Protocol Deviations|3|||
147117021|NCT01179516|530592978|FG000|Overall Study|Withdrawal of Consent|2|||
147117022|NCT01179516|530592979|FG001|Overall Study|Withdrawal of Consent|6|||
147117023|NCT01179516|530592980|FG002|Overall Study|Withdrawal of Consent|10|||
147117024|NCT01179516|530592978|FG000|Overall Study|Lost to Follow-up|7|||
147117025|NCT01179516|530592979|FG001|Overall Study|Lost to Follow-up|7|||
147117026|NCT01179516|530592980|FG002|Overall Study|Lost to Follow-up|3|||
147117027|NCT01179516|530592978|FG000|Overall Study|Other|2|||
147117028|NCT01179516|530592979|FG001|Overall Study|Other|0|||
147117029|NCT01179516|530592980|FG002|Overall Study|Other|2|||
147117030|NCT02697422|530592981|FG000|Overall Study|Declined exit survey|9|||
147117031|NCT02697422|530592982|FG001|Overall Study|Declined exit survey|2|||
147117032|NCT02697422|530592981|FG000|Overall Study|Lost to Follow-up|13|||
147117033|NCT02697422|530592982|FG001|Overall Study|Lost to Follow-up|8|||
147117034|NCT02697422|530592981|FG000|Overall Study|Death|2|||
147117035|NCT02697422|530592982|FG001|Overall Study|Death|1|||
147117036|NCT02697422|530592981|FG000|Overall Study|Withdrawal by Subject|0|||
147117037|NCT02697422|530592982|FG001|Overall Study|Withdrawal by Subject|1|||
147117038|NCT02697422|530592981|FG000|Overall Study|Physician Decision|1|||
147117039|NCT02697422|530592982|FG001|Overall Study|Physician Decision|1|||
147117040|NCT02697422|530592981|FG000|Overall Study|Exit survey data lost|1|||
147117041|NCT02697422|530592982|FG001|Overall Study|Exit survey data lost|0|||
147117042|NCT03501277|530592984|FG000|Intervention Period 1 (4 Days)|Other|0|||
147117043|NCT03501277|530592985|FG001|Intervention Period 1 (4 Days)|Other|0|||
147117044|NCT03501277|530592986|FG002|Intervention Period 1 (4 Days)|Other|1|||
147117045|NCT03501277|530592987|FG003|Intervention Period 1 (4 Days)|Other|0|||
147117046|NCT03501277|530592984|FG000|Intervention Period 1 (4 Days)|Adverse Event|0|||
147117047|NCT03501277|530592985|FG001|Intervention Period 1 (4 Days)|Adverse Event|0|||
147117048|NCT03501277|530592986|FG002|Intervention Period 1 (4 Days)|Adverse Event|0|||
147117049|NCT03501277|530592987|FG003|Intervention Period 1 (4 Days)|Adverse Event|1|||
147117050|NCT03501277|530592984|FG000|Intervention Period 2 (4 Days)|Adverse Event|0|||
147566329|NCT02100228|532232143|FG000|Overall Study|Death|1|||
147566330|NCT02100228|532232144|FG001|Overall Study|Death|1|||
147117051|NCT03501277|530592985|FG001|Intervention Period 2 (4 Days)|Adverse Event|0|||
147117052|NCT03501277|530592986|FG002|Intervention Period 2 (4 Days)|Adverse Event|0|||
147117053|NCT03501277|530592987|FG003|Intervention Period 2 (4 Days)|Adverse Event|1|||
147117054|NCT03501277|530592984|FG000|Intervention Period 3 (4 Days)|Adverse Event|0|||
147117055|NCT03501277|530592985|FG001|Intervention Period 3 (4 Days)|Adverse Event|0|||
147117056|NCT03501277|530592986|FG002|Intervention Period 3 (4 Days)|Adverse Event|0|||
147117057|NCT03501277|530592987|FG003|Intervention Period 3 (4 Days)|Adverse Event|1|||
147117058|NCT03983109|530592988|FG000|Overall Study|Operational Hurdles Linked to Usage Methodologies|12|||
147117059|NCT03983109|530592989|FG001|Overall Study|Operational Hurdles Linked to Usage Methodologies|0|||
147117060|NCT02939781|530592990|FG000|Overall Study|Protocol Violation|8|||
147566331|NCT00214422|532232145|FG000|Overall Study|Physician Decision|2|||
147566332|NCT00214422|532232146|FG001|Overall Study|Physician Decision|0|||
147117061|NCT02939781|530592990|FG000|Overall Study|Withdrawal by Subject|1|||
147117062|NCT01740427|530592991|FG000|Overall Study|Objective Progression or Relapse|286|||
147117063|NCT01740427|530592992|FG001|Overall Study|Objective Progression or Relapse|172|||
147117064|NCT01740427|530592991|FG000|Overall Study|Adverse Event|32|||
147117065|NCT01740427|530592992|FG001|Overall Study|Adverse Event|9|||
147117066|NCT01740427|530592991|FG000|Overall Study|Global Deterioration of Health Status|28|||
147117067|NCT01740427|530592992|FG001|Overall Study|Global Deterioration of Health Status|12|||
147117068|NCT01740427|530592991|FG000|Overall Study|Participant Refused Continued Treatment|27|||
147117069|NCT01740427|530592992|FG001|Overall Study|Participant Refused Continued Treatment|15|||
147117070|NCT01740427|530592991|FG000|Overall Study|Unspecified reasons|52|||
147117071|NCT01740427|530592992|FG001|Overall Study|Unspecified reasons|8|||
147117072|NCT01740427|530592991|FG000|Overall Study|Death|10|||
147117073|NCT01740427|530592992|FG001|Overall Study|Death|3|||
147117074|NCT01740427|530592991|FG000|Overall Study|Protocol Violation|5|||
147117075|NCT01740427|530592992|FG001|Overall Study|Protocol Violation|3|||
147117076|NCT01740427|530592991|FG000|Overall Study|Lost to Follow-up|3|||
147117077|NCT01740427|530592992|FG001|Overall Study|Lost to Follow-up|0|||
147117078|NCT01740427|530592991|FG000|Overall Study|Site Terminated by Sponsor|1|||
147117079|NCT01740427|530592992|FG001|Overall Study|Site Terminated by Sponsor|0|||
147117080|NCT04739709|530592998|FG000|Overall Study|Physician Decision|1|||
147117081|NCT04739709|530592999|FG001|Overall Study|Physician Decision|0|||
147117082|NCT01980888|530593000|FG000|Overall Study|Study Terminated by Sponsor|116|||
147117083|NCT01980888|530593001|FG001|Overall Study|Study Terminated by Sponsor|122|||
147117084|NCT01980888|530593000|FG000|Overall Study|Withdrew Consent|17|||
147117085|NCT01980888|530593001|FG001|Overall Study|Withdrew Consent|6|||
147117086|NCT01980888|530593000|FG000|Overall Study|Investigator's Discretion|8|||
147117087|NCT01980888|530593001|FG001|Overall Study|Investigator's Discretion|3|||
147117088|NCT01980888|530593000|FG000|Overall Study|Non-Compliance with Study Drug|3|||
147117089|NCT01980888|530593001|FG001|Overall Study|Non-Compliance with Study Drug|2|||
147117090|NCT04625972|530593003|FG000|Overall Study|Death|3|||
147117091|NCT04625972|530593004|FG001|Overall Study|Death|2|||
147117092|NCT04625972|530593003|FG000|Overall Study|Lost to Follow-up|82|||
147117093|NCT04625972|530593004|FG001|Overall Study|Lost to Follow-up|38|||
147117094|NCT04625972|530593003|FG000|Overall Study|Physician Decision|2|||
147117095|NCT04625972|530593004|FG001|Overall Study|Physician Decision|0|||
147117096|NCT04625972|530593003|FG000|Overall Study|Protocol Violation|0|||
147117097|NCT04625972|530593004|FG001|Overall Study|Protocol Violation|1|||
147117098|NCT04625972|530593003|FG000|Overall Study|Withdrawal by Subject|37|||
147117099|NCT04625972|530593004|FG001|Overall Study|Withdrawal by Subject|24|||
147117100|NCT04625972|530593003|FG000|Overall Study|Not specified elsewhere|8|||
147117101|NCT04625972|530593004|FG001|Overall Study|Not specified elsewhere|6|||
147117102|NCT00433290|530593005|FG000|Overall Study|Adverse Event|24|||
147117103|NCT00433290|530593006|FG001|Overall Study|Adverse Event|7|||
147117104|NCT00433290|530593005|FG000|Overall Study|Lack of Efficacy|1|||
147117105|NCT00433290|530593006|FG001|Overall Study|Lack of Efficacy|5|||
147117106|NCT00433290|530593005|FG000|Overall Study|Withdrawal by Subject|4|||
147117107|NCT00433290|530593006|FG001|Overall Study|Withdrawal by Subject|2|||
147117108|NCT00433290|530593005|FG000|Overall Study|Protocol Violation|3|||
147117109|NCT00433290|530593006|FG001|Overall Study|Protocol Violation|2|||
147117110|NCT00433290|530593005|FG000|Overall Study|Physician Decision|2|||
147117111|NCT00433290|530593006|FG001|Overall Study|Physician Decision|0|||
147117112|NCT00433290|530593005|FG000|Overall Study|Entry Criteria Not Met|0|||
147117113|NCT00433290|530593006|FG001|Overall Study|Entry Criteria Not Met|1|||
147117114|NCT00433290|530593005|FG000|Overall Study|Lost to Follow-up|1|||
147229328|NCT03635788|531011959|FG002|Step 2|Lost to Follow-up|15|||
147229329|NCT03635788|531011957|FG000|Step 2|Withdrawal by Subject|0|||
147229330|NCT03635788|531011958|FG001|Step 2|Withdrawal by Subject|6|||
147229331|NCT03635788|531011959|FG002|Step 2|Withdrawal by Subject|6|||
147229332|NCT03635788|531011957|FG000|Step 2|Death|0|||
147229333|NCT03635788|531011958|FG001|Step 2|Death|2|||
147117115|NCT00433290|530593006|FG001|Overall Study|Lost to Follow-up|0|||
147117116|NCT01483651|530593007|FG000|Overall Study|Withdrawal by Subject|0|||
147117117|NCT01483651|530593008|FG001|Overall Study|Withdrawal by Subject|1|||
147117118|NCT01483651|530593009|FG002|Overall Study|Withdrawal by Subject|1|||
147117119|NCT01483651|530593010|FG003|Overall Study|Withdrawal by Subject|0|||
147229334|NCT03635788|531011959|FG002|Step 2|Death|0|||
147229335|NCT03635788|531011957|FG000|Step 2|Incarceration|0|||
147117120|NCT01483651|530593011|FG004|Overall Study|Withdrawal by Subject|0|||
147117121|NCT01483651|530593012|FG005|Overall Study|Withdrawal by Subject|1|||
147117122|NCT00724503|530593014|FG000|Overall Study|Lost to Follow-up|4|||
147117123|NCT00724503|530593015|FG001|Overall Study|Lost to Follow-up|8|||
147117124|NCT00724503|530593014|FG000|Overall Study|Withdrawal by Subject|11|||
147117125|NCT00724503|530593015|FG001|Overall Study|Withdrawal by Subject|23|||
147117126|NCT00724503|530593014|FG000|Overall Study|Death|190|||
147117127|NCT00724503|530593015|FG001|Overall Study|Death|182|||
147117128|NCT00724503|530593014|FG000|Overall Study|Adverse Event|1|||
147229336|NCT03635788|531011958|FG001|Step 2|Incarceration|2|||
147229337|NCT03635788|531011959|FG002|Step 2|Incarceration|0|||
147229338|NCT03635788|531011957|FG000|Step 2|Non-Compliance With Study Requirements|0|||
147117129|NCT00724503|530593015|FG001|Overall Study|Adverse Event|0|||
147117130|NCT00724503|530593014|FG000|Overall Study|Not otherwise specified|4|||
147117131|NCT00724503|530593015|FG001|Overall Study|Not otherwise specified|7|||
147117132|NCT01928771|530593017|FG000|Overall Study|Adverse Event|6|||
147117133|NCT01928771|530593018|FG001|Overall Study|Adverse Event|5|||
147117134|NCT01928771|530593019|FG002|Overall Study|Adverse Event|1|||
147117135|NCT01928771|530593017|FG000|Overall Study|Death|2|||
147117136|NCT01928771|530593018|FG001|Overall Study|Death|2|||
147117137|NCT01928771|530593019|FG002|Overall Study|Death|2|||
147117138|NCT01928771|530593017|FG000|Overall Study|Lost to Follow-up|5|||
147566333|NCT00214422|532232147|FG002|Overall Study|Physician Decision|0|||
147566334|NCT00214422|532232145|FG000|Overall Study|Developed esophageal ca|1|||
147566335|NCT00214422|532232146|FG001|Overall Study|Developed esophageal ca|0|||
147566336|NCT00214422|532232147|FG002|Overall Study|Developed esophageal ca|0|||
147566337|NCT00214422|532232145|FG000|Overall Study|Pt taken off study|1|||
147566338|NCT00214422|532232146|FG001|Overall Study|Pt taken off study|1|||
147566339|NCT00214422|532232147|FG002|Overall Study|Pt taken off study|0|||
147566340|NCT00214422|532232145|FG000|Overall Study|Disease progression on study|1|||
147566341|NCT00214422|532232146|FG001|Overall Study|Disease progression on study|0|||
147566342|NCT00214422|532232147|FG002|Overall Study|Disease progression on study|0|||
147566343|NCT00214422|532232145|FG000|Overall Study|Unable to make a radiation treatment|0|||
147566344|NCT00214422|532232146|FG001|Overall Study|Unable to make a radiation treatment|0|||
147566345|NCT00214422|532232147|FG002|Overall Study|Unable to make a radiation treatment|1|||
147566346|NCT02612337|532232149|FG000|Overall Study|Lack of Efficacy|1|||
147566347|NCT02612337|532232150|FG001|Overall Study|Lack of Efficacy|0|||
147566348|NCT02612337|532232149|FG000|Overall Study|Withdrawal by Subject|2|||
147566349|NCT02612337|532232150|FG001|Overall Study|Withdrawal by Subject|2|||
147566350|NCT02612337|532232149|FG000|Overall Study|Did not receive study drug|0|||
147117139|NCT01928771|530593018|FG001|Overall Study|Lost to Follow-up|6|||
147117140|NCT01928771|530593019|FG002|Overall Study|Lost to Follow-up|3|||
147117141|NCT01928771|530593017|FG000|Overall Study|Withdrawal by Subject|20|||
147229339|NCT03635788|531011958|FG001|Step 2|Non-Compliance With Study Requirements|1|||
147229340|NCT03635788|531011959|FG002|Step 2|Non-Compliance With Study Requirements|1|||
147229341|NCT03635788|531011957|FG000|Step 2|Confounding Medical Condition|0|||
147229342|NCT03635788|531011958|FG001|Step 2|Confounding Medical Condition|0|||
147229343|NCT03635788|531011959|FG002|Step 2|Confounding Medical Condition|1|||
147229344|NCT03635788|531011957|FG000|Step 2|Out Of State With No Plan To Return|0|||
147229345|NCT03635788|531011958|FG001|Step 2|Out Of State With No Plan To Return|1|||
147229346|NCT03635788|531011959|FG002|Step 2|Out Of State With No Plan To Return|0|||
147229347|NCT03635788|531011957|FG000|Step 2|Switched To Injectables|0|||
147229348|NCT03635788|531011958|FG001|Step 2|Switched To Injectables|0|||
147229349|NCT03635788|531011959|FG002|Step 2|Switched To Injectables|1|||
147229350|NCT03635788|531011957|FG000|Step 2|On Step 2 as of February 12, 2024|0|||
147229351|NCT03635788|531011958|FG001|Step 2|On Step 2 as of February 12, 2024|56|||
147229352|NCT03635788|531011959|FG002|Step 2|On Step 2 as of February 12, 2024|56|||
147229353|NCT01015131|531011960|FG000|Overall Study|Physician Decision|1|||
147229354|NCT01015131|531011960|FG000|Overall Study|Protocol Violation|1|||
147229355|NCT01015131|531011960|FG000|Overall Study|Withdrawal by Subject|2|||
147229356|NCT01015131|531011960|FG000|Overall Study|Other Protocol Specified Criteria|4|||
147229357|NCT05521906|531011966|FG000|Overall Study|removed by researchers for offensive or deceptive behavior|9|||
147229358|NCT05521906|531011967|FG001|Overall Study|removed by researchers for offensive or deceptive behavior|1|||
147229359|NCT02339285|531013073|FG000|Overall Study|Withdrawal by Subject|0|||
147229360|NCT02339285|531013074|FG001|Overall Study|Withdrawal by Subject|1|||
147229361|NCT02339285|531013075|FG002|Overall Study|Withdrawal by Subject|1|||
147229362|NCT02339285|531013073|FG000|Overall Study|Lost to Follow-up|1|||
147229363|NCT02339285|531013074|FG001|Overall Study|Lost to Follow-up|1|||
147229364|NCT02339285|531013075|FG002|Overall Study|Lost to Follow-up|1|||
147229365|NCT02339285|531013073|FG000|Overall Study|Protocol Deviation|0|||
147229366|NCT02339285|531013074|FG001|Overall Study|Protocol Deviation|1|||
147229367|NCT02339285|531013075|FG002|Overall Study|Protocol Deviation|0|||
147229368|NCT00282412|531013078|FG000|Overall Study|Death|2|||
147229369|NCT01920555|531013081|FG000|Overall Study|Physician Decision|1|||
147229370|NCT01920555|531013082|FG001|Overall Study|Physician Decision|2|||
147229371|NCT01920555|531013083|FG002|Overall Study|Physician Decision|1|||
147229372|NCT01920555|531013084|FG003|Overall Study|Physician Decision|2|||
147229373|NCT01920555|531013085|FG004|Overall Study|Physician Decision|0|||
147229374|NCT01920555|531013081|FG000|Overall Study|Lack of Efficacy|2|||
147117142|NCT01928771|530593018|FG001|Overall Study|Withdrawal by Subject|15|||
147117143|NCT01928771|530593019|FG002|Overall Study|Withdrawal by Subject|17|||
147229375|NCT01920555|531013082|FG001|Overall Study|Lack of Efficacy|0|||
147229376|NCT01920555|531013083|FG002|Overall Study|Lack of Efficacy|0|||
147229377|NCT01920555|531013084|FG003|Overall Study|Lack of Efficacy|0|||
147229378|NCT01920555|531013085|FG004|Overall Study|Lack of Efficacy|0|||
147229379|NCT01920555|531013081|FG000|Overall Study|Travel Difficulties|1|||
147566351|NCT02612337|532232150|FG001|Overall Study|Did not receive study drug|1|||
147566352|NCT02421952|532232153|FG000|Overall Study|Diary Not Returned|93|||
147566353|NCT02421952|532232153|FG000|Overall Study|Failed seriation task|13|||
147117144|NCT01928771|530593017|FG000|Overall Study|Study-Specific Withdrawal Criteria|0|||
147117145|NCT01928771|530593018|FG001|Overall Study|Study-Specific Withdrawal Criteria|1|||
147117146|NCT01928771|530593019|FG002|Overall Study|Study-Specific Withdrawal Criteria|1|||
147117147|NCT01928771|530593017|FG000|Overall Study|Other Reasons|9|||
147117148|NCT01928771|530593018|FG001|Overall Study|Other Reasons|9|||
147117149|NCT01928771|530593019|FG002|Overall Study|Other Reasons|14|||
147117150|NCT01928771|530593017|FG000|Overall Study|Severe Non-Compliance to Protocol|4|||
147117151|NCT01928771|530593018|FG001|Overall Study|Severe Non-Compliance to Protocol|2|||
147117152|NCT01928771|530593019|FG002|Overall Study|Severe Non-Compliance to Protocol|2|||
147117153|NCT01937117|530593020|FG000|Overall Study|Disease Progression|7|||
147117154|NCT01937117|530593020|FG000|Overall Study|Physician Decision|4|||
147117155|NCT01937117|530593020|FG000|Overall Study|Adverse Event|2|||
147117156|NCT01407367|530593023|FG000|Overall Study|Death|24|||
147117157|NCT01407367|530593024|FG001|Overall Study|Death|32|||
147117158|NCT01407367|530593023|FG000|Overall Study|Renal Replacement Therapy (RRT)|12|||
147117159|NCT01407367|530593024|FG001|Overall Study|Renal Replacement Therapy (RRT)|29|||
147117160|NCT01407367|530593023|FG000|Overall Study|Withdrawal by Subject|4|||
147117161|NCT01407367|530593024|FG001|Overall Study|Withdrawal by Subject|15|||
147117162|NCT01407367|530593023|FG000|Overall Study|Lost to Follow-up|0|||
147117163|NCT01407367|530593024|FG001|Overall Study|Lost to Follow-up|2|||
147117164|NCT01245062|530593028|FG000|Randomization and Crossover Phase|Lost to Follow-up|4|||
147117165|NCT01245062|530593029|FG001|Randomization and Crossover Phase|Lost to Follow-up|2|||
147117166|NCT01245062|530593030|FG002|Randomization and Crossover Phase|Lost to Follow-up|0|||
147117167|NCT01245062|530593028|FG000|Randomization and Crossover Phase|Physician Decision|2|||
147117168|NCT01245062|530593029|FG001|Randomization and Crossover Phase|Physician Decision|4|||
147117169|NCT01245062|530593030|FG002|Randomization and Crossover Phase|Physician Decision|0|||
147117170|NCT01245062|530593028|FG000|Randomization and Crossover Phase|Withdrew Consent|12|||
147117171|NCT01245062|530593029|FG001|Randomization and Crossover Phase|Withdrew Consent|11|||
147117172|NCT01245062|530593030|FG002|Randomization and Crossover Phase|Withdrew Consent|0|||
147117173|NCT01245062|530593028|FG000|Randomization and Crossover Phase|Study closed/ terminated|23|||
147117174|NCT01245062|530593029|FG001|Randomization and Crossover Phase|Study closed/ terminated|14|||
147117175|NCT01245062|530593030|FG002|Randomization and Crossover Phase|Study closed/ terminated|0|||
147117176|NCT01245062|530593028|FG000|Cross-over Phase|Lost to Follow-up|0|||
147117177|NCT01245062|530593029|FG001|Cross-over Phase|Lost to Follow-up|0|||
147117178|NCT01245062|530593030|FG002|Cross-over Phase|Lost to Follow-up|1|||
147117179|NCT01245062|530593028|FG000|Cross-over Phase|Physician Decision|0|||
147117180|NCT01245062|530593029|FG001|Cross-over Phase|Physician Decision|0|||
147117181|NCT01245062|530593030|FG002|Cross-over Phase|Physician Decision|1|||
147117182|NCT01245062|530593028|FG000|Cross-over Phase|Withdrew Consent|0|||
147117183|NCT01245062|530593029|FG001|Cross-over Phase|Withdrew Consent|0|||
147117184|NCT01245062|530593030|FG002|Cross-over Phase|Withdrew Consent|4|||
147117185|NCT01245062|530593028|FG000|Cross-over Phase|Study closed/ terminated|0|||
147117186|NCT01245062|530593029|FG001|Cross-over Phase|Study closed/ terminated|0|||
147117187|NCT01245062|530593030|FG002|Cross-over Phase|Study closed/ terminated|11|||
147117188|NCT01452347|530593031|FG000|Overall Study|Adverse Event|2|||
147117189|NCT01452347|530593032|FG001|Overall Study|Adverse Event|1|||
147117190|NCT01452347|530593031|FG000|Overall Study|Non compliance protocol|2|||
147117191|NCT01452347|530593032|FG001|Overall Study|Non compliance protocol|0|||
147117192|NCT01452347|530593031|FG000|Overall Study|Lost to Follow-up|2|||
147117193|NCT01452347|530593032|FG001|Overall Study|Lost to Follow-up|0|||
147117194|NCT01452347|530593031|FG000|Overall Study|Withdrawal by Subject|3|||
147117195|NCT01452347|530593032|FG001|Overall Study|Withdrawal by Subject|3|||
147117196|NCT01452347|530593031|FG000|Overall Study|Not treated|6|||
147117197|NCT01452347|530593032|FG001|Overall Study|Not treated|3|||
147117198|NCT01452347|530593031|FG000|Overall Study|Other reason not defined above|2|||
147117199|NCT01452347|530593032|FG001|Overall Study|Other reason not defined above|0|||
147117200|NCT05762744|530593033|FG000|1st iv Glucose Tolerance Test|Withdrawal by Subject|0|||
147229380|NCT01920555|531013082|FG001|Overall Study|Travel Difficulties|1|||
147229381|NCT01920555|531013083|FG002|Overall Study|Travel Difficulties|0|||
147229382|NCT01920555|531013084|FG003|Overall Study|Travel Difficulties|0|||
147229383|NCT01920555|531013085|FG004|Overall Study|Travel Difficulties|1|||
147229384|NCT01920555|531013081|FG000|Overall Study|Lost to Follow-up|0|||
147229385|NCT01920555|531013082|FG001|Overall Study|Lost to Follow-up|1|||
147229386|NCT01920555|531013083|FG002|Overall Study|Lost to Follow-up|0|||
147229387|NCT01920555|531013084|FG003|Overall Study|Lost to Follow-up|1|||
147229388|NCT01920555|531013085|FG004|Overall Study|Lost to Follow-up|0|||
147229389|NCT03911713|531013086|FG000|Overall Study|Lost to Follow-up|0|||
147117201|NCT05762744|530593034|FG001|1st iv Glucose Tolerance Test|Withdrawal by Subject|1|||
147117202|NCT05762744|530593033|FG000|1st iv Glucose Tolerance Test|Some critical blood samples not collecte|5|||
147117203|NCT05762744|530593034|FG001|1st iv Glucose Tolerance Test|Some critical blood samples not collecte|5|||
147229390|NCT03911713|531013087|FG001|Overall Study|Lost to Follow-up|2|||
147229391|NCT03911713|531013088|FG002|Overall Study|Lost to Follow-up|0|||
147229392|NCT03911713|531013089|FG003|Overall Study|Lost to Follow-up|0|||
147117204|NCT01560416|530593038|FG000|Randomized Phase|Crossover Participants|7|||
147117205|NCT01560416|530593039|FG001|Randomized Phase|Crossover Participants|0|||
147117206|NCT02724644|530594281|FG000|Overall Study|Adverse Event|7|||
147117207|NCT02724644|530594282|FG001|Overall Study|Adverse Event|1|||
147117208|NCT02724644|530594281|FG000|Overall Study|Lost to Follow-up|6|||
147117209|NCT02724644|530594282|FG001|Overall Study|Lost to Follow-up|2|||
147117210|NCT02724644|530594281|FG000|Overall Study|Withdrawal by Subject|7|||
147117211|NCT02724644|530594282|FG001|Overall Study|Withdrawal by Subject|1|||
147117212|NCT02724644|530594281|FG000|Overall Study|Administrative|1|||
147117213|NCT02724644|530594282|FG001|Overall Study|Administrative|0|||
147117214|NCT02545127|530594285|FG000|Overall Study|Lost to Follow-up|1|||
147117215|NCT02545127|530594286|FG001|Overall Study|Lost to Follow-up|0|||
147117216|NCT03197935|530594287|FG000|Overall Study|Death due to any cause|26|||
147117217|NCT03197935|530594288|FG001|Overall Study|Death due to any cause|15|||
147117218|NCT03197935|530594287|FG000|Overall Study|Lost to Follow-up|3|||
147117219|NCT03197935|530594288|FG001|Overall Study|Lost to Follow-up|5|||
147117220|NCT03197935|530594287|FG000|Overall Study|Physician Decision|2|||
147117221|NCT03197935|530594288|FG001|Overall Study|Physician Decision|1|||
147312554|NCT00882921|531310789|FG000|Overall Study|Other|3|||
147312555|NCT00882921|531310789|FG000|Overall Study|Lost to Follow-up|2|||
147312556|NCT00882921|531310789|FG000|Overall Study|Termination By Investigator|3|||
147312557|NCT00882921|531310789|FG000|Overall Study|Withdrawal Of Consent|1|||
147312558|NCT05027074|531310790|FG000|Overall Study|Death|47|||
147312559|NCT05027074|531310791|FG001|Overall Study|Death|42|||
147312560|NCT05027074|531310792|FG002|Overall Study|Death|39|||
147312561|NCT05027074|531310790|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
147312562|NCT05027074|531310791|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
147312563|NCT05027074|531310792|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
147312564|NCT05027074|531310790|FG000|Overall Study|Site Terminated By Sponsor|3|||
147312565|NCT05027074|531310791|FG001|Overall Study|Site Terminated By Sponsor|0|||
147312566|NCT05027074|531310792|FG002|Overall Study|Site Terminated By Sponsor|2|||
147312567|NCT05027074|531310790|FG000|Overall Study|Withdrawal by Subject|13|||
147312568|NCT05027074|531310791|FG001|Overall Study|Withdrawal by Subject|8|||
147312569|NCT05027074|531310792|FG002|Overall Study|Withdrawal by Subject|10|||
147312570|NCT05027074|531310790|FG000|Overall Study|Lost to Follow-up|2|||
147312571|NCT05027074|531310791|FG001|Overall Study|Lost to Follow-up|4|||
147312572|NCT05027074|531310792|FG002|Overall Study|Lost to Follow-up|3|||
147312573|NCT05027074|531310790|FG000|Overall Study|Status Not Recorded|0|||
147312574|NCT05027074|531310791|FG001|Overall Study|Status Not Recorded|0|||
147312575|NCT05027074|531310792|FG002|Overall Study|Status Not Recorded|1|||
147312576|NCT04150029|531310793|FG000|Overall Study|Disease Relapse|0|||
147312577|NCT04150029|531310794|FG001|Overall Study|Disease Relapse|18|||
147312578|NCT04150029|531310793|FG000|Overall Study|Progressive Disease|2|||
147312579|NCT04150029|531310794|FG001|Overall Study|Progressive Disease|16|||
147312580|NCT04150029|531310793|FG000|Overall Study|Adverse Event|1|||
147312581|NCT04150029|531310794|FG001|Overall Study|Adverse Event|11|||
147312582|NCT04150029|531310793|FG000|Overall Study|Physician Decision|0|||
147312583|NCT04150029|531310794|FG001|Overall Study|Physician Decision|10|||
147312584|NCT04150029|531310793|FG000|Overall Study|Study Terminated by Sponsor|1|||
147312585|NCT04150029|531310794|FG001|Overall Study|Study Terminated by Sponsor|10|||
147312586|NCT04150029|531310793|FG000|Overall Study|Death|0|||
147312587|NCT04150029|531310794|FG001|Overall Study|Death|8|||
147312588|NCT04150029|531310793|FG000|Overall Study|Participant Decision|0|||
147312589|NCT04150029|531310794|FG001|Overall Study|Participant Decision|7|||
147312590|NCT04150029|531310793|FG000|Overall Study|Hemopoietic Stem Cell Transplant (HSCT)|1|||
147312591|NCT04150029|531310794|FG001|Overall Study|Hemopoietic Stem Cell Transplant (HSCT)|5|||
147312592|NCT02364713|531310798|FG000|Overall Study|Ineligible|2|||
147312593|NCT02364713|531310799|FG001|Overall Study|Ineligible|2|||
147312594|NCT01032044|531310800|FG000|Overall Study|Protocol Violation|14|||
147312595|NCT01032044|531310801|FG001|Overall Study|Protocol Violation|8|||
147566354|NCT02421952|532232153|FG000|Overall Study|Subject uncooperative for baseline test|2|||
147312596|NCT01032044|531310800|FG000|Overall Study|Adverse Event|0|||
147312597|NCT01032044|531310801|FG001|Overall Study|Adverse Event|1|||
147312598|NCT01032044|531310800|FG000|Overall Study|Lost to Follow-up|11|||
147312599|NCT01032044|531310801|FG001|Overall Study|Lost to Follow-up|11|||
147312600|NCT01233609|531310802|FG000|Overall Study|Death|1|||
147312601|NCT01233609|531310803|FG001|Overall Study|Death|0|||
147312602|NCT01233609|531310802|FG000|Overall Study|Lost to Follow-up|3|||
147566355|NCT02421952|532232153|FG000|Overall Study|Surgery cancelled|1|||
147117222|NCT03197935|530594287|FG000|Overall Study|Withdrawal by Subject|16|||
147117223|NCT03197935|530594288|FG001|Overall Study|Withdrawal by Subject|8|||
147117224|NCT00985192|530594290|FG000|Overall Study|Withdrawal by Subject|1|||
147117225|NCT00985192|530594290|FG000|Overall Study|Disease Progression|1|||
147312603|NCT01233609|531310803|FG001|Overall Study|Lost to Follow-up|1|||
147566356|NCT00854100|532232154|FG000|Overall Study|Inability to complete the study visits|0|||
147117226|NCT00985192|530594290|FG000|Overall Study|Determined to be Ineligible During Trial|2|||
147312604|NCT01233609|531310802|FG000|Overall Study|Adverse Event|2|||
147312605|NCT01233609|531310803|FG001|Overall Study|Adverse Event|1|||
147312606|NCT01233609|531310802|FG000|Overall Study|Withdrawal by Subject|3|||
147117227|NCT00669331|530594291|FG000|Randomisation to First Dose|Adverse Event|1|||
147117228|NCT00669331|530594292|FG001|Randomisation to First Dose|Adverse Event|0|||
147117229|NCT00669331|530594291|FG000|Randomisation to First Dose|Protocol Violation|1|||
147117230|NCT00669331|530594292|FG001|Randomisation to First Dose|Protocol Violation|0|||
147117231|NCT00669331|530594291|FG000|Randomisation to First Dose|Withdrawal by Subject|3|||
147117232|NCT00669331|530594292|FG001|Randomisation to First Dose|Withdrawal by Subject|2|||
147117233|NCT00669331|530594291|FG000|Randomisation to First Dose|Lost to Follow-up|2|||
147117234|NCT00669331|530594292|FG001|Randomisation to First Dose|Lost to Follow-up|0|||
147117235|NCT00669331|530594291|FG000|Randomisation to First Dose|Death|1|||
147117236|NCT00669331|530594292|FG001|Randomisation to First Dose|Death|0|||
147117237|NCT00669331|530594291|FG000|Randomisation to First Dose|Sponsor decision|0|||
147117238|NCT00669331|530594292|FG001|Randomisation to First Dose|Sponsor decision|1|||
147117239|NCT00669331|530594291|FG000|Randomisation to First Dose|Randomised in error|3|||
147117240|NCT00669331|530594292|FG001|Randomisation to First Dose|Randomised in error|10|||
147117241|NCT00669331|530594291|FG000|Blinded Treatment Period|Adverse Event|16|||
147117242|NCT00669331|530594292|FG001|Blinded Treatment Period|Adverse Event|10|||
147117243|NCT00669331|530594291|FG000|Blinded Treatment Period|Protocol Violation|1|||
147117244|NCT00669331|530594292|FG001|Blinded Treatment Period|Protocol Violation|1|||
147117245|NCT00669331|530594291|FG000|Blinded Treatment Period|Withdrawal by Subject|17|||
147117246|NCT00669331|530594292|FG001|Blinded Treatment Period|Withdrawal by Subject|19|||
147117247|NCT00669331|530594291|FG000|Blinded Treatment Period|Lost to Follow-up|3|||
147117248|NCT00669331|530594292|FG001|Blinded Treatment Period|Lost to Follow-up|2|||
147117249|NCT00669331|530594291|FG000|Blinded Treatment Period|Death|0|||
147117250|NCT00669331|530594292|FG001|Blinded Treatment Period|Death|2|||
147117251|NCT00669331|530594291|FG000|Blinded Treatment Period|Physician Decision|3|||
147117252|NCT00669331|530594292|FG001|Blinded Treatment Period|Physician Decision|3|||
147117253|NCT00669331|530594291|FG000|Blinded Treatment Period|Unable/unwilling to comply w trial reqs|2|||
147117254|NCT00669331|530594292|FG001|Blinded Treatment Period|Unable/unwilling to comply w trial reqs|2|||
147117255|NCT02595749|530594293|FG000|Overall Study|Withdrawal by Subject|12|||
147117256|NCT02595749|530594294|FG001|Overall Study|Withdrawal by Subject|7|||
147117257|NCT01454063|530594295|FG000|Randomized|Adverse Event|1|||
147117258|NCT01454063|530594296|FG001|Randomized|Adverse Event|1|||
147117259|NCT01454063|530594295|FG000|Randomized|Protocol Violation|0|||
147117260|NCT01454063|530594296|FG001|Randomized|Protocol Violation|1|||
147117261|NCT03387046|530594305|FG000|Overall Study|Adverse Event|1|||
147117262|NCT03387046|530594306|FG001|Overall Study|Adverse Event|1|||
147117263|NCT00509600|530594307|FG000|Overall Study|Adverse Event|1|||
147117264|NCT02568423|530594310|FG000|Overall Study|Lost to Follow-up|0|||
147117265|NCT02568423|530594311|FG001|Overall Study|Lost to Follow-up|2|||
147117266|NCT02568423|530594312|FG002|Overall Study|Lost to Follow-up|0|||
147117267|NCT02568423|530594313|FG003|Overall Study|Lost to Follow-up|0|||
147117268|NCT02568423|530594314|FG004|Overall Study|Lost to Follow-up|0|||
147117269|NCT02568423|530594315|FG005|Overall Study|Lost to Follow-up|0|||
147117270|NCT02568423|530594316|FG006|Overall Study|Lost to Follow-up|0|||
147117271|NCT02568423|530594317|FG007|Overall Study|Lost to Follow-up|0|||
147117272|NCT02568423|530594310|FG000|Overall Study|Physician Decision|0|||
147117273|NCT02568423|530594311|FG001|Overall Study|Physician Decision|0|||
147117274|NCT02568423|530594312|FG002|Overall Study|Physician Decision|0|||
147117275|NCT02568423|530594313|FG003|Overall Study|Physician Decision|0|||
147117276|NCT02568423|530594314|FG004|Overall Study|Physician Decision|0|||
147229393|NCT03911713|531013090|FG004|Overall Study|Lost to Follow-up|0|||
147229394|NCT03911713|531013086|FG000|Overall Study|Other|0|||
147229395|NCT03911713|531013087|FG001|Overall Study|Other|0|||
147229396|NCT03911713|531013088|FG002|Overall Study|Other|0|||
147229397|NCT03911713|531013089|FG003|Overall Study|Other|1|||
147229398|NCT03911713|531013090|FG004|Overall Study|Other|0|||
147229399|NCT03911713|531013086|FG000|Overall Study|Randomized, Never Dosed|1|||
147229400|NCT03911713|531013087|FG001|Overall Study|Randomized, Never Dosed|0|||
147229401|NCT03911713|531013088|FG002|Overall Study|Randomized, Never Dosed|0|||
147229402|NCT03911713|531013089|FG003|Overall Study|Randomized, Never Dosed|1|||
147229403|NCT03911713|531013090|FG004|Overall Study|Randomized, Never Dosed|0|||
147229404|NCT01845818|531013093|FG000|Overall Study|Withdrawal by Subject|0|||
147229405|NCT01845818|531013094|FG001|Overall Study|Withdrawal by Subject|1|||
147229406|NCT01845818|531013093|FG000|Overall Study|Lost to Follow-up|7|||
147229407|NCT01845818|531013094|FG001|Overall Study|Lost to Follow-up|5|||
147229408|NCT01845818|531013093|FG000|Overall Study|Administrative Reasons|3|||
147229409|NCT01845818|531013094|FG001|Overall Study|Administrative Reasons|1|||
147117277|NCT02568423|530594315|FG005|Overall Study|Physician Decision|1|||
147229410|NCT01845818|531013093|FG000|Overall Study|Serious Adverse Event|1|||
147229411|NCT01845818|531013094|FG001|Overall Study|Serious Adverse Event|1|||
147229412|NCT01845818|531013093|FG000|Overall Study|Other|25|||
147229413|NCT01845818|531013094|FG001|Overall Study|Other|8|||
147117278|NCT02568423|530594316|FG006|Overall Study|Physician Decision|0|||
147117279|NCT02568423|530594317|FG007|Overall Study|Physician Decision|0|||
147117280|NCT03794544|530594320|FG000|Overall Study|Withdrawal by Subject|1|||
147117281|NCT03794544|530594321|FG001|Overall Study|Withdrawal by Subject|1|||
147229414|NCT01845818|531013093|FG000|Overall Study|Did Not Receive Any Dose of Adalimumab|5|||
147117282|NCT03794544|530594322|FG002|Overall Study|Withdrawal by Subject|0|||
147117283|NCT03794544|530594323|FG003|Overall Study|Withdrawal by Subject|0|||
147117284|NCT03794544|530594320|FG000|Overall Study|Death|0|||
147117285|NCT03794544|530594321|FG001|Overall Study|Death|0|||
147117286|NCT03794544|530594322|FG002|Overall Study|Death|0|||
147117287|NCT03794544|530594323|FG003|Overall Study|Death|1|||
147117288|NCT03794544|530594320|FG000|Overall Study|Lost to Follow-up|0|||
147117289|NCT03794544|530594321|FG001|Overall Study|Lost to Follow-up|1|||
147117290|NCT03794544|530594322|FG002|Overall Study|Lost to Follow-up|1|||
147117291|NCT03794544|530594323|FG003|Overall Study|Lost to Follow-up|0|||
147117292|NCT03794544|530594320|FG000|Overall Study|Other|0|||
147117293|NCT03794544|530594321|FG001|Overall Study|Other|1|||
147566357|NCT00854100|532232155|FG001|Overall Study|Inability to complete the study visits|0|||
147566358|NCT00854100|532232156|FG002|Overall Study|Inability to complete the study visits|1|||
147566359|NCT00854100|532232154|FG000|Overall Study|Lost to Follow-up|2|||
147117294|NCT03794544|530594322|FG002|Overall Study|Other|0|||
147117295|NCT03794544|530594323|FG003|Overall Study|Other|0|||
147117296|NCT01027416|530594324|FG000|Overall Study|Withdrawal by Subject|0|||
147117297|NCT01027416|530594325|FG001|Overall Study|Withdrawal by Subject|1|||
147117298|NCT01027416|530594324|FG000|Overall Study|Physician Decision|1|||
147117299|NCT01027416|530594325|FG001|Overall Study|Physician Decision|4|||
147117300|NCT00421733|530594326|FG000|Overall Study|Adverse Event|4|||
147229415|NCT01845818|531013094|FG001|Overall Study|Did Not Receive Any Dose of Adalimumab|0|||
147229416|NCT01845818|531013093|FG000|Overall Study|No Follow-Up Data Available|4|||
147229417|NCT01845818|531013094|FG001|Overall Study|No Follow-Up Data Available|1|||
147229418|NCT00195273|531013095|FG000|Overall Study|Adverse Event|9|||
147229419|NCT00195273|531013096|FG001|Overall Study|Adverse Event|9|||
147229420|NCT00195273|531013095|FG000|Overall Study|Protocol deviation|0|||
147229421|NCT00195273|531013096|FG001|Overall Study|Protocol deviation|1|||
147229422|NCT00195273|531013095|FG000|Overall Study|Lack of Efficacy|3|||
147229423|NCT00195273|531013096|FG001|Overall Study|Lack of Efficacy|1|||
147229424|NCT00195273|531013095|FG000|Overall Study|Procedural complications|9|||
147229425|NCT00195273|531013096|FG001|Overall Study|Procedural complications|3|||
147229426|NCT01680965|531013097|FG000|Overall Study|Death|0|||
147229427|NCT01680965|531013098|FG001|Overall Study|Death|0|||
147229428|NCT01680965|531013099|FG002|Overall Study|Death|0|||
147229429|NCT01680965|531013100|FG003|Overall Study|Death|6|||
147229430|NCT02595970|531013101|FG000|Overall Study|Withdrawal by Subject|2|||
147229431|NCT02595970|531013101|FG000|Overall Study|Physician Decision|2|||
147229432|NCT02595970|531013101|FG000|Overall Study|Protocol Violation|4|||
147229433|NCT02595970|531013101|FG000|Overall Study|Adverse Event|5|||
147229434|NCT02595970|531013101|FG000|Overall Study|Lack of Efficacy|7|||
147229435|NCT02570074|531013102|FG000|Period 2 (Second Dosing Regimen)|Lost to Follow-up|1|||
147229436|NCT02570074|531013103|FG001|Period 2 (Second Dosing Regimen)|Lost to Follow-up|0|||
147229437|NCT02923427|531013104|FG000|Overall Study|convert to laparatomy|2|||
147229438|NCT02923427|531013105|FG001|Overall Study|convert to laparatomy|2|||
147229439|NCT02923427|531013104|FG000|Overall Study|destaturation|1|||
147229440|NCT02923427|531013105|FG001|Overall Study|destaturation|0|||
147229441|NCT02923427|531013104|FG000|Overall Study|can not replace LMA|1|||
147229442|NCT02923427|531013105|FG001|Overall Study|can not replace LMA|0|||
147229443|NCT01325623|531013106|FG000|Overall Study|Withdrawal by Subject|3|||
147229444|NCT01539642|531013111|FG000|Overall Study|Lack of Efficacy|20|||
147229445|NCT01539642|531013112|FG001|Overall Study|Lack of Efficacy|18|||
147229446|NCT01539642|531013111|FG000|Overall Study|Patient ready for early discharge|8|||
147229447|NCT01539642|531013112|FG001|Overall Study|Patient ready for early discharge|7|||
147229448|NCT01539642|531013111|FG000|Overall Study|Adverse Event|6|||
147229449|NCT01539642|531013112|FG001|Overall Study|Adverse Event|4|||
147229450|NCT01539642|531013111|FG000|Overall Study|Withdrawal by Subject|2|||
147229451|NCT01539642|531013112|FG001|Overall Study|Withdrawal by Subject|2|||
147229452|NCT02063880|531013113|FG000|Overall Study|Death|21|||
147229453|NCT02063880|531013114|FG001|Overall Study|Death|18|||
147229454|NCT02063880|531013113|FG000|Overall Study|Lost to Follow-up|7|||
147229455|NCT02063880|531013114|FG001|Overall Study|Lost to Follow-up|7|||
147229456|NCT02063880|531013113|FG000|Overall Study|Ineligible|0|||
147229457|NCT02063880|531013114|FG001|Overall Study|Ineligible|2|||
147229458|NCT02556203|531013115|FG000|Overall Study|Withdrawal by Subject|21|||
147229459|NCT02556203|531013116|FG001|Overall Study|Withdrawal by Subject|21|||
147229460|NCT02556203|531013115|FG000|Overall Study|Lost to Follow-up|5|||
147229461|NCT02556203|531013116|FG001|Overall Study|Lost to Follow-up|5|||
147229462|NCT02556203|531013115|FG000|Overall Study|Adverse Event|1|||
147229463|NCT02556203|531013116|FG001|Overall Study|Adverse Event|0|||
147117301|NCT00421733|530594327|FG001|Overall Study|Adverse Event|9|||
147117302|NCT00421733|530594328|FG002|Overall Study|Adverse Event|2|||
147117303|NCT00421733|530594326|FG000|Overall Study|Lost to Follow-up|1|||
147117304|NCT00421733|530594327|FG001|Overall Study|Lost to Follow-up|2|||
147229464|NCT02943460|531013119|FG000|Blinded Study Phase|Adverse Event|3|||
147229465|NCT02943460|531013120|FG001|Blinded Study Phase|Adverse Event|0|||
147229466|NCT02943460|531013121|FG002|Blinded Study Phase|Adverse Event|0|||
147229467|NCT02943460|531013119|FG000|Blinded Study Phase|Withdrew Consent|0|||
147566360|NCT00854100|532232155|FG001|Overall Study|Lost to Follow-up|0|||
147444439|NCT00804570|531792613|FG001|Overall Study|Sponsor decision|4|||
147444440|NCT00804570|531792612|FG000|Overall Study|Withdrawal by Subject|21|||
147444441|NCT00804570|531792613|FG001|Overall Study|Withdrawal by Subject|38|||
147444442|NCT00290342|531792614|FG000|Overall Study|Other|0|||
147444443|NCT00290342|531792615|FG001|Overall Study|Other|1|||
147117305|NCT00421733|530594328|FG002|Overall Study|Lost to Follow-up|4|||
147117306|NCT00421733|530594326|FG000|Overall Study|Withdrawal by Subject|1|||
147117307|NCT00421733|530594327|FG001|Overall Study|Withdrawal by Subject|2|||
147117308|NCT00421733|530594328|FG002|Overall Study|Withdrawal by Subject|7|||
147117309|NCT00421733|530594326|FG000|Overall Study|Death|0|||
147117310|NCT00421733|530594327|FG001|Overall Study|Death|3|||
147117311|NCT00421733|530594328|FG002|Overall Study|Death|0|||
147117312|NCT00421733|530594326|FG000|Overall Study|Required dialysis|1|||
147117313|NCT00421733|530594327|FG001|Overall Study|Required dialysis|0|||
147117314|NCT00421733|530594328|FG002|Overall Study|Required dialysis|0|||
147117315|NCT00421733|530594326|FG000|Overall Study|Administrative|2|||
147117316|NCT00421733|530594327|FG001|Overall Study|Administrative|0|||
147117317|NCT00421733|530594328|FG002|Overall Study|Administrative|0|||
147117318|NCT00421733|530594326|FG000|Overall Study|Did not satisfy entry criteria|1|||
147117319|NCT00421733|530594327|FG001|Overall Study|Did not satisfy entry criteria|3|||
147117320|NCT00421733|530594328|FG002|Overall Study|Did not satisfy entry criteria|2|||
147117321|NCT00421733|530594326|FG000|Overall Study|Sponsor request|1|||
147117322|NCT00421733|530594327|FG001|Overall Study|Sponsor request|0|||
147117323|NCT00421733|530594328|FG002|Overall Study|Sponsor request|3|||
147117324|NCT00421733|530594326|FG000|Overall Study|Protocol deviation|4|||
147117325|NCT00421733|530594327|FG001|Overall Study|Protocol deviation|7|||
147117326|NCT00421733|530594328|FG002|Overall Study|Protocol deviation|2|||
147117327|NCT00120250|530594329|FG000|Overall Study|Lost to Follow-up|1|||
147117328|NCT00120250|530594330|FG001|Overall Study|Lost to Follow-up|1|||
147117329|NCT00120250|530594329|FG000|Overall Study|Protocol Violation|0|||
147117330|NCT00120250|530594330|FG001|Overall Study|Protocol Violation|1|||
147117331|NCT00720083|530594331|FG000|Overall Study|Ineligible|1|||
147117332|NCT00720083|530594332|FG001|Overall Study|Ineligible|2|||
147117333|NCT00103506|530594335|FG000|Overall Study|Study closed by sponsor|34|||
147117334|NCT00103506|530594336|FG001|Overall Study|Study closed by sponsor|37|||
147117335|NCT00103506|530594335|FG000|Overall Study|Death|257|||
147117336|NCT00103506|530594336|FG001|Overall Study|Death|253|||
147117337|NCT00103506|530594335|FG000|Overall Study|Lost to Follow-up|13|||
147117338|NCT00103506|530594336|FG001|Overall Study|Lost to Follow-up|13|||
147117339|NCT00103506|530594335|FG000|Overall Study|Withdrawal by Subject|18|||
147117340|NCT00103506|530594336|FG001|Overall Study|Withdrawal by Subject|21|||
147117341|NCT00585585|530594337|FG000|Overall Study|Adverse Event|1|||
147117342|NCT02056288|530594338|FG000|In-Hospital Data|Surgery cancelled|1|||
147117343|NCT02056288|530594339|FG001|In-Hospital Data|Surgery cancelled|0|||
147117344|NCT02056288|530594338|FG000|In-Hospital Data|Protocol Violation|3|||
147117345|NCT02056288|530594339|FG001|In-Hospital Data|Protocol Violation|0|||
147117346|NCT02056288|530594338|FG000|In-Hospital Data|Physician Decision|1|||
147117347|NCT02056288|530594339|FG001|In-Hospital Data|Physician Decision|0|||
147117348|NCT02056288|530594338|FG000|48-Hour Post-Discharge Data|Did not return diary|14|||
147117349|NCT02056288|530594339|FG001|48-Hour Post-Discharge Data|Did not return diary|20|||
147117350|NCT01433978|530594340|FG000|Core Study|Adverse Event, Non-Fatal|0|||
147117351|NCT01433978|530594341|FG001|Core Study|Adverse Event, Non-Fatal|1|||
147117352|NCT01433978|530594342|FG002|Core Study|Adverse Event, Non-Fatal|0|||
147117353|NCT01433978|530594340|FG000|Core Study|Lack of Efficacy|5|||
147117354|NCT01433978|530594341|FG001|Core Study|Lack of Efficacy|1|||
147444444|NCT00290342|531792614|FG000|Overall Study|Withdrawal by Subject|6|||
147444445|NCT00290342|531792615|FG001|Overall Study|Withdrawal by Subject|4|||
147444446|NCT00290342|531792614|FG000|Overall Study|Lost to Follow-up|1|||
147117355|NCT01433978|530594342|FG002|Core Study|Lack of Efficacy|0|||
147117356|NCT01433978|530594340|FG000|Core Study|Study Terminated by Sponsor|6|||
147117357|NCT01433978|530594341|FG001|Core Study|Study Terminated by Sponsor|9|||
147117358|NCT01433978|530594342|FG002|Core Study|Study Terminated by Sponsor|0|||
147117359|NCT01433978|530594340|FG000|Extension Phase|Adverse Event, Non-Fatal|0|||
147117360|NCT01433978|530594341|FG001|Extension Phase|Adverse Event, Non-Fatal|0|||
147117361|NCT01433978|530594342|FG002|Extension Phase|Adverse Event, Non-Fatal|1|||
147117362|NCT01433978|530594340|FG000|Extension Phase|Lack of Efficacy|0|||
147117363|NCT01433978|530594341|FG001|Extension Phase|Lack of Efficacy|0|||
147117364|NCT01433978|530594342|FG002|Extension Phase|Lack of Efficacy|1|||
147117365|NCT01433978|530594340|FG000|Extension Phase|Study Terminated by Sponsor|0|||
147117366|NCT01433978|530594341|FG001|Extension Phase|Study Terminated by Sponsor|0|||
147117367|NCT01433978|530594342|FG002|Extension Phase|Study Terminated by Sponsor|4|||
147117368|NCT01441414|530594343|FG000|Overall Study|Participant died|9|||
147117369|NCT01441414|530594343|FG000|Overall Study|Other reasons|3|||
147117370|NCT01441414|530594343|FG000|Overall Study|Study terminated by sponsor|2|||
147117371|NCT01441414|530594343|FG000|Overall Study|Subject refused further follow-up|1|||
147117372|NCT01773889|530594344|FG000|Overall Study|lack of funding|2|||
147117373|NCT03954938|530594345|FG000|Overall Study|Withdrawal by Subject|2|||
147117374|NCT03954938|530594345|FG000|Overall Study|Adverse Event|1|||
147117375|NCT00617903|530594346|FG000|Overall Study|Withdrawal by Subject|2|||
147117376|NCT00617903|530594347|FG001|Overall Study|Withdrawal by Subject|3|||
147117377|NCT00617903|530594346|FG000|Overall Study|Lost to Follow-up|1|||
147117378|NCT00617903|530594347|FG001|Overall Study|Lost to Follow-up|1|||
147117379|NCT00617903|530594346|FG000|Overall Study|Lack of Efficacy|0|||
147117380|NCT00617903|530594347|FG001|Overall Study|Lack of Efficacy|1|||
147117381|NCT00617903|530594346|FG000|Overall Study|Adverse Event|0|||
147117382|NCT00617903|530594347|FG001|Overall Study|Adverse Event|1|||
147117383|NCT00617903|530594346|FG000|Overall Study|noncompliance|0|||
147444447|NCT00290342|531792615|FG001|Overall Study|Lost to Follow-up|0|||
147444448|NCT01056510|531792618|FG000|Overall Study|Dropout Before Start of Treatment|1|||
147444449|NCT01056510|531792619|FG001|Overall Study|Dropout Before Start of Treatment|1|||
147444450|NCT01056510|531792618|FG000|Overall Study|Withdrawal by Subject|4|||
147117384|NCT00617903|530594347|FG001|Overall Study|noncompliance|1|||
147444451|NCT01056510|531792619|FG001|Overall Study|Withdrawal by Subject|2|||
147566361|NCT00854100|532232156|FG002|Overall Study|Lost to Follow-up|3|||
147117385|NCT02565186|530594348|FG000|Overall Study|Adverse Event|113|||
147117386|NCT02565186|530594349|FG001|Overall Study|Adverse Event|148|||
147117387|NCT02565186|530594348|FG000|Overall Study|Lost to Follow-up|102|||
147117388|NCT02565186|530594349|FG001|Overall Study|Lost to Follow-up|93|||
147117389|NCT02565186|530594348|FG000|Overall Study|Non-Compliance|57|||
147117390|NCT02565186|530594349|FG001|Overall Study|Non-Compliance|55|||
147117391|NCT02565186|530594348|FG000|Overall Study|Withdrawal by Subject|229|||
147229468|NCT02943460|531013120|FG001|Blinded Study Phase|Withdrew Consent|1|||
147229469|NCT02943460|531013121|FG002|Blinded Study Phase|Withdrew Consent|0|||
147229470|NCT02943460|531013119|FG000|Open Label Extension (OLE) Phase|Adverse Event|2|||
147229471|NCT02943460|531013120|FG001|Open Label Extension (OLE) Phase|Adverse Event|5|||
147229472|NCT02943460|531013121|FG002|Open Label Extension (OLE) Phase|Adverse Event|2|||
147229473|NCT02943460|531013119|FG000|Open Label Extension (OLE) Phase|Withdrew Consent|2|||
147229474|NCT02943460|531013120|FG001|Open Label Extension (OLE) Phase|Withdrew Consent|1|||
147229475|NCT02943460|531013121|FG002|Open Label Extension (OLE) Phase|Withdrew Consent|0|||
147229476|NCT02943460|531013119|FG000|Open Label Extension (OLE) Phase|Investigator's Discretion|1|||
147229477|NCT02943460|531013120|FG001|Open Label Extension (OLE) Phase|Investigator's Discretion|1|||
147229478|NCT02943460|531013121|FG002|Open Label Extension (OLE) Phase|Investigator's Discretion|0|||
147229479|NCT00122109|531013122|FG000|Overall Study|Did not meet criteria|6|||
147229480|NCT00122109|531013123|FG001|Overall Study|Did not meet criteria|7|||
147229481|NCT00100178|531013124|FG000|Overall Study|Lost to Follow-up|0|||
147229482|NCT00100178|531013125|FG001|Overall Study|Lost to Follow-up|6|||
147229483|NCT00100178|531013126|FG002|Overall Study|Lost to Follow-up|5|||
147229484|NCT00100178|531013124|FG000|Overall Study|Adverse Event|2|||
147229485|NCT00100178|531013125|FG001|Overall Study|Adverse Event|2|||
147229486|NCT00100178|531013126|FG002|Overall Study|Adverse Event|1|||
147229487|NCT00100178|531013124|FG000|Overall Study|Withdrawal by Subject|1|||
147229488|NCT00100178|531013125|FG001|Overall Study|Withdrawal by Subject|1|||
147229489|NCT00100178|531013126|FG002|Overall Study|Withdrawal by Subject|1|||
147229490|NCT00100178|531013124|FG000|Overall Study|Physician Decision|6|||
147229491|NCT00100178|531013125|FG001|Overall Study|Physician Decision|1|||
147229492|NCT00100178|531013126|FG002|Overall Study|Physician Decision|3|||
147229493|NCT00631696|531013133|FG000|Overall Study|Entered, not randomized to treatment|1|||
147229494|NCT00631696|531013134|FG001|Overall Study|Entered, not randomized to treatment|1|||
147229495|NCT00631696|531013133|FG000|Overall Study|Discontinued after database release date|1|||
147229496|NCT00631696|531013134|FG001|Overall Study|Discontinued after database release date|0|||
147229497|NCT00631696|531013133|FG000|Overall Study|Follow up after database release date|1|||
147229498|NCT00631696|531013134|FG001|Overall Study|Follow up after database release date|0|||
147229499|NCT00631696|531013133|FG000|Overall Study|Lost to Follow-up|7|||
147229500|NCT00631696|531013134|FG001|Overall Study|Lost to Follow-up|10|||
147229501|NCT00631696|531013133|FG000|Overall Study|Withdrawal by Subject|2|||
147229502|NCT00631696|531013134|FG001|Overall Study|Withdrawal by Subject|9|||
147229503|NCT00631696|531013133|FG000|Overall Study|Other|8|||
147229504|NCT00631696|531013134|FG001|Overall Study|Other|8|||
147229505|NCT00631696|531013133|FG000|Overall Study|Protocol Violation|9|||
147229506|NCT00631696|531013134|FG001|Overall Study|Protocol Violation|9|||
147229507|NCT00631696|531013133|FG000|Overall Study|Study terminated by sponsor|3|||
147229508|NCT00631696|531013134|FG001|Overall Study|Study terminated by sponsor|3|||
147229509|NCT00631696|531013133|FG000|Overall Study|Adverse Event|5|||
147229510|NCT00631696|531013134|FG001|Overall Study|Adverse Event|0|||
147229511|NCT01439568|531013136|FG000|Overall Study|Lost to Follow-up|1|||
147229512|NCT01439568|531013137|FG001|Overall Study|Lost to Follow-up|0|||
147229513|NCT01439568|531013136|FG000|Overall Study|Withdrawal by Subject|2|||
147444452|NCT01056510|531792618|FG000|Overall Study|Death|29|||
147444453|NCT01056510|531792619|FG001|Overall Study|Death|34|||
147117392|NCT02565186|530594349|FG001|Overall Study|Withdrawal by Subject|214|||
147117393|NCT02565186|530594348|FG000|Overall Study|Physician Decision|18|||
147117394|NCT02565186|530594349|FG001|Overall Study|Physician Decision|16|||
147229514|NCT01439568|531013137|FG001|Overall Study|Withdrawal by Subject|2|||
147117395|NCT02565186|530594348|FG000|Overall Study|Sponsor Request|5|||
147117396|NCT02565186|530594349|FG001|Overall Study|Sponsor Request|9|||
147117397|NCT02565186|530594348|FG000|Overall Study|Missing|1|||
147117398|NCT02565186|530594349|FG001|Overall Study|Missing|0|||
147117399|NCT02565186|530594348|FG000|Overall Study|Did Not Receive Study Drug|55|||
147117400|NCT02565186|530594349|FG001|Overall Study|Did Not Receive Study Drug|86|||
147117401|NCT00976391|530594350|FG000|Treatment Period (52 Weeks)|Adverse Event|16|||
147117402|NCT00976391|530594351|FG001|Treatment Period (52 Weeks)|Adverse Event|2|||
147117403|NCT00976391|530594350|FG000|Treatment Period (52 Weeks)|Protocol Violation|1|||
147117404|NCT00976391|530594351|FG001|Treatment Period (52 Weeks)|Protocol Violation|1|||
147117405|NCT00976391|530594350|FG000|Treatment Period (52 Weeks)|Noncompliance|4|||
147117406|NCT00976391|530594351|FG001|Treatment Period (52 Weeks)|Noncompliance|4|||
147117407|NCT00976391|530594350|FG000|Treatment Period (52 Weeks)|Lost to Follow-up|10|||
147117408|NCT00976391|530594351|FG001|Treatment Period (52 Weeks)|Lost to Follow-up|8|||
147117409|NCT00976391|530594350|FG000|Treatment Period (52 Weeks)|Withdrawal by Subject|9|||
147117410|NCT00976391|530594351|FG001|Treatment Period (52 Weeks)|Withdrawal by Subject|19|||
147117411|NCT00976391|530594350|FG000|Treatment Period (52 Weeks)|Physician Decision|1|||
147117412|NCT00976391|530594351|FG001|Treatment Period (52 Weeks)|Physician Decision|1|||
147117413|NCT00976391|530594350|FG000|Treatment Period (52 Weeks)|Termination of Study/Site by GSK|0|||
147117414|NCT00976391|530594351|FG001|Treatment Period (52 Weeks)|Termination of Study/Site by GSK|4|||
147117415|NCT00976391|530594350|FG000|Treatment Period (52 Weeks)|Pregnancy|1|||
147117416|NCT00976391|530594351|FG001|Treatment Period (52 Weeks)|Pregnancy|0|||
147117417|NCT00976391|530594350|FG000|Follow-up Period (8 Weeks)|Adverse Event|3|||
147117418|NCT00976391|530594351|FG001|Follow-up Period (8 Weeks)|Adverse Event|1|||
147117419|NCT00976391|530594350|FG000|Follow-up Period (8 Weeks)|Noncompliance|2|||
147117420|NCT00976391|530594351|FG001|Follow-up Period (8 Weeks)|Noncompliance|2|||
147117421|NCT00976391|530594350|FG000|Follow-up Period (8 Weeks)|Lost to Follow-up|14|||
147117422|NCT00976391|530594351|FG001|Follow-up Period (8 Weeks)|Lost to Follow-up|12|||
147117423|NCT00976391|530594350|FG000|Follow-up Period (8 Weeks)|Did not Entered Follow-up|6|||
147117424|NCT00976391|530594351|FG001|Follow-up Period (8 Weeks)|Did not Entered Follow-up|8|||
147117425|NCT00976391|530594350|FG000|Follow-up Period (8 Weeks)|Withdrawal by Subject|4|||
147117426|NCT00976391|530594351|FG001|Follow-up Period (8 Weeks)|Withdrawal by Subject|7|||
147117427|NCT00976391|530594350|FG000|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|0|||
147117428|NCT00976391|530594351|FG001|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|4|||
147117429|NCT04676646|530594352|FG000|Open-label Run-in Phase|Adverse Event|3|||
147117430|NCT04676646|530594353|FG001|Open-label Run-in Phase|Adverse Event|0|||
147117431|NCT04676646|530594354|FG002|Open-label Run-in Phase|Adverse Event|0|||
147117432|NCT04676646|530594352|FG000|Open-label Run-in Phase|Death|3|||
147117433|NCT04676646|530594353|FG001|Open-label Run-in Phase|Death|0|||
147117434|NCT04676646|530594354|FG002|Open-label Run-in Phase|Death|0|||
147117435|NCT04676646|530594352|FG000|Open-label Run-in Phase|Study-specific Withdrawal Criteria|2|||
147117436|NCT04676646|530594353|FG001|Open-label Run-in Phase|Study-specific Withdrawal Criteria|0|||
147117437|NCT04676646|530594354|FG002|Open-label Run-in Phase|Study-specific Withdrawal Criteria|0|||
147117438|NCT04676646|530594352|FG000|Open-label Run-in Phase|Failure to Meet Randomization Criteria|144|||
147117439|NCT04676646|530594353|FG001|Open-label Run-in Phase|Failure to Meet Randomization Criteria|0|||
147117440|NCT04676646|530594354|FG002|Open-label Run-in Phase|Failure to Meet Randomization Criteria|0|||
147117441|NCT04676646|530594352|FG000|Open-label Run-in Phase|Lost to Follow-up|1|||
147117442|NCT04676646|530594353|FG001|Open-label Run-in Phase|Lost to Follow-up|0|||
147117443|NCT04676646|530594354|FG002|Open-label Run-in Phase|Lost to Follow-up|0|||
147117444|NCT04676646|530594352|FG000|Open-label Run-in Phase|Withdrawal by Subject|8|||
147117445|NCT04676646|530594353|FG001|Open-label Run-in Phase|Withdrawal by Subject|0|||
147117446|NCT04676646|530594354|FG002|Open-label Run-in Phase|Withdrawal by Subject|0|||
147117447|NCT04676646|530594352|FG000|Open-label Run-in Phase|Withdrawn from study due to withdrawal by co-investigator|1|||
147117448|NCT04676646|530594353|FG001|Open-label Run-in Phase|Withdrawn from study due to withdrawal by co-investigator|0|||
147117449|NCT04676646|530594354|FG002|Open-label Run-in Phase|Withdrawn from study due to withdrawal by co-investigator|0|||
147117450|NCT04676646|530594352|FG000|Open-label Run-in Phase|Withdrawn from study due to withdrawal by PI|1|||
147117451|NCT04676646|530594353|FG001|Open-label Run-in Phase|Withdrawn from study due to withdrawal by PI|0|||
147229515|NCT01578330|531013138|FG000|Overall Study|Adverse Event|2|||
147229516|NCT01578330|531013138|FG000|Overall Study|Protocol Violation|5|||
147229517|NCT01134731|531013139|FG000|Overall Study|Adverse Event|3|||
147229518|NCT01134731|531013140|FG001|Overall Study|Adverse Event|2|||
147229519|NCT01134731|531013141|FG002|Overall Study|Adverse Event|1|||
147229520|NCT01134731|531013139|FG000|Overall Study|Physician Decision|2|||
147229521|NCT01134731|531013140|FG001|Overall Study|Physician Decision|2|||
147229522|NCT01134731|531013141|FG002|Overall Study|Physician Decision|2|||
147229523|NCT01134731|531013139|FG000|Overall Study|Lack of Efficacy|0|||
147229524|NCT01134731|531013140|FG001|Overall Study|Lack of Efficacy|0|||
147229525|NCT01134731|531013141|FG002|Overall Study|Lack of Efficacy|1|||
147117452|NCT04676646|530594354|FG002|Open-label Run-in Phase|Withdrawn from study due to withdrawal by PI|0|||
147229526|NCT01134731|531013139|FG000|Overall Study|Withdrawal by Subject|3|||
147229527|NCT01134731|531013140|FG001|Overall Study|Withdrawal by Subject|3|||
147229528|NCT01134731|531013141|FG002|Overall Study|Withdrawal by Subject|1|||
147117453|NCT04676646|530594352|FG000|Randomised-withdrawal Phase|Adverse Event|0|||
147117454|NCT04676646|530594353|FG001|Randomised-withdrawal Phase|Adverse Event|5|||
147117455|NCT04676646|530594354|FG002|Randomised-withdrawal Phase|Adverse Event|5|||
147117456|NCT04676646|530594352|FG000|Randomised-withdrawal Phase|Death|0|||
147117457|NCT04676646|530594353|FG001|Randomised-withdrawal Phase|Death|1|||
147117458|NCT04676646|530594354|FG002|Randomised-withdrawal Phase|Death|2|||
147117459|NCT04676646|530594352|FG000|Randomised-withdrawal Phase|Development of Study-specific Withdrawal Criteria|0|||
147117460|NCT04676646|530594353|FG001|Randomised-withdrawal Phase|Development of Study-specific Withdrawal Criteria|2|||
147117461|NCT04676646|530594354|FG002|Randomised-withdrawal Phase|Development of Study-specific Withdrawal Criteria|4|||
147117462|NCT04676646|530594352|FG000|Randomised-withdrawal Phase|Lost to Follow-up|0|||
147117463|NCT04676646|530594353|FG001|Randomised-withdrawal Phase|Lost to Follow-up|1|||
147117464|NCT04676646|530594354|FG002|Randomised-withdrawal Phase|Lost to Follow-up|0|||
147117465|NCT04676646|530594352|FG000|Randomised-withdrawal Phase|Withdrawn from study due to PD - Wrong doses of spironolactone|0|||
147117466|NCT04676646|530594353|FG001|Randomised-withdrawal Phase|Withdrawn from study due to PD - Wrong doses of spironolactone|1|||
147229529|NCT01134731|531013139|FG000|Overall Study|Lost to Follow-up|5|||
147229530|NCT01134731|531013140|FG001|Overall Study|Lost to Follow-up|4|||
147229531|NCT01134731|531013141|FG002|Overall Study|Lost to Follow-up|3|||
147229532|NCT01669928|531013142|FG000|First Intervention|Withdrawal by Subject|3|||
147229533|NCT01669928|531013143|FG001|First Intervention|Withdrawal by Subject|5|||
147229534|NCT01199731|531013148|FG000|Overall Study|Adverse Event|0|||
147229535|NCT01199731|531013149|FG001|Overall Study|Adverse Event|1|||
147229536|NCT01199731|531013150|FG002|Overall Study|Adverse Event|0|||
147229537|NCT01199731|531013148|FG000|Overall Study|Study closed/terminated|7|||
147229538|NCT01199731|531013149|FG001|Overall Study|Study closed/terminated|9|||
147229539|NCT01199731|531013150|FG002|Overall Study|Study closed/terminated|7|||
147229540|NCT01199731|531013148|FG000|Overall Study|Lost to Follow-up|0|||
147229541|NCT01199731|531013149|FG001|Overall Study|Lost to Follow-up|0|||
147229542|NCT01199731|531013150|FG002|Overall Study|Lost to Follow-up|2|||
147229543|NCT01199731|531013148|FG000|Overall Study|Physician Decision|0|||
147229544|NCT01199731|531013149|FG001|Overall Study|Physician Decision|1|||
147229545|NCT01199731|531013150|FG002|Overall Study|Physician Decision|1|||
147229546|NCT01199731|531013148|FG000|Overall Study|Withdrawal by Subject|2|||
147229547|NCT01199731|531013149|FG001|Overall Study|Withdrawal by Subject|0|||
147229548|NCT01199731|531013150|FG002|Overall Study|Withdrawal by Subject|0|||
147229549|NCT02448810|531013151|FG000|Overall Study|Adverse Event|0|||
147229550|NCT02448810|531013152|FG001|Overall Study|Adverse Event|0|||
147229551|NCT02448810|531013153|FG002|Overall Study|Adverse Event|1|||
147566362|NCT00854100|532232154|FG000|Overall Study|Withdrawal by Subject|3|||
147566363|NCT00854100|532232155|FG001|Overall Study|Withdrawal by Subject|1|||
147566364|NCT00854100|532232156|FG002|Overall Study|Withdrawal by Subject|2|||
147566365|NCT00854100|532232154|FG000|Overall Study|Protocol Violation|2|||
147566366|NCT00854100|532232155|FG001|Overall Study|Protocol Violation|4|||
147444454|NCT01056510|531792618|FG000|Overall Study|Noncompliance|1|||
147566367|NCT00854100|532232156|FG002|Overall Study|Protocol Violation|3|||
147566368|NCT00854100|532232154|FG000|Overall Study|Adverse Event|2|||
147566369|NCT00854100|532232155|FG001|Overall Study|Adverse Event|1|||
147566370|NCT00854100|532232156|FG002|Overall Study|Adverse Event|2|||
147566371|NCT02216071|532232168|FG000|Overall Study|Withdrawal by Subject|7|||
147566372|NCT02216071|532232169|FG001|Overall Study|Withdrawal by Subject|2|||
147566373|NCT02216071|532232168|FG000|Overall Study|Lost to Follow-up|3|||
147566374|NCT02216071|532232169|FG001|Overall Study|Lost to Follow-up|3|||
147566375|NCT02216071|532232168|FG000|Overall Study|Protocol Violation|3|||
147566376|NCT02216071|532232169|FG001|Overall Study|Protocol Violation|5|||
147566377|NCT02216071|532232168|FG000|Overall Study|Other|2|||
147566378|NCT02216071|532232169|FG001|Overall Study|Other|2|||
147566379|NCT04753437|532232170|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
147566380|NCT04753437|532232171|FG001|Overall Study|Pretreatment Event/Adverse Event|1|||
147566381|NCT04753437|532232170|FG000|Overall Study|Liver Function Test Abnormalities|2|||
147566382|NCT04753437|532232171|FG001|Overall Study|Liver Function Test Abnormalities|4|||
147566383|NCT02865122|532232172|FG000|Overall Study|Adverse Event|1|||
147566384|NCT02865122|532232173|FG001|Overall Study|Adverse Event|0|||
147566385|NCT02865122|532232174|FG002|Overall Study|Adverse Event|0|||
147566386|NCT01948258|532233328|FG000|Overall Study|Pregnancy|41|||
147566387|NCT01948258|532233328|FG000|Overall Study|Did not complete by cut-off date|35|||
147566388|NCT01948258|532233328|FG000|Overall Study|Lost to Follow-up|27|||
147566389|NCT01948258|532233328|FG000|Overall Study|Withdrawal by SPD|8|||
147566390|NCT01948258|532233328|FG000|Overall Study|Withdrawal by Subject|6|||
147566391|NCT01948258|532233328|FG000|Overall Study|Health Care Professional|43|||
147566392|NCT01948258|532233328|FG000|Overall Study|Removed from statistical analysis|2|||
147566393|NCT01466166|532233332|FG000|Overall Study|Death|1|||
147566394|NCT01466166|532233332|FG000|Overall Study|Lost to Follow-up|7|||
147566395|NCT01466166|532233332|FG000|Overall Study|Infusion Reaction (IR)|27|||
147566396|NCT01466166|532233332|FG000|Overall Study|Adverse Event (Other than IR)|11|||
147566397|NCT01466166|532233332|FG000|Overall Study|Elevated Serum Uric Acid|78|||
147566398|NCT01466166|532233332|FG000|Overall Study|Withdrawal by Subject|13|||
147566399|NCT01466166|532233332|FG000|Overall Study|Sponsor Decision|4|||
147312607|NCT01233609|531310803|FG001|Overall Study|Withdrawal by Subject|0|||
147312608|NCT01567865|531310804|FG000|Evaluated for Immunogenicity|Sero+ for anti-JEV at Visit 1|0|||
147312609|NCT01567865|531310805|FG001|Evaluated for Immunogenicity|Sero+ for anti-JEV at Visit 1|1|||
147312610|NCT01567865|531310806|FG002|Evaluated for Immunogenicity|Sero+ for anti-JEV at Visit 1|3|||
147312611|NCT01567865|531310807|FG003|Evaluated for Immunogenicity|Sero+ for anti-JEV at Visit 1|2|||
147312612|NCT01567865|531310804|FG000|Evaluated for Immunogenicity|Missing blood sample|17|||
147312613|NCT01567865|531310805|FG001|Evaluated for Immunogenicity|Missing blood sample|24|||
147312614|NCT01567865|531310806|FG002|Evaluated for Immunogenicity|Missing blood sample|16|||
147312615|NCT01567865|531310807|FG003|Evaluated for Immunogenicity|Missing blood sample|28|||
147312616|NCT00309608|531310808|FG000|Overall Study|Adverse Event|1|||
147312617|NCT00309608|531310809|FG001|Overall Study|Adverse Event|5|||
147312618|NCT00309608|531310810|FG002|Overall Study|Adverse Event|3|||
147312619|NCT00309608|531310811|FG003|Overall Study|Adverse Event|2|||
147312620|NCT00309608|531310812|FG004|Overall Study|Adverse Event|3|||
147312621|NCT00309608|531310808|FG000|Overall Study|Protocol Violation|2|||
147312622|NCT00309608|531310809|FG001|Overall Study|Protocol Violation|0|||
147312623|NCT00309608|531310810|FG002|Overall Study|Protocol Violation|0|||
147312624|NCT00309608|531310811|FG003|Overall Study|Protocol Violation|0|||
147229552|NCT02448810|531013154|FG003|Overall Study|Adverse Event|0|||
147312625|NCT00309608|531310812|FG004|Overall Study|Protocol Violation|0|||
147312626|NCT00309608|531310808|FG000|Overall Study|Lost to Follow-up|0|||
147312627|NCT00309608|531310809|FG001|Overall Study|Lost to Follow-up|0|||
147312628|NCT00309608|531310810|FG002|Overall Study|Lost to Follow-up|2|||
147312629|NCT00309608|531310811|FG003|Overall Study|Lost to Follow-up|0|||
147312630|NCT00309608|531310812|FG004|Overall Study|Lost to Follow-up|1|||
147312631|NCT00309608|531310808|FG000|Overall Study|Withdrawal by Subject|1|||
147312632|NCT00309608|531310809|FG001|Overall Study|Withdrawal by Subject|4|||
147566400|NCT01466166|532233332|FG000|Overall Study|Protocol Violation/Noncompliance|2|||
147566401|NCT01466166|532233332|FG000|Overall Study|Other|20|||
147566402|NCT00851877|532233340|FG000|Phase I-1|Death|1|||
147566403|NCT00851877|532233341|FG001|Phase I-1|Death|0|||
147229553|NCT02448810|531013155|FG004|Overall Study|Adverse Event|0|||
147229554|NCT02448810|531013156|FG005|Overall Study|Adverse Event|0|||
147229555|NCT02448810|531013157|FG006|Overall Study|Adverse Event|0|||
147229556|NCT02448810|531013158|FG007|Overall Study|Adverse Event|0|||
147229557|NCT02448810|531013151|FG000|Overall Study|Withdrawal by Subject|0|||
147229558|NCT02448810|531013152|FG001|Overall Study|Withdrawal by Subject|0|||
147229559|NCT02448810|531013153|FG002|Overall Study|Withdrawal by Subject|1|||
147229560|NCT02448810|531013154|FG003|Overall Study|Withdrawal by Subject|0|||
147229561|NCT02448810|531013155|FG004|Overall Study|Withdrawal by Subject|3|||
147229562|NCT02448810|531013156|FG005|Overall Study|Withdrawal by Subject|5|||
147229563|NCT02448810|531013157|FG006|Overall Study|Withdrawal by Subject|0|||
147229564|NCT02448810|531013158|FG007|Overall Study|Withdrawal by Subject|2|||
147229565|NCT02448810|531013151|FG000|Overall Study|Other (study terminated by sponsor)|0|||
147229566|NCT02448810|531013152|FG001|Overall Study|Other (study terminated by sponsor)|0|||
147229567|NCT02448810|531013153|FG002|Overall Study|Other (study terminated by sponsor)|0|||
147229568|NCT02448810|531013154|FG003|Overall Study|Other (study terminated by sponsor)|0|||
147229569|NCT02448810|531013155|FG004|Overall Study|Other (study terminated by sponsor)|4|||
147229570|NCT02448810|531013156|FG005|Overall Study|Other (study terminated by sponsor)|2|||
147229571|NCT02448810|531013157|FG006|Overall Study|Other (study terminated by sponsor)|2|||
147229572|NCT02448810|531013158|FG007|Overall Study|Other (study terminated by sponsor)|1|||
147229573|NCT02448810|531013151|FG000|Overall Study|Death|1|||
147229574|NCT02448810|531013152|FG001|Overall Study|Death|0|||
147229575|NCT02448810|531013153|FG002|Overall Study|Death|1|||
147229576|NCT02448810|531013154|FG003|Overall Study|Death|0|||
147229577|NCT02448810|531013155|FG004|Overall Study|Death|1|||
147229578|NCT02448810|531013156|FG005|Overall Study|Death|0|||
147229579|NCT02448810|531013157|FG006|Overall Study|Death|0|||
147229580|NCT02448810|531013158|FG007|Overall Study|Death|0|||
147229581|NCT02448810|531013151|FG000|Overall Study|Other (Progressive disease)|2|||
147229582|NCT02448810|531013152|FG001|Overall Study|Other (Progressive disease)|2|||
147229583|NCT02448810|531013153|FG002|Overall Study|Other (Progressive disease)|0|||
147566404|NCT00851877|532233342|FG002|Phase I-1|Death|0|||
147229584|NCT02448810|531013154|FG003|Overall Study|Other (Progressive disease)|3|||
147229585|NCT02448810|531013155|FG004|Overall Study|Other (Progressive disease)|23|||
147229586|NCT02448810|531013156|FG005|Overall Study|Other (Progressive disease)|9|||
147229587|NCT02448810|531013157|FG006|Overall Study|Other (Progressive disease)|14|||
147229588|NCT02448810|531013158|FG007|Overall Study|Other (Progressive disease)|5|||
147312633|NCT00309608|531310810|FG002|Overall Study|Withdrawal by Subject|2|||
147229589|NCT02448810|531013151|FG000|Overall Study|Lost to Follow-up|0|||
147312634|NCT00309608|531310811|FG003|Overall Study|Withdrawal by Subject|0|||
147312635|NCT00309608|531310812|FG004|Overall Study|Withdrawal by Subject|0|||
147444455|NCT01056510|531792619|FG001|Overall Study|Noncompliance|3|||
147566405|NCT00851877|532233340|FG000|Phase II|Withdrawal by Subject|0|||
147229590|NCT02448810|531013152|FG001|Overall Study|Lost to Follow-up|1|||
147229591|NCT02448810|531013153|FG002|Overall Study|Lost to Follow-up|0|||
147566406|NCT00851877|532233341|FG001|Phase II|Withdrawal by Subject|0|||
147650879|NCT02757352|532544538|FG001|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
147650880|NCT02757352|532544539|FG002|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
147650881|NCT02757352|532544540|FG003|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|3|||
147650882|NCT02757352|532544541|FG004|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
147650883|NCT02757352|532544542|FG005|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|1|||
147650884|NCT02757352|532544543|FG006|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
147650885|NCT02757352|532544544|FG007|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
147650886|NCT02757352|532544545|FG008|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
147650887|NCT02757352|532544546|FG009|IR-Open Label Period (Week 16 - Week 52)|Adverse Event|0|||
147650888|NCT02757352|532544537|FG000|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
147650889|NCT02757352|532544538|FG001|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
147650890|NCT02757352|532544539|FG002|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
147650891|NCT02757352|532544540|FG003|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|2|||
147650892|NCT02757352|532544541|FG004|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|1|||
147117467|NCT04676646|530594354|FG002|Randomised-withdrawal Phase|Withdrawn from study due to PD - Wrong doses of spironolactone|0|||
147117468|NCT04676646|530594352|FG000|Randomised-withdrawal Phase|Withdrawn from study due to spironolactone was stopped on May 28, related hyperkalaemia|0|||
147117469|NCT04676646|530594353|FG001|Randomised-withdrawal Phase|Withdrawn from study due to spironolactone was stopped on May 28, related hyperkalaemia|1|||
147117470|NCT04676646|530594354|FG002|Randomised-withdrawal Phase|Withdrawn from study due to spironolactone was stopped on May 28, related hyperkalaemia|0|||
147117471|NCT04676646|530594352|FG000|Randomised-withdrawal Phase|Withdrawn from study due to the participant did not have enough medication by issues in IWRS|0|||
147117472|NCT04676646|530594353|FG001|Randomised-withdrawal Phase|Withdrawn from study due to the participant did not have enough medication by issues in IWRS|0|||
147117473|NCT04676646|530594354|FG002|Randomised-withdrawal Phase|Withdrawn from study due to the participant did not have enough medication by issues in IWRS|1|||
147117474|NCT04676646|530594352|FG000|Randomised-withdrawal Phase|Withdrawn from study due to the patient was random by mistake on this date he was an OLRIF|0|||
147117475|NCT04676646|530594353|FG001|Randomised-withdrawal Phase|Withdrawn from study due to the patient was random by mistake on this date he was an OLRIF|1|||
147117476|NCT04676646|530594354|FG002|Randomised-withdrawal Phase|Withdrawn from study due to the patient was random by mistake on this date he was an OLRIF|0|||
147117477|NCT04676646|530594352|FG000|Randomised-withdrawal Phase|Withdrawal by Subject|0|||
147117478|NCT04676646|530594353|FG001|Randomised-withdrawal Phase|Withdrawal by Subject|2|||
147117479|NCT04676646|530594354|FG002|Randomised-withdrawal Phase|Withdrawal by Subject|2|||
147117480|NCT02217982|530594355|FG000|Overall Study|Trial discontinued|1|||
147117481|NCT02217982|530594356|FG001|Overall Study|Trial discontinued|0|||
147117482|NCT02217982|530594355|FG000|Overall Study|Adverse Event|0|||
147117483|NCT02217982|530594356|FG001|Overall Study|Adverse Event|1|||
147117484|NCT05156125|530594357|FG000|Overall Study|Lack of Efficacy|1|||
147117485|NCT05156125|530594358|FG001|Overall Study|Lack of Efficacy|1|||
147117486|NCT05156125|530594359|FG002|Overall Study|Lack of Efficacy|1|||
147117487|NCT05156125|530594357|FG000|Overall Study|Physician Decision|0|||
147117488|NCT05156125|530594358|FG001|Overall Study|Physician Decision|0|||
147117489|NCT05156125|530594359|FG002|Overall Study|Physician Decision|1|||
147117490|NCT05156125|530594357|FG000|Overall Study|Non-compliance|0|||
147117491|NCT05156125|530594358|FG001|Overall Study|Non-compliance|1|||
147117492|NCT05156125|530594359|FG002|Overall Study|Non-compliance|1|||
147117493|NCT05156125|530594357|FG000|Overall Study|Withdrawal by Subject|0|||
147117494|NCT05156125|530594358|FG001|Overall Study|Withdrawal by Subject|0|||
147117495|NCT05156125|530594359|FG002|Overall Study|Withdrawal by Subject|1|||
147117496|NCT05156125|530594357|FG000|Overall Study|Adverse Event|2|||
147117497|NCT05156125|530594358|FG001|Overall Study|Adverse Event|1|||
147117498|NCT05156125|530594359|FG002|Overall Study|Adverse Event|0|||
147117499|NCT03123588|530594360|FG000|Overall Study|Study Terminated by Sponsor|2|||
147117500|NCT03123588|530594361|FG001|Overall Study|Study Terminated by Sponsor|5|||
147117501|NCT03123588|530594360|FG000|Overall Study|Withdrawal by Subject|1|||
147117502|NCT03123588|530594361|FG001|Overall Study|Withdrawal by Subject|0|||
147117503|NCT03123588|530594360|FG000|Overall Study|Adverse Event|1|||
147117504|NCT03123588|530594361|FG001|Overall Study|Adverse Event|0|||
147117505|NCT03123588|530594360|FG000|Overall Study|Physician Decision|2|||
147117506|NCT03123588|530594361|FG001|Overall Study|Physician Decision|1|||
147117507|NCT01623752|530594363|FG000|Phase 1 (78 Weeks)|No Data|249|||
147117508|NCT01623752|530594364|FG001|Phase 1 (78 Weeks)|No Data|66|||
147117509|NCT01623752|530594365|FG002|Phase 1 (78 Weeks)|No Data|2|||
147117510|NCT01623752|530594363|FG000|Phase 1 (78 Weeks)|Other|33|||
147117511|NCT01623752|530594364|FG001|Phase 1 (78 Weeks)|Other|20|||
147117512|NCT01623752|530594365|FG002|Phase 1 (78 Weeks)|Other|0|||
147117513|NCT01623752|530594363|FG000|Phase 1 (78 Weeks)|Adverse Event|122|||
147117514|NCT01623752|530594364|FG001|Phase 1 (78 Weeks)|Adverse Event|39|||
147117515|NCT01623752|530594365|FG002|Phase 1 (78 Weeks)|Adverse Event|0|||
147117516|NCT01623752|530594363|FG000|Phase 1 (78 Weeks)|Lack of Efficacy|227|||
147117517|NCT01623752|530594364|FG001|Phase 1 (78 Weeks)|Lack of Efficacy|82|||
147117518|NCT01623752|530594365|FG002|Phase 1 (78 Weeks)|Lack of Efficacy|0|||
147117519|NCT01623752|530594363|FG000|Phase 2 (78 Weeks)|Lack of Efficacy|14|||
147117520|NCT01623752|530594364|FG001|Phase 2 (78 Weeks)|Lack of Efficacy|2|||
147566407|NCT00851877|532233342|FG002|Phase II|Withdrawal by Subject|3|||
147566408|NCT00620074|532233343|FG000|Overall Study|Adverse Event|1|||
147566409|NCT00829673|532233344|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
147566410|NCT00829673|532233345|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
147566411|NCT03214952|532233346|FG000|Overall Study|Protocol Deviation|45|||
147566412|NCT03214952|532233346|FG000|Overall Study|Case Report Forms Uncollected|13|||
147566413|NCT00829790|532233347|FG000|Washout of 14 Days|Withdrawal by Subject|0|||
147566414|NCT00829790|532233348|FG001|Washout of 14 Days|Withdrawal by Subject|1|||
147566415|NCT03769896|532233349|FG000|Open-label Phase|Lack of Efficacy|5|||
147566416|NCT03769896|532233350|FG001|Open-label Phase|Lack of Efficacy|0|||
147566417|NCT03769896|532233349|FG000|Open-label Phase|Adverse Event|3|||
147566418|NCT03769896|532233350|FG001|Open-label Phase|Adverse Event|0|||
147566419|NCT03769896|532233349|FG000|Open-label Phase|Withdrawal by Subject|1|||
147566420|NCT03769896|532233350|FG001|Open-label Phase|Withdrawal by Subject|0|||
147566421|NCT00086996|532233354|FG000|Overall Study|Adverse Event|29|||
147566422|NCT00086996|532233354|FG000|Overall Study|Death|4|||
147566423|NCT00086996|532233354|FG000|Overall Study|progression/relapse|7|||
147566424|NCT00086996|532233354|FG000|Overall Study|Withdrawal by Subject|13|||
147229592|NCT02448810|531013154|FG003|Overall Study|Lost to Follow-up|0|||
147229593|NCT02448810|531013155|FG004|Overall Study|Lost to Follow-up|0|||
147229594|NCT02448810|531013156|FG005|Overall Study|Lost to Follow-up|0|||
147229595|NCT02448810|531013157|FG006|Overall Study|Lost to Follow-up|0|||
147229596|NCT02448810|531013158|FG007|Overall Study|Lost to Follow-up|0|||
147229597|NCT02448810|531013151|FG000|Overall Study|Other (unspecified)|0|||
147229598|NCT02448810|531013152|FG001|Overall Study|Other (unspecified)|0|||
147229599|NCT02448810|531013153|FG002|Overall Study|Other (unspecified)|0|||
147229600|NCT02448810|531013154|FG003|Overall Study|Other (unspecified)|0|||
147229601|NCT02448810|531013155|FG004|Overall Study|Other (unspecified)|0|||
147229602|NCT02448810|531013156|FG005|Overall Study|Other (unspecified)|0|||
147229603|NCT02448810|531013157|FG006|Overall Study|Other (unspecified)|2|||
147229604|NCT02448810|531013158|FG007|Overall Study|Other (unspecified)|0|||
147229605|NCT00381381|531013162|FG000|Overall Study|Adverse Event|3|||
147229606|NCT00381381|531013162|FG000|Overall Study|Lost to Follow-up|52|||
147229607|NCT00381381|531013162|FG000|Overall Study|Withdrawal by Subject|9|||
147229608|NCT03538431|531013168|FG000|Overall Study|Physician Decision|0|||
147229609|NCT03538431|531013169|FG001|Overall Study|Physician Decision|1|||
147229610|NCT03538431|531013168|FG000|Overall Study|Withdrawal by Subject|1|||
147229611|NCT03538431|531013169|FG001|Overall Study|Withdrawal by Subject|0|||
147229612|NCT01231347|531013172|FG000|Overall Study|Full Consent withdrawn|19|||
147229613|NCT01231347|531013173|FG001|Overall Study|Full Consent withdrawn|19|||
147229614|NCT01231347|531013174|FG002|Overall Study|Full Consent withdrawn|11|||
147229615|NCT01231347|531013172|FG000|Overall Study|Lost to Follow-up|4|||
147229616|NCT01231347|531013173|FG001|Overall Study|Lost to Follow-up|2|||
147229617|NCT01231347|531013174|FG002|Overall Study|Lost to Follow-up|2|||
147229618|NCT01231347|531013172|FG000|Overall Study|Death|202|||
147229619|NCT01231347|531013173|FG001|Overall Study|Death|210|||
147229620|NCT01231347|531013174|FG002|Overall Study|Death|101|||
147229621|NCT01231347|531013172|FG000|Overall Study|other event|7|||
147229622|NCT01231347|531013173|FG001|Overall Study|other event|9|||
147229623|NCT01231347|531013174|FG002|Overall Study|other event|3|||
147229624|NCT00292318|531013190|FG000|Overall Study|Study terminated by officials|2|||
147229625|NCT00292318|531013191|FG001|Overall Study|Study terminated by officials|1|||
147229626|NCT02027376|531013192|FG000|Overall Study|Death|1|||
147229627|NCT02027376|531013193|FG001|Overall Study|Death|0|||
147229628|NCT02027376|531013194|FG002|Overall Study|Death|0|||
147229629|NCT01278160|531013198|FG000|Overall Study|Adverse Event|1|||
147229630|NCT01278160|531013199|FG001|Overall Study|Adverse Event|1|||
147229631|NCT01278160|531013198|FG000|Overall Study|Lost to Follow-up|0|||
147229632|NCT01278160|531013199|FG001|Overall Study|Lost to Follow-up|1|||
147229633|NCT01278160|531013198|FG000|Overall Study|Withdrawal by Subject|3|||
147229634|NCT01278160|531013199|FG001|Overall Study|Withdrawal by Subject|2|||
147229635|NCT01278160|531013198|FG000|Overall Study|Unclassified|1|||
147229636|NCT01278160|531013199|FG001|Overall Study|Unclassified|2|||
147229637|NCT02030938|531013202|FG000|Overall Study|Lost to Follow-up|4|||
147229638|NCT02030938|531013202|FG000|Overall Study|Withdrawal by Subject|1|||
147566425|NCT00086996|532233354|FG000|Overall Study|Other|6|||
147566426|NCT00086996|532233354|FG000|Overall Study|not eligible|5|||
147229639|NCT03148275|531013203|FG000|Overall Study|Death|6|||
147229640|NCT03148275|531013203|FG000|Overall Study|Adverse Event|3|||
147229641|NCT03148275|531013203|FG000|Overall Study|Liver transplant|2|||
147566427|NCT00004562|532233355|FG000|Overall Study|Lost to Follow-up|102|||
147229642|NCT03148275|531013203|FG000|Overall Study|Patient decision|5|||
147229643|NCT03148275|531013203|FG000|Overall Study|transition to commercial drug|1|||
147229644|NCT03148275|531013203|FG000|Overall Study|subjects withdrew from the trial after registration, but before starting study treatment|2|||
147566428|NCT00004562|532233356|FG001|Overall Study|Lost to Follow-up|91|||
147566429|NCT02770820|532233357|FG000|Overall Study|Death|1|||
147566430|NCT02770820|532233357|FG000|Overall Study|Physician Decision|2|||
147566431|NCT00301366|532233358|FG000|Overall Study|Adverse Event|1|||
147566432|NCT00552669|532233361|FG000|Overall Study|Death|3|||
147117521|NCT01623752|530594365|FG002|Phase 2 (78 Weeks)|Lack of Efficacy|0|||
147117522|NCT01623752|530594363|FG000|Phase 2 (78 Weeks)|Other|5|||
147117523|NCT01623752|530594364|FG001|Phase 2 (78 Weeks)|Other|1|||
147117524|NCT01623752|530594365|FG002|Phase 2 (78 Weeks)|Other|0|||
147117525|NCT01623752|530594363|FG000|Phase 2 (78 Weeks)|No Data|43|||
147117526|NCT01623752|530594364|FG001|Phase 2 (78 Weeks)|No Data|11|||
147117527|NCT01623752|530594365|FG002|Phase 2 (78 Weeks)|No Data|0|||
147117528|NCT01623752|530594363|FG000|Phase 2 (78 Weeks)|Adverse Event|4|||
147117529|NCT01623752|530594364|FG001|Phase 2 (78 Weeks)|Adverse Event|4|||
147117530|NCT01623752|530594365|FG002|Phase 2 (78 Weeks)|Adverse Event|0|||
147117531|NCT01814332|530594366|FG000|Overall Study|Adverse Event|8|||
147117532|NCT01814332|530594367|FG001|Overall Study|Adverse Event|3|||
147117533|NCT01814332|530594366|FG000|Overall Study|Withdrawal by Subject|3|||
147117534|NCT01814332|530594367|FG001|Overall Study|Withdrawal by Subject|8|||
147117535|NCT01814332|530594366|FG000|Overall Study|Protocol Violation|0|||
147229645|NCT05098938|531013204|FG000|Overall Study|Adverse Event|4|||
147229646|NCT05098938|531013205|FG001|Overall Study|Adverse Event|3|||
147229647|NCT05098938|531013204|FG000|Overall Study|inclusion/exclusion criteria change|11|||
147229648|NCT05098938|531013205|FG001|Overall Study|inclusion/exclusion criteria change|5|||
147229649|NCT05098938|531013204|FG000|Overall Study|lack of compliance|26|||
147229650|NCT05098938|531013205|FG001|Overall Study|lack of compliance|19|||
147229651|NCT05098938|531013204|FG000|Overall Study|Lost to Follow-up|37|||
147229652|NCT05098938|531013205|FG001|Overall Study|Lost to Follow-up|40|||
147229653|NCT05098938|531013204|FG000|Overall Study|Lost in treatment period|17|||
147229654|NCT05098938|531013205|FG001|Overall Study|Lost in treatment period|13|||
147229655|NCT05098938|531013204|FG000|Overall Study|Met an exclusion criterion|0|||
147229656|NCT05098938|531013205|FG001|Overall Study|Met an exclusion criterion|3|||
147229657|NCT05098938|531013204|FG000|Overall Study|no prodromal symptoms after 6 months|1|||
147229658|NCT05098938|531013205|FG001|Overall Study|no prodromal symptoms after 6 months|0|||
147229659|NCT05098938|531013204|FG000|Overall Study|Physician Decision|25|||
147229660|NCT05098938|531013205|FG001|Overall Study|Physician Decision|32|||
147229661|NCT05098938|531013204|FG000|Overall Study|Run in failure in treatment phase|1|||
147229662|NCT05098938|531013205|FG001|Overall Study|Run in failure in treatment phase|1|||
147229663|NCT05098938|531013204|FG000|Overall Study|Withdrawal by Subject|0|||
147229664|NCT05098938|531013205|FG001|Overall Study|Withdrawal by Subject|3|||
147229665|NCT05098938|531013204|FG000|Overall Study|Run-in Failure in early study|505|||
147229666|NCT05098938|531013205|FG001|Overall Study|Run-in Failure in early study|514|||
147229667|NCT05098938|531013204|FG000|Overall Study|IMP delivery missed|1|||
147229668|NCT05098938|531013205|FG001|Overall Study|IMP delivery missed|5|||
147229669|NCT05098938|531013204|FG000|Overall Study|6 months visit was missed|2|||
147229670|NCT05098938|531013205|FG001|Overall Study|6 months visit was missed|0|||
147229671|NCT05098938|531013204|FG000|Overall Study|fit for use was not completed within window|3|||
147229672|NCT05098938|531013205|FG001|Overall Study|fit for use was not completed within window|0|||
147229673|NCT05098938|531013204|FG000|Overall Study|V2 visit was not completed within window|0|||
147229674|NCT05098938|531013205|FG001|Overall Study|V2 visit was not completed within window|1|||
147229675|NCT05098938|531013204|FG000|Overall Study|exclusionary medication use|1|||
147229676|NCT05098938|531013205|FG001|Overall Study|exclusionary medication use|2|||
147229677|NCT05098938|531013204|FG000|Overall Study|change in medication|1|||
147229678|NCT05098938|531013205|FG001|Overall Study|change in medication|0|||
147229679|NCT05098938|531013204|FG000|Overall Study|treatment failure|2|||
147229680|NCT05098938|531013205|FG001|Overall Study|treatment failure|1|||
147229681|NCT03803683|531013206|FG000|Overall Study|Lost to Follow-up|41|||
147229682|NCT03803683|531013207|FG001|Overall Study|Lost to Follow-up|18|||
147229683|NCT03803683|531013208|FG002|Overall Study|Lost to Follow-up|12|||
147229684|NCT03803683|531013206|FG000|Overall Study|Withdrawal by Subject|9|||
147229685|NCT03803683|531013207|FG001|Overall Study|Withdrawal by Subject|1|||
147229686|NCT03803683|531013208|FG002|Overall Study|Withdrawal by Subject|4|||
147229687|NCT00492050|531013209|FG000|Overall Study|Adverse Event|1|||
147229688|NCT00492050|531013209|FG000|Overall Study|Lack of Efficacy|1|||
147229689|NCT00492050|531013209|FG000|Overall Study|Withdrawal by Subject|3|||
147229690|NCT00492050|531013209|FG000|Overall Study|Unable to collect SCT|2|||
147229691|NCT00492050|531013209|FG000|Overall Study|Progressive Disease|2|||
147229692|NCT00866788|531015810|FG000|Overall Study|Adverse Event|0|||
147229693|NCT00866788|531015811|FG001|Overall Study|Adverse Event|2|||
147117536|NCT01814332|530594367|FG001|Overall Study|Protocol Violation|4|||
147229694|NCT00866788|531015812|FG002|Overall Study|Adverse Event|0|||
147229695|NCT00866788|531015813|FG003|Overall Study|Adverse Event|1|||
147229696|NCT00866788|531015810|FG000|Overall Study|Lost to Follow-up|1|||
147229697|NCT00866788|531015811|FG001|Overall Study|Lost to Follow-up|1|||
147229698|NCT00866788|531015812|FG002|Overall Study|Lost to Follow-up|0|||
147229699|NCT00866788|531015813|FG003|Overall Study|Lost to Follow-up|2|||
147117537|NCT01814332|530594366|FG000|Overall Study|Lost to Follow-up|5|||
147117538|NCT01814332|530594367|FG001|Overall Study|Lost to Follow-up|1|||
147117539|NCT05987540|530594369|FG000|Overall Study|Withdrawal by Subject|2|||
147229700|NCT00866788|531015810|FG000|Overall Study|Withdrawal by Subject|2|||
147229701|NCT00866788|531015811|FG001|Overall Study|Withdrawal by Subject|1|||
147117540|NCT05987540|530594369|FG000|Overall Study|Death|1|||
147566433|NCT00552669|532233362|FG001|Overall Study|Death|7|||
147566434|NCT03195491|532233363|FG000|Overall Study|Study drug toxicity|25|||
147566435|NCT03195491|532233364|FG001|Overall Study|Study drug toxicity|3|||
147566436|NCT03195491|532233363|FG000|Overall Study|Maximum clinical benefit|5|||
147117541|NCT05987540|530594369|FG000|Overall Study|Study Termination|1|||
147117542|NCT05987540|530594369|FG000|Overall Study|Adverse Event|2|||
147117543|NCT01290731|530594376|FG000|Overall Study|Withdrawal by Subject|1|||
147117544|NCT01399099|530594379|FG000|Overall Study|Lost to Follow-up|14|||
147117545|NCT01399099|530594379|FG000|Overall Study|Physician Decision|1|||
147117546|NCT01399099|530594379|FG000|Overall Study|Protocol Violation|1|||
147117547|NCT01399099|530594379|FG000|Overall Study|Skin Irritation|13|||
147117548|NCT01399099|530594379|FG000|Overall Study|Infection|1|||
147117549|NCT01399099|530594379|FG000|Overall Study|Miscellaneous|4|||
147229702|NCT00866788|531015812|FG002|Overall Study|Withdrawal by Subject|0|||
147229703|NCT00866788|531015813|FG003|Overall Study|Withdrawal by Subject|1|||
147229704|NCT00866788|531015810|FG000|Overall Study|Pregnancy|0|||
147229705|NCT00866788|531015811|FG001|Overall Study|Pregnancy|1|||
147229706|NCT00866788|531015812|FG002|Overall Study|Pregnancy|0|||
147229707|NCT00866788|531015813|FG003|Overall Study|Pregnancy|0|||
147229708|NCT00866788|531015810|FG000|Overall Study|Disease progression|3|||
147229709|NCT00866788|531015811|FG001|Overall Study|Disease progression|1|||
147229710|NCT00866788|531015812|FG002|Overall Study|Disease progression|1|||
147229711|NCT00866788|531015813|FG003|Overall Study|Disease progression|0|||
147229712|NCT00866788|531015810|FG000|Overall Study|Physician Decision|0|||
147229713|NCT00866788|531015811|FG001|Overall Study|Physician Decision|0|||
147229714|NCT00866788|531015812|FG002|Overall Study|Physician Decision|1|||
147229715|NCT00866788|531015813|FG003|Overall Study|Physician Decision|1|||
147229716|NCT00537238|531015816|FG000|Overall Study|Death|1|||
147229717|NCT00537238|531015817|FG001|Overall Study|Death|2|||
147229718|NCT00537238|531015816|FG000|Overall Study|Adverse Event|31|||
147229719|NCT00537238|531015817|FG001|Overall Study|Adverse Event|22|||
147229720|NCT00537238|531015816|FG000|Overall Study|Lack of Efficacy|20|||
147229721|NCT00537238|531015817|FG001|Overall Study|Lack of Efficacy|21|||
147229722|NCT00537238|531015816|FG000|Overall Study|Lost to Follow-up|12|||
147229723|NCT00537238|531015817|FG001|Overall Study|Lost to Follow-up|8|||
147229724|NCT00537238|531015816|FG000|Overall Study|Withdrawal by Subject|51|||
147229725|NCT00537238|531015817|FG001|Overall Study|Withdrawal by Subject|47|||
147229726|NCT00537238|531015816|FG000|Overall Study|Protocol Violation|15|||
147229727|NCT00537238|531015817|FG001|Overall Study|Protocol Violation|19|||
147229728|NCT00537238|531015816|FG000|Overall Study|Does not meet entrance criteria|0|||
147229729|NCT00537238|531015817|FG001|Overall Study|Does not meet entrance criteria|2|||
147229730|NCT00537238|531015816|FG000|Overall Study|Other|44|||
147229731|NCT00537238|531015817|FG001|Overall Study|Other|52|||
147229732|NCT01854658|531015818|FG000|Overall Study|Protocol Violation|6|||
147229733|NCT01854658|531015819|FG001|Overall Study|Protocol Violation|2|||
147229734|NCT01854658|531015820|FG002|Overall Study|Protocol Violation|2|||
147229735|NCT01854658|531015821|FG003|Overall Study|Protocol Violation|1|||
147229736|NCT01854658|531015818|FG000|Overall Study|Physician Decision|7|||
147229737|NCT01854658|531015819|FG001|Overall Study|Physician Decision|5|||
147229738|NCT01854658|531015820|FG002|Overall Study|Physician Decision|2|||
147229739|NCT01854658|531015821|FG003|Overall Study|Physician Decision|4|||
147229740|NCT01854658|531015818|FG000|Overall Study|Lost to Follow-up|8|||
147229741|NCT01854658|531015819|FG001|Overall Study|Lost to Follow-up|9|||
147229742|NCT01854658|531015820|FG002|Overall Study|Lost to Follow-up|8|||
147229743|NCT01854658|531015821|FG003|Overall Study|Lost to Follow-up|4|||
147229744|NCT01854658|531015818|FG000|Overall Study|Withdrawal by Subject|28|||
147229745|NCT01854658|531015819|FG001|Overall Study|Withdrawal by Subject|21|||
147229746|NCT01854658|531015820|FG002|Overall Study|Withdrawal by Subject|29|||
147229747|NCT01854658|531015821|FG003|Overall Study|Withdrawal by Subject|15|||
147229748|NCT01854658|531015818|FG000|Overall Study|Protocol-specified criteria|15|||
147229749|NCT01854658|531015819|FG001|Overall Study|Protocol-specified criteria|15|||
147229750|NCT01854658|531015820|FG002|Overall Study|Protocol-specified criteria|10|||
147229751|NCT01854658|531015821|FG003|Overall Study|Protocol-specified criteria|7|||
147229752|NCT01854658|531015818|FG000|Overall Study|Lack of Efficacy|3|||
147229753|NCT01854658|531015819|FG001|Overall Study|Lack of Efficacy|8|||
147229754|NCT01854658|531015820|FG002|Overall Study|Lack of Efficacy|4|||
147229755|NCT01854658|531015821|FG003|Overall Study|Lack of Efficacy|7|||
147229756|NCT01854658|531015818|FG000|Overall Study|Adverse Event|21|||
147229757|NCT01854658|531015819|FG001|Overall Study|Adverse Event|14|||
147566437|NCT03195491|532233364|FG001|Overall Study|Maximum clinical benefit|0|||
147117550|NCT01149538|530594382|FG000|Overall Study|Lost to Follow-up|0|||
147229758|NCT01854658|531015820|FG002|Overall Study|Adverse Event|23|||
147229759|NCT01854658|531015821|FG003|Overall Study|Adverse Event|19|||
147229760|NCT01854658|531015818|FG000|Overall Study|Administrative reasons|5|||
147229761|NCT01854658|531015819|FG001|Overall Study|Administrative reasons|1|||
147229762|NCT01854658|531015820|FG002|Overall Study|Administrative reasons|2|||
147229763|NCT01854658|531015821|FG003|Overall Study|Administrative reasons|2|||
147229764|NCT01193660|531015824|FG000|Overall Study|Withdrawal by Subject|2|||
147229765|NCT01193660|531015825|FG001|Overall Study|Withdrawal by Subject|3|||
147566438|NCT03195491|532233363|FG000|Overall Study|Lost to Follow-up|1|||
147117551|NCT01149538|530594383|FG001|Overall Study|Lost to Follow-up|1|||
147117552|NCT01149538|530594382|FG000|Overall Study|Withdrawal by Subject|5|||
147117553|NCT01149538|530594383|FG001|Overall Study|Withdrawal by Subject|3|||
147229766|NCT01193660|531015826|FG002|Overall Study|Withdrawal by Subject|1|||
147229767|NCT01193660|531015824|FG000|Overall Study|Death|1|||
147229768|NCT01193660|531015825|FG001|Overall Study|Death|0|||
147229769|NCT01193660|531015826|FG002|Overall Study|Death|0|||
147229770|NCT01193660|531015824|FG000|Overall Study|Physician Decision|1|||
147229771|NCT01193660|531015825|FG001|Overall Study|Physician Decision|0|||
147229772|NCT01193660|531015826|FG002|Overall Study|Physician Decision|1|||
147229773|NCT02367131|531015830|FG000|Overall Study|Adverse Event|64|||
147229774|NCT02367131|531015830|FG000|Overall Study|No visit since the first visit|3|||
147229775|NCT02367131|531015830|FG000|Overall Study|Request by patient|53|||
147117554|NCT00888849|530594384|FG000|Overall Study|Death|4|||
147117555|NCT00888849|530594385|FG001|Overall Study|Death|7|||
147117556|NCT00888849|530594384|FG000|Overall Study|Lost to Follow-up|1|||
147117557|NCT00888849|530594385|FG001|Overall Study|Lost to Follow-up|2|||
147117558|NCT02336503|530594387|FG000|Overall Study|Lost to Follow-up|0|||
147117559|NCT02336503|530594388|FG001|Overall Study|Lost to Follow-up|3|||
147117560|NCT02336503|530594389|FG002|Overall Study|Lost to Follow-up|0|||
147117561|NCT02336503|530594390|FG003|Overall Study|Lost to Follow-up|2|||
147117562|NCT02336503|530594387|FG000|Overall Study|Withdrawal by Subject|2|||
147117563|NCT02336503|530594388|FG001|Overall Study|Withdrawal by Subject|0|||
147117564|NCT02336503|530594389|FG002|Overall Study|Withdrawal by Subject|0|||
147117565|NCT02336503|530594390|FG003|Overall Study|Withdrawal by Subject|4|||
147117566|NCT02336503|530594387|FG000|Overall Study|Adverse Event|0|||
147117567|NCT02336503|530594388|FG001|Overall Study|Adverse Event|0|||
147117568|NCT02336503|530594389|FG002|Overall Study|Adverse Event|1|||
147117569|NCT02336503|530594390|FG003|Overall Study|Adverse Event|0|||
147117570|NCT02583477|530594394|FG000|Overall Study|Adverse Event|0|||
147117571|NCT02583477|530594395|FG001|Overall Study|Adverse Event|2|||
147117572|NCT02583477|530594394|FG000|Overall Study|Death|1|||
147117573|NCT02583477|530594395|FG001|Overall Study|Death|16|||
147117574|NCT02583477|530594394|FG000|Overall Study|Study terminated|2|||
147117575|NCT02583477|530594395|FG001|Overall Study|Study terminated|2|||
147117576|NCT01873833|530594402|FG000|Overall Study|Withdrawal by Subject|1|||
147117577|NCT06025695|530594405|FG000|Overall Study|Adverse Event|5|||
147117578|NCT06025695|530594406|FG001|Overall Study|Adverse Event|6|||
147117579|NCT06025695|530594405|FG000|Overall Study|Migrated / Moved from the Study Area|13|||
147117580|NCT06025695|530594406|FG001|Overall Study|Migrated / Moved from the Study Area|10|||
147117581|NCT06025695|530594405|FG000|Overall Study|Other|23|||
147117582|NCT06025695|530594406|FG001|Overall Study|Other|19|||
147117583|NCT06025695|530594405|FG000|Overall Study|Adverse Event Requiring Expedited Report|1|||
147117584|NCT06025695|530594406|FG001|Overall Study|Adverse Event Requiring Expedited Report|0|||
147117585|NCT01301092|530594407|FG000|Overall Study|Lost to Follow-up|0|||
147117586|NCT01301092|530594408|FG001|Overall Study|Lost to Follow-up|0|||
147117587|NCT01301092|530594409|FG002|Overall Study|Lost to Follow-up|1|||
147117588|NCT01350973|530594410|FG000|Overall Study|Adverse Event|4|||
147117589|NCT01350973|530594411|FG001|Overall Study|Adverse Event|7|||
147117590|NCT01350973|530594412|FG002|Overall Study|Adverse Event|7|||
147117591|NCT01350973|530594410|FG000|Overall Study|Voluntary Withdrawal|2|||
147117592|NCT01350973|530594411|FG001|Overall Study|Voluntary Withdrawal|1|||
147117593|NCT01350973|530594412|FG002|Overall Study|Voluntary Withdrawal|1|||
147117594|NCT03738215|530594413|FG000|Double-blind Treatment Period (6 Weeks)|Protocol Violation|0|||
147117595|NCT03738215|530594414|FG001|Double-blind Treatment Period (6 Weeks)|Protocol Violation|1|||
147117596|NCT03738215|530594415|FG002|Double-blind Treatment Period (6 Weeks)|Protocol Violation|0|||
147117597|NCT03738215|530594413|FG000|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|2|||
147117598|NCT03738215|530594414|FG001|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|2|||
147117599|NCT03738215|530594415|FG002|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
147117600|NCT03738215|530594413|FG000|Double-blind Treatment Period (6 Weeks)|Adverse Event|6|||
147117601|NCT03738215|530594414|FG001|Double-blind Treatment Period (6 Weeks)|Adverse Event|3|||
147117602|NCT03738215|530594415|FG002|Double-blind Treatment Period (6 Weeks)|Adverse Event|18|||
147117603|NCT03738215|530594413|FG000|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|13|||
147117604|NCT03738215|530594414|FG001|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|11|||
147117605|NCT03738215|530594415|FG002|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|9|||
147117606|NCT03738215|530594413|FG000|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|0|||
147117607|NCT03738215|530594414|FG001|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|1|||
147117608|NCT03738215|530594415|FG002|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|1|||
147117609|NCT03738215|530594413|FG000|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|3|||
147117610|NCT03738215|530594414|FG001|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|3|||
147117611|NCT03738215|530594415|FG002|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|5|||
147117612|NCT03738215|530594413|FG000|Safety Follow Up Period (4 Weeks)|Adverse Event|0|||
147566439|NCT03195491|532233364|FG001|Overall Study|Lost to Follow-up|0|||
147117613|NCT03738215|530594414|FG001|Safety Follow Up Period (4 Weeks)|Adverse Event|0|||
147117614|NCT03738215|530594415|FG002|Safety Follow Up Period (4 Weeks)|Adverse Event|1|||
147117615|NCT03738215|530594413|FG000|Safety Follow Up Period (4 Weeks)|Reason Not Specified|0|||
147117616|NCT03738215|530594414|FG001|Safety Follow Up Period (4 Weeks)|Reason Not Specified|2|||
147117617|NCT03738215|530594415|FG002|Safety Follow Up Period (4 Weeks)|Reason Not Specified|0|||
147117618|NCT03738215|530594413|FG000|Safety Follow Up Period (4 Weeks)|Withdrawal by Subject|1|||
147117619|NCT03738215|530594414|FG001|Safety Follow Up Period (4 Weeks)|Withdrawal by Subject|1|||
147117620|NCT03738215|530594415|FG002|Safety Follow Up Period (4 Weeks)|Withdrawal by Subject|3|||
147117621|NCT03738215|530594413|FG000|Safety Follow Up Period (4 Weeks)|Lost to Follow-up|2|||
147117622|NCT03738215|530594414|FG001|Safety Follow Up Period (4 Weeks)|Lost to Follow-up|2|||
147117623|NCT03738215|530594415|FG002|Safety Follow Up Period (4 Weeks)|Lost to Follow-up|4|||
147117624|NCT02638493|530594416|FG000|Overall Study|Inability to provide semen samples|2|||
147117625|NCT02638493|530594417|FG001|Overall Study|Inability to provide semen samples|0|||
147117626|NCT02638493|530594418|FG002|Overall Study|Inability to provide semen samples|0|||
147117627|NCT03882801|530596380|FG000|Period 1|Adverse Event|0|||
147117628|NCT03882801|530596381|FG001|Period 1|Adverse Event|1|||
147117629|NCT03882801|530596380|FG000|Period 1|Non-compliance with study drug|1|||
147117630|NCT03882801|530596381|FG001|Period 1|Non-compliance with study drug|1|||
147117631|NCT03882801|530596380|FG000|Period 1|Never treated with study drug|1|||
147117632|NCT03882801|530596381|FG001|Period 1|Never treated with study drug|0|||
147117633|NCT03882801|530596380|FG000|Washout Period|Physician Decision|0|||
147117634|NCT03882801|530596381|FG001|Washout Period|Physician Decision|1|||
147117635|NCT03882801|530596380|FG000|Period 2|Non-compliance with study drug|0|||
147117636|NCT03882801|530596381|FG001|Period 2|Non-compliance with study drug|1|||
147117637|NCT00944645|530596385|FG000|Period 2|Adverse Event|1|||
147117638|NCT00944645|530596386|FG001|Period 2|Adverse Event|0|||
147117639|NCT00944645|530596385|FG000|Period 2|Lost to Follow-up|0|||
147117640|NCT00944645|530596386|FG001|Period 2|Lost to Follow-up|3|||
147117641|NCT00944645|530596385|FG000|Period 2|Withdrawal by Subject|7|||
147117642|NCT00944645|530596386|FG001|Period 2|Withdrawal by Subject|6|||
147117643|NCT03928704|530596390|FG000|Double-Blind Treatment Period:Week 1-16|Patient Compliance|0|||
147117644|NCT03928704|530596391|FG001|Double-Blind Treatment Period:Week 1-16|Patient Compliance|1|||
147117645|NCT03928704|530596392|FG002|Double-Blind Treatment Period:Week 1-16|Patient Compliance|0|||
147117646|NCT03928704|530596393|FG003|Double-Blind Treatment Period:Week 1-16|Patient Compliance|0|||
147117647|NCT03928704|530596394|FG004|Double-Blind Treatment Period:Week 1-16|Patient Compliance|0|||
147117648|NCT03928704|530596395|FG005|Double-Blind Treatment Period:Week 1-16|Patient Compliance|0|||
147117649|NCT03928704|530596390|FG000|Double-Blind Treatment Period:Week 1-16|Withdrawal By Study Participant|4|||
147117650|NCT03928704|530596391|FG001|Double-Blind Treatment Period:Week 1-16|Withdrawal By Study Participant|0|||
147117651|NCT03928704|530596392|FG002|Double-Blind Treatment Period:Week 1-16|Withdrawal By Study Participant|0|||
147117652|NCT03928704|530596393|FG003|Double-Blind Treatment Period:Week 1-16|Withdrawal By Study Participant|0|||
147117653|NCT03928704|530596394|FG004|Double-Blind Treatment Period:Week 1-16|Withdrawal By Study Participant|0|||
147117654|NCT03928704|530596395|FG005|Double-Blind Treatment Period:Week 1-16|Withdrawal By Study Participant|0|||
147117655|NCT03928704|530596390|FG000|Double-Blind Treatment Period:Week 1-16|Lack of Efficacy|1|||
147117656|NCT03928704|530596391|FG001|Double-Blind Treatment Period:Week 1-16|Lack of Efficacy|0|||
147117657|NCT03928704|530596392|FG002|Double-Blind Treatment Period:Week 1-16|Lack of Efficacy|0|||
147117658|NCT03928704|530596393|FG003|Double-Blind Treatment Period:Week 1-16|Lack of Efficacy|0|||
147117659|NCT03928704|530596394|FG004|Double-Blind Treatment Period:Week 1-16|Lack of Efficacy|0|||
147117660|NCT03928704|530596395|FG005|Double-Blind Treatment Period:Week 1-16|Lack of Efficacy|0|||
147117661|NCT03928704|530596390|FG000|Double-Blind Treatment Period:Week 1-16|Adverse Event|3|||
147117662|NCT03928704|530596391|FG001|Double-Blind Treatment Period:Week 1-16|Adverse Event|1|||
147117663|NCT03928704|530596392|FG002|Double-Blind Treatment Period:Week 1-16|Adverse Event|0|||
147117664|NCT03928704|530596393|FG003|Double-Blind Treatment Period:Week 1-16|Adverse Event|0|||
147117665|NCT03928704|530596394|FG004|Double-Blind Treatment Period:Week 1-16|Adverse Event|0|||
147117666|NCT03928704|530596395|FG005|Double-Blind Treatment Period:Week 1-16|Adverse Event|0|||
147117667|NCT03928704|530596390|FG000|Maintenance Period: Week 16-52|Withdrawal By Study Participant|0|||
147117668|NCT03928704|530596391|FG001|Maintenance Period: Week 16-52|Withdrawal By Study Participant|0|||
147117669|NCT03928704|530596392|FG002|Maintenance Period: Week 16-52|Withdrawal By Study Participant|12|||
147117670|NCT03928704|530596393|FG003|Maintenance Period: Week 16-52|Withdrawal By Study Participant|0|||
147566440|NCT03195491|532233363|FG000|Overall Study|Death|3|||
147566441|NCT03195491|532233364|FG001|Overall Study|Death|0|||
147117671|NCT03928704|530596394|FG004|Maintenance Period: Week 16-52|Withdrawal By Study Participant|0|||
147117672|NCT03928704|530596395|FG005|Maintenance Period: Week 16-52|Withdrawal By Study Participant|0|||
147566442|NCT03195491|532233363|FG000|Overall Study|Adverse event unrelated to study drug|19|||
147566443|NCT03195491|532233364|FG001|Overall Study|Adverse event unrelated to study drug|2|||
147117673|NCT03928704|530596390|FG000|Maintenance Period: Week 16-52|Lack of Efficacy|0|||
147566444|NCT03195491|532233363|FG000|Overall Study|Disease progression|266|||
147566445|NCT03195491|532233364|FG001|Overall Study|Disease progression|8|||
147566446|NCT03195491|532233363|FG000|Overall Study|Other reasons|10|||
147566447|NCT03195491|532233364|FG001|Overall Study|Other reasons|0|||
147566448|NCT03195491|532233363|FG000|Overall Study|Participant withdrew consent|8|||
147566449|NCT03195491|532233364|FG001|Overall Study|Participant withdrew consent|1|||
147566450|NCT03195491|532233363|FG000|Overall Study|Participant no longer meets study criteria|0|||
147566451|NCT03195491|532233364|FG001|Overall Study|Participant no longer meets study criteria|1|||
147566452|NCT03195491|532233363|FG000|Overall Study|Participant request to discontinue study treatment|10|||
147566453|NCT03195491|532233364|FG001|Overall Study|Participant request to discontinue study treatment|0|||
147566454|NCT01270503|532233365|FG000|Overall Study|Lost to Follow-up|1|||
147566455|NCT02459951|532233366|FG000|Overall Study|Unable to meet holding requirement|1|||
147566456|NCT00252720|532233368|FG000|Overall Study|Withdrawal by Subject|95|||
147566457|NCT00252720|532233369|FG001|Overall Study|Withdrawal by Subject|97|||
147566458|NCT00252720|532233368|FG000|Overall Study|Death|7|||
147566459|NCT00252720|532233369|FG001|Overall Study|Death|8|||
147117674|NCT03928704|530596391|FG001|Maintenance Period: Week 16-52|Lack of Efficacy|0|||
147117675|NCT03928704|530596392|FG002|Maintenance Period: Week 16-52|Lack of Efficacy|4|||
147566460|NCT00252720|532233368|FG000|Overall Study|Moving|23|||
147566461|NCT00252720|532233369|FG001|Overall Study|Moving|42|||
147566462|NCT00252720|532233368|FG000|Overall Study|Mainly patients lost to follow-up|7|||
147566463|NCT00252720|532233369|FG001|Overall Study|Mainly patients lost to follow-up|18|||
147566464|NCT00102440|532233370|FG000|Overall Study|Lost to Follow-up|25|||
147566465|NCT00102440|532233371|FG001|Overall Study|Lost to Follow-up|18|||
147566466|NCT00102440|532233372|FG002|Overall Study|Lost to Follow-up|21|||
147566467|NCT00102440|532233370|FG000|Overall Study|Adverse Event|16|||
147117676|NCT03928704|530596393|FG003|Maintenance Period: Week 16-52|Lack of Efficacy|0|||
147117677|NCT03928704|530596394|FG004|Maintenance Period: Week 16-52|Lack of Efficacy|0|||
147117678|NCT03928704|530596395|FG005|Maintenance Period: Week 16-52|Lack of Efficacy|0|||
147117679|NCT03928704|530596390|FG000|Maintenance Period: Week 16-52|Adverse Event|0|||
147117680|NCT03928704|530596391|FG001|Maintenance Period: Week 16-52|Adverse Event|0|||
147117681|NCT03928704|530596392|FG002|Maintenance Period: Week 16-52|Adverse Event|5|||
147117682|NCT03928704|530596393|FG003|Maintenance Period: Week 16-52|Adverse Event|0|||
147117683|NCT03928704|530596394|FG004|Maintenance Period: Week 16-52|Adverse Event|0|||
147117684|NCT03928704|530596395|FG005|Maintenance Period: Week 16-52|Adverse Event|0|||
147117685|NCT03928704|530596390|FG000|Maintenance Period: Week 16-52|Lost to Follow-up|0|||
147117686|NCT03928704|530596391|FG001|Maintenance Period: Week 16-52|Lost to Follow-up|0|||
147117687|NCT03928704|530596392|FG002|Maintenance Period: Week 16-52|Lost to Follow-up|1|||
147117688|NCT03928704|530596393|FG003|Maintenance Period: Week 16-52|Lost to Follow-up|0|||
147117689|NCT03928704|530596394|FG004|Maintenance Period: Week 16-52|Lost to Follow-up|0|||
147117690|NCT03928704|530596395|FG005|Maintenance Period: Week 16-52|Lost to Follow-up|0|||
147117691|NCT03928704|530596390|FG000|Maintenance Period: Week 16-52|COVID-19 pandemic situation & site restrictions|0|||
147117692|NCT03928704|530596391|FG001|Maintenance Period: Week 16-52|COVID-19 pandemic situation & site restrictions|0|||
147117693|NCT03928704|530596392|FG002|Maintenance Period: Week 16-52|COVID-19 pandemic situation & site restrictions|0|||
147117694|NCT03928704|530596393|FG003|Maintenance Period: Week 16-52|COVID-19 pandemic situation & site restrictions|0|||
147117695|NCT03928704|530596394|FG004|Maintenance Period: Week 16-52|COVID-19 pandemic situation & site restrictions|0|||
147117696|NCT03928704|530596395|FG005|Maintenance Period: Week 16-52|COVID-19 pandemic situation & site restrictions|2|||
147117697|NCT03928704|530596390|FG000|Maintenance Period: Week 16-52|Non- Compliance|0|||
147117698|NCT03928704|530596391|FG001|Maintenance Period: Week 16-52|Non- Compliance|0|||
147117699|NCT03928704|530596392|FG002|Maintenance Period: Week 16-52|Non- Compliance|0|||
147117700|NCT03928704|530596393|FG003|Maintenance Period: Week 16-52|Non- Compliance|0|||
147117701|NCT03928704|530596394|FG004|Maintenance Period: Week 16-52|Non- Compliance|0|||
147117702|NCT03928704|530596395|FG005|Maintenance Period: Week 16-52|Non- Compliance|1|||
147117703|NCT01245751|530596401|FG000|Part 1: Day 1 to Week 52 (1 Year)|Death|2|||
147117704|NCT01245751|530596402|FG001|Part 1: Day 1 to Week 52 (1 Year)|Death|1|||
147117705|NCT01245751|530596403|FG002|Part 1: Day 1 to Week 52 (1 Year)|Death|0|||
147117706|NCT01245751|530596404|FG003|Part 1: Day 1 to Week 52 (1 Year)|Death|0|||
147117707|NCT01245751|530596401|FG000|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|0|||
147117708|NCT01245751|530596402|FG001|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|0|||
147117709|NCT01245751|530596403|FG002|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|0|||
147117710|NCT01245751|530596404|FG003|Part 1: Day 1 to Week 52 (1 Year)|Lost to Follow-up|2|||
147117711|NCT01245751|530596401|FG000|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|0|||
147117712|NCT01245751|530596402|FG001|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|4|||
147117713|NCT01245751|530596403|FG002|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|0|||
147117714|NCT01245751|530596404|FG003|Part 1: Day 1 to Week 52 (1 Year)|Withdrawal by Subject|0|||
147117715|NCT02082483|530596405|FG000|Overall Study|Lost to Follow-up|1|||
147566468|NCT00102440|532233371|FG001|Overall Study|Adverse Event|23|||
147566469|NCT00102440|532233372|FG002|Overall Study|Adverse Event|8|||
147566470|NCT00102440|532233370|FG000|Overall Study|Gout Flare|10|||
147566471|NCT00102440|532233371|FG001|Overall Study|Gout Flare|28|||
147566472|NCT00102440|532233372|FG002|Overall Study|Gout Flare|9|||
147566473|NCT00102440|532233370|FG000|Overall Study|Personal Reason(s)|19|||
147117716|NCT02082483|530596406|FG001|Overall Study|Lost to Follow-up|1|||
147117717|NCT02082483|530596405|FG000|Overall Study|Withdrawal by Subject|2|||
147117718|NCT02082483|530596406|FG001|Overall Study|Withdrawal by Subject|1|||
147117719|NCT02082483|530596405|FG000|Overall Study|Physician Decision|1|||
147117720|NCT02082483|530596406|FG001|Overall Study|Physician Decision|1|||
147117721|NCT02082483|530596405|FG000|Overall Study|Death|2|||
147117722|NCT02082483|530596406|FG001|Overall Study|Death|3|||
147117723|NCT02181621|530596407|FG000|Overall Study|Adverse Event|1|||
147117724|NCT02181621|530596408|FG001|Overall Study|Adverse Event|0|||
147117725|NCT02181621|530596407|FG000|Overall Study|Previously Enrolled|0|||
147117726|NCT02181621|530596408|FG001|Overall Study|Previously Enrolled|1|||
147117727|NCT02181621|530596407|FG000|Overall Study|Enrollment Hold|1|||
147117728|NCT02181621|530596408|FG001|Overall Study|Enrollment Hold|1|||
147117729|NCT00762788|530596409|FG000|Overall Study|Lost to Follow-up|26|||
147117730|NCT00762788|530596410|FG001|Overall Study|Lost to Follow-up|37|||
147117731|NCT00762788|530596411|FG002|Overall Study|Lost to Follow-up|21|||
147117732|NCT00762788|530596412|FG003|Overall Study|Lost to Follow-up|26|||
147117733|NCT00762788|530596413|FG004|Overall Study|Lost to Follow-up|13|||
147117734|NCT00762788|530596414|FG005|Overall Study|Lost to Follow-up|21|||
147117735|NCT01783015|530596415|FG000|Blinded Treatment|Adverse Event|0|||
147117736|NCT01783015|530596416|FG001|Blinded Treatment|Adverse Event|1|||
147117737|NCT01783015|530596417|FG002|Blinded Treatment|Adverse Event|0|||
147117738|NCT01783015|530596415|FG000|Blinded Treatment|Protocol Violation|0|||
147117739|NCT01783015|530596416|FG001|Blinded Treatment|Protocol Violation|1|||
147117740|NCT01783015|530596417|FG002|Blinded Treatment|Protocol Violation|0|||
147117741|NCT01783015|530596415|FG000|Blinded Treatment|Withdrawal by Subject|0|||
147117742|NCT01783015|530596416|FG001|Blinded Treatment|Withdrawal by Subject|1|||
147117743|NCT01783015|530596417|FG002|Blinded Treatment|Withdrawal by Subject|0|||
147117744|NCT01783015|530596415|FG000|Blinded Treatment|Study Terminated by Sponsor|2|||
147117745|NCT01783015|530596416|FG001|Blinded Treatment|Study Terminated by Sponsor|0|||
147117746|NCT01783015|530596417|FG002|Blinded Treatment|Study Terminated by Sponsor|0|||
147117747|NCT01783015|530596415|FG000|Open Label Treatment|Study Terminated by Sponsor|0|||
147117748|NCT01783015|530596416|FG001|Open Label Treatment|Study Terminated by Sponsor|0|||
147117749|NCT01783015|530596417|FG002|Open Label Treatment|Study Terminated by Sponsor|6|||
147117750|NCT00289978|530596421|FG000|Overall Study|Withdrawal by Subject|31|||
147117751|NCT00289978|530596422|FG001|Overall Study|Withdrawal by Subject|17|||
147117752|NCT00289978|530596423|FG002|Overall Study|Withdrawal by Subject|28|||
147117753|NCT00289978|530596421|FG000|Overall Study|Adverse Event|22|||
147117754|NCT00289978|530596422|FG001|Overall Study|Adverse Event|13|||
147117755|NCT00289978|530596423|FG002|Overall Study|Adverse Event|18|||
147117756|NCT00289978|530596421|FG000|Overall Study|Lack of Efficacy|13|||
147117757|NCT00289978|530596422|FG001|Overall Study|Lack of Efficacy|6|||
147117758|NCT00289978|530596423|FG002|Overall Study|Lack of Efficacy|25|||
147117759|NCT00289978|530596421|FG000|Overall Study|Abnormal laboratory value(s)|20|||
147117760|NCT00289978|530596422|FG001|Overall Study|Abnormal laboratory value(s)|9|||
147229776|NCT02367131|531015830|FG000|Overall Study|Improvement/remission|2|||
147229777|NCT02367131|531015830|FG000|Overall Study|No change/progressive disease|78|||
147229778|NCT02367131|531015830|FG000|Overall Study|Other than stated above|20|||
147229779|NCT02367131|531015830|FG000|Overall Study|Not treated|2|||
147229780|NCT01973569|531015833|FG000|Overall Study|Adverse Event|9|||
147229781|NCT01973569|531015834|FG001|Overall Study|Adverse Event|2|||
147229782|NCT01973569|531015835|FG002|Overall Study|Adverse Event|4|||
147566474|NCT00102440|532233371|FG001|Overall Study|Personal Reason(s)|13|||
147566475|NCT00102440|532233372|FG002|Overall Study|Personal Reason(s)|13|||
147566476|NCT00102440|532233370|FG000|Overall Study|Other|11|||
147229783|NCT01973569|531015833|FG000|Overall Study|Protocol Violation|2|||
147566477|NCT00102440|532233371|FG001|Overall Study|Other|14|||
147566478|NCT00102440|532233372|FG002|Overall Study|Other|14|||
147566479|NCT00102440|532233370|FG000|Overall Study|Protocol Violation|7|||
147566480|NCT00102440|532233371|FG001|Overall Study|Protocol Violation|2|||
147566481|NCT00102440|532233372|FG002|Overall Study|Protocol Violation|1|||
147566482|NCT00772941|532233373|FG000|Overall Study|CRFs not available|195|||
147566483|NCT00772941|532233373|FG000|Overall Study|Study not completed|16|||
147566484|NCT00772941|532233373|FG000|Overall Study|Missed Visits|374|||
147566485|NCT00772941|532233373|FG000|Overall Study|Poor Compliance|7|||
147117761|NCT00289978|530596423|FG002|Overall Study|Abnormal laboratory value(s)|1|||
147117762|NCT00289978|530596421|FG000|Overall Study|Lost to Follow-up|3|||
147117763|NCT00289978|530596422|FG001|Overall Study|Lost to Follow-up|5|||
147117764|NCT00289978|530596423|FG002|Overall Study|Lost to Follow-up|7|||
147117765|NCT00289978|530596421|FG000|Overall Study|Protocol Violation|5|||
147117766|NCT00289978|530596422|FG001|Overall Study|Protocol Violation|5|||
147229784|NCT01973569|531015834|FG001|Overall Study|Protocol Violation|1|||
147229785|NCT01973569|531015835|FG002|Overall Study|Protocol Violation|3|||
147444456|NCT01056510|531792618|FG000|Overall Study|Physician Decision|4|||
147117767|NCT00289978|530596423|FG002|Overall Study|Protocol Violation|4|||
147117768|NCT00289978|530596421|FG000|Overall Study|Abnormal test procedure result(s)|2|||
147117769|NCT00289978|530596422|FG001|Overall Study|Abnormal test procedure result(s)|1|||
147117770|NCT00289978|530596423|FG002|Overall Study|Abnormal test procedure result(s)|1|||
147566486|NCT00772941|532233373|FG000|Overall Study|GPSP Violation|90|||
147566487|NCT04786184|532233375|FG000|Overall Study|Adverse Event|4|||
147566488|NCT04786184|532233376|FG001|Overall Study|Adverse Event|0|||
147566489|NCT04786184|532233375|FG000|Overall Study|Withdrawal by Subject|3|||
147566490|NCT04786184|532233376|FG001|Overall Study|Withdrawal by Subject|1|||
147566491|NCT04786184|532233375|FG000|Overall Study|Lost to Follow-up|4|||
147566492|NCT04786184|532233376|FG001|Overall Study|Lost to Follow-up|2|||
147566493|NCT01745120|532233377|FG000|Overall Study|Investigator decision|1|||
147566494|NCT01745120|532233378|FG001|Overall Study|Investigator decision|0|||
147566495|NCT01185821|532233381|FG000|Overall Study|Abnormal laboratory value(s)|1|||
147566496|NCT01185821|532233382|FG001|Overall Study|Abnormal laboratory value(s)|2|||
147566497|NCT01185821|532233383|FG002|Overall Study|Abnormal laboratory value(s)|1|||
147566498|NCT01185821|532233384|FG003|Overall Study|Abnormal laboratory value(s)|0|||
147566499|NCT01185821|532233385|FG004|Overall Study|Abnormal laboratory value(s)|0|||
147566500|NCT01185821|532233381|FG000|Overall Study|Protocol Violation|0|||
147566501|NCT01185821|532233382|FG001|Overall Study|Protocol Violation|0|||
147566502|NCT01185821|532233383|FG002|Overall Study|Protocol Violation|0|||
147566503|NCT01185821|532233384|FG003|Overall Study|Protocol Violation|1|||
147566504|NCT01185821|532233385|FG004|Overall Study|Protocol Violation|1|||
147566505|NCT01185821|532233381|FG000|Overall Study|Abnormal test procedure result|0|||
147566506|NCT01185821|532233382|FG001|Overall Study|Abnormal test procedure result|0|||
147566507|NCT01185821|532233383|FG002|Overall Study|Abnormal test procedure result|0|||
147566508|NCT01185821|532233384|FG003|Overall Study|Abnormal test procedure result|0|||
147566509|NCT01185821|532233385|FG004|Overall Study|Abnormal test procedure result|1|||
147566510|NCT01185821|532233381|FG000|Overall Study|Death|0|||
147566511|NCT01185821|532233382|FG001|Overall Study|Death|1|||
147566512|NCT01185821|532233383|FG002|Overall Study|Death|0|||
147566513|NCT01185821|532233384|FG003|Overall Study|Death|0|||
147566514|NCT01185821|532233385|FG004|Overall Study|Death|0|||
147566515|NCT01185821|532233381|FG000|Overall Study|Condition no longer required study drug|0|||
147566516|NCT01185821|532233382|FG001|Overall Study|Condition no longer required study drug|0|||
147566517|NCT01185821|532233383|FG002|Overall Study|Condition no longer required study drug|0|||
147566518|NCT01185821|532233384|FG003|Overall Study|Condition no longer required study drug|0|||
147566519|NCT01185821|532233385|FG004|Overall Study|Condition no longer required study drug|1|||
147566520|NCT01185821|532233381|FG000|Overall Study|Adverse Event|2|||
147566521|NCT01185821|532233382|FG001|Overall Study|Adverse Event|3|||
147566522|NCT01185821|532233383|FG002|Overall Study|Adverse Event|1|||
147566523|NCT01185821|532233384|FG003|Overall Study|Adverse Event|2|||
147566524|NCT01185821|532233385|FG004|Overall Study|Adverse Event|5|||
147566525|NCT01185821|532233381|FG000|Overall Study|Lack of Efficacy|0|||
147566526|NCT01185821|532233382|FG001|Overall Study|Lack of Efficacy|0|||
147566527|NCT01185821|532233383|FG002|Overall Study|Lack of Efficacy|3|||
147566528|NCT01185821|532233384|FG003|Overall Study|Lack of Efficacy|0|||
147566529|NCT01185821|532233385|FG004|Overall Study|Lack of Efficacy|9|||
147566530|NCT01185821|532233381|FG000|Overall Study|Withdrawal by Subject|3|||
147566531|NCT01185821|532233382|FG001|Overall Study|Withdrawal by Subject|2|||
147566532|NCT01185821|532233383|FG002|Overall Study|Withdrawal by Subject|2|||
147566533|NCT01185821|532233384|FG003|Overall Study|Withdrawal by Subject|1|||
147566534|NCT01185821|532233385|FG004|Overall Study|Withdrawal by Subject|3|||
147566535|NCT01185821|532233381|FG000|Overall Study|Lost to Follow-up|1|||
147566536|NCT01185821|532233382|FG001|Overall Study|Lost to Follow-up|1|||
147566537|NCT01185821|532233383|FG002|Overall Study|Lost to Follow-up|2|||
147566538|NCT01185821|532233384|FG003|Overall Study|Lost to Follow-up|1|||
147566539|NCT01185821|532233385|FG004|Overall Study|Lost to Follow-up|2|||
147566540|NCT01185821|532233381|FG000|Overall Study|Administrative problems|0|||
147117771|NCT00289978|530596421|FG000|Overall Study|Death|1|||
147117772|NCT00289978|530596422|FG001|Overall Study|Death|0|||
147117773|NCT00289978|530596423|FG002|Overall Study|Death|2|||
147566541|NCT01185821|532233382|FG001|Overall Study|Administrative problems|0|||
147566542|NCT01185821|532233383|FG002|Overall Study|Administrative problems|1|||
147566543|NCT01185821|532233384|FG003|Overall Study|Administrative problems|1|||
147566544|NCT01185821|532233385|FG004|Overall Study|Administrative problems|2|||
147566545|NCT02392000|532233397|FG000|Overall Study|Greater than mild sleep apnea exclusion|18|||
147566546|NCT02392000|532233397|FG000|Overall Study|Withdrawal by Subject|1|||
147566547|NCT02392000|532233397|FG000|Overall Study|Lost to Follow-up|8|||
147566548|NCT00385593|532233398|FG000|Overall Study|Adverse Event|3|||
147566549|NCT00385593|532233399|FG001|Overall Study|Adverse Event|2|||
147566550|NCT00385593|532233398|FG000|Overall Study|Withdrawal by Subject|17|||
147566551|NCT00385593|532233399|FG001|Overall Study|Withdrawal by Subject|7|||
147566552|NCT00385593|532233398|FG000|Overall Study|Lost to Follow-up|12|||
147650893|NCT02757352|532544542|FG005|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|4|||
147117774|NCT01524705|530596424|FG000|Overall Study|Adverse Event|2|||
147117775|NCT01524705|530596425|FG001|Overall Study|Adverse Event|0|||
147117776|NCT01524705|530596424|FG000|Overall Study|Death|1|||
147117777|NCT01524705|530596425|FG001|Overall Study|Death|0|||
147117778|NCT01524705|530596424|FG000|Overall Study|Lost to Follow-up|0|||
147117779|NCT01524705|530596425|FG001|Overall Study|Lost to Follow-up|1|||
147117780|NCT01524705|530596424|FG000|Overall Study|Withdrawal by Subject|0|||
147117781|NCT01524705|530596425|FG001|Overall Study|Withdrawal by Subject|1|||
147117782|NCT01524705|530596424|FG000|Overall Study|Pancreatic Cancer|0|||
147117783|NCT01524705|530596425|FG001|Overall Study|Pancreatic Cancer|1|||
147117784|NCT01243424|530596426|FG000|Discontinuation From Study (Treated Set)|Consent Withdrawn (Status Alive)|49|||
147117785|NCT01243424|530596427|FG001|Discontinuation From Study (Treated Set)|Consent Withdrawn (Status Alive)|37|||
147566553|NCT00385593|532233399|FG001|Overall Study|Lost to Follow-up|8|||
147566554|NCT00385593|532233398|FG000|Overall Study|Protocol Violation|7|||
147117786|NCT01243424|530596426|FG000|Discontinuation From Study (Treated Set)|Consent Withdrawn (Status Unknown)|14|||
147117787|NCT01243424|530596427|FG001|Discontinuation From Study (Treated Set)|Consent Withdrawn (Status Unknown)|12|||
147117788|NCT01243424|530596426|FG000|Discontinuation From Study (Treated Set)|Site Closure (Status Alive)|15|||
147117789|NCT01243424|530596427|FG001|Discontinuation From Study (Treated Set)|Site Closure (Status Alive)|22|||
147117790|NCT01243424|530596426|FG000|Discontinuation From Study (Treated Set)|Site Closure (Status Unknown)|0|||
147117791|NCT01243424|530596427|FG001|Discontinuation From Study (Treated Set)|Site Closure (Status Unknown)|1|||
147229786|NCT01973569|531015833|FG000|Overall Study|Withdrawal by Subject|7|||
147229787|NCT01973569|531015834|FG001|Overall Study|Withdrawal by Subject|5|||
147229788|NCT01973569|531015835|FG002|Overall Study|Withdrawal by Subject|2|||
147229789|NCT01973569|531015833|FG000|Overall Study|Invasive dental treatment|3|||
147229790|NCT01973569|531015834|FG001|Overall Study|Invasive dental treatment|5|||
147229791|NCT01973569|531015835|FG002|Overall Study|Invasive dental treatment|6|||
147229792|NCT01973569|531015833|FG000|Overall Study|Prohibited concomitant d|1|||
147229793|NCT01973569|531015834|FG001|Overall Study|Prohibited concomitant d|5|||
147229794|NCT01973569|531015835|FG002|Overall Study|Prohibited concomitant d|0|||
147229795|NCT01973569|531015833|FG000|Overall Study|Disease progression|0|||
147229796|NCT01973569|531015834|FG001|Overall Study|Disease progression|3|||
147229797|NCT01973569|531015835|FG002|Overall Study|Disease progression|0|||
147229798|NCT01973569|531015833|FG000|Overall Study|Other|1|||
147229799|NCT01973569|531015834|FG001|Overall Study|Other|1|||
147229800|NCT01973569|531015835|FG002|Overall Study|Other|0|||
147229801|NCT01973569|531015833|FG000|Overall Study|Did not receive study drug|6|||
147229802|NCT01973569|531015834|FG001|Overall Study|Did not receive study drug|3|||
147229803|NCT01973569|531015835|FG002|Overall Study|Did not receive study drug|3|||
147229804|NCT05061966|531015836|FG000|Overall Study|Lost to Follow-up|13|||
147229805|NCT05061966|531015837|FG001|Overall Study|Lost to Follow-up|13|||
147229806|NCT03793556|531015840|FG000|Overall Study|Withdrawal by Subject|12|||
147229807|NCT03793556|531015841|FG001|Overall Study|Withdrawal by Subject|1|||
147229808|NCT03793556|531015840|FG000|Overall Study|Lost to Follow-up|1|||
147229809|NCT03793556|531015841|FG001|Overall Study|Lost to Follow-up|1|||
147229810|NCT04416633|531015842|FG000|Overall Study|Death|1|||
147229811|NCT04416633|531015842|FG000|Overall Study|Disease progression as per investigator's clinical and imaging assessment|17|||
147229812|NCT04416633|531015842|FG000|Overall Study|AE greater than Grade 3 related to study drug|1|||
147229813|NCT04416633|531015842|FG000|Overall Study|Adverse Event|6|||
147229814|NCT04416633|531015842|FG000|Overall Study|Withdrawal by Subject|6|||
147229815|NCT00785928|531015843|FG000|Treatment Phase|Adverse Event|1|||
147229816|NCT00785928|531015844|FG001|Treatment Phase|Adverse Event|1|||
147229817|NCT00785928|531015845|FG002|Treatment Phase|Adverse Event|2|||
147229818|NCT00785928|531015846|FG003|Treatment Phase|Adverse Event|0|||
147229819|NCT00785928|531015847|FG004|Treatment Phase|Adverse Event|0|||
147229820|NCT00785928|531015848|FG005|Treatment Phase|Adverse Event|0|||
147229821|NCT00785928|531015849|FG006|Treatment Phase|Adverse Event|2|||
147229822|NCT00785928|531015843|FG000|Treatment Phase|Inadequate Response|0|||
147229823|NCT00785928|531015844|FG001|Treatment Phase|Inadequate Response|1|||
147229824|NCT00785928|531015845|FG002|Treatment Phase|Inadequate Response|0|||
147229825|NCT00785928|531015846|FG003|Treatment Phase|Inadequate Response|0|||
147229826|NCT00785928|531015847|FG004|Treatment Phase|Inadequate Response|0|||
147229827|NCT00785928|531015848|FG005|Treatment Phase|Inadequate Response|0|||
147229828|NCT00785928|531015849|FG006|Treatment Phase|Inadequate Response|0|||
147229829|NCT00785928|531015843|FG000|Treatment Phase|Lack of Efficacy|0|||
147229830|NCT00785928|531015844|FG001|Treatment Phase|Lack of Efficacy|1|||
147229831|NCT00785928|531015845|FG002|Treatment Phase|Lack of Efficacy|1|||
147229832|NCT00785928|531015846|FG003|Treatment Phase|Lack of Efficacy|0|||
147229833|NCT00785928|531015847|FG004|Treatment Phase|Lack of Efficacy|0|||
147229834|NCT00785928|531015848|FG005|Treatment Phase|Lack of Efficacy|0|||
147229835|NCT00785928|531015849|FG006|Treatment Phase|Lack of Efficacy|0|||
147229836|NCT00785928|531015843|FG000|Treatment Phase|Physician Decision|0|||
147229837|NCT00785928|531015844|FG001|Treatment Phase|Physician Decision|0|||
147229838|NCT00785928|531015845|FG002|Treatment Phase|Physician Decision|0|||
147229839|NCT00785928|531015846|FG003|Treatment Phase|Physician Decision|0|||
147229840|NCT00785928|531015847|FG004|Treatment Phase|Physician Decision|1|||
147229841|NCT00785928|531015848|FG005|Treatment Phase|Physician Decision|0|||
147229842|NCT00785928|531015849|FG006|Treatment Phase|Physician Decision|0|||
147229843|NCT00785928|531015843|FG000|Treatment Phase|Sponsor Decision|1|||
147229844|NCT00785928|531015844|FG001|Treatment Phase|Sponsor Decision|0|||
147117792|NCT01243424|530596426|FG000|Discontinuation From Study (Treated Set)|LostToFollowUpfor3P-MACE(StatusAlive)|38|||
147117793|NCT01243424|530596427|FG001|Discontinuation From Study (Treated Set)|LostToFollowUpfor3P-MACE(StatusAlive)|35|||
147117794|NCT01243424|530596426|FG000|Discontinuation From Study (Treated Set)|LostToFollowUpfor3P-MACE(StatusUnknown)|8|||
147117795|NCT01243424|530596427|FG001|Discontinuation From Study (Treated Set)|LostToFollowUpfor3P-MACE(StatusUnknown)|8|||
147117796|NCT01243424|530596426|FG000|Discontinuation From Study (Treated Set)|Not treated|5|||
147117797|NCT01243424|530596427|FG001|Discontinuation From Study (Treated Set)|Not treated|4|||
147229845|NCT00785928|531015845|FG002|Treatment Phase|Sponsor Decision|0|||
147229846|NCT00785928|531015846|FG003|Treatment Phase|Sponsor Decision|0|||
147229847|NCT00785928|531015847|FG004|Treatment Phase|Sponsor Decision|0|||
147229848|NCT00785928|531015848|FG005|Treatment Phase|Sponsor Decision|0|||
147229849|NCT00785928|531015849|FG006|Treatment Phase|Sponsor Decision|1|||
147229850|NCT00785928|531015843|FG000|Treatment Phase|Withdrawal by Subject|1|||
147229851|NCT00785928|531015844|FG001|Treatment Phase|Withdrawal by Subject|2|||
147229852|NCT00785928|531015845|FG002|Treatment Phase|Withdrawal by Subject|0|||
147229853|NCT00785928|531015846|FG003|Treatment Phase|Withdrawal by Subject|0|||
147229854|NCT00785928|531015847|FG004|Treatment Phase|Withdrawal by Subject|1|||
147229855|NCT00785928|531015848|FG005|Treatment Phase|Withdrawal by Subject|0|||
147229856|NCT00785928|531015849|FG006|Treatment Phase|Withdrawal by Subject|0|||
147229857|NCT01675427|531015855|FG000|Overall Study|Withdrawal by Subject|7|||
147229858|NCT01675427|531015855|FG000|Overall Study|Participant Refused Sample Collection|18|||
147229859|NCT01675427|531015855|FG000|Overall Study|Sample not Collected by Mistake|2|||
147229860|NCT01675427|531015855|FG000|Overall Study|Lost to Follow-up|5|||
147229861|NCT01675427|531015855|FG000|Overall Study|Other|2|||
147229862|NCT00611533|531015858|FG000|First Intervention (6 Weeks)|Never started study|0|||
147229863|NCT00611533|531015859|FG001|First Intervention (6 Weeks)|Never started study|1|||
147229864|NCT00611533|531015858|FG000|First Intervention (6 Weeks)|Adverse Event|0|||
147444457|NCT01056510|531792619|FG001|Overall Study|Physician Decision|5|||
147566555|NCT00385593|532233399|FG001|Overall Study|Protocol Violation|4|||
147566556|NCT00385593|532233398|FG000|Overall Study|Several reasons|17|||
147566557|NCT00385593|532233399|FG001|Overall Study|Several reasons|15|||
147566558|NCT00385593|532233398|FG000|Overall Study|Incorrect inclusion|2|||
147566559|NCT00385593|532233399|FG001|Overall Study|Incorrect inclusion|0|||
147566560|NCT00385593|532233398|FG000|Overall Study|Incorrect randomization|0|||
147566561|NCT00385593|532233399|FG001|Overall Study|Incorrect randomization|1|||
147566562|NCT04384978|532233400|FG000|Overall Study|Withdrawal by Subject|4|||
147566563|NCT04384978|532233401|FG001|Overall Study|Withdrawal by Subject|0|||
147566564|NCT03586726|532233406|FG000|Overall Study|Withdrawal by Subject|1|||
147566565|NCT00965185|532233407|FG000|Overall Study|Lost to Follow-up|2|||
147566566|NCT00965185|532233408|FG001|Overall Study|Lost to Follow-up|0|||
147566567|NCT00965185|532233407|FG000|Overall Study|Withdrawal by Subject|0|||
147566568|NCT00965185|532233408|FG001|Overall Study|Withdrawal by Subject|1|||
147566569|NCT03197883|532233409|FG000|Overall Study|Adverse Event|1|||
147566570|NCT03197883|532233410|FG001|Overall Study|Adverse Event|1|||
147566571|NCT03197883|532233409|FG000|Overall Study|Lost to Follow-up|1|||
147566572|NCT03197883|532233410|FG001|Overall Study|Lost to Follow-up|0|||
147566573|NCT03197883|532233409|FG000|Overall Study|Protocol Violation|1|||
147566574|NCT03197883|532233410|FG001|Overall Study|Protocol Violation|0|||
147566575|NCT03197883|532233409|FG000|Overall Study|Other (Not Specified)|0|||
147566576|NCT03197883|532233410|FG001|Overall Study|Other (Not Specified)|5|||
147566577|NCT00389064|532233417|FG000|Overall Study|Adverse Event|11|||
147566578|NCT00389064|532233418|FG001|Overall Study|Adverse Event|3|||
147566579|NCT00389064|532233417|FG000|Overall Study|Lack of Efficacy|3|||
147566580|NCT00389064|532233418|FG001|Overall Study|Lack of Efficacy|14|||
147566581|NCT00389064|532233417|FG000|Overall Study|Withdrawal by Subject|17|||
147566582|NCT00389064|532233418|FG001|Overall Study|Withdrawal by Subject|27|||
147566583|NCT00389064|532233417|FG000|Overall Study|Physician Decision|2|||
147566584|NCT00389064|532233418|FG001|Overall Study|Physician Decision|2|||
147566585|NCT00389064|532233417|FG000|Overall Study|Lost to Follow-up|1|||
147566586|NCT00389064|532233418|FG001|Overall Study|Lost to Follow-up|2|||
147566587|NCT00389064|532233417|FG000|Overall Study|Protocol Violation|2|||
147566588|NCT00389064|532233418|FG001|Overall Study|Protocol Violation|0|||
147566589|NCT00389064|532233417|FG000|Overall Study|Multiple Reasons|9|||
147566590|NCT00389064|532233418|FG001|Overall Study|Multiple Reasons|11|||
147566591|NCT05275205|532233427|FG000|Overall Study|Adverse Event|1|||
147566592|NCT05275205|532233428|FG001|Overall Study|Adverse Event|2|||
147229865|NCT00611533|531015859|FG001|First Intervention (6 Weeks)|Adverse Event|1|||
147566593|NCT05275205|532233427|FG000|Overall Study|Physician Decision|1|||
147566594|NCT05275205|532233428|FG001|Overall Study|Physician Decision|1|||
147566595|NCT05275205|532233427|FG000|Overall Study|Withdrawal by Subject|2|||
147566596|NCT05275205|532233428|FG001|Overall Study|Withdrawal by Subject|3|||
147566597|NCT05275205|532233427|FG000|Overall Study|Death|1|||
147566598|NCT05275205|532233428|FG001|Overall Study|Death|0|||
147566599|NCT05275205|532233427|FG000|Overall Study|Patient unable to attend visits|1|||
147566600|NCT05275205|532233428|FG001|Overall Study|Patient unable to attend visits|0|||
147566601|NCT02963259|532233431|FG000|Overall Study|IPG Replacement not Done with Abbott Device|2|||
147566602|NCT02963259|532233431|FG000|Overall Study|Subject Participation Terminated by Investigator|1|||
147566603|NCT02963259|532233431|FG000|Overall Study|Death|1|||
147566604|NCT02963259|532233431|FG000|Overall Study|Subject Did Not Meet Inclusion/Exclusion Criteria|1|||
147566605|NCT03243630|532233433|FG000|Overall Study|Protocol Violation|1|||
147566606|NCT03243630|532233433|FG000|Overall Study|Physician Decision|1|||
147566607|NCT00939003|532233434|FG000|Double-blind Treatment Period|Adverse Event|1|||
147566608|NCT00939003|532233435|FG001|Double-blind Treatment Period|Adverse Event|1|||
147566609|NCT00939003|532233434|FG000|Double-blind Treatment Period|Lack of Efficacy|0|||
147566610|NCT00939003|532233435|FG001|Double-blind Treatment Period|Lack of Efficacy|1|||
147566611|NCT00939003|532233434|FG000|Double-blind Treatment Period|Pregnancy|0|||
147566612|NCT00939003|532233435|FG001|Double-blind Treatment Period|Pregnancy|1|||
147566613|NCT00939003|532233434|FG000|Double-blind Treatment Period|MRI Not Diagnostic|1|||
147566614|NCT00939003|532233435|FG001|Double-blind Treatment Period|MRI Not Diagnostic|1|||
147566615|NCT00939003|532233434|FG000|Open-label Treatment Period|Adverse Event|4|||
147566616|NCT00939003|532233435|FG001|Open-label Treatment Period|Adverse Event|8|||
147566617|NCT00939003|532233434|FG000|Open-label Treatment Period|Withdrawal by Subject|14|||
147566618|NCT00939003|532233435|FG001|Open-label Treatment Period|Withdrawal by Subject|7|||
147566619|NCT00939003|532233434|FG000|Open-label Treatment Period|Lack of Efficacy|6|||
147566620|NCT00939003|532233435|FG001|Open-label Treatment Period|Lack of Efficacy|9|||
147566621|NCT00939003|532233434|FG000|Open-label Treatment Period|Pregnancy|1|||
147566622|NCT00939003|532233435|FG001|Open-label Treatment Period|Pregnancy|1|||
147566623|NCT00939003|532233434|FG000|Open-label Treatment Period|Exclusion Criteria|1|||
147566624|NCT00939003|532233435|FG001|Open-label Treatment Period|Exclusion Criteria|0|||
147566625|NCT00939003|532233434|FG000|Open-label Treatment Period|Site Closure|3|||
147566626|NCT00939003|532233435|FG001|Open-label Treatment Period|Site Closure|4|||
147566627|NCT02131129|532233436|FG000|Overall Study|Withdrawal by Subject|1|||
147566628|NCT02131129|532233437|FG001|Overall Study|Withdrawal by Subject|0|||
147566629|NCT03707912|532233438|FG000|Overall Study|Violation of inclusion criteria|1|||
147566630|NCT03707912|532233439|FG001|Overall Study|Violation of inclusion criteria|0|||
147566631|NCT01313780|532233442|FG000|Overall Study|Lack of Efficacy|4|||
147566632|NCT01313780|532233443|FG001|Overall Study|Lack of Efficacy|2|||
147566633|NCT01313780|532233442|FG000|Overall Study|Adverse Event|6|||
147566634|NCT01313780|532233443|FG001|Overall Study|Adverse Event|11|||
147566635|NCT01313780|532233442|FG000|Overall Study|Withdrawal by Subject|2|||
147566636|NCT01313780|532233443|FG001|Overall Study|Withdrawal by Subject|8|||
147566637|NCT01313780|532233442|FG000|Overall Study|Protocol Violation|10|||
147566638|NCT01313780|532233443|FG001|Overall Study|Protocol Violation|4|||
147229866|NCT00611533|531015858|FG000|Second Intervention (6 Weeks)|Adverse Event|0|||
147229867|NCT00611533|531015859|FG001|Second Intervention (6 Weeks)|Adverse Event|2|||
147229868|NCT05021081|531015863|FG000|Phase 2|Subject enrolled in error|1|||
147229869|NCT05021081|531015864|FG001|Phase 2|Subject enrolled in error|1|||
147229870|NCT05021081|531015865|FG002|Phase 2|Subject enrolled in error|0|||
147229871|NCT01461980|531015871|FG000|Overall Study|Other|9|||
147229872|NCT01461980|531015872|FG001|Overall Study|Other|8|||
147229873|NCT01461980|531015873|FG002|Overall Study|Other|6|||
147229874|NCT01461980|531015871|FG000|Overall Study|Medication error|7|||
147229875|NCT01461980|531015872|FG001|Overall Study|Medication error|5|||
147229876|NCT01461980|531015873|FG002|Overall Study|Medication error|6|||
147229877|NCT01461980|531015871|FG000|Overall Study|Adverse Event|12|||
147229878|NCT01461980|531015872|FG001|Overall Study|Adverse Event|5|||
147444458|NCT01056510|531792618|FG000|Overall Study|Lost to Follow-up|5|||
147444459|NCT01056510|531792619|FG001|Overall Study|Lost to Follow-up|6|||
147566639|NCT01313780|532233442|FG000|Overall Study|missing data|3|||
147566640|NCT01313780|532233443|FG001|Overall Study|missing data|3|||
147566641|NCT05369208|532234805|FG000|Core Phase|Prohibited Medication Required|2|||
147566642|NCT05369208|532234805|FG000|Core Phase|Adverse Event|1|||
147566643|NCT05369208|532234805|FG000|Core Phase|Lack of Efficacy|1|||
147566644|NCT04934722|532234806|FG000|Overall Study|Death|4|||
147566645|NCT04934722|532234807|FG001|Overall Study|Death|3|||
147566646|NCT04934722|532234806|FG000|Overall Study|Participants Ongoing|88|||
147566647|NCT04934722|532234807|FG001|Overall Study|Participants Ongoing|91|||
147566648|NCT00371839|532234808|FG000|Overall Study|Death|4|||
147566649|NCT00371839|532234809|FG001|Overall Study|Death|0|||
147566650|NCT00371839|532234810|FG002|Overall Study|Death|0|||
147566651|NCT00371839|532234808|FG000|Overall Study|Withdrawal by Subject|7|||
147229879|NCT01461980|531015873|FG002|Overall Study|Adverse Event|6|||
147229880|NCT01461980|531015871|FG000|Overall Study|Protocol Violation|12|||
147229881|NCT01461980|531015872|FG001|Overall Study|Protocol Violation|19|||
147444460|NCT01056510|531792618|FG000|Overall Study|Other|10|||
147566652|NCT00371839|532234809|FG001|Overall Study|Withdrawal by Subject|4|||
147566653|NCT00371839|532234810|FG002|Overall Study|Withdrawal by Subject|0|||
147229882|NCT01461980|531015873|FG002|Overall Study|Protocol Violation|16|||
147229883|NCT01461980|531015871|FG000|Overall Study|No longer meets eligibility criteria|18|||
147444461|NCT01056510|531792619|FG001|Overall Study|Other|12|||
147566654|NCT00371839|532234808|FG000|Overall Study|Lost to Follow-up|6|||
147566655|NCT00371839|532234809|FG001|Overall Study|Lost to Follow-up|3|||
147566656|NCT00371839|532234810|FG002|Overall Study|Lost to Follow-up|2|||
147566657|NCT01149473|532234811|FG000|First Intervention|Adverse Event|1|||
147566658|NCT01149473|532234812|FG001|First Intervention|Adverse Event|1|||
147566659|NCT01149473|532234811|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
147566660|NCT01149473|532234812|FG001|Washout of 7 Days|Withdrawal by Subject|1|||
147566661|NCT00834249|532234816|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
147566662|NCT00834249|532234817|FG001|Washout: 7 Days|Withdrawal by Subject|1|||
147566663|NCT00834249|532234816|FG000|Second Intervention|Adverse Event|1|||
147566664|NCT00834249|532234817|FG001|Second Intervention|Adverse Event|0|||
147566665|NCT03450057|532234818|FG000|Overall Study|Death|17|||
147566666|NCT03450057|532234818|FG000|Overall Study|ICF withdrawal|4|||
147566667|NCT03450057|532234818|FG000|Overall Study|Lost to Follow-up|2|||
147566668|NCT05755282|532234819|FG000|Overall Study|Protocol Violation|0|||
147566669|NCT05755282|532234820|FG001|Overall Study|Protocol Violation|1|||
147566670|NCT00573066|532234821|FG000|Overall Study|Exclusion criteria|18|||
147566671|NCT00573066|532234821|FG000|Overall Study|IV malfunction|1|||
147566672|NCT00573066|532234821|FG000|Overall Study|Postoperative bleeding|1|||
147566673|NCT01015703|532234822|FG000|Overall Study|Withdrawal by Subject|0|||
147566674|NCT01015703|532234823|FG001|Overall Study|Withdrawal by Subject|1|||
147566675|NCT01015703|532234824|FG002|Overall Study|Withdrawal by Subject|0|||
147566676|NCT01015703|532234825|FG003|Overall Study|Withdrawal by Subject|0|||
147566677|NCT01015703|532234826|FG004|Overall Study|Withdrawal by Subject|0|||
147566678|NCT01015703|532234822|FG000|Overall Study|Adverse Event|1|||
147566679|NCT01015703|532234823|FG001|Overall Study|Adverse Event|0|||
147566680|NCT01015703|532234824|FG002|Overall Study|Adverse Event|0|||
147566681|NCT01015703|532234825|FG003|Overall Study|Adverse Event|0|||
147566682|NCT01015703|532234826|FG004|Overall Study|Adverse Event|0|||
147566683|NCT01015703|532234822|FG000|Overall Study|Protocol Violation|1|||
147566684|NCT01015703|532234823|FG001|Overall Study|Protocol Violation|0|||
147117798|NCT01243424|530596426|FG000|Discontinuation From Treatment|Not treated|5|||
147117799|NCT01243424|530596427|FG001|Discontinuation From Treatment|Not treated|4|||
147117800|NCT01243424|530596426|FG000|Discontinuation From Treatment|Adverse Event|457|||
147117801|NCT01243424|530596427|FG001|Discontinuation From Treatment|Adverse Event|523|||
147566685|NCT01015703|532234824|FG002|Overall Study|Protocol Violation|0|||
147566686|NCT01015703|532234825|FG003|Overall Study|Protocol Violation|0|||
147566687|NCT01015703|532234826|FG004|Overall Study|Protocol Violation|0|||
147566688|NCT01693523|532234827|FG000|Overall Study|Adverse Event|2|||
147566689|NCT01693523|532234828|FG001|Overall Study|Adverse Event|1|||
147566690|NCT01693523|532234829|FG002|Overall Study|Adverse Event|0|||
147566691|NCT01693523|532234827|FG000|Overall Study|Death|0|||
147566692|NCT01693523|532234828|FG001|Overall Study|Death|1|||
147566693|NCT01693523|532234829|FG002|Overall Study|Death|1|||
147566694|NCT01693523|532234827|FG000|Overall Study|Lost to Follow-up|0|||
147566695|NCT01693523|532234828|FG001|Overall Study|Lost to Follow-up|0|||
147566696|NCT01693523|532234829|FG002|Overall Study|Lost to Follow-up|4|||
147566697|NCT01693523|532234827|FG000|Overall Study|Physician Decision|0|||
147566698|NCT01693523|532234828|FG001|Overall Study|Physician Decision|0|||
147566699|NCT01693523|532234829|FG002|Overall Study|Physician Decision|1|||
147566700|NCT01693523|532234827|FG000|Overall Study|Withdrawal by Subject|1|||
147566701|NCT01693523|532234828|FG001|Overall Study|Withdrawal by Subject|2|||
147566702|NCT01693523|532234829|FG002|Overall Study|Withdrawal by Subject|2|||
147566703|NCT01693523|532234827|FG000|Overall Study|Lack of compliance study medication|1|||
147566704|NCT01693523|532234828|FG001|Overall Study|Lack of compliance study medication|2|||
147566705|NCT01693523|532234829|FG002|Overall Study|Lack of compliance study medication|0|||
147566706|NCT01693523|532234827|FG000|Overall Study|Chemotherapy was held|1|||
147566707|NCT01693523|532234828|FG001|Overall Study|Chemotherapy was held|2|||
147566708|NCT01693523|532234829|FG002|Overall Study|Chemotherapy was held|0|||
147566709|NCT00834418|532234830|FG000|Overall Study|Adverse Event|0|||
147566710|NCT00834418|532234831|FG001|Overall Study|Adverse Event|2|||
147566711|NCT02331394|532234833|FG000|Overall Study|Disease progression|1|||
147566712|NCT02098876|532234836|FG000|Overall Study|Withdrawal by Subject|5|||
147566713|NCT02098876|532234837|FG001|Overall Study|Withdrawal by Subject|5|||
147566714|NCT01602419|532234840|FG000|Overall Study|Not treated with Wilate|9|||
147566715|NCT01602419|532234840|FG000|Overall Study|Adverse Drug Reaction|4|||
147117802|NCT01243424|530596426|FG000|Discontinuation From Treatment|Lack of Efficacy|61|||
147117803|NCT01243424|530596427|FG001|Discontinuation From Treatment|Lack of Efficacy|41|||
147117804|NCT01243424|530596426|FG000|Discontinuation From Treatment|Protocol Violation|46|||
147117805|NCT01243424|530596427|FG001|Discontinuation From Treatment|Protocol Violation|47|||
147117806|NCT01243424|530596426|FG000|Discontinuation From Treatment|Lost to Follow-up|24|||
147117807|NCT01243424|530596427|FG001|Discontinuation From Treatment|Lost to Follow-up|28|||
147117808|NCT01243424|530596426|FG000|Discontinuation From Treatment|Withdrawal by Subject|309|||
147117809|NCT01243424|530596427|FG001|Discontinuation From Treatment|Withdrawal by Subject|328|||
147117810|NCT01243424|530596426|FG000|Discontinuation From Treatment|Other than listed above|230|||
147117811|NCT01243424|530596427|FG001|Discontinuation From Treatment|Other than listed above|211|||
147117812|NCT01160744|530596436|FG000|Overall Study|Withdrawal by Subject|11|||
147117813|NCT01160744|530596437|FG001|Overall Study|Withdrawal by Subject|5|||
147117814|NCT01160744|530596438|FG002|Overall Study|Withdrawal by Subject|6|||
147117815|NCT01160744|530596439|FG003|Overall Study|Withdrawal by Subject|4|||
147117816|NCT01160744|530596436|FG000|Overall Study|Not meet inclusion/exclusion criteria|0|||
147117817|NCT01160744|530596437|FG001|Overall Study|Not meet inclusion/exclusion criteria|0|||
147117818|NCT01160744|530596438|FG002|Overall Study|Not meet inclusion/exclusion criteria|1|||
147117819|NCT01160744|530596439|FG003|Overall Study|Not meet inclusion/exclusion criteria|0|||
147117820|NCT00500110|530596442|FG000|Overall Study|Withdrawal by Subject|3|||
147117821|NCT02421510|530596451|FG000|Overall Study|Other|4|||
147117822|NCT02421510|530596452|FG001|Overall Study|Other|2|||
147117823|NCT02421510|530596453|FG002|Overall Study|Other|3|||
147117824|NCT02421510|530596451|FG000|Overall Study|Protocol Violation|1|||
147117825|NCT02421510|530596452|FG001|Overall Study|Protocol Violation|2|||
147117826|NCT02421510|530596453|FG002|Overall Study|Protocol Violation|0|||
147117827|NCT02421510|530596451|FG000|Overall Study|Death|1|||
147117828|NCT02421510|530596452|FG001|Overall Study|Death|0|||
147117829|NCT02421510|530596453|FG002|Overall Study|Death|0|||
147117830|NCT02421510|530596451|FG000|Overall Study|Noncompliance with study drug|1|||
147117831|NCT02421510|530596452|FG001|Overall Study|Noncompliance with study drug|0|||
147117832|NCT02421510|530596453|FG002|Overall Study|Noncompliance with study drug|0|||
147117833|NCT02421510|530596451|FG000|Overall Study|Physician Decision|1|||
147117834|NCT02421510|530596452|FG001|Overall Study|Physician Decision|1|||
147117835|NCT02421510|530596453|FG002|Overall Study|Physician Decision|3|||
147117836|NCT02421510|530596451|FG000|Overall Study|Adverse Event|9|||
147117837|NCT02421510|530596452|FG001|Overall Study|Adverse Event|10|||
147117838|NCT02421510|530596453|FG002|Overall Study|Adverse Event|18|||
147117839|NCT02421510|530596451|FG000|Overall Study|Pregnancy|1|||
147117840|NCT02421510|530596452|FG001|Overall Study|Pregnancy|1|||
147117841|NCT02421510|530596453|FG002|Overall Study|Pregnancy|0|||
147117842|NCT02421510|530596451|FG000|Overall Study|Withdrawal by Subject|14|||
147117843|NCT02421510|530596452|FG001|Overall Study|Withdrawal by Subject|18|||
147117844|NCT02421510|530596453|FG002|Overall Study|Withdrawal by Subject|12|||
147117845|NCT02421510|530596451|FG000|Overall Study|Lost to Follow-up|1|||
147117846|NCT02421510|530596452|FG001|Overall Study|Lost to Follow-up|1|||
147117847|NCT02421510|530596453|FG002|Overall Study|Lost to Follow-up|0|||
147117848|NCT02852434|530596454|FG000|Overall Study|Withdrawal by Subject|0|||
147117849|NCT02852434|530596455|FG001|Overall Study|Withdrawal by Subject|1|||
147117850|NCT02852434|530596454|FG000|Overall Study|Unsuccessful Dilator Procedure|2|||
147117851|NCT02852434|530596455|FG001|Overall Study|Unsuccessful Dilator Procedure|0|||
147117852|NCT01717859|530596463|FG000|Overall Study|Adverse Event|5|||
147117853|NCT01717859|530596463|FG000|Overall Study|Moved out of state|1|||
147117854|NCT01717859|530596463|FG000|Overall Study|Patient concerned about mental health|1|||
147117855|NCT01717859|530596463|FG000|Overall Study|Lost to Follow-up|1|||
147117856|NCT01717859|530596463|FG000|Overall Study|Withdrawal by Subject|2|||
147117857|NCT01755637|530596464|FG000|Period 1|Adverse Event|0|||
147117858|NCT01755637|530596465|FG001|Period 1|Adverse Event|1|||
147117859|NCT04389671|530596466|FG000|Overall Study|Death|7|||
147117860|NCT00899847|530596467|FG000|Overall Study|Lack of suitable allogeneic donor|2|||
147117861|NCT02287025|530596468|FG000|Overall Study|Not treated|2|||
147117862|NCT02287025|530596469|FG001|Overall Study|Not treated|0|||
147117863|NCT02287025|530596468|FG000|Overall Study|Progression of disease|3|||
147117864|NCT02287025|530596469|FG001|Overall Study|Progression of disease|2|||
147117865|NCT02287025|530596468|FG000|Overall Study|Adverse Event|2|||
147117866|NCT02287025|530596469|FG001|Overall Study|Adverse Event|4|||
147117867|NCT02287025|530596468|FG000|Overall Study|Withdrawal by Subject|2|||
147117868|NCT02287025|530596469|FG001|Overall Study|Withdrawal by Subject|2|||
147117869|NCT02287025|530596468|FG000|Overall Study|Screening failed|1|||
147117870|NCT02287025|530596469|FG001|Overall Study|Screening failed|1|||
147117871|NCT04053452|530596470|FG000|Overall Study|Withdrawal by Subject|1|||
147117872|NCT04053452|530596471|FG001|Overall Study|Withdrawal by Subject|0|||
147117873|NCT04053452|530596470|FG000|Overall Study|Time restraint due to inpatient needs|1|||
147117874|NCT04053452|530596471|FG001|Overall Study|Time restraint due to inpatient needs|2|||
147117875|NCT01421134|530596472|FG000|Overall Study|Adverse Event|3|||
147229884|NCT01461980|531015872|FG001|Overall Study|No longer meets eligibility criteria|9|||
147229885|NCT01461980|531015873|FG002|Overall Study|No longer meets eligibility criteria|19|||
147229886|NCT01461980|531015871|FG000|Overall Study|Lost to Follow-up|52|||
147229887|NCT01461980|531015872|FG001|Overall Study|Lost to Follow-up|53|||
147117876|NCT01421134|530596473|FG001|Overall Study|Adverse Event|5|||
147229888|NCT01461980|531015873|FG002|Overall Study|Lost to Follow-up|51|||
147117877|NCT01421134|530596472|FG000|Overall Study|Lack of Efficacy|2|||
147117878|NCT01421134|530596473|FG001|Overall Study|Lack of Efficacy|4|||
147117879|NCT01421134|530596472|FG000|Overall Study|Protocol Violation|0|||
147117880|NCT01421134|530596473|FG001|Overall Study|Protocol Violation|3|||
147117881|NCT01421134|530596472|FG000|Overall Study|Withdrawal by Subject|1|||
147117882|NCT01421134|530596473|FG001|Overall Study|Withdrawal by Subject|1|||
147117883|NCT01421134|530596472|FG000|Overall Study|Administrative|0|||
147117884|NCT01421134|530596473|FG001|Overall Study|Administrative|1|||
147229889|NCT01461980|531015871|FG000|Overall Study|No longer willing to participate|52|||
147117885|NCT01421134|530596472|FG000|Overall Study|Lost to Follow-up|1|||
147117886|NCT01421134|530596473|FG001|Overall Study|Lost to Follow-up|1|||
147117887|NCT02959892|530596474|FG000|Overall Study|PET tracer synthesis failure|1|||
147117888|NCT02959892|530596475|FG001|Overall Study|PET tracer synthesis failure|0|||
147117889|NCT02959892|530596474|FG000|Overall Study|Study termination|0|||
147117890|NCT02959892|530596475|FG001|Overall Study|Study termination|1|||
147117891|NCT03338023|530596476|FG000|Overall Study|Withdrawal by Subject|3|||
147117892|NCT03338023|530596477|FG001|Overall Study|Withdrawal by Subject|4|||
147117893|NCT03338023|530596476|FG000|Overall Study|Protocol Violation|3|||
147117894|NCT03338023|530596477|FG001|Overall Study|Protocol Violation|3|||
147117895|NCT03338023|530596476|FG000|Overall Study|Lost to Follow-up|2|||
147117896|NCT03338023|530596477|FG001|Overall Study|Lost to Follow-up|1|||
147117897|NCT03338023|530596476|FG000|Overall Study|Physician Decision|1|||
147117898|NCT03338023|530596477|FG001|Overall Study|Physician Decision|2|||
147117899|NCT03528577|530596478|FG000|Sequence 1|Failed Spirometry|1|||
147117900|NCT03528577|530596478|FG000|Sequence 1|Restricted medication|1|||
147117901|NCT03528577|530596478|FG000|Sequence 2|Adverse Event|1|||
147117902|NCT03528577|530596478|FG000|Sequence 2|Withdrawal by Subject|1|||
147117903|NCT03528577|530596478|FG000|Sequence 2|Failed Spirometry|1|||
147117904|NCT03528577|530596478|FG000|Sequence 3|Failed Spirometry|1|||
147117905|NCT03528577|530596478|FG000|Sequence 4|Failed Spirometry|2|||
147117906|NCT03528577|530596478|FG000|Sequence 4|Adverse Event|1|||
147117907|NCT04882215|530596479|FG000|Overall Study|Withdrawal by Subject|5|||
147117908|NCT04882215|530596480|FG001|Overall Study|Withdrawal by Subject|0|||
147117909|NCT04098302|530596483|FG000|Wk 1-12 Phase 1 Dutasteride or Placebo|Withdrawal by Subject|3|||
147117910|NCT04098302|530596484|FG001|Wk 1-12 Phase 1 Dutasteride or Placebo|Withdrawal by Subject|11|||
147117911|NCT04098302|530596485|FG002|Wk 1-12 Phase 1 Dutasteride or Placebo|Withdrawal by Subject|0|||
147117912|NCT04098302|530596486|FG003|Wk 1-12 Phase 1 Dutasteride or Placebo|Withdrawal by Subject|0|||
147117913|NCT04098302|530596483|FG000|Wk 1-12 Phase 1 Dutasteride or Placebo|Lost to Follow-up|5|||
147117914|NCT04098302|530596484|FG001|Wk 1-12 Phase 1 Dutasteride or Placebo|Lost to Follow-up|0|||
147117915|NCT04098302|530596485|FG002|Wk 1-12 Phase 1 Dutasteride or Placebo|Lost to Follow-up|0|||
147117916|NCT04098302|530596486|FG003|Wk 1-12 Phase 1 Dutasteride or Placebo|Lost to Follow-up|0|||
147117917|NCT04098302|530596483|FG000|Wk 1-12 Phase 1 Dutasteride or Placebo|Lack of Efficacy|2|||
147117918|NCT04098302|530596484|FG001|Wk 1-12 Phase 1 Dutasteride or Placebo|Lack of Efficacy|3|||
147117919|NCT04098302|530596485|FG002|Wk 1-12 Phase 1 Dutasteride or Placebo|Lack of Efficacy|0|||
147117920|NCT04098302|530596486|FG003|Wk 1-12 Phase 1 Dutasteride or Placebo|Lack of Efficacy|0|||
147117921|NCT04098302|530596483|FG000|Wk 13-24 for Phase 1 Non-responders|Lost to Follow-up|0|||
147117922|NCT04098302|530596484|FG001|Wk 13-24 for Phase 1 Non-responders|Lost to Follow-up|0|||
147117923|NCT04098302|530596485|FG002|Wk 13-24 for Phase 1 Non-responders|Lost to Follow-up|3|||
147117924|NCT04098302|530596486|FG003|Wk 13-24 for Phase 1 Non-responders|Lost to Follow-up|3|||
147117925|NCT04098302|530596483|FG000|Wk 13-24 for Phase 1 Non-responders|Adverse Event|0|||
147117926|NCT04098302|530596484|FG001|Wk 13-24 for Phase 1 Non-responders|Adverse Event|0|||
147117927|NCT04098302|530596485|FG002|Wk 13-24 for Phase 1 Non-responders|Adverse Event|1|||
147117928|NCT04098302|530596486|FG003|Wk 13-24 for Phase 1 Non-responders|Adverse Event|1|||
147117929|NCT04098302|530596483|FG000|Wk 13-24 for Phase 1 Non-responders|Lack of Efficacy|0|||
147117930|NCT04098302|530596484|FG001|Wk 13-24 for Phase 1 Non-responders|Lack of Efficacy|0|||
147117931|NCT04098302|530596485|FG002|Wk 13-24 for Phase 1 Non-responders|Lack of Efficacy|0|||
147117932|NCT04098302|530596486|FG003|Wk 13-24 for Phase 1 Non-responders|Lack of Efficacy|1|||
147117933|NCT04098302|530596483|FG000|Wk 13-24 for Phase 1 Non-responders|Withdrawal by Subject|0|||
147117934|NCT04098302|530596484|FG001|Wk 13-24 for Phase 1 Non-responders|Withdrawal by Subject|0|||
147117935|NCT04098302|530596485|FG002|Wk 13-24 for Phase 1 Non-responders|Withdrawal by Subject|1|||
147117936|NCT04098302|530596486|FG003|Wk 13-24 for Phase 1 Non-responders|Withdrawal by Subject|0|||
147117937|NCT04098302|530596483|FG000|Wk 13-24 for Phase 1 Non-responders|Protocol Violation|0|||
147117938|NCT04098302|530596484|FG001|Wk 13-24 for Phase 1 Non-responders|Protocol Violation|0|||
147117939|NCT04098302|530596485|FG002|Wk 13-24 for Phase 1 Non-responders|Protocol Violation|0|||
147117940|NCT04098302|530596486|FG003|Wk 13-24 for Phase 1 Non-responders|Protocol Violation|1|||
147117941|NCT05061706|530596489|FG000|Overall Study|Adverse Event|29|||
147117942|NCT05061706|530596490|FG001|Overall Study|Adverse Event|1|||
147117943|NCT05061706|530596489|FG000|Overall Study|Lack of Efficacy|0|||
147117944|NCT05061706|530596490|FG001|Overall Study|Lack of Efficacy|1|||
147117945|NCT05061706|530596489|FG000|Overall Study|Lost to Follow-up|2|||
147117946|NCT05061706|530596490|FG001|Overall Study|Lost to Follow-up|2|||
147117947|NCT05061706|530596489|FG000|Overall Study|Protocol Violation|3|||
147117948|NCT05061706|530596490|FG001|Overall Study|Protocol Violation|1|||
147117949|NCT05061706|530596489|FG000|Overall Study|Withdrawal by Subject|3|||
147117950|NCT05061706|530596490|FG001|Overall Study|Withdrawal by Subject|9|||
147117951|NCT00724893|530596491|FG000|Overall Study|Adverse Event|76|||
147229890|NCT01461980|531015872|FG001|Overall Study|No longer willing to participate|38|||
147229891|NCT01461980|531015873|FG002|Overall Study|No longer willing to participate|54|||
147229892|NCT01461980|531015871|FG000|Overall Study|Randomized but not vaccinated|4|||
147117952|NCT00724893|530596492|FG001|Overall Study|Adverse Event|142|||
147117953|NCT00724893|530596491|FG000|Overall Study|Withdrawal by Subject|0|||
147117954|NCT00724893|530596492|FG001|Overall Study|Withdrawal by Subject|1|||
147117955|NCT00724893|530596491|FG000|Overall Study|Lack of virologic response|94|||
147566716|NCT01602419|532234840|FG000|Overall Study|Insurance issues|3|||
147566717|NCT01602419|532234840|FG000|Overall Study|Changed treatment centre|1|||
147566718|NCT01602419|532234840|FG000|Overall Study|Treatment centre closed|1|||
147566719|NCT01602419|532234840|FG000|Overall Study|Withdrawal by Subject|5|||
147117956|NCT00724893|530596492|FG001|Overall Study|Lack of virologic response|202|||
147117957|NCT00724893|530596491|FG000|Overall Study|Reason not specified|193|||
147117958|NCT00724893|530596492|FG001|Overall Study|Reason not specified|7|||
147117959|NCT00724893|530596491|FG000|Overall Study|Patient choice|0|||
147117960|NCT00724893|530596492|FG001|Overall Study|Patient choice|26|||
147117961|NCT00724893|530596491|FG000|Overall Study|Geographic reasons|0|||
147117962|NCT00724893|530596492|FG001|Overall Study|Geographic reasons|11|||
147117963|NCT00724893|530596491|FG000|Overall Study|Incarceration|0|||
147117964|NCT00724893|530596492|FG001|Overall Study|Incarceration|9|||
147117965|NCT00724893|530596491|FG000|Overall Study|Substance abuse|0|||
147117966|NCT00724893|530596492|FG001|Overall Study|Substance abuse|3|||
147117967|NCT00724893|530596491|FG000|Overall Study|Financial reasons|0|||
147117968|NCT00724893|530596492|FG001|Overall Study|Financial reasons|2|||
147312636|NCT00309608|531310808|FG000|Overall Study|Other incl. Lack of efficacy|10|||
147312637|NCT00309608|531310809|FG001|Overall Study|Other incl. Lack of efficacy|4|||
147312638|NCT00309608|531310810|FG002|Overall Study|Other incl. Lack of efficacy|3|||
147312639|NCT00309608|531310811|FG003|Overall Study|Other incl. Lack of efficacy|4|||
147312640|NCT00309608|531310812|FG004|Overall Study|Other incl. Lack of efficacy|0|||
147312641|NCT00127413|531310813|FG000|Overall Study|Lost to Follow-up|6|||
147312642|NCT00127413|531310814|FG001|Overall Study|Lost to Follow-up|4|||
147312643|NCT00127413|531310815|FG002|Overall Study|Lost to Follow-up|8|||
147312644|NCT00127413|531310816|FG003|Overall Study|Lost to Follow-up|2|||
147312645|NCT01051063|531310817|FG000|Overall Study|Death|2|||
147312646|NCT01051063|531310818|FG001|Overall Study|Death|2|||
147312647|NCT01051063|531310817|FG000|Overall Study|Withdrawal by Subject|1|||
147117969|NCT00724893|530596491|FG000|Overall Study|Assigned shorter treatment|0|||
147117970|NCT00724893|530596492|FG001|Overall Study|Assigned shorter treatment|2|||
147117971|NCT00724893|530596491|FG000|Overall Study|Lost to Follow-up|0|||
147117972|NCT00724893|530596492|FG001|Overall Study|Lost to Follow-up|52|||
147117973|NCT00724893|530596491|FG000|Overall Study|Unknown, missing data|1|||
147117974|NCT00724893|530596492|FG001|Overall Study|Unknown, missing data|1|||
147117975|NCT01279200|530596495|FG000|Overall Study|Withdrawal by Subject|1|||
147117976|NCT01279200|530596496|FG001|Overall Study|Withdrawal by Subject|3|||
147117977|NCT01279200|530596495|FG000|Overall Study|Patient withdrawal due to high cost|0|||
147117978|NCT01279200|530596496|FG001|Overall Study|Patient withdrawal due to high cost|1|||
147117979|NCT01279200|530596495|FG000|Overall Study|Inconvenience of ultrasound visit|0|||
147312648|NCT01051063|531310818|FG001|Overall Study|Withdrawal by Subject|1|||
147312649|NCT01051063|531310817|FG000|Overall Study|Termination of the study|5|||
147312650|NCT01051063|531310818|FG001|Overall Study|Termination of the study|0|||
147312651|NCT01051063|531310817|FG000|Overall Study|Moved from the study site area|1|||
147312652|NCT01051063|531310818|FG001|Overall Study|Moved from the study site area|0|||
147312653|NCT01051063|531310817|FG000|Overall Study|Other|1|||
147566720|NCT01602419|532234840|FG000|Overall Study|Lost to Follow-up|6|||
147566721|NCT01792635|532234841|FG000|Part B|Adverse Event|0|||
147566722|NCT01792635|532234842|FG001|Part B|Adverse Event|0|||
147566723|NCT01792635|532234843|FG002|Part B|Adverse Event|1|||
147566724|NCT01792635|532234841|FG000|Part B|Study terminated|0|||
147566725|NCT01792635|532234842|FG001|Part B|Study terminated|4|||
147566726|NCT01792635|532234843|FG002|Part B|Study terminated|3|||
147566727|NCT02714062|532234847|FG000|Overall Study|Adverse Event|0|||
147566728|NCT02714062|532234848|FG001|Overall Study|Adverse Event|0|||
147566729|NCT02714062|532234849|FG002|Overall Study|Adverse Event|2|||
147566730|NCT02714062|532234847|FG000|Overall Study|Withdrawal by Subject|1|||
147566731|NCT02714062|532234848|FG001|Overall Study|Withdrawal by Subject|0|||
147566732|NCT02714062|532234849|FG002|Overall Study|Withdrawal by Subject|1|||
147566733|NCT02714062|532234847|FG000|Overall Study|Protocol Violation|0|||
147566734|NCT02714062|532234848|FG001|Overall Study|Protocol Violation|1|||
147117980|NCT01279200|530596496|FG001|Overall Study|Inconvenience of ultrasound visit|1|||
147117981|NCT01279200|530596495|FG000|Overall Study|ultrasound screening failure|0|||
147444462|NCT01056510|531792618|FG000|Overall Study|Missing|0|||
147566735|NCT02714062|532234849|FG002|Overall Study|Protocol Violation|0|||
147566736|NCT03956862|532234850|FG000|Overall Study|Lost to Follow-up|1|||
147117982|NCT01279200|530596496|FG001|Overall Study|ultrasound screening failure|1|||
147117983|NCT01279200|530596495|FG000|Overall Study|Lost to Follow-up|0|||
147117984|NCT01279200|530596496|FG001|Overall Study|Lost to Follow-up|1|||
147117985|NCT01279200|530596495|FG000|Overall Study|Adverse Event|1|||
147312654|NCT01051063|531310818|FG001|Overall Study|Other|0|||
147312655|NCT01051063|531310817|FG000|Overall Study|Lost to Follow-up|0|||
147444463|NCT01056510|531792619|FG001|Overall Study|Missing|1|||
147312656|NCT01051063|531310818|FG001|Overall Study|Lost to Follow-up|1|||
147312657|NCT04213989|531312237|FG000|Overall Study|Withdrawal by Subject|3|||
147566737|NCT03956862|532234851|FG001|Overall Study|Lost to Follow-up|1|||
147566738|NCT03956862|532234850|FG000|Overall Study|Withdrawal by Subject|1|||
147566739|NCT03956862|532234851|FG001|Overall Study|Withdrawal by Subject|1|||
147117986|NCT01279200|530596496|FG001|Overall Study|Adverse Event|0|||
147117987|NCT05064800|530596498|FG000|Period 3|Withdrawal by Subject|0|||
147117988|NCT05064800|530596499|FG001|Period 3|Withdrawal by Subject|0|||
147117989|NCT05064800|530596500|FG002|Period 3|Withdrawal by Subject|0|||
147117990|NCT05064800|530596501|FG003|Period 3|Withdrawal by Subject|0|||
147117991|NCT05064800|530596502|FG004|Period 3|Withdrawal by Subject|1|||
147117992|NCT05064800|530596503|FG005|Period 3|Withdrawal by Subject|0|||
147117993|NCT00629239|530596504|FG000|Overall Study|Adverse Event|7|||
147117994|NCT00629239|530596505|FG001|Overall Study|Adverse Event|4|||
147117995|NCT00629239|530596504|FG000|Overall Study|Physician Decision|1|||
147312658|NCT04213989|531312238|FG001|Overall Study|Withdrawal by Subject|2|||
147312659|NCT04213989|531312237|FG000|Overall Study|Physician Decision|1|||
147117996|NCT00629239|530596505|FG001|Overall Study|Physician Decision|0|||
147117997|NCT01181128|530596506|FG000|Overall Study|Withdrawal by Subject|2|||
147117998|NCT01181128|530596507|FG001|Overall Study|Withdrawal by Subject|2|||
147117999|NCT01181128|530596508|FG002|Overall Study|Withdrawal by Subject|0|||
147118000|NCT01181128|530596506|FG000|Overall Study|Death|1|||
147312660|NCT04213989|531312238|FG001|Overall Study|Physician Decision|0|||
147312661|NCT04213989|531312237|FG000|Overall Study|Lost to Follow-up|0|||
147312662|NCT04213989|531312238|FG001|Overall Study|Lost to Follow-up|4|||
147312663|NCT03390036|531312241|FG000|Overall Study|Lost to Follow-up|1|||
147312664|NCT03390036|531312242|FG001|Overall Study|Lost to Follow-up|0|||
147312665|NCT03390036|531312243|FG002|Overall Study|Lost to Follow-up|0|||
147312666|NCT03390036|531312241|FG000|Overall Study|Lack of Efficacy|1|||
147312667|NCT03390036|531312242|FG001|Overall Study|Lack of Efficacy|0|||
147312668|NCT03390036|531312243|FG002|Overall Study|Lack of Efficacy|0|||
147312669|NCT00744237|531312246|FG000|Overall Study|Lack of Efficacy|1|||
147312670|NCT00744237|531312247|FG001|Overall Study|Lack of Efficacy|1|||
147312671|NCT00744237|531312248|FG002|Overall Study|Lack of Efficacy|0|||
147312672|NCT00744237|531312246|FG000|Overall Study|Withdrawal by Subject|9|||
147312673|NCT00744237|531312247|FG001|Overall Study|Withdrawal by Subject|5|||
147312674|NCT00744237|531312248|FG002|Overall Study|Withdrawal by Subject|3|||
147312675|NCT00744237|531312246|FG000|Overall Study|Lost to Follow-up|1|||
147312676|NCT00744237|531312247|FG001|Overall Study|Lost to Follow-up|1|||
147312677|NCT00744237|531312248|FG002|Overall Study|Lost to Follow-up|1|||
147312678|NCT00744237|531312246|FG000|Overall Study|Protocol Violation|3|||
147312679|NCT00744237|531312247|FG001|Overall Study|Protocol Violation|4|||
147312680|NCT00744237|531312248|FG002|Overall Study|Protocol Violation|3|||
147312681|NCT00744237|531312246|FG000|Overall Study|Inclusion/Exclusion criteria not met|1|||
147312682|NCT00744237|531312247|FG001|Overall Study|Inclusion/Exclusion criteria not met|0|||
147312683|NCT00744237|531312248|FG002|Overall Study|Inclusion/Exclusion criteria not met|0|||
147312684|NCT00744237|531312246|FG000|Overall Study|Dosing Error|1|||
147312685|NCT00744237|531312247|FG001|Overall Study|Dosing Error|0|||
147312686|NCT00744237|531312248|FG002|Overall Study|Dosing Error|1|||
147312687|NCT00744237|531312246|FG000|Overall Study|Study Drug Error|1|||
147312688|NCT00744237|531312247|FG001|Overall Study|Study Drug Error|0|||
147312689|NCT00744237|531312248|FG002|Overall Study|Study Drug Error|0|||
147312690|NCT00744237|531312246|FG000|Overall Study|Prohibited Concomitant Medication|0|||
147312691|NCT00744237|531312247|FG001|Overall Study|Prohibited Concomitant Medication|0|||
147566740|NCT00850174|532234852|FG000|Washout: One Week|Withdrawal by Subject|0|||
147566741|NCT00850174|532234853|FG001|Washout: One Week|Withdrawal by Subject|2|||
147566742|NCT00850174|532234852|FG000|Second Intervention|Withdrawal by Subject|1|||
147566743|NCT00850174|532234853|FG001|Second Intervention|Withdrawal by Subject|0|||
147566744|NCT02682784|532234863|FG000|Overall Study|Withdrawal by Subject|0|||
147566745|NCT02682784|532234864|FG001|Overall Study|Withdrawal by Subject|2|||
147566746|NCT02682784|532234865|FG002|Overall Study|Withdrawal by Subject|1|||
147566747|NCT02682784|532234866|FG003|Overall Study|Withdrawal by Subject|2|||
147566748|NCT02682784|532234863|FG000|Overall Study|Physician Decision|1|||
147566749|NCT02682784|532234864|FG001|Overall Study|Physician Decision|0|||
147118001|NCT01181128|530596507|FG001|Overall Study|Death|0|||
147312692|NCT00744237|531312248|FG002|Overall Study|Prohibited Concomitant Medication|1|||
147312693|NCT00744237|531312246|FG000|Overall Study|Poor Compliance|0|||
147118002|NCT01181128|530596508|FG002|Overall Study|Death|0|||
147312694|NCT00744237|531312247|FG001|Overall Study|Poor Compliance|2|||
147312695|NCT00744237|531312248|FG002|Overall Study|Poor Compliance|0|||
147312696|NCT00744237|531312246|FG000|Overall Study|Administrative. Site Closed|1|||
147312697|NCT00744237|531312247|FG001|Overall Study|Administrative. Site Closed|1|||
147312698|NCT00744237|531312248|FG002|Overall Study|Administrative. Site Closed|1|||
147312699|NCT00744237|531312246|FG000|Overall Study|Adverse Event|9|||
147312700|NCT00744237|531312247|FG001|Overall Study|Adverse Event|13|||
147312701|NCT00744237|531312248|FG002|Overall Study|Adverse Event|5|||
147118003|NCT01181128|530596506|FG000|Overall Study|Physician Decision|2|||
147118004|NCT01181128|530596507|FG001|Overall Study|Physician Decision|0|||
147118005|NCT01181128|530596508|FG002|Overall Study|Physician Decision|0|||
147118006|NCT01181128|530596506|FG000|Overall Study|Adverse Event|0|||
147312702|NCT01984424|531312249|FG000|Overall Study|Withdrawal by Subject|3|||
147566750|NCT02682784|532234865|FG002|Overall Study|Physician Decision|1|||
147566751|NCT02682784|532234866|FG003|Overall Study|Physician Decision|1|||
147566752|NCT01702987|532234867|FG000|Overall Study|Withdrawal by Subject|1|||
147312703|NCT01984424|531312250|FG001|Overall Study|Withdrawal by Subject|5|||
147312704|NCT01984424|531312249|FG000|Overall Study|Sponsor Decision|0|||
147312705|NCT01984424|531312250|FG001|Overall Study|Sponsor Decision|1|||
147312706|NCT01984424|531312249|FG000|Overall Study|Lost to Follow-up|0|||
147312707|NCT01984424|531312250|FG001|Overall Study|Lost to Follow-up|1|||
147312708|NCT01807221|531312251|FG000|Overall Study|Progressive disease|1|||
147312709|NCT01807221|531312252|FG001|Overall Study|Progressive disease|0|||
147312710|NCT01807221|531312253|FG002|Overall Study|Progressive disease|1|||
147312711|NCT01807221|531312254|FG003|Overall Study|Progressive disease|0|||
147312712|NCT01807221|531312255|FG004|Overall Study|Progressive disease|0|||
147312713|NCT01807221|531312256|FG005|Overall Study|Progressive disease|0|||
147312714|NCT01807221|531312251|FG000|Overall Study|Death|7|||
147312715|NCT01807221|531312252|FG001|Overall Study|Death|9|||
147312716|NCT01807221|531312253|FG002|Overall Study|Death|4|||
147312717|NCT01807221|531312254|FG003|Overall Study|Death|2|||
147118007|NCT01181128|530596507|FG001|Overall Study|Adverse Event|2|||
147118008|NCT01181128|530596508|FG002|Overall Study|Adverse Event|0|||
147118009|NCT01181128|530596506|FG000|Overall Study|Other|1|||
147118010|NCT01181128|530596507|FG001|Overall Study|Other|1|||
147118011|NCT01181128|530596508|FG002|Overall Study|Other|1|||
147118012|NCT01851369|530596511|FG000|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
147118013|NCT01851369|530596512|FG001|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
147118014|NCT01851369|530596513|FG002|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
147118015|NCT01851369|530596514|FG003|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
147118016|NCT01851369|530596515|FG004|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
147118017|NCT01851369|530596516|FG005|Phase I Dose Escalation|Declined to participate (before treatment started)|1|||
147118018|NCT01851369|530596517|FG006|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
147118019|NCT01851369|530596518|FG007|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
147118020|NCT01851369|530596519|FG008|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
147118021|NCT01851369|530596520|FG009|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
147118022|NCT01851369|530596521|FG010|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
147118023|NCT01851369|530596522|FG011|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
147118024|NCT01851369|530596523|FG012|Phase I Dose Escalation|Declined to participate (before treatment started)|0|||
147118025|NCT00183391|530596524|FG000|Block 1 - 5 Weeks|Withdrawal by Subject|13|||
147118026|NCT00183391|530596525|FG001|Block 1 - 5 Weeks|Withdrawal by Subject|14|||
147118027|NCT00183391|530596524|FG000|Block 2 - 5 Weeks|Withdrawal by Subject|4|||
147118028|NCT00183391|530596525|FG001|Block 2 - 5 Weeks|Withdrawal by Subject|2|||
147118029|NCT00395512|530596526|FG000|Overall Study|Adverse Event|3|||
147118030|NCT00395512|530596527|FG001|Overall Study|Adverse Event|8|||
147118031|NCT00395512|530596528|FG002|Overall Study|Adverse Event|6|||
147118032|NCT00395512|530596529|FG003|Overall Study|Adverse Event|6|||
147118033|NCT00395512|530596526|FG000|Overall Study|Protocol Violation|2|||
147118034|NCT00395512|530596527|FG001|Overall Study|Protocol Violation|3|||
147118035|NCT00395512|530596528|FG002|Overall Study|Protocol Violation|6|||
147118036|NCT00395512|530596529|FG003|Overall Study|Protocol Violation|7|||
147118037|NCT00395512|530596526|FG000|Overall Study|Lost to Follow-up|2|||
147118038|NCT00395512|530596527|FG001|Overall Study|Lost to Follow-up|6|||
147118039|NCT00395512|530596528|FG002|Overall Study|Lost to Follow-up|5|||
147118040|NCT00395512|530596529|FG003|Overall Study|Lost to Follow-up|5|||
147118041|NCT00395512|530596526|FG000|Overall Study|Withdrawal by Subject|6|||
147118042|NCT00395512|530596527|FG001|Overall Study|Withdrawal by Subject|5|||
147118043|NCT00395512|530596528|FG002|Overall Study|Withdrawal by Subject|5|||
147118044|NCT00395512|530596529|FG003|Overall Study|Withdrawal by Subject|12|||
147118045|NCT00395512|530596526|FG000|Overall Study|Physician Decision|6|||
147118046|NCT00395512|530596527|FG001|Overall Study|Physician Decision|4|||
147118047|NCT00395512|530596528|FG002|Overall Study|Physician Decision|2|||
147118048|NCT00395512|530596529|FG003|Overall Study|Physician Decision|2|||
147118049|NCT00395512|530596526|FG000|Overall Study|Other|1|||
147118050|NCT00395512|530596527|FG001|Overall Study|Other|1|||
147444464|NCT00912028|531792622|FG000|Overall Study|Lost to Follow-up|2|||
147444465|NCT00912028|531792623|FG001|Overall Study|Lost to Follow-up|3|||
147444466|NCT00912028|531792624|FG002|Overall Study|Lost to Follow-up|0|||
147118051|NCT00395512|530596528|FG002|Overall Study|Other|0|||
147118052|NCT00395512|530596529|FG003|Overall Study|Other|0|||
147118053|NCT00395512|530596526|FG000|Overall Study|Hyperglycemic Rescue|18|||
147118054|NCT00395512|530596527|FG001|Overall Study|Hyperglycemic Rescue|10|||
147118055|NCT00395512|530596528|FG002|Overall Study|Hyperglycemic Rescue|4|||
147312718|NCT01807221|531312255|FG004|Overall Study|Death|1|||
147312719|NCT01807221|531312256|FG005|Overall Study|Death|6|||
147312720|NCT01807221|531312251|FG000|Overall Study|Physician Decision|2|||
147312721|NCT01807221|531312252|FG001|Overall Study|Physician Decision|1|||
147312722|NCT01807221|531312253|FG002|Overall Study|Physician Decision|0|||
147444467|NCT00912028|531792625|FG003|Overall Study|Lost to Follow-up|1|||
147444468|NCT00912028|531792626|FG004|Overall Study|Lost to Follow-up|3|||
147444469|NCT00912028|531792622|FG000|Overall Study|Withdrawal by Subject|3|||
147566753|NCT01702987|532234868|FG001|Overall Study|Withdrawal by Subject|0|||
147566754|NCT02017223|532234869|FG000|Overall Study|Algorithm problems|2|||
147566755|NCT01401647|532234870|FG000|Overall Study|Withdrawal by Subject|1|||
147566756|NCT01401647|532234871|FG001|Overall Study|Withdrawal by Subject|5|||
147566757|NCT01401647|532234872|FG002|Overall Study|Withdrawal by Subject|2|||
147566758|NCT01401647|532234870|FG000|Overall Study|Lost to Follow-up|3|||
147566759|NCT01401647|532234871|FG001|Overall Study|Lost to Follow-up|3|||
147566760|NCT01401647|532234872|FG002|Overall Study|Lost to Follow-up|1|||
147566761|NCT00365846|532234877|FG000|Overall Study|Lost to Follow-up|1|||
147566762|NCT02057458|532234882|FG000|Met Inclusion Criteria|Prior history of migraine headaches|0|||
147566763|NCT02057458|532234883|FG001|Met Inclusion Criteria|Prior history of migraine headaches|1|||
147566764|NCT02057458|532234884|FG002|Met Inclusion Criteria|Prior history of migraine headaches|0|||
147566765|NCT02057458|532234882|FG000|Acute Study (1 Hour): First Intervention|Lost to Follow-up|2|||
147566766|NCT02057458|532234883|FG001|Acute Study (1 Hour): First Intervention|Lost to Follow-up|0|||
147566767|NCT02057458|532234884|FG002|Acute Study (1 Hour): First Intervention|Lost to Follow-up|0|||
147566768|NCT02057458|532234882|FG000|Sub-Chronic Study (4 Weeks)|Lost to Follow-up|1|||
147566769|NCT02057458|532234883|FG001|Sub-Chronic Study (4 Weeks)|Lost to Follow-up|0|||
147566770|NCT02057458|532234884|FG002|Sub-Chronic Study (4 Weeks)|Lost to Follow-up|0|||
147566771|NCT04263649|532234885|FG000|Overall Study|Adverse Event|53|||
147566772|NCT04263649|532234885|FG000|Overall Study|Lost to Follow-up|3|||
147566773|NCT04263649|532234885|FG000|Overall Study|Death|29|||
147566774|NCT04263649|532234885|FG000|Overall Study|Device deficiency|19|||
147566775|NCT04263649|532234885|FG000|Overall Study|other reasons|11|||
147566776|NCT04400890|532234889|FG000|Overall Study|Withdrawal by Subject|3|||
147566777|NCT04400890|532234890|FG001|Overall Study|Withdrawal by Subject|2|||
147566778|NCT00846495|532234895|FG000|Overall Study|Lost to Follow-up|1|||
147118056|NCT00395512|530596529|FG003|Overall Study|Hyperglycemic Rescue|6|||
147118057|NCT01478087|530596532|FG000|Overall Study|due to sponsor closing study|1|||
147118058|NCT05507450|530596537|FG000|Overall Study|Death|0|||
147118059|NCT05507450|530596538|FG001|Overall Study|Death|0|||
147118060|NCT05507450|530596539|FG002|Overall Study|Death|1|||
147118061|NCT05507450|530596540|FG003|Overall Study|Death|0|||
147118062|NCT05507450|530596537|FG000|Overall Study|Lost to Follow-up|22|||
147118063|NCT05507450|530596538|FG001|Overall Study|Lost to Follow-up|20|||
147118064|NCT05507450|530596539|FG002|Overall Study|Lost to Follow-up|20|||
147118065|NCT05507450|530596540|FG003|Overall Study|Lost to Follow-up|7|||
147118066|NCT05507450|530596537|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
147229893|NCT01461980|531015872|FG001|Overall Study|Randomized but not vaccinated|8|||
147229894|NCT01461980|531015873|FG002|Overall Study|Randomized but not vaccinated|7|||
147229895|NCT04171765|531015874|FG000|Overall Study|Adverse Event|2|||
147229896|NCT04171765|531015875|FG001|Overall Study|Adverse Event|0|||
147229897|NCT04171765|531015876|FG002|Overall Study|Adverse Event|1|||
147229898|NCT04171765|531015877|FG003|Overall Study|Adverse Event|0|||
147229899|NCT04171765|531015874|FG000|Overall Study|Lost to Follow-up|0|||
147229900|NCT04171765|531015875|FG001|Overall Study|Lost to Follow-up|2|||
147229901|NCT04171765|531015876|FG002|Overall Study|Lost to Follow-up|2|||
147229902|NCT04171765|531015877|FG003|Overall Study|Lost to Follow-up|2|||
147229903|NCT04171765|531015874|FG000|Overall Study|Week 58 visit missed|0|||
147229904|NCT04171765|531015875|FG001|Overall Study|Week 58 visit missed|0|||
147229905|NCT04171765|531015876|FG002|Overall Study|Week 58 visit missed|1|||
147229906|NCT04171765|531015877|FG003|Overall Study|Week 58 visit missed|0|||
147229907|NCT04171765|531015874|FG000|Overall Study|Study terminated by sponsor|2|||
147229908|NCT04171765|531015875|FG001|Overall Study|Study terminated by sponsor|0|||
147229909|NCT04171765|531015876|FG002|Overall Study|Study terminated by sponsor|0|||
147229910|NCT04171765|531015877|FG003|Overall Study|Study terminated by sponsor|0|||
147312723|NCT01807221|531312254|FG003|Overall Study|Physician Decision|0|||
147566779|NCT00846495|532234896|FG001|Overall Study|Lost to Follow-up|0|||
147566780|NCT00846495|532234895|FG000|Overall Study|Adverse Event|5|||
147566781|NCT00846495|532234896|FG001|Overall Study|Adverse Event|1|||
147650894|NCT02757352|532544543|FG006|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
147118067|NCT05507450|530596538|FG001|Overall Study|Randomized By Mistake Without Study Treatment|2|||
147118068|NCT05507450|530596539|FG002|Overall Study|Randomized By Mistake Without Study Treatment|1|||
147118069|NCT05507450|530596540|FG003|Overall Study|Randomized By Mistake Without Study Treatment|0|||
147118070|NCT05507450|530596537|FG000|Overall Study|Withdrawal by Subject|4|||
147118071|NCT05507450|530596538|FG001|Overall Study|Withdrawal by Subject|11|||
147229911|NCT04171765|531015874|FG000|Overall Study|Withdrawal by Subject|1|||
147229912|NCT04171765|531015875|FG001|Overall Study|Withdrawal by Subject|0|||
147229913|NCT04171765|531015876|FG002|Overall Study|Withdrawal by Subject|0|||
147229914|NCT04171765|531015877|FG003|Overall Study|Withdrawal by Subject|3|||
147566782|NCT00846495|532234895|FG000|Overall Study|Lack of Efficacy|1|||
147566783|NCT00846495|532234896|FG001|Overall Study|Lack of Efficacy|2|||
147566784|NCT00846495|532234895|FG000|Overall Study|Physician Decision|1|||
147566785|NCT00846495|532234896|FG001|Overall Study|Physician Decision|0|||
147566786|NCT01265056|532234897|FG000|Initial Study Period|Withdrawal by Subject|1|||
147566787|NCT01265056|532234898|FG001|Initial Study Period|Withdrawal by Subject|1|||
147566788|NCT01265056|532234897|FG000|Initial Study Period|Withdrawal by Subject|1|||
147566789|NCT01265056|532234898|FG001|Initial Study Period|Withdrawal by Subject|1|||
147229915|NCT00809354|531015881|FG000|Overall Study|Adverse Event|32|||
147229916|NCT00809354|531015882|FG001|Overall Study|Adverse Event|45|||
147229917|NCT00809354|531015883|FG002|Overall Study|Adverse Event|37|||
147229918|NCT00809354|531015884|FG003|Overall Study|Adverse Event|53|||
147229919|NCT00809354|531015885|FG004|Overall Study|Adverse Event|26|||
147229920|NCT00809354|531015886|FG005|Overall Study|Adverse Event|33|||
147566790|NCT01265056|532234897|FG000|Follow up|Lost to Follow-up|7|||
147566791|NCT01265056|532234898|FG001|Follow up|Lost to Follow-up|3|||
147566792|NCT00537979|532234904|FG000|Overall Study|Adverse Event|2|||
147566793|NCT00537979|532234905|FG001|Overall Study|Adverse Event|2|||
147566794|NCT00537979|532234904|FG000|Overall Study|Withdrawal by Subject|1|||
147566795|NCT00537979|532234905|FG001|Overall Study|Withdrawal by Subject|4|||
147566796|NCT00537979|532234904|FG000|Overall Study|Lost to Follow-up|1|||
147566797|NCT00537979|532234905|FG001|Overall Study|Lost to Follow-up|4|||
147566798|NCT00537979|532234904|FG000|Overall Study|Lack of Efficacy|0|||
147566799|NCT00537979|532234905|FG001|Overall Study|Lack of Efficacy|1|||
147566800|NCT00537979|532234904|FG000|Overall Study|Non-compliance with treatment/procedure|2|||
147566801|NCT00537979|532234905|FG001|Overall Study|Non-compliance with treatment/procedure|2|||
147566802|NCT00537979|532234904|FG000|Overall Study|Death|0|||
147566803|NCT00537979|532234905|FG001|Overall Study|Death|3|||
147566804|NCT00537979|532234904|FG000|Overall Study|Kidney transplant|0|||
147566805|NCT00537979|532234905|FG001|Overall Study|Kidney transplant|3|||
147566806|NCT00537979|532234904|FG000|Overall Study|Heart failure|0|||
147566807|NCT00537979|532234905|FG001|Overall Study|Heart failure|1|||
147566808|NCT02601560|532234906|FG000|Overall Study|Other|0|||
147566809|NCT02601560|532234907|FG001|Overall Study|Other|0|||
147566810|NCT02601560|532234908|FG002|Overall Study|Other|0|||
147566811|NCT02601560|532234909|FG003|Overall Study|Other|0|||
147566812|NCT02601560|532234910|FG004|Overall Study|Other|0|||
147566813|NCT02601560|532234911|FG005|Overall Study|Other|0|||
147566814|NCT02601560|532234912|FG006|Overall Study|Other|1|||
147566815|NCT02601560|532234913|FG007|Overall Study|Other|0|||
147566816|NCT03459807|532234914|FG000|Overall Study|Withdrawal due to transplant|0|||
147566817|NCT03459807|532234915|FG001|Overall Study|Withdrawal due to transplant|1|||
147566818|NCT00576056|532234919|FG000|Overall Study|Adverse Event|1|||
147566819|NCT00576056|532234919|FG000|Overall Study|Death|1|||
147566820|NCT00576056|532234919|FG000|Overall Study|Lack of Efficacy|1|||
147566821|NCT00576056|532234919|FG000|Overall Study|Withdrawal by Subject|2|||
147566822|NCT00576056|532234919|FG000|Overall Study|did not meet eligibility criteria|8|||
147566823|NCT00576056|532234919|FG000|Overall Study|Physician Decision|1|||
147566824|NCT00858845|532234920|FG000|Overall Study|Patient underwent heart transplant.|0|||
147566825|NCT00858845|532234921|FG001|Overall Study|Patient underwent heart transplant.|1|||
147566826|NCT03420300|532234927|FG000|Overall Study|Death|2|||
147566827|NCT03500692|532234931|FG000|Overall Study|Death|163|||
147566828|NCT03500692|532234931|FG000|Overall Study|Lost to Follow-up|75|||
147566829|NCT03500692|532234931|FG000|Overall Study|Termination Reasons|3|||
147566830|NCT04149964|532234932|FG000|Overall Study|Lost to Follow-up|19|||
147566831|NCT04149964|532234933|FG001|Overall Study|Lost to Follow-up|18|||
147566832|NCT03041025|532234936|FG000|Overall Study|Adverse Event|0|||
147566833|NCT03041025|532234937|FG001|Overall Study|Adverse Event|0|||
147566834|NCT03041025|532234938|FG002|Overall Study|Adverse Event|1|||
147229921|NCT00809354|531015887|FG006|Overall Study|Adverse Event|44|||
147229922|NCT00809354|531015888|FG007|Overall Study|Adverse Event|40|||
147229923|NCT00809354|531015889|FG008|Overall Study|Adverse Event|46|||
147566835|NCT03041025|532234936|FG000|Overall Study|Lost to Follow-up|1|||
147566836|NCT03041025|532234937|FG001|Overall Study|Lost to Follow-up|0|||
147566837|NCT03041025|532234938|FG002|Overall Study|Lost to Follow-up|0|||
147229924|NCT00809354|531015890|FG009|Overall Study|Adverse Event|26|||
147229925|NCT00809354|531015881|FG000|Overall Study|Lack of Efficacy|23|||
147229926|NCT00809354|531015882|FG001|Overall Study|Lack of Efficacy|23|||
147566838|NCT03041025|532234936|FG000|Overall Study|Withdrawal by Subject|0|||
147566839|NCT03041025|532234937|FG001|Overall Study|Withdrawal by Subject|0|||
147566840|NCT03041025|532234938|FG002|Overall Study|Withdrawal by Subject|1|||
147566841|NCT03880266|532234940|FG000|Overall Study|Withdrawal by Subject|0|||
147229927|NCT00809354|531015883|FG002|Overall Study|Lack of Efficacy|22|||
147566842|NCT03880266|532234941|FG001|Overall Study|Withdrawal by Subject|1|||
147566843|NCT03880266|532234942|FG002|Overall Study|Withdrawal by Subject|1|||
147566844|NCT03880266|532234943|FG003|Overall Study|Withdrawal by Subject|0|||
147566845|NCT03880266|532234944|FG004|Overall Study|Withdrawal by Subject|0|||
147566846|NCT03880266|532234945|FG005|Overall Study|Withdrawal by Subject|0|||
147566847|NCT03880266|532234946|FG006|Overall Study|Withdrawal by Subject|0|||
147566848|NCT03880266|532234947|FG007|Overall Study|Withdrawal by Subject|0|||
147229928|NCT00809354|531015884|FG003|Overall Study|Lack of Efficacy|15|||
147229929|NCT00809354|531015885|FG004|Overall Study|Lack of Efficacy|40|||
147566849|NCT01577381|532234951|FG000|Overall Study|Discontinued|2|||
147566850|NCT01577381|532234952|FG001|Overall Study|Discontinued|1|||
147566851|NCT01577381|532234953|FG002|Overall Study|Discontinued|2|||
147566852|NCT01577381|532234954|FG003|Overall Study|Discontinued|2|||
147566853|NCT01577381|532234951|FG000|Overall Study|Ongoing at Date of Cut-Off|0|||
147566854|NCT01577381|532234952|FG001|Overall Study|Ongoing at Date of Cut-Off|2|||
147566855|NCT01577381|532234953|FG002|Overall Study|Ongoing at Date of Cut-Off|1|||
147566856|NCT01577381|532234954|FG003|Overall Study|Ongoing at Date of Cut-Off|0|||
147566857|NCT02186821|532234955|FG000|Overall Study|Adverse Event|9|||
147566858|NCT02186821|532234955|FG000|Overall Study|Death|2|||
147566859|NCT02186821|532234955|FG000|Overall Study|Disease progression|32|||
147566860|NCT02186821|532234955|FG000|Overall Study|Protocol Violation|1|||
147566861|NCT02186821|532234955|FG000|Overall Study|Physician Decision|1|||
147566862|NCT02186821|532234955|FG000|Overall Study|Study terminated by sponsor|2|||
147566863|NCT00467896|532236367|FG000|Overall Study|Consent Withdrawal|18|||
147566864|NCT00467896|532236367|FG000|Overall Study|Adverse Event|7|||
147566865|NCT00467896|532236367|FG000|Overall Study|Serious Adverse Event|13|||
147566866|NCT00467896|532236367|FG000|Overall Study|Non-compliance|3|||
147566867|NCT00467896|532236367|FG000|Overall Study|Changed therapy|2|||
147566868|NCT00467896|532236367|FG000|Overall Study|Patient received transplant|2|||
147566869|NCT00467896|532236367|FG000|Overall Study|Patient had atrial septostomy|1|||
147566870|NCT00467896|532236367|FG000|Overall Study|Patient weaned off iloprost|1|||
147566871|NCT00467896|532236367|FG000|Overall Study|Mainly used Prodose not I-neb® device|1|||
147566872|NCT00467896|532236367|FG000|Overall Study|Started intravenous prostacyclin|1|||
147566873|NCT00467896|532236367|FG000|Overall Study|Started inhaled Remodulin|1|||
147566874|NCT00467896|532236367|FG000|Overall Study|Patient had no improvement|1|||
147566875|NCT03772522|532236368|FG000|Pre-intervention|Withdrawal by Subject|3|||
147566876|NCT03772522|532236369|FG001|Pre-intervention|Withdrawal by Subject|4|||
147566877|NCT03772522|532236368|FG000|Intervention|Withdrawal by Subject|1|||
147566878|NCT03772522|532236369|FG001|Intervention|Withdrawal by Subject|0|||
147566879|NCT03772522|532236368|FG000|Post-intervention Follow-up|Lost to Follow-up|1|||
147118072|NCT05507450|530596539|FG002|Overall Study|Withdrawal by Subject|7|||
147118073|NCT05507450|530596540|FG003|Overall Study|Withdrawal by Subject|3|||
147118074|NCT05507450|530596537|FG000|Overall Study|Participant left the country|0|||
147118075|NCT05507450|530596538|FG001|Overall Study|Participant left the country|0|||
147118076|NCT05507450|530596539|FG002|Overall Study|Participant left the country|1|||
147118077|NCT05507450|530596540|FG003|Overall Study|Participant left the country|0|||
147229930|NCT00809354|531015886|FG005|Overall Study|Lack of Efficacy|19|||
147566880|NCT03772522|532236369|FG001|Post-intervention Follow-up|Lost to Follow-up|0|||
147566881|NCT03818581|532236372|FG000|Overall Study|Adverse Event|1|||
147118078|NCT05436288|530596541|FG000|Overall Study|Lost to Follow-up|1|||
147229931|NCT00809354|531015887|FG006|Overall Study|Lack of Efficacy|21|||
147229932|NCT00809354|531015888|FG007|Overall Study|Lack of Efficacy|15|||
147229933|NCT00809354|531015889|FG008|Overall Study|Lack of Efficacy|18|||
147229934|NCT00809354|531015890|FG009|Overall Study|Lack of Efficacy|38|||
147229935|NCT00809354|531015881|FG000|Overall Study|Lost to Follow-up|10|||
147229936|NCT00809354|531015882|FG001|Overall Study|Lost to Follow-up|11|||
147229937|NCT00809354|531015883|FG002|Overall Study|Lost to Follow-up|8|||
147229938|NCT00809354|531015884|FG003|Overall Study|Lost to Follow-up|13|||
147229939|NCT00809354|531015885|FG004|Overall Study|Lost to Follow-up|6|||
147229940|NCT00809354|531015886|FG005|Overall Study|Lost to Follow-up|2|||
147229941|NCT00809354|531015887|FG006|Overall Study|Lost to Follow-up|0|||
147229942|NCT00809354|531015888|FG007|Overall Study|Lost to Follow-up|5|||
147229943|NCT00809354|531015889|FG008|Overall Study|Lost to Follow-up|4|||
147229944|NCT00809354|531015890|FG009|Overall Study|Lost to Follow-up|0|||
147229945|NCT00809354|531015881|FG000|Overall Study|Protocol Violation|7|||
147229946|NCT00809354|531015882|FG001|Overall Study|Protocol Violation|14|||
147229947|NCT00809354|531015883|FG002|Overall Study|Protocol Violation|14|||
147229948|NCT00809354|531015884|FG003|Overall Study|Protocol Violation|12|||
147229949|NCT00809354|531015885|FG004|Overall Study|Protocol Violation|14|||
147229950|NCT00809354|531015886|FG005|Overall Study|Protocol Violation|6|||
147229951|NCT00809354|531015887|FG006|Overall Study|Protocol Violation|4|||
147229952|NCT00809354|531015888|FG007|Overall Study|Protocol Violation|6|||
147229953|NCT00809354|531015889|FG008|Overall Study|Protocol Violation|9|||
147229954|NCT00809354|531015890|FG009|Overall Study|Protocol Violation|3|||
147229955|NCT00809354|531015881|FG000|Overall Study|Withdrawal by Subject|32|||
147229956|NCT00809354|531015882|FG001|Overall Study|Withdrawal by Subject|27|||
147229957|NCT00809354|531015883|FG002|Overall Study|Withdrawal by Subject|31|||
147229958|NCT00809354|531015884|FG003|Overall Study|Withdrawal by Subject|33|||
147229959|NCT00809354|531015885|FG004|Overall Study|Withdrawal by Subject|34|||
147229960|NCT00809354|531015886|FG005|Overall Study|Withdrawal by Subject|29|||
147229961|NCT00809354|531015887|FG006|Overall Study|Withdrawal by Subject|27|||
147229962|NCT00809354|531015888|FG007|Overall Study|Withdrawal by Subject|19|||
147229963|NCT00809354|531015889|FG008|Overall Study|Withdrawal by Subject|18|||
147229964|NCT00809354|531015890|FG009|Overall Study|Withdrawal by Subject|20|||
147229965|NCT00809354|531015881|FG000|Overall Study|Other|10|||
147566882|NCT03818581|532236373|FG001|Overall Study|Adverse Event|0|||
147566883|NCT03818581|532236374|FG002|Overall Study|Adverse Event|0|||
147566884|NCT03818581|532236375|FG003|Overall Study|Adverse Event|0|||
147566885|NCT03818581|532236376|FG004|Overall Study|Adverse Event|0|||
147566886|NCT03818581|532236372|FG000|Overall Study|Covid-19|2|||
147566887|NCT03818581|532236373|FG001|Overall Study|Covid-19|0|||
147118079|NCT05436288|530596541|FG000|Overall Study|Adverse Event|1|||
147118080|NCT03767894|530596545|FG000|Overall Study|Withdrawal by Subject|1|||
147118081|NCT01860404|530596546|FG000|Overall Study|Lost to Follow-up|3|||
147118082|NCT01860404|530596547|FG001|Overall Study|Lost to Follow-up|4|||
147118083|NCT01860404|530596548|FG002|Overall Study|Lost to Follow-up|1|||
147118084|NCT01860404|530596549|FG003|Overall Study|Lost to Follow-up|6|||
147118085|NCT01860404|530596550|FG004|Overall Study|Lost to Follow-up|4|||
147118086|NCT01860404|530596546|FG000|Overall Study|Withdrawal by Subject|0|||
147118087|NCT01860404|530596547|FG001|Overall Study|Withdrawal by Subject|0|||
147118088|NCT01860404|530596548|FG002|Overall Study|Withdrawal by Subject|4|||
147118089|NCT01860404|530596549|FG003|Overall Study|Withdrawal by Subject|0|||
147118090|NCT01860404|530596550|FG004|Overall Study|Withdrawal by Subject|0|||
147118091|NCT00356421|530596553|FG000|Overall Study|Lack of Efficacy|3|||
147118092|NCT00356421|530596554|FG001|Overall Study|Lack of Efficacy|0|||
147118093|NCT00356421|530596553|FG000|Overall Study|Withdrawal by Subject|9|||
147118094|NCT00356421|530596554|FG001|Overall Study|Withdrawal by Subject|2|||
147118095|NCT00356421|530596553|FG000|Overall Study|Related to study drug|15|||
147118096|NCT00356421|530596554|FG001|Overall Study|Related to study drug|12|||
147118097|NCT00356421|530596553|FG000|Overall Study|Not related to study drug|5|||
147118098|NCT00356421|530596554|FG001|Overall Study|Not related to study drug|3|||
147118099|NCT00421993|530596557|FG000|Overall Study|Withdrawal by Subject|22|||
147118100|NCT00421993|530596558|FG001|Overall Study|Withdrawal by Subject|23|||
147118101|NCT00421993|530596559|FG002|Overall Study|Withdrawal by Subject|23|||
147118102|NCT00421993|530596560|FG003|Overall Study|Withdrawal by Subject|24|||
147118103|NCT00421993|530596557|FG000|Overall Study|Lost to Follow-up|18|||
147118104|NCT00421993|530596558|FG001|Overall Study|Lost to Follow-up|19|||
147118105|NCT00421993|530596559|FG002|Overall Study|Lost to Follow-up|22|||
147118106|NCT00421993|530596560|FG003|Overall Study|Lost to Follow-up|20|||
147118107|NCT00421993|530596557|FG000|Overall Study|Adverse Event|11|||
147118108|NCT00421993|530596558|FG001|Overall Study|Adverse Event|1|||
147118109|NCT00421993|530596559|FG002|Overall Study|Adverse Event|6|||
147118110|NCT00421993|530596560|FG003|Overall Study|Adverse Event|4|||
147118111|NCT00421993|530596557|FG000|Overall Study|Protocol Violation|2|||
147118112|NCT00421993|530596558|FG001|Overall Study|Protocol Violation|2|||
147118113|NCT00421993|530596559|FG002|Overall Study|Protocol Violation|0|||
147118114|NCT00421993|530596560|FG003|Overall Study|Protocol Violation|1|||
147118115|NCT00421993|530596557|FG000|Overall Study|Lack of Efficacy|0|||
147118116|NCT00421993|530596558|FG001|Overall Study|Lack of Efficacy|3|||
147118117|NCT00421993|530596559|FG002|Overall Study|Lack of Efficacy|0|||
147118118|NCT00421993|530596560|FG003|Overall Study|Lack of Efficacy|5|||
147118119|NCT00421993|530596557|FG000|Overall Study|Pregnancy|0|||
147229966|NCT00809354|531015882|FG001|Overall Study|Other|2|||
147229967|NCT00809354|531015883|FG002|Overall Study|Other|7|||
147229968|NCT00809354|531015884|FG003|Overall Study|Other|10|||
147229969|NCT00809354|531015885|FG004|Overall Study|Other|5|||
147229970|NCT00809354|531015886|FG005|Overall Study|Other|3|||
147229971|NCT00809354|531015887|FG006|Overall Study|Other|2|||
147229972|NCT00809354|531015888|FG007|Overall Study|Other|3|||
147229973|NCT00809354|531015889|FG008|Overall Study|Other|4|||
147229974|NCT00809354|531015890|FG009|Overall Study|Other|3|||
147229975|NCT00809354|531015881|FG000|Overall Study|Study terminated by sponsor|138|||
147229976|NCT00809354|531015882|FG001|Overall Study|Study terminated by sponsor|134|||
147229977|NCT00809354|531015883|FG002|Overall Study|Study terminated by sponsor|129|||
147229978|NCT00809354|531015884|FG003|Overall Study|Study terminated by sponsor|120|||
147229979|NCT00809354|531015885|FG004|Overall Study|Study terminated by sponsor|126|||
147229980|NCT00809354|531015886|FG005|Overall Study|Study terminated by sponsor|133|||
147229981|NCT00809354|531015887|FG006|Overall Study|Study terminated by sponsor|124|||
147229982|NCT00809354|531015888|FG007|Overall Study|Study terminated by sponsor|148|||
147229983|NCT00809354|531015889|FG008|Overall Study|Study terminated by sponsor|127|||
147229984|NCT00809354|531015890|FG009|Overall Study|Study terminated by sponsor|135|||
147229985|NCT00809354|531015881|FG000|Overall Study|Withdrawn due to pregnancy|0|||
147229986|NCT00809354|531015882|FG001|Overall Study|Withdrawn due to pregnancy|1|||
147229987|NCT00809354|531015883|FG002|Overall Study|Withdrawn due to pregnancy|0|||
147312724|NCT01807221|531312255|FG004|Overall Study|Physician Decision|0|||
147118120|NCT00421993|530596558|FG001|Overall Study|Pregnancy|1|||
147118121|NCT00421993|530596559|FG002|Overall Study|Pregnancy|1|||
147118122|NCT00421993|530596560|FG003|Overall Study|Pregnancy|2|||
147118123|NCT00421993|530596557|FG000|Overall Study|Subject transportation issues|0|||
147118124|NCT00421993|530596558|FG001|Overall Study|Subject transportation issues|0|||
147118125|NCT00421993|530596559|FG002|Overall Study|Subject transportation issues|0|||
147118126|NCT00421993|530596560|FG003|Overall Study|Subject transportation issues|1|||
147118127|NCT02547935|530596561|FG000|Overall Study|Other|0|||
147229988|NCT00809354|531015884|FG003|Overall Study|Withdrawn due to pregnancy|0|||
147229989|NCT00809354|531015885|FG004|Overall Study|Withdrawn due to pregnancy|0|||
147118128|NCT02547935|530596562|FG001|Overall Study|Other|1|||
147118129|NCT02547935|530596563|FG002|Overall Study|Other|0|||
147229990|NCT00809354|531015886|FG005|Overall Study|Withdrawn due to pregnancy|0|||
147229991|NCT00809354|531015887|FG006|Overall Study|Withdrawn due to pregnancy|0|||
147229992|NCT00809354|531015888|FG007|Overall Study|Withdrawn due to pregnancy|0|||
147566888|NCT03818581|532236374|FG002|Overall Study|Covid-19|0|||
147566889|NCT03818581|532236375|FG003|Overall Study|Covid-19|0|||
147229993|NCT00809354|531015889|FG008|Overall Study|Withdrawn due to pregnancy|0|||
147229994|NCT00809354|531015890|FG009|Overall Study|Withdrawn due to pregnancy|0|||
147229995|NCT00809354|531015881|FG000|Overall Study|Randomized but not Treated|3|||
147229996|NCT00809354|531015882|FG001|Overall Study|Randomized but not Treated|1|||
147229997|NCT00809354|531015883|FG002|Overall Study|Randomized but not Treated|6|||
147229998|NCT00809354|531015884|FG003|Overall Study|Randomized but not Treated|0|||
147229999|NCT00809354|531015885|FG004|Overall Study|Randomized but not Treated|5|||
147230000|NCT00809354|531015886|FG005|Overall Study|Randomized but not Treated|0|||
147230001|NCT00809354|531015887|FG006|Overall Study|Randomized but not Treated|1|||
147230002|NCT00809354|531015888|FG007|Overall Study|Randomized but not Treated|1|||
147230003|NCT00809354|531015889|FG008|Overall Study|Randomized but not Treated|2|||
147230004|NCT00809354|531015890|FG009|Overall Study|Randomized but not Treated|1|||
147230005|NCT00809354|531015881|FG000|Overall Study|Death|0|||
147230006|NCT00809354|531015882|FG001|Overall Study|Death|0|||
147230007|NCT00809354|531015883|FG002|Overall Study|Death|0|||
147230008|NCT00809354|531015884|FG003|Overall Study|Death|0|||
147230009|NCT00809354|531015885|FG004|Overall Study|Death|0|||
147230010|NCT00809354|531015886|FG005|Overall Study|Death|0|||
147230011|NCT00809354|531015887|FG006|Overall Study|Death|0|||
147230012|NCT00809354|531015888|FG007|Overall Study|Death|1|||
147230013|NCT00809354|531015889|FG008|Overall Study|Death|0|||
147230014|NCT00809354|531015890|FG009|Overall Study|Death|0|||
147230015|NCT01954342|531015893|FG000|Overall Study|Missing data from 13-16week study visit|0|||
147230016|NCT01954342|531015894|FG001|Overall Study|Missing data from 13-16week study visit|0|||
147230017|NCT01954342|531015895|FG002|Overall Study|Missing data from 13-16week study visit|0|||
147230018|NCT01954342|531015896|FG003|Overall Study|Missing data from 13-16week study visit|1|||
147230019|NCT01954342|531015893|FG000|Overall Study|Miscarriage|0|||
147230020|NCT01954342|531015894|FG001|Overall Study|Miscarriage|0|||
147230021|NCT01954342|531015895|FG002|Overall Study|Miscarriage|0|||
147230022|NCT01954342|531015896|FG003|Overall Study|Miscarriage|3|||
147230023|NCT01954342|531015893|FG000|Overall Study|Lost to Follow-up|0|||
147230024|NCT01954342|531015894|FG001|Overall Study|Lost to Follow-up|0|||
147230025|NCT01954342|531015895|FG002|Overall Study|Lost to Follow-up|0|||
147230026|NCT01954342|531015896|FG003|Overall Study|Lost to Follow-up|5|||
147230027|NCT01954342|531015893|FG000|Overall Study|Preterm delivery|0|||
147230028|NCT01954342|531015894|FG001|Overall Study|Preterm delivery|0|||
147230029|NCT01954342|531015895|FG002|Overall Study|Preterm delivery|0|||
147230030|NCT01954342|531015896|FG003|Overall Study|Preterm delivery|3|||
147230031|NCT01954342|531015893|FG000|Overall Study|Pre-eclampsia|0|||
147230032|NCT01954342|531015894|FG001|Overall Study|Pre-eclampsia|0|||
147230033|NCT01954342|531015895|FG002|Overall Study|Pre-eclampsia|0|||
147230034|NCT01954342|531015896|FG003|Overall Study|Pre-eclampsia|4|||
147230035|NCT01954342|531015893|FG000|Overall Study|Unreliable Data|0|||
147230036|NCT01954342|531015894|FG001|Overall Study|Unreliable Data|0|||
147230037|NCT01954342|531015895|FG002|Overall Study|Unreliable Data|0|||
147230038|NCT01954342|531015896|FG003|Overall Study|Unreliable Data|2|||
147230039|NCT01465191|531015898|FG000|Overall Study|Protocol Violation|6|||
147230040|NCT01465191|531015899|FG001|Overall Study|Protocol Violation|3|||
147230041|NCT01465191|531015900|FG002|Overall Study|Protocol Violation|3|||
147230042|NCT01465191|531015898|FG000|Overall Study|Lost to Follow-up|3|||
147230043|NCT01465191|531015899|FG001|Overall Study|Lost to Follow-up|6|||
147230044|NCT01465191|531015900|FG002|Overall Study|Lost to Follow-up|4|||
147230045|NCT01916967|531015903|FG000|Overall Study|Adverse Event|0|||
147230046|NCT01916967|531015904|FG001|Overall Study|Adverse Event|0|||
147230047|NCT01916967|531015905|FG002|Overall Study|Adverse Event|2|||
147230048|NCT01916967|531015903|FG000|Overall Study|Lack of Efficacy|0|||
147230049|NCT01916967|531015904|FG001|Overall Study|Lack of Efficacy|0|||
147230050|NCT01916967|531015905|FG002|Overall Study|Lack of Efficacy|6|||
147230051|NCT01916967|531015903|FG000|Overall Study|Physician Decision|0|||
147230052|NCT01916967|531015904|FG001|Overall Study|Physician Decision|0|||
147230053|NCT01916967|531015905|FG002|Overall Study|Physician Decision|1|||
147230054|NCT01916967|531015903|FG000|Overall Study|Protocol Violation|0|||
147230055|NCT01916967|531015904|FG001|Overall Study|Protocol Violation|1|||
147230056|NCT01916967|531015905|FG002|Overall Study|Protocol Violation|0|||
147230057|NCT00620464|531015906|FG000|Overall Study|Adverse Event|15|||
147230058|NCT00620464|531015907|FG001|Overall Study|Adverse Event|17|||
147230059|NCT00620464|531015906|FG000|Overall Study|Lost to Follow-up|1|||
147230060|NCT00620464|531015907|FG001|Overall Study|Lost to Follow-up|1|||
147230061|NCT00620464|531015906|FG000|Overall Study|Planning Pregnancy|1|||
147230062|NCT00620464|531015907|FG001|Overall Study|Planning Pregnancy|4|||
147230063|NCT00620464|531015906|FG000|Overall Study|Personal|2|||
147230064|NCT00620464|531015907|FG001|Overall Study|Personal|2|||
147230065|NCT00620464|531015906|FG000|Overall Study|Used prohibited medication|1|||
147230066|NCT00620464|531015907|FG001|Overall Study|Used prohibited medication|0|||
147230067|NCT05394350|531015908|FG000|Overall Study|Death|2|||
147230068|NCT05394350|531015909|FG001|Overall Study|Death|2|||
147230069|NCT05394350|531015910|FG002|Overall Study|Death|4|||
147230070|NCT05394350|531015911|FG003|Overall Study|Death|0|||
147566890|NCT03818581|532236376|FG004|Overall Study|Covid-19|1|||
147650895|NCT02757352|532544544|FG007|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
147230071|NCT05394350|531015912|FG004|Overall Study|Death|1|||
147230072|NCT05394350|531015913|FG005|Overall Study|Death|0|||
147230073|NCT05394350|531015908|FG000|Overall Study|Study terminated by sponsor|1|||
147230074|NCT05394350|531015909|FG001|Overall Study|Study terminated by sponsor|1|||
147230075|NCT05394350|531015910|FG002|Overall Study|Study terminated by sponsor|7|||
147230076|NCT05394350|531015911|FG003|Overall Study|Study terminated by sponsor|3|||
147230077|NCT05394350|531015912|FG004|Overall Study|Study terminated by sponsor|2|||
147230078|NCT05394350|531015913|FG005|Overall Study|Study terminated by sponsor|4|||
147230079|NCT01336569|531015914|FG000|Overall Study|Lost to Follow-up|4|||
147230080|NCT03911154|531015915|FG000|Overall Study|Withdrawal by Subject|1|||
147230081|NCT00406354|531015916|FG000|All Randomized Patients|Protocol Violation|0|||
147230082|NCT00406354|531015917|FG001|All Randomized Patients|Protocol Violation|0|||
147230083|NCT00406354|531015918|FG002|All Randomized Patients|Protocol Violation|1|||
147230084|NCT00406354|531015916|FG000|All Randomized and Treated Patients|Lack of Efficacy|7|||
147230085|NCT00406354|531015917|FG001|All Randomized and Treated Patients|Lack of Efficacy|4|||
147230086|NCT00406354|531015918|FG002|All Randomized and Treated Patients|Lack of Efficacy|17|||
147230087|NCT00406354|531015916|FG000|All Randomized and Treated Patients|Adverse Event|6|||
147230088|NCT00406354|531015917|FG001|All Randomized and Treated Patients|Adverse Event|2|||
147230089|NCT00406354|531015918|FG002|All Randomized and Treated Patients|Adverse Event|1|||
147230090|NCT00406354|531015916|FG000|All Randomized and Treated Patients|Parent/Caregiver Decision|2|||
147230091|NCT00406354|531015917|FG001|All Randomized and Treated Patients|Parent/Caregiver Decision|6|||
147230092|NCT00406354|531015918|FG002|All Randomized and Treated Patients|Parent/Caregiver Decision|1|||
147230093|NCT00406354|531015916|FG000|All Randomized and Treated Patients|Withdrawal by Subject|1|||
147230094|NCT00406354|531015917|FG001|All Randomized and Treated Patients|Withdrawal by Subject|1|||
147230095|NCT00406354|531015918|FG002|All Randomized and Treated Patients|Withdrawal by Subject|2|||
147230096|NCT00406354|531015916|FG000|All Randomized and Treated Patients|Physician Decision|0|||
147230097|NCT00406354|531015917|FG001|All Randomized and Treated Patients|Physician Decision|0|||
147230098|NCT00406354|531015918|FG002|All Randomized and Treated Patients|Physician Decision|1|||
147230099|NCT01385371|531015919|FG000|Overall Study|Adverse Event|54|||
147230100|NCT01385371|531015920|FG001|Overall Study|Adverse Event|19|||
147230101|NCT01385371|531015919|FG000|Overall Study|Lost to Follow-up|16|||
147230102|NCT01385371|531015920|FG001|Overall Study|Lost to Follow-up|16|||
147230103|NCT01385371|531015919|FG000|Overall Study|Withdrawal by Subject|52|||
147230104|NCT01385371|531015920|FG001|Overall Study|Withdrawal by Subject|39|||
147230105|NCT01385371|531015919|FG000|Overall Study|Protocol Violation|25|||
147230106|NCT01385371|531015920|FG001|Overall Study|Protocol Violation|21|||
147230107|NCT01385371|531015919|FG000|Overall Study|Administrative|2|||
147230108|NCT01385371|531015920|FG001|Overall Study|Administrative|2|||
147230109|NCT00304239|531015923|FG000|Overall Study|Protocol Deviations/Violations|15|||
147230110|NCT00304239|531015924|FG001|Overall Study|Protocol Deviations/Violations|0|||
147230111|NCT00304239|531015923|FG000|Overall Study|Adverse Event|2|||
147230112|NCT00304239|531015924|FG001|Overall Study|Adverse Event|0|||
147230113|NCT02979197|531015925|FG000|Overall Study|Adverse Event|4|||
147230114|NCT02979197|531015926|FG001|Overall Study|Adverse Event|2|||
147230115|NCT02979197|531015927|FG002|Overall Study|Adverse Event|0|||
147230116|NCT02979197|531015925|FG000|Overall Study|Protocol Violation|0|||
147230117|NCT02979197|531015926|FG001|Overall Study|Protocol Violation|1|||
147230118|NCT02979197|531015927|FG002|Overall Study|Protocol Violation|0|||
147230119|NCT02979197|531015925|FG000|Overall Study|Subject unable to commit to study dates|0|||
147230120|NCT02979197|531015926|FG001|Overall Study|Subject unable to commit to study dates|1|||
147230121|NCT02979197|531015927|FG002|Overall Study|Subject unable to commit to study dates|0|||
147230122|NCT01631812|531015928|FG000|Overall Study|Adverse Event|25|||
147230123|NCT01631812|531015928|FG000|Overall Study|Lack of Efficacy|5|||
147230124|NCT01631812|531015928|FG000|Overall Study|Withdrawal by Subject|4|||
147230125|NCT01631812|531015928|FG000|Overall Study|Physician Decision|3|||
147230126|NCT02436681|531015929|FG000|Overall Study|Lost to Follow-up|10|||
147230127|NCT02436681|531015929|FG000|Overall Study|Withdrawal by Subject|2|||
147230128|NCT02436681|531015929|FG000|Overall Study|Death|2|||
147230129|NCT01414608|531015930|FG000|Overall Study|Ineligible|5|||
147230130|NCT01414608|531015931|FG001|Overall Study|Ineligible|2|||
147230131|NCT05156073|531015932|FG000|Overall Study|Patient canceled appointment with PCP|1|||
147230132|NCT00973349|531015933|FG000|Overall Study|Adverse Event|0|||
147230133|NCT00973349|531015934|FG001|Overall Study|Adverse Event|0|||
147230134|NCT00973349|531015935|FG002|Overall Study|Adverse Event|0|||
147230135|NCT00973349|531015936|FG003|Overall Study|Adverse Event|0|||
147230136|NCT00973349|531015937|FG004|Overall Study|Adverse Event|1|||
147230137|NCT00973349|531015938|FG005|Overall Study|Adverse Event|0|||
147230138|NCT00973349|531015939|FG006|Overall Study|Adverse Event|0|||
147230139|NCT00973349|531015940|FG007|Overall Study|Adverse Event|0|||
147230140|NCT00973349|531015941|FG008|Overall Study|Adverse Event|1|||
147230141|NCT00973349|531015942|FG009|Overall Study|Adverse Event|0|||
147230142|NCT00973349|531015943|FG010|Overall Study|Adverse Event|0|||
147230143|NCT00973349|531015944|FG011|Overall Study|Adverse Event|0|||
147230144|NCT00973349|531015945|FG012|Overall Study|Adverse Event|0|||
147566891|NCT03818581|532236372|FG000|Overall Study|Withdrawal by Subject|0|||
147566892|NCT03818581|532236373|FG001|Overall Study|Withdrawal by Subject|0|||
147566893|NCT03818581|532236374|FG002|Overall Study|Withdrawal by Subject|0|||
147566894|NCT03818581|532236375|FG003|Overall Study|Withdrawal by Subject|0|||
147566895|NCT03818581|532236376|FG004|Overall Study|Withdrawal by Subject|1|||
147566896|NCT03818581|532236372|FG000|Overall Study|No longer met study criteria|0|||
147566897|NCT03818581|532236373|FG001|Overall Study|No longer met study criteria|0|||
147566898|NCT03818581|532236374|FG002|Overall Study|No longer met study criteria|0|||
147566899|NCT03818581|532236375|FG003|Overall Study|No longer met study criteria|0|||
147566900|NCT03818581|532236376|FG004|Overall Study|No longer met study criteria|1|||
147566901|NCT02096211|532236379|FG000|Overall Study|Death|2|||
147566902|NCT02096211|532236379|FG000|Overall Study|Withdrawal by Subject|8|||
147566903|NCT02096211|532236379|FG000|Overall Study|Revision of implant|7|||
147566904|NCT02096211|532236379|FG000|Overall Study|Lost to Follow-up|43|||
147566905|NCT01439880|532236384|FG000|SOC-controlled Period (Year 1)|Withdrawal by Subject|24|||
147566906|NCT01439880|532236385|FG001|SOC-controlled Period (Year 1)|Withdrawal by Subject|38|||
147566907|NCT01439880|532236384|FG000|SOC-controlled Period (Year 1)|Death|2|||
147566908|NCT01439880|532236385|FG001|SOC-controlled Period (Year 1)|Death|1|||
147566909|NCT01439880|532236384|FG000|SOC-controlled Period (Year 1)|Sponsor Decision|0|||
147566910|NCT01439880|532236385|FG001|SOC-controlled Period (Year 1)|Sponsor Decision|1|||
147566911|NCT01439880|532236384|FG000|SOC-controlled Period (Year 1)|Lost to Follow-up|10|||
147566912|NCT01439880|532236385|FG001|SOC-controlled Period (Year 1)|Lost to Follow-up|5|||
147566913|NCT01439880|532236384|FG000|SOC-controlled Period (Year 1)|Other|8|||
147566914|NCT01439880|532236385|FG001|SOC-controlled Period (Year 1)|Other|13|||
147566915|NCT01439880|532236384|FG000|SOC-controlled Period (Year 1)|Reason Missing|0|||
147566916|NCT01439880|532236385|FG001|SOC-controlled Period (Year 1)|Reason Missing|2|||
147566917|NCT01439880|532236384|FG000|All-IP Period (Years 2 to 5)|Lost to Follow-up|21|||
147566918|NCT01439880|532236385|FG001|All-IP Period (Years 2 to 5)|Lost to Follow-up|30|||
147566919|NCT01439880|532236384|FG000|All-IP Period (Years 2 to 5)|Withdrawal by Subject|30|||
147566920|NCT01439880|532236385|FG001|All-IP Period (Years 2 to 5)|Withdrawal by Subject|66|||
147566921|NCT01439880|532236384|FG000|All-IP Period (Years 2 to 5)|Death|3|||
147566922|NCT01439880|532236385|FG001|All-IP Period (Years 2 to 5)|Death|13|||
147566923|NCT01439880|532236384|FG000|All-IP Period (Years 2 to 5)|Sponsor Decision|1|||
147566924|NCT01439880|532236385|FG001|All-IP Period (Years 2 to 5)|Sponsor Decision|0|||
147566925|NCT01439880|532236384|FG000|All-IP Period (Years 2 to 5)|Other|14|||
147566926|NCT01439880|532236385|FG001|All-IP Period (Years 2 to 5)|Other|31|||
147118130|NCT02547935|530596561|FG000|Overall Study|Withdrawal by Subject|2|||
147118131|NCT02547935|530596562|FG001|Overall Study|Withdrawal by Subject|3|||
147312725|NCT01807221|531312256|FG005|Overall Study|Physician Decision|0|||
147312726|NCT01807221|531312251|FG000|Overall Study|Adverse Event|33|||
147312727|NCT01807221|531312252|FG001|Overall Study|Adverse Event|22|||
147566927|NCT01439880|532236384|FG000|All-IP Period (Years 2 to 5)|Reason Missing|1|||
147566928|NCT01439880|532236385|FG001|All-IP Period (Years 2 to 5)|Reason Missing|0|||
147566929|NCT00328926|532236386|FG000|Overall Study|Pregnancy|2|||
147566930|NCT00328926|532236387|FG001|Overall Study|Pregnancy|1|||
147118132|NCT02547935|530596563|FG002|Overall Study|Withdrawal by Subject|4|||
147312728|NCT01807221|531312253|FG002|Overall Study|Adverse Event|26|||
147566931|NCT00328926|532236388|FG002|Overall Study|Pregnancy|0|||
147566932|NCT00328926|532236386|FG000|Overall Study|Lost to Follow-up|0|||
147566933|NCT00328926|532236387|FG001|Overall Study|Lost to Follow-up|1|||
147566934|NCT00328926|532236388|FG002|Overall Study|Lost to Follow-up|0|||
147566935|NCT00328926|532236386|FG000|Overall Study|Death|0|||
147566936|NCT00328926|532236387|FG001|Overall Study|Death|0|||
147118133|NCT02547935|530596561|FG000|Overall Study|Screen Failure|2|||
147118134|NCT02547935|530596562|FG001|Overall Study|Screen Failure|0|||
147118135|NCT02547935|530596563|FG002|Overall Study|Screen Failure|0|||
147118136|NCT02547935|530596561|FG000|Overall Study|Physician Decision|0|||
147118137|NCT02547935|530596562|FG001|Overall Study|Physician Decision|1|||
147118138|NCT02547935|530596563|FG002|Overall Study|Physician Decision|0|||
147118139|NCT02547935|530596561|FG000|Overall Study|Lost to Follow-up|0|||
147118140|NCT02547935|530596562|FG001|Overall Study|Lost to Follow-up|2|||
147118141|NCT02547935|530596563|FG002|Overall Study|Lost to Follow-up|1|||
147118142|NCT02547935|530596561|FG000|Overall Study|Death|1|||
147118143|NCT02547935|530596562|FG001|Overall Study|Death|1|||
147118144|NCT02547935|530596563|FG002|Overall Study|Death|0|||
147118145|NCT00003474|530596567|FG000|Overall Study|Not Evaluable|14|||
147118146|NCT03334175|530596568|FG000|Overall Study|Lost to Follow-up|0|||
147118147|NCT03334175|530596569|FG001|Overall Study|Lost to Follow-up|1|||
147118148|NCT04193176|530598454|FG000|Overall Study|Withdrawal by Subject|6|||
147118149|NCT04193176|530598455|FG001|Overall Study|Withdrawal by Subject|10|||
147118150|NCT01058005|530598456|FG000|Overall Study|Adverse Event|0|||
147118151|NCT01058005|530598457|FG001|Overall Study|Adverse Event|2|||
147118152|NCT01058005|530598458|FG002|Overall Study|Adverse Event|1|||
147118153|NCT01058005|530598456|FG000|Overall Study|Physician Decision|2|||
147118154|NCT01058005|530598457|FG001|Overall Study|Physician Decision|2|||
147118155|NCT01058005|530598458|FG002|Overall Study|Physician Decision|0|||
147566937|NCT00328926|532236388|FG002|Overall Study|Death|1|||
147566938|NCT00328926|532236386|FG000|Overall Study|In vitro fertilization treatment|0|||
147566939|NCT00328926|532236387|FG001|Overall Study|In vitro fertilization treatment|0|||
147566940|NCT00328926|532236388|FG002|Overall Study|In vitro fertilization treatment|1|||
147566941|NCT00328926|532236386|FG000|Overall Study|Lack of ovarian response|0|||
147566942|NCT00328926|532236387|FG001|Overall Study|Lack of ovarian response|1|||
147566943|NCT00328926|532236388|FG002|Overall Study|Lack of ovarian response|0|||
147566944|NCT02269657|532236389|FG000|Overall Study|Protocol Violation|3|||
147566945|NCT02956460|532236390|FG000|Lens 1|Lost to Follow-up|1|||
147566946|NCT02956460|532236391|FG001|Lens 1|Lost to Follow-up|0|||
147566947|NCT02440711|532236394|FG000|Second Intervention|Lost to Follow-up|1|||
147566948|NCT02440711|532236395|FG001|Second Intervention|Lost to Follow-up|0|||
147566949|NCT04129346|532236398|FG000|Overall Study|Death|1|||
147566950|NCT04129346|532236399|FG001|Overall Study|Death|0|||
147566951|NCT02646124|532236400|FG000|Overall Study|Lost to Follow-up|0|||
147566952|NCT02646124|532236401|FG001|Overall Study|Lost to Follow-up|2|||
147566953|NCT03154047|532236402|FG000|Overall Study|Death|1|||
147566954|NCT03154047|532236402|FG000|Overall Study|Study terminated by sponsor|76|||
147566955|NCT03154047|532236402|FG000|Overall Study|Withdrawal by Subject|3|||
147566956|NCT00857454|532236403|FG000|Overall Study|Withdrawal by Subject|2|||
147566957|NCT00857454|532236403|FG000|Overall Study|Lost to Follow-up|1|||
147566958|NCT00857454|532236403|FG000|Overall Study|Adverse Event|2|||
147566959|NCT00857454|532236403|FG000|Overall Study|Total Testosterone >1050 ng/dL|1|||
147566960|NCT00857454|532236403|FG000|Overall Study|Total Testosterone <300 ng/dL|8|||
147566961|NCT00857454|532236403|FG000|Overall Study|MTE09 enrollment criteria not met|6|||
147566962|NCT00365365|532236404|FG000|Overall Study|Randomized but not treated|0|||
147566963|NCT00365365|532236405|FG001|Overall Study|Randomized but not treated|2|||
147566964|NCT00365365|532236406|FG002|Overall Study|Randomized but not treated|0|||
147566965|NCT00365365|532236404|FG000|Overall Study|Poor compliance to protocol|0|||
147566966|NCT00365365|532236405|FG001|Overall Study|Poor compliance to protocol|1|||
147566967|NCT00365365|532236406|FG002|Overall Study|Poor compliance to protocol|0|||
147566968|NCT00365365|532236404|FG000|Overall Study|Lost to Follow-up|3|||
147566969|NCT00365365|532236405|FG001|Overall Study|Lost to Follow-up|3|||
147566970|NCT00365365|532236406|FG002|Overall Study|Lost to Follow-up|3|||
147566971|NCT00365365|532236404|FG000|Overall Study|Death|1|||
147566972|NCT00365365|532236405|FG001|Overall Study|Death|3|||
147566973|NCT00365365|532236406|FG002|Overall Study|Death|0|||
147566974|NCT00365365|532236404|FG000|Overall Study|Subject's request|11|||
147566975|NCT00365365|532236405|FG001|Overall Study|Subject's request|13|||
147566976|NCT00365365|532236406|FG002|Overall Study|Subject's request|1|||
147566977|NCT00365365|532236404|FG000|Overall Study|Disease progression/relapse|9|||
147566978|NCT00365365|532236405|FG001|Overall Study|Disease progression/relapse|6|||
147566979|NCT00365365|532236406|FG002|Overall Study|Disease progression/relapse|7|||
147566980|NCT00365365|532236404|FG000|Overall Study|Adverse Event|6|||
147566981|NCT00365365|532236405|FG001|Overall Study|Adverse Event|6|||
147566982|NCT00365365|532236406|FG002|Overall Study|Adverse Event|3|||
147566983|NCT00365365|532236404|FG000|Overall Study|Moved|2|||
147566984|NCT00365365|532236405|FG001|Overall Study|Moved|0|||
147566985|NCT00365365|532236406|FG002|Overall Study|Moved|0|||
147566986|NCT00365365|532236404|FG000|Overall Study|New cancer|1|||
147566987|NCT00365365|532236405|FG001|Overall Study|New cancer|0|||
147566988|NCT00365365|532236406|FG002|Overall Study|New cancer|0|||
147566989|NCT00365365|532236404|FG000|Overall Study|Withdrew consent|1|||
147566990|NCT00365365|532236405|FG001|Overall Study|Withdrew consent|1|||
147566991|NCT00365365|532236406|FG002|Overall Study|Withdrew consent|0|||
147566992|NCT00365365|532236404|FG000|Overall Study|Second malignancy|0|||
147566993|NCT00365365|532236405|FG001|Overall Study|Second malignancy|1|||
147566994|NCT00365365|532236406|FG002|Overall Study|Second malignancy|0|||
147566995|NCT00365365|532236404|FG000|Overall Study|Patient/physician decision|0|||
147566996|NCT00365365|532236405|FG001|Overall Study|Patient/physician decision|0|||
147566997|NCT00365365|532236406|FG002|Overall Study|Patient/physician decision|1|||
147566998|NCT01083693|532236409|FG000|Overall Study|Adverse Event|1|||
147566999|NCT01083693|532236410|FG001|Overall Study|Adverse Event|1|||
147567000|NCT01083693|532236411|FG002|Overall Study|Adverse Event|0|||
147567001|NCT01083693|532236409|FG000|Overall Study|Lost to Follow-up|2|||
147567002|NCT01083693|532236410|FG001|Overall Study|Lost to Follow-up|0|||
147567003|NCT01083693|532236411|FG002|Overall Study|Lost to Follow-up|2|||
147567004|NCT01083693|532236409|FG000|Overall Study|Lack of effectiveness|13|||
147567005|NCT01083693|532236410|FG001|Overall Study|Lack of effectiveness|2|||
147567006|NCT01083693|532236411|FG002|Overall Study|Lack of effectiveness|2|||
147567007|NCT01083693|532236409|FG000|Overall Study|Patient Moved|0|||
147567008|NCT01083693|532236410|FG001|Overall Study|Patient Moved|1|||
147567009|NCT01083693|532236411|FG002|Overall Study|Patient Moved|0|||
147567010|NCT01083693|532236409|FG000|Overall Study|Complete remission|0|||
147567011|NCT01083693|532236410|FG001|Overall Study|Complete remission|1|||
147567012|NCT01083693|532236411|FG002|Overall Study|Complete remission|0|||
147567013|NCT01083693|532236409|FG000|Overall Study|Other medical condition/surgery|1|||
147567014|NCT01083693|532236410|FG001|Overall Study|Other medical condition/surgery|1|||
147567015|NCT01083693|532236411|FG002|Overall Study|Other medical condition/surgery|0|||
147118156|NCT01058005|530598456|FG000|Overall Study|Withdrawal by Subject|4|||
147118157|NCT01058005|530598457|FG001|Overall Study|Withdrawal by Subject|5|||
147118158|NCT01058005|530598458|FG002|Overall Study|Withdrawal by Subject|11|||
147118159|NCT01058005|530598456|FG000|Overall Study|Withdrawn Due to Study Termination|27|||
147118160|NCT01058005|530598457|FG001|Overall Study|Withdrawn Due to Study Termination|13|||
147118161|NCT01058005|530598458|FG002|Overall Study|Withdrawn Due to Study Termination|7|||
147118162|NCT01058005|530598456|FG000|Overall Study|Reason Missing|5|||
147118163|NCT01058005|530598457|FG001|Overall Study|Reason Missing|3|||
147118164|NCT01058005|530598458|FG002|Overall Study|Reason Missing|1|||
147118165|NCT01145222|530598459|FG000|Overall Study|Procedure not done (no anesthesiologist)|0|||
147118166|NCT01145222|530598460|FG001|Overall Study|Procedure not done (no anesthesiologist)|0|||
147118167|NCT01145222|530598461|FG002|Overall Study|Procedure not done (no anesthesiologist)|1|||
147118168|NCT01145222|530598462|FG003|Overall Study|Procedure not done (no anesthesiologist)|0|||
147118169|NCT01145222|530598459|FG000|Overall Study|Poor bowel preparation|0|||
147118170|NCT01145222|530598460|FG001|Overall Study|Poor bowel preparation|0|||
147118171|NCT01145222|530598461|FG002|Overall Study|Poor bowel preparation|0|||
147118172|NCT01145222|530598462|FG003|Overall Study|Poor bowel preparation|1|||
147118173|NCT01698008|530598463|FG000|Overall Study|Withdrawal by Subject|1|||
147118174|NCT01698008|530598464|FG001|Overall Study|Withdrawal by Subject|2|||
147118175|NCT00122187|530598472|FG000|Overall Study|Withdrew because of resource limitations|2|||
147118176|NCT00122187|530598473|FG001|Overall Study|Withdrew because of resource limitations|2|||
147118177|NCT04865978|530598477|FG000|Overall Study|One patient did not complete the study due to infection and device explant|1|||
147118178|NCT04865978|530598478|FG001|Overall Study|One patient did not complete the study due to infection and device explant|0|||
147118179|NCT04263532|530598481|FG000|Overall Study|Withdrawal by Subject|2|||
147118180|NCT04263532|530598482|FG001|Overall Study|Withdrawal by Subject|0|||
147118181|NCT02181738|530598490|FG000|Overall Study|Participant Withdrew Consent|2|||
147118182|NCT02181738|530598491|FG001|Overall Study|Participant Withdrew Consent|1|||
147118183|NCT02181738|530598492|FG002|Overall Study|Participant Withdrew Consent|1|||
147118184|NCT02181738|530598493|FG003|Overall Study|Participant Withdrew Consent|1|||
147118185|NCT02181738|530598490|FG000|Overall Study|Lost to Follow-up|1|||
147118186|NCT02181738|530598491|FG001|Overall Study|Lost to Follow-up|2|||
147118187|NCT02181738|530598492|FG002|Overall Study|Lost to Follow-up|1|||
147118188|NCT02181738|530598493|FG003|Overall Study|Lost to Follow-up|1|||
147118189|NCT02181738|530598490|FG000|Overall Study|Participant no Longer Meets Study Criteria|0|||
147118190|NCT02181738|530598491|FG001|Overall Study|Participant no Longer Meets Study Criteria|0|||
147118191|NCT02181738|530598492|FG002|Overall Study|Participant no Longer Meets Study Criteria|0|||
147118192|NCT02181738|530598493|FG003|Overall Study|Participant no Longer Meets Study Criteria|1|||
147118193|NCT02181738|530598490|FG000|Overall Study|Poor/Non-Compliance|1|||
147118194|NCT02181738|530598491|FG001|Overall Study|Poor/Non-Compliance|0|||
147118195|NCT02181738|530598492|FG002|Overall Study|Poor/Non-Compliance|2|||
147230145|NCT00973349|531015946|FG013|Overall Study|Adverse Event|0|||
147230146|NCT00973349|531015947|FG014|Overall Study|Adverse Event|1|||
147230147|NCT00973349|531015948|FG015|Overall Study|Adverse Event|0|||
147230148|NCT00973349|531015933|FG000|Overall Study|Withdrawal by Subject|1|||
147230149|NCT00973349|531015934|FG001|Overall Study|Withdrawal by Subject|2|||
147230150|NCT00973349|531015935|FG002|Overall Study|Withdrawal by Subject|2|||
147230151|NCT00973349|531015936|FG003|Overall Study|Withdrawal by Subject|3|||
147230152|NCT00973349|531015937|FG004|Overall Study|Withdrawal by Subject|2|||
147230153|NCT00973349|531015938|FG005|Overall Study|Withdrawal by Subject|0|||
147230154|NCT00973349|531015939|FG006|Overall Study|Withdrawal by Subject|2|||
147230155|NCT00973349|531015940|FG007|Overall Study|Withdrawal by Subject|2|||
147230156|NCT00973349|531015941|FG008|Overall Study|Withdrawal by Subject|0|||
147230157|NCT00973349|531015942|FG009|Overall Study|Withdrawal by Subject|2|||
147230158|NCT00973349|531015943|FG010|Overall Study|Withdrawal by Subject|0|||
147230159|NCT00973349|531015944|FG011|Overall Study|Withdrawal by Subject|1|||
147230160|NCT00973349|531015945|FG012|Overall Study|Withdrawal by Subject|0|||
147230161|NCT00973349|531015946|FG013|Overall Study|Withdrawal by Subject|0|||
147230162|NCT00973349|531015947|FG014|Overall Study|Withdrawal by Subject|0|||
147230163|NCT00973349|531015948|FG015|Overall Study|Withdrawal by Subject|0|||
147230164|NCT00973349|531015933|FG000|Overall Study|Lost to Follow-up|3|||
147230165|NCT00973349|531015934|FG001|Overall Study|Lost to Follow-up|1|||
147230166|NCT00973349|531015935|FG002|Overall Study|Lost to Follow-up|2|||
147230167|NCT00973349|531015936|FG003|Overall Study|Lost to Follow-up|2|||
147650896|NCT02757352|532544545|FG008|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
147118196|NCT02181738|530598493|FG003|Overall Study|Poor/Non-Compliance|1|||
147118197|NCT02181738|530598490|FG000|Overall Study|Disease Progression|28|||
147118198|NCT02181738|530598491|FG001|Overall Study|Disease Progression|35|||
147118199|NCT02181738|530598492|FG002|Overall Study|Disease Progression|40|||
147118200|NCT02181738|530598493|FG003|Overall Study|Disease Progression|0|||
147118201|NCT02181738|530598490|FG000|Overall Study|Participant Request to Discontinue Study Treatment|5|||
147230168|NCT00973349|531015937|FG004|Overall Study|Lost to Follow-up|1|||
147230169|NCT00973349|531015938|FG005|Overall Study|Lost to Follow-up|3|||
147230170|NCT00973349|531015939|FG006|Overall Study|Lost to Follow-up|0|||
147650897|NCT02757352|532544546|FG009|IR-Open Label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
147118202|NCT02181738|530598491|FG001|Overall Study|Participant Request to Discontinue Study Treatment|12|||
147118203|NCT02181738|530598492|FG002|Overall Study|Participant Request to Discontinue Study Treatment|5|||
147118204|NCT02181738|530598493|FG003|Overall Study|Participant Request to Discontinue Study Treatment|1|||
147118205|NCT02181738|530598490|FG000|Overall Study|Study Drug Toxicity|6|||
147118206|NCT02181738|530598491|FG001|Overall Study|Study Drug Toxicity|11|||
147118207|NCT02181738|530598492|FG002|Overall Study|Study Drug Toxicity|8|||
147118208|NCT02181738|530598493|FG003|Overall Study|Study Drug Toxicity|1|||
147118209|NCT02181738|530598490|FG000|Overall Study|Other Reasons|14|||
147118210|NCT02181738|530598491|FG001|Overall Study|Other Reasons|16|||
147118211|NCT02181738|530598492|FG002|Overall Study|Other Reasons|28|||
147118212|NCT02181738|530598493|FG003|Overall Study|Other Reasons|0|||
147118213|NCT02181738|530598490|FG000|Overall Study|Maximum Clinical Benefit|3|||
147118214|NCT02181738|530598491|FG001|Overall Study|Maximum Clinical Benefit|0|||
147118215|NCT02181738|530598492|FG002|Overall Study|Maximum Clinical Benefit|1|||
147230171|NCT00973349|531015940|FG007|Overall Study|Lost to Follow-up|1|||
147230172|NCT00973349|531015941|FG008|Overall Study|Lost to Follow-up|2|||
147230173|NCT00973349|531015942|FG009|Overall Study|Lost to Follow-up|1|||
147230174|NCT00973349|531015943|FG010|Overall Study|Lost to Follow-up|0|||
147230175|NCT00973349|531015944|FG011|Overall Study|Lost to Follow-up|1|||
147567016|NCT01083693|532236409|FG000|Overall Study|Withdrawal by Subject|3|||
147567017|NCT01083693|532236410|FG001|Overall Study|Withdrawal by Subject|0|||
147567018|NCT01083693|532236411|FG002|Overall Study|Withdrawal by Subject|2|||
147567019|NCT01083693|532236409|FG000|Overall Study|Reason unknown|0|||
147567020|NCT01083693|532236410|FG001|Overall Study|Reason unknown|0|||
147567021|NCT01083693|532236411|FG002|Overall Study|Reason unknown|1|||
147567022|NCT04567186|532236414|FG000|Period 1|COVID-19 related|1|||
147567023|NCT04567186|532236415|FG001|Period 1|COVID-19 related|0|||
147567024|NCT04567186|532236414|FG000|Period 1|Protocol Violation|0|||
147230176|NCT00973349|531015945|FG012|Overall Study|Lost to Follow-up|0|||
147230177|NCT00973349|531015946|FG013|Overall Study|Lost to Follow-up|0|||
147230178|NCT00973349|531015947|FG014|Overall Study|Lost to Follow-up|0|||
147230179|NCT00973349|531015948|FG015|Overall Study|Lost to Follow-up|1|||
147230180|NCT00973349|531015933|FG000|Overall Study|Inappropriate enrolment|0|||
147230181|NCT00973349|531015934|FG001|Overall Study|Inappropriate enrolment|0|||
147230182|NCT00973349|531015935|FG002|Overall Study|Inappropriate enrolment|1|||
147230183|NCT00973349|531015936|FG003|Overall Study|Inappropriate enrolment|0|||
147230184|NCT00973349|531015937|FG004|Overall Study|Inappropriate enrolment|0|||
147230185|NCT00973349|531015938|FG005|Overall Study|Inappropriate enrolment|0|||
147230186|NCT00973349|531015939|FG006|Overall Study|Inappropriate enrolment|0|||
147230187|NCT00973349|531015940|FG007|Overall Study|Inappropriate enrolment|0|||
147230188|NCT00973349|531015941|FG008|Overall Study|Inappropriate enrolment|0|||
147230189|NCT00973349|531015942|FG009|Overall Study|Inappropriate enrolment|2|||
147230190|NCT00973349|531015943|FG010|Overall Study|Inappropriate enrolment|0|||
147230191|NCT00973349|531015944|FG011|Overall Study|Inappropriate enrolment|0|||
147230192|NCT00973349|531015945|FG012|Overall Study|Inappropriate enrolment|1|||
147230193|NCT00973349|531015946|FG013|Overall Study|Inappropriate enrolment|0|||
147230194|NCT00973349|531015947|FG014|Overall Study|Inappropriate enrolment|1|||
147230195|NCT00973349|531015948|FG015|Overall Study|Inappropriate enrolment|1|||
147230196|NCT00973349|531015933|FG000|Overall Study|Protocol Violation|0|||
147230197|NCT00973349|531015934|FG001|Overall Study|Protocol Violation|0|||
147230198|NCT00973349|531015935|FG002|Overall Study|Protocol Violation|0|||
147230199|NCT00973349|531015936|FG003|Overall Study|Protocol Violation|0|||
147230200|NCT00973349|531015937|FG004|Overall Study|Protocol Violation|0|||
147230201|NCT00973349|531015938|FG005|Overall Study|Protocol Violation|0|||
147230202|NCT00973349|531015939|FG006|Overall Study|Protocol Violation|0|||
147230203|NCT00973349|531015940|FG007|Overall Study|Protocol Violation|0|||
147230204|NCT00973349|531015941|FG008|Overall Study|Protocol Violation|1|||
147230205|NCT00973349|531015942|FG009|Overall Study|Protocol Violation|0|||
147230206|NCT00973349|531015943|FG010|Overall Study|Protocol Violation|0|||
147567025|NCT04567186|532236415|FG001|Period 1|Protocol Violation|1|||
147567026|NCT04567186|532236414|FG000|Period 1|Adverse Event|0|||
147567027|NCT04567186|532236415|FG001|Period 1|Adverse Event|2|||
147567028|NCT04567186|532236414|FG000|Period 2|COVID-19 Related|0|||
147118216|NCT02181738|530598493|FG003|Overall Study|Maximum Clinical Benefit|0|||
147118217|NCT02181738|530598490|FG000|Overall Study|Adverse Event Unrelated to Study Drug|3|||
147230207|NCT00973349|531015944|FG011|Overall Study|Protocol Violation|0|||
147118218|NCT02181738|530598491|FG001|Overall Study|Adverse Event Unrelated to Study Drug|3|||
147118219|NCT02181738|530598492|FG002|Overall Study|Adverse Event Unrelated to Study Drug|1|||
147230208|NCT00973349|531015945|FG012|Overall Study|Protocol Violation|0|||
147230209|NCT00973349|531015946|FG013|Overall Study|Protocol Violation|0|||
147230210|NCT00973349|531015947|FG014|Overall Study|Protocol Violation|0|||
147230211|NCT00973349|531015948|FG015|Overall Study|Protocol Violation|0|||
147230212|NCT00973349|531015933|FG000|Overall Study|Unable to classify|0|||
147567029|NCT04567186|532236415|FG001|Period 2|COVID-19 Related|1|||
147567030|NCT04567186|532236414|FG000|Period 2|Protocol Violation|0|||
147567031|NCT04567186|532236415|FG001|Period 2|Protocol Violation|1|||
147230213|NCT00973349|531015934|FG001|Overall Study|Unable to classify|0|||
147567032|NCT04567186|532236414|FG000|Period 2|Lost to Follow-up|0|||
147567033|NCT04567186|532236415|FG001|Period 2|Lost to Follow-up|1|||
147567034|NCT04567186|532236414|FG000|Period 3|Subject no longer meets eligibilty criteria|1|||
147567035|NCT04567186|532236415|FG001|Period 3|Subject no longer meets eligibilty criteria|0|||
147567036|NCT04274686|532236416|FG000|Overall Study|Physician Decision|1|||
147567037|NCT04274686|532236417|FG001|Overall Study|Physician Decision|0|||
147567038|NCT00376623|532236418|FG000|Overall Study|Progressive disease|35|||
147567039|NCT00376623|532236419|FG001|Overall Study|Progressive disease|22|||
147444470|NCT00912028|531792623|FG001|Overall Study|Withdrawal by Subject|0|||
147444471|NCT00912028|531792624|FG002|Overall Study|Withdrawal by Subject|0|||
147444472|NCT00912028|531792625|FG003|Overall Study|Withdrawal by Subject|0|||
147444473|NCT00912028|531792626|FG004|Overall Study|Withdrawal by Subject|0|||
147444474|NCT03418129|531792629|FG000|Overall Study|Lost to Follow-up|11|||
147567040|NCT00376623|532236420|FG002|Overall Study|Progressive disease|17|||
147567041|NCT00376623|532236418|FG000|Overall Study|Lost to Follow-up|0|||
147567042|NCT00376623|532236419|FG001|Overall Study|Lost to Follow-up|1|||
147567043|NCT00376623|532236420|FG002|Overall Study|Lost to Follow-up|0|||
147567044|NCT00376623|532236418|FG000|Overall Study|Adverse Event other than Dose Limiting Toxicity|6|||
147567045|NCT00376623|532236419|FG001|Overall Study|Adverse Event other than Dose Limiting Toxicity|1|||
147567046|NCT00376623|532236420|FG002|Overall Study|Adverse Event other than Dose Limiting Toxicity|2|||
147567047|NCT00376623|532236418|FG000|Overall Study|Not treated with BI 2536|1|||
147567048|NCT00376623|532236419|FG001|Overall Study|Not treated with BI 2536|0|||
147567049|NCT00376623|532236420|FG002|Overall Study|Not treated with BI 2536|0|||
147567050|NCT00376623|532236418|FG000|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536 after 6 cycles|1|||
147567051|NCT00376623|532236419|FG001|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536 after 6 cycles|0|||
147567052|NCT00376623|532236420|FG002|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536 after 6 cycles|0|||
147567053|NCT00376623|532236418|FG000|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536|1|||
147567054|NCT00376623|532236419|FG001|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536|0|||
147567055|NCT00376623|532236420|FG002|Overall Study|Investigator's and participant's decision to stop treatment with BI 2536|0|||
147567056|NCT00376623|532236418|FG000|Overall Study|Investigator's decision to stop treatment with BI 2536 after 6 cycles|2|||
147567057|NCT00376623|532236419|FG001|Overall Study|Investigator's decision to stop treatment with BI 2536 after 6 cycles|0|||
147567058|NCT00376623|532236420|FG002|Overall Study|Investigator's decision to stop treatment with BI 2536 after 6 cycles|0|||
147567059|NCT00376623|532236418|FG000|Overall Study|Investigator's decision to stop treatment with BI 2536|0|||
147230214|NCT00973349|531015935|FG002|Overall Study|Unable to classify|0|||
147230215|NCT00973349|531015936|FG003|Overall Study|Unable to classify|0|||
147230216|NCT00973349|531015937|FG004|Overall Study|Unable to classify|1|||
147230217|NCT00973349|531015938|FG005|Overall Study|Unable to classify|1|||
147230218|NCT00973349|531015939|FG006|Overall Study|Unable to classify|0|||
147230219|NCT00973349|531015940|FG007|Overall Study|Unable to classify|0|||
147230220|NCT00973349|531015941|FG008|Overall Study|Unable to classify|0|||
147230221|NCT00973349|531015942|FG009|Overall Study|Unable to classify|1|||
147230222|NCT00973349|531015943|FG010|Overall Study|Unable to classify|0|||
147230223|NCT00973349|531015944|FG011|Overall Study|Unable to classify|0|||
147230224|NCT00973349|531015945|FG012|Overall Study|Unable to classify|0|||
147230225|NCT00973349|531015946|FG013|Overall Study|Unable to classify|0|||
147230226|NCT00973349|531015947|FG014|Overall Study|Unable to classify|0|||
147230227|NCT00973349|531015948|FG015|Overall Study|Unable to classify|0|||
147230228|NCT05597020|531015952|FG000|Washout|Forbidden medication|2|||
147230229|NCT05597020|531015953|FG001|Washout|Forbidden medication|0|||
147230230|NCT05597020|531015952|FG000|Treatment Period II|Advice from primary care physician|1|||
147230231|NCT05597020|531015953|FG001|Treatment Period II|Advice from primary care physician|0|||
147230232|NCT05597020|531015952|FG000|Treatment Period II|Subject lost investigational product|1|||
147230233|NCT05597020|531015953|FG001|Treatment Period II|Subject lost investigational product|0|||
147230234|NCT05597020|531015952|FG000|Treatment Period II|Private reasons|0|||
147230235|NCT05597020|531015953|FG001|Treatment Period II|Private reasons|1|||
147230236|NCT05430022|531015954|FG000|Overall Study|Withdrawal by Subject|4|||
147230237|NCT05430022|531015955|FG001|Overall Study|Withdrawal by Subject|4|||
147230238|NCT02718300|531015958|FG000|Overall Study|Death|4|||
147230239|NCT02718300|531015959|FG001|Overall Study|Death|5|||
147444475|NCT03418129|531792630|FG001|Overall Study|Lost to Follow-up|20|||
147444476|NCT03418129|531792631|FG002|Overall Study|Lost to Follow-up|15|||
147567060|NCT00376623|532236419|FG001|Overall Study|Investigator's decision to stop treatment with BI 2536|1|||
147567061|NCT00376623|532236420|FG002|Overall Study|Investigator's decision to stop treatment with BI 2536|0|||
147650898|NCT02757352|532544537|FG000|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
147444477|NCT03418129|531792629|FG000|Overall Study|Withdrawal by Subject|3|||
147444478|NCT03418129|531792630|FG001|Overall Study|Withdrawal by Subject|6|||
147230240|NCT02718300|531015960|FG002|Overall Study|Death|17|||
147230241|NCT02718300|531015958|FG000|Overall Study|Lost to Follow-up|1|||
147230242|NCT02718300|531015959|FG001|Overall Study|Lost to Follow-up|0|||
147230243|NCT02718300|531015960|FG002|Overall Study|Lost to Follow-up|2|||
147230244|NCT02718300|531015958|FG000|Overall Study|Physician Decision|1|||
147230245|NCT02718300|531015959|FG001|Overall Study|Physician Decision|0|||
147567062|NCT00376623|532236418|FG000|Overall Study|Participant's decision to stop treatment with BI 2536 after 6 cycles|0|||
147567063|NCT00376623|532236419|FG001|Overall Study|Participant's decision to stop treatment with BI 2536 after 6 cycles|0|||
147567064|NCT00376623|532236420|FG002|Overall Study|Participant's decision to stop treatment with BI 2536 after 6 cycles|1|||
147567065|NCT00376623|532236418|FG000|Overall Study|Participant's decision to stop treatment with BI 2536|2|||
147567066|NCT00376623|532236419|FG001|Overall Study|Participant's decision to stop treatment with BI 2536|0|||
147567067|NCT00376623|532236420|FG002|Overall Study|Participant's decision to stop treatment with BI 2536|1|||
147230246|NCT02718300|531015960|FG002|Overall Study|Physician Decision|2|||
147230247|NCT02718300|531015958|FG000|Overall Study|Study Terminated by Sponsor|6|||
147230248|NCT02718300|531015959|FG001|Overall Study|Study Terminated by Sponsor|3|||
147230249|NCT02718300|531015960|FG002|Overall Study|Study Terminated by Sponsor|4|||
147230250|NCT02718300|531015958|FG000|Overall Study|Withdrawal by Subject|0|||
147230251|NCT02718300|531015959|FG001|Overall Study|Withdrawal by Subject|4|||
147230252|NCT02718300|531015960|FG002|Overall Study|Withdrawal by Subject|3|||
147230253|NCT02718300|531015958|FG000|Overall Study|Transitioned to Rollover Study or Pursued Allogenic Transplant|9|||
147230254|NCT02718300|531015959|FG001|Overall Study|Transitioned to Rollover Study or Pursued Allogenic Transplant|9|||
147230255|NCT02718300|531015960|FG002|Overall Study|Transitioned to Rollover Study or Pursued Allogenic Transplant|4|||
147230256|NCT02452697|531015961|FG000|Overall Study|Physician Decision|4|||
147230257|NCT02452697|531015962|FG001|Overall Study|Physician Decision|4|||
147230258|NCT02452697|531015963|FG002|Overall Study|Physician Decision|3|||
147230259|NCT02452697|531015964|FG003|Overall Study|Physician Decision|2|||
147230260|NCT02452697|531015961|FG000|Overall Study|Withdrawal by Subject|1|||
147230261|NCT02452697|531015962|FG001|Overall Study|Withdrawal by Subject|0|||
147230262|NCT02452697|531015963|FG002|Overall Study|Withdrawal by Subject|0|||
147230263|NCT02452697|531015964|FG003|Overall Study|Withdrawal by Subject|0|||
147230264|NCT02452697|531015961|FG000|Overall Study|still in follow-up|2|||
147230265|NCT02452697|531015962|FG001|Overall Study|still in follow-up|2|||
147230266|NCT02452697|531015963|FG002|Overall Study|still in follow-up|1|||
147230267|NCT02452697|531015964|FG003|Overall Study|still in follow-up|3|||
147230268|NCT00560885|531015967|FG000|Overall Study|Death|7|||
147230269|NCT00560885|531015967|FG000|Overall Study|Withdrawal by Subject|1|||
147230270|NCT02887859|531015968|FG000|Overall Study|Ongoing|6|||
147230271|NCT02887859|531015968|FG000|Overall Study|Adverse Event|7|||
147230272|NCT02887859|531015968|FG000|Overall Study|Death|1|||
147230273|NCT02887859|531015968|FG000|Overall Study|Physician Decision|1|||
147230274|NCT00257608|531017914|FG000|Chemotherapy Phase|Adverse Event|138|||
147230275|NCT00257608|531017915|FG001|Chemotherapy Phase|Adverse Event|0|||
147230276|NCT00257608|531017916|FG002|Chemotherapy Phase|Adverse Event|0|||
147230277|NCT00257608|531017914|FG000|Chemotherapy Phase|Disease progression|139|||
147230278|NCT00257608|531017915|FG001|Chemotherapy Phase|Disease progression|0|||
147230279|NCT00257608|531017916|FG002|Chemotherapy Phase|Disease progression|0|||
147230280|NCT00257608|531017914|FG000|Chemotherapy Phase|Unwillingness or inability to comply|6|||
147230281|NCT00257608|531017915|FG001|Chemotherapy Phase|Unwillingness or inability to comply|0|||
147230282|NCT00257608|531017916|FG002|Chemotherapy Phase|Unwillingness or inability to comply|0|||
147230283|NCT00257608|531017914|FG000|Chemotherapy Phase|Need for concomitant/ancillary therapy|27|||
147230284|NCT00257608|531017915|FG001|Chemotherapy Phase|Need for concomitant/ancillary therapy|0|||
147230285|NCT00257608|531017916|FG002|Chemotherapy Phase|Need for concomitant/ancillary therapy|0|||
147230286|NCT00257608|531017914|FG000|Chemotherapy Phase|Patient's decision to discontinue|35|||
147230287|NCT00257608|531017915|FG001|Chemotherapy Phase|Patient's decision to discontinue|0|||
147230288|NCT00257608|531017916|FG002|Chemotherapy Phase|Patient's decision to discontinue|0|||
147230289|NCT00257608|531017914|FG000|Chemotherapy Phase|Unrelated intercurrent illness|3|||
147230290|NCT00257608|531017915|FG001|Chemotherapy Phase|Unrelated intercurrent illness|0|||
147230291|NCT00257608|531017916|FG002|Chemotherapy Phase|Unrelated intercurrent illness|0|||
147230292|NCT00257608|531017914|FG000|Chemotherapy Phase|Physician Decision|28|||
147230293|NCT00257608|531017915|FG001|Chemotherapy Phase|Physician Decision|0|||
147230294|NCT00257608|531017916|FG002|Chemotherapy Phase|Physician Decision|0|||
147230295|NCT00257608|531017914|FG000|Post Chemotherapy Phase|Adverse Event|0|||
147230296|NCT00257608|531017915|FG001|Post Chemotherapy Phase|Adverse Event|34|||
147230297|NCT00257608|531017916|FG002|Post Chemotherapy Phase|Adverse Event|38|||
147444479|NCT03418129|531792631|FG002|Overall Study|Withdrawal by Subject|4|||
147444480|NCT01617070|531792635|FG000|BH4 and LNAA (4 Weeks)|started medication interfere with study|1|||
147444481|NCT00942175|531792636|FG000|Overall Study|Adverse Event|2|||
147230298|NCT00257608|531017914|FG000|Post Chemotherapy Phase|Disease progression|0|||
147230299|NCT00257608|531017915|FG001|Post Chemotherapy Phase|Disease progression|204|||
147230300|NCT00257608|531017916|FG002|Post Chemotherapy Phase|Disease progression|168|||
147230301|NCT00257608|531017914|FG000|Post Chemotherapy Phase|Unwillingness or inability to comply|0|||
147230302|NCT00257608|531017915|FG001|Post Chemotherapy Phase|Unwillingness or inability to comply|4|||
147230303|NCT00257608|531017916|FG002|Post Chemotherapy Phase|Unwillingness or inability to comply|5|||
147230304|NCT00257608|531017914|FG000|Post Chemotherapy Phase|Need for concomitant/ancillary therapy|0|||
147230305|NCT00257608|531017915|FG001|Post Chemotherapy Phase|Need for concomitant/ancillary therapy|5|||
147230306|NCT00257608|531017916|FG002|Post Chemotherapy Phase|Need for concomitant/ancillary therapy|5|||
147118220|NCT02181738|530598493|FG003|Overall Study|Adverse Event Unrelated to Study Drug|0|||
147118221|NCT01668537|530598494|FG000|Overall Study|Request to Discontinue Prematurely|1|||
147118222|NCT01668537|530598495|FG001|Overall Study|Request to Discontinue Prematurely|1|||
147118223|NCT01668537|530598494|FG000|Overall Study|Subject unwilling/unable to comply|5|||
147118224|NCT01668537|530598495|FG001|Overall Study|Subject unwilling/unable to comply|0|||
147118225|NCT01668537|530598494|FG000|Overall Study|Reason Precludes Participation|1|||
147118226|NCT01668537|530598495|FG001|Overall Study|Reason Precludes Participation|0|||
147118227|NCT01668537|530598494|FG000|Overall Study|Lost to Follow-up|13|||
147118228|NCT01668537|530598495|FG001|Overall Study|Lost to Follow-up|6|||
147118229|NCT01668537|530598494|FG000|Overall Study|Other|2|||
147118230|NCT01668537|530598495|FG001|Overall Study|Other|3|||
147118231|NCT04477486|530598501|FG000|Overall Study|Death|2|||
147118232|NCT04477486|530598501|FG000|Overall Study|Ongoing at Time of Analysis|11|||
147118233|NCT01543503|530598503|FG000|Overall Study|Lost to Follow-up|32|||
147118234|NCT01543503|530598504|FG001|Overall Study|Lost to Follow-up|36|||
147118235|NCT01543503|530598503|FG000|Overall Study|Adverse Event|9|||
147118236|NCT01543503|530598504|FG001|Overall Study|Adverse Event|13|||
147118237|NCT01543503|530598503|FG000|Overall Study|Lack of Efficacy|4|||
147118238|NCT01543503|530598504|FG001|Overall Study|Lack of Efficacy|16|||
147118239|NCT01543503|530598503|FG000|Overall Study|Participant withdrew informed consent|8|||
147118240|NCT01543503|530598504|FG001|Overall Study|Participant withdrew informed consent|10|||
147118241|NCT01543503|530598503|FG000|Overall Study|Change of jobs|0|||
147118242|NCT01543503|530598504|FG001|Overall Study|Change of jobs|1|||
147118243|NCT01543503|530598503|FG000|Overall Study|Intolerance to the biologic treatment|0|||
147118244|NCT01543503|530598504|FG001|Overall Study|Intolerance to the biologic treatment|1|||
147118245|NCT01543503|530598503|FG000|Overall Study|Probable overlap of RA with fibromyalgia|1|||
147118246|NCT01543503|530598504|FG001|Overall Study|Probable overlap of RA with fibromyalgia|0|||
147118247|NCT01543503|530598503|FG000|Overall Study|Participant did not complete last visit|0|||
147118248|NCT01543503|530598504|FG001|Overall Study|Participant did not complete last visit|2|||
147118249|NCT01543503|530598503|FG000|Overall Study|Refused to continue treatment|7|||
147118250|NCT01543503|530598504|FG001|Overall Study|Refused to continue treatment|0|||
147118251|NCT01543503|530598503|FG000|Overall Study|Incorrect medication received|1|||
147118252|NCT01543503|530598504|FG001|Overall Study|Incorrect medication received|0|||
147118253|NCT01543503|530598503|FG000|Overall Study|Participant moved to another city|2|||
147118254|NCT01543503|530598504|FG001|Overall Study|Participant moved to another city|0|||
147118255|NCT01543503|530598503|FG000|Overall Study|Participant will not return for visits|0|||
147118256|NCT01543503|530598504|FG001|Overall Study|Participant will not return for visits|2|||
147118257|NCT01543503|530598503|FG000|Overall Study|Participant transferred to another city|1|||
147118258|NCT01543503|530598504|FG001|Overall Study|Participant transferred to another city|0|||
147230307|NCT00257608|531017914|FG000|Post Chemotherapy Phase|Patient's decision to discontinue|0|||
147230308|NCT00257608|531017915|FG001|Post Chemotherapy Phase|Patient's decision to discontinue|4|||
147230309|NCT00257608|531017916|FG002|Post Chemotherapy Phase|Patient's decision to discontinue|8|||
147230310|NCT00257608|531017914|FG000|Post Chemotherapy Phase|Unrelated intercurrent illness|0|||
147230311|NCT00257608|531017915|FG001|Post Chemotherapy Phase|Unrelated intercurrent illness|0|||
147230312|NCT00257608|531017916|FG002|Post Chemotherapy Phase|Unrelated intercurrent illness|1|||
147230313|NCT00257608|531017914|FG000|Post Chemotherapy Phase|Lost to Follow-up|0|||
147230314|NCT00257608|531017915|FG001|Post Chemotherapy Phase|Lost to Follow-up|0|||
147230315|NCT00257608|531017916|FG002|Post Chemotherapy Phase|Lost to Follow-up|1|||
147230316|NCT00257608|531017914|FG000|Post Chemotherapy Phase|Physician Decision|0|||
147230317|NCT00257608|531017915|FG001|Post Chemotherapy Phase|Physician Decision|8|||
147230318|NCT00257608|531017916|FG002|Post Chemotherapy Phase|Physician Decision|11|||
147230319|NCT00257608|531017914|FG000|Post Chemotherapy Phase|Sponsor's decision to terminate study|0|||
147230320|NCT00257608|531017915|FG001|Post Chemotherapy Phase|Sponsor's decision to terminate study|1|||
147230321|NCT00257608|531017916|FG002|Post Chemotherapy Phase|Sponsor's decision to terminate study|0|||
147230322|NCT00257608|531017914|FG000|Post Chemotherapy Phase|Not treated|0|||
147230323|NCT00257608|531017915|FG001|Post Chemotherapy Phase|Not treated|4|||
147230324|NCT00257608|531017916|FG002|Post Chemotherapy Phase|Not treated|7|||
147230325|NCT00697073|531017917|FG000|Overall Study|Withdrawal by Subject|2|||
147230326|NCT00697073|531017917|FG000|Overall Study|Pregnancy|1|||
147230327|NCT00697073|531017917|FG000|Overall Study|non compliance and other|6|||
147230328|NCT00108433|531017918|FG000|Overall Study|Lack of Efficacy|1|||
147118259|NCT01543503|530598503|FG000|Overall Study|Participant moved to Scotland|1|||
147118260|NCT01543503|530598504|FG001|Overall Study|Participant moved to Scotland|0|||
147118261|NCT01543503|530598503|FG000|Overall Study|Participant decision to stop treatment|1|||
147118262|NCT01543503|530598504|FG001|Overall Study|Participant decision to stop treatment|0|||
147118263|NCT01543503|530598503|FG000|Overall Study|Investigator did not wish to participate|1|||
147118264|NCT01543503|530598504|FG001|Overall Study|Investigator did not wish to participate|1|||
147230329|NCT00108433|531017919|FG001|Overall Study|Lack of Efficacy|2|||
147230330|NCT00108433|531017918|FG000|Overall Study|Death|3|||
147230331|NCT00108433|531017919|FG001|Overall Study|Death|0|||
147230332|NCT00108433|531017918|FG000|Overall Study|Adverse Event|3|||
147230333|NCT00108433|531017919|FG001|Overall Study|Adverse Event|1|||
147567068|NCT00376623|532236418|FG000|Overall Study|Increase of tumour markers|0|||
147567069|NCT00376623|532236419|FG001|Overall Study|Increase of tumour markers|1|||
147567070|NCT00376623|532236420|FG002|Overall Study|Increase of tumour markers|0|||
147567071|NCT00376623|532236418|FG000|Overall Study|Bone metastasis|1|||
147567072|NCT00376623|532236419|FG001|Overall Study|Bone metastasis|0|||
147567073|NCT00376623|532236420|FG002|Overall Study|Bone metastasis|0|||
147567074|NCT04247282|532236421|FG000|Overall Study|Participant declined to participate before treatment started.|0|||
147567075|NCT04247282|532236422|FG001|Overall Study|Participant declined to participate before treatment started.|0|||
147567076|NCT04247282|532236423|FG002|Overall Study|Participant declined to participate before treatment started.|0|||
147567077|NCT04247282|532236424|FG003|Overall Study|Participant declined to participate before treatment started.|1|||
147567078|NCT04247282|532236421|FG000|Overall Study|Refused further treatment|0|||
147567079|NCT04247282|532236422|FG001|Overall Study|Refused further treatment|1|||
147567080|NCT04247282|532236423|FG002|Overall Study|Refused further treatment|0|||
147567081|NCT04247282|532236424|FG003|Overall Study|Refused further treatment|0|||
147567082|NCT01313273|532236425|FG000|Overall Study|INCLUSION CRITERIA 4 NOT RESPECTED|1|||
147567083|NCT01313273|532236426|FG001|Overall Study|INCLUSION CRITERIA 4 NOT RESPECTED|0|||
147567084|NCT01313273|532236425|FG000|Overall Study|Withdrawal by Subject|1|||
147567085|NCT01313273|532236426|FG001|Overall Study|Withdrawal by Subject|0|||
147567086|NCT01313273|532236425|FG000|Overall Study|Screening Chromogranin A-in normal range|0|||
147567087|NCT01313273|532236426|FG001|Overall Study|Screening Chromogranin A-in normal range|1|||
147567088|NCT03687736|532236427|FG000|Overall Study|Lost to Follow-up|7|||
147567089|NCT03687736|532236427|FG000|Overall Study|Withdrawal by Subject|3|||
147567090|NCT03496623|532236430|FG000|Run-In Period (2 Weeks)|Death|1|||
147567091|NCT03496623|532236431|FG001|Run-In Period (2 Weeks)|Death|0|||
147567092|NCT03496623|532236432|FG002|Run-In Period (2 Weeks)|Death|0|||
147567093|NCT03496623|532236433|FG003|Run-In Period (2 Weeks)|Death|0|||
147567094|NCT03496623|532236434|FG004|Run-In Period (2 Weeks)|Death|0|||
147567095|NCT03496623|532236430|FG000|Run-In Period (2 Weeks)|Discontinued Prior to Randomization|31|||
147567096|NCT03496623|532236431|FG001|Run-In Period (2 Weeks)|Discontinued Prior to Randomization|0|||
147567097|NCT03496623|532236432|FG002|Run-In Period (2 Weeks)|Discontinued Prior to Randomization|0|||
147567098|NCT03496623|532236433|FG003|Run-In Period (2 Weeks)|Discontinued Prior to Randomization|0|||
147567099|NCT03496623|532236434|FG004|Run-In Period (2 Weeks)|Discontinued Prior to Randomization|0|||
147567100|NCT03496623|532236430|FG000|Period 1 (12 Weeks)|Death|0|||
147567101|NCT03496623|532236431|FG001|Period 1 (12 Weeks)|Death|3|||
147567102|NCT03496623|532236432|FG002|Period 1 (12 Weeks)|Death|0|||
147567103|NCT03496623|532236433|FG003|Period 1 (12 Weeks)|Death|0|||
147567104|NCT03496623|532236434|FG004|Period 1 (12 Weeks)|Death|0|||
147567105|NCT03496623|532236430|FG000|Period 1 (12 Weeks)|Study Terminated by Sponsor|0|||
147567106|NCT03496623|532236431|FG001|Period 1 (12 Weeks)|Study Terminated by Sponsor|0|||
147567107|NCT03496623|532236432|FG002|Period 1 (12 Weeks)|Study Terminated by Sponsor|0|||
147567108|NCT03496623|532236433|FG003|Period 1 (12 Weeks)|Study Terminated by Sponsor|1|||
147567109|NCT03496623|532236434|FG004|Period 1 (12 Weeks)|Study Terminated by Sponsor|2|||
147567110|NCT03496623|532236430|FG000|Period 1 (12 Weeks)|Withdrawal by Subject|0|||
147567111|NCT03496623|532236431|FG001|Period 1 (12 Weeks)|Withdrawal by Subject|3|||
147567112|NCT03496623|532236432|FG002|Period 1 (12 Weeks)|Withdrawal by Subject|3|||
147567113|NCT03496623|532236433|FG003|Period 1 (12 Weeks)|Withdrawal by Subject|0|||
147567114|NCT03496623|532236434|FG004|Period 1 (12 Weeks)|Withdrawal by Subject|0|||
147567115|NCT03496623|532236430|FG000|Period 2 (12 Weeks)|COVID-19 Pandemic Impact|0|||
147567116|NCT03496623|532236431|FG001|Period 2 (12 Weeks)|COVID-19 Pandemic Impact|4|||
147567117|NCT03496623|532236432|FG002|Period 2 (12 Weeks)|COVID-19 Pandemic Impact|5|||
147567118|NCT03496623|532236433|FG003|Period 2 (12 Weeks)|COVID-19 Pandemic Impact|0|||
147567119|NCT03496623|532236434|FG004|Period 2 (12 Weeks)|COVID-19 Pandemic Impact|0|||
147567120|NCT03496623|532236430|FG000|Period 2 (12 Weeks)|Lost to Follow-up|0|||
147567121|NCT03496623|532236431|FG001|Period 2 (12 Weeks)|Lost to Follow-up|0|||
147567122|NCT03496623|532236432|FG002|Period 2 (12 Weeks)|Lost to Follow-up|1|||
147567123|NCT03496623|532236433|FG003|Period 2 (12 Weeks)|Lost to Follow-up|0|||
147567124|NCT03496623|532236434|FG004|Period 2 (12 Weeks)|Lost to Follow-up|0|||
147567125|NCT03496623|532236430|FG000|Period 2 (12 Weeks)|Study Terminated by Sponsor|0|||
147567126|NCT03496623|532236431|FG001|Period 2 (12 Weeks)|Study Terminated by Sponsor|0|||
147567127|NCT03496623|532236432|FG002|Period 2 (12 Weeks)|Study Terminated by Sponsor|1|||
147567128|NCT03496623|532236433|FG003|Period 2 (12 Weeks)|Study Terminated by Sponsor|0|||
147567129|NCT03496623|532236434|FG004|Period 2 (12 Weeks)|Study Terminated by Sponsor|0|||
147567130|NCT03496623|532236430|FG000|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
147567131|NCT03496623|532236431|FG001|Period 2 (12 Weeks)|Withdrawal by Subject|3|||
147567132|NCT03496623|532236432|FG002|Period 2 (12 Weeks)|Withdrawal by Subject|1|||
147567133|NCT03496623|532236433|FG003|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
147567134|NCT03496623|532236434|FG004|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
147567135|NCT02543203|532236435|FG000|Overall Study|Unpalatable Fragrance|2|||
147567136|NCT02543203|532236436|FG001|Overall Study|Unpalatable Fragrance|2|||
147567137|NCT02543203|532236435|FG000|Overall Study|Lost to Follow-up|1|||
147567138|NCT02543203|532236436|FG001|Overall Study|Lost to Follow-up|0|||
147567139|NCT02543203|532236435|FG000|Overall Study|Increased Irritability|1|||
147567140|NCT02543203|532236436|FG001|Overall Study|Increased Irritability|0|||
147567141|NCT02543203|532236435|FG000|Overall Study|Family|1|||
147567142|NCT02543203|532236436|FG001|Overall Study|Family|2|||
147567143|NCT02543203|532236435|FG000|Overall Study|Negative Behavior|1|||
147567144|NCT02543203|532236436|FG001|Overall Study|Negative Behavior|0|||
147567145|NCT02543203|532236435|FG000|Overall Study|Withdrawal by Subject|0|||
147567146|NCT02543203|532236436|FG001|Overall Study|Withdrawal by Subject|1|||
147567147|NCT03020615|532236437|FG000|Overall Study|Physician Decision|3|||
147567148|NCT03020615|532236438|FG001|Overall Study|Physician Decision|1|||
147567149|NCT03020615|532236439|FG002|Overall Study|Physician Decision|2|||
147567150|NCT03020615|532236437|FG000|Overall Study|Parent/guardian/patient choice|3|||
147567151|NCT03020615|532236438|FG001|Overall Study|Parent/guardian/patient choice|0|||
147567152|NCT03020615|532236439|FG002|Overall Study|Parent/guardian/patient choice|4|||
147567153|NCT03020615|532236437|FG000|Overall Study|Screen failure|0|||
147567154|NCT03020615|532236438|FG001|Overall Study|Screen failure|0|||
147567155|NCT03020615|532236439|FG002|Overall Study|Screen failure|1|||
147567156|NCT03020615|532236437|FG000|Overall Study|Death|1|||
147567157|NCT03020615|532236438|FG001|Overall Study|Death|0|||
147567158|NCT03020615|532236439|FG002|Overall Study|Death|0|||
147567159|NCT03020615|532236437|FG000|Overall Study|Lost to Follow-up|0|||
147230334|NCT00108433|531017918|FG000|Overall Study|Other|14|||
147567160|NCT03020615|532236438|FG001|Overall Study|Lost to Follow-up|1|||
147567161|NCT03020615|532236439|FG002|Overall Study|Lost to Follow-up|0|||
147567162|NCT00089661|532236440|FG000|Overall Study|Adverse Event|0|||
147567163|NCT00089661|532236441|FG001|Overall Study|Adverse Event|2|||
147567164|NCT00089661|532236440|FG000|Overall Study|Death|1|||
147567165|NCT00089661|532236441|FG001|Overall Study|Death|0|||
147567166|NCT00089661|532236440|FG000|Overall Study|Lost to Follow-up|0|||
147567167|NCT00089661|532236441|FG001|Overall Study|Lost to Follow-up|3|||
147567168|NCT00089661|532236440|FG000|Overall Study|Withdrawal by Subject|11|||
147567169|NCT00089661|532236441|FG001|Overall Study|Withdrawal by Subject|9|||
147567170|NCT00089661|532236440|FG000|Overall Study|Disease progression|1|||
147567171|NCT00089661|532236441|FG001|Overall Study|Disease progression|3|||
147567172|NCT00089661|532236440|FG000|Overall Study|Ineligibility determined|4|||
147567173|NCT00089661|532236441|FG001|Overall Study|Ineligibility determined|4|||
147567174|NCT00089661|532236440|FG000|Overall Study|Noncompliance|2|||
147567175|NCT00089661|532236441|FG001|Overall Study|Noncompliance|4|||
147567176|NCT00089661|532236440|FG000|Overall Study|Other|2|||
147567177|NCT00089661|532236441|FG001|Overall Study|Other|1|||
147567178|NCT02077465|532236445|FG000|Overall Study|Withdrew Consent|0|||
147567179|NCT02077465|532236446|FG001|Overall Study|Withdrew Consent|1|||
147567180|NCT02077465|532236445|FG000|Overall Study|Lost to Follow-up|1|||
147567181|NCT02077465|532236446|FG001|Overall Study|Lost to Follow-up|0|||
147567182|NCT02481830|532236448|FG000|Pre-treatment|Participant no longer meets Study Criteria|1|||
147230335|NCT00108433|531017919|FG001|Overall Study|Other|14|||
147567183|NCT02481830|532236449|FG001|Pre-treatment|Participant no longer meets Study Criteria|4|||
147567184|NCT02481830|532236448|FG000|Pre-treatment|Withdrawal by Subject|0|||
147567185|NCT02481830|532236449|FG001|Pre-treatment|Withdrawal by Subject|10|||
147567186|NCT02481830|532236448|FG000|Pre-treatment|Disease Progression|1|||
147567187|NCT02481830|532236449|FG001|Pre-treatment|Disease Progression|1|||
147567188|NCT02481830|532236448|FG000|Pre-treatment|Other reasons|0|||
147567189|NCT02481830|532236449|FG001|Pre-treatment|Other reasons|1|||
147567190|NCT02481830|532236448|FG000|Pre-treatment|Participant request to discontinue study treatment|0|||
147567191|NCT02481830|532236449|FG001|Pre-treatment|Participant request to discontinue study treatment|4|||
147567192|NCT02481830|532236448|FG000|Treatment|Disease Progression|233|||
147567193|NCT02481830|532236449|FG001|Treatment|Disease Progression|171|||
147567194|NCT02481830|532236448|FG000|Treatment|Study drug toxicity|18|||
147567195|NCT02481830|532236449|FG001|Treatment|Study drug toxicity|38|||
147567196|NCT02481830|532236448|FG000|Treatment|Death|1|||
147567197|NCT02481830|532236449|FG001|Treatment|Death|1|||
147567198|NCT02481830|532236448|FG000|Treatment|Adverse Event unrelated to Study drug|14|||
147567199|NCT02481830|532236449|FG001|Treatment|Adverse Event unrelated to Study drug|11|||
147230336|NCT02203071|531017920|FG000|Overall Study|Lost to Follow-up|3|||
147230337|NCT02203071|531017921|FG001|Overall Study|Lost to Follow-up|1|||
147230338|NCT01886716|531017922|FG000|Week 1|Lost to Follow-up|0|||
147567200|NCT02481830|532236448|FG000|Treatment|Participants request to discontinue Study treatment|6|||
147567201|NCT02481830|532236449|FG001|Treatment|Participants request to discontinue Study treatment|34|||
147567202|NCT02481830|532236448|FG000|Treatment|Withdrawal by Subject|2|||
147567203|NCT02481830|532236449|FG001|Treatment|Withdrawal by Subject|3|||
147567204|NCT02481830|532236448|FG000|Treatment|Lost to Follow-up|1|||
147567205|NCT02481830|532236449|FG001|Treatment|Lost to Follow-up|0|||
147567206|NCT02481830|532236448|FG000|Treatment|Maximum Clinical Benefit|0|||
147567207|NCT02481830|532236449|FG001|Treatment|Maximum Clinical Benefit|5|||
147567208|NCT02481830|532236448|FG000|Treatment|Administrative reason by sponsor|1|||
147567209|NCT02481830|532236449|FG001|Treatment|Administrative reason by sponsor|1|||
147567210|NCT02481830|532236448|FG000|Treatment|Other reasons|6|||
147567211|NCT02481830|532236449|FG001|Treatment|Other reasons|1|||
147230339|NCT01886716|531017923|FG001|Week 1|Lost to Follow-up|0|||
147567212|NCT04627038|532236450|FG000|Overall Study|Adverse Event|36|||
147567213|NCT04627038|532236451|FG001|Overall Study|Adverse Event|8|||
147118265|NCT01543503|530598503|FG000|Overall Study|Participant recruited after closing date|0|||
147118266|NCT01543503|530598504|FG001|Overall Study|Participant recruited after closing date|1|||
147118267|NCT01543503|530598503|FG000|Overall Study|Site stopped participation|5|||
147118268|NCT01543503|530598504|FG001|Overall Study|Site stopped participation|1|||
147118269|NCT01543503|530598503|FG000|Overall Study|Participant did not attend a visit|1|||
147118270|NCT01543503|530598504|FG001|Overall Study|Participant did not attend a visit|0|||
147118271|NCT01543503|530598503|FG000|Overall Study|Moved to other rheumatologic site|0|||
147118272|NCT01543503|530598504|FG001|Overall Study|Moved to other rheumatologic site|1|||
147118273|NCT01543503|530598503|FG000|Overall Study|Participant consented to another study|0|||
147118274|NCT01543503|530598504|FG001|Overall Study|Participant consented to another study|2|||
147118275|NCT01543503|530598503|FG000|Overall Study|Participant went to United States|1|||
147118276|NCT01543503|530598504|FG001|Overall Study|Participant went to United States|0|||
147118277|NCT01543503|530598503|FG000|Overall Study|Screen failure|1|||
147118278|NCT01543503|530598504|FG001|Overall Study|Screen failure|0|||
147118279|NCT02460380|530598505|FG000|Overall Study|Withdrawal by Subject|10|||
147118280|NCT02460380|530598506|FG001|Overall Study|Withdrawal by Subject|5|||
147118281|NCT04576949|530598508|FG000|Overall Study|Adverse Event|1|||
147118282|NCT04576949|530598509|FG001|Overall Study|Adverse Event|3|||
147118283|NCT04576949|530598510|FG002|Overall Study|Adverse Event|2|||
147118284|NCT04576949|530598508|FG000|Overall Study|Withdrawal by Subject|41|||
147567214|NCT04627038|532236450|FG000|Overall Study|Lost to Follow-up|1|||
147567215|NCT04627038|532236451|FG001|Overall Study|Lost to Follow-up|0|||
147567216|NCT04627038|532236450|FG000|Overall Study|Physician Decision|0|||
147567217|NCT04627038|532236451|FG001|Overall Study|Physician Decision|1|||
147567218|NCT04627038|532236450|FG000|Overall Study|Protocol Violation|3|||
147567219|NCT04627038|532236451|FG001|Overall Study|Protocol Violation|1|||
147567220|NCT04627038|532236450|FG000|Overall Study|Withdrawal by Subject|13|||
147567221|NCT04627038|532236451|FG001|Overall Study|Withdrawal by Subject|3|||
147567222|NCT04627038|532236450|FG000|Overall Study|Non-compliance with study drug|0|||
147567223|NCT04627038|532236451|FG001|Overall Study|Non-compliance with study drug|1|||
147567224|NCT04627038|532236450|FG000|Overall Study|Prohibited Concomitant Medication|1|||
147567225|NCT04627038|532236451|FG001|Overall Study|Prohibited Concomitant Medication|0|||
147567226|NCT00794963|532236456|FG000|Overall Study|Withdrawal by Subject|1|||
147567227|NCT00794963|532236457|FG001|Overall Study|Withdrawal by Subject|4|||
147567228|NCT03375463|532236458|FG000|Period 1|Lost to Follow-up|0|||
147567229|NCT03375463|532236459|FG001|Period 1|Lost to Follow-up|0|||
147567230|NCT03375463|532236460|FG002|Period 1|Lost to Follow-up|1|||
147567231|NCT03375463|532236461|FG003|Period 1|Lost to Follow-up|0|||
147567232|NCT03375463|532236462|FG004|Period 1|Lost to Follow-up|0|||
147567233|NCT03375463|532236463|FG005|Period 1|Lost to Follow-up|0|||
147567234|NCT03375463|532236458|FG000|Period 1|Adverse Event|0|||
147567235|NCT03375463|532236459|FG001|Period 1|Adverse Event|0|||
147567236|NCT03375463|532236460|FG002|Period 1|Adverse Event|0|||
147567237|NCT03375463|532236461|FG003|Period 1|Adverse Event|0|||
147567238|NCT03375463|532236462|FG004|Period 1|Adverse Event|1|||
147567239|NCT03375463|532236463|FG005|Period 1|Adverse Event|0|||
147567240|NCT03375463|532236458|FG000|Period 2|Lost to Follow-up|1|||
147567241|NCT03375463|532236459|FG001|Period 2|Lost to Follow-up|1|||
147567242|NCT03375463|532236460|FG002|Period 2|Lost to Follow-up|0|||
147567243|NCT03375463|532236461|FG003|Period 2|Lost to Follow-up|0|||
147567244|NCT03375463|532236462|FG004|Period 2|Lost to Follow-up|0|||
147567245|NCT03375463|532236463|FG005|Period 2|Lost to Follow-up|0|||
147567246|NCT01827163|532236464|FG000|Overall Study|Hypersensitivity reaction to Paclitaxel|2|||
147567247|NCT01827163|532236464|FG000|Overall Study|Adverse Event|9|||
147567248|NCT01037114|532236465|FG000|Year 20|Others|1|||
147567249|NCT02294604|532236473|FG000|Overall Study|Did not provide samples for culture|0|||
147567250|NCT02294604|532236474|FG001|Overall Study|Did not provide samples for culture|1|||
147567251|NCT02294604|532236475|FG002|Overall Study|Did not provide samples for culture|0|||
147567252|NCT02294604|532236473|FG000|Overall Study|Culture contamination|1|||
147567253|NCT02294604|532236474|FG001|Overall Study|Culture contamination|2|||
147567254|NCT02294604|532236475|FG002|Overall Study|Culture contamination|0|||
147567255|NCT01513174|532236478|FG000|Overall Study|Inclusion Error|1|||
147567256|NCT01513174|532236479|FG001|Overall Study|Inclusion Error|7|||
147567257|NCT01513174|532236478|FG000|Overall Study|Not receive study treatment|3|||
147567258|NCT01513174|532236479|FG001|Overall Study|Not receive study treatment|1|||
147567259|NCT01363765|532236480|FG000|Overall Study|non-diagnostic|2621|||
147567260|NCT01363765|532236481|FG001|Overall Study|non-diagnostic|1124|||
147567261|NCT01363765|532236480|FG000|Overall Study|duplicate records|736|||
147567262|NCT01363765|532236481|FG001|Overall Study|duplicate records|3177|||
147567263|NCT01363765|532236480|FG000|Overall Study|non-resident|156|||
147567264|NCT01363765|532236481|FG001|Overall Study|non-resident|76|||
147567265|NCT01363765|532236480|FG000|Overall Study|age not recorded (used for cross-linkage|117|||
147567266|NCT01363765|532236481|FG001|Overall Study|age not recorded (used for cross-linkage|354|||
147567267|NCT01363765|532236480|FG000|Overall Study|smear during intervention|2170|||
147567268|NCT01363765|532236481|FG001|Overall Study|smear during intervention|0|||
147567269|NCT01900626|532236482|FG000|Overall Study|study was closed due to low enrollment|1|||
147118285|NCT04576949|530598509|FG001|Overall Study|Withdrawal by Subject|26|||
147118286|NCT04576949|530598510|FG002|Overall Study|Withdrawal by Subject|18|||
147118287|NCT04576949|530598508|FG000|Overall Study|Physician Decision|3|||
147118288|NCT04576949|530598509|FG001|Overall Study|Physician Decision|0|||
147118289|NCT04576949|530598510|FG002|Overall Study|Physician Decision|0|||
147118290|NCT04576949|530598508|FG000|Overall Study|Death|0|||
147118291|NCT04576949|530598509|FG001|Overall Study|Death|1|||
147118292|NCT04576949|530598510|FG002|Overall Study|Death|0|||
147118293|NCT04576949|530598508|FG000|Overall Study|Lost to Follow-up|29|||
147118294|NCT04576949|530598509|FG001|Overall Study|Lost to Follow-up|37|||
147118295|NCT04576949|530598510|FG002|Overall Study|Lost to Follow-up|24|||
147118296|NCT04576949|530598508|FG000|Overall Study|Other, Not Specified|2|||
147118297|NCT04576949|530598509|FG001|Overall Study|Other, Not Specified|3|||
147118298|NCT04576949|530598510|FG002|Overall Study|Other, Not Specified|1|||
147118299|NCT04576949|530598508|FG000|Overall Study|Other|1|||
147118300|NCT04576949|530598509|FG001|Overall Study|Other|0|||
147118301|NCT04576949|530598510|FG002|Overall Study|Other|0|||
147118302|NCT00052715|530598511|FG000|Overall Study|wrong histology|1|||
147118303|NCT01936974|530598512|FG000|Overall Study|Physician Decision|2|||
147118304|NCT01936974|530598513|FG001|Overall Study|Physician Decision|5|||
147118305|NCT04584554|530598514|FG000|Overall Study|Withdrawal by Subject|2|||
147118306|NCT04584554|530598515|FG001|Overall Study|Withdrawal by Subject|2|||
147118307|NCT02280499|530598519|FG000|Overall Study|Death|14|||
147118308|NCT02280499|530598519|FG000|Overall Study|Lost to Follow-up|42|||
147118309|NCT02280499|530598519|FG000|Overall Study|Adverse Event|5|||
147118310|NCT01436500|530598521|FG000|Overall Study|Death|1|||
147118311|NCT01436500|530598522|FG001|Overall Study|Death|0|||
147118312|NCT01436500|530598523|FG002|Overall Study|Death|0|||
147118313|NCT01436500|530598524|FG003|Overall Study|Death|0|||
147118314|NCT01436500|530598525|FG004|Overall Study|Death|0|||
147118315|NCT01436500|530598521|FG000|Overall Study|Adverse Event|0|||
147118316|NCT01436500|530598522|FG001|Overall Study|Adverse Event|2|||
147118317|NCT01436500|530598523|FG002|Overall Study|Adverse Event|2|||
147118318|NCT01436500|530598524|FG003|Overall Study|Adverse Event|0|||
147118319|NCT01436500|530598525|FG004|Overall Study|Adverse Event|1|||
147118320|NCT01436500|530598521|FG000|Overall Study|Withdrawal by Subject|0|||
147118321|NCT01436500|530598522|FG001|Overall Study|Withdrawal by Subject|0|||
147118322|NCT01436500|530598523|FG002|Overall Study|Withdrawal by Subject|2|||
147118323|NCT01436500|530598524|FG003|Overall Study|Withdrawal by Subject|0|||
147118324|NCT01436500|530598525|FG004|Overall Study|Withdrawal by Subject|2|||
147118325|NCT01436500|530598521|FG000|Overall Study|Physician Decision|0|||
147118326|NCT01436500|530598522|FG001|Overall Study|Physician Decision|0|||
147118327|NCT01436500|530598523|FG002|Overall Study|Physician Decision|1|||
147118328|NCT01436500|530598524|FG003|Overall Study|Physician Decision|0|||
147118329|NCT01436500|530598525|FG004|Overall Study|Physician Decision|0|||
147118330|NCT01436500|530598521|FG000|Overall Study|liver transplant|1|||
147118331|NCT01436500|530598522|FG001|Overall Study|liver transplant|0|||
147118332|NCT01436500|530598523|FG002|Overall Study|liver transplant|0|||
147118333|NCT01436500|530598524|FG003|Overall Study|liver transplant|0|||
147118334|NCT01436500|530598525|FG004|Overall Study|liver transplant|0|||
147118335|NCT01436500|530598521|FG000|Overall Study|initiation of dialysis|0|||
147118336|NCT01436500|530598522|FG001|Overall Study|initiation of dialysis|0|||
147118337|NCT01436500|530598523|FG002|Overall Study|initiation of dialysis|0|||
147118338|NCT01436500|530598524|FG003|Overall Study|initiation of dialysis|0|||
147118339|NCT01436500|530598525|FG004|Overall Study|initiation of dialysis|1|||
147118340|NCT01436500|530598521|FG000|Overall Study|discontinued study drug|1|||
147118341|NCT01436500|530598522|FG001|Overall Study|discontinued study drug|0|||
147118342|NCT01436500|530598523|FG002|Overall Study|discontinued study drug|0|||
147118343|NCT01436500|530598524|FG003|Overall Study|discontinued study drug|0|||
147118344|NCT01436500|530598525|FG004|Overall Study|discontinued study drug|0|||
147118345|NCT01436500|530598521|FG000|Overall Study|Other|0|||
147118346|NCT01436500|530598522|FG001|Overall Study|Other|1|||
147118347|NCT01436500|530598523|FG002|Overall Study|Other|0|||
147118348|NCT01436500|530598524|FG003|Overall Study|Other|1|||
147118349|NCT01436500|530598525|FG004|Overall Study|Other|0|||
147118350|NCT00977561|530598526|FG000|Overall Study|Death|3|||
147118351|NCT00977561|530598527|FG001|Overall Study|Death|2|||
147118352|NCT00977561|530598526|FG000|Overall Study|Study terminated|0|||
147118353|NCT00977561|530598527|FG001|Overall Study|Study terminated|2|||
147118354|NCT00977561|530598526|FG000|Overall Study|Other|2|||
147118355|NCT00977561|530598527|FG001|Overall Study|Other|0|||
147118356|NCT03511066|530598542|FG000|Overall Study|Withdrawal by Subject|1|||
147118357|NCT03511066|530598543|FG001|Overall Study|Withdrawal by Subject|2|||
147118358|NCT03511066|530598544|FG002|Overall Study|Withdrawal by Subject|3|||
147118359|NCT03511066|530598542|FG000|Overall Study|Lost to Follow-up|2|||
147118360|NCT03511066|530598543|FG001|Overall Study|Lost to Follow-up|3|||
147118361|NCT03511066|530598544|FG002|Overall Study|Lost to Follow-up|0|||
147118362|NCT04560309|530598546|FG000|Overall Study|Meet drop out criteria|1|||
147118363|NCT04560309|530598547|FG001|Overall Study|Meet drop out criteria|1|||
147118364|NCT05085405|530598548|FG000|Overall Study|Patient closed to the anticoagulation clinic monitoring service|0|||
147567270|NCT01900626|532236483|FG001|Overall Study|study was closed due to low enrollment|1|||
147567271|NCT04533594|532236484|FG000|Overall Study|Death|26|||
147567272|NCT01975948|532236488|FG000|Overall Study|Withdrawal by Subject|17|||
147567273|NCT01975948|532236489|FG001|Overall Study|Withdrawal by Subject|21|||
147567274|NCT01975948|532236490|FG002|Overall Study|Withdrawal by Subject|7|||
147567275|NCT01975948|532236491|FG003|Overall Study|Withdrawal by Subject|6|||
147567276|NCT05169710|532236494|FG000|Overall Study|Adverse Event|1|||
147567277|NCT05169710|532236495|FG001|Overall Study|Adverse Event|2|||
147567278|NCT05169710|532236496|FG002|Overall Study|Adverse Event|2|||
147567279|NCT05169710|532236494|FG000|Overall Study|Lost to Follow-up|0|||
147567280|NCT05169710|532236495|FG001|Overall Study|Lost to Follow-up|0|||
147567281|NCT05169710|532236496|FG002|Overall Study|Lost to Follow-up|1|||
147567282|NCT05169710|532236494|FG000|Overall Study|Withdrawal by Subject|2|||
147567283|NCT05169710|532236495|FG001|Overall Study|Withdrawal by Subject|1|||
147567284|NCT05169710|532236496|FG002|Overall Study|Withdrawal by Subject|0|||
147567285|NCT05169710|532236494|FG000|Overall Study|Other Study Discontinuation Reason|0|||
147567286|NCT05169710|532236495|FG001|Overall Study|Other Study Discontinuation Reason|2|||
147567287|NCT05169710|532236496|FG002|Overall Study|Other Study Discontinuation Reason|0|||
147650899|NCT02757352|532544538|FG001|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
147650900|NCT02757352|532544539|FG002|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
147118365|NCT05085405|530598549|FG001|Overall Study|Patient closed to the anticoagulation clinic monitoring service|0|||
147118366|NCT05085405|530598550|FG002|Overall Study|Patient closed to the anticoagulation clinic monitoring service|1|||
147118367|NCT05085405|530598551|FG003|Overall Study|Patient closed to the anticoagulation clinic monitoring service|2|||
147118368|NCT05085405|530598552|FG004|Overall Study|Patient closed to the anticoagulation clinic monitoring service|0|||
147118369|NCT05085405|530598553|FG005|Overall Study|Patient closed to the anticoagulation clinic monitoring service|0|||
147118370|NCT05085405|530598548|FG000|Overall Study|Patient started PPI prior to intervention delivery.|0|||
147118371|NCT05085405|530598549|FG001|Overall Study|Patient started PPI prior to intervention delivery.|0|||
147118372|NCT05085405|530598550|FG002|Overall Study|Patient started PPI prior to intervention delivery.|0|||
147118373|NCT05085405|530598551|FG003|Overall Study|Patient started PPI prior to intervention delivery.|1|||
147118374|NCT05085405|530598552|FG004|Overall Study|Patient started PPI prior to intervention delivery.|0|||
147118375|NCT05085405|530598553|FG005|Overall Study|Patient started PPI prior to intervention delivery.|0|||
147118376|NCT04146909|530598554|FG000|Overall Study|Withdrawal by Subject|3|||
147118377|NCT04146909|530598554|FG000|Overall Study|Did not qualify after consented|1|||
147118378|NCT03808909|530598557|FG000|Overall Study|Lost to Follow-up|3|||
147118379|NCT03808909|530598558|FG001|Overall Study|Lost to Follow-up|0|||
147118380|NCT00676689|530598559|FG000|Overall Study|Screen Failure|2|||
147118381|NCT00676689|530598559|FG000|Overall Study|Death|2|||
147118382|NCT00676689|530598559|FG000|Overall Study|Lost to Follow-up|4|||
147118383|NCT00676689|530598559|FG000|Overall Study|Physician Decision|1|||
147118384|NCT00676689|530598559|FG000|Overall Study|Withdrawal by Subject|3|||
147118385|NCT00676689|530598559|FG000|Overall Study|Continuing FU|49|||
147118386|NCT01827943|530598560|FG000|Overall Study|Protocol Violation|8|||
147118387|NCT01827943|530598560|FG000|Overall Study|Never treated because of an rapid progression|1|||
147118388|NCT00309244|530598562|FG000|Overall Study|Adverse Event|29|||
147118389|NCT00309244|530598563|FG001|Overall Study|Adverse Event|12|||
147650901|NCT02757352|532544540|FG003|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
147650902|NCT02757352|532544541|FG004|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|1|||
147650903|NCT02757352|532544542|FG005|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
147650904|NCT02757352|532544543|FG006|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
147118390|NCT00309244|530598562|FG000|Overall Study|Lost to Follow-up|6|||
147118391|NCT00309244|530598563|FG001|Overall Study|Lost to Follow-up|22|||
147118392|NCT00309244|530598562|FG000|Overall Study|Physician Decision|5|||
147118393|NCT00309244|530598563|FG001|Overall Study|Physician Decision|8|||
147230340|NCT01886716|531017924|FG002|Week 1|Lost to Follow-up|2|||
147230341|NCT01886716|531017925|FG003|Week 1|Lost to Follow-up|2|||
147230342|NCT01886716|531017922|FG000|Week 2|Lost to Follow-up|3|||
147230343|NCT01886716|531017923|FG001|Week 2|Lost to Follow-up|2|||
147230344|NCT01886716|531017924|FG002|Week 2|Lost to Follow-up|1|||
147230345|NCT01886716|531017925|FG003|Week 2|Lost to Follow-up|3|||
147230346|NCT01886716|531017922|FG000|Week 3|Lost to Follow-up|1|||
147230347|NCT01886716|531017923|FG001|Week 3|Lost to Follow-up|1|||
147567288|NCT00836056|532236498|FG000|First Intervention|Adverse Event|1|||
147567289|NCT00836056|532236499|FG001|First Intervention|Adverse Event|0|||
147567290|NCT02158663|532236500|FG000|Overall Study|Withdrawal by Subject|5|||
147567291|NCT02158663|532236501|FG001|Overall Study|Withdrawal by Subject|4|||
147567292|NCT02711852|532236502|FG000|Overall Study|Death|5|||
147650905|NCT02757352|532544544|FG007|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
147567293|NCT02711852|532236502|FG000|Overall Study|Lost to Follow-up|1|||
147567294|NCT02711852|532236502|FG000|Overall Study|Completed follow-up|3|||
147567295|NCT02711852|532236502|FG000|Overall Study|Withdrawal by Subject|1|||
147567296|NCT03616106|532236504|FG000|Overall Study|Removed by PI|6|||
147230348|NCT01886716|531017924|FG002|Week 3|Lost to Follow-up|0|||
147230349|NCT01886716|531017925|FG003|Week 3|Lost to Follow-up|1|||
147567297|NCT03616106|532236505|FG001|Overall Study|Removed by PI|0|||
147118394|NCT00309244|530598562|FG000|Overall Study|Protocol Violation|6|||
147118395|NCT00309244|530598563|FG001|Overall Study|Protocol Violation|3|||
147118396|NCT00309244|530598562|FG000|Overall Study|Withdrawal by Subject|50|||
147118397|NCT00309244|530598563|FG001|Overall Study|Withdrawal by Subject|32|||
147118398|NCT00309244|530598562|FG000|Overall Study|Various|7|||
147118399|NCT00309244|530598563|FG001|Overall Study|Various|7|||
147118400|NCT00309244|530598562|FG000|Overall Study|Randomized but not dosed|11|||
147118401|NCT00309244|530598563|FG001|Overall Study|Randomized but not dosed|12|||
147118402|NCT00309244|530598562|FG000|Overall Study|Death|4|||
147118403|NCT00309244|530598563|FG001|Overall Study|Death|1|||
147118404|NCT00501085|530598564|FG000|Overall Study|Lost to Follow-up|195|||
147118405|NCT00501085|530598564|FG000|Overall Study|Withdrawal by Subject|34|||
147118406|NCT00501085|530598564|FG000|Overall Study|Subject Decision|1|||
147118407|NCT00501085|530598564|FG000|Overall Study|Revision Surgery|7|||
147118408|NCT00501085|530598564|FG000|Overall Study|Explantation Surgery|26|||
147312729|NCT01807221|531312254|FG003|Overall Study|Adverse Event|25|||
147312730|NCT01807221|531312255|FG004|Overall Study|Adverse Event|18|||
147312731|NCT01807221|531312256|FG005|Overall Study|Adverse Event|21|||
147312732|NCT01807221|531312251|FG000|Overall Study|Protocol Violation|0|||
147312733|NCT01807221|531312252|FG001|Overall Study|Protocol Violation|2|||
147312734|NCT01807221|531312253|FG002|Overall Study|Protocol Violation|1|||
147312735|NCT01807221|531312254|FG003|Overall Study|Protocol Violation|2|||
147312736|NCT01807221|531312255|FG004|Overall Study|Protocol Violation|0|||
147312737|NCT01807221|531312256|FG005|Overall Study|Protocol Violation|1|||
147312738|NCT01807221|531312251|FG000|Overall Study|Non-compliance|1|||
147312739|NCT01807221|531312252|FG001|Overall Study|Non-compliance|2|||
147312740|NCT01807221|531312253|FG002|Overall Study|Non-compliance|0|||
147312741|NCT01807221|531312254|FG003|Overall Study|Non-compliance|1|||
147650906|NCT02757352|532544545|FG008|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
147118409|NCT00501085|530598564|FG000|Overall Study|Adverse Event|4|||
147118410|NCT00501085|530598564|FG000|Overall Study|Non-Compliance|24|||
147118411|NCT00501085|530598564|FG000|Overall Study|Study closed by sponsor|109|||
147118412|NCT00501085|530598564|FG000|Overall Study|Other loss to follow-up|32|||
147118413|NCT01487161|530598565|FG000|Overall Study|Adverse Event|1|||
147118414|NCT01487161|530598566|FG001|Overall Study|Adverse Event|0|||
147118415|NCT01487161|530598567|FG002|Overall Study|Adverse Event|0|||
147118416|NCT01487161|530598568|FG003|Overall Study|Adverse Event|0|||
147118417|NCT01487161|530598565|FG000|Overall Study|Withdrawal by Subject|1|||
147118418|NCT01487161|530598566|FG001|Overall Study|Withdrawal by Subject|1|||
147118419|NCT01487161|530598567|FG002|Overall Study|Withdrawal by Subject|1|||
147118420|NCT01487161|530598568|FG003|Overall Study|Withdrawal by Subject|2|||
147118421|NCT01487161|530598565|FG000|Overall Study|missing data|0|||
147118422|NCT01487161|530598566|FG001|Overall Study|missing data|1|||
147118423|NCT01487161|530598567|FG002|Overall Study|missing data|0|||
147118424|NCT01487161|530598568|FG003|Overall Study|missing data|0|||
147118425|NCT00663351|530598569|FG000|Initial Study (Year 1 up to Year 6)|Lost to Follow-up|10|||
147118426|NCT00663351|530598570|FG001|Initial Study (Year 1 up to Year 6)|Lost to Follow-up|19|||
147118427|NCT00663351|530598569|FG000|Post-Approval Study (Year 6 to Year 10)|Revision Surgery|29|||
147118428|NCT00663351|530598570|FG001|Post-Approval Study (Year 6 to Year 10)|Revision Surgery|10|||
147118429|NCT00663351|530598569|FG000|Post-Approval Study (Year 6 to Year 10)|Withdrawal by Subject|8|||
147118430|NCT00663351|530598570|FG001|Post-Approval Study (Year 6 to Year 10)|Withdrawal by Subject|15|||
147118431|NCT00663351|530598569|FG000|Post-Approval Study (Year 6 to Year 10)|Death|18|||
147118432|NCT00663351|530598570|FG001|Post-Approval Study (Year 6 to Year 10)|Death|7|||
147118433|NCT00663351|530598569|FG000|Post-Approval Study (Year 6 to Year 10)|Lost to Follow-up|13|||
147230350|NCT04806503|531017932|FG000|Overall Study|Lost to Follow-up|0|||
147230351|NCT04806503|531017933|FG001|Overall Study|Lost to Follow-up|0|||
147230352|NCT04806503|531017934|FG002|Overall Study|Lost to Follow-up|1|||
147230353|NCT04806503|531017935|FG003|Overall Study|Lost to Follow-up|0|||
147230354|NCT04806503|531017936|FG004|Overall Study|Lost to Follow-up|0|||
147230355|NCT04806503|531017932|FG000|Overall Study|Withdrawal by Subject|1|||
147230356|NCT04806503|531017933|FG001|Overall Study|Withdrawal by Subject|0|||
147230357|NCT04806503|531017934|FG002|Overall Study|Withdrawal by Subject|1|||
147230358|NCT04806503|531017935|FG003|Overall Study|Withdrawal by Subject|1|||
147312742|NCT01807221|531312255|FG004|Overall Study|Non-compliance|0|||
147650907|NCT02757352|532544546|FG009|IR-Open Label Period (Week 16 - Week 52)|Pregnancy|0|||
147230359|NCT04806503|531017936|FG004|Overall Study|Withdrawal by Subject|1|||
147230360|NCT04806503|531017932|FG000|Overall Study|Adverse Event|1|||
147312743|NCT01807221|531312256|FG005|Overall Study|Non-compliance|0|||
147312744|NCT01807221|531312251|FG000|Overall Study|Logistical difficulties|0|||
147312745|NCT01807221|531312252|FG001|Overall Study|Logistical difficulties|1|||
147118434|NCT00663351|530598570|FG001|Post-Approval Study (Year 6 to Year 10)|Lost to Follow-up|7|||
147118435|NCT00663351|530598569|FG000|Post-Approval Study (Year 6 to Year 10)|Withdrawn for Site Termination|44|||
147118436|NCT00663351|530598570|FG001|Post-Approval Study (Year 6 to Year 10)|Withdrawn for Site Termination|32|||
147118437|NCT00567112|530598571|FG000|Treatment Period 2 (3 Days)|Protocol Violation|0|||
147118438|NCT00567112|530598572|FG001|Treatment Period 2 (3 Days)|Protocol Violation|1|||
147230361|NCT04806503|531017933|FG001|Overall Study|Adverse Event|1|||
147567298|NCT03616106|532236504|FG000|Overall Study|Withdrawal by Subject|1|||
147567299|NCT03616106|532236505|FG001|Overall Study|Withdrawal by Subject|1|||
147118439|NCT00567112|530598573|FG002|Treatment Period 2 (3 Days)|Protocol Violation|0|||
147118440|NCT00567112|530598571|FG000|Washout Period 3 (3 Days)|Lost to Follow-up|2|||
147118441|NCT00567112|530598572|FG001|Washout Period 3 (3 Days)|Lost to Follow-up|0|||
147118442|NCT00567112|530598573|FG002|Washout Period 3 (3 Days)|Lost to Follow-up|0|||
147118443|NCT00567112|530598571|FG000|Washout Period 3 (3 Days)|Protocol Violation|1|||
147118444|NCT00567112|530598572|FG001|Washout Period 3 (3 Days)|Protocol Violation|0|||
147118445|NCT00567112|530598573|FG002|Washout Period 3 (3 Days)|Protocol Violation|0|||
147118446|NCT03113136|530598574|FG000|Overall Study|Lost to Follow-up|22|||
147118447|NCT03113136|530598575|FG001|Overall Study|Lost to Follow-up|47|||
147118448|NCT03113136|530598576|FG002|Overall Study|Lost to Follow-up|54|||
147230362|NCT04806503|531017934|FG002|Overall Study|Adverse Event|0|||
147230363|NCT04806503|531017935|FG003|Overall Study|Adverse Event|1|||
147230364|NCT04806503|531017936|FG004|Overall Study|Adverse Event|0|||
147230365|NCT03589469|531017937|FG000|Overall Study|Withdrawal by Subject|8|||
147230366|NCT03589469|531017937|FG000|Overall Study|Physician Decision|20|||
147230367|NCT03589469|531017937|FG000|Overall Study|Death|97|||
147230368|NCT03589469|531017937|FG000|Overall Study|Lost to Follow-up|8|||
147230369|NCT03589469|531017937|FG000|Overall Study|Miscellaneous|1|||
147230370|NCT02202837|531017940|FG000|Overall Study|Enbrel treatment discontinued|36|||
147230371|NCT02202837|531017941|FG001|Overall Study|Enbrel treatment discontinued|4|||
147230372|NCT02202837|531017940|FG000|Overall Study|Other|10|||
147230373|NCT02202837|531017941|FG001|Overall Study|Other|0|||
147230374|NCT02202837|531017940|FG000|Overall Study|Lost to Follow-up|7|||
147230375|NCT02202837|531017941|FG001|Overall Study|Lost to Follow-up|1|||
147230376|NCT02486302|531017942|FG000|Overall Study|Discontinued prematurely|410|||
147230377|NCT02486302|531017942|FG000|Overall Study|Documentation not completed|255|||
147230378|NCT02486302|531017942|FG000|Overall Study|Excluded due to legal reasons|8|||
147230379|NCT02486302|531017942|FG000|Overall Study|Not treated|3|||
147230380|NCT01871142|531017943|FG000|Overall Study|Adverse Event|1|||
147230381|NCT00734474|531017947|FG000|Overall Study|Entry Criteria Not Met|0|||
147230382|NCT00734474|531017948|FG001|Overall Study|Entry Criteria Not Met|0|||
147230383|NCT00734474|531017949|FG002|Overall Study|Entry Criteria Not Met|5|||
147230384|NCT00734474|531017950|FG003|Overall Study|Entry Criteria Not Met|0|||
147230385|NCT00734474|531017951|FG004|Overall Study|Entry Criteria Not Met|3|||
147230386|NCT00734474|531017952|FG005|Overall Study|Entry Criteria Not Met|1|||
147230387|NCT00734474|531017953|FG006|Overall Study|Entry Criteria Not Met|0|||
147230388|NCT00734474|531017954|FG007|Overall Study|Entry Criteria Not Met|1|||
147230389|NCT00734474|531017955|FG008|Overall Study|Entry Criteria Not Met|1|||
147230390|NCT00734474|531017947|FG000|Overall Study|Lost to Follow-up|1|||
147230391|NCT00734474|531017948|FG001|Overall Study|Lost to Follow-up|0|||
147230392|NCT00734474|531017949|FG002|Overall Study|Lost to Follow-up|13|||
147230393|NCT00734474|531017950|FG003|Overall Study|Lost to Follow-up|0|||
147230394|NCT00734474|531017951|FG004|Overall Study|Lost to Follow-up|11|||
147230395|NCT00734474|531017952|FG005|Overall Study|Lost to Follow-up|1|||
147230396|NCT00734474|531017953|FG006|Overall Study|Lost to Follow-up|0|||
147230397|NCT00734474|531017954|FG007|Overall Study|Lost to Follow-up|9|||
147230398|NCT00734474|531017955|FG008|Overall Study|Lost to Follow-up|4|||
147230399|NCT00734474|531017947|FG000|Overall Study|Withdrawal by Subject|2|||
147230400|NCT00734474|531017948|FG001|Overall Study|Withdrawal by Subject|1|||
147230401|NCT00734474|531017949|FG002|Overall Study|Withdrawal by Subject|18|||
147230402|NCT00734474|531017950|FG003|Overall Study|Withdrawal by Subject|0|||
147230403|NCT00734474|531017951|FG004|Overall Study|Withdrawal by Subject|24|||
147230404|NCT00734474|531017952|FG005|Overall Study|Withdrawal by Subject|2|||
147230405|NCT00734474|531017953|FG006|Overall Study|Withdrawal by Subject|0|||
147230406|NCT00734474|531017954|FG007|Overall Study|Withdrawal by Subject|36|||
147230407|NCT00734474|531017955|FG008|Overall Study|Withdrawal by Subject|21|||
147567300|NCT03616106|532236504|FG000|Overall Study|Lost to Follow-up|7|||
147567301|NCT03616106|532236505|FG001|Overall Study|Lost to Follow-up|0|||
147567302|NCT01880593|532236506|FG000|Overall Study|Adverse Event|1|||
147230408|NCT00734474|531017947|FG000|Overall Study|Physician Decision|0|||
147230409|NCT00734474|531017948|FG001|Overall Study|Physician Decision|0|||
147230410|NCT00734474|531017949|FG002|Overall Study|Physician Decision|4|||
147230411|NCT00734474|531017950|FG003|Overall Study|Physician Decision|1|||
147567303|NCT01880593|532236507|FG001|Overall Study|Adverse Event|0|||
147567304|NCT01880593|532236506|FG000|Overall Study|Lack of Efficacy|1|||
147118449|NCT03113136|530598574|FG000|Overall Study|Withdrawal by Subject|4|||
147118450|NCT03113136|530598575|FG001|Overall Study|Withdrawal by Subject|13|||
147118451|NCT03113136|530598576|FG002|Overall Study|Withdrawal by Subject|14|||
147230412|NCT00734474|531017951|FG004|Overall Study|Physician Decision|11|||
147230413|NCT00734474|531017952|FG005|Overall Study|Physician Decision|0|||
147230414|NCT00734474|531017953|FG006|Overall Study|Physician Decision|0|||
147230415|NCT00734474|531017954|FG007|Overall Study|Physician Decision|9|||
147230416|NCT00734474|531017955|FG008|Overall Study|Physician Decision|9|||
147230417|NCT00734474|531017947|FG000|Overall Study|Adverse Event|4|||
147230418|NCT00734474|531017948|FG001|Overall Study|Adverse Event|4|||
147230419|NCT00734474|531017949|FG002|Overall Study|Adverse Event|63|||
147118452|NCT03113136|530598574|FG000|Overall Study|Ineligible|0|||
147118453|NCT03113136|530598575|FG001|Overall Study|Ineligible|2|||
147118454|NCT03113136|530598576|FG002|Overall Study|Ineligible|1|||
147118455|NCT03113136|530598574|FG000|Overall Study|Study Team Decision|1|||
147118456|NCT03113136|530598575|FG001|Overall Study|Study Team Decision|4|||
147118457|NCT03113136|530598576|FG002|Overall Study|Study Team Decision|0|||
147118458|NCT04689009|530598581|FG000|Overall Study|Adverse Event|1|||
147118459|NCT04689009|530598582|FG001|Overall Study|Adverse Event|0|||
147118460|NCT04689009|530598581|FG000|Overall Study|Lost to Follow-up|1|||
147118461|NCT04689009|530598582|FG001|Overall Study|Lost to Follow-up|2|||
147118462|NCT04689009|530598581|FG000|Overall Study|Withdrawal by Subject|4|||
147118463|NCT04689009|530598582|FG001|Overall Study|Withdrawal by Subject|3|||
147118464|NCT04689009|530598581|FG000|Overall Study|Protocol Violation|1|||
147118465|NCT04689009|530598582|FG001|Overall Study|Protocol Violation|0|||
147118466|NCT02362412|530598583|FG000|Treatment Period III|Lost to Follow-up|0|||
147118467|NCT02362412|530598584|FG001|Treatment Period III|Lost to Follow-up|1|||
147118468|NCT02187055|530598585|FG000|Overall Study|Lack of Efficacy|10|||
147118469|NCT02187055|530598586|FG001|Overall Study|Lack of Efficacy|3|||
147118470|NCT02187055|530598587|FG002|Overall Study|Lack of Efficacy|7|||
147230420|NCT00734474|531017950|FG003|Overall Study|Adverse Event|1|||
147230421|NCT00734474|531017951|FG004|Overall Study|Adverse Event|64|||
147230422|NCT00734474|531017952|FG005|Overall Study|Adverse Event|0|||
147230423|NCT00734474|531017953|FG006|Overall Study|Adverse Event|1|||
147230424|NCT00734474|531017954|FG007|Overall Study|Adverse Event|65|||
147230425|NCT00734474|531017955|FG008|Overall Study|Adverse Event|39|||
147230426|NCT00734474|531017947|FG000|Overall Study|Protocol Violation|0|||
147230427|NCT00734474|531017948|FG001|Overall Study|Protocol Violation|0|||
147230428|NCT00734474|531017949|FG002|Overall Study|Protocol Violation|4|||
147230429|NCT00734474|531017950|FG003|Overall Study|Protocol Violation|0|||
147230430|NCT00734474|531017951|FG004|Overall Study|Protocol Violation|3|||
147230431|NCT00734474|531017952|FG005|Overall Study|Protocol Violation|0|||
147230432|NCT00734474|531017953|FG006|Overall Study|Protocol Violation|0|||
147230433|NCT00734474|531017954|FG007|Overall Study|Protocol Violation|3|||
147230434|NCT00734474|531017955|FG008|Overall Study|Protocol Violation|1|||
147230435|NCT00734474|531017947|FG000|Overall Study|Sponsor Decision, Arm Discontinued|8|||
147230436|NCT00734474|531017948|FG001|Overall Study|Sponsor Decision, Arm Discontinued|25|||
147230437|NCT00734474|531017949|FG002|Overall Study|Sponsor Decision, Arm Discontinued|0|||
147230438|NCT00734474|531017950|FG003|Overall Study|Sponsor Decision, Arm Discontinued|8|||
147230439|NCT00734474|531017951|FG004|Overall Study|Sponsor Decision, Arm Discontinued|0|||
147230440|NCT00734474|531017952|FG005|Overall Study|Sponsor Decision, Arm Discontinued|21|||
147230441|NCT00734474|531017953|FG006|Overall Study|Sponsor Decision, Arm Discontinued|23|||
147230442|NCT00734474|531017954|FG007|Overall Study|Sponsor Decision, Arm Discontinued|0|||
147230443|NCT00734474|531017955|FG008|Overall Study|Sponsor Decision, Arm Discontinued|0|||
147230444|NCT00734474|531017947|FG000|Overall Study|Sponsor Decision|0|||
147230445|NCT00734474|531017948|FG001|Overall Study|Sponsor Decision|0|||
147230446|NCT00734474|531017949|FG002|Overall Study|Sponsor Decision|0|||
147230447|NCT00734474|531017950|FG003|Overall Study|Sponsor Decision|0|||
147230448|NCT00734474|531017951|FG004|Overall Study|Sponsor Decision|2|||
147230449|NCT00734474|531017952|FG005|Overall Study|Sponsor Decision|0|||
147230450|NCT00734474|531017953|FG006|Overall Study|Sponsor Decision|0|||
147230451|NCT00734474|531017954|FG007|Overall Study|Sponsor Decision|0|||
147230452|NCT00734474|531017955|FG008|Overall Study|Sponsor Decision|0|||
147230453|NCT00734474|531017947|FG000|Overall Study|Death|0|||
147230454|NCT00734474|531017948|FG001|Overall Study|Death|0|||
147230455|NCT00734474|531017949|FG002|Overall Study|Death|1|||
147230456|NCT00734474|531017950|FG003|Overall Study|Death|0|||
147230457|NCT00734474|531017951|FG004|Overall Study|Death|0|||
147230458|NCT00734474|531017952|FG005|Overall Study|Death|0|||
147230459|NCT00734474|531017953|FG006|Overall Study|Death|0|||
147230460|NCT00734474|531017954|FG007|Overall Study|Death|2|||
147230461|NCT00734474|531017955|FG008|Overall Study|Death|1|||
147230462|NCT00734474|531017947|FG000|Overall Study|Lack of Efficacy|0|||
147230463|NCT00734474|531017948|FG001|Overall Study|Lack of Efficacy|0|||
147118471|NCT02187055|530598585|FG000|Overall Study|Lost to Follow-up|2|||
147118472|NCT02187055|530598586|FG001|Overall Study|Lost to Follow-up|7|||
147118473|NCT02187055|530598587|FG002|Overall Study|Lost to Follow-up|3|||
147118474|NCT02187055|530598585|FG000|Overall Study|No longer meets eligibility criteria|0|||
147118475|NCT02187055|530598586|FG001|Overall Study|No longer meets eligibility criteria|2|||
147118476|NCT02187055|530598587|FG002|Overall Study|No longer meets eligibility criteria|0|||
147230464|NCT00734474|531017949|FG002|Overall Study|Lack of Efficacy|4|||
147230465|NCT00734474|531017950|FG003|Overall Study|Lack of Efficacy|0|||
147230466|NCT00734474|531017951|FG004|Overall Study|Lack of Efficacy|0|||
147230467|NCT00734474|531017952|FG005|Overall Study|Lack of Efficacy|0|||
147230468|NCT00734474|531017953|FG006|Overall Study|Lack of Efficacy|0|||
147230469|NCT00734474|531017954|FG007|Overall Study|Lack of Efficacy|4|||
147230470|NCT00734474|531017955|FG008|Overall Study|Lack of Efficacy|6|||
147230471|NCT00231842|531017964|FG000|Overall Study|Withdrawal by Subject|3|||
147230472|NCT00231842|531017964|FG000|Overall Study|Did not complete the last 3 cycle|8|||
147230473|NCT00639678|531017965|FG000|Overall Study|Withdrawal by Subject|3|||
147230474|NCT00639678|531017966|FG001|Overall Study|Withdrawal by Subject|0|||
147230475|NCT00639678|531017967|FG002|Overall Study|Withdrawal by Subject|4|||
147230476|NCT00639678|531017968|FG003|Overall Study|Withdrawal by Subject|0|||
147230477|NCT00639678|531017965|FG000|Overall Study|Lost to Follow-up|1|||
147230478|NCT00639678|531017966|FG001|Overall Study|Lost to Follow-up|0|||
147230479|NCT00639678|531017967|FG002|Overall Study|Lost to Follow-up|6|||
147230480|NCT00639678|531017968|FG003|Overall Study|Lost to Follow-up|0|||
147230481|NCT00639678|531017965|FG000|Overall Study|Adverse Event|0|||
147230482|NCT00639678|531017966|FG001|Overall Study|Adverse Event|1|||
147230483|NCT00639678|531017967|FG002|Overall Study|Adverse Event|0|||
147230484|NCT00639678|531017968|FG003|Overall Study|Adverse Event|0|||
147230485|NCT00639678|531017965|FG000|Overall Study|Lack of Compliance|0|||
147230486|NCT00639678|531017966|FG001|Overall Study|Lack of Compliance|0|||
147230487|NCT00639678|531017967|FG002|Overall Study|Lack of Compliance|1|||
147230488|NCT00639678|531017968|FG003|Overall Study|Lack of Compliance|0|||
147230489|NCT02436304|531017969|FG000|Overall Study|Lost to Follow-up|0|||
147230490|NCT02436304|531017970|FG001|Overall Study|Lost to Follow-up|1|||
147230491|NCT02436304|531017971|FG002|Overall Study|Lost to Follow-up|0|||
147230492|NCT02436304|531017969|FG000|Overall Study|Withdrawal by Subject|0|||
147230493|NCT02436304|531017970|FG001|Overall Study|Withdrawal by Subject|1|||
147230494|NCT02436304|531017971|FG002|Overall Study|Withdrawal by Subject|0|||
147230495|NCT02436304|531017969|FG000|Overall Study|Randomized in error didn't meet I/E crit|0|||
147230496|NCT02436304|531017970|FG001|Overall Study|Randomized in error didn't meet I/E crit|0|||
147230497|NCT02436304|531017971|FG002|Overall Study|Randomized in error didn't meet I/E crit|1|||
147230498|NCT02477839|531017974|FG000|Overall Study|Adverse Event|0|||
147230499|NCT02477839|531017975|FG001|Overall Study|Adverse Event|1|||
147230500|NCT02477839|531017974|FG000|Overall Study|Protocol Violation|0|||
147230501|NCT02477839|531017975|FG001|Overall Study|Protocol Violation|2|||
147230502|NCT02477839|531017974|FG000|Overall Study|Withdrawal by Subject|3|||
147230503|NCT02477839|531017975|FG001|Overall Study|Withdrawal by Subject|3|||
147230504|NCT02477839|531017974|FG000|Overall Study|Participant had PGS during V6|0|||
147230505|NCT02477839|531017975|FG001|Overall Study|Participant had PGS during V6|1|||
147230506|NCT02477839|531017974|FG000|Overall Study|Parents decided to stop medication|0|||
147230507|NCT02477839|531017975|FG001|Overall Study|Parents decided to stop medication|1|||
147230508|NCT02477839|531017974|FG000|Overall Study|Lack of tolerability|0|||
147230509|NCT02477839|531017975|FG001|Overall Study|Lack of tolerability|1|||
147230510|NCT02477839|531017974|FG000|Overall Study|Exclusion criterion|0|||
147230511|NCT02477839|531017975|FG001|Overall Study|Exclusion criterion|1|||
147230512|NCT02607930|531017978|FG000|Double-Blinded Treatment Phase|Lost to Follow-up|25|||
147230513|NCT02607930|531017979|FG001|Double-Blinded Treatment Phase|Lost to Follow-up|19|||
147230514|NCT02607930|531017980|FG002|Double-Blinded Treatment Phase|Lost to Follow-up|0|||
147230515|NCT02607930|531017981|FG003|Double-Blinded Treatment Phase|Lost to Follow-up|0|||
147230516|NCT02607930|531017978|FG000|Double-Blinded Treatment Phase|Withdrew consent|14|||
147230517|NCT02607930|531017979|FG001|Double-Blinded Treatment Phase|Withdrew consent|18|||
147230518|NCT02607930|531017980|FG002|Double-Blinded Treatment Phase|Withdrew consent|0|||
147230519|NCT02607930|531017981|FG003|Double-Blinded Treatment Phase|Withdrew consent|0|||
147230520|NCT02607930|531017978|FG000|Double-Blinded Treatment Phase|Investigator's discretion|6|||
147230521|NCT02607930|531017979|FG001|Double-Blinded Treatment Phase|Investigator's discretion|3|||
147230522|NCT02607930|531017980|FG002|Double-Blinded Treatment Phase|Investigator's discretion|0|||
147230523|NCT02607930|531017981|FG003|Double-Blinded Treatment Phase|Investigator's discretion|0|||
147230524|NCT02607930|531017978|FG000|Double-Blinded Treatment Phase|Non-compliance with study drug|3|||
147230525|NCT02607930|531017979|FG001|Double-Blinded Treatment Phase|Non-compliance with study drug|5|||
147230526|NCT02607930|531017980|FG002|Double-Blinded Treatment Phase|Non-compliance with study drug|0|||
147230527|NCT02607930|531017981|FG003|Double-Blinded Treatment Phase|Non-compliance with study drug|0|||
147230528|NCT02607930|531017978|FG000|Double-Blinded Treatment Phase|Protocol Violation|2|||
147230529|NCT02607930|531017979|FG001|Double-Blinded Treatment Phase|Protocol Violation|3|||
147230530|NCT02607930|531017980|FG002|Double-Blinded Treatment Phase|Protocol Violation|0|||
147230531|NCT02607930|531017981|FG003|Double-Blinded Treatment Phase|Protocol Violation|0|||
147230532|NCT02607930|531017978|FG000|Double-Blinded Treatment Phase|Adverse Event|0|||
147230533|NCT02607930|531017979|FG001|Double-Blinded Treatment Phase|Adverse Event|4|||
147230534|NCT02607930|531017980|FG002|Double-Blinded Treatment Phase|Adverse Event|0|||
147230535|NCT02607930|531017981|FG003|Double-Blinded Treatment Phase|Adverse Event|0|||
147230536|NCT02607930|531017978|FG000|Double-Blinded Treatment Phase|Death|2|||
147567305|NCT01880593|532236507|FG001|Overall Study|Lack of Efficacy|5|||
147567306|NCT01880593|532236506|FG000|Overall Study|Withdrawal by Subject|6|||
147230537|NCT02607930|531017979|FG001|Double-Blinded Treatment Phase|Death|1|||
147230538|NCT02607930|531017980|FG002|Double-Blinded Treatment Phase|Death|0|||
147230539|NCT02607930|531017981|FG003|Double-Blinded Treatment Phase|Death|0|||
147567307|NCT01880593|532236507|FG001|Overall Study|Withdrawal by Subject|1|||
147230540|NCT02607930|531017978|FG000|Double-Blinded Treatment Phase|Randomized but never treated|2|||
147230541|NCT02607930|531017979|FG001|Double-Blinded Treatment Phase|Randomized but never treated|0|||
147567308|NCT02272777|532236508|FG000|Overall Study|Adverse Event|0|||
147567309|NCT02272777|532236509|FG001|Overall Study|Adverse Event|1|||
147567310|NCT02272777|532236508|FG000|Overall Study|Withdrawal by Subject|0|||
147567311|NCT02272777|532236509|FG001|Overall Study|Withdrawal by Subject|3|||
147567312|NCT02272777|532236508|FG000|Overall Study|Lost to Follow-up|2|||
147567313|NCT02272777|532236509|FG001|Overall Study|Lost to Follow-up|0|||
147567314|NCT02272777|532236508|FG000|Overall Study|Other|2|||
147567315|NCT02272777|532236509|FG001|Overall Study|Other|0|||
147567316|NCT00440297|532236513|FG000|Overall Study|Adverse Event|8|||
147567317|NCT00440297|532236514|FG001|Overall Study|Adverse Event|5|||
147567318|NCT00440297|532236513|FG000|Overall Study|Lost to Follow-up|1|||
147567319|NCT00440297|532236514|FG001|Overall Study|Lost to Follow-up|0|||
147567320|NCT00440297|532236513|FG000|Overall Study|Physician Decision|1|||
147567321|NCT00440297|532236514|FG001|Overall Study|Physician Decision|0|||
147567322|NCT00440297|532236513|FG000|Overall Study|Protocol Violation|11|||
147118477|NCT02187055|530598585|FG000|Overall Study|No longer willing to participate|6|||
147118478|NCT02187055|530598586|FG001|Overall Study|No longer willing to participate|8|||
147118479|NCT02187055|530598587|FG002|Overall Study|No longer willing to participate|10|||
147118480|NCT02187055|530598585|FG000|Overall Study|Other|5|||
147118481|NCT02187055|530598586|FG001|Overall Study|Other|6|||
147118482|NCT02187055|530598587|FG002|Overall Study|Other|3|||
147118483|NCT02187055|530598585|FG000|Overall Study|Protocol Violation|9|||
147118484|NCT02187055|530598586|FG001|Overall Study|Protocol Violation|9|||
147230542|NCT02607930|531017980|FG002|Double-Blinded Treatment Phase|Randomized but never treated|0|||
147230543|NCT02607930|531017981|FG003|Double-Blinded Treatment Phase|Randomized but never treated|0|||
147230544|NCT02607930|531017978|FG000|Open-Label B/F/TAF Extension Phase|Lost to Follow-up|0|||
147230545|NCT02607930|531017979|FG001|Open-Label B/F/TAF Extension Phase|Lost to Follow-up|0|||
147230546|NCT02607930|531017980|FG002|Open-Label B/F/TAF Extension Phase|Lost to Follow-up|15|||
147230547|NCT02607930|531017981|FG003|Open-Label B/F/TAF Extension Phase|Lost to Follow-up|10|||
147230548|NCT02607930|531017978|FG000|Open-Label B/F/TAF Extension Phase|Withdrew consent|0|||
147230549|NCT02607930|531017979|FG001|Open-Label B/F/TAF Extension Phase|Withdrew consent|0|||
147230550|NCT02607930|531017980|FG002|Open-Label B/F/TAF Extension Phase|Withdrew consent|10|||
147230551|NCT02607930|531017981|FG003|Open-Label B/F/TAF Extension Phase|Withdrew consent|13|||
147230552|NCT02607930|531017978|FG000|Open-Label B/F/TAF Extension Phase|Investigator's discretion|0|||
147230553|NCT02607930|531017979|FG001|Open-Label B/F/TAF Extension Phase|Investigator's discretion|0|||
147230554|NCT02607930|531017980|FG002|Open-Label B/F/TAF Extension Phase|Investigator's discretion|2|||
147230555|NCT02607930|531017981|FG003|Open-Label B/F/TAF Extension Phase|Investigator's discretion|5|||
147230556|NCT02607930|531017978|FG000|Open-Label B/F/TAF Extension Phase|Adverse Event|0|||
147230557|NCT02607930|531017979|FG001|Open-Label B/F/TAF Extension Phase|Adverse Event|0|||
147230558|NCT02607930|531017980|FG002|Open-Label B/F/TAF Extension Phase|Adverse Event|4|||
147230559|NCT02607930|531017981|FG003|Open-Label B/F/TAF Extension Phase|Adverse Event|2|||
147230560|NCT02607930|531017978|FG000|Open-Label B/F/TAF Extension Phase|Lack of Efficacy|0|||
147230561|NCT02607930|531017979|FG001|Open-Label B/F/TAF Extension Phase|Lack of Efficacy|0|||
147230562|NCT02607930|531017980|FG002|Open-Label B/F/TAF Extension Phase|Lack of Efficacy|1|||
147230563|NCT02607930|531017981|FG003|Open-Label B/F/TAF Extension Phase|Lack of Efficacy|1|||
147230564|NCT02607930|531017978|FG000|Open-Label B/F/TAF Extension Phase|Protocol Violation|0|||
147230565|NCT02607930|531017979|FG001|Open-Label B/F/TAF Extension Phase|Protocol Violation|0|||
147230566|NCT02607930|531017980|FG002|Open-Label B/F/TAF Extension Phase|Protocol Violation|1|||
147230567|NCT02607930|531017981|FG003|Open-Label B/F/TAF Extension Phase|Protocol Violation|1|||
147230568|NCT02607930|531017978|FG000|Open-Label B/F/TAF Extension Phase|Death|0|||
147230569|NCT02607930|531017979|FG001|Open-Label B/F/TAF Extension Phase|Death|0|||
147230570|NCT02607930|531017980|FG002|Open-Label B/F/TAF Extension Phase|Death|0|||
147230571|NCT02607930|531017981|FG003|Open-Label B/F/TAF Extension Phase|Death|1|||
147230572|NCT02607930|531017978|FG000|Open-Label B/F/TAF Extension Phase|Non-compliance with study drug|0|||
147230573|NCT02607930|531017979|FG001|Open-Label B/F/TAF Extension Phase|Non-compliance with study drug|0|||
147230574|NCT02607930|531017980|FG002|Open-Label B/F/TAF Extension Phase|Non-compliance with study drug|1|||
147230575|NCT02607930|531017981|FG003|Open-Label B/F/TAF Extension Phase|Non-compliance with study drug|0|||
147230576|NCT01050543|531017982|FG000|Overall Study|Withdrawal by Subject|0|||
147312746|NCT01807221|531312253|FG002|Overall Study|Logistical difficulties|0|||
147444482|NCT00942175|531792637|FG001|Overall Study|Adverse Event|1|||
147567323|NCT00440297|532236514|FG001|Overall Study|Protocol Violation|7|||
147567324|NCT00440297|532236513|FG000|Overall Study|Withdrawal by Subject|1|||
147567325|NCT00440297|532236514|FG001|Overall Study|Withdrawal by Subject|6|||
147567326|NCT00440297|532236513|FG000|Overall Study|Randomized by mistake|1|||
147567327|NCT00440297|532236514|FG001|Overall Study|Randomized by mistake|0|||
147567328|NCT03206177|532236515|FG000|Overall Study|Withdrawal by Subject|1|||
147567329|NCT02024932|532236516|FG000|Overall Study|Adverse Event|2|||
147567330|NCT02024932|532236517|FG001|Overall Study|Adverse Event|3|||
147567331|NCT02024932|532236518|FG002|Overall Study|Adverse Event|0|||
147567332|NCT02024932|532236519|FG003|Overall Study|Adverse Event|0|||
147118485|NCT02187055|530598587|FG002|Overall Study|Protocol Violation|4|||
147118486|NCT02187055|530598585|FG000|Overall Study|Pregnancy|3|||
147118487|NCT02187055|530598586|FG001|Overall Study|Pregnancy|1|||
147118488|NCT02187055|530598587|FG002|Overall Study|Pregnancy|0|||
147567333|NCT02024932|532236520|FG004|Overall Study|Adverse Event|2|||
147567334|NCT02024932|532236521|FG005|Overall Study|Adverse Event|0|||
147567335|NCT02024932|532236516|FG000|Overall Study|Abnormal laboratory value|0|||
147567336|NCT02024932|532236517|FG001|Overall Study|Abnormal laboratory value|0|||
147567337|NCT02024932|532236518|FG002|Overall Study|Abnormal laboratory value|0|||
147567338|NCT02024932|532236519|FG003|Overall Study|Abnormal laboratory value|2|||
147567339|NCT02024932|532236520|FG004|Overall Study|Abnormal laboratory value|0|||
147567340|NCT02024932|532236521|FG005|Overall Study|Abnormal laboratory value|0|||
147567341|NCT02445339|532236522|FG000|Overall Study|Physician Decision|1|||
147567342|NCT02445339|532236523|FG001|Overall Study|Physician Decision|0|||
147567343|NCT02445339|532236522|FG000|Overall Study|Lost to Follow-up|11|||
147567344|NCT02445339|532236523|FG001|Overall Study|Lost to Follow-up|15|||
147567345|NCT03020641|532236524|FG000|Overall Study|Lost to Follow-up|0|||
147567346|NCT03020641|532236525|FG001|Overall Study|Lost to Follow-up|1|||
147567347|NCT03020641|532236524|FG000|Overall Study|Converted to open surgery|2|||
147567348|NCT03020641|532236525|FG001|Overall Study|Converted to open surgery|1|||
147567349|NCT03020641|532236524|FG000|Overall Study|for surgery not performed|0|||
147567350|NCT03020641|532236525|FG001|Overall Study|for surgery not performed|1|||
147567351|NCT04611789|532236526|FG000|Overall Study|Lost to Follow-up|1|||
147567352|NCT04611789|532236527|FG001|Overall Study|Lost to Follow-up|0|||
147567353|NCT04611789|532236528|FG002|Overall Study|Lost to Follow-up|0|||
147567354|NCT05472038|532238268|FG000|Overall Study|Adverse Event|0|||
147567355|NCT05472038|532238269|FG001|Overall Study|Adverse Event|0|||
147567356|NCT05472038|532238270|FG002|Overall Study|Adverse Event|1|||
147567357|NCT05472038|532238271|FG003|Overall Study|Adverse Event|0|||
147567358|NCT05472038|532238272|FG004|Overall Study|Adverse Event|0|||
147567359|NCT05472038|532238273|FG005|Overall Study|Adverse Event|0|||
147567360|NCT05472038|532238274|FG006|Overall Study|Adverse Event|0|||
147567361|NCT05472038|532238275|FG007|Overall Study|Adverse Event|0|||
147567362|NCT05472038|532238276|FG008|Overall Study|Adverse Event|0|||
147567363|NCT05472038|532238277|FG009|Overall Study|Adverse Event|0|||
147567364|NCT05472038|532238278|FG010|Overall Study|Adverse Event|0|||
147312747|NCT01807221|531312254|FG003|Overall Study|Logistical difficulties|0|||
147312748|NCT01807221|531312255|FG004|Overall Study|Logistical difficulties|1|||
147312749|NCT01807221|531312256|FG005|Overall Study|Logistical difficulties|0|||
147312750|NCT01807221|531312251|FG000|Overall Study|Withdrawal by Subject|33|||
147312751|NCT01807221|531312252|FG001|Overall Study|Withdrawal by Subject|15|||
147312752|NCT01807221|531312253|FG002|Overall Study|Withdrawal by Subject|8|||
147312753|NCT01807221|531312254|FG003|Overall Study|Withdrawal by Subject|14|||
147312754|NCT01807221|531312255|FG004|Overall Study|Withdrawal by Subject|16|||
147312755|NCT01807221|531312256|FG005|Overall Study|Withdrawal by Subject|13|||
147312756|NCT01807221|531312251|FG000|Overall Study|Sponsor decision|2|||
147312757|NCT01807221|531312252|FG001|Overall Study|Sponsor decision|0|||
147312758|NCT01807221|531312253|FG002|Overall Study|Sponsor decision|1|||
147312759|NCT01807221|531312254|FG003|Overall Study|Sponsor decision|1|||
147312760|NCT01807221|531312255|FG004|Overall Study|Sponsor decision|0|||
147312761|NCT01807221|531312256|FG005|Overall Study|Sponsor decision|0|||
147312762|NCT01807221|531312251|FG000|Overall Study|Lost to Follow-up|1|||
147312763|NCT01807221|531312252|FG001|Overall Study|Lost to Follow-up|0|||
147312764|NCT01807221|531312253|FG002|Overall Study|Lost to Follow-up|2|||
147312765|NCT01807221|531312254|FG003|Overall Study|Lost to Follow-up|1|||
147312766|NCT01807221|531312255|FG004|Overall Study|Lost to Follow-up|0|||
147312767|NCT01807221|531312256|FG005|Overall Study|Lost to Follow-up|0|||
147312768|NCT06017999|531312257|FG000|Overall Study|Withdrawal by Subject|0|||
147312769|NCT06017999|531312258|FG001|Overall Study|Withdrawal by Subject|4|||
147312770|NCT06017999|531312259|FG002|Overall Study|Withdrawal by Subject|3|||
147312771|NCT06017999|531312257|FG000|Overall Study|Adverse Event|2|||
147312772|NCT06017999|531312258|FG001|Overall Study|Adverse Event|1|||
147312773|NCT06017999|531312259|FG002|Overall Study|Adverse Event|1|||
147567365|NCT05472038|532238279|FG011|Overall Study|Adverse Event|0|||
147567366|NCT05472038|532238268|FG000|Overall Study|Death|0|||
147567367|NCT05472038|532238269|FG001|Overall Study|Death|0|||
147567368|NCT05472038|532238270|FG002|Overall Study|Death|0|||
147567369|NCT05472038|532238271|FG003|Overall Study|Death|0|||
147567370|NCT05472038|532238272|FG004|Overall Study|Death|0|||
147567371|NCT05472038|532238273|FG005|Overall Study|Death|1|||
147567372|NCT05472038|532238274|FG006|Overall Study|Death|0|||
147567373|NCT05472038|532238275|FG007|Overall Study|Death|0|||
147567374|NCT05472038|532238276|FG008|Overall Study|Death|0|||
147567375|NCT05472038|532238277|FG009|Overall Study|Death|0|||
147567376|NCT05472038|532238278|FG010|Overall Study|Death|0|||
147567377|NCT05472038|532238279|FG011|Overall Study|Death|0|||
147567378|NCT05472038|532238268|FG000|Overall Study|Lost to Follow-up|1|||
147567379|NCT05472038|532238269|FG001|Overall Study|Lost to Follow-up|3|||
147567380|NCT05472038|532238270|FG002|Overall Study|Lost to Follow-up|3|||
147567381|NCT05472038|532238271|FG003|Overall Study|Lost to Follow-up|9|||
147312774|NCT06017999|531312257|FG000|Overall Study|Lost to Follow-up|0|||
147312775|NCT06017999|531312258|FG001|Overall Study|Lost to Follow-up|0|||
147312776|NCT06017999|531312259|FG002|Overall Study|Lost to Follow-up|1|||
147567382|NCT05472038|532238272|FG004|Overall Study|Lost to Follow-up|2|||
147567383|NCT05472038|532238273|FG005|Overall Study|Lost to Follow-up|2|||
147118489|NCT02187055|530598585|FG000|Overall Study|Withdrawal by Subject|11|||
147118490|NCT02187055|530598586|FG001|Overall Study|Withdrawal by Subject|11|||
147118491|NCT02187055|530598587|FG002|Overall Study|Withdrawal by Subject|11|||
147118492|NCT02187055|530598585|FG000|Overall Study|Adverse Event|21|||
147118493|NCT02187055|530598586|FG001|Overall Study|Adverse Event|26|||
147118494|NCT02187055|530598587|FG002|Overall Study|Adverse Event|36|||
147118495|NCT02187055|530598585|FG000|Overall Study|Death|2|||
147118496|NCT02187055|530598586|FG001|Overall Study|Death|0|||
147118497|NCT02187055|530598587|FG002|Overall Study|Death|0|||
147118498|NCT03336866|530598588|FG000|Overall Study|Lost to Follow-up|2|||
147230577|NCT01050543|531017983|FG001|Overall Study|Withdrawal by Subject|2|||
147567384|NCT05472038|532238274|FG006|Overall Study|Lost to Follow-up|1|||
147567385|NCT05472038|532238275|FG007|Overall Study|Lost to Follow-up|0|||
147567386|NCT05472038|532238276|FG008|Overall Study|Lost to Follow-up|1|||
147230578|NCT01050543|531017982|FG000|Overall Study|Protocol Violation|0|||
147230579|NCT01050543|531017983|FG001|Overall Study|Protocol Violation|1|||
147230580|NCT01050543|531017982|FG000|Overall Study|Administrative|4|||
147230581|NCT01050543|531017983|FG001|Overall Study|Administrative|1|||
147230582|NCT03053271|531017986|FG000|Overall Study|Did not meet randomization criteria|3|||
147230583|NCT03053271|531017986|FG000|Overall Study|Withdrawal by Subject|1|||
147230584|NCT00570765|531017987|FG000|DB Phase|Withdrawal by Subject|1|||
147230585|NCT00570765|531017988|FG001|DB Phase|Withdrawal by Subject|0|||
147230586|NCT00570765|531017989|FG002|DB Phase|Withdrawal by Subject|0|||
147230587|NCT00570765|531017990|FG003|DB Phase|Withdrawal by Subject|0|||
147230588|NCT00570765|531017987|FG000|DB Phase|Protocol Violation|0|||
147230589|NCT00570765|531017988|FG001|DB Phase|Protocol Violation|1|||
147230590|NCT00570765|531017989|FG002|DB Phase|Protocol Violation|0|||
147230591|NCT00570765|531017990|FG003|DB Phase|Protocol Violation|0|||
147230592|NCT00570765|531017987|FG000|DB Phase|Adverse Event|3|||
147230593|NCT00570765|531017988|FG001|DB Phase|Adverse Event|6|||
147230594|NCT00570765|531017989|FG002|DB Phase|Adverse Event|0|||
147230595|NCT00570765|531017990|FG003|DB Phase|Adverse Event|0|||
147230596|NCT00570765|531017987|FG000|DB Phase|Did Not Receive Study Drug|0|||
147230597|NCT00570765|531017988|FG001|DB Phase|Did Not Receive Study Drug|0|||
147230598|NCT00570765|531017989|FG002|DB Phase|Did Not Receive Study Drug|1|||
147230599|NCT00570765|531017990|FG003|DB Phase|Did Not Receive Study Drug|0|||
147230600|NCT00570765|531017987|FG000|LTSE Phase|Withdrawal by Subject|0|||
147230601|NCT00570765|531017988|FG001|LTSE Phase|Withdrawal by Subject|0|||
147230602|NCT00570765|531017989|FG002|LTSE Phase|Withdrawal by Subject|0|||
147230603|NCT00570765|531017990|FG003|LTSE Phase|Withdrawal by Subject|1|||
147230604|NCT00570765|531017987|FG000|LTSE Phase|Adverse Event|0|||
147230605|NCT00570765|531017988|FG001|LTSE Phase|Adverse Event|0|||
147230606|NCT00570765|531017989|FG002|LTSE Phase|Adverse Event|0|||
147230607|NCT00570765|531017990|FG003|LTSE Phase|Adverse Event|7|||
147230608|NCT00570765|531017987|FG000|LTSE Phase|Physician Decision|0|||
147230609|NCT00570765|531017988|FG001|LTSE Phase|Physician Decision|0|||
147230610|NCT00570765|531017989|FG002|LTSE Phase|Physician Decision|0|||
147230611|NCT00570765|531017990|FG003|LTSE Phase|Physician Decision|4|||
147230612|NCT02517866|531017991|FG000|Overall Study|Pretreatment Event/Adverse Event|9|||
147230613|NCT02517866|531017992|FG001|Overall Study|Pretreatment Event/Adverse Event|2|||
147230614|NCT02517866|531017993|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
147230615|NCT02517866|531017991|FG000|Overall Study|Significant Protocol Deviation|4|||
147230616|NCT02517866|531017992|FG001|Overall Study|Significant Protocol Deviation|1|||
147230617|NCT02517866|531017993|FG002|Overall Study|Significant Protocol Deviation|0|||
147230618|NCT02517866|531017991|FG000|Overall Study|Lost to Follow-up|1|||
147230619|NCT02517866|531017992|FG001|Overall Study|Lost to Follow-up|0|||
147230620|NCT02517866|531017993|FG002|Overall Study|Lost to Follow-up|0|||
147230621|NCT02517866|531017991|FG000|Overall Study|Voluntary Withdrawal|2|||
147230622|NCT02517866|531017992|FG001|Overall Study|Voluntary Withdrawal|2|||
147230623|NCT02517866|531017993|FG002|Overall Study|Voluntary Withdrawal|0|||
147230624|NCT02517866|531017991|FG000|Overall Study|Investigator Decision|2|||
147230625|NCT02517866|531017992|FG001|Overall Study|Investigator Decision|1|||
147230626|NCT02517866|531017993|FG002|Overall Study|Investigator Decision|0|||
147230627|NCT02517866|531017991|FG000|Overall Study|Reason not specified|2|||
147567387|NCT05472038|532238277|FG009|Overall Study|Lost to Follow-up|0|||
147567388|NCT05472038|532238278|FG010|Overall Study|Lost to Follow-up|2|||
147118499|NCT03336866|530598589|FG001|Overall Study|Lost to Follow-up|0|||
147118500|NCT03336866|530598590|FG002|Overall Study|Lost to Follow-up|3|||
147118501|NCT03336866|530598588|FG000|Overall Study|Withdrawal by Subject|1|||
147230628|NCT02517866|531017992|FG001|Overall Study|Reason not specified|0|||
147230629|NCT02517866|531017993|FG002|Overall Study|Reason not specified|0|||
147230630|NCT03114488|531017995|FG000|Time Period 2|Withdrawal by Subject|1|||
147230631|NCT03114488|531017996|FG001|Time Period 2|Withdrawal by Subject|3|||
147230632|NCT03711266|531017998|FG000|Overall Study|Lost to Follow-up|10|||
147230633|NCT01646073|531017999|FG000|Period A (12 Weeks)|Adverse Event|0|||
147230634|NCT01646073|531018000|FG001|Period A (12 Weeks)|Adverse Event|2|||
147230635|NCT01646073|531017999|FG000|Period A (12 Weeks)|Withdrawal by Subject|1|||
147230636|NCT01646073|531018000|FG001|Period A (12 Weeks)|Withdrawal by Subject|1|||
147230637|NCT01646073|531017999|FG000|Period A (12 Weeks)|Lack of Efficacy|1|||
147230638|NCT01646073|531018000|FG001|Period A (12 Weeks)|Lack of Efficacy|0|||
147230639|NCT01646073|531017999|FG000|Period A (12 Weeks)|Protocol Violation|0|||
147230640|NCT01646073|531018000|FG001|Period A (12 Weeks)|Protocol Violation|1|||
147230641|NCT01646073|531017999|FG000|Period A (12 Weeks)|Other|0|||
147230642|NCT01646073|531018000|FG001|Period A (12 Weeks)|Other|1|||
147230643|NCT01646073|531017999|FG000|Period B (12 Weeks)|Adverse Event|0|||
147230644|NCT01646073|531018000|FG001|Period B (12 Weeks)|Adverse Event|7|||
147230645|NCT01646073|531017999|FG000|Period B (12 Weeks)|Withdrawal by Subject|1|||
147230646|NCT01646073|531018000|FG001|Period B (12 Weeks)|Withdrawal by Subject|5|||
147230647|NCT01646073|531017999|FG000|Period B (12 Weeks)|Lost to Follow-up|0|||
147230648|NCT01646073|531018000|FG001|Period B (12 Weeks)|Lost to Follow-up|1|||
147230649|NCT05095454|531018003|FG000|Overall Study|Lengthy COVID-19 infection interrupted intervention to an unsatisfactory degree.|0|||
147230650|NCT05095454|531018004|FG001|Overall Study|Lengthy COVID-19 infection interrupted intervention to an unsatisfactory degree.|1|||
147230651|NCT00057876|531018005|FG000|Overall Study|Adverse Event|8|||
147230652|NCT00057876|531018006|FG001|Overall Study|Adverse Event|8|||
147230653|NCT00057876|531018005|FG000|Overall Study|Death|2|||
147230654|NCT00057876|531018006|FG001|Overall Study|Death|1|||
147230655|NCT00057876|531018005|FG000|Overall Study|Withdrawal by Subject|5|||
147230656|NCT00057876|531018006|FG001|Overall Study|Withdrawal by Subject|6|||
147230657|NCT00057876|531018005|FG000|Overall Study|Lack of Efficacy|10|||
147230658|NCT00057876|531018006|FG001|Overall Study|Lack of Efficacy|8|||
147230659|NCT00057876|531018005|FG000|Overall Study|Ineligible|1|||
147230660|NCT00057876|531018006|FG001|Overall Study|Ineligible|2|||
147230661|NCT00057876|531018005|FG000|Overall Study|other reason|2|||
147230662|NCT00057876|531018006|FG001|Overall Study|other reason|2|||
147230663|NCT00057876|531018005|FG000|Overall Study|other complicating disease|1|||
147230664|NCT00057876|531018006|FG001|Overall Study|other complicating disease|0|||
147230665|NCT00679055|531018007|FG000|Overall Study|Adverse Event|0|||
147230666|NCT00679055|531018008|FG001|Overall Study|Adverse Event|1|||
147230667|NCT00679055|531018007|FG000|Overall Study|Other|0|||
147230668|NCT00679055|531018008|FG001|Overall Study|Other|3|||
147230669|NCT00679055|531018007|FG000|Overall Study|Study Terminated|2|||
147230670|NCT00679055|531018008|FG001|Overall Study|Study Terminated|1|||
147230671|NCT00853073|531018009|FG000|Overall Study|Withdrawal by Subject|3|||
147230672|NCT00853073|531018010|FG001|Overall Study|Withdrawal by Subject|2|||
147230673|NCT02758171|531018011|FG000|Wash-out|Withdrawal by Subject|1|||
147230674|NCT02758171|531018012|FG001|Wash-out|Withdrawal by Subject|0|||
147230675|NCT02758171|531018011|FG000|Wash-out|Other reason|1|||
147230676|NCT02758171|531018012|FG001|Wash-out|Other reason|0|||
147230677|NCT01999114|531018013|FG000|Overall Study|Adverse Event|8|||
147230678|NCT01999114|531018014|FG001|Overall Study|Adverse Event|7|||
147230679|NCT01999114|531018015|FG002|Overall Study|Adverse Event|2|||
147230680|NCT01999114|531018016|FG003|Overall Study|Adverse Event|2|||
147230681|NCT01999114|531018017|FG004|Overall Study|Adverse Event|1|||
147230682|NCT01999114|531018013|FG000|Overall Study|Withdrawal by Subject|0|||
147230683|NCT01999114|531018014|FG001|Overall Study|Withdrawal by Subject|0|||
147230684|NCT01999114|531018015|FG002|Overall Study|Withdrawal by Subject|1|||
147230685|NCT01999114|531018016|FG003|Overall Study|Withdrawal by Subject|0|||
147230686|NCT01999114|531018017|FG004|Overall Study|Withdrawal by Subject|1|||
147230687|NCT01999114|531018013|FG000|Overall Study|Lost to Follow-up|0|||
147230688|NCT01999114|531018014|FG001|Overall Study|Lost to Follow-up|0|||
147230689|NCT01999114|531018015|FG002|Overall Study|Lost to Follow-up|1|||
147230690|NCT01999114|531018016|FG003|Overall Study|Lost to Follow-up|0|||
147230691|NCT01999114|531018017|FG004|Overall Study|Lost to Follow-up|0|||
147230692|NCT01999114|531018013|FG000|Overall Study|Administrative|0|||
147230693|NCT01999114|531018014|FG001|Overall Study|Administrative|0|||
147230694|NCT01999114|531018015|FG002|Overall Study|Administrative|1|||
147230695|NCT01999114|531018016|FG003|Overall Study|Administrative|1|||
147230696|NCT01999114|531018017|FG004|Overall Study|Administrative|2|||
147230697|NCT00943124|531018020|FG000|Period 1|Withdrawal by Subject|1|||
147230698|NCT00943124|531018021|FG001|Period 1|Withdrawal by Subject|1|||
147230699|NCT00943124|531018020|FG000|Period 1|Did Not Follow Study Procedures|1|||
147230700|NCT00943124|531018021|FG001|Period 1|Did Not Follow Study Procedures|0|||
147230701|NCT00943124|531018020|FG000|Period 1|Personal Reasons|0|||
147230702|NCT00943124|531018021|FG001|Period 1|Personal Reasons|1|||
147230703|NCT02992132|531018022|FG000|Overall Study|Adverse Event|4|||
147230704|NCT02992132|531018023|FG001|Overall Study|Adverse Event|1|||
147230705|NCT02992132|531018024|FG002|Overall Study|Adverse Event|3|||
147230706|NCT02992132|531018022|FG000|Overall Study|Lack of Efficacy|2|||
147230707|NCT02992132|531018023|FG001|Overall Study|Lack of Efficacy|0|||
147230708|NCT02992132|531018024|FG002|Overall Study|Lack of Efficacy|0|||
147230709|NCT02992132|531018022|FG000|Overall Study|Non-compliance with study drug|2|||
147230710|NCT02992132|531018023|FG001|Overall Study|Non-compliance with study drug|0|||
147230711|NCT02992132|531018024|FG002|Overall Study|Non-compliance with study drug|0|||
147230712|NCT02992132|531018022|FG000|Overall Study|Progressive disease|1|||
147230713|NCT02992132|531018023|FG001|Overall Study|Progressive disease|0|||
147230714|NCT02992132|531018024|FG002|Overall Study|Progressive disease|0|||
147230715|NCT02992132|531018022|FG000|Overall Study|Protocol Violation|2|||
147230716|NCT02992132|531018023|FG001|Overall Study|Protocol Violation|2|||
147118502|NCT03336866|530598589|FG001|Overall Study|Withdrawal by Subject|1|||
147118503|NCT03336866|530598590|FG002|Overall Study|Withdrawal by Subject|0|||
147118504|NCT03336866|530598588|FG000|Overall Study|Noncompliance with clinic house rules|0|||
147118505|NCT03336866|530598589|FG001|Overall Study|Noncompliance with clinic house rules|0|||
147118506|NCT03336866|530598590|FG002|Overall Study|Noncompliance with clinic house rules|1|||
147118507|NCT03462563|530598593|FG000|Overall Study|Death|1|||
147118508|NCT03462563|530598594|FG001|Overall Study|Death|1|||
147118509|NCT03462563|530598593|FG000|Overall Study|Termination of study|2|||
147118510|NCT03462563|530598594|FG001|Overall Study|Termination of study|1|||
147118511|NCT03462563|530598593|FG000|Overall Study|Adverse Event|1|||
147118512|NCT03462563|530598594|FG001|Overall Study|Adverse Event|3|||
147118513|NCT03462563|530598593|FG000|Overall Study|Unspecified reason|10|||
147118514|NCT03462563|530598594|FG001|Overall Study|Unspecified reason|12|||
147118515|NCT03462563|530598593|FG000|Overall Study|Physician Decision|1|||
147118516|NCT03462563|530598594|FG001|Overall Study|Physician Decision|0|||
147118517|NCT05737745|530598595|FG000|Overall Study|Withdrawal by Subject|0|||
147118518|NCT05737745|530598596|FG001|Overall Study|Withdrawal by Subject|6|||
147118519|NCT05737745|530598597|FG002|Overall Study|Withdrawal by Subject|1|||
147118520|NCT02021318|530598598|FG000|Overall Study|Adverse Event|2|||
147118521|NCT02021318|530598599|FG001|Overall Study|Adverse Event|1|||
147118522|NCT02021318|530598598|FG000|Overall Study|Death|33|||
147118523|NCT02021318|530598599|FG001|Overall Study|Death|34|||
147118524|NCT02021318|530598598|FG000|Overall Study|Lost to Follow-up|3|||
147118525|NCT02021318|530598599|FG001|Overall Study|Lost to Follow-up|3|||
147118526|NCT02021318|530598598|FG000|Overall Study|Progressive Disease|0|||
147118527|NCT02021318|530598599|FG001|Overall Study|Progressive Disease|1|||
147118528|NCT02021318|530598598|FG000|Overall Study|Withdrawal by Subject|30|||
147118529|NCT02021318|530598599|FG001|Overall Study|Withdrawal by Subject|18|||
147118530|NCT02021318|530598598|FG000|Overall Study|Physician Decision|3|||
147118531|NCT02021318|530598599|FG001|Overall Study|Physician Decision|3|||
147118532|NCT02021318|530598598|FG000|Overall Study|Miscellaneous|2|||
147118533|NCT02021318|530598599|FG001|Overall Study|Miscellaneous|3|||
147118534|NCT00689052|530598600|FG000|Overall Study|Adverse Event|4|||
147118535|NCT00689052|530598601|FG001|Overall Study|Adverse Event|6|||
147118536|NCT00689052|530598600|FG000|Overall Study|Protocol Violation|1|||
147118537|NCT00689052|530598601|FG001|Overall Study|Protocol Violation|0|||
147118538|NCT00689052|530598600|FG000|Overall Study|Lost to Follow-up|2|||
147118539|NCT00689052|530598601|FG001|Overall Study|Lost to Follow-up|0|||
147118540|NCT00689052|530598600|FG000|Overall Study|Withdrawal by Subject|2|||
147118541|NCT00689052|530598601|FG001|Overall Study|Withdrawal by Subject|0|||
147118542|NCT00689052|530598600|FG000|Overall Study|Early termination of the trial|22|||
147118543|NCT00689052|530598601|FG001|Overall Study|Early termination of the trial|24|||
147118544|NCT02569242|530598602|FG000|Overall Study|Death|1|||
147118545|NCT02569242|530598603|FG001|Overall Study|Death|0|||
147118546|NCT02569242|530598602|FG000|Overall Study|Withdrawal by Subject|0|||
147118547|NCT02569242|530598603|FG001|Overall Study|Withdrawal by Subject|1|||
147118548|NCT04796207|530598606|FG000|Overall Study|Lost to Follow-up|7|||
147118549|NCT04796207|530598607|FG001|Overall Study|Lost to Follow-up|2|||
147118550|NCT03003468|530598608|FG000|Overall Study|Withdrawal by Subject|0|||
147118551|NCT03003468|530598609|FG001|Overall Study|Withdrawal by Subject|0|||
147118552|NCT03003468|530598610|FG002|Overall Study|Withdrawal by Subject|1|||
147118553|NCT03003468|530598608|FG000|Overall Study|No measurable lesions|0|||
147118554|NCT03003468|530598609|FG001|Overall Study|No measurable lesions|0|||
147118555|NCT03003468|530598610|FG002|Overall Study|No measurable lesions|1|||
147118556|NCT02405962|530598611|FG000|Overall Study|Lost to Follow-up|1|||
147118557|NCT02405962|530598612|FG001|Overall Study|Lost to Follow-up|4|||
147118558|NCT02405962|530598611|FG000|Overall Study|A participant has moved to another place|0|||
147118559|NCT02405962|530598612|FG001|Overall Study|A participant has moved to another place|1|||
147118560|NCT00165698|530598613|FG000|Overall Study|Adverse Event|2|||
147230717|NCT02992132|531018024|FG002|Overall Study|Protocol Violation|0|||
147230718|NCT02992132|531018022|FG000|Overall Study|Caregiver withdrew consent|2|||
147230719|NCT02992132|531018023|FG001|Overall Study|Caregiver withdrew consent|3|||
147230720|NCT02992132|531018024|FG002|Overall Study|Caregiver withdrew consent|2|||
147230721|NCT02992132|531018022|FG000|Overall Study|Withdrawal by Subject|0|||
147230722|NCT02992132|531018023|FG001|Overall Study|Withdrawal by Subject|2|||
147230723|NCT02992132|531018024|FG002|Overall Study|Withdrawal by Subject|1|||
147230724|NCT02992132|531018022|FG000|Overall Study|Physician Decision|0|||
147118561|NCT00165698|530598614|FG001|Overall Study|Adverse Event|10|||
147118562|NCT00165698|530598613|FG000|Overall Study|Lost to Follow-up|2|||
147118563|NCT00165698|530598614|FG001|Overall Study|Lost to Follow-up|2|||
147118564|NCT00165698|530598613|FG000|Overall Study|Withdrawal by Subject|2|||
147567389|NCT05472038|532238279|FG011|Overall Study|Lost to Follow-up|1|||
147118565|NCT00165698|530598614|FG001|Overall Study|Withdrawal by Subject|1|||
147118566|NCT00165698|530598613|FG000|Overall Study|Protocol Violation|1|||
147230725|NCT02992132|531018023|FG001|Overall Study|Physician Decision|0|||
147118567|NCT00165698|530598614|FG001|Overall Study|Protocol Violation|0|||
147230726|NCT02992132|531018024|FG002|Overall Study|Physician Decision|1|||
147230727|NCT01104155|531018035|FG000|Overall Study|Adverse Event|15|||
147118568|NCT00165698|530598613|FG000|Overall Study|Not Taken/Lost the medicine|1|||
147118569|NCT00165698|530598614|FG001|Overall Study|Not Taken/Lost the medicine|2|||
147118570|NCT01107457|530598615|FG000|Part A|Adverse Event|1|||
147118571|NCT01107457|530598616|FG001|Part A|Adverse Event|2|||
147118572|NCT01107457|530598617|FG002|Part A|Adverse Event|1|||
147118573|NCT01107457|530598618|FG003|Part A|Adverse Event|0|||
147118574|NCT01107457|530598619|FG004|Part A|Adverse Event|0|||
147118575|NCT01107457|530598620|FG005|Part A|Adverse Event|0|||
147118576|NCT01107457|530598615|FG000|Part A|Withdrawal by Subject|3|||
147118577|NCT01107457|530598616|FG001|Part A|Withdrawal by Subject|3|||
147118578|NCT01107457|530598617|FG002|Part A|Withdrawal by Subject|0|||
147118579|NCT01107457|530598618|FG003|Part A|Withdrawal by Subject|3|||
147118580|NCT01107457|530598619|FG004|Part A|Withdrawal by Subject|1|||
147118581|NCT01107457|530598620|FG005|Part A|Withdrawal by Subject|0|||
147118582|NCT01107457|530598615|FG000|Part A|Lost to Follow-up|0|||
147118583|NCT01107457|530598616|FG001|Part A|Lost to Follow-up|1|||
147118584|NCT01107457|530598617|FG002|Part A|Lost to Follow-up|0|||
147118585|NCT01107457|530598618|FG003|Part A|Lost to Follow-up|0|||
147118586|NCT01107457|530598619|FG004|Part A|Lost to Follow-up|0|||
147118587|NCT01107457|530598620|FG005|Part A|Lost to Follow-up|0|||
147118588|NCT01107457|530598615|FG000|Part A|Lack of Efficacy|1|||
147118589|NCT01107457|530598616|FG001|Part A|Lack of Efficacy|0|||
147118590|NCT01107457|530598617|FG002|Part A|Lack of Efficacy|0|||
147118591|NCT01107457|530598618|FG003|Part A|Lack of Efficacy|0|||
147118592|NCT01107457|530598619|FG004|Part A|Lack of Efficacy|0|||
147118593|NCT01107457|530598620|FG005|Part A|Lack of Efficacy|0|||
147118594|NCT01107457|530598615|FG000|Part A|Protocol Violation|0|||
147118595|NCT01107457|530598616|FG001|Part A|Protocol Violation|1|||
147118596|NCT01107457|530598617|FG002|Part A|Protocol Violation|0|||
147118597|NCT01107457|530598618|FG003|Part A|Protocol Violation|0|||
147118598|NCT01107457|530598619|FG004|Part A|Protocol Violation|0|||
147118599|NCT01107457|530598620|FG005|Part A|Protocol Violation|0|||
147567390|NCT05472038|532238268|FG000|Overall Study|Physician Decision|0|||
147118600|NCT01107457|530598615|FG000|Part B and C|Adverse Event|0|||
147118601|NCT01107457|530598616|FG001|Part B and C|Adverse Event|0|||
147118602|NCT01107457|530598617|FG002|Part B and C|Adverse Event|0|||
147118603|NCT01107457|530598618|FG003|Part B and C|Adverse Event|0|||
147118604|NCT01107457|530598619|FG004|Part B and C|Adverse Event|0|||
147118605|NCT01107457|530598620|FG005|Part B and C|Adverse Event|12|||
147118606|NCT01107457|530598615|FG000|Part B and C|Inclusion/Exclusion Criteria Not Met|0|||
147118607|NCT01107457|530598616|FG001|Part B and C|Inclusion/Exclusion Criteria Not Met|0|||
147118608|NCT01107457|530598617|FG002|Part B and C|Inclusion/Exclusion Criteria Not Met|0|||
147118609|NCT01107457|530598618|FG003|Part B and C|Inclusion/Exclusion Criteria Not Met|0|||
147118610|NCT01107457|530598619|FG004|Part B and C|Inclusion/Exclusion Criteria Not Met|0|||
147118611|NCT01107457|530598620|FG005|Part B and C|Inclusion/Exclusion Criteria Not Met|1|||
147118612|NCT01107457|530598615|FG000|Part B and C|Physician Decision|0|||
147230728|NCT01104155|531018036|FG001|Overall Study|Adverse Event|8|||
147230729|NCT01104155|531018035|FG000|Overall Study|Participant choice|6|||
147567391|NCT05472038|532238269|FG001|Overall Study|Physician Decision|0|||
147567392|NCT05472038|532238270|FG002|Overall Study|Physician Decision|0|||
147567393|NCT05472038|532238271|FG003|Overall Study|Physician Decision|0|||
147230730|NCT01104155|531018036|FG001|Overall Study|Participant choice|5|||
147567394|NCT05472038|532238272|FG004|Overall Study|Physician Decision|1|||
147118613|NCT01107457|530598616|FG001|Part B and C|Physician Decision|0|||
147118614|NCT01107457|530598617|FG002|Part B and C|Physician Decision|0|||
147230731|NCT01104155|531018035|FG000|Overall Study|Withdrawal of consent|1|||
147230732|NCT01104155|531018036|FG001|Overall Study|Withdrawal of consent|1|||
147230733|NCT01104155|531018035|FG000|Overall Study|Other|3|||
147230734|NCT01104155|531018036|FG001|Overall Study|Other|4|||
147230735|NCT02787551|531018042|FG000|Core Period: 26 Weeks|Adverse Event|10|||
147230736|NCT02787551|531018043|FG001|Core Period: 26 Weeks|Adverse Event|0|||
147230737|NCT02787551|531018042|FG000|Core Period: 26 Weeks|Lack of Efficacy|1|||
147230738|NCT02787551|531018043|FG001|Core Period: 26 Weeks|Lack of Efficacy|0|||
147230739|NCT02787551|531018042|FG000|Core Period: 26 Weeks|Poor compliance to protocol|2|||
147230740|NCT02787551|531018043|FG001|Core Period: 26 Weeks|Poor compliance to protocol|0|||
147230741|NCT02787551|531018042|FG000|Core Period: 26 Weeks|Withdrawal by Subject|9|||
147230742|NCT02787551|531018043|FG001|Core Period: 26 Weeks|Withdrawal by Subject|9|||
147567395|NCT05472038|532238273|FG005|Overall Study|Physician Decision|0|||
147567396|NCT05472038|532238274|FG006|Overall Study|Physician Decision|0|||
147118615|NCT01107457|530598618|FG003|Part B and C|Physician Decision|0|||
147118616|NCT01107457|530598619|FG004|Part B and C|Physician Decision|0|||
147118617|NCT01107457|530598620|FG005|Part B and C|Physician Decision|3|||
147567397|NCT05472038|532238275|FG007|Overall Study|Physician Decision|0|||
147567398|NCT05472038|532238276|FG008|Overall Study|Physician Decision|0|||
147118618|NCT01107457|530598615|FG000|Part B and C|Lack of Efficacy|0|||
147118619|NCT01107457|530598616|FG001|Part B and C|Lack of Efficacy|0|||
147230743|NCT02787551|531018042|FG000|Core Period: 26 Weeks|Randomized but not treated|2|||
147230744|NCT02787551|531018043|FG001|Core Period: 26 Weeks|Randomized but not treated|1|||
147118620|NCT01107457|530598617|FG002|Part B and C|Lack of Efficacy|0|||
147230745|NCT02787551|531018042|FG000|Core Period: 26 Weeks|Other than specified|3|||
147312777|NCT06017999|531312257|FG000|Overall Study|Physician Decision|1|||
147118621|NCT01107457|530598618|FG003|Part B and C|Lack of Efficacy|0|||
147118622|NCT01107457|530598619|FG004|Part B and C|Lack of Efficacy|0|||
147118623|NCT01107457|530598620|FG005|Part B and C|Lack of Efficacy|7|||
147118624|NCT01107457|530598615|FG000|Part B and C|Lost to Follow-up|0|||
147118625|NCT01107457|530598616|FG001|Part B and C|Lost to Follow-up|0|||
147118626|NCT01107457|530598617|FG002|Part B and C|Lost to Follow-up|0|||
147118627|NCT01107457|530598618|FG003|Part B and C|Lost to Follow-up|0|||
147118628|NCT01107457|530598619|FG004|Part B and C|Lost to Follow-up|0|||
147118629|NCT01107457|530598620|FG005|Part B and C|Lost to Follow-up|10|||
147118630|NCT01107457|530598615|FG000|Part B and C|Protocol Violation|0|||
147118631|NCT01107457|530598616|FG001|Part B and C|Protocol Violation|0|||
147118632|NCT01107457|530598617|FG002|Part B and C|Protocol Violation|0|||
147118633|NCT01107457|530598618|FG003|Part B and C|Protocol Violation|0|||
147118634|NCT01107457|530598619|FG004|Part B and C|Protocol Violation|0|||
147118635|NCT01107457|530598620|FG005|Part B and C|Protocol Violation|1|||
147118636|NCT01107457|530598615|FG000|Part B and C|Sponsor Decision|0|||
147118637|NCT01107457|530598616|FG001|Part B and C|Sponsor Decision|0|||
147118638|NCT01107457|530598617|FG002|Part B and C|Sponsor Decision|0|||
147118639|NCT01107457|530598618|FG003|Part B and C|Sponsor Decision|0|||
147118640|NCT01107457|530598619|FG004|Part B and C|Sponsor Decision|0|||
147118641|NCT01107457|530598620|FG005|Part B and C|Sponsor Decision|66|||
147118642|NCT01107457|530598615|FG000|Part B and C|Withdrawal by Subject|0|||
147118643|NCT01107457|530598616|FG001|Part B and C|Withdrawal by Subject|0|||
147118644|NCT01107457|530598617|FG002|Part B and C|Withdrawal by Subject|0|||
147118645|NCT01107457|530598618|FG003|Part B and C|Withdrawal by Subject|0|||
147118646|NCT01107457|530598619|FG004|Part B and C|Withdrawal by Subject|0|||
147118647|NCT01107457|530598620|FG005|Part B and C|Withdrawal by Subject|16|||
147118648|NCT01107457|530598615|FG000|Part B and C|Clinical Relapse|0|||
147118649|NCT01107457|530598616|FG001|Part B and C|Clinical Relapse|0|||
147118650|NCT01107457|530598617|FG002|Part B and C|Clinical Relapse|0|||
147118651|NCT01107457|530598618|FG003|Part B and C|Clinical Relapse|0|||
147118652|NCT01107457|530598619|FG004|Part B and C|Clinical Relapse|0|||
147118653|NCT01107457|530598620|FG005|Part B and C|Clinical Relapse|4|||
147118654|NCT03020888|530598621|FG000|Overall Study|Physician Decision|4|||
147118655|NCT03020888|530598621|FG000|Overall Study|Withdrawal by Subject|6|||
147118656|NCT03020888|530598621|FG000|Overall Study|Insurance coverage|2|||
147118657|NCT03020888|530598621|FG000|Overall Study|Lost to Follow-up|1|||
147118658|NCT01348490|530598622|FG000|Overall Study|Death|1|||
147118659|NCT01348490|530598622|FG000|Overall Study|Adverse Event|3|||
147118660|NCT01348490|530598622|FG000|Overall Study|Consent withdrawn|7|||
147118661|NCT01348490|530598622|FG000|Overall Study|Disease progression|3|||
147118662|NCT01348490|530598622|FG000|Overall Study|Lost to Follow-up|1|||
147118663|NCT01348490|530598622|FG000|Overall Study|Termination of clinical trial by sponsor|1|||
147118664|NCT01348490|530598622|FG000|Overall Study|Other Unspecified|8|||
147118665|NCT00300495|530598623|FG000|Overall Study|Protocol Violation|4|||
147118666|NCT00300495|530598624|FG001|Overall Study|Protocol Violation|1|||
147118667|NCT02186171|530598627|FG000|Overall Study|Withdrawal by Subject|1|||
147118668|NCT02186171|530598628|FG001|Overall Study|Withdrawal by Subject|9|||
147118669|NCT02186171|530598627|FG000|Overall Study|Lost to Follow-up|2|||
147118670|NCT02186171|530598628|FG001|Overall Study|Lost to Follow-up|2|||
147118671|NCT02186171|530598627|FG000|Overall Study|Death|1|||
147118672|NCT02186171|530598628|FG001|Overall Study|Death|2|||
147118673|NCT02186171|530598627|FG000|Overall Study|Protocol-specified Criteria|0|||
147118674|NCT02186171|530598628|FG001|Overall Study|Protocol-specified Criteria|2|||
147118675|NCT02015104|530598630|FG000|Overall Study|Withdrew consent after first dose drug|1|||
147312778|NCT06017999|531312258|FG001|Overall Study|Physician Decision|1|||
147312779|NCT06017999|531312259|FG002|Overall Study|Physician Decision|0|||
147312780|NCT06017999|531312257|FG000|Overall Study|Non-Compliance|0|||
147312781|NCT06017999|531312258|FG001|Overall Study|Non-Compliance|0|||
147312782|NCT06017999|531312259|FG002|Overall Study|Non-Compliance|1|||
147312783|NCT06017999|531312257|FG000|Overall Study|Lack of Efficacy|1|||
147312784|NCT06017999|531312258|FG001|Overall Study|Lack of Efficacy|0|||
147312785|NCT06017999|531312259|FG002|Overall Study|Lack of Efficacy|7|||
147312786|NCT06017999|531312257|FG000|Overall Study|COVID Positive|0|||
147312787|NCT06017999|531312258|FG001|Overall Study|COVID Positive|1|||
147312788|NCT06017999|531312259|FG002|Overall Study|COVID Positive|0|||
147118676|NCT02015104|530598631|FG001|Overall Study|Withdrew consent after first dose drug|0|||
147118677|NCT02015104|530598630|FG000|Overall Study|Withdrew consent prior to treatment|0|||
147118678|NCT02015104|530598631|FG001|Overall Study|Withdrew consent prior to treatment|1|||
147118679|NCT01030900|530598632|FG000|Overall Study|Not treated due to congestive heart failure|1|||
147118680|NCT01030900|530598632|FG000|Overall Study|Not treated due to rapid disease|1|||
147118681|NCT03055221|530600563|FG000|Overall Study|Adverse Event|2|||
147118682|NCT03055221|530600563|FG000|Overall Study|Withdrawal by Subject|4|||
147118683|NCT03055221|530600563|FG000|Overall Study|Death|6|||
147312789|NCT06017999|531312257|FG000|Overall Study|Did Not Disclose Amount of EtOH Consumed|0|||
147118684|NCT03055221|530600563|FG000|Overall Study|Physician Decision|1|||
147118685|NCT03055221|530600563|FG000|Overall Study|Study terminated by Sponsor|3|||
147118686|NCT03055221|530600563|FG000|Overall Study|Lost to Follow-up|4|||
147312790|NCT06017999|531312258|FG001|Overall Study|Did Not Disclose Amount of EtOH Consumed|0|||
147567399|NCT05472038|532238277|FG009|Overall Study|Physician Decision|0|||
147567400|NCT05472038|532238278|FG010|Overall Study|Physician Decision|0|||
147567401|NCT05472038|532238279|FG011|Overall Study|Physician Decision|0|||
147118687|NCT01964560|530600568|FG000|Overall Study|Adverse Event|23|||
147118688|NCT01964560|530600568|FG000|Overall Study|Lack of Efficacy|46|||
147118689|NCT01964560|530600568|FG000|Overall Study|Protocol deviation|2|||
147118690|NCT01964560|530600568|FG000|Overall Study|Lost to Follow-up|4|||
147118691|NCT01964560|530600568|FG000|Overall Study|Withdrawal by Subject|64|||
147118692|NCT01964560|530600568|FG000|Overall Study|Surgery-hemispherotomy|1|||
147118693|NCT01964560|530600568|FG000|Overall Study|Surgery|1|||
147118694|NCT01964560|530600568|FG000|Overall Study|Seizures appeared resolved with epilepsy surgery|1|||
147118695|NCT01964560|530600568|FG000|Overall Study|Patient and Investigator choice|1|||
147118696|NCT01964560|530600568|FG000|Overall Study|Patient was prescribed CBD|1|||
147118697|NCT01964560|530600568|FG000|Overall Study|Participant moved to another country|1|||
147118698|NCT01093885|530600574|FG000|Overall Study|Adverse Event|4|||
147118699|NCT01093885|530600574|FG000|Overall Study|Lost to Follow-up|1|||
147118700|NCT01301001|530600575|FG000|First Intervention|Lost to Follow-up|4|||
147118701|NCT01301001|530600576|FG001|First Intervention|Lost to Follow-up|4|||
147118702|NCT01301001|530600575|FG000|First Intervention|Withdrawal by Subject|1|||
147118703|NCT01301001|530600576|FG001|First Intervention|Withdrawal by Subject|4|||
147118704|NCT01301001|530600575|FG000|First Intervention|Adverse Event|5|||
147118705|NCT01301001|530600576|FG001|First Intervention|Adverse Event|0|||
147118706|NCT01301001|530600575|FG000|First Intervention|Protocol Violation|0|||
147118707|NCT01301001|530600576|FG001|First Intervention|Protocol Violation|1|||
147118708|NCT01301001|530600575|FG000|Second Intervention|Adverse Event|2|||
147118709|NCT01301001|530600576|FG001|Second Intervention|Adverse Event|0|||
147118710|NCT01301001|530600575|FG000|Second Intervention|Withdrawal by Subject|2|||
147118711|NCT01301001|530600576|FG001|Second Intervention|Withdrawal by Subject|0|||
147230746|NCT02787551|531018043|FG001|Core Period: 26 Weeks|Other than specified|1|||
147230747|NCT02787551|531018042|FG000|Extension Period:26 Weeks(Upto 52 Weeks)|Adverse Event|1|||
147230748|NCT02787551|531018043|FG001|Extension Period:26 Weeks(Upto 52 Weeks)|Adverse Event|0|||
147230749|NCT02787551|531018042|FG000|Extension Period:26 Weeks(Upto 52 Weeks)|Poor compliance to protocol|3|||
147230750|NCT02787551|531018043|FG001|Extension Period:26 Weeks(Upto 52 Weeks)|Poor compliance to protocol|0|||
147230751|NCT02787551|531018042|FG000|Extension Period:26 Weeks(Upto 52 Weeks)|Other than specified|5|||
147230752|NCT02787551|531018043|FG001|Extension Period:26 Weeks(Upto 52 Weeks)|Other than specified|0|||
147230753|NCT03799211|531018044|FG000|Overall Study|Lost to Follow-up|2|||
147230754|NCT03799211|531018045|FG001|Overall Study|Lost to Follow-up|13|||
147230755|NCT03799211|531018044|FG000|Overall Study|Withdrawal by Subject|2|||
147230756|NCT03799211|531018045|FG001|Overall Study|Withdrawal by Subject|0|||
147230757|NCT00764491|531018046|FG000|Overall Study|Lost to Follow-up|35|||
147230758|NCT00764491|531018047|FG001|Overall Study|Lost to Follow-up|17|||
147230759|NCT00923936|531018048|FG000|Overall Study|progressive disease on study|2|||
147230760|NCT00923936|531018049|FG001|Overall Study|progressive disease on study|1|||
147230761|NCT00923936|531018048|FG000|Overall Study|Adverse Event|2|||
147230762|NCT00923936|531018049|FG001|Overall Study|Adverse Event|1|||
147230763|NCT00923936|531018048|FG000|Overall Study|Lost to follow up|2|||
147230764|NCT00923936|531018049|FG001|Overall Study|Lost to follow up|0|||
147230765|NCT00923936|531018048|FG000|Overall Study|Continuing in follow up period|2|||
147230766|NCT00923936|531018049|FG001|Overall Study|Continuing in follow up period|1|||
147230767|NCT02038452|531018051|FG000|Overall Study|Withdrawal by Subject|7|||
147230768|NCT02038452|531018052|FG001|Overall Study|Withdrawal by Subject|9|||
147230769|NCT02038452|531018051|FG000|Overall Study|Lost to Follow-up|31|||
147230770|NCT02038452|531018052|FG001|Overall Study|Lost to Follow-up|28|||
147230771|NCT03139279|531018053|FG000|Overall Study|Physician Decision|2|||
147230772|NCT03139279|531018054|FG001|Overall Study|Physician Decision|0|||
147230773|NCT03139279|531018053|FG000|Overall Study|Protocol Violation|5|||
147230774|NCT03139279|531018054|FG001|Overall Study|Protocol Violation|4|||
147230775|NCT03139279|531018053|FG000|Overall Study|Withdrawal by Subject|0|||
147230776|NCT03139279|531018054|FG001|Overall Study|Withdrawal by Subject|2|||
147230777|NCT02337738|531018055|FG000|Overall Study|Major Protocol Deviation (Pre-Treatment)|0|||
147230778|NCT02337738|531018056|FG001|Overall Study|Major Protocol Deviation (Pre-Treatment)|1|||
147230779|NCT02337738|531018057|FG002|Overall Study|Major Protocol Deviation (Pre-Treatment)|0|||
147230780|NCT02337738|531018055|FG000|Overall Study|Pretreatment Event/Adverse Event|9|||
147230781|NCT02337738|531018056|FG001|Overall Study|Pretreatment Event/Adverse Event|18|||
147230782|NCT02337738|531018057|FG002|Overall Study|Pretreatment Event/Adverse Event|21|||
147567402|NCT05472038|532238268|FG000|Overall Study|Withdrawal by Subject|1|||
147567403|NCT05472038|532238269|FG001|Overall Study|Withdrawal by Subject|3|||
147118712|NCT01560988|530600577|FG000|First Intervention (Six Weeks)|Lost to Follow-up|7|||
147118713|NCT01560988|530600578|FG001|First Intervention (Six Weeks)|Lost to Follow-up|4|||
147118714|NCT01560988|530600577|FG000|First Intervention (Six Weeks)|Withdrawal by Subject|3|||
147118715|NCT01560988|530600578|FG001|First Intervention (Six Weeks)|Withdrawal by Subject|0|||
147230783|NCT02337738|531018055|FG000|Overall Study|Major Protocol Deviation (in-Treatment)|0|||
147230784|NCT02337738|531018056|FG001|Overall Study|Major Protocol Deviation (in-Treatment)|1|||
147230785|NCT02337738|531018057|FG002|Overall Study|Major Protocol Deviation (in-Treatment)|0|||
147118716|NCT01560988|530600577|FG000|Washout (Six Weeks)|Lost to Follow-up|2|||
147118717|NCT01560988|530600578|FG001|Washout (Six Weeks)|Lost to Follow-up|2|||
147118718|NCT02301429|530600585|FG000|Overall Study|not acceptable vascular anatomy|3|||
147118719|NCT01502072|530600586|FG000|Overall Study|Withdrawal by Subject|1|||
147118720|NCT01502072|530600587|FG001|Overall Study|Withdrawal by Subject|0|||
147118721|NCT01502072|530600588|FG002|Overall Study|Withdrawal by Subject|0|||
147118722|NCT01502072|530600586|FG000|Overall Study|Death|0|||
147118723|NCT01502072|530600587|FG001|Overall Study|Death|1|||
147118724|NCT01502072|530600588|FG002|Overall Study|Death|0|||
147118725|NCT01975285|530600599|FG000|Overall Study|Failed Block and follow up|2|||
147118726|NCT01975285|530600600|FG001|Overall Study|Failed Block and follow up|2|||
147118727|NCT04535362|530600601|FG000|Overall Study|Lost to Follow-up|3|||
147118728|NCT04535362|530600602|FG001|Overall Study|Lost to Follow-up|1|||
147118729|NCT03791060|530600603|FG000|Overall Study|Withdrawal by Subject|1|||
147118730|NCT02018887|530600606|FG000|Part A: Cohorts 1-2: Period 3|Adverse Event|1|||
147118731|NCT02018887|530600607|FG001|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
147118732|NCT02018887|530600608|FG002|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
147118733|NCT02018887|530600609|FG003|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
147118734|NCT02018887|530600610|FG004|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
147118735|NCT02018887|530600611|FG005|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
147118736|NCT02018887|530600612|FG006|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
147118737|NCT02018887|530600613|FG007|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
147118738|NCT02018887|530600614|FG008|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
147118739|NCT02018887|530600615|FG009|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
147118740|NCT02018887|530600616|FG010|Part A: Cohorts 1-2: Period 3|Adverse Event|0|||
147118741|NCT02018887|530600606|FG000|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
147118742|NCT02018887|530600607|FG001|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
147118743|NCT02018887|530600608|FG002|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
147118744|NCT02018887|530600609|FG003|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
147118745|NCT02018887|530600610|FG004|Part B: Cohorts 3-7 Overall|Adverse Event|1|||
147118746|NCT02018887|530600611|FG005|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
147118747|NCT02018887|530600612|FG006|Part B: Cohorts 3-7 Overall|Adverse Event|1|||
147118748|NCT02018887|530600613|FG007|Part B: Cohorts 3-7 Overall|Adverse Event|4|||
147118749|NCT02018887|530600614|FG008|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
147118750|NCT02018887|530600615|FG009|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
147118751|NCT02018887|530600616|FG010|Part B: Cohorts 3-7 Overall|Adverse Event|0|||
147230786|NCT02337738|531018055|FG000|Overall Study|Voluntary Withdrawal|10|||
147230787|NCT02337738|531018056|FG001|Overall Study|Voluntary Withdrawal|5|||
147230788|NCT02337738|531018057|FG002|Overall Study|Voluntary Withdrawal|2|||
147230789|NCT02337738|531018055|FG000|Overall Study|Lack of Efficacy|2|||
147230790|NCT02337738|531018056|FG001|Overall Study|Lack of Efficacy|4|||
147230791|NCT02337738|531018057|FG002|Overall Study|Lack of Efficacy|0|||
147230792|NCT02337738|531018055|FG000|Overall Study|Investigator's Judgment|1|||
147230793|NCT02337738|531018056|FG001|Overall Study|Investigator's Judgment|1|||
147230794|NCT02337738|531018057|FG002|Overall Study|Investigator's Judgment|3|||
147230795|NCT01565642|531018058|FG000|Overall Study|Withdrawal by Subject|2|||
147230796|NCT01565642|531018059|FG001|Overall Study|Withdrawal by Subject|1|||
147230797|NCT01934972|531018060|FG000|Overall Study|Withdrawal by Subject|9|||
147230798|NCT01934972|531018061|FG001|Overall Study|Withdrawal by Subject|6|||
147230799|NCT03954132|531018064|FG000|Overall Study|Adverse Event|2|||
147230800|NCT03954132|531018065|FG001|Overall Study|Adverse Event|0|||
147230801|NCT03954132|531018064|FG000|Overall Study|Patient's wish|5|||
147230802|NCT03954132|531018065|FG001|Overall Study|Patient's wish|0|||
147230803|NCT03954132|531018064|FG000|Overall Study|Lost to Follow-up|10|||
147230804|NCT03954132|531018065|FG001|Overall Study|Lost to Follow-up|0|||
147230805|NCT03954132|531018064|FG000|Overall Study|Screening failure|0|||
147230806|NCT03954132|531018065|FG001|Overall Study|Screening failure|1|||
147230807|NCT03954132|531018064|FG000|Overall Study|No registration after Visit 1|5|||
147230808|NCT03954132|531018065|FG001|Overall Study|No registration after Visit 1|2|||
147230809|NCT03954132|531018064|FG000|Overall Study|Other reason than listed|2|||
147230810|NCT03954132|531018065|FG001|Overall Study|Other reason than listed|2|||
147230811|NCT03954132|531018064|FG000|Overall Study|Patient could not make visit due to vertebral fracture|1|||
147230812|NCT03954132|531018065|FG001|Overall Study|Patient could not make visit due to vertebral fracture|0|||
147230813|NCT03954132|531018064|FG000|Overall Study|False inclusion, violation of exclusion criteria|1|||
147312791|NCT06017999|531312259|FG002|Overall Study|Did Not Disclose Amount of EtOH Consumed|1|||
147118752|NCT02018887|530600606|FG000|Part C: Cohort 8 Overall|Adverse Event|0|||
147118753|NCT02018887|530600607|FG001|Part C: Cohort 8 Overall|Adverse Event|0|||
147118754|NCT02018887|530600608|FG002|Part C: Cohort 8 Overall|Adverse Event|0|||
147118755|NCT02018887|530600609|FG003|Part C: Cohort 8 Overall|Adverse Event|0|||
147118756|NCT02018887|530600610|FG004|Part C: Cohort 8 Overall|Adverse Event|0|||
147118757|NCT02018887|530600611|FG005|Part C: Cohort 8 Overall|Adverse Event|0|||
147230814|NCT03954132|531018065|FG001|Overall Study|False inclusion, violation of exclusion criteria|0|||
147230815|NCT00932737|531018068|FG000|Overall Study|Not treated in second episode|1|||
147230816|NCT00932737|531018069|FG001|Overall Study|Not treated in second episode|0|||
147118758|NCT02018887|530600612|FG006|Part C: Cohort 8 Overall|Adverse Event|0|||
147118759|NCT02018887|530600613|FG007|Part C: Cohort 8 Overall|Adverse Event|0|||
147118760|NCT02018887|530600614|FG008|Part C: Cohort 8 Overall|Adverse Event|1|||
147118761|NCT02018887|530600615|FG009|Part C: Cohort 8 Overall|Adverse Event|3|||
147118762|NCT02018887|530600616|FG010|Part C: Cohort 8 Overall|Adverse Event|0|||
147118763|NCT02018887|530600606|FG000|Part C: Cohort 8 Overall|Physician Decision|0|||
147118764|NCT02018887|530600607|FG001|Part C: Cohort 8 Overall|Physician Decision|0|||
147118765|NCT02018887|530600608|FG002|Part C: Cohort 8 Overall|Physician Decision|0|||
147118766|NCT02018887|530600609|FG003|Part C: Cohort 8 Overall|Physician Decision|0|||
147118767|NCT02018887|530600610|FG004|Part C: Cohort 8 Overall|Physician Decision|0|||
147118768|NCT02018887|530600611|FG005|Part C: Cohort 8 Overall|Physician Decision|0|||
147118769|NCT02018887|530600612|FG006|Part C: Cohort 8 Overall|Physician Decision|0|||
147118770|NCT02018887|530600613|FG007|Part C: Cohort 8 Overall|Physician Decision|0|||
147118771|NCT02018887|530600614|FG008|Part C: Cohort 8 Overall|Physician Decision|2|||
147118772|NCT02018887|530600615|FG009|Part C: Cohort 8 Overall|Physician Decision|0|||
147118773|NCT02018887|530600616|FG010|Part C: Cohort 8 Overall|Physician Decision|1|||
147118774|NCT00927186|530600617|FG000|12 Months Primary Study|Adverse Event|5|||
147118775|NCT00927186|530600618|FG001|12 Months Primary Study|Adverse Event|2|||
147118776|NCT00927186|530600617|FG000|12 Months Primary Study|Lost to Follow-up|1|||
147118777|NCT00927186|530600618|FG001|12 Months Primary Study|Lost to Follow-up|0|||
147118778|NCT00927186|530600617|FG000|12 Months Primary Study|Protocol Violation|0|||
147118779|NCT00927186|530600618|FG001|12 Months Primary Study|Protocol Violation|1|||
147118780|NCT00927186|530600617|FG000|12 Months Primary Study|Withdrawal by Subject|1|||
147118781|NCT00927186|530600618|FG001|12 Months Primary Study|Withdrawal by Subject|1|||
147118782|NCT01011283|530600619|FG000|Overall Study|Adverse Event|4|||
147118783|NCT01011283|530600620|FG001|Overall Study|Adverse Event|2|||
147118784|NCT01011283|530600619|FG000|Overall Study|Progressive Disease|0|||
147118785|NCT01011283|530600620|FG001|Overall Study|Progressive Disease|2|||
147118786|NCT01011283|530600619|FG000|Overall Study|Terminated by Sponsor|5|||
147118787|NCT01011283|530600620|FG001|Overall Study|Terminated by Sponsor|5|||
147118788|NCT01011283|530600619|FG000|Overall Study|Other|2|||
147118789|NCT01011283|530600620|FG001|Overall Study|Other|2|||
147118790|NCT02619812|530600621|FG000|Overall Study|Withdrawal by Subject|0|||
147118791|NCT02619812|530600622|FG001|Overall Study|Withdrawal by Subject|0|||
147118792|NCT02619812|530600623|FG002|Overall Study|Withdrawal by Subject|1|||
147118793|NCT02619812|530600624|FG003|Overall Study|Withdrawal by Subject|2|||
147118794|NCT00799864|530600625|FG000|Overall Study|Participant reached a virologic endpoint|9|||
147118795|NCT00799864|530600626|FG001|Overall Study|Participant reached a virologic endpoint|2|||
147118796|NCT00799864|530600627|FG002|Overall Study|Participant reached a virologic endpoint|2|||
147118797|NCT00799864|530600628|FG003|Overall Study|Participant reached a virologic endpoint|0|||
147118798|NCT00799864|530600629|FG004|Overall Study|Participant reached a virologic endpoint|0|||
147118799|NCT00799864|530600625|FG000|Overall Study|Other|2|||
147118800|NCT00799864|530600626|FG001|Overall Study|Other|1|||
147118801|NCT00799864|530600627|FG002|Overall Study|Other|0|||
147118802|NCT00799864|530600628|FG003|Overall Study|Other|0|||
147118803|NCT00799864|530600629|FG004|Overall Study|Other|0|||
147118804|NCT01210443|530600631|FG000|Overall Study|Study terminated by sponsor|2|||
147118805|NCT02807181|530600634|FG000|Overall Study|Death|28|||
147118806|NCT02807181|530600635|FG001|Overall Study|Death|24|||
147118807|NCT02807181|530600634|FG000|Overall Study|Withdrawal by Subject|1|||
147118808|NCT02807181|530600635|FG001|Overall Study|Withdrawal by Subject|1|||
147118809|NCT02807181|530600634|FG000|Overall Study|Lost to Follow-up|0|||
147118810|NCT02807181|530600635|FG001|Overall Study|Lost to Follow-up|2|||
147118811|NCT02807181|530600634|FG000|Overall Study|Subject decision|1|||
147118812|NCT02807181|530600635|FG001|Overall Study|Subject decision|0|||
147118813|NCT02807181|530600634|FG000|Overall Study|Biopsy of tumor removed from resection|1|||
147118814|NCT02807181|530600635|FG001|Overall Study|Biopsy of tumor removed from resection|0|||
147118815|NCT02807181|530600634|FG000|Overall Study|In Study|3|||
147118816|NCT02807181|530600635|FG001|Overall Study|In Study|3|||
147118817|NCT02807181|530600634|FG000|Overall Study|Post Progression|3|||
147118818|NCT02807181|530600635|FG001|Overall Study|Post Progression|2|||
147118819|NCT00063999|530600636|FG000|Overall Study|Withdrawal by Subject|1|||
147118820|NCT00063999|530600637|FG001|Overall Study|Withdrawal by Subject|0|||
147118821|NCT00063999|530600636|FG000|Overall Study|Ineligible|44|||
147118822|NCT00063999|530600637|FG001|Overall Study|Ineligible|24|||
147230817|NCT00932737|531018068|FG000|Overall Study|Adverse Event|0|||
147230818|NCT00932737|531018069|FG001|Overall Study|Adverse Event|1|||
147230819|NCT02906332|531018075|FG000|Overall Study|Withdrawal by Subject|1|||
147118823|NCT01078545|530600638|FG000|Overall Study|Lost to Follow-up|13|||
147118824|NCT01078545|530600638|FG000|Overall Study|Physician Decision|6|||
147118825|NCT01078545|530600638|FG000|Overall Study|Withdrawal by Subject|3|||
147118826|NCT01078545|530600638|FG000|Overall Study|Death|3|||
147118827|NCT01078545|530600638|FG000|Overall Study|Participant moved to another physician|1|||
147118828|NCT02497755|530600639|FG000|Overall Study|Protocol Violation|1|||
147118829|NCT02497755|530600640|FG001|Overall Study|Protocol Violation|0|||
147230820|NCT02949700|531018076|FG000|Phase I|Withdrawal by Subject|1|||
147118830|NCT01774370|530600641|FG000|Overall Study|Never taken the PRADAXA during the study|4|||
147118831|NCT01774370|530600641|FG000|Overall Study|Administered prior to the contract date|4|||
147118832|NCT01774370|530600641|FG000|Overall Study|Subjects of contraindications|34|||
147118833|NCT01774370|530600641|FG000|Overall Study|Violated inclusion/exclusion criteria|53|||
147118834|NCT01774370|530600641|FG000|Overall Study|Follow-up failure|34|||
147118835|NCT00514917|530600642|FG000|Overall Study|Death|4|||
147118836|NCT00514917|530600643|FG001|Overall Study|Death|10|||
147118837|NCT00514917|530600642|FG000|Overall Study|Protocol Violation|1|||
147118838|NCT00514917|530600643|FG001|Overall Study|Protocol Violation|0|||
147118839|NCT00514917|530600642|FG000|Overall Study|Lost to Follow-up|4|||
147118840|NCT00514917|530600643|FG001|Overall Study|Lost to Follow-up|3|||
147118841|NCT00514917|530600642|FG000|Overall Study|Withdrawal by Subject|18|||
147118842|NCT00514917|530600643|FG001|Overall Study|Withdrawal by Subject|16|||
147118843|NCT00514917|530600642|FG000|Overall Study|Discontinued due to study closure|88|||
147118844|NCT00514917|530600643|FG001|Overall Study|Discontinued due to study closure|81|||
147118845|NCT00514917|530600642|FG000|Overall Study|Undefined|11|||
147118846|NCT00514917|530600643|FG001|Overall Study|Undefined|5|||
147118847|NCT02829957|530600645|FG000|Overall Study|Lost to Follow-up|2|||
147118848|NCT02829957|530600646|FG001|Overall Study|Lost to Follow-up|1|||
147118849|NCT01663987|530600647|FG000|Overall Study|Adverse Event|7|||
147118850|NCT01663987|530600648|FG001|Overall Study|Adverse Event|2|||
147118851|NCT01663987|530600647|FG000|Overall Study|Lost to Follow-up|1|||
147118852|NCT01663987|530600648|FG001|Overall Study|Lost to Follow-up|1|||
147118853|NCT01663987|530600647|FG000|Overall Study|Withdrawal by Subject|2|||
147118854|NCT01663987|530600648|FG001|Overall Study|Withdrawal by Subject|3|||
147118855|NCT01663987|530600647|FG000|Overall Study|Other reason not defined above|3|||
147118856|NCT01663987|530600648|FG001|Overall Study|Other reason not defined above|0|||
147118857|NCT04193527|530600651|FG000|Overall Study|Other|1|||
147567404|NCT05472038|532238270|FG002|Overall Study|Withdrawal by Subject|1|||
147118858|NCT04193527|530600652|FG001|Overall Study|Other|1|||
147118859|NCT04193527|530600653|FG002|Overall Study|Other|0|||
147118860|NCT02945046|530600654|FG000|Overall Study|Adverse Event|1|||
147118861|NCT02945046|530600655|FG001|Overall Study|Adverse Event|0|||
147118862|NCT02945046|530600656|FG002|Overall Study|Adverse Event|2|||
147118863|NCT02945046|530600654|FG000|Overall Study|Withdrawal by Subject|3|||
147118864|NCT02945046|530600655|FG001|Overall Study|Withdrawal by Subject|3|||
147230821|NCT02949700|531018077|FG001|Phase I|Withdrawal by Subject|1|||
147230822|NCT02949700|531018078|FG002|Phase I|Withdrawal by Subject|0|||
147230823|NCT02949700|531018079|FG003|Phase I|Withdrawal by Subject|0|||
147230824|NCT02949700|531018076|FG000|Phase I|Protocol Violation|1|||
147230825|NCT02949700|531018077|FG001|Phase I|Protocol Violation|0|||
147230826|NCT02949700|531018078|FG002|Phase I|Protocol Violation|0|||
147230827|NCT02949700|531018079|FG003|Phase I|Protocol Violation|0|||
147230828|NCT02949700|531018076|FG000|Phase II|Withdrawal by Subject|0|||
147230829|NCT02949700|531018077|FG001|Phase II|Withdrawal by Subject|0|||
147230830|NCT02949700|531018078|FG002|Phase II|Withdrawal by Subject|0|||
147230831|NCT02949700|531018079|FG003|Phase II|Withdrawal by Subject|2|||
147230832|NCT02949700|531018076|FG000|Phase II|Protocol Violation|0|||
147230833|NCT02949700|531018077|FG001|Phase II|Protocol Violation|0|||
147230834|NCT02949700|531018078|FG002|Phase II|Protocol Violation|1|||
147567405|NCT05472038|532238271|FG003|Overall Study|Withdrawal by Subject|6|||
147567406|NCT05472038|532238272|FG004|Overall Study|Withdrawal by Subject|1|||
147118865|NCT02945046|530600656|FG002|Overall Study|Withdrawal by Subject|3|||
147118866|NCT02945046|530600654|FG000|Overall Study|Protocol Violation|2|||
147118867|NCT02945046|530600655|FG001|Overall Study|Protocol Violation|3|||
147118868|NCT02945046|530600656|FG002|Overall Study|Protocol Violation|2|||
147118869|NCT02945046|530600654|FG000|Overall Study|Lost to Follow-up|1|||
147118870|NCT02945046|530600655|FG001|Overall Study|Lost to Follow-up|1|||
147118871|NCT02945046|530600656|FG002|Overall Study|Lost to Follow-up|0|||
147118872|NCT02945046|530600654|FG000|Overall Study|Lack of Efficacy|1|||
147118873|NCT02945046|530600655|FG001|Overall Study|Lack of Efficacy|2|||
147230835|NCT02949700|531018079|FG003|Phase II|Protocol Violation|3|||
147567407|NCT05472038|532238273|FG005|Overall Study|Withdrawal by Subject|3|||
147567408|NCT05472038|532238274|FG006|Overall Study|Withdrawal by Subject|0|||
147567409|NCT05472038|532238275|FG007|Overall Study|Withdrawal by Subject|2|||
147118874|NCT02945046|530600656|FG002|Overall Study|Lack of Efficacy|1|||
147118875|NCT02945046|530600654|FG000|Overall Study|Other than specified|5|||
147118876|NCT02945046|530600655|FG001|Overall Study|Other than specified|4|||
147118877|NCT02945046|530600656|FG002|Overall Study|Other than specified|7|||
147118878|NCT00541775|530600672|FG000|Overall Study|Adverse Event|3|||
147118879|NCT00541775|530600673|FG001|Overall Study|Adverse Event|2|||
147118880|NCT00541775|530600674|FG002|Overall Study|Adverse Event|1|||
147118881|NCT00541775|530600672|FG000|Overall Study|Lack of Efficacy|0|||
147118882|NCT00541775|530600673|FG001|Overall Study|Lack of Efficacy|0|||
147118883|NCT00541775|530600674|FG002|Overall Study|Lack of Efficacy|3|||
147118884|NCT00541775|530600672|FG000|Overall Study|Lost to Follow-up|0|||
147118885|NCT00541775|530600673|FG001|Overall Study|Lost to Follow-up|0|||
147230836|NCT01554397|531018092|FG000|Overall Study|Withdrawal by Subject|1|||
147230837|NCT01554397|531018093|FG001|Overall Study|Withdrawal by Subject|0|||
147312792|NCT04338581|531312260|FG000|Overall Study|Lack of Efficacy|1|||
147312793|NCT04338581|531312261|FG001|Overall Study|Lack of Efficacy|0|||
147312794|NCT04338581|531312260|FG000|Overall Study|Withdrawal by Subject|4|||
147312795|NCT04338581|531312261|FG001|Overall Study|Withdrawal by Subject|4|||
147312796|NCT04338581|531312260|FG000|Overall Study|Prohibited Medication|1|||
147312797|NCT04338581|531312261|FG001|Overall Study|Prohibited Medication|0|||
147312798|NCT01089556|531312262|FG000|Study Period II (Weeks 1-8)|Adverse Event|35|||
147312799|NCT01089556|531312263|FG001|Study Period II (Weeks 1-8)|Adverse Event|39|||
147312800|NCT01089556|531312264|FG002|Study Period II (Weeks 1-8)|Adverse Event|0|||
147312801|NCT01089556|531312265|FG003|Study Period II (Weeks 1-8)|Adverse Event|0|||
147312802|NCT01089556|531312266|FG004|Study Period II (Weeks 1-8)|Adverse Event|0|||
147312803|NCT01089556|531312267|FG005|Study Period II (Weeks 1-8)|Adverse Event|0|||
147312804|NCT01089556|531312262|FG000|Study Period II (Weeks 1-8)|Entry Criteria Not Met|12|||
147312805|NCT01089556|531312263|FG001|Study Period II (Weeks 1-8)|Entry Criteria Not Met|8|||
147312806|NCT01089556|531312264|FG002|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0|||
147312807|NCT01089556|531312265|FG003|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0|||
147312808|NCT01089556|531312266|FG004|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0|||
147312809|NCT01089556|531312267|FG005|Study Period II (Weeks 1-8)|Entry Criteria Not Met|0|||
147312810|NCT01089556|531312262|FG000|Study Period II (Weeks 1-8)|Lack of Efficacy|1|||
147312811|NCT01089556|531312263|FG001|Study Period II (Weeks 1-8)|Lack of Efficacy|2|||
147312812|NCT01089556|531312264|FG002|Study Period II (Weeks 1-8)|Lack of Efficacy|0|||
147312813|NCT01089556|531312265|FG003|Study Period II (Weeks 1-8)|Lack of Efficacy|0|||
147312814|NCT01089556|531312266|FG004|Study Period II (Weeks 1-8)|Lack of Efficacy|0|||
147312815|NCT01089556|531312267|FG005|Study Period II (Weeks 1-8)|Lack of Efficacy|0|||
147312816|NCT01089556|531312262|FG000|Study Period II (Weeks 1-8)|Lost to Follow-up|0|||
147312817|NCT01089556|531312263|FG001|Study Period II (Weeks 1-8)|Lost to Follow-up|3|||
147312818|NCT01089556|531312264|FG002|Study Period II (Weeks 1-8)|Lost to Follow-up|0|||
147312819|NCT01089556|531312265|FG003|Study Period II (Weeks 1-8)|Lost to Follow-up|0|||
147312820|NCT01089556|531312266|FG004|Study Period II (Weeks 1-8)|Lost to Follow-up|0|||
147312821|NCT01089556|531312267|FG005|Study Period II (Weeks 1-8)|Lost to Follow-up|0|||
147312822|NCT01089556|531312262|FG000|Study Period II (Weeks 1-8)|Physician Decision|4|||
147312823|NCT01089556|531312263|FG001|Study Period II (Weeks 1-8)|Physician Decision|0|||
147312824|NCT01089556|531312264|FG002|Study Period II (Weeks 1-8)|Physician Decision|0|||
147312825|NCT01089556|531312265|FG003|Study Period II (Weeks 1-8)|Physician Decision|0|||
147312826|NCT01089556|531312266|FG004|Study Period II (Weeks 1-8)|Physician Decision|0|||
147312827|NCT01089556|531312267|FG005|Study Period II (Weeks 1-8)|Physician Decision|0|||
147312828|NCT01089556|531312262|FG000|Study Period II (Weeks 1-8)|Protocol Violation|4|||
147312829|NCT01089556|531312263|FG001|Study Period II (Weeks 1-8)|Protocol Violation|4|||
147312830|NCT01089556|531312264|FG002|Study Period II (Weeks 1-8)|Protocol Violation|0|||
147312831|NCT01089556|531312265|FG003|Study Period II (Weeks 1-8)|Protocol Violation|0|||
147312832|NCT01089556|531312266|FG004|Study Period II (Weeks 1-8)|Protocol Violation|0|||
147312833|NCT01089556|531312267|FG005|Study Period II (Weeks 1-8)|Protocol Violation|0|||
147312834|NCT01089556|531312262|FG000|Study Period II (Weeks 1-8)|Withdrawal by Subject|12|||
147312835|NCT01089556|531312263|FG001|Study Period II (Weeks 1-8)|Withdrawal by Subject|14|||
147312836|NCT01089556|531312264|FG002|Study Period II (Weeks 1-8)|Withdrawal by Subject|0|||
147312837|NCT01089556|531312265|FG003|Study Period II (Weeks 1-8)|Withdrawal by Subject|0|||
147312838|NCT01089556|531312266|FG004|Study Period II (Weeks 1-8)|Withdrawal by Subject|0|||
147312839|NCT01089556|531312267|FG005|Study Period II (Weeks 1-8)|Withdrawal by Subject|0|||
147312840|NCT01089556|531312262|FG000|Study Period II (Weeks 1-8)|Not received any study drug|3|||
147312841|NCT01089556|531312263|FG001|Study Period II (Weeks 1-8)|Not received any study drug|4|||
147312842|NCT01089556|531312264|FG002|Study Period II (Weeks 1-8)|Not received any study drug|0|||
147312843|NCT01089556|531312265|FG003|Study Period II (Weeks 1-8)|Not received any study drug|0|||
147312844|NCT01089556|531312266|FG004|Study Period II (Weeks 1-8)|Not received any study drug|0|||
147312845|NCT01089556|531312267|FG005|Study Period II (Weeks 1-8)|Not received any study drug|0|||
147312846|NCT01089556|531312262|FG000|Study Period III (Weeks 9-16)|Adverse Event|0|||
147312847|NCT01089556|531312263|FG001|Study Period III (Weeks 9-16)|Adverse Event|0|||
147312848|NCT01089556|531312264|FG002|Study Period III (Weeks 9-16)|Adverse Event|4|||
147312849|NCT01089556|531312265|FG003|Study Period III (Weeks 9-16)|Adverse Event|2|||
147312850|NCT01089556|531312266|FG004|Study Period III (Weeks 9-16)|Adverse Event|4|||
147312851|NCT01089556|531312267|FG005|Study Period III (Weeks 9-16)|Adverse Event|3|||
147312852|NCT01089556|531312262|FG000|Study Period III (Weeks 9-16)|Entry Criteria Not Met|0|||
147312853|NCT01089556|531312263|FG001|Study Period III (Weeks 9-16)|Entry Criteria Not Met|0|||
147312854|NCT01089556|531312264|FG002|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1|||
147312855|NCT01089556|531312265|FG003|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1|||
147312856|NCT01089556|531312266|FG004|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1|||
147312857|NCT01089556|531312267|FG005|Study Period III (Weeks 9-16)|Entry Criteria Not Met|1|||
147312858|NCT01089556|531312262|FG000|Study Period III (Weeks 9-16)|Lack of Efficacy|0|||
147118886|NCT00541775|530600674|FG002|Overall Study|Lost to Follow-up|2|||
147312859|NCT01089556|531312263|FG001|Study Period III (Weeks 9-16)|Lack of Efficacy|0|||
147312860|NCT01089556|531312264|FG002|Study Period III (Weeks 9-16)|Lack of Efficacy|0|||
147118887|NCT00541775|530600672|FG000|Overall Study|Protocol Violation|1|||
147312861|NCT01089556|531312265|FG003|Study Period III (Weeks 9-16)|Lack of Efficacy|2|||
147312862|NCT01089556|531312266|FG004|Study Period III (Weeks 9-16)|Lack of Efficacy|1|||
147312863|NCT01089556|531312267|FG005|Study Period III (Weeks 9-16)|Lack of Efficacy|0|||
147312864|NCT01089556|531312262|FG000|Study Period III (Weeks 9-16)|Lost to Follow-up|0|||
147312865|NCT01089556|531312263|FG001|Study Period III (Weeks 9-16)|Lost to Follow-up|0|||
147312866|NCT01089556|531312264|FG002|Study Period III (Weeks 9-16)|Lost to Follow-up|1|||
147312867|NCT01089556|531312265|FG003|Study Period III (Weeks 9-16)|Lost to Follow-up|0|||
147312868|NCT01089556|531312266|FG004|Study Period III (Weeks 9-16)|Lost to Follow-up|0|||
147312869|NCT01089556|531312267|FG005|Study Period III (Weeks 9-16)|Lost to Follow-up|0|||
147312870|NCT01089556|531312262|FG000|Study Period III (Weeks 9-16)|Protocol Violation|0|||
147312871|NCT01089556|531312263|FG001|Study Period III (Weeks 9-16)|Protocol Violation|0|||
147312872|NCT01089556|531312264|FG002|Study Period III (Weeks 9-16)|Protocol Violation|1|||
147312873|NCT01089556|531312265|FG003|Study Period III (Weeks 9-16)|Protocol Violation|1|||
147118888|NCT00541775|530600673|FG001|Overall Study|Protocol Violation|0|||
147118889|NCT00541775|530600674|FG002|Overall Study|Protocol Violation|0|||
147118890|NCT00541775|530600672|FG000|Overall Study|Withdrawal by Subject and Other|5|||
147118891|NCT00541775|530600673|FG001|Overall Study|Withdrawal by Subject and Other|0|||
147118892|NCT00541775|530600674|FG002|Overall Study|Withdrawal by Subject and Other|2|||
147118893|NCT01666314|530600675|FG000|Overall Study|Adverse Event|3|||
147118894|NCT01666314|530600676|FG001|Overall Study|Adverse Event|13|||
147118895|NCT01666314|530600677|FG002|Overall Study|Adverse Event|7|||
147118896|NCT01666314|530600678|FG003|Overall Study|Adverse Event|7|||
147118897|NCT01666314|530600675|FG000|Overall Study|Progressive Disease|11|||
147118898|NCT01666314|530600676|FG001|Overall Study|Progressive Disease|9|||
147118899|NCT01666314|530600677|FG002|Overall Study|Progressive Disease|19|||
147118900|NCT01666314|530600678|FG003|Overall Study|Progressive Disease|20|||
147118901|NCT01666314|530600675|FG000|Overall Study|Symptomatic Deterioration|1|||
147118902|NCT01666314|530600676|FG001|Overall Study|Symptomatic Deterioration|0|||
147118903|NCT01666314|530600677|FG002|Overall Study|Symptomatic Deterioration|2|||
147118904|NCT01666314|530600678|FG003|Overall Study|Symptomatic Deterioration|0|||
147118905|NCT01666314|530600675|FG000|Overall Study|Unsatisfactory Therapeutic Response|7|||
147118906|NCT01666314|530600676|FG001|Overall Study|Unsatisfactory Therapeutic Response|2|||
147118907|NCT01666314|530600677|FG002|Overall Study|Unsatisfactory Therapeutic Response|1|||
147118908|NCT01666314|530600678|FG003|Overall Study|Unsatisfactory Therapeutic Response|1|||
147118909|NCT01666314|530600675|FG000|Overall Study|Withdrawal by Subject|1|||
147118910|NCT01666314|530600676|FG001|Overall Study|Withdrawal by Subject|1|||
147118911|NCT01666314|530600677|FG002|Overall Study|Withdrawal by Subject|2|||
147118912|NCT01666314|530600678|FG003|Overall Study|Withdrawal by Subject|3|||
147118913|NCT01666314|530600675|FG000|Overall Study|Reason not Specified|10|||
147118914|NCT01666314|530600676|FG001|Overall Study|Reason not Specified|7|||
147118915|NCT01666314|530600677|FG002|Overall Study|Reason not Specified|5|||
147118916|NCT01666314|530600678|FG003|Overall Study|Reason not Specified|5|||
147118917|NCT00032487|530600679|FG000|Overall Study|Withdrawal by Subject|67|||
147118918|NCT00032487|530600680|FG001|Overall Study|Withdrawal by Subject|43|||
147118919|NCT00032487|530600679|FG000|Overall Study|Adverse Event|3|||
147118920|NCT00032487|530600680|FG001|Overall Study|Adverse Event|7|||
147118921|NCT00032487|530600679|FG000|Overall Study|Lost to Follow-up|57|||
147118922|NCT00032487|530600680|FG001|Overall Study|Lost to Follow-up|58|||
147118923|NCT00032487|530600679|FG000|Overall Study|Had other reason|12|||
147118924|NCT00032487|530600680|FG001|Overall Study|Had other reason|12|||
147118925|NCT04913675|530600682|FG000|Main Study (Up to Week 36)|Death|0|||
147118926|NCT04913675|530600683|FG001|Main Study (Up to Week 36)|Death|2|||
147118927|NCT04913675|530600684|FG002|Main Study (Up to Week 36)|Death|2|||
147118928|NCT04913675|530600685|FG003|Main Study (Up to Week 36)|Death|0|||
147118929|NCT04913675|530600682|FG000|Main Study (Up to Week 36)|Lost to Follow-up|12|||
147118930|NCT04913675|530600683|FG001|Main Study (Up to Week 36)|Lost to Follow-up|8|||
147118931|NCT04913675|530600684|FG002|Main Study (Up to Week 36)|Lost to Follow-up|4|||
147312874|NCT01089556|531312266|FG004|Study Period III (Weeks 9-16)|Protocol Violation|1|||
147312875|NCT01089556|531312267|FG005|Study Period III (Weeks 9-16)|Protocol Violation|0|||
147312876|NCT01089556|531312262|FG000|Study Period III (Weeks 9-16)|Satisfactory Response|0|||
147444483|NCT00942175|531792638|FG002|Overall Study|Adverse Event|0|||
147444484|NCT00942175|531792639|FG003|Overall Study|Adverse Event|0|||
147444485|NCT00942175|531792636|FG000|Overall Study|Protocol Violation|0|||
147444486|NCT00942175|531792637|FG001|Overall Study|Protocol Violation|1|||
147118932|NCT04913675|530600685|FG003|Main Study (Up to Week 36)|Lost to Follow-up|0|||
147118933|NCT04913675|530600682|FG000|Main Study (Up to Week 36)|Physician Decision|0|||
147118934|NCT04913675|530600683|FG001|Main Study (Up to Week 36)|Physician Decision|1|||
147118935|NCT04913675|530600684|FG002|Main Study (Up to Week 36)|Physician Decision|1|||
147118936|NCT04913675|530600685|FG003|Main Study (Up to Week 36)|Physician Decision|0|||
147118937|NCT04913675|530600682|FG000|Main Study (Up to Week 36)|Withdrawal by Subject|25|||
147118938|NCT04913675|530600683|FG001|Main Study (Up to Week 36)|Withdrawal by Subject|33|||
147118939|NCT04913675|530600684|FG002|Main Study (Up to Week 36)|Withdrawal by Subject|12|||
147118940|NCT04913675|530600685|FG003|Main Study (Up to Week 36)|Withdrawal by Subject|0|||
147118941|NCT04913675|530600682|FG000|Safety Sub-study (Up to Week 36)|Withdrawal by Subject|0|||
147118942|NCT04913675|530600683|FG001|Safety Sub-study (Up to Week 36)|Withdrawal by Subject|0|||
147118943|NCT04913675|530600684|FG002|Safety Sub-study (Up to Week 36)|Withdrawal by Subject|0|||
147118944|NCT04913675|530600685|FG003|Safety Sub-study (Up to Week 36)|Withdrawal by Subject|1|||
147118945|NCT02975700|530600686|FG000|Overall Study|Adverse Event|1|||
147118946|NCT02975700|530600686|FG000|Overall Study|Progressive disease|3|||
147118947|NCT02975700|530600686|FG000|Overall Study|Failed screening criteria|2|||
147118948|NCT01125748|530600690|FG000|Overall Study|Adverse Event|0|||
147118949|NCT01125748|530600691|FG001|Overall Study|Adverse Event|2|||
147118950|NCT01125748|530600690|FG000|Overall Study|Lost to Follow-up|0|||
147118951|NCT01125748|530600691|FG001|Overall Study|Lost to Follow-up|1|||
147118952|NCT01125748|530600690|FG000|Overall Study|Physician Decision|8|||
147118953|NCT01125748|530600691|FG001|Overall Study|Physician Decision|7|||
147118954|NCT01125748|530600690|FG000|Overall Study|Patient Decision to Withdraw|2|||
147118955|NCT01125748|530600691|FG001|Overall Study|Patient Decision to Withdraw|4|||
147118956|NCT01751685|530600692|FG000|6-mo Followup|Missed study visit|1|||
147118957|NCT01751685|530600693|FG001|6-mo Followup|Missed study visit|0|||
147118958|NCT01751685|530600692|FG000|6-mo Followup|Withdrawal by Subject|2|||
147118959|NCT01751685|530600693|FG001|6-mo Followup|Withdrawal by Subject|2|||
147118960|NCT01751685|530600692|FG000|6-mo Followup|Lost to Follow-up|0|||
147118961|NCT01751685|530600693|FG001|6-mo Followup|Lost to Follow-up|1|||
147118962|NCT01751685|530600692|FG000|12-mo Followup|Lost to Follow-up|5|||
147118963|NCT01751685|530600693|FG001|12-mo Followup|Lost to Follow-up|0|||
147118964|NCT01028391|530600694|FG000|Overall Study|Adverse Event|4|||
147118965|NCT01028391|530600695|FG001|Overall Study|Adverse Event|0|||
147118966|NCT01028391|530600694|FG000|Overall Study|Lack of Efficacy|0|||
147118967|NCT01028391|530600695|FG001|Overall Study|Lack of Efficacy|2|||
147118968|NCT01028391|530600694|FG000|Overall Study|Lost to Follow-up|3|||
147118969|NCT01028391|530600695|FG001|Overall Study|Lost to Follow-up|4|||
147118970|NCT01028391|530600694|FG000|Overall Study|Physician Decision|0|||
147118971|NCT01028391|530600695|FG001|Overall Study|Physician Decision|1|||
147118972|NCT01028391|530600694|FG000|Overall Study|Withdrawal by Subject|6|||
147118973|NCT01028391|530600695|FG001|Overall Study|Withdrawal by Subject|3|||
147230838|NCT01554397|531018092|FG000|Overall Study|Ineligible|7|||
147230839|NCT01554397|531018093|FG001|Overall Study|Ineligible|0|||
147230840|NCT01896050|531019543|FG000|Overall Study|Adverse Event|37|||
147230841|NCT01896050|531019544|FG001|Overall Study|Adverse Event|2|||
147230842|NCT01896050|531019543|FG000|Overall Study|Death|1|||
147230843|NCT01896050|531019544|FG001|Overall Study|Death|0|||
147118974|NCT01028391|530600694|FG000|Overall Study|Needed excluded medication|1|||
147118975|NCT01028391|530600695|FG001|Overall Study|Needed excluded medication|1|||
147118976|NCT00694161|530600696|FG000|Part 2 (After Week 6 up to Month 12)|Adverse Event|1|||
147230844|NCT03693300|531019545|FG000|Overall Study|Withdrawal by Subject|6|||
147230845|NCT03693300|531019546|FG001|Overall Study|Withdrawal by Subject|0|||
147230846|NCT03693300|531019545|FG000|Overall Study|Death|50|||
147230847|NCT03693300|531019546|FG001|Overall Study|Death|2|||
147230848|NCT03693300|531019545|FG000|Overall Study|Lost to Follow-up|2|||
147230849|NCT03693300|531019546|FG001|Overall Study|Lost to Follow-up|0|||
147230850|NCT02206048|531019547|FG000|Overall Study|Change in OR schedule and availability of study staff|1|||
147230851|NCT03265665|531019548|FG000|24-week Data Collection|Withdrawal by Subject|2|||
147230852|NCT03265665|531019549|FG001|24-week Data Collection|Withdrawal by Subject|2|||
147230853|NCT03265665|531019548|FG000|24-week Data Collection|Lost to Follow-up|4|||
147230854|NCT03265665|531019549|FG001|24-week Data Collection|Lost to Follow-up|5|||
147230855|NCT03265665|531019548|FG000|36-week Data Collection|Lost to Follow-up|6|||
147230856|NCT03265665|531019549|FG001|36-week Data Collection|Lost to Follow-up|8|||
147230857|NCT01858376|531019550|FG000|Overall Study|Dropped d/t lab work not fitting criter|4|||
147444487|NCT00942175|531792638|FG002|Overall Study|Protocol Violation|2|||
147118977|NCT00694161|530600696|FG000|Part 2 (After Week 6 up to Month 12)|Physician Decision|1|||
147118978|NCT00694161|530600696|FG000|Part 2 (After Week 6 up to Month 12)|Death|1|||
147118979|NCT03601052|530600697|FG000|Overall Study|Lost to Follow-up|2|||
147118980|NCT00837330|530600698|FG000|Overall Study|Lost to Follow-up|1|||
147118981|NCT00837330|530600699|FG001|Overall Study|Lost to Follow-up|3|||
147567410|NCT05472038|532238276|FG008|Overall Study|Withdrawal by Subject|3|||
147118982|NCT00694122|530600710|FG000|First Intervention (3-4 Weeks)|Withdrawal by Subject|7|||
147230858|NCT03894046|531019556|FG000|Overall Study|Protocol Violation|1|||
147444488|NCT00942175|531792639|FG003|Overall Study|Protocol Violation|0|||
147230859|NCT03894046|531019557|FG001|Overall Study|Protocol Violation|0|||
147230860|NCT03894046|531019558|FG002|Overall Study|Protocol Violation|0|||
147118983|NCT00694122|530600711|FG001|First Intervention (3-4 Weeks)|Withdrawal by Subject|0|||
147118984|NCT00694122|530600710|FG000|First Intervention (3-4 Weeks)|Lost to Follow-up|1|||
147118985|NCT00694122|530600711|FG001|First Intervention (3-4 Weeks)|Lost to Follow-up|1|||
147118986|NCT00694122|530600710|FG000|First Intervention (3-4 Weeks)|Did not meet entrance criteria|2|||
147118987|NCT00694122|530600711|FG001|First Intervention (3-4 Weeks)|Did not meet entrance criteria|1|||
147118988|NCT00086307|530600712|FG000|Overall Study|Lack of Efficacy|1|||
147118989|NCT00086307|530600713|FG001|Overall Study|Lack of Efficacy|1|||
147118990|NCT00086307|530600714|FG002|Overall Study|Lack of Efficacy|2|||
147118991|NCT00086307|530600712|FG000|Overall Study|Shortness of breath and muscle spasms|1|||
147118992|NCT00086307|530600713|FG001|Overall Study|Shortness of breath and muscle spasms|0|||
147118993|NCT00086307|530600714|FG002|Overall Study|Shortness of breath and muscle spasms|0|||
147118994|NCT00086307|530600712|FG000|Overall Study|Nausea and headaches|0|||
147118995|NCT00086307|530600713|FG001|Overall Study|Nausea and headaches|0|||
147118996|NCT00086307|530600714|FG002|Overall Study|Nausea and headaches|1|||
147118997|NCT00086307|530600712|FG000|Overall Study|Constipation and sleepiness|0|||
147118998|NCT00086307|530600713|FG001|Overall Study|Constipation and sleepiness|0|||
147118999|NCT00086307|530600714|FG002|Overall Study|Constipation and sleepiness|1|||
147119000|NCT00086307|530600712|FG000|Overall Study|Suicidal ideation|0|||
147119001|NCT00086307|530600713|FG001|Overall Study|Suicidal ideation|0|||
147119002|NCT00086307|530600714|FG002|Overall Study|Suicidal ideation|1|||
147119003|NCT00086307|530600712|FG000|Overall Study|Fatigue and difficulty falling asleep|0|||
147119004|NCT00086307|530600713|FG001|Overall Study|Fatigue and difficulty falling asleep|0|||
147119005|NCT00086307|530600714|FG002|Overall Study|Fatigue and difficulty falling asleep|1|||
147119006|NCT00086307|530600712|FG000|Overall Study|Withdrawal by Subject|0|||
147119007|NCT00086307|530600713|FG001|Overall Study|Withdrawal by Subject|0|||
147119008|NCT00086307|530600714|FG002|Overall Study|Withdrawal by Subject|2|||
147119009|NCT00105508|530600715|FG000|Overall Study|Prephase Dropout|1|||
147119010|NCT00105508|530600716|FG001|Overall Study|Prephase Dropout|0|||
147119011|NCT00105508|530600715|FG000|Overall Study|Adverse Event|16|||
147119012|NCT00105508|530600716|FG001|Overall Study|Adverse Event|19|||
147567411|NCT05472038|532238277|FG009|Overall Study|Withdrawal by Subject|1|||
147567412|NCT05472038|532238278|FG010|Overall Study|Withdrawal by Subject|2|||
147567413|NCT05472038|532238279|FG011|Overall Study|Withdrawal by Subject|2|||
147567414|NCT05472038|532238268|FG000|Overall Study|Protocol Violation|0|||
147567415|NCT05472038|532238269|FG001|Overall Study|Protocol Violation|0|||
147567416|NCT05472038|532238270|FG002|Overall Study|Protocol Violation|0|||
147119013|NCT00105508|530600715|FG000|Overall Study|Insufficient Efficacy|1|||
147119014|NCT00105508|530600716|FG001|Overall Study|Insufficient Efficacy|0|||
147230861|NCT03894046|531019556|FG000|Overall Study|Adverse Event|0|||
147230862|NCT03894046|531019557|FG001|Overall Study|Adverse Event|1|||
147230863|NCT03894046|531019558|FG002|Overall Study|Adverse Event|0|||
147230864|NCT03894046|531019556|FG000|Overall Study|Withdrawal by Subject|2|||
147230865|NCT03894046|531019557|FG001|Overall Study|Withdrawal by Subject|3|||
147230866|NCT03894046|531019558|FG002|Overall Study|Withdrawal by Subject|1|||
147230867|NCT03894046|531019556|FG000|Overall Study|Death|15|||
147230868|NCT03894046|531019557|FG001|Overall Study|Death|21|||
147230869|NCT03894046|531019558|FG002|Overall Study|Death|4|||
147230870|NCT03894046|531019556|FG000|Overall Study|No growth of ABC|2|||
147230871|NCT03894046|531019557|FG001|Overall Study|No growth of ABC|1|||
147230872|NCT03894046|531019558|FG002|Overall Study|No growth of ABC|0|||
147230873|NCT03894046|531019556|FG000|Overall Study|Physician Decision|1|||
147230874|NCT03894046|531019557|FG001|Overall Study|Physician Decision|1|||
147230875|NCT03894046|531019558|FG002|Overall Study|Physician Decision|1|||
147230876|NCT03894046|531019556|FG000|Overall Study|Prohibited concomitant medication|1|||
147230877|NCT03894046|531019557|FG001|Overall Study|Prohibited concomitant medication|0|||
147230878|NCT03894046|531019558|FG002|Overall Study|Prohibited concomitant medication|0|||
147230879|NCT03894046|531019556|FG000|Overall Study|Transferred to other arm/group|1|||
147230880|NCT03894046|531019557|FG001|Overall Study|Transferred to other arm/group|1|||
147230881|NCT03894046|531019558|FG002|Overall Study|Transferred to other arm/group|0|||
147230882|NCT00369122|531019567|FG000|Overall Study|Ineligible|10|||
147230883|NCT00369122|531019567|FG000|Overall Study|No protocol treatment|1|||
147230884|NCT02651467|531019568|FG000|Overall Study|Withdrawal by Subject|0|||
147230885|NCT02651467|531019569|FG001|Overall Study|Withdrawal by Subject|0|||
147230886|NCT02651467|531019570|FG002|Overall Study|Withdrawal by Subject|2|||
147230887|NCT02651467|531019568|FG000|Overall Study|Other (Not specified)|1|||
147230888|NCT02651467|531019569|FG001|Overall Study|Other (Not specified)|0|||
147230889|NCT02651467|531019570|FG002|Overall Study|Other (Not specified)|2|||
147230890|NCT00408629|531019571|FG000|Overall Study|Adverse Event|13|||
147312877|NCT01089556|531312263|FG001|Study Period III (Weeks 9-16)|Satisfactory Response|0|||
147312878|NCT01089556|531312264|FG002|Study Period III (Weeks 9-16)|Satisfactory Response|4|||
147312879|NCT01089556|531312265|FG003|Study Period III (Weeks 9-16)|Satisfactory Response|3|||
147312880|NCT01089556|531312266|FG004|Study Period III (Weeks 9-16)|Satisfactory Response|4|||
147312881|NCT01089556|531312267|FG005|Study Period III (Weeks 9-16)|Satisfactory Response|1|||
147567417|NCT05472038|532238271|FG003|Overall Study|Protocol Violation|0|||
147567418|NCT05472038|532238272|FG004|Overall Study|Protocol Violation|0|||
147230891|NCT00408629|531019572|FG001|Overall Study|Adverse Event|27|||
147567419|NCT05472038|532238273|FG005|Overall Study|Protocol Violation|0|||
147230892|NCT00408629|531019571|FG000|Overall Study|Withdrawal by Subject|8|||
147230893|NCT00408629|531019572|FG001|Overall Study|Withdrawal by Subject|4|||
147567420|NCT05472038|532238274|FG006|Overall Study|Protocol Violation|0|||
147119015|NCT00105508|530600715|FG000|Overall Study|Withdrawal by Subject|10|||
147119016|NCT00105508|530600716|FG001|Overall Study|Withdrawal by Subject|6|||
147119017|NCT00105508|530600715|FG000|Overall Study|Lost to Follow-up|3|||
147230894|NCT00408629|531019571|FG000|Overall Study|Lost to Follow-up|1|||
147567421|NCT05472038|532238275|FG007|Overall Study|Protocol Violation|1|||
147567422|NCT05472038|532238276|FG008|Overall Study|Protocol Violation|1|||
147567423|NCT05472038|532238277|FG009|Overall Study|Protocol Violation|1|||
147567424|NCT05472038|532238278|FG010|Overall Study|Protocol Violation|1|||
147567425|NCT05472038|532238279|FG011|Overall Study|Protocol Violation|1|||
147119018|NCT00105508|530600716|FG001|Overall Study|Lost to Follow-up|0|||
147312882|NCT01089556|531312262|FG000|Study Period III (Weeks 9-16)|Withdrawal by Subject|0|||
147567426|NCT05472038|532238268|FG000|Overall Study|Not vaccinated|0|||
147567427|NCT05472038|532238269|FG001|Overall Study|Not vaccinated|0|||
147567428|NCT05472038|532238270|FG002|Overall Study|Not vaccinated|0|||
147567429|NCT05472038|532238271|FG003|Overall Study|Not vaccinated|1|||
147567430|NCT05472038|532238272|FG004|Overall Study|Not vaccinated|0|||
147567431|NCT05472038|532238273|FG005|Overall Study|Not vaccinated|0|||
147119019|NCT00105508|530600715|FG000|Overall Study|Protocol Violation|1|||
147119020|NCT00105508|530600716|FG001|Overall Study|Protocol Violation|2|||
147119021|NCT00105508|530600715|FG000|Overall Study|Other|8|||
147119022|NCT00105508|530600716|FG001|Overall Study|Other|9|||
147119023|NCT00683384|530600717|FG000|Overall Study|Death|1|||
147119024|NCT00683384|530600717|FG000|Overall Study|Adverse Event|1|||
147119025|NCT00120874|530600718|FG000|Overall Study|Death|0|||
147119026|NCT00120874|530600719|FG001|Overall Study|Death|1|||
147119027|NCT01727154|530600720|FG000|Overall Study|Death|17|||
147119028|NCT01727154|530600720|FG000|Overall Study|Withdrawal by Subject|14|||
147119029|NCT01727154|530600720|FG000|Overall Study|Subject Withdrew Consent|18|||
147119030|NCT01727154|530600720|FG000|Overall Study|Study Terminated|6|||
147119031|NCT01727154|530600720|FG000|Overall Study|No Discontinuation Documentation|4|||
147119032|NCT01184118|530600727|FG000|Overall Study|Only asthma step 1 - screen fail|1|||
147119033|NCT01184118|530600727|FG000|Overall Study|No physiologic confirmation of asthma|8|||
147119034|NCT01184118|530600727|FG000|Overall Study|FEV1 <60% predicted|2|||
147119035|NCT01184118|530600727|FG000|Overall Study|Exclusionary medical condition|2|||
147119036|NCT01184118|530600727|FG000|Overall Study|Withdrawal by Subject|5|||
147119037|NCT01198548|530600739|FG000|Overall Study|Disease Progression|9|||
147119038|NCT01198548|530600739|FG000|Overall Study|Administrative Decision|1|||
147119039|NCT03834883|530600740|FG000|Second Treatment|Withdrawal by Subject|1|||
147119040|NCT03834883|530600741|FG001|Second Treatment|Withdrawal by Subject|0|||
147119041|NCT03834883|530600742|FG002|Second Treatment|Withdrawal by Subject|0|||
147119042|NCT03834883|530600743|FG003|Second Treatment|Withdrawal by Subject|0|||
147119043|NCT03834883|530600740|FG000|Second Treatment|COVID-19 pandemic|1|||
147119044|NCT03834883|530600741|FG001|Second Treatment|COVID-19 pandemic|0|||
147119045|NCT03834883|530600742|FG002|Second Treatment|COVID-19 pandemic|1|||
147119046|NCT03834883|530600743|FG003|Second Treatment|COVID-19 pandemic|1|||
147119047|NCT01179399|530600744|FG000|Overall Study|Adverse Event|1|||
147119048|NCT01179399|530600744|FG000|Overall Study|Lack of Efficacy|30|||
147119049|NCT01179399|530600744|FG000|Overall Study|Withdrawal by Subject|1|||
147119050|NCT00441896|530600745|FG000|Overall Study|Withdrawal by Subject|0|||
147119051|NCT00441896|530600746|FG001|Overall Study|Withdrawal by Subject|0|||
147119052|NCT00441896|530600747|FG002|Overall Study|Withdrawal by Subject|0|||
147119053|NCT00441896|530600748|FG003|Overall Study|Withdrawal by Subject|1|||
147119054|NCT00441896|530600749|FG004|Overall Study|Withdrawal by Subject|0|||
147119055|NCT00441896|530600750|FG005|Overall Study|Withdrawal by Subject|0|||
147119056|NCT00441896|530600751|FG006|Overall Study|Withdrawal by Subject|0|||
147119057|NCT00441896|530600752|FG007|Overall Study|Withdrawal by Subject|0|||
147119058|NCT00441896|530600753|FG008|Overall Study|Withdrawal by Subject|0|||
147119059|NCT00441896|530600754|FG009|Overall Study|Withdrawal by Subject|0|||
147119060|NCT00441896|530600745|FG000|Overall Study|Other|0|||
147119061|NCT00441896|530600746|FG001|Overall Study|Other|0|||
147119062|NCT00441896|530600747|FG002|Overall Study|Other|0|||
147119063|NCT00441896|530600748|FG003|Overall Study|Other|0|||
147119064|NCT00441896|530600749|FG004|Overall Study|Other|1|||
147119065|NCT00441896|530600750|FG005|Overall Study|Other|0|||
147119066|NCT00441896|530600751|FG006|Overall Study|Other|0|||
147119067|NCT00441896|530600752|FG007|Overall Study|Other|0|||
147119068|NCT00441896|530600753|FG008|Overall Study|Other|0|||
147119069|NCT00441896|530600754|FG009|Overall Study|Other|0|||
147119070|NCT03572218|530600755|FG000|Overall Study|Lost to Follow-up|3|||
147119071|NCT03572218|530600756|FG001|Overall Study|Lost to Follow-up|2|||
147119072|NCT03572218|530600755|FG000|Overall Study|No longer available for study visits|2|||
147119073|NCT03572218|530600756|FG001|Overall Study|No longer available for study visits|1|||
147119074|NCT03572218|530600755|FG000|Overall Study|No longer interested|1|||
147119075|NCT03572218|530600756|FG001|Overall Study|No longer interested|2|||
147119076|NCT01793129|530603254|FG000|Overall Study|Lost to Follow-up|3|||
147119077|NCT01793129|530603255|FG001|Overall Study|Lost to Follow-up|7|||
147119078|NCT01793129|530603254|FG000|Overall Study|Withdrawal by Subject|0|||
147119079|NCT01793129|530603255|FG001|Overall Study|Withdrawal by Subject|2|||
147119080|NCT01567085|530603258|FG000|Overall Study|Death|6|||
147119081|NCT01567085|530603258|FG000|Overall Study|Adverse Event|6|||
147119082|NCT01567085|530603258|FG000|Overall Study|Lost to Follow-up|3|||
147567432|NCT05472038|532238274|FG006|Overall Study|Not vaccinated|0|||
147567433|NCT05472038|532238275|FG007|Overall Study|Not vaccinated|0|||
147567434|NCT05472038|532238276|FG008|Overall Study|Not vaccinated|0|||
147567435|NCT05472038|532238277|FG009|Overall Study|Not vaccinated|0|||
147230895|NCT00408629|531019572|FG001|Overall Study|Lost to Follow-up|1|||
147230896|NCT00408629|531019571|FG000|Overall Study|Lack of Efficacy|63|||
147230897|NCT00408629|531019572|FG001|Overall Study|Lack of Efficacy|73|||
147230898|NCT00408629|531019571|FG000|Overall Study|Protocol Violation|1|||
147230899|NCT00408629|531019572|FG001|Overall Study|Protocol Violation|5|||
147230900|NCT00408629|531019571|FG000|Overall Study|Miscellaneous|11|||
147230901|NCT00408629|531019572|FG001|Overall Study|Miscellaneous|15|||
147230902|NCT00191906|531019573|FG000|Study Period II|Adverse Event|0|||
147230903|NCT00191906|531019574|FG001|Study Period II|Adverse Event|1|||
147230904|NCT00191906|531019575|FG002|Study Period II|Adverse Event|0|||
147230905|NCT00191906|531019576|FG003|Study Period II|Adverse Event|0|||
147230906|NCT00191906|531019573|FG000|Study Period II|Withdrawal by Subject|0|||
147230907|NCT00191906|531019574|FG001|Study Period II|Withdrawal by Subject|3|||
147230908|NCT00191906|531019575|FG002|Study Period II|Withdrawal by Subject|0|||
147230909|NCT00191906|531019576|FG003|Study Period II|Withdrawal by Subject|0|||
147230910|NCT00191906|531019573|FG000|Study Period II|Parent/Caregiver Decision|0|||
147230911|NCT00191906|531019574|FG001|Study Period II|Parent/Caregiver Decision|1|||
147230912|NCT00191906|531019575|FG002|Study Period II|Parent/Caregiver Decision|0|||
147230913|NCT00191906|531019576|FG003|Study Period II|Parent/Caregiver Decision|0|||
147230914|NCT00191906|531019573|FG000|Study Period II|Entry Criteria Exclusion|0|||
147230915|NCT00191906|531019574|FG001|Study Period II|Entry Criteria Exclusion|0|||
147230916|NCT00191906|531019575|FG002|Study Period II|Entry Criteria Exclusion|1|||
147230917|NCT00191906|531019576|FG003|Study Period II|Entry Criteria Exclusion|0|||
147230918|NCT00191906|531019573|FG000|Study Period III|Adverse Event|1|||
147230919|NCT00191906|531019574|FG001|Study Period III|Adverse Event|0|||
147230920|NCT00191906|531019575|FG002|Study Period III|Adverse Event|0|||
147230921|NCT00191906|531019576|FG003|Study Period III|Adverse Event|0|||
147230922|NCT00191906|531019573|FG000|Study Period III|Lost to Follow-up|0|||
147230923|NCT00191906|531019574|FG001|Study Period III|Lost to Follow-up|1|||
147230924|NCT00191906|531019575|FG002|Study Period III|Lost to Follow-up|0|||
147230925|NCT00191906|531019576|FG003|Study Period III|Lost to Follow-up|0|||
147230926|NCT00191906|531019573|FG000|Study Period III|Parent/Caregiver Decision|1|||
147230927|NCT00191906|531019574|FG001|Study Period III|Parent/Caregiver Decision|0|||
147230928|NCT00191906|531019575|FG002|Study Period III|Parent/Caregiver Decision|0|||
147230929|NCT00191906|531019576|FG003|Study Period III|Parent/Caregiver Decision|0|||
147230930|NCT00191906|531019573|FG000|Study Period III|Lack of Efficacy|3|||
147230931|NCT00191906|531019574|FG001|Study Period III|Lack of Efficacy|3|||
147230932|NCT00191906|531019575|FG002|Study Period III|Lack of Efficacy|0|||
147230933|NCT00191906|531019576|FG003|Study Period III|Lack of Efficacy|0|||
147230934|NCT00573937|531019577|FG000|Overall Study|Study Terminated|0|||
147230935|NCT00573937|531019578|FG001|Overall Study|Study Terminated|1|||
147230936|NCT00333801|531019579|FG000|Overall Study|Moved to another state|5|||
147230937|NCT00333801|531019580|FG001|Overall Study|Moved to another state|3|||
147230938|NCT00333801|531019579|FG000|Overall Study|Lost to Follow-up|2|||
147230939|NCT00333801|531019580|FG001|Overall Study|Lost to Follow-up|0|||
147230940|NCT00333801|531019579|FG000|Overall Study|Incarcerated|1|||
147230941|NCT00333801|531019580|FG001|Overall Study|Incarcerated|2|||
147230942|NCT00333801|531019579|FG000|Overall Study|Withdrawal by Subject|0|||
147230943|NCT00333801|531019580|FG001|Overall Study|Withdrawal by Subject|1|||
147230944|NCT03633617|531019581|FG000|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|1|||
147230945|NCT03633617|531019582|FG001|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|3|||
147230946|NCT03633617|531019583|FG002|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
147230947|NCT03633617|531019584|FG003|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
147230948|NCT03633617|531019585|FG004|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
147444489|NCT00942175|531792636|FG000|Overall Study|Pregnancy|0|||
147567436|NCT05472038|532238278|FG010|Overall Study|Not vaccinated|0|||
147567437|NCT05472038|532238279|FG011|Overall Study|Not vaccinated|0|||
147567438|NCT03235739|532238282|FG000|Overall Study|Withdrawal by Subject|2|||
147119083|NCT01567085|530603258|FG000|Overall Study|Graft loss|2|||
147119084|NCT01567085|530603258|FG000|Overall Study|Renal transplantectomy|1|||
147119085|NCT01567085|530603258|FG000|Overall Study|Returned to chronic dialysis|1|||
147119086|NCT01567085|530603258|FG000|Overall Study|Terminal chronic kidney dysfunction|1|||
147119087|NCT03312114|530603264|FG000|Overall Study|All the five enrolled dropped out of the|5|||
147119088|NCT03537729|530603265|FG000|Overall Study|Death|2|||
147119089|NCT03537729|530603266|FG001|Overall Study|Death|2|||
147119090|NCT03537729|530603267|FG002|Overall Study|Death|7|||
147119091|NCT03537729|530603265|FG000|Overall Study|Withdrawal by Subject|3|||
147119092|NCT03537729|530603266|FG001|Overall Study|Withdrawal by Subject|3|||
147119093|NCT03537729|530603267|FG002|Overall Study|Withdrawal by Subject|0|||
147119094|NCT03537729|530603265|FG000|Overall Study|Subject Moved|8|||
147119095|NCT03537729|530603266|FG001|Overall Study|Subject Moved|5|||
147119096|NCT03537729|530603267|FG002|Overall Study|Subject Moved|4|||
147567439|NCT03235739|532238283|FG001|Overall Study|Withdrawal by Subject|2|||
147567440|NCT03235739|532238282|FG000|Overall Study|Physician Decision|0|||
147567441|NCT03235739|532238283|FG001|Overall Study|Physician Decision|1|||
147567442|NCT02847650|532238284|FG000|Overall Study|Adverse Event|2|||
147567443|NCT02847650|532238285|FG001|Overall Study|Adverse Event|4|||
147230949|NCT03633617|531019586|FG005|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
147230950|NCT03633617|531019587|FG006|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
147230951|NCT03633617|531019588|FG007|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
147230952|NCT03633617|531019589|FG008|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
147230953|NCT03633617|531019590|FG009|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
147230954|NCT03633617|531019591|FG010|Part A|Week 24 not performed due to Coronavirus Disease-2019 (COVID-19)|0|||
147230955|NCT03633617|531019581|FG000|Part A|Unconfirmed early termination visit|1|||
147230956|NCT03633617|531019582|FG001|Part A|Unconfirmed early termination visit|0|||
147230957|NCT03633617|531019583|FG002|Part A|Unconfirmed early termination visit|0|||
147230958|NCT03633617|531019584|FG003|Part A|Unconfirmed early termination visit|0|||
147230959|NCT03633617|531019585|FG004|Part A|Unconfirmed early termination visit|0|||
147230960|NCT03633617|531019586|FG005|Part A|Unconfirmed early termination visit|0|||
147230961|NCT03633617|531019587|FG006|Part A|Unconfirmed early termination visit|0|||
147230962|NCT03633617|531019588|FG007|Part A|Unconfirmed early termination visit|0|||
147230963|NCT03633617|531019589|FG008|Part A|Unconfirmed early termination visit|0|||
147230964|NCT03633617|531019590|FG009|Part A|Unconfirmed early termination visit|0|||
147230965|NCT03633617|531019591|FG010|Part A|Unconfirmed early termination visit|0|||
147230966|NCT03633617|531019581|FG000|Part A|Adverse Event|0|||
147230967|NCT03633617|531019582|FG001|Part A|Adverse Event|1|||
147230968|NCT03633617|531019583|FG002|Part A|Adverse Event|0|||
147230969|NCT03633617|531019584|FG003|Part A|Adverse Event|0|||
147230970|NCT03633617|531019585|FG004|Part A|Adverse Event|0|||
147230971|NCT03633617|531019586|FG005|Part A|Adverse Event|0|||
147230972|NCT03633617|531019587|FG006|Part A|Adverse Event|0|||
147230973|NCT03633617|531019588|FG007|Part A|Adverse Event|0|||
147230974|NCT03633617|531019589|FG008|Part A|Adverse Event|0|||
147230975|NCT03633617|531019590|FG009|Part A|Adverse Event|0|||
147230976|NCT03633617|531019591|FG010|Part A|Adverse Event|0|||
147230977|NCT03633617|531019581|FG000|Part A|Pregnancy|1|||
147230978|NCT03633617|531019582|FG001|Part A|Pregnancy|0|||
147230979|NCT03633617|531019583|FG002|Part A|Pregnancy|0|||
147230980|NCT03633617|531019584|FG003|Part A|Pregnancy|0|||
147230981|NCT03633617|531019585|FG004|Part A|Pregnancy|0|||
147230982|NCT03633617|531019586|FG005|Part A|Pregnancy|0|||
147230983|NCT03633617|531019587|FG006|Part A|Pregnancy|0|||
147230984|NCT03633617|531019588|FG007|Part A|Pregnancy|0|||
147230985|NCT03633617|531019589|FG008|Part A|Pregnancy|0|||
147230986|NCT03633617|531019590|FG009|Part A|Pregnancy|0|||
147230987|NCT03633617|531019591|FG010|Part A|Pregnancy|0|||
147230988|NCT03633617|531019581|FG000|Part A|Withdrawal by Subject|0|||
147230989|NCT03633617|531019582|FG001|Part A|Withdrawal by Subject|1|||
147230990|NCT03633617|531019583|FG002|Part A|Withdrawal by Subject|0|||
147230991|NCT03633617|531019584|FG003|Part A|Withdrawal by Subject|0|||
147230992|NCT03633617|531019585|FG004|Part A|Withdrawal by Subject|0|||
147230993|NCT03633617|531019586|FG005|Part A|Withdrawal by Subject|0|||
147230994|NCT03633617|531019587|FG006|Part A|Withdrawal by Subject|0|||
147230995|NCT03633617|531019588|FG007|Part A|Withdrawal by Subject|0|||
147230996|NCT03633617|531019589|FG008|Part A|Withdrawal by Subject|0|||
147230997|NCT03633617|531019590|FG009|Part A|Withdrawal by Subject|0|||
147230998|NCT03633617|531019591|FG010|Part A|Withdrawal by Subject|0|||
147230999|NCT03633617|531019581|FG000|Part B|Adverse Event|0|||
147231000|NCT03633617|531019582|FG001|Part B|Adverse Event|0|||
147231001|NCT03633617|531019583|FG002|Part B|Adverse Event|2|||
147231002|NCT03633617|531019584|FG003|Part B|Adverse Event|2|||
147231003|NCT03633617|531019585|FG004|Part B|Adverse Event|1|||
147231004|NCT03633617|531019586|FG005|Part B|Adverse Event|0|||
147231005|NCT03633617|531019587|FG006|Part B|Adverse Event|0|||
147231006|NCT03633617|531019588|FG007|Part B|Adverse Event|0|||
147231007|NCT03633617|531019589|FG008|Part B|Adverse Event|0|||
147231008|NCT03633617|531019590|FG009|Part B|Adverse Event|0|||
147231009|NCT03633617|531019591|FG010|Part B|Adverse Event|0|||
147567444|NCT02847650|532238284|FG000|Overall Study|Lost to Follow-up|1|||
147567445|NCT02847650|532238285|FG001|Overall Study|Lost to Follow-up|0|||
147567446|NCT02847650|532238284|FG000|Overall Study|Protocol Violation|0|||
147567447|NCT02847650|532238285|FG001|Overall Study|Protocol Violation|1|||
147231010|NCT03633617|531019581|FG000|Part B|Withdrawal by Subject|0|||
147231011|NCT03633617|531019582|FG001|Part B|Withdrawal by Subject|0|||
147231012|NCT03633617|531019583|FG002|Part B|Withdrawal by Subject|1|||
147231013|NCT03633617|531019584|FG003|Part B|Withdrawal by Subject|0|||
147231014|NCT03633617|531019585|FG004|Part B|Withdrawal by Subject|2|||
147231015|NCT03633617|531019586|FG005|Part B|Withdrawal by Subject|0|||
147231016|NCT03633617|531019587|FG006|Part B|Withdrawal by Subject|0|||
147231017|NCT03633617|531019588|FG007|Part B|Withdrawal by Subject|0|||
147231018|NCT03633617|531019589|FG008|Part B|Withdrawal by Subject|0|||
147231019|NCT03633617|531019590|FG009|Part B|Withdrawal by Subject|0|||
147312883|NCT01089556|531312263|FG001|Study Period III (Weeks 9-16)|Withdrawal by Subject|0|||
147312884|NCT01089556|531312264|FG002|Study Period III (Weeks 9-16)|Withdrawal by Subject|3|||
147312885|NCT01089556|531312265|FG003|Study Period III (Weeks 9-16)|Withdrawal by Subject|0|||
147312886|NCT01089556|531312266|FG004|Study Period III (Weeks 9-16)|Withdrawal by Subject|1|||
147312887|NCT01089556|531312267|FG005|Study Period III (Weeks 9-16)|Withdrawal by Subject|2|||
147312888|NCT00594906|531312270|FG000|Overall Study|Physician Decision|1|||
147312889|NCT00594906|531312271|FG001|Overall Study|Physician Decision|0|||
147312890|NCT00594906|531312270|FG000|Overall Study|Physician Decision|0|||
147312891|NCT00594906|531312271|FG001|Overall Study|Physician Decision|1|||
147312892|NCT00594906|531312270|FG000|Overall Study|Death|0|||
147312893|NCT00594906|531312271|FG001|Overall Study|Death|1|||
147312894|NCT02564055|531312273|FG000|Overall Study|Adverse Event|1|||
147312895|NCT02564055|531312274|FG001|Overall Study|Adverse Event|0|||
147312896|NCT02564055|531312275|FG002|Overall Study|Adverse Event|4|||
147312897|NCT02564055|531312276|FG003|Overall Study|Adverse Event|1|||
147312898|NCT02564055|531312277|FG004|Overall Study|Adverse Event|4|||
147312899|NCT02564055|531312278|FG005|Overall Study|Adverse Event|1|||
147312900|NCT02564055|531312273|FG000|Overall Study|Protocol Violation|1|||
147312901|NCT02564055|531312274|FG001|Overall Study|Protocol Violation|0|||
147312902|NCT02564055|531312275|FG002|Overall Study|Protocol Violation|0|||
147312903|NCT02564055|531312276|FG003|Overall Study|Protocol Violation|0|||
147312904|NCT02564055|531312277|FG004|Overall Study|Protocol Violation|0|||
147312905|NCT02564055|531312278|FG005|Overall Study|Protocol Violation|0|||
147312906|NCT02564055|531312273|FG000|Overall Study|Reached stopping criteria|0|||
147312907|NCT02564055|531312274|FG001|Overall Study|Reached stopping criteria|0|||
147312908|NCT02564055|531312275|FG002|Overall Study|Reached stopping criteria|0|||
147312909|NCT02564055|531312276|FG003|Overall Study|Reached stopping criteria|0|||
147312910|NCT02564055|531312277|FG004|Overall Study|Reached stopping criteria|0|||
147312911|NCT02564055|531312278|FG005|Overall Study|Reached stopping criteria|1|||
147312912|NCT02564055|531312273|FG000|Overall Study|Lost to Follow-up|0|||
147312913|NCT02564055|531312274|FG001|Overall Study|Lost to Follow-up|1|||
147312914|NCT02564055|531312275|FG002|Overall Study|Lost to Follow-up|4|||
147312915|NCT02564055|531312276|FG003|Overall Study|Lost to Follow-up|2|||
147312916|NCT02564055|531312277|FG004|Overall Study|Lost to Follow-up|1|||
147312917|NCT02564055|531312278|FG005|Overall Study|Lost to Follow-up|0|||
147312918|NCT02564055|531312273|FG000|Overall Study|Physician Decision|0|||
147312919|NCT02564055|531312274|FG001|Overall Study|Physician Decision|0|||
147312920|NCT02564055|531312275|FG002|Overall Study|Physician Decision|1|||
147312921|NCT02564055|531312276|FG003|Overall Study|Physician Decision|0|||
147312922|NCT02564055|531312277|FG004|Overall Study|Physician Decision|0|||
147312923|NCT02564055|531312278|FG005|Overall Study|Physician Decision|0|||
147312924|NCT02564055|531312273|FG000|Overall Study|Withdrawal by Subject|4|||
147312925|NCT02564055|531312274|FG001|Overall Study|Withdrawal by Subject|4|||
147312926|NCT02564055|531312275|FG002|Overall Study|Withdrawal by Subject|3|||
147312927|NCT02564055|531312276|FG003|Overall Study|Withdrawal by Subject|3|||
147567448|NCT02847650|532238284|FG000|Overall Study|Withdrawal by Subject|1|||
147567449|NCT02847650|532238285|FG001|Overall Study|Withdrawal by Subject|1|||
147567450|NCT00218257|532238286|FG000|Period Between Visit 1 and 2|Lost to Follow-up|4|||
147567451|NCT00218257|532238287|FG001|Period Between Visit 1 and 2|Lost to Follow-up|3|||
147567452|NCT02175095|532238290|FG000|Overall Study|Withdrawal by Subject|3|||
147567453|NCT00462345|532238291|FG000|Overall Study|Withdrawal by Subject|2|||
147567454|NCT00462345|532238291|FG000|Overall Study|Did not complete second course|1|||
147567455|NCT03255733|532238292|FG000|Overall Study|Lost to Follow-up|4|||
147567456|NCT03874715|532238298|FG000|Overall Study|Adverse Event|2|||
147567457|NCT03874715|532238299|FG001|Overall Study|Adverse Event|0|||
147567458|NCT03874715|532238298|FG000|Overall Study|Poor compliance to protocol|5|||
147567459|NCT03874715|532238299|FG001|Overall Study|Poor compliance to protocol|1|||
147567460|NCT03874715|532238298|FG000|Overall Study|Withdrawal by Subject|1|||
147567461|NCT03874715|532238299|FG001|Overall Study|Withdrawal by Subject|0|||
147567462|NCT03874715|532238298|FG000|Overall Study|Other-unspecified|1|||
147567463|NCT03874715|532238299|FG001|Overall Study|Other-unspecified|0|||
147567464|NCT00461786|532238300|FG000|Overall Study|Entry Criteria Not Met|2|||
147567465|NCT00461786|532238300|FG000|Overall Study|Inevaluable (Never Treated)|1|||
147567466|NCT00835991|532238303|FG000|First Intervention|Adverse Event|0|||
147567467|NCT00835991|532238304|FG001|First Intervention|Adverse Event|1|||
147567468|NCT00835991|532238303|FG000|Washout|Protocol Violation|0|||
147567469|NCT00835991|532238304|FG001|Washout|Protocol Violation|2|||
147567470|NCT00835991|532238303|FG000|Washout|Withdrawal by Subject|3|||
147312928|NCT02564055|531312277|FG004|Overall Study|Withdrawal by Subject|10|||
147312929|NCT02564055|531312278|FG005|Overall Study|Withdrawal by Subject|10|||
147312930|NCT01375959|531312279|FG000|First Intervention (6 Weeks)|Adverse Event|2|||
147312931|NCT01375959|531312280|FG001|First Intervention (6 Weeks)|Adverse Event|3|||
147312932|NCT01375959|531312279|FG000|Second Intervention (6 Weeks)|Withdrawal by Subject|0|||
147312933|NCT01375959|531312280|FG001|Second Intervention (6 Weeks)|Withdrawal by Subject|1|||
147312934|NCT01375959|531312279|FG000|Second Intervention (6 Weeks)|Adverse Event|0|||
147312935|NCT01375959|531312280|FG001|Second Intervention (6 Weeks)|Adverse Event|2|||
147444490|NCT00942175|531792637|FG001|Overall Study|Pregnancy|0|||
147119097|NCT03537729|530603265|FG000|Overall Study|Investigator determined not in best interest for subject to continue|1|||
147312936|NCT01394250|531312281|FG000|Randomization and IV Placement Attempt|Unsuccessful IV Access on First Attempt|14|||
147312937|NCT01394250|531312282|FG001|Randomization and IV Placement Attempt|Unsuccessful IV Access on First Attempt|13|||
147312938|NCT01394250|531312281|FG000|Successful IV Placement & Follow-Up|Withdrawal by Subject|6|||
147312939|NCT01394250|531312282|FG001|Successful IV Placement & Follow-Up|Withdrawal by Subject|11|||
147312940|NCT02310126|531312283|FG000|Period 1 (15 Minutes)|Lost to Follow-up|0|||
147312941|NCT02310126|531312284|FG001|Period 1 (15 Minutes)|Lost to Follow-up|1|||
147312942|NCT02310126|531312283|FG000|Period 1 (15 Minutes)|Protocol Violation|0|||
147312943|NCT02310126|531312284|FG001|Period 1 (15 Minutes)|Protocol Violation|1|||
147312944|NCT02222896|531312288|FG000|Abdomen|Did not qualify|34|||
147312945|NCT02222896|531312289|FG001|Abdomen|Did not qualify|10|||
147312946|NCT02222896|531312290|FG002|Abdomen|Did not qualify|32|||
147312947|NCT02222896|531312288|FG000|Groin|Did not qualify|43|||
147312948|NCT02222896|531312289|FG001|Groin|Did not qualify|9|||
147119098|NCT03537729|530603266|FG001|Overall Study|Investigator determined not in best interest for subject to continue|0|||
147119099|NCT03537729|530603267|FG002|Overall Study|Investigator determined not in best interest for subject to continue|0|||
147119100|NCT03537729|530603265|FG000|Overall Study|COVID-19 Site Restrictions|11|||
147119101|NCT03537729|530603266|FG001|Overall Study|COVID-19 Site Restrictions|15|||
147119102|NCT03537729|530603267|FG002|Overall Study|COVID-19 Site Restrictions|18|||
147119103|NCT03537729|530603265|FG000|Overall Study|Decline in Health|5|||
147119104|NCT03537729|530603266|FG001|Overall Study|Decline in Health|9|||
147119105|NCT03537729|530603267|FG002|Overall Study|Decline in Health|4|||
147119106|NCT03537729|530603265|FG000|Overall Study|Determined Ineligible|0|||
147312949|NCT02222896|531312290|FG002|Groin|Did not qualify|40|||
147312950|NCT02441946|531312291|FG000|Cycle 1 Period 1 (2 Weeks)|Adverse Event|1|||
147312951|NCT02441946|531312292|FG001|Cycle 1 Period 1 (2 Weeks)|Adverse Event|1|||
147312952|NCT02441946|531312293|FG002|Cycle 1 Period 1 (2 Weeks)|Adverse Event|0|||
147312953|NCT02441946|531312291|FG000|Cycle 1 Period 1 (2 Weeks)|Physician Decision|1|||
147312954|NCT02441946|531312292|FG001|Cycle 1 Period 1 (2 Weeks)|Physician Decision|0|||
147312955|NCT02441946|531312293|FG002|Cycle 1 Period 1 (2 Weeks)|Physician Decision|0|||
147312956|NCT02441946|531312291|FG000|Cycle 1 Period 1 (2 Weeks)|Withdrawal by Subject|0|||
147312957|NCT02441946|531312292|FG001|Cycle 1 Period 1 (2 Weeks)|Withdrawal by Subject|3|||
147312958|NCT02441946|531312293|FG002|Cycle 1 Period 1 (2 Weeks)|Withdrawal by Subject|0|||
147312959|NCT02441946|531312291|FG000|Cycle 1 Period 1 (2 Weeks)|Never Treated|0|||
147312960|NCT02441946|531312292|FG001|Cycle 1 Period 1 (2 Weeks)|Never Treated|1|||
147312961|NCT02441946|531312293|FG002|Cycle 1 Period 1 (2 Weeks)|Never Treated|0|||
147312962|NCT02441946|531312291|FG000|Cycle 2-5 Period 2 (14 Weeks)|Adverse Event|15|||
147312963|NCT02441946|531312292|FG001|Cycle 2-5 Period 2 (14 Weeks)|Adverse Event|0|||
147312964|NCT02441946|531312293|FG002|Cycle 2-5 Period 2 (14 Weeks)|Adverse Event|0|||
147312965|NCT02441946|531312291|FG000|Cycle 2-5 Period 2 (14 Weeks)|Noncompliance with study drug|1|||
147312966|NCT02441946|531312292|FG001|Cycle 2-5 Period 2 (14 Weeks)|Noncompliance with study drug|0|||
147312967|NCT02441946|531312293|FG002|Cycle 2-5 Period 2 (14 Weeks)|Noncompliance with study drug|0|||
147312968|NCT02441946|531312291|FG000|Cycle 2-5 Period 2 (14 Weeks)|Physician Decision|1|||
147312969|NCT02441946|531312292|FG001|Cycle 2-5 Period 2 (14 Weeks)|Physician Decision|0|||
147312970|NCT02441946|531312293|FG002|Cycle 2-5 Period 2 (14 Weeks)|Physician Decision|0|||
147312971|NCT02441946|531312291|FG000|Cycle 2-5 Period 2 (14 Weeks)|Protocol Deviation|1|||
147312972|NCT02441946|531312292|FG001|Cycle 2-5 Period 2 (14 Weeks)|Protocol Deviation|0|||
147312973|NCT02441946|531312293|FG002|Cycle 2-5 Period 2 (14 Weeks)|Protocol Deviation|0|||
147312974|NCT02441946|531312291|FG000|Cycle 2-5 Period 2 (14 Weeks)|Withdrawal by Subject|9|||
147312975|NCT02441946|531312292|FG001|Cycle 2-5 Period 2 (14 Weeks)|Withdrawal by Subject|0|||
147312976|NCT02441946|531312293|FG002|Cycle 2-5 Period 2 (14 Weeks)|Withdrawal by Subject|0|||
147312977|NCT02441946|531312291|FG000|Extension Period (8 Weeks)|Adverse Event|1|||
147312978|NCT02441946|531312292|FG001|Extension Period (8 Weeks)|Adverse Event|0|||
147312979|NCT02441946|531312293|FG002|Extension Period (8 Weeks)|Adverse Event|0|||
147312980|NCT02441946|531312291|FG000|Extension Period (8 Weeks)|Withdrawal by Subject|1|||
147312981|NCT02441946|531312292|FG001|Extension Period (8 Weeks)|Withdrawal by Subject|0|||
147312982|NCT02441946|531312293|FG002|Extension Period (8 Weeks)|Withdrawal by Subject|0|||
147312983|NCT02111213|531312294|FG000|Overall Study|Withdrawal by Subject|3|||
147312984|NCT02111213|531312295|FG001|Overall Study|Withdrawal by Subject|2|||
147312985|NCT02111213|531312294|FG000|Overall Study|Lost to Follow-up|3|||
147312986|NCT02111213|531312295|FG001|Overall Study|Lost to Follow-up|4|||
147312987|NCT01613027|531312296|FG000|Overall Study|Lost to Follow-up|5|||
147312988|NCT01613027|531312296|FG000|Overall Study|Switched Physician|1|||
147567471|NCT00835991|532238304|FG001|Washout|Withdrawal by Subject|1|||
147567472|NCT02378935|532238305|FG000|Overall Study|Lack of Efficacy|10|||
147119107|NCT03537729|530603266|FG001|Overall Study|Determined Ineligible|0|||
147312989|NCT01613027|531312296|FG000|Overall Study|Lack of Efficacy|1|||
147312990|NCT01613027|531312296|FG000|Overall Study|Patient's Decision Due to Adverse Event|1|||
147312991|NCT02153359|531312299|FG000|Intervention 2 (1 Month)|Lost to Follow-up|0|||
147312992|NCT02153359|531312300|FG001|Intervention 2 (1 Month)|Lost to Follow-up|2|||
147312993|NCT04267614|531312303|FG000|Overall Study|Participants did not meet inclusion criteria|132|||
147567473|NCT02378935|532238306|FG001|Overall Study|Lack of Efficacy|0|||
147119108|NCT03537729|530603267|FG002|Overall Study|Determined Ineligible|1|||
147312994|NCT04267614|531312303|FG000|Overall Study|Lost to Follow-up|115|||
147312995|NCT01463293|531312304|FG000|Overall Study|Lost to Follow-up|1|||
147312996|NCT01463293|531312305|FG001|Overall Study|Lost to Follow-up|4|||
147312997|NCT01463293|531312306|FG002|Overall Study|Lost to Follow-up|5|||
147312998|NCT01463293|531312304|FG000|Overall Study|Adverse Event|1|||
147312999|NCT01463293|531312305|FG001|Overall Study|Adverse Event|2|||
147313000|NCT01463293|531312306|FG002|Overall Study|Adverse Event|0|||
147313001|NCT01463293|531312304|FG000|Overall Study|Withdrawal by Subject|4|||
147313002|NCT01463293|531312305|FG001|Overall Study|Withdrawal by Subject|10|||
147313003|NCT01463293|531312306|FG002|Overall Study|Withdrawal by Subject|5|||
147313004|NCT01463293|531312304|FG000|Overall Study|Other|0|||
147313005|NCT01463293|531312305|FG001|Overall Study|Other|0|||
147313006|NCT01463293|531312306|FG002|Overall Study|Other|2|||
147313007|NCT00779584|531312310|FG000|Overall Study|Protocol Violation|0|||
147313008|NCT00779584|531312311|FG001|Overall Study|Protocol Violation|0|||
147313009|NCT00779584|531312312|FG002|Overall Study|Protocol Violation|0|||
147313010|NCT00779584|531312313|FG003|Overall Study|Protocol Violation|0|||
147313011|NCT00779584|531312314|FG004|Overall Study|Protocol Violation|0|||
147313012|NCT00779584|531312315|FG005|Overall Study|Protocol Violation|1|||
147313013|NCT00779584|531312316|FG006|Overall Study|Protocol Violation|0|||
147313014|NCT00779584|531312317|FG007|Overall Study|Protocol Violation|0|||
147313015|NCT00779584|531312318|FG008|Overall Study|Protocol Violation|0|||
147313016|NCT00779584|531312310|FG000|Overall Study|Withdrawal by Subject|1|||
147313017|NCT00779584|531312311|FG001|Overall Study|Withdrawal by Subject|1|||
147313018|NCT00779584|531312312|FG002|Overall Study|Withdrawal by Subject|2|||
147313019|NCT00779584|531312313|FG003|Overall Study|Withdrawal by Subject|0|||
147313020|NCT00779584|531312314|FG004|Overall Study|Withdrawal by Subject|0|||
147313021|NCT00779584|531312315|FG005|Overall Study|Withdrawal by Subject|2|||
147313022|NCT00779584|531312316|FG006|Overall Study|Withdrawal by Subject|1|||
147313023|NCT00779584|531312317|FG007|Overall Study|Withdrawal by Subject|0|||
147313024|NCT00779584|531312318|FG008|Overall Study|Withdrawal by Subject|0|||
147313025|NCT00779584|531312310|FG000|Overall Study|Lost to Follow-up|0|||
147313026|NCT00779584|531312311|FG001|Overall Study|Lost to Follow-up|0|||
147313027|NCT00779584|531312312|FG002|Overall Study|Lost to Follow-up|0|||
147313028|NCT00779584|531312313|FG003|Overall Study|Lost to Follow-up|0|||
147313029|NCT00779584|531312314|FG004|Overall Study|Lost to Follow-up|1|||
147313030|NCT00779584|531312315|FG005|Overall Study|Lost to Follow-up|0|||
147313031|NCT00779584|531312316|FG006|Overall Study|Lost to Follow-up|0|||
147313032|NCT00779584|531312317|FG007|Overall Study|Lost to Follow-up|0|||
147313033|NCT00779584|531312318|FG008|Overall Study|Lost to Follow-up|0|||
147313034|NCT00779584|531312310|FG000|Overall Study|Progression of Disease|0|||
147313035|NCT00779584|531312311|FG001|Overall Study|Progression of Disease|1|||
147313036|NCT00779584|531312312|FG002|Overall Study|Progression of Disease|2|||
147313037|NCT00779584|531312313|FG003|Overall Study|Progression of Disease|6|||
147313038|NCT00779584|531312314|FG004|Overall Study|Progression of Disease|5|||
147313039|NCT00779584|531312315|FG005|Overall Study|Progression of Disease|1|||
147313040|NCT00779584|531312316|FG006|Overall Study|Progression of Disease|4|||
147313041|NCT00779584|531312317|FG007|Overall Study|Progression of Disease|2|||
147313042|NCT00779584|531312318|FG008|Overall Study|Progression of Disease|1|||
147313043|NCT00779584|531312310|FG000|Overall Study|Adverse Event|1|||
147313044|NCT00779584|531312311|FG001|Overall Study|Adverse Event|0|||
147313045|NCT00779584|531312312|FG002|Overall Study|Adverse Event|2|||
147313046|NCT00779584|531312313|FG003|Overall Study|Adverse Event|0|||
147313047|NCT00779584|531312314|FG004|Overall Study|Adverse Event|0|||
147313048|NCT00779584|531312315|FG005|Overall Study|Adverse Event|0|||
147119109|NCT00284934|530603268|FG000|Overall Study|Adverse Event|1|||
147119110|NCT00284934|530603269|FG001|Overall Study|Adverse Event|2|||
147119111|NCT00284934|530603268|FG000|Overall Study|Other reasons|3|||
147119112|NCT00284934|530603269|FG001|Overall Study|Other reasons|1|||
147119113|NCT00454142|530603270|FG000|Overall Study|Withdrawal by Subject|1|||
147119114|NCT01748552|530603278|FG000|Intervention Period 2 and Washout|Physician Decision|0|||
147119115|NCT01748552|530603279|FG001|Intervention Period 2 and Washout|Physician Decision|0|||
147313049|NCT00779584|531312316|FG006|Overall Study|Adverse Event|2|||
147444491|NCT00942175|531792638|FG002|Overall Study|Pregnancy|0|||
147567474|NCT02378935|532238307|FG002|Overall Study|Lack of Efficacy|2|||
147119116|NCT01748552|530603280|FG002|Intervention Period 2 and Washout|Physician Decision|1|||
147119117|NCT01748552|530603281|FG003|Intervention Period 2 and Washout|Physician Decision|0|||
147313050|NCT00779584|531312317|FG007|Overall Study|Adverse Event|1|||
147313051|NCT00779584|531312318|FG008|Overall Study|Adverse Event|1|||
147313052|NCT00779584|531312310|FG000|Overall Study|Symptomatic Deterioration|1|||
147313053|NCT00779584|531312311|FG001|Overall Study|Symptomatic Deterioration|1|||
147313054|NCT00779584|531312312|FG002|Overall Study|Symptomatic Deterioration|1|||
147313055|NCT00779584|531312313|FG003|Overall Study|Symptomatic Deterioration|0|||
147313056|NCT00779584|531312314|FG004|Overall Study|Symptomatic Deterioration|0|||
147313057|NCT00779584|531312315|FG005|Overall Study|Symptomatic Deterioration|1|||
147313058|NCT00779584|531312316|FG006|Overall Study|Symptomatic Deterioration|1|||
147313059|NCT00779584|531312317|FG007|Overall Study|Symptomatic Deterioration|0|||
147313060|NCT00779584|531312318|FG008|Overall Study|Symptomatic Deterioration|0|||
147313061|NCT00779584|531312310|FG000|Overall Study|Ongoing in Study|0|||
147313062|NCT00779584|531312311|FG001|Overall Study|Ongoing in Study|0|||
147313063|NCT00779584|531312312|FG002|Overall Study|Ongoing in Study|0|||
147313064|NCT00779584|531312313|FG003|Overall Study|Ongoing in Study|0|||
147313065|NCT00779584|531312314|FG004|Overall Study|Ongoing in Study|1|||
147313066|NCT00779584|531312315|FG005|Overall Study|Ongoing in Study|1|||
147313067|NCT00779584|531312316|FG006|Overall Study|Ongoing in Study|0|||
147313068|NCT00779584|531312317|FG007|Overall Study|Ongoing in Study|0|||
147313069|NCT00779584|531312318|FG008|Overall Study|Ongoing in Study|0|||
147313070|NCT03632434|531312323|FG000|Overall Study|Withdrawal by Subject|2|||
147313071|NCT04297241|531312325|FG000|Overall Study|Withdrawal by Subject|1|||
147313072|NCT04297241|531312325|FG000|Overall Study|Adverse Event|1|||
147313073|NCT04297241|531312325|FG000|Overall Study|Physician Decision|3|||
147313074|NCT00786474|531312334|FG000|Overall Study|Death|5|||
147313075|NCT00786474|531312335|FG001|Overall Study|Death|4|||
147313076|NCT00786474|531312334|FG000|Overall Study|Withdrawal by Subject|23|||
147313077|NCT00786474|531312335|FG001|Overall Study|Withdrawal by Subject|31|||
147313078|NCT00786474|531312334|FG000|Overall Study|Lost to Follow-up|3|||
147313079|NCT00786474|531312335|FG001|Overall Study|Lost to Follow-up|3|||
147313080|NCT00786474|531312334|FG000|Overall Study|Physician Decision|2|||
147313081|NCT00786474|531312335|FG001|Overall Study|Physician Decision|1|||
147313082|NCT00786474|531312334|FG000|Overall Study|Other|4|||
147313083|NCT00786474|531312335|FG001|Overall Study|Other|4|||
147313084|NCT01868074|531312336|FG000|Overall Study|Lost to Follow-up|3|||
147313085|NCT01868074|531312337|FG001|Overall Study|Lost to Follow-up|2|||
147313086|NCT01868074|531312336|FG000|Overall Study|Withdrawal by Subject|4|||
147313087|NCT01868074|531312337|FG001|Overall Study|Withdrawal by Subject|2|||
147313088|NCT03688711|531312338|FG000|Overall Study|Withdrawal by Subject|0|||
147313089|NCT03688711|531312339|FG001|Overall Study|Withdrawal by Subject|1|||
147313090|NCT04175912|531312343|FG000|Overall Study|Disease progression- relapse during active treatment|17|||
147313091|NCT04175912|531312344|FG001|Overall Study|Disease progression- relapse during active treatment|13|||
147313092|NCT04175912|531312343|FG000|Overall Study|Adverse Event|0|||
147313093|NCT04175912|531312344|FG001|Overall Study|Adverse Event|3|||
147313094|NCT04175912|531312343|FG000|Overall Study|Never started treatment|3|||
147313095|NCT04175912|531312344|FG001|Overall Study|Never started treatment|3|||
147313096|NCT04175912|531312343|FG000|Overall Study|Death|0|||
147313097|NCT04175912|531312344|FG001|Overall Study|Death|1|||
147313098|NCT02303626|531312345|FG000|Overall Study|Lack of Efficacy|1|||
147313099|NCT02303626|531312346|FG001|Overall Study|Lack of Efficacy|0|||
147313100|NCT02303626|531312347|FG002|Overall Study|Lack of Efficacy|1|||
147313101|NCT02303626|531312345|FG000|Overall Study|Adverse Event|0|||
147313102|NCT02303626|531312346|FG001|Overall Study|Adverse Event|2|||
147313103|NCT02303626|531312347|FG002|Overall Study|Adverse Event|0|||
147313104|NCT02303626|531312345|FG000|Overall Study|Protocol Violation|0|||
147313105|NCT02303626|531312346|FG001|Overall Study|Protocol Violation|1|||
147313106|NCT02303626|531312347|FG002|Overall Study|Protocol Violation|0|||
147313107|NCT02303626|531312345|FG000|Overall Study|Pregnancy|0|||
147313108|NCT02303626|531312346|FG001|Overall Study|Pregnancy|0|||
147313109|NCT02303626|531312347|FG002|Overall Study|Pregnancy|1|||
147313110|NCT02303626|531312345|FG000|Overall Study|Subject Non-Compliance|0|||
147313111|NCT02303626|531312346|FG001|Overall Study|Subject Non-Compliance|0|||
147313112|NCT02303626|531312347|FG002|Overall Study|Subject Non-Compliance|1|||
147444492|NCT00942175|531792639|FG003|Overall Study|Pregnancy|1|||
147444493|NCT00942175|531792636|FG000|Overall Study|Elevated Alanine Amino Transferase|0|||
147444494|NCT00942175|531792637|FG001|Overall Study|Elevated Alanine Amino Transferase|0|||
147444495|NCT00942175|531792638|FG002|Overall Study|Elevated Alanine Amino Transferase|0|||
147444496|NCT00942175|531792639|FG003|Overall Study|Elevated Alanine Amino Transferase|1|||
147444497|NCT00942175|531792636|FG000|Overall Study|Low Platelet Count|0|||
147444498|NCT00942175|531792637|FG001|Overall Study|Low Platelet Count|2|||
147444499|NCT00942175|531792638|FG002|Overall Study|Low Platelet Count|0|||
147444500|NCT00942175|531792639|FG003|Overall Study|Low Platelet Count|0|||
147444501|NCT01066585|531792640|FG000|Overall Study|Protocol Violation|1|||
147444502|NCT01066585|531792641|FG001|Overall Study|Protocol Violation|0|||
147444503|NCT01066585|531792640|FG000|Overall Study|Withdrawal by Subject|0|||
147444504|NCT01066585|531792641|FG001|Overall Study|Withdrawal by Subject|3|||
147444505|NCT01940471|531792642|FG000|Period 1: Double-blind Phase|Withdrew Consent|31|||
147444506|NCT01940471|531792643|FG001|Period 1: Double-blind Phase|Withdrew Consent|18|||
147444507|NCT01940471|531792644|FG002|Period 1: Double-blind Phase|Withdrew Consent|0|||
147444508|NCT01940471|531792645|FG003|Period 1: Double-blind Phase|Withdrew Consent|0|||
147444509|NCT01940471|531792642|FG000|Period 1: Double-blind Phase|Lost to Follow-up|8|||
147444510|NCT01940471|531792643|FG001|Period 1: Double-blind Phase|Lost to Follow-up|6|||
147444511|NCT01940471|531792644|FG002|Period 1: Double-blind Phase|Lost to Follow-up|0|||
147444512|NCT01940471|531792645|FG003|Period 1: Double-blind Phase|Lost to Follow-up|0|||
147444513|NCT01940471|531792642|FG000|Period 1: Double-blind Phase|Investigator's Discretion|8|||
147444514|NCT01940471|531792643|FG001|Period 1: Double-blind Phase|Investigator's Discretion|5|||
147444515|NCT01940471|531792644|FG002|Period 1: Double-blind Phase|Investigator's Discretion|0|||
147444516|NCT01940471|531792645|FG003|Period 1: Double-blind Phase|Investigator's Discretion|0|||
147231020|NCT03633617|531019591|FG010|Part B|Withdrawal by Subject|0|||
147231021|NCT03633617|531019581|FG000|Part B|Lost to Follow-up|0|||
147231022|NCT03633617|531019582|FG001|Part B|Lost to Follow-up|0|||
147231023|NCT03633617|531019583|FG002|Part B|Lost to Follow-up|0|||
147231024|NCT03633617|531019584|FG003|Part B|Lost to Follow-up|0|||
147231025|NCT03633617|531019585|FG004|Part B|Lost to Follow-up|1|||
147231026|NCT03633617|531019586|FG005|Part B|Lost to Follow-up|0|||
147231027|NCT03633617|531019587|FG006|Part B|Lost to Follow-up|0|||
147231028|NCT03633617|531019588|FG007|Part B|Lost to Follow-up|0|||
147231029|NCT03633617|531019589|FG008|Part B|Lost to Follow-up|0|||
147231030|NCT03633617|531019590|FG009|Part B|Lost to Follow-up|0|||
147231031|NCT03633617|531019591|FG010|Part B|Lost to Follow-up|0|||
147231032|NCT03633617|531019581|FG000|Part B|Physician Decision|0|||
147231033|NCT03633617|531019582|FG001|Part B|Physician Decision|0|||
147231034|NCT03633617|531019583|FG002|Part B|Physician Decision|0|||
147231035|NCT03633617|531019584|FG003|Part B|Physician Decision|0|||
147231036|NCT03633617|531019585|FG004|Part B|Physician Decision|1|||
147231037|NCT03633617|531019586|FG005|Part B|Physician Decision|0|||
147231038|NCT03633617|531019587|FG006|Part B|Physician Decision|0|||
147231039|NCT03633617|531019588|FG007|Part B|Physician Decision|0|||
147231040|NCT03633617|531019589|FG008|Part B|Physician Decision|0|||
147231041|NCT03633617|531019590|FG009|Part B|Physician Decision|0|||
147231042|NCT03633617|531019591|FG010|Part B|Physician Decision|0|||
147231043|NCT03633617|531019581|FG000|Part B|COVID-19 Restrictions|0|||
147231044|NCT03633617|531019582|FG001|Part B|COVID-19 Restrictions|0|||
147231045|NCT03633617|531019583|FG002|Part B|COVID-19 Restrictions|1|||
147231046|NCT03633617|531019584|FG003|Part B|COVID-19 Restrictions|0|||
147231047|NCT03633617|531019585|FG004|Part B|COVID-19 Restrictions|0|||
147231048|NCT03633617|531019586|FG005|Part B|COVID-19 Restrictions|0|||
147231049|NCT03633617|531019587|FG006|Part B|COVID-19 Restrictions|0|||
147231050|NCT03633617|531019588|FG007|Part B|COVID-19 Restrictions|0|||
147231051|NCT03633617|531019589|FG008|Part B|COVID-19 Restrictions|0|||
147231052|NCT03633617|531019590|FG009|Part B|COVID-19 Restrictions|0|||
147231053|NCT03633617|531019591|FG010|Part B|COVID-19 Restrictions|0|||
147231054|NCT03633617|531019581|FG000|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
147231055|NCT03633617|531019582|FG001|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
147231056|NCT03633617|531019583|FG002|Part B|Subject randomized, but did not receive study drug; did not qualify for study|1|||
147231057|NCT03633617|531019584|FG003|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
147231058|NCT03633617|531019585|FG004|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
147231059|NCT03633617|531019586|FG005|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
147231060|NCT03633617|531019587|FG006|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
147231061|NCT03633617|531019588|FG007|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
147231062|NCT03633617|531019589|FG008|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
147231063|NCT03633617|531019590|FG009|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
147444517|NCT01940471|531792642|FG000|Period 1: Double-blind Phase|Pregnancy|9|||
147119118|NCT01748552|530603282|FG004|Intervention Period 2 and Washout|Physician Decision|0|||
147119119|NCT01748552|530603283|FG005|Intervention Period 2 and Washout|Physician Decision|0|||
147119120|NCT01748552|530603284|FG006|Intervention Period 2 and Washout|Physician Decision|0|||
147119121|NCT01748552|530603285|FG007|Intervention Period 2 and Washout|Physician Decision|0|||
147119122|NCT01748552|530603286|FG008|Intervention Period 2 and Washout|Physician Decision|0|||
147119123|NCT01748552|530603287|FG009|Intervention Period 2 and Washout|Physician Decision|0|||
147119124|NCT01748552|530603288|FG010|Intervention Period 2 and Washout|Physician Decision|0|||
147119125|NCT01748552|530603289|FG011|Intervention Period 2 and Washout|Physician Decision|0|||
147119126|NCT01748552|530603278|FG000|Intervention Period 2 and Washout|Contingency dose not tested|0|||
147119127|NCT01748552|530603279|FG001|Intervention Period 2 and Washout|Contingency dose not tested|0|||
147119128|NCT01748552|530603280|FG002|Intervention Period 2 and Washout|Contingency dose not tested|0|||
147119129|NCT01748552|530603281|FG003|Intervention Period 2 and Washout|Contingency dose not tested|0|||
147119130|NCT01748552|530603282|FG004|Intervention Period 2 and Washout|Contingency dose not tested|0|||
147119131|NCT01748552|530603283|FG005|Intervention Period 2 and Washout|Contingency dose not tested|0|||
147119132|NCT01748552|530603284|FG006|Intervention Period 2 and Washout|Contingency dose not tested|3|||
147119133|NCT01748552|530603285|FG007|Intervention Period 2 and Washout|Contingency dose not tested|3|||
147119134|NCT01748552|530603286|FG008|Intervention Period 2 and Washout|Contingency dose not tested|3|||
147119135|NCT01748552|530603287|FG009|Intervention Period 2 and Washout|Contingency dose not tested|0|||
147119136|NCT01748552|530603288|FG010|Intervention Period 2 and Washout|Contingency dose not tested|0|||
147119137|NCT01748552|530603289|FG011|Intervention Period 2 and Washout|Contingency dose not tested|0|||
147119138|NCT00504556|530603290|FG000|Overall Study|Adverse Event|11|||
147119139|NCT00504556|530603291|FG001|Overall Study|Adverse Event|11|||
147119140|NCT00504556|530603292|FG002|Overall Study|Adverse Event|14|||
147119141|NCT00504556|530603293|FG003|Overall Study|Adverse Event|13|||
147231064|NCT03633617|531019591|FG010|Part B|Subject randomized, but did not receive study drug; did not qualify for study|0|||
147231065|NCT03633617|531019581|FG000|Part C (& Follow-up)|Adverse Event|0|||
147231066|NCT03633617|531019582|FG001|Part C (& Follow-up)|Adverse Event|0|||
147231067|NCT03633617|531019583|FG002|Part C (& Follow-up)|Adverse Event|0|||
147231068|NCT03633617|531019584|FG003|Part C (& Follow-up)|Adverse Event|0|||
147231069|NCT03633617|531019585|FG004|Part C (& Follow-up)|Adverse Event|0|||
147231070|NCT03633617|531019586|FG005|Part C (& Follow-up)|Adverse Event|1|||
147231071|NCT03633617|531019587|FG006|Part C (& Follow-up)|Adverse Event|0|||
147231072|NCT03633617|531019588|FG007|Part C (& Follow-up)|Adverse Event|1|||
147231073|NCT03633617|531019589|FG008|Part C (& Follow-up)|Adverse Event|0|||
147231074|NCT03633617|531019590|FG009|Part C (& Follow-up)|Adverse Event|0|||
147231075|NCT03633617|531019591|FG010|Part C (& Follow-up)|Adverse Event|0|||
147231076|NCT03633617|531019581|FG000|Part C (& Follow-up)|Pregnancy|0|||
147231077|NCT03633617|531019582|FG001|Part C (& Follow-up)|Pregnancy|0|||
147231078|NCT03633617|531019583|FG002|Part C (& Follow-up)|Pregnancy|0|||
147231079|NCT03633617|531019584|FG003|Part C (& Follow-up)|Pregnancy|0|||
147231080|NCT03633617|531019585|FG004|Part C (& Follow-up)|Pregnancy|0|||
147231081|NCT03633617|531019586|FG005|Part C (& Follow-up)|Pregnancy|0|||
147231082|NCT03633617|531019587|FG006|Part C (& Follow-up)|Pregnancy|0|||
147231083|NCT03633617|531019588|FG007|Part C (& Follow-up)|Pregnancy|0|||
147231084|NCT03633617|531019589|FG008|Part C (& Follow-up)|Pregnancy|0|||
147231085|NCT03633617|531019590|FG009|Part C (& Follow-up)|Pregnancy|1|||
147231086|NCT03633617|531019591|FG010|Part C (& Follow-up)|Pregnancy|0|||
147231087|NCT03633617|531019581|FG000|Part C (& Follow-up)|Withdrawal by Subject|0|||
147231088|NCT03633617|531019582|FG001|Part C (& Follow-up)|Withdrawal by Subject|0|||
147231089|NCT03633617|531019583|FG002|Part C (& Follow-up)|Withdrawal by Subject|0|||
147231090|NCT03633617|531019584|FG003|Part C (& Follow-up)|Withdrawal by Subject|0|||
147231091|NCT03633617|531019585|FG004|Part C (& Follow-up)|Withdrawal by Subject|0|||
147231092|NCT03633617|531019586|FG005|Part C (& Follow-up)|Withdrawal by Subject|2|||
147231093|NCT03633617|531019587|FG006|Part C (& Follow-up)|Withdrawal by Subject|2|||
147231094|NCT03633617|531019588|FG007|Part C (& Follow-up)|Withdrawal by Subject|0|||
147231095|NCT03633617|531019589|FG008|Part C (& Follow-up)|Withdrawal by Subject|1|||
147231096|NCT03633617|531019590|FG009|Part C (& Follow-up)|Withdrawal by Subject|1|||
147231097|NCT03633617|531019591|FG010|Part C (& Follow-up)|Withdrawal by Subject|6|||
147231098|NCT03633617|531019581|FG000|Part C (& Follow-up)|Lost to Follow-up|0|||
147231099|NCT03633617|531019582|FG001|Part C (& Follow-up)|Lost to Follow-up|0|||
147231100|NCT03633617|531019583|FG002|Part C (& Follow-up)|Lost to Follow-up|0|||
147231101|NCT03633617|531019584|FG003|Part C (& Follow-up)|Lost to Follow-up|0|||
147231102|NCT03633617|531019585|FG004|Part C (& Follow-up)|Lost to Follow-up|0|||
147231103|NCT03633617|531019586|FG005|Part C (& Follow-up)|Lost to Follow-up|3|||
147231104|NCT03633617|531019587|FG006|Part C (& Follow-up)|Lost to Follow-up|3|||
147231105|NCT03633617|531019588|FG007|Part C (& Follow-up)|Lost to Follow-up|1|||
147231106|NCT03633617|531019589|FG008|Part C (& Follow-up)|Lost to Follow-up|0|||
147231107|NCT03633617|531019590|FG009|Part C (& Follow-up)|Lost to Follow-up|7|||
147231108|NCT03633617|531019591|FG010|Part C (& Follow-up)|Lost to Follow-up|2|||
147231109|NCT03633617|531019581|FG000|Part C (& Follow-up)|Physician Decision|0|||
147231110|NCT03633617|531019582|FG001|Part C (& Follow-up)|Physician Decision|0|||
147231111|NCT03633617|531019583|FG002|Part C (& Follow-up)|Physician Decision|0|||
147231112|NCT03633617|531019584|FG003|Part C (& Follow-up)|Physician Decision|0|||
147231113|NCT03633617|531019585|FG004|Part C (& Follow-up)|Physician Decision|0|||
147231114|NCT03633617|531019586|FG005|Part C (& Follow-up)|Physician Decision|0|||
147231115|NCT03633617|531019587|FG006|Part C (& Follow-up)|Physician Decision|0|||
147231116|NCT03633617|531019588|FG007|Part C (& Follow-up)|Physician Decision|1|||
147231117|NCT03633617|531019589|FG008|Part C (& Follow-up)|Physician Decision|0|||
147231118|NCT03633617|531019590|FG009|Part C (& Follow-up)|Physician Decision|0|||
147231119|NCT03633617|531019591|FG010|Part C (& Follow-up)|Physician Decision|1|||
147231120|NCT03633617|531019581|FG000|Part C (& Follow-up)|COVID-19 related|0|||
147231121|NCT03633617|531019582|FG001|Part C (& Follow-up)|COVID-19 related|0|||
147231122|NCT03633617|531019583|FG002|Part C (& Follow-up)|COVID-19 related|0|||
147231123|NCT03633617|531019584|FG003|Part C (& Follow-up)|COVID-19 related|0|||
147231124|NCT03633617|531019585|FG004|Part C (& Follow-up)|COVID-19 related|0|||
147231125|NCT03633617|531019586|FG005|Part C (& Follow-up)|COVID-19 related|1|||
147231126|NCT03633617|531019587|FG006|Part C (& Follow-up)|COVID-19 related|0|||
147231127|NCT03633617|531019588|FG007|Part C (& Follow-up)|COVID-19 related|0|||
147231128|NCT03633617|531019589|FG008|Part C (& Follow-up)|COVID-19 related|0|||
147231129|NCT03633617|531019590|FG009|Part C (& Follow-up)|COVID-19 related|0|||
147231130|NCT03633617|531019591|FG010|Part C (& Follow-up)|COVID-19 related|0|||
147231131|NCT03633617|531019581|FG000|Part C (& Follow-up)|Protocol Violation|0|||
147231132|NCT03633617|531019582|FG001|Part C (& Follow-up)|Protocol Violation|0|||
147231133|NCT03633617|531019583|FG002|Part C (& Follow-up)|Protocol Violation|0|||
147231134|NCT03633617|531019584|FG003|Part C (& Follow-up)|Protocol Violation|0|||
147231135|NCT03633617|531019585|FG004|Part C (& Follow-up)|Protocol Violation|0|||
147231136|NCT03633617|531019586|FG005|Part C (& Follow-up)|Protocol Violation|0|||
147231137|NCT03633617|531019587|FG006|Part C (& Follow-up)|Protocol Violation|0|||
147231138|NCT03633617|531019588|FG007|Part C (& Follow-up)|Protocol Violation|0|||
147444518|NCT01940471|531792643|FG001|Period 1: Double-blind Phase|Pregnancy|2|||
147444519|NCT01940471|531792644|FG002|Period 1: Double-blind Phase|Pregnancy|0|||
147444520|NCT01940471|531792645|FG003|Period 1: Double-blind Phase|Pregnancy|0|||
147444521|NCT01940471|531792642|FG000|Period 1: Double-blind Phase|Non-Compliance with Study Drug|3|||
147444522|NCT01940471|531792643|FG001|Period 1: Double-blind Phase|Non-Compliance with Study Drug|2|||
147444523|NCT01940471|531792644|FG002|Period 1: Double-blind Phase|Non-Compliance with Study Drug|0|||
147444524|NCT01940471|531792645|FG003|Period 1: Double-blind Phase|Non-Compliance with Study Drug|0|||
147444525|NCT01940471|531792642|FG000|Period 1: Double-blind Phase|Adverse Event|2|||
147444526|NCT01940471|531792643|FG001|Period 1: Double-blind Phase|Adverse Event|2|||
147444527|NCT01940471|531792644|FG002|Period 1: Double-blind Phase|Adverse Event|0|||
147444528|NCT01940471|531792645|FG003|Period 1: Double-blind Phase|Adverse Event|0|||
147444529|NCT01940471|531792642|FG000|Period 1: Double-blind Phase|Death|2|||
147444530|NCT01940471|531792643|FG001|Period 1: Double-blind Phase|Death|1|||
147444531|NCT01940471|531792644|FG002|Period 1: Double-blind Phase|Death|0|||
147444532|NCT01940471|531792645|FG003|Period 1: Double-blind Phase|Death|0|||
147444533|NCT01940471|531792642|FG000|Period 1: Double-blind Phase|Lack of Efficacy|1|||
147444534|NCT01940471|531792643|FG001|Period 1: Double-blind Phase|Lack of Efficacy|1|||
147313151|NCT05376371|531312350|FG000|Overall Study|change in release date|10|||
147313152|NCT05407311|531312351|FG000|Overall Study|Withdrawal by Subject|5|||
147313153|NCT05407311|531312351|FG000|Overall Study|Protocol Violation|3|||
147313154|NCT05407311|531312351|FG000|Overall Study|Physician Decision|1|||
147313155|NCT05407311|531312351|FG000|Overall Study|Non-compliance|1|||
147313156|NCT03797326|531312356|FG000|Overall Study|Lost to Follow-up|1|||
147313157|NCT03797326|531312357|FG001|Overall Study|Lost to Follow-up|0|||
147313158|NCT03797326|531312358|FG002|Overall Study|Lost to Follow-up|0|||
147313159|NCT03797326|531312359|FG003|Overall Study|Lost to Follow-up|1|||
147313160|NCT03797326|531312360|FG004|Overall Study|Lost to Follow-up|0|||
147313161|NCT03797326|531312361|FG005|Overall Study|Lost to Follow-up|0|||
147313162|NCT03797326|531312362|FG006|Overall Study|Lost to Follow-up|0|||
147313163|NCT03797326|531312363|FG007|Overall Study|Lost to Follow-up|0|||
147313164|NCT03797326|531312356|FG000|Overall Study|Withdrawal by Subject|0|||
147313165|NCT03797326|531312357|FG001|Overall Study|Withdrawal by Subject|0|||
147313166|NCT03797326|531312358|FG002|Overall Study|Withdrawal by Subject|1|||
147313167|NCT03797326|531312359|FG003|Overall Study|Withdrawal by Subject|3|||
147313168|NCT03797326|531312360|FG004|Overall Study|Withdrawal by Subject|0|||
147313169|NCT03797326|531312361|FG005|Overall Study|Withdrawal by Subject|2|||
147313170|NCT03797326|531312362|FG006|Overall Study|Withdrawal by Subject|2|||
147313171|NCT03797326|531312363|FG007|Overall Study|Withdrawal by Subject|3|||
147313172|NCT03797326|531312356|FG000|Overall Study|Sponsor Decision|3|||
147313173|NCT03797326|531312357|FG001|Overall Study|Sponsor Decision|3|||
147313174|NCT03797326|531312358|FG002|Overall Study|Sponsor Decision|3|||
147313175|NCT03797326|531312359|FG003|Overall Study|Sponsor Decision|6|||
147313176|NCT03797326|531312360|FG004|Overall Study|Sponsor Decision|0|||
147313177|NCT03797326|531312361|FG005|Overall Study|Sponsor Decision|3|||
147313178|NCT03797326|531312362|FG006|Overall Study|Sponsor Decision|3|||
147313179|NCT03797326|531312363|FG007|Overall Study|Sponsor Decision|2|||
147313180|NCT03797326|531312356|FG000|Overall Study|Death|27|||
147313181|NCT03797326|531312357|FG001|Overall Study|Death|28|||
147313182|NCT03797326|531312358|FG002|Overall Study|Death|95|||
147313183|NCT03797326|531312359|FG003|Overall Study|Death|95|||
147313184|NCT03797326|531312360|FG004|Overall Study|Death|30|||
147313185|NCT03797326|531312361|FG005|Overall Study|Death|96|||
147313186|NCT03797326|531312362|FG006|Overall Study|Death|97|||
147313187|NCT03797326|531312363|FG007|Overall Study|Death|98|||
147313188|NCT03797326|531312356|FG000|Overall Study|Enrolled in error|0|||
147313189|NCT03797326|531312357|FG001|Overall Study|Enrolled in error|0|||
147313190|NCT03797326|531312358|FG002|Overall Study|Enrolled in error|3|||
147313191|NCT03797326|531312359|FG003|Overall Study|Enrolled in error|2|||
147313192|NCT03797326|531312360|FG004|Overall Study|Enrolled in error|2|||
147313193|NCT03797326|531312361|FG005|Overall Study|Enrolled in error|1|||
147313194|NCT03797326|531312362|FG006|Overall Study|Enrolled in error|1|||
147313195|NCT03797326|531312363|FG007|Overall Study|Enrolled in error|0|||
147313196|NCT04908449|531312364|FG000|Overall Study|Patient with major surgical bleeding unerlated to block|0|||
147313197|NCT04908449|531312365|FG001|Overall Study|Patient with major surgical bleeding unerlated to block|1|||
147313198|NCT04908449|531312364|FG000|Overall Study|Patient required postop RVAD, unrelated to block|0|||
147313199|NCT04908449|531312365|FG001|Overall Study|Patient required postop RVAD, unrelated to block|1|||
147313200|NCT00147225|531312366|FG000|Overall Study|Withdrawal by Subject|1|||
147313201|NCT00147225|531312367|FG001|Overall Study|Withdrawal by Subject|0|||
147119142|NCT00504556|530603294|FG004|Overall Study|Adverse Event|5|||
147119143|NCT00504556|530603290|FG000|Overall Study|Death|3|||
147313202|NCT00147225|531312368|FG002|Overall Study|Withdrawal by Subject|1|||
147313203|NCT00147225|531312369|FG003|Overall Study|Withdrawal by Subject|0|||
147313204|NCT00147225|531312370|FG004|Overall Study|Withdrawal by Subject|0|||
147313205|NCT00147225|531312371|FG005|Overall Study|Withdrawal by Subject|1|||
147313206|NCT00147225|531312366|FG000|Overall Study|Adverse Event|0|||
147119144|NCT00504556|530603291|FG001|Overall Study|Death|3|||
147567475|NCT02378935|532238308|FG003|Overall Study|Lack of Efficacy|6|||
147567476|NCT02378935|532238309|FG004|Overall Study|Lack of Efficacy|0|||
147567477|NCT02378935|532238310|FG005|Overall Study|Lack of Efficacy|0|||
147567478|NCT02378935|532238311|FG006|Overall Study|Lack of Efficacy|0|||
147567479|NCT02378935|532238305|FG000|Overall Study|Death|0|||
147567480|NCT02378935|532238306|FG001|Overall Study|Death|0|||
147567481|NCT02378935|532238307|FG002|Overall Study|Death|1|||
147567482|NCT02378935|532238308|FG003|Overall Study|Death|0|||
147567483|NCT02378935|532238309|FG004|Overall Study|Death|0|||
147567484|NCT02378935|532238310|FG005|Overall Study|Death|0|||
147567485|NCT02378935|532238311|FG006|Overall Study|Death|0|||
147567486|NCT00272779|532238312|FG000|Baseline Through Week 48|Adverse event before Week 48|10|||
147567487|NCT00272779|532238313|FG001|Baseline Through Week 48|Adverse event before Week 48|14|||
147567488|NCT00272779|532238312|FG000|Baseline Through Week 48|Death before Week 48|4|||
147567489|NCT00272779|532238313|FG001|Baseline Through Week 48|Death before Week 48|4|||
147567490|NCT00272779|532238312|FG000|Baseline Through Week 48|Lack of efficacy before Week 48|5|||
147567491|NCT00272779|532238313|FG001|Baseline Through Week 48|Lack of efficacy before Week 48|8|||
147567492|NCT00272779|532238312|FG000|Baseline Through Week 48|Lost to follow-up before Week 48|6|||
147567493|NCT00272779|532238313|FG001|Baseline Through Week 48|Lost to follow-up before Week 48|6|||
147567494|NCT00272779|532238312|FG000|Baseline Through Week 48|Viral load rebound before Week 48|1|||
147567495|NCT00272779|532238313|FG001|Baseline Through Week 48|Viral load rebound before Week 48|0|||
147567496|NCT00272779|532238312|FG000|Baseline Through Week 48|Poor/non compliance before Week 48|6|||
147567497|NCT00272779|532238313|FG001|Baseline Through Week 48|Poor/non compliance before Week 48|9|||
147567498|NCT00272779|532238312|FG000|Baseline Through Week 48|Pregnancy before Week 48|2|||
147567499|NCT00272779|532238313|FG001|Baseline Through Week 48|Pregnancy before Week 48|2|||
147567500|NCT00272779|532238312|FG000|Baseline Through Week 48|No longer meets criteria before Week 48|1|||
147567501|NCT00272779|532238313|FG001|Baseline Through Week 48|No longer meets criteria before Week 48|0|||
147567502|NCT00272779|532238312|FG000|Baseline Through Week 48|Withdrew consent before Week 48|4|||
147567503|NCT00272779|532238313|FG001|Baseline Through Week 48|Withdrew consent before Week 48|13|||
147567504|NCT00272779|532238312|FG000|Baseline Through Week 48|Participant's decision before wk 48|0|||
147567505|NCT00272779|532238313|FG001|Baseline Through Week 48|Participant's decision before wk 48|1|||
147567506|NCT00272779|532238312|FG000|Baseline Through Week 48|Chose different site before wk 48|0|||
147567507|NCT00272779|532238313|FG001|Baseline Through Week 48|Chose different site before wk 48|1|||
147119145|NCT00504556|530603292|FG002|Overall Study|Death|1|||
147567508|NCT00272779|532238312|FG000|Baseline Through Week 48|Adverse event on/after Week 48|1|||
147567509|NCT00272779|532238313|FG001|Baseline Through Week 48|Adverse event on/after Week 48|1|||
147567510|NCT00272779|532238312|FG000|Baseline Through Week 48|Death on/after Week 48|1|||
147567511|NCT00272779|532238313|FG001|Baseline Through Week 48|Death on/after Week 48|1|||
147567512|NCT00272779|532238312|FG000|Baseline Through Week 48|Lack of efficacy on/after Week 48|7|||
147567513|NCT00272779|532238313|FG001|Baseline Through Week 48|Lack of efficacy on/after Week 48|1|||
147119146|NCT00504556|530603293|FG003|Overall Study|Death|0|||
147119147|NCT00504556|530603294|FG004|Overall Study|Death|2|||
147119148|NCT00504556|530603290|FG000|Overall Study|Protocol Violation|1|||
147567514|NCT00272779|532238312|FG000|Baseline Through Week 48|Poor/non compliance on/after Week|2|||
147567515|NCT00272779|532238313|FG001|Baseline Through Week 48|Poor/non compliance on/after Week|2|||
147567516|NCT00272779|532238312|FG000|Baseline Through Week 48|No longer meets criteria on/after Wk 48|2|||
147567517|NCT00272779|532238313|FG001|Baseline Through Week 48|No longer meets criteria on/after Wk 48|2|||
147567518|NCT00272779|532238312|FG000|Baseline Through Week 48|Pregnancy on/after Week 48|1|||
147119149|NCT00504556|530603291|FG001|Overall Study|Protocol Violation|3|||
147119150|NCT00504556|530603292|FG002|Overall Study|Protocol Violation|2|||
147119151|NCT00504556|530603293|FG003|Overall Study|Protocol Violation|1|||
147119152|NCT00504556|530603294|FG004|Overall Study|Protocol Violation|2|||
147119153|NCT00504556|530603290|FG000|Overall Study|Lost to Follow-up|0|||
147119154|NCT00504556|530603291|FG001|Overall Study|Lost to Follow-up|0|||
147119155|NCT00504556|530603292|FG002|Overall Study|Lost to Follow-up|1|||
147119156|NCT00504556|530603293|FG003|Overall Study|Lost to Follow-up|1|||
147119157|NCT00504556|530603294|FG004|Overall Study|Lost to Follow-up|1|||
147119158|NCT00504556|530603290|FG000|Overall Study|Withdrawal by Subject|16|||
147119159|NCT00504556|530603291|FG001|Overall Study|Withdrawal by Subject|16|||
147119160|NCT00504556|530603292|FG002|Overall Study|Withdrawal by Subject|7|||
147119161|NCT00504556|530603293|FG003|Overall Study|Withdrawal by Subject|8|||
147119162|NCT00504556|530603294|FG004|Overall Study|Withdrawal by Subject|12|||
147119163|NCT00504556|530603290|FG000|Overall Study|administrative reasons|0|||
147119164|NCT00504556|530603291|FG001|Overall Study|administrative reasons|2|||
147119165|NCT00504556|530603292|FG002|Overall Study|administrative reasons|2|||
147119166|NCT00504556|530603293|FG003|Overall Study|administrative reasons|1|||
147119167|NCT00504556|530603294|FG004|Overall Study|administrative reasons|2|||
147119168|NCT00504556|530603290|FG000|Overall Study|did not meet entry criteria|2|||
147119169|NCT00504556|530603291|FG001|Overall Study|did not meet entry criteria|0|||
147119170|NCT00504556|530603292|FG002|Overall Study|did not meet entry criteria|1|||
147119171|NCT00504556|530603293|FG003|Overall Study|did not meet entry criteria|1|||
147567519|NCT00272779|532238313|FG001|Baseline Through Week 48|Pregnancy on/after Week 48|2|||
147567520|NCT00272779|532238312|FG000|Baseline Through Week 48|Withdrew consent on/after Week 48|0|||
147567521|NCT00272779|532238313|FG001|Baseline Through Week 48|Withdrew consent on/after Week 48|2|||
147567522|NCT00272779|532238312|FG000|Baseline Through Week 48|Continuing treatment|385|||
147567523|NCT00272779|532238313|FG001|Baseline Through Week 48|Continuing treatment|368|||
147567524|NCT00272779|532238312|FG000|Baseline Through Week 48|Lost to follow-up on/after Week 48|0|||
147567525|NCT00272779|532238313|FG001|Baseline Through Week 48|Lost to follow-up on/after Week 48|3|||
147567526|NCT00272779|532238312|FG000|Baseline Through Week 48|Never treated|2|||
147567527|NCT00272779|532238313|FG001|Baseline Through Week 48|Never treated|3|||
147567528|NCT00272779|532238312|FG000|Baseline Through Week 96|Adverse event before Week 96|13|||
147567529|NCT00272779|532238313|FG001|Baseline Through Week 96|Adverse event before Week 96|22|||
147567530|NCT00272779|532238312|FG000|Baseline Through Week 96|Death before Week 96|6|||
147567531|NCT00272779|532238313|FG001|Baseline Through Week 96|Death before Week 96|5|||
147567532|NCT00272779|532238312|FG000|Baseline Through Week 96|Lack of efficacy before Week 96|16|||
147567533|NCT00272779|532238313|FG001|Baseline Through Week 96|Lack of efficacy before Week 96|10|||
147567534|NCT00272779|532238312|FG000|Baseline Through Week 96|Lost to follow up before Week 96|10|||
147567535|NCT00272779|532238313|FG001|Baseline Through Week 96|Lost to follow up before Week 96|13|||
147567536|NCT00272779|532238312|FG000|Baseline Through Week 96|Participant Imprisoned before Week 96|1|||
147567537|NCT00272779|532238313|FG001|Baseline Through Week 96|Participant Imprisoned before Week 96|0|||
147567538|NCT00272779|532238312|FG000|Baseline Through Week 96|Poor/non compliance before Week 96|12|||
147567539|NCT00272779|532238313|FG001|Baseline Through Week 96|Poor/non compliance before Week 96|16|||
147567540|NCT00272779|532238312|FG000|Baseline Through Week 96|Pregnancy before Week 96|5|||
147567541|NCT00272779|532238313|FG001|Baseline Through Week 96|Pregnancy before Week 96|7|||
147567542|NCT00272779|532238312|FG000|Baseline Through Week 96|No longer meets criteria before Week 96|4|||
147567543|NCT00272779|532238313|FG001|Baseline Through Week 96|No longer meets criteria before Week 96|3|||
147567544|NCT00272779|532238312|FG000|Baseline Through Week 96|Withdrew consent before Week 96|5|||
147567545|NCT00272779|532238313|FG001|Baseline Through Week 96|Withdrew consent before Week 96|18|||
147567546|NCT00272779|532238312|FG000|Baseline Through Week 96|Changed address before Week 96|0|||
147567547|NCT00272779|532238313|FG001|Baseline Through Week 96|Changed address before Week 96|1|||
147567548|NCT00272779|532238312|FG000|Baseline Through Week 96|Lost to follow-up at Week 96|1|||
147567549|NCT00272779|532238313|FG001|Baseline Through Week 96|Lost to follow-up at Week 96|0|||
147567550|NCT00272779|532238312|FG000|Baseline Through Week 96|Poor/non compliance at Week 96]|2|||
147567551|NCT00272779|532238313|FG001|Baseline Through Week 96|Poor/non compliance at Week 96]|0|||
147567552|NCT00272779|532238312|FG000|Baseline Through Week 96|Pregnancy at Week 96|1|||
147567553|NCT00272779|532238313|FG001|Baseline Through Week 96|Pregnancy at Week 96|0|||
147567554|NCT00272779|532238312|FG000|Baseline Through Week 96|Never treated|2|||
147567555|NCT00272779|532238313|FG001|Baseline Through Week 96|Never treated|3|||
147567556|NCT00272779|532238312|FG000|Baseline Through Week 96|Continuing on treatment|61|||
147567557|NCT00272779|532238313|FG001|Baseline Through Week 96|Continuing on treatment|38|||
147567558|NCT02146105|532238316|FG000|Overall Study|Adverse Event|1|||
147313207|NCT00147225|531312367|FG001|Overall Study|Adverse Event|0|||
147313208|NCT00147225|531312368|FG002|Overall Study|Adverse Event|1|||
147313209|NCT00147225|531312369|FG003|Overall Study|Adverse Event|1|||
147313210|NCT00147225|531312370|FG004|Overall Study|Adverse Event|0|||
147313211|NCT00147225|531312371|FG005|Overall Study|Adverse Event|0|||
147313212|NCT00147225|531312366|FG000|Overall Study|Screen Failure|0|||
147313213|NCT00147225|531312367|FG001|Overall Study|Screen Failure|0|||
147313214|NCT00147225|531312368|FG002|Overall Study|Screen Failure|0|||
147313215|NCT00147225|531312369|FG003|Overall Study|Screen Failure|0|||
147313216|NCT00147225|531312370|FG004|Overall Study|Screen Failure|1|||
147313217|NCT00147225|531312371|FG005|Overall Study|Screen Failure|0|||
147567559|NCT02146105|532238316|FG000|Overall Study|Withdrawal by Subject|5|||
147567560|NCT03935880|532238320|FG000|Overall Study|Lost to Follow-up|0|||
147567561|NCT03935880|532238321|FG001|Overall Study|Lost to Follow-up|1|||
147567562|NCT02476994|532238322|FG000|Overall Study|Based on feedback from FDA|1|||
147567563|NCT02476994|532238323|FG001|Overall Study|Based on feedback from FDA|0|||
147567564|NCT02563561|532238324|FG000|Overall Study|Histology Other than Ta, G1-G2|3|||
147567565|NCT02563561|532238325|FG001|Overall Study|Histology Other than Ta, G1-G2|6|||
147567566|NCT02563561|532238326|FG002|Overall Study|Histology Other than Ta, G1-G2|6|||
147567567|NCT02563561|532238324|FG000|Overall Study|Withdrew of Consent|1|||
147567568|NCT02563561|532238325|FG001|Overall Study|Withdrew of Consent|1|||
147567569|NCT02563561|532238326|FG002|Overall Study|Withdrew of Consent|2|||
147313218|NCT00147225|531312366|FG000|Overall Study|Chemotherapy Changed|0|||
147313219|NCT00147225|531312367|FG001|Overall Study|Chemotherapy Changed|0|||
147313220|NCT00147225|531312368|FG002|Overall Study|Chemotherapy Changed|0|||
147313221|NCT00147225|531312369|FG003|Overall Study|Chemotherapy Changed|0|||
147444535|NCT01940471|531792644|FG002|Period 1: Double-blind Phase|Lack of Efficacy|0|||
147444536|NCT01940471|531792645|FG003|Period 1: Double-blind Phase|Lack of Efficacy|0|||
147567570|NCT02563561|532238324|FG000|Overall Study|Lost to Follow-up|1|||
147567571|NCT02563561|532238325|FG001|Overall Study|Lost to Follow-up|1|||
147313222|NCT00147225|531312370|FG004|Overall Study|Chemotherapy Changed|0|||
147444537|NCT01940471|531792642|FG000|Period 1: Double-blind Phase|Protocol-Specified Criteria for Withdrawal|1|||
147444538|NCT01940471|531792643|FG001|Period 1: Double-blind Phase|Protocol-Specified Criteria for Withdrawal|1|||
147444539|NCT01940471|531792644|FG002|Period 1: Double-blind Phase|Protocol-Specified Criteria for Withdrawal|0|||
147444540|NCT01940471|531792645|FG003|Period 1: Double-blind Phase|Protocol-Specified Criteria for Withdrawal|0|||
147444541|NCT01940471|531792642|FG000|Period 1: Double-blind Phase|Randomized but Never Treated|1|||
147444542|NCT01940471|531792643|FG001|Period 1: Double-blind Phase|Randomized but Never Treated|1|||
147444543|NCT01940471|531792644|FG002|Period 1: Double-blind Phase|Randomized but Never Treated|0|||
147444544|NCT01940471|531792645|FG003|Period 1: Double-blind Phase|Randomized but Never Treated|0|||
147444545|NCT01940471|531792642|FG000|Period 1: Double-blind Phase|HbsAg Seroconversion|1|||
147444546|NCT01940471|531792643|FG001|Period 1: Double-blind Phase|HbsAg Seroconversion|0|||
147444547|NCT01940471|531792644|FG002|Period 1: Double-blind Phase|HbsAg Seroconversion|0|||
147444548|NCT01940471|531792645|FG003|Period 1: Double-blind Phase|HbsAg Seroconversion|0|||
147444549|NCT01940471|531792642|FG000|Period 1: Double-blind Phase|Protocol Violation|0|||
147444550|NCT01940471|531792643|FG001|Period 1: Double-blind Phase|Protocol Violation|1|||
147444551|NCT01940471|531792644|FG002|Period 1: Double-blind Phase|Protocol Violation|0|||
147444552|NCT01940471|531792645|FG003|Period 1: Double-blind Phase|Protocol Violation|0|||
147444553|NCT01940471|531792642|FG000|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|0|||
147444554|NCT01940471|531792643|FG001|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|0|||
147444555|NCT01940471|531792644|FG002|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|48|||
147444556|NCT01940471|531792645|FG003|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|22|||
147444557|NCT01940471|531792642|FG000|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|0|||
147444558|NCT01940471|531792643|FG001|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|0|||
147444559|NCT01940471|531792644|FG002|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|13|||
147444560|NCT01940471|531792645|FG003|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|8|||
147444561|NCT01940471|531792642|FG000|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|0|||
147444562|NCT01940471|531792643|FG001|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|0|||
147444563|NCT01940471|531792644|FG002|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|9|||
147444564|NCT01940471|531792645|FG003|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|4|||
147444565|NCT01940471|531792642|FG000|Period 2: Open-Label TAF Extension Phase|Protocol-specified Criteria for Withdrawal|0|||
147231139|NCT03633617|531019589|FG008|Part C (& Follow-up)|Protocol Violation|0|||
147231140|NCT03633617|531019590|FG009|Part C (& Follow-up)|Protocol Violation|3|||
147231141|NCT03633617|531019591|FG010|Part C (& Follow-up)|Protocol Violation|1|||
147231142|NCT03633617|531019581|FG000|Part C (& Follow-up)|Lack of Efficacy|0|||
147231143|NCT03633617|531019582|FG001|Part C (& Follow-up)|Lack of Efficacy|0|||
147231144|NCT03633617|531019583|FG002|Part C (& Follow-up)|Lack of Efficacy|0|||
147231145|NCT03633617|531019584|FG003|Part C (& Follow-up)|Lack of Efficacy|0|||
147231146|NCT03633617|531019585|FG004|Part C (& Follow-up)|Lack of Efficacy|0|||
147231147|NCT03633617|531019586|FG005|Part C (& Follow-up)|Lack of Efficacy|0|||
147231148|NCT03633617|531019587|FG006|Part C (& Follow-up)|Lack of Efficacy|0|||
147231149|NCT03633617|531019588|FG007|Part C (& Follow-up)|Lack of Efficacy|1|||
147231150|NCT03633617|531019589|FG008|Part C (& Follow-up)|Lack of Efficacy|0|||
147231151|NCT03633617|531019590|FG009|Part C (& Follow-up)|Lack of Efficacy|0|||
147231152|NCT03633617|531019591|FG010|Part C (& Follow-up)|Lack of Efficacy|0|||
147231153|NCT01890746|531019592|FG000|Overall Study|Death|39|||
147231154|NCT01890746|531019593|FG001|Overall Study|Death|30|||
147313223|NCT00147225|531312371|FG005|Overall Study|Chemotherapy Changed|1|||
147313224|NCT06385483|531312372|FG000|Overall Study|Withdrawal by Subject|2|||
147313225|NCT06385483|531312372|FG000|Overall Study|Never start protocol therapy|2|||
147313226|NCT06385483|531312372|FG000|Overall Study|Disease progression|15|||
147313227|NCT05569954|531312373|FG000|Overall Study|Lost to Follow-up|3|||
147313228|NCT05569954|531312374|FG001|Overall Study|Lost to Follow-up|4|||
147313229|NCT05569954|531312373|FG000|Overall Study|Protocol Violation|1|||
147313230|NCT05569954|531312374|FG001|Overall Study|Protocol Violation|2|||
147313231|NCT05569954|531312373|FG000|Overall Study|Withdrawal by Subject|4|||
147313232|NCT05569954|531312374|FG001|Overall Study|Withdrawal by Subject|2|||
147313233|NCT00802737|531313836|FG000|Overall Study|Withdrawn due to Disease Progression|9|||
147313234|NCT00802737|531313837|FG001|Overall Study|Withdrawn due to Disease Progression|3|||
147313235|NCT00802737|531313838|FG002|Overall Study|Withdrawn due to Disease Progression|0|||
147313236|NCT00802737|531313836|FG000|Overall Study|Death|6|||
147313237|NCT00802737|531313837|FG001|Overall Study|Death|5|||
147313238|NCT00802737|531313838|FG002|Overall Study|Death|1|||
147313239|NCT00802737|531313836|FG000|Overall Study|Adverse Event|1|||
147313240|NCT00802737|531313837|FG001|Overall Study|Adverse Event|0|||
147444566|NCT01940471|531792643|FG001|Period 2: Open-Label TAF Extension Phase|Protocol-specified Criteria for Withdrawal|0|||
147444567|NCT01940471|531792644|FG002|Period 2: Open-Label TAF Extension Phase|Protocol-specified Criteria for Withdrawal|5|||
147313241|NCT00802737|531313838|FG002|Overall Study|Adverse Event|0|||
147313242|NCT00802737|531313836|FG000|Overall Study|Received Prohibited Therapy|1|||
147313243|NCT00802737|531313837|FG001|Overall Study|Received Prohibited Therapy|0|||
147313244|NCT00802737|531313838|FG002|Overall Study|Received Prohibited Therapy|0|||
147650908|NCT02757352|532544537|FG000|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
147119172|NCT00504556|530603294|FG004|Overall Study|did not meet entry criteria|0|||
147119173|NCT00504556|530603290|FG000|Overall Study|data monitor committee decision|0|||
147119174|NCT00504556|530603291|FG001|Overall Study|data monitor committee decision|0|||
147119175|NCT00504556|530603292|FG002|Overall Study|data monitor committee decision|0|||
147119176|NCT00504556|530603293|FG003|Overall Study|data monitor committee decision|100|||
147119177|NCT00504556|530603294|FG004|Overall Study|data monitor committee decision|0|||
147119178|NCT00504556|530603290|FG000|Overall Study|Other|2|||
147119179|NCT00504556|530603291|FG001|Overall Study|Other|2|||
147119180|NCT00504556|530603292|FG002|Overall Study|Other|2|||
147119181|NCT00504556|530603293|FG003|Overall Study|Other|3|||
147119182|NCT00504556|530603294|FG004|Overall Study|Other|0|||
147119183|NCT00504556|530603290|FG000|Overall Study|not in safety analysis set|0|||
147119184|NCT00504556|530603291|FG001|Overall Study|not in safety analysis set|1|||
147119185|NCT00504556|530603292|FG002|Overall Study|not in safety analysis set|1|||
147119186|NCT00504556|530603293|FG003|Overall Study|not in safety analysis set|0|||
147119187|NCT00504556|530603294|FG004|Overall Study|not in safety analysis set|1|||
147119188|NCT03607695|530603297|FG000|10 Week|Local and institutional restrictions on research enacted due to COVID-19 pandemic|1|||
147119189|NCT03607695|530603297|FG000|16 Week|Local and institutional restrictions on research enacted due to COVID-19 pandemic|2|||
147119190|NCT02741193|530603298|FG000|Overall Study|Participant deemed not to be a surgical resection candidate|1|||
147119191|NCT02741193|530603298|FG000|Overall Study|Participant found to be seizure-free due to new epilepsy medication, did not participate|1|||
147119192|NCT02502383|530603299|FG000|Overall Study|Lost to Follow-up|130|||
147119193|NCT02502383|530603300|FG001|Overall Study|Lost to Follow-up|131|||
147119194|NCT02502383|530603299|FG000|Overall Study|Withdrawal by Subject|31|||
147119195|NCT02502383|530603300|FG001|Overall Study|Withdrawal by Subject|24|||
147119196|NCT00676052|530603301|FG000|Overall Study|Adverse Event|0|||
147119197|NCT00676052|530603302|FG001|Overall Study|Adverse Event|1|||
147231155|NCT01890746|531019592|FG000|Overall Study|Adverse Event|1|||
147231156|NCT01890746|531019593|FG001|Overall Study|Adverse Event|0|||
147231157|NCT01890746|531019592|FG000|Overall Study|Lost to Follow-up|4|||
147231158|NCT01890746|531019593|FG001|Overall Study|Lost to Follow-up|1|||
147231159|NCT01890746|531019592|FG000|Overall Study|Physician Decision|3|||
147231160|NCT01890746|531019593|FG001|Overall Study|Physician Decision|2|||
147231161|NCT01890746|531019592|FG000|Overall Study|Withdrawal by Subject|5|||
147231162|NCT01890746|531019593|FG001|Overall Study|Withdrawal by Subject|8|||
147231163|NCT00777205|531019596|FG000|Overall Study|Lost to Follow-up|25|||
147231164|NCT00777205|531019597|FG001|Overall Study|Lost to Follow-up|9|||
147231165|NCT00777205|531019596|FG000|Overall Study|Withdrawal by Subject|6|||
147231166|NCT00777205|531019597|FG001|Overall Study|Withdrawal by Subject|4|||
147231167|NCT00777205|531019596|FG000|Overall Study|Death|0|||
147231168|NCT00777205|531019597|FG001|Overall Study|Death|2|||
147231169|NCT00777205|531019596|FG000|Overall Study|Protocol Violation|0|||
147231170|NCT00777205|531019597|FG001|Overall Study|Protocol Violation|56|||
147231171|NCT03257371|531019598|FG000|Overall Study|Lost to Follow-up|1|||
147231172|NCT03198078|531019602|FG000|Overall Study|Adverse Event|0|||
147231173|NCT03198078|531019603|FG001|Overall Study|Adverse Event|1|||
147231174|NCT03198078|531019604|FG002|Overall Study|Adverse Event|2|||
147231175|NCT03198078|531019602|FG000|Overall Study|Lack of Efficacy|0|||
147231176|NCT03198078|531019603|FG001|Overall Study|Lack of Efficacy|0|||
147231177|NCT03198078|531019604|FG002|Overall Study|Lack of Efficacy|3|||
147231178|NCT03198078|531019602|FG000|Overall Study|Lost to Follow-up|1|||
147231179|NCT03198078|531019603|FG001|Overall Study|Lost to Follow-up|0|||
147231180|NCT03198078|531019604|FG002|Overall Study|Lost to Follow-up|0|||
147231181|NCT03198078|531019602|FG000|Overall Study|Pregnancy|0|||
147231182|NCT03198078|531019603|FG001|Overall Study|Pregnancy|1|||
147231183|NCT03198078|531019604|FG002|Overall Study|Pregnancy|0|||
147231184|NCT03198078|531019602|FG000|Overall Study|Withdrawal by Subject|1|||
147231185|NCT03198078|531019603|FG001|Overall Study|Withdrawal by Subject|0|||
147650909|NCT02757352|532544538|FG001|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
147119198|NCT00676052|530603303|FG002|Overall Study|Adverse Event|1|||
147119199|NCT00676052|530603304|FG003|Overall Study|Adverse Event|2|||
147119200|NCT00676052|530603305|FG004|Overall Study|Adverse Event|2|||
147119201|NCT00676052|530603306|FG005|Overall Study|Adverse Event|2|||
147119202|NCT00676052|530603301|FG000|Overall Study|Lack of Efficacy|2|||
147231186|NCT03198078|531019604|FG002|Overall Study|Withdrawal by Subject|2|||
147231187|NCT03198078|531019602|FG000|Overall Study|Withdrawal by Caregiver|1|||
147231188|NCT03198078|531019603|FG001|Overall Study|Withdrawal by Caregiver|3|||
147119203|NCT00676052|530603302|FG001|Overall Study|Lack of Efficacy|2|||
147119204|NCT00676052|530603303|FG002|Overall Study|Lack of Efficacy|1|||
147119205|NCT00676052|530603304|FG003|Overall Study|Lack of Efficacy|1|||
147119206|NCT00676052|530603305|FG004|Overall Study|Lack of Efficacy|2|||
147119207|NCT00676052|530603306|FG005|Overall Study|Lack of Efficacy|1|||
147231189|NCT03198078|531019604|FG002|Overall Study|Withdrawal by Caregiver|5|||
147231190|NCT01676727|531019605|FG000|Overall Study|Death|18|||
147231191|NCT01676727|531019605|FG000|Overall Study|Withdrawal by Subject|6|||
147231192|NCT01676727|531019605|FG000|Overall Study|Screening failure|5|||
147650910|NCT02757352|532544539|FG002|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
147119208|NCT00676052|530603301|FG000|Overall Study|Protocol Violation|5|||
147119209|NCT00676052|530603302|FG001|Overall Study|Protocol Violation|3|||
147119210|NCT00676052|530603303|FG002|Overall Study|Protocol Violation|2|||
147119211|NCT00676052|530603304|FG003|Overall Study|Protocol Violation|2|||
147119212|NCT00676052|530603305|FG004|Overall Study|Protocol Violation|1|||
147119213|NCT00676052|530603306|FG005|Overall Study|Protocol Violation|2|||
147119214|NCT00676052|530603301|FG000|Overall Study|Lost to Follow-up|0|||
147119215|NCT00676052|530603302|FG001|Overall Study|Lost to Follow-up|0|||
147119216|NCT00676052|530603303|FG002|Overall Study|Lost to Follow-up|0|||
147119217|NCT00676052|530603304|FG003|Overall Study|Lost to Follow-up|0|||
147119218|NCT00676052|530603305|FG004|Overall Study|Lost to Follow-up|1|||
147119219|NCT00676052|530603306|FG005|Overall Study|Lost to Follow-up|0|||
147119220|NCT00676052|530603301|FG000|Overall Study|Physician Decision|1|||
147119221|NCT00676052|530603302|FG001|Overall Study|Physician Decision|1|||
147119222|NCT00676052|530603303|FG002|Overall Study|Physician Decision|1|||
147119223|NCT00676052|530603304|FG003|Overall Study|Physician Decision|0|||
147119224|NCT00676052|530603305|FG004|Overall Study|Physician Decision|0|||
147119225|NCT00676052|530603306|FG005|Overall Study|Physician Decision|1|||
147119226|NCT00676052|530603301|FG000|Overall Study|Withdrawal by Subject|1|||
147119227|NCT00676052|530603302|FG001|Overall Study|Withdrawal by Subject|0|||
147119228|NCT00676052|530603303|FG002|Overall Study|Withdrawal by Subject|1|||
147119229|NCT00676052|530603304|FG003|Overall Study|Withdrawal by Subject|0|||
147231193|NCT01676727|531019605|FG000|Overall Study|Not willing to attend 1-year visit|2|||
147231194|NCT01676727|531019605|FG000|Overall Study|Valve explanted|1|||
147231195|NCT00580970|531019606|FG000|Pre-treatment|Non-compliance|1|||
147231196|NCT00580970|531019606|FG000|Treatment (Lovastatin)|Non-compliance|6|||
147231197|NCT00580970|531019606|FG000|Treatment (Lovastatin)|Intolerance of Lovastatin|7|||
147231198|NCT00580970|531019606|FG000|Treatment (Lovastatin)|Physician Decision|4|||
147231199|NCT00580970|531019606|FG000|Treatment (Lovastatin)|Development of metastatic second primary|1|||
147231200|NCT00580970|531019606|FG000|Treatment (Lovastatin)|Death|1|||
147231201|NCT03161093|531019609|FG000|Overall Study|Protocol Violation|11|||
147231202|NCT03161093|531019610|FG001|Overall Study|Protocol Violation|14|||
147231203|NCT03161093|531019611|FG002|Overall Study|Protocol Violation|6|||
147231204|NCT03161093|531019612|FG003|Overall Study|Protocol Violation|13|||
147231205|NCT03161093|531019613|FG004|Overall Study|Protocol Violation|1|||
147231206|NCT03161093|531019614|FG005|Overall Study|Protocol Violation|0|||
147231207|NCT03161093|531019609|FG000|Overall Study|Adverse Event|5|||
147231208|NCT03161093|531019610|FG001|Overall Study|Adverse Event|21|||
147231209|NCT03161093|531019611|FG002|Overall Study|Adverse Event|16|||
147231210|NCT03161093|531019612|FG003|Overall Study|Adverse Event|35|||
147231211|NCT03161093|531019613|FG004|Overall Study|Adverse Event|2|||
147231212|NCT03161093|531019614|FG005|Overall Study|Adverse Event|1|||
147231213|NCT03161093|531019609|FG000|Overall Study|Lack of Efficacy|9|||
147231214|NCT03161093|531019610|FG001|Overall Study|Lack of Efficacy|13|||
147231215|NCT03161093|531019611|FG002|Overall Study|Lack of Efficacy|9|||
147231216|NCT03161093|531019612|FG003|Overall Study|Lack of Efficacy|24|||
147231217|NCT03161093|531019613|FG004|Overall Study|Lack of Efficacy|4|||
147231218|NCT03161093|531019614|FG005|Overall Study|Lack of Efficacy|1|||
147231219|NCT03161093|531019609|FG000|Overall Study|Physician Decision|0|||
147231220|NCT03161093|531019610|FG001|Overall Study|Physician Decision|1|||
147231221|NCT03161093|531019611|FG002|Overall Study|Physician Decision|0|||
147313245|NCT00802737|531313836|FG000|Overall Study|Ongoing CLL-Treatment|0|||
147231222|NCT03161093|531019612|FG003|Overall Study|Physician Decision|2|||
147231223|NCT03161093|531019613|FG004|Overall Study|Physician Decision|17|||
147231224|NCT03161093|531019614|FG005|Overall Study|Physician Decision|15|||
147231225|NCT03161093|531019609|FG000|Overall Study|Withdrawal by Subject|24|||
147231226|NCT03161093|531019610|FG001|Overall Study|Withdrawal by Subject|73|||
147231227|NCT03161093|531019611|FG002|Overall Study|Withdrawal by Subject|44|||
147231228|NCT03161093|531019612|FG003|Overall Study|Withdrawal by Subject|97|||
147231229|NCT03161093|531019613|FG004|Overall Study|Withdrawal by Subject|11|||
147231230|NCT03161093|531019614|FG005|Overall Study|Withdrawal by Subject|10|||
147567572|NCT02563561|532238326|FG002|Overall Study|Lost to Follow-up|0|||
147567573|NCT02563561|532238324|FG000|Overall Study|Participant Had Recurrence and Received Therapy|4|||
147567574|NCT02563561|532238325|FG001|Overall Study|Participant Had Recurrence and Received Therapy|2|||
147567575|NCT02563561|532238326|FG002|Overall Study|Participant Had Recurrence and Received Therapy|1|||
147567576|NCT02563561|532238324|FG000|Overall Study|Investigator Decision|3|||
147119230|NCT00676052|530603305|FG004|Overall Study|Withdrawal by Subject|0|||
147231231|NCT03161093|531019609|FG000|Overall Study|Lost to Follow-up|3|||
147231232|NCT03161093|531019610|FG001|Overall Study|Lost to Follow-up|12|||
147231233|NCT03161093|531019611|FG002|Overall Study|Lost to Follow-up|4|||
147231234|NCT03161093|531019612|FG003|Overall Study|Lost to Follow-up|7|||
147231235|NCT03161093|531019613|FG004|Overall Study|Lost to Follow-up|8|||
147119231|NCT00676052|530603306|FG005|Overall Study|Withdrawal by Subject|0|||
147119232|NCT01428713|530603307|FG000|Overall Study|Non-compliance|2|||
147231236|NCT03161093|531019614|FG005|Overall Study|Lost to Follow-up|13|||
147231237|NCT03161093|531019609|FG000|Overall Study|Death|3|||
147231238|NCT03161093|531019610|FG001|Overall Study|Death|9|||
147231239|NCT03161093|531019611|FG002|Overall Study|Death|7|||
147119233|NCT01428713|530603308|FG001|Overall Study|Non-compliance|2|||
147119234|NCT01428713|530603307|FG000|Overall Study|Withdrawal by Subject|1|||
147119235|NCT01428713|530603308|FG001|Overall Study|Withdrawal by Subject|1|||
147119236|NCT01428713|530603307|FG000|Overall Study|Adverse Event|0|||
147119237|NCT01428713|530603308|FG001|Overall Study|Adverse Event|2|||
147119238|NCT02930941|530603309|FG000|Overall Study|Lost to Follow-up|1|||
147119239|NCT02930941|530603310|FG001|Overall Study|Lost to Follow-up|2|||
147119240|NCT00903344|530603313|FG000|Overall Study|Pregnancy|2|||
147119241|NCT00903344|530603314|FG001|Overall Study|Pregnancy|3|||
147119242|NCT00903344|530603313|FG000|Overall Study|Lost to Follow-up|3|||
147119243|NCT00903344|530603314|FG001|Overall Study|Lost to Follow-up|0|||
147119244|NCT00585169|530603317|FG000|Overall Study|Withdrawal by Subject|1|||
147119245|NCT00710554|530603329|FG000|Overall Study|Adverse Event|24|||
147119246|NCT00710554|530603330|FG001|Overall Study|Adverse Event|7|||
147119247|NCT00710554|530603329|FG000|Overall Study|Withdrawal by Subject|7|||
147119248|NCT00710554|530603330|FG001|Overall Study|Withdrawal by Subject|3|||
147119249|NCT00710554|530603329|FG000|Overall Study|Lost to Follow-up|7|||
147119250|NCT00710554|530603330|FG001|Overall Study|Lost to Follow-up|1|||
147119251|NCT00710554|530603329|FG000|Overall Study|Lack of Efficacy|11|||
147119252|NCT00710554|530603330|FG001|Overall Study|Lack of Efficacy|12|||
147119253|NCT00710554|530603329|FG000|Overall Study|Receiving radiotherapy - prostate cancer|0|||
147119254|NCT00710554|530603330|FG001|Overall Study|Receiving radiotherapy - prostate cancer|1|||
147119255|NCT03774810|530603337|FG000|Phase 1|Lack of Efficacy|21|||
147119256|NCT03774810|530603338|FG001|Phase 1|Lack of Efficacy|0|||
147119257|NCT03774810|530603339|FG002|Phase 1|Lack of Efficacy|0|||
147119258|NCT03774810|530603340|FG003|Phase 1|Lack of Efficacy|0|||
147119259|NCT03774810|530603341|FG004|Phase 1|Lack of Efficacy|0|||
147119260|NCT03774810|530603337|FG000|Phase 1|Withdrawal by Subject|9|||
147119261|NCT03774810|530603338|FG001|Phase 1|Withdrawal by Subject|0|||
147119262|NCT03774810|530603339|FG002|Phase 1|Withdrawal by Subject|0|||
147231240|NCT03161093|531019612|FG003|Overall Study|Death|9|||
147231241|NCT03161093|531019613|FG004|Overall Study|Death|0|||
147231242|NCT03161093|531019614|FG005|Overall Study|Death|0|||
147231243|NCT03161093|531019609|FG000|Overall Study|Unknown - Not reported|0|||
147231244|NCT03161093|531019610|FG001|Overall Study|Unknown - Not reported|1|||
147231245|NCT03161093|531019611|FG002|Overall Study|Unknown - Not reported|0|||
147231246|NCT03161093|531019612|FG003|Overall Study|Unknown - Not reported|0|||
147231247|NCT03161093|531019613|FG004|Overall Study|Unknown - Not reported|0|||
147231248|NCT03161093|531019614|FG005|Overall Study|Unknown - Not reported|1|||
147567577|NCT02563561|532238325|FG001|Overall Study|Investigator Decision|4|||
147567578|NCT02563561|532238326|FG002|Overall Study|Investigator Decision|2|||
147567579|NCT02563561|532238324|FG000|Overall Study|Sponsor Decision|5|||
147231249|NCT01031706|531019615|FG000|Overall Study|Adverse Event|1|||
147231250|NCT01031706|531019616|FG001|Overall Study|Adverse Event|0|||
147231251|NCT01031706|531019615|FG000|Overall Study|Withdrawal by Subject|1|||
147231252|NCT01031706|531019616|FG001|Overall Study|Withdrawal by Subject|1|||
147231253|NCT02124161|531019617|FG000|Overall Study|Other unspecified|0|||
147231254|NCT02124161|531019618|FG001|Overall Study|Other unspecified|1|||
147567580|NCT02563561|532238325|FG001|Overall Study|Sponsor Decision|2|||
147119263|NCT03774810|530603340|FG003|Phase 1|Withdrawal by Subject|0|||
147119264|NCT03774810|530603341|FG004|Phase 1|Withdrawal by Subject|0|||
147119265|NCT03774810|530603337|FG000|Phase 1|Lost to Follow-up|2|||
147119266|NCT03774810|530603338|FG001|Phase 1|Lost to Follow-up|0|||
147231255|NCT02124161|531019617|FG000|Overall Study|Death|1|||
147231256|NCT02124161|531019618|FG001|Overall Study|Death|0|||
147231257|NCT02124161|531019617|FG000|Overall Study|Protocol Violation|2|||
147231258|NCT02124161|531019618|FG001|Overall Study|Protocol Violation|1|||
147231259|NCT02124161|531019617|FG000|Overall Study|Withdrawal by Subject|1|||
147231260|NCT02124161|531019618|FG001|Overall Study|Withdrawal by Subject|2|||
147231261|NCT02124161|531019617|FG000|Overall Study|Adverse Event|2|||
147119267|NCT03774810|530603339|FG002|Phase 1|Lost to Follow-up|0|||
147119268|NCT03774810|530603340|FG003|Phase 1|Lost to Follow-up|0|||
147119269|NCT03774810|530603341|FG004|Phase 1|Lost to Follow-up|0|||
147119270|NCT03774810|530603337|FG000|Phase 2 (3 Months)|Lack of Efficacy|0|||
147231262|NCT02124161|531019618|FG001|Overall Study|Adverse Event|0|||
147119271|NCT03774810|530603338|FG001|Phase 2 (3 Months)|Lack of Efficacy|3|||
147119272|NCT03774810|530603339|FG002|Phase 2 (3 Months)|Lack of Efficacy|2|||
147119273|NCT03774810|530603340|FG003|Phase 2 (3 Months)|Lack of Efficacy|3|||
147119274|NCT03774810|530603341|FG004|Phase 2 (3 Months)|Lack of Efficacy|1|||
147119275|NCT03774810|530603337|FG000|Phase 2 (3 Months)|Withdrawal by Subject|0|||
147231263|NCT02124161|531019617|FG000|Overall Study|Does not meet entrance criteria|2|||
147231264|NCT02124161|531019618|FG001|Overall Study|Does not meet entrance criteria|3|||
147231265|NCT02124161|531019617|FG000|Overall Study|No longer meets eligibility criteria|5|||
147231266|NCT02124161|531019618|FG001|Overall Study|No longer meets eligibility criteria|4|||
147313246|NCT00802737|531313837|FG001|Overall Study|Ongoing CLL-Treatment|1|||
147119276|NCT03774810|530603338|FG001|Phase 2 (3 Months)|Withdrawal by Subject|5|||
147119277|NCT03774810|530603339|FG002|Phase 2 (3 Months)|Withdrawal by Subject|2|||
147231267|NCT02124161|531019617|FG000|Overall Study|Lost to Follow-up|3|||
147567581|NCT02563561|532238326|FG002|Overall Study|Sponsor Decision|4|||
147567582|NCT02563561|532238324|FG000|Overall Study|Other|1|||
147567583|NCT02563561|532238325|FG001|Overall Study|Other|5|||
147567584|NCT02563561|532238326|FG002|Overall Study|Other|2|||
147567585|NCT02718326|532238329|FG000|Overall Study|Adverse Event|4|||
147567586|NCT02718326|532238330|FG001|Overall Study|Adverse Event|9|||
147567587|NCT02718326|532238331|FG002|Overall Study|Adverse Event|0|||
147567588|NCT02718326|532238329|FG000|Overall Study|Death|8|||
147567589|NCT02718326|532238330|FG001|Overall Study|Death|1|||
147567590|NCT02718326|532238331|FG002|Overall Study|Death|2|||
147567591|NCT02718326|532238329|FG000|Overall Study|Withdrawal by Subject|4|||
147567592|NCT02718326|532238330|FG001|Overall Study|Withdrawal by Subject|9|||
147567593|NCT02718326|532238331|FG002|Overall Study|Withdrawal by Subject|6|||
147567594|NCT02718326|532238329|FG000|Overall Study|Lost to Follow-up|18|||
147567595|NCT02718326|532238330|FG001|Overall Study|Lost to Follow-up|5|||
147567596|NCT02718326|532238331|FG002|Overall Study|Lost to Follow-up|14|||
147567597|NCT02718326|532238329|FG000|Overall Study|Protocol Deviation|1|||
147567598|NCT02718326|532238330|FG001|Overall Study|Protocol Deviation|0|||
147567599|NCT02718326|532238331|FG002|Overall Study|Protocol Deviation|0|||
147231268|NCT02124161|531019618|FG001|Overall Study|Lost to Follow-up|4|||
147231269|NCT01393301|531019619|FG000|Overall Study|Lost to Follow-up|5|||
147231270|NCT01393301|531019620|FG001|Overall Study|Lost to Follow-up|3|||
147231271|NCT01393301|531019619|FG000|Overall Study|Withdrawal by Subject|2|||
147567600|NCT02718326|532238329|FG000|Overall Study|Pregnancy|1|||
147567601|NCT02718326|532238330|FG001|Overall Study|Pregnancy|0|||
147567602|NCT02718326|532238331|FG002|Overall Study|Pregnancy|0|||
147567603|NCT03122535|532238332|FG000|Overall Study|Lost to Follow-up|68|||
147567604|NCT03122535|532238333|FG001|Overall Study|Lost to Follow-up|68|||
147567605|NCT03122535|532238332|FG000|Overall Study|Physician Decision|3|||
147567606|NCT03122535|532238333|FG001|Overall Study|Physician Decision|3|||
147567607|NCT03122535|532238332|FG000|Overall Study|Withdrawal by Subject|2|||
147231272|NCT01393301|531019620|FG001|Overall Study|Withdrawal by Subject|0|||
147231273|NCT01393301|531019619|FG000|Overall Study|Completed <7 sessions (intervention)|2|||
147231274|NCT01393301|531019620|FG001|Overall Study|Completed <7 sessions (intervention)|0|||
147231275|NCT03342963|531019621|FG000|Overall Study|Adverse Event|1|||
147231276|NCT03342963|531019622|FG001|Overall Study|Adverse Event|2|||
147231277|NCT03342963|531019623|FG002|Overall Study|Adverse Event|0|||
147231278|NCT03342963|531019624|FG003|Overall Study|Adverse Event|0|||
147231279|NCT03342963|531019621|FG000|Overall Study|Withdrawal by Subject|1|||
147231280|NCT03342963|531019622|FG001|Overall Study|Withdrawal by Subject|0|||
147231281|NCT03342963|531019623|FG002|Overall Study|Withdrawal by Subject|0|||
147231282|NCT03342963|531019624|FG003|Overall Study|Withdrawal by Subject|0|||
147231283|NCT01008150|531019625|FG000|Overall Study|did not receive study drug|1|||
147231284|NCT01008150|531019626|FG001|Overall Study|did not receive study drug|1|||
147231285|NCT01008150|531019627|FG002|Overall Study|did not receive study drug|1|||
147231286|NCT01008150|531019628|FG003|Overall Study|did not receive study drug|0|||
147231287|NCT01309165|531019630|FG000|Overall Study|Lost to Follow-up|4|||
147231288|NCT01309165|531019631|FG001|Overall Study|Lost to Follow-up|3|||
147231289|NCT01309165|531019630|FG000|Overall Study|Return to work|1|||
147231290|NCT01309165|531019631|FG001|Overall Study|Return to work|2|||
147231291|NCT01309165|531019630|FG000|Overall Study|Left country|0|||
147231292|NCT01309165|531019631|FG001|Overall Study|Left country|1|||
147231293|NCT01309165|531019630|FG000|Overall Study|No transportation|0|||
147231294|NCT01309165|531019631|FG001|Overall Study|No transportation|1|||
147231295|NCT01309165|531019630|FG000|Overall Study|Admitted to hospital for second stroke|1|||
147231296|NCT01309165|531019631|FG001|Overall Study|Admitted to hospital for second stroke|0|||
147231297|NCT01497275|531019632|FG000|Overall Study|Death|1|||
147567608|NCT03122535|532238333|FG001|Overall Study|Withdrawal by Subject|2|||
147567609|NCT00984022|532238337|FG000|Overall Study|Lost to Follow-up|10|||
147567610|NCT00984022|532238338|FG001|Overall Study|Lost to Follow-up|14|||
147567611|NCT00573443|532238339|FG000|Double-Blind Phase|Lost to Follow-up|1|||
147567612|NCT00573443|532238340|FG001|Double-Blind Phase|Lost to Follow-up|3|||
147567613|NCT00573443|532238341|FG002|Double-Blind Phase|Lost to Follow-up|2|||
147567614|NCT00573443|532238339|FG000|Double-Blind Phase|Exacerbation of MS symptoms|1|||
147567615|NCT00573443|532238340|FG001|Double-Blind Phase|Exacerbation of MS symptoms|0|||
147567616|NCT00573443|532238341|FG002|Double-Blind Phase|Exacerbation of MS symptoms|1|||
147567617|NCT00573443|532238339|FG000|Double-Blind Phase|Adverse Event|1|||
147567618|NCT00573443|532238340|FG001|Double-Blind Phase|Adverse Event|5|||
147567619|NCT00573443|532238341|FG002|Double-Blind Phase|Adverse Event|0|||
147567620|NCT00573443|532238339|FG000|Double-Blind Phase|Serious Adverse Event (AE)|2|||
147567621|NCT00573443|532238340|FG001|Double-Blind Phase|Serious Adverse Event (AE)|3|||
147231298|NCT01497275|531019632|FG000|Overall Study|Adverse Event|1|||
147231299|NCT00737438|531019638|FG000|Overall Study|Withdrawal by Subject|2|||
147231300|NCT00737438|531019638|FG000|Overall Study|Patient ineligible|1|||
147231301|NCT02410551|531019639|FG000|Overall Study|Adverse Event|1|||
147231302|NCT02410551|531019639|FG000|Overall Study|Withdrawal by Subject|1|||
147231303|NCT02410551|531019639|FG000|Overall Study|FDA Clinical hold-patients taken off|2|||
147567622|NCT00573443|532238341|FG002|Double-Blind Phase|Serious Adverse Event (AE)|1|||
147567623|NCT00573443|532238339|FG000|Double-Blind Phase|Medication refusal due to AE|2|||
147119278|NCT03774810|530603340|FG003|Phase 2 (3 Months)|Withdrawal by Subject|3|||
147119279|NCT03774810|530603341|FG004|Phase 2 (3 Months)|Withdrawal by Subject|1|||
147119280|NCT03774810|530603337|FG000|Phase 2 (3 Months)|Lost to Follow-up|0|||
147119281|NCT03774810|530603338|FG001|Phase 2 (3 Months)|Lost to Follow-up|1|||
147119282|NCT03774810|530603339|FG002|Phase 2 (3 Months)|Lost to Follow-up|0|||
147119283|NCT03774810|530603340|FG003|Phase 2 (3 Months)|Lost to Follow-up|0|||
147119284|NCT03774810|530603341|FG004|Phase 2 (3 Months)|Lost to Follow-up|0|||
147119285|NCT03774810|530603337|FG000|Phase 3 (9-month Extension of Phase 2)|Lack of Efficacy|0|||
147119286|NCT03774810|530603338|FG001|Phase 3 (9-month Extension of Phase 2)|Lack of Efficacy|3|||
147119287|NCT03774810|530603339|FG002|Phase 3 (9-month Extension of Phase 2)|Lack of Efficacy|2|||
147119288|NCT03774810|530603340|FG003|Phase 3 (9-month Extension of Phase 2)|Lack of Efficacy|1|||
147119289|NCT03774810|530603341|FG004|Phase 3 (9-month Extension of Phase 2)|Lack of Efficacy|2|||
147119290|NCT03774810|530603337|FG000|Phase 3 (9-month Extension of Phase 2)|Withdrawal by Subject|0|||
147119291|NCT03774810|530603338|FG001|Phase 3 (9-month Extension of Phase 2)|Withdrawal by Subject|1|||
147119292|NCT03774810|530603339|FG002|Phase 3 (9-month Extension of Phase 2)|Withdrawal by Subject|3|||
147119293|NCT03774810|530603340|FG003|Phase 3 (9-month Extension of Phase 2)|Withdrawal by Subject|5|||
147119294|NCT03774810|530603341|FG004|Phase 3 (9-month Extension of Phase 2)|Withdrawal by Subject|2|||
147231304|NCT01739309|531019640|FG000|Overall Study|Adverse Event|1|||
147231305|NCT01739309|531019640|FG000|Overall Study|Withdrawal by Subject|1|||
147231306|NCT01649804|531019643|FG000|Overall Study|Administrative/Other|8|||
147231307|NCT03719586|531019644|FG000|Overall Study|"not completed simply refers to pts who could not be contemporaneously compared to the ZMapp arm"|8|||
147231308|NCT03719586|531019645|FG001|Overall Study|"not completed simply refers to pts who could not be contemporaneously compared to the ZMapp arm"|7|||
147231309|NCT03719586|531019646|FG002|Overall Study|"not completed simply refers to pts who could not be contemporaneously compared to the ZMapp arm"|4|||
147231310|NCT03719586|531019647|FG003|Overall Study|"not completed simply refers to pts who could not be contemporaneously compared to the ZMapp arm"|0|||
147231311|NCT03845543|531019648|FG000|Overall Study|Death|25|||
147231312|NCT03845543|531019648|FG000|Overall Study|Withdrawal by Subject|2|||
147231313|NCT03845543|531019648|FG000|Overall Study|Lost to Follow-up|12|||
147231314|NCT03845543|531019648|FG000|Overall Study|Adverse Event|17|||
147231315|NCT02028871|531019652|FG000|Overall Study|Positive urine drug screen|1|||
147231316|NCT02028871|531019653|FG001|Overall Study|Positive urine drug screen|1|||
147231317|NCT02028871|531019652|FG000|Overall Study|Withdrawal by Subject|1|||
147231318|NCT02028871|531019653|FG001|Overall Study|Withdrawal by Subject|2|||
147231319|NCT02028871|531019652|FG000|Overall Study|IV placement difficulty|1|||
147231320|NCT02028871|531019653|FG001|Overall Study|IV placement difficulty|0|||
147231321|NCT02028871|531019652|FG000|Overall Study|Current Illness|1|||
147231322|NCT02028871|531019653|FG001|Overall Study|Current Illness|0|||
147231323|NCT02633501|531019656|FG000|Overall Study|Adverse Event|0|||
147231324|NCT02633501|531019657|FG001|Overall Study|Adverse Event|0|||
147231325|NCT02633501|531019658|FG002|Overall Study|Adverse Event|1|||
147231326|NCT02633501|531019659|FG003|Overall Study|Adverse Event|0|||
147231327|NCT02633501|531019660|FG004|Overall Study|Adverse Event|1|||
147231328|NCT02633501|531019661|FG005|Overall Study|Adverse Event|1|||
147231329|NCT02633501|531019656|FG000|Overall Study|Withdrawal by Subject|2|||
147231330|NCT02633501|531019657|FG001|Overall Study|Withdrawal by Subject|1|||
147231331|NCT02633501|531019658|FG002|Overall Study|Withdrawal by Subject|2|||
147231332|NCT02633501|531019659|FG003|Overall Study|Withdrawal by Subject|2|||
147231333|NCT02633501|531019660|FG004|Overall Study|Withdrawal by Subject|1|||
147231334|NCT02633501|531019661|FG005|Overall Study|Withdrawal by Subject|3|||
147231335|NCT02633501|531019656|FG000|Overall Study|Various other reasons|0|||
147231336|NCT02633501|531019657|FG001|Overall Study|Various other reasons|2|||
147231337|NCT02633501|531019658|FG002|Overall Study|Various other reasons|4|||
147231338|NCT02633501|531019659|FG003|Overall Study|Various other reasons|1|||
147231339|NCT02633501|531019660|FG004|Overall Study|Various other reasons|7|||
147119295|NCT03774810|530603337|FG000|Phase 3 (9-month Extension of Phase 2)|Withdrawn by PI due to study end.|0|||
147231340|NCT02633501|531019661|FG005|Overall Study|Various other reasons|11|||
147231341|NCT02633501|531019656|FG000|Overall Study|Lost to Follow-up|0|||
147231342|NCT02633501|531019657|FG001|Overall Study|Lost to Follow-up|0|||
147231343|NCT02633501|531019658|FG002|Overall Study|Lost to Follow-up|0|||
147231344|NCT02633501|531019659|FG003|Overall Study|Lost to Follow-up|1|||
147231345|NCT02633501|531019660|FG004|Overall Study|Lost to Follow-up|2|||
147231346|NCT02633501|531019661|FG005|Overall Study|Lost to Follow-up|0|||
147231347|NCT01626495|531019664|FG000|Overall Study|Adverse Event|3|||
147231348|NCT01626495|531019664|FG000|Overall Study|Disease progression|27|||
147231349|NCT01626495|531019664|FG000|Overall Study|Withdrawal by Subject|1|||
147231350|NCT01626495|531019664|FG000|Overall Study|Administrative problem|1|||
147231351|NCT01626495|531019664|FG000|Overall Study|Death|2|||
147231352|NCT01626495|531019664|FG000|Overall Study|Physician Decision|1|||
147231353|NCT01626495|531019664|FG000|Overall Study|New cancer therapy|16|||
147231354|NCT01626495|531019664|FG000|Overall Study|Manufacturing failure|1|||
147231355|NCT02955797|531019665|FG000|Overall Study|Protocol Violation|1|||
147231356|NCT02955797|531019666|FG001|Overall Study|Protocol Violation|0|||
147231357|NCT02955797|531019667|FG002|Overall Study|Protocol Violation|0|||
147567624|NCT00573443|532238340|FG001|Double-Blind Phase|Medication refusal due to AE|2|||
147567625|NCT00573443|532238341|FG002|Double-Blind Phase|Medication refusal due to AE|0|||
147567626|NCT00573443|532238339|FG000|Double-Blind Phase|Withdrawal by Subject|2|||
147567627|NCT00573443|532238340|FG001|Double-Blind Phase|Withdrawal by Subject|2|||
147567628|NCT00573443|532238341|FG002|Double-Blind Phase|Withdrawal by Subject|7|||
147567629|NCT00573443|532238339|FG000|Double-Blind Phase|Protocol Violation|0|||
147567630|NCT00573443|532238340|FG001|Double-Blind Phase|Protocol Violation|2|||
147567631|NCT00573443|532238341|FG002|Double-Blind Phase|Protocol Violation|1|||
147567632|NCT00573443|532238339|FG000|Double-Blind Phase|Other|0|||
147567633|NCT00573443|532238340|FG001|Double-Blind Phase|Other|2|||
147567634|NCT00573443|532238341|FG002|Double-Blind Phase|Other|3|||
147567635|NCT00573443|532238339|FG000|Open-Label Extension Phase|Lost to Follow-up|1|||
147567636|NCT00573443|532238340|FG001|Open-Label Extension Phase|Lost to Follow-up|0|||
147567637|NCT00573443|532238341|FG002|Open-Label Extension Phase|Lost to Follow-up|0|||
147567638|NCT00573443|532238339|FG000|Open-Label Extension Phase|Exacerbation of MS symptoms|2|||
147567639|NCT00573443|532238340|FG001|Open-Label Extension Phase|Exacerbation of MS symptoms|0|||
147567640|NCT00573443|532238341|FG002|Open-Label Extension Phase|Exacerbation of MS symptoms|0|||
147567641|NCT00573443|532238339|FG000|Open-Label Extension Phase|Adverse Event|3|||
147567642|NCT00573443|532238340|FG001|Open-Label Extension Phase|Adverse Event|0|||
147567643|NCT00573443|532238341|FG002|Open-Label Extension Phase|Adverse Event|0|||
147567644|NCT00573443|532238339|FG000|Open-Label Extension Phase|Serious Adverse Event|5|||
147567645|NCT00573443|532238340|FG001|Open-Label Extension Phase|Serious Adverse Event|0|||
147567646|NCT00573443|532238341|FG002|Open-Label Extension Phase|Serious Adverse Event|0|||
147567647|NCT00573443|532238339|FG000|Open-Label Extension Phase|Withdrawal by Subject|3|||
147567648|NCT00573443|532238340|FG001|Open-Label Extension Phase|Withdrawal by Subject|0|||
147567649|NCT00573443|532238341|FG002|Open-Label Extension Phase|Withdrawal by Subject|0|||
147567650|NCT00573443|532238339|FG000|Open-Label Extension Phase|Protocol Violation|2|||
147567651|NCT00573443|532238340|FG001|Open-Label Extension Phase|Protocol Violation|0|||
147567652|NCT00573443|532238341|FG002|Open-Label Extension Phase|Protocol Violation|0|||
147567653|NCT00573443|532238339|FG000|Open-Label Extension Phase|Other|2|||
147567654|NCT00573443|532238340|FG001|Open-Label Extension Phase|Other|0|||
147567655|NCT00573443|532238341|FG002|Open-Label Extension Phase|Other|0|||
147567656|NCT00418561|532238347|FG000|Overall Study|Participant's (guardian's) decision|0|||
147567657|NCT00418561|532238348|FG001|Overall Study|Participant's (guardian's) decision|1|||
147567658|NCT00418561|532238349|FG002|Overall Study|Participant's (guardian's) decision|0|||
147567659|NCT01796171|532238350|FG000|Enrolled|Death|0|||
147567660|NCT01796171|532238351|FG001|Enrolled|Death|0|||
147567661|NCT01796171|532238352|FG002|Enrolled|Death|0|||
147567662|NCT01796171|532238353|FG003|Enrolled|Death|0|||
147567663|NCT01796171|532238354|FG004|Enrolled|Death|0|||
147567664|NCT01796171|532238355|FG005|Enrolled|Death|0|||
147567665|NCT01796171|532238356|FG006|Enrolled|Death|0|||
147567666|NCT01796171|532238357|FG007|Enrolled|Death|0|||
147567667|NCT01796171|532238358|FG008|Enrolled|Death|0|||
147567668|NCT01796171|532238359|FG009|Enrolled|Death|0|||
147567669|NCT01796171|532238360|FG010|Enrolled|Death|0|||
147567670|NCT01796171|532238361|FG011|Enrolled|Death|0|||
147567671|NCT01796171|532238362|FG012|Enrolled|Death|0|||
147567672|NCT01796171|532238363|FG013|Enrolled|Death|0|||
147567673|NCT01796171|532238364|FG014|Enrolled|Death|1|||
147567674|NCT01796171|532238350|FG000|Pre-reatment With Rituximab|Adverse Event|0|||
147567675|NCT01796171|532238351|FG001|Pre-reatment With Rituximab|Adverse Event|0|||
147567676|NCT01796171|532238352|FG002|Pre-reatment With Rituximab|Adverse Event|0|||
147567677|NCT01796171|532238353|FG003|Pre-reatment With Rituximab|Adverse Event|0|||
147567678|NCT01796171|532238354|FG004|Pre-reatment With Rituximab|Adverse Event|0|||
147567679|NCT01796171|532238355|FG005|Pre-reatment With Rituximab|Adverse Event|0|||
147567680|NCT01796171|532238356|FG006|Pre-reatment With Rituximab|Adverse Event|0|||
147567681|NCT01796171|532238357|FG007|Pre-reatment With Rituximab|Adverse Event|0|||
147567682|NCT01796171|532238358|FG008|Pre-reatment With Rituximab|Adverse Event|0|||
147567683|NCT01796171|532238359|FG009|Pre-reatment With Rituximab|Adverse Event|2|||
147567684|NCT01796171|532238360|FG010|Pre-reatment With Rituximab|Adverse Event|0|||
147567685|NCT01796171|532238361|FG011|Pre-reatment With Rituximab|Adverse Event|0|||
147567686|NCT01796171|532238362|FG012|Pre-reatment With Rituximab|Adverse Event|0|||
147567687|NCT01796171|532238363|FG013|Pre-reatment With Rituximab|Adverse Event|0|||
147567688|NCT01796171|532238364|FG014|Pre-reatment With Rituximab|Adverse Event|0|||
147567689|NCT01796171|532238350|FG000|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
147567690|NCT01796171|532238351|FG001|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
147567691|NCT01796171|532238352|FG002|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
147567692|NCT01796171|532238353|FG003|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
147567693|NCT01796171|532238354|FG004|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
147567694|NCT01796171|532238355|FG005|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
147567695|NCT01796171|532238356|FG006|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
147567696|NCT01796171|532238357|FG007|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
147567697|NCT01796171|532238358|FG008|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
147567698|NCT01796171|532238359|FG009|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
147567699|NCT01796171|532238360|FG010|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
147567700|NCT01796171|532238361|FG011|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
147567701|NCT01796171|532238362|FG012|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
147567702|NCT01796171|532238363|FG013|Pre-reatment With Rituximab|Withdrawal by Subject|1|||
147567703|NCT01796171|532238364|FG014|Pre-reatment With Rituximab|Withdrawal by Subject|0|||
147567704|NCT01796171|532238350|FG000|Treatment Period With Betalutin|Progressive disease|0|||
147567705|NCT01796171|532238351|FG001|Treatment Period With Betalutin|Progressive disease|1|||
147567706|NCT01796171|532238352|FG002|Treatment Period With Betalutin|Progressive disease|0|||
147567707|NCT01796171|532238353|FG003|Treatment Period With Betalutin|Progressive disease|0|||
147567708|NCT01796171|532238354|FG004|Treatment Period With Betalutin|Progressive disease|0|||
147567709|NCT01796171|532238355|FG005|Treatment Period With Betalutin|Progressive disease|0|||
147567710|NCT01796171|532238356|FG006|Treatment Period With Betalutin|Progressive disease|0|||
147567711|NCT01796171|532238357|FG007|Treatment Period With Betalutin|Progressive disease|0|||
147567712|NCT01796171|532238358|FG008|Treatment Period With Betalutin|Progressive disease|0|||
147567713|NCT01796171|532238359|FG009|Treatment Period With Betalutin|Progressive disease|0|||
147567714|NCT01796171|532238360|FG010|Treatment Period With Betalutin|Progressive disease|0|||
147313247|NCT00802737|531313838|FG002|Overall Study|Ongoing CLL-Treatment|0|||
147313248|NCT00802737|531313836|FG000|Overall Study|Participant too Unwell|0|||
147313249|NCT00802737|531313837|FG001|Overall Study|Participant too Unwell|2|||
147313250|NCT00802737|531313838|FG002|Overall Study|Participant too Unwell|0|||
147313251|NCT03864926|531313839|FG000|Overall Study|Death|0|||
147313252|NCT03864926|531313840|FG001|Overall Study|Death|2|||
147313253|NCT00445601|531313841|FG000|Overall Study|Withdrawal by Subject|11|||
147313254|NCT00445601|531313842|FG001|Overall Study|Withdrawal by Subject|11|||
147313255|NCT00445601|531313841|FG000|Overall Study|TURBT Complication|12|||
147313256|NCT00445601|531313842|FG001|Overall Study|TURBT Complication|8|||
147313257|NCT00445601|531313841|FG000|Overall Study|Incorrect Disease Status|6|||
147313258|NCT00445601|531313842|FG001|Overall Study|Incorrect Disease Status|6|||
147313259|NCT00445601|531313841|FG000|Overall Study|Drug Delivery Issue|2|||
147313260|NCT00445601|531313842|FG001|Overall Study|Drug Delivery Issue|2|||
147313261|NCT00445601|531313841|FG000|Overall Study|Adverse Event|2|||
147313262|NCT00445601|531313842|FG001|Overall Study|Adverse Event|0|||
147313263|NCT00445601|531313841|FG000|Overall Study|Death prior to TURBT|0|||
147313264|NCT00445601|531313842|FG001|Overall Study|Death prior to TURBT|1|||
147313265|NCT01091428|531313843|FG000|Phase 1|Progressive Disease|24|||
147313266|NCT01091428|531313844|FG001|Phase 1|Progressive Disease|8|||
147567715|NCT01796171|532238361|FG011|Treatment Period With Betalutin|Progressive disease|0|||
147567716|NCT01796171|532238362|FG012|Treatment Period With Betalutin|Progressive disease|0|||
147567717|NCT01796171|532238363|FG013|Treatment Period With Betalutin|Progressive disease|0|||
147567718|NCT01796171|532238364|FG014|Treatment Period With Betalutin|Progressive disease|0|||
147567719|NCT01796171|532238350|FG000|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
147567720|NCT01796171|532238351|FG001|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
147567721|NCT01796171|532238352|FG002|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
147567722|NCT01796171|532238353|FG003|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
147567723|NCT01796171|532238354|FG004|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
147567724|NCT01796171|532238355|FG005|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
147567725|NCT01796171|532238356|FG006|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
147567726|NCT01796171|532238357|FG007|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
147567727|NCT01796171|532238358|FG008|Treatment Period With Betalutin|Start of further anticancer therapy|1|||
147567728|NCT01796171|532238359|FG009|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
147567729|NCT01796171|532238360|FG010|Treatment Period With Betalutin|Start of further anticancer therapy|1|||
147567730|NCT01796171|532238361|FG011|Treatment Period With Betalutin|Start of further anticancer therapy|1|||
147567731|NCT01796171|532238362|FG012|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
147567732|NCT01796171|532238363|FG013|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
147567733|NCT01796171|532238364|FG014|Treatment Period With Betalutin|Start of further anticancer therapy|0|||
147567734|NCT01796171|532238350|FG000|Treatment Period With Betalutin|Physician Decision|0|||
147567735|NCT01796171|532238351|FG001|Treatment Period With Betalutin|Physician Decision|0|||
147567736|NCT01796171|532238352|FG002|Treatment Period With Betalutin|Physician Decision|0|||
147567737|NCT01796171|532238353|FG003|Treatment Period With Betalutin|Physician Decision|0|||
147567738|NCT01796171|532238354|FG004|Treatment Period With Betalutin|Physician Decision|0|||
147567739|NCT01796171|532238355|FG005|Treatment Period With Betalutin|Physician Decision|0|||
147650911|NCT02757352|532544540|FG003|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
147650912|NCT02757352|532544541|FG004|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
147313267|NCT01091428|531313845|FG002|Phase 1|Progressive Disease|0|||
147313268|NCT01091428|531313846|FG003|Phase 1|Progressive Disease|0|||
147313269|NCT01091428|531313843|FG000|Phase 1|Symptomatic Deterioration|3|||
147313270|NCT01091428|531313844|FG001|Phase 1|Symptomatic Deterioration|2|||
147313271|NCT01091428|531313845|FG002|Phase 1|Symptomatic Deterioration|0|||
147313272|NCT01091428|531313846|FG003|Phase 1|Symptomatic Deterioration|0|||
147119296|NCT03774810|530603338|FG001|Phase 3 (9-month Extension of Phase 2)|Withdrawn by PI due to study end.|0|||
147119297|NCT03774810|530603339|FG002|Phase 3 (9-month Extension of Phase 2)|Withdrawn by PI due to study end.|0|||
147119298|NCT03774810|530603340|FG003|Phase 3 (9-month Extension of Phase 2)|Withdrawn by PI due to study end.|1|||
147119299|NCT03774810|530603341|FG004|Phase 3 (9-month Extension of Phase 2)|Withdrawn by PI due to study end.|2|||
147119300|NCT00604383|530603342|FG000|Overall Study|Withdrawal by Subject|33|||
147119301|NCT00604383|530603343|FG001|Overall Study|Withdrawal by Subject|31|||
147119302|NCT00604383|530603342|FG000|Overall Study|Lost to Follow-up|24|||
147119303|NCT00604383|530603343|FG001|Overall Study|Lost to Follow-up|19|||
147119304|NCT00604383|530603342|FG000|Overall Study|Death|14|||
147119305|NCT00604383|530603343|FG001|Overall Study|Death|22|||
147119306|NCT00604383|530603342|FG000|Overall Study|Adverse Event|16|||
147119307|NCT00604383|530603343|FG001|Overall Study|Adverse Event|9|||
147119308|NCT00604383|530603342|FG000|Overall Study|Physician Decision|0|||
147119309|NCT00604383|530603343|FG001|Overall Study|Physician Decision|3|||
147119310|NCT00290758|530603348|FG000|Pre-Intervention rFNA Through Follow-Up|Adverse Event|1|||
147119311|NCT00290758|530603349|FG001|Pre-Intervention rFNA Through Follow-Up|Adverse Event|2|||
147119312|NCT00290758|530603348|FG000|Pre-Intervention rFNA Through Follow-Up|ConMeds|1|||
147119313|NCT00290758|530603349|FG001|Pre-Intervention rFNA Through Follow-Up|ConMeds|0|||
147119314|NCT00290758|530603348|FG000|Pre-Intervention rFNA Through Follow-Up|Physician Decision|3|||
147119315|NCT00290758|530603349|FG001|Pre-Intervention rFNA Through Follow-Up|Physician Decision|1|||
147119316|NCT00290758|530603348|FG000|Pre-Intervention rFNA Through Follow-Up|Lost to Follow-up|1|||
147119317|NCT00290758|530603349|FG001|Pre-Intervention rFNA Through Follow-Up|Lost to Follow-up|1|||
147119318|NCT00290758|530603348|FG000|Pre-Intervention rFNA Through Follow-Up|Withdrawal by Subject|0|||
147119319|NCT00290758|530603349|FG001|Pre-Intervention rFNA Through Follow-Up|Withdrawal by Subject|5|||
147119320|NCT00290758|530603348|FG000|Pre-Intervention rFNA Through Follow-Up|Medical Contraindication|1|||
147119321|NCT00290758|530603349|FG001|Pre-Intervention rFNA Through Follow-Up|Medical Contraindication|0|||
147119322|NCT00290758|530603348|FG000|Pre-Intervention rFNA Through Follow-Up|Non Compliant|0|||
147119323|NCT00290758|530603349|FG001|Pre-Intervention rFNA Through Follow-Up|Non Compliant|1|||
147119324|NCT00290758|530603348|FG000|Post Intervention rFNA|<4000 Epithelial Cells|6|||
147119325|NCT00290758|530603349|FG001|Post Intervention rFNA|<4000 Epithelial Cells|5|||
147119326|NCT03994120|530603351|FG000|Overall Study|Lost to Follow-up|3|||
147119327|NCT03994120|530603352|FG001|Overall Study|Lost to Follow-up|1|||
147119328|NCT01111292|530603353|FG000|Treatment|Physician Decision|1|||
147119329|NCT01111292|530603354|FG001|Treatment|Physician Decision|1|||
147119330|NCT01096186|530603355|FG000|Overall Study|Adverse Event|16|||
147119331|NCT01096186|530603355|FG000|Overall Study|Death|4|||
147119332|NCT01096186|530603355|FG000|Overall Study|Lack of Efficacy|4|||
147119333|NCT01096186|530603355|FG000|Overall Study|Lost to Follow-up|2|||
147119334|NCT01096186|530603355|FG000|Overall Study|Withdrawal by Subject|22|||
147313273|NCT01091428|531313843|FG000|Phase 1|Adverse Event|2|||
147313274|NCT01091428|531313844|FG001|Phase 1|Adverse Event|0|||
147313275|NCT01091428|531313845|FG002|Phase 1|Adverse Event|0|||
147313276|NCT01091428|531313846|FG003|Phase 1|Adverse Event|0|||
147313277|NCT01091428|531313843|FG000|Phase 1|Withdrawal by Subject|7|||
147313278|NCT01091428|531313844|FG001|Phase 1|Withdrawal by Subject|0|||
147313279|NCT01091428|531313845|FG002|Phase 1|Withdrawal by Subject|0|||
147444568|NCT01940471|531792645|FG003|Period 2: Open-Label TAF Extension Phase|Protocol-specified Criteria for Withdrawal|4|||
147444569|NCT01940471|531792642|FG000|Period 2: Open-Label TAF Extension Phase|Adverse Event|0|||
147444570|NCT01940471|531792643|FG001|Period 2: Open-Label TAF Extension Phase|Adverse Event|0|||
147444571|NCT01940471|531792644|FG002|Period 2: Open-Label TAF Extension Phase|Adverse Event|5|||
147444572|NCT01940471|531792645|FG003|Period 2: Open-Label TAF Extension Phase|Adverse Event|1|||
147444573|NCT01940471|531792642|FG000|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|0|||
147444574|NCT01940471|531792643|FG001|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|0|||
147444575|NCT01940471|531792644|FG002|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|4|||
147444576|NCT01940471|531792645|FG003|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|1|||
147444577|NCT01940471|531792642|FG000|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
147119335|NCT01096186|530603355|FG000|Overall Study|Physician Decision|1|||
147119336|NCT01096186|530603355|FG000|Overall Study|Noncompliance with study drug|1|||
147444578|NCT01940471|531792643|FG001|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
147444579|NCT01940471|531792644|FG002|Period 2: Open-Label TAF Extension Phase|Pregnancy|5|||
147119337|NCT05587998|530603361|FG000|Overall Study|Withdrawal by Subject|1|||
147119338|NCT05587998|530603362|FG001|Overall Study|Withdrawal by Subject|1|||
147119339|NCT05587998|530603361|FG000|Overall Study|Not treated|3|||
147119340|NCT05587998|530603362|FG001|Overall Study|Not treated|1|||
147119341|NCT05587998|530603361|FG000|Overall Study|Non-compliance with study procedures|0|||
147119342|NCT05587998|530603362|FG001|Overall Study|Non-compliance with study procedures|1|||
147119343|NCT03892915|530603363|FG000|Overall Study|Lost to Follow-up|6|||
147119344|NCT03892915|530603364|FG001|Overall Study|Lost to Follow-up|12|||
147313280|NCT01091428|531313846|FG003|Phase 1|Withdrawal by Subject|0|||
147313281|NCT01091428|531313843|FG000|Phase 1|Reason not specified|0|||
147313282|NCT01091428|531313844|FG001|Phase 1|Reason not specified|1|||
147119345|NCT03892915|530603363|FG000|Overall Study|Death|0|||
147119346|NCT03892915|530603364|FG001|Overall Study|Death|2|||
147119347|NCT03892915|530603363|FG000|Overall Study|Withdrawal by Subject|1|||
147119348|NCT03892915|530603364|FG001|Overall Study|Withdrawal by Subject|1|||
147119349|NCT03892915|530603363|FG000|Overall Study|unsuccessful delivery|13|||
147119350|NCT03892915|530603364|FG001|Overall Study|unsuccessful delivery|18|||
147119351|NCT00191152|530603365|FG000|Initial Treatment|Adverse Event|43|||
147119352|NCT00191152|530603366|FG001|Initial Treatment|Adverse Event|67|||
147119353|NCT00191152|530603365|FG000|Initial Treatment|Physician Decision|40|||
147119354|NCT00191152|530603366|FG001|Initial Treatment|Physician Decision|31|||
147119355|NCT00191152|530603365|FG000|Initial Treatment|Withdrawal by Subject|40|||
147119356|NCT00191152|530603366|FG001|Initial Treatment|Withdrawal by Subject|28|||
147119357|NCT00191152|530603365|FG000|Initial Treatment|Lost to Follow-up|0|||
147119358|NCT00191152|530603366|FG001|Initial Treatment|Lost to Follow-up|6|||
147119359|NCT00191152|530603365|FG000|Initial Treatment|Other|18|||
147119360|NCT00191152|530603366|FG001|Initial Treatment|Other|21|||
147119361|NCT00191152|530603365|FG000|Crossover Treatment|Adverse Event|8|||
147119362|NCT00191152|530603366|FG001|Crossover Treatment|Adverse Event|8|||
147119363|NCT00191152|530603365|FG000|Crossover Treatment|Physician Decision|7|||
147119364|NCT00191152|530603366|FG001|Crossover Treatment|Physician Decision|7|||
147119365|NCT00191152|530603365|FG000|Crossover Treatment|Withdrawal by Subject|6|||
147119366|NCT00191152|530603366|FG001|Crossover Treatment|Withdrawal by Subject|9|||
147119367|NCT00191152|530603365|FG000|Crossover Treatment|Lost to Follow-up|2|||
147231358|NCT02955797|531019668|FG003|Overall Study|Protocol Violation|1|||
147231359|NCT02955797|531019665|FG000|Overall Study|Withdrawal by Subject|2|||
147119368|NCT00191152|530603366|FG001|Crossover Treatment|Lost to Follow-up|1|||
147119369|NCT00191152|530603365|FG000|Crossover Treatment|Other|4|||
147119370|NCT00191152|530603366|FG001|Crossover Treatment|Other|3|||
147119371|NCT00114777|530603367|FG000|Randomization to Month 36|Death|10|||
147119372|NCT00114777|530603368|FG001|Randomization to Month 36|Death|4|||
147231360|NCT02955797|531019666|FG001|Overall Study|Withdrawal by Subject|2|||
147231361|NCT02955797|531019667|FG002|Overall Study|Withdrawal by Subject|0|||
147231362|NCT02955797|531019668|FG003|Overall Study|Withdrawal by Subject|1|||
147231363|NCT02955797|531019665|FG000|Overall Study|Lost to Follow-up|0|||
147231364|NCT02955797|531019666|FG001|Overall Study|Lost to Follow-up|1|||
147231365|NCT02955797|531019667|FG002|Overall Study|Lost to Follow-up|0|||
147231366|NCT02955797|531019668|FG003|Overall Study|Lost to Follow-up|0|||
147231367|NCT03131453|531019669|FG000|Overall Study|Study terminated by Sponsor|424|||
147231368|NCT03131453|531019670|FG001|Overall Study|Study terminated by Sponsor|222|||
147231369|NCT03131453|531019671|FG002|Overall Study|Study terminated by Sponsor|438|||
147231370|NCT03131453|531019669|FG000|Overall Study|Withdrawal by Subject|18|||
147231371|NCT03131453|531019670|FG001|Overall Study|Withdrawal by Subject|7|||
147231372|NCT03131453|531019671|FG002|Overall Study|Withdrawal by Subject|13|||
147231373|NCT03131453|531019669|FG000|Overall Study|Adverse Event|10|||
147231374|NCT03131453|531019670|FG001|Overall Study|Adverse Event|3|||
147231375|NCT03131453|531019671|FG002|Overall Study|Adverse Event|3|||
147231376|NCT03131453|531019669|FG000|Overall Study|Lost to Follow-up|1|||
147231377|NCT03131453|531019670|FG001|Overall Study|Lost to Follow-up|0|||
147231378|NCT03131453|531019671|FG002|Overall Study|Lost to Follow-up|1|||
147231379|NCT03131453|531019669|FG000|Overall Study|Physician Decision|1|||
147231380|NCT03131453|531019670|FG001|Overall Study|Physician Decision|0|||
147231381|NCT03131453|531019671|FG002|Overall Study|Physician Decision|1|||
147231382|NCT03131453|531019669|FG000|Overall Study|Non-compliance with study treatment|1|||
147231383|NCT03131453|531019670|FG001|Overall Study|Non-compliance with study treatment|0|||
147231384|NCT03131453|531019671|FG002|Overall Study|Non-compliance with study treatment|0|||
147231385|NCT03131453|531019669|FG000|Overall Study|Technical problems|1|||
147231386|NCT03131453|531019670|FG001|Overall Study|Technical problems|0|||
147231387|NCT03131453|531019671|FG002|Overall Study|Technical problems|0|||
147231388|NCT03131453|531019669|FG000|Overall Study|Protocol deviation|0|||
147231389|NCT03131453|531019670|FG001|Overall Study|Protocol deviation|1|||
147313283|NCT01091428|531313845|FG002|Phase 1|Reason not specified|0|||
147313284|NCT01091428|531313846|FG003|Phase 1|Reason not specified|0|||
147313285|NCT01091428|531313843|FG000|Phase 1|Single-Patient IND|2|||
147119373|NCT00114777|530603369|FG002|Randomization to Month 36|Death|3|||
147119374|NCT00114777|530603367|FG000|Randomization to Month 36|No Longer Met Study Criteria|0|||
147119375|NCT00114777|530603368|FG001|Randomization to Month 36|No Longer Met Study Criteria|0|||
147119376|NCT00114777|530603369|FG002|Randomization to Month 36|No Longer Met Study Criteria|2|||
147119377|NCT00114777|530603367|FG000|Randomization to Month 36|Lack of Efficacy|19|||
147119378|NCT00114777|530603368|FG001|Randomization to Month 36|Lack of Efficacy|15|||
147119379|NCT00114777|530603369|FG002|Randomization to Month 36|Lack of Efficacy|17|||
147231390|NCT03131453|531019671|FG002|Overall Study|Protocol deviation|0|||
147231391|NCT04176705|531019672|FG000|Overall Study|Withdrawal by Subject|4|||
147231392|NCT04176705|531019673|FG001|Overall Study|Withdrawal by Subject|4|||
147119380|NCT00114777|530603367|FG000|Randomization to Month 36|Poor or Non-Compliance|0|||
147231393|NCT04176705|531019672|FG000|Overall Study|Death|1|||
147231394|NCT04176705|531019673|FG001|Overall Study|Death|1|||
147231395|NCT04176705|531019672|FG000|Overall Study|Lost to Follow-up|3|||
147119381|NCT00114777|530603368|FG001|Randomization to Month 36|Poor or Non-Compliance|0|||
147119382|NCT00114777|530603369|FG002|Randomization to Month 36|Poor or Non-Compliance|1|||
147231396|NCT04176705|531019673|FG001|Overall Study|Lost to Follow-up|3|||
147231397|NCT03805646|531019686|FG000|Overall Study|Death|40|||
147231398|NCT03805646|531019687|FG001|Overall Study|Death|49|||
147231399|NCT03805646|531019686|FG000|Overall Study|Not reached on phone/ Did not consent|614|||
147231400|NCT03805646|531019687|FG001|Overall Study|Not reached on phone/ Did not consent|936|||
147231401|NCT02925923|531021198|FG000|Overall Study|blood samples hemolyzed|0|||
147231402|NCT02925923|531021199|FG001|Overall Study|blood samples hemolyzed|2|||
147231403|NCT01863953|531021200|FG000|Overall Study|Adverse Event|0|||
147231404|NCT01863953|531021201|FG001|Overall Study|Adverse Event|0|||
147231405|NCT01863953|531021202|FG002|Overall Study|Adverse Event|1|||
147231406|NCT01824342|531021210|FG000|Overall Study|Withdrawal by Subject|0|||
147231407|NCT01824342|531021211|FG001|Overall Study|Withdrawal by Subject|3|||
147231408|NCT01824342|531021210|FG000|Overall Study|Adverse Event|1|||
147231409|NCT01824342|531021211|FG001|Overall Study|Adverse Event|1|||
147231410|NCT01824342|531021210|FG000|Overall Study|Disease Progression|1|||
147231411|NCT01824342|531021211|FG001|Overall Study|Disease Progression|1|||
147231412|NCT01824342|531021210|FG000|Overall Study|Physician Decision|5|||
147231413|NCT01824342|531021211|FG001|Overall Study|Physician Decision|0|||
147231414|NCT01824342|531021210|FG000|Overall Study|Death|2|||
147231415|NCT01824342|531021211|FG001|Overall Study|Death|0|||
147231416|NCT04195906|531021214|FG000|Part 1|Adverse Event|3|||
147231417|NCT04195906|531021215|FG001|Part 1|Adverse Event|7|||
147231418|NCT04195906|531021214|FG000|Part 1|Withdrawal by Subject|0|||
147231419|NCT04195906|531021215|FG001|Part 1|Withdrawal by Subject|1|||
147231420|NCT04195906|531021214|FG000|Part 2|Adverse Event|1|||
147231421|NCT04195906|531021215|FG001|Part 2|Adverse Event|1|||
147231422|NCT04195906|531021214|FG000|Part 2|Withdrawal by Subject|0|||
147231423|NCT04195906|531021215|FG001|Part 2|Withdrawal by Subject|3|||
147231424|NCT04195906|531021214|FG000|Part 2|Other|1|||
147231425|NCT04195906|531021215|FG001|Part 2|Other|3|||
147231426|NCT00385762|531021222|FG000|Overall Study|Adverse Event|1|||
147231427|NCT00385762|531021222|FG000|Overall Study|Lost to Follow-up|1|||
147119383|NCT00114777|530603367|FG000|Randomization to Month 36|Adverse Event|34|||
147119384|NCT00114777|530603368|FG001|Randomization to Month 36|Adverse Event|35|||
147119385|NCT00114777|530603369|FG002|Randomization to Month 36|Adverse Event|44|||
147119386|NCT00114777|530603367|FG000|Randomization to Month 36|Withdrawal by Subject|3|||
147119387|NCT00114777|530603368|FG001|Randomization to Month 36|Withdrawal by Subject|4|||
147119388|NCT00114777|530603369|FG002|Randomization to Month 36|Withdrawal by Subject|5|||
147119389|NCT00114777|530603367|FG000|Randomization to Month 36|Other|9|||
147119390|NCT00114777|530603368|FG001|Randomization to Month 36|Other|3|||
147119391|NCT00114777|530603369|FG002|Randomization to Month 36|Other|12|||
147119392|NCT00114777|530603367|FG000|Long-Term Extension to Month 84|Death|8|||
147119393|NCT00114777|530603368|FG001|Long-Term Extension to Month 84|Death|13|||
147119394|NCT00114777|530603369|FG002|Long-Term Extension to Month 84|Death|7|||
147119395|NCT00114777|530603367|FG000|Long-Term Extension to Month 84|No Longer Met Study Criteria|1|||
147119396|NCT00114777|530603368|FG001|Long-Term Extension to Month 84|No Longer Met Study Criteria|0|||
147119397|NCT00114777|530603369|FG002|Long-Term Extension to Month 84|No Longer Met Study Criteria|1|||
147119398|NCT00114777|530603367|FG000|Long-Term Extension to Month 84|Lack of Efficacy|1|||
147119399|NCT00114777|530603368|FG001|Long-Term Extension to Month 84|Lack of Efficacy|0|||
147119400|NCT00114777|530603369|FG002|Long-Term Extension to Month 84|Lack of Efficacy|1|||
147119401|NCT00114777|530603367|FG000|Long-Term Extension to Month 84|Poor or Non-Compliance|1|||
147119402|NCT00114777|530603368|FG001|Long-Term Extension to Month 84|Poor or Non-Compliance|1|||
147119403|NCT00114777|530603369|FG002|Long-Term Extension to Month 84|Poor or Non-Compliance|3|||
147119404|NCT00114777|530603367|FG000|Long-Term Extension to Month 84|Adverse Event|15|||
147119405|NCT00114777|530603368|FG001|Long-Term Extension to Month 84|Adverse Event|14|||
147119406|NCT00114777|530603369|FG002|Long-Term Extension to Month 84|Adverse Event|7|||
147119407|NCT00114777|530603367|FG000|Long-Term Extension to Month 84|Withdrawal by Subject|2|||
147119408|NCT00114777|530603368|FG001|Long-Term Extension to Month 84|Withdrawal by Subject|1|||
147119409|NCT00114777|530603369|FG002|Long-Term Extension to Month 84|Withdrawal by Subject|6|||
147119410|NCT00114777|530603367|FG000|Long-Term Extension to Month 84|Lost to Follow-up|0|||
147119411|NCT00114777|530603368|FG001|Long-Term Extension to Month 84|Lost to Follow-up|0|||
147119412|NCT00114777|530603369|FG002|Long-Term Extension to Month 84|Lost to Follow-up|2|||
147119413|NCT00114777|530603367|FG000|Long-Term Extension to Month 84|Administrative Reason by Sponsor|0|||
147119414|NCT00114777|530603368|FG001|Long-Term Extension to Month 84|Administrative Reason by Sponsor|0|||
147119415|NCT00114777|530603369|FG002|Long-Term Extension to Month 84|Administrative Reason by Sponsor|1|||
147119416|NCT00114777|530603367|FG000|Long-Term Extension to Month 84|Other|2|||
147119417|NCT00114777|530603368|FG001|Long-Term Extension to Month 84|Other|0|||
147119418|NCT00114777|530603369|FG002|Long-Term Extension to Month 84|Other|2|||
147119419|NCT04243837|530603373|FG000|Overall Study|Adverse Event|2|||
147119420|NCT04243837|530603374|FG001|Overall Study|Adverse Event|1|||
147119421|NCT04243837|530603373|FG000|Overall Study|Withdrawal by Subject|4|||
147119422|NCT04243837|530603374|FG001|Overall Study|Withdrawal by Subject|2|||
147119423|NCT04243837|530603373|FG000|Overall Study|Covid-19 lock down|1|||
147119424|NCT04243837|530603374|FG001|Overall Study|Covid-19 lock down|0|||
147119425|NCT04243837|530603373|FG000|Overall Study|Study Terminated by Sponsor|11|||
147119426|NCT04243837|530603374|FG001|Overall Study|Study Terminated by Sponsor|12|||
147119427|NCT02675452|530603382|FG000|Overall Study|Sponsor decision|0|||
147119428|NCT02675452|530603383|FG001|Overall Study|Sponsor decision|0|||
147119429|NCT02675452|530603384|FG002|Overall Study|Sponsor decision|0|||
147119430|NCT02675452|530603385|FG003|Overall Study|Sponsor decision|0|||
147119431|NCT02675452|530603386|FG004|Overall Study|Sponsor decision|0|||
147119432|NCT02675452|530603387|FG005|Overall Study|Sponsor decision|0|||
147119433|NCT02675452|530603388|FG006|Overall Study|Sponsor decision|0|||
147119434|NCT02675452|530603389|FG007|Overall Study|Sponsor decision|0|||
147119435|NCT02675452|530603390|FG008|Overall Study|Sponsor decision|0|||
147119436|NCT02675452|530603391|FG009|Overall Study|Sponsor decision|1|||
147119437|NCT02675452|530603392|FG010|Overall Study|Sponsor decision|0|||
147119438|NCT02675452|530603393|FG011|Overall Study|Sponsor decision|0|||
147119439|NCT02675452|530603394|FG012|Overall Study|Sponsor decision|0|||
147119440|NCT02675452|530603395|FG013|Overall Study|Sponsor decision|2|||
147119441|NCT02675452|530603396|FG014|Overall Study|Sponsor decision|1|||
147119442|NCT02675452|530603397|FG015|Overall Study|Sponsor decision|0|||
147119443|NCT02675452|530603398|FG016|Overall Study|Sponsor decision|1|||
147119444|NCT02675452|530603399|FG017|Overall Study|Sponsor decision|0|||
147119445|NCT02675452|530603400|FG018|Overall Study|Sponsor decision|0|||
147119446|NCT02675452|530603401|FG019|Overall Study|Sponsor decision|0|||
147119447|NCT02675452|530603402|FG020|Overall Study|Sponsor decision|0|||
147119448|NCT02675452|530603403|FG021|Overall Study|Sponsor decision|0|||
147119449|NCT02675452|530603404|FG022|Overall Study|Sponsor decision|0|||
147119450|NCT02675452|530603405|FG023|Overall Study|Sponsor decision|0|||
147119451|NCT02675452|530603406|FG024|Overall Study|Sponsor decision|0|||
147119452|NCT02675452|530603407|FG025|Overall Study|Sponsor decision|0|||
147119453|NCT02675452|530603408|FG026|Overall Study|Sponsor decision|2|||
147119454|NCT02675452|530603409|FG027|Overall Study|Sponsor decision|0|||
147119455|NCT02675452|530603410|FG028|Overall Study|Sponsor decision|0|||
147119456|NCT02675452|530603382|FG000|Overall Study|Withdrawal by Subject|0|||
147119457|NCT02675452|530603383|FG001|Overall Study|Withdrawal by Subject|0|||
147119458|NCT02675452|530603384|FG002|Overall Study|Withdrawal by Subject|0|||
147119459|NCT02675452|530603385|FG003|Overall Study|Withdrawal by Subject|0|||
147119460|NCT02675452|530603386|FG004|Overall Study|Withdrawal by Subject|0|||
147119461|NCT02675452|530603387|FG005|Overall Study|Withdrawal by Subject|0|||
147119462|NCT02675452|530603388|FG006|Overall Study|Withdrawal by Subject|0|||
147119463|NCT02675452|530603389|FG007|Overall Study|Withdrawal by Subject|0|||
147119464|NCT02675452|530603390|FG008|Overall Study|Withdrawal by Subject|0|||
147119465|NCT02675452|530603391|FG009|Overall Study|Withdrawal by Subject|1|||
147119466|NCT02675452|530603392|FG010|Overall Study|Withdrawal by Subject|0|||
147119467|NCT02675452|530603393|FG011|Overall Study|Withdrawal by Subject|1|||
147119468|NCT02675452|530603394|FG012|Overall Study|Withdrawal by Subject|0|||
147119469|NCT02675452|530603395|FG013|Overall Study|Withdrawal by Subject|1|||
147119470|NCT02675452|530603396|FG014|Overall Study|Withdrawal by Subject|1|||
147119471|NCT02675452|530603397|FG015|Overall Study|Withdrawal by Subject|0|||
147119472|NCT02675452|530603398|FG016|Overall Study|Withdrawal by Subject|2|||
147119473|NCT02675452|530603399|FG017|Overall Study|Withdrawal by Subject|0|||
147119474|NCT02675452|530603400|FG018|Overall Study|Withdrawal by Subject|0|||
147119475|NCT02675452|530603401|FG019|Overall Study|Withdrawal by Subject|0|||
147119476|NCT02675452|530603402|FG020|Overall Study|Withdrawal by Subject|0|||
147119477|NCT02675452|530603403|FG021|Overall Study|Withdrawal by Subject|0|||
147119478|NCT02675452|530603404|FG022|Overall Study|Withdrawal by Subject|3|||
147119479|NCT02675452|530603405|FG023|Overall Study|Withdrawal by Subject|0|||
147119480|NCT02675452|530603406|FG024|Overall Study|Withdrawal by Subject|1|||
147119481|NCT02675452|530603407|FG025|Overall Study|Withdrawal by Subject|0|||
147119482|NCT02675452|530603408|FG026|Overall Study|Withdrawal by Subject|1|||
147119483|NCT02675452|530603409|FG027|Overall Study|Withdrawal by Subject|3|||
147119484|NCT02675452|530603410|FG028|Overall Study|Withdrawal by Subject|4|||
147231428|NCT02104752|531021223|FG000|Overall Study|Withdrawal by Subject|1|||
147231429|NCT02104752|531021224|FG001|Overall Study|Withdrawal by Subject|0|||
147119485|NCT02675452|530603382|FG000|Overall Study|Death|0|||
147119486|NCT02675452|530603383|FG001|Overall Study|Death|0|||
147231430|NCT02104752|531021223|FG000|Overall Study|Weight gain; unrelated anxiety|0|||
147231431|NCT02104752|531021224|FG001|Overall Study|Weight gain; unrelated anxiety|2|||
147231432|NCT02899299|531021225|FG000|Pre-treatment|Participant request to discontinue study treatment|0|||
147231433|NCT02899299|531021226|FG001|Pre-treatment|Participant request to discontinue study treatment|3|||
147119487|NCT02675452|530603384|FG002|Overall Study|Death|1|||
147119488|NCT02675452|530603385|FG003|Overall Study|Death|0|||
147119489|NCT02675452|530603386|FG004|Overall Study|Death|0|||
147119490|NCT02675452|530603387|FG005|Overall Study|Death|1|||
147119491|NCT02675452|530603388|FG006|Overall Study|Death|0|||
147119492|NCT02675452|530603389|FG007|Overall Study|Death|0|||
147119493|NCT02675452|530603390|FG008|Overall Study|Death|1|||
147119494|NCT02675452|530603391|FG009|Overall Study|Death|0|||
147119495|NCT02675452|530603392|FG010|Overall Study|Death|0|||
147119496|NCT02675452|530603393|FG011|Overall Study|Death|0|||
147119497|NCT02675452|530603394|FG012|Overall Study|Death|1|||
147119498|NCT02675452|530603395|FG013|Overall Study|Death|0|||
147119499|NCT02675452|530603396|FG014|Overall Study|Death|0|||
147119500|NCT02675452|530603397|FG015|Overall Study|Death|2|||
147119501|NCT02675452|530603398|FG016|Overall Study|Death|0|||
147119502|NCT02675452|530603399|FG017|Overall Study|Death|0|||
147119503|NCT02675452|530603400|FG018|Overall Study|Death|4|||
147231434|NCT02899299|531021225|FG000|Pre-treatment|Participant withdrew consent|1|||
147231435|NCT02899299|531021226|FG001|Pre-treatment|Participant withdrew consent|11|||
147231436|NCT02899299|531021225|FG000|Pre-treatment|Participant no longer meets study criteria|2|||
147231437|NCT02899299|531021226|FG001|Pre-treatment|Participant no longer meets study criteria|3|||
147231438|NCT02899299|531021225|FG000|Pre-treatment|Not reported|0|||
147231439|NCT02899299|531021226|FG001|Pre-treatment|Not reported|1|||
147231440|NCT02899299|531021225|FG000|Treatment|Disease Progression|182|||
147231441|NCT02899299|531021226|FG001|Treatment|Disease Progression|43|||
147231442|NCT02899299|531021225|FG000|Treatment|Study Drug Toxicity|60|||
147231443|NCT02899299|531021226|FG001|Treatment|Study Drug Toxicity|24|||
147231444|NCT02899299|531021225|FG000|Treatment|Adverse Event unrelated to Study Drug|11|||
147231445|NCT02899299|531021226|FG001|Treatment|Adverse Event unrelated to Study Drug|9|||
147231446|NCT02899299|531021225|FG000|Treatment|Participant request to discontinue Study treatment|4|||
147231447|NCT02899299|531021226|FG001|Treatment|Participant request to discontinue Study treatment|10|||
147231448|NCT02899299|531021225|FG000|Treatment|Participant withdrew consent|6|||
147231449|NCT02899299|531021226|FG001|Treatment|Participant withdrew consent|3|||
147231450|NCT02899299|531021225|FG000|Treatment|Lost to Follow-up|0|||
147231451|NCT02899299|531021226|FG001|Treatment|Lost to Follow-up|2|||
147231452|NCT02899299|531021225|FG000|Treatment|Maximum Clinical Benefit|11|||
147231453|NCT02899299|531021226|FG001|Treatment|Maximum Clinical Benefit|2|||
147231454|NCT02899299|531021225|FG000|Treatment|Poor/Non-compliance|1|||
147231455|NCT02899299|531021226|FG001|Treatment|Poor/Non-compliance|0|||
147231456|NCT02899299|531021225|FG000|Treatment|Participant no longer meets Study criteria|4|||
147231457|NCT02899299|531021226|FG001|Treatment|Participant no longer meets Study criteria|0|||
147231458|NCT02899299|531021225|FG000|Treatment|Administrative reason by Sponsor|2|||
147231459|NCT02899299|531021226|FG001|Treatment|Administrative reason by Sponsor|0|||
147231460|NCT02899299|531021225|FG000|Treatment|Other reasons|12|||
147231461|NCT02899299|531021226|FG001|Treatment|Other reasons|2|||
147231462|NCT02899299|531021225|FG000|Treatment|Not reported|7|||
147231463|NCT02899299|531021226|FG001|Treatment|Not reported|0|||
147231464|NCT00313300|531021227|FG000|Randomized in Phase A (26 Weeks)|Adverse Event|19|||
147231465|NCT00313300|531021228|FG001|Randomized in Phase A (26 Weeks)|Adverse Event|14|||
147231466|NCT00313300|531021229|FG002|Randomized in Phase A (26 Weeks)|Adverse Event|17|||
147231467|NCT00313300|531021230|FG003|Randomized in Phase A (26 Weeks)|Adverse Event|0|||
147231468|NCT00313300|531021231|FG004|Randomized in Phase A (26 Weeks)|Adverse Event|0|||
147231469|NCT00313300|531021227|FG000|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|20|||
147231470|NCT00313300|531021228|FG001|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|12|||
147231471|NCT00313300|531021229|FG002|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|13|||
147231472|NCT00313300|531021230|FG003|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|0|||
147231473|NCT00313300|531021231|FG004|Randomized in Phase A (26 Weeks)|Withdrawal by Subject|0|||
147231474|NCT00313300|531021227|FG000|Randomized in Phase A (26 Weeks)|Death|3|||
147231475|NCT00313300|531021228|FG001|Randomized in Phase A (26 Weeks)|Death|4|||
147231476|NCT00313300|531021229|FG002|Randomized in Phase A (26 Weeks)|Death|0|||
147231477|NCT00313300|531021230|FG003|Randomized in Phase A (26 Weeks)|Death|0|||
147231478|NCT00313300|531021231|FG004|Randomized in Phase A (26 Weeks)|Death|0|||
147231479|NCT00313300|531021227|FG000|Randomized in Phase A (26 Weeks)|Lost to Follow-up|4|||
147231480|NCT00313300|531021228|FG001|Randomized in Phase A (26 Weeks)|Lost to Follow-up|4|||
147231481|NCT00313300|531021229|FG002|Randomized in Phase A (26 Weeks)|Lost to Follow-up|2|||
147231482|NCT00313300|531021230|FG003|Randomized in Phase A (26 Weeks)|Lost to Follow-up|0|||
147231483|NCT00313300|531021231|FG004|Randomized in Phase A (26 Weeks)|Lost to Follow-up|0|||
147231484|NCT00313300|531021227|FG000|Randomized in Phase A (26 Weeks)|Poor/non-compliance|3|||
147231485|NCT00313300|531021228|FG001|Randomized in Phase A (26 Weeks)|Poor/non-compliance|2|||
147231486|NCT00313300|531021229|FG002|Randomized in Phase A (26 Weeks)|Poor/non-compliance|1|||
147231487|NCT00313300|531021230|FG003|Randomized in Phase A (26 Weeks)|Poor/non-compliance|0|||
147231488|NCT00313300|531021231|FG004|Randomized in Phase A (26 Weeks)|Poor/non-compliance|0|||
147231489|NCT00313300|531021227|FG000|Randomized in Phase A (26 Weeks)|no longer meets criteria|4|||
147119504|NCT02675452|530603401|FG019|Overall Study|Death|3|||
147231490|NCT00313300|531021228|FG001|Randomized in Phase A (26 Weeks)|no longer meets criteria|3|||
147231491|NCT00313300|531021229|FG002|Randomized in Phase A (26 Weeks)|no longer meets criteria|2|||
147231492|NCT00313300|531021230|FG003|Randomized in Phase A (26 Weeks)|no longer meets criteria|0|||
147231493|NCT00313300|531021231|FG004|Randomized in Phase A (26 Weeks)|no longer meets criteria|0|||
147231494|NCT00313300|531021227|FG000|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|1|||
147119505|NCT02675452|530603402|FG020|Overall Study|Death|3|||
147119506|NCT02675452|530603403|FG021|Overall Study|Death|3|||
147119507|NCT02675452|530603404|FG022|Overall Study|Death|7|||
147119508|NCT02675452|530603405|FG023|Overall Study|Death|5|||
147119509|NCT02675452|530603406|FG024|Overall Study|Death|3|||
147119510|NCT02675452|530603407|FG025|Overall Study|Death|4|||
147119511|NCT02675452|530603408|FG026|Overall Study|Death|7|||
147119512|NCT02675452|530603409|FG027|Overall Study|Death|6|||
147119513|NCT02675452|530603410|FG028|Overall Study|Death|9|||
147119514|NCT02675452|530603382|FG000|Overall Study|Lost to Follow-up|0|||
147119515|NCT02675452|530603383|FG001|Overall Study|Lost to Follow-up|1|||
147119516|NCT02675452|530603384|FG002|Overall Study|Lost to Follow-up|0|||
147119517|NCT02675452|530603385|FG003|Overall Study|Lost to Follow-up|0|||
147119518|NCT02675452|530603386|FG004|Overall Study|Lost to Follow-up|0|||
147119519|NCT02675452|530603387|FG005|Overall Study|Lost to Follow-up|0|||
147119520|NCT02675452|530603388|FG006|Overall Study|Lost to Follow-up|0|||
147119521|NCT02675452|530603389|FG007|Overall Study|Lost to Follow-up|0|||
147119522|NCT02675452|530603390|FG008|Overall Study|Lost to Follow-up|0|||
147119523|NCT02675452|530603391|FG009|Overall Study|Lost to Follow-up|0|||
147119524|NCT02675452|530603392|FG010|Overall Study|Lost to Follow-up|0|||
147119525|NCT02675452|530603393|FG011|Overall Study|Lost to Follow-up|0|||
147119526|NCT02675452|530603394|FG012|Overall Study|Lost to Follow-up|1|||
147119527|NCT02675452|530603395|FG013|Overall Study|Lost to Follow-up|0|||
147119528|NCT02675452|530603396|FG014|Overall Study|Lost to Follow-up|0|||
147119529|NCT02675452|530603397|FG015|Overall Study|Lost to Follow-up|0|||
147119530|NCT02675452|530603398|FG016|Overall Study|Lost to Follow-up|0|||
147119531|NCT02675452|530603399|FG017|Overall Study|Lost to Follow-up|0|||
147231495|NCT00313300|531021228|FG001|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0|||
147231496|NCT00313300|531021229|FG002|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0|||
147231497|NCT00313300|531021230|FG003|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0|||
147231498|NCT00313300|531021231|FG004|Randomized in Phase A (26 Weeks)|Administrative reason (arm terminated)|0|||
147231499|NCT00313300|531021227|FG000|Randomized in Phase B (26 Weeks)|Adverse Event|34|||
147231500|NCT00313300|531021228|FG001|Randomized in Phase B (26 Weeks)|Adverse Event|9|||
147231501|NCT00313300|531021229|FG002|Randomized in Phase B (26 Weeks)|Adverse Event|12|||
147231502|NCT00313300|531021230|FG003|Randomized in Phase B (26 Weeks)|Adverse Event|23|||
147231503|NCT00313300|531021231|FG004|Randomized in Phase B (26 Weeks)|Adverse Event|19|||
147231504|NCT00313300|531021227|FG000|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|35|||
147231505|NCT00313300|531021228|FG001|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|14|||
147231506|NCT00313300|531021229|FG002|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|19|||
147231507|NCT00313300|531021230|FG003|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|15|||
147231508|NCT00313300|531021231|FG004|Randomized in Phase B (26 Weeks)|Withdrawal by Subject|19|||
147231509|NCT00313300|531021227|FG000|Randomized in Phase B (26 Weeks)|Death|5|||
147231510|NCT00313300|531021228|FG001|Randomized in Phase B (26 Weeks)|Death|3|||
147231511|NCT00313300|531021229|FG002|Randomized in Phase B (26 Weeks)|Death|1|||
147231512|NCT00313300|531021230|FG003|Randomized in Phase B (26 Weeks)|Death|0|||
147231513|NCT00313300|531021231|FG004|Randomized in Phase B (26 Weeks)|Death|1|||
147231514|NCT00313300|531021227|FG000|Randomized in Phase B (26 Weeks)|Lost to Follow-up|5|||
147231515|NCT00313300|531021228|FG001|Randomized in Phase B (26 Weeks)|Lost to Follow-up|2|||
147231516|NCT00313300|531021229|FG002|Randomized in Phase B (26 Weeks)|Lost to Follow-up|3|||
147231517|NCT00313300|531021230|FG003|Randomized in Phase B (26 Weeks)|Lost to Follow-up|2|||
147231518|NCT00313300|531021231|FG004|Randomized in Phase B (26 Weeks)|Lost to Follow-up|3|||
147231519|NCT00313300|531021227|FG000|Randomized in Phase B (26 Weeks)|poor/non-compliance|3|||
147313286|NCT01091428|531313844|FG001|Phase 1|Single-Patient IND|0|||
147119532|NCT02675452|530603400|FG018|Overall Study|Lost to Follow-up|0|||
147119533|NCT02675452|530603401|FG019|Overall Study|Lost to Follow-up|0|||
147119534|NCT02675452|530603402|FG020|Overall Study|Lost to Follow-up|0|||
147231520|NCT00313300|531021228|FG001|Randomized in Phase B (26 Weeks)|poor/non-compliance|1|||
147231521|NCT00313300|531021229|FG002|Randomized in Phase B (26 Weeks)|poor/non-compliance|3|||
147231522|NCT00313300|531021230|FG003|Randomized in Phase B (26 Weeks)|poor/non-compliance|0|||
147231523|NCT00313300|531021231|FG004|Randomized in Phase B (26 Weeks)|poor/non-compliance|0|||
147231524|NCT00313300|531021227|FG000|Randomized in Phase B (26 Weeks)|no longer meets criteria|9|||
147231525|NCT00313300|531021228|FG001|Randomized in Phase B (26 Weeks)|no longer meets criteria|3|||
147231526|NCT00313300|531021229|FG002|Randomized in Phase B (26 Weeks)|no longer meets criteria|2|||
147231527|NCT00313300|531021230|FG003|Randomized in Phase B (26 Weeks)|no longer meets criteria|0|||
147313287|NCT01091428|531313845|FG002|Phase 1|Single-Patient IND|0|||
147119535|NCT02675452|530603403|FG021|Overall Study|Lost to Follow-up|0|||
147119536|NCT02675452|530603404|FG022|Overall Study|Lost to Follow-up|0|||
147119537|NCT02675452|530603405|FG023|Overall Study|Lost to Follow-up|0|||
147119538|NCT02675452|530603406|FG024|Overall Study|Lost to Follow-up|0|||
147119539|NCT02675452|530603407|FG025|Overall Study|Lost to Follow-up|0|||
147119540|NCT02675452|530603408|FG026|Overall Study|Lost to Follow-up|1|||
147119541|NCT02675452|530603409|FG027|Overall Study|Lost to Follow-up|0|||
147313288|NCT01091428|531313846|FG003|Phase 1|Single-Patient IND|0|||
147119542|NCT02675452|530603410|FG028|Overall Study|Lost to Follow-up|0|||
147119543|NCT02675452|530603382|FG000|Overall Study|Other|0|||
147119544|NCT02675452|530603383|FG001|Overall Study|Other|0|||
147119545|NCT02675452|530603384|FG002|Overall Study|Other|0|||
147119546|NCT02675452|530603385|FG003|Overall Study|Other|0|||
147119547|NCT02675452|530603386|FG004|Overall Study|Other|0|||
147119548|NCT02675452|530603387|FG005|Overall Study|Other|0|||
147119549|NCT02675452|530603388|FG006|Overall Study|Other|0|||
147119550|NCT02675452|530603389|FG007|Overall Study|Other|0|||
147119551|NCT02675452|530603390|FG008|Overall Study|Other|0|||
147119552|NCT02675452|530603391|FG009|Overall Study|Other|0|||
147119553|NCT02675452|530603392|FG010|Overall Study|Other|0|||
147119554|NCT02675452|530603393|FG011|Overall Study|Other|0|||
147119555|NCT02675452|530603394|FG012|Overall Study|Other|0|||
147119556|NCT02675452|530603395|FG013|Overall Study|Other|0|||
147119557|NCT02675452|530603396|FG014|Overall Study|Other|0|||
147119558|NCT02675452|530603397|FG015|Overall Study|Other|0|||
147119559|NCT02675452|530603398|FG016|Overall Study|Other|0|||
147119560|NCT02675452|530603399|FG017|Overall Study|Other|0|||
147119561|NCT02675452|530603400|FG018|Overall Study|Other|0|||
147119562|NCT02675452|530603401|FG019|Overall Study|Other|0|||
147119563|NCT02675452|530603402|FG020|Overall Study|Other|0|||
147119564|NCT02675452|530603403|FG021|Overall Study|Other|0|||
147119565|NCT02675452|530603404|FG022|Overall Study|Other|0|||
147119566|NCT02675452|530603405|FG023|Overall Study|Other|0|||
147119567|NCT02675452|530603406|FG024|Overall Study|Other|0|||
147119568|NCT02675452|530603407|FG025|Overall Study|Other|0|||
147119569|NCT02675452|530603408|FG026|Overall Study|Other|1|||
147119570|NCT02675452|530603409|FG027|Overall Study|Other|0|||
147119571|NCT02675452|530603410|FG028|Overall Study|Other|0|||
147119572|NCT00545948|530603411|FG000|Overall Study|Not Treated|1|||
147119573|NCT00545948|530603412|FG001|Overall Study|Not Treated|1|||
147119574|NCT00545948|530603413|FG002|Overall Study|Not Treated|7|||
147119575|NCT03467945|530603414|FG000|Treatment Period 2|Withdrawal by Subject|0|||
147119576|NCT03467945|530603415|FG001|Treatment Period 2|Withdrawal by Subject|1|||
147119577|NCT03467945|530603416|FG002|Treatment Period 2|Withdrawal by Subject|0|||
147119578|NCT03467945|530603417|FG003|Treatment Period 2|Withdrawal by Subject|0|||
147119579|NCT03467945|530603414|FG000|Treatment Period 3|Withdrawal by Subject|1|||
147119580|NCT03467945|530603415|FG001|Treatment Period 3|Withdrawal by Subject|0|||
147119581|NCT03467945|530603416|FG002|Treatment Period 3|Withdrawal by Subject|2|||
147119582|NCT03467945|530603417|FG003|Treatment Period 3|Withdrawal by Subject|1|||
147119583|NCT01541254|530603420|FG000|Overall Study|Withdrawal by Subject|1|||
147119584|NCT01541254|530603420|FG000|Overall Study|excluded - metal allergy|1|||
147119585|NCT01541254|530603420|FG000|Overall Study|enrolled after study closed|1|||
147119586|NCT01541254|530603420|FG000|Overall Study|GI bleed prior to procedure|1|||
147119587|NCT01541254|530603420|FG000|Overall Study|stent not required|1|||
147119588|NCT01541254|530603420|FG000|Overall Study|alternate stent used|1|||
147119589|NCT05660538|530603421|FG000|Overall Study|Adverse Event|0|||
147119590|NCT05660538|530603422|FG001|Overall Study|Adverse Event|0|||
147119591|NCT05660538|530603423|FG002|Overall Study|Adverse Event|1|||
147119592|NCT05660538|530603424|FG003|Overall Study|Adverse Event|0|||
147231528|NCT00313300|531021231|FG004|Randomized in Phase B (26 Weeks)|no longer meets criteria|2|||
147231529|NCT00313300|531021227|FG000|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|2|||
147231530|NCT00313300|531021228|FG001|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|1|||
147567740|NCT01796171|532238356|FG006|Treatment Period With Betalutin|Physician Decision|0|||
147567741|NCT01796171|532238357|FG007|Treatment Period With Betalutin|Physician Decision|0|||
147119593|NCT05660538|530603421|FG000|Overall Study|Withdrawal of consent (not due to AE)|1|||
147119594|NCT05660538|530603422|FG001|Overall Study|Withdrawal of consent (not due to AE)|0|||
147231531|NCT00313300|531021229|FG002|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|0|||
147313289|NCT01091428|531313843|FG000|Phase 2|Progressive Disease|0|||
147567742|NCT01796171|532238358|FG008|Treatment Period With Betalutin|Physician Decision|0|||
147567743|NCT01796171|532238359|FG009|Treatment Period With Betalutin|Physician Decision|0|||
147567744|NCT01796171|532238360|FG010|Treatment Period With Betalutin|Physician Decision|5|||
147567745|NCT01796171|532238361|FG011|Treatment Period With Betalutin|Physician Decision|1|||
147119595|NCT05660538|530603423|FG002|Overall Study|Withdrawal of consent (not due to AE)|1|||
147119596|NCT05660538|530603424|FG003|Overall Study|Withdrawal of consent (not due to AE)|0|||
147119597|NCT05660538|530603421|FG000|Overall Study|Lost to Follow-up|0|||
147119598|NCT05660538|530603422|FG001|Overall Study|Lost to Follow-up|0|||
147119599|NCT05660538|530603423|FG002|Overall Study|Lost to Follow-up|1|||
147119600|NCT05660538|530603424|FG003|Overall Study|Lost to Follow-up|1|||
147119601|NCT05660538|530603421|FG000|Overall Study|Death|0|||
147119602|NCT05660538|530603422|FG001|Overall Study|Death|0|||
147119603|NCT05660538|530603423|FG002|Overall Study|Death|1|||
147119604|NCT05660538|530603424|FG003|Overall Study|Death|0|||
147119605|NCT05660538|530603421|FG000|Overall Study|Physician Decision|0|||
147119606|NCT05660538|530603422|FG001|Overall Study|Physician Decision|0|||
147119607|NCT05660538|530603423|FG002|Overall Study|Physician Decision|0|||
147119608|NCT05660538|530603424|FG003|Overall Study|Physician Decision|1|||
147119609|NCT05660538|530603421|FG000|Overall Study|Sponsor Decision|1|||
147119610|NCT05660538|530603422|FG001|Overall Study|Sponsor Decision|0|||
147119611|NCT05660538|530603423|FG002|Overall Study|Sponsor Decision|0|||
147313290|NCT01091428|531313844|FG001|Phase 2|Progressive Disease|0|||
147313291|NCT01091428|531313845|FG002|Phase 2|Progressive Disease|44|||
147313292|NCT01091428|531313846|FG003|Phase 2|Progressive Disease|46|||
147313293|NCT01091428|531313843|FG000|Phase 2|Symptomatic Deterioration|0|||
147313294|NCT01091428|531313844|FG001|Phase 2|Symptomatic Deterioration|0|||
147313295|NCT01091428|531313845|FG002|Phase 2|Symptomatic Deterioration|1|||
147313296|NCT01091428|531313846|FG003|Phase 2|Symptomatic Deterioration|6|||
147313297|NCT01091428|531313843|FG000|Phase 2|Adverse Event|0|||
147313298|NCT01091428|531313844|FG001|Phase 2|Adverse Event|0|||
147313299|NCT01091428|531313845|FG002|Phase 2|Adverse Event|12|||
147313300|NCT01091428|531313846|FG003|Phase 2|Adverse Event|5|||
147313301|NCT01091428|531313843|FG000|Phase 2|Withdrawal by Subject|0|||
147313302|NCT01091428|531313844|FG001|Phase 2|Withdrawal by Subject|0|||
147313303|NCT01091428|531313845|FG002|Phase 2|Withdrawal by Subject|9|||
147313304|NCT01091428|531313846|FG003|Phase 2|Withdrawal by Subject|8|||
147313305|NCT01091428|531313843|FG000|Phase 2|Unsatisfactory Therapeutic Response|0|||
147313306|NCT01091428|531313844|FG001|Phase 2|Unsatisfactory Therapeutic Response|0|||
147313307|NCT01091428|531313845|FG002|Phase 2|Unsatisfactory Therapeutic Response|1|||
147313308|NCT01091428|531313846|FG003|Phase 2|Unsatisfactory Therapeutic Response|1|||
147313309|NCT01091428|531313843|FG000|Phase 2|Reason not specified|0|||
147313310|NCT01091428|531313844|FG001|Phase 2|Reason not specified|0|||
147313311|NCT01091428|531313845|FG002|Phase 2|Reason not specified|4|||
147313312|NCT01091428|531313846|FG003|Phase 2|Reason not specified|3|||
147313313|NCT01091428|531313843|FG000|Phase 2|Physician Decision|0|||
147313314|NCT01091428|531313844|FG001|Phase 2|Physician Decision|0|||
147313315|NCT01091428|531313845|FG002|Phase 2|Physician Decision|2|||
147313316|NCT01091428|531313846|FG003|Phase 2|Physician Decision|0|||
147313317|NCT01625910|531313853|FG000|Overall Study|Lost to Follow-up|3|||
147313318|NCT01625910|531313854|FG001|Overall Study|Lost to Follow-up|4|||
147313319|NCT02391038|531313855|FG000|Overall Study|Progressive disease|3|||
147313320|NCT02391038|531313856|FG001|Overall Study|Progressive disease|3|||
147313321|NCT02391038|531313857|FG002|Overall Study|Progressive disease|6|||
147313322|NCT02959138|531313858|FG000|Overall Study|Enrolled but Never Treated|0|||
147313323|NCT02959138|531313859|FG001|Overall Study|Enrolled but Never Treated|1|||
147313324|NCT02959138|531313860|FG002|Overall Study|Enrolled but Never Treated|0|||
147313325|NCT01327547|531313866|FG000|Overall Study|Adverse Event|4|||
147313326|NCT01327547|531313867|FG001|Overall Study|Adverse Event|1|||
147313327|NCT01327547|531313866|FG000|Overall Study|Death|1|||
147313328|NCT01327547|531313867|FG001|Overall Study|Death|2|||
147313329|NCT01327547|531313866|FG000|Overall Study|Lost to Follow-up|6|||
147313330|NCT01327547|531313867|FG001|Overall Study|Lost to Follow-up|6|||
147313331|NCT01327547|531313866|FG000|Overall Study|Non-Compliance With Study Treatment|0|||
147313332|NCT01327547|531313867|FG001|Overall Study|Non-Compliance With Study Treatment|2|||
147313333|NCT01327547|531313866|FG000|Overall Study|Withdrawal by Subject|3|||
147313334|NCT01327547|531313867|FG001|Overall Study|Withdrawal by Subject|7|||
147313335|NCT01327547|531313866|FG000|Overall Study|Does Not Meet Entrance Criteria|2|||
147313336|NCT01327547|531313867|FG001|Overall Study|Does Not Meet Entrance Criteria|2|||
147313337|NCT01327547|531313866|FG000|Overall Study|Protocol Violation|1|||
147313338|NCT01327547|531313867|FG001|Overall Study|Protocol Violation|0|||
147313339|NCT01327547|531313866|FG000|Overall Study|Non-compliance due to alcohol intake|0|||
147313340|NCT01327547|531313867|FG001|Overall Study|Non-compliance due to alcohol intake|1|||
147313341|NCT01327547|531313866|FG000|Overall Study|Required prohibited medication|2|||
147313342|NCT01327547|531313867|FG001|Overall Study|Required prohibited medication|0|||
147313343|NCT01327547|531313866|FG000|Overall Study|Non-compliance with study procedures|1|||
147119612|NCT05660538|530603424|FG003|Overall Study|Sponsor Decision|0|||
147313344|NCT01327547|531313867|FG001|Overall Study|Non-compliance with study procedures|0|||
147313345|NCT01327547|531313866|FG000|Overall Study|By investigator in subject's interest|0|||
147313346|NCT01327547|531313867|FG001|Overall Study|By investigator in subject's interest|1|||
147444580|NCT01940471|531792645|FG003|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
147444581|NCT01940471|531792642|FG000|Period 2: Open-Label TAF Extension Phase|Lack of Efficacy|0|||
147567746|NCT01796171|532238362|FG012|Treatment Period With Betalutin|Physician Decision|1|||
147567747|NCT01796171|532238363|FG013|Treatment Period With Betalutin|Physician Decision|0|||
147567748|NCT01796171|532238364|FG014|Treatment Period With Betalutin|Physician Decision|0|||
147444582|NCT01940471|531792643|FG001|Period 2: Open-Label TAF Extension Phase|Lack of Efficacy|0|||
147567749|NCT01796171|532238350|FG000|Treatment Period With Betalutin|Death|0|||
147119613|NCT05660538|530603421|FG000|Overall Study|Other|1|||
147313347|NCT00329719|531313868|FG000|Overall Study|Lost to Follow-up|0|||
147313348|NCT00329719|531313869|FG001|Overall Study|Lost to Follow-up|0|||
147313349|NCT00329719|531313870|FG002|Overall Study|Lost to Follow-up|0|||
147444583|NCT01940471|531792644|FG002|Period 2: Open-Label TAF Extension Phase|Lack of Efficacy|2|||
147313350|NCT00329719|531313871|FG003|Overall Study|Lost to Follow-up|1|||
147313351|NCT03918239|531313872|FG000|Overall Study|Lost to Follow-up|3|||
147313352|NCT03918239|531313873|FG001|Overall Study|Lost to Follow-up|1|||
147313353|NCT03918239|531313872|FG000|Overall Study|Pregnancy|0|||
147313354|NCT03918239|531313873|FG001|Overall Study|Pregnancy|2|||
147313355|NCT03918239|531313872|FG000|Overall Study|Withdrawal by Subject|3|||
147119614|NCT05660538|530603422|FG001|Overall Study|Other|0|||
147119615|NCT05660538|530603423|FG002|Overall Study|Other|0|||
147119616|NCT05660538|530603424|FG003|Overall Study|Other|1|||
147119617|NCT05660538|530603421|FG000|Overall Study|Randomized but did not receive study drug|1|||
147119618|NCT05660538|530603422|FG001|Overall Study|Randomized but did not receive study drug|0|||
147119619|NCT05660538|530603423|FG002|Overall Study|Randomized but did not receive study drug|0|||
147119620|NCT05660538|530603424|FG003|Overall Study|Randomized but did not receive study drug|1|||
147119621|NCT05660538|530603421|FG000|Overall Study|Enrolled at clinical trial site excluded from mFAS due to lack of compliance with study drug|5|||
147119622|NCT05660538|530603422|FG001|Overall Study|Enrolled at clinical trial site excluded from mFAS due to lack of compliance with study drug|4|||
147119623|NCT05660538|530603423|FG002|Overall Study|Enrolled at clinical trial site excluded from mFAS due to lack of compliance with study drug|5|||
147119624|NCT05660538|530603424|FG003|Overall Study|Enrolled at clinical trial site excluded from mFAS due to lack of compliance with study drug|5|||
147119625|NCT04518410|530603425|FG000|Overall Study|Lost to Follow-up|1|||
147119626|NCT04518410|530603426|FG001|Overall Study|Lost to Follow-up|1|||
147119627|NCT04518410|530603427|FG002|Overall Study|Lost to Follow-up|8|||
147119628|NCT04518410|530603428|FG003|Overall Study|Lost to Follow-up|5|||
147119629|NCT04518410|530603429|FG004|Overall Study|Lost to Follow-up|92|||
147119630|NCT04518410|530603430|FG005|Overall Study|Lost to Follow-up|25|||
147119631|NCT04518410|530603431|FG006|Overall Study|Lost to Follow-up|25|||
147119632|NCT04518410|530603432|FG007|Overall Study|Lost to Follow-up|3|||
147119633|NCT04518410|530603433|FG008|Overall Study|Lost to Follow-up|2|||
147119634|NCT04518410|530603434|FG009|Overall Study|Lost to Follow-up|13|||
147119635|NCT04518410|530603435|FG010|Overall Study|Lost to Follow-up|9|||
147119636|NCT04518410|530603436|FG011|Overall Study|Lost to Follow-up|13|||
147119637|NCT04518410|530603437|FG012|Overall Study|Lost to Follow-up|9|||
147119638|NCT04518410|530603438|FG013|Overall Study|Lost to Follow-up|13|||
147119639|NCT04518410|530603439|FG014|Overall Study|Lost to Follow-up|8|||
147119640|NCT04518410|530603440|FG015|Overall Study|Lost to Follow-up|10|||
147119641|NCT04518410|530603441|FG016|Overall Study|Lost to Follow-up|6|||
147119642|NCT04518410|530603442|FG017|Overall Study|Lost to Follow-up|13|||
147119643|NCT04518410|530603443|FG018|Overall Study|Lost to Follow-up|21|||
147119644|NCT04518410|530603444|FG019|Overall Study|Lost to Follow-up|6|||
147119645|NCT04518410|530603445|FG020|Overall Study|Lost to Follow-up|7|||
147119646|NCT04518410|530603446|FG021|Overall Study|Lost to Follow-up|21|||
147119647|NCT04518410|530603447|FG022|Overall Study|Lost to Follow-up|1|||
147119648|NCT04518410|530603448|FG023|Overall Study|Lost to Follow-up|7|||
147119649|NCT04518410|530603449|FG024|Overall Study|Lost to Follow-up|6|||
147119650|NCT04518410|530603425|FG000|Overall Study|Withdrawal by Subject|1|||
147119651|NCT04518410|530603426|FG001|Overall Study|Withdrawal by Subject|2|||
147119652|NCT04518410|530603427|FG002|Overall Study|Withdrawal by Subject|2|||
147119653|NCT04518410|530603428|FG003|Overall Study|Withdrawal by Subject|3|||
147119654|NCT04518410|530603429|FG004|Overall Study|Withdrawal by Subject|20|||
147119655|NCT04518410|530603430|FG005|Overall Study|Withdrawal by Subject|20|||
147119656|NCT04518410|530603431|FG006|Overall Study|Withdrawal by Subject|25|||
147119657|NCT04518410|530603432|FG007|Overall Study|Withdrawal by Subject|6|||
147119658|NCT04518410|530603433|FG008|Overall Study|Withdrawal by Subject|1|||
147119659|NCT04518410|530603434|FG009|Overall Study|Withdrawal by Subject|12|||
147119660|NCT04518410|530603435|FG010|Overall Study|Withdrawal by Subject|5|||
147231532|NCT00313300|531021230|FG003|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|193|||
147231533|NCT00313300|531021231|FG004|Randomized in Phase B (26 Weeks)|Administrative reason by Sponsor|164|||
147567750|NCT01796171|532238351|FG001|Treatment Period With Betalutin|Death|0|||
147567751|NCT01796171|532238352|FG002|Treatment Period With Betalutin|Death|0|||
147567752|NCT01796171|532238353|FG003|Treatment Period With Betalutin|Death|0|||
147567753|NCT01796171|532238354|FG004|Treatment Period With Betalutin|Death|0|||
147231534|NCT00313300|531021227|FG000|Randomized in Phase B (26 Weeks)|non-specified|1|||
147231535|NCT00313300|531021228|FG001|Randomized in Phase B (26 Weeks)|non-specified|0|||
147231536|NCT00313300|531021229|FG002|Randomized in Phase B (26 Weeks)|non-specified|0|||
147231537|NCT00313300|531021230|FG003|Randomized in Phase B (26 Weeks)|non-specified|0|||
147231538|NCT00313300|531021231|FG004|Randomized in Phase B (26 Weeks)|non-specified|0|||
147231539|NCT00313300|531021227|FG000|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|5|||
147231540|NCT00313300|531021228|FG001|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|5|||
147231541|NCT00313300|531021229|FG002|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|2|||
147567754|NCT01796171|532238355|FG005|Treatment Period With Betalutin|Death|0|||
147119661|NCT04518410|530603436|FG011|Overall Study|Withdrawal by Subject|7|||
147231542|NCT00313300|531021230|FG003|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|0|||
147119662|NCT04518410|530603437|FG012|Overall Study|Withdrawal by Subject|2|||
147119663|NCT04518410|530603438|FG013|Overall Study|Withdrawal by Subject|13|||
147119664|NCT04518410|530603439|FG014|Overall Study|Withdrawal by Subject|4|||
147119665|NCT04518410|530603440|FG015|Overall Study|Withdrawal by Subject|9|||
147119666|NCT04518410|530603441|FG016|Overall Study|Withdrawal by Subject|0|||
147119667|NCT04518410|530603442|FG017|Overall Study|Withdrawal by Subject|15|||
147119668|NCT04518410|530603443|FG018|Overall Study|Withdrawal by Subject|12|||
147119669|NCT04518410|530603444|FG019|Overall Study|Withdrawal by Subject|9|||
147119670|NCT04518410|530603445|FG020|Overall Study|Withdrawal by Subject|14|||
147119671|NCT04518410|530603446|FG021|Overall Study|Withdrawal by Subject|3|||
147119672|NCT04518410|530603447|FG022|Overall Study|Withdrawal by Subject|2|||
147119673|NCT04518410|530603448|FG023|Overall Study|Withdrawal by Subject|9|||
147313356|NCT03918239|531313873|FG001|Overall Study|Withdrawal by Subject|3|||
147313357|NCT03918239|531313872|FG000|Overall Study|positive urine drug screening results|4|||
147313358|NCT03918239|531313873|FG001|Overall Study|positive urine drug screening results|1|||
147313359|NCT02930122|531313874|FG000|Overall Study|The trial was terminated prior to participating completing the study due to lack of funding.|3|||
147313360|NCT02930122|531313875|FG001|Overall Study|The trial was terminated prior to participating completing the study due to lack of funding.|3|||
147313361|NCT00358215|531313876|FG000|Overall Study|Ineligibility determined|4|||
147313362|NCT00358215|531313877|FG001|Overall Study|Ineligibility determined|3|||
147313363|NCT00358215|531313876|FG000|Overall Study|Adverse Event|83|||
147313364|NCT00358215|531313877|FG001|Overall Study|Adverse Event|65|||
147313365|NCT00358215|531313876|FG000|Overall Study|Withdrawal by Subject|111|||
147313366|NCT00358215|531313877|FG001|Overall Study|Withdrawal by Subject|102|||
147313367|NCT00358215|531313876|FG000|Overall Study|Participant request|65|||
147313368|NCT00358215|531313877|FG001|Overall Study|Participant request|64|||
147313369|NCT00358215|531313876|FG000|Overall Study|Physician Decision|47|||
147313370|NCT00358215|531313877|FG001|Overall Study|Physician Decision|39|||
147313371|NCT00358215|531313876|FG000|Overall Study|Lost to Follow-up|16|||
147313372|NCT00358215|531313877|FG001|Overall Study|Lost to Follow-up|22|||
147313373|NCT00358215|531313876|FG000|Overall Study|Death|265|||
147313374|NCT00358215|531313877|FG001|Overall Study|Death|281|||
147313375|NCT00358215|531313876|FG000|Overall Study|Protocol Violation|64|||
147313376|NCT00358215|531313877|FG001|Overall Study|Protocol Violation|59|||
147313377|NCT00358215|531313876|FG000|Overall Study|Pregnancy|1|||
147313378|NCT00358215|531313877|FG001|Overall Study|Pregnancy|0|||
147313379|NCT00358215|531313876|FG000|Overall Study|Other|21|||
147313380|NCT00358215|531313877|FG001|Overall Study|Other|14|||
147119674|NCT04518410|530603449|FG024|Overall Study|Withdrawal by Subject|8|||
147119675|NCT04518410|530603425|FG000|Overall Study|Other|1|||
147119676|NCT04518410|530603426|FG001|Overall Study|Other|0|||
147119677|NCT04518410|530603427|FG002|Overall Study|Other|0|||
147119678|NCT04518410|530603428|FG003|Overall Study|Other|1|||
147119679|NCT04518410|530603429|FG004|Overall Study|Other|6|||
147119680|NCT04518410|530603430|FG005|Overall Study|Other|6|||
147119681|NCT04518410|530603431|FG006|Overall Study|Other|5|||
147119682|NCT04518410|530603432|FG007|Overall Study|Other|2|||
147119683|NCT04518410|530603433|FG008|Overall Study|Other|0|||
147313381|NCT00358215|531313876|FG000|Overall Study|Did not receive investigational product|2|||
147313382|NCT00358215|531313877|FG001|Overall Study|Did not receive investigational product|3|||
147313383|NCT01681368|531313878|FG000|Overall Study|Refused further treatment|1|||
147313384|NCT01681368|531313878|FG000|Overall Study|Refused further follow up|1|||
147313385|NCT01757665|531313888|FG000|Overall Study|Still on Study - Visit Completed|240|||
147313386|NCT01757665|531313889|FG001|Overall Study|Still on Study - Visit Completed|30|||
147313387|NCT01757665|531313888|FG000|Overall Study|Still on Study - Visit Pending|398|||
147313388|NCT01757665|531313889|FG001|Overall Study|Still on Study - Visit Pending|40|||
147313389|NCT01757665|531313888|FG000|Overall Study|Still on Study - Missed Visit|14|||
147119684|NCT04518410|530603434|FG009|Overall Study|Other|1|||
147119685|NCT04518410|530603435|FG010|Overall Study|Other|0|||
147119686|NCT04518410|530603436|FG011|Overall Study|Other|2|||
147119687|NCT04518410|530603437|FG012|Overall Study|Other|0|||
147119688|NCT04518410|530603438|FG013|Overall Study|Other|0|||
147119689|NCT04518410|530603439|FG014|Overall Study|Other|0|||
147119690|NCT04518410|530603440|FG015|Overall Study|Other|3|||
147119691|NCT04518410|530603441|FG016|Overall Study|Other|1|||
147119692|NCT04518410|530603442|FG017|Overall Study|Other|1|||
147119693|NCT04518410|530603443|FG018|Overall Study|Other|1|||
147119694|NCT04518410|530603444|FG019|Overall Study|Other|0|||
147119695|NCT04518410|530603445|FG020|Overall Study|Other|1|||
147119696|NCT04518410|530603446|FG021|Overall Study|Other|0|||
147119697|NCT04518410|530603447|FG022|Overall Study|Other|1|||
147119698|NCT04518410|530603448|FG023|Overall Study|Other|2|||
147313390|NCT01757665|531313889|FG001|Overall Study|Still on Study - Missed Visit|1|||
147313391|NCT01757665|531313888|FG000|Overall Study|Death|25|||
147313392|NCT01757665|531313889|FG001|Overall Study|Death|8|||
147313393|NCT01757665|531313888|FG000|Overall Study|Explant|1|||
147313394|NCT01757665|531313889|FG001|Overall Study|Explant|2|||
147313395|NCT01757665|531313888|FG000|Overall Study|Withdrawal by Subject|10|||
147444584|NCT01940471|531792645|FG003|Period 2: Open-Label TAF Extension Phase|Lack of Efficacy|0|||
147119699|NCT04518410|530603449|FG024|Overall Study|Other|2|||
147119700|NCT04518410|530603425|FG000|Overall Study|Protocol Violation|0|||
147444585|NCT01940471|531792642|FG000|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
147119701|NCT04518410|530603426|FG001|Overall Study|Protocol Violation|0|||
147119702|NCT04518410|530603427|FG002|Overall Study|Protocol Violation|0|||
147119703|NCT04518410|530603428|FG003|Overall Study|Protocol Violation|2|||
147119704|NCT04518410|530603429|FG004|Overall Study|Protocol Violation|17|||
147119705|NCT04518410|530603430|FG005|Overall Study|Protocol Violation|1|||
147119706|NCT04518410|530603431|FG006|Overall Study|Protocol Violation|2|||
147119707|NCT04518410|530603432|FG007|Overall Study|Protocol Violation|1|||
147119708|NCT04518410|530603433|FG008|Overall Study|Protocol Violation|0|||
147119709|NCT04518410|530603434|FG009|Overall Study|Protocol Violation|0|||
147119710|NCT04518410|530603435|FG010|Overall Study|Protocol Violation|0|||
147119711|NCT04518410|530603436|FG011|Overall Study|Protocol Violation|0|||
147119712|NCT04518410|530603437|FG012|Overall Study|Protocol Violation|0|||
147119713|NCT04518410|530603438|FG013|Overall Study|Protocol Violation|0|||
147119714|NCT04518410|530603439|FG014|Overall Study|Protocol Violation|0|||
147119715|NCT04518410|530603440|FG015|Overall Study|Protocol Violation|0|||
147119716|NCT04518410|530603441|FG016|Overall Study|Protocol Violation|1|||
147119717|NCT04518410|530603442|FG017|Overall Study|Protocol Violation|1|||
147119718|NCT04518410|530603443|FG018|Overall Study|Protocol Violation|0|||
147119719|NCT04518410|530603444|FG019|Overall Study|Protocol Violation|0|||
147119720|NCT04518410|530603445|FG020|Overall Study|Protocol Violation|1|||
147119721|NCT04518410|530603446|FG021|Overall Study|Protocol Violation|2|||
147119722|NCT04518410|530603447|FG022|Overall Study|Protocol Violation|0|||
147119723|NCT04518410|530603448|FG023|Overall Study|Protocol Violation|3|||
147119724|NCT04518410|530603449|FG024|Overall Study|Protocol Violation|0|||
147119725|NCT04518410|530603425|FG000|Overall Study|Death|0|||
147119726|NCT04518410|530603426|FG001|Overall Study|Death|0|||
147119727|NCT04518410|530603427|FG002|Overall Study|Death|0|||
147119728|NCT04518410|530603428|FG003|Overall Study|Death|0|||
147119729|NCT04518410|530603429|FG004|Overall Study|Death|12|||
147119730|NCT04518410|530603430|FG005|Overall Study|Death|2|||
147119731|NCT04518410|530603431|FG006|Overall Study|Death|11|||
147119732|NCT04518410|530603432|FG007|Overall Study|Death|0|||
147567755|NCT01796171|532238356|FG006|Treatment Period With Betalutin|Death|0|||
147119733|NCT04518410|530603433|FG008|Overall Study|Death|1|||
147119734|NCT04518410|530603434|FG009|Overall Study|Death|0|||
147119735|NCT04518410|530603435|FG010|Overall Study|Death|0|||
147119736|NCT04518410|530603436|FG011|Overall Study|Death|0|||
147119737|NCT04518410|530603437|FG012|Overall Study|Death|0|||
147119738|NCT04518410|530603438|FG013|Overall Study|Death|1|||
147119739|NCT04518410|530603439|FG014|Overall Study|Death|1|||
147119740|NCT04518410|530603440|FG015|Overall Study|Death|0|||
147119741|NCT04518410|530603441|FG016|Overall Study|Death|0|||
147119742|NCT04518410|530603442|FG017|Overall Study|Death|1|||
147119743|NCT04518410|530603443|FG018|Overall Study|Death|4|||
147119744|NCT04518410|530603444|FG019|Overall Study|Death|4|||
147119745|NCT04518410|530603445|FG020|Overall Study|Death|1|||
147119746|NCT04518410|530603446|FG021|Overall Study|Death|0|||
147119747|NCT04518410|530603447|FG022|Overall Study|Death|0|||
147119748|NCT04518410|530603448|FG023|Overall Study|Death|0|||
147119749|NCT04518410|530603449|FG024|Overall Study|Death|0|||
147119750|NCT04518410|530603425|FG000|Overall Study|Requirement to start alternative therapy|0|||
147119751|NCT04518410|530603426|FG001|Overall Study|Requirement to start alternative therapy|0|||
147119752|NCT04518410|530603427|FG002|Overall Study|Requirement to start alternative therapy|1|||
147119753|NCT04518410|530603428|FG003|Overall Study|Requirement to start alternative therapy|0|||
147119754|NCT04518410|530603429|FG004|Overall Study|Requirement to start alternative therapy|0|||
147119755|NCT04518410|530603430|FG005|Overall Study|Requirement to start alternative therapy|0|||
147119756|NCT04518410|530603431|FG006|Overall Study|Requirement to start alternative therapy|0|||
147119757|NCT04518410|530603432|FG007|Overall Study|Requirement to start alternative therapy|0|||
147231543|NCT00313300|531021231|FG004|Follow-Up(30days)-Randomized Phase A|Withdrawal by Subject|0|||
147231544|NCT00313300|531021227|FG000|Follow-Up(30days)-Randomized Phase A|Death|0|||
147231545|NCT00313300|531021228|FG001|Follow-Up(30days)-Randomized Phase A|Death|1|||
147231546|NCT00313300|531021229|FG002|Follow-Up(30days)-Randomized Phase A|Death|0|||
147231547|NCT00313300|531021230|FG003|Follow-Up(30days)-Randomized Phase A|Death|0|||
147231548|NCT00313300|531021231|FG004|Follow-Up(30days)-Randomized Phase A|Death|0|||
147231549|NCT00313300|531021227|FG000|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|1|||
147231550|NCT00313300|531021228|FG001|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|0|||
147231551|NCT00313300|531021229|FG002|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|2|||
147231552|NCT00313300|531021230|FG003|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|1|||
147231553|NCT00313300|531021231|FG004|Follow-Up(30days)-Randomized Phase B|Withdrawal by Subject|1|||
147231554|NCT00313300|531021227|FG000|Follow-Up(30days)-Randomized Phase B|Death|1|||
147231555|NCT00313300|531021228|FG001|Follow-Up(30days)-Randomized Phase B|Death|0|||
147567756|NCT01796171|532238357|FG007|Treatment Period With Betalutin|Death|0|||
147567757|NCT01796171|532238358|FG008|Treatment Period With Betalutin|Death|0|||
147567758|NCT01796171|532238359|FG009|Treatment Period With Betalutin|Death|0|||
147567759|NCT01796171|532238360|FG010|Treatment Period With Betalutin|Death|2|||
147119758|NCT04518410|530603433|FG008|Overall Study|Requirement to start alternative therapy|0|||
147119759|NCT04518410|530603434|FG009|Overall Study|Requirement to start alternative therapy|0|||
147119760|NCT04518410|530603435|FG010|Overall Study|Requirement to start alternative therapy|0|||
147119761|NCT04518410|530603436|FG011|Overall Study|Requirement to start alternative therapy|0|||
147119762|NCT04518410|530603437|FG012|Overall Study|Requirement to start alternative therapy|0|||
147119763|NCT04518410|530603438|FG013|Overall Study|Requirement to start alternative therapy|0|||
147119764|NCT04518410|530603439|FG014|Overall Study|Requirement to start alternative therapy|0|||
147119765|NCT04518410|530603440|FG015|Overall Study|Requirement to start alternative therapy|0|||
147119766|NCT04518410|530603441|FG016|Overall Study|Requirement to start alternative therapy|0|||
147119767|NCT04518410|530603442|FG017|Overall Study|Requirement to start alternative therapy|0|||
147119768|NCT04518410|530603443|FG018|Overall Study|Requirement to start alternative therapy|0|||
147119769|NCT04518410|530603444|FG019|Overall Study|Requirement to start alternative therapy|0|||
147119770|NCT04518410|530603445|FG020|Overall Study|Requirement to start alternative therapy|0|||
147119771|NCT04518410|530603446|FG021|Overall Study|Requirement to start alternative therapy|0|||
147119772|NCT04518410|530603447|FG022|Overall Study|Requirement to start alternative therapy|0|||
147119773|NCT04518410|530603448|FG023|Overall Study|Requirement to start alternative therapy|0|||
147119774|NCT04518410|530603449|FG024|Overall Study|Requirement to start alternative therapy|0|||
147119775|NCT04518410|530603425|FG000|Overall Study|Randomized but not treated|0|||
147119776|NCT04518410|530603426|FG001|Overall Study|Randomized but not treated|0|||
147119777|NCT04518410|530603427|FG002|Overall Study|Randomized but not treated|0|||
147119778|NCT04518410|530603428|FG003|Overall Study|Randomized but not treated|2|||
147119779|NCT04518410|530603429|FG004|Overall Study|Randomized but not treated|6|||
147119780|NCT04518410|530603430|FG005|Overall Study|Randomized but not treated|4|||
147119781|NCT04518410|530603431|FG006|Overall Study|Randomized but not treated|3|||
147119782|NCT04518410|530603432|FG007|Overall Study|Randomized but not treated|3|||
147119783|NCT04518410|530603433|FG008|Overall Study|Randomized but not treated|0|||
147119784|NCT04518410|530603434|FG009|Overall Study|Randomized but not treated|4|||
147119785|NCT04518410|530603435|FG010|Overall Study|Randomized but not treated|0|||
147119786|NCT04518410|530603436|FG011|Overall Study|Randomized but not treated|0|||
147119787|NCT04518410|530603437|FG012|Overall Study|Randomized but not treated|1|||
147119788|NCT04518410|530603438|FG013|Overall Study|Randomized but not treated|3|||
147119789|NCT04518410|530603439|FG014|Overall Study|Randomized but not treated|3|||
147119790|NCT04518410|530603440|FG015|Overall Study|Randomized but not treated|3|||
147119791|NCT04518410|530603441|FG016|Overall Study|Randomized but not treated|4|||
147119792|NCT04518410|530603442|FG017|Overall Study|Randomized but not treated|5|||
147119793|NCT04518410|530603443|FG018|Overall Study|Randomized but not treated|4|||
147119794|NCT04518410|530603444|FG019|Overall Study|Randomized but not treated|0|||
147119795|NCT04518410|530603445|FG020|Overall Study|Randomized but not treated|0|||
147119796|NCT04518410|530603446|FG021|Overall Study|Randomized but not treated|5|||
147119797|NCT04518410|530603447|FG022|Overall Study|Randomized but not treated|0|||
147119798|NCT04518410|530603448|FG023|Overall Study|Randomized but not treated|3|||
147119799|NCT04518410|530603449|FG024|Overall Study|Randomized but not treated|1|||
147119800|NCT04518410|530603425|FG000|Overall Study|Screen Fail but Randomized|0|||
147119801|NCT04518410|530603426|FG001|Overall Study|Screen Fail but Randomized|0|||
147119802|NCT04518410|530603427|FG002|Overall Study|Screen Fail but Randomized|0|||
147119803|NCT04518410|530603428|FG003|Overall Study|Screen Fail but Randomized|0|||
147119804|NCT04518410|530603429|FG004|Overall Study|Screen Fail but Randomized|2|||
147119805|NCT04518410|530603430|FG005|Overall Study|Screen Fail but Randomized|0|||
147119806|NCT04518410|530603431|FG006|Overall Study|Screen Fail but Randomized|0|||
147119807|NCT04518410|530603432|FG007|Overall Study|Screen Fail but Randomized|0|||
147119808|NCT04518410|530603433|FG008|Overall Study|Screen Fail but Randomized|0|||
147119809|NCT04518410|530603434|FG009|Overall Study|Screen Fail but Randomized|0|||
147119810|NCT04518410|530603435|FG010|Overall Study|Screen Fail but Randomized|0|||
147119811|NCT04518410|530603436|FG011|Overall Study|Screen Fail but Randomized|0|||
147119812|NCT04518410|530603437|FG012|Overall Study|Screen Fail but Randomized|0|||
147119813|NCT04518410|530603438|FG013|Overall Study|Screen Fail but Randomized|0|||
147119814|NCT04518410|530603439|FG014|Overall Study|Screen Fail but Randomized|0|||
147119815|NCT04518410|530603440|FG015|Overall Study|Screen Fail but Randomized|0|||
147119816|NCT04518410|530603441|FG016|Overall Study|Screen Fail but Randomized|0|||
147119817|NCT04518410|530603442|FG017|Overall Study|Screen Fail but Randomized|0|||
147119818|NCT04518410|530603443|FG018|Overall Study|Screen Fail but Randomized|0|||
147119819|NCT04518410|530603444|FG019|Overall Study|Screen Fail but Randomized|0|||
147119820|NCT04518410|530603445|FG020|Overall Study|Screen Fail but Randomized|0|||
147119821|NCT04518410|530603446|FG021|Overall Study|Screen Fail but Randomized|0|||
147119822|NCT04518410|530603447|FG022|Overall Study|Screen Fail but Randomized|0|||
147119823|NCT04518410|530603448|FG023|Overall Study|Screen Fail but Randomized|0|||
147119824|NCT04518410|530603449|FG024|Overall Study|Screen Fail but Randomized|0|||
147119825|NCT04518410|530603425|FG000|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
147119826|NCT04518410|530603426|FG001|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
147119827|NCT04518410|530603427|FG002|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
147119828|NCT04518410|530603428|FG003|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
147119829|NCT04518410|530603429|FG004|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|81|||
147119830|NCT04518410|530603430|FG005|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|37|||
147231556|NCT00313300|531021229|FG002|Follow-Up(30days)-Randomized Phase B|Death|0|||
147231557|NCT00313300|531021230|FG003|Follow-Up(30days)-Randomized Phase B|Death|0|||
147231558|NCT00313300|531021231|FG004|Follow-Up(30days)-Randomized Phase B|Death|0|||
147444586|NCT01940471|531792643|FG001|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
147444587|NCT01940471|531792644|FG002|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|1|||
147567760|NCT01796171|532238361|FG011|Treatment Period With Betalutin|Death|0|||
147567761|NCT01796171|532238362|FG012|Treatment Period With Betalutin|Death|0|||
147567762|NCT01796171|532238363|FG013|Treatment Period With Betalutin|Death|0|||
147567763|NCT01796171|532238364|FG014|Treatment Period With Betalutin|Death|0|||
147567764|NCT01796171|532238350|FG000|Treatment Period With Betalutin|Sponsor Decision|0|||
147567765|NCT01796171|532238351|FG001|Treatment Period With Betalutin|Sponsor Decision|0|||
147567766|NCT01796171|532238352|FG002|Treatment Period With Betalutin|Sponsor Decision|0|||
147567767|NCT01796171|532238353|FG003|Treatment Period With Betalutin|Sponsor Decision|0|||
147567768|NCT01796171|532238354|FG004|Treatment Period With Betalutin|Sponsor Decision|0|||
147567769|NCT01796171|532238355|FG005|Treatment Period With Betalutin|Sponsor Decision|0|||
147567770|NCT01796171|532238356|FG006|Treatment Period With Betalutin|Sponsor Decision|0|||
147567771|NCT01796171|532238357|FG007|Treatment Period With Betalutin|Sponsor Decision|0|||
147567772|NCT01796171|532238358|FG008|Treatment Period With Betalutin|Sponsor Decision|0|||
147567773|NCT01796171|532238359|FG009|Treatment Period With Betalutin|Sponsor Decision|0|||
147567774|NCT01796171|532238360|FG010|Treatment Period With Betalutin|Sponsor Decision|2|||
147567775|NCT01796171|532238361|FG011|Treatment Period With Betalutin|Sponsor Decision|0|||
147567776|NCT01796171|532238362|FG012|Treatment Period With Betalutin|Sponsor Decision|0|||
147567777|NCT01796171|532238363|FG013|Treatment Period With Betalutin|Sponsor Decision|0|||
147567778|NCT01796171|532238364|FG014|Treatment Period With Betalutin|Sponsor Decision|0|||
147567779|NCT01796171|532238350|FG000|Treatment Period With Betalutin|Withdrawal by Subject|0|||
147567780|NCT01796171|532238351|FG001|Treatment Period With Betalutin|Withdrawal by Subject|0|||
147567781|NCT01796171|532238352|FG002|Treatment Period With Betalutin|Withdrawal by Subject|0|||
147567782|NCT01796171|532238353|FG003|Treatment Period With Betalutin|Withdrawal by Subject|0|||
147567783|NCT01796171|532238354|FG004|Treatment Period With Betalutin|Withdrawal by Subject|0|||
147567784|NCT01796171|532238355|FG005|Treatment Period With Betalutin|Withdrawal by Subject|0|||
147567785|NCT01796171|532238356|FG006|Treatment Period With Betalutin|Withdrawal by Subject|0|||
147567786|NCT01796171|532238357|FG007|Treatment Period With Betalutin|Withdrawal by Subject|0|||
147567787|NCT01796171|532238358|FG008|Treatment Period With Betalutin|Withdrawal by Subject|0|||
147567788|NCT01796171|532238359|FG009|Treatment Period With Betalutin|Withdrawal by Subject|0|||
147567789|NCT01796171|532238360|FG010|Treatment Period With Betalutin|Withdrawal by Subject|1|||
147567790|NCT01796171|532238361|FG011|Treatment Period With Betalutin|Withdrawal by Subject|1|||
147567791|NCT01796171|532238362|FG012|Treatment Period With Betalutin|Withdrawal by Subject|0|||
147567792|NCT01796171|532238363|FG013|Treatment Period With Betalutin|Withdrawal by Subject|0|||
147567793|NCT01796171|532238364|FG014|Treatment Period With Betalutin|Withdrawal by Subject|0|||
147567794|NCT01796171|532238350|FG000|Follow-up Period|Start of further anticancer therapy|4|||
147567795|NCT01796171|532238351|FG001|Follow-up Period|Start of further anticancer therapy|25|||
147567796|NCT01796171|532238352|FG002|Follow-up Period|Start of further anticancer therapy|2|||
147567797|NCT01796171|532238353|FG003|Follow-up Period|Start of further anticancer therapy|1|||
147567798|NCT01796171|532238354|FG004|Follow-up Period|Start of further anticancer therapy|2|||
147567799|NCT01796171|532238355|FG005|Follow-up Period|Start of further anticancer therapy|2|||
147567800|NCT01796171|532238356|FG006|Follow-up Period|Start of further anticancer therapy|1|||
147567801|NCT01796171|532238357|FG007|Follow-up Period|Start of further anticancer therapy|15|||
147567802|NCT01796171|532238358|FG008|Follow-up Period|Start of further anticancer therapy|2|||
147567803|NCT01796171|532238359|FG009|Follow-up Period|Start of further anticancer therapy|0|||
147567804|NCT01796171|532238360|FG010|Follow-up Period|Start of further anticancer therapy|0|||
147567805|NCT01796171|532238361|FG011|Follow-up Period|Start of further anticancer therapy|0|||
147567806|NCT01796171|532238362|FG012|Follow-up Period|Start of further anticancer therapy|0|||
147567807|NCT01796171|532238363|FG013|Follow-up Period|Start of further anticancer therapy|0|||
147567808|NCT01796171|532238364|FG014|Follow-up Period|Start of further anticancer therapy|0|||
147567809|NCT01796171|532238350|FG000|Follow-up Period|Progressive disease|0|||
147567810|NCT01796171|532238351|FG001|Follow-up Period|Progressive disease|1|||
147567811|NCT01796171|532238352|FG002|Follow-up Period|Progressive disease|0|||
147567812|NCT01796171|532238353|FG003|Follow-up Period|Progressive disease|0|||
147650913|NCT02757352|532544542|FG005|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|1|||
147231559|NCT00313300|531021227|FG000|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|0|||
147231560|NCT00313300|531021228|FG001|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|0|||
147231561|NCT00313300|531021229|FG002|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|0|||
147231562|NCT00313300|531021230|FG003|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|2|||
147231563|NCT00313300|531021231|FG004|Follow-Up(30days)-Randomized Phase B|Lost to Follow-up|1|||
147231564|NCT00313300|531021227|FG000|Follow-Up(30days)-Randomized Phase B|missing end of study status|1|||
147231565|NCT00313300|531021228|FG001|Follow-Up(30days)-Randomized Phase B|missing end of study status|0|||
147231566|NCT00313300|531021229|FG002|Follow-Up(30days)-Randomized Phase B|missing end of study status|0|||
147231567|NCT00313300|531021230|FG003|Follow-Up(30days)-Randomized Phase B|missing end of study status|2|||
147231568|NCT00313300|531021231|FG004|Follow-Up(30days)-Randomized Phase B|missing end of study status|0|||
147119831|NCT04518410|530603431|FG006|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|23|||
147119832|NCT04518410|530603432|FG007|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|4|||
147119833|NCT04518410|530603433|FG008|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|6|||
147119834|NCT04518410|530603434|FG009|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|3|||
147119835|NCT04518410|530603435|FG010|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|4|||
147119836|NCT04518410|530603436|FG011|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
147231569|NCT02336373|531021232|FG000|Overall Study|Protocol closed early|4|||
147231570|NCT02336373|531021232|FG000|Overall Study|Physician Decision|14|||
147231571|NCT00428792|531021233|FG000|Overall Study|Lack of Efficacy|1|||
147231572|NCT00428792|531021234|FG001|Overall Study|Lack of Efficacy|3|||
147231573|NCT00428792|531021233|FG000|Overall Study|Lost to Follow-up|0|||
147231574|NCT00428792|531021234|FG001|Overall Study|Lost to Follow-up|1|||
147231575|NCT00850343|531021235|FG000|Overall Study|Withdrawal by Subject|11|||
147231576|NCT00850343|531021236|FG001|Overall Study|Withdrawal by Subject|0|||
147231577|NCT00850343|531021237|FG002|Overall Study|Withdrawal by Subject|3|||
147231578|NCT00850343|531021238|FG003|Overall Study|Withdrawal by Subject|2|||
147231579|NCT00850343|531021235|FG000|Overall Study|Adverse Event|15|||
147231580|NCT00850343|531021236|FG001|Overall Study|Adverse Event|2|||
147231581|NCT00850343|531021237|FG002|Overall Study|Adverse Event|6|||
147231582|NCT00850343|531021238|FG003|Overall Study|Adverse Event|6|||
147231583|NCT00850343|531021235|FG000|Overall Study|Pregnancy|0|||
147231584|NCT00850343|531021236|FG001|Overall Study|Pregnancy|0|||
147231585|NCT00850343|531021237|FG002|Overall Study|Pregnancy|0|||
147231586|NCT00850343|531021238|FG003|Overall Study|Pregnancy|1|||
147231587|NCT00850343|531021235|FG000|Overall Study|Lack of Efficacy|17|||
147231588|NCT00850343|531021236|FG001|Overall Study|Lack of Efficacy|0|||
147231589|NCT00850343|531021237|FG002|Overall Study|Lack of Efficacy|3|||
147231590|NCT00850343|531021238|FG003|Overall Study|Lack of Efficacy|2|||
147231591|NCT00850343|531021235|FG000|Overall Study|Non-compliance with Study Procedures|1|||
147231592|NCT00850343|531021236|FG001|Overall Study|Non-compliance with Study Procedures|0|||
147231593|NCT00850343|531021237|FG002|Overall Study|Non-compliance with Study Procedures|1|||
147231594|NCT00850343|531021238|FG003|Overall Study|Non-compliance with Study Procedures|1|||
147231595|NCT00850343|531021235|FG000|Overall Study|Physician Decision|2|||
147231596|NCT00850343|531021236|FG001|Overall Study|Physician Decision|1|||
147231597|NCT00850343|531021237|FG002|Overall Study|Physician Decision|1|||
147231598|NCT00850343|531021238|FG003|Overall Study|Physician Decision|1|||
147231599|NCT00371826|531021239|FG000|Core Phase (12 Months)|Adverse Event|15|||
147231600|NCT00371826|531021240|FG001|Core Phase (12 Months)|Adverse Event|4|||
147231601|NCT00371826|531021241|FG002|Core Phase (12 Months)|Adverse Event|9|||
147231602|NCT00371826|531021239|FG000|Core Phase (12 Months)|Abnormal test procedure result(s)|1|||
147231603|NCT00371826|531021240|FG001|Core Phase (12 Months)|Abnormal test procedure result(s)|0|||
147231604|NCT00371826|531021241|FG002|Core Phase (12 Months)|Abnormal test procedure result(s)|1|||
147231605|NCT00371826|531021239|FG000|Core Phase (12 Months)|Unsatisfactory therapeutic effect|6|||
147231606|NCT00371826|531021240|FG001|Core Phase (12 Months)|Unsatisfactory therapeutic effect|3|||
147231607|NCT00371826|531021241|FG002|Core Phase (12 Months)|Unsatisfactory therapeutic effect|2|||
147231608|NCT00371826|531021239|FG000|Core Phase (12 Months)|Protocol Violation|1|||
147231609|NCT00371826|531021240|FG001|Core Phase (12 Months)|Protocol Violation|0|||
147231610|NCT00371826|531021241|FG002|Core Phase (12 Months)|Protocol Violation|1|||
147231611|NCT00371826|531021239|FG000|Core Phase (12 Months)|Subject withdrew consent|0|||
147231612|NCT00371826|531021240|FG001|Core Phase (12 Months)|Subject withdrew consent|0|||
147231613|NCT00371826|531021241|FG002|Core Phase (12 Months)|Subject withdrew consent|3|||
147231614|NCT00371826|531021239|FG000|Core Phase (12 Months)|Administrative problems|1|||
147231615|NCT00371826|531021240|FG001|Core Phase (12 Months)|Administrative problems|0|||
147231616|NCT00371826|531021241|FG002|Core Phase (12 Months)|Administrative problems|8|||
147231617|NCT00371826|531021239|FG000|Core Phase (12 Months)|Graft Loss|0|||
147231618|NCT00371826|531021240|FG001|Core Phase (12 Months)|Graft Loss|1|||
147231619|NCT00371826|531021241|FG002|Core Phase (12 Months)|Graft Loss|0|||
147231620|NCT00371826|531021239|FG000|Extension Phase (24 Months)|Adverse Event|4|||
147231621|NCT00371826|531021240|FG001|Extension Phase (24 Months)|Adverse Event|5|||
147231622|NCT00371826|531021241|FG002|Extension Phase (24 Months)|Adverse Event|0|||
147231623|NCT00371826|531021239|FG000|Extension Phase (24 Months)|Abnormal test procedure result(s)|0|||
147231624|NCT00371826|531021240|FG001|Extension Phase (24 Months)|Abnormal test procedure result(s)|1|||
147231625|NCT00371826|531021241|FG002|Extension Phase (24 Months)|Abnormal test procedure result(s)|0|||
147231626|NCT00371826|531021239|FG000|Extension Phase (24 Months)|Unsatisfactory therapeutic effect|0|||
147231627|NCT00371826|531021240|FG001|Extension Phase (24 Months)|Unsatisfactory therapeutic effect|2|||
147231628|NCT00371826|531021241|FG002|Extension Phase (24 Months)|Unsatisfactory therapeutic effect|0|||
147231629|NCT00371826|531021239|FG000|Extension Phase (24 Months)|Subject withdrew consent|1|||
147231630|NCT00371826|531021240|FG001|Extension Phase (24 Months)|Subject withdrew consent|2|||
147231631|NCT00371826|531021241|FG002|Extension Phase (24 Months)|Subject withdrew consent|0|||
147119837|NCT04518410|530603437|FG012|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
147119838|NCT04518410|530603438|FG013|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|4|||
147119839|NCT04518410|530603439|FG014|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|0|||
147119840|NCT04518410|530603440|FG015|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|1|||
147119841|NCT04518410|530603441|FG016|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|1|||
147119842|NCT04518410|530603442|FG017|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|21|||
147231632|NCT00371826|531021239|FG000|Extension Phase (24 Months)|Administrative problems|0|||
147231633|NCT00371826|531021240|FG001|Extension Phase (24 Months)|Administrative problems|0|||
147231634|NCT00371826|531021241|FG002|Extension Phase (24 Months)|Administrative problems|2|||
147231635|NCT04612790|531021247|FG000|DB Period (Up to 36 Weeks)|Death|1|||
147231636|NCT04612790|531021248|FG001|DB Period (Up to 36 Weeks)|Death|1|||
147231637|NCT04612790|531021249|FG002|DB Period (Up to 36 Weeks)|Death|0|||
147231638|NCT04612790|531021250|FG003|DB Period (Up to 36 Weeks)|Death|0|||
147231639|NCT04612790|531021247|FG000|DB Period (Up to 36 Weeks)|Adverse Event|2|||
147231640|NCT04612790|531021248|FG001|DB Period (Up to 36 Weeks)|Adverse Event|0|||
147231641|NCT04612790|531021249|FG002|DB Period (Up to 36 Weeks)|Adverse Event|0|||
147231642|NCT04612790|531021250|FG003|DB Period (Up to 36 Weeks)|Adverse Event|0|||
147231643|NCT04612790|531021247|FG000|DB Period (Up to 36 Weeks)|Study terminated by sponsor|8|||
147231644|NCT04612790|531021248|FG001|DB Period (Up to 36 Weeks)|Study terminated by sponsor|6|||
147231645|NCT04612790|531021249|FG002|DB Period (Up to 36 Weeks)|Study terminated by sponsor|0|||
147231646|NCT04612790|531021250|FG003|DB Period (Up to 36 Weeks)|Study terminated by sponsor|0|||
147231647|NCT04612790|531021247|FG000|DB Period (Up to 36 Weeks)|Withdrawal by Subject|2|||
147231648|NCT04612790|531021248|FG001|DB Period (Up to 36 Weeks)|Withdrawal by Subject|4|||
147231649|NCT04612790|531021249|FG002|DB Period (Up to 36 Weeks)|Withdrawal by Subject|0|||
147231650|NCT04612790|531021250|FG003|DB Period (Up to 36 Weeks)|Withdrawal by Subject|0|||
147231651|NCT04612790|531021247|FG000|DB Period (Up to 36 Weeks)|Physician Decision|4|||
147231652|NCT04612790|531021248|FG001|DB Period (Up to 36 Weeks)|Physician Decision|3|||
147231653|NCT04612790|531021249|FG002|DB Period (Up to 36 Weeks)|Physician Decision|0|||
147231654|NCT04612790|531021250|FG003|DB Period (Up to 36 Weeks)|Physician Decision|0|||
147231655|NCT04612790|531021247|FG000|DB Period (Up to 36 Weeks)|Other|1|||
147231656|NCT04612790|531021248|FG001|DB Period (Up to 36 Weeks)|Other|0|||
147231657|NCT04612790|531021249|FG002|DB Period (Up to 36 Weeks)|Other|0|||
147231658|NCT04612790|531021250|FG003|DB Period (Up to 36 Weeks)|Other|0|||
147231659|NCT04612790|531021247|FG000|OLE Period (Up to 1 Year)|Withdrawal by Subject|0|||
147231660|NCT04612790|531021248|FG001|OLE Period (Up to 1 Year)|Withdrawal by Subject|0|||
147231661|NCT04612790|531021249|FG002|OLE Period (Up to 1 Year)|Withdrawal by Subject|0|||
147231662|NCT04612790|531021250|FG003|OLE Period (Up to 1 Year)|Withdrawal by Subject|1|||
147231663|NCT04612790|531021247|FG000|OLE Period (Up to 1 Year)|Investigator decision|0|||
147231664|NCT04612790|531021248|FG001|OLE Period (Up to 1 Year)|Investigator decision|0|||
147231665|NCT04612790|531021249|FG002|OLE Period (Up to 1 Year)|Investigator decision|2|||
147231666|NCT04612790|531021250|FG003|OLE Period (Up to 1 Year)|Investigator decision|1|||
147231667|NCT04612790|531021247|FG000|OLE Period (Up to 1 Year)|Study terminated by sponsor|0|||
147231668|NCT04612790|531021248|FG001|OLE Period (Up to 1 Year)|Study terminated by sponsor|0|||
147231669|NCT04612790|531021249|FG002|OLE Period (Up to 1 Year)|Study terminated by sponsor|14|||
147231670|NCT04612790|531021250|FG003|OLE Period (Up to 1 Year)|Study terminated by sponsor|15|||
147231671|NCT04612790|531021247|FG000|OLE Period (Up to 1 Year)|Other|0|||
147231672|NCT04612790|531021248|FG001|OLE Period (Up to 1 Year)|Other|0|||
147231673|NCT04612790|531021249|FG002|OLE Period (Up to 1 Year)|Other|0|||
147231674|NCT04612790|531021250|FG003|OLE Period (Up to 1 Year)|Other|1|||
147231675|NCT02497612|531021251|FG000|Overall Study|Met >=1 anti-malarial treatment criteria|57|||
147231676|NCT02497612|531021252|FG001|Overall Study|Met >=1 anti-malarial treatment criteria|51|||
147231677|NCT02497612|531021253|FG002|Overall Study|Met >=1 anti-malarial treatment criteria|39|||
147231678|NCT02497612|531021254|FG003|Overall Study|Met >=1 anti-malarial treatment criteria|41|||
147231679|NCT02497612|531021251|FG000|Overall Study|Participant's request|2|||
147231680|NCT02497612|531021252|FG001|Overall Study|Participant's request|3|||
147231681|NCT02497612|531021253|FG002|Overall Study|Participant's request|4|||
147231682|NCT02497612|531021254|FG003|Overall Study|Participant's request|1|||
147231683|NCT02497612|531021251|FG000|Overall Study|Investigator's judgement|1|||
147231684|NCT02497612|531021252|FG001|Overall Study|Investigator's judgement|0|||
147231685|NCT02497612|531021253|FG002|Overall Study|Investigator's judgement|0|||
147231686|NCT02497612|531021254|FG003|Overall Study|Investigator's judgement|2|||
147231687|NCT02497612|531021251|FG000|Overall Study|Adverse Event|3|||
147231688|NCT02497612|531021252|FG001|Overall Study|Adverse Event|1|||
147231689|NCT02497612|531021253|FG002|Overall Study|Adverse Event|4|||
147231690|NCT02497612|531021254|FG003|Overall Study|Adverse Event|1|||
147231691|NCT02497612|531021251|FG000|Overall Study|Lost to Follow-up|1|||
147231692|NCT02497612|531021252|FG001|Overall Study|Lost to Follow-up|1|||
147231693|NCT02497612|531021253|FG002|Overall Study|Lost to Follow-up|0|||
147231694|NCT02497612|531021254|FG003|Overall Study|Lost to Follow-up|1|||
147119843|NCT04518410|530603443|FG018|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|16|||
147119844|NCT04518410|530603444|FG019|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|21|||
147119845|NCT04518410|530603445|FG020|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|19|||
147119846|NCT04518410|530603446|FG021|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|3|||
147119847|NCT04518410|530603447|FG022|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|2|||
147119848|NCT04518410|530603448|FG023|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|4|||
147119849|NCT04518410|530603449|FG024|Overall Study|Excluded from analysis at NIH request (due to suspected scientific misconduct at site level)|2|||
147119850|NCT04518410|530603425|FG000|Overall Study|Dual Enrolled Subject|0|||
147119851|NCT04518410|530603426|FG001|Overall Study|Dual Enrolled Subject|0|||
147119852|NCT04518410|530603427|FG002|Overall Study|Dual Enrolled Subject|0|||
147119853|NCT04518410|530603428|FG003|Overall Study|Dual Enrolled Subject|0|||
147119854|NCT04518410|530603429|FG004|Overall Study|Dual Enrolled Subject|0|||
147119855|NCT04518410|530603430|FG005|Overall Study|Dual Enrolled Subject|0|||
147119856|NCT04518410|530603431|FG006|Overall Study|Dual Enrolled Subject|0|||
147119857|NCT04518410|530603432|FG007|Overall Study|Dual Enrolled Subject|0|||
147119858|NCT04518410|530603433|FG008|Overall Study|Dual Enrolled Subject|0|||
147119859|NCT04518410|530603434|FG009|Overall Study|Dual Enrolled Subject|0|||
147119860|NCT04518410|530603435|FG010|Overall Study|Dual Enrolled Subject|0|||
147119861|NCT04518410|530603436|FG011|Overall Study|Dual Enrolled Subject|0|||
147119862|NCT04518410|530603437|FG012|Overall Study|Dual Enrolled Subject|0|||
147119863|NCT04518410|530603438|FG013|Overall Study|Dual Enrolled Subject|0|||
147119864|NCT04518410|530603439|FG014|Overall Study|Dual Enrolled Subject|0|||
147119865|NCT04518410|530603440|FG015|Overall Study|Dual Enrolled Subject|0|||
147119866|NCT04518410|530603441|FG016|Overall Study|Dual Enrolled Subject|0|||
147119867|NCT04518410|530603442|FG017|Overall Study|Dual Enrolled Subject|1|||
147119868|NCT04518410|530603443|FG018|Overall Study|Dual Enrolled Subject|0|||
147119869|NCT04518410|530603444|FG019|Overall Study|Dual Enrolled Subject|0|||
147119870|NCT04518410|530603445|FG020|Overall Study|Dual Enrolled Subject|0|||
147119871|NCT04518410|530603446|FG021|Overall Study|Dual Enrolled Subject|0|||
147119872|NCT04518410|530603447|FG022|Overall Study|Dual Enrolled Subject|0|||
147119873|NCT04518410|530603448|FG023|Overall Study|Dual Enrolled Subject|0|||
147119874|NCT04518410|530603449|FG024|Overall Study|Dual Enrolled Subject|0|||
147119875|NCT01227395|530603450|FG000|Overall Study|Protocol Violation|0|||
147119876|NCT01227395|530603451|FG001|Overall Study|Protocol Violation|1|||
147119877|NCT03259308|530603456|FG000|Overall Study|Adverse Event|5|||
147119878|NCT03259308|530603457|FG001|Overall Study|Adverse Event|4|||
147119879|NCT03259308|530603458|FG002|Overall Study|Adverse Event|1|||
147119880|NCT03259308|530603456|FG000|Overall Study|Withdrawal by Subject|2|||
147119881|NCT03259308|530603457|FG001|Overall Study|Withdrawal by Subject|1|||
147119882|NCT03259308|530603458|FG002|Overall Study|Withdrawal by Subject|3|||
147119883|NCT03259308|530603456|FG000|Overall Study|Lost to Follow-up|0|||
147119884|NCT03259308|530603457|FG001|Overall Study|Lost to Follow-up|0|||
147119885|NCT03259308|530603458|FG002|Overall Study|Lost to Follow-up|1|||
147119886|NCT03259308|530603456|FG000|Overall Study|Pregnancy|0|||
147119887|NCT03259308|530603457|FG001|Overall Study|Pregnancy|0|||
147119888|NCT03259308|530603458|FG002|Overall Study|Pregnancy|1|||
147119889|NCT03259308|530603456|FG000|Overall Study|Protocol Deviation|0|||
147119890|NCT03259308|530603457|FG001|Overall Study|Protocol Deviation|3|||
147119891|NCT03259308|530603458|FG002|Overall Study|Protocol Deviation|0|||
147119892|NCT03259308|530603456|FG000|Overall Study|Lack of Efficacy|0|||
147119893|NCT03259308|530603457|FG001|Overall Study|Lack of Efficacy|0|||
147119894|NCT03259308|530603458|FG002|Overall Study|Lack of Efficacy|1|||
147119895|NCT03632720|530603461|FG000|Overall Study|Adverse Event|2|||
147119896|NCT03632720|530603462|FG001|Overall Study|Adverse Event|0|||
147119897|NCT03632720|530603463|FG002|Overall Study|Adverse Event|0|||
147119898|NCT03632720|530603461|FG000|Overall Study|Lost to Follow-up|0|||
147313396|NCT01757665|531313889|FG001|Overall Study|Withdrawal by Subject|0|||
147567813|NCT01796171|532238354|FG004|Follow-up Period|Progressive disease|0|||
147567814|NCT01796171|532238355|FG005|Follow-up Period|Progressive disease|0|||
147567815|NCT01796171|532238356|FG006|Follow-up Period|Progressive disease|0|||
147119899|NCT03632720|530603462|FG001|Overall Study|Lost to Follow-up|1|||
147119900|NCT03632720|530603463|FG002|Overall Study|Lost to Follow-up|0|||
147119901|NCT03632720|530603461|FG000|Overall Study|Withdrawal by parent/legally acceptable representative|11|||
147313397|NCT01757665|531313888|FG000|Overall Study|Lost to Follow-up|1|||
147567816|NCT01796171|532238357|FG007|Follow-up Period|Progressive disease|3|||
147567817|NCT01796171|532238358|FG008|Follow-up Period|Progressive disease|0|||
147567818|NCT01796171|532238359|FG009|Follow-up Period|Progressive disease|0|||
147567819|NCT01796171|532238360|FG010|Follow-up Period|Progressive disease|0|||
147119902|NCT03632720|530603462|FG001|Overall Study|Withdrawal by parent/legally acceptable representative|9|||
147119903|NCT03632720|530603463|FG002|Overall Study|Withdrawal by parent/legally acceptable representative|8|||
147119904|NCT03632720|530603461|FG000|Overall Study|Screen failure|0|||
147119905|NCT03632720|530603462|FG001|Overall Study|Screen failure|1|||
147119906|NCT03632720|530603463|FG002|Overall Study|Screen failure|0|||
147119907|NCT01117350|530603465|FG000|Comparative Period|Not Treated|5|||
147119908|NCT01117350|530603466|FG001|Comparative Period|Not Treated|8|||
147119909|NCT01117350|530603465|FG000|Comparative Period|Adverse Event|6|||
147119910|NCT01117350|530603466|FG001|Comparative Period|Adverse Event|33|||
147119911|NCT01117350|530603465|FG000|Comparative Period|Lost to Follow-up|11|||
147119912|NCT01117350|530603466|FG001|Comparative Period|Lost to Follow-up|7|||
147119913|NCT01117350|530603465|FG000|Comparative Period|Withdrawal by Subject|9|||
147119914|NCT01117350|530603466|FG001|Comparative Period|Withdrawal by Subject|13|||
147119915|NCT01117350|530603465|FG000|Comparative Period|Protocol Violation|8|||
147119916|NCT01117350|530603466|FG001|Comparative Period|Protocol Violation|12|||
147119917|NCT01117350|530603465|FG000|Comparative Period|Lack of Efficacy|1|||
147119918|NCT01117350|530603466|FG001|Comparative Period|Lack of Efficacy|0|||
147119919|NCT01117350|530603465|FG000|Comparative Period|Physician Decision|0|||
147119920|NCT01117350|530603466|FG001|Comparative Period|Physician Decision|1|||
147119921|NCT01117350|530603465|FG000|Comparative Period|Move to another city/country|2|||
147119922|NCT01117350|530603466|FG001|Comparative Period|Move to another city/country|1|||
147119923|NCT01117350|530603465|FG000|Extension Period|Not included in extension, not treated|0|||
147119924|NCT01117350|530603466|FG001|Extension Period|Not included in extension, not treated|50|||
147119925|NCT01117350|530603465|FG000|Extension Period|Adverse Event|0|||
147119926|NCT01117350|530603466|FG001|Extension Period|Adverse Event|2|||
147119927|NCT01117350|530603465|FG000|Extension Period|Protocol Violation|0|||
147119928|NCT01117350|530603466|FG001|Extension Period|Protocol Violation|2|||
147119929|NCT01117350|530603465|FG000|Extension Period|Lost to Follow-up|0|||
147119930|NCT01117350|530603466|FG001|Extension Period|Lost to Follow-up|2|||
147119931|NCT01117350|530603465|FG000|Extension Period|Withdrawal by Subject|0|||
147119932|NCT01117350|530603466|FG001|Extension Period|Withdrawal by Subject|3|||
147119933|NCT01117350|530603465|FG000|Extension Period|Lack of Efficacy|0|||
147119934|NCT01117350|530603466|FG001|Extension Period|Lack of Efficacy|2|||
147119935|NCT01117350|530603465|FG000|Extension Period|Inclusion criteria not respected|0|||
147119936|NCT01117350|530603466|FG001|Extension Period|Inclusion criteria not respected|1|||
147119937|NCT01117350|530603465|FG000|Extension Period|Prohibited medication|0|||
147119938|NCT01117350|530603466|FG001|Extension Period|Prohibited medication|1|||
147119939|NCT01049828|530603468|FG000|Overall Study|Claustrophibia and Frustration|2|||
147119940|NCT00290238|530603469|FG000|Overall Study|Study terminated|27|||
147119941|NCT00290238|530603470|FG001|Overall Study|Study terminated|27|||
147119942|NCT00290238|530603469|FG000|Overall Study|Lost to Follow-up|0|||
147119943|NCT00290238|530603470|FG001|Overall Study|Lost to Follow-up|1|||
147119944|NCT00290238|530603469|FG000|Overall Study|Withdrawal by Subject|15|||
147119945|NCT00290238|530603470|FG001|Overall Study|Withdrawal by Subject|13|||
147119946|NCT02487199|530603477|FG000|Overall Study|Withdrew Consent|0|||
147119947|NCT02487199|530603478|FG001|Overall Study|Withdrew Consent|1|||
147119948|NCT01213251|530605045|FG000|Overall Study|Death|2|||
147119949|NCT01213251|530605046|FG001|Overall Study|Death|1|||
147119950|NCT01213251|530605047|FG002|Overall Study|Death|2|||
147119951|NCT01213251|530605045|FG000|Overall Study|Exit|3|||
147119952|NCT01213251|530605046|FG001|Overall Study|Exit|2|||
147119953|NCT01213251|530605047|FG002|Overall Study|Exit|8|||
147119954|NCT01213251|530605045|FG000|Overall Study|Protocol Violation|1|||
147119955|NCT01213251|530605046|FG001|Overall Study|Protocol Violation|1|||
147119956|NCT01213251|530605047|FG002|Overall Study|Protocol Violation|0|||
147119957|NCT01213251|530605045|FG000|Overall Study|Missed 18-Month Follow-up|0|||
147119958|NCT01213251|530605046|FG001|Overall Study|Missed 18-Month Follow-up|0|||
147119959|NCT01213251|530605047|FG002|Overall Study|Missed 18-Month Follow-up|1|||
147119960|NCT00520572|530605052|FG000|Overall Study|Adverse Event|9|||
147119961|NCT00520572|530605053|FG001|Overall Study|Adverse Event|3|||
147119962|NCT00520572|530605054|FG002|Overall Study|Adverse Event|6|||
147119963|NCT00520572|530605055|FG003|Overall Study|Adverse Event|9|||
147119964|NCT00520572|530605056|FG004|Overall Study|Adverse Event|7|||
147119965|NCT00520572|530605057|FG005|Overall Study|Adverse Event|2|||
147119966|NCT00520572|530605052|FG000|Overall Study|Withdrawal by Subject|0|||
147119967|NCT00520572|530605053|FG001|Overall Study|Withdrawal by Subject|9|||
147119968|NCT00520572|530605054|FG002|Overall Study|Withdrawal by Subject|5|||
147119969|NCT00520572|530605055|FG003|Overall Study|Withdrawal by Subject|2|||
147119970|NCT00520572|530605056|FG004|Overall Study|Withdrawal by Subject|2|||
147119971|NCT00520572|530605057|FG005|Overall Study|Withdrawal by Subject|0|||
147119972|NCT00520572|530605052|FG000|Overall Study|Protocol Violation|0|||
147119973|NCT00520572|530605053|FG001|Overall Study|Protocol Violation|0|||
147119974|NCT00520572|530605054|FG002|Overall Study|Protocol Violation|1|||
147119975|NCT00520572|530605055|FG003|Overall Study|Protocol Violation|0|||
147119976|NCT00520572|530605056|FG004|Overall Study|Protocol Violation|0|||
147119977|NCT00520572|530605057|FG005|Overall Study|Protocol Violation|0|||
147119978|NCT00520572|530605052|FG000|Overall Study|Lack of Efficacy|1|||
147119979|NCT00520572|530605053|FG001|Overall Study|Lack of Efficacy|1|||
147119980|NCT00520572|530605054|FG002|Overall Study|Lack of Efficacy|1|||
147119981|NCT00520572|530605055|FG003|Overall Study|Lack of Efficacy|2|||
147119982|NCT00520572|530605056|FG004|Overall Study|Lack of Efficacy|1|||
147119983|NCT00520572|530605057|FG005|Overall Study|Lack of Efficacy|0|||
147119984|NCT00520572|530605052|FG000|Overall Study|Lost to Follow-up|0|||
147119985|NCT00520572|530605053|FG001|Overall Study|Lost to Follow-up|0|||
147119986|NCT00520572|530605054|FG002|Overall Study|Lost to Follow-up|0|||
147119987|NCT00520572|530605055|FG003|Overall Study|Lost to Follow-up|0|||
147567820|NCT01796171|532238361|FG011|Follow-up Period|Progressive disease|0|||
147567821|NCT01796171|532238362|FG012|Follow-up Period|Progressive disease|0|||
147119988|NCT00520572|530605056|FG004|Overall Study|Lost to Follow-up|1|||
147119989|NCT00520572|530605057|FG005|Overall Study|Lost to Follow-up|0|||
147119990|NCT00520572|530605052|FG000|Overall Study|Incorrect enrollment|1|||
147119991|NCT00520572|530605053|FG001|Overall Study|Incorrect enrollment|0|||
147119992|NCT00520572|530605054|FG002|Overall Study|Incorrect enrollment|1|||
147119993|NCT00520572|530605055|FG003|Overall Study|Incorrect enrollment|0|||
147119994|NCT00520572|530605056|FG004|Overall Study|Incorrect enrollment|1|||
147119995|NCT00520572|530605057|FG005|Overall Study|Incorrect enrollment|0|||
147119996|NCT00520572|530605052|FG000|Overall Study|Oral corticotherapy for acute urticaria|0|||
147119997|NCT00520572|530605053|FG001|Overall Study|Oral corticotherapy for acute urticaria|1|||
147119998|NCT00520572|530605054|FG002|Overall Study|Oral corticotherapy for acute urticaria|0|||
147119999|NCT00520572|530605055|FG003|Overall Study|Oral corticotherapy for acute urticaria|0|||
147120000|NCT00520572|530605056|FG004|Overall Study|Oral corticotherapy for acute urticaria|0|||
147120001|NCT00520572|530605057|FG005|Overall Study|Oral corticotherapy for acute urticaria|0|||
147120002|NCT00520572|530605052|FG000|Overall Study|Long break in taking Medication|0|||
147120003|NCT00520572|530605053|FG001|Overall Study|Long break in taking Medication|0|||
147120004|NCT00520572|530605054|FG002|Overall Study|Long break in taking Medication|0|||
147567822|NCT01796171|532238363|FG013|Follow-up Period|Progressive disease|0|||
147120005|NCT00520572|530605055|FG003|Overall Study|Long break in taking Medication|1|||
147120006|NCT00520572|530605056|FG004|Overall Study|Long break in taking Medication|0|||
147120007|NCT00520572|530605057|FG005|Overall Study|Long break in taking Medication|0|||
147120008|NCT00520572|530605052|FG000|Overall Study|Did not receive Treatment|1|||
147120009|NCT00520572|530605053|FG001|Overall Study|Did not receive Treatment|0|||
147120010|NCT00520572|530605054|FG002|Overall Study|Did not receive Treatment|1|||
147120011|NCT00520572|530605055|FG003|Overall Study|Did not receive Treatment|0|||
147120012|NCT00520572|530605056|FG004|Overall Study|Did not receive Treatment|0|||
147120013|NCT00520572|530605057|FG005|Overall Study|Did not receive Treatment|0|||
147120014|NCT02802865|530605060|FG000|Overall Study|Pregnancy|1|||
147120015|NCT02802865|530605061|FG001|Overall Study|Pregnancy|1|||
147120016|NCT02802865|530605060|FG000|Overall Study|Ineliegible due to tuberculosis|0|||
147120017|NCT02802865|530605061|FG001|Overall Study|Ineliegible due to tuberculosis|1|||
147120018|NCT01803737|530605065|FG000|Overall Study|Lack of Time|1|||
147120019|NCT01803737|530605066|FG001|Overall Study|Lack of Time|0|||
147120020|NCT01803737|530605065|FG000|Overall Study|Medical Reason|0|||
147120021|NCT01803737|530605066|FG001|Overall Study|Medical Reason|1|||
147120022|NCT01803737|530605065|FG000|Overall Study|Lost to Follow-up|0|||
147120023|NCT01803737|530605066|FG001|Overall Study|Lost to Follow-up|2|||
147120024|NCT01529112|530605067|FG000|Overall Study|Adverse Event|2|||
147120025|NCT01529112|530605068|FG001|Overall Study|Adverse Event|0|||
147120026|NCT01529112|530605067|FG000|Overall Study|Death|59|||
147120027|NCT01529112|530605068|FG001|Overall Study|Death|38|||
147120028|NCT01529112|530605067|FG000|Overall Study|Protocol Violation|1|||
147120029|NCT01529112|530605068|FG001|Overall Study|Protocol Violation|0|||
147120030|NCT01529112|530605067|FG000|Overall Study|Withdrawal by Subject|7|||
147120031|NCT01529112|530605068|FG001|Overall Study|Withdrawal by Subject|3|||
147231695|NCT02497612|531021251|FG000|Overall Study|Other unspecified|1|||
147231696|NCT02497612|531021252|FG001|Overall Study|Other unspecified|1|||
147231697|NCT02497612|531021253|FG002|Overall Study|Other unspecified|2|||
147231698|NCT02497612|531021254|FG003|Overall Study|Other unspecified|0|||
147231699|NCT02497612|531021251|FG000|Overall Study|Not eligible|1|||
147567823|NCT01796171|532238364|FG014|Follow-up Period|Progressive disease|0|||
147120032|NCT01530256|530605070|FG000|Overall Study|Death|2|||
147120033|NCT00527748|530605072|FG000|Overall Study|Other|3|||
147231700|NCT02497612|531021252|FG001|Overall Study|Not eligible|0|||
147231701|NCT02497612|531021253|FG002|Overall Study|Not eligible|0|||
147231702|NCT02497612|531021254|FG003|Overall Study|Not eligible|1|||
147231703|NCT03387683|531021257|FG000|Overall Study|In receipt of disallowed medication|1|||
147567824|NCT01796171|532238350|FG000|Follow-up Period|Physician Decision|0|||
147567825|NCT01796171|532238351|FG001|Follow-up Period|Physician Decision|2|||
147567826|NCT01796171|532238352|FG002|Follow-up Period|Physician Decision|0|||
147120034|NCT02004275|530605079|FG000|Phase 1|Ineligible|0|||
147120035|NCT02004275|530605080|FG001|Phase 1|Ineligible|0|||
147120036|NCT02004275|530605081|FG002|Phase 1|Ineligible|0|||
147120037|NCT02004275|530605082|FG003|Phase 1|Ineligible|1|||
147120038|NCT02004275|530605083|FG004|Phase 1|Ineligible|1|||
147313398|NCT01757665|531313889|FG001|Overall Study|Lost to Follow-up|1|||
147120039|NCT02004275|530605084|FG005|Phase 1|Ineligible|0|||
147231704|NCT03387683|531021258|FG001|Overall Study|In receipt of disallowed medication|0|||
147231705|NCT03387683|531021257|FG000|Overall Study|Did not receive treatment|1|||
147567827|NCT01796171|532238353|FG003|Follow-up Period|Physician Decision|0|||
147120040|NCT02004275|530605079|FG000|Phase 1|Protocol Violation|0|||
147120041|NCT02004275|530605080|FG001|Phase 1|Protocol Violation|0|||
147120042|NCT02004275|530605081|FG002|Phase 1|Protocol Violation|0|||
147120043|NCT02004275|530605082|FG003|Phase 1|Protocol Violation|1|||
147120044|NCT02004275|530605083|FG004|Phase 1|Protocol Violation|0|||
147120045|NCT02004275|530605084|FG005|Phase 1|Protocol Violation|5|||
147120046|NCT02004275|530605079|FG000|Phase 2 Part 1|Ineligible|6|||
147120047|NCT02004275|530605080|FG001|Phase 2 Part 1|Ineligible|9|||
147120048|NCT02004275|530605081|FG002|Phase 2 Part 1|Ineligible|0|||
147120049|NCT02004275|530605082|FG003|Phase 2 Part 1|Ineligible|0|||
147120050|NCT02004275|530605083|FG004|Phase 2 Part 1|Ineligible|0|||
147120051|NCT02004275|530605084|FG005|Phase 2 Part 1|Ineligible|0|||
147120052|NCT02004275|530605079|FG000|Phase 2 Part 2|Withdrawal by Subject|4|||
147120053|NCT02004275|530605080|FG001|Phase 2 Part 2|Withdrawal by Subject|0|||
147120054|NCT02004275|530605081|FG002|Phase 2 Part 2|Withdrawal by Subject|0|||
147120055|NCT02004275|530605082|FG003|Phase 2 Part 2|Withdrawal by Subject|0|||
147120056|NCT02004275|530605083|FG004|Phase 2 Part 2|Withdrawal by Subject|0|||
147120057|NCT02004275|530605084|FG005|Phase 2 Part 2|Withdrawal by Subject|0|||
147120058|NCT04621786|530605085|FG000|Overall Study|Lost to Follow-up|9|||
147120059|NCT04621786|530605085|FG000|Overall Study|Protocol Violation|3|||
147120060|NCT00292370|530605086|FG000|Phase I - Open-Label Paroxetine (OLP)|Adverse Event|12|||
147120061|NCT00292370|530605087|FG001|Phase I - Open-Label Paroxetine (OLP)|Adverse Event|0|||
147120062|NCT00292370|530605088|FG002|Phase I - Open-Label Paroxetine (OLP)|Adverse Event|0|||
147120063|NCT00292370|530605086|FG000|Phase I - Open-Label Paroxetine (OLP)|Lost to Follow-up|22|||
147120064|NCT00292370|530605087|FG001|Phase I - Open-Label Paroxetine (OLP)|Lost to Follow-up|0|||
147120065|NCT00292370|530605088|FG002|Phase I - Open-Label Paroxetine (OLP)|Lost to Follow-up|0|||
147120066|NCT00292370|530605086|FG000|Phase I - Open-Label Paroxetine (OLP)|Physician Decision|8|||
147120067|NCT00292370|530605087|FG001|Phase I - Open-Label Paroxetine (OLP)|Physician Decision|0|||
147120068|NCT00292370|530605088|FG002|Phase I - Open-Label Paroxetine (OLP)|Physician Decision|0|||
147120069|NCT00292370|530605086|FG000|Phase I - Open-Label Paroxetine (OLP)|Withdrawal by Subject|4|||
147120070|NCT00292370|530605087|FG001|Phase I - Open-Label Paroxetine (OLP)|Withdrawal by Subject|0|||
147120071|NCT00292370|530605088|FG002|Phase I - Open-Label Paroxetine (OLP)|Withdrawal by Subject|0|||
147120072|NCT00292370|530605086|FG000|Phase II: OLP + DB Quetiapine or Placebo|Lost to Follow-up|0|||
147120073|NCT00292370|530605087|FG001|Phase II: OLP + DB Quetiapine or Placebo|Lost to Follow-up|3|||
147120074|NCT00292370|530605088|FG002|Phase II: OLP + DB Quetiapine or Placebo|Lost to Follow-up|2|||
147231706|NCT03387683|531021258|FG001|Overall Study|Did not receive treatment|0|||
147231707|NCT00629772|531021259|FG000|Second Intervention Week 14 - Week 26|Adverse Event|1|||
147231708|NCT00629772|531021260|FG001|Second Intervention Week 14 - Week 26|Adverse Event|1|||
147231709|NCT00629772|531021259|FG000|Second Intervention Week 14 - Week 26|Lack of Efficacy|0|||
147231710|NCT00629772|531021260|FG001|Second Intervention Week 14 - Week 26|Lack of Efficacy|1|||
147231711|NCT03840174|531021261|FG000|Overall Study|Withdrawal by Subject|1|||
147231712|NCT03840174|531021262|FG001|Overall Study|Withdrawal by Subject|0|||
147231713|NCT03840174|531021263|FG002|Overall Study|Withdrawal by Subject|0|||
147231714|NCT03840174|531021264|FG003|Overall Study|Withdrawal by Subject|0|||
147231715|NCT00722423|531021265|FG000|Overall Study|Protocol Violation|0|||
147231716|NCT00722423|531021266|FG001|Overall Study|Protocol Violation|1|||
147231717|NCT01950169|531021267|FG000|Overall Study|Withdrawal by Subject|2|||
147231718|NCT01950169|531021268|FG001|Overall Study|Withdrawal by Subject|8|||
147231719|NCT01950169|531021269|FG002|Overall Study|Withdrawal by Subject|1|||
147231720|NCT01950169|531021267|FG000|Overall Study|Death|1|||
147231721|NCT01950169|531021268|FG001|Overall Study|Death|0|||
147231722|NCT01950169|531021269|FG002|Overall Study|Death|0|||
147231723|NCT01938573|531021271|FG000|Overall Study|Lack of Efficacy|1|||
147231724|NCT01938573|531021272|FG001|Overall Study|Lack of Efficacy|0|||
147231725|NCT01938573|531021271|FG000|Overall Study|Operation at other hospital|1|||
147231726|NCT01938573|531021272|FG001|Overall Study|Operation at other hospital|0|||
147231727|NCT01495975|531021274|FG000|Overall Study|Lost to Follow-up|1|||
147567828|NCT01796171|532238354|FG004|Follow-up Period|Physician Decision|0|||
147567829|NCT01796171|532238355|FG005|Follow-up Period|Physician Decision|0|||
147231728|NCT01495975|531021275|FG001|Overall Study|Lost to Follow-up|0|||
147231729|NCT05085730|531021276|FG000|Overall Study|Withdrawal by Subject|4|||
147231730|NCT05085730|531021276|FG000|Overall Study|Physician Decision|1|||
147231731|NCT05447897|531021277|FG000|Overall Study|Did not participate in survey|2|||
147231732|NCT04553679|531021278|FG000|Overall Study|Withdrawal by Subject|2|||
147120075|NCT00292370|530605086|FG000|Phase II: OLP + DB Quetiapine or Placebo|Withdrawal by Subject|0|||
147120076|NCT00292370|530605087|FG001|Phase II: OLP + DB Quetiapine or Placebo|Withdrawal by Subject|1|||
147120077|NCT00292370|530605088|FG002|Phase II: OLP + DB Quetiapine or Placebo|Withdrawal by Subject|5|||
147120078|NCT01346709|530605089|FG000|Overall Study|Protocol Violation|35|||
147120079|NCT01346709|530605089|FG000|Overall Study|Lost to Follow-up|31|||
147231733|NCT04553679|531021279|FG001|Overall Study|Withdrawal by Subject|0|||
147231734|NCT04553679|531021278|FG000|Overall Study|Caregiver only took part in the qualitative interview (no quantitative outcomes)|0|||
147249856|NCT01018186|531083796|FG003|2-week Run-in Period|Lost to Follow-up|0|||
147567830|NCT01796171|532238356|FG006|Follow-up Period|Physician Decision|0|||
147313399|NCT01757665|531313888|FG000|Overall Study|Not Implanted with Device|5|||
147313400|NCT01757665|531313889|FG001|Overall Study|Not Implanted with Device|1|||
147313401|NCT02771210|531313894|FG000|Period 1|Adverse Event|5|||
147313402|NCT02771210|531313895|FG001|Period 1|Adverse Event|3|||
147313403|NCT02771210|531313894|FG000|Period 1|Lack of Efficacy|3|||
147313404|NCT02771210|531313895|FG001|Period 1|Lack of Efficacy|6|||
147313405|NCT02771210|531313894|FG000|Period 1|Lost to Follow-up|2|||
147313406|NCT02771210|531313895|FG001|Period 1|Lost to Follow-up|0|||
147313407|NCT02771210|531313894|FG000|Period 1|Physician Decision|0|||
147313408|NCT02771210|531313895|FG001|Period 1|Physician Decision|1|||
147313409|NCT02771210|531313894|FG000|Period 1|Withdrawal by Subject|0|||
147313410|NCT02771210|531313895|FG001|Period 1|Withdrawal by Subject|3|||
147313411|NCT02771210|531313894|FG000|Period 1|Withdrawal of informed consent|1|||
147313412|NCT02771210|531313895|FG001|Period 1|Withdrawal of informed consent|5|||
147313413|NCT02771210|531313894|FG000|Period 2|Adverse Event|1|||
147313414|NCT02771210|531313895|FG001|Period 2|Adverse Event|0|||
147313415|NCT02771210|531313894|FG000|Period 2|Lack of Efficacy|0|||
147313416|NCT02771210|531313895|FG001|Period 2|Lack of Efficacy|1|||
147313417|NCT02771210|531313894|FG000|Period 2|Withdrawal by Subject|1|||
147313418|NCT02771210|531313895|FG001|Period 2|Withdrawal by Subject|0|||
147313419|NCT02771210|531313894|FG000|Period 2|Withdrawal of informed consent|0|||
147313420|NCT02771210|531313895|FG001|Period 2|Withdrawal of informed consent|2|||
147313421|NCT04012814|531313900|FG000|Overall Study|Lost to Follow-up|4|||
147313422|NCT04012814|531313900|FG000|Overall Study|Withdrawal by Subject|2|||
147313423|NCT04012814|531313900|FG000|Overall Study|Protocol Violation|1|||
147313424|NCT04012814|531313900|FG000|Overall Study|Adverse Event|1|||
147313425|NCT04397523|531313901|FG000|Overall Study|Lost to Follow-up|3|||
147313426|NCT04397523|531313901|FG000|Overall Study|Transfer from/to other hospital|8|||
147313427|NCT01865617|531313909|FG000|Overall Study|Death|27|||
147313428|NCT01865617|531313910|FG001|Overall Study|Death|3|||
147313429|NCT01865617|531313911|FG002|Overall Study|Death|1|||
147120080|NCT01346709|530605089|FG000|Overall Study|Missing data in candidate risk factor|285|||
147313430|NCT01865617|531313912|FG003|Overall Study|Death|1|||
147313431|NCT01865617|531313913|FG004|Overall Study|Death|5|||
147313432|NCT01865617|531313914|FG005|Overall Study|Death|1|||
147313433|NCT01865617|531313915|FG006|Overall Study|Death|11|||
147313434|NCT01865617|531313916|FG007|Overall Study|Death|1|||
147313435|NCT01865617|531313917|FG008|Overall Study|Death|11|||
147313436|NCT01865617|531313918|FG009|Overall Study|Death|3|||
147313437|NCT01865617|531313919|FG010|Overall Study|Death|32|||
147313438|NCT01865617|531313920|FG011|Overall Study|Death|6|||
147313439|NCT01865617|531313921|FG012|Overall Study|Death|13|||
147313440|NCT01865617|531313909|FG000|Overall Study|Lost to Follow-up|2|||
147313441|NCT01865617|531313910|FG001|Overall Study|Lost to Follow-up|0|||
147313442|NCT01865617|531313911|FG002|Overall Study|Lost to Follow-up|0|||
147313443|NCT01865617|531313912|FG003|Overall Study|Lost to Follow-up|0|||
147313444|NCT01865617|531313913|FG004|Overall Study|Lost to Follow-up|0|||
147313445|NCT01865617|531313914|FG005|Overall Study|Lost to Follow-up|0|||
147313446|NCT01865617|531313915|FG006|Overall Study|Lost to Follow-up|0|||
147313447|NCT01865617|531313916|FG007|Overall Study|Lost to Follow-up|0|||
147313448|NCT01865617|531313917|FG008|Overall Study|Lost to Follow-up|0|||
147313449|NCT01865617|531313918|FG009|Overall Study|Lost to Follow-up|0|||
147313450|NCT01865617|531313919|FG010|Overall Study|Lost to Follow-up|0|||
147313451|NCT01865617|531313920|FG011|Overall Study|Lost to Follow-up|0|||
147313452|NCT01865617|531313921|FG012|Overall Study|Lost to Follow-up|0|||
147313453|NCT01865617|531313909|FG000|Overall Study|Withdrawal by Subject|1|||
147313454|NCT01865617|531313910|FG001|Overall Study|Withdrawal by Subject|0|||
147313455|NCT01865617|531313911|FG002|Overall Study|Withdrawal by Subject|0|||
147313456|NCT01865617|531313912|FG003|Overall Study|Withdrawal by Subject|0|||
147313457|NCT01865617|531313913|FG004|Overall Study|Withdrawal by Subject|0|||
147313458|NCT01865617|531313914|FG005|Overall Study|Withdrawal by Subject|0|||
147313459|NCT01865617|531313915|FG006|Overall Study|Withdrawal by Subject|0|||
147313460|NCT01865617|531313916|FG007|Overall Study|Withdrawal by Subject|0|||
147313461|NCT01865617|531313917|FG008|Overall Study|Withdrawal by Subject|0|||
147313462|NCT01865617|531313918|FG009|Overall Study|Withdrawal by Subject|0|||
147313463|NCT01865617|531313919|FG010|Overall Study|Withdrawal by Subject|0|||
147313464|NCT01865617|531313920|FG011|Overall Study|Withdrawal by Subject|0|||
147313465|NCT01865617|531313921|FG012|Overall Study|Withdrawal by Subject|0|||
147313466|NCT01865617|531313909|FG000|Overall Study|Patient proceeded to new therapy|0|||
147313467|NCT01865617|531313910|FG001|Overall Study|Patient proceeded to new therapy|0|||
147313468|NCT01865617|531313911|FG002|Overall Study|Patient proceeded to new therapy|0|||
147313469|NCT01865617|531313912|FG003|Overall Study|Patient proceeded to new therapy|0|||
147313470|NCT01865617|531313913|FG004|Overall Study|Patient proceeded to new therapy|2|||
147313471|NCT01865617|531313914|FG005|Overall Study|Patient proceeded to new therapy|0|||
147650914|NCT02757352|532544543|FG006|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
147313472|NCT01865617|531313915|FG006|Overall Study|Patient proceeded to new therapy|0|||
147313473|NCT01865617|531313916|FG007|Overall Study|Patient proceeded to new therapy|0|||
147313474|NCT01865617|531313917|FG008|Overall Study|Patient proceeded to new therapy|0|||
147313475|NCT01865617|531313918|FG009|Overall Study|Patient proceeded to new therapy|0|||
147567831|NCT01796171|532238357|FG007|Follow-up Period|Physician Decision|0|||
147567832|NCT01796171|532238358|FG008|Follow-up Period|Physician Decision|0|||
147567833|NCT01796171|532238359|FG009|Follow-up Period|Physician Decision|0|||
147567834|NCT01796171|532238360|FG010|Follow-up Period|Physician Decision|5|||
147567835|NCT01796171|532238361|FG011|Follow-up Period|Physician Decision|0|||
147120081|NCT04821245|530605099|FG000|Overall Study|Withdrawal by Subject|3|||
147120082|NCT04821245|530605099|FG000|Overall Study|Physician Decision|1|||
147120083|NCT04821245|530605099|FG000|Overall Study|Protocol Violation|5|||
147120084|NCT00605657|530605100|FG000|Overall Study|Adverse Event|1|||
147120085|NCT00605657|530605100|FG000|Overall Study|Protocol Violation|1|||
147120086|NCT02773537|530605103|FG000|Overall Study|Lost to Follow-up|0|||
147120087|NCT02773537|530605104|FG001|Overall Study|Lost to Follow-up|1|||
147120088|NCT02773537|530605105|FG002|Overall Study|Lost to Follow-up|4|||
147120089|NCT01840163|530605106|FG000|First Follow up -Primary Outcome|Lost to Follow-up|19|||
147120090|NCT01840163|530605107|FG001|First Follow up -Primary Outcome|Lost to Follow-up|16|||
147120091|NCT01840163|530605106|FG000|Systemic Follow Up-secondary Outcome|Lost to Follow-up|48|||
147120092|NCT01840163|530605107|FG001|Systemic Follow Up-secondary Outcome|Lost to Follow-up|40|||
147120093|NCT01840163|530605106|FG000|Systemic Follow Up-secondary Outcome|excluded -DCIS not eligible|43|||
147120094|NCT01840163|530605107|FG001|Systemic Follow Up-secondary Outcome|excluded -DCIS not eligible|35|||
147120095|NCT00662038|530605108|FG000|Overall Study|Reason not specified|3|||
147120096|NCT00662038|530605108|FG000|Overall Study|Withdrawn consent|22|||
147120097|NCT00662038|530605108|FG000|Overall Study|Withdrawal by Subject|83|||
147120098|NCT00662038|530605108|FG000|Overall Study|Sponsor decision|1|||
147120099|NCT00662038|530605108|FG000|Overall Study|Physician Decision|19|||
147120100|NCT00662038|530605108|FG000|Overall Study|Lung transplantation|44|||
147120101|NCT00662038|530605108|FG000|Overall Study|Lost to Follow-up|1|||
147120102|NCT00662038|530605108|FG000|Overall Study|Death|95|||
147120103|NCT00662038|530605108|FG000|Overall Study|Adverse Event|358|||
147120104|NCT00662038|530605108|FG000|Overall Study|Continued treatment|5|||
147120105|NCT00397046|530605109|FG000|Overall Study|Disease Progression|3|||
147120106|NCT00397046|530605110|FG001|Overall Study|Disease Progression|3|||
147120107|NCT00397046|530605111|FG002|Overall Study|Disease Progression|10|||
147120108|NCT00397046|530605112|FG003|Overall Study|Disease Progression|5|||
147231735|NCT04553679|531021279|FG001|Overall Study|Caregiver only took part in the qualitative interview (no quantitative outcomes)|1|||
147231736|NCT00178633|531021280|FG000|Overall Study|Lost to Follow-up|6|||
147231737|NCT01912963|531021286|FG000|Overall Study|Disease Progression (RECIST1.1)|6|||
147231738|NCT01912963|531021287|FG001|Overall Study|Disease Progression (RECIST1.1)|9|||
147231739|NCT01912963|531021288|FG002|Overall Study|Disease Progression (RECIST1.1)|5|||
147231740|NCT01912963|531021286|FG000|Overall Study|Disease Progression (not RECIST1.1)|0|||
147231741|NCT01912963|531021287|FG001|Overall Study|Disease Progression (not RECIST1.1)|7|||
147231742|NCT01912963|531021288|FG002|Overall Study|Disease Progression (not RECIST1.1)|1|||
147231743|NCT01912963|531021286|FG000|Overall Study|Adverse Event|0|||
147231744|NCT01912963|531021287|FG001|Overall Study|Adverse Event|1|||
147231745|NCT01912963|531021288|FG002|Overall Study|Adverse Event|1|||
147231746|NCT01912963|531021286|FG000|Overall Study|Withdrawal by Subject|0|||
147231747|NCT01912963|531021287|FG001|Overall Study|Withdrawal by Subject|1|||
147231748|NCT01912963|531021288|FG002|Overall Study|Withdrawal by Subject|0|||
147231749|NCT01912963|531021286|FG000|Overall Study|Sought treatment locally|0|||
147231750|NCT01912963|531021287|FG001|Overall Study|Sought treatment locally|1|||
147231751|NCT01912963|531021288|FG002|Overall Study|Sought treatment locally|0|||
147231752|NCT01147172|531021299|FG000|Overall Study|Withdrawal by Subject|2|||
147231753|NCT01147172|531021299|FG000|Overall Study|Lost to Follow-up|2|||
147231754|NCT01069627|531021300|FG000|Overall Study|Disease progression|7|||
147231755|NCT01069627|531021300|FG000|Overall Study|Adverse Event|12|||
147231756|NCT01069627|531021300|FG000|Overall Study|Protocol Violation|1|||
147231757|NCT02963935|531021305|FG000|Overall Study|Adverse Event|12|||
147231758|NCT02963935|531021306|FG001|Overall Study|Adverse Event|6|||
147231759|NCT02963935|531021305|FG000|Overall Study|Protocol Violation|2|||
147231760|NCT02963935|531021306|FG001|Overall Study|Protocol Violation|1|||
147231761|NCT02963935|531021305|FG000|Overall Study|Lack of Efficacy|0|||
147231762|NCT02963935|531021306|FG001|Overall Study|Lack of Efficacy|2|||
147231763|NCT02963935|531021305|FG000|Overall Study|Lost to Follow-up|1|||
147231764|NCT02963935|531021306|FG001|Overall Study|Lost to Follow-up|6|||
147231765|NCT02963935|531021305|FG000|Overall Study|Unclassified|13|||
147120109|NCT00493285|530605119|FG000|Overall Study|Lost to Follow-up|0|||
147231766|NCT02963935|531021306|FG001|Overall Study|Unclassified|22|||
147231767|NCT00464269|531021307|FG000|Overall Study|Lack of Efficacy|1|||
147231768|NCT00464269|531021308|FG001|Overall Study|Lack of Efficacy|0|||
147231769|NCT00464269|531021309|FG002|Overall Study|Lack of Efficacy|0|||
147231770|NCT00464269|531021310|FG003|Overall Study|Lack of Efficacy|0|||
147231771|NCT00464269|531021307|FG000|Overall Study|Lost to Follow-up|0|||
147120110|NCT00493285|530605120|FG001|Overall Study|Lost to Follow-up|0|||
147120111|NCT00493285|530605121|FG002|Overall Study|Lost to Follow-up|0|||
147231772|NCT00464269|531021308|FG001|Overall Study|Lost to Follow-up|4|||
147231773|NCT00464269|531021309|FG002|Overall Study|Lost to Follow-up|0|||
147231774|NCT00464269|531021310|FG003|Overall Study|Lost to Follow-up|1|||
147567836|NCT01796171|532238362|FG012|Follow-up Period|Physician Decision|0|||
147120112|NCT00493285|530605122|FG003|Overall Study|Lost to Follow-up|0|||
147120113|NCT00493285|530605123|FG004|Overall Study|Lost to Follow-up|1|||
147120114|NCT00493285|530605124|FG005|Overall Study|Lost to Follow-up|0|||
147120115|NCT03021005|530605125|FG000|Overall Study|Lost to Follow-up|39|||
147120116|NCT03021005|530605126|FG001|Overall Study|Lost to Follow-up|26|||
147120117|NCT00337194|530605127|FG000|Overall Study|Adverse Event|5|||
147120118|NCT00337194|530605128|FG001|Overall Study|Adverse Event|1|||
147120119|NCT00337194|530605127|FG000|Overall Study|Death|2|||
147120120|NCT00337194|530605128|FG001|Overall Study|Death|0|||
147120121|NCT00337194|530605127|FG000|Overall Study|Withdrawal by Subject|1|||
147120122|NCT00337194|530605128|FG001|Overall Study|Withdrawal by Subject|0|||
147120123|NCT00337194|530605127|FG000|Overall Study|Disease progression|1|||
147120124|NCT00337194|530605128|FG001|Overall Study|Disease progression|2|||
147120125|NCT00337194|530605127|FG000|Overall Study|Subsequent non-protocol therapy|3|||
147120126|NCT00337194|530605128|FG001|Overall Study|Subsequent non-protocol therapy|1|||
147120127|NCT03188705|530605129|FG000|Clopidogrel Treatment|Withdrawal by Subject|1|||
147120128|NCT03188705|530605129|FG000|Clopidogrel Plus Aspirin Treatment|Withdrawal by Subject|1|||
147120129|NCT01174459|530605135|FG000|Overall Study|case report form (CRF) not collected|5|||
147120130|NCT04914000|530605142|FG000|Overall Study|Lost to Follow-up|8|||
147120131|NCT04914000|530605142|FG000|Overall Study|Withdrawal by Subject|1|||
147120132|NCT00981175|530605143|FG000|Primary Dose Vaccination|Adverse Event|1|||
147120133|NCT00981175|530605144|FG001|Primary Dose Vaccination|Adverse Event|0|||
147120134|NCT00981175|530605143|FG000|Primary Dose Vaccination|Protocol Violation|0|||
147120135|NCT00981175|530605144|FG001|Primary Dose Vaccination|Protocol Violation|1|||
147120136|NCT00981175|530605143|FG000|Primary Dose Vaccination|Lost to Follow-up|2|||
147120137|NCT00981175|530605144|FG001|Primary Dose Vaccination|Lost to Follow-up|1|||
147120138|NCT00981175|530605143|FG000|Booster Dose Vaccination|Lost to Follow-up|2|||
147120139|NCT00981175|530605144|FG001|Booster Dose Vaccination|Lost to Follow-up|3|||
147120140|NCT01750281|530605146|FG000|Overall Study|Discontinued Selumetinib/Placebo|37|||
147120141|NCT01750281|530605147|FG001|Overall Study|Discontinued Selumetinib/Placebo|77|||
147120142|NCT01750281|530605148|FG002|Overall Study|Discontinued Selumetinib/Placebo|75|||
147120143|NCT01750281|530605146|FG000|Overall Study|Ongoing Selumetinib/Pbo at data cut-off|6|||
147120144|NCT01750281|530605147|FG001|Overall Study|Ongoing Selumetinib/Pbo at data cut-off|7|||
147120145|NCT01750281|530605148|FG002|Overall Study|Ongoing Selumetinib/Pbo at data cut-off|9|||
147120146|NCT01750281|530605146|FG000|Overall Study|Did not receive treatment|0|||
147120147|NCT01750281|530605147|FG001|Overall Study|Did not receive treatment|1|||
147120148|NCT01750281|530605148|FG002|Overall Study|Did not receive treatment|0|||
147120149|NCT04189588|530605149|FG000|Overall Study|Death|0|||
147120150|NCT04189588|530605150|FG001|Overall Study|Death|1|||
147120151|NCT04189588|530605149|FG000|Overall Study|Lost to Follow-up|0|||
147120152|NCT04189588|530605150|FG001|Overall Study|Lost to Follow-up|1|||
147120153|NCT03302936|530605151|FG000|Overall Study|Protocol Violation|3|||
147120154|NCT03302936|530605152|FG001|Overall Study|Protocol Violation|4|||
147120155|NCT01122680|530605153|FG000|Period 1 (4 Weeks)|Adverse Event|1|||
147120156|NCT01122680|530605154|FG001|Period 1 (4 Weeks)|Adverse Event|0|||
147313476|NCT01865617|531313919|FG010|Overall Study|Patient proceeded to new therapy|0|||
147313477|NCT01865617|531313920|FG011|Overall Study|Patient proceeded to new therapy|0|||
147313478|NCT01865617|531313921|FG012|Overall Study|Patient proceeded to new therapy|0|||
147313479|NCT01865617|531313909|FG000|Overall Study|Other|0|||
147313480|NCT01865617|531313910|FG001|Overall Study|Other|0|||
147313481|NCT01865617|531313911|FG002|Overall Study|Other|0|||
147313482|NCT01865617|531313912|FG003|Overall Study|Other|0|||
147313483|NCT01865617|531313913|FG004|Overall Study|Other|0|||
147313484|NCT01865617|531313914|FG005|Overall Study|Other|0|||
147313485|NCT01865617|531313915|FG006|Overall Study|Other|1|||
147567837|NCT01796171|532238363|FG013|Follow-up Period|Physician Decision|0|||
147567838|NCT01796171|532238364|FG014|Follow-up Period|Physician Decision|0|||
147120157|NCT01122680|530605155|FG002|Period 1 (4 Weeks)|Adverse Event|0|||
147567839|NCT01796171|532238350|FG000|Follow-up Period|Withdrawal by Subject|0|||
147567840|NCT01796171|532238351|FG001|Follow-up Period|Withdrawal by Subject|1|||
147120158|NCT01122680|530605156|FG003|Period 1 (4 Weeks)|Adverse Event|0|||
147120159|NCT01122680|530605153|FG000|Period 1 (4 Weeks)|Protocol Violation|1|||
147313486|NCT01865617|531313916|FG007|Overall Study|Other|0|||
147313487|NCT01865617|531313917|FG008|Overall Study|Other|0|||
147313488|NCT01865617|531313918|FG009|Overall Study|Other|0|||
147313489|NCT01865617|531313919|FG010|Overall Study|Other|0|||
147120160|NCT01122680|530605154|FG001|Period 1 (4 Weeks)|Protocol Violation|0|||
147120161|NCT01122680|530605155|FG002|Period 1 (4 Weeks)|Protocol Violation|0|||
147313490|NCT01865617|531313920|FG011|Overall Study|Other|0|||
147120162|NCT01122680|530605156|FG003|Period 1 (4 Weeks)|Protocol Violation|0|||
147120163|NCT01122680|530605153|FG000|Period 1 (4 Weeks)|Other|1|||
147120164|NCT01122680|530605154|FG001|Period 1 (4 Weeks)|Other|1|||
147120165|NCT01122680|530605155|FG002|Period 1 (4 Weeks)|Other|0|||
147120166|NCT01122680|530605156|FG003|Period 1 (4 Weeks)|Other|0|||
147120167|NCT01122680|530605153|FG000|Period 2 (4 Weeks)|Protocol Violation|0|||
147313491|NCT01865617|531313921|FG012|Overall Study|Other|0|||
147567841|NCT01796171|532238352|FG002|Follow-up Period|Withdrawal by Subject|0|||
147567842|NCT01796171|532238353|FG003|Follow-up Period|Withdrawal by Subject|0|||
147120168|NCT01122680|530605154|FG001|Period 2 (4 Weeks)|Protocol Violation|0|||
147120169|NCT01122680|530605155|FG002|Period 2 (4 Weeks)|Protocol Violation|0|||
147120170|NCT01122680|530605156|FG003|Period 2 (4 Weeks)|Protocol Violation|1|||
147120171|NCT01122680|530605153|FG000|Period 2 (4 Weeks)|Other|1|||
147120172|NCT01122680|530605154|FG001|Period 2 (4 Weeks)|Other|0|||
147120173|NCT01122680|530605155|FG002|Period 2 (4 Weeks)|Other|0|||
147120174|NCT01122680|530605156|FG003|Period 2 (4 Weeks)|Other|0|||
147120175|NCT01122680|530605153|FG000|Period 3 (4 Weeks)|Adverse Event|1|||
147120176|NCT01122680|530605154|FG001|Period 3 (4 Weeks)|Adverse Event|0|||
147120177|NCT01122680|530605155|FG002|Period 3 (4 Weeks)|Adverse Event|0|||
147120178|NCT01122680|530605156|FG003|Period 3 (4 Weeks)|Adverse Event|0|||
147120179|NCT01122680|530605153|FG000|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
147120180|NCT01122680|530605154|FG001|Period 3 (4 Weeks)|Withdrawal by Subject|1|||
147120181|NCT01122680|530605155|FG002|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
147120182|NCT01122680|530605156|FG003|Period 3 (4 Weeks)|Withdrawal by Subject|0|||
147120183|NCT01986751|530605167|FG000|Overall Study|improperly consented|10|||
147120184|NCT01986751|530605168|FG001|Overall Study|improperly consented|2|||
147120185|NCT03566550|530605169|FG000|Overall Study|Withdrawal by Subject|0|||
147120186|NCT03566550|530605170|FG001|Overall Study|Withdrawal by Subject|1|||
147120187|NCT01968785|530605172|FG000|Overall Study|Withdrawal by Subject|1|||
147120188|NCT01968785|530605173|FG001|Overall Study|Withdrawal by Subject|0|||
147120189|NCT00098293|530605174|FG000|Double-blind (DB) Phase|Adverse Event|14|||
147120190|NCT00098293|530605175|FG001|Double-blind (DB) Phase|Adverse Event|27|||
147120191|NCT00098293|530605176|FG002|Double-blind (DB) Phase|Adverse Event|60|||
147120192|NCT00098293|530605177|FG003|Double-blind (DB) Phase|Adverse Event|0|||
147120193|NCT00098293|530605178|FG004|Double-blind (DB) Phase|Adverse Event|0|||
147120194|NCT00098293|530605174|FG000|Double-blind (DB) Phase|Pregnancy|0|||
147120195|NCT00098293|530605175|FG001|Double-blind (DB) Phase|Pregnancy|7|||
147120196|NCT00098293|530605176|FG002|Double-blind (DB) Phase|Pregnancy|9|||
147120197|NCT00098293|530605177|FG003|Double-blind (DB) Phase|Pregnancy|0|||
147120198|NCT00098293|530605178|FG004|Double-blind (DB) Phase|Pregnancy|0|||
147120199|NCT00098293|530605174|FG000|Double-blind (DB) Phase|Participant Defaulted|11|||
147120200|NCT00098293|530605175|FG001|Double-blind (DB) Phase|Participant Defaulted|40|||
147120201|NCT00098293|530605176|FG002|Double-blind (DB) Phase|Participant Defaulted|36|||
147120202|NCT00098293|530605177|FG003|Double-blind (DB) Phase|Participant Defaulted|0|||
147120203|NCT00098293|530605178|FG004|Double-blind (DB) Phase|Participant Defaulted|0|||
147120204|NCT00098293|530605174|FG000|Double-blind (DB) Phase|Lack of Efficacy|11|||
147120205|NCT00098293|530605175|FG001|Double-blind (DB) Phase|Lack of Efficacy|64|||
147120206|NCT00098293|530605176|FG002|Double-blind (DB) Phase|Lack of Efficacy|30|||
147120207|NCT00098293|530605177|FG003|Double-blind (DB) Phase|Lack of Efficacy|0|||
147120208|NCT00098293|530605178|FG004|Double-blind (DB) Phase|Lack of Efficacy|0|||
147120209|NCT00098293|530605174|FG000|Double-blind (DB) Phase|Death|1|||
147120210|NCT00098293|530605175|FG001|Double-blind (DB) Phase|Death|2|||
147120211|NCT00098293|530605176|FG002|Double-blind (DB) Phase|Death|2|||
147120212|NCT00098293|530605177|FG003|Double-blind (DB) Phase|Death|0|||
147120213|NCT00098293|530605178|FG004|Double-blind (DB) Phase|Death|0|||
147120214|NCT00098293|530605174|FG000|Double-blind (DB) Phase|Randomized, Not Treated|3|||
147120215|NCT00098293|530605175|FG001|Double-blind (DB) Phase|Randomized, Not Treated|8|||
147120216|NCT00098293|530605176|FG002|Double-blind (DB) Phase|Randomized, Not Treated|11|||
147120217|NCT00098293|530605177|FG003|Double-blind (DB) Phase|Randomized, Not Treated|0|||
147120218|NCT00098293|530605178|FG004|Double-blind (DB) Phase|Randomized, Not Treated|0|||
147120219|NCT00098293|530605174|FG000|Double-blind (DB) Phase|Protocol Violation|2|||
147120220|NCT00098293|530605175|FG001|Double-blind (DB) Phase|Protocol Violation|18|||
147120221|NCT00098293|530605176|FG002|Double-blind (DB) Phase|Protocol Violation|22|||
147120222|NCT00098293|530605177|FG003|Double-blind (DB) Phase|Protocol Violation|0|||
147120223|NCT00098293|530605178|FG004|Double-blind (DB) Phase|Protocol Violation|0|||
147120224|NCT00098293|530605174|FG000|Double-blind (DB) Phase|Terminated by sponsor|135|||
147120225|NCT00098293|530605175|FG001|Double-blind (DB) Phase|Terminated by sponsor|0|||
147120226|NCT00098293|530605176|FG002|Double-blind (DB) Phase|Terminated by sponsor|0|||
147120227|NCT00098293|530605177|FG003|Double-blind (DB) Phase|Terminated by sponsor|0|||
147120228|NCT00098293|530605178|FG004|Double-blind (DB) Phase|Terminated by sponsor|0|||
147120229|NCT00098293|530605174|FG000|Between DB and OL Phase|Did Not Enter Open-label Phase|0|||
147120230|NCT00098293|530605175|FG001|Between DB and OL Phase|Did Not Enter Open-label Phase|0|||
147120231|NCT00098293|530605176|FG002|Between DB and OL Phase|Did Not Enter Open-label Phase|3|||
147231775|NCT00464269|531021307|FG000|Overall Study|Withdrawal by Subject|0|||
147231776|NCT00464269|531021308|FG001|Overall Study|Withdrawal by Subject|2|||
147231777|NCT00464269|531021309|FG002|Overall Study|Withdrawal by Subject|1|||
147231778|NCT00464269|531021310|FG003|Overall Study|Withdrawal by Subject|1|||
147231779|NCT00464269|531021307|FG000|Overall Study|Other reason|3|||
147231780|NCT00464269|531021308|FG001|Overall Study|Other reason|3|||
147231781|NCT00464269|531021309|FG002|Overall Study|Other reason|1|||
147231782|NCT00464269|531021310|FG003|Overall Study|Other reason|1|||
147231783|NCT00464269|531021307|FG000|Overall Study|AE, serious fatal|0|||
147231784|NCT00464269|531021308|FG001|Overall Study|AE, serious fatal|0|||
147231785|NCT00464269|531021309|FG002|Overall Study|AE, serious fatal|1|||
147567843|NCT01796171|532238354|FG004|Follow-up Period|Withdrawal by Subject|0|||
147567844|NCT01796171|532238355|FG005|Follow-up Period|Withdrawal by Subject|1|||
147567845|NCT01796171|532238356|FG006|Follow-up Period|Withdrawal by Subject|0|||
147567846|NCT01796171|532238357|FG007|Follow-up Period|Withdrawal by Subject|0|||
147567847|NCT01796171|532238358|FG008|Follow-up Period|Withdrawal by Subject|0|||
147567848|NCT01796171|532238359|FG009|Follow-up Period|Withdrawal by Subject|0|||
147567849|NCT01796171|532238360|FG010|Follow-up Period|Withdrawal by Subject|3|||
147567850|NCT01796171|532238361|FG011|Follow-up Period|Withdrawal by Subject|1|||
147567851|NCT01796171|532238362|FG012|Follow-up Period|Withdrawal by Subject|0|||
147567852|NCT01796171|532238363|FG013|Follow-up Period|Withdrawal by Subject|0|||
147567853|NCT01796171|532238364|FG014|Follow-up Period|Withdrawal by Subject|0|||
147567854|NCT01796171|532238350|FG000|Follow-up Period|Death|0|||
147567855|NCT01796171|532238351|FG001|Follow-up Period|Death|0|||
147567856|NCT01796171|532238352|FG002|Follow-up Period|Death|0|||
147567857|NCT01796171|532238353|FG003|Follow-up Period|Death|0|||
147567858|NCT01796171|532238354|FG004|Follow-up Period|Death|0|||
147567859|NCT01796171|532238355|FG005|Follow-up Period|Death|0|||
147567860|NCT01796171|532238356|FG006|Follow-up Period|Death|1|||
147567861|NCT01796171|532238357|FG007|Follow-up Period|Death|0|||
147567862|NCT01796171|532238358|FG008|Follow-up Period|Death|0|||
147567863|NCT01796171|532238359|FG009|Follow-up Period|Death|0|||
147567864|NCT01796171|532238360|FG010|Follow-up Period|Death|17|||
147567865|NCT01796171|532238361|FG011|Follow-up Period|Death|9|||
147567866|NCT01796171|532238362|FG012|Follow-up Period|Death|1|||
147567867|NCT01796171|532238363|FG013|Follow-up Period|Death|0|||
147567868|NCT01796171|532238364|FG014|Follow-up Period|Death|0|||
147567869|NCT01796171|532238350|FG000|Follow-up Period|Patient transferred to other hospital|0|||
147567870|NCT01796171|532238351|FG001|Follow-up Period|Patient transferred to other hospital|1|||
147567871|NCT01796171|532238352|FG002|Follow-up Period|Patient transferred to other hospital|0|||
147567872|NCT01796171|532238353|FG003|Follow-up Period|Patient transferred to other hospital|0|||
147567873|NCT01796171|532238354|FG004|Follow-up Period|Patient transferred to other hospital|0|||
147567874|NCT01796171|532238355|FG005|Follow-up Period|Patient transferred to other hospital|0|||
147567875|NCT01796171|532238356|FG006|Follow-up Period|Patient transferred to other hospital|0|||
147567876|NCT01796171|532238357|FG007|Follow-up Period|Patient transferred to other hospital|0|||
147567877|NCT01796171|532238358|FG008|Follow-up Period|Patient transferred to other hospital|0|||
147567878|NCT01796171|532238359|FG009|Follow-up Period|Patient transferred to other hospital|0|||
147567879|NCT01796171|532238360|FG010|Follow-up Period|Patient transferred to other hospital|0|||
147567880|NCT01796171|532238361|FG011|Follow-up Period|Patient transferred to other hospital|0|||
147567881|NCT01796171|532238362|FG012|Follow-up Period|Patient transferred to other hospital|0|||
147567882|NCT01796171|532238363|FG013|Follow-up Period|Patient transferred to other hospital|0|||
147567883|NCT01796171|532238364|FG014|Follow-up Period|Patient transferred to other hospital|0|||
147567884|NCT01796171|532238350|FG000|Follow-up Period|Sponsor Decision|0|||
147567885|NCT01796171|532238351|FG001|Follow-up Period|Sponsor Decision|0|||
147567886|NCT01796171|532238352|FG002|Follow-up Period|Sponsor Decision|0|||
147567887|NCT01796171|532238353|FG003|Follow-up Period|Sponsor Decision|0|||
147567888|NCT01796171|532238354|FG004|Follow-up Period|Sponsor Decision|0|||
147567889|NCT01796171|532238355|FG005|Follow-up Period|Sponsor Decision|0|||
147231786|NCT00464269|531021310|FG003|Overall Study|AE, serious fatal|1|||
147231787|NCT00464269|531021307|FG000|Overall Study|SAE, non-fatal|0|||
147231788|NCT00464269|531021308|FG001|Overall Study|SAE, non-fatal|0|||
147231789|NCT00464269|531021309|FG002|Overall Study|SAE, non-fatal|0|||
147231790|NCT00464269|531021310|FG003|Overall Study|SAE, non-fatal|1|||
147567890|NCT01796171|532238356|FG006|Follow-up Period|Sponsor Decision|0|||
147567891|NCT01796171|532238357|FG007|Follow-up Period|Sponsor Decision|0|||
147567892|NCT01796171|532238358|FG008|Follow-up Period|Sponsor Decision|0|||
147567893|NCT01796171|532238359|FG009|Follow-up Period|Sponsor Decision|0|||
147567894|NCT01796171|532238360|FG010|Follow-up Period|Sponsor Decision|40|||
147567895|NCT01796171|532238361|FG011|Follow-up Period|Sponsor Decision|15|||
147567896|NCT01796171|532238362|FG012|Follow-up Period|Sponsor Decision|7|||
147567897|NCT01796171|532238363|FG013|Follow-up Period|Sponsor Decision|0|||
147231791|NCT00464269|531021307|FG000|Overall Study|AE, non-serious non-fatal|2|||
147231792|NCT00464269|531021308|FG001|Overall Study|AE, non-serious non-fatal|8|||
147231793|NCT00464269|531021309|FG002|Overall Study|AE, non-serious non-fatal|3|||
147567898|NCT01796171|532238364|FG014|Follow-up Period|Sponsor Decision|0|||
147567899|NCT01705574|532238365|FG000|Double-Blind Phase|Lost to Follow-up|12|||
147567900|NCT01705574|532238366|FG001|Double-Blind Phase|Lost to Follow-up|16|||
147231794|NCT00464269|531021310|FG003|Overall Study|AE, non-serious non-fatal|4|||
147231795|NCT00464269|531021307|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
147231796|NCT00464269|531021308|FG001|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
147231797|NCT00464269|531021309|FG002|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|1|||
147231798|NCT00464269|531021310|FG003|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
147567901|NCT01705574|532238367|FG002|Double-Blind Phase|Lost to Follow-up|0|||
147567902|NCT01705574|532238368|FG003|Double-Blind Phase|Lost to Follow-up|0|||
147567903|NCT01705574|532238365|FG000|Double-Blind Phase|Adverse Event|3|||
147567904|NCT01705574|532238366|FG001|Double-Blind Phase|Adverse Event|10|||
147567905|NCT01705574|532238367|FG002|Double-Blind Phase|Adverse Event|0|||
147120232|NCT00098293|530605177|FG003|Between DB and OL Phase|Did Not Enter Open-label Phase|0|||
147120233|NCT00098293|530605178|FG004|Between DB and OL Phase|Did Not Enter Open-label Phase|0|||
147120234|NCT00098293|530605174|FG000|Open-label (OL) Phase|Adverse Event|0|||
147120235|NCT00098293|530605175|FG001|Open-label (OL) Phase|Adverse Event|3|||
147120236|NCT00098293|530605176|FG002|Open-label (OL) Phase|Adverse Event|7|||
147120237|NCT00098293|530605177|FG003|Open-label (OL) Phase|Adverse Event|6|||
147120238|NCT00098293|530605178|FG004|Open-label (OL) Phase|Adverse Event|0|||
147120239|NCT00098293|530605174|FG000|Open-label (OL) Phase|Lack of Efficacy|0|||
147120240|NCT00098293|530605175|FG001|Open-label (OL) Phase|Lack of Efficacy|7|||
147120241|NCT00098293|530605176|FG002|Open-label (OL) Phase|Lack of Efficacy|2|||
147120242|NCT00098293|530605177|FG003|Open-label (OL) Phase|Lack of Efficacy|20|||
147120243|NCT00098293|530605178|FG004|Open-label (OL) Phase|Lack of Efficacy|0|||
147120244|NCT00098293|530605174|FG000|Open-label (OL) Phase|Pregnancy|0|||
147120245|NCT00098293|530605175|FG001|Open-label (OL) Phase|Pregnancy|1|||
147120246|NCT00098293|530605176|FG002|Open-label (OL) Phase|Pregnancy|0|||
147120247|NCT00098293|530605177|FG003|Open-label (OL) Phase|Pregnancy|3|||
147120248|NCT00098293|530605178|FG004|Open-label (OL) Phase|Pregnancy|0|||
147120249|NCT00098293|530605174|FG000|Open-label (OL) Phase|Protocol Violation|0|||
147120250|NCT00098293|530605175|FG001|Open-label (OL) Phase|Protocol Violation|6|||
147120251|NCT00098293|530605176|FG002|Open-label (OL) Phase|Protocol Violation|13|||
147120252|NCT00098293|530605177|FG003|Open-label (OL) Phase|Protocol Violation|16|||
147120253|NCT00098293|530605178|FG004|Open-label (OL) Phase|Protocol Violation|0|||
147120254|NCT00098293|530605174|FG000|Open-label (OL) Phase|Participant Defaulted|0|||
147120255|NCT00098293|530605175|FG001|Open-label (OL) Phase|Participant Defaulted|6|||
147120256|NCT00098293|530605176|FG002|Open-label (OL) Phase|Participant Defaulted|16|||
147567906|NCT01705574|532238368|FG003|Double-Blind Phase|Adverse Event|0|||
147567907|NCT01705574|532238365|FG000|Double-Blind Phase|Withdrew Consent|8|||
147120257|NCT00098293|530605177|FG003|Open-label (OL) Phase|Participant Defaulted|20|||
147120258|NCT00098293|530605178|FG004|Open-label (OL) Phase|Participant Defaulted|0|||
147120259|NCT00098293|530605174|FG000|Open-label (OL) Phase|Death|0|||
147120260|NCT00098293|530605175|FG001|Open-label (OL) Phase|Death|2|||
147120261|NCT00098293|530605176|FG002|Open-label (OL) Phase|Death|3|||
147567908|NCT01705574|532238366|FG001|Double-Blind Phase|Withdrew Consent|5|||
147120262|NCT00098293|530605177|FG003|Open-label (OL) Phase|Death|0|||
147120263|NCT00098293|530605178|FG004|Open-label (OL) Phase|Death|0|||
147120264|NCT00098293|530605174|FG000|Supplemental Phase (SP)|Death|0|||
147120265|NCT00098293|530605175|FG001|Supplemental Phase (SP)|Death|0|||
147120266|NCT00098293|530605176|FG002|Supplemental Phase (SP)|Death|0|||
147120267|NCT00098293|530605177|FG003|Supplemental Phase (SP)|Death|0|||
147231799|NCT00747461|531021311|FG000|Overall Study|study terminated by sponsor|5|||
147231800|NCT02149875|531021312|FG000|Overall Study|Lost to Follow-up|3|||
147231801|NCT02149875|531021313|FG001|Overall Study|Lost to Follow-up|4|||
147231802|NCT02149875|531021314|FG002|Overall Study|Lost to Follow-up|5|||
147231803|NCT02149875|531021312|FG000|Overall Study|Withdrawal by Subject|3|||
147231804|NCT02149875|531021313|FG001|Overall Study|Withdrawal by Subject|2|||
147231805|NCT02149875|531021314|FG002|Overall Study|Withdrawal by Subject|2|||
147231806|NCT02149875|531021312|FG000|Overall Study|Physician Decision|1|||
147231807|NCT02149875|531021313|FG001|Overall Study|Physician Decision|2|||
147231808|NCT02149875|531021314|FG002|Overall Study|Physician Decision|2|||
147231809|NCT00299182|531021316|FG000|Overall Study|Withdrawal by Subject|0|||
147231810|NCT00299182|531021317|FG001|Overall Study|Withdrawal by Subject|0|||
147231811|NCT00299182|531021318|FG002|Overall Study|Withdrawal by Subject|1|||
147231812|NCT00299182|531021319|FG003|Overall Study|Withdrawal by Subject|0|||
147231813|NCT00299182|531021320|FG004|Overall Study|Withdrawal by Subject|1|||
147231814|NCT00299182|531021321|FG005|Overall Study|Withdrawal by Subject|2|||
147231815|NCT00299182|531021322|FG006|Overall Study|Withdrawal by Subject|0|||
147231816|NCT00299182|531021316|FG000|Overall Study|Chemotherapy Changed|0|||
147231817|NCT00299182|531021317|FG001|Overall Study|Chemotherapy Changed|0|||
147231818|NCT00299182|531021318|FG002|Overall Study|Chemotherapy Changed|1|||
147231819|NCT00299182|531021319|FG003|Overall Study|Chemotherapy Changed|0|||
147231820|NCT00299182|531021320|FG004|Overall Study|Chemotherapy Changed|1|||
147231821|NCT00299182|531021321|FG005|Overall Study|Chemotherapy Changed|0|||
147231822|NCT00299182|531021322|FG006|Overall Study|Chemotherapy Changed|1|||
147231823|NCT00299182|531021316|FG000|Overall Study|Adverse Event|0|||
147231824|NCT00299182|531021317|FG001|Overall Study|Adverse Event|0|||
147231825|NCT00299182|531021318|FG002|Overall Study|Adverse Event|0|||
147231826|NCT00299182|531021319|FG003|Overall Study|Adverse Event|0|||
147231827|NCT00299182|531021320|FG004|Overall Study|Adverse Event|0|||
147231828|NCT00299182|531021321|FG005|Overall Study|Adverse Event|1|||
147231829|NCT00299182|531021322|FG006|Overall Study|Adverse Event|0|||
147231830|NCT00299182|531021316|FG000|Overall Study|Not Eligible|0|||
147231831|NCT00299182|531021317|FG001|Overall Study|Not Eligible|0|||
147120268|NCT00098293|530605178|FG004|Supplemental Phase (SP)|Death|1|||
147120269|NCT00098293|530605174|FG000|Supplemental Phase (SP)|Lost to Follow-up|0|||
147120270|NCT00098293|530605175|FG001|Supplemental Phase (SP)|Lost to Follow-up|0|||
147120271|NCT00098293|530605176|FG002|Supplemental Phase (SP)|Lost to Follow-up|0|||
147231832|NCT00299182|531021318|FG002|Overall Study|Not Eligible|0|||
147567909|NCT01705574|532238367|FG002|Double-Blind Phase|Withdrew Consent|0|||
147567910|NCT01705574|532238368|FG003|Double-Blind Phase|Withdrew Consent|0|||
147567911|NCT01705574|532238365|FG000|Double-Blind Phase|Non-Compliance with Study Drug|4|||
147567912|NCT01705574|532238366|FG001|Double-Blind Phase|Non-Compliance with Study Drug|5|||
147567913|NCT01705574|532238367|FG002|Double-Blind Phase|Non-Compliance with Study Drug|0|||
147567914|NCT01705574|532238368|FG003|Double-Blind Phase|Non-Compliance with Study Drug|0|||
147567915|NCT01705574|532238365|FG000|Double-Blind Phase|Pregnancy|1|||
147567916|NCT01705574|532238366|FG001|Double-Blind Phase|Pregnancy|1|||
147567917|NCT01705574|532238367|FG002|Double-Blind Phase|Pregnancy|0|||
147567918|NCT01705574|532238368|FG003|Double-Blind Phase|Pregnancy|0|||
147567919|NCT01705574|532238365|FG000|Double-Blind Phase|Protocol Violation|1|||
147567920|NCT01705574|532238366|FG001|Double-Blind Phase|Protocol Violation|0|||
147567921|NCT01705574|532238367|FG002|Double-Blind Phase|Protocol Violation|0|||
147567922|NCT01705574|532238368|FG003|Double-Blind Phase|Protocol Violation|0|||
147567923|NCT01705574|532238365|FG000|Double-Blind Phase|Randomized but Not Treated|4|||
147567924|NCT01705574|532238366|FG001|Double-Blind Phase|Randomized but Not Treated|4|||
147567925|NCT01705574|532238367|FG002|Double-Blind Phase|Randomized but Not Treated|0|||
147120272|NCT00098293|530605177|FG003|Supplemental Phase (SP)|Lost to Follow-up|0|||
147120273|NCT00098293|530605178|FG004|Supplemental Phase (SP)|Lost to Follow-up|2|||
147120274|NCT00098293|530605174|FG000|Supplemental Phase (SP)|Withdrawal by Subject|0|||
147120275|NCT00098293|530605175|FG001|Supplemental Phase (SP)|Withdrawal by Subject|0|||
147120276|NCT00098293|530605176|FG002|Supplemental Phase (SP)|Withdrawal by Subject|0|||
147120277|NCT00098293|530605177|FG003|Supplemental Phase (SP)|Withdrawal by Subject|0|||
147120278|NCT00098293|530605178|FG004|Supplemental Phase (SP)|Withdrawal by Subject|8|||
147120279|NCT00098293|530605174|FG000|Supplemental Phase (SP)|Other|0|||
147120280|NCT00098293|530605175|FG001|Supplemental Phase (SP)|Other|0|||
147120281|NCT00098293|530605176|FG002|Supplemental Phase (SP)|Other|0|||
147120282|NCT00098293|530605177|FG003|Supplemental Phase (SP)|Other|0|||
147120283|NCT00098293|530605178|FG004|Supplemental Phase (SP)|Other|22|||
147120284|NCT00754559|530605179|FG000|Overall Study|Adverse Event|15|||
147120285|NCT00754559|530605179|FG000|Overall Study|Protocol Violation|11|||
147120286|NCT00754559|530605179|FG000|Overall Study|Lack of Efficacy|10|||
147120287|NCT00754559|530605179|FG000|Overall Study|Lost to Follow-up|2|||
147120288|NCT00754559|530605179|FG000|Overall Study|Administrative reason|1|||
147120289|NCT00754559|530605179|FG000|Overall Study|Other|5|||
147120290|NCT00754559|530605179|FG000|Overall Study|Withdrawal by Subject|3|||
147567926|NCT01705574|532238368|FG003|Double-Blind Phase|Randomized but Not Treated|0|||
147567927|NCT01705574|532238365|FG000|Open-Label Extension Phase|Lost to Follow-up|6|||
147567928|NCT01705574|532238366|FG001|Open-Label Extension Phase|Lost to Follow-up|0|||
147567929|NCT01705574|532238367|FG002|Open-Label Extension Phase|Lost to Follow-up|2|||
147650915|NCT02757352|532544544|FG007|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
147650916|NCT02757352|532544545|FG008|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
147650917|NCT02757352|532544546|FG009|IR-Open Label Period (Week 16 - Week 52)|Physician Decision|0|||
147120291|NCT00455455|530605180|FG000|Washout|Withdrawal by Subject|0|||
147120292|NCT00455455|530605181|FG001|Washout|Withdrawal by Subject|1|||
147120293|NCT00455455|530605180|FG000|Washout|Withdrawal by Subject|1|||
147120294|NCT00455455|530605181|FG001|Washout|Withdrawal by Subject|0|||
147120295|NCT01370538|530605182|FG000|Overall Study|Voluntary Discontinuation by Subject|3|||
147231833|NCT00299182|531021319|FG003|Overall Study|Not Eligible|0|||
147231834|NCT00299182|531021320|FG004|Overall Study|Not Eligible|1|||
147231835|NCT00299182|531021321|FG005|Overall Study|Not Eligible|0|||
147231836|NCT00299182|531021322|FG006|Overall Study|Not Eligible|0|||
147231837|NCT00771316|531021327|FG000|Overall Study|Adverse Event|0|||
147231838|NCT00771316|531021328|FG001|Overall Study|Adverse Event|1|||
147231839|NCT00771316|531021327|FG000|Overall Study|Patient withdrew consent|1|||
147231840|NCT00771316|531021328|FG001|Overall Study|Patient withdrew consent|0|||
147231841|NCT00771316|531021327|FG000|Overall Study|Discontinued due to early termination|1|||
147231842|NCT00771316|531021328|FG001|Overall Study|Discontinued due to early termination|0|||
147231843|NCT02081183|531021330|FG000|Overall Study|Lost to Follow-up|0|||
147231844|NCT02081183|531021331|FG001|Overall Study|Lost to Follow-up|1|||
147231845|NCT02081183|531021330|FG000|Overall Study|Protocol Violation|1|||
147231846|NCT02081183|531021331|FG001|Overall Study|Protocol Violation|0|||
147231847|NCT02081183|531021330|FG000|Overall Study|Other|3|||
147231848|NCT02081183|531021331|FG001|Overall Study|Other|3|||
147231849|NCT02024555|531021332|FG000|Overall Study|Lost to Follow-up|1|||
147231850|NCT02024555|531021333|FG001|Overall Study|Lost to Follow-up|1|||
147231851|NCT02024555|531021332|FG000|Overall Study|Withdrawal by Subject|5|||
147120296|NCT01370538|530605183|FG001|Overall Study|Voluntary Discontinuation by Subject|2|||
147120297|NCT01370538|530605182|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
147120298|NCT01370538|530605183|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
147120299|NCT01370538|530605182|FG000|Overall Study|Adverse Event|1|||
147231852|NCT02024555|531021333|FG001|Overall Study|Withdrawal by Subject|1|||
147567930|NCT01705574|532238368|FG003|Open-Label Extension Phase|Lost to Follow-up|2|||
147567931|NCT01705574|532238365|FG000|Open-Label Extension Phase|Withdrew Consent|4|||
147567932|NCT01705574|532238366|FG001|Open-Label Extension Phase|Withdrew Consent|0|||
147567933|NCT01705574|532238367|FG002|Open-Label Extension Phase|Withdrew Consent|4|||
147567934|NCT01705574|532238368|FG003|Open-Label Extension Phase|Withdrew Consent|1|||
147567935|NCT01705574|532238365|FG000|Open-Label Extension Phase|Adverse Event|3|||
147567936|NCT01705574|532238366|FG001|Open-Label Extension Phase|Adverse Event|0|||
147567937|NCT01705574|532238367|FG002|Open-Label Extension Phase|Adverse Event|0|||
147650918|NCT02757352|532544537|FG000|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
147650919|NCT02757352|532544538|FG001|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
147650920|NCT02757352|532544539|FG002|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
147650921|NCT02757352|532544540|FG003|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|2|||
147650922|NCT02757352|532544541|FG004|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|1|||
147650923|NCT02757352|532544542|FG005|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|1|||
147650924|NCT02757352|532544543|FG006|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
147650925|NCT02757352|532544544|FG007|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
147650926|NCT02757352|532544545|FG008|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
147650927|NCT02757352|532544546|FG009|IR-Open Label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
147650928|NCT02757352|532544537|FG000|Follow-Up Period|Adverse Event|0|||
147567938|NCT01705574|532238368|FG003|Open-Label Extension Phase|Adverse Event|1|||
147567939|NCT01705574|532238365|FG000|Open-Label Extension Phase|Death|2|||
147567940|NCT01705574|532238366|FG001|Open-Label Extension Phase|Death|0|||
147567941|NCT01705574|532238367|FG002|Open-Label Extension Phase|Death|1|||
147567942|NCT01705574|532238368|FG003|Open-Label Extension Phase|Death|0|||
147120300|NCT01370538|530605183|FG001|Overall Study|Adverse Event|0|||
147120301|NCT01370538|530605182|FG000|Overall Study|Protocol Violation|8|||
147120302|NCT01370538|530605183|FG001|Overall Study|Protocol Violation|5|||
147120303|NCT01370538|530605182|FG000|Overall Study|Development of study specific withdrawal|1|||
147120304|NCT01370538|530605183|FG001|Overall Study|Development of study specific withdrawal|1|||
147120305|NCT01370538|530605182|FG000|Overall Study|Lost to follow up|6|||
147120306|NCT01370538|530605183|FG001|Overall Study|Lost to follow up|10|||
147120307|NCT03335566|530605184|FG000|Overall Study|Adverse Event|0|||
147120308|NCT03335566|530605185|FG001|Overall Study|Adverse Event|1|||
147120309|NCT03335566|530605184|FG000|Overall Study|Lost to Follow-up|1|||
147120310|NCT03335566|530605185|FG001|Overall Study|Lost to Follow-up|0|||
147120311|NCT03335566|530605184|FG000|Overall Study|Technical Problems|1|||
147120312|NCT03335566|530605185|FG001|Overall Study|Technical Problems|0|||
147120313|NCT03335566|530605184|FG000|Overall Study|Protocol Violation|1|||
147120314|NCT03335566|530605185|FG001|Overall Study|Protocol Violation|0|||
147120315|NCT03335566|530605184|FG000|Overall Study|Other than specified above|1|||
147120316|NCT03335566|530605185|FG001|Overall Study|Other than specified above|2|||
147120317|NCT01084135|530605186|FG000|20 Week|Physician Decision|0|||
147120318|NCT01084135|530605187|FG001|20 Week|Physician Decision|1|||
147120319|NCT04595370|530605189|FG000|Overall Study|Subjects randomised, not treated, Protocol Deviation|1|||
147120320|NCT04595370|530605190|FG001|Overall Study|Subjects randomised, not treated, Protocol Deviation|0|||
147120321|NCT04595370|530605191|FG002|Overall Study|Subjects randomised, not treated, Protocol Deviation|0|||
147120322|NCT04595370|530605192|FG003|Overall Study|Subjects randomised, not treated, Protocol Deviation|0|||
147120323|NCT04595370|530605193|FG004|Overall Study|Subjects randomised, not treated, Protocol Deviation|0|||
147120324|NCT04595370|530605194|FG005|Overall Study|Subjects randomised, not treated, Protocol Deviation|0|||
147120325|NCT04595370|530605189|FG000|Overall Study|Subjects randomised, not treated, Withdrawal by Subject|0|||
147120326|NCT04595370|530605190|FG001|Overall Study|Subjects randomised, not treated, Withdrawal by Subject|0|||
147120327|NCT04595370|530605191|FG002|Overall Study|Subjects randomised, not treated, Withdrawal by Subject|1|||
147120328|NCT04595370|530605192|FG003|Overall Study|Subjects randomised, not treated, Withdrawal by Subject|0|||
147120329|NCT04595370|530605193|FG004|Overall Study|Subjects randomised, not treated, Withdrawal by Subject|0|||
147120330|NCT04595370|530605194|FG005|Overall Study|Subjects randomised, not treated, Withdrawal by Subject|0|||
147120331|NCT04595370|530605189|FG000|Overall Study|Adverse Event|0|||
147120332|NCT04595370|530605190|FG001|Overall Study|Adverse Event|4|||
147120333|NCT04595370|530605191|FG002|Overall Study|Adverse Event|3|||
147120334|NCT04595370|530605192|FG003|Overall Study|Adverse Event|1|||
147120335|NCT04595370|530605193|FG004|Overall Study|Adverse Event|1|||
147120336|NCT04595370|530605194|FG005|Overall Study|Adverse Event|1|||
147120337|NCT04595370|530605189|FG000|Overall Study|Withdrawal of Consent|1|||
147120338|NCT04595370|530605190|FG001|Overall Study|Withdrawal of Consent|1|||
147120339|NCT04595370|530605191|FG002|Overall Study|Withdrawal of Consent|1|||
147120340|NCT04595370|530605192|FG003|Overall Study|Withdrawal of Consent|0|||
147120341|NCT04595370|530605193|FG004|Overall Study|Withdrawal of Consent|0|||
147120342|NCT04595370|530605194|FG005|Overall Study|Withdrawal of Consent|0|||
147120343|NCT04595370|530605189|FG000|Overall Study|Death|0|||
147120344|NCT04595370|530605190|FG001|Overall Study|Death|1|||
147120345|NCT04595370|530605191|FG002|Overall Study|Death|0|||
147120346|NCT04595370|530605192|FG003|Overall Study|Death|0|||
147120347|NCT04595370|530605193|FG004|Overall Study|Death|1|||
147567943|NCT01705574|532238365|FG000|Open-Label Extension Phase|Non-Compliance with Study Drug|0|||
147567944|NCT01705574|532238366|FG001|Open-Label Extension Phase|Non-Compliance with Study Drug|0|||
147567945|NCT01705574|532238367|FG002|Open-Label Extension Phase|Non-Compliance with Study Drug|1|||
147567946|NCT01705574|532238368|FG003|Open-Label Extension Phase|Non-Compliance with Study Drug|0|||
147567947|NCT01705574|532238365|FG000|Open-Label Extension Phase|Physician Decision|0|||
147313492|NCT02226172|531313922|FG000|Overall Study|Participant refused further follow-up|4|||
147313493|NCT02226172|531313922|FG000|Overall Study|Other|5|||
147313494|NCT02226172|531313922|FG000|Overall Study|Death|1|||
147313495|NCT02226172|531313922|FG000|Overall Study|Study terminated by sponsor|1|||
147313496|NCT02226172|531313922|FG000|Overall Study|Adverse Event|6|||
147313497|NCT00502996|531313923|FG000|Overall Study|Lost to Follow-up|9|||
147313498|NCT00502996|531313923|FG000|Overall Study|Protocol Violation|2|||
147313499|NCT00502996|531313923|FG000|Overall Study|Treatment failure|25|||
147313500|NCT00502996|531313923|FG000|Overall Study|Withdrawal Informed Consent|6|||
147313501|NCT00502996|531313923|FG000|Overall Study|Adverse Event|2|||
147313502|NCT02500979|531313924|FG000|Period 1|Hyperglycemia|1|||
147313503|NCT02500979|531313925|FG001|Period 1|Hyperglycemia|0|||
147313504|NCT02500979|531313924|FG000|Period 1|Severe non-compliance to protocol|0|||
147313505|NCT02500979|531313925|FG001|Period 1|Severe non-compliance to protocol|1|||
147313506|NCT02500979|531313924|FG000|Period 1|Adverse Event|1|||
147313507|NCT02500979|531313925|FG001|Period 1|Adverse Event|0|||
147313508|NCT02500979|531313924|FG000|Period 1|Subject decision|2|||
147313509|NCT02500979|531313925|FG001|Period 1|Subject decision|0|||
147313510|NCT02500979|531313924|FG000|Period 2|Change in risk|1|||
147313511|NCT02500979|531313925|FG001|Period 2|Change in risk|0|||
147567948|NCT01705574|532238366|FG001|Open-Label Extension Phase|Physician Decision|0|||
147567949|NCT01705574|532238367|FG002|Open-Label Extension Phase|Physician Decision|2|||
147567950|NCT01705574|532238368|FG003|Open-Label Extension Phase|Physician Decision|0|||
147313512|NCT04422639|531313928|FG000|Overall Study|Death|1|||
147313513|NCT04422639|531313929|FG001|Overall Study|Death|0|||
147313514|NCT04422639|531313928|FG000|Overall Study|study closed prior to completion of FU visits|0|||
147313515|NCT04422639|531313929|FG001|Overall Study|study closed prior to completion of FU visits|2|||
147313516|NCT01964521|531313930|FG000|Overall Study|Lost to Follow-up|4|||
147313517|NCT00119262|531313933|FG000|Overall Study|Lack of Efficacy|0|||
147313518|NCT00119262|531313934|FG001|Overall Study|Lack of Efficacy|3|||
147313519|NCT00119262|531313933|FG000|Overall Study|Withdrawal by Subject|12|||
147313520|NCT00119262|531313934|FG001|Overall Study|Withdrawal by Subject|11|||
147313521|NCT00119262|531313933|FG000|Overall Study|Adverse Event|33|||
147313522|NCT00119262|531313934|FG001|Overall Study|Adverse Event|35|||
147313523|NCT00119262|531313933|FG000|Overall Study|other disease|0|||
147313524|NCT00119262|531313934|FG001|Overall Study|other disease|2|||
147313525|NCT00119262|531313933|FG000|Overall Study|ineligble|1|||
147313526|NCT00119262|531313934|FG001|Overall Study|ineligble|2|||
147313527|NCT00119262|531313933|FG000|Overall Study|others|0|||
147313528|NCT00119262|531313934|FG001|Overall Study|others|5|||
147313529|NCT00988351|531313935|FG000|Overall Study|Withdrawal by Subject|8|||
147313530|NCT00988351|531313936|FG001|Overall Study|Withdrawal by Subject|0|||
147313531|NCT00988351|531313935|FG000|Overall Study|Lost to Follow-up|6|||
147313532|NCT00988351|531313936|FG001|Overall Study|Lost to Follow-up|9|||
147313533|NCT00988351|531313935|FG000|Overall Study|not using CPAP|5|||
147313534|NCT00988351|531313936|FG001|Overall Study|not using CPAP|3|||
147313535|NCT03853317|531313937|FG000|Overall Study|Progressive Disease|5|||
147313536|NCT03853317|531313937|FG000|Overall Study|Adverse Event|1|||
147313537|NCT03853317|531313937|FG000|Overall Study|Death|1|||
147313538|NCT03853317|531313937|FG000|Overall Study|other event|2|||
147313539|NCT01088529|531313943|FG000|Overall Study|Did not receive study treatment|0|||
147313540|NCT01088529|531313944|FG001|Overall Study|Did not receive study treatment|1|||
147567951|NCT01705574|532238365|FG000|Open-Label Extension Phase|Pregnancy|0|||
147567952|NCT01705574|532238366|FG001|Open-Label Extension Phase|Pregnancy|0|||
147567953|NCT01705574|532238367|FG002|Open-Label Extension Phase|Pregnancy|1|||
147567954|NCT01705574|532238368|FG003|Open-Label Extension Phase|Pregnancy|1|||
147567955|NCT00777023|532238369|FG000|Overall Study|Adverse Event|15|||
147567956|NCT00777023|532238370|FG001|Overall Study|Adverse Event|21|||
147567957|NCT00777023|532238371|FG002|Overall Study|Adverse Event|8|||
147313541|NCT01265823|531313945|FG000|Overall Study|Unsatisfactory Response Efficacy|1|||
147313542|NCT01265823|531313945|FG000|Overall Study|Failure to Return|4|||
147313543|NCT01265823|531313945|FG000|Overall Study|Protocol Violation|1|||
147313544|NCT01265823|531313945|FG000|Overall Study|Participant Request|1|||
147313545|NCT01263106|531313946|FG000|Washout (at Least 7 Days)|Lost to Follow-up|1|||
147313546|NCT01263106|531313947|FG001|Washout (at Least 7 Days)|Lost to Follow-up|1|||
147313547|NCT00654940|531315123|FG000|Period 1|Adverse Event|0|||
147313548|NCT00654940|531315124|FG001|Period 1|Adverse Event|1|||
147313549|NCT00654940|531315123|FG000|Period 1|Intolerable Pain Level|1|||
147313550|NCT00654940|531315124|FG001|Period 1|Intolerable Pain Level|0|||
147567958|NCT00777023|532238369|FG000|Overall Study|Lack of Efficacy|1|||
147567959|NCT00777023|532238370|FG001|Overall Study|Lack of Efficacy|0|||
147313551|NCT00373295|531315129|FG000|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
147313552|NCT00373295|531315130|FG001|Intervention 1 (8 Days)|Withdrawal by Subject|2|||
147313553|NCT00373295|531315131|FG002|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
147313554|NCT00373295|531315132|FG003|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
147313555|NCT00373295|531315133|FG004|Intervention 1 (8 Days)|Withdrawal by Subject|1|||
147313556|NCT00373295|531315134|FG005|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
147313557|NCT01238575|531315139|FG000|Overall Study|Lack of Efficacy|2|||
147313558|NCT01238575|531315140|FG001|Overall Study|Lack of Efficacy|4|||
147313559|NCT01238575|531315139|FG000|Overall Study|Adverse Event|2|||
147313560|NCT01238575|531315140|FG001|Overall Study|Adverse Event|0|||
147313561|NCT01744496|531315147|FG000|Titration Period|Adverse Event|2|||
147313562|NCT01744496|531315148|FG001|Titration Period|Adverse Event|1|||
147313563|NCT01744496|531315147|FG000|Titration Period|Personal reasons|0|||
147313564|NCT01744496|531315148|FG001|Titration Period|Personal reasons|1|||
147313565|NCT01744496|531315147|FG000|Maintenance Period|Adverse Event|1|||
147313566|NCT01744496|531315148|FG001|Maintenance Period|Adverse Event|3|||
147313567|NCT01744496|531315147|FG000|Maintenance Period|Protocol Violation|1|||
147313568|NCT01744496|531315148|FG001|Maintenance Period|Protocol Violation|0|||
147313569|NCT01744496|531315147|FG000|Maintenance Period|Withdrawal by Subject|1|||
147313570|NCT01744496|531315148|FG001|Maintenance Period|Withdrawal by Subject|1|||
147313571|NCT01744496|531315147|FG000|Maintenance Period|Subject left town|1|||
147313572|NCT01744496|531315148|FG001|Maintenance Period|Subject left town|0|||
147313573|NCT03772314|531315153|FG000|Overall Study|Adverse Event|7|||
147313574|NCT03772314|531315154|FG001|Overall Study|Adverse Event|2|||
147313575|NCT02796963|531315155|FG000|Overall Study|Lost to Follow-up|89|||
147313576|NCT02796963|531315156|FG001|Overall Study|Lost to Follow-up|76|||
147313577|NCT02796963|531315157|FG002|Overall Study|Lost to Follow-up|69|||
147313578|NCT02796963|531315158|FG003|Overall Study|Lost to Follow-up|72|||
147313579|NCT01630590|531315172|FG000|Overall Study|Adverse Event|9|||
147313580|NCT01630590|531315172|FG000|Overall Study|Lack of Efficacy|37|||
147313581|NCT01630590|531315172|FG000|Overall Study|Withdrawal by Subject|4|||
147313582|NCT01630590|531315172|FG000|Overall Study|2nd primary tumor|2|||
147313583|NCT01630590|531315172|FG000|Overall Study|Automobile accident|1|||
147313584|NCT01630590|531315172|FG000|Overall Study|Maximum benefit|4|||
147313585|NCT02366936|531315175|FG000|Overall Study|Withdrawal by Subject|2|||
147313586|NCT02366936|531315175|FG000|Overall Study|Lost to Follow-up|4|||
147313587|NCT02366936|531315175|FG000|Overall Study|Physician Decision|2|||
147313588|NCT01751113|531315176|FG000|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
147313589|NCT01751113|531315177|FG001|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
147313590|NCT01751113|531315178|FG002|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
147313591|NCT01751113|531315179|FG003|Treatment Period 1 (4 Weeks)|Adverse Event|1|||
147313592|NCT01751113|531315180|FG004|Treatment Period 1 (4 Weeks)|Adverse Event|1|||
147313593|NCT01751113|531315181|FG005|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
147313594|NCT01751113|531315176|FG000|Treatment Period 3 (4 Weeks)|Adverse Event|0|||
147313595|NCT01751113|531315177|FG001|Treatment Period 3 (4 Weeks)|Adverse Event|0|||
147313596|NCT01751113|531315178|FG002|Treatment Period 3 (4 Weeks)|Adverse Event|0|||
147313597|NCT01751113|531315179|FG003|Treatment Period 3 (4 Weeks)|Adverse Event|0|||
147313598|NCT01751113|531315180|FG004|Treatment Period 3 (4 Weeks)|Adverse Event|0|||
147313599|NCT01751113|531315181|FG005|Treatment Period 3 (4 Weeks)|Adverse Event|1|||
147313600|NCT01551303|531315182|FG000|Overall Study|failed awareness check on vision test|4|||
147313601|NCT01551303|531315183|FG001|Overall Study|failed awareness check on vision test|7|||
147313602|NCT02878213|531315184|FG000|Overall Study|Withdrawal by Subject|2|||
147313603|NCT02878213|531315184|FG000|Overall Study|Adverse Event|1|||
147313604|NCT02471404|531315192|FG000|Overall Study|Adverse Event|7|||
147313605|NCT02471404|531315193|FG001|Overall Study|Adverse Event|1|||
147313606|NCT02471404|531315194|FG002|Overall Study|Adverse Event|2|||
147313607|NCT02471404|531315192|FG000|Overall Study|Developed Study Withdrawal Criteria|4|||
147313608|NCT02471404|531315193|FG001|Overall Study|Developed Study Withdrawal Criteria|1|||
147313609|NCT02471404|531315194|FG002|Overall Study|Developed Study Withdrawal Criteria|2|||
147313610|NCT02471404|531315192|FG000|Overall Study|Failure to Meet Randomization Criteria|2|||
147313611|NCT02471404|531315193|FG001|Overall Study|Failure to Meet Randomization Criteria|0|||
147313612|NCT02471404|531315194|FG002|Overall Study|Failure to Meet Randomization Criteria|1|||
147313613|NCT02471404|531315192|FG000|Overall Study|Lost to Follow-up|1|||
147313614|NCT02471404|531315193|FG001|Overall Study|Lost to Follow-up|1|||
147567960|NCT00777023|532238371|FG002|Overall Study|Lack of Efficacy|14|||
147567961|NCT00777023|532238369|FG000|Overall Study|Protocol Violation|2|||
147567962|NCT00777023|532238370|FG001|Overall Study|Protocol Violation|1|||
147567963|NCT00777023|532238371|FG002|Overall Study|Protocol Violation|1|||
147313615|NCT02471404|531315194|FG002|Overall Study|Lost to Follow-up|3|||
147313616|NCT02471404|531315192|FG000|Overall Study|Protocol Violation|1|||
147313617|NCT02471404|531315193|FG001|Overall Study|Protocol Violation|0|||
147313618|NCT02471404|531315194|FG002|Overall Study|Protocol Violation|0|||
147313619|NCT02471404|531315192|FG000|Overall Study|Withdrawal by Subject|8|||
147313620|NCT02471404|531315193|FG001|Overall Study|Withdrawal by Subject|4|||
147313621|NCT02471404|531315194|FG002|Overall Study|Withdrawal by Subject|5|||
147567964|NCT00777023|532238369|FG000|Overall Study|Lost to Follow-up|2|||
147567965|NCT00777023|532238370|FG001|Overall Study|Lost to Follow-up|3|||
147567966|NCT00777023|532238371|FG002|Overall Study|Lost to Follow-up|3|||
147120348|NCT04595370|530605194|FG005|Overall Study|Death|0|||
147120349|NCT04595370|530605189|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
147120350|NCT04595370|530605190|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
147120351|NCT04595370|530605191|FG002|Overall Study|Protocol-Specified Withdrawal Criterion Met|1|||
147120352|NCT04595370|530605192|FG003|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
147120353|NCT04595370|530605193|FG004|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
147120354|NCT04595370|530605194|FG005|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
147120355|NCT04595370|530605189|FG000|Overall Study|Withdrawal by Subject|0|||
147120356|NCT04595370|530605190|FG001|Overall Study|Withdrawal by Subject|0|||
147120357|NCT04595370|530605191|FG002|Overall Study|Withdrawal by Subject|1|||
147120358|NCT04595370|530605192|FG003|Overall Study|Withdrawal by Subject|0|||
147120359|NCT04595370|530605193|FG004|Overall Study|Withdrawal by Subject|2|||
147120360|NCT04595370|530605194|FG005|Overall Study|Withdrawal by Subject|0|||
147120361|NCT04595370|530605189|FG000|Overall Study|Lost to Follow-up|0|||
147120362|NCT04595370|530605190|FG001|Overall Study|Lost to Follow-up|0|||
147120363|NCT04595370|530605191|FG002|Overall Study|Lost to Follow-up|0|||
147120364|NCT04595370|530605192|FG003|Overall Study|Lost to Follow-up|0|||
147120365|NCT04595370|530605193|FG004|Overall Study|Lost to Follow-up|1|||
147120366|NCT04595370|530605194|FG005|Overall Study|Lost to Follow-up|0|||
147120367|NCT04595370|530605189|FG000|Overall Study|Participants discontinued study treatment due to other reasons|0|||
147120368|NCT04595370|530605190|FG001|Overall Study|Participants discontinued study treatment due to other reasons|2|||
147120369|NCT04595370|530605191|FG002|Overall Study|Participants discontinued study treatment due to other reasons|2|||
147120370|NCT04595370|530605192|FG003|Overall Study|Participants discontinued study treatment due to other reasons|0|||
147120371|NCT04595370|530605193|FG004|Overall Study|Participants discontinued study treatment due to other reasons|1|||
147120372|NCT04595370|530605194|FG005|Overall Study|Participants discontinued study treatment due to other reasons|0|||
147120373|NCT02218268|530605195|FG000|24 Hour Washout|Physician Decision|11|||
147120374|NCT02218268|530605196|FG001|24 Hour Washout|Physician Decision|9|||
147120375|NCT03651336|530605197|FG000|Overall Study|Withdrawal by Subject|4|||
147120376|NCT01341990|530605198|FG000|Overall Study|Adverse Event|0|||
147120377|NCT01341990|530605199|FG001|Overall Study|Adverse Event|1|||
147120378|NCT01341990|530605198|FG000|Overall Study|Torn Study Lens|1|||
147120379|NCT01341990|530605199|FG001|Overall Study|Torn Study Lens|0|||
147120380|NCT01341990|530605198|FG000|Overall Study|Withdrawal by Subject|2|||
147120381|NCT01341990|530605199|FG001|Overall Study|Withdrawal by Subject|0|||
147120382|NCT01557244|530606973|FG000|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|2|||
147120383|NCT01557244|530606974|FG001|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0|||
147120384|NCT01557244|530606975|FG002|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0|||
147120385|NCT01557244|530606976|FG003|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0|||
147120386|NCT01557244|530606977|FG004|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0|||
147120387|NCT01557244|530606978|FG005|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|2|||
147120388|NCT01557244|530606979|FG006|Active Comparator/Efficacy Phase:12Weeks|Adverse Event|0|||
147120389|NCT01557244|530606973|FG000|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|2|||
147120390|NCT01557244|530606974|FG001|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0|||
147120391|NCT01557244|530606975|FG002|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|1|||
147120392|NCT01557244|530606976|FG003|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0|||
147120393|NCT01557244|530606977|FG004|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0|||
147120394|NCT01557244|530606978|FG005|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0|||
147120395|NCT01557244|530606979|FG006|Active Comparator/Efficacy Phase:12Weeks|Protocol Violation|0|||
147120396|NCT01557244|530606973|FG000|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|1|||
147120397|NCT01557244|530606974|FG001|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
147120398|NCT01557244|530606975|FG002|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
147120399|NCT01557244|530606976|FG003|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
147120400|NCT01557244|530606977|FG004|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
147120401|NCT01557244|530606978|FG005|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
147120402|NCT01557244|530606979|FG006|Active Comparator/Efficacy Phase:12Weeks|Lost to Follow-up|0|||
147120403|NCT01557244|530606973|FG000|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|2|||
147120404|NCT01557244|530606974|FG001|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0|||
147120405|NCT01557244|530606975|FG002|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0|||
147120406|NCT01557244|530606976|FG003|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0|||
147120407|NCT01557244|530606977|FG004|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0|||
147120408|NCT01557244|530606978|FG005|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|3|||
147231853|NCT03673046|531022987|FG000|Overall Study|Adverse Event|1|||
147231854|NCT03673046|531022988|FG001|Overall Study|Adverse Event|1|||
147231855|NCT03673046|531022987|FG000|Overall Study|Withdrawal by Subject|8|||
147231856|NCT03673046|531022988|FG001|Overall Study|Withdrawal by Subject|2|||
147231857|NCT03817879|531022989|FG000|Overall Study|Drop out|5|||
147231858|NCT03817879|531022990|FG001|Overall Study|Drop out|12|||
147567967|NCT00777023|532238369|FG000|Overall Study|Death|0|||
147120409|NCT01557244|530606979|FG006|Active Comparator/Efficacy Phase:12Weeks|Withdrawal By Parent/Guardian|0|||
147120410|NCT01557244|530606973|FG000|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
147120411|NCT01557244|530606974|FG001|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|1|||
147120412|NCT01557244|530606975|FG002|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
147231859|NCT03817879|531022989|FG000|Overall Study|Withdrawal by Subject|0|||
147231860|NCT03817879|531022990|FG001|Overall Study|Withdrawal by Subject|1|||
147231861|NCT00392015|531022994|FG000|Overall Study|Lost to Follow-up|2|||
147231862|NCT00392015|531022995|FG001|Overall Study|Lost to Follow-up|0|||
147231863|NCT00392015|531022996|FG002|Overall Study|Lost to Follow-up|2|||
147231864|NCT00392015|531022997|FG003|Overall Study|Lost to Follow-up|1|||
147231865|NCT00392015|531022998|FG004|Overall Study|Lost to Follow-up|1|||
147231866|NCT00392015|531022999|FG005|Overall Study|Lost to Follow-up|0|||
147231867|NCT00392015|531022994|FG000|Overall Study|Withdrawal by Subject|0|||
147231868|NCT00392015|531022995|FG001|Overall Study|Withdrawal by Subject|0|||
147231869|NCT00392015|531022996|FG002|Overall Study|Withdrawal by Subject|2|||
147231870|NCT00392015|531022997|FG003|Overall Study|Withdrawal by Subject|0|||
147231871|NCT00392015|531022998|FG004|Overall Study|Withdrawal by Subject|0|||
147231872|NCT00392015|531022999|FG005|Overall Study|Withdrawal by Subject|0|||
147231873|NCT00392015|531022994|FG000|Overall Study|Adverse Event|0|||
147231874|NCT00392015|531022995|FG001|Overall Study|Adverse Event|0|||
147231875|NCT00392015|531022996|FG002|Overall Study|Adverse Event|0|||
147231876|NCT00392015|531022997|FG003|Overall Study|Adverse Event|0|||
147231877|NCT00392015|531022998|FG004|Overall Study|Adverse Event|1|||
147231878|NCT00392015|531022999|FG005|Overall Study|Adverse Event|0|||
147231879|NCT00392015|531022994|FG000|Overall Study|Previous trial recipient|0|||
147313622|NCT02471404|531315192|FG000|Overall Study|Other reasons not specified|10|||
147313623|NCT02471404|531315193|FG001|Overall Study|Other reasons not specified|7|||
147120413|NCT01557244|530606976|FG003|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
147120414|NCT01557244|530606977|FG004|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
147120415|NCT01557244|530606978|FG005|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
147120416|NCT01557244|530606979|FG006|Active Comparator/Efficacy Phase:12Weeks|Medication Error Without Associated AEs|0|||
147120417|NCT01557244|530606973|FG000|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0|||
147120418|NCT01557244|530606974|FG001|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0|||
147120419|NCT01557244|530606975|FG002|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0|||
147120420|NCT01557244|530606976|FG003|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0|||
147120421|NCT01557244|530606977|FG004|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|0|||
147120422|NCT01557244|530606978|FG005|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|1|||
147120423|NCT01557244|530606979|FG006|Active Comparator/Efficacy Phase:12Weeks|Insufficient Clinical Response|1|||
147120424|NCT01557244|530606973|FG000|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|0|||
147120425|NCT01557244|530606974|FG001|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|1|||
147120426|NCT01557244|530606975|FG002|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|1|||
147120427|NCT01557244|530606976|FG003|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|0|||
147120428|NCT01557244|530606977|FG004|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|0|||
147120429|NCT01557244|530606978|FG005|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|1|||
147120430|NCT01557244|530606979|FG006|Active Comparator/Efficacy Phase:12Weeks|Failure to Meet Randomization Criteria|0|||
147120431|NCT01557244|530606973|FG000|Active Comparator/Efficacy Phase:12Weeks|Other|2|||
147120432|NCT01557244|530606974|FG001|Active Comparator/Efficacy Phase:12Weeks|Other|0|||
147120433|NCT01557244|530606975|FG002|Active Comparator/Efficacy Phase:12Weeks|Other|2|||
147120434|NCT01557244|530606976|FG003|Active Comparator/Efficacy Phase:12Weeks|Other|0|||
147120435|NCT01557244|530606977|FG004|Active Comparator/Efficacy Phase:12Weeks|Other|0|||
147120436|NCT01557244|530606978|FG005|Active Comparator/Efficacy Phase:12Weeks|Other|0|||
147120437|NCT01557244|530606979|FG006|Active Comparator/Efficacy Phase:12Weeks|Other|0|||
147120438|NCT01557244|530606973|FG000|Safety Extension Phase: 12 Weeks|Adverse Event|1|||
147120439|NCT01557244|530606974|FG001|Safety Extension Phase: 12 Weeks|Adverse Event|1|||
147120440|NCT01557244|530606975|FG002|Safety Extension Phase: 12 Weeks|Adverse Event|0|||
147120441|NCT01557244|530606976|FG003|Safety Extension Phase: 12 Weeks|Adverse Event|0|||
147120442|NCT01557244|530606977|FG004|Safety Extension Phase: 12 Weeks|Adverse Event|0|||
147120443|NCT01557244|530606978|FG005|Safety Extension Phase: 12 Weeks|Adverse Event|1|||
147120444|NCT01557244|530606979|FG006|Safety Extension Phase: 12 Weeks|Adverse Event|0|||
147120445|NCT01557244|530606973|FG000|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|1|||
147120446|NCT01557244|530606974|FG001|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|1|||
147120447|NCT01557244|530606975|FG002|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0|||
147231880|NCT00392015|531022995|FG001|Overall Study|Previous trial recipient|0|||
147231881|NCT00392015|531022996|FG002|Overall Study|Previous trial recipient|0|||
147231882|NCT00392015|531022997|FG003|Overall Study|Previous trial recipient|0|||
147231883|NCT00392015|531022998|FG004|Overall Study|Previous trial recipient|1|||
147313624|NCT02471404|531315194|FG002|Overall Study|Other reasons not specified|12|||
147120448|NCT01557244|530606976|FG003|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0|||
147120449|NCT01557244|530606977|FG004|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0|||
147231884|NCT00392015|531022999|FG005|Overall Study|Previous trial recipient|0|||
147231885|NCT00717093|531023000|FG000|Overall Study|Adverse Event|19|||
147231886|NCT00717093|531023001|FG001|Overall Study|Adverse Event|9|||
147231887|NCT00717093|531023000|FG000|Overall Study|Lack of Efficacy|3|||
147231888|NCT00717093|531023001|FG001|Overall Study|Lack of Efficacy|13|||
147231889|NCT00717093|531023000|FG000|Overall Study|Lost to Follow-up|9|||
147231890|NCT00717093|531023001|FG001|Overall Study|Lost to Follow-up|6|||
147231891|NCT00717093|531023000|FG000|Overall Study|Withdrawal by Subject|12|||
147231892|NCT00717093|531023001|FG001|Overall Study|Withdrawal by Subject|19|||
147231893|NCT00717093|531023000|FG000|Overall Study|Other|0|||
147231894|NCT00717093|531023001|FG001|Overall Study|Other|1|||
147231895|NCT00717093|531023000|FG000|Overall Study|Randomized but not treated|1|||
147231896|NCT00717093|531023001|FG001|Overall Study|Randomized but not treated|0|||
147231897|NCT01543698|531023006|FG000|Phase 1b|Disease progression|2|||
147231898|NCT01543698|531023007|FG001|Phase 1b|Disease progression|4|||
147231899|NCT01543698|531023008|FG002|Phase 1b|Disease progression|3|||
147231900|NCT01543698|531023009|FG003|Phase 1b|Disease progression|2|||
147231901|NCT01543698|531023010|FG004|Phase 1b|Disease progression|10|||
147231902|NCT01543698|531023011|FG005|Phase 1b|Disease progression|6|||
147231903|NCT01543698|531023012|FG006|Phase 1b|Disease progression|5|||
147231904|NCT01543698|531023013|FG007|Phase 1b|Disease progression|3|||
147231905|NCT01543698|531023014|FG008|Phase 1b|Disease progression|4|||
147231906|NCT01543698|531023015|FG009|Phase 1b|Disease progression|5|||
147231907|NCT01543698|531023016|FG010|Phase 1b|Disease progression|1|||
147231908|NCT01543698|531023017|FG011|Phase 1b|Disease progression|0|||
147231909|NCT01543698|531023018|FG012|Phase 1b|Disease progression|0|||
147231910|NCT01543698|531023019|FG013|Phase 1b|Disease progression|0|||
147231911|NCT01543698|531023020|FG014|Phase 1b|Disease progression|0|||
147231912|NCT01543698|531023006|FG000|Phase 1b|Death|0|||
147231913|NCT01543698|531023007|FG001|Phase 1b|Death|0|||
147231914|NCT01543698|531023008|FG002|Phase 1b|Death|1|||
147231915|NCT01543698|531023009|FG003|Phase 1b|Death|1|||
147231916|NCT01543698|531023010|FG004|Phase 1b|Death|0|||
147567968|NCT00777023|532238370|FG001|Overall Study|Death|1|||
147567969|NCT00777023|532238371|FG002|Overall Study|Death|0|||
147567970|NCT00777023|532238369|FG000|Overall Study|Withdrawal by Subject|7|||
147567971|NCT00777023|532238370|FG001|Overall Study|Withdrawal by Subject|7|||
147567972|NCT00777023|532238371|FG002|Overall Study|Withdrawal by Subject|8|||
147567973|NCT00777023|532238369|FG000|Overall Study|Missing data|1|||
147567974|NCT00777023|532238370|FG001|Overall Study|Missing data|1|||
147120450|NCT01557244|530606978|FG005|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0|||
147120451|NCT01557244|530606979|FG006|Safety Extension Phase: 12 Weeks|Withdrawal By Parent/Guardian|0|||
147120452|NCT01557244|530606973|FG000|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
147120453|NCT01557244|530606974|FG001|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
147120454|NCT01557244|530606975|FG002|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
147120455|NCT01557244|530606976|FG003|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|1|||
147120456|NCT01557244|530606977|FG004|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
147120457|NCT01557244|530606978|FG005|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
147120458|NCT01557244|530606979|FG006|Safety Extension Phase: 12 Weeks|Medication Error Without Associated AEs|0|||
147120459|NCT01557244|530606973|FG000|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|1|||
147120460|NCT01557244|530606974|FG001|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|2|||
147120461|NCT01557244|530606975|FG002|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0|||
147120462|NCT01557244|530606976|FG003|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0|||
147120463|NCT01557244|530606977|FG004|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0|||
147120464|NCT01557244|530606978|FG005|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0|||
147120465|NCT01557244|530606979|FG006|Safety Extension Phase: 12 Weeks|Insufficient Clinical Response|0|||
147120466|NCT01313676|530606980|FG000|Overall Study|Adverse Event|395|||
147120467|NCT01313676|530606981|FG001|Overall Study|Adverse Event|365|||
147120468|NCT01313676|530606982|FG002|Overall Study|Adverse Event|372|||
147120469|NCT01313676|530606983|FG003|Overall Study|Adverse Event|333|||
147120470|NCT01313676|530606980|FG000|Overall Study|Lack of Efficacy|98|||
147120471|NCT01313676|530606981|FG001|Overall Study|Lack of Efficacy|90|||
147120472|NCT01313676|530606982|FG002|Overall Study|Lack of Efficacy|65|||
147120473|NCT01313676|530606983|FG003|Overall Study|Lack of Efficacy|46|||
147120474|NCT01313676|530606980|FG000|Overall Study|Protocol Violation|37|||
147120475|NCT01313676|530606981|FG001|Overall Study|Protocol Violation|44|||
147120476|NCT01313676|530606982|FG002|Overall Study|Protocol Violation|46|||
147120477|NCT01313676|530606983|FG003|Overall Study|Protocol Violation|44|||
147120478|NCT01313676|530606980|FG000|Overall Study|Met Protocol-Defined Stopping Critera|3|||
147120479|NCT01313676|530606981|FG001|Overall Study|Met Protocol-Defined Stopping Critera|4|||
147120480|NCT01313676|530606982|FG002|Overall Study|Met Protocol-Defined Stopping Critera|2|||
147313625|NCT01927731|531315195|FG000|Overall Study|Graft Failure|1|||
147313626|NCT01927731|531315196|FG001|Overall Study|Graft Failure|2|||
147313627|NCT01927731|531315195|FG000|Overall Study|Physician Decision|2|||
147313628|NCT01927731|531315196|FG001|Overall Study|Physician Decision|3|||
147313629|NCT01927731|531315195|FG000|Overall Study|Withdrawal by Subject|0|||
147313630|NCT01927731|531315196|FG001|Overall Study|Withdrawal by Subject|2|||
147313631|NCT01927731|531315195|FG000|Overall Study|Death|0|||
147313632|NCT01927731|531315196|FG001|Overall Study|Death|3|||
147313633|NCT01464255|531315197|FG000|Overall Study|unresolve corneal staining|0|||
147313634|NCT01464255|531315198|FG001|Overall Study|unresolve corneal staining|1|||
147313635|NCT00849680|531315201|FG000|Overall Study|Adverse Event|0|||
147313636|NCT00849680|531315202|FG001|Overall Study|Adverse Event|0|||
147313637|NCT00849680|531315203|FG002|Overall Study|Adverse Event|0|||
147313638|NCT00849680|531315204|FG003|Overall Study|Adverse Event|0|||
147313639|NCT00849680|531315205|FG004|Overall Study|Adverse Event|0|||
147313640|NCT00849680|531315206|FG005|Overall Study|Adverse Event|0|||
147313641|NCT00849680|531315207|FG006|Overall Study|Adverse Event|2|||
147313642|NCT00849680|531315208|FG007|Overall Study|Adverse Event|0|||
147313643|NCT00849680|531315201|FG000|Overall Study|Lost to Follow-up|7|||
147313644|NCT00849680|531315202|FG001|Overall Study|Lost to Follow-up|3|||
147313645|NCT00849680|531315203|FG002|Overall Study|Lost to Follow-up|12|||
147313646|NCT00849680|531315204|FG003|Overall Study|Lost to Follow-up|11|||
147313647|NCT00849680|531315205|FG004|Overall Study|Lost to Follow-up|8|||
147313648|NCT00849680|531315206|FG005|Overall Study|Lost to Follow-up|11|||
147313649|NCT00849680|531315207|FG006|Overall Study|Lost to Follow-up|12|||
147313650|NCT00849680|531315208|FG007|Overall Study|Lost to Follow-up|5|||
147313651|NCT00849680|531315201|FG000|Overall Study|Subject moved|1|||
147313652|NCT00849680|531315202|FG001|Overall Study|Subject moved|0|||
147313653|NCT00849680|531315203|FG002|Overall Study|Subject moved|3|||
147313654|NCT00849680|531315204|FG003|Overall Study|Subject moved|1|||
147313655|NCT00849680|531315205|FG004|Overall Study|Subject moved|0|||
147313656|NCT00849680|531315206|FG005|Overall Study|Subject moved|2|||
147313657|NCT00849680|531315207|FG006|Overall Study|Subject moved|2|||
147313658|NCT00849680|531315208|FG007|Overall Study|Subject moved|2|||
147313659|NCT00849680|531315201|FG000|Overall Study|Withdrawal by Subject|2|||
147313660|NCT00849680|531315202|FG001|Overall Study|Withdrawal by Subject|0|||
147313661|NCT00849680|531315203|FG002|Overall Study|Withdrawal by Subject|0|||
147313662|NCT00849680|531315204|FG003|Overall Study|Withdrawal by Subject|2|||
147313663|NCT00849680|531315205|FG004|Overall Study|Withdrawal by Subject|2|||
147313664|NCT00849680|531315206|FG005|Overall Study|Withdrawal by Subject|2|||
147313665|NCT00849680|531315207|FG006|Overall Study|Withdrawal by Subject|1|||
147313666|NCT00849680|531315208|FG007|Overall Study|Withdrawal by Subject|1|||
147313667|NCT00849680|531315201|FG000|Overall Study|Subject unable to comply with protocol|1|||
147313668|NCT00849680|531315202|FG001|Overall Study|Subject unable to comply with protocol|0|||
147313669|NCT00849680|531315203|FG002|Overall Study|Subject unable to comply with protocol|0|||
147313670|NCT00849680|531315204|FG003|Overall Study|Subject unable to comply with protocol|0|||
147313671|NCT00849680|531315205|FG004|Overall Study|Subject unable to comply with protocol|0|||
147313672|NCT00849680|531315206|FG005|Overall Study|Subject unable to comply with protocol|0|||
147313673|NCT00849680|531315207|FG006|Overall Study|Subject unable to comply with protocol|0|||
147313674|NCT00849680|531315208|FG007|Overall Study|Subject unable to comply with protocol|0|||
147313675|NCT00785538|531315209|FG000|Treatment Period|Adverse Event|1|||
147313676|NCT00785538|531315210|FG001|Treatment Period|Adverse Event|2|||
147313677|NCT00785538|531315211|FG002|Treatment Period|Adverse Event|2|||
147313678|NCT00785538|531315212|FG003|Treatment Period|Adverse Event|0|||
147313679|NCT00785538|531315209|FG000|Treatment Period|Withdrawal by Subject|0|||
147313680|NCT00785538|531315210|FG001|Treatment Period|Withdrawal by Subject|0|||
147313681|NCT00785538|531315211|FG002|Treatment Period|Withdrawal by Subject|0|||
147313682|NCT00785538|531315212|FG003|Treatment Period|Withdrawal by Subject|1|||
147313683|NCT04276090|531315215|FG000|Overall Study|Rapid disease progression after surgery led to liver dysfunction; prevented administration of HAI|1|||
147313684|NCT04276090|531315216|FG001|Overall Study|Rapid disease progression after surgery led to liver dysfunction; prevented administration of HAI|0|||
147313685|NCT04642469|531315217|FG000|Overall Study|Failure to meet inclusion/exclusion criteria|1|||
147313686|NCT04642469|531315218|FG001|Overall Study|Failure to meet inclusion/exclusion criteria|0|||
147313687|NCT04642469|531315217|FG000|Overall Study|Death|1|||
147313688|NCT04642469|531315218|FG001|Overall Study|Death|2|||
147313689|NCT04642469|531315217|FG000|Overall Study|Study/site closed following amendment 1|11|||
147313690|NCT04642469|531315218|FG001|Overall Study|Study/site closed following amendment 1|11|||
147313691|NCT04642469|531315217|FG000|Overall Study|Other|1|||
147313692|NCT04642469|531315218|FG001|Overall Study|Other|1|||
147313693|NCT04642469|531315217|FG000|Overall Study|Withdrawal by Subject|1|||
147313694|NCT04642469|531315218|FG001|Overall Study|Withdrawal by Subject|0|||
147313695|NCT02066532|531315221|FG000|Phase II|Withdrawal by Subject|1|||
147313696|NCT02066532|531315222|FG001|Phase II|Withdrawal by Subject|0|||
147313697|NCT02066532|531315223|FG002|Phase II|Withdrawal by Subject|0|||
147313698|NCT02066532|531315224|FG003|Phase II|Withdrawal by Subject|0|||
147313699|NCT05033080|531315225|FG000|Overall Study|Adverse Event|4|||
147313700|NCT05033080|531315226|FG001|Overall Study|Adverse Event|4|||
147120481|NCT01313676|530606983|FG003|Overall Study|Met Protocol-Defined Stopping Critera|11|||
147120482|NCT01313676|530606980|FG000|Overall Study|Study Closed/terminated|7|||
147120483|NCT01313676|530606981|FG001|Overall Study|Study Closed/terminated|6|||
147120484|NCT01313676|530606982|FG002|Overall Study|Study Closed/terminated|9|||
147120485|NCT01313676|530606983|FG003|Overall Study|Study Closed/terminated|9|||
147120486|NCT01313676|530606980|FG000|Overall Study|Lost to Follow-up|0|||
147120487|NCT01313676|530606981|FG001|Overall Study|Lost to Follow-up|0|||
147120488|NCT01313676|530606982|FG002|Overall Study|Lost to Follow-up|1|||
147120489|NCT01313676|530606983|FG003|Overall Study|Lost to Follow-up|0|||
147231917|NCT01543698|531023011|FG005|Phase 1b|Death|0|||
147231918|NCT01543698|531023012|FG006|Phase 1b|Death|0|||
147231919|NCT01543698|531023013|FG007|Phase 1b|Death|0|||
147231920|NCT01543698|531023014|FG008|Phase 1b|Death|0|||
147231921|NCT01543698|531023015|FG009|Phase 1b|Death|0|||
147231922|NCT01543698|531023016|FG010|Phase 1b|Death|1|||
147231923|NCT01543698|531023017|FG011|Phase 1b|Death|0|||
147231924|NCT01543698|531023018|FG012|Phase 1b|Death|0|||
147231925|NCT01543698|531023019|FG013|Phase 1b|Death|0|||
147231926|NCT01543698|531023020|FG014|Phase 1b|Death|0|||
147231927|NCT01543698|531023006|FG000|Phase 1b|Withdrawal by Subject|0|||
147231928|NCT01543698|531023007|FG001|Phase 1b|Withdrawal by Subject|1|||
147231929|NCT01543698|531023008|FG002|Phase 1b|Withdrawal by Subject|0|||
147231930|NCT01543698|531023009|FG003|Phase 1b|Withdrawal by Subject|1|||
147231931|NCT01543698|531023010|FG004|Phase 1b|Withdrawal by Subject|0|||
147231932|NCT01543698|531023011|FG005|Phase 1b|Withdrawal by Subject|0|||
147231933|NCT01543698|531023012|FG006|Phase 1b|Withdrawal by Subject|1|||
147231934|NCT01543698|531023013|FG007|Phase 1b|Withdrawal by Subject|0|||
147231935|NCT01543698|531023014|FG008|Phase 1b|Withdrawal by Subject|0|||
147231936|NCT01543698|531023015|FG009|Phase 1b|Withdrawal by Subject|0|||
147231937|NCT01543698|531023016|FG010|Phase 1b|Withdrawal by Subject|0|||
147231938|NCT01543698|531023017|FG011|Phase 1b|Withdrawal by Subject|0|||
147231939|NCT01543698|531023018|FG012|Phase 1b|Withdrawal by Subject|0|||
147231940|NCT01543698|531023019|FG013|Phase 1b|Withdrawal by Subject|0|||
147231941|NCT01543698|531023020|FG014|Phase 1b|Withdrawal by Subject|0|||
147231942|NCT01543698|531023006|FG000|Phase 1b|Adverse Event|1|||
147231943|NCT01543698|531023007|FG001|Phase 1b|Adverse Event|0|||
147231944|NCT01543698|531023008|FG002|Phase 1b|Adverse Event|0|||
147231945|NCT01543698|531023009|FG003|Phase 1b|Adverse Event|1|||
147231946|NCT01543698|531023010|FG004|Phase 1b|Adverse Event|2|||
147231947|NCT01543698|531023011|FG005|Phase 1b|Adverse Event|2|||
147231948|NCT01543698|531023012|FG006|Phase 1b|Adverse Event|0|||
147231949|NCT01543698|531023013|FG007|Phase 1b|Adverse Event|0|||
147231950|NCT01543698|531023014|FG008|Phase 1b|Adverse Event|1|||
147231951|NCT01543698|531023015|FG009|Phase 1b|Adverse Event|1|||
147231952|NCT01543698|531023016|FG010|Phase 1b|Adverse Event|2|||
147231953|NCT01543698|531023017|FG011|Phase 1b|Adverse Event|0|||
147231954|NCT01543698|531023018|FG012|Phase 1b|Adverse Event|0|||
147231955|NCT01543698|531023019|FG013|Phase 1b|Adverse Event|0|||
147231956|NCT01543698|531023020|FG014|Phase 1b|Adverse Event|0|||
147231957|NCT01543698|531023006|FG000|Phase 1b|Administrative problems|1|||
147231958|NCT01543698|531023007|FG001|Phase 1b|Administrative problems|0|||
147231959|NCT01543698|531023008|FG002|Phase 1b|Administrative problems|0|||
147231960|NCT01543698|531023009|FG003|Phase 1b|Administrative problems|0|||
147231961|NCT01543698|531023010|FG004|Phase 1b|Administrative problems|1|||
147231962|NCT01543698|531023011|FG005|Phase 1b|Administrative problems|0|||
147231963|NCT01543698|531023012|FG006|Phase 1b|Administrative problems|0|||
147231964|NCT01543698|531023013|FG007|Phase 1b|Administrative problems|1|||
147231965|NCT01543698|531023014|FG008|Phase 1b|Administrative problems|0|||
147231966|NCT01543698|531023015|FG009|Phase 1b|Administrative problems|0|||
147231967|NCT01543698|531023016|FG010|Phase 1b|Administrative problems|2|||
147231968|NCT01543698|531023017|FG011|Phase 1b|Administrative problems|0|||
147231969|NCT01543698|531023018|FG012|Phase 1b|Administrative problems|0|||
147231970|NCT01543698|531023019|FG013|Phase 1b|Administrative problems|0|||
147231971|NCT01543698|531023020|FG014|Phase 1b|Administrative problems|0|||
147231972|NCT01543698|531023006|FG000|Phase 1b|Protocol Violation|2|||
147231973|NCT01543698|531023007|FG001|Phase 1b|Protocol Violation|0|||
147231974|NCT01543698|531023008|FG002|Phase 1b|Protocol Violation|0|||
147231975|NCT01543698|531023009|FG003|Phase 1b|Protocol Violation|0|||
147313701|NCT05033080|531315225|FG000|Overall Study|Withdrawal of consent (not due to AE)|5|||
147120490|NCT01313676|530606980|FG000|Overall Study|Physician Decision|53|||
147120491|NCT01313676|530606981|FG001|Overall Study|Physician Decision|64|||
147120492|NCT01313676|530606982|FG002|Overall Study|Physician Decision|62|||
147120493|NCT01313676|530606983|FG003|Overall Study|Physician Decision|48|||
147231976|NCT01543698|531023010|FG004|Phase 1b|Protocol Violation|0|||
147231977|NCT01543698|531023011|FG005|Phase 1b|Protocol Violation|0|||
147231978|NCT01543698|531023012|FG006|Phase 1b|Protocol Violation|0|||
147231979|NCT01543698|531023013|FG007|Phase 1b|Protocol Violation|0|||
147231980|NCT01543698|531023014|FG008|Phase 1b|Protocol Violation|0|||
147231981|NCT01543698|531023015|FG009|Phase 1b|Protocol Violation|0|||
147231982|NCT01543698|531023016|FG010|Phase 1b|Protocol Violation|0|||
147231983|NCT01543698|531023017|FG011|Phase 1b|Protocol Violation|0|||
147231984|NCT01543698|531023018|FG012|Phase 1b|Protocol Violation|0|||
147231985|NCT01543698|531023019|FG013|Phase 1b|Protocol Violation|0|||
147120494|NCT01313676|530606980|FG000|Overall Study|Decision by Participant or Proxy|643|||
147120495|NCT01313676|530606981|FG001|Overall Study|Decision by Participant or Proxy|527|||
147120496|NCT01313676|530606982|FG002|Overall Study|Decision by Participant or Proxy|515|||
147120497|NCT01313676|530606983|FG003|Overall Study|Decision by Participant or Proxy|492|||
147120498|NCT01313676|530606980|FG000|Overall Study|Sponsor Terminated Study Treatment|1|||
147120499|NCT01313676|530606981|FG001|Overall Study|Sponsor Terminated Study Treatment|1|||
147120500|NCT01313676|530606982|FG002|Overall Study|Sponsor Terminated Study Treatment|0|||
147120501|NCT01313676|530606983|FG003|Overall Study|Sponsor Terminated Study Treatment|1|||
147120502|NCT01313676|530606980|FG000|Overall Study|Investigator Site Closed|12|||
147120503|NCT01313676|530606981|FG001|Overall Study|Investigator Site Closed|11|||
147120504|NCT01313676|530606982|FG002|Overall Study|Investigator Site Closed|15|||
147120505|NCT01313676|530606983|FG003|Overall Study|Investigator Site Closed|10|||
147120506|NCT01313676|530606980|FG000|Overall Study|Missing|1|||
147120507|NCT01313676|530606981|FG001|Overall Study|Missing|1|||
147120508|NCT01313676|530606982|FG002|Overall Study|Missing|1|||
147120509|NCT01313676|530606983|FG003|Overall Study|Missing|0|||
147120510|NCT01862029|530606984|FG000|Overall Study|Physician Decision|1|||
147120511|NCT03931785|530606986|FG000|Overall Study|Lost to Follow-up|4|||
147120512|NCT03931785|530606987|FG001|Overall Study|Lost to Follow-up|1|||
147120513|NCT03931785|530606988|FG002|Overall Study|Lost to Follow-up|4|||
147120514|NCT03931785|530606989|FG003|Overall Study|Lost to Follow-up|3|||
147120515|NCT03931785|530606986|FG000|Overall Study|Adverse Event|1|||
147120516|NCT03931785|530606987|FG001|Overall Study|Adverse Event|0|||
147120517|NCT03931785|530606988|FG002|Overall Study|Adverse Event|3|||
147120518|NCT03931785|530606989|FG003|Overall Study|Adverse Event|4|||
147120519|NCT03931785|530606986|FG000|Overall Study|Protocol Violation|0|||
147120520|NCT03931785|530606987|FG001|Overall Study|Protocol Violation|1|||
147120521|NCT03931785|530606988|FG002|Overall Study|Protocol Violation|0|||
147120522|NCT03931785|530606989|FG003|Overall Study|Protocol Violation|0|||
147120523|NCT03931785|530606986|FG000|Overall Study|Noncompliance With Study drug|0|||
147120524|NCT03931785|530606987|FG001|Overall Study|Noncompliance With Study drug|1|||
147120525|NCT03931785|530606988|FG002|Overall Study|Noncompliance With Study drug|0|||
147120526|NCT03931785|530606989|FG003|Overall Study|Noncompliance With Study drug|0|||
147120527|NCT03931785|530606986|FG000|Overall Study|Other Not specified|0|||
147120528|NCT03931785|530606987|FG001|Overall Study|Other Not specified|2|||
147120529|NCT03931785|530606988|FG002|Overall Study|Other Not specified|2|||
147120530|NCT03931785|530606989|FG003|Overall Study|Other Not specified|2|||
147120531|NCT03931785|530606986|FG000|Overall Study|Withdrawal by Subject|0|||
147120532|NCT03931785|530606987|FG001|Overall Study|Withdrawal by Subject|2|||
147120533|NCT03931785|530606988|FG002|Overall Study|Withdrawal by Subject|4|||
147120534|NCT03931785|530606989|FG003|Overall Study|Withdrawal by Subject|1|||
147120535|NCT03931785|530606986|FG000|Overall Study|Pregnancy|0|||
147120536|NCT03931785|530606987|FG001|Overall Study|Pregnancy|0|||
147120537|NCT03931785|530606988|FG002|Overall Study|Pregnancy|0|||
147120538|NCT03931785|530606989|FG003|Overall Study|Pregnancy|1|||
147120539|NCT03548415|530606990|FG000|Overall Study|Adverse Event or Serious Adverse Event|0|||
147120540|NCT03548415|530606991|FG001|Overall Study|Adverse Event or Serious Adverse Event|1|||
147120541|NCT03548415|530606992|FG002|Overall Study|Adverse Event or Serious Adverse Event|0|||
147120542|NCT03548415|530606993|FG003|Overall Study|Adverse Event or Serious Adverse Event|0|||
147120543|NCT03548415|530606994|FG004|Overall Study|Adverse Event or Serious Adverse Event|1|||
147120544|NCT04605588|530606995|FG000|Overall Study|Withdrawal by Subject|1|||
147120545|NCT04605588|530606996|FG001|Overall Study|Withdrawal by Subject|0|||
147120546|NCT01230814|530606997|FG000|Overall Study|Lost to Follow-up|11|||
147120547|NCT01230814|530606998|FG001|Overall Study|Lost to Follow-up|3|||
147120548|NCT01230814|530606997|FG000|Overall Study|Discontinued (not due to adverse event)|2|||
147120549|NCT01230814|530606998|FG001|Overall Study|Discontinued (not due to adverse event)|1|||
147120550|NCT02533674|530607003|FG000|Dose Level I|Progressive disease|1|||
147120551|NCT02533674|530607004|FG001|Dose Level I|Progressive disease|0|||
147120552|NCT02533674|530607005|FG002|Dose Level I|Progressive disease|0|||
147120553|NCT02533674|530607006|FG003|Dose Level I|Progressive disease|0|||
147120554|NCT02533674|530607007|FG004|Dose Level I|Progressive disease|0|||
147120555|NCT02533674|530607008|FG005|Dose Level I|Progressive disease|0|||
147120556|NCT02533674|530607009|FG006|Dose Level I|Progressive disease|0|||
147120557|NCT02533674|530607010|FG007|Dose Level I|Progressive disease|0|||
147120558|NCT02533674|530607003|FG000|Dose Level I|Withdrawal by Subject|1|||
147120559|NCT02533674|530607004|FG001|Dose Level I|Withdrawal by Subject|0|||
147120560|NCT02533674|530607005|FG002|Dose Level I|Withdrawal by Subject|0|||
147120561|NCT02533674|530607006|FG003|Dose Level I|Withdrawal by Subject|0|||
147120562|NCT02533674|530607007|FG004|Dose Level I|Withdrawal by Subject|0|||
147120563|NCT02533674|530607008|FG005|Dose Level I|Withdrawal by Subject|0|||
147120564|NCT02533674|530607009|FG006|Dose Level I|Withdrawal by Subject|0|||
147120565|NCT02533674|530607010|FG007|Dose Level I|Withdrawal by Subject|0|||
147120566|NCT02533674|530607003|FG000|Dose Level I|Physician Decision|1|||
147120567|NCT02533674|530607004|FG001|Dose Level I|Physician Decision|0|||
147120568|NCT02533674|530607005|FG002|Dose Level I|Physician Decision|0|||
147120569|NCT02533674|530607006|FG003|Dose Level I|Physician Decision|0|||
147120570|NCT02533674|530607007|FG004|Dose Level I|Physician Decision|0|||
147120571|NCT02533674|530607008|FG005|Dose Level I|Physician Decision|0|||
147120572|NCT02533674|530607009|FG006|Dose Level I|Physician Decision|0|||
147120573|NCT02533674|530607010|FG007|Dose Level I|Physician Decision|0|||
147120574|NCT02533674|530607003|FG000|Dose Level I|Death|1|||
147120575|NCT02533674|530607004|FG001|Dose Level I|Death|0|||
147120576|NCT02533674|530607005|FG002|Dose Level I|Death|0|||
147120577|NCT02533674|530607006|FG003|Dose Level I|Death|0|||
147120578|NCT02533674|530607007|FG004|Dose Level I|Death|0|||
147120579|NCT02533674|530607008|FG005|Dose Level I|Death|0|||
147120580|NCT02533674|530607009|FG006|Dose Level I|Death|0|||
147120581|NCT02533674|530607010|FG007|Dose Level I|Death|0|||
147120582|NCT02533674|530607003|FG000|Dose Level I|Never Treated|1|||
147120583|NCT02533674|530607004|FG001|Dose Level I|Never Treated|0|||
147120584|NCT02533674|530607005|FG002|Dose Level I|Never Treated|0|||
147120585|NCT02533674|530607006|FG003|Dose Level I|Never Treated|0|||
147120586|NCT02533674|530607007|FG004|Dose Level I|Never Treated|0|||
147120587|NCT02533674|530607008|FG005|Dose Level I|Never Treated|0|||
147120588|NCT02533674|530607009|FG006|Dose Level I|Never Treated|0|||
147120589|NCT02533674|530607010|FG007|Dose Level I|Never Treated|0|||
147120590|NCT02533674|530607003|FG000|Dose Level II|Progressive disease|0|||
147120591|NCT02533674|530607004|FG001|Dose Level II|Progressive disease|3|||
147120592|NCT02533674|530607005|FG002|Dose Level II|Progressive disease|0|||
147650929|NCT02757352|532544538|FG001|Follow-Up Period|Adverse Event|0|||
147120593|NCT02533674|530607006|FG003|Dose Level II|Progressive disease|0|||
147120594|NCT02533674|530607007|FG004|Dose Level II|Progressive disease|0|||
147120595|NCT02533674|530607008|FG005|Dose Level II|Progressive disease|0|||
147120596|NCT02533674|530607009|FG006|Dose Level II|Progressive disease|0|||
147120597|NCT02533674|530607010|FG007|Dose Level II|Progressive disease|0|||
147120598|NCT02533674|530607003|FG000|Dose Level II|Withdrawal by Subject|0|||
147120599|NCT02533674|530607004|FG001|Dose Level II|Withdrawal by Subject|1|||
147120600|NCT02533674|530607005|FG002|Dose Level II|Withdrawal by Subject|0|||
147120601|NCT02533674|530607006|FG003|Dose Level II|Withdrawal by Subject|0|||
147120602|NCT02533674|530607007|FG004|Dose Level II|Withdrawal by Subject|0|||
147120603|NCT02533674|530607008|FG005|Dose Level II|Withdrawal by Subject|0|||
147120604|NCT02533674|530607009|FG006|Dose Level II|Withdrawal by Subject|0|||
147120605|NCT02533674|530607010|FG007|Dose Level II|Withdrawal by Subject|0|||
147120606|NCT02533674|530607003|FG000|Dose Level II|Treatment-related AE|0|||
147120607|NCT02533674|530607004|FG001|Dose Level II|Treatment-related AE|1|||
147120608|NCT02533674|530607005|FG002|Dose Level II|Treatment-related AE|0|||
147120609|NCT02533674|530607006|FG003|Dose Level II|Treatment-related AE|0|||
147120610|NCT02533674|530607007|FG004|Dose Level II|Treatment-related AE|0|||
147120611|NCT02533674|530607008|FG005|Dose Level II|Treatment-related AE|0|||
147120612|NCT02533674|530607009|FG006|Dose Level II|Treatment-related AE|0|||
147120613|NCT02533674|530607010|FG007|Dose Level II|Treatment-related AE|0|||
147120614|NCT02533674|530607003|FG000|Dose Level II|Physician Decision|0|||
147120615|NCT02533674|530607004|FG001|Dose Level II|Physician Decision|1|||
147120616|NCT02533674|530607005|FG002|Dose Level II|Physician Decision|0|||
147120617|NCT02533674|530607006|FG003|Dose Level II|Physician Decision|0|||
147120618|NCT02533674|530607007|FG004|Dose Level II|Physician Decision|0|||
147120619|NCT02533674|530607008|FG005|Dose Level II|Physician Decision|0|||
147120620|NCT02533674|530607009|FG006|Dose Level II|Physician Decision|0|||
147650930|NCT02757352|532544539|FG002|Follow-Up Period|Adverse Event|0|||
147120621|NCT02533674|530607010|FG007|Dose Level II|Physician Decision|0|||
147120622|NCT02533674|530607003|FG000|Dose Level II|Non-treatment-related AE|0|||
147120623|NCT02533674|530607004|FG001|Dose Level II|Non-treatment-related AE|1|||
147120624|NCT02533674|530607005|FG002|Dose Level II|Non-treatment-related AE|0|||
147120625|NCT02533674|530607006|FG003|Dose Level II|Non-treatment-related AE|0|||
147120626|NCT02533674|530607007|FG004|Dose Level II|Non-treatment-related AE|0|||
147120627|NCT02533674|530607008|FG005|Dose Level II|Non-treatment-related AE|0|||
147120628|NCT02533674|530607009|FG006|Dose Level II|Non-treatment-related AE|0|||
147231986|NCT01543698|531023020|FG014|Phase 1b|Protocol Violation|0|||
147231987|NCT01543698|531023006|FG000|Phase 2|Protocol Violation|0|||
147231988|NCT01543698|531023007|FG001|Phase 2|Protocol Violation|0|||
147231989|NCT01543698|531023008|FG002|Phase 2|Protocol Violation|0|||
147120629|NCT02533674|530607010|FG007|Dose Level II|Non-treatment-related AE|0|||
147231990|NCT01543698|531023009|FG003|Phase 2|Protocol Violation|0|||
147231991|NCT01543698|531023010|FG004|Phase 2|Protocol Violation|0|||
147120630|NCT02533674|530607003|FG000|Dose Level III|Progressive disease|0|||
147120631|NCT02533674|530607004|FG001|Dose Level III|Progressive disease|0|||
147120632|NCT02533674|530607005|FG002|Dose Level III|Progressive disease|2|||
147120633|NCT02533674|530607006|FG003|Dose Level III|Progressive disease|0|||
147120634|NCT02533674|530607007|FG004|Dose Level III|Progressive disease|0|||
147120635|NCT02533674|530607008|FG005|Dose Level III|Progressive disease|0|||
147120636|NCT02533674|530607009|FG006|Dose Level III|Progressive disease|0|||
147120637|NCT02533674|530607010|FG007|Dose Level III|Progressive disease|0|||
147120638|NCT02533674|530607003|FG000|Dose Level III|Withdrawal by Subject|0|||
147120639|NCT02533674|530607004|FG001|Dose Level III|Withdrawal by Subject|0|||
147120640|NCT02533674|530607005|FG002|Dose Level III|Withdrawal by Subject|1|||
147120641|NCT02533674|530607006|FG003|Dose Level III|Withdrawal by Subject|0|||
147120642|NCT02533674|530607007|FG004|Dose Level III|Withdrawal by Subject|0|||
147120643|NCT02533674|530607008|FG005|Dose Level III|Withdrawal by Subject|0|||
147120644|NCT02533674|530607009|FG006|Dose Level III|Withdrawal by Subject|0|||
147120645|NCT02533674|530607010|FG007|Dose Level III|Withdrawal by Subject|0|||
147120646|NCT02533674|530607003|FG000|Dose Level III|Treatment-related AE|0|||
147120647|NCT02533674|530607004|FG001|Dose Level III|Treatment-related AE|0|||
147120648|NCT02533674|530607005|FG002|Dose Level III|Treatment-related AE|1|||
147120649|NCT02533674|530607006|FG003|Dose Level III|Treatment-related AE|0|||
147120650|NCT02533674|530607007|FG004|Dose Level III|Treatment-related AE|0|||
147120651|NCT02533674|530607008|FG005|Dose Level III|Treatment-related AE|0|||
147120652|NCT02533674|530607009|FG006|Dose Level III|Treatment-related AE|0|||
147120653|NCT02533674|530607010|FG007|Dose Level III|Treatment-related AE|0|||
147120654|NCT02533674|530607003|FG000|Dose Level IV|Progressive disease|0|||
147120655|NCT02533674|530607004|FG001|Dose Level IV|Progressive disease|0|||
147567975|NCT00777023|532238371|FG002|Overall Study|Missing data|0|||
147567976|NCT00777023|532238369|FG000|Overall Study|Reasons not specified|4|||
147567977|NCT00777023|532238370|FG001|Overall Study|Reasons not specified|4|||
147567978|NCT00777023|532238371|FG002|Overall Study|Reasons not specified|2|||
147567979|NCT00777023|532238369|FG000|Overall Study|Last dose date unknown|3|||
147567980|NCT00777023|532238370|FG001|Overall Study|Last dose date unknown|3|||
147567981|NCT00777023|532238371|FG002|Overall Study|Last dose date unknown|1|||
147567982|NCT02659150|532238372|FG000|Subject Enrollment|Physician Decision|3|||
147567983|NCT02659150|532238372|FG000|Subject Enrollment|Withdrawal by Subject|2|||
147567984|NCT02659150|532238372|FG000|Baseline Imaging|Withdrawal by Subject|1|||
147567985|NCT02659150|532238372|FG000|Baseline Imaging|Physician Decision|1|||
147567986|NCT02659150|532238372|FG000|Study Drug Dosing|Adverse Event|1|||
147567987|NCT02472366|532238375|FG000|Overall Study|Lost to Follow-up|1|||
147567988|NCT02472366|532238376|FG001|Overall Study|Lost to Follow-up|0|||
147567989|NCT03699020|532238379|FG000|Overall Study|Withdrawal by Subject|3|||
147567990|NCT03699020|532238380|FG001|Overall Study|Withdrawal by Subject|2|||
147567991|NCT03620747|532238384|FG000|Overall Study|Participant decision|7|||
147567992|NCT03620747|532238384|FG000|Overall Study|Adverse Event|6|||
147567993|NCT03620747|532238384|FG000|Overall Study|Lack of Efficacy|1|||
147567994|NCT03620747|532238384|FG000|Overall Study|Poor compliance to protocol|2|||
147567995|NCT03620747|532238384|FG000|Overall Study|Other-unspecified|3|||
147567996|NCT00635492|532238393|FG000|Overall Study|Death|12|||
147567997|NCT00635492|532238394|FG001|Overall Study|Death|40|||
147567998|NCT00635492|532238393|FG000|Overall Study|Lost to Follow-up|151|||
147567999|NCT00635492|532238394|FG001|Overall Study|Lost to Follow-up|172|||
147568000|NCT00635492|532238393|FG000|Overall Study|Physician Decision|32|||
147568001|NCT00635492|532238394|FG001|Overall Study|Physician Decision|22|||
147568002|NCT00635492|532238393|FG000|Overall Study|Sponsor decision|2|||
147568003|NCT00635492|532238394|FG001|Overall Study|Sponsor decision|3|||
147568004|NCT00635492|532238393|FG000|Overall Study|Withdrawal by Subject|82|||
147568005|NCT00635492|532238394|FG001|Overall Study|Withdrawal by Subject|45|||
147568006|NCT00467363|532238400|FG000|Overall Study|Lost to Follow-up|80|||
147568007|NCT00467363|532238401|FG001|Overall Study|Lost to Follow-up|70|||
147568008|NCT00473330|532238402|FG000|Core Study|Adverse Event|4|||
147568009|NCT00473330|532238403|FG001|Core Study|Adverse Event|4|||
147568010|NCT00473330|532238404|FG002|Core Study|Adverse Event|1|||
147568011|NCT00473330|532238402|FG000|Core Study|Death|6|||
147568012|NCT00473330|532238403|FG001|Core Study|Death|4|||
147568013|NCT00473330|532238404|FG002|Core Study|Death|4|||
147568014|NCT00473330|532238402|FG000|Core Study|Lost to Follow-up|5|||
147568015|NCT00473330|532238403|FG001|Core Study|Lost to Follow-up|5|||
147120656|NCT02533674|530607005|FG002|Dose Level IV|Progressive disease|0|||
147120657|NCT02533674|530607006|FG003|Dose Level IV|Progressive disease|3|||
147120658|NCT02533674|530607007|FG004|Dose Level IV|Progressive disease|0|||
147120659|NCT02533674|530607008|FG005|Dose Level IV|Progressive disease|0|||
147231992|NCT01543698|531023011|FG005|Phase 2|Protocol Violation|0|||
147568016|NCT00473330|532238404|FG002|Core Study|Lost to Follow-up|10|||
147568017|NCT00473330|532238402|FG000|Core Study|Physician Decision|2|||
147568018|NCT00473330|532238403|FG001|Core Study|Physician Decision|1|||
147568019|NCT00473330|532238404|FG002|Core Study|Physician Decision|3|||
147568020|NCT00473330|532238402|FG000|Core Study|Subject Non-compliance|1|||
147568021|NCT00473330|532238403|FG001|Core Study|Subject Non-compliance|2|||
147568022|NCT00473330|532238404|FG002|Core Study|Subject Non-compliance|1|||
147568023|NCT00473330|532238402|FG000|Core Study|Subject Required Other Therapy|0|||
147568024|NCT00473330|532238403|FG001|Core Study|Subject Required Other Therapy|1|||
147120660|NCT02533674|530607009|FG006|Dose Level IV|Progressive disease|0|||
147120661|NCT02533674|530607010|FG007|Dose Level IV|Progressive disease|0|||
147120662|NCT02533674|530607003|FG000|Dose Level IV|Withdrawal by Subject|0|||
147120663|NCT02533674|530607004|FG001|Dose Level IV|Withdrawal by Subject|0|||
147568025|NCT00473330|532238404|FG002|Core Study|Subject Required Other Therapy|3|||
147568026|NCT00473330|532238402|FG000|Core Study|Subject's Decision|9|||
147568027|NCT00473330|532238403|FG001|Core Study|Subject's Decision|8|||
147568028|NCT00473330|532238404|FG002|Core Study|Subject's Decision|19|||
147568029|NCT00473330|532238402|FG000|Open-label Extension Through Month 48|Adverse Event|0|||
147568030|NCT00473330|532238403|FG001|Open-label Extension Through Month 48|Adverse Event|0|||
147120664|NCT02533674|530607005|FG002|Dose Level IV|Withdrawal by Subject|0|||
147120665|NCT02533674|530607006|FG003|Dose Level IV|Withdrawal by Subject|1|||
147120666|NCT02533674|530607007|FG004|Dose Level IV|Withdrawal by Subject|0|||
147120667|NCT02533674|530607008|FG005|Dose Level IV|Withdrawal by Subject|0|||
147120668|NCT02533674|530607009|FG006|Dose Level IV|Withdrawal by Subject|0|||
147120669|NCT02533674|530607010|FG007|Dose Level IV|Withdrawal by Subject|0|||
147120670|NCT02533674|530607003|FG000|Dose Level IV|Physician Decision|0|||
147120671|NCT02533674|530607004|FG001|Dose Level IV|Physician Decision|0|||
147120672|NCT02533674|530607005|FG002|Dose Level IV|Physician Decision|0|||
147120673|NCT02533674|530607006|FG003|Dose Level IV|Physician Decision|1|||
147120674|NCT02533674|530607007|FG004|Dose Level IV|Physician Decision|0|||
147120675|NCT02533674|530607008|FG005|Dose Level IV|Physician Decision|0|||
147120676|NCT02533674|530607009|FG006|Dose Level IV|Physician Decision|0|||
147120677|NCT02533674|530607010|FG007|Dose Level IV|Physician Decision|0|||
147120678|NCT02533674|530607003|FG000|Dose Level V|Progressive disease|0|||
147120679|NCT02533674|530607004|FG001|Dose Level V|Progressive disease|0|||
147120680|NCT02533674|530607005|FG002|Dose Level V|Progressive disease|0|||
147120681|NCT02533674|530607006|FG003|Dose Level V|Progressive disease|0|||
147120682|NCT02533674|530607007|FG004|Dose Level V|Progressive disease|3|||
147120683|NCT02533674|530607008|FG005|Dose Level V|Progressive disease|0|||
147120684|NCT02533674|530607009|FG006|Dose Level V|Progressive disease|0|||
147120685|NCT02533674|530607010|FG007|Dose Level V|Progressive disease|0|||
147120686|NCT02533674|530607003|FG000|Dose Level V|Withdrawal by Subject|0|||
147120687|NCT02533674|530607004|FG001|Dose Level V|Withdrawal by Subject|0|||
147120688|NCT02533674|530607005|FG002|Dose Level V|Withdrawal by Subject|0|||
147120689|NCT02533674|530607006|FG003|Dose Level V|Withdrawal by Subject|0|||
147120690|NCT02533674|530607007|FG004|Dose Level V|Withdrawal by Subject|1|||
147120691|NCT02533674|530607008|FG005|Dose Level V|Withdrawal by Subject|0|||
147120692|NCT02533674|530607009|FG006|Dose Level V|Withdrawal by Subject|0|||
147120693|NCT02533674|530607010|FG007|Dose Level V|Withdrawal by Subject|0|||
147120694|NCT02533674|530607003|FG000|Dose Level V|Physician Decision|0|||
147120695|NCT02533674|530607004|FG001|Dose Level V|Physician Decision|0|||
147120696|NCT02533674|530607005|FG002|Dose Level V|Physician Decision|0|||
147120697|NCT02533674|530607006|FG003|Dose Level V|Physician Decision|0|||
147120698|NCT02533674|530607007|FG004|Dose Level V|Physician Decision|1|||
147120699|NCT02533674|530607008|FG005|Dose Level V|Physician Decision|0|||
147120700|NCT02533674|530607009|FG006|Dose Level V|Physician Decision|0|||
147120701|NCT02533674|530607010|FG007|Dose Level V|Physician Decision|0|||
147120702|NCT02533674|530607003|FG000|Dose Level VI|Progressive disease|0|||
147120703|NCT02533674|530607004|FG001|Dose Level VI|Progressive disease|0|||
147120704|NCT02533674|530607005|FG002|Dose Level VI|Progressive disease|0|||
147120705|NCT02533674|530607006|FG003|Dose Level VI|Progressive disease|0|||
147120706|NCT02533674|530607007|FG004|Dose Level VI|Progressive disease|0|||
147120707|NCT02533674|530607008|FG005|Dose Level VI|Progressive disease|7|||
147120708|NCT02533674|530607009|FG006|Dose Level VI|Progressive disease|0|||
147120709|NCT02533674|530607010|FG007|Dose Level VI|Progressive disease|0|||
147120710|NCT02533674|530607003|FG000|Dose Level VI|Withdrawal by Subject|0|||
147120711|NCT02533674|530607004|FG001|Dose Level VI|Withdrawal by Subject|0|||
147120712|NCT02533674|530607005|FG002|Dose Level VI|Withdrawal by Subject|0|||
147120713|NCT02533674|530607006|FG003|Dose Level VI|Withdrawal by Subject|0|||
147120714|NCT02533674|530607007|FG004|Dose Level VI|Withdrawal by Subject|0|||
147120715|NCT02533674|530607008|FG005|Dose Level VI|Withdrawal by Subject|1|||
147120716|NCT02533674|530607009|FG006|Dose Level VI|Withdrawal by Subject|0|||
147120717|NCT02533674|530607010|FG007|Dose Level VI|Withdrawal by Subject|0|||
147120718|NCT02533674|530607003|FG000|Dose Level VI|Treatment-related AE|0|||
147120719|NCT02533674|530607004|FG001|Dose Level VI|Treatment-related AE|0|||
147231993|NCT01543698|531023012|FG006|Phase 2|Protocol Violation|0|||
147231994|NCT01543698|531023013|FG007|Phase 2|Protocol Violation|0|||
147231995|NCT01543698|531023014|FG008|Phase 2|Protocol Violation|0|||
147231996|NCT01543698|531023015|FG009|Phase 2|Protocol Violation|0|||
147231997|NCT01543698|531023016|FG010|Phase 2|Protocol Violation|0|||
147231998|NCT01543698|531023017|FG011|Phase 2|Protocol Violation|0|||
147231999|NCT01543698|531023018|FG012|Phase 2|Protocol Violation|1|||
147232000|NCT01543698|531023019|FG013|Phase 2|Protocol Violation|0|||
147232001|NCT01543698|531023020|FG014|Phase 2|Protocol Violation|0|||
147232002|NCT01543698|531023006|FG000|Phase 2|Disease progression|0|||
147232003|NCT01543698|531023007|FG001|Phase 2|Disease progression|0|||
147120720|NCT02533674|530607005|FG002|Dose Level VI|Treatment-related AE|0|||
147120721|NCT02533674|530607006|FG003|Dose Level VI|Treatment-related AE|0|||
147120722|NCT02533674|530607007|FG004|Dose Level VI|Treatment-related AE|0|||
147120723|NCT02533674|530607008|FG005|Dose Level VI|Treatment-related AE|1|||
147120724|NCT02533674|530607009|FG006|Dose Level VI|Treatment-related AE|0|||
147120725|NCT02533674|530607010|FG007|Dose Level VI|Treatment-related AE|0|||
147120726|NCT02533674|530607003|FG000|Dose Level VII|Progressive disease|0|||
147120727|NCT02533674|530607004|FG001|Dose Level VII|Progressive disease|0|||
147120728|NCT02533674|530607005|FG002|Dose Level VII|Progressive disease|0|||
147120729|NCT02533674|530607006|FG003|Dose Level VII|Progressive disease|0|||
147120730|NCT02533674|530607007|FG004|Dose Level VII|Progressive disease|0|||
147120731|NCT02533674|530607008|FG005|Dose Level VII|Progressive disease|0|||
147120732|NCT02533674|530607009|FG006|Dose Level VII|Progressive disease|10|||
147120733|NCT02533674|530607010|FG007|Dose Level VII|Progressive disease|0|||
147120734|NCT02533674|530607003|FG000|Dose Level VII|Withdrawal by Subject|0|||
147120735|NCT02533674|530607004|FG001|Dose Level VII|Withdrawal by Subject|0|||
147120736|NCT02533674|530607005|FG002|Dose Level VII|Withdrawal by Subject|0|||
147120737|NCT02533674|530607006|FG003|Dose Level VII|Withdrawal by Subject|0|||
147120738|NCT02533674|530607007|FG004|Dose Level VII|Withdrawal by Subject|0|||
147120739|NCT02533674|530607008|FG005|Dose Level VII|Withdrawal by Subject|0|||
147120740|NCT02533674|530607009|FG006|Dose Level VII|Withdrawal by Subject|3|||
147120741|NCT02533674|530607010|FG007|Dose Level VII|Withdrawal by Subject|0|||
147120742|NCT02533674|530607003|FG000|Dose Level VII|Treatment-related AE|0|||
147120743|NCT02533674|530607004|FG001|Dose Level VII|Treatment-related AE|0|||
147120744|NCT02533674|530607005|FG002|Dose Level VII|Treatment-related AE|0|||
147120745|NCT02533674|530607006|FG003|Dose Level VII|Treatment-related AE|0|||
147120746|NCT02533674|530607007|FG004|Dose Level VII|Treatment-related AE|0|||
147120747|NCT02533674|530607008|FG005|Dose Level VII|Treatment-related AE|0|||
147120748|NCT02533674|530607009|FG006|Dose Level VII|Treatment-related AE|1|||
147120749|NCT02533674|530607010|FG007|Dose Level VII|Treatment-related AE|0|||
147120750|NCT02533674|530607003|FG000|Dose Level VII|Death|0|||
147120751|NCT02533674|530607004|FG001|Dose Level VII|Death|0|||
147120752|NCT02533674|530607005|FG002|Dose Level VII|Death|0|||
147120753|NCT02533674|530607006|FG003|Dose Level VII|Death|0|||
147120754|NCT02533674|530607007|FG004|Dose Level VII|Death|0|||
147120755|NCT02533674|530607008|FG005|Dose Level VII|Death|0|||
147120756|NCT02533674|530607009|FG006|Dose Level VII|Death|2|||
147120757|NCT02533674|530607010|FG007|Dose Level VII|Death|0|||
147120758|NCT02533674|530607003|FG000|Dose Level VIII|Progressive disease|0|||
147120759|NCT02533674|530607004|FG001|Dose Level VIII|Progressive disease|0|||
147120760|NCT02533674|530607005|FG002|Dose Level VIII|Progressive disease|0|||
147120761|NCT02533674|530607006|FG003|Dose Level VIII|Progressive disease|0|||
147120762|NCT02533674|530607007|FG004|Dose Level VIII|Progressive disease|0|||
147120763|NCT02533674|530607008|FG005|Dose Level VIII|Progressive disease|0|||
147120764|NCT02533674|530607009|FG006|Dose Level VIII|Progressive disease|0|||
147120765|NCT02533674|530607010|FG007|Dose Level VIII|Progressive disease|3|||
147120766|NCT02533674|530607003|FG000|Dose Level VIII|Withdrawal by Subject|0|||
147120767|NCT02533674|530607004|FG001|Dose Level VIII|Withdrawal by Subject|0|||
147120768|NCT02533674|530607005|FG002|Dose Level VIII|Withdrawal by Subject|0|||
147120769|NCT02533674|530607006|FG003|Dose Level VIII|Withdrawal by Subject|0|||
147120770|NCT02533674|530607007|FG004|Dose Level VIII|Withdrawal by Subject|0|||
147120771|NCT02533674|530607008|FG005|Dose Level VIII|Withdrawal by Subject|0|||
147120772|NCT02533674|530607009|FG006|Dose Level VIII|Withdrawal by Subject|0|||
147120773|NCT02533674|530607010|FG007|Dose Level VIII|Withdrawal by Subject|1|||
147120774|NCT02533674|530607003|FG000|Dose Level VIII|Treatment-related AE|0|||
147120775|NCT02533674|530607004|FG001|Dose Level VIII|Treatment-related AE|0|||
147120776|NCT02533674|530607005|FG002|Dose Level VIII|Treatment-related AE|0|||
147120777|NCT02533674|530607006|FG003|Dose Level VIII|Treatment-related AE|0|||
147120778|NCT02533674|530607007|FG004|Dose Level VIII|Treatment-related AE|0|||
147120779|NCT02533674|530607008|FG005|Dose Level VIII|Treatment-related AE|0|||
147120780|NCT02533674|530607009|FG006|Dose Level VIII|Treatment-related AE|0|||
147120781|NCT02533674|530607010|FG007|Dose Level VIII|Treatment-related AE|1|||
147120782|NCT02533674|530607003|FG000|Dose Level VIII|Never treated|0|||
147120783|NCT02533674|530607004|FG001|Dose Level VIII|Never treated|0|||
147120784|NCT02533674|530607005|FG002|Dose Level VIII|Never treated|0|||
147120785|NCT02533674|530607006|FG003|Dose Level VIII|Never treated|0|||
147120786|NCT02533674|530607007|FG004|Dose Level VIII|Never treated|0|||
147120787|NCT02533674|530607008|FG005|Dose Level VIII|Never treated|0|||
147120788|NCT02533674|530607009|FG006|Dose Level VIII|Never treated|0|||
147120789|NCT02533674|530607010|FG007|Dose Level VIII|Never treated|1|||
147120790|NCT02365064|530607014|FG000|Overall Study|Patients met baseline exclusion requirem|2|||
147120791|NCT02365064|530607015|FG001|Overall Study|Patients met baseline exclusion requirem|15|||
147650931|NCT02757352|532544540|FG003|Follow-Up Period|Adverse Event|0|||
147120792|NCT02365064|530607014|FG000|Overall Study|Withdrawal by Subject|6|||
147120793|NCT02365064|530607015|FG001|Overall Study|Withdrawal by Subject|9|||
147120794|NCT02365064|530607014|FG000|Overall Study|Treatment intolerance|2|||
147120795|NCT02365064|530607015|FG001|Overall Study|Treatment intolerance|4|||
147120796|NCT02123511|530607016|FG000|Overall Study|Cancelled treatment|1|||
147232004|NCT01543698|531023008|FG002|Phase 2|Disease progression|0|||
147120797|NCT02123511|530607017|FG001|Overall Study|Cancelled treatment|0|||
147120798|NCT02123511|530607016|FG000|Overall Study|Incomplete data|1|||
147120799|NCT02123511|530607017|FG001|Overall Study|Incomplete data|3|||
147120800|NCT02123511|530607016|FG000|Overall Study|Ineligible|0|||
147120801|NCT02123511|530607017|FG001|Overall Study|Ineligible|1|||
147120802|NCT00458705|530607018|FG000|Overall Study|Adverse Event|4|||
147120803|NCT00458705|530607018|FG000|Overall Study|Not Treated|1|||
147120804|NCT00378560|530607021|FG000|Overall Study|Adverse Event|1|||
147120805|NCT00378560|530607022|FG001|Overall Study|Adverse Event|0|||
147120806|NCT00378560|530607021|FG000|Overall Study|Lost to Follow-up|24|||
147120807|NCT00378560|530607022|FG001|Overall Study|Lost to Follow-up|29|||
147120808|NCT00378560|530607021|FG000|Overall Study|Protocol Violation|2|||
147120809|NCT00378560|530607022|FG001|Overall Study|Protocol Violation|0|||
147120810|NCT00378560|530607021|FG000|Overall Study|Withdrawal by Subject|17|||
147120811|NCT00378560|530607022|FG001|Overall Study|Withdrawal by Subject|21|||
147120812|NCT00378560|530607021|FG000|Overall Study|Moved|4|||
147120813|NCT00378560|530607022|FG001|Overall Study|Moved|3|||
147120814|NCT00378560|530607021|FG000|Overall Study|Pregnancy|7|||
147120815|NCT00378560|530607022|FG001|Overall Study|Pregnancy|5|||
147120816|NCT00378560|530607021|FG000|Overall Study|Laboratory test values abnormal|1|||
147120817|NCT00378560|530607022|FG001|Overall Study|Laboratory test values abnormal|0|||
147120818|NCT03636269|530607023|FG000|Period 1: Double-blind Phase|Adverse Event|13|||
147120819|NCT03636269|530607024|FG001|Period 1: Double-blind Phase|Adverse Event|7|||
147120820|NCT03636269|530607025|FG002|Period 1: Double-blind Phase|Adverse Event|0|||
147120821|NCT03636269|530607023|FG000|Period 1: Double-blind Phase|Lack of Efficacy|1|||
147120822|NCT03636269|530607024|FG001|Period 1: Double-blind Phase|Lack of Efficacy|0|||
147120823|NCT03636269|530607025|FG002|Period 1: Double-blind Phase|Lack of Efficacy|0|||
147120824|NCT03636269|530607023|FG000|Period 1: Double-blind Phase|Eligibility (inclusion/exclusion criteria)|2|||
147120825|NCT03636269|530607024|FG001|Period 1: Double-blind Phase|Eligibility (inclusion/exclusion criteria)|0|||
147120826|NCT03636269|530607025|FG002|Period 1: Double-blind Phase|Eligibility (inclusion/exclusion criteria)|0|||
147120827|NCT03636269|530607023|FG000|Period 1: Double-blind Phase|Withdrawal by Subject|5|||
147120828|NCT03636269|530607024|FG001|Period 1: Double-blind Phase|Withdrawal by Subject|1|||
147120829|NCT03636269|530607025|FG002|Period 1: Double-blind Phase|Withdrawal by Subject|0|||
147120830|NCT03636269|530607023|FG000|Period 1: Double-blind Phase|Other|6|||
147120831|NCT03636269|530607024|FG001|Period 1: Double-blind Phase|Other|3|||
147120832|NCT03636269|530607025|FG002|Period 1: Double-blind Phase|Other|0|||
147120833|NCT03636269|530607023|FG000|Period 1: Double-blind Phase|Lost to Follow-up|1|||
147120834|NCT03636269|530607024|FG001|Period 1: Double-blind Phase|Lost to Follow-up|0|||
147120835|NCT03636269|530607025|FG002|Period 1: Double-blind Phase|Lost to Follow-up|0|||
147120836|NCT03636269|530607023|FG000|Period 1: Double-blind Phase|Subject non-compliance|1|||
147120837|NCT03636269|530607024|FG001|Period 1: Double-blind Phase|Subject non-compliance|2|||
147120838|NCT03636269|530607025|FG002|Period 1: Double-blind Phase|Subject non-compliance|0|||
147120839|NCT03636269|530607023|FG000|Period 2: Open-label Phase|Adverse Event|0|||
147120840|NCT03636269|530607024|FG001|Period 2: Open-label Phase|Adverse Event|0|||
147120841|NCT03636269|530607025|FG002|Period 2: Open-label Phase|Adverse Event|21|||
147120842|NCT03636269|530607023|FG000|Period 2: Open-label Phase|Lack of Efficacy|0|||
147120843|NCT03636269|530607024|FG001|Period 2: Open-label Phase|Lack of Efficacy|0|||
147120844|NCT03636269|530607025|FG002|Period 2: Open-label Phase|Lack of Efficacy|2|||
147120845|NCT03636269|530607023|FG000|Period 2: Open-label Phase|Eligibility (inclusion/exclusion criteria)|0|||
147120846|NCT03636269|530607024|FG001|Period 2: Open-label Phase|Eligibility (inclusion/exclusion criteria)|0|||
147120847|NCT03636269|530607025|FG002|Period 2: Open-label Phase|Eligibility (inclusion/exclusion criteria)|2|||
147120848|NCT03636269|530607023|FG000|Period 2: Open-label Phase|Withdrawal by Subject|0|||
147120849|NCT03636269|530607024|FG001|Period 2: Open-label Phase|Withdrawal by Subject|0|||
147120850|NCT03636269|530607025|FG002|Period 2: Open-label Phase|Withdrawal by Subject|11|||
147120851|NCT03636269|530607023|FG000|Period 2: Open-label Phase|Administrative|0|||
147120852|NCT03636269|530607024|FG001|Period 2: Open-label Phase|Administrative|0|||
147120853|NCT03636269|530607025|FG002|Period 2: Open-label Phase|Administrative|36|||
147120854|NCT03636269|530607023|FG000|Period 2: Open-label Phase|Other|0|||
147120855|NCT03636269|530607024|FG001|Period 2: Open-label Phase|Other|0|||
147120856|NCT03636269|530607025|FG002|Period 2: Open-label Phase|Other|9|||
147120857|NCT03636269|530607023|FG000|Period 2: Open-label Phase|Sponsor stopping study|0|||
147120858|NCT03636269|530607024|FG001|Period 2: Open-label Phase|Sponsor stopping study|0|||
147120859|NCT03636269|530607025|FG002|Period 2: Open-label Phase|Sponsor stopping study|313|||
147120860|NCT01658735|530607033|FG000|Overall Study|Lack of Efficacy|1|||
147120861|NCT01658735|530607034|FG001|Overall Study|Lack of Efficacy|0|||
147444588|NCT01940471|531792645|FG003|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
147444589|NCT00884273|531792646|FG000|Overall Study|Adverse Event|0|||
147120862|NCT01658735|530607035|FG002|Overall Study|Lack of Efficacy|1|||
147120863|NCT01658735|530607033|FG000|Overall Study|Lost to Follow-up|1|||
147120864|NCT01658735|530607034|FG001|Overall Study|Lost to Follow-up|1|||
147120865|NCT01658735|530607035|FG002|Overall Study|Lost to Follow-up|0|||
147120866|NCT01658735|530607033|FG000|Overall Study|Protocol Violation|0|||
147120867|NCT01658735|530607034|FG001|Overall Study|Protocol Violation|1|||
147120868|NCT01658735|530607035|FG002|Overall Study|Protocol Violation|0|||
147120869|NCT01658735|530607033|FG000|Overall Study|Withdrawal by Subject|3|||
147120870|NCT01658735|530607034|FG001|Overall Study|Withdrawal by Subject|5|||
147120871|NCT01658735|530607035|FG002|Overall Study|Withdrawal by Subject|3|||
147120872|NCT03757715|530607036|FG000|Overall Study|Lost to Follow-up|4|||
147120873|NCT03757715|530607037|FG001|Overall Study|Lost to Follow-up|9|||
147120874|NCT03757715|530607036|FG000|Overall Study|Withdrawal by Subject|1|||
147120875|NCT03757715|530607037|FG001|Overall Study|Withdrawal by Subject|1|||
147120876|NCT03156621|530607038|FG000|Open-Label Treatment Period (OLTP)|Adverse Event|0|||
147444590|NCT00884273|531792647|FG001|Overall Study|Adverse Event|2|||
147120877|NCT03156621|530607039|FG001|Open-Label Treatment Period (OLTP)|Adverse Event|2|||
147120878|NCT03156621|530607038|FG000|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|0|||
147120879|NCT03156621|530607039|FG001|Open-Label Treatment Period (OLTP)|Withdrawal by Subject|1|||
147120880|NCT01379937|530607040|FG000|Overall Study|Protocol Violation|0|||
147120881|NCT01379937|530607041|FG001|Overall Study|Protocol Violation|0|||
147120882|NCT01379937|530607042|FG002|Overall Study|Protocol Violation|0|||
147120883|NCT01379937|530607043|FG003|Overall Study|Protocol Violation|1|||
147120884|NCT01379937|530607040|FG000|Overall Study|Consent withdrawal|0|||
147120885|NCT01379937|530607041|FG001|Overall Study|Consent withdrawal|1|||
147120886|NCT01379937|530607042|FG002|Overall Study|Consent withdrawal|0|||
147120887|NCT01379937|530607043|FG003|Overall Study|Consent withdrawal|0|||
147120888|NCT01379937|530607040|FG000|Overall Study|Lost to Follow-up|1|||
147120889|NCT01379937|530607041|FG001|Overall Study|Lost to Follow-up|2|||
147120890|NCT01379937|530607042|FG002|Overall Study|Lost to Follow-up|2|||
147120891|NCT01379937|530607043|FG003|Overall Study|Lost to Follow-up|0|||
147120892|NCT00079781|530607044|FG000|Pre-implant Period|Withdrawal by Subject|2|||
147120893|NCT00079781|530607045|FG001|Pre-implant Period|Withdrawal by Subject|0|||
147120894|NCT00079781|530607046|FG002|Pre-implant Period|Withdrawal by Subject|0|||
147120895|NCT00079781|530607044|FG000|Pre-implant Period|Did not meet I/E criteria|1|||
147120896|NCT00079781|530607045|FG001|Pre-implant Period|Did not meet I/E criteria|1|||
147120897|NCT00079781|530607046|FG002|Pre-implant Period|Did not meet I/E criteria|1|||
147120898|NCT00079781|530607044|FG000|Follow-up Period|Withdrawal by Subject|3|||
147120899|NCT00079781|530607045|FG001|Follow-up Period|Withdrawal by Subject|0|||
147120900|NCT00079781|530607046|FG002|Follow-up Period|Withdrawal by Subject|1|||
147120901|NCT00079781|530607044|FG000|Follow-up Period|Lost to Follow-up|1|||
147120902|NCT00079781|530607045|FG001|Follow-up Period|Lost to Follow-up|0|||
147120903|NCT00079781|530607046|FG002|Follow-up Period|Lost to Follow-up|0|||
147120904|NCT00079781|530607044|FG000|Follow-up Period|Death|0|||
147120905|NCT00079781|530607045|FG001|Follow-up Period|Death|0|||
147120906|NCT00079781|530607046|FG002|Follow-up Period|Death|1|||
147120907|NCT00576407|530607047|FG000|Overall Study|Death|7|||
147120908|NCT00576407|530607047|FG000|Overall Study|Physician Decision|1|||
147120909|NCT04641975|530607048|FG000|Overall Study|Protocol Violation|1|||
147120910|NCT04641975|530607049|FG001|Overall Study|Protocol Violation|2|||
147120911|NCT04641975|530607050|FG002|Overall Study|Protocol Violation|0|||
147120912|NCT04641975|530607051|FG003|Overall Study|Protocol Violation|0|||
147120913|NCT04641975|530607048|FG000|Overall Study|Adverse Event|0|||
147120914|NCT04641975|530607049|FG001|Overall Study|Adverse Event|0|||
147120915|NCT04641975|530607050|FG002|Overall Study|Adverse Event|1|||
147120916|NCT04641975|530607051|FG003|Overall Study|Adverse Event|1|||
147120917|NCT04641975|530607048|FG000|Overall Study|Withdrawal by Subject|1|||
147120918|NCT04641975|530607049|FG001|Overall Study|Withdrawal by Subject|0|||
147120919|NCT04641975|530607050|FG002|Overall Study|Withdrawal by Subject|0|||
147120920|NCT04641975|530607051|FG003|Overall Study|Withdrawal by Subject|0|||
147120921|NCT01259024|530607055|FG000|Overall Study|Physician Decision|1|||
147120922|NCT01657500|530607056|FG000|Overall Study|set impropperly matched|3|||
147120923|NCT01657500|530607057|FG001|Overall Study|set impropperly matched|3|||
147120924|NCT01657500|530607056|FG000|Overall Study|Lost to Follow-up|2|||
147120925|NCT01657500|530607057|FG001|Overall Study|Lost to Follow-up|2|||
147120926|NCT00756444|530607060|FG000|Overall Study|Adverse Event|1|||
147120927|NCT00756444|530607061|FG001|Overall Study|Adverse Event|1|||
147120928|NCT00756444|530607060|FG000|Overall Study|Withdrawal by Subject|6|||
147120929|NCT00756444|530607061|FG001|Overall Study|Withdrawal by Subject|8|||
147120930|NCT00756444|530607060|FG000|Overall Study|Lost to Follow-up|0|||
147120931|NCT00756444|530607061|FG001|Overall Study|Lost to Follow-up|1|||
147120932|NCT00756444|530607060|FG000|Overall Study|Death|5|||
147120933|NCT00756444|530607061|FG001|Overall Study|Death|4|||
147120934|NCT00756444|530607060|FG000|Overall Study|Disease Progression|2|||
147120935|NCT00756444|530607061|FG001|Overall Study|Disease Progression|7|||
147120936|NCT00756444|530607060|FG000|Overall Study|Ineligibility Determined|1|||
147120937|NCT00756444|530607061|FG001|Overall Study|Ineligibility Determined|0|||
147120938|NCT00564070|530607062|FG000|Overall Study|Lost to Follow-up|9|||
147120939|NCT00564070|530607063|FG001|Overall Study|Lost to Follow-up|7|||
147120940|NCT00564070|530607062|FG000|Overall Study|Worsening depression, referred to care|3|||
147120941|NCT00564070|530607063|FG001|Overall Study|Worsening depression, referred to care|0|||
147120942|NCT02264821|530607065|FG000|Overall Study|Protocol Violation|1|||
147120943|NCT02264821|530607066|FG001|Overall Study|Protocol Violation|3|||
147120944|NCT02264821|530607067|FG002|Overall Study|Protocol Violation|6|||
147120945|NCT00552279|530607068|FG000|Overall Study|Adverse Event|0|||
147120946|NCT00552279|530607069|FG001|Overall Study|Adverse Event|1|||
147120947|NCT00552279|530607068|FG000|Overall Study|Withdrawal by Subject|12|||
147232005|NCT01543698|531023009|FG003|Phase 2|Disease progression|0|||
147232006|NCT01543698|531023010|FG004|Phase 2|Disease progression|0|||
147120948|NCT00552279|530607069|FG001|Overall Study|Withdrawal by Subject|1|||
147232007|NCT01543698|531023011|FG005|Phase 2|Disease progression|0|||
147232008|NCT01543698|531023012|FG006|Phase 2|Disease progression|0|||
147120949|NCT00552279|530607068|FG000|Overall Study|Lost to Follow-up|1|||
147120950|NCT00552279|530607069|FG001|Overall Study|Lost to Follow-up|0|||
147120951|NCT00552279|530607068|FG000|Overall Study|Other|1|||
147120952|NCT00552279|530607069|FG001|Overall Study|Other|1|||
147120953|NCT03142334|530607071|FG000|Overall Study|Death|18|||
147120954|NCT03142334|530607072|FG001|Overall Study|Death|33|||
147120955|NCT03142334|530607071|FG000|Overall Study|Withdrawal by Subject|15|||
147120956|NCT03142334|530607072|FG001|Overall Study|Withdrawal by Subject|11|||
147120957|NCT03142334|530607071|FG000|Overall Study|Ongoing on trial follow up|463|||
147120958|NCT03142334|530607072|FG001|Overall Study|Ongoing on trial follow up|454|||
147120959|NCT03835117|530607073|FG000|Phase II - Week 13- Week 24|Lost to Follow-up|2|||
147120960|NCT03835117|530607074|FG001|Phase II - Week 13- Week 24|Lost to Follow-up|3|||
147120961|NCT06083493|530607075|FG000|Overall Study|Technical issues with the interventional device|2|||
147120962|NCT06083493|530607076|FG001|Overall Study|Technical issues with the interventional device|2|||
147120963|NCT06083493|530607075|FG000|Overall Study|Performed incorrect visual task|1|||
147120964|NCT06083493|530607076|FG001|Overall Study|Performed incorrect visual task|0|||
147120965|NCT06083493|530607075|FG000|Overall Study|Insufficient baseline performance|0|||
147120966|NCT06083493|530607076|FG001|Overall Study|Insufficient baseline performance|1|||
147120967|NCT04034056|530607077|FG000|Overall Study|Withdrawal by Subject|2|||
147120968|NCT04034056|530607077|FG000|Overall Study|Reason Not Specified|13|||
147120969|NCT04034056|530607077|FG000|Overall Study|Adverse Event|56|||
147120970|NCT03225989|530607078|FG000|Group 1: LOAd703 Dose Level 5x10e10VP|Progressive Disease|2|||
147120971|NCT03225989|530607079|FG001|Group 1: LOAd703 Dose Level 5x10e10VP|Progressive Disease|0|||
147120972|NCT03225989|530607080|FG002|Group 1: LOAd703 Dose Level 5x10e10VP|Progressive Disease|0|||
147120973|NCT03225989|530607078|FG000|Group 2: LOAd703 Dose Level 1x10e11 VP|Adverse Event|0|||
147120974|NCT03225989|530607079|FG001|Group 2: LOAd703 Dose Level 1x10e11 VP|Adverse Event|1|||
147120975|NCT03225989|530607080|FG002|Group 2: LOAd703 Dose Level 1x10e11 VP|Adverse Event|0|||
147120976|NCT03225989|530607078|FG000|Group 2: LOAd703 Dose Level 1x10e11 VP|Death|0|||
147120977|NCT03225989|530607079|FG001|Group 2: LOAd703 Dose Level 1x10e11 VP|Death|1|||
147120978|NCT03225989|530607080|FG002|Group 2: LOAd703 Dose Level 1x10e11 VP|Death|0|||
147120979|NCT03225989|530607078|FG000|Group 2: LOAd703 Dose Level 1x10e11 VP|Progressive Disease|0|||
147120980|NCT03225989|530607079|FG001|Group 2: LOAd703 Dose Level 1x10e11 VP|Progressive Disease|7|||
147120981|NCT03225989|530607080|FG002|Group 2: LOAd703 Dose Level 1x10e11 VP|Progressive Disease|0|||
147120982|NCT03225989|530607078|FG000|Group 2: LOAd703 Dose Level 1x10e11 VP|Other Reason|0|||
147120983|NCT03225989|530607079|FG001|Group 2: LOAd703 Dose Level 1x10e11 VP|Other Reason|1|||
147120984|NCT03225989|530607080|FG002|Group 2: LOAd703 Dose Level 1x10e11 VP|Other Reason|0|||
147120985|NCT03225989|530607078|FG000|Group 3: LOAd703 Dose Level 5x10e11VP|Withdrawal by Subject|0|||
147120986|NCT03225989|530607079|FG001|Group 3: LOAd703 Dose Level 5x10e11VP|Withdrawal by Subject|0|||
147120987|NCT03225989|530607080|FG002|Group 3: LOAd703 Dose Level 5x10e11VP|Withdrawal by Subject|1|||
147120988|NCT03225989|530607078|FG000|Group 3: LOAd703 Dose Level 5x10e11VP|Adverse Event|0|||
147120989|NCT03225989|530607079|FG001|Group 3: LOAd703 Dose Level 5x10e11VP|Adverse Event|0|||
147120990|NCT03225989|530607080|FG002|Group 3: LOAd703 Dose Level 5x10e11VP|Adverse Event|2|||
147120991|NCT03225989|530607078|FG000|Group 3: LOAd703 Dose Level 5x10e11VP|Death|0|||
147120992|NCT03225989|530607079|FG001|Group 3: LOAd703 Dose Level 5x10e11VP|Death|0|||
147120993|NCT03225989|530607080|FG002|Group 3: LOAd703 Dose Level 5x10e11VP|Death|4|||
147120994|NCT03225989|530607078|FG000|Group 3: LOAd703 Dose Level 5x10e11VP|Progressive Disease|0|||
147120995|NCT03225989|530607079|FG001|Group 3: LOAd703 Dose Level 5x10e11VP|Progressive Disease|0|||
147120996|NCT03225989|530607080|FG002|Group 3: LOAd703 Dose Level 5x10e11VP|Progressive Disease|16|||
147120997|NCT03225989|530607078|FG000|Group 3: LOAd703 Dose Level 5x10e11VP|Physician Decision|0|||
147120998|NCT03225989|530607079|FG001|Group 3: LOAd703 Dose Level 5x10e11VP|Physician Decision|0|||
147120999|NCT03225989|530607080|FG002|Group 3: LOAd703 Dose Level 5x10e11VP|Physician Decision|1|||
147121000|NCT03225989|530607078|FG000|Group 3: LOAd703 Dose Level 5x10e11VP|Not Exposed to LOAd703|0|||
147121001|NCT03225989|530607079|FG001|Group 3: LOAd703 Dose Level 5x10e11VP|Not Exposed to LOAd703|0|||
147121002|NCT03225989|530607080|FG002|Group 3: LOAd703 Dose Level 5x10e11VP|Not Exposed to LOAd703|1|||
147121003|NCT03225989|530607078|FG000|Group 3: LOAd703 Dose Level 5x10e11VP|Other Reason|0|||
147121004|NCT03225989|530607079|FG001|Group 3: LOAd703 Dose Level 5x10e11VP|Other Reason|0|||
147121005|NCT03225989|530607080|FG002|Group 3: LOAd703 Dose Level 5x10e11VP|Other Reason|1|||
147121006|NCT03093870|530607081|FG000|Overall Study|Withdrawal by Subject|2|||
147121007|NCT03093870|530607082|FG001|Overall Study|Withdrawal by Subject|6|||
147121008|NCT03093870|530607083|FG002|Overall Study|Withdrawal by Subject|5|||
147121009|NCT03093870|530607081|FG000|Overall Study|Death|1|||
147121010|NCT03093870|530607082|FG001|Overall Study|Death|35|||
147121011|NCT03093870|530607083|FG002|Overall Study|Death|35|||
147121012|NCT03093870|530607081|FG000|Overall Study|Radiographic disease progression|10|||
147121013|NCT03093870|530607082|FG001|Overall Study|Radiographic disease progression|0|||
147121014|NCT03093870|530607083|FG002|Overall Study|Radiographic disease progression|0|||
147121015|NCT03093870|530607081|FG000|Overall Study|Clinical disease progression|1|||
147121016|NCT03093870|530607082|FG001|Overall Study|Clinical disease progression|0|||
147121017|NCT03093870|530607083|FG002|Overall Study|Clinical disease progression|0|||
147121018|NCT03093870|530607081|FG000|Overall Study|Physician Decision|2|||
147121019|NCT03093870|530607082|FG001|Overall Study|Physician Decision|0|||
147650932|NCT02757352|532544541|FG004|Follow-Up Period|Adverse Event|0|||
147121020|NCT03093870|530607083|FG002|Overall Study|Physician Decision|0|||
147121021|NCT03093870|530607081|FG000|Overall Study|Adverse Event|7|||
147121022|NCT03093870|530607082|FG001|Overall Study|Adverse Event|0|||
147121023|NCT03093870|530607083|FG002|Overall Study|Adverse Event|0|||
147121024|NCT03093870|530607081|FG000|Overall Study|Patient withdrew from treatment voluntarily due to intermittent constipation and anorexia|1|||
147121025|NCT03093870|530607082|FG001|Overall Study|Patient withdrew from treatment voluntarily due to intermittent constipation and anorexia|0|||
147121026|NCT03093870|530607083|FG002|Overall Study|Patient withdrew from treatment voluntarily due to intermittent constipation and anorexia|0|||
147121027|NCT03093870|530607081|FG000|Overall Study|Lost to Follow-up|0|||
147121028|NCT03093870|530607082|FG001|Overall Study|Lost to Follow-up|0|||
147121029|NCT03093870|530607083|FG002|Overall Study|Lost to Follow-up|1|||
147121030|NCT00601107|530607084|FG000|Overall Study|Adverse Event|0|||
147121031|NCT00601107|530607085|FG001|Overall Study|Adverse Event|1|||
147121032|NCT00601107|530607086|FG002|Overall Study|Adverse Event|3|||
147121033|NCT00601107|530607087|FG003|Overall Study|Adverse Event|0|||
147121034|NCT00601107|530607084|FG000|Overall Study|Withdrawal by Subject|5|||
147121035|NCT00601107|530607085|FG001|Overall Study|Withdrawal by Subject|4|||
147121036|NCT00601107|530607086|FG002|Overall Study|Withdrawal by Subject|7|||
147121037|NCT00601107|530607087|FG003|Overall Study|Withdrawal by Subject|4|||
147121038|NCT00601107|530607084|FG000|Overall Study|Lost to Follow-up|3|||
147121039|NCT00601107|530607085|FG001|Overall Study|Lost to Follow-up|3|||
147121040|NCT00601107|530607086|FG002|Overall Study|Lost to Follow-up|0|||
147121041|NCT00601107|530607087|FG003|Overall Study|Lost to Follow-up|3|||
147121042|NCT00601107|530607084|FG000|Overall Study|Serum Calcium >11.5 milligram/deciliter|0|||
147121043|NCT00601107|530607085|FG001|Overall Study|Serum Calcium >11.5 milligram/deciliter|0|||
147121044|NCT00601107|530607086|FG002|Overall Study|Serum Calcium >11.5 milligram/deciliter|0|||
147121045|NCT00601107|530607087|FG003|Overall Study|Serum Calcium >11.5 milligram/deciliter|1|||
147121046|NCT00601107|530607084|FG000|Overall Study|Worsening of Psoriasis|4|||
147121047|NCT00601107|530607085|FG001|Overall Study|Worsening of Psoriasis|1|||
147121048|NCT00601107|530607086|FG002|Overall Study|Worsening of Psoriasis|1|||
147121049|NCT00601107|530607087|FG003|Overall Study|Worsening of Psoriasis|4|||
147121050|NCT00601107|530607084|FG000|Overall Study|Undefined|1|||
147121051|NCT00601107|530607085|FG001|Overall Study|Undefined|0|||
147121052|NCT00601107|530607086|FG002|Overall Study|Undefined|1|||
147121053|NCT00601107|530607087|FG003|Overall Study|Undefined|0|||
147121054|NCT01362270|530607088|FG000|Overall Study|Withdrawal by Subject|1|||
147121055|NCT01362270|530607089|FG001|Overall Study|Withdrawal by Subject|0|||
147121056|NCT01362270|530607088|FG000|Overall Study|Met exclusion criteria after 1st session|0|||
147121057|NCT01362270|530607089|FG001|Overall Study|Met exclusion criteria after 1st session|1|||
147121058|NCT01362270|530607088|FG000|Overall Study|Met excl. criteria before 1st session|1|||
147121059|NCT01362270|530607089|FG001|Overall Study|Met excl. criteria before 1st session|1|||
147121060|NCT02318277|530607090|FG000|Overall Study|Physician Decision|0|||
147121061|NCT02318277|530607091|FG001|Overall Study|Physician Decision|0|||
147121062|NCT02318277|530607092|FG002|Overall Study|Physician Decision|0|||
147121063|NCT02318277|530607093|FG003|Overall Study|Physician Decision|0|||
147121064|NCT02318277|530607094|FG004|Overall Study|Physician Decision|0|||
147121065|NCT02318277|530607095|FG005|Overall Study|Physician Decision|0|||
147121066|NCT02318277|530607096|FG006|Overall Study|Physician Decision|0|||
147121067|NCT02318277|530607097|FG007|Overall Study|Physician Decision|1|||
147121068|NCT02318277|530607090|FG000|Overall Study|Other|0|||
147121069|NCT02318277|530607091|FG001|Overall Study|Other|0|||
147121070|NCT02318277|530607092|FG002|Overall Study|Other|0|||
147313702|NCT05033080|531315226|FG001|Overall Study|Withdrawal of consent (not due to AE)|5|||
147313703|NCT05033080|531315225|FG000|Overall Study|Lost to Follow-up|1|||
147313704|NCT05033080|531315226|FG001|Overall Study|Lost to Follow-up|0|||
147313705|NCT05033080|531315225|FG000|Overall Study|Other non-compliance|0|||
147650933|NCT02757352|532544542|FG005|Follow-Up Period|Adverse Event|0|||
147650934|NCT02757352|532544543|FG006|Follow-Up Period|Adverse Event|1|||
147121071|NCT02318277|530607093|FG003|Overall Study|Other|0|||
147121072|NCT02318277|530607094|FG004|Overall Study|Other|0|||
147121073|NCT02318277|530607095|FG005|Overall Study|Other|0|||
147121074|NCT02318277|530607096|FG006|Overall Study|Other|1|||
147121075|NCT02318277|530607097|FG007|Overall Study|Other|0|||
147121076|NCT02318277|530607090|FG000|Overall Study|Withdrawal by Subject|0|||
147121077|NCT02318277|530607091|FG001|Overall Study|Withdrawal by Subject|0|||
147121078|NCT02318277|530607092|FG002|Overall Study|Withdrawal by Subject|1|||
147121079|NCT02318277|530607093|FG003|Overall Study|Withdrawal by Subject|0|||
147121080|NCT02318277|530607094|FG004|Overall Study|Withdrawal by Subject|1|||
147121081|NCT02318277|530607095|FG005|Overall Study|Withdrawal by Subject|1|||
147121082|NCT02318277|530607096|FG006|Overall Study|Withdrawal by Subject|6|||
147121083|NCT02318277|530607097|FG007|Overall Study|Withdrawal by Subject|14|||
147121084|NCT02318277|530607090|FG000|Overall Study|Participant trial terminated by sponsor|0|||
147121085|NCT02318277|530607091|FG001|Overall Study|Participant trial terminated by sponsor|0|||
147121086|NCT02318277|530607092|FG002|Overall Study|Participant trial terminated by sponsor|1|||
147121087|NCT02318277|530607093|FG003|Overall Study|Participant trial terminated by sponsor|0|||
147313706|NCT05033080|531315226|FG001|Overall Study|Other non-compliance|1|||
147121088|NCT02318277|530607094|FG004|Overall Study|Participant trial terminated by sponsor|1|||
147121089|NCT02318277|530607095|FG005|Overall Study|Participant trial terminated by sponsor|2|||
147121090|NCT02318277|530607096|FG006|Overall Study|Participant trial terminated by sponsor|5|||
147121091|NCT02318277|530607097|FG007|Overall Study|Participant trial terminated by sponsor|16|||
147121092|NCT02318277|530607090|FG000|Overall Study|Lost to Follow-up|1|||
147121093|NCT02318277|530607091|FG001|Overall Study|Lost to Follow-up|0|||
147121094|NCT02318277|530607092|FG002|Overall Study|Lost to Follow-up|1|||
147121095|NCT02318277|530607093|FG003|Overall Study|Lost to Follow-up|0|||
147121096|NCT02318277|530607094|FG004|Overall Study|Lost to Follow-up|0|||
147121097|NCT02318277|530607095|FG005|Overall Study|Lost to Follow-up|0|||
147121098|NCT02318277|530607096|FG006|Overall Study|Lost to Follow-up|3|||
147121099|NCT02318277|530607097|FG007|Overall Study|Lost to Follow-up|4|||
147121100|NCT02318277|530607090|FG000|Overall Study|Death|5|||
147121101|NCT02318277|530607091|FG001|Overall Study|Death|3|||
147121102|NCT02318277|530607092|FG002|Overall Study|Death|1|||
147121103|NCT02318277|530607093|FG003|Overall Study|Death|4|||
147121104|NCT02318277|530607094|FG004|Overall Study|Death|6|||
147121105|NCT02318277|530607095|FG005|Overall Study|Death|5|||
147121106|NCT02318277|530607096|FG006|Overall Study|Death|34|||
147121107|NCT02318277|530607097|FG007|Overall Study|Death|58|||
147121108|NCT02318277|530607090|FG000|Overall Study|Transitioned to Hospice|0|||
147121109|NCT02318277|530607091|FG001|Overall Study|Transitioned to Hospice|0|||
147121110|NCT02318277|530607092|FG002|Overall Study|Transitioned to Hospice|0|||
147121111|NCT02318277|530607093|FG003|Overall Study|Transitioned to Hospice|0|||
147121112|NCT02318277|530607094|FG004|Overall Study|Transitioned to Hospice|0|||
147121113|NCT02318277|530607095|FG005|Overall Study|Transitioned to Hospice|1|||
147121114|NCT02318277|530607096|FG006|Overall Study|Transitioned to Hospice|0|||
147121115|NCT02318277|530607097|FG007|Overall Study|Transitioned to Hospice|0|||
147121116|NCT02453191|530607098|FG000|Overall Study|Withdrawal by Subject|1|||
147121117|NCT03364686|530607099|FG000|Overall Study|Physician Decision|2|||
147121118|NCT01520714|530607100|FG000|Overall Study|Protocol Violation|0|||
147121119|NCT01520714|530607101|FG001|Overall Study|Protocol Violation|3|||
147121120|NCT01520714|530607100|FG000|Overall Study|Adverse Event|0|||
147121121|NCT01520714|530607101|FG001|Overall Study|Adverse Event|2|||
147121122|NCT01520714|530607100|FG000|Overall Study|Lack of Efficacy|0|||
147121123|NCT01520714|530607101|FG001|Overall Study|Lack of Efficacy|1|||
147121124|NCT00407030|530607106|FG000|Main Period - 8 to 20 Weeks|Adverse Event|2|||
147121125|NCT00407030|530607107|FG001|Main Period - 8 to 20 Weeks|Adverse Event|1|||
147121126|NCT00407030|530607108|FG002|Main Period - 8 to 20 Weeks|Adverse Event|0|||
147121127|NCT00407030|530607106|FG000|Main Period - 8 to 20 Weeks|Lack of Efficacy|0|||
147121128|NCT00407030|530607107|FG001|Main Period - 8 to 20 Weeks|Lack of Efficacy|0|||
147121129|NCT00407030|530607108|FG002|Main Period - 8 to 20 Weeks|Lack of Efficacy|3|||
147121130|NCT00407030|530607106|FG000|Main Period - 8 to 20 Weeks|Lost to Follow-up|1|||
147121131|NCT00407030|530607107|FG001|Main Period - 8 to 20 Weeks|Lost to Follow-up|1|||
147121132|NCT00407030|530607108|FG002|Main Period - 8 to 20 Weeks|Lost to Follow-up|1|||
147121133|NCT00407030|530607106|FG000|Main Period - 8 to 20 Weeks|Consent Withdrawn|1|||
147121134|NCT00407030|530607107|FG001|Main Period - 8 to 20 Weeks|Consent Withdrawn|1|||
147121135|NCT00407030|530607108|FG002|Main Period - 8 to 20 Weeks|Consent Withdrawn|1|||
147121136|NCT00407030|530607106|FG000|Main Period - 8 to 20 Weeks|Withdrawal Criteria Occurred|0|||
147121137|NCT00407030|530607107|FG001|Main Period - 8 to 20 Weeks|Withdrawal Criteria Occurred|0|||
147121138|NCT00407030|530607108|FG002|Main Period - 8 to 20 Weeks|Withdrawal Criteria Occurred|1|||
147121139|NCT00407030|530607106|FG000|Main Period - 8 to 20 Weeks|Patient Decision|1|||
147121140|NCT00407030|530607107|FG001|Main Period - 8 to 20 Weeks|Patient Decision|0|||
147121141|NCT00407030|530607108|FG002|Main Period - 8 to 20 Weeks|Patient Decision|0|||
147121142|NCT00407030|530607106|FG000|Extension Period - up to 68 Weeks|Withdrawal Criteria Occurred|4|||
147121143|NCT00407030|530607107|FG001|Extension Period - up to 68 Weeks|Withdrawal Criteria Occurred|5|||
147121144|NCT00407030|530607108|FG002|Extension Period - up to 68 Weeks|Withdrawal Criteria Occurred|0|||
147121145|NCT00407030|530607106|FG000|Extension Period - up to 68 Weeks|Lack of Efficacy|11|||
147121146|NCT00407030|530607107|FG001|Extension Period - up to 68 Weeks|Lack of Efficacy|11|||
147121147|NCT00407030|530607108|FG002|Extension Period - up to 68 Weeks|Lack of Efficacy|0|||
147121148|NCT00407030|530607106|FG000|Extension Period - up to 68 Weeks|Adverse Event|1|||
147568031|NCT00473330|532238404|FG002|Open-label Extension Through Month 48|Adverse Event|2|||
147568032|NCT00473330|532238402|FG000|Open-label Extension Through Month 48|Death|2|||
147121149|NCT00407030|530607107|FG001|Extension Period - up to 68 Weeks|Adverse Event|0|||
147121150|NCT00407030|530607108|FG002|Extension Period - up to 68 Weeks|Adverse Event|0|||
147568033|NCT00473330|532238403|FG001|Open-label Extension Through Month 48|Death|0|||
147121151|NCT00407030|530607106|FG000|Extension Period - up to 68 Weeks|Consent Withdrawn|4|||
147121152|NCT00407030|530607107|FG001|Extension Period - up to 68 Weeks|Consent Withdrawn|4|||
147121153|NCT00407030|530607108|FG002|Extension Period - up to 68 Weeks|Consent Withdrawn|0|||
147121154|NCT00407030|530607106|FG000|Extension Period - up to 68 Weeks|Lost to Follow-up|5|||
147121155|NCT00407030|530607107|FG001|Extension Period - up to 68 Weeks|Lost to Follow-up|5|||
147121156|NCT00407030|530607108|FG002|Extension Period - up to 68 Weeks|Lost to Follow-up|0|||
147232009|NCT01543698|531023013|FG007|Phase 2|Disease progression|0|||
147121157|NCT00407030|530607106|FG000|Extension Period - up to 68 Weeks|Patient Decision|1|||
147121158|NCT00407030|530607107|FG001|Extension Period - up to 68 Weeks|Patient Decision|2|||
147121159|NCT00407030|530607108|FG002|Extension Period - up to 68 Weeks|Patient Decision|0|||
147121160|NCT00407030|530607106|FG000|Extension Period - up to 68 Weeks|Physician Decision|1|||
147121161|NCT00407030|530607107|FG001|Extension Period - up to 68 Weeks|Physician Decision|2|||
147121162|NCT00407030|530607108|FG002|Extension Period - up to 68 Weeks|Physician Decision|0|||
147121163|NCT01489358|530607109|FG000|Overall Study|Lost to Follow-up|0|||
147121164|NCT01489358|530607110|FG001|Overall Study|Lost to Follow-up|0|||
147121165|NCT01489358|530607111|FG002|Overall Study|Lost to Follow-up|2|||
147121166|NCT03722030|530607112|FG000|Overall Study|Withdrawal by Subject|1|||
147121167|NCT03722030|530607113|FG001|Overall Study|Withdrawal by Subject|0|||
147121168|NCT00736476|530607114|FG000|Overall Study|Adverse Event|1|||
147121169|NCT00736476|530607115|FG001|Overall Study|Adverse Event|0|||
147121170|NCT03518203|530607118|FG000|Overall Study|The participant died on study prior to receiving 4 doses and was not evaluable.|1|||
147121171|NCT03518203|530607118|FG000|Overall Study|Relapsed with primary malignancy within 6 months of TMA diagnosis making participant unevaluable.|1|||
147121172|NCT00345592|530607119|FG000|Overall Study|Death|14|||
147121173|NCT00345592|530607120|FG001|Overall Study|Death|16|||
147121174|NCT00345592|530607119|FG000|Overall Study|Withdrawal by Subject|11|||
147121175|NCT00345592|530607120|FG001|Overall Study|Withdrawal by Subject|8|||
147121176|NCT04000724|530607122|FG000|Overall Study|Withdrawal by Subject|5|||
147121177|NCT04000724|530607123|FG001|Overall Study|Withdrawal by Subject|3|||
147121178|NCT04000724|530607124|FG002|Overall Study|Withdrawal by Subject|4|||
147121179|NCT04000724|530607122|FG000|Overall Study|Lost to Follow-up|11|||
147121180|NCT04000724|530607123|FG001|Overall Study|Lost to Follow-up|7|||
147121181|NCT04000724|530607124|FG002|Overall Study|Lost to Follow-up|13|||
147121182|NCT02366130|530607125|FG000|Overall Study|Withdrawal by Subject|3|||
147121183|NCT02366130|530607125|FG000|Overall Study|Ineligible|6|||
147121184|NCT01065766|530607126|FG000|Overall Study|Assessed before the contracted date|1|||
147121185|NCT01065766|530607126|FG000|Overall Study|Contraindication to administration|6|||
147121186|NCT01065766|530607126|FG000|Overall Study|Violated dosage/administration|25|||
147121187|NCT04223687|530607127|FG000|Overall Study|Missing primary outcome|1|||
147121188|NCT04223687|530607128|FG001|Overall Study|Missing primary outcome|0|||
147121189|NCT01608308|530607129|FG000|Overall Study|pretreatment medical and billing reasons|0|||
147121190|NCT01608308|530607130|FG001|Overall Study|pretreatment medical and billing reasons|2|||
147121191|NCT00286455|530607132|FG000|Overall Study|Hyperglycemia rescue|19|||
147121192|NCT00286455|530607133|FG001|Overall Study|Hyperglycemia rescue|13|||
147121193|NCT00286455|530607134|FG002|Overall Study|Hyperglycemia rescue|10|||
147121194|NCT00286455|530607132|FG000|Overall Study|Adverse Event|1|||
147121195|NCT00286455|530607133|FG001|Overall Study|Adverse Event|3|||
147121196|NCT00286455|530607134|FG002|Overall Study|Adverse Event|2|||
147121197|NCT00286455|530607132|FG000|Overall Study|Lost to Follow-up|0|||
147121198|NCT00286455|530607133|FG001|Overall Study|Lost to Follow-up|3|||
147232010|NCT01543698|531023014|FG008|Phase 2|Disease progression|0|||
147232011|NCT01543698|531023015|FG009|Phase 2|Disease progression|0|||
147232012|NCT01543698|531023016|FG010|Phase 2|Disease progression|0|||
147232013|NCT01543698|531023017|FG011|Phase 2|Disease progression|10|||
147232014|NCT01543698|531023018|FG012|Phase 2|Disease progression|21|||
147232015|NCT01543698|531023019|FG013|Phase 2|Disease progression|30|||
147232016|NCT01543698|531023020|FG014|Phase 2|Disease progression|25|||
147232017|NCT01543698|531023006|FG000|Phase 2|Death|0|||
147232018|NCT01543698|531023007|FG001|Phase 2|Death|0|||
147232019|NCT01543698|531023008|FG002|Phase 2|Death|0|||
147232020|NCT01543698|531023009|FG003|Phase 2|Death|0|||
147232021|NCT01543698|531023010|FG004|Phase 2|Death|0|||
147232022|NCT01543698|531023011|FG005|Phase 2|Death|0|||
147232023|NCT01543698|531023012|FG006|Phase 2|Death|0|||
147232024|NCT01543698|531023013|FG007|Phase 2|Death|0|||
147232025|NCT01543698|531023014|FG008|Phase 2|Death|0|||
147232026|NCT01543698|531023015|FG009|Phase 2|Death|0|||
147232027|NCT01543698|531023016|FG010|Phase 2|Death|0|||
147232028|NCT01543698|531023017|FG011|Phase 2|Death|0|||
147232029|NCT01543698|531023018|FG012|Phase 2|Death|1|||
147232030|NCT01543698|531023019|FG013|Phase 2|Death|1|||
147313707|NCT05033080|531315225|FG000|Overall Study|Physician Decision|0|||
147313708|NCT05033080|531315226|FG001|Overall Study|Physician Decision|1|||
147121199|NCT00286455|530607134|FG002|Overall Study|Lost to Follow-up|3|||
147232031|NCT01543698|531023020|FG014|Phase 2|Death|1|||
147232032|NCT01543698|531023006|FG000|Phase 2|Administrative problems|0|||
147232033|NCT01543698|531023007|FG001|Phase 2|Administrative problems|0|||
147232034|NCT01543698|531023008|FG002|Phase 2|Administrative problems|0|||
147232035|NCT01543698|531023009|FG003|Phase 2|Administrative problems|0|||
147650935|NCT02757352|532544544|FG007|Follow-Up Period|Adverse Event|0|||
147121200|NCT00286455|530607132|FG000|Overall Study|Physician Decision|3|||
147121201|NCT00286455|530607133|FG001|Overall Study|Physician Decision|0|||
147121202|NCT00286455|530607134|FG002|Overall Study|Physician Decision|2|||
147232036|NCT01543698|531023010|FG004|Phase 2|Administrative problems|0|||
147232037|NCT01543698|531023011|FG005|Phase 2|Administrative problems|0|||
147232038|NCT01543698|531023012|FG006|Phase 2|Administrative problems|0|||
147232039|NCT01543698|531023013|FG007|Phase 2|Administrative problems|0|||
147232040|NCT01543698|531023014|FG008|Phase 2|Administrative problems|0|||
147232041|NCT01543698|531023015|FG009|Phase 2|Administrative problems|0|||
147232042|NCT01543698|531023016|FG010|Phase 2|Administrative problems|0|||
147232043|NCT01543698|531023017|FG011|Phase 2|Administrative problems|0|||
147232044|NCT01543698|531023018|FG012|Phase 2|Administrative problems|0|||
147232045|NCT01543698|531023019|FG013|Phase 2|Administrative problems|3|||
147232046|NCT01543698|531023020|FG014|Phase 2|Administrative problems|1|||
147232047|NCT01543698|531023006|FG000|Phase 2|Withdrawal by Subject|0|||
147232048|NCT01543698|531023007|FG001|Phase 2|Withdrawal by Subject|0|||
147232049|NCT01543698|531023008|FG002|Phase 2|Withdrawal by Subject|0|||
147232050|NCT01543698|531023009|FG003|Phase 2|Withdrawal by Subject|0|||
147232051|NCT01543698|531023010|FG004|Phase 2|Withdrawal by Subject|0|||
147232052|NCT01543698|531023011|FG005|Phase 2|Withdrawal by Subject|0|||
147232053|NCT01543698|531023012|FG006|Phase 2|Withdrawal by Subject|0|||
147232054|NCT01543698|531023013|FG007|Phase 2|Withdrawal by Subject|0|||
147232055|NCT01543698|531023014|FG008|Phase 2|Withdrawal by Subject|0|||
147232056|NCT01543698|531023015|FG009|Phase 2|Withdrawal by Subject|0|||
147232057|NCT01543698|531023016|FG010|Phase 2|Withdrawal by Subject|0|||
147232058|NCT01543698|531023017|FG011|Phase 2|Withdrawal by Subject|0|||
147232059|NCT01543698|531023018|FG012|Phase 2|Withdrawal by Subject|0|||
147232060|NCT01543698|531023019|FG013|Phase 2|Withdrawal by Subject|3|||
147232061|NCT01543698|531023020|FG014|Phase 2|Withdrawal by Subject|1|||
147232062|NCT01543698|531023006|FG000|Phase 2|Adverse Event|0|||
147121203|NCT00286455|530607132|FG000|Overall Study|Protocol Violation|1|||
147121204|NCT00286455|530607133|FG001|Overall Study|Protocol Violation|1|||
147232063|NCT01543698|531023007|FG001|Phase 2|Adverse Event|0|||
147232064|NCT01543698|531023008|FG002|Phase 2|Adverse Event|0|||
147568034|NCT00473330|532238404|FG002|Open-label Extension Through Month 48|Death|0|||
147568035|NCT00473330|532238402|FG000|Open-label Extension Through Month 48|Lost to Follow-up|1|||
147568036|NCT00473330|532238403|FG001|Open-label Extension Through Month 48|Lost to Follow-up|0|||
147568037|NCT00473330|532238404|FG002|Open-label Extension Through Month 48|Lost to Follow-up|2|||
147568038|NCT00473330|532238402|FG000|Open-label Extension Through Month 48|Physician's Decision|2|||
147568039|NCT00473330|532238403|FG001|Open-label Extension Through Month 48|Physician's Decision|1|||
147121205|NCT00286455|530607134|FG002|Overall Study|Protocol Violation|0|||
147121206|NCT00286455|530607132|FG000|Overall Study|Participant Non-compliance|1|||
147121207|NCT00286455|530607133|FG001|Overall Study|Participant Non-compliance|0|||
147121208|NCT00286455|530607134|FG002|Overall Study|Participant Non-compliance|0|||
147121209|NCT00286455|530607132|FG000|Overall Study|Withdrawal by Subject|0|||
147121210|NCT00286455|530607133|FG001|Overall Study|Withdrawal by Subject|8|||
147121211|NCT00286455|530607134|FG002|Overall Study|Withdrawal by Subject|7|||
147121212|NCT04985682|530608823|FG000|Overall Study|Withdrawal by Subject|1|||
147121213|NCT03016403|530608828|FG000|Baseline|Death|5|||
147121214|NCT03016403|530608829|FG001|Baseline|Death|8|||
147121215|NCT03016403|530608830|FG002|Baseline|Death|1|||
147121216|NCT03016403|530608831|FG003|Baseline|Death|0|||
147121217|NCT03016403|530608828|FG000|Baseline|Withdrawal by Subject|2|||
147121218|NCT03016403|530608829|FG001|Baseline|Withdrawal by Subject|8|||
147121219|NCT03016403|530608830|FG002|Baseline|Withdrawal by Subject|4|||
147121220|NCT03016403|530608831|FG003|Baseline|Withdrawal by Subject|10|||
147568040|NCT00473330|532238404|FG002|Open-label Extension Through Month 48|Physician's Decision|3|||
147568041|NCT00473330|532238402|FG000|Open-label Extension Through Month 48|Subject's Decision|1|||
147568042|NCT00473330|532238403|FG001|Open-label Extension Through Month 48|Subject's Decision|3|||
147568043|NCT00473330|532238404|FG002|Open-label Extension Through Month 48|Subject's Decision|3|||
147121221|NCT03016403|530608828|FG000|Baseline|Lost to Follow-up|9|||
147121222|NCT03016403|530608829|FG001|Baseline|Lost to Follow-up|11|||
147232065|NCT01543698|531023009|FG003|Phase 2|Adverse Event|0|||
147232066|NCT01543698|531023010|FG004|Phase 2|Adverse Event|0|||
147232067|NCT01543698|531023011|FG005|Phase 2|Adverse Event|0|||
147232068|NCT01543698|531023012|FG006|Phase 2|Adverse Event|0|||
147232069|NCT01543698|531023013|FG007|Phase 2|Adverse Event|0|||
147232070|NCT01543698|531023014|FG008|Phase 2|Adverse Event|0|||
147232071|NCT01543698|531023015|FG009|Phase 2|Adverse Event|0|||
147232072|NCT01543698|531023016|FG010|Phase 2|Adverse Event|0|||
147232073|NCT01543698|531023017|FG011|Phase 2|Adverse Event|1|||
147232074|NCT01543698|531023018|FG012|Phase 2|Adverse Event|3|||
147232075|NCT01543698|531023019|FG013|Phase 2|Adverse Event|5|||
147232076|NCT01543698|531023020|FG014|Phase 2|Adverse Event|14|||
147232077|NCT02742441|531023021|FG000|Overall Study|Lost to Follow-up|4|||
147232078|NCT02742441|531023022|FG001|Overall Study|Lost to Follow-up|4|||
147568044|NCT00473330|532238402|FG000|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|18|||
147232079|NCT02742441|531023021|FG000|Overall Study|Withdrawal by Subject|2|||
147232080|NCT02742441|531023022|FG001|Overall Study|Withdrawal by Subject|2|||
147121223|NCT03016403|530608830|FG002|Baseline|Lost to Follow-up|6|||
147121224|NCT03016403|530608831|FG003|Baseline|Lost to Follow-up|24|||
147121225|NCT03016403|530608828|FG000|6-week Follow-up|Death|1|||
147121226|NCT03016403|530608829|FG001|6-week Follow-up|Death|4|||
147232081|NCT02742441|531023021|FG000|Overall Study|Adverse Event|0|||
147232082|NCT02742441|531023022|FG001|Overall Study|Adverse Event|2|||
147232083|NCT02422303|531023027|FG000|Overall Study|Lost to Follow-up|1|||
147121227|NCT03016403|530608830|FG002|6-week Follow-up|Death|0|||
147121228|NCT03016403|530608831|FG003|6-week Follow-up|Death|0|||
147121229|NCT03016403|530608828|FG000|6-week Follow-up|Lost to Follow-up|2|||
147121230|NCT03016403|530608829|FG001|6-week Follow-up|Lost to Follow-up|7|||
147121231|NCT03016403|530608830|FG002|6-week Follow-up|Lost to Follow-up|4|||
147121232|NCT03016403|530608831|FG003|6-week Follow-up|Lost to Follow-up|8|||
147121233|NCT03016403|530608828|FG000|6-week Follow-up|Withdrawal by Subject|0|||
147121234|NCT03016403|530608829|FG001|6-week Follow-up|Withdrawal by Subject|2|||
147121235|NCT03016403|530608830|FG002|6-week Follow-up|Withdrawal by Subject|0|||
147121236|NCT03016403|530608831|FG003|6-week Follow-up|Withdrawal by Subject|1|||
147121237|NCT03016403|530608828|FG000|3-month Follow-up and 6-month Follow-up|Death|6|||
147121238|NCT03016403|530608829|FG001|3-month Follow-up and 6-month Follow-up|Death|4|||
147121239|NCT03016403|530608830|FG002|3-month Follow-up and 6-month Follow-up|Death|0|||
147232084|NCT02422303|531023028|FG001|Overall Study|Lost to Follow-up|1|||
147232085|NCT01364649|531023032|FG000|Overall Study|Pretreatment Event or Adverse Event|20|||
147232086|NCT01364649|531023033|FG001|Overall Study|Pretreatment Event or Adverse Event|14|||
147232087|NCT01364649|531023032|FG000|Overall Study|Lack of Efficacy|6|||
147232088|NCT01364649|531023033|FG001|Overall Study|Lack of Efficacy|0|||
147232089|NCT01364649|531023032|FG000|Overall Study|Non-compliance with Investigational Drug|1|||
147568045|NCT00473330|532238403|FG001|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|15|||
147568046|NCT00473330|532238404|FG002|Open-label Extension Through Month 48|Sponsor's Decision to Terminate Study|16|||
147568047|NCT00473330|532238402|FG000|Open-label Extension Through Month 48|Subject Non-compliance|2|||
147568048|NCT00473330|532238403|FG001|Open-label Extension Through Month 48|Subject Non-compliance|1|||
147568049|NCT00473330|532238404|FG002|Open-label Extension Through Month 48|Subject Non-compliance|0|||
147568050|NCT00473330|532238402|FG000|Open-label Extension Through Month 48|Subject Required Other Therapy|0|||
147568051|NCT00473330|532238403|FG001|Open-label Extension Through Month 48|Subject Required Other Therapy|0|||
147568052|NCT00473330|532238404|FG002|Open-label Extension Through Month 48|Subject Required Other Therapy|1|||
147568053|NCT00473330|532238402|FG000|Open-label Extension Through Month 60|Adverse Event|0|||
147568054|NCT00473330|532238403|FG001|Open-label Extension Through Month 60|Adverse Event|0|||
147568055|NCT00473330|532238404|FG002|Open-label Extension Through Month 60|Adverse Event|2|||
147568056|NCT00473330|532238402|FG000|Open-label Extension Through Month 60|Death|2|||
147568057|NCT00473330|532238403|FG001|Open-label Extension Through Month 60|Death|2|||
147568058|NCT00473330|532238404|FG002|Open-label Extension Through Month 60|Death|1|||
147568059|NCT00473330|532238402|FG000|Open-label Extension Through Month 60|Lost to Follow-up|3|||
147568060|NCT00473330|532238403|FG001|Open-label Extension Through Month 60|Lost to Follow-up|0|||
147568061|NCT00473330|532238404|FG002|Open-label Extension Through Month 60|Lost to Follow-up|4|||
147568062|NCT00473330|532238402|FG000|Open-label Extension Through Month 60|Physician's Decision|2|||
147568063|NCT00473330|532238403|FG001|Open-label Extension Through Month 60|Physician's Decision|1|||
147568064|NCT00473330|532238404|FG002|Open-label Extension Through Month 60|Physician's Decision|3|||
147568065|NCT00473330|532238402|FG000|Open-label Extension Through Month 60|Subject's Decision|1|||
147568066|NCT00473330|532238403|FG001|Open-label Extension Through Month 60|Subject's Decision|3|||
147568067|NCT00473330|532238404|FG002|Open-label Extension Through Month 60|Subject's Decision|4|||
147568068|NCT00473330|532238402|FG000|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|77|||
147568069|NCT00473330|532238403|FG001|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|71|||
147568070|NCT00473330|532238404|FG002|Open-label Extension Through Month 60|Sponsor's Decision to Terminate Study|62|||
147568071|NCT00473330|532238402|FG000|Open-label Extension Through Month 60|Subject Non-compliance|2|||
147568072|NCT00473330|532238403|FG001|Open-label Extension Through Month 60|Subject Non-compliance|1|||
147568073|NCT00473330|532238404|FG002|Open-label Extension Through Month 60|Subject Non-compliance|0|||
147568074|NCT00473330|532238402|FG000|Open-label Extension Through Month 60|Subject Required Other Therapy|1|||
147568075|NCT00473330|532238403|FG001|Open-label Extension Through Month 60|Subject Required Other Therapy|0|||
147568076|NCT00473330|532238404|FG002|Open-label Extension Through Month 60|Subject Required Other Therapy|1|||
147568077|NCT05615935|532238405|FG000|Overall Study|Lost to Follow-up|1|||
147568078|NCT05615935|532238406|FG001|Overall Study|Lost to Follow-up|1|||
147568079|NCT03925532|532238407|FG000|Overall Study|Lost to Follow-up|1|||
147568080|NCT01079988|532238408|FG000|Overall Study|Lost to Follow-up|0|||
147568081|NCT01079988|532238409|FG001|Overall Study|Lost to Follow-up|0|||
147568082|NCT01079988|532238410|FG002|Overall Study|Lost to Follow-up|0|||
147568083|NCT01079988|532238411|FG003|Overall Study|Lost to Follow-up|1|||
147568084|NCT01079988|532238412|FG004|Overall Study|Lost to Follow-up|0|||
147568085|NCT01079988|532238408|FG000|Overall Study|Lack of Efficacy|1|||
147568086|NCT01079988|532238409|FG001|Overall Study|Lack of Efficacy|0|||
147568087|NCT01079988|532238410|FG002|Overall Study|Lack of Efficacy|0|||
147568088|NCT01079988|532238411|FG003|Overall Study|Lack of Efficacy|0|||
147568089|NCT01079988|532238412|FG004|Overall Study|Lack of Efficacy|0|||
147568090|NCT01079988|532238408|FG000|Overall Study|Other|0|||
147568091|NCT01079988|532238409|FG001|Overall Study|Other|0|||
147568092|NCT01079988|532238410|FG002|Overall Study|Other|0|||
147121240|NCT03016403|530608831|FG003|3-month Follow-up and 6-month Follow-up|Death|0|||
147232090|NCT01364649|531023033|FG001|Overall Study|Non-compliance with Investigational Drug|0|||
147121241|NCT03016403|530608828|FG000|3-month Follow-up and 6-month Follow-up|Lost to Follow-up|6|||
147121242|NCT03016403|530608829|FG001|3-month Follow-up and 6-month Follow-up|Lost to Follow-up|7|||
147121243|NCT03016403|530608830|FG002|3-month Follow-up and 6-month Follow-up|Lost to Follow-up|8|||
147121244|NCT03016403|530608831|FG003|3-month Follow-up and 6-month Follow-up|Lost to Follow-up|6|||
147121245|NCT03016403|530608828|FG000|3-month Follow-up and 6-month Follow-up|Withdrawal by Subject|0|||
147121246|NCT03016403|530608829|FG001|3-month Follow-up and 6-month Follow-up|Withdrawal by Subject|0|||
147121247|NCT03016403|530608830|FG002|3-month Follow-up and 6-month Follow-up|Withdrawal by Subject|0|||
147121248|NCT03016403|530608831|FG003|3-month Follow-up and 6-month Follow-up|Withdrawal by Subject|1|||
147121249|NCT05463705|530608832|FG000|Overall Study|Did not complete a visit during study intervention period|103|||
147121250|NCT05463705|530608833|FG001|Overall Study|Did not complete a visit during study intervention period|107|||
147121251|NCT05463705|530608834|FG002|Overall Study|Did not complete a visit during study intervention period|100|||
147121252|NCT05463705|530608835|FG003|Overall Study|Did not complete a visit during study intervention period|4|||
147121253|NCT05463705|530608836|FG004|Overall Study|Did not complete a visit during study intervention period|8|||
147568093|NCT01079988|532238411|FG003|Overall Study|Other|2|||
147121254|NCT05463705|530608837|FG005|Overall Study|Did not complete a visit during study intervention period|4|||
147121255|NCT00621322|530608838|FG000|Overall Study|Lost to Follow-up|0|||
147121256|NCT00621322|530608839|FG001|Overall Study|Lost to Follow-up|0|||
147121257|NCT00621322|530608840|FG002|Overall Study|Lost to Follow-up|0|||
147121258|NCT00621322|530608841|FG003|Overall Study|Lost to Follow-up|0|||
147121259|NCT00621322|530608842|FG004|Overall Study|Lost to Follow-up|1|||
147121260|NCT00621322|530608843|FG005|Overall Study|Lost to Follow-up|0|||
147121261|NCT00621322|530608838|FG000|Overall Study|Physician Decision|0|||
147121262|NCT00621322|530608839|FG001|Overall Study|Physician Decision|0|||
147121263|NCT00621322|530608840|FG002|Overall Study|Physician Decision|1|||
147121264|NCT00621322|530608841|FG003|Overall Study|Physician Decision|1|||
147121265|NCT00621322|530608842|FG004|Overall Study|Physician Decision|0|||
147121266|NCT00621322|530608843|FG005|Overall Study|Physician Decision|0|||
147121267|NCT00621322|530608838|FG000|Overall Study|Withdrawal by Subject|0|||
147121268|NCT00621322|530608839|FG001|Overall Study|Withdrawal by Subject|0|||
147121269|NCT00621322|530608840|FG002|Overall Study|Withdrawal by Subject|0|||
147121270|NCT00621322|530608841|FG003|Overall Study|Withdrawal by Subject|1|||
147121271|NCT00621322|530608842|FG004|Overall Study|Withdrawal by Subject|0|||
147121272|NCT00621322|530608843|FG005|Overall Study|Withdrawal by Subject|2|||
147121273|NCT00621322|530608838|FG000|Overall Study|Migrated/moved from study area|1|||
147121274|NCT00621322|530608839|FG001|Overall Study|Migrated/moved from study area|0|||
147121275|NCT00621322|530608840|FG002|Overall Study|Migrated/moved from study area|1|||
147121276|NCT00621322|530608841|FG003|Overall Study|Migrated/moved from study area|1|||
147121277|NCT00621322|530608842|FG004|Overall Study|Migrated/moved from study area|0|||
147121278|NCT00621322|530608843|FG005|Overall Study|Migrated/moved from study area|2|||
147121279|NCT00225758|530608844|FG000|Overall Study|Adverse Event|4|||
147121280|NCT01655069|530608846|FG000|Overall Study|Physician Decision|0|||
147121281|NCT01655069|530608847|FG001|Overall Study|Physician Decision|0|||
147121282|NCT01655069|530608848|FG002|Overall Study|Physician Decision|0|||
147121283|NCT01655069|530608849|FG003|Overall Study|Physician Decision|1|||
147121284|NCT01655069|530608846|FG000|Overall Study|Adverse Event|6|||
147121285|NCT01655069|530608847|FG001|Overall Study|Adverse Event|7|||
147121286|NCT01655069|530608848|FG002|Overall Study|Adverse Event|2|||
147121287|NCT01655069|530608849|FG003|Overall Study|Adverse Event|3|||
147121288|NCT01655069|530608846|FG000|Overall Study|Lack of Efficacy|0|||
147121289|NCT01655069|530608847|FG001|Overall Study|Lack of Efficacy|1|||
147121290|NCT01655069|530608848|FG002|Overall Study|Lack of Efficacy|0|||
147121291|NCT01655069|530608849|FG003|Overall Study|Lack of Efficacy|0|||
147121292|NCT01655069|530608846|FG000|Overall Study|No Treatment Needed|0|||
147121293|NCT01655069|530608847|FG001|Overall Study|No Treatment Needed|1|||
147121294|NCT01655069|530608848|FG002|Overall Study|No Treatment Needed|0|||
147568094|NCT01079988|532238412|FG004|Overall Study|Other|1|||
147121295|NCT01655069|530608849|FG003|Overall Study|No Treatment Needed|0|||
147121296|NCT01655069|530608846|FG000|Overall Study|Withdrawal by Subject|2|||
147121297|NCT01655069|530608847|FG001|Overall Study|Withdrawal by Subject|3|||
147121298|NCT01655069|530608848|FG002|Overall Study|Withdrawal by Subject|0|||
147121299|NCT01655069|530608849|FG003|Overall Study|Withdrawal by Subject|0|||
147121300|NCT02346370|530608850|FG000|Overall Study|Not treated|1|||
147121301|NCT02346370|530608851|FG001|Overall Study|Not treated|0|||
147121302|NCT02346370|530608852|FG002|Overall Study|Not treated|0|||
147121303|NCT02346370|530608850|FG000|Overall Study|Withdrawal of consent|1|||
147121304|NCT02346370|530608851|FG001|Overall Study|Withdrawal of consent|0|||
147121305|NCT02346370|530608852|FG002|Overall Study|Withdrawal of consent|0|||
147121306|NCT02346370|530608850|FG000|Overall Study|Death|1|||
147121307|NCT02346370|530608851|FG001|Overall Study|Death|3|||
147121308|NCT02346370|530608852|FG002|Overall Study|Death|1|||
147121309|NCT02346370|530608850|FG000|Overall Study|Sponsor discontinued study|5|||
147121310|NCT02346370|530608851|FG001|Overall Study|Sponsor discontinued study|0|||
147121311|NCT02346370|530608852|FG002|Overall Study|Sponsor discontinued study|2|||
147121312|NCT02346370|530608850|FG000|Overall Study|Radiologic progression|0|||
147232091|NCT01364649|531023032|FG000|Overall Study|Protocol Deviations|4|||
147121313|NCT02346370|530608851|FG001|Overall Study|Radiologic progression|0|||
147121314|NCT02346370|530608852|FG002|Overall Study|Radiologic progression|1|||
147121315|NCT02346370|530608850|FG000|Overall Study|Physician Decision|0|||
147121316|NCT02346370|530608851|FG001|Overall Study|Physician Decision|1|||
147121317|NCT02346370|530608852|FG002|Overall Study|Physician Decision|0|||
147121318|NCT01217047|530608853|FG000|Overall Study|Lost to Follow-up|0|||
147121319|NCT01217047|530608854|FG001|Overall Study|Lost to Follow-up|1|||
147121320|NCT01217047|530608855|FG002|Overall Study|Lost to Follow-up|0|||
147121321|NCT06399471|530608856|FG000|Overall Study|Withdrawal by Subject|1|||
147121322|NCT05529173|530608857|FG000|Overall Study|Physician Decision|3|||
147568095|NCT01001208|532238413|FG000|Overall Study|Adverse Event|10|||
147568096|NCT01001208|532238414|FG001|Overall Study|Adverse Event|5|||
147121323|NCT05529173|530608858|FG001|Overall Study|Physician Decision|6|||
147121324|NCT05529173|530608857|FG000|Overall Study|Sample shipment delay more than one day|4|||
147121325|NCT05529173|530608858|FG001|Overall Study|Sample shipment delay more than one day|0|||
147121326|NCT01530997|530608859|FG000|Overall Study|Physician Decision|1|||
147121327|NCT01530997|530608859|FG000|Overall Study|Withdrawal by Subject|1|||
147121328|NCT00609973|530608861|FG000|Overall Study|Adverse Event|2|||
147121329|NCT00609973|530608862|FG001|Overall Study|Adverse Event|1|||
147121330|NCT00609973|530608861|FG000|Overall Study|Protocol Violation|4|||
147121331|NCT00609973|530608862|FG001|Overall Study|Protocol Violation|3|||
147121332|NCT00609973|530608861|FG000|Overall Study|Lost to Follow-up|2|||
147121333|NCT00609973|530608862|FG001|Overall Study|Lost to Follow-up|1|||
147121334|NCT00609973|530608861|FG000|Overall Study|Withdrawal by Subject|0|||
147121335|NCT00609973|530608862|FG001|Overall Study|Withdrawal by Subject|1|||
147121336|NCT01691482|530608864|FG000|Treatment Period 2|Adverse Event|0|||
147121337|NCT01691482|530608865|FG001|Treatment Period 2|Adverse Event|1|||
147121338|NCT01691482|530608864|FG000|Treatment Period 2|Protocol Violation|1|||
147121339|NCT01691482|530608865|FG001|Treatment Period 2|Protocol Violation|1|||
147121340|NCT01392495|530608866|FG000|Overall Study|Death|3|||
147121341|NCT01392495|530608866|FG000|Overall Study|Administrative problems|8|||
147121342|NCT01392495|530608866|FG000|Overall Study|Withdrawal by Subject|2|||
147121343|NCT01392495|530608866|FG000|Overall Study|Adverse Event|3|||
147121344|NCT01796470|530608877|FG000|Overall Study|Adverse Event|4|||
147121345|NCT01796470|530608878|FG001|Overall Study|Adverse Event|2|||
147121346|NCT01796470|530608879|FG002|Overall Study|Adverse Event|2|||
147121347|NCT01796470|530608880|FG003|Overall Study|Adverse Event|1|||
147121348|NCT01796470|530608881|FG004|Overall Study|Adverse Event|3|||
147121349|NCT01796470|530608877|FG000|Overall Study|Death|2|||
147121350|NCT01796470|530608878|FG001|Overall Study|Death|0|||
147121351|NCT01796470|530608879|FG002|Overall Study|Death|0|||
147121352|NCT01796470|530608880|FG003|Overall Study|Death|0|||
147121353|NCT01796470|530608881|FG004|Overall Study|Death|1|||
147121354|NCT01796470|530608877|FG000|Overall Study|Initiated New Therapy|9|||
147121355|NCT01796470|530608878|FG001|Overall Study|Initiated New Therapy|0|||
147121356|NCT01796470|530608879|FG002|Overall Study|Initiated New Therapy|0|||
147121357|NCT01796470|530608880|FG003|Overall Study|Initiated New Therapy|0|||
147121358|NCT01796470|530608881|FG004|Overall Study|Initiated New Therapy|2|||
147121359|NCT01796470|530608877|FG000|Overall Study|Lost to Follow-up|0|||
147121360|NCT01796470|530608878|FG001|Overall Study|Lost to Follow-up|1|||
147121361|NCT01796470|530608879|FG002|Overall Study|Lost to Follow-up|0|||
147121362|NCT01796470|530608880|FG003|Overall Study|Lost to Follow-up|0|||
147121363|NCT01796470|530608881|FG004|Overall Study|Lost to Follow-up|0|||
147121364|NCT01796470|530608877|FG000|Overall Study|Physician Decision|5|||
147121365|NCT01796470|530608878|FG001|Overall Study|Physician Decision|4|||
147121366|NCT01796470|530608879|FG002|Overall Study|Physician Decision|1|||
147313709|NCT05033080|531315225|FG000|Overall Study|Other|1|||
147568097|NCT01001208|532238413|FG000|Overall Study|Lost to Follow-up|5|||
147568098|NCT01001208|532238414|FG001|Overall Study|Lost to Follow-up|9|||
147568099|NCT01001208|532238413|FG000|Overall Study|Physician Decision|1|||
147568100|NCT01001208|532238414|FG001|Overall Study|Physician Decision|0|||
147121367|NCT01796470|530608880|FG003|Overall Study|Physician Decision|0|||
147121368|NCT01796470|530608881|FG004|Overall Study|Physician Decision|1|||
147121369|NCT01796470|530608877|FG000|Overall Study|Progressive Disease|7|||
147121370|NCT01796470|530608878|FG001|Overall Study|Progressive Disease|7|||
147121371|NCT01796470|530608879|FG002|Overall Study|Progressive Disease|3|||
147121372|NCT01796470|530608880|FG003|Overall Study|Progressive Disease|2|||
147121373|NCT01796470|530608881|FG004|Overall Study|Progressive Disease|0|||
147121374|NCT01796470|530608877|FG000|Overall Study|Protocol Criteria for Withdrawal|1|||
147121375|NCT01796470|530608878|FG001|Overall Study|Protocol Criteria for Withdrawal|0|||
147121376|NCT01796470|530608879|FG002|Overall Study|Protocol Criteria for Withdrawal|0|||
147121377|NCT01796470|530608880|FG003|Overall Study|Protocol Criteria for Withdrawal|0|||
147313710|NCT05033080|531315226|FG001|Overall Study|Other|1|||
147121378|NCT01796470|530608881|FG004|Overall Study|Protocol Criteria for Withdrawal|0|||
147121379|NCT01796470|530608877|FG000|Overall Study|Withdrawal by Subject|7|||
147121380|NCT01796470|530608878|FG001|Overall Study|Withdrawal by Subject|0|||
147121381|NCT01796470|530608879|FG002|Overall Study|Withdrawal by Subject|0|||
147121382|NCT01796470|530608880|FG003|Overall Study|Withdrawal by Subject|0|||
147568101|NCT01001208|532238413|FG000|Overall Study|Withdrawal by Subject|4|||
147121383|NCT01796470|530608881|FG004|Overall Study|Withdrawal by Subject|1|||
147121384|NCT00147537|530608882|FG000|Phase 1b|Death|0|||
147121385|NCT00147537|530608883|FG001|Phase 1b|Death|1|||
147121386|NCT00147537|530608884|FG002|Phase 1b|Death|2|||
147121387|NCT00147537|530608885|FG003|Phase 1b|Death|1|||
147121388|NCT00147537|530608886|FG004|Phase 1b|Death|2|||
147121389|NCT00147537|530608887|FG005|Phase 1b|Death|2|||
147121390|NCT00147537|530608888|FG006|Phase 1b|Death|1|||
147121391|NCT00147537|530608889|FG007|Phase 1b|Death|3|||
147121392|NCT00147537|530608890|FG008|Phase 1b|Death|9|||
147121393|NCT00147537|530608891|FG009|Phase 1b|Death|0|||
147121394|NCT00147537|530608892|FG010|Phase 1b|Death|0|||
147121395|NCT00147537|530608882|FG000|Phase 1b|Lost to Follow-up|2|||
147121396|NCT00147537|530608883|FG001|Phase 1b|Lost to Follow-up|1|||
147121397|NCT00147537|530608884|FG002|Phase 1b|Lost to Follow-up|0|||
147121398|NCT00147537|530608885|FG003|Phase 1b|Lost to Follow-up|0|||
147121399|NCT00147537|530608886|FG004|Phase 1b|Lost to Follow-up|0|||
147121400|NCT00147537|530608887|FG005|Phase 1b|Lost to Follow-up|0|||
147121401|NCT00147537|530608888|FG006|Phase 1b|Lost to Follow-up|2|||
147121402|NCT00147537|530608889|FG007|Phase 1b|Lost to Follow-up|0|||
147121403|NCT00147537|530608890|FG008|Phase 1b|Lost to Follow-up|1|||
147121404|NCT00147537|530608891|FG009|Phase 1b|Lost to Follow-up|0|||
147121405|NCT00147537|530608892|FG010|Phase 1b|Lost to Follow-up|0|||
147121406|NCT00147537|530608882|FG000|Phase 1b|Other|0|||
147121407|NCT00147537|530608883|FG001|Phase 1b|Other|0|||
147121408|NCT00147537|530608884|FG002|Phase 1b|Other|2|||
147121409|NCT00147537|530608885|FG003|Phase 1b|Other|1|||
147121410|NCT00147537|530608886|FG004|Phase 1b|Other|1|||
147121411|NCT00147537|530608887|FG005|Phase 1b|Other|1|||
147121412|NCT00147537|530608888|FG006|Phase 1b|Other|14|||
147121413|NCT00147537|530608889|FG007|Phase 1b|Other|4|||
147121414|NCT00147537|530608890|FG008|Phase 1b|Other|4|||
147121415|NCT00147537|530608891|FG009|Phase 1b|Other|0|||
147121416|NCT00147537|530608892|FG010|Phase 1b|Other|0|||
147121417|NCT00147537|530608882|FG000|Phase 1b|Withdrawal by Subject|0|||
147121418|NCT00147537|530608883|FG001|Phase 1b|Withdrawal by Subject|0|||
147121419|NCT00147537|530608884|FG002|Phase 1b|Withdrawal by Subject|0|||
147121420|NCT00147537|530608885|FG003|Phase 1b|Withdrawal by Subject|0|||
147121421|NCT00147537|530608886|FG004|Phase 1b|Withdrawal by Subject|0|||
147121422|NCT00147537|530608887|FG005|Phase 1b|Withdrawal by Subject|0|||
147121423|NCT00147537|530608888|FG006|Phase 1b|Withdrawal by Subject|0|||
147121424|NCT00147537|530608889|FG007|Phase 1b|Withdrawal by Subject|0|||
147121425|NCT00147537|530608890|FG008|Phase 1b|Withdrawal by Subject|2|||
147121426|NCT00147537|530608891|FG009|Phase 1b|Withdrawal by Subject|0|||
147121427|NCT00147537|530608892|FG010|Phase 1b|Withdrawal by Subject|0|||
147121428|NCT00147537|530608882|FG000|Phase 1b|Randomized but not treated|0|||
147121429|NCT00147537|530608883|FG001|Phase 1b|Randomized but not treated|0|||
147121430|NCT00147537|530608884|FG002|Phase 1b|Randomized but not treated|0|||
147121431|NCT00147537|530608885|FG003|Phase 1b|Randomized but not treated|0|||
147121432|NCT00147537|530608886|FG004|Phase 1b|Randomized but not treated|0|||
147121433|NCT00147537|530608887|FG005|Phase 1b|Randomized but not treated|0|||
147121434|NCT00147537|530608888|FG006|Phase 1b|Randomized but not treated|1|||
147121435|NCT00147537|530608889|FG007|Phase 1b|Randomized but not treated|0|||
147121436|NCT00147537|530608890|FG008|Phase 1b|Randomized but not treated|1|||
147121437|NCT00147537|530608891|FG009|Phase 1b|Randomized but not treated|0|||
147121438|NCT00147537|530608892|FG010|Phase 1b|Randomized but not treated|0|||
147121439|NCT00147537|530608882|FG000|Phase 2|Death|0|||
147232092|NCT01364649|531023033|FG001|Overall Study|Protocol Deviations|8|||
147232093|NCT01364649|531023032|FG000|Overall Study|Withdrawal of Consent|9|||
147232094|NCT01364649|531023033|FG001|Overall Study|Withdrawal of Consent|7|||
147232095|NCT01364649|531023032|FG000|Overall Study|Lost to Follow-up|12|||
147232096|NCT01364649|531023033|FG001|Overall Study|Lost to Follow-up|13|||
147121440|NCT00147537|530608883|FG001|Phase 2|Death|0|||
147232097|NCT01364649|531023032|FG000|Overall Study|Other|4|||
147232098|NCT01364649|531023033|FG001|Overall Study|Other|1|||
147232099|NCT00902668|531023034|FG000|Overall Study|Protocol stopped due to slow accrual.|3|||
147232100|NCT00004635|531023035|FG000|Period One|refused|2|||
147313711|NCT03560245|531315228|FG000|Overall Study|Withdrawal by Subject|3|||
147313712|NCT03560245|531315229|FG001|Overall Study|Withdrawal by Subject|2|||
147121441|NCT00147537|530608884|FG002|Phase 2|Death|0|||
147121442|NCT00147537|530608885|FG003|Phase 2|Death|0|||
147121443|NCT00147537|530608886|FG004|Phase 2|Death|0|||
147121444|NCT00147537|530608887|FG005|Phase 2|Death|0|||
147121445|NCT00147537|530608888|FG006|Phase 2|Death|0|||
147121446|NCT00147537|530608889|FG007|Phase 2|Death|0|||
147121447|NCT00147537|530608890|FG008|Phase 2|Death|0|||
147121448|NCT00147537|530608891|FG009|Phase 2|Death|85|||
147121449|NCT00147537|530608892|FG010|Phase 2|Death|31|||
147121450|NCT00147537|530608882|FG000|Phase 2|Lost to Follow-up|0|||
147121451|NCT00147537|530608883|FG001|Phase 2|Lost to Follow-up|0|||
147121452|NCT00147537|530608884|FG002|Phase 2|Lost to Follow-up|0|||
147121453|NCT00147537|530608885|FG003|Phase 2|Lost to Follow-up|0|||
147121454|NCT00147537|530608886|FG004|Phase 2|Lost to Follow-up|0|||
147121455|NCT00147537|530608887|FG005|Phase 2|Lost to Follow-up|0|||
147121456|NCT00147537|530608888|FG006|Phase 2|Lost to Follow-up|0|||
147232101|NCT00004635|531023036|FG001|Period One|refused|1|||
147121457|NCT00147537|530608889|FG007|Phase 2|Lost to Follow-up|0|||
147121458|NCT00147537|530608890|FG008|Phase 2|Lost to Follow-up|0|||
147121459|NCT00147537|530608891|FG009|Phase 2|Lost to Follow-up|12|||
147121460|NCT00147537|530608892|FG010|Phase 2|Lost to Follow-up|4|||
147121461|NCT00147537|530608882|FG000|Phase 2|Other|0|||
147121462|NCT00147537|530608883|FG001|Phase 2|Other|0|||
147121463|NCT00147537|530608884|FG002|Phase 2|Other|0|||
147121464|NCT00147537|530608885|FG003|Phase 2|Other|0|||
147121465|NCT00147537|530608886|FG004|Phase 2|Other|0|||
147121466|NCT00147537|530608887|FG005|Phase 2|Other|0|||
147121467|NCT00147537|530608888|FG006|Phase 2|Other|0|||
147121468|NCT00147537|530608889|FG007|Phase 2|Other|0|||
147121469|NCT00147537|530608890|FG008|Phase 2|Other|0|||
147121470|NCT00147537|530608891|FG009|Phase 2|Other|47|||
147121471|NCT00147537|530608892|FG010|Phase 2|Other|12|||
147121472|NCT00147537|530608882|FG000|Phase 2|Withdrawal by Subject|0|||
147121473|NCT00147537|530608883|FG001|Phase 2|Withdrawal by Subject|0|||
147121474|NCT00147537|530608884|FG002|Phase 2|Withdrawal by Subject|0|||
147121475|NCT00147537|530608885|FG003|Phase 2|Withdrawal by Subject|0|||
147121476|NCT00147537|530608886|FG004|Phase 2|Withdrawal by Subject|0|||
147232102|NCT00004635|531023035|FG000|Period One|Withdrawal by Subject|1|||
147232103|NCT00004635|531023036|FG001|Period One|Withdrawal by Subject|1|||
147232104|NCT00004635|531023035|FG000|Period One|Protocol Violation|1|||
147232105|NCT00004635|531023036|FG001|Period One|Protocol Violation|0|||
147232106|NCT00004635|531023035|FG000|Period One|PSA did not go <5 ng/mL|1|||
147232107|NCT00004635|531023036|FG001|Period One|PSA did not go <5 ng/mL|0|||
147232108|NCT00004635|531023035|FG000|Period One|second malignancy|1|||
147232109|NCT00004635|531023036|FG001|Period One|second malignancy|0|||
147232110|NCT00004635|531023035|FG000|Period One|progressed|0|||
147232111|NCT00004635|531023036|FG001|Period One|progressed|2|||
147232112|NCT00004635|531023035|FG000|Period One|health problem|0|||
147232113|NCT00004635|531023036|FG001|Period One|health problem|1|||
147232114|NCT00004635|531023035|FG000|Period One|discrepancy in data entry|0|||
147232115|NCT00004635|531023036|FG001|Period One|discrepancy in data entry|1|||
147232116|NCT00004635|531023035|FG000|Period Two|progression|2|||
147232117|NCT00004635|531023036|FG001|Period Two|progression|3|||
147232118|NCT00004635|531023035|FG000|Period Two|Adverse Event|1|||
147232119|NCT00004635|531023036|FG001|Period Two|Adverse Event|0|||
147232120|NCT00004635|531023035|FG000|Period Two|refused|0|||
147232121|NCT00004635|531023036|FG001|Period Two|refused|2|||
147232122|NCT00004635|531023035|FG000|Period Two|health problem|1|||
147232123|NCT00004635|531023036|FG001|Period Two|health problem|1|||
147232124|NCT00004635|531023035|FG000|Period Two|travel issues|0|||
147232125|NCT00004635|531023036|FG001|Period Two|travel issues|1|||
147232126|NCT00004635|531023035|FG000|Period Two|secondary malignancy|1|||
147232127|NCT00004635|531023036|FG001|Period Two|secondary malignancy|1|||
147232128|NCT00004635|531023035|FG000|Period Two|Lost to Follow-up|1|||
147232129|NCT00004635|531023036|FG001|Period Two|Lost to Follow-up|0|||
147232130|NCT00004635|531023035|FG000|Period Two|discrepancy in data entry|0|||
147232131|NCT00004635|531023036|FG001|Period Two|discrepancy in data entry|1|||
147232132|NCT01788046|531023037|FG000|Overall Study|Withdrawal by Subject|12|||
147232133|NCT01788046|531023038|FG001|Overall Study|Withdrawal by Subject|12|||
147232134|NCT01788046|531023037|FG000|Overall Study|Lost to Follow-up|12|||
147232135|NCT01788046|531023038|FG001|Overall Study|Lost to Follow-up|19|||
147232136|NCT01788046|531023037|FG000|Overall Study|Death|7|||
147232137|NCT01788046|531023038|FG001|Overall Study|Death|5|||
147232138|NCT01788046|531023037|FG000|Overall Study|Protocol Specified Criteria|25|||
147232139|NCT01788046|531023038|FG001|Overall Study|Protocol Specified Criteria|1|||
147232140|NCT01453725|531023039|FG000|Overall Study|Adverse Event|3|||
147232141|NCT01453725|531023040|FG001|Overall Study|Adverse Event|3|||
147232142|NCT01453725|531023039|FG000|Overall Study|Lost to Follow-up|4|||
147232143|NCT01453725|531023040|FG001|Overall Study|Lost to Follow-up|0|||
147121477|NCT00147537|530608887|FG005|Phase 2|Withdrawal by Subject|0|||
147232144|NCT01453725|531023039|FG000|Overall Study|Non-compliance With Protocol|1|||
147232145|NCT01453725|531023040|FG001|Overall Study|Non-compliance With Protocol|2|||
147232146|NCT01453725|531023039|FG000|Overall Study|Protocol Violation|1|||
147232147|NCT01453725|531023040|FG001|Overall Study|Protocol Violation|0|||
147232148|NCT01453725|531023039|FG000|Overall Study|Withdrawal by Subject|2|||
147232149|NCT01453725|531023040|FG001|Overall Study|Withdrawal by Subject|3|||
147121478|NCT00147537|530608888|FG006|Phase 2|Withdrawal by Subject|0|||
147121479|NCT00147537|530608889|FG007|Phase 2|Withdrawal by Subject|0|||
147121480|NCT00147537|530608890|FG008|Phase 2|Withdrawal by Subject|0|||
147121481|NCT00147537|530608891|FG009|Phase 2|Withdrawal by Subject|16|||
147121482|NCT00147537|530608892|FG010|Phase 2|Withdrawal by Subject|4|||
147121483|NCT00147537|530608882|FG000|Phase 2|Randomized but not treated|0|||
147232150|NCT01453725|531023039|FG000|Overall Study|Pregnancy Wish|0|||
147232151|NCT01453725|531023040|FG001|Overall Study|Pregnancy Wish|2|||
147232152|NCT01453725|531023039|FG000|Overall Study|Pregnancy|1|||
147232153|NCT01453725|531023040|FG001|Overall Study|Pregnancy|0|||
147232154|NCT01453725|531023039|FG000|Overall Study|Physician Decision|1|||
147232155|NCT01453725|531023040|FG001|Overall Study|Physician Decision|1|||
147232156|NCT03605212|531023042|FG000|Treatment Period|Adverse Event|1|||
147232157|NCT03605212|531023043|FG001|Treatment Period|Adverse Event|0|||
147121484|NCT00147537|530608883|FG001|Phase 2|Randomized but not treated|0|||
147121485|NCT00147537|530608884|FG002|Phase 2|Randomized but not treated|0|||
147121486|NCT00147537|530608885|FG003|Phase 2|Randomized but not treated|0|||
147121487|NCT00147537|530608886|FG004|Phase 2|Randomized but not treated|0|||
147121488|NCT00147537|530608887|FG005|Phase 2|Randomized but not treated|0|||
147121489|NCT00147537|530608888|FG006|Phase 2|Randomized but not treated|0|||
147121490|NCT00147537|530608889|FG007|Phase 2|Randomized but not treated|0|||
147121491|NCT00147537|530608890|FG008|Phase 2|Randomized but not treated|0|||
147121492|NCT00147537|530608891|FG009|Phase 2|Randomized but not treated|1|||
147121493|NCT00147537|530608892|FG010|Phase 2|Randomized but not treated|1|||
147121494|NCT01927861|530608893|FG000|Extension Phase (104 Weeks)|Adverse Event|0|||
147121495|NCT01927861|530608894|FG001|Extension Phase (104 Weeks)|Adverse Event|2|||
147121496|NCT01927861|530608893|FG000|Extension Phase (104 Weeks)|Unclassified|0|||
147121497|NCT01927861|530608894|FG001|Extension Phase (104 Weeks)|Unclassified|1|||
147121498|NCT00468546|530608896|FG000|Week 24 Analysis|Lack of Efficacy|83|||
147121499|NCT00468546|530608897|FG001|Week 24 Analysis|Lack of Efficacy|37|||
147121500|NCT00468546|530608896|FG000|Week 24 Analysis|Refused treatment|5|||
147121501|NCT00468546|530608897|FG001|Week 24 Analysis|Refused treatment|5|||
147121502|NCT00468546|530608896|FG000|Week 24 Analysis|Adverse Event|1|||
147121503|NCT00468546|530608897|FG001|Week 24 Analysis|Adverse Event|8|||
147121504|NCT00468546|530608896|FG000|Week 24 Analysis|Failure to return|3|||
147121505|NCT00468546|530608897|FG001|Week 24 Analysis|Failure to return|4|||
147121506|NCT00468546|530608896|FG000|Week 24 Analysis|Rescue therapy|2|||
147121507|NCT00468546|530608897|FG001|Week 24 Analysis|Rescue therapy|0|||
147121508|NCT00468546|530608896|FG000|Week 24 Analysis|Incorrect diagnosis and treatment|0|||
147121509|NCT00468546|530608897|FG001|Week 24 Analysis|Incorrect diagnosis and treatment|1|||
147121510|NCT00468546|530608896|FG000|Week 24 Analysis|Due to clinical hold|1|||
147121511|NCT00468546|530608897|FG001|Week 24 Analysis|Due to clinical hold|0|||
147121512|NCT00468546|530608896|FG000|Week 24 Analysis|Went onto rescue therapy|1|||
147121513|NCT00468546|530608897|FG001|Week 24 Analysis|Went onto rescue therapy|0|||
147121514|NCT00468546|530608896|FG000|Week 24 Analysis|Participant unblinded (clinical hold)|1|||
147121515|NCT00468546|530608897|FG001|Week 24 Analysis|Participant unblinded (clinical hold)|0|||
147121516|NCT00468546|530608896|FG000|Week 24 to Week 104 Analysis|Adverse Event|2|||
147121517|NCT00468546|530608897|FG001|Week 24 to Week 104 Analysis|Adverse Event|5|||
147121518|NCT00468546|530608896|FG000|Week 24 to Week 104 Analysis|Death|1|||
147121519|NCT00468546|530608897|FG001|Week 24 to Week 104 Analysis|Death|0|||
147121520|NCT00468546|530608896|FG000|Week 24 to Week 104 Analysis|Lack of Efficacy|3|||
147121521|NCT00468546|530608897|FG001|Week 24 to Week 104 Analysis|Lack of Efficacy|12|||
147121522|NCT00468546|530608896|FG000|Week 24 to Week 104 Analysis|Protocol Violation|0|||
147121523|NCT00468546|530608897|FG001|Week 24 to Week 104 Analysis|Protocol Violation|2|||
147121524|NCT00468546|530608896|FG000|Week 24 to Week 104 Analysis|Refused treatment|4|||
147121525|NCT00468546|530608897|FG001|Week 24 to Week 104 Analysis|Refused treatment|7|||
147121526|NCT00468546|530608896|FG000|Week 24 to Week 104 Analysis|Failure to return|1|||
147121527|NCT00468546|530608897|FG001|Week 24 to Week 104 Analysis|Failure to return|2|||
147121528|NCT00468546|530608896|FG000|Week 24 to Week 104 Analysis|Movement into re-treatment study|77|||
147121529|NCT00468546|530608897|FG001|Week 24 to Week 104 Analysis|Movement into re-treatment study|183|||
147121530|NCT00468546|530608896|FG000|Week 24 to Week 104 Analysis|Other|17|||
147121531|NCT00468546|530608897|FG001|Week 24 to Week 104 Analysis|Other|14|||
147121532|NCT00472641|530608898|FG000|Overall Study|Lack of Efficacy|3|||
147121533|NCT00472641|530608898|FG000|Overall Study|Adverse Event|3|||
147121534|NCT00472641|530608898|FG000|Overall Study|Lost to Follow-up|1|||
147313713|NCT03560245|531315228|FG000|Overall Study|Adverse Event|1|||
147313714|NCT03560245|531315229|FG001|Overall Study|Adverse Event|1|||
147313715|NCT03560245|531315228|FG000|Overall Study|Protocol Violation|1|||
147313716|NCT03560245|531315229|FG001|Overall Study|Protocol Violation|0|||
147313717|NCT03560245|531315228|FG000|Overall Study|Death|0|||
147313718|NCT03560245|531315229|FG001|Overall Study|Death|1|||
147313719|NCT03560245|531315228|FG000|Overall Study|Lost to Follow-up|0|||
147313720|NCT03560245|531315229|FG001|Overall Study|Lost to Follow-up|1|||
147313721|NCT03560245|531315228|FG000|Overall Study|Physician Decision|0|||
147313722|NCT03560245|531315229|FG001|Overall Study|Physician Decision|1|||
147313723|NCT03560245|531315228|FG000|Overall Study|Other|0|||
147313724|NCT03560245|531315229|FG001|Overall Study|Other|1|||
147313725|NCT02302066|531315233|FG000|Overall Study|Adverse Event|1|||
147121535|NCT02006654|530608899|FG000|Overall Study|Withdrawal before treatment|4|||
147121536|NCT02006654|530608900|FG001|Overall Study|Withdrawal before treatment|2|||
147121537|NCT02006654|530608899|FG000|Overall Study|Adverse Event|16|||
147313726|NCT02302066|531315234|FG001|Overall Study|Adverse Event|1|||
147444591|NCT00884273|531792646|FG000|Overall Study|Protocol Violation|1|||
147121538|NCT02006654|530608900|FG001|Overall Study|Adverse Event|17|||
147121539|NCT02006654|530608899|FG000|Overall Study|Death|1|||
147121540|NCT02006654|530608900|FG001|Overall Study|Death|0|||
147121541|NCT02006654|530608899|FG000|Overall Study|Withdrawal by Subject|14|||
147313727|NCT02302066|531315235|FG002|Overall Study|Adverse Event|3|||
147313728|NCT02302066|531315236|FG003|Overall Study|Adverse Event|0|||
147313729|NCT02302066|531315233|FG000|Overall Study|Lost to Follow-up|4|||
147121542|NCT02006654|530608900|FG001|Overall Study|Withdrawal by Subject|12|||
147121543|NCT02006654|530608899|FG000|Overall Study|Protocol Violation|5|||
147121544|NCT02006654|530608900|FG001|Overall Study|Protocol Violation|8|||
147121545|NCT02006654|530608899|FG000|Overall Study|Lost to Follow-up|1|||
147121546|NCT02006654|530608900|FG001|Overall Study|Lost to Follow-up|0|||
147121547|NCT02006654|530608899|FG000|Overall Study|patient's will|2|||
147121548|NCT02006654|530608900|FG001|Overall Study|patient's will|1|||
147121549|NCT02006654|530608899|FG000|Overall Study|insufficient compliance|1|||
147121550|NCT02006654|530608900|FG001|Overall Study|insufficient compliance|0|||
147121551|NCT02006654|530608899|FG000|Overall Study|worsening cognitive condition|0|||
147121552|NCT02006654|530608900|FG001|Overall Study|worsening cognitive condition|1|||
147121553|NCT02006654|530608899|FG000|Overall Study|faecal incontinence|0|||
147121554|NCT02006654|530608900|FG001|Overall Study|faecal incontinence|1|||
147121555|NCT02006654|530608899|FG000|Overall Study|mood disorder|0|||
147121556|NCT02006654|530608900|FG001|Overall Study|mood disorder|1|||
147121557|NCT02006654|530608899|FG000|Overall Study|disallowed medication|1|||
147121558|NCT02006654|530608900|FG001|Overall Study|disallowed medication|0|||
147121559|NCT02006654|530608899|FG000|Overall Study|moving out of state|0|||
147121560|NCT02006654|530608900|FG001|Overall Study|moving out of state|1|||
147121561|NCT02991859|530608903|FG000|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
147121562|NCT02991859|530608904|FG001|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|1|||
147121563|NCT02991859|530608905|FG002|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
147121564|NCT02991859|530608906|FG003|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
147121565|NCT02991859|530608907|FG004|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|1|||
147121566|NCT02991859|530608908|FG005|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
147121567|NCT02991859|530608909|FG006|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
147121568|NCT02991859|530608910|FG007|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
147121569|NCT02991859|530608911|FG008|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
147121570|NCT02991859|530608912|FG009|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
147121571|NCT02991859|530608913|FG010|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
147121572|NCT02991859|530608914|FG011|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
147121573|NCT02991859|530608915|FG012|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
147121574|NCT02991859|530608916|FG013|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
147121575|NCT02991859|530608917|FG014|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
147121576|NCT02991859|530608918|FG015|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
147121577|NCT02991859|530608919|FG016|Period 1,Escalation Phase 1,Upto Day 7|Withdrawal by Subject|0|||
147121578|NCT02991859|530608903|FG000|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
147121579|NCT02991859|530608904|FG001|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
147121580|NCT02991859|530608905|FG002|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
147121581|NCT02991859|530608906|FG003|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
147121582|NCT02991859|530608907|FG004|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
147121583|NCT02991859|530608908|FG005|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
147121584|NCT02991859|530608909|FG006|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
147121585|NCT02991859|530608910|FG007|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
147121586|NCT02991859|530608911|FG008|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
147121587|NCT02991859|530608912|FG009|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
147121588|NCT02991859|530608913|FG010|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
147121589|NCT02991859|530608914|FG011|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
147121590|NCT02991859|530608915|FG012|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|1|||
147121591|NCT02991859|530608916|FG013|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|1|||
147121592|NCT02991859|530608917|FG014|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
147121593|NCT02991859|530608918|FG015|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
147121594|NCT02991859|530608919|FG016|Period1, Escalation Phase3, Upto Day21|Withdrawal by Subject|0|||
147121595|NCT02991859|530608903|FG000|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
147121596|NCT02991859|530608904|FG001|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
147121597|NCT02991859|530608905|FG002|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
147121598|NCT02991859|530608906|FG003|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
147121599|NCT02991859|530608907|FG004|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
147121600|NCT02991859|530608908|FG005|Wash Out, Up to Day 77|Withdrawal by Subject|1|||
147121601|NCT02991859|530608909|FG006|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
147121602|NCT02991859|530608910|FG007|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
147121603|NCT02991859|530608911|FG008|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
147313730|NCT02302066|531315234|FG001|Overall Study|Lost to Follow-up|5|||
147121604|NCT02991859|530608912|FG009|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
147121605|NCT02991859|530608913|FG010|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
147121606|NCT02991859|530608914|FG011|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
147121607|NCT02991859|530608915|FG012|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
147313731|NCT02302066|531315235|FG002|Overall Study|Lost to Follow-up|24|||
147121608|NCT02991859|530608916|FG013|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
147121609|NCT02991859|530608917|FG014|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
147121610|NCT02991859|530608918|FG015|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
147121611|NCT02991859|530608919|FG016|Wash Out, Up to Day 77|Withdrawal by Subject|0|||
147121612|NCT02991859|530608903|FG000|Wash Out, Up to Day 77|Lost to Follow-up|0|||
147121613|NCT02991859|530608904|FG001|Wash Out, Up to Day 77|Lost to Follow-up|0|||
147121614|NCT02991859|530608905|FG002|Wash Out, Up to Day 77|Lost to Follow-up|0|||
147121615|NCT02991859|530608906|FG003|Wash Out, Up to Day 77|Lost to Follow-up|0|||
147121616|NCT02991859|530608907|FG004|Wash Out, Up to Day 77|Lost to Follow-up|0|||
147121617|NCT02991859|530608908|FG005|Wash Out, Up to Day 77|Lost to Follow-up|0|||
147121618|NCT02991859|530608909|FG006|Wash Out, Up to Day 77|Lost to Follow-up|0|||
147121619|NCT02991859|530608910|FG007|Wash Out, Up to Day 77|Lost to Follow-up|0|||
147121620|NCT02991859|530608911|FG008|Wash Out, Up to Day 77|Lost to Follow-up|0|||
147121621|NCT02991859|530608912|FG009|Wash Out, Up to Day 77|Lost to Follow-up|1|||
147121622|NCT02991859|530608913|FG010|Wash Out, Up to Day 77|Lost to Follow-up|0|||
147121623|NCT02991859|530608914|FG011|Wash Out, Up to Day 77|Lost to Follow-up|0|||
147121624|NCT02991859|530608915|FG012|Wash Out, Up to Day 77|Lost to Follow-up|0|||
147121625|NCT02991859|530608916|FG013|Wash Out, Up to Day 77|Lost to Follow-up|0|||
147121626|NCT02991859|530608917|FG014|Wash Out, Up to Day 77|Lost to Follow-up|0|||
147121627|NCT02991859|530608918|FG015|Wash Out, Up to Day 77|Lost to Follow-up|0|||
147121628|NCT02991859|530608919|FG016|Wash Out, Up to Day 77|Lost to Follow-up|0|||
147121629|NCT02991859|530608903|FG000|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
147121630|NCT02991859|530608904|FG001|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
147121631|NCT02991859|530608905|FG002|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
147121632|NCT02991859|530608906|FG003|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
147121633|NCT02991859|530608907|FG004|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
147121634|NCT02991859|530608908|FG005|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
147121635|NCT02991859|530608909|FG006|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
147121636|NCT02991859|530608910|FG007|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
147121637|NCT02991859|530608911|FG008|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|1|||
147121638|NCT02991859|530608912|FG009|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
147121639|NCT02991859|530608913|FG010|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
147121640|NCT02991859|530608914|FG011|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
147121641|NCT02991859|530608915|FG012|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
147121642|NCT02991859|530608916|FG013|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
147121643|NCT02991859|530608917|FG014|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
147121644|NCT02991859|530608918|FG015|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
147121645|NCT02991859|530608919|FG016|Period2, Escalation Phase4, Upto Day 105|Withdrawal by Subject|0|||
147121646|NCT01945242|530608927|FG000|Overall Study|Physician Decision|3|||
147121647|NCT01945242|530608928|FG001|Overall Study|Physician Decision|3|||
147121648|NCT01016015|530608931|FG000|Overall Study|Not Treated|3|||
147121649|NCT01016015|530608931|FG000|Overall Study|Withdrawal by Subject|1|||
147121650|NCT01016015|530608931|FG000|Overall Study|Adverse Event|15|||
147121651|NCT03163264|530608932|FG000|Overall Study|Withdrawal by Subject|13|||
147121652|NCT03163264|530608933|FG001|Overall Study|Withdrawal by Subject|3|||
147121653|NCT03163264|530608934|FG002|Overall Study|Withdrawal by Subject|4|||
147121654|NCT03163264|530608935|FG003|Overall Study|Withdrawal by Subject|2|||
147121655|NCT03163264|530608932|FG000|Overall Study|Lost to Follow-up|17|||
147121656|NCT03163264|530608933|FG001|Overall Study|Lost to Follow-up|20|||
147121657|NCT03163264|530608934|FG002|Overall Study|Lost to Follow-up|0|||
147121658|NCT03163264|530608935|FG003|Overall Study|Lost to Follow-up|0|||
147444592|NCT00884273|531792647|FG001|Overall Study|Protocol Violation|3|||
147568102|NCT01001208|532238414|FG001|Overall Study|Withdrawal by Subject|5|||
147568103|NCT01001208|532238413|FG000|Overall Study|Ineligibility Determined|4|||
147568104|NCT01001208|532238414|FG001|Overall Study|Ineligibility Determined|2|||
147568105|NCT01001208|532238413|FG000|Overall Study|Noncompliance|4|||
147121659|NCT03163264|530608932|FG000|Overall Study|Death|0|||
147121660|NCT03163264|530608933|FG001|Overall Study|Death|2|||
147121661|NCT03163264|530608934|FG002|Overall Study|Death|0|||
147121662|NCT03163264|530608935|FG003|Overall Study|Death|0|||
147121663|NCT02057666|530608936|FG000|Double Blind Treatment Period|Withdrawal by Subject|8|||
147121664|NCT02057666|530608937|FG001|Double Blind Treatment Period|Withdrawal by Subject|5|||
147121665|NCT02057666|530608936|FG000|Double Blind Treatment Period|Poor tolerability|7|||
147121666|NCT02057666|530608937|FG001|Double Blind Treatment Period|Poor tolerability|2|||
147121667|NCT02057666|530608936|FG000|Double Blind Treatment Period|Symptomatic disease progression|8|||
147121668|NCT02057666|530608937|FG001|Double Blind Treatment Period|Symptomatic disease progression|3|||
147121669|NCT02057666|530608936|FG000|Double Blind Treatment Period|Physician Decision|1|||
147121670|NCT02057666|530608937|FG001|Double Blind Treatment Period|Physician Decision|0|||
147121671|NCT02057666|530608936|FG000|Double Blind Treatment Period|Progressive disease for bone lesion|1|||
147121672|NCT02057666|530608937|FG001|Double Blind Treatment Period|Progressive disease for bone lesion|0|||
147444593|NCT00884273|531792646|FG000|Overall Study|Practical reasons|1|||
147121673|NCT02057666|530608936|FG000|Double Blind Treatment Period|Subject planning to withdraw|1|||
147121674|NCT02057666|530608937|FG001|Double Blind Treatment Period|Subject planning to withdraw|0|||
147121675|NCT02057666|530608936|FG000|Double Blind Treatment Period|Sponsor's request|70|||
147121676|NCT02057666|530608937|FG001|Double Blind Treatment Period|Sponsor's request|34|||
147121677|NCT02057666|530608936|FG000|Open-Label Treatment Period|Poor tolerability|0|||
147121678|NCT02057666|530608937|FG001|Open-Label Treatment Period|Poor tolerability|1|||
147121679|NCT02057666|530608936|FG000|Open-Label Treatment Period|Symptomatic disease progression|0|||
147121680|NCT02057666|530608937|FG001|Open-Label Treatment Period|Symptomatic disease progression|1|||
147121681|NCT02057666|530608936|FG000|Open-Label Treatment Period|Sponsor's request|0|||
147121682|NCT02057666|530608937|FG001|Open-Label Treatment Period|Sponsor's request|4|||
147121683|NCT05661734|530608938|FG000|Overall Study|Withdrawal of consent (not due to AE)|3|||
147121684|NCT05661734|530608938|FG000|Overall Study|Lost to Follow-up|13|||
147121685|NCT05661734|530608938|FG000|Overall Study|Enrolled but not dosed|2|||
147121686|NCT02489045|530608941|FG000|Overall Study|unable to collect usable data|53|||
147121687|NCT02489045|530608941|FG000|Follow-up|Lost to Follow-up|10|||
147121688|NCT00930176|530608945|FG000|Overall Study|Death|1|||
147121689|NCT01108055|530608946|FG000|Overall Study|Ineligible|11|||
147121690|NCT01108055|530608946|FG000|Overall Study|Not evaluable- didn't complete treatment|4|||
147121691|NCT00362609|530608947|FG000|Overall Study|Withdrawal by Subject|0|||
147121692|NCT00362609|530608948|FG001|Overall Study|Withdrawal by Subject|1|||
147121693|NCT00362609|530608947|FG000|Overall Study|Protocol Violation|0|||
147121694|NCT00362609|530608948|FG001|Overall Study|Protocol Violation|1|||
147121695|NCT00236197|530608953|FG000|Overall Study|Withdrawal by Subject|3|||
147121696|NCT00236197|530608954|FG001|Overall Study|Withdrawal by Subject|2|||
147121697|NCT00236197|530608953|FG000|Overall Study|Lost to Follow-up|1|||
147121698|NCT00236197|530608954|FG001|Overall Study|Lost to Follow-up|5|||
147121699|NCT00236197|530608953|FG000|Overall Study|Protocol Violation|0|||
147121700|NCT00236197|530608954|FG001|Overall Study|Protocol Violation|3|||
147121701|NCT00236197|530608953|FG000|Overall Study|Medication non-compliance|1|||
147121702|NCT00236197|530608954|FG001|Overall Study|Medication non-compliance|2|||
147121703|NCT00236197|530608953|FG000|Overall Study|Other|0|||
147121704|NCT00236197|530608954|FG001|Overall Study|Other|2|||
147121705|NCT00682435|530608955|FG000|Overall Study|Insufficient data|5|||
147121706|NCT00682435|530608955|FG000|Overall Study|Erroneously enrolled twice|2|||
147121707|NCT01800058|530608956|FG000|Overall Study|Lost to Follow-up|1|||
147121708|NCT00800384|530608957|FG000|Overall Study|Withdrawal by Subject|24|||
147121709|NCT00800384|530608958|FG001|Overall Study|Withdrawal by Subject|17|||
147121710|NCT00800384|530608957|FG000|Overall Study|Lost to Follow-up|17|||
147121711|NCT00800384|530608958|FG001|Overall Study|Lost to Follow-up|26|||
147121712|NCT05486065|530608959|FG000|Overall Study|Withdrawal by Subject|1|||
147121713|NCT05486065|530608960|FG001|Overall Study|Withdrawal by Subject|5|||
147121714|NCT05486065|530608961|FG002|Overall Study|Withdrawal by Subject|4|||
147121715|NCT05486065|530608962|FG003|Overall Study|Withdrawal by Subject|3|||
147121716|NCT05486065|530608959|FG000|Overall Study|Lost to Follow-up|4|||
147121717|NCT05486065|530608960|FG001|Overall Study|Lost to Follow-up|2|||
147121718|NCT05486065|530608961|FG002|Overall Study|Lost to Follow-up|2|||
147121719|NCT05486065|530608962|FG003|Overall Study|Lost to Follow-up|2|||
147121720|NCT05486065|530608959|FG000|Overall Study|Physician Decision|0|||
147121721|NCT05486065|530608960|FG001|Overall Study|Physician Decision|1|||
147121722|NCT05486065|530608961|FG002|Overall Study|Physician Decision|1|||
147121723|NCT05486065|530608962|FG003|Overall Study|Physician Decision|0|||
147121724|NCT05486065|530608959|FG000|Overall Study|Failure to meet randomization criteria|0|||
147121725|NCT05486065|530608960|FG001|Overall Study|Failure to meet randomization criteria|0|||
147121726|NCT05486065|530608961|FG002|Overall Study|Failure to meet randomization criteria|0|||
147232158|NCT03605212|531023044|FG002|Treatment Period|Adverse Event|0|||
147232159|NCT03605212|531023045|FG003|Treatment Period|Adverse Event|0|||
147232160|NCT03605212|531023046|FG004|Treatment Period|Adverse Event|0|||
147232161|NCT03605212|531023042|FG000|Treatment Period|Physician Decision|0|||
147232162|NCT03605212|531023043|FG001|Treatment Period|Physician Decision|0|||
147232163|NCT03605212|531023044|FG002|Treatment Period|Physician Decision|0|||
147650936|NCT02757352|532544545|FG008|Follow-Up Period|Adverse Event|2|||
147650937|NCT02757352|532544546|FG009|Follow-Up Period|Adverse Event|0|||
147121727|NCT05486065|530608962|FG003|Overall Study|Failure to meet randomization criteria|1|||
147121728|NCT01064622|530608963|FG000|Randomized Phase II|Withdrawal by Subject|2|||
147121729|NCT01064622|530608964|FG001|Randomized Phase II|Withdrawal by Subject|2|||
147121730|NCT01064622|530608963|FG000|Randomized Phase II|Protocol Violation|0|||
147121731|NCT01064622|530608964|FG001|Randomized Phase II|Protocol Violation|1|||
147121732|NCT01245049|530608965|FG000|Overall Study|Migrated/moved from study area|0|||
147121733|NCT01245049|530608966|FG001|Overall Study|Migrated/moved from study area|1|||
147121734|NCT01245049|530608965|FG000|Overall Study|Withdrawal by Subject|0|||
147121735|NCT01245049|530608966|FG001|Overall Study|Withdrawal by Subject|1|||
147232164|NCT03605212|531023045|FG003|Treatment Period|Physician Decision|0|||
147232165|NCT03605212|531023046|FG004|Treatment Period|Physician Decision|1|||
147232166|NCT01254292|531023047|FG000|Comparative Phase|Adverse Event|25|||
147232167|NCT01254292|531023048|FG001|Comparative Phase|Adverse Event|25|||
147121736|NCT01245049|530608965|FG000|Overall Study|Lost to Follow-up|1|||
147121737|NCT01245049|530608966|FG001|Overall Study|Lost to Follow-up|2|||
147121738|NCT02151604|530608967|FG000|Overall Study|Lost to Follow-up|3|||
147121739|NCT02151604|530608967|FG000|Overall Study|Withdrawal by Subject|2|||
147121740|NCT02151604|530608967|FG000|Overall Study|Physician Decision|3|||
147121741|NCT02151604|530608967|FG000|Overall Study|Death|1|||
147121742|NCT04495478|530608969|FG000|Overall Study|Withdrawal by Subject|0|||
147121743|NCT04495478|530608970|FG001|Overall Study|Withdrawal by Subject|0|||
147121744|NCT04495478|530608971|FG002|Overall Study|Withdrawal by Subject|0|||
147121745|NCT04495478|530608972|FG003|Overall Study|Withdrawal by Subject|1|||
147121746|NCT04495478|530608973|FG004|Overall Study|Withdrawal by Subject|0|||
147121747|NCT04495478|530608974|FG005|Overall Study|Withdrawal by Subject|0|||
147121748|NCT04495478|530608975|FG006|Overall Study|Withdrawal by Subject|0|||
147121749|NCT04495478|530608969|FG000|Overall Study|Physician Decision|0|||
147121750|NCT04495478|530608970|FG001|Overall Study|Physician Decision|1|||
147121751|NCT04495478|530608971|FG002|Overall Study|Physician Decision|0|||
147121752|NCT04495478|530608972|FG003|Overall Study|Physician Decision|0|||
147121753|NCT04495478|530608973|FG004|Overall Study|Physician Decision|1|||
147121754|NCT04495478|530608974|FG005|Overall Study|Physician Decision|0|||
147121755|NCT04495478|530608975|FG006|Overall Study|Physician Decision|0|||
147121756|NCT03178942|530608976|FG000|Overall Study|Withdrawal by Subject|2|||
147121757|NCT03178942|530608977|FG001|Overall Study|Withdrawal by Subject|0|||
147121758|NCT03178942|530608976|FG000|Overall Study|Lost to Follow-up|1|||
147121759|NCT03178942|530608977|FG001|Overall Study|Lost to Follow-up|2|||
147121760|NCT06097273|530608978|FG000|Overall Study|Death|2|||
147121761|NCT06097273|530608979|FG001|Overall Study|Death|1|||
147121762|NCT06097273|530608980|FG002|Overall Study|Death|2|||
147121763|NCT06097273|530608981|FG003|Overall Study|Death|2|||
147121764|NCT06097273|530608978|FG000|Overall Study|Lost to Follow-up|27|||
147121765|NCT06097273|530608979|FG001|Overall Study|Lost to Follow-up|18|||
147121766|NCT06097273|530608980|FG002|Overall Study|Lost to Follow-up|36|||
147121767|NCT06097273|530608981|FG003|Overall Study|Lost to Follow-up|31|||
147121768|NCT06097273|530608978|FG000|Overall Study|Physician Decision|0|||
147121769|NCT06097273|530608979|FG001|Overall Study|Physician Decision|1|||
147121770|NCT06097273|530608980|FG002|Overall Study|Physician Decision|0|||
147121771|NCT06097273|530608981|FG003|Overall Study|Physician Decision|3|||
147121772|NCT06097273|530608978|FG000|Overall Study|Protocol Violation|1|||
147121773|NCT06097273|530608979|FG001|Overall Study|Protocol Violation|1|||
147121774|NCT06097273|530608980|FG002|Overall Study|Protocol Violation|2|||
147121775|NCT06097273|530608981|FG003|Overall Study|Protocol Violation|1|||
147121776|NCT06097273|530608978|FG000|Overall Study|Withdrawal by Subject|14|||
147121777|NCT06097273|530608979|FG001|Overall Study|Withdrawal by Subject|11|||
147121778|NCT06097273|530608980|FG002|Overall Study|Withdrawal by Subject|14|||
147121779|NCT06097273|530608981|FG003|Overall Study|Withdrawal by Subject|15|||
147121780|NCT06097273|530608978|FG000|Overall Study|Other Than Specified|7|||
147121781|NCT06097273|530608979|FG001|Overall Study|Other Than Specified|3|||
147121782|NCT06097273|530608980|FG002|Overall Study|Other Than Specified|11|||
147121783|NCT06097273|530608981|FG003|Overall Study|Other Than Specified|6|||
147121784|NCT00326495|530610424|FG000|Overall Study|Switched to alternative treatment|1|||
147121785|NCT00326495|530610424|FG000|Overall Study|Disease progression before treatment|1|||
147121786|NCT00326495|530610424|FG000|Overall Study|Refused further treatment|2|||
147121787|NCT00326495|530610424|FG000|Overall Study|Subject off study before assessment|1|||
147121788|NCT02933151|530610425|FG000|Overall Study|Lost to Follow-up|19|||
147568106|NCT01001208|532238414|FG001|Overall Study|Noncompliance|7|||
147568107|NCT01001208|532238413|FG000|Overall Study|Disease Progression|0|||
147568108|NCT01001208|532238414|FG001|Overall Study|Disease Progression|3|||
147568109|NCT01001208|532238413|FG000|Overall Study|Other|0|||
147568110|NCT01001208|532238414|FG001|Overall Study|Other|2|||
147568111|NCT00833937|532238415|FG000|Washout|Withdrawal by Subject|1|||
147568112|NCT00833937|532238416|FG001|Washout|Withdrawal by Subject|0|||
147568113|NCT00095212|532238417|FG000|Overall Study|Withdrawal by Subject|1|||
147121789|NCT02933151|530610426|FG001|Overall Study|Lost to Follow-up|18|||
147121790|NCT02933151|530610425|FG000|Overall Study|Death|1732|||
147121791|NCT02933151|530610426|FG001|Overall Study|Death|1827|||
147121792|NCT02933151|530610425|FG000|Overall Study|Transplant|210|||
147568114|NCT00095212|532238418|FG001|Overall Study|Withdrawal by Subject|3|||
147568115|NCT02032888|532238422|FG000|Treatment Period|Poor compliance/noncompliance|1|||
147568116|NCT02032888|532238423|FG001|Treatment Period|Poor compliance/noncompliance|1|||
147568117|NCT02032888|532238424|FG002|Treatment Period|Poor compliance/noncompliance|0|||
147568118|NCT02032888|532238422|FG000|Treatment Period|Other|1|||
147121793|NCT02933151|530610426|FG001|Overall Study|Transplant|278|||
147121794|NCT02933151|530610425|FG000|Overall Study|Withdrawal from HD (Death equivalent analytically)|24|||
147121795|NCT02933151|530610426|FG001|Overall Study|Withdrawal from HD (Death equivalent analytically)|29|||
147121796|NCT02933151|530610425|FG000|Overall Study|Transferred to PD or a non-DCI facility|516|||
147121797|NCT02933151|530610426|FG001|Overall Study|Transferred to PD or a non-DCI facility|632|||
147121798|NCT02933151|530610425|FG000|Overall Study|Recovered Kidney Function|47|||
147121799|NCT02933151|530610426|FG001|Overall Study|Recovered Kidney Function|29|||
147121800|NCT00394472|530610427|FG000|Overall Study|Protocol Violation|1|||
147121801|NCT00394472|530610428|FG001|Overall Study|Protocol Violation|3|||
147121802|NCT00394472|530610427|FG000|Overall Study|incorrect enrolment|4|||
147121803|NCT00394472|530610428|FG001|Overall Study|incorrect enrolment|2|||
147121804|NCT00394472|530610427|FG000|Overall Study|Adverse Event|4|||
147121805|NCT00394472|530610428|FG001|Overall Study|Adverse Event|2|||
147121806|NCT00394472|530610427|FG000|Overall Study|Withdrawal by Subject|0|||
147121807|NCT00394472|530610428|FG001|Overall Study|Withdrawal by Subject|2|||
147121808|NCT00394472|530610427|FG000|Overall Study|Physician Decision|0|||
147121809|NCT00394472|530610428|FG001|Overall Study|Physician Decision|1|||
147121810|NCT00394472|530610427|FG000|Overall Study|Lost to Follow-up|0|||
147121811|NCT00394472|530610428|FG001|Overall Study|Lost to Follow-up|1|||
147121812|NCT01013870|530610429|FG000|Overall Study|Lost to Follow-up|1|||
147121813|NCT01013870|530610430|FG001|Overall Study|Lost to Follow-up|3|||
147121814|NCT01755156|530610431|FG000|Phase A (Weeks 0-24)|Adverse Event|2|||
147121815|NCT01755156|530610432|FG001|Phase A (Weeks 0-24)|Adverse Event|3|||
147121816|NCT01755156|530610431|FG000|Phase A (Weeks 0-24)|Lack of Efficacy|1|||
147121817|NCT01755156|530610432|FG001|Phase A (Weeks 0-24)|Lack of Efficacy|0|||
147121818|NCT01755156|530610431|FG000|Phase A (Weeks 0-24)|Lost to Follow-up|5|||
147121819|NCT01755156|530610432|FG001|Phase A (Weeks 0-24)|Lost to Follow-up|3|||
147121820|NCT01755156|530610431|FG000|Phase A (Weeks 0-24)|Non-compliance with study drug|1|||
147121821|NCT01755156|530610432|FG001|Phase A (Weeks 0-24)|Non-compliance with study drug|0|||
147121822|NCT01755156|530610431|FG000|Phase A (Weeks 0-24)|Physician Decision|0|||
147121823|NCT01755156|530610432|FG001|Phase A (Weeks 0-24)|Physician Decision|1|||
147121824|NCT01755156|530610431|FG000|Phase A (Weeks 0-24)|Protocol Violation|1|||
147121825|NCT01755156|530610432|FG001|Phase A (Weeks 0-24)|Protocol Violation|1|||
147121826|NCT01755156|530610431|FG000|Phase A (Weeks 0-24)|Withdrawal by Subject|6|||
147121827|NCT01755156|530610432|FG001|Phase A (Weeks 0-24)|Withdrawal by Subject|13|||
147121828|NCT01755156|530610431|FG000|Phase A (Weeks 0-24)|Creatinine or eGFR Discon. Criteria|0|||
147121829|NCT01755156|530610432|FG001|Phase A (Weeks 0-24)|Creatinine or eGFR Discon. Criteria|2|||
147121830|NCT01755156|530610431|FG000|Phase A (Weeks 0-24)|Need for Excluded Med. Discon. Criteria|1|||
147121831|NCT01755156|530610432|FG001|Phase A (Weeks 0-24)|Need for Excluded Med. Discon. Criteria|1|||
147121832|NCT01755156|530610431|FG000|Phase B (Weeks 24-104)|Lost to Follow-up|12|||
147121833|NCT01755156|530610432|FG001|Phase B (Weeks 24-104)|Lost to Follow-up|5|||
147121834|NCT01755156|530610431|FG000|Phase B (Weeks 24-104)|Withdrawal by Subject|27|||
147121835|NCT01755156|530610432|FG001|Phase B (Weeks 24-104)|Withdrawal by Subject|31|||
147121836|NCT01292473|530610433|FG000|Overall Study|Adverse Event|1|||
147121837|NCT01292473|530610434|FG001|Overall Study|Adverse Event|0|||
147121838|NCT01292473|530610435|FG002|Overall Study|Adverse Event|1|||
147121839|NCT01292473|530610436|FG003|Overall Study|Adverse Event|1|||
147313732|NCT02302066|531315236|FG003|Overall Study|Lost to Follow-up|7|||
147313733|NCT02302066|531315233|FG000|Overall Study|Withdrawal by Subject|25|||
147313734|NCT02302066|531315234|FG001|Overall Study|Withdrawal by Subject|58|||
147313735|NCT02302066|531315235|FG002|Overall Study|Withdrawal by Subject|124|||
147313736|NCT02302066|531315236|FG003|Overall Study|Withdrawal by Subject|33|||
147313737|NCT02302066|531315233|FG000|Overall Study|Pregnancy|2|||
147313738|NCT02302066|531315234|FG001|Overall Study|Pregnancy|10|||
147313739|NCT02302066|531315235|FG002|Overall Study|Pregnancy|12|||
147313740|NCT02302066|531315236|FG003|Overall Study|Pregnancy|0|||
147121840|NCT01292473|530610433|FG000|Overall Study|Lost to Follow-up|1|||
147121841|NCT01292473|530610434|FG001|Overall Study|Lost to Follow-up|1|||
147121842|NCT01292473|530610435|FG002|Overall Study|Lost to Follow-up|2|||
147121843|NCT01292473|530610436|FG003|Overall Study|Lost to Follow-up|2|||
147121844|NCT01292473|530610433|FG000|Overall Study|Withdrawal by Subject|3|||
147121845|NCT01292473|530610434|FG001|Overall Study|Withdrawal by Subject|4|||
147121846|NCT01292473|530610435|FG002|Overall Study|Withdrawal by Subject|3|||
147121847|NCT01292473|530610436|FG003|Overall Study|Withdrawal by Subject|3|||
147121848|NCT01292473|530610433|FG000|Overall Study|Physician Decision|0|||
147121849|NCT01292473|530610434|FG001|Overall Study|Physician Decision|1|||
147313741|NCT02302066|531315233|FG000|Overall Study|Reason Not Specified|1|||
147313742|NCT02302066|531315234|FG001|Overall Study|Reason Not Specified|1|||
147313743|NCT02302066|531315235|FG002|Overall Study|Reason Not Specified|9|||
147568119|NCT02032888|532238423|FG001|Treatment Period|Other|1|||
147568120|NCT02032888|532238424|FG002|Treatment Period|Other|0|||
147121850|NCT01292473|530610435|FG002|Overall Study|Physician Decision|0|||
147121851|NCT01292473|530610436|FG003|Overall Study|Physician Decision|0|||
147121852|NCT01292473|530610433|FG000|Overall Study|Disease Progression|0|||
147121853|NCT01292473|530610434|FG001|Overall Study|Disease Progression|1|||
147121854|NCT01292473|530610435|FG002|Overall Study|Disease Progression|3|||
147121855|NCT01292473|530610436|FG003|Overall Study|Disease Progression|6|||
147121856|NCT04432298|530610437|FG000|Overall Study|Other than specified|1|||
147121857|NCT04432298|530610438|FG001|Overall Study|Other than specified|0|||
147121858|NCT04432298|530610437|FG000|Overall Study|Lost to Follow-up|0|||
147121859|NCT04432298|530610438|FG001|Overall Study|Lost to Follow-up|1|||
147121860|NCT04432298|530610437|FG000|Overall Study|Death|3|||
147121861|NCT04432298|530610438|FG001|Overall Study|Death|2|||
147313744|NCT02302066|531315236|FG003|Overall Study|Reason Not Specified|1|||
147444594|NCT00884273|531792647|FG001|Overall Study|Practical reasons|0|||
147121862|NCT04432298|530610437|FG000|Overall Study|Withdrawal by Subject|2|||
147121863|NCT04432298|530610438|FG001|Overall Study|Withdrawal by Subject|0|||
147121864|NCT02451007|530610441|FG000|Overall Study|Withdrawal by Subject|4|||
147121865|NCT02451007|530610441|FG000|Overall Study|Adverse Event|1|||
147121866|NCT02451007|530610441|FG000|Overall Study|Disease Progression|2|||
147121867|NCT02105012|530610451|FG000|Overall Study|Withdrawal by Subject|11|||
147121868|NCT02105012|530610451|FG000|Overall Study|Protocol Specified Criteria|9|||
147121869|NCT02105012|530610451|FG000|Overall Study|Lost to Follow-up|4|||
147121870|NCT02105012|530610451|FG000|Overall Study|Protocol Violation|4|||
147121871|NCT02105012|530610451|FG000|Overall Study|Physician Decision|3|||
147121872|NCT02105012|530610451|FG000|Overall Study|Adverse Event|1|||
147121873|NCT02105012|530610451|FG000|Overall Study|Lack of Efficacy|1|||
147121874|NCT00474968|530610456|FG000|Overall Study|Withdrawal by Subject|8|||
147121875|NCT00474968|530610457|FG001|Overall Study|Withdrawal by Subject|7|||
147121876|NCT00474968|530610456|FG000|Overall Study|Protocol Violation|9|||
147121877|NCT00474968|530610457|FG001|Overall Study|Protocol Violation|8|||
147121878|NCT00474968|530610456|FG000|Overall Study|Sample not collected|1|||
147121879|NCT00474968|530610457|FG001|Overall Study|Sample not collected|1|||
147121880|NCT00215553|530610458|FG000|Overall Study|Adverse Event|0|||
147121881|NCT00215553|530610459|FG001|Overall Study|Adverse Event|1|||
147121882|NCT00215553|530610460|FG002|Overall Study|Adverse Event|2|||
147121883|NCT00215553|530610461|FG003|Overall Study|Adverse Event|1|||
147121884|NCT00215553|530610462|FG004|Overall Study|Adverse Event|2|||
147121885|NCT00215553|530610463|FG005|Overall Study|Adverse Event|6|||
147121886|NCT00215553|530610464|FG006|Overall Study|Adverse Event|0|||
147121887|NCT01429623|530610465|FG000|Overall Study|Death|1|||
147121888|NCT01429623|530610466|FG001|Overall Study|Death|0|||
147121889|NCT01429623|530610465|FG000|Overall Study|Adverse Event|7|||
147121890|NCT01429623|530610466|FG001|Overall Study|Adverse Event|14|||
147121891|NCT01429623|530610465|FG000|Overall Study|Withdrawal by Subject|19|||
147121892|NCT01429623|530610466|FG001|Overall Study|Withdrawal by Subject|13|||
147121893|NCT01429623|530610465|FG000|Overall Study|Physician Decision|2|||
147121894|NCT01429623|530610466|FG001|Overall Study|Physician Decision|3|||
147121895|NCT01429623|530610465|FG000|Overall Study|Protocol Violation|3|||
147121896|NCT01429623|530610466|FG001|Overall Study|Protocol Violation|2|||
147121897|NCT01429623|530610465|FG000|Overall Study|Assorted|1|||
147121898|NCT01429623|530610466|FG001|Overall Study|Assorted|2|||
147121899|NCT01429623|530610465|FG000|Overall Study|Conversion to Alzheimer's disease|14|||
147121900|NCT01429623|530610466|FG001|Overall Study|Conversion to Alzheimer's disease|21|||
147121901|NCT01429623|530610465|FG000|Overall Study|No post baseline data|4|||
147121902|NCT01429623|530610466|FG001|Overall Study|No post baseline data|4|||
147121903|NCT05345405|530610467|FG000|Overall Study|Withdrawal by Subject|2|||
147121904|NCT05345405|530610468|FG001|Overall Study|Withdrawal by Subject|0|||
147121905|NCT05345405|530610469|FG002|Overall Study|Withdrawal by Subject|0|||
147121906|NCT05345405|530610467|FG000|Overall Study|Did not meet eligibility criteria|0|||
147121907|NCT05345405|530610468|FG001|Overall Study|Did not meet eligibility criteria|2|||
147121908|NCT05345405|530610469|FG002|Overall Study|Did not meet eligibility criteria|0|||
147121909|NCT05345405|530610467|FG000|Overall Study|Lost to Follow-up|0|||
147121910|NCT05345405|530610468|FG001|Overall Study|Lost to Follow-up|0|||
147121911|NCT05345405|530610469|FG002|Overall Study|Lost to Follow-up|1|||
147232168|NCT01254292|531023047|FG000|Comparative Phase|Lost to Follow-up|3|||
147232169|NCT01254292|531023048|FG001|Comparative Phase|Lost to Follow-up|21|||
147568121|NCT02032888|532238422|FG000|Follow-up Period|Lost to Follow-up|1|||
147232170|NCT01254292|531023047|FG000|Comparative Phase|Pregnancy|2|||
147232171|NCT01254292|531023048|FG001|Comparative Phase|Pregnancy|6|||
147232172|NCT01254292|531023047|FG000|Comparative Phase|Withdrawal by Subject|20|||
147232173|NCT01254292|531023048|FG001|Comparative Phase|Withdrawal by Subject|21|||
147568122|NCT02032888|532238423|FG001|Follow-up Period|Lost to Follow-up|1|||
147568123|NCT02032888|532238424|FG002|Follow-up Period|Lost to Follow-up|0|||
147568124|NCT02032888|532238422|FG000|Follow-up Period|Death|1|||
147568125|NCT02032888|532238423|FG001|Follow-up Period|Death|1|||
147568126|NCT02032888|532238424|FG002|Follow-up Period|Death|0|||
147121912|NCT01550965|530610471|FG000|Overall Study|Adverse Event|26|||
147121913|NCT01550965|530610471|FG000|Overall Study|Withdrawal by Subject|10|||
147121914|NCT01550965|530610471|FG000|Overall Study|Lost to Follow-up|2|||
147121915|NCT01550965|530610471|FG000|Overall Study|Lack of Efficacy|59|||
147121916|NCT01550965|530610471|FG000|Overall Study|Other|13|||
147121917|NCT03071965|530610472|FG000|Overall Study|Adverse Event|0|||
147121918|NCT03071965|530610473|FG001|Overall Study|Adverse Event|0|||
147121919|NCT03071965|530610474|FG002|Overall Study|Adverse Event|1|||
147121920|NCT03071965|530610475|FG003|Overall Study|Adverse Event|0|||
147121921|NCT03071965|530610472|FG000|Overall Study|Death|0|||
147121922|NCT03071965|530610473|FG001|Overall Study|Death|0|||
147121923|NCT03071965|530610474|FG002|Overall Study|Death|1|||
147232174|NCT01254292|531023047|FG000|Comparative Phase|Protocol Violation|1|||
147232175|NCT01254292|531023048|FG001|Comparative Phase|Protocol Violation|2|||
147232176|NCT01254292|531023047|FG000|Comparative Phase|Wish for pregnancy|4|||
147232177|NCT01254292|531023048|FG001|Comparative Phase|Wish for pregnancy|6|||
147568127|NCT02032888|532238422|FG000|Follow-up Period|Other|1|||
147121924|NCT03071965|530610475|FG003|Overall Study|Death|1|||
147121925|NCT03071965|530610472|FG000|Overall Study|COVID-19|0|||
147121926|NCT03071965|530610473|FG001|Overall Study|COVID-19|1|||
147121927|NCT03071965|530610474|FG002|Overall Study|COVID-19|0|||
147121928|NCT03071965|530610475|FG003|Overall Study|COVID-19|1|||
147121929|NCT03071965|530610472|FG000|Overall Study|Other Health Reason|0|||
147121930|NCT03071965|530610473|FG001|Overall Study|Other Health Reason|0|||
147121931|NCT03071965|530610474|FG002|Overall Study|Other Health Reason|0|||
147121932|NCT03071965|530610475|FG003|Overall Study|Other Health Reason|1|||
147121933|NCT00986102|530610476|FG000|Overall Study|Lost to Follow-up|0|||
147121934|NCT00986102|530610477|FG001|Overall Study|Lost to Follow-up|1|||
147121935|NCT00986102|530610478|FG002|Overall Study|Lost to Follow-up|0|||
147121936|NCT00986102|530610479|FG003|Overall Study|Lost to Follow-up|1|||
147121937|NCT00986102|530610476|FG000|Overall Study|Withdrawal by Subject|1|||
147121938|NCT00986102|530610477|FG001|Overall Study|Withdrawal by Subject|1|||
147121939|NCT00986102|530610478|FG002|Overall Study|Withdrawal by Subject|0|||
147121940|NCT00986102|530610479|FG003|Overall Study|Withdrawal by Subject|0|||
147121941|NCT04135352|530610481|FG000|Overall Study|Not treated-randomization error|0|||
147121942|NCT04135352|530610482|FG001|Overall Study|Not treated-randomization error|0|||
147121943|NCT04135352|530610483|FG002|Overall Study|Not treated-randomization error|1|||
147121944|NCT04135352|530610484|FG003|Overall Study|Not treated-randomization error|0|||
147121945|NCT04135352|530610485|FG004|Overall Study|Not treated-randomization error|0|||
147121946|NCT04135352|530610486|FG005|Overall Study|Not treated-randomization error|0|||
147121947|NCT04135352|530610487|FG006|Overall Study|Not treated-randomization error|0|||
147121948|NCT04135352|530610488|FG007|Overall Study|Not treated-randomization error|0|||
147121949|NCT04135352|530610481|FG000|Overall Study|Withdrawal by Subject|0|||
147121950|NCT04135352|530610482|FG001|Overall Study|Withdrawal by Subject|0|||
147121951|NCT04135352|530610483|FG002|Overall Study|Withdrawal by Subject|2|||
147121952|NCT04135352|530610484|FG003|Overall Study|Withdrawal by Subject|0|||
147121953|NCT04135352|530610485|FG004|Overall Study|Withdrawal by Subject|0|||
147121954|NCT04135352|530610486|FG005|Overall Study|Withdrawal by Subject|0|||
147121955|NCT04135352|530610487|FG006|Overall Study|Withdrawal by Subject|0|||
147121956|NCT04135352|530610488|FG007|Overall Study|Withdrawal by Subject|0|||
147121957|NCT04135352|530610481|FG000|Overall Study|Sponsor Decision|0|||
147568128|NCT02032888|532238423|FG001|Follow-up Period|Other|0|||
147121958|NCT04135352|530610482|FG001|Overall Study|Sponsor Decision|0|||
147121959|NCT04135352|530610483|FG002|Overall Study|Sponsor Decision|2|||
147121960|NCT04135352|530610484|FG003|Overall Study|Sponsor Decision|5|||
147121961|NCT04135352|530610485|FG004|Overall Study|Sponsor Decision|1|||
147121962|NCT04135352|530610486|FG005|Overall Study|Sponsor Decision|4|||
147121963|NCT04135352|530610487|FG006|Overall Study|Sponsor Decision|0|||
147121964|NCT04135352|530610488|FG007|Overall Study|Sponsor Decision|0|||
147121965|NCT04135352|530610481|FG000|Overall Study|Physician Decision|0|||
147121966|NCT04135352|530610482|FG001|Overall Study|Physician Decision|0|||
147121967|NCT04135352|530610483|FG002|Overall Study|Physician Decision|1|||
147121968|NCT04135352|530610484|FG003|Overall Study|Physician Decision|0|||
147121969|NCT04135352|530610485|FG004|Overall Study|Physician Decision|1|||
147121970|NCT04135352|530610486|FG005|Overall Study|Physician Decision|0|||
147121971|NCT04135352|530610487|FG006|Overall Study|Physician Decision|0|||
147121972|NCT04135352|530610488|FG007|Overall Study|Physician Decision|0|||
147121973|NCT04135352|530610481|FG000|Overall Study|Death|3|||
147232178|NCT01254292|531023047|FG000|LCS12 Extension Phase|Wish for pregnancy|14|||
147232179|NCT01254292|531023048|FG001|LCS12 Extension Phase|Wish for pregnancy|0|||
147232180|NCT01254292|531023047|FG000|LCS12 Extension Phase|Adverse Event|9|||
147232181|NCT01254292|531023048|FG001|LCS12 Extension Phase|Adverse Event|0|||
147232182|NCT01254292|531023047|FG000|LCS12 Extension Phase|Withdrawal by Subject|7|||
147568129|NCT02032888|532238424|FG002|Follow-up Period|Other|0|||
147568130|NCT01697696|532238425|FG000|Overall Study|Study terminated by sponsor|0|||
147568131|NCT01697696|532238426|FG001|Overall Study|Study terminated by sponsor|3|||
147121974|NCT04135352|530610482|FG001|Overall Study|Death|4|||
147121975|NCT04135352|530610483|FG002|Overall Study|Death|7|||
147568132|NCT01697696|532238425|FG000|Overall Study|Protocol deviation|1|||
147568133|NCT01697696|532238426|FG001|Overall Study|Protocol deviation|0|||
147121976|NCT04135352|530610484|FG003|Overall Study|Death|0|||
147121977|NCT04135352|530610485|FG004|Overall Study|Death|3|||
147121978|NCT04135352|530610486|FG005|Overall Study|Death|1|||
147121979|NCT04135352|530610487|FG006|Overall Study|Death|0|||
147121980|NCT04135352|530610488|FG007|Overall Study|Death|0|||
147121981|NCT00819832|530610493|FG000|Overall Study|Sponsor Termination of Study|3|||
147121982|NCT00819832|530610494|FG001|Overall Study|Sponsor Termination of Study|0|||
147121983|NCT00819832|530610495|FG002|Overall Study|Sponsor Termination of Study|0|||
147121984|NCT00819832|530610496|FG003|Overall Study|Sponsor Termination of Study|0|||
147121985|NCT00819832|530610497|FG004|Overall Study|Sponsor Termination of Study|0|||
147121986|NCT00819832|530610498|FG005|Overall Study|Sponsor Termination of Study|0|||
147121987|NCT01063881|530610499|FG000|Overall Study|Adverse Event|12|||
147121988|NCT01063881|530610500|FG001|Overall Study|Adverse Event|2|||
147232183|NCT01254292|531023048|FG001|LCS12 Extension Phase|Withdrawal by Subject|0|||
147232184|NCT01254292|531023047|FG000|LCS12 Extension Phase|Other unknown|4|||
147121989|NCT01063881|530610501|FG002|Overall Study|Adverse Event|0|||
147121990|NCT01063881|530610499|FG000|Overall Study|Lost to Follow-up|13|||
147121991|NCT01063881|530610500|FG001|Overall Study|Lost to Follow-up|7|||
147121992|NCT01063881|530610501|FG002|Overall Study|Lost to Follow-up|1|||
147121993|NCT01063881|530610499|FG000|Overall Study|Withdrawal by Subject|25|||
147121994|NCT01063881|530610500|FG001|Overall Study|Withdrawal by Subject|1|||
147121995|NCT01063881|530610501|FG002|Overall Study|Withdrawal by Subject|0|||
147121996|NCT01063881|530610499|FG000|Overall Study|Reason for not completed not specified|5|||
147121997|NCT01063881|530610500|FG001|Overall Study|Reason for not completed not specified|1|||
147121998|NCT01063881|530610501|FG002|Overall Study|Reason for not completed not specified|0|||
147121999|NCT01309100|530610502|FG000|Overall Study|Protocol Violation|1|||
147122000|NCT01309100|530610502|FG000|Overall Study|Positive Slit lamp finding|1|||
147122001|NCT01452789|530610505|FG000|Overall Study|Withdrawal by Subject|3|||
147122002|NCT01452789|530610506|FG001|Overall Study|Withdrawal by Subject|2|||
147122003|NCT01340170|530610507|FG000|Overall Study|Lost to Follow-up|2|||
147122004|NCT01340170|530610508|FG001|Overall Study|Lost to Follow-up|4|||
147122005|NCT01340170|530610509|FG002|Overall Study|Lost to Follow-up|0|||
147122006|NCT01340170|530610507|FG000|Overall Study|Implant failure|1|||
147313745|NCT02180438|531315252|FG000|Overall Study|Lost to Follow-up|1|||
147122007|NCT01340170|530610508|FG001|Overall Study|Implant failure|3|||
147122008|NCT01340170|530610509|FG002|Overall Study|Implant failure|0|||
147122009|NCT01248468|530610511|FG000|Overall Study|Administrative problem|1|||
147122010|NCT01248468|530610512|FG001|Overall Study|Administrative problem|0|||
147313746|NCT02058290|531315253|FG000|Overall Study|Protocol Violation|2|||
147313747|NCT02058290|531315254|FG001|Overall Study|Protocol Violation|1|||
147313748|NCT02058290|531315253|FG000|Overall Study|Physician Decision|1|||
147313749|NCT02058290|531315254|FG001|Overall Study|Physician Decision|0|||
147313750|NCT02058290|531315253|FG000|Overall Study|Didn't meet intraoperative criteria|8|||
147313751|NCT02058290|531315254|FG001|Overall Study|Didn't meet intraoperative criteria|7|||
147313752|NCT02058290|531315253|FG000|Overall Study|Withdrawal by Subject|0|||
147313753|NCT02058290|531315254|FG001|Overall Study|Withdrawal by Subject|1|||
147568134|NCT01697696|532238425|FG000|Overall Study|Physician Decision|1|||
147122011|NCT01248468|530610513|FG002|Overall Study|Administrative problem|0|||
147122012|NCT01248468|530610511|FG000|Overall Study|Lost to Follow-up|9|||
147122013|NCT01248468|530610512|FG001|Overall Study|Lost to Follow-up|12|||
147122014|NCT01248468|530610513|FG002|Overall Study|Lost to Follow-up|4|||
147122015|NCT01248468|530610511|FG000|Overall Study|Pregnancy|1|||
147122016|NCT01248468|530610512|FG001|Overall Study|Pregnancy|0|||
147122017|NCT01248468|530610513|FG002|Overall Study|Pregnancy|0|||
147122018|NCT01248468|530610511|FG000|Overall Study|Withdrawal by Subject|4|||
147122019|NCT01248468|530610512|FG001|Overall Study|Withdrawal by Subject|2|||
147122020|NCT01248468|530610513|FG002|Overall Study|Withdrawal by Subject|0|||
147122021|NCT01905267|530610517|FG000|Overall Study|Physician Decision|2|||
147122022|NCT01905267|530610518|FG001|Overall Study|Physician Decision|2|||
147122023|NCT03438656|530610519|FG000|Overall Study|Lost to Follow-up|2|||
147122024|NCT04128228|530610522|FG000|Overall Study|Withdrawal by Subject|3|||
147122025|NCT04128228|530610523|FG001|Overall Study|Withdrawal by Subject|3|||
147122026|NCT04128228|530610524|FG002|Overall Study|Withdrawal by Subject|0|||
147122027|NCT04128228|530610525|FG003|Overall Study|Withdrawal by Subject|0|||
147122028|NCT04128228|530610522|FG000|Overall Study|noncompliance|2|||
147122029|NCT04128228|530610523|FG001|Overall Study|noncompliance|2|||
147122030|NCT04128228|530610524|FG002|Overall Study|noncompliance|0|||
147122031|NCT04128228|530610525|FG003|Overall Study|noncompliance|0|||
147122032|NCT03520387|530610526|FG000|Pre-Randomization|Withdrawal by Subject|1|||
147122033|NCT03520387|530610527|FG001|Pre-Randomization|Withdrawal by Subject|0|||
147122034|NCT03520387|530610528|FG002|Pre-Randomization|Withdrawal by Subject|0|||
147122035|NCT03520387|530610529|FG003|Pre-Randomization|Withdrawal by Subject|0|||
147122036|NCT03520387|530610530|FG004|Pre-Randomization|Withdrawal by Subject|0|||
147122037|NCT03520387|530610526|FG000|Pre-Randomization|Failed eligibility criteria or run-in period criteria|2|||
147122038|NCT03520387|530610527|FG001|Pre-Randomization|Failed eligibility criteria or run-in period criteria|0|||
147122039|NCT03520387|530610528|FG002|Pre-Randomization|Failed eligibility criteria or run-in period criteria|0|||
147122040|NCT03520387|530610529|FG003|Pre-Randomization|Failed eligibility criteria or run-in period criteria|0|||
147313754|NCT00785707|531315256|FG000|Overall Study|Lost to Follow-up|7|||
147313755|NCT00105586|531315259|FG000|Overall Study|Adverse Event|4|||
147568135|NCT01697696|532238426|FG001|Overall Study|Physician Decision|0|||
147568136|NCT01697696|532238425|FG000|Overall Study|Death|4|||
147568137|NCT01697696|532238426|FG001|Overall Study|Death|2|||
147568138|NCT01697696|532238425|FG000|Overall Study|Lost to Follow-up|10|||
147122041|NCT03520387|530610530|FG004|Pre-Randomization|Failed eligibility criteria or run-in period criteria|0|||
147122042|NCT05652140|530610531|FG000|Overall Study|Lost to Follow-up|7|||
147122043|NCT05652140|530610532|FG001|Overall Study|Lost to Follow-up|16|||
147313756|NCT00105586|531315260|FG001|Overall Study|Adverse Event|3|||
147313757|NCT00105586|531315259|FG000|Overall Study|Physician Decision|13|||
147568139|NCT01697696|532238426|FG001|Overall Study|Lost to Follow-up|7|||
147568140|NCT01697696|532238425|FG000|Overall Study|Subject/guardian decision|31|||
147568141|NCT01697696|532238426|FG001|Overall Study|Subject/guardian decision|35|||
147568142|NCT01424644|532238427|FG000|Overall Study|Adverse Event|2|||
147122044|NCT05652140|530610533|FG002|Overall Study|Lost to Follow-up|22|||
147122045|NCT05652140|530610534|FG003|Overall Study|Lost to Follow-up|31|||
147122046|NCT04648241|530610536|FG000|Overall Study|Lost to Follow-up|1|||
147122047|NCT04648241|530610537|FG001|Overall Study|Lost to Follow-up|0|||
147122048|NCT04401293|530610538|FG000|Overall Study|Withdrawal by Subject|1|||
147122049|NCT04401293|530610539|FG001|Overall Study|Withdrawal by Subject|3|||
147122050|NCT03679884|530610540|FG000|Overall Study|Other|12|||
147122051|NCT03679884|530610541|FG001|Overall Study|Other|12|||
147122052|NCT03679884|530610542|FG002|Overall Study|Other|12|||
147122053|NCT03679884|530610543|FG003|Overall Study|Other|7|||
147122054|NCT03679884|530610544|FG004|Overall Study|Other|8|||
147122055|NCT03679884|530610540|FG000|Overall Study|Lack of Efficacy|15|||
147122056|NCT03679884|530610541|FG001|Overall Study|Lack of Efficacy|29|||
147122057|NCT03679884|530610542|FG002|Overall Study|Lack of Efficacy|13|||
147122058|NCT03679884|530610543|FG003|Overall Study|Lack of Efficacy|29|||
147122059|NCT03679884|530610544|FG004|Overall Study|Lack of Efficacy|10|||
147122060|NCT03679884|530610540|FG000|Overall Study|Death|1|||
147122061|NCT03679884|530610541|FG001|Overall Study|Death|0|||
147122062|NCT03679884|530610542|FG002|Overall Study|Death|0|||
147122063|NCT03679884|530610543|FG003|Overall Study|Death|0|||
147122064|NCT03679884|530610544|FG004|Overall Study|Death|0|||
147122065|NCT03679884|530610540|FG000|Overall Study|Adverse Event|2|||
147122066|NCT03679884|530610541|FG001|Overall Study|Adverse Event|10|||
147122067|NCT03679884|530610542|FG002|Overall Study|Adverse Event|9|||
147122068|NCT03679884|530610543|FG003|Overall Study|Adverse Event|6|||
147122069|NCT03679884|530610544|FG004|Overall Study|Adverse Event|6|||
147122070|NCT03679884|530610540|FG000|Overall Study|Withdrawal by Subject|12|||
147122071|NCT03679884|530610541|FG001|Overall Study|Withdrawal by Subject|23|||
147122072|NCT03679884|530610542|FG002|Overall Study|Withdrawal by Subject|8|||
147122073|NCT03679884|530610543|FG003|Overall Study|Withdrawal by Subject|8|||
147122074|NCT03679884|530610544|FG004|Overall Study|Withdrawal by Subject|9|||
147122075|NCT03679884|530610540|FG000|Overall Study|Lost to Follow-up|1|||
147122076|NCT03679884|530610541|FG001|Overall Study|Lost to Follow-up|4|||
147122077|NCT03679884|530610542|FG002|Overall Study|Lost to Follow-up|2|||
147122078|NCT03679884|530610543|FG003|Overall Study|Lost to Follow-up|0|||
147122079|NCT03679884|530610544|FG004|Overall Study|Lost to Follow-up|3|||
147122080|NCT01026038|530610545|FG000|Overall Study|Lost to Follow-up|1|||
147122081|NCT01026038|530610546|FG001|Overall Study|Lost to Follow-up|1|||
147122082|NCT01026038|530610547|FG002|Overall Study|Lost to Follow-up|0|||
147122083|NCT02774278|530610548|FG000|Overall Study|Lack of Efficacy|199|||
147122084|NCT02774278|530610548|FG000|Overall Study|Death|29|||
147122085|NCT02774278|530610548|FG000|Overall Study|Adverse event/intercurrent illness|16|||
147122086|NCT02774278|530610548|FG000|Overall Study|Refused treatment/did not cooperate|9|||
147122087|NCT02774278|530610548|FG000|Overall Study|Administrative reasons|6|||
147122088|NCT02774278|530610548|FG000|Overall Study|Withdrawal by Subject|3|||
147122089|NCT02774278|530610548|FG000|Overall Study|Protocol Violation|2|||
147122090|NCT03339453|530610558|FG000|First Visit of Glucagon Treatment|Adverse Event|0|||
147122091|NCT03339453|530610559|FG001|First Visit of Glucagon Treatment|Adverse Event|1|||
147122092|NCT02946996|530610565|FG000|Overall Study|non-evaluable|3|||
147122093|NCT02946996|530610566|FG001|Overall Study|non-evaluable|6|||
147122094|NCT02946996|530610567|FG002|Overall Study|non-evaluable|5|||
147122095|NCT06868667|530610568|FG000|Overall Study|Death|0|||
147122096|NCT06868667|530610569|FG001|Overall Study|Death|4|||
147122097|NCT06868667|530610568|FG000|Overall Study|Lost to Follow-up|0|||
147122098|NCT06868667|530610569|FG001|Overall Study|Lost to Follow-up|1|||
147122099|NCT06868667|530610568|FG000|Overall Study|Withdrawal by Subject|1|||
147122100|NCT06868667|530610569|FG001|Overall Study|Withdrawal by Subject|0|||
147122101|NCT06868667|530610568|FG000|Overall Study|Ongoing|9|||
147122102|NCT06868667|530610569|FG001|Overall Study|Ongoing|9|||
147122103|NCT05330429|530610572|FG000|Overall Study|Study Terminated by Sponsor|4|||
147122104|NCT05330429|530610573|FG001|Overall Study|Study Terminated by Sponsor|33|||
147122105|NCT05330429|530610574|FG002|Overall Study|Study Terminated by Sponsor|12|||
147122106|NCT05330429|530610572|FG000|Overall Study|Death|5|||
147122107|NCT05330429|530610573|FG001|Overall Study|Death|2|||
147122108|NCT05330429|530610574|FG002|Overall Study|Death|4|||
147122109|NCT05330429|530610572|FG000|Overall Study|Withdrew Consent|0|||
147122110|NCT05330429|530610573|FG001|Overall Study|Withdrew Consent|5|||
147122111|NCT05330429|530610574|FG002|Overall Study|Withdrew Consent|4|||
147122112|NCT05330429|530610572|FG000|Overall Study|Investigator's Discretion|0|||
147122113|NCT05330429|530610573|FG001|Overall Study|Investigator's Discretion|1|||
147122114|NCT05330429|530610574|FG002|Overall Study|Investigator's Discretion|3|||
147122115|NCT05330429|530610572|FG000|Overall Study|Subject Decision|1|||
147122116|NCT05330429|530610573|FG001|Overall Study|Subject Decision|2|||
147122117|NCT05330429|530610574|FG002|Overall Study|Subject Decision|0|||
147122118|NCT05330429|530610572|FG000|Overall Study|Lost to Follow-up|0|||
147444595|NCT00258674|531792648|FG000|Overall Study|Death|32|||
147122119|NCT05330429|530610573|FG001|Overall Study|Lost to Follow-up|1|||
147122120|NCT05330429|530610574|FG002|Overall Study|Lost to Follow-up|0|||
147122121|NCT00450749|530610575|FG000|Overall Study|Withdrawal by Subject|0|||
147122122|NCT00450749|530610576|FG001|Overall Study|Withdrawal by Subject|0|||
147444596|NCT00258674|531792649|FG001|Overall Study|Death|53|||
147122123|NCT00450749|530610577|FG002|Overall Study|Withdrawal by Subject|2|||
147122124|NCT00450749|530610575|FG000|Overall Study|Noncompliant|0|||
147122125|NCT00450749|530610576|FG001|Overall Study|Noncompliant|1|||
147122126|NCT00450749|530610577|FG002|Overall Study|Noncompliant|0|||
147122127|NCT00655746|530610578|FG000|Overall Study|Withdrawal by Subject|1|||
147122128|NCT02931539|530610579|FG000|Period 1: Treatment Phase|Investigator discretion|1|||
147122129|NCT02931539|530610580|FG001|Period 1: Treatment Phase|Investigator discretion|1|||
147122130|NCT02931539|530610581|FG002|Period 1: Treatment Phase|Investigator discretion|0|||
147122131|NCT02931539|530610579|FG000|Period 1: Treatment Phase|Adverse Event|5|||
147122132|NCT02931539|530610580|FG001|Period 1: Treatment Phase|Adverse Event|1|||
147122133|NCT02931539|530610581|FG002|Period 1: Treatment Phase|Adverse Event|0|||
147122134|NCT02931539|530610579|FG000|Period 1: Treatment Phase|Lost to Follow-up|1|||
147122135|NCT02931539|530610580|FG001|Period 1: Treatment Phase|Lost to Follow-up|2|||
147122136|NCT02931539|530610581|FG002|Period 1: Treatment Phase|Lost to Follow-up|0|||
147122137|NCT02931539|530610579|FG000|Period 1: Treatment Phase|Death|8|||
147122138|NCT02931539|530610580|FG001|Period 1: Treatment Phase|Death|24|||
147122139|NCT02931539|530610581|FG002|Period 1: Treatment Phase|Death|0|||
147122140|NCT02931539|530610579|FG000|Period 1: Treatment Phase|Withdrawal by Subject|16|||
147122141|NCT02931539|530610580|FG001|Period 1: Treatment Phase|Withdrawal by Subject|8|||
147122142|NCT02931539|530610581|FG002|Period 1: Treatment Phase|Withdrawal by Subject|0|||
147122143|NCT02931539|530610579|FG000|Period 1: Treatment Phase|Protocol Violation|6|||
147122144|NCT02931539|530610580|FG001|Period 1: Treatment Phase|Protocol Violation|0|||
147122145|NCT02931539|530610581|FG002|Period 1: Treatment Phase|Protocol Violation|0|||
147122146|NCT02931539|530610579|FG000|Period 1: Treatment Phase|Participants transitioned into maribavir rescue arm|22|||
147122147|NCT02931539|530610580|FG001|Period 1: Treatment Phase|Participants transitioned into maribavir rescue arm|0|||
147122148|NCT02931539|530610581|FG002|Period 1: Treatment Phase|Participants transitioned into maribavir rescue arm|0|||
147122149|NCT02931539|530610579|FG000|Period 2: Maribavir Rescue Therapy|Sponsor decision|0|||
147122150|NCT02931539|530610580|FG001|Period 2: Maribavir Rescue Therapy|Sponsor decision|0|||
147122151|NCT02931539|530610581|FG002|Period 2: Maribavir Rescue Therapy|Sponsor decision|2|||
147122152|NCT01569763|530612622|FG000|Overall Study|Lack of Efficacy|2|||
147122153|NCT01569763|530612623|FG001|Overall Study|Lack of Efficacy|7|||
147122154|NCT01569763|530612622|FG000|Overall Study|Adverse Event|1|||
147122155|NCT01569763|530612623|FG001|Overall Study|Adverse Event|0|||
147122156|NCT01926509|530612624|FG000|Overall Study|vital sign met discontinuation criteria|1|||
147122157|NCT01926509|530612625|FG001|Overall Study|vital sign met discontinuation criteria|0|||
147122158|NCT01926509|530612626|FG002|Overall Study|vital sign met discontinuation criteria|0|||
147122159|NCT01926509|530612627|FG003|Overall Study|vital sign met discontinuation criteria|0|||
147122160|NCT02730169|530612628|FG000|Overall Study|Protocol Violation|1|||
147122161|NCT02730169|530612629|FG001|Overall Study|Protocol Violation|0|||
147122162|NCT02730169|530612630|FG002|Overall Study|Protocol Violation|0|||
147122163|NCT02730169|530612631|FG003|Overall Study|Protocol Violation|1|||
147122164|NCT02730169|530612628|FG000|Overall Study|Adverse Event|2|||
147122165|NCT02730169|530612629|FG001|Overall Study|Adverse Event|3|||
147122166|NCT02730169|530612630|FG002|Overall Study|Adverse Event|3|||
147122167|NCT02730169|530612631|FG003|Overall Study|Adverse Event|0|||
147122168|NCT02730169|530612628|FG000|Overall Study|Adverse Event of Special Interest|0|||
147122169|NCT02730169|530612629|FG001|Overall Study|Adverse Event of Special Interest|1|||
147122170|NCT02730169|530612630|FG002|Overall Study|Adverse Event of Special Interest|2|||
147122171|NCT02730169|530612631|FG003|Overall Study|Adverse Event of Special Interest|0|||
147122172|NCT02730169|530612628|FG000|Overall Study|Withdrawal by Subject|6|||
147122173|NCT02730169|530612629|FG001|Overall Study|Withdrawal by Subject|11|||
147122174|NCT02730169|530612630|FG002|Overall Study|Withdrawal by Subject|6|||
147122175|NCT02730169|530612631|FG003|Overall Study|Withdrawal by Subject|8|||
147122176|NCT02730169|530612628|FG000|Overall Study|Lost to Follow-up|5|||
147122177|NCT02730169|530612629|FG001|Overall Study|Lost to Follow-up|6|||
147122178|NCT02730169|530612630|FG002|Overall Study|Lost to Follow-up|5|||
147122179|NCT02730169|530612631|FG003|Overall Study|Lost to Follow-up|6|||
147122180|NCT02730169|530612628|FG000|Overall Study|Other|0|||
147122181|NCT02730169|530612629|FG001|Overall Study|Other|0|||
147232185|NCT01254292|531023048|FG001|LCS12 Extension Phase|Other unknown|0|||
147232186|NCT01254292|531023047|FG000|LCS12 Extension Phase|Pregnancy|2|||
147232187|NCT01254292|531023048|FG001|LCS12 Extension Phase|Pregnancy|0|||
147232188|NCT01254292|531023047|FG000|LCS12 Extension Phase|Lost to Follow-up|1|||
147232189|NCT01254292|531023048|FG001|LCS12 Extension Phase|Lost to Follow-up|0|||
147232190|NCT03277690|531023049|FG000|Dose Titration and Maintenance|Protocol Violation|3|||
147122182|NCT02730169|530612630|FG002|Overall Study|Other|1|||
147122183|NCT02730169|530612631|FG003|Overall Study|Other|1|||
147122184|NCT03004183|530612632|FG000|Overall Study|Adverse Event|7|||
147122185|NCT03004183|530612632|FG000|Overall Study|Lost to Follow-up|1|||
147122186|NCT03004183|530612632|FG000|Overall Study|Physician Decision|40|||
147122187|NCT03004183|530612632|FG000|Overall Study|Withdrawal by Subject|1|||
147122188|NCT03004183|530612632|FG000|Overall Study|COVID-19|1|||
147232191|NCT03277690|531023050|FG001|Dose Titration and Maintenance|Protocol Violation|0|||
147232192|NCT03277690|531023049|FG000|Dose Titration and Maintenance|Physician Decision|1|||
147122189|NCT03681093|530612633|FG000|Overall Study|Subject decision|0|||
147122190|NCT03681093|530612634|FG001|Overall Study|Subject decision|2|||
147122191|NCT03681093|530612635|FG002|Overall Study|Subject decision|1|||
147122192|NCT02529488|530612636|FG000|Overall Study|Adverse Event|1|||
147122193|NCT02529488|530612636|FG000|Overall Study|Death|3|||
147122194|NCT02698787|530612637|FG000|Second Intervention (3 Months)|Withdrawal by Subject|0|||
147122195|NCT02698787|530612638|FG001|Second Intervention (3 Months)|Withdrawal by Subject|1|||
147122196|NCT01882829|530612642|FG000|Overall Study|Adverse Event|4|||
147122197|NCT01882829|530612642|FG000|Overall Study|Protocol Violation|1|||
147122198|NCT01882829|530612642|FG000|Overall Study|Withdrawal by Subject|1|||
147122199|NCT02469961|530612648|FG000|Overall Study|Physician Decision|4|||
147122200|NCT02469961|530612649|FG001|Overall Study|Physician Decision|1|||
147122201|NCT03635996|530612653|FG000|Overall Study|Study terminated by Sponsor|94|||
147122202|NCT03635996|530612653|FG000|Overall Study|Withdrawal by Subject|20|||
147122203|NCT03635996|530612653|FG000|Overall Study|Ablation|26|||
147122204|NCT03635996|530612653|FG000|Overall Study|Adverse Event|7|||
147122205|NCT03635996|530612653|FG000|Overall Study|Physician Decision|3|||
147122206|NCT03635996|530612653|FG000|Overall Study|Prohibited medication|5|||
147122207|NCT03635996|530612653|FG000|Overall Study|Did not meet eligibility criteria|5|||
147122208|NCT03635996|530612653|FG000|Overall Study|Site closure (2), compliance with IP, directed by sponsor and site termination.|5|||
147122209|NCT03635996|530612653|FG000|Overall Study|Protocol Violation|1|||
147122210|NCT03635996|530612653|FG000|Overall Study|Lost to Follow-up|1|||
147122211|NCT02821000|530612654|FG000|Overall Study|Death|89|||
147122212|NCT02821000|530612654|FG000|Overall Study|Sponsor Decision|12|||
147122213|NCT02821000|530612654|FG000|Overall Study|Withdrawal by Subject|2|||
147122214|NCT04359680|530612655|FG000|Overall Study|Withdrawal by Subject|29|||
147122215|NCT04359680|530612656|FG001|Overall Study|Withdrawal by Subject|24|||
147122216|NCT04359680|530612655|FG000|Overall Study|Adverse Event|6|||
147122217|NCT04359680|530612656|FG001|Overall Study|Adverse Event|2|||
147122218|NCT04359680|530612655|FG000|Overall Study|Lost to Follow-up|56|||
147122219|NCT04359680|530612656|FG001|Overall Study|Lost to Follow-up|59|||
147568143|NCT01424644|532238428|FG001|Overall Study|Adverse Event|0|||
147568144|NCT01424644|532238427|FG000|Overall Study|Withdrawal by Subject|9|||
147568145|NCT01424644|532238428|FG001|Overall Study|Withdrawal by Subject|12|||
147568146|NCT01424644|532238427|FG000|Overall Study|Lost to Follow-up|16|||
147568147|NCT01424644|532238428|FG001|Overall Study|Lost to Follow-up|12|||
147568148|NCT01424644|532238427|FG000|Overall Study|Protocol Violation|4|||
147568149|NCT01424644|532238428|FG001|Overall Study|Protocol Violation|3|||
147568150|NCT01424644|532238427|FG000|Overall Study|Administrative Reason|1|||
147568151|NCT01424644|532238428|FG001|Overall Study|Administrative Reason|0|||
147122220|NCT04359680|530612655|FG000|Overall Study|Protocol Violation|3|||
147122221|NCT04359680|530612656|FG001|Overall Study|Protocol Violation|5|||
147122222|NCT04359680|530612655|FG000|Overall Study|Physician Decision|1|||
147122223|NCT04359680|530612656|FG001|Overall Study|Physician Decision|1|||
147122224|NCT04359680|530612655|FG000|Overall Study|Sponsor Decision|0|||
147122225|NCT04359680|530612656|FG001|Overall Study|Sponsor Decision|1|||
147122226|NCT02596893|530612657|FG000|Overall Double-Blind Period Weeks 0-52|Study Terminated by Sponsor|61|||
147122227|NCT02596893|530612658|FG001|Overall Double-Blind Period Weeks 0-52|Study Terminated by Sponsor|56|||
147122228|NCT02596893|530612659|FG002|Overall Double-Blind Period Weeks 0-52|Study Terminated by Sponsor|48|||
147122229|NCT02596893|530612660|FG003|Overall Double-Blind Period Weeks 0-52|Study Terminated by Sponsor|58|||
147122230|NCT02596893|530612657|FG000|Overall Double-Blind Period Weeks 0-52|Adverse Event|11|||
147122231|NCT02596893|530612658|FG001|Overall Double-Blind Period Weeks 0-52|Adverse Event|15|||
147122232|NCT02596893|530612659|FG002|Overall Double-Blind Period Weeks 0-52|Adverse Event|15|||
147122233|NCT02596893|530612660|FG003|Overall Double-Blind Period Weeks 0-52|Adverse Event|12|||
147122234|NCT02596893|530612657|FG000|Overall Double-Blind Period Weeks 0-52|Pregnancy|0|||
147122235|NCT02596893|530612658|FG001|Overall Double-Blind Period Weeks 0-52|Pregnancy|0|||
147122236|NCT02596893|530612659|FG002|Overall Double-Blind Period Weeks 0-52|Pregnancy|0|||
147122237|NCT02596893|530612660|FG003|Overall Double-Blind Period Weeks 0-52|Pregnancy|1|||
147122238|NCT02596893|530612657|FG000|Overall Double-Blind Period Weeks 0-52|Lack of Efficacy|15|||
147122239|NCT02596893|530612658|FG001|Overall Double-Blind Period Weeks 0-52|Lack of Efficacy|14|||
147122240|NCT02596893|530612659|FG002|Overall Double-Blind Period Weeks 0-52|Lack of Efficacy|14|||
147122241|NCT02596893|530612660|FG003|Overall Double-Blind Period Weeks 0-52|Lack of Efficacy|13|||
147122242|NCT02596893|530612657|FG000|Overall Double-Blind Period Weeks 0-52|Withdrawal by Subject|10|||
147122243|NCT02596893|530612658|FG001|Overall Double-Blind Period Weeks 0-52|Withdrawal by Subject|4|||
147122244|NCT02596893|530612659|FG002|Overall Double-Blind Period Weeks 0-52|Withdrawal by Subject|13|||
147122245|NCT02596893|530612660|FG003|Overall Double-Blind Period Weeks 0-52|Withdrawal by Subject|5|||
147122246|NCT02596893|530612657|FG000|Overall Double-Blind Period Weeks 0-52|Miscellaneous|1|||
147122247|NCT02596893|530612658|FG001|Overall Double-Blind Period Weeks 0-52|Miscellaneous|2|||
147122248|NCT02596893|530612659|FG002|Overall Double-Blind Period Weeks 0-52|Miscellaneous|0|||
147568152|NCT01424644|532238427|FG000|Overall Study|Unable to Classify|1|||
147568153|NCT01424644|532238428|FG001|Overall Study|Unable to Classify|0|||
147568154|NCT02066922|532238429|FG000|Overall Study|Adverse Event|1|||
147568155|NCT00727961|532238431|FG000|Overall Study|Lost to Follow-up|1|||
147122249|NCT02596893|530612660|FG003|Overall Double-Blind Period Weeks 0-52|Miscellaneous|2|||
147122250|NCT02596893|530612657|FG000|Overall Double-Blind Period Weeks 0-52|Lost to Follow-up|0|||
147122251|NCT02596893|530612658|FG001|Overall Double-Blind Period Weeks 0-52|Lost to Follow-up|1|||
147122252|NCT02596893|530612659|FG002|Overall Double-Blind Period Weeks 0-52|Lost to Follow-up|1|||
147122253|NCT02596893|530612660|FG003|Overall Double-Blind Period Weeks 0-52|Lost to Follow-up|1|||
147122254|NCT02596893|530612657|FG000|Overall Double-Blind Period Weeks 0-52|Non-Compliance with Study Drug|0|||
147122255|NCT02596893|530612658|FG001|Overall Double-Blind Period Weeks 0-52|Non-Compliance with Study Drug|0|||
147122256|NCT02596893|530612659|FG002|Overall Double-Blind Period Weeks 0-52|Non-Compliance with Study Drug|1|||
147122257|NCT02596893|530612660|FG003|Overall Double-Blind Period Weeks 0-52|Non-Compliance with Study Drug|2|||
147122258|NCT02596893|530612657|FG000|Overall Double-Blind Period Weeks 0-52|Death|0|||
147122259|NCT02596893|530612658|FG001|Overall Double-Blind Period Weeks 0-52|Death|0|||
147122260|NCT02596893|530612659|FG002|Overall Double-Blind Period Weeks 0-52|Death|1|||
147122261|NCT02596893|530612660|FG003|Overall Double-Blind Period Weeks 0-52|Death|0|||
147122262|NCT02596893|530612657|FG000|Overall Double-Blind Period Weeks 0-52|Protocol Violation|0|||
147122263|NCT02596893|530612658|FG001|Overall Double-Blind Period Weeks 0-52|Protocol Violation|0|||
147122264|NCT02596893|530612659|FG002|Overall Double-Blind Period Weeks 0-52|Protocol Violation|0|||
147122265|NCT02596893|530612660|FG003|Overall Double-Blind Period Weeks 0-52|Protocol Violation|2|||
147122266|NCT02596893|530612657|FG000|Overall Double-Blind Period Weeks 0-52|Early Escape|66|||
147122267|NCT02596893|530612658|FG001|Overall Double-Blind Period Weeks 0-52|Early Escape|76|||
147122268|NCT02596893|530612659|FG002|Overall Double-Blind Period Weeks 0-52|Early Escape|69|||
147122269|NCT02596893|530612660|FG003|Overall Double-Blind Period Weeks 0-52|Early Escape|70|||
147122270|NCT03280615|530612661|FG000|Overall Study|Lost to Follow-up|1|||
147122271|NCT03280615|530612662|FG001|Overall Study|Lost to Follow-up|2|||
147122272|NCT03280615|530612661|FG000|Overall Study|Adverse Event|1|||
147122273|NCT03280615|530612662|FG001|Overall Study|Adverse Event|1|||
147122274|NCT03280615|530612661|FG000|Overall Study|Withdrawal by Subject|2|||
147122275|NCT03280615|530612662|FG001|Overall Study|Withdrawal by Subject|2|||
147122276|NCT00004228|530612667|FG000|Overall Study|Adverse Event|0|||
147122277|NCT00004228|530612668|FG001|Overall Study|Adverse Event|1|||
147122278|NCT00004228|530612669|FG002|Overall Study|Adverse Event|0|||
147232193|NCT03277690|531023050|FG001|Dose Titration and Maintenance|Physician Decision|0|||
147232194|NCT03277690|531023049|FG000|Dose Titration and Maintenance|Sponsor decision - Randomization closed|4|||
147232195|NCT03277690|531023050|FG001|Dose Titration and Maintenance|Sponsor decision - Randomization closed|0|||
147232196|NCT03277690|531023049|FG000|Dose Titration and Maintenance|Lack of Efficacy|9|||
147232197|NCT03277690|531023050|FG001|Dose Titration and Maintenance|Lack of Efficacy|0|||
147232198|NCT03277690|531023049|FG000|Dose Titration and Maintenance|Adverse Event|15|||
147232199|NCT03277690|531023050|FG001|Dose Titration and Maintenance|Adverse Event|0|||
147232200|NCT03277690|531023049|FG000|Dose Titration and Maintenance|Withdrawal by Subject|8|||
147232201|NCT03277690|531023050|FG001|Dose Titration and Maintenance|Withdrawal by Subject|0|||
147232202|NCT03277690|531023049|FG000|Randomized Withdrawal|Withdrawal by Subject|1|||
147232203|NCT03277690|531023050|FG001|Randomized Withdrawal|Withdrawal by Subject|0|||
147232204|NCT00747812|531023051|FG000|Overall Study|Research Site Staff Relocation|5|||
147232205|NCT00747812|531023052|FG001|Overall Study|Research Site Staff Relocation|3|||
147232206|NCT01484132|531023053|FG000|Overall Study|Lost to Follow-up|8|||
147232207|NCT01484132|531023053|FG000|Overall Study|Difficulty with time commitment|2|||
147232208|NCT01484132|531023053|FG000|Overall Study|Ineligible|1|||
147232209|NCT01484132|531023053|FG000|Overall Study|No pre-treatment urine sample collected|1|||
147232210|NCT01484132|531023053|FG000|Overall Study|No post-treatment urine sample collected|10|||
147232211|NCT04209348|531023059|FG000|Overall Study|Lost to Follow-up|1|||
147232212|NCT04209348|531023060|FG001|Overall Study|Lost to Follow-up|0|||
147232213|NCT01697358|531023061|FG000|Period I: Randomization to 6 Months|Withdrawal by Subject|6|||
147232214|NCT01697358|531023062|FG001|Period I: Randomization to 6 Months|Withdrawal by Subject|0|||
147232215|NCT01697358|531023061|FG000|Period I: Randomization to 6 Months|Physician Decision|4|||
147232216|NCT01697358|531023062|FG001|Period I: Randomization to 6 Months|Physician Decision|0|||
147232217|NCT01697358|531023061|FG000|Period I: Randomization to 6 Months|Adverse Event|1|||
147232218|NCT01697358|531023062|FG001|Period I: Randomization to 6 Months|Adverse Event|1|||
147232219|NCT01697358|531023061|FG000|Period I: Randomization to 6 Months|Lost to Follow-up|2|||
147232220|NCT01697358|531023062|FG001|Period I: Randomization to 6 Months|Lost to Follow-up|0|||
147232221|NCT01697358|531023061|FG000|Period II: 6-24M Long-term Follow-up|Physician Decision|3|||
147232222|NCT01697358|531023062|FG001|Period II: 6-24M Long-term Follow-up|Physician Decision|12|||
147444597|NCT00258674|531792650|FG002|Overall Study|Death|34|||
147444598|NCT03715153|531792651|FG000|Double-blind Period (From W0 to W26)|Protocol Violation|1|||
147568156|NCT00727961|532238431|FG000|Overall Study|Adverse Event|4|||
147568157|NCT00727961|532238431|FG000|Overall Study|Patient's refusal|2|||
147568158|NCT00727961|532238431|FG000|Overall Study|Progression|30|||
147122279|NCT00004228|530612670|FG003|Overall Study|Adverse Event|0|||
147122280|NCT00004228|530612671|FG004|Overall Study|Adverse Event|1|||
147122281|NCT00004228|530612672|FG005|Overall Study|Adverse Event|0|||
147122282|NCT00004228|530612673|FG006|Overall Study|Adverse Event|0|||
147122283|NCT00004228|530612667|FG000|Overall Study|Death|0|||
147122284|NCT00004228|530612668|FG001|Overall Study|Death|1|||
147122285|NCT00004228|530612669|FG002|Overall Study|Death|2|||
147122286|NCT00004228|530612670|FG003|Overall Study|Death|0|||
147122287|NCT00004228|530612671|FG004|Overall Study|Death|1|||
147232223|NCT01697358|531023061|FG000|Period II: 6-24M Long-term Follow-up|Withdrawal by Subject|8|||
147232224|NCT01697358|531023062|FG001|Period II: 6-24M Long-term Follow-up|Withdrawal by Subject|10|||
147232225|NCT01697358|531023061|FG000|Period II: 6-24M Long-term Follow-up|Lost to Follow-up|3|||
147232226|NCT01697358|531023062|FG001|Period II: 6-24M Long-term Follow-up|Lost to Follow-up|3|||
147122288|NCT00004228|530612672|FG005|Overall Study|Death|0|||
147122289|NCT00004228|530612673|FG006|Overall Study|Death|0|||
147122290|NCT00004228|530612667|FG000|Overall Study|Lack of Efficacy|1|||
147122291|NCT00004228|530612668|FG001|Overall Study|Lack of Efficacy|6|||
147122292|NCT00004228|530612669|FG002|Overall Study|Lack of Efficacy|5|||
147122293|NCT00004228|530612670|FG003|Overall Study|Lack of Efficacy|3|||
147122294|NCT00004228|530612671|FG004|Overall Study|Lack of Efficacy|9|||
147122295|NCT00004228|530612672|FG005|Overall Study|Lack of Efficacy|8|||
147122296|NCT00004228|530612673|FG006|Overall Study|Lack of Efficacy|4|||
147122297|NCT00004228|530612667|FG000|Overall Study|Lost to Follow-up|0|||
147122298|NCT00004228|530612668|FG001|Overall Study|Lost to Follow-up|0|||
147122299|NCT00004228|530612669|FG002|Overall Study|Lost to Follow-up|1|||
147122300|NCT00004228|530612670|FG003|Overall Study|Lost to Follow-up|0|||
147122301|NCT00004228|530612671|FG004|Overall Study|Lost to Follow-up|0|||
147122302|NCT00004228|530612672|FG005|Overall Study|Lost to Follow-up|0|||
147122303|NCT00004228|530612673|FG006|Overall Study|Lost to Follow-up|0|||
147122304|NCT00004228|530612667|FG000|Overall Study|Physician Decision|1|||
147122305|NCT00004228|530612668|FG001|Overall Study|Physician Decision|0|||
147122306|NCT00004228|530612669|FG002|Overall Study|Physician Decision|3|||
147122307|NCT00004228|530612670|FG003|Overall Study|Physician Decision|2|||
147122308|NCT00004228|530612671|FG004|Overall Study|Physician Decision|1|||
147122309|NCT00004228|530612672|FG005|Overall Study|Physician Decision|1|||
147122310|NCT00004228|530612673|FG006|Overall Study|Physician Decision|1|||
147122311|NCT00004228|530612667|FG000|Overall Study|Protocol Violation|0|||
147122312|NCT00004228|530612668|FG001|Overall Study|Protocol Violation|5|||
147122313|NCT00004228|530612669|FG002|Overall Study|Protocol Violation|2|||
147122314|NCT00004228|530612670|FG003|Overall Study|Protocol Violation|1|||
147122315|NCT00004228|530612671|FG004|Overall Study|Protocol Violation|1|||
147122316|NCT00004228|530612672|FG005|Overall Study|Protocol Violation|2|||
147122317|NCT00004228|530612673|FG006|Overall Study|Protocol Violation|0|||
147122318|NCT00004228|530612667|FG000|Overall Study|Withdrawal by Subject|3|||
147122319|NCT00004228|530612668|FG001|Overall Study|Withdrawal by Subject|0|||
147122320|NCT00004228|530612669|FG002|Overall Study|Withdrawal by Subject|1|||
147122321|NCT00004228|530612670|FG003|Overall Study|Withdrawal by Subject|0|||
147122322|NCT00004228|530612671|FG004|Overall Study|Withdrawal by Subject|2|||
147122323|NCT00004228|530612672|FG005|Overall Study|Withdrawal by Subject|1|||
147122324|NCT00004228|530612673|FG006|Overall Study|Withdrawal by Subject|2|||
147122325|NCT00004228|530612667|FG000|Overall Study|Other|0|||
147122326|NCT00004228|530612668|FG001|Overall Study|Other|0|||
147122327|NCT00004228|530612669|FG002|Overall Study|Other|1|||
147122328|NCT00004228|530612670|FG003|Overall Study|Other|0|||
147122329|NCT00004228|530612671|FG004|Overall Study|Other|0|||
147232227|NCT01697358|531023061|FG000|Period II: 6-24M Long-term Follow-up|Death|1|||
147232228|NCT01697358|531023062|FG001|Period II: 6-24M Long-term Follow-up|Death|1|||
147232229|NCT01697358|531023061|FG000|Period II: 6-24M Long-term Follow-up|Adverse Event|0|||
147232230|NCT01697358|531023062|FG001|Period II: 6-24M Long-term Follow-up|Adverse Event|3|||
147232231|NCT01697358|531023061|FG000|Period II: 6-24M Long-term Follow-up|Active subjects at the time of posting|34|||
147232232|NCT01697358|531023062|FG001|Period II: 6-24M Long-term Follow-up|Active subjects at the time of posting|26|||
147232233|NCT05055128|531023063|FG000|Overall Study|Adverse Event|0|||
147232234|NCT05055128|531023064|FG001|Overall Study|Adverse Event|0|||
147650938|NCT02757352|532544537|FG000|Follow-Up Period|Lost to Follow-up|0|||
147650939|NCT02757352|532544538|FG001|Follow-Up Period|Lost to Follow-up|0|||
147122330|NCT00004228|530612672|FG005|Overall Study|Other|0|||
147122331|NCT00004228|530612673|FG006|Overall Study|Other|0|||
147122332|NCT00004228|530612667|FG000|Overall Study|ineligible|4|||
147122333|NCT00004228|530612668|FG001|Overall Study|ineligible|2|||
147122334|NCT00004228|530612669|FG002|Overall Study|ineligible|4|||
147122335|NCT00004228|530612670|FG003|Overall Study|ineligible|1|||
147122336|NCT00004228|530612671|FG004|Overall Study|ineligible|1|||
147122337|NCT00004228|530612672|FG005|Overall Study|ineligible|2|||
147122338|NCT00004228|530612673|FG006|Overall Study|ineligible|5|||
147122339|NCT02255279|530612674|FG000|Overall Study|Lost to Follow-up|2|||
147122340|NCT02255279|530612675|FG001|Overall Study|Lost to Follow-up|2|||
147444599|NCT03715153|531792652|FG001|Double-blind Period (From W0 to W26)|Protocol Violation|1|||
147122341|NCT02255279|530612674|FG000|Overall Study|Protocol Violation|0|||
147122342|NCT02255279|530612675|FG001|Overall Study|Protocol Violation|1|||
147122343|NCT02255279|530612674|FG000|Overall Study|Withdrawal by Subject|3|||
147122344|NCT02255279|530612675|FG001|Overall Study|Withdrawal by Subject|6|||
147122345|NCT01386645|530612676|FG000|Overall Study|Physician Decision|0|||
147122346|NCT01386645|530612677|FG001|Overall Study|Physician Decision|0|||
147122347|NCT01386645|530612678|FG002|Overall Study|Physician Decision|1|||
147313758|NCT00105586|531315260|FG001|Overall Study|Physician Decision|13|||
147313759|NCT02262260|531315261|FG000|Overall Study|Adverse Event|4|||
147313760|NCT02262260|531315262|FG001|Overall Study|Adverse Event|1|||
147313761|NCT02262260|531315261|FG000|Overall Study|Withdrawal of consent|4|||
147313762|NCT02262260|531315262|FG001|Overall Study|Withdrawal of consent|2|||
147313763|NCT02262260|531315261|FG000|Overall Study|Lost to Follow-up|1|||
147313764|NCT02262260|531315262|FG001|Overall Study|Lost to Follow-up|2|||
147313765|NCT02262260|531315261|FG000|Overall Study|Protocol deviation|2|||
147313766|NCT02262260|531315262|FG001|Overall Study|Protocol deviation|5|||
147313767|NCT01794117|531315265|FG000|Overall Study|Adverse Event|1|||
147313768|NCT01794117|531315266|FG001|Overall Study|Adverse Event|0|||
147313769|NCT01794117|531315267|FG002|Overall Study|Adverse Event|0|||
147313770|NCT01794117|531315268|FG003|Overall Study|Adverse Event|0|||
147313771|NCT01794117|531315265|FG000|Overall Study|Participant noncompliance|0|||
147313772|NCT01794117|531315266|FG001|Overall Study|Participant noncompliance|1|||
147313773|NCT01794117|531315267|FG002|Overall Study|Participant noncompliance|0|||
147313774|NCT01794117|531315268|FG003|Overall Study|Participant noncompliance|0|||
147313775|NCT01794117|531315265|FG000|Overall Study|Refused further treatment|0|||
147313776|NCT01794117|531315266|FG001|Overall Study|Refused further treatment|2|||
147313777|NCT01794117|531315267|FG002|Overall Study|Refused further treatment|0|||
147313778|NCT01794117|531315268|FG003|Overall Study|Refused further treatment|0|||
147313779|NCT02696902|531315271|FG000|Overall Study|Lost to Follow-up|0|||
147313780|NCT02696902|531315272|FG001|Overall Study|Lost to Follow-up|1|||
147313781|NCT02696902|531315273|FG002|Overall Study|Lost to Follow-up|1|||
147313782|NCT02696902|531315271|FG000|Overall Study|Withdrawal by Subject|0|||
147313783|NCT02696902|531315272|FG001|Overall Study|Withdrawal by Subject|0|||
147313784|NCT02696902|531315273|FG002|Overall Study|Withdrawal by Subject|1|||
147313785|NCT02696902|531315271|FG000|Overall Study|Death|19|||
147313786|NCT02696902|531315272|FG001|Overall Study|Death|3|||
147313787|NCT02696902|531315273|FG002|Overall Study|Death|24|||
147313788|NCT02696902|531315271|FG000|Overall Study|Participant not fit post-randomization|0|||
147313789|NCT02696902|531315272|FG001|Overall Study|Participant not fit post-randomization|0|||
147313790|NCT02696902|531315273|FG002|Overall Study|Participant not fit post-randomization|1|||
147313791|NCT02696902|531315271|FG000|Overall Study|Participant not eligible (negative PCR)|0|||
147313792|NCT02696902|531315272|FG001|Overall Study|Participant not eligible (negative PCR)|0|||
147313793|NCT02696902|531315273|FG002|Overall Study|Participant not eligible (negative PCR)|1|||
147313794|NCT02696902|531315271|FG000|Overall Study|Principal investigator's decision|1|||
147313795|NCT02696902|531315272|FG001|Overall Study|Principal investigator's decision|0|||
147313796|NCT02696902|531315273|FG002|Overall Study|Principal investigator's decision|0|||
147122348|NCT01386645|530612676|FG000|Overall Study|Withdrawal by Subject|0|||
147232235|NCT05055128|531023065|FG002|Overall Study|Adverse Event|0|||
147232236|NCT05055128|531023066|FG003|Overall Study|Adverse Event|1|||
147232237|NCT05055128|531023067|FG004|Overall Study|Adverse Event|1|||
147232238|NCT05055128|531023063|FG000|Overall Study|Protocol Violation|0|||
147232239|NCT05055128|531023064|FG001|Overall Study|Protocol Violation|0|||
147232240|NCT05055128|531023065|FG002|Overall Study|Protocol Violation|0|||
147232241|NCT05055128|531023066|FG003|Overall Study|Protocol Violation|1|||
147232242|NCT05055128|531023067|FG004|Overall Study|Protocol Violation|0|||
147232243|NCT05055128|531023063|FG000|Overall Study|Withdrawal by Subject|5|||
147232244|NCT05055128|531023064|FG001|Overall Study|Withdrawal by Subject|2|||
147232245|NCT05055128|531023065|FG002|Overall Study|Withdrawal by Subject|2|||
147232246|NCT05055128|531023066|FG003|Overall Study|Withdrawal by Subject|4|||
147232247|NCT05055128|531023067|FG004|Overall Study|Withdrawal by Subject|2|||
147232248|NCT05055128|531023063|FG000|Overall Study|Randomized By Mistake|0|||
147232249|NCT05055128|531023064|FG001|Overall Study|Randomized By Mistake|1|||
147232250|NCT05055128|531023065|FG002|Overall Study|Randomized By Mistake|0|||
147232251|NCT05055128|531023066|FG003|Overall Study|Randomized By Mistake|0|||
147232252|NCT05055128|531023067|FG004|Overall Study|Randomized By Mistake|0|||
147232253|NCT05055128|531023063|FG000|Overall Study|Other|1|||
147313797|NCT02696902|531315271|FG000|Overall Study|Sponsor's decision|1|||
147313798|NCT02696902|531315272|FG001|Overall Study|Sponsor's decision|0|||
147313799|NCT02696902|531315273|FG002|Overall Study|Sponsor's decision|0|||
147313800|NCT02696902|531315271|FG000|Overall Study|Transferred to other hospital|1|||
147313801|NCT02696902|531315272|FG001|Overall Study|Transferred to other hospital|0|||
147313802|NCT02696902|531315273|FG002|Overall Study|Transferred to other hospital|0|||
147313803|NCT02401308|531315278|FG000|Overall Study|Study was terminated by the PI due to lack of enrollment.|0|||
147568159|NCT03161405|532238432|FG000|Second Intervention Period (6 Days)|Positive urine drug screen|1|||
147122349|NCT01386645|530612677|FG001|Overall Study|Withdrawal by Subject|1|||
147122350|NCT01386645|530612678|FG002|Overall Study|Withdrawal by Subject|1|||
147122351|NCT00432991|530612679|FG000|Overall Study|Protocol Violation|7|||
147122352|NCT00432991|530612680|FG001|Overall Study|Protocol Violation|12|||
147122353|NCT03048019|530612690|FG000|Overall Study|Adverse Event|1|||
147122354|NCT03048019|530612691|FG001|Overall Study|Adverse Event|0|||
147122355|NCT00862277|530612692|FG000|Overall Study|Protocol Violation|1|||
147122356|NCT00862277|530612693|FG001|Overall Study|Protocol Violation|2|||
147122357|NCT00862277|530612694|FG002|Overall Study|Protocol Violation|5|||
147122358|NCT00382863|530612695|FG000|Overall Study|Death|9|||
147122359|NCT00382863|530612696|FG001|Overall Study|Death|9|||
147122360|NCT00382863|530612695|FG000|Overall Study|Lost to Follow-up|1|||
147122361|NCT00382863|530612696|FG001|Overall Study|Lost to Follow-up|2|||
147122362|NCT00382863|530612695|FG000|Overall Study|Withdrawal by Subject|5|||
147122363|NCT00382863|530612696|FG001|Overall Study|Withdrawal by Subject|25|||
147122364|NCT02168439|530612697|FG000|Overall Study|Protocol Violation|0|||
147122365|NCT02168439|530612698|FG001|Overall Study|Protocol Violation|2|||
147122366|NCT00348374|530612703|FG000|Overall Study|Adverse Event|1|||
147122367|NCT00348374|530612704|FG001|Overall Study|Adverse Event|4|||
147122368|NCT00348374|530612703|FG000|Overall Study|Lost to Follow-up|1|||
147122369|NCT00348374|530612704|FG001|Overall Study|Lost to Follow-up|3|||
147122370|NCT00348374|530612703|FG000|Overall Study|Withdrawal by Subject|5|||
147122371|NCT00348374|530612704|FG001|Overall Study|Withdrawal by Subject|5|||
147122372|NCT00348374|530612703|FG000|Overall Study|Other|11|||
147122373|NCT00348374|530612704|FG001|Overall Study|Other|12|||
147122374|NCT00348374|530612703|FG000|Overall Study|ongoing at date of cutoff|1|||
147122375|NCT00348374|530612704|FG001|Overall Study|ongoing at date of cutoff|1|||
147122376|NCT00348374|530612703|FG000|Overall Study|randomized but did not receive treatment|0|||
147122377|NCT00348374|530612704|FG001|Overall Study|randomized but did not receive treatment|7|||
147122378|NCT02595437|530612710|FG000|Triferic Via IV|Withdrawal by Subject|1|||
147122379|NCT01423084|530612711|FG000|Overall Study|Adverse Event|0|||
147122380|NCT01423084|530612712|FG001|Overall Study|Adverse Event|1|||
147122381|NCT01423084|530612711|FG000|Overall Study|Withdrawal by Subject|2|||
147122382|NCT01423084|530612712|FG001|Overall Study|Withdrawal by Subject|3|||
147122383|NCT02180672|530612717|FG000|Overall Study|Lost to Follow-up|5|||
147122384|NCT02180672|530612718|FG001|Overall Study|Lost to Follow-up|7|||
147122385|NCT00661687|530612719|FG000|Overall Study|Study related symptoms and complaints|5|||
147122386|NCT00661687|530612719|FG000|Overall Study|Positive slit lamp findings|4|||
147122387|NCT00661687|530612719|FG000|Overall Study|Inability to maintain wearing schedule|3|||
147122388|NCT00661687|530612719|FG000|Overall Study|Physician Decision|1|||
147122389|NCT00661687|530612719|FG000|Overall Study|Adverse Event|2|||
147122390|NCT03574389|530612723|FG000|Vaccination Period|Noncompliance With Investigational Product|3|||
147122391|NCT03574389|530612724|FG001|Vaccination Period|Noncompliance With Investigational Product|0|||
147122392|NCT03574389|530612725|FG002|Vaccination Period|Noncompliance With Investigational Product|0|||
147122393|NCT03574389|530612726|FG003|Vaccination Period|Noncompliance With Investigational Product|0|||
147122394|NCT03574389|530612727|FG004|Vaccination Period|Noncompliance With Investigational Product|0|||
147122395|NCT03574389|530612728|FG005|Vaccination Period|Noncompliance With Investigational Product|0|||
147122396|NCT03574389|530612729|FG006|Vaccination Period|Noncompliance With Investigational Product|0|||
147122397|NCT03574389|530612723|FG000|Vaccination Period|Withdrawal by Parent/guardian|26|||
147122398|NCT03574389|530612724|FG001|Vaccination Period|Withdrawal by Parent/guardian|21|||
147122399|NCT03574389|530612725|FG002|Vaccination Period|Withdrawal by Parent/guardian|10|||
147122400|NCT03574389|530612726|FG003|Vaccination Period|Withdrawal by Parent/guardian|19|||
147122401|NCT03574389|530612727|FG004|Vaccination Period|Withdrawal by Parent/guardian|0|||
147122402|NCT03574389|530612728|FG005|Vaccination Period|Withdrawal by Parent/guardian|0|||
147122403|NCT03574389|530612729|FG006|Vaccination Period|Withdrawal by Parent/guardian|0|||
147122404|NCT03574389|530612723|FG000|Vaccination Period|Other|6|||
147122405|NCT03574389|530612724|FG001|Vaccination Period|Other|0|||
147122406|NCT03574389|530612725|FG002|Vaccination Period|Other|0|||
147122407|NCT03574389|530612726|FG003|Vaccination Period|Other|0|||
147122408|NCT03574389|530612727|FG004|Vaccination Period|Other|0|||
147122409|NCT03574389|530612728|FG005|Vaccination Period|Other|0|||
147122410|NCT03574389|530612729|FG006|Vaccination Period|Other|0|||
147122411|NCT03574389|530612723|FG000|Vaccination Period|Adverse Event|0|||
147122412|NCT03574389|530612724|FG001|Vaccination Period|Adverse Event|1|||
147122413|NCT03574389|530612725|FG002|Vaccination Period|Adverse Event|0|||
147122414|NCT03574389|530612726|FG003|Vaccination Period|Adverse Event|0|||
147122415|NCT03574389|530612727|FG004|Vaccination Period|Adverse Event|0|||
147122416|NCT03574389|530612728|FG005|Vaccination Period|Adverse Event|0|||
147122417|NCT03574389|530612729|FG006|Vaccination Period|Adverse Event|0|||
147122418|NCT03574389|530612723|FG000|Follow-up Period|Withdrawal by parent/guardian|1|||
147122419|NCT03574389|530612724|FG001|Follow-up Period|Withdrawal by parent/guardian|13|||
147122420|NCT03574389|530612725|FG002|Follow-up Period|Withdrawal by parent/guardian|9|||
147122421|NCT03574389|530612726|FG003|Follow-up Period|Withdrawal by parent/guardian|9|||
147122422|NCT03574389|530612727|FG004|Follow-up Period|Withdrawal by parent/guardian|7|||
147122423|NCT03574389|530612728|FG005|Follow-up Period|Withdrawal by parent/guardian|7|||
147122424|NCT03574389|530612729|FG006|Follow-up Period|Withdrawal by parent/guardian|1|||
147122425|NCT02070380|530612733|FG000|Washout (no Second Injection/MRI)|Withdrawal by Subject|0|||
147122426|NCT02070380|530612734|FG001|Washout (no Second Injection/MRI)|Withdrawal by Subject|5|||
147122427|NCT02070380|530612735|FG002|Washout (no Second Injection/MRI)|Withdrawal by Subject|2|||
147122428|NCT02070380|530612736|FG003|Washout (no Second Injection/MRI)|Withdrawal by Subject|3|||
147122429|NCT02070380|530612733|FG000|Second Injection|Image sets missing or technically inadeq|0|||
147122430|NCT02070380|530612734|FG001|Second Injection|Image sets missing or technically inadeq|1|||
147122431|NCT02070380|530612735|FG002|Second Injection|Image sets missing or technically inadeq|0|||
147122432|NCT02070380|530612736|FG003|Second Injection|Image sets missing or technically inadeq|0|||
147122433|NCT02070380|530612733|FG000|Second Injection|Protocol Violation|0|||
147122434|NCT02070380|530612734|FG001|Second Injection|Protocol Violation|1|||
147122435|NCT02070380|530612735|FG002|Second Injection|Protocol Violation|1|||
147122436|NCT02070380|530612736|FG003|Second Injection|Protocol Violation|5|||
147122437|NCT02837952|530612737|FG000|Overall Study|Adverse Event|0|||
147122438|NCT02837952|530612738|FG001|Overall Study|Adverse Event|1|||
147122439|NCT02837952|530612737|FG000|Overall Study|Withdrawal by Subject|4|||
147122440|NCT02837952|530612738|FG001|Overall Study|Withdrawal by Subject|5|||
147122441|NCT02837952|530612737|FG000|Overall Study|Medication Error|1|||
147122442|NCT02837952|530612738|FG001|Overall Study|Medication Error|0|||
147122443|NCT01362530|530612751|FG000|Base Study (Cycle 1)|Adverse Event|2|||
147122444|NCT01362530|530612752|FG001|Base Study (Cycle 1)|Adverse Event|0|||
147122445|NCT01362530|530612751|FG000|Base Study (Cycle 1)|Physician Decision|0|||
147122446|NCT01362530|530612752|FG001|Base Study (Cycle 1)|Physician Decision|1|||
147122447|NCT01362530|530612751|FG000|Base Study (Cycle 1)|Protocol Violation|2|||
147122448|NCT01362530|530612752|FG001|Base Study (Cycle 1)|Protocol Violation|0|||
147122449|NCT01362530|530612751|FG000|Base Study (Cycle 1)|Withdrawal by Subject|1|||
147122450|NCT01362530|530612752|FG001|Base Study (Cycle 1)|Withdrawal by Subject|2|||
147122451|NCT01362530|530612751|FG000|Optional Extension (Cycles 2-6)|Adverse Event|2|||
147122452|NCT01362530|530612752|FG001|Optional Extension (Cycles 2-6)|Adverse Event|0|||
147122453|NCT01362530|530612751|FG000|Optional Extension (Cycles 2-6)|Completed Chemotherapy Regimen|51|||
147122454|NCT01362530|530612752|FG001|Optional Extension (Cycles 2-6)|Completed Chemotherapy Regimen|0|||
147122455|NCT01362530|530612751|FG000|Optional Extension (Cycles 2-6)|Did Not Meet Additional Criteria|25|||
147122456|NCT01362530|530612752|FG001|Optional Extension (Cycles 2-6)|Did Not Meet Additional Criteria|0|||
147122457|NCT01362530|530612751|FG000|Optional Extension (Cycles 2-6)|Did Not Respond To Chemotherapy Regimen|4|||
147122458|NCT01362530|530612752|FG001|Optional Extension (Cycles 2-6)|Did Not Respond To Chemotherapy Regimen|0|||
147650940|NCT02757352|532544539|FG002|Follow-Up Period|Lost to Follow-up|0|||
147650941|NCT02757352|532544540|FG003|Follow-Up Period|Lost to Follow-up|0|||
147122459|NCT01362530|530612751|FG000|Optional Extension (Cycles 2-6)|Lack of Efficacy|1|||
147122460|NCT01362530|530612752|FG001|Optional Extension (Cycles 2-6)|Lack of Efficacy|0|||
147122461|NCT01362530|530612751|FG000|Optional Extension (Cycles 2-6)|Lost to Follow-up|1|||
147122462|NCT01362530|530612752|FG001|Optional Extension (Cycles 2-6)|Lost to Follow-up|0|||
147122463|NCT01362530|530612751|FG000|Optional Extension (Cycles 2-6)|Physician Decision|19|||
147122464|NCT01362530|530612752|FG001|Optional Extension (Cycles 2-6)|Physician Decision|0|||
147122465|NCT01362530|530612751|FG000|Optional Extension (Cycles 2-6)|Protocol Violation|4|||
147232254|NCT05055128|531023064|FG001|Overall Study|Other|0|||
147232255|NCT05055128|531023065|FG002|Overall Study|Other|0|||
147232256|NCT05055128|531023066|FG003|Overall Study|Other|0|||
147232257|NCT05055128|531023067|FG004|Overall Study|Other|0|||
147232258|NCT00936611|531023074|FG000|Overall Study|Progressive Disease|3|||
147232259|NCT00936611|531023074|FG000|Overall Study|New Systemic Therapy|22|||
147232260|NCT00936611|531023074|FG000|Overall Study|Lost to Follow-up|1|||
147232261|NCT00936611|531023074|FG000|Overall Study|Withdrawal by Subject|2|||
147232262|NCT00936611|531023074|FG000|Overall Study|Still on Follow-up|1|||
147232263|NCT00936611|531023074|FG000|Overall Study|Still on Active Therapy|7|||
147232264|NCT00936611|531023074|FG000|Overall Study|Ineligible for Study Drug|3|||
147232265|NCT01822496|531023078|FG000|Overall Study|Protocol Violation|2|||
147232266|NCT01822496|531023079|FG001|Overall Study|Protocol Violation|2|||
147232267|NCT01822496|531023080|FG002|Overall Study|Protocol Violation|0|||
147232268|NCT01822496|531023081|FG003|Overall Study|Protocol Violation|1|||
147232269|NCT01822496|531023078|FG000|Overall Study|Withdrawal by Subject|0|||
147232270|NCT01822496|531023079|FG001|Overall Study|Withdrawal by Subject|0|||
147232271|NCT01822496|531023080|FG002|Overall Study|Withdrawal by Subject|0|||
147232272|NCT01822496|531023081|FG003|Overall Study|Withdrawal by Subject|3|||
147232273|NCT03841448|531023084|FG000|Double-blind Treatment (DBT) Period|Death|1|||
147232274|NCT03841448|531023085|FG001|Double-blind Treatment (DBT) Period|Death|1|||
147232275|NCT03841448|531023086|FG002|Double-blind Treatment (DBT) Period|Death|0|||
147232276|NCT03841448|531023087|FG003|Double-blind Treatment (DBT) Period|Death|0|||
147232277|NCT03841448|531023084|FG000|Open-Label Extension (OLE) Period|Adverse Event|0|||
147232278|NCT03841448|531023085|FG001|Open-Label Extension (OLE) Period|Adverse Event|0|||
147232279|NCT03841448|531023086|FG002|Open-Label Extension (OLE) Period|Adverse Event|1|||
147232280|NCT03841448|531023087|FG003|Open-Label Extension (OLE) Period|Adverse Event|2|||
147232281|NCT03841448|531023084|FG000|Open-Label Extension (OLE) Period|Death|0|||
147232282|NCT03841448|531023085|FG001|Open-Label Extension (OLE) Period|Death|0|||
147232283|NCT03841448|531023086|FG002|Open-Label Extension (OLE) Period|Death|0|||
147444600|NCT03715153|531792651|FG000|Double-blind Period (From W0 to W26)|Non medical reason|8|||
147122466|NCT01362530|530612752|FG001|Optional Extension (Cycles 2-6)|Protocol Violation|0|||
147232284|NCT03841448|531023087|FG003|Open-Label Extension (OLE) Period|Death|1|||
147232285|NCT03841448|531023084|FG000|Open-Label Extension (OLE) Period|Physician Decision|0|||
147232286|NCT03841448|531023085|FG001|Open-Label Extension (OLE) Period|Physician Decision|0|||
147232287|NCT03841448|531023086|FG002|Open-Label Extension (OLE) Period|Physician Decision|1|||
147444601|NCT03715153|531792652|FG001|Double-blind Period (From W0 to W26)|Non medical reason|2|||
147122467|NCT01362530|530612751|FG000|Optional Extension (Cycles 2-6)|Withdrawal by Subject|18|||
147122468|NCT01362530|530612752|FG001|Optional Extension (Cycles 2-6)|Withdrawal by Subject|0|||
147122469|NCT01133977|530612753|FG000|Overall Study|Adverse Event|0|||
147122470|NCT01133977|530612754|FG001|Overall Study|Adverse Event|0|||
147122471|NCT01133977|530612755|FG002|Overall Study|Adverse Event|1|||
147122472|NCT01133977|530612756|FG003|Overall Study|Adverse Event|0|||
147122473|NCT01133977|530612757|FG004|Overall Study|Adverse Event|0|||
147122474|NCT01133977|530612753|FG000|Overall Study|Death|1|||
147122475|NCT01133977|530612754|FG001|Overall Study|Death|1|||
147122476|NCT01133977|530612755|FG002|Overall Study|Death|1|||
147122477|NCT01133977|530612756|FG003|Overall Study|Death|7|||
147122478|NCT01133977|530612757|FG004|Overall Study|Death|3|||
147122479|NCT01133977|530612753|FG000|Overall Study|Started a New Line of Therapy|2|||
147122480|NCT01133977|530612754|FG001|Overall Study|Started a New Line of Therapy|6|||
147122481|NCT01133977|530612755|FG002|Overall Study|Started a New Line of Therapy|4|||
147122482|NCT01133977|530612756|FG003|Overall Study|Started a New Line of Therapy|25|||
147122483|NCT01133977|530612757|FG004|Overall Study|Started a New Line of Therapy|33|||
147122484|NCT01133977|530612753|FG000|Overall Study|Lost to Follow-up|0|||
147122485|NCT01133977|530612754|FG001|Overall Study|Lost to Follow-up|0|||
147122486|NCT01133977|530612755|FG002|Overall Study|Lost to Follow-up|0|||
147122487|NCT01133977|530612756|FG003|Overall Study|Lost to Follow-up|2|||
147122488|NCT01133977|530612757|FG004|Overall Study|Lost to Follow-up|1|||
147122489|NCT01133977|530612753|FG000|Overall Study|Withdrawal by Subject|0|||
147122490|NCT01133977|530612754|FG001|Overall Study|Withdrawal by Subject|0|||
147122491|NCT01133977|530612755|FG002|Overall Study|Withdrawal by Subject|0|||
147122492|NCT01133977|530612756|FG003|Overall Study|Withdrawal by Subject|5|||
147122493|NCT01133977|530612757|FG004|Overall Study|Withdrawal by Subject|1|||
147122494|NCT01682603|530612758|FG000|Overall Study|Lost to Follow-up|3|||
147122495|NCT02462057|530612759|FG000|Overall Study|Left Vitality|32|||
147122496|NCT02462057|530612760|FG001|Overall Study|Left Vitality|27|||
147122497|NCT02462057|530612761|FG002|Overall Study|Left Vitality|23|||
147122498|NCT02462057|530612762|FG003|Overall Study|Left Vitality|35|||
147122499|NCT02462057|530612763|FG004|Overall Study|Left Vitality|33|||
147122500|NCT02462057|530612759|FG000|Overall Study|Joined HealthyFood Before Intervention|22|||
147122501|NCT02462057|530612760|FG001|Overall Study|Joined HealthyFood Before Intervention|13|||
147122502|NCT02462057|530612761|FG002|Overall Study|Joined HealthyFood Before Intervention|23|||
147122503|NCT02462057|530612762|FG003|Overall Study|Joined HealthyFood Before Intervention|16|||
147122504|NCT02462057|530612763|FG004|Overall Study|Joined HealthyFood Before Intervention|17|||
147122505|NCT00281580|530612769|FG000|Overall Study|Adverse Event|2|||
147122506|NCT00281580|530612770|FG001|Overall Study|Adverse Event|0|||
147122507|NCT00281580|530612771|FG002|Overall Study|Adverse Event|2|||
147122508|NCT00281580|530612772|FG003|Overall Study|Adverse Event|4|||
147122509|NCT00281580|530612773|FG004|Overall Study|Adverse Event|1|||
147122510|NCT00281580|530612774|FG005|Overall Study|Adverse Event|0|||
147122511|NCT00281580|530612775|FG006|Overall Study|Adverse Event|1|||
147122512|NCT00281580|530612776|FG007|Overall Study|Adverse Event|0|||
147122513|NCT00281580|530612777|FG008|Overall Study|Adverse Event|1|||
147122514|NCT00281580|530612778|FG009|Overall Study|Adverse Event|6|||
147122515|NCT00281580|530612779|FG010|Overall Study|Adverse Event|0|||
147122516|NCT00281580|530612780|FG011|Overall Study|Adverse Event|5|||
147122517|NCT00281580|530612781|FG012|Overall Study|Adverse Event|8|||
147122518|NCT00281580|530612782|FG013|Overall Study|Adverse Event|2|||
147122519|NCT00281580|530612783|FG014|Overall Study|Adverse Event|3|||
147568160|NCT00837486|532238433|FG000|Blinded-treatment Phase|Physician Decision|1|||
147568161|NCT00837486|532238434|FG001|Blinded-treatment Phase|Physician Decision|0|||
147568162|NCT00837486|532238433|FG000|Long-term Follow-up Phase - Open Label|Physician Decision|2|||
147568163|NCT00837486|532238434|FG001|Long-term Follow-up Phase - Open Label|Physician Decision|0|||
147568164|NCT00837486|532238433|FG000|Long-term Follow-up Phase - Open Label|Withdrawal by Subject|2|||
147122520|NCT00281580|530612784|FG015|Overall Study|Adverse Event|3|||
147122521|NCT00281580|530612769|FG000|Overall Study|Protocol Violation|0|||
147122522|NCT00281580|530612770|FG001|Overall Study|Protocol Violation|0|||
147122523|NCT00281580|530612771|FG002|Overall Study|Protocol Violation|1|||
147122524|NCT00281580|530612772|FG003|Overall Study|Protocol Violation|1|||
147122525|NCT00281580|530612773|FG004|Overall Study|Protocol Violation|0|||
147122526|NCT00281580|530612774|FG005|Overall Study|Protocol Violation|0|||
147122527|NCT00281580|530612775|FG006|Overall Study|Protocol Violation|1|||
147122528|NCT00281580|530612776|FG007|Overall Study|Protocol Violation|0|||
147122529|NCT00281580|530612777|FG008|Overall Study|Protocol Violation|2|||
147122530|NCT00281580|530612778|FG009|Overall Study|Protocol Violation|0|||
147122531|NCT00281580|530612779|FG010|Overall Study|Protocol Violation|1|||
147122532|NCT00281580|530612780|FG011|Overall Study|Protocol Violation|2|||
147568165|NCT00837486|532238434|FG001|Long-term Follow-up Phase - Open Label|Withdrawal by Subject|0|||
147122533|NCT00281580|530612781|FG012|Overall Study|Protocol Violation|0|||
147122534|NCT00281580|530612782|FG013|Overall Study|Protocol Violation|1|||
147122535|NCT00281580|530612783|FG014|Overall Study|Protocol Violation|1|||
147122536|NCT00281580|530612784|FG015|Overall Study|Protocol Violation|3|||
147122537|NCT00281580|530612769|FG000|Overall Study|Withdrawal by Subject|3|||
147568166|NCT00837486|532238433|FG000|Long-term Follow-up Phase - Open Label|Death|1|||
147568167|NCT00837486|532238434|FG001|Long-term Follow-up Phase - Open Label|Death|0|||
147568168|NCT02655679|532238435|FG000|Overall Study|Adverse Event|0|||
147568169|NCT02655679|532238436|FG001|Overall Study|Adverse Event|1|||
147568170|NCT02655679|532238437|FG002|Overall Study|Adverse Event|0|||
147568171|NCT02655679|532238438|FG003|Overall Study|Adverse Event|0|||
147568172|NCT02655679|532238439|FG004|Overall Study|Adverse Event|0|||
147568173|NCT02655679|532238435|FG000|Overall Study|Withdrawal by Subject|1|||
147568174|NCT02655679|532238436|FG001|Overall Study|Withdrawal by Subject|1|||
147568175|NCT02655679|532238437|FG002|Overall Study|Withdrawal by Subject|0|||
147568176|NCT02655679|532238438|FG003|Overall Study|Withdrawal by Subject|3|||
147568177|NCT02655679|532238439|FG004|Overall Study|Withdrawal by Subject|1|||
147568178|NCT02655679|532238435|FG000|Overall Study|Inability to Comply with the Protocol|1|||
147568179|NCT02655679|532238436|FG001|Overall Study|Inability to Comply with the Protocol|0|||
147568180|NCT02655679|532238437|FG002|Overall Study|Inability to Comply with the Protocol|0|||
147122538|NCT00281580|530612770|FG001|Overall Study|Withdrawal by Subject|0|||
147122539|NCT00281580|530612771|FG002|Overall Study|Withdrawal by Subject|1|||
147122540|NCT00281580|530612772|FG003|Overall Study|Withdrawal by Subject|1|||
147122541|NCT00281580|530612773|FG004|Overall Study|Withdrawal by Subject|1|||
147122542|NCT00281580|530612774|FG005|Overall Study|Withdrawal by Subject|2|||
147122543|NCT00281580|530612775|FG006|Overall Study|Withdrawal by Subject|2|||
147122544|NCT00281580|530612776|FG007|Overall Study|Withdrawal by Subject|0|||
147122545|NCT00281580|530612777|FG008|Overall Study|Withdrawal by Subject|1|||
147122546|NCT00281580|530612778|FG009|Overall Study|Withdrawal by Subject|4|||
147122547|NCT00281580|530612779|FG010|Overall Study|Withdrawal by Subject|1|||
147122548|NCT00281580|530612780|FG011|Overall Study|Withdrawal by Subject|1|||
147122549|NCT00281580|530612781|FG012|Overall Study|Withdrawal by Subject|2|||
147122550|NCT00281580|530612782|FG013|Overall Study|Withdrawal by Subject|2|||
147122551|NCT00281580|530612783|FG014|Overall Study|Withdrawal by Subject|1|||
147122552|NCT00281580|530612784|FG015|Overall Study|Withdrawal by Subject|5|||
147122553|NCT00281580|530612769|FG000|Overall Study|Lack of Efficacy|2|||
147122554|NCT00281580|530612770|FG001|Overall Study|Lack of Efficacy|1|||
147122555|NCT00281580|530612771|FG002|Overall Study|Lack of Efficacy|1|||
147122556|NCT00281580|530612772|FG003|Overall Study|Lack of Efficacy|6|||
147122557|NCT00281580|530612773|FG004|Overall Study|Lack of Efficacy|2|||
147122558|NCT00281580|530612774|FG005|Overall Study|Lack of Efficacy|0|||
147568181|NCT02655679|532238438|FG003|Overall Study|Inability to Comply with the Protocol|0|||
147568182|NCT02655679|532238439|FG004|Overall Study|Inability to Comply with the Protocol|0|||
147568183|NCT02655679|532238435|FG000|Overall Study|Lost to Follow-up|0|||
147568184|NCT02655679|532238436|FG001|Overall Study|Lost to Follow-up|1|||
147122559|NCT00281580|530612775|FG006|Overall Study|Lack of Efficacy|0|||
147122560|NCT00281580|530612776|FG007|Overall Study|Lack of Efficacy|0|||
147122561|NCT00281580|530612777|FG008|Overall Study|Lack of Efficacy|0|||
147122562|NCT00281580|530612778|FG009|Overall Study|Lack of Efficacy|0|||
147122563|NCT00281580|530612779|FG010|Overall Study|Lack of Efficacy|0|||
147122564|NCT00281580|530612780|FG011|Overall Study|Lack of Efficacy|1|||
147122565|NCT00281580|530612781|FG012|Overall Study|Lack of Efficacy|0|||
147444602|NCT03715153|531792651|FG000|Double-blind Period (From W0 to W26)|Adverse Event|8|||
147122566|NCT00281580|530612782|FG013|Overall Study|Lack of Efficacy|2|||
147122567|NCT00281580|530612783|FG014|Overall Study|Lack of Efficacy|1|||
147122568|NCT00281580|530612784|FG015|Overall Study|Lack of Efficacy|0|||
147122569|NCT00281580|530612769|FG000|Overall Study|Lost to Follow-up|0|||
147122570|NCT00281580|530612770|FG001|Overall Study|Lost to Follow-up|0|||
147122571|NCT00281580|530612771|FG002|Overall Study|Lost to Follow-up|0|||
147122572|NCT00281580|530612772|FG003|Overall Study|Lost to Follow-up|3|||
147122573|NCT00281580|530612773|FG004|Overall Study|Lost to Follow-up|0|||
147122574|NCT00281580|530612774|FG005|Overall Study|Lost to Follow-up|1|||
147122575|NCT00281580|530612775|FG006|Overall Study|Lost to Follow-up|0|||
147122576|NCT00281580|530612776|FG007|Overall Study|Lost to Follow-up|1|||
147122577|NCT00281580|530612777|FG008|Overall Study|Lost to Follow-up|2|||
147122578|NCT00281580|530612778|FG009|Overall Study|Lost to Follow-up|1|||
147122579|NCT00281580|530612779|FG010|Overall Study|Lost to Follow-up|1|||
147122580|NCT00281580|530612780|FG011|Overall Study|Lost to Follow-up|0|||
147122581|NCT00281580|530612781|FG012|Overall Study|Lost to Follow-up|1|||
147122582|NCT00281580|530612782|FG013|Overall Study|Lost to Follow-up|0|||
147122583|NCT00281580|530612783|FG014|Overall Study|Lost to Follow-up|0|||
147122584|NCT00281580|530612784|FG015|Overall Study|Lost to Follow-up|0|||
147122585|NCT00281580|530612769|FG000|Overall Study|Randomised in error; pregnancy; moving|0|||
147122586|NCT00281580|530612770|FG001|Overall Study|Randomised in error; pregnancy; moving|0|||
147568185|NCT02655679|532238437|FG002|Overall Study|Lost to Follow-up|1|||
147568186|NCT02655679|532238438|FG003|Overall Study|Lost to Follow-up|1|||
147568187|NCT02655679|532238439|FG004|Overall Study|Lost to Follow-up|0|||
147568188|NCT02655679|532238435|FG000|Overall Study|Other Miscellaneous Reasons|1|||
147568189|NCT02655679|532238436|FG001|Overall Study|Other Miscellaneous Reasons|0|||
147568190|NCT02655679|532238437|FG002|Overall Study|Other Miscellaneous Reasons|0|||
147568191|NCT02655679|532238438|FG003|Overall Study|Other Miscellaneous Reasons|0|||
147568192|NCT02655679|532238439|FG004|Overall Study|Other Miscellaneous Reasons|0|||
147122587|NCT00281580|530612771|FG002|Overall Study|Randomised in error; pregnancy; moving|0|||
147122588|NCT00281580|530612772|FG003|Overall Study|Randomised in error; pregnancy; moving|2|||
147122589|NCT00281580|530612773|FG004|Overall Study|Randomised in error; pregnancy; moving|0|||
147122590|NCT00281580|530612774|FG005|Overall Study|Randomised in error; pregnancy; moving|0|||
147122591|NCT00281580|530612775|FG006|Overall Study|Randomised in error; pregnancy; moving|1|||
147122592|NCT00281580|530612776|FG007|Overall Study|Randomised in error; pregnancy; moving|0|||
147122593|NCT00281580|530612777|FG008|Overall Study|Randomised in error; pregnancy; moving|2|||
147122594|NCT00281580|530612778|FG009|Overall Study|Randomised in error; pregnancy; moving|1|||
147122595|NCT00281580|530612779|FG010|Overall Study|Randomised in error; pregnancy; moving|1|||
147122596|NCT00281580|530612780|FG011|Overall Study|Randomised in error; pregnancy; moving|1|||
147122597|NCT00281580|530612781|FG012|Overall Study|Randomised in error; pregnancy; moving|2|||
147122598|NCT00281580|530612782|FG013|Overall Study|Randomised in error; pregnancy; moving|0|||
147122599|NCT00281580|530612783|FG014|Overall Study|Randomised in error; pregnancy; moving|1|||
147122600|NCT00281580|530612784|FG015|Overall Study|Randomised in error; pregnancy; moving|2|||
147122601|NCT01696214|530612787|FG000|Overall Study|Lost to Follow-up|1|||
147122602|NCT01696214|530612788|FG001|Overall Study|Lost to Follow-up|0|||
147122603|NCT01696214|530612789|FG002|Overall Study|Lost to Follow-up|0|||
147122604|NCT01696214|530612790|FG003|Overall Study|Lost to Follow-up|0|||
147122605|NCT00066170|530612792|FG000|Overall Study|Adverse Event|2|||
147122606|NCT00066170|530612793|FG001|Overall Study|Adverse Event|4|||
147232288|NCT03841448|531023087|FG003|Open-Label Extension (OLE) Period|Physician Decision|3|||
147232289|NCT03841448|531023084|FG000|Open-Label Extension (OLE) Period|Study termination by Sponsor|0|||
147232290|NCT03841448|531023085|FG001|Open-Label Extension (OLE) Period|Study termination by Sponsor|0|||
147232291|NCT03841448|531023086|FG002|Open-Label Extension (OLE) Period|Study termination by Sponsor|4|||
147232292|NCT03841448|531023087|FG003|Open-Label Extension (OLE) Period|Study termination by Sponsor|9|||
147232293|NCT03841448|531023084|FG000|Open-Label Extension (OLE) Period|Other Reason Not Specified|0|||
147232294|NCT03841448|531023085|FG001|Open-Label Extension (OLE) Period|Other Reason Not Specified|0|||
147232295|NCT03841448|531023086|FG002|Open-Label Extension (OLE) Period|Other Reason Not Specified|2|||
147232296|NCT03841448|531023087|FG003|Open-Label Extension (OLE) Period|Other Reason Not Specified|5|||
147232297|NCT00543543|531023088|FG000|Base Study|Adverse Event|1|||
147232298|NCT00543543|531023089|FG001|Base Study|Adverse Event|11|||
147232299|NCT00543543|531023090|FG002|Base Study|Adverse Event|0|||
147232300|NCT00543543|531023091|FG003|Base Study|Adverse Event|5|||
147232301|NCT00543543|531023088|FG000|Base Study|Lost to Follow-up|12|||
147232302|NCT00543543|531023089|FG001|Base Study|Lost to Follow-up|749|||
147232303|NCT00543543|531023090|FG002|Base Study|Lost to Follow-up|9|||
147232304|NCT00543543|531023091|FG003|Base Study|Lost to Follow-up|701|||
147232305|NCT00543543|531023088|FG000|Base Study|Physician Decision|0|||
147232306|NCT00543543|531023089|FG001|Base Study|Physician Decision|4|||
147232307|NCT00543543|531023090|FG002|Base Study|Physician Decision|0|||
147232308|NCT00543543|531023091|FG003|Base Study|Physician Decision|7|||
147232309|NCT00543543|531023088|FG000|Base Study|Protocol Violation|0|||
147232310|NCT00543543|531023089|FG001|Base Study|Protocol Violation|6|||
147232311|NCT00543543|531023090|FG002|Base Study|Protocol Violation|0|||
147232312|NCT00543543|531023091|FG003|Base Study|Protocol Violation|6|||
147232313|NCT00543543|531023088|FG000|Base Study|Withdrawal by Subject|7|||
147232314|NCT00543543|531023089|FG001|Base Study|Withdrawal by Subject|482|||
147232315|NCT00543543|531023090|FG002|Base Study|Withdrawal by Subject|5|||
147232316|NCT00543543|531023091|FG003|Base Study|Withdrawal by Subject|503|||
147232317|NCT00543543|531023088|FG000|Extension Study|Adverse Event|0|||
147232318|NCT00543543|531023089|FG001|Extension Study|Adverse Event|0|||
147232319|NCT00543543|531023090|FG002|Extension Study|Adverse Event|0|||
147232320|NCT00543543|531023091|FG003|Extension Study|Adverse Event|5|||
147232321|NCT00543543|531023088|FG000|Extension Study|Lost to Follow-up|0|||
147232322|NCT00543543|531023089|FG001|Extension Study|Lost to Follow-up|0|||
147232323|NCT00543543|531023090|FG002|Extension Study|Lost to Follow-up|0|||
147232324|NCT00543543|531023091|FG003|Extension Study|Lost to Follow-up|77|||
147232325|NCT00543543|531023088|FG000|Extension Study|Physician Decision|0|||
147232326|NCT00543543|531023089|FG001|Extension Study|Physician Decision|0|||
147122607|NCT00066170|530612794|FG002|Overall Study|Adverse Event|1|||
147122608|NCT00066170|530612795|FG003|Overall Study|Adverse Event|7|||
147232327|NCT00543543|531023090|FG002|Extension Study|Physician Decision|0|||
147232328|NCT00543543|531023091|FG003|Extension Study|Physician Decision|7|||
147232329|NCT00543543|531023088|FG000|Extension Study|Pregnancy|0|||
147122609|NCT00066170|530612792|FG000|Overall Study|Serious Adverse Event|0|||
147122610|NCT00066170|530612793|FG001|Overall Study|Serious Adverse Event|0|||
147232330|NCT00543543|531023089|FG001|Extension Study|Pregnancy|0|||
147232331|NCT00543543|531023090|FG002|Extension Study|Pregnancy|0|||
147232332|NCT00543543|531023091|FG003|Extension Study|Pregnancy|6|||
147232333|NCT00543543|531023088|FG000|Extension Study|Protocol Violation|0|||
147232334|NCT00543543|531023089|FG001|Extension Study|Protocol Violation|0|||
147232335|NCT00543543|531023090|FG002|Extension Study|Protocol Violation|0|||
147232336|NCT00543543|531023091|FG003|Extension Study|Protocol Violation|11|||
147232337|NCT00543543|531023088|FG000|Extension Study|Withdrawal by Subject|0|||
147232338|NCT00543543|531023089|FG001|Extension Study|Withdrawal by Subject|0|||
147122611|NCT00066170|530612794|FG002|Overall Study|Serious Adverse Event|1|||
147122612|NCT00066170|530612795|FG003|Overall Study|Serious Adverse Event|1|||
147122613|NCT00066170|530612792|FG000|Overall Study|Lost to Follow-up|0|||
147122614|NCT00066170|530612793|FG001|Overall Study|Lost to Follow-up|1|||
147122615|NCT00066170|530612794|FG002|Overall Study|Lost to Follow-up|0|||
147122616|NCT00066170|530612795|FG003|Overall Study|Lost to Follow-up|0|||
147122617|NCT00066170|530612792|FG000|Overall Study|Non-Compliance with Trial Medicine|1|||
147122618|NCT00066170|530612793|FG001|Overall Study|Non-Compliance with Trial Medicine|0|||
147313804|NCT02401308|531315279|FG001|Overall Study|Study was terminated by the PI due to lack of enrollment.|1|||
147313805|NCT02998021|531315280|FG000|Overall Study|Withdrawal by Subject|3|||
147313806|NCT02998021|531315281|FG001|Overall Study|Withdrawal by Subject|1|||
147313807|NCT02998021|531315280|FG000|Overall Study|unsafe home|0|||
147313808|NCT02998021|531315281|FG001|Overall Study|unsafe home|1|||
147313809|NCT01734434|531315282|FG000|Overall Study|Death Infant|3|||
147313810|NCT01734434|531315283|FG001|Overall Study|Death Infant|1|||
147313811|NCT01734434|531315284|FG002|Overall Study|Death Infant|17|||
147313812|NCT01734434|531315285|FG003|Overall Study|Death Infant|5|||
147313813|NCT01734434|531315282|FG000|Overall Study|Lost to Follow-up|2|||
147313814|NCT01734434|531315283|FG001|Overall Study|Lost to Follow-up|9|||
147313815|NCT01734434|531315284|FG002|Overall Study|Lost to Follow-up|67|||
147313816|NCT01734434|531315285|FG003|Overall Study|Lost to Follow-up|11|||
147313817|NCT01734434|531315282|FG000|Overall Study|No Live Birth|1|||
147313818|NCT01734434|531315283|FG001|Overall Study|No Live Birth|2|||
147313819|NCT01734434|531315284|FG002|Overall Study|No Live Birth|32|||
147313820|NCT01734434|531315285|FG003|Overall Study|No Live Birth|6|||
147313821|NCT01734434|531315282|FG000|Overall Study|Withdrawal by Subject|4|||
147313822|NCT01734434|531315283|FG001|Overall Study|Withdrawal by Subject|0|||
147313823|NCT01734434|531315284|FG002|Overall Study|Withdrawal by Subject|8|||
147313824|NCT01734434|531315285|FG003|Overall Study|Withdrawal by Subject|1|||
147313825|NCT01734434|531315282|FG000|Overall Study|Signed Adult Version of Consent Form|0|||
147313826|NCT01734434|531315283|FG001|Overall Study|Signed Adult Version of Consent Form|0|||
147313827|NCT01734434|531315284|FG002|Overall Study|Signed Adult Version of Consent Form|1|||
147313828|NCT01734434|531315285|FG003|Overall Study|Signed Adult Version of Consent Form|0|||
147313829|NCT01734434|531315282|FG000|Overall Study|Subject Not Reachable|0|||
147313830|NCT01734434|531315283|FG001|Overall Study|Subject Not Reachable|0|||
147313831|NCT01734434|531315284|FG002|Overall Study|Subject Not Reachable|1|||
147650942|NCT02757352|532544541|FG004|Follow-Up Period|Lost to Follow-up|0|||
147650943|NCT02757352|532544542|FG005|Follow-Up Period|Lost to Follow-up|0|||
147650944|NCT02757352|532544543|FG006|Follow-Up Period|Lost to Follow-up|0|||
147650945|NCT02757352|532544544|FG007|Follow-Up Period|Lost to Follow-up|0|||
147650946|NCT02757352|532544545|FG008|Follow-Up Period|Lost to Follow-up|1|||
147650947|NCT02757352|532544546|FG009|Follow-Up Period|Lost to Follow-up|0|||
147650948|NCT02757352|532544537|FG000|Follow-Up Period|Lack of Efficacy|0|||
147313832|NCT01734434|531315285|FG003|Overall Study|Subject Not Reachable|0|||
147313833|NCT01734434|531315282|FG000|Overall Study|Treatment Defaulter|0|||
147313834|NCT01734434|531315283|FG001|Overall Study|Treatment Defaulter|0|||
147313835|NCT01734434|531315284|FG002|Overall Study|Treatment Defaulter|1|||
147313836|NCT01734434|531315285|FG003|Overall Study|Treatment Defaulter|0|||
147313837|NCT01734434|531315282|FG000|Overall Study|Wrong Version of Consent Form Signed|0|||
147313838|NCT01734434|531315283|FG001|Overall Study|Wrong Version of Consent Form Signed|0|||
147313839|NCT01734434|531315284|FG002|Overall Study|Wrong Version of Consent Form Signed|1|||
147313840|NCT01734434|531315285|FG003|Overall Study|Wrong Version of Consent Form Signed|0|||
147313841|NCT01734434|531315282|FG000|Overall Study|17 Yr Old Subject Signed Consent form|0|||
147313842|NCT01734434|531315283|FG001|Overall Study|17 Yr Old Subject Signed Consent form|0|||
147313843|NCT01734434|531315284|FG002|Overall Study|17 Yr Old Subject Signed Consent form|1|||
147313844|NCT01734434|531315285|FG003|Overall Study|17 Yr Old Subject Signed Consent form|0|||
147313845|NCT01040780|531317288|FG000|Overall Study|Protocol Violation|1|||
147313846|NCT01040780|531317289|FG001|Overall Study|Protocol Violation|3|||
147313847|NCT03681639|531317290|FG000|Overall Study|Death|4|||
147444603|NCT03715153|531792652|FG001|Double-blind Period (From W0 to W26)|Adverse Event|6|||
147650949|NCT02757352|532544538|FG001|Follow-Up Period|Lack of Efficacy|0|||
147650950|NCT02757352|532544539|FG002|Follow-Up Period|Lack of Efficacy|0|||
147650951|NCT02757352|532544540|FG003|Follow-Up Period|Lack of Efficacy|0|||
147122619|NCT00066170|530612794|FG002|Overall Study|Non-Compliance with Trial Medicine|0|||
147122620|NCT00066170|530612795|FG003|Overall Study|Non-Compliance with Trial Medicine|1|||
147122621|NCT00066170|530612792|FG000|Overall Study|Protocol Violation|3|||
147122622|NCT00066170|530612793|FG001|Overall Study|Protocol Violation|0|||
147122623|NCT00066170|530612794|FG002|Overall Study|Protocol Violation|0|||
147122624|NCT00066170|530612795|FG003|Overall Study|Protocol Violation|0|||
147122625|NCT00066170|530612792|FG000|Overall Study|Other|1|||
147313848|NCT03681639|531317290|FG000|Overall Study|Lost to Follow-up|2|||
147313849|NCT03681639|531317290|FG000|Overall Study|Withdrawal by Subject|1|||
147313850|NCT03681639|531317290|FG000|Overall Study|Adverse Event|2|||
147313851|NCT00619476|531317296|FG000|Overall Study|Adverse Event|12|||
147650952|NCT02757352|532544541|FG004|Follow-Up Period|Lack of Efficacy|0|||
147313852|NCT00619476|531317297|FG001|Overall Study|Adverse Event|6|||
147232339|NCT00543543|531023090|FG002|Extension Study|Withdrawal by Subject|0|||
147232340|NCT00543543|531023091|FG003|Extension Study|Withdrawal by Subject|120|||
147232341|NCT04308304|531023092|FG000|Overall Study|Withdrawal by Subject|4|||
147232342|NCT04308304|531023093|FG001|Overall Study|Withdrawal by Subject|0|||
147232343|NCT04308304|531023092|FG000|Overall Study|Protocol Violation|1|||
147232344|NCT04308304|531023093|FG001|Overall Study|Protocol Violation|0|||
147232345|NCT00945555|531023094|FG000|Overall Study|Referred to another hospital|5|||
147232346|NCT00945555|531023094|FG000|Overall Study|Worsening condition, intensive care unit|1|||
147232347|NCT00945555|531023094|FG000|Overall Study|Withdrawal by Subject|2|||
147232348|NCT00945555|531023094|FG000|Overall Study|Participant continued treatment at home|1|||
147232349|NCT00945555|531023094|FG000|Overall Study|Death|18|||
147232350|NCT00945555|531023094|FG000|Overall Study|Other|1|||
147232351|NCT04502979|531023096|FG000|Overall Study|Lost to Follow-up|1|||
147232352|NCT04502979|531023097|FG001|Overall Study|Lost to Follow-up|3|||
147232353|NCT04502979|531023096|FG000|Overall Study|Withdrawal by Subject|2|||
147232354|NCT04502979|531023097|FG001|Overall Study|Withdrawal by Subject|1|||
147232355|NCT00165984|531023102|FG000|Overall Study|Death|15|||
147232356|NCT03945266|531023103|FG000|Overall Study|Withdrawal by Subject|1|||
147232357|NCT03945266|531023104|FG001|Overall Study|Withdrawal by Subject|0|||
147232358|NCT03945266|531023103|FG000|Overall Study|Miscarriage|0|||
147232359|NCT03945266|531023104|FG001|Overall Study|Miscarriage|2|||
147232360|NCT03945266|531023103|FG000|Overall Study|Lost to Follow-up|1|||
147232361|NCT03945266|531023104|FG001|Overall Study|Lost to Follow-up|0|||
147232362|NCT01686828|531023105|FG000|Overall Study|Physician Decision|1|||
147232363|NCT01686828|531023106|FG001|Overall Study|Physician Decision|0|||
147232364|NCT01686828|531023107|FG002|Overall Study|Physician Decision|0|||
147232365|NCT01686828|531023108|FG003|Overall Study|Physician Decision|0|||
147232366|NCT01686828|531023105|FG000|Overall Study|New Job|0|||
147232367|NCT01686828|531023106|FG001|Overall Study|New Job|1|||
147232368|NCT01686828|531023107|FG002|Overall Study|New Job|0|||
147232369|NCT01686828|531023108|FG003|Overall Study|New Job|0|||
147232370|NCT01686828|531023105|FG000|Overall Study|Weight Loss|0|||
147232371|NCT01686828|531023106|FG001|Overall Study|Weight Loss|0|||
147232372|NCT01686828|531023107|FG002|Overall Study|Weight Loss|1|||
147232373|NCT01686828|531023108|FG003|Overall Study|Weight Loss|0|||
147232374|NCT01736124|531023121|FG000|Post-intervention Assessment|Death|2|||
147232375|NCT01736124|531023122|FG001|Post-intervention Assessment|Death|2|||
147232376|NCT01736124|531023121|FG000|Post-intervention Assessment|lost computer access|1|||
147232377|NCT01736124|531023122|FG001|Post-intervention Assessment|lost computer access|1|||
147232378|NCT01736124|531023121|FG000|Post-intervention Assessment|Moved away|3|||
147232379|NCT01736124|531023122|FG001|Post-intervention Assessment|Moved away|1|||
147232380|NCT01736124|531023121|FG000|Post-intervention Assessment|Withdrawal by Subject|11|||
147232381|NCT01736124|531023122|FG001|Post-intervention Assessment|Withdrawal by Subject|9|||
147232382|NCT01736124|531023121|FG000|Post-intervention Assessment|Illness|3|||
147232383|NCT01736124|531023122|FG001|Post-intervention Assessment|Illness|2|||
147232384|NCT01736124|531023121|FG000|Post-intervention Assessment|Lost to Follow-up|8|||
147232385|NCT01736124|531023122|FG001|Post-intervention Assessment|Lost to Follow-up|5|||
147232386|NCT01736124|531023121|FG000|Post-intervention Assessment|Temporarily away|3|||
147232387|NCT01736124|531023122|FG001|Post-intervention Assessment|Temporarily away|1|||
147232388|NCT01736124|531023121|FG000|6 Mo. Post-Intervention Assessment|Death|0|||
147568193|NCT01421277|532238440|FG000|Overall Study|Lack of qualifying event|0|||
147568194|NCT01421277|532238441|FG001|Overall Study|Lack of qualifying event|61|||
147568195|NCT01421277|532238440|FG000|Overall Study|Incomplete baseline data|0|||
147568196|NCT01421277|532238441|FG001|Overall Study|Incomplete baseline data|31|||
147568197|NCT02039908|532238442|FG000|Phase 1-Summer|Withdrawal by Subject|7|||
147568198|NCT02039908|532238443|FG001|Phase 1-Summer|Withdrawal by Subject|6|||
147568199|NCT02039908|532238444|FG002|Phase 1-Summer|Withdrawal by Subject|0|||
147568200|NCT02039908|532238445|FG003|Phase 1-Summer|Withdrawal by Subject|0|||
147568201|NCT02039908|532238442|FG000|Phase 1-Summer|Protocol Violation|6|||
147568202|NCT02039908|532238443|FG001|Phase 1-Summer|Protocol Violation|0|||
147568203|NCT02039908|532238444|FG002|Phase 1-Summer|Protocol Violation|0|||
147568204|NCT02039908|532238445|FG003|Phase 1-Summer|Protocol Violation|0|||
147568205|NCT02039908|532238442|FG000|Phase 2-School Year|Lost to Follow-up|0|||
147568206|NCT02039908|532238443|FG001|Phase 2-School Year|Lost to Follow-up|0|||
147568207|NCT02039908|532238444|FG002|Phase 2-School Year|Lost to Follow-up|1|||
147568208|NCT02039908|532238445|FG003|Phase 2-School Year|Lost to Follow-up|3|||
147568209|NCT02039908|532238442|FG000|Phase 2-School Year|Protocol Violation|0|||
147568210|NCT02039908|532238443|FG001|Phase 2-School Year|Protocol Violation|0|||
147232389|NCT01736124|531023122|FG001|6 Mo. Post-Intervention Assessment|Death|1|||
147232390|NCT01736124|531023121|FG000|6 Mo. Post-Intervention Assessment|Moved away|0|||
147232391|NCT01736124|531023122|FG001|6 Mo. Post-Intervention Assessment|Moved away|2|||
147232392|NCT01736124|531023121|FG000|6 Mo. Post-Intervention Assessment|Withdrawal by Subject|3|||
147232393|NCT01736124|531023122|FG001|6 Mo. Post-Intervention Assessment|Withdrawal by Subject|3|||
147232394|NCT01736124|531023121|FG000|6 Mo. Post-Intervention Assessment|Illness|1|||
147232395|NCT01736124|531023122|FG001|6 Mo. Post-Intervention Assessment|Illness|2|||
147568211|NCT02039908|532238444|FG002|Phase 2-School Year|Protocol Violation|3|||
147122626|NCT00066170|530612793|FG001|Overall Study|Other|5|||
147122627|NCT00066170|530612794|FG002|Overall Study|Other|2|||
147232396|NCT01736124|531023121|FG000|6 Mo. Post-Intervention Assessment|Temporarily away|1|||
147232397|NCT01736124|531023122|FG001|6 Mo. Post-Intervention Assessment|Temporarily away|4|||
147232398|NCT01736124|531023121|FG000|12 Mo. Post-Intervention Assessment|Death|1|||
147232399|NCT01736124|531023122|FG001|12 Mo. Post-Intervention Assessment|Death|0|||
147232400|NCT01736124|531023121|FG000|12 Mo. Post-Intervention Assessment|Moved away|1|||
147232401|NCT01736124|531023122|FG001|12 Mo. Post-Intervention Assessment|Moved away|0|||
147232402|NCT01736124|531023121|FG000|12 Mo. Post-Intervention Assessment|Withdrawal by Subject|0|||
147232403|NCT01736124|531023122|FG001|12 Mo. Post-Intervention Assessment|Withdrawal by Subject|2|||
147232404|NCT01736124|531023121|FG000|12 Mo. Post-Intervention Assessment|End of study|10|||
147232405|NCT01736124|531023122|FG001|12 Mo. Post-Intervention Assessment|End of study|10|||
147232406|NCT02734433|531023123|FG000|Overall Study|Disease progression|1|||
147232407|NCT02734433|531023124|FG001|Overall Study|Disease progression|5|||
147232408|NCT02734433|531023123|FG000|Overall Study|Clinical progression|0|||
147232409|NCT02734433|531023124|FG001|Overall Study|Clinical progression|1|||
147232410|NCT02734433|531023123|FG000|Overall Study|Withdrawal by Subject|1|||
147232411|NCT02734433|531023124|FG001|Overall Study|Withdrawal by Subject|2|||
147232412|NCT02628769|531023125|FG000|First Intervention|Adverse Event|1|||
147232413|NCT02628769|531023126|FG001|First Intervention|Adverse Event|0|||
147232414|NCT02628769|531023125|FG000|First Intervention|Withdrawal by Subject|0|||
147232415|NCT02628769|531023126|FG001|First Intervention|Withdrawal by Subject|1|||
147232416|NCT02628769|531023125|FG000|Second Intervention|Adverse Event|2|||
147232417|NCT02628769|531023126|FG001|Second Intervention|Adverse Event|0|||
147232418|NCT02628769|531023125|FG000|Second Intervention|Physician Decision|0|||
147232419|NCT02628769|531023126|FG001|Second Intervention|Physician Decision|1|||
147232420|NCT03698331|531023130|FG000|Overall Study|Adverse Event|2|||
147232421|NCT03698331|531023131|FG001|Overall Study|Adverse Event|3|||
147232422|NCT03698331|531023130|FG000|Overall Study|Withdrawal by Subject|1|||
147232423|NCT03698331|531023131|FG001|Overall Study|Withdrawal by Subject|1|||
147122628|NCT00066170|530612795|FG003|Overall Study|Other|0|||
147122629|NCT01089543|530612796|FG000|Overall Study|Withdrawal by Subject|2|||
147122630|NCT01089543|530612797|FG001|Overall Study|Withdrawal by Subject|3|||
147122631|NCT01089543|530612798|FG002|Overall Study|Withdrawal by Subject|3|||
147122632|NCT01089543|530612799|FG003|Overall Study|Withdrawal by Subject|1|||
147122633|NCT01089543|530612796|FG000|Overall Study|Physician Decision|1|||
147122634|NCT01089543|530612797|FG001|Overall Study|Physician Decision|0|||
147122635|NCT01089543|530612798|FG002|Overall Study|Physician Decision|0|||
147122636|NCT01089543|530612799|FG003|Overall Study|Physician Decision|1|||
147122637|NCT01089543|530612796|FG000|Overall Study|Adverse Event|0|||
147122638|NCT01089543|530612797|FG001|Overall Study|Adverse Event|1|||
147122639|NCT01089543|530612798|FG002|Overall Study|Adverse Event|0|||
147122640|NCT01089543|530612799|FG003|Overall Study|Adverse Event|0|||
147122641|NCT03888482|530612800|FG000|Second Wear (8 -1/+2 Days)|Adverse Event|0|||
147122642|NCT03888482|530612801|FG001|Second Wear (8 -1/+2 Days)|Adverse Event|1|||
147122643|NCT03888482|530612800|FG000|Second Wear (8 -1/+2 Days)|Other|1|||
147122644|NCT03888482|530612801|FG001|Second Wear (8 -1/+2 Days)|Other|0|||
147122645|NCT01189227|530612802|FG000|Overall Study|Study terminated due to low accrual|6|||
147122646|NCT01189227|530612803|FG001|Overall Study|Study terminated due to low accrual|3|||
147122647|NCT00563316|530612804|FG000|Overall Study|Adverse Event|2|||
147122648|NCT00563316|530612804|FG000|Overall Study|Physician Decision|1|||
147122649|NCT00563316|530612804|FG000|Overall Study|Lost to Follow-up|2|||
147122650|NCT00563316|530612804|FG000|Overall Study|Death|1|||
147122651|NCT00563316|530612804|FG000|Overall Study|On-going in study as of 16 July 2009.|5|||
147122652|NCT00563316|530612804|FG000|Overall Study|Other|1|||
147122653|NCT00425854|530612806|FG000|Overall Study|Progressive Disease|19|||
147122654|NCT00425854|530612807|FG001|Overall Study|Progressive Disease|12|||
147122655|NCT00425854|530612806|FG000|Overall Study|Dose reduction toxicity AE|8|||
147122656|NCT00425854|530612807|FG001|Overall Study|Dose reduction toxicity AE|7|||
147122657|NCT00425854|530612806|FG000|Overall Study|Other Adverse Event|2|||
147122658|NCT00425854|530612807|FG001|Overall Study|Other Adverse Event|2|||
147122659|NCT01630811|530612811|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|1|||
147122660|NCT01630811|530612812|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|0|||
147122661|NCT03760666|530612820|FG000|Overall Study|Adverse Event|2|||
147122662|NCT03760666|530612821|FG001|Overall Study|Adverse Event|4|||
147122663|NCT03760666|530612822|FG002|Overall Study|Adverse Event|1|||
147122664|NCT03760666|530612820|FG000|Overall Study|AML Disease Progression|3|||
147122665|NCT03760666|530612821|FG001|Overall Study|AML Disease Progression|3|||
147122666|NCT03760666|530612822|FG002|Overall Study|AML Disease Progression|0|||
147122667|NCT03760666|530612820|FG000|Overall Study|Physician Decision|0|||
147122668|NCT03760666|530612821|FG001|Overall Study|Physician Decision|3|||
147122669|NCT03760666|530612822|FG002|Overall Study|Physician Decision|0|||
147122670|NCT03760666|530612820|FG000|Overall Study|Withdrawal by Subject|0|||
147122671|NCT03760666|530612821|FG001|Overall Study|Withdrawal by Subject|1|||
147122672|NCT03760666|530612822|FG002|Overall Study|Withdrawal by Subject|0|||
147650953|NCT02757352|532544542|FG005|Follow-Up Period|Lack of Efficacy|0|||
147232424|NCT03698331|531023130|FG000|Overall Study|Lost to Follow-up|0|||
147232425|NCT03698331|531023131|FG001|Overall Study|Lost to Follow-up|2|||
147232426|NCT03698331|531023130|FG000|Overall Study|Non-compliance with study drug|1|||
147232427|NCT03698331|531023131|FG001|Overall Study|Non-compliance with study drug|0|||
147232428|NCT02130024|531023133|FG000|Overall Study|Adverse Event|10|||
147232429|NCT02130024|531023134|FG001|Overall Study|Adverse Event|11|||
147232430|NCT02130024|531023133|FG000|Overall Study|Death|2|||
147232431|NCT02130024|531023134|FG001|Overall Study|Death|2|||
147232432|NCT02130024|531023133|FG000|Overall Study|Lost to Follow-up|1|||
147232433|NCT02130024|531023134|FG001|Overall Study|Lost to Follow-up|1|||
147232434|NCT02130024|531023133|FG000|Overall Study|Physician Decision|1|||
147232435|NCT02130024|531023134|FG001|Overall Study|Physician Decision|3|||
147232436|NCT02130024|531023133|FG000|Overall Study|Protocol Deviation|4|||
147232437|NCT02130024|531023134|FG001|Overall Study|Protocol Deviation|0|||
147232438|NCT02130024|531023133|FG000|Overall Study|Site Administration Problems|1|||
147232439|NCT02130024|531023134|FG001|Overall Study|Site Administration Problems|0|||
147232440|NCT02130024|531023133|FG000|Overall Study|Subject Withdrew Consent|6|||
147232441|NCT02130024|531023134|FG001|Overall Study|Subject Withdrew Consent|14|||
147232442|NCT01467583|531023135|FG000|Overall Study|Death|1|||
147232443|NCT01467583|531023136|FG001|Overall Study|Death|1|||
147232444|NCT01467583|531023137|FG002|Overall Study|Death|0|||
147232445|NCT01467583|531023135|FG000|Overall Study|Withdrawal by Subject|1|||
147232446|NCT01467583|531023136|FG001|Overall Study|Withdrawal by Subject|0|||
147232447|NCT01467583|531023137|FG002|Overall Study|Withdrawal by Subject|0|||
147232448|NCT01467583|531023135|FG000|Overall Study|Protocol Violation|0|||
147232449|NCT01467583|531023136|FG001|Overall Study|Protocol Violation|0|||
147232450|NCT01467583|531023137|FG002|Overall Study|Protocol Violation|2|||
147232451|NCT05274165|531023139|FG000|Overall Study|Withdrawal by Subject|3|||
147650954|NCT02757352|532544543|FG006|Follow-Up Period|Lack of Efficacy|0|||
147650955|NCT02757352|532544544|FG007|Follow-Up Period|Lack of Efficacy|0|||
147650956|NCT02757352|532544545|FG008|Follow-Up Period|Lack of Efficacy|1|||
147650957|NCT02757352|532544546|FG009|Follow-Up Period|Lack of Efficacy|1|||
147650958|NCT02757352|532544537|FG000|Follow-Up Period|Withdrawal by Subject|0|||
147650959|NCT02757352|532544538|FG001|Follow-Up Period|Withdrawal by Subject|0|||
147650960|NCT02757352|532544539|FG002|Follow-Up Period|Withdrawal by Subject|0|||
147650961|NCT02757352|532544540|FG003|Follow-Up Period|Withdrawal by Subject|0|||
147650962|NCT02757352|532544541|FG004|Follow-Up Period|Withdrawal by Subject|0|||
147650963|NCT02757352|532544542|FG005|Follow-Up Period|Withdrawal by Subject|0|||
147650964|NCT02757352|532544543|FG006|Follow-Up Period|Withdrawal by Subject|0|||
147650965|NCT02757352|532544544|FG007|Follow-Up Period|Withdrawal by Subject|1|||
147650966|NCT02757352|532544545|FG008|Follow-Up Period|Withdrawal by Subject|6|||
147650967|NCT02757352|532544546|FG009|Follow-Up Period|Withdrawal by Subject|2|||
147650968|NCT00497146|532544548|FG000|Treatment Period|Adverse Event|6|||
147650969|NCT00497146|532544549|FG001|Treatment Period|Adverse Event|2|||
147650970|NCT00497146|532544548|FG000|Treatment Period|Withdrawal by Subject|5|||
147650971|NCT00497146|532544549|FG001|Treatment Period|Withdrawal by Subject|9|||
147650972|NCT00497146|532544548|FG000|Treatment Period|Lost to Follow-up|1|||
147650973|NCT00497146|532544549|FG001|Treatment Period|Lost to Follow-up|3|||
147650974|NCT00497146|532544548|FG000|Treatment Period|Required dialysis|4|||
147650975|NCT00497146|532544549|FG001|Treatment Period|Required dialysis|1|||
147650976|NCT00497146|532544548|FG000|Treatment Period|Change in RAAS inhibitor therapy|5|||
147650977|NCT00497146|532544549|FG001|Treatment Period|Change in RAAS inhibitor therapy|2|||
147650978|NCT00497146|532544548|FG000|Treatment Period|Unable to dose reduce per protocol|4|||
147650979|NCT00497146|532544549|FG001|Treatment Period|Unable to dose reduce per protocol|1|||
147650980|NCT00497146|532544548|FG000|Treatment Period|Other Reason|2|||
147650981|NCT00497146|532544549|FG001|Treatment Period|Other Reason|3|||
147650982|NCT00497146|532544548|FG000|Long-term Follow-up Period|Adverse Event|2|||
147650983|NCT00497146|532544549|FG001|Long-term Follow-up Period|Adverse Event|2|||
147650984|NCT00497146|532544548|FG000|Long-term Follow-up Period|Withdrawal by Subject|8|||
147650985|NCT00497146|532544549|FG001|Long-term Follow-up Period|Withdrawal by Subject|2|||
147232452|NCT05274165|531023140|FG001|Overall Study|Withdrawal by Subject|3|||
147232453|NCT04916769|531023146|FG000|Period 1|Physician Decision|0|||
147232454|NCT04916769|531023147|FG001|Period 1|Physician Decision|0|||
147650986|NCT00497146|532544548|FG000|Long-term Follow-up Period|Lost to Follow-up|5|||
147650987|NCT00497146|532544549|FG001|Long-term Follow-up Period|Lost to Follow-up|1|||
147650988|NCT00497146|532544548|FG000|Long-term Follow-up Period|Other|0|||
147650989|NCT00497146|532544549|FG001|Long-term Follow-up Period|Other|1|||
147650990|NCT01471444|532544550|FG000|Overall Study|Physician Decision|3|||
147650991|NCT01471444|532544551|FG001|Overall Study|Physician Decision|2|||
147232455|NCT04916769|531023148|FG002|Period 1|Physician Decision|0|||
147232456|NCT04916769|531023149|FG003|Period 1|Physician Decision|0|||
147232457|NCT04916769|531023150|FG004|Period 1|Physician Decision|0|||
147232458|NCT04916769|531023151|FG005|Period 1|Physician Decision|1|||
147232459|NCT04916769|531023146|FG000|Period 2|Physician Decision|0|||
147232460|NCT04916769|531023147|FG001|Period 2|Physician Decision|1|||
147232461|NCT04916769|531023148|FG002|Period 2|Physician Decision|0|||
147232462|NCT04916769|531023149|FG003|Period 2|Physician Decision|0|||
147232463|NCT04916769|531023150|FG004|Period 2|Physician Decision|0|||
147232464|NCT04916769|531023151|FG005|Period 2|Physician Decision|0|||
147232465|NCT05736224|531023152|FG000|Overall Study|Excluded from analysis because processed biopsy sample was inadequate for analysis|1|||
147232466|NCT04526509|531023153|FG000|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|40|||
147232467|NCT04526509|531023154|FG001|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|0|||
147232468|NCT04526509|531023155|FG002|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|0|||
147232469|NCT04526509|531023156|FG003|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|0|||
147232470|NCT04526509|531023157|FG004|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|0|||
147232471|NCT04526509|531023158|FG005|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|0|||
147232472|NCT04526509|531023159|FG006|Screening (Day -35 to Day -8)|Not tested for both HLA-type and NY-ESO-1 tumor expression|0|||
147232473|NCT04526509|531023153|FG000|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|9|||
147232474|NCT04526509|531023154|FG001|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|0|||
147232475|NCT04526509|531023155|FG002|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|0|||
147232476|NCT04526509|531023156|FG003|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|0|||
147232477|NCT04526509|531023157|FG004|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|0|||
147232478|NCT04526509|531023158|FG005|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|0|||
147232479|NCT04526509|531023159|FG006|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 tumor expression but not HLA-type and were NY-ESO-1 negative|0|||
147232480|NCT04526509|531023153|FG000|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|1|||
147232481|NCT04526509|531023154|FG001|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|0|||
147232482|NCT04526509|531023155|FG002|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|0|||
147232483|NCT04526509|531023156|FG003|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|0|||
147232484|NCT04526509|531023157|FG004|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|0|||
147232485|NCT04526509|531023158|FG005|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|0|||
147232486|NCT04526509|531023159|FG006|Screening (Day -35 to Day -8)|Tested for NY-ESO-1 but not HLA-type and were NY-ESO-1 positive but not met other inclusion criteria|0|||
147232487|NCT04526509|531023153|FG000|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|131|||
147232488|NCT04526509|531023154|FG001|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|0|||
147232489|NCT04526509|531023155|FG002|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|0|||
147232490|NCT04526509|531023156|FG003|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|0|||
147232491|NCT04526509|531023157|FG004|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|0|||
147232492|NCT04526509|531023158|FG005|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|0|||
147232493|NCT04526509|531023159|FG006|Screening (Day -35 to Day -8)|Tested for HLA-type and were HLA negative|0|||
147232494|NCT04526509|531023153|FG000|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|97|||
147232495|NCT04526509|531023154|FG001|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|0|||
147232496|NCT04526509|531023155|FG002|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|0|||
147232497|NCT04526509|531023156|FG003|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|0|||
147232498|NCT04526509|531023157|FG004|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|0|||
147232499|NCT04526509|531023158|FG005|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|0|||
147232500|NCT04526509|531023159|FG006|Screening (Day -35 to Day -8)|Tested HLA positive and were NY-ESO-1 Negative or Not Evaluable|0|||
147232501|NCT04526509|531023153|FG000|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|23|||
147232502|NCT04526509|531023154|FG001|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|0|||
147232503|NCT04526509|531023155|FG002|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|0|||
147232504|NCT04526509|531023156|FG003|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|0|||
147232505|NCT04526509|531023157|FG004|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|0|||
147232506|NCT04526509|531023158|FG005|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|0|||
147232507|NCT04526509|531023159|FG006|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive but not enrol in the study due to study terminated by sponsor|0|||
147232508|NCT04526509|531023153|FG000|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|6|||
147232509|NCT04526509|531023154|FG001|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|0|||
147568212|NCT02039908|532238445|FG003|Phase 2-School Year|Protocol Violation|0|||
147568213|NCT02039908|532238442|FG000|Phase 2-School Year|Withdrawal by Subject|0|||
147568214|NCT02039908|532238443|FG001|Phase 2-School Year|Withdrawal by Subject|0|||
147568215|NCT02039908|532238444|FG002|Phase 2-School Year|Withdrawal by Subject|8|||
147568216|NCT02039908|532238445|FG003|Phase 2-School Year|Withdrawal by Subject|5|||
147568217|NCT00829309|532239972|FG000|Washout: 7 Days|Protocol Violation|1|||
147568218|NCT00829309|532239973|FG001|Washout: 7 Days|Protocol Violation|0|||
147568219|NCT02246920|532239975|FG000|Overall Study|Adverse Event|3|||
147568220|NCT02246920|532239976|FG001|Overall Study|Adverse Event|1|||
147568221|NCT02246920|532239977|FG002|Overall Study|Adverse Event|1|||
147568222|NCT02246920|532239975|FG000|Overall Study|Lost to Follow-up|2|||
147568223|NCT02246920|532239976|FG001|Overall Study|Lost to Follow-up|1|||
147568224|NCT02246920|532239977|FG002|Overall Study|Lost to Follow-up|0|||
147568225|NCT02246920|532239975|FG000|Overall Study|Protocol Violation|2|||
147568226|NCT02246920|532239976|FG001|Overall Study|Protocol Violation|5|||
147568227|NCT02246920|532239977|FG002|Overall Study|Protocol Violation|1|||
147568228|NCT02246920|532239975|FG000|Overall Study|Withdrawal by Subject|0|||
147568229|NCT02246920|532239976|FG001|Overall Study|Withdrawal by Subject|0|||
147568230|NCT02246920|532239977|FG002|Overall Study|Withdrawal by Subject|1|||
147568231|NCT02678286|532239978|FG000|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|2|||
147568232|NCT02678286|532239979|FG001|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|1|||
147568233|NCT02678286|532239978|FG000|Treatment Phase (48 Hours Post-Dose 1)|Adverse Event|0|||
147568234|NCT02678286|532239979|FG001|Treatment Phase (48 Hours Post-Dose 1)|Adverse Event|1|||
147568235|NCT02678286|532239978|FG000|Study Overall (28 Day Follow-Up)|Lack of Efficacy|1|||
147568236|NCT02678286|532239979|FG001|Study Overall (28 Day Follow-Up)|Lack of Efficacy|0|||
147568237|NCT02678286|532239978|FG000|Study Overall (28 Day Follow-Up)|Withdrawal by Subject|3|||
147568238|NCT02678286|532239979|FG001|Study Overall (28 Day Follow-Up)|Withdrawal by Subject|2|||
147568239|NCT02678286|532239978|FG000|Study Overall (28 Day Follow-Up)|Lost to Follow-up|2|||
147568240|NCT02678286|532239979|FG001|Study Overall (28 Day Follow-Up)|Lost to Follow-up|2|||
147568241|NCT00448019|532239980|FG000|Overall Study|Withdrawal by Subject|3|||
147568242|NCT00448019|532239980|FG000|Overall Study|Disease progression|1|||
147568243|NCT00448019|532239980|FG000|Overall Study|Death|2|||
147568244|NCT00448019|532239980|FG000|Overall Study|Insurance Issues|1|||
147568245|NCT01273805|532239985|FG000|Overall Study|Radiologic PD or Symptom Deterioration|10|||
147568246|NCT01273805|532239986|FG001|Overall Study|Radiologic PD or Symptom Deterioration|10|||
147568247|NCT02647944|532239987|FG000|Overall Study|Withdrawal by Subject|0|||
147568248|NCT02647944|532239988|FG001|Overall Study|Withdrawal by Subject|3|||
147568249|NCT02647944|532239987|FG000|Overall Study|Adverse Event|2|||
147568250|NCT02647944|532239988|FG001|Overall Study|Adverse Event|0|||
147568251|NCT02760368|532239990|FG000|Overall Study|Withdrawal by Subject|8|||
147568252|NCT02760368|532239991|FG001|Overall Study|Withdrawal by Subject|12|||
147232510|NCT04526509|531023155|FG002|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|0|||
147232511|NCT04526509|531023156|FG003|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|0|||
147232512|NCT04526509|531023157|FG004|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|0|||
147232513|NCT04526509|531023158|FG005|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|0|||
147232514|NCT04526509|531023159|FG006|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not meet inclusion/exclusion criteria|0|||
147232515|NCT04526509|531023153|FG000|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|4|||
147232516|NCT04526509|531023154|FG001|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|0|||
147232517|NCT04526509|531023155|FG002|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|0|||
147232518|NCT04526509|531023156|FG003|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|0|||
147232519|NCT04526509|531023157|FG004|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|0|||
147232520|NCT04526509|531023158|FG005|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|0|||
147232521|NCT04526509|531023159|FG006|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to physician decision|0|||
147232522|NCT04526509|531023153|FG000|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|3|||
147232523|NCT04526509|531023154|FG001|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|0|||
147249857|NCT01018186|531083793|FG000|2-week Run-in Period|Physician Decision|3|||
147568253|NCT02760368|532239992|FG002|Overall Study|Withdrawal by Subject|9|||
147568254|NCT02760368|532239990|FG000|Overall Study|Screen Failure|0|||
147568255|NCT02760368|532239991|FG001|Overall Study|Screen Failure|0|||
147568256|NCT02760368|532239992|FG002|Overall Study|Screen Failure|1|||
147568257|NCT02760368|532239990|FG000|Overall Study|Death|0|||
147568258|NCT02760368|532239991|FG001|Overall Study|Death|1|||
147568259|NCT02760368|532239992|FG002|Overall Study|Death|0|||
147568260|NCT02760368|532239990|FG000|Overall Study|Withdrawal by Sponsor|0|||
147568261|NCT02760368|532239991|FG001|Overall Study|Withdrawal by Sponsor|0|||
147568262|NCT02760368|532239992|FG002|Overall Study|Withdrawal by Sponsor|1|||
147444604|NCT03715153|531792651|FG000|Open-label Period (From W26 to W52)|Adverse Event|8|||
147568263|NCT02902211|532240000|FG000|First Three Months|Withdrawal by Subject|7|||
147568264|NCT02902211|532240001|FG001|First Three Months|Withdrawal by Subject|3|||
147568265|NCT01200810|532240002|FG000|Overall Study|Physician Decision|1|||
147232524|NCT04526509|531023155|FG002|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|0|||
147232525|NCT04526509|531023156|FG003|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|0|||
147232526|NCT04526509|531023157|FG004|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|0|||
147232527|NCT04526509|531023158|FG005|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|0|||
147232528|NCT04526509|531023159|FG006|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol as met eligibility criteria but not needed|0|||
147232529|NCT04526509|531023153|FG000|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|1|||
147232530|NCT04526509|531023154|FG001|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|0|||
147232531|NCT04526509|531023155|FG002|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|0|||
147232532|NCT04526509|531023156|FG003|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|0|||
147232533|NCT04526509|531023157|FG004|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|0|||
147232534|NCT04526509|531023158|FG005|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|0|||
147232535|NCT04526509|531023159|FG006|Screening (Day -35 to Day -8)|HLA and NY-ESO-1 expression positive and did not enrol due to withdrawal by participant|0|||
147232536|NCT04526509|531023153|FG000|Enrolled|Study Terminated by Sponsor|0|||
147232537|NCT04526509|531023154|FG001|Enrolled|Study Terminated by Sponsor|0|||
147232538|NCT04526509|531023155|FG002|Enrolled|Study Terminated by Sponsor|0|||
147232539|NCT04526509|531023156|FG003|Enrolled|Study Terminated by Sponsor|0|||
147232540|NCT04526509|531023157|FG004|Enrolled|Study Terminated by Sponsor|0|||
147232541|NCT04526509|531023158|FG005|Enrolled|Study Terminated by Sponsor|0|||
147232542|NCT04526509|531023159|FG006|Enrolled|Study Terminated by Sponsor|1|||
147232543|NCT04526509|531023153|FG000|Enrolled|Death prior to lymphodepletion|0|||
147232544|NCT04526509|531023154|FG001|Enrolled|Death prior to lymphodepletion|0|||
147232545|NCT04526509|531023155|FG002|Enrolled|Death prior to lymphodepletion|0|||
147232546|NCT04526509|531023156|FG003|Enrolled|Death prior to lymphodepletion|1|||
147232547|NCT04526509|531023157|FG004|Enrolled|Death prior to lymphodepletion|0|||
147232548|NCT04526509|531023158|FG005|Enrolled|Death prior to lymphodepletion|0|||
147232549|NCT04526509|531023159|FG006|Enrolled|Death prior to lymphodepletion|0|||
147232550|NCT04526509|531023153|FG000|Enrolled|Did not meet Inclusion/Exclusion Criteria|0|||
147232551|NCT04526509|531023154|FG001|Enrolled|Did not meet Inclusion/Exclusion Criteria|0|||
147232552|NCT04526509|531023155|FG002|Enrolled|Did not meet Inclusion/Exclusion Criteria|0|||
147232553|NCT04526509|531023156|FG003|Enrolled|Did not meet Inclusion/Exclusion Criteria|1|||
147232554|NCT04526509|531023157|FG004|Enrolled|Did not meet Inclusion/Exclusion Criteria|0|||
147232555|NCT04526509|531023158|FG005|Enrolled|Did not meet Inclusion/Exclusion Criteria|0|||
147232556|NCT04526509|531023159|FG006|Enrolled|Did not meet Inclusion/Exclusion Criteria|0|||
147232557|NCT04526509|531023153|FG000|Enrolled|Physician Decision|0|||
147232558|NCT04526509|531023154|FG001|Enrolled|Physician Decision|1|||
147232559|NCT04526509|531023155|FG002|Enrolled|Physician Decision|0|||
147232560|NCT04526509|531023156|FG003|Enrolled|Physician Decision|0|||
147232561|NCT04526509|531023157|FG004|Enrolled|Physician Decision|0|||
147232562|NCT04526509|531023158|FG005|Enrolled|Physician Decision|0|||
147232563|NCT04526509|531023159|FG006|Enrolled|Physician Decision|0|||
147232564|NCT02719327|531023164|FG000|Overall Study|Withdrawal by Subject|11|||
147232565|NCT02719327|531023165|FG001|Overall Study|Withdrawal by Subject|8|||
147232566|NCT04340193|531023166|FG000|Overall Study|Other reason|0|||
147232567|NCT04340193|531023167|FG001|Overall Study|Other reason|0|||
147232568|NCT04340193|531023168|FG002|Overall Study|Other reason|1|||
147232569|NCT04340193|531023166|FG000|Overall Study|Disease recurrence|0|||
147232570|NCT04340193|531023167|FG001|Overall Study|Disease recurrence|1|||
147232571|NCT04340193|531023168|FG002|Overall Study|Disease recurrence|0|||
147232572|NCT04340193|531023166|FG000|Overall Study|Study drug toxicity|1|||
147232573|NCT04340193|531023167|FG001|Overall Study|Study drug toxicity|0|||
147232574|NCT04340193|531023168|FG002|Overall Study|Study drug toxicity|0|||
147232575|NCT04340193|531023166|FG000|Overall Study|Disease progression|1|||
147232576|NCT04340193|531023167|FG001|Overall Study|Disease progression|2|||
147232577|NCT04340193|531023168|FG002|Overall Study|Disease progression|3|||
147232578|NCT04340193|531023166|FG000|Overall Study|Administrative reasons by sponsor|0|||
147232579|NCT04340193|531023167|FG001|Overall Study|Administrative reasons by sponsor|1|||
147444605|NCT03715153|531792652|FG001|Open-label Period (From W26 to W52)|Adverse Event|3|||
147444606|NCT03715153|531792651|FG000|Open-label Period (From W26 to W52)|Non medical reason|31|||
147444607|NCT03715153|531792652|FG001|Open-label Period (From W26 to W52)|Non medical reason|38|||
147444608|NCT03715153|531792651|FG000|Open-label Period (From W26 to W52)|Protocol Violation|1|||
147568266|NCT01200810|532240003|FG001|Overall Study|Physician Decision|0|||
147568267|NCT01200810|532240002|FG000|Overall Study|Withdrawal by Subject|1|||
147232580|NCT04340193|531023168|FG002|Overall Study|Administrative reasons by sponsor|0|||
147232581|NCT04340193|531023166|FG000|Overall Study|Adverse Event|1|||
147232582|NCT04340193|531023167|FG001|Overall Study|Adverse Event|1|||
147232583|NCT04340193|531023168|FG002|Overall Study|Adverse Event|0|||
147232584|NCT03350620|531023169|FG000|Stage 2|Adverse Event|0|||
147232585|NCT03350620|531023170|FG001|Stage 2|Adverse Event|1|||
147232586|NCT03350620|531023171|FG002|Stage 2|Adverse Event|1|||
147232587|NCT03350620|531023169|FG000|Stage 2|Lack of Efficacy|0|||
147232588|NCT03350620|531023170|FG001|Stage 2|Lack of Efficacy|2|||
147232589|NCT03350620|531023171|FG002|Stage 2|Lack of Efficacy|0|||
147232590|NCT03350620|531023169|FG000|Stage 2|Lost to Follow-up|1|||
147232591|NCT03350620|531023170|FG001|Stage 2|Lost to Follow-up|2|||
147232592|NCT03350620|531023171|FG002|Stage 2|Lost to Follow-up|2|||
147232593|NCT03350620|531023169|FG000|Stage 2|unable to visit (1); used prohibited concomitant medication / withdrew consent (4); relocation (1).|2|||
147232594|NCT03350620|531023170|FG001|Stage 2|unable to visit (1); used prohibited concomitant medication / withdrew consent (4); relocation (1).|4|||
147232595|NCT03350620|531023171|FG002|Stage 2|unable to visit (1); used prohibited concomitant medication / withdrew consent (4); relocation (1).|0|||
147232596|NCT01066000|531023172|FG000|Overall Study|Protocol Violation|4|||
147232597|NCT01066000|531023172|FG000|Overall Study|Death|3|||
147232598|NCT01066000|531023172|FG000|Overall Study|Withdrawal by Subject|1|||
147232599|NCT01066000|531023172|FG000|Overall Study|Adverse Event|1|||
147232600|NCT03507400|531023173|FG000|Overall Study|discontinued|5|||
147232601|NCT03507400|531023174|FG001|Overall Study|discontinued|1|||
147232602|NCT03507400|531023173|FG000|Overall Study|Lost to Follow-up|8|||
147232603|NCT03507400|531023174|FG001|Overall Study|Lost to Follow-up|6|||
147232604|NCT03507400|531023173|FG000|Overall Study|Protocol Violation|0|||
147232605|NCT03507400|531023174|FG001|Overall Study|Protocol Violation|1|||
147232606|NCT00217620|531024573|FG000|Overall Study|Adverse Event|2|||
147232607|NCT00217620|531024573|FG000|Overall Study|Progression|31|||
147232608|NCT00217620|531024573|FG000|Overall Study|Not Protocol Specified|4|||
147232609|NCT00217620|531024573|FG000|Overall Study|Ineligible|13|||
147232610|NCT00217620|531024573|FG000|Overall Study|Never received treatment|1|||
147232611|NCT02008318|531024582|FG000|Overall Study|Adverse Event|4|||
147232612|NCT02008318|531024583|FG001|Overall Study|Adverse Event|0|||
147232613|NCT02008318|531024582|FG000|Overall Study|Physician Decision|2|||
147232614|NCT02008318|531024583|FG001|Overall Study|Physician Decision|0|||
147232615|NCT02008318|531024582|FG000|Overall Study|Progressive Disease|2|||
147232616|NCT02008318|531024583|FG001|Overall Study|Progressive Disease|0|||
147232617|NCT02008318|531024582|FG000|Overall Study|Protocol Violation|1|||
147232618|NCT02008318|531024583|FG001|Overall Study|Protocol Violation|1|||
147232619|NCT02008318|531024582|FG000|Overall Study|Withdrawal by Subject|3|||
147232620|NCT02008318|531024583|FG001|Overall Study|Withdrawal by Subject|0|||
147232621|NCT02281773|531024584|FG000|Overall Study|Adverse Event|6|||
147232622|NCT02281773|531024585|FG001|Overall Study|Adverse Event|1|||
147232623|NCT02281773|531024586|FG002|Overall Study|Adverse Event|4|||
147232624|NCT02281773|531024587|FG003|Overall Study|Adverse Event|8|||
147232625|NCT02281773|531024588|FG004|Overall Study|Adverse Event|9|||
147232626|NCT02281773|531024584|FG000|Overall Study|Protocol Violation|1|||
147232627|NCT02281773|531024585|FG001|Overall Study|Protocol Violation|0|||
147232628|NCT02281773|531024586|FG002|Overall Study|Protocol Violation|0|||
147232629|NCT02281773|531024587|FG003|Overall Study|Protocol Violation|2|||
147232630|NCT02281773|531024588|FG004|Overall Study|Protocol Violation|2|||
147232631|NCT02281773|531024584|FG000|Overall Study|Lost to Follow-up|2|||
147232632|NCT02281773|531024585|FG001|Overall Study|Lost to Follow-up|2|||
147232633|NCT02281773|531024586|FG002|Overall Study|Lost to Follow-up|6|||
147232634|NCT02281773|531024587|FG003|Overall Study|Lost to Follow-up|2|||
147232635|NCT02281773|531024588|FG004|Overall Study|Lost to Follow-up|10|||
147232636|NCT02281773|531024584|FG000|Overall Study|Withdrawal by Subject|2|||
147232637|NCT02281773|531024585|FG001|Overall Study|Withdrawal by Subject|8|||
147232638|NCT02281773|531024586|FG002|Overall Study|Withdrawal by Subject|6|||
147232639|NCT02281773|531024587|FG003|Overall Study|Withdrawal by Subject|6|||
147232640|NCT02281773|531024588|FG004|Overall Study|Withdrawal by Subject|8|||
147232641|NCT02281773|531024584|FG000|Overall Study|Other Reason|0|||
147232642|NCT02281773|531024585|FG001|Overall Study|Other Reason|4|||
147444609|NCT03715153|531792652|FG001|Open-label Period (From W26 to W52)|Protocol Violation|1|||
147444610|NCT02973087|531792655|FG000|Overall Study|Withdrawal by Subject|2|||
147232643|NCT02281773|531024586|FG002|Overall Study|Other Reason|2|||
147232644|NCT02281773|531024587|FG003|Overall Study|Other Reason|3|||
147232645|NCT02281773|531024588|FG004|Overall Study|Other Reason|1|||
147232646|NCT01797731|531024591|FG000|Overall Study|Didn't have proper radiographs required|3|||
147232647|NCT01797731|531024592|FG001|Overall Study|Didn't have proper radiographs required|3|||
147232648|NCT00091442|531024594|FG000|Overall Study|Progressive Disease|220|||
147232649|NCT00091442|531024595|FG001|Overall Study|Progressive Disease|189|||
147232650|NCT00091442|531024594|FG000|Overall Study|Physician Decision|61|||
147232651|NCT00091442|531024595|FG001|Overall Study|Physician Decision|58|||
147232652|NCT00091442|531024594|FG000|Overall Study|Withdrawal by Subject|38|||
147232653|NCT00091442|531024595|FG001|Overall Study|Withdrawal by Subject|46|||
147232654|NCT00091442|531024594|FG000|Overall Study|Adverse Event|29|||
147568268|NCT01200810|532240003|FG001|Overall Study|Withdrawal by Subject|2|||
147232655|NCT00091442|531024595|FG001|Overall Study|Adverse Event|48|||
147232656|NCT00091442|531024594|FG000|Overall Study|2cycles therapy beyond Complete response|9|||
147232657|NCT00091442|531024595|FG001|Overall Study|2cycles therapy beyond Complete response|16|||
147232658|NCT00091442|531024594|FG000|Overall Study|Death|9|||
147232659|NCT00091442|531024595|FG001|Overall Study|Death|7|||
147232660|NCT00091442|531024594|FG000|Overall Study|Lost to Follow-up|1|||
147232661|NCT00091442|531024595|FG001|Overall Study|Lost to Follow-up|3|||
147232662|NCT00091442|531024594|FG000|Overall Study|Other|2|||
147232663|NCT00091442|531024595|FG001|Overall Study|Other|6|||
147232664|NCT00917501|531024596|FG000|Overall Study|Lost to Follow-up|4|||
147232665|NCT00917501|531024597|FG001|Overall Study|Lost to Follow-up|1|||
147232666|NCT00917501|531024596|FG000|Overall Study|Withdrawal by Subject|3|||
147232667|NCT00917501|531024597|FG001|Overall Study|Withdrawal by Subject|1|||
147232668|NCT00917501|531024596|FG000|Overall Study|Lack of Efficacy|1|||
147232669|NCT00917501|531024597|FG001|Overall Study|Lack of Efficacy|2|||
147232670|NCT00917501|531024596|FG000|Overall Study|trouble swollowing capsules|0|||
147232671|NCT00917501|531024597|FG001|Overall Study|trouble swollowing capsules|1|||
147232672|NCT00808483|531024602|FG000|From 3 to 5 Months After Surgery|Withdrawal by Subject|1|||
147232673|NCT00808483|531024603|FG001|From 3 to 5 Months After Surgery|Withdrawal by Subject|1|||
147232674|NCT00808483|531024602|FG000|From 3 to 5 Months After Surgery|Lack of Efficacy|1|||
147232675|NCT00808483|531024603|FG001|From 3 to 5 Months After Surgery|Lack of Efficacy|0|||
147232676|NCT00808483|531024602|FG000|From 5 Months to 12 Months|Lack of Efficacy|1|||
147232677|NCT00808483|531024603|FG001|From 5 Months to 12 Months|Lack of Efficacy|0|||
147232678|NCT02038881|531024604|FG000|Overall Study|Withdrawal by Subject|0|||
147232679|NCT02038881|531024605|FG001|Overall Study|Withdrawal by Subject|0|||
147232680|NCT02038881|531024606|FG002|Overall Study|Withdrawal by Subject|1|||
147232681|NCT02038881|531024604|FG000|Overall Study|Lost to Follow-up|2|||
147232682|NCT02038881|531024605|FG001|Overall Study|Lost to Follow-up|0|||
147232683|NCT02038881|531024606|FG002|Overall Study|Lost to Follow-up|0|||
147232684|NCT02038881|531024604|FG000|Overall Study|incarcerated|1|||
147232685|NCT02038881|531024605|FG001|Overall Study|incarcerated|0|||
147232686|NCT02038881|531024606|FG002|Overall Study|incarcerated|0|||
147232687|NCT00333840|531024607|FG000|First-line Treatment Period|Adverse Event|38|||
147232688|NCT00333840|531024608|FG001|First-line Treatment Period|Adverse Event|37|||
147232689|NCT00333840|531024609|FG002|First-line Treatment Period|Adverse Event|0|||
147232690|NCT00333840|531024610|FG003|First-line Treatment Period|Adverse Event|0|||
147232691|NCT00333840|531024607|FG000|First-line Treatment Period|Abnormal laboratory values|3|||
147232692|NCT00333840|531024608|FG001|First-line Treatment Period|Abnormal laboratory values|1|||
147232693|NCT00333840|531024609|FG002|First-line Treatment Period|Abnormal laboratory values|0|||
147232694|NCT00333840|531024610|FG003|First-line Treatment Period|Abnormal laboratory values|0|||
147232695|NCT00333840|531024607|FG000|First-line Treatment Period|Abnormal procedure|2|||
147232696|NCT00333840|531024608|FG001|First-line Treatment Period|Abnormal procedure|0|||
147232697|NCT00333840|531024609|FG002|First-line Treatment Period|Abnormal procedure|0|||
147232698|NCT00333840|531024610|FG003|First-line Treatment Period|Abnormal procedure|0|||
147232699|NCT00333840|531024607|FG000|First-line Treatment Period|Unsatisfactory therapeutic effect|88|||
147232700|NCT00333840|531024608|FG001|First-line Treatment Period|Unsatisfactory therapeutic effect|29|||
147232701|NCT00333840|531024609|FG002|First-line Treatment Period|Unsatisfactory therapeutic effect|0|||
147232702|NCT00333840|531024610|FG003|First-line Treatment Period|Unsatisfactory therapeutic effect|0|||
147232703|NCT00333840|531024607|FG000|First-line Treatment Period|No longer required study drug|21|||
147232704|NCT00333840|531024608|FG001|First-line Treatment Period|No longer required study drug|8|||
147232705|NCT00333840|531024609|FG002|First-line Treatment Period|No longer required study drug|0|||
147232706|NCT00333840|531024610|FG003|First-line Treatment Period|No longer required study drug|0|||
147232707|NCT00333840|531024607|FG000|First-line Treatment Period|Protocol Violation|17|||
147232708|NCT00333840|531024608|FG001|First-line Treatment Period|Protocol Violation|17|||
147232709|NCT00333840|531024609|FG002|First-line Treatment Period|Protocol Violation|0|||
147232710|NCT00333840|531024610|FG003|First-line Treatment Period|Protocol Violation|0|||
147232711|NCT00333840|531024607|FG000|First-line Treatment Period|Subject withdrew consent|57|||
147232712|NCT00333840|531024608|FG001|First-line Treatment Period|Subject withdrew consent|77|||
147232713|NCT00333840|531024609|FG002|First-line Treatment Period|Subject withdrew consent|0|||
147232714|NCT00333840|531024610|FG003|First-line Treatment Period|Subject withdrew consent|0|||
147232715|NCT00333840|531024607|FG000|First-line Treatment Period|Lost to Follow-up|15|||
147232716|NCT00333840|531024608|FG001|First-line Treatment Period|Lost to Follow-up|6|||
147232717|NCT00333840|531024609|FG002|First-line Treatment Period|Lost to Follow-up|0|||
147568269|NCT01200810|532240002|FG000|Overall Study|Sponsor stopped making study drug|3|||
147232718|NCT00333840|531024610|FG003|First-line Treatment Period|Lost to Follow-up|0|||
147232719|NCT00333840|531024607|FG000|First-line Treatment Period|Administrative problems|12|||
147232720|NCT00333840|531024608|FG001|First-line Treatment Period|Administrative problems|6|||
147232721|NCT00333840|531024609|FG002|First-line Treatment Period|Administrative problems|0|||
147232722|NCT00333840|531024610|FG003|First-line Treatment Period|Administrative problems|0|||
147232723|NCT00333840|531024607|FG000|First-line Treatment Period|Death|19|||
147232724|NCT00333840|531024608|FG001|First-line Treatment Period|Death|2|||
147232725|NCT00333840|531024609|FG002|First-line Treatment Period|Death|0|||
147232726|NCT00333840|531024610|FG003|First-line Treatment Period|Death|0|||
147232727|NCT00333840|531024607|FG000|First-line Treatment Period|Crossed over to other treatment arm|14|||
147232728|NCT00333840|531024608|FG001|First-line Treatment Period|Crossed over to other treatment arm|363|||
147232729|NCT00333840|531024609|FG002|First-line Treatment Period|Crossed over to other treatment arm|0|||
147232730|NCT00333840|531024610|FG003|First-line Treatment Period|Crossed over to other treatment arm|0|||
147232731|NCT00333840|531024607|FG000|Second-line Treatment Period|Adverse Event|0|||
147232732|NCT00333840|531024608|FG001|Second-line Treatment Period|Adverse Event|0|||
147232733|NCT00333840|531024609|FG002|Second-line Treatment Period|Adverse Event|3|||
147232734|NCT00333840|531024610|FG003|Second-line Treatment Period|Adverse Event|34|||
147232735|NCT00333840|531024607|FG000|Second-line Treatment Period|Abnormal Laboratory Values|0|||
147232736|NCT00333840|531024608|FG001|Second-line Treatment Period|Abnormal Laboratory Values|0|||
147232737|NCT00333840|531024609|FG002|Second-line Treatment Period|Abnormal Laboratory Values|0|||
147232738|NCT00333840|531024610|FG003|Second-line Treatment Period|Abnormal Laboratory Values|3|||
147232739|NCT00333840|531024607|FG000|Second-line Treatment Period|Abnormal procedure|0|||
147232740|NCT00333840|531024608|FG001|Second-line Treatment Period|Abnormal procedure|0|||
147232741|NCT00333840|531024609|FG002|Second-line Treatment Period|Abnormal procedure|0|||
147232742|NCT00333840|531024610|FG003|Second-line Treatment Period|Abnormal procedure|1|||
147232743|NCT00333840|531024607|FG000|Second-line Treatment Period|Unsatisfactory therapeutic effect|0|||
147232744|NCT00333840|531024608|FG001|Second-line Treatment Period|Unsatisfactory therapeutic effect|0|||
147232745|NCT00333840|531024609|FG002|Second-line Treatment Period|Unsatisfactory therapeutic effect|9|||
147232746|NCT00333840|531024610|FG003|Second-line Treatment Period|Unsatisfactory therapeutic effect|70|||
147232747|NCT00333840|531024607|FG000|Second-line Treatment Period|No longer required study drug|0|||
147232748|NCT00333840|531024608|FG001|Second-line Treatment Period|No longer required study drug|0|||
147232749|NCT00333840|531024609|FG002|Second-line Treatment Period|No longer required study drug|1|||
147232750|NCT00333840|531024610|FG003|Second-line Treatment Period|No longer required study drug|14|||
147232751|NCT00333840|531024607|FG000|Second-line Treatment Period|Protocol Violation|0|||
147232752|NCT00333840|531024608|FG001|Second-line Treatment Period|Protocol Violation|0|||
147232753|NCT00333840|531024609|FG002|Second-line Treatment Period|Protocol Violation|1|||
147232754|NCT00333840|531024610|FG003|Second-line Treatment Period|Protocol Violation|10|||
147232755|NCT00333840|531024607|FG000|Second-line Treatment Period|Subject withdrew consent|0|||
147232756|NCT00333840|531024608|FG001|Second-line Treatment Period|Subject withdrew consent|0|||
147232757|NCT00333840|531024609|FG002|Second-line Treatment Period|Subject withdrew consent|0|||
147232758|NCT00333840|531024610|FG003|Second-line Treatment Period|Subject withdrew consent|34|||
147232759|NCT00333840|531024607|FG000|Second-line Treatment Period|Lost to Follow-up|0|||
147232760|NCT00333840|531024608|FG001|Second-line Treatment Period|Lost to Follow-up|0|||
147232761|NCT00333840|531024609|FG002|Second-line Treatment Period|Lost to Follow-up|0|||
147232762|NCT00333840|531024610|FG003|Second-line Treatment Period|Lost to Follow-up|6|||
147232763|NCT00333840|531024607|FG000|Second-line Treatment Period|Administrative problems|0|||
147232764|NCT00333840|531024608|FG001|Second-line Treatment Period|Administrative problems|0|||
147232765|NCT00333840|531024609|FG002|Second-line Treatment Period|Administrative problems|0|||
147232766|NCT00333840|531024610|FG003|Second-line Treatment Period|Administrative problems|7|||
147232767|NCT00333840|531024607|FG000|Second-line Treatment Period|Death|0|||
147232768|NCT00333840|531024608|FG001|Second-line Treatment Period|Death|0|||
147232769|NCT00333840|531024609|FG002|Second-line Treatment Period|Death|0|||
147232770|NCT00333840|531024610|FG003|Second-line Treatment Period|Death|9|||
147232771|NCT03945214|531024611|FG000|Overall Study|Lost to Follow-up|3|||
147232772|NCT03945214|531024612|FG001|Overall Study|Lost to Follow-up|4|||
147232773|NCT03945214|531024613|FG002|Overall Study|Lost to Follow-up|7|||
147232774|NCT03945214|531024614|FG003|Overall Study|Lost to Follow-up|4|||
147232775|NCT01436396|531024625|FG000|Overall Study|Protocol Violation|7|||
147232776|NCT01436396|531024626|FG001|Overall Study|Protocol Violation|5|||
147232777|NCT01436396|531024625|FG000|Overall Study|Adverse Event|1|||
147232778|NCT01436396|531024626|FG001|Overall Study|Adverse Event|2|||
147232779|NCT01436396|531024625|FG000|Overall Study|Withdrawal by Subject|19|||
147232780|NCT01436396|531024626|FG001|Overall Study|Withdrawal by Subject|29|||
147232781|NCT01436396|531024625|FG000|Overall Study|Serious adverse event|2|||
147232782|NCT01436396|531024626|FG001|Overall Study|Serious adverse event|3|||
147232783|NCT01436396|531024625|FG000|Overall Study|Lost to Follow-up|3|||
147232784|NCT01436396|531024626|FG001|Overall Study|Lost to Follow-up|3|||
147232785|NCT00875979|531024627|FG000|Dose Escalation Phase - 3.0 mg/kg|Disease Progression|1|||
147232786|NCT00875979|531024628|FG001|Dose Escalation Phase - 3.0 mg/kg|Disease Progression|0|||
147232787|NCT00875979|531024627|FG000|Dose Escalation Phase - 3.0 mg/kg|Physician Decision|1|||
147232788|NCT00875979|531024628|FG001|Dose Escalation Phase - 3.0 mg/kg|Physician Decision|0|||
147232789|NCT00875979|531024627|FG000|Dose Escalation Phase - 3.0 mg/kg|Patient/Legal Guardian Decision|1|||
147568270|NCT01200810|532240003|FG001|Overall Study|Sponsor stopped making study drug|3|||
147568271|NCT00904215|532240005|FG000|Overall Study|Adverse Event|25|||
147232790|NCT00875979|531024628|FG001|Dose Escalation Phase - 3.0 mg/kg|Patient/Legal Guardian Decision|0|||
147232791|NCT00875979|531024627|FG000|Dose Escalation Phase - 3.6 mg/kg|Disease Progression|0|||
147313853|NCT00619476|531317298|FG002|Overall Study|Adverse Event|12|||
147313854|NCT00619476|531317299|FG003|Overall Study|Adverse Event|16|||
147313855|NCT00619476|531317296|FG000|Overall Study|Lack of Efficacy|6|||
147313856|NCT00619476|531317297|FG001|Overall Study|Lack of Efficacy|1|||
147313857|NCT00619476|531317298|FG002|Overall Study|Lack of Efficacy|1|||
147313858|NCT00619476|531317299|FG003|Overall Study|Lack of Efficacy|4|||
147313859|NCT00619476|531317296|FG000|Overall Study|Protocol Violation|5|||
147313860|NCT00619476|531317297|FG001|Overall Study|Protocol Violation|4|||
147313861|NCT00619476|531317298|FG002|Overall Study|Protocol Violation|4|||
147313862|NCT00619476|531317299|FG003|Overall Study|Protocol Violation|9|||
147313863|NCT00619476|531317296|FG000|Overall Study|Lost to Follow-up|1|||
147313864|NCT00619476|531317297|FG001|Overall Study|Lost to Follow-up|2|||
147313865|NCT00619476|531317298|FG002|Overall Study|Lost to Follow-up|0|||
147313866|NCT00619476|531317299|FG003|Overall Study|Lost to Follow-up|1|||
147313867|NCT00619476|531317296|FG000|Overall Study|Investigator Discretion|2|||
147313868|NCT00619476|531317297|FG001|Overall Study|Investigator Discretion|2|||
147313869|NCT00619476|531317298|FG002|Overall Study|Investigator Discretion|2|||
147313870|NCT00619476|531317299|FG003|Overall Study|Investigator Discretion|0|||
147313871|NCT00619476|531317296|FG000|Overall Study|Withdrawal by Subject|5|||
147313872|NCT00619476|531317297|FG001|Overall Study|Withdrawal by Subject|7|||
147313873|NCT00619476|531317298|FG002|Overall Study|Withdrawal by Subject|5|||
147313874|NCT00619476|531317299|FG003|Overall Study|Withdrawal by Subject|4|||
147313875|NCT00900627|531317309|FG000|Overall Study|Condition under investigation worsened|4|||
147313876|NCT00900627|531317310|FG001|Overall Study|Condition under investigation worsened|0|||
147313877|NCT00900627|531317311|FG002|Overall Study|Condition under investigation worsened|5|||
147313878|NCT00900627|531317312|FG003|Overall Study|Condition under investigation worsened|3|||
147313879|NCT00900627|531317313|FG004|Overall Study|Condition under investigation worsened|0|||
147313880|NCT00900627|531317314|FG005|Overall Study|Condition under investigation worsened|0|||
147313881|NCT00900627|531317309|FG000|Overall Study|Withdrawal by Subject|1|||
147313882|NCT00900627|531317310|FG001|Overall Study|Withdrawal by Subject|0|||
147313883|NCT00900627|531317311|FG002|Overall Study|Withdrawal by Subject|1|||
147313884|NCT00900627|531317312|FG003|Overall Study|Withdrawal by Subject|0|||
147313885|NCT00900627|531317313|FG004|Overall Study|Withdrawal by Subject|1|||
147313886|NCT00900627|531317314|FG005|Overall Study|Withdrawal by Subject|2|||
147313887|NCT00900627|531317309|FG000|Overall Study|Adverse Event|1|||
147313888|NCT00900627|531317310|FG001|Overall Study|Adverse Event|2|||
147313889|NCT00900627|531317311|FG002|Overall Study|Adverse Event|0|||
147313890|NCT00900627|531317312|FG003|Overall Study|Adverse Event|3|||
147313891|NCT00900627|531317313|FG004|Overall Study|Adverse Event|0|||
147313892|NCT00900627|531317314|FG005|Overall Study|Adverse Event|0|||
147313893|NCT00900627|531317309|FG000|Overall Study|Death|0|||
147313894|NCT00900627|531317310|FG001|Overall Study|Death|0|||
147313895|NCT00900627|531317311|FG002|Overall Study|Death|0|||
147313896|NCT00900627|531317312|FG003|Overall Study|Death|0|||
147313897|NCT00900627|531317313|FG004|Overall Study|Death|28|||
147313898|NCT00900627|531317314|FG005|Overall Study|Death|24|||
147313899|NCT00962585|531317315|FG000|Overall Study|Adverse Event|0|||
147313900|NCT00962585|531317316|FG001|Overall Study|Adverse Event|2|||
147313901|NCT00962585|531317317|FG002|Overall Study|Adverse Event|1|||
147313902|NCT00962585|531317318|FG003|Overall Study|Adverse Event|0|||
147313903|NCT00962585|531317315|FG000|Overall Study|Lost to Follow-up|3|||
147313904|NCT00962585|531317316|FG001|Overall Study|Lost to Follow-up|0|||
147313905|NCT00962585|531317317|FG002|Overall Study|Lost to Follow-up|1|||
147313906|NCT00962585|531317318|FG003|Overall Study|Lost to Follow-up|0|||
147313907|NCT00962585|531317315|FG000|Overall Study|Protocol Violation|0|||
147313908|NCT00962585|531317316|FG001|Overall Study|Protocol Violation|0|||
147313909|NCT00962585|531317317|FG002|Overall Study|Protocol Violation|1|||
147313910|NCT00962585|531317318|FG003|Overall Study|Protocol Violation|0|||
147313911|NCT00962585|531317315|FG000|Overall Study|Withdrawal by Subject|1|||
147313912|NCT00962585|531317316|FG001|Overall Study|Withdrawal by Subject|0|||
147568272|NCT00904215|532240005|FG000|Overall Study|Protocol Violation|10|||
147568273|NCT00904215|532240005|FG000|Overall Study|Lost to Follow-up|63|||
147568274|NCT00904215|532240005|FG000|Overall Study|Withdrawal by Subject|9|||
147568275|NCT00904215|532240005|FG000|Overall Study|Other|28|||
147568276|NCT00838630|532240006|FG000|First Intervention|Adverse Event|1|||
147313913|NCT00962585|531317317|FG002|Overall Study|Withdrawal by Subject|0|||
147313914|NCT00962585|531317318|FG003|Overall Study|Withdrawal by Subject|0|||
147568277|NCT00838630|532240007|FG001|First Intervention|Adverse Event|0|||
147568278|NCT00838630|532240006|FG000|Washout: 7 Days|Protocol Violation|1|||
147313915|NCT00962585|531317315|FG000|Overall Study|Withdrew Consent|2|||
147313916|NCT00962585|531317316|FG001|Overall Study|Withdrew Consent|0|||
147313917|NCT00962585|531317317|FG002|Overall Study|Withdrew Consent|0|||
147313918|NCT00962585|531317318|FG003|Overall Study|Withdrew Consent|0|||
147313919|NCT02254421|531317322|FG000|Overall Study|Randomized but Not Treated|1|||
147313920|NCT02254421|531317323|FG001|Overall Study|Randomized but Not Treated|0|||
147313921|NCT02254421|531317322|FG000|Overall Study|Death|0|||
147313922|NCT02254421|531317323|FG001|Overall Study|Death|2|||
147313923|NCT02254421|531317322|FG000|Overall Study|Withdrew Consent|1|||
147313924|NCT02254421|531317323|FG001|Overall Study|Withdrew Consent|1|||
147122673|NCT03061214|530612832|FG000|Overall Study|Withdrawal by Subject|21|||
147122674|NCT03061214|530612833|FG001|Overall Study|Withdrawal by Subject|26|||
147122675|NCT03061214|530612834|FG002|Overall Study|Withdrawal by Subject|9|||
147122676|NCT03061214|530612832|FG000|Overall Study|Lost to Follow-up|3|||
147122677|NCT03061214|530612833|FG001|Overall Study|Lost to Follow-up|1|||
147122678|NCT03061214|530612834|FG002|Overall Study|Lost to Follow-up|1|||
147122679|NCT03061214|530612832|FG000|Overall Study|Death|1|||
147122680|NCT03061214|530612833|FG001|Overall Study|Death|1|||
147122681|NCT03061214|530612834|FG002|Overall Study|Death|0|||
147122682|NCT01027754|530614581|FG000|Overall Study|withdrew/lost to follow-up after interve|2|||
147122683|NCT01027754|530614582|FG001|Overall Study|withdrew/lost to follow-up after interve|3|||
147122684|NCT01027754|530614581|FG000|Overall Study|Withdrawal by Subject|0|||
147122685|NCT01027754|530614582|FG001|Overall Study|Withdrawal by Subject|5|||
147122686|NCT02562040|530614583|FG000|Overall Study|Lost to Follow-up|20|||
147122687|NCT02562040|530614584|FG001|Overall Study|Lost to Follow-up|28|||
147122688|NCT02562040|530614583|FG000|Overall Study|Withdrawal by Subject|8|||
147122689|NCT02562040|530614584|FG001|Overall Study|Withdrawal by Subject|7|||
147122690|NCT02562040|530614583|FG000|Overall Study|Adverse Event|1|||
147122691|NCT02562040|530614584|FG001|Overall Study|Adverse Event|0|||
147122692|NCT00368849|530614585|FG000|Overall Study|Withdrawal by Subject|0|||
147122693|NCT00368849|530614586|FG001|Overall Study|Withdrawal by Subject|1|||
147122694|NCT00368849|530614585|FG000|Overall Study|Physician Decision|0|||
147122695|NCT00368849|530614586|FG001|Overall Study|Physician Decision|1|||
147122696|NCT01902303|530614590|FG000|Overall Study|Adverse Event|0|||
147122697|NCT01902303|530614591|FG001|Overall Study|Adverse Event|1|||
147122698|NCT01902303|530614590|FG000|Overall Study|Lost to Follow-up|0|||
147122699|NCT01902303|530614591|FG001|Overall Study|Lost to Follow-up|1|||
147122700|NCT01902303|530614590|FG000|Overall Study|Protocol Violation|2|||
147122701|NCT01902303|530614591|FG001|Overall Study|Protocol Violation|2|||
147122702|NCT01902303|530614590|FG000|Overall Study|subject lost investigational product|0|||
147122703|NCT01902303|530614591|FG001|Overall Study|subject lost investigational product|1|||
147122704|NCT01902303|530614590|FG000|Overall Study|Did not develop a cold sore|21|||
147122705|NCT01902303|530614591|FG001|Overall Study|Did not develop a cold sore|19|||
147122706|NCT01699685|530614592|FG000|Period 1|Adverse Event|1|||
147122707|NCT01699685|530614593|FG001|Period 1|Adverse Event|1|||
147122708|NCT01699685|530614592|FG000|Period 1|Medical or ethical, noncompliance|2|||
147122709|NCT01699685|530614593|FG001|Period 1|Medical or ethical, noncompliance|0|||
147122710|NCT01699685|530614592|FG000|Period 1|Other|0|||
147122711|NCT01699685|530614593|FG001|Period 1|Other|1|||
147122712|NCT01699685|530614592|FG000|Period 1|Patient request|0|||
147122713|NCT01699685|530614593|FG001|Period 1|Patient request|1|||
147122714|NCT01699685|530614592|FG000|Period 2|Lost to Follow-up|1|||
147122715|NCT01699685|530614593|FG001|Period 2|Lost to Follow-up|0|||
147122716|NCT05058456|530614594|FG000|Overall Study|Death|1|||
147122717|NCT05058456|530614594|FG000|Overall Study|End of Study data not yet due for release|34|||
147122718|NCT01654250|530614595|FG000|Overall Study|Lost to Follow-up|1|||
147122719|NCT01654250|530614596|FG001|Overall Study|Lost to Follow-up|0|||
147122720|NCT01832038|530614597|FG000|Overall Study|Death|5|||
147122721|NCT01832038|530614597|FG000|Overall Study|Adverse Event|50|||
147122722|NCT01832038|530614597|FG000|Overall Study|Lack of Efficacy|81|||
147122723|NCT01832038|530614597|FG000|Overall Study|Protocol Violation|7|||
147122724|NCT01832038|530614597|FG000|Overall Study|Lost to Follow-up|10|||
147122725|NCT01832038|530614597|FG000|Overall Study|Withdrawal by Subject|49|||
147122726|NCT01832038|530614597|FG000|Overall Study|Visit non-compliance|2|||
147122727|NCT01832038|530614597|FG000|Overall Study|Subject refused to return visit|2|||
147122728|NCT01832038|530614597|FG000|Overall Study|Not convenient to come back to site|2|||
147122729|NCT01832038|530614597|FG000|Overall Study|Participant was asked to quit|5|||
147122730|NCT01832038|530614597|FG000|Overall Study|Back home|1|||
147122731|NCT01832038|530614597|FG000|Overall Study|Pregnancy|1|||
147122732|NCT01832038|530614597|FG000|Overall Study|Low compliance|3|||
147122733|NCT01832038|530614597|FG000|Overall Study|Prohibit procedure|2|||
147122734|NCT01832038|530614597|FG000|Overall Study|Not possible to visit the hospital|1|||
147122735|NCT01832038|530614597|FG000|Overall Study|Changes of implementation system|3|||
147122736|NCT01832038|530614597|FG000|Overall Study|Plan to pregnancy|7|||
147122737|NCT01832038|530614597|FG000|Overall Study|Bad mood and has suicidal thought|1|||
147122738|NCT01832038|530614597|FG000|Overall Study|Prohibited concomitant medication|1|||
147122739|NCT01832038|530614597|FG000|Overall Study|Pregnancy and abortion in EP0008 study|1|||
147122740|NCT01832038|530614597|FG000|Overall Study|Subject considered the efficacy was poor|1|||
147122741|NCT03211858|530614598|FG000|Overall Study|Adverse Event|8|||
147122742|NCT03211858|530614599|FG001|Overall Study|Adverse Event|6|||
147122743|NCT03211858|530614598|FG000|Overall Study|Lack of Efficacy|0|||
147122744|NCT03211858|530614599|FG001|Overall Study|Lack of Efficacy|4|||
147122745|NCT03211858|530614598|FG000|Overall Study|Poor compliance to protocol|6|||
147122746|NCT03211858|530614599|FG001|Overall Study|Poor compliance to protocol|2|||
147122747|NCT03211858|530614598|FG000|Overall Study|Non-serious Hypoglycemia|1|||
147650992|NCT01471444|532544550|FG000|Overall Study|Withdrawal by Subject|0|||
147650993|NCT01471444|532544551|FG001|Overall Study|Withdrawal by Subject|1|||
147650994|NCT01214668|532544557|FG000|Overall Study|Adverse Event|0|||
147444611|NCT02973087|531792656|FG001|Overall Study|Withdrawal by Subject|1|||
147650995|NCT01214668|532544558|FG001|Overall Study|Adverse Event|1|||
147650996|NCT01214668|532544559|FG002|Overall Study|Adverse Event|0|||
147650997|NCT01214668|532544560|FG003|Overall Study|Adverse Event|2|||
147122748|NCT03211858|530614599|FG001|Overall Study|Non-serious Hypoglycemia|0|||
147122749|NCT03211858|530614598|FG000|Overall Study|Other than specified above|22|||
147122750|NCT03211858|530614599|FG001|Overall Study|Other than specified above|21|||
147122751|NCT02457546|530614603|FG000|Overall Study|Other reasons|4|||
147122752|NCT02457546|530614604|FG001|Overall Study|Other reasons|1|||
147122753|NCT02457546|530614603|FG000|Overall Study|Refused to complete study/procedures|1|||
147122754|NCT02457546|530614604|FG001|Overall Study|Refused to complete study/procedures|1|||
147122755|NCT02457546|530614603|FG000|Overall Study|Lost to Follow-up|4|||
147122756|NCT02457546|530614604|FG001|Overall Study|Lost to Follow-up|1|||
147122757|NCT02457546|530614603|FG000|Overall Study|Adverse Event|0|||
147122758|NCT02457546|530614604|FG001|Overall Study|Adverse Event|1|||
147122759|NCT00363467|530614605|FG000|Overall Study|Physician Decision|1|||
147122760|NCT05069415|530614606|FG000|Overall Study|Withdrawal by Subject|2|||
147122761|NCT05069415|530614607|FG001|Overall Study|Withdrawal by Subject|0|||
147122762|NCT05069415|530614606|FG000|Overall Study|Adverse Event|2|||
147122763|NCT05069415|530614607|FG001|Overall Study|Adverse Event|0|||
147122764|NCT00090402|530614608|FG000|Overall Study|Death|1|||
147122765|NCT00090402|530614609|FG001|Overall Study|Death|1|||
147122766|NCT00090402|530614610|FG002|Overall Study|Death|0|||
147122767|NCT00090402|530614608|FG000|Overall Study|subject moved|0|||
147122768|NCT00090402|530614609|FG001|Overall Study|subject moved|1|||
147122769|NCT00090402|530614610|FG002|Overall Study|subject moved|0|||
147122770|NCT00090402|530614608|FG000|Overall Study|stopped taking study medication|1|||
147122771|NCT00090402|530614609|FG001|Overall Study|stopped taking study medication|0|||
147122772|NCT00090402|530614610|FG002|Overall Study|stopped taking study medication|1|||
147122773|NCT01052428|530614611|FG000|Overall Study|Death|1|||
147122774|NCT01052428|530614612|FG001|Overall Study|Death|0|||
147122775|NCT01052428|530614611|FG000|Overall Study|Withdrawal by Subject|0|||
147122776|NCT01052428|530614612|FG001|Overall Study|Withdrawal by Subject|1|||
147122777|NCT03400787|530614613|FG000|Overall Study|Lost to Follow-up|1|||
147122778|NCT03400787|530614614|FG001|Overall Study|Lost to Follow-up|0|||
147122779|NCT03400787|530614613|FG000|Overall Study|Death|1|||
147122780|NCT03400787|530614614|FG001|Overall Study|Death|0|||
147122781|NCT03400787|530614613|FG000|Overall Study|Protocol Violation|0|||
147122782|NCT03400787|530614614|FG001|Overall Study|Protocol Violation|2|||
147122783|NCT03400787|530614613|FG000|Overall Study|Unblinded before 3-month follow-upa-|0|||
147122784|NCT03400787|530614614|FG001|Overall Study|Unblinded before 3-month follow-upa-|6|||
147122785|NCT01716559|530614615|FG000|Overall Study|Adverse Event|11|||
147122786|NCT01716559|530614615|FG000|Overall Study|Death|21|||
147122787|NCT01716559|530614615|FG000|Overall Study|Withdrawal by Subject|4|||
147122788|NCT01716559|530614615|FG000|Overall Study|Other withdrawal reason|75|||
147122789|NCT01791205|530614618|FG000|Phase II|Lack of Efficacy|6|||
147122790|NCT01791205|530614619|FG001|Phase II|Lack of Efficacy|0|||
147122791|NCT01791205|530614618|FG000|Phase II|Adverse Event|2|||
147122792|NCT01791205|530614619|FG001|Phase II|Adverse Event|0|||
147122793|NCT01791205|530614618|FG000|Phase II|Safety|1|||
147122794|NCT01791205|530614619|FG001|Phase II|Safety|0|||
147122795|NCT01791205|530614618|FG000|Phase II|Lost to Follow-up|1|||
147122796|NCT01791205|530614619|FG001|Phase II|Lost to Follow-up|0|||
147122797|NCT01791205|530614618|FG000|Phase II|Remission of disease|1|||
147122798|NCT01791205|530614619|FG001|Phase II|Remission of disease|0|||
147122799|NCT01791205|530614618|FG000|Phase II|Physician's decision|1|||
147122800|NCT01791205|530614619|FG001|Phase II|Physician's decision|0|||
147122801|NCT01908699|530614620|FG000|Overall Study|Adverse Event|8|||
147122802|NCT01908699|530614621|FG001|Overall Study|Adverse Event|12|||
147122803|NCT01908699|530614620|FG000|Overall Study|Lack of Efficacy|2|||
147122804|NCT01908699|530614621|FG001|Overall Study|Lack of Efficacy|2|||
147122805|NCT01908699|530614620|FG000|Overall Study|Lost to Follow-up|2|||
147122806|NCT01908699|530614621|FG001|Overall Study|Lost to Follow-up|4|||
147122807|NCT01908699|530614620|FG000|Overall Study|Physician Decision|8|||
147122808|NCT01908699|530614621|FG001|Overall Study|Physician Decision|8|||
147122809|NCT01908699|530614620|FG000|Overall Study|Withdrawal by Subject|15|||
147122810|NCT01908699|530614621|FG001|Overall Study|Withdrawal by Subject|10|||
147122811|NCT01908699|530614620|FG000|Overall Study|Pregnancy|0|||
147122812|NCT01908699|530614621|FG001|Overall Study|Pregnancy|1|||
147122813|NCT01908699|530614620|FG000|Overall Study|Randomized in Error|1|||
147122814|NCT01908699|530614621|FG001|Overall Study|Randomized in Error|0|||
147122815|NCT01908699|530614620|FG000|Overall Study|Death|9|||
147122816|NCT01908699|530614621|FG001|Overall Study|Death|12|||
147122817|NCT01908699|530614620|FG000|Overall Study|Progressive Disease|30|||
147122818|NCT01908699|530614621|FG001|Overall Study|Progressive Disease|29|||
147650998|NCT01214668|532544561|FG004|Overall Study|Adverse Event|1|||
147650999|NCT01214668|532544562|FG005|Overall Study|Adverse Event|1|||
147232792|NCT00875979|531024628|FG001|Dose Escalation Phase - 3.6 mg/kg|Disease Progression|6|||
147232793|NCT00875979|531024627|FG000|Dose Expansion Phase - 3.6 mg/kg|Disease Progression|0|||
147232794|NCT00875979|531024628|FG001|Dose Expansion Phase - 3.6 mg/kg|Disease Progression|37|||
147232795|NCT00875979|531024627|FG000|Dose Expansion Phase - 3.6 mg/kg|Physician Decision|0|||
147232796|NCT00875979|531024628|FG001|Dose Expansion Phase - 3.6 mg/kg|Physician Decision|3|||
147232797|NCT00875979|531024627|FG000|Dose Expansion Phase - 3.6 mg/kg|Patient/legal Guardian Decision|0|||
147232798|NCT00875979|531024628|FG001|Dose Expansion Phase - 3.6 mg/kg|Patient/legal Guardian Decision|3|||
147232799|NCT00875979|531024627|FG000|Dose Expansion Phase - 3.6 mg/kg|Started Non-protocol Anti-Cancer Therapy|0|||
147232800|NCT00875979|531024628|FG001|Dose Expansion Phase - 3.6 mg/kg|Started Non-protocol Anti-Cancer Therapy|3|||
147232801|NCT00875979|531024627|FG000|Dose Expansion Phase - 3.6 mg/kg|Death|0|||
147232802|NCT00875979|531024628|FG001|Dose Expansion Phase - 3.6 mg/kg|Death|1|||
147232803|NCT00216476|531024629|FG000|Overall Study|Withdrawal by Subject|59|||
147232804|NCT00216476|531024630|FG001|Overall Study|Withdrawal by Subject|72|||
147232805|NCT00216476|531024631|FG002|Overall Study|Withdrawal by Subject|9|||
147232806|NCT00216476|531024629|FG000|Overall Study|Lost to Follow-up|10|||
147232807|NCT00216476|531024630|FG001|Overall Study|Lost to Follow-up|9|||
147232808|NCT00216476|531024631|FG002|Overall Study|Lost to Follow-up|1|||
147232809|NCT00216476|531024629|FG000|Overall Study|Adverse Event|6|||
147232810|NCT00216476|531024630|FG001|Overall Study|Adverse Event|10|||
147232811|NCT00216476|531024631|FG002|Overall Study|Adverse Event|1|||
147232812|NCT00216476|531024629|FG000|Overall Study|Lack of Efficacy|4|||
147232813|NCT00216476|531024630|FG001|Overall Study|Lack of Efficacy|3|||
147232814|NCT00216476|531024631|FG002|Overall Study|Lack of Efficacy|0|||
147232815|NCT00216476|531024629|FG000|Overall Study|Death|2|||
147232816|NCT00216476|531024630|FG001|Overall Study|Death|0|||
147232817|NCT00216476|531024631|FG002|Overall Study|Death|0|||
147232818|NCT00216476|531024629|FG000|Overall Study|Pregnancy|0|||
147232819|NCT00216476|531024630|FG001|Overall Study|Pregnancy|1|||
147232820|NCT00216476|531024631|FG002|Overall Study|Pregnancy|1|||
147232821|NCT00216476|531024629|FG000|Overall Study|Other|0|||
147232822|NCT00216476|531024630|FG001|Overall Study|Other|0|||
147232823|NCT00216476|531024631|FG002|Overall Study|Other|1|||
147232824|NCT00216476|531024629|FG000|Overall Study|Refuses Injection|11|||
147232825|NCT00216476|531024630|FG001|Overall Study|Refuses Injection|0|||
147232826|NCT00216476|531024631|FG002|Overall Study|Refuses Injection|0|||
147232827|NCT00216476|531024629|FG000|Overall Study|No Further Need for Treatment|3|||
147232828|NCT00216476|531024630|FG001|Overall Study|No Further Need for Treatment|4|||
147232829|NCT00216476|531024631|FG002|Overall Study|No Further Need for Treatment|1|||
147232830|NCT00216476|531024629|FG000|Overall Study|Non-compliance|0|||
147232831|NCT00216476|531024630|FG001|Overall Study|Non-compliance|4|||
147232832|NCT00216476|531024631|FG002|Overall Study|Non-compliance|1|||
147232833|NCT00216476|531024629|FG000|Overall Study|Higher dose/Extra Medication Required|2|||
147232834|NCT00216476|531024630|FG001|Overall Study|Higher dose/Extra Medication Required|0|||
147232835|NCT00216476|531024631|FG002|Overall Study|Higher dose/Extra Medication Required|2|||
147232836|NCT00216476|531024629|FG000|Overall Study|Administrative Reasons|1|||
147232837|NCT00216476|531024630|FG001|Overall Study|Administrative Reasons|1|||
147232838|NCT00216476|531024631|FG002|Overall Study|Administrative Reasons|0|||
147232839|NCT00216476|531024629|FG000|Overall Study|Protocol Deviation|5|||
147232840|NCT00216476|531024630|FG001|Overall Study|Protocol Deviation|1|||
147232841|NCT00216476|531024631|FG002|Overall Study|Protocol Deviation|0|||
147232842|NCT00216476|531024629|FG000|Overall Study|Patient Moved|2|||
147232843|NCT00216476|531024630|FG001|Overall Study|Patient Moved|2|||
147232844|NCT00216476|531024631|FG002|Overall Study|Patient Moved|0|||
147232845|NCT00369707|531024634|FG000|Induction Part B (2 Cycles)|Adverse Event|3|||
147232846|NCT00369707|531024634|FG000|Induction Part B (2 Cycles)|Withdrawal by Subject|2|||
147232847|NCT00369707|531024634|FG000|Induction Part B (2 Cycles)|Inadequate response/MD decision|1|||
147232848|NCT00369707|531024634|FG000|Induction Part B (2 Cycles)|Progressive disease|1|||
147232849|NCT00369707|531024634|FG000|Maintenance Period (up to 4 Cycles)|Withdrawal by Subject|2|||
147232850|NCT00369707|531024634|FG000|Maintenance Period (up to 4 Cycles)|inadequate response/MD decision|2|||
147232851|NCT00369707|531024634|FG000|Maintenance Period (up to 4 Cycles)|Progressive disease|4|||
147232852|NCT00369707|531024634|FG000|Follow up for 2 Years After Treatment|Death|1|||
147444612|NCT02973087|531792655|FG000|Overall Study|Adverse Event|1|||
147444613|NCT02973087|531792656|FG001|Overall Study|Adverse Event|0|||
147444614|NCT02973087|531792655|FG000|Overall Study|other|1|||
147232853|NCT00369707|531024634|FG000|Follow up for 2 Years After Treatment|Other|2|||
147232854|NCT02083081|531024639|FG000|Overall Study|Lost to Follow-up|31|||
147232855|NCT02083081|531024640|FG001|Overall Study|Lost to Follow-up|9|||
147232856|NCT01230710|531024643|FG000|Overall Study|Disease Progression|41|||
147232857|NCT01230710|531024643|FG000|Overall Study|Lost to Follow-up|3|||
147232858|NCT01230710|531024643|FG000|Overall Study|Death|4|||
147232859|NCT01230710|531024643|FG000|Overall Study|Withdrawal of Consent|1|||
147232860|NCT02905149|531024644|FG000|Overall Study|Lost to Follow-up|2|||
147232861|NCT02905149|531024645|FG001|Overall Study|Lost to Follow-up|0|||
147232862|NCT01708161|531024646|FG000|Overall Study|Adverse Event|1|||
147232863|NCT01708161|531024647|FG001|Overall Study|Adverse Event|3|||
147444615|NCT02973087|531792656|FG001|Overall Study|other|1|||
147313925|NCT00867490|531317324|FG000|Phase 1 - Candesartan+HCTZ|Adverse Event|5|||
147313926|NCT00867490|531317324|FG000|Phase 1 - Candesartan+HCTZ|Withdrawal by Subject|4|||
147313927|NCT00867490|531317324|FG000|Phase 1 - Candesartan+HCTZ|Administrative Problems|1|||
147313928|NCT00867490|531317324|FG000|Phase 2 - Aliskiren+HCTZ|Adverse Event|2|||
147313929|NCT00867490|531317324|FG000|Phase 2 - Aliskiren+HCTZ|Withdrawal by Subject|1|||
147313930|NCT00358150|531317325|FG000|Overall Study|Adverse Event|3|||
147313931|NCT00358150|531317325|FG000|Overall Study|Withdrawal by Subject|1|||
147313932|NCT00358150|531317325|FG000|Overall Study|Undefined|3|||
147313933|NCT03685708|531317326|FG000|Overall Study|Withdrawal by Subject|0|||
147568279|NCT00838630|532240007|FG001|Washout: 7 Days|Protocol Violation|0|||
147568280|NCT00640562|532240008|FG000|Overall Study|Adverse Event|8|||
147568281|NCT00640562|532240009|FG001|Overall Study|Adverse Event|5|||
147568282|NCT00640562|532240008|FG000|Overall Study|Lack of Efficacy|1|||
147313934|NCT03685708|531317327|FG001|Overall Study|Withdrawal by Subject|0|||
147313935|NCT03685708|531317328|FG002|Overall Study|Withdrawal by Subject|1|||
147313936|NCT03685708|531317326|FG000|Overall Study|Screen Fail|0|||
147313937|NCT03685708|531317327|FG001|Overall Study|Screen Fail|1|||
147313938|NCT03685708|531317328|FG002|Overall Study|Screen Fail|1|||
147313939|NCT03685708|531317326|FG000|Overall Study|COVID 19 Pandemic|1|||
147313940|NCT03685708|531317327|FG001|Overall Study|COVID 19 Pandemic|1|||
147313941|NCT03685708|531317328|FG002|Overall Study|COVID 19 Pandemic|6|||
147313942|NCT03685708|531317326|FG000|Overall Study|Disease Progression|0|||
147313943|NCT03685708|531317327|FG001|Overall Study|Disease Progression|0|||
147313944|NCT03685708|531317328|FG002|Overall Study|Disease Progression|1|||
147313945|NCT00179010|531317329|FG000|Overall Study|Muscle probe defective|1|||
147313946|NCT00179010|531317330|FG001|Overall Study|Muscle probe defective|1|||
147313947|NCT00179010|531317329|FG000|Overall Study|Failure to place arterial line|0|||
147313948|NCT00179010|531317330|FG001|Overall Study|Failure to place arterial line|1|||
147313949|NCT02823964|531317344|FG000|Overall Study|Adverse Event|2|||
147313950|NCT02823964|531317344|FG000|Overall Study|Physician Decision|1|||
147313951|NCT02823964|531317344|FG000|Overall Study|Lack of Efficacy|1|||
147313952|NCT02823964|531317344|FG000|Overall Study|Withdrawal by Subject|1|||
147313953|NCT03537261|531317353|FG000|Overall Study|Lost to Follow-up|4|||
147313954|NCT03537261|531317354|FG001|Overall Study|Lost to Follow-up|5|||
147313955|NCT03537261|531317353|FG000|Overall Study|Withdrawal by Subject|4|||
147313956|NCT03537261|531317354|FG001|Overall Study|Withdrawal by Subject|6|||
147313957|NCT03537261|531317353|FG000|Overall Study|Did not return study questionnaires|0|||
147313958|NCT03537261|531317354|FG001|Overall Study|Did not return study questionnaires|1|||
147313959|NCT01177813|531317355|FG000|Overall Study|Adverse Event|8|||
147313960|NCT01177813|531317356|FG001|Overall Study|Adverse Event|2|||
147313961|NCT01177813|531317357|FG002|Overall Study|Adverse Event|4|||
147313962|NCT01177813|531317358|FG003|Overall Study|Adverse Event|6|||
147313963|NCT01177813|531317359|FG004|Overall Study|Adverse Event|3|||
147313964|NCT01177813|531317355|FG000|Overall Study|Lack of Efficacy|1|||
147313965|NCT01177813|531317356|FG001|Overall Study|Lack of Efficacy|0|||
147313966|NCT01177813|531317357|FG002|Overall Study|Lack of Efficacy|0|||
147313967|NCT01177813|531317358|FG003|Overall Study|Lack of Efficacy|0|||
147313968|NCT01177813|531317359|FG004|Overall Study|Lack of Efficacy|0|||
147313969|NCT01177813|531317355|FG000|Overall Study|Protocol Violation|3|||
147313970|NCT01177813|531317356|FG001|Overall Study|Protocol Violation|2|||
147313971|NCT01177813|531317357|FG002|Overall Study|Protocol Violation|2|||
147313972|NCT01177813|531317358|FG003|Overall Study|Protocol Violation|0|||
147313973|NCT01177813|531317359|FG004|Overall Study|Protocol Violation|1|||
147313974|NCT01177813|531317355|FG000|Overall Study|Lost to Follow-up|12|||
147313975|NCT01177813|531317356|FG001|Overall Study|Lost to Follow-up|5|||
147313976|NCT01177813|531317357|FG002|Overall Study|Lost to Follow-up|6|||
147313977|NCT01177813|531317358|FG003|Overall Study|Lost to Follow-up|3|||
147568283|NCT00640562|532240009|FG001|Overall Study|Lack of Efficacy|4|||
147568284|NCT00640562|532240008|FG000|Overall Study|Protocol Violation|2|||
147568285|NCT00640562|532240009|FG001|Overall Study|Protocol Violation|4|||
147568286|NCT00640562|532240008|FG000|Overall Study|Withdrawal by Subject|6|||
147568287|NCT00640562|532240009|FG001|Overall Study|Withdrawal by Subject|10|||
147568288|NCT00640562|532240008|FG000|Overall Study|Known risperidone intolerance|0|||
147313978|NCT01177813|531317359|FG004|Overall Study|Lost to Follow-up|0|||
147313979|NCT01177813|531317355|FG000|Overall Study|Withdrawal by Subject|12|||
147313980|NCT01177813|531317356|FG001|Overall Study|Withdrawal by Subject|7|||
147313981|NCT01177813|531317357|FG002|Overall Study|Withdrawal by Subject|6|||
147568289|NCT00640562|532240009|FG001|Overall Study|Known risperidone intolerance|1|||
147122819|NCT01697501|530614622|FG000|Overall Study|Protocol Violation|2|||
147313982|NCT01177813|531317358|FG003|Overall Study|Withdrawal by Subject|5|||
147313983|NCT01177813|531317359|FG004|Overall Study|Withdrawal by Subject|3|||
147444616|NCT01147744|531792657|FG000|Overall Study|Protocol Violation|1|||
147313984|NCT01177813|531317355|FG000|Overall Study|Other reason not defined above|5|||
147313985|NCT01177813|531317356|FG001|Overall Study|Other reason not defined above|2|||
147313986|NCT01177813|531317357|FG002|Overall Study|Other reason not defined above|2|||
147313987|NCT01177813|531317358|FG003|Overall Study|Other reason not defined above|3|||
147313988|NCT01177813|531317359|FG004|Overall Study|Other reason not defined above|2|||
147313989|NCT01729728|531317360|FG000|Overall Study|Adverse Event|0|||
147568290|NCT00640562|532240008|FG000|Overall Study|Past use of Seroquel -stopped due to AE|0|||
147568291|NCT00640562|532240009|FG001|Overall Study|Past use of Seroquel -stopped due to AE|1|||
147568292|NCT00640562|532240008|FG000|Overall Study|Low study drug dose|0|||
147568293|NCT00640562|532240009|FG001|Overall Study|Low study drug dose|1|||
147568294|NCT00640562|532240008|FG000|Overall Study|Glycosylated Hemoglobin >8|1|||
147568295|NCT00640562|532240009|FG001|Overall Study|Glycosylated Hemoglobin >8|0|||
147568296|NCT00448591|532240010|FG000|Overall Study|Withdrawal by Subject|178|||
147568297|NCT00448591|532240010|FG000|Overall Study|Progressive Disease|1382|||
147568298|NCT00448591|532240010|FG000|Overall Study|Adverse Event|382|||
147232864|NCT01708161|531024648|FG002|Overall Study|Adverse Event|4|||
147232865|NCT01708161|531024649|FG003|Overall Study|Adverse Event|2|||
147232866|NCT01708161|531024650|FG004|Overall Study|Adverse Event|3|||
147232867|NCT01708161|531024651|FG005|Overall Study|Adverse Event|0|||
147232868|NCT01708161|531024646|FG000|Overall Study|Death|0|||
147232869|NCT01708161|531024647|FG001|Overall Study|Death|0|||
147232870|NCT01708161|531024648|FG002|Overall Study|Death|0|||
147232871|NCT01708161|531024649|FG003|Overall Study|Death|1|||
147232872|NCT01708161|531024650|FG004|Overall Study|Death|0|||
147232873|NCT01708161|531024651|FG005|Overall Study|Death|1|||
147232874|NCT01708161|531024646|FG000|Overall Study|Withdrawal by Subject|0|||
147232875|NCT01708161|531024647|FG001|Overall Study|Withdrawal by Subject|1|||
147232876|NCT01708161|531024648|FG002|Overall Study|Withdrawal by Subject|1|||
147232877|NCT01708161|531024649|FG003|Overall Study|Withdrawal by Subject|0|||
147232878|NCT01708161|531024650|FG004|Overall Study|Withdrawal by Subject|0|||
147232879|NCT01708161|531024651|FG005|Overall Study|Withdrawal by Subject|0|||
147232880|NCT01708161|531024646|FG000|Overall Study|Administrative problems|0|||
147232881|NCT01708161|531024647|FG001|Overall Study|Administrative problems|1|||
147232882|NCT01708161|531024648|FG002|Overall Study|Administrative problems|0|||
147232883|NCT01708161|531024649|FG003|Overall Study|Administrative problems|0|||
147232884|NCT01708161|531024650|FG004|Overall Study|Administrative problems|0|||
147232885|NCT01708161|531024651|FG005|Overall Study|Administrative problems|0|||
147232886|NCT01708161|531024646|FG000|Overall Study|Disease progression|3|||
147232887|NCT01708161|531024647|FG001|Overall Study|Disease progression|5|||
147232888|NCT01708161|531024648|FG002|Overall Study|Disease progression|5|||
147232889|NCT01708161|531024649|FG003|Overall Study|Disease progression|13|||
147232890|NCT01708161|531024650|FG004|Overall Study|Disease progression|3|||
147232891|NCT01708161|531024651|FG005|Overall Study|Disease progression|0|||
147232892|NCT01986140|531024654|FG000|Overall Study|Withdrawal by Subject|31|||
147232893|NCT01986140|531024655|FG001|Overall Study|Withdrawal by Subject|25|||
147232894|NCT01986140|531024654|FG000|Overall Study|alternative treatment|1|||
147232895|NCT01986140|531024655|FG001|Overall Study|alternative treatment|1|||
147232896|NCT01986140|531024654|FG000|Overall Study|found not eligible|3|||
147232897|NCT01986140|531024655|FG001|Overall Study|found not eligible|0|||
147232898|NCT01986140|531024654|FG000|Overall Study|Adverse Event|0|||
147232899|NCT01986140|531024655|FG001|Overall Study|Adverse Event|1|||
147232900|NCT01986140|531024654|FG000|Overall Study|progression disease|0|||
147232901|NCT01986140|531024655|FG001|Overall Study|progression disease|1|||
147232902|NCT02927262|531024656|FG000|Treatment Period (Up to 744 Days)|Withdrawal by Subject|3|||
147232903|NCT02927262|531024657|FG001|Treatment Period (Up to 744 Days)|Withdrawal by Subject|0|||
147232904|NCT02927262|531024656|FG000|Treatment Period (Up to 744 Days)|Death|1|||
147232905|NCT02927262|531024657|FG001|Treatment Period (Up to 744 Days)|Death|0|||
147232906|NCT02927262|531024656|FG000|Treatment Period (Up to 744 Days)|Treatment ended due to transplant procedure|1|||
147232907|NCT02927262|531024657|FG001|Treatment Period (Up to 744 Days)|Treatment ended due to transplant procedure|0|||
147232908|NCT02927262|531024656|FG000|Treatment Period (Up to 744 Days)|Physician Decision|1|||
147232909|NCT02927262|531024657|FG001|Treatment Period (Up to 744 Days)|Physician Decision|0|||
147232910|NCT02927262|531024656|FG000|Treatment Period (Up to 744 Days)|Becomes eligible for and proceeds to transplant|0|||
147232911|NCT02927262|531024657|FG001|Treatment Period (Up to 744 Days)|Becomes eligible for and proceeds to transplant|1|||
147232912|NCT02927262|531024656|FG000|Treatment Period (Up to 744 Days)|Participant relapsed and became eligible for and proceeded to transplant|0|||
147232913|NCT02927262|531024657|FG001|Treatment Period (Up to 744 Days)|Participant relapsed and became eligible for and proceeded to transplant|1|||
147232914|NCT02927262|531024656|FG000|Treatment Period (Up to 744 Days)|Randomized in error|1|||
147232915|NCT02927262|531024657|FG001|Treatment Period (Up to 744 Days)|Randomized in error|0|||
147232916|NCT02927262|531024656|FG000|Treatment Period (Up to 744 Days)|Participant was not eligible for the study|1|||
147232917|NCT02927262|531024657|FG001|Treatment Period (Up to 744 Days)|Participant was not eligible for the study|0|||
147232918|NCT02927262|531024656|FG000|Treatment Period (Up to 744 Days)|MRD positive|0|||
147232919|NCT02927262|531024657|FG001|Treatment Period (Up to 744 Days)|MRD positive|1|||
147232920|NCT02927262|531024656|FG000|Treatment Period (Up to 744 Days)|Disease Relapse|23|||
147232921|NCT02927262|531024657|FG001|Treatment Period (Up to 744 Days)|Disease Relapse|18|||
147232922|NCT02927262|531024656|FG000|Treatment Period (Up to 744 Days)|Adverse Event|7|||
147232923|NCT02927262|531024657|FG001|Treatment Period (Up to 744 Days)|Adverse Event|1|||
147232924|NCT02927262|531024656|FG000|Treatment Period (Up to 744 Days)|Investigators decision to take participant off trial due to molecular relapse|1|||
147444617|NCT01147744|531792658|FG001|Overall Study|Protocol Violation|0|||
147568299|NCT00448591|532240010|FG000|Overall Study|Protocol Violation|41|||
147232925|NCT02927262|531024657|FG001|Treatment Period (Up to 744 Days)|Investigators decision to take participant off trial due to molecular relapse|0|||
147232926|NCT02927262|531024656|FG000|Treatment Period (Up to 744 Days)|Clinicians decision as suspected relapse|0|||
147232927|NCT02927262|531024657|FG001|Treatment Period (Up to 744 Days)|Clinicians decision as suspected relapse|1|||
147232928|NCT02927262|531024656|FG000|Long Term Follow-up (Up to 1201 Days)|Withdrawal by Subject|0|||
147232929|NCT02927262|531024657|FG001|Long Term Follow-up (Up to 1201 Days)|Withdrawal by Subject|2|||
147232930|NCT02927262|531024656|FG000|Long Term Follow-up (Up to 1201 Days)|Lost to Follow-up|2|||
147232931|NCT02927262|531024657|FG001|Long Term Follow-up (Up to 1201 Days)|Lost to Follow-up|0|||
147232932|NCT02927262|531024656|FG000|Long Term Follow-up (Up to 1201 Days)|Death|23|||
147232933|NCT02927262|531024657|FG001|Long Term Follow-up (Up to 1201 Days)|Death|12|||
147232934|NCT02853344|531024658|FG000|Overall Study|Lost to Follow-up|1|||
147232935|NCT02853344|531024659|FG001|Overall Study|Lost to Follow-up|1|||
147232936|NCT02853344|531024658|FG000|Overall Study|Withdrawal by Subject|2|||
147232937|NCT02853344|531024659|FG001|Overall Study|Withdrawal by Subject|4|||
147232938|NCT02853344|531024658|FG000|Overall Study|Participation in Study Terminated by Sponsor|37|||
147232939|NCT02853344|531024659|FG001|Overall Study|Participation in Study Terminated by Sponsor|48|||
147232940|NCT02853344|531024658|FG000|Overall Study|Death|70|||
147232941|NCT02853344|531024659|FG001|Overall Study|Death|112|||
147232942|NCT02913612|531024660|FG000|Overall Study|Lost to Follow-up|6|||
147232943|NCT02913612|531024661|FG001|Overall Study|Lost to Follow-up|5|||
147232944|NCT02913612|531024662|FG002|Overall Study|Lost to Follow-up|2|||
147232945|NCT02913612|531024663|FG003|Overall Study|Lost to Follow-up|0|||
147232946|NCT02913612|531024660|FG000|Overall Study|Physician Decision|1|||
147232947|NCT02913612|531024661|FG001|Overall Study|Physician Decision|4|||
147232948|NCT02913612|531024662|FG002|Overall Study|Physician Decision|1|||
147232949|NCT02913612|531024663|FG003|Overall Study|Physician Decision|0|||
147232950|NCT02913612|531024660|FG000|Overall Study|Withdrawal by Subject|2|||
147232951|NCT02913612|531024661|FG001|Overall Study|Withdrawal by Subject|4|||
147232952|NCT02913612|531024662|FG002|Overall Study|Withdrawal by Subject|0|||
147232953|NCT02913612|531024663|FG003|Overall Study|Withdrawal by Subject|0|||
147232954|NCT02913612|531024660|FG000|Overall Study|Hemangioma resolved|1|||
147232955|NCT02913612|531024661|FG001|Overall Study|Hemangioma resolved|0|||
147232956|NCT02913612|531024662|FG002|Overall Study|Hemangioma resolved|0|||
147232957|NCT02913612|531024663|FG003|Overall Study|Hemangioma resolved|0|||
147232958|NCT02913612|531024660|FG000|Overall Study|Local IRB decision|1|||
147232959|NCT02913612|531024661|FG001|Overall Study|Local IRB decision|0|||
147232960|NCT02913612|531024662|FG002|Overall Study|Local IRB decision|0|||
147232961|NCT02913612|531024663|FG003|Overall Study|Local IRB decision|0|||
147232962|NCT02913612|531024660|FG000|Overall Study|Study drug non-compliance|1|||
147232963|NCT02913612|531024661|FG001|Overall Study|Study drug non-compliance|1|||
147232964|NCT02913612|531024662|FG002|Overall Study|Study drug non-compliance|0|||
147232965|NCT02913612|531024663|FG003|Overall Study|Study drug non-compliance|0|||
147232966|NCT02913612|531024660|FG000|Overall Study|Insurance issues|0|||
147232967|NCT02913612|531024661|FG001|Overall Study|Insurance issues|1|||
147232968|NCT02913612|531024662|FG002|Overall Study|Insurance issues|0|||
147232969|NCT02913612|531024663|FG003|Overall Study|Insurance issues|0|||
147232970|NCT02913612|531024660|FG000|Overall Study|Needed to treat second hemangioma|0|||
147232971|NCT02913612|531024661|FG001|Overall Study|Needed to treat second hemangioma|1|||
147232972|NCT02913612|531024662|FG002|Overall Study|Needed to treat second hemangioma|0|||
147232973|NCT02913612|531024663|FG003|Overall Study|Needed to treat second hemangioma|0|||
147232974|NCT02913612|531024660|FG000|Overall Study|Study completion criteria not met|0|||
147232975|NCT02913612|531024661|FG001|Overall Study|Study completion criteria not met|1|||
147232976|NCT02913612|531024662|FG002|Overall Study|Study completion criteria not met|0|||
147232977|NCT02913612|531024663|FG003|Overall Study|Study completion criteria not met|0|||
147232978|NCT02913612|531024660|FG000|Overall Study|Ineligible|0|||
147232979|NCT02913612|531024661|FG001|Overall Study|Ineligible|1|||
147232980|NCT02913612|531024662|FG002|Overall Study|Ineligible|0|||
147232981|NCT02913612|531024663|FG003|Overall Study|Ineligible|0|||
147232982|NCT02711345|531024669|FG000|Overall Study|Adverse Event|0|||
147232983|NCT02711345|531024670|FG001|Overall Study|Adverse Event|0|||
147651000|NCT01214668|532544557|FG000|Overall Study|Death|0|||
147232984|NCT02711345|531024671|FG002|Overall Study|Adverse Event|0|||
147232985|NCT02711345|531024672|FG003|Overall Study|Adverse Event|1|||
147232986|NCT02711345|531024673|FG004|Overall Study|Adverse Event|1|||
147232987|NCT02711345|531024674|FG005|Overall Study|Adverse Event|2|||
147232988|NCT02711345|531024675|FG006|Overall Study|Adverse Event|1|||
147232989|NCT02711345|531024676|FG007|Overall Study|Adverse Event|0|||
147313990|NCT01729728|531317361|FG001|Overall Study|Adverse Event|6|||
147313991|NCT01729728|531317362|FG002|Overall Study|Adverse Event|0|||
147232990|NCT02711345|531024677|FG008|Overall Study|Adverse Event|0|||
147232991|NCT02711345|531024678|FG009|Overall Study|Adverse Event|2|||
147232992|NCT02711345|531024669|FG000|Overall Study|Physician Decision|0|||
147232993|NCT02711345|531024670|FG001|Overall Study|Physician Decision|0|||
147232994|NCT02711345|531024671|FG002|Overall Study|Physician Decision|1|||
147232995|NCT02711345|531024672|FG003|Overall Study|Physician Decision|0|||
147232996|NCT02711345|531024673|FG004|Overall Study|Physician Decision|0|||
147313992|NCT01729728|531317360|FG000|Overall Study|Protocol Violation|1|||
147313993|NCT01729728|531317361|FG001|Overall Study|Protocol Violation|0|||
147313994|NCT01729728|531317362|FG002|Overall Study|Protocol Violation|1|||
147313995|NCT04011384|531317363|FG000|Overall Study|Withdrawal by Subject|2|||
147122820|NCT02242903|530614623|FG000|Overall Study|Withdrawal by Subject|1|||
147122821|NCT02242903|530614624|FG001|Overall Study|Withdrawal by Subject|0|||
147122822|NCT02242903|530614625|FG002|Overall Study|Withdrawal by Subject|0|||
147122823|NCT02242903|530614626|FG003|Overall Study|Withdrawal by Subject|0|||
147122824|NCT02242903|530614627|FG004|Overall Study|Withdrawal by Subject|0|||
147122825|NCT02242903|530614628|FG005|Overall Study|Withdrawal by Subject|0|||
147122826|NCT02242903|530614629|FG006|Overall Study|Withdrawal by Subject|0|||
147122827|NCT01896986|530614630|FG000|Overall Study|samples lost|14|||
147122828|NCT01896986|530614631|FG001|Overall Study|samples lost|23|||
147122829|NCT00276380|530614636|FG000|Overall Study|Adverse Event|5|||
147122830|NCT00276380|530614637|FG001|Overall Study|Adverse Event|3|||
147122831|NCT00276380|530614636|FG000|Overall Study|Lost to Follow-up|1|||
147122832|NCT00276380|530614637|FG001|Overall Study|Lost to Follow-up|1|||
147122833|NCT00276380|530614636|FG000|Overall Study|Withdrawal by Subject|3|||
147122834|NCT00276380|530614637|FG001|Overall Study|Withdrawal by Subject|6|||
147122835|NCT00276380|530614636|FG000|Overall Study|Death|5|||
147122836|NCT00276380|530614637|FG001|Overall Study|Death|3|||
147122837|NCT00276380|530614636|FG000|Overall Study|Abnormal aPPT Levels|0|||
147122838|NCT00276380|530614637|FG001|Overall Study|Abnormal aPPT Levels|1|||
147122839|NCT01651208|530614642|FG000|Overall Study|Lost to Follow-up|14|||
147122840|NCT01651208|530614643|FG001|Overall Study|Lost to Follow-up|16|||
147122841|NCT02067156|530614644|FG000|Overall Study|Lost to Follow-up|4|||
147122842|NCT03473301|530614645|FG000|Overall Study|Protocol Violation|4|||
147122843|NCT03473301|530614646|FG001|Overall Study|Protocol Violation|0|||
147122844|NCT03473301|530614647|FG002|Overall Study|Protocol Violation|0|||
147122845|NCT03473301|530614645|FG000|Overall Study|Withdrawal by Subject|0|||
147122846|NCT03473301|530614646|FG001|Overall Study|Withdrawal by Subject|1|||
147122847|NCT03473301|530614647|FG002|Overall Study|Withdrawal by Subject|0|||
147122848|NCT03473301|530614645|FG000|Overall Study|Missed study visit due to pandemic restrictions|7|||
147122849|NCT03473301|530614646|FG001|Overall Study|Missed study visit due to pandemic restrictions|5|||
147122850|NCT03473301|530614647|FG002|Overall Study|Missed study visit due to pandemic restrictions|6|||
147122851|NCT04829214|530614648|FG000|Follow-up and Efficacy Analysis|Withdrawal by Subject|5|||
147122852|NCT04829214|530614649|FG001|Follow-up and Efficacy Analysis|Withdrawal by Subject|3|||
147122853|NCT04829214|530614648|FG000|Follow-up and Efficacy Analysis|Lost to Follow-up|2|||
147122854|NCT04829214|530614649|FG001|Follow-up and Efficacy Analysis|Lost to Follow-up|1|||
147122855|NCT02965976|530614650|FG000|Overall Study|Withdrawal by Subject|2|||
147122856|NCT02965976|530614651|FG001|Overall Study|Withdrawal by Subject|0|||
147122857|NCT01370642|530614652|FG000|Overall Study|Adverse Event|2|||
147122858|NCT01370642|530614653|FG001|Overall Study|Adverse Event|1|||
147122859|NCT01370642|530614654|FG002|Overall Study|Adverse Event|1|||
147122860|NCT01370642|530614652|FG000|Overall Study|Detectable HCV RNA|0|||
147122861|NCT01370642|530614653|FG001|Overall Study|Detectable HCV RNA|0|||
147122862|NCT01370642|530614654|FG002|Overall Study|Detectable HCV RNA|22|||
147122863|NCT01370642|530614652|FG000|Overall Study|Lost to Follow-up|0|||
147122864|NCT01370642|530614653|FG001|Overall Study|Lost to Follow-up|0|||
147122865|NCT01370642|530614654|FG002|Overall Study|Lost to Follow-up|1|||
147122866|NCT01370642|530614652|FG000|Overall Study|Physician Decision|4|||
147232997|NCT02711345|531024674|FG005|Overall Study|Physician Decision|0|||
147232998|NCT02711345|531024675|FG006|Overall Study|Physician Decision|0|||
147232999|NCT02711345|531024676|FG007|Overall Study|Physician Decision|0|||
147233000|NCT02711345|531024677|FG008|Overall Study|Physician Decision|1|||
147233001|NCT02711345|531024678|FG009|Overall Study|Physician Decision|0|||
147233002|NCT02711345|531024669|FG000|Overall Study|Progressive disease|1|||
147233003|NCT02711345|531024670|FG001|Overall Study|Progressive disease|3|||
147313996|NCT04011384|531317364|FG001|Overall Study|Withdrawal by Subject|0|||
147313997|NCT02001974|531317365|FG000|Reparixin + Paclitaxel (28-day Cycles)|Disease progression|2|||
147313998|NCT02001974|531317366|FG001|Reparixin + Paclitaxel (28-day Cycles)|Disease progression|3|||
147651001|NCT01214668|532544558|FG001|Overall Study|Death|0|||
147651002|NCT01214668|532544559|FG002|Overall Study|Death|1|||
147233004|NCT02711345|531024671|FG002|Overall Study|Progressive disease|5|||
147651003|NCT01214668|532544560|FG003|Overall Study|Death|0|||
147122867|NCT01370642|530614653|FG001|Overall Study|Physician Decision|1|||
147122868|NCT01370642|530614654|FG002|Overall Study|Physician Decision|2|||
147313999|NCT02001974|531317367|FG002|Reparixin + Paclitaxel (28-day Cycles)|Disease progression|14|||
147122869|NCT01370642|530614652|FG000|Overall Study|Withdrawal by Subject|2|||
147122870|NCT01370642|530614653|FG001|Overall Study|Withdrawal by Subject|4|||
147122871|NCT01370642|530614654|FG002|Overall Study|Withdrawal by Subject|3|||
147122872|NCT00987935|530614661|FG000|Overall Study|Progressive disease|3|||
147233005|NCT02711345|531024672|FG003|Overall Study|Progressive disease|3|||
147122873|NCT00987935|530614662|FG001|Overall Study|Progressive disease|2|||
147122874|NCT00987935|530614663|FG002|Overall Study|Progressive disease|3|||
147122875|NCT00987935|530614664|FG003|Overall Study|Progressive disease|2|||
147314000|NCT02001974|531317365|FG000|Reparixin + Paclitaxel (28-day Cycles)|Adverse Event|1|||
147651004|NCT01214668|532544561|FG004|Overall Study|Death|0|||
147122876|NCT00987935|530614665|FG004|Overall Study|Progressive disease|5|||
147122877|NCT00987935|530614666|FG005|Overall Study|Progressive disease|3|||
147122878|NCT00987935|530614667|FG006|Overall Study|Progressive disease|9|||
147122879|NCT00987935|530614668|FG007|Overall Study|Progressive disease|48|||
147122880|NCT00987935|530614669|FG008|Overall Study|Progressive disease|23|||
147122881|NCT00987935|530614661|FG000|Overall Study|Adverse Event|0|||
147122882|NCT00987935|530614662|FG001|Overall Study|Adverse Event|1|||
147122883|NCT00987935|530614663|FG002|Overall Study|Adverse Event|0|||
147122884|NCT00987935|530614664|FG003|Overall Study|Adverse Event|1|||
147122885|NCT00987935|530614665|FG004|Overall Study|Adverse Event|1|||
147122886|NCT00987935|530614666|FG005|Overall Study|Adverse Event|0|||
147122887|NCT00987935|530614667|FG006|Overall Study|Adverse Event|2|||
147122888|NCT00987935|530614668|FG007|Overall Study|Adverse Event|10|||
147122889|NCT00987935|530614669|FG008|Overall Study|Adverse Event|6|||
147122890|NCT00987935|530614661|FG000|Overall Study|Refused to continue taking trial med.|1|||
147122891|NCT00987935|530614662|FG001|Overall Study|Refused to continue taking trial med.|0|||
147122892|NCT00987935|530614663|FG002|Overall Study|Refused to continue taking trial med.|0|||
147122893|NCT00987935|530614664|FG003|Overall Study|Refused to continue taking trial med.|0|||
147122894|NCT00987935|530614665|FG004|Overall Study|Refused to continue taking trial med.|1|||
147122895|NCT00987935|530614666|FG005|Overall Study|Refused to continue taking trial med.|0|||
147122896|NCT00987935|530614667|FG006|Overall Study|Refused to continue taking trial med.|4|||
147122897|NCT00987935|530614668|FG007|Overall Study|Refused to continue taking trial med.|4|||
147122898|NCT00987935|530614669|FG008|Overall Study|Refused to continue taking trial med.|2|||
147122899|NCT00987935|530614661|FG000|Overall Study|Reason other than those specified above|0|||
147122900|NCT00987935|530614662|FG001|Overall Study|Reason other than those specified above|0|||
147122901|NCT00987935|530614663|FG002|Overall Study|Reason other than those specified above|0|||
147122902|NCT00987935|530614664|FG003|Overall Study|Reason other than those specified above|0|||
147122903|NCT00987935|530614665|FG004|Overall Study|Reason other than those specified above|0|||
147122904|NCT00987935|530614666|FG005|Overall Study|Reason other than those specified above|0|||
147122905|NCT00987935|530614667|FG006|Overall Study|Reason other than those specified above|0|||
147122906|NCT00987935|530614668|FG007|Overall Study|Reason other than those specified above|0|||
147122907|NCT00987935|530614669|FG008|Overall Study|Reason other than those specified above|1|||
147122908|NCT00452530|530614670|FG000|Overall Study|Death|1|||
147122909|NCT00452530|530614671|FG001|Overall Study|Death|0|||
147122910|NCT00452530|530614670|FG000|Overall Study|Adverse Event|40|||
147122911|NCT00452530|530614671|FG001|Overall Study|Adverse Event|44|||
147122912|NCT00452530|530614670|FG000|Overall Study|Withdrawal by Subject|68|||
147122913|NCT00452530|530614671|FG001|Overall Study|Withdrawal by Subject|57|||
147568300|NCT00448591|532240010|FG000|Overall Study|Lost to Follow-up|19|||
147122914|NCT00452530|530614670|FG000|Overall Study|Lost to Follow-up|1|||
147122915|NCT00452530|530614671|FG001|Overall Study|Lost to Follow-up|0|||
147122916|NCT00452530|530614670|FG000|Overall Study|Poor compliance/noncompliance|1|||
147122917|NCT00452530|530614671|FG001|Overall Study|Poor compliance/noncompliance|2|||
147122918|NCT00452530|530614670|FG000|Overall Study|No longer met study criteria|18|||
147122919|NCT00452530|530614671|FG001|Overall Study|No longer met study criteria|22|||
147122920|NCT00452530|530614670|FG000|Overall Study|Other|7|||
147122921|NCT00452530|530614671|FG001|Overall Study|Other|11|||
147122922|NCT03721107|530614672|FG000|Overall Study|Adverse Event|1|||
147122923|NCT03721107|530614673|FG001|Overall Study|Adverse Event|1|||
147122924|NCT03721107|530614674|FG002|Overall Study|Adverse Event|6|||
147122925|NCT03721107|530614675|FG003|Overall Study|Adverse Event|5|||
147122926|NCT03721107|530614672|FG000|Overall Study|Lost to Follow-up|2|||
147122927|NCT03721107|530614673|FG001|Overall Study|Lost to Follow-up|0|||
147122928|NCT03721107|530614674|FG002|Overall Study|Lost to Follow-up|3|||
147122929|NCT03721107|530614675|FG003|Overall Study|Lost to Follow-up|0|||
147122930|NCT03721107|530614672|FG000|Overall Study|Inclusion/Exclusion Criteria not Met|0|||
147122931|NCT03721107|530614673|FG001|Overall Study|Inclusion/Exclusion Criteria not Met|0|||
147122932|NCT03721107|530614674|FG002|Overall Study|Inclusion/Exclusion Criteria not Met|0|||
147122933|NCT03721107|530614675|FG003|Overall Study|Inclusion/Exclusion Criteria not Met|1|||
147122934|NCT03721107|530614672|FG000|Overall Study|Physician Decision|0|||
147122935|NCT03721107|530614673|FG001|Overall Study|Physician Decision|1|||
147122936|NCT03721107|530614674|FG002|Overall Study|Physician Decision|0|||
147122937|NCT03721107|530614675|FG003|Overall Study|Physician Decision|0|||
147122938|NCT03721107|530614672|FG000|Overall Study|Pregnancy|0|||
147122939|NCT03721107|530614673|FG001|Overall Study|Pregnancy|0|||
147122940|NCT03721107|530614674|FG002|Overall Study|Pregnancy|1|||
147122941|NCT03721107|530614675|FG003|Overall Study|Pregnancy|0|||
147122942|NCT03721107|530614672|FG000|Overall Study|Withdrawal by Subject|1|||
147568301|NCT00448591|532240010|FG000|Overall Study|Treatment Regimen Completed|70|||
147122943|NCT03721107|530614673|FG001|Overall Study|Withdrawal by Subject|1|||
147122944|NCT03721107|530614674|FG002|Overall Study|Withdrawal by Subject|5|||
147122945|NCT03721107|530614675|FG003|Overall Study|Withdrawal by Subject|5|||
147122946|NCT03721107|530614672|FG000|Overall Study|Other|1|||
147122947|NCT03721107|530614673|FG001|Overall Study|Other|0|||
147122948|NCT03721107|530614674|FG002|Overall Study|Other|0|||
147122949|NCT03721107|530614675|FG003|Overall Study|Other|1|||
147122950|NCT02294019|530614676|FG000|Overall Study|Adverse Event|2|||
147122951|NCT02294019|530614676|FG000|Overall Study|Protocol Violation|68|||
147122952|NCT02294019|530614676|FG000|Overall Study|Lost to Follow-up|31|||
147122953|NCT02294019|530614676|FG000|Overall Study|Other|1|||
147122954|NCT02294019|530614676|FG000|Overall Study|Withdrawal by Subject|1|||
147122955|NCT04818086|530614680|FG000|Overall Study|Physician Decision|1|||
147122956|NCT04818086|530614681|FG001|Overall Study|Physician Decision|0|||
147122957|NCT04818086|530614680|FG000|Overall Study|Withdrawal by Subject|0|||
147122958|NCT04818086|530614681|FG001|Overall Study|Withdrawal by Subject|1|||
147122959|NCT06048705|530614683|FG000|Overall Study|Physician Decision|1|||
147122960|NCT06048705|530614684|FG001|Overall Study|Physician Decision|0|||
147122961|NCT06048705|530614685|FG002|Overall Study|Physician Decision|0|||
147122962|NCT06048705|530614683|FG000|Overall Study|Did not meet Inclusion/Exclusion Criteria|0|||
147122963|NCT06048705|530614684|FG001|Overall Study|Did not meet Inclusion/Exclusion Criteria|0|||
147122964|NCT06048705|530614685|FG002|Overall Study|Did not meet Inclusion/Exclusion Criteria|1|||
147122965|NCT06048705|530614683|FG000|Overall Study|Death prior to lymphodepletion|0|||
147122966|NCT06048705|530614684|FG001|Overall Study|Death prior to lymphodepletion|0|||
147568302|NCT00448591|532240010|FG000|Overall Study|Other|154|||
147568303|NCT00448591|532240010|FG000|Overall Study|Termination of Study|70|||
147122967|NCT06048705|530614685|FG002|Overall Study|Death prior to lymphodepletion|1|||
147122968|NCT00968968|530614686|FG000|Overall Study|Study closed/terminated|10|||
147122969|NCT00968968|530614687|FG001|Overall Study|Study closed/terminated|10|||
147122970|NCT00968968|530614686|FG000|Overall Study|Protocol defined stopping criteria|3|||
147122971|NCT00968968|530614687|FG001|Overall Study|Protocol defined stopping criteria|1|||
147122972|NCT00968968|530614686|FG000|Overall Study|Withdrawal by Subject|2|||
147122973|NCT00968968|530614687|FG001|Overall Study|Withdrawal by Subject|0|||
147122974|NCT00968968|530614686|FG000|Overall Study|Physician Decision|1|||
147122975|NCT00968968|530614687|FG001|Overall Study|Physician Decision|2|||
147122976|NCT00968968|530614686|FG000|Overall Study|Lost to Follow-up|0|||
147122977|NCT00968968|530614687|FG001|Overall Study|Lost to Follow-up|1|||
147122978|NCT01185366|530614688|FG000|First Line Therapy|Insurance Coverage Denied|1|||
147122979|NCT01185366|530614689|FG001|First Line Therapy|Insurance Coverage Denied|1|||
147122980|NCT01185366|530614688|FG000|First Line Therapy|Withdrawal by Subject|1|||
147122981|NCT01185366|530614689|FG001|First Line Therapy|Withdrawal by Subject|0|||
147122982|NCT01185366|530614688|FG000|First Line Therapy|Lack of Metastatic Site|1|||
147122983|NCT01185366|530614689|FG001|First Line Therapy|Lack of Metastatic Site|0|||
147122984|NCT01185366|530614688|FG000|Crossover to Second Line Therapy|Adverse Event|3|||
147122985|NCT01185366|530614689|FG001|Crossover to Second Line Therapy|Adverse Event|6|||
147122986|NCT01185366|530614688|FG000|Crossover to Second Line Therapy|Physician Decision|5|||
147122987|NCT01185366|530614689|FG001|Crossover to Second Line Therapy|Physician Decision|1|||
147122988|NCT01185366|530614688|FG000|Crossover to Second Line Therapy|Withdrawal by Subject|1|||
147122989|NCT01185366|530614689|FG001|Crossover to Second Line Therapy|Withdrawal by Subject|0|||
147122990|NCT01185366|530614688|FG000|Crossover to Second Line Therapy|Continued with 1st drug|5|||
147122991|NCT01185366|530614689|FG001|Crossover to Second Line Therapy|Continued with 1st drug|3|||
147122992|NCT00127933|530614692|FG000|Overall Study|Randomized but not dosed|1|||
147122993|NCT00127933|530614693|FG001|Overall Study|Randomized but not dosed|0|||
147122994|NCT01783938|530614699|FG000|Overall Study|Disease Progression|18|||
147122995|NCT01783938|530614700|FG001|Overall Study|Disease Progression|41|||
147122996|NCT01783938|530614699|FG000|Overall Study|Study Drug Toxicity|27|||
147122997|NCT01783938|530614700|FG001|Overall Study|Study Drug Toxicity|14|||
147122998|NCT01783938|530614699|FG000|Overall Study|Adverse Event Unrelated to Study Drug|4|||
147122999|NCT01783938|530614700|FG001|Overall Study|Adverse Event Unrelated to Study Drug|2|||
147123000|NCT01783938|530614699|FG000|Overall Study|Participant Request to Discontinue Study Treatment|2|||
147123001|NCT01783938|530614700|FG001|Overall Study|Participant Request to Discontinue Study Treatment|3|||
147123002|NCT01783938|530614699|FG000|Overall Study|Participant Withdrew Consent|2|||
147123003|NCT01783938|530614700|FG001|Overall Study|Participant Withdrew Consent|0|||
147123004|NCT01783938|530614699|FG000|Overall Study|Maximum Clinical Benefit|1|||
147123005|NCT01783938|530614700|FG001|Overall Study|Maximum Clinical Benefit|0|||
147123006|NCT01783938|530614699|FG000|Overall Study|Other Reasons|3|||
147123007|NCT01783938|530614700|FG001|Overall Study|Other Reasons|1|||
147123008|NCT03111732|530614701|FG000|Overall Study|Enrolled in different study|1|||
147123009|NCT03111732|530614701|FG000|Overall Study|Progressive disease|3|||
147123010|NCT03111732|530614701|FG000|Overall Study|Withdrawal by Subject|1|||
147123011|NCT03072875|530614702|FG000|Overall Study|Lost to Follow-up|1|||
147123012|NCT00401830|530614706|FG000|Overall Study|Adverse Event|10|||
147123013|NCT00401830|530614707|FG001|Overall Study|Adverse Event|18|||
147123014|NCT00401830|530614706|FG000|Overall Study|Lack of Efficacy|11|||
147123015|NCT00401830|530614707|FG001|Overall Study|Lack of Efficacy|5|||
147123016|NCT00401830|530614706|FG000|Overall Study|Withdrawal by Subject|4|||
147123017|NCT00401830|530614707|FG001|Overall Study|Withdrawal by Subject|3|||
147123018|NCT00401830|530614706|FG000|Overall Study|Protocol Violation|3|||
147123019|NCT00401830|530614707|FG001|Overall Study|Protocol Violation|3|||
147123020|NCT00401830|530614706|FG000|Overall Study|Non-compliance with drug study|1|||
147123021|NCT00401830|530614707|FG001|Overall Study|Non-compliance with drug study|0|||
147314001|NCT02001974|531317366|FG001|Reparixin + Paclitaxel (28-day Cycles)|Adverse Event|0|||
147314002|NCT02001974|531317367|FG002|Reparixin + Paclitaxel (28-day Cycles)|Adverse Event|4|||
147314003|NCT02001974|531317365|FG000|Reparixin + Paclitaxel (28-day Cycles)|Withdrawal by Subject|1|||
147314004|NCT02001974|531317366|FG001|Reparixin + Paclitaxel (28-day Cycles)|Withdrawal by Subject|0|||
147314005|NCT02001974|531317367|FG002|Reparixin + Paclitaxel (28-day Cycles)|Withdrawal by Subject|6|||
147314006|NCT02001974|531317365|FG000|Reparixin + Paclitaxel (28-day Cycles)|Physician Decision|0|||
147314007|NCT02001974|531317366|FG001|Reparixin + Paclitaxel (28-day Cycles)|Physician Decision|0|||
147314008|NCT02001974|531317367|FG002|Reparixin + Paclitaxel (28-day Cycles)|Physician Decision|2|||
147314009|NCT00993317|531317368|FG000|Overall Study|Adverse Event|2|||
147314010|NCT00993317|531317369|FG001|Overall Study|Adverse Event|4|||
147314011|NCT00993317|531317368|FG000|Overall Study|Lack of Efficacy|18|||
147314012|NCT00993317|531317369|FG001|Overall Study|Lack of Efficacy|18|||
147314013|NCT00993317|531317368|FG000|Overall Study|Withdrawal by Subject|0|||
147314014|NCT00993317|531317369|FG001|Overall Study|Withdrawal by Subject|2|||
147314015|NCT00993317|531317368|FG000|Overall Study|Investigator's opinion|0|||
147314016|NCT00993317|531317369|FG001|Overall Study|Investigator's opinion|1|||
147314017|NCT00993317|531317368|FG000|Overall Study|Early study termination at the site|1|||
147314018|NCT00993317|531317369|FG001|Overall Study|Early study termination at the site|0|||
147314019|NCT00672958|531317370|FG000|Overall Study|Adverse Event|11|||
147314020|NCT00672958|531317371|FG001|Overall Study|Adverse Event|9|||
147314021|NCT00672958|531317370|FG000|Overall Study|Lack of Efficacy|6|||
147314022|NCT00672958|531317371|FG001|Overall Study|Lack of Efficacy|11|||
147314023|NCT00672958|531317370|FG000|Overall Study|Non-compliance with study drug|2|||
147314024|NCT00672958|531317371|FG001|Overall Study|Non-compliance with study drug|3|||
147314025|NCT00672958|531317370|FG000|Overall Study|Protocol deviations|11|||
147314026|NCT00672958|531317371|FG001|Overall Study|Protocol deviations|5|||
147314027|NCT00672958|531317370|FG000|Overall Study|Voluntary withdrawal|12|||
147314028|NCT00672958|531317371|FG001|Overall Study|Voluntary withdrawal|8|||
147314029|NCT00672958|531317370|FG000|Overall Study|Lost to Follow-up|22|||
147314030|NCT00672958|531317371|FG001|Overall Study|Lost to Follow-up|17|||
147314031|NCT00672958|531317370|FG000|Overall Study|Reason not specified|0|||
147314032|NCT00672958|531317371|FG001|Overall Study|Reason not specified|3|||
147314033|NCT01380990|531317372|FG000|Overall Study|Treatment Failure|1|||
147314034|NCT01380990|531317373|FG001|Overall Study|Treatment Failure|0|||
147314035|NCT01380990|531317372|FG000|Overall Study|Death|0|||
147314036|NCT01380990|531317373|FG001|Overall Study|Death|1|||
147314037|NCT02374593|531317374|FG000|Overall Study|non-compliant|2|||
147314038|NCT02374593|531317375|FG001|Overall Study|non-compliant|0|||
147314039|NCT01009047|531317378|FG000|Overall Study|Adverse Event|5|||
147123022|NCT00401830|530614706|FG000|Overall Study|Lost to Follow-up|1|||
147123023|NCT00401830|530614707|FG001|Overall Study|Lost to Follow-up|3|||
147123024|NCT00401830|530614706|FG000|Overall Study|Other: Personal / Family problems|1|||
147123025|NCT00401830|530614707|FG001|Overall Study|Other: Personal / Family problems|0|||
147123026|NCT00452400|530614708|FG000|Overall Study|Adverse Event|1|||
147233006|NCT02711345|531024673|FG004|Overall Study|Progressive disease|7|||
147233007|NCT02711345|531024674|FG005|Overall Study|Progressive disease|2|||
147233008|NCT02711345|531024675|FG006|Overall Study|Progressive disease|8|||
147314040|NCT01009047|531317379|FG001|Overall Study|Adverse Event|0|||
147314041|NCT01009047|531317378|FG000|Overall Study|Lost to Follow-up|0|||
147314042|NCT01009047|531317379|FG001|Overall Study|Lost to Follow-up|2|||
147314043|NCT01009047|531317378|FG000|Overall Study|Lack of Efficacy|4|||
147123027|NCT00452400|530614709|FG001|Overall Study|Adverse Event|1|||
147123028|NCT00452400|530614710|FG002|Overall Study|Adverse Event|5|||
147233009|NCT02711345|531024676|FG007|Overall Study|Progressive disease|4|||
147233010|NCT02711345|531024677|FG008|Overall Study|Progressive disease|5|||
147233011|NCT02711345|531024678|FG009|Overall Study|Progressive disease|6|||
147233012|NCT02711345|531024669|FG000|Overall Study|Subject/guardian decision|0|||
147233013|NCT02711345|531024670|FG001|Overall Study|Subject/guardian decision|0|||
147233014|NCT02711345|531024671|FG002|Overall Study|Subject/guardian decision|0|||
147233015|NCT02711345|531024672|FG003|Overall Study|Subject/guardian decision|0|||
147314044|NCT01009047|531317379|FG001|Overall Study|Lack of Efficacy|11|||
147314045|NCT01009047|531317378|FG000|Overall Study|Withdrawal by consent|16|||
147314046|NCT01009047|531317379|FG001|Overall Study|Withdrawal by consent|11|||
147123029|NCT00452400|530614711|FG003|Overall Study|Adverse Event|0|||
147123030|NCT00452400|530614712|FG004|Overall Study|Adverse Event|2|||
147123031|NCT00452400|530614708|FG000|Overall Study|Protocol Violation|0|||
147123032|NCT00452400|530614709|FG001|Overall Study|Protocol Violation|0|||
147233016|NCT02711345|531024673|FG004|Overall Study|Subject/guardian decision|0|||
147233017|NCT02711345|531024674|FG005|Overall Study|Subject/guardian decision|2|||
147233018|NCT02711345|531024675|FG006|Overall Study|Subject/guardian decision|3|||
147314047|NCT01009047|531317378|FG000|Overall Study|Other|3|||
147314048|NCT01009047|531317379|FG001|Overall Study|Other|2|||
147314049|NCT02141659|531317380|FG000|Overall Study|Major Protocol Deviation|0|||
147314050|NCT02141659|531317381|FG001|Overall Study|Major Protocol Deviation|1|||
147314051|NCT02141659|531317382|FG002|Overall Study|Major Protocol Deviation|0|||
147314052|NCT02141659|531317383|FG003|Overall Study|Major Protocol Deviation|0|||
147314053|NCT02141659|531317384|FG004|Overall Study|Major Protocol Deviation|0|||
147123033|NCT00452400|530614710|FG002|Overall Study|Protocol Violation|1|||
147123034|NCT00452400|530614711|FG003|Overall Study|Protocol Violation|0|||
147123035|NCT00452400|530614712|FG004|Overall Study|Protocol Violation|0|||
147123036|NCT00452400|530614708|FG000|Overall Study|Lost to Follow-up|1|||
147123037|NCT00452400|530614709|FG001|Overall Study|Lost to Follow-up|0|||
147123038|NCT00452400|530614710|FG002|Overall Study|Lost to Follow-up|0|||
147123039|NCT00452400|530614711|FG003|Overall Study|Lost to Follow-up|0|||
147123040|NCT00452400|530614712|FG004|Overall Study|Lost to Follow-up|0|||
147123041|NCT00452400|530614708|FG000|Overall Study|Withdrawal by Subject|1|||
147123042|NCT00452400|530614709|FG001|Overall Study|Withdrawal by Subject|0|||
147123043|NCT00452400|530614710|FG002|Overall Study|Withdrawal by Subject|1|||
147123044|NCT00452400|530614711|FG003|Overall Study|Withdrawal by Subject|0|||
147123045|NCT00452400|530614712|FG004|Overall Study|Withdrawal by Subject|0|||
147123046|NCT00452400|530614708|FG000|Overall Study|Lack of Efficacy|2|||
147123047|NCT00452400|530614709|FG001|Overall Study|Lack of Efficacy|0|||
147123048|NCT00452400|530614710|FG002|Overall Study|Lack of Efficacy|0|||
147123049|NCT00452400|530614711|FG003|Overall Study|Lack of Efficacy|0|||
147123050|NCT00452400|530614712|FG004|Overall Study|Lack of Efficacy|0|||
147123051|NCT00452400|530614708|FG000|Overall Study|Other reasons not listed above|0|||
147123052|NCT00452400|530614709|FG001|Overall Study|Other reasons not listed above|0|||
147123053|NCT00452400|530614710|FG002|Overall Study|Other reasons not listed above|0|||
147123054|NCT00452400|530614711|FG003|Overall Study|Other reasons not listed above|1|||
147123055|NCT00452400|530614712|FG004|Overall Study|Other reasons not listed above|1|||
147123056|NCT01943825|530614713|FG000|Overall Study|Lost to Follow-up|9|||
147123057|NCT01943825|530614714|FG001|Overall Study|Lost to Follow-up|3|||
147123058|NCT01943825|530614715|FG002|Overall Study|Lost to Follow-up|12|||
147123059|NCT01943825|530614716|FG003|Overall Study|Lost to Follow-up|8|||
147123060|NCT01943825|530614713|FG000|Overall Study|Withdrawal by Subject|1|||
147123061|NCT01943825|530614714|FG001|Overall Study|Withdrawal by Subject|0|||
147123062|NCT01943825|530614715|FG002|Overall Study|Withdrawal by Subject|3|||
147123063|NCT01943825|530614716|FG003|Overall Study|Withdrawal by Subject|2|||
147123064|NCT01943825|530614713|FG000|Overall Study|Other than specified above|0|||
147123065|NCT01943825|530614714|FG001|Overall Study|Other than specified above|1|||
147123066|NCT01943825|530614715|FG002|Overall Study|Other than specified above|0|||
147123067|NCT01943825|530614716|FG003|Overall Study|Other than specified above|1|||
147123068|NCT02792257|530614721|FG000|Overall Study|Lost to Follow-up|3|||
147123069|NCT02792257|530614722|FG001|Overall Study|Lost to Follow-up|4|||
147123070|NCT02792257|530614721|FG000|Overall Study|Allergy|0|||
147123071|NCT02792257|530614722|FG001|Overall Study|Allergy|1|||
147123072|NCT02792257|530614721|FG000|Overall Study|Protocol Violation|2|||
147123073|NCT02792257|530614722|FG001|Overall Study|Protocol Violation|0|||
147123074|NCT02792257|530614721|FG000|Overall Study|Excessive Agitation|0|||
147123075|NCT02792257|530614722|FG001|Overall Study|Excessive Agitation|1|||
147123076|NCT02792257|530614721|FG000|Overall Study|Not Feeling Well|0|||
147123077|NCT02792257|530614722|FG001|Overall Study|Not Feeling Well|1|||
147123078|NCT00553475|530614723|FG000|Overall Study|Adverse Event|7|||
147123079|NCT00553475|530614724|FG001|Overall Study|Adverse Event|17|||
147123080|NCT00553475|530614725|FG002|Overall Study|Adverse Event|13|||
147123081|NCT00553475|530614723|FG000|Overall Study|Lack of Efficacy|7|||
147123082|NCT00553475|530614724|FG001|Overall Study|Lack of Efficacy|1|||
147568304|NCT02937870|532240011|FG000|Overall Study|Adverse Event|1|||
147568305|NCT02937870|532240011|FG000|Overall Study|Protocol Deviation|2|||
147123083|NCT00553475|530614725|FG002|Overall Study|Lack of Efficacy|0|||
147123084|NCT00553475|530614723|FG000|Overall Study|Withdrawal by Subject|1|||
147123085|NCT00553475|530614724|FG001|Overall Study|Withdrawal by Subject|1|||
147123086|NCT00553475|530614725|FG002|Overall Study|Withdrawal by Subject|0|||
147123087|NCT00553475|530614723|FG000|Overall Study|Physician Decision|1|||
147123088|NCT00553475|530614724|FG001|Overall Study|Physician Decision|0|||
147123089|NCT00553475|530614725|FG002|Overall Study|Physician Decision|0|||
147123090|NCT00553475|530614723|FG000|Overall Study|Due to moving|0|||
147123091|NCT00553475|530614724|FG001|Overall Study|Due to moving|1|||
147123092|NCT00553475|530614725|FG002|Overall Study|Due to moving|0|||
147123093|NCT01623154|530614726|FG000|Overall Study|Did not drink Pranactin Citric|4|||
147568306|NCT00609674|532240015|FG000|Overall Study|Adverse Event|1|||
147123094|NCT00954538|530614732|FG000|Part III|Withdrawal by Subject|0|||
147123095|NCT00954538|530614733|FG001|Part III|Withdrawal by Subject|0|||
147123096|NCT00954538|530614734|FG002|Part III|Withdrawal by Subject|0|||
147123097|NCT00954538|530614735|FG003|Part III|Withdrawal by Subject|0|||
147123098|NCT00954538|530614736|FG004|Part III|Withdrawal by Subject|1|||
147568307|NCT00609674|532240016|FG001|Overall Study|Adverse Event|1|||
147568308|NCT00609674|532240015|FG000|Overall Study|Protocol Violation|3|||
147123099|NCT00954538|530614737|FG005|Part III|Withdrawal by Subject|0|||
147123100|NCT01905683|530614738|FG000|Overall Study|Protocol Violation|1|||
147123101|NCT01905683|530614738|FG000|Overall Study|Re-injection criteria not met; others|13|||
147123102|NCT01905683|530614738|FG000|Overall Study|Physician Decision|1|||
147123103|NCT01905683|530614738|FG000|Overall Study|Lack of Efficacy|8|||
147123104|NCT01905683|530614738|FG000|Overall Study|Withdrawal by Subject|20|||
147123105|NCT01905683|530614738|FG000|Overall Study|Adverse Event|4|||
147123106|NCT01905683|530614738|FG000|Overall Study|Lost to Follow-up|4|||
147233019|NCT02711345|531024676|FG007|Overall Study|Subject/guardian decision|1|||
147233020|NCT02711345|531024677|FG008|Overall Study|Subject/guardian decision|0|||
147233021|NCT02711345|531024678|FG009|Overall Study|Subject/guardian decision|4|||
147233022|NCT02711345|531024669|FG000|Overall Study|Death|1|||
147233023|NCT02711345|531024670|FG001|Overall Study|Death|0|||
147233024|NCT02711345|531024671|FG002|Overall Study|Death|0|||
147233025|NCT02711345|531024672|FG003|Overall Study|Death|0|||
147233026|NCT02711345|531024673|FG004|Overall Study|Death|0|||
147233027|NCT02711345|531024674|FG005|Overall Study|Death|0|||
147233028|NCT02711345|531024675|FG006|Overall Study|Death|0|||
147233029|NCT02711345|531024676|FG007|Overall Study|Death|1|||
147233030|NCT02711345|531024677|FG008|Overall Study|Death|0|||
147233031|NCT02711345|531024678|FG009|Overall Study|Death|0|||
147233032|NCT00961649|531024679|FG000|Overall Study|Adverse Event|4|||
147233033|NCT00961649|531024680|FG001|Overall Study|Adverse Event|0|||
147233034|NCT00961649|531024681|FG002|Overall Study|Adverse Event|0|||
147233035|NCT00961649|531024682|FG003|Overall Study|Adverse Event|2|||
147233036|NCT00961649|531024679|FG000|Overall Study|Inadequate control of IOP|0|||
147233037|NCT00961649|531024680|FG001|Overall Study|Inadequate control of IOP|0|||
147233038|NCT00961649|531024681|FG002|Overall Study|Inadequate control of IOP|0|||
147233039|NCT00961649|531024682|FG003|Overall Study|Inadequate control of IOP|1|||
147233040|NCT00961649|531024679|FG000|Overall Study|Patient has travel plans during holidays|0|||
147233041|NCT00961649|531024680|FG001|Overall Study|Patient has travel plans during holidays|0|||
147233042|NCT00961649|531024681|FG002|Overall Study|Patient has travel plans during holidays|1|||
147233043|NCT00961649|531024682|FG003|Overall Study|Patient has travel plans during holidays|0|||
147233044|NCT00961649|531024679|FG000|Overall Study|Patient left to Mexico-family emergency|1|||
147233045|NCT00961649|531024680|FG001|Overall Study|Patient left to Mexico-family emergency|0|||
147233046|NCT00961649|531024681|FG002|Overall Study|Patient left to Mexico-family emergency|0|||
147233047|NCT00961649|531024682|FG003|Overall Study|Patient left to Mexico-family emergency|0|||
147233048|NCT00961649|531024679|FG000|Overall Study|Study terminated by sponsor|4|||
147233049|NCT00961649|531024680|FG001|Overall Study|Study terminated by sponsor|4|||
147233050|NCT00961649|531024681|FG002|Overall Study|Study terminated by sponsor|4|||
147233051|NCT00961649|531024682|FG003|Overall Study|Study terminated by sponsor|1|||
147233052|NCT04043728|531024683|FG000|Overall Study|Lost to Follow-up|1|||
147233053|NCT04043728|531024684|FG001|Overall Study|Lost to Follow-up|2|||
147233054|NCT04043728|531024685|FG002|Overall Study|Lost to Follow-up|0|||
147233055|NCT00072176|531024687|FG000|Overall Study|Withdrawal by Subject|1|||
147233056|NCT00072176|531024688|FG001|Overall Study|Withdrawal by Subject|0|||
147233057|NCT00072176|531024687|FG000|Overall Study|Protocol Violation|0|||
147233058|NCT00072176|531024688|FG001|Overall Study|Protocol Violation|1|||
147233059|NCT04128371|531024691|FG000|Overall Study|Lack of Efficacy|1|||
147233060|NCT00968864|531024694|FG000|Overall Study|Protocol exception/ not evaluable|1|||
147233061|NCT01346969|531024695|FG000|Overall Study|Withdrawal by Subject|0|||
147233062|NCT01346969|531024696|FG001|Overall Study|Withdrawal by Subject|0|||
147233063|NCT01346969|531024697|FG002|Overall Study|Withdrawal by Subject|1|||
147233064|NCT01346969|531024698|FG003|Overall Study|Withdrawal by Subject|0|||
147233065|NCT01346969|531024695|FG000|Overall Study|Lost to Follow-up|1|||
147233066|NCT01346969|531024696|FG001|Overall Study|Lost to Follow-up|0|||
147233067|NCT01346969|531024697|FG002|Overall Study|Lost to Follow-up|2|||
147233068|NCT01346969|531024698|FG003|Overall Study|Lost to Follow-up|0|||
147233069|NCT01346969|531024695|FG000|Overall Study|Physician Decision|0|||
147233070|NCT01346969|531024696|FG001|Overall Study|Physician Decision|0|||
147233071|NCT01346969|531024697|FG002|Overall Study|Physician Decision|0|||
147233072|NCT01346969|531024698|FG003|Overall Study|Physician Decision|1|||
147233073|NCT01346969|531024695|FG000|Overall Study|Randomized but not treated|1|||
147568309|NCT00609674|532240016|FG001|Overall Study|Protocol Violation|5|||
147568310|NCT00609674|532240015|FG000|Overall Study|Lost to Follow-up|1|||
147568311|NCT00609674|532240016|FG001|Overall Study|Lost to Follow-up|0|||
147568312|NCT00609674|532240015|FG000|Overall Study|Withdrew consent|2|||
147568313|NCT00609674|532240016|FG001|Overall Study|Withdrew consent|1|||
147568314|NCT03098394|532240017|FG000|Overall Study|Pregnancy|0|||
147568315|NCT03098394|532240018|FG001|Overall Study|Pregnancy|1|||
147568316|NCT00244764|532240022|FG000|Overall Study|Adverse Event|37|||
147568317|NCT00244764|532240022|FG000|Overall Study|Lost to Follow-up|23|||
147233074|NCT01346969|531024696|FG001|Overall Study|Randomized but not treated|0|||
147233075|NCT01346969|531024697|FG002|Overall Study|Randomized but not treated|0|||
147233076|NCT01346969|531024698|FG003|Overall Study|Randomized but not treated|0|||
147233077|NCT00586625|531024699|FG000|Overall Study|Adverse Event|6|||
147233078|NCT00586625|531024700|FG001|Overall Study|Adverse Event|6|||
147568318|NCT00244764|532240022|FG000|Overall Study|Withdrawal by Subject|12|||
147568319|NCT00244764|532240022|FG000|Overall Study|Disease Progression|13|||
147233079|NCT00586625|531024699|FG000|Overall Study|Protocol Violation|3|||
147233080|NCT00586625|531024700|FG001|Overall Study|Protocol Violation|0|||
147233081|NCT00586625|531024699|FG000|Overall Study|Withdrawal by Subject|32|||
147233082|NCT00586625|531024700|FG001|Overall Study|Withdrawal by Subject|10|||
147233083|NCT00586625|531024699|FG000|Overall Study|Subject non-compliance|0|||
147233084|NCT00586625|531024700|FG001|Overall Study|Subject non-compliance|1|||
147233085|NCT00586625|531024699|FG000|Overall Study|Subject unable to return for visit|2|||
147123107|NCT00537082|530614743|FG000|Overall Study|Adverse Event|6|||
147123108|NCT00537082|530614744|FG001|Overall Study|Adverse Event|6|||
147123109|NCT00537082|530614745|FG002|Overall Study|Adverse Event|3|||
147123110|NCT00537082|530614743|FG000|Overall Study|Protocol Violation|0|||
147123111|NCT00537082|530614744|FG001|Overall Study|Protocol Violation|2|||
147123112|NCT00537082|530614745|FG002|Overall Study|Protocol Violation|1|||
147123113|NCT00537082|530614743|FG000|Overall Study|Lack of Efficacy|0|||
147123114|NCT00537082|530614744|FG001|Overall Study|Lack of Efficacy|0|||
147123115|NCT00537082|530614745|FG002|Overall Study|Lack of Efficacy|2|||
147123116|NCT00537082|530614743|FG000|Overall Study|Withdrawal by Subject|0|||
147123117|NCT00537082|530614744|FG001|Overall Study|Withdrawal by Subject|1|||
147123118|NCT00537082|530614745|FG002|Overall Study|Withdrawal by Subject|0|||
147123119|NCT00537082|530614743|FG000|Overall Study|Discontinued before initiating treatment|3|||
147123120|NCT00537082|530614744|FG001|Overall Study|Discontinued before initiating treatment|0|||
147123121|NCT00537082|530614745|FG002|Overall Study|Discontinued before initiating treatment|0|||
147123122|NCT02568254|530614746|FG000|Period 2|Adverse Event|0|||
147123123|NCT02568254|530614747|FG001|Period 2|Adverse Event|0|||
147123124|NCT02568254|530614748|FG002|Period 2|Adverse Event|1|||
147123125|NCT02568254|530614749|FG003|Period 2|Adverse Event|0|||
147123126|NCT02568254|530614750|FG004|Period 2|Adverse Event|0|||
147123127|NCT02568254|530614751|FG005|Period 2|Adverse Event|0|||
147123128|NCT02568254|530614746|FG000|Period 3|Unstatisfactory Lens fitting|0|||
147123129|NCT02568254|530614747|FG001|Period 3|Unstatisfactory Lens fitting|0|||
147123130|NCT02568254|530614748|FG002|Period 3|Unstatisfactory Lens fitting|0|||
147123131|NCT02568254|530614749|FG003|Period 3|Unstatisfactory Lens fitting|0|||
147123132|NCT02568254|530614750|FG004|Period 3|Unstatisfactory Lens fitting|1|||
147233086|NCT00586625|531024700|FG001|Overall Study|Subject unable to return for visit|0|||
147233087|NCT04032652|531024702|FG000|Overall Study|The study was terminated and the PI has|1|||
147233088|NCT04032652|531024703|FG001|Overall Study|The study was terminated and the PI has|1|||
147233089|NCT02423772|531024704|FG000|Overall Study|Lost to Follow-up|3|||
147233090|NCT02423772|531024705|FG001|Overall Study|Lost to Follow-up|3|||
147123133|NCT02568254|530614751|FG005|Period 3|Unstatisfactory Lens fitting|0|||
147123134|NCT00107614|530616696|FG000|Overall Study|Physician Decision|10|||
147123135|NCT00107614|530616696|FG000|Overall Study|Death|2|||
147123136|NCT01897896|530616700|FG000|Overall Study|Death|1|||
147123137|NCT01897896|530616701|FG001|Overall Study|Death|0|||
147123138|NCT01897896|530616700|FG000|Overall Study|Adverse Event|11|||
147123139|NCT01897896|530616701|FG001|Overall Study|Adverse Event|1|||
147123140|NCT01897896|530616700|FG000|Overall Study|Lost to Follow-up|1|||
147123141|NCT01897896|530616701|FG001|Overall Study|Lost to Follow-up|0|||
147123142|NCT01897896|530616700|FG000|Overall Study|Non-compliance with study drug dosing|1|||
147123143|NCT01897896|530616701|FG001|Overall Study|Non-compliance with study drug dosing|1|||
147123144|NCT01897896|530616700|FG000|Overall Study|Withdrawal by Subject|7|||
147123145|NCT01897896|530616701|FG001|Overall Study|Withdrawal by Subject|1|||
147123146|NCT01897896|530616700|FG000|Overall Study|Require drug that interfere with study|1|||
147123147|NCT01897896|530616701|FG001|Overall Study|Require drug that interfere with study|4|||
147123148|NCT01897896|530616700|FG000|Overall Study|Protocol Violation|1|||
147123149|NCT01897896|530616701|FG001|Overall Study|Protocol Violation|1|||
147123150|NCT01897896|530616700|FG000|Overall Study|Withdrawal per Investigator's judgement|1|||
147123151|NCT01897896|530616701|FG001|Overall Study|Withdrawal per Investigator's judgement|1|||
147123152|NCT01897896|530616700|FG000|Overall Study|Caregiver can no longer participate|0|||
147123153|NCT01897896|530616701|FG001|Overall Study|Caregiver can no longer participate|2|||
147123154|NCT01897896|530616700|FG000|Overall Study|Other than specified|2|||
147123155|NCT01897896|530616701|FG001|Overall Study|Other than specified|1|||
147123156|NCT00101400|530616704|FG000|Survival Follow-Up|Alive|7|||
147123157|NCT03160573|530616705|FG000|First Sequence (3 Weeks)|Withdrawal by Subject|1|||
147123158|NCT03160573|530616706|FG001|First Sequence (3 Weeks)|Withdrawal by Subject|3|||
147123159|NCT03160573|530616707|FG002|First Sequence (3 Weeks)|Withdrawal by Subject|2|||
147123160|NCT03160573|530616708|FG003|First Sequence (3 Weeks)|Withdrawal by Subject|2|||
147123161|NCT03142451|530616712|FG000|Overall Study|Adverse Event|5|||
147123162|NCT03142451|530616713|FG001|Overall Study|Adverse Event|2|||
147123163|NCT03142451|530616712|FG000|Overall Study|Lost to Follow-up|25|||
147123164|NCT03142451|530616713|FG001|Overall Study|Lost to Follow-up|8|||
147123165|NCT03142451|530616712|FG000|Overall Study|Participant request|24|||
147123166|NCT03142451|530616713|FG001|Overall Study|Participant request|12|||
147123167|NCT03142451|530616712|FG000|Overall Study|Protocol Violation|3|||
147123168|NCT03142451|530616713|FG001|Overall Study|Protocol Violation|1|||
147123169|NCT03142451|530616712|FG000|Overall Study|Other|1|||
147233091|NCT02423772|531024704|FG000|Overall Study|Did not begin intervention|2|||
147233092|NCT02423772|531024705|FG001|Overall Study|Did not begin intervention|5|||
147233093|NCT01386008|531024708|FG000|Overall Study|exited w/o incident /study discontinued|17|||
147123170|NCT03142451|530616713|FG001|Overall Study|Other|1|||
147123171|NCT01730729|530616718|FG000|Overall Study|Adverse Event|1|||
147123172|NCT01730729|530616718|FG000|Overall Study|Death|1|||
147123173|NCT01730729|530616718|FG000|Overall Study|Progressive Disease|12|||
147123174|NCT00871000|530616719|FG000|Overall Study|Withdrawal by Subject|1|||
147123175|NCT00871000|530616720|FG001|Overall Study|Withdrawal by Subject|0|||
147123176|NCT02402907|530616723|FG000|Overall Study|Delivered vaginally|9|||
147123177|NCT02402907|530616724|FG001|Overall Study|Delivered vaginally|3|||
147123178|NCT02402907|530616723|FG000|Overall Study|Delivered outside of Sinai|1|||
147123179|NCT02402907|530616724|FG001|Overall Study|Delivered outside of Sinai|1|||
147123180|NCT02402907|530616723|FG000|Overall Study|Lost to follow up after C-Section|10|||
147123181|NCT02402907|530616724|FG001|Overall Study|Lost to follow up after C-Section|23|||
147123182|NCT00449787|530616725|FG000|Overall Study|Lost to Follow-up|10|||
147123183|NCT00449787|530616726|FG001|Overall Study|Lost to Follow-up|8|||
147123184|NCT00449787|530616725|FG000|Overall Study|Did not require medication|95|||
147123185|NCT00449787|530616726|FG001|Overall Study|Did not require medication|92|||
147123186|NCT02003898|530616727|FG000|Overall Study|Death|3|||
147123187|NCT02003898|530616727|FG000|Overall Study|Lost to Follow-up|12|||
147123188|NCT02003898|530616727|FG000|Overall Study|Withdrawal by Subject|52|||
147123189|NCT01537432|530616728|FG000|Overall Study|Lost to Follow-up|3|||
147123190|NCT01537432|530616729|FG001|Overall Study|Lost to Follow-up|1|||
147123191|NCT01537432|530616728|FG000|Overall Study|Withdrawal by Subject|0|||
147123192|NCT01537432|530616729|FG001|Overall Study|Withdrawal by Subject|1|||
147123193|NCT01537432|530616728|FG000|Overall Study|Administrative problems|1|||
147123194|NCT01537432|530616729|FG001|Overall Study|Administrative problems|0|||
147123195|NCT01537432|530616728|FG000|Overall Study|Adverse Event|1|||
147123196|NCT01537432|530616729|FG001|Overall Study|Adverse Event|0|||
147123197|NCT01537432|530616728|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
147123198|NCT01537432|530616729|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
147123199|NCT05166902|530616730|FG000|First Intervention|Lost to Follow-up|0|||
147123200|NCT05166902|530616731|FG001|First Intervention|Lost to Follow-up|1|||
147123201|NCT01998477|530616732|FG000|Overall Study|Lost to Follow-up|4|||
147123202|NCT01998477|530616733|FG001|Overall Study|Lost to Follow-up|5|||
147123203|NCT01998477|530616732|FG000|Overall Study|Withdrawal by Subject|6|||
147123204|NCT01998477|530616733|FG001|Overall Study|Withdrawal by Subject|0|||
147123205|NCT03436420|530616734|FG000|Overall Study|Lack of Efficacy|3|||
147123206|NCT01061710|530616735|FG000|Overall Study|Protocol Violation|14|||
147123207|NCT00159874|530616736|FG000|Overall Study|Adverse Event|2|||
147123208|NCT00159874|530616737|FG001|Overall Study|Adverse Event|2|||
147123209|NCT00159874|530616738|FG002|Overall Study|Adverse Event|5|||
147123210|NCT00159874|530616739|FG003|Overall Study|Adverse Event|1|||
147123211|NCT00159874|530616740|FG004|Overall Study|Adverse Event|1|||
147123212|NCT00159874|530616741|FG005|Overall Study|Adverse Event|2|||
147123213|NCT00159874|530616742|FG006|Overall Study|Adverse Event|0|||
147123214|NCT00159874|530616736|FG000|Overall Study|Does Not Meet Entrance Criteria|1|||
147123215|NCT00159874|530616737|FG001|Overall Study|Does Not Meet Entrance Criteria|0|||
147123216|NCT00159874|530616738|FG002|Overall Study|Does Not Meet Entrance Criteria|1|||
147123217|NCT00159874|530616739|FG003|Overall Study|Does Not Meet Entrance Criteria|0|||
147123218|NCT00159874|530616740|FG004|Overall Study|Does Not Meet Entrance Criteria|0|||
147123219|NCT00159874|530616741|FG005|Overall Study|Does Not Meet Entrance Criteria|0|||
147123220|NCT00159874|530616742|FG006|Overall Study|Does Not Meet Entrance Criteria|0|||
147123221|NCT00159874|530616736|FG000|Overall Study|Lack of Efficacy|2|||
147123222|NCT00159874|530616737|FG001|Overall Study|Lack of Efficacy|0|||
147123223|NCT00159874|530616738|FG002|Overall Study|Lack of Efficacy|1|||
147123224|NCT00159874|530616739|FG003|Overall Study|Lack of Efficacy|1|||
147123225|NCT00159874|530616740|FG004|Overall Study|Lack of Efficacy|0|||
147123226|NCT00159874|530616741|FG005|Overall Study|Lack of Efficacy|3|||
147123227|NCT00159874|530616742|FG006|Overall Study|Lack of Efficacy|0|||
147123228|NCT00159874|530616736|FG000|Overall Study|Lost to Follow-up|1|||
147123229|NCT00159874|530616737|FG001|Overall Study|Lost to Follow-up|0|||
147123230|NCT00159874|530616738|FG002|Overall Study|Lost to Follow-up|3|||
147123231|NCT00159874|530616739|FG003|Overall Study|Lost to Follow-up|0|||
147123232|NCT00159874|530616740|FG004|Overall Study|Lost to Follow-up|1|||
147123233|NCT00159874|530616741|FG005|Overall Study|Lost to Follow-up|2|||
147123234|NCT00159874|530616742|FG006|Overall Study|Lost to Follow-up|1|||
147123235|NCT00159874|530616736|FG000|Overall Study|Other|8|||
147568320|NCT00244764|532240022|FG000|Overall Study|Protocol Violation|2|||
147568321|NCT00244764|532240022|FG000|Overall Study|Death|1|||
147568322|NCT00244764|532240022|FG000|Overall Study|Off Study Medication for >21 Days|1|||
147568323|NCT00244764|532240022|FG000|Overall Study|Declining Performance Status|1|||
147568324|NCT00244764|532240022|FG000|Overall Study|Participant was Hospitalized until Death|1|||
147123236|NCT00159874|530616737|FG001|Overall Study|Other|8|||
147123237|NCT00159874|530616738|FG002|Overall Study|Other|8|||
147123238|NCT00159874|530616739|FG003|Overall Study|Other|0|||
147123239|NCT00159874|530616740|FG004|Overall Study|Other|2|||
147123240|NCT00159874|530616741|FG005|Overall Study|Other|1|||
147123241|NCT00159874|530616742|FG006|Overall Study|Other|3|||
147123242|NCT00159874|530616736|FG000|Overall Study|Protocol Violation|0|||
147123243|NCT00159874|530616737|FG001|Overall Study|Protocol Violation|5|||
147123244|NCT00159874|530616738|FG002|Overall Study|Protocol Violation|2|||
147123245|NCT00159874|530616739|FG003|Overall Study|Protocol Violation|0|||
147123246|NCT00159874|530616740|FG004|Overall Study|Protocol Violation|0|||
147123247|NCT00159874|530616741|FG005|Overall Study|Protocol Violation|0|||
147123248|NCT00159874|530616742|FG006|Overall Study|Protocol Violation|0|||
147123249|NCT00159874|530616736|FG000|Overall Study|Death|3|||
147123250|NCT00159874|530616737|FG001|Overall Study|Death|8|||
147123251|NCT00159874|530616738|FG002|Overall Study|Death|15|||
147123252|NCT00159874|530616739|FG003|Overall Study|Death|0|||
147123253|NCT00159874|530616740|FG004|Overall Study|Death|1|||
147123254|NCT00159874|530616741|FG005|Overall Study|Death|2|||
147123255|NCT00159874|530616742|FG006|Overall Study|Death|0|||
147123256|NCT00159874|530616736|FG000|Overall Study|Withdrawal by Subject|2|||
147123257|NCT00159874|530616737|FG001|Overall Study|Withdrawal by Subject|6|||
147123258|NCT00159874|530616738|FG002|Overall Study|Withdrawal by Subject|8|||
147123259|NCT00159874|530616739|FG003|Overall Study|Withdrawal by Subject|4|||
147123260|NCT00159874|530616740|FG004|Overall Study|Withdrawal by Subject|3|||
147123261|NCT00159874|530616741|FG005|Overall Study|Withdrawal by Subject|2|||
147123262|NCT00159874|530616742|FG006|Overall Study|Withdrawal by Subject|1|||
147123263|NCT00159874|530616736|FG000|Overall Study|Pregnancy|1|||
147123264|NCT00159874|530616737|FG001|Overall Study|Pregnancy|1|||
147123265|NCT00159874|530616738|FG002|Overall Study|Pregnancy|0|||
147123266|NCT00159874|530616739|FG003|Overall Study|Pregnancy|0|||
147123267|NCT00159874|530616740|FG004|Overall Study|Pregnancy|0|||
147123268|NCT00159874|530616741|FG005|Overall Study|Pregnancy|0|||
147123269|NCT00159874|530616742|FG006|Overall Study|Pregnancy|0|||
147123270|NCT02771145|530616746|FG000|Overall Study|Adverse Event|3|||
147123271|NCT02771145|530616746|FG000|Overall Study|Lost to Follow-up|1|||
147123272|NCT03596983|530616750|FG000|Overall Study|Withdrawal by Subject|3|||
147123273|NCT05287685|530616751|FG000|Pilot Randomized Controlled Trial|Withdrawal by Subject|2|||
147123274|NCT05287685|530616752|FG001|Pilot Randomized Controlled Trial|Withdrawal by Subject|1|||
147123275|NCT05287685|530616751|FG000|Pilot Randomized Controlled Trial|Lost to Follow-up|1|||
147123276|NCT05287685|530616752|FG001|Pilot Randomized Controlled Trial|Lost to Follow-up|0|||
147123277|NCT02134028|530616753|FG000|Overall Study|Lack of Efficacy|1|||
147123278|NCT02134028|530616754|FG001|Overall Study|Lack of Efficacy|0|||
147123279|NCT02134028|530616755|FG002|Overall Study|Lack of Efficacy|3|||
147123280|NCT02134028|530616756|FG003|Overall Study|Lack of Efficacy|2|||
147123281|NCT02134028|530616757|FG004|Overall Study|Lack of Efficacy|1|||
147123282|NCT02134028|530616758|FG005|Overall Study|Lack of Efficacy|2|||
147123283|NCT02134028|530616759|FG006|Overall Study|Lack of Efficacy|1|||
147123284|NCT02134028|530616760|FG007|Overall Study|Lack of Efficacy|0|||
147123285|NCT02134028|530616753|FG000|Overall Study|Poor compliance to protocol|1|||
147123286|NCT02134028|530616754|FG001|Overall Study|Poor compliance to protocol|1|||
147123287|NCT02134028|530616755|FG002|Overall Study|Poor compliance to protocol|3|||
147123288|NCT02134028|530616756|FG003|Overall Study|Poor compliance to protocol|7|||
147123289|NCT02134028|530616757|FG004|Overall Study|Poor compliance to protocol|1|||
147123290|NCT02134028|530616758|FG005|Overall Study|Poor compliance to protocol|1|||
147123291|NCT02134028|530616759|FG006|Overall Study|Poor compliance to protocol|0|||
147123292|NCT02134028|530616760|FG007|Overall Study|Poor compliance to protocol|0|||
147123293|NCT02134028|530616753|FG000|Overall Study|Other unspecified|4|||
147123294|NCT02134028|530616754|FG001|Overall Study|Other unspecified|22|||
147123295|NCT02134028|530616755|FG002|Overall Study|Other unspecified|33|||
147123296|NCT02134028|530616756|FG003|Overall Study|Other unspecified|64|||
147123297|NCT02134028|530616757|FG004|Overall Study|Other unspecified|8|||
147123298|NCT02134028|530616758|FG005|Overall Study|Other unspecified|6|||
147123299|NCT02134028|530616759|FG006|Overall Study|Other unspecified|2|||
147123300|NCT02134028|530616760|FG007|Overall Study|Other unspecified|1|||
147123301|NCT02134028|530616753|FG000|Overall Study|Adverse Event|3|||
147123302|NCT02134028|530616754|FG001|Overall Study|Adverse Event|19|||
147123303|NCT02134028|530616755|FG002|Overall Study|Adverse Event|13|||
147123304|NCT02134028|530616756|FG003|Overall Study|Adverse Event|32|||
147123305|NCT02134028|530616757|FG004|Overall Study|Adverse Event|4|||
147123306|NCT02134028|530616758|FG005|Overall Study|Adverse Event|5|||
147123307|NCT02134028|530616759|FG006|Overall Study|Adverse Event|1|||
147123308|NCT02134028|530616760|FG007|Overall Study|Adverse Event|2|||
147123309|NCT00806026|530616761|FG000|Overall Study|Death|0|||
147123310|NCT00806026|530616762|FG001|Overall Study|Death|0|||
147123311|NCT00806026|530616763|FG002|Overall Study|Death|0|||
147123312|NCT00806026|530616764|FG003|Overall Study|Death|1|||
147123313|NCT00806026|530616765|FG004|Overall Study|Death|0|||
147123314|NCT00806026|530616766|FG005|Overall Study|Death|0|||
147123315|NCT00806026|530616761|FG000|Overall Study|Did not meet entrance criteria|4|||
147123316|NCT00806026|530616762|FG001|Overall Study|Did not meet entrance criteria|1|||
147123317|NCT00806026|530616763|FG002|Overall Study|Did not meet entrance criteria|2|||
147123318|NCT00806026|530616764|FG003|Overall Study|Did not meet entrance criteria|1|||
147123319|NCT00806026|530616765|FG004|Overall Study|Did not meet entrance criteria|0|||
147123320|NCT00806026|530616766|FG005|Overall Study|Did not meet entrance criteria|0|||
147123321|NCT00806026|530616761|FG000|Overall Study|Lack of Efficacy|5|||
147123322|NCT00806026|530616762|FG001|Overall Study|Lack of Efficacy|18|||
147123323|NCT00806026|530616763|FG002|Overall Study|Lack of Efficacy|13|||
147123324|NCT00806026|530616764|FG003|Overall Study|Lack of Efficacy|4|||
147123325|NCT00806026|530616765|FG004|Overall Study|Lack of Efficacy|8|||
147123326|NCT00806026|530616766|FG005|Overall Study|Lack of Efficacy|7|||
147123327|NCT00806026|530616761|FG000|Overall Study|Lost to Follow-up|8|||
147123328|NCT00806026|530616762|FG001|Overall Study|Lost to Follow-up|15|||
147123329|NCT00806026|530616763|FG002|Overall Study|Lost to Follow-up|8|||
147123330|NCT00806026|530616764|FG003|Overall Study|Lost to Follow-up|2|||
147123331|NCT00806026|530616765|FG004|Overall Study|Lost to Follow-up|6|||
147123332|NCT00806026|530616766|FG005|Overall Study|Lost to Follow-up|6|||
147123333|NCT00806026|530616761|FG000|Overall Study|Withdrawal by Subject|14|||
147123334|NCT00806026|530616762|FG001|Overall Study|Withdrawal by Subject|17|||
147123335|NCT00806026|530616763|FG002|Overall Study|Withdrawal by Subject|9|||
147123336|NCT00806026|530616764|FG003|Overall Study|Withdrawal by Subject|2|||
147123337|NCT00806026|530616765|FG004|Overall Study|Withdrawal by Subject|5|||
147123338|NCT00806026|530616766|FG005|Overall Study|Withdrawal by Subject|3|||
147123339|NCT00806026|530616761|FG000|Overall Study|Other|3|||
147123340|NCT00806026|530616762|FG001|Overall Study|Other|6|||
147123341|NCT00806026|530616763|FG002|Overall Study|Other|8|||
147123342|NCT00806026|530616764|FG003|Overall Study|Other|2|||
147123343|NCT00806026|530616765|FG004|Overall Study|Other|0|||
147123344|NCT00806026|530616766|FG005|Overall Study|Other|4|||
147123345|NCT00806026|530616761|FG000|Overall Study|Protocol Violation|6|||
147123346|NCT00806026|530616762|FG001|Overall Study|Protocol Violation|9|||
147123347|NCT00806026|530616763|FG002|Overall Study|Protocol Violation|9|||
147123348|NCT00806026|530616764|FG003|Overall Study|Protocol Violation|0|||
147314054|NCT02141659|531317385|FG005|Overall Study|Major Protocol Deviation|0|||
147314055|NCT02141659|531317380|FG000|Overall Study|Lack of Efficacy|0|||
147314056|NCT02141659|531317381|FG001|Overall Study|Lack of Efficacy|0|||
147314057|NCT02141659|531317382|FG002|Overall Study|Lack of Efficacy|0|||
147314058|NCT02141659|531317383|FG003|Overall Study|Lack of Efficacy|0|||
147314059|NCT02141659|531317384|FG004|Overall Study|Lack of Efficacy|0|||
147314060|NCT02141659|531317385|FG005|Overall Study|Lack of Efficacy|1|||
147314061|NCT02141659|531317380|FG000|Overall Study|Pretreatment Event/ Adverse Event|0|||
147568325|NCT00244764|532240022|FG000|Overall Study|Primary Investigator Discretion|2|||
147568326|NCT00244764|532240022|FG000|Overall Study|Sponsor Terminated Study|2|||
147568327|NCT00244764|532240022|FG000|Overall Study|Developed Secondary Malignancy|1|||
147568328|NCT02648438|532240028|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
147568329|NCT02648438|532240029|FG001|Overall Study|Eligibility criteria not fulfilled|2|||
147568330|NCT02648438|532240030|FG002|Overall Study|Eligibility criteria not fulfilled|0|||
147568331|NCT02648438|532240028|FG000|Overall Study|Protocol Violation|2|||
147568332|NCT02648438|532240029|FG001|Overall Study|Protocol Violation|0|||
147568333|NCT02648438|532240030|FG002|Overall Study|Protocol Violation|0|||
147314062|NCT02141659|531317381|FG001|Overall Study|Pretreatment Event/ Adverse Event|0|||
147314063|NCT02141659|531317382|FG002|Overall Study|Pretreatment Event/ Adverse Event|0|||
147314064|NCT02141659|531317383|FG003|Overall Study|Pretreatment Event/ Adverse Event|0|||
147314065|NCT02141659|531317384|FG004|Overall Study|Pretreatment Event/ Adverse Event|2|||
147314066|NCT02141659|531317385|FG005|Overall Study|Pretreatment Event/ Adverse Event|1|||
147314067|NCT00305864|531317390|FG000|Overall Study|Ineligible / No protocol treatment|0|||
147314068|NCT00305864|531317391|FG001|Overall Study|Ineligible / No protocol treatment|1|||
147314069|NCT00305864|531317392|FG002|Overall Study|Ineligible / No protocol treatment|1|||
147314070|NCT00305864|531317393|FG003|Overall Study|Ineligible / No protocol treatment|13|||
147314071|NCT02836613|531317396|FG000|Overall Study|Accidental drowning|1|||
147314072|NCT02836613|531317397|FG001|Overall Study|Accidental drowning|0|||
147314073|NCT02836613|531317396|FG000|Overall Study|Lost to Follow-up|0|||
147314074|NCT02836613|531317397|FG001|Overall Study|Lost to Follow-up|1|||
147568334|NCT02648438|532240028|FG000|Overall Study|Withdrawal by Subject|1|||
147568335|NCT02648438|532240029|FG001|Overall Study|Withdrawal by Subject|1|||
147568336|NCT02648438|532240030|FG002|Overall Study|Withdrawal by Subject|0|||
147568337|NCT03138967|532240031|FG000|Overall Study|Death|0|||
147568338|NCT03138967|532240032|FG001|Overall Study|Death|1|||
147568339|NCT03138967|532240031|FG000|Overall Study|Physician Decision|1|||
147568340|NCT03138967|532240032|FG001|Overall Study|Physician Decision|3|||
147314075|NCT02836613|531317396|FG000|Overall Study|Withdrawal by Subject|0|||
147444618|NCT01147744|531792659|FG002|Overall Study|Protocol Violation|1|||
147568341|NCT04604275|532240033|FG000|Washout-1 Week|Withdrawal by Subject|1|||
147568342|NCT04604275|532240034|FG001|Washout-1 Week|Withdrawal by Subject|0|||
147651005|NCT01214668|532544562|FG005|Overall Study|Death|0|||
147123349|NCT00806026|530616765|FG004|Overall Study|Protocol Violation|2|||
147123350|NCT00806026|530616766|FG005|Overall Study|Protocol Violation|3|||
147123351|NCT00806026|530616761|FG000|Overall Study|Adverse Event|52|||
147123352|NCT00806026|530616762|FG001|Overall Study|Adverse Event|35|||
147123353|NCT00806026|530616763|FG002|Overall Study|Adverse Event|44|||
147123354|NCT00806026|530616764|FG003|Overall Study|Adverse Event|17|||
147123355|NCT00806026|530616765|FG004|Overall Study|Adverse Event|9|||
147123356|NCT00806026|530616766|FG005|Overall Study|Adverse Event|9|||
147123357|NCT01903733|530616769|FG000|Overall Study|Death|23|||
147123358|NCT01903733|530616770|FG001|Overall Study|Death|54|||
147123359|NCT01903733|530616771|FG002|Overall Study|Death|30|||
147123360|NCT01903733|530616772|FG003|Overall Study|Death|98|||
147123361|NCT01903733|530616769|FG000|Overall Study|Participant refused further follow-up|35|||
147123362|NCT01903733|530616770|FG001|Overall Study|Participant refused further follow-up|38|||
147123363|NCT01903733|530616771|FG002|Overall Study|Participant refused further follow-up|13|||
147314076|NCT02836613|531317397|FG001|Overall Study|Withdrawal by Subject|2|||
147314077|NCT03881059|531317398|FG000|Treatment Period - Part A|Adverse Event|1|||
147314078|NCT03881059|531317399|FG001|Treatment Period - Part A|Adverse Event|3|||
147314079|NCT03881059|531317400|FG002|Treatment Period - Part A|Adverse Event|4|||
147314080|NCT03881059|531317398|FG000|Treatment Period - Part A|Randomized by mistake with study treatment|0|||
147314081|NCT03881059|531317399|FG001|Treatment Period - Part A|Randomized by mistake with study treatment|1|||
147314082|NCT03881059|531317400|FG002|Treatment Period - Part A|Randomized by mistake with study treatment|1|||
147314083|NCT03881059|531317398|FG000|Treatment Period - Part A|Withdrawal by Subject|5|||
147314084|NCT03881059|531317399|FG001|Treatment Period - Part A|Withdrawal by Subject|2|||
147314085|NCT03881059|531317400|FG002|Treatment Period - Part A|Withdrawal by Subject|3|||
147314086|NCT03881059|531317398|FG000|Treatment Period - Part A|Other reasons|2|||
147314087|NCT03881059|531317399|FG001|Treatment Period - Part A|Other reasons|1|||
147314088|NCT03881059|531317400|FG002|Treatment Period - Part A|Other reasons|0|||
147314089|NCT03881059|531317398|FG000|Treatment Period - Part B|Adverse Event|0|||
147314090|NCT03881059|531317399|FG001|Treatment Period - Part B|Adverse Event|0|||
147568343|NCT02689505|532240035|FG000|Overall Study|Progressive disease|2|||
147568344|NCT02689505|532240036|FG001|Overall Study|Progressive disease|2|||
147568345|NCT02689505|532240037|FG002|Overall Study|Progressive disease|3|||
147568346|NCT02689505|532240038|FG003|Overall Study|Progressive disease|9|||
147568347|NCT02689505|532240039|FG004|Overall Study|Progressive disease|1|||
147568348|NCT02689505|532240035|FG000|Overall Study|Dose Limiting Toxicity|0|||
147568349|NCT02689505|532240036|FG001|Overall Study|Dose Limiting Toxicity|1|||
147568350|NCT02689505|532240037|FG002|Overall Study|Dose Limiting Toxicity|0|||
147568351|NCT02689505|532240038|FG003|Overall Study|Dose Limiting Toxicity|0|||
147568352|NCT02689505|532240039|FG004|Overall Study|Dose Limiting Toxicity|2|||
147568353|NCT02689505|532240035|FG000|Overall Study|Other AE or clinical progression|0|||
147568354|NCT02689505|532240036|FG001|Overall Study|Other AE or clinical progression|2|||
147568355|NCT02689505|532240037|FG002|Overall Study|Other AE or clinical progression|0|||
147568356|NCT02689505|532240038|FG003|Overall Study|Other AE or clinical progression|2|||
147568357|NCT02689505|532240039|FG004|Overall Study|Other AE or clinical progression|0|||
147568358|NCT00723710|532240043|FG000|Overall Study|Disease progression|48|||
147568359|NCT00723710|532240043|FG000|Overall Study|Adverse Event|88|||
147568360|NCT00723710|532240043|FG000|Overall Study|Withdrawal by Subject|36|||
147568361|NCT00723710|532240043|FG000|Overall Study|Physician Decision|2|||
147568362|NCT04405570|532240044|FG000|Overall Study|Adverse Event|0|||
147568363|NCT04405570|532240045|FG001|Overall Study|Adverse Event|1|||
147568364|NCT04405570|532240046|FG002|Overall Study|Adverse Event|1|||
147233094|NCT01386008|531024708|FG000|Overall Study|Adverse Event|3|||
147233095|NCT03001882|531024709|FG000|Overall Study|Death|1|||
147233096|NCT03001882|531024710|FG001|Overall Study|Death|0|||
147233097|NCT03001882|531024711|FG002|Overall Study|Death|0|||
147233098|NCT03001882|531024712|FG003|Overall Study|Death|3|||
147233099|NCT03001882|531024709|FG000|Overall Study|Participant withdrew consent|0|||
147233100|NCT03001882|531024710|FG001|Overall Study|Participant withdrew consent|1|||
147233101|NCT03001882|531024711|FG002|Overall Study|Participant withdrew consent|0|||
147233102|NCT03001882|531024712|FG003|Overall Study|Participant withdrew consent|5|||
147233103|NCT03001882|531024709|FG000|Overall Study|Other reasons|1|||
147233104|NCT03001882|531024710|FG001|Overall Study|Other reasons|2|||
147233105|NCT03001882|531024711|FG002|Overall Study|Other reasons|0|||
147233106|NCT03001882|531024712|FG003|Overall Study|Other reasons|5|||
147233107|NCT03001882|531024709|FG000|Overall Study|Administrative reason by sponsor|0|||
147233108|NCT03001882|531024710|FG001|Overall Study|Administrative reason by sponsor|0|||
147233109|NCT03001882|531024711|FG002|Overall Study|Administrative reason by sponsor|0|||
147233110|NCT03001882|531024712|FG003|Overall Study|Administrative reason by sponsor|1|||
147233111|NCT03001882|531024709|FG000|Overall Study|Participant requested to discontinue study treatment|0|||
147233112|NCT03001882|531024710|FG001|Overall Study|Participant requested to discontinue study treatment|0|||
147233113|NCT03001882|531024711|FG002|Overall Study|Participant requested to discontinue study treatment|0|||
147314091|NCT03881059|531317400|FG002|Treatment Period - Part B|Adverse Event|3|||
147568365|NCT04405570|532240047|FG003|Overall Study|Adverse Event|1|||
147568366|NCT04405570|532240044|FG000|Overall Study|Lost to Follow-up|0|||
147568367|NCT04405570|532240045|FG001|Overall Study|Lost to Follow-up|1|||
147568368|NCT04405570|532240046|FG002|Overall Study|Lost to Follow-up|0|||
147568369|NCT04405570|532240047|FG003|Overall Study|Lost to Follow-up|0|||
147568370|NCT04405570|532240044|FG000|Overall Study|Physician Decision|0|||
147568371|NCT04405570|532240045|FG001|Overall Study|Physician Decision|0|||
147568372|NCT04405570|532240046|FG002|Overall Study|Physician Decision|1|||
147233114|NCT03001882|531024712|FG003|Overall Study|Participant requested to discontinue study treatment|2|||
147314092|NCT03881059|531317398|FG000|Treatment Period - Part B|Death|0|||
147314093|NCT03881059|531317399|FG001|Treatment Period - Part B|Death|1|||
147568373|NCT04405570|532240047|FG003|Overall Study|Physician Decision|0|||
147568374|NCT04405570|532240044|FG000|Overall Study|Withdrawal by Subject|0|||
147568375|NCT04405570|532240045|FG001|Overall Study|Withdrawal by Subject|1|||
147568376|NCT04405570|532240046|FG002|Overall Study|Withdrawal by Subject|1|||
147233115|NCT03001882|531024709|FG000|Overall Study|Not reported|0|||
147233116|NCT03001882|531024710|FG001|Overall Study|Not reported|0|||
147233117|NCT03001882|531024711|FG002|Overall Study|Not reported|0|||
147568377|NCT04405570|532240047|FG003|Overall Study|Withdrawal by Subject|0|||
147568378|NCT04405570|532240044|FG000|Overall Study|Randomized not dosed|0|||
147568379|NCT04405570|532240045|FG001|Overall Study|Randomized not dosed|2|||
147568380|NCT04405570|532240046|FG002|Overall Study|Randomized not dosed|0|||
147568381|NCT04405570|532240047|FG003|Overall Study|Randomized not dosed|0|||
147568382|NCT04499963|532240048|FG000|Overall Study|Adverse Event|3|||
147568383|NCT04499963|532240049|FG001|Overall Study|Adverse Event|0|||
147568384|NCT04499963|532240048|FG000|Overall Study|Death|3|||
147568385|NCT04499963|532240049|FG001|Overall Study|Death|0|||
147568386|NCT04499963|532240048|FG000|Overall Study|Lack of Efficacy|7|||
147568387|NCT04499963|532240049|FG001|Overall Study|Lack of Efficacy|0|||
147568388|NCT04499963|532240048|FG000|Overall Study|Lost to Follow-up|2|||
147568389|NCT04499963|532240049|FG001|Overall Study|Lost to Follow-up|0|||
147568390|NCT03546842|532240050|FG000|Overall Study|Protocol Violation|1|||
147568391|NCT03546842|532240050|FG000|Overall Study|Withdrawal by Subject|2|||
147568392|NCT01723397|532240053|FG000|Study Period 1|Protocol Violation|0|||
147568393|NCT01723397|532240054|FG001|Study Period 1|Protocol Violation|1|||
147568394|NCT01723397|532240053|FG000|Study Period 2|Protocol Violation|0|||
147568395|NCT01723397|532240054|FG001|Study Period 2|Protocol Violation|1|||
147568396|NCT03031847|532240065|FG000|Overall Study|Death|1|||
147568397|NCT03031847|532240066|FG001|Overall Study|Death|1|||
147568398|NCT03031847|532240067|FG002|Overall Study|Death|2|||
147568399|NCT03031847|532240068|FG003|Overall Study|Death|3|||
147568400|NCT03031847|532240065|FG000|Overall Study|Lost to Follow-up|1|||
147568401|NCT03031847|532240066|FG001|Overall Study|Lost to Follow-up|1|||
147568402|NCT03031847|532240067|FG002|Overall Study|Lost to Follow-up|2|||
147568403|NCT03031847|532240068|FG003|Overall Study|Lost to Follow-up|3|||
147568404|NCT01353664|532240069|FG000|Overall Study|Other|3|||
147568405|NCT01353664|532240069|FG000|Overall Study|Disease Progression|16|||
147568406|NCT03273153|532240070|FG000|Overall Study|Adverse Event|1|||
147568407|NCT03273153|532240071|FG001|Overall Study|Adverse Event|2|||
147568408|NCT03273153|532240070|FG000|Overall Study|Missing|0|||
147568409|NCT03273153|532240071|FG001|Overall Study|Missing|2|||
147568410|NCT03273153|532240070|FG000|Overall Study|Other|3|||
147568411|NCT03273153|532240071|FG001|Overall Study|Other|2|||
147568412|NCT03273153|532240070|FG000|Overall Study|Symptomatic Deterioration|0|||
147123364|NCT01903733|530616772|FG003|Overall Study|Participant refused further follow-up|9|||
147123365|NCT01903733|530616769|FG000|Overall Study|Lost to Follow-up|18|||
147123366|NCT01903733|530616770|FG001|Overall Study|Lost to Follow-up|19|||
147123367|NCT01903733|530616771|FG002|Overall Study|Lost to Follow-up|6|||
147123368|NCT01903733|530616772|FG003|Overall Study|Lost to Follow-up|9|||
147123369|NCT01903733|530616769|FG000|Overall Study|Other|10|||
147314094|NCT03881059|531317400|FG002|Treatment Period - Part B|Death|1|||
147568413|NCT03273153|532240071|FG001|Overall Study|Symptomatic Deterioration|1|||
147568414|NCT03273153|532240070|FG000|Overall Study|Progressive Disease|6|||
147568415|NCT03273153|532240071|FG001|Overall Study|Progressive Disease|5|||
147568416|NCT03273153|532240070|FG000|Overall Study|Physician Decision|1|||
147568417|NCT03273153|532240071|FG001|Overall Study|Physician Decision|3|||
147568418|NCT03273153|532240070|FG000|Overall Study|Study Terminated by Sponsor|112|||
147123370|NCT01903733|530616770|FG001|Overall Study|Other|15|||
147123371|NCT01903733|530616771|FG002|Overall Study|Other|12|||
147123372|NCT01903733|530616772|FG003|Overall Study|Other|3|||
147123373|NCT01903733|530616769|FG000|Overall Study|Missing|2|||
147123374|NCT01903733|530616770|FG001|Overall Study|Missing|0|||
147123375|NCT01903733|530616771|FG002|Overall Study|Missing|0|||
147123376|NCT01903733|530616772|FG003|Overall Study|Missing|0|||
147123377|NCT01903733|530616769|FG000|Overall Study|Investigator request|18|||
147123378|NCT01903733|530616770|FG001|Overall Study|Investigator request|0|||
147123379|NCT01903733|530616771|FG002|Overall Study|Investigator request|0|||
147123380|NCT01903733|530616772|FG003|Overall Study|Investigator request|0|||
147123381|NCT01714063|530616773|FG000|Overall Study|Equipment malfunction|2|||
147123382|NCT03878602|530616774|FG000|Overall Study|cord blood donation|7|||
147123383|NCT03878602|530616775|FG001|Overall Study|cord blood donation|1|||
147314095|NCT03881059|531317398|FG000|Treatment Period - Part B|Lack of Efficacy|1|||
147314096|NCT03881059|531317399|FG001|Treatment Period - Part B|Lack of Efficacy|1|||
147568419|NCT03273153|532240071|FG001|Overall Study|Study Terminated by Sponsor|102|||
147568420|NCT03273153|532240070|FG000|Overall Study|Withdrawal by Subject|26|||
147568421|NCT03273153|532240071|FG001|Overall Study|Withdrawal by Subject|25|||
147568422|NCT03273153|532240070|FG000|Overall Study|Protocol Deviation|3|||
147568423|NCT03273153|532240071|FG001|Overall Study|Protocol Deviation|0|||
147568424|NCT03273153|532240070|FG000|Overall Study|Lost to Follow-up|6|||
147568425|NCT03273153|532240071|FG001|Overall Study|Lost to Follow-up|11|||
147568426|NCT03273153|532240070|FG000|Overall Study|Death|66|||
147568427|NCT03273153|532240071|FG001|Overall Study|Death|69|||
147123384|NCT03878602|530616774|FG000|Overall Study|incomplete data collection|2|||
147123385|NCT03878602|530616775|FG001|Overall Study|incomplete data collection|0|||
147123386|NCT02191397|530616777|FG000|Overall Study|Adverse Event|28|||
147123387|NCT02191397|530616778|FG001|Overall Study|Adverse Event|17|||
147123388|NCT02191397|530616777|FG000|Overall Study|Lack of Efficacy|10|||
147123389|NCT02191397|530616778|FG001|Overall Study|Lack of Efficacy|5|||
147568428|NCT01237054|532240074|FG000|Overall Study|imaging 10C0096|1|||
147123390|NCT02191397|530616777|FG000|Overall Study|Protocol Violation|0|||
147123391|NCT02191397|530616778|FG001|Overall Study|Protocol Violation|3|||
147123392|NCT02191397|530616777|FG000|Overall Study|Met protocol-defined stopping criteria|5|||
147123393|NCT02191397|530616778|FG001|Overall Study|Met protocol-defined stopping criteria|4|||
147123394|NCT02191397|530616777|FG000|Overall Study|Lost to Follow-up|10|||
147123395|NCT02191397|530616778|FG001|Overall Study|Lost to Follow-up|11|||
147123396|NCT02191397|530616777|FG000|Overall Study|Physician Decision|8|||
147123397|NCT02191397|530616778|FG001|Overall Study|Physician Decision|3|||
147123398|NCT02191397|530616777|FG000|Overall Study|Withdrawal by Subject|22|||
147123399|NCT02191397|530616778|FG001|Overall Study|Withdrawal by Subject|27|||
147123400|NCT02176525|530616780|FG000|Overall Study|Adverse Event|0|||
147123401|NCT02176525|530616781|FG001|Overall Study|Adverse Event|0|||
147123402|NCT02176525|530616782|FG002|Overall Study|Adverse Event|0|||
147123403|NCT02176525|530616783|FG003|Overall Study|Adverse Event|1|||
147123404|NCT02176525|530616784|FG004|Overall Study|Adverse Event|1|||
147123405|NCT02176525|530616785|FG005|Overall Study|Adverse Event|0|||
147123406|NCT02176525|530616786|FG006|Overall Study|Adverse Event|1|||
147123407|NCT02176525|530616787|FG007|Overall Study|Adverse Event|0|||
147123408|NCT02176525|530616780|FG000|Overall Study|not treated|1|||
147123409|NCT02176525|530616781|FG001|Overall Study|not treated|0|||
147123410|NCT02176525|530616782|FG002|Overall Study|not treated|0|||
147123411|NCT02176525|530616783|FG003|Overall Study|not treated|0|||
147123412|NCT02176525|530616784|FG004|Overall Study|not treated|0|||
147123413|NCT02176525|530616785|FG005|Overall Study|not treated|1|||
147123414|NCT02176525|530616786|FG006|Overall Study|not treated|0|||
147123415|NCT02176525|530616787|FG007|Overall Study|not treated|0|||
147123416|NCT00478140|530616790|FG000|Overall Study|Clinical Disease Progression|1|||
147123417|NCT00728182|530616791|FG000|Overall Study|Adverse Event|1|||
147314097|NCT03881059|531317400|FG002|Treatment Period - Part B|Lack of Efficacy|0|||
147314098|NCT03881059|531317398|FG000|Treatment Period - Part B|Lost to Follow-up|1|||
147314099|NCT03881059|531317399|FG001|Treatment Period - Part B|Lost to Follow-up|1|||
147314100|NCT03881059|531317400|FG002|Treatment Period - Part B|Lost to Follow-up|0|||
147314101|NCT03881059|531317398|FG000|Treatment Period - Part B|Site terminated by sponsor|1|||
147568429|NCT00838539|532240075|FG000|Overall Study|Disease Progression|2|||
147568430|NCT00838539|532240076|FG001|Overall Study|Disease Progression|4|||
147568431|NCT00838539|532240077|FG002|Overall Study|Disease Progression|3|||
147568432|NCT00838539|532240078|FG003|Overall Study|Disease Progression|2|||
147568433|NCT00838539|532240079|FG004|Overall Study|Disease Progression|4|||
147568434|NCT00838539|532240080|FG005|Overall Study|Disease Progression|2|||
147568435|NCT00838539|532240081|FG006|Overall Study|Disease Progression|3|||
147568436|NCT00838539|532240082|FG007|Overall Study|Disease Progression|4|||
147568437|NCT00838539|532240083|FG008|Overall Study|Disease Progression|4|||
147314102|NCT03881059|531317399|FG001|Treatment Period - Part B|Site terminated by sponsor|0|||
147314103|NCT03881059|531317400|FG002|Treatment Period - Part B|Site terminated by sponsor|3|||
147568438|NCT00838539|532240084|FG009|Overall Study|Disease Progression|5|||
147568439|NCT00838539|532240085|FG010|Overall Study|Disease Progression|1|||
147568440|NCT00838539|532240086|FG011|Overall Study|Disease Progression|4|||
147568441|NCT00838539|532240075|FG000|Overall Study|Adverse Event|1|||
147314104|NCT03881059|531317398|FG000|Treatment Period - Part B|Withdrawal by Subject|1|||
147314105|NCT03881059|531317399|FG001|Treatment Period - Part B|Withdrawal by Subject|0|||
147314106|NCT03881059|531317400|FG002|Treatment Period - Part B|Withdrawal by Subject|1|||
147314107|NCT03881059|531317398|FG000|Treatment Period - Part B|Other reasons|4|||
147568442|NCT00838539|532240076|FG001|Overall Study|Adverse Event|1|||
147568443|NCT00838539|532240077|FG002|Overall Study|Adverse Event|1|||
147568444|NCT00838539|532240078|FG003|Overall Study|Adverse Event|1|||
147568445|NCT00838539|532240079|FG004|Overall Study|Adverse Event|2|||
147568446|NCT00838539|532240080|FG005|Overall Study|Adverse Event|1|||
147568447|NCT00838539|532240081|FG006|Overall Study|Adverse Event|0|||
147123418|NCT00728182|530616792|FG001|Overall Study|Adverse Event|0|||
147568448|NCT00838539|532240082|FG007|Overall Study|Adverse Event|2|||
147568449|NCT00838539|532240083|FG008|Overall Study|Adverse Event|0|||
147568450|NCT00838539|532240084|FG009|Overall Study|Adverse Event|1|||
147568451|NCT00838539|532240085|FG010|Overall Study|Adverse Event|2|||
147568452|NCT00838539|532240086|FG011|Overall Study|Adverse Event|0|||
147568453|NCT00838539|532240075|FG000|Overall Study|Withdrawal by Subject|0|||
147123419|NCT00728182|530616791|FG000|Overall Study|Lost to Follow-up|2|||
147123420|NCT00728182|530616792|FG001|Overall Study|Lost to Follow-up|0|||
147123421|NCT00728182|530616791|FG000|Overall Study|Death|0|||
147123422|NCT00728182|530616792|FG001|Overall Study|Death|2|||
147123423|NCT00728182|530616791|FG000|Overall Study|Protocol Noncompliance|0|||
147123424|NCT00728182|530616792|FG001|Overall Study|Protocol Noncompliance|1|||
147123425|NCT01725308|530616799|FG000|Treatment Period I|Did Not Receive Drug|1|||
147123426|NCT01725308|530616800|FG001|Treatment Period I|Did Not Receive Drug|0|||
147123427|NCT01725308|530616801|FG002|Treatment Period I|Did Not Receive Drug|0|||
147123428|NCT01725308|530616799|FG000|Treatment Period I|Adverse Event|5|||
147568454|NCT00838539|532240076|FG001|Overall Study|Withdrawal by Subject|1|||
147568455|NCT00838539|532240077|FG002|Overall Study|Withdrawal by Subject|0|||
147568456|NCT00838539|532240078|FG003|Overall Study|Withdrawal by Subject|0|||
147651006|NCT01214668|532544557|FG000|Overall Study|Progressive Disease|4|||
147444619|NCT01147744|531792660|FG003|Overall Study|Protocol Violation|0|||
147568457|NCT00838539|532240079|FG004|Overall Study|Withdrawal by Subject|0|||
147568458|NCT00838539|532240080|FG005|Overall Study|Withdrawal by Subject|0|||
147568459|NCT00838539|532240081|FG006|Overall Study|Withdrawal by Subject|0|||
147568460|NCT00838539|532240082|FG007|Overall Study|Withdrawal by Subject|0|||
147444620|NCT01147744|531792661|FG004|Overall Study|Protocol Violation|1|||
147568461|NCT00838539|532240083|FG008|Overall Study|Withdrawal by Subject|0|||
147568462|NCT00838539|532240084|FG009|Overall Study|Withdrawal by Subject|1|||
147568463|NCT00838539|532240085|FG010|Overall Study|Withdrawal by Subject|2|||
147568464|NCT00838539|532240086|FG011|Overall Study|Withdrawal by Subject|0|||
147568465|NCT00838539|532240075|FG000|Overall Study|Death|0|||
147568466|NCT00838539|532240076|FG001|Overall Study|Death|0|||
147568467|NCT00838539|532240077|FG002|Overall Study|Death|0|||
147568468|NCT00838539|532240078|FG003|Overall Study|Death|0|||
147568469|NCT00838539|532240079|FG004|Overall Study|Death|0|||
147568470|NCT00838539|532240080|FG005|Overall Study|Death|0|||
147568471|NCT00838539|532240081|FG006|Overall Study|Death|1|||
147568472|NCT00838539|532240082|FG007|Overall Study|Death|0|||
147568473|NCT00838539|532240083|FG008|Overall Study|Death|0|||
147568474|NCT00838539|532240084|FG009|Overall Study|Death|0|||
147568475|NCT00838539|532240085|FG010|Overall Study|Death|0|||
147568476|NCT00838539|532240086|FG011|Overall Study|Death|0|||
147568477|NCT00838539|532240075|FG000|Overall Study|Physician Decision|0|||
147568478|NCT00838539|532240076|FG001|Overall Study|Physician Decision|0|||
147568479|NCT00838539|532240077|FG002|Overall Study|Physician Decision|0|||
147568480|NCT00838539|532240078|FG003|Overall Study|Physician Decision|0|||
147568481|NCT00838539|532240079|FG004|Overall Study|Physician Decision|0|||
147568482|NCT00838539|532240080|FG005|Overall Study|Physician Decision|0|||
147568483|NCT00838539|532240081|FG006|Overall Study|Physician Decision|0|||
147568484|NCT00838539|532240082|FG007|Overall Study|Physician Decision|0|||
147568485|NCT00838539|532240083|FG008|Overall Study|Physician Decision|1|||
147568486|NCT00838539|532240084|FG009|Overall Study|Physician Decision|0|||
147568487|NCT00838539|532240085|FG010|Overall Study|Physician Decision|0|||
147568488|NCT00838539|532240086|FG011|Overall Study|Physician Decision|0|||
147568489|NCT00838539|532240075|FG000|Overall Study|Clinical Progression|0|||
147568490|NCT00838539|532240076|FG001|Overall Study|Clinical Progression|0|||
147568491|NCT00838539|532240077|FG002|Overall Study|Clinical Progression|0|||
147568492|NCT00838539|532240078|FG003|Overall Study|Clinical Progression|0|||
147568493|NCT00838539|532240079|FG004|Overall Study|Clinical Progression|0|||
147568494|NCT00838539|532240080|FG005|Overall Study|Clinical Progression|0|||
147568495|NCT00838539|532240081|FG006|Overall Study|Clinical Progression|1|||
147568496|NCT00838539|532240082|FG007|Overall Study|Clinical Progression|0|||
147568497|NCT00838539|532240083|FG008|Overall Study|Clinical Progression|0|||
147568498|NCT00838539|532240084|FG009|Overall Study|Clinical Progression|0|||
147568499|NCT00838539|532240085|FG010|Overall Study|Clinical Progression|0|||
147568500|NCT00838539|532240086|FG011|Overall Study|Clinical Progression|0|||
147568501|NCT00838539|532240075|FG000|Overall Study|Symptomatic Deterioration|0|||
147568502|NCT00838539|532240076|FG001|Overall Study|Symptomatic Deterioration|0|||
147568503|NCT00838539|532240077|FG002|Overall Study|Symptomatic Deterioration|1|||
147568504|NCT00838539|532240078|FG003|Overall Study|Symptomatic Deterioration|1|||
147568505|NCT00838539|532240079|FG004|Overall Study|Symptomatic Deterioration|0|||
147568506|NCT00838539|532240080|FG005|Overall Study|Symptomatic Deterioration|1|||
147568507|NCT00838539|532240081|FG006|Overall Study|Symptomatic Deterioration|0|||
147568508|NCT00838539|532240082|FG007|Overall Study|Symptomatic Deterioration|0|||
147568509|NCT00838539|532240083|FG008|Overall Study|Symptomatic Deterioration|0|||
147233118|NCT03001882|531024712|FG003|Overall Study|Not reported|6|||
147233119|NCT03001882|531024709|FG000|Overall Study|Maximum clinical benefit|2|||
147233120|NCT03001882|531024710|FG001|Overall Study|Maximum clinical benefit|3|||
147233121|NCT03001882|531024711|FG002|Overall Study|Maximum clinical benefit|0|||
147233122|NCT03001882|531024712|FG003|Overall Study|Maximum clinical benefit|10|||
147233123|NCT03001882|531024709|FG000|Overall Study|AE unrelated to study drug|3|||
147233124|NCT03001882|531024710|FG001|Overall Study|AE unrelated to study drug|3|||
147233125|NCT03001882|531024711|FG002|Overall Study|AE unrelated to study drug|0|||
147233126|NCT03001882|531024712|FG003|Overall Study|AE unrelated to study drug|11|||
147233127|NCT03001882|531024709|FG000|Overall Study|Study Drug Toxicity|8|||
147233128|NCT03001882|531024710|FG001|Overall Study|Study Drug Toxicity|5|||
147568510|NCT00838539|532240084|FG009|Overall Study|Symptomatic Deterioration|1|||
147568511|NCT00838539|532240085|FG010|Overall Study|Symptomatic Deterioration|0|||
147568512|NCT00838539|532240086|FG011|Overall Study|Symptomatic Deterioration|0|||
147568513|NCT01908205|532240087|FG000|Overall Study|Lost to Follow-up|2|||
147233129|NCT03001882|531024711|FG002|Overall Study|Study Drug Toxicity|0|||
147444621|NCT01147744|531792662|FG005|Overall Study|Protocol Violation|3|||
147568514|NCT01908205|532240088|FG001|Overall Study|Lost to Follow-up|0|||
147568515|NCT01908205|532240087|FG000|Overall Study|Withdrawal by Subject|3|||
147568516|NCT01908205|532240088|FG001|Overall Study|Withdrawal by Subject|1|||
147568517|NCT05323396|532240089|FG000|Overall Study|Lost to Follow-up|1|||
147568518|NCT05323396|532240090|FG001|Overall Study|Lost to Follow-up|35|||
147233130|NCT03001882|531024712|FG003|Overall Study|Study Drug Toxicity|37|||
147233131|NCT03001882|531024709|FG000|Overall Study|Disease progression|16|||
147568519|NCT05323396|532240089|FG000|Overall Study|Pregnancy|1|||
147568520|NCT05323396|532240090|FG001|Overall Study|Pregnancy|0|||
147568521|NCT03134222|532240091|FG000|Treatment Period (Up to Week 12)|Adverse Event|4|||
147568522|NCT03134222|532240092|FG001|Treatment Period (Up to Week 12)|Adverse Event|1|||
147568523|NCT03134222|532240093|FG002|Treatment Period (Up to Week 12)|Adverse Event|0|||
147568524|NCT03134222|532240094|FG003|Treatment Period (Up to Week 12)|Adverse Event|0|||
147568525|NCT03134222|532240095|FG004|Treatment Period (Up to Week 12)|Adverse Event|0|||
147568526|NCT03134222|532240091|FG000|Treatment Period (Up to Week 12)|Lost to Follow-up|1|||
147568527|NCT03134222|532240092|FG001|Treatment Period (Up to Week 12)|Lost to Follow-up|1|||
147568528|NCT03134222|532240093|FG002|Treatment Period (Up to Week 12)|Lost to Follow-up|1|||
147568529|NCT03134222|532240094|FG003|Treatment Period (Up to Week 12)|Lost to Follow-up|0|||
147123429|NCT01725308|530616800|FG001|Treatment Period I|Adverse Event|4|||
147123430|NCT01725308|530616801|FG002|Treatment Period I|Adverse Event|21|||
147568530|NCT03134222|532240095|FG004|Treatment Period (Up to Week 12)|Lost to Follow-up|0|||
147233132|NCT03001882|531024710|FG001|Overall Study|Disease progression|14|||
147233133|NCT03001882|531024711|FG002|Overall Study|Disease progression|1|||
147233134|NCT03001882|531024712|FG003|Overall Study|Disease progression|90|||
147233135|NCT00566111|531024713|FG000|Overall Study|Adverse Event|0|||
147233136|NCT00566111|531024714|FG001|Overall Study|Adverse Event|2|||
147233137|NCT04449861|531024715|FG000|Overall Study|Withdrawal by Subject|4|||
147233138|NCT04449861|531024715|FG000|Overall Study|Lost to Follow-up|5|||
147233139|NCT04449861|531024715|FG000|Overall Study|Death|112|||
147233140|NCT05268055|531024716|FG000|Overall Study|Lost to Follow-up|68|||
147233141|NCT05268055|531024717|FG001|Overall Study|Lost to Follow-up|68|||
147233142|NCT05268055|531024716|FG000|Overall Study|Withdrawal by Subject|12|||
147233143|NCT05268055|531024717|FG001|Overall Study|Withdrawal by Subject|8|||
147233144|NCT01555983|531024718|FG000|Overall Study|Withdrawal by Subject|1|||
147233145|NCT01555983|531024719|FG001|Overall Study|Withdrawal by Subject|0|||
147233146|NCT01555983|531024720|FG002|Overall Study|Withdrawal by Subject|0|||
147233147|NCT01555983|531024721|FG003|Overall Study|Withdrawal by Subject|0|||
147233148|NCT01555983|531024722|FG004|Overall Study|Withdrawal by Subject|1|||
147233149|NCT01555983|531024723|FG005|Overall Study|Withdrawal by Subject|1|||
147233150|NCT00573183|531026301|FG000|Overall Study|Lost to Follow-up|52|||
147233151|NCT00573183|531026302|FG001|Overall Study|Lost to Follow-up|50|||
147233152|NCT00573183|531026301|FG000|Overall Study|Withdrawal by Subject|8|||
147233153|NCT00573183|531026302|FG001|Overall Study|Withdrawal by Subject|2|||
147233154|NCT00573183|531026301|FG000|Overall Study|Death|0|||
147233155|NCT00573183|531026302|FG001|Overall Study|Death|1|||
147233156|NCT00573183|531026301|FG000|Overall Study|Adverse Event|2|||
147233157|NCT00573183|531026302|FG001|Overall Study|Adverse Event|0|||
147233158|NCT00573183|531026301|FG000|Overall Study|Incarceration|5|||
147233159|NCT00573183|531026302|FG001|Overall Study|Incarceration|8|||
147233160|NCT00573183|531026301|FG000|Overall Study|Other|5|||
147233161|NCT00573183|531026302|FG001|Overall Study|Other|2|||
147233162|NCT05439941|531026303|FG000|Overall Study|Lack of Efficacy|8|||
147233163|NCT05439941|531026304|FG001|Overall Study|Lack of Efficacy|5|||
147233164|NCT05439941|531026305|FG002|Overall Study|Lack of Efficacy|3|||
147444622|NCT01147744|531792663|FG006|Overall Study|Protocol Violation|1|||
147568531|NCT03134222|532240091|FG000|Treatment Period (Up to Week 12)|Withdrew Consent|0|||
147568532|NCT03134222|532240092|FG001|Treatment Period (Up to Week 12)|Withdrew Consent|1|||
147568533|NCT03134222|532240093|FG002|Treatment Period (Up to Week 12)|Withdrew Consent|0|||
147123431|NCT01725308|530616799|FG000|Treatment Period I|Insufficient Response|7|||
147123432|NCT01725308|530616800|FG001|Treatment Period I|Insufficient Response|0|||
147123433|NCT01725308|530616801|FG002|Treatment Period I|Insufficient Response|5|||
147123434|NCT01725308|530616799|FG000|Treatment Period I|Worsening of the Target Disease|8|||
147123435|NCT01725308|530616800|FG001|Treatment Period I|Worsening of the Target Disease|0|||
147123436|NCT01725308|530616801|FG002|Treatment Period I|Worsening of the Target Disease|2|||
147123437|NCT01725308|530616799|FG000|Treatment Period I|Changes in the Episodes|3|||
147123438|NCT01725308|530616800|FG001|Treatment Period I|Changes in the Episodes|0|||
147123439|NCT01725308|530616801|FG002|Treatment Period I|Changes in the Episodes|2|||
147123440|NCT01725308|530616799|FG000|Treatment Period I|Withdrawal of Consent|12|||
147123441|NCT01725308|530616800|FG001|Treatment Period I|Withdrawal of Consent|7|||
147123442|NCT01725308|530616801|FG002|Treatment Period I|Withdrawal of Consent|5|||
147123443|NCT01725308|530616799|FG000|Treatment Period I|Lost to Follow-up|3|||
147123444|NCT01725308|530616800|FG001|Treatment Period I|Lost to Follow-up|2|||
147123445|NCT01725308|530616801|FG002|Treatment Period I|Lost to Follow-up|2|||
147123446|NCT01725308|530616799|FG000|Treatment Period I|Protocol Deviations|3|||
147123447|NCT01725308|530616800|FG001|Treatment Period I|Protocol Deviations|1|||
147123448|NCT01725308|530616801|FG002|Treatment Period I|Protocol Deviations|1|||
147123449|NCT01725308|530616799|FG000|Treatment Period I|Miscellaneous|2|||
147123450|NCT01725308|530616800|FG001|Treatment Period I|Miscellaneous|0|||
147123451|NCT01725308|530616801|FG002|Treatment Period I|Miscellaneous|3|||
147123452|NCT01725308|530616799|FG000|Treatment Period II|Did Not Meet Transition Criteria|0|||
147123453|NCT01725308|530616800|FG001|Treatment Period II|Did Not Meet Transition Criteria|3|||
147123454|NCT01725308|530616801|FG002|Treatment Period II|Did Not Meet Transition Criteria|4|||
147568534|NCT03134222|532240094|FG003|Treatment Period (Up to Week 12)|Withdrew Consent|0|||
147568535|NCT03134222|532240095|FG004|Treatment Period (Up to Week 12)|Withdrew Consent|0|||
147568536|NCT03134222|532240091|FG000|Treatment Period (Up to Week 12)|Randomized but not treated|0|||
147568537|NCT03134222|532240092|FG001|Treatment Period (Up to Week 12)|Randomized but not treated|1|||
147568538|NCT03134222|532240093|FG002|Treatment Period (Up to Week 12)|Randomized but not treated|1|||
147568539|NCT03134222|532240094|FG003|Treatment Period (Up to Week 12)|Randomized but not treated|0|||
147568540|NCT03134222|532240095|FG004|Treatment Period (Up to Week 12)|Randomized but not treated|0|||
147568541|NCT03134222|532240091|FG000|Treatment Period (Week 12 to 48)|Withdrew Consent|0|||
147568542|NCT03134222|532240092|FG001|Treatment Period (Week 12 to 48)|Withdrew Consent|2|||
147568543|NCT03134222|532240093|FG002|Treatment Period (Week 12 to 48)|Withdrew Consent|0|||
147568544|NCT03134222|532240094|FG003|Treatment Period (Week 12 to 48)|Withdrew Consent|0|||
147568545|NCT03134222|532240095|FG004|Treatment Period (Week 12 to 48)|Withdrew Consent|1|||
147568546|NCT03134222|532240091|FG000|Treatment Period (Week 12 to 48)|Lack of Efficacy|2|||
147568547|NCT03134222|532240092|FG001|Treatment Period (Week 12 to 48)|Lack of Efficacy|0|||
147568548|NCT03134222|532240093|FG002|Treatment Period (Week 12 to 48)|Lack of Efficacy|0|||
147568549|NCT03134222|532240094|FG003|Treatment Period (Week 12 to 48)|Lack of Efficacy|0|||
147568550|NCT03134222|532240095|FG004|Treatment Period (Week 12 to 48)|Lack of Efficacy|0|||
147568551|NCT03134222|532240091|FG000|Treatment Period (Week 12 to 48)|Investigator's Discretion|0|||
147568552|NCT03134222|532240092|FG001|Treatment Period (Week 12 to 48)|Investigator's Discretion|0|||
147568553|NCT03134222|532240093|FG002|Treatment Period (Week 12 to 48)|Investigator's Discretion|0|||
147568554|NCT03134222|532240094|FG003|Treatment Period (Week 12 to 48)|Investigator's Discretion|1|||
147568555|NCT03134222|532240095|FG004|Treatment Period (Week 12 to 48)|Investigator's Discretion|0|||
147568556|NCT03134222|532240091|FG000|Treatment Period (Week 12 to 48)|Lost to Follow-up|0|||
147568557|NCT03134222|532240092|FG001|Treatment Period (Week 12 to 48)|Lost to Follow-up|1|||
147568558|NCT03134222|532240093|FG002|Treatment Period (Week 12 to 48)|Lost to Follow-up|0|||
147568559|NCT03134222|532240094|FG003|Treatment Period (Week 12 to 48)|Lost to Follow-up|0|||
147568560|NCT03134222|532240095|FG004|Treatment Period (Week 12 to 48)|Lost to Follow-up|0|||
147568561|NCT02089997|532240104|FG000|Overall Study|Case report forms uncollected|99|||
147568562|NCT02089997|532240104|FG000|Overall Study|Protocol Violation|147|||
147568563|NCT02242201|532240109|FG000|Overall Study|preoperative identified neuropathy|2|||
147568564|NCT02242201|532240110|FG001|Overall Study|preoperative identified neuropathy|0|||
147568565|NCT02242201|532240111|FG002|Overall Study|preoperative identified neuropathy|0|||
147568566|NCT02242201|532240109|FG000|Overall Study|planned post-op anticoagulation|1|||
147568567|NCT02242201|532240110|FG001|Overall Study|planned post-op anticoagulation|0|||
147568568|NCT02242201|532240111|FG002|Overall Study|planned post-op anticoagulation|0|||
147568569|NCT02242201|532240109|FG000|Overall Study|changed surgical procedure|1|||
147568570|NCT02242201|532240110|FG001|Overall Study|changed surgical procedure|0|||
147568571|NCT02242201|532240111|FG002|Overall Study|changed surgical procedure|0|||
147568572|NCT02242201|532240109|FG000|Overall Study|postponed surgery|0|||
147568573|NCT02242201|532240110|FG001|Overall Study|postponed surgery|0|||
147568574|NCT02242201|532240111|FG002|Overall Study|postponed surgery|1|||
147568575|NCT02242201|532240109|FG000|Overall Study|preoperative opioid consumption|0|||
147233165|NCT05439941|531026303|FG000|Overall Study|Treatment Failure|0|||
147233166|NCT05439941|531026304|FG001|Overall Study|Treatment Failure|1|||
147233167|NCT05439941|531026305|FG002|Overall Study|Treatment Failure|0|||
147233168|NCT05439941|531026303|FG000|Overall Study|Adverse Event|1|||
147233169|NCT05439941|531026304|FG001|Overall Study|Adverse Event|3|||
147233170|NCT05439941|531026305|FG002|Overall Study|Adverse Event|0|||
147233171|NCT05439941|531026303|FG000|Overall Study|Adverse Event - Parent Study|1|||
147233172|NCT05439941|531026304|FG001|Overall Study|Adverse Event - Parent Study|0|||
147233173|NCT05439941|531026305|FG002|Overall Study|Adverse Event - Parent Study|0|||
147233174|NCT05439941|531026303|FG000|Overall Study|Pregnancy|1|||
147233175|NCT05439941|531026304|FG001|Overall Study|Pregnancy|0|||
147233176|NCT05439941|531026305|FG002|Overall Study|Pregnancy|0|||
147233177|NCT05439941|531026303|FG000|Overall Study|Withdrawal by Subject|9|||
147233178|NCT05439941|531026304|FG001|Overall Study|Withdrawal by Subject|6|||
147233179|NCT05439941|531026305|FG002|Overall Study|Withdrawal by Subject|10|||
147233180|NCT05439941|531026303|FG000|Overall Study|Non-Compliance|1|||
147233181|NCT05439941|531026304|FG001|Overall Study|Non-Compliance|1|||
147233182|NCT05439941|531026305|FG002|Overall Study|Non-Compliance|1|||
147233183|NCT05439941|531026303|FG000|Overall Study|Lost to Follow-up|2|||
147233184|NCT05439941|531026304|FG001|Overall Study|Lost to Follow-up|2|||
147233185|NCT05439941|531026305|FG002|Overall Study|Lost to Follow-up|0|||
147233186|NCT05439941|531026303|FG000|Overall Study|Physician Decision|1|||
147233187|NCT05439941|531026304|FG001|Overall Study|Physician Decision|0|||
147233188|NCT05439941|531026305|FG002|Overall Study|Physician Decision|0|||
147233189|NCT05439941|531026303|FG000|Overall Study|Trial Termination by Sponsor|78|||
147233190|NCT05439941|531026304|FG001|Overall Study|Trial Termination by Sponsor|83|||
147568576|NCT02242201|532240110|FG001|Overall Study|preoperative opioid consumption|1|||
147568577|NCT02242201|532240111|FG002|Overall Study|preoperative opioid consumption|0|||
147233191|NCT05439941|531026305|FG002|Overall Study|Trial Termination by Sponsor|65|||
147233192|NCT05439941|531026303|FG000|Overall Study|Other than Reasons Listed|2|||
147568578|NCT02335658|532240112|FG000|Overall Study|Adverse Event|18|||
147568579|NCT02335658|532240113|FG001|Overall Study|Adverse Event|12|||
147568580|NCT02335658|532240112|FG000|Overall Study|Lack of Efficacy|4|||
147123455|NCT01725308|530616799|FG000|Treatment Period II|Did Not Receive Drug|4|||
147123456|NCT01725308|530616800|FG001|Treatment Period II|Did Not Receive Drug|0|||
147314108|NCT03881059|531317399|FG001|Treatment Period - Part B|Other reasons|3|||
147314109|NCT03881059|531317400|FG002|Treatment Period - Part B|Other reasons|3|||
147314110|NCT05284019|531317401|FG000|Overall Study|Study terminated|2|||
147314111|NCT05284019|531317402|FG001|Overall Study|Study terminated|2|||
147314112|NCT05284019|531317403|FG002|Overall Study|Study terminated|2|||
147314113|NCT05284019|531317404|FG003|Overall Study|Study terminated|5|||
147314114|NCT05284019|531317405|FG004|Overall Study|Study terminated|15|||
147314115|NCT05284019|531317401|FG000|Overall Study|Withdrawal by Subject|0|||
147314116|NCT05284019|531317402|FG001|Overall Study|Withdrawal by Subject|0|||
147314117|NCT05284019|531317403|FG002|Overall Study|Withdrawal by Subject|0|||
147314118|NCT05284019|531317404|FG003|Overall Study|Withdrawal by Subject|1|||
147314119|NCT05284019|531317405|FG004|Overall Study|Withdrawal by Subject|1|||
147314120|NCT05284019|531317401|FG000|Overall Study|Lost to Follow-up|1|||
147314121|NCT05284019|531317402|FG001|Overall Study|Lost to Follow-up|0|||
147314122|NCT05284019|531317403|FG002|Overall Study|Lost to Follow-up|0|||
147314123|NCT05284019|531317404|FG003|Overall Study|Lost to Follow-up|2|||
147314124|NCT05284019|531317405|FG004|Overall Study|Lost to Follow-up|1|||
147314125|NCT02743793|531317406|FG000|Overall Study|Death|1|||
147314126|NCT02743793|531317407|FG001|Overall Study|Death|1|||
147314127|NCT02743793|531317406|FG000|Overall Study|Withdrawal by Subject|0|||
147314128|NCT02743793|531317407|FG001|Overall Study|Withdrawal by Subject|1|||
147314129|NCT02743793|531317406|FG000|Overall Study|Screen Failure|4|||
147314130|NCT02743793|531317407|FG001|Overall Study|Screen Failure|0|||
147314131|NCT02743793|531317406|FG000|Overall Study|No Primary Care Physician|0|||
147314132|NCT02743793|531317407|FG001|Overall Study|No Primary Care Physician|1|||
147314133|NCT02743793|531317406|FG000|Overall Study|Travel/remote visits could not be performed at nursing facility|0|||
147314134|NCT02743793|531317407|FG001|Overall Study|Travel/remote visits could not be performed at nursing facility|1|||
147314135|NCT02743793|531317406|FG000|Overall Study|Study stopped due to COVID-19 pandemic|0|||
147314136|NCT02743793|531317407|FG001|Overall Study|Study stopped due to COVID-19 pandemic|32|||
147314137|NCT02065570|531317408|FG000|Induction Study|Adverse Event|5|||
147314138|NCT02065570|531317409|FG001|Induction Study|Adverse Event|12|||
147314139|NCT02065570|531317410|FG002|Induction Study|Adverse Event|0|||
147314140|NCT02065570|531317411|FG003|Induction Study|Adverse Event|0|||
147314141|NCT02065570|531317408|FG000|Induction Study|Withdrawal by Subject|2|||
147314142|NCT02065570|531317409|FG001|Induction Study|Withdrawal by Subject|3|||
147314143|NCT02065570|531317410|FG002|Induction Study|Withdrawal by Subject|0|||
147314144|NCT02065570|531317411|FG003|Induction Study|Withdrawal by Subject|0|||
147314145|NCT02065570|531317408|FG000|Induction Study|Lost to Follow-up|1|||
147314146|NCT02065570|531317409|FG001|Induction Study|Lost to Follow-up|1|||
147314147|NCT02065570|531317410|FG002|Induction Study|Lost to Follow-up|0|||
147314148|NCT02065570|531317411|FG003|Induction Study|Lost to Follow-up|0|||
147314149|NCT02065570|531317408|FG000|Induction Study|Other, Not Specified|6|||
147314150|NCT02065570|531317409|FG001|Induction Study|Other, Not Specified|5|||
147314151|NCT02065570|531317410|FG002|Induction Study|Other, Not Specified|0|||
147314152|NCT02065570|531317411|FG003|Induction Study|Other, Not Specified|0|||
147314153|NCT02065570|531317408|FG000|Maintenance Study|Adverse Event|0|||
147314154|NCT02065570|531317409|FG001|Maintenance Study|Adverse Event|0|||
147314155|NCT02065570|531317410|FG002|Maintenance Study|Adverse Event|8|||
147314156|NCT02065570|531317411|FG003|Maintenance Study|Adverse Event|8|||
147314157|NCT02065570|531317408|FG000|Maintenance Study|Withdrawal by Subject|0|||
147314158|NCT02065570|531317409|FG001|Maintenance Study|Withdrawal by Subject|0|||
147123457|NCT01725308|530616801|FG002|Treatment Period II|Did Not Receive Drug|0|||
147314159|NCT02065570|531317410|FG002|Maintenance Study|Withdrawal by Subject|1|||
147314160|NCT02065570|531317411|FG003|Maintenance Study|Withdrawal by Subject|4|||
147314161|NCT02065570|531317408|FG000|Maintenance Study|Lost to Follow-up|0|||
147314162|NCT02065570|531317409|FG001|Maintenance Study|Lost to Follow-up|0|||
147314163|NCT02065570|531317410|FG002|Maintenance Study|Lost to Follow-up|2|||
147314164|NCT02065570|531317411|FG003|Maintenance Study|Lost to Follow-up|2|||
147314165|NCT02065570|531317408|FG000|Maintenance Study|Other, Not Specified|0|||
147314166|NCT02065570|531317409|FG001|Maintenance Study|Other, Not Specified|0|||
147314167|NCT02065570|531317410|FG002|Maintenance Study|Other, Not Specified|11|||
147314168|NCT02065570|531317411|FG003|Maintenance Study|Other, Not Specified|5|||
147314169|NCT01231503|531317412|FG000|Overall Study|Adverse Event|0|||
147314170|NCT01231503|531317413|FG001|Overall Study|Adverse Event|0|||
147568581|NCT02335658|532240113|FG001|Overall Study|Lack of Efficacy|5|||
147568582|NCT02335658|532240112|FG000|Overall Study|Pregnancy|1|||
147568583|NCT02335658|532240113|FG001|Overall Study|Pregnancy|0|||
147314171|NCT01231503|531317414|FG002|Overall Study|Adverse Event|0|||
147123458|NCT01725308|530616799|FG000|Treatment Period II|Adverse Event|13|||
147314172|NCT01231503|531317415|FG003|Overall Study|Adverse Event|0|||
147314173|NCT01231503|531317416|FG004|Overall Study|Adverse Event|0|||
147314174|NCT01231503|531317417|FG005|Overall Study|Adverse Event|1|||
147568584|NCT02335658|532240112|FG000|Overall Study|Withdrawal by Subject|13|||
147568585|NCT02335658|532240113|FG001|Overall Study|Withdrawal by Subject|21|||
147568586|NCT02335658|532240112|FG000|Overall Study|non-compliance|2|||
147568587|NCT02335658|532240113|FG001|Overall Study|non-compliance|3|||
147568588|NCT02335658|532240112|FG000|Overall Study|other reason|2|||
147568589|NCT02335658|532240113|FG001|Overall Study|other reason|3|||
147568590|NCT05593965|532240114|FG000|1st Intervention (1 Day)|Technical error|1|||
147568591|NCT05593965|532240115|FG001|1st Intervention (1 Day)|Technical error|0|||
147568592|NCT03238781|532240118|FG000|Overall Study|Adverse Event|1|||
147568593|NCT03238781|532240119|FG001|Overall Study|Adverse Event|1|||
147568594|NCT03238781|532240120|FG002|Overall Study|Adverse Event|2|||
147568595|NCT03238781|532240118|FG000|Overall Study|Lost to Follow-up|2|||
147568596|NCT03238781|532240119|FG001|Overall Study|Lost to Follow-up|1|||
147568597|NCT03238781|532240120|FG002|Overall Study|Lost to Follow-up|2|||
147568598|NCT03238781|532240118|FG000|Overall Study|Withdrawal by Subject|23|||
147568599|NCT03238781|532240119|FG001|Overall Study|Withdrawal by Subject|14|||
147568600|NCT03238781|532240120|FG002|Overall Study|Withdrawal by Subject|16|||
147123459|NCT01725308|530616800|FG001|Treatment Period II|Adverse Event|8|||
147123460|NCT01725308|530616801|FG002|Treatment Period II|Adverse Event|20|||
147123461|NCT01725308|530616799|FG000|Treatment Period II|Insufficient Response|2|||
147123462|NCT01725308|530616800|FG001|Treatment Period II|Insufficient Response|4|||
147123463|NCT01725308|530616801|FG002|Treatment Period II|Insufficient Response|6|||
147123464|NCT01725308|530616799|FG000|Treatment Period II|Worsening of the Target Disease|1|||
147123465|NCT01725308|530616800|FG001|Treatment Period II|Worsening of the Target Disease|4|||
147123466|NCT01725308|530616801|FG002|Treatment Period II|Worsening of the Target Disease|2|||
147123467|NCT01725308|530616799|FG000|Treatment Period II|Changes in the Episodes|1|||
147123468|NCT01725308|530616800|FG001|Treatment Period II|Changes in the Episodes|0|||
147123469|NCT01725308|530616801|FG002|Treatment Period II|Changes in the Episodes|5|||
147123470|NCT01725308|530616799|FG000|Treatment Period II|Withdrawal of Consent|28|||
147123471|NCT01725308|530616800|FG001|Treatment Period II|Withdrawal of Consent|2|||
147123472|NCT01725308|530616801|FG002|Treatment Period II|Withdrawal of Consent|16|||
147123473|NCT01725308|530616799|FG000|Treatment Period II|Lost to Follow-up|1|||
147123474|NCT01725308|530616800|FG001|Treatment Period II|Lost to Follow-up|5|||
147123475|NCT01725308|530616801|FG002|Treatment Period II|Lost to Follow-up|3|||
147123476|NCT01725308|530616799|FG000|Treatment Period II|Protocol Deviations|0|||
147123477|NCT01725308|530616800|FG001|Treatment Period II|Protocol Deviations|0|||
147123478|NCT01725308|530616801|FG002|Treatment Period II|Protocol Deviations|1|||
147123479|NCT01725308|530616799|FG000|Treatment Period II|Miscellaneous|5|||
147123480|NCT01725308|530616800|FG001|Treatment Period II|Miscellaneous|3|||
147123481|NCT01725308|530616801|FG002|Treatment Period II|Miscellaneous|7|||
147123482|NCT02971137|530616804|FG000|Overall Study|Lost to Follow-up|44|||
147123483|NCT02971137|530616805|FG001|Overall Study|Lost to Follow-up|56|||
147123484|NCT02614066|530616809|FG000|Overall Study|Death|6|||
147123485|NCT02614066|530616810|FG001|Overall Study|Death|14|||
147123486|NCT02614066|530616811|FG002|Overall Study|Death|11|||
147123487|NCT02614066|530616812|FG003|Overall Study|Death|29|||
147123488|NCT02614066|530616809|FG000|Overall Study|Full consent withdrawn|0|||
147123489|NCT02614066|530616810|FG001|Overall Study|Full consent withdrawn|1|||
147123490|NCT02614066|530616811|FG002|Overall Study|Full consent withdrawn|0|||
147123491|NCT02614066|530616812|FG003|Overall Study|Full consent withdrawn|8|||
147123492|NCT02614066|530616809|FG000|Overall Study|Lost to Follow-up|0|||
147123493|NCT02614066|530616810|FG001|Overall Study|Lost to Follow-up|2|||
147123494|NCT02614066|530616811|FG002|Overall Study|Lost to Follow-up|2|||
147123495|NCT02614066|530616812|FG003|Overall Study|Lost to Follow-up|2|||
147123496|NCT02614066|530616809|FG000|Overall Study|Enrolled but did not Initiate KTE-X19|0|||
147123497|NCT02614066|530616810|FG001|Overall Study|Enrolled but did not Initiate KTE-X19|5|||
147123498|NCT02614066|530616811|FG002|Overall Study|Enrolled but did not Initiate KTE-X19|4|||
147123499|NCT02614066|530616812|FG003|Overall Study|Enrolled but did not Initiate KTE-X19|16|||
147123500|NCT02614066|530616809|FG000|Overall Study|Rolled over or consented to a long term follow-up (LFTU) study|0|||
147123501|NCT02614066|530616810|FG001|Overall Study|Rolled over or consented to a long term follow-up (LFTU) study|4|||
147123502|NCT02614066|530616811|FG002|Overall Study|Rolled over or consented to a long term follow-up (LFTU) study|2|||
147123503|NCT02614066|530616812|FG003|Overall Study|Rolled over or consented to a long term follow-up (LFTU) study|15|||
147123504|NCT02614066|530616809|FG000|Overall Study|Reason not specified|0|||
147123505|NCT02614066|530616810|FG001|Overall Study|Reason not specified|2|||
147314175|NCT01231503|531317418|FG006|Overall Study|Adverse Event|0|||
147314176|NCT01231503|531317419|FG007|Overall Study|Adverse Event|0|||
147568601|NCT03238781|532240118|FG000|Overall Study|Decision by sponsor|0|||
147568602|NCT03238781|532240119|FG001|Overall Study|Decision by sponsor|1|||
147568603|NCT03238781|532240120|FG002|Overall Study|Decision by sponsor|0|||
147123506|NCT02614066|530616811|FG002|Overall Study|Reason not specified|1|||
147123507|NCT02614066|530616812|FG003|Overall Study|Reason not specified|1|||
147568604|NCT01597245|532240121|FG000|Induction Period (Week 0 - Week 12)|Adverse Event|1|||
147568605|NCT01597245|532240122|FG001|Induction Period (Week 0 - Week 12)|Adverse Event|5|||
147123508|NCT01539525|530616825|FG000|Overall Study|Lost to Follow-up|19|||
147568606|NCT01597245|532240123|FG002|Induction Period (Week 0 - Week 12)|Adverse Event|5|||
147568607|NCT01597245|532240124|FG003|Induction Period (Week 0 - Week 12)|Adverse Event|4|||
147568608|NCT01597245|532240125|FG004|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
147568609|NCT01597245|532240126|FG005|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
147568610|NCT01597245|532240127|FG006|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
147568611|NCT01597245|532240128|FG007|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
147568612|NCT01597245|532240129|FG008|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
147568613|NCT01597245|532240130|FG009|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
147568614|NCT01597245|532240131|FG010|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
147568615|NCT01597245|532240132|FG011|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
147568616|NCT01597245|532240133|FG012|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
147568617|NCT01597245|532240134|FG013|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
147568618|NCT01597245|532240135|FG014|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
147568619|NCT01597245|532240136|FG015|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
147568620|NCT01597245|532240137|FG016|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
147568621|NCT01597245|532240138|FG017|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
147568622|NCT01597245|532240139|FG018|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
147568623|NCT01597245|532240140|FG019|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
147568624|NCT01597245|532240141|FG020|Induction Period (Week 0 - Week 12)|Adverse Event|0|||
147568625|NCT01597245|532240121|FG000|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|2|||
147123509|NCT01539525|530616826|FG001|Overall Study|Lost to Follow-up|12|||
147314177|NCT01231503|531317412|FG000|Overall Study|Adverse event, serious fatal|0|||
147314178|NCT01231503|531317413|FG001|Overall Study|Adverse event, serious fatal|0|||
147314179|NCT01231503|531317414|FG002|Overall Study|Adverse event, serious fatal|1|||
147314180|NCT01231503|531317415|FG003|Overall Study|Adverse event, serious fatal|1|||
147314181|NCT01231503|531317416|FG004|Overall Study|Adverse event, serious fatal|0|||
147314182|NCT01231503|531317417|FG005|Overall Study|Adverse event, serious fatal|1|||
147314183|NCT01231503|531317418|FG006|Overall Study|Adverse event, serious fatal|0|||
147314184|NCT01231503|531317419|FG007|Overall Study|Adverse event, serious fatal|0|||
147314185|NCT01231503|531317412|FG000|Overall Study|Withdrawal by Subject|6|||
147314186|NCT01231503|531317413|FG001|Overall Study|Withdrawal by Subject|3|||
147314187|NCT01231503|531317414|FG002|Overall Study|Withdrawal by Subject|3|||
147314188|NCT01231503|531317415|FG003|Overall Study|Withdrawal by Subject|1|||
147314189|NCT01231503|531317416|FG004|Overall Study|Withdrawal by Subject|3|||
147314190|NCT01231503|531317417|FG005|Overall Study|Withdrawal by Subject|5|||
147314191|NCT01231503|531317418|FG006|Overall Study|Withdrawal by Subject|1|||
147314192|NCT01231503|531317419|FG007|Overall Study|Withdrawal by Subject|2|||
147314193|NCT01231503|531317412|FG000|Overall Study|Lost to Follow-up|8|||
147314194|NCT01231503|531317413|FG001|Overall Study|Lost to Follow-up|10|||
147314195|NCT01231503|531317414|FG002|Overall Study|Lost to Follow-up|8|||
147314196|NCT01231503|531317415|FG003|Overall Study|Lost to Follow-up|5|||
147314197|NCT01231503|531317416|FG004|Overall Study|Lost to Follow-up|7|||
147314198|NCT01231503|531317417|FG005|Overall Study|Lost to Follow-up|9|||
147314199|NCT01231503|531317418|FG006|Overall Study|Lost to Follow-up|6|||
147314200|NCT01231503|531317419|FG007|Overall Study|Lost to Follow-up|6|||
147314201|NCT01231503|531317412|FG000|Overall Study|Protocol Violation|0|||
147314202|NCT01231503|531317413|FG001|Overall Study|Protocol Violation|0|||
147314203|NCT01231503|531317414|FG002|Overall Study|Protocol Violation|0|||
147314204|NCT01231503|531317415|FG003|Overall Study|Protocol Violation|1|||
147314205|NCT01231503|531317416|FG004|Overall Study|Protocol Violation|0|||
147314206|NCT01231503|531317417|FG005|Overall Study|Protocol Violation|0|||
147314207|NCT01231503|531317418|FG006|Overall Study|Protocol Violation|0|||
147314208|NCT01231503|531317419|FG007|Overall Study|Protocol Violation|0|||
147314209|NCT01146574|531317424|FG000|Overall Study|Death|0|||
147314210|NCT01146574|531317425|FG001|Overall Study|Death|1|||
147314211|NCT01146574|531317426|FG002|Overall Study|Death|1|||
147314212|NCT01146574|531317427|FG003|Overall Study|Death|0|||
147314213|NCT01146574|531317428|FG004|Overall Study|Death|0|||
147314214|NCT01146574|531317429|FG005|Overall Study|Death|0|||
147568626|NCT01597245|532240122|FG001|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|8|||
147568627|NCT01597245|532240123|FG002|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|6|||
147568628|NCT01597245|532240124|FG003|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|2|||
147123510|NCT01539525|530616827|FG002|Overall Study|Lost to Follow-up|11|||
147123511|NCT01539525|530616825|FG000|Overall Study|Withdrawal by Subject|0|||
147314215|NCT01146574|531317430|FG006|Overall Study|Death|0|||
147314216|NCT01146574|531317424|FG000|Overall Study|Other reasons|0|||
147314217|NCT01146574|531317425|FG001|Overall Study|Other reasons|0|||
147314218|NCT01146574|531317426|FG002|Overall Study|Other reasons|3|||
147314219|NCT01146574|531317427|FG003|Overall Study|Other reasons|0|||
147314220|NCT01146574|531317428|FG004|Overall Study|Other reasons|0|||
147314221|NCT01146574|531317429|FG005|Overall Study|Other reasons|0|||
147314222|NCT01146574|531317430|FG006|Overall Study|Other reasons|0|||
147651007|NCT01214668|532544558|FG001|Overall Study|Progressive Disease|2|||
147123512|NCT01539525|530616826|FG001|Overall Study|Withdrawal by Subject|3|||
147314223|NCT01146574|531317424|FG000|Overall Study|Kidney transplant|0|||
147314224|NCT01146574|531317425|FG001|Overall Study|Kidney transplant|0|||
147314225|NCT01146574|531317426|FG002|Overall Study|Kidney transplant|1|||
147568629|NCT01597245|532240125|FG004|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
147568630|NCT01597245|532240126|FG005|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
147568631|NCT01597245|532240127|FG006|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
147568632|NCT01597245|532240128|FG007|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
147568633|NCT01597245|532240129|FG008|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
147568634|NCT01597245|532240130|FG009|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
147568635|NCT01597245|532240131|FG010|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
147123513|NCT01539525|530616827|FG002|Overall Study|Withdrawal by Subject|2|||
147123514|NCT01539525|530616825|FG000|Overall Study|Protocol Violation|1|||
147123515|NCT01539525|530616826|FG001|Overall Study|Protocol Violation|1|||
147123516|NCT01539525|530616827|FG002|Overall Study|Protocol Violation|4|||
147123517|NCT02205359|530616829|FG000|Overall Study|Death|293|||
147123518|NCT02205359|530616830|FG001|Overall Study|Death|327|||
147123519|NCT02205359|530616829|FG000|Overall Study|Lost to Follow-up|182|||
147123520|NCT02205359|530616830|FG001|Overall Study|Lost to Follow-up|162|||
147568636|NCT01597245|532240132|FG011|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
147568637|NCT01597245|532240133|FG012|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
147568638|NCT01597245|532240134|FG013|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
147568639|NCT01597245|532240135|FG014|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
147568640|NCT01597245|532240136|FG015|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
147568641|NCT01597245|532240137|FG016|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
147568642|NCT01597245|532240138|FG017|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
147568643|NCT01597245|532240139|FG018|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
147568644|NCT01597245|532240140|FG019|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
147568645|NCT01597245|532240141|FG020|Induction Period (Week 0 - Week 12)|Withdrawal by Subject|0|||
147568646|NCT01597245|532240121|FG000|Induction Period (Week 0 - Week 12)|Protocol Violation|2|||
147568647|NCT01597245|532240122|FG001|Induction Period (Week 0 - Week 12)|Protocol Violation|4|||
147568648|NCT01597245|532240123|FG002|Induction Period (Week 0 - Week 12)|Protocol Violation|5|||
147568649|NCT01597245|532240124|FG003|Induction Period (Week 0 - Week 12)|Protocol Violation|2|||
147568650|NCT01597245|532240125|FG004|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
147568651|NCT01597245|532240126|FG005|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
147123521|NCT02205359|530616829|FG000|Overall Study|Physician Decision|51|||
147123522|NCT02205359|530616830|FG001|Overall Study|Physician Decision|53|||
147123523|NCT02205359|530616829|FG000|Overall Study|Withdrawal by Subject|167|||
147123524|NCT02205359|530616830|FG001|Overall Study|Withdrawal by Subject|169|||
147123525|NCT02496156|530616833|FG000|Overall Study|Lost to Follow-up|5|||
147123526|NCT02496156|530616834|FG001|Overall Study|Lost to Follow-up|0|||
147123527|NCT02496156|530616833|FG000|Overall Study|13SDM dyads did not access Decision Aids|0|||
147123528|NCT02496156|530616834|FG001|Overall Study|13SDM dyads did not access Decision Aids|13|||
147123529|NCT01412983|530616835|FG000|1st Period|Ineligible|0|||
147123530|NCT01412983|530616836|FG001|1st Period|Ineligible|1|||
147123531|NCT01412983|530616835|FG000|1st Period|Positive slit lamp finding|0|||
147123532|NCT01412983|530616836|FG001|1st Period|Positive slit lamp finding|1|||
147123533|NCT01412983|530616835|FG000|1st Period|Unacceptable lens movement|0|||
147123534|NCT01412983|530616836|FG001|1st Period|Unacceptable lens movement|1|||
147123535|NCT01412983|530616835|FG000|1st Period|Inability to maintain wear|0|||
147123536|NCT01412983|530616836|FG001|1st Period|Inability to maintain wear|1|||
147123537|NCT00890097|530616837|FG000|Overall Study|Adverse Event|21|||
147123538|NCT00890097|530616838|FG001|Overall Study|Adverse Event|32|||
147123539|NCT00890097|530616839|FG002|Overall Study|Adverse Event|28|||
147123540|NCT00890097|530616837|FG000|Overall Study|Decision Unrelated to an Adverse Event|15|||
147233193|NCT05439941|531026304|FG001|Overall Study|Other than Reasons Listed|1|||
147233194|NCT05439941|531026305|FG002|Overall Study|Other than Reasons Listed|0|||
147233195|NCT01926015|531026307|FG000|Overall Study|Withdrawal by parent/guardian|0|||
147568652|NCT01597245|532240127|FG006|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
147568653|NCT01597245|532240128|FG007|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
147233196|NCT01926015|531026308|FG001|Overall Study|Withdrawal by parent/guardian|1|||
147233197|NCT01926015|531026307|FG000|Overall Study|Randomized not treated|2|||
147233198|NCT01926015|531026308|FG001|Overall Study|Randomized not treated|0|||
147233199|NCT01914757|531026309|FG000|Overall Study|Severe non-compliance to protocol|3|||
147233200|NCT01914757|531026310|FG001|Overall Study|Severe non-compliance to protocol|1|||
147568654|NCT01597245|532240129|FG008|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
147233201|NCT01914757|531026311|FG002|Overall Study|Severe non-compliance to protocol|2|||
147233202|NCT01914757|531026309|FG000|Overall Study|Lost to Follow-up|5|||
147233203|NCT01914757|531026310|FG001|Overall Study|Lost to Follow-up|8|||
147233204|NCT01914757|531026311|FG002|Overall Study|Lost to Follow-up|6|||
147123541|NCT00890097|530616838|FG001|Overall Study|Decision Unrelated to an Adverse Event|12|||
147123542|NCT00890097|530616839|FG002|Overall Study|Decision Unrelated to an Adverse Event|17|||
147233205|NCT01914757|531026309|FG000|Overall Study|Withdrawal by Subject|15|||
147123543|NCT00890097|530616837|FG000|Overall Study|Withdrew Consent|9|||
147123544|NCT00890097|530616838|FG001|Overall Study|Withdrew Consent|6|||
147123545|NCT00890097|530616839|FG002|Overall Study|Withdrew Consent|9|||
147123546|NCT00890097|530616837|FG000|Overall Study|Lost to Follow-up|5|||
147123547|NCT00890097|530616838|FG001|Overall Study|Lost to Follow-up|5|||
147123548|NCT00890097|530616839|FG002|Overall Study|Lost to Follow-up|5|||
147568655|NCT01597245|532240130|FG009|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
147568656|NCT01597245|532240131|FG010|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
147568657|NCT01597245|532240132|FG011|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
147568658|NCT01597245|532240133|FG012|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
147568659|NCT01597245|532240134|FG013|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
147568660|NCT01597245|532240135|FG014|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
147568661|NCT01597245|532240136|FG015|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
147568662|NCT01597245|532240137|FG016|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
147568663|NCT01597245|532240138|FG017|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
147568664|NCT01597245|532240139|FG018|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
147123549|NCT00890097|530616837|FG000|Overall Study|Noncompliance|0|||
147444623|NCT01147744|531792657|FG000|Overall Study|Physician Decision|0|||
147568665|NCT01597245|532240140|FG019|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
147123550|NCT00890097|530616838|FG001|Overall Study|Noncompliance|4|||
147123551|NCT00890097|530616839|FG002|Overall Study|Noncompliance|4|||
147123552|NCT00890097|530616837|FG000|Overall Study|Sponsor Decision|7|||
147123553|NCT00890097|530616838|FG001|Overall Study|Sponsor Decision|11|||
147123554|NCT00890097|530616839|FG002|Overall Study|Sponsor Decision|7|||
147123555|NCT00890097|530616837|FG000|Overall Study|Did not attend final visit|2|||
147123556|NCT00890097|530616838|FG001|Overall Study|Did not attend final visit|3|||
147568666|NCT01597245|532240141|FG020|Induction Period (Week 0 - Week 12)|Protocol Violation|0|||
147568667|NCT01597245|532240121|FG000|Induction Period (Week 0 - Week 12)|Lost to Follow-up|1|||
147568668|NCT01597245|532240122|FG001|Induction Period (Week 0 - Week 12)|Lost to Follow-up|5|||
147568669|NCT01597245|532240123|FG002|Induction Period (Week 0 - Week 12)|Lost to Follow-up|2|||
147568670|NCT01597245|532240124|FG003|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
147568671|NCT01597245|532240125|FG004|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
147651008|NCT01214668|532544559|FG002|Overall Study|Progressive Disease|5|||
147651009|NCT01214668|532544560|FG003|Overall Study|Progressive Disease|4|||
147651010|NCT01214668|532544561|FG004|Overall Study|Progressive Disease|4|||
147651011|NCT01214668|532544562|FG005|Overall Study|Progressive Disease|5|||
147651012|NCT01214668|532544557|FG000|Overall Study|Withdrawal by Subject|0|||
147651013|NCT01214668|532544558|FG001|Overall Study|Withdrawal by Subject|0|||
147651014|NCT01214668|532544559|FG002|Overall Study|Withdrawal by Subject|0|||
147651015|NCT01214668|532544560|FG003|Overall Study|Withdrawal by Subject|0|||
147651016|NCT01214668|532544561|FG004|Overall Study|Withdrawal by Subject|1|||
147651017|NCT01214668|532544562|FG005|Overall Study|Withdrawal by Subject|0|||
147651018|NCT02769312|532544563|FG000|Double-Blind (0-2 Weeks)|Withdrawal by Subject|1|||
147651019|NCT02769312|532544564|FG001|Double-Blind (0-2 Weeks)|Withdrawal by Subject|1|||
147651020|NCT02769312|532544563|FG000|Double-Blind (0-2 Weeks)|Adverse Event|1|||
147651021|NCT02769312|532544564|FG001|Double-Blind (0-2 Weeks)|Adverse Event|0|||
147651022|NCT02769312|532544563|FG000|Unblinded (Optional 2-4 Weeks)|Withdrawal by Subject|1|||
147123557|NCT00890097|530616839|FG002|Overall Study|Did not attend final visit|0|||
147123558|NCT00890097|530616837|FG000|Overall Study|Subject Decision|3|||
147233206|NCT01914757|531026310|FG001|Overall Study|Withdrawal by Subject|27|||
147233207|NCT01914757|531026311|FG002|Overall Study|Withdrawal by Subject|19|||
147233208|NCT01914757|531026309|FG000|Overall Study|Death|2|||
147233209|NCT01914757|531026310|FG001|Overall Study|Death|2|||
147233210|NCT01914757|531026311|FG002|Overall Study|Death|1|||
147233211|NCT01914757|531026309|FG000|Overall Study|Adverse Event|4|||
147233212|NCT01914757|531026310|FG001|Overall Study|Adverse Event|3|||
147233213|NCT01914757|531026311|FG002|Overall Study|Adverse Event|4|||
147233214|NCT01914757|531026309|FG000|Overall Study|Study specific withdrawal criteria|0|||
147233215|NCT01914757|531026310|FG001|Overall Study|Study specific withdrawal criteria|1|||
147233216|NCT01914757|531026311|FG002|Overall Study|Study specific withdrawal criteria|0|||
147568672|NCT01597245|532240126|FG005|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
147568673|NCT01597245|532240127|FG006|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
147568674|NCT01597245|532240128|FG007|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
147651023|NCT02769312|532544564|FG001|Unblinded (Optional 2-4 Weeks)|Withdrawal by Subject|0|||
147123559|NCT00890097|530616838|FG001|Overall Study|Subject Decision|2|||
147123560|NCT00890097|530616839|FG002|Overall Study|Subject Decision|6|||
147233217|NCT01914757|531026309|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
147233218|NCT01914757|531026310|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
147233219|NCT01914757|531026311|FG002|Overall Study|Eligibility criteria not fulfilled|2|||
147568675|NCT01597245|532240129|FG008|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
147651024|NCT02769312|532544563|FG000|Unblinded (Optional 2-4 Weeks)|Lost to Follow-up|0|||
147123561|NCT00890097|530616837|FG000|Overall Study|Randomization Error|2|||
147123562|NCT00890097|530616838|FG001|Overall Study|Randomization Error|0|||
147123563|NCT00890097|530616839|FG002|Overall Study|Randomization Error|0|||
147123564|NCT00890097|530616837|FG000|Overall Study|Failed inclusion criteria|3|||
147233220|NCT01914757|531026309|FG000|Overall Study|Other reasons|5|||
147123565|NCT00890097|530616838|FG001|Overall Study|Failed inclusion criteria|4|||
147123566|NCT00890097|530616839|FG002|Overall Study|Failed inclusion criteria|0|||
147123567|NCT00890097|530616837|FG000|Overall Study|Transportation|0|||
147123568|NCT00890097|530616838|FG001|Overall Study|Transportation|2|||
147123569|NCT00890097|530616839|FG002|Overall Study|Transportation|0|||
147123570|NCT00890097|530616837|FG000|Overall Study|Subject Moved|0|||
147123571|NCT00890097|530616838|FG001|Overall Study|Subject Moved|4|||
147123572|NCT00890097|530616839|FG002|Overall Study|Subject Moved|0|||
147123573|NCT00890097|530616837|FG000|Overall Study|Protocol Deviation|1|||
147123574|NCT00890097|530616838|FG001|Overall Study|Protocol Deviation|1|||
147651025|NCT02769312|532544564|FG001|Unblinded (Optional 2-4 Weeks)|Lost to Follow-up|1|||
147651026|NCT02769312|532544563|FG000|Follow-up|Lost to Follow-up|1|||
147123575|NCT00890097|530616839|FG002|Overall Study|Protocol Deviation|1|||
147123576|NCT01703221|530616840|FG000|Phase A (Up to 24 Weeks)|Adverse Event|2|||
147123577|NCT01703221|530616841|FG001|Phase A (Up to 24 Weeks)|Adverse Event|4|||
147233221|NCT01914757|531026310|FG001|Overall Study|Other reasons|9|||
147651027|NCT02769312|532544564|FG001|Follow-up|Lost to Follow-up|1|||
147123578|NCT01703221|530616842|FG002|Phase A (Up to 24 Weeks)|Adverse Event|0|||
147123579|NCT01703221|530616840|FG000|Phase A (Up to 24 Weeks)|Lack of Efficacy|2|||
147233222|NCT01914757|531026311|FG002|Overall Study|Other reasons|4|||
147233223|NCT00615108|531026312|FG000|Overall Study|Adverse Event|122|||
147568676|NCT01597245|532240130|FG009|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
147568677|NCT01597245|532240131|FG010|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
147568678|NCT01597245|532240132|FG011|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
147568679|NCT01597245|532240133|FG012|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
147568680|NCT01597245|532240134|FG013|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
147568681|NCT01597245|532240135|FG014|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
147568682|NCT01597245|532240136|FG015|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
147568683|NCT01597245|532240137|FG016|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
147568684|NCT01597245|532240138|FG017|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
147568685|NCT01597245|532240139|FG018|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
147568686|NCT01597245|532240140|FG019|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
147568687|NCT01597245|532240141|FG020|Induction Period (Week 0 - Week 12)|Lost to Follow-up|0|||
147568688|NCT01597245|532240121|FG000|Induction Period (Week 0 - Week 12)|Physician Decision|1|||
147123580|NCT01703221|530616841|FG001|Phase A (Up to 24 Weeks)|Lack of Efficacy|0|||
147233224|NCT00615108|531026312|FG000|Overall Study|Other|370|||
147233225|NCT00615108|531026312|FG000|Overall Study|Lost to Follow-up|15|||
147233226|NCT01147640|531026317|FG000|Overall Study|Adverse Event|2|||
147233227|NCT01147640|531026318|FG001|Overall Study|Adverse Event|0|||
147233228|NCT01147640|531026317|FG000|Overall Study|Physician Decision|1|||
147233229|NCT01147640|531026318|FG001|Overall Study|Physician Decision|0|||
147233230|NCT01147640|531026317|FG000|Overall Study|Withdrawal by Subject|1|||
147233231|NCT01147640|531026318|FG001|Overall Study|Withdrawal by Subject|0|||
147233232|NCT01147640|531026317|FG000|Overall Study|Lost to Follow-up|0|||
147233233|NCT01147640|531026318|FG001|Overall Study|Lost to Follow-up|1|||
147233234|NCT01147640|531026317|FG000|Overall Study|Didn't meet eligibility criteria|1|||
147233235|NCT01147640|531026318|FG001|Overall Study|Didn't meet eligibility criteria|0|||
147233236|NCT01856907|531026319|FG000|Overall Study|Pregnancy|0|||
147233237|NCT01856907|531026320|FG001|Overall Study|Pregnancy|1|||
147233238|NCT01856907|531026321|FG002|Overall Study|Pregnancy|0|||
147233239|NCT01856907|531026319|FG000|Overall Study|Pregnancy|0|||
147233240|NCT01856907|531026320|FG001|Overall Study|Pregnancy|1|||
147233241|NCT01856907|531026321|FG002|Overall Study|Pregnancy|0|||
147233242|NCT01856907|531026319|FG000|Overall Study|Withdrawal by Subject|0|||
147233243|NCT01856907|531026320|FG001|Overall Study|Withdrawal by Subject|1|||
147233244|NCT01856907|531026321|FG002|Overall Study|Withdrawal by Subject|0|||
147233245|NCT00986830|531026330|FG000|Overall Study|Death|1|||
147233246|NCT00986830|531026330|FG000|Overall Study|Lost to Follow-up|1|||
147568689|NCT01597245|532240122|FG001|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
147568690|NCT01597245|532240123|FG002|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
147568691|NCT01597245|532240124|FG003|Induction Period (Week 0 - Week 12)|Physician Decision|1|||
147568692|NCT01597245|532240125|FG004|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
147233247|NCT00986830|531026330|FG000|Overall Study|Lack of Efficacy|1|||
147233248|NCT00986830|531026330|FG000|Overall Study|Unable to access sinus with device|5|||
147233249|NCT02191137|531026331|FG000|Treatment|Death|4|||
147233250|NCT02191137|531026331|FG000|Treatment|Withdrawal by Subject|3|||
147568693|NCT01597245|532240126|FG005|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
147651028|NCT02496039|532544569|FG000|Overall Study|Adverse Event|3|||
147651029|NCT02496039|532544569|FG000|Overall Study|Protocol Violation|1|||
147123581|NCT01703221|530616842|FG002|Phase A (Up to 24 Weeks)|Lack of Efficacy|1|||
147233251|NCT02191137|531026331|FG000|Treatment|Adverse Event|2|||
147233252|NCT02191137|531026331|FG000|Treatment|Other|1|||
147233253|NCT02191137|531026331|FG000|Follow-up|Lost to Follow-up|2|||
147233254|NCT02191137|531026331|FG000|Follow-up|Ongoing/unknown|2|||
147233255|NCT02191137|531026331|FG000|Follow-up|Adverse Event|1|||
147233256|NCT01332331|531026332|FG000|Overall Study|Lost to Follow-up|0|||
147568694|NCT01597245|532240127|FG006|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
147568695|NCT01597245|532240128|FG007|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
147568696|NCT01597245|532240129|FG008|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
147568697|NCT01597245|532240130|FG009|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
147568698|NCT01597245|532240131|FG010|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
147568699|NCT01597245|532240132|FG011|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
147568700|NCT01597245|532240133|FG012|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
147568701|NCT01597245|532240134|FG013|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
147568702|NCT01597245|532240135|FG014|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
147568703|NCT01597245|532240136|FG015|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
147568704|NCT01597245|532240137|FG016|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
147568705|NCT01597245|532240138|FG017|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
147314226|NCT01146574|531317427|FG003|Overall Study|Kidney transplant|1|||
147314227|NCT01146574|531317428|FG004|Overall Study|Kidney transplant|0|||
147314228|NCT01146574|531317429|FG005|Overall Study|Kidney transplant|0|||
147314229|NCT01146574|531317430|FG006|Overall Study|Kidney transplant|0|||
147314230|NCT01146574|531317424|FG000|Overall Study|Withdrew consent|0|||
147314231|NCT01146574|531317425|FG001|Overall Study|Withdrew consent|0|||
147314232|NCT01146574|531317426|FG002|Overall Study|Withdrew consent|1|||
147314233|NCT01146574|531317427|FG003|Overall Study|Withdrew consent|1|||
147314234|NCT01146574|531317428|FG004|Overall Study|Withdrew consent|2|||
147314235|NCT01146574|531317429|FG005|Overall Study|Withdrew consent|1|||
147314236|NCT01146574|531317430|FG006|Overall Study|Withdrew consent|1|||
147314237|NCT03053492|531317431|FG000|Overall Study|Adverse Event|1|||
147314238|NCT03053492|531317432|FG001|Overall Study|Adverse Event|1|||
147314239|NCT03053492|531317431|FG000|Overall Study|Withdrawal by Subject|7|||
147314240|NCT03053492|531317432|FG001|Overall Study|Withdrawal by Subject|5|||
147314241|NCT03382600|531317434|FG000|Overall Study|Adverse Event|3|||
147314242|NCT03382600|531317435|FG001|Overall Study|Adverse Event|3|||
147314243|NCT03382600|531317434|FG000|Overall Study|Clinical Disease Progression|2|||
147314244|NCT03382600|531317435|FG001|Overall Study|Clinical Disease Progression|4|||
147314245|NCT03382600|531317434|FG000|Overall Study|Radiological Progression|40|||
147314246|NCT03382600|531317435|FG001|Overall Study|Radiological Progression|31|||
147314247|NCT03382600|531317434|FG000|Overall Study|Withdrawal by Subject|0|||
147314248|NCT03382600|531317435|FG001|Overall Study|Withdrawal by Subject|1|||
147314249|NCT03382600|531317434|FG000|Overall Study|Other|9|||
147314250|NCT03382600|531317435|FG001|Overall Study|Other|7|||
147314251|NCT00967018|531317439|FG000|Overall Study|Adverse Event|2|||
147314252|NCT00967018|531317439|FG000|Overall Study|Physician Decision|7|||
147314253|NCT00967018|531317439|FG000|Overall Study|Lost to Follow-up|2|||
147314254|NCT00967018|531317439|FG000|Overall Study|Withdrawal by Subject|1|||
147314255|NCT00967018|531317439|FG000|Overall Study|Miscellaneous Reasons|9|||
147314256|NCT01680458|531317442|FG000|Overall Study|Protocol Violation|3|||
147314257|NCT03406702|531317443|FG000|Overall Study|Missed Day 27 Dosing|1|||
147314258|NCT00514046|531317448|FG000|Overall Study|transferred to another protocol|2|||
147314259|NCT00514046|531317449|FG001|Overall Study|transferred to another protocol|1|||
147314260|NCT00514046|531317450|FG002|Overall Study|transferred to another protocol|3|||
147314261|NCT00514046|531317451|FG003|Overall Study|transferred to another protocol|0|||
147314262|NCT00514046|531317452|FG004|Overall Study|transferred to another protocol|1|||
147314263|NCT00514046|531317453|FG005|Overall Study|transferred to another protocol|0|||
147314264|NCT00514046|531317454|FG006|Overall Study|transferred to another protocol|0|||
147314265|NCT00514046|531317455|FG007|Overall Study|transferred to another protocol|0|||
147314266|NCT00514046|531317456|FG008|Overall Study|transferred to another protocol|0|||
147314267|NCT00514046|531317448|FG000|Overall Study|Getting vandetanib via the REMS program|1|||
147314268|NCT00514046|531317449|FG001|Overall Study|Getting vandetanib via the REMS program|0|||
147314269|NCT00514046|531317450|FG002|Overall Study|Getting vandetanib via the REMS program|0|||
147568706|NCT01597245|532240139|FG018|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
147568707|NCT01597245|532240140|FG019|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
147314270|NCT00514046|531317451|FG003|Overall Study|Getting vandetanib via the REMS program|0|||
147314271|NCT00514046|531317452|FG004|Overall Study|Getting vandetanib via the REMS program|0|||
147314272|NCT00514046|531317453|FG005|Overall Study|Getting vandetanib via the REMS program|0|||
147314273|NCT00514046|531317454|FG006|Overall Study|Getting vandetanib via the REMS program|0|||
147314274|NCT00514046|531317455|FG007|Overall Study|Getting vandetanib via the REMS program|1|||
147314275|NCT00514046|531317456|FG008|Overall Study|Getting vandetanib via the REMS program|1|||
147568708|NCT01597245|532240141|FG020|Induction Period (Week 0 - Week 12)|Physician Decision|0|||
147568709|NCT01597245|532240121|FG000|Induction Period (Week 0 - Week 12)|Lack of Efficacy|3|||
147568710|NCT01597245|532240122|FG001|Induction Period (Week 0 - Week 12)|Lack of Efficacy|3|||
147568711|NCT01597245|532240123|FG002|Induction Period (Week 0 - Week 12)|Lack of Efficacy|1|||
147314276|NCT00514046|531317448|FG000|Overall Study|Disease progression on study|0|||
147568712|NCT01597245|532240124|FG003|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
147314277|NCT00514046|531317449|FG001|Overall Study|Disease progression on study|0|||
147314278|NCT00514046|531317450|FG002|Overall Study|Disease progression on study|2|||
147568713|NCT01597245|532240125|FG004|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
147568714|NCT01597245|532240126|FG005|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
147568715|NCT01597245|532240127|FG006|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
147568716|NCT01597245|532240128|FG007|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
147568717|NCT01597245|532240129|FG008|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
147568718|NCT01597245|532240130|FG009|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
147568719|NCT01597245|532240131|FG010|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
147568720|NCT01597245|532240132|FG011|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
147568721|NCT01597245|532240133|FG012|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
147568722|NCT01597245|532240134|FG013|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
147568723|NCT01597245|532240135|FG014|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
147123582|NCT01703221|530616840|FG000|Phase A (Up to 24 Weeks)|Physician Decision|1|||
147123583|NCT01703221|530616841|FG001|Phase A (Up to 24 Weeks)|Physician Decision|0|||
147123584|NCT01703221|530616842|FG002|Phase A (Up to 24 Weeks)|Physician Decision|0|||
147123585|NCT01703221|530616840|FG000|Phase A (Up to 24 Weeks)|Withdrawal by Subject|2|||
147123586|NCT01703221|530616841|FG001|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
147123587|NCT01703221|530616842|FG002|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1|||
147123588|NCT01703221|530616840|FG000|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
147123589|NCT01703221|530616841|FG001|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
147123590|NCT01703221|530616842|FG002|Phase A (Up to 24 Weeks)|Protocol Violation|1|||
147123591|NCT01703221|530616840|FG000|Phase B - (Week 25 to 52)|Withdrawal by Subject|2|||
147123592|NCT01703221|530616841|FG001|Phase B - (Week 25 to 52)|Withdrawal by Subject|1|||
147123593|NCT01703221|530616842|FG002|Phase B - (Week 25 to 52)|Withdrawal by Subject|0|||
147123594|NCT01703221|530616840|FG000|Phase B - (Week 25 to 52)|Adverse Event|2|||
147123595|NCT01703221|530616841|FG001|Phase B - (Week 25 to 52)|Adverse Event|3|||
147123596|NCT01703221|530616842|FG002|Phase B - (Week 25 to 52)|Adverse Event|2|||
147123597|NCT01703221|530616840|FG000|Phase B - (Week 25 to 52)|Lack of Efficacy|12|||
147123598|NCT01703221|530616841|FG001|Phase B - (Week 25 to 52)|Lack of Efficacy|10|||
147123599|NCT01703221|530616842|FG002|Phase B - (Week 25 to 52)|Lack of Efficacy|3|||
147123600|NCT03810495|530616843|FG000|Overall Study|Lost to Follow-up|2|||
147123601|NCT03810495|530616843|FG000|Overall Study|Withdrawal by Subject|1|||
147123602|NCT03810365|530618482|FG000|Overall Study|Lost to Follow-up|2|||
147123603|NCT03810365|530618483|FG001|Overall Study|Lost to Follow-up|2|||
147123604|NCT03810365|530618482|FG000|Overall Study|Withdrawal by Subject|4|||
147123605|NCT03810365|530618483|FG001|Overall Study|Withdrawal by Subject|5|||
147123606|NCT05333965|530618485|FG000|First Intervention|Adverse Event|0|||
147123607|NCT05333965|530618486|FG001|First Intervention|Adverse Event|1|||
147123608|NCT05333965|530618485|FG000|First Intervention|Withdrawal by Subject|0|||
147123609|NCT05333965|530618486|FG001|First Intervention|Withdrawal by Subject|1|||
147123610|NCT03701074|530618487|FG000|Overall Study|Physician Decision|1|||
147123611|NCT03701074|530618488|FG001|Overall Study|Physician Decision|0|||
147123612|NCT01517178|530618489|FG000|Period 1|Adverse Event|1|||
147123613|NCT01517178|530618490|FG001|Period 1|Adverse Event|2|||
147123614|NCT01517178|530618489|FG000|Period 1|Lack of Efficacy|0|||
147123615|NCT01517178|530618490|FG001|Period 1|Lack of Efficacy|1|||
147123616|NCT01517178|530618489|FG000|Period 1|E.g. study termination|3|||
147123617|NCT01517178|530618490|FG001|Period 1|E.g. study termination|1|||
147123618|NCT01517178|530618489|FG000|Period 1|Withdrawal by Subject|0|||
147123619|NCT01517178|530618490|FG001|Period 1|Withdrawal by Subject|1|||
147123620|NCT01517178|530618489|FG000|Period 2|Adverse Event|1|||
147123621|NCT01517178|530618490|FG001|Period 2|Adverse Event|0|||
147123622|NCT01517178|530618489|FG000|Period 2|Withdrawal by Subject|3|||
147123623|NCT01517178|530618490|FG001|Period 2|Withdrawal by Subject|0|||
147123624|NCT01517178|530618489|FG000|Period 2|E.g. study termination|2|||
147123625|NCT01517178|530618490|FG001|Period 2|E.g. study termination|2|||
147123626|NCT01959919|530618491|FG000|Overall Study|Did not meet the eligibility criteria|2|||
147123627|NCT02094885|530618493|FG000|Overall Study|Death|1|||
147123628|NCT02094885|530618494|FG001|Overall Study|Death|5|||
147123629|NCT02094885|530618493|FG000|Overall Study|Withdrawn due to age|1|||
147123630|NCT02094885|530618494|FG001|Overall Study|Withdrawn due to age|0|||
147123631|NCT00779909|530618495|FG000|Overall Study|Lost to Follow-up|1|||
147123632|NCT00779909|530618496|FG001|Overall Study|Lost to Follow-up|0|||
147123633|NCT00779909|530618497|FG002|Overall Study|Lost to Follow-up|0|||
147123634|NCT00779909|530618498|FG003|Overall Study|Lost to Follow-up|1|||
147123635|NCT00779909|530618495|FG000|Overall Study|Withdrawal by Subject|0|||
147123636|NCT00779909|530618496|FG001|Overall Study|Withdrawal by Subject|1|||
147123637|NCT00779909|530618497|FG002|Overall Study|Withdrawal by Subject|0|||
147123638|NCT00779909|530618498|FG003|Overall Study|Withdrawal by Subject|0|||
147123639|NCT01104870|530618499|FG000|Overall Study|Adverse Event|1|||
147123640|NCT01104870|530618500|FG001|Overall Study|Adverse Event|1|||
147123641|NCT01104870|530618501|FG002|Overall Study|Adverse Event|0|||
147123642|NCT01104870|530618499|FG000|Overall Study|Death|0|||
147123643|NCT01104870|530618500|FG001|Overall Study|Death|0|||
147651030|NCT03297021|532544570|FG000|Overall Study|Incomplete/illegible data sheet|4|||
147651031|NCT03297021|532544571|FG001|Overall Study|Incomplete/illegible data sheet|2|||
147651032|NCT03297021|532544572|FG002|Overall Study|Incomplete/illegible data sheet|3|||
147651033|NCT03297021|532544570|FG000|Overall Study|Missing Post-Op Data|1|||
147651034|NCT03297021|532544571|FG001|Overall Study|Missing Post-Op Data|2|||
147651035|NCT03297021|532544572|FG002|Overall Study|Missing Post-Op Data|1|||
147651036|NCT02734862|532544573|FG000|Part A|Death|3|||
147651037|NCT02734862|532544574|FG001|Part A|Death|4|||
147651038|NCT02734862|532544575|FG002|Part A|Death|6|||
147651039|NCT02734862|532544573|FG000|Part A|Lost to Follow-up|2|||
147123644|NCT01104870|530618501|FG002|Overall Study|Death|1|||
147233257|NCT01332331|531026333|FG001|Overall Study|Lost to Follow-up|1|||
147233258|NCT01332331|531026332|FG000|Overall Study|Adverse Event|1|||
147233259|NCT01332331|531026333|FG001|Overall Study|Adverse Event|1|||
147233260|NCT01332331|531026332|FG000|Overall Study|Physician Decision|1|||
147233261|NCT01332331|531026333|FG001|Overall Study|Physician Decision|0|||
147233262|NCT01904058|531026335|FG000|Overall Study|Adverse Event|2|||
147651040|NCT02734862|532544574|FG001|Part A|Lost to Follow-up|1|||
147651041|NCT02734862|532544575|FG002|Part A|Lost to Follow-up|1|||
147651042|NCT02734862|532544573|FG000|Part A|Withdrawal by Subject|1|||
147651043|NCT02734862|532544574|FG001|Part A|Withdrawal by Subject|1|||
147123645|NCT01104870|530618499|FG000|Overall Study|Withdrawal by Subject|0|||
147123646|NCT01104870|530618500|FG001|Overall Study|Withdrawal by Subject|0|||
147123647|NCT01104870|530618501|FG002|Overall Study|Withdrawal by Subject|1|||
147123648|NCT02150863|530618509|FG000|Overall Study|Lost to Follow-up|0|||
147123649|NCT02150863|530618510|FG001|Overall Study|Lost to Follow-up|1|||
147123650|NCT02150863|530618511|FG002|Overall Study|Lost to Follow-up|0|||
147123651|NCT00835549|530618514|FG000|Washout of 7 Days|Withdrawal by Subject|2|||
147123652|NCT00835549|530618515|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
147123653|NCT00835042|530618516|FG000|First Intervention|Withdrawal by Subject|3|||
147123654|NCT00835042|530618517|FG001|First Intervention|Withdrawal by Subject|0|||
147123655|NCT00835042|530618516|FG000|First Intervention|Adverse Event|1|||
147123656|NCT00835042|530618517|FG001|First Intervention|Adverse Event|2|||
147123657|NCT00835042|530618516|FG000|Washout of 21 Days|Withdrawal by Subject|0|||
147123658|NCT00835042|530618517|FG001|Washout of 21 Days|Withdrawal by Subject|2|||
147123659|NCT04008069|530618518|FG000|Open-Label Period|Adverse Event|1|||
147123660|NCT04008069|530618519|FG001|Open-Label Period|Adverse Event|0|||
147123661|NCT04008069|530618520|FG002|Open-Label Period|Adverse Event|0|||
147123662|NCT04008069|530618518|FG000|Open-Label Period|Lack of Efficacy|4|||
147123663|NCT04008069|530618519|FG001|Open-Label Period|Lack of Efficacy|0|||
147123664|NCT04008069|530618520|FG002|Open-Label Period|Lack of Efficacy|0|||
147123665|NCT04008069|530618518|FG000|Randomized-Withdrawal Period|Adverse Event|0|||
147123666|NCT04008069|530618519|FG001|Randomized-Withdrawal Period|Adverse Event|1|||
147123667|NCT04008069|530618520|FG002|Randomized-Withdrawal Period|Adverse Event|2|||
147123668|NCT04008069|530618518|FG000|Randomized-Withdrawal Period|Lack of Efficacy|0|||
147123669|NCT04008069|530618519|FG001|Randomized-Withdrawal Period|Lack of Efficacy|0|||
147123670|NCT04008069|530618520|FG002|Randomized-Withdrawal Period|Lack of Efficacy|1|||
147123671|NCT00511199|530618521|FG000|Overall Study|Unacceptable Vaginal Bleeding|63|||
147123672|NCT00511199|530618522|FG001|Overall Study|Unacceptable Vaginal Bleeding|4|||
147123673|NCT00511199|530618521|FG000|Overall Study|Other Adverse Event (AE)/ Serious AE|227|||
147123674|NCT00511199|530618522|FG001|Overall Study|Other Adverse Event (AE)/ Serious AE|52|||
147123675|NCT00511199|530618521|FG000|Overall Study|Withdrawal of Informed Consent|19|||
147123676|NCT00511199|530618522|FG001|Overall Study|Withdrawal of Informed Consent|4|||
147123677|NCT00511199|530618521|FG000|Overall Study|Pregnancy|6|||
147123678|NCT00511199|530618522|FG001|Overall Study|Pregnancy|3|||
147123679|NCT00511199|530618521|FG000|Overall Study|Pregnancy Wish|16|||
147123680|NCT00511199|530618522|FG001|Overall Study|Pregnancy Wish|8|||
147123681|NCT00511199|530618521|FG000|Overall Study|Lost to Follow-up|40|||
147123682|NCT00511199|530618522|FG001|Overall Study|Lost to Follow-up|17|||
147123683|NCT00511199|530618521|FG000|Overall Study|Other Reason|78|||
147123684|NCT00511199|530618522|FG001|Overall Study|Other Reason|37|||
147123685|NCT02314247|530618528|FG000|Overall Study|Adverse Event|2|||
147123686|NCT02314247|530618529|FG001|Overall Study|Adverse Event|1|||
147123687|NCT02314247|530618530|FG002|Overall Study|Adverse Event|0|||
147123688|NCT02314247|530618528|FG000|Overall Study|Withdrawal by Subject|1|||
147123689|NCT02314247|530618529|FG001|Overall Study|Withdrawal by Subject|3|||
147123690|NCT02314247|530618530|FG002|Overall Study|Withdrawal by Subject|1|||
147123691|NCT02314247|530618528|FG000|Overall Study|Progression of Disease|6|||
147123692|NCT02314247|530618529|FG001|Overall Study|Progression of Disease|2|||
147123693|NCT02314247|530618530|FG002|Overall Study|Progression of Disease|0|||
147123694|NCT01953354|530618531|FG000|Overall Study|Withdrawal by Subject|0|||
147123695|NCT01953354|530618532|FG001|Overall Study|Withdrawal by Subject|1|||
147123696|NCT01953354|530618531|FG000|Overall Study|Decision of Sponsor|0|||
147123697|NCT01953354|530618532|FG001|Overall Study|Decision of Sponsor|1|||
147123698|NCT01953354|530618531|FG000|Overall Study|Disease Exacerbation|1|||
147123699|NCT01953354|530618532|FG001|Overall Study|Disease Exacerbation|0|||
147568724|NCT01597245|532240136|FG015|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
147568725|NCT01597245|532240137|FG016|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
147568726|NCT01597245|532240138|FG017|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
147568727|NCT01597245|532240139|FG018|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
147568728|NCT01597245|532240140|FG019|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
147568729|NCT01597245|532240141|FG020|Induction Period (Week 0 - Week 12)|Lack of Efficacy|0|||
147568730|NCT01597245|532240121|FG000|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
147568731|NCT01597245|532240122|FG001|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
147568732|NCT01597245|532240123|FG002|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
147568733|NCT01597245|532240124|FG003|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
147568734|NCT01597245|532240125|FG004|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
147568735|NCT01597245|532240126|FG005|Maintenance Period (Week 12 to Week 60)|On study treatment|1|||
147568736|NCT01597245|532240127|FG006|Maintenance Period (Week 12 to Week 60)|On study treatment|1|||
147568737|NCT01597245|532240128|FG007|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
147568738|NCT01597245|532240129|FG008|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
147568739|NCT01597245|532240130|FG009|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
147568740|NCT01597245|532240131|FG010|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
147568741|NCT01597245|532240132|FG011|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
147568742|NCT01597245|532240133|FG012|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
147568743|NCT01597245|532240134|FG013|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
147568744|NCT01597245|532240135|FG014|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
147568745|NCT01597245|532240136|FG015|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
147568746|NCT01597245|532240137|FG016|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
147568747|NCT01597245|532240138|FG017|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
147568748|NCT01597245|532240139|FG018|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
147568749|NCT01597245|532240140|FG019|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
147568750|NCT01597245|532240141|FG020|Maintenance Period (Week 12 to Week 60)|On study treatment|0|||
147568751|NCT01597245|532240121|FG000|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
147568752|NCT01597245|532240122|FG001|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
147568753|NCT01597245|532240123|FG002|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
147568754|NCT01597245|532240124|FG003|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
147568755|NCT01597245|532240125|FG004|Maintenance Period (Week 12 to Week 60)|Relapsed|150|||
147568756|NCT01597245|532240126|FG005|Maintenance Period (Week 12 to Week 60)|Relapsed|22|||
147568757|NCT01597245|532240127|FG006|Maintenance Period (Week 12 to Week 60)|Relapsed|80|||
147568758|NCT01597245|532240128|FG007|Maintenance Period (Week 12 to Week 60)|Relapsed|2|||
147568759|NCT01597245|532240129|FG008|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
147568760|NCT01597245|532240130|FG009|Maintenance Period (Week 12 to Week 60)|Relapsed|114|||
147568761|NCT01597245|532240131|FG010|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
147568762|NCT01597245|532240132|FG011|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
147568763|NCT01597245|532240133|FG012|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
147568764|NCT01597245|532240134|FG013|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
147568765|NCT01597245|532240135|FG014|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
147568766|NCT01597245|532240136|FG015|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
147568767|NCT01597245|532240137|FG016|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
147568768|NCT01597245|532240138|FG017|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
147568769|NCT01597245|532240139|FG018|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
147568770|NCT01597245|532240140|FG019|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
147123700|NCT02571244|530618533|FG000|Overall Study|Lost to Follow-up|0|||
147568771|NCT01597245|532240141|FG020|Maintenance Period (Week 12 to Week 60)|Relapsed|0|||
147568772|NCT01597245|532240121|FG000|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
147568773|NCT01597245|532240122|FG001|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
147568774|NCT01597245|532240123|FG002|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
147568775|NCT01597245|532240124|FG003|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
147568776|NCT01597245|532240125|FG004|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
147568777|NCT01597245|532240126|FG005|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|1|||
147568778|NCT01597245|532240127|FG006|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
147568779|NCT01597245|532240128|FG007|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
147568780|NCT01597245|532240129|FG008|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|3|||
147568781|NCT01597245|532240130|FG009|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
147568782|NCT01597245|532240131|FG010|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|2|||
147568783|NCT01597245|532240132|FG011|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|10|||
147123701|NCT02571244|530618534|FG001|Overall Study|Lost to Follow-up|1|||
147123702|NCT02571244|530618533|FG000|Overall Study|Unable to reach out post discharge|3|||
147123703|NCT02571244|530618534|FG001|Overall Study|Unable to reach out post discharge|0|||
147123704|NCT01570192|530618535|FG000|Overall Study|no qualifying organism|6|||
147123705|NCT01570192|530618536|FG001|Overall Study|no qualifying organism|12|||
147568784|NCT01597245|532240133|FG012|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|4|||
147568785|NCT01597245|532240134|FG013|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
147568786|NCT01597245|532240135|FG014|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
147568787|NCT01597245|532240136|FG015|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
147568788|NCT01597245|532240137|FG016|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
147568789|NCT01597245|532240138|FG017|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
147568790|NCT01597245|532240139|FG018|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
147568791|NCT01597245|532240140|FG019|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
147568792|NCT01597245|532240141|FG020|Maintenance Period (Week 12 to Week 60)|Lack of Efficacy|0|||
147568793|NCT01597245|532240121|FG000|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
147568794|NCT01597245|532240122|FG001|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
147568795|NCT01597245|532240123|FG002|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
147568796|NCT01597245|532240124|FG003|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
147568797|NCT01597245|532240125|FG004|Maintenance Period (Week 12 to Week 60)|Adverse Event|4|||
147568798|NCT01597245|532240126|FG005|Maintenance Period (Week 12 to Week 60)|Adverse Event|6|||
147568799|NCT01597245|532240127|FG006|Maintenance Period (Week 12 to Week 60)|Adverse Event|6|||
147568800|NCT01597245|532240128|FG007|Maintenance Period (Week 12 to Week 60)|Adverse Event|1|||
147568801|NCT01597245|532240129|FG008|Maintenance Period (Week 12 to Week 60)|Adverse Event|8|||
147568802|NCT01597245|532240130|FG009|Maintenance Period (Week 12 to Week 60)|Adverse Event|2|||
147568803|NCT01597245|532240131|FG010|Maintenance Period (Week 12 to Week 60)|Adverse Event|8|||
147568804|NCT01597245|532240132|FG011|Maintenance Period (Week 12 to Week 60)|Adverse Event|1|||
147123706|NCT01570192|530618535|FG000|Overall Study|changed to palliative care|1|||
147123707|NCT01570192|530618536|FG001|Overall Study|changed to palliative care|0|||
147123708|NCT01570192|530618535|FG000|Overall Study|Physician Decision|0|||
147123709|NCT01570192|530618536|FG001|Overall Study|Physician Decision|1|||
147123710|NCT00489359|530618539|FG000|Overall Study|Death|0|||
147123711|NCT00489359|530618540|FG001|Overall Study|Death|2|||
147123712|NCT00489359|530618539|FG000|Overall Study|Progressive Disease|5|||
147123713|NCT00489359|530618540|FG001|Overall Study|Progressive Disease|6|||
147123714|NCT00489359|530618539|FG000|Overall Study|Lost to Follow-up|1|||
147123715|NCT00489359|530618540|FG001|Overall Study|Lost to Follow-up|0|||
147123716|NCT00489359|530618539|FG000|Overall Study|Withdrawal by Subject|1|||
147123717|NCT00489359|530618540|FG001|Overall Study|Withdrawal by Subject|5|||
147123718|NCT00489359|530618539|FG000|Overall Study|Adverse Event|0|||
147123719|NCT00489359|530618540|FG001|Overall Study|Adverse Event|16|||
147123720|NCT03180138|530618541|FG000|Overall Study|Mobile-phone could not be verified|2|||
147123721|NCT03180138|530618542|FG001|Overall Study|Mobile-phone could not be verified|13|||
147123722|NCT03180138|530618543|FG002|Overall Study|Mobile-phone could not be verified|15|||
147123723|NCT03180138|530618541|FG000|Overall Study|No prior immunization records|17|||
147123724|NCT03180138|530618542|FG001|Overall Study|No prior immunization records|0|||
147123725|NCT03180138|530618543|FG002|Overall Study|No prior immunization records|6|||
147123726|NCT03180138|530618541|FG000|Overall Study|Found to be >24 mon after randomization|3|||
147123727|NCT03180138|530618542|FG001|Overall Study|Found to be >24 mon after randomization|0|||
147123728|NCT03180138|530618543|FG002|Overall Study|Found to be >24 mon after randomization|3|||
147123729|NCT04191733|530618544|FG000|Overall Study|Withdrawn due to study closure|13|||
147123730|NCT04191733|530618545|FG001|Overall Study|Withdrawn due to study closure|14|||
147123731|NCT04191733|530618544|FG000|Overall Study|Withdrawal by Subject|2|||
147123732|NCT04191733|530618545|FG001|Overall Study|Withdrawal by Subject|4|||
147123733|NCT04191733|530618544|FG000|Overall Study|Physician Decision|1|||
147123734|NCT04191733|530618545|FG001|Overall Study|Physician Decision|1|||
147123735|NCT04191733|530618544|FG000|Overall Study|Lost to Follow-up|5|||
147123736|NCT04191733|530618545|FG001|Overall Study|Lost to Follow-up|6|||
147123737|NCT04191733|530618544|FG000|Overall Study|Death|0|||
147123738|NCT04191733|530618545|FG001|Overall Study|Death|1|||
147233263|NCT01904058|531026336|FG001|Overall Study|Adverse Event|0|||
147233264|NCT01904058|531026337|FG002|Overall Study|Adverse Event|0|||
147233265|NCT01904058|531026338|FG003|Overall Study|Adverse Event|0|||
147233266|NCT01904058|531026335|FG000|Overall Study|Withdrawal by Subject|1|||
147233267|NCT01904058|531026336|FG001|Overall Study|Withdrawal by Subject|0|||
147233268|NCT01904058|531026337|FG002|Overall Study|Withdrawal by Subject|1|||
147233269|NCT01904058|531026338|FG003|Overall Study|Withdrawal by Subject|0|||
147444624|NCT01147744|531792658|FG001|Overall Study|Physician Decision|1|||
147568805|NCT01597245|532240133|FG012|Maintenance Period (Week 12 to Week 60)|Adverse Event|2|||
147568806|NCT01597245|532240134|FG013|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
147123739|NCT01260311|530618547|FG000|Overall Study|Adverse Event|11|||
147123740|NCT01260311|530618547|FG000|Overall Study|Lack of Efficacy|4|||
147123741|NCT01260311|530618547|FG000|Overall Study|Lost to Follow-up|25|||
147123742|NCT01260311|530618547|FG000|Overall Study|Withdrawal by Subject|6|||
147123743|NCT01260311|530618547|FG000|Overall Study|Financial Constraints|77|||
147123744|NCT01260311|530618547|FG000|Overall Study|Gone to Province|2|||
147123745|NCT01260311|530618547|FG000|Overall Study|Medication Stopped|1|||
147233270|NCT01904058|531026335|FG000|Overall Study|Pregnancy|0|||
147233271|NCT01904058|531026336|FG001|Overall Study|Pregnancy|0|||
147123746|NCT01260311|530618547|FG000|Overall Study|Fesoterodine Started Before Enrollment|1|||
147123747|NCT02633527|530618548|FG000|Overall Study|Failed to meet eligibility|0|||
147123748|NCT02633527|530618549|FG001|Overall Study|Failed to meet eligibility|1|||
147123749|NCT02633527|530618550|FG002|Overall Study|Failed to meet eligibility|1|||
147123750|NCT02633527|530618551|FG003|Overall Study|Failed to meet eligibility|0|||
147123751|NCT02633527|530618552|FG004|Overall Study|Failed to meet eligibility|1|||
147123752|NCT02633527|530618548|FG000|Overall Study|Adverse Event|0|||
147123753|NCT02633527|530618549|FG001|Overall Study|Adverse Event|4|||
147123754|NCT02633527|530618550|FG002|Overall Study|Adverse Event|3|||
147123755|NCT02633527|530618551|FG003|Overall Study|Adverse Event|1|||
147123756|NCT02633527|530618552|FG004|Overall Study|Adverse Event|5|||
147123757|NCT02633527|530618548|FG000|Overall Study|Lost to Follow-up|1|||
147123758|NCT02633527|530618549|FG001|Overall Study|Lost to Follow-up|2|||
147123759|NCT02633527|530618550|FG002|Overall Study|Lost to Follow-up|5|||
147123760|NCT02633527|530618551|FG003|Overall Study|Lost to Follow-up|5|||
147123761|NCT02633527|530618552|FG004|Overall Study|Lost to Follow-up|4|||
147123762|NCT02633527|530618548|FG000|Overall Study|Withdrawal by Subject|0|||
147123763|NCT02633527|530618549|FG001|Overall Study|Withdrawal by Subject|3|||
147123764|NCT02633527|530618550|FG002|Overall Study|Withdrawal by Subject|5|||
147123765|NCT02633527|530618551|FG003|Overall Study|Withdrawal by Subject|4|||
147123766|NCT02633527|530618552|FG004|Overall Study|Withdrawal by Subject|4|||
147123767|NCT02633527|530618548|FG000|Overall Study|Protocol Violation|0|||
147123768|NCT02633527|530618549|FG001|Overall Study|Protocol Violation|1|||
147123769|NCT02633527|530618550|FG002|Overall Study|Protocol Violation|1|||
147123770|NCT02633527|530618551|FG003|Overall Study|Protocol Violation|1|||
147123771|NCT02633527|530618552|FG004|Overall Study|Protocol Violation|1|||
147123772|NCT02633527|530618548|FG000|Overall Study|Physician Decision|0|||
147123773|NCT02633527|530618549|FG001|Overall Study|Physician Decision|0|||
147123774|NCT02633527|530618550|FG002|Overall Study|Physician Decision|0|||
147123775|NCT02633527|530618551|FG003|Overall Study|Physician Decision|0|||
147123776|NCT02633527|530618552|FG004|Overall Study|Physician Decision|1|||
147123777|NCT02633527|530618548|FG000|Overall Study|Administrative reason|1|||
147123778|NCT02633527|530618549|FG001|Overall Study|Administrative reason|0|||
147123779|NCT02633527|530618550|FG002|Overall Study|Administrative reason|0|||
147123780|NCT02633527|530618551|FG003|Overall Study|Administrative reason|1|||
147123781|NCT02633527|530618552|FG004|Overall Study|Administrative reason|0|||
147123782|NCT02633527|530618548|FG000|Overall Study|Multiple reasons|1|||
147123783|NCT02633527|530618549|FG001|Overall Study|Multiple reasons|0|||
147123784|NCT02633527|530618550|FG002|Overall Study|Multiple reasons|2|||
147123785|NCT02633527|530618551|FG003|Overall Study|Multiple reasons|2|||
147123786|NCT02633527|530618552|FG004|Overall Study|Multiple reasons|1|||
147123787|NCT01898091|530618557|FG000|Overall Study|Lost to Follow-up|1|||
147233272|NCT01904058|531026337|FG002|Overall Study|Pregnancy|0|||
147233273|NCT01904058|531026338|FG003|Overall Study|Pregnancy|1|||
147233274|NCT03096483|531026339|FG000|Overall Study|Withdrawal by site|1|||
147233275|NCT04810481|531026340|FG000|Overall Study|Disqualified data sets|10|||
147233276|NCT04810481|531026341|FG001|Overall Study|Disqualified data sets|28|||
147233277|NCT00285818|531026349|FG000|Overall Study|Withdrawal by Subject|3|||
147233278|NCT00285818|531026350|FG001|Overall Study|Withdrawal by Subject|2|||
147233279|NCT00285818|531026349|FG000|Overall Study|Lost to Follow-up|1|||
147233280|NCT00285818|531026350|FG001|Overall Study|Lost to Follow-up|0|||
147233281|NCT04041375|531026354|FG000|Intervention Phase|Withdrawal by Subject|2|||
147233282|NCT04041375|531026355|FG001|Intervention Phase|Withdrawal by Subject|2|||
147233283|NCT04041375|531026354|FG000|Follow-up Phase|Death|2|||
147233284|NCT04041375|531026355|FG001|Follow-up Phase|Death|0|||
147233285|NCT04041375|531026354|FG000|Follow-up Phase|Lost to Follow-up|2|||
147233286|NCT04041375|531026355|FG001|Follow-up Phase|Lost to Follow-up|1|||
147233287|NCT04041375|531026354|FG000|Follow-up Phase|Too ill|3|||
147233288|NCT04041375|531026355|FG001|Follow-up Phase|Too ill|0|||
147123788|NCT01898091|530618558|FG001|Overall Study|Lost to Follow-up|1|||
147123789|NCT01898091|530618557|FG000|Overall Study|Withdrawal by Subject|1|||
147233289|NCT04674644|531026361|FG000|Overall Study|with missing data|37|||
147233290|NCT01268150|531026362|FG000|Treatment Phase|Progression of disease|18|||
147233291|NCT01268150|531026362|FG000|Treatment Phase|Adverse Event|3|||
147233292|NCT01268150|531026362|FG000|Treatment Phase|Withdrawal by Subject|3|||
147123790|NCT01898091|530618558|FG001|Overall Study|Withdrawal by Subject|5|||
147123791|NCT03211832|530618559|FG000|Overall Study|No longer with agency|32|||
147123792|NCT03211832|530618560|FG001|Overall Study|No longer with agency|49|||
147123793|NCT03211832|530618561|FG002|Overall Study|No longer with agency|30|||
147123794|NCT03211832|530618559|FG000|Overall Study|Declined survey|3|||
147123795|NCT03211832|530618560|FG001|Overall Study|Declined survey|3|||
147123796|NCT03211832|530618561|FG002|Overall Study|Declined survey|2|||
147123797|NCT03211832|530618559|FG000|Overall Study|Not available during data collection|1|||
147123798|NCT03211832|530618560|FG001|Overall Study|Not available during data collection|0|||
147123799|NCT03211832|530618561|FG002|Overall Study|Not available during data collection|2|||
147233293|NCT01268150|531026362|FG000|Treatment Phase|Other|4|||
147233294|NCT01268150|531026362|FG000|Extension Phase|Adverse Event|3|||
147233295|NCT01268150|531026362|FG000|Extension Phase|Disease progression|18|||
147233296|NCT01268150|531026362|FG000|Extension Phase|Other|6|||
147123800|NCT02913326|530618566|FG000|Overall Study|Reason not listed|0|||
147123801|NCT02913326|530618567|FG001|Overall Study|Reason not listed|1|||
147123802|NCT02913326|530618566|FG000|Overall Study|Lost to Follow-up|0|||
147123803|NCT02913326|530618567|FG001|Overall Study|Lost to Follow-up|1|||
147123804|NCT02913326|530618566|FG000|Overall Study|Adverse Event|1|||
147123805|NCT02913326|530618567|FG001|Overall Study|Adverse Event|0|||
147123806|NCT01514422|530618568|FG000|Overall Study|Lost to Follow-up|1|||
147123807|NCT03511209|530618569|FG000|Overall Study|Withdrawal by Subject|2|||
147123808|NCT03511209|530618570|FG001|Overall Study|Withdrawal by Subject|4|||
147123809|NCT03511209|530618569|FG000|Overall Study|Death|1|||
147123810|NCT03511209|530618570|FG001|Overall Study|Death|0|||
147123811|NCT03511209|530618569|FG000|Overall Study|Lost to Follow-up|0|||
147123812|NCT03511209|530618570|FG001|Overall Study|Lost to Follow-up|2|||
147123813|NCT00911157|530618578|FG000|Overall Study|Adverse Event|4|||
147123814|NCT00911157|530618579|FG001|Overall Study|Adverse Event|1|||
147123815|NCT00911157|530618578|FG000|Overall Study|Withdrawal by Subject|1|||
147123816|NCT00911157|530618579|FG001|Overall Study|Withdrawal by Subject|1|||
147123817|NCT00911157|530618578|FG000|Overall Study|Need for prohibited drug (heparin)|1|||
147123818|NCT00911157|530618579|FG001|Overall Study|Need for prohibited drug (heparin)|0|||
147123819|NCT00911157|530618578|FG000|Overall Study|Need to treat for lung cancer|1|||
147123820|NCT00911157|530618579|FG001|Overall Study|Need to treat for lung cancer|0|||
147123821|NCT00215657|530618580|FG000|Overall Study|Adverse Event|5|||
147123822|NCT00215657|530618581|FG001|Overall Study|Adverse Event|1|||
147123823|NCT00215657|530618582|FG002|Overall Study|Adverse Event|3|||
147123824|NCT00215657|530618583|FG003|Overall Study|Adverse Event|0|||
147123825|NCT00215657|530618584|FG004|Overall Study|Adverse Event|3|||
147123826|NCT00215657|530618585|FG005|Overall Study|Adverse Event|1|||
147123827|NCT00215657|530618586|FG006|Overall Study|Adverse Event|0|||
147123828|NCT00215657|530618587|FG007|Overall Study|Adverse Event|3|||
147123829|NCT00215657|530618580|FG000|Overall Study|Withdrawal by Subject|6|||
147123830|NCT00215657|530618581|FG001|Overall Study|Withdrawal by Subject|3|||
147123831|NCT00215657|530618582|FG002|Overall Study|Withdrawal by Subject|3|||
147123832|NCT00215657|530618583|FG003|Overall Study|Withdrawal by Subject|1|||
147123833|NCT00215657|530618584|FG004|Overall Study|Withdrawal by Subject|6|||
147123834|NCT00215657|530618585|FG005|Overall Study|Withdrawal by Subject|1|||
147123835|NCT00215657|530618586|FG006|Overall Study|Withdrawal by Subject|10|||
147233297|NCT00395733|531026363|FG000|Period 2|Withdrawal by Subject|1|||
147233298|NCT00395733|531026364|FG001|Period 2|Withdrawal by Subject|2|||
147233299|NCT00395733|531026363|FG000|Period 2|Protocol Violation|0|||
147233300|NCT00395733|531026364|FG001|Period 2|Protocol Violation|1|||
147233301|NCT00395733|531026363|FG000|Period 2|Adverse Event|0|||
147233302|NCT00395733|531026364|FG001|Period 2|Adverse Event|2|||
147233303|NCT00395733|531026363|FG000|Period 2|Technical problems|1|||
147233304|NCT00395733|531026364|FG001|Period 2|Technical problems|0|||
147233305|NCT03725852|531026365|FG000|Overall Study|Death|1|||
147233306|NCT03725852|531026366|FG001|Overall Study|Death|0|||
147233307|NCT03725852|531026365|FG000|Overall Study|Withdrawal by Subject|1|||
147233308|NCT03725852|531026366|FG001|Overall Study|Withdrawal by Subject|0|||
147233309|NCT03725852|531026365|FG000|Overall Study|Travel restrictions due to COVID-19|2|||
147233310|NCT03725852|531026366|FG001|Overall Study|Travel restrictions due to COVID-19|0|||
147233311|NCT02808650|531026368|FG000|Overall Study|Death|0|||
147233312|NCT02808650|531026369|FG001|Overall Study|Death|0|||
147233313|NCT02808650|531026370|FG002|Overall Study|Death|0|||
147233314|NCT02808650|531026371|FG003|Overall Study|Death|0|||
147233315|NCT02808650|531026372|FG004|Overall Study|Death|1|||
147233316|NCT02808650|531026368|FG000|Overall Study|Lack of Efficacy|5|||
147233317|NCT02808650|531026369|FG001|Overall Study|Lack of Efficacy|5|||
147233318|NCT02808650|531026370|FG002|Overall Study|Lack of Efficacy|6|||
147233319|NCT02808650|531026371|FG003|Overall Study|Lack of Efficacy|5|||
147233320|NCT02808650|531026372|FG004|Overall Study|Lack of Efficacy|4|||
147233321|NCT02808650|531026368|FG000|Overall Study|Physician Decision|1|||
147233322|NCT02808650|531026369|FG001|Overall Study|Physician Decision|1|||
147233323|NCT02808650|531026370|FG002|Overall Study|Physician Decision|0|||
147233324|NCT02808650|531026371|FG003|Overall Study|Physician Decision|0|||
147233325|NCT02808650|531026372|FG004|Overall Study|Physician Decision|0|||
147233326|NCT02808650|531026368|FG000|Overall Study|Withdrawal by Subject|0|||
147568807|NCT01597245|532240135|FG014|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
147568808|NCT01597245|532240136|FG015|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
147123836|NCT00215657|530618587|FG007|Overall Study|Withdrawal by Subject|3|||
147123837|NCT00215657|530618580|FG000|Overall Study|Insuff prostate specific antigen resp|3|||
147123838|NCT00215657|530618581|FG001|Overall Study|Insuff prostate specific antigen resp|2|||
147123839|NCT00215657|530618582|FG002|Overall Study|Insuff prostate specific antigen resp|2|||
147123840|NCT00215657|530618583|FG003|Overall Study|Insuff prostate specific antigen resp|2|||
147233327|NCT02808650|531026369|FG001|Overall Study|Withdrawal by Subject|0|||
147233328|NCT02808650|531026370|FG002|Overall Study|Withdrawal by Subject|0|||
147233329|NCT02808650|531026371|FG003|Overall Study|Withdrawal by Subject|1|||
147233330|NCT02808650|531026372|FG004|Overall Study|Withdrawal by Subject|1|||
147233331|NCT01672736|531026375|FG000|Overall Study|Available drug expired on 31 May 16|3|||
147123841|NCT00215657|530618584|FG004|Overall Study|Insuff prostate specific antigen resp|1|||
147123842|NCT00215657|530618585|FG005|Overall Study|Insuff prostate specific antigen resp|2|||
147123843|NCT00215657|530618586|FG006|Overall Study|Insuff prostate specific antigen resp|3|||
147123844|NCT00215657|530618587|FG007|Overall Study|Insuff prostate specific antigen resp|2|||
147123845|NCT00215657|530618580|FG000|Overall Study|Insufficient testosterone response|5|||
147123846|NCT00215657|530618581|FG001|Overall Study|Insufficient testosterone response|4|||
147123847|NCT00215657|530618582|FG002|Overall Study|Insufficient testosterone response|1|||
147123848|NCT00215657|530618583|FG003|Overall Study|Insufficient testosterone response|12|||
147123849|NCT00215657|530618584|FG004|Overall Study|Insufficient testosterone response|8|||
147123850|NCT00215657|530618585|FG005|Overall Study|Insufficient testosterone response|12|||
147123851|NCT00215657|530618586|FG006|Overall Study|Insufficient testosterone response|4|||
147568809|NCT01597245|532240137|FG016|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
147568810|NCT01597245|532240138|FG017|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
147568811|NCT01597245|532240139|FG018|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
147568812|NCT01597245|532240140|FG019|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
147568813|NCT01597245|532240141|FG020|Maintenance Period (Week 12 to Week 60)|Adverse Event|0|||
147568814|NCT01597245|532240121|FG000|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
147568815|NCT01597245|532240122|FG001|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
147568816|NCT01597245|532240123|FG002|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
147568817|NCT01597245|532240124|FG003|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
147568818|NCT01597245|532240125|FG004|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|3|||
147568819|NCT01597245|532240126|FG005|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|3|||
147568820|NCT01597245|532240127|FG006|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|1|||
147568821|NCT01597245|532240128|FG007|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
147568822|NCT01597245|532240129|FG008|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|4|||
147568823|NCT01597245|532240130|FG009|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|1|||
147568824|NCT01597245|532240131|FG010|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|6|||
147123852|NCT00215657|530618587|FG007|Overall Study|Insufficient testosterone response|7|||
147123853|NCT00215657|530618580|FG000|Overall Study|Other|3|||
147123854|NCT00215657|530618581|FG001|Overall Study|Other|1|||
147123855|NCT00215657|530618582|FG002|Overall Study|Other|2|||
147123856|NCT00215657|530618583|FG003|Overall Study|Other|3|||
147314279|NCT00514046|531317451|FG003|Overall Study|Disease progression on study|0|||
147314280|NCT00514046|531317452|FG004|Overall Study|Disease progression on study|0|||
147314281|NCT00514046|531317453|FG005|Overall Study|Disease progression on study|1|||
147568825|NCT01597245|532240132|FG011|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|5|||
147568826|NCT01597245|532240133|FG012|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|4|||
147568827|NCT01597245|532240134|FG013|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
147568828|NCT01597245|532240135|FG014|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
147568829|NCT01597245|532240136|FG015|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
147568830|NCT01597245|532240137|FG016|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
147568831|NCT01597245|532240138|FG017|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
147568832|NCT01597245|532240139|FG018|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
147568833|NCT01597245|532240140|FG019|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
147568834|NCT01597245|532240141|FG020|Maintenance Period (Week 12 to Week 60)|Withdrawal by Subject|0|||
147568835|NCT01597245|532240121|FG000|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
147568836|NCT01597245|532240122|FG001|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
147568837|NCT01597245|532240123|FG002|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
147568838|NCT01597245|532240124|FG003|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
147568839|NCT01597245|532240125|FG004|Maintenance Period (Week 12 to Week 60)|Protocol Violation|1|||
147568840|NCT01597245|532240126|FG005|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
147568841|NCT01597245|532240127|FG006|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
147568842|NCT01597245|532240128|FG007|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
147568843|NCT01597245|532240129|FG008|Maintenance Period (Week 12 to Week 60)|Protocol Violation|3|||
147568844|NCT01597245|532240130|FG009|Maintenance Period (Week 12 to Week 60)|Protocol Violation|1|||
147568845|NCT01597245|532240131|FG010|Maintenance Period (Week 12 to Week 60)|Protocol Violation|2|||
147651044|NCT02734862|532544575|FG002|Part A|Withdrawal by Subject|2|||
147123857|NCT00215657|530618584|FG004|Overall Study|Other|5|||
147123858|NCT00215657|530618585|FG005|Overall Study|Other|4|||
147314282|NCT00514046|531317454|FG006|Overall Study|Disease progression on study|0|||
147314283|NCT00514046|531317455|FG007|Overall Study|Disease progression on study|0|||
147123859|NCT00215657|530618586|FG006|Overall Study|Other|6|||
147314284|NCT00514046|531317456|FG008|Overall Study|Disease progression on study|0|||
147123860|NCT00215657|530618587|FG007|Overall Study|Other|1|||
147314285|NCT00655551|531317457|FG000|All Periods Combined|Adverse Event|0|||
147314286|NCT00655551|531317458|FG001|All Periods Combined|Adverse Event|3|||
147123861|NCT03769467|530618588|FG000|Overall Study|Adverse Event|1|||
147568846|NCT01597245|532240132|FG011|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
147568847|NCT01597245|532240133|FG012|Maintenance Period (Week 12 to Week 60)|Protocol Violation|1|||
147568848|NCT01597245|532240134|FG013|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
147568849|NCT01597245|532240135|FG014|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
147568850|NCT01597245|532240136|FG015|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
147568851|NCT01597245|532240137|FG016|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
147568852|NCT01597245|532240138|FG017|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
147568853|NCT01597245|532240139|FG018|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
147568854|NCT01597245|532240140|FG019|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
147568855|NCT01597245|532240141|FG020|Maintenance Period (Week 12 to Week 60)|Protocol Violation|0|||
147568856|NCT01597245|532240121|FG000|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
147568857|NCT01597245|532240122|FG001|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
147568858|NCT01597245|532240123|FG002|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
147568859|NCT01597245|532240124|FG003|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
147123862|NCT03769467|530618589|FG001|Overall Study|Adverse Event|1|||
147123863|NCT03769467|530618590|FG002|Overall Study|Adverse Event|0|||
147123864|NCT03769467|530618588|FG000|Overall Study|Death|3|||
147314287|NCT00655551|531317459|FG002|All Periods Combined|Adverse Event|4|||
147444625|NCT01147744|531792659|FG002|Overall Study|Physician Decision|1|||
147568860|NCT01597245|532240125|FG004|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|3|||
147568861|NCT01597245|532240126|FG005|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|4|||
147568862|NCT01597245|532240127|FG006|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|1|||
147568863|NCT01597245|532240128|FG007|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
147568864|NCT01597245|532240129|FG008|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|1|||
147568865|NCT01597245|532240130|FG009|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|2|||
147568866|NCT01597245|532240131|FG010|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|2|||
147568867|NCT01597245|532240132|FG011|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|2|||
147568868|NCT01597245|532240133|FG012|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|1|||
147568869|NCT01597245|532240134|FG013|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
147568870|NCT01597245|532240135|FG014|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
147568871|NCT01597245|532240136|FG015|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
147568872|NCT01597245|532240137|FG016|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
147568873|NCT01597245|532240138|FG017|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
147568874|NCT01597245|532240139|FG018|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
147568875|NCT01597245|532240140|FG019|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
147568876|NCT01597245|532240141|FG020|Maintenance Period (Week 12 to Week 60)|Lost to Follow-up|0|||
147568877|NCT01597245|532240121|FG000|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
147568878|NCT01597245|532240122|FG001|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
147568879|NCT01597245|532240123|FG002|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
147568880|NCT01597245|532240124|FG003|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
147568881|NCT01597245|532240125|FG004|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
147568882|NCT01597245|532240126|FG005|Maintenance Period (Week 12 to Week 60)|Physician Decision|1|||
147568883|NCT01597245|532240127|FG006|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
147123865|NCT03769467|530618589|FG001|Overall Study|Death|3|||
147123866|NCT03769467|530618590|FG002|Overall Study|Death|0|||
147123867|NCT03769467|530618588|FG000|Overall Study|Study Terminated By Sponsor|2|||
147123868|NCT03769467|530618589|FG001|Overall Study|Study Terminated By Sponsor|1|||
147123869|NCT03769467|530618590|FG002|Overall Study|Study Terminated By Sponsor|0|||
147123870|NCT03769467|530618588|FG000|Overall Study|Withdrawal by Subject|0|||
147123871|NCT03769467|530618589|FG001|Overall Study|Withdrawal by Subject|1|||
147123872|NCT03769467|530618590|FG002|Overall Study|Withdrawal by Subject|0|||
147123873|NCT04565756|530618591|FG000|Overall Study|Withdrawal by Subject|0|||
147123874|NCT04565756|530618592|FG001|Overall Study|Withdrawal by Subject|0|||
147123875|NCT04565756|530618593|FG002|Overall Study|Withdrawal by Subject|0|||
147123876|NCT04565756|530618594|FG003|Overall Study|Withdrawal by Subject|0|||
147123877|NCT04565756|530618595|FG004|Overall Study|Withdrawal by Subject|1|||
147123878|NCT04565756|530618596|FG005|Overall Study|Withdrawal by Subject|0|||
147123879|NCT04565756|530618591|FG000|Overall Study|Protocol Violation|0|||
147123880|NCT04565756|530618592|FG001|Overall Study|Protocol Violation|0|||
147123881|NCT04565756|530618593|FG002|Overall Study|Protocol Violation|0|||
147123882|NCT04565756|530618594|FG003|Overall Study|Protocol Violation|0|||
147123883|NCT04565756|530618595|FG004|Overall Study|Protocol Violation|0|||
147123884|NCT04565756|530618596|FG005|Overall Study|Protocol Violation|1|||
147123885|NCT05259722|530618597|FG000|Overall Study|Adverse Event|2|||
147123886|NCT05259722|530618598|FG001|Overall Study|Adverse Event|24|||
147123887|NCT05259722|530618597|FG000|Overall Study|Lost to Follow-up|5|||
147123888|NCT05259722|530618598|FG001|Overall Study|Lost to Follow-up|1|||
147123889|NCT05259722|530618597|FG000|Overall Study|Lack of Efficacy|8|||
147123890|NCT05259722|530618598|FG001|Overall Study|Lack of Efficacy|26|||
147568884|NCT01597245|532240128|FG007|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
147568885|NCT01597245|532240129|FG008|Maintenance Period (Week 12 to Week 60)|Physician Decision|1|||
147568886|NCT01597245|532240130|FG009|Maintenance Period (Week 12 to Week 60)|Physician Decision|1|||
147568887|NCT01597245|532240131|FG010|Maintenance Period (Week 12 to Week 60)|Physician Decision|1|||
147568888|NCT01597245|532240132|FG011|Maintenance Period (Week 12 to Week 60)|Physician Decision|1|||
147568889|NCT01597245|532240133|FG012|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
147568890|NCT01597245|532240134|FG013|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
147568891|NCT01597245|532240135|FG014|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
147568892|NCT01597245|532240136|FG015|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
147568893|NCT01597245|532240137|FG016|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
147568894|NCT01597245|532240138|FG017|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
147568895|NCT01597245|532240139|FG018|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
147568896|NCT01597245|532240140|FG019|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
147568897|NCT01597245|532240141|FG020|Maintenance Period (Week 12 to Week 60)|Physician Decision|0|||
147568898|NCT01597245|532240121|FG000|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
147568899|NCT01597245|532240122|FG001|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
147568900|NCT01597245|532240123|FG002|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
147568901|NCT01597245|532240124|FG003|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
147568902|NCT01597245|532240125|FG004|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
147568903|NCT01597245|532240126|FG005|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
147568904|NCT01597245|532240127|FG006|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
147568905|NCT01597245|532240128|FG007|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
147568906|NCT01597245|532240129|FG008|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
147568907|NCT01597245|532240130|FG009|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
147568908|NCT01597245|532240131|FG010|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|1|||
147568909|NCT01597245|532240132|FG011|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
147568910|NCT01597245|532240133|FG012|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
147568911|NCT01597245|532240134|FG013|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
147568912|NCT01597245|532240135|FG014|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
147568913|NCT01597245|532240136|FG015|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
147568914|NCT01597245|532240137|FG016|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
147568915|NCT01597245|532240138|FG017|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
147568916|NCT01597245|532240139|FG018|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
147568917|NCT01597245|532240140|FG019|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
147568918|NCT01597245|532240141|FG020|Maintenance Period (Week 12 to Week 60)|Sponsor Decision|0|||
147568919|NCT01597245|532240121|FG000|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
147568920|NCT01597245|532240122|FG001|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
147568921|NCT01597245|532240123|FG002|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
147568922|NCT01597245|532240124|FG003|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
147568923|NCT01597245|532240125|FG004|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
147568924|NCT01597245|532240126|FG005|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
147568925|NCT01597245|532240127|FG006|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
147123891|NCT05259722|530618597|FG000|Overall Study|Withdrawal by Subject|15|||
147123892|NCT05259722|530618598|FG001|Overall Study|Withdrawal by Subject|33|||
147123893|NCT05259722|530618597|FG000|Overall Study|Various reasons|3|||
147123894|NCT05259722|530618598|FG001|Overall Study|Various reasons|9|||
147123895|NCT05259722|530618597|FG000|Overall Study|Not exposed to IMP|1|||
147123896|NCT05259722|530618598|FG001|Overall Study|Not exposed to IMP|12|||
147123897|NCT05259722|530618597|FG000|Overall Study|Discontinuation of IMP, related to COVID-19|1|||
147123898|NCT05259722|530618598|FG001|Overall Study|Discontinuation of IMP, related to COVID-19|0|||
147123899|NCT03688139|530618599|FG000|Overall Study|Lost to Follow-up|2|||
147123900|NCT03688139|530618600|FG001|Overall Study|Lost to Follow-up|0|||
147123901|NCT03688139|530618599|FG000|Overall Study|Physician Decision|0|||
147123902|NCT03688139|530618600|FG001|Overall Study|Physician Decision|1|||
147123903|NCT03688139|530618599|FG000|Overall Study|Withdrawal by Subject|2|||
147123904|NCT03688139|530618600|FG001|Overall Study|Withdrawal by Subject|3|||
147123905|NCT00420056|530618601|FG000|Overall Study|Objective progression or relapse|17|||
147123906|NCT01390584|530618603|FG000|Step 1: Induction Tx (ABVD Then PET/CT)|Ineligible|0|||
147123907|NCT01390584|530618604|FG001|Step 1: Induction Tx (ABVD Then PET/CT)|Ineligible|0|||
147123908|NCT01390584|530618605|FG002|Step 1: Induction Tx (ABVD Then PET/CT)|Ineligible|1|||
147123909|NCT00498485|530618606|FG000|Overall Study|Adverse Event|1|||
147123910|NCT00498485|530618607|FG001|Overall Study|Adverse Event|5|||
147123911|NCT01712074|530618610|FG000|Placebo Run-in Period|Adverse Event|2|||
147123912|NCT01712074|530618611|FG001|Placebo Run-in Period|Adverse Event|0|||
147123913|NCT01712074|530618612|FG002|Placebo Run-in Period|Adverse Event|0|||
147123914|NCT01712074|530618610|FG000|Placebo Run-in Period|Lost to Follow-up|1|||
147123915|NCT01712074|530618611|FG001|Placebo Run-in Period|Lost to Follow-up|0|||
147568926|NCT01597245|532240128|FG007|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
147568927|NCT01597245|532240129|FG008|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
147568928|NCT01597245|532240130|FG009|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
147568929|NCT01597245|532240131|FG010|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
147568930|NCT01597245|532240132|FG011|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
147568931|NCT01597245|532240133|FG012|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
147568932|NCT01597245|532240134|FG013|Long Term Extension (Week 60 - Week 264)|Adverse Event|1|||
147568933|NCT01597245|532240135|FG014|Long Term Extension (Week 60 - Week 264)|Adverse Event|69|||
147568934|NCT01597245|532240136|FG015|Long Term Extension (Week 60 - Week 264)|Adverse Event|70|||
147568935|NCT01597245|532240137|FG016|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
147568936|NCT01597245|532240138|FG017|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
147568937|NCT01597245|532240139|FG018|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
147568938|NCT01597245|532240140|FG019|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
147568939|NCT01597245|532240141|FG020|Long Term Extension (Week 60 - Week 264)|Adverse Event|0|||
147568940|NCT01597245|532240121|FG000|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
147568941|NCT01597245|532240122|FG001|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
147568942|NCT01597245|532240123|FG002|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
147568943|NCT01597245|532240124|FG003|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
147568944|NCT01597245|532240125|FG004|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
147568945|NCT01597245|532240126|FG005|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
147568946|NCT01597245|532240127|FG006|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
147568947|NCT01597245|532240128|FG007|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
147568948|NCT01597245|532240129|FG008|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
147568949|NCT01597245|532240130|FG009|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
147568950|NCT01597245|532240131|FG010|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
147568951|NCT01597245|532240132|FG011|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
147233332|NCT02345226|531026378|FG000|Double-Blind Phase|Adverse Event|5|||
147233333|NCT02345226|531026379|FG001|Double-Blind Phase|Adverse Event|6|||
147233334|NCT02345226|531026378|FG000|Double-Blind Phase|Death|3|||
147233335|NCT02345226|531026379|FG001|Double-Blind Phase|Death|0|||
147233336|NCT02345226|531026378|FG000|Double-Blind Phase|Pregnancy|0|||
147233337|NCT02345226|531026379|FG001|Double-Blind Phase|Pregnancy|1|||
147233338|NCT02345226|531026378|FG000|Double-Blind Phase|Lack of Efficacy|1|||
147233339|NCT02345226|531026379|FG001|Double-Blind Phase|Lack of Efficacy|0|||
147233340|NCT02345226|531026378|FG000|Double-Blind Phase|Investigator's Discretion|4|||
147233341|NCT02345226|531026379|FG001|Double-Blind Phase|Investigator's Discretion|3|||
147233342|NCT02345226|531026378|FG000|Double-Blind Phase|Non-Compliance with Study Drug|1|||
147233343|NCT02345226|531026379|FG001|Double-Blind Phase|Non-Compliance with Study Drug|2|||
147233344|NCT02345226|531026378|FG000|Double-Blind Phase|Withdrew Consent|41|||
147233345|NCT02345226|531026379|FG001|Double-Blind Phase|Withdrew Consent|39|||
147233346|NCT02345226|531026378|FG000|Double-Blind Phase|Lost to Follow-up|12|||
147233347|NCT02345226|531026379|FG001|Double-Blind Phase|Lost to Follow-up|16|||
147233348|NCT02345226|531026378|FG000|Double-Blind Phase|Randomized but Never Treated|2|||
147233349|NCT02345226|531026379|FG001|Double-Blind Phase|Randomized but Never Treated|4|||
147233350|NCT02345226|531026378|FG000|Open-Label Extension Phase|Lost to Follow-up|0|||
147233351|NCT02345226|531026379|FG001|Open-Label Extension Phase|Lost to Follow-up|1|||
147444626|NCT01147744|531792660|FG003|Overall Study|Physician Decision|0|||
147568952|NCT01597245|532240133|FG012|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
147568953|NCT01597245|532240134|FG013|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|1|||
147568954|NCT01597245|532240135|FG014|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|62|||
147568955|NCT01597245|532240136|FG015|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|63|||
147568956|NCT01597245|532240137|FG016|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
147651045|NCT02734862|532544573|FG000|Part A|Physician Decision|2|||
147651046|NCT02734862|532544574|FG001|Part A|Physician Decision|0|||
147123916|NCT01712074|530618612|FG002|Placebo Run-in Period|Lost to Follow-up|0|||
147123917|NCT01712074|530618610|FG000|Placebo Run-in Period|No longer meets eligibility criteria|5|||
147123918|NCT01712074|530618611|FG001|Placebo Run-in Period|No longer meets eligibility criteria|0|||
147123919|NCT01712074|530618612|FG002|Placebo Run-in Period|No longer meets eligibility criteria|0|||
147123920|NCT01712074|530618610|FG000|Placebo Run-in Period|Other|1|||
147123921|NCT01712074|530618611|FG001|Placebo Run-in Period|Other|0|||
147123922|NCT01712074|530618612|FG002|Placebo Run-in Period|Other|0|||
147123923|NCT01712074|530618610|FG000|Placebo Run-in Period|No longer willing to participate|1|||
147123924|NCT01712074|530618611|FG001|Placebo Run-in Period|No longer willing to participate|0|||
147123925|NCT01712074|530618612|FG002|Placebo Run-in Period|No longer willing to participate|0|||
147123926|NCT01712074|530618610|FG000|Double Blind Period|Adverse Event|0|||
147123927|NCT01712074|530618611|FG001|Double Blind Period|Adverse Event|2|||
147123928|NCT01712074|530618612|FG002|Double Blind Period|Adverse Event|1|||
147123929|NCT01712074|530618610|FG000|Double Blind Period|No longer willing to participate|0|||
147568957|NCT01597245|532240138|FG017|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
147568958|NCT01597245|532240139|FG018|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
147568959|NCT01597245|532240140|FG019|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
147568960|NCT01597245|532240141|FG020|Long Term Extension (Week 60 - Week 264)|Withdrawal by Subject|0|||
147568961|NCT01597245|532240121|FG000|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
147568962|NCT01597245|532240122|FG001|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
147568963|NCT01597245|532240123|FG002|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
147568964|NCT01597245|532240124|FG003|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
147568965|NCT01597245|532240125|FG004|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
147568966|NCT01597245|532240126|FG005|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
147568967|NCT01597245|532240127|FG006|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
147568968|NCT01597245|532240128|FG007|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
147568969|NCT01597245|532240129|FG008|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
147568970|NCT01597245|532240130|FG009|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
147123930|NCT01712074|530618611|FG001|Double Blind Period|No longer willing to participate|2|||
147123931|NCT01712074|530618612|FG002|Double Blind Period|No longer willing to participate|4|||
147123932|NCT01712074|530618610|FG000|Double Blind Period|Death|0|||
147123933|NCT01712074|530618611|FG001|Double Blind Period|Death|1|||
147314288|NCT00655551|531317457|FG000|Period 2 (up to 7 Days)|Adverse Event|0|||
147314289|NCT00655551|531317458|FG001|Period 2 (up to 7 Days)|Adverse Event|1|||
147314290|NCT00655551|531317459|FG002|Period 2 (up to 7 Days)|Adverse Event|0|||
147314291|NCT00655551|531317457|FG000|Period 3 (up to 7 Days)|Adverse Event|0|||
147314292|NCT00655551|531317458|FG001|Period 3 (up to 7 Days)|Adverse Event|0|||
147314293|NCT00655551|531317459|FG002|Period 3 (up to 7 Days)|Adverse Event|4|||
147314294|NCT00655551|531317457|FG000|Period 4 (up to 7 Days)|Adverse Event|0|||
147314295|NCT00655551|531317458|FG001|Period 4 (up to 7 Days)|Adverse Event|2|||
147314296|NCT00655551|531317459|FG002|Period 4 (up to 7 Days)|Adverse Event|0|||
147314297|NCT02049710|531317464|FG000|Overall Study|Lost to Follow-up|319|||
147314298|NCT02049710|531317465|FG001|Overall Study|Lost to Follow-up|324|||
147314299|NCT03391960|531317466|FG000|Overall Study|Protocol Violation|0|||
147314300|NCT03391960|531317467|FG001|Overall Study|Protocol Violation|0|||
147314301|NCT00581113|531319399|FG000|Overall Study|Withdrawal by Subject|0|||
147314302|NCT00581113|531319400|FG001|Overall Study|Withdrawal by Subject|1|||
147314303|NCT01818141|531319401|FG000|Overall Study|Withdrawal by Subject|2|||
147314304|NCT01818141|531319402|FG001|Overall Study|Withdrawal by Subject|0|||
147314305|NCT01818141|531319401|FG000|Overall Study|No baseline C.diff colonies|1|||
147314306|NCT01818141|531319402|FG001|Overall Study|No baseline C.diff colonies|1|||
147314307|NCT01818141|531319401|FG000|Overall Study|Lost to Follow-up|0|||
147123934|NCT01712074|530618612|FG002|Double Blind Period|Death|0|||
147123935|NCT01712074|530618610|FG000|Double Blind Period|Lost to Follow-up|0|||
147123936|NCT01712074|530618611|FG001|Double Blind Period|Lost to Follow-up|2|||
147123937|NCT01712074|530618612|FG002|Double Blind Period|Lost to Follow-up|1|||
147123938|NCT01712074|530618610|FG000|Double Blind Period|Other|0|||
147123939|NCT01712074|530618611|FG001|Double Blind Period|Other|4|||
147123940|NCT01712074|530618612|FG002|Double Blind Period|Other|1|||
147123941|NCT01712074|530618610|FG000|Double Blind Period|Protocol Violation|0|||
147233352|NCT01710046|531026382|FG000|Overall Study|Lost to Follow-up|1|||
147233353|NCT01710046|531026383|FG001|Overall Study|Lost to Follow-up|0|||
147233354|NCT02282358|531026390|FG000|Overall Study|Nonevaluable|1|||
147233355|NCT01898208|531026391|FG000|Overall Study|Positive blood culture|17|||
147233356|NCT01898208|531026392|FG001|Overall Study|Positive blood culture|23|||
147233357|NCT01898208|531026393|FG002|Overall Study|Positive blood culture|15|||
147233358|NCT01898208|531026391|FG000|Overall Study|Death/comfort care within 24 hours|10|||
147233359|NCT01898208|531026392|FG001|Overall Study|Death/comfort care within 24 hours|9|||
147233360|NCT01898208|531026393|FG002|Overall Study|Death/comfort care within 24 hours|8|||
147233361|NCT01898208|531026391|FG000|Overall Study|Negative Gram Stain|6|||
147233362|NCT01898208|531026392|FG001|Overall Study|Negative Gram Stain|9|||
147233363|NCT01898208|531026393|FG002|Overall Study|Negative Gram Stain|6|||
147233364|NCT01898208|531026391|FG000|Overall Study|Non-Blood Specimens in Bottles|3|||
147233365|NCT01898208|531026392|FG001|Overall Study|Non-Blood Specimens in Bottles|5|||
147233366|NCT01898208|531026393|FG002|Overall Study|Non-Blood Specimens in Bottles|4|||
147233367|NCT01898208|531026391|FG000|Overall Study|System/Technical Error|1|||
147233368|NCT01898208|531026392|FG001|Overall Study|System/Technical Error|2|||
147233369|NCT01898208|531026393|FG002|Overall Study|System/Technical Error|3|||
147233370|NCT01898208|531026391|FG000|Overall Study|Lost to Follow-up|3|||
147233371|NCT01898208|531026392|FG001|Overall Study|Lost to Follow-up|1|||
147233372|NCT01898208|531026393|FG002|Overall Study|Lost to Follow-up|1|||
147233373|NCT01033851|531026395|FG000|Overall Study|Withdrawal by Subject|3|||
147233374|NCT01033851|531026396|FG001|Overall Study|Withdrawal by Subject|7|||
147233375|NCT02349542|531026397|FG000|Overall Study|Withdrawal by Subject|5|||
147314308|NCT01818141|531319402|FG001|Overall Study|Lost to Follow-up|2|||
147314309|NCT02169830|531319403|FG000|Diet Intervention (4 Weeks)|Lost to Follow-up|0|||
147314310|NCT02169830|531319404|FG001|Diet Intervention (4 Weeks)|Lost to Follow-up|0|||
147123942|NCT01712074|530618611|FG001|Double Blind Period|Protocol Violation|0|||
147123943|NCT01712074|530618612|FG002|Double Blind Period|Protocol Violation|1|||
147123944|NCT01712074|530618610|FG000|Double Blind Period|No longer met eligibility criteria|0|||
147123945|NCT01712074|530618611|FG001|Double Blind Period|No longer met eligibility criteria|3|||
147123946|NCT01712074|530618612|FG002|Double Blind Period|No longer met eligibility criteria|0|||
147123947|NCT02268851|530618613|FG000|Overall Study|Death|0|||
147123948|NCT02268851|530618614|FG001|Overall Study|Death|0|||
147123949|NCT02268851|530618615|FG002|Overall Study|Death|0|||
147123950|NCT02268851|530618616|FG003|Overall Study|Death|1|||
147123951|NCT02268851|530618617|FG004|Overall Study|Death|2|||
147123952|NCT02268851|530618618|FG005|Overall Study|Death|1|||
147123953|NCT02268851|530618613|FG000|Overall Study|Adverse Event|0|||
147123954|NCT02268851|530618614|FG001|Overall Study|Adverse Event|0|||
147123955|NCT02268851|530618615|FG002|Overall Study|Adverse Event|0|||
147233376|NCT01011738|531026398|FG000|Overall Study|Death|12|||
147233377|NCT01011738|531026399|FG001|Overall Study|Death|3|||
147233378|NCT01011738|531026400|FG002|Overall Study|Death|0|||
147233379|NCT01011738|531026398|FG000|Overall Study|Unknown reasons|312|||
147233380|NCT01011738|531026399|FG001|Overall Study|Unknown reasons|291|||
147233381|NCT01011738|531026400|FG002|Overall Study|Unknown reasons|17|||
147233382|NCT03896165|531026403|FG000|Overall Study|Withdrawal by Subject|2|||
147233383|NCT01163266|531026404|FG000|Overall Study|Pretreatment Event or Adverse Event|2|||
147233384|NCT01163266|531026405|FG001|Overall Study|Pretreatment Event or Adverse Event|9|||
147233385|NCT01163266|531026406|FG002|Overall Study|Pretreatment Event or Adverse Event|7|||
147233386|NCT01163266|531026404|FG000|Overall Study|Lack of Efficacy|1|||
147233387|NCT01163266|531026405|FG001|Overall Study|Lack of Efficacy|3|||
147233388|NCT01163266|531026406|FG002|Overall Study|Lack of Efficacy|1|||
147233389|NCT01163266|531026404|FG000|Overall Study|Noncompliance with Study Drug|0|||
147233390|NCT01163266|531026405|FG001|Overall Study|Noncompliance with Study Drug|2|||
147233391|NCT01163266|531026406|FG002|Overall Study|Noncompliance with Study Drug|0|||
147233392|NCT01163266|531026404|FG000|Overall Study|Protocol Deviations|2|||
147233393|NCT01163266|531026405|FG001|Overall Study|Protocol Deviations|2|||
147233394|NCT01163266|531026406|FG002|Overall Study|Protocol Deviations|5|||
147233395|NCT01163266|531026404|FG000|Overall Study|Withdrawal of Consent|5|||
147233396|NCT01163266|531026405|FG001|Overall Study|Withdrawal of Consent|7|||
147233397|NCT01163266|531026406|FG002|Overall Study|Withdrawal of Consent|3|||
147233398|NCT01163266|531026404|FG000|Overall Study|Lost to Follow-up|7|||
147233399|NCT01163266|531026405|FG001|Overall Study|Lost to Follow-up|7|||
147233400|NCT01163266|531026406|FG002|Overall Study|Lost to Follow-up|10|||
147233401|NCT01163266|531026404|FG000|Overall Study|Other|1|||
147233402|NCT01163266|531026405|FG001|Overall Study|Other|1|||
147233403|NCT01163266|531026406|FG002|Overall Study|Other|2|||
147233404|NCT02919696|531026407|FG000|Overall Study|Adverse Event|1|||
147233405|NCT02919696|531026408|FG001|Overall Study|Adverse Event|2|||
147233406|NCT02919696|531026407|FG000|Overall Study|Withdrawal by Subject|2|||
147233407|NCT02919696|531026408|FG001|Overall Study|Withdrawal by Subject|1|||
147233408|NCT02919696|531026407|FG000|Overall Study|Sponsor Decision|1|||
147233409|NCT02919696|531026408|FG001|Overall Study|Sponsor Decision|1|||
147233410|NCT02919696|531026407|FG000|Overall Study|Never Treated|0|||
147233411|NCT02919696|531026408|FG001|Overall Study|Never Treated|1|||
147233412|NCT03181893|531026409|FG000|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
147233413|NCT03181893|531026410|FG001|Baseline to Week 12 (All Stages)|Withdrawal by Subject|1|||
147233414|NCT03181893|531026411|FG002|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
147233415|NCT03181893|531026412|FG003|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
147233416|NCT03181893|531026413|FG004|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
147233417|NCT03181893|531026414|FG005|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
147233418|NCT03181893|531026415|FG006|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
147233419|NCT03181893|531026416|FG007|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
147233420|NCT03181893|531026417|FG008|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
147233421|NCT03181893|531026418|FG009|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
147233422|NCT03181893|531026419|FG010|Baseline to Week 12 (All Stages)|Withdrawal by Subject|0|||
147233423|NCT03181893|531026409|FG000|Baseline to Week 12 (All Stages)|Adverse Event|1|||
147233424|NCT03181893|531026410|FG001|Baseline to Week 12 (All Stages)|Adverse Event|1|||
147233425|NCT03181893|531026411|FG002|Baseline to Week 12 (All Stages)|Adverse Event|0|||
147233426|NCT03181893|531026412|FG003|Baseline to Week 12 (All Stages)|Adverse Event|0|||
147233427|NCT03181893|531026413|FG004|Baseline to Week 12 (All Stages)|Adverse Event|0|||
147233428|NCT03181893|531026414|FG005|Baseline to Week 12 (All Stages)|Adverse Event|0|||
147233429|NCT03181893|531026415|FG006|Baseline to Week 12 (All Stages)|Adverse Event|0|||
147233430|NCT03181893|531026416|FG007|Baseline to Week 12 (All Stages)|Adverse Event|0|||
147233431|NCT03181893|531026417|FG008|Baseline to Week 12 (All Stages)|Adverse Event|0|||
147233432|NCT03181893|531026418|FG009|Baseline to Week 12 (All Stages)|Adverse Event|0|||
147233433|NCT03181893|531026419|FG010|Baseline to Week 12 (All Stages)|Adverse Event|0|||
147233434|NCT03181893|531026409|FG000|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
147123956|NCT02268851|530618616|FG003|Overall Study|Adverse Event|0|||
147123957|NCT02268851|530618617|FG004|Overall Study|Adverse Event|2|||
147314311|NCT02169830|531319405|FG002|Diet Intervention (4 Weeks)|Lost to Follow-up|1|||
147314312|NCT02169830|531319403|FG000|Second Intervention (8 Weeks)|Lost to Follow-up|1|||
147314313|NCT02169830|531319404|FG001|Second Intervention (8 Weeks)|Lost to Follow-up|0|||
147314314|NCT02169830|531319405|FG002|Second Intervention (8 Weeks)|Lost to Follow-up|0|||
147314315|NCT02169830|531319403|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|2|||
147123958|NCT02268851|530618618|FG005|Overall Study|Adverse Event|2|||
147123959|NCT02268851|530618613|FG000|Overall Study|Withdrawal by Subject|0|||
147123960|NCT02268851|530618614|FG001|Overall Study|Withdrawal by Subject|0|||
147123961|NCT02268851|530618615|FG002|Overall Study|Withdrawal by Subject|0|||
147123962|NCT02268851|530618616|FG003|Overall Study|Withdrawal by Subject|2|||
147123963|NCT02268851|530618617|FG004|Overall Study|Withdrawal by Subject|0|||
147123964|NCT02268851|530618618|FG005|Overall Study|Withdrawal by Subject|1|||
147123965|NCT02268851|530618613|FG000|Overall Study|Progressive Disease|1|||
147123966|NCT02268851|530618614|FG001|Overall Study|Progressive Disease|3|||
147123967|NCT02268851|530618615|FG002|Overall Study|Progressive Disease|0|||
147123968|NCT02268851|530618616|FG003|Overall Study|Progressive Disease|0|||
147123969|NCT02268851|530618617|FG004|Overall Study|Progressive Disease|1|||
147123970|NCT02268851|530618618|FG005|Overall Study|Progressive Disease|4|||
147123971|NCT02268851|530618613|FG000|Overall Study|Physician Decision|0|||
147123972|NCT02268851|530618614|FG001|Overall Study|Physician Decision|0|||
147123973|NCT02268851|530618615|FG002|Overall Study|Physician Decision|1|||
147123974|NCT02268851|530618616|FG003|Overall Study|Physician Decision|0|||
147123975|NCT02268851|530618617|FG004|Overall Study|Physician Decision|0|||
147123976|NCT02268851|530618618|FG005|Overall Study|Physician Decision|1|||
147123977|NCT02268851|530618613|FG000|Overall Study|Patient Compliance|0|||
147123978|NCT02268851|530618614|FG001|Overall Study|Patient Compliance|0|||
147123979|NCT02268851|530618615|FG002|Overall Study|Patient Compliance|0|||
147123980|NCT02268851|530618616|FG003|Overall Study|Patient Compliance|0|||
147123981|NCT02268851|530618617|FG004|Overall Study|Patient Compliance|1|||
147314316|NCT02169830|531319404|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|5|||
147314317|NCT02169830|531319405|FG002|Second Intervention (8 Weeks)|Withdrawal by Subject|0|||
147314318|NCT02169830|531319403|FG000|Third Intervention (8 Weeks)|Lost to Follow-up|0|||
147314319|NCT02169830|531319404|FG001|Third Intervention (8 Weeks)|Lost to Follow-up|1|||
147314320|NCT02169830|531319405|FG002|Third Intervention (8 Weeks)|Lost to Follow-up|0|||
147314321|NCT02169830|531319403|FG000|Third Intervention (8 Weeks)|Withdrawal by Subject|0|||
147314322|NCT02169830|531319404|FG001|Third Intervention (8 Weeks)|Withdrawal by Subject|1|||
147314323|NCT02169830|531319405|FG002|Third Intervention (8 Weeks)|Withdrawal by Subject|0|||
147314324|NCT03204695|531319406|FG000|Overall Study|Death|1|||
147314325|NCT03204695|531319406|FG000|Overall Study|Participant was treated with another device|1|||
147314326|NCT03204695|531319406|FG000|Overall Study|Physician Decision|2|||
147314327|NCT04834362|531319407|FG000|Overall Study|Death|1|||
147314328|NCT04834362|531319408|FG001|Overall Study|Death|2|||
147314329|NCT02555371|531319409|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|1|||
147314330|NCT02555371|531319410|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|0|||
147314331|NCT02555371|531319411|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|0|||
147314332|NCT02555371|531319412|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|0|||
147314333|NCT02555371|531319413|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Adverse Event|0|||
147123982|NCT02268851|530618618|FG005|Overall Study|Patient Compliance|1|||
147123983|NCT02268851|530618613|FG000|Overall Study|Co-Morbid Condition|0|||
147123984|NCT02268851|530618614|FG001|Overall Study|Co-Morbid Condition|0|||
147123985|NCT02268851|530618615|FG002|Overall Study|Co-Morbid Condition|0|||
147123986|NCT02268851|530618616|FG003|Overall Study|Co-Morbid Condition|0|||
147123987|NCT02268851|530618617|FG004|Overall Study|Co-Morbid Condition|1|||
147123988|NCT02268851|530618618|FG005|Overall Study|Co-Morbid Condition|1|||
147123989|NCT03378635|530618621|FG000|Overall Study|Adverse Event|1|||
147123990|NCT03378635|530618622|FG001|Overall Study|Adverse Event|0|||
147123991|NCT03378635|530618623|FG002|Overall Study|Adverse Event|0|||
147123992|NCT03378635|530618621|FG000|Overall Study|Withdrawal by Subject|1|||
147314334|NCT02555371|531319409|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|2|||
147444627|NCT01147744|531792661|FG004|Overall Study|Physician Decision|0|||
147314335|NCT02555371|531319410|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|0|||
147314336|NCT02555371|531319411|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|0|||
147314337|NCT02555371|531319412|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|0|||
147314338|NCT02555371|531319413|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Failure to meet continuation criteria|0|||
147123993|NCT03378635|530618622|FG001|Overall Study|Withdrawal by Subject|0|||
147123994|NCT03378635|530618623|FG002|Overall Study|Withdrawal by Subject|0|||
147123995|NCT02539394|530618624|FG000|Overall Study|Protocol Violation|1|||
147123996|NCT02539394|530618625|FG001|Overall Study|Protocol Violation|3|||
147444628|NCT01147744|531792662|FG005|Overall Study|Physician Decision|0|||
147123997|NCT02539394|530618624|FG000|Overall Study|Lost to Follow-up|1|||
147123998|NCT02539394|530618625|FG001|Overall Study|Lost to Follow-up|2|||
147123999|NCT02539394|530618624|FG000|Overall Study|Incomplete dataset|6|||
147124000|NCT02539394|530618625|FG001|Overall Study|Incomplete dataset|6|||
147124001|NCT02413346|530618626|FG000|Overall Study|Adverse Event|6|||
147124002|NCT02413346|530618627|FG001|Overall Study|Adverse Event|6|||
147233435|NCT03181893|531026410|FG001|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
147233436|NCT03181893|531026411|FG002|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
147233437|NCT03181893|531026412|FG003|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
147233438|NCT03181893|531026413|FG004|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
147233439|NCT03181893|531026414|FG005|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
147233440|NCT03181893|531026415|FG006|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
147233441|NCT03181893|531026416|FG007|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|1|||
147233442|NCT03181893|531026417|FG008|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|1|||
147233443|NCT03181893|531026418|FG009|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
147314339|NCT02555371|531319409|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|5|||
147314340|NCT02555371|531319410|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|0|||
147314341|NCT02555371|531319411|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|0|||
147314342|NCT02555371|531319412|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|0|||
147314343|NCT02555371|531319413|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Withdrawal by Subject|0|||
147314344|NCT02555371|531319409|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|1|||
147314345|NCT02555371|531319410|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|0|||
147314346|NCT02555371|531319411|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|0|||
147314347|NCT02555371|531319412|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|0|||
147314348|NCT02555371|531319413|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Physician Decision|0|||
147314349|NCT02555371|531319409|FG000|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|2|||
147314350|NCT02555371|531319410|FG001|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|0|||
147314351|NCT02555371|531319411|FG002|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|0|||
147314352|NCT02555371|531319412|FG003|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|0|||
147314353|NCT02555371|531319413|FG004|PartA(Upto 132W)+PartB(Upto 8W)|Lack of Efficacy|0|||
147314354|NCT02555371|531319409|FG000|Part C (DB Period: Up to 52W)|Switched to Part D treatment|0|||
147314355|NCT02555371|531319410|FG001|Part C (DB Period: Up to 52W)|Switched to Part D treatment|84|||
147314356|NCT02555371|531319411|FG002|Part C (DB Period: Up to 52W)|Switched to Part D treatment|45|||
147314357|NCT02555371|531319412|FG003|Part C (DB Period: Up to 52W)|Switched to Part D treatment|0|||
147314358|NCT02555371|531319413|FG004|Part C (DB Period: Up to 52W)|Switched to Part D treatment|0|||
147314359|NCT02555371|531319409|FG000|Part C (DB Period: Up to 52W)|Withdrawal by Subject|0|||
147314360|NCT02555371|531319410|FG001|Part C (DB Period: Up to 52W)|Withdrawal by Subject|2|||
147314361|NCT02555371|531319411|FG002|Part C (DB Period: Up to 52W)|Withdrawal by Subject|2|||
147314362|NCT02555371|531319412|FG003|Part C (DB Period: Up to 52W)|Withdrawal by Subject|0|||
147314363|NCT02555371|531319413|FG004|Part C (DB Period: Up to 52W)|Withdrawal by Subject|0|||
147314364|NCT02555371|531319409|FG000|Part C (DB Period: Up to 52W)|Lack of Efficacy|0|||
147314365|NCT02555371|531319410|FG001|Part C (DB Period: Up to 52W)|Lack of Efficacy|1|||
147314366|NCT02555371|531319411|FG002|Part C (DB Period: Up to 52W)|Lack of Efficacy|0|||
147314367|NCT02555371|531319412|FG003|Part C (DB Period: Up to 52W)|Lack of Efficacy|0|||
147314368|NCT02555371|531319413|FG004|Part C (DB Period: Up to 52W)|Lack of Efficacy|0|||
147314369|NCT02555371|531319409|FG000|Part C (DB Period: Up to 52W)|Adverse Event|0|||
147314370|NCT02555371|531319410|FG001|Part C (DB Period: Up to 52W)|Adverse Event|2|||
147314371|NCT02555371|531319411|FG002|Part C (DB Period: Up to 52W)|Adverse Event|1|||
147314372|NCT02555371|531319412|FG003|Part C (DB Period: Up to 52W)|Adverse Event|0|||
147314373|NCT02555371|531319413|FG004|Part C (DB Period: Up to 52W)|Adverse Event|0|||
147314374|NCT02555371|531319409|FG000|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|0|||
147314375|NCT02555371|531319410|FG001|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|0|||
147314376|NCT02555371|531319411|FG002|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|0|||
147314377|NCT02555371|531319412|FG003|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|1|||
147314378|NCT02555371|531319413|FG004|PartD(OL: 52W Post-randomization PartC)|Withdrawal by Subject|0|||
147314379|NCT02555371|531319409|FG000|PartD(OL: 52W Post-randomization PartC)|Physician Decision|0|||
147314380|NCT02555371|531319410|FG001|PartD(OL: 52W Post-randomization PartC)|Physician Decision|0|||
147314381|NCT02555371|531319411|FG002|PartD(OL: 52W Post-randomization PartC)|Physician Decision|0|||
147314382|NCT02555371|531319412|FG003|PartD(OL: 52W Post-randomization PartC)|Physician Decision|2|||
147314383|NCT02555371|531319413|FG004|PartD(OL: 52W Post-randomization PartC)|Physician Decision|0|||
147314384|NCT02555371|531319409|FG000|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|0|||
147314385|NCT02555371|531319410|FG001|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|0|||
147314386|NCT02555371|531319411|FG002|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|0|||
147314387|NCT02555371|531319412|FG003|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|0|||
147314388|NCT02555371|531319413|FG004|PartD(OL: 52W Post-randomization PartC)|Lost to Follow-up|2|||
147314389|NCT02555371|531319409|FG000|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|0|||
147314390|NCT02555371|531319410|FG001|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|0|||
147233444|NCT03181893|531026419|FG010|Weeks 12-24 (Amended Stage 2, Stage 3)|Other|0|||
147314391|NCT02555371|531319411|FG002|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|0|||
147314392|NCT02555371|531319412|FG003|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|0|||
147314393|NCT02555371|531319413|FG004|PartD(OL: 52W Post-randomization PartC)|Lack of Efficacy|1|||
147233445|NCT03181893|531026409|FG000|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
147124003|NCT02413346|530618626|FG000|Overall Study|Withdrawal by Subject|30|||
147124004|NCT02413346|530618627|FG001|Overall Study|Withdrawal by Subject|40|||
147124005|NCT02413346|530618626|FG000|Overall Study|Lost to Follow-up|17|||
147124006|NCT02413346|530618627|FG001|Overall Study|Lost to Follow-up|21|||
147314394|NCT02555371|531319409|FG000|PartD(OL: 52W Post-randomization PartC)|Adverse Event|0|||
147314395|NCT02555371|531319410|FG001|PartD(OL: 52W Post-randomization PartC)|Adverse Event|0|||
147314396|NCT02555371|531319411|FG002|PartD(OL: 52W Post-randomization PartC)|Adverse Event|0|||
147314397|NCT02555371|531319412|FG003|PartD(OL: 52W Post-randomization PartC)|Adverse Event|1|||
147314398|NCT02555371|531319413|FG004|PartD(OL: 52W Post-randomization PartC)|Adverse Event|0|||
147314399|NCT03095599|531319414|FG000|Overall Study|Withdrawal by Subject|1|||
147314400|NCT03095599|531319415|FG001|Overall Study|Withdrawal by Subject|0|||
147314401|NCT03095599|531319414|FG000|Overall Study|Lost to Follow-up|1|||
147314402|NCT03095599|531319415|FG001|Overall Study|Lost to Follow-up|0|||
147314403|NCT03095599|531319414|FG000|Overall Study|Withdrawal prior to vaccination|1|||
147314404|NCT03095599|531319415|FG001|Overall Study|Withdrawal prior to vaccination|0|||
147314405|NCT00742885|531319419|FG000|Overall Study|Lost to Follow-up|1|||
147314406|NCT00742885|531319420|FG001|Overall Study|Lost to Follow-up|0|||
147314407|NCT04781647|531319421|FG000|Overall Study|Study terminated by Sponsor|11|||
147314408|NCT04781647|531319422|FG001|Overall Study|Study terminated by Sponsor|9|||
147314409|NCT04781647|531319423|FG002|Overall Study|Study terminated by Sponsor|9|||
147314410|NCT04781647|531319421|FG000|Overall Study|Withdrawal by Subject|1|||
147314411|NCT04781647|531319422|FG001|Overall Study|Withdrawal by Subject|2|||
147314412|NCT04781647|531319423|FG002|Overall Study|Withdrawal by Subject|0|||
147314413|NCT04781647|531319421|FG000|Overall Study|Adverse Event|0|||
147314414|NCT04781647|531319422|FG001|Overall Study|Adverse Event|1|||
147314415|NCT04781647|531319423|FG002|Overall Study|Adverse Event|1|||
147314416|NCT04781647|531319421|FG000|Overall Study|Protocol Violation|1|||
147314417|NCT04781647|531319422|FG001|Overall Study|Protocol Violation|0|||
147314418|NCT04781647|531319423|FG002|Overall Study|Protocol Violation|0|||
147314419|NCT04781647|531319421|FG000|Overall Study|Pregnancy|0|||
147314420|NCT04781647|531319422|FG001|Overall Study|Pregnancy|0|||
147314421|NCT04781647|531319423|FG002|Overall Study|Pregnancy|1|||
147314422|NCT04781647|531319421|FG000|Overall Study|Virology rebounded|1|||
147314423|NCT04781647|531319422|FG001|Overall Study|Virology rebounded|0|||
147314424|NCT04781647|531319423|FG002|Overall Study|Virology rebounded|0|||
147314425|NCT01755689|531319424|FG000|Overall Study|Withdrawal by Subject|1|||
147314426|NCT01755689|531319425|FG001|Overall Study|Withdrawal by Subject|3|||
147314427|NCT01755689|531319426|FG002|Overall Study|Withdrawal by Subject|2|||
147314428|NCT01755689|531319427|FG003|Overall Study|Withdrawal by Subject|1|||
147314429|NCT01755689|531319428|FG004|Overall Study|Withdrawal by Subject|1|||
147314430|NCT01755689|531319424|FG000|Overall Study|Migrated/moved from study area|0|||
147314431|NCT01755689|531319425|FG001|Overall Study|Migrated/moved from study area|1|||
147314432|NCT01755689|531319426|FG002|Overall Study|Migrated/moved from study area|1|||
147314433|NCT01755689|531319427|FG003|Overall Study|Migrated/moved from study area|1|||
147314434|NCT01755689|531319428|FG004|Overall Study|Migrated/moved from study area|1|||
147314435|NCT01755689|531319424|FG000|Overall Study|Lost to Follow-up|1|||
147314436|NCT01755689|531319425|FG001|Overall Study|Lost to Follow-up|0|||
147314437|NCT01755689|531319426|FG002|Overall Study|Lost to Follow-up|1|||
147314438|NCT01755689|531319427|FG003|Overall Study|Lost to Follow-up|0|||
147314439|NCT01755689|531319428|FG004|Overall Study|Lost to Follow-up|2|||
147314440|NCT01755689|531319424|FG000|Overall Study|Pregnancy|1|||
147314441|NCT01755689|531319425|FG001|Overall Study|Pregnancy|1|||
147314442|NCT01755689|531319426|FG002|Overall Study|Pregnancy|2|||
147314443|NCT01755689|531319427|FG003|Overall Study|Pregnancy|4|||
147314444|NCT01755689|531319428|FG004|Overall Study|Pregnancy|2|||
147314445|NCT02609659|531319429|FG000|Overall Study|Adverse Event|1|||
147314446|NCT02609659|531319429|FG000|Overall Study|Lost to Follow-up|6|||
147314447|NCT02609659|531319429|FG000|Overall Study|Other|1|||
147314448|NCT01155388|531319432|FG000|Overall Study|Adverse Event|1|||
147314449|NCT01155388|531319433|FG001|Overall Study|Adverse Event|0|||
147314450|NCT01004250|531319434|FG000|Induction Therapy Period|Adverse Event|10|||
147314451|NCT01004250|531319434|FG000|Induction Therapy Period|Entry Criteria Not Met|1|||
147314452|NCT01004250|531319434|FG000|Induction Therapy Period|Withdrawal by Subject|2|||
147314453|NCT01004250|531319434|FG000|Induction Therapy Period|Physician Decision|2|||
147314454|NCT01004250|531319434|FG000|Maintenance Therapy Period|Adverse Event|15|||
147314455|NCT01004250|531319434|FG000|Maintenance Therapy Period|Lost to Follow-up|1|||
147124007|NCT02413346|530618626|FG000|Overall Study|Protocol Violation|2|||
147124008|NCT02413346|530618627|FG001|Overall Study|Protocol Violation|0|||
147124009|NCT02413346|530618626|FG000|Overall Study|Other Miscellaneous Reasons|4|||
147124010|NCT02413346|530618627|FG001|Overall Study|Other Miscellaneous Reasons|3|||
147124011|NCT01472835|530618628|FG000|Overall Study|Lost to Follow-up|2|||
147124012|NCT01472835|530618629|FG001|Overall Study|Lost to Follow-up|0|||
147124013|NCT03425188|530618648|FG000|Overall Study|Withdrawal by Subject|1|||
147124014|NCT01835431|530618649|FG000|Overall Study|Adverse Event|1|||
147124015|NCT01835431|530618650|FG001|Overall Study|Adverse Event|0|||
147124016|NCT01835431|530618649|FG000|Overall Study|other|0|||
147124017|NCT01835431|530618650|FG001|Overall Study|other|2|||
147314456|NCT01004250|531319434|FG000|Maintenance Therapy Period|Protocol Violation|1|||
147314457|NCT01004250|531319434|FG000|Maintenance Therapy Period|Withdrawal by Subject|5|||
147314458|NCT01004250|531319434|FG000|Maintenance Therapy Period|Physician Decision|4|||
147314459|NCT01004250|531319434|FG000|Follow-Up (FU) Period|Lost to Follow-up|1|||
147314460|NCT03943589|531319435|FG000|Overall Study|Death|1|||
147314461|NCT03943589|531319435|FG000|Overall Study|Diagnosed with encephalomyelitis|1|||
147314462|NCT04329104|531319436|FG000|Efficacy Study|Withdrawal by Subject|0|||
147314463|NCT04329104|531319437|FG001|Efficacy Study|Withdrawal by Subject|0|||
147314464|NCT04329104|531319438|FG002|Efficacy Study|Withdrawal by Subject|0|||
147314465|NCT04329104|531319439|FG003|Efficacy Study|Withdrawal by Subject|5|||
147314466|NCT04329104|531319440|FG004|Efficacy Study|Withdrawal by Subject|6|||
147314467|NCT04329104|531319441|FG005|Efficacy Study|Withdrawal by Subject|8|||
147314468|NCT03884231|531319442|FG000|Overall Study|Subject Did Not Meet Inclusion/Exclusion Criteria|1|||
147314469|NCT03884231|531319442|FG000|Overall Study|Subject Withdrew Consent|1|||
147124018|NCT01835431|530618649|FG000|Overall Study|Withdrawal by Subject|6|||
147314470|NCT03884231|531319442|FG000|Overall Study|MRI Scan Not Performed|1|||
147124019|NCT01835431|530618650|FG001|Overall Study|Withdrawal by Subject|10|||
147314471|NCT01853254|531319443|FG000|Overall Study|Abnormal Laboratory Test|1|||
147314472|NCT01853254|531319443|FG000|Overall Study|Adverse Event/Intercurrent Illness|3|||
147314473|NCT01853254|531319443|FG000|Overall Study|Death|1|||
147314474|NCT01853254|531319443|FG000|Overall Study|Failure to Return|43|||
147314475|NCT01853254|531319443|FG000|Overall Study|Insufficient Therapeutic Response|22|||
147314476|NCT01853254|531319443|FG000|Overall Study|Refusal of Treatment|1|||
147314477|NCT01853254|531319443|FG000|Overall Study|Other Protocol Violation|1|||
147314478|NCT01853254|531319443|FG000|Overall Study|Withdrawal of Consent|16|||
147314479|NCT01853254|531319443|FG000|Overall Study|Administrative/Other|16|||
147314480|NCT00830947|531319444|FG000|Overall Study|Lost to Follow-up|4|||
147314481|NCT00830947|531319445|FG001|Overall Study|Lost to Follow-up|4|||
147314482|NCT02462083|531319446|FG000|Overall Study|Sponsor request|39|||
147314483|NCT02462083|531319446|FG000|Overall Study|Withdrawal by Subject|87|||
147314484|NCT02462083|531319446|FG000|Overall Study|Lost to Follow-up|41|||
147314485|NCT02462083|531319446|FG000|Overall Study|Lack of Efficacy|151|||
147314486|NCT02462083|531319446|FG000|Overall Study|Pregnancy|1|||
147314487|NCT02462083|531319446|FG000|Overall Study|Protocol Violation|6|||
147314488|NCT02462083|531319446|FG000|Overall Study|Adverse Event|33|||
147314489|NCT02462083|531319446|FG000|Overall Study|Worsening condition|16|||
147314490|NCT02462083|531319446|FG000|Overall Study|Other than specified|45|||
147314491|NCT01474512|531319448|FG000|Induction Period|Adverse Event|6|||
147314492|NCT01474512|531319449|FG001|Induction Period|Adverse Event|10|||
147314493|NCT01474512|531319450|FG002|Induction Period|Adverse Event|10|||
147314494|NCT01474512|531319451|FG003|Induction Period|Adverse Event|0|||
147314495|NCT01474512|531319452|FG004|Induction Period|Adverse Event|0|||
147314496|NCT01474512|531319453|FG005|Induction Period|Adverse Event|0|||
147314497|NCT01474512|531319454|FG006|Induction Period|Adverse Event|0|||
147314498|NCT01474512|531319455|FG007|Induction Period|Adverse Event|0|||
147314499|NCT01474512|531319456|FG008|Induction Period|Adverse Event|0|||
147314500|NCT01474512|531319457|FG009|Induction Period|Adverse Event|0|||
147314501|NCT01474512|531319458|FG010|Induction Period|Adverse Event|0|||
147314502|NCT01474512|531319459|FG011|Induction Period|Adverse Event|0|||
147314503|NCT01474512|531319460|FG012|Induction Period|Adverse Event|0|||
147314504|NCT01474512|531319461|FG013|Induction Period|Adverse Event|0|||
147314505|NCT01474512|531319462|FG014|Induction Period|Adverse Event|0|||
147314506|NCT01474512|531319463|FG015|Induction Period|Adverse Event|0|||
147314507|NCT01474512|531319464|FG016|Induction Period|Adverse Event|0|||
147314508|NCT01474512|531319465|FG017|Induction Period|Adverse Event|0|||
147314509|NCT01474512|531319448|FG000|Induction Period|Lack of Efficacy|7|||
147124020|NCT01835431|530618649|FG000|Overall Study|Protocol Violation|1|||
147124021|NCT01835431|530618650|FG001|Overall Study|Protocol Violation|0|||
147314510|NCT01474512|531319449|FG001|Induction Period|Lack of Efficacy|1|||
147314511|NCT01474512|531319450|FG002|Induction Period|Lack of Efficacy|0|||
147314512|NCT01474512|531319451|FG003|Induction Period|Lack of Efficacy|0|||
147314513|NCT01474512|531319452|FG004|Induction Period|Lack of Efficacy|0|||
147314514|NCT01474512|531319453|FG005|Induction Period|Lack of Efficacy|0|||
147314515|NCT01474512|531319454|FG006|Induction Period|Lack of Efficacy|0|||
147314516|NCT01474512|531319455|FG007|Induction Period|Lack of Efficacy|0|||
147314517|NCT01474512|531319456|FG008|Induction Period|Lack of Efficacy|0|||
147314518|NCT01474512|531319457|FG009|Induction Period|Lack of Efficacy|0|||
147314519|NCT01474512|531319458|FG010|Induction Period|Lack of Efficacy|0|||
147314520|NCT01474512|531319459|FG011|Induction Period|Lack of Efficacy|0|||
147314521|NCT01474512|531319460|FG012|Induction Period|Lack of Efficacy|0|||
147314522|NCT01474512|531319461|FG013|Induction Period|Lack of Efficacy|0|||
147314523|NCT01474512|531319462|FG014|Induction Period|Lack of Efficacy|0|||
147314524|NCT01474512|531319463|FG015|Induction Period|Lack of Efficacy|0|||
147314525|NCT01474512|531319464|FG016|Induction Period|Lack of Efficacy|0|||
147314526|NCT01474512|531319465|FG017|Induction Period|Lack of Efficacy|0|||
147314527|NCT01474512|531319448|FG000|Induction Period|Withdrawal by Subject|6|||
147314528|NCT01474512|531319449|FG001|Induction Period|Withdrawal by Subject|6|||
147124022|NCT01316900|530618655|FG000|Overall Study|Adverse Event|10|||
147444629|NCT01147744|531792663|FG006|Overall Study|Physician Decision|1|||
147314529|NCT01474512|531319450|FG002|Induction Period|Withdrawal by Subject|5|||
147314530|NCT01474512|531319451|FG003|Induction Period|Withdrawal by Subject|0|||
147314531|NCT01474512|531319452|FG004|Induction Period|Withdrawal by Subject|0|||
147314532|NCT01474512|531319453|FG005|Induction Period|Withdrawal by Subject|0|||
147314533|NCT01474512|531319454|FG006|Induction Period|Withdrawal by Subject|0|||
147314534|NCT01474512|531319455|FG007|Induction Period|Withdrawal by Subject|0|||
147314535|NCT01474512|531319456|FG008|Induction Period|Withdrawal by Subject|0|||
147314536|NCT01474512|531319457|FG009|Induction Period|Withdrawal by Subject|0|||
147314537|NCT01474512|531319458|FG010|Induction Period|Withdrawal by Subject|0|||
147314538|NCT01474512|531319459|FG011|Induction Period|Withdrawal by Subject|0|||
147314539|NCT01474512|531319460|FG012|Induction Period|Withdrawal by Subject|0|||
147314540|NCT01474512|531319461|FG013|Induction Period|Withdrawal by Subject|0|||
147314541|NCT01474512|531319462|FG014|Induction Period|Withdrawal by Subject|0|||
147314542|NCT01474512|531319463|FG015|Induction Period|Withdrawal by Subject|0|||
147314543|NCT01474512|531319464|FG016|Induction Period|Withdrawal by Subject|0|||
147314544|NCT01474512|531319465|FG017|Induction Period|Withdrawal by Subject|0|||
147314545|NCT01474512|531319448|FG000|Induction Period|Protocol Violation|3|||
147314546|NCT01474512|531319449|FG001|Induction Period|Protocol Violation|6|||
147314547|NCT01474512|531319450|FG002|Induction Period|Protocol Violation|0|||
147314548|NCT01474512|531319451|FG003|Induction Period|Protocol Violation|0|||
147314549|NCT01474512|531319452|FG004|Induction Period|Protocol Violation|0|||
147314550|NCT01474512|531319453|FG005|Induction Period|Protocol Violation|0|||
147124023|NCT01316900|530618656|FG001|Overall Study|Adverse Event|10|||
147124024|NCT01316900|530618657|FG002|Overall Study|Adverse Event|15|||
147124025|NCT01316900|530618658|FG003|Overall Study|Adverse Event|9|||
147124026|NCT01316900|530618655|FG000|Overall Study|Lack of Efficacy|17|||
147124027|NCT01316900|530618656|FG001|Overall Study|Lack of Efficacy|9|||
147124028|NCT01316900|530618657|FG002|Overall Study|Lack of Efficacy|5|||
147124029|NCT01316900|530618658|FG003|Overall Study|Lack of Efficacy|7|||
147124030|NCT01316900|530618655|FG000|Overall Study|Protocol Violation|7|||
147314551|NCT01474512|531319454|FG006|Induction Period|Protocol Violation|0|||
147314552|NCT01474512|531319455|FG007|Induction Period|Protocol Violation|0|||
147314553|NCT01474512|531319456|FG008|Induction Period|Protocol Violation|0|||
147314554|NCT01474512|531319457|FG009|Induction Period|Protocol Violation|0|||
147314555|NCT01474512|531319458|FG010|Induction Period|Protocol Violation|0|||
147314556|NCT01474512|531319459|FG011|Induction Period|Protocol Violation|0|||
147314557|NCT01474512|531319460|FG012|Induction Period|Protocol Violation|0|||
147314558|NCT01474512|531319461|FG013|Induction Period|Protocol Violation|0|||
147314559|NCT01474512|531319462|FG014|Induction Period|Protocol Violation|0|||
147314560|NCT01474512|531319463|FG015|Induction Period|Protocol Violation|0|||
147314561|NCT01474512|531319464|FG016|Induction Period|Protocol Violation|0|||
147314562|NCT01474512|531319465|FG017|Induction Period|Protocol Violation|0|||
147314563|NCT01474512|531319448|FG000|Induction Period|Sponsor Decision|1|||
147314564|NCT01474512|531319449|FG001|Induction Period|Sponsor Decision|1|||
147314565|NCT01474512|531319450|FG002|Induction Period|Sponsor Decision|1|||
147314566|NCT01474512|531319451|FG003|Induction Period|Sponsor Decision|0|||
147314567|NCT01474512|531319452|FG004|Induction Period|Sponsor Decision|0|||
147314568|NCT01474512|531319453|FG005|Induction Period|Sponsor Decision|0|||
147314569|NCT01474512|531319454|FG006|Induction Period|Sponsor Decision|0|||
147314570|NCT01474512|531319455|FG007|Induction Period|Sponsor Decision|0|||
147314571|NCT01474512|531319456|FG008|Induction Period|Sponsor Decision|0|||
147314572|NCT01474512|531319457|FG009|Induction Period|Sponsor Decision|0|||
147314573|NCT01474512|531319458|FG010|Induction Period|Sponsor Decision|0|||
147314574|NCT01474512|531319459|FG011|Induction Period|Sponsor Decision|0|||
147314575|NCT01474512|531319460|FG012|Induction Period|Sponsor Decision|0|||
147314576|NCT01474512|531319461|FG013|Induction Period|Sponsor Decision|0|||
147314577|NCT01474512|531319462|FG014|Induction Period|Sponsor Decision|0|||
147314578|NCT01474512|531319463|FG015|Induction Period|Sponsor Decision|0|||
147314579|NCT01474512|531319464|FG016|Induction Period|Sponsor Decision|0|||
147314580|NCT01474512|531319465|FG017|Induction Period|Sponsor Decision|0|||
147314581|NCT01474512|531319448|FG000|Induction Period|Lost to Follow-up|1|||
147124031|NCT01316900|530618656|FG001|Overall Study|Protocol Violation|1|||
147124032|NCT01316900|530618657|FG002|Overall Study|Protocol Violation|4|||
147314582|NCT01474512|531319449|FG001|Induction Period|Lost to Follow-up|0|||
147314583|NCT01474512|531319450|FG002|Induction Period|Lost to Follow-up|2|||
147314584|NCT01474512|531319451|FG003|Induction Period|Lost to Follow-up|0|||
147314585|NCT01474512|531319452|FG004|Induction Period|Lost to Follow-up|0|||
147314586|NCT01474512|531319453|FG005|Induction Period|Lost to Follow-up|0|||
147314587|NCT01474512|531319454|FG006|Induction Period|Lost to Follow-up|0|||
147444630|NCT01147744|531792657|FG000|Overall Study|Lack of Efficacy|11|||
147314588|NCT01474512|531319455|FG007|Induction Period|Lost to Follow-up|0|||
147314589|NCT01474512|531319456|FG008|Induction Period|Lost to Follow-up|0|||
147314590|NCT01474512|531319457|FG009|Induction Period|Lost to Follow-up|0|||
147444631|NCT01147744|531792658|FG001|Overall Study|Lack of Efficacy|11|||
147444632|NCT01147744|531792659|FG002|Overall Study|Lack of Efficacy|9|||
147124033|NCT01316900|530618658|FG003|Overall Study|Protocol Violation|0|||
147124034|NCT01316900|530618655|FG000|Overall Study|Protocol-defined Stopping Criteria|2|||
147314591|NCT01474512|531319458|FG010|Induction Period|Lost to Follow-up|0|||
147314592|NCT01474512|531319459|FG011|Induction Period|Lost to Follow-up|0|||
147314593|NCT01474512|531319460|FG012|Induction Period|Lost to Follow-up|0|||
147314594|NCT01474512|531319461|FG013|Induction Period|Lost to Follow-up|0|||
147314595|NCT01474512|531319462|FG014|Induction Period|Lost to Follow-up|0|||
147314596|NCT01474512|531319463|FG015|Induction Period|Lost to Follow-up|0|||
147314597|NCT01474512|531319464|FG016|Induction Period|Lost to Follow-up|0|||
147314598|NCT01474512|531319465|FG017|Induction Period|Lost to Follow-up|0|||
147314599|NCT01474512|531319448|FG000|Maintenance Period|Relapsed (sPGA ≥3)|0|||
147314600|NCT01474512|531319449|FG001|Maintenance Period|Relapsed (sPGA ≥3)|0|||
147314601|NCT01474512|531319450|FG002|Maintenance Period|Relapsed (sPGA ≥3)|0|||
147314602|NCT01474512|531319451|FG003|Maintenance Period|Relapsed (sPGA ≥3)|186|||
147314603|NCT01474512|531319452|FG004|Maintenance Period|Relapsed (sPGA ≥3)|111|||
147314604|NCT01474512|531319453|FG005|Maintenance Period|Relapsed (sPGA ≥3)|39|||
147314605|NCT01474512|531319454|FG006|Maintenance Period|Relapsed (sPGA ≥3)|9|||
147314606|NCT01474512|531319455|FG007|Maintenance Period|Relapsed (sPGA ≥3)|0|||
147314607|NCT01474512|531319456|FG008|Maintenance Period|Relapsed (sPGA ≥3)|0|||
147314608|NCT01474512|531319457|FG009|Maintenance Period|Relapsed (sPGA ≥3)|0|||
147233446|NCT03181893|531026410|FG001|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
147233447|NCT03181893|531026411|FG002|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
147233448|NCT03181893|531026412|FG003|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
147233449|NCT03181893|531026413|FG004|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
147233450|NCT03181893|531026414|FG005|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
147233451|NCT03181893|531026415|FG006|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
147233452|NCT03181893|531026416|FG007|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
147233453|NCT03181893|531026417|FG008|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
147233454|NCT03181893|531026418|FG009|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|1|||
147233455|NCT03181893|531026419|FG010|Weeks 12-24 (Amended Stage 2, Stage 3)|Withdrawal by Subject|0|||
147233456|NCT03181893|531026409|FG000|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
147233457|NCT03181893|531026410|FG001|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
147233458|NCT03181893|531026411|FG002|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
147233459|NCT03181893|531026412|FG003|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
147233460|NCT03181893|531026413|FG004|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
147233461|NCT03181893|531026414|FG005|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
147233462|NCT03181893|531026415|FG006|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
147233463|NCT03181893|531026416|FG007|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
147233464|NCT03181893|531026417|FG008|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
147233465|NCT03181893|531026418|FG009|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|0|||
147233466|NCT03181893|531026419|FG010|Weeks 12-24 (Amended Stage 2, Stage 3)|Adverse Event|1|||
147233467|NCT02158975|531026420|FG000|Overall Study|Did not complete 1 cycle nor > 1dose|1|||
147233468|NCT04815031|531026426|FG000|Overall Study|No adverse event information (missing information)|33|||
147233469|NCT01558739|531026427|FG000|Overall Study|Adverse Event|7|||
147233470|NCT01558739|531026427|FG000|Overall Study|Withdrawal by Subject|2|||
147233471|NCT01558739|531026427|FG000|Overall Study|Death|3|||
147233472|NCT01558739|531026427|FG000|Overall Study|Disease Progression|4|||
147233473|NCT01558739|531026427|FG000|Overall Study|Protocol Violation|1|||
147233474|NCT01193842|531026429|FG000|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0|||
147233475|NCT01193842|531026430|FG001|Phase I: VR-DA-EPOCH, DL 2|Ineligible|1|||
147233476|NCT01193842|531026431|FG002|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0|||
147233477|NCT01193842|531026432|FG003|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0|||
147233478|NCT01193842|531026433|FG004|Phase I: VR-DA-EPOCH, DL 2|Ineligible|0|||
147233479|NCT01193842|531026429|FG000|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|1|||
147233480|NCT01193842|531026430|FG001|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0|||
147233481|NCT01193842|531026431|FG002|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0|||
147233482|NCT01193842|531026432|FG003|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0|||
147233483|NCT01193842|531026433|FG004|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)|Ineligible|0|||
147233484|NCT01193842|531026429|FG000|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0|||
147233485|NCT01193842|531026430|FG001|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0|||
147233486|NCT01193842|531026431|FG002|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|1|||
147233487|NCT01193842|531026432|FG003|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0|||
147233488|NCT01193842|531026433|FG004|Phase I: VR-CHOP, DL 1|Noncompliant (Cycle 1 not complete)|0|||
147233489|NCT01193842|531026429|FG000|Phase II: Randomized Groups|Death|0|||
147233490|NCT01193842|531026430|FG001|Phase II: Randomized Groups|Death|0|||
147233491|NCT01193842|531026431|FG002|Phase II: Randomized Groups|Death|0|||
147233492|NCT01193842|531026432|FG003|Phase II: Randomized Groups|Death|1|||
147233493|NCT01193842|531026433|FG004|Phase II: Randomized Groups|Death|1|||
147314609|NCT01474512|531319458|FG010|Maintenance Period|Relapsed (sPGA ≥3)|0|||
147314610|NCT01474512|531319459|FG011|Maintenance Period|Relapsed (sPGA ≥3)|0|||
147314611|NCT01474512|531319460|FG012|Maintenance Period|Relapsed (sPGA ≥3)|0|||
147314612|NCT01474512|531319461|FG013|Maintenance Period|Relapsed (sPGA ≥3)|0|||
147314613|NCT01474512|531319462|FG014|Maintenance Period|Relapsed (sPGA ≥3)|0|||
147314614|NCT01474512|531319463|FG015|Maintenance Period|Relapsed (sPGA ≥3)|0|||
147314615|NCT01474512|531319464|FG016|Maintenance Period|Relapsed (sPGA ≥3)|0|||
147314616|NCT01474512|531319465|FG017|Maintenance Period|Relapsed (sPGA ≥3)|0|||
147314617|NCT01474512|531319448|FG000|Maintenance Period|Adverse Event|0|||
147314618|NCT01474512|531319449|FG001|Maintenance Period|Adverse Event|0|||
147314619|NCT01474512|531319450|FG002|Maintenance Period|Adverse Event|0|||
147314620|NCT01474512|531319451|FG003|Maintenance Period|Adverse Event|4|||
147314621|NCT01474512|531319452|FG004|Maintenance Period|Adverse Event|2|||
147314622|NCT01474512|531319453|FG005|Maintenance Period|Adverse Event|7|||
147314623|NCT01474512|531319454|FG006|Maintenance Period|Adverse Event|0|||
147314624|NCT01474512|531319455|FG007|Maintenance Period|Adverse Event|19|||
147314625|NCT01474512|531319456|FG008|Maintenance Period|Adverse Event|1|||
147314626|NCT01474512|531319457|FG009|Maintenance Period|Adverse Event|3|||
147314627|NCT01474512|531319458|FG010|Maintenance Period|Adverse Event|0|||
147314628|NCT01474512|531319459|FG011|Maintenance Period|Adverse Event|0|||
147314629|NCT01474512|531319460|FG012|Maintenance Period|Adverse Event|0|||
147314630|NCT01474512|531319461|FG013|Maintenance Period|Adverse Event|0|||
147314631|NCT01474512|531319462|FG014|Maintenance Period|Adverse Event|0|||
147314632|NCT01474512|531319463|FG015|Maintenance Period|Adverse Event|0|||
147314633|NCT01474512|531319464|FG016|Maintenance Period|Adverse Event|0|||
147314634|NCT01474512|531319465|FG017|Maintenance Period|Adverse Event|0|||
147314635|NCT01474512|531319448|FG000|Maintenance Period|Withdrawal by Subject|0|||
147314636|NCT01474512|531319449|FG001|Maintenance Period|Withdrawal by Subject|0|||
147314637|NCT01474512|531319450|FG002|Maintenance Period|Withdrawal by Subject|0|||
147314638|NCT01474512|531319451|FG003|Maintenance Period|Withdrawal by Subject|6|||
147314639|NCT01474512|531319452|FG004|Maintenance Period|Withdrawal by Subject|2|||
147314640|NCT01474512|531319453|FG005|Maintenance Period|Withdrawal by Subject|3|||
147314641|NCT01474512|531319454|FG006|Maintenance Period|Withdrawal by Subject|1|||
147314642|NCT01474512|531319455|FG007|Maintenance Period|Withdrawal by Subject|6|||
147314643|NCT01474512|531319456|FG008|Maintenance Period|Withdrawal by Subject|3|||
147314644|NCT01474512|531319457|FG009|Maintenance Period|Withdrawal by Subject|1|||
147314645|NCT01474512|531319458|FG010|Maintenance Period|Withdrawal by Subject|0|||
147314646|NCT01474512|531319459|FG011|Maintenance Period|Withdrawal by Subject|0|||
147314647|NCT01474512|531319460|FG012|Maintenance Period|Withdrawal by Subject|0|||
147314648|NCT01474512|531319461|FG013|Maintenance Period|Withdrawal by Subject|0|||
147314649|NCT01474512|531319462|FG014|Maintenance Period|Withdrawal by Subject|0|||
147314650|NCT01474512|531319463|FG015|Maintenance Period|Withdrawal by Subject|0|||
147314651|NCT01474512|531319464|FG016|Maintenance Period|Withdrawal by Subject|0|||
147314652|NCT01474512|531319465|FG017|Maintenance Period|Withdrawal by Subject|0|||
147314653|NCT01474512|531319448|FG000|Maintenance Period|Lost to Follow-up|0|||
147314654|NCT01474512|531319449|FG001|Maintenance Period|Lost to Follow-up|0|||
147314655|NCT01474512|531319450|FG002|Maintenance Period|Lost to Follow-up|0|||
147314656|NCT01474512|531319451|FG003|Maintenance Period|Lost to Follow-up|3|||
147314657|NCT01474512|531319452|FG004|Maintenance Period|Lost to Follow-up|3|||
147314658|NCT01474512|531319453|FG005|Maintenance Period|Lost to Follow-up|0|||
147314659|NCT01474512|531319454|FG006|Maintenance Period|Lost to Follow-up|0|||
147314660|NCT01474512|531319455|FG007|Maintenance Period|Lost to Follow-up|2|||
147314661|NCT01474512|531319456|FG008|Maintenance Period|Lost to Follow-up|1|||
147314662|NCT01474512|531319457|FG009|Maintenance Period|Lost to Follow-up|1|||
147314663|NCT01474512|531319458|FG010|Maintenance Period|Lost to Follow-up|0|||
147314664|NCT01474512|531319459|FG011|Maintenance Period|Lost to Follow-up|0|||
147314665|NCT01474512|531319460|FG012|Maintenance Period|Lost to Follow-up|0|||
147314666|NCT01474512|531319461|FG013|Maintenance Period|Lost to Follow-up|0|||
147314667|NCT01474512|531319462|FG014|Maintenance Period|Lost to Follow-up|0|||
147314668|NCT01474512|531319463|FG015|Maintenance Period|Lost to Follow-up|0|||
147314669|NCT01474512|531319464|FG016|Maintenance Period|Lost to Follow-up|0|||
147314670|NCT01474512|531319465|FG017|Maintenance Period|Lost to Follow-up|0|||
147314671|NCT01474512|531319448|FG000|Maintenance Period|Death|0|||
147314672|NCT01474512|531319449|FG001|Maintenance Period|Death|0|||
147314673|NCT01474512|531319450|FG002|Maintenance Period|Death|0|||
147314674|NCT01474512|531319451|FG003|Maintenance Period|Death|0|||
147314675|NCT01474512|531319452|FG004|Maintenance Period|Death|0|||
147314676|NCT01474512|531319453|FG005|Maintenance Period|Death|2|||
147314677|NCT01474512|531319454|FG006|Maintenance Period|Death|0|||
147314678|NCT01474512|531319455|FG007|Maintenance Period|Death|0|||
147444633|NCT01147744|531792660|FG003|Overall Study|Lack of Efficacy|11|||
147444634|NCT01147744|531792661|FG004|Overall Study|Lack of Efficacy|13|||
147444635|NCT01147744|531792662|FG005|Overall Study|Lack of Efficacy|8|||
147314679|NCT01474512|531319456|FG008|Maintenance Period|Death|0|||
147314680|NCT01474512|531319457|FG009|Maintenance Period|Death|0|||
147314681|NCT01474512|531319458|FG010|Maintenance Period|Death|0|||
147314682|NCT01474512|531319459|FG011|Maintenance Period|Death|0|||
147314683|NCT01474512|531319460|FG012|Maintenance Period|Death|0|||
147314684|NCT01474512|531319461|FG013|Maintenance Period|Death|0|||
147314685|NCT01474512|531319462|FG014|Maintenance Period|Death|0|||
147314686|NCT01474512|531319463|FG015|Maintenance Period|Death|0|||
147314687|NCT01474512|531319464|FG016|Maintenance Period|Death|0|||
147314688|NCT01474512|531319465|FG017|Maintenance Period|Death|0|||
147314689|NCT01474512|531319448|FG000|Maintenance Period|Physician Decision|0|||
147314690|NCT01474512|531319449|FG001|Maintenance Period|Physician Decision|0|||
147314691|NCT01474512|531319450|FG002|Maintenance Period|Physician Decision|0|||
147314692|NCT01474512|531319451|FG003|Maintenance Period|Physician Decision|0|||
147314693|NCT01474512|531319452|FG004|Maintenance Period|Physician Decision|0|||
147314694|NCT01474512|531319453|FG005|Maintenance Period|Physician Decision|1|||
147314695|NCT01474512|531319454|FG006|Maintenance Period|Physician Decision|0|||
147314696|NCT01474512|531319455|FG007|Maintenance Period|Physician Decision|2|||
147314697|NCT01474512|531319456|FG008|Maintenance Period|Physician Decision|0|||
147314698|NCT01474512|531319457|FG009|Maintenance Period|Physician Decision|0|||
147314699|NCT01474512|531319458|FG010|Maintenance Period|Physician Decision|0|||
147314700|NCT01474512|531319459|FG011|Maintenance Period|Physician Decision|0|||
147314701|NCT01474512|531319460|FG012|Maintenance Period|Physician Decision|0|||
147314702|NCT01474512|531319461|FG013|Maintenance Period|Physician Decision|0|||
147314703|NCT01474512|531319462|FG014|Maintenance Period|Physician Decision|0|||
147314704|NCT01474512|531319463|FG015|Maintenance Period|Physician Decision|0|||
147314705|NCT01474512|531319464|FG016|Maintenance Period|Physician Decision|0|||
147314706|NCT01474512|531319465|FG017|Maintenance Period|Physician Decision|0|||
147314707|NCT01474512|531319448|FG000|Maintenance Period|Clinical Relapse|0|||
147314708|NCT01474512|531319449|FG001|Maintenance Period|Clinical Relapse|0|||
147314709|NCT01474512|531319450|FG002|Maintenance Period|Clinical Relapse|0|||
147314710|NCT01474512|531319451|FG003|Maintenance Period|Clinical Relapse|1|||
147314711|NCT01474512|531319452|FG004|Maintenance Period|Clinical Relapse|0|||
147314712|NCT01474512|531319453|FG005|Maintenance Period|Clinical Relapse|0|||
147314713|NCT01474512|531319454|FG006|Maintenance Period|Clinical Relapse|0|||
147314714|NCT01474512|531319455|FG007|Maintenance Period|Clinical Relapse|0|||
147314715|NCT01474512|531319456|FG008|Maintenance Period|Clinical Relapse|0|||
147314716|NCT01474512|531319457|FG009|Maintenance Period|Clinical Relapse|0|||
147314717|NCT01474512|531319458|FG010|Maintenance Period|Clinical Relapse|0|||
147314718|NCT01474512|531319459|FG011|Maintenance Period|Clinical Relapse|0|||
147314719|NCT01474512|531319460|FG012|Maintenance Period|Clinical Relapse|0|||
147314720|NCT01474512|531319461|FG013|Maintenance Period|Clinical Relapse|0|||
147314721|NCT01474512|531319462|FG014|Maintenance Period|Clinical Relapse|0|||
147314722|NCT01474512|531319463|FG015|Maintenance Period|Clinical Relapse|0|||
147314723|NCT01474512|531319464|FG016|Maintenance Period|Clinical Relapse|0|||
147314724|NCT01474512|531319465|FG017|Maintenance Period|Clinical Relapse|0|||
147314725|NCT01474512|531319448|FG000|Maintenance Period|Lack of Efficacy|0|||
147314726|NCT01474512|531319449|FG001|Maintenance Period|Lack of Efficacy|0|||
147314727|NCT01474512|531319450|FG002|Maintenance Period|Lack of Efficacy|0|||
147314728|NCT01474512|531319451|FG003|Maintenance Period|Lack of Efficacy|1|||
147314729|NCT01474512|531319452|FG004|Maintenance Period|Lack of Efficacy|0|||
147314730|NCT01474512|531319453|FG005|Maintenance Period|Lack of Efficacy|0|||
147314731|NCT01474512|531319454|FG006|Maintenance Period|Lack of Efficacy|0|||
147314732|NCT01474512|531319455|FG007|Maintenance Period|Lack of Efficacy|11|||
147314733|NCT01474512|531319456|FG008|Maintenance Period|Lack of Efficacy|11|||
147314734|NCT01474512|531319457|FG009|Maintenance Period|Lack of Efficacy|12|||
147314735|NCT01474512|531319458|FG010|Maintenance Period|Lack of Efficacy|0|||
147314736|NCT01474512|531319459|FG011|Maintenance Period|Lack of Efficacy|0|||
147314737|NCT01474512|531319460|FG012|Maintenance Period|Lack of Efficacy|0|||
147314738|NCT01474512|531319461|FG013|Maintenance Period|Lack of Efficacy|0|||
147314739|NCT01474512|531319462|FG014|Maintenance Period|Lack of Efficacy|0|||
147314740|NCT01474512|531319463|FG015|Maintenance Period|Lack of Efficacy|0|||
147314741|NCT01474512|531319464|FG016|Maintenance Period|Lack of Efficacy|0|||
147314742|NCT01474512|531319465|FG017|Maintenance Period|Lack of Efficacy|0|||
147314743|NCT01474512|531319448|FG000|Maintenance Period|Protocol Violation|0|||
147314744|NCT01474512|531319449|FG001|Maintenance Period|Protocol Violation|0|||
147314745|NCT01474512|531319450|FG002|Maintenance Period|Protocol Violation|0|||
147314746|NCT01474512|531319451|FG003|Maintenance Period|Protocol Violation|1|||
147124035|NCT01316900|530618656|FG001|Overall Study|Protocol-defined Stopping Criteria|3|||
147124036|NCT01316900|530618657|FG002|Overall Study|Protocol-defined Stopping Criteria|10|||
147124037|NCT01316900|530618658|FG003|Overall Study|Protocol-defined Stopping Criteria|5|||
147124038|NCT01316900|530618655|FG000|Overall Study|Lost to Follow-up|1|||
147124039|NCT01316900|530618656|FG001|Overall Study|Lost to Follow-up|0|||
147124040|NCT01316900|530618657|FG002|Overall Study|Lost to Follow-up|1|||
147124041|NCT01316900|530618658|FG003|Overall Study|Lost to Follow-up|1|||
147124042|NCT01316900|530618655|FG000|Overall Study|Withdrawal by Subject|7|||
147124043|NCT01316900|530618656|FG001|Overall Study|Withdrawal by Subject|8|||
147124044|NCT01316900|530618657|FG002|Overall Study|Withdrawal by Subject|6|||
147124045|NCT01316900|530618658|FG003|Overall Study|Withdrawal by Subject|9|||
147124046|NCT00562861|530618659|FG000|Overall Study|Adverse Event|1|||
147124047|NCT00562861|530618660|FG001|Overall Study|Adverse Event|1|||
147124048|NCT00562861|530618659|FG000|Overall Study|Lack of Efficacy|5|||
147124049|NCT00562861|530618660|FG001|Overall Study|Lack of Efficacy|5|||
147124050|NCT00562861|530618659|FG000|Overall Study|noncompliance, moved|7|||
147124051|NCT00562861|530618660|FG001|Overall Study|noncompliance, moved|2|||
147314747|NCT01474512|531319452|FG004|Maintenance Period|Protocol Violation|0|||
147314748|NCT01474512|531319453|FG005|Maintenance Period|Protocol Violation|0|||
147314749|NCT01474512|531319454|FG006|Maintenance Period|Protocol Violation|0|||
147314750|NCT01474512|531319455|FG007|Maintenance Period|Protocol Violation|1|||
147314751|NCT01474512|531319456|FG008|Maintenance Period|Protocol Violation|0|||
147314752|NCT01474512|531319457|FG009|Maintenance Period|Protocol Violation|1|||
147314753|NCT01474512|531319458|FG010|Maintenance Period|Protocol Violation|0|||
147314754|NCT01474512|531319459|FG011|Maintenance Period|Protocol Violation|0|||
147314755|NCT01474512|531319460|FG012|Maintenance Period|Protocol Violation|0|||
147314756|NCT01474512|531319461|FG013|Maintenance Period|Protocol Violation|0|||
147314757|NCT01474512|531319462|FG014|Maintenance Period|Protocol Violation|0|||
147314758|NCT01474512|531319463|FG015|Maintenance Period|Protocol Violation|0|||
147314759|NCT01474512|531319464|FG016|Maintenance Period|Protocol Violation|0|||
147314760|NCT01474512|531319465|FG017|Maintenance Period|Protocol Violation|0|||
147314761|NCT01474512|531319448|FG000|Maintenance Period|Treated but Discontinued in Induction|0|||
147314762|NCT01474512|531319449|FG001|Maintenance Period|Treated but Discontinued in Induction|0|||
147314763|NCT01474512|531319450|FG002|Maintenance Period|Treated but Discontinued in Induction|0|||
147314764|NCT01474512|531319451|FG003|Maintenance Period|Treated but Discontinued in Induction|0|||
147314765|NCT01474512|531319452|FG004|Maintenance Period|Treated but Discontinued in Induction|1|||
147314766|NCT01474512|531319453|FG005|Maintenance Period|Treated but Discontinued in Induction|0|||
147314767|NCT01474512|531319454|FG006|Maintenance Period|Treated but Discontinued in Induction|0|||
147314768|NCT01474512|531319455|FG007|Maintenance Period|Treated but Discontinued in Induction|0|||
147314769|NCT01474512|531319456|FG008|Maintenance Period|Treated but Discontinued in Induction|0|||
147314770|NCT01474512|531319457|FG009|Maintenance Period|Treated but Discontinued in Induction|0|||
147314771|NCT01474512|531319458|FG010|Maintenance Period|Treated but Discontinued in Induction|0|||
147314772|NCT01474512|531319459|FG011|Maintenance Period|Treated but Discontinued in Induction|0|||
147314773|NCT01474512|531319460|FG012|Maintenance Period|Treated but Discontinued in Induction|0|||
147314774|NCT01474512|531319461|FG013|Maintenance Period|Treated but Discontinued in Induction|0|||
147314775|NCT01474512|531319462|FG014|Maintenance Period|Treated but Discontinued in Induction|0|||
147314776|NCT01474512|531319463|FG015|Maintenance Period|Treated but Discontinued in Induction|0|||
147314777|NCT01474512|531319464|FG016|Maintenance Period|Treated but Discontinued in Induction|0|||
147314778|NCT01474512|531319465|FG017|Maintenance Period|Treated but Discontinued in Induction|0|||
147314779|NCT01474512|531319448|FG000|Long-Term Extension Period|Withdrawal by Subject|0|||
147314780|NCT01474512|531319449|FG001|Long-Term Extension Period|Withdrawal by Subject|0|||
147314781|NCT01474512|531319450|FG002|Long-Term Extension Period|Withdrawal by Subject|0|||
147314782|NCT01474512|531319451|FG003|Long-Term Extension Period|Withdrawal by Subject|0|||
147314783|NCT01474512|531319452|FG004|Long-Term Extension Period|Withdrawal by Subject|0|||
147314784|NCT01474512|531319453|FG005|Long-Term Extension Period|Withdrawal by Subject|0|||
147314785|NCT01474512|531319454|FG006|Long-Term Extension Period|Withdrawal by Subject|0|||
147314786|NCT01474512|531319455|FG007|Long-Term Extension Period|Withdrawal by Subject|0|||
147314787|NCT01474512|531319456|FG008|Long-Term Extension Period|Withdrawal by Subject|0|||
147314788|NCT01474512|531319457|FG009|Long-Term Extension Period|Withdrawal by Subject|0|||
147314789|NCT01474512|531319458|FG010|Long-Term Extension Period|Withdrawal by Subject|0|||
147314790|NCT01474512|531319459|FG011|Long-Term Extension Period|Withdrawal by Subject|3|||
147314791|NCT01474512|531319460|FG012|Long-Term Extension Period|Withdrawal by Subject|61|||
147314792|NCT01474512|531319461|FG013|Long-Term Extension Period|Withdrawal by Subject|61|||
147314793|NCT01474512|531319462|FG014|Long-Term Extension Period|Withdrawal by Subject|0|||
147314794|NCT01474512|531319463|FG015|Long-Term Extension Period|Withdrawal by Subject|0|||
147314795|NCT01474512|531319464|FG016|Long-Term Extension Period|Withdrawal by Subject|0|||
147314796|NCT01474512|531319465|FG017|Long-Term Extension Period|Withdrawal by Subject|0|||
147314797|NCT01474512|531319448|FG000|Long-Term Extension Period|Adverse Event|0|||
147314798|NCT01474512|531319449|FG001|Long-Term Extension Period|Adverse Event|0|||
147314799|NCT01474512|531319450|FG002|Long-Term Extension Period|Adverse Event|0|||
147314800|NCT01474512|531319451|FG003|Long-Term Extension Period|Adverse Event|0|||
147314801|NCT01474512|531319452|FG004|Long-Term Extension Period|Adverse Event|0|||
147314802|NCT01474512|531319453|FG005|Long-Term Extension Period|Adverse Event|0|||
147314803|NCT01474512|531319454|FG006|Long-Term Extension Period|Adverse Event|0|||
147314804|NCT01474512|531319455|FG007|Long-Term Extension Period|Adverse Event|0|||
147314805|NCT01474512|531319456|FG008|Long-Term Extension Period|Adverse Event|0|||
147314806|NCT01474512|531319457|FG009|Long-Term Extension Period|Adverse Event|0|||
147314807|NCT01474512|531319458|FG010|Long-Term Extension Period|Adverse Event|0|||
147314808|NCT01474512|531319459|FG011|Long-Term Extension Period|Adverse Event|1|||
147314809|NCT01474512|531319460|FG012|Long-Term Extension Period|Adverse Event|57|||
147314810|NCT01474512|531319461|FG013|Long-Term Extension Period|Adverse Event|58|||
147314811|NCT01474512|531319462|FG014|Long-Term Extension Period|Adverse Event|0|||
147314812|NCT01474512|531319463|FG015|Long-Term Extension Period|Adverse Event|0|||
147314813|NCT01474512|531319464|FG016|Long-Term Extension Period|Adverse Event|0|||
147314814|NCT01474512|531319465|FG017|Long-Term Extension Period|Adverse Event|0|||
147314815|NCT01474512|531319448|FG000|Long-Term Extension Period|Lost to Follow-up|0|||
147314816|NCT01474512|531319449|FG001|Long-Term Extension Period|Lost to Follow-up|0|||
147314817|NCT01474512|531319450|FG002|Long-Term Extension Period|Lost to Follow-up|0|||
147314818|NCT01474512|531319451|FG003|Long-Term Extension Period|Lost to Follow-up|0|||
147314819|NCT01474512|531319452|FG004|Long-Term Extension Period|Lost to Follow-up|0|||
147314820|NCT01474512|531319453|FG005|Long-Term Extension Period|Lost to Follow-up|0|||
147314821|NCT01474512|531319454|FG006|Long-Term Extension Period|Lost to Follow-up|0|||
147314822|NCT01474512|531319455|FG007|Long-Term Extension Period|Lost to Follow-up|0|||
147314823|NCT01474512|531319456|FG008|Long-Term Extension Period|Lost to Follow-up|0|||
147314824|NCT01474512|531319457|FG009|Long-Term Extension Period|Lost to Follow-up|0|||
147314825|NCT01474512|531319458|FG010|Long-Term Extension Period|Lost to Follow-up|0|||
147314826|NCT01474512|531319459|FG011|Long-Term Extension Period|Lost to Follow-up|0|||
147314827|NCT01474512|531319460|FG012|Long-Term Extension Period|Lost to Follow-up|25|||
147314828|NCT01474512|531319461|FG013|Long-Term Extension Period|Lost to Follow-up|25|||
147314829|NCT01474512|531319462|FG014|Long-Term Extension Period|Lost to Follow-up|0|||
147314830|NCT01474512|531319463|FG015|Long-Term Extension Period|Lost to Follow-up|0|||
147314831|NCT01474512|531319464|FG016|Long-Term Extension Period|Lost to Follow-up|0|||
147314832|NCT01474512|531319465|FG017|Long-Term Extension Period|Lost to Follow-up|0|||
147314833|NCT01474512|531319448|FG000|Long-Term Extension Period|Lack of Efficacy|0|||
147314834|NCT01474512|531319449|FG001|Long-Term Extension Period|Lack of Efficacy|0|||
147314835|NCT01474512|531319450|FG002|Long-Term Extension Period|Lack of Efficacy|0|||
147314836|NCT01474512|531319451|FG003|Long-Term Extension Period|Lack of Efficacy|0|||
147314837|NCT01474512|531319452|FG004|Long-Term Extension Period|Lack of Efficacy|0|||
147314838|NCT01474512|531319453|FG005|Long-Term Extension Period|Lack of Efficacy|0|||
147314839|NCT01474512|531319454|FG006|Long-Term Extension Period|Lack of Efficacy|0|||
147314840|NCT01474512|531319455|FG007|Long-Term Extension Period|Lack of Efficacy|0|||
147314841|NCT01474512|531319456|FG008|Long-Term Extension Period|Lack of Efficacy|0|||
147314842|NCT01474512|531319457|FG009|Long-Term Extension Period|Lack of Efficacy|0|||
147314843|NCT01474512|531319458|FG010|Long-Term Extension Period|Lack of Efficacy|0|||
147314844|NCT01474512|531319459|FG011|Long-Term Extension Period|Lack of Efficacy|1|||
147314845|NCT01474512|531319460|FG012|Long-Term Extension Period|Lack of Efficacy|24|||
147314846|NCT01474512|531319461|FG013|Long-Term Extension Period|Lack of Efficacy|25|||
147314847|NCT01474512|531319462|FG014|Long-Term Extension Period|Lack of Efficacy|0|||
147314848|NCT01474512|531319463|FG015|Long-Term Extension Period|Lack of Efficacy|0|||
147314849|NCT01474512|531319464|FG016|Long-Term Extension Period|Lack of Efficacy|0|||
147314850|NCT01474512|531319465|FG017|Long-Term Extension Period|Lack of Efficacy|0|||
147314851|NCT01474512|531319448|FG000|Long-Term Extension Period|Physician Decision|0|||
147314852|NCT01474512|531319449|FG001|Long-Term Extension Period|Physician Decision|0|||
147314853|NCT01474512|531319450|FG002|Long-Term Extension Period|Physician Decision|0|||
147314854|NCT01474512|531319451|FG003|Long-Term Extension Period|Physician Decision|0|||
147314855|NCT01474512|531319452|FG004|Long-Term Extension Period|Physician Decision|0|||
147314856|NCT01474512|531319453|FG005|Long-Term Extension Period|Physician Decision|0|||
147314857|NCT01474512|531319454|FG006|Long-Term Extension Period|Physician Decision|0|||
147314858|NCT01474512|531319455|FG007|Long-Term Extension Period|Physician Decision|0|||
147314859|NCT01474512|531319456|FG008|Long-Term Extension Period|Physician Decision|0|||
147314860|NCT01474512|531319457|FG009|Long-Term Extension Period|Physician Decision|0|||
147314861|NCT01474512|531319458|FG010|Long-Term Extension Period|Physician Decision|0|||
147314862|NCT01474512|531319459|FG011|Long-Term Extension Period|Physician Decision|0|||
147314863|NCT01474512|531319460|FG012|Long-Term Extension Period|Physician Decision|21|||
147314864|NCT01474512|531319461|FG013|Long-Term Extension Period|Physician Decision|21|||
147314865|NCT01474512|531319462|FG014|Long-Term Extension Period|Physician Decision|0|||
147314866|NCT01474512|531319463|FG015|Long-Term Extension Period|Physician Decision|0|||
147314867|NCT01474512|531319464|FG016|Long-Term Extension Period|Physician Decision|0|||
147314868|NCT01474512|531319465|FG017|Long-Term Extension Period|Physician Decision|0|||
147314869|NCT01474512|531319448|FG000|Long-Term Extension Period|Clinical Relapse|0|||
147314870|NCT01474512|531319449|FG001|Long-Term Extension Period|Clinical Relapse|0|||
147314871|NCT01474512|531319450|FG002|Long-Term Extension Period|Clinical Relapse|0|||
147314872|NCT01474512|531319451|FG003|Long-Term Extension Period|Clinical Relapse|0|||
147314873|NCT01474512|531319452|FG004|Long-Term Extension Period|Clinical Relapse|0|||
147314874|NCT01474512|531319453|FG005|Long-Term Extension Period|Clinical Relapse|0|||
147314875|NCT01474512|531319454|FG006|Long-Term Extension Period|Clinical Relapse|0|||
147314876|NCT01474512|531319455|FG007|Long-Term Extension Period|Clinical Relapse|0|||
147314877|NCT01474512|531319456|FG008|Long-Term Extension Period|Clinical Relapse|0|||
147124052|NCT00562861|530618659|FG000|Overall Study|Lost to Follow-up|7|||
147314878|NCT01474512|531319457|FG009|Long-Term Extension Period|Clinical Relapse|0|||
147314879|NCT01474512|531319458|FG010|Long-Term Extension Period|Clinical Relapse|0|||
147314880|NCT01474512|531319459|FG011|Long-Term Extension Period|Clinical Relapse|0|||
147314881|NCT01474512|531319460|FG012|Long-Term Extension Period|Clinical Relapse|9|||
147314882|NCT01474512|531319461|FG013|Long-Term Extension Period|Clinical Relapse|9|||
147314883|NCT01474512|531319462|FG014|Long-Term Extension Period|Clinical Relapse|0|||
147314884|NCT01474512|531319463|FG015|Long-Term Extension Period|Clinical Relapse|0|||
147314885|NCT01474512|531319464|FG016|Long-Term Extension Period|Clinical Relapse|0|||
147314886|NCT01474512|531319465|FG017|Long-Term Extension Period|Clinical Relapse|0|||
147314887|NCT01474512|531319448|FG000|Long-Term Extension Period|Death|0|||
147314888|NCT01474512|531319449|FG001|Long-Term Extension Period|Death|0|||
147314889|NCT01474512|531319450|FG002|Long-Term Extension Period|Death|0|||
147314890|NCT01474512|531319451|FG003|Long-Term Extension Period|Death|0|||
147314891|NCT01474512|531319452|FG004|Long-Term Extension Period|Death|0|||
147314892|NCT01474512|531319453|FG005|Long-Term Extension Period|Death|0|||
147314893|NCT01474512|531319454|FG006|Long-Term Extension Period|Death|0|||
147314894|NCT01474512|531319455|FG007|Long-Term Extension Period|Death|0|||
147314895|NCT01474512|531319456|FG008|Long-Term Extension Period|Death|0|||
147314896|NCT01474512|531319457|FG009|Long-Term Extension Period|Death|0|||
147314897|NCT01474512|531319458|FG010|Long-Term Extension Period|Death|0|||
147314898|NCT01474512|531319459|FG011|Long-Term Extension Period|Death|0|||
147314899|NCT01474512|531319460|FG012|Long-Term Extension Period|Death|9|||
147314900|NCT01474512|531319461|FG013|Long-Term Extension Period|Death|9|||
147314901|NCT01474512|531319462|FG014|Long-Term Extension Period|Death|0|||
147314902|NCT01474512|531319463|FG015|Long-Term Extension Period|Death|0|||
147314903|NCT01474512|531319464|FG016|Long-Term Extension Period|Death|0|||
147314904|NCT01474512|531319465|FG017|Long-Term Extension Period|Death|0|||
147314905|NCT01474512|531319448|FG000|Long-Term Extension Period|Sponsor Decision|0|||
147314906|NCT01474512|531319449|FG001|Long-Term Extension Period|Sponsor Decision|0|||
147314907|NCT01474512|531319450|FG002|Long-Term Extension Period|Sponsor Decision|0|||
147314908|NCT01474512|531319451|FG003|Long-Term Extension Period|Sponsor Decision|0|||
147314909|NCT01474512|531319452|FG004|Long-Term Extension Period|Sponsor Decision|0|||
147314910|NCT01474512|531319453|FG005|Long-Term Extension Period|Sponsor Decision|0|||
147314911|NCT01474512|531319454|FG006|Long-Term Extension Period|Sponsor Decision|0|||
147314912|NCT01474512|531319455|FG007|Long-Term Extension Period|Sponsor Decision|0|||
147314913|NCT01474512|531319456|FG008|Long-Term Extension Period|Sponsor Decision|0|||
147314914|NCT01474512|531319457|FG009|Long-Term Extension Period|Sponsor Decision|0|||
147314915|NCT01474512|531319458|FG010|Long-Term Extension Period|Sponsor Decision|0|||
147314916|NCT01474512|531319459|FG011|Long-Term Extension Period|Sponsor Decision|0|||
147314917|NCT01474512|531319460|FG012|Long-Term Extension Period|Sponsor Decision|6|||
147314918|NCT01474512|531319461|FG013|Long-Term Extension Period|Sponsor Decision|6|||
147314919|NCT01474512|531319462|FG014|Long-Term Extension Period|Sponsor Decision|0|||
147314920|NCT01474512|531319463|FG015|Long-Term Extension Period|Sponsor Decision|0|||
147314921|NCT01474512|531319464|FG016|Long-Term Extension Period|Sponsor Decision|0|||
147314922|NCT01474512|531319465|FG017|Long-Term Extension Period|Sponsor Decision|0|||
147314923|NCT01474512|531319448|FG000|Long-Term Extension Period|Protocol Violation|0|||
147314924|NCT01474512|531319449|FG001|Long-Term Extension Period|Protocol Violation|0|||
147314925|NCT01474512|531319450|FG002|Long-Term Extension Period|Protocol Violation|0|||
147651047|NCT02734862|532544575|FG002|Part A|Physician Decision|1|||
147651048|NCT02734862|532544573|FG000|Part A|Adverse Event|2|||
147651049|NCT02734862|532544574|FG001|Part A|Adverse Event|0|||
147651050|NCT02734862|532544575|FG002|Part A|Adverse Event|1|||
147651051|NCT02734862|532544573|FG000|Part A|Noncompliance|1|||
147651052|NCT02734862|532544574|FG001|Part A|Noncompliance|1|||
147651053|NCT02734862|532544575|FG002|Part A|Noncompliance|0|||
147651054|NCT02734862|532544573|FG000|Part A|Other|1|||
147651055|NCT02734862|532544574|FG001|Part A|Other|1|||
147651056|NCT02734862|532544575|FG002|Part A|Other|3|||
147651057|NCT02734862|532544573|FG000|Part B|Death|8|||
147651058|NCT02734862|532544574|FG001|Part B|Death|3|||
147651059|NCT02734862|532544575|FG002|Part B|Death|5|||
147651060|NCT02734862|532544573|FG000|Part B|Lost to Follow-up|2|||
147651061|NCT02734862|532544574|FG001|Part B|Lost to Follow-up|2|||
147651062|NCT02734862|532544575|FG002|Part B|Lost to Follow-up|0|||
147651063|NCT02734862|532544573|FG000|Part B|Withdrawal by Subject|3|||
147651064|NCT02734862|532544574|FG001|Part B|Withdrawal by Subject|1|||
147651065|NCT02734862|532544575|FG002|Part B|Withdrawal by Subject|0|||
147124053|NCT00562861|530618660|FG001|Overall Study|Lost to Follow-up|3|||
147314926|NCT01474512|531319451|FG003|Long-Term Extension Period|Protocol Violation|0|||
147314927|NCT01474512|531319452|FG004|Long-Term Extension Period|Protocol Violation|0|||
147314928|NCT01474512|531319453|FG005|Long-Term Extension Period|Protocol Violation|0|||
147314929|NCT01474512|531319454|FG006|Long-Term Extension Period|Protocol Violation|0|||
147314930|NCT01474512|531319455|FG007|Long-Term Extension Period|Protocol Violation|0|||
147314931|NCT01474512|531319456|FG008|Long-Term Extension Period|Protocol Violation|0|||
147314932|NCT01474512|531319457|FG009|Long-Term Extension Period|Protocol Violation|0|||
147314933|NCT01474512|531319458|FG010|Long-Term Extension Period|Protocol Violation|0|||
147314934|NCT01474512|531319459|FG011|Long-Term Extension Period|Protocol Violation|0|||
147651066|NCT02734862|532544573|FG000|Part B|Other|0|||
147651067|NCT02734862|532544574|FG001|Part B|Other|1|||
147651068|NCT02734862|532544575|FG002|Part B|Other|0|||
147651069|NCT00790556|532544576|FG000|Treatment Period 1|Physician Decision|1|||
147651070|NCT00790556|532544577|FG001|Treatment Period 1|Physician Decision|0|||
147651071|NCT00790556|532544576|FG000|Treatment Period 1|Withdrawal by Subject|1|||
147651072|NCT00790556|532544577|FG001|Treatment Period 1|Withdrawal by Subject|0|||
147651073|NCT00255840|532544578|FG000|Overall Study|Lost to Follow-up|10|||
147651074|NCT00255840|532544579|FG001|Overall Study|Lost to Follow-up|14|||
147651075|NCT00255840|532544578|FG000|Overall Study|Discontinued intervention|53|||
147444636|NCT01147744|531792663|FG006|Overall Study|Lack of Efficacy|7|||
147233494|NCT01193842|531026429|FG000|Phase II: Randomized Groups|Adverse Event|0|||
147233495|NCT01193842|531026430|FG001|Phase II: Randomized Groups|Adverse Event|0|||
147233496|NCT01193842|531026431|FG002|Phase II: Randomized Groups|Adverse Event|0|||
147233497|NCT01193842|531026432|FG003|Phase II: Randomized Groups|Adverse Event|5|||
147233498|NCT01193842|531026433|FG004|Phase II: Randomized Groups|Adverse Event|3|||
147233499|NCT01193842|531026429|FG000|Phase II: Randomized Groups|Withdrawal by Subject|0|||
147233500|NCT01193842|531026430|FG001|Phase II: Randomized Groups|Withdrawal by Subject|0|||
147233501|NCT01193842|531026431|FG002|Phase II: Randomized Groups|Withdrawal by Subject|0|||
147233502|NCT01193842|531026432|FG003|Phase II: Randomized Groups|Withdrawal by Subject|1|||
147233503|NCT01193842|531026433|FG004|Phase II: Randomized Groups|Withdrawal by Subject|2|||
147233504|NCT01193842|531026429|FG000|Phase II: Randomized Groups|Ineligible|0|||
147233505|NCT01193842|531026430|FG001|Phase II: Randomized Groups|Ineligible|0|||
147233506|NCT01193842|531026431|FG002|Phase II: Randomized Groups|Ineligible|0|||
147233507|NCT01193842|531026432|FG003|Phase II: Randomized Groups|Ineligible|0|||
147233508|NCT01193842|531026433|FG004|Phase II: Randomized Groups|Ineligible|1|||
147233509|NCT01193842|531026429|FG000|Phase II: Randomized Groups|Disease progression/relapse on treatment|0|||
147233510|NCT01193842|531026430|FG001|Phase II: Randomized Groups|Disease progression/relapse on treatment|0|||
147233511|NCT01193842|531026431|FG002|Phase II: Randomized Groups|Disease progression/relapse on treatment|0|||
147233512|NCT01193842|531026432|FG003|Phase II: Randomized Groups|Disease progression/relapse on treatment|5|||
147233513|NCT01193842|531026433|FG004|Phase II: Randomized Groups|Disease progression/relapse on treatment|3|||
147233514|NCT02484690|531026435|FG000|Overall Study|Adverse Event|1|||
147233515|NCT02484690|531026436|FG001|Overall Study|Adverse Event|3|||
147233516|NCT02484690|531026437|FG002|Overall Study|Adverse Event|0|||
147233517|NCT02484690|531026438|FG003|Overall Study|Adverse Event|0|||
147233518|NCT02484690|531026439|FG004|Overall Study|Adverse Event|5|||
147233519|NCT02484690|531026435|FG000|Overall Study|Death|0|||
147233520|NCT02484690|531026436|FG001|Overall Study|Death|0|||
147233521|NCT02484690|531026437|FG002|Overall Study|Death|0|||
147233522|NCT02484690|531026438|FG003|Overall Study|Death|0|||
147233523|NCT02484690|531026439|FG004|Overall Study|Death|1|||
147233524|NCT02484690|531026435|FG000|Overall Study|Withdrawal by Subject|1|||
147233525|NCT02484690|531026436|FG001|Overall Study|Withdrawal by Subject|3|||
147233526|NCT02484690|531026437|FG002|Overall Study|Withdrawal by Subject|1|||
147233527|NCT02484690|531026438|FG003|Overall Study|Withdrawal by Subject|2|||
147233528|NCT02484690|531026439|FG004|Overall Study|Withdrawal by Subject|0|||
147233529|NCT02484690|531026435|FG000|Overall Study|Physician Decision|2|||
147233530|NCT02484690|531026436|FG001|Overall Study|Physician Decision|0|||
147233531|NCT02484690|531026437|FG002|Overall Study|Physician Decision|1|||
147233532|NCT02484690|531026438|FG003|Overall Study|Physician Decision|0|||
147233533|NCT02484690|531026439|FG004|Overall Study|Physician Decision|0|||
147233534|NCT02484690|531026435|FG000|Overall Study|Lost to Follow-up|0|||
147233535|NCT02484690|531026436|FG001|Overall Study|Lost to Follow-up|0|||
147233536|NCT02484690|531026437|FG002|Overall Study|Lost to Follow-up|1|||
147233537|NCT02484690|531026438|FG003|Overall Study|Lost to Follow-up|0|||
147233538|NCT02484690|531026439|FG004|Overall Study|Lost to Follow-up|0|||
147233539|NCT03672643|531026440|FG000|Overall Study|Adverse Event|3|||
147233540|NCT03672643|531026440|FG000|Overall Study|Death|2|||
147233541|NCT03672643|531026440|FG000|Overall Study|Withdrawal by Subject|1|||
147233542|NCT03672643|531026440|FG000|Overall Study|Progressive disease|11|||
147233543|NCT03672643|531026440|FG000|Overall Study|Global deterioration of health status|1|||
147233544|NCT03672643|531026440|FG000|Overall Study|Refused further treatment|7|||
147233545|NCT03672643|531026440|FG000|Overall Study|Rolled over to a continuous study for Crizotinib treatment|16|||
147233546|NCT01067976|531026441|FG000|Overall Study|Study drug never administered|20|||
147233547|NCT01067976|531026441|FG000|Overall Study|Study prematurely discontinued|2|||
147233548|NCT00589290|531026442|FG000|Overall Study|Withdrawal by Subject|1|||
147233549|NCT00976677|531026443|FG000|Overall Study|Adverse Event|1|||
147233550|NCT00976677|531026444|FG001|Overall Study|Adverse Event|0|||
147233551|NCT00976677|531026443|FG000|Overall Study|Withdrawal by Subject|0|||
147233552|NCT00976677|531026444|FG001|Overall Study|Withdrawal by Subject|2|||
147233553|NCT00976677|531026443|FG000|Overall Study|Disease progression|1|||
147233554|NCT00976677|531026444|FG001|Overall Study|Disease progression|1|||
147233555|NCT00976677|531026443|FG000|Overall Study|Trial unblinded|2|||
147233556|NCT00976677|531026444|FG001|Overall Study|Trial unblinded|2|||
147233557|NCT00976677|531026443|FG000|Overall Study|Unknown/Missing|1|||
147233558|NCT00976677|531026444|FG001|Overall Study|Unknown/Missing|0|||
147233559|NCT02468232|531027954|FG000|Core Part of Study|Adverse Event|0|||
147233560|NCT02468232|531027955|FG001|Core Part of Study|Adverse Event|1|||
147233561|NCT02468232|531027956|FG002|Core Part of Study|Adverse Event|0|||
147233562|NCT02468232|531027957|FG003|Core Part of Study|Adverse Event|0|||
147233563|NCT02468232|531027954|FG000|Core Part of Study|Death|20|||
147233564|NCT02468232|531027955|FG001|Core Part of Study|Death|17|||
147233565|NCT02468232|531027956|FG002|Core Part of Study|Death|0|||
147233566|NCT02468232|531027957|FG003|Core Part of Study|Death|0|||
147233567|NCT02468232|531027954|FG000|Core Part of Study|Technical Problems|1|||
147233568|NCT02468232|531027955|FG001|Core Part of Study|Technical Problems|1|||
147314935|NCT01474512|531319460|FG012|Long-Term Extension Period|Protocol Violation|5|||
147314936|NCT01474512|531319461|FG013|Long-Term Extension Period|Protocol Violation|5|||
147314937|NCT01474512|531319462|FG014|Long-Term Extension Period|Protocol Violation|0|||
147314938|NCT01474512|531319463|FG015|Long-Term Extension Period|Protocol Violation|0|||
147314939|NCT01474512|531319464|FG016|Long-Term Extension Period|Protocol Violation|0|||
147314940|NCT01474512|531319465|FG017|Long-Term Extension Period|Protocol Violation|0|||
147314941|NCT01474512|531319448|FG000|Long-Term Extension Period|Parent/Caregiver Decision|0|||
147314942|NCT01474512|531319449|FG001|Long-Term Extension Period|Parent/Caregiver Decision|0|||
147314943|NCT01474512|531319450|FG002|Long-Term Extension Period|Parent/Caregiver Decision|0|||
147314944|NCT01474512|531319451|FG003|Long-Term Extension Period|Parent/Caregiver Decision|0|||
147314945|NCT01474512|531319452|FG004|Long-Term Extension Period|Parent/Caregiver Decision|0|||
147314946|NCT01474512|531319453|FG005|Long-Term Extension Period|Parent/Caregiver Decision|0|||
147314947|NCT01474512|531319454|FG006|Long-Term Extension Period|Parent/Caregiver Decision|0|||
147314948|NCT01474512|531319455|FG007|Long-Term Extension Period|Parent/Caregiver Decision|0|||
147314949|NCT01474512|531319456|FG008|Long-Term Extension Period|Parent/Caregiver Decision|0|||
147314950|NCT01474512|531319457|FG009|Long-Term Extension Period|Parent/Caregiver Decision|0|||
147314951|NCT01474512|531319458|FG010|Long-Term Extension Period|Parent/Caregiver Decision|0|||
147314952|NCT01474512|531319459|FG011|Long-Term Extension Period|Parent/Caregiver Decision|0|||
147314953|NCT01474512|531319460|FG012|Long-Term Extension Period|Parent/Caregiver Decision|1|||
147314954|NCT01474512|531319461|FG013|Long-Term Extension Period|Parent/Caregiver Decision|1|||
147314955|NCT01474512|531319462|FG014|Long-Term Extension Period|Parent/Caregiver Decision|0|||
147314956|NCT01474512|531319463|FG015|Long-Term Extension Period|Parent/Caregiver Decision|0|||
147314957|NCT01474512|531319464|FG016|Long-Term Extension Period|Parent/Caregiver Decision|0|||
147314958|NCT01474512|531319465|FG017|Long-Term Extension Period|Parent/Caregiver Decision|0|||
147314959|NCT01474512|531319448|FG000|Long-Term Extension Period|Switched From PBO to Ixe|0|||
147314960|NCT01474512|531319449|FG001|Long-Term Extension Period|Switched From PBO to Ixe|0|||
147314961|NCT01474512|531319450|FG002|Long-Term Extension Period|Switched From PBO to Ixe|0|||
147314962|NCT01474512|531319451|FG003|Long-Term Extension Period|Switched From PBO to Ixe|0|||
147314963|NCT01474512|531319452|FG004|Long-Term Extension Period|Switched From PBO to Ixe|0|||
147314964|NCT01474512|531319453|FG005|Long-Term Extension Period|Switched From PBO to Ixe|0|||
147314965|NCT01474512|531319454|FG006|Long-Term Extension Period|Switched From PBO to Ixe|0|||
147124054|NCT01684033|530618661|FG000|Period 1, First 30 Days|Adverse Event|1|||
147124055|NCT01684033|530618662|FG001|Period 1, First 30 Days|Adverse Event|1|||
147124056|NCT01684033|530618661|FG000|Period 1, First 30 Days|Noncompliance|1|||
147124057|NCT01684033|530618662|FG001|Period 1, First 30 Days|Noncompliance|0|||
147124058|NCT01684033|530618661|FG000|Period 1, First 30 Days|Withdrawal by Subject|1|||
147124059|NCT01684033|530618662|FG001|Period 1, First 30 Days|Withdrawal by Subject|0|||
147124060|NCT01684033|530618661|FG000|Period 1, First 30 Days|Lost to Follow-up|1|||
147124061|NCT01684033|530618662|FG001|Period 1, First 30 Days|Lost to Follow-up|0|||
147124062|NCT01684033|530618661|FG000|Period 2, Second 30 Days|Adverse Event|1|||
147124063|NCT01684033|530618662|FG001|Period 2, Second 30 Days|Adverse Event|0|||
147124064|NCT00480025|530618663|FG000|Overall Study|Protocol Violation|12|||
147124065|NCT00480025|530618664|FG001|Overall Study|Protocol Violation|7|||
147124066|NCT00480025|530618663|FG000|Overall Study|Patients remaining ongoing at Data Lock|101|||
147124067|NCT00480025|530618664|FG001|Overall Study|Patients remaining ongoing at Data Lock|55|||
147124068|NCT00480025|530618663|FG000|Overall Study|Disease Progression / Recurrence|449|||
147124069|NCT00480025|530618664|FG001|Overall Study|Disease Progression / Recurrence|224|||
147124070|NCT00480025|530618663|FG000|Overall Study|Adverse Event|44|||
147124071|NCT00480025|530618664|FG001|Overall Study|Adverse Event|12|||
147124072|NCT00480025|530618663|FG000|Overall Study|Other|70|||
147124073|NCT00480025|530618664|FG001|Overall Study|Other|29|||
147124074|NCT00480025|530618663|FG000|Overall Study|SAE including intercurrent illness|76|||
147124075|NCT00480025|530618664|FG001|Overall Study|SAE including intercurrent illness|42|||
147124076|NCT03726879|530618666|FG000|Overall Study|Death|11|||
147124077|NCT03726879|530618667|FG001|Overall Study|Death|13|||
147124078|NCT03726879|530618666|FG000|Overall Study|Physician Decision|0|||
147124079|NCT03726879|530618667|FG001|Overall Study|Physician Decision|2|||
147124080|NCT03726879|530618666|FG000|Overall Study|Protocol Violation|0|||
147124081|NCT03726879|530618667|FG001|Overall Study|Protocol Violation|1|||
147124082|NCT03726879|530618666|FG000|Overall Study|Withdrawal by Subject|5|||
147124083|NCT03726879|530618667|FG001|Overall Study|Withdrawal by Subject|6|||
147124084|NCT03726879|530618666|FG000|Overall Study|TSH result is unstable|0|||
147124085|NCT03726879|530618667|FG001|Overall Study|TSH result is unstable|1|||
147124086|NCT03726879|530618666|FG000|Overall Study|Disease relapse|1|||
147124087|NCT03726879|530618667|FG001|Overall Study|Disease relapse|0|||
147124088|NCT03726879|530618666|FG000|Overall Study|Lost to Follow-up|3|||
147124089|NCT03726879|530618667|FG001|Overall Study|Lost to Follow-up|0|||
147124090|NCT02766478|530618668|FG000|Overall Study|Withdrawal by Subject|1|||
147124091|NCT02766478|530618669|FG001|Overall Study|Withdrawal by Subject|1|||
147124092|NCT01093573|530618671|FG000|Overall Study|Physician Decision|0|||
147314966|NCT01474512|531319455|FG007|Long-Term Extension Period|Switched From PBO to Ixe|0|||
147314967|NCT01474512|531319456|FG008|Long-Term Extension Period|Switched From PBO to Ixe|0|||
147314968|NCT01474512|531319457|FG009|Long-Term Extension Period|Switched From PBO to Ixe|0|||
147314969|NCT01474512|531319458|FG010|Long-Term Extension Period|Switched From PBO to Ixe|0|||
147314970|NCT01474512|531319459|FG011|Long-Term Extension Period|Switched From PBO to Ixe|21|||
147314971|NCT01474512|531319460|FG012|Long-Term Extension Period|Switched From PBO to Ixe|0|||
147314972|NCT01474512|531319461|FG013|Long-Term Extension Period|Switched From PBO to Ixe|0|||
147314973|NCT01474512|531319462|FG014|Long-Term Extension Period|Switched From PBO to Ixe|0|||
147314974|NCT01474512|531319463|FG015|Long-Term Extension Period|Switched From PBO to Ixe|0|||
147314975|NCT01474512|531319464|FG016|Long-Term Extension Period|Switched From PBO to Ixe|0|||
147314976|NCT01474512|531319465|FG017|Long-Term Extension Period|Switched From PBO to Ixe|0|||
147314977|NCT01474512|531319448|FG000|Post-Treatment Follow-Up|Adverse Event|0|||
147314978|NCT01474512|531319449|FG001|Post-Treatment Follow-Up|Adverse Event|0|||
147314979|NCT01474512|531319450|FG002|Post-Treatment Follow-Up|Adverse Event|0|||
147314980|NCT01474512|531319451|FG003|Post-Treatment Follow-Up|Adverse Event|0|||
147314981|NCT01474512|531319452|FG004|Post-Treatment Follow-Up|Adverse Event|0|||
147314982|NCT01474512|531319453|FG005|Post-Treatment Follow-Up|Adverse Event|0|||
147314983|NCT01474512|531319454|FG006|Post-Treatment Follow-Up|Adverse Event|0|||
147314984|NCT01474512|531319455|FG007|Post-Treatment Follow-Up|Adverse Event|0|||
147314985|NCT01474512|531319456|FG008|Post-Treatment Follow-Up|Adverse Event|0|||
147314986|NCT01474512|531319457|FG009|Post-Treatment Follow-Up|Adverse Event|0|||
147314987|NCT01474512|531319458|FG010|Post-Treatment Follow-Up|Adverse Event|0|||
147314988|NCT01474512|531319459|FG011|Post-Treatment Follow-Up|Adverse Event|0|||
147314989|NCT01474512|531319460|FG012|Post-Treatment Follow-Up|Adverse Event|0|||
147314990|NCT01474512|531319461|FG013|Post-Treatment Follow-Up|Adverse Event|0|||
147314991|NCT01474512|531319462|FG014|Post-Treatment Follow-Up|Adverse Event|8|||
147314992|NCT01474512|531319463|FG015|Post-Treatment Follow-Up|Adverse Event|2|||
147314993|NCT01474512|531319464|FG016|Post-Treatment Follow-Up|Adverse Event|58|||
147314994|NCT01474512|531319465|FG017|Post-Treatment Follow-Up|Adverse Event|11|||
147314995|NCT01474512|531319448|FG000|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
147314996|NCT01474512|531319449|FG001|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
147314997|NCT01474512|531319450|FG002|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
147314998|NCT01474512|531319451|FG003|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
147314999|NCT01474512|531319452|FG004|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
147315000|NCT01474512|531319453|FG005|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
147315001|NCT01474512|531319454|FG006|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
147315002|NCT01474512|531319455|FG007|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
147315003|NCT01474512|531319456|FG008|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
147315004|NCT01474512|531319457|FG009|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
147315005|NCT01474512|531319458|FG010|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
147315006|NCT01474512|531319459|FG011|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
147315007|NCT01474512|531319460|FG012|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
147315008|NCT01474512|531319461|FG013|Post-Treatment Follow-Up|Withdrawal by Subject|0|||
147315009|NCT01474512|531319462|FG014|Post-Treatment Follow-Up|Withdrawal by Subject|3|||
147315010|NCT01474512|531319463|FG015|Post-Treatment Follow-Up|Withdrawal by Subject|2|||
147315011|NCT01474512|531319464|FG016|Post-Treatment Follow-Up|Withdrawal by Subject|36|||
147315012|NCT01474512|531319465|FG017|Post-Treatment Follow-Up|Withdrawal by Subject|17|||
147315013|NCT01474512|531319448|FG000|Post-Treatment Follow-Up|Lack of Efficacy|0|||
147315014|NCT01474512|531319449|FG001|Post-Treatment Follow-Up|Lack of Efficacy|0|||
147124093|NCT01093573|530618672|FG001|Overall Study|Physician Decision|0|||
147124094|NCT01093573|530618673|FG002|Overall Study|Physician Decision|1|||
147124095|NCT01093573|530618671|FG000|Overall Study|Insurance Denied|0|||
147124096|NCT01093573|530618672|FG001|Overall Study|Insurance Denied|0|||
147124097|NCT01093573|530618673|FG002|Overall Study|Insurance Denied|1|||
147124098|NCT00089583|530618674|FG000|Overall Study|Adverse Event|0|||
147124099|NCT00089583|530618675|FG001|Overall Study|Adverse Event|3|||
147124100|NCT00089583|530618674|FG000|Overall Study|Insufficient Viral Load Response|5|||
147124101|NCT00089583|530618675|FG001|Overall Study|Insufficient Viral Load Response|5|||
147315015|NCT01474512|531319450|FG002|Post-Treatment Follow-Up|Lack of Efficacy|0|||
147315016|NCT01474512|531319451|FG003|Post-Treatment Follow-Up|Lack of Efficacy|0|||
147315017|NCT01474512|531319452|FG004|Post-Treatment Follow-Up|Lack of Efficacy|0|||
147315018|NCT01474512|531319453|FG005|Post-Treatment Follow-Up|Lack of Efficacy|0|||
147315019|NCT01474512|531319454|FG006|Post-Treatment Follow-Up|Lack of Efficacy|0|||
147315020|NCT01474512|531319455|FG007|Post-Treatment Follow-Up|Lack of Efficacy|0|||
147315021|NCT01474512|531319456|FG008|Post-Treatment Follow-Up|Lack of Efficacy|0|||
147315022|NCT01474512|531319457|FG009|Post-Treatment Follow-Up|Lack of Efficacy|0|||
147315023|NCT01474512|531319458|FG010|Post-Treatment Follow-Up|Lack of Efficacy|0|||
147315024|NCT01474512|531319459|FG011|Post-Treatment Follow-Up|Lack of Efficacy|0|||
147315025|NCT01474512|531319460|FG012|Post-Treatment Follow-Up|Lack of Efficacy|0|||
147315026|NCT01474512|531319461|FG013|Post-Treatment Follow-Up|Lack of Efficacy|0|||
147124102|NCT00089583|530618674|FG000|Overall Study|Withdrawal by Subject|0|||
147124103|NCT00089583|530618675|FG001|Overall Study|Withdrawal by Subject|4|||
147124104|NCT00089583|530618674|FG000|Overall Study|Participant (Par) Didn't Take Medication|1|||
147124105|NCT00089583|530618675|FG001|Overall Study|Participant (Par) Didn't Take Medication|0|||
147124106|NCT00089583|530618674|FG000|Overall Study|Participant Refused Study Medication|0|||
147315027|NCT01474512|531319462|FG014|Post-Treatment Follow-Up|Lack of Efficacy|3|||
147315028|NCT01474512|531319463|FG015|Post-Treatment Follow-Up|Lack of Efficacy|2|||
147315029|NCT01474512|531319464|FG016|Post-Treatment Follow-Up|Lack of Efficacy|31|||
147315030|NCT01474512|531319465|FG017|Post-Treatment Follow-Up|Lack of Efficacy|3|||
147315031|NCT01474512|531319448|FG000|Post-Treatment Follow-Up|Lost to Follow-up|0|||
147315032|NCT01474512|531319449|FG001|Post-Treatment Follow-Up|Lost to Follow-up|0|||
147315033|NCT01474512|531319450|FG002|Post-Treatment Follow-Up|Lost to Follow-up|0|||
147315034|NCT01474512|531319451|FG003|Post-Treatment Follow-Up|Lost to Follow-up|0|||
147315035|NCT01474512|531319452|FG004|Post-Treatment Follow-Up|Lost to Follow-up|0|||
147315036|NCT01474512|531319453|FG005|Post-Treatment Follow-Up|Lost to Follow-up|0|||
147315037|NCT01474512|531319454|FG006|Post-Treatment Follow-Up|Lost to Follow-up|0|||
147315038|NCT01474512|531319455|FG007|Post-Treatment Follow-Up|Lost to Follow-up|0|||
147315039|NCT01474512|531319456|FG008|Post-Treatment Follow-Up|Lost to Follow-up|0|||
147315040|NCT01474512|531319457|FG009|Post-Treatment Follow-Up|Lost to Follow-up|0|||
147315041|NCT01474512|531319458|FG010|Post-Treatment Follow-Up|Lost to Follow-up|0|||
147315042|NCT01474512|531319459|FG011|Post-Treatment Follow-Up|Lost to Follow-up|0|||
147315043|NCT01474512|531319460|FG012|Post-Treatment Follow-Up|Lost to Follow-up|0|||
147315044|NCT01474512|531319461|FG013|Post-Treatment Follow-Up|Lost to Follow-up|0|||
147315045|NCT01474512|531319462|FG014|Post-Treatment Follow-Up|Lost to Follow-up|0|||
147315046|NCT01474512|531319463|FG015|Post-Treatment Follow-Up|Lost to Follow-up|0|||
147315047|NCT01474512|531319464|FG016|Post-Treatment Follow-Up|Lost to Follow-up|12|||
147315048|NCT01474512|531319465|FG017|Post-Treatment Follow-Up|Lost to Follow-up|7|||
147444637|NCT01147744|531792657|FG000|Overall Study|Adverse Event|1|||
147444638|NCT01147744|531792658|FG001|Overall Study|Adverse Event|2|||
147444639|NCT01147744|531792659|FG002|Overall Study|Adverse Event|3|||
147124107|NCT00089583|530618675|FG001|Overall Study|Participant Refused Study Medication|2|||
147124108|NCT00089583|530618674|FG000|Overall Study|Non-Compliance|0|||
147124109|NCT00089583|530618675|FG001|Overall Study|Non-Compliance|4|||
147124110|NCT00089583|530618674|FG000|Overall Study|Poor Medical Compliance/Adherence Issues|0|||
147124111|NCT00089583|530618675|FG001|Overall Study|Poor Medical Compliance/Adherence Issues|3|||
147124112|NCT00089583|530618674|FG000|Overall Study|Participant Management Criteria Met|0|||
147124113|NCT00089583|530618675|FG001|Overall Study|Participant Management Criteria Met|1|||
147124114|NCT00089583|530618674|FG000|Overall Study|Reason Not Provided|0|||
147124115|NCT00089583|530618675|FG001|Overall Study|Reason Not Provided|1|||
147124116|NCT00089583|530618674|FG000|Overall Study|Protocol Violation|0|||
147124117|NCT00089583|530618675|FG001|Overall Study|Protocol Violation|3|||
147124118|NCT00089583|530618674|FG000|Overall Study|Principal Investigator Decision|0|||
147124119|NCT00089583|530618675|FG001|Overall Study|Principal Investigator Decision|10|||
147124120|NCT00089583|530618674|FG000|Overall Study|Start of Disallowed Medication|0|||
147124121|NCT00089583|530618675|FG001|Overall Study|Start of Disallowed Medication|1|||
147124122|NCT00089583|530618674|FG000|Overall Study|Necessity to Use Prohibited Drug|1|||
147124123|NCT00089583|530618675|FG001|Overall Study|Necessity to Use Prohibited Drug|0|||
147124124|NCT00089583|530618674|FG000|Overall Study|Participant Incarcerated|0|||
147124125|NCT00089583|530618675|FG001|Overall Study|Participant Incarcerated|1|||
147124126|NCT04349098|530618676|FG000|Overall Study|Death|16|||
147124127|NCT04349098|530618677|FG001|Overall Study|Death|8|||
147124128|NCT04349098|530618676|FG000|Overall Study|Lost to Follow-up|11|||
147124129|NCT04349098|530618677|FG001|Overall Study|Lost to Follow-up|8|||
147124130|NCT04349098|530618676|FG000|Overall Study|Withdrawal by Subject|8|||
147124131|NCT04349098|530618677|FG001|Overall Study|Withdrawal by Subject|5|||
147124132|NCT04349098|530618676|FG000|Overall Study|Other|3|||
147124133|NCT04349098|530618677|FG001|Overall Study|Other|5|||
147124134|NCT02113878|530620641|FG000|Overall Study|Adverse Event|1|||
147124135|NCT02113878|530620642|FG001|Overall Study|Adverse Event|0|||
147124136|NCT02113878|530620641|FG000|Overall Study|Withdrawal by Subject|1|||
147124137|NCT02113878|530620642|FG001|Overall Study|Withdrawal by Subject|0|||
147124138|NCT02113878|530620641|FG000|Overall Study|patient non-compliance|1|||
147124139|NCT02113878|530620642|FG001|Overall Study|patient non-compliance|0|||
147124140|NCT01251965|530620643|FG000|Overall Study|Participant/physician decision|1|||
147124141|NCT01251965|530620644|FG001|Overall Study|Participant/physician decision|2|||
147124142|NCT01251965|530620645|FG002|Overall Study|Participant/physician decision|0|||
147124143|NCT01251965|530620643|FG000|Overall Study|Death|0|||
147124144|NCT01251965|530620644|FG001|Overall Study|Death|0|||
147124145|NCT01251965|530620645|FG002|Overall Study|Death|11|||
147124146|NCT00530257|530620646|FG000|Overall Study|Lost to Follow-up|1|||
147124147|NCT05130281|530620649|FG000|Overall Study|Withdrawal by Subject|0|||
147124148|NCT05130281|530620650|FG001|Overall Study|Withdrawal by Subject|0|||
147124149|NCT05130281|530620651|FG002|Overall Study|Withdrawal by Subject|1|||
147124150|NCT02144337|530620656|FG000|T2 Follow-up (Post-intervention)|Lack of Efficacy|1|||
147124151|NCT02144337|530620657|FG001|T2 Follow-up (Post-intervention)|Lack of Efficacy|1|||
147124152|NCT02144337|530620656|FG000|T2 Follow-up (Post-intervention)|Lost to Follow-up|2|||
147124153|NCT02144337|530620657|FG001|T2 Follow-up (Post-intervention)|Lost to Follow-up|0|||
147124154|NCT02144337|530620656|FG000|T2 Follow-up (Post-intervention)|Withdrawal by Subject|1|||
147124155|NCT02144337|530620657|FG001|T2 Follow-up (Post-intervention)|Withdrawal by Subject|0|||
147124156|NCT02144337|530620656|FG000|T3 Follow-up (3 Month Post-intervention)|Lost to Follow-up|2|||
147124157|NCT02144337|530620657|FG001|T3 Follow-up (3 Month Post-intervention)|Lost to Follow-up|0|||
147124158|NCT02144337|530620656|FG000|T3 Follow-up (3 Month Post-intervention)|Withdrawal by Subject|1|||
147124159|NCT02144337|530620657|FG001|T3 Follow-up (3 Month Post-intervention)|Withdrawal by Subject|0|||
147124160|NCT00203242|530620658|FG000|Overall Study|Lost to Follow-up|1|||
147124161|NCT01500135|530620659|FG000|Overall Study|Withdrawal of Consent|4|||
147233569|NCT02468232|531027956|FG002|Core Part of Study|Technical Problems|0|||
147651076|NCT00255840|532544579|FG001|Overall Study|Discontinued intervention|56|||
147651077|NCT00339833|532544582|FG000|Overall Study|Withdrawal by Subject|1|||
147233570|NCT02468232|531027957|FG003|Core Part of Study|Technical Problems|0|||
147233571|NCT02468232|531027954|FG000|OLE Part of Study|Adverse Event|0|||
147233572|NCT02468232|531027955|FG001|OLE Part of Study|Adverse Event|0|||
147233573|NCT02468232|531027956|FG002|OLE Part of Study|Adverse Event|4|||
147233574|NCT02468232|531027957|FG003|OLE Part of Study|Adverse Event|5|||
147233575|NCT02468232|531027954|FG000|OLE Part of Study|Death|0|||
147233576|NCT02468232|531027955|FG001|OLE Part of Study|Death|0|||
147233577|NCT02468232|531027956|FG002|OLE Part of Study|Death|4|||
147233578|NCT02468232|531027957|FG003|OLE Part of Study|Death|2|||
147233579|NCT02468232|531027954|FG000|OLE Part of Study|Physician Decision|0|||
147233580|NCT02468232|531027955|FG001|OLE Part of Study|Physician Decision|0|||
147233581|NCT02468232|531027956|FG002|OLE Part of Study|Physician Decision|4|||
147233582|NCT02468232|531027957|FG003|OLE Part of Study|Physician Decision|0|||
147233583|NCT02468232|531027954|FG000|OLE Part of Study|Subject/Guardian decision|0|||
147233584|NCT02468232|531027955|FG001|OLE Part of Study|Subject/Guardian decision|0|||
147233585|NCT02468232|531027956|FG002|OLE Part of Study|Subject/Guardian decision|2|||
147233586|NCT02468232|531027957|FG003|OLE Part of Study|Subject/Guardian decision|5|||
147233587|NCT02024529|531027960|FG000|Overall Study|Withdrawal by Subject|11|||
147233588|NCT02024529|531027961|FG001|Overall Study|Withdrawal by Subject|21|||
147233589|NCT02024529|531027960|FG000|Overall Study|Lost to Follow-up|2|||
147233590|NCT02024529|531027961|FG001|Overall Study|Lost to Follow-up|4|||
147233591|NCT00354614|531027962|FG000|Overall Study|Lack of Efficacy|28|||
147233592|NCT03650556|531027963|FG000|Overall Study|Death|2|||
147233593|NCT03650556|531027963|FG000|Overall Study|Withdrawal by Subject|20|||
147233594|NCT03650556|531027963|FG000|Overall Study|Physician Decision|2|||
147233595|NCT03650556|531027963|FG000|Overall Study|Lost to Follow-up|8|||
147233596|NCT03650556|531027963|FG000|Overall Study|Subject did not complete follow-up but did not meet criteria for lost-to-follow-up|4|||
147233597|NCT03650556|531027963|FG000|Overall Study|Enrolled, but no ablation performed-investigational catheter was not inserted|1|||
147233598|NCT01426438|531027964|FG000|Overall Study|Lost to Follow-up|1|||
147233599|NCT01426438|531027965|FG001|Overall Study|Lost to Follow-up|3|||
147233600|NCT01426438|531027964|FG000|Overall Study|Off study Treatment|9|||
147233601|NCT01426438|531027965|FG001|Overall Study|Off study Treatment|3|||
147233602|NCT01426438|531027964|FG000|Overall Study|Poor scan quality|3|||
147233603|NCT01426438|531027965|FG001|Overall Study|Poor scan quality|2|||
147233604|NCT01426438|531027964|FG000|Overall Study|Missed Scan|2|||
147233605|NCT01426438|531027965|FG001|Overall Study|Missed Scan|2|||
147233606|NCT02122458|531027966|FG000|Overall Study|Withdrawal by Subject|0|||
147233607|NCT02122458|531027967|FG001|Overall Study|Withdrawal by Subject|0|||
147233608|NCT02122458|531027968|FG002|Overall Study|Withdrawal by Subject|0|||
147233609|NCT02122458|531027969|FG003|Overall Study|Withdrawal by Subject|4|||
147233610|NCT02122458|531027970|FG004|Overall Study|Withdrawal by Subject|4|||
147233611|NCT02122458|531027971|FG005|Overall Study|Withdrawal by Subject|4|||
147233612|NCT02122458|531027972|FG006|Overall Study|Withdrawal by Subject|0|||
147233613|NCT02122458|531027966|FG000|Overall Study|Lost to Follow-up|1|||
147233614|NCT02122458|531027967|FG001|Overall Study|Lost to Follow-up|3|||
147233615|NCT02122458|531027968|FG002|Overall Study|Lost to Follow-up|0|||
147233616|NCT02122458|531027969|FG003|Overall Study|Lost to Follow-up|7|||
147233617|NCT02122458|531027970|FG004|Overall Study|Lost to Follow-up|5|||
147233618|NCT02122458|531027971|FG005|Overall Study|Lost to Follow-up|15|||
147233619|NCT02122458|531027972|FG006|Overall Study|Lost to Follow-up|1|||
147233620|NCT02122458|531027966|FG000|Overall Study|Did not qualify at initial testing or after chart review|1|||
147233621|NCT02122458|531027967|FG001|Overall Study|Did not qualify at initial testing or after chart review|0|||
147233622|NCT02122458|531027968|FG002|Overall Study|Did not qualify at initial testing or after chart review|0|||
147233623|NCT02122458|531027969|FG003|Overall Study|Did not qualify at initial testing or after chart review|0|||
147233624|NCT02122458|531027970|FG004|Overall Study|Did not qualify at initial testing or after chart review|0|||
147233625|NCT02122458|531027971|FG005|Overall Study|Did not qualify at initial testing or after chart review|0|||
147233626|NCT02122458|531027972|FG006|Overall Study|Did not qualify at initial testing or after chart review|0|||
147124162|NCT01500135|530620660|FG001|Overall Study|Withdrawal of Consent|0|||
147233627|NCT02122458|531027966|FG000|Overall Study|Adverse Event|1|||
147315049|NCT01474512|531319448|FG000|Post-Treatment Follow-Up|Physician Decision|0|||
147315050|NCT01474512|531319449|FG001|Post-Treatment Follow-Up|Physician Decision|0|||
147315051|NCT01474512|531319450|FG002|Post-Treatment Follow-Up|Physician Decision|0|||
147315052|NCT01474512|531319451|FG003|Post-Treatment Follow-Up|Physician Decision|0|||
147315053|NCT01474512|531319452|FG004|Post-Treatment Follow-Up|Physician Decision|0|||
147315054|NCT01474512|531319453|FG005|Post-Treatment Follow-Up|Physician Decision|0|||
147315055|NCT01474512|531319454|FG006|Post-Treatment Follow-Up|Physician Decision|0|||
147315056|NCT01474512|531319455|FG007|Post-Treatment Follow-Up|Physician Decision|0|||
147315057|NCT01474512|531319456|FG008|Post-Treatment Follow-Up|Physician Decision|0|||
147315058|NCT01474512|531319457|FG009|Post-Treatment Follow-Up|Physician Decision|0|||
147315059|NCT01474512|531319458|FG010|Post-Treatment Follow-Up|Physician Decision|0|||
147315060|NCT01474512|531319459|FG011|Post-Treatment Follow-Up|Physician Decision|0|||
147315061|NCT01474512|531319460|FG012|Post-Treatment Follow-Up|Physician Decision|0|||
147315062|NCT01474512|531319461|FG013|Post-Treatment Follow-Up|Physician Decision|0|||
147315063|NCT01474512|531319462|FG014|Post-Treatment Follow-Up|Physician Decision|0|||
147315064|NCT01474512|531319463|FG015|Post-Treatment Follow-Up|Physician Decision|0|||
147315065|NCT01474512|531319464|FG016|Post-Treatment Follow-Up|Physician Decision|4|||
147315066|NCT01474512|531319465|FG017|Post-Treatment Follow-Up|Physician Decision|5|||
147315067|NCT01474512|531319448|FG000|Post-Treatment Follow-Up|Clinical Relapse|0|||
147315068|NCT01474512|531319449|FG001|Post-Treatment Follow-Up|Clinical Relapse|0|||
147315069|NCT01474512|531319450|FG002|Post-Treatment Follow-Up|Clinical Relapse|0|||
147315070|NCT01474512|531319451|FG003|Post-Treatment Follow-Up|Clinical Relapse|0|||
147315071|NCT01474512|531319452|FG004|Post-Treatment Follow-Up|Clinical Relapse|0|||
147315072|NCT01474512|531319453|FG005|Post-Treatment Follow-Up|Clinical Relapse|0|||
147315073|NCT01474512|531319454|FG006|Post-Treatment Follow-Up|Clinical Relapse|0|||
147315074|NCT01474512|531319455|FG007|Post-Treatment Follow-Up|Clinical Relapse|0|||
147315075|NCT01474512|531319456|FG008|Post-Treatment Follow-Up|Clinical Relapse|0|||
147315076|NCT01474512|531319457|FG009|Post-Treatment Follow-Up|Clinical Relapse|0|||
147315077|NCT01474512|531319458|FG010|Post-Treatment Follow-Up|Clinical Relapse|0|||
147315078|NCT01474512|531319459|FG011|Post-Treatment Follow-Up|Clinical Relapse|0|||
147315079|NCT01474512|531319460|FG012|Post-Treatment Follow-Up|Clinical Relapse|0|||
147315080|NCT01474512|531319461|FG013|Post-Treatment Follow-Up|Clinical Relapse|0|||
147315081|NCT01474512|531319462|FG014|Post-Treatment Follow-Up|Clinical Relapse|0|||
147315082|NCT01474512|531319463|FG015|Post-Treatment Follow-Up|Clinical Relapse|0|||
147315083|NCT01474512|531319464|FG016|Post-Treatment Follow-Up|Clinical Relapse|6|||
147315084|NCT01474512|531319465|FG017|Post-Treatment Follow-Up|Clinical Relapse|2|||
147315085|NCT01474512|531319448|FG000|Post-Treatment Follow-Up|Protocol Violation|0|||
147315086|NCT01474512|531319449|FG001|Post-Treatment Follow-Up|Protocol Violation|0|||
147315087|NCT01474512|531319450|FG002|Post-Treatment Follow-Up|Protocol Violation|0|||
147315088|NCT01474512|531319451|FG003|Post-Treatment Follow-Up|Protocol Violation|0|||
147315089|NCT01474512|531319452|FG004|Post-Treatment Follow-Up|Protocol Violation|0|||
147315090|NCT01474512|531319453|FG005|Post-Treatment Follow-Up|Protocol Violation|0|||
147315091|NCT01474512|531319454|FG006|Post-Treatment Follow-Up|Protocol Violation|0|||
147315092|NCT01474512|531319455|FG007|Post-Treatment Follow-Up|Protocol Violation|0|||
147315093|NCT01474512|531319456|FG008|Post-Treatment Follow-Up|Protocol Violation|0|||
147315094|NCT01474512|531319457|FG009|Post-Treatment Follow-Up|Protocol Violation|0|||
147315095|NCT01474512|531319458|FG010|Post-Treatment Follow-Up|Protocol Violation|0|||
147315096|NCT01474512|531319459|FG011|Post-Treatment Follow-Up|Protocol Violation|0|||
147315097|NCT01474512|531319460|FG012|Post-Treatment Follow-Up|Protocol Violation|0|||
147315098|NCT01474512|531319461|FG013|Post-Treatment Follow-Up|Protocol Violation|0|||
147315099|NCT01474512|531319462|FG014|Post-Treatment Follow-Up|Protocol Violation|2|||
147315100|NCT01474512|531319463|FG015|Post-Treatment Follow-Up|Protocol Violation|2|||
147315101|NCT01474512|531319464|FG016|Post-Treatment Follow-Up|Protocol Violation|4|||
147315102|NCT01474512|531319465|FG017|Post-Treatment Follow-Up|Protocol Violation|0|||
147315103|NCT01474512|531319448|FG000|Post-Treatment Follow-Up|Sponsor Decision|0|||
147315104|NCT01474512|531319449|FG001|Post-Treatment Follow-Up|Sponsor Decision|0|||
147315105|NCT01474512|531319450|FG002|Post-Treatment Follow-Up|Sponsor Decision|0|||
147315106|NCT01474512|531319451|FG003|Post-Treatment Follow-Up|Sponsor Decision|0|||
147315107|NCT01474512|531319452|FG004|Post-Treatment Follow-Up|Sponsor Decision|0|||
147444640|NCT01147744|531792660|FG003|Overall Study|Adverse Event|0|||
147444641|NCT01147744|531792661|FG004|Overall Study|Adverse Event|2|||
147444642|NCT01147744|531792662|FG005|Overall Study|Adverse Event|1|||
147315108|NCT01474512|531319453|FG005|Post-Treatment Follow-Up|Sponsor Decision|0|||
147315109|NCT01474512|531319454|FG006|Post-Treatment Follow-Up|Sponsor Decision|0|||
147315110|NCT01474512|531319455|FG007|Post-Treatment Follow-Up|Sponsor Decision|0|||
147315111|NCT01474512|531319456|FG008|Post-Treatment Follow-Up|Sponsor Decision|0|||
147315112|NCT01474512|531319457|FG009|Post-Treatment Follow-Up|Sponsor Decision|0|||
147315113|NCT01474512|531319458|FG010|Post-Treatment Follow-Up|Sponsor Decision|0|||
147315114|NCT01474512|531319459|FG011|Post-Treatment Follow-Up|Sponsor Decision|0|||
147315115|NCT01474512|531319460|FG012|Post-Treatment Follow-Up|Sponsor Decision|0|||
147315116|NCT01474512|531319461|FG013|Post-Treatment Follow-Up|Sponsor Decision|0|||
147444643|NCT01147744|531792663|FG006|Overall Study|Adverse Event|2|||
147124163|NCT01500135|530620659|FG000|Overall Study|Lost to Follow-up|6|||
147315117|NCT01474512|531319462|FG014|Post-Treatment Follow-Up|Sponsor Decision|1|||
147315118|NCT01474512|531319463|FG015|Post-Treatment Follow-Up|Sponsor Decision|0|||
147315119|NCT01474512|531319464|FG016|Post-Treatment Follow-Up|Sponsor Decision|4|||
147315120|NCT01474512|531319465|FG017|Post-Treatment Follow-Up|Sponsor Decision|0|||
147315121|NCT01474512|531319448|FG000|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
147315122|NCT01474512|531319449|FG001|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
147315123|NCT01474512|531319450|FG002|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
147315124|NCT01474512|531319451|FG003|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
147315125|NCT01474512|531319452|FG004|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
147315126|NCT01474512|531319453|FG005|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
147315127|NCT01474512|531319454|FG006|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
147315128|NCT01474512|531319455|FG007|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
147315129|NCT01474512|531319456|FG008|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
147315130|NCT01474512|531319457|FG009|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
147315131|NCT01474512|531319458|FG010|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
147315132|NCT01474512|531319459|FG011|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
147315133|NCT01474512|531319460|FG012|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
147315134|NCT01474512|531319461|FG013|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
147315135|NCT01474512|531319462|FG014|Post-Treatment Follow-Up|Parent/Caregiver Decision|1|||
147315136|NCT01474512|531319463|FG015|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
147315137|NCT01474512|531319464|FG016|Post-Treatment Follow-Up|Parent/Caregiver Decision|0|||
147315138|NCT01474512|531319465|FG017|Post-Treatment Follow-Up|Parent/Caregiver Decision|1|||
147315139|NCT01474512|531319448|FG000|Post-Treatment Follow-Up|Death|0|||
147315140|NCT01474512|531319449|FG001|Post-Treatment Follow-Up|Death|0|||
147315141|NCT01474512|531319450|FG002|Post-Treatment Follow-Up|Death|0|||
147315142|NCT01474512|531319451|FG003|Post-Treatment Follow-Up|Death|0|||
147315143|NCT01474512|531319452|FG004|Post-Treatment Follow-Up|Death|0|||
147315144|NCT01474512|531319453|FG005|Post-Treatment Follow-Up|Death|0|||
147315145|NCT01474512|531319454|FG006|Post-Treatment Follow-Up|Death|0|||
147315146|NCT01474512|531319455|FG007|Post-Treatment Follow-Up|Death|0|||
147315147|NCT01474512|531319456|FG008|Post-Treatment Follow-Up|Death|0|||
147315148|NCT01474512|531319457|FG009|Post-Treatment Follow-Up|Death|0|||
147315149|NCT01474512|531319458|FG010|Post-Treatment Follow-Up|Death|0|||
147315150|NCT01474512|531319459|FG011|Post-Treatment Follow-Up|Death|0|||
147315151|NCT01474512|531319460|FG012|Post-Treatment Follow-Up|Death|0|||
147315152|NCT01474512|531319461|FG013|Post-Treatment Follow-Up|Death|0|||
147315153|NCT01474512|531319462|FG014|Post-Treatment Follow-Up|Death|0|||
147315154|NCT01474512|531319463|FG015|Post-Treatment Follow-Up|Death|0|||
147315155|NCT01474512|531319464|FG016|Post-Treatment Follow-Up|Death|1|||
147315156|NCT01474512|531319465|FG017|Post-Treatment Follow-Up|Death|0|||
147315157|NCT03268590|531319478|FG000|Overall Study|Previously unknown exclusion criteria|1|||
147315158|NCT00531011|531319479|FG000|Overall Study|Withdrawal by Subject|2|||
147315159|NCT00531011|531319480|FG001|Overall Study|Withdrawal by Subject|4|||
147315160|NCT00531011|531319479|FG000|Overall Study|Death|1|||
147315161|NCT00531011|531319480|FG001|Overall Study|Death|0|||
147315162|NCT00531011|531319479|FG000|Overall Study|Lost to Follow-up|1|||
147315163|NCT00531011|531319480|FG001|Overall Study|Lost to Follow-up|0|||
147233628|NCT02122458|531027967|FG001|Overall Study|Adverse Event|0|||
147233629|NCT02122458|531027968|FG002|Overall Study|Adverse Event|0|||
147233630|NCT02122458|531027969|FG003|Overall Study|Adverse Event|0|||
147233631|NCT02122458|531027970|FG004|Overall Study|Adverse Event|0|||
147233632|NCT02122458|531027971|FG005|Overall Study|Adverse Event|0|||
147233633|NCT02122458|531027972|FG006|Overall Study|Adverse Event|0|||
147233634|NCT02122458|531027966|FG000|Overall Study|Experimental Error|0|||
147233635|NCT02122458|531027967|FG001|Overall Study|Experimental Error|0|||
147233636|NCT02122458|531027968|FG002|Overall Study|Experimental Error|0|||
147233637|NCT02122458|531027969|FG003|Overall Study|Experimental Error|0|||
147233638|NCT02122458|531027970|FG004|Overall Study|Experimental Error|3|||
147233639|NCT02122458|531027971|FG005|Overall Study|Experimental Error|0|||
147233640|NCT02122458|531027972|FG006|Overall Study|Experimental Error|0|||
147233641|NCT02122458|531027966|FG000|Overall Study|Deployed or Moved|0|||
147233642|NCT02122458|531027967|FG001|Overall Study|Deployed or Moved|0|||
147233643|NCT02122458|531027968|FG002|Overall Study|Deployed or Moved|0|||
147315164|NCT00531011|531319479|FG000|Overall Study|Physician Decision|0|||
147315165|NCT00531011|531319480|FG001|Overall Study|Physician Decision|3|||
147315166|NCT00579982|531319521|FG000|Overall Study|Adverse Event|4|||
147315167|NCT00579982|531319521|FG000|Overall Study|Protocol Violation|4|||
147315168|NCT03192215|531319522|FG000|Overall Study|Death|28|||
147315169|NCT03192215|531319523|FG001|Overall Study|Death|23|||
147315170|NCT03192215|531319522|FG000|Overall Study|Lost to Follow-up|10|||
147315171|NCT03192215|531319523|FG001|Overall Study|Lost to Follow-up|15|||
147233644|NCT02122458|531027969|FG003|Overall Study|Deployed or Moved|0|||
147315172|NCT03192215|531319522|FG000|Overall Study|Withdrawal by Subject|49|||
147315173|NCT03192215|531319523|FG001|Overall Study|Withdrawal by Subject|48|||
147315174|NCT03192215|531319522|FG000|Overall Study|Other as reported in analysis|4|||
147233645|NCT02122458|531027970|FG004|Overall Study|Deployed or Moved|1|||
147315175|NCT03192215|531319523|FG001|Overall Study|Other as reported in analysis|1|||
147315176|NCT02038764|531319524|FG000|Overall Study|Adverse Event|0|||
147315177|NCT02038764|531319525|FG001|Overall Study|Adverse Event|0|||
147315178|NCT02038764|531319526|FG002|Overall Study|Adverse Event|1|||
147315179|NCT02038764|531319527|FG003|Overall Study|Adverse Event|0|||
147315180|NCT02038764|531319528|FG004|Overall Study|Adverse Event|0|||
147315181|NCT02038764|531319524|FG000|Overall Study|Lost to Follow-up|0|||
147315182|NCT02038764|531319525|FG001|Overall Study|Lost to Follow-up|1|||
147315183|NCT02038764|531319526|FG002|Overall Study|Lost to Follow-up|0|||
147315184|NCT02038764|531319527|FG003|Overall Study|Lost to Follow-up|0|||
147315185|NCT02038764|531319528|FG004|Overall Study|Lost to Follow-up|0|||
147315186|NCT02038764|531319524|FG000|Overall Study|Withdrawal by Subject|0|||
147315187|NCT02038764|531319525|FG001|Overall Study|Withdrawal by Subject|0|||
147315188|NCT02038764|531319526|FG002|Overall Study|Withdrawal by Subject|0|||
147315189|NCT02038764|531319527|FG003|Overall Study|Withdrawal by Subject|0|||
147315190|NCT02038764|531319528|FG004|Overall Study|Withdrawal by Subject|1|||
147315191|NCT02038764|531319524|FG000|Overall Study|Other|1|||
147315192|NCT02038764|531319525|FG001|Overall Study|Other|0|||
147315193|NCT02038764|531319526|FG002|Overall Study|Other|1|||
147315194|NCT02038764|531319527|FG003|Overall Study|Other|0|||
147315195|NCT02038764|531319528|FG004|Overall Study|Other|0|||
147315196|NCT04844918|531319530|FG000|Overall Study|Adverse Event|7|||
147315197|NCT04844918|531319531|FG001|Overall Study|Adverse Event|8|||
147315198|NCT04844918|531319532|FG002|Overall Study|Adverse Event|5|||
147315199|NCT04844918|531319530|FG000|Overall Study|Physician Decision|0|||
147315200|NCT04844918|531319531|FG001|Overall Study|Physician Decision|1|||
147315201|NCT04844918|531319532|FG002|Overall Study|Physician Decision|0|||
147315202|NCT04844918|531319530|FG000|Overall Study|Withdrawal by Subject|6|||
147315203|NCT04844918|531319531|FG001|Overall Study|Withdrawal by Subject|3|||
147315204|NCT04844918|531319532|FG002|Overall Study|Withdrawal by Subject|3|||
147315205|NCT04844918|531319530|FG000|Overall Study|Participants Excluded Due to GCP Compliance Issue|15|||
147315206|NCT04844918|531319531|FG001|Overall Study|Participants Excluded Due to GCP Compliance Issue|13|||
147315207|NCT04844918|531319532|FG002|Overall Study|Participants Excluded Due to GCP Compliance Issue|14|||
147315208|NCT04716881|531319534|FG000|Overall Study|Adverse Event|1|||
147315209|NCT04716881|531319534|FG000|Overall Study|Lost to Follow-up|1|||
147315210|NCT00363896|531319535|FG000|Overall Study|Withdrawal by Subject|29|||
147315211|NCT00363896|531319536|FG001|Overall Study|Withdrawal by Subject|16|||
147315212|NCT00363896|531319535|FG000|Overall Study|Adverse Event|24|||
147315213|NCT00363896|531319536|FG001|Overall Study|Adverse Event|13|||
147315214|NCT00363896|531319535|FG000|Overall Study|COPD exacerbation|13|||
147315215|NCT00363896|531319536|FG001|Overall Study|COPD exacerbation|7|||
147315216|NCT00363896|531319535|FG000|Overall Study|Lack of Efficacy|12|||
147315217|NCT00363896|531319536|FG001|Overall Study|Lack of Efficacy|8|||
147315218|NCT00363896|531319535|FG000|Overall Study|Protocol Violation|6|||
147315219|NCT00363896|531319536|FG001|Overall Study|Protocol Violation|1|||
147315220|NCT00363896|531319535|FG000|Overall Study|Lost to Follow-up|3|||
147315221|NCT00363896|531319536|FG001|Overall Study|Lost to Follow-up|0|||
147315222|NCT00363896|531319535|FG000|Overall Study|Non-fulfilment of entry criteria|1|||
147315223|NCT00363896|531319536|FG001|Overall Study|Non-fulfilment of entry criteria|0|||
147315224|NCT00363896|531319535|FG000|Overall Study|Other|1|||
147315225|NCT00363896|531319536|FG001|Overall Study|Other|2|||
147315226|NCT01558674|531319537|FG000|Part 1|Study Terminated by Sponsor|10|||
147315227|NCT01558674|531319538|FG001|Part 1|Study Terminated by Sponsor|0|||
147315228|NCT01558674|531319537|FG000|Part 1|Withdrawal by Subject|1|||
147315229|NCT01558674|531319538|FG001|Part 1|Withdrawal by Subject|0|||
147315230|NCT00924469|531319539|FG000|Overall Study|Adverse Event|2|||
147315231|NCT00924469|531319540|FG001|Overall Study|Adverse Event|0|||
147315232|NCT00924469|531319539|FG000|Overall Study|Withdrawal by Subject|0|||
147315233|NCT00924469|531319540|FG001|Overall Study|Withdrawal by Subject|1|||
147315234|NCT00924469|531319539|FG000|Overall Study|Lost to Follow-up|0|||
147315235|NCT00924469|531319540|FG001|Overall Study|Lost to Follow-up|1|||
147315236|NCT00630058|531319541|FG000|Overall Study|Adverse Event|1|||
147315237|NCT00630058|531319542|FG001|Overall Study|Adverse Event|1|||
147315238|NCT00630058|531319541|FG000|Overall Study|Withdrawal by Subject|0|||
147315239|NCT00630058|531319542|FG001|Overall Study|Withdrawal by Subject|1|||
147315240|NCT00630058|531319541|FG000|Overall Study|stopping criteria|3|||
147651078|NCT00339833|532544583|FG001|Overall Study|Withdrawal by Subject|2|||
147315241|NCT00630058|531319542|FG001|Overall Study|stopping criteria|2|||
147315242|NCT01651936|531319543|FG000|Base Study|Adverse Event|3|||
147315243|NCT01651936|531319544|FG001|Base Study|Adverse Event|0|||
147124164|NCT01500135|530620660|FG001|Overall Study|Lost to Follow-up|4|||
147315244|NCT01651936|531319545|FG002|Base Study|Adverse Event|0|||
147315245|NCT01651936|531319543|FG000|Base Study|Withdrawal by Subject|1|||
147315246|NCT01651936|531319544|FG001|Base Study|Withdrawal by Subject|1|||
147315247|NCT01651936|531319545|FG002|Base Study|Withdrawal by Subject|0|||
147315248|NCT01651936|531319543|FG000|Base Study|Early Escape|2|||
147315249|NCT01651936|531319544|FG001|Base Study|Early Escape|8|||
147315250|NCT01651936|531319545|FG002|Base Study|Early Escape|0|||
147315251|NCT01651936|531319543|FG000|Base Study|Study terminated by sponsor|21|||
147315252|NCT01651936|531319544|FG001|Base Study|Study terminated by sponsor|16|||
147315253|NCT01651936|531319545|FG002|Base Study|Study terminated by sponsor|0|||
147315254|NCT01651936|531319543|FG000|Extension Study|Lack of Efficacy|0|||
147315255|NCT01651936|531319544|FG001|Extension Study|Lack of Efficacy|0|||
147315256|NCT01651936|531319545|FG002|Extension Study|Lack of Efficacy|1|||
147315257|NCT01651936|531319543|FG000|Extension Study|Study terminated by sponsor|0|||
147315258|NCT01651936|531319544|FG001|Extension Study|Study terminated by sponsor|0|||
147315259|NCT01651936|531319545|FG002|Extension Study|Study terminated by sponsor|13|||
147315260|NCT03044353|531319546|FG000|Overall Study|Adverse Event|0|||
147315261|NCT03044353|531319547|FG001|Overall Study|Adverse Event|1|||
147315262|NCT03044353|531319548|FG002|Overall Study|Adverse Event|0|||
147315263|NCT03285113|531319557|FG000|Overall Study|Unable to implant leads|2|||
147315264|NCT01076088|531319559|FG000|Overall Study|Adverse Event|1|||
147315265|NCT01076088|531319560|FG001|Overall Study|Adverse Event|6|||
147315266|NCT01076088|531319561|FG002|Overall Study|Adverse Event|3|||
147315267|NCT01076088|531319562|FG003|Overall Study|Adverse Event|2|||
147315268|NCT01076088|531319563|FG004|Overall Study|Adverse Event|3|||
147315269|NCT01076088|531319564|FG005|Overall Study|Adverse Event|3|||
147315270|NCT01076088|531319559|FG000|Overall Study|Lost to Follow-up|1|||
147315271|NCT01076088|531319560|FG001|Overall Study|Lost to Follow-up|1|||
147315272|NCT01076088|531319561|FG002|Overall Study|Lost to Follow-up|0|||
147315273|NCT01076088|531319562|FG003|Overall Study|Lost to Follow-up|1|||
147315274|NCT01076088|531319563|FG004|Overall Study|Lost to Follow-up|1|||
147315275|NCT01076088|531319564|FG005|Overall Study|Lost to Follow-up|2|||
147315276|NCT01076088|531319559|FG000|Overall Study|Non-compliance with study drug|0|||
147315277|NCT01076088|531319560|FG001|Overall Study|Non-compliance with study drug|0|||
147315278|NCT01076088|531319561|FG002|Overall Study|Non-compliance with study drug|0|||
147315279|NCT01076088|531319562|FG003|Overall Study|Non-compliance with study drug|1|||
147315280|NCT01076088|531319563|FG004|Overall Study|Non-compliance with study drug|0|||
147315281|NCT01076088|531319564|FG005|Overall Study|Non-compliance with study drug|0|||
147315282|NCT01076088|531319559|FG000|Overall Study|Physician Decision|1|||
147315283|NCT01076088|531319560|FG001|Overall Study|Physician Decision|3|||
147315284|NCT01076088|531319561|FG002|Overall Study|Physician Decision|0|||
147315285|NCT01076088|531319562|FG003|Overall Study|Physician Decision|1|||
147315286|NCT01076088|531319563|FG004|Overall Study|Physician Decision|1|||
147315287|NCT01076088|531319564|FG005|Overall Study|Physician Decision|0|||
147315288|NCT01076088|531319559|FG000|Overall Study|Withdrawal by Subject|8|||
147315289|NCT01076088|531319560|FG001|Overall Study|Withdrawal by Subject|8|||
147315290|NCT01076088|531319561|FG002|Overall Study|Withdrawal by Subject|14|||
147315291|NCT01076088|531319562|FG003|Overall Study|Withdrawal by Subject|10|||
147315292|NCT01076088|531319563|FG004|Overall Study|Withdrawal by Subject|11|||
147315293|NCT01076088|531319564|FG005|Overall Study|Withdrawal by Subject|17|||
147315294|NCT01076088|531319559|FG000|Overall Study|Other protocol specified criteria|0|||
147315295|NCT01076088|531319560|FG001|Overall Study|Other protocol specified criteria|0|||
147315296|NCT01076088|531319561|FG002|Overall Study|Other protocol specified criteria|0|||
147315297|NCT01076088|531319562|FG003|Overall Study|Other protocol specified criteria|0|||
147315298|NCT01076088|531319563|FG004|Overall Study|Other protocol specified criteria|0|||
147315299|NCT01076088|531319564|FG005|Overall Study|Other protocol specified criteria|1|||
147315300|NCT02207374|531319569|FG000|Overall Study|Withdrawal by Subject|5|||
147315301|NCT02207374|531319570|FG001|Overall Study|Withdrawal by Subject|9|||
147315302|NCT02207374|531319571|FG002|Overall Study|Withdrawal by Subject|4|||
147315303|NCT02207374|531319569|FG000|Overall Study|Death|1|||
147315304|NCT02207374|531319570|FG001|Overall Study|Death|0|||
147315305|NCT02207374|531319571|FG002|Overall Study|Death|1|||
147315306|NCT02207374|531319569|FG000|Overall Study|Missing follow-up information|0|||
147315307|NCT02207374|531319570|FG001|Overall Study|Missing follow-up information|1|||
147315308|NCT02207374|531319571|FG002|Overall Study|Missing follow-up information|1|||
147315309|NCT00322374|531319572|FG000|Starting Dose|Physician Decision|2|||
147315310|NCT00322374|531319573|FG001|Starting Dose|Physician Decision|0|||
147315311|NCT00322374|531319574|FG002|Starting Dose|Physician Decision|0|||
147315312|NCT00322374|531319575|FG003|Starting Dose|Physician Decision|0|||
147315313|NCT00322374|531319572|FG000|Starting Dose|Study Drug Toxicity|4|||
147315314|NCT00322374|531319573|FG001|Starting Dose|Study Drug Toxicity|0|||
147315315|NCT00322374|531319574|FG002|Starting Dose|Study Drug Toxicity|0|||
147315316|NCT00322374|531319575|FG003|Starting Dose|Study Drug Toxicity|0|||
147315317|NCT00322374|531319572|FG000|First Escalation|Documented Disease Progression|0|||
147315318|NCT00322374|531319573|FG001|First Escalation|Documented Disease Progression|6|||
147315319|NCT00322374|531319574|FG002|First Escalation|Documented Disease Progression|0|||
147315320|NCT00322374|531319575|FG003|First Escalation|Documented Disease Progression|0|||
147315321|NCT00322374|531319572|FG000|First Escalation|Physician Decision|0|||
147315322|NCT00322374|531319573|FG001|First Escalation|Physician Decision|12|||
147315323|NCT00322374|531319574|FG002|First Escalation|Physician Decision|0|||
147315324|NCT00322374|531319575|FG003|First Escalation|Physician Decision|0|||
147315325|NCT00322374|531319572|FG000|First Escalation|Study Drug Toxicity|0|||
147315326|NCT00322374|531319573|FG001|First Escalation|Study Drug Toxicity|11|||
147315327|NCT00322374|531319574|FG002|First Escalation|Study Drug Toxicity|0|||
147233646|NCT02122458|531027971|FG005|Overall Study|Deployed or Moved|0|||
147233647|NCT02122458|531027972|FG006|Overall Study|Deployed or Moved|0|||
147233648|NCT02122458|531027966|FG000|Overall Study|Scheduling Delays - Unable to Complete|0|||
147233649|NCT02122458|531027967|FG001|Overall Study|Scheduling Delays - Unable to Complete|1|||
147233650|NCT02122458|531027968|FG002|Overall Study|Scheduling Delays - Unable to Complete|0|||
147233651|NCT02122458|531027969|FG003|Overall Study|Scheduling Delays - Unable to Complete|4|||
147233652|NCT02122458|531027970|FG004|Overall Study|Scheduling Delays - Unable to Complete|1|||
147233653|NCT02122458|531027971|FG005|Overall Study|Scheduling Delays - Unable to Complete|1|||
147233654|NCT02122458|531027972|FG006|Overall Study|Scheduling Delays - Unable to Complete|0|||
147233655|NCT02122458|531027966|FG000|Overall Study|Noncompliance|0|||
147233656|NCT02122458|531027967|FG001|Overall Study|Noncompliance|1|||
147233657|NCT02122458|531027968|FG002|Overall Study|Noncompliance|0|||
147233658|NCT02122458|531027969|FG003|Overall Study|Noncompliance|0|||
147233659|NCT02122458|531027970|FG004|Overall Study|Noncompliance|0|||
147233660|NCT02122458|531027971|FG005|Overall Study|Noncompliance|0|||
147233661|NCT02122458|531027972|FG006|Overall Study|Noncompliance|0|||
147233662|NCT02833350|531027973|FG000|Overall Study|Adverse Event|0|||
147233663|NCT02833350|531027974|FG001|Overall Study|Adverse Event|3|||
147233664|NCT02833350|531027975|FG002|Overall Study|Adverse Event|4|||
147233665|NCT02833350|531027976|FG003|Overall Study|Adverse Event|4|||
147233666|NCT02833350|531027977|FG004|Overall Study|Adverse Event|1|||
147233667|NCT02833350|531027978|FG005|Overall Study|Adverse Event|0|||
147233668|NCT02833350|531027979|FG006|Overall Study|Adverse Event|1|||
147233669|NCT02833350|531027973|FG000|Overall Study|Death|0|||
147233670|NCT02833350|531027974|FG001|Overall Study|Death|0|||
147233671|NCT02833350|531027975|FG002|Overall Study|Death|1|||
147233672|NCT02833350|531027976|FG003|Overall Study|Death|0|||
147233673|NCT02833350|531027977|FG004|Overall Study|Death|0|||
147233674|NCT02833350|531027978|FG005|Overall Study|Death|0|||
147233675|NCT02833350|531027979|FG006|Overall Study|Death|0|||
147233676|NCT02833350|531027973|FG000|Overall Study|Lack of Efficacy|0|||
147233677|NCT02833350|531027974|FG001|Overall Study|Lack of Efficacy|2|||
147233678|NCT02833350|531027975|FG002|Overall Study|Lack of Efficacy|1|||
147233679|NCT02833350|531027976|FG003|Overall Study|Lack of Efficacy|4|||
147233680|NCT02833350|531027977|FG004|Overall Study|Lack of Efficacy|0|||
147233681|NCT02833350|531027978|FG005|Overall Study|Lack of Efficacy|1|||
147233682|NCT02833350|531027979|FG006|Overall Study|Lack of Efficacy|1|||
147233683|NCT02833350|531027973|FG000|Overall Study|Lost to Follow-up|0|||
147233684|NCT02833350|531027974|FG001|Overall Study|Lost to Follow-up|1|||
147233685|NCT02833350|531027975|FG002|Overall Study|Lost to Follow-up|0|||
147233686|NCT02833350|531027976|FG003|Overall Study|Lost to Follow-up|0|||
147233687|NCT02833350|531027977|FG004|Overall Study|Lost to Follow-up|0|||
147233688|NCT02833350|531027978|FG005|Overall Study|Lost to Follow-up|0|||
147233689|NCT02833350|531027979|FG006|Overall Study|Lost to Follow-up|1|||
147233690|NCT02833350|531027973|FG000|Overall Study|Withdrawal by Subject|3|||
147233691|NCT02833350|531027974|FG001|Overall Study|Withdrawal by Subject|3|||
147233692|NCT02833350|531027975|FG002|Overall Study|Withdrawal by Subject|2|||
147233693|NCT02833350|531027976|FG003|Overall Study|Withdrawal by Subject|0|||
147233694|NCT02833350|531027977|FG004|Overall Study|Withdrawal by Subject|2|||
147233695|NCT02833350|531027978|FG005|Overall Study|Withdrawal by Subject|0|||
147233696|NCT02833350|531027979|FG006|Overall Study|Withdrawal by Subject|2|||
147233697|NCT01500031|531027982|FG000|Overall Study|Death|1|||
147233698|NCT01500031|531027982|FG000|Overall Study|Withdrawal by Subject|4|||
147233699|NCT01604408|531027986|FG000|Treatment Period 1|Protocol Violation|0|||
147233700|NCT01604408|531027987|FG001|Treatment Period 1|Protocol Violation|1|||
147233701|NCT01604408|531027986|FG000|Treatment Period 2|Withdrawal by Subject|1|||
147233702|NCT01604408|531027987|FG001|Treatment Period 2|Withdrawal by Subject|1|||
147233703|NCT01604408|531027986|FG000|Treatment Period 2|Protocol Violation|1|||
147233704|NCT01604408|531027987|FG001|Treatment Period 2|Protocol Violation|0|||
147233705|NCT01604408|531027986|FG000|Treatment Period 2|Adverse Event|0|||
147233706|NCT01604408|531027987|FG001|Treatment Period 2|Adverse Event|1|||
147233707|NCT01604408|531027986|FG000|Treatment Period 3|Protocol Violation|1|||
147233708|NCT01604408|531027987|FG001|Treatment Period 3|Protocol Violation|1|||
147233709|NCT01604408|531027986|FG000|Treatment Period 3|Adverse Event|0|||
147233710|NCT01604408|531027987|FG001|Treatment Period 3|Adverse Event|3|||
147233711|NCT01604408|531027986|FG000|Treatment Period 3|Withdrawal by Subject|3|||
147233712|NCT01604408|531027987|FG001|Treatment Period 3|Withdrawal by Subject|1|||
147233713|NCT01604408|531027986|FG000|Treatment Period 3|Sponsor Decision|1|||
147233714|NCT01604408|531027987|FG001|Treatment Period 3|Sponsor Decision|0|||
147233715|NCT01604408|531027986|FG000|Treatment Period 4|Death|1|||
147233716|NCT01604408|531027987|FG001|Treatment Period 4|Death|0|||
147233717|NCT01604408|531027986|FG000|Treatment Period 4|Withdrawal by Subject|2|||
147233718|NCT01604408|531027987|FG001|Treatment Period 4|Withdrawal by Subject|1|||
147233719|NCT01604408|531027986|FG000|Treatment Period 4|Adverse Event|0|||
147233720|NCT01604408|531027987|FG001|Treatment Period 4|Adverse Event|1|||
147233721|NCT01604408|531027986|FG000|Treatment Period 5|Adverse Event|4|||
147233722|NCT01604408|531027987|FG001|Treatment Period 5|Adverse Event|0|||
147233723|NCT01604408|531027986|FG000|Treatment Period 6|Lost to Follow-up|0|||
147315328|NCT00322374|531319575|FG003|First Escalation|Study Drug Toxicity|0|||
147315329|NCT00322374|531319572|FG000|First Escalation|Participant Request|0|||
147315330|NCT00322374|531319573|FG001|First Escalation|Participant Request|1|||
147315331|NCT00322374|531319574|FG002|First Escalation|Participant Request|0|||
147315332|NCT00322374|531319575|FG003|First Escalation|Participant Request|0|||
147315333|NCT00322374|531319572|FG000|Second Escalation|Physician Decision|0|||
147233724|NCT01604408|531027987|FG001|Treatment Period 6|Lost to Follow-up|1|||
147233725|NCT01604408|531027986|FG000|Treatment Period 6|Adverse Event|2|||
147315334|NCT00322374|531319573|FG001|Second Escalation|Physician Decision|0|||
147315335|NCT00322374|531319574|FG002|Second Escalation|Physician Decision|5|||
147315336|NCT00322374|531319575|FG003|Second Escalation|Physician Decision|0|||
147315337|NCT00322374|531319572|FG000|Second Escalation|Study Drug Toxicity|0|||
147315338|NCT00322374|531319573|FG001|Second Escalation|Study Drug Toxicity|0|||
147315339|NCT00322374|531319574|FG002|Second Escalation|Study Drug Toxicity|1|||
147315340|NCT00322374|531319575|FG003|Second Escalation|Study Drug Toxicity|0|||
147315341|NCT01000376|531319576|FG000|Cycle 1 Day 1|Adverse Event|1|||
147315342|NCT01000376|531319577|FG001|Cycle 1 Day 1|Adverse Event|0|||
147315343|NCT01000376|531319576|FG000|Cycle 1 Day 1|Progressive Disease|1|||
147315344|NCT01000376|531319577|FG001|Cycle 1 Day 1|Progressive Disease|0|||
147315345|NCT02372058|531319578|FG000|Overall Study|Withdrawal by Subject|3|||
147315346|NCT01994720|531319579|FG000|Overall Study|Withdrawal by Subject|46|||
147315347|NCT01994720|531319580|FG001|Overall Study|Withdrawal by Subject|56|||
147315348|NCT04318093|531319586|FG000|Overall Study|Adverse Event|2|||
147315349|NCT04318093|531319587|FG001|Overall Study|Adverse Event|2|||
147315350|NCT04318093|531319586|FG000|Overall Study|Participant withdrew consent|1|||
147315351|NCT04318093|531319587|FG001|Overall Study|Participant withdrew consent|0|||
147315352|NCT04318093|531319586|FG000|Overall Study|Other reasons|0|||
147315353|NCT04318093|531319587|FG001|Overall Study|Other reasons|1|||
147315354|NCT02855164|531319595|FG000|Parts A + B (Randomized Set)|Withdrawal by Subject|0|||
147315355|NCT02855164|531319596|FG001|Parts A + B (Randomized Set)|Withdrawal by Subject|0|||
147233726|NCT01604408|531027987|FG001|Treatment Period 6|Adverse Event|0|||
147233727|NCT01604408|531027986|FG000|Treatment Period 6|Sponsor decision|0|||
147233728|NCT01604408|531027987|FG001|Treatment Period 6|Sponsor decision|1|||
147233729|NCT01604408|531027986|FG000|Observation Period|Adverse Event|1|||
147233730|NCT01604408|531027987|FG001|Observation Period|Adverse Event|1|||
147233731|NCT01604408|531027986|FG000|Observation Period|Withdrawal by Subject|0|||
147233732|NCT01604408|531027987|FG001|Observation Period|Withdrawal by Subject|2|||
147233733|NCT00075218|531027988|FG000|Double-Blind Treatment|Adverse Event|23|||
147233734|NCT00075218|531027989|FG001|Double-Blind Treatment|Adverse Event|4|||
147233735|NCT00075218|531027990|FG002|Double-Blind Treatment|Adverse Event|0|||
147233736|NCT00075218|531027988|FG000|Double-Blind Treatment|Withdrawal by Subject|7|||
147233737|NCT00075218|531027989|FG001|Double-Blind Treatment|Withdrawal by Subject|4|||
147233738|NCT00075218|531027990|FG002|Double-Blind Treatment|Withdrawal by Subject|0|||
147233739|NCT00075218|531027988|FG000|Double-Blind Treatment|Lost to Follow-up|1|||
147233740|NCT00075218|531027989|FG001|Double-Blind Treatment|Lost to Follow-up|0|||
147233741|NCT00075218|531027990|FG002|Double-Blind Treatment|Lost to Follow-up|0|||
147233742|NCT00075218|531027988|FG000|Double-Blind Treatment|Lack of Efficacy|58|||
147233743|NCT00075218|531027989|FG001|Double-Blind Treatment|Lack of Efficacy|6|||
147233744|NCT00075218|531027990|FG002|Double-Blind Treatment|Lack of Efficacy|0|||
147233745|NCT00075218|531027988|FG000|Double-Blind Treatment|Decision of Sponsor|0|||
147233746|NCT00075218|531027989|FG001|Double-Blind Treatment|Decision of Sponsor|1|||
147233747|NCT00075218|531027990|FG002|Double-Blind Treatment|Decision of Sponsor|0|||
147233748|NCT00075218|531027988|FG000|Double-Blind Treatment|No study medication taken|2|||
147233749|NCT00075218|531027989|FG001|Double-Blind Treatment|No study medication taken|0|||
147233750|NCT00075218|531027990|FG002|Double-Blind Treatment|No study medication taken|0|||
147233751|NCT00075218|531027988|FG000|Open-Label Treatment|Lack of Efficacy|0|||
147315356|NCT02855164|531319597|FG002|Parts A + B (Randomized Set)|Withdrawal by Subject|1|||
147315357|NCT02855164|531319598|FG003|Parts A + B (Randomized Set)|Withdrawal by Subject|2|||
147315358|NCT02855164|531319599|FG004|Parts A + B (Randomized Set)|Withdrawal by Subject|1|||
147315359|NCT02855164|531319600|FG005|Parts A + B (Randomized Set)|Withdrawal by Subject|0|||
147315360|NCT02855164|531319601|FG006|Parts A + B (Randomized Set)|Withdrawal by Subject|0|||
147315361|NCT02855164|531319602|FG007|Parts A + B (Randomized Set)|Withdrawal by Subject|0|||
147315362|NCT02855164|531319595|FG000|Parts A + B (Randomized Set)|Physician Decision|0|||
147315363|NCT02855164|531319596|FG001|Parts A + B (Randomized Set)|Physician Decision|0|||
147315364|NCT02855164|531319597|FG002|Parts A + B (Randomized Set)|Physician Decision|0|||
147233752|NCT00075218|531027989|FG001|Open-Label Treatment|Lack of Efficacy|0|||
147315365|NCT02855164|531319598|FG003|Parts A + B (Randomized Set)|Physician Decision|2|||
147233753|NCT00075218|531027990|FG002|Open-Label Treatment|Lack of Efficacy|174|||
147315366|NCT02855164|531319599|FG004|Parts A + B (Randomized Set)|Physician Decision|0|||
147315367|NCT02855164|531319600|FG005|Parts A + B (Randomized Set)|Physician Decision|0|||
147233754|NCT00075218|531027988|FG000|Open-Label Treatment|Adverse Event|0|||
147233755|NCT00075218|531027989|FG001|Open-Label Treatment|Adverse Event|0|||
147315368|NCT02855164|531319601|FG006|Parts A + B (Randomized Set)|Physician Decision|0|||
147651079|NCT00339833|532544582|FG000|Overall Study|toothache|0|||
147315369|NCT02855164|531319602|FG007|Parts A + B (Randomized Set)|Physician Decision|0|||
147315370|NCT02855164|531319595|FG000|Parts A + B (Randomized Set)|Adverse Event|0|||
147315371|NCT02855164|531319596|FG001|Parts A + B (Randomized Set)|Adverse Event|0|||
147315372|NCT02855164|531319597|FG002|Parts A + B (Randomized Set)|Adverse Event|0|||
147315373|NCT02855164|531319598|FG003|Parts A + B (Randomized Set)|Adverse Event|4|||
147315374|NCT02855164|531319599|FG004|Parts A + B (Randomized Set)|Adverse Event|0|||
147315375|NCT02855164|531319600|FG005|Parts A + B (Randomized Set)|Adverse Event|0|||
147315376|NCT02855164|531319601|FG006|Parts A + B (Randomized Set)|Adverse Event|0|||
147315377|NCT02855164|531319602|FG007|Parts A + B (Randomized Set)|Adverse Event|0|||
147315378|NCT02855164|531319595|FG000|Part C (Randomized Set)|Adverse Event|0|||
147315379|NCT02855164|531319596|FG001|Part C (Randomized Set)|Adverse Event|0|||
147315380|NCT02855164|531319597|FG002|Part C (Randomized Set)|Adverse Event|0|||
147315381|NCT02855164|531319598|FG003|Part C (Randomized Set)|Adverse Event|0|||
147315382|NCT02855164|531319599|FG004|Part C (Randomized Set)|Adverse Event|0|||
147315383|NCT02855164|531319600|FG005|Part C (Randomized Set)|Adverse Event|5|||
147315384|NCT02855164|531319601|FG006|Part C (Randomized Set)|Adverse Event|9|||
147315385|NCT02855164|531319602|FG007|Part C (Randomized Set)|Adverse Event|2|||
147315386|NCT02855164|531319595|FG000|Part C (Randomized Set)|Lost to Follow-up|0|||
147315387|NCT02855164|531319596|FG001|Part C (Randomized Set)|Lost to Follow-up|0|||
147315388|NCT02855164|531319597|FG002|Part C (Randomized Set)|Lost to Follow-up|0|||
147315389|NCT02855164|531319598|FG003|Part C (Randomized Set)|Lost to Follow-up|0|||
147315390|NCT02855164|531319599|FG004|Part C (Randomized Set)|Lost to Follow-up|0|||
147315391|NCT02855164|531319600|FG005|Part C (Randomized Set)|Lost to Follow-up|1|||
147315392|NCT02855164|531319601|FG006|Part C (Randomized Set)|Lost to Follow-up|1|||
147315393|NCT02855164|531319602|FG007|Part C (Randomized Set)|Lost to Follow-up|1|||
147315394|NCT02855164|531319595|FG000|Part C (Randomized Set)|Physician Decision|0|||
147315395|NCT02855164|531319596|FG001|Part C (Randomized Set)|Physician Decision|0|||
147315396|NCT02855164|531319597|FG002|Part C (Randomized Set)|Physician Decision|0|||
147315397|NCT02855164|531319598|FG003|Part C (Randomized Set)|Physician Decision|0|||
147315398|NCT02855164|531319599|FG004|Part C (Randomized Set)|Physician Decision|0|||
147315399|NCT02855164|531319600|FG005|Part C (Randomized Set)|Physician Decision|1|||
147315400|NCT02855164|531319601|FG006|Part C (Randomized Set)|Physician Decision|0|||
147315401|NCT02855164|531319602|FG007|Part C (Randomized Set)|Physician Decision|1|||
147315402|NCT02855164|531319595|FG000|Part C (Randomized Set)|Withdrawal by Subject|0|||
147315403|NCT02855164|531319596|FG001|Part C (Randomized Set)|Withdrawal by Subject|0|||
147315404|NCT02855164|531319597|FG002|Part C (Randomized Set)|Withdrawal by Subject|0|||
147315405|NCT02855164|531319598|FG003|Part C (Randomized Set)|Withdrawal by Subject|0|||
147315406|NCT02855164|531319599|FG004|Part C (Randomized Set)|Withdrawal by Subject|0|||
147315407|NCT02855164|531319600|FG005|Part C (Randomized Set)|Withdrawal by Subject|5|||
147315408|NCT02855164|531319601|FG006|Part C (Randomized Set)|Withdrawal by Subject|4|||
147651080|NCT00339833|532544583|FG001|Overall Study|toothache|1|||
147651081|NCT00339833|532544582|FG000|Overall Study|indigestion|0|||
147651082|NCT00339833|532544583|FG001|Overall Study|indigestion|1|||
147651083|NCT00339833|532544582|FG000|Overall Study|Chest pain|0|||
147651084|NCT00339833|532544583|FG001|Overall Study|Chest pain|1|||
147651085|NCT00339833|532544582|FG000|Overall Study|minor infection|0|||
147651086|NCT00339833|532544583|FG001|Overall Study|minor infection|1|||
147651087|NCT00339833|532544582|FG000|Overall Study|Poor venous access|2|||
147651088|NCT00339833|532544583|FG001|Overall Study|Poor venous access|2|||
147651089|NCT00339833|532544582|FG000|Overall Study|anaemia or excess drop in glycaemia|2|||
147651090|NCT00339833|532544583|FG001|Overall Study|anaemia or excess drop in glycaemia|0|||
147124165|NCT01500135|530620659|FG000|Overall Study|Fatal Adverse Event (AE)|5|||
147124166|NCT01500135|530620660|FG001|Overall Study|Fatal Adverse Event (AE)|5|||
147315409|NCT02855164|531319602|FG007|Part C (Randomized Set)|Withdrawal by Subject|3|||
147315410|NCT00876460|531319603|FG000|Combination Therapy Phase|Progressive disease|2|||
147315411|NCT00876460|531319604|FG001|Combination Therapy Phase|Progressive disease|3|||
147315412|NCT00876460|531319605|FG002|Combination Therapy Phase|Progressive disease|3|||
147651091|NCT00339833|532544582|FG000|Overall Study|Error in data records|1|||
147651092|NCT00339833|532544583|FG001|Overall Study|Error in data records|0|||
147651093|NCT00217581|532544584|FG000|Overall Study|Withdrawal by Subject|1|||
147651094|NCT02829047|532544585|FG000|Overall Study|Withdrawal by Subject|1|||
147124167|NCT01500135|530620659|FG000|Overall Study|Principal Investigator (PI) Discretion|1|||
147124168|NCT01500135|530620660|FG001|Overall Study|Principal Investigator (PI) Discretion|0|||
147124169|NCT01500135|530620659|FG000|Overall Study|Patient Missed Scheduled Appointments|0|||
147124170|NCT01500135|530620660|FG001|Overall Study|Patient Missed Scheduled Appointments|1|||
147124171|NCT01500135|530620659|FG000|Overall Study|Participant was a Safety Concern|1|||
147124172|NCT01500135|530620660|FG001|Overall Study|Participant was a Safety Concern|0|||
147124173|NCT01500135|530620659|FG000|Overall Study|Patient Unable to Make Follow-up Visit|0|||
147124174|NCT01500135|530620660|FG001|Overall Study|Patient Unable to Make Follow-up Visit|1|||
147124175|NCT01661595|530620661|FG000|Phase 1: Week 0-4|Adverse Event|1|||
147124176|NCT01661595|530620662|FG001|Phase 1: Week 0-4|Adverse Event|0|||
147124177|NCT01661595|530620663|FG002|Phase 1: Week 0-4|Adverse Event|0|||
147124178|NCT01661595|530620664|FG003|Phase 1: Week 0-4|Adverse Event|0|||
147315413|NCT00876460|531319606|FG003|Combination Therapy Phase|Progressive disease|3|||
147315414|NCT00876460|531319607|FG004|Combination Therapy Phase|Progressive disease|3|||
147315415|NCT00876460|531319608|FG005|Combination Therapy Phase|Progressive disease|1|||
147315416|NCT00876460|531319609|FG006|Combination Therapy Phase|Progressive disease|1|||
147315417|NCT00876460|531319610|FG007|Combination Therapy Phase|Progressive disease|1|||
147315418|NCT00876460|531319603|FG000|Combination Therapy Phase|Dose limiting toxicity|0|||
147315419|NCT00876460|531319604|FG001|Combination Therapy Phase|Dose limiting toxicity|1|||
147315420|NCT00876460|531319605|FG002|Combination Therapy Phase|Dose limiting toxicity|0|||
147315421|NCT00876460|531319606|FG003|Combination Therapy Phase|Dose limiting toxicity|1|||
147315422|NCT00876460|531319607|FG004|Combination Therapy Phase|Dose limiting toxicity|1|||
147315423|NCT00876460|531319608|FG005|Combination Therapy Phase|Dose limiting toxicity|2|||
147315424|NCT00876460|531319609|FG006|Combination Therapy Phase|Dose limiting toxicity|2|||
147315425|NCT00876460|531319610|FG007|Combination Therapy Phase|Dose limiting toxicity|1|||
147315426|NCT00876460|531319603|FG000|Combination Therapy Phase|Adverse Event|0|||
147315427|NCT00876460|531319604|FG001|Combination Therapy Phase|Adverse Event|2|||
147315428|NCT00876460|531319605|FG002|Combination Therapy Phase|Adverse Event|0|||
147315429|NCT00876460|531319606|FG003|Combination Therapy Phase|Adverse Event|2|||
147315430|NCT00876460|531319607|FG004|Combination Therapy Phase|Adverse Event|2|||
147315431|NCT00876460|531319608|FG005|Combination Therapy Phase|Adverse Event|0|||
147315432|NCT00876460|531319609|FG006|Combination Therapy Phase|Adverse Event|3|||
147315433|NCT00876460|531319610|FG007|Combination Therapy Phase|Adverse Event|2|||
147315434|NCT00876460|531319603|FG000|Combination Therapy Phase|Withdrawal by Subject|1|||
147315435|NCT00876460|531319604|FG001|Combination Therapy Phase|Withdrawal by Subject|1|||
147315436|NCT00876460|531319605|FG002|Combination Therapy Phase|Withdrawal by Subject|0|||
147315437|NCT00876460|531319606|FG003|Combination Therapy Phase|Withdrawal by Subject|0|||
147315438|NCT00876460|531319607|FG004|Combination Therapy Phase|Withdrawal by Subject|1|||
147315439|NCT00876460|531319608|FG005|Combination Therapy Phase|Withdrawal by Subject|0|||
147315440|NCT00876460|531319609|FG006|Combination Therapy Phase|Withdrawal by Subject|0|||
147315441|NCT00876460|531319610|FG007|Combination Therapy Phase|Withdrawal by Subject|0|||
147315442|NCT00876460|531319603|FG000|Combination Therapy Phase|Other reason not defined above|0|||
147315443|NCT00876460|531319604|FG001|Combination Therapy Phase|Other reason not defined above|0|||
147315444|NCT00876460|531319605|FG002|Combination Therapy Phase|Other reason not defined above|0|||
147315445|NCT00876460|531319606|FG003|Combination Therapy Phase|Other reason not defined above|0|||
147315446|NCT00876460|531319607|FG004|Combination Therapy Phase|Other reason not defined above|0|||
147124179|NCT01661595|530620661|FG000|Phase 2: Week 5-8.|Protocol Violation|0|||
147124180|NCT01661595|530620662|FG001|Phase 2: Week 5-8.|Protocol Violation|0|||
147124181|NCT01661595|530620663|FG002|Phase 2: Week 5-8.|Protocol Violation|1|||
147124182|NCT01661595|530620664|FG003|Phase 2: Week 5-8.|Protocol Violation|0|||
147124183|NCT00912509|530620665|FG000|Overall Study|Lost to Follow-up|1|||
147124184|NCT00912509|530620666|FG001|Overall Study|Lost to Follow-up|0|||
147124185|NCT00912509|530620665|FG000|Overall Study|Lack of Efficacy|4|||
147124186|NCT00912509|530620666|FG001|Overall Study|Lack of Efficacy|3|||
147124187|NCT02715856|530620667|FG000|Overall Study|Software Issues|12|||
147124188|NCT02715856|530620668|FG001|Overall Study|Software Issues|7|||
147124189|NCT02715856|530620667|FG000|Overall Study|Death|6|||
147124190|NCT02715856|530620668|FG001|Overall Study|Death|5|||
147124191|NCT02715856|530620667|FG000|Overall Study|Non- Compliant|0|||
147124192|NCT02715856|530620668|FG001|Overall Study|Non- Compliant|40|||
147124193|NCT01050218|530620669|FG000|Overall Study|Adverse Event|37|||
147124194|NCT01050218|530620669|FG000|Overall Study|Lack of Efficacy|8|||
147124195|NCT01050218|530620669|FG000|Overall Study|Protocol Violation|3|||
147124196|NCT01050218|530620669|FG000|Overall Study|Withdrawal by Subject|18|||
147124197|NCT01050218|530620669|FG000|Overall Study|Discontinued by sponsor|18|||
147124198|NCT01050218|530620669|FG000|Overall Study|Compliance|2|||
147124199|NCT01050218|530620669|FG000|Overall Study|Failed to return|7|||
147124200|NCT01050218|530620669|FG000|Overall Study|Serious Adverse Event|1|||
147124201|NCT01050218|530620669|FG000|Overall Study|Family emergency|1|||
147124202|NCT01772693|530620670|FG000|Overall Study|Health Concerns Unrelated to Study|2|||
147124203|NCT01772693|530620671|FG001|Overall Study|Health Concerns Unrelated to Study|1|||
147315447|NCT00876460|531319608|FG005|Combination Therapy Phase|Other reason not defined above|0|||
147315448|NCT00876460|531319609|FG006|Combination Therapy Phase|Other reason not defined above|1|||
147315449|NCT00876460|531319610|FG007|Combination Therapy Phase|Other reason not defined above|2|||
147315450|NCT00876460|531319603|FG000|Combination Therapy Phase|Not treated|0|||
147315451|NCT00876460|531319604|FG001|Combination Therapy Phase|Not treated|0|||
147315452|NCT00876460|531319605|FG002|Combination Therapy Phase|Not treated|0|||
147315453|NCT00876460|531319606|FG003|Combination Therapy Phase|Not treated|0|||
147315454|NCT00876460|531319607|FG004|Combination Therapy Phase|Not treated|0|||
147315455|NCT00876460|531319608|FG005|Combination Therapy Phase|Not treated|0|||
147124204|NCT01772693|530620670|FG000|Overall Study|Withdrawal by Subject|2|||
147124205|NCT01772693|530620671|FG001|Overall Study|Withdrawal by Subject|0|||
147124206|NCT01772693|530620670|FG000|Overall Study|Alternative Treatment|2|||
147124207|NCT01772693|530620671|FG001|Overall Study|Alternative Treatment|0|||
147124208|NCT01633112|530620672|FG000|Overall Study|Lack of Efficacy|1|||
147233756|NCT00075218|531027990|FG002|Open-Label Treatment|Adverse Event|51|||
147233757|NCT00075218|531027988|FG000|Open-Label Treatment|Withdrawal by Subject|0|||
147233758|NCT00075218|531027989|FG001|Open-Label Treatment|Withdrawal by Subject|0|||
147233759|NCT00075218|531027990|FG002|Open-Label Treatment|Withdrawal by Subject|12|||
147233760|NCT00075218|531027988|FG000|Open-Label Treatment|Decision of Sponsor|0|||
147233761|NCT00075218|531027989|FG001|Open-Label Treatment|Decision of Sponsor|0|||
147233762|NCT00075218|531027990|FG002|Open-Label Treatment|Decision of Sponsor|8|||
147315456|NCT00876460|531319609|FG006|Combination Therapy Phase|Not treated|1|||
147315457|NCT00876460|531319610|FG007|Combination Therapy Phase|Not treated|0|||
147315458|NCT00876460|531319603|FG000|Mono Therapy Phase|Progressive disease|0|||
147315459|NCT00876460|531319604|FG001|Mono Therapy Phase|Progressive disease|0|||
147315460|NCT00876460|531319605|FG002|Mono Therapy Phase|Progressive disease|0|||
147315461|NCT00876460|531319606|FG003|Mono Therapy Phase|Progressive disease|0|||
147315462|NCT00876460|531319607|FG004|Mono Therapy Phase|Progressive disease|2|||
147315463|NCT00876460|531319608|FG005|Mono Therapy Phase|Progressive disease|0|||
147315464|NCT00876460|531319609|FG006|Mono Therapy Phase|Progressive disease|1|||
147315465|NCT00876460|531319610|FG007|Mono Therapy Phase|Progressive disease|3|||
147315466|NCT00876460|531319603|FG000|Mono Therapy Phase|Withdrawal by Subject|0|||
147315467|NCT00876460|531319604|FG001|Mono Therapy Phase|Withdrawal by Subject|1|||
147315468|NCT00876460|531319605|FG002|Mono Therapy Phase|Withdrawal by Subject|0|||
147315469|NCT00876460|531319606|FG003|Mono Therapy Phase|Withdrawal by Subject|0|||
147315470|NCT00876460|531319607|FG004|Mono Therapy Phase|Withdrawal by Subject|0|||
147315471|NCT00876460|531319608|FG005|Mono Therapy Phase|Withdrawal by Subject|0|||
147315472|NCT00876460|531319609|FG006|Mono Therapy Phase|Withdrawal by Subject|0|||
147315473|NCT00876460|531319610|FG007|Mono Therapy Phase|Withdrawal by Subject|0|||
147315474|NCT00876460|531319603|FG000|Mono Therapy Phase|Adverse Event|0|||
147315475|NCT00876460|531319604|FG001|Mono Therapy Phase|Adverse Event|0|||
147315476|NCT00876460|531319605|FG002|Mono Therapy Phase|Adverse Event|0|||
147315477|NCT00876460|531319606|FG003|Mono Therapy Phase|Adverse Event|1|||
147315478|NCT00876460|531319607|FG004|Mono Therapy Phase|Adverse Event|0|||
147315479|NCT00876460|531319608|FG005|Mono Therapy Phase|Adverse Event|0|||
147315480|NCT00876460|531319609|FG006|Mono Therapy Phase|Adverse Event|0|||
147315481|NCT00876460|531319610|FG007|Mono Therapy Phase|Adverse Event|0|||
147315482|NCT00383240|531319611|FG000|Overall Study|Adverse Event|4|||
147315483|NCT00383240|531319612|FG001|Overall Study|Adverse Event|6|||
147315484|NCT00383240|531319613|FG002|Overall Study|Adverse Event|9|||
147315485|NCT00383240|531319614|FG003|Overall Study|Adverse Event|7|||
147315486|NCT00383240|531319611|FG000|Overall Study|Treatment Failure|8|||
147315487|NCT00383240|531319612|FG001|Overall Study|Treatment Failure|13|||
147315488|NCT00383240|531319613|FG002|Overall Study|Treatment Failure|47|||
147315489|NCT00383240|531319614|FG003|Overall Study|Treatment Failure|46|||
147315490|NCT00383240|531319611|FG000|Overall Study|Lost to Follow-up|3|||
147315491|NCT00383240|531319612|FG001|Overall Study|Lost to Follow-up|0|||
147315492|NCT00383240|531319613|FG002|Overall Study|Lost to Follow-up|0|||
147315493|NCT00383240|531319614|FG003|Overall Study|Lost to Follow-up|2|||
147315494|NCT00383240|531319611|FG000|Overall Study|Withdrawal by subject, reasons unrelated|6|||
147315495|NCT00383240|531319612|FG001|Overall Study|Withdrawal by subject, reasons unrelated|3|||
147315496|NCT00383240|531319613|FG002|Overall Study|Withdrawal by subject, reasons unrelated|8|||
147315497|NCT00383240|531319614|FG003|Overall Study|Withdrawal by subject, reasons unrelated|8|||
147315498|NCT00383240|531319611|FG000|Overall Study|Withdrawal by subjects, reasons related|0|||
147315499|NCT00383240|531319612|FG001|Overall Study|Withdrawal by subjects, reasons related|1|||
147315500|NCT00383240|531319613|FG002|Overall Study|Withdrawal by subjects, reasons related|3|||
147315501|NCT00383240|531319614|FG003|Overall Study|Withdrawal by subjects, reasons related|5|||
147315502|NCT00383240|531319611|FG000|Overall Study|Protocol Violation|4|||
147315503|NCT00383240|531319612|FG001|Overall Study|Protocol Violation|5|||
147315504|NCT00383240|531319613|FG002|Overall Study|Protocol Violation|9|||
147315505|NCT00383240|531319614|FG003|Overall Study|Protocol Violation|6|||
147315506|NCT00383240|531319611|FG000|Overall Study|Did not meet protocol eligibility|9|||
147315507|NCT00383240|531319612|FG001|Overall Study|Did not meet protocol eligibility|4|||
147315508|NCT00383240|531319613|FG002|Overall Study|Did not meet protocol eligibility|9|||
147233763|NCT00075218|531027988|FG000|Open-Label Treatment|Protocol Violation|0|||
147315509|NCT00383240|531319614|FG003|Overall Study|Did not meet protocol eligibility|3|||
147315510|NCT00383240|531319611|FG000|Overall Study|Administrative|1|||
147315511|NCT00383240|531319612|FG001|Overall Study|Administrative|1|||
147315512|NCT00383240|531319613|FG002|Overall Study|Administrative|0|||
147315513|NCT00383240|531319614|FG003|Overall Study|Administrative|0|||
147315514|NCT02044458|531319615|FG000|Overall Study|Protocol Violation|3|||
147315515|NCT02044458|531319616|FG001|Overall Study|Protocol Violation|8|||
147315516|NCT02924389|531319618|FG000|Overall Study|Lost to Follow-up|1|||
147315517|NCT02924389|531319619|FG001|Overall Study|Lost to Follow-up|0|||
147315518|NCT02924389|531319618|FG000|Overall Study|Physician Decision|2|||
147315519|NCT02924389|531319619|FG001|Overall Study|Physician Decision|0|||
147315520|NCT02924389|531319618|FG000|Overall Study|Withdrawal by Subject|3|||
147233764|NCT00075218|531027989|FG001|Open-Label Treatment|Protocol Violation|0|||
147233765|NCT00075218|531027990|FG002|Open-Label Treatment|Protocol Violation|1|||
147233766|NCT00075218|531027988|FG000|Open-Label Treatment|enrolled in a separate continuation|0|||
147315521|NCT02924389|531319619|FG001|Overall Study|Withdrawal by Subject|0|||
147315522|NCT02924389|531319618|FG000|Overall Study|Participant began ARVs prior to study intervention|2|||
147233767|NCT00075218|531027989|FG001|Open-Label Treatment|enrolled in a separate continuation|0|||
147315523|NCT02924389|531319619|FG001|Overall Study|Participant began ARVs prior to study intervention|0|||
147315524|NCT01642186|531321713|FG000|Overall Study|Death|0|||
147315525|NCT01642186|531321714|FG001|Overall Study|Death|2|||
147315526|NCT01642186|531321715|FG002|Overall Study|Death|2|||
147315527|NCT01642186|531321713|FG000|Overall Study|Lost to Follow-up|0|||
147315528|NCT01642186|531321714|FG001|Overall Study|Lost to Follow-up|0|||
147315529|NCT01642186|531321715|FG002|Overall Study|Lost to Follow-up|1|||
147315530|NCT01668147|531321716|FG000|Overall Study|Withdrawal by Subject|6|||
147315531|NCT01118962|531321717|FG000|Overall Study|Adverse Event|2|||
147315532|NCT01118962|531321717|FG000|Overall Study|Lack of Efficacy|1|||
147315533|NCT01118962|531321717|FG000|Overall Study|Protocol Violation|1|||
147315534|NCT01118962|531321717|FG000|Overall Study|Withdrawal by Subject|4|||
147315535|NCT01118962|531321717|FG000|Overall Study|Pregnancy|1|||
147315536|NCT01118962|531321717|FG000|Overall Study|Non-compliance with Medicinal Product|1|||
147315537|NCT01383993|531321723|FG000|Overall Study|Adverse Event|1|||
147315538|NCT01383993|531321724|FG001|Overall Study|Adverse Event|1|||
147315539|NCT01383993|531321725|FG002|Overall Study|Adverse Event|0|||
147315540|NCT01383993|531321723|FG000|Overall Study|Withdrawal by Subject|0|||
147315541|NCT01383993|531321724|FG001|Overall Study|Withdrawal by Subject|0|||
147315542|NCT01383993|531321725|FG002|Overall Study|Withdrawal by Subject|1|||
147315543|NCT01383993|531321723|FG000|Overall Study|Marketed voriconazole in post-therapy|2|||
147315544|NCT01383993|531321724|FG001|Overall Study|Marketed voriconazole in post-therapy|0|||
147315545|NCT01383993|531321725|FG002|Overall Study|Marketed voriconazole in post-therapy|0|||
147315546|NCT01254565|531321732|FG000|Overall Study|Non-compliance to Study Procedures|0|||
147315547|NCT01254565|531321733|FG001|Overall Study|Non-compliance to Study Procedures|0|||
147315548|NCT01254565|531321734|FG002|Overall Study|Non-compliance to Study Procedures|0|||
147315549|NCT01254565|531321735|FG003|Overall Study|Non-compliance to Study Procedures|0|||
147315550|NCT01254565|531321736|FG004|Overall Study|Non-compliance to Study Procedures|1|||
147315551|NCT01254565|531321737|FG005|Overall Study|Non-compliance to Study Procedures|0|||
147315552|NCT01254565|531321732|FG000|Overall Study|Did not Receive Treatment|1|||
147315553|NCT01254565|531321733|FG001|Overall Study|Did not Receive Treatment|1|||
147315554|NCT01254565|531321734|FG002|Overall Study|Did not Receive Treatment|0|||
147233768|NCT00075218|531027990|FG002|Open-Label Treatment|enrolled in a separate continuation|9|||
147233769|NCT00538291|531027996|FG000|Overall Study|Adverse Event|2|||
147233770|NCT00538291|531027996|FG000|Overall Study|Withdrawal by Subject|1|||
147233771|NCT00694707|531027997|FG000|Overall Study|Did Not Receive Treatment|0|||
147233772|NCT00694707|531027998|FG001|Overall Study|Did Not Receive Treatment|0|||
147233773|NCT00694707|531027999|FG002|Overall Study|Did Not Receive Treatment|1|||
147233774|NCT00694707|531028000|FG003|Overall Study|Did Not Receive Treatment|1|||
147233775|NCT00694707|531028001|FG004|Overall Study|Did Not Receive Treatment|1|||
147233776|NCT00694707|531027997|FG000|Overall Study|Adverse Event|22|||
147233777|NCT00694707|531027998|FG001|Overall Study|Adverse Event|14|||
147233778|NCT00694707|531027999|FG002|Overall Study|Adverse Event|8|||
147233779|NCT00694707|531028000|FG003|Overall Study|Adverse Event|12|||
147233780|NCT00694707|531028001|FG004|Overall Study|Adverse Event|13|||
147233781|NCT00694707|531027997|FG000|Overall Study|Insufficient Therapeutic Response|33|||
147233782|NCT00694707|531027998|FG001|Overall Study|Insufficient Therapeutic Response|18|||
147233783|NCT00694707|531027999|FG002|Overall Study|Insufficient Therapeutic Response|17|||
147233784|NCT00694707|531028000|FG003|Overall Study|Insufficient Therapeutic Response|15|||
147233785|NCT00694707|531028001|FG004|Overall Study|Insufficient Therapeutic Response|10|||
147233786|NCT00694707|531027997|FG000|Overall Study|Protocol Violation|1|||
147233787|NCT00694707|531027998|FG001|Overall Study|Protocol Violation|2|||
147233788|NCT00694707|531027999|FG002|Overall Study|Protocol Violation|1|||
147233789|NCT00694707|531028000|FG003|Overall Study|Protocol Violation|3|||
147233790|NCT00694707|531028001|FG004|Overall Study|Protocol Violation|1|||
147233791|NCT00694707|531027997|FG000|Overall Study|Withdrawal of Consent|14|||
147233792|NCT00694707|531027998|FG001|Overall Study|Withdrawal of Consent|18|||
147233793|NCT00694707|531027999|FG002|Overall Study|Withdrawal of Consent|22|||
147233794|NCT00694707|531028000|FG003|Overall Study|Withdrawal of Consent|16|||
147233795|NCT00694707|531028001|FG004|Overall Study|Withdrawal of Consent|15|||
147233796|NCT00694707|531027997|FG000|Overall Study|Lost to Follow-up|0|||
147233797|NCT00694707|531027998|FG001|Overall Study|Lost to Follow-up|1|||
147233798|NCT00694707|531027999|FG002|Overall Study|Lost to Follow-up|2|||
147233799|NCT00694707|531028000|FG003|Overall Study|Lost to Follow-up|0|||
147233800|NCT00694707|531028001|FG004|Overall Study|Lost to Follow-up|0|||
147315555|NCT01254565|531321735|FG003|Overall Study|Did not Receive Treatment|0|||
147315556|NCT01254565|531321736|FG004|Overall Study|Did not Receive Treatment|3|||
147315557|NCT01254565|531321737|FG005|Overall Study|Did not Receive Treatment|4|||
147315558|NCT01254565|531321732|FG000|Overall Study|Other|0|||
147315559|NCT01254565|531321733|FG001|Overall Study|Other|0|||
147315560|NCT01254565|531321734|FG002|Overall Study|Other|0|||
147315561|NCT01254565|531321735|FG003|Overall Study|Other|1|||
147315562|NCT01254565|531321736|FG004|Overall Study|Other|0|||
147315563|NCT01254565|531321737|FG005|Overall Study|Other|0|||
147315564|NCT02726399|531321738|FG000|Overall Study|Participant Non-Compliance|1|||
147315565|NCT02726399|531321738|FG000|Overall Study|Adverse Event|2|||
147315566|NCT02726399|531321738|FG000|Overall Study|Progression of disease|4|||
147315567|NCT04747275|531321739|FG000|Overall Study|Study terminated|0|||
147315568|NCT04747275|531321740|FG001|Overall Study|Study terminated|1|||
147315569|NCT02206152|531321743|FG000|Pre-Randomization|Withdrawal by Subject|2|||
147315570|NCT02080520|531321744|FG000|Overall Study|Self-reported symptoms|5|||
147315571|NCT02080520|531321745|FG001|Overall Study|Self-reported symptoms|6|||
147315572|NCT02080520|531321744|FG000|Overall Study|Unable to contact|2|||
147315573|NCT02080520|531321745|FG001|Overall Study|Unable to contact|1|||
147315574|NCT02080520|531321744|FG000|Overall Study|Initiated aspirin|2|||
147315575|NCT02080520|531321745|FG001|Overall Study|Initiated aspirin|0|||
147315576|NCT02080520|531321744|FG000|Overall Study|Atrial fibrillation|1|||
147315577|NCT02080520|531321745|FG001|Overall Study|Atrial fibrillation|1|||
147315578|NCT02080520|531321744|FG000|Overall Study|Cancer|1|||
147315579|NCT02080520|531321745|FG001|Overall Study|Cancer|2|||
147315580|NCT02080520|531321744|FG000|Overall Study|Not interested in study|1|||
147315581|NCT02080520|531321745|FG001|Overall Study|Not interested in study|3|||
147315582|NCT02080520|531321744|FG000|Overall Study|Too busy|1|||
147315583|NCT02080520|531321745|FG001|Overall Study|Too busy|1|||
147315584|NCT02080520|531321744|FG000|Overall Study|Work-related injury|1|||
147315585|NCT02080520|531321745|FG001|Overall Study|Work-related injury|0|||
147315586|NCT02080520|531321744|FG000|Overall Study|Personal reasons|0|||
147315587|NCT02080520|531321745|FG001|Overall Study|Personal reasons|3|||
147315588|NCT00390455|531321746|FG000|Overall Study|Adverse Event|17|||
147315589|NCT00390455|531321747|FG001|Overall Study|Adverse Event|3|||
147315590|NCT00390455|531321746|FG000|Overall Study|Withdrawal by Subject|8|||
147315591|NCT00390455|531321747|FG001|Overall Study|Withdrawal by Subject|8|||
147315592|NCT00390455|531321746|FG000|Overall Study|Alternate Treatment|0|||
147315593|NCT00390455|531321747|FG001|Overall Study|Alternate Treatment|1|||
147315594|NCT00390455|531321746|FG000|Overall Study|Other Medical Reasons|7|||
147315595|NCT00390455|531321747|FG001|Overall Study|Other Medical Reasons|11|||
147315596|NCT00794820|531321750|FG000|Overall Study|Adverse Event|11|||
147315597|NCT00794820|531321750|FG000|Overall Study|Secondary Malignancies|2|||
147315598|NCT00794820|531321750|FG000|Overall Study|Resistant Disease|2|||
147315599|NCT00794820|531321750|FG000|Overall Study|Ineligible/Screen Failure|1|||
147315600|NCT04076020|531321752|FG000|Overall Study|Death|4|||
147315601|NCT04076020|531321753|FG001|Overall Study|Death|6|||
147315602|NCT04076020|531321752|FG000|Overall Study|Withdrawal by Subject|12|||
147315603|NCT04076020|531321753|FG001|Overall Study|Withdrawal by Subject|8|||
147315604|NCT01591460|531321754|FG000|Overall Study|Adverse Event or Intercurrent Illness|5|||
147315605|NCT01591460|531321754|FG000|Overall Study|Futility Rule (Week 12)|7|||
147315606|NCT01591460|531321754|FG000|Overall Study|Futility Rule (Week 24)|3|||
147315607|NCT01591460|531321754|FG000|Overall Study|Rebound or Breakthrough|3|||
147315608|NCT01591460|531321754|FG000|Overall Study|Treatment Discontinued by Error|1|||
147315609|NCT01591460|531321754|FG000|Overall Study|Lost to Follow-up|1|||
147315610|NCT01591460|531321754|FG000|Overall Study|Noncompliance|1|||
147315611|NCT01591460|531321754|FG000|Overall Study|Participant Refusal|3|||
147315612|NCT01591460|531321754|FG000|Overall Study|Withdrawal by Subject|1|||
147315613|NCT01591460|531321754|FG000|Overall Study|Protocol Violation|1|||
147315614|NCT00432679|531321759|FG000|Overall Study|Adverse Event|2|||
147315615|NCT00432679|531321760|FG001|Overall Study|Adverse Event|1|||
147315616|NCT00432679|531321759|FG000|Overall Study|Withdrawal by Subject|3|||
147315617|NCT00432679|531321760|FG001|Overall Study|Withdrawal by Subject|2|||
147315618|NCT00610675|531321761|FG000|Overall Study|Untreated|4|||
147315619|NCT00610675|531321761|FG000|Overall Study|Adverse Event|67|||
147315620|NCT00610675|531321761|FG000|Overall Study|Insufficient Effect|31|||
147315621|NCT00610675|531321761|FG000|Overall Study|Withdrawal by Subject|28|||
147315622|NCT00610675|531321761|FG000|Overall Study|Reasons unrelated to trial|27|||
147315623|NCT00610675|531321761|FG000|Overall Study|Lack of Compliance|7|||
147315624|NCT00610675|531321761|FG000|Overall Study|Lost to Follow-up|31|||
147315625|NCT00610675|531321761|FG000|Overall Study|Other reason (not specified)|25|||
147315626|NCT01686932|531321768|FG000|Period 1|Adverse Event|1|||
147315627|NCT01686932|531321769|FG001|Period 1|Adverse Event|1|||
147315628|NCT01284140|531321770|FG000|Subjects With Paired 24hr Collections|Day 3 urinary profile not available|5|||
147315629|NCT01284140|531321771|FG001|Subjects With Paired 24hr Collections|Day 3 urinary profile not available|5|||
147315630|NCT01284140|531321770|FG000|Subjects With Paired 24hr Collections|Day 1 urinary profile incomplete|0|||
147315631|NCT01284140|531321771|FG001|Subjects With Paired 24hr Collections|Day 1 urinary profile incomplete|1|||
147315632|NCT04147260|531321773|FG000|Overall Study|Adverse Event|1|||
147315633|NCT04147260|531321774|FG001|Overall Study|Adverse Event|0|||
147444644|NCT01147744|531792657|FG000|Overall Study|Withdrawal by Subject|8|||
147444645|NCT01147744|531792658|FG001|Overall Study|Withdrawal by Subject|4|||
147315634|NCT04147260|531321775|FG002|Overall Study|Adverse Event|1|||
147315635|NCT04147260|531321776|FG003|Overall Study|Adverse Event|2|||
147315636|NCT04147260|531321777|FG004|Overall Study|Adverse Event|0|||
147315637|NCT04147260|531321773|FG000|Overall Study|Withdrawal by Subject|0|||
147315638|NCT04147260|531321774|FG001|Overall Study|Withdrawal by Subject|0|||
147233801|NCT00694707|531027997|FG000|Overall Study|Jeopardizing Parole Status|1|||
147233802|NCT00694707|531027998|FG001|Overall Study|Jeopardizing Parole Status|0|||
147233803|NCT00694707|531027999|FG002|Overall Study|Jeopardizing Parole Status|0|||
147233804|NCT00694707|531028000|FG003|Overall Study|Jeopardizing Parole Status|0|||
147233805|NCT00694707|531028001|FG004|Overall Study|Jeopardizing Parole Status|0|||
147233806|NCT00694707|531027997|FG000|Overall Study|Death in the Family|1|||
147233807|NCT00694707|531027998|FG001|Overall Study|Death in the Family|0|||
147233808|NCT00694707|531027999|FG002|Overall Study|Death in the Family|0|||
147233809|NCT00694707|531028000|FG003|Overall Study|Death in the Family|0|||
147233810|NCT00694707|531028001|FG004|Overall Study|Death in the Family|0|||
147233811|NCT00694707|531027997|FG000|Overall Study|Arrest by Police|0|||
147233812|NCT00694707|531027998|FG001|Overall Study|Arrest by Police|1|||
147233813|NCT00694707|531027999|FG002|Overall Study|Arrest by Police|0|||
147233814|NCT00694707|531028000|FG003|Overall Study|Arrest by Police|0|||
147233815|NCT00694707|531028001|FG004|Overall Study|Arrest by Police|0|||
147233816|NCT00694707|531027997|FG000|Overall Study|Administrative Reasons|0|||
147233817|NCT00694707|531027998|FG001|Overall Study|Administrative Reasons|1|||
147233818|NCT00694707|531027999|FG002|Overall Study|Administrative Reasons|0|||
147233819|NCT00694707|531028000|FG003|Overall Study|Administrative Reasons|2|||
147233820|NCT00694707|531028001|FG004|Overall Study|Administrative Reasons|0|||
147233821|NCT00694707|531027997|FG000|Overall Study|Notification of Past Head Injury|0|||
147233822|NCT00694707|531027998|FG001|Overall Study|Notification of Past Head Injury|0|||
147233823|NCT00694707|531027999|FG002|Overall Study|Notification of Past Head Injury|0|||
147233824|NCT00694707|531028000|FG003|Overall Study|Notification of Past Head Injury|1|||
147233825|NCT00694707|531028001|FG004|Overall Study|Notification of Past Head Injury|0|||
147233826|NCT01696695|531028002|FG000|Overall Study|Disease progression|373|||
147233827|NCT01696695|531028002|FG000|Overall Study|Death|29|||
147233828|NCT01696695|531028002|FG000|Overall Study|Adverse Event|74|||
147233829|NCT01696695|531028002|FG000|Overall Study|Withdrawal by Subject|92|||
147233830|NCT01696695|531028002|FG000|Overall Study|Lost to Follow-up|48|||
147233831|NCT01696695|531028002|FG000|Overall Study|Other|74|||
147233832|NCT01696695|531028002|FG000|Overall Study|Major Protocol Violation|192|||
147233833|NCT02046733|531028011|FG000|Overall Study|never initiated 'treatment visits'|6|||
147233834|NCT02046733|531028012|FG001|Overall Study|never initiated 'treatment visits'|0|||
147233835|NCT01756053|531028013|FG000|Period 1 (10 Days)|Protocol Violation|1|||
147233836|NCT01756053|531028014|FG001|Period 1 (10 Days)|Protocol Violation|1|||
147233837|NCT01756053|531028013|FG000|Period 2 (10 Days)|Protocol Violation|0|||
147233838|NCT01756053|531028014|FG001|Period 2 (10 Days)|Protocol Violation|2|||
147233839|NCT02404220|531028015|FG000|Overall Study|Adverse Event|0|||
147233840|NCT02404220|531028016|FG001|Overall Study|Adverse Event|0|||
147233841|NCT02404220|531028017|FG002|Overall Study|Adverse Event|1|||
147233842|NCT02404220|531028018|FG003|Overall Study|Adverse Event|0|||
147233843|NCT02404220|531028015|FG000|Overall Study|Death|5|||
147233844|NCT02404220|531028016|FG001|Overall Study|Death|5|||
147233845|NCT02404220|531028017|FG002|Overall Study|Death|3|||
147233846|NCT02404220|531028018|FG003|Overall Study|Death|8|||
147233847|NCT02404220|531028015|FG000|Overall Study|Progressive Disease|0|||
147233848|NCT02404220|531028016|FG001|Overall Study|Progressive Disease|0|||
147233849|NCT02404220|531028017|FG002|Overall Study|Progressive Disease|1|||
147233850|NCT02404220|531028018|FG003|Overall Study|Progressive Disease|1|||
147233851|NCT02404220|531028015|FG000|Overall Study|Study Terminated by Sponsor|0|||
147233852|NCT02404220|531028016|FG001|Overall Study|Study Terminated by Sponsor|0|||
147233853|NCT02404220|531028017|FG002|Overall Study|Study Terminated by Sponsor|2|||
147233854|NCT02404220|531028018|FG003|Overall Study|Study Terminated by Sponsor|1|||
147233855|NCT02404220|531028015|FG000|Overall Study|Withdrawal by Subject|0|||
147233856|NCT02404220|531028016|FG001|Overall Study|Withdrawal by Subject|1|||
147233857|NCT02404220|531028017|FG002|Overall Study|Withdrawal by Subject|0|||
147233858|NCT02404220|531028018|FG003|Overall Study|Withdrawal by Subject|0|||
147233859|NCT02404220|531028015|FG000|Overall Study|Enrolled but Never Treated|0|||
147233860|NCT02404220|531028016|FG001|Overall Study|Enrolled but Never Treated|2|||
147233861|NCT02404220|531028017|FG002|Overall Study|Enrolled but Never Treated|0|||
147233862|NCT02404220|531028018|FG003|Overall Study|Enrolled but Never Treated|0|||
147233863|NCT02019277|531028021|FG000|Overall Study|Withdrawal by Subject|3|||
147233864|NCT02019277|531028021|FG000|Overall Study|Death|7|||
147233865|NCT02019277|531028021|FG000|Overall Study|Did no Cooperate|1|||
147233866|NCT02019277|531028021|FG000|Overall Study|Adverse Event|1|||
147233867|NCT00669396|531028026|FG000|Overall Study|Lost to Follow-up|10|||
147233868|NCT00669396|531028027|FG001|Overall Study|Lost to Follow-up|12|||
147233869|NCT01262573|531028028|FG000|Overall Study|Withdrawal by Subject|0|||
147233870|NCT01262573|531028029|FG001|Overall Study|Withdrawal by Subject|1|||
147233871|NCT04251273|531028030|FG000|Overall Study|Lost to Follow-up|331|||
147233872|NCT04251273|531028031|FG001|Overall Study|Lost to Follow-up|290|||
147233873|NCT04402060|531028032|FG000|Overall Study|Death|1|||
147233874|NCT04402060|531028033|FG001|Overall Study|Death|12|||
147233875|NCT04402060|531028034|FG002|Overall Study|Death|7|||
147233876|NCT04402060|531028032|FG000|Overall Study|Adverse Event|0|||
147233877|NCT04402060|531028033|FG001|Overall Study|Adverse Event|0|||
147233878|NCT04402060|531028034|FG002|Overall Study|Adverse Event|1|||
147233879|NCT04402060|531028032|FG000|Overall Study|Withdrawal by Subject|0|||
147233880|NCT04402060|531028033|FG001|Overall Study|Withdrawal by Subject|1|||
147233881|NCT04402060|531028034|FG002|Overall Study|Withdrawal by Subject|2|||
147233882|NCT04402060|531028032|FG000|Overall Study|Sponsor Request|0|||
147233883|NCT04402060|531028033|FG001|Overall Study|Sponsor Request|2|||
147233884|NCT04402060|531028034|FG002|Overall Study|Sponsor Request|0|||
147233885|NCT04402060|531028032|FG000|Overall Study|Physician Decision|0|||
147233886|NCT04402060|531028033|FG001|Overall Study|Physician Decision|0|||
147233887|NCT04402060|531028034|FG002|Overall Study|Physician Decision|1|||
147233888|NCT04402060|531028032|FG000|Overall Study|Other|0|||
147233889|NCT04402060|531028033|FG001|Overall Study|Other|1|||
147233890|NCT04402060|531028034|FG002|Overall Study|Other|0|||
147233891|NCT00810693|531028035|FG000|Treatment Period|Adverse Event|8|||
147233892|NCT00810693|531028036|FG001|Treatment Period|Adverse Event|1|||
147233893|NCT00810693|531028037|FG002|Treatment Period|Adverse Event|7|||
147233894|NCT00810693|531028035|FG000|Treatment Period|Death|0|||
147233895|NCT00810693|531028036|FG001|Treatment Period|Death|1|||
147233896|NCT00810693|531028037|FG002|Treatment Period|Death|2|||
147233897|NCT00810693|531028035|FG000|Treatment Period|Lack of Efficacy|0|||
147233898|NCT00810693|531028036|FG001|Treatment Period|Lack of Efficacy|0|||
147233899|NCT00810693|531028037|FG002|Treatment Period|Lack of Efficacy|1|||
147233900|NCT00810693|531028035|FG000|Treatment Period|Lost to Follow-up|1|||
147233901|NCT00810693|531028036|FG001|Treatment Period|Lost to Follow-up|0|||
147233902|NCT00810693|531028037|FG002|Treatment Period|Lost to Follow-up|0|||
147233903|NCT00810693|531028035|FG000|Treatment Period|Non-compliance|1|||
147233904|NCT00810693|531028036|FG001|Treatment Period|Non-compliance|0|||
147233905|NCT00810693|531028037|FG002|Treatment Period|Non-compliance|0|||
147233906|NCT00810693|531028035|FG000|Treatment Period|Protocol Violation|1|||
147233907|NCT00810693|531028036|FG001|Treatment Period|Protocol Violation|2|||
147315639|NCT04147260|531321775|FG002|Overall Study|Withdrawal by Subject|1|||
147233908|NCT00810693|531028037|FG002|Treatment Period|Protocol Violation|2|||
147233909|NCT00810693|531028035|FG000|Treatment Period|Withdrawal by Subject|6|||
147233910|NCT00810693|531028036|FG001|Treatment Period|Withdrawal by Subject|2|||
147233911|NCT00810693|531028037|FG002|Treatment Period|Withdrawal by Subject|3|||
147233912|NCT00810693|531028035|FG000|Treatment Period|Not treated|0|||
147233913|NCT00810693|531028036|FG001|Treatment Period|Not treated|1|||
147233914|NCT00810693|531028037|FG002|Treatment Period|Not treated|1|||
147233915|NCT00810693|531028035|FG000|Follow-up Period (FUP)|Adverse Event|3|||
147233916|NCT00810693|531028036|FG001|Follow-up Period (FUP)|Adverse Event|1|||
147233917|NCT00810693|531028037|FG002|Follow-up Period (FUP)|Adverse Event|1|||
147233918|NCT00810693|531028035|FG000|Follow-up Period (FUP)|Death|2|||
147233919|NCT00810693|531028036|FG001|Follow-up Period (FUP)|Death|0|||
147233920|NCT00810693|531028037|FG002|Follow-up Period (FUP)|Death|1|||
147233921|NCT00810693|531028035|FG000|Follow-up Period (FUP)|Lost to Follow-up|1|||
147233922|NCT00810693|531028036|FG001|Follow-up Period (FUP)|Lost to Follow-up|0|||
147233923|NCT00810693|531028037|FG002|Follow-up Period (FUP)|Lost to Follow-up|2|||
147233924|NCT00810693|531028035|FG000|Follow-up Period (FUP)|Protocol Violation|0|||
147233925|NCT00810693|531028036|FG001|Follow-up Period (FUP)|Protocol Violation|1|||
147233926|NCT00810693|531028037|FG002|Follow-up Period (FUP)|Protocol Violation|0|||
147233927|NCT00810693|531028035|FG000|Follow-up Period (FUP)|Withdrawal by Subject|2|||
147233928|NCT00810693|531028036|FG001|Follow-up Period (FUP)|Withdrawal by Subject|1|||
147233929|NCT00810693|531028037|FG002|Follow-up Period (FUP)|Withdrawal by Subject|0|||
147233930|NCT02507973|531028042|FG000|Overall Study|Adverse Event|1|||
147233931|NCT00331422|531028043|FG000|Overall Study|Did not receive entire study regimen|5|||
147233932|NCT03386474|531028046|FG000|Overall Study|Death|1|||
147233933|NCT03386474|531028047|FG001|Overall Study|Death|0|||
147233934|NCT03386474|531028046|FG000|Overall Study|Adverse Event|0|||
147233935|NCT03386474|531028047|FG001|Overall Study|Adverse Event|1|||
147233936|NCT02155881|531028048|FG000|Overall Study|Withdrawal by Subject|0|||
147233937|NCT02155881|531028049|FG001|Overall Study|Withdrawal by Subject|2|||
147233938|NCT02155881|531028048|FG000|Overall Study|Inappropriately randomized|2|||
147233939|NCT02155881|531028049|FG001|Overall Study|Inappropriately randomized|2|||
147233940|NCT04357782|531028050|FG000|Overall Study|Discharged from hospital|1|||
147233941|NCT04357782|531028051|FG001|Overall Study|Discharged from hospital|0|||
147233942|NCT04357782|531028050|FG000|Overall Study|Death|0|||
147233943|NCT04357782|531028051|FG001|Overall Study|Death|2|||
147233944|NCT01786148|531028052|FG000|Overall Study|Lost to Follow-up|21|||
147233945|NCT01786148|531028053|FG001|Overall Study|Lost to Follow-up|13|||
147233946|NCT01786148|531028052|FG000|Overall Study|Death|0|||
147233947|NCT01786148|531028053|FG001|Overall Study|Death|1|||
147233948|NCT01786148|531028052|FG000|Overall Study|Withdrawal by Subject|0|||
147233949|NCT01786148|531028053|FG001|Overall Study|Withdrawal by Subject|7|||
147233950|NCT01786148|531028052|FG000|Overall Study|Incarceration|1|||
147233951|NCT01786148|531028053|FG001|Overall Study|Incarceration|1|||
147233952|NCT03780543|531028054|FG000|Overall Study|Adverse Event|1|||
147233953|NCT03780543|531028055|FG001|Overall Study|Adverse Event|0|||
147233954|NCT03780543|531028056|FG002|Overall Study|Adverse Event|2|||
147233955|NCT03780543|531028054|FG000|Overall Study|Lost to Follow-up|2|||
147233956|NCT03780543|531028055|FG001|Overall Study|Lost to Follow-up|0|||
147124209|NCT01633112|530620673|FG001|Overall Study|Lack of Efficacy|6|||
147124210|NCT01633112|530620674|FG002|Overall Study|Lack of Efficacy|13|||
147124211|NCT01633112|530620672|FG000|Overall Study|Abnormal laboratory value(s)|3|||
147124212|NCT01633112|530620673|FG001|Overall Study|Abnormal laboratory value(s)|1|||
147124213|NCT01633112|530620674|FG002|Overall Study|Abnormal laboratory value(s)|0|||
147124214|NCT01633112|530620672|FG000|Overall Study|Abnormal test procedure result(s)|0|||
147124215|NCT01633112|530620673|FG001|Overall Study|Abnormal test procedure result(s)|1|||
147124216|NCT01633112|530620674|FG002|Overall Study|Abnormal test procedure result(s)|0|||
147124217|NCT01633112|530620672|FG000|Overall Study|Administrative problems|1|||
147124218|NCT01633112|530620673|FG001|Overall Study|Administrative problems|2|||
147233957|NCT03780543|531028056|FG002|Overall Study|Lost to Follow-up|1|||
147233958|NCT03780543|531028054|FG000|Overall Study|Study terminated by Sponsor|8|||
147233959|NCT03780543|531028055|FG001|Overall Study|Study terminated by Sponsor|7|||
147233960|NCT03780543|531028056|FG002|Overall Study|Study terminated by Sponsor|13|||
147233961|NCT03780543|531028054|FG000|Overall Study|Withdrawal by Subject|1|||
147233962|NCT03780543|531028055|FG001|Overall Study|Withdrawal by Subject|8|||
147233963|NCT03780543|531028056|FG002|Overall Study|Withdrawal by Subject|1|||
147233964|NCT03780543|531028054|FG000|Overall Study|Noncompliance with study drug|1|||
147233965|NCT03780543|531028055|FG001|Overall Study|Noncompliance with study drug|0|||
147233966|NCT03780543|531028056|FG002|Overall Study|Noncompliance with study drug|0|||
147233967|NCT00066729|531028057|FG000|Overall Study|Lost to Follow-up|1|||
147233968|NCT00066729|531028057|FG000|Overall Study|Disease progression|1|||
147233969|NCT02840721|531028058|FG000|Treatment Period|Adverse Event|1|||
147233970|NCT02840721|531028058|FG000|Follow-Up|Lack of Efficacy|1|||
147233971|NCT02840721|531028058|FG000|Follow-Up|Withdrawal by Subject|4|||
147233972|NCT02840721|531028058|FG000|Follow-Up|Withdrawal of Consent|2|||
147233973|NCT01967173|531028059|FG000|Overall Study|Lost to Follow-up|5|||
147233974|NCT01967173|531028060|FG001|Overall Study|Lost to Follow-up|3|||
147233975|NCT01967173|531028061|FG002|Overall Study|Lost to Follow-up|2|||
147233976|NCT01967173|531028062|FG003|Overall Study|Lost to Follow-up|4|||
147233977|NCT01967173|531028063|FG004|Overall Study|Lost to Follow-up|8|||
147233978|NCT01967173|531028064|FG005|Overall Study|Lost to Follow-up|12|||
147233979|NCT01967173|531028065|FG006|Overall Study|Lost to Follow-up|6|||
147233980|NCT01967173|531028066|FG007|Overall Study|Lost to Follow-up|8|||
147233981|NCT01967173|531028059|FG000|Overall Study|Physician Decision|2|||
147233982|NCT01967173|531028060|FG001|Overall Study|Physician Decision|0|||
147233983|NCT01967173|531028061|FG002|Overall Study|Physician Decision|2|||
147233984|NCT01967173|531028062|FG003|Overall Study|Physician Decision|1|||
147233985|NCT01967173|531028063|FG004|Overall Study|Physician Decision|1|||
147233986|NCT01967173|531028064|FG005|Overall Study|Physician Decision|1|||
147233987|NCT01967173|531028065|FG006|Overall Study|Physician Decision|1|||
147233988|NCT01967173|531028066|FG007|Overall Study|Physician Decision|0|||
147233989|NCT01967173|531028059|FG000|Overall Study|Lack of Efficacy|2|||
147233990|NCT01967173|531028060|FG001|Overall Study|Lack of Efficacy|0|||
147233991|NCT01967173|531028061|FG002|Overall Study|Lack of Efficacy|2|||
147233992|NCT01967173|531028062|FG003|Overall Study|Lack of Efficacy|2|||
147233993|NCT01967173|531028063|FG004|Overall Study|Lack of Efficacy|0|||
147233994|NCT01967173|531028064|FG005|Overall Study|Lack of Efficacy|1|||
147233995|NCT01967173|531028065|FG006|Overall Study|Lack of Efficacy|0|||
147233996|NCT01967173|531028066|FG007|Overall Study|Lack of Efficacy|2|||
147233997|NCT01967173|531028059|FG000|Overall Study|Pregnancy|0|||
147233998|NCT01967173|531028060|FG001|Overall Study|Pregnancy|0|||
147233999|NCT01967173|531028061|FG002|Overall Study|Pregnancy|0|||
147234000|NCT01967173|531028062|FG003|Overall Study|Pregnancy|0|||
147234001|NCT01967173|531028063|FG004|Overall Study|Pregnancy|0|||
147234002|NCT01967173|531028064|FG005|Overall Study|Pregnancy|0|||
147234003|NCT01967173|531028065|FG006|Overall Study|Pregnancy|1|||
147234004|NCT01967173|531028066|FG007|Overall Study|Pregnancy|1|||
147234005|NCT01967173|531028059|FG000|Overall Study|Adverse Event|0|||
147234006|NCT01967173|531028060|FG001|Overall Study|Adverse Event|0|||
147234007|NCT01967173|531028061|FG002|Overall Study|Adverse Event|0|||
147234008|NCT01967173|531028062|FG003|Overall Study|Adverse Event|0|||
147234009|NCT01967173|531028063|FG004|Overall Study|Adverse Event|0|||
147234010|NCT01967173|531028064|FG005|Overall Study|Adverse Event|0|||
147234011|NCT01967173|531028065|FG006|Overall Study|Adverse Event|0|||
147234012|NCT01967173|531028066|FG007|Overall Study|Adverse Event|1|||
147234013|NCT01967173|531028059|FG000|Overall Study|Withdrawal by Subject|15|||
147234014|NCT01967173|531028060|FG001|Overall Study|Withdrawal by Subject|14|||
147124219|NCT01633112|530620674|FG002|Overall Study|Administrative problems|5|||
147124220|NCT01633112|530620672|FG000|Overall Study|Adverse Event|16|||
147234015|NCT01967173|531028061|FG002|Overall Study|Withdrawal by Subject|10|||
147234016|NCT01967173|531028062|FG003|Overall Study|Withdrawal by Subject|7|||
147234017|NCT01967173|531028063|FG004|Overall Study|Withdrawal by Subject|8|||
147234018|NCT01967173|531028064|FG005|Overall Study|Withdrawal by Subject|9|||
147234019|NCT01967173|531028065|FG006|Overall Study|Withdrawal by Subject|10|||
147234020|NCT01967173|531028066|FG007|Overall Study|Withdrawal by Subject|12|||
147234021|NCT03540030|531028070|FG000|Overall Study|Withdrawal by Subject|2|||
147234022|NCT03540030|531028071|FG001|Overall Study|Withdrawal by Subject|1|||
147234023|NCT03540030|531028070|FG000|Overall Study|screen fail|7|||
147651095|NCT01005901|532544586|FG000|Overall Study|Withdrawal by Subject|38|||
147651096|NCT01005901|532544587|FG001|Overall Study|Withdrawal by Subject|14|||
147315640|NCT04147260|531321776|FG003|Overall Study|Withdrawal by Subject|1|||
147651097|NCT01005901|532544586|FG000|Overall Study|Adverse Event|30|||
147651098|NCT01005901|532544587|FG001|Overall Study|Adverse Event|16|||
147651099|NCT01005901|532544586|FG000|Overall Study|Administrative problems|21|||
147651100|NCT01005901|532544587|FG001|Overall Study|Administrative problems|13|||
147651101|NCT01005901|532544586|FG000|Overall Study|Unsatisfactory therapeutic effect|5|||
147651102|NCT01005901|532544587|FG001|Overall Study|Unsatisfactory therapeutic effect|5|||
147651103|NCT01005901|532544586|FG000|Overall Study|Protocol Violation|4|||
147651104|NCT01005901|532544587|FG001|Overall Study|Protocol Violation|3|||
147651105|NCT01005901|532544586|FG000|Overall Study|Death|2|||
147651106|NCT01005901|532544587|FG001|Overall Study|Death|3|||
147651107|NCT01005901|532544586|FG000|Overall Study|Lost to Follow-up|1|||
147651108|NCT01005901|532544587|FG001|Overall Study|Lost to Follow-up|2|||
147651109|NCT01005901|532544586|FG000|Overall Study|Patient's inability to use the device|1|||
147651110|NCT01005901|532544587|FG001|Overall Study|Patient's inability to use the device|1|||
147651111|NCT01005901|532544586|FG000|Overall Study|No longer requires study drug|0|||
147651112|NCT01005901|532544587|FG001|Overall Study|No longer requires study drug|1|||
147651113|NCT00760487|532544588|FG000|Overall Study|Unilateral implantation|3|||
147651114|NCT00496587|532544589|FG000|Overall Study|Adverse Event|2|||
147651115|NCT00496587|532544589|FG000|Overall Study|Progressive Disease|24|||
147651116|NCT00496587|532544589|FG000|Overall Study|Withdrawal by Subject|2|||
147651117|NCT00496587|532544589|FG000|Overall Study|Death|1|||
147651118|NCT00496587|532544589|FG000|Overall Study|Complications unrelated|2|||
147651119|NCT00482170|532544590|FG000|Overall Study|Adverse Event|5|||
147651120|NCT00482170|532544591|FG001|Overall Study|Adverse Event|14|||
147651121|NCT00482170|532544590|FG000|Overall Study|Withdrawal by Subject|6|||
147651122|NCT00482170|532544591|FG001|Overall Study|Withdrawal by Subject|1|||
147651123|NCT00482170|532544590|FG000|Overall Study|Protocol Violation|2|||
147651124|NCT00482170|532544591|FG001|Overall Study|Protocol Violation|3|||
147651125|NCT00482170|532544590|FG000|Overall Study|Lost to Follow-up|2|||
147651126|NCT00482170|532544591|FG001|Overall Study|Lost to Follow-up|0|||
147651127|NCT00482170|532544590|FG000|Overall Study|Unspecified reason|0|||
147651128|NCT00482170|532544591|FG001|Overall Study|Unspecified reason|2|||
147651129|NCT01134263|532544592|FG000|Overall Study|Serious adverse event|2|||
147651130|NCT01134263|532544593|FG001|Overall Study|Serious adverse event|1|||
147651131|NCT01134263|532544594|FG002|Overall Study|Serious adverse event|1|||
147651132|NCT01134263|532544595|FG003|Overall Study|Serious adverse event|1|||
147651133|NCT01134263|532544596|FG004|Overall Study|Serious adverse event|1|||
147651134|NCT01134263|532544592|FG000|Overall Study|Other adverse event|1|||
147651135|NCT01134263|532544593|FG001|Overall Study|Other adverse event|2|||
147651136|NCT01134263|532544594|FG002|Overall Study|Other adverse event|5|||
147651137|NCT01134263|532544595|FG003|Overall Study|Other adverse event|3|||
147651138|NCT01134263|532544596|FG004|Overall Study|Other adverse event|0|||
147651139|NCT01134263|532544592|FG000|Overall Study|Protocol Violation|8|||
147315641|NCT04147260|531321777|FG004|Overall Study|Withdrawal by Subject|0|||
147315642|NCT01555021|531321778|FG000|Overall Study|Lost to Follow-up|1|||
147315643|NCT01555021|531321779|FG001|Overall Study|Lost to Follow-up|2|||
147315644|NCT01313923|531321783|FG000|Overall Study|Physician Decision|3|||
147315645|NCT01388530|531321784|FG000|Overall Study|Lost to Follow-up|5|||
147315646|NCT01990300|531321785|FG000|Overall Study|Case Report Forms Uncollected|89|||
147315647|NCT01990300|531321785|FG000|Overall Study|Protocol Deviation|53|||
147315648|NCT02420327|531321786|FG000|Overall Study|Adverse Event|7|||
147315649|NCT02420327|531321786|FG000|Overall Study|Pregnancy|1|||
147315650|NCT02420327|531321786|FG000|Overall Study|Withdrawal by Subject|6|||
147315651|NCT02420327|531321786|FG000|Overall Study|Lost to Follow-up|1|||
147315652|NCT02420327|531321786|FG000|Overall Study|Protocol Violation|1|||
147315653|NCT02204293|531321787|FG000|Core Study Part I|Met one or more exclusion criteria|1|||
147315654|NCT02204293|531321788|FG001|Core Study Part I|Met one or more exclusion criteria|0|||
147651140|NCT01134263|532544593|FG001|Overall Study|Protocol Violation|7|||
147651141|NCT01134263|532544594|FG002|Overall Study|Protocol Violation|2|||
147651142|NCT01134263|532544595|FG003|Overall Study|Protocol Violation|4|||
147651143|NCT01134263|532544596|FG004|Overall Study|Protocol Violation|2|||
147651144|NCT01134263|532544592|FG000|Overall Study|Lost to Follow-up|4|||
147651145|NCT01134263|532544593|FG001|Overall Study|Lost to Follow-up|3|||
147651146|NCT01134263|532544594|FG002|Overall Study|Lost to Follow-up|5|||
147651147|NCT01134263|532544595|FG003|Overall Study|Lost to Follow-up|3|||
147651148|NCT01134263|532544596|FG004|Overall Study|Lost to Follow-up|1|||
147651149|NCT01134263|532544592|FG000|Overall Study|Withdrawal by Subject|8|||
147651150|NCT01134263|532544593|FG001|Overall Study|Withdrawal by Subject|6|||
147651151|NCT01134263|532544594|FG002|Overall Study|Withdrawal by Subject|16|||
147651152|NCT01134263|532544595|FG003|Overall Study|Withdrawal by Subject|7|||
147651153|NCT01134263|532544596|FG004|Overall Study|Withdrawal by Subject|5|||
147651154|NCT01134263|532544592|FG000|Overall Study|Enrolled, but not treated|1|||
147651155|NCT01134263|532544593|FG001|Overall Study|Enrolled, but not treated|1|||
147651156|NCT01134263|532544594|FG002|Overall Study|Enrolled, but not treated|0|||
147651157|NCT01134263|532544595|FG003|Overall Study|Enrolled, but not treated|1|||
147124221|NCT01633112|530620673|FG001|Overall Study|Adverse Event|18|||
147124222|NCT01633112|530620674|FG002|Overall Study|Adverse Event|20|||
147124223|NCT01633112|530620672|FG000|Overall Study|Lost to Follow-up|7|||
147124224|NCT01633112|530620673|FG001|Overall Study|Lost to Follow-up|19|||
147124225|NCT01633112|530620674|FG002|Overall Study|Lost to Follow-up|6|||
147124226|NCT01633112|530620672|FG000|Overall Study|Protocol Violation|4|||
147124227|NCT01633112|530620673|FG001|Overall Study|Protocol Violation|0|||
147124228|NCT01633112|530620674|FG002|Overall Study|Protocol Violation|2|||
147124229|NCT01633112|530620672|FG000|Overall Study|Subject no longer requires study drug|0|||
147124230|NCT01633112|530620673|FG001|Overall Study|Subject no longer requires study drug|0|||
147124231|NCT01633112|530620674|FG002|Overall Study|Subject no longer requires study drug|1|||
147124232|NCT01633112|530620672|FG000|Overall Study|Withdrawal by Subject|20|||
147124233|NCT01633112|530620673|FG001|Overall Study|Withdrawal by Subject|12|||
147124234|NCT01633112|530620674|FG002|Overall Study|Withdrawal by Subject|41|||
147124235|NCT01633112|530620672|FG000|Overall Study|missing Study Completion CRF|1|||
147124236|NCT01633112|530620673|FG001|Overall Study|missing Study Completion CRF|1|||
147124237|NCT01633112|530620674|FG002|Overall Study|missing Study Completion CRF|4|||
147124238|NCT03439072|530620677|FG000|Overall Study|Withdrawal by Subject|2|||
147124239|NCT03439072|530620678|FG001|Overall Study|Withdrawal by Subject|3|||
147124240|NCT03439072|530620677|FG000|Overall Study|Physician Decision|0|||
147124241|NCT03439072|530620678|FG001|Overall Study|Physician Decision|1|||
147124242|NCT00128492|530620681|FG000|Overall Study|AE unrelated to study|2|||
147124243|NCT00128492|530620682|FG001|Overall Study|AE unrelated to study|9|||
147124244|NCT00128492|530620681|FG000|Overall Study|Study drug intolerance (AE)|2|||
147124245|NCT00128492|530620682|FG001|Overall Study|Study drug intolerance (AE)|8|||
147124246|NCT00128492|530620681|FG000|Overall Study|AE related to study|1|||
147124247|NCT00128492|530620682|FG001|Overall Study|AE related to study|4|||
147124248|NCT00128492|530620681|FG000|Overall Study|Death|1|||
147124249|NCT00128492|530620682|FG001|Overall Study|Death|0|||
147124250|NCT00128492|530620681|FG000|Overall Study|Lost to Follow-up|1|||
147124251|NCT00128492|530620682|FG001|Overall Study|Lost to Follow-up|5|||
147124252|NCT00128492|530620681|FG000|Overall Study|Noncompliance|0|||
147124253|NCT00128492|530620682|FG001|Overall Study|Noncompliance|5|||
147124254|NCT00128492|530620681|FG000|Overall Study|Personal or administrative|10|||
147124255|NCT00128492|530620682|FG001|Overall Study|Personal or administrative|22|||
147124256|NCT00128492|530620681|FG000|Overall Study|Withdrawal by Subject|3|||
147124257|NCT00128492|530620682|FG001|Overall Study|Withdrawal by Subject|5|||
147124258|NCT00128492|530620681|FG000|Overall Study|Pregnancy|0|||
147124259|NCT00128492|530620682|FG001|Overall Study|Pregnancy|1|||
147124260|NCT00692237|530620686|FG000|Overall Study|Withdrawal by Subject|1|||
147124261|NCT00692237|530620687|FG001|Overall Study|Withdrawal by Subject|3|||
147124262|NCT00692237|530620686|FG000|Overall Study|Adverse Event|0|||
147124263|NCT00692237|530620687|FG001|Overall Study|Adverse Event|1|||
147124264|NCT01347086|530620688|FG000|Overall Study|failed screening visit|0|||
147124265|NCT01347086|530620689|FG001|Overall Study|failed screening visit|0|||
147124266|NCT01347086|530620690|FG002|Overall Study|failed screening visit|1|||
147124267|NCT01347086|530620691|FG003|Overall Study|failed screening visit|0|||
147124268|NCT01347086|530620692|FG004|Overall Study|failed screening visit|0|||
147124269|NCT01347086|530620693|FG005|Overall Study|failed screening visit|0|||
147124270|NCT01347086|530620694|FG006|Overall Study|failed screening visit|1|||
147124271|NCT01347086|530620695|FG007|Overall Study|failed screening visit|1|||
147124272|NCT01347086|530620696|FG008|Overall Study|failed screening visit|0|||
147124273|NCT01347086|530620697|FG009|Overall Study|failed screening visit|1|||
147124274|NCT02624687|530620698|FG000|Overall Study|Withdrawal by Subject|1|||
147124275|NCT02624687|530620699|FG001|Overall Study|Withdrawal by Subject|1|||
147124276|NCT02624687|530620698|FG000|Overall Study|medical leave from work|0|||
147124277|NCT02624687|530620699|FG001|Overall Study|medical leave from work|1|||
147124278|NCT00347269|530620700|FG000|Overall Study|Lost to Follow-up|74|||
147124279|NCT00347269|530620701|FG001|Overall Study|Lost to Follow-up|65|||
147124280|NCT00347269|530620700|FG000|Overall Study|Withdrawal by Subject|18|||
147124281|NCT00347269|530620701|FG001|Overall Study|Withdrawal by Subject|38|||
147124282|NCT00347269|530620700|FG000|Overall Study|Death|2|||
147124283|NCT00347269|530620701|FG001|Overall Study|Death|3|||
147124284|NCT03654326|530620702|FG000|Overall Study|Withdrawal by Subject|5|||
147234024|NCT03540030|531028071|FG001|Overall Study|screen fail|1|||
147234025|NCT03540030|531028070|FG000|Overall Study|never had surgery after signing consent|9|||
147124285|NCT03654326|530620703|FG001|Overall Study|Withdrawal by Subject|3|||
147234026|NCT03540030|531028071|FG001|Overall Study|never had surgery after signing consent|1|||
147234027|NCT03666624|531028072|FG000|Overall Study|participant grieving over recent death of parent|1|||
147124286|NCT03654326|530620702|FG000|Overall Study|Physician Decision|0|||
147124287|NCT03654326|530620703|FG001|Overall Study|Physician Decision|1|||
147124288|NCT03654326|530620702|FG000|Overall Study|Unable to adhere to study schedule|0|||
147124289|NCT03654326|530620703|FG001|Overall Study|Unable to adhere to study schedule|1|||
147124290|NCT03654326|530620702|FG000|Overall Study|Lost to Follow-up|1|||
147124291|NCT03654326|530620703|FG001|Overall Study|Lost to Follow-up|1|||
147124292|NCT04893811|530620704|FG000|Vaccination Phase|Death|1|||
147124293|NCT04893811|530620705|FG001|Vaccination Phase|Death|0|||
147124294|NCT04893811|530620704|FG000|Vaccination Phase|Lost to Follow-up|1|||
147124295|NCT04893811|530620705|FG001|Vaccination Phase|Lost to Follow-up|1|||
147124296|NCT04893811|530620704|FG000|Vaccination Phase|Protocol Violation|2|||
147124297|NCT04893811|530620705|FG001|Vaccination Phase|Protocol Violation|0|||
147124298|NCT04893811|530620704|FG000|Vaccination Phase|Withdrawal by Subject|2|||
147124299|NCT04893811|530620705|FG001|Vaccination Phase|Withdrawal by Subject|1|||
147124300|NCT04893811|530620704|FG000|Vaccination Phase|Other|0|||
147124301|NCT04893811|530620705|FG001|Vaccination Phase|Other|1|||
147124302|NCT04893811|530620704|FG000|Vaccination Phase|No longer met eligibility criteria|0|||
147124303|NCT04893811|530620705|FG001|Vaccination Phase|No longer met eligibility criteria|1|||
147124304|NCT04893811|530620704|FG000|Follow-up Phase|Lost to Follow-up|0|||
147124305|NCT04893811|530620705|FG001|Follow-up Phase|Lost to Follow-up|1|||
147124306|NCT02662582|530620706|FG000|Treatment Period 1 (14 Days)|Adverse Event|3|||
147124307|NCT02662582|530620707|FG001|Treatment Period 1 (14 Days)|Adverse Event|2|||
147124308|NCT02662582|530620706|FG000|Treatment Period 1 (14 Days)|Miscellaneous|0|||
147124309|NCT02662582|530620707|FG001|Treatment Period 1 (14 Days)|Miscellaneous|1|||
147124310|NCT02662582|530620706|FG000|Treatment Period 1 (14 Days)|Protocol Deviation|1|||
147124311|NCT02662582|530620707|FG001|Treatment Period 1 (14 Days)|Protocol Deviation|0|||
147124312|NCT02662582|530620706|FG000|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
147124313|NCT02662582|530620707|FG001|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
147124314|NCT01725282|530620708|FG000|Overall Study|Adverse Event|1|||
147124315|NCT01725282|530620709|FG001|Overall Study|Adverse Event|3|||
147124316|NCT01725282|530620710|FG002|Overall Study|Adverse Event|6|||
147124317|NCT01725282|530620711|FG003|Overall Study|Adverse Event|4|||
147124318|NCT01725282|530620708|FG000|Overall Study|Exacerbation of Target Disease|1|||
147124319|NCT01725282|530620709|FG001|Overall Study|Exacerbation of Target Disease|0|||
147124320|NCT01725282|530620710|FG002|Overall Study|Exacerbation of Target Disease|0|||
147124321|NCT01725282|530620711|FG003|Overall Study|Exacerbation of Target Disease|1|||
147124322|NCT01725282|530620708|FG000|Overall Study|Met Exclusion Criteria|0|||
147124323|NCT01725282|530620709|FG001|Overall Study|Met Exclusion Criteria|0|||
147124324|NCT01725282|530620710|FG002|Overall Study|Met Exclusion Criteria|1|||
147124325|NCT01725282|530620711|FG003|Overall Study|Met Exclusion Criteria|0|||
147124326|NCT01725282|530620708|FG000|Overall Study|Study Site Withdrawal|0|||
147124327|NCT01725282|530620709|FG001|Overall Study|Study Site Withdrawal|1|||
147124328|NCT01725282|530620710|FG002|Overall Study|Study Site Withdrawal|0|||
147124329|NCT01725282|530620711|FG003|Overall Study|Study Site Withdrawal|0|||
147124330|NCT01725282|530620708|FG000|Overall Study|Withdrawal by Subject|0|||
147124331|NCT01725282|530620709|FG001|Overall Study|Withdrawal by Subject|0|||
147124332|NCT01725282|530620710|FG002|Overall Study|Withdrawal by Subject|1|||
147234028|NCT03666624|531028073|FG001|Overall Study|participant grieving over recent death of parent|0|||
147234029|NCT02959983|531028077|FG000|Overall Study|Protocol Violation|0|||
147234030|NCT02959983|531028078|FG001|Overall Study|Protocol Violation|1|||
147234031|NCT02959983|531028077|FG000|Overall Study|Lack of Efficacy|0|||
147234032|NCT02959983|531028078|FG001|Overall Study|Lack of Efficacy|1|||
147234033|NCT02959983|531028077|FG000|Overall Study|Lost to Follow-up|12|||
147234034|NCT02959983|531028078|FG001|Overall Study|Lost to Follow-up|9|||
147234035|NCT02959983|531028077|FG000|Overall Study|Other|1|||
147234036|NCT02959983|531028078|FG001|Overall Study|Other|1|||
147234037|NCT02959983|531028077|FG000|Overall Study|Physician Decision|1|||
147234038|NCT02959983|531028078|FG001|Overall Study|Physician Decision|0|||
147234039|NCT02959983|531028077|FG000|Overall Study|Adverse Event|5|||
147234040|NCT02959983|531028078|FG001|Overall Study|Adverse Event|1|||
147234041|NCT02959983|531028077|FG000|Overall Study|Withdrawal by Subject|7|||
147234042|NCT02959983|531028078|FG001|Overall Study|Withdrawal by Subject|12|||
147234043|NCT01254630|531028079|FG000|Overall Study|Adverse Event|36|||
147234044|NCT01254630|531028080|FG001|Overall Study|Adverse Event|15|||
147234045|NCT01254630|531028081|FG002|Overall Study|Adverse Event|40|||
147234046|NCT01254630|531028082|FG003|Overall Study|Adverse Event|8|||
147234047|NCT01254630|531028079|FG000|Overall Study|Death|461|||
147234048|NCT01254630|531028080|FG001|Overall Study|Death|151|||
147234049|NCT01254630|531028081|FG002|Overall Study|Death|478|||
147234050|NCT01254630|531028082|FG003|Overall Study|Death|139|||
147234051|NCT01254630|531028079|FG000|Overall Study|Lost to Follow-up|80|||
147234052|NCT01254630|531028080|FG001|Overall Study|Lost to Follow-up|26|||
147234053|NCT01254630|531028081|FG002|Overall Study|Lost to Follow-up|89|||
147234054|NCT01254630|531028082|FG003|Overall Study|Lost to Follow-up|32|||
147315655|NCT02204293|531321789|FG002|Core Study Part I|Met one or more exclusion criteria|0|||
147124333|NCT01725282|530620711|FG003|Overall Study|Withdrawal by Subject|1|||
147124334|NCT01725282|530620708|FG000|Overall Study|Lack of Efficacy|0|||
147124335|NCT01725282|530620709|FG001|Overall Study|Lack of Efficacy|1|||
147124336|NCT01725282|530620710|FG002|Overall Study|Lack of Efficacy|0|||
147124337|NCT01725282|530620711|FG003|Overall Study|Lack of Efficacy|1|||
147124338|NCT01687595|530620716|FG000|Overall Study|Withdrawal by Subject|8|||
147234055|NCT01254630|531028079|FG000|Overall Study|Physician Decision|24|||
147234056|NCT01254630|531028080|FG001|Overall Study|Physician Decision|8|||
147234057|NCT01254630|531028081|FG002|Overall Study|Physician Decision|16|||
147234058|NCT01254630|531028082|FG003|Overall Study|Physician Decision|7|||
147315656|NCT02204293|531321790|FG003|Core Study Part I|Met one or more exclusion criteria|0|||
147315657|NCT02204293|531321791|FG004|Core Study Part I|Met one or more exclusion criteria|0|||
147315658|NCT02204293|531321792|FG005|Core Study Part I|Met one or more exclusion criteria|0|||
147315659|NCT02204293|531321787|FG000|Core Study Part I|Adverse Event|1|||
147315660|NCT02204293|531321788|FG001|Core Study Part I|Adverse Event|0|||
147315661|NCT02204293|531321789|FG002|Core Study Part I|Adverse Event|0|||
147315662|NCT02204293|531321790|FG003|Core Study Part I|Adverse Event|0|||
147315663|NCT02204293|531321791|FG004|Core Study Part I|Adverse Event|0|||
147315664|NCT02204293|531321792|FG005|Core Study Part I|Adverse Event|0|||
147315665|NCT02204293|531321787|FG000|Core Study Part I|Physician Decision|0|||
147315666|NCT02204293|531321788|FG001|Core Study Part I|Physician Decision|3|||
147315667|NCT02204293|531321789|FG002|Core Study Part I|Physician Decision|0|||
147315668|NCT02204293|531321790|FG003|Core Study Part I|Physician Decision|0|||
147315669|NCT02204293|531321791|FG004|Core Study Part I|Physician Decision|0|||
147315670|NCT02204293|531321792|FG005|Core Study Part I|Physician Decision|0|||
147315671|NCT02204293|531321787|FG000|LTE Phase|Study Suspended|0|||
147315672|NCT02204293|531321788|FG001|LTE Phase|Study Suspended|0|||
147315673|NCT02204293|531321789|FG002|LTE Phase|Study Suspended|0|||
147315674|NCT02204293|531321790|FG003|LTE Phase|Study Suspended|0|||
147315675|NCT02204293|531321791|FG004|LTE Phase|Study Suspended|0|||
147315676|NCT02204293|531321792|FG005|LTE Phase|Study Suspended|7|||
147315677|NCT01225835|531321795|FG000|Overall Study|Completed protocol|2|||
147315678|NCT01225835|531321796|FG001|Overall Study|Completed protocol|1|||
147315679|NCT01225835|531321795|FG000|Overall Study|Did not meet hCG criterion|2|||
147315680|NCT01225835|531321796|FG001|Overall Study|Did not meet hCG criterion|0|||
147315681|NCT01225835|531321795|FG000|Overall Study|Adverse Event|2|||
147315682|NCT01225835|531321796|FG001|Overall Study|Adverse Event|1|||
147315683|NCT01225835|531321795|FG000|Overall Study|Other|1|||
147315684|NCT01225835|531321796|FG001|Overall Study|Other|1|||
147315685|NCT03051659|531321797|FG000|Treatment Period|Withdrawal by Subject|0|||
147315686|NCT03051659|531321798|FG001|Treatment Period|Withdrawal by Subject|2|||
147315687|NCT03051659|531321797|FG000|Survival Follow-up|Lost to Follow-up|23|||
147315688|NCT03051659|531321798|FG001|Survival Follow-up|Lost to Follow-up|22|||
147315689|NCT01266993|531321799|FG000|Booster Phase (Month 68-69)|Lost to Follow-up|5|||
147315690|NCT01266993|531321800|FG001|Booster Phase (Month 68-69)|Lost to Follow-up|1|||
147315691|NCT01266993|531321799|FG000|Booster Phase (Month 68-69)|Withdrawal by Subject|0|||
147315692|NCT01266993|531321800|FG001|Booster Phase (Month 68-69)|Withdrawal by Subject|1|||
147315693|NCT02589392|531321801|FG000|Overall Study|Adverse Event|1|||
147315694|NCT02589392|531321802|FG001|Overall Study|Adverse Event|1|||
147315695|NCT02589392|531321801|FG000|Overall Study|Withdrawal by Subject|1|||
147315696|NCT02589392|531321802|FG001|Overall Study|Withdrawal by Subject|2|||
147315697|NCT02589392|531321801|FG000|Overall Study|Protocol Violation|1|||
147315698|NCT02589392|531321802|FG001|Overall Study|Protocol Violation|1|||
147315699|NCT02589392|531321801|FG000|Overall Study|Lost to Follow-up|2|||
147315700|NCT02589392|531321802|FG001|Overall Study|Lost to Follow-up|2|||
147315701|NCT02589392|531321801|FG000|Overall Study|Sponsor decision to withdraw subject|1|||
147315702|NCT02589392|531321802|FG001|Overall Study|Sponsor decision to withdraw subject|0|||
147315703|NCT02293837|531321803|FG000|Overall Study|Lost to Follow-up|0|||
147315704|NCT02293837|531321804|FG001|Overall Study|Lost to Follow-up|2|||
147315705|NCT02293837|531321805|FG002|Overall Study|Lost to Follow-up|1|||
147315706|NCT02293837|531321806|FG003|Overall Study|Lost to Follow-up|0|||
147315707|NCT02293837|531321803|FG000|Overall Study|Withdrawal by Subject|2|||
147315708|NCT02293837|531321804|FG001|Overall Study|Withdrawal by Subject|1|||
147315709|NCT02293837|531321805|FG002|Overall Study|Withdrawal by Subject|2|||
147315710|NCT02293837|531321806|FG003|Overall Study|Withdrawal by Subject|1|||
147315711|NCT02293837|531321803|FG000|Overall Study|COVID-19 Related|1|||
147315712|NCT02293837|531321804|FG001|Overall Study|COVID-19 Related|1|||
147315713|NCT02293837|531321805|FG002|Overall Study|COVID-19 Related|0|||
147315714|NCT02293837|531321806|FG003|Overall Study|COVID-19 Related|0|||
147315715|NCT02293837|531321803|FG000|Overall Study|Participant ill and could not be infused|0|||
147315716|NCT02293837|531321804|FG001|Overall Study|Participant ill and could not be infused|0|||
147315717|NCT02293837|531321805|FG002|Overall Study|Participant ill and could not be infused|1|||
147315718|NCT02293837|531321806|FG003|Overall Study|Participant ill and could not be infused|0|||
147315719|NCT04779242|531321807|FG000|Overall Study|Adverse Event|1|||
147315720|NCT04779242|531321808|FG001|Overall Study|Adverse Event|1|||
147315721|NCT04779242|531321807|FG000|Overall Study|Lost to Follow-up|2|||
147315722|NCT04779242|531321808|FG001|Overall Study|Lost to Follow-up|4|||
147315723|NCT04779242|531321807|FG000|Overall Study|Withdrawal by Subject|7|||
147315724|NCT04779242|531321808|FG001|Overall Study|Withdrawal by Subject|9|||
147315725|NCT04779242|531321807|FG000|Overall Study|Death|6|||
147315726|NCT04779242|531321808|FG001|Overall Study|Death|6|||
147315727|NCT04779242|531321807|FG000|Overall Study|COVID-19 related reasons|2|||
147315728|NCT04779242|531321808|FG001|Overall Study|COVID-19 related reasons|1|||
147315729|NCT04779242|531321807|FG000|Overall Study|Unavailability for post therapy evaluation Visit|8|||
147315730|NCT04779242|531321808|FG001|Overall Study|Unavailability for post therapy evaluation Visit|4|||
147315731|NCT04779242|531321807|FG000|Overall Study|Martial Law in Ukraine|2|||
147315732|NCT04779242|531321808|FG001|Overall Study|Martial Law in Ukraine|3|||
147124339|NCT01687595|530620717|FG001|Overall Study|Withdrawal by Subject|0|||
147124340|NCT01687595|530620716|FG000|Overall Study|Lost to Follow-up|3|||
147124341|NCT01687595|530620717|FG001|Overall Study|Lost to Follow-up|1|||
147124342|NCT01687595|530620716|FG000|Overall Study|Investigator's decision|1|||
147124343|NCT01687595|530620717|FG001|Overall Study|Investigator's decision|0|||
147124344|NCT01687595|530620716|FG000|Overall Study|Sponsor's decision|1|||
147124345|NCT01687595|530620717|FG001|Overall Study|Sponsor's decision|0|||
147124346|NCT01687595|530620716|FG000|Overall Study|Noncompliance|1|||
147124347|NCT01687595|530620717|FG001|Overall Study|Noncompliance|2|||
147124348|NCT01687595|530620716|FG000|Overall Study|Other than specified|56|||
147124349|NCT01687595|530620717|FG001|Overall Study|Other than specified|7|||
147124350|NCT05451329|530620720|FG000|Overall Study|Adverse Event|1|||
147124351|NCT05451329|530620721|FG001|Overall Study|Adverse Event|1|||
147124352|NCT05451329|530620722|FG002|Overall Study|Adverse Event|0|||
147124353|NCT05451329|530620720|FG000|Overall Study|Withdrawal by Subject|1|||
147124354|NCT05451329|530620721|FG001|Overall Study|Withdrawal by Subject|0|||
147124355|NCT05451329|530620722|FG002|Overall Study|Withdrawal by Subject|0|||
147124356|NCT05451329|530620720|FG000|Overall Study|Investigational Product Lot exchange|1|||
147124357|NCT05451329|530620721|FG001|Overall Study|Investigational Product Lot exchange|1|||
147124358|NCT05451329|530620722|FG002|Overall Study|Investigational Product Lot exchange|0|||
147124359|NCT02100644|530620725|FG000|LTG Escalation Phase|Adverse Event|9|||
147124360|NCT02100644|530620726|FG001|LTG Escalation Phase|Adverse Event|0|||
147124361|NCT02100644|530620727|FG002|LTG Escalation Phase|Adverse Event|0|||
147124362|NCT02100644|530620725|FG000|LTG Escalation Phase|Protocol-defined Stopping Criteria|1|||
147124363|NCT02100644|530620726|FG001|LTG Escalation Phase|Protocol-defined Stopping Criteria|0|||
147124364|NCT02100644|530620727|FG002|LTG Escalation Phase|Protocol-defined Stopping Criteria|0|||
147124365|NCT02100644|530620725|FG000|LTG Escalation Phase|Withdrawal by Subject|3|||
147124366|NCT02100644|530620726|FG001|LTG Escalation Phase|Withdrawal by Subject|0|||
147124367|NCT02100644|530620727|FG002|LTG Escalation Phase|Withdrawal by Subject|0|||
147124368|NCT02852005|530620728|FG000|Overall Study|Lost to Follow-up|0|||
147124369|NCT02852005|530620729|FG001|Overall Study|Lost to Follow-up|0|||
147124370|NCT02852005|530620730|FG002|Overall Study|Lost to Follow-up|0|||
147124371|NCT02852005|530620731|FG003|Overall Study|Lost to Follow-up|0|||
147124372|NCT02852005|530620732|FG004|Overall Study|Lost to Follow-up|1|||
147124373|NCT02852005|530620728|FG000|Overall Study|Withdrawal by Subject|1|||
147124374|NCT02852005|530620729|FG001|Overall Study|Withdrawal by Subject|0|||
147124375|NCT02852005|530620730|FG002|Overall Study|Withdrawal by Subject|0|||
147124376|NCT02852005|530620731|FG003|Overall Study|Withdrawal by Subject|0|||
147124377|NCT02852005|530620732|FG004|Overall Study|Withdrawal by Subject|0|||
147124378|NCT04629521|530620733|FG000|Overall Study|Death|1|||
147124379|NCT04629521|530620733|FG000|Overall Study|Lost to Follow-up|3|||
147124380|NCT04629521|530620733|FG000|Overall Study|Subject withdrew consent|3|||
147124381|NCT04629521|530620733|FG000|Overall Study|Enrolled in error|1|||
147124382|NCT01618708|530620734|FG000|Overall Study|Adverse Event|10|||
147124383|NCT01618708|530620735|FG001|Overall Study|Adverse Event|10|||
147124384|NCT01618708|530620734|FG000|Overall Study|Lost to Follow-up|3|||
147124385|NCT01618708|530620735|FG001|Overall Study|Lost to Follow-up|3|||
147124386|NCT01618708|530620734|FG000|Overall Study|Withdrawal by Subject|17|||
147124387|NCT01618708|530620735|FG001|Overall Study|Withdrawal by Subject|22|||
147124388|NCT01618708|530620734|FG000|Overall Study|Lack of Efficacy|8|||
147124389|NCT01618708|530620735|FG001|Overall Study|Lack of Efficacy|8|||
147124390|NCT01618708|530620734|FG000|Overall Study|Technical problems|2|||
147124391|NCT01618708|530620735|FG001|Overall Study|Technical problems|0|||
147124392|NCT01618708|530620734|FG000|Overall Study|Other than specified above|1|||
147124393|NCT01618708|530620735|FG001|Overall Study|Other than specified above|1|||
147124394|NCT01618708|530620734|FG000|Overall Study|Randomized but not treated|3|||
147124395|NCT01618708|530620735|FG001|Overall Study|Randomized but not treated|2|||
147124396|NCT02369159|530620738|FG000|Overall Study|Adverse Event|0|||
147124397|NCT02369159|530620739|FG001|Overall Study|Adverse Event|1|||
147124398|NCT02369159|530620738|FG000|Overall Study|Lost to Follow-up|1|||
147124399|NCT02369159|530620739|FG001|Overall Study|Lost to Follow-up|1|||
147124400|NCT02369159|530620738|FG000|Overall Study|Withdrawal by Subject|7|||
147124401|NCT02369159|530620739|FG001|Overall Study|Withdrawal by Subject|0|||
147124402|NCT02554474|530620740|FG000|Overall Study|Protocol Violation|1|||
147124403|NCT02554474|530620741|FG001|Overall Study|Protocol Violation|1|||
147124404|NCT02554474|530620740|FG000|Overall Study|Health issue not related to the study|1|||
147124405|NCT02554474|530620741|FG001|Overall Study|Health issue not related to the study|0|||
147124406|NCT02554474|530620740|FG000|Overall Study|Withdrawal by Subject|1|||
147568971|NCT01597245|532240131|FG010|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
147124407|NCT02554474|530620741|FG001|Overall Study|Withdrawal by Subject|1|||
147124408|NCT00489476|530620747|FG000|Overall Study|Lost to Follow-up|0|||
147124409|NCT00489476|530620748|FG001|Overall Study|Lost to Follow-up|1|||
147124410|NCT00489476|530620749|FG002|Overall Study|Lost to Follow-up|0|||
147124411|NCT00489476|530620750|FG003|Overall Study|Lost to Follow-up|0|||
147124412|NCT02757963|530620759|FG000|Overall Study|Adverse Event|3|||
147124413|NCT02757963|530620759|FG000|Overall Study|Reached Stopping Criteria|1054|||
147124414|NCT02757963|530620759|FG000|Overall Study|Lost to Follow-up|5|||
147124415|NCT02757963|530620759|FG000|Overall Study|Physician Decision|1|||
147124416|NCT02757963|530620759|FG000|Overall Study|Withdrawal by Subject|34|||
147124417|NCT01887600|530620760|FG000|Overall Study|Death|39|||
147124418|NCT01887600|530620761|FG001|Overall Study|Death|16|||
147124419|NCT01887600|530620760|FG000|Overall Study|Lack of Efficacy|3|||
147124420|NCT01887600|530620761|FG001|Overall Study|Lack of Efficacy|26|||
147124421|NCT01887600|530620760|FG000|Overall Study|Lost to Follow-up|5|||
147124422|NCT01887600|530620761|FG001|Overall Study|Lost to Follow-up|1|||
147124423|NCT01887600|530620760|FG000|Overall Study|Physician Decision|7|||
147124424|NCT01887600|530620761|FG001|Overall Study|Physician Decision|8|||
147124425|NCT01887600|530620760|FG000|Overall Study|Protocol Deviation|3|||
147124426|NCT01887600|530620761|FG001|Overall Study|Protocol Deviation|0|||
147124427|NCT01887600|530620760|FG000|Overall Study|Withdrawal by Subject|58|||
147124428|NCT01887600|530620761|FG001|Overall Study|Withdrawal by Subject|52|||
147124429|NCT01887600|530620760|FG000|Overall Study|Adverse Event|21|||
147124430|NCT01887600|530620761|FG001|Overall Study|Adverse Event|9|||
147124431|NCT01887600|530620760|FG000|Overall Study|Non-compliance with study drug|3|||
147124432|NCT01887600|530620761|FG001|Overall Study|Non-compliance with study drug|0|||
147124433|NCT01887600|530620760|FG000|Overall Study|Miscellaneous|6|||
147124434|NCT01887600|530620761|FG001|Overall Study|Miscellaneous|2|||
147124435|NCT01887600|530620760|FG000|Overall Study|Progressive Disease|1|||
147124436|NCT01887600|530620761|FG001|Overall Study|Progressive Disease|0|||
147124437|NCT00962650|530620762|FG000|Overall Study|Transgastric DP was not completed|2|||
147124438|NCT00231465|530620763|FG000|Overall Study|Completed only one cycle|1|||
147124439|NCT00231465|530620763|FG000|Overall Study|Did not have follow up CT scans|1|||
147124440|NCT03624036|530620764|FG000|Overall Study|Death|2|||
147124441|NCT03624036|530620765|FG001|Overall Study|Death|3|||
147124442|NCT03624036|530620766|FG002|Overall Study|Death|0|||
147124443|NCT03624036|530620767|FG003|Overall Study|Death|1|||
147124444|NCT03624036|530620764|FG000|Overall Study|Withdrawal by Subject|1|||
147124445|NCT03624036|530620765|FG001|Overall Study|Withdrawal by Subject|0|||
147124446|NCT03624036|530620766|FG002|Overall Study|Withdrawal by Subject|1|||
147124447|NCT03624036|530620767|FG003|Overall Study|Withdrawal by Subject|0|||
147124448|NCT03624036|530620764|FG000|Overall Study|Enrolled but Never Treated|1|||
147124449|NCT03624036|530620765|FG001|Overall Study|Enrolled but Never Treated|0|||
147124450|NCT03624036|530620766|FG002|Overall Study|Enrolled but Never Treated|0|||
147124451|NCT03624036|530620767|FG003|Overall Study|Enrolled but Never Treated|0|||
147124452|NCT03624036|530620764|FG000|Overall Study|Reason not Specified|3|||
147124453|NCT03624036|530620765|FG001|Overall Study|Reason not Specified|0|||
147124454|NCT03624036|530620766|FG002|Overall Study|Reason not Specified|2|||
147124455|NCT03624036|530620767|FG003|Overall Study|Reason not Specified|2|||
147124456|NCT03478787|530620776|FG000|Overall Study|Adverse Event|5|||
147124457|NCT03478787|530620777|FG001|Overall Study|Adverse Event|1|||
147124458|NCT03478787|530620776|FG000|Overall Study|Protocol Violation|3|||
147124459|NCT03478787|530620777|FG001|Overall Study|Protocol Violation|0|||
147124460|NCT03478787|530620776|FG000|Overall Study|Lack of Efficacy|7|||
147124461|NCT03478787|530620777|FG001|Overall Study|Lack of Efficacy|1|||
147124462|NCT03478787|530620776|FG000|Overall Study|Lost to Follow-up|9|||
147124463|NCT03478787|530620777|FG001|Overall Study|Lost to Follow-up|5|||
147234059|NCT01254630|531028079|FG000|Overall Study|Withdrawal by Subject|201|||
147234060|NCT01254630|531028080|FG001|Overall Study|Withdrawal by Subject|94|||
147234061|NCT01254630|531028081|FG002|Overall Study|Withdrawal by Subject|188|||
147234062|NCT01254630|531028082|FG003|Overall Study|Withdrawal by Subject|89|||
147234063|NCT01254630|531028079|FG000|Overall Study|Study terminated by sponsor|0|||
147234064|NCT01254630|531028080|FG001|Overall Study|Study terminated by sponsor|994|||
147124464|NCT03478787|530620776|FG000|Overall Study|Withdrawal by Subject|2|||
147124465|NCT03478787|530620777|FG001|Overall Study|Withdrawal by Subject|6|||
147124466|NCT03478787|530620776|FG000|Overall Study|Other, Not Specified|3|||
147234065|NCT01254630|531028081|FG002|Overall Study|Study terminated by sponsor|0|||
147234066|NCT01254630|531028082|FG003|Overall Study|Study terminated by sponsor|1010|||
147234067|NCT01254630|531028079|FG000|Overall Study|Status not recorded|0|||
147234068|NCT01254630|531028080|FG001|Overall Study|Status not recorded|0|||
147234069|NCT01254630|531028081|FG002|Overall Study|Status not recorded|1|||
147234070|NCT01254630|531028082|FG003|Overall Study|Status not recorded|0|||
147234071|NCT00484094|531028083|FG000|Overall Study|Discontinued|39|||
147234072|NCT00484094|531028083|FG000|Overall Study|Other|3|||
147315733|NCT02087150|531321809|FG000|Overall Study|Death|0|||
147315734|NCT02087150|531321810|FG001|Overall Study|Death|1|||
147124467|NCT03478787|530620777|FG001|Overall Study|Other, Not Specified|0|||
147124468|NCT00655356|530620780|FG000|Overall Study|Withdrawal by Subject|3|||
147124469|NCT00655356|530620781|FG001|Overall Study|Withdrawal by Subject|4|||
147124470|NCT00655356|530620780|FG000|Overall Study|Sponsor Request|10|||
147124471|NCT00655356|530620781|FG001|Overall Study|Sponsor Request|4|||
147124472|NCT00655356|530620780|FG000|Overall Study|Adverse Event|1|||
147124473|NCT00655356|530620781|FG001|Overall Study|Adverse Event|1|||
147124474|NCT00655356|530620780|FG000|Overall Study|Protocol Violation|2|||
147124475|NCT00655356|530620781|FG001|Overall Study|Protocol Violation|1|||
147124476|NCT00655356|530620780|FG000|Overall Study|Other Reason|1|||
147124477|NCT00655356|530620781|FG001|Overall Study|Other Reason|0|||
147124478|NCT01044459|530620782|FG000|Overall Study|Withdrawal by Subject|21|||
147124479|NCT01044459|530620783|FG001|Overall Study|Withdrawal by Subject|28|||
147124480|NCT01044459|530620782|FG000|Overall Study|Terminated by Sponsor|22|||
147124481|NCT01044459|530620783|FG001|Overall Study|Terminated by Sponsor|21|||
147124482|NCT01044459|530620782|FG000|Overall Study|Adverse Event|22|||
147124483|NCT01044459|530620783|FG001|Overall Study|Adverse Event|20|||
147124484|NCT01044459|530620782|FG000|Overall Study|Lack of Efficacy|23|||
147124485|NCT01044459|530620783|FG001|Overall Study|Lack of Efficacy|12|||
147124486|NCT01044459|530620782|FG000|Overall Study|Protocol Violation|11|||
147651158|NCT01134263|532544596|FG004|Overall Study|Enrolled, but not treated|0|||
147124487|NCT01044459|530620783|FG001|Overall Study|Protocol Violation|16|||
147124488|NCT01044459|530620782|FG000|Overall Study|Other Reason|7|||
147124489|NCT01044459|530620783|FG001|Overall Study|Other Reason|14|||
147124490|NCT01044459|530620782|FG000|Overall Study|COPD exacerbation|9|||
147124491|NCT01044459|530620783|FG001|Overall Study|COPD exacerbation|8|||
147124492|NCT01044459|530620782|FG000|Overall Study|Lost to Follow-up|18|||
147124493|NCT01044459|530620783|FG001|Overall Study|Lost to Follow-up|12|||
147124494|NCT04105725|530620784|FG000|Primary Intervention|Lost to Follow-up|0|||
147124495|NCT04105725|530620785|FG001|Primary Intervention|Lost to Follow-up|2|||
147124496|NCT04105725|530620784|FG000|Primary Intervention|Withdrawal by Subject|0|||
147124497|NCT04105725|530620785|FG001|Primary Intervention|Withdrawal by Subject|1|||
147124498|NCT05346640|530620786|FG000|Overall Study|Lack of Efficacy|2|||
147124499|NCT05346640|530620786|FG000|Overall Study|Lost to Follow-up|14|||
147124500|NCT05346640|530620786|FG000|Overall Study|Protocol Violation|4|||
147124501|NCT05346640|530620786|FG000|Overall Study|Withdrawal by Subject|2|||
147124502|NCT05346640|530620786|FG000|Overall Study|Physiological Complications|3|||
147124503|NCT05346640|530620786|FG000|Overall Study|Other Reason|3|||
147124504|NCT04634331|530620787|FG000|Overall Study|Withdrawal by Subject|2|||
147124505|NCT04634331|530620788|FG001|Overall Study|Withdrawal by Subject|2|||
147124506|NCT05626686|530620789|FG000|Overall Study|Protocol Violation|3|||
147124507|NCT05626686|530620789|FG000|Overall Study|Withdrawal by Subject|3|||
147124508|NCT00289900|530620790|FG000|Overall Study|Adverse Event|28|||
147124509|NCT00289900|530620791|FG001|Overall Study|Adverse Event|40|||
147124510|NCT00289900|530620792|FG002|Overall Study|Adverse Event|13|||
147124511|NCT00289900|530620793|FG003|Overall Study|Adverse Event|19|||
147124512|NCT00289900|530620794|FG004|Overall Study|Adverse Event|20|||
147124513|NCT00289900|530620795|FG005|Overall Study|Adverse Event|33|||
147124514|NCT00289900|530620790|FG000|Overall Study|Lost to Follow-up|7|||
147124515|NCT00289900|530620791|FG001|Overall Study|Lost to Follow-up|7|||
147124516|NCT00289900|530620792|FG002|Overall Study|Lost to Follow-up|8|||
147124517|NCT00289900|530620793|FG003|Overall Study|Lost to Follow-up|8|||
147124518|NCT00289900|530620794|FG004|Overall Study|Lost to Follow-up|4|||
147124519|NCT00289900|530620795|FG005|Overall Study|Lost to Follow-up|8|||
147124520|NCT00289900|530620790|FG000|Overall Study|Participant had flushing|18|||
147124521|NCT00289900|530620791|FG001|Overall Study|Participant had flushing|42|||
147124522|NCT00289900|530620792|FG002|Overall Study|Participant had flushing|1|||
147124523|NCT00289900|530620793|FG003|Overall Study|Participant had flushing|2|||
147124524|NCT00289900|530620794|FG004|Overall Study|Participant had flushing|0|||
147124525|NCT00289900|530620795|FG005|Overall Study|Participant had flushing|4|||
147124526|NCT00289900|530620790|FG000|Overall Study|Other|0|||
147124527|NCT00289900|530620791|FG001|Overall Study|Other|0|||
147124528|NCT00289900|530620792|FG002|Overall Study|Other|0|||
147124529|NCT00289900|530620793|FG003|Overall Study|Other|5|||
147124530|NCT00289900|530620794|FG004|Overall Study|Other|1|||
147124531|NCT00289900|530620795|FG005|Overall Study|Other|0|||
147124532|NCT00289900|530620790|FG000|Overall Study|Participant moved|1|||
147124533|NCT00289900|530620791|FG001|Overall Study|Participant moved|0|||
147651159|NCT01557517|532544597|FG000|Overall Study|Death|1|||
147651160|NCT01557517|532544598|FG001|Overall Study|Death|0|||
147124534|NCT00289900|530620792|FG002|Overall Study|Participant moved|0|||
147124535|NCT00289900|530620793|FG003|Overall Study|Participant moved|1|||
147124536|NCT00289900|530620794|FG004|Overall Study|Participant moved|1|||
147124537|NCT00289900|530620795|FG005|Overall Study|Participant moved|1|||
147124538|NCT00289900|530620790|FG000|Overall Study|Withdrawal by Subject|10|||
147124539|NCT00289900|530620791|FG001|Overall Study|Withdrawal by Subject|21|||
147124540|NCT00289900|530620792|FG002|Overall Study|Withdrawal by Subject|8|||
147234073|NCT02612129|531028098|FG000|Single Dose Treatment Period|Screening Failure|1|||
147124541|NCT00289900|530620793|FG003|Overall Study|Withdrawal by Subject|18|||
147124542|NCT00289900|530620794|FG004|Overall Study|Withdrawal by Subject|12|||
147124543|NCT00289900|530620795|FG005|Overall Study|Withdrawal by Subject|11|||
147124544|NCT00289900|530620790|FG000|Overall Study|Protocol Violation|3|||
147234074|NCT02612129|531028099|FG001|Single Dose Treatment Period|Screening Failure|0|||
147124545|NCT00289900|530620791|FG001|Overall Study|Protocol Violation|9|||
147234075|NCT02612129|531028100|FG002|Single Dose Treatment Period|Screening Failure|0|||
147651161|NCT01557517|532544597|FG000|Overall Study|Refused further treatment|0|||
147234076|NCT02612129|531028098|FG000|Continuous Treatment Period|Early Escape|0|||
147124546|NCT00289900|530620792|FG002|Overall Study|Protocol Violation|2|||
147124547|NCT00289900|530620793|FG003|Overall Study|Protocol Violation|6|||
147124548|NCT00289900|530620794|FG004|Overall Study|Protocol Violation|7|||
147124549|NCT00289900|530620795|FG005|Overall Study|Protocol Violation|4|||
147124550|NCT00289900|530620790|FG000|Overall Study|site terminated|1|||
147124551|NCT00289900|530620791|FG001|Overall Study|site terminated|0|||
147124552|NCT00289900|530620792|FG002|Overall Study|site terminated|1|||
147124553|NCT00289900|530620793|FG003|Overall Study|site terminated|0|||
147124554|NCT00289900|530620794|FG004|Overall Study|site terminated|0|||
147124555|NCT00289900|530620795|FG005|Overall Study|site terminated|0|||
147124556|NCT00289900|530620790|FG000|Overall Study|Not treated|0|||
147124557|NCT00289900|530620791|FG001|Overall Study|Not treated|1|||
147124558|NCT00289900|530620792|FG002|Overall Study|Not treated|0|||
147124559|NCT00289900|530620793|FG003|Overall Study|Not treated|0|||
147234077|NCT02612129|531028099|FG001|Continuous Treatment Period|Early Escape|2|||
147234078|NCT02612129|531028100|FG002|Continuous Treatment Period|Early Escape|0|||
147234079|NCT02612129|531028098|FG000|Continuous Treatment Period|Participant's Parents/legal guardian have Withdrawn Informed Consent|0|||
147234080|NCT02612129|531028099|FG001|Continuous Treatment Period|Participant's Parents/legal guardian have Withdrawn Informed Consent|1|||
147234081|NCT02612129|531028100|FG002|Continuous Treatment Period|Participant's Parents/legal guardian have Withdrawn Informed Consent|0|||
147234082|NCT02612129|531028098|FG000|Continuous Treatment Period|Safety Reasons|0|||
147234083|NCT02612129|531028099|FG001|Continuous Treatment Period|Safety Reasons|3|||
147234084|NCT02612129|531028100|FG002|Continuous Treatment Period|Safety Reasons|0|||
147124560|NCT00289900|530620794|FG004|Overall Study|Not treated|0|||
147124561|NCT00289900|530620795|FG005|Overall Study|Not treated|0|||
147124562|NCT01152385|530620796|FG000|Overall Study|Withdrawal by Subject|3|||
147124563|NCT01152385|530620797|FG001|Overall Study|Withdrawal by Subject|1|||
147124564|NCT01152385|530620798|FG002|Overall Study|Withdrawal by Subject|1|||
147124565|NCT01152385|530620799|FG003|Overall Study|Withdrawal by Subject|1|||
147124566|NCT01152385|530620796|FG000|Overall Study|Protocol Violation|0|||
147124567|NCT01152385|530620797|FG001|Overall Study|Protocol Violation|0|||
147124568|NCT01152385|530620798|FG002|Overall Study|Protocol Violation|0|||
147124569|NCT01152385|530620799|FG003|Overall Study|Protocol Violation|1|||
147124570|NCT01152385|530620796|FG000|Overall Study|Adverse Event|1|||
147124571|NCT01152385|530620797|FG001|Overall Study|Adverse Event|1|||
147124572|NCT01152385|530620798|FG002|Overall Study|Adverse Event|0|||
147124573|NCT01152385|530620799|FG003|Overall Study|Adverse Event|0|||
147124574|NCT01152385|530620796|FG000|Overall Study|Study-specific withdrawal criteria|1|||
147124575|NCT01152385|530620797|FG001|Overall Study|Study-specific withdrawal criteria|1|||
147124576|NCT01152385|530620798|FG002|Overall Study|Study-specific withdrawal criteria|2|||
147124577|NCT01152385|530620799|FG003|Overall Study|Study-specific withdrawal criteria|0|||
147124578|NCT01152385|530620796|FG000|Overall Study|Other|4|||
147124579|NCT01152385|530620797|FG001|Overall Study|Other|3|||
147315735|NCT02087150|531321811|FG002|Overall Study|Death|0|||
147315736|NCT02087150|531321809|FG000|Overall Study|Lost to Follow-up|6|||
147124580|NCT01152385|530620798|FG002|Overall Study|Other|2|||
147124581|NCT01152385|530620799|FG003|Overall Study|Other|3|||
147124582|NCT02656173|530620800|FG000|Overall Study|Deviation from the Eligible Criteria|3|||
147124583|NCT02656173|530620801|FG001|Overall Study|Deviation from the Eligible Criteria|2|||
147124584|NCT02656173|530620800|FG000|Overall Study|Adverse Event|7|||
147234085|NCT02612129|531028098|FG000|Continuous Treatment Period|Death|0|||
147234086|NCT02612129|531028099|FG001|Continuous Treatment Period|Death|1|||
147234087|NCT02612129|531028100|FG002|Continuous Treatment Period|Death|0|||
147234088|NCT02612129|531028098|FG000|Continuous Treatment Period|Participant Meets Criteria for IMP Administration to be Stopped and Subsequent Withdrawal|0|||
147234089|NCT02612129|531028099|FG001|Continuous Treatment Period|Participant Meets Criteria for IMP Administration to be Stopped and Subsequent Withdrawal|0|||
147234090|NCT02612129|531028100|FG002|Continuous Treatment Period|Participant Meets Criteria for IMP Administration to be Stopped and Subsequent Withdrawal|1|||
147234091|NCT02557295|531028101|FG000|Overall Study|Withdrawal by Subject|9|||
147234092|NCT02557295|531028102|FG001|Overall Study|Withdrawal by Subject|2|||
147234093|NCT02557295|531028103|FG002|Overall Study|Withdrawal by Subject|4|||
147234094|NCT02557295|531028104|FG003|Overall Study|Withdrawal by Subject|0|||
147234095|NCT02557295|531028105|FG004|Overall Study|Withdrawal by Subject|0|||
147234096|NCT02557295|531028106|FG005|Overall Study|Withdrawal by Subject|0|||
147234097|NCT02557295|531028107|FG006|Overall Study|Withdrawal by Subject|15|||
147234098|NCT02557295|531028108|FG007|Overall Study|Withdrawal by Subject|1|||
147315737|NCT02087150|531321810|FG001|Overall Study|Lost to Follow-up|13|||
147315738|NCT02087150|531321811|FG002|Overall Study|Lost to Follow-up|7|||
147315739|NCT02087150|531321809|FG000|Overall Study|Withdrawal by Subject|2|||
147124585|NCT02656173|530620801|FG001|Overall Study|Adverse Event|5|||
147124586|NCT02656173|530620800|FG000|Overall Study|Withdrawal by Subject|1|||
147124587|NCT02656173|530620801|FG001|Overall Study|Withdrawal by Subject|3|||
147124588|NCT02656173|530620800|FG000|Overall Study|Protocol Violation|0|||
147124589|NCT02656173|530620801|FG001|Overall Study|Protocol Violation|1|||
147315740|NCT02087150|531321810|FG001|Overall Study|Withdrawal by Subject|5|||
147124590|NCT02656173|530620800|FG000|Overall Study|Miscellaneous|2|||
147124591|NCT02656173|530620801|FG001|Overall Study|Miscellaneous|0|||
147124592|NCT03449147|530620802|FG000|52-week Treatment Period|Death|0|||
147124593|NCT03449147|530620803|FG001|52-week Treatment Period|Death|1|||
147124594|NCT03449147|530620804|FG002|52-week Treatment Period|Death|0|||
147124595|NCT03449147|530620802|FG000|52-week Treatment Period|Lost to Follow-up|6|||
147124596|NCT03449147|530620803|FG001|52-week Treatment Period|Lost to Follow-up|2|||
147124597|NCT03449147|530620804|FG002|52-week Treatment Period|Lost to Follow-up|5|||
147124598|NCT03449147|530620802|FG000|52-week Treatment Period|Other|0|||
147124599|NCT03449147|530620803|FG001|52-week Treatment Period|Other|1|||
147124600|NCT03449147|530620804|FG002|52-week Treatment Period|Other|2|||
147124601|NCT03449147|530620802|FG000|52-week Treatment Period|Physician Decision|1|||
147124602|NCT03449147|530620803|FG001|52-week Treatment Period|Physician Decision|0|||
147124603|NCT03449147|530620804|FG002|52-week Treatment Period|Physician Decision|3|||
147124604|NCT03449147|530620802|FG000|52-week Treatment Period|Screen Failure|1|||
147124605|NCT03449147|530620803|FG001|52-week Treatment Period|Screen Failure|2|||
147124606|NCT03449147|530620804|FG002|52-week Treatment Period|Screen Failure|0|||
147124607|NCT03449147|530620802|FG000|52-week Treatment Period|Withdrawal by Subject|46|||
147124608|NCT03449147|530620803|FG001|52-week Treatment Period|Withdrawal by Subject|68|||
147124609|NCT03449147|530620804|FG002|52-week Treatment Period|Withdrawal by Subject|74|||
147124610|NCT03449147|530620802|FG000|12-Week Off-Treatment Durability Period|Withdrawal by Subject|1|||
147124611|NCT03449147|530620803|FG001|12-Week Off-Treatment Durability Period|Withdrawal by Subject|0|||
147124612|NCT03449147|530620804|FG002|12-Week Off-Treatment Durability Period|Withdrawal by Subject|0|||
147124613|NCT03449147|530620802|FG000|12-Week Off-Treatment Durability Period|Other|0|||
147124614|NCT03449147|530620803|FG001|12-Week Off-Treatment Durability Period|Other|1|||
147124615|NCT03449147|530620804|FG002|12-Week Off-Treatment Durability Period|Other|0|||
147124616|NCT00992394|530620805|FG000|Overall Study|Lack of Efficacy|6|||
147124617|NCT00992394|530620806|FG001|Overall Study|Lack of Efficacy|3|||
147124618|NCT00992394|530620805|FG000|Overall Study|Adverse Event|4|||
147124619|NCT00992394|530620806|FG001|Overall Study|Adverse Event|5|||
147124620|NCT00992394|530620805|FG000|Overall Study|Withdrawal by Subject|8|||
147124621|NCT00992394|530620806|FG001|Overall Study|Withdrawal by Subject|2|||
147124622|NCT00992394|530620805|FG000|Overall Study|Physician Decision|1|||
147124623|NCT00992394|530620806|FG001|Overall Study|Physician Decision|0|||
147124624|NCT00992394|530620805|FG000|Overall Study|Protocol Violation|2|||
147124625|NCT00992394|530620806|FG001|Overall Study|Protocol Violation|4|||
147124626|NCT00992394|530620805|FG000|Overall Study|Lost to Follow-up|2|||
147124627|NCT00992394|530620806|FG001|Overall Study|Lost to Follow-up|0|||
147124628|NCT00992394|530620805|FG000|Overall Study|Other event|1|||
147124629|NCT00992394|530620806|FG001|Overall Study|Other event|0|||
147124630|NCT01197300|530622124|FG000|Overall Study|Lost to Follow-up|0|||
147124631|NCT01197300|530622125|FG001|Overall Study|Lost to Follow-up|1|||
147124632|NCT01197300|530622124|FG000|Overall Study|Protocol Violation|0|||
147124633|NCT01197300|530622125|FG001|Overall Study|Protocol Violation|1|||
147124634|NCT04744831|530622126|FG000|Overall Study|Progressive Disease|31|||
147124635|NCT04744831|530622127|FG001|Overall Study|Progressive Disease|27|||
147124636|NCT04744831|530622128|FG002|Overall Study|Progressive Disease|25|||
147124637|NCT04744831|530622126|FG000|Overall Study|Adverse Event|3|||
147124638|NCT04744831|530622127|FG001|Overall Study|Adverse Event|3|||
147124639|NCT04744831|530622128|FG002|Overall Study|Adverse Event|3|||
147124640|NCT04744831|530622126|FG000|Overall Study|Clinical Progression|3|||
147124641|NCT04744831|530622127|FG001|Overall Study|Clinical Progression|2|||
147124642|NCT04744831|530622128|FG002|Overall Study|Clinical Progression|5|||
147124643|NCT04744831|530622126|FG000|Overall Study|Other|0|||
147124644|NCT04744831|530622127|FG001|Overall Study|Other|2|||
147124645|NCT04744831|530622128|FG002|Overall Study|Other|1|||
147234099|NCT02557295|531028109|FG008|Overall Study|Withdrawal by Subject|3|||
147234100|NCT02557295|531028101|FG000|Overall Study|Disease Progression|0|||
147234101|NCT02557295|531028102|FG001|Overall Study|Disease Progression|0|||
147651162|NCT01557517|532544598|FG001|Overall Study|Refused further treatment|2|||
147651163|NCT01557517|532544597|FG000|Overall Study|Adverse Event|0|||
147124646|NCT04744831|530622126|FG000|Overall Study|Death|0|||
147124647|NCT04744831|530622127|FG001|Overall Study|Death|2|||
147124648|NCT04744831|530622128|FG002|Overall Study|Death|1|||
147124649|NCT00590317|530622131|FG000|Overall Study|Lack of Efficacy|1|||
147124650|NCT00590317|530622132|FG001|Overall Study|Lack of Efficacy|5|||
147124651|NCT03443401|530622141|FG000|Overall Study|Lost to Follow-up|13|||
147124652|NCT03443401|530622141|FG000|Overall Study|Influential outlier|1|||
147124653|NCT02363283|530622142|FG000|Overall Study|Withdrawal by Subject|1|||
147124654|NCT02363283|530622142|FG000|Overall Study|Not eligible due to transaminitis|1|||
147124655|NCT01394185|530622149|FG000|Overall Study|Withdrawal by Subject|2|||
147124656|NCT01394185|530622150|FG001|Overall Study|Withdrawal by Subject|0|||
147124657|NCT01394185|530622151|FG002|Overall Study|Withdrawal by Subject|0|||
147651164|NCT01557517|532544598|FG001|Overall Study|Adverse Event|2|||
147124658|NCT01394185|530622152|FG003|Overall Study|Withdrawal by Subject|0|||
147124659|NCT01394185|530622153|FG004|Overall Study|Withdrawal by Subject|1|||
147124660|NCT01394185|530622154|FG005|Overall Study|Withdrawal by Subject|0|||
147124661|NCT01394185|530622149|FG000|Overall Study|Change in protocol|3|||
147124662|NCT01394185|530622150|FG001|Overall Study|Change in protocol|0|||
147124663|NCT01394185|530622151|FG002|Overall Study|Change in protocol|0|||
147234102|NCT02557295|531028103|FG002|Overall Study|Disease Progression|0|||
147315741|NCT02087150|531321811|FG002|Overall Study|Withdrawal by Subject|3|||
147315742|NCT02087150|531321809|FG000|Overall Study|Physician Decision|0|||
147315743|NCT02087150|531321810|FG001|Overall Study|Physician Decision|1|||
147315744|NCT02087150|531321811|FG002|Overall Study|Physician Decision|0|||
147315745|NCT02087150|531321809|FG000|Overall Study|Procedure not done|1|||
147315746|NCT02087150|531321810|FG001|Overall Study|Procedure not done|13|||
147315747|NCT02087150|531321811|FG002|Overall Study|Procedure not done|0|||
147315748|NCT02087150|531321809|FG000|Overall Study|F/U not completed w/in study window|0|||
147315749|NCT02087150|531321810|FG001|Overall Study|F/U not completed w/in study window|0|||
147315750|NCT02087150|531321811|FG002|Overall Study|F/U not completed w/in study window|1|||
147315751|NCT02087150|531321809|FG000|Overall Study|Other|1|||
147315752|NCT02087150|531321810|FG001|Overall Study|Other|0|||
147315753|NCT02087150|531321811|FG002|Overall Study|Other|0|||
147315754|NCT02087150|531321809|FG000|Overall Study|Pt moved out of town|0|||
147315755|NCT02087150|531321810|FG001|Overall Study|Pt moved out of town|1|||
147315756|NCT02087150|531321811|FG002|Overall Study|Pt moved out of town|0|||
147315757|NCT00318149|531321817|FG000|Overall Study|Adverse Event|0|||
147315758|NCT00318149|531321818|FG001|Overall Study|Adverse Event|0|||
147315759|NCT00318149|531321819|FG002|Overall Study|Adverse Event|0|||
147315760|NCT00318149|531321820|FG003|Overall Study|Adverse Event|0|||
147315761|NCT00318149|531321821|FG004|Overall Study|Adverse Event|0|||
147315762|NCT00318149|531321822|FG005|Overall Study|Adverse Event|2|||
147315763|NCT00219141|531321823|FG000|Overall Study|Adverse Event|4|||
147315764|NCT00219141|531321824|FG001|Overall Study|Adverse Event|10|||
147315765|NCT00219141|531321825|FG002|Overall Study|Adverse Event|5|||
147315766|NCT00219141|531321823|FG000|Overall Study|Lack of Efficacy|3|||
147315767|NCT00219141|531321824|FG001|Overall Study|Lack of Efficacy|2|||
147315768|NCT00219141|531321825|FG002|Overall Study|Lack of Efficacy|0|||
147315769|NCT00219141|531321823|FG000|Overall Study|Administrative problems|0|||
147315770|NCT00219141|531321824|FG001|Overall Study|Administrative problems|1|||
147315771|NCT00219141|531321825|FG002|Overall Study|Administrative problems|0|||
147315772|NCT00219141|531321823|FG000|Overall Study|Lost to Follow-up|2|||
147315773|NCT00219141|531321824|FG001|Overall Study|Lost to Follow-up|4|||
147315774|NCT00219141|531321825|FG002|Overall Study|Lost to Follow-up|1|||
147315775|NCT00219141|531321823|FG000|Overall Study|Protocol Violation|3|||
147315776|NCT00219141|531321824|FG001|Overall Study|Protocol Violation|1|||
147315777|NCT00219141|531321825|FG002|Overall Study|Protocol Violation|1|||
147315778|NCT00219141|531321823|FG000|Overall Study|Withdrawal by Subject|1|||
147315779|NCT00219141|531321824|FG001|Overall Study|Withdrawal by Subject|3|||
147315780|NCT00219141|531321825|FG002|Overall Study|Withdrawal by Subject|5|||
147315781|NCT00219141|531321823|FG000|Overall Study|Condition no longer requires study drug|1|||
147315782|NCT00219141|531321824|FG001|Overall Study|Condition no longer requires study drug|0|||
147315783|NCT00219141|531321825|FG002|Overall Study|Condition no longer requires study drug|0|||
147315784|NCT01012973|531321827|FG000|Overall Study|Adverse Event|5|||
147315785|NCT01012973|531321828|FG001|Overall Study|Adverse Event|5|||
147315786|NCT01012973|531321827|FG000|Overall Study|Lack of Efficacy|0|||
147315787|NCT01012973|531321828|FG001|Overall Study|Lack of Efficacy|5|||
147315788|NCT01012973|531321827|FG000|Overall Study|Lost to Follow-up|1|||
147315789|NCT01012973|531321828|FG001|Overall Study|Lost to Follow-up|0|||
147315790|NCT01012973|531321827|FG000|Overall Study|(Overseas travel - indefinite period)|1|||
147315791|NCT01012973|531321828|FG001|Overall Study|(Overseas travel - indefinite period)|0|||
147315792|NCT01012973|531321827|FG000|Overall Study|Increase in vis. acuity, never injected|0|||
147315793|NCT01012973|531321828|FG001|Overall Study|Increase in vis. acuity, never injected|1|||
147315794|NCT01012973|531321827|FG000|Overall Study|Protocol Violation|5|||
147315795|NCT01012973|531321828|FG001|Overall Study|Protocol Violation|2|||
147315796|NCT01012973|531321827|FG000|Overall Study|Withdrawal by Subject|4|||
147315797|NCT01012973|531321828|FG001|Overall Study|Withdrawal by Subject|6|||
147315798|NCT02061761|531321829|FG000|Overall Study|Disease progression|2|||
147315799|NCT02061761|531321830|FG001|Overall Study|Disease progression|8|||
147315800|NCT02061761|531321831|FG002|Overall Study|Disease progression|4|||
147315801|NCT02061761|531321832|FG003|Overall Study|Disease progression|5|||
147315802|NCT02061761|531321833|FG004|Overall Study|Disease progression|9|||
147315803|NCT02061761|531321834|FG005|Overall Study|Disease progression|3|||
147315804|NCT02061761|531321835|FG006|Overall Study|Disease progression|1|||
147315805|NCT02061761|531321836|FG007|Overall Study|Disease progression|2|||
147315806|NCT02061761|531321837|FG008|Overall Study|Disease progression|28|||
147315807|NCT02061761|531321829|FG000|Overall Study|Study Drug toxicity|0|||
147315808|NCT02061761|531321830|FG001|Overall Study|Study Drug toxicity|0|||
147315809|NCT02061761|531321831|FG002|Overall Study|Study Drug toxicity|0|||
147315810|NCT02061761|531321832|FG003|Overall Study|Study Drug toxicity|0|||
147315811|NCT02061761|531321833|FG004|Overall Study|Study Drug toxicity|0|||
147315812|NCT02061761|531321834|FG005|Overall Study|Study Drug toxicity|1|||
147315813|NCT02061761|531321835|FG006|Overall Study|Study Drug toxicity|0|||
147315814|NCT02061761|531321836|FG007|Overall Study|Study Drug toxicity|2|||
147315815|NCT02061761|531321837|FG008|Overall Study|Study Drug toxicity|6|||
147315816|NCT02061761|531321829|FG000|Overall Study|Adverse event unrelated to study Drug|1|||
147315817|NCT02061761|531321830|FG001|Overall Study|Adverse event unrelated to study Drug|0|||
147124664|NCT01394185|530622152|FG003|Overall Study|Change in protocol|0|||
147124665|NCT01394185|530622153|FG004|Overall Study|Change in protocol|3|||
147124666|NCT01394185|530622154|FG005|Overall Study|Change in protocol|0|||
147124667|NCT01394185|530622149|FG000|Overall Study|Protocol Violation|1|||
147124668|NCT01394185|530622150|FG001|Overall Study|Protocol Violation|0|||
147124669|NCT01394185|530622151|FG002|Overall Study|Protocol Violation|0|||
147124670|NCT01394185|530622152|FG003|Overall Study|Protocol Violation|1|||
147124671|NCT01394185|530622153|FG004|Overall Study|Protocol Violation|0|||
147124672|NCT01394185|530622154|FG005|Overall Study|Protocol Violation|1|||
147124673|NCT05401409|530622155|FG000|Overall Study|Lost to Follow-up|1|||
147124674|NCT05401409|530622156|FG001|Overall Study|Lost to Follow-up|0|||
147124675|NCT02371889|530622157|FG000|Overall Study|Adverse medication effect|11|||
147124676|NCT02371889|530622158|FG001|Overall Study|Adverse medication effect|2|||
147124677|NCT02371889|530622157|FG000|Overall Study|Lost to Follow-up|6|||
147124678|NCT02371889|530622158|FG001|Overall Study|Lost to Follow-up|5|||
147124679|NCT02371889|530622157|FG000|Overall Study|Personal time constraints|2|||
147124680|NCT02371889|530622158|FG001|Overall Study|Personal time constraints|4|||
147124681|NCT02371889|530622157|FG000|Overall Study|Lack of Efficacy|0|||
147124682|NCT02371889|530622158|FG001|Overall Study|Lack of Efficacy|2|||
147124683|NCT02371889|530622157|FG000|Overall Study|Relapse|0|||
147124684|NCT02371889|530622158|FG001|Overall Study|Relapse|1|||
147124685|NCT05520333|530622159|FG000|Overall Study|Lost to Follow-up|3|||
147124686|NCT05520333|530622160|FG001|Overall Study|Lost to Follow-up|6|||
147124687|NCT02410200|530622161|FG000|Overall Study|Adverse Event|2|||
147124688|NCT00866775|530622162|FG000|Overall Study|Adverse Event|5|||
147124689|NCT00866775|530622163|FG001|Overall Study|Adverse Event|19|||
147124690|NCT00866775|530622162|FG000|Overall Study|Death|1|||
147124691|NCT00866775|530622163|FG001|Overall Study|Death|0|||
147124692|NCT00866775|530622162|FG000|Overall Study|Lost to Follow-up|0|||
147124693|NCT00866775|530622163|FG001|Overall Study|Lost to Follow-up|4|||
147124694|NCT00866775|530622162|FG000|Overall Study|Physician Decision|0|||
147124695|NCT00866775|530622163|FG001|Overall Study|Physician Decision|3|||
147124696|NCT00866775|530622162|FG000|Overall Study|Protocol Violation|3|||
147124697|NCT00866775|530622163|FG001|Overall Study|Protocol Violation|4|||
147124698|NCT00866775|530622162|FG000|Overall Study|Withdrawal by Subject|4|||
147124699|NCT00866775|530622163|FG001|Overall Study|Withdrawal by Subject|4|||
147124700|NCT00866775|530622162|FG000|Overall Study|met exit criteria|23|||
147124701|NCT00866775|530622163|FG001|Overall Study|met exit criteria|17|||
147124702|NCT00866775|530622162|FG000|Overall Study|discontinued due to communication error|0|||
147124703|NCT00866775|530622163|FG001|Overall Study|discontinued due to communication error|1|||
147234103|NCT02557295|531028104|FG003|Overall Study|Disease Progression|0|||
147234104|NCT02557295|531028105|FG004|Overall Study|Disease Progression|0|||
147234105|NCT02557295|531028106|FG005|Overall Study|Disease Progression|0|||
147234106|NCT02557295|531028107|FG006|Overall Study|Disease Progression|1|||
147234107|NCT02557295|531028108|FG007|Overall Study|Disease Progression|0|||
147234108|NCT02557295|531028109|FG008|Overall Study|Disease Progression|0|||
147234109|NCT02557295|531028101|FG000|Overall Study|Lack of Efficacy|24|||
147234110|NCT02557295|531028102|FG001|Overall Study|Lack of Efficacy|1|||
147234111|NCT02557295|531028103|FG002|Overall Study|Lack of Efficacy|3|||
147234112|NCT02557295|531028104|FG003|Overall Study|Lack of Efficacy|0|||
147234113|NCT02557295|531028105|FG004|Overall Study|Lack of Efficacy|0|||
147234114|NCT02557295|531028106|FG005|Overall Study|Lack of Efficacy|0|||
147234115|NCT02557295|531028107|FG006|Overall Study|Lack of Efficacy|12|||
147234116|NCT02557295|531028108|FG007|Overall Study|Lack of Efficacy|1|||
147234117|NCT02557295|531028109|FG008|Overall Study|Lack of Efficacy|0|||
147234118|NCT02557295|531028101|FG000|Overall Study|Adverse Event|16|||
147234119|NCT02557295|531028102|FG001|Overall Study|Adverse Event|2|||
147234120|NCT02557295|531028103|FG002|Overall Study|Adverse Event|3|||
147234121|NCT02557295|531028104|FG003|Overall Study|Adverse Event|0|||
147234122|NCT02557295|531028105|FG004|Overall Study|Adverse Event|0|||
147234123|NCT02557295|531028106|FG005|Overall Study|Adverse Event|0|||
147234124|NCT02557295|531028107|FG006|Overall Study|Adverse Event|2|||
147234125|NCT02557295|531028108|FG007|Overall Study|Adverse Event|1|||
147234126|NCT02557295|531028109|FG008|Overall Study|Adverse Event|1|||
147124704|NCT05538728|530622164|FG000|Overall Study|Withdrawal by Subject|1|||
147124705|NCT05538728|530622165|FG001|Overall Study|Withdrawal by Subject|1|||
147124706|NCT01034657|530622166|FG000|Core Phase|Withdrawal by Subject|1|||
147124707|NCT01034657|530622167|FG001|Core Phase|Withdrawal by Subject|0|||
147234127|NCT02557295|531028101|FG000|Overall Study|Lost to Follow-up|4|||
147234128|NCT02557295|531028102|FG001|Overall Study|Lost to Follow-up|0|||
147234129|NCT02557295|531028103|FG002|Overall Study|Lost to Follow-up|0|||
147234130|NCT02557295|531028104|FG003|Overall Study|Lost to Follow-up|0|||
147234131|NCT02557295|531028105|FG004|Overall Study|Lost to Follow-up|0|||
147234132|NCT02557295|531028106|FG005|Overall Study|Lost to Follow-up|0|||
147124708|NCT01034657|530622168|FG002|Core Phase|Withdrawal by Subject|0|||
147124709|NCT01034657|530622166|FG000|Core Phase|Lack of Efficacy|2|||
147124710|NCT01034657|530622167|FG001|Core Phase|Lack of Efficacy|0|||
147124711|NCT01034657|530622168|FG002|Core Phase|Lack of Efficacy|0|||
147124712|NCT01034657|530622166|FG000|Core Phase|Abnormal laboratory value|1|||
147234133|NCT02557295|531028107|FG006|Overall Study|Lost to Follow-up|9|||
147124713|NCT01034657|530622167|FG001|Core Phase|Abnormal laboratory value|0|||
147124714|NCT01034657|530622168|FG002|Core Phase|Abnormal laboratory value|0|||
147124715|NCT01034657|530622166|FG000|Core Phase|Adverse Event|8|||
147124716|NCT01034657|530622167|FG001|Core Phase|Adverse Event|0|||
147124717|NCT01034657|530622168|FG002|Core Phase|Adverse Event|0|||
147124718|NCT01034657|530622166|FG000|Core Phase|Protocol Violation|2|||
147124719|NCT01034657|530622167|FG001|Core Phase|Protocol Violation|0|||
147124720|NCT01034657|530622168|FG002|Core Phase|Protocol Violation|0|||
147124721|NCT01034657|530622166|FG000|Randomized Phase|Withdrawal by Subject|0|||
147124722|NCT01034657|530622167|FG001|Randomized Phase|Withdrawal by Subject|2|||
147124723|NCT01034657|530622168|FG002|Randomized Phase|Withdrawal by Subject|0|||
147124724|NCT01034657|530622166|FG000|Randomized Phase|Lack of Efficacy|5|||
147124725|NCT01034657|530622167|FG001|Randomized Phase|Lack of Efficacy|1|||
147124726|NCT01034657|530622168|FG002|Randomized Phase|Lack of Efficacy|0|||
147124727|NCT01034657|530622166|FG000|Randomized Phase|Abnormal laboratory value|0|||
147124728|NCT01034657|530622167|FG001|Randomized Phase|Abnormal laboratory value|1|||
147124729|NCT01034657|530622168|FG002|Randomized Phase|Abnormal laboratory value|0|||
147124730|NCT01034657|530622166|FG000|Randomized Phase|Adverse Event|0|||
147124731|NCT01034657|530622167|FG001|Randomized Phase|Adverse Event|2|||
147124732|NCT01034657|530622168|FG002|Randomized Phase|Adverse Event|1|||
147124733|NCT00889005|530622175|FG000|Overall Study|Lost to Follow-up|4|||
147124734|NCT00889005|530622176|FG001|Overall Study|Lost to Follow-up|2|||
147124735|NCT00889005|530622175|FG000|Overall Study|Withdrawal by Subject|4|||
147124736|NCT00889005|530622176|FG001|Overall Study|Withdrawal by Subject|0|||
147124737|NCT00756314|530622182|FG000|Overall Study|Lost to Follow-up|2|||
147124738|NCT00756314|530622183|FG001|Overall Study|Lost to Follow-up|59|||
147124739|NCT02872142|530622185|FG000|Overall Study|Adverse Event|2|||
147124740|NCT02872142|530622185|FG000|Overall Study|Death|1|||
147124741|NCT02872142|530622185|FG000|Overall Study|Participant Decision|3|||
147124742|NCT02605967|530622186|FG000|Overall Study|subject / guardian decision|1|||
147124743|NCT02605967|530622187|FG001|Overall Study|subject / guardian decision|2|||
147124744|NCT02605967|530622186|FG000|Overall Study|Physician Decision|10|||
147124745|NCT02605967|530622187|FG001|Overall Study|Physician Decision|1|||
147234134|NCT02557295|531028108|FG007|Overall Study|Lost to Follow-up|0|||
147234135|NCT02557295|531028109|FG008|Overall Study|Lost to Follow-up|0|||
147234136|NCT02557295|531028101|FG000|Overall Study|Study Close|54|||
147234137|NCT02557295|531028102|FG001|Overall Study|Study Close|3|||
147234138|NCT02557295|531028103|FG002|Overall Study|Study Close|5|||
147234139|NCT02557295|531028104|FG003|Overall Study|Study Close|3|||
147234140|NCT02557295|531028105|FG004|Overall Study|Study Close|0|||
147234141|NCT02557295|531028106|FG005|Overall Study|Study Close|0|||
147234142|NCT02557295|531028107|FG006|Overall Study|Study Close|37|||
147315818|NCT02061761|531321831|FG002|Overall Study|Adverse event unrelated to study Drug|0|||
147315819|NCT02061761|531321832|FG003|Overall Study|Adverse event unrelated to study Drug|1|||
147315820|NCT02061761|531321833|FG004|Overall Study|Adverse event unrelated to study Drug|0|||
147315821|NCT02061761|531321834|FG005|Overall Study|Adverse event unrelated to study Drug|0|||
147315822|NCT02061761|531321835|FG006|Overall Study|Adverse event unrelated to study Drug|0|||
147315823|NCT02061761|531321836|FG007|Overall Study|Adverse event unrelated to study Drug|0|||
147315824|NCT02061761|531321837|FG008|Overall Study|Adverse event unrelated to study Drug|0|||
147315825|NCT02061761|531321829|FG000|Overall Study|Participant request to discontinue study treatment|0|||
147315826|NCT02061761|531321830|FG001|Overall Study|Participant request to discontinue study treatment|0|||
147315827|NCT02061761|531321831|FG002|Overall Study|Participant request to discontinue study treatment|2|||
147315828|NCT02061761|531321832|FG003|Overall Study|Participant request to discontinue study treatment|2|||
147315829|NCT02061761|531321833|FG004|Overall Study|Participant request to discontinue study treatment|0|||
147315830|NCT02061761|531321834|FG005|Overall Study|Participant request to discontinue study treatment|1|||
147315831|NCT02061761|531321835|FG006|Overall Study|Participant request to discontinue study treatment|0|||
147315832|NCT02061761|531321836|FG007|Overall Study|Participant request to discontinue study treatment|0|||
147315833|NCT02061761|531321837|FG008|Overall Study|Participant request to discontinue study treatment|2|||
147315834|NCT02061761|531321829|FG000|Overall Study|Withdrawal by Subject|0|||
147315835|NCT02061761|531321830|FG001|Overall Study|Withdrawal by Subject|0|||
147124746|NCT02605967|530622186|FG000|Overall Study|Death|4|||
147124747|NCT02605967|530622187|FG001|Overall Study|Death|2|||
147124748|NCT02605967|530622186|FG000|Overall Study|Adverse Event|1|||
147124749|NCT02605967|530622187|FG001|Overall Study|Adverse Event|0|||
147124750|NCT02605967|530622186|FG000|Overall Study|progressive disease|66|||
147124751|NCT02605967|530622187|FG001|Overall Study|progressive disease|35|||
147124752|NCT01903720|530622189|FG000|Overall Study|Inclusion / exclusion criteria not met|6|||
147124753|NCT01903720|530622189|FG000|Overall Study|Adverse Event|1|||
147124754|NCT01903720|530622189|FG000|Overall Study|Rescinding of informed consent|2|||
147124755|NCT01903720|530622189|FG000|Overall Study|Lost to Follow-up|2|||
147124756|NCT01903720|530622189|FG000|Overall Study|Treatment with alternative drug|1|||
147234143|NCT02557295|531028108|FG007|Overall Study|Study Close|3|||
147234144|NCT02557295|531028109|FG008|Overall Study|Study Close|19|||
147124757|NCT03627468|530622192|FG000|Overall Study|Adverse Event|5|||
147234145|NCT02557295|531028101|FG000|Overall Study|except for study close|4|||
147315836|NCT02061761|531321831|FG002|Overall Study|Withdrawal by Subject|0|||
147315837|NCT02061761|531321832|FG003|Overall Study|Withdrawal by Subject|0|||
147315838|NCT02061761|531321833|FG004|Overall Study|Withdrawal by Subject|0|||
147315839|NCT02061761|531321834|FG005|Overall Study|Withdrawal by Subject|0|||
147315840|NCT02061761|531321835|FG006|Overall Study|Withdrawal by Subject|0|||
147315841|NCT02061761|531321836|FG007|Overall Study|Withdrawal by Subject|0|||
147315842|NCT02061761|531321837|FG008|Overall Study|Withdrawal by Subject|2|||
147315843|NCT02061761|531321829|FG000|Overall Study|Maximum clinical benefit|0|||
147315844|NCT02061761|531321830|FG001|Overall Study|Maximum clinical benefit|0|||
147315845|NCT02061761|531321831|FG002|Overall Study|Maximum clinical benefit|0|||
147315846|NCT02061761|531321832|FG003|Overall Study|Maximum clinical benefit|1|||
147315847|NCT02061761|531321833|FG004|Overall Study|Maximum clinical benefit|0|||
147315848|NCT02061761|531321834|FG005|Overall Study|Maximum clinical benefit|0|||
147315849|NCT02061761|531321835|FG006|Overall Study|Maximum clinical benefit|0|||
147315850|NCT02061761|531321836|FG007|Overall Study|Maximum clinical benefit|0|||
147315851|NCT02061761|531321837|FG008|Overall Study|Maximum clinical benefit|6|||
147315852|NCT02061761|531321829|FG000|Overall Study|Participant no longer meets study criteria|0|||
147315853|NCT02061761|531321830|FG001|Overall Study|Participant no longer meets study criteria|0|||
147124758|NCT03627468|530622193|FG001|Overall Study|Adverse Event|33|||
147124759|NCT03627468|530622192|FG000|Overall Study|Withdrawal by Subject|13|||
147124760|NCT03627468|530622193|FG001|Overall Study|Withdrawal by Subject|23|||
147124761|NCT03627468|530622192|FG000|Overall Study|Physician Decision|1|||
147124762|NCT03627468|530622193|FG001|Overall Study|Physician Decision|0|||
147124763|NCT03627468|530622192|FG000|Overall Study|Protocol Violation|0|||
147124764|NCT03627468|530622193|FG001|Overall Study|Protocol Violation|2|||
147315854|NCT02061761|531321831|FG002|Overall Study|Participant no longer meets study criteria|0|||
147315855|NCT02061761|531321832|FG003|Overall Study|Participant no longer meets study criteria|0|||
147315856|NCT02061761|531321833|FG004|Overall Study|Participant no longer meets study criteria|0|||
147315857|NCT02061761|531321834|FG005|Overall Study|Participant no longer meets study criteria|0|||
147315858|NCT02061761|531321835|FG006|Overall Study|Participant no longer meets study criteria|0|||
147315859|NCT02061761|531321836|FG007|Overall Study|Participant no longer meets study criteria|0|||
147315860|NCT02061761|531321837|FG008|Overall Study|Participant no longer meets study criteria|1|||
147315861|NCT02061761|531321829|FG000|Overall Study|Other reasons|0|||
147315862|NCT02061761|531321830|FG001|Overall Study|Other reasons|0|||
147315863|NCT02061761|531321831|FG002|Overall Study|Other reasons|0|||
147315864|NCT02061761|531321832|FG003|Overall Study|Other reasons|0|||
147315865|NCT02061761|531321833|FG004|Overall Study|Other reasons|2|||
147315866|NCT02061761|531321834|FG005|Overall Study|Other reasons|0|||
147315867|NCT02061761|531321835|FG006|Overall Study|Other reasons|0|||
147315868|NCT02061761|531321836|FG007|Overall Study|Other reasons|0|||
147315869|NCT02061761|531321837|FG008|Overall Study|Other reasons|6|||
147315870|NCT02138747|531321843|FG000|Treatment Period 1|Adverse Event|10|||
147315871|NCT02138747|531321844|FG001|Treatment Period 1|Adverse Event|14|||
147315872|NCT02138747|531321845|FG002|Treatment Period 1|Adverse Event|2|||
147315873|NCT02138747|531321846|FG003|Treatment Period 1|Adverse Event|1|||
147315874|NCT02138747|531321843|FG000|Treatment Period 1|Lost to Follow-up|0|||
147315875|NCT02138747|531321844|FG001|Treatment Period 1|Lost to Follow-up|1|||
147315876|NCT02138747|531321845|FG002|Treatment Period 1|Lost to Follow-up|1|||
147315877|NCT02138747|531321846|FG003|Treatment Period 1|Lost to Follow-up|0|||
147315878|NCT02138747|531321843|FG000|Treatment Period 1|Protocol Violation|0|||
147315879|NCT02138747|531321844|FG001|Treatment Period 1|Protocol Violation|2|||
147315880|NCT02138747|531321845|FG002|Treatment Period 1|Protocol Violation|0|||
147315881|NCT02138747|531321846|FG003|Treatment Period 1|Protocol Violation|0|||
147315882|NCT02138747|531321843|FG000|Treatment Period 1|Withdrawal by Subject|8|||
147315883|NCT02138747|531321844|FG001|Treatment Period 1|Withdrawal by Subject|4|||
147315884|NCT02138747|531321845|FG002|Treatment Period 1|Withdrawal by Subject|1|||
147315885|NCT02138747|531321846|FG003|Treatment Period 1|Withdrawal by Subject|3|||
147315886|NCT02138747|531321843|FG000|Treatment Period 1|Other - Miscellaneous|2|||
147315887|NCT02138747|531321844|FG001|Treatment Period 1|Other - Miscellaneous|4|||
147315888|NCT02138747|531321845|FG002|Treatment Period 1|Other - Miscellaneous|0|||
147315889|NCT02138747|531321846|FG003|Treatment Period 1|Other - Miscellaneous|0|||
147315890|NCT02138747|531321843|FG000|Treatment Period 2|Adverse Event|6|||
147315891|NCT02138747|531321844|FG001|Treatment Period 2|Adverse Event|3|||
147315892|NCT02138747|531321845|FG002|Treatment Period 2|Adverse Event|1|||
147124765|NCT03627468|530622192|FG000|Overall Study|Lost to Follow-up|10|||
147315893|NCT02138747|531321846|FG003|Treatment Period 2|Adverse Event|1|||
147315894|NCT02138747|531321843|FG000|Treatment Period 2|Lost to Follow-up|2|||
147315895|NCT02138747|531321844|FG001|Treatment Period 2|Lost to Follow-up|0|||
147315896|NCT02138747|531321845|FG002|Treatment Period 2|Lost to Follow-up|0|||
147315897|NCT02138747|531321846|FG003|Treatment Period 2|Lost to Follow-up|0|||
147124766|NCT03627468|530622193|FG001|Overall Study|Lost to Follow-up|16|||
147124767|NCT03627468|530622192|FG000|Overall Study|Death|1|||
147315898|NCT02138747|531321843|FG000|Treatment Period 2|Protocol Violation|1|||
147315899|NCT02138747|531321844|FG001|Treatment Period 2|Protocol Violation|0|||
147124768|NCT03627468|530622193|FG001|Overall Study|Death|0|||
147124769|NCT03627468|530622192|FG000|Overall Study|Pregnancy|1|||
147124770|NCT03627468|530622193|FG001|Overall Study|Pregnancy|1|||
147124771|NCT03627468|530622192|FG000|Overall Study|Lack of Efficacy|0|||
147124772|NCT03627468|530622193|FG001|Overall Study|Lack of Efficacy|2|||
147124773|NCT03627468|530622192|FG000|Overall Study|Poor Compliance or Noncompliance|0|||
147124774|NCT03627468|530622193|FG001|Overall Study|Poor Compliance or Noncompliance|2|||
147124775|NCT05122143|530622194|FG000|Overall Study|Adverse Event|1|||
147124776|NCT05122143|530622195|FG001|Overall Study|Adverse Event|0|||
147124777|NCT05122143|530622196|FG002|Overall Study|Adverse Event|0|||
147124778|NCT05122143|530622197|FG003|Overall Study|Adverse Event|0|||
147124779|NCT05122143|530622198|FG004|Overall Study|Adverse Event|1|||
147124780|NCT05122143|530622199|FG005|Overall Study|Adverse Event|0|||
147124781|NCT05122143|530622194|FG000|Overall Study|Protocol non-compliance|0|||
147124782|NCT05122143|530622195|FG001|Overall Study|Protocol non-compliance|0|||
147124783|NCT05122143|530622196|FG002|Overall Study|Protocol non-compliance|1|||
147124784|NCT05122143|530622197|FG003|Overall Study|Protocol non-compliance|0|||
147124785|NCT05122143|530622198|FG004|Overall Study|Protocol non-compliance|0|||
147124786|NCT05122143|530622199|FG005|Overall Study|Protocol non-compliance|0|||
147124787|NCT05122143|530622194|FG000|Overall Study|Covid contact|0|||
147124788|NCT05122143|530622195|FG001|Overall Study|Covid contact|0|||
147124789|NCT05122143|530622196|FG002|Overall Study|Covid contact|0|||
147124790|NCT05122143|530622197|FG003|Overall Study|Covid contact|0|||
147124791|NCT05122143|530622198|FG004|Overall Study|Covid contact|1|||
147124792|NCT05122143|530622199|FG005|Overall Study|Covid contact|0|||
147124793|NCT00309946|530622200|FG000|Overall Study|Withdrawal by Subject|1|||
147124794|NCT02244957|530622201|FG000|Overall Study|Lack of Efficacy|1|||
147124795|NCT02244957|530622202|FG001|Overall Study|Lack of Efficacy|0|||
147124796|NCT00395447|530622205|FG000|Overall Study|Death|37|||
147124797|NCT00395447|530622206|FG001|Overall Study|Death|32|||
147124798|NCT00395447|530622205|FG000|Overall Study|Lost to Follow-up|52|||
147124799|NCT00395447|530622206|FG001|Overall Study|Lost to Follow-up|43|||
147124800|NCT00395447|530622205|FG000|Overall Study|Withdrawal by Subject|24|||
147124801|NCT00395447|530622206|FG001|Overall Study|Withdrawal by Subject|19|||
147124802|NCT00395447|530622205|FG000|Overall Study|Withdrawl - Other (not subject)|8|||
147124803|NCT00395447|530622206|FG001|Overall Study|Withdrawl - Other (not subject)|17|||
147124804|NCT03111108|530622208|FG000|Overall Study|Death|0|||
147124805|NCT03111108|530622209|FG001|Overall Study|Death|1|||
147124806|NCT03111108|530622208|FG000|Overall Study|Withdrawal by Subject|1|||
147124807|NCT03111108|530622209|FG001|Overall Study|Withdrawal by Subject|0|||
147315900|NCT02138747|531321845|FG002|Treatment Period 2|Protocol Violation|0|||
147315901|NCT02138747|531321846|FG003|Treatment Period 2|Protocol Violation|0|||
147315902|NCT02138747|531321843|FG000|Treatment Period 2|Withdrawal by Subject|5|||
147315903|NCT02138747|531321844|FG001|Treatment Period 2|Withdrawal by Subject|4|||
147315904|NCT02138747|531321845|FG002|Treatment Period 2|Withdrawal by Subject|1|||
147315905|NCT02138747|531321846|FG003|Treatment Period 2|Withdrawal by Subject|2|||
147315906|NCT02138747|531321843|FG000|Treatment Period 2|Other - Miscellaneous|3|||
147315907|NCT02138747|531321844|FG001|Treatment Period 2|Other - Miscellaneous|0|||
147315908|NCT02138747|531321845|FG002|Treatment Period 2|Other - Miscellaneous|0|||
147315909|NCT02138747|531321846|FG003|Treatment Period 2|Other - Miscellaneous|0|||
147315910|NCT04793464|531321850|FG000|Overall Study|Lost to Follow-up|458|||
147315911|NCT04793464|531321851|FG001|Overall Study|Lost to Follow-up|168|||
147315912|NCT04793464|531321852|FG002|Overall Study|Lost to Follow-up|5|||
147315913|NCT04793464|531321850|FG000|Overall Study|Withdrawal by Subject|43|||
147315914|NCT04793464|531321851|FG001|Overall Study|Withdrawal by Subject|15|||
147315915|NCT04793464|531321852|FG002|Overall Study|Withdrawal by Subject|0|||
147315916|NCT00903786|531321854|FG000|Overall Study|Physician Decision|6|||
147315917|NCT00903786|531321854|FG000|Overall Study|Lack of Efficacy|5|||
147315918|NCT00903786|531321854|FG000|Overall Study|Reason other than lack of efficacy|4|||
147315919|NCT00845871|531321861|FG000|Assessment Period|Adverse Event|2|||
147315920|NCT00845871|531321861|FG000|Assessment Period|Abnormal laboratory values|1|||
147315921|NCT00845871|531321861|FG000|Assessment Period|Abnormal test procedure results|1|||
147315922|NCT00845871|531321861|FG000|Assessment Period|Patient withdrew consent|3|||
147315923|NCT01857622|531321862|FG000|Overall Study|Adverse Event|5|||
147315924|NCT01857622|531321863|FG001|Overall Study|Adverse Event|0|||
147315925|NCT01857622|531321864|FG002|Overall Study|Adverse Event|2|||
147315926|NCT01857622|531321862|FG000|Overall Study|Physician Decision|1|||
147315927|NCT01857622|531321863|FG001|Overall Study|Physician Decision|0|||
147315928|NCT01857622|531321864|FG002|Overall Study|Physician Decision|0|||
147315929|NCT01857622|531321862|FG000|Overall Study|Protocol Violation|4|||
147124808|NCT01853280|530622210|FG000|Overall Study|Lack of Efficacy|2|||
147315930|NCT01857622|531321863|FG001|Overall Study|Protocol Violation|1|||
147315931|NCT01857622|531321864|FG002|Overall Study|Protocol Violation|0|||
147315932|NCT01857622|531321862|FG000|Overall Study|Withdrawal by Subject|1|||
147124809|NCT01853280|530622211|FG001|Overall Study|Lack of Efficacy|2|||
147124810|NCT01853280|530622210|FG000|Overall Study|Lost to Follow-up|0|||
147124811|NCT01853280|530622211|FG001|Overall Study|Lost to Follow-up|1|||
147124812|NCT01853280|530622210|FG000|Overall Study|Physician Decision|0|||
147124813|NCT01853280|530622211|FG001|Overall Study|Physician Decision|1|||
147124814|NCT01853280|530622210|FG000|Overall Study|Withdrawal by Subject|0|||
147124815|NCT01853280|530622211|FG001|Overall Study|Withdrawal by Subject|1|||
147124816|NCT01853280|530622210|FG000|Overall Study|Ineligible|0|||
147124817|NCT01853280|530622211|FG001|Overall Study|Ineligible|1|||
147124818|NCT00104884|530622212|FG000|Overall Study|Disease progression|4|||
147124819|NCT03032484|530622213|FG000|Overall Study Cycle 1 (C1)|Withdrawal by Subject|1|||
147124820|NCT03032484|530622214|FG001|Overall Study Cycle 1 (C1)|Withdrawal by Subject|0|||
147124821|NCT03032484|530622213|FG000|Start of Second Cycle (C2)|Withdrawal by Subject|1|||
147124822|NCT03032484|530622214|FG001|Start of Second Cycle (C2)|Withdrawal by Subject|0|||
147124823|NCT01689649|530622215|FG000|Overall Study|Lack of Efficacy|3|||
147124824|NCT01689649|530622215|FG000|Overall Study|Non-compliance|11|||
147124825|NCT01689649|530622215|FG000|Overall Study|Protocol Violation|3|||
147124826|NCT01689649|530622215|FG000|Overall Study|Lost to Follow-up|5|||
147124827|NCT03760081|530622229|FG000|Overall Study|Miscellaneous|0|||
147124828|NCT03760081|530622230|FG001|Overall Study|Miscellaneous|1|||
147124829|NCT03760081|530622229|FG000|Overall Study|Progressive Disease|5|||
147124830|NCT03760081|530622230|FG001|Overall Study|Progressive Disease|10|||
147124831|NCT03760081|530622229|FG000|Overall Study|Death|1|||
147124832|NCT03760081|530622230|FG001|Overall Study|Death|1|||
147124833|NCT04064567|530622231|FG000|Overall Study|Lost to Follow-up|23|||
147124834|NCT04064567|530622232|FG001|Overall Study|Lost to Follow-up|22|||
147124835|NCT04064567|530622231|FG000|Overall Study|Withdrawal by Subject|0|||
147124836|NCT04064567|530622232|FG001|Overall Study|Withdrawal by Subject|1|||
147124837|NCT04064567|530622231|FG000|Overall Study|Reincarcerated|7|||
147124838|NCT04064567|530622232|FG001|Overall Study|Reincarcerated|10|||
147124839|NCT04064567|530622231|FG000|Overall Study|Moved out of U.S.|0|||
147124840|NCT04064567|530622232|FG001|Overall Study|Moved out of U.S.|1|||
147124841|NCT05524948|530622235|FG000|Overall Study|Withdrawal by Subject|1|||
147124842|NCT05524948|530622236|FG001|Overall Study|Withdrawal by Subject|0|||
147124843|NCT05524948|530622235|FG000|Overall Study|Participant did not receive call or showed up for final visit|1|||
147124844|NCT05524948|530622236|FG001|Overall Study|Participant did not receive call or showed up for final visit|1|||
147124845|NCT02758626|530622239|FG000|Double-Blind Phase (Week 0 - Week 28)|Adverse Event|1|||
147124846|NCT02758626|530622240|FG001|Double-Blind Phase (Week 0 - Week 28)|Adverse Event|0|||
147124847|NCT02758626|530622239|FG000|Open-Label Extension (Week 28-Week 124)|Adverse Event|1|||
147124848|NCT02758626|530622240|FG001|Open-Label Extension (Week 28-Week 124)|Adverse Event|1|||
147124849|NCT02758626|530622239|FG000|Open-Label Extension (Week 28-Week 124)|Parental/Legal Guardian withdrawal of consent|1|||
147124850|NCT02758626|530622240|FG001|Open-Label Extension (Week 28-Week 124)|Parental/Legal Guardian withdrawal of consent|1|||
147124851|NCT02758626|530622239|FG000|Open-Label Extension (Week 28-Week 124)|Lost to Follow-up|0|||
147124852|NCT02758626|530622240|FG001|Open-Label Extension (Week 28-Week 124)|Lost to Follow-up|1|||
147124853|NCT02739828|530622241|FG000|Overall Study|Adverse Event|1|||
147124854|NCT02739828|530622241|FG000|Overall Study|Lost to Follow-up|4|||
147124855|NCT01682720|530622249|FG000|Overall Study|Randomized but Not Treated|0|||
147124856|NCT01682720|530622250|FG001|Overall Study|Randomized but Not Treated|1|||
147124857|NCT01682720|530622251|FG002|Overall Study|Randomized but Not Treated|1|||
147124858|NCT01682720|530622252|FG003|Overall Study|Randomized but Not Treated|0|||
147124859|NCT01682720|530622249|FG000|Overall Study|Terminated by Sponsor|83|||
147124860|NCT01682720|530622250|FG001|Overall Study|Terminated by Sponsor|0|||
147315933|NCT01857622|531321863|FG001|Overall Study|Withdrawal by Subject|0|||
147315934|NCT01857622|531321864|FG002|Overall Study|Withdrawal by Subject|0|||
147315935|NCT01291225|531321868|FG000|Overall Study|Lost to Follow-up|85|||
147315936|NCT01291225|531321869|FG001|Overall Study|Lost to Follow-up|39|||
147315937|NCT01267253|531321870|FG000|Overall Study|Ineligible - required test not done|1|||
147315938|NCT01267253|531321870|FG000|Overall Study|Inevaluable-never received study treatme|2|||
147315939|NCT00064025|531321871|FG000|Overall Study|Ineligible|4|||
147315940|NCT00064025|531321871|FG000|Overall Study|Inevaluable|3|||
147315941|NCT02468934|531321872|FG000|Overall Study|Withdrawal by Subject|4|||
147124861|NCT01682720|530622251|FG002|Overall Study|Terminated by Sponsor|0|||
147124862|NCT01682720|530622252|FG003|Overall Study|Terminated by Sponsor|0|||
147124863|NCT01682720|530622249|FG000|Overall Study|Efficacy Failure|0|||
147124864|NCT01682720|530622250|FG001|Overall Study|Efficacy Failure|3|||
147124865|NCT01682720|530622251|FG002|Overall Study|Efficacy Failure|3|||
147124866|NCT01682720|530622252|FG003|Overall Study|Efficacy Failure|30|||
147124867|NCT01682720|530622249|FG000|Overall Study|Lost to Follow-up|1|||
147124868|NCT01682720|530622250|FG001|Overall Study|Lost to Follow-up|1|||
147315942|NCT02468934|531321872|FG000|Overall Study|Screen Failure|3|||
147124869|NCT01682720|530622251|FG002|Overall Study|Lost to Follow-up|0|||
147124870|NCT01682720|530622252|FG003|Overall Study|Lost to Follow-up|6|||
147124871|NCT01682720|530622249|FG000|Overall Study|Subject Withdrew Consent|0|||
147124872|NCT01682720|530622250|FG001|Overall Study|Subject Withdrew Consent|0|||
147124873|NCT01682720|530622251|FG002|Overall Study|Subject Withdrew Consent|2|||
147124874|NCT01682720|530622252|FG003|Overall Study|Subject Withdrew Consent|2|||
147124875|NCT01682720|530622249|FG000|Overall Study|Adverse Event|1|||
147124876|NCT01682720|530622250|FG001|Overall Study|Adverse Event|0|||
147124877|NCT01682720|530622251|FG002|Overall Study|Adverse Event|1|||
147124878|NCT01682720|530622252|FG003|Overall Study|Adverse Event|1|||
147124879|NCT04204902|530622255|FG000|Treatment Period 2 (Day 22)|Withdrawal by Subject|0|||
147124880|NCT04204902|530622256|FG001|Treatment Period 2 (Day 22)|Withdrawal by Subject|1|||
147124881|NCT02202577|530622257|FG000|Overall Study|Lost to Follow-up|6|||
147124882|NCT02202577|530622258|FG001|Overall Study|Lost to Follow-up|16|||
147124883|NCT02202577|530622257|FG000|Overall Study|Protocol Violation|7|||
147124884|NCT02202577|530622258|FG001|Overall Study|Protocol Violation|3|||
147124885|NCT04754399|530622261|FG000|Overall Study|Adverse Event|5|||
147124886|NCT04754399|530622261|FG000|Overall Study|Withdrawal by Subject|6|||
147124887|NCT00025233|530622262|FG000|Overall Study|Ineligible: wrong cell type|1|||
147124888|NCT00025233|530622262|FG000|Overall Study|Ineligible: wrong primary|1|||
147124889|NCT00025233|530622262|FG000|Overall Study|Ineligible: improper prior treatment|1|||
147124890|NCT00025233|530622262|FG000|Overall Study|Never treated|1|||
147124891|NCT00507507|530622263|FG000|Treatment Period|Lost to Follow-up|0|||
147315943|NCT01370603|531321874|FG000|Period 1|Adverse Event|5|||
147315944|NCT01370603|531321875|FG001|Period 1|Adverse Event|3|||
147315945|NCT01370603|531321874|FG000|Period 1|Lost to Follow-up|2|||
147315946|NCT01370603|531321875|FG001|Period 1|Lost to Follow-up|0|||
147315947|NCT01370603|531321874|FG000|Period 1|Protocol Violation|2|||
147315948|NCT01370603|531321875|FG001|Period 1|Protocol Violation|2|||
147315949|NCT01370603|531321874|FG000|Period 1|Withdrawal by Subject|5|||
147315950|NCT01370603|531321875|FG001|Period 1|Withdrawal by Subject|5|||
147315951|NCT01370603|531321874|FG000|Crossover Washout|Adverse Event|2|||
147315952|NCT01370603|531321875|FG001|Crossover Washout|Adverse Event|1|||
147315953|NCT01370603|531321874|FG000|Crossover Washout|Lost to Follow-up|2|||
147315954|NCT01370603|531321875|FG001|Crossover Washout|Lost to Follow-up|0|||
147315955|NCT01370603|531321874|FG000|Crossover Washout|Protocol Violation|1|||
147315956|NCT01370603|531321875|FG001|Crossover Washout|Protocol Violation|0|||
147315957|NCT01370603|531321874|FG000|Crossover Washout|Withdrawal by Subject|4|||
147315958|NCT01370603|531321875|FG001|Crossover Washout|Withdrawal by Subject|1|||
147315959|NCT01370603|531321874|FG000|Crossover Washout|Non-compliance with Study Drug|0|||
147315960|NCT01370603|531321875|FG001|Crossover Washout|Non-compliance with Study Drug|2|||
147315961|NCT01370603|531321874|FG000|Period 2|Adverse Event|1|||
147315962|NCT01370603|531321875|FG001|Period 2|Adverse Event|4|||
147315963|NCT01370603|531321874|FG000|Period 2|Lost to Follow-up|1|||
147315964|NCT01370603|531321875|FG001|Period 2|Lost to Follow-up|0|||
147315965|NCT01370603|531321874|FG000|Period 2|Withdrawal by Subject|1|||
147315966|NCT01370603|531321875|FG001|Period 2|Withdrawal by Subject|0|||
147315967|NCT00547911|531321882|FG000|Overall Study|Adverse Event|0|||
147315968|NCT00547911|531321883|FG001|Overall Study|Adverse Event|0|||
147315969|NCT00547911|531321884|FG002|Overall Study|Adverse Event|0|||
147315970|NCT00547911|531321885|FG003|Overall Study|Adverse Event|1|||
147315971|NCT00547911|531321886|FG004|Overall Study|Adverse Event|0|||
147315972|NCT00547911|531321887|FG005|Overall Study|Adverse Event|0|||
147315973|NCT00003458|531321888|FG000|Overall Study|Not evaluable|4|||
147315974|NCT02133924|531321889|FG000|Overall Study|Death|38|||
147315975|NCT02133924|531321889|FG000|Overall Study|Physician Decision|1|||
147315976|NCT02133924|531321889|FG000|Overall Study|Withdrawal by Subject|3|||
147315977|NCT01644474|531321891|FG000|Overall Study|Poor compliance to protocol|1|||
147315978|NCT01644474|531321892|FG001|Overall Study|Poor compliance to protocol|0|||
147315979|NCT01644474|531321891|FG000|Overall Study|Consent withdrawn by participant|0|||
147315980|NCT01644474|531321892|FG001|Overall Study|Consent withdrawn by participant|1|||
147315981|NCT01644474|531321891|FG000|Overall Study|Participant moved|0|||
147315982|NCT01644474|531321892|FG001|Overall Study|Participant moved|1|||
147315983|NCT01644474|531321891|FG000|Overall Study|Adverse Event|4|||
147315984|NCT01644474|531321892|FG001|Overall Study|Adverse Event|5|||
147315985|NCT01644474|531321891|FG000|Overall Study|Site scheduling error|1|||
147124892|NCT00507507|530622264|FG001|Treatment Period|Lost to Follow-up|2|||
147124893|NCT00507507|530622263|FG000|Treatment Period|Physician Decision|4|||
147124894|NCT00507507|530622264|FG001|Treatment Period|Physician Decision|1|||
147315986|NCT01644474|531321892|FG001|Overall Study|Site scheduling error|1|||
147124895|NCT00507507|530622263|FG000|Treatment Period|Protocol Violation|1|||
147315987|NCT01644474|531321891|FG000|Overall Study|Protocol Violation|1|||
147315988|NCT01644474|531321892|FG001|Overall Study|Protocol Violation|0|||
147315989|NCT01163747|531321898|FG000|Overall Study|Adverse Event|0|||
147315990|NCT01163747|531321899|FG001|Overall Study|Adverse Event|5|||
147444646|NCT01147744|531792659|FG002|Overall Study|Withdrawal by Subject|2|||
147444647|NCT01147744|531792660|FG003|Overall Study|Withdrawal by Subject|2|||
147124896|NCT00507507|530622264|FG001|Treatment Period|Protocol Violation|2|||
147124897|NCT00507507|530622263|FG000|Treatment Period|Adverse Event|1|||
147124898|NCT00507507|530622264|FG001|Treatment Period|Adverse Event|1|||
147124899|NCT00507507|530622263|FG000|Treatment Period|Withdrawal by Subject|46|||
147315991|NCT01163747|531321898|FG000|Overall Study|Insufficient Therapeutic Response|0|||
147315992|NCT01163747|531321899|FG001|Overall Study|Insufficient Therapeutic Response|1|||
147315993|NCT01163747|531321898|FG000|Overall Study|Protocol Violation|0|||
147315994|NCT01163747|531321899|FG001|Overall Study|Protocol Violation|1|||
147315995|NCT01163747|531321898|FG000|Overall Study|Refused Treatment|6|||
147315996|NCT01163747|531321899|FG001|Overall Study|Refused Treatment|4|||
147315997|NCT01216293|531321903|FG000|Main Study|Adverse Event|1|||
147315998|NCT01216293|531321904|FG001|Main Study|Adverse Event|4|||
147315999|NCT01216293|531321905|FG002|Main Study|Adverse Event|2|||
147316000|NCT01216293|531321903|FG000|Main Study|Major Protocol Deviation|1|||
147316001|NCT01216293|531321904|FG001|Main Study|Major Protocol Deviation|0|||
147316002|NCT01216293|531321905|FG002|Main Study|Major Protocol Deviation|1|||
147316003|NCT01216293|531321903|FG000|Main Study|Lost to Follow-up|3|||
147316004|NCT01216293|531321904|FG001|Main Study|Lost to Follow-up|1|||
147316005|NCT01216293|531321905|FG002|Main Study|Lost to Follow-up|0|||
147316006|NCT01216293|531321903|FG000|Main Study|Voluntary Withdrawal|2|||
147316007|NCT01216293|531321904|FG001|Main Study|Voluntary Withdrawal|2|||
147316008|NCT01216293|531321905|FG002|Main Study|Voluntary Withdrawal|2|||
147316009|NCT01216293|531321903|FG000|Main Study|Other Reason Not Specified|0|||
147316010|NCT01216293|531321904|FG001|Main Study|Other Reason Not Specified|1|||
147316011|NCT01216293|531321905|FG002|Main Study|Other Reason Not Specified|1|||
147316012|NCT01216293|531321903|FG000|Main Study|Randomized, Not Treated|1|||
147316013|NCT01216293|531321904|FG001|Main Study|Randomized, Not Treated|0|||
147316014|NCT01216293|531321905|FG002|Main Study|Randomized, Not Treated|0|||
147316015|NCT01216293|531321903|FG000|Calcium Absorption Substudy|Adverse Event|0|||
147316016|NCT01216293|531321904|FG001|Calcium Absorption Substudy|Adverse Event|2|||
147316017|NCT01216293|531321905|FG002|Calcium Absorption Substudy|Adverse Event|0|||
147316018|NCT01216293|531321903|FG000|Calcium Absorption Substudy|Major Protocol Deviation|1|||
147316019|NCT01216293|531321904|FG001|Calcium Absorption Substudy|Major Protocol Deviation|0|||
147316020|NCT01216293|531321905|FG002|Calcium Absorption Substudy|Major Protocol Deviation|0|||
147316021|NCT01216293|531321903|FG000|Calcium Absorption Substudy|Voluntary Withdrawal|1|||
147316022|NCT01216293|531321904|FG001|Calcium Absorption Substudy|Voluntary Withdrawal|0|||
147316023|NCT01216293|531321905|FG002|Calcium Absorption Substudy|Voluntary Withdrawal|0|||
147316024|NCT00513019|531323581|FG000|Overall Study|Adverse Event|1|||
147316025|NCT00513019|531323582|FG001|Overall Study|Adverse Event|0|||
147316026|NCT00513019|531323581|FG000|Overall Study|Withdrawal by Subject|4|||
147316027|NCT00513019|531323582|FG001|Overall Study|Withdrawal by Subject|5|||
147316028|NCT01500226|531323585|FG000|Overall Study|Adverse Event|31|||
147316029|NCT01500226|531323586|FG001|Overall Study|Adverse Event|38|||
147316030|NCT01500226|531323585|FG000|Overall Study|Chemo Completed or Change in Therapy|235|||
147316031|NCT01500226|531323586|FG001|Overall Study|Chemo Completed or Change in Therapy|237|||
147316032|NCT01500226|531323585|FG000|Overall Study|Withdrawal by Subject|93|||
147316033|NCT01500226|531323586|FG001|Overall Study|Withdrawal by Subject|96|||
147316034|NCT01500226|531323585|FG000|Overall Study|Death|12|||
147316035|NCT01500226|531323586|FG001|Overall Study|Death|4|||
147316036|NCT01500226|531323585|FG000|Overall Study|Disease Progression|16|||
147316037|NCT01500226|531323586|FG001|Overall Study|Disease Progression|14|||
147316038|NCT01500226|531323585|FG000|Overall Study|Protocol Violation|53|||
147316039|NCT01500226|531323586|FG001|Overall Study|Protocol Violation|39|||
147316040|NCT01500226|531323585|FG000|Overall Study|Physician Decision|17|||
147316041|NCT01500226|531323586|FG001|Overall Study|Physician Decision|15|||
147316042|NCT01500226|531323585|FG000|Overall Study|Lack of Efficacy|14|||
147316043|NCT01500226|531323586|FG001|Overall Study|Lack of Efficacy|30|||
147316044|NCT01500226|531323585|FG000|Overall Study|Lost to Follow-up|9|||
147316045|NCT01500226|531323586|FG001|Overall Study|Lost to Follow-up|5|||
147316046|NCT01500226|531323585|FG000|Overall Study|Other Reasons|19|||
147316047|NCT01500226|531323586|FG001|Overall Study|Other Reasons|16|||
147316048|NCT02176928|531323587|FG000|Overall Study|Lost to Follow-up|2|||
147316049|NCT02176928|531323588|FG001|Overall Study|Lost to Follow-up|4|||
147316050|NCT02018861|531323596|FG000|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0|||
147316051|NCT02018861|531323597|FG001|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|2|||
147316052|NCT02018861|531323598|FG002|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|1|||
147316053|NCT02018861|531323599|FG003|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|6|||
147316054|NCT02018861|531323600|FG004|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|4|||
147316055|NCT02018861|531323601|FG005|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|1|||
147316056|NCT02018861|531323602|FG006|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0|||
147124900|NCT00507507|530622264|FG001|Treatment Period|Withdrawal by Subject|47|||
147124901|NCT00507507|530622263|FG000|24-week Treatment-free Follow-up Period|Physician Decision|1|||
147124902|NCT00507507|530622264|FG001|24-week Treatment-free Follow-up Period|Physician Decision|0|||
147124903|NCT00507507|530622263|FG000|24-week Treatment-free Follow-up Period|Adverse Event|0|||
147316057|NCT02018861|531323603|FG007|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0|||
147316058|NCT02018861|531323604|FG008|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0|||
147316059|NCT02018861|531323605|FG009|Parsaclisib Monotherapy: 21-day Cycles|Adverse Event|0|||
147316060|NCT02018861|531323596|FG000|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
147316061|NCT02018861|531323597|FG001|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
147316062|NCT02018861|531323598|FG002|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
147316063|NCT02018861|531323599|FG003|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|1|||
147316064|NCT02018861|531323600|FG004|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|1|||
147316065|NCT02018861|531323601|FG005|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
147124904|NCT00507507|530622264|FG001|24-week Treatment-free Follow-up Period|Adverse Event|1|||
147316066|NCT02018861|531323602|FG006|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
147124905|NCT00507507|530622263|FG000|24-week Treatment-free Follow-up Period|Withdrawal by Subject|9|||
147124906|NCT00507507|530622264|FG001|24-week Treatment-free Follow-up Period|Withdrawal by Subject|16|||
147124907|NCT02916433|530622265|FG000|Overall Study|Withdrawal by Subject|1|||
147124908|NCT02916433|530622266|FG001|Overall Study|Withdrawal by Subject|0|||
147124909|NCT02916433|530622265|FG000|Overall Study|Physician Decision|1|||
147124910|NCT02916433|530622266|FG001|Overall Study|Physician Decision|0|||
147124911|NCT01694771|530622268|FG000|Overall Study|Adverse Event|18|||
147124912|NCT01694771|530622269|FG001|Overall Study|Adverse Event|16|||
147124913|NCT01694771|530622268|FG000|Overall Study|Lack of Efficacy|1|||
147124914|NCT01694771|530622269|FG001|Overall Study|Lack of Efficacy|0|||
147234146|NCT02557295|531028102|FG001|Overall Study|except for study close|0|||
147234147|NCT02557295|531028103|FG002|Overall Study|except for study close|0|||
147234148|NCT02557295|531028104|FG003|Overall Study|except for study close|0|||
147234149|NCT02557295|531028105|FG004|Overall Study|except for study close|0|||
147234150|NCT02557295|531028106|FG005|Overall Study|except for study close|0|||
147234151|NCT02557295|531028107|FG006|Overall Study|except for study close|5|||
147234152|NCT02557295|531028108|FG007|Overall Study|except for study close|1|||
147234153|NCT02557295|531028109|FG008|Overall Study|except for study close|0|||
147234154|NCT03487549|531028110|FG000|Overall Study|Protocol Violation|0|||
147234155|NCT03487549|531028111|FG001|Overall Study|Protocol Violation|1|||
147234156|NCT03487549|531028110|FG000|Overall Study|Lost to Follow-up|2|||
147234157|NCT03487549|531028111|FG001|Overall Study|Lost to Follow-up|1|||
147234158|NCT03487549|531028110|FG000|Overall Study|Withdrawal by Subject|2|||
147234159|NCT03487549|531028111|FG001|Overall Study|Withdrawal by Subject|0|||
147234160|NCT01826604|531030035|FG000|Overall Study|Lost to Follow-up|8|||
147234161|NCT01826604|531030036|FG001|Overall Study|Lost to Follow-up|9|||
147234162|NCT01303861|531030042|FG000|Overall Study|Lost to Follow-up|34|||
147234163|NCT01303861|531030043|FG001|Overall Study|Lost to Follow-up|14|||
147234164|NCT01303861|531030044|FG002|Overall Study|Lost to Follow-up|27|||
147234165|NCT01303861|531030045|FG003|Overall Study|Lost to Follow-up|31|||
147234166|NCT01303861|531030042|FG000|Overall Study|Lack of Efficacy|3|||
147234167|NCT01303861|531030043|FG001|Overall Study|Lack of Efficacy|2|||
147234168|NCT01303861|531030044|FG002|Overall Study|Lack of Efficacy|1|||
147234169|NCT01303861|531030045|FG003|Overall Study|Lack of Efficacy|0|||
147234170|NCT01303861|531030042|FG000|Overall Study|Withdrawal by Subject|16|||
147234171|NCT01303861|531030043|FG001|Overall Study|Withdrawal by Subject|8|||
147234172|NCT01303861|531030044|FG002|Overall Study|Withdrawal by Subject|8|||
147234173|NCT01303861|531030045|FG003|Overall Study|Withdrawal by Subject|23|||
147234174|NCT01303861|531030042|FG000|Overall Study|Adverse Event|4|||
147234175|NCT01303861|531030043|FG001|Overall Study|Adverse Event|1|||
147234176|NCT01303861|531030044|FG002|Overall Study|Adverse Event|0|||
147234177|NCT01303861|531030045|FG003|Overall Study|Adverse Event|5|||
147234178|NCT01303861|531030042|FG000|Overall Study|Pregnancy|1|||
147234179|NCT01303861|531030043|FG001|Overall Study|Pregnancy|0|||
147234180|NCT01303861|531030044|FG002|Overall Study|Pregnancy|0|||
147234181|NCT01303861|531030045|FG003|Overall Study|Pregnancy|0|||
147234182|NCT03270644|531030057|FG000|Day 1 Lasmiditan Reference|Physician Decision|1|||
147234183|NCT03270644|531030057|FG000|Day 4 - 10 Propranolol Reference|Adverse Event|1|||
147234184|NCT01868503|531030058|FG000|Overall Study|Withdrawal by Subject|1|||
147234185|NCT01868503|531030058|FG000|Overall Study|Protocol Violation|1|||
147234186|NCT02476201|531030063|FG000|Overall Study|Unable to program MPP|9|||
147234187|NCT02476201|531030063|FG000|Overall Study|Study echo not performed|5|||
147234188|NCT02476201|531030063|FG000|Overall Study|Adverse Event|4|||
147234189|NCT02476201|531030063|FG000|Overall Study|Death|2|||
147234190|NCT02476201|531030063|FG000|Overall Study|Lost to Follow-up|2|||
147234191|NCT02476201|531030063|FG000|Overall Study|MPP programmed to OFF|2|||
147234192|NCT02476201|531030063|FG000|Overall Study|Withdrawal by Subject|1|||
147234193|NCT02476201|531030063|FG000|Overall Study|Unsuccessful implant|1|||
147234194|NCT00691301|531030064|FG000|Overall Study|Adverse Event|10|||
147234195|NCT00691301|531030064|FG000|Overall Study|Death|2|||
147234196|NCT00691301|531030064|FG000|Overall Study|Lack of Efficacy|32|||
147234197|NCT00691301|531030064|FG000|Overall Study|Withdrawal by Subject|4|||
147234198|NCT00691301|531030064|FG000|Overall Study|Concurrent illness|2|||
147124915|NCT01694771|530622268|FG000|Overall Study|Non compliance protocol|7|||
147124916|NCT01694771|530622269|FG001|Overall Study|Non compliance protocol|6|||
147234199|NCT00691301|531030064|FG000|Overall Study|other reason|3|||
147234200|NCT00691301|531030064|FG000|Overall Study|Did not initiate study treatment|1|||
147234201|NCT02642029|531030065|FG000|Washout 1 (≥ 36 Hours)|Adverse Event|1|||
147234202|NCT02642029|531030066|FG001|Washout 1 (≥ 36 Hours)|Adverse Event|0|||
147234203|NCT02642029|531030067|FG002|Washout 1 (≥ 36 Hours)|Adverse Event|0|||
147234204|NCT02642029|531030068|FG003|Washout 1 (≥ 36 Hours)|Adverse Event|0|||
147234205|NCT02642029|531030069|FG004|Washout 1 (≥ 36 Hours)|Adverse Event|0|||
147124917|NCT01694771|530622268|FG000|Overall Study|Lost to Follow-up|2|||
147234206|NCT02642029|531030070|FG005|Washout 1 (≥ 36 Hours)|Adverse Event|0|||
147234207|NCT02642029|531030065|FG000|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|0|||
147234208|NCT02642029|531030066|FG001|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|1|||
147234209|NCT02642029|531030067|FG002|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|0|||
147316067|NCT02018861|531323603|FG007|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
147124918|NCT01694771|530622269|FG001|Overall Study|Lost to Follow-up|3|||
147124919|NCT01694771|530622268|FG000|Overall Study|Consent withdrawn|7|||
147124920|NCT01694771|530622269|FG001|Overall Study|Consent withdrawn|9|||
147124921|NCT01694771|530622268|FG000|Overall Study|Other reasons|5|||
147124922|NCT01694771|530622269|FG001|Overall Study|Other reasons|6|||
147124923|NCT00974233|530622270|FG000|Induction Chemoimmunotherapy|Death|2|||
147124924|NCT00974233|530622270|FG000|Induction Chemoimmunotherapy|Lack of Efficacy|5|||
147124925|NCT00974233|530622270|FG000|Induction Chemoimmunotherapy|Adverse Event|7|||
147124926|NCT00974233|530622270|FG000|Induction Chemoimmunotherapy|Withdrawal by Subject|1|||
147124927|NCT00974233|530622270|FG000|Maintenance Lenalidomide|Lack of Efficacy|5|||
147124928|NCT00974233|530622270|FG000|Maintenance Lenalidomide|Adverse Event|8|||
147124929|NCT04616196|530623570|FG000|Overall Study|Progressive Disease|3|||
147124930|NCT04616196|530623571|FG001|Overall Study|Progressive Disease|0|||
147124931|NCT04616196|530623572|FG002|Overall Study|Progressive Disease|4|||
147124932|NCT04616196|530623573|FG003|Overall Study|Progressive Disease|1|||
147124933|NCT04616196|530623570|FG000|Overall Study|Death|2|||
147124934|NCT04616196|530623571|FG001|Overall Study|Death|4|||
147124935|NCT04616196|530623572|FG002|Overall Study|Death|1|||
147124936|NCT04616196|530623573|FG003|Overall Study|Death|0|||
147124937|NCT04616196|530623570|FG000|Overall Study|Withdrawal by Subject|0|||
147124938|NCT04616196|530623571|FG001|Overall Study|Withdrawal by Subject|2|||
147124939|NCT04616196|530623572|FG002|Overall Study|Withdrawal by Subject|0|||
147124940|NCT04616196|530623573|FG003|Overall Study|Withdrawal by Subject|0|||
147124941|NCT04616196|530623570|FG000|Overall Study|Lost to Follow-up|1|||
147124942|NCT04616196|530623571|FG001|Overall Study|Lost to Follow-up|0|||
147124943|NCT04616196|530623572|FG002|Overall Study|Lost to Follow-up|0|||
147124944|NCT04616196|530623573|FG003|Overall Study|Lost to Follow-up|0|||
147124945|NCT04616196|530623570|FG000|Overall Study|Sponsor request|2|||
147124946|NCT04616196|530623571|FG001|Overall Study|Sponsor request|1|||
147234210|NCT02642029|531030068|FG003|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|0|||
147234211|NCT02642029|531030069|FG004|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|0|||
147234212|NCT02642029|531030070|FG005|Washout 1 (≥ 36 Hours)|Withdrawal by Subject|0|||
147234213|NCT02642029|531030065|FG000|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|0|||
147234214|NCT02642029|531030066|FG001|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|0|||
147234215|NCT02642029|531030067|FG002|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|0|||
147234216|NCT02642029|531030068|FG003|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|0|||
147234217|NCT02642029|531030069|FG004|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|1|||
147234218|NCT02642029|531030070|FG005|Washout 1 (≥ 36 Hours)|Protocol violation: Excluded due to change in psychiatric medications|0|||
147234219|NCT02642029|531030065|FG000|Study Visit 2 (1 Day)|Adverse Event|1|||
147234220|NCT02642029|531030066|FG001|Study Visit 2 (1 Day)|Adverse Event|0|||
147234221|NCT02642029|531030067|FG002|Study Visit 2 (1 Day)|Adverse Event|0|||
147234222|NCT02642029|531030068|FG003|Study Visit 2 (1 Day)|Adverse Event|0|||
147234223|NCT02642029|531030069|FG004|Study Visit 2 (1 Day)|Adverse Event|0|||
147234224|NCT02642029|531030070|FG005|Study Visit 2 (1 Day)|Adverse Event|0|||
147234225|NCT02642029|531030065|FG000|Washout 2 (≥ 36 Hours)|Adverse Event|1|||
147234226|NCT02642029|531030066|FG001|Washout 2 (≥ 36 Hours)|Adverse Event|0|||
147234227|NCT02642029|531030067|FG002|Washout 2 (≥ 36 Hours)|Adverse Event|0|||
147234228|NCT02642029|531030068|FG003|Washout 2 (≥ 36 Hours)|Adverse Event|0|||
147234229|NCT02642029|531030069|FG004|Washout 2 (≥ 36 Hours)|Adverse Event|0|||
147234230|NCT02642029|531030070|FG005|Washout 2 (≥ 36 Hours)|Adverse Event|0|||
147234231|NCT02642029|531030065|FG000|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|1|||
147234232|NCT02642029|531030066|FG001|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|0|||
147234233|NCT02642029|531030067|FG002|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|0|||
147234234|NCT02642029|531030068|FG003|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|0|||
147234235|NCT02642029|531030069|FG004|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|0|||
147234236|NCT02642029|531030070|FG005|Washout 2 (≥ 36 Hours)|Excluded due to hospitalization for substance misuse|0|||
147124947|NCT04616196|530623572|FG002|Overall Study|Sponsor request|1|||
147124948|NCT04616196|530623573|FG003|Overall Study|Sponsor request|2|||
147124949|NCT06844812|530623574|FG000|Overall Study|Lost to Follow-up|5|||
147234237|NCT01823146|531030071|FG000|Overall Study|Withdrawal by Subject|0|||
147234238|NCT01823146|531030072|FG001|Overall Study|Withdrawal by Subject|1|||
147444648|NCT01147744|531792661|FG004|Overall Study|Withdrawal by Subject|2|||
147124950|NCT06844812|530623574|FG000|Overall Study|stigmatization concerns|2|||
147124951|NCT06844812|530623574|FG000|Overall Study|medication refusal|2|||
147124952|NCT06844812|530623574|FG000|Overall Study|concerns about possible side effects|2|||
147124953|NCT06844812|530623574|FG000|Overall Study|wanting to seek another specialist opinion|2|||
147124954|NCT06844812|530623574|FG000|Overall Study|side effects (dizziness)|1|||
147124955|NCT00003907|530623598|FG000|Overall Study|Adverse Event|2|||
147124956|NCT00003907|530623599|FG001|Overall Study|Adverse Event|11|||
147124957|NCT00003907|530623598|FG000|Overall Study|Death|2|||
147124958|NCT00003907|530623599|FG001|Overall Study|Death|0|||
147124959|NCT00003907|530623598|FG000|Overall Study|Withdrawal by Subject|1|||
147124960|NCT00003907|530623599|FG001|Overall Study|Withdrawal by Subject|3|||
147316068|NCT02018861|531323604|FG008|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
147124961|NCT00003907|530623598|FG000|Overall Study|Progressive disease|4|||
147124962|NCT00003907|530623599|FG001|Overall Study|Progressive disease|4|||
147124963|NCT00003907|530623598|FG000|Overall Study|Complicating disease|1|||
147124964|NCT00003907|530623599|FG001|Overall Study|Complicating disease|0|||
147124965|NCT00003907|530623598|FG000|Overall Study|Other|1|||
147124966|NCT00003907|530623599|FG001|Overall Study|Other|3|||
147124967|NCT00003907|530623598|FG000|Overall Study|ineligible or not treated|2|||
147124968|NCT00003907|530623599|FG001|Overall Study|ineligible or not treated|2|||
147124969|NCT02336555|530623600|FG000|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
147124970|NCT02336555|530623601|FG001|Treatment Period 1 (28 Days)|Withdrawal by Subject|1|||
147124971|NCT02336555|530623600|FG000|Treatment Period 1 (28 Days)|Physician Decision|2|||
147124972|NCT02336555|530623601|FG001|Treatment Period 1 (28 Days)|Physician Decision|0|||
147124973|NCT02336555|530623600|FG000|Treatment Period 2 (28 Days)|Adverse Event|0|||
147124974|NCT02336555|530623601|FG001|Treatment Period 2 (28 Days)|Adverse Event|1|||
147124975|NCT00993473|530623602|FG000|Overall Study|Adverse Event|0|||
147124976|NCT00993473|530623603|FG001|Overall Study|Adverse Event|2|||
147124977|NCT00993473|530623602|FG000|Overall Study|Protocol Violation|1|||
147124978|NCT00993473|530623603|FG001|Overall Study|Protocol Violation|2|||
147124979|NCT00993473|530623602|FG000|Overall Study|Lost to Follow-up|1|||
147124980|NCT00993473|530623603|FG001|Overall Study|Lost to Follow-up|0|||
147124981|NCT00993473|530623602|FG000|Overall Study|Withdrawal by Subject|1|||
147124982|NCT00993473|530623603|FG001|Overall Study|Withdrawal by Subject|5|||
147124983|NCT00993473|530623602|FG000|Overall Study|Technical problem with CGM device|0|||
147124984|NCT00993473|530623603|FG001|Overall Study|Technical problem with CGM device|1|||
147124985|NCT00993473|530623602|FG000|Overall Study|Family event|1|||
147124986|NCT00993473|530623603|FG001|Overall Study|Family event|0|||
147124987|NCT03682367|530623612|FG000|Overall Study|Protocol Violation|2|||
147124988|NCT03682367|530623613|FG001|Overall Study|Protocol Violation|1|||
147124989|NCT03682367|530623612|FG000|Overall Study|Closed Study Early|0|||
147124990|NCT03682367|530623613|FG001|Overall Study|Closed Study Early|3|||
147124991|NCT04157738|530623614|FG000|Overall Study|Moved out of state|0|||
147124992|NCT04157738|530623615|FG001|Overall Study|Moved out of state|2|||
147124993|NCT04157738|530623614|FG000|Overall Study|Did not show up to the Follow-up appointment|1|||
147124994|NCT04157738|530623615|FG001|Overall Study|Did not show up to the Follow-up appointment|0|||
147124995|NCT00160563|530623616|FG000|Overall Study|Adverse Event|1|||
147124996|NCT00160563|530623617|FG001|Overall Study|Adverse Event|1|||
147316069|NCT02018861|531323605|FG009|Parsaclisib Monotherapy: 21-day Cycles|Withdrawal by Subject|0|||
147234239|NCT01823146|531030071|FG000|Overall Study|Lost to Follow-up|2|||
147234240|NCT01823146|531030072|FG001|Overall Study|Lost to Follow-up|1|||
147234241|NCT00463580|531030074|FG000|Overall Study|Lost to Follow-up|1|||
147234242|NCT00463580|531030075|FG001|Overall Study|Lost to Follow-up|0|||
147234243|NCT00463580|531030074|FG000|Overall Study|Schedule conflict|2|||
147234244|NCT00463580|531030075|FG001|Overall Study|Schedule conflict|0|||
147234245|NCT00463580|531030074|FG000|Overall Study|Medical/psychiatric complications|0|||
147234246|NCT00463580|531030075|FG001|Overall Study|Medical/psychiatric complications|2|||
147234247|NCT03917459|531030076|FG000|Overall Study|Adverse Event|1|||
147234248|NCT03917459|531030077|FG001|Overall Study|Adverse Event|0|||
147234249|NCT03917459|531030076|FG000|Overall Study|Withdrawal by Subject|0|||
147234250|NCT03917459|531030077|FG001|Overall Study|Withdrawal by Subject|1|||
147234251|NCT00736944|531030078|FG000|Induction|Death|1|||
147234252|NCT00736944|531030078|FG000|Definitive Treatment|Physician Decision|1|||
147234253|NCT00676338|531030079|FG000|Overall Study|Adverse Event|6|||
147234254|NCT00676338|531030080|FG001|Overall Study|Adverse Event|6|||
147234255|NCT00676338|531030081|FG002|Overall Study|Adverse Event|5|||
147234256|NCT00676338|531030082|FG003|Overall Study|Adverse Event|1|||
147234257|NCT00676338|531030079|FG000|Overall Study|Lost to Follow-up|4|||
147316070|NCT02018861|531323596|FG000|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0|||
147316071|NCT02018861|531323597|FG001|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|1|||
147124997|NCT00160563|530623618|FG002|Overall Study|Adverse Event|1|||
147124998|NCT00160563|530623616|FG000|Overall Study|Lost to Follow-up|1|||
147234258|NCT00676338|531030080|FG001|Overall Study|Lost to Follow-up|1|||
147124999|NCT00160563|530623617|FG001|Overall Study|Lost to Follow-up|1|||
147234259|NCT00676338|531030081|FG002|Overall Study|Lost to Follow-up|3|||
147234260|NCT00676338|531030082|FG003|Overall Study|Lost to Follow-up|4|||
147234261|NCT00676338|531030079|FG000|Overall Study|Physician Decision|3|||
147444649|NCT01147744|531792662|FG005|Overall Study|Withdrawal by Subject|5|||
147234262|NCT00676338|531030080|FG001|Overall Study|Physician Decision|3|||
147125000|NCT00160563|530623618|FG002|Overall Study|Lost to Follow-up|2|||
147125001|NCT00160563|530623616|FG000|Overall Study|Protocol Violation|0|||
147125002|NCT00160563|530623617|FG001|Overall Study|Protocol Violation|0|||
147125003|NCT00160563|530623618|FG002|Overall Study|Protocol Violation|3|||
147125004|NCT00160563|530623616|FG000|Overall Study|Withdrawal by Subject|1|||
147125005|NCT00160563|530623617|FG001|Overall Study|Withdrawal by Subject|2|||
147125006|NCT00160563|530623618|FG002|Overall Study|Withdrawal by Subject|3|||
147125007|NCT00160563|530623616|FG000|Overall Study|Other (listed in the study report)|48|||
147125008|NCT00160563|530623617|FG001|Overall Study|Other (listed in the study report)|40|||
147125009|NCT00160563|530623618|FG002|Overall Study|Other (listed in the study report)|81|||
147125010|NCT00160563|530623616|FG000|Overall Study|Missing reason|0|||
147316072|NCT02018861|531323598|FG002|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|1|||
147316073|NCT02018861|531323599|FG003|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|13|||
147316074|NCT02018861|531323600|FG004|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|18|||
147316075|NCT02018861|531323601|FG005|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|1|||
147316076|NCT02018861|531323602|FG006|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0|||
147316077|NCT02018861|531323603|FG007|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0|||
147316078|NCT02018861|531323604|FG008|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0|||
147125011|NCT00160563|530623617|FG001|Overall Study|Missing reason|1|||
147125012|NCT00160563|530623618|FG002|Overall Study|Missing reason|0|||
147125013|NCT03766906|530623623|FG000|Overall Study|Withdrawal by Subject|6|||
147125014|NCT01514357|530623624|FG000|Overall Study|Screen failure|2|||
147125015|NCT01514357|530623625|FG001|Overall Study|Screen failure|0|||
147125016|NCT01514357|530623624|FG000|Overall Study|Withdrawal by Subject|2|||
147125017|NCT01514357|530623625|FG001|Overall Study|Withdrawal by Subject|0|||
147125018|NCT00752219|530623626|FG000|Overall Study|Clinical failure|0|||
147125019|NCT00752219|530623627|FG001|Overall Study|Clinical failure|1|||
147125020|NCT00752219|530623626|FG000|Overall Study|Adverse Event|5|||
147125021|NCT00752219|530623627|FG001|Overall Study|Adverse Event|3|||
147125022|NCT00752219|530623626|FG000|Overall Study|Protocol deviation|1|||
147125023|NCT00752219|530623627|FG001|Overall Study|Protocol deviation|0|||
147234263|NCT00676338|531030081|FG002|Overall Study|Physician Decision|2|||
147234264|NCT00676338|531030082|FG003|Overall Study|Physician Decision|3|||
147234265|NCT00676338|531030079|FG000|Overall Study|Protocol Violation|5|||
147234266|NCT00676338|531030080|FG001|Overall Study|Protocol Violation|9|||
147234267|NCT00676338|531030081|FG002|Overall Study|Protocol Violation|2|||
147125024|NCT00752219|530623626|FG000|Overall Study|Lost to Follow-up|1|||
147234268|NCT00676338|531030082|FG003|Overall Study|Protocol Violation|5|||
147234269|NCT00676338|531030079|FG000|Overall Study|Withdrawal by Subject|17|||
147234270|NCT00676338|531030080|FG001|Overall Study|Withdrawal by Subject|9|||
147234271|NCT00676338|531030081|FG002|Overall Study|Withdrawal by Subject|12|||
147234272|NCT00676338|531030082|FG003|Overall Study|Withdrawal by Subject|6|||
147234273|NCT00676338|531030079|FG000|Overall Study|Entry Criteria Not Met|0|||
147234274|NCT00676338|531030080|FG001|Overall Study|Entry Criteria Not Met|2|||
147234275|NCT00676338|531030081|FG002|Overall Study|Entry Criteria Not Met|1|||
147234276|NCT00676338|531030082|FG003|Overall Study|Entry Criteria Not Met|1|||
147234277|NCT00676338|531030079|FG000|Overall Study|Lack of Efficacy-Loss of Glucose Control|3|||
147234278|NCT00676338|531030080|FG001|Overall Study|Lack of Efficacy-Loss of Glucose Control|3|||
147234279|NCT00676338|531030081|FG002|Overall Study|Lack of Efficacy-Loss of Glucose Control|5|||
147234280|NCT00676338|531030082|FG003|Overall Study|Lack of Efficacy-Loss of Glucose Control|3|||
147234281|NCT00412542|531030083|FG000|Overall Study|Withdrawal by Subject|0|||
147234282|NCT00412542|531030084|FG001|Overall Study|Withdrawal by Subject|2|||
147234283|NCT00412542|531030083|FG000|Overall Study|Not Eligible|0|||
147234284|NCT00412542|531030084|FG001|Overall Study|Not Eligible|1|||
147234285|NCT03643575|531030087|FG000|Washout: 7 Days|Withdrew consent due to illness|0|||
147234286|NCT03643575|531030088|FG001|Washout: 7 Days|Withdrew consent due to illness|0|||
147234287|NCT03643575|531030089|FG002|Washout: 7 Days|Withdrew consent due to illness|0|||
147234288|NCT03643575|531030090|FG003|Washout: 7 Days|Withdrew consent due to illness|1|||
147234289|NCT03643575|531030091|FG004|Washout: 7 Days|Withdrew consent due to illness|0|||
147234290|NCT03643575|531030092|FG005|Washout: 7 Days|Withdrew consent due to illness|0|||
147234291|NCT03643575|531030087|FG000|Washout: 7 Days|Adverse Event|1|||
147234292|NCT03643575|531030088|FG001|Washout: 7 Days|Adverse Event|0|||
147234293|NCT03643575|531030089|FG002|Washout: 7 Days|Adverse Event|0|||
147234294|NCT03643575|531030090|FG003|Washout: 7 Days|Adverse Event|0|||
147234295|NCT03643575|531030091|FG004|Washout: 7 Days|Adverse Event|0|||
147234296|NCT03643575|531030092|FG005|Washout: 7 Days|Adverse Event|0|||
147234297|NCT03643575|531030087|FG000|Washout: 7 Days|Non compliance check in|0|||
147316079|NCT02018861|531323605|FG009|Parsaclisib Monotherapy: 21-day Cycles|Disease Progression|0|||
147444650|NCT01147744|531792663|FG006|Overall Study|Withdrawal by Subject|2|||
147234298|NCT03643575|531030088|FG001|Washout: 7 Days|Non compliance check in|1|||
147234299|NCT03643575|531030089|FG002|Washout: 7 Days|Non compliance check in|0|||
147234300|NCT03643575|531030090|FG003|Washout: 7 Days|Non compliance check in|0|||
147234301|NCT03643575|531030091|FG004|Washout: 7 Days|Non compliance check in|0|||
147234302|NCT03643575|531030092|FG005|Washout: 7 Days|Non compliance check in|0|||
147234303|NCT01189604|531030093|FG000|Overall Study|Impossible to visit|0|||
147234304|NCT01189604|531030094|FG001|Overall Study|Impossible to visit|0|||
147234305|NCT01189604|531030095|FG002|Overall Study|Impossible to visit|0|||
147125025|NCT00752219|530623627|FG001|Overall Study|Lost to Follow-up|2|||
147125026|NCT00752219|530623626|FG000|Overall Study|Randomized but not treated|1|||
147444651|NCT01147744|531792657|FG000|Overall Study|Lost to Follow-up|0|||
147234306|NCT01189604|531030096|FG003|Overall Study|Impossible to visit|0|||
147234307|NCT01189604|531030097|FG004|Overall Study|Impossible to visit|0|||
147234308|NCT01189604|531030098|FG005|Overall Study|Impossible to visit|1|||
147234309|NCT01189604|531030099|FG006|Overall Study|Impossible to visit|0|||
147234310|NCT01189604|531030093|FG000|Overall Study|Adverse Event|0|||
147234311|NCT01189604|531030094|FG001|Overall Study|Adverse Event|1|||
147234312|NCT01189604|531030095|FG002|Overall Study|Adverse Event|0|||
147234313|NCT01189604|531030096|FG003|Overall Study|Adverse Event|0|||
147234314|NCT01189604|531030097|FG004|Overall Study|Adverse Event|2|||
147234315|NCT01189604|531030098|FG005|Overall Study|Adverse Event|0|||
147234316|NCT01189604|531030099|FG006|Overall Study|Adverse Event|1|||
147234317|NCT01189604|531030093|FG000|Overall Study|Withdrawal by Subject|1|||
147234318|NCT01189604|531030094|FG001|Overall Study|Withdrawal by Subject|0|||
147234319|NCT01189604|531030095|FG002|Overall Study|Withdrawal by Subject|0|||
147234320|NCT01189604|531030096|FG003|Overall Study|Withdrawal by Subject|0|||
147234321|NCT01189604|531030097|FG004|Overall Study|Withdrawal by Subject|0|||
147234322|NCT01189604|531030098|FG005|Overall Study|Withdrawal by Subject|0|||
147234323|NCT01189604|531030099|FG006|Overall Study|Withdrawal by Subject|0|||
147234324|NCT03626168|531030100|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
147234325|NCT03626168|531030101|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|0|||
147234326|NCT03626168|531030100|FG000|First Intervention (4 Weeks)|Began a medication that precluded participation|0|||
147234327|NCT03626168|531030101|FG001|First Intervention (4 Weeks)|Began a medication that precluded participation|1|||
147234328|NCT03626168|531030100|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
147234329|NCT03626168|531030101|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|2|||
147234330|NCT02357979|531030102|FG000|Overall Study|Lost to Follow-up|5|||
147234331|NCT02357979|531030103|FG001|Overall Study|Lost to Follow-up|5|||
147234332|NCT05047770|531030104|FG000|Overall Study|Withdrawal by Subject|15|||
147234333|NCT05047770|531030105|FG001|Overall Study|Withdrawal by Subject|10|||
147234334|NCT05047770|531030106|FG002|Overall Study|Withdrawal by Subject|6|||
147234335|NCT05047770|531030107|FG003|Overall Study|Withdrawal by Subject|12|||
147234336|NCT05047770|531030104|FG000|Overall Study|Lost to Follow-up|7|||
147234337|NCT05047770|531030105|FG001|Overall Study|Lost to Follow-up|5|||
147234338|NCT05047770|531030106|FG002|Overall Study|Lost to Follow-up|12|||
147234339|NCT05047770|531030107|FG003|Overall Study|Lost to Follow-up|13|||
147234340|NCT05047770|531030104|FG000|Overall Study|Other|1|||
147234341|NCT05047770|531030105|FG001|Overall Study|Other|0|||
147234342|NCT05047770|531030106|FG002|Overall Study|Other|1|||
147234343|NCT05047770|531030107|FG003|Overall Study|Other|0|||
147234344|NCT03758443|531030108|FG000|Induction Period|Adverse Event|2|||
147234345|NCT03758443|531030109|FG001|Induction Period|Adverse Event|4|||
147234346|NCT03758443|531030110|FG002|Induction Period|Adverse Event|2|||
147234347|NCT03758443|531030111|FG003|Induction Period|Adverse Event|3|||
147234348|NCT03758443|531030108|FG000|Induction Period|Physician Decision|1|||
147234349|NCT03758443|531030109|FG001|Induction Period|Physician Decision|1|||
147234350|NCT03758443|531030110|FG002|Induction Period|Physician Decision|3|||
147234351|NCT03758443|531030111|FG003|Induction Period|Physician Decision|0|||
147234352|NCT03758443|531030108|FG000|Induction Period|Protocol Violation|0|||
147234353|NCT03758443|531030109|FG001|Induction Period|Protocol Violation|0|||
147234354|NCT03758443|531030110|FG002|Induction Period|Protocol Violation|0|||
147234355|NCT03758443|531030111|FG003|Induction Period|Protocol Violation|1|||
147234356|NCT03758443|531030108|FG000|Induction Period|Withdrawal by Subject|3|||
147234357|NCT03758443|531030109|FG001|Induction Period|Withdrawal by Subject|2|||
147234358|NCT03758443|531030110|FG002|Induction Period|Withdrawal by Subject|2|||
147234359|NCT03758443|531030111|FG003|Induction Period|Withdrawal by Subject|4|||
147234360|NCT03758443|531030108|FG000|Extended Induction Period|Adverse Event|1|||
147234361|NCT03758443|531030109|FG001|Extended Induction Period|Adverse Event|1|||
147234362|NCT03758443|531030110|FG002|Extended Induction Period|Adverse Event|0|||
147234363|NCT03758443|531030111|FG003|Extended Induction Period|Adverse Event|1|||
147234364|NCT03758443|531030108|FG000|Extended Induction Period|Lost to Follow-up|1|||
147234365|NCT03758443|531030109|FG001|Extended Induction Period|Lost to Follow-up|0|||
147234366|NCT03758443|531030110|FG002|Extended Induction Period|Lost to Follow-up|0|||
147234367|NCT03758443|531030111|FG003|Extended Induction Period|Lost to Follow-up|0|||
147234368|NCT03758443|531030108|FG000|Extended Induction Period|Physician Decision|2|||
147234369|NCT03758443|531030109|FG001|Extended Induction Period|Physician Decision|1|||
147234370|NCT03758443|531030110|FG002|Extended Induction Period|Physician Decision|2|||
147234371|NCT03758443|531030111|FG003|Extended Induction Period|Physician Decision|2|||
147234372|NCT03758443|531030108|FG000|Extended Induction Period|Protocol Violation|0|||
147234373|NCT03758443|531030109|FG001|Extended Induction Period|Protocol Violation|0|||
147234374|NCT03758443|531030110|FG002|Extended Induction Period|Protocol Violation|0|||
147234375|NCT03758443|531030111|FG003|Extended Induction Period|Protocol Violation|1|||
147234376|NCT03758443|531030108|FG000|Extended Induction Period|Withdrawal by Subject|8|||
147234377|NCT03758443|531030109|FG001|Extended Induction Period|Withdrawal by Subject|1|||
147234378|NCT03758443|531030110|FG002|Extended Induction Period|Withdrawal by Subject|7|||
147234379|NCT03758443|531030111|FG003|Extended Induction Period|Withdrawal by Subject|3|||
147125027|NCT00752219|530623627|FG001|Overall Study|Randomized but not treated|0|||
147125028|NCT00752219|530623626|FG000|Overall Study|Other|3|||
147125029|NCT00752219|530623627|FG001|Overall Study|Other|0|||
147125030|NCT04691115|530623630|FG000|Overall Study|Withdrawal by Subject|0|||
147125031|NCT04691115|530623631|FG001|Overall Study|Withdrawal by Subject|0|||
147234380|NCT03758443|531030108|FG000|Extended Induction Period|Miscellaneous|1|||
147234381|NCT03758443|531030109|FG001|Extended Induction Period|Miscellaneous|0|||
147234382|NCT03758443|531030110|FG002|Extended Induction Period|Miscellaneous|0|||
147234383|NCT03758443|531030111|FG003|Extended Induction Period|Miscellaneous|0|||
147444652|NCT01147744|531792658|FG001|Overall Study|Lost to Follow-up|1|||
147125032|NCT04691115|530623632|FG002|Overall Study|Withdrawal by Subject|0|||
147125033|NCT04691115|530623633|FG003|Overall Study|Withdrawal by Subject|0|||
147125034|NCT04691115|530623634|FG004|Overall Study|Withdrawal by Subject|0|||
147125035|NCT04691115|530623635|FG005|Overall Study|Withdrawal by Subject|1|||
147125036|NCT04691115|530623636|FG006|Overall Study|Withdrawal by Subject|0|||
147125037|NCT04691115|530623637|FG007|Overall Study|Withdrawal by Subject|0|||
147125038|NCT04691115|530623638|FG008|Overall Study|Withdrawal by Subject|0|||
147125039|NCT04691115|530623639|FG009|Overall Study|Withdrawal by Subject|0|||
147125040|NCT04691115|530623640|FG010|Overall Study|Withdrawal by Subject|0|||
147125041|NCT04691115|530623641|FG011|Overall Study|Withdrawal by Subject|0|||
147125042|NCT04691115|530623642|FG012|Overall Study|Withdrawal by Subject|0|||
147125043|NCT04691115|530623643|FG013|Overall Study|Withdrawal by Subject|0|||
147125044|NCT04525183|530623655|FG000|Overall Study|Withdrawal by Subject|0|||
147125045|NCT04525183|530623656|FG001|Overall Study|Withdrawal by Subject|0|||
147125046|NCT04525183|530623657|FG002|Overall Study|Withdrawal by Subject|3|||
147125047|NCT04525183|530623655|FG000|Overall Study|Study non-compliance|0|||
147125048|NCT04525183|530623656|FG001|Overall Study|Study non-compliance|0|||
147125049|NCT04525183|530623657|FG002|Overall Study|Study non-compliance|1|||
147125050|NCT04525183|530623655|FG000|Overall Study|Recurrent disease before starting on study|0|||
147125051|NCT04525183|530623656|FG001|Overall Study|Recurrent disease before starting on study|0|||
147125052|NCT04525183|530623657|FG002|Overall Study|Recurrent disease before starting on study|1|||
147125053|NCT03777020|530623660|FG000|Overall Study|Withdrawal by Subject|4|||
147125054|NCT03777020|530623661|FG001|Overall Study|Withdrawal by Subject|4|||
147125055|NCT03777020|530623660|FG000|Overall Study|No longer met inclusion criteria at initial visit|0|||
147125056|NCT03777020|530623661|FG001|Overall Study|No longer met inclusion criteria at initial visit|1|||
147125057|NCT04439903|530623662|FG000|Overall Study|Withdrawal by Subject|2|||
147125058|NCT04439903|530623662|FG000|Overall Study|Screen Failure|1|||
147125059|NCT02899754|530623663|FG000|Overall Study|Lost to Follow-up|7|||
147125060|NCT02899754|530623664|FG001|Overall Study|Lost to Follow-up|9|||
147125061|NCT04818229|530623665|FG000|Overall Study|The cohort was canceled due to COVID-19|20|||
147125062|NCT04818229|530623666|FG001|Overall Study|The cohort was canceled due to COVID-19|10|||
147125063|NCT04818229|530623667|FG002|Overall Study|The cohort was canceled due to COVID-19|10|||
147125064|NCT04818229|530623665|FG000|Overall Study|Adverse Event|3|||
147125065|NCT04818229|530623666|FG001|Overall Study|Adverse Event|1|||
147125066|NCT04818229|530623667|FG002|Overall Study|Adverse Event|1|||
147125067|NCT04818229|530623665|FG000|Overall Study|Withdrawal by Subject|0|||
147125068|NCT04818229|530623666|FG001|Overall Study|Withdrawal by Subject|0|||
147125069|NCT04818229|530623667|FG002|Overall Study|Withdrawal by Subject|2|||
147125070|NCT04818229|530623665|FG000|Overall Study|Lost to Follow-up|0|||
147125071|NCT04818229|530623666|FG001|Overall Study|Lost to Follow-up|0|||
147125072|NCT04818229|530623667|FG002|Overall Study|Lost to Follow-up|1|||
147125073|NCT03769116|530623668|FG000|Part 3 - Open Label|Study Terminated by Sponsor|1|||
147125074|NCT03769116|530623669|FG001|Part 3 - Open Label|Study Terminated by Sponsor|2|||
147125075|NCT03769116|530623668|FG000|Part 3 - Open Label|Physician Decision|1|||
147125076|NCT03769116|530623669|FG001|Part 3 - Open Label|Physician Decision|0|||
147125077|NCT03769116|530623668|FG000|Part 3 - Open Label|Withdrawal by Subject|1|||
147125078|NCT03769116|530623669|FG001|Part 3 - Open Label|Withdrawal by Subject|0|||
147125079|NCT02181413|530623670|FG000|Overall Study|Withdrawal by Subject|45|||
147125080|NCT02181413|530623671|FG001|Overall Study|Withdrawal by Subject|61|||
147125081|NCT02181413|530623670|FG000|Overall Study|Reason Not Specified|2|||
147125082|NCT02181413|530623671|FG001|Overall Study|Reason Not Specified|5|||
147125083|NCT02181413|530623670|FG000|Overall Study|Lost to Follow-up|8|||
147125084|NCT02181413|530623671|FG001|Overall Study|Lost to Follow-up|7|||
147125085|NCT04003142|530623674|FG000|Double-blind Period (12 Weeks)|Adverse Event|1|||
147125086|NCT04003142|530623675|FG001|Double-blind Period (12 Weeks)|Adverse Event|1|||
147125087|NCT04003142|530623676|FG002|Double-blind Period (12 Weeks)|Adverse Event|2|||
147125088|NCT04003142|530623677|FG003|Double-blind Period (12 Weeks)|Adverse Event|0|||
147125089|NCT04003142|530623678|FG004|Double-blind Period (12 Weeks)|Adverse Event|0|||
147125090|NCT04003142|530623674|FG000|Double-blind Period (12 Weeks)|Lost to Follow-up|2|||
147125091|NCT04003142|530623675|FG001|Double-blind Period (12 Weeks)|Lost to Follow-up|1|||
147125092|NCT04003142|530623676|FG002|Double-blind Period (12 Weeks)|Lost to Follow-up|2|||
147125093|NCT04003142|530623677|FG003|Double-blind Period (12 Weeks)|Lost to Follow-up|0|||
147234384|NCT03758443|531030108|FG000|Maintenance Period|Adverse Event|1|||
147234385|NCT03758443|531030109|FG001|Maintenance Period|Adverse Event|2|||
147234386|NCT03758443|531030110|FG002|Maintenance Period|Adverse Event|0|||
147234387|NCT03758443|531030111|FG003|Maintenance Period|Adverse Event|0|||
147234388|NCT03758443|531030108|FG000|Maintenance Period|Lost to Follow-up|0|||
147234389|NCT03758443|531030109|FG001|Maintenance Period|Lost to Follow-up|0|||
147234390|NCT03758443|531030110|FG002|Maintenance Period|Lost to Follow-up|0|||
147234391|NCT03758443|531030111|FG003|Maintenance Period|Lost to Follow-up|1|||
147234392|NCT03758443|531030108|FG000|Maintenance Period|Persistent Loss of Response During Maintenance|3|||
147234393|NCT03758443|531030109|FG001|Maintenance Period|Persistent Loss of Response During Maintenance|1|||
147234394|NCT03758443|531030110|FG002|Maintenance Period|Persistent Loss of Response During Maintenance|2|||
147234395|NCT03758443|531030111|FG003|Maintenance Period|Persistent Loss of Response During Maintenance|0|||
147234396|NCT03758443|531030108|FG000|Maintenance Period|Protocol Violation|0|||
147234397|NCT03758443|531030109|FG001|Maintenance Period|Protocol Violation|1|||
147234398|NCT03758443|531030110|FG002|Maintenance Period|Protocol Violation|0|||
147234399|NCT03758443|531030111|FG003|Maintenance Period|Protocol Violation|0|||
147234400|NCT03758443|531030108|FG000|Maintenance Period|Study Terminated by Sponsor|11|||
147234401|NCT03758443|531030109|FG001|Maintenance Period|Study Terminated by Sponsor|16|||
147234402|NCT03758443|531030110|FG002|Maintenance Period|Study Terminated by Sponsor|9|||
147234403|NCT03758443|531030111|FG003|Maintenance Period|Study Terminated by Sponsor|11|||
147234404|NCT03758443|531030108|FG000|Maintenance Period|Withdrawal by Subject|1|||
147234405|NCT03758443|531030109|FG001|Maintenance Period|Withdrawal by Subject|0|||
147234406|NCT03758443|531030110|FG002|Maintenance Period|Withdrawal by Subject|1|||
147234407|NCT03758443|531030111|FG003|Maintenance Period|Withdrawal by Subject|1|||
147234408|NCT03758443|531030108|FG000|Maintenance Period|Miscellaneous|0|||
147234409|NCT03758443|531030109|FG001|Maintenance Period|Miscellaneous|0|||
147234410|NCT03758443|531030110|FG002|Maintenance Period|Miscellaneous|1|||
147234411|NCT03758443|531030111|FG003|Maintenance Period|Miscellaneous|0|||
147234412|NCT01772160|531030113|FG000|Overall Study|Death|3|||
147234413|NCT01772160|531030113|FG000|Overall Study|Eligibility criteria not fulfilled|3|||
147234414|NCT01772160|531030113|FG000|Overall Study|Consent withdrawal|3|||
147234415|NCT01772160|531030113|FG000|Overall Study|Migrated / moved from the study area|4|||
147234416|NCT01772160|531030113|FG000|Overall Study|Lost to Follow-up|30|||
147234417|NCT01772160|531030113|FG000|Overall Study|Other|5|||
147234418|NCT00199875|531030118|FG000|Overall Study|Withdrawal by Subject|0|||
147234419|NCT00199875|531030119|FG001|Overall Study|Withdrawal by Subject|0|||
147234420|NCT00199875|531030120|FG002|Overall Study|Withdrawal by Subject|0|||
147234421|NCT00199875|531030121|FG003|Overall Study|Withdrawal by Subject|0|||
147234422|NCT00199875|531030122|FG004|Overall Study|Withdrawal by Subject|1|||
147234423|NCT03469934|531030123|FG000|Overall Study|Withdrawal by Subject|0|||
147234424|NCT03469934|531030124|FG001|Overall Study|Withdrawal by Subject|1|||
147234425|NCT01024231|531030128|FG000|Overall Study|Other Reasons|1|||
147234426|NCT01024231|531030129|FG001|Overall Study|Other Reasons|2|||
147234427|NCT01024231|531030130|FG002|Overall Study|Other Reasons|0|||
147234428|NCT01024231|531030131|FG003|Overall Study|Other Reasons|0|||
147234429|NCT01024231|531030132|FG004|Overall Study|Other Reasons|2|||
147234430|NCT01024231|531030133|FG005|Overall Study|Other Reasons|0|||
147234431|NCT01024231|531030134|FG006|Overall Study|Other Reasons|1|||
147234432|NCT01024231|531030128|FG000|Overall Study|Maximum Clinical Benefit|1|||
147234433|NCT01024231|531030129|FG001|Overall Study|Maximum Clinical Benefit|2|||
147234434|NCT01024231|531030130|FG002|Overall Study|Maximum Clinical Benefit|0|||
147234435|NCT01024231|531030131|FG003|Overall Study|Maximum Clinical Benefit|1|||
147234436|NCT01024231|531030132|FG004|Overall Study|Maximum Clinical Benefit|1|||
147234437|NCT01024231|531030133|FG005|Overall Study|Maximum Clinical Benefit|0|||
147234438|NCT01024231|531030134|FG006|Overall Study|Maximum Clinical Benefit|0|||
147234439|NCT01024231|531030128|FG000|Overall Study|Disease Progression|3|||
147234440|NCT01024231|531030129|FG001|Overall Study|Disease Progression|1|||
147234441|NCT01024231|531030130|FG002|Overall Study|Disease Progression|3|||
147234442|NCT01024231|531030131|FG003|Overall Study|Disease Progression|0|||
147234443|NCT01024231|531030132|FG004|Overall Study|Disease Progression|4|||
147234444|NCT01024231|531030133|FG005|Overall Study|Disease Progression|11|||
147234445|NCT01024231|531030134|FG006|Overall Study|Disease Progression|6|||
147234446|NCT01024231|531030128|FG000|Overall Study|AE unrelated to Study Drug|0|||
147234447|NCT01024231|531030129|FG001|Overall Study|AE unrelated to Study Drug|1|||
147234448|NCT01024231|531030130|FG002|Overall Study|AE unrelated to Study Drug|0|||
147234449|NCT01024231|531030131|FG003|Overall Study|AE unrelated to Study Drug|0|||
147234450|NCT01024231|531030132|FG004|Overall Study|AE unrelated to Study Drug|0|||
147234451|NCT01024231|531030133|FG005|Overall Study|AE unrelated to Study Drug|0|||
147234452|NCT01024231|531030134|FG006|Overall Study|AE unrelated to Study Drug|0|||
147234453|NCT01024231|531030128|FG000|Overall Study|No longer meets criteria|0|||
147234454|NCT01024231|531030129|FG001|Overall Study|No longer meets criteria|0|||
147234455|NCT01024231|531030130|FG002|Overall Study|No longer meets criteria|0|||
147234456|NCT01024231|531030131|FG003|Overall Study|No longer meets criteria|0|||
147234457|NCT01024231|531030132|FG004|Overall Study|No longer meets criteria|1|||
147234458|NCT01024231|531030133|FG005|Overall Study|No longer meets criteria|0|||
147234459|NCT01024231|531030134|FG006|Overall Study|No longer meets criteria|1|||
147316080|NCT02018861|531323596|FG000|Parsaclisib Monotherapy: 21-day Cycles|Death|1|||
147316081|NCT02018861|531323597|FG001|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
147316082|NCT02018861|531323598|FG002|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
147316083|NCT02018861|531323599|FG003|Parsaclisib Monotherapy: 21-day Cycles|Death|3|||
147316084|NCT02018861|531323600|FG004|Parsaclisib Monotherapy: 21-day Cycles|Death|1|||
147316085|NCT02018861|531323601|FG005|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
147316086|NCT02018861|531323602|FG006|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
147316087|NCT02018861|531323603|FG007|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
147316088|NCT02018861|531323604|FG008|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
147316089|NCT02018861|531323605|FG009|Parsaclisib Monotherapy: 21-day Cycles|Death|0|||
147316090|NCT02018861|531323596|FG000|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
147316091|NCT02018861|531323597|FG001|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
147316092|NCT02018861|531323598|FG002|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|1|||
147316093|NCT02018861|531323599|FG003|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|1|||
147316094|NCT02018861|531323600|FG004|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
147316095|NCT02018861|531323601|FG005|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
147316096|NCT02018861|531323602|FG006|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
147316097|NCT02018861|531323603|FG007|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
147316098|NCT02018861|531323604|FG008|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
147316099|NCT02018861|531323605|FG009|Parsaclisib Monotherapy: 21-day Cycles|Lost to Follow-up|0|||
147316100|NCT02018861|531323596|FG000|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
147316101|NCT02018861|531323597|FG001|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
147316102|NCT02018861|531323598|FG002|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
147316103|NCT02018861|531323599|FG003|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
147316104|NCT02018861|531323600|FG004|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|1|||
147316105|NCT02018861|531323601|FG005|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
147316106|NCT02018861|531323602|FG006|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
147316107|NCT02018861|531323603|FG007|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
147316108|NCT02018861|531323604|FG008|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
147316109|NCT02018861|531323605|FG009|Parsaclisib Monotherapy: 21-day Cycles|Non-compliance with Study Treatment|0|||
147316110|NCT02018861|531323596|FG000|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
147316111|NCT02018861|531323597|FG001|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
147316112|NCT02018861|531323598|FG002|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
147316113|NCT02018861|531323599|FG003|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|4|||
147316114|NCT02018861|531323600|FG004|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|1|||
147316115|NCT02018861|531323601|FG005|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|2|||
147316116|NCT02018861|531323602|FG006|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
147316117|NCT02018861|531323603|FG007|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
147316118|NCT02018861|531323604|FG008|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
147316119|NCT02018861|531323605|FG009|Parsaclisib Monotherapy: 21-day Cycles|Physician Decision|0|||
147316120|NCT02018861|531323596|FG000|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
147316121|NCT02018861|531323597|FG001|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
147316122|NCT02018861|531323598|FG002|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
147316123|NCT02018861|531323599|FG003|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|2|||
147316124|NCT02018861|531323600|FG004|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|1|||
147316125|NCT02018861|531323601|FG005|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
147316126|NCT02018861|531323602|FG006|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
147316127|NCT02018861|531323603|FG007|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
147316128|NCT02018861|531323604|FG008|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
147316129|NCT02018861|531323605|FG009|Parsaclisib Monotherapy: 21-day Cycles|Unknown or Not Reported|0|||
147316130|NCT02018861|531323596|FG000|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
147316131|NCT02018861|531323597|FG001|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
147316132|NCT02018861|531323598|FG002|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
147316133|NCT02018861|531323599|FG003|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
147316134|NCT02018861|531323600|FG004|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
147316135|NCT02018861|531323601|FG005|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
147316136|NCT02018861|531323602|FG006|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|5|||
147316137|NCT02018861|531323603|FG007|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|2|||
147316138|NCT02018861|531323604|FG008|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
147316139|NCT02018861|531323605|FG009|Parsaclisib + Itacitinib; 21-day Cycles|Disease Progression|0|||
147316140|NCT02018861|531323596|FG000|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
147316141|NCT02018861|531323597|FG001|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
147316142|NCT02018861|531323598|FG002|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
147316143|NCT02018861|531323599|FG003|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
147316144|NCT02018861|531323600|FG004|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
147316145|NCT02018861|531323601|FG005|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
147316146|NCT02018861|531323602|FG006|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|3|||
147316147|NCT02018861|531323603|FG007|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|1|||
147316148|NCT02018861|531323604|FG008|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
147316149|NCT02018861|531323605|FG009|Parsaclisib + Itacitinib; 21-day Cycles|Unknown or Not Reported|0|||
147316150|NCT02018861|531323596|FG000|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
147316151|NCT02018861|531323597|FG001|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
147316152|NCT02018861|531323598|FG002|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
147316153|NCT02018861|531323599|FG003|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
147316154|NCT02018861|531323600|FG004|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
147316155|NCT02018861|531323601|FG005|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
147316156|NCT02018861|531323602|FG006|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
147316157|NCT02018861|531323603|FG007|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
147316158|NCT02018861|531323604|FG008|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|1|||
147316159|NCT02018861|531323605|FG009|Parsaclisib + R-ICE; 21-day Cycles|Physician Decision|0|||
147316160|NCT02018861|531323596|FG000|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
147316161|NCT02018861|531323597|FG001|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
147316162|NCT02018861|531323598|FG002|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
147316163|NCT02018861|531323599|FG003|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
147316164|NCT02018861|531323600|FG004|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
147316165|NCT02018861|531323601|FG005|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
147316166|NCT02018861|531323602|FG006|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
147316167|NCT02018861|531323603|FG007|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
147316168|NCT02018861|531323604|FG008|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|1|||
147316169|NCT02018861|531323605|FG009|Parsaclisib + R-ICE; 21-day Cycles|Disease Progression|0|||
147316170|NCT02018861|531323596|FG000|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
147316171|NCT02018861|531323597|FG001|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
147316172|NCT02018861|531323598|FG002|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
147316173|NCT02018861|531323599|FG003|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
147316174|NCT02018861|531323600|FG004|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
147316175|NCT02018861|531323601|FG005|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
147316176|NCT02018861|531323602|FG006|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
147316177|NCT02018861|531323603|FG007|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
147316178|NCT02018861|531323604|FG008|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|1|||
147316179|NCT02018861|531323605|FG009|Parsaclisib + R-ICE; 21-day Cycles|Adverse Event|0|||
147316180|NCT00504348|531323609|FG000|Overall Study|Adverse Event|3|||
147316181|NCT00504348|531323609|FG000|Overall Study|Lack of Efficacy|4|||
147316182|NCT00504348|531323609|FG000|Overall Study|Physician Decision|1|||
147316183|NCT00224133|531323610|FG000|Overall Study|Adverse Event|93|||
147316184|NCT00224133|531323610|FG000|Overall Study|Protocol Violation|6|||
147316185|NCT00224133|531323610|FG000|Overall Study|Withdrawal by Subject|33|||
147316186|NCT00224133|531323610|FG000|Overall Study|Lack of Efficacy|58|||
147316187|NCT00224133|531323610|FG000|Overall Study|Lost to Follow-up|21|||
147316188|NCT00224133|531323610|FG000|Overall Study|Physician Decision|1|||
147316189|NCT00224133|531323610|FG000|Overall Study|Other|14|||
147316190|NCT03699124|531323612|FG000|Overall Study|Adverse Event|6|||
147316191|NCT03699124|531323613|FG001|Overall Study|Adverse Event|5|||
147316192|NCT03699124|531323614|FG002|Overall Study|Adverse Event|2|||
147316193|NCT03699124|531323612|FG000|Overall Study|Death|0|||
147316194|NCT03699124|531323613|FG001|Overall Study|Death|2|||
147316195|NCT03699124|531323614|FG002|Overall Study|Death|0|||
147316196|NCT03699124|531323612|FG000|Overall Study|Lost to Follow-up|20|||
147316197|NCT03699124|531323613|FG001|Overall Study|Lost to Follow-up|16|||
147316198|NCT03699124|531323614|FG002|Overall Study|Lost to Follow-up|15|||
147316199|NCT03699124|531323612|FG000|Overall Study|Protocol Violation|1|||
147316200|NCT03699124|531323613|FG001|Overall Study|Protocol Violation|0|||
147316201|NCT03699124|531323614|FG002|Overall Study|Protocol Violation|0|||
147316202|NCT03699124|531323612|FG000|Overall Study|Withdrawal by Subject|13|||
147316203|NCT03699124|531323613|FG001|Overall Study|Withdrawal by Subject|14|||
147316204|NCT03699124|531323614|FG002|Overall Study|Withdrawal by Subject|13|||
147316205|NCT03699124|531323612|FG000|Overall Study|Other reasons|5|||
147316206|NCT03699124|531323613|FG001|Overall Study|Other reasons|3|||
147316207|NCT03699124|531323614|FG002|Overall Study|Other reasons|10|||
147316208|NCT00506285|531323615|FG000|3 Week Screening Phase|Withdrawal by Subject|17|||
147316209|NCT00506285|531323616|FG001|3 Week Screening Phase|Withdrawal by Subject|10|||
147316210|NCT00506285|531323615|FG000|Double Blind Cross-Over Phase|Withdrawal by Subject|4|||
147316211|NCT00506285|531323616|FG001|Double Blind Cross-Over Phase|Withdrawal by Subject|3|||
147316212|NCT00506285|531323615|FG000|Double Blind Cross-Over Phase|Lost to Follow-up|5|||
147316213|NCT00506285|531323616|FG001|Double Blind Cross-Over Phase|Lost to Follow-up|2|||
147316214|NCT00506285|531323615|FG000|6-month Open Label Phase|Lost to Follow-up|1|||
147316215|NCT00506285|531323616|FG001|6-month Open Label Phase|Lost to Follow-up|7|||
147316216|NCT00506285|531323615|FG000|6-month Open Label Phase|Withdrawal by Subject|9|||
147316217|NCT00506285|531323616|FG001|6-month Open Label Phase|Withdrawal by Subject|5|||
147125094|NCT04003142|530623678|FG004|Double-blind Period (12 Weeks)|Lost to Follow-up|0|||
147125095|NCT04003142|530623674|FG000|Double-blind Period (12 Weeks)|Protocol Deviation|1|||
147125096|NCT04003142|530623675|FG001|Double-blind Period (12 Weeks)|Protocol Deviation|5|||
147125097|NCT04003142|530623676|FG002|Double-blind Period (12 Weeks)|Protocol Deviation|0|||
147125098|NCT04003142|530623677|FG003|Double-blind Period (12 Weeks)|Protocol Deviation|0|||
147125099|NCT04003142|530623678|FG004|Double-blind Period (12 Weeks)|Protocol Deviation|0|||
147316218|NCT00551213|531323619|FG000|Overall Study|Adverse Event|6|||
147316219|NCT00551213|531323620|FG001|Overall Study|Adverse Event|3|||
147125100|NCT04003142|530623674|FG000|Double-blind Period (12 Weeks)|Withdrawal by Subject|11|||
147125101|NCT04003142|530623675|FG001|Double-blind Period (12 Weeks)|Withdrawal by Subject|6|||
147125102|NCT04003142|530623676|FG002|Double-blind Period (12 Weeks)|Withdrawal by Subject|6|||
147125103|NCT04003142|530623677|FG003|Double-blind Period (12 Weeks)|Withdrawal by Subject|0|||
147125104|NCT04003142|530623678|FG004|Double-blind Period (12 Weeks)|Withdrawal by Subject|0|||
147125105|NCT04003142|530623674|FG000|Double-blind Period (12 Weeks)|Miscellaneous|2|||
147125106|NCT04003142|530623675|FG001|Double-blind Period (12 Weeks)|Miscellaneous|1|||
147316220|NCT00551213|531323619|FG000|Overall Study|Progressive Disease|41|||
147316221|NCT00551213|531323620|FG001|Overall Study|Progressive Disease|12|||
147316222|NCT00551213|531323619|FG000|Overall Study|Withdrawal by Subject|2|||
147316223|NCT00551213|531323620|FG001|Overall Study|Withdrawal by Subject|0|||
147316224|NCT00551213|531323619|FG000|Overall Study|Not Treated|1|||
147316225|NCT00551213|531323620|FG001|Overall Study|Not Treated|2|||
147316226|NCT01890967|531323621|FG000|Overall Study|Adverse Event|3|||
147316227|NCT01890967|531323622|FG001|Overall Study|Adverse Event|3|||
147316228|NCT01890967|531323623|FG002|Overall Study|Adverse Event|3|||
147316229|NCT01890967|531323624|FG003|Overall Study|Adverse Event|2|||
147316230|NCT01890967|531323625|FG004|Overall Study|Adverse Event|1|||
147316231|NCT01890967|531323626|FG005|Overall Study|Adverse Event|7|||
147316232|NCT01890967|531323621|FG000|Overall Study|Death|1|||
147316233|NCT01890967|531323622|FG001|Overall Study|Death|0|||
147316234|NCT01890967|531323623|FG002|Overall Study|Death|0|||
147316235|NCT01890967|531323624|FG003|Overall Study|Death|0|||
147316236|NCT01890967|531323625|FG004|Overall Study|Death|0|||
147125107|NCT04003142|530623676|FG002|Double-blind Period (12 Weeks)|Miscellaneous|2|||
147125108|NCT04003142|530623677|FG003|Double-blind Period (12 Weeks)|Miscellaneous|0|||
147125109|NCT04003142|530623678|FG004|Double-blind Period (12 Weeks)|Miscellaneous|0|||
147125110|NCT04003142|530623674|FG000|Extension Period (40 Weeks)|Adverse Event|0|||
147125111|NCT04003142|530623675|FG001|Extension Period (40 Weeks)|Adverse Event|4|||
147125112|NCT04003142|530623676|FG002|Extension Period (40 Weeks)|Adverse Event|4|||
147125113|NCT04003142|530623677|FG003|Extension Period (40 Weeks)|Adverse Event|2|||
147316237|NCT01890967|531323626|FG005|Overall Study|Death|0|||
147316238|NCT01890967|531323621|FG000|Overall Study|Lost to Follow-up|1|||
147316239|NCT01890967|531323622|FG001|Overall Study|Lost to Follow-up|1|||
147316240|NCT01890967|531323623|FG002|Overall Study|Lost to Follow-up|1|||
147316241|NCT01890967|531323624|FG003|Overall Study|Lost to Follow-up|1|||
147316242|NCT01890967|531323625|FG004|Overall Study|Lost to Follow-up|0|||
147316243|NCT01890967|531323626|FG005|Overall Study|Lost to Follow-up|1|||
147316244|NCT01890967|531323621|FG000|Overall Study|Protocol Violation|0|||
147316245|NCT01890967|531323622|FG001|Overall Study|Protocol Violation|3|||
147316246|NCT01890967|531323623|FG002|Overall Study|Protocol Violation|3|||
147316247|NCT01890967|531323624|FG003|Overall Study|Protocol Violation|2|||
147316248|NCT01890967|531323625|FG004|Overall Study|Protocol Violation|4|||
147316249|NCT01890967|531323626|FG005|Overall Study|Protocol Violation|1|||
147316250|NCT01890967|531323621|FG000|Overall Study|Sponsor Decision|2|||
147125114|NCT04003142|530623678|FG004|Extension Period (40 Weeks)|Adverse Event|3|||
147316251|NCT01890967|531323622|FG001|Overall Study|Sponsor Decision|0|||
147316252|NCT01890967|531323623|FG002|Overall Study|Sponsor Decision|1|||
147316253|NCT01890967|531323624|FG003|Overall Study|Sponsor Decision|3|||
147316254|NCT01890967|531323625|FG004|Overall Study|Sponsor Decision|2|||
147316255|NCT01890967|531323626|FG005|Overall Study|Sponsor Decision|3|||
147316256|NCT01890967|531323621|FG000|Overall Study|Withdrawal by Subject|3|||
147316257|NCT01890967|531323622|FG001|Overall Study|Withdrawal by Subject|4|||
147316258|NCT01890967|531323623|FG002|Overall Study|Withdrawal by Subject|2|||
147316259|NCT01890967|531323624|FG003|Overall Study|Withdrawal by Subject|3|||
147125115|NCT04003142|530623674|FG000|Extension Period (40 Weeks)|Death|0|||
147125116|NCT04003142|530623675|FG001|Extension Period (40 Weeks)|Death|0|||
147316260|NCT01890967|531323625|FG004|Overall Study|Withdrawal by Subject|3|||
147316261|NCT01890967|531323626|FG005|Overall Study|Withdrawal by Subject|1|||
147316262|NCT00593554|531323628|FG000|Overall Study|Death|1|||
147444653|NCT01147744|531792659|FG002|Overall Study|Lost to Follow-up|0|||
147125117|NCT04003142|530623676|FG002|Extension Period (40 Weeks)|Death|0|||
147316263|NCT00593554|531323629|FG001|Overall Study|Death|2|||
147316264|NCT00593554|531323628|FG000|Overall Study|Physician Decision|0|||
147316265|NCT00593554|531323629|FG001|Overall Study|Physician Decision|1|||
147125118|NCT04003142|530623677|FG003|Extension Period (40 Weeks)|Death|0|||
147125119|NCT04003142|530623678|FG004|Extension Period (40 Weeks)|Death|1|||
147125120|NCT04003142|530623674|FG000|Extension Period (40 Weeks)|Lost to Follow-up|0|||
147125121|NCT04003142|530623675|FG001|Extension Period (40 Weeks)|Lost to Follow-up|2|||
147125122|NCT04003142|530623676|FG002|Extension Period (40 Weeks)|Lost to Follow-up|1|||
147125123|NCT04003142|530623677|FG003|Extension Period (40 Weeks)|Lost to Follow-up|2|||
147125124|NCT04003142|530623678|FG004|Extension Period (40 Weeks)|Lost to Follow-up|1|||
147125125|NCT04003142|530623674|FG000|Extension Period (40 Weeks)|Protocol Deviation|0|||
147125126|NCT04003142|530623675|FG001|Extension Period (40 Weeks)|Protocol Deviation|0|||
147125127|NCT04003142|530623676|FG002|Extension Period (40 Weeks)|Protocol Deviation|2|||
147125128|NCT04003142|530623677|FG003|Extension Period (40 Weeks)|Protocol Deviation|0|||
147125129|NCT04003142|530623678|FG004|Extension Period (40 Weeks)|Protocol Deviation|0|||
147125130|NCT04003142|530623674|FG000|Extension Period (40 Weeks)|Withdrawal by Subject|0|||
147125131|NCT04003142|530623675|FG001|Extension Period (40 Weeks)|Withdrawal by Subject|17|||
147125132|NCT04003142|530623676|FG002|Extension Period (40 Weeks)|Withdrawal by Subject|14|||
147125133|NCT04003142|530623677|FG003|Extension Period (40 Weeks)|Withdrawal by Subject|9|||
147125134|NCT04003142|530623678|FG004|Extension Period (40 Weeks)|Withdrawal by Subject|5|||
147125135|NCT04003142|530623674|FG000|Extension Period (40 Weeks)|Miscellaneous|0|||
147125136|NCT04003142|530623675|FG001|Extension Period (40 Weeks)|Miscellaneous|4|||
147125137|NCT04003142|530623676|FG002|Extension Period (40 Weeks)|Miscellaneous|1|||
147125138|NCT04003142|530623677|FG003|Extension Period (40 Weeks)|Miscellaneous|0|||
147125139|NCT04003142|530623678|FG004|Extension Period (40 Weeks)|Miscellaneous|2|||
147125140|NCT04755231|530623684|FG000|Overall Study|Lost to Follow-up|5|||
147125141|NCT04755231|530623684|FG000|Overall Study|Withdrawal by Subject|5|||
147125142|NCT01720602|530623687|FG000|Overall Study|Adverse Event|3|||
147125143|NCT01720602|530623687|FG000|Overall Study|Progressive disease on therapy|2|||
147125144|NCT03927846|530623695|FG000|Overall Study|Lost to Follow-up|10|||
147125145|NCT03927846|530623696|FG001|Overall Study|Lost to Follow-up|11|||
147125146|NCT03878069|530623697|FG000|Overall Study|Death|0|||
147125147|NCT03878069|530623698|FG001|Overall Study|Death|1|||
147125148|NCT03878069|530623699|FG002|Overall Study|Death|0|||
147125149|NCT00834587|530623700|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
147125150|NCT00834587|530623701|FG001|Washout: 7 Days|Withdrawal by Subject|0|||
147125151|NCT00176254|530623702|FG000|Overall Study|Lost to Follow-up|1|||
147125152|NCT03289741|530623703|FG000|Overall Study|Adverse Event|1|||
147125153|NCT03289741|530623704|FG001|Overall Study|Adverse Event|1|||
147125154|NCT03289741|530623703|FG000|Overall Study|Physician Decision|2|||
147125155|NCT03289741|530623704|FG001|Overall Study|Physician Decision|2|||
147125156|NCT03289741|530623703|FG000|Overall Study|Withdrawal by Subject|1|||
147125157|NCT03289741|530623704|FG001|Overall Study|Withdrawal by Subject|0|||
147125158|NCT02536339|530623706|FG000|Overall Study|Death|20|||
147125159|NCT02536339|530623706|FG000|Overall Study|Withdrawal by Subject|3|||
147125160|NCT02536339|530623706|FG000|Overall Study|Lost to Follow-up|2|||
147125161|NCT02536339|530623706|FG000|Overall Study|Treatment discontinued|2|||
147125162|NCT02536339|530623706|FG000|Overall Study|Physician Decision|1|||
147125163|NCT02037984|530623708|FG000|Overall Study|Lack of Efficacy|0|||
147125164|NCT02037984|530623709|FG001|Overall Study|Lack of Efficacy|0|||
147125165|NCT02037984|530623710|FG002|Overall Study|Lack of Efficacy|3|||
147125166|NCT02037984|530623711|FG003|Overall Study|Lack of Efficacy|10|||
147125167|NCT02037984|530623712|FG004|Overall Study|Lack of Efficacy|2|||
147125168|NCT02037984|530623713|FG005|Overall Study|Lack of Efficacy|2|||
147125169|NCT02037984|530623714|FG006|Overall Study|Lack of Efficacy|4|||
147125170|NCT02037984|530623715|FG007|Overall Study|Lack of Efficacy|3|||
147125171|NCT02037984|530623708|FG000|Overall Study|Lost to Follow-up|1|||
147125172|NCT02037984|530623709|FG001|Overall Study|Lost to Follow-up|0|||
147125173|NCT02037984|530623710|FG002|Overall Study|Lost to Follow-up|3|||
147125174|NCT02037984|530623711|FG003|Overall Study|Lost to Follow-up|5|||
147125175|NCT02037984|530623712|FG004|Overall Study|Lost to Follow-up|2|||
147125176|NCT02037984|530623713|FG005|Overall Study|Lost to Follow-up|2|||
147125177|NCT02037984|530623714|FG006|Overall Study|Lost to Follow-up|2|||
147125178|NCT02037984|530623715|FG007|Overall Study|Lost to Follow-up|4|||
147125179|NCT02037984|530623708|FG000|Overall Study|Physician Decision|0|||
147125180|NCT02037984|530623709|FG001|Overall Study|Physician Decision|0|||
147125181|NCT02037984|530623710|FG002|Overall Study|Physician Decision|0|||
147125182|NCT02037984|530623711|FG003|Overall Study|Physician Decision|0|||
147125183|NCT02037984|530623712|FG004|Overall Study|Physician Decision|0|||
147125184|NCT02037984|530623713|FG005|Overall Study|Physician Decision|0|||
147125185|NCT02037984|530623714|FG006|Overall Study|Physician Decision|1|||
147125186|NCT02037984|530623715|FG007|Overall Study|Physician Decision|0|||
147125187|NCT02037984|530623708|FG000|Overall Study|Protocol Violation|0|||
147125188|NCT02037984|530623709|FG001|Overall Study|Protocol Violation|0|||
147125189|NCT02037984|530623710|FG002|Overall Study|Protocol Violation|0|||
147125190|NCT02037984|530623711|FG003|Overall Study|Protocol Violation|0|||
147125191|NCT02037984|530623712|FG004|Overall Study|Protocol Violation|0|||
147125192|NCT02037984|530623713|FG005|Overall Study|Protocol Violation|1|||
147125193|NCT02037984|530623714|FG006|Overall Study|Protocol Violation|2|||
147125194|NCT02037984|530623715|FG007|Overall Study|Protocol Violation|0|||
147125195|NCT02037984|530623708|FG000|Overall Study|Technical Problems|0|||
147316266|NCT00593554|531323628|FG000|Overall Study|Withdrawal by Subject|1|||
147316267|NCT00593554|531323629|FG001|Overall Study|Withdrawal by Subject|0|||
147316268|NCT00593554|531323628|FG000|Overall Study|Disease Progression|1|||
147316269|NCT00593554|531323629|FG001|Overall Study|Disease Progression|2|||
147316270|NCT00795132|531323633|FG000|Overall Study|Death|1|||
147316271|NCT00795132|531323633|FG000|Overall Study|Relapse|2|||
147316272|NCT02561455|531323634|FG000|Overall Study|Participant Transitioned to Commercial Drug|1|||
147316273|NCT02561455|531323635|FG001|Overall Study|Participant Transitioned to Commercial Drug|1|||
147316274|NCT02561455|531323636|FG002|Overall Study|Participant Transitioned to Commercial Drug|2|||
147316275|NCT02561455|531323637|FG003|Overall Study|Participant Transitioned to Commercial Drug|1|||
147316276|NCT02561455|531323634|FG000|Overall Study|Withdrawal by Subject|1|||
147316277|NCT02561455|531323635|FG001|Overall Study|Withdrawal by Subject|0|||
147316278|NCT02561455|531323636|FG002|Overall Study|Withdrawal by Subject|1|||
147316279|NCT02561455|531323637|FG003|Overall Study|Withdrawal by Subject|0|||
147316280|NCT02561455|531323634|FG000|Overall Study|Disease Progression|0|||
147316281|NCT02561455|531323635|FG001|Overall Study|Disease Progression|1|||
147125196|NCT02037984|530623709|FG001|Overall Study|Technical Problems|0|||
147125197|NCT02037984|530623710|FG002|Overall Study|Technical Problems|3|||
147125198|NCT02037984|530623711|FG003|Overall Study|Technical Problems|3|||
147125199|NCT02037984|530623712|FG004|Overall Study|Technical Problems|2|||
147125200|NCT02037984|530623713|FG005|Overall Study|Technical Problems|3|||
147125201|NCT02037984|530623714|FG006|Overall Study|Technical Problems|4|||
147125202|NCT02037984|530623715|FG007|Overall Study|Technical Problems|2|||
147125203|NCT02037984|530623708|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
147125204|NCT02037984|530623709|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
147125205|NCT02037984|530623710|FG002|Overall Study|Withdrawal by Parent/Guardian|3|||
147125206|NCT02037984|530623711|FG003|Overall Study|Withdrawal by Parent/Guardian|2|||
147125207|NCT02037984|530623712|FG004|Overall Study|Withdrawal by Parent/Guardian|5|||
147125208|NCT02037984|530623713|FG005|Overall Study|Withdrawal by Parent/Guardian|1|||
147125209|NCT02037984|530623714|FG006|Overall Study|Withdrawal by Parent/Guardian|4|||
147125210|NCT02037984|530623715|FG007|Overall Study|Withdrawal by Parent/Guardian|2|||
147125211|NCT02037984|530623708|FG000|Overall Study|Withdrawal by Subject|0|||
147125212|NCT02037984|530623709|FG001|Overall Study|Withdrawal by Subject|0|||
147125213|NCT02037984|530623710|FG002|Overall Study|Withdrawal by Subject|0|||
147125214|NCT02037984|530623711|FG003|Overall Study|Withdrawal by Subject|1|||
147125215|NCT02037984|530623712|FG004|Overall Study|Withdrawal by Subject|1|||
147125216|NCT02037984|530623713|FG005|Overall Study|Withdrawal by Subject|3|||
147125217|NCT02037984|530623714|FG006|Overall Study|Withdrawal by Subject|0|||
147125218|NCT02037984|530623715|FG007|Overall Study|Withdrawal by Subject|1|||
147125219|NCT01691092|530623718|FG000|Overall Study|Lost to Follow-up|10|||
147125220|NCT01691092|530623718|FG000|Overall Study|Physician Decision|4|||
147125221|NCT01691092|530623718|FG000|Overall Study|Withdrawal by Subject|3|||
147125222|NCT01691092|530623718|FG000|Overall Study|non-compliance|3|||
147125223|NCT01691092|530623718|FG000|Overall Study|used for different study|2|||
147125224|NCT01691092|530623718|FG000|Overall Study|screen fail|19|||
147125225|NCT00561821|530623719|FG000|Overall Study|Not treated|0|||
147125226|NCT00561821|530623720|FG001|Overall Study|Not treated|0|||
147125227|NCT00561821|530623721|FG002|Overall Study|Not treated|1|||
147316282|NCT02561455|531323636|FG002|Overall Study|Disease Progression|0|||
147316283|NCT02561455|531323637|FG003|Overall Study|Disease Progression|0|||
147316284|NCT00262743|531323638|FG000|Overall Study|Adverse Event|0|||
147316285|NCT00262743|531323639|FG001|Overall Study|Adverse Event|9|||
147316286|NCT00262743|531323638|FG000|Overall Study|Disease progression|0|||
147125228|NCT00561821|530623722|FG003|Overall Study|Not treated|0|||
147125229|NCT00561821|530623719|FG000|Overall Study|Withdrawal by Subject|0|||
147125230|NCT00561821|530623720|FG001|Overall Study|Withdrawal by Subject|1|||
147125231|NCT00561821|530623721|FG002|Overall Study|Withdrawal by Subject|0|||
147125232|NCT00561821|530623722|FG003|Overall Study|Withdrawal by Subject|2|||
147125233|NCT00561821|530623719|FG000|Overall Study|Reasons not related to trial|2|||
147125234|NCT00561821|530623720|FG001|Overall Study|Reasons not related to trial|1|||
147125235|NCT00561821|530623721|FG002|Overall Study|Reasons not related to trial|0|||
147125236|NCT00561821|530623722|FG003|Overall Study|Reasons not related to trial|0|||
147125237|NCT00561821|530623719|FG000|Overall Study|Other (reason not specified)|1|||
147125238|NCT00561821|530623720|FG001|Overall Study|Other (reason not specified)|1|||
147125239|NCT00561821|530623721|FG002|Overall Study|Other (reason not specified)|0|||
147125240|NCT00561821|530623722|FG003|Overall Study|Other (reason not specified)|0|||
147125241|NCT00561821|530623719|FG000|Overall Study|Adverse Event|2|||
147125242|NCT00561821|530623720|FG001|Overall Study|Adverse Event|3|||
147125243|NCT00561821|530623721|FG002|Overall Study|Adverse Event|1|||
147125244|NCT00561821|530623722|FG003|Overall Study|Adverse Event|1|||
147125245|NCT01657942|530623723|FG000|Overall Study|Alternative Treatment|7|||
147125246|NCT01657942|530623723|FG000|Overall Study|Lost to Follow-up|1|||
147125247|NCT00581100|530625422|FG000|Overall Study|Death|1|||
147316287|NCT00262743|531323639|FG001|Overall Study|Disease progression|3|||
147316288|NCT01950273|531323649|FG000|Overall Study|Protocol Violation|1|||
147316289|NCT01950273|531323650|FG001|Overall Study|Protocol Violation|0|||
147316290|NCT01950273|531323649|FG000|Overall Study|Withdrawal by Subject|2|||
147125248|NCT00581100|530625423|FG001|Overall Study|Death|0|||
147125249|NCT00581100|530625422|FG000|Overall Study|Adverse Event|2|||
147125250|NCT00581100|530625423|FG001|Overall Study|Adverse Event|1|||
147125251|NCT00581100|530625422|FG000|Overall Study|Withdrawal by Subject|1|||
147125252|NCT00581100|530625423|FG001|Overall Study|Withdrawal by Subject|4|||
147125253|NCT00581100|530625422|FG000|Overall Study|Other|3|||
147125254|NCT00581100|530625423|FG001|Overall Study|Other|0|||
147125255|NCT04129398|530625424|FG000|Overall Study|Physician Decision|2|||
147125256|NCT04280783|530625425|FG000|Overall Study|Family issues unrelated to the study.|1|||
147125257|NCT04280783|530625426|FG001|Overall Study|Family issues unrelated to the study.|0|||
147125258|NCT04280783|530625425|FG000|Overall Study|Withdrawal by Subject|0|||
147125259|NCT04280783|530625426|FG001|Overall Study|Withdrawal by Subject|1|||
147125260|NCT02904265|530625427|FG000|Overall Study|Physician Decision|1|||
147125261|NCT02904265|530625428|FG001|Overall Study|Physician Decision|2|||
147125262|NCT00185614|530625429|FG000|Inter-treatment Period|Physician Decision|1|||
147125263|NCT00185614|530625429|FG000|Inter-treatment Period|Relapse|2|||
147125264|NCT00185614|530625429|FG000|Inter-treatment Period|Lack of allogenic donor|1|||
147125265|NCT02579759|530625430|FG000|Overall Study|Protocol Violation|2|||
147125266|NCT02579759|530625431|FG001|Overall Study|Protocol Violation|0|||
147125267|NCT02579759|530625432|FG002|Overall Study|Protocol Violation|0|||
147125268|NCT02579759|530625430|FG000|Overall Study|Other (Sponsor stopped Dose 2)|0|||
147125269|NCT02579759|530625431|FG001|Overall Study|Other (Sponsor stopped Dose 2)|1|||
147125270|NCT02579759|530625432|FG002|Overall Study|Other (Sponsor stopped Dose 2)|0|||
147125271|NCT02579759|530625430|FG000|Overall Study|BfArM hold|13|||
147125272|NCT02579759|530625431|FG001|Overall Study|BfArM hold|12|||
147125273|NCT02579759|530625432|FG002|Overall Study|BfArM hold|12|||
147125274|NCT02579759|530625430|FG000|Overall Study|Sponsor stopped Dose 2|0|||
147125275|NCT02579759|530625431|FG001|Overall Study|Sponsor stopped Dose 2|41|||
147125276|NCT02579759|530625432|FG002|Overall Study|Sponsor stopped Dose 2|0|||
147125277|NCT02579759|530625430|FG000|Overall Study|Non compliance|0|||
147125278|NCT02579759|530625431|FG001|Overall Study|Non compliance|1|||
147125279|NCT02579759|530625432|FG002|Overall Study|Non compliance|0|||
147125280|NCT02579759|530625430|FG000|Overall Study|Pregnancy|0|||
147125281|NCT02579759|530625431|FG001|Overall Study|Pregnancy|1|||
147125282|NCT02579759|530625432|FG002|Overall Study|Pregnancy|0|||
147125283|NCT02579759|530625430|FG000|Overall Study|Inclusion/exclusion criteria|0|||
147125284|NCT02579759|530625431|FG001|Overall Study|Inclusion/exclusion criteria|0|||
147125285|NCT02579759|530625432|FG002|Overall Study|Inclusion/exclusion criteria|1|||
147125286|NCT02579759|530625430|FG000|Overall Study|Adverse Event|4|||
147125287|NCT02579759|530625431|FG001|Overall Study|Adverse Event|3|||
147125288|NCT02579759|530625432|FG002|Overall Study|Adverse Event|1|||
147125289|NCT02579759|530625430|FG000|Overall Study|Withdrawal by Subject|3|||
147125290|NCT02579759|530625431|FG001|Overall Study|Withdrawal by Subject|3|||
147125291|NCT02579759|530625432|FG002|Overall Study|Withdrawal by Subject|5|||
147125292|NCT02579759|530625430|FG000|Overall Study|Lost to Follow-up|2|||
147125293|NCT02579759|530625431|FG001|Overall Study|Lost to Follow-up|2|||
147125294|NCT02579759|530625432|FG002|Overall Study|Lost to Follow-up|2|||
147125295|NCT00770679|530625442|FG000|Overall Study|Lost to Follow-up|3|||
147125296|NCT00770679|530625442|FG000|Overall Study|Follow-up LDL measurement not collected|3|||
147125297|NCT00129974|530625443|FG000|Overall Study|Other|1|||
147125298|NCT01475825|530625449|FG000|Overall Study|Adverse Event|41|||
147125299|NCT01475825|530625450|FG001|Overall Study|Adverse Event|15|||
147125300|NCT01475825|530625451|FG002|Overall Study|Adverse Event|27|||
147125301|NCT01475825|530625452|FG003|Overall Study|Adverse Event|11|||
147125302|NCT01475825|530625449|FG000|Overall Study|Death|1|||
147125303|NCT01475825|530625450|FG001|Overall Study|Death|0|||
147125304|NCT01475825|530625451|FG002|Overall Study|Death|1|||
147316291|NCT01950273|531323650|FG001|Overall Study|Withdrawal by Subject|0|||
147316292|NCT01950273|531323649|FG000|Overall Study|Other not defined above|1|||
147316293|NCT01950273|531323650|FG001|Overall Study|Other not defined above|0|||
147316294|NCT00472186|531323651|FG000|Overall Study|Study was terminated due to poor compliance with returning logbooks by families.|1|||
147125305|NCT01475825|530625452|FG003|Overall Study|Death|0|||
147125306|NCT01475825|530625449|FG000|Overall Study|Lack of Efficacy|0|||
147125307|NCT01475825|530625450|FG001|Overall Study|Lack of Efficacy|0|||
147125308|NCT01475825|530625451|FG002|Overall Study|Lack of Efficacy|1|||
147125309|NCT01475825|530625452|FG003|Overall Study|Lack of Efficacy|0|||
147125310|NCT01475825|530625449|FG000|Overall Study|Lost to Follow-up|0|||
147125311|NCT01475825|530625450|FG001|Overall Study|Lost to Follow-up|0|||
147125312|NCT01475825|530625451|FG002|Overall Study|Lost to Follow-up|3|||
147125313|NCT01475825|530625452|FG003|Overall Study|Lost to Follow-up|1|||
147125314|NCT01475825|530625449|FG000|Overall Study|Non-compliance with Study Drug|1|||
147125315|NCT01475825|530625450|FG001|Overall Study|Non-compliance with Study Drug|2|||
147125316|NCT01475825|530625451|FG002|Overall Study|Non-compliance with Study Drug|4|||
147125317|NCT01475825|530625452|FG003|Overall Study|Non-compliance with Study Drug|0|||
147125318|NCT01475825|530625449|FG000|Overall Study|Other: Not available|0|||
147125319|NCT01475825|530625450|FG001|Overall Study|Other: Not available|0|||
147125320|NCT01475825|530625451|FG002|Overall Study|Other: Not available|2|||
147125321|NCT01475825|530625452|FG003|Overall Study|Other: Not available|0|||
147125322|NCT01475825|530625449|FG000|Overall Study|Protocol Violation|1|||
147125323|NCT01475825|530625450|FG001|Overall Study|Protocol Violation|0|||
147125324|NCT01475825|530625451|FG002|Overall Study|Protocol Violation|0|||
147125325|NCT01475825|530625452|FG003|Overall Study|Protocol Violation|0|||
147125326|NCT01475825|530625449|FG000|Overall Study|Physician Decision|0|||
147125327|NCT01475825|530625450|FG001|Overall Study|Physician Decision|1|||
147125328|NCT01475825|530625451|FG002|Overall Study|Physician Decision|0|||
147125329|NCT01475825|530625452|FG003|Overall Study|Physician Decision|0|||
147125330|NCT01475825|530625449|FG000|Overall Study|Withdrawal by Subject|8|||
147125331|NCT01475825|530625450|FG001|Overall Study|Withdrawal by Subject|3|||
147125332|NCT01475825|530625451|FG002|Overall Study|Withdrawal by Subject|11|||
147125333|NCT01475825|530625452|FG003|Overall Study|Withdrawal by Subject|7|||
147125334|NCT01475825|530625449|FG000|Overall Study|Did not enter OLC|15|||
147125335|NCT01475825|530625450|FG001|Overall Study|Did not enter OLC|11|||
147125336|NCT01475825|530625451|FG002|Overall Study|Did not enter OLC|15|||
147125337|NCT01475825|530625452|FG003|Overall Study|Did not enter OLC|11|||
147125338|NCT00867334|530625453|FG000|Overall Study|Withdrawal by Subject|0|||
147125339|NCT00867334|530625454|FG001|Overall Study|Withdrawal by Subject|1|||
147125340|NCT00867334|530625453|FG000|Overall Study|Withdrawal by Subject|1|||
147125341|NCT00867334|530625454|FG001|Overall Study|Withdrawal by Subject|0|||
147125342|NCT00867334|530625453|FG000|Overall Study|Withdrawal by Subject|1|||
147125343|NCT00867334|530625454|FG001|Overall Study|Withdrawal by Subject|0|||
147125344|NCT01047540|530625461|FG000|Overall Study|Protocol Violation|1|||
147125345|NCT01047540|530625462|FG001|Overall Study|Protocol Violation|0|||
147125346|NCT01047540|530625463|FG002|Overall Study|Protocol Violation|0|||
147125347|NCT01047540|530625464|FG003|Overall Study|Protocol Violation|0|||
147125348|NCT01047540|530625465|FG004|Overall Study|Protocol Violation|0|||
147125349|NCT01047540|530625461|FG000|Overall Study|Lost to Follow-up|1|||
147125350|NCT01047540|530625462|FG001|Overall Study|Lost to Follow-up|0|||
147125351|NCT01047540|530625463|FG002|Overall Study|Lost to Follow-up|0|||
147125352|NCT01047540|530625464|FG003|Overall Study|Lost to Follow-up|0|||
147125353|NCT01047540|530625465|FG004|Overall Study|Lost to Follow-up|0|||
147125354|NCT01047540|530625461|FG000|Overall Study|Withdrawal by Subject|1|||
147125355|NCT01047540|530625462|FG001|Overall Study|Withdrawal by Subject|0|||
147125356|NCT01047540|530625463|FG002|Overall Study|Withdrawal by Subject|3|||
147125357|NCT01047540|530625464|FG003|Overall Study|Withdrawal by Subject|0|||
147125358|NCT01047540|530625465|FG004|Overall Study|Withdrawal by Subject|1|||
147125359|NCT01047540|530625461|FG000|Overall Study|Pregnancy|1|||
147125360|NCT01047540|530625462|FG001|Overall Study|Pregnancy|0|||
147125361|NCT01047540|530625463|FG002|Overall Study|Pregnancy|0|||
147125362|NCT01047540|530625464|FG003|Overall Study|Pregnancy|0|||
147125363|NCT01047540|530625465|FG004|Overall Study|Pregnancy|0|||
147125364|NCT01047540|530625461|FG000|Overall Study|Adverse Event|1|||
147125365|NCT01047540|530625462|FG001|Overall Study|Adverse Event|0|||
147125366|NCT01047540|530625463|FG002|Overall Study|Adverse Event|0|||
147125367|NCT01047540|530625464|FG003|Overall Study|Adverse Event|0|||
147125368|NCT01047540|530625465|FG004|Overall Study|Adverse Event|0|||
147125369|NCT01437189|530625469|FG000|Overall Study|Adverse Event|3|||
147125370|NCT01437189|530625469|FG000|Overall Study|Lack of Efficacy|4|||
147125371|NCT01437189|530625469|FG000|Overall Study|Withdrawal by Subject|8|||
147125372|NCT04576481|530625478|FG000|Randomized Controlled Trial (Phase 2)|Lost to Follow-up|0|||
147125373|NCT04576481|530625479|FG001|Randomized Controlled Trial (Phase 2)|Lost to Follow-up|1|||
147125374|NCT04576481|530625480|FG002|Randomized Controlled Trial (Phase 2)|Lost to Follow-up|3|||
147125375|NCT04576481|530625481|FG003|Randomized Controlled Trial (Phase 2)|Lost to Follow-up|1|||
147125376|NCT03464461|530625482|FG000|Overall Study|exclusionary medication given ,|1|||
147125377|NCT03464461|530625483|FG001|Overall Study|exclusionary medication given ,|2|||
147125378|NCT03464461|530625484|FG002|Overall Study|exclusionary medication given ,|0|||
147125379|NCT03464461|530625482|FG000|Overall Study|Physician Decision|0|||
147125380|NCT03464461|530625483|FG001|Overall Study|Physician Decision|1|||
147125381|NCT03464461|530625484|FG002|Overall Study|Physician Decision|0|||
147125382|NCT05261490|530625486|FG000|Overall Study|Other|1|||
147125383|NCT05261490|530625487|FG001|Overall Study|Other|0|||
147125384|NCT05261490|530625488|FG002|Overall Study|Other|0|||
147125385|NCT05261490|530625486|FG000|Overall Study|Study Terminated by Sponsor|1|||
147125386|NCT05261490|530625487|FG001|Overall Study|Study Terminated by Sponsor|1|||
147125387|NCT05261490|530625488|FG002|Overall Study|Study Terminated by Sponsor|4|||
147125388|NCT05261490|530625486|FG000|Overall Study|Death|1|||
147125389|NCT05261490|530625487|FG001|Overall Study|Death|2|||
147125390|NCT05261490|530625488|FG002|Overall Study|Death|0|||
147125391|NCT00456365|530625496|FG000|Overall Study|Lost to Follow-up|1|||
147125392|NCT00456365|530625497|FG001|Overall Study|Lost to Follow-up|3|||
147125393|NCT00456365|530625496|FG000|Overall Study|Withdrawal by Subject|4|||
147125394|NCT00456365|530625497|FG001|Overall Study|Withdrawal by Subject|7|||
147125395|NCT00456365|530625496|FG000|Overall Study|Pregnancy|1|||
147125396|NCT00456365|530625497|FG001|Overall Study|Pregnancy|1|||
147125397|NCT00456365|530625496|FG000|Overall Study|oncologic diagnosis|1|||
147125398|NCT00456365|530625497|FG001|Overall Study|oncologic diagnosis|1|||
147125399|NCT06091956|530625498|FG000|Overall Study|Withdrawal by Subject|1|||
147125400|NCT06091956|530625498|FG000|Overall Study|Complicating Disease|1|||
147125401|NCT01681849|530625504|FG000|Overall Study|Protocol Violation|2|||
147125402|NCT01681849|530625505|FG001|Overall Study|Protocol Violation|0|||
147125403|NCT01681849|530625506|FG002|Overall Study|Protocol Violation|0|||
147125404|NCT01681849|530625504|FG000|Overall Study|Withdrawal by Subject|3|||
147125405|NCT01681849|530625505|FG001|Overall Study|Withdrawal by Subject|5|||
147125406|NCT01681849|530625506|FG002|Overall Study|Withdrawal by Subject|33|||
147125407|NCT01681849|530625504|FG000|Overall Study|Lost to Follow-up|3|||
147125408|NCT01681849|530625505|FG001|Overall Study|Lost to Follow-up|2|||
147125409|NCT01681849|530625506|FG002|Overall Study|Lost to Follow-up|6|||
147125410|NCT00979407|530625507|FG000|Overall Study|Withdrawal by Subject|3|||
147125411|NCT00979407|530625508|FG001|Overall Study|Withdrawal by Subject|4|||
147125412|NCT00979407|530625507|FG000|Overall Study|Lost to Follow-up|3|||
147125413|NCT00979407|530625508|FG001|Overall Study|Lost to Follow-up|3|||
147125414|NCT01166646|530625509|FG000|Overall Study|Protocol Violation|0|||
147125415|NCT01166646|530625510|FG001|Overall Study|Protocol Violation|1|||
147125416|NCT01166646|530625509|FG000|Overall Study|Adverse Event|1|||
147125417|NCT01166646|530625510|FG001|Overall Study|Adverse Event|0|||
147125418|NCT01335685|530625513|FG000|Overall Study|Study Terminated by Sponsor|2|||
147125419|NCT01335685|530625514|FG001|Overall Study|Study Terminated by Sponsor|1|||
147125420|NCT01335685|530625515|FG002|Overall Study|Study Terminated by Sponsor|1|||
147125421|NCT01335685|530625516|FG003|Overall Study|Study Terminated by Sponsor|10|||
147125422|NCT01335685|530625517|FG004|Overall Study|Study Terminated by Sponsor|0|||
147125423|NCT01335685|530625518|FG005|Overall Study|Study Terminated by Sponsor|4|||
147125424|NCT01335685|530625519|FG006|Overall Study|Study Terminated by Sponsor|2|||
147125425|NCT01335685|530625520|FG007|Overall Study|Study Terminated by Sponsor|3|||
147125426|NCT01335685|530625513|FG000|Overall Study|Withdrawal by Subject|1|||
147125427|NCT01335685|530625514|FG001|Overall Study|Withdrawal by Subject|0|||
147125428|NCT01335685|530625515|FG002|Overall Study|Withdrawal by Subject|0|||
147125429|NCT01335685|530625516|FG003|Overall Study|Withdrawal by Subject|1|||
147125430|NCT01335685|530625517|FG004|Overall Study|Withdrawal by Subject|0|||
147125431|NCT01335685|530625518|FG005|Overall Study|Withdrawal by Subject|0|||
147125432|NCT01335685|530625519|FG006|Overall Study|Withdrawal by Subject|0|||
147125433|NCT01335685|530625520|FG007|Overall Study|Withdrawal by Subject|0|||
147125434|NCT01335685|530625513|FG000|Overall Study|Reason not Specified|0|||
147125435|NCT01335685|530625514|FG001|Overall Study|Reason not Specified|0|||
147125436|NCT01335685|530625515|FG002|Overall Study|Reason not Specified|1|||
147125437|NCT01335685|530625516|FG003|Overall Study|Reason not Specified|0|||
147125438|NCT01335685|530625517|FG004|Overall Study|Reason not Specified|0|||
147125439|NCT01335685|530625518|FG005|Overall Study|Reason not Specified|1|||
147125440|NCT01335685|530625519|FG006|Overall Study|Reason not Specified|0|||
147125441|NCT01335685|530625520|FG007|Overall Study|Reason not Specified|0|||
147125442|NCT03460704|530625521|FG000|Overall Study|Withdrawal by Subject|11|||
147125443|NCT03460704|530625522|FG001|Overall Study|Withdrawal by Subject|14|||
147125444|NCT03460704|530625521|FG000|Overall Study|Study terminated by the Sponsor|29|||
147125445|NCT03460704|530625522|FG001|Overall Study|Study terminated by the Sponsor|19|||
147125446|NCT03460704|530625521|FG000|Overall Study|Adverse Event|10|||
147125447|NCT03460704|530625522|FG001|Overall Study|Adverse Event|5|||
147234460|NCT01024231|531030128|FG000|Overall Study|Study Drug Toxicity|1|||
147234461|NCT01024231|531030129|FG001|Overall Study|Study Drug Toxicity|6|||
147234462|NCT01024231|531030130|FG002|Overall Study|Study Drug Toxicity|6|||
147234463|NCT01024231|531030131|FG003|Overall Study|Study Drug Toxicity|4|||
147234464|NCT01024231|531030132|FG004|Overall Study|Study Drug Toxicity|2|||
147234465|NCT01024231|531030133|FG005|Overall Study|Study Drug Toxicity|0|||
147234466|NCT01024231|531030134|FG006|Overall Study|Study Drug Toxicity|7|||
147234467|NCT01024231|531030128|FG000|Overall Study|Death|6|||
147234468|NCT01024231|531030129|FG001|Overall Study|Death|2|||
147234469|NCT01024231|531030130|FG002|Overall Study|Death|1|||
147234470|NCT01024231|531030131|FG003|Overall Study|Death|0|||
147234471|NCT01024231|531030132|FG004|Overall Study|Death|4|||
147234472|NCT01024231|531030133|FG005|Overall Study|Death|3|||
147234473|NCT01024231|531030134|FG006|Overall Study|Death|5|||
147234474|NCT01024231|531030128|FG000|Overall Study|Lost to Follow-up|0|||
147234475|NCT01024231|531030129|FG001|Overall Study|Lost to Follow-up|0|||
147125448|NCT03460704|530625521|FG000|Overall Study|Death|3|||
147125449|NCT03460704|530625522|FG001|Overall Study|Death|2|||
147125450|NCT03460704|530625521|FG000|Overall Study|Non-Compliance with Study Drug|3|||
147125451|NCT03460704|530625522|FG001|Overall Study|Non-Compliance with Study Drug|0|||
147125452|NCT03460704|530625521|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
147125453|NCT03460704|530625522|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|5|||
147125454|NCT03460704|530625521|FG000|Overall Study|Other|2|||
147234476|NCT01024231|531030130|FG002|Overall Study|Lost to Follow-up|0|||
147125455|NCT03460704|530625522|FG001|Overall Study|Other|1|||
147125456|NCT01767857|530625523|FG000|Overall Study|Adverse Event|27|||
147125457|NCT01767857|530625524|FG001|Overall Study|Adverse Event|7|||
147125458|NCT01767857|530625523|FG000|Overall Study|Death|28|||
147234477|NCT01024231|531030131|FG003|Overall Study|Lost to Follow-up|0|||
147234478|NCT01024231|531030132|FG004|Overall Study|Lost to Follow-up|0|||
147234479|NCT01024231|531030133|FG005|Overall Study|Lost to Follow-up|0|||
147234480|NCT01024231|531030134|FG006|Overall Study|Lost to Follow-up|1|||
147125459|NCT01767857|530625524|FG001|Overall Study|Death|13|||
147125460|NCT01767857|530625523|FG000|Overall Study|Lack of Efficacy|299|||
147125461|NCT01767857|530625524|FG001|Overall Study|Lack of Efficacy|151|||
147125462|NCT01767857|530625523|FG000|Overall Study|Lost to Follow-up|1|||
147125463|NCT01767857|530625524|FG001|Overall Study|Lost to Follow-up|1|||
147125464|NCT01767857|530625523|FG000|Overall Study|Withdrawal by Subject|38|||
147125465|NCT01767857|530625524|FG001|Overall Study|Withdrawal by Subject|18|||
147125466|NCT01767857|530625523|FG000|Overall Study|Physician Decision|17|||
147125467|NCT01767857|530625524|FG001|Overall Study|Physician Decision|10|||
147125468|NCT01767857|530625523|FG000|Overall Study|Protocol Terminated|1|||
147125469|NCT01767857|530625524|FG001|Overall Study|Protocol Terminated|0|||
147125470|NCT01767857|530625523|FG000|Overall Study|Randomized But Never Treated|19|||
147125471|NCT01767857|530625524|FG001|Overall Study|Randomized But Never Treated|13|||
147125472|NCT01421459|530625525|FG000|Overall Study|Adverse Event|6|||
147125473|NCT01421459|530625526|FG001|Overall Study|Adverse Event|10|||
147125474|NCT01421459|530625525|FG000|Overall Study|Death|1|||
147125475|NCT01421459|530625526|FG001|Overall Study|Death|1|||
147125476|NCT01421459|530625525|FG000|Overall Study|Lack of Efficacy|1|||
147125477|NCT01421459|530625526|FG001|Overall Study|Lack of Efficacy|2|||
147125478|NCT01421459|530625525|FG000|Overall Study|Lost to Follow-up|8|||
147125479|NCT01421459|530625526|FG001|Overall Study|Lost to Follow-up|9|||
147125480|NCT01421459|530625525|FG000|Overall Study|Physician Decision|9|||
147125481|NCT01421459|530625526|FG001|Overall Study|Physician Decision|9|||
147125482|NCT01421459|530625525|FG000|Overall Study|Protocol Violation|8|||
147125483|NCT01421459|530625526|FG001|Overall Study|Protocol Violation|5|||
147125484|NCT01421459|530625525|FG000|Overall Study|Withdrawal by Subject|12|||
147125485|NCT01421459|530625526|FG001|Overall Study|Withdrawal by Subject|16|||
147125486|NCT01422382|530625527|FG000|NK-104 4mg QD and Diltiazem 240 mg QD|personal reasons|1|||
147125487|NCT04126174|530625528|FG000|Overall Study|Lost to Follow-up|3|||
147125488|NCT04126174|530625529|FG001|Overall Study|Lost to Follow-up|3|||
147125489|NCT03186378|530625546|FG000|Overall Study|Lost to Follow-up|1|||
147125490|NCT03186378|530625547|FG001|Overall Study|Lost to Follow-up|0|||
147125491|NCT02514746|530625554|FG000|Overall Study|Chronically Ill|1|||
147125492|NCT02514746|530625555|FG001|Overall Study|Chronically Ill|2|||
147125493|NCT02514746|530625554|FG000|Overall Study|Physician Decision|4|||
147125494|NCT02514746|530625555|FG001|Overall Study|Physician Decision|2|||
147125495|NCT02514746|530625554|FG000|Overall Study|Withdrawal by Subject|12|||
147125496|NCT02514746|530625555|FG001|Overall Study|Withdrawal by Subject|10|||
147125497|NCT02514746|530625554|FG000|Overall Study|Other|5|||
147125498|NCT02514746|530625555|FG001|Overall Study|Other|1|||
147125499|NCT03382873|530625557|FG000|Overall Study|Lost to Follow-up|9|||
147125500|NCT03382873|530625558|FG001|Overall Study|Lost to Follow-up|10|||
147125501|NCT03382873|530625557|FG000|Overall Study|Withdrawal by Subject|6|||
147125502|NCT03382873|530625558|FG001|Overall Study|Withdrawal by Subject|11|||
147125503|NCT03382873|530625557|FG000|Overall Study|Visit not completed due to pandemic|16|||
147125504|NCT03382873|530625558|FG001|Overall Study|Visit not completed due to pandemic|41|||
147125505|NCT05021224|530625559|FG000|Overall Study|Did not complete all survey items|4|||
147125506|NCT05021224|530625560|FG001|Overall Study|Did not complete all survey items|1|||
147125507|NCT05021224|530625561|FG002|Overall Study|Did not complete all survey items|0|||
147125508|NCT05021224|530625562|FG003|Overall Study|Did not complete all survey items|2|||
147125509|NCT03996395|530625563|FG000|Overall Study|Lost to Follow-up|4|||
147125510|NCT03996395|530625563|FG000|Overall Study|Withdrawal by Subject|1|||
147125511|NCT03996395|530625563|FG000|Overall Study|Study halted due to COVID-19 pandemic.|7|||
147125512|NCT05375929|530625564|FG000|Main Study: Treatment Phase (12 Weeks)|Adverse Event|1|||
147125513|NCT05375929|530625565|FG001|Main Study: Treatment Phase (12 Weeks)|Adverse Event|0|||
147125514|NCT05375929|530625566|FG002|Main Study: Treatment Phase (12 Weeks)|Adverse Event|0|||
147125515|NCT05375929|530625567|FG003|Main Study: Treatment Phase (12 Weeks)|Adverse Event|0|||
147125516|NCT05375929|530625564|FG000|Main Study: Treatment Phase (12 Weeks)|Lost to Follow-up|1|||
147125517|NCT05375929|530625565|FG001|Main Study: Treatment Phase (12 Weeks)|Lost to Follow-up|1|||
147125518|NCT05375929|530625566|FG002|Main Study: Treatment Phase (12 Weeks)|Lost to Follow-up|0|||
147125519|NCT05375929|530625567|FG003|Main Study: Treatment Phase (12 Weeks)|Lost to Follow-up|0|||
147125520|NCT05375929|530625564|FG000|Main Study: Treatment Phase (12 Weeks)|Withdrawal by Subject|6|||
147125521|NCT05375929|530625565|FG001|Main Study: Treatment Phase (12 Weeks)|Withdrawal by Subject|5|||
147125522|NCT05375929|530625566|FG002|Main Study: Treatment Phase (12 Weeks)|Withdrawal by Subject|0|||
147125523|NCT05375929|530625567|FG003|Main Study: Treatment Phase (12 Weeks)|Withdrawal by Subject|0|||
147125524|NCT05375929|530625564|FG000|Main Study: Treatment Phase (12 Weeks)|Withdrawal by parent/guardian|0|||
147125525|NCT05375929|530625565|FG001|Main Study: Treatment Phase (12 Weeks)|Withdrawal by parent/guardian|1|||
147125526|NCT05375929|530625566|FG002|Main Study: Treatment Phase (12 Weeks)|Withdrawal by parent/guardian|0|||
147125527|NCT05375929|530625567|FG003|Main Study: Treatment Phase (12 Weeks)|Withdrawal by parent/guardian|0|||
147125528|NCT05375929|530625564|FG000|Main Study: Follow-up (4 Weeks)|Lost to Follow-up|1|||
147125529|NCT05375929|530625565|FG001|Main Study: Follow-up (4 Weeks)|Lost to Follow-up|0|||
147125530|NCT05375929|530625566|FG002|Main Study: Follow-up (4 Weeks)|Lost to Follow-up|0|||
147125531|NCT05375929|530625567|FG003|Main Study: Follow-up (4 Weeks)|Lost to Follow-up|0|||
147234481|NCT01024231|531030128|FG000|Overall Study|Withdrew Consent|0|||
147651165|NCT01557517|532544597|FG000|Overall Study|Pt declined before treatment started|1|||
147651166|NCT01557517|532544598|FG001|Overall Study|Pt declined before treatment started|0|||
147125532|NCT05375929|530625564|FG000|Main Study: Follow-up (4 Weeks)|Did not complete study follow-up|0|||
147125533|NCT05375929|530625565|FG001|Main Study: Follow-up (4 Weeks)|Did not complete study follow-up|1|||
147125534|NCT05375929|530625566|FG002|Main Study: Follow-up (4 Weeks)|Did not complete study follow-up|0|||
147125535|NCT05375929|530625567|FG003|Main Study: Follow-up (4 Weeks)|Did not complete study follow-up|0|||
147125536|NCT05375929|530625564|FG000|Substudy: Treatment Phase (1 Year)|Withdrawal by parent/guardian|0|||
147125537|NCT05375929|530625565|FG001|Substudy: Treatment Phase (1 Year)|Withdrawal by parent/guardian|0|||
147125538|NCT05375929|530625566|FG002|Substudy: Treatment Phase (1 Year)|Withdrawal by parent/guardian|0|||
147125539|NCT05375929|530625567|FG003|Substudy: Treatment Phase (1 Year)|Withdrawal by parent/guardian|1|||
147125540|NCT05375929|530625564|FG000|Substudy: Treatment Phase (1 Year)|Physician Decision|0|||
147125541|NCT05375929|530625565|FG001|Substudy: Treatment Phase (1 Year)|Physician Decision|0|||
147125542|NCT05375929|530625566|FG002|Substudy: Treatment Phase (1 Year)|Physician Decision|4|||
147125543|NCT05375929|530625567|FG003|Substudy: Treatment Phase (1 Year)|Physician Decision|0|||
147125544|NCT05375929|530625564|FG000|Substudy: Treatment Phase (1 Year)|Lost to Follow-up|0|||
147125545|NCT05375929|530625565|FG001|Substudy: Treatment Phase (1 Year)|Lost to Follow-up|0|||
147125546|NCT05375929|530625566|FG002|Substudy: Treatment Phase (1 Year)|Lost to Follow-up|1|||
147125547|NCT05375929|530625567|FG003|Substudy: Treatment Phase (1 Year)|Lost to Follow-up|0|||
147125548|NCT05375929|530625564|FG000|Substudy: Treatment Phase (1 Year)|Adverse Event|0|||
147125549|NCT05375929|530625565|FG001|Substudy: Treatment Phase (1 Year)|Adverse Event|0|||
147125550|NCT05375929|530625566|FG002|Substudy: Treatment Phase (1 Year)|Adverse Event|2|||
147125551|NCT05375929|530625567|FG003|Substudy: Treatment Phase (1 Year)|Adverse Event|0|||
147125552|NCT03973489|530625568|FG000|Washout Period (at Least 3 Days)|Lost to Follow-up|1|||
147125553|NCT03973489|530625569|FG001|Washout Period (at Least 3 Days)|Lost to Follow-up|0|||
147234482|NCT01024231|531030129|FG001|Overall Study|Withdrew Consent|1|||
147234483|NCT01024231|531030130|FG002|Overall Study|Withdrew Consent|0|||
147234484|NCT01024231|531030131|FG003|Overall Study|Withdrew Consent|0|||
147234485|NCT01024231|531030132|FG004|Overall Study|Withdrew Consent|0|||
147234486|NCT01024231|531030133|FG005|Overall Study|Withdrew Consent|0|||
147234487|NCT01024231|531030134|FG006|Overall Study|Withdrew Consent|0|||
147234488|NCT01024231|531030128|FG000|Overall Study|Continuing on Treatment|0|||
147234489|NCT01024231|531030129|FG001|Overall Study|Continuing on Treatment|0|||
147234490|NCT01024231|531030130|FG002|Overall Study|Continuing on Treatment|0|||
147234491|NCT01024231|531030131|FG003|Overall Study|Continuing on Treatment|0|||
147234492|NCT01024231|531030132|FG004|Overall Study|Continuing on Treatment|3|||
147234493|NCT01024231|531030133|FG005|Overall Study|Continuing on Treatment|2|||
147234494|NCT01024231|531030134|FG006|Overall Study|Continuing on Treatment|0|||
147234495|NCT01691898|531030135|FG000|Overall Study|Death|34|||
147234496|NCT01691898|531030136|FG001|Overall Study|Death|32|||
147234497|NCT01691898|531030137|FG002|Overall Study|Death|6|||
147234498|NCT01691898|531030138|FG003|Overall Study|Death|3|||
147234499|NCT01691898|531030139|FG004|Overall Study|Death|8|||
147234500|NCT01691898|531030140|FG005|Overall Study|Death|31|||
147234501|NCT01691898|531030135|FG000|Overall Study|Adverse Event|0|||
147234502|NCT01691898|531030136|FG001|Overall Study|Adverse Event|1|||
147234503|NCT01691898|531030137|FG002|Overall Study|Adverse Event|0|||
147234504|NCT01691898|531030138|FG003|Overall Study|Adverse Event|1|||
147234505|NCT01691898|531030139|FG004|Overall Study|Adverse Event|1|||
147234506|NCT01691898|531030140|FG005|Overall Study|Adverse Event|0|||
147234507|NCT01691898|531030135|FG000|Overall Study|Progression of Disease|1|||
147234508|NCT01691898|531030136|FG001|Overall Study|Progression of Disease|2|||
147234509|NCT01691898|531030137|FG002|Overall Study|Progression of Disease|1|||
147234510|NCT01691898|531030138|FG003|Overall Study|Progression of Disease|0|||
147234511|NCT01691898|531030139|FG004|Overall Study|Progression of Disease|0|||
147234512|NCT01691898|531030140|FG005|Overall Study|Progression of Disease|1|||
147234513|NCT01691898|531030135|FG000|Overall Study|Lost to Follow-up|3|||
147234514|NCT01691898|531030136|FG001|Overall Study|Lost to Follow-up|1|||
147234515|NCT01691898|531030137|FG002|Overall Study|Lost to Follow-up|0|||
147234516|NCT01691898|531030138|FG003|Overall Study|Lost to Follow-up|0|||
147234517|NCT01691898|531030139|FG004|Overall Study|Lost to Follow-up|1|||
147234518|NCT01691898|531030140|FG005|Overall Study|Lost to Follow-up|0|||
147234519|NCT01691898|531030135|FG000|Overall Study|Withdrawal by Subject|9|||
147234520|NCT01691898|531030136|FG001|Overall Study|Withdrawal by Subject|8|||
147234521|NCT01691898|531030137|FG002|Overall Study|Withdrawal by Subject|2|||
147234522|NCT01691898|531030138|FG003|Overall Study|Withdrawal by Subject|1|||
147234523|NCT01691898|531030139|FG004|Overall Study|Withdrawal by Subject|3|||
147234524|NCT01691898|531030140|FG005|Overall Study|Withdrawal by Subject|3|||
147234525|NCT01691898|531030135|FG000|Overall Study|Non-Compliance|0|||
147234526|NCT01691898|531030136|FG001|Overall Study|Non-Compliance|0|||
147234527|NCT01691898|531030137|FG002|Overall Study|Non-Compliance|0|||
147234528|NCT01691898|531030138|FG003|Overall Study|Non-Compliance|0|||
147234529|NCT01691898|531030139|FG004|Overall Study|Non-Compliance|1|||
147234530|NCT01691898|531030140|FG005|Overall Study|Non-Compliance|0|||
147234531|NCT01013350|531030141|FG000|Overall Study|Lost to Follow-up|15|||
147125554|NCT03973489|530625570|FG002|Washout Period (at Least 3 Days)|Lost to Follow-up|0|||
147125555|NCT03973489|530625571|FG003|Washout Period (at Least 3 Days)|Lost to Follow-up|0|||
147125556|NCT03973489|530625572|FG004|Washout Period (at Least 3 Days)|Lost to Follow-up|1|||
147125557|NCT03973489|530625573|FG005|Washout Period (at Least 3 Days)|Lost to Follow-up|0|||
147125558|NCT03973489|530625574|FG006|Washout Period (at Least 3 Days)|Lost to Follow-up|0|||
147125559|NCT03973489|530625575|FG007|Washout Period (at Least 3 Days)|Lost to Follow-up|0|||
147125560|NCT03973489|530625568|FG000|Washout Period (at Least 3 Days)|Withdrawal by Subject|0|||
147125561|NCT03973489|530625569|FG001|Washout Period (at Least 3 Days)|Withdrawal by Subject|0|||
147125562|NCT03973489|530625570|FG002|Washout Period (at Least 3 Days)|Withdrawal by Subject|0|||
147125563|NCT03973489|530625571|FG003|Washout Period (at Least 3 Days)|Withdrawal by Subject|1|||
147125564|NCT03973489|530625572|FG004|Washout Period (at Least 3 Days)|Withdrawal by Subject|1|||
147125565|NCT03973489|530625573|FG005|Washout Period (at Least 3 Days)|Withdrawal by Subject|0|||
147125566|NCT03973489|530625574|FG006|Washout Period (at Least 3 Days)|Withdrawal by Subject|0|||
147125567|NCT03973489|530625575|FG007|Washout Period (at Least 3 Days)|Withdrawal by Subject|0|||
147125568|NCT03973489|530625568|FG000|Washout Period (at Least 3 Days)|Physician Decision|0|||
147125569|NCT03973489|530625569|FG001|Washout Period (at Least 3 Days)|Physician Decision|0|||
147125570|NCT03973489|530625570|FG002|Washout Period (at Least 3 Days)|Physician Decision|0|||
147125571|NCT03973489|530625571|FG003|Washout Period (at Least 3 Days)|Physician Decision|0|||
147125572|NCT03973489|530625572|FG004|Washout Period (at Least 3 Days)|Physician Decision|1|||
147125573|NCT03973489|530625573|FG005|Washout Period (at Least 3 Days)|Physician Decision|0|||
147125574|NCT03973489|530625574|FG006|Washout Period (at Least 3 Days)|Physician Decision|1|||
147125575|NCT03973489|530625575|FG007|Washout Period (at Least 3 Days)|Physician Decision|0|||
147125576|NCT03973489|530625568|FG000|Washout Period (at Least 3 Days)|Too much motion in scanner|1|||
147125577|NCT03973489|530625569|FG001|Washout Period (at Least 3 Days)|Too much motion in scanner|0|||
147125578|NCT03973489|530625570|FG002|Washout Period (at Least 3 Days)|Too much motion in scanner|0|||
147125579|NCT03973489|530625571|FG003|Washout Period (at Least 3 Days)|Too much motion in scanner|1|||
147125580|NCT03973489|530625572|FG004|Washout Period (at Least 3 Days)|Too much motion in scanner|0|||
147125581|NCT03973489|530625573|FG005|Washout Period (at Least 3 Days)|Too much motion in scanner|0|||
147125582|NCT03973489|530625574|FG006|Washout Period (at Least 3 Days)|Too much motion in scanner|0|||
147125583|NCT03973489|530625575|FG007|Washout Period (at Least 3 Days)|Too much motion in scanner|0|||
147125584|NCT03973489|530625568|FG000|Second Intervention (1 Day)|Adverse Event|0|||
147125585|NCT03973489|530625569|FG001|Second Intervention (1 Day)|Adverse Event|0|||
147125586|NCT03973489|530625570|FG002|Second Intervention (1 Day)|Adverse Event|0|||
147125587|NCT03973489|530625571|FG003|Second Intervention (1 Day)|Adverse Event|1|||
147125588|NCT03973489|530625572|FG004|Second Intervention (1 Day)|Adverse Event|0|||
147125589|NCT03973489|530625573|FG005|Second Intervention (1 Day)|Adverse Event|0|||
147125590|NCT03973489|530625574|FG006|Second Intervention (1 Day)|Adverse Event|0|||
147125591|NCT03973489|530625575|FG007|Second Intervention (1 Day)|Adverse Event|0|||
147125592|NCT03301415|530625576|FG000|Overall Study|Lost to Follow-up|2|||
147125593|NCT03301415|530625576|FG000|Overall Study|Unable to comply with visit schedule|2|||
147125594|NCT03247673|530625577|FG000|Overall Study|Withdrawal by Subject|1|||
147125595|NCT03247673|530625578|FG001|Overall Study|Withdrawal by Subject|0|||
147125596|NCT03247673|530625579|FG002|Overall Study|Withdrawal by Subject|3|||
147125597|NCT03247673|530625577|FG000|Overall Study|Lost to Follow-up|0|||
147125598|NCT03247673|530625578|FG001|Overall Study|Lost to Follow-up|0|||
147234532|NCT01013350|531030142|FG001|Overall Study|Lost to Follow-up|95|||
147234533|NCT01013350|531030141|FG000|Overall Study|Adverse Event|0|||
147234534|NCT01013350|531030142|FG001|Overall Study|Adverse Event|1|||
147234535|NCT01013350|531030141|FG000|Overall Study|Physician Decision|4|||
147234536|NCT01013350|531030142|FG001|Overall Study|Physician Decision|20|||
147234537|NCT01013350|531030141|FG000|Overall Study|Withdrawal by Subject|15|||
147234538|NCT01013350|531030142|FG001|Overall Study|Withdrawal by Subject|38|||
147234539|NCT01013350|531030141|FG000|Overall Study|Death|3|||
147234540|NCT01013350|531030142|FG001|Overall Study|Death|5|||
147234541|NCT01013350|531030141|FG000|Overall Study|Participant entered interventional study|0|||
147234542|NCT01013350|531030142|FG001|Overall Study|Participant entered interventional study|8|||
147234543|NCT01013350|531030141|FG000|Overall Study|Other|1|||
147234544|NCT01013350|531030142|FG001|Overall Study|Other|25|||
147234545|NCT04738734|531030143|FG000|Overall Study|Withdrawal by Subject|2|||
147234546|NCT04738734|531030144|FG001|Overall Study|Withdrawal by Subject|4|||
147234547|NCT04738734|531030143|FG000|Overall Study|Lost to Follow-up|5|||
147234548|NCT04738734|531030144|FG001|Overall Study|Lost to Follow-up|2|||
147234549|NCT04738734|531030143|FG000|Overall Study|Physician Decision|0|||
147234550|NCT04738734|531030144|FG001|Overall Study|Physician Decision|1|||
147234551|NCT04738734|531030143|FG000|Overall Study|Mistake of termination of subject by clinical site|0|||
147234552|NCT04738734|531030144|FG001|Overall Study|Mistake of termination of subject by clinical site|1|||
147234553|NCT03212690|531030147|FG000|Overall Study|Protocol Violation|1|||
147234554|NCT01927627|531030149|FG000|Overall Study|Adverse Event|3|||
147234555|NCT01927627|531030149|FG000|Overall Study|Lack of Efficacy|1|||
147234556|NCT01927627|531030149|FG000|Overall Study|Financial Concerns|1|||
147234557|NCT00910273|531030150|FG000|Overall Study|Lack of Efficacy|6|||
147125599|NCT03247673|530625579|FG002|Overall Study|Lost to Follow-up|1|||
147125600|NCT02184442|530625583|FG000|Overall Study|Death|61|||
147125601|NCT02184442|530625584|FG001|Overall Study|Death|65|||
147125602|NCT02184442|530625583|FG000|Overall Study|Withdrawal by Subject|3|||
147125603|NCT02184442|530625584|FG001|Overall Study|Withdrawal by Subject|11|||
147125604|NCT04110145|530626888|FG000|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|0|||
147125605|NCT04110145|530626889|FG001|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|0|||
147125606|NCT04110145|530626890|FG002|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|0|||
147125607|NCT04110145|530626891|FG003|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|1|||
147125608|NCT04110145|530626892|FG004|Double-Blind Treatment Period (4 Weeks)|Site Terminated by the Sponsor|0|||
147125609|NCT00980044|530626893|FG000|Overall Study|Withdrawal by Subject|5|||
147125610|NCT00980044|530626894|FG001|Overall Study|Withdrawal by Subject|7|||
147125611|NCT00980044|530626895|FG002|Overall Study|Withdrawal by Subject|3|||
147125612|NCT00980044|530626893|FG000|Overall Study|Protocol Violation|0|||
147125613|NCT00980044|530626894|FG001|Overall Study|Protocol Violation|0|||
147125614|NCT00980044|530626895|FG002|Overall Study|Protocol Violation|2|||
147125615|NCT00833703|530626902|FG000|Overall Study|Parent(s)/guardian(s)'s request|0|||
147125616|NCT00833703|530626903|FG001|Overall Study|Parent(s)/guardian(s)'s request|1|||
147125617|NCT01557569|530626906|FG000|Overall Study|Adverse Event|2|||
147125618|NCT01557569|530626907|FG001|Overall Study|Adverse Event|0|||
147125619|NCT01557569|530626906|FG000|Overall Study|high blood pressure|0|||
147125620|NCT01557569|530626907|FG001|Overall Study|high blood pressure|1|||
147125621|NCT01557569|530626906|FG000|Overall Study|Withdrawal by Subject|3|||
147125622|NCT01557569|530626907|FG001|Overall Study|Withdrawal by Subject|5|||
147125623|NCT01557569|530626906|FG000|Overall Study|noncompliance with rules of residential|0|||
147125624|NCT01557569|530626907|FG001|Overall Study|noncompliance with rules of residential|1|||
147125625|NCT02254460|530626912|FG000|Overall Study|Adverse Event|1|||
147125626|NCT02254460|530626913|FG001|Overall Study|Adverse Event|0|||
147125627|NCT03257657|530626916|FG000|Overall Study|Lost to Follow-up|0|||
147125628|NCT03257657|530626917|FG001|Overall Study|Lost to Follow-up|3|||
147125629|NCT03257657|530626916|FG000|Overall Study|Withdrawn|0|||
147125630|NCT03257657|530626917|FG001|Overall Study|Withdrawn|1|||
147125631|NCT03257657|530626916|FG000|Overall Study|Noted not eligible right after enrolled|0|||
147125632|NCT03257657|530626917|FG001|Overall Study|Noted not eligible right after enrolled|1|||
147125633|NCT00137449|530626918|FG000|Overall Study|Disease Progression|8|||
147125634|NCT00137449|530626919|FG001|Overall Study|Disease Progression|13|||
147125635|NCT00137449|530626918|FG000|Overall Study|Death|4|||
147125636|NCT00137449|530626919|FG001|Overall Study|Death|3|||
147125637|NCT00137449|530626918|FG000|Overall Study|Adverse Event|3|||
147125638|NCT00137449|530626919|FG001|Overall Study|Adverse Event|1|||
147234558|NCT00910273|531030151|FG001|Overall Study|Lack of Efficacy|9|||
147234559|NCT00910273|531030150|FG000|Overall Study|Adverse Event|1|||
147234560|NCT00910273|531030151|FG001|Overall Study|Adverse Event|1|||
147234561|NCT00910273|531030150|FG000|Overall Study|Withdrawal by Subject|1|||
147234562|NCT00910273|531030151|FG001|Overall Study|Withdrawal by Subject|0|||
147234563|NCT00910273|531030150|FG000|Overall Study|Discontinuation of study by sponsor|8|||
147234564|NCT00910273|531030151|FG001|Overall Study|Discontinuation of study by sponsor|2|||
147234565|NCT00910273|531030150|FG000|Overall Study|Protocol Violation|1|||
147234566|NCT00910273|531030151|FG001|Overall Study|Protocol Violation|0|||
147234567|NCT00910273|531030150|FG000|Overall Study|Lost to Follow-up|1|||
147234568|NCT00910273|531030151|FG001|Overall Study|Lost to Follow-up|1|||
147234569|NCT02215096|531030152|FG000|Run-In Period (Up to Week 2)|Adverse Event|1|||
147234570|NCT02215096|531030153|FG001|Run-In Period (Up to Week 2)|Adverse Event|0|||
147234571|NCT02215096|531030154|FG002|Run-In Period (Up to Week 2)|Adverse Event|0|||
147234572|NCT02215096|531030155|FG003|Run-In Period (Up to Week 2)|Adverse Event|0|||
147234573|NCT02215096|531030156|FG004|Run-In Period (Up to Week 2)|Adverse Event|0|||
147234574|NCT02215096|531030152|FG000|Combination TP (Up to Maximum 654 Days)|Physician Decision|0|||
147234575|NCT02215096|531030153|FG001|Combination TP (Up to Maximum 654 Days)|Physician Decision|0|||
147234576|NCT02215096|531030154|FG002|Combination TP (Up to Maximum 654 Days)|Physician Decision|0|||
147234577|NCT02215096|531030155|FG003|Combination TP (Up to Maximum 654 Days)|Physician Decision|0|||
147234578|NCT02215096|531030156|FG004|Combination TP (Up to Maximum 654 Days)|Physician Decision|1|||
147234579|NCT02215096|531030152|FG000|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|0|||
147234580|NCT02215096|531030153|FG001|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|0|||
147444654|NCT01147744|531792660|FG003|Overall Study|Lost to Follow-up|0|||
147444655|NCT01147744|531792661|FG004|Overall Study|Lost to Follow-up|0|||
147125639|NCT00137449|530626918|FG000|Overall Study|Withdrawal by Subject|1|||
147125640|NCT00137449|530626919|FG001|Overall Study|Withdrawal by Subject|1|||
147125641|NCT02263547|530626926|FG000|Overall Study|Adverse Event|1|||
147125642|NCT02263547|530626926|FG000|Overall Study|Lost to Follow-up|2|||
147125643|NCT03707821|530626929|FG000|Overall Study|Protocol Violation|0|||
147125644|NCT03707821|530626930|FG001|Overall Study|Protocol Violation|1|||
147125645|NCT03707821|530626929|FG000|Overall Study|Unsatisfactory Visual Response|1|||
147234581|NCT02215096|531030154|FG002|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|0|||
147234582|NCT02215096|531030155|FG003|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|1|||
147125646|NCT03707821|530626930|FG001|Overall Study|Unsatisfactory Visual Response|0|||
147125647|NCT03707821|530626929|FG000|Overall Study|Unsatisfactory Lens Fitting|1|||
147125648|NCT03707821|530626930|FG001|Overall Study|Unsatisfactory Lens Fitting|0|||
147125649|NCT00414609|530626931|FG000|Core Study|Adverse Event|9|||
147125650|NCT00414609|530626932|FG001|Core Study|Adverse Event|11|||
147125651|NCT00414609|530626933|FG002|Core Study|Adverse Event|0|||
147125652|NCT00414609|530626931|FG000|Core Study|Abnormal laboratory values|0|||
147125653|NCT00414609|530626932|FG001|Core Study|Abnormal laboratory values|1|||
147125654|NCT00414609|530626933|FG002|Core Study|Abnormal laboratory values|0|||
147125655|NCT00414609|530626931|FG000|Core Study|Abnormal test procedure results|1|||
147125656|NCT00414609|530626932|FG001|Core Study|Abnormal test procedure results|1|||
147125657|NCT00414609|530626933|FG002|Core Study|Abnormal test procedure results|0|||
147125658|NCT00414609|530626931|FG000|Core Study|Protocol deviation|0|||
147125659|NCT00414609|530626932|FG001|Core Study|Protocol deviation|1|||
147125660|NCT00414609|530626933|FG002|Core Study|Protocol deviation|0|||
147125661|NCT00414609|530626931|FG000|Core Study|Patient withdrew consent|10|||
147125662|NCT00414609|530626932|FG001|Core Study|Patient withdrew consent|11|||
147125663|NCT00414609|530626933|FG002|Core Study|Patient withdrew consent|0|||
147125664|NCT00414609|530626931|FG000|Core Study|Lost to Follow-up|7|||
147125665|NCT00414609|530626932|FG001|Core Study|Lost to Follow-up|4|||
147125666|NCT00414609|530626933|FG002|Core Study|Lost to Follow-up|0|||
147125667|NCT00414609|530626931|FG000|Core Study|Administrative problems|0|||
147125668|NCT00414609|530626932|FG001|Core Study|Administrative problems|2|||
147125669|NCT00414609|530626933|FG002|Core Study|Administrative problems|0|||
147125670|NCT00414609|530626931|FG000|Core Study|Death|7|||
147125671|NCT00414609|530626932|FG001|Core Study|Death|14|||
147125672|NCT00414609|530626933|FG002|Core Study|Death|0|||
147125673|NCT00414609|530626931|FG000|Extension Study|Adverse Event|0|||
147125674|NCT00414609|530626932|FG001|Extension Study|Adverse Event|0|||
147125675|NCT00414609|530626933|FG002|Extension Study|Adverse Event|14|||
147125676|NCT00414609|530626931|FG000|Extension Study|Unsatisfactory therapeutic effect|0|||
147125677|NCT00414609|530626932|FG001|Extension Study|Unsatisfactory therapeutic effect|0|||
147125678|NCT00414609|530626933|FG002|Extension Study|Unsatisfactory therapeutic effect|2|||
147125679|NCT00414609|530626931|FG000|Extension Study|Withdrawal by Subject|0|||
147125680|NCT00414609|530626932|FG001|Extension Study|Withdrawal by Subject|0|||
147125681|NCT00414609|530626933|FG002|Extension Study|Withdrawal by Subject|13|||
147125682|NCT00414609|530626931|FG000|Extension Study|Lost to Follow-up|0|||
147125683|NCT00414609|530626932|FG001|Extension Study|Lost to Follow-up|0|||
147125684|NCT00414609|530626933|FG002|Extension Study|Lost to Follow-up|10|||
147125685|NCT00414609|530626931|FG000|Extension Study|Administrative problems|0|||
147125686|NCT00414609|530626932|FG001|Extension Study|Administrative problems|0|||
147125687|NCT00414609|530626933|FG002|Extension Study|Administrative problems|1|||
147125688|NCT00414609|530626931|FG000|Extension Study|Death|0|||
147125689|NCT00414609|530626932|FG001|Extension Study|Death|0|||
147125690|NCT00414609|530626933|FG002|Extension Study|Death|17|||
147125691|NCT00266032|530626934|FG000|Treatment|Adverse Event|42|||
147125692|NCT00266032|530626935|FG001|Treatment|Adverse Event|26|||
147125693|NCT00266032|530626936|FG002|Treatment|Adverse Event|10|||
147125694|NCT00266032|530626934|FG000|Treatment|Lost to Follow-up|19|||
147125695|NCT00266032|530626935|FG001|Treatment|Lost to Follow-up|4|||
147125696|NCT00266032|530626936|FG002|Treatment|Lost to Follow-up|2|||
147125697|NCT00266032|530626934|FG000|Treatment|Pregnancy|3|||
147125698|NCT00266032|530626935|FG001|Treatment|Pregnancy|2|||
147234583|NCT02215096|531030156|FG004|Combination TP (Up to Maximum 654 Days)|Lost to Follow-up|0|||
147234584|NCT02215096|531030152|FG000|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|0|||
147234585|NCT02215096|531030153|FG001|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|2|||
147234586|NCT02215096|531030154|FG002|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|1|||
147234587|NCT02215096|531030155|FG003|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|1|||
147234588|NCT02215096|531030156|FG004|Combination TP (Up to Maximum 654 Days)|Withdrawal by Subject|0|||
147234589|NCT02586064|531030157|FG000|Overall Study|Other Obligations|6|||
147234590|NCT02586064|531030158|FG001|Overall Study|Other Obligations|6|||
147234591|NCT02586064|531030157|FG000|Overall Study|Other|3|||
147234592|NCT02586064|531030158|FG001|Overall Study|Other|7|||
147234593|NCT02586064|531030157|FG000|Overall Study|Never Started|3|||
147125699|NCT00266032|530626936|FG002|Treatment|Pregnancy|2|||
147125700|NCT00266032|530626934|FG000|Treatment|Protocol Violation|6|||
147125701|NCT00266032|530626935|FG001|Treatment|Protocol Violation|14|||
147125702|NCT00266032|530626936|FG002|Treatment|Protocol Violation|13|||
147125703|NCT00266032|530626934|FG000|Treatment|Withdrawal by Subject|28|||
147125704|NCT00266032|530626935|FG001|Treatment|Withdrawal by Subject|13|||
147125705|NCT00266032|530626936|FG002|Treatment|Withdrawal by Subject|12|||
147125706|NCT00266032|530626934|FG000|Treatment|patient moved/wish for pregnancy/no need|13|||
147125707|NCT00266032|530626935|FG001|Treatment|patient moved/wish for pregnancy/no need|5|||
147125708|NCT00266032|530626936|FG002|Treatment|patient moved/wish for pregnancy/no need|8|||
147125709|NCT00266032|530626934|FG000|Open-label Safety Extension|Adverse Event|5|||
147125710|NCT00266032|530626935|FG001|Open-label Safety Extension|Adverse Event|0|||
147234594|NCT02586064|531030158|FG001|Overall Study|Never Started|3|||
147234595|NCT02586064|531030157|FG000|Overall Study|Lost Interest|1|||
147125711|NCT00266032|530626936|FG002|Open-label Safety Extension|Adverse Event|4|||
147125712|NCT00266032|530626934|FG000|Open-label Safety Extension|Lost to Follow-up|2|||
147125713|NCT00266032|530626935|FG001|Open-label Safety Extension|Lost to Follow-up|5|||
147125714|NCT00266032|530626936|FG002|Open-label Safety Extension|Lost to Follow-up|4|||
147125715|NCT00266032|530626934|FG000|Open-label Safety Extension|Pregnancy|4|||
147125716|NCT00266032|530626935|FG001|Open-label Safety Extension|Pregnancy|1|||
147125717|NCT00266032|530626936|FG002|Open-label Safety Extension|Pregnancy|2|||
147125718|NCT00266032|530626934|FG000|Open-label Safety Extension|Protocol Violation|1|||
147125719|NCT00266032|530626935|FG001|Open-label Safety Extension|Protocol Violation|3|||
147125720|NCT00266032|530626936|FG002|Open-label Safety Extension|Protocol Violation|2|||
147125721|NCT00266032|530626934|FG000|Open-label Safety Extension|Withdrawal by Subject|19|||
147125722|NCT00266032|530626935|FG001|Open-label Safety Extension|Withdrawal by Subject|3|||
147125723|NCT00266032|530626936|FG002|Open-label Safety Extension|Withdrawal by Subject|12|||
147125724|NCT00266032|530626934|FG000|Open-label Safety Extension|patient moved/wish for pregnancy/no need|10|||
147125725|NCT00266032|530626935|FG001|Open-label Safety Extension|patient moved/wish for pregnancy/no need|2|||
147125726|NCT00266032|530626936|FG002|Open-label Safety Extension|patient moved/wish for pregnancy/no need|1|||
147125727|NCT00124657|530626937|FG000|Overall Study|Toxicity|0|||
147125728|NCT00124657|530626938|FG001|Overall Study|Toxicity|0|||
147125729|NCT00124657|530626939|FG002|Overall Study|Toxicity|1|||
147125730|NCT00124657|530626937|FG000|Overall Study|Non-compliance|1|||
147125731|NCT00124657|530626938|FG001|Overall Study|Non-compliance|0|||
147125732|NCT00124657|530626939|FG002|Overall Study|Non-compliance|4|||
147125733|NCT00124657|530626937|FG000|Overall Study|Progressive disease|14|||
147125734|NCT00124657|530626938|FG001|Overall Study|Progressive disease|5|||
147125735|NCT00124657|530626939|FG002|Overall Study|Progressive disease|27|||
147125736|NCT00124657|530626937|FG000|Overall Study|Intercurrent illness|1|||
147125737|NCT00124657|530626938|FG001|Overall Study|Intercurrent illness|0|||
147125738|NCT00124657|530626939|FG002|Overall Study|Intercurrent illness|0|||
147125739|NCT00814983|530626944|FG000|Overall Study|Screen failure|1|||
147125740|NCT00814983|530626945|FG001|Overall Study|Screen failure|0|||
147125741|NCT00814983|530626944|FG000|Overall Study|Withdrawal by Subject|1|||
147125742|NCT00814983|530626945|FG001|Overall Study|Withdrawal by Subject|0|||
147125743|NCT00814983|530626944|FG000|Overall Study|Graft failure|1|||
147125744|NCT00814983|530626945|FG001|Overall Study|Graft failure|0|||
147125745|NCT01935947|530626946|FG000|Overall Study|Adverse Event|0|||
147125746|NCT01935947|530626947|FG001|Overall Study|Adverse Event|2|||
147125747|NCT01935947|530626948|FG002|Overall Study|Adverse Event|0|||
147125748|NCT01935947|530626946|FG000|Overall Study|Diease Progression|2|||
147125749|NCT01935947|530626947|FG001|Overall Study|Diease Progression|2|||
147125750|NCT01935947|530626948|FG002|Overall Study|Diease Progression|2|||
147125751|NCT01935947|530626946|FG000|Overall Study|Death|1|||
147125752|NCT01935947|530626947|FG001|Overall Study|Death|0|||
147125753|NCT01935947|530626948|FG002|Overall Study|Death|0|||
147125754|NCT00836901|530626949|FG000|First Intervention|Withdrawal by Subject|1|||
147125755|NCT00836901|530626950|FG001|First Intervention|Withdrawal by Subject|0|||
147125756|NCT00830336|530626951|FG000|Washout: 21 Days|Withdrawal by Subject|1|||
147125757|NCT00830336|530626952|FG001|Washout: 21 Days|Withdrawal by Subject|0|||
147125758|NCT01148771|530626953|FG000|Washout Period|Withdrawal by Subject|0|||
147125759|NCT01148771|530626954|FG001|Washout Period|Withdrawal by Subject|1|||
147125760|NCT01229111|530626955|FG000|Overall Study|Death|1|||
147125761|NCT04102514|530626956|FG000|Overall Study|Death|3|||
147125762|NCT04102514|530626957|FG001|Overall Study|Death|0|||
147125763|NCT04102514|530626958|FG002|Overall Study|Death|0|||
147125764|NCT04102514|530626959|FG003|Overall Study|Death|0|||
147125765|NCT04102514|530626956|FG000|Overall Study|Lost to Follow-up|0|||
147125766|NCT04102514|530626957|FG001|Overall Study|Lost to Follow-up|0|||
147125767|NCT04102514|530626958|FG002|Overall Study|Lost to Follow-up|3|||
147125768|NCT04102514|530626959|FG003|Overall Study|Lost to Follow-up|0|||
147125769|NCT04102514|530626956|FG000|Overall Study|Physician Decision|0|||
147125770|NCT04102514|530626957|FG001|Overall Study|Physician Decision|0|||
147125771|NCT04102514|530626958|FG002|Overall Study|Physician Decision|1|||
147125772|NCT04102514|530626959|FG003|Overall Study|Physician Decision|0|||
147125773|NCT04102514|530626956|FG000|Overall Study|Withdrawal by Subject|7|||
147125774|NCT04102514|530626957|FG001|Overall Study|Withdrawal by Subject|13|||
147125775|NCT04102514|530626958|FG002|Overall Study|Withdrawal by Subject|7|||
147125776|NCT04102514|530626959|FG003|Overall Study|Withdrawal by Subject|14|||
147125777|NCT04102514|530626956|FG000|Overall Study|Moved to longterm care facility|6|||
147234596|NCT02586064|531030158|FG001|Overall Study|Lost Interest|4|||
147125778|NCT04102514|530626957|FG001|Overall Study|Moved to longterm care facility|0|||
147125779|NCT04102514|530626958|FG002|Overall Study|Moved to longterm care facility|4|||
147125780|NCT04102514|530626959|FG003|Overall Study|Moved to longterm care facility|0|||
147125781|NCT03268499|530626960|FG000|Overall Study|Withdrawal by Subject|2|||
147125782|NCT03268499|530626961|FG001|Overall Study|Withdrawal by Subject|1|||
147125783|NCT05071027|530626971|FG000|Overall Study|Lost to Follow-up|1|||
147125784|NCT05071027|530626972|FG001|Overall Study|Lost to Follow-up|4|||
147125785|NCT05463952|530626976|FG000|Treatment|Progressive disease|4|||
147234597|NCT02586064|531030157|FG000|Overall Study|Miscellaneous Life Issues|0|||
147125786|NCT05463952|530626976|FG000|Treatment|Ongoing|2|||
147125787|NCT00595075|530626977|FG000|Overall Study|Withdrawal by Subject|1|||
147125788|NCT00595075|530626978|FG001|Overall Study|Withdrawal by Subject|0|||
147125789|NCT02096354|530626983|FG000|Overall Study|Physician Decision|4|||
147125790|NCT02096354|530626984|FG001|Overall Study|Physician Decision|5|||
147125791|NCT02096354|530626985|FG002|Overall Study|Physician Decision|0|||
147125792|NCT02096354|530626983|FG000|Overall Study|Withdrawal by Subject|3|||
147125793|NCT02096354|530626984|FG001|Overall Study|Withdrawal by Subject|1|||
147125794|NCT02096354|530626985|FG002|Overall Study|Withdrawal by Subject|0|||
147125795|NCT02096354|530626983|FG000|Overall Study|Adverse Event|7|||
147125796|NCT02096354|530626984|FG001|Overall Study|Adverse Event|4|||
147125797|NCT02096354|530626985|FG002|Overall Study|Adverse Event|0|||
147125798|NCT02096354|530626983|FG000|Overall Study|Ineligible|0|||
147125799|NCT02096354|530626984|FG001|Overall Study|Ineligible|0|||
147125800|NCT02096354|530626985|FG002|Overall Study|Ineligible|11|||
147125801|NCT03579719|530626988|FG000|Overall Study|Protocol deviation, pre-existent disease|1|||
147125802|NCT00069953|530626989|FG000|Overall Study|Protocol Violation|2|||
147125803|NCT01646216|530626990|FG000|Overall Study|Baseline step length difference (<5cm)|10|||
147125804|NCT01646216|530626991|FG001|Overall Study|Baseline step length difference (<5cm)|10|||
147125805|NCT01646216|530626990|FG000|Overall Study|Did not complete training|0|||
147125806|NCT01646216|530626991|FG001|Overall Study|Did not complete training|2|||
147125807|NCT01646216|530626990|FG000|Overall Study|Investigator decision|1|||
147125808|NCT01646216|530626991|FG001|Overall Study|Investigator decision|1|||
147125809|NCT00113373|530626994|FG000|Overall Study|Ineligible: wrong primary|1|||
147125810|NCT00113373|530626994|FG000|Overall Study|Ineligible: second primary|1|||
147125811|NCT00113373|530626994|FG000|Overall Study|Never Treated|1|||
147125812|NCT02395627|530626995|FG000|Overall Study|Withdrawal by Subject|0|||
147125813|NCT02395627|530626996|FG001|Overall Study|Withdrawal by Subject|2|||
147125814|NCT02395627|530626997|FG002|Overall Study|Withdrawal by Subject|0|||
147125815|NCT02395627|530626995|FG000|Overall Study|Did not receive pembrolizumab|3|||
147125816|NCT02395627|530626996|FG001|Overall Study|Did not receive pembrolizumab|1|||
147125817|NCT02395627|530626997|FG002|Overall Study|Did not receive pembrolizumab|0|||
147125818|NCT03253627|530626998|FG000|Overall Study|Lost to Follow-up|1|||
147125819|NCT03253627|530626999|FG001|Overall Study|Lost to Follow-up|2|||
147125820|NCT03253627|530626998|FG000|Overall Study|Withdrawal by Subject|0|||
147316295|NCT00472186|531323652|FG001|Overall Study|Study was terminated due to poor compliance with returning logbooks by families.|0|||
147316296|NCT02264574|531323657|FG000|Overall Study|Death|21|||
147316297|NCT02264574|531323658|FG001|Overall Study|Death|21|||
147316298|NCT02264574|531323657|FG000|Overall Study|Withdrawal by Subject|8|||
147316299|NCT02264574|531323658|FG001|Overall Study|Withdrawal by Subject|6|||
147316300|NCT02264574|531323657|FG000|Overall Study|Other, Not Specified|0|||
147316301|NCT02264574|531323658|FG001|Overall Study|Other, Not Specified|3|||
147316302|NCT04254679|531323661|FG000|Overall Study|Protocol Violation|1|||
147316303|NCT04254679|531323662|FG001|Overall Study|Protocol Violation|1|||
147316304|NCT04254679|531323661|FG000|Overall Study|Excluded owing to intraoperative complication requiring hospital stay|2|||
147125821|NCT03253627|530626999|FG001|Overall Study|Withdrawal by Subject|2|||
147125822|NCT03253627|530626998|FG000|Overall Study|Inability to complete MRI|1|||
147316305|NCT04254679|531323662|FG001|Overall Study|Excluded owing to intraoperative complication requiring hospital stay|1|||
147316306|NCT00478608|531323663|FG000|Overall Study|Adverse Event|1|||
147316307|NCT00478608|531323663|FG000|Overall Study|Serious Adverse Event|14|||
147316308|NCT00478608|531323663|FG000|Overall Study|Withdrawal by Subject|2|||
147316309|NCT00478608|531323663|FG000|Overall Study|Protocol Violation|3|||
147316310|NCT02406261|531323665|FG000|Period 1|Lost to Follow-up|2|||
147316311|NCT02406261|531323666|FG001|Period 1|Lost to Follow-up|0|||
147125823|NCT03253627|530626999|FG001|Overall Study|Inability to complete MRI|0|||
147125824|NCT03829683|530627000|FG000|Overall Study|Lost to Follow-up|1|||
147125825|NCT03829683|530627001|FG001|Overall Study|Lost to Follow-up|0|||
147125826|NCT03829683|530627000|FG000|Overall Study|Physician Decision|3|||
147125827|NCT03829683|530627001|FG001|Overall Study|Physician Decision|1|||
147125828|NCT03829683|530627000|FG000|Overall Study|Withdrawal by Subject|0|||
147125829|NCT03829683|530627001|FG001|Overall Study|Withdrawal by Subject|1|||
147125830|NCT03829683|530627000|FG000|Overall Study|Discharge from hospital|1|||
147125831|NCT03829683|530627001|FG001|Overall Study|Discharge from hospital|0|||
147125832|NCT03163667|530627002|FG000|Overall Study|Death|15|||
147125833|NCT03163667|530627003|FG001|Overall Study|Death|27|||
147316312|NCT02406261|531323665|FG000|Period 1|Adverse Event|1|||
147125834|NCT03163667|530627002|FG000|Overall Study|Study terminated by sponsor (after primary endpoint was met)|8|||
147125835|NCT03163667|530627003|FG001|Overall Study|Study terminated by sponsor (after primary endpoint was met)|19|||
147125836|NCT02420314|530627004|FG000|Overall Study|Withdrawal by Subject|1|||
147125837|NCT02420314|530627004|FG000|Overall Study|Protocol Violation|1|||
147125838|NCT03760068|530627005|FG000|Overall Study|Withdrawal by Subject|7|||
147125839|NCT03760068|530627006|FG001|Overall Study|Withdrawal by Subject|8|||
147125840|NCT03760068|530627005|FG000|Overall Study|Adverse Event|1|||
147125841|NCT03760068|530627006|FG001|Overall Study|Adverse Event|2|||
147125842|NCT03760068|530627005|FG000|Overall Study|Administrative Decision by Sponsor|0|||
147125843|NCT03760068|530627006|FG001|Overall Study|Administrative Decision by Sponsor|2|||
147125844|NCT03760068|530627005|FG000|Overall Study|Physician Decision|1|||
147125845|NCT03760068|530627006|FG001|Overall Study|Physician Decision|2|||
147125846|NCT03760068|530627005|FG000|Overall Study|Lost to Follow-up|4|||
147125847|NCT03760068|530627006|FG001|Overall Study|Lost to Follow-up|9|||
147125848|NCT03760068|530627005|FG000|Overall Study|Subject Moved Out of State|1|||
147125849|NCT03760068|530627006|FG001|Overall Study|Subject Moved Out of State|0|||
147125850|NCT05430919|530627007|FG000|Overall Study|Protocol Violation|0|||
147125851|NCT05430919|530627008|FG001|Overall Study|Protocol Violation|0|||
147125852|NCT05430919|530627009|FG002|Overall Study|Protocol Violation|1|||
147316313|NCT02406261|531323666|FG001|Period 1|Adverse Event|0|||
147316314|NCT02406261|531323665|FG000|Period 2|Physician Decision|0|||
147316315|NCT02406261|531323666|FG001|Period 2|Physician Decision|1|||
147316316|NCT02406261|531323665|FG000|Period 2|Protocol Violation|0|||
147316317|NCT02406261|531323666|FG001|Period 2|Protocol Violation|1|||
147316318|NCT02406261|531323665|FG000|Period 2|Withdrawal by Subject|0|||
147316319|NCT02406261|531323666|FG001|Period 2|Withdrawal by Subject|1|||
147316320|NCT03230864|531323669|FG000|Prospective Confirmation (PC) Period|Adverse Event|3|||
147316321|NCT03230864|531323670|FG001|Prospective Confirmation (PC) Period|Adverse Event|0|||
147316322|NCT03230864|531323671|FG002|Prospective Confirmation (PC) Period|Adverse Event|0|||
147316323|NCT03230864|531323672|FG003|Prospective Confirmation (PC) Period|Adverse Event|0|||
147316324|NCT03230864|531323669|FG000|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
147316325|NCT03230864|531323670|FG001|Prospective Confirmation (PC) Period|Lack of Efficacy|2|||
147316326|NCT03230864|531323671|FG002|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
147316327|NCT03230864|531323672|FG003|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
147316328|NCT03230864|531323669|FG000|Prospective Confirmation (PC) Period|Protocol Violation|1|||
147316329|NCT03230864|531323670|FG001|Prospective Confirmation (PC) Period|Protocol Violation|2|||
147316330|NCT03230864|531323671|FG002|Prospective Confirmation (PC) Period|Protocol Violation|0|||
147316331|NCT03230864|531323672|FG003|Prospective Confirmation (PC) Period|Protocol Violation|0|||
147316332|NCT03230864|531323669|FG000|Prospective Confirmation (PC) Period|Withdrawal by Subject|4|||
147316333|NCT03230864|531323670|FG001|Prospective Confirmation (PC) Period|Withdrawal by Subject|1|||
147316334|NCT03230864|531323671|FG002|Prospective Confirmation (PC) Period|Withdrawal by Subject|0|||
147316335|NCT03230864|531323672|FG003|Prospective Confirmation (PC) Period|Withdrawal by Subject|0|||
147316336|NCT03230864|531323669|FG000|Prospective Confirmation (PC) Period|Did not fulfill rand criteria DBT|14|||
147316337|NCT03230864|531323670|FG001|Prospective Confirmation (PC) Period|Did not fulfill rand criteria DBT|5|||
147316338|NCT03230864|531323671|FG002|Prospective Confirmation (PC) Period|Did not fulfill rand criteria DBT|0|||
147316339|NCT03230864|531323672|FG003|Prospective Confirmation (PC) Period|Did not fulfill rand criteria DBT|0|||
147316340|NCT03230864|531323669|FG000|Prospective Confirmation (PC) Period|Sponsor Decision|9|||
147316341|NCT03230864|531323670|FG001|Prospective Confirmation (PC) Period|Sponsor Decision|9|||
147316342|NCT03230864|531323671|FG002|Prospective Confirmation (PC) Period|Sponsor Decision|0|||
147316343|NCT03230864|531323672|FG003|Prospective Confirmation (PC) Period|Sponsor Decision|0|||
147316344|NCT03230864|531323669|FG000|Prospective Confirmation (PC) Period|Study Personnel Decision|1|||
147316345|NCT03230864|531323670|FG001|Prospective Confirmation (PC) Period|Study Personnel Decision|0|||
147316346|NCT03230864|531323671|FG002|Prospective Confirmation (PC) Period|Study Personnel Decision|0|||
147316347|NCT03230864|531323672|FG003|Prospective Confirmation (PC) Period|Study Personnel Decision|0|||
147316348|NCT03230864|531323669|FG000|Double Blind Treatment (DBT) Period|Adverse Event|0|||
147316349|NCT03230864|531323670|FG001|Double Blind Treatment (DBT) Period|Adverse Event|0|||
147316350|NCT03230864|531323671|FG002|Double Blind Treatment (DBT) Period|Adverse Event|5|||
147316351|NCT03230864|531323672|FG003|Double Blind Treatment (DBT) Period|Adverse Event|1|||
147316352|NCT03230864|531323669|FG000|Double Blind Treatment (DBT) Period|Withdrawal by Subject|0|||
147316353|NCT03230864|531323670|FG001|Double Blind Treatment (DBT) Period|Withdrawal by Subject|0|||
147316354|NCT03230864|531323671|FG002|Double Blind Treatment (DBT) Period|Withdrawal by Subject|1|||
147316355|NCT03230864|531323672|FG003|Double Blind Treatment (DBT) Period|Withdrawal by Subject|1|||
147316356|NCT03230864|531323669|FG000|Double Blind Treatment (DBT) Period|Sponsor Decision|0|||
147316357|NCT03230864|531323670|FG001|Double Blind Treatment (DBT) Period|Sponsor Decision|0|||
147316358|NCT03230864|531323671|FG002|Double Blind Treatment (DBT) Period|Sponsor Decision|2|||
147316359|NCT03230864|531323672|FG003|Double Blind Treatment (DBT) Period|Sponsor Decision|0|||
147316360|NCT01458249|531323675|FG000|Overall Study|Not treated|1|||
147316361|NCT01458249|531323675|FG000|Overall Study|Adverse Event|4|||
147316362|NCT01458249|531323675|FG000|Overall Study|Other|2|||
147316363|NCT01458249|531323675|FG000|Overall Study|Ongoing|1|||
147316364|NCT02056119|531323676|FG000|Overall Study|Death|1|||
147316365|NCT02056119|531323677|FG001|Overall Study|Death|2|||
147316366|NCT02056119|531323676|FG000|Overall Study|Intubated for less than 24 hrs|2|||
147316367|NCT02056119|531323677|FG001|Overall Study|Intubated for less than 24 hrs|7|||
147316368|NCT02056119|531323676|FG000|Overall Study|No aerosol treatments were given.|3|||
147651167|NCT00162097|532544599|FG000|Overall Study|Participant no longer met study criteria|0|||
147125853|NCT05430919|530627010|FG003|Overall Study|Protocol Violation|0|||
147125854|NCT05430919|530627007|FG000|Overall Study|Lost to Follow-up|0|||
147125855|NCT05430919|530627008|FG001|Overall Study|Lost to Follow-up|1|||
147125856|NCT05430919|530627009|FG002|Overall Study|Lost to Follow-up|0|||
147125857|NCT05430919|530627010|FG003|Overall Study|Lost to Follow-up|0|||
147125858|NCT05430919|530627007|FG000|Overall Study|Withdrawal by Subject|3|||
147125859|NCT05430919|530627008|FG001|Overall Study|Withdrawal by Subject|0|||
147125860|NCT05430919|530627009|FG002|Overall Study|Withdrawal by Subject|0|||
147125861|NCT05430919|530627010|FG003|Overall Study|Withdrawal by Subject|1|||
147125862|NCT00855166|530627011|FG000|Overall Study|Adverse Event|0|||
147125863|NCT00855166|530627012|FG001|Overall Study|Adverse Event|2|||
147125864|NCT00855166|530627011|FG000|Overall Study|Death|0|||
147125865|NCT00855166|530627012|FG001|Overall Study|Death|1|||
147125866|NCT00855166|530627011|FG000|Overall Study|Withdrawal by Subject|1|||
147125867|NCT00855166|530627012|FG001|Overall Study|Withdrawal by Subject|4|||
147125868|NCT00855166|530627011|FG000|Overall Study|Poor/non-compliance|2|||
147125869|NCT00855166|530627012|FG001|Overall Study|Poor/non-compliance|0|||
147125870|NCT00855166|530627011|FG000|Overall Study|Administrative reasons by sponsor|1|||
147125871|NCT00855166|530627012|FG001|Overall Study|Administrative reasons by sponsor|0|||
147125872|NCT00855166|530627011|FG000|Overall Study|Subject no longer meets study criteria|1|||
147125873|NCT00855166|530627012|FG001|Overall Study|Subject no longer meets study criteria|1|||
147125874|NCT00803049|530627013|FG000|Overall Study|Adverse Event|21|||
147125875|NCT00803049|530627014|FG001|Overall Study|Adverse Event|33|||
147125876|NCT00803049|530627015|FG002|Overall Study|Adverse Event|13|||
147125877|NCT00803049|530627016|FG003|Overall Study|Adverse Event|27|||
147125878|NCT00803049|530627013|FG000|Overall Study|Lack of Efficacy|10|||
147125879|NCT00803049|530627014|FG001|Overall Study|Lack of Efficacy|19|||
147125880|NCT00803049|530627015|FG002|Overall Study|Lack of Efficacy|6|||
147125881|NCT00803049|530627016|FG003|Overall Study|Lack of Efficacy|13|||
147125882|NCT00803049|530627013|FG000|Overall Study|Lost to Follow-up|0|||
147125883|NCT00803049|530627014|FG001|Overall Study|Lost to Follow-up|2|||
147125884|NCT00803049|530627015|FG002|Overall Study|Lost to Follow-up|0|||
147125885|NCT00803049|530627016|FG003|Overall Study|Lost to Follow-up|3|||
147125886|NCT00803049|530627013|FG000|Overall Study|Death|2|||
147125887|NCT00803049|530627014|FG001|Overall Study|Death|1|||
147125888|NCT00803049|530627015|FG002|Overall Study|Death|0|||
147125889|NCT00803049|530627016|FG003|Overall Study|Death|2|||
147125890|NCT00803049|530627013|FG000|Overall Study|Progressive Disease|6|||
147125891|NCT00803049|530627014|FG001|Overall Study|Progressive Disease|10|||
147125892|NCT00803049|530627015|FG002|Overall Study|Progressive Disease|6|||
147125893|NCT00803049|530627016|FG003|Overall Study|Progressive Disease|6|||
147125894|NCT00803049|530627013|FG000|Overall Study|Withdrawal by Subject|19|||
147125895|NCT00803049|530627014|FG001|Overall Study|Withdrawal by Subject|43|||
147125896|NCT00803049|530627015|FG002|Overall Study|Withdrawal by Subject|16|||
147125897|NCT00803049|530627016|FG003|Overall Study|Withdrawal by Subject|44|||
147125898|NCT00803049|530627013|FG000|Overall Study|Protocol Violation|0|||
147125899|NCT00803049|530627014|FG001|Overall Study|Protocol Violation|1|||
147125900|NCT00803049|530627015|FG002|Overall Study|Protocol Violation|1|||
147125901|NCT00803049|530627016|FG003|Overall Study|Protocol Violation|0|||
147125902|NCT00803049|530627013|FG000|Overall Study|Randomized and Not Treated|0|||
147125903|NCT00803049|530627014|FG001|Overall Study|Randomized and Not Treated|0|||
147125904|NCT00803049|530627015|FG002|Overall Study|Randomized and Not Treated|0|||
147125905|NCT00803049|530627016|FG003|Overall Study|Randomized and Not Treated|2|||
147125906|NCT00803049|530627013|FG000|Overall Study|Other than Specified Above|3|||
147125907|NCT00803049|530627014|FG001|Overall Study|Other than Specified Above|9|||
147125908|NCT00803049|530627015|FG002|Overall Study|Other than Specified Above|2|||
147125909|NCT00803049|530627016|FG003|Overall Study|Other than Specified Above|5|||
147125910|NCT04082364|530627017|FG000|Overall Study|Death|23|||
147125911|NCT04082364|530627018|FG001|Overall Study|Death|1|||
147125912|NCT04082364|530627019|FG002|Overall Study|Death|1|||
147125913|NCT04082364|530627020|FG003|Overall Study|Death|2|||
147125914|NCT04082364|530627021|FG004|Overall Study|Death|1|||
147125915|NCT04082364|530627017|FG000|Overall Study|Lost to Follow-up|1|||
147125916|NCT04082364|530627018|FG001|Overall Study|Lost to Follow-up|0|||
147125917|NCT04082364|530627019|FG002|Overall Study|Lost to Follow-up|0|||
147125918|NCT04082364|530627020|FG003|Overall Study|Lost to Follow-up|0|||
147125919|NCT04082364|530627021|FG004|Overall Study|Lost to Follow-up|1|||
147234598|NCT02586064|531030158|FG001|Overall Study|Miscellaneous Life Issues|5|||
147234599|NCT02586064|531030157|FG000|Overall Study|Infrequent Attendance|2|||
147234600|NCT02586064|531030158|FG001|Overall Study|Infrequent Attendance|1|||
147234601|NCT02586064|531030157|FG000|Overall Study|Timed Out|2|||
147125920|NCT04082364|530627017|FG000|Overall Study|Physician Decision|1|||
147125921|NCT04082364|530627018|FG001|Overall Study|Physician Decision|1|||
147125922|NCT04082364|530627019|FG002|Overall Study|Physician Decision|0|||
147234602|NCT02586064|531030158|FG001|Overall Study|Timed Out|0|||
147125923|NCT04082364|530627020|FG003|Overall Study|Physician Decision|2|||
147125924|NCT04082364|530627021|FG004|Overall Study|Physician Decision|1|||
147125925|NCT04082364|530627017|FG000|Overall Study|Withdrawal by Subject|1|||
147234603|NCT02586064|531030157|FG000|Overall Study|AUD relapse|0|||
147125926|NCT04082364|530627018|FG001|Overall Study|Withdrawal by Subject|1|||
147125927|NCT04082364|530627019|FG002|Overall Study|Withdrawal by Subject|0|||
147125928|NCT04082364|530627020|FG003|Overall Study|Withdrawal by Subject|0|||
147234604|NCT02586064|531030158|FG001|Overall Study|AUD relapse|2|||
147651168|NCT00162097|532544600|FG001|Overall Study|Participant no longer met study criteria|0|||
147651169|NCT00162097|532544601|FG002|Overall Study|Participant no longer met study criteria|0|||
147125929|NCT04082364|530627021|FG004|Overall Study|Withdrawal by Subject|1|||
147125930|NCT04082364|530627017|FG000|Overall Study|Follow-up terminated by Sponsor|5|||
147125931|NCT04082364|530627018|FG001|Overall Study|Follow-up terminated by Sponsor|0|||
147125932|NCT04082364|530627019|FG002|Overall Study|Follow-up terminated by Sponsor|2|||
147125933|NCT04082364|530627020|FG003|Overall Study|Follow-up terminated by Sponsor|3|||
147125934|NCT04082364|530627021|FG004|Overall Study|Follow-up terminated by Sponsor|2|||
147125935|NCT04082364|530627017|FG000|Overall Study|Disease progression|0|||
147125936|NCT04082364|530627018|FG001|Overall Study|Disease progression|0|||
147125937|NCT04082364|530627019|FG002|Overall Study|Disease progression|0|||
147125938|NCT04082364|530627020|FG003|Overall Study|Disease progression|1|||
147125939|NCT04082364|530627021|FG004|Overall Study|Disease progression|0|||
147125940|NCT04042311|530627022|FG000|Overall Study|Abnormal cardiopulmonary exercise test (CPET) or unable to achieve a maximal test|9|||
147125941|NCT04042311|530627022|FG000|Overall Study|Unable to tolerate|4|||
147125942|NCT04042311|530627022|FG000|Overall Study|Concurrent illness|2|||
147125943|NCT04042311|530627022|FG000|Overall Study|Adverse Event|2|||
147125944|NCT04042311|530627022|FG000|Overall Study|No longer meeting inclusion criteria|2|||
147125945|NCT04042311|530627022|FG000|Overall Study|No reason given|1|||
147125946|NCT04042311|530627022|FG000|Overall Study|Withdrawal by Subject|4|||
147125947|NCT03249558|530627023|FG000|Overall Study|Lost to Follow-up|2|||
147125948|NCT03249558|530627024|FG001|Overall Study|Lost to Follow-up|1|||
147125949|NCT03249558|530627025|FG002|Overall Study|Lost to Follow-up|4|||
147125950|NCT03249558|530627023|FG000|Overall Study|Physician Decision|1|||
147125951|NCT03249558|530627024|FG001|Overall Study|Physician Decision|0|||
147125952|NCT03249558|530627025|FG002|Overall Study|Physician Decision|0|||
147125953|NCT03249558|530627023|FG000|Overall Study|Withdrawal by Subject|6|||
147125954|NCT03249558|530627024|FG001|Overall Study|Withdrawal by Subject|5|||
147125955|NCT03249558|530627025|FG002|Overall Study|Withdrawal by Subject|7|||
147125956|NCT03249558|530627023|FG000|Overall Study|COVID-19 pandemic shutdown|1|||
147125957|NCT03249558|530627024|FG001|Overall Study|COVID-19 pandemic shutdown|0|||
147125958|NCT03249558|530627025|FG002|Overall Study|COVID-19 pandemic shutdown|0|||
147125959|NCT03249558|530627023|FG000|Overall Study|Protocol Violation|1|||
147234605|NCT02586064|531030157|FG000|Overall Study|Legal Issue|1|||
147234606|NCT02586064|531030158|FG001|Overall Study|Legal Issue|0|||
147234607|NCT03021304|531030159|FG000|Overall Study|Lack of Efficacy|1|||
147125960|NCT03249558|530627024|FG001|Overall Study|Protocol Violation|1|||
147125961|NCT03249558|530627025|FG002|Overall Study|Protocol Violation|2|||
147125962|NCT00908141|530627028|FG000|Overall Study|Withdrawal by Subject|0|||
147125963|NCT00908141|530627029|FG001|Overall Study|Withdrawal by Subject|1|||
147125964|NCT02254291|530628477|FG000|Overall Study|Withdrawal by Subject|0|||
147125965|NCT02254291|530628478|FG001|Overall Study|Withdrawal by Subject|3|||
147125966|NCT02254291|530628479|FG002|Overall Study|Withdrawal by Subject|1|||
147234608|NCT00397215|531030165|FG000|Month 0 (Day 0)|Adverse Event|0|||
147234609|NCT00397215|531030166|FG001|Month 0 (Day 0)|Adverse Event|1|||
147125967|NCT02254291|530628477|FG000|Overall Study|Missing follow-up information|0|||
147125968|NCT02254291|530628478|FG001|Overall Study|Missing follow-up information|0|||
147125969|NCT02254291|530628479|FG002|Overall Study|Missing follow-up information|1|||
147125970|NCT00267488|530628484|FG000|Overall Study|Sponsor Terminated Study|9|||
147125971|NCT00267488|530628484|FG000|Overall Study|Protocol Violation|1|||
147125972|NCT00267488|530628484|FG000|Overall Study|Other (Disease Progression)|1|||
147125973|NCT01904279|530628489|FG000|Overall Study|Lack of Efficacy|2|||
147125974|NCT01904279|530628490|FG001|Overall Study|Lack of Efficacy|3|||
147125975|NCT01904279|530628489|FG000|Overall Study|Withdrawal by Subject|1|||
147125976|NCT01904279|530628490|FG001|Overall Study|Withdrawal by Subject|0|||
147125977|NCT02801578|530628498|FG000|Overall Study|Adverse Event|2|||
147125978|NCT01356940|530628499|FG000|First Intervention (28 Days)|Adverse Event|1|||
147125979|NCT01356940|530628500|FG001|First Intervention (28 Days)|Adverse Event|0|||
147125980|NCT01356940|530628499|FG000|Second Intervention (28 Days)|Withdrawal by Subject|1|||
147125981|NCT01356940|530628500|FG001|Second Intervention (28 Days)|Withdrawal by Subject|0|||
147125982|NCT00668642|530628506|FG000|First Off-cycle|Cancer progression|1|||
147234610|NCT00397215|531030167|FG002|Month 0 (Day 0)|Adverse Event|0|||
147234611|NCT00397215|531030168|FG003|Month 0 (Day 0)|Adverse Event|0|||
147234612|NCT00397215|531030165|FG000|Month 0 (Day 0)|Withdrawal by Subject|3|||
147234613|NCT00397215|531030166|FG001|Month 0 (Day 0)|Withdrawal by Subject|3|||
147234614|NCT00397215|531030167|FG002|Month 0 (Day 0)|Withdrawal by Subject|3|||
147234615|NCT00397215|531030168|FG003|Month 0 (Day 0)|Withdrawal by Subject|1|||
147234616|NCT00397215|531030165|FG000|Month 0 (Day 0)|Other|4|||
147234617|NCT00397215|531030166|FG001|Month 0 (Day 0)|Other|1|||
147234618|NCT00397215|531030167|FG002|Month 0 (Day 0)|Other|3|||
147234619|NCT00397215|531030168|FG003|Month 0 (Day 0)|Other|3|||
147234620|NCT00397215|531030165|FG000|Month 6 (Day 180)|Adverse Event|0|||
147234621|NCT00397215|531030166|FG001|Month 6 (Day 180)|Adverse Event|3|||
147234622|NCT00397215|531030167|FG002|Month 6 (Day 180)|Adverse Event|2|||
147234623|NCT00397215|531030168|FG003|Month 6 (Day 180)|Adverse Event|0|||
147234624|NCT00397215|531030165|FG000|Month 6 (Day 180)|Other|2|||
147316369|NCT02056119|531323677|FG001|Overall Study|No aerosol treatments were given.|2|||
147125983|NCT00668642|530628507|FG001|First Off-cycle|Cancer progression|0|||
147125984|NCT00668642|530628506|FG000|Second AAT Treatment (On-cycle 2)|Cancer progression|2|||
147125985|NCT00668642|530628507|FG001|Second AAT Treatment (On-cycle 2)|Cancer progression|1|||
147125986|NCT03412591|530628508|FG000|Overall Study|Withdrawal by Subject|1|||
147125987|NCT03412591|530628509|FG001|Overall Study|Withdrawal by Subject|8|||
147125988|NCT03412591|530628508|FG000|Overall Study|Adverse Event|0|||
147125989|NCT03412591|530628509|FG001|Overall Study|Adverse Event|1|||
147125990|NCT02272985|530628510|FG000|Overall Study|Withdrawal by Subject|1|||
147125991|NCT02272985|530628510|FG000|Overall Study|hip fracture|1|||
147125992|NCT02272985|530628510|FG000|Overall Study|kidney transplantation|1|||
147125993|NCT02489279|530628511|FG000|Overall Study|Lost to Follow-up|12|||
147125994|NCT02489279|530628512|FG001|Overall Study|Lost to Follow-up|10|||
147125995|NCT00505687|530628513|FG000|Overall Study|Important protocol violation|2|||
147316370|NCT02056119|531323676|FG000|Overall Study|Received Metaneb treatment|0|||
147316371|NCT02056119|531323677|FG001|Overall Study|Received Metaneb treatment|2|||
147316372|NCT02056119|531323676|FG000|Overall Study|Protocol Violation|4|||
147316373|NCT02056119|531323677|FG001|Overall Study|Protocol Violation|7|||
147125996|NCT00505687|530628513|FG000|Overall Study|Lack of Efficacy|15|||
147125997|NCT00505687|530628513|FG000|Overall Study|Adverse Event|48|||
147125998|NCT00505687|530628513|FG000|Overall Study|Subject withdrew consent|15|||
147125999|NCT00505687|530628513|FG000|Overall Study|Lost to Follow-up|1|||
147126000|NCT00505687|530628513|FG000|Overall Study|Other: Underwent Implantation Of DBS|1|||
147126001|NCT00505687|530628513|FG000|Overall Study|Other: Scheduled DBS Surgery|1|||
147126002|NCT00505687|530628513|FG000|Overall Study|Other: Prolonged Hospitalization|1|||
147126003|NCT00505687|530628513|FG000|Overall Study|Other: Patches Would Not Stick D/T Sweat|1|||
147126004|NCT00505687|530628513|FG000|Overall Study|Other: Neupro Given In Hospital|1|||
147126005|NCT00505687|530628513|FG000|Overall Study|Other: Disease Progression|1|||
147126006|NCT00505687|530628513|FG000|Overall Study|Other: As Per Sponsor|8|||
147126007|NCT03283241|530628514|FG000|Overall Study|Adverse Event|4|||
147126008|NCT03283241|530628515|FG001|Overall Study|Adverse Event|1|||
147234625|NCT00397215|531030166|FG001|Month 6 (Day 180)|Other|0|||
147234626|NCT00397215|531030167|FG002|Month 6 (Day 180)|Other|3|||
147234627|NCT00397215|531030168|FG003|Month 6 (Day 180)|Other|0|||
147234628|NCT01361568|531030173|FG000|Overall Study|Adverse Event|0|||
147234629|NCT01361568|531030174|FG001|Overall Study|Adverse Event|0|||
147234630|NCT01361568|531030175|FG002|Overall Study|Adverse Event|0|||
147234631|NCT01361568|531030176|FG003|Overall Study|Adverse Event|0|||
147234632|NCT01361568|531030177|FG004|Overall Study|Adverse Event|1|||
147234633|NCT01361568|531030178|FG005|Overall Study|Adverse Event|0|||
147234634|NCT01361568|531030173|FG000|Overall Study|Physician Decision|0|||
147234635|NCT01361568|531030174|FG001|Overall Study|Physician Decision|0|||
147234636|NCT01361568|531030175|FG002|Overall Study|Physician Decision|0|||
147234637|NCT01361568|531030176|FG003|Overall Study|Physician Decision|0|||
147234638|NCT01361568|531030177|FG004|Overall Study|Physician Decision|0|||
147234639|NCT01361568|531030178|FG005|Overall Study|Physician Decision|1|||
147234640|NCT01361568|531030173|FG000|Overall Study|Withdrawal by Subject|2|||
147234641|NCT01361568|531030174|FG001|Overall Study|Withdrawal by Subject|1|||
147234642|NCT01361568|531030175|FG002|Overall Study|Withdrawal by Subject|0|||
147234643|NCT01361568|531030176|FG003|Overall Study|Withdrawal by Subject|0|||
147234644|NCT01361568|531030177|FG004|Overall Study|Withdrawal by Subject|0|||
147234645|NCT01361568|531030178|FG005|Overall Study|Withdrawal by Subject|1|||
147234646|NCT02020577|531030179|FG000|Overall Study|Progressive disease|3|||
147234647|NCT02020577|531030180|FG001|Overall Study|Progressive disease|38|||
147234648|NCT02020577|531030179|FG000|Overall Study|Other AE or clinical progression|0|||
147234649|NCT02020577|531030180|FG001|Overall Study|Other AE or clinical progression|15|||
147234650|NCT02020577|531030179|FG000|Overall Study|Withdrawal by Subject|0|||
147316374|NCT01316692|531323678|FG000|Overall Study|Adverse Event|5|||
147316375|NCT01316692|531323678|FG000|Overall Study|Disease Progression|7|||
147316376|NCT03220737|531323679|FG000|Main Study (Day 1 - 181)|Withdrawal by Subject|4|||
147316377|NCT03220737|531323680|FG001|Main Study (Day 1 - 181)|Withdrawal by Subject|1|||
147316378|NCT03220737|531323681|FG002|Main Study (Day 1 - 181)|Withdrawal by Subject|4|||
147316379|NCT03220737|531323682|FG003|Main Study (Day 1 - 181)|Withdrawal by Subject|1|||
147316380|NCT03220737|531323683|FG004|Main Study (Day 1 - 181)|Withdrawal by Subject|4|||
147126009|NCT03283241|530628514|FG000|Overall Study|Withdrawal by Subject|0|||
147126010|NCT03283241|530628515|FG001|Overall Study|Withdrawal by Subject|1|||
147126011|NCT03283241|530628514|FG000|Overall Study|Subject relocated to Finland|0|||
147234651|NCT02020577|531030180|FG001|Overall Study|Withdrawal by Subject|1|||
147234652|NCT02020577|531030179|FG000|Overall Study|Other than stated above|0|||
147234653|NCT02020577|531030180|FG001|Overall Study|Other than stated above|1|||
147234654|NCT02728596|531030181|FG000|Overall Study|Refusal unrelated to adverse event|3|||
147234655|NCT02728596|531030182|FG001|Overall Study|Refusal unrelated to adverse event|6|||
147234656|NCT02728596|531030183|FG002|Overall Study|Refusal unrelated to adverse event|7|||
147234657|NCT02728596|531030184|FG003|Overall Study|Refusal unrelated to adverse event|7|||
147316381|NCT03220737|531323684|FG005|Main Study (Day 1 - 181)|Withdrawal by Subject|0|||
147234658|NCT02728596|531030181|FG000|Overall Study|Death|44|||
147316382|NCT03220737|531323685|FG006|Main Study (Day 1 - 181)|Withdrawal by Subject|0|||
147316383|NCT03220737|531323679|FG000|Main Study (Day 1 - 181)|Lost to Follow-up|2|||
147316384|NCT03220737|531323680|FG001|Main Study (Day 1 - 181)|Lost to Follow-up|1|||
147316385|NCT03220737|531323681|FG002|Main Study (Day 1 - 181)|Lost to Follow-up|6|||
147316386|NCT03220737|531323682|FG003|Main Study (Day 1 - 181)|Lost to Follow-up|1|||
147316387|NCT03220737|531323683|FG004|Main Study (Day 1 - 181)|Lost to Follow-up|13|||
147316388|NCT03220737|531323684|FG005|Main Study (Day 1 - 181)|Lost to Follow-up|1|||
147316389|NCT03220737|531323685|FG006|Main Study (Day 1 - 181)|Lost to Follow-up|0|||
147316390|NCT03220737|531323679|FG000|Main Study (Day 1 - 181)|Protocol Violation|0|||
147316391|NCT03220737|531323680|FG001|Main Study (Day 1 - 181)|Protocol Violation|0|||
147316392|NCT03220737|531323681|FG002|Main Study (Day 1 - 181)|Protocol Violation|1|||
147316393|NCT03220737|531323682|FG003|Main Study (Day 1 - 181)|Protocol Violation|1|||
147126012|NCT03283241|530628515|FG001|Overall Study|Subject relocated to Finland|1|||
147126013|NCT00666263|530628518|FG000|Study Part 1 (Stabilization Phase 1)|Adverse Event|0|||
147126014|NCT00666263|530628519|FG001|Study Part 1 (Stabilization Phase 1)|Adverse Event|1|||
147126015|NCT00666263|530628518|FG000|Study Part 4 (Cross-over Period 2)|Adverse Event|1|||
147126016|NCT00666263|530628519|FG001|Study Part 4 (Cross-over Period 2)|Adverse Event|0|||
147126017|NCT00666263|530628518|FG000|Study Part 5 (Stabilization Phase 3)|Withdrawal by Subject|0|||
147126018|NCT00666263|530628519|FG001|Study Part 5 (Stabilization Phase 3)|Withdrawal by Subject|1|||
147126019|NCT02439957|530628520|FG000|Overall Study|Study Terminated|3|||
147126020|NCT02439957|530628521|FG001|Overall Study|Study Terminated|3|||
147126021|NCT00586157|530628522|FG000|First Intervention|Worsening behavior|1|||
147126022|NCT00586157|530628523|FG001|First Intervention|Worsening behavior|0|||
147126023|NCT00586157|530628522|FG000|Second Intervention|Withdrawal by Subject|1|||
147126024|NCT00586157|530628523|FG001|Second Intervention|Withdrawal by Subject|0|||
147126025|NCT00586157|530628522|FG000|Second Intervention|Worsening behavior|1|||
147126026|NCT00586157|530628523|FG001|Second Intervention|Worsening behavior|0|||
147126027|NCT00586157|530628522|FG000|Second Intervention|Adverse Event|0|||
147126028|NCT00586157|530628523|FG001|Second Intervention|Adverse Event|1|||
147126029|NCT02014467|530628525|FG000|Overall Study|Adverse Event|4|||
147126030|NCT02014467|530628526|FG001|Overall Study|Adverse Event|0|||
147126031|NCT02014467|530628525|FG000|Overall Study|Protocol Violation|3|||
147126032|NCT02014467|530628526|FG001|Overall Study|Protocol Violation|0|||
147126033|NCT02014467|530628525|FG000|Overall Study|Physician Decision|2|||
147126034|NCT02014467|530628526|FG001|Overall Study|Physician Decision|3|||
147126035|NCT02014467|530628525|FG000|Overall Study|Withdrawal by Subject|16|||
147234659|NCT02728596|531030182|FG001|Overall Study|Death|42|||
147234660|NCT02728596|531030183|FG002|Overall Study|Death|123|||
147234661|NCT02728596|531030184|FG003|Overall Study|Death|68|||
147234662|NCT03439657|531030185|FG000|Overall Study|Adverse Event|2|||
147234663|NCT03439657|531030186|FG001|Overall Study|Adverse Event|3|||
147234664|NCT03439657|531030185|FG000|Overall Study|Lost to Follow-up|1|||
147234665|NCT03439657|531030186|FG001|Overall Study|Lost to Follow-up|0|||
147234666|NCT03439657|531030185|FG000|Overall Study|Protocol Violation|1|||
147234667|NCT03439657|531030186|FG001|Overall Study|Protocol Violation|1|||
147234668|NCT03439657|531030185|FG000|Overall Study|Consent withdrawal, not due to an Adverse Event|3|||
147234669|NCT03439657|531030186|FG001|Overall Study|Consent withdrawal, not due to an Adverse Event|0|||
147234670|NCT00370071|531030187|FG000|Overall Study|Withdrawal by Subject|2|||
147234671|NCT00667875|531030190|FG000|Overall Study|Adverse Event|0|||
147234672|NCT00667875|531030191|FG001|Overall Study|Adverse Event|2|||
147234673|NCT00667875|531030192|FG002|Overall Study|Adverse Event|6|||
147234674|NCT00667875|531030190|FG000|Overall Study|Withdrawal by Subject|10|||
147234675|NCT00667875|531030191|FG001|Overall Study|Withdrawal by Subject|9|||
147234676|NCT00667875|531030192|FG002|Overall Study|Withdrawal by Subject|7|||
147234677|NCT03553927|531030193|FG000|Study A (Men With a Normal Sperm Conc.)|Withdrawal by Subject|2|||
147234678|NCT03553927|531030194|FG001|Study A (Men With a Normal Sperm Conc.)|Withdrawal by Subject|2|||
147234679|NCT03553927|531030193|FG000|Study B (Men With a Low Sperm Conc.)|Withdrawal by Subject|2|||
147234680|NCT03553927|531030194|FG001|Study B (Men With a Low Sperm Conc.)|Withdrawal by Subject|0|||
147234681|NCT01759511|531030196|FG000|Overall Study|Adverse Event|4|||
147234682|NCT01759511|531030196|FG000|Overall Study|Death|2|||
147316394|NCT03220737|531323683|FG004|Main Study (Day 1 - 181)|Protocol Violation|3|||
147126036|NCT02014467|530628526|FG001|Overall Study|Withdrawal by Subject|4|||
147126037|NCT01230060|530628527|FG000|Overall Study|Withdrawal by Subject|1|||
147126038|NCT03802916|530628528|FG000|Overall Study|Adverse Event|0|||
147126039|NCT03802916|530628529|FG001|Overall Study|Adverse Event|1|||
147234683|NCT01759511|531030196|FG000|Overall Study|Lack of Efficacy|2|||
147234684|NCT01759511|531030196|FG000|Overall Study|Physician Decision|1|||
147234685|NCT01759511|531030196|FG000|Overall Study|Progressive Disease|5|||
147234686|NCT01759511|531030196|FG000|Overall Study|Protocol-Specified Criteria for Withdraw|4|||
147234687|NCT01759511|531030196|FG000|Overall Study|Study Terminated by Sponsor|13|||
147234688|NCT01759511|531030196|FG000|Overall Study|Withdrawal by Subject|3|||
147316395|NCT03220737|531323684|FG005|Main Study (Day 1 - 181)|Protocol Violation|0|||
147316396|NCT03220737|531323685|FG006|Main Study (Day 1 - 181)|Protocol Violation|1|||
147126040|NCT03802916|530628528|FG000|Overall Study|Withdrawal by Subject|0|||
147234689|NCT02569671|531030197|FG000|Overall Study|Lost to Follow-up|2|||
147234690|NCT02569671|531030198|FG001|Overall Study|Lost to Follow-up|1|||
147234691|NCT02569671|531030197|FG000|Overall Study|Withdrawal by Subject|1|||
147234692|NCT02569671|531030198|FG001|Overall Study|Withdrawal by Subject|3|||
147234693|NCT01757535|531030199|FG000|Overall Study|Disease Relapse|151|||
147234694|NCT01757535|531030200|FG001|Overall Study|Disease Relapse|181|||
147234695|NCT01757535|531030199|FG000|Overall Study|Other Reasons|28|||
147234696|NCT01757535|531030200|FG001|Overall Study|Other Reasons|27|||
147234697|NCT01757535|531030199|FG000|Overall Study|Adverse Event|31|||
147234698|NCT01757535|531030200|FG001|Overall Study|Adverse Event|11|||
147234699|NCT01757535|531030199|FG000|Overall Study|Withdrew Consent|19|||
147234700|NCT01757535|531030200|FG001|Overall Study|Withdrew Consent|13|||
147234701|NCT01757535|531030199|FG000|Overall Study|Physician Decision|7|||
147234702|NCT01757535|531030200|FG001|Overall Study|Physician Decision|0|||
147234703|NCT01757535|531030199|FG000|Overall Study|Death|2|||
147234704|NCT01757535|531030200|FG001|Overall Study|Death|2|||
147234705|NCT06238362|531030201|FG000|Overall Study|Insufficient total sleep time|1|||
147234706|NCT06238362|531030202|FG001|Overall Study|Insufficient total sleep time|0|||
147234707|NCT06238362|531030201|FG000|Overall Study|Inadequate signal quality|1|||
147234708|NCT06238362|531030202|FG001|Overall Study|Inadequate signal quality|0|||
147234709|NCT01313858|531031582|FG000|Overall Study|Premature Treatment Termination|251|||
147234710|NCT01313858|531031583|FG001|Overall Study|Premature Treatment Termination|219|||
147234711|NCT01313858|531031584|FG002|Overall Study|Premature Treatment Termination|191|||
147234712|NCT01313858|531031582|FG000|Overall Study|Lost to Follow-up|35|||
147234713|NCT01313858|531031583|FG001|Overall Study|Lost to Follow-up|51|||
147234714|NCT01313858|531031584|FG002|Overall Study|Lost to Follow-up|47|||
147234715|NCT03689530|531031589|FG000|Overall Study|Withdrawal by Subject|53|||
147234716|NCT03689530|531031590|FG001|Overall Study|Withdrawal by Subject|16|||
147234717|NCT01392443|531031591|FG000|Overall Study|Disease progression|30|||
147234718|NCT01392443|531031591|FG000|Overall Study|Adverse Event|24|||
147234719|NCT01392443|531031591|FG000|Overall Study|Death|7|||
147234720|NCT01392443|531031591|FG000|Overall Study|Withdrawal by Subject|5|||
147234721|NCT01392443|531031591|FG000|Overall Study|Lost to Follow-up|1|||
147234722|NCT01392443|531031591|FG000|Overall Study|Protocol Violation|1|||
147234723|NCT01546207|531031604|FG000|Overall Study|Death|1|||
147234724|NCT01626456|531031605|FG000|Overall Study|Withdrawal by Subject|21|||
147234725|NCT01626456|531031606|FG001|Overall Study|Withdrawal by Subject|46|||
147234726|NCT01626456|531031605|FG000|Overall Study|Adverse Event|2|||
147234727|NCT01626456|531031606|FG001|Overall Study|Adverse Event|27|||
147234728|NCT01626456|531031605|FG000|Overall Study|Lost to Follow-up|2|||
147234729|NCT01626456|531031606|FG001|Overall Study|Lost to Follow-up|27|||
147234730|NCT01626456|531031605|FG000|Overall Study|Lack of Efficacy|6|||
147234731|NCT01626456|531031606|FG001|Overall Study|Lack of Efficacy|7|||
147234732|NCT01626456|531031605|FG000|Overall Study|Physician Decision|1|||
147234733|NCT01626456|531031606|FG001|Overall Study|Physician Decision|4|||
147234734|NCT01626456|531031605|FG000|Overall Study|Protocol Violation|1|||
147234735|NCT01626456|531031606|FG001|Overall Study|Protocol Violation|1|||
147234736|NCT01626456|531031605|FG000|Overall Study|Site Closure|2|||
147234737|NCT01626456|531031606|FG001|Overall Study|Site Closure|3|||
147234738|NCT01626456|531031605|FG000|Overall Study|Incarceration|0|||
147234739|NCT01626456|531031606|FG001|Overall Study|Incarceration|2|||
147234740|NCT01816074|531031607|FG000|Phase 1|Time commitment issues|0|||
147234741|NCT01816074|531031608|FG001|Phase 1|Time commitment issues|0|||
147234742|NCT01816074|531031609|FG002|Phase 1|Time commitment issues|1|||
147234743|NCT01816074|531031610|FG003|Phase 1|Time commitment issues|0|||
147234744|NCT01816074|531031607|FG000|Phase 2|Time commitment Issues|0|||
147234745|NCT01816074|531031608|FG001|Phase 2|Time commitment Issues|2|||
147234746|NCT01816074|531031609|FG002|Phase 2|Time commitment Issues|0|||
147234747|NCT01816074|531031610|FG003|Phase 2|Time commitment Issues|0|||
147234748|NCT01816074|531031607|FG000|Phase 2|Unsatisfied with Randomization assignmen|1|||
147234749|NCT01816074|531031608|FG001|Phase 2|Unsatisfied with Randomization assignmen|0|||
147234750|NCT01816074|531031609|FG002|Phase 2|Unsatisfied with Randomization assignmen|0|||
147234751|NCT01816074|531031610|FG003|Phase 2|Unsatisfied with Randomization assignmen|0|||
147234752|NCT01816074|531031607|FG000|Phase 2|Physician Decision|0|||
147234753|NCT01816074|531031608|FG001|Phase 2|Physician Decision|0|||
147234754|NCT01816074|531031609|FG002|Phase 2|Physician Decision|0|||
147234755|NCT01816074|531031610|FG003|Phase 2|Physician Decision|1|||
147234756|NCT01816074|531031607|FG000|Phase 2|Withdrawal by Subject|1|||
147234757|NCT01816074|531031608|FG001|Phase 2|Withdrawal by Subject|0|||
147234758|NCT01816074|531031609|FG002|Phase 2|Withdrawal by Subject|0|||
147234759|NCT01816074|531031610|FG003|Phase 2|Withdrawal by Subject|0|||
147234760|NCT00131508|531031616|FG000|Overall Study|Disease progression|0|||
147316397|NCT03220737|531323679|FG000|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
147234761|NCT00131508|531031617|FG001|Overall Study|Disease progression|2|||
147234762|NCT00131508|531031616|FG000|Overall Study|Non-Compliance|2|||
147234763|NCT00131508|531031617|FG001|Overall Study|Non-Compliance|4|||
147234764|NCT00131508|531031616|FG000|Overall Study|Withdrawal by Subject|1|||
147234765|NCT00131508|531031617|FG001|Overall Study|Withdrawal by Subject|2|||
147234766|NCT01330030|531031618|FG000|Overall Study|Lost to Follow-up|16|||
147126041|NCT03802916|530628529|FG001|Overall Study|Withdrawal by Subject|1|||
147126042|NCT00480532|530628532|FG000|Overall Study|Withdrawal by Subject|2|||
147126043|NCT00480532|530628533|FG001|Overall Study|Withdrawal by Subject|4|||
147126044|NCT00480532|530628534|FG002|Overall Study|Withdrawal by Subject|3|||
147126045|NCT00480532|530628535|FG003|Overall Study|Withdrawal by Subject|1|||
147126046|NCT00480532|530628532|FG000|Overall Study|Protocol Violation|0|||
147126047|NCT00480532|530628533|FG001|Overall Study|Protocol Violation|0|||
147126048|NCT00480532|530628534|FG002|Overall Study|Protocol Violation|1|||
147126049|NCT00480532|530628535|FG003|Overall Study|Protocol Violation|0|||
147126050|NCT00831389|530628536|FG000|Overall Study|Withdrawal by Subject|0|||
147126051|NCT00831389|530628537|FG001|Overall Study|Withdrawal by Subject|1|||
147126052|NCT00278161|530628539|FG000|Overall Study|Death|11|||
147126053|NCT01817777|530628540|FG000|Observational Phase (8 Weeks)|Lost to Follow-up|3|||
147126054|NCT01817777|530628541|FG001|Observational Phase (8 Weeks)|Lost to Follow-up|0|||
147126055|NCT01817777|530628542|FG002|Observational Phase (8 Weeks)|Lost to Follow-up|0|||
147126056|NCT01817777|530628540|FG000|Observational Phase (8 Weeks)|Early Study Termination|2|||
147126057|NCT01817777|530628541|FG001|Observational Phase (8 Weeks)|Early Study Termination|0|||
147126058|NCT01817777|530628542|FG002|Observational Phase (8 Weeks)|Early Study Termination|0|||
147126059|NCT01817777|530628540|FG000|Interventional Phase (20 Weeks)|Withdrawal by Subject|0|||
147126060|NCT01817777|530628541|FG001|Interventional Phase (20 Weeks)|Withdrawal by Subject|3|||
147126061|NCT01817777|530628542|FG002|Interventional Phase (20 Weeks)|Withdrawal by Subject|0|||
147126062|NCT01817777|530628540|FG000|Interventional Phase (20 Weeks)|Lost to Follow-up|0|||
147316398|NCT03220737|531323680|FG001|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
147316399|NCT03220737|531323681|FG002|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|1|||
147316400|NCT03220737|531323682|FG003|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
147316401|NCT03220737|531323683|FG004|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
147316402|NCT03220737|531323684|FG005|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
147316403|NCT03220737|531323685|FG006|Main Study (Day 1 - 181)|Failed Exl 8 and randomized in error|0|||
147316404|NCT03220737|531323679|FG000|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
147316405|NCT03220737|531323680|FG001|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
147316406|NCT03220737|531323681|FG002|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
147316407|NCT03220737|531323682|FG003|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
147126063|NCT01817777|530628541|FG001|Interventional Phase (20 Weeks)|Lost to Follow-up|1|||
147126064|NCT01817777|530628542|FG002|Interventional Phase (20 Weeks)|Lost to Follow-up|2|||
147126065|NCT01817777|530628540|FG000|Interventional Phase (20 Weeks)|Early Study Termination|0|||
147126066|NCT01817777|530628541|FG001|Interventional Phase (20 Weeks)|Early Study Termination|1|||
147126067|NCT01817777|530628542|FG002|Interventional Phase (20 Weeks)|Early Study Termination|3|||
147126068|NCT00443456|530628543|FG000|Overall Study|Adverse Event|16|||
147316408|NCT03220737|531323683|FG004|Placebo Crossover (Day 181-365)|Lost to Follow-up|2|||
147126069|NCT00443456|530628543|FG000|Overall Study|Move|1|||
147126070|NCT00443456|530628543|FG000|Overall Study|Withdrawal by Subject|1|||
147126071|NCT03242434|530628544|FG000|Overall Study|Death|0|||
147126072|NCT03242434|530628545|FG001|Overall Study|Death|2|||
147126073|NCT01592747|530628546|FG000|Overall Study|Loss of Therapeutic Response|107|||
147126074|NCT01592747|530628547|FG001|Overall Study|Loss of Therapeutic Response|108|||
147126075|NCT01592747|530628548|FG002|Overall Study|Loss of Therapeutic Response|100|||
147126076|NCT01592747|530628546|FG000|Overall Study|Inclusion/Exclusion criteria not met|0|||
147126077|NCT01592747|530628547|FG001|Overall Study|Inclusion/Exclusion criteria not met|1|||
147126078|NCT01592747|530628548|FG002|Overall Study|Inclusion/Exclusion criteria not met|1|||
147126079|NCT01592747|530628546|FG000|Overall Study|Adverse Event|1|||
147126080|NCT01592747|530628547|FG001|Overall Study|Adverse Event|0|||
147126081|NCT01592747|530628548|FG002|Overall Study|Adverse Event|0|||
147126082|NCT01592747|530628546|FG000|Overall Study|Protocol Violation|4|||
147126083|NCT01592747|530628547|FG001|Overall Study|Protocol Violation|0|||
147126084|NCT01592747|530628548|FG002|Overall Study|Protocol Violation|4|||
147126085|NCT01592747|530628546|FG000|Overall Study|Lack of Efficacy|0|||
147126086|NCT01592747|530628547|FG001|Overall Study|Lack of Efficacy|1|||
147126087|NCT01592747|530628548|FG002|Overall Study|Lack of Efficacy|0|||
147126088|NCT01592747|530628546|FG000|Overall Study|Withdrawal by Subject|2|||
147126089|NCT01592747|530628547|FG001|Overall Study|Withdrawal by Subject|0|||
147126090|NCT01592747|530628548|FG002|Overall Study|Withdrawal by Subject|2|||
147126091|NCT01592747|530628546|FG000|Overall Study|Lost to Follow-up|1|||
147126092|NCT01592747|530628547|FG001|Overall Study|Lost to Follow-up|0|||
147126093|NCT01592747|530628548|FG002|Overall Study|Lost to Follow-up|1|||
147126094|NCT01592747|530628546|FG000|Overall Study|Other Reasons|1|||
147126095|NCT01592747|530628547|FG001|Overall Study|Other Reasons|1|||
147126096|NCT01592747|530628548|FG002|Overall Study|Other Reasons|0|||
147126097|NCT00425555|530628551|FG000|Overall Study|Withdrawal by Subject|11|||
147126098|NCT00425555|530628552|FG001|Overall Study|Withdrawal by Subject|8|||
147126099|NCT00425555|530628551|FG000|Overall Study|Lost to Follow-up|0|||
147126100|NCT00425555|530628552|FG001|Overall Study|Lost to Follow-up|1|||
147126101|NCT00425555|530628551|FG000|Overall Study|Administrative problems|3|||
147316409|NCT03220737|531323684|FG005|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
147126102|NCT00425555|530628552|FG001|Overall Study|Administrative problems|0|||
147126103|NCT00425555|530628551|FG000|Overall Study|Death|1|||
147126104|NCT00425555|530628552|FG001|Overall Study|Death|2|||
147126105|NCT00425555|530628551|FG000|Overall Study|New cancer therapy|2|||
147126106|NCT00425555|530628552|FG001|Overall Study|New cancer therapy|1|||
147126107|NCT00425555|530628551|FG000|Overall Study|Disease progression|36|||
147126108|NCT00425555|530628552|FG001|Overall Study|Disease progression|33|||
147126109|NCT00425555|530628551|FG000|Overall Study|Adverse Event|25|||
147126110|NCT00425555|530628552|FG001|Overall Study|Adverse Event|15|||
147126111|NCT00425555|530628551|FG000|Overall Study|Protocol Violation|1|||
147126112|NCT00425555|530628552|FG001|Overall Study|Protocol Violation|0|||
147126113|NCT00619918|530628553|FG000|Overall Study|Withdrawal by Subject|4|||
147126114|NCT00619918|530628554|FG001|Overall Study|Withdrawal by Subject|3|||
147126115|NCT00619918|530628553|FG000|Overall Study|Physician Decision|2|||
147126116|NCT00619918|530628554|FG001|Overall Study|Physician Decision|4|||
147126117|NCT00619918|530628553|FG000|Overall Study|Transfer to outside facility|3|||
147126118|NCT00619918|530628554|FG001|Overall Study|Transfer to outside facility|3|||
147126119|NCT00619918|530628553|FG000|Overall Study|Left before receiving first dose|7|||
147126120|NCT00619918|530628554|FG001|Overall Study|Left before receiving first dose|6|||
147126121|NCT00619918|530628553|FG000|Overall Study|ICU admission|4|||
147126122|NCT00619918|530628554|FG001|Overall Study|ICU admission|6|||
147126123|NCT03533491|530628555|FG000|Overall Study|Lost to Follow-up|2|||
147126124|NCT04661839|530628560|FG000|Overall Study|Not Treated|0|||
147126125|NCT04661839|530628561|FG001|Overall Study|Not Treated|0|||
147126126|NCT04661839|530628562|FG002|Overall Study|Not Treated|1|||
147126127|NCT04661839|530628563|FG003|Overall Study|Not Treated|0|||
147126128|NCT04661839|530628560|FG000|Overall Study|Lost to Follow-up|1|||
147126129|NCT04661839|530628561|FG001|Overall Study|Lost to Follow-up|0|||
147126130|NCT04661839|530628562|FG002|Overall Study|Lost to Follow-up|0|||
147126131|NCT04661839|530628563|FG003|Overall Study|Lost to Follow-up|1|||
147126132|NCT02951819|530628567|FG000|Overall Study|Death|9|||
147126133|NCT02951819|530628568|FG001|Overall Study|Death|7|||
147126134|NCT02951819|530628567|FG000|Overall Study|Withdrawal by Subject|3|||
147126135|NCT02951819|530628568|FG001|Overall Study|Withdrawal by Subject|0|||
147126136|NCT02951819|530628567|FG000|Overall Study|Adverse Event|1|||
147126137|NCT02951819|530628568|FG001|Overall Study|Adverse Event|0|||
147126138|NCT02951819|530628567|FG000|Overall Study|Lack of Efficacy|4|||
147126139|NCT02951819|530628568|FG001|Overall Study|Lack of Efficacy|0|||
147126140|NCT02951819|530628567|FG000|Overall Study|Lost to Follow-up|1|||
147126141|NCT02951819|530628568|FG001|Overall Study|Lost to Follow-up|0|||
147126142|NCT02951819|530628567|FG000|Overall Study|Progressive Disease|1|||
147126143|NCT02951819|530628568|FG001|Overall Study|Progressive Disease|0|||
147126144|NCT02951819|530628567|FG000|Overall Study|Other|9|||
147126145|NCT02951819|530628568|FG001|Overall Study|Other|0|||
147126146|NCT03715829|530628569|FG000|Dose Ranging Period|Adverse Event|2|||
147126147|NCT03715829|530628570|FG001|Dose Ranging Period|Adverse Event|4|||
147126148|NCT03715829|530628571|FG002|Dose Ranging Period|Adverse Event|5|||
147126149|NCT03715829|530628572|FG003|Dose Ranging Period|Adverse Event|2|||
147126150|NCT03715829|530628573|FG004|Dose Ranging Period|Adverse Event|3|||
147126151|NCT03715829|530628574|FG005|Dose Ranging Period|Adverse Event|3|||
147126152|NCT03715829|530628575|FG006|Dose Ranging Period|Adverse Event|0|||
147126153|NCT03715829|530628576|FG007|Dose Ranging Period|Adverse Event|0|||
147126154|NCT03715829|530628577|FG008|Dose Ranging Period|Adverse Event|0|||
147126155|NCT03715829|530628578|FG009|Dose Ranging Period|Adverse Event|0|||
147126156|NCT03715829|530628579|FG010|Dose Ranging Period|Adverse Event|0|||
147126157|NCT03715829|530628569|FG000|Dose Ranging Period|Lack of Efficacy|0|||
147126158|NCT03715829|530628570|FG001|Dose Ranging Period|Lack of Efficacy|1|||
147126159|NCT03715829|530628571|FG002|Dose Ranging Period|Lack of Efficacy|0|||
147126160|NCT03715829|530628572|FG003|Dose Ranging Period|Lack of Efficacy|1|||
147126161|NCT03715829|530628573|FG004|Dose Ranging Period|Lack of Efficacy|0|||
147126162|NCT03715829|530628574|FG005|Dose Ranging Period|Lack of Efficacy|0|||
147126163|NCT03715829|530628575|FG006|Dose Ranging Period|Lack of Efficacy|0|||
147126164|NCT03715829|530628576|FG007|Dose Ranging Period|Lack of Efficacy|0|||
147126165|NCT03715829|530628577|FG008|Dose Ranging Period|Lack of Efficacy|0|||
147126166|NCT03715829|530628578|FG009|Dose Ranging Period|Lack of Efficacy|0|||
147126167|NCT03715829|530628579|FG010|Dose Ranging Period|Lack of Efficacy|0|||
147126168|NCT03715829|530628569|FG000|Dose Ranging Period|Lost to Follow-up|2|||
147126169|NCT03715829|530628570|FG001|Dose Ranging Period|Lost to Follow-up|0|||
147126170|NCT03715829|530628571|FG002|Dose Ranging Period|Lost to Follow-up|1|||
147126171|NCT03715829|530628572|FG003|Dose Ranging Period|Lost to Follow-up|1|||
147126172|NCT03715829|530628573|FG004|Dose Ranging Period|Lost to Follow-up|1|||
147126173|NCT03715829|530628574|FG005|Dose Ranging Period|Lost to Follow-up|2|||
147126174|NCT03715829|530628575|FG006|Dose Ranging Period|Lost to Follow-up|0|||
147126175|NCT03715829|530628576|FG007|Dose Ranging Period|Lost to Follow-up|0|||
147126176|NCT03715829|530628577|FG008|Dose Ranging Period|Lost to Follow-up|0|||
147126177|NCT03715829|530628578|FG009|Dose Ranging Period|Lost to Follow-up|0|||
147126178|NCT03715829|530628579|FG010|Dose Ranging Period|Lost to Follow-up|0|||
147126179|NCT03715829|530628569|FG000|Dose Ranging Period|Protocol Violation|0|||
147126180|NCT03715829|530628570|FG001|Dose Ranging Period|Protocol Violation|0|||
147126181|NCT03715829|530628571|FG002|Dose Ranging Period|Protocol Violation|0|||
147126182|NCT03715829|530628572|FG003|Dose Ranging Period|Protocol Violation|1|||
147126183|NCT03715829|530628573|FG004|Dose Ranging Period|Protocol Violation|0|||
147126184|NCT03715829|530628574|FG005|Dose Ranging Period|Protocol Violation|0|||
147126185|NCT03715829|530628575|FG006|Dose Ranging Period|Protocol Violation|0|||
147126186|NCT03715829|530628576|FG007|Dose Ranging Period|Protocol Violation|0|||
147126187|NCT03715829|530628577|FG008|Dose Ranging Period|Protocol Violation|0|||
147126188|NCT03715829|530628578|FG009|Dose Ranging Period|Protocol Violation|0|||
147126189|NCT03715829|530628579|FG010|Dose Ranging Period|Protocol Violation|0|||
147126190|NCT03715829|530628569|FG000|Dose Ranging Period|Withdrawal by Subject|8|||
147126191|NCT03715829|530628570|FG001|Dose Ranging Period|Withdrawal by Subject|4|||
147126192|NCT03715829|530628571|FG002|Dose Ranging Period|Withdrawal by Subject|3|||
147126193|NCT03715829|530628572|FG003|Dose Ranging Period|Withdrawal by Subject|9|||
147126194|NCT03715829|530628573|FG004|Dose Ranging Period|Withdrawal by Subject|2|||
147126195|NCT03715829|530628574|FG005|Dose Ranging Period|Withdrawal by Subject|3|||
147126196|NCT03715829|530628575|FG006|Dose Ranging Period|Withdrawal by Subject|0|||
147126197|NCT03715829|530628576|FG007|Dose Ranging Period|Withdrawal by Subject|0|||
147126198|NCT03715829|530628577|FG008|Dose Ranging Period|Withdrawal by Subject|0|||
147126199|NCT03715829|530628578|FG009|Dose Ranging Period|Withdrawal by Subject|0|||
147126200|NCT03715829|530628579|FG010|Dose Ranging Period|Withdrawal by Subject|0|||
147126201|NCT03715829|530628569|FG000|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
147126202|NCT03715829|530628570|FG001|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
147126203|NCT03715829|530628571|FG002|Dose Ranging Period|Medication Error Without Associated Adverse Event|1|||
147126204|NCT03715829|530628572|FG003|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
147126205|NCT03715829|530628573|FG004|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
147126206|NCT03715829|530628574|FG005|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
147126207|NCT03715829|530628575|FG006|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
147126208|NCT03715829|530628576|FG007|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
147126209|NCT03715829|530628577|FG008|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
147126210|NCT03715829|530628578|FG009|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
147126211|NCT03715829|530628579|FG010|Dose Ranging Period|Medication Error Without Associated Adverse Event|0|||
147126212|NCT03715829|530628569|FG000|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
147126213|NCT03715829|530628570|FG001|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
147126214|NCT03715829|530628571|FG002|Dose Ranging Period|No Longer Meets Eligibility Criteria|1|||
147126215|NCT03715829|530628572|FG003|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
147126216|NCT03715829|530628573|FG004|Dose Ranging Period|No Longer Meets Eligibility Criteria|1|||
147126217|NCT03715829|530628574|FG005|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
147126218|NCT03715829|530628575|FG006|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
147126219|NCT03715829|530628576|FG007|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
147126220|NCT03715829|530628577|FG008|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
147126221|NCT03715829|530628578|FG009|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
147126222|NCT03715829|530628579|FG010|Dose Ranging Period|No Longer Meets Eligibility Criteria|0|||
147126223|NCT03715829|530628569|FG000|Dose Ranging Period|Other|0|||
147126224|NCT03715829|530628570|FG001|Dose Ranging Period|Other|0|||
147126225|NCT03715829|530628571|FG002|Dose Ranging Period|Other|2|||
147126226|NCT03715829|530628572|FG003|Dose Ranging Period|Other|0|||
147126227|NCT03715829|530628573|FG004|Dose Ranging Period|Other|0|||
147126228|NCT03715829|530628574|FG005|Dose Ranging Period|Other|3|||
147126229|NCT03715829|530628575|FG006|Dose Ranging Period|Other|0|||
147126230|NCT03715829|530628576|FG007|Dose Ranging Period|Other|0|||
147126231|NCT03715829|530628577|FG008|Dose Ranging Period|Other|0|||
147126232|NCT03715829|530628578|FG009|Dose Ranging Period|Other|0|||
147126233|NCT03715829|530628579|FG010|Dose Ranging Period|Other|0|||
147126234|NCT03715829|530628569|FG000|Extension Period|Adverse Event|0|||
147126235|NCT03715829|530628570|FG001|Extension Period|Adverse Event|0|||
147126236|NCT03715829|530628571|FG002|Extension Period|Adverse Event|0|||
147126237|NCT03715829|530628572|FG003|Extension Period|Adverse Event|0|||
147126238|NCT03715829|530628573|FG004|Extension Period|Adverse Event|0|||
147126239|NCT03715829|530628574|FG005|Extension Period|Adverse Event|0|||
147126240|NCT03715829|530628575|FG006|Extension Period|Adverse Event|3|||
147126241|NCT03715829|530628576|FG007|Extension Period|Adverse Event|1|||
147126242|NCT03715829|530628577|FG008|Extension Period|Adverse Event|6|||
147126243|NCT03715829|530628578|FG009|Extension Period|Adverse Event|0|||
147126244|NCT03715829|530628579|FG010|Extension Period|Adverse Event|0|||
147126245|NCT03715829|530628569|FG000|Extension Period|Lack of Efficacy|0|||
147126246|NCT03715829|530628570|FG001|Extension Period|Lack of Efficacy|0|||
147126247|NCT03715829|530628571|FG002|Extension Period|Lack of Efficacy|0|||
147126248|NCT03715829|530628572|FG003|Extension Period|Lack of Efficacy|0|||
147126249|NCT03715829|530628573|FG004|Extension Period|Lack of Efficacy|0|||
147126250|NCT03715829|530628574|FG005|Extension Period|Lack of Efficacy|0|||
147126251|NCT03715829|530628575|FG006|Extension Period|Lack of Efficacy|1|||
147126252|NCT03715829|530628576|FG007|Extension Period|Lack of Efficacy|9|||
147234767|NCT01330030|531031619|FG001|Overall Study|Lost to Follow-up|17|||
147126253|NCT03715829|530628577|FG008|Extension Period|Lack of Efficacy|2|||
147126254|NCT03715829|530628578|FG009|Extension Period|Lack of Efficacy|0|||
147126255|NCT03715829|530628579|FG010|Extension Period|Lack of Efficacy|0|||
147126256|NCT03715829|530628569|FG000|Extension Period|Lost to Follow-up|0|||
147126257|NCT03715829|530628570|FG001|Extension Period|Lost to Follow-up|0|||
147126258|NCT03715829|530628571|FG002|Extension Period|Lost to Follow-up|0|||
147126259|NCT03715829|530628572|FG003|Extension Period|Lost to Follow-up|0|||
147126260|NCT03715829|530628573|FG004|Extension Period|Lost to Follow-up|0|||
147126261|NCT03715829|530628574|FG005|Extension Period|Lost to Follow-up|0|||
147126262|NCT03715829|530628575|FG006|Extension Period|Lost to Follow-up|0|||
147126263|NCT03715829|530628576|FG007|Extension Period|Lost to Follow-up|0|||
147126264|NCT03715829|530628577|FG008|Extension Period|Lost to Follow-up|2|||
147126265|NCT03715829|530628578|FG009|Extension Period|Lost to Follow-up|0|||
147126266|NCT03715829|530628579|FG010|Extension Period|Lost to Follow-up|0|||
147126267|NCT03715829|530628569|FG000|Extension Period|Protocol Violation|0|||
147126268|NCT03715829|530628570|FG001|Extension Period|Protocol Violation|0|||
147126269|NCT03715829|530628571|FG002|Extension Period|Protocol Violation|0|||
147126270|NCT03715829|530628572|FG003|Extension Period|Protocol Violation|0|||
147126271|NCT03715829|530628573|FG004|Extension Period|Protocol Violation|0|||
147234768|NCT00845858|531031620|FG000|Overall Study|Withdrawal by Subject|5|||
147234769|NCT00845858|531031621|FG001|Overall Study|Withdrawal by Subject|1|||
147234770|NCT00845858|531031622|FG002|Overall Study|Withdrawal by Subject|1|||
147234771|NCT00845858|531031620|FG000|Overall Study|Adverse Event|3|||
147234772|NCT00845858|531031621|FG001|Overall Study|Adverse Event|8|||
147234773|NCT00845858|531031622|FG002|Overall Study|Adverse Event|4|||
147234774|NCT00845858|531031620|FG000|Overall Study|Protocol Violation|0|||
147234775|NCT00845858|531031621|FG001|Overall Study|Protocol Violation|0|||
147234776|NCT00845858|531031622|FG002|Overall Study|Protocol Violation|1|||
147234777|NCT00845858|531031620|FG000|Overall Study|not eligible|0|||
147234778|NCT00845858|531031621|FG001|Overall Study|not eligible|3|||
147234779|NCT00845858|531031622|FG002|Overall Study|not eligible|2|||
147234780|NCT02980783|531031623|FG000|Overall Study|Lost to Follow-up|1|||
147234781|NCT00850070|531031624|FG000|Overall Study|Lack of Efficacy|1|||
147234782|NCT00850070|531031625|FG001|Overall Study|Lack of Efficacy|1|||
147234783|NCT00850070|531031624|FG000|Overall Study|Adverse Event|2|||
147234784|NCT00850070|531031625|FG001|Overall Study|Adverse Event|0|||
147234785|NCT01522248|531031626|FG000|Overall Study|Lost to Follow-up|1|||
147234786|NCT01522248|531031627|FG001|Overall Study|Lost to Follow-up|0|||
147234787|NCT00696800|531031632|FG000|Overall Study|Adverse Event|16|||
147234788|NCT00696800|531031633|FG001|Overall Study|Adverse Event|3|||
147234789|NCT00696800|531031632|FG000|Overall Study|Insufficient compliance with medication|2|||
147234790|NCT00696800|531031633|FG001|Overall Study|Insufficient compliance with medication|1|||
147234791|NCT00696800|531031632|FG000|Overall Study|Insufficient ovarian response on Day 8|4|||
147234792|NCT00696800|531031633|FG001|Overall Study|Insufficient ovarian response on Day 8|1|||
147234793|NCT00696800|531031632|FG000|Overall Study|Insufficient ovarian response|4|||
147234794|NCT00696800|531031633|FG001|Overall Study|Insufficient ovarian response|1|||
147234795|NCT00696800|531031632|FG000|Overall Study|Risk Ovarian Hyperstimulation Syndrome|8|||
147234796|NCT00696800|531031633|FG001|Overall Study|Risk Ovarian Hyperstimulation Syndrome|2|||
147234797|NCT00696800|531031632|FG000|Overall Study|Too high ovarian response|6|||
147234798|NCT00696800|531031633|FG001|Overall Study|Too high ovarian response|1|||
147234799|NCT00696800|531031632|FG000|Overall Study|No/too few/bad quality oocytes|4|||
147234800|NCT00696800|531031633|FG001|Overall Study|No/too few/bad quality oocytes|3|||
147234801|NCT00696800|531031632|FG000|Overall Study|No/abnormal fertilization|11|||
147234802|NCT00696800|531031633|FG001|Overall Study|No/abnormal fertilization|13|||
147234803|NCT00696800|531031632|FG000|Overall Study|No/too few/bad quality embryos|24|||
147234804|NCT00696800|531031633|FG001|Overall Study|No/too few/bad quality embryos|18|||
147234805|NCT00696800|531031632|FG000|Overall Study|Other Reasons|5|||
147234806|NCT00696800|531031633|FG001|Overall Study|Other Reasons|3|||
147234807|NCT00696800|531031632|FG000|Overall Study|Not treated|1|||
147234808|NCT00696800|531031633|FG001|Overall Study|Not treated|2|||
147234809|NCT05224141|531031636|FG000|Overall Study|Ongoing|75|||
147234810|NCT05224141|531031637|FG001|Overall Study|Ongoing|88|||
147234811|NCT05224141|531031636|FG000|Overall Study|Withdrawal by Subject|2|||
147234812|NCT05224141|531031637|FG001|Overall Study|Withdrawal by Subject|4|||
147234813|NCT05224141|531031636|FG000|Overall Study|Death|153|||
147234814|NCT05224141|531031637|FG001|Overall Study|Death|138|||
147234815|NCT02435147|531031650|FG000|Overall Study|non-evaluable DXA scan|11|||
147234816|NCT02639546|531031651|FG000|Overall Study|Death|2|||
147234817|NCT02639546|531031652|FG001|Overall Study|Death|2|||
147234818|NCT02639546|531031653|FG002|Overall Study|Death|1|||
147234819|NCT02639546|531031654|FG003|Overall Study|Death|2|||
147234820|NCT02639546|531031655|FG004|Overall Study|Death|2|||
147234821|NCT02639546|531031656|FG005|Overall Study|Death|2|||
147234822|NCT02639546|531031657|FG006|Overall Study|Death|0|||
147234823|NCT02639546|531031658|FG007|Overall Study|Death|0|||
147234824|NCT02639546|531031651|FG000|Overall Study|Lost to Follow-up|0|||
147126272|NCT03715829|530628574|FG005|Extension Period|Protocol Violation|0|||
147126273|NCT03715829|530628575|FG006|Extension Period|Protocol Violation|0|||
147126274|NCT03715829|530628576|FG007|Extension Period|Protocol Violation|0|||
147126275|NCT03715829|530628577|FG008|Extension Period|Protocol Violation|1|||
147126276|NCT03715829|530628578|FG009|Extension Period|Protocol Violation|0|||
147126277|NCT03715829|530628579|FG010|Extension Period|Protocol Violation|0|||
147126278|NCT03715829|530628569|FG000|Extension Period|Withdrawal by Subject|0|||
147126279|NCT03715829|530628570|FG001|Extension Period|Withdrawal by Subject|0|||
147126280|NCT03715829|530628571|FG002|Extension Period|Withdrawal by Subject|0|||
147126281|NCT03715829|530628572|FG003|Extension Period|Withdrawal by Subject|0|||
147126282|NCT03715829|530628573|FG004|Extension Period|Withdrawal by Subject|0|||
147126283|NCT03715829|530628574|FG005|Extension Period|Withdrawal by Subject|0|||
147126284|NCT03715829|530628575|FG006|Extension Period|Withdrawal by Subject|3|||
147126285|NCT03715829|530628576|FG007|Extension Period|Withdrawal by Subject|3|||
147126286|NCT03715829|530628577|FG008|Extension Period|Withdrawal by Subject|12|||
147126287|NCT03715829|530628578|FG009|Extension Period|Withdrawal by Subject|3|||
147126288|NCT03715829|530628579|FG010|Extension Period|Withdrawal by Subject|0|||
147126289|NCT03715829|530628569|FG000|Extension Period|Medication Error Without Associated Adverse Event|0|||
147126290|NCT03715829|530628570|FG001|Extension Period|Medication Error Without Associated Adverse Event|0|||
147126291|NCT03715829|530628571|FG002|Extension Period|Medication Error Without Associated Adverse Event|0|||
147126292|NCT03715829|530628572|FG003|Extension Period|Medication Error Without Associated Adverse Event|0|||
147126293|NCT03715829|530628573|FG004|Extension Period|Medication Error Without Associated Adverse Event|0|||
147126294|NCT03715829|530628574|FG005|Extension Period|Medication Error Without Associated Adverse Event|0|||
147126295|NCT03715829|530628575|FG006|Extension Period|Medication Error Without Associated Adverse Event|0|||
147126296|NCT03715829|530628576|FG007|Extension Period|Medication Error Without Associated Adverse Event|1|||
147126297|NCT03715829|530628577|FG008|Extension Period|Medication Error Without Associated Adverse Event|1|||
147126298|NCT03715829|530628578|FG009|Extension Period|Medication Error Without Associated Adverse Event|0|||
147126299|NCT03715829|530628579|FG010|Extension Period|Medication Error Without Associated Adverse Event|0|||
147126300|NCT03715829|530628569|FG000|Extension Period|No Longer Meets Eligibility Criteria|0|||
147126301|NCT03715829|530628570|FG001|Extension Period|No Longer Meets Eligibility Criteria|0|||
147126302|NCT03715829|530628571|FG002|Extension Period|No Longer Meets Eligibility Criteria|0|||
147126303|NCT03715829|530628572|FG003|Extension Period|No Longer Meets Eligibility Criteria|0|||
147126304|NCT03715829|530628573|FG004|Extension Period|No Longer Meets Eligibility Criteria|0|||
147126305|NCT03715829|530628574|FG005|Extension Period|No Longer Meets Eligibility Criteria|0|||
147126306|NCT03715829|530628575|FG006|Extension Period|No Longer Meets Eligibility Criteria|0|||
147126307|NCT03715829|530628576|FG007|Extension Period|No Longer Meets Eligibility Criteria|0|||
147126308|NCT03715829|530628577|FG008|Extension Period|No Longer Meets Eligibility Criteria|1|||
147126309|NCT03715829|530628578|FG009|Extension Period|No Longer Meets Eligibility Criteria|0|||
147126310|NCT03715829|530628579|FG010|Extension Period|No Longer Meets Eligibility Criteria|0|||
147126311|NCT03715829|530628569|FG000|Extension Period|Other|0|||
147126312|NCT03715829|530628570|FG001|Extension Period|Other|0|||
147126313|NCT03715829|530628571|FG002|Extension Period|Other|0|||
147126314|NCT03715829|530628572|FG003|Extension Period|Other|0|||
147126315|NCT03715829|530628573|FG004|Extension Period|Other|0|||
147126316|NCT03715829|530628574|FG005|Extension Period|Other|0|||
147126317|NCT03715829|530628575|FG006|Extension Period|Other|1|||
147316410|NCT03220737|531323685|FG006|Placebo Crossover (Day 181-365)|Lost to Follow-up|0|||
147316411|NCT03220737|531323679|FG000|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|1|||
147316412|NCT03220737|531323680|FG001|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
147316413|NCT03220737|531323681|FG002|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
147316414|NCT03220737|531323682|FG003|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
147316415|NCT03220737|531323683|FG004|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
147316416|NCT03220737|531323684|FG005|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
147316417|NCT03220737|531323685|FG006|Long-term Follow-up (Day 365-730)|Withdrawal by Subject|0|||
147316418|NCT03220737|531323679|FG000|Long-term Follow-up (Day 365-730)|Lost to Follow-up|9|||
147316419|NCT03220737|531323680|FG001|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
147316420|NCT03220737|531323681|FG002|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
147316421|NCT03220737|531323682|FG003|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
147316422|NCT03220737|531323683|FG004|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
147316423|NCT03220737|531323684|FG005|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
147316424|NCT03220737|531323685|FG006|Long-term Follow-up (Day 365-730)|Lost to Follow-up|0|||
147316425|NCT03220737|531323679|FG000|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|1|||
147316426|NCT03220737|531323680|FG001|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
147316427|NCT03220737|531323681|FG002|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
147316428|NCT03220737|531323682|FG003|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
147126318|NCT03715829|530628576|FG007|Extension Period|Other|2|||
147126319|NCT03715829|530628577|FG008|Extension Period|Other|4|||
147126320|NCT03715829|530628578|FG009|Extension Period|Other|0|||
147126321|NCT03715829|530628579|FG010|Extension Period|Other|0|||
147126322|NCT03773562|530628583|FG000|Overall Study|Did not have 6-25 migraine days during run-in|10|||
147126323|NCT03773562|530628583|FG000|Overall Study|Lost to Follow-up|10|||
147126324|NCT03773562|530628583|FG000|Overall Study|Withdrawal by Subject|1|||
147126325|NCT03131479|530628584|FG000|Overall Study|Adverse Event|0|||
147126326|NCT03131479|530628585|FG001|Overall Study|Adverse Event|0|||
147126327|NCT03131479|530628586|FG002|Overall Study|Adverse Event|1|||
147126328|NCT03131479|530628587|FG003|Overall Study|Adverse Event|1|||
147126329|NCT03131479|530628588|FG004|Overall Study|Adverse Event|0|||
147126330|NCT03131479|530628584|FG000|Overall Study|Subject/Guardian Decision|0|||
147126331|NCT03131479|530628585|FG001|Overall Study|Subject/Guardian Decision|0|||
147126332|NCT03131479|530628586|FG002|Overall Study|Subject/Guardian Decision|0|||
147126333|NCT03131479|530628587|FG003|Overall Study|Subject/Guardian Decision|1|||
147126334|NCT03131479|530628588|FG004|Overall Study|Subject/Guardian Decision|0|||
147126335|NCT01272219|530628589|FG000|Main Period: Week 0 to Week 56|Adverse Event|86|||
147126336|NCT01272219|530628590|FG001|Main Period: Week 0 to Week 56|Adverse Event|0|||
147126337|NCT01272219|530628591|FG002|Main Period: Week 0 to Week 56|Adverse Event|0|||
147126338|NCT01272219|530628592|FG003|Main Period: Week 0 to Week 56|Adverse Event|16|||
147126339|NCT01272219|530628593|FG004|Main Period: Week 0 to Week 56|Adverse Event|152|||
147126340|NCT01272219|530628594|FG005|Main Period: Week 0 to Week 56|Adverse Event|29|||
147126341|NCT01272219|530628589|FG000|Main Period: Week 0 to Week 56|Lack of Efficacy|11|||
147126342|NCT01272219|530628590|FG001|Main Period: Week 0 to Week 56|Lack of Efficacy|0|||
147126343|NCT01272219|530628591|FG002|Main Period: Week 0 to Week 56|Lack of Efficacy|0|||
147126344|NCT01272219|530628592|FG003|Main Period: Week 0 to Week 56|Lack of Efficacy|14|||
147126345|NCT01272219|530628593|FG004|Main Period: Week 0 to Week 56|Lack of Efficacy|12|||
147126346|NCT01272219|530628594|FG005|Main Period: Week 0 to Week 56|Lack of Efficacy|22|||
147126347|NCT01272219|530628589|FG000|Main Period: Week 0 to Week 56|Protocol Violation|25|||
147126348|NCT01272219|530628590|FG001|Main Period: Week 0 to Week 56|Protocol Violation|0|||
147126349|NCT01272219|530628591|FG002|Main Period: Week 0 to Week 56|Protocol Violation|0|||
147126350|NCT01272219|530628592|FG003|Main Period: Week 0 to Week 56|Protocol Violation|18|||
147126351|NCT01272219|530628593|FG004|Main Period: Week 0 to Week 56|Protocol Violation|40|||
147126352|NCT01272219|530628594|FG005|Main Period: Week 0 to Week 56|Protocol Violation|20|||
147126353|NCT01272219|530628589|FG000|Main Period: Week 0 to Week 56|Withdrawal criteria|122|||
147126354|NCT01272219|530628590|FG001|Main Period: Week 0 to Week 56|Withdrawal criteria|0|||
147126355|NCT01272219|530628591|FG002|Main Period: Week 0 to Week 56|Withdrawal criteria|0|||
147126356|NCT01272219|530628592|FG003|Main Period: Week 0 to Week 56|Withdrawal criteria|114|||
147126357|NCT01272219|530628593|FG004|Main Period: Week 0 to Week 56|Withdrawal criteria|172|||
147126358|NCT01272219|530628594|FG005|Main Period: Week 0 to Week 56|Withdrawal criteria|147|||
147126359|NCT01272219|530628589|FG000|Main Period: Week 0 to Week 56|Unclassified|36|||
147126360|NCT01272219|530628590|FG001|Main Period: Week 0 to Week 56|Unclassified|0|||
147126361|NCT01272219|530628591|FG002|Main Period: Week 0 to Week 56|Unclassified|0|||
147126362|NCT01272219|530628592|FG003|Main Period: Week 0 to Week 56|Unclassified|29|||
147126363|NCT01272219|530628593|FG004|Main Period: Week 0 to Week 56|Unclassified|42|||
147126364|NCT01272219|530628594|FG005|Main Period: Week 0 to Week 56|Unclassified|34|||
147126365|NCT01272219|530628589|FG000|Re-randomised Period: Week 56 to Week 68|Adverse Event|0|||
147126366|NCT01272219|530628590|FG001|Re-randomised Period: Week 56 to Week 68|Adverse Event|1|||
147126367|NCT01272219|530628591|FG002|Re-randomised Period: Week 56 to Week 68|Adverse Event|1|||
147126368|NCT01272219|530628592|FG003|Re-randomised Period: Week 56 to Week 68|Adverse Event|2|||
147126369|NCT01272219|530628593|FG004|Re-randomised Period: Week 56 to Week 68|Adverse Event|0|||
147126370|NCT01272219|530628594|FG005|Re-randomised Period: Week 56 to Week 68|Adverse Event|0|||
147126371|NCT01272219|530628589|FG000|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0|||
147126372|NCT01272219|530628590|FG001|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0|||
147126373|NCT01272219|530628591|FG002|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0|||
147234825|NCT02639546|531031652|FG001|Overall Study|Lost to Follow-up|0|||
147234826|NCT02639546|531031653|FG002|Overall Study|Lost to Follow-up|1|||
147234827|NCT02639546|531031654|FG003|Overall Study|Lost to Follow-up|0|||
147234828|NCT02639546|531031655|FG004|Overall Study|Lost to Follow-up|1|||
147234829|NCT02639546|531031656|FG005|Overall Study|Lost to Follow-up|1|||
147126374|NCT01272219|530628592|FG003|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|1|||
147126375|NCT01272219|530628593|FG004|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0|||
147126376|NCT01272219|530628594|FG005|Re-randomised Period: Week 56 to Week 68|Lack of Efficacy|0|||
147126377|NCT01272219|530628589|FG000|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0|||
147126378|NCT01272219|530628590|FG001|Re-randomised Period: Week 56 to Week 68|Protocol Violation|1|||
147126379|NCT01272219|530628591|FG002|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0|||
147234830|NCT02639546|531031657|FG006|Overall Study|Lost to Follow-up|0|||
147234831|NCT02639546|531031658|FG007|Overall Study|Lost to Follow-up|1|||
147234832|NCT02639546|531031651|FG000|Overall Study|PI, physician decision; no response to trt.|2|||
147234833|NCT02639546|531031652|FG001|Overall Study|PI, physician decision; no response to trt.|0|||
147234834|NCT02639546|531031653|FG002|Overall Study|PI, physician decision; no response to trt.|0|||
147126380|NCT01272219|530628592|FG003|Re-randomised Period: Week 56 to Week 68|Protocol Violation|3|||
147126381|NCT01272219|530628593|FG004|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0|||
147126382|NCT01272219|530628594|FG005|Re-randomised Period: Week 56 to Week 68|Protocol Violation|0|||
147126383|NCT01272219|530628589|FG000|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|0|||
147126384|NCT01272219|530628590|FG001|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|6|||
147126385|NCT01272219|530628591|FG002|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|4|||
147316429|NCT03220737|531323683|FG004|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
147316430|NCT03220737|531323684|FG005|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
147126386|NCT01272219|530628592|FG003|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|7|||
147126387|NCT01272219|530628593|FG004|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|0|||
147126388|NCT01272219|530628594|FG005|Re-randomised Period: Week 56 to Week 68|Withdrawal criteria|0|||
147316431|NCT03220737|531323685|FG006|Long-term Follow-up (Day 365-730)|Subject did not want lab drawn|0|||
147316432|NCT00681187|531323694|FG000|Overall Study|Withdrawal by Subject|1|||
147316433|NCT00681187|531323695|FG001|Overall Study|Withdrawal by Subject|0|||
147316434|NCT00681187|531323694|FG000|Overall Study|Death|0|||
147316435|NCT00681187|531323695|FG001|Overall Study|Death|1|||
147316436|NCT00681187|531323694|FG000|Overall Study|Adverse Event|0|||
147316437|NCT00681187|531323695|FG001|Overall Study|Adverse Event|1|||
147316438|NCT04230980|531323698|FG000|Overall Study|Lost to Follow-up|1|||
147316439|NCT04230980|531323699|FG001|Overall Study|Lost to Follow-up|2|||
147316440|NCT04230980|531323698|FG000|Overall Study|Adverse Event|0|||
147316441|NCT04230980|531323699|FG001|Overall Study|Adverse Event|1|||
147316442|NCT02269943|531323700|FG000|Treatment Period|Death|0|||
147126389|NCT01272219|530628589|FG000|Re-randomised Period: Week 56 to Week 68|Unclassified|0|||
147126390|NCT01272219|530628590|FG001|Re-randomised Period: Week 56 to Week 68|Unclassified|1|||
147126391|NCT01272219|530628591|FG002|Re-randomised Period: Week 56 to Week 68|Unclassified|2|||
147126392|NCT01272219|530628592|FG003|Re-randomised Period: Week 56 to Week 68|Unclassified|2|||
147126393|NCT01272219|530628593|FG004|Re-randomised Period: Week 56 to Week 68|Unclassified|0|||
147126394|NCT01272219|530628594|FG005|Re-randomised Period: Week 56 to Week 68|Unclassified|0|||
147126395|NCT01272219|530628589|FG000|Main + Extension Period: Week 0-172|Adverse Event|0|||
147126396|NCT01272219|530628590|FG001|Main + Extension Period: Week 0-172|Adverse Event|0|||
147126397|NCT01272219|530628591|FG002|Main + Extension Period: Week 0-172|Adverse Event|0|||
147126398|NCT01272219|530628592|FG003|Main + Extension Period: Week 0-172|Adverse Event|0|||
147126399|NCT01272219|530628593|FG004|Main + Extension Period: Week 0-172|Adverse Event|191|||
147126400|NCT01272219|530628594|FG005|Main + Extension Period: Week 0-172|Adverse Event|43|||
147126401|NCT01272219|530628589|FG000|Main + Extension Period: Week 0-172|Lack of Efficacy|0|||
147126402|NCT01272219|530628590|FG001|Main + Extension Period: Week 0-172|Lack of Efficacy|0|||
147126403|NCT01272219|530628591|FG002|Main + Extension Period: Week 0-172|Lack of Efficacy|0|||
147316443|NCT02269943|531323701|FG001|Treatment Period|Death|1|||
147316444|NCT02269943|531323700|FG000|Treatment Period|Adverse Event|1|||
147316445|NCT02269943|531323701|FG001|Treatment Period|Adverse Event|10|||
147316446|NCT02269943|531323700|FG000|Treatment Period|Progressive Disease|5|||
147316447|NCT02269943|531323701|FG001|Treatment Period|Progressive Disease|17|||
147316448|NCT02269943|531323700|FG000|Treatment Period|Symptomatic Deterioration|0|||
147316449|NCT02269943|531323701|FG001|Treatment Period|Symptomatic Deterioration|2|||
147316450|NCT02269943|531323700|FG000|Follow-Up Survival Period|Death|3|||
147316451|NCT02269943|531323701|FG001|Follow-Up Survival Period|Death|16|||
147316452|NCT02269943|531323700|FG000|Follow-Up Survival Period|Lost to Follow-up|0|||
147126404|NCT01272219|530628592|FG003|Main + Extension Period: Week 0-172|Lack of Efficacy|0|||
147126405|NCT01272219|530628593|FG004|Main + Extension Period: Week 0-172|Lack of Efficacy|29|||
147126406|NCT01272219|530628594|FG005|Main + Extension Period: Week 0-172|Lack of Efficacy|36|||
147126407|NCT01272219|530628589|FG000|Main + Extension Period: Week 0-172|Protocol Violation|0|||
147126408|NCT01272219|530628590|FG001|Main + Extension Period: Week 0-172|Protocol Violation|0|||
147126409|NCT01272219|530628591|FG002|Main + Extension Period: Week 0-172|Protocol Violation|0|||
147126410|NCT01272219|530628592|FG003|Main + Extension Period: Week 0-172|Protocol Violation|0|||
147126411|NCT01272219|530628593|FG004|Main + Extension Period: Week 0-172|Protocol Violation|76|||
147126412|NCT01272219|530628594|FG005|Main + Extension Period: Week 0-172|Protocol Violation|36|||
147126413|NCT01272219|530628589|FG000|Main + Extension Period: Week 0-172|Withdrawal criteria|0|||
147126414|NCT01272219|530628590|FG001|Main + Extension Period: Week 0-172|Withdrawal criteria|0|||
147126415|NCT01272219|530628591|FG002|Main + Extension Period: Week 0-172|Withdrawal criteria|0|||
147126416|NCT01272219|530628592|FG003|Main + Extension Period: Week 0-172|Withdrawal criteria|0|||
147126417|NCT01272219|530628593|FG004|Main + Extension Period: Week 0-172|Withdrawal criteria|364|||
147126418|NCT01272219|530628594|FG005|Main + Extension Period: Week 0-172|Withdrawal criteria|256|||
147126419|NCT01272219|530628589|FG000|Main + Extension Period: Week 0-172|Missing reason|0|||
147126420|NCT01272219|530628590|FG001|Main + Extension Period: Week 0-172|Missing reason|0|||
147316453|NCT02269943|531323701|FG001|Follow-Up Survival Period|Lost to Follow-up|2|||
147316454|NCT02269943|531323700|FG000|Follow-Up Survival Period|Alive|2|||
147316455|NCT02269943|531323701|FG001|Follow-Up Survival Period|Alive|8|||
147316456|NCT03541642|531323702|FG000|Overall Study|Withdrawal by Subject|1|||
147316457|NCT03541642|531323703|FG001|Overall Study|Withdrawal by Subject|2|||
147316458|NCT03541642|531323702|FG000|Overall Study|Lost to Follow-up|16|||
147316459|NCT03541642|531323703|FG001|Overall Study|Lost to Follow-up|12|||
147316460|NCT03541642|531323702|FG000|Overall Study|Found out previously on PrEP after randomization before eligibility was expanded|1|||
147331198|NCT04436120|531377599|FG000|Overall Study|neither a de novo biopsy nor a research blood draw|0|||
147126421|NCT01272219|530628591|FG002|Main + Extension Period: Week 0-172|Missing reason|0|||
147126422|NCT01272219|530628592|FG003|Main + Extension Period: Week 0-172|Missing reason|0|||
147126423|NCT01272219|530628593|FG004|Main + Extension Period: Week 0-172|Missing reason|1|||
147126424|NCT01272219|530628594|FG005|Main + Extension Period: Week 0-172|Missing reason|0|||
147126425|NCT01272219|530628589|FG000|Main + Extension Period: Week 0-172|Unclassified|0|||
147126426|NCT01272219|530628590|FG001|Main + Extension Period: Week 0-172|Unclassified|0|||
147126427|NCT01272219|530628591|FG002|Main + Extension Period: Week 0-172|Unclassified|0|||
147126428|NCT01272219|530628592|FG003|Main + Extension Period: Week 0-172|Unclassified|0|||
147126429|NCT01272219|530628593|FG004|Main + Extension Period: Week 0-172|Unclassified|61|||
147126430|NCT01272219|530628594|FG005|Main + Extension Period: Week 0-172|Unclassified|51|||
147126431|NCT01491919|530628595|FG000|Overall Study|Insufficient PK sampling|1|||
147126432|NCT01491919|530628596|FG001|Overall Study|Insufficient PK sampling|2|||
147126433|NCT01491919|530628597|FG002|Overall Study|Insufficient PK sampling|1|||
147126434|NCT04003389|530628598|FG000|Overall Study|Adverse Event|27|||
147126435|NCT04003389|530628599|FG001|Overall Study|Adverse Event|34|||
147126436|NCT04003389|530628600|FG002|Overall Study|Adverse Event|28|||
147126437|NCT04003389|530628598|FG000|Overall Study|Lost to Follow-up|39|||
147126438|NCT04003389|530628599|FG001|Overall Study|Lost to Follow-up|30|||
147126439|NCT04003389|530628600|FG002|Overall Study|Lost to Follow-up|33|||
147126440|NCT04003389|530628598|FG000|Overall Study|Protocol Violation|1|||
147126441|NCT04003389|530628599|FG001|Overall Study|Protocol Violation|6|||
147126442|NCT04003389|530628600|FG002|Overall Study|Protocol Violation|5|||
147126443|NCT04003389|530628598|FG000|Overall Study|Withdrawal by Subject|119|||
147126444|NCT04003389|530628599|FG001|Overall Study|Withdrawal by Subject|79|||
147126445|NCT04003389|530628600|FG002|Overall Study|Withdrawal by Subject|85|||
147126446|NCT04003389|530628598|FG000|Overall Study|Miscellaneous|14|||
147126447|NCT04003389|530628599|FG001|Overall Study|Miscellaneous|11|||
147126448|NCT04003389|530628600|FG002|Overall Study|Miscellaneous|14|||
147126449|NCT04003389|530628598|FG000|Overall Study|Participant did not receive study drug|1|||
147126450|NCT04003389|530628599|FG001|Overall Study|Participant did not receive study drug|0|||
147126451|NCT04003389|530628600|FG002|Overall Study|Participant did not receive study drug|0|||
147126452|NCT00392288|530628603|FG000|Overall Study|Adverse Event|17|||
147126453|NCT00392288|530628604|FG001|Overall Study|Adverse Event|7|||
147126454|NCT00392288|530628605|FG002|Overall Study|Adverse Event|8|||
147126455|NCT00392288|530628603|FG000|Overall Study|Lack of Efficacy|8|||
147126456|NCT00392288|530628604|FG001|Overall Study|Lack of Efficacy|5|||
147126457|NCT00392288|530628605|FG002|Overall Study|Lack of Efficacy|3|||
147126458|NCT00392288|530628603|FG000|Overall Study|Protocol Violation|1|||
147126459|NCT00392288|530628604|FG001|Overall Study|Protocol Violation|3|||
147126460|NCT00392288|530628605|FG002|Overall Study|Protocol Violation|1|||
147126461|NCT00392288|530628603|FG000|Overall Study|Lost to Follow-up|1|||
147126462|NCT00392288|530628604|FG001|Overall Study|Lost to Follow-up|1|||
147126463|NCT00392288|530628605|FG002|Overall Study|Lost to Follow-up|1|||
147126464|NCT00392288|530628603|FG000|Overall Study|Withdrawal by Subject|1|||
147126465|NCT00392288|530628604|FG001|Overall Study|Withdrawal by Subject|0|||
147126466|NCT00392288|530628605|FG002|Overall Study|Withdrawal by Subject|2|||
147126467|NCT00392288|530628603|FG000|Overall Study|Parent/legal guardian withdrawal|1|||
147126468|NCT00392288|530628604|FG001|Overall Study|Parent/legal guardian withdrawal|2|||
147126469|NCT00392288|530628605|FG002|Overall Study|Parent/legal guardian withdrawal|1|||
147126470|NCT00392288|530628603|FG000|Overall Study|Other|3|||
147126471|NCT00392288|530628604|FG001|Overall Study|Other|4|||
147126472|NCT00392288|530628605|FG002|Overall Study|Other|1|||
147126473|NCT04091438|530628606|FG000|Treatment Period 1 (1 Day)|Other|1|||
147126474|NCT04091438|530628607|FG001|Treatment Period 1 (1 Day)|Other|0|||
147126475|NCT04091438|530628606|FG000|Washout Period (1 Day)|Protocol deviation|0|||
147126476|NCT04091438|530628607|FG001|Washout Period (1 Day)|Protocol deviation|1|||
147126477|NCT04091438|530628606|FG000|Washout Period (1 Day)|Other|0|||
147126478|NCT04091438|530628607|FG001|Washout Period (1 Day)|Other|1|||
147126479|NCT02691494|530628612|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|1|||
147126480|NCT02691494|530628613|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|2|||
147126481|NCT02691494|530628614|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|8|||
147126482|NCT02691494|530628612|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|2|||
147126483|NCT02691494|530628613|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|3|||
147126484|NCT02691494|530628614|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|4|||
147234835|NCT02639546|531031654|FG003|Overall Study|PI, physician decision; no response to trt.|0|||
147234836|NCT02639546|531031655|FG004|Overall Study|PI, physician decision; no response to trt.|0|||
147126485|NCT02691494|530628612|FG000|Post-Treatment Follow-Up Period|Other|2|||
147126486|NCT02691494|530628613|FG001|Post-Treatment Follow-Up Period|Other|1|||
147126487|NCT02691494|530628614|FG002|Post-Treatment Follow-Up Period|Other|1|||
147126488|NCT02691494|530628612|FG000|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|0|||
147126489|NCT02691494|530628613|FG001|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|0|||
147126490|NCT02691494|530628614|FG002|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|3|||
147126491|NCT02691494|530628612|FG000|Post-Treatment Follow-Up Period|Non-Compliance|0|||
147126492|NCT02691494|530628613|FG001|Post-Treatment Follow-Up Period|Non-Compliance|1|||
147126493|NCT02691494|530628614|FG002|Post-Treatment Follow-Up Period|Non-Compliance|1|||
147126494|NCT02657356|530630003|FG000|Overall Study|Death|1|||
147126495|NCT02657356|530630004|FG001|Overall Study|Death|0|||
147126496|NCT02657356|530630003|FG000|Overall Study|Withdrawal by Subject|5|||
147126497|NCT02657356|530630004|FG001|Overall Study|Withdrawal by Subject|6|||
147126498|NCT02657356|530630003|FG000|Overall Study|Terminated by Sponsor|8|||
147126499|NCT02657356|530630004|FG001|Overall Study|Terminated by Sponsor|5|||
147126500|NCT02657356|530630003|FG000|Overall Study|Rolled over to EAP study|6|||
147126501|NCT02657356|530630004|FG001|Overall Study|Rolled over to EAP study|4|||
147126502|NCT03379870|530630005|FG000|Overall Study|Lost to Follow-up|1|||
147126503|NCT03379870|530630006|FG001|Overall Study|Lost to Follow-up|0|||
147126504|NCT03379870|530630005|FG000|Overall Study|Protocol Violation|1|||
147126505|NCT03379870|530630006|FG001|Overall Study|Protocol Violation|1|||
147126506|NCT02471144|530630007|FG000|Induction Period (Up to Week 12)|Adverse Event|0|||
147126507|NCT02471144|530630008|FG001|Induction Period (Up to Week 12)|Adverse Event|1|||
147126508|NCT02471144|530630009|FG002|Induction Period (Up to Week 12)|Adverse Event|1|||
147126509|NCT02471144|530630010|FG003|Induction Period (Up to Week 12)|Adverse Event|0|||
147126510|NCT02471144|530630011|FG004|Induction Period (Up to Week 12)|Adverse Event|0|||
147126511|NCT02471144|530630012|FG005|Induction Period (Up to Week 12)|Adverse Event|0|||
147126512|NCT02471144|530630013|FG006|Induction Period (Up to Week 12)|Adverse Event|0|||
147126513|NCT02471144|530630014|FG007|Induction Period (Up to Week 12)|Adverse Event|0|||
147126514|NCT02471144|530630015|FG008|Induction Period (Up to Week 12)|Adverse Event|0|||
147234837|NCT02639546|531031656|FG005|Overall Study|PI, physician decision; no response to trt.|1|||
147234838|NCT02639546|531031657|FG006|Overall Study|PI, physician decision; no response to trt.|0|||
147234839|NCT02639546|531031658|FG007|Overall Study|PI, physician decision; no response to trt.|1|||
147234840|NCT02639546|531031651|FG000|Overall Study|Study Terminated By Sponsor|0|||
147234841|NCT02639546|531031652|FG001|Overall Study|Study Terminated By Sponsor|2|||
147234842|NCT02639546|531031653|FG002|Overall Study|Study Terminated By Sponsor|3|||
147234843|NCT02639546|531031654|FG003|Overall Study|Study Terminated By Sponsor|4|||
147234844|NCT02639546|531031655|FG004|Overall Study|Study Terminated By Sponsor|4|||
147234845|NCT02639546|531031656|FG005|Overall Study|Study Terminated By Sponsor|3|||
147234846|NCT02639546|531031657|FG006|Overall Study|Study Terminated By Sponsor|3|||
147126515|NCT02471144|530630016|FG009|Induction Period (Up to Week 12)|Adverse Event|0|||
147126516|NCT02471144|530630017|FG010|Induction Period (Up to Week 12)|Adverse Event|0|||
147126517|NCT02471144|530630007|FG000|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
147126518|NCT02471144|530630008|FG001|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
147126519|NCT02471144|530630009|FG002|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
147126520|NCT02471144|530630010|FG003|Induction Period (Up to Week 12)|Lack of Efficacy|1|||
147126521|NCT02471144|530630011|FG004|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
147126522|NCT02471144|530630012|FG005|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
147126523|NCT02471144|530630013|FG006|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
147126524|NCT02471144|530630014|FG007|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
147126525|NCT02471144|530630015|FG008|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
147126526|NCT02471144|530630016|FG009|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
147126527|NCT02471144|530630017|FG010|Induction Period (Up to Week 12)|Lack of Efficacy|0|||
147126528|NCT02471144|530630007|FG000|Induction Period (Up to Week 12)|Protocol Deviation|0|||
147234847|NCT02639546|531031658|FG007|Overall Study|Study Terminated By Sponsor|9|||
147234848|NCT02639546|531031651|FG000|Overall Study|Withdrawal by Subject|2|||
147234849|NCT02639546|531031652|FG001|Overall Study|Withdrawal by Subject|2|||
147234850|NCT02639546|531031653|FG002|Overall Study|Withdrawal by Subject|1|||
147126529|NCT02471144|530630008|FG001|Induction Period (Up to Week 12)|Protocol Deviation|0|||
147126530|NCT02471144|530630009|FG002|Induction Period (Up to Week 12)|Protocol Deviation|1|||
147126531|NCT02471144|530630010|FG003|Induction Period (Up to Week 12)|Protocol Deviation|0|||
147126532|NCT02471144|530630011|FG004|Induction Period (Up to Week 12)|Protocol Deviation|0|||
147126533|NCT02471144|530630012|FG005|Induction Period (Up to Week 12)|Protocol Deviation|0|||
147234851|NCT02639546|531031654|FG003|Overall Study|Withdrawal by Subject|0|||
147234852|NCT02639546|531031655|FG004|Overall Study|Withdrawal by Subject|0|||
147234853|NCT02639546|531031656|FG005|Overall Study|Withdrawal by Subject|1|||
147234854|NCT02639546|531031657|FG006|Overall Study|Withdrawal by Subject|2|||
147234855|NCT02639546|531031658|FG007|Overall Study|Withdrawal by Subject|1|||
147316461|NCT03541642|531323703|FG001|Overall Study|Found out previously on PrEP after randomization before eligibility was expanded|1|||
147316462|NCT03523871|531323704|FG000|Overall Study|Death|1|||
147126534|NCT02471144|530630013|FG006|Induction Period (Up to Week 12)|Protocol Deviation|0|||
147234856|NCT02478372|531031659|FG000|Overall Study|Protocol Violation|12|||
147234857|NCT02478372|531031660|FG001|Overall Study|Protocol Violation|8|||
147234858|NCT02478372|531031659|FG000|Overall Study|Lost to Follow-up|1|||
147316463|NCT00972179|531323706|FG000|Overall Study|Noncompliance|1|||
147126535|NCT02471144|530630014|FG007|Induction Period (Up to Week 12)|Protocol Deviation|0|||
147126536|NCT02471144|530630015|FG008|Induction Period (Up to Week 12)|Protocol Deviation|0|||
147126537|NCT02471144|530630016|FG009|Induction Period (Up to Week 12)|Protocol Deviation|0|||
147126538|NCT02471144|530630017|FG010|Induction Period (Up to Week 12)|Protocol Deviation|0|||
147316464|NCT00972179|531323707|FG001|Overall Study|Noncompliance|0|||
147126539|NCT02471144|530630007|FG000|Induction Period (Up to Week 12)|Subject/Guardian Decision|1|||
147126540|NCT02471144|530630008|FG001|Induction Period (Up to Week 12)|Subject/Guardian Decision|1|||
147126541|NCT02471144|530630009|FG002|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
147126542|NCT02471144|530630010|FG003|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
147126543|NCT02471144|530630011|FG004|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
147126544|NCT02471144|530630012|FG005|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
147126545|NCT02471144|530630013|FG006|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
147126546|NCT02471144|530630014|FG007|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
147126547|NCT02471144|530630015|FG008|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
147126548|NCT02471144|530630016|FG009|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
147126549|NCT02471144|530630017|FG010|Induction Period (Up to Week 12)|Subject/Guardian Decision|0|||
147126550|NCT02471144|530630007|FG000|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
147126551|NCT02471144|530630008|FG001|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
147126552|NCT02471144|530630009|FG002|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
147126553|NCT02471144|530630010|FG003|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
147126554|NCT02471144|530630011|FG004|Maintenance Period (Week 12 to Week 52)|Adverse Event|1|||
147126555|NCT02471144|530630012|FG005|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
147126556|NCT02471144|530630013|FG006|Maintenance Period (Week 12 to Week 52)|Adverse Event|1|||
147126557|NCT02471144|530630014|FG007|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
147126558|NCT02471144|530630015|FG008|Maintenance Period (Week 12 to Week 52)|Adverse Event|1|||
147126559|NCT02471144|530630016|FG009|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
147126560|NCT02471144|530630017|FG010|Maintenance Period (Week 12 to Week 52)|Adverse Event|0|||
147126561|NCT02471144|530630007|FG000|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
147126562|NCT02471144|530630008|FG001|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
147126563|NCT02471144|530630009|FG002|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
147126564|NCT02471144|530630010|FG003|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
147126565|NCT02471144|530630011|FG004|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
147126566|NCT02471144|530630012|FG005|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|1|||
147126567|NCT02471144|530630013|FG006|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
147126568|NCT02471144|530630014|FG007|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
147126569|NCT02471144|530630015|FG008|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|3|||
147126570|NCT02471144|530630016|FG009|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
147126571|NCT02471144|530630017|FG010|Maintenance Period (Week 12 to Week 52)|Lack of Efficacy|0|||
147126572|NCT02471144|530630007|FG000|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
147126573|NCT02471144|530630008|FG001|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
147126574|NCT02471144|530630009|FG002|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
147126575|NCT02471144|530630010|FG003|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
147126576|NCT02471144|530630011|FG004|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
147126577|NCT02471144|530630012|FG005|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
147126578|NCT02471144|530630013|FG006|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
147126579|NCT02471144|530630014|FG007|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
147126580|NCT02471144|530630015|FG008|Maintenance Period (Week 12 to Week 52)|Pregnancy|1|||
147126581|NCT02471144|530630016|FG009|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
147126582|NCT02471144|530630017|FG010|Maintenance Period (Week 12 to Week 52)|Pregnancy|0|||
147126583|NCT02471144|530630007|FG000|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
147126584|NCT02471144|530630008|FG001|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
147126585|NCT02471144|530630009|FG002|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
147126586|NCT02471144|530630010|FG003|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
147126587|NCT02471144|530630011|FG004|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
147126588|NCT02471144|530630012|FG005|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
147126589|NCT02471144|530630013|FG006|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
147126590|NCT02471144|530630014|FG007|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|2|||
147126591|NCT02471144|530630015|FG008|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|1|||
147126592|NCT02471144|530630016|FG009|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
147126593|NCT02471144|530630017|FG010|Maintenance Period (Week 12 to Week 52)|Protocol Deviation|0|||
147126594|NCT02471144|530630007|FG000|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
147126595|NCT02471144|530630008|FG001|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
147126596|NCT02471144|530630009|FG002|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
147126597|NCT02471144|530630010|FG003|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
147234859|NCT02478372|531031660|FG001|Overall Study|Lost to Follow-up|4|||
147234860|NCT02478372|531031659|FG000|Overall Study|Death|0|||
147234861|NCT02478372|531031660|FG001|Overall Study|Death|2|||
147234862|NCT01297920|531031661|FG000|Overall Study|Adverse Event|42|||
147234863|NCT01297920|531031662|FG001|Overall Study|Adverse Event|10|||
147234864|NCT01297920|531031663|FG002|Overall Study|Adverse Event|38|||
147234865|NCT01297920|531031661|FG000|Overall Study|Patient Decision Unrelated to AE|6|||
147126598|NCT02471144|530630011|FG004|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
147126599|NCT02471144|530630012|FG005|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
147126600|NCT02471144|530630013|FG006|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
147126601|NCT02471144|530630014|FG007|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
147126602|NCT02471144|530630015|FG008|Extension Period (Week 52 to Week 236)|Lack of Efficacy|0|||
147126603|NCT02471144|530630016|FG009|Extension Period (Week 52 to Week 236)|Lack of Efficacy|6|||
147126604|NCT02471144|530630017|FG010|Extension Period (Week 52 to Week 236)|Lack of Efficacy|3|||
147126605|NCT02471144|530630007|FG000|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
147126606|NCT02471144|530630008|FG001|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
147126607|NCT02471144|530630009|FG002|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
147126608|NCT02471144|530630010|FG003|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
147126609|NCT02471144|530630011|FG004|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
147126610|NCT02471144|530630012|FG005|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
147126611|NCT02471144|530630013|FG006|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
147126612|NCT02471144|530630014|FG007|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
147126613|NCT02471144|530630015|FG008|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
147126614|NCT02471144|530630016|FG009|Extension Period (Week 52 to Week 236)|Pregnancy|2|||
147126615|NCT02471144|530630017|FG010|Extension Period (Week 52 to Week 236)|Pregnancy|0|||
147126616|NCT02471144|530630007|FG000|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
147126617|NCT02471144|530630008|FG001|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
147126618|NCT02471144|530630009|FG002|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
147126619|NCT02471144|530630010|FG003|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
147126620|NCT02471144|530630011|FG004|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
147126621|NCT02471144|530630012|FG005|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
147126622|NCT02471144|530630013|FG006|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
147126623|NCT02471144|530630014|FG007|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
147126624|NCT02471144|530630015|FG008|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
147126625|NCT02471144|530630016|FG009|Extension Period (Week 52 to Week 236)|Lost to Follow-up|0|||
147126626|NCT02471144|530630017|FG010|Extension Period (Week 52 to Week 236)|Lost to Follow-up|2|||
147126627|NCT02471144|530630007|FG000|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
147126628|NCT02471144|530630008|FG001|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
147126629|NCT02471144|530630009|FG002|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
147126630|NCT02471144|530630010|FG003|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
147126631|NCT02471144|530630011|FG004|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
147126632|NCT02471144|530630012|FG005|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
147126633|NCT02471144|530630013|FG006|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
147126634|NCT02471144|530630014|FG007|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
147126635|NCT02471144|530630015|FG008|Extension Period (Week 52 to Week 236)|Adverse Event|0|||
147126636|NCT02471144|530630016|FG009|Extension Period (Week 52 to Week 236)|Adverse Event|2|||
147126637|NCT02471144|530630017|FG010|Extension Period (Week 52 to Week 236)|Adverse Event|2|||
147126638|NCT02471144|530630007|FG000|Extension Period (Week 52 to Week 236)|Technical problems|0|||
147234866|NCT01297920|531031662|FG001|Overall Study|Patient Decision Unrelated to AE|5|||
147234867|NCT01297920|531031663|FG002|Overall Study|Patient Decision Unrelated to AE|2|||
147234868|NCT01297920|531031661|FG000|Overall Study|Noncompliance|1|||
147316465|NCT00972179|531323708|FG002|Overall Study|Noncompliance|0|||
147316466|NCT00972179|531323709|FG003|Overall Study|Noncompliance|0|||
147316467|NCT00972179|531323710|FG004|Overall Study|Noncompliance|1|||
147316468|NCT00972179|531323711|FG005|Overall Study|Noncompliance|0|||
147316469|NCT00972179|531323712|FG006|Overall Study|Noncompliance|1|||
147234869|NCT01297920|531031662|FG001|Overall Study|Noncompliance|0|||
147234870|NCT01297920|531031663|FG002|Overall Study|Noncompliance|0|||
147234871|NCT01297920|531031661|FG000|Overall Study|Protocol Violation|1|||
147234872|NCT01297920|531031662|FG001|Overall Study|Protocol Violation|3|||
147234873|NCT01297920|531031663|FG002|Overall Study|Protocol Violation|0|||
147234874|NCT01297920|531031661|FG000|Overall Study|Inadequate Control of IOP|7|||
147234875|NCT01297920|531031662|FG001|Overall Study|Inadequate Control of IOP|9|||
147234876|NCT01297920|531031663|FG002|Overall Study|Inadequate Control of IOP|17|||
147234877|NCT01297920|531031661|FG000|Overall Study|Patient Did Not Meet Entrance Criteria|1|||
147234878|NCT01297920|531031662|FG001|Overall Study|Patient Did Not Meet Entrance Criteria|0|||
147234879|NCT01297920|531031663|FG002|Overall Study|Patient Did Not Meet Entrance Criteria|0|||
147234880|NCT00474760|531031664|FG000|Overall Study|Death|0|||
147234881|NCT00474760|531031665|FG001|Overall Study|Death|0|||
147234882|NCT00474760|531031666|FG002|Overall Study|Death|0|||
147234883|NCT00474760|531031667|FG003|Overall Study|Death|0|||
147234884|NCT00474760|531031668|FG004|Overall Study|Death|2|||
147234885|NCT00474760|531031669|FG005|Overall Study|Death|0|||
147316470|NCT00972179|531323706|FG000|Overall Study|Withdrawal by Subject|0|||
147316471|NCT00972179|531323707|FG001|Overall Study|Withdrawal by Subject|3|||
147234886|NCT00474760|531031670|FG006|Overall Study|Death|0|||
147234887|NCT00474760|531031664|FG000|Overall Study|Adverse Event|0|||
147234888|NCT00474760|531031665|FG001|Overall Study|Adverse Event|0|||
147126639|NCT02471144|530630008|FG001|Extension Period (Week 52 to Week 236)|Technical problems|0|||
147126640|NCT02471144|530630009|FG002|Extension Period (Week 52 to Week 236)|Technical problems|0|||
147126641|NCT02471144|530630010|FG003|Extension Period (Week 52 to Week 236)|Technical problems|0|||
147126642|NCT02471144|530630011|FG004|Extension Period (Week 52 to Week 236)|Technical problems|0|||
147126643|NCT02471144|530630012|FG005|Extension Period (Week 52 to Week 236)|Technical problems|0|||
147126644|NCT02471144|530630013|FG006|Extension Period (Week 52 to Week 236)|Technical problems|0|||
147126645|NCT02471144|530630014|FG007|Extension Period (Week 52 to Week 236)|Technical problems|0|||
147126646|NCT02471144|530630015|FG008|Extension Period (Week 52 to Week 236)|Technical problems|0|||
147126647|NCT02471144|530630016|FG009|Extension Period (Week 52 to Week 236)|Technical problems|1|||
147126648|NCT02471144|530630017|FG010|Extension Period (Week 52 to Week 236)|Technical problems|0|||
147126649|NCT02471144|530630007|FG000|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
147126650|NCT02471144|530630008|FG001|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
147126651|NCT02471144|530630009|FG002|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
147126652|NCT02471144|530630010|FG003|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
147126653|NCT02471144|530630011|FG004|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
147126654|NCT02471144|530630012|FG005|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
147126655|NCT02471144|530630013|FG006|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
147126656|NCT02471144|530630014|FG007|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
147126657|NCT02471144|530630015|FG008|Extension Period (Week 52 to Week 236)|Subject/guardian decision|0|||
147126658|NCT02471144|530630016|FG009|Extension Period (Week 52 to Week 236)|Subject/guardian decision|3|||
147126659|NCT02471144|530630017|FG010|Extension Period (Week 52 to Week 236)|Subject/guardian decision|3|||
147126660|NCT03058952|530630020|FG000|Overall Study|Adverse Event|1|||
147126661|NCT03058952|530630021|FG001|Overall Study|Adverse Event|0|||
147126662|NCT03058952|530630020|FG000|Overall Study|Lost to Follow-up|15|||
147126663|NCT03058952|530630021|FG001|Overall Study|Lost to Follow-up|15|||
147126664|NCT03058952|530630020|FG000|Overall Study|Withdrawal by Subject|7|||
147126665|NCT03058952|530630021|FG001|Overall Study|Withdrawal by Subject|11|||
147126666|NCT03768336|530630024|FG000|Overall Study|Lost to Follow-up|3|||
147126667|NCT03768336|530630025|FG001|Overall Study|Lost to Follow-up|2|||
147126668|NCT03768336|530630024|FG000|Overall Study|Became Ineligible|2|||
147126669|NCT03768336|530630025|FG001|Overall Study|Became Ineligible|0|||
147126670|NCT03768336|530630024|FG000|Overall Study|Missed final survey (3-month follow-up)|1|||
147126671|NCT03768336|530630025|FG001|Overall Study|Missed final survey (3-month follow-up)|0|||
147126672|NCT03768336|530630024|FG000|Overall Study|Missed final survey (post-treatment|0|||
147126673|NCT03768336|530630025|FG001|Overall Study|Missed final survey (post-treatment|1|||
147126674|NCT05654181|530630026|FG000|Overall Study|Adverse Event|1|||
147126675|NCT05654181|530630027|FG001|Overall Study|Adverse Event|0|||
147126676|NCT05654181|530630028|FG002|Overall Study|Adverse Event|0|||
147126677|NCT05654181|530630029|FG003|Overall Study|Adverse Event|0|||
147126678|NCT05654181|530630030|FG004|Overall Study|Adverse Event|0|||
147126679|NCT05654181|530630031|FG005|Overall Study|Adverse Event|0|||
147126680|NCT05654181|530630032|FG006|Overall Study|Adverse Event|0|||
147126681|NCT05654181|530630033|FG007|Overall Study|Adverse Event|1|||
147126682|NCT05654181|530630034|FG008|Overall Study|Adverse Event|0|||
147126683|NCT05654181|530630035|FG009|Overall Study|Adverse Event|0|||
147126684|NCT05654181|530630026|FG000|Overall Study|Withdrawal by Subject|0|||
147126685|NCT05654181|530630027|FG001|Overall Study|Withdrawal by Subject|0|||
147126686|NCT05654181|530630028|FG002|Overall Study|Withdrawal by Subject|0|||
147126687|NCT05654181|530630029|FG003|Overall Study|Withdrawal by Subject|0|||
147126688|NCT05654181|530630030|FG004|Overall Study|Withdrawal by Subject|0|||
147126689|NCT05654181|530630031|FG005|Overall Study|Withdrawal by Subject|0|||
147126690|NCT05654181|530630032|FG006|Overall Study|Withdrawal by Subject|0|||
147126691|NCT05654181|530630033|FG007|Overall Study|Withdrawal by Subject|1|||
147126692|NCT05654181|530630034|FG008|Overall Study|Withdrawal by Subject|0|||
147126693|NCT05654181|530630035|FG009|Overall Study|Withdrawal by Subject|0|||
147126694|NCT05654181|530630026|FG000|Overall Study|Other|0|||
147126695|NCT05654181|530630027|FG001|Overall Study|Other|0|||
147126696|NCT05654181|530630028|FG002|Overall Study|Other|0|||
147126697|NCT05654181|530630029|FG003|Overall Study|Other|0|||
147234889|NCT00474760|531031666|FG002|Overall Study|Adverse Event|0|||
147234890|NCT00474760|531031667|FG003|Overall Study|Adverse Event|0|||
147234891|NCT00474760|531031668|FG004|Overall Study|Adverse Event|1|||
147234892|NCT00474760|531031669|FG005|Overall Study|Adverse Event|7|||
147234893|NCT00474760|531031670|FG006|Overall Study|Adverse Event|0|||
147126698|NCT05654181|530630030|FG004|Overall Study|Other|1|||
147234894|NCT00474760|531031664|FG000|Overall Study|Laboratory abnormality|0|||
147126699|NCT05654181|530630031|FG005|Overall Study|Other|1|||
147126700|NCT05654181|530630032|FG006|Overall Study|Other|0|||
147126701|NCT05654181|530630033|FG007|Overall Study|Other|0|||
147126702|NCT05654181|530630034|FG008|Overall Study|Other|0|||
147126703|NCT05654181|530630035|FG009|Overall Study|Other|0|||
147126704|NCT04101331|530630036|FG000|Overall Study|Adverse Event|9|||
147126705|NCT04101331|530630036|FG000|Overall Study|Disease progression|82|||
147234895|NCT00474760|531031665|FG001|Overall Study|Laboratory abnormality|0|||
147126706|NCT04101331|530630036|FG000|Overall Study|Withdrawal by Subject|1|||
147126707|NCT04101331|530630036|FG000|Overall Study|Investigator decision|6|||
147126708|NCT04101331|530630036|FG000|Overall Study|Death|6|||
147126709|NCT04101331|530630036|FG000|Overall Study|Allogenic transplant|1|||
147126710|NCT01444781|530630037|FG000|Overall Study|Lost to Follow-up|0|||
147126711|NCT01444781|530630038|FG001|Overall Study|Lost to Follow-up|3|||
147126712|NCT01444781|530630039|FG002|Overall Study|Lost to Follow-up|1|||
147126713|NCT01444781|530630037|FG000|Overall Study|Withdrawal by Subject|3|||
147126714|NCT01444781|530630038|FG001|Overall Study|Withdrawal by Subject|1|||
147126715|NCT01444781|530630039|FG002|Overall Study|Withdrawal by Subject|2|||
147126716|NCT06790303|530630040|FG000|Overall Study|Study Terminated by sponsor|4|||
147126717|NCT06790303|530630040|FG000|Overall Study|Death|4|||
147126718|NCT00500331|530630043|FG000|Overall Study|Adverse Event|0|||
147126719|NCT00500331|530630044|FG001|Overall Study|Adverse Event|2|||
147126720|NCT00500331|530630045|FG002|Overall Study|Adverse Event|0|||
147126721|NCT00500331|530630046|FG003|Overall Study|Adverse Event|1|||
147126722|NCT00500331|530630047|FG004|Overall Study|Adverse Event|2|||
147126723|NCT00500331|530630048|FG005|Overall Study|Adverse Event|2|||
147126724|NCT00500331|530630049|FG006|Overall Study|Adverse Event|0|||
147126725|NCT00500331|530630043|FG000|Overall Study|Lost to Follow-up|1|||
147126726|NCT00500331|530630044|FG001|Overall Study|Lost to Follow-up|1|||
147126727|NCT00500331|530630045|FG002|Overall Study|Lost to Follow-up|1|||
147126728|NCT00500331|530630046|FG003|Overall Study|Lost to Follow-up|2|||
147126729|NCT00500331|530630047|FG004|Overall Study|Lost to Follow-up|1|||
147126730|NCT00500331|530630048|FG005|Overall Study|Lost to Follow-up|0|||
147126731|NCT00500331|530630049|FG006|Overall Study|Lost to Follow-up|0|||
147126732|NCT00500331|530630043|FG000|Overall Study|Protocol Violation|3|||
147126733|NCT00500331|530630044|FG001|Overall Study|Protocol Violation|1|||
147126734|NCT00500331|530630045|FG002|Overall Study|Protocol Violation|1|||
147126735|NCT00500331|530630046|FG003|Overall Study|Protocol Violation|0|||
147126736|NCT00500331|530630047|FG004|Overall Study|Protocol Violation|1|||
147126737|NCT00500331|530630048|FG005|Overall Study|Protocol Violation|1|||
147126738|NCT00500331|530630049|FG006|Overall Study|Protocol Violation|1|||
147126739|NCT00500331|530630043|FG000|Overall Study|Withdrawal by Subject|4|||
147126740|NCT00500331|530630044|FG001|Overall Study|Withdrawal by Subject|0|||
147126741|NCT00500331|530630045|FG002|Overall Study|Withdrawal by Subject|1|||
147126742|NCT00500331|530630046|FG003|Overall Study|Withdrawal by Subject|5|||
147126743|NCT00500331|530630047|FG004|Overall Study|Withdrawal by Subject|0|||
147126744|NCT00500331|530630048|FG005|Overall Study|Withdrawal by Subject|1|||
147126745|NCT00500331|530630049|FG006|Overall Study|Withdrawal by Subject|1|||
147126746|NCT00500331|530630043|FG000|Overall Study|Lack of Efficacy|3|||
147126747|NCT00500331|530630044|FG001|Overall Study|Lack of Efficacy|1|||
147126748|NCT00500331|530630045|FG002|Overall Study|Lack of Efficacy|0|||
147126749|NCT00500331|530630046|FG003|Overall Study|Lack of Efficacy|0|||
147126750|NCT00500331|530630047|FG004|Overall Study|Lack of Efficacy|0|||
147126751|NCT00500331|530630048|FG005|Overall Study|Lack of Efficacy|0|||
147126752|NCT00500331|530630049|FG006|Overall Study|Lack of Efficacy|0|||
147234896|NCT00474760|531031666|FG002|Overall Study|Laboratory abnormality|0|||
147234897|NCT00474760|531031667|FG003|Overall Study|Laboratory abnormality|0|||
147234898|NCT00474760|531031668|FG004|Overall Study|Laboratory abnormality|0|||
147234899|NCT00474760|531031669|FG005|Overall Study|Laboratory abnormality|1|||
147234900|NCT00474760|531031670|FG006|Overall Study|Laboratory abnormality|0|||
147234901|NCT00474760|531031664|FG000|Overall Study|Withdrawal by Subject|0|||
147234902|NCT00474760|531031665|FG001|Overall Study|Withdrawal by Subject|0|||
147234903|NCT00474760|531031666|FG002|Overall Study|Withdrawal by Subject|0|||
147234904|NCT00474760|531031667|FG003|Overall Study|Withdrawal by Subject|1|||
147234905|NCT00474760|531031668|FG004|Overall Study|Withdrawal by Subject|0|||
147234906|NCT00474760|531031669|FG005|Overall Study|Withdrawal by Subject|1|||
147234907|NCT00474760|531031670|FG006|Overall Study|Withdrawal by Subject|1|||
147234908|NCT00474760|531031664|FG000|Overall Study|Other|0|||
147234909|NCT00474760|531031665|FG001|Overall Study|Other|1|||
147234910|NCT00474760|531031666|FG002|Overall Study|Other|0|||
147234911|NCT00474760|531031667|FG003|Overall Study|Other|0|||
147234912|NCT00474760|531031668|FG004|Overall Study|Other|1|||
147234913|NCT00474760|531031669|FG005|Overall Study|Other|0|||
147234914|NCT00474760|531031670|FG006|Overall Study|Other|0|||
147126753|NCT00500331|530630043|FG000|Overall Study|Liver function test abnormality|0|||
147234915|NCT00474760|531031664|FG000|Overall Study|Progressive disease|3|||
147234916|NCT00474760|531031665|FG001|Overall Study|Progressive disease|2|||
147234917|NCT00474760|531031666|FG002|Overall Study|Progressive disease|3|||
147444656|NCT01147744|531792662|FG005|Overall Study|Lost to Follow-up|0|||
147126754|NCT00500331|530630044|FG001|Overall Study|Liver function test abnormality|0|||
147126755|NCT00500331|530630045|FG002|Overall Study|Liver function test abnormality|1|||
147126756|NCT00500331|530630046|FG003|Overall Study|Liver function test abnormality|0|||
147126757|NCT00500331|530630047|FG004|Overall Study|Liver function test abnormality|0|||
147126758|NCT00500331|530630048|FG005|Overall Study|Liver function test abnormality|0|||
147126759|NCT00500331|530630049|FG006|Overall Study|Liver function test abnormality|0|||
147234918|NCT00474760|531031667|FG003|Overall Study|Progressive disease|2|||
147234919|NCT00474760|531031668|FG004|Overall Study|Progressive disease|8|||
147126760|NCT00500331|530630043|FG000|Overall Study|Increased serum creatinine from Baseline|0|||
147126761|NCT00500331|530630044|FG001|Overall Study|Increased serum creatinine from Baseline|0|||
147126762|NCT00500331|530630045|FG002|Overall Study|Increased serum creatinine from Baseline|0|||
147126763|NCT00500331|530630046|FG003|Overall Study|Increased serum creatinine from Baseline|0|||
147126764|NCT00500331|530630047|FG004|Overall Study|Increased serum creatinine from Baseline|0|||
147126765|NCT00500331|530630048|FG005|Overall Study|Increased serum creatinine from Baseline|1|||
147126766|NCT00500331|530630049|FG006|Overall Study|Increased serum creatinine from Baseline|0|||
147126767|NCT00500331|530630043|FG000|Overall Study|Didn't return for continuation of study|1|||
147126768|NCT00500331|530630044|FG001|Overall Study|Didn't return for continuation of study|0|||
147126769|NCT00500331|530630045|FG002|Overall Study|Didn't return for continuation of study|0|||
147126770|NCT00500331|530630046|FG003|Overall Study|Didn't return for continuation of study|0|||
147126771|NCT00500331|530630047|FG004|Overall Study|Didn't return for continuation of study|0|||
147126772|NCT00500331|530630048|FG005|Overall Study|Didn't return for continuation of study|0|||
147126773|NCT00500331|530630049|FG006|Overall Study|Didn't return for continuation of study|0|||
147126774|NCT00500331|530630043|FG000|Overall Study|Exclusion citeria not met on Visit 4|1|||
147126775|NCT00500331|530630044|FG001|Overall Study|Exclusion citeria not met on Visit 4|0|||
147126776|NCT00500331|530630045|FG002|Overall Study|Exclusion citeria not met on Visit 4|0|||
147126777|NCT00500331|530630046|FG003|Overall Study|Exclusion citeria not met on Visit 4|0|||
147126778|NCT00500331|530630047|FG004|Overall Study|Exclusion citeria not met on Visit 4|0|||
147126779|NCT00500331|530630048|FG005|Overall Study|Exclusion citeria not met on Visit 4|0|||
147126780|NCT00500331|530630049|FG006|Overall Study|Exclusion citeria not met on Visit 4|0|||
147126781|NCT00500331|530630043|FG000|Overall Study|Sponsor decided to withdraw participant|1|||
147126782|NCT00500331|530630044|FG001|Overall Study|Sponsor decided to withdraw participant|0|||
147126783|NCT00500331|530630045|FG002|Overall Study|Sponsor decided to withdraw participant|0|||
147126784|NCT00500331|530630046|FG003|Overall Study|Sponsor decided to withdraw participant|0|||
147126785|NCT00500331|530630047|FG004|Overall Study|Sponsor decided to withdraw participant|0|||
147126786|NCT00500331|530630048|FG005|Overall Study|Sponsor decided to withdraw participant|0|||
147126787|NCT00500331|530630049|FG006|Overall Study|Sponsor decided to withdraw participant|0|||
147126788|NCT00500331|530630043|FG000|Overall Study|Participant was randomized by mistake|1|||
147126789|NCT00500331|530630044|FG001|Overall Study|Participant was randomized by mistake|0|||
147126790|NCT00500331|530630045|FG002|Overall Study|Participant was randomized by mistake|0|||
147126791|NCT00500331|530630046|FG003|Overall Study|Participant was randomized by mistake|0|||
147126792|NCT00500331|530630047|FG004|Overall Study|Participant was randomized by mistake|0|||
147126793|NCT00500331|530630048|FG005|Overall Study|Participant was randomized by mistake|0|||
147126794|NCT00500331|530630049|FG006|Overall Study|Participant was randomized by mistake|0|||
147126795|NCT00500331|530630043|FG000|Overall Study|Diabetologist nurse in the study|0|||
147126796|NCT00500331|530630044|FG001|Overall Study|Diabetologist nurse in the study|0|||
147126797|NCT00500331|530630045|FG002|Overall Study|Diabetologist nurse in the study|1|||
147126798|NCT00500331|530630046|FG003|Overall Study|Diabetologist nurse in the study|0|||
147126799|NCT00500331|530630047|FG004|Overall Study|Diabetologist nurse in the study|0|||
147126800|NCT00500331|530630048|FG005|Overall Study|Diabetologist nurse in the study|0|||
147126801|NCT00500331|530630049|FG006|Overall Study|Diabetologist nurse in the study|0|||
147126802|NCT00500331|530630043|FG000|Overall Study|State ban of biological samples export|0|||
147126803|NCT00500331|530630044|FG001|Overall Study|State ban of biological samples export|0|||
147126804|NCT00500331|530630045|FG002|Overall Study|State ban of biological samples export|0|||
147126805|NCT00500331|530630046|FG003|Overall Study|State ban of biological samples export|1|||
147126806|NCT00500331|530630047|FG004|Overall Study|State ban of biological samples export|0|||
147126807|NCT00500331|530630048|FG005|Overall Study|State ban of biological samples export|0|||
147126808|NCT00500331|530630049|FG006|Overall Study|State ban of biological samples export|0|||
147126809|NCT00500331|530630043|FG000|Overall Study|Protocol violated|0|||
147126810|NCT00500331|530630044|FG001|Overall Study|Protocol violated|0|||
147126811|NCT00500331|530630045|FG002|Overall Study|Protocol violated|0|||
147126812|NCT00500331|530630046|FG003|Overall Study|Protocol violated|1|||
147126813|NCT00500331|530630047|FG004|Overall Study|Protocol violated|0|||
147126814|NCT00500331|530630048|FG005|Overall Study|Protocol violated|0|||
147126815|NCT00500331|530630049|FG006|Overall Study|Protocol violated|0|||
147126816|NCT03345550|530630050|FG000|Overall Study|Withdrawal by Subject|1|||
147126817|NCT03345550|530630051|FG001|Overall Study|Withdrawal by Subject|0|||
147126818|NCT03345550|530630050|FG000|Overall Study|Lost to Follow-up|4|||
147126819|NCT03345550|530630051|FG001|Overall Study|Lost to Follow-up|5|||
147126820|NCT03033784|530630055|FG000|Overall Study|Anxiety related to MRI scanner|0|||
147126821|NCT03033784|530630056|FG001|Overall Study|Anxiety related to MRI scanner|1|||
147126822|NCT03033784|530630057|FG002|Overall Study|Anxiety related to MRI scanner|0|||
147126823|NCT03033784|530630058|FG003|Overall Study|Anxiety related to MRI scanner|0|||
147126824|NCT03033784|530630059|FG004|Overall Study|Anxiety related to MRI scanner|0|||
147126825|NCT03033784|530630060|FG005|Overall Study|Anxiety related to MRI scanner|0|||
147126826|NCT03033784|530630061|FG006|Overall Study|Anxiety related to MRI scanner|0|||
147126827|NCT03033784|530630062|FG007|Overall Study|Anxiety related to MRI scanner|0|||
147234920|NCT00474760|531031669|FG005|Overall Study|Progressive disease|20|||
147316472|NCT00972179|531323708|FG002|Overall Study|Withdrawal by Subject|0|||
147316473|NCT00972179|531323709|FG003|Overall Study|Withdrawal by Subject|1|||
147316474|NCT00972179|531323710|FG004|Overall Study|Withdrawal by Subject|0|||
147316475|NCT00972179|531323711|FG005|Overall Study|Withdrawal by Subject|0|||
147316476|NCT00972179|531323712|FG006|Overall Study|Withdrawal by Subject|2|||
147316477|NCT00972179|531323706|FG000|Overall Study|Administrative Decision|0|||
147316478|NCT00972179|531323707|FG001|Overall Study|Administrative Decision|0|||
147316479|NCT00972179|531323708|FG002|Overall Study|Administrative Decision|0|||
147316480|NCT00972179|531323709|FG003|Overall Study|Administrative Decision|0|||
147316481|NCT00972179|531323710|FG004|Overall Study|Administrative Decision|1|||
147316482|NCT00972179|531323711|FG005|Overall Study|Administrative Decision|0|||
147316483|NCT00972179|531323712|FG006|Overall Study|Administrative Decision|0|||
147316484|NCT00972179|531323706|FG000|Overall Study|Lost to Follow-up|0|||
147316485|NCT00972179|531323707|FG001|Overall Study|Lost to Follow-up|0|||
147316486|NCT00972179|531323708|FG002|Overall Study|Lost to Follow-up|1|||
147316487|NCT00972179|531323709|FG003|Overall Study|Lost to Follow-up|0|||
147316488|NCT00972179|531323710|FG004|Overall Study|Lost to Follow-up|0|||
147316489|NCT00972179|531323711|FG005|Overall Study|Lost to Follow-up|3|||
147316490|NCT00972179|531323712|FG006|Overall Study|Lost to Follow-up|1|||
147316491|NCT03055832|531323713|FG000|Week 2|Withdrawal by Subject|1|||
147316492|NCT03055832|531323714|FG001|Week 2|Withdrawal by Subject|0|||
147316493|NCT03619174|531323715|FG000|Overall Study|Lost to Follow-up|3|||
147316494|NCT03619174|531323716|FG001|Overall Study|Lost to Follow-up|0|||
147316495|NCT03619174|531323715|FG000|Overall Study|Withdrawal by Subject|4|||
147316496|NCT03619174|531323716|FG001|Overall Study|Withdrawal by Subject|3|||
147316497|NCT03619174|531323715|FG000|Overall Study|Pregnancy|1|||
147316498|NCT03619174|531323716|FG001|Overall Study|Pregnancy|1|||
147316499|NCT03619174|531323715|FG000|Overall Study|Discomfort during treatment|1|||
147316500|NCT03619174|531323716|FG001|Overall Study|Discomfort during treatment|0|||
147316501|NCT04285229|531323719|FG000|Double-Blind Treatment Period|Withdrawal by Subject|2|||
147316502|NCT04285229|531323720|FG001|Double-Blind Treatment Period|Withdrawal by Subject|0|||
147316503|NCT04285229|531323721|FG002|Double-Blind Treatment Period|Withdrawal by Subject|0|||
147316504|NCT04285229|531323722|FG003|Double-Blind Treatment Period|Withdrawal by Subject|0|||
147316505|NCT04285229|531323723|FG004|Double-Blind Treatment Period|Withdrawal by Subject|0|||
147316506|NCT04285229|531323724|FG005|Double-Blind Treatment Period|Withdrawal by Subject|0|||
147316507|NCT04285229|531323719|FG000|Extended Treatment Period|Withdrawal by Subject|0|||
147316508|NCT04285229|531323720|FG001|Extended Treatment Period|Withdrawal by Subject|0|||
147316509|NCT04285229|531323721|FG002|Extended Treatment Period|Withdrawal by Subject|0|||
147316510|NCT04285229|531323722|FG003|Extended Treatment Period|Withdrawal by Subject|7|||
147316511|NCT04285229|531323723|FG004|Extended Treatment Period|Withdrawal by Subject|0|||
147316512|NCT04285229|531323724|FG005|Extended Treatment Period|Withdrawal by Subject|0|||
147316513|NCT04285229|531323719|FG000|Extended Treatment Period|Adverse Event|0|||
147316514|NCT04285229|531323720|FG001|Extended Treatment Period|Adverse Event|0|||
147316515|NCT04285229|531323721|FG002|Extended Treatment Period|Adverse Event|0|||
147316516|NCT04285229|531323722|FG003|Extended Treatment Period|Adverse Event|1|||
147316517|NCT04285229|531323723|FG004|Extended Treatment Period|Adverse Event|0|||
147316518|NCT04285229|531323724|FG005|Extended Treatment Period|Adverse Event|0|||
147316519|NCT04285229|531323719|FG000|Extended Treatment Period|Physician Decision|0|||
147316520|NCT04285229|531323720|FG001|Extended Treatment Period|Physician Decision|0|||
147316521|NCT04285229|531323721|FG002|Extended Treatment Period|Physician Decision|1|||
147316522|NCT04285229|531323722|FG003|Extended Treatment Period|Physician Decision|0|||
147316523|NCT04285229|531323723|FG004|Extended Treatment Period|Physician Decision|0|||
147316524|NCT04285229|531323724|FG005|Extended Treatment Period|Physician Decision|0|||
147316525|NCT04285229|531323719|FG000|Follow-up Period|Adverse Event|0|||
147316526|NCT04285229|531323720|FG001|Follow-up Period|Adverse Event|0|||
147316527|NCT04285229|531323721|FG002|Follow-up Period|Adverse Event|0|||
147316528|NCT04285229|531323722|FG003|Follow-up Period|Adverse Event|0|||
147316529|NCT04285229|531323723|FG004|Follow-up Period|Adverse Event|1|||
147316530|NCT04285229|531323724|FG005|Follow-up Period|Adverse Event|4|||
147316531|NCT04285229|531323719|FG000|Follow-up Period|Withdrawal by Subject|0|||
147316532|NCT04285229|531323720|FG001|Follow-up Period|Withdrawal by Subject|0|||
147316533|NCT04285229|531323721|FG002|Follow-up Period|Withdrawal by Subject|0|||
147316534|NCT04285229|531323722|FG003|Follow-up Period|Withdrawal by Subject|0|||
147316535|NCT04285229|531323723|FG004|Follow-up Period|Withdrawal by Subject|0|||
147316536|NCT04285229|531323724|FG005|Follow-up Period|Withdrawal by Subject|5|||
147316537|NCT04285229|531323719|FG000|Follow-up Period|Covid-19|0|||
147316538|NCT04285229|531323720|FG001|Follow-up Period|Covid-19|0|||
147316539|NCT04285229|531323721|FG002|Follow-up Period|Covid-19|0|||
147316540|NCT04285229|531323722|FG003|Follow-up Period|Covid-19|0|||
147316541|NCT04285229|531323723|FG004|Follow-up Period|Covid-19|0|||
147316542|NCT04285229|531323724|FG005|Follow-up Period|Covid-19|2|||
147316543|NCT04285229|531323719|FG000|Follow-up Period|Physician Decision|0|||
147316544|NCT04285229|531323720|FG001|Follow-up Period|Physician Decision|0|||
147316545|NCT04285229|531323721|FG002|Follow-up Period|Physician Decision|0|||
147316546|NCT04285229|531323722|FG003|Follow-up Period|Physician Decision|0|||
147316547|NCT04285229|531323723|FG004|Follow-up Period|Physician Decision|0|||
147126828|NCT03033784|530630063|FG008|Overall Study|Anxiety related to MRI scanner|0|||
147126829|NCT03033784|530630064|FG009|Overall Study|Anxiety related to MRI scanner|0|||
147126830|NCT03033784|530630065|FG010|Overall Study|Anxiety related to MRI scanner|0|||
147126831|NCT03033784|530630066|FG011|Overall Study|Anxiety related to MRI scanner|0|||
147126832|NCT03033784|530630067|FG012|Overall Study|Anxiety related to MRI scanner|0|||
147126833|NCT03033784|530630055|FG000|Overall Study|Withdrawal by Subject|0|||
147126834|NCT03033784|530630056|FG001|Overall Study|Withdrawal by Subject|0|||
147126835|NCT03033784|530630057|FG002|Overall Study|Withdrawal by Subject|0|||
147126836|NCT03033784|530630058|FG003|Overall Study|Withdrawal by Subject|0|||
147126837|NCT03033784|530630059|FG004|Overall Study|Withdrawal by Subject|0|||
147126838|NCT03033784|530630060|FG005|Overall Study|Withdrawal by Subject|0|||
147126839|NCT03033784|530630061|FG006|Overall Study|Withdrawal by Subject|0|||
147126840|NCT03033784|530630062|FG007|Overall Study|Withdrawal by Subject|0|||
147126841|NCT03033784|530630063|FG008|Overall Study|Withdrawal by Subject|0|||
147126842|NCT03033784|530630064|FG009|Overall Study|Withdrawal by Subject|0|||
147126843|NCT03033784|530630065|FG010|Overall Study|Withdrawal by Subject|0|||
147126844|NCT03033784|530630066|FG011|Overall Study|Withdrawal by Subject|0|||
147126845|NCT03033784|530630067|FG012|Overall Study|Withdrawal by Subject|2|||
147126846|NCT01149460|530630068|FG000|Overall Study|Withdrawal by Subject|0|||
147126847|NCT01149460|530630069|FG001|Overall Study|Withdrawal by Subject|2|||
147126848|NCT01432444|530630071|FG000|Tolerability/Cross-titration Phase|Lost to Follow-up|10|||
147126849|NCT01432444|530630072|FG001|Tolerability/Cross-titration Phase|Lost to Follow-up|0|||
147126850|NCT01432444|530630073|FG002|Tolerability/Cross-titration Phase|Lost to Follow-up|0|||
147126851|NCT01432444|530630071|FG000|Tolerability/Cross-titration Phase|Adverse Event|16|||
147126852|NCT01432444|530630072|FG001|Tolerability/Cross-titration Phase|Adverse Event|0|||
147126853|NCT01432444|530630073|FG002|Tolerability/Cross-titration Phase|Adverse Event|0|||
147126854|NCT01432444|530630071|FG000|Tolerability/Cross-titration Phase|Met Withdrawal Criteria|5|||
147126855|NCT01432444|530630072|FG001|Tolerability/Cross-titration Phase|Met Withdrawal Criteria|0|||
147126856|NCT01432444|530630073|FG002|Tolerability/Cross-titration Phase|Met Withdrawal Criteria|0|||
147126857|NCT01432444|530630071|FG000|Tolerability/Cross-titration Phase|Physician Decision|8|||
147126858|NCT01432444|530630072|FG001|Tolerability/Cross-titration Phase|Physician Decision|0|||
147126859|NCT01432444|530630073|FG002|Tolerability/Cross-titration Phase|Physician Decision|0|||
147126860|NCT01432444|530630071|FG000|Tolerability/Cross-titration Phase|Withdrawal by Subject|15|||
147126861|NCT01432444|530630072|FG001|Tolerability/Cross-titration Phase|Withdrawal by Subject|0|||
147126862|NCT01432444|530630073|FG002|Tolerability/Cross-titration Phase|Withdrawal by Subject|0|||
147126863|NCT01432444|530630071|FG000|Tolerability/Cross-titration Phase|Protocol Deviation|1|||
147126864|NCT01432444|530630072|FG001|Tolerability/Cross-titration Phase|Protocol Deviation|0|||
147126865|NCT01432444|530630073|FG002|Tolerability/Cross-titration Phase|Protocol Deviation|0|||
147126866|NCT01432444|530630071|FG000|Tolerability/Cross-titration Phase|Lack of Efficacy|5|||
147126867|NCT01432444|530630072|FG001|Tolerability/Cross-titration Phase|Lack of Efficacy|0|||
147126868|NCT01432444|530630073|FG002|Tolerability/Cross-titration Phase|Lack of Efficacy|0|||
147126869|NCT01432444|530630071|FG000|Treatment Phase|Lost to Follow-up|0|||
147126870|NCT01432444|530630072|FG001|Treatment Phase|Lost to Follow-up|33|||
147126871|NCT01432444|530630073|FG002|Treatment Phase|Lost to Follow-up|0|||
147126872|NCT01432444|530630071|FG000|Treatment Phase|Adverse Event|0|||
147126873|NCT01432444|530630072|FG001|Treatment Phase|Adverse Event|37|||
147126874|NCT01432444|530630073|FG002|Treatment Phase|Adverse Event|0|||
147126875|NCT01432444|530630071|FG000|Treatment Phase|Met Withdrawal Criteria|0|||
147126876|NCT01432444|530630072|FG001|Treatment Phase|Met Withdrawal Criteria|11|||
147126877|NCT01432444|530630073|FG002|Treatment Phase|Met Withdrawal Criteria|0|||
147126878|NCT01432444|530630071|FG000|Treatment Phase|Physician Decision|0|||
147126879|NCT01432444|530630072|FG001|Treatment Phase|Physician Decision|5|||
147234921|NCT00474760|531031670|FG006|Overall Study|Progressive disease|7|||
147234922|NCT00474760|531031664|FG000|Overall Study|Terminated by sponsor|0|||
147234923|NCT00474760|531031665|FG001|Overall Study|Terminated by sponsor|0|||
147234924|NCT00474760|531031666|FG002|Overall Study|Terminated by sponsor|0|||
147234925|NCT00474760|531031667|FG003|Overall Study|Terminated by sponsor|0|||
147234926|NCT00474760|531031668|FG004|Overall Study|Terminated by sponsor|0|||
147234927|NCT00474760|531031669|FG005|Overall Study|Terminated by sponsor|0|||
147234928|NCT00474760|531031670|FG006|Overall Study|Terminated by sponsor|2|||
147234929|NCT02362269|531031673|FG000|Overall Study|Moved|1|||
147316548|NCT04285229|531323724|FG005|Follow-up Period|Physician Decision|1|||
147126880|NCT01432444|530630073|FG002|Treatment Phase|Physician Decision|0|||
147126881|NCT01432444|530630071|FG000|Treatment Phase|Withdrawal by Subject|0|||
147126882|NCT01432444|530630072|FG001|Treatment Phase|Withdrawal by Subject|41|||
147126883|NCT01432444|530630073|FG002|Treatment Phase|Withdrawal by Subject|0|||
147316549|NCT01556763|531323736|FG000|Overall Study|Withdrawal by Subject|0|||
147444657|NCT01147744|531792663|FG006|Overall Study|Lost to Follow-up|0|||
147126884|NCT01432444|530630071|FG000|Treatment Phase|Protocol Deviation|0|||
147126885|NCT01432444|530630072|FG001|Treatment Phase|Protocol Deviation|3|||
147126886|NCT01432444|530630073|FG002|Treatment Phase|Protocol Deviation|0|||
147126887|NCT01432444|530630071|FG000|Treatment Phase|Lack of Efficacy|0|||
147126888|NCT01432444|530630072|FG001|Treatment Phase|Lack of Efficacy|10|||
147126889|NCT01432444|530630073|FG002|Treatment Phase|Lack of Efficacy|0|||
147126890|NCT01432444|530630071|FG000|Extension Phase|Lost to Follow-up|0|||
147126891|NCT01432444|530630072|FG001|Extension Phase|Lost to Follow-up|0|||
147126892|NCT01432444|530630073|FG002|Extension Phase|Lost to Follow-up|17|||
147126893|NCT01432444|530630071|FG000|Extension Phase|Adverse Event|0|||
147126894|NCT01432444|530630072|FG001|Extension Phase|Adverse Event|0|||
147126895|NCT01432444|530630073|FG002|Extension Phase|Adverse Event|10|||
147126896|NCT01432444|530630071|FG000|Extension Phase|Sponsor Discontinued Trial|0|||
147126897|NCT01432444|530630072|FG001|Extension Phase|Sponsor Discontinued Trial|0|||
147126898|NCT01432444|530630073|FG002|Extension Phase|Sponsor Discontinued Trial|7|||
147126899|NCT01432444|530630071|FG000|Extension Phase|Met Withdrawal Criteria|0|||
147126900|NCT01432444|530630072|FG001|Extension Phase|Met Withdrawal Criteria|0|||
147126901|NCT01432444|530630073|FG002|Extension Phase|Met Withdrawal Criteria|144|||
147126902|NCT01432444|530630071|FG000|Extension Phase|Physician Decision|0|||
147126903|NCT01432444|530630072|FG001|Extension Phase|Physician Decision|0|||
147126904|NCT01432444|530630073|FG002|Extension Phase|Physician Decision|1|||
147126905|NCT01432444|530630071|FG000|Extension Phase|Withdrawal by Subject|0|||
147126906|NCT01432444|530630072|FG001|Extension Phase|Withdrawal by Subject|0|||
147126907|NCT01432444|530630073|FG002|Extension Phase|Withdrawal by Subject|13|||
147126908|NCT02157610|530630074|FG000|Overall Study|Death|4|||
147126909|NCT02157610|530630075|FG001|Overall Study|Death|4|||
147126910|NCT01946880|530630079|FG000|Overall Study|Lost to Follow-up|1|||
147126911|NCT01946880|530630080|FG001|Overall Study|Lost to Follow-up|0|||
147126912|NCT01946880|530630079|FG000|Overall Study|Physician Decision|1|||
147126913|NCT01946880|530630080|FG001|Overall Study|Physician Decision|1|||
147126914|NCT01946880|530630079|FG000|Overall Study|Withdrawal by Subject|3|||
147126915|NCT01946880|530630080|FG001|Overall Study|Withdrawal by Subject|2|||
147126916|NCT01946880|530630079|FG000|Overall Study|Met Primary Endpoint|1|||
147126917|NCT01946880|530630080|FG001|Overall Study|Met Primary Endpoint|0|||
147126918|NCT01946880|530630079|FG000|Overall Study|Personal and Family Issues|1|||
147126919|NCT01946880|530630080|FG001|Overall Study|Personal and Family Issues|0|||
147126920|NCT03647137|530630081|FG000|Overall Study|Scan Limitation|2|||
147126921|NCT03647137|530630082|FG001|Overall Study|Scan Limitation|1|||
147126922|NCT03647137|530630083|FG002|Overall Study|Scan Limitation|1|||
147126923|NCT03647137|530630084|FG003|Overall Study|Scan Limitation|2|||
147126924|NCT01443026|530630085|FG000|Overall Study|Physician Decision|1|||
147126925|NCT01443026|530630086|FG001|Overall Study|Physician Decision|0|||
147126926|NCT01443026|530630085|FG000|Overall Study|Death|0|||
147126927|NCT01443026|530630086|FG001|Overall Study|Death|1|||
147126928|NCT01443026|530630085|FG000|Overall Study|Withdrawal by Subject|0|||
147126929|NCT01443026|530630086|FG001|Overall Study|Withdrawal by Subject|3|||
147126930|NCT01443026|530630085|FG000|Overall Study|Lost to Follow-up|2|||
147126931|NCT01443026|530630086|FG001|Overall Study|Lost to Follow-up|1|||
147126932|NCT02034565|530630087|FG000|Overall Study|Adverse Event|1|||
147126933|NCT02034565|530630088|FG001|Overall Study|Adverse Event|0|||
147126934|NCT00581919|530630089|FG000|Overall Study|Adverse Event|8|||
147126935|NCT00581919|530630089|FG000|Overall Study|Death|1|||
147126936|NCT00581919|530630089|FG000|Overall Study|Disease Progression|10|||
147126937|NCT00581919|530630089|FG000|Overall Study|Physician Decision|1|||
147126938|NCT00581919|530630089|FG000|Overall Study|Other Complicating Disease|1|||
147126939|NCT00581919|530630089|FG000|Overall Study|Started Non-Protocol Therapy|2|||
147234930|NCT02362269|531031674|FG001|Overall Study|Moved|0|||
147126940|NCT00581919|530630089|FG000|Overall Study|Withdrawal by Subject|1|||
147126941|NCT02655601|530630090|FG000|Overall Study|Adverse Event|0|||
147234931|NCT02362269|531031673|FG000|Overall Study|Lost to Follow-up|0|||
147234932|NCT02362269|531031674|FG001|Overall Study|Lost to Follow-up|6|||
147234933|NCT04122534|531031675|FG000|Overall Study|Lost to Follow-up|4|||
147234934|NCT00423514|531031683|FG000|Overall Study|Ineligible|1|||
147234935|NCT00423514|531031684|FG001|Overall Study|Ineligible|0|||
147126942|NCT02655601|530630091|FG001|Overall Study|Adverse Event|0|||
147126943|NCT02655601|530630092|FG002|Overall Study|Adverse Event|0|||
147126944|NCT02655601|530630093|FG003|Overall Study|Adverse Event|1|||
147234936|NCT02128932|531031685|FG000|Overall Study|Withdrawal by Subject|11|||
147234937|NCT02128932|531031686|FG001|Overall Study|Withdrawal by Subject|7|||
147234938|NCT02128932|531031687|FG002|Overall Study|Withdrawal by Subject|8|||
147234939|NCT02128932|531031685|FG000|Overall Study|Death|2|||
147234940|NCT02128932|531031686|FG001|Overall Study|Death|0|||
147126945|NCT02655601|530630094|FG004|Overall Study|Adverse Event|1|||
147126946|NCT02655601|530630095|FG005|Overall Study|Adverse Event|0|||
147126947|NCT02655601|530630090|FG000|Overall Study|Physician Decision|0|||
147126948|NCT02655601|530630091|FG001|Overall Study|Physician Decision|0|||
147126949|NCT02655601|530630092|FG002|Overall Study|Physician Decision|0|||
147126950|NCT02655601|530630093|FG003|Overall Study|Physician Decision|0|||
147126951|NCT02655601|530630094|FG004|Overall Study|Physician Decision|1|||
147234941|NCT02128932|531031687|FG002|Overall Study|Death|2|||
147234942|NCT02128932|531031685|FG000|Overall Study|Lost to Follow-up|2|||
147126952|NCT02655601|530630095|FG005|Overall Study|Physician Decision|1|||
147126953|NCT02655601|530630090|FG000|Overall Study|Withdrawal by Subject|0|||
147126954|NCT02655601|530630091|FG001|Overall Study|Withdrawal by Subject|0|||
147234943|NCT02128932|531031686|FG001|Overall Study|Lost to Follow-up|1|||
147316550|NCT01556763|531323737|FG001|Overall Study|Withdrawal by Subject|1|||
147316551|NCT01556763|531323738|FG002|Overall Study|Withdrawal by Subject|0|||
147316552|NCT02258464|531323739|FG000|Overall Study|Progressive disease (PD)|9|||
147316553|NCT02258464|531323740|FG001|Overall Study|Progressive disease (PD)|17|||
147316554|NCT02258464|531323739|FG000|Overall Study|Study drug never administered|1|||
147316555|NCT02258464|531323740|FG001|Overall Study|Study drug never administered|1|||
147316556|NCT02258464|531323739|FG000|Overall Study|AE not related to clinical PD|1|||
147316557|NCT02258464|531323740|FG001|Overall Study|AE not related to clinical PD|3|||
147316558|NCT02258464|531323739|FG000|Overall Study|Withdrawal by Subject|5|||
147316559|NCT02258464|531323740|FG001|Overall Study|Withdrawal by Subject|4|||
147316560|NCT02258464|531323739|FG000|Overall Study|AE related to clinical PD|1|||
147316561|NCT02258464|531323740|FG001|Overall Study|AE related to clinical PD|0|||
147316562|NCT04170296|531323741|FG000|Overall Study|Adverse Event|1|||
147316563|NCT04170296|531323742|FG001|Overall Study|Adverse Event|0|||
147316564|NCT04170296|531323741|FG000|Overall Study|Withdrawal by Subject|3|||
147316565|NCT04170296|531323742|FG001|Overall Study|Withdrawal by Subject|2|||
147316566|NCT04170296|531323741|FG000|Overall Study|Lost to Follow-up|4|||
147316567|NCT04170296|531323742|FG001|Overall Study|Lost to Follow-up|2|||
147316568|NCT00932646|531323743|FG000|Overall Study|Adverse Event|2|||
147316569|NCT00932646|531323744|FG001|Overall Study|Adverse Event|1|||
147316570|NCT00932646|531323745|FG002|Overall Study|Adverse Event|1|||
147316571|NCT00932646|531323746|FG003|Overall Study|Adverse Event|1|||
147316572|NCT00932646|531323743|FG000|Overall Study|Lost to Follow-up|2|||
147316573|NCT00932646|531323744|FG001|Overall Study|Lost to Follow-up|1|||
147316574|NCT00932646|531323745|FG002|Overall Study|Lost to Follow-up|0|||
147316575|NCT00932646|531323746|FG003|Overall Study|Lost to Follow-up|0|||
147316576|NCT00932646|531323743|FG000|Overall Study|Withdrawal by Subject|1|||
147316577|NCT00932646|531323744|FG001|Overall Study|Withdrawal by Subject|1|||
147316578|NCT00932646|531323745|FG002|Overall Study|Withdrawal by Subject|3|||
147316579|NCT00932646|531323746|FG003|Overall Study|Withdrawal by Subject|0|||
147316580|NCT00653263|531323747|FG000|Overall Study|Withdrawal by Subject|1|||
147316581|NCT00653263|531323747|FG000|Overall Study|Physician Decision|1|||
147316582|NCT00776100|531323748|FG000|Overall Study|Disease Progression|1|||
147126955|NCT02655601|530630092|FG002|Overall Study|Withdrawal by Subject|0|||
147126956|NCT02655601|530630093|FG003|Overall Study|Withdrawal by Subject|0|||
147126957|NCT02655601|530630094|FG004|Overall Study|Withdrawal by Subject|4|||
147126958|NCT02655601|530630095|FG005|Overall Study|Withdrawal by Subject|8|||
147126959|NCT02655601|530630090|FG000|Overall Study|Treatment delayed too long per protocol due to adverse events|1|||
147126960|NCT02655601|530630091|FG001|Overall Study|Treatment delayed too long per protocol due to adverse events|0|||
147126961|NCT02655601|530630092|FG002|Overall Study|Treatment delayed too long per protocol due to adverse events|0|||
147126962|NCT02655601|530630093|FG003|Overall Study|Treatment delayed too long per protocol due to adverse events|0|||
147126963|NCT02655601|530630094|FG004|Overall Study|Treatment delayed too long per protocol due to adverse events|0|||
147126964|NCT02655601|530630095|FG005|Overall Study|Treatment delayed too long per protocol due to adverse events|0|||
147126965|NCT00829868|530630096|FG000|Washout|Physician Decision|1|||
147126966|NCT00829868|530630097|FG001|Washout|Physician Decision|0|||
147126967|NCT01969409|530630098|FG000|Overall Study|Death|2|||
147126968|NCT01969409|530630099|FG001|Overall Study|Death|2|||
147316583|NCT00776100|531323749|FG001|Overall Study|Disease Progression|0|||
147316584|NCT02285595|531323750|FG000|Overall Study|Lost to Follow-up|14|||
147316585|NCT02285595|531323750|FG000|Overall Study|Withdrawal by Subject|1|||
147316586|NCT01960790|531323751|FG000|Overall Study|Survey forms could not be recovered|3|||
147316587|NCT01960790|531323751|FG000|Overall Study|Treat with Humira outside survey period|3|||
147316588|NCT01960790|531323751|FG000|Overall Study|Transferred to another hospital|4|||
147316589|NCT01960790|531323751|FG000|Overall Study|Unevaluable for safety|1|||
147316590|NCT00195715|531323752|FG000|Overall Study|Adverse Event|122|||
147316591|NCT00195715|531323752|FG000|Overall Study|Withdrawal by Subject|58|||
147316592|NCT00195715|531323752|FG000|Overall Study|Lost to Follow-up|27|||
147316593|NCT00195715|531323752|FG000|Overall Study|Protocol Violation|13|||
147316594|NCT00195715|531323752|FG000|Overall Study|Lack of Efficacy|93|||
147316595|NCT00195715|531323752|FG000|Overall Study|Pregnancy|14|||
147568972|NCT01597245|532240132|FG011|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
147316596|NCT00195715|531323752|FG000|Overall Study|Investigative site closure|8|||
147126969|NCT01969409|530630098|FG000|Overall Study|Transplant|1|||
147126970|NCT01969409|530630099|FG001|Overall Study|Transplant|1|||
147126971|NCT01969409|530630098|FG000|Overall Study|Withdrawal by Subject|0|||
147126972|NCT01969409|530630099|FG001|Overall Study|Withdrawal by Subject|1|||
147316597|NCT00195715|531323752|FG000|Overall Study|Subject moved/relocated|7|||
147316598|NCT00195715|531323752|FG000|Overall Study|Subject non-compliance|6|||
147316599|NCT00195715|531323752|FG000|Overall Study|Subject started commercial Humira|5|||
147316600|NCT00195715|531323752|FG000|Overall Study|Subject choice|3|||
147316601|NCT00195715|531323752|FG000|Overall Study|Loss of response/no improvement|3|||
147316602|NCT00195715|531323752|FG000|Overall Study|Sponsor stopped study|1|||
147316603|NCT00195715|531323752|FG000|Overall Study|Administrative reasons|2|||
147316604|NCT00195715|531323752|FG000|Overall Study|Investigator's decision|2|||
147126973|NCT02799043|530630101|FG000|Overall Study|Adverse Event|0|||
147126974|NCT02799043|530630102|FG001|Overall Study|Adverse Event|1|||
147126975|NCT02799043|530630101|FG000|Overall Study|Death|1|||
147126976|NCT02799043|530630102|FG001|Overall Study|Death|1|||
147126977|NCT02799043|530630101|FG000|Overall Study|Lost to Follow-up|3|||
147126978|NCT02799043|530630102|FG001|Overall Study|Lost to Follow-up|6|||
147316605|NCT00195715|531323752|FG000|Overall Study|Subject wants to get pregnant|4|||
147316606|NCT00195715|531323752|FG000|Overall Study|Use of prohibited medication|2|||
147316607|NCT00195715|531323752|FG000|Overall Study|Planned surgery|2|||
147316608|NCT00195715|531323752|FG000|Overall Study|Increased infection rate|1|||
147316609|NCT00195715|531323752|FG000|Overall Study|Ineligible|1|||
147316610|NCT00195715|531323752|FG000|Overall Study|Colonic stricture|1|||
147126979|NCT02799043|530630101|FG000|Overall Study|Withdrawal by Subject|4|||
147126980|NCT02799043|530630102|FG001|Overall Study|Withdrawal by Subject|4|||
147126981|NCT02799043|530630101|FG000|Overall Study|Moved to different country|0|||
147126982|NCT02799043|530630102|FG001|Overall Study|Moved to different country|1|||
147126983|NCT02799043|530630101|FG000|Overall Study|Trial Screen Failure|1|||
147126984|NCT02799043|530630102|FG001|Overall Study|Trial Screen Failure|0|||
147126985|NCT02799043|530630101|FG000|Overall Study|Failed Inclusion/Exclusion Criteria|2|||
147126986|NCT02799043|530630102|FG001|Overall Study|Failed Inclusion/Exclusion Criteria|2|||
147126987|NCT01554904|530630105|FG000|Overall Study|Withdrawal by Subject|3|||
147126988|NCT01554904|530630105|FG000|Overall Study|Had sleep apnea on Home Study 1|1|||
147126989|NCT04806373|530630109|FG000|Overall Study|Withdrawal by Subject|1|||
147126990|NCT04806373|530630110|FG001|Overall Study|Withdrawal by Subject|1|||
147126991|NCT05810597|530630111|FG000|Period 1|Adverse Event|2|||
147126992|NCT05810597|530630112|FG001|Period 1|Adverse Event|0|||
147126993|NCT05810597|530630111|FG000|Period 1|Physician Decision|1|||
147126994|NCT05810597|530630112|FG001|Period 1|Physician Decision|0|||
147126995|NCT02061085|530630117|FG000|Overall Study|Adverse Event|8|||
147126996|NCT03204812|530630127|FG000|Overall Study|Adverse Event|3|||
147126997|NCT02412436|530630128|FG000|Overall Study|Protocol-mandated Discontinuation|7|||
147126998|NCT02412436|530630128|FG000|Overall Study|Lost to Follow-up|6|||
147126999|NCT02412436|530630128|FG000|Overall Study|Unable to get to clinic|3|||
147127000|NCT02412436|530630128|FG000|Overall Study|Death|1|||
147127001|NCT02412436|530630128|FG000|Overall Study|Not Willing to Adhere to Requirements|1|||
147127002|NCT02544763|530630129|FG000|Overall Study|Adverse Event|8|||
147127003|NCT02544763|530630130|FG001|Overall Study|Adverse Event|8|||
147127004|NCT02544763|530630131|FG002|Overall Study|Adverse Event|0|||
147127005|NCT02544763|530630129|FG000|Overall Study|Withdrawn by parent/guardian|1|||
147127006|NCT02544763|530630130|FG001|Overall Study|Withdrawn by parent/guardian|1|||
147127007|NCT02544763|530630131|FG002|Overall Study|Withdrawn by parent/guardian|1|||
147127008|NCT02544763|530630129|FG000|Overall Study|Met withdrawal criteria|0|||
147127009|NCT02544763|530630130|FG001|Overall Study|Met withdrawal criteria|2|||
147127010|NCT02544763|530630131|FG002|Overall Study|Met withdrawal criteria|0|||
147316611|NCT00195715|531323752|FG000|Overall Study|Sponsor discontinued trial|1|||
147316612|NCT00195715|531323752|FG000|Overall Study|Sponsor discretion - trial ended early|1|||
147127011|NCT02544763|530630129|FG000|Overall Study|Physician Decision|0|||
147127012|NCT02544763|530630130|FG001|Overall Study|Physician Decision|1|||
147127013|NCT02544763|530630131|FG002|Overall Study|Physician Decision|0|||
147127014|NCT02544763|530630129|FG000|Overall Study|Difficulties taking IMP|1|||
147127015|NCT02544763|530630130|FG001|Overall Study|Difficulties taking IMP|0|||
147127016|NCT02544763|530630131|FG002|Overall Study|Difficulties taking IMP|0|||
147127017|NCT00787800|530630133|FG000|Overall Study|Withdrawal by Subject|3|||
147127018|NCT00787800|530630134|FG001|Overall Study|Withdrawal by Subject|5|||
147127019|NCT00787800|530630133|FG000|Overall Study|Death|0|||
147127020|NCT00787800|530630134|FG001|Overall Study|Death|2|||
147127021|NCT04309500|530630138|FG000|Overall Study|Lost to Follow-up|1|||
147127022|NCT04309500|530630139|FG001|Overall Study|Lost to Follow-up|0|||
147127023|NCT04309500|530630140|FG002|Overall Study|Lost to Follow-up|0|||
147127024|NCT04309500|530630141|FG003|Overall Study|Lost to Follow-up|0|||
147127025|NCT00773461|530630143|FG000|Overall Study|Adverse Event|1|||
147127026|NCT00773461|530630144|FG001|Overall Study|Adverse Event|3|||
147127027|NCT00773461|530630143|FG000|Overall Study|Withdrawal by Subject|4|||
147127028|NCT00773461|530630144|FG001|Overall Study|Withdrawal by Subject|1|||
147127029|NCT00913835|530630145|FG000|Olara+Lip Dox and Lip Dox Monotherapy|Withdrawal by Subject|2|||
147127030|NCT00913835|530630146|FG001|Olara+Lip Dox and Lip Dox Monotherapy|Withdrawal by Subject|3|||
147127031|NCT00913835|530630145|FG000|Olara+Lip Dox and Lip Dox Monotherapy|Lost to Follow-up|1|||
147127032|NCT00913835|530630146|FG001|Olara+Lip Dox and Lip Dox Monotherapy|Lost to Follow-up|0|||
147127033|NCT00913835|530630145|FG000|Olara+Lip Dox and Lip Dox Monotherapy|Other|4|||
147127034|NCT00913835|530630146|FG001|Olara+Lip Dox and Lip Dox Monotherapy|Other|3|||
147127035|NCT00913835|530630145|FG000|Olara+Lip Dox and Lip Dox Monotherapy|Off Study Treatment/Alive|1|||
147127036|NCT00913835|530630146|FG001|Olara+Lip Dox and Lip Dox Monotherapy|Off Study Treatment/Alive|1|||
147127037|NCT00913835|530630145|FG000|Lip Dox: Olaratumab Monotherapy|Other|0|||
147127038|NCT00913835|530630146|FG001|Lip Dox: Olaratumab Monotherapy|Other|3|||
147127039|NCT00637156|530630149|FG000|Overall Study|Withdrawal by Subject|0|||
147316613|NCT00544544|531323757|FG000|Overall Study|Withdrawal by Subject|1|||
147127040|NCT00637156|530630150|FG001|Overall Study|Withdrawal by Subject|7|||
147127041|NCT00637156|530630149|FG000|Overall Study|Death|0|||
147127042|NCT00637156|530630150|FG001|Overall Study|Death|1|||
147127043|NCT00637156|530630149|FG000|Overall Study|Lost to Follow-up|10|||
147127044|NCT00637156|530630150|FG001|Overall Study|Lost to Follow-up|16|||
147127045|NCT02374255|530631829|FG000|Overall Study|Withdrawal by Subject|2|||
147127046|NCT02374255|530631830|FG001|Overall Study|Withdrawal by Subject|0|||
147127047|NCT02374255|530631831|FG002|Overall Study|Withdrawal by Subject|0|||
147127048|NCT02374255|530631832|FG003|Overall Study|Withdrawal by Subject|0|||
147127049|NCT02093520|530631833|FG000|Overall Study|Not treated|6|||
147127050|NCT02093520|530631834|FG001|Overall Study|Not treated|22|||
147127051|NCT03014089|530631835|FG000|Overall Study|Withdrawal by Subject|0|||
147127052|NCT03014089|530631836|FG001|Overall Study|Withdrawal by Subject|1|||
147127053|NCT03014089|530631837|FG002|Overall Study|Withdrawal by Subject|1|||
147127054|NCT03014089|530631838|FG003|Overall Study|Withdrawal by Subject|1|||
147127055|NCT03014089|530631835|FG000|Overall Study|Lost to Follow-up|1|||
147127056|NCT03014089|530631836|FG001|Overall Study|Lost to Follow-up|0|||
147127057|NCT03014089|530631837|FG002|Overall Study|Lost to Follow-up|0|||
147127058|NCT03014089|530631838|FG003|Overall Study|Lost to Follow-up|0|||
147127059|NCT03014089|530631835|FG000|Overall Study|Adverse Event|1|||
147127060|NCT03014089|530631836|FG001|Overall Study|Adverse Event|0|||
147127061|NCT03014089|530631837|FG002|Overall Study|Adverse Event|1|||
147127062|NCT03014089|530631838|FG003|Overall Study|Adverse Event|0|||
147127063|NCT00851084|530631839|FG000|Overall Study|Randomized but not treated|1|||
147127064|NCT00851084|530631840|FG001|Overall Study|Randomized but not treated|0|||
147127065|NCT00851084|530631839|FG000|Overall Study|Adverse Event|26|||
147127066|NCT00851084|530631840|FG001|Overall Study|Adverse Event|36|||
147127067|NCT00851084|530631839|FG000|Overall Study|Disease progression|52|||
147127068|NCT00851084|530631840|FG001|Overall Study|Disease progression|47|||
147127069|NCT00851084|530631839|FG000|Overall Study|Poor compliance to protocol|1|||
147127070|NCT00851084|530631840|FG001|Overall Study|Poor compliance to protocol|1|||
147127071|NCT00851084|530631839|FG000|Overall Study|Physician Decision|13|||
147127072|NCT00851084|530631840|FG001|Overall Study|Physician Decision|14|||
147127073|NCT00851084|530631839|FG000|Overall Study|Consent withdrawn|0|||
147127074|NCT00851084|530631840|FG001|Overall Study|Consent withdrawn|2|||
147127075|NCT00851084|530631839|FG000|Overall Study|Withdrawal by Subject|11|||
147127076|NCT00851084|530631840|FG001|Overall Study|Withdrawal by Subject|12|||
147127077|NCT00851084|530631839|FG000|Overall Study|Metastatic surgery|6|||
147127078|NCT00851084|530631840|FG001|Overall Study|Metastatic surgery|6|||
147127079|NCT00851084|530631839|FG000|Overall Study|Other|7|||
147127080|NCT00851084|530631840|FG001|Overall Study|Other|1|||
147127081|NCT00734032|530631841|FG000|Overall Study|Adverse Event|0|||
147127082|NCT00734032|530631842|FG001|Overall Study|Adverse Event|1|||
147127083|NCT00734032|530631843|FG002|Overall Study|Adverse Event|0|||
147127084|NCT00734032|530631844|FG003|Overall Study|Adverse Event|0|||
147127085|NCT00337168|530631846|FG000|Overall Study|Death|5|||
147127086|NCT00337168|530631846|FG000|Overall Study|Not protocol specified|2|||
147127087|NCT00337168|530631846|FG000|Overall Study|Did not start therapy|1|||
147127088|NCT01225952|530631847|FG000|Overall Study|Lost to Follow-up|1|||
147127089|NCT01225952|530631848|FG001|Overall Study|Lost to Follow-up|0|||
147127090|NCT01225952|530631849|FG002|Overall Study|Lost to Follow-up|0|||
147127091|NCT01225952|530631847|FG000|Overall Study|Study Eye Explanted|0|||
147127092|NCT01225952|530631848|FG001|Overall Study|Study Eye Explanted|0|||
147127093|NCT01225952|530631849|FG002|Overall Study|Study Eye Explanted|1|||
147127094|NCT01225952|530631847|FG000|Overall Study|Withdrawal by Subject|4|||
147127095|NCT01225952|530631848|FG001|Overall Study|Withdrawal by Subject|4|||
147127096|NCT01225952|530631849|FG002|Overall Study|Withdrawal by Subject|5|||
147127097|NCT01225952|530631847|FG000|Overall Study|Surgical complications|1|||
147127098|NCT01225952|530631848|FG001|Overall Study|Surgical complications|0|||
147127099|NCT01225952|530631849|FG002|Overall Study|Surgical complications|0|||
147127100|NCT01052779|530631850|FG000|Overall Study|Adverse Event|1|||
147127101|NCT01052779|530631851|FG001|Overall Study|Adverse Event|4|||
147127102|NCT01052779|530631850|FG000|Overall Study|Withdrawal by Subject|1|||
147127103|NCT01052779|530631851|FG001|Overall Study|Withdrawal by Subject|2|||
147127104|NCT01052779|530631850|FG000|Overall Study|Other-Protocol Violation|1|||
147127105|NCT01052779|530631851|FG001|Overall Study|Other-Protocol Violation|1|||
147127106|NCT01052779|530631850|FG000|Overall Study|Other-Surgery|0|||
147127107|NCT01052779|530631851|FG001|Overall Study|Other-Surgery|2|||
147127108|NCT01052779|530631850|FG000|Overall Study|Other-Missed Week 5 Visit|2|||
147127109|NCT01052779|530631851|FG001|Overall Study|Other-Missed Week 5 Visit|0|||
147127110|NCT03663582|530631852|FG000|Overall Study|Physician Decision|1|||
147127111|NCT02367885|530631853|FG000|Overall Study|Lost to Follow-up|1|||
147127112|NCT02367885|530631854|FG001|Overall Study|Lost to Follow-up|0|||
147127113|NCT02367885|530631855|FG002|Overall Study|Lost to Follow-up|0|||
147127114|NCT02367885|530631853|FG000|Overall Study|Withdrawal by Subject|1|||
147127115|NCT02367885|530631854|FG001|Overall Study|Withdrawal by Subject|0|||
147127116|NCT02367885|530631855|FG002|Overall Study|Withdrawal by Subject|0|||
147127117|NCT01602484|530631856|FG000|Overall Study|Airway issues unrelated to study|0|||
147127118|NCT01602484|530631857|FG001|Overall Study|Airway issues unrelated to study|1|||
147127119|NCT01378195|530631858|FG000|Overall Study|Lost to Follow-up|29|||
147127120|NCT01378195|530631859|FG001|Overall Study|Lost to Follow-up|18|||
147127121|NCT03427619|530631860|FG000|Overall Study|Physician Decision|3|||
147127122|NCT03427619|530631860|FG000|Overall Study|Withdrawal by Subject|4|||
147127123|NCT03427619|530631860|FG000|Overall Study|Lost to Follow-up|5|||
147127124|NCT03427619|530631860|FG000|Overall Study|Administrative|4|||
147127125|NCT03427619|530631860|FG000|Overall Study|Other|2|||
147127126|NCT03427619|530631860|FG000|Overall Study|Unknown or Missing Completion Status|48|||
147127127|NCT05763381|530631866|FG000|Overall Study|Lost to Follow-up|2|||
147127128|NCT05763381|530631867|FG001|Overall Study|Lost to Follow-up|3|||
147127129|NCT05763381|530631866|FG000|Overall Study|Withdrawal by Subject|1|||
147127130|NCT05763381|530631867|FG001|Overall Study|Withdrawal by Subject|2|||
147127131|NCT02853136|530631868|FG000|Wash-out|Adverse Event|0|||
147127132|NCT02853136|530631869|FG001|Wash-out|Adverse Event|0|||
147127133|NCT02853136|530631870|FG002|Wash-out|Adverse Event|0|||
147127134|NCT02853136|530631871|FG003|Wash-out|Adverse Event|1|||
147127135|NCT00841815|530631872|FG000|Washout|Withdrawal by Subject|0|||
147127136|NCT00841815|530631873|FG001|Washout|Withdrawal by Subject|1|||
147127137|NCT03729609|530631874|FG000|Overall Study|Protocol Violation|1|||
147127138|NCT03787615|530631880|FG000|Overall Study|Withdrawal by Subject|2|||
147127139|NCT03787615|530631880|FG000|Overall Study|Lost to Follow-up|2|||
147127140|NCT03412929|530631883|FG000|Overall Study|Protocol Violation|3|||
147127141|NCT05418426|530631885|FG000|Overall Study|Adverse Event|0|||
147127142|NCT05418426|530631886|FG001|Overall Study|Adverse Event|1|||
147127143|NCT05418426|530631887|FG002|Overall Study|Adverse Event|0|||
147127144|NCT05418426|530631885|FG000|Overall Study|Withdrawal by Subject|0|||
147127145|NCT05418426|530631886|FG001|Overall Study|Withdrawal by Subject|1|||
147127146|NCT05418426|530631887|FG002|Overall Study|Withdrawal by Subject|0|||
147127147|NCT05418426|530631885|FG000|Overall Study|Protocol Violation|0|||
147127148|NCT05418426|530631886|FG001|Overall Study|Protocol Violation|0|||
147127149|NCT05418426|530631887|FG002|Overall Study|Protocol Violation|1|||
147127150|NCT01674062|530631888|FG000|Overall Study|Insufficient Therapeutic Response|56|||
147127151|NCT01674062|530631889|FG001|Overall Study|Insufficient Therapeutic Response|26|||
147127152|NCT01674062|530631888|FG000|Overall Study|Other|8|||
147127153|NCT01674062|530631889|FG001|Overall Study|Other|1|||
147127154|NCT01674062|530631888|FG000|Overall Study|Adverse Event|1|||
147127155|NCT01674062|530631889|FG001|Overall Study|Adverse Event|1|||
147127156|NCT01674062|530631888|FG000|Overall Study|Death|0|||
147127157|NCT01674062|530631889|FG001|Overall Study|Death|1|||
147127158|NCT01674062|530631888|FG000|Overall Study|Programming Error|1|||
147127159|NCT01674062|530631889|FG001|Overall Study|Programming Error|0|||
147127160|NCT01051661|530631892|FG000|Overall Study|Adverse Event|1|||
147127161|NCT01051661|530631893|FG001|Overall Study|Adverse Event|1|||
147127162|NCT01051661|530631894|FG002|Overall Study|Adverse Event|1|||
147127163|NCT01051661|530631895|FG003|Overall Study|Adverse Event|1|||
147127164|NCT01051661|530631896|FG004|Overall Study|Adverse Event|0|||
147127165|NCT01051661|530631897|FG005|Overall Study|Adverse Event|0|||
147127166|NCT01051661|530631892|FG000|Overall Study|Lost to Follow-up|13|||
147127167|NCT01051661|530631893|FG001|Overall Study|Lost to Follow-up|22|||
147127168|NCT01051661|530631894|FG002|Overall Study|Lost to Follow-up|15|||
147127169|NCT01051661|530631895|FG003|Overall Study|Lost to Follow-up|17|||
147127170|NCT01051661|530631896|FG004|Overall Study|Lost to Follow-up|10|||
147127171|NCT01051661|530631897|FG005|Overall Study|Lost to Follow-up|24|||
147127172|NCT01051661|530631892|FG000|Overall Study|Migrated/moved from study area|1|||
147127173|NCT01051661|530631893|FG001|Overall Study|Migrated/moved from study area|6|||
147127174|NCT01051661|530631894|FG002|Overall Study|Migrated/moved from study area|6|||
147127175|NCT01051661|530631895|FG003|Overall Study|Migrated/moved from study area|8|||
147127176|NCT01051661|530631896|FG004|Overall Study|Migrated/moved from study area|7|||
147127177|NCT01051661|530631897|FG005|Overall Study|Migrated/moved from study area|3|||
147127178|NCT01051661|530631892|FG000|Overall Study|Refused blood sampling|0|||
147127179|NCT01051661|530631893|FG001|Overall Study|Refused blood sampling|0|||
147127180|NCT01051661|530631894|FG002|Overall Study|Refused blood sampling|0|||
147127181|NCT01051661|530631895|FG003|Overall Study|Refused blood sampling|0|||
147127182|NCT01051661|530631896|FG004|Overall Study|Refused blood sampling|0|||
147127183|NCT01051661|530631897|FG005|Overall Study|Refused blood sampling|1|||
147127184|NCT01051661|530631892|FG000|Overall Study|Data not reliable|1|||
147568973|NCT01597245|532240133|FG012|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
147127185|NCT01051661|530631893|FG001|Overall Study|Data not reliable|0|||
147127186|NCT01051661|530631894|FG002|Overall Study|Data not reliable|0|||
147127187|NCT01051661|530631895|FG003|Overall Study|Data not reliable|0|||
147127188|NCT01051661|530631896|FG004|Overall Study|Data not reliable|0|||
147127189|NCT01051661|530631897|FG005|Overall Study|Data not reliable|1|||
147127190|NCT01051661|530631892|FG000|Overall Study|Unable to attend visit(s)|2|||
147127191|NCT01051661|530631893|FG001|Overall Study|Unable to attend visit(s)|4|||
147127192|NCT01051661|530631894|FG002|Overall Study|Unable to attend visit(s)|2|||
147234944|NCT02128932|531031687|FG002|Overall Study|Lost to Follow-up|1|||
147127193|NCT01051661|530631895|FG003|Overall Study|Unable to attend visit(s)|1|||
147127194|NCT01051661|530631896|FG004|Overall Study|Unable to attend visit(s)|3|||
147127195|NCT01051661|530631897|FG005|Overall Study|Unable to attend visit(s)|2|||
147127196|NCT01051661|530631892|FG000|Overall Study|Consent not received from both parents|0|||
147127197|NCT01051661|530631893|FG001|Overall Study|Consent not received from both parents|0|||
147651170|NCT00162097|532544602|FG003|Overall Study|Participant no longer met study criteria|1|||
147651171|NCT02819440|532544603|FG000|Overall Study|Adverse Event|3|||
147651172|NCT02819440|532544604|FG001|Overall Study|Adverse Event|1|||
147651173|NCT02819440|532544603|FG000|Overall Study|Lost to Follow-up|1|||
147651174|NCT02819440|532544604|FG001|Overall Study|Lost to Follow-up|3|||
147651175|NCT02819440|532544603|FG000|Overall Study|Withdrawal by Subject|9|||
147651176|NCT02819440|532544604|FG001|Overall Study|Withdrawal by Subject|8|||
147651177|NCT02007278|532544613|FG000|Overall Study|Failure to comply with an eligibility|0|||
147651178|NCT02007278|532544614|FG001|Overall Study|Failure to comply with an eligibility|1|||
147651179|NCT02007278|532544613|FG000|Overall Study|Ingestion of drugs not allowed in study|0|||
147651180|NCT02007278|532544614|FG001|Overall Study|Ingestion of drugs not allowed in study|1|||
147651181|NCT02007278|532544613|FG000|Overall Study|Incorrect medication administration|1|||
147651182|NCT02007278|532544614|FG001|Overall Study|Incorrect medication administration|0|||
147651183|NCT02007278|532544613|FG000|Overall Study|Mis-randomization|1|||
147651184|NCT02007278|532544614|FG001|Overall Study|Mis-randomization|1|||
147651185|NCT03304184|532544619|FG000|Overall Study|Withdrawal by Subject|1|||
147651186|NCT03304184|532544620|FG001|Overall Study|Withdrawal by Subject|2|||
147651187|NCT03230838|532544621|FG000|Overall Study|Withdrawal by Subject|3|||
147651188|NCT03230838|532544622|FG001|Overall Study|Withdrawal by Subject|0|||
147651189|NCT03230838|532544621|FG000|Overall Study|Temperature excursion|1|||
147651190|NCT03230838|532544622|FG001|Overall Study|Temperature excursion|0|||
147651191|NCT00435188|532544623|FG000|Overall Study|Death|1|||
147651192|NCT00435188|532544624|FG001|Overall Study|Death|6|||
147651193|NCT00435188|532544623|FG000|Overall Study|Withdrawal by Subject|16|||
147651194|NCT00435188|532544624|FG001|Overall Study|Withdrawal by Subject|11|||
147651195|NCT00435188|532544623|FG000|Overall Study|Lost to Follow-up|5|||
147651196|NCT00435188|532544624|FG001|Overall Study|Lost to Follow-up|6|||
147651197|NCT01915771|532544627|FG000|Day 1|Withdrawal by Subject|1|||
147651198|NCT01915771|532544627|FG000|Day 15|Withdrawal by Subject|1|||
147127198|NCT01051661|530631894|FG002|Overall Study|Consent not received from both parents|0|||
147127199|NCT01051661|530631895|FG003|Overall Study|Consent not received from both parents|0|||
147127200|NCT01051661|530631896|FG004|Overall Study|Consent not received from both parents|0|||
147234945|NCT02128932|531031685|FG000|Overall Study|No reason for withdrawal|12|||
147234946|NCT02128932|531031686|FG001|Overall Study|No reason for withdrawal|11|||
147234947|NCT02128932|531031687|FG002|Overall Study|No reason for withdrawal|7|||
147234948|NCT03113916|531031688|FG000|Overall Study|Withdrawal by Subject|9|||
147234949|NCT03113916|531031689|FG001|Overall Study|Withdrawal by Subject|7|||
147234950|NCT03113916|531031688|FG000|Overall Study|Pregnancy|1|||
147234951|NCT03113916|531031689|FG001|Overall Study|Pregnancy|3|||
147234952|NCT03113916|531031688|FG000|Overall Study|Lost to Follow-up|1|||
147234953|NCT03113916|531031689|FG001|Overall Study|Lost to Follow-up|2|||
147651199|NCT00575510|532544630|FG000|Overall Study|Lost to Follow-up|4|||
147651200|NCT00575510|532544631|FG001|Overall Study|Lost to Follow-up|6|||
147651201|NCT00575510|532544632|FG002|Overall Study|Lost to Follow-up|9|||
147651202|NCT00575510|532544630|FG000|Overall Study|Withdrawal by Subject|1|||
147127201|NCT01051661|530631897|FG005|Overall Study|Consent not received from both parents|1|||
147127202|NCT01051661|530631892|FG000|Overall Study|Failure to comply with protocol|0|||
147127203|NCT01051661|530631893|FG001|Overall Study|Failure to comply with protocol|0|||
147127204|NCT01051661|530631894|FG002|Overall Study|Failure to comply with protocol|2|||
147127205|NCT01051661|530631895|FG003|Overall Study|Failure to comply with protocol|0|||
147127206|NCT01051661|530631896|FG004|Overall Study|Failure to comply with protocol|0|||
147127207|NCT01051661|530631897|FG005|Overall Study|Failure to comply with protocol|0|||
147127208|NCT01051661|530631892|FG000|Overall Study|Subject lost legal representation|0|||
147127209|NCT01051661|530631893|FG001|Overall Study|Subject lost legal representation|0|||
147127210|NCT01051661|530631894|FG002|Overall Study|Subject lost legal representation|0|||
147127211|NCT01051661|530631895|FG003|Overall Study|Subject lost legal representation|0|||
147127212|NCT01051661|530631896|FG004|Overall Study|Subject lost legal representation|1|||
147127213|NCT01051661|530631897|FG005|Overall Study|Subject lost legal representation|0|||
147127214|NCT01051661|530631892|FG000|Overall Study|Protocol Violation|0|||
147127215|NCT01051661|530631893|FG001|Overall Study|Protocol Violation|0|||
147127216|NCT01051661|530631894|FG002|Overall Study|Protocol Violation|0|||
147127217|NCT01051661|530631895|FG003|Overall Study|Protocol Violation|1|||
147127218|NCT01051661|530631896|FG004|Overall Study|Protocol Violation|2|||
147127219|NCT01051661|530631897|FG005|Overall Study|Protocol Violation|1|||
147127220|NCT01051661|530631892|FG000|Overall Study|Withdrawal by Subject|16|||
147127221|NCT01051661|530631893|FG001|Overall Study|Withdrawal by Subject|30|||
147127222|NCT01051661|530631894|FG002|Overall Study|Withdrawal by Subject|13|||
147127223|NCT01051661|530631895|FG003|Overall Study|Withdrawal by Subject|28|||
147127224|NCT01051661|530631896|FG004|Overall Study|Withdrawal by Subject|12|||
147127225|NCT01051661|530631897|FG005|Overall Study|Withdrawal by Subject|34|||
147234954|NCT04729621|531031690|FG000|Main Treatment Period (Week1 to Week 52)|Adverse Event|3|||
147127226|NCT01916226|530631898|FG000|Overall Study|Adverse Event|1|||
147127227|NCT01916226|530631899|FG001|Overall Study|Adverse Event|0|||
147127228|NCT01916226|530631900|FG002|Overall Study|Adverse Event|1|||
147127229|NCT01916226|530631901|FG003|Overall Study|Adverse Event|1|||
147127230|NCT01916226|530631898|FG000|Overall Study|Lack of Efficacy|0|||
147127231|NCT01916226|530631899|FG001|Overall Study|Lack of Efficacy|0|||
147127232|NCT01916226|530631900|FG002|Overall Study|Lack of Efficacy|2|||
147127233|NCT01916226|530631901|FG003|Overall Study|Lack of Efficacy|1|||
147127234|NCT01916226|530631898|FG000|Overall Study|Protocol Violation|0|||
147127235|NCT01916226|530631899|FG001|Overall Study|Protocol Violation|1|||
147127236|NCT01916226|530631900|FG002|Overall Study|Protocol Violation|0|||
147127237|NCT01916226|530631901|FG003|Overall Study|Protocol Violation|1|||
147127238|NCT01916226|530631898|FG000|Overall Study|Physician Decision|0|||
147127239|NCT01916226|530631899|FG001|Overall Study|Physician Decision|0|||
147127240|NCT01916226|530631900|FG002|Overall Study|Physician Decision|0|||
147127241|NCT01916226|530631901|FG003|Overall Study|Physician Decision|1|||
147127242|NCT00680914|530631904|FG000|Overall Study|Consent withdrawal|6|||
147127243|NCT00680914|530631905|FG001|Overall Study|Consent withdrawal|3|||
147127244|NCT00680914|530631904|FG000|Overall Study|Lost to Follow-up|4|||
147127245|NCT00680914|530631905|FG001|Overall Study|Lost to Follow-up|0|||
147127246|NCT00680914|530631904|FG000|Overall Study|serious adverse event (SAE)|0|||
147127247|NCT00680914|530631905|FG001|Overall Study|serious adverse event (SAE)|1|||
147127248|NCT01848457|530631906|FG000|Overall Study|Death|1|||
147127249|NCT01848457|530631907|FG001|Overall Study|Death|0|||
147127250|NCT01848457|530631908|FG002|Overall Study|Death|0|||
147127251|NCT01848457|530631909|FG003|Overall Study|Death|0|||
147127252|NCT01813357|530631913|FG000|Overall Study|Lost to Follow-up|5|||
147127253|NCT01813357|530631914|FG001|Overall Study|Lost to Follow-up|6|||
147127254|NCT02298946|530631915|FG000|Overall Study|Did not receive treatment|2|||
147127255|NCT02298946|530631916|FG001|Overall Study|Did not receive treatment|0|||
147127256|NCT02298946|530631915|FG000|Overall Study|Unevaluable|2|||
147127257|NCT02298946|530631916|FG001|Overall Study|Unevaluable|1|||
147127258|NCT00050011|530631917|FG000|Overall Study|Adverse Event|41|||
147127259|NCT00050011|530631918|FG001|Overall Study|Adverse Event|46|||
147127260|NCT00050011|530631917|FG000|Overall Study|Abnormal laboratory value(s)|1|||
147127261|NCT00050011|530631918|FG001|Overall Study|Abnormal laboratory value(s)|1|||
147127262|NCT00050011|530631917|FG000|Overall Study|Abnormal test procedure results|0|||
147127263|NCT00050011|530631918|FG001|Overall Study|Abnormal test procedure results|1|||
147127264|NCT00050011|530631917|FG000|Overall Study|Lack of Efficacy|16|||
147127265|NCT00050011|530631918|FG001|Overall Study|Lack of Efficacy|21|||
147127266|NCT00050011|530631917|FG000|Overall Study|Participant condition no longer required|1|||
147127267|NCT00050011|530631918|FG001|Overall Study|Participant condition no longer required|0|||
147127268|NCT00050011|530631917|FG000|Overall Study|Protocol Violation|4|||
147127269|NCT00050011|530631918|FG001|Overall Study|Protocol Violation|10|||
147127270|NCT00050011|530631917|FG000|Overall Study|Withdrawal by Subject|34|||
147127271|NCT00050011|530631918|FG001|Overall Study|Withdrawal by Subject|26|||
147127272|NCT00050011|530631917|FG000|Overall Study|Lost to Follow-up|7|||
147127273|NCT00050011|530631918|FG001|Overall Study|Lost to Follow-up|9|||
147127274|NCT00050011|530631917|FG000|Overall Study|Administrative problems|10|||
147127275|NCT00050011|530631918|FG001|Overall Study|Administrative problems|6|||
147127276|NCT00050011|530631917|FG000|Overall Study|Death|7|||
147127277|NCT00050011|530631918|FG001|Overall Study|Death|4|||
147127278|NCT00050011|530631917|FG000|Overall Study|Unknown - Reason is missing|0|||
147127279|NCT00050011|530631918|FG001|Overall Study|Unknown - Reason is missing|2|||
147568974|NCT01597245|532240134|FG013|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
147127280|NCT05535972|530631919|FG000|Overall Study|Withdrawal by Subject|31|||
147127281|NCT05535972|530631919|FG000|Overall Study|Lost to Follow-up|5|||
147127282|NCT05535972|530631919|FG000|Overall Study|Adverse Event|6|||
147127283|NCT05535972|530631919|FG000|Overall Study|Protocol Deviation|2|||
147127284|NCT04197583|530631922|FG000|Overall Study|Study Stent Replacement|34|||
147127285|NCT04197583|530631923|FG001|Overall Study|Study Stent Replacement|8|||
147234955|NCT04729621|531031691|FG001|Main Treatment Period (Week1 to Week 52)|Adverse Event|7|||
147234956|NCT04729621|531031692|FG002|Main Treatment Period (Week1 to Week 52)|Adverse Event|0|||
147234957|NCT04729621|531031693|FG003|Main Treatment Period (Week1 to Week 52)|Adverse Event|0|||
147234958|NCT04729621|531031694|FG004|Main Treatment Period (Week1 to Week 52)|Adverse Event|0|||
147234959|NCT04729621|531031690|FG000|Main Treatment Period (Week1 to Week 52)|Withdrawal by Subject|13|||
147234960|NCT04729621|531031691|FG001|Main Treatment Period (Week1 to Week 52)|Withdrawal by Subject|12|||
147127286|NCT04197583|530631922|FG000|Overall Study|Lost to Follow-up|14|||
147127287|NCT04197583|530631923|FG001|Overall Study|Lost to Follow-up|3|||
147127288|NCT04197583|530631922|FG000|Overall Study|Death|3|||
147127289|NCT04197583|530631923|FG001|Overall Study|Death|0|||
147127290|NCT04197583|530631922|FG000|Overall Study|Physician Decision|1|||
147127291|NCT04197583|530631923|FG001|Overall Study|Physician Decision|0|||
147127292|NCT04197583|530631922|FG000|Overall Study|Withdrawal by Subject|1|||
147127293|NCT04197583|530631923|FG001|Overall Study|Withdrawal by Subject|1|||
147127294|NCT04197583|530631922|FG000|Overall Study|Discontinued. Patient had disseminated metastatic condition|0|||
147127295|NCT04197583|530631923|FG001|Overall Study|Discontinued. Patient had disseminated metastatic condition|1|||
147127296|NCT04197583|530631922|FG000|Overall Study|Screen Failure|0|||
147127297|NCT04197583|530631923|FG001|Overall Study|Screen Failure|20|||
147127298|NCT04629196|530631924|FG000|Overall Study|Subject discontinued study drug|1|||
147127299|NCT04629196|530631925|FG001|Overall Study|Subject discontinued study drug|0|||
147127300|NCT04629196|530631924|FG000|Overall Study|Subject study drug dosing increased|1|||
147127301|NCT04629196|530631925|FG001|Overall Study|Subject study drug dosing increased|1|||
147127302|NCT04629196|530631924|FG000|Overall Study|Withdrawal by Subject|1|||
147127303|NCT04629196|530631925|FG001|Overall Study|Withdrawal by Subject|2|||
147127304|NCT01450631|530631929|FG000|Overall Study|Lost to Follow-up|2|||
147127305|NCT01450631|530631930|FG001|Overall Study|Lost to Follow-up|4|||
147127306|NCT01450631|530631929|FG000|Overall Study|Withdrawal by Subject|1|||
147127307|NCT01450631|530631930|FG001|Overall Study|Withdrawal by Subject|0|||
147127308|NCT04903093|530631933|FG000|Overall Study|Withdrawal by Subject|0|||
147127309|NCT04903093|530631934|FG001|Overall Study|Withdrawal by Subject|0|||
147127310|NCT04903093|530631935|FG002|Overall Study|Withdrawal by Subject|0|||
147127311|NCT04903093|530631936|FG003|Overall Study|Withdrawal by Subject|1|||
147127312|NCT04903093|530631937|FG004|Overall Study|Withdrawal by Subject|0|||
147127313|NCT04903093|530631938|FG005|Overall Study|Withdrawal by Subject|0|||
147127314|NCT01111552|530631939|FG000|Phase B (Day 1 to Week 8)|Lost to Follow-up|9|||
147127315|NCT01111552|530631940|FG001|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
147127316|NCT01111552|530631941|FG002|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
147127317|NCT01111552|530631942|FG003|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
147127318|NCT01111552|530631943|FG004|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
147127319|NCT01111552|530631939|FG000|Phase B (Day 1 to Week 8)|Adverse Event|4|||
147127320|NCT01111552|530631940|FG001|Phase B (Day 1 to Week 8)|Adverse Event|0|||
147127321|NCT01111552|530631941|FG002|Phase B (Day 1 to Week 8)|Adverse Event|0|||
147127322|NCT01111552|530631942|FG003|Phase B (Day 1 to Week 8)|Adverse Event|0|||
147127323|NCT01111552|530631943|FG004|Phase B (Day 1 to Week 8)|Adverse Event|0|||
147127324|NCT01111552|530631939|FG000|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|89|||
147127325|NCT01111552|530631940|FG001|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
147127326|NCT01111552|530631941|FG002|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
147127327|NCT01111552|530631942|FG003|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
147127328|NCT01111552|530631943|FG004|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
147127329|NCT01111552|530631939|FG000|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|3|||
147127330|NCT01111552|530631940|FG001|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|0|||
147127331|NCT01111552|530631941|FG002|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|0|||
147127332|NCT01111552|530631942|FG003|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|0|||
147127333|NCT01111552|530631943|FG004|Phase B (Day 1 to Week 8)|Participant Met Withdrawal Criteria|0|||
147127334|NCT01111552|530631939|FG000|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|3|||
147127335|NCT01111552|530631940|FG001|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|0|||
147127336|NCT01111552|530631941|FG002|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|0|||
147127337|NCT01111552|530631942|FG003|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|0|||
147127338|NCT01111552|530631943|FG004|Phase B (Day 1 to Week 8)|Investigator Withdrew Participant|0|||
147127339|NCT01111552|530631939|FG000|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|7|||
147127340|NCT01111552|530631940|FG001|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|0|||
147127341|NCT01111552|530631941|FG002|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|0|||
147127342|NCT01111552|530631942|FG003|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|0|||
147127343|NCT01111552|530631943|FG004|Phase B (Day 1 to Week 8)|Participant Withdrew Consent|0|||
147127344|NCT01111552|530631939|FG000|Phase B (Day 1 to Week 8)|Protocol Deviation|1|||
147127345|NCT01111552|530631940|FG001|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
147127346|NCT01111552|530631941|FG002|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
147127347|NCT01111552|530631942|FG003|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
147127348|NCT01111552|530631943|FG004|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
147127349|NCT01111552|530631939|FG000|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|1|||
147127350|NCT01111552|530631940|FG001|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|0|||
147127351|NCT01111552|530631941|FG002|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|0|||
147127352|NCT01111552|530631942|FG003|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|0|||
147127353|NCT01111552|530631943|FG004|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by Investigator|0|||
147127354|NCT01111552|530631939|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
147127355|NCT01111552|530631940|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
147127356|NCT01111552|530631941|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
147127357|NCT01111552|530631942|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|1|||
147127358|NCT01111552|530631943|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
147127359|NCT01111552|530631939|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|0|||
147127360|NCT01111552|530631940|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|5|||
147127361|NCT01111552|530631941|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|4|||
147127362|NCT01111552|530631942|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|3|||
147316614|NCT00544544|531323757|FG000|Overall Study|Adverse Event|1|||
147127363|NCT01111552|530631943|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|5|||
147127364|NCT01111552|530631939|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|0|||
147127365|NCT01111552|530631940|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|2|||
147127366|NCT01111552|530631941|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|0|||
147127367|NCT01111552|530631942|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|0|||
147127368|NCT01111552|530631943|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Participant Met Withdrawal Criteria|0|||
147127369|NCT01111552|530631939|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|0|||
147127370|NCT01111552|530631940|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|1|||
147316615|NCT00544544|531323757|FG000|Overall Study|Lost to Follow-up|1|||
147316616|NCT02955277|531325639|FG000|Pre-Post Intervention|Withdrawal by Subject|5|||
147316617|NCT02955277|531325640|FG001|Pre-Post Intervention|Withdrawal by Subject|6|||
147316618|NCT02955277|531325639|FG000|Post to Follow-up|Lost to Follow-up|8|||
147316619|NCT02955277|531325640|FG001|Post to Follow-up|Lost to Follow-up|11|||
147316620|NCT04212169|531325641|FG000|Overall Study|Adverse Event|0|||
147316621|NCT04212169|531325642|FG001|Overall Study|Adverse Event|0|||
147316622|NCT04212169|531325643|FG002|Overall Study|Adverse Event|0|||
147316623|NCT04212169|531325644|FG003|Overall Study|Adverse Event|2|||
147316624|NCT04212169|531325641|FG000|Overall Study|Lost to Follow-up|1|||
147316625|NCT04212169|531325642|FG001|Overall Study|Lost to Follow-up|0|||
147316626|NCT04212169|531325643|FG002|Overall Study|Lost to Follow-up|0|||
147316627|NCT04212169|531325644|FG003|Overall Study|Lost to Follow-up|2|||
147316628|NCT04212169|531325641|FG000|Overall Study|Withdrawal by Subject|10|||
147316629|NCT04212169|531325642|FG001|Overall Study|Withdrawal by Subject|2|||
147316630|NCT04212169|531325643|FG002|Overall Study|Withdrawal by Subject|5|||
147651203|NCT00575510|532544631|FG001|Overall Study|Withdrawal by Subject|0|||
147127371|NCT01111552|530631941|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|0|||
147127372|NCT01111552|530631942|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|0|||
147651204|NCT00575510|532544632|FG002|Overall Study|Withdrawal by Subject|0|||
147651205|NCT00575510|532544630|FG000|Overall Study|Clinic Called Patient|7|||
147651206|NCT00575510|532544631|FG001|Overall Study|Clinic Called Patient|7|||
147651207|NCT00575510|532544632|FG002|Overall Study|Clinic Called Patient|7|||
147651208|NCT00575510|532544630|FG000|Overall Study|Pregnancy|0|||
147651209|NCT00575510|532544631|FG001|Overall Study|Pregnancy|0|||
147651210|NCT00575510|532544632|FG002|Overall Study|Pregnancy|1|||
147651211|NCT03420222|532544633|FG000|Overall Study|Withdrawal by Subject|5|||
147651212|NCT03420222|532544634|FG001|Overall Study|Withdrawal by Subject|0|||
147651213|NCT03420222|532544633|FG000|Overall Study|Physician Decision|0|||
147651214|NCT03420222|532544634|FG001|Overall Study|Physician Decision|1|||
147651215|NCT02334384|532544635|FG000|Overall Study|Lost to Follow-up|1|||
147651216|NCT02334384|532544636|FG001|Overall Study|Lost to Follow-up|1|||
147651217|NCT03469999|532544638|FG000|Overall Study|Lost to Follow-up|2|||
147651218|NCT04424914|532544644|FG000|Overall Study|Other|0|||
147651219|NCT04424914|532544645|FG001|Overall Study|Other|0|||
147651220|NCT04424914|532544646|FG002|Overall Study|Other|28|||
147651221|NCT04424914|532544644|FG000|Overall Study|Withdrawal by Subject|3|||
147651222|NCT04424914|532544645|FG001|Overall Study|Withdrawal by Subject|0|||
147651223|NCT04424914|532544646|FG002|Overall Study|Withdrawal by Subject|0|||
147127373|NCT01111552|530631943|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Participant|0|||
147127374|NCT01111552|530631939|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|0|||
147316631|NCT04212169|531325644|FG003|Overall Study|Withdrawal by Subject|7|||
147316632|NCT04212169|531325641|FG000|Overall Study|Other reason, unspecified|3|||
147316633|NCT04212169|531325642|FG001|Overall Study|Other reason, unspecified|1|||
147316634|NCT04212169|531325643|FG002|Overall Study|Other reason, unspecified|0|||
147316635|NCT04212169|531325644|FG003|Overall Study|Other reason, unspecified|2|||
147316636|NCT02819479|531325645|FG000|Overall Study|Adverse Event|2|||
147316637|NCT04006366|531325651|FG000|Overall Study|Withdrawal by Subject|1|||
147316638|NCT04430335|531325652|FG000|Overall Study|Withdrawal by Subject|1|||
147316639|NCT03249376|531325662|FG000|Overall Study|Adverse Event|11|||
147316640|NCT03249376|531325663|FG001|Overall Study|Adverse Event|5|||
147316641|NCT03249376|531325662|FG000|Overall Study|Lack of Efficacy|2|||
147316642|NCT03249376|531325663|FG001|Overall Study|Lack of Efficacy|4|||
147316643|NCT03249376|531325662|FG000|Overall Study|Protocol Violation|3|||
147316644|NCT03249376|531325663|FG001|Overall Study|Protocol Violation|2|||
147316645|NCT03249376|531325662|FG000|Overall Study|Physician Decision|0|||
147316646|NCT03249376|531325663|FG001|Overall Study|Physician Decision|2|||
147316647|NCT03249376|531325662|FG000|Overall Study|Withdrawal by Subject|3|||
147651224|NCT04424914|532544644|FG000|Overall Study|Study terminated by sponsor|23|||
147651225|NCT04424914|532544645|FG001|Overall Study|Study terminated by sponsor|7|||
147651226|NCT04424914|532544646|FG002|Overall Study|Study terminated by sponsor|0|||
147651227|NCT04424914|532544644|FG000|Overall Study|Lost to Follow-up|0|||
147651228|NCT04424914|532544645|FG001|Overall Study|Lost to Follow-up|0|||
147316648|NCT03249376|531325663|FG001|Overall Study|Withdrawal by Subject|9|||
147316649|NCT03249376|531325662|FG000|Overall Study|LTFU|2|||
147316650|NCT03249376|531325663|FG001|Overall Study|LTFU|1|||
147651229|NCT04424914|532544646|FG002|Overall Study|Lost to Follow-up|1|||
147234961|NCT04729621|531031692|FG002|Main Treatment Period (Week1 to Week 52)|Withdrawal by Subject|0|||
147234962|NCT04729621|531031693|FG003|Main Treatment Period (Week1 to Week 52)|Withdrawal by Subject|0|||
147234963|NCT04729621|531031694|FG004|Main Treatment Period (Week1 to Week 52)|Withdrawal by Subject|0|||
147234964|NCT04729621|531031690|FG000|Main Treatment Period (Week1 to Week 52)|Multiple Other Reasons|2|||
147234965|NCT04729621|531031691|FG001|Main Treatment Period (Week1 to Week 52)|Multiple Other Reasons|4|||
147234966|NCT04729621|531031692|FG002|Main Treatment Period (Week1 to Week 52)|Multiple Other Reasons|0|||
147234967|NCT04729621|531031693|FG003|Main Treatment Period (Week1 to Week 52)|Multiple Other Reasons|0|||
147234968|NCT04729621|531031694|FG004|Main Treatment Period (Week1 to Week 52)|Multiple Other Reasons|0|||
147234969|NCT04729621|531031690|FG000|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|0|||
147234970|NCT04729621|531031691|FG001|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|0|||
147234971|NCT04729621|531031692|FG002|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|7|||
147234972|NCT04729621|531031693|FG003|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|2|||
147234973|NCT04729621|531031694|FG004|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|1|||
147234974|NCT04729621|531031690|FG000|Transition Period (Week 52 to Week 78)|Lost to Follow-up|0|||
147234975|NCT04729621|531031691|FG001|Transition Period (Week 52 to Week 78)|Lost to Follow-up|0|||
147234976|NCT04729621|531031692|FG002|Transition Period (Week 52 to Week 78)|Lost to Follow-up|0|||
147234977|NCT04729621|531031693|FG003|Transition Period (Week 52 to Week 78)|Lost to Follow-up|1|||
147234978|NCT04729621|531031694|FG004|Transition Period (Week 52 to Week 78)|Lost to Follow-up|0|||
147234979|NCT04729621|531031690|FG000|Transition Period (Week 52 to Week 78)|Multiple Other Reasons|0|||
147234980|NCT04729621|531031691|FG001|Transition Period (Week 52 to Week 78)|Multiple Other Reasons|0|||
147234981|NCT04729621|531031692|FG002|Transition Period (Week 52 to Week 78)|Multiple Other Reasons|1|||
147234982|NCT04729621|531031693|FG003|Transition Period (Week 52 to Week 78)|Multiple Other Reasons|2|||
147234983|NCT04729621|531031694|FG004|Transition Period (Week 52 to Week 78)|Multiple Other Reasons|1|||
147234984|NCT02663908|531031695|FG000|Overall Study|Withdrawal by Subject|8|||
147316651|NCT00627042|531325664|FG000|Overall Study|Withdrawal by Subject|2|||
147127375|NCT01111552|530631940|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|1|||
147127376|NCT01111552|530631941|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|0|||
147127377|NCT01111552|530631942|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|0|||
147127378|NCT01111552|530631943|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Participant Withdrew Consent|0|||
147127379|NCT01111552|530631939|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
147127380|NCT01111552|530631940|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
147127381|NCT01111552|530631941|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|1|||
147127382|NCT01111552|530631942|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
147127383|NCT01111552|530631943|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
147127384|NCT01027351|530631944|FG000|Overall Study|Withdrawal by Subject|1|||
147127385|NCT01027351|530631945|FG001|Overall Study|Withdrawal by Subject|0|||
147127386|NCT01027351|530631946|FG002|Overall Study|Withdrawal by Subject|1|||
147127387|NCT01027351|530631947|FG003|Overall Study|Withdrawal by Subject|0|||
147127388|NCT01027351|530631948|FG004|Overall Study|Withdrawal by Subject|3|||
147127389|NCT01027351|530631949|FG005|Overall Study|Withdrawal by Subject|5|||
147127390|NCT01027351|530631944|FG000|Overall Study|Lost to Follow-up|1|||
147127391|NCT01027351|530631945|FG001|Overall Study|Lost to Follow-up|1|||
147127392|NCT01027351|530631946|FG002|Overall Study|Lost to Follow-up|0|||
147127393|NCT01027351|530631947|FG003|Overall Study|Lost to Follow-up|1|||
147127394|NCT01027351|530631948|FG004|Overall Study|Lost to Follow-up|6|||
147127395|NCT01027351|530631949|FG005|Overall Study|Lost to Follow-up|0|||
147127396|NCT01027351|530631944|FG000|Overall Study|Inappropriate enrollment|0|||
147127397|NCT01027351|530631945|FG001|Overall Study|Inappropriate enrollment|0|||
147127398|NCT01027351|530631946|FG002|Overall Study|Inappropriate enrollment|0|||
147127399|NCT01027351|530631947|FG003|Overall Study|Inappropriate enrollment|0|||
147127400|NCT01027351|530631948|FG004|Overall Study|Inappropriate enrollment|1|||
147127401|NCT01027351|530631949|FG005|Overall Study|Inappropriate enrollment|0|||
147127402|NCT01027351|530631944|FG000|Overall Study|Protocol Violation|1|||
147127403|NCT01027351|530631945|FG001|Overall Study|Protocol Violation|0|||
147316652|NCT01154036|531325665|FG000|Phase I|Physician Decision|0|||
147316653|NCT01154036|531325666|FG001|Phase I|Physician Decision|1|||
147316654|NCT01154036|531325667|FG002|Phase I|Physician Decision|0|||
147316655|NCT01154036|531325668|FG003|Phase I|Physician Decision|0|||
147316656|NCT01154036|531325669|FG004|Phase I|Physician Decision|0|||
147568975|NCT01597245|532240135|FG014|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|38|||
147127404|NCT01027351|530631946|FG002|Overall Study|Protocol Violation|0|||
147127405|NCT01027351|530631947|FG003|Overall Study|Protocol Violation|1|||
147127406|NCT01027351|530631948|FG004|Overall Study|Protocol Violation|1|||
147127407|NCT01027351|530631949|FG005|Overall Study|Protocol Violation|0|||
147127408|NCT04650893|530631950|FG000|Overall Study|Lost to Follow-up|11|||
147127409|NCT04650893|530631951|FG001|Overall Study|Lost to Follow-up|10|||
147127410|NCT04650893|530631952|FG002|Overall Study|Lost to Follow-up|11|||
147316657|NCT01154036|531325670|FG005|Phase I|Physician Decision|0|||
147127411|NCT04090749|530631955|FG000|Open Label Pilot|Lost to Follow-up|1|||
147568976|NCT01597245|532240136|FG015|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|38|||
147127412|NCT04090749|530631956|FG001|Open Label Pilot|Lost to Follow-up|0|||
147127413|NCT04090749|530631957|FG002|Open Label Pilot|Lost to Follow-up|0|||
147127414|NCT04090749|530631955|FG000|Pilot Trial|Care recipient of enrolled caregiver died|0|||
147127415|NCT04090749|530631956|FG001|Pilot Trial|Care recipient of enrolled caregiver died|1|||
147127416|NCT04090749|530631957|FG002|Pilot Trial|Care recipient of enrolled caregiver died|0|||
147127417|NCT04090749|530631955|FG000|Pilot Trial|Lost to Follow-up|0|||
147127418|NCT04090749|530631956|FG001|Pilot Trial|Lost to Follow-up|1|||
147127419|NCT04090749|530631957|FG002|Pilot Trial|Lost to Follow-up|1|||
147127420|NCT02528305|530631958|FG000|Overall Study|Withdrawal by Subject|1|||
147127421|NCT02528305|530631958|FG000|Overall Study|Adverse Event|1|||
147127422|NCT02528305|530631958|FG000|Overall Study|Physician Decision|1|||
147127423|NCT00421408|530631959|FG000|Overall Study|Lost to Follow-up|30|||
147127424|NCT00421408|530631960|FG001|Overall Study|Lost to Follow-up|20|||
147127425|NCT00421408|530631959|FG000|Overall Study|Discountinued from treatment/ f/u cont.|12|||
147127426|NCT00421408|530631960|FG001|Overall Study|Discountinued from treatment/ f/u cont.|25|||
147127427|NCT00461812|530631963|FG000|Overall Study|study terminated|10|||
147127428|NCT01308788|530631964|FG000|2-year Treatment|medication change by treating physician|4|||
147127429|NCT01308788|530631965|FG001|2-year Treatment|medication change by treating physician|11|||
147127430|NCT00322218|530631966|FG000|Overall Study|Death|3|||
147127431|NCT00322218|530631967|FG001|Overall Study|Death|6|||
147127432|NCT03193437|530631974|FG000|Overall Study|Adverse Event|4|||
147127433|NCT03193437|530631974|FG000|Overall Study|Withdrawal by Subject|2|||
147127434|NCT03193437|530631974|FG000|Overall Study|Disease Progression|2|||
147127435|NCT02414841|530631977|FG000|Overall Study|Withdrawal by Subject|7|||
147127436|NCT02414841|530631978|FG001|Overall Study|Withdrawal by Subject|5|||
147127437|NCT02414841|530631977|FG000|Overall Study|Lost to Follow-up|13|||
147651230|NCT04424914|532544644|FG000|Overall Study|Death|3|||
147651231|NCT04424914|532544645|FG001|Overall Study|Death|1|||
147651232|NCT04424914|532544646|FG002|Overall Study|Death|0|||
147651233|NCT00460746|532544647|FG000|Overall Study|Adverse Event|1|||
147651234|NCT00460746|532544647|FG000|Overall Study|Lost to Follow-up|1|||
147651235|NCT01778751|532544650|FG000|Overall Study|Lost to Follow-up|1|||
147651236|NCT01778751|532544651|FG001|Overall Study|Lost to Follow-up|0|||
147651237|NCT01778751|532544650|FG000|Overall Study|Withdrawal by Subject|0|||
147651238|NCT01778751|532544651|FG001|Overall Study|Withdrawal by Subject|2|||
147651239|NCT01778751|532544650|FG000|Overall Study|Transfered care|1|||
147651240|NCT01778751|532544651|FG001|Overall Study|Transfered care|0|||
147651241|NCT00394771|532544652|FG000|Overall Study|Did not meet protocol requirements|1|||
147651242|NCT00394771|532544653|FG001|Overall Study|Did not meet protocol requirements|0|||
147651243|NCT00394771|532544654|FG002|Overall Study|Did not meet protocol requirements|2|||
147651244|NCT00394771|532544655|FG003|Overall Study|Did not meet protocol requirements|0|||
147651245|NCT00394771|532544652|FG000|Overall Study|Protocol Violation|2|||
147651246|NCT00394771|532544653|FG001|Overall Study|Protocol Violation|4|||
147651247|NCT00394771|532544654|FG002|Overall Study|Protocol Violation|9|||
147651248|NCT00394771|532544655|FG003|Overall Study|Protocol Violation|7|||
147127438|NCT02414841|530631978|FG001|Overall Study|Lost to Follow-up|6|||
147127439|NCT02414841|530631977|FG000|Overall Study|Death|17|||
147127440|NCT02414841|530631978|FG001|Overall Study|Death|14|||
147127441|NCT02414841|530631977|FG000|Overall Study|Received a Kidney Transplant|13|||
147127442|NCT02414841|530631978|FG001|Overall Study|Received a Kidney Transplant|4|||
147127443|NCT02414841|530631977|FG000|Overall Study|Randomized But Not Treated|6|||
147127444|NCT02414841|530631978|FG001|Overall Study|Randomized But Not Treated|4|||
147127445|NCT03941093|530631987|FG000|Overall Study|Protocol Violation|0|||
147127446|NCT03941093|530631988|FG001|Overall Study|Protocol Violation|1|||
147234985|NCT02663908|531031696|FG001|Overall Study|Withdrawal by Subject|5|||
147234986|NCT02663908|531031695|FG000|Overall Study|Lost to Follow-up|1|||
147234987|NCT02663908|531031696|FG001|Overall Study|Lost to Follow-up|5|||
147234988|NCT02663908|531031695|FG000|Overall Study|Adverse Event|13|||
147234989|NCT02663908|531031696|FG001|Overall Study|Adverse Event|11|||
147234990|NCT02663908|531031695|FG000|Overall Study|Protocol Violation|1|||
147234991|NCT02663908|531031696|FG001|Overall Study|Protocol Violation|2|||
147234992|NCT02663908|531031695|FG000|Overall Study|Lack of therapeutic response|2|||
147127447|NCT03941093|530631987|FG000|Overall Study|Withdrawal by Subject|9|||
147127448|NCT03941093|530631988|FG001|Overall Study|Withdrawal by Subject|6|||
147127449|NCT04191135|530631998|FG000|Induction Treatment|Not Treated|2|||
147127450|NCT04191135|530631999|FG001|Induction Treatment|Not Treated|0|||
147127451|NCT04191135|530632000|FG002|Induction Treatment|Not Treated|0|||
147234993|NCT02663908|531031696|FG001|Overall Study|Lack of therapeutic response|0|||
147234994|NCT02663908|531031695|FG000|Overall Study|COVID-19|1|||
147234995|NCT02663908|531031696|FG001|Overall Study|COVID-19|0|||
147651249|NCT00394771|532544652|FG000|Overall Study|Withdrawal by Subject|10|||
147651250|NCT00394771|532544653|FG001|Overall Study|Withdrawal by Subject|6|||
147651251|NCT00394771|532544654|FG002|Overall Study|Withdrawal by Subject|8|||
147651252|NCT00394771|532544655|FG003|Overall Study|Withdrawal by Subject|12|||
147651253|NCT00394771|532544652|FG000|Overall Study|Adverse Event|10|||
147651254|NCT00394771|532544653|FG001|Overall Study|Adverse Event|5|||
147127452|NCT04191135|530631998|FG000|Induction Treatment|Ongoing to Blinded Treatment Period|271|||
147127453|NCT04191135|530631999|FG001|Induction Treatment|Ongoing to Blinded Treatment Period|0|||
147127454|NCT04191135|530632000|FG002|Induction Treatment|Ongoing to Blinded Treatment Period|0|||
147127455|NCT04191135|530631998|FG000|Induction Treatment|Adverse Event|25|||
147127456|NCT04191135|530631999|FG001|Induction Treatment|Adverse Event|0|||
147127457|NCT04191135|530632000|FG002|Induction Treatment|Adverse Event|0|||
147127458|NCT04191135|530631998|FG000|Induction Treatment|Clinical Progression|8|||
147127459|NCT04191135|530631999|FG001|Induction Treatment|Clinical Progression|0|||
147127460|NCT04191135|530632000|FG002|Induction Treatment|Clinical Progression|0|||
147127461|NCT04191135|530631998|FG000|Induction Treatment|Excluded Medication|1|||
147127462|NCT04191135|530631999|FG001|Induction Treatment|Excluded Medication|0|||
147127463|NCT04191135|530632000|FG002|Induction Treatment|Excluded Medication|0|||
147127464|NCT04191135|530631998|FG000|Induction Treatment|Failure to Meet Continuation Criteria|2|||
147127465|NCT04191135|530631999|FG001|Induction Treatment|Failure to Meet Continuation Criteria|0|||
147127466|NCT04191135|530632000|FG002|Induction Treatment|Failure to Meet Continuation Criteria|0|||
147127467|NCT04191135|530631998|FG000|Induction Treatment|Failure to Meet Randomization Criteria|2|||
147127468|NCT04191135|530631999|FG001|Induction Treatment|Failure to Meet Randomization Criteria|0|||
147127469|NCT04191135|530632000|FG002|Induction Treatment|Failure to Meet Randomization Criteria|0|||
147127470|NCT04191135|530631998|FG000|Induction Treatment|Physician Decision|2|||
147127471|NCT04191135|530631999|FG001|Induction Treatment|Physician Decision|0|||
147127472|NCT04191135|530632000|FG002|Induction Treatment|Physician Decision|0|||
147127473|NCT04191135|530631998|FG000|Induction Treatment|Progressive Disease|135|||
147127474|NCT04191135|530631999|FG001|Induction Treatment|Progressive Disease|0|||
147127475|NCT04191135|530632000|FG002|Induction Treatment|Progressive Disease|0|||
147127476|NCT04191135|530631998|FG000|Induction Treatment|Protocol Violation|10|||
147127477|NCT04191135|530631999|FG001|Induction Treatment|Protocol Violation|0|||
147127478|NCT04191135|530632000|FG002|Induction Treatment|Protocol Violation|0|||
147127479|NCT04191135|530631998|FG000|Induction Treatment|Withdrawal by Subject|4|||
147127480|NCT04191135|530631999|FG001|Induction Treatment|Withdrawal by Subject|0|||
147127481|NCT04191135|530632000|FG002|Induction Treatment|Withdrawal by Subject|0|||
147127482|NCT04191135|530631998|FG000|Randomized Treatment|Death|0|||
147127483|NCT04191135|530631999|FG001|Randomized Treatment|Death|50|||
147127484|NCT04191135|530632000|FG002|Randomized Treatment|Death|54|||
147127485|NCT04191135|530631998|FG000|Randomized Treatment|Lost to Follow-up|0|||
147127486|NCT04191135|530631999|FG001|Randomized Treatment|Lost to Follow-up|0|||
147127487|NCT04191135|530632000|FG002|Randomized Treatment|Lost to Follow-up|1|||
147127488|NCT04191135|530631998|FG000|Randomized Treatment|Withdrawal by Subject|0|||
147127489|NCT04191135|530631999|FG001|Randomized Treatment|Withdrawal by Subject|2|||
147234996|NCT02663908|531031695|FG000|Overall Study|Site closed|1|||
147234997|NCT02663908|531031696|FG001|Overall Study|Site closed|0|||
147234998|NCT02663908|531031695|FG000|Overall Study|Subject to begin treatment with an exclusionary medication|1|||
147234999|NCT02663908|531031696|FG001|Overall Study|Subject to begin treatment with an exclusionary medication|0|||
147235000|NCT02663908|531031695|FG000|Overall Study|Subject ended trial due to being prescribed prohibited medication|1|||
147235001|NCT02663908|531031696|FG001|Overall Study|Subject ended trial due to being prescribed prohibited medication|0|||
147235002|NCT02663908|531031695|FG000|Overall Study|Intolerance to FIRMAGON therapy|1|||
147235003|NCT02663908|531031696|FG001|Overall Study|Intolerance to FIRMAGON therapy|0|||
147235004|NCT02663908|531031695|FG000|Overall Study|Death|1|||
147235005|NCT02663908|531031696|FG001|Overall Study|Death|0|||
147235006|NCT02663908|531031695|FG000|Overall Study|Subject randomized in error and did not receive the IMP|1|||
147235007|NCT02663908|531031696|FG001|Overall Study|Subject randomized in error and did not receive the IMP|0|||
147127490|NCT04191135|530632000|FG002|Randomized Treatment|Withdrawal by Subject|0|||
147127491|NCT04191135|530631998|FG000|Randomized Treatment|Ongoing in Trial|0|||
147127492|NCT04191135|530631999|FG001|Randomized Treatment|Ongoing in Trial|83|||
147127493|NCT04191135|530632000|FG002|Randomized Treatment|Ongoing in Trial|81|||
147127494|NCT00003645|530633595|FG000|Overall Study|Death|4|||
147127495|NCT00003645|530633596|FG001|Overall Study|Death|1|||
147127496|NCT00003645|530633595|FG000|Overall Study|Lost to Follow-up|7|||
147127497|NCT00003645|530633596|FG001|Overall Study|Lost to Follow-up|8|||
147127498|NCT00003645|530633595|FG000|Overall Study|Withdrawal by Subject|1|||
147127499|NCT00003645|530633596|FG001|Overall Study|Withdrawal by Subject|3|||
147127500|NCT03332056|530633599|FG000|Overall Study|Incomplete questionnaires|8|||
147127501|NCT03332056|530633600|FG001|Overall Study|Incomplete questionnaires|9|||
147127502|NCT03332056|530633599|FG000|Overall Study|Passed stone prior to surgery date|1|||
147127503|NCT03332056|530633600|FG001|Overall Study|Passed stone prior to surgery date|0|||
147568977|NCT01597245|532240137|FG016|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
147127504|NCT03332056|530633599|FG000|Overall Study|Did not require a ureteral stent|0|||
147127505|NCT03332056|530633600|FG001|Overall Study|Did not require a ureteral stent|1|||
147235008|NCT02663908|531031695|FG000|Overall Study|Subject discontinued treatment as he was in hospice and could not make it for end-of-trial visit|0|||
147127506|NCT00321932|530633601|FG000|Overall Study|Death|3|||
147127507|NCT00321932|530633602|FG001|Overall Study|Death|6|||
147127508|NCT00321932|530633601|FG000|Overall Study|Withdrawal by Subject|3|||
147127509|NCT00321932|530633602|FG001|Overall Study|Withdrawal by Subject|6|||
147127510|NCT00321932|530633601|FG000|Overall Study|Early relapse|2|||
147127511|NCT00321932|530633602|FG001|Overall Study|Early relapse|8|||
147127512|NCT00321932|530633601|FG000|Overall Study|Missing data|2|||
147127513|NCT00321932|530633602|FG001|Overall Study|Missing data|1|||
147127514|NCT03360344|530633605|FG000|Overall Study|Withdrawal by Subject|0|||
147127515|NCT03360344|530633606|FG001|Overall Study|Withdrawal by Subject|1|||
147127516|NCT03360344|530633607|FG002|Overall Study|Withdrawal by Subject|1|||
147127517|NCT00133705|530633612|FG000|Overall Study|Withdrawal by Subject|2|||
147127518|NCT00133705|530633613|FG001|Overall Study|Withdrawal by Subject|3|||
147127519|NCT00959049|530633614|FG000|Overall Study|Adverse Event|1|||
147127520|NCT00959049|530633615|FG001|Overall Study|Adverse Event|0|||
147127521|NCT00959049|530633616|FG002|Overall Study|Adverse Event|0|||
147127522|NCT00959049|530633617|FG003|Overall Study|Adverse Event|0|||
147127523|NCT00959049|530633618|FG004|Overall Study|Adverse Event|0|||
147127524|NCT00959049|530633619|FG005|Overall Study|Adverse Event|0|||
147127525|NCT00959049|530633614|FG000|Overall Study|Lost to Follow-up|17|||
147127526|NCT00959049|530633615|FG001|Overall Study|Lost to Follow-up|5|||
147127527|NCT00959049|530633616|FG002|Overall Study|Lost to Follow-up|1|||
147127528|NCT00959049|530633617|FG003|Overall Study|Lost to Follow-up|10|||
147127529|NCT00959049|530633618|FG004|Overall Study|Lost to Follow-up|9|||
147127530|NCT00959049|530633619|FG005|Overall Study|Lost to Follow-up|1|||
147127531|NCT00959049|530633614|FG000|Overall Study|Contraindicated medication|0|||
147127532|NCT00959049|530633615|FG001|Overall Study|Contraindicated medication|0|||
147127533|NCT00959049|530633616|FG002|Overall Study|Contraindicated medication|0|||
147127534|NCT00959049|530633617|FG003|Overall Study|Contraindicated medication|1|||
147127535|NCT00959049|530633618|FG004|Overall Study|Contraindicated medication|0|||
147127536|NCT00959049|530633619|FG005|Overall Study|Contraindicated medication|0|||
147127537|NCT00959049|530633614|FG000|Overall Study|Withdrawal by Subject|0|||
147127538|NCT00959049|530633615|FG001|Overall Study|Withdrawal by Subject|2|||
147127539|NCT00959049|530633616|FG002|Overall Study|Withdrawal by Subject|0|||
147127540|NCT00959049|530633617|FG003|Overall Study|Withdrawal by Subject|0|||
147127541|NCT00959049|530633618|FG004|Overall Study|Withdrawal by Subject|0|||
147127542|NCT00959049|530633619|FG005|Overall Study|Withdrawal by Subject|0|||
147127543|NCT01892189|530633627|FG000|Washout Period 1 (7 Days)|Adverse Event|0|||
147127544|NCT01892189|530633628|FG001|Washout Period 1 (7 Days)|Adverse Event|0|||
147127545|NCT01892189|530633629|FG002|Washout Period 1 (7 Days)|Adverse Event|0|||
147127546|NCT01892189|530633630|FG003|Washout Period 1 (7 Days)|Adverse Event|0|||
147127547|NCT01892189|530633631|FG004|Washout Period 1 (7 Days)|Adverse Event|0|||
147127548|NCT01892189|530633632|FG005|Washout Period 1 (7 Days)|Adverse Event|0|||
147127549|NCT01892189|530633633|FG006|Washout Period 1 (7 Days)|Adverse Event|0|||
147127550|NCT01892189|530633634|FG007|Washout Period 1 (7 Days)|Adverse Event|0|||
147127551|NCT01892189|530633635|FG008|Washout Period 1 (7 Days)|Adverse Event|1|||
147127552|NCT01892189|530633627|FG000|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
147127553|NCT01892189|530633628|FG001|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
147127554|NCT01892189|530633629|FG002|Washout Period 1 (7 Days)|Withdrawal by Subject|2|||
147127555|NCT01892189|530633630|FG003|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
147127556|NCT01892189|530633631|FG004|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
147316658|NCT01154036|531325671|FG006|Phase I|Physician Decision|0|||
147316659|NCT01154036|531325672|FG007|Phase I|Physician Decision|0|||
147316660|NCT01154036|531325665|FG000|Phase I|Lost to Follow-up|0|||
147316661|NCT01154036|531325666|FG001|Phase I|Lost to Follow-up|3|||
147127557|NCT01892189|530633632|FG005|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
147127558|NCT01892189|530633633|FG006|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
147127559|NCT01892189|530633634|FG007|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
147127560|NCT01892189|530633635|FG008|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
147127561|NCT01892189|530633627|FG000|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
147127562|NCT01892189|530633628|FG001|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
147127563|NCT01892189|530633629|FG002|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
147127564|NCT01892189|530633630|FG003|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
147127565|NCT01892189|530633631|FG004|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
147127566|NCT01892189|530633632|FG005|Washout Period 1 (7 Days)|Noncompliance, Irritability|1|||
147127567|NCT01892189|530633633|FG006|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
147127568|NCT01892189|530633634|FG007|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
147316662|NCT01154036|531325667|FG002|Phase I|Lost to Follow-up|6|||
147316663|NCT01154036|531325668|FG003|Phase I|Lost to Follow-up|0|||
147316664|NCT01154036|531325669|FG004|Phase I|Lost to Follow-up|0|||
147127569|NCT01892189|530633635|FG008|Washout Period 1 (7 Days)|Noncompliance, Irritability|0|||
147127570|NCT01992757|530633638|FG000|Overall Study|2 patients excluded due to FFP given.|2|||
147127571|NCT03440411|530633639|FG000|Overall Study|Adverse Event|0|||
147127572|NCT03440411|530633640|FG001|Overall Study|Adverse Event|0|||
147127573|NCT03440411|530633641|FG002|Overall Study|Adverse Event|1|||
147127574|NCT03440411|530633642|FG003|Overall Study|Adverse Event|0|||
147127575|NCT03440411|530633639|FG000|Overall Study|PD|2|||
147316665|NCT01154036|531325670|FG005|Phase I|Lost to Follow-up|0|||
147316666|NCT01154036|531325671|FG006|Phase I|Lost to Follow-up|0|||
147316667|NCT01154036|531325672|FG007|Phase I|Lost to Follow-up|0|||
147316668|NCT01154036|531325665|FG000|Phase I|Protocol Violation|0|||
147127576|NCT03440411|530633640|FG001|Overall Study|PD|1|||
147127577|NCT03440411|530633641|FG002|Overall Study|PD|1|||
147127578|NCT03440411|530633642|FG003|Overall Study|PD|1|||
147127579|NCT03440411|530633639|FG000|Overall Study|Withdrawal by Subject|1|||
147127580|NCT03440411|530633640|FG001|Overall Study|Withdrawal by Subject|0|||
147127581|NCT03440411|530633641|FG002|Overall Study|Withdrawal by Subject|0|||
147127582|NCT03440411|530633642|FG003|Overall Study|Withdrawal by Subject|0|||
147127583|NCT03440411|530633639|FG000|Overall Study|Closed study by sponsor|0|||
147127584|NCT03440411|530633640|FG001|Overall Study|Closed study by sponsor|0|||
147127585|NCT03440411|530633641|FG002|Overall Study|Closed study by sponsor|0|||
147127586|NCT03440411|530633642|FG003|Overall Study|Closed study by sponsor|1|||
147235009|NCT02663908|531031696|FG001|Overall Study|Subject discontinued treatment as he was in hospice and could not make it for end-of-trial visit|1|||
147235010|NCT03308786|531031697|FG000|Overall Study|study terminated after discussion with Safety Monitoring Committee|9|||
147235011|NCT02004522|531031698|FG000|Overall Study|Adverse Event|55|||
147316669|NCT01154036|531325666|FG001|Phase I|Protocol Violation|3|||
147316670|NCT01154036|531325667|FG002|Phase I|Protocol Violation|9|||
147316671|NCT01154036|531325668|FG003|Phase I|Protocol Violation|0|||
147316672|NCT01154036|531325669|FG004|Phase I|Protocol Violation|0|||
147316673|NCT01154036|531325670|FG005|Phase I|Protocol Violation|0|||
147316674|NCT01154036|531325671|FG006|Phase I|Protocol Violation|0|||
147316675|NCT01154036|531325672|FG007|Phase I|Protocol Violation|0|||
147316676|NCT01154036|531325665|FG000|Phase I|Withdrawal by Subject|2|||
147316677|NCT01154036|531325666|FG001|Phase I|Withdrawal by Subject|10|||
147316678|NCT01154036|531325667|FG002|Phase I|Withdrawal by Subject|29|||
147316679|NCT01154036|531325668|FG003|Phase I|Withdrawal by Subject|0|||
147316680|NCT01154036|531325669|FG004|Phase I|Withdrawal by Subject|0|||
147316681|NCT01154036|531325670|FG005|Phase I|Withdrawal by Subject|0|||
147316682|NCT01154036|531325671|FG006|Phase I|Withdrawal by Subject|0|||
147316683|NCT01154036|531325672|FG007|Phase I|Withdrawal by Subject|0|||
147316684|NCT01154036|531325665|FG000|Phase I|Adverse Event|1|||
147316685|NCT01154036|531325666|FG001|Phase I|Adverse Event|11|||
147316686|NCT01154036|531325667|FG002|Phase I|Adverse Event|12|||
147316687|NCT01154036|531325668|FG003|Phase I|Adverse Event|0|||
147316688|NCT01154036|531325669|FG004|Phase I|Adverse Event|0|||
147316689|NCT01154036|531325670|FG005|Phase I|Adverse Event|0|||
147316690|NCT01154036|531325671|FG006|Phase I|Adverse Event|0|||
147316691|NCT01154036|531325672|FG007|Phase I|Adverse Event|0|||
147316692|NCT01154036|531325665|FG000|Phase II|Adverse Event|0|||
147316693|NCT01154036|531325666|FG001|Phase II|Adverse Event|0|||
147316694|NCT01154036|531325667|FG002|Phase II|Adverse Event|0|||
147316695|NCT01154036|531325668|FG003|Phase II|Adverse Event|0|||
147316696|NCT01154036|531325669|FG004|Phase II|Adverse Event|1|||
147316697|NCT01154036|531325670|FG005|Phase II|Adverse Event|1|||
147316698|NCT01154036|531325671|FG006|Phase II|Adverse Event|1|||
147316699|NCT01154036|531325672|FG007|Phase II|Adverse Event|1|||
147316700|NCT01154036|531325665|FG000|Phase II|Physician Decision|0|||
147316701|NCT01154036|531325666|FG001|Phase II|Physician Decision|0|||
147316702|NCT01154036|531325667|FG002|Phase II|Physician Decision|0|||
147316703|NCT01154036|531325668|FG003|Phase II|Physician Decision|0|||
147316704|NCT01154036|531325669|FG004|Phase II|Physician Decision|0|||
147316705|NCT01154036|531325670|FG005|Phase II|Physician Decision|0|||
147316706|NCT01154036|531325671|FG006|Phase II|Physician Decision|1|||
147316707|NCT01154036|531325672|FG007|Phase II|Physician Decision|0|||
147316708|NCT01154036|531325665|FG000|Phase II|Lost to Follow-up|0|||
147444658|NCT01147744|531792657|FG000|Overall Study|Sponsor decision to amend protocol|7|||
147127587|NCT00095576|530633643|FG000|Overall Study|Adverse Event|5|||
147127588|NCT00095576|530633644|FG001|Overall Study|Adverse Event|3|||
147235012|NCT02004522|531031699|FG001|Overall Study|Adverse Event|6|||
147235013|NCT02004522|531031698|FG000|Overall Study|Withdrawal by Subject|13|||
147235014|NCT02004522|531031699|FG001|Overall Study|Withdrawal by Subject|7|||
147235015|NCT02004522|531031698|FG000|Overall Study|Death|12|||
147235016|NCT02004522|531031699|FG001|Overall Study|Death|3|||
147235017|NCT02004522|531031698|FG000|Overall Study|Physician Decision|3|||
147235018|NCT02004522|531031699|FG001|Overall Study|Physician Decision|4|||
147235019|NCT02004522|531031698|FG000|Overall Study|Protocol Violation|1|||
147316709|NCT01154036|531325666|FG001|Phase II|Lost to Follow-up|0|||
147316710|NCT01154036|531325667|FG002|Phase II|Lost to Follow-up|0|||
147316711|NCT01154036|531325668|FG003|Phase II|Lost to Follow-up|1|||
147316712|NCT01154036|531325669|FG004|Phase II|Lost to Follow-up|2|||
147316713|NCT01154036|531325670|FG005|Phase II|Lost to Follow-up|0|||
147316714|NCT01154036|531325671|FG006|Phase II|Lost to Follow-up|2|||
147316715|NCT01154036|531325672|FG007|Phase II|Lost to Follow-up|1|||
147316716|NCT01154036|531325665|FG000|Phase II|Protocol Violation|0|||
147316717|NCT01154036|531325666|FG001|Phase II|Protocol Violation|0|||
147316718|NCT01154036|531325667|FG002|Phase II|Protocol Violation|0|||
147316719|NCT01154036|531325668|FG003|Phase II|Protocol Violation|0|||
147316720|NCT01154036|531325669|FG004|Phase II|Protocol Violation|1|||
147316721|NCT01154036|531325670|FG005|Phase II|Protocol Violation|2|||
147127589|NCT00095576|530633643|FG000|Overall Study|Lost to Follow-up|233|||
147127590|NCT00095576|530633644|FG001|Overall Study|Lost to Follow-up|229|||
147127591|NCT00095576|530633643|FG000|Overall Study|Protocol Violation|1|||
147127592|NCT00095576|530633644|FG001|Overall Study|Protocol Violation|0|||
147127593|NCT00095576|530633643|FG000|Overall Study|Withdrawal by Subject|34|||
147127594|NCT00095576|530633644|FG001|Overall Study|Withdrawal by Subject|47|||
147127595|NCT00095576|530633643|FG000|Overall Study|Option to switch to a rollover study|1097|||
147127596|NCT00095576|530633644|FG001|Overall Study|Option to switch to a rollover study|1099|||
147127597|NCT00095576|530633643|FG000|Overall Study|Site terminated|75|||
147127598|NCT00095576|530633644|FG001|Overall Study|Site terminated|67|||
147127599|NCT00095576|530633643|FG000|Overall Study|Subject moved|30|||
147127600|NCT00095576|530633644|FG001|Overall Study|Subject moved|36|||
147127601|NCT01344356|530633645|FG000|Overall Study|Physician Decision|0|||
147127602|NCT01344356|530633646|FG001|Overall Study|Physician Decision|3|||
147127603|NCT01344356|530633645|FG000|Overall Study|Lost to Follow-up|0|||
147127604|NCT01344356|530633646|FG001|Overall Study|Lost to Follow-up|6|||
147127605|NCT02301897|530633647|FG000|Treatment Course 1|Non-Compliance|0|||
147127606|NCT02301897|530633648|FG001|Treatment Course 1|Non-Compliance|0|||
147127607|NCT02301897|530633649|FG002|Treatment Course 1|Non-Compliance|1|||
147127608|NCT02301897|530633647|FG000|Treatment Course 1|Adverse Event|1|||
147127609|NCT02301897|530633648|FG001|Treatment Course 1|Adverse Event|1|||
147127610|NCT02301897|530633649|FG002|Treatment Course 1|Adverse Event|0|||
147127611|NCT02301897|530633647|FG000|Treatment Course 1|Lost to Follow-up|1|||
147127612|NCT02301897|530633648|FG001|Treatment Course 1|Lost to Follow-up|2|||
147127613|NCT02301897|530633649|FG002|Treatment Course 1|Lost to Follow-up|1|||
147127614|NCT02301897|530633647|FG000|Treatment Course 1|Withdrawal by Sponsor|0|||
147127615|NCT02301897|530633648|FG001|Treatment Course 1|Withdrawal by Sponsor|0|||
147127616|NCT02301897|530633649|FG002|Treatment Course 1|Withdrawal by Sponsor|2|||
147127617|NCT02301897|530633647|FG000|Treatment Course 1|Withdrawal by Subject|0|||
147127618|NCT02301897|530633648|FG001|Treatment Course 1|Withdrawal by Subject|0|||
147127619|NCT02301897|530633649|FG002|Treatment Course 1|Withdrawal by Subject|2|||
147127620|NCT02301897|530633647|FG000|Treatment Course 1|Other Miscellaneous Reasons|1|||
147127621|NCT02301897|530633648|FG001|Treatment Course 1|Other Miscellaneous Reasons|0|||
147127622|NCT02301897|530633649|FG002|Treatment Course 1|Other Miscellaneous Reasons|0|||
147127623|NCT02301897|530633647|FG000|Treatment Course 2|Lost to Follow-up|0|||
147127624|NCT02301897|530633648|FG001|Treatment Course 2|Lost to Follow-up|2|||
147127625|NCT02301897|530633649|FG002|Treatment Course 2|Lost to Follow-up|0|||
147127626|NCT02301897|530633647|FG000|Treatment Course 2|Pregnancy|0|||
147127627|NCT02301897|530633648|FG001|Treatment Course 2|Pregnancy|1|||
147127628|NCT02301897|530633649|FG002|Treatment Course 2|Pregnancy|1|||
147127629|NCT02301897|530633647|FG000|Treatment Course 2|Withdrawal by Subject|0|||
147127630|NCT02301897|530633648|FG001|Treatment Course 2|Withdrawal by Subject|2|||
147127631|NCT02301897|530633649|FG002|Treatment Course 2|Withdrawal by Subject|0|||
147127632|NCT02301897|530633647|FG000|Treatment Course 2|Other Miscellaneous Reasons|1|||
147127633|NCT02301897|530633648|FG001|Treatment Course 2|Other Miscellaneous Reasons|0|||
147127634|NCT02301897|530633649|FG002|Treatment Course 2|Other Miscellaneous Reasons|0|||
147127635|NCT01217892|530633653|FG000|Overall Study|Adverse Event|1|||
147127636|NCT01217892|530633654|FG001|Overall Study|Adverse Event|1|||
147127637|NCT01217892|530633655|FG002|Overall Study|Adverse Event|1|||
147127638|NCT01217892|530633656|FG003|Overall Study|Adverse Event|0|||
147235020|NCT02004522|531031699|FG001|Overall Study|Protocol Violation|0|||
147235021|NCT02004522|531031698|FG000|Overall Study|Other is reason listed by PI|4|||
147235022|NCT02004522|531031699|FG001|Overall Study|Other is reason listed by PI|1|||
147235023|NCT02004522|531031698|FG000|Overall Study|Never Dosed|2|||
147235024|NCT02004522|531031699|FG001|Overall Study|Never Dosed|4|||
147235025|NCT02004522|531031698|FG000|Overall Study|Disease Progression|35|||
147235026|NCT02004522|531031699|FG001|Overall Study|Disease Progression|31|||
147235027|NCT02004522|531031698|FG000|Overall Study|Completed Treatment Cycles Per Protocol|1|||
147235028|NCT02004522|531031699|FG001|Overall Study|Completed Treatment Cycles Per Protocol|103|||
147235029|NCT01787331|531031700|FG000|Overall Study|Physician Decision|1|||
147235030|NCT01787331|531031700|FG000|Overall Study|Withdrawal by Subject|1|||
147235031|NCT01999868|531031702|FG000|Lead-in Phase (Week 0 - 12)|Lost to Follow-up|0|||
147235032|NCT01999868|531031703|FG001|Lead-in Phase (Week 0 - 12)|Lost to Follow-up|0|||
147235033|NCT01999868|531031704|FG002|Lead-in Phase (Week 0 - 12)|Lost to Follow-up|5|||
147235034|NCT01999868|531031702|FG000|Blinded Treatment Phase (Week 12 - 40)|Adverse Event|1|||
147316722|NCT01154036|531325671|FG006|Phase II|Protocol Violation|0|||
147127639|NCT01217892|530633653|FG000|Overall Study|Withdrawal by Subject|0|||
147316723|NCT01154036|531325672|FG007|Phase II|Protocol Violation|0|||
147127640|NCT01217892|530633654|FG001|Overall Study|Withdrawal by Subject|2|||
147127641|NCT01217892|530633655|FG002|Overall Study|Withdrawal by Subject|1|||
147127642|NCT01217892|530633656|FG003|Overall Study|Withdrawal by Subject|0|||
147127643|NCT01217892|530633653|FG000|Overall Study|Lab value|1|||
147127644|NCT01217892|530633654|FG001|Overall Study|Lab value|0|||
147235035|NCT01999868|531031703|FG001|Blinded Treatment Phase (Week 12 - 40)|Adverse Event|1|||
147127645|NCT01217892|530633655|FG002|Overall Study|Lab value|1|||
147127646|NCT01217892|530633656|FG003|Overall Study|Lab value|0|||
147127647|NCT01217892|530633653|FG000|Overall Study|Subject no longer meets study criteria|5|||
147127648|NCT01217892|530633654|FG001|Overall Study|Subject no longer meets study criteria|2|||
147127649|NCT01217892|530633655|FG002|Overall Study|Subject no longer meets study criteria|4|||
147127650|NCT01217892|530633656|FG003|Overall Study|Subject no longer meets study criteria|8|||
147127651|NCT01217892|530633653|FG000|Overall Study|Incorrect enrollment|0|||
147127652|NCT01217892|530633654|FG001|Overall Study|Incorrect enrollment|1|||
147127653|NCT01217892|530633655|FG002|Overall Study|Incorrect enrollment|1|||
147127654|NCT01217892|530633656|FG003|Overall Study|Incorrect enrollment|0|||
147127655|NCT01217892|530633653|FG000|Overall Study|Poor/Non-Compliance|0|||
147127656|NCT01217892|530633654|FG001|Overall Study|Poor/Non-Compliance|0|||
147127657|NCT01217892|530633655|FG002|Overall Study|Poor/Non-Compliance|1|||
147127658|NCT01217892|530633656|FG003|Overall Study|Poor/Non-Compliance|0|||
147127659|NCT00605189|530633657|FG000|Overall Study|Adverse Event|1|||
147127660|NCT00605189|530633658|FG001|Overall Study|Adverse Event|0|||
147127661|NCT00605189|530633659|FG002|Overall Study|Adverse Event|0|||
147127662|NCT00605189|530633657|FG000|Overall Study|Other|2|||
147127663|NCT00605189|530633658|FG001|Overall Study|Other|2|||
147127664|NCT00605189|530633659|FG002|Overall Study|Other|0|||
147127665|NCT02697448|530633660|FG000|Overall Study|Protocol Violation|2|||
147127666|NCT02697448|530633661|FG001|Overall Study|Protocol Violation|4|||
147127667|NCT02697448|530633660|FG000|Overall Study|Clinical concerns during ablation|1|||
147127668|NCT02697448|530633661|FG001|Overall Study|Clinical concerns during ablation|1|||
147127669|NCT02697448|530633660|FG000|Overall Study|No data collected|2|||
147127670|NCT02697448|530633661|FG001|Overall Study|No data collected|0|||
147127671|NCT04620668|530633662|FG000|Overall Study|Withdrawal by Subject|2|||
147127672|NCT04620668|530633663|FG001|Overall Study|Withdrawal by Subject|0|||
147127673|NCT04620668|530633662|FG000|Overall Study|Ineligible despite claims at outset of the study|1|||
147127674|NCT04620668|530633663|FG001|Overall Study|Ineligible despite claims at outset of the study|0|||
147127675|NCT04620668|530633662|FG000|Overall Study|Removed before analysis: missing data|2|||
147127676|NCT04620668|530633663|FG001|Overall Study|Removed before analysis: missing data|0|||
147127677|NCT04620668|530633662|FG000|Overall Study|Removed before analysis: failed multiple quality check questions|1|||
147127678|NCT04620668|530633663|FG001|Overall Study|Removed before analysis: failed multiple quality check questions|2|||
147127679|NCT04620668|530633662|FG000|Overall Study|Removed before analysis: statistical outlier|1|||
147127680|NCT04620668|530633663|FG001|Overall Study|Removed before analysis: statistical outlier|2|||
147127681|NCT03685149|530633664|FG000|First Intervention (4 Weeks)|Adverse Event|0|||
147127682|NCT03685149|530633665|FG001|First Intervention (4 Weeks)|Adverse Event|2|||
147127683|NCT03685149|530633664|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
147127684|NCT03685149|530633665|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|0|||
147127685|NCT03685149|530633664|FG000|Second Intervention (4 Weeks)|Adverse Event|1|||
147127686|NCT03685149|530633665|FG001|Second Intervention (4 Weeks)|Adverse Event|0|||
147127687|NCT01922895|530633667|FG000|Overall Study|Death|0|||
147127688|NCT01922895|530633668|FG001|Overall Study|Death|1|||
147127689|NCT01922895|530633667|FG000|Overall Study|Withdrawal by Subject|1|||
147127690|NCT01922895|530633668|FG001|Overall Study|Withdrawal by Subject|2|||
147127691|NCT01922895|530633667|FG000|Overall Study|Lost to Follow-up|5|||
147127692|NCT01922895|530633668|FG001|Overall Study|Lost to Follow-up|11|||
147127693|NCT05360784|530633672|FG000|Overall Study|Discontinued|25|||
147127694|NCT05360784|530633673|FG001|Overall Study|Discontinued|11|||
147127695|NCT02796651|530633674|FG000|Overall Study|Adverse Event|6|||
147127696|NCT02796651|530633674|FG000|Overall Study|Lost to Follow-up|1|||
147127697|NCT02796651|530633674|FG000|Overall Study|Withdrawal by Subject|4|||
147127698|NCT02796651|530633674|FG000|Overall Study|Protocol Violation|4|||
147127699|NCT02796651|530633674|FG000|Overall Study|Lack of Efficacy|1|||
147127700|NCT02796651|530633674|FG000|Overall Study|Other|10|||
147127701|NCT05142306|530633678|FG000|Overall Study|Withdrawal by Subject|0|||
147127702|NCT05142306|530633679|FG001|Overall Study|Withdrawal by Subject|0|||
147127703|NCT05142306|530633680|FG002|Overall Study|Withdrawal by Subject|1|||
147127704|NCT02251041|530633681|FG000|Overall Study|Did not receive intervention|15|||
147127705|NCT02251041|530633682|FG001|Overall Study|Did not receive intervention|4|||
147127706|NCT04079920|530633683|FG000|Overall Study|Adverse event, not related to study drug|2|||
147127707|NCT04079920|530633683|FG000|Overall Study|Adverse event related to study drug|10|||
147127708|NCT04079920|530633683|FG000|Overall Study|Death|2|||
147127709|NCT04079920|530633683|FG000|Overall Study|Lost to Follow-up|22|||
147127710|NCT04079920|530633683|FG000|Overall Study|Physician Decision|1|||
147127711|NCT04079920|530633683|FG000|Overall Study|Withdrawal by Subject|11|||
147127712|NCT04918771|530633684|FG000|Overall Study|Withdrawal by Subject|4|||
147127713|NCT04918771|530633685|FG001|Overall Study|Withdrawal by Subject|5|||
147235036|NCT01999868|531031704|FG002|Blinded Treatment Phase (Week 12 - 40)|Adverse Event|0|||
147235037|NCT01999868|531031702|FG000|Blinded Treatment Phase (Week 12 - 40)|Lost to Follow-up|3|||
147235038|NCT01999868|531031703|FG001|Blinded Treatment Phase (Week 12 - 40)|Lost to Follow-up|4|||
147235039|NCT01999868|531031704|FG002|Blinded Treatment Phase (Week 12 - 40)|Lost to Follow-up|0|||
147235040|NCT01999868|531031702|FG000|Blinded Treatment Phase (Week 12 - 40)|Pregnancy|0|||
147235041|NCT01999868|531031703|FG001|Blinded Treatment Phase (Week 12 - 40)|Pregnancy|1|||
147235042|NCT01999868|531031704|FG002|Blinded Treatment Phase (Week 12 - 40)|Pregnancy|0|||
147316724|NCT01154036|531325665|FG000|Phase II|Withdrawal by Subject|0|||
147127714|NCT04918771|530633684|FG000|Overall Study|Incorrect inclusion ineligible patient|3|||
147316725|NCT01154036|531325666|FG001|Phase II|Withdrawal by Subject|0|||
147316726|NCT01154036|531325667|FG002|Phase II|Withdrawal by Subject|0|||
147316727|NCT01154036|531325668|FG003|Phase II|Withdrawal by Subject|0|||
147316728|NCT01154036|531325669|FG004|Phase II|Withdrawal by Subject|4|||
147316729|NCT01154036|531325670|FG005|Phase II|Withdrawal by Subject|2|||
147316730|NCT01154036|531325671|FG006|Phase II|Withdrawal by Subject|5|||
147316731|NCT01154036|531325672|FG007|Phase II|Withdrawal by Subject|4|||
147316732|NCT02086552|531325673|FG000|Overall Study|Withdrawal by Subject|1|||
147316733|NCT04102540|531325681|FG000|Overall Study|Withdrawn by PI|2|||
147316734|NCT04102540|531325681|FG000|Overall Study|Lost to Follow-up|6|||
147316735|NCT01567163|531325684|FG000|Overall Study|Progressive Disease|2|||
147316736|NCT01567163|531325684|FG000|Overall Study|Lost to Follow-up|2|||
147316737|NCT03405662|531325685|FG000|Overall Study|COVID-19 restriction|1|||
147316738|NCT03405662|531325686|FG001|Overall Study|COVID-19 restriction|0|||
147316739|NCT03405662|531325685|FG000|Overall Study|unblinding|0|||
147316740|NCT03405662|531325686|FG001|Overall Study|unblinding|1|||
147316741|NCT03405662|531325685|FG000|Overall Study|placement in memory care facility|0|||
147316742|NCT03405662|531325686|FG001|Overall Study|placement in memory care facility|2|||
147316743|NCT00280293|531325687|FG000|Overall Study|Protocol Violation|3|||
147316744|NCT00280293|531325688|FG001|Overall Study|Protocol Violation|0|||
147316745|NCT00280293|531325687|FG000|Overall Study|Physician Decision|5|||
147316746|NCT00280293|531325688|FG001|Overall Study|Physician Decision|4|||
147316747|NCT00280293|531325687|FG000|Overall Study|Lost to Follow-up|14|||
147316748|NCT00280293|531325688|FG001|Overall Study|Lost to Follow-up|12|||
147316749|NCT00280293|531325687|FG000|Overall Study|Withdrawal by Subject|3|||
147316750|NCT00280293|531325688|FG001|Overall Study|Withdrawal by Subject|5|||
147316751|NCT00280293|531325687|FG000|Overall Study|Incarceration/Legal Reasons|1|||
147316752|NCT00280293|531325688|FG001|Overall Study|Incarceration/Legal Reasons|1|||
147316753|NCT00280293|531325687|FG000|Overall Study|Adverse Event|0|||
147316754|NCT00280293|531325688|FG001|Overall Study|Adverse Event|1|||
147316755|NCT01348854|531325691|FG000|Overall Study|Lost to Follow-up|2|||
147316756|NCT01348854|531325692|FG001|Overall Study|Lost to Follow-up|1|||
147316757|NCT01348854|531325691|FG000|Overall Study|Withdrawal by Subject|1|||
147316758|NCT01348854|531325692|FG001|Overall Study|Withdrawal by Subject|0|||
147316759|NCT01720797|531325693|FG000|Overall Study|Withdrawal by Subject|3|||
147316760|NCT01720797|531325694|FG001|Overall Study|Withdrawal by Subject|0|||
147316761|NCT00983619|531325697|FG000|Overall Study|Lost to Follow-up|0|||
147316762|NCT00983619|531325698|FG001|Overall Study|Lost to Follow-up|1|||
147316763|NCT00983619|531325699|FG002|Overall Study|Lost to Follow-up|0|||
147316764|NCT00983619|531325700|FG003|Overall Study|Lost to Follow-up|0|||
147316765|NCT00983619|531325701|FG004|Overall Study|Lost to Follow-up|0|||
147316766|NCT00983619|531325702|FG005|Overall Study|Lost to Follow-up|2|||
147316767|NCT00983619|531325703|FG006|Overall Study|Lost to Follow-up|0|||
147316768|NCT00983619|531325704|FG007|Overall Study|Lost to Follow-up|0|||
147316769|NCT00983619|531325705|FG008|Overall Study|Lost to Follow-up|0|||
147316770|NCT00983619|531325706|FG009|Overall Study|Lost to Follow-up|0|||
147316771|NCT00983619|531325707|FG010|Overall Study|Lost to Follow-up|0|||
147316772|NCT00983619|531325708|FG011|Overall Study|Lost to Follow-up|2|||
147316773|NCT00983619|531325697|FG000|Overall Study|Withdrawal by Subject|2|||
147316774|NCT00983619|531325698|FG001|Overall Study|Withdrawal by Subject|1|||
147316775|NCT00983619|531325699|FG002|Overall Study|Withdrawal by Subject|1|||
147316776|NCT00983619|531325700|FG003|Overall Study|Withdrawal by Subject|3|||
147316777|NCT00983619|531325701|FG004|Overall Study|Withdrawal by Subject|1|||
147316778|NCT00983619|531325702|FG005|Overall Study|Withdrawal by Subject|23|||
147316779|NCT00983619|531325703|FG006|Overall Study|Withdrawal by Subject|0|||
147316780|NCT00983619|531325704|FG007|Overall Study|Withdrawal by Subject|0|||
147316781|NCT00983619|531325705|FG008|Overall Study|Withdrawal by Subject|0|||
147316782|NCT00983619|531325706|FG009|Overall Study|Withdrawal by Subject|0|||
147316783|NCT00983619|531325707|FG010|Overall Study|Withdrawal by Subject|1|||
147316784|NCT00983619|531325708|FG011|Overall Study|Withdrawal by Subject|1|||
147316785|NCT00983619|531325697|FG000|Overall Study|Death|0|||
147316786|NCT00983619|531325698|FG001|Overall Study|Death|2|||
147316787|NCT00983619|531325699|FG002|Overall Study|Death|2|||
147316788|NCT00983619|531325700|FG003|Overall Study|Death|1|||
147316789|NCT00983619|531325701|FG004|Overall Study|Death|2|||
147316790|NCT00983619|531325702|FG005|Overall Study|Death|30|||
147316791|NCT00983619|531325703|FG006|Overall Study|Death|1|||
147316792|NCT00983619|531325704|FG007|Overall Study|Death|0|||
147316793|NCT00983619|531325705|FG008|Overall Study|Death|1|||
147316794|NCT00983619|531325706|FG009|Overall Study|Death|2|||
147316795|NCT00983619|531325707|FG010|Overall Study|Death|9|||
147316796|NCT00983619|531325708|FG011|Overall Study|Death|8|||
147316797|NCT00983619|531325697|FG000|Overall Study|Other|1|||
147316798|NCT00983619|531325698|FG001|Overall Study|Other|0|||
147316799|NCT00983619|531325699|FG002|Overall Study|Other|0|||
147316800|NCT00983619|531325700|FG003|Overall Study|Other|1|||
147316801|NCT00983619|531325701|FG004|Overall Study|Other|0|||
147316802|NCT00983619|531325702|FG005|Overall Study|Other|12|||
147316803|NCT00983619|531325703|FG006|Overall Study|Other|2|||
147316804|NCT00983619|531325704|FG007|Overall Study|Other|2|||
147316805|NCT00983619|531325705|FG008|Overall Study|Other|0|||
147316806|NCT00983619|531325706|FG009|Overall Study|Other|1|||
147127715|NCT04918771|530633685|FG001|Overall Study|Incorrect inclusion ineligible patient|4|||
147127716|NCT05014919|530633688|FG000|Open-Label (12 Weeks)|Adverse Event|1|||
147127717|NCT05014919|530633689|FG001|Open-Label (12 Weeks)|Adverse Event|0|||
147127718|NCT05014919|530633690|FG002|Open-Label (12 Weeks)|Adverse Event|0|||
147127719|NCT05014919|530633688|FG000|Open-Label (12 Weeks)|Lack of Efficacy|1|||
147127720|NCT05014919|530633689|FG001|Open-Label (12 Weeks)|Lack of Efficacy|0|||
147235043|NCT01999868|531031702|FG000|Blinded Treatment Phase (Week 12 - 40)|Withdrawal by Subject|0|||
147235044|NCT01999868|531031703|FG001|Blinded Treatment Phase (Week 12 - 40)|Withdrawal by Subject|2|||
147235045|NCT01999868|531031704|FG002|Blinded Treatment Phase (Week 12 - 40)|Withdrawal by Subject|0|||
147235046|NCT01999868|531031702|FG000|Blinded Treatment Phase (Week 12 - 40)|Met study drug Discontinuation Criteria|1|||
147235047|NCT01999868|531031703|FG001|Blinded Treatment Phase (Week 12 - 40)|Met study drug Discontinuation Criteria|2|||
147235048|NCT01999868|531031704|FG002|Blinded Treatment Phase (Week 12 - 40)|Met study drug Discontinuation Criteria|0|||
147235049|NCT01999868|531031702|FG000|Blinded Treatment Phase (Week 12 - 40)|Met psoriasis relapse criterion|8|||
147235050|NCT01999868|531031703|FG001|Blinded Treatment Phase (Week 12 - 40)|Met psoriasis relapse criterion|1|||
147235051|NCT01999868|531031704|FG002|Blinded Treatment Phase (Week 12 - 40)|Met psoriasis relapse criterion|0|||
147316807|NCT00983619|531325707|FG010|Overall Study|Other|1|||
147127721|NCT05014919|530633690|FG002|Open-Label (12 Weeks)|Lack of Efficacy|0|||
147127722|NCT05014919|530633688|FG000|Open-Label (12 Weeks)|Withdrawal by Subject|2|||
147127723|NCT05014919|530633689|FG001|Open-Label (12 Weeks)|Withdrawal by Subject|0|||
147127724|NCT05014919|530633690|FG002|Open-Label (12 Weeks)|Withdrawal by Subject|0|||
147127725|NCT05014919|530633688|FG000|Open-Label (12 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|15|||
147127726|NCT05014919|530633689|FG001|Open-Label (12 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|0|||
147127727|NCT05014919|530633690|FG002|Open-Label (12 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|0|||
147127728|NCT05014919|530633688|FG000|Open-Label (12 Weeks)|Sponsor Decision|4|||
147127729|NCT05014919|530633689|FG001|Open-Label (12 Weeks)|Sponsor Decision|0|||
147127730|NCT05014919|530633690|FG002|Open-Label (12 Weeks)|Sponsor Decision|0|||
147127731|NCT05014919|530633688|FG000|Open-Label (12 Weeks)|Study Terminated by Sponsor|5|||
147127732|NCT05014919|530633689|FG001|Open-Label (12 Weeks)|Study Terminated by Sponsor|0|||
147127733|NCT05014919|530633690|FG002|Open-Label (12 Weeks)|Study Terminated by Sponsor|0|||
147316808|NCT00983619|531325708|FG011|Overall Study|Other|0|||
147316809|NCT00724061|531325709|FG000|Dose Escalation Phase|Adverse Event|2|||
147316810|NCT00724061|531325709|FG000|Dose Escalation Phase|Disease Progression|3|||
147316811|NCT00088205|531325712|FG000|Overall Study|Adverse Event|4|||
147316812|NCT00088205|531325712|FG000|Overall Study|Progressive Disease|51|||
147316813|NCT00088205|531325712|FG000|Overall Study|Physician Decision|1|||
147316814|NCT00088205|531325712|FG000|Overall Study|Death Due to Study Disease|4|||
147316815|NCT04827134|531325713|FG000|Treatment Period 1 (1 Day)|Withdrawal by Subject|0|||
147316816|NCT04827134|531325714|FG001|Treatment Period 1 (1 Day)|Withdrawal by Subject|0|||
147316817|NCT04827134|531325715|FG002|Treatment Period 1 (1 Day)|Withdrawal by Subject|1|||
147316818|NCT04827134|531325716|FG003|Treatment Period 1 (1 Day)|Withdrawal by Subject|0|||
147316819|NCT02443103|531325721|FG000|Overall Study|Adverse Event|2|||
147316820|NCT02443103|531325721|FG000|Overall Study|Noncompliance|1|||
147316821|NCT03358329|531325726|FG000|Overall Study|Lost to Follow-up|2|||
147316822|NCT03358329|531325726|FG000|Overall Study|Withdrawal by Subject|2|||
147316823|NCT02982720|531325727|FG000|Overall Study|Adverse Event|3|||
147316824|NCT02982720|531325727|FG000|Overall Study|Death|1|||
147316825|NCT03875911|531325730|FG000|Overall Study|Lost to Follow-up|3|||
147316826|NCT03875911|531325731|FG001|Overall Study|Lost to Follow-up|6|||
147316827|NCT03875911|531325732|FG002|Overall Study|Lost to Follow-up|2|||
147316828|NCT03875911|531325730|FG000|Overall Study|Surgery cancelled|1|||
147316829|NCT03875911|531325731|FG001|Overall Study|Surgery cancelled|0|||
147316830|NCT03875911|531325732|FG002|Overall Study|Surgery cancelled|1|||
147316831|NCT03875911|531325730|FG000|Overall Study|Insurance changed, standard of care visit not covered|0|||
147316832|NCT03875911|531325731|FG001|Overall Study|Insurance changed, standard of care visit not covered|0|||
147316833|NCT03875911|531325732|FG002|Overall Study|Insurance changed, standard of care visit not covered|1|||
147316834|NCT03824938|531325737|FG000|Overall Study|Withdrawal by Subject|2|||
147316835|NCT03824938|531325738|FG001|Overall Study|Withdrawal by Subject|1|||
147316836|NCT03824938|531325739|FG002|Overall Study|Withdrawal by Subject|0|||
147316837|NCT03824938|531325740|FG003|Overall Study|Withdrawal by Subject|2|||
147444659|NCT01147744|531792658|FG001|Overall Study|Sponsor decision to amend protocol|4|||
147127734|NCT05014919|530633688|FG000|Double-Blind (26 Weeks)|Study Terminated by Sponsor|0|||
147127735|NCT05014919|530633689|FG001|Double-Blind (26 Weeks)|Study Terminated by Sponsor|0|||
147316838|NCT03824938|531325741|FG004|Overall Study|Withdrawal by Subject|0|||
147316839|NCT03824938|531325742|FG005|Overall Study|Withdrawal by Subject|1|||
147316840|NCT03824938|531325737|FG000|Overall Study|Lost to Follow-up|0|||
147316841|NCT03824938|531325738|FG001|Overall Study|Lost to Follow-up|1|||
147316842|NCT03824938|531325739|FG002|Overall Study|Lost to Follow-up|0|||
147316843|NCT03824938|531325740|FG003|Overall Study|Lost to Follow-up|0|||
147316844|NCT03824938|531325741|FG004|Overall Study|Lost to Follow-up|1|||
147127736|NCT05014919|530633690|FG002|Double-Blind (26 Weeks)|Study Terminated by Sponsor|1|||
147127737|NCT05014919|530633688|FG000|Double-Blind (26 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|0|||
147127738|NCT05014919|530633689|FG001|Double-Blind (26 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|1|||
147127739|NCT05014919|530633690|FG002|Double-Blind (26 Weeks)|Based on Sponsor Information of Results From Vortioxetine Study|1|||
147127740|NCT02971163|530633691|FG000|Overall Study|Lost to Follow-up|4|||
147127741|NCT02971163|530633692|FG001|Overall Study|Lost to Follow-up|2|||
147127742|NCT02940223|530633701|FG000|Overall Study|Failed Requirement|2|||
147127743|NCT02940223|530633702|FG001|Overall Study|Failed Requirement|0|||
147127744|NCT05305651|530633703|FG000|Overall Study|Death|1|||
147127745|NCT05305651|530633703|FG000|Overall Study|Withdrawal by Subject|4|||
147127746|NCT05305651|530633703|FG000|Overall Study|Lost to Follow-up|4|||
147127747|NCT00526799|530633704|FG000|Overall Study|Withdrawal by Subject|1|||
147127748|NCT00526799|530633705|FG001|Overall Study|Withdrawal by Subject|0|||
147127749|NCT00526799|530633704|FG000|Overall Study|Intercurrent Complicating Disease|0|||
147127750|NCT00526799|530633705|FG001|Overall Study|Intercurrent Complicating Disease|1|||
147127751|NCT00522379|530633708|FG000|Overall Study|Adverse Event|12|||
147127752|NCT00522379|530633709|FG001|Overall Study|Adverse Event|15|||
147127753|NCT00522379|530633710|FG002|Overall Study|Adverse Event|12|||
147127754|NCT00522379|530633711|FG003|Overall Study|Adverse Event|5|||
147127755|NCT00522379|530633712|FG004|Overall Study|Adverse Event|17|||
147127756|NCT00522379|530633708|FG000|Overall Study|Lack of Efficacy|3|||
147127757|NCT00522379|530633709|FG001|Overall Study|Lack of Efficacy|0|||
147127758|NCT00522379|530633710|FG002|Overall Study|Lack of Efficacy|2|||
147127759|NCT00522379|530633711|FG003|Overall Study|Lack of Efficacy|2|||
147127760|NCT00522379|530633712|FG004|Overall Study|Lack of Efficacy|7|||
147127761|NCT00522379|530633708|FG000|Overall Study|Withdrawal by Subject|2|||
147127762|NCT00522379|530633709|FG001|Overall Study|Withdrawal by Subject|3|||
147127763|NCT00522379|530633710|FG002|Overall Study|Withdrawal by Subject|1|||
147127764|NCT00522379|530633711|FG003|Overall Study|Withdrawal by Subject|2|||
147127765|NCT00522379|530633712|FG004|Overall Study|Withdrawal by Subject|0|||
147127766|NCT00522379|530633708|FG000|Overall Study|Protocol Violation|1|||
147127767|NCT00522379|530633709|FG001|Overall Study|Protocol Violation|1|||
147127768|NCT00522379|530633710|FG002|Overall Study|Protocol Violation|2|||
147127769|NCT00522379|530633711|FG003|Overall Study|Protocol Violation|0|||
147127770|NCT00522379|530633712|FG004|Overall Study|Protocol Violation|0|||
147127771|NCT00522379|530633708|FG000|Overall Study|Unsatisfactory Subject Compliance|1|||
147127772|NCT00522379|530633709|FG001|Overall Study|Unsatisfactory Subject Compliance|2|||
147127773|NCT00522379|530633710|FG002|Overall Study|Unsatisfactory Subject Compliance|0|||
147127774|NCT00522379|530633711|FG003|Overall Study|Unsatisfactory Subject Compliance|0|||
147127775|NCT00522379|530633712|FG004|Overall Study|Unsatisfactory Subject Compliance|0|||
147127776|NCT00522379|530633708|FG000|Overall Study|Lost to Follow-up|1|||
147127777|NCT00522379|530633709|FG001|Overall Study|Lost to Follow-up|0|||
147127778|NCT00522379|530633710|FG002|Overall Study|Lost to Follow-up|4|||
147127779|NCT00522379|530633711|FG003|Overall Study|Lost to Follow-up|2|||
147127780|NCT00522379|530633712|FG004|Overall Study|Lost to Follow-up|2|||
147127781|NCT00522379|530633708|FG000|Overall Study|Randomization error|0|||
147127782|NCT00522379|530633709|FG001|Overall Study|Randomization error|0|||
147127783|NCT00522379|530633710|FG002|Overall Study|Randomization error|0|||
147127784|NCT00522379|530633711|FG003|Overall Study|Randomization error|0|||
147127785|NCT00522379|530633712|FG004|Overall Study|Randomization error|1|||
147127786|NCT00522379|530633708|FG000|Overall Study|Dispensing error|1|||
147127787|NCT00522379|530633709|FG001|Overall Study|Dispensing error|0|||
147127788|NCT00522379|530633710|FG002|Overall Study|Dispensing error|0|||
147127789|NCT00522379|530633711|FG003|Overall Study|Dispensing error|1|||
147127790|NCT00522379|530633712|FG004|Overall Study|Dispensing error|0|||
147127791|NCT00522379|530633708|FG000|Overall Study|Subject Moved|1|||
147127792|NCT00522379|530633709|FG001|Overall Study|Subject Moved|1|||
147127793|NCT00522379|530633710|FG002|Overall Study|Subject Moved|0|||
147127794|NCT00522379|530633711|FG003|Overall Study|Subject Moved|0|||
147127795|NCT00522379|530633712|FG004|Overall Study|Subject Moved|0|||
147127796|NCT00522379|530633708|FG000|Overall Study|Sponsor Request|0|||
147127797|NCT00522379|530633709|FG001|Overall Study|Sponsor Request|1|||
147127798|NCT00522379|530633710|FG002|Overall Study|Sponsor Request|0|||
147127799|NCT00522379|530633711|FG003|Overall Study|Sponsor Request|0|||
147127800|NCT00522379|530633712|FG004|Overall Study|Sponsor Request|0|||
147127801|NCT00522379|530633708|FG000|Overall Study|Family Problem|0|||
147127802|NCT00522379|530633709|FG001|Overall Study|Family Problem|0|||
147127803|NCT00522379|530633710|FG002|Overall Study|Family Problem|1|||
147127804|NCT00522379|530633711|FG003|Overall Study|Family Problem|0|||
147127805|NCT00522379|530633712|FG004|Overall Study|Family Problem|0|||
147127806|NCT00522379|530633708|FG000|Overall Study|Site Closed|0|||
147127807|NCT00522379|530633709|FG001|Overall Study|Site Closed|0|||
147127808|NCT00522379|530633710|FG002|Overall Study|Site Closed|0|||
147235052|NCT01999868|531031702|FG000|Blinded Treatment Phase (Week 12 - 40)|Transportation issues|1|||
147235053|NCT01999868|531031703|FG001|Blinded Treatment Phase (Week 12 - 40)|Transportation issues|0|||
147127809|NCT00522379|530633711|FG003|Overall Study|Site Closed|1|||
147127810|NCT00522379|530633712|FG004|Overall Study|Site Closed|0|||
147127811|NCT00522379|530633708|FG000|Overall Study|Subject Withdrawal|0|||
147127812|NCT00522379|530633709|FG001|Overall Study|Subject Withdrawal|0|||
147127813|NCT00522379|530633710|FG002|Overall Study|Subject Withdrawal|0|||
147127814|NCT00522379|530633711|FG003|Overall Study|Subject Withdrawal|1|||
147127815|NCT00522379|530633712|FG004|Overall Study|Subject Withdrawal|0|||
147127816|NCT00967499|530633717|FG000|Overall Study|Adverse Event|0|||
147127817|NCT00967499|530633718|FG001|Overall Study|Adverse Event|1|||
147127818|NCT00967499|530633717|FG000|Overall Study|Protocol Violation|1|||
147127819|NCT00967499|530633718|FG001|Overall Study|Protocol Violation|0|||
147127820|NCT00967499|530633717|FG000|Overall Study|Sponsor Decision|1|||
147127821|NCT00967499|530633718|FG001|Overall Study|Sponsor Decision|0|||
147127822|NCT00967499|530633717|FG000|Overall Study|Randomized but not treated|63|||
147127823|NCT00967499|530633718|FG001|Overall Study|Randomized but not treated|59|||
147127824|NCT04134936|530633722|FG000|Overall Study|Adverse Event|3|||
147127825|NCT04134936|530633723|FG001|Overall Study|Adverse Event|2|||
147127826|NCT04134936|530633722|FG000|Overall Study|Withdrawal by Subject|2|||
147127827|NCT04134936|530633723|FG001|Overall Study|Withdrawal by Subject|3|||
147127828|NCT04134936|530633722|FG000|Overall Study|Physician Decision|0|||
147127829|NCT04134936|530633723|FG001|Overall Study|Physician Decision|1|||
147127830|NCT04134936|530633722|FG000|Overall Study|Progressive disease, joined another trial|1|||
147127831|NCT04134936|530633723|FG001|Overall Study|Progressive disease, joined another trial|0|||
147127832|NCT04134936|530633722|FG000|Overall Study|Progressive disease|1|||
147127833|NCT04134936|530633723|FG001|Overall Study|Progressive disease|0|||
147127834|NCT03518060|530633724|FG000|Overall Study|Death|1|||
147127835|NCT03518060|530633724|FG000|Overall Study|Poor adherence|1|||
147127836|NCT03518060|530633724|FG000|Overall Study|Withdrawal of informed consent|2|||
147127837|NCT03518060|530633724|FG000|Overall Study|Interaction with comedication or comorbidities|4|||
147127838|NCT03518060|530633724|FG000|Overall Study|Physician Decision|7|||
147127839|NCT03518060|530633724|FG000|Overall Study|Adverse drug reactions|23|||
147127840|NCT03518060|530633724|FG000|Overall Study|Withdrawal by Subject|25|||
147127841|NCT03518060|530633724|FG000|Overall Study|Lost to Follow-up|13|||
147127842|NCT00323622|530633726|FG000|Overall Study|Other|30|||
147127843|NCT00323622|530633727|FG001|Overall Study|Other|91|||
147127844|NCT00323622|530633728|FG002|Overall Study|Other|4|||
147127845|NCT00323622|530633729|FG003|Overall Study|Other|12|||
147127846|NCT00323622|530633730|FG004|Overall Study|Other|32|||
147127847|NCT00323622|530633731|FG005|Overall Study|Other|74|||
147127848|NCT00323622|530633732|FG006|Overall Study|Other|5|||
147127849|NCT00323622|530633733|FG007|Overall Study|Other|13|||
147127850|NCT00323622|530633726|FG000|Overall Study|Death|1|||
147127851|NCT00323622|530633727|FG001|Overall Study|Death|1|||
147127852|NCT00323622|530633728|FG002|Overall Study|Death|0|||
147127853|NCT00323622|530633729|FG003|Overall Study|Death|0|||
147127854|NCT00323622|530633730|FG004|Overall Study|Death|7|||
147127855|NCT00323622|530633731|FG005|Overall Study|Death|0|||
147127856|NCT00323622|530633732|FG006|Overall Study|Death|0|||
147127857|NCT00323622|530633733|FG007|Overall Study|Death|2|||
147127858|NCT00835354|530633734|FG000|First Intervention|Adverse Event|0|||
147127859|NCT00835354|530633735|FG001|First Intervention|Adverse Event|1|||
147127860|NCT02097225|530633740|FG000|Dose Level 4|Adverse Event|0|||
147127861|NCT02097225|530633741|FG001|Dose Level 4|Adverse Event|0|||
147127862|NCT02097225|530633742|FG002|Dose Level 4|Adverse Event|0|||
147127863|NCT02097225|530633743|FG003|Dose Level 4|Adverse Event|0|||
147127864|NCT02097225|530633744|FG004|Dose Level 4|Adverse Event|1|||
147127865|NCT01852214|530633746|FG000|Period 1|Adverse Event|1|||
147127866|NCT01852214|530633747|FG001|Period 1|Adverse Event|2|||
147127867|NCT01852214|530633746|FG000|Period 1|Withdrawal by Subject|0|||
147127868|NCT01852214|530633747|FG001|Period 1|Withdrawal by Subject|1|||
147127869|NCT01852214|530633746|FG000|Washout Period|Withdrawal by Subject|0|||
147127870|NCT01852214|530633747|FG001|Washout Period|Withdrawal by Subject|1|||
147127871|NCT02679274|530633748|FG000|Overall Study|Withdrawal by Subject|1|||
147127872|NCT02679274|530633749|FG001|Overall Study|Withdrawal by Subject|0|||
147127873|NCT04976855|530633750|FG000|Part I|Withdrawal by Subject|0|||
147127874|NCT04976855|530633751|FG001|Part I|Withdrawal by Subject|1|||
147127875|NCT04976855|530633752|FG002|Part I|Withdrawal by Subject|0|||
147127876|NCT04976855|530633753|FG003|Part I|Withdrawal by Subject|0|||
147127877|NCT04976855|530633754|FG004|Part I|Withdrawal by Subject|0|||
147127878|NCT04976855|530633755|FG005|Part I|Withdrawal by Subject|0|||
147127879|NCT04976855|530633756|FG006|Part I|Withdrawal by Subject|0|||
147127880|NCT04976855|530633750|FG000|Part II|Adverse Event|0|||
147127881|NCT04976855|530633751|FG001|Part II|Adverse Event|0|||
147127882|NCT04976855|530633752|FG002|Part II|Adverse Event|0|||
147127883|NCT04976855|530633753|FG003|Part II|Adverse Event|1|||
147127884|NCT04976855|530633754|FG004|Part II|Adverse Event|0|||
147127885|NCT04976855|530633755|FG005|Part II|Adverse Event|0|||
147127886|NCT04976855|530633756|FG006|Part II|Adverse Event|0|||
147127887|NCT04976855|530633750|FG000|Part II|Withdrawal by Subject|0|||
147127888|NCT04976855|530633751|FG001|Part II|Withdrawal by Subject|0|||
147127889|NCT04976855|530633752|FG002|Part II|Withdrawal by Subject|0|||
147127890|NCT04976855|530633753|FG003|Part II|Withdrawal by Subject|0|||
147127891|NCT04976855|530633754|FG004|Part II|Withdrawal by Subject|1|||
147127892|NCT04976855|530633755|FG005|Part II|Withdrawal by Subject|0|||
147127893|NCT04976855|530633756|FG006|Part II|Withdrawal by Subject|0|||
147316845|NCT03824938|531325742|FG005|Overall Study|Lost to Follow-up|0|||
147316846|NCT00287469|531325746|FG000|Overall Study|serious adverse event|1|||
147316847|NCT00287469|531325747|FG001|Overall Study|serious adverse event|6|||
147316848|NCT00287469|531325746|FG000|Overall Study|Adverse Event|1|||
147316849|NCT00287469|531325747|FG001|Overall Study|Adverse Event|1|||
147316850|NCT00287469|531325746|FG000|Overall Study|moved from area|144|||
147316851|NCT00287469|531325747|FG001|Overall Study|moved from area|138|||
147316852|NCT00287469|531325746|FG000|Overall Study|Lost to Follow-up|74|||
147316853|NCT00287469|531325747|FG001|Overall Study|Lost to Follow-up|69|||
147316854|NCT00065468|531325748|FG000|Overall Study|Death|172|||
147316855|NCT00065468|531325749|FG001|Overall Study|Death|169|||
147316856|NCT00065468|531325750|FG002|Overall Study|Death|171|||
147316857|NCT00065468|531325748|FG000|Overall Study|Withdrawal by Subject|3|||
147316858|NCT00065468|531325749|FG001|Overall Study|Withdrawal by Subject|4|||
147316859|NCT00065468|531325750|FG002|Overall Study|Withdrawal by Subject|5|||
147316860|NCT00065468|531325748|FG000|Overall Study|Lost to Follow-up|5|||
147316861|NCT00065468|531325749|FG001|Overall Study|Lost to Follow-up|3|||
147316862|NCT00065468|531325750|FG002|Overall Study|Lost to Follow-up|2|||
147316863|NCT00065468|531325748|FG000|Overall Study|Discontinuation of study by Sponsor|13|||
147316864|NCT00065468|531325749|FG001|Overall Study|Discontinuation of study by Sponsor|9|||
147316865|NCT00065468|531325750|FG002|Overall Study|Discontinuation of study by Sponsor|13|||
147316866|NCT00065468|531325748|FG000|Overall Study|Disease progression|0|||
147316867|NCT00065468|531325749|FG001|Overall Study|Disease progression|0|||
147316868|NCT00065468|531325750|FG002|Overall Study|Disease progression|1|||
147316869|NCT00065468|531325748|FG000|Overall Study|Other|14|||
147316870|NCT00065468|531325749|FG001|Overall Study|Other|24|||
147316871|NCT00065468|531325750|FG002|Overall Study|Other|18|||
147316872|NCT02019602|531325757|FG000|Screening Period|Ineligibility|4|||
147316873|NCT02019602|531325758|FG001|Screening Period|Ineligibility|0|||
147316874|NCT02019602|531325757|FG000|Screening Period|Adverse Event|1|||
147316875|NCT02019602|531325758|FG001|Screening Period|Adverse Event|0|||
147316876|NCT00683449|531325759|FG000|Overall Study|Lost to Follow-up|0|||
147316877|NCT00683449|531325760|FG001|Overall Study|Lost to Follow-up|1|||
147316878|NCT00683449|531325761|FG002|Overall Study|Lost to Follow-up|0|||
147316879|NCT00683449|531325762|FG003|Overall Study|Lost to Follow-up|0|||
147316880|NCT00683449|531325763|FG004|Overall Study|Lost to Follow-up|0|||
147316881|NCT01448044|531325764|FG000|Treatment Period|Adverse Event|4|||
147316882|NCT01448044|531325765|FG001|Treatment Period|Adverse Event|3|||
147316883|NCT01448044|531325764|FG000|Treatment Period|Lack of Efficacy|5|||
147316884|NCT01448044|531325765|FG001|Treatment Period|Lack of Efficacy|12|||
147316885|NCT01448044|531325764|FG000|Treatment Period|Subject requested discontinue study drug|1|||
147316886|NCT01448044|531325765|FG001|Treatment Period|Subject requested discontinue study drug|0|||
147316887|NCT01448044|531325764|FG000|Treatment Period|Completed 24 weeks treatment period only|8|||
147316888|NCT01448044|531325765|FG001|Treatment Period|Completed 24 weeks treatment period only|0|||
147316889|NCT01448044|531325764|FG000|Treatment Period|Participant does not meet study criteria|1|||
147316890|NCT01448044|531325765|FG001|Treatment Period|Participant does not meet study criteria|0|||
147316891|NCT01448044|531325764|FG000|Treatment Period|Lost to Follow-up|2|||
147316892|NCT01448044|531325765|FG001|Treatment Period|Lost to Follow-up|1|||
147316893|NCT01448044|531325764|FG000|Treatment Period|Other reason|2|||
147316894|NCT01448044|531325765|FG001|Treatment Period|Other reason|0|||
147316895|NCT01448044|531325764|FG000|Follow Up Period|Withdrawal by Subject|1|||
147316896|NCT01448044|531325765|FG001|Follow Up Period|Withdrawal by Subject|1|||
147316897|NCT01448044|531325764|FG000|Follow Up Period|Lost to Follow-up|6|||
147316898|NCT01448044|531325765|FG001|Follow Up Period|Lost to Follow-up|2|||
147316899|NCT01448044|531325764|FG000|Follow Up Period|Other|5|||
147316900|NCT01448044|531325765|FG001|Follow Up Period|Other|11|||
147316901|NCT01058863|531325766|FG000|Overall Study|Lost to Follow-up|1|||
147316902|NCT01058863|531325766|FG000|Overall Study|Withdrawal by Subject|1|||
147316903|NCT01058863|531325766|FG000|Overall Study|Sponsor requested withdrawal|1|||
147316904|NCT01058863|531325766|FG000|Overall Study|Randomized in error|1|||
147316905|NCT00507026|531325767|FG000|Overall Study|Lack of Efficacy|6|||
147316906|NCT00507026|531325768|FG001|Overall Study|Lack of Efficacy|4|||
147316907|NCT00507026|531325769|FG002|Overall Study|Lack of Efficacy|21|||
147316908|NCT00507026|531325767|FG000|Overall Study|Withdrawal by Subject|2|||
147316909|NCT00507026|531325768|FG001|Overall Study|Withdrawal by Subject|0|||
147316910|NCT00507026|531325769|FG002|Overall Study|Withdrawal by Subject|0|||
147316911|NCT00507026|531325767|FG000|Overall Study|Investigator Decision|1|||
147316912|NCT00507026|531325768|FG001|Overall Study|Investigator Decision|0|||
147651255|NCT00394771|532544654|FG002|Overall Study|Adverse Event|12|||
147316913|NCT00507026|531325769|FG002|Overall Study|Investigator Decision|0|||
147316914|NCT00507026|531325767|FG000|Overall Study|Adverse Event|2|||
147316915|NCT00507026|531325768|FG001|Overall Study|Adverse Event|0|||
147316916|NCT00507026|531325769|FG002|Overall Study|Adverse Event|0|||
147316917|NCT00507026|531325767|FG000|Overall Study|Protocol Violation|1|||
147316918|NCT00507026|531325768|FG001|Overall Study|Protocol Violation|0|||
147316919|NCT00507026|531325769|FG002|Overall Study|Protocol Violation|0|||
147316920|NCT00507026|531325767|FG000|Overall Study|Other|1|||
147316921|NCT00507026|531325768|FG001|Overall Study|Other|0|||
147316922|NCT00507026|531325769|FG002|Overall Study|Other|0|||
147127894|NCT04976855|530633750|FG000|Part II|Lost to Follow-up|0|||
147127895|NCT04976855|530633751|FG001|Part II|Lost to Follow-up|0|||
147127896|NCT04976855|530633752|FG002|Part II|Lost to Follow-up|0|||
147316923|NCT03653416|531325770|FG000|Overall Study|Protocol Violation|6|||
147316924|NCT03653416|531325771|FG001|Overall Study|Protocol Violation|1|||
147127897|NCT04976855|530633753|FG003|Part II|Lost to Follow-up|0|||
147316925|NCT02788006|531325774|FG000|Overall Study|Patient not treated|1|||
147127898|NCT04976855|530633754|FG004|Part II|Lost to Follow-up|0|||
147127899|NCT04976855|530633755|FG005|Part II|Lost to Follow-up|1|||
147127900|NCT04976855|530633756|FG006|Part II|Lost to Follow-up|0|||
147127901|NCT05487378|530633757|FG000|1st Intervention (1week)|Withdrawal by Subject|2|||
147127902|NCT05487378|530633758|FG001|1st Intervention (1week)|Withdrawal by Subject|0|||
147127903|NCT05487378|530633757|FG000|2nd Intervention (1 Week)|Withdrawal by Subject|0|||
147235054|NCT01999868|531031704|FG002|Blinded Treatment Phase (Week 12 - 40)|Transportation issues|0|||
147235055|NCT01999868|531031702|FG000|Blinded Treatment Phase (Week 12 - 40)|Worsening psoriasis|4|||
147235056|NCT01999868|531031703|FG001|Blinded Treatment Phase (Week 12 - 40)|Worsening psoriasis|0|||
147235057|NCT01999868|531031704|FG002|Blinded Treatment Phase (Week 12 - 40)|Worsening psoriasis|0|||
147235058|NCT01999868|531031702|FG000|Blinded Observation Phase (Week 40 - 88)|Adverse Event|0|||
147235059|NCT01999868|531031703|FG001|Blinded Observation Phase (Week 40 - 88)|Adverse Event|1|||
147235060|NCT01999868|531031704|FG002|Blinded Observation Phase (Week 40 - 88)|Adverse Event|0|||
147235061|NCT01999868|531031702|FG000|Blinded Observation Phase (Week 40 - 88)|Lost to Follow-up|0|||
147235062|NCT01999868|531031703|FG001|Blinded Observation Phase (Week 40 - 88)|Lost to Follow-up|1|||
147235063|NCT01999868|531031704|FG002|Blinded Observation Phase (Week 40 - 88)|Lost to Follow-up|0|||
147235064|NCT01999868|531031702|FG000|Blinded Observation Phase (Week 40 - 88)|Withdrawal by Subject|1|||
147235065|NCT01999868|531031703|FG001|Blinded Observation Phase (Week 40 - 88)|Withdrawal by Subject|2|||
147235066|NCT01999868|531031704|FG002|Blinded Observation Phase (Week 40 - 88)|Withdrawal by Subject|0|||
147235067|NCT01999868|531031702|FG000|Blinded Observation Phase (Week 40 - 88)|Met psoriasis relapse criterion|10|||
147235068|NCT01999868|531031703|FG001|Blinded Observation Phase (Week 40 - 88)|Met psoriasis relapse criterion|19|||
147235069|NCT01999868|531031704|FG002|Blinded Observation Phase (Week 40 - 88)|Met psoriasis relapse criterion|0|||
147235070|NCT01999868|531031702|FG000|Blinded Observation Phase (Week 40 - 88)|Terminated early from study in error|0|||
147235071|NCT01999868|531031703|FG001|Blinded Observation Phase (Week 40 - 88)|Terminated early from study in error|2|||
147235072|NCT01999868|531031704|FG002|Blinded Observation Phase (Week 40 - 88)|Terminated early from study in error|0|||
147235073|NCT01999868|531031702|FG000|Blinded Observation Phase (Week 40 - 88)|Worsening psoriasis|12|||
147235074|NCT01999868|531031703|FG001|Blinded Observation Phase (Week 40 - 88)|Worsening psoriasis|4|||
147235075|NCT01999868|531031704|FG002|Blinded Observation Phase (Week 40 - 88)|Worsening psoriasis|0|||
147235076|NCT00761631|531031705|FG000|Overall Study|Parent/legal guardian request|8|||
147235077|NCT00761631|531031706|FG001|Overall Study|Parent/legal guardian request|3|||
147235078|NCT00761631|531031707|FG002|Overall Study|Parent/legal guardian request|8|||
147235079|NCT00761631|531031708|FG003|Overall Study|Parent/legal guardian request|0|||
147235080|NCT00761631|531031709|FG004|Overall Study|Parent/legal guardian request|5|||
147235081|NCT00761631|531031710|FG005|Overall Study|Parent/legal guardian request|0|||
147235082|NCT00761631|531031705|FG000|Overall Study|Lost to Follow-up|2|||
147235083|NCT00761631|531031706|FG001|Overall Study|Lost to Follow-up|4|||
147235084|NCT00761631|531031707|FG002|Overall Study|Lost to Follow-up|7|||
147235085|NCT00761631|531031708|FG003|Overall Study|Lost to Follow-up|1|||
147235086|NCT00761631|531031709|FG004|Overall Study|Lost to Follow-up|6|||
147235087|NCT00761631|531031710|FG005|Overall Study|Lost to Follow-up|1|||
147235088|NCT00761631|531031705|FG000|Overall Study|Protocol Violation|2|||
147235089|NCT00761631|531031706|FG001|Overall Study|Protocol Violation|0|||
147235090|NCT00761631|531031707|FG002|Overall Study|Protocol Violation|0|||
147235091|NCT00761631|531031708|FG003|Overall Study|Protocol Violation|1|||
147235092|NCT00761631|531031709|FG004|Overall Study|Protocol Violation|5|||
147235093|NCT00761631|531031710|FG005|Overall Study|Protocol Violation|1|||
147235094|NCT00761631|531031705|FG000|Overall Study|Randomized, not treated|1|||
147235095|NCT00761631|531031706|FG001|Overall Study|Randomized, not treated|0|||
147235096|NCT00761631|531031707|FG002|Overall Study|Randomized, not treated|0|||
147235097|NCT00761631|531031708|FG003|Overall Study|Randomized, not treated|0|||
147235098|NCT00761631|531031709|FG004|Overall Study|Randomized, not treated|0|||
147235099|NCT00761631|531031710|FG005|Overall Study|Randomized, not treated|0|||
147235100|NCT00761631|531031705|FG000|Overall Study|Failed to return|1|||
147235101|NCT00761631|531031706|FG001|Overall Study|Failed to return|0|||
147235102|NCT00761631|531031707|FG002|Overall Study|Failed to return|1|||
147316926|NCT01991197|531325777|FG000|Overall Study|Lost to Follow-up|1|||
147235103|NCT00761631|531031708|FG003|Overall Study|Failed to return|1|||
147235104|NCT00761631|531031709|FG004|Overall Study|Failed to return|5|||
147235105|NCT00761631|531031710|FG005|Overall Study|Failed to return|2|||
147235106|NCT00761631|531031705|FG000|Overall Study|Physician Decision|1|||
147235107|NCT00761631|531031706|FG001|Overall Study|Physician Decision|0|||
147316927|NCT01991197|531325778|FG001|Overall Study|Lost to Follow-up|1|||
147316928|NCT01991197|531325777|FG000|Overall Study|Physician Decision|0|||
147127904|NCT05487378|530633758|FG001|2nd Intervention (1 Week)|Withdrawal by Subject|1|||
147127905|NCT01385995|530633766|FG000|Period 1, 2 Months|Physician Decision|1|||
147316929|NCT01991197|531325778|FG001|Overall Study|Physician Decision|2|||
147316930|NCT01991197|531325777|FG000|Overall Study|Withdrawal by Subject|2|||
147316931|NCT01991197|531325778|FG001|Overall Study|Withdrawal by Subject|0|||
147316932|NCT01010217|531325781|FG000|Overall Study|Lost to Follow-up|4|||
147316933|NCT01010217|531325782|FG001|Overall Study|Lost to Follow-up|5|||
147316934|NCT01010217|531325783|FG002|Overall Study|Lost to Follow-up|1|||
147316935|NCT01010217|531325784|FG003|Overall Study|Lost to Follow-up|0|||
147316936|NCT01010217|531325785|FG004|Overall Study|Lost to Follow-up|0|||
147316937|NCT01010217|531325781|FG000|Overall Study|Withdrawal by Subject|1|||
147316938|NCT01010217|531325782|FG001|Overall Study|Withdrawal by Subject|0|||
147316939|NCT01010217|531325783|FG002|Overall Study|Withdrawal by Subject|0|||
147316940|NCT01010217|531325784|FG003|Overall Study|Withdrawal by Subject|0|||
147316941|NCT01010217|531325785|FG004|Overall Study|Withdrawal by Subject|0|||
147316942|NCT01010217|531325781|FG000|Overall Study|Physician Decision|0|||
147316943|NCT01010217|531325782|FG001|Overall Study|Physician Decision|0|||
147316944|NCT01010217|531325783|FG002|Overall Study|Physician Decision|0|||
147316945|NCT01010217|531325784|FG003|Overall Study|Physician Decision|6|||
147316946|NCT01010217|531325785|FG004|Overall Study|Physician Decision|3|||
147316947|NCT05822921|531325786|FG000|Overall Study|Lost to Follow-up|1|||
147127906|NCT01385995|530633767|FG001|Period 1, 2 Months|Physician Decision|0|||
147127907|NCT00112385|530633768|FG000|Overall Study|Lost to Follow-up|1|||
147127908|NCT00112385|530633769|FG001|Overall Study|Lost to Follow-up|0|||
147127909|NCT00112385|530633768|FG000|Overall Study|Withdrawal by Subject|0|||
147127910|NCT00112385|530633769|FG001|Overall Study|Withdrawal by Subject|1|||
147127911|NCT02613507|530633784|FG000|Pre-Treamtent|Participant request to discontinue study treatment|0|||
147127912|NCT02613507|530633785|FG001|Pre-Treamtent|Participant request to discontinue study treatment|5|||
147127913|NCT02613507|530633784|FG000|Pre-Treamtent|Participant withdrew consent|0|||
147127914|NCT02613507|530633785|FG001|Pre-Treamtent|Participant withdrew consent|4|||
147127915|NCT02613507|530633784|FG000|Pre-Treamtent|Participant no longer meets study criteria|1|||
147127916|NCT02613507|530633785|FG001|Pre-Treamtent|Participant no longer meets study criteria|1|||
147127917|NCT02613507|530633784|FG000|Treatment|Not reported|3|||
147127918|NCT02613507|530633785|FG001|Treatment|Not reported|0|||
147127919|NCT02613507|530633784|FG000|Treatment|Other reasons|8|||
147127920|NCT02613507|530633785|FG001|Treatment|Other reasons|0|||
147127921|NCT02613507|530633784|FG000|Treatment|Participant no longer meets criteria|3|||
147127922|NCT02613507|530633785|FG001|Treatment|Participant no longer meets criteria|0|||
147127923|NCT02613507|530633784|FG000|Treatment|Maximum clinical benefit|5|||
147127924|NCT02613507|530633785|FG001|Treatment|Maximum clinical benefit|10|||
147127925|NCT02613507|530633784|FG000|Treatment|Lost to Follow-up|1|||
147316948|NCT05822921|531325787|FG001|Overall Study|Lost to Follow-up|1|||
147316949|NCT04714216|531327202|FG000|Overall Study|Did not initiate AID due to CGM inaccuracies|2|||
147316950|NCT04714216|531327202|FG000|Overall Study|Discharged prior to 48 hours of AID|2|||
147316951|NCT01349829|531327206|FG000|Overall Study|Lost to Follow-up|4|||
147316952|NCT01349829|531327207|FG001|Overall Study|Lost to Follow-up|8|||
147316953|NCT01349829|531327206|FG000|Overall Study|Consent withdrawal|3|||
147316954|NCT01349829|531327207|FG001|Overall Study|Consent withdrawal|8|||
147316955|NCT01349829|531327206|FG000|Overall Study|Migrated/moved|2|||
147316956|NCT01349829|531327207|FG001|Overall Study|Migrated/moved|7|||
147316957|NCT00777803|531327208|FG000|Overall Study|Lost to Follow-up|12|||
147316958|NCT00777803|531327209|FG001|Overall Study|Lost to Follow-up|5|||
147316959|NCT00777803|531327208|FG000|Overall Study|Adverse Event|1|||
147316960|NCT00777803|531327209|FG001|Overall Study|Adverse Event|0|||
147316961|NCT00777803|531327208|FG000|Overall Study|Non-compliance|2|||
147316962|NCT00777803|531327209|FG001|Overall Study|Non-compliance|2|||
147316963|NCT01995357|531327212|FG000|Period 5|Lack of Efficacy|1|||
147316964|NCT01995357|531327213|FG001|Period 5|Lack of Efficacy|0|||
147316965|NCT01995357|531327214|FG002|Period 5|Lack of Efficacy|0|||
147316966|NCT01995357|531327215|FG003|Period 5|Lack of Efficacy|0|||
147316967|NCT01995357|531327216|FG004|Period 5|Lack of Efficacy|0|||
147316968|NCT01995357|531327217|FG005|Period 5|Lack of Efficacy|0|||
147316969|NCT01995357|531327212|FG000|Period 5|Adverse Event|1|||
147316970|NCT01995357|531327213|FG001|Period 5|Adverse Event|0|||
147316971|NCT01995357|531327214|FG002|Period 5|Adverse Event|1|||
147316972|NCT01995357|531327215|FG003|Period 5|Adverse Event|0|||
147316973|NCT01995357|531327216|FG004|Period 5|Adverse Event|0|||
147316974|NCT01995357|531327217|FG005|Period 5|Adverse Event|0|||
147568978|NCT01597245|532240138|FG017|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
147127926|NCT02613507|530633785|FG001|Treatment|Lost to Follow-up|0|||
147127927|NCT02613507|530633784|FG000|Treatment|Participant withdrew consent|0|||
147127928|NCT02613507|530633785|FG001|Treatment|Participant withdrew consent|2|||
147127929|NCT02613507|530633784|FG000|Treatment|Participant request to discontinue study treatment|13|||
147127930|NCT02613507|530633785|FG001|Treatment|Participant request to discontinue study treatment|17|||
147316975|NCT04129580|531327218|FG000|Overall Study|Lost to Follow-up|14|||
147316976|NCT04129580|531327219|FG001|Overall Study|Lost to Follow-up|25|||
147316977|NCT02711995|531327222|FG000|Washout (90 Days)|Conflicting medication|1|||
147316978|NCT00322868|531327223|FG000|Overall Study|disease progression|1|||
147316979|NCT01852162|531327225|FG000|Overall Study|Adverse Event|1|||
147316980|NCT01852162|531327226|FG001|Overall Study|Adverse Event|0|||
147316981|NCT01852162|531327225|FG000|Overall Study|Withdrawal by Subject|3|||
147127931|NCT02613507|530633784|FG000|Treatment|Adverse event unrelated to study drug|20|||
147127932|NCT02613507|530633785|FG001|Treatment|Adverse event unrelated to study drug|3|||
147127933|NCT02613507|530633784|FG000|Treatment|Death|2|||
147127934|NCT02613507|530633785|FG001|Treatment|Death|0|||
147127935|NCT02613507|530633784|FG000|Treatment|Study drug toxicity|19|||
147127936|NCT02613507|530633785|FG001|Treatment|Study drug toxicity|14|||
147127937|NCT02613507|530633784|FG000|Treatment|Disease progression|263|||
147127938|NCT02613507|530633785|FG001|Treatment|Disease progression|110|||
147127939|NCT03514134|530635160|FG000|Overall Study|Lost to Follow-up|0|||
147235108|NCT00761631|531031707|FG002|Overall Study|Physician Decision|0|||
147235109|NCT00761631|531031708|FG003|Overall Study|Physician Decision|0|||
147235110|NCT00761631|531031709|FG004|Overall Study|Physician Decision|0|||
147235111|NCT00761631|531031710|FG005|Overall Study|Physician Decision|0|||
147235112|NCT00761631|531031705|FG000|Overall Study|Other|0|||
147235113|NCT00761631|531031706|FG001|Overall Study|Other|0|||
147235114|NCT00761631|531031707|FG002|Overall Study|Other|0|||
147235115|NCT00761631|531031708|FG003|Overall Study|Other|0|||
147235116|NCT00761631|531031709|FG004|Overall Study|Other|1|||
147235117|NCT00761631|531031710|FG005|Overall Study|Other|1|||
147235118|NCT00289016|531031713|FG000|Overall Study|Disease Progression|29|||
147127940|NCT03514134|530635161|FG001|Overall Study|Lost to Follow-up|1|||
147127941|NCT00363298|530635172|FG000|First Study Week|Lack of Efficacy|6|||
147127942|NCT00363298|530635173|FG001|First Study Week|Lack of Efficacy|5|||
147127943|NCT00363298|530635172|FG000|4-week Study Continuation Phase|Lack of Efficacy|1|||
147127944|NCT00363298|530635173|FG001|4-week Study Continuation Phase|Lack of Efficacy|0|||
147127945|NCT00688740|530635174|FG000|Overall Study|Adverse Event|45|||
147127946|NCT00688740|530635175|FG001|Overall Study|Adverse Event|8|||
147127947|NCT00688740|530635174|FG000|Overall Study|Death|2|||
147127948|NCT00688740|530635175|FG001|Overall Study|Death|2|||
147127949|NCT00688740|530635174|FG000|Overall Study|Lost to Follow-up|0|||
147127950|NCT00688740|530635175|FG001|Overall Study|Lost to Follow-up|1|||
147127951|NCT00688740|530635174|FG000|Overall Study|Consent Withdrawn|17|||
147127952|NCT00688740|530635175|FG001|Overall Study|Consent Withdrawn|17|||
147127953|NCT00688740|530635174|FG000|Overall Study|Breast Cancer Relapse|1|||
147127954|NCT00688740|530635175|FG001|Overall Study|Breast Cancer Relapse|4|||
147127955|NCT00688740|530635174|FG000|Overall Study|Violation of Inclusion Criteria|1|||
147127956|NCT00688740|530635175|FG001|Overall Study|Violation of Inclusion Criteria|3|||
147127957|NCT00856557|530635178|FG000|Overall Study|No patients with contextual flags|12|||
147127958|NCT00856557|530635179|FG001|Overall Study|No patients with contextual flags|16|||
147127959|NCT03673176|530635180|FG000|Overall Study|Death prior to intervention|1|||
147127960|NCT03673176|530635180|FG000|Overall Study|Death following intervention|3|||
147127961|NCT03673176|530635180|FG000|Overall Study|Withdrawal by Subject|1|||
147127962|NCT02378480|530635181|FG000|Overall Study|Physician Decision|1|||
147127963|NCT02378480|530635182|FG001|Overall Study|Physician Decision|1|||
147127964|NCT02378480|530635181|FG000|Overall Study|Death|1|||
147127965|NCT02378480|530635182|FG001|Overall Study|Death|2|||
147127966|NCT02378480|530635181|FG000|Overall Study|Randomized, but Not Treated|6|||
147127967|NCT02378480|530635182|FG001|Overall Study|Randomized, but Not Treated|4|||
147127968|NCT02378480|530635181|FG000|Overall Study|Adverse Event|0|||
147127969|NCT02378480|530635182|FG001|Overall Study|Adverse Event|1|||
147127970|NCT02378480|530635181|FG000|Overall Study|Missed EOT/PTE Visit|1|||
147127971|NCT02378480|530635182|FG001|Overall Study|Missed EOT/PTE Visit|2|||
147127972|NCT02378480|530635181|FG000|Overall Study|Withdrawal by Subject|9|||
147127973|NCT02378480|530635182|FG001|Overall Study|Withdrawal by Subject|4|||
147127974|NCT02378480|530635181|FG000|Overall Study|Lost to Follow-up|10|||
147127975|NCT02378480|530635182|FG001|Overall Study|Lost to Follow-up|18|||
147127976|NCT01285102|530635185|FG000|Overall Study|Closed to accrual by sponsor due to poor accrual and challenge with dosing|4|||
147127977|NCT00557440|530635195|FG000|Treatment Period 1|Adverse Event|0|||
147127978|NCT00557440|530635196|FG001|Treatment Period 1|Adverse Event|0|||
147127979|NCT00557440|530635197|FG002|Treatment Period 1|Adverse Event|1|||
147127980|NCT03524157|530635198|FG000|Overall Study|cytology not readable|0|||
147127981|NCT03524157|530635199|FG001|Overall Study|cytology not readable|0|||
147127982|NCT03524157|530635200|FG002|Overall Study|cytology not readable|1|||
147127983|NCT04507763|530635201|FG000|Overall Study|Participants did not meet entrance criteria|201|||
147127984|NCT03322566|530635202|FG000|Overall Study|Death|34|||
147235119|NCT00289016|531031713|FG000|Overall Study|Death|2|||
147316982|NCT01852162|531327226|FG001|Overall Study|Withdrawal by Subject|1|||
147127985|NCT03322566|530635203|FG001|Overall Study|Death|35|||
147127986|NCT03322566|530635204|FG002|Overall Study|Death|23|||
147127987|NCT03322566|530635202|FG000|Overall Study|Physician Decision|6|||
147127988|NCT03322566|530635203|FG001|Overall Study|Physician Decision|7|||
147235120|NCT00289016|531031713|FG000|Overall Study|Unrelated Medical Condition or Accident|2|||
147235121|NCT00289016|531031713|FG000|Overall Study|Withdrawal by Subject|2|||
147127989|NCT03322566|530635204|FG002|Overall Study|Physician Decision|2|||
147127990|NCT03322566|530635202|FG000|Overall Study|Withdrawal by Subject|4|||
147127991|NCT03322566|530635203|FG001|Overall Study|Withdrawal by Subject|3|||
147127992|NCT03322566|530635204|FG002|Overall Study|Withdrawal by Subject|6|||
147316983|NCT00163215|531327231|FG000|Overall Study|Lack of Efficacy|3|||
147127993|NCT03322566|530635202|FG000|Overall Study|Lost to Follow-up|0|||
147127994|NCT03322566|530635203|FG001|Overall Study|Lost to Follow-up|0|||
147127995|NCT03322566|530635204|FG002|Overall Study|Lost to Follow-up|1|||
147127996|NCT03322566|530635202|FG000|Overall Study|Study terminated by sponsor|1|||
147127997|NCT03322566|530635203|FG001|Overall Study|Study terminated by sponsor|0|||
147127998|NCT03322566|530635204|FG002|Overall Study|Study terminated by sponsor|1|||
147127999|NCT05473715|530635207|FG000|Overall Study|Trial terminate|2|||
147128000|NCT05473715|530635208|FG001|Overall Study|Trial terminate|1|||
147128001|NCT02592863|530635210|FG000|Overall Study|Withdrawal by Subject|2|||
147128002|NCT02592863|530635211|FG001|Overall Study|Withdrawal by Subject|2|||
147128003|NCT02592863|530635210|FG000|Overall Study|Lost to Follow-up|1|||
147128004|NCT02592863|530635211|FG001|Overall Study|Lost to Follow-up|1|||
147128005|NCT02743221|530635212|FG000|Overall Study|Progressive disease|29|||
147128006|NCT02743221|530635213|FG001|Overall Study|Progressive disease|38|||
147128007|NCT02743221|530635212|FG000|Overall Study|Adverse Event|17|||
147128008|NCT02743221|530635213|FG001|Overall Study|Adverse Event|14|||
147128009|NCT02743221|530635212|FG000|Overall Study|non medical reason|8|||
147128010|NCT02743221|530635213|FG001|Overall Study|non medical reason|2|||
147128011|NCT02743221|530635212|FG000|Overall Study|Physician Decision|2|||
147128012|NCT02743221|530635213|FG001|Overall Study|Physician Decision|5|||
147128013|NCT02743221|530635212|FG000|Overall Study|Patient not eligible, not treated|0|||
147128014|NCT02743221|530635213|FG001|Overall Study|Patient not eligible, not treated|1|||
147128015|NCT03528902|530635216|FG000|Overall Study|Adverse Event|1|||
147128016|NCT03528902|530635217|FG001|Overall Study|Adverse Event|0|||
147128017|NCT03411044|530635218|FG000|Overall Study|Death|30|||
147128018|NCT03411044|530635218|FG000|Overall Study|Withdrawal by Subject|48|||
147128019|NCT03411044|530635218|FG000|Overall Study|Lost to Follow-up|78|||
147128020|NCT03411044|530635218|FG000|Overall Study|Adverse Event|30|||
147128021|NCT03411044|530635218|FG000|Overall Study|Missing status|4|||
147128022|NCT02609503|530635226|FG000|Overall Study|Adverse Event|1|||
147128023|NCT02609503|530635226|FG000|Overall Study|Death|1|||
147128024|NCT02609503|530635226|FG000|Overall Study|Withdrawal by Subject|1|||
147128025|NCT02609503|530635226|FG000|Overall Study|Disease progression|1|||
147128026|NCT05889468|530635227|FG000|Overall Study|Lost to Follow-up|9|||
147128027|NCT05889468|530635228|FG001|Overall Study|Lost to Follow-up|2|||
147128028|NCT05889468|530635227|FG000|Overall Study|Withdrawal by Subject|2|||
147128029|NCT05889468|530635228|FG001|Overall Study|Withdrawal by Subject|2|||
147128030|NCT02457065|530635237|FG000|Overall Study|Lost to Follow-up|9|||
147128031|NCT02457065|530635238|FG001|Overall Study|Lost to Follow-up|11|||
147128032|NCT04642079|530635244|FG000|Overall Study|Lost to Follow-up|2|||
147128033|NCT04642079|530635245|FG001|Overall Study|Lost to Follow-up|5|||
147128034|NCT04642079|530635246|FG002|Overall Study|Lost to Follow-up|2|||
147128035|NCT04642079|530635247|FG003|Overall Study|Lost to Follow-up|0|||
147128036|NCT04642079|530635244|FG000|Overall Study|Withdrawal by Subject|0|||
147128037|NCT04642079|530635245|FG001|Overall Study|Withdrawal by Subject|4|||
147128038|NCT04642079|530635246|FG002|Overall Study|Withdrawal by Subject|1|||
147128039|NCT04642079|530635247|FG003|Overall Study|Withdrawal by Subject|2|||
147128040|NCT04642079|530635244|FG000|Overall Study|Other|0|||
147128041|NCT04642079|530635245|FG001|Overall Study|Other|0|||
147128042|NCT04642079|530635246|FG002|Overall Study|Other|0|||
147128043|NCT04642079|530635247|FG003|Overall Study|Other|1|||
147128044|NCT04642079|530635244|FG000|Overall Study|No longer met eligibility criteria|1|||
147128045|NCT04642079|530635245|FG001|Overall Study|No longer met eligibility criteria|0|||
147128046|NCT04642079|530635246|FG002|Overall Study|No longer met eligibility criteria|1|||
147128047|NCT04642079|530635247|FG003|Overall Study|No longer met eligibility criteria|1|||
147128048|NCT02226653|530635250|FG000|Treatment Period 2 Fasted State|Lost to Follow-up|1|||
147128049|NCT02226653|530635251|FG001|Treatment Period 2 Fasted State|Lost to Follow-up|0|||
147128050|NCT02226653|530635250|FG000|Treatment Period 5 Fed State|Adverse Event|0|||
147128051|NCT02226653|530635251|FG001|Treatment Period 5 Fed State|Adverse Event|1|||
147128052|NCT02871219|530635261|FG000|Overall Study|Adverse Event|15|||
147128053|NCT02871219|530635261|FG000|Overall Study|Death|3|||
147128054|NCT02871219|530635261|FG000|Overall Study|Progression|3|||
147128055|NCT02871219|530635261|FG000|Overall Study|Infections|7|||
147128056|NCT02871219|530635261|FG000|Overall Study|Infusion Related|4|||
147128057|NCT00835172|530635266|FG000|Washout|Protocol Violation|0|||
147316984|NCT00163215|531327231|FG000|Overall Study|Withdrawal by Subject|5|||
147128058|NCT00835172|530635267|FG001|Washout|Protocol Violation|1|||
147128059|NCT03648372|530635275|FG000|Overall Study|Withdrawal by Subject|2|||
147316985|NCT00163215|531327231|FG000|Overall Study|Other|7|||
147316986|NCT01809210|531327234|FG000|Overall Study|Withdrawal by Subject|0|||
147128060|NCT03648372|530635276|FG001|Overall Study|Withdrawal by Subject|0|||
147128061|NCT03648372|530635277|FG002|Overall Study|Withdrawal by Subject|0|||
147128062|NCT03648372|530635278|FG003|Overall Study|Withdrawal by Subject|0|||
147128063|NCT03648372|530635279|FG004|Overall Study|Withdrawal by Subject|0|||
147128064|NCT03648372|530635280|FG005|Overall Study|Withdrawal by Subject|1|||
147128065|NCT03648372|530635281|FG006|Overall Study|Withdrawal by Subject|2|||
147128066|NCT03648372|530635282|FG007|Overall Study|Withdrawal by Subject|0|||
147128067|NCT03648372|530635283|FG008|Overall Study|Withdrawal by Subject|0|||
147128068|NCT03648372|530635284|FG009|Overall Study|Withdrawal by Subject|0|||
147128069|NCT03648372|530635285|FG010|Overall Study|Withdrawal by Subject|2|||
147128070|NCT03648372|530635286|FG011|Overall Study|Withdrawal by Subject|0|||
147128071|NCT03648372|530635287|FG012|Overall Study|Withdrawal by Subject|2|||
147128072|NCT03648372|530635288|FG013|Overall Study|Withdrawal by Subject|0|||
147128073|NCT03648372|530635289|FG014|Overall Study|Withdrawal by Subject|0|||
147128074|NCT03648372|530635290|FG015|Overall Study|Withdrawal by Subject|0|||
147128075|NCT03648372|530635291|FG016|Overall Study|Withdrawal by Subject|1|||
147128076|NCT03648372|530635292|FG017|Overall Study|Withdrawal by Subject|0|||
147128077|NCT03648372|530635293|FG018|Overall Study|Withdrawal by Subject|0|||
147128078|NCT03648372|530635294|FG019|Overall Study|Withdrawal by Subject|0|||
147128079|NCT03648372|530635295|FG020|Overall Study|Withdrawal by Subject|0|||
147128080|NCT03648372|530635275|FG000|Overall Study|Progressive Disease|2|||
147235122|NCT00289016|531031713|FG000|Overall Study|Adverse Event|1|||
147235123|NCT00289016|531031713|FG000|Overall Study|Other|1|||
147235124|NCT00319501|531031714|FG000|Double-blind Period|Withdrawal by Subject|0|||
147235125|NCT00319501|531031715|FG001|Double-blind Period|Withdrawal by Subject|3|||
147235126|NCT00319501|531031714|FG000|Double-blind Period|Sponsor Request|1|||
147235127|NCT00319501|531031715|FG001|Double-blind Period|Sponsor Request|0|||
147235128|NCT00319501|531031714|FG000|Double-blind Period|Did not receive treatment|42|||
147235129|NCT00319501|531031715|FG001|Double-blind Period|Did not receive treatment|29|||
147235130|NCT00319501|531031714|FG000|Open-label Period|Adverse Event|5|||
147235131|NCT00319501|531031715|FG001|Open-label Period|Adverse Event|0|||
147235132|NCT00319501|531031714|FG000|Open-label Period|Protocol Violation|6|||
147235133|NCT00319501|531031715|FG001|Open-label Period|Protocol Violation|0|||
147235134|NCT00319501|531031714|FG000|Open-label Period|Withdrawal by Subject|38|||
147235135|NCT00319501|531031715|FG001|Open-label Period|Withdrawal by Subject|0|||
147235136|NCT00319501|531031714|FG000|Open-label Period|Principal Investigator decision|6|||
147235137|NCT00319501|531031715|FG001|Open-label Period|Principal Investigator decision|0|||
147235138|NCT00319501|531031714|FG000|Open-label Period|Sponsor request|12|||
147235139|NCT00319501|531031715|FG001|Open-label Period|Sponsor request|0|||
147235140|NCT00319501|531031714|FG000|Open-label Period|Lost to Follow-up|5|||
147235141|NCT00319501|531031715|FG001|Open-label Period|Lost to Follow-up|0|||
147235142|NCT00319501|531031714|FG000|Open-label Period|Did not receive treatment|33|||
147235143|NCT00319501|531031715|FG001|Open-label Period|Did not receive treatment|0|||
147235144|NCT00319501|531031714|FG000|Open-label Period|Other|11|||
147235145|NCT00319501|531031715|FG001|Open-label Period|Other|0|||
147235146|NCT00319501|531031714|FG000|Open-label Extension Period|Adverse Event|2|||
147235147|NCT00319501|531031715|FG001|Open-label Extension Period|Adverse Event|0|||
147235148|NCT00319501|531031714|FG000|Open-label Extension Period|Did not receive treatment|18|||
147235149|NCT00319501|531031715|FG001|Open-label Extension Period|Did not receive treatment|0|||
147235150|NCT00319501|531031714|FG000|Open-label Extension Period|Other|1|||
147235151|NCT00319501|531031715|FG001|Open-label Extension Period|Other|0|||
147235152|NCT00319501|531031714|FG000|Open-label Extension Period|Principal investigator decision|2|||
147235153|NCT00319501|531031715|FG001|Open-label Extension Period|Principal investigator decision|0|||
147235154|NCT00319501|531031714|FG000|Open-label Extension Period|Sponsor request|26|||
147235155|NCT00319501|531031715|FG001|Open-label Extension Period|Sponsor request|0|||
147235156|NCT00319501|531031714|FG000|Open-label Extension Period|Withdrawal by Subject|2|||
147235157|NCT00319501|531031715|FG001|Open-label Extension Period|Withdrawal by Subject|0|||
147235158|NCT00450255|531031717|FG000|Overall Study|Prior RFA ablation of liver|1|||
147235159|NCT01441180|531031718|FG000|Overall Study|Lost to Follow-up|1|||
147235160|NCT01441180|531031719|FG001|Overall Study|Lost to Follow-up|1|||
147235161|NCT01441180|531031720|FG002|Overall Study|Lost to Follow-up|1|||
147235162|NCT01441180|531031718|FG000|Overall Study|Discontinued|0|||
147235163|NCT01441180|531031719|FG001|Overall Study|Discontinued|0|||
147235164|NCT01441180|531031720|FG002|Overall Study|Discontinued|2|||
147235165|NCT01402011|531031721|FG000|Delayed Treatment Period|Withdrawal by Subject|1|||
147235166|NCT01402011|531031722|FG001|Delayed Treatment Period|Withdrawal by Subject|0|||
147235167|NCT01402011|531031723|FG002|Delayed Treatment Period|Withdrawal by Subject|0|||
147235168|NCT01402011|531031721|FG000|Active Treatment Period|Withdrawal by Subject|1|||
147235169|NCT01402011|531031722|FG001|Active Treatment Period|Withdrawal by Subject|3|||
147235170|NCT01402011|531031723|FG002|Active Treatment Period|Withdrawal by Subject|0|||
147235171|NCT01402011|531031721|FG000|Nine Month Follow-up|Withdrawal by Subject|0|||
147235172|NCT01402011|531031722|FG001|Nine Month Follow-up|Withdrawal by Subject|1|||
147235173|NCT01402011|531031723|FG002|Nine Month Follow-up|Withdrawal by Subject|0|||
147235174|NCT00142298|531031724|FG000|Overall Study|Adverse Event|10|||
147235175|NCT00142298|531031725|FG001|Overall Study|Adverse Event|10|||
147235176|NCT00142298|531031726|FG002|Overall Study|Adverse Event|1|||
147235177|NCT00142298|531031727|FG003|Overall Study|Adverse Event|5|||
147235178|NCT00142298|531031728|FG004|Overall Study|Adverse Event|2|||
147235179|NCT00142298|531031729|FG005|Overall Study|Adverse Event|2|||
147235180|NCT00142298|531031730|FG006|Overall Study|Adverse Event|0|||
147235181|NCT00142298|531031731|FG007|Overall Study|Adverse Event|0|||
147128081|NCT03648372|530635276|FG001|Overall Study|Progressive Disease|3|||
147128082|NCT03648372|530635277|FG002|Overall Study|Progressive Disease|4|||
147128083|NCT03648372|530635278|FG003|Overall Study|Progressive Disease|3|||
147128084|NCT03648372|530635279|FG004|Overall Study|Progressive Disease|2|||
147128085|NCT03648372|530635280|FG005|Overall Study|Progressive Disease|2|||
147128086|NCT03648372|530635281|FG006|Overall Study|Progressive Disease|3|||
147128087|NCT03648372|530635282|FG007|Overall Study|Progressive Disease|3|||
147128088|NCT03648372|530635283|FG008|Overall Study|Progressive Disease|5|||
147128089|NCT03648372|530635284|FG009|Overall Study|Progressive Disease|5|||
147128090|NCT03648372|530635285|FG010|Overall Study|Progressive Disease|2|||
147128091|NCT03648372|530635286|FG011|Overall Study|Progressive Disease|3|||
147128092|NCT03648372|530635287|FG012|Overall Study|Progressive Disease|3|||
147128093|NCT03648372|530635288|FG013|Overall Study|Progressive Disease|3|||
147128094|NCT03648372|530635289|FG014|Overall Study|Progressive Disease|6|||
147128095|NCT03648372|530635290|FG015|Overall Study|Progressive Disease|0|||
147128096|NCT03648372|530635291|FG016|Overall Study|Progressive Disease|0|||
147128097|NCT03648372|530635292|FG017|Overall Study|Progressive Disease|0|||
147128098|NCT03648372|530635293|FG018|Overall Study|Progressive Disease|0|||
147128099|NCT03648372|530635294|FG019|Overall Study|Progressive Disease|0|||
147128100|NCT03648372|530635295|FG020|Overall Study|Progressive Disease|0|||
147128101|NCT03648372|530635275|FG000|Overall Study|Other|0|||
147128102|NCT03648372|530635276|FG001|Overall Study|Other|0|||
147128103|NCT03648372|530635277|FG002|Overall Study|Other|0|||
147128104|NCT03648372|530635278|FG003|Overall Study|Other|0|||
147128105|NCT03648372|530635279|FG004|Overall Study|Other|1|||
147128106|NCT03648372|530635280|FG005|Overall Study|Other|0|||
147128107|NCT03648372|530635281|FG006|Overall Study|Other|0|||
147128108|NCT03648372|530635282|FG007|Overall Study|Other|0|||
147128109|NCT03648372|530635283|FG008|Overall Study|Other|0|||
147128110|NCT03648372|530635284|FG009|Overall Study|Other|0|||
147128111|NCT03648372|530635285|FG010|Overall Study|Other|1|||
147128112|NCT03648372|530635286|FG011|Overall Study|Other|2|||
147128113|NCT03648372|530635287|FG012|Overall Study|Other|1|||
147128114|NCT03648372|530635288|FG013|Overall Study|Other|3|||
147128115|NCT03648372|530635289|FG014|Overall Study|Other|0|||
147128116|NCT03648372|530635290|FG015|Overall Study|Other|5|||
147128117|NCT03648372|530635291|FG016|Overall Study|Other|1|||
147128118|NCT03648372|530635292|FG017|Overall Study|Other|5|||
147128119|NCT03648372|530635293|FG018|Overall Study|Other|0|||
147128120|NCT03648372|530635294|FG019|Overall Study|Other|1|||
147128121|NCT03648372|530635295|FG020|Overall Study|Other|0|||
147128122|NCT03648372|530635275|FG000|Overall Study|Lost to Follow-up|0|||
147128123|NCT03648372|530635276|FG001|Overall Study|Lost to Follow-up|0|||
147128124|NCT03648372|530635277|FG002|Overall Study|Lost to Follow-up|0|||
147128125|NCT03648372|530635278|FG003|Overall Study|Lost to Follow-up|0|||
147128126|NCT03648372|530635279|FG004|Overall Study|Lost to Follow-up|0|||
147128127|NCT03648372|530635280|FG005|Overall Study|Lost to Follow-up|0|||
147128128|NCT03648372|530635281|FG006|Overall Study|Lost to Follow-up|0|||
147128129|NCT03648372|530635282|FG007|Overall Study|Lost to Follow-up|0|||
147128130|NCT03648372|530635283|FG008|Overall Study|Lost to Follow-up|0|||
147128131|NCT03648372|530635284|FG009|Overall Study|Lost to Follow-up|0|||
147128132|NCT03648372|530635285|FG010|Overall Study|Lost to Follow-up|0|||
147128133|NCT03648372|530635286|FG011|Overall Study|Lost to Follow-up|0|||
147128134|NCT03648372|530635287|FG012|Overall Study|Lost to Follow-up|0|||
147128135|NCT03648372|530635288|FG013|Overall Study|Lost to Follow-up|1|||
147128136|NCT03648372|530635289|FG014|Overall Study|Lost to Follow-up|0|||
147128137|NCT03648372|530635290|FG015|Overall Study|Lost to Follow-up|1|||
147128138|NCT03648372|530635291|FG016|Overall Study|Lost to Follow-up|0|||
147128139|NCT03648372|530635292|FG017|Overall Study|Lost to Follow-up|1|||
147128140|NCT03648372|530635293|FG018|Overall Study|Lost to Follow-up|0|||
147128141|NCT03648372|530635294|FG019|Overall Study|Lost to Follow-up|0|||
147128142|NCT03648372|530635295|FG020|Overall Study|Lost to Follow-up|0|||
147128143|NCT03648372|530635275|FG000|Overall Study|Start of a New Systemic Treatment|0|||
147128144|NCT03648372|530635276|FG001|Overall Study|Start of a New Systemic Treatment|0|||
147128145|NCT03648372|530635277|FG002|Overall Study|Start of a New Systemic Treatment|0|||
147128146|NCT03648372|530635278|FG003|Overall Study|Start of a New Systemic Treatment|0|||
147128147|NCT03648372|530635279|FG004|Overall Study|Start of a New Systemic Treatment|0|||
147128148|NCT03648372|530635280|FG005|Overall Study|Start of a New Systemic Treatment|0|||
147128149|NCT03648372|530635281|FG006|Overall Study|Start of a New Systemic Treatment|0|||
147128150|NCT03648372|530635282|FG007|Overall Study|Start of a New Systemic Treatment|2|||
147128151|NCT03648372|530635283|FG008|Overall Study|Start of a New Systemic Treatment|0|||
147128152|NCT03648372|530635284|FG009|Overall Study|Start of a New Systemic Treatment|0|||
147128153|NCT03648372|530635285|FG010|Overall Study|Start of a New Systemic Treatment|1|||
147128154|NCT03648372|530635286|FG011|Overall Study|Start of a New Systemic Treatment|0|||
147651256|NCT00394771|532544655|FG003|Overall Study|Adverse Event|8|||
147128155|NCT03648372|530635287|FG012|Overall Study|Start of a New Systemic Treatment|0|||
147128156|NCT03648372|530635288|FG013|Overall Study|Start of a New Systemic Treatment|0|||
147128157|NCT03648372|530635289|FG014|Overall Study|Start of a New Systemic Treatment|0|||
147128158|NCT03648372|530635290|FG015|Overall Study|Start of a New Systemic Treatment|0|||
147128159|NCT03648372|530635291|FG016|Overall Study|Start of a New Systemic Treatment|0|||
147128160|NCT03648372|530635292|FG017|Overall Study|Start of a New Systemic Treatment|0|||
147128161|NCT03648372|530635293|FG018|Overall Study|Start of a New Systemic Treatment|0|||
147316987|NCT01809210|531327235|FG001|Overall Study|Withdrawal by Subject|0|||
147316988|NCT01809210|531327236|FG002|Overall Study|Withdrawal by Subject|1|||
147316989|NCT01809210|531327237|FG003|Overall Study|Withdrawal by Subject|1|||
147128162|NCT03648372|530635294|FG019|Overall Study|Start of a New Systemic Treatment|0|||
147128163|NCT03648372|530635295|FG020|Overall Study|Start of a New Systemic Treatment|0|||
147128164|NCT00791648|530636417|FG000|Overall Study|Physician Decision|0|||
147128165|NCT00791648|530636418|FG001|Overall Study|Physician Decision|1|||
147128166|NCT00791648|530636417|FG000|Overall Study|Withdrawal by Subject|0|||
147128167|NCT00791648|530636418|FG001|Overall Study|Withdrawal by Subject|1|||
147128168|NCT00462826|530636419|FG000|Overall Study|Ineligible - second primary|1|||
147128169|NCT00462826|530636419|FG000|Overall Study|Ineligible - wrong cell type|1|||
147128170|NCT00462826|530636419|FG000|Overall Study|Ineligible - wrong primary|2|||
147128171|NCT00462826|530636419|FG000|Overall Study|Never treated|1|||
147128172|NCT01373281|530636421|FG000|Vaccination Phase (Up to 25 Months)|Withdrawal by Subject|40|||
147128173|NCT01373281|530636422|FG001|Vaccination Phase (Up to 25 Months)|Withdrawal by Subject|23|||
147128174|NCT01373281|530636421|FG000|Vaccination Phase (Up to 25 Months)|Protocol Violation|5|||
147128175|NCT01373281|530636422|FG001|Vaccination Phase (Up to 25 Months)|Protocol Violation|2|||
147128176|NCT01373281|530636421|FG000|Vaccination Phase (Up to 25 Months)|Lost to Follow-up|5|||
147128177|NCT01373281|530636422|FG001|Vaccination Phase (Up to 25 Months)|Lost to Follow-up|1|||
147128178|NCT01373281|530636421|FG000|Vaccination Phase (Up to 25 Months)|Serious adverse event|4|||
147128179|NCT01373281|530636422|FG001|Vaccination Phase (Up to 25 Months)|Serious adverse event|1|||
147128180|NCT01373281|530636421|FG000|Surveillance Expansion Period|Withdrawal by Subject|180|||
147128181|NCT01373281|530636422|FG001|Surveillance Expansion Period|Withdrawal by Subject|105|||
147128182|NCT01373281|530636421|FG000|Surveillance Expansion Period|Protocol Violation|9|||
147128183|NCT01373281|530636422|FG001|Surveillance Expansion Period|Protocol Violation|1|||
147128184|NCT01373281|530636421|FG000|Surveillance Expansion Period|Lost to Follow-up|10|||
147128185|NCT01373281|530636422|FG001|Surveillance Expansion Period|Lost to Follow-up|8|||
147128186|NCT01373281|530636421|FG000|Surveillance Expansion Period|Serious adverse event|3|||
147128187|NCT01373281|530636422|FG001|Surveillance Expansion Period|Serious adverse event|4|||
147235182|NCT00142298|531031732|FG008|Overall Study|Adverse Event|0|||
147235183|NCT00142298|531031733|FG009|Overall Study|Adverse Event|0|||
147235184|NCT00142298|531031724|FG000|Overall Study|Clinical disease progression|1|||
147316990|NCT01809210|531327238|FG004|Overall Study|Withdrawal by Subject|1|||
147316991|NCT01809210|531327239|FG005|Overall Study|Withdrawal by Subject|0|||
147316992|NCT01809210|531327240|FG006|Overall Study|Withdrawal by Subject|4|||
147316993|NCT01809210|531327234|FG000|Overall Study|Death|1|||
147316994|NCT01809210|531327235|FG001|Overall Study|Death|1|||
147316995|NCT01809210|531327236|FG002|Overall Study|Death|2|||
147316996|NCT01809210|531327237|FG003|Overall Study|Death|0|||
147316997|NCT01809210|531327238|FG004|Overall Study|Death|1|||
147316998|NCT01809210|531327239|FG005|Overall Study|Death|3|||
147316999|NCT01809210|531327240|FG006|Overall Study|Death|1|||
147317000|NCT00590980|531327241|FG000|Overall Study|Did not meet all inclusion criteria|10|||
147317001|NCT01489020|531327248|FG000|Overall Study|Withdrawal by Subject|1|||
147317002|NCT01489020|531327249|FG001|Overall Study|Withdrawal by Subject|0|||
147317003|NCT01489020|531327250|FG002|Overall Study|Withdrawal by Subject|0|||
147317004|NCT01489020|531327251|FG003|Overall Study|Withdrawal by Subject|0|||
147317005|NCT01489020|531327252|FG004|Overall Study|Withdrawal by Subject|0|||
147317006|NCT01489020|531327253|FG005|Overall Study|Withdrawal by Subject|0|||
147317007|NCT01489020|531327248|FG000|Overall Study|Adverse Event|0|||
147317008|NCT01489020|531327249|FG001|Overall Study|Adverse Event|0|||
147317009|NCT01489020|531327250|FG002|Overall Study|Adverse Event|3|||
147317010|NCT01489020|531327251|FG003|Overall Study|Adverse Event|0|||
147317011|NCT01489020|531327252|FG004|Overall Study|Adverse Event|3|||
147317012|NCT01489020|531327253|FG005|Overall Study|Adverse Event|0|||
147317013|NCT01489020|531327248|FG000|Overall Study|Concomitant disease|0|||
147317014|NCT01489020|531327249|FG001|Overall Study|Concomitant disease|0|||
147235185|NCT00142298|531031725|FG001|Overall Study|Clinical disease progression|0|||
147235186|NCT00142298|531031726|FG002|Overall Study|Clinical disease progression|0|||
147235187|NCT00142298|531031727|FG003|Overall Study|Clinical disease progression|0|||
147235188|NCT00142298|531031728|FG004|Overall Study|Clinical disease progression|0|||
147235189|NCT00142298|531031729|FG005|Overall Study|Clinical disease progression|0|||
147235190|NCT00142298|531031730|FG006|Overall Study|Clinical disease progression|0|||
147235191|NCT00142298|531031731|FG007|Overall Study|Clinical disease progression|0|||
147235192|NCT00142298|531031732|FG008|Overall Study|Clinical disease progression|0|||
147235193|NCT00142298|531031733|FG009|Overall Study|Clinical disease progression|0|||
147317015|NCT01489020|531327250|FG002|Overall Study|Concomitant disease|0|||
147317016|NCT01489020|531327251|FG003|Overall Study|Concomitant disease|0|||
147651257|NCT00394771|532544652|FG000|Overall Study|Participant pregnant|0|||
147235194|NCT00142298|531031724|FG000|Overall Study|Death|1|||
147235195|NCT00142298|531031725|FG001|Overall Study|Death|1|||
147235196|NCT00142298|531031726|FG002|Overall Study|Death|1|||
147317017|NCT01489020|531327252|FG004|Overall Study|Concomitant disease|3|||
147317018|NCT01489020|531327253|FG005|Overall Study|Concomitant disease|0|||
147317019|NCT02451930|531327255|FG000|Overall Study|Death|0|||
147568979|NCT01597245|532240139|FG018|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
147128188|NCT03502681|530636423|FG000|Overall Study|Adverse Event|1|||
147128189|NCT03502681|530636424|FG001|Overall Study|Adverse Event|1|||
147128190|NCT03502681|530636423|FG000|Overall Study|Disease Progression|2|||
147128191|NCT03502681|530636424|FG001|Overall Study|Disease Progression|1|||
147128192|NCT03436732|530636425|FG000|Overall Study|Not treated-enrolled in different study|1|||
147128193|NCT03436732|530636426|FG001|Overall Study|Not treated-enrolled in different study|0|||
147128194|NCT03436732|530636425|FG000|Overall Study|Off study after cycle 1|1|||
147128195|NCT03436732|530636426|FG001|Overall Study|Off study after cycle 1|0|||
147128196|NCT03436732|530636425|FG000|Overall Study|Adverse Event|2|||
147128197|NCT03436732|530636426|FG001|Overall Study|Adverse Event|0|||
147128198|NCT03436732|530636425|FG000|Overall Study|Death|0|||
147128199|NCT03436732|530636426|FG001|Overall Study|Death|1|||
147128200|NCT00939185|530636427|FG000|Overall Study|Adverse Event|3|||
147128201|NCT00939185|530636427|FG000|Overall Study|Lack of Efficacy|1|||
147128202|NCT00939185|530636427|FG000|Overall Study|Lost to Follow-up|6|||
147128203|NCT00939185|530636427|FG000|Overall Study|Other|3|||
147128204|NCT00939185|530636427|FG000|Overall Study|Withdrawal by Subject|2|||
147128205|NCT00939185|530636427|FG000|Overall Study|Randomized But Did Not Receive Treatment|10|||
147128206|NCT03552029|530636428|FG000|Overall Study|Death|3|||
147128207|NCT03552029|530636429|FG001|Overall Study|Death|0|||
147128208|NCT03552029|530636428|FG000|Overall Study|Adverse Event|1|||
147128209|NCT03552029|530636429|FG001|Overall Study|Adverse Event|0|||
147128210|NCT03552029|530636428|FG000|Overall Study|Lack of Efficacy|0|||
147128211|NCT03552029|530636429|FG001|Overall Study|Lack of Efficacy|2|||
147128212|NCT03552029|530636428|FG000|Overall Study|Physician Decision|0|||
147128213|NCT03552029|530636429|FG001|Overall Study|Physician Decision|1|||
147128214|NCT03552029|530636428|FG000|Overall Study|Study terminated by Sponsor|0|||
147128215|NCT03552029|530636429|FG001|Overall Study|Study terminated by Sponsor|1|||
147128216|NCT03552029|530636428|FG000|Overall Study|Other|0|||
147128217|NCT03552029|530636429|FG001|Overall Study|Other|2|||
147128218|NCT03468998|530636431|FG000|Overall Study|Withdrawal by Subject|1|||
147128219|NCT03468998|530636432|FG001|Overall Study|Withdrawal by Subject|1|||
147128220|NCT03468998|530636433|FG002|Overall Study|Withdrawal by Subject|0|||
147128221|NCT03468998|530636434|FG003|Overall Study|Withdrawal by Subject|4|||
147128222|NCT03468998|530636435|FG004|Overall Study|Withdrawal by Subject|1|||
147128223|NCT03468998|530636436|FG005|Overall Study|Withdrawal by Subject|0|||
147128224|NCT00836706|530636437|FG000|Washout: 7 Days|Withdrawal by Subject|0|||
147128225|NCT00836706|530636438|FG001|Washout: 7 Days|Withdrawal by Subject|1|||
147128226|NCT02989857|530636439|FG000|Randomization Phase|Not Treated|3|||
147128227|NCT02989857|530636440|FG001|Randomization Phase|Not Treated|2|||
147128228|NCT02989857|530636441|FG002|Randomization Phase|Not Treated|0|||
147128229|NCT01905540|530636444|FG000|Period 3|Other|1|||
147128230|NCT01905540|530636445|FG001|Period 3|Other|0|||
147128231|NCT01905540|530636446|FG002|Period 3|Other|1|||
147128232|NCT01905540|530636447|FG003|Period 3|Other|1|||
147128233|NCT03847519|530636448|FG000|Overall Study|Death|5|||
147128234|NCT03847519|530636449|FG001|Overall Study|Death|8|||
147128235|NCT03847519|530636450|FG002|Overall Study|Death|1|||
147128236|NCT03847519|530636448|FG000|Overall Study|Lost to Follow-up|1|||
147128237|NCT03847519|530636449|FG001|Overall Study|Lost to Follow-up|2|||
147128238|NCT03847519|530636450|FG002|Overall Study|Lost to Follow-up|0|||
147128239|NCT03847519|530636448|FG000|Overall Study|Study Terminated by Sponsor|0|||
147128240|NCT03847519|530636449|FG001|Overall Study|Study Terminated by Sponsor|3|||
147128241|NCT03847519|530636450|FG002|Overall Study|Study Terminated by Sponsor|2|||
147128242|NCT02743962|530636451|FG000|Overall Study|Atrophic vaginitis diagnosed|1|||
147128243|NCT02743962|530636452|FG001|Overall Study|Atrophic vaginitis diagnosed|0|||
147128244|NCT00725985|530636456|FG000|ITP- Treatment Disposition|Adverse Event|20|||
147128245|NCT00725985|530636457|FG001|ITP- Treatment Disposition|Adverse Event|10|||
147128246|NCT00725985|530636458|FG002|ITP- Treatment Disposition|Adverse Event|5|||
147128247|NCT00725985|530636459|FG003|ITP- Treatment Disposition|Adverse Event|0|||
147128248|NCT00725985|530636460|FG004|ITP- Treatment Disposition|Adverse Event|0|||
147128249|NCT00725985|530636461|FG005|ITP- Treatment Disposition|Adverse Event|0|||
147128250|NCT00725985|530636462|FG006|ITP- Treatment Disposition|Adverse Event|0|||
147128251|NCT00725985|530636463|FG007|ITP- Treatment Disposition|Adverse Event|0|||
147128252|NCT00725985|530636464|FG008|ITP- Treatment Disposition|Adverse Event|0|||
147128253|NCT00725985|530636465|FG009|ITP- Treatment Disposition|Adverse Event|0|||
147128254|NCT00725985|530636466|FG010|ITP- Treatment Disposition|Adverse Event|0|||
147128255|NCT00725985|530636467|FG011|ITP- Treatment Disposition|Adverse Event|0|||
147128256|NCT00725985|530636456|FG000|ITP- Treatment Disposition|Lost to Follow-up|0|||
147128257|NCT00725985|530636457|FG001|ITP- Treatment Disposition|Lost to Follow-up|0|||
147128258|NCT00725985|530636458|FG002|ITP- Treatment Disposition|Lost to Follow-up|2|||
147235197|NCT00142298|531031727|FG003|Overall Study|Death|0|||
147235198|NCT00142298|531031728|FG004|Overall Study|Death|0|||
147235199|NCT00142298|531031729|FG005|Overall Study|Death|6|||
147235200|NCT00142298|531031730|FG006|Overall Study|Death|0|||
147235201|NCT00142298|531031731|FG007|Overall Study|Death|0|||
147235202|NCT00142298|531031732|FG008|Overall Study|Death|0|||
147235203|NCT00142298|531031733|FG009|Overall Study|Death|0|||
147128259|NCT00725985|530636459|FG003|ITP- Treatment Disposition|Lost to Follow-up|0|||
147128260|NCT00725985|530636460|FG004|ITP- Treatment Disposition|Lost to Follow-up|0|||
147128261|NCT00725985|530636461|FG005|ITP- Treatment Disposition|Lost to Follow-up|0|||
147128262|NCT00725985|530636462|FG006|ITP- Treatment Disposition|Lost to Follow-up|0|||
147128263|NCT00725985|530636463|FG007|ITP- Treatment Disposition|Lost to Follow-up|0|||
147128264|NCT00725985|530636464|FG008|ITP- Treatment Disposition|Lost to Follow-up|0|||
147128265|NCT00725985|530636465|FG009|ITP- Treatment Disposition|Lost to Follow-up|0|||
147128266|NCT00725985|530636466|FG010|ITP- Treatment Disposition|Lost to Follow-up|0|||
147235204|NCT00142298|531031724|FG000|Overall Study|Lack of Efficacy|44|||
147235205|NCT00142298|531031725|FG001|Overall Study|Lack of Efficacy|62|||
147235206|NCT00142298|531031726|FG002|Overall Study|Lack of Efficacy|9|||
147235207|NCT00142298|531031727|FG003|Overall Study|Lack of Efficacy|12|||
147235208|NCT00142298|531031728|FG004|Overall Study|Lack of Efficacy|1|||
147235209|NCT00142298|531031729|FG005|Overall Study|Lack of Efficacy|0|||
147235210|NCT00142298|531031730|FG006|Overall Study|Lack of Efficacy|0|||
147235211|NCT00142298|531031731|FG007|Overall Study|Lack of Efficacy|1|||
147235212|NCT00142298|531031732|FG008|Overall Study|Lack of Efficacy|0|||
147235213|NCT00142298|531031733|FG009|Overall Study|Lack of Efficacy|0|||
147235214|NCT00142298|531031724|FG000|Overall Study|Non-compliance|15|||
147235215|NCT00142298|531031725|FG001|Overall Study|Non-compliance|13|||
147235216|NCT00142298|531031726|FG002|Overall Study|Non-compliance|0|||
147235217|NCT00142298|531031727|FG003|Overall Study|Non-compliance|6|||
147235218|NCT00142298|531031728|FG004|Overall Study|Non-compliance|1|||
147235219|NCT00142298|531031729|FG005|Overall Study|Non-compliance|0|||
147235220|NCT00142298|531031730|FG006|Overall Study|Non-compliance|0|||
147235221|NCT00142298|531031731|FG007|Overall Study|Non-compliance|3|||
147235222|NCT00142298|531031732|FG008|Overall Study|Non-compliance|3|||
147235223|NCT00142298|531031733|FG009|Overall Study|Non-compliance|0|||
147235224|NCT00142298|531031724|FG000|Overall Study|Patient, Investigator,or Sponsor request|66|||
147235225|NCT00142298|531031725|FG001|Overall Study|Patient, Investigator,or Sponsor request|60|||
147235226|NCT00142298|531031726|FG002|Overall Study|Patient, Investigator,or Sponsor request|11|||
147235227|NCT00142298|531031727|FG003|Overall Study|Patient, Investigator,or Sponsor request|51|||
147235228|NCT00142298|531031728|FG004|Overall Study|Patient, Investigator,or Sponsor request|4|||
147235229|NCT00142298|531031729|FG005|Overall Study|Patient, Investigator,or Sponsor request|3|||
147235230|NCT00142298|531031730|FG006|Overall Study|Patient, Investigator,or Sponsor request|1|||
147235231|NCT00142298|531031731|FG007|Overall Study|Patient, Investigator,or Sponsor request|4|||
147235232|NCT00142298|531031732|FG008|Overall Study|Patient, Investigator,or Sponsor request|1|||
147235233|NCT00142298|531031733|FG009|Overall Study|Patient, Investigator,or Sponsor request|0|||
147235234|NCT00142298|531031724|FG000|Overall Study|Pregnancy|4|||
147235235|NCT00142298|531031725|FG001|Overall Study|Pregnancy|4|||
147235236|NCT00142298|531031726|FG002|Overall Study|Pregnancy|2|||
147235237|NCT00142298|531031727|FG003|Overall Study|Pregnancy|3|||
147235238|NCT00142298|531031728|FG004|Overall Study|Pregnancy|0|||
147235239|NCT00142298|531031729|FG005|Overall Study|Pregnancy|0|||
147235240|NCT00142298|531031730|FG006|Overall Study|Pregnancy|0|||
147235241|NCT00142298|531031731|FG007|Overall Study|Pregnancy|0|||
147235242|NCT00142298|531031732|FG008|Overall Study|Pregnancy|1|||
147235243|NCT00142298|531031733|FG009|Overall Study|Pregnancy|0|||
147235244|NCT00142298|531031724|FG000|Overall Study|Virologic breakthrough|19|||
147235245|NCT00142298|531031725|FG001|Overall Study|Virologic breakthrough|23|||
147235246|NCT00142298|531031726|FG002|Overall Study|Virologic breakthrough|9|||
147235247|NCT00142298|531031727|FG003|Overall Study|Virologic breakthrough|7|||
147235248|NCT00142298|531031728|FG004|Overall Study|Virologic breakthrough|2|||
147235249|NCT00142298|531031729|FG005|Overall Study|Virologic breakthrough|3|||
147235250|NCT00142298|531031730|FG006|Overall Study|Virologic breakthrough|3|||
147235251|NCT00142298|531031731|FG007|Overall Study|Virologic breakthrough|0|||
147235252|NCT00142298|531031732|FG008|Overall Study|Virologic breakthrough|0|||
147235253|NCT00142298|531031733|FG009|Overall Study|Virologic breakthrough|0|||
147235254|NCT00142298|531031724|FG000|Overall Study|Other- not specified|0|||
147235255|NCT00142298|531031725|FG001|Overall Study|Other- not specified|3|||
147235256|NCT00142298|531031726|FG002|Overall Study|Other- not specified|0|||
147235257|NCT00142298|531031727|FG003|Overall Study|Other- not specified|1|||
147235258|NCT00142298|531031728|FG004|Overall Study|Other- not specified|0|||
147235259|NCT00142298|531031729|FG005|Overall Study|Other- not specified|0|||
147235260|NCT00142298|531031730|FG006|Overall Study|Other- not specified|0|||
147568980|NCT01597245|532240140|FG019|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
147568981|NCT01597245|532240141|FG020|Long Term Extension (Week 60 - Week 264)|Lost to Follow-up|0|||
147128267|NCT00725985|530636467|FG011|ITP- Treatment Disposition|Lost to Follow-up|0|||
147235261|NCT00142298|531031731|FG007|Overall Study|Other- not specified|0|||
147235262|NCT00142298|531031732|FG008|Overall Study|Other- not specified|0|||
147235263|NCT00142298|531031733|FG009|Overall Study|Other- not specified|0|||
147235264|NCT00142298|531031724|FG000|Overall Study|Lost to Follow-up|0|||
147235265|NCT00142298|531031725|FG001|Overall Study|Lost to Follow-up|0|||
147235266|NCT00142298|531031726|FG002|Overall Study|Lost to Follow-up|0|||
147235267|NCT00142298|531031727|FG003|Overall Study|Lost to Follow-up|0|||
147568982|NCT01597245|532240121|FG000|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
147128268|NCT00725985|530636456|FG000|ITP- Treatment Disposition|Randomized but not treated|1|||
147128269|NCT00725985|530636457|FG001|ITP- Treatment Disposition|Randomized but not treated|0|||
147128270|NCT00725985|530636458|FG002|ITP- Treatment Disposition|Randomized but not treated|0|||
147128271|NCT00725985|530636459|FG003|ITP- Treatment Disposition|Randomized but not treated|0|||
147128272|NCT00725985|530636460|FG004|ITP- Treatment Disposition|Randomized but not treated|0|||
147128273|NCT00725985|530636461|FG005|ITP- Treatment Disposition|Randomized but not treated|0|||
147128274|NCT00725985|530636462|FG006|ITP- Treatment Disposition|Randomized but not treated|0|||
147128275|NCT00725985|530636463|FG007|ITP- Treatment Disposition|Randomized but not treated|0|||
147128276|NCT00725985|530636464|FG008|ITP- Treatment Disposition|Randomized but not treated|0|||
147128277|NCT00725985|530636465|FG009|ITP- Treatment Disposition|Randomized but not treated|0|||
147128278|NCT00725985|530636466|FG010|ITP- Treatment Disposition|Randomized but not treated|0|||
147128279|NCT00725985|530636467|FG011|ITP- Treatment Disposition|Randomized but not treated|0|||
147128280|NCT00725985|530636456|FG000|ITP- Treatment Disposition|Converted to CDMS|30|||
147128281|NCT00725985|530636457|FG001|ITP- Treatment Disposition|Converted to CDMS|27|||
147128282|NCT00725985|530636458|FG002|ITP- Treatment Disposition|Converted to CDMS|71|||
147128283|NCT00725985|530636459|FG003|ITP- Treatment Disposition|Converted to CDMS|0|||
147128284|NCT00725985|530636460|FG004|ITP- Treatment Disposition|Converted to CDMS|0|||
147128285|NCT00725985|530636461|FG005|ITP- Treatment Disposition|Converted to CDMS|0|||
147128286|NCT00725985|530636462|FG006|ITP- Treatment Disposition|Converted to CDMS|0|||
147128287|NCT00725985|530636463|FG007|ITP- Treatment Disposition|Converted to CDMS|0|||
147128288|NCT00725985|530636464|FG008|ITP- Treatment Disposition|Converted to CDMS|0|||
147128289|NCT00725985|530636465|FG009|ITP- Treatment Disposition|Converted to CDMS|0|||
147128290|NCT00725985|530636466|FG010|ITP- Treatment Disposition|Converted to CDMS|0|||
147128291|NCT00725985|530636467|FG011|ITP- Treatment Disposition|Converted to CDMS|0|||
147128292|NCT00725985|530636456|FG000|ITP- Treatment Disposition|Other|50|||
147128293|NCT00725985|530636457|FG001|ITP- Treatment Disposition|Other|38|||
147128294|NCT00725985|530636458|FG002|ITP- Treatment Disposition|Other|24|||
147128295|NCT00725985|530636459|FG003|ITP- Treatment Disposition|Other|0|||
147128296|NCT00725985|530636460|FG004|ITP- Treatment Disposition|Other|0|||
147128297|NCT00725985|530636461|FG005|ITP- Treatment Disposition|Other|0|||
147128298|NCT00725985|530636462|FG006|ITP- Treatment Disposition|Other|0|||
147128299|NCT00725985|530636463|FG007|ITP- Treatment Disposition|Other|0|||
147128300|NCT00725985|530636464|FG008|ITP- Treatment Disposition|Other|0|||
147128301|NCT00725985|530636465|FG009|ITP- Treatment Disposition|Other|0|||
147128302|NCT00725985|530636466|FG010|ITP- Treatment Disposition|Other|0|||
147128303|NCT00725985|530636467|FG011|ITP- Treatment Disposition|Other|0|||
147128304|NCT00725985|530636456|FG000|OLMP (Up to 96 Weeks)|Adverse Event|0|||
147128305|NCT00725985|530636457|FG001|OLMP (Up to 96 Weeks)|Adverse Event|0|||
147128306|NCT00725985|530636458|FG002|OLMP (Up to 96 Weeks)|Adverse Event|0|||
147128307|NCT00725985|530636459|FG003|OLMP (Up to 96 Weeks)|Adverse Event|2|||
147128308|NCT00725985|530636460|FG004|OLMP (Up to 96 Weeks)|Adverse Event|2|||
147128309|NCT00725985|530636461|FG005|OLMP (Up to 96 Weeks)|Adverse Event|5|||
147128310|NCT00725985|530636462|FG006|OLMP (Up to 96 Weeks)|Adverse Event|0|||
147128311|NCT00725985|530636463|FG007|OLMP (Up to 96 Weeks)|Adverse Event|0|||
147128312|NCT00725985|530636464|FG008|OLMP (Up to 96 Weeks)|Adverse Event|0|||
147128313|NCT00725985|530636465|FG009|OLMP (Up to 96 Weeks)|Adverse Event|0|||
147128314|NCT00725985|530636466|FG010|OLMP (Up to 96 Weeks)|Adverse Event|0|||
147128315|NCT00725985|530636467|FG011|OLMP (Up to 96 Weeks)|Adverse Event|0|||
147128316|NCT00725985|530636456|FG000|OLMP (Up to 96 Weeks)|Death|0|||
147128317|NCT00725985|530636457|FG001|OLMP (Up to 96 Weeks)|Death|0|||
147128318|NCT00725985|530636458|FG002|OLMP (Up to 96 Weeks)|Death|0|||
147128319|NCT00725985|530636459|FG003|OLMP (Up to 96 Weeks)|Death|0|||
147128320|NCT00725985|530636460|FG004|OLMP (Up to 96 Weeks)|Death|1|||
147128321|NCT00725985|530636461|FG005|OLMP (Up to 96 Weeks)|Death|0|||
147128322|NCT00725985|530636462|FG006|OLMP (Up to 96 Weeks)|Death|0|||
147128323|NCT00725985|530636463|FG007|OLMP (Up to 96 Weeks)|Death|0|||
147128324|NCT00725985|530636464|FG008|OLMP (Up to 96 Weeks)|Death|0|||
147128325|NCT00725985|530636465|FG009|OLMP (Up to 96 Weeks)|Death|0|||
147128326|NCT00725985|530636466|FG010|OLMP (Up to 96 Weeks)|Death|0|||
147128327|NCT00725985|530636467|FG011|OLMP (Up to 96 Weeks)|Death|0|||
147128328|NCT00725985|530636456|FG000|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
147128329|NCT00725985|530636457|FG001|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
147128330|NCT00725985|530636458|FG002|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
147128331|NCT00725985|530636459|FG003|OLMP (Up to 96 Weeks)|Lost to Follow-up|1|||
147128332|NCT00725985|530636460|FG004|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
147128333|NCT00725985|530636461|FG005|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
147128334|NCT00725985|530636462|FG006|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
147128335|NCT00725985|530636463|FG007|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
147128336|NCT00725985|530636464|FG008|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
147128337|NCT00725985|530636465|FG009|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
147128338|NCT00725985|530636466|FG010|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
147235268|NCT00142298|531031728|FG004|Overall Study|Lost to Follow-up|0|||
147128339|NCT00725985|530636467|FG011|OLMP (Up to 96 Weeks)|Lost to Follow-up|0|||
147128340|NCT00725985|530636456|FG000|OLMP (Up to 96 Weeks)|Disease progression|0|||
147128341|NCT00725985|530636457|FG001|OLMP (Up to 96 Weeks)|Disease progression|0|||
147444660|NCT01147744|531792659|FG002|Overall Study|Sponsor decision to amend protocol|2|||
147128342|NCT00725985|530636458|FG002|OLMP (Up to 96 Weeks)|Disease progression|0|||
147128343|NCT00725985|530636459|FG003|OLMP (Up to 96 Weeks)|Disease progression|0|||
147128344|NCT00725985|530636460|FG004|OLMP (Up to 96 Weeks)|Disease progression|0|||
147128345|NCT00725985|530636461|FG005|OLMP (Up to 96 Weeks)|Disease progression|4|||
147128346|NCT00725985|530636462|FG006|OLMP (Up to 96 Weeks)|Disease progression|0|||
147128347|NCT00725985|530636463|FG007|OLMP (Up to 96 Weeks)|Disease progression|0|||
147128348|NCT00725985|530636464|FG008|OLMP (Up to 96 Weeks)|Disease progression|0|||
147128349|NCT00725985|530636465|FG009|OLMP (Up to 96 Weeks)|Disease progression|0|||
147128350|NCT00725985|530636466|FG010|OLMP (Up to 96 Weeks)|Disease progression|0|||
147128351|NCT00725985|530636467|FG011|OLMP (Up to 96 Weeks)|Disease progression|0|||
147128352|NCT00725985|530636456|FG000|OLMP (Up to 96 Weeks)|Other|0|||
147128353|NCT00725985|530636457|FG001|OLMP (Up to 96 Weeks)|Other|0|||
147128354|NCT00725985|530636458|FG002|OLMP (Up to 96 Weeks)|Other|0|||
147128355|NCT00725985|530636459|FG003|OLMP (Up to 96 Weeks)|Other|15|||
147128356|NCT00725985|530636460|FG004|OLMP (Up to 96 Weeks)|Other|20|||
147128357|NCT00725985|530636461|FG005|OLMP (Up to 96 Weeks)|Other|44|||
147128358|NCT00725985|530636462|FG006|OLMP (Up to 96 Weeks)|Other|0|||
147128359|NCT00725985|530636463|FG007|OLMP (Up to 96 Weeks)|Other|0|||
147128360|NCT00725985|530636464|FG008|OLMP (Up to 96 Weeks)|Other|0|||
147128361|NCT00725985|530636465|FG009|OLMP (Up to 96 Weeks)|Other|0|||
147128362|NCT00725985|530636466|FG010|OLMP (Up to 96 Weeks)|Other|0|||
147128363|NCT00725985|530636467|FG011|OLMP (Up to 96 Weeks)|Other|0|||
147128364|NCT00725985|530636456|FG000|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
147128365|NCT00725985|530636457|FG001|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
147128366|NCT00725985|530636458|FG002|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
147128367|NCT00725985|530636459|FG003|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
147128368|NCT00725985|530636460|FG004|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
147128369|NCT00725985|530636461|FG005|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
147128370|NCT00725985|530636462|FG006|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
147128371|NCT00725985|530636463|FG007|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|1|||
147128372|NCT00725985|530636464|FG008|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
147128373|NCT00725985|530636465|FG009|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
147128374|NCT00725985|530636466|FG010|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
147128375|NCT00725985|530636467|FG011|LTFU (Cladribine Treatment) (48 Weeks)|Adverse Event|0|||
147128376|NCT00725985|530636456|FG000|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
147128377|NCT00725985|530636457|FG001|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
147128378|NCT00725985|530636458|FG002|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
147128379|NCT00725985|530636459|FG003|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
147128380|NCT00725985|530636460|FG004|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
147128381|NCT00725985|530636461|FG005|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
147128382|NCT00725985|530636462|FG006|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
147128383|NCT00725985|530636463|FG007|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
147128384|NCT00725985|530636464|FG008|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|1|||
147128385|NCT00725985|530636465|FG009|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
147128386|NCT00725985|530636466|FG010|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
147128387|NCT00725985|530636467|FG011|LTFU (Cladribine Treatment) (48 Weeks)|Lost to Follow-up|0|||
147128388|NCT00725985|530636456|FG000|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
147128389|NCT00725985|530636457|FG001|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
147128390|NCT00725985|530636458|FG002|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
147128391|NCT00725985|530636459|FG003|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
147128392|NCT00725985|530636460|FG004|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
147128393|NCT00725985|530636461|FG005|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
147128394|NCT00725985|530636462|FG006|LTFU (Cladribine Treatment) (48 Weeks)|Other|9|||
147128395|NCT00725985|530636463|FG007|LTFU (Cladribine Treatment) (48 Weeks)|Other|8|||
147128396|NCT00725985|530636464|FG008|LTFU (Cladribine Treatment) (48 Weeks)|Other|16|||
147128397|NCT00725985|530636465|FG009|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
147128398|NCT00725985|530636466|FG010|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
147235269|NCT00142298|531031729|FG005|Overall Study|Lost to Follow-up|0|||
147235270|NCT00142298|531031730|FG006|Overall Study|Lost to Follow-up|2|||
147235271|NCT00142298|531031731|FG007|Overall Study|Lost to Follow-up|0|||
147235272|NCT00142298|531031732|FG008|Overall Study|Lost to Follow-up|0|||
147235273|NCT00142298|531031733|FG009|Overall Study|Lost to Follow-up|0|||
147235274|NCT00142298|531031724|FG000|Overall Study|Treatment Failure|0|||
147235275|NCT00142298|531031725|FG001|Overall Study|Treatment Failure|0|||
147235276|NCT00142298|531031726|FG002|Overall Study|Treatment Failure|0|||
147235277|NCT00142298|531031727|FG003|Overall Study|Treatment Failure|0|||
147235278|NCT00142298|531031728|FG004|Overall Study|Treatment Failure|0|||
147235279|NCT00142298|531031729|FG005|Overall Study|Treatment Failure|2|||
147235280|NCT00142298|531031730|FG006|Overall Study|Treatment Failure|2|||
147235281|NCT00142298|531031731|FG007|Overall Study|Treatment Failure|0|||
147128399|NCT00725985|530636467|FG011|LTFU (Cladribine Treatment) (48 Weeks)|Other|0|||
147128400|NCT00725985|530636456|FG000|LTFU (No Cladribine) (48 Weeks)|Other|0|||
147128401|NCT00725985|530636457|FG001|LTFU (No Cladribine) (48 Weeks)|Other|0|||
147128402|NCT00725985|530636458|FG002|LTFU (No Cladribine) (48 Weeks)|Other|0|||
147128403|NCT00725985|530636459|FG003|LTFU (No Cladribine) (48 Weeks)|Other|0|||
147128404|NCT00725985|530636460|FG004|LTFU (No Cladribine) (48 Weeks)|Other|0|||
147128405|NCT00725985|530636461|FG005|LTFU (No Cladribine) (48 Weeks)|Other|0|||
147128406|NCT00725985|530636462|FG006|LTFU (No Cladribine) (48 Weeks)|Other|0|||
147128407|NCT00725985|530636463|FG007|LTFU (No Cladribine) (48 Weeks)|Other|0|||
147128408|NCT00725985|530636464|FG008|LTFU (No Cladribine) (48 Weeks)|Other|0|||
147128409|NCT00725985|530636465|FG009|LTFU (No Cladribine) (48 Weeks)|Other|34|||
147128410|NCT00725985|530636466|FG010|LTFU (No Cladribine) (48 Weeks)|Other|36|||
147128411|NCT00725985|530636467|FG011|LTFU (No Cladribine) (48 Weeks)|Other|14|||
147128412|NCT03931330|530636469|FG000|Overall Study|Physician Decision|1|||
147128413|NCT01381679|530636474|FG000|Overall Study|Adverse Event|3|||
147128414|NCT01381679|530636474|FG000|Overall Study|Lost to Follow-up|885|||
147128415|NCT04023487|530636475|FG000|Overall Study|Lost to Follow-up|5|||
147128416|NCT04023487|530636476|FG001|Overall Study|Lost to Follow-up|4|||
147128417|NCT04023487|530636475|FG000|Overall Study|Pregnancy|1|||
147128418|NCT04023487|530636476|FG001|Overall Study|Pregnancy|2|||
147128419|NCT04023487|530636475|FG000|Overall Study|Withdrawal by Subject|4|||
147128420|NCT04023487|530636476|FG001|Overall Study|Withdrawal by Subject|5|||
147128421|NCT04023487|530636475|FG000|Overall Study|Partially completed testing|8|||
147128422|NCT04023487|530636476|FG001|Overall Study|Partially completed testing|4|||
147128423|NCT03900650|530636477|FG000|Overall Study|Withdrawal by Subject|1|||
147128424|NCT03900650|530636478|FG001|Overall Study|Withdrawal by Subject|1|||
147128425|NCT03900650|530636479|FG002|Overall Study|Withdrawal by Subject|0|||
147128426|NCT03900650|530636480|FG003|Overall Study|Withdrawal by Subject|0|||
147128427|NCT03900650|530636477|FG000|Overall Study|Withdrawn by staff|1|||
147128428|NCT03900650|530636478|FG001|Overall Study|Withdrawn by staff|0|||
147128429|NCT03900650|530636479|FG002|Overall Study|Withdrawn by staff|0|||
147128430|NCT03900650|530636480|FG003|Overall Study|Withdrawn by staff|0|||
147128431|NCT02014376|530636483|FG000|Overall Study|Adverse Event|1|||
147128432|NCT02014376|530636484|FG001|Overall Study|Adverse Event|1|||
147128433|NCT02014376|530636485|FG002|Overall Study|Adverse Event|0|||
147128434|NCT02014376|530636483|FG000|Overall Study|Lost to Follow-up|2|||
147128435|NCT02014376|530636484|FG001|Overall Study|Lost to Follow-up|0|||
147128436|NCT02014376|530636485|FG002|Overall Study|Lost to Follow-up|0|||
147128437|NCT00721110|530636490|FG000|Overall Study|Ultram use|1|||
147128438|NCT00721110|530636491|FG001|Overall Study|Ultram use|0|||
147128439|NCT00721110|530636492|FG002|Overall Study|Ultram use|0|||
147128440|NCT00721110|530636493|FG003|Overall Study|Ultram use|0|||
147128441|NCT00721110|530636490|FG000|Overall Study|vertical incision|0|||
147128442|NCT00721110|530636491|FG001|Overall Study|vertical incision|0|||
147128443|NCT00721110|530636492|FG002|Overall Study|vertical incision|1|||
147128444|NCT00721110|530636493|FG003|Overall Study|vertical incision|0|||
147128445|NCT00635050|530636496|FG000|Overall Study|Withdrawal by Subject|1|||
147128446|NCT00086515|530636501|FG000|Phase A (Weeks 0-24)|Adverse Event|17|||
147128447|NCT00086515|530636502|FG001|Phase A (Weeks 0-24)|Adverse Event|9|||
147651258|NCT00394771|532544653|FG001|Overall Study|Participant pregnant|1|||
147651259|NCT00394771|532544654|FG002|Overall Study|Participant pregnant|2|||
147235282|NCT00142298|531031732|FG008|Overall Study|Treatment Failure|0|||
147235283|NCT00142298|531031733|FG009|Overall Study|Treatment Failure|0|||
147235284|NCT03360747|531031734|FG000|Overall Study|Voluntary Withdrawal|1|||
147235285|NCT00531934|531033682|FG000|Overall Study|Adverse Event|4|||
147235286|NCT00531934|531033683|FG001|Overall Study|Adverse Event|8|||
147235287|NCT00531934|531033682|FG000|Overall Study|Progression|52|||
147235288|NCT00531934|531033683|FG001|Overall Study|Progression|42|||
147235289|NCT00531934|531033682|FG000|Overall Study|Death|7|||
147317020|NCT02451930|531327256|FG001|Overall Study|Death|15|||
147317021|NCT02451930|531327255|FG000|Overall Study|Lost to Follow-up|0|||
147317022|NCT02451930|531327256|FG001|Overall Study|Lost to Follow-up|3|||
147317023|NCT02451930|531327255|FG000|Overall Study|Sponsor Decision|2|||
147128448|NCT00086515|530636501|FG000|Phase A (Weeks 0-24)|Lack of Efficacy|7|||
147128449|NCT00086515|530636502|FG001|Phase A (Weeks 0-24)|Lack of Efficacy|13|||
147128450|NCT00086515|530636501|FG000|Phase A (Weeks 0-24)|Lost to Follow-up|4|||
147128451|NCT00086515|530636502|FG001|Phase A (Weeks 0-24)|Lost to Follow-up|5|||
147235290|NCT00531934|531033683|FG001|Overall Study|Death|10|||
147317024|NCT02451930|531327256|FG001|Overall Study|Sponsor Decision|10|||
147317025|NCT02451930|531327255|FG000|Overall Study|Withdrawal by Subject|0|||
147651260|NCT00394771|532544655|FG003|Overall Study|Participant pregnant|2|||
147128452|NCT00086515|530636501|FG000|Phase A (Weeks 0-24)|Protocol Violation|3|||
147128453|NCT00086515|530636502|FG001|Phase A (Weeks 0-24)|Protocol Violation|1|||
147128454|NCT00086515|530636501|FG000|Phase A (Weeks 0-24)|Withdrawal by Subject|10|||
147235291|NCT00531934|531033682|FG000|Overall Study|Withdrawal by Subject|1|||
147235292|NCT00531934|531033683|FG001|Overall Study|Withdrawal by Subject|1|||
147235293|NCT00531934|531033682|FG000|Overall Study|Other|2|||
147128455|NCT00086515|530636502|FG001|Phase A (Weeks 0-24)|Withdrawal by Subject|10|||
147128456|NCT00086515|530636501|FG000|Phase A (Weeks 0-24)|Patient Moved|2|||
147128457|NCT00086515|530636502|FG001|Phase A (Weeks 0-24)|Patient Moved|3|||
147128458|NCT00086515|530636501|FG000|Phase A (Weeks 0-24)|Protocol-Spec lab discon criteria|4|||
147128459|NCT00086515|530636502|FG001|Phase A (Weeks 0-24)|Protocol-Spec lab discon criteria|3|||
147128460|NCT00086515|530636501|FG000|Phase A (Weeks 0-24)|Poor compliance|1|||
147128461|NCT00086515|530636502|FG001|Phase A (Weeks 0-24)|Poor compliance|0|||
147128462|NCT00086515|530636501|FG000|Phase A (Weeks 0-24)|Patient needed prohibited treatment|0|||
147128463|NCT00086515|530636502|FG001|Phase A (Weeks 0-24)|Patient needed prohibited treatment|1|||
147128464|NCT00086515|530636501|FG000|Phase A (Weeks 0-24)|Personal Circumstance|1|||
147128465|NCT00086515|530636502|FG001|Phase A (Weeks 0-24)|Personal Circumstance|0|||
147128466|NCT00086515|530636501|FG000|Phase A to Phase B Transition Period|Adverse Event|2|||
147128467|NCT00086515|530636502|FG001|Phase A to Phase B Transition Period|Adverse Event|1|||
147128468|NCT00086515|530636501|FG000|Phase A to Phase B Transition Period|Lack of Efficacy|2|||
147128469|NCT00086515|530636502|FG001|Phase A to Phase B Transition Period|Lack of Efficacy|2|||
147128470|NCT00086515|530636501|FG000|Phase A to Phase B Transition Period|Withdrawal by Subject|1|||
147128471|NCT00086515|530636502|FG001|Phase A to Phase B Transition Period|Withdrawal by Subject|0|||
147128472|NCT00086515|530636501|FG000|Phase A to Phase B Transition Period|Protocol Violation|0|||
147128473|NCT00086515|530636502|FG001|Phase A to Phase B Transition Period|Protocol Violation|1|||
147128474|NCT00086515|530636501|FG000|Phase A to Phase B Transition Period|Patient received Phase A rescue therapy|16|||
147128475|NCT00086515|530636502|FG001|Phase A to Phase B Transition Period|Patient received Phase A rescue therapy|23|||
147128476|NCT00086515|530636501|FG000|Phase A to Phase B Transition Period|Protocol-Spec lab discon criteria|1|||
147128477|NCT00086515|530636502|FG001|Phase A to Phase B Transition Period|Protocol-Spec lab discon criteria|1|||
147128478|NCT00086515|530636501|FG000|Phase A to Phase B Transition Period|Poor compliance|1|||
147128479|NCT00086515|530636502|FG001|Phase A to Phase B Transition Period|Poor compliance|0|||
147128480|NCT00086515|530636501|FG000|Phase A to Phase B Transition Period|Patient needed prohibited treatment|1|||
147128481|NCT00086515|530636502|FG001|Phase A to Phase B Transition Period|Patient needed prohibited treatment|0|||
147128482|NCT00086515|530636501|FG000|Phase B (Weeks 24-104)|Adverse Event|16|||
147128483|NCT00086515|530636502|FG001|Phase B (Weeks 24-104)|Adverse Event|10|||
147128484|NCT00086515|530636501|FG000|Phase B (Weeks 24-104)|Lack of Efficacy|94|||
147128485|NCT00086515|530636502|FG001|Phase B (Weeks 24-104)|Lack of Efficacy|19|||
147128486|NCT00086515|530636501|FG000|Phase B (Weeks 24-104)|Lost to Follow-up|13|||
147128487|NCT00086515|530636502|FG001|Phase B (Weeks 24-104)|Lost to Follow-up|4|||
147128488|NCT00086515|530636501|FG000|Phase B (Weeks 24-104)|Physician Decision|3|||
147128489|NCT00086515|530636502|FG001|Phase B (Weeks 24-104)|Physician Decision|0|||
147128490|NCT00086515|530636501|FG000|Phase B (Weeks 24-104)|Protocol Violation|1|||
147128491|NCT00086515|530636502|FG001|Phase B (Weeks 24-104)|Protocol Violation|0|||
147128492|NCT00086515|530636501|FG000|Phase B (Weeks 24-104)|Withdrawal by Subject|15|||
147128493|NCT00086515|530636502|FG001|Phase B (Weeks 24-104)|Withdrawal by Subject|5|||
147128494|NCT00086515|530636501|FG000|Phase B (Weeks 24-104)|Patient Moved|2|||
147128495|NCT00086515|530636502|FG001|Phase B (Weeks 24-104)|Patient Moved|2|||
147128496|NCT00086515|530636501|FG000|Phase B (Weeks 24-104)|Protocol-Specific discontinuation|5|||
147128497|NCT00086515|530636502|FG001|Phase B (Weeks 24-104)|Protocol-Specific discontinuation|3|||
147128498|NCT00086515|530636501|FG000|Phase B (Weeks 24-104)|Protocol-Specific lab discon criteria|36|||
147128499|NCT00086515|530636502|FG001|Phase B (Weeks 24-104)|Protocol-Specific lab discon criteria|10|||
147128500|NCT00086515|530636501|FG000|Phase B (Weeks 24-104)|Patient Died|3|||
147128501|NCT00086515|530636502|FG001|Phase B (Weeks 24-104)|Patient Died|1|||
147128502|NCT00086515|530636501|FG000|Phase B (Weeks 24-104)|Patient needed prohibited treatment|0|||
147128503|NCT00086515|530636502|FG001|Phase B (Weeks 24-104)|Patient needed prohibited treatment|1|||
147128504|NCT00086515|530636501|FG000|Phase B (Weeks 24-104)|Personal Circumstance|1|||
147128505|NCT00086515|530636502|FG001|Phase B (Weeks 24-104)|Personal Circumstance|0|||
147128506|NCT00086515|530636501|FG000|Phase B (Weeks 24-104)|Discontinued in error|1|||
147128507|NCT00086515|530636502|FG001|Phase B (Weeks 24-104)|Discontinued in error|0|||
147128508|NCT00209131|530636506|FG000|Overall Study|Lack of personnel due to turnovers.|15|||
147128509|NCT00209131|530636507|FG001|Overall Study|Lack of personnel due to turnovers.|11|||
147128510|NCT05081843|530636509|FG000|Overall Study|Lost to Follow-up|135|||
147128511|NCT05081843|530636510|FG001|Overall Study|Lost to Follow-up|145|||
147128512|NCT03034044|530636511|FG000|Overall Study|Enrolled, but not received Xyntha|1|||
147128513|NCT03709472|530636517|FG000|4 Month Assessment (Post Treatment)|Lost to Follow-up|8|||
147128514|NCT03709472|530636518|FG001|4 Month Assessment (Post Treatment)|Lost to Follow-up|30|||
147317026|NCT02451930|531327256|FG001|Overall Study|Withdrawal by Subject|1|||
147317027|NCT02451930|531327255|FG000|Overall Study|Other|0|||
147317028|NCT02451930|531327256|FG001|Overall Study|Other|1|||
147317029|NCT02485353|531327257|FG000|Overall Study|Death|1|||
147317030|NCT02485353|531327257|FG000|Overall Study|Disease Progression|1|||
147317031|NCT00839917|531327262|FG000|Overall Study|Lost to Follow-up|1|||
147317032|NCT00839917|531327263|FG001|Overall Study|Lost to Follow-up|0|||
147317033|NCT00839917|531327262|FG000|Overall Study|Did not receive vaccine|0|||
147317034|NCT00839917|531327263|FG001|Overall Study|Did not receive vaccine|1|||
147317035|NCT03354637|531327264|FG000|Double-blind Period|Protocol Violation|2|||
147317036|NCT03354637|531327265|FG001|Double-blind Period|Protocol Violation|0|||
147317037|NCT03354637|531327266|FG002|Double-blind Period|Protocol Violation|0|||
147128515|NCT03709472|530636517|FG000|Assessment (12-month Post Baseline)|Lost to Follow-up|12|||
147128516|NCT03709472|530636518|FG001|Assessment (12-month Post Baseline)|Lost to Follow-up|46|||
147128517|NCT03559556|530636519|FG000|Overall Study|Withdrawal by Subject|1|||
147128518|NCT01969058|530636521|FG000|Overall Study|Withdrawal by Subject|2|||
147128519|NCT01969058|530636522|FG001|Overall Study|Withdrawal by Subject|0|||
147128520|NCT01969058|530636521|FG000|Overall Study|Adverse Event|1|||
147128521|NCT01969058|530636522|FG001|Overall Study|Adverse Event|0|||
147128522|NCT02038036|530636527|FG000|Core Study|Adverse Event|7|||
147128523|NCT02038036|530636528|FG001|Core Study|Adverse Event|7|||
147128524|NCT02038036|530636527|FG000|Core Study|Death|1|||
147128525|NCT02038036|530636528|FG001|Core Study|Death|1|||
147128526|NCT02038036|530636527|FG000|Core Study|Disease progression|2|||
147128527|NCT02038036|530636528|FG001|Core Study|Disease progression|2|||
147128528|NCT02038036|530636527|FG000|Core Study|Lost to Follow-up|0|||
147128529|NCT02038036|530636528|FG001|Core Study|Lost to Follow-up|1|||
147128530|NCT02038036|530636527|FG000|Core Study|Physician Decision|2|||
147128531|NCT02038036|530636528|FG001|Core Study|Physician Decision|1|||
147128532|NCT02038036|530636527|FG000|Core Study|Subject/guardian decision|0|||
147128533|NCT02038036|530636528|FG001|Core Study|Subject/guardian decision|1|||
147128534|NCT02038036|530636527|FG000|Core Study|Withdrawal by Subject|3|||
147128535|NCT02038036|530636528|FG001|Core Study|Withdrawal by Subject|1|||
147128536|NCT02038036|530636527|FG000|Crossover Period|Withdrawal by Subject|0|||
147128537|NCT02038036|530636528|FG001|Crossover Period|Withdrawal by Subject|3|||
147128538|NCT02038036|530636527|FG000|Crossover Period|Adverse Event|0|||
147128539|NCT02038036|530636528|FG001|Crossover Period|Adverse Event|9|||
147128540|NCT02038036|530636527|FG000|Crossover Period|Death|0|||
147128541|NCT02038036|530636528|FG001|Crossover Period|Death|2|||
147128542|NCT02038036|530636527|FG000|Crossover Period|Disease progression|0|||
147128543|NCT02038036|530636528|FG001|Crossover Period|Disease progression|3|||
147128544|NCT02038036|530636527|FG000|Crossover Period|Lost to Follow-up|0|||
147128545|NCT02038036|530636528|FG001|Crossover Period|Lost to Follow-up|1|||
147128546|NCT02038036|530636527|FG000|Crossover Period|Physician Decision|0|||
147128547|NCT02038036|530636528|FG001|Crossover Period|Physician Decision|2|||
147128548|NCT01397253|530638172|FG000|Overall Study|Reviewed by only 1 pharmacist|126|||
147128549|NCT01397253|530638173|FG001|Overall Study|Reviewed by only 1 pharmacist|149|||
147128550|NCT00488293|530638176|FG000|Overall Study|Lost to Follow-up|28|||
147128551|NCT00488293|530638177|FG001|Overall Study|Lost to Follow-up|25|||
147128552|NCT00488293|530638176|FG000|Overall Study|Withdrawal by Subject|5|||
147128553|NCT00488293|530638177|FG001|Overall Study|Withdrawal by Subject|3|||
147128554|NCT00488293|530638176|FG000|Overall Study|Death|2|||
147128555|NCT00488293|530638177|FG001|Overall Study|Death|1|||
147128556|NCT00488293|530638176|FG000|Overall Study|Misrandomization/Other Unspecified|1|||
147128557|NCT00488293|530638177|FG001|Overall Study|Misrandomization/Other Unspecified|1|||
147128558|NCT00633126|530638181|FG000|Overall Study|Did not receive full dose|1|||
147128559|NCT00567502|530638187|FG000|Overall Study|Lost to Follow-up|91|||
147128560|NCT00567502|530638188|FG001|Overall Study|Lost to Follow-up|14|||
147128561|NCT00567502|530638189|FG002|Overall Study|Lost to Follow-up|351|||
147128562|NCT00567502|530638190|FG003|Overall Study|Lost to Follow-up|2|||
147128563|NCT00567502|530638187|FG000|Overall Study|Death|65|||
147128564|NCT00567502|530638188|FG001|Overall Study|Death|16|||
147128565|NCT00567502|530638189|FG002|Overall Study|Death|360|||
147128566|NCT00567502|530638190|FG003|Overall Study|Death|5|||
147128567|NCT00567502|530638187|FG000|Overall Study|Other|64|||
147128568|NCT00567502|530638188|FG001|Overall Study|Other|2|||
147128569|NCT00567502|530638189|FG002|Overall Study|Other|134|||
147128570|NCT00567502|530638190|FG003|Overall Study|Other|6|||
147128571|NCT00567502|530638187|FG000|Overall Study|Participant request|12|||
147128572|NCT00567502|530638188|FG001|Overall Study|Participant request|1|||
147128573|NCT00567502|530638189|FG002|Overall Study|Participant request|33|||
147128574|NCT00567502|530638190|FG003|Overall Study|Participant request|1|||
147128575|NCT00567502|530638187|FG000|Overall Study|Sponsor request|9|||
147128576|NCT00567502|530638188|FG001|Overall Study|Sponsor request|0|||
147128577|NCT00567502|530638189|FG002|Overall Study|Sponsor request|30|||
147128578|NCT00567502|530638190|FG003|Overall Study|Sponsor request|1|||
147128579|NCT00567502|530638187|FG000|Overall Study|Never Initiated Treatment|0|||
147128580|NCT00567502|530638188|FG001|Overall Study|Never Initiated Treatment|0|||
147128581|NCT00567502|530638189|FG002|Overall Study|Never Initiated Treatment|0|||
147128582|NCT00567502|530638190|FG003|Overall Study|Never Initiated Treatment|72|||
147128583|NCT00863304|530638194|FG000|Overall Study|Adverse Event|10|||
147128584|NCT00863304|530638195|FG001|Overall Study|Adverse Event|4|||
147128585|NCT00863304|530638196|FG002|Overall Study|Adverse Event|14|||
147128586|NCT00863304|530638197|FG003|Overall Study|Adverse Event|16|||
147128587|NCT00863304|530638194|FG000|Overall Study|Lost to Follow-up|1|||
147128588|NCT00863304|530638195|FG001|Overall Study|Lost to Follow-up|5|||
147128589|NCT00863304|530638196|FG002|Overall Study|Lost to Follow-up|4|||
147128590|NCT00863304|530638197|FG003|Overall Study|Lost to Follow-up|2|||
147128591|NCT00863304|530638194|FG000|Overall Study|Lack of Efficacy|57|||
147128592|NCT00863304|530638195|FG001|Overall Study|Lack of Efficacy|26|||
147128593|NCT00863304|530638196|FG002|Overall Study|Lack of Efficacy|30|||
147128594|NCT00863304|530638197|FG003|Overall Study|Lack of Efficacy|28|||
147128595|NCT00863304|530638194|FG000|Overall Study|Withdrawal by Subject|19|||
147128596|NCT00863304|530638195|FG001|Overall Study|Withdrawal by Subject|14|||
147128597|NCT00863304|530638196|FG002|Overall Study|Withdrawal by Subject|20|||
147128598|NCT00863304|530638197|FG003|Overall Study|Withdrawal by Subject|18|||
147128599|NCT00863304|530638194|FG000|Overall Study|Other|1|||
147128600|NCT00863304|530638195|FG001|Overall Study|Other|0|||
147128601|NCT00863304|530638196|FG002|Overall Study|Other|0|||
147128602|NCT00863304|530638197|FG003|Overall Study|Other|1|||
147128603|NCT00863304|530638194|FG000|Overall Study|Protocol Violation|2|||
147128604|NCT00863304|530638195|FG001|Overall Study|Protocol Violation|6|||
147128605|NCT00863304|530638196|FG002|Overall Study|Protocol Violation|2|||
147128606|NCT00863304|530638197|FG003|Overall Study|Protocol Violation|0|||
147128607|NCT00863304|530638194|FG000|Overall Study|Randomized, but not Treated|3|||
147128608|NCT00863304|530638195|FG001|Overall Study|Randomized, but not Treated|1|||
147128609|NCT00863304|530638196|FG002|Overall Study|Randomized, but not Treated|4|||
147128610|NCT00863304|530638197|FG003|Overall Study|Randomized, but not Treated|1|||
147128611|NCT00863304|530638194|FG000|Overall Study|Entered extension study|101|||
147128612|NCT00863304|530638195|FG001|Overall Study|Entered extension study|129|||
147128613|NCT00863304|530638196|FG002|Overall Study|Entered extension study|113|||
147128614|NCT00863304|530638197|FG003|Overall Study|Entered extension study|125|||
147128615|NCT02327169|530638198|FG000|Overall Study|Progressive Disease|1|||
147128616|NCT02327169|530638199|FG001|Overall Study|Progressive Disease|3|||
147128617|NCT02327169|530638200|FG002|Overall Study|Progressive Disease|4|||
147128618|NCT02327169|530638201|FG003|Overall Study|Progressive Disease|3|||
147128619|NCT02327169|530638202|FG004|Overall Study|Progressive Disease|4|||
147128620|NCT02327169|530638203|FG005|Overall Study|Progressive Disease|3|||
147128621|NCT02327169|530638204|FG006|Overall Study|Progressive Disease|3|||
147128622|NCT02327169|530638205|FG007|Overall Study|Progressive Disease|3|||
147128623|NCT02327169|530638206|FG008|Overall Study|Progressive Disease|4|||
147128624|NCT02327169|530638207|FG009|Overall Study|Progressive Disease|4|||
147128625|NCT02327169|530638208|FG010|Overall Study|Progressive Disease|4|||
147128626|NCT02327169|530638209|FG011|Overall Study|Progressive Disease|3|||
147128627|NCT02327169|530638210|FG012|Overall Study|Progressive Disease|1|||
147128628|NCT02327169|530638211|FG013|Overall Study|Progressive Disease|3|||
147128629|NCT02327169|530638212|FG014|Overall Study|Progressive Disease|3|||
147128630|NCT02327169|530638198|FG000|Overall Study|Adverse Event|2|||
147128631|NCT02327169|530638199|FG001|Overall Study|Adverse Event|0|||
147128632|NCT02327169|530638200|FG002|Overall Study|Adverse Event|1|||
147128633|NCT02327169|530638201|FG003|Overall Study|Adverse Event|0|||
147128634|NCT02327169|530638202|FG004|Overall Study|Adverse Event|1|||
147128635|NCT02327169|530638203|FG005|Overall Study|Adverse Event|0|||
147128636|NCT02327169|530638204|FG006|Overall Study|Adverse Event|0|||
147128637|NCT02327169|530638205|FG007|Overall Study|Adverse Event|0|||
147128638|NCT02327169|530638206|FG008|Overall Study|Adverse Event|0|||
147128639|NCT02327169|530638207|FG009|Overall Study|Adverse Event|2|||
147128640|NCT02327169|530638208|FG010|Overall Study|Adverse Event|0|||
147128641|NCT02327169|530638209|FG011|Overall Study|Adverse Event|3|||
147128642|NCT02327169|530638210|FG012|Overall Study|Adverse Event|0|||
147128643|NCT02327169|530638211|FG013|Overall Study|Adverse Event|2|||
147128644|NCT02327169|530638212|FG014|Overall Study|Adverse Event|1|||
147128645|NCT02327169|530638198|FG000|Overall Study|Symptomatic Deterioration|0|||
147128646|NCT02327169|530638199|FG001|Overall Study|Symptomatic Deterioration|0|||
147128647|NCT02327169|530638200|FG002|Overall Study|Symptomatic Deterioration|1|||
147128648|NCT02327169|530638201|FG003|Overall Study|Symptomatic Deterioration|0|||
147128649|NCT02327169|530638202|FG004|Overall Study|Symptomatic Deterioration|1|||
147128650|NCT02327169|530638203|FG005|Overall Study|Symptomatic Deterioration|1|||
147128651|NCT02327169|530638204|FG006|Overall Study|Symptomatic Deterioration|0|||
147128652|NCT02327169|530638205|FG007|Overall Study|Symptomatic Deterioration|0|||
147128653|NCT02327169|530638206|FG008|Overall Study|Symptomatic Deterioration|2|||
147128654|NCT02327169|530638207|FG009|Overall Study|Symptomatic Deterioration|1|||
147128655|NCT02327169|530638208|FG010|Overall Study|Symptomatic Deterioration|0|||
147128656|NCT02327169|530638209|FG011|Overall Study|Symptomatic Deterioration|0|||
147128657|NCT02327169|530638210|FG012|Overall Study|Symptomatic Deterioration|0|||
147128658|NCT02327169|530638211|FG013|Overall Study|Symptomatic Deterioration|2|||
147128659|NCT02327169|530638212|FG014|Overall Study|Symptomatic Deterioration|1|||
147128660|NCT02327169|530638198|FG000|Overall Study|Reason Not Specified|0|||
147128661|NCT02327169|530638199|FG001|Overall Study|Reason Not Specified|0|||
147317038|NCT03354637|531327264|FG000|Double-blind Period|Adverse Event|1|||
147128662|NCT02327169|530638200|FG002|Overall Study|Reason Not Specified|1|||
147128663|NCT02327169|530638201|FG003|Overall Study|Reason Not Specified|0|||
147128664|NCT02327169|530638202|FG004|Overall Study|Reason Not Specified|0|||
147128665|NCT02327169|530638203|FG005|Overall Study|Reason Not Specified|0|||
147128666|NCT02327169|530638204|FG006|Overall Study|Reason Not Specified|0|||
147128667|NCT02327169|530638205|FG007|Overall Study|Reason Not Specified|0|||
147128668|NCT02327169|530638206|FG008|Overall Study|Reason Not Specified|0|||
147128669|NCT02327169|530638207|FG009|Overall Study|Reason Not Specified|1|||
147128670|NCT02327169|530638208|FG010|Overall Study|Reason Not Specified|2|||
147128671|NCT02327169|530638209|FG011|Overall Study|Reason Not Specified|1|||
147128672|NCT02327169|530638210|FG012|Overall Study|Reason Not Specified|0|||
147128673|NCT02327169|530638211|FG013|Overall Study|Reason Not Specified|0|||
147128674|NCT02327169|530638212|FG014|Overall Study|Reason Not Specified|2|||
147128675|NCT02327169|530638198|FG000|Overall Study|Withdrawal by Subject|1|||
147128676|NCT02327169|530638199|FG001|Overall Study|Withdrawal by Subject|0|||
147128677|NCT02327169|530638200|FG002|Overall Study|Withdrawal by Subject|0|||
147128678|NCT02327169|530638201|FG003|Overall Study|Withdrawal by Subject|0|||
147128679|NCT02327169|530638202|FG004|Overall Study|Withdrawal by Subject|1|||
147128680|NCT02327169|530638203|FG005|Overall Study|Withdrawal by Subject|0|||
147128681|NCT02327169|530638204|FG006|Overall Study|Withdrawal by Subject|0|||
147128682|NCT02327169|530638205|FG007|Overall Study|Withdrawal by Subject|1|||
147128683|NCT02327169|530638206|FG008|Overall Study|Withdrawal by Subject|0|||
147128684|NCT02327169|530638207|FG009|Overall Study|Withdrawal by Subject|0|||
147128685|NCT02327169|530638208|FG010|Overall Study|Withdrawal by Subject|0|||
147128686|NCT02327169|530638209|FG011|Overall Study|Withdrawal by Subject|0|||
147128687|NCT02327169|530638210|FG012|Overall Study|Withdrawal by Subject|0|||
147128688|NCT02327169|530638211|FG013|Overall Study|Withdrawal by Subject|0|||
147128689|NCT02327169|530638212|FG014|Overall Study|Withdrawal by Subject|3|||
147128690|NCT02327169|530638198|FG000|Overall Study|Lost to Follow-up|0|||
147128691|NCT02327169|530638199|FG001|Overall Study|Lost to Follow-up|0|||
147128692|NCT02327169|530638200|FG002|Overall Study|Lost to Follow-up|0|||
147128693|NCT02327169|530638201|FG003|Overall Study|Lost to Follow-up|0|||
147128694|NCT02327169|530638202|FG004|Overall Study|Lost to Follow-up|1|||
147128695|NCT02327169|530638203|FG005|Overall Study|Lost to Follow-up|0|||
147128696|NCT02327169|530638204|FG006|Overall Study|Lost to Follow-up|0|||
147128697|NCT02327169|530638205|FG007|Overall Study|Lost to Follow-up|0|||
147128698|NCT02327169|530638206|FG008|Overall Study|Lost to Follow-up|0|||
147128699|NCT02327169|530638207|FG009|Overall Study|Lost to Follow-up|0|||
147128700|NCT02327169|530638208|FG010|Overall Study|Lost to Follow-up|0|||
147128701|NCT02327169|530638209|FG011|Overall Study|Lost to Follow-up|0|||
147128702|NCT02327169|530638210|FG012|Overall Study|Lost to Follow-up|0|||
147128703|NCT02327169|530638211|FG013|Overall Study|Lost to Follow-up|0|||
147128704|NCT02327169|530638212|FG014|Overall Study|Lost to Follow-up|0|||
147128705|NCT00023595|530638215|FG000|5 Year Follow up|Lost to Follow-up|2|||
147128706|NCT00023595|530638216|FG001|5 Year Follow up|Lost to Follow-up|2|||
147128707|NCT00023595|530638217|FG002|5 Year Follow up|Lost to Follow-up|1|||
147128708|NCT00023595|530638218|FG003|5 Year Follow up|Lost to Follow-up|7|||
147128709|NCT00023595|530638219|FG004|5 Year Follow up|Lost to Follow-up|3|||
147128710|NCT00023595|530638215|FG000|10 Year Follow up|Lost to Follow-up|12|||
147128711|NCT00023595|530638216|FG001|10 Year Follow up|Lost to Follow-up|10|||
147128712|NCT00023595|530638217|FG002|10 Year Follow up|Lost to Follow-up|3|||
147128713|NCT00023595|530638218|FG003|10 Year Follow up|Lost to Follow-up|0|||
147128714|NCT00023595|530638219|FG004|10 Year Follow up|Lost to Follow-up|0|||
147128715|NCT01309230|530638220|FG000|Overall Study|Withdrawal by Subject|0|||
147128716|NCT01309230|530638221|FG001|Overall Study|Withdrawal by Subject|2|||
147128717|NCT01309230|530638220|FG000|Overall Study|Observation arm closed|0|||
147128718|NCT01309230|530638221|FG001|Overall Study|Observation arm closed|2|||
147128719|NCT00427700|530638224|FG000|Overall Study|Lost to Follow-up|2|||
147128720|NCT00427700|530638225|FG001|Overall Study|Lost to Follow-up|5|||
147128721|NCT00427700|530638224|FG000|Overall Study|no induction of menses|1|||
147128722|NCT00427700|530638225|FG001|Overall Study|no induction of menses|4|||
147128723|NCT00427700|530638224|FG000|Overall Study|Pregnancy|0|||
147128724|NCT00427700|530638225|FG001|Overall Study|Pregnancy|2|||
147128725|NCT01362790|530638228|FG000|Pilot Phase & Phase 2|Changed treatment, too early to assess|1|||
147128726|NCT01362790|530638229|FG001|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
147128727|NCT01362790|530638230|FG002|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
147128728|NCT01362790|530638231|FG003|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
147235294|NCT00531934|531033683|FG001|Overall Study|Other|2|||
147235295|NCT00150709|531033685|FG000|Overall Study|Protocol Violation|7|||
147235296|NCT00150709|531033686|FG001|Overall Study|Protocol Violation|8|||
147235297|NCT00150709|531033687|FG002|Overall Study|Protocol Violation|3|||
147128729|NCT01362790|530638232|FG004|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
147128730|NCT01362790|530638233|FG005|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
147128731|NCT01362790|530638234|FG006|Pilot Phase & Phase 2|Changed treatment, too early to assess|0|||
147128732|NCT01362790|530638228|FG000|Pilot Phase & Phase 2|Adverse Event|0|||
147128733|NCT01362790|530638229|FG001|Pilot Phase & Phase 2|Adverse Event|1|||
147128734|NCT01362790|530638230|FG002|Pilot Phase & Phase 2|Adverse Event|0|||
147128735|NCT01362790|530638231|FG003|Pilot Phase & Phase 2|Adverse Event|1|||
147128736|NCT01362790|530638232|FG004|Pilot Phase & Phase 2|Adverse Event|0|||
147235298|NCT00150709|531033688|FG003|Overall Study|Protocol Violation|1|||
147235299|NCT00150709|531033685|FG000|Overall Study|Adverse Event|8|||
147235300|NCT00150709|531033686|FG001|Overall Study|Adverse Event|2|||
147128737|NCT01362790|530638233|FG005|Pilot Phase & Phase 2|Adverse Event|2|||
147128738|NCT01362790|530638234|FG006|Pilot Phase & Phase 2|Adverse Event|0|||
147128739|NCT01362790|530638228|FG000|Pilot Phase & Phase 2|Physician Decision|0|||
147235301|NCT00150709|531033687|FG002|Overall Study|Adverse Event|2|||
147128740|NCT01362790|530638229|FG001|Pilot Phase & Phase 2|Physician Decision|0|||
147128741|NCT01362790|530638230|FG002|Pilot Phase & Phase 2|Physician Decision|0|||
147128742|NCT01362790|530638231|FG003|Pilot Phase & Phase 2|Physician Decision|1|||
147317039|NCT03354637|531327265|FG001|Double-blind Period|Adverse Event|2|||
147317040|NCT03354637|531327266|FG002|Double-blind Period|Adverse Event|0|||
147128743|NCT01362790|530638232|FG004|Pilot Phase & Phase 2|Physician Decision|0|||
147128744|NCT01362790|530638233|FG005|Pilot Phase & Phase 2|Physician Decision|0|||
147128745|NCT01362790|530638234|FG006|Pilot Phase & Phase 2|Physician Decision|0|||
147128746|NCT01362790|530638228|FG000|Pilot Phase & Phase 2|Developed antibodies|7|||
147128747|NCT01362790|530638229|FG001|Pilot Phase & Phase 2|Developed antibodies|2|||
147128748|NCT01362790|530638230|FG002|Pilot Phase & Phase 2|Developed antibodies|3|||
147128749|NCT01362790|530638231|FG003|Pilot Phase & Phase 2|Developed antibodies|8|||
147128750|NCT01362790|530638232|FG004|Pilot Phase & Phase 2|Developed antibodies|0|||
147128751|NCT01362790|530638233|FG005|Pilot Phase & Phase 2|Developed antibodies|0|||
147128752|NCT01362790|530638234|FG006|Pilot Phase & Phase 2|Developed antibodies|0|||
147128753|NCT01362790|530638228|FG000|Pilot Phase & Phase 2|Refused further treatment|0|||
147128754|NCT01362790|530638229|FG001|Pilot Phase & Phase 2|Refused further treatment|1|||
147128755|NCT01362790|530638230|FG002|Pilot Phase & Phase 2|Refused further treatment|0|||
147128756|NCT01362790|530638231|FG003|Pilot Phase & Phase 2|Refused further treatment|0|||
147128757|NCT01362790|530638232|FG004|Pilot Phase & Phase 2|Refused further treatment|0|||
147128758|NCT01362790|530638233|FG005|Pilot Phase & Phase 2|Refused further treatment|0|||
147128759|NCT01362790|530638234|FG006|Pilot Phase & Phase 2|Refused further treatment|0|||
147128760|NCT01362790|530638228|FG000|Pilot Phase & Phase 2|Progressive disease|1|||
147128761|NCT01362790|530638229|FG001|Pilot Phase & Phase 2|Progressive disease|2|||
147128762|NCT01362790|530638230|FG002|Pilot Phase & Phase 2|Progressive disease|2|||
147128763|NCT01362790|530638231|FG003|Pilot Phase & Phase 2|Progressive disease|3|||
147317041|NCT03354637|531327264|FG000|Double-blind Period|Lost to Follow-up|3|||
147317042|NCT03354637|531327265|FG001|Double-blind Period|Lost to Follow-up|4|||
147128764|NCT01362790|530638232|FG004|Pilot Phase & Phase 2|Progressive disease|0|||
147128765|NCT01362790|530638233|FG005|Pilot Phase & Phase 2|Progressive disease|2|||
147128766|NCT01362790|530638234|FG006|Pilot Phase & Phase 2|Progressive disease|0|||
147128767|NCT01362790|530638228|FG000|Pilot Phase & Phase 2|Treatment delay >3 weeks|1|||
147128768|NCT01362790|530638229|FG001|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
147128769|NCT01362790|530638230|FG002|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
147128770|NCT01362790|530638231|FG003|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
147128771|NCT01362790|530638232|FG004|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
147128772|NCT01362790|530638233|FG005|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
147128773|NCT01362790|530638234|FG006|Pilot Phase & Phase 2|Treatment delay >3 weeks|0|||
147128774|NCT01362790|530638228|FG000|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
147317043|NCT03354637|531327266|FG002|Double-blind Period|Lost to Follow-up|3|||
147317044|NCT03354637|531327264|FG000|Double-blind Period|Withdrawal by Subject|10|||
147128775|NCT01362790|530638229|FG001|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|2|||
147128776|NCT01362790|530638230|FG002|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
147128777|NCT01362790|530638231|FG003|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
147128778|NCT01362790|530638232|FG004|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
147128779|NCT01362790|530638233|FG005|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
147128780|NCT01362790|530638234|FG006|Pilot Phase & Phase 2|Complicating disease/intercurr. illness|0|||
147128781|NCT01362790|530638228|FG000|Pilot Phase & Phase 2|Death on study|0|||
147128782|NCT01362790|530638229|FG001|Pilot Phase & Phase 2|Death on study|0|||
147128783|NCT01362790|530638230|FG002|Pilot Phase & Phase 2|Death on study|0|||
147128784|NCT01362790|530638231|FG003|Pilot Phase & Phase 2|Death on study|1|||
147128785|NCT01362790|530638232|FG004|Pilot Phase & Phase 2|Death on study|0|||
147128786|NCT01362790|530638233|FG005|Pilot Phase & Phase 2|Death on study|0|||
147128787|NCT01362790|530638234|FG006|Pilot Phase & Phase 2|Death on study|0|||
147128788|NCT01362790|530638228|FG000|Dose De-escalation of Regimen A|Adverse Event|0|||
147128789|NCT01362790|530638229|FG001|Dose De-escalation of Regimen A|Adverse Event|0|||
147128790|NCT01362790|530638230|FG002|Dose De-escalation of Regimen A|Adverse Event|0|||
147317045|NCT03354637|531327265|FG001|Double-blind Period|Withdrawal by Subject|6|||
147317046|NCT03354637|531327266|FG002|Double-blind Period|Withdrawal by Subject|4|||
147317047|NCT03354637|531327264|FG000|Double-blind Period|Incomplete Efficacy Data Collection|1|||
147317048|NCT03354637|531327265|FG001|Double-blind Period|Incomplete Efficacy Data Collection|1|||
147568983|NCT01597245|532240122|FG001|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
147568984|NCT01597245|532240123|FG002|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
147651261|NCT00394771|532544652|FG000|Overall Study|Lost to Follow-up|15|||
147128791|NCT01362790|530638231|FG003|Dose De-escalation of Regimen A|Adverse Event|0|||
147128792|NCT01362790|530638232|FG004|Dose De-escalation of Regimen A|Adverse Event|1|||
147128793|NCT01362790|530638233|FG005|Dose De-escalation of Regimen A|Adverse Event|0|||
147128794|NCT01362790|530638234|FG006|Dose De-escalation of Regimen A|Adverse Event|0|||
147128795|NCT01362790|530638228|FG000|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
147128796|NCT01362790|530638229|FG001|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
147317049|NCT03354637|531327266|FG002|Double-blind Period|Incomplete Efficacy Data Collection|0|||
147128797|NCT01362790|530638230|FG002|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
147128798|NCT01362790|530638231|FG003|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
147128799|NCT01362790|530638232|FG004|Dose De-escalation of Regimen A|Deveoped antibodies|3|||
147128800|NCT01362790|530638233|FG005|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
147128801|NCT01362790|530638234|FG006|Dose De-escalation of Regimen A|Deveoped antibodies|0|||
147128802|NCT01362790|530638228|FG000|Dose De-escalation of Regimen A|Progressive disease|0|||
147128803|NCT01362790|530638229|FG001|Dose De-escalation of Regimen A|Progressive disease|0|||
147128804|NCT01362790|530638230|FG002|Dose De-escalation of Regimen A|Progressive disease|0|||
147128805|NCT01362790|530638231|FG003|Dose De-escalation of Regimen A|Progressive disease|0|||
147128806|NCT01362790|530638232|FG004|Dose De-escalation of Regimen A|Progressive disease|2|||
147128807|NCT01362790|530638233|FG005|Dose De-escalation of Regimen A|Progressive disease|0|||
147128808|NCT01362790|530638234|FG006|Dose De-escalation of Regimen A|Progressive disease|0|||
147128809|NCT03038087|530638235|FG000|Overall Study|lost data|1|||
147128810|NCT00759395|530638237|FG000|Overall Study|Adverse Event|1|||
147317050|NCT03354637|531327264|FG000|Open Label Extension|Adverse Event|0|||
147317051|NCT03354637|531327265|FG001|Open Label Extension|Adverse Event|0|||
147317052|NCT03354637|531327266|FG002|Open Label Extension|Adverse Event|1|||
147317053|NCT03354637|531327264|FG000|Open Label Extension|Lost to Follow-up|0|||
147317054|NCT03354637|531327265|FG001|Open Label Extension|Lost to Follow-up|0|||
147317055|NCT03354637|531327266|FG002|Open Label Extension|Lost to Follow-up|2|||
147317056|NCT03354637|531327264|FG000|Open Label Extension|Withdrawal by Subject|0|||
147317057|NCT03354637|531327265|FG001|Open Label Extension|Withdrawal by Subject|0|||
147317058|NCT03354637|531327266|FG002|Open Label Extension|Withdrawal by Subject|5|||
147317059|NCT03354637|531327264|FG000|Open Label Extension|Study Terminated by Sponsor|0|||
147317060|NCT03354637|531327265|FG001|Open Label Extension|Study Terminated by Sponsor|0|||
147317061|NCT03354637|531327266|FG002|Open Label Extension|Study Terminated by Sponsor|17|||
147317062|NCT03354637|531327264|FG000|Open Label Extension|Subject Noncompliance|0|||
147317063|NCT03354637|531327265|FG001|Open Label Extension|Subject Noncompliance|0|||
147317064|NCT03354637|531327266|FG002|Open Label Extension|Subject Noncompliance|1|||
147317065|NCT03354637|531327264|FG000|Open Label Extension|Lack of Efficacy|0|||
147317066|NCT03354637|531327265|FG001|Open Label Extension|Lack of Efficacy|0|||
147317067|NCT03354637|531327266|FG002|Open Label Extension|Lack of Efficacy|1|||
147317068|NCT03354637|531327264|FG000|Open Label Extension|Physician Decision|0|||
147317069|NCT03354637|531327265|FG001|Open Label Extension|Physician Decision|0|||
147317070|NCT03354637|531327266|FG002|Open Label Extension|Physician Decision|1|||
147317071|NCT02268552|531327271|FG000|Part 1|Death|1|||
147317072|NCT02268552|531327272|FG001|Part 1|Death|1|||
147317073|NCT02268552|531327273|FG002|Part 1|Death|1|||
147568985|NCT01597245|532240124|FG003|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
147317074|NCT02268552|531327274|FG003|Part 1|Death|2|||
147568986|NCT01597245|532240125|FG004|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
147568987|NCT01597245|532240126|FG005|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
147568988|NCT01597245|532240127|FG006|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
147568989|NCT01597245|532240128|FG007|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
147568990|NCT01597245|532240129|FG008|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
147568991|NCT01597245|532240130|FG009|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
147568992|NCT01597245|532240131|FG010|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
147568993|NCT01597245|532240132|FG011|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
147568994|NCT01597245|532240133|FG012|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
147568995|NCT01597245|532240134|FG013|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
147568996|NCT01597245|532240135|FG014|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|26|||
147128811|NCT00759395|530638238|FG001|Overall Study|Adverse Event|0|||
147128812|NCT00759395|530638237|FG000|Overall Study|Withdrawal by Subject|1|||
147317075|NCT02268552|531327275|FG004|Part 1|Death|0|||
147317076|NCT02268552|531327276|FG005|Part 1|Death|0|||
147317077|NCT02268552|531327277|FG006|Part 1|Death|0|||
147317078|NCT02268552|531327271|FG000|Part 1|Subject/guardian decision|0|||
147317079|NCT02268552|531327272|FG001|Part 1|Subject/guardian decision|0|||
147317080|NCT02268552|531327273|FG002|Part 1|Subject/guardian decision|0|||
147317081|NCT02268552|531327274|FG003|Part 1|Subject/guardian decision|1|||
147317082|NCT02268552|531327275|FG004|Part 1|Subject/guardian decision|0|||
147317083|NCT02268552|531327276|FG005|Part 1|Subject/guardian decision|0|||
147317084|NCT02268552|531327277|FG006|Part 1|Subject/guardian decision|0|||
147317085|NCT02268552|531327271|FG000|Part 2|Death|0|||
147128813|NCT00759395|530638238|FG001|Overall Study|Withdrawal by Subject|0|||
147128814|NCT00759395|530638237|FG000|Overall Study|Lack of Efficacy|0|||
147317086|NCT02268552|531327272|FG001|Part 2|Death|0|||
147317087|NCT02268552|531327273|FG002|Part 2|Death|0|||
147317088|NCT02268552|531327274|FG003|Part 2|Death|0|||
147317089|NCT02268552|531327275|FG004|Part 2|Death|0|||
147317090|NCT02268552|531327276|FG005|Part 2|Death|0|||
147317091|NCT02268552|531327277|FG006|Part 2|Death|2|||
147568997|NCT01597245|532240136|FG015|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|26|||
147568998|NCT01597245|532240137|FG016|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
147317092|NCT02268552|531327271|FG000|Part 2|Subject/guardian decision|0|||
147128815|NCT00759395|530638238|FG001|Overall Study|Lack of Efficacy|2|||
147128816|NCT01435356|530638239|FG000|Overall Study|Adverse Event|2|||
147128817|NCT01435356|530638240|FG001|Overall Study|Adverse Event|0|||
147128818|NCT01435356|530638239|FG000|Overall Study|Disease progression/recurrence|17|||
147128819|NCT01435356|530638240|FG001|Overall Study|Disease progression/recurrence|10|||
147128820|NCT01435356|530638239|FG000|Overall Study|Protocol Violation|0|||
147128821|NCT01435356|530638240|FG001|Overall Study|Protocol Violation|1|||
147128822|NCT01435356|530638239|FG000|Overall Study|Study Discontinuation, amendment 4|5|||
147128823|NCT01435356|530638240|FG001|Overall Study|Study Discontinuation, amendment 4|11|||
147128824|NCT01435356|530638239|FG000|Overall Study|Withdrawal by Subject|1|||
147128825|NCT01435356|530638240|FG001|Overall Study|Withdrawal by Subject|1|||
147128826|NCT01435356|530638239|FG000|Overall Study|Facial palsy|1|||
147128827|NCT01435356|530638240|FG001|Overall Study|Facial palsy|0|||
147128828|NCT01435356|530638239|FG000|Overall Study|IC withdrawal due to study cancellation|1|||
147128829|NCT01435356|530638240|FG001|Overall Study|IC withdrawal due to study cancellation|0|||
147128830|NCT01435356|530638239|FG000|Overall Study|Physician Decision|1|||
147128831|NCT01435356|530638240|FG001|Overall Study|Physician Decision|0|||
147128832|NCT01435356|530638239|FG000|Overall Study|Patient decision|3|||
147128833|NCT01435356|530638240|FG001|Overall Study|Patient decision|0|||
147128834|NCT01435356|530638239|FG000|Overall Study|Patient moved to another city|1|||
147128835|NCT01435356|530638240|FG001|Overall Study|Patient moved to another city|1|||
147128836|NCT03485157|530638241|FG000|Double Blind Phase|Lost to Follow-up|4|||
147128837|NCT03485157|530638242|FG001|Double Blind Phase|Lost to Follow-up|4|||
147128838|NCT03485157|530638241|FG000|Double Blind Phase|Adverse Event|2|||
147128839|NCT03485157|530638242|FG001|Double Blind Phase|Adverse Event|1|||
147128840|NCT03485157|530638241|FG000|Double Blind Phase|Withdrawal by Subject|6|||
147128841|NCT03485157|530638242|FG001|Double Blind Phase|Withdrawal by Subject|9|||
147128842|NCT03485157|530638241|FG000|Double Blind Phase|Removal by PI|3|||
147128843|NCT03485157|530638242|FG001|Double Blind Phase|Removal by PI|7|||
147128844|NCT03485157|530638241|FG000|Open Label Phase|Lost to Follow-up|1|||
147128845|NCT03485157|530638242|FG001|Open Label Phase|Lost to Follow-up|2|||
147128846|NCT03485157|530638241|FG000|Open Label Phase|Adverse Event|0|||
147128847|NCT03485157|530638242|FG001|Open Label Phase|Adverse Event|1|||
147128848|NCT03485157|530638241|FG000|Open Label Phase|Withdrawal by Subject|1|||
147128849|NCT03485157|530638242|FG001|Open Label Phase|Withdrawal by Subject|2|||
147128850|NCT03485157|530638241|FG000|Open Label Phase|Removal by PI|2|||
147128851|NCT03485157|530638242|FG001|Open Label Phase|Removal by PI|0|||
147128852|NCT01849276|530638243|FG000|Followed for Survival for 5 Years|Death|1|||
147128853|NCT01849276|530638243|FG000|Followed for Survival for 5 Years|Early termination of the study|1|||
147128854|NCT00539500|530638244|FG000|Overall Study|Disease Progression|1|||
147128855|NCT00539500|530638244|FG000|Overall Study|Lost to Follow-up|2|||
147128856|NCT02011542|530638245|FG000|Overall Study|Physician Decision|1|||
147128857|NCT01299961|530638246|FG000|Overall Study|Adverse Event|3|||
147128858|NCT01299961|530638246|FG000|Overall Study|Lack of Efficacy|2|||
147128859|NCT01299961|530638246|FG000|Overall Study|Lost to Follow-up|1|||
147128860|NCT02904096|530638247|FG000|Overall Study|Adverse Event|1|||
147317093|NCT02268552|531327272|FG001|Part 2|Subject/guardian decision|0|||
147317094|NCT02268552|531327273|FG002|Part 2|Subject/guardian decision|0|||
147317095|NCT02268552|531327274|FG003|Part 2|Subject/guardian decision|0|||
147317096|NCT02268552|531327275|FG004|Part 2|Subject/guardian decision|0|||
147317097|NCT02268552|531327276|FG005|Part 2|Subject/guardian decision|0|||
147317098|NCT02268552|531327277|FG006|Part 2|Subject/guardian decision|1|||
147317099|NCT02268552|531327271|FG000|Part 3 Extension|Death|0|||
147317100|NCT02268552|531327272|FG001|Part 3 Extension|Death|1|||
147317101|NCT02268552|531327273|FG002|Part 3 Extension|Death|1|||
147317102|NCT02268552|531327274|FG003|Part 3 Extension|Death|1|||
147317103|NCT02268552|531327275|FG004|Part 3 Extension|Death|1|||
147317104|NCT02268552|531327276|FG005|Part 3 Extension|Death|1|||
147317105|NCT02268552|531327277|FG006|Part 3 Extension|Death|0|||
147317106|NCT02268552|531327271|FG000|Part 3 Extension|Early termination of trial|1|||
147317107|NCT02268552|531327272|FG001|Part 3 Extension|Early termination of trial|0|||
147317108|NCT02268552|531327273|FG002|Part 3 Extension|Early termination of trial|0|||
147317109|NCT02268552|531327274|FG003|Part 3 Extension|Early termination of trial|0|||
147317110|NCT02268552|531327275|FG004|Part 3 Extension|Early termination of trial|2|||
147317111|NCT02268552|531327276|FG005|Part 3 Extension|Early termination of trial|9|||
147128861|NCT02904096|530638248|FG001|Overall Study|Adverse Event|0|||
147128862|NCT02904096|530638247|FG000|Overall Study|Withdrawal by Subject|4|||
147128863|NCT02904096|530638248|FG001|Overall Study|Withdrawal by Subject|3|||
147128864|NCT02904096|530638247|FG000|Overall Study|Lost to Follow-up|10|||
147128865|NCT02904096|530638248|FG001|Overall Study|Lost to Follow-up|17|||
147128866|NCT02904096|530638247|FG000|Overall Study|Non-compliant|3|||
147128867|NCT02904096|530638248|FG001|Overall Study|Non-compliant|1|||
147128868|NCT02904096|530638247|FG000|Overall Study|Sponsor instructed|1|||
147128869|NCT02904096|530638248|FG001|Overall Study|Sponsor instructed|0|||
147444661|NCT01147744|531792660|FG003|Overall Study|Sponsor decision to amend protocol|5|||
147128870|NCT00663260|530638250|FG000|Overall Study|Lack of Efficacy|2|||
147128871|NCT00663260|530638251|FG001|Overall Study|Lack of Efficacy|0|||
147128872|NCT00663260|530638252|FG002|Overall Study|Lack of Efficacy|0|||
147128873|NCT00663260|530638250|FG000|Overall Study|Adverse Event|12|||
147128874|NCT00663260|530638251|FG001|Overall Study|Adverse Event|7|||
147128875|NCT00663260|530638252|FG002|Overall Study|Adverse Event|6|||
147128876|NCT00663260|530638250|FG000|Overall Study|Withdrawal by Subject|3|||
147128877|NCT00663260|530638251|FG001|Overall Study|Withdrawal by Subject|1|||
147128878|NCT00663260|530638252|FG002|Overall Study|Withdrawal by Subject|6|||
147128879|NCT00663260|530638250|FG000|Overall Study|Death|1|||
147128880|NCT00663260|530638251|FG001|Overall Study|Death|0|||
147128881|NCT00663260|530638252|FG002|Overall Study|Death|1|||
147128882|NCT00663260|530638250|FG000|Overall Study|Lost to Follow-up|0|||
147128883|NCT00663260|530638251|FG001|Overall Study|Lost to Follow-up|1|||
147128884|NCT00663260|530638252|FG002|Overall Study|Lost to Follow-up|0|||
147128885|NCT00663260|530638250|FG000|Overall Study|non-compliance, not met criteria, etc.|3|||
147128886|NCT00663260|530638251|FG001|Overall Study|non-compliance, not met criteria, etc.|2|||
147128887|NCT00663260|530638252|FG002|Overall Study|non-compliance, not met criteria, etc.|3|||
147128888|NCT01979185|530638256|FG000|Period 2|Other|0|||
147128889|NCT01979185|530638257|FG001|Period 2|Other|1|||
147128890|NCT00980798|530638258|FG000|Overall Study|Adverse Event|7|||
147128891|NCT00980798|530638259|FG001|Overall Study|Adverse Event|36|||
147128892|NCT00980798|530638258|FG000|Overall Study|Lack of Efficacy|16|||
147317112|NCT02268552|531327277|FG006|Part 3 Extension|Early termination of trial|11|||
147128893|NCT00980798|530638259|FG001|Overall Study|Lack of Efficacy|5|||
147128894|NCT00980798|530638258|FG000|Overall Study|Lost to Follow-up|0|||
147128895|NCT00980798|530638259|FG001|Overall Study|Lost to Follow-up|1|||
147128896|NCT00980798|530638258|FG000|Overall Study|Physician Decision|2|||
147128897|NCT00980798|530638259|FG001|Overall Study|Physician Decision|1|||
147128898|NCT00980798|530638258|FG000|Overall Study|Withdrawal by Subject|8|||
147128899|NCT00980798|530638259|FG001|Overall Study|Withdrawal by Subject|11|||
147128900|NCT00980798|530638258|FG000|Overall Study|Other|0|||
147128901|NCT00980798|530638259|FG001|Overall Study|Other|1|||
147128902|NCT02402647|530638260|FG000|Overall Study|Lost to Follow-up|13|||
147128903|NCT02402647|530638261|FG001|Overall Study|Lost to Follow-up|7|||
147128904|NCT02402647|530638260|FG000|Overall Study|Protocol Violation|1|||
147128905|NCT02402647|530638261|FG001|Overall Study|Protocol Violation|1|||
147128906|NCT02402647|530638260|FG000|Overall Study|scheduled and timed out|2|||
147128907|NCT02402647|530638261|FG001|Overall Study|scheduled and timed out|1|||
147128908|NCT02402647|530638260|FG000|Overall Study|medical illness|2|||
147128909|NCT02402647|530638261|FG001|Overall Study|medical illness|4|||
147128910|NCT02402647|530638260|FG000|Overall Study|Moved|2|||
147128911|NCT02402647|530638261|FG001|Overall Study|Moved|0|||
147128912|NCT02402647|530638260|FG000|Overall Study|loved one illness|1|||
147128913|NCT02402647|530638261|FG001|Overall Study|loved one illness|0|||
147128914|NCT02402647|530638260|FG000|Overall Study|deceased preexisting condition|2|||
147128915|NCT02402647|530638261|FG001|Overall Study|deceased preexisting condition|0|||
147128916|NCT02402647|530638260|FG000|Overall Study|Other|2|||
147128917|NCT02402647|530638261|FG001|Overall Study|Other|1|||
147128918|NCT03211416|530638270|FG000|Overall Study|Adverse Event|7|||
147128919|NCT03211416|530638270|FG000|Overall Study|Lack of Efficacy|2|||
147128920|NCT03211416|530638270|FG000|Overall Study|Physician Decision|1|||
147128921|NCT02496000|530638275|FG000|Overall Study|Withdrawal by Subject|1|||
147128922|NCT02496000|530638276|FG001|Overall Study|Withdrawal by Subject|2|||
147128923|NCT02496000|530638277|FG002|Overall Study|Withdrawal by Subject|0|||
147128924|NCT02496000|530638275|FG000|Overall Study|Lost to Follow-up|1|||
147128925|NCT02496000|530638276|FG001|Overall Study|Lost to Follow-up|0|||
147128926|NCT02496000|530638277|FG002|Overall Study|Lost to Follow-up|1|||
147128927|NCT02496000|530638275|FG000|Overall Study|Protocol Violation|0|||
147128928|NCT02496000|530638276|FG001|Overall Study|Protocol Violation|0|||
147128929|NCT02496000|530638277|FG002|Overall Study|Protocol Violation|1|||
147128930|NCT02496000|530638275|FG000|Overall Study|Non-compliance or lack of cooperation|0|||
147317113|NCT02268552|531327271|FG000|Part 3 Extension|Subject/guardian decision|0|||
147317114|NCT02268552|531327272|FG001|Part 3 Extension|Subject/guardian decision|0|||
147317115|NCT02268552|531327273|FG002|Part 3 Extension|Subject/guardian decision|0|||
147317116|NCT02268552|531327274|FG003|Part 3 Extension|Subject/guardian decision|0|||
147128931|NCT02496000|530638276|FG001|Overall Study|Non-compliance or lack of cooperation|2|||
147128932|NCT02496000|530638277|FG002|Overall Study|Non-compliance or lack of cooperation|0|||
147128933|NCT02496000|530638275|FG000|Overall Study|undetermined|0|||
147128934|NCT02496000|530638276|FG001|Overall Study|undetermined|1|||
147128935|NCT02496000|530638277|FG002|Overall Study|undetermined|0|||
147128936|NCT02255656|530638278|FG000|Overall Study|Adverse Event|11|||
147128937|NCT02255656|530638278|FG000|Overall Study|Poor compliance to protocol|3|||
147128938|NCT02255656|530638278|FG000|Overall Study|Lost to Follow-up|30|||
147128939|NCT02255656|530638278|FG000|Overall Study|Due to Coronavirus Disease (Covid-19)|300|||
147128940|NCT02255656|530638278|FG000|Overall Study|Other|126|||
147128941|NCT01877278|530638279|FG000|Overall Study|Lost to Follow-up|3|||
147128942|NCT01877278|530638280|FG001|Overall Study|Lost to Follow-up|3|||
147128943|NCT04727151|530638281|FG000|Overall Study|Death|0|||
147128944|NCT04727151|530638282|FG001|Overall Study|Death|0|||
147128945|NCT04727151|530638283|FG002|Overall Study|Death|0|||
147128946|NCT04727151|530638284|FG003|Overall Study|Death|0|||
147317117|NCT02268552|531327275|FG004|Part 3 Extension|Subject/guardian decision|0|||
147317118|NCT02268552|531327276|FG005|Part 3 Extension|Subject/guardian decision|0|||
147317119|NCT02268552|531327277|FG006|Part 3 Extension|Subject/guardian decision|1|||
147317120|NCT00997243|531327278|FG000|Overall Study|Early termination of study by sponsor|7|||
147317121|NCT03415022|531327285|FG000|Overall Study|Withdrawal by Subject|1|||
147317122|NCT03415022|531327286|FG001|Overall Study|Withdrawal by Subject|2|||
147317123|NCT03415022|531327285|FG000|Overall Study|COVID-19 Suspension|2|||
147128947|NCT04727151|530638285|FG004|Overall Study|Death|3|||
147128948|NCT04727151|530638281|FG000|Overall Study|failed to meet pre-treatment inclusion criteria|0|||
147128949|NCT04727151|530638282|FG001|Overall Study|failed to meet pre-treatment inclusion criteria|0|||
147128950|NCT04727151|530638283|FG002|Overall Study|failed to meet pre-treatment inclusion criteria|0|||
147128951|NCT04727151|530638284|FG003|Overall Study|failed to meet pre-treatment inclusion criteria|0|||
147128952|NCT04727151|530638285|FG004|Overall Study|failed to meet pre-treatment inclusion criteria|2|||
147128953|NCT03510715|530638286|FG000|Overall Study|Adverse Event|1|||
147128954|NCT03510715|530638287|FG001|Overall Study|Adverse Event|0|||
147128955|NCT05318287|530638292|FG000|Overall Study|Lost to Follow-up|8|||
147128956|NCT04144517|530638295|FG000|Overall Study|Physician Decision|0|||
147128957|NCT04144517|530638296|FG001|Overall Study|Physician Decision|1|||
147128958|NCT04144517|530638295|FG000|Overall Study|Other|2|||
147128959|NCT04144517|530638296|FG001|Overall Study|Other|2|||
147128960|NCT04144517|530638295|FG000|Overall Study|Death|6|||
147128961|NCT04144517|530638296|FG001|Overall Study|Death|3|||
147128962|NCT02757768|530638300|FG000|Overall Study|Randomized Never Received Study Drug|3|||
147128963|NCT02757768|530638301|FG001|Overall Study|Randomized Never Received Study Drug|4|||
147128964|NCT02757768|530638300|FG000|Overall Study|Adverse Event|5|||
147128965|NCT02757768|530638301|FG001|Overall Study|Adverse Event|3|||
147128966|NCT02757768|530638300|FG000|Overall Study|Lack of Efficacy|2|||
147128967|NCT02757768|530638301|FG001|Overall Study|Lack of Efficacy|1|||
147128968|NCT02757768|530638300|FG000|Overall Study|Lost to Follow-up|1|||
147128969|NCT02757768|530638301|FG001|Overall Study|Lost to Follow-up|0|||
147128970|NCT02757768|530638300|FG000|Overall Study|Protocol Deviation|2|||
147128971|NCT02757768|530638301|FG001|Overall Study|Protocol Deviation|9|||
147128972|NCT02757768|530638300|FG000|Overall Study|Withdrawal by Subject|16|||
147128973|NCT02757768|530638301|FG001|Overall Study|Withdrawal by Subject|9|||
147128974|NCT02757768|530638300|FG000|Overall Study|Miscellaneous|4|||
147128975|NCT02757768|530638301|FG001|Overall Study|Miscellaneous|2|||
147128976|NCT02495883|530638308|FG000|Overall Study|Excessive head motion|1|||
147128977|NCT02495883|530638309|FG001|Overall Study|Excessive head motion|0|||
147317124|NCT03415022|531327286|FG001|Overall Study|COVID-19 Suspension|3|||
147317125|NCT03415022|531327285|FG000|Overall Study|Lost to Follow-up|2|||
147317126|NCT03415022|531327286|FG001|Overall Study|Lost to Follow-up|0|||
147317127|NCT03583541|531327289|FG000|Overall Study|Lost to Follow-up|31|||
147317128|NCT03583541|531327290|FG001|Overall Study|Lost to Follow-up|65|||
147317129|NCT00884286|531327291|FG000|Overall Study|Progressive disease|21|||
147317130|NCT00884286|531327292|FG001|Overall Study|Progressive disease|28|||
147317131|NCT00884286|531327291|FG000|Overall Study|Toxicity|4|||
147317132|NCT00884286|531327292|FG001|Overall Study|Toxicity|1|||
147317133|NCT00884286|531327291|FG000|Overall Study|Death|2|||
147317134|NCT00884286|531327292|FG001|Overall Study|Death|2|||
147317135|NCT00884286|531327291|FG000|Overall Study|Physician Decision|1|||
147317136|NCT00884286|531327292|FG001|Overall Study|Physician Decision|0|||
147317137|NCT00884286|531327291|FG000|Overall Study|Septic shock|1|||
147317138|NCT00884286|531327292|FG001|Overall Study|Septic shock|0|||
147317139|NCT00884286|531327291|FG000|Overall Study|Thrombus in right auricle|1|||
147317140|NCT00884286|531327292|FG001|Overall Study|Thrombus in right auricle|0|||
147317141|NCT00884286|531327291|FG000|Overall Study|Not treated|2|||
147317142|NCT00884286|531327292|FG001|Overall Study|Not treated|1|||
147317143|NCT00884286|531327291|FG000|Overall Study|Comprised lung carcinoma|0|||
147317144|NCT00884286|531327292|FG001|Overall Study|Comprised lung carcinoma|1|||
147317145|NCT01196104|531327293|FG000|Overall Study|Lost to Follow-up|1|||
147317146|NCT01196104|531327294|FG001|Overall Study|Lost to Follow-up|0|||
147317147|NCT01196104|531327293|FG000|Overall Study|Physician Decision|0|||
147128978|NCT03557502|530638310|FG000|Protocol 2|Withdrawal by Subject|1|||
147128979|NCT03557502|530638311|FG001|Protocol 2|Withdrawal by Subject|1|||
147128980|NCT03557502|530638310|FG000|Protocol 2|Met exclusion criteria at Post timepoint|1|||
147128981|NCT03557502|530638311|FG001|Protocol 2|Met exclusion criteria at Post timepoint|1|||
147128982|NCT00964678|530638316|FG000|Overall Study|Physician Decision|4|||
147128983|NCT03359395|530638317|FG000|First Intervention A / B|Withdrawal by Subject|1|||
147317148|NCT01196104|531327294|FG001|Overall Study|Physician Decision|1|||
147317149|NCT01196104|531327293|FG000|Overall Study|Withdrawal by Subject|3|||
147317150|NCT01196104|531327294|FG001|Overall Study|Withdrawal by Subject|3|||
147317151|NCT01196104|531327293|FG000|Overall Study|Various|0|||
147317152|NCT01196104|531327294|FG001|Overall Study|Various|1|||
147317153|NCT00594932|531327299|FG000|First 3 Months|Withdrawal by Subject|1|||
147128984|NCT03359395|530638318|FG001|First Intervention A / B|Withdrawal by Subject|0|||
147128985|NCT03359395|530638317|FG000|First Intervention A / B|Lost to Follow-up|2|||
147317154|NCT00594932|531327300|FG001|First 3 Months|Withdrawal by Subject|3|||
147444662|NCT01147744|531792661|FG004|Overall Study|Sponsor decision to amend protocol|7|||
147128986|NCT03359395|530638318|FG001|First Intervention A / B|Lost to Follow-up|3|||
147128987|NCT03359395|530638317|FG000|Second Intervention B/A|Exclusion criteria|0|||
147128988|NCT03359395|530638318|FG001|Second Intervention B/A|Exclusion criteria|1|||
147128989|NCT03359395|530638317|FG000|Second Intervention B/A|Lost to Follow-up|3|||
147128990|NCT03359395|530638318|FG001|Second Intervention B/A|Lost to Follow-up|2|||
147128991|NCT03164356|530638319|FG000|Overall Study|Lost to Follow-up|1|||
147128992|NCT03164356|530638320|FG001|Overall Study|Lost to Follow-up|1|||
147128993|NCT03164356|530638321|FG002|Overall Study|Lost to Follow-up|2|||
147128994|NCT03164356|530638322|FG003|Overall Study|Lost to Follow-up|1|||
147128995|NCT03164356|530638319|FG000|Overall Study|Physician Decision|0|||
147128996|NCT03164356|530638320|FG001|Overall Study|Physician Decision|0|||
147128997|NCT03164356|530638321|FG002|Overall Study|Physician Decision|3|||
147128998|NCT03164356|530638322|FG003|Overall Study|Physician Decision|0|||
147128999|NCT03164356|530638319|FG000|Overall Study|Protocol Violation|2|||
147129000|NCT03164356|530638320|FG001|Overall Study|Protocol Violation|1|||
147129001|NCT03164356|530638321|FG002|Overall Study|Protocol Violation|0|||
147129002|NCT03164356|530638322|FG003|Overall Study|Protocol Violation|0|||
147129003|NCT03164356|530638319|FG000|Overall Study|Withdrawal by Subject|1|||
147129004|NCT03164356|530638320|FG001|Overall Study|Withdrawal by Subject|0|||
147129005|NCT03164356|530638321|FG002|Overall Study|Withdrawal by Subject|0|||
147444663|NCT01147744|531792662|FG005|Overall Study|Sponsor decision to amend protocol|2|||
147444664|NCT01147744|531792663|FG006|Overall Study|Sponsor decision to amend protocol|6|||
147444665|NCT01147744|531792657|FG000|Overall Study|Met Protocol-defined Stopping Criteria|1|||
147444666|NCT01147744|531792658|FG001|Overall Study|Met Protocol-defined Stopping Criteria|0|||
147444667|NCT01147744|531792659|FG002|Overall Study|Met Protocol-defined Stopping Criteria|0|||
147444668|NCT01147744|531792660|FG003|Overall Study|Met Protocol-defined Stopping Criteria|0|||
147444669|NCT01147744|531792661|FG004|Overall Study|Met Protocol-defined Stopping Criteria|0|||
147444670|NCT01147744|531792662|FG005|Overall Study|Met Protocol-defined Stopping Criteria|1|||
147444671|NCT01147744|531792663|FG006|Overall Study|Met Protocol-defined Stopping Criteria|0|||
147444672|NCT01342484|531792664|FG000|Overall Study|Other Reasons|1|||
147444673|NCT01342484|531792665|FG001|Overall Study|Other Reasons|0|||
147444674|NCT01342484|531792666|FG002|Overall Study|Other Reasons|0|||
147444675|NCT01342484|531792664|FG000|Overall Study|Protocol Violation|0|||
147444676|NCT01342484|531792665|FG001|Overall Study|Protocol Violation|0|||
147444677|NCT01342484|531792666|FG002|Overall Study|Protocol Violation|1|||
147444678|NCT01342484|531792664|FG000|Overall Study|Withdrawal by Subject|1|||
147444679|NCT01342484|531792665|FG001|Overall Study|Withdrawal by Subject|0|||
147444680|NCT01342484|531792666|FG002|Overall Study|Withdrawal by Subject|0|||
147129006|NCT03164356|530638322|FG003|Overall Study|Withdrawal by Subject|0|||
147444681|NCT01840579|531792667|FG000|Overall Study|Status not recorded|0|||
147444682|NCT01840579|531792668|FG001|Overall Study|Status not recorded|0|||
147568999|NCT01597245|532240138|FG017|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
147569000|NCT01597245|532240139|FG018|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
147569001|NCT01597245|532240140|FG019|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
147569002|NCT01597245|532240141|FG020|Long Term Extension (Week 60 - Week 264)|Lack of Efficacy|0|||
147569003|NCT01597245|532240121|FG000|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
147569004|NCT01597245|532240122|FG001|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
147569005|NCT01597245|532240123|FG002|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
147569006|NCT01597245|532240124|FG003|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
147569007|NCT01597245|532240125|FG004|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
147569008|NCT01597245|532240126|FG005|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
147569009|NCT01597245|532240127|FG006|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
147569010|NCT01597245|532240128|FG007|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
147569011|NCT01597245|532240129|FG008|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
147569012|NCT01597245|532240130|FG009|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
147569013|NCT01597245|532240131|FG010|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
147569014|NCT01597245|532240132|FG011|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
147569015|NCT01597245|532240133|FG012|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
147569016|NCT01597245|532240134|FG013|Long Term Extension (Week 60 - Week 264)|Physician Decision|1|||
147569017|NCT01597245|532240135|FG014|Long Term Extension (Week 60 - Week 264)|Physician Decision|11|||
147569018|NCT01597245|532240136|FG015|Long Term Extension (Week 60 - Week 264)|Physician Decision|12|||
147569019|NCT01597245|532240137|FG016|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
147651262|NCT00394771|532544653|FG001|Overall Study|Lost to Follow-up|15|||
147569020|NCT01597245|532240138|FG017|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
147129007|NCT03164356|530638319|FG000|Overall Study|Study timeframe interrupted by Coronavirus disease 2019 (COVID-19)|1|||
147129008|NCT03164356|530638320|FG001|Overall Study|Study timeframe interrupted by Coronavirus disease 2019 (COVID-19)|0|||
147129009|NCT03164356|530638321|FG002|Overall Study|Study timeframe interrupted by Coronavirus disease 2019 (COVID-19)|0|||
147129010|NCT03164356|530638322|FG003|Overall Study|Study timeframe interrupted by Coronavirus disease 2019 (COVID-19)|1|||
147129011|NCT03164356|530638319|FG000|Overall Study|Subject Incarcerated|0|||
147129012|NCT03164356|530638320|FG001|Overall Study|Subject Incarcerated|1|||
147129013|NCT03164356|530638321|FG002|Overall Study|Subject Incarcerated|0|||
147129014|NCT03164356|530638322|FG003|Overall Study|Subject Incarcerated|0|||
147129015|NCT03164356|530638319|FG000|Overall Study|Prosthetist unable to participate|0|||
147129016|NCT03164356|530638320|FG001|Overall Study|Prosthetist unable to participate|2|||
147129017|NCT03164356|530638321|FG002|Overall Study|Prosthetist unable to participate|1|||
147129018|NCT03164356|530638322|FG003|Overall Study|Prosthetist unable to participate|0|||
147129019|NCT02520154|530638329|FG000|Overall Study|Death|1|||
147129020|NCT02520154|530638329|FG000|Overall Study|Withdrawal by Subject|2|||
147129021|NCT02520154|530638329|FG000|Overall Study|Physician Decision|2|||
147129022|NCT05943990|530638333|FG000|Overall Study|Study Terminated by Sponsor|0|||
147129023|NCT05943990|530638334|FG001|Overall Study|Study Terminated by Sponsor|0|||
147129024|NCT05943990|530638335|FG002|Overall Study|Study Terminated by Sponsor|1|||
147129025|NCT03977155|530640431|FG000|Overall Study|Adverse Event|3|||
147129026|NCT03977155|530640432|FG001|Overall Study|Adverse Event|0|||
147129027|NCT03977155|530640433|FG002|Overall Study|Adverse Event|0|||
147129028|NCT03977155|530640431|FG000|Overall Study|Lost to Follow-up|0|||
147235302|NCT00150709|531033688|FG003|Overall Study|Adverse Event|3|||
147235303|NCT00150709|531033685|FG000|Overall Study|Lack of Efficacy|6|||
147235304|NCT00150709|531033686|FG001|Overall Study|Lack of Efficacy|11|||
147235305|NCT00150709|531033687|FG002|Overall Study|Lack of Efficacy|9|||
147235306|NCT00150709|531033688|FG003|Overall Study|Lack of Efficacy|0|||
147235307|NCT00150709|531033685|FG000|Overall Study|Withdrawal by Subject|7|||
147235308|NCT00150709|531033686|FG001|Overall Study|Withdrawal by Subject|10|||
147235309|NCT00150709|531033687|FG002|Overall Study|Withdrawal by Subject|5|||
147235310|NCT00150709|531033688|FG003|Overall Study|Withdrawal by Subject|0|||
147235311|NCT00150709|531033685|FG000|Overall Study|Lost to Follow-up|3|||
147235312|NCT00150709|531033686|FG001|Overall Study|Lost to Follow-up|2|||
147235313|NCT00150709|531033687|FG002|Overall Study|Lost to Follow-up|0|||
147235314|NCT00150709|531033688|FG003|Overall Study|Lost to Follow-up|0|||
147235315|NCT00150709|531033685|FG000|Overall Study|Sponsor decision|0|||
147235316|NCT00150709|531033686|FG001|Overall Study|Sponsor decision|0|||
147235317|NCT00150709|531033687|FG002|Overall Study|Sponsor decision|0|||
147235318|NCT00150709|531033688|FG003|Overall Study|Sponsor decision|1|||
147235319|NCT00150709|531033685|FG000|Overall Study|Site/Investigator discontinued the study|5|||
147235320|NCT00150709|531033686|FG001|Overall Study|Site/Investigator discontinued the study|5|||
147235321|NCT00150709|531033687|FG002|Overall Study|Site/Investigator discontinued the study|2|||
147235322|NCT00150709|531033688|FG003|Overall Study|Site/Investigator discontinued the study|0|||
147235323|NCT00150709|531033685|FG000|Overall Study|Decision of parent(s)|1|||
147235324|NCT00150709|531033686|FG001|Overall Study|Decision of parent(s)|2|||
147235325|NCT00150709|531033687|FG002|Overall Study|Decision of parent(s)|0|||
147235326|NCT00150709|531033688|FG003|Overall Study|Decision of parent(s)|0|||
147235327|NCT00150709|531033685|FG000|Overall Study|Decision of parent(s) and investigator|3|||
147235328|NCT00150709|531033686|FG001|Overall Study|Decision of parent(s) and investigator|0|||
147235329|NCT00150709|531033687|FG002|Overall Study|Decision of parent(s) and investigator|0|||
147235330|NCT00150709|531033688|FG003|Overall Study|Decision of parent(s) and investigator|0|||
147235331|NCT00150709|531033685|FG000|Overall Study|Loss/ incompleteness of efficacy|12|||
147235332|NCT00150709|531033686|FG001|Overall Study|Loss/ incompleteness of efficacy|12|||
147235333|NCT00150709|531033687|FG002|Overall Study|Loss/ incompleteness of efficacy|2|||
147235334|NCT00150709|531033688|FG003|Overall Study|Loss/ incompleteness of efficacy|2|||
147235335|NCT00150709|531033685|FG000|Overall Study|Investigator decision|1|||
147235336|NCT00150709|531033686|FG001|Overall Study|Investigator decision|0|||
147235337|NCT00150709|531033687|FG002|Overall Study|Investigator decision|0|||
147129029|NCT03977155|530640432|FG001|Overall Study|Lost to Follow-up|1|||
147129030|NCT03977155|530640433|FG002|Overall Study|Lost to Follow-up|0|||
147129031|NCT03977155|530640431|FG000|Overall Study|Withdrawal by Subject|1|||
147129032|NCT03977155|530640432|FG001|Overall Study|Withdrawal by Subject|1|||
147129033|NCT03977155|530640433|FG002|Overall Study|Withdrawal by Subject|2|||
147129034|NCT03977155|530640431|FG000|Overall Study|Participant was unable to come in for the Visit|1|||
147129035|NCT03977155|530640432|FG001|Overall Study|Participant was unable to come in for the Visit|0|||
147129036|NCT03977155|530640433|FG002|Overall Study|Participant was unable to come in for the Visit|0|||
147129037|NCT00936936|530640434|FG000|Overall Study|Adverse Event|7|||
147129038|NCT00936936|530640435|FG001|Overall Study|Adverse Event|1|||
147129039|NCT00936936|530640434|FG000|Overall Study|Disease Progression|2|||
147129040|NCT00936936|530640435|FG001|Overall Study|Disease Progression|2|||
147129041|NCT00936936|530640434|FG000|Overall Study|Unrelated|3|||
147129042|NCT00936936|530640435|FG001|Overall Study|Unrelated|1|||
147129043|NCT02278003|530640436|FG000|Overall Study|Withdrawal by Subject|11|||
147129044|NCT02278003|530640437|FG001|Overall Study|Withdrawal by Subject|0|||
147129045|NCT02278003|530640436|FG000|Overall Study|Not Treated|1|||
147129046|NCT02278003|530640437|FG001|Overall Study|Not Treated|0|||
147129047|NCT02278003|530640436|FG000|Overall Study|Recognition task improperly completed|7|||
147129048|NCT02278003|530640437|FG001|Overall Study|Recognition task improperly completed|0|||
147235338|NCT00150709|531033688|FG003|Overall Study|Investigator decision|1|||
147317155|NCT00594932|531327299|FG000|Final 3 Months|Withdrawal by Subject|4|||
147317156|NCT00594932|531327300|FG001|Final 3 Months|Withdrawal by Subject|3|||
147317157|NCT01094171|531327301|FG000|Overall Study|Lost to Follow-up|2|||
147317158|NCT01094171|531327301|FG000|Overall Study|Informed consent withdrawal|4|||
147317159|NCT01094171|531327301|FG000|Overall Study|Migration from the study area|3|||
147317160|NCT01094171|531327301|FG000|Overall Study|Other|1|||
147651263|NCT00394771|532544654|FG002|Overall Study|Lost to Follow-up|13|||
147129049|NCT02296476|530640438|FG000|Overall Study|Disease Progression|6|||
147129050|NCT02296476|530640439|FG001|Overall Study|Disease Progression|4|||
147129051|NCT02296476|530640440|FG002|Overall Study|Disease Progression|2|||
147129052|NCT03440385|530640442|FG000|Overall Study|Other Reason|4|||
147129053|NCT03440385|530640443|FG001|Overall Study|Other Reason|1|||
147129054|NCT03440385|530640442|FG000|Overall Study|Site Closed|1|||
147129055|NCT03440385|530640443|FG001|Overall Study|Site Closed|0|||
147129056|NCT03440385|530640442|FG000|Overall Study|Lost to Follow-up|2|||
147129057|NCT03440385|530640443|FG001|Overall Study|Lost to Follow-up|0|||
147129058|NCT03440385|530640442|FG000|Overall Study|Withdrawal by Subject|12|||
147129059|NCT03440385|530640443|FG001|Overall Study|Withdrawal by Subject|6|||
147129060|NCT03440385|530640442|FG000|Overall Study|Lack of Efficacy|9|||
147129061|NCT03440385|530640443|FG001|Overall Study|Lack of Efficacy|2|||
147129062|NCT03440385|530640442|FG000|Overall Study|Adverse Event|15|||
147129063|NCT03440385|530640443|FG001|Overall Study|Adverse Event|11|||
147129064|NCT00730327|530640445|FG000|Overall Study|Lost to Follow-up|14|||
147129065|NCT00730327|530640446|FG001|Overall Study|Lost to Follow-up|16|||
147129066|NCT00730327|530640445|FG000|Overall Study|Adverse Event|8|||
147129067|NCT00730327|530640446|FG001|Overall Study|Adverse Event|1|||
147129068|NCT00730327|530640445|FG000|Overall Study|Withdrawal by Subject|3|||
147129069|NCT00730327|530640446|FG001|Overall Study|Withdrawal by Subject|13|||
147129070|NCT00730327|530640445|FG000|Overall Study|Subject withdrew (reason not specified)|2|||
147129071|NCT00730327|530640446|FG001|Overall Study|Subject withdrew (reason not specified)|7|||
147129072|NCT02332928|530640452|FG000|Overall Study|Withdrawal by Subject|0|||
147317161|NCT01536145|531327302|FG000|Overall Study|Progressive disease|3|||
147317162|NCT01536145|531327303|FG001|Overall Study|Progressive disease|4|||
147317163|NCT01536145|531327304|FG002|Overall Study|Progressive disease|1|||
147317164|NCT01536145|531327305|FG003|Overall Study|Progressive disease|2|||
147651264|NCT00394771|532544655|FG003|Overall Study|Lost to Follow-up|10|||
147651265|NCT00394771|532544652|FG000|Overall Study|Other|3|||
147129073|NCT02332928|530640453|FG001|Overall Study|Withdrawal by Subject|2|||
147129074|NCT02332928|530640452|FG000|Overall Study|Cronavirus disease (COVID-19) Precautions|1|||
147129075|NCT02332928|530640453|FG001|Overall Study|Cronavirus disease (COVID-19) Precautions|0|||
147129076|NCT04484857|530640459|FG000|Overall Study|Adverse Event|2|||
147317165|NCT01536145|531327306|FG004|Overall Study|Progressive disease|1|||
147317166|NCT01536145|531327307|FG005|Overall Study|Progressive disease|2|||
147317167|NCT01536145|531327308|FG006|Overall Study|Progressive disease|1|||
147317168|NCT01536145|531327309|FG007|Overall Study|Progressive disease|2|||
147317169|NCT01536145|531327310|FG008|Overall Study|Progressive disease|1|||
147317170|NCT01536145|531327311|FG009|Overall Study|Progressive disease|3|||
147317171|NCT01536145|531327312|FG010|Overall Study|Progressive disease|3|||
147317172|NCT01536145|531327302|FG000|Overall Study|Withdrawal by Subject|0|||
147317173|NCT01536145|531327303|FG001|Overall Study|Withdrawal by Subject|0|||
147317174|NCT01536145|531327304|FG002|Overall Study|Withdrawal by Subject|1|||
147317175|NCT01536145|531327305|FG003|Overall Study|Withdrawal by Subject|0|||
147317176|NCT01536145|531327306|FG004|Overall Study|Withdrawal by Subject|0|||
147317177|NCT01536145|531327307|FG005|Overall Study|Withdrawal by Subject|1|||
147317178|NCT01536145|531327308|FG006|Overall Study|Withdrawal by Subject|0|||
147317179|NCT01536145|531327309|FG007|Overall Study|Withdrawal by Subject|0|||
147317180|NCT01536145|531327310|FG008|Overall Study|Withdrawal by Subject|2|||
147317181|NCT01536145|531327311|FG009|Overall Study|Withdrawal by Subject|0|||
147317182|NCT01536145|531327312|FG010|Overall Study|Withdrawal by Subject|2|||
147317183|NCT01536145|531327302|FG000|Overall Study|Other|0|||
147317184|NCT01536145|531327303|FG001|Overall Study|Other|0|||
147317185|NCT01536145|531327304|FG002|Overall Study|Other|0|||
147317186|NCT01536145|531327305|FG003|Overall Study|Other|0|||
147651266|NCT00394771|532544653|FG001|Overall Study|Other|3|||
147651267|NCT00394771|532544654|FG002|Overall Study|Other|1|||
147651268|NCT00394771|532544655|FG003|Overall Study|Other|0|||
147317187|NCT01536145|531327306|FG004|Overall Study|Other|1|||
147317188|NCT01536145|531327307|FG005|Overall Study|Other|0|||
147651269|NCT02839876|532544656|FG000|Overall Study|Protocol Violation|10|||
147651270|NCT02839876|532544657|FG001|Overall Study|Protocol Violation|11|||
147129077|NCT04484857|530640459|FG000|Overall Study|Death|10|||
147129078|NCT04484857|530640459|FG000|Overall Study|Withdrawal by Subject|3|||
147129079|NCT04484857|530640459|FG000|Overall Study|Transferred/Relocation|5|||
147129080|NCT04484857|530640459|FG000|Overall Study|Kidney Transplant|7|||
147129081|NCT04484857|530640459|FG000|Overall Study|Other than specified|4|||
147129082|NCT04484857|530640459|FG000|Overall Study|Participants continued an Optional Extension of Roxadustat Treatment|216|||
147129083|NCT01425814|530640460|FG000|Period 1|Stability criteria not fulfilled|0|||
147129084|NCT01425814|530640461|FG001|Period 1|Stability criteria not fulfilled|1|||
147129085|NCT01425814|530640462|FG002|Period 1|Stability criteria not fulfilled|0|||
147129086|NCT01425814|530640463|FG003|Period 1|Stability criteria not fulfilled|0|||
147129087|NCT01425814|530640464|FG004|Period 1|Stability criteria not fulfilled|0|||
147129088|NCT01425814|530640465|FG005|Period 1|Stability criteria not fulfilled|0|||
147129089|NCT01425814|530640460|FG000|Period 2|Stability criteria not fulfilled|0|||
147129090|NCT01425814|530640461|FG001|Period 2|Stability criteria not fulfilled|1|||
147129091|NCT01425814|530640462|FG002|Period 2|Stability criteria not fulfilled|0|||
147129092|NCT01425814|530640463|FG003|Period 2|Stability criteria not fulfilled|0|||
147129093|NCT01425814|530640464|FG004|Period 2|Stability criteria not fulfilled|0|||
147129094|NCT01425814|530640465|FG005|Period 2|Stability criteria not fulfilled|0|||
147129095|NCT01425814|530640460|FG000|Period 3|Adverse Event|0|||
147129096|NCT01425814|530640461|FG001|Period 3|Adverse Event|0|||
147129097|NCT01425814|530640462|FG002|Period 3|Adverse Event|0|||
147129098|NCT01425814|530640463|FG003|Period 3|Adverse Event|0|||
147129099|NCT01425814|530640464|FG004|Period 3|Adverse Event|0|||
147129100|NCT01425814|530640465|FG005|Period 3|Adverse Event|1|||
147129101|NCT01425814|530640460|FG000|Period 4|Adverse Event|1|||
147129102|NCT01425814|530640461|FG001|Period 4|Adverse Event|0|||
147235339|NCT00150709|531033685|FG000|Overall Study|Subject relocated|2|||
147235340|NCT00150709|531033686|FG001|Overall Study|Subject relocated|2|||
147235341|NCT00150709|531033687|FG002|Overall Study|Subject relocated|1|||
147129103|NCT01425814|530640462|FG002|Period 4|Adverse Event|1|||
147129104|NCT01425814|530640463|FG003|Period 4|Adverse Event|0|||
147129105|NCT01425814|530640464|FG004|Period 4|Adverse Event|0|||
147129106|NCT01425814|530640465|FG005|Period 4|Adverse Event|0|||
147129107|NCT01425814|530640460|FG000|Period 5|Stability criteria not fulfilled|0|||
147129108|NCT01425814|530640461|FG001|Period 5|Stability criteria not fulfilled|0|||
147129109|NCT01425814|530640462|FG002|Period 5|Stability criteria not fulfilled|1|||
147129110|NCT01425814|530640463|FG003|Period 5|Stability criteria not fulfilled|0|||
147129111|NCT01425814|530640464|FG004|Period 5|Stability criteria not fulfilled|0|||
147129112|NCT01425814|530640465|FG005|Period 5|Stability criteria not fulfilled|1|||
147129113|NCT03243084|530640466|FG000|Washout (1-3 Weeks)|Lost to Follow-up|1|||
147129114|NCT03243084|530640467|FG001|Washout (1-3 Weeks)|Lost to Follow-up|0|||
147129115|NCT02095106|530640474|FG000|Second Intervention (14 Days)|Withdrawal by Subject|0|||
147129116|NCT02095106|530640475|FG001|Second Intervention (14 Days)|Withdrawal by Subject|1|||
147129117|NCT02546323|530640476|FG000|Overall Study|Withdrawal by Subject|36|||
147129118|NCT02546323|530640477|FG001|Overall Study|Withdrawal by Subject|33|||
147129119|NCT02546323|530640476|FG000|Overall Study|Eligibility Criteria not Fulfilled|0|||
147129120|NCT02546323|530640477|FG001|Overall Study|Eligibility Criteria not Fulfilled|1|||
147129121|NCT02546323|530640476|FG000|Overall Study|Adverse Event|17|||
147129122|NCT02546323|530640477|FG001|Overall Study|Adverse Event|11|||
147129123|NCT02546323|530640476|FG000|Overall Study|Patient Specific Reasons|1|||
147129124|NCT02546323|530640477|FG001|Overall Study|Patient Specific Reasons|2|||
147129125|NCT02546323|530640476|FG000|Overall Study|Lost to Follow-up|2|||
147129126|NCT02546323|530640477|FG001|Overall Study|Lost to Follow-up|3|||
147129127|NCT02546323|530640476|FG000|Overall Study|Non-compliance with Study Drug|2|||
147129128|NCT02546323|530640477|FG001|Overall Study|Non-compliance with Study Drug|2|||
147129129|NCT02546323|530640476|FG000|Overall Study|Met Withdrawal Criteria|2|||
147129130|NCT02546323|530640477|FG001|Overall Study|Met Withdrawal Criteria|14|||
147129131|NCT04476784|530640478|FG000|First Wear Period (30 Days ± 2 Days)|Withdrawal by Subject|1|||
147129132|NCT04476784|530640479|FG001|First Wear Period (30 Days ± 2 Days)|Withdrawal by Subject|0|||
147129133|NCT00478257|530640480|FG000|Overall Study|Withdrawal by Subject|8|||
147129134|NCT00478257|530640481|FG001|Overall Study|Withdrawal by Subject|3|||
147129135|NCT01055028|530640483|FG000|Screening|Screen Failure|1|||
147129136|NCT01055028|530640484|FG001|Screening|Screen Failure|1|||
147129137|NCT01055028|530640483|FG000|Treatment Cycles 1 to 3|Adverse Event|0|||
147129138|NCT01055028|530640484|FG001|Treatment Cycles 1 to 3|Adverse Event|1|||
147129139|NCT01055028|530640483|FG000|Treatment Cycles 1 to 3|Discontinued, < 3 cycles treatment|2|||
147129140|NCT01055028|530640484|FG001|Treatment Cycles 1 to 3|Discontinued, < 3 cycles treatment|2|||
147129141|NCT01055028|530640483|FG000|Inter-treatment Period|Did not start Cycle 4|0|||
147129142|NCT01055028|530640484|FG001|Inter-treatment Period|Did not start Cycle 4|3|||
147129143|NCT06582732|530640485|FG000|Initial Study Period|Adverse Event|0|||
147129144|NCT06582732|530640486|FG001|Initial Study Period|Adverse Event|0|||
147129145|NCT06582732|530640487|FG002|Initial Study Period|Adverse Event|0|||
147129146|NCT06582732|530640488|FG003|Initial Study Period|Adverse Event|2|||
147129147|NCT06582732|530640489|FG004|Initial Study Period|Adverse Event|0|||
147129148|NCT06582732|530640490|FG005|Initial Study Period|Adverse Event|0|||
147129149|NCT06582732|530640491|FG006|Initial Study Period|Adverse Event|0|||
147129150|NCT06582732|530640485|FG000|Initial Study Period|Death|1|||
147129151|NCT06582732|530640486|FG001|Initial Study Period|Death|0|||
147129152|NCT06582732|530640487|FG002|Initial Study Period|Death|0|||
147129153|NCT06582732|530640488|FG003|Initial Study Period|Death|0|||
147129154|NCT06582732|530640489|FG004|Initial Study Period|Death|1|||
147129155|NCT06582732|530640490|FG005|Initial Study Period|Death|0|||
147129156|NCT06582732|530640491|FG006|Initial Study Period|Death|0|||
147129157|NCT06582732|530640485|FG000|Initial Study Period|Lost to Follow-up|0|||
147235342|NCT00150709|531033688|FG003|Overall Study|Subject relocated|0|||
147129158|NCT06582732|530640486|FG001|Initial Study Period|Lost to Follow-up|0|||
147129159|NCT06582732|530640487|FG002|Initial Study Period|Lost to Follow-up|2|||
147129160|NCT06582732|530640488|FG003|Initial Study Period|Lost to Follow-up|0|||
147129161|NCT06582732|530640489|FG004|Initial Study Period|Lost to Follow-up|0|||
147129162|NCT06582732|530640490|FG005|Initial Study Period|Lost to Follow-up|0|||
147129163|NCT06582732|530640491|FG006|Initial Study Period|Lost to Follow-up|0|||
147129164|NCT06582732|530640485|FG000|Initial Study Period|Withdrawal by Subject|0|||
147129165|NCT06582732|530640486|FG001|Initial Study Period|Withdrawal by Subject|1|||
147129166|NCT06582732|530640487|FG002|Initial Study Period|Withdrawal by Subject|0|||
147129167|NCT06582732|530640488|FG003|Initial Study Period|Withdrawal by Subject|1|||
147129168|NCT06582732|530640489|FG004|Initial Study Period|Withdrawal by Subject|3|||
147235343|NCT00150709|531033685|FG000|Overall Study|Subject continues Keppra through prescriptions|0|||
147317189|NCT01536145|531327308|FG006|Overall Study|Other|0|||
147317190|NCT01536145|531327309|FG007|Overall Study|Other|0|||
147317191|NCT01536145|531327310|FG008|Overall Study|Other|0|||
147317192|NCT01536145|531327311|FG009|Overall Study|Other|3|||
147317193|NCT01536145|531327312|FG010|Overall Study|Other|2|||
147317194|NCT01536145|531327302|FG000|Overall Study|Death|0|||
147317195|NCT01536145|531327303|FG001|Overall Study|Death|0|||
147317196|NCT01536145|531327304|FG002|Overall Study|Death|0|||
147317197|NCT01536145|531327305|FG003|Overall Study|Death|0|||
147317198|NCT01536145|531327306|FG004|Overall Study|Death|0|||
147317199|NCT01536145|531327307|FG005|Overall Study|Death|0|||
147317200|NCT01536145|531327308|FG006|Overall Study|Death|1|||
147317201|NCT01536145|531327309|FG007|Overall Study|Death|0|||
147317202|NCT01536145|531327310|FG008|Overall Study|Death|0|||
147317203|NCT01536145|531327311|FG009|Overall Study|Death|0|||
147317204|NCT01536145|531327312|FG010|Overall Study|Death|0|||
147317205|NCT01536145|531327302|FG000|Overall Study|Adverse Event|0|||
147317206|NCT01536145|531327303|FG001|Overall Study|Adverse Event|0|||
147317207|NCT01536145|531327304|FG002|Overall Study|Adverse Event|0|||
147317208|NCT01536145|531327305|FG003|Overall Study|Adverse Event|0|||
147317209|NCT01536145|531327306|FG004|Overall Study|Adverse Event|0|||
147317210|NCT01536145|531327307|FG005|Overall Study|Adverse Event|0|||
147317211|NCT01536145|531327308|FG006|Overall Study|Adverse Event|0|||
147235344|NCT00150709|531033686|FG001|Overall Study|Subject continues Keppra through prescriptions|4|||
147235345|NCT00150709|531033687|FG002|Overall Study|Subject continues Keppra through prescriptions|0|||
147235346|NCT00150709|531033688|FG003|Overall Study|Subject continues Keppra through prescriptions|0|||
147235347|NCT00150709|531033685|FG000|Overall Study|Convenience|0|||
147235348|NCT00150709|531033686|FG001|Overall Study|Convenience|1|||
147235349|NCT00150709|531033687|FG002|Overall Study|Convenience|0|||
147235350|NCT00150709|531033688|FG003|Overall Study|Convenience|0|||
147235351|NCT00150709|531033685|FG000|Overall Study|Subject entered new drug study|0|||
147235352|NCT00150709|531033686|FG001|Overall Study|Subject entered new drug study|1|||
147235353|NCT00150709|531033687|FG002|Overall Study|Subject entered new drug study|0|||
147235354|NCT00150709|531033688|FG003|Overall Study|Subject entered new drug study|0|||
147235355|NCT00150709|531033685|FG000|Overall Study|Subject to undergo surgery for seizures|0|||
147235356|NCT00150709|531033686|FG001|Overall Study|Subject to undergo surgery for seizures|1|||
147235357|NCT00150709|531033687|FG002|Overall Study|Subject to undergo surgery for seizures|0|||
147235358|NCT00150709|531033688|FG003|Overall Study|Subject to undergo surgery for seizures|0|||
147235359|NCT00150709|531033685|FG000|Overall Study|Lack of ease of swallowing|0|||
147235360|NCT00150709|531033686|FG001|Overall Study|Lack of ease of swallowing|1|||
147235361|NCT00150709|531033687|FG002|Overall Study|Lack of ease of swallowing|0|||
147235362|NCT00150709|531033688|FG003|Overall Study|Lack of ease of swallowing|0|||
147235363|NCT04092582|531033689|FG000|Overall Study|Death|1|||
147235364|NCT04092582|531033690|FG001|Overall Study|Death|1|||
147235365|NCT04092582|531033689|FG000|Overall Study|Withdrawal by Subject|4|||
147235366|NCT04092582|531033690|FG001|Overall Study|Withdrawal by Subject|1|||
147235367|NCT04092582|531033689|FG000|Overall Study|Enrolled but Failed to Meet Randomization Criteria; Excluded from Study Analysis|0|||
147235368|NCT04092582|531033690|FG001|Overall Study|Enrolled but Failed to Meet Randomization Criteria; Excluded from Study Analysis|1|||
147569021|NCT01597245|532240139|FG018|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
147317212|NCT01536145|531327309|FG007|Overall Study|Adverse Event|2|||
147235369|NCT02280304|531033696|FG000|Overall Study|Lost to Follow-up|7|||
147317213|NCT01536145|531327310|FG008|Overall Study|Adverse Event|0|||
147317214|NCT01536145|531327311|FG009|Overall Study|Adverse Event|0|||
147317215|NCT01536145|531327312|FG010|Overall Study|Adverse Event|3|||
147317216|NCT05199233|531327315|FG000|Overall Study|Lack of Efficacy|1|||
147317217|NCT01364727|531327320|FG000|Overall Study|Not Eligible|2|||
147317218|NCT00688259|531327321|FG000|Overall Study|Lost to Follow-up|2|||
147317219|NCT00688259|531327322|FG001|Overall Study|Lost to Follow-up|4|||
147317220|NCT00688259|531327321|FG000|Overall Study|Physician Decision|1|||
147317221|NCT00688259|531327322|FG001|Overall Study|Physician Decision|0|||
147317222|NCT00688259|531327321|FG000|Overall Study|Withdrawal by Subject|2|||
147569022|NCT01597245|532240140|FG019|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
147129169|NCT06582732|530640490|FG005|Initial Study Period|Withdrawal by Subject|1|||
147569023|NCT01597245|532240141|FG020|Long Term Extension (Week 60 - Week 264)|Physician Decision|0|||
147129170|NCT06582732|530640491|FG006|Initial Study Period|Withdrawal by Subject|2|||
147129171|NCT06582732|530640485|FG000|Initial Study Period|Moved Away|0|||
147129172|NCT06582732|530640486|FG001|Initial Study Period|Moved Away|0|||
147129173|NCT06582732|530640487|FG002|Initial Study Period|Moved Away|0|||
147129174|NCT06582732|530640488|FG003|Initial Study Period|Moved Away|0|||
147129175|NCT06582732|530640489|FG004|Initial Study Period|Moved Away|1|||
147129176|NCT06582732|530640490|FG005|Initial Study Period|Moved Away|0|||
147129177|NCT06582732|530640491|FG006|Initial Study Period|Moved Away|0|||
147129178|NCT01182350|530640492|FG000|Overall Study|Adverse Event|5|||
147129179|NCT01182350|530640493|FG001|Overall Study|Adverse Event|0|||
147129180|NCT01182350|530640494|FG002|Overall Study|Adverse Event|0|||
147129181|NCT01182350|530640495|FG003|Overall Study|Adverse Event|0|||
147129182|NCT01182350|530640496|FG004|Overall Study|Adverse Event|0|||
147129183|NCT01182350|530640492|FG000|Overall Study|Disease Progression|15|||
147129184|NCT01182350|530640493|FG001|Overall Study|Disease Progression|12|||
147129185|NCT01182350|530640494|FG002|Overall Study|Disease Progression|0|||
147129186|NCT01182350|530640495|FG003|Overall Study|Disease Progression|1|||
147129187|NCT01182350|530640496|FG004|Overall Study|Disease Progression|0|||
147129188|NCT01182350|530640492|FG000|Overall Study|Death|0|||
147129189|NCT01182350|530640493|FG001|Overall Study|Death|1|||
147129190|NCT01182350|530640494|FG002|Overall Study|Death|1|||
147129191|NCT01182350|530640495|FG003|Overall Study|Death|0|||
147129192|NCT01182350|530640496|FG004|Overall Study|Death|0|||
147129193|NCT01182350|530640492|FG000|Overall Study|Withdrawal by Subject|3|||
147129194|NCT01182350|530640493|FG001|Overall Study|Withdrawal by Subject|1|||
147129195|NCT01182350|530640494|FG002|Overall Study|Withdrawal by Subject|0|||
147129196|NCT01182350|530640495|FG003|Overall Study|Withdrawal by Subject|1|||
147129197|NCT01182350|530640496|FG004|Overall Study|Withdrawal by Subject|0|||
147129198|NCT01182350|530640492|FG000|Overall Study|Alternative Therapy|2|||
147129199|NCT01182350|530640493|FG001|Overall Study|Alternative Therapy|0|||
147129200|NCT01182350|530640494|FG002|Overall Study|Alternative Therapy|1|||
147129201|NCT01182350|530640495|FG003|Overall Study|Alternative Therapy|0|||
147129202|NCT01182350|530640496|FG004|Overall Study|Alternative Therapy|0|||
147129203|NCT01182350|530640492|FG000|Overall Study|Travel Issue/Prefer Treatment at Home|2|||
147129204|NCT01182350|530640493|FG001|Overall Study|Travel Issue/Prefer Treatment at Home|0|||
147129205|NCT01182350|530640494|FG002|Overall Study|Travel Issue/Prefer Treatment at Home|1|||
147129206|NCT01182350|530640495|FG003|Overall Study|Travel Issue/Prefer Treatment at Home|1|||
147129207|NCT01182350|530640496|FG004|Overall Study|Travel Issue/Prefer Treatment at Home|0|||
147129208|NCT01182350|530640492|FG000|Overall Study|Unevaluable for Biopsy|0|||
147129209|NCT01182350|530640493|FG001|Overall Study|Unevaluable for Biopsy|0|||
147129210|NCT01182350|530640494|FG002|Overall Study|Unevaluable for Biopsy|0|||
147129211|NCT01182350|530640495|FG003|Overall Study|Unevaluable for Biopsy|0|||
147129212|NCT01182350|530640496|FG004|Overall Study|Unevaluable for Biopsy|3|||
147129213|NCT02919618|530640499|FG000|Overall Study|Death|1|||
147129214|NCT04770285|530640501|FG000|Overall Study|Non-Compliance With Study Treatment|3|||
147129215|NCT04770285|530640502|FG001|Overall Study|Non-Compliance With Study Treatment|3|||
147235370|NCT02280304|531033697|FG001|Overall Study|Lost to Follow-up|8|||
147235371|NCT01977794|531033701|FG000|Overall Study|Adverse Event|2|||
147235372|NCT01977794|531033702|FG001|Overall Study|Adverse Event|2|||
147235373|NCT01977794|531033701|FG000|Overall Study|Lost to Follow-up|2|||
147129216|NCT04770285|530640501|FG000|Overall Study|Lack of Efficacy|0|||
147129217|NCT04770285|530640502|FG001|Overall Study|Lack of Efficacy|1|||
147129218|NCT04770285|530640501|FG000|Overall Study|Lost to Follow-up|11|||
147129219|NCT04770285|530640502|FG001|Overall Study|Lost to Follow-up|8|||
147129220|NCT04770285|530640501|FG000|Overall Study|Protocol Deviation|6|||
147129221|NCT04770285|530640502|FG001|Overall Study|Protocol Deviation|6|||
147129222|NCT04770285|530640501|FG000|Overall Study|Technical Problem|0|||
147129223|NCT04770285|530640502|FG001|Overall Study|Technical Problem|1|||
147129224|NCT04770285|530640501|FG000|Overall Study|Withdrawal by Subject|9|||
147129225|NCT04770285|530640502|FG001|Overall Study|Withdrawal by Subject|8|||
147129226|NCT04770285|530640501|FG000|Overall Study|Reason Not Specified|0|||
147129227|NCT04770285|530640502|FG001|Overall Study|Reason Not Specified|1|||
147129228|NCT03766399|530640503|FG000|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
147129229|NCT03766399|530640504|FG001|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
147129230|NCT03766399|530640505|FG002|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
147129231|NCT03766399|530640506|FG003|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
147235374|NCT01977794|531033702|FG001|Overall Study|Lost to Follow-up|1|||
147235375|NCT01977794|531033701|FG000|Overall Study|Protocol Violation|1|||
147129232|NCT03766399|530640507|FG004|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
147129233|NCT03766399|530640508|FG005|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
147235376|NCT01977794|531033702|FG001|Overall Study|Protocol Violation|0|||
147235377|NCT01977794|531033701|FG000|Overall Study|Death|1|||
147235378|NCT01977794|531033702|FG001|Overall Study|Death|1|||
147235379|NCT01977794|531033701|FG000|Overall Study|Withdrew consent|2|||
147129234|NCT03766399|530640509|FG006|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
147129235|NCT03766399|530640510|FG007|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
147129236|NCT03766399|530640511|FG008|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
147444683|NCT01840579|531792669|FG002|Overall Study|Status not recorded|2|||
147444684|NCT01840579|531792670|FG003|Overall Study|Status not recorded|3|||
147444685|NCT01840579|531792671|FG004|Overall Study|Status not recorded|4|||
147444686|NCT01840579|531792672|FG005|Overall Study|Status not recorded|3|||
147444687|NCT01840579|531792673|FG006|Overall Study|Status not recorded|0|||
147444688|NCT01840579|531792674|FG007|Overall Study|Status not recorded|3|||
147444689|NCT01840579|531792675|FG008|Overall Study|Status not recorded|3|||
147444690|NCT01840579|531792676|FG009|Overall Study|Status not recorded|3|||
147444691|NCT01840579|531792667|FG000|Overall Study|Progressive disease|3|||
147444692|NCT01840579|531792668|FG001|Overall Study|Progressive disease|5|||
147444693|NCT01840579|531792669|FG002|Overall Study|Progressive disease|0|||
147444694|NCT01840579|531792670|FG003|Overall Study|Progressive disease|0|||
147444695|NCT01840579|531792671|FG004|Overall Study|Progressive disease|0|||
147444696|NCT01840579|531792672|FG005|Overall Study|Progressive disease|0|||
147444697|NCT01840579|531792673|FG006|Overall Study|Progressive disease|0|||
147444698|NCT01840579|531792674|FG007|Overall Study|Progressive disease|0|||
147444699|NCT01840579|531792675|FG008|Overall Study|Progressive disease|0|||
147444700|NCT01840579|531792676|FG009|Overall Study|Progressive disease|0|||
147444701|NCT01840579|531792667|FG000|Overall Study|Ongoing in study|0|||
147444702|NCT01840579|531792668|FG001|Overall Study|Ongoing in study|1|||
147444703|NCT01840579|531792669|FG002|Overall Study|Ongoing in study|0|||
147444704|NCT01840579|531792670|FG003|Overall Study|Ongoing in study|0|||
147444705|NCT01840579|531792671|FG004|Overall Study|Ongoing in study|0|||
147444706|NCT01840579|531792672|FG005|Overall Study|Ongoing in study|0|||
147444707|NCT01840579|531792673|FG006|Overall Study|Ongoing in study|0|||
147444708|NCT01840579|531792674|FG007|Overall Study|Ongoing in study|0|||
147444709|NCT01840579|531792675|FG008|Overall Study|Ongoing in study|0|||
147444710|NCT01840579|531792676|FG009|Overall Study|Ongoing in study|0|||
147444711|NCT01840579|531792667|FG000|Overall Study|Death|0|||
147444712|NCT01840579|531792668|FG001|Overall Study|Death|0|||
147444713|NCT01840579|531792669|FG002|Overall Study|Death|0|||
147444714|NCT01840579|531792670|FG003|Overall Study|Death|0|||
147444715|NCT01840579|531792671|FG004|Overall Study|Death|0|||
147444716|NCT01840579|531792672|FG005|Overall Study|Death|1|||
147444717|NCT01840579|531792673|FG006|Overall Study|Death|0|||
147444718|NCT01840579|531792674|FG007|Overall Study|Death|0|||
147444719|NCT01840579|531792675|FG008|Overall Study|Death|0|||
147444720|NCT01840579|531792676|FG009|Overall Study|Death|0|||
147444721|NCT01840579|531792667|FG000|Overall Study|Adverse Event|0|||
147444722|NCT01840579|531792668|FG001|Overall Study|Adverse Event|1|||
147444723|NCT01840579|531792669|FG002|Overall Study|Adverse Event|0|||
147444724|NCT01840579|531792670|FG003|Overall Study|Adverse Event|0|||
147444725|NCT01840579|531792671|FG004|Overall Study|Adverse Event|0|||
147444726|NCT01840579|531792672|FG005|Overall Study|Adverse Event|0|||
147444727|NCT01840579|531792673|FG006|Overall Study|Adverse Event|0|||
147444728|NCT01840579|531792674|FG007|Overall Study|Adverse Event|0|||
147444729|NCT01840579|531792675|FG008|Overall Study|Adverse Event|0|||
147444730|NCT01840579|531792676|FG009|Overall Study|Adverse Event|0|||
147444731|NCT01840579|531792667|FG000|Overall Study|Follow-up ended by Sponsor|0|||
147444732|NCT01840579|531792668|FG001|Overall Study|Follow-up ended by Sponsor|0|||
147444733|NCT01840579|531792669|FG002|Overall Study|Follow-up ended by Sponsor|0|||
147444734|NCT01840579|531792670|FG003|Overall Study|Follow-up ended by Sponsor|0|||
147444735|NCT01840579|531792671|FG004|Overall Study|Follow-up ended by Sponsor|0|||
147444736|NCT01840579|531792672|FG005|Overall Study|Follow-up ended by Sponsor|0|||
147444737|NCT01840579|531792673|FG006|Overall Study|Follow-up ended by Sponsor|2|||
147444738|NCT01840579|531792674|FG007|Overall Study|Follow-up ended by Sponsor|0|||
147444739|NCT01840579|531792675|FG008|Overall Study|Follow-up ended by Sponsor|0|||
147444740|NCT01840579|531792676|FG009|Overall Study|Follow-up ended by Sponsor|0|||
147444741|NCT03302975|531792678|FG000|Overall Study|Lost to Follow-up|4|||
147444742|NCT00432042|531792680|FG000|Overall Study|Protocol Violation|2|||
147444743|NCT00432042|531792681|FG001|Overall Study|Protocol Violation|0|||
147444744|NCT00432042|531792682|FG002|Overall Study|Protocol Violation|0|||
147444745|NCT00432042|531792680|FG000|Overall Study|Withdrawal by Subject|0|||
147444746|NCT00432042|531792681|FG001|Overall Study|Withdrawal by Subject|0|||
147444747|NCT00432042|531792682|FG002|Overall Study|Withdrawal by Subject|2|||
147444748|NCT00432042|531792680|FG000|Overall Study|Lost to Follow-up|5|||
147444749|NCT00432042|531792681|FG001|Overall Study|Lost to Follow-up|1|||
147444750|NCT00432042|531792682|FG002|Overall Study|Lost to Follow-up|0|||
147444751|NCT00492752|531792683|FG000|Double Blind Treatment|Death|13|||
147444752|NCT00492752|531792684|FG001|Double Blind Treatment|Death|0|||
147444753|NCT00492752|531792685|FG002|Double Blind Treatment|Death|2|||
147444754|NCT00492752|531792686|FG003|Double Blind Treatment|Death|0|||
147444755|NCT00492752|531792683|FG000|Double Blind Treatment|Adverse Event|1|||
147444756|NCT00492752|531792684|FG001|Double Blind Treatment|Adverse Event|0|||
147444757|NCT00492752|531792685|FG002|Double Blind Treatment|Adverse Event|0|||
147444758|NCT00492752|531792686|FG003|Double Blind Treatment|Adverse Event|0|||
147444759|NCT00492752|531792683|FG000|Double Blind Treatment|Protocol Violation|0|||
147444760|NCT00492752|531792684|FG001|Double Blind Treatment|Protocol Violation|0|||
147444761|NCT00492752|531792685|FG002|Double Blind Treatment|Protocol Violation|1|||
147444762|NCT00492752|531792686|FG003|Double Blind Treatment|Protocol Violation|0|||
147444763|NCT00492752|531792683|FG000|Follow-up and/or Open Label Sorafenib|Adverse Event|0|||
147444764|NCT00492752|531792684|FG001|Follow-up and/or Open Label Sorafenib|Adverse Event|2|||
147444765|NCT00492752|531792685|FG002|Follow-up and/or Open Label Sorafenib|Adverse Event|0|||
147444766|NCT00492752|531792686|FG003|Follow-up and/or Open Label Sorafenib|Adverse Event|2|||
147444767|NCT00492752|531792683|FG000|Follow-up and/or Open Label Sorafenib|Death|75|||
147444768|NCT00492752|531792684|FG001|Follow-up and/or Open Label Sorafenib|Death|5|||
147444769|NCT00492752|531792685|FG002|Follow-up and/or Open Label Sorafenib|Death|45|||
147444770|NCT00492752|531792686|FG003|Follow-up and/or Open Label Sorafenib|Death|1|||
147444771|NCT00492752|531792683|FG000|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|8|||
147444772|NCT00492752|531792684|FG001|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|1|||
147444773|NCT00492752|531792685|FG002|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|2|||
147444774|NCT00492752|531792686|FG003|Follow-up and/or Open Label Sorafenib|Lost to Follow-up|0|||
147444775|NCT00492752|531792683|FG000|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|2|||
147444776|NCT00492752|531792684|FG001|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|1|||
147444777|NCT00492752|531792685|FG002|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|0|||
147444778|NCT00492752|531792686|FG003|Follow-up and/or Open Label Sorafenib|Withdrawal by Subject|0|||
147444779|NCT00492752|531792683|FG000|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|0|||
147444780|NCT00492752|531792684|FG001|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|1|||
147444781|NCT00492752|531792685|FG002|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|0|||
147444782|NCT00492752|531792686|FG003|Follow-up and/or Open Label Sorafenib|Progression by clinical judgement|2|||
147444783|NCT00492752|531792683|FG000|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|0|||
147444784|NCT00492752|531792684|FG001|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|0|||
147444785|NCT00492752|531792685|FG002|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|0|||
147444786|NCT00492752|531792686|FG003|Follow-up and/or Open Label Sorafenib|Radiological and clinical progression|1|||
147444787|NCT00492752|531792683|FG000|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|0|||
147444788|NCT00492752|531792684|FG001|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|6|||
147444789|NCT00492752|531792685|FG002|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|0|||
147129237|NCT03766399|530640512|FG009|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
147129238|NCT03766399|530640513|FG010|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
147129239|NCT03766399|530640514|FG011|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
147129240|NCT03766399|530640515|FG012|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
147129241|NCT03766399|530640516|FG013|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|1|||
147129242|NCT03766399|530640517|FG014|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
147129243|NCT03766399|530640518|FG015|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
147129244|NCT03766399|530640519|FG016|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
147129245|NCT03766399|530640520|FG017|Part 2b: MAD (Nebulized Inhalation)|Physician Decision|0|||
147129246|NCT05030766|530640521|FG000|Phase 1 Participants|Lost to Follow-up|12|||
147129247|NCT05030766|530640522|FG001|Phase 1 Participants|Lost to Follow-up|22|||
147317223|NCT00688259|531327322|FG001|Overall Study|Withdrawal by Subject|0|||
147317224|NCT00688259|531327321|FG000|Overall Study|Declined Interview|2|||
147317225|NCT00688259|531327322|FG001|Overall Study|Declined Interview|3|||
147317226|NCT00688259|531327321|FG000|Overall Study|Hospitalized at Follow-up|0|||
147317227|NCT00688259|531327322|FG001|Overall Study|Hospitalized at Follow-up|1|||
147317228|NCT01676220|531327324|FG000|Overall Study|Randomized But Not Treated|4|||
147317229|NCT01676220|531327325|FG001|Overall Study|Randomized But Not Treated|1|||
147317230|NCT01676220|531327324|FG000|Overall Study|Adverse Event|10|||
147444790|NCT00492752|531792686|FG003|Follow-up and/or Open Label Sorafenib|Switch to commercial drug|0|||
147444791|NCT00492752|531792683|FG000|Follow-up and/or Open Label Sorafenib|Progression measurement proven|1|||
147129248|NCT05030766|530640523|FG002|Phase 1 Participants|Lost to Follow-up|0|||
147129249|NCT05030766|530640524|FG003|Phase 1 Participants|Lost to Follow-up|0|||
147129250|NCT05030766|530640521|FG000|Phase 1 Participants|Did not attend sessions after being randomized|16|||
147129251|NCT05030766|530640522|FG001|Phase 1 Participants|Did not attend sessions after being randomized|9|||
147129252|NCT05030766|530640523|FG002|Phase 1 Participants|Did not attend sessions after being randomized|0|||
147129253|NCT05030766|530640524|FG003|Phase 1 Participants|Did not attend sessions after being randomized|0|||
147129254|NCT05030766|530640521|FG000|Phase 2 Participants|Lost to Follow-up|0|||
147129255|NCT05030766|530640522|FG001|Phase 2 Participants|Lost to Follow-up|0|||
147129256|NCT05030766|530640523|FG002|Phase 2 Participants|Lost to Follow-up|6|||
147444792|NCT00492752|531792684|FG001|Follow-up and/or Open Label Sorafenib|Progression measurement proven|0|||
147444793|NCT00492752|531792685|FG002|Follow-up and/or Open Label Sorafenib|Progression measurement proven|0|||
147444794|NCT00492752|531792686|FG003|Follow-up and/or Open Label Sorafenib|Progression measurement proven|0|||
147129257|NCT05030766|530640524|FG003|Phase 2 Participants|Lost to Follow-up|2|||
147129258|NCT00645658|530640525|FG000|Overall Study|Withdrawal by Subject|1|||
147129259|NCT00645658|530640526|FG001|Overall Study|Withdrawal by Subject|0|||
147129260|NCT00645658|530640525|FG000|Overall Study|Did not complete all assesments|0|||
147129261|NCT00645658|530640526|FG001|Overall Study|Did not complete all assesments|2|||
147129262|NCT03605693|530640527|FG000|Overall Study|Lost to Follow-up|4|||
147317231|NCT01676220|531327325|FG001|Overall Study|Adverse Event|8|||
147317232|NCT01676220|531327324|FG000|Overall Study|Lack of Efficacy|2|||
147317233|NCT01676220|531327325|FG001|Overall Study|Lack of Efficacy|5|||
147317234|NCT01676220|531327324|FG000|Overall Study|Protocol Violation|11|||
147317235|NCT01676220|531327325|FG001|Overall Study|Protocol Violation|12|||
147317236|NCT01676220|531327324|FG000|Overall Study|Received Rescue Therapy|14|||
147317237|NCT01676220|531327325|FG001|Overall Study|Received Rescue Therapy|22|||
147317238|NCT01676220|531327324|FG000|Overall Study|Personal Reason|34|||
147317239|NCT01676220|531327325|FG001|Overall Study|Personal Reason|45|||
147317240|NCT01676220|531327324|FG000|Overall Study|Lost to Follow-up|11|||
147317241|NCT01676220|531327325|FG001|Overall Study|Lost to Follow-up|18|||
147317242|NCT01676220|531327324|FG000|Overall Study|Selection Criterion/Protocol Violation|9|||
147317243|NCT01676220|531327325|FG001|Overall Study|Selection Criterion/Protocol Violation|9|||
147317244|NCT01676220|531327324|FG000|Overall Study|Site Closure/Site Withdrawal|1|||
147317245|NCT01676220|531327325|FG001|Overall Study|Site Closure/Site Withdrawal|4|||
147317246|NCT01676220|531327324|FG000|Overall Study|Perceived Lack of Efficacy|3|||
147317247|NCT01676220|531327325|FG001|Overall Study|Perceived Lack of Efficacy|1|||
147317248|NCT01676220|531327324|FG000|Overall Study|Non Serious Hypoglycemia|2|||
147317249|NCT01676220|531327325|FG001|Overall Study|Non Serious Hypoglycemia|0|||
147317250|NCT01676220|531327324|FG000|Overall Study|No More Need of Insulin|1|||
147317251|NCT01676220|531327325|FG001|Overall Study|No More Need of Insulin|0|||
147317252|NCT04227340|531327326|FG000|Overall Study|Withdrawal by Subject|3|||
147317253|NCT00393094|531327329|FG000|Period1Bevacizumab & Irinotecan Patients|Disease progression before treatment|1|||
147317254|NCT00393094|531327329|FG000|Disease Progression After Trtmt: Onstudy|Refused further treatment|1|||
147317255|NCT03050398|531327333|FG000|Overall Study|Study terminated by sponsor|8|||
147317256|NCT03018106|531327334|FG000|Overall Study|Lost to Follow-up|0|||
147317257|NCT03018106|531327335|FG001|Overall Study|Lost to Follow-up|1|||
147317258|NCT04242875|531327336|FG000|Overall Study|Adverse Event|2|||
147317259|NCT02611830|531327339|FG000|OL Induction Phase|Pretreatment Event/Adverse Event|9|||
147317260|NCT02611830|531327340|FG001|OL Induction Phase|Pretreatment Event/Adverse Event|0|||
147317261|NCT02611830|531327341|FG002|OL Induction Phase|Pretreatment Event/Adverse Event|0|||
147317262|NCT02611830|531327342|FG003|OL Induction Phase|Pretreatment Event/Adverse Event|0|||
147317263|NCT02611830|531327339|FG000|OL Induction Phase|Significant Protocol Deviation|4|||
147317264|NCT02611830|531327340|FG001|OL Induction Phase|Significant Protocol Deviation|0|||
147317265|NCT02611830|531327341|FG002|OL Induction Phase|Significant Protocol Deviation|0|||
147317266|NCT02611830|531327342|FG003|OL Induction Phase|Significant Protocol Deviation|0|||
147444795|NCT01357655|531792687|FG000|Overall Study|Administrative Reason by Sponsor|45|||
147444796|NCT01357655|531792688|FG001|Overall Study|Administrative Reason by Sponsor|0|||
147444797|NCT01357655|531792687|FG000|Overall Study|Adverse Event Unrelated to Study Drug|3|||
147651271|NCT03816007|532544660|FG000|End of 12-week Intervention|Withdrawal by Subject|0|||
147129263|NCT03605693|530640528|FG001|Overall Study|Lost to Follow-up|0|||
147129264|NCT03605693|530640527|FG000|Overall Study|Physician Decision|1|||
147129265|NCT03605693|530640528|FG001|Overall Study|Physician Decision|0|||
147129266|NCT03093415|530640531|FG000|Assessed for Eligibility --> Enrollment|Lost to Follow-up|17|||
147129267|NCT03093415|530640532|FG001|Assessed for Eligibility --> Enrollment|Lost to Follow-up|36|||
147129268|NCT03093415|530640533|FG002|Assessed for Eligibility --> Enrollment|Lost to Follow-up|0|||
147129269|NCT03093415|530640531|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No MAT|40|||
147129270|NCT03093415|530640532|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No MAT|0|||
147129271|NCT03093415|530640533|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No MAT|0|||
147129272|NCT03093415|530640531|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: neg HCV|28|||
147129273|NCT03093415|530640532|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: neg HCV|6|||
147129274|NCT03093415|530640533|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: neg HCV|0|||
147235380|NCT01977794|531033702|FG001|Overall Study|Withdrew consent|1|||
147235381|NCT01977794|531033701|FG000|Overall Study|Other|0|||
147235382|NCT01977794|531033702|FG001|Overall Study|Other|1|||
147235383|NCT00533897|531033705|FG000|Lead-in (LI) Period 1|Adverse Event|1|||
147235384|NCT00533897|531033706|FG001|Lead-in (LI) Period 1|Adverse Event|0|||
147235385|NCT00533897|531033707|FG002|Lead-in (LI) Period 1|Adverse Event|0|||
147235386|NCT00533897|531033708|FG003|Lead-in (LI) Period 1|Adverse Event|0|||
147235387|NCT00533897|531033709|FG004|Lead-in (LI) Period 1|Adverse Event|0|||
147235388|NCT00533897|531033710|FG005|Lead-in (LI) Period 1|Adverse Event|0|||
147235389|NCT00533897|531033711|FG006|Lead-in (LI) Period 1|Adverse Event|0|||
147235390|NCT00533897|531033712|FG007|Lead-in (LI) Period 1|Adverse Event|0|||
147235391|NCT00533897|531033705|FG000|Lead-in (LI) Period 1|Participant Withdrew Consent|2|||
147235392|NCT00533897|531033706|FG001|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
147235393|NCT00533897|531033707|FG002|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
147235394|NCT00533897|531033708|FG003|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
147235395|NCT00533897|531033709|FG004|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
147235396|NCT00533897|531033710|FG005|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
147235397|NCT00533897|531033711|FG006|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
147235398|NCT00533897|531033712|FG007|Lead-in (LI) Period 1|Participant Withdrew Consent|0|||
147129275|NCT03093415|530640531|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No active use|0|||
147129276|NCT03093415|530640532|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No active use|12|||
147129277|NCT03093415|530640533|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: No active use|0|||
147129278|NCT03093415|530640531|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Fibrosis > F2|18|||
147129279|NCT03093415|530640532|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Fibrosis > F2|12|||
147129280|NCT03093415|530640533|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Fibrosis > F2|0|||
147129281|NCT03093415|530640531|FG000|Assessed for Eligibility --> Enrollment|Exclusion Criteria: HIV|4|||
147129282|NCT03093415|530640532|FG001|Assessed for Eligibility --> Enrollment|Exclusion Criteria: HIV|4|||
147129283|NCT03093415|530640533|FG002|Assessed for Eligibility --> Enrollment|Exclusion Criteria: HIV|0|||
147129284|NCT03093415|530640531|FG000|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Wrong Genotype|15|||
147129285|NCT03093415|530640532|FG001|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Wrong Genotype|32|||
147129286|NCT03093415|530640533|FG002|Assessed for Eligibility --> Enrollment|Inclusion Criteria: Wrong Genotype|0|||
147129287|NCT03093415|530640531|FG000|Assessed for Eligibility --> Enrollment|Exclusion Criteria: NS5a Resistance|5|||
147129288|NCT03093415|530640532|FG001|Assessed for Eligibility --> Enrollment|Exclusion Criteria: NS5a Resistance|3|||
147129289|NCT03093415|530640533|FG002|Assessed for Eligibility --> Enrollment|Exclusion Criteria: NS5a Resistance|0|||
147129290|NCT03093415|530640531|FG000|Assessed for Eligibility --> Enrollment|Exclusion Criteria: Treatment Readiness|4|||
147129291|NCT03093415|530640532|FG001|Assessed for Eligibility --> Enrollment|Exclusion Criteria: Treatment Readiness|2|||
147129292|NCT03093415|530640533|FG002|Assessed for Eligibility --> Enrollment|Exclusion Criteria: Treatment Readiness|0|||
147129293|NCT03093415|530640531|FG000|Assessed for Eligibility --> Enrollment|Other Lab exclusion Criteria|9|||
147129294|NCT03093415|530640532|FG001|Assessed for Eligibility --> Enrollment|Other Lab exclusion Criteria|3|||
147317267|NCT02611830|531327339|FG000|OL Induction Phase|Voluntary Withdrawal|5|||
147129295|NCT03093415|530640533|FG002|Assessed for Eligibility --> Enrollment|Other Lab exclusion Criteria|0|||
147129296|NCT03093415|530640531|FG000|Enrollment to SVR12 Results|Lost to Follow-up|1|||
147129297|NCT03093415|530640532|FG001|Enrollment to SVR12 Results|Lost to Follow-up|8|||
147129298|NCT03093415|530640533|FG002|Enrollment to SVR12 Results|Lost to Follow-up|3|||
147129299|NCT03895372|530640534|FG000|Investigational Treatment Period|Adverse Event|1|||
147129300|NCT03895372|530640535|FG001|Investigational Treatment Period|Adverse Event|0|||
147129301|NCT03895372|530640536|FG002|Investigational Treatment Period|Adverse Event|0|||
147129302|NCT03895372|530640537|FG003|Investigational Treatment Period|Adverse Event|0|||
147129303|NCT03895372|530640538|FG004|Investigational Treatment Period|Adverse Event|0|||
147129304|NCT03895372|530640539|FG005|Investigational Treatment Period|Adverse Event|0|||
147129305|NCT03895372|530640540|FG006|Investigational Treatment Period|Adverse Event|4|||
147129306|NCT03895372|530640541|FG007|Investigational Treatment Period|Adverse Event|3|||
147129307|NCT03895372|530640534|FG000|Investigational Treatment Period|Lack of Efficacy|1|||
147129308|NCT03895372|530640535|FG001|Investigational Treatment Period|Lack of Efficacy|0|||
147129309|NCT03895372|530640536|FG002|Investigational Treatment Period|Lack of Efficacy|0|||
147129310|NCT03895372|530640537|FG003|Investigational Treatment Period|Lack of Efficacy|0|||
147129311|NCT03895372|530640538|FG004|Investigational Treatment Period|Lack of Efficacy|0|||
147129312|NCT03895372|530640539|FG005|Investigational Treatment Period|Lack of Efficacy|0|||
147129313|NCT03895372|530640540|FG006|Investigational Treatment Period|Lack of Efficacy|0|||
147129314|NCT03895372|530640541|FG007|Investigational Treatment Period|Lack of Efficacy|0|||
147129315|NCT03895372|530640534|FG000|Investigational Treatment Period|Lost to Follow-up|0|||
147129316|NCT03895372|530640535|FG001|Investigational Treatment Period|Lost to Follow-up|0|||
147129317|NCT03895372|530640536|FG002|Investigational Treatment Period|Lost to Follow-up|0|||
147129318|NCT03895372|530640537|FG003|Investigational Treatment Period|Lost to Follow-up|0|||
147129319|NCT03895372|530640538|FG004|Investigational Treatment Period|Lost to Follow-up|0|||
147235399|NCT00533897|531033705|FG000|Lead-in (LI) Period 1|Lost to Follow-up|1|||
147235400|NCT00533897|531033706|FG001|Lead-in (LI) Period 1|Lost to Follow-up|0|||
147235401|NCT00533897|531033707|FG002|Lead-in (LI) Period 1|Lost to Follow-up|0|||
147235402|NCT00533897|531033708|FG003|Lead-in (LI) Period 1|Lost to Follow-up|0|||
147235403|NCT00533897|531033709|FG004|Lead-in (LI) Period 1|Lost to Follow-up|0|||
147235404|NCT00533897|531033710|FG005|Lead-in (LI) Period 1|Lost to Follow-up|0|||
147235405|NCT00533897|531033711|FG006|Lead-in (LI) Period 1|Lost to Follow-up|0|||
147235406|NCT00533897|531033712|FG007|Lead-in (LI) Period 1|Lost to Follow-up|0|||
147235407|NCT00533897|531033705|FG000|Lead-in (LI) Period 1|Administrative Reason By Sponsor|2|||
147235408|NCT00533897|531033706|FG001|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
147235409|NCT00533897|531033707|FG002|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
147235410|NCT00533897|531033708|FG003|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
147235411|NCT00533897|531033709|FG004|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
147317268|NCT02611830|531327340|FG001|OL Induction Phase|Voluntary Withdrawal|0|||
147317269|NCT02611830|531327341|FG002|OL Induction Phase|Voluntary Withdrawal|0|||
147651272|NCT03816007|532544661|FG001|End of 12-week Intervention|Withdrawal by Subject|2|||
147129320|NCT03895372|530640539|FG005|Investigational Treatment Period|Lost to Follow-up|0|||
147235412|NCT00533897|531033710|FG005|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
147317270|NCT02611830|531327342|FG003|OL Induction Phase|Voluntary Withdrawal|0|||
147129321|NCT03895372|530640540|FG006|Investigational Treatment Period|Lost to Follow-up|1|||
147129322|NCT03895372|530640541|FG007|Investigational Treatment Period|Lost to Follow-up|0|||
147129323|NCT03895372|530640534|FG000|Investigational Treatment Period|Other|0|||
147129324|NCT03895372|530640535|FG001|Investigational Treatment Period|Other|0|||
147129325|NCT03895372|530640536|FG002|Investigational Treatment Period|Other|0|||
147129326|NCT03895372|530640537|FG003|Investigational Treatment Period|Other|0|||
147129327|NCT03895372|530640538|FG004|Investigational Treatment Period|Other|0|||
147129328|NCT03895372|530640539|FG005|Investigational Treatment Period|Other|1|||
147129329|NCT03895372|530640540|FG006|Investigational Treatment Period|Other|0|||
147129330|NCT03895372|530640541|FG007|Investigational Treatment Period|Other|2|||
147129331|NCT03895372|530640534|FG000|Investigational Treatment Period|Protocol Violation|0|||
147129332|NCT03895372|530640535|FG001|Investigational Treatment Period|Protocol Violation|0|||
147129333|NCT03895372|530640536|FG002|Investigational Treatment Period|Protocol Violation|0|||
147129334|NCT03895372|530640537|FG003|Investigational Treatment Period|Protocol Violation|1|||
147129335|NCT03895372|530640538|FG004|Investigational Treatment Period|Protocol Violation|0|||
147129336|NCT03895372|530640539|FG005|Investigational Treatment Period|Protocol Violation|0|||
147129337|NCT03895372|530640540|FG006|Investigational Treatment Period|Protocol Violation|0|||
147129338|NCT03895372|530640541|FG007|Investigational Treatment Period|Protocol Violation|0|||
147129339|NCT03895372|530640534|FG000|Investigational Treatment Period|Withdrawal by Subject|2|||
147129340|NCT03895372|530640535|FG001|Investigational Treatment Period|Withdrawal by Subject|3|||
147129341|NCT03895372|530640536|FG002|Investigational Treatment Period|Withdrawal by Subject|1|||
147129342|NCT03895372|530640537|FG003|Investigational Treatment Period|Withdrawal by Subject|1|||
147129343|NCT03895372|530640538|FG004|Investigational Treatment Period|Withdrawal by Subject|0|||
147129344|NCT03895372|530640539|FG005|Investigational Treatment Period|Withdrawal by Subject|1|||
147129345|NCT03895372|530640540|FG006|Investigational Treatment Period|Withdrawal by Subject|3|||
147129346|NCT03895372|530640541|FG007|Investigational Treatment Period|Withdrawal by Subject|0|||
147129347|NCT03895372|530640534|FG000|Extension Treatment Period|Adverse Event|0|||
147129348|NCT03895372|530640535|FG001|Extension Treatment Period|Adverse Event|1|||
147129349|NCT03895372|530640536|FG002|Extension Treatment Period|Adverse Event|0|||
147129350|NCT03895372|530640537|FG003|Extension Treatment Period|Adverse Event|1|||
147129351|NCT03895372|530640538|FG004|Extension Treatment Period|Adverse Event|0|||
147129352|NCT03895372|530640539|FG005|Extension Treatment Period|Adverse Event|0|||
147129353|NCT03895372|530640540|FG006|Extension Treatment Period|Adverse Event|3|||
147129354|NCT03895372|530640541|FG007|Extension Treatment Period|Adverse Event|3|||
147129355|NCT03895372|530640534|FG000|Extension Treatment Period|Other|1|||
147129356|NCT03895372|530640535|FG001|Extension Treatment Period|Other|3|||
147129357|NCT03895372|530640536|FG002|Extension Treatment Period|Other|0|||
147129358|NCT03895372|530640537|FG003|Extension Treatment Period|Other|0|||
147129359|NCT03895372|530640538|FG004|Extension Treatment Period|Other|1|||
147129360|NCT03895372|530640539|FG005|Extension Treatment Period|Other|0|||
147129361|NCT03895372|530640540|FG006|Extension Treatment Period|Other|0|||
147129362|NCT03895372|530640541|FG007|Extension Treatment Period|Other|2|||
147129363|NCT03895372|530640534|FG000|Extension Treatment Period|Pregnancy|0|||
147129364|NCT03895372|530640535|FG001|Extension Treatment Period|Pregnancy|0|||
147129365|NCT03895372|530640536|FG002|Extension Treatment Period|Pregnancy|0|||
147129366|NCT03895372|530640537|FG003|Extension Treatment Period|Pregnancy|0|||
147129367|NCT03895372|530640538|FG004|Extension Treatment Period|Pregnancy|1|||
147129368|NCT03895372|530640539|FG005|Extension Treatment Period|Pregnancy|0|||
147129369|NCT03895372|530640540|FG006|Extension Treatment Period|Pregnancy|0|||
147235413|NCT00533897|531033711|FG006|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
147235414|NCT00533897|531033712|FG007|Lead-in (LI) Period 1|Administrative Reason By Sponsor|0|||
147235415|NCT00533897|531033705|FG000|Lead-in (LI) Period 1|Lack of Efficacy|3|||
147235416|NCT00533897|531033706|FG001|Lead-in (LI) Period 1|Lack of Efficacy|0|||
147235417|NCT00533897|531033707|FG002|Lead-in (LI) Period 1|Lack of Efficacy|0|||
147235418|NCT00533897|531033708|FG003|Lead-in (LI) Period 1|Lack of Efficacy|0|||
147235419|NCT00533897|531033709|FG004|Lead-in (LI) Period 1|Lack of Efficacy|0|||
147235420|NCT00533897|531033710|FG005|Lead-in (LI) Period 1|Lack of Efficacy|0|||
147235421|NCT00533897|531033711|FG006|Lead-in (LI) Period 1|Lack of Efficacy|0|||
147235422|NCT00533897|531033712|FG007|Lead-in (LI) Period 1|Lack of Efficacy|0|||
147235423|NCT00533897|531033705|FG000|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|1|||
147235424|NCT00533897|531033706|FG001|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
147235425|NCT00533897|531033707|FG002|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
147235426|NCT00533897|531033708|FG003|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
147235427|NCT00533897|531033709|FG004|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
147235428|NCT00533897|531033710|FG005|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
147235429|NCT00533897|531033711|FG006|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
147235430|NCT00533897|531033712|FG007|Lead-in (LI) Period 1|Missed 2 Consecutive Doses of Study Drug|0|||
147235431|NCT00533897|531033705|FG000|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
147235432|NCT00533897|531033706|FG001|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|1|||
147235433|NCT00533897|531033707|FG002|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|2|||
147129370|NCT03895372|530640541|FG007|Extension Treatment Period|Pregnancy|0|||
147129371|NCT03895372|530640534|FG000|Extension Treatment Period|Withdrawal by Subject|2|||
147129372|NCT03895372|530640535|FG001|Extension Treatment Period|Withdrawal by Subject|1|||
147129373|NCT03895372|530640536|FG002|Extension Treatment Period|Withdrawal by Subject|0|||
147129374|NCT03895372|530640537|FG003|Extension Treatment Period|Withdrawal by Subject|0|||
147129375|NCT03895372|530640538|FG004|Extension Treatment Period|Withdrawal by Subject|1|||
147129376|NCT03895372|530640539|FG005|Extension Treatment Period|Withdrawal by Subject|1|||
147129377|NCT03895372|530640540|FG006|Extension Treatment Period|Withdrawal by Subject|1|||
147129378|NCT03895372|530640541|FG007|Extension Treatment Period|Withdrawal by Subject|1|||
147569024|NCT01597245|532240121|FG000|Long Term Extension (Week 60 - Week 264)|Death|0|||
147569025|NCT01597245|532240122|FG001|Long Term Extension (Week 60 - Week 264)|Death|0|||
147569026|NCT01597245|532240123|FG002|Long Term Extension (Week 60 - Week 264)|Death|0|||
147129379|NCT03559530|530640542|FG000|Overall Study|non-location of medical records|44|||
147129380|NCT03559530|530640543|FG001|Overall Study|non-location of medical records|0|||
147129381|NCT03559530|530640542|FG000|Overall Study|culture results not considered for treat|29|||
147129382|NCT03559530|530640543|FG001|Overall Study|culture results not considered for treat|0|||
147129383|NCT03559530|530640542|FG000|Overall Study|duplicate cases|8|||
147129384|NCT03559530|530640543|FG001|Overall Study|duplicate cases|0|||
147235434|NCT00533897|531033708|FG003|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
147235435|NCT00533897|531033709|FG004|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
147129385|NCT03559530|530640542|FG000|Overall Study|other species of Acinetobacte|7|||
147235436|NCT00533897|531033710|FG005|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
147235437|NCT00533897|531033711|FG006|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
147235438|NCT00533897|531033712|FG007|Double-blind Withdrawal (DBW) Period 2|Lack of Efficacy|0|||
147235439|NCT00533897|531033705|FG000|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
147235440|NCT00533897|531033706|FG001|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
147235441|NCT00533897|531033707|FG002|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|1|||
147235442|NCT00533897|531033708|FG003|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
147235443|NCT00533897|531033709|FG004|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
147235444|NCT00533897|531033710|FG005|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
147235445|NCT00533897|531033711|FG006|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
147235446|NCT00533897|531033712|FG007|Double-blind Withdrawal (DBW) Period 2|Poor/Non-Compliance|0|||
147235447|NCT00533897|531033705|FG000|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
147235448|NCT00533897|531033706|FG001|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
147235449|NCT00533897|531033707|FG002|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
147235450|NCT00533897|531033708|FG003|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
147235451|NCT00533897|531033709|FG004|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
147235452|NCT00533897|531033710|FG005|Re-introduction (RI) Period 3|Participant Withdrew Consent|1|||
147235453|NCT00533897|531033711|FG006|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
147235454|NCT00533897|531033712|FG007|Re-introduction (RI) Period 3|Participant Withdrew Consent|0|||
147235455|NCT00533897|531033705|FG000|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
147235456|NCT00533897|531033706|FG001|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
147235457|NCT00533897|531033707|FG002|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
147235458|NCT00533897|531033708|FG003|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
147235459|NCT00533897|531033709|FG004|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
147235460|NCT00533897|531033710|FG005|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|1|||
147235461|NCT00533897|531033711|FG006|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
147235462|NCT00533897|531033712|FG007|Re-introduction (RI) Period 3|No Longer Meets Study Criteria|0|||
147235463|NCT00533897|531033705|FG000|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
147235464|NCT00533897|531033706|FG001|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
147235465|NCT00533897|531033707|FG002|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
147235466|NCT00533897|531033708|FG003|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
147235467|NCT00533897|531033709|FG004|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
147235468|NCT00533897|531033710|FG005|Long Term Extension (LTE)|Participant Withdrew Consent|0|||
147235469|NCT00533897|531033711|FG006|Long Term Extension (LTE)|Participant Withdrew Consent|2|||
147235470|NCT00533897|531033712|FG007|Long Term Extension (LTE)|Participant Withdrew Consent|5|||
147235471|NCT00533897|531033705|FG000|Long Term Extension (LTE)|Death|0|||
147235472|NCT00533897|531033706|FG001|Long Term Extension (LTE)|Death|0|||
147235473|NCT00533897|531033707|FG002|Long Term Extension (LTE)|Death|0|||
147235474|NCT00533897|531033708|FG003|Long Term Extension (LTE)|Death|0|||
147235475|NCT00533897|531033709|FG004|Long Term Extension (LTE)|Death|0|||
147235476|NCT00533897|531033710|FG005|Long Term Extension (LTE)|Death|0|||
147235477|NCT00533897|531033711|FG006|Long Term Extension (LTE)|Death|1|||
147235478|NCT00533897|531033712|FG007|Long Term Extension (LTE)|Death|3|||
147569027|NCT01597245|532240124|FG003|Long Term Extension (Week 60 - Week 264)|Death|0|||
147569028|NCT01597245|532240125|FG004|Long Term Extension (Week 60 - Week 264)|Death|0|||
147129386|NCT03559530|530640543|FG001|Overall Study|other species of Acinetobacte|0|||
147129387|NCT03559530|530640542|FG000|Overall Study|contamination / colonization|3|||
147129388|NCT03559530|530640543|FG001|Overall Study|contamination / colonization|0|||
147129389|NCT01646827|530640546|FG000|Overall Study|Lost to Follow-up|0|||
147129390|NCT01646827|530640547|FG001|Overall Study|Lost to Follow-up|3|||
147129391|NCT01646827|530640546|FG000|Overall Study|Physician Decision|1|||
147129392|NCT01646827|530640547|FG001|Overall Study|Physician Decision|2|||
147129393|NCT01646827|530640546|FG000|Overall Study|Withdrawal by Subject|1|||
147129394|NCT01646827|530640547|FG001|Overall Study|Withdrawal by Subject|0|||
147129395|NCT04380142|530640550|FG000|LD/CD Stabilization Period|Adverse Event|3|||
147129396|NCT04380142|530640551|FG001|LD/CD Stabilization Period|Adverse Event|0|||
147129397|NCT04380142|530640552|FG002|LD/CD Stabilization Period|Adverse Event|0|||
147129398|NCT04380142|530640550|FG000|LD/CD Stabilization Period|Withdrawal by Subject|4|||
147129399|NCT04380142|530640551|FG001|LD/CD Stabilization Period|Withdrawal by Subject|0|||
147129400|NCT04380142|530640552|FG002|LD/CD Stabilization Period|Withdrawal by Subject|0|||
147129401|NCT04380142|530640550|FG000|LD/CD Stabilization Period|Lost to Follow-up|1|||
147129402|NCT04380142|530640551|FG001|LD/CD Stabilization Period|Lost to Follow-up|0|||
147129403|NCT04380142|530640552|FG002|LD/CD Stabilization Period|Lost to Follow-up|0|||
147129404|NCT04380142|530640550|FG000|LD/CD Stabilization Period|Lack of Efficacy|1|||
147129405|NCT04380142|530640551|FG001|LD/CD Stabilization Period|Lack of Efficacy|0|||
147129406|NCT04380142|530640552|FG002|LD/CD Stabilization Period|Lack of Efficacy|0|||
147129407|NCT04380142|530640550|FG000|LD/CD Stabilization Period|Difficulty With Drug Delivery System|2|||
147129408|NCT04380142|530640551|FG001|LD/CD Stabilization Period|Difficulty With Drug Delivery System|0|||
147129409|NCT04380142|530640552|FG002|LD/CD Stabilization Period|Difficulty With Drug Delivery System|0|||
147129410|NCT04380142|530640550|FG000|LD/CD Stabilization Period|Other, Not Specified|18|||
147129411|NCT04380142|530640551|FG001|LD/CD Stabilization Period|Other, Not Specified|0|||
147129412|NCT04380142|530640552|FG002|LD/CD Stabilization Period|Other, Not Specified|0|||
147129413|NCT04380142|530640550|FG000|Double-Blind Treatment Period|Adverse Event|0|||
147129414|NCT04380142|530640551|FG001|Double-Blind Treatment Period|Adverse Event|1|||
147129415|NCT04380142|530640552|FG002|Double-Blind Treatment Period|Adverse Event|14|||
147129416|NCT04380142|530640550|FG000|Double-Blind Treatment Period|Withdrew Consent|0|||
147129417|NCT04380142|530640551|FG001|Double-Blind Treatment Period|Withdrew Consent|3|||
147129418|NCT04380142|530640552|FG002|Double-Blind Treatment Period|Withdrew Consent|6|||
147129419|NCT04380142|530640550|FG000|Double-Blind Treatment Period|Lack of Efficacy|0|||
147129420|NCT04380142|530640551|FG001|Double-Blind Treatment Period|Lack of Efficacy|0|||
147129421|NCT04380142|530640552|FG002|Double-Blind Treatment Period|Lack of Efficacy|2|||
147129422|NCT04380142|530640550|FG000|Double-Blind Treatment Period|Difficulty With Drug Delivery System|0|||
147129423|NCT04380142|530640551|FG001|Double-Blind Treatment Period|Difficulty With Drug Delivery System|1|||
147129424|NCT04380142|530640552|FG002|Double-Blind Treatment Period|Difficulty With Drug Delivery System|3|||
147235479|NCT00533897|531033705|FG000|Long Term Extension (LTE)|Lack of Efficacy|0|||
147129425|NCT04380142|530640550|FG000|Double-Blind Treatment Period|Other, Not Specified|0|||
147129426|NCT04380142|530640551|FG001|Double-Blind Treatment Period|Other, Not Specified|0|||
147129427|NCT04380142|530640552|FG002|Double-Blind Treatment Period|Other, Not Specified|1|||
147129428|NCT04380142|530640550|FG000|Double-Blind Treatment Period|Did Not Receive Study Drug|0|||
147129429|NCT04380142|530640551|FG001|Double-Blind Treatment Period|Did Not Receive Study Drug|2|||
147129430|NCT04380142|530640552|FG002|Double-Blind Treatment Period|Did Not Receive Study Drug|2|||
147129431|NCT00437073|530640553|FG000|Overall Study|Sponsor Terminated Study|1|||
147129432|NCT00437073|530640554|FG001|Overall Study|Sponsor Terminated Study|0|||
147129433|NCT00437073|530640553|FG000|Overall Study|Physician Decision|0|||
147129434|NCT00437073|530640554|FG001|Overall Study|Physician Decision|1|||
147129435|NCT05205616|530640555|FG000|Overall Study|Lost to Follow-up|4|||
147129436|NCT05205616|530640556|FG001|Overall Study|Lost to Follow-up|4|||
147129437|NCT04875533|530640557|FG000|Overall Study|Adverse Event|6|||
147129438|NCT04875533|530640558|FG001|Overall Study|Adverse Event|4|||
147129439|NCT04875533|530640557|FG000|Overall Study|Protocol Violation|4|||
147129440|NCT04875533|530640558|FG001|Overall Study|Protocol Violation|0|||
147129441|NCT04875533|530640557|FG000|Overall Study|Withdrawal by Subject|8|||
147129442|NCT04875533|530640558|FG001|Overall Study|Withdrawal by Subject|5|||
147129443|NCT04875533|530640557|FG000|Overall Study|No longer meets eligibility criteria|1|||
147129444|NCT04875533|530640558|FG001|Overall Study|No longer meets eligibility criteria|0|||
147129445|NCT04875533|530640557|FG000|Overall Study|Other|0|||
147129446|NCT04875533|530640558|FG001|Overall Study|Other|2|||
147129447|NCT02657343|530640563|FG000|Overall Study|Death|0|||
147129448|NCT02657343|530640564|FG001|Overall Study|Death|2|||
147129449|NCT02657343|530640565|FG002|Overall Study|Death|0|||
147129450|NCT02657343|530640566|FG003|Overall Study|Death|0|||
147129451|NCT02657343|530640567|FG004|Overall Study|Death|0|||
147129452|NCT02657343|530640568|FG005|Overall Study|Death|0|||
147129453|NCT02657343|530640563|FG000|Overall Study|Patient went to hospice|1|||
147129454|NCT02657343|530640564|FG001|Overall Study|Patient went to hospice|0|||
147129455|NCT02657343|530640565|FG002|Overall Study|Patient went to hospice|0|||
147129456|NCT02657343|530640566|FG003|Overall Study|Patient went to hospice|0|||
147129457|NCT02657343|530640567|FG004|Overall Study|Patient went to hospice|0|||
147129458|NCT02657343|530640568|FG005|Overall Study|Patient went to hospice|0|||
147129459|NCT02657343|530640563|FG000|Overall Study|Withdrawal by Subject|0|||
147129460|NCT02657343|530640564|FG001|Overall Study|Withdrawal by Subject|0|||
147129461|NCT02657343|530640565|FG002|Overall Study|Withdrawal by Subject|0|||
147129462|NCT02657343|530640566|FG003|Overall Study|Withdrawal by Subject|0|||
147129463|NCT02657343|530640567|FG004|Overall Study|Withdrawal by Subject|1|||
147129464|NCT02657343|530640568|FG005|Overall Study|Withdrawal by Subject|0|||
147129465|NCT02607722|530640569|FG000|Overall Study|No data reliability|1|||
147129466|NCT02607722|530640569|FG000|Overall Study|no patient visit|18|||
147129467|NCT02607722|530640569|FG000|Overall Study|missing info in CRF|13|||
147129468|NCT02607722|530640569|FG000|Overall Study|Withdrawal by Subject|616|||
147129469|NCT02607722|530640569|FG000|Overall Study|Lost to Follow-up|312|||
147129470|NCT02607722|530640569|FG000|Overall Study|Improved|22|||
147129471|NCT02607722|530640569|FG000|Overall Study|Lack of Efficacy|316|||
147129472|NCT02607722|530640569|FG000|Overall Study|Adverse Event|2553|||
147129473|NCT02607722|530640569|FG000|Overall Study|Not treated|1|||
147129474|NCT02607722|530640569|FG000|Overall Study|No CRF collected|138|||
147129475|NCT02607722|530640569|FG000|Overall Study|without CRF|4225|||
147129476|NCT02607722|530640569|FG000|Overall Study|Physician Decision|367|||
147129477|NCT04347538|530640570|FG000|Overall Study|Lost to Follow-up|4|||
147129478|NCT04347538|530640571|FG001|Overall Study|Lost to Follow-up|5|||
147129479|NCT04347538|530640572|FG002|Overall Study|Lost to Follow-up|7|||
147129480|NCT02135133|530640573|FG000|Overall Study|Adverse Event|10|||
147129481|NCT02135133|530640573|FG000|Overall Study|regulatory mandate|5|||
147129482|NCT02259231|530640574|FG000|Overall Study|Adverse Event|1|||
147129483|NCT02259231|530640575|FG001|Overall Study|Adverse Event|1|||
147129484|NCT02259231|530640576|FG002|Overall Study|Adverse Event|2|||
147129485|NCT02259231|530640577|FG003|Overall Study|Adverse Event|0|||
147129486|NCT02259231|530640578|FG004|Overall Study|Adverse Event|0|||
147129487|NCT02259231|530640579|FG005|Overall Study|Adverse Event|0|||
147129488|NCT02259231|530640580|FG006|Overall Study|Adverse Event|0|||
147129489|NCT02259231|530640574|FG000|Overall Study|Progressive Disease|4|||
147129490|NCT02259231|530640575|FG001|Overall Study|Progressive Disease|5|||
147129491|NCT02259231|530640576|FG002|Overall Study|Progressive Disease|4|||
147129492|NCT02259231|530640577|FG003|Overall Study|Progressive Disease|5|||
147129493|NCT02259231|530640578|FG004|Overall Study|Progressive Disease|4|||
147129494|NCT02259231|530640579|FG005|Overall Study|Progressive Disease|5|||
147129495|NCT02259231|530640580|FG006|Overall Study|Progressive Disease|4|||
147129496|NCT02259231|530640574|FG000|Overall Study|Sponsor termination of study|1|||
147129497|NCT02259231|530640575|FG001|Overall Study|Sponsor termination of study|0|||
147129498|NCT02259231|530640576|FG002|Overall Study|Sponsor termination of study|0|||
147129499|NCT02259231|530640577|FG003|Overall Study|Sponsor termination of study|1|||
147129500|NCT02259231|530640578|FG004|Overall Study|Sponsor termination of study|2|||
147129501|NCT02259231|530640579|FG005|Overall Study|Sponsor termination of study|1|||
147129502|NCT02259231|530640580|FG006|Overall Study|Sponsor termination of study|1|||
147129503|NCT03238196|530640581|FG000|Overall Study|Adverse Event|3|||
147129504|NCT03238196|530640582|FG001|Overall Study|Adverse Event|0|||
147129505|NCT03238196|530640583|FG002|Overall Study|Adverse Event|2|||
147129506|NCT03238196|530640584|FG003|Overall Study|Adverse Event|2|||
147129507|NCT03238196|530640581|FG000|Overall Study|Withdrawal by Subject|4|||
147129508|NCT03238196|530640582|FG001|Overall Study|Withdrawal by Subject|1|||
147129509|NCT03238196|530640583|FG002|Overall Study|Withdrawal by Subject|1|||
147129510|NCT03238196|530640584|FG003|Overall Study|Withdrawal by Subject|0|||
147129511|NCT03238196|530640581|FG000|Overall Study|Disease progression|14|||
147235480|NCT00533897|531033706|FG001|Long Term Extension (LTE)|Lack of Efficacy|0|||
147235481|NCT00533897|531033707|FG002|Long Term Extension (LTE)|Lack of Efficacy|0|||
147235482|NCT00533897|531033708|FG003|Long Term Extension (LTE)|Lack of Efficacy|0|||
147235483|NCT00533897|531033709|FG004|Long Term Extension (LTE)|Lack of Efficacy|0|||
147235484|NCT00533897|531033710|FG005|Long Term Extension (LTE)|Lack of Efficacy|0|||
147235485|NCT00533897|531033711|FG006|Long Term Extension (LTE)|Lack of Efficacy|5|||
147235486|NCT00533897|531033712|FG007|Long Term Extension (LTE)|Lack of Efficacy|3|||
147235487|NCT00533897|531033705|FG000|Long Term Extension (LTE)|Poor/Non-compliance|0|||
147129512|NCT03238196|530640582|FG001|Overall Study|Disease progression|2|||
147129513|NCT03238196|530640583|FG002|Overall Study|Disease progression|3|||
147129514|NCT03238196|530640584|FG003|Overall Study|Disease progression|2|||
147129515|NCT03238196|530640581|FG000|Overall Study|Still on treatment|1|||
147129516|NCT03238196|530640582|FG001|Overall Study|Still on treatment|0|||
147129517|NCT03238196|530640583|FG002|Overall Study|Still on treatment|0|||
147235488|NCT00533897|531033706|FG001|Long Term Extension (LTE)|Poor/Non-compliance|0|||
147129518|NCT03238196|530640584|FG003|Overall Study|Still on treatment|0|||
147129519|NCT04562090|530640585|FG000|Overall Study|Withdrawal by Subject|3|||
147129520|NCT04562090|530640586|FG001|Overall Study|Withdrawal by Subject|4|||
147129521|NCT04562090|530640585|FG000|Overall Study|Protocol Violation|2|||
147129522|NCT04562090|530640586|FG001|Overall Study|Protocol Violation|0|||
147129523|NCT04562090|530640585|FG000|Overall Study|Lack of Efficacy|0|||
147129524|NCT04562090|530640586|FG001|Overall Study|Lack of Efficacy|1|||
147129525|NCT04562090|530640585|FG000|Overall Study|Adverse Event|1|||
147129526|NCT04562090|530640586|FG001|Overall Study|Adverse Event|4|||
147129527|NCT04562090|530640585|FG000|Overall Study|Miscellaneous|0|||
147129528|NCT04562090|530640586|FG001|Overall Study|Miscellaneous|3|||
147129529|NCT00847730|530640587|FG000|Overall Study|Multiple interruptions in therapy|8|||
147129530|NCT04938427|530640590|FG000|Overall Study|Adverse Event|5|||
147129531|NCT04938427|530640591|FG001|Overall Study|Adverse Event|19|||
147129532|NCT04938427|530640590|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
147129533|NCT04938427|530640591|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
147129534|NCT04938427|530640590|FG000|Overall Study|Withdrawal by Subject|1|||
147129535|NCT04938427|530640591|FG001|Overall Study|Withdrawal by Subject|0|||
147129536|NCT04938427|530640590|FG000|Overall Study|Reason Not Specified|2|||
147129537|NCT04938427|530640591|FG001|Overall Study|Reason Not Specified|1|||
147129538|NCT03633058|530640600|FG000|Overall Study|Adverse Event|0|||
147129539|NCT03633058|530640601|FG001|Overall Study|Adverse Event|0|||
147129540|NCT03633058|530640602|FG002|Overall Study|Adverse Event|1|||
147129541|NCT03633058|530640603|FG003|Overall Study|Adverse Event|0|||
147129542|NCT03312543|530640606|FG000|Before Treatment (Screening to Baseline)|Lost to Follow-up|0|||
147129543|NCT03312543|530640607|FG001|Before Treatment (Screening to Baseline)|Lost to Follow-up|2|||
147129544|NCT03312543|530640606|FG000|Before Treatment (Screening to Baseline)|Withdrawal by Subject|1|||
147129545|NCT03312543|530640607|FG001|Before Treatment (Screening to Baseline)|Withdrawal by Subject|2|||
147129546|NCT03312543|530640606|FG000|Treatment (Baseline to Week 12)|Withdrawal by Subject|3|||
147129547|NCT03312543|530640607|FG001|Treatment (Baseline to Week 12)|Withdrawal by Subject|4|||
147129548|NCT03312543|530640606|FG000|Treatment (Baseline to Week 12)|Protocol Violation|1|||
147129549|NCT03312543|530640607|FG001|Treatment (Baseline to Week 12)|Protocol Violation|1|||
147129550|NCT03312543|530640606|FG000|Regression (Week 12 to Week 24)|Protocol Violation|1|||
147129551|NCT03312543|530640607|FG001|Regression (Week 12 to Week 24)|Protocol Violation|1|||
147129552|NCT03312543|530640606|FG000|Regression (Week 12 to Week 24)|Death|0|||
147129553|NCT03312543|530640607|FG001|Regression (Week 12 to Week 24)|Death|1|||
147129554|NCT04507269|530640608|FG000|Overall Study|Withdrawal by Subject|1|||
147129555|NCT04507269|530640609|FG001|Overall Study|Withdrawal by Subject|1|||
147129556|NCT04507269|530640610|FG002|Overall Study|Withdrawal by Subject|0|||
147129557|NCT04507269|530640611|FG003|Overall Study|Withdrawal by Subject|0|||
147129558|NCT04507269|530640612|FG004|Overall Study|Withdrawal by Subject|0|||
147129559|NCT04507269|530640613|FG005|Overall Study|Withdrawal by Subject|0|||
147129560|NCT04507269|530640608|FG000|Overall Study|Lost to Follow-up|0|||
147129561|NCT04507269|530640609|FG001|Overall Study|Lost to Follow-up|0|||
147129562|NCT04507269|530640610|FG002|Overall Study|Lost to Follow-up|0|||
147129563|NCT04507269|530640611|FG003|Overall Study|Lost to Follow-up|0|||
147129564|NCT04507269|530640612|FG004|Overall Study|Lost to Follow-up|1|||
147129565|NCT04507269|530640613|FG005|Overall Study|Lost to Follow-up|0|||
147129566|NCT05852340|530640614|FG000|Period 5|Not completing the meal|0|||
147129567|NCT05852340|530640615|FG001|Period 5|Not completing the meal|1|||
147129568|NCT05852340|530640616|FG002|Period 5|Not completing the meal|0|||
147129569|NCT05852340|530640617|FG003|Period 5|Not completing the meal|0|||
147129570|NCT05852340|530640614|FG000|Period 5|Adverse Event|0|||
147129571|NCT05852340|530640615|FG001|Period 5|Adverse Event|0|||
147129572|NCT05852340|530640616|FG002|Period 5|Adverse Event|0|||
147129573|NCT05852340|530640617|FG003|Period 5|Adverse Event|1|||
147129574|NCT01722669|530640620|FG000|Overall Study|Withdrawal by Subject|0|||
147129575|NCT01722669|530640621|FG001|Overall Study|Withdrawal by Subject|0|||
147129576|NCT01722669|530640622|FG002|Overall Study|Withdrawal by Subject|0|||
147129577|NCT01722669|530640623|FG003|Overall Study|Withdrawal by Subject|0|||
147129578|NCT01722669|530640624|FG004|Overall Study|Withdrawal by Subject|0|||
147129579|NCT01722669|530640625|FG005|Overall Study|Withdrawal by Subject|2|||
147129580|NCT02457793|530640626|FG000|Overall Study|Reason not specified|0|||
147235489|NCT00533897|531033707|FG002|Long Term Extension (LTE)|Poor/Non-compliance|0|||
147235490|NCT00533897|531033708|FG003|Long Term Extension (LTE)|Poor/Non-compliance|0|||
147235491|NCT00533897|531033709|FG004|Long Term Extension (LTE)|Poor/Non-compliance|0|||
147235492|NCT00533897|531033710|FG005|Long Term Extension (LTE)|Poor/Non-compliance|0|||
147235493|NCT00533897|531033711|FG006|Long Term Extension (LTE)|Poor/Non-compliance|1|||
147235494|NCT00533897|531033712|FG007|Long Term Extension (LTE)|Poor/Non-compliance|0|||
147235495|NCT00533897|531033705|FG000|Long Term Extension (LTE)|Adverse Event|0|||
147235496|NCT00533897|531033706|FG001|Long Term Extension (LTE)|Adverse Event|0|||
147235497|NCT00533897|531033707|FG002|Long Term Extension (LTE)|Adverse Event|0|||
147129581|NCT02457793|530640627|FG001|Overall Study|Reason not specified|0|||
147129582|NCT02457793|530640628|FG002|Overall Study|Reason not specified|0|||
147129583|NCT02457793|530640629|FG003|Overall Study|Reason not specified|1|||
147129584|NCT02457793|530640630|FG004|Overall Study|Reason not specified|1|||
147129585|NCT02457793|530640631|FG005|Overall Study|Reason not specified|1|||
147129586|NCT02457793|530640626|FG000|Overall Study|Withdrawal by Subject|0|||
147129587|NCT02457793|530640627|FG001|Overall Study|Withdrawal by Subject|4|||
147129588|NCT02457793|530640628|FG002|Overall Study|Withdrawal by Subject|2|||
147129589|NCT02457793|530640629|FG003|Overall Study|Withdrawal by Subject|2|||
147129590|NCT02457793|530640630|FG004|Overall Study|Withdrawal by Subject|2|||
147235498|NCT00533897|531033708|FG003|Long Term Extension (LTE)|Adverse Event|0|||
147235499|NCT00533897|531033709|FG004|Long Term Extension (LTE)|Adverse Event|0|||
147235500|NCT00533897|531033710|FG005|Long Term Extension (LTE)|Adverse Event|0|||
147129591|NCT02457793|530640631|FG005|Overall Study|Withdrawal by Subject|2|||
147129592|NCT02457793|530640626|FG000|Overall Study|Adverse Event|0|||
147129593|NCT02457793|530640627|FG001|Overall Study|Adverse Event|0|||
147129594|NCT02457793|530640628|FG002|Overall Study|Adverse Event|0|||
147129595|NCT02457793|530640629|FG003|Overall Study|Adverse Event|1|||
147129596|NCT02457793|530640630|FG004|Overall Study|Adverse Event|0|||
147129597|NCT02457793|530640631|FG005|Overall Study|Adverse Event|0|||
147129598|NCT02457793|530640626|FG000|Overall Study|Physician Decision|1|||
147129599|NCT02457793|530640627|FG001|Overall Study|Physician Decision|0|||
147129600|NCT02457793|530640628|FG002|Overall Study|Physician Decision|1|||
147129601|NCT02457793|530640629|FG003|Overall Study|Physician Decision|1|||
147129602|NCT02457793|530640630|FG004|Overall Study|Physician Decision|1|||
147129603|NCT02457793|530640631|FG005|Overall Study|Physician Decision|3|||
147129604|NCT03814044|530640636|FG000|Overall Study|Protocol deviation|1|||
147129605|NCT00835367|530640648|FG000|Washout|Adverse Event|2|||
147129606|NCT00835367|530640649|FG001|Washout|Adverse Event|0|||
147129607|NCT00835367|530640648|FG000|Washout|Withdrawal by Subject|1|||
147129608|NCT00835367|530640649|FG001|Washout|Withdrawal by Subject|0|||
147129609|NCT00835367|530640648|FG000|Second Intervention|Adverse Event|1|||
147129610|NCT00835367|530640649|FG001|Second Intervention|Adverse Event|1|||
147129611|NCT05929326|530640650|FG000|Overall Study|unqualified sample|2|||
147129612|NCT05929326|530640651|FG001|Overall Study|unqualified sample|3|||
147129613|NCT05929326|530640652|FG002|Overall Study|unqualified sample|7|||
147129614|NCT04890509|530640653|FG000|Overall Study|Death|4|||
147129615|NCT04890509|530640654|FG001|Overall Study|Death|4|||
147129616|NCT00442702|530642863|FG000|Titration Period|Adverse Event|2|||
147129617|NCT00442702|530642864|FG001|Titration Period|Adverse Event|0|||
147129618|NCT00442702|530642863|FG000|Titration Period|Death|3|||
147651273|NCT03816007|532544660|FG000|End of 12-week Intervention|Lost to Follow-up|3|||
147651274|NCT03816007|532544661|FG001|End of 12-week Intervention|Lost to Follow-up|4|||
147651275|NCT03816007|532544660|FG000|Final Assessment at 18 Weeks.|Lost to Follow-up|4|||
147651276|NCT03816007|532544661|FG001|Final Assessment at 18 Weeks.|Lost to Follow-up|4|||
147129619|NCT00442702|530642864|FG001|Titration Period|Death|2|||
147651277|NCT01428115|532544662|FG000|Overall Study|Lack of Efficacy|3|||
147651278|NCT01428115|532544662|FG000|Overall Study|Lost to Follow-up|10|||
147651279|NCT01428115|532544662|FG000|Overall Study|Pregnancy|1|||
147129620|NCT00442702|530642863|FG000|Titration Period|Insufficient Therapeutic Response|1|||
147129621|NCT00442702|530642864|FG001|Titration Period|Insufficient Therapeutic Response|0|||
147129622|NCT00442702|530642863|FG000|Titration Period|Refused Treatment|4|||
147129623|NCT00442702|530642864|FG001|Titration Period|Refused Treatment|1|||
147129624|NCT00442702|530642863|FG000|Titration Period|Failure to return|1|||
147129625|NCT00442702|530642864|FG001|Titration Period|Failure to return|0|||
147129626|NCT00442702|530642863|FG000|Titration Period|Hospitalized in another hospital|1|||
147129627|NCT00442702|530642864|FG001|Titration Period|Hospitalized in another hospital|0|||
147129628|NCT00442702|530642863|FG000|Evaluation Period|Adverse Event|1|||
147129629|NCT00442702|530642864|FG001|Evaluation Period|Adverse Event|0|||
147129630|NCT00442702|530642863|FG000|Evaluation Period|Death|1|||
147129631|NCT00442702|530642864|FG001|Evaluation Period|Death|1|||
147129632|NCT00442702|530642863|FG000|Evaluation Period|Insufficient Therapeutic Response|1|||
147129633|NCT00442702|530642864|FG001|Evaluation Period|Insufficient Therapeutic Response|0|||
147129634|NCT00442702|530642863|FG000|Evaluation Period|Refused treatment|1|||
147129635|NCT00442702|530642864|FG001|Evaluation Period|Refused treatment|1|||
147317271|NCT02611830|531327339|FG000|OL Induction Phase|Lack of Efficacy|9|||
147317272|NCT02611830|531327340|FG001|OL Induction Phase|Lack of Efficacy|0|||
147317273|NCT02611830|531327341|FG002|OL Induction Phase|Lack of Efficacy|0|||
147317274|NCT02611830|531327342|FG003|OL Induction Phase|Lack of Efficacy|0|||
147317275|NCT02611830|531327339|FG000|OL Induction Phase|Reason not specified|3|||
147317276|NCT02611830|531327340|FG001|OL Induction Phase|Reason not specified|0|||
147317277|NCT02611830|531327341|FG002|OL Induction Phase|Reason not specified|0|||
147317278|NCT02611830|531327342|FG003|OL Induction Phase|Reason not specified|0|||
147317279|NCT02611830|531327339|FG000|Maintenance Phase|Lack of Efficacy|0|||
147317280|NCT02611830|531327340|FG001|Maintenance Phase|Lack of Efficacy|29|||
147317281|NCT02611830|531327341|FG002|Maintenance Phase|Lack of Efficacy|18|||
147317282|NCT02611830|531327342|FG003|Maintenance Phase|Lack of Efficacy|6|||
147317283|NCT02611830|531327339|FG000|Maintenance Phase|Pretreatment Event/Adverse Event|0|||
147317284|NCT02611830|531327340|FG001|Maintenance Phase|Pretreatment Event/Adverse Event|5|||
147129636|NCT00442702|530642863|FG000|Evaluation Period|Renal transplant|0|||
147129637|NCT00442702|530642864|FG001|Evaluation Period|Renal transplant|1|||
147129638|NCT00442702|530642863|FG000|Evaluation Period|Failure to return|1|||
147129639|NCT00442702|530642864|FG001|Evaluation Period|Failure to return|0|||
147129640|NCT00442702|530642863|FG000|Evaluation Period|Site closure|0|||
147129641|NCT00442702|530642864|FG001|Evaluation Period|Site closure|1|||
147129642|NCT04123704|530642875|FG000|Overall Study|Disease progression|2|||
147129643|NCT03122184|530642876|FG000|Overall Study|Lost to Follow-up|4|||
147129644|NCT03122184|530642877|FG001|Overall Study|Lost to Follow-up|6|||
147129645|NCT03122184|530642876|FG000|Overall Study|Withdrawal by Subject|3|||
147317285|NCT02611830|531327341|FG002|Maintenance Phase|Pretreatment Event/Adverse Event|5|||
147317286|NCT02611830|531327342|FG003|Maintenance Phase|Pretreatment Event/Adverse Event|2|||
147317287|NCT02611830|531327339|FG000|Maintenance Phase|Significant Protocol Deviation|0|||
147317288|NCT02611830|531327340|FG001|Maintenance Phase|Significant Protocol Deviation|0|||
147317289|NCT02611830|531327341|FG002|Maintenance Phase|Significant Protocol Deviation|1|||
147317290|NCT02611830|531327342|FG003|Maintenance Phase|Significant Protocol Deviation|1|||
147317291|NCT02611830|531327339|FG000|Maintenance Phase|Lost to Follow-up|0|||
147317292|NCT02611830|531327340|FG001|Maintenance Phase|Lost to Follow-up|0|||
147317293|NCT02611830|531327341|FG002|Maintenance Phase|Lost to Follow-up|0|||
147317294|NCT02611830|531327342|FG003|Maintenance Phase|Lost to Follow-up|1|||
147317295|NCT02611830|531327339|FG000|Maintenance Phase|Voluntary Withdrawal|0|||
147317296|NCT02611830|531327340|FG001|Maintenance Phase|Voluntary Withdrawal|1|||
147317297|NCT02611830|531327341|FG002|Maintenance Phase|Voluntary Withdrawal|2|||
147317298|NCT02611830|531327342|FG003|Maintenance Phase|Voluntary Withdrawal|5|||
147129646|NCT03122184|530642877|FG001|Overall Study|Withdrawal by Subject|0|||
147129647|NCT03122184|530642876|FG000|Overall Study|Terminated due to cognitive problem|1|||
147129648|NCT03122184|530642877|FG001|Overall Study|Terminated due to cognitive problem|0|||
147129649|NCT01497197|530642883|FG000|Overall Study|Lost to Follow-up|1|||
147129650|NCT01497197|530642884|FG001|Overall Study|Lost to Follow-up|0|||
147129651|NCT01497197|530642883|FG000|Overall Study|Protocol Violation|0|||
147129652|NCT01497197|530642884|FG001|Overall Study|Protocol Violation|2|||
147129653|NCT01497197|530642883|FG000|Overall Study|Withdrawal by Subject|2|||
147129654|NCT01497197|530642884|FG001|Overall Study|Withdrawal by Subject|1|||
147129655|NCT01497197|530642883|FG000|Overall Study|Excessive/lack of response to treatment|1|||
147129656|NCT01497197|530642884|FG001|Overall Study|Excessive/lack of response to treatment|0|||
147129657|NCT01497197|530642883|FG000|Overall Study|Risk of OHSS|1|||
147129658|NCT01497197|530642884|FG001|Overall Study|Risk of OHSS|0|||
147129659|NCT01497197|530642883|FG000|Overall Study|No oocytes retrieved|3|||
147129660|NCT01497197|530642884|FG001|Overall Study|No oocytes retrieved|2|||
147129661|NCT01497197|530642883|FG000|Overall Study|No fertilisation|6|||
147129662|NCT01497197|530642884|FG001|Overall Study|No fertilisation|5|||
147129663|NCT01497197|530642883|FG000|Overall Study|Intention to freeze all embryos|0|||
147129664|NCT01497197|530642884|FG001|Overall Study|Intention to freeze all embryos|1|||
147129665|NCT01497197|530642883|FG000|Overall Study|All embryos discarded|0|||
147129666|NCT01497197|530642884|FG001|Overall Study|All embryos discarded|3|||
147129667|NCT01497197|530642883|FG000|Overall Study|Other|3|||
147129668|NCT01497197|530642884|FG001|Overall Study|Other|1|||
147129669|NCT02390076|530642885|FG000|Overall Study|Lost to Follow-up|2|||
147129670|NCT02390076|530642886|FG001|Overall Study|Lost to Follow-up|1|||
147129671|NCT02390076|530642887|FG002|Overall Study|Lost to Follow-up|4|||
147129672|NCT01206517|530642890|FG000|Overall Study|Withdrawal by Subject|0|||
147129673|NCT01206517|530642891|FG001|Overall Study|Withdrawal by Subject|0|||
147129674|NCT01206517|530642892|FG002|Overall Study|Withdrawal by Subject|2|||
147129675|NCT01206517|530642893|FG003|Overall Study|Withdrawal by Subject|0|||
147129676|NCT01206517|530642894|FG004|Overall Study|Withdrawal by Subject|1|||
147129677|NCT01206517|530642895|FG005|Overall Study|Withdrawal by Subject|0|||
147129678|NCT03493958|530642896|FG000|Overall Study|Withdrawal by Subject|6|||
147129679|NCT03493958|530642896|FG000|Overall Study|Lost to Follow-up|7|||
147129680|NCT03493958|530642896|FG000|Overall Study|Did not complete all required study procedures|2|||
147129681|NCT01029535|530642897|FG000|Overall Study|Lost to Follow-up|24|||
147129682|NCT01029535|530642897|FG000|Overall Study|Protocol Violation|2|||
147129683|NCT01029535|530642897|FG000|Overall Study|Participant Withdrew Consent|2|||
147129684|NCT01029535|530642897|FG000|Overall Study|Adverse Event|1|||
147129685|NCT01029535|530642897|FG000|Overall Study|Use of Another Treatment|1|||
147129686|NCT01029535|530642897|FG000|Overall Study|Death|1|||
147129687|NCT01358734|530642900|FG000|Overall Study|Adverse Event|4|||
147129688|NCT01358734|530642901|FG001|Overall Study|Adverse Event|7|||
147129689|NCT01358734|530642902|FG002|Overall Study|Adverse Event|3|||
147129690|NCT01358734|530642900|FG000|Overall Study|Lack of Efficacy|0|||
147129691|NCT01358734|530642901|FG001|Overall Study|Lack of Efficacy|1|||
147129692|NCT01358734|530642902|FG002|Overall Study|Lack of Efficacy|3|||
147129693|NCT01358734|530642900|FG000|Overall Study|Withdrawal by Subject|1|||
147129694|NCT01358734|530642901|FG001|Overall Study|Withdrawal by Subject|6|||
147129695|NCT01358734|530642902|FG002|Overall Study|Withdrawal by Subject|3|||
147129696|NCT01358734|530642900|FG000|Overall Study|Death|3|||
147129697|NCT01358734|530642901|FG001|Overall Study|Death|7|||
147129698|NCT01358734|530642902|FG002|Overall Study|Death|2|||
147129699|NCT01358734|530642900|FG000|Overall Study|Progressive Disease|5|||
147129700|NCT01358734|530642901|FG001|Overall Study|Progressive Disease|13|||
147129701|NCT01358734|530642902|FG002|Overall Study|Progressive Disease|16|||
147129702|NCT01358734|530642900|FG000|Overall Study|Non-compliance with study drug|0|||
147129703|NCT01358734|530642901|FG001|Overall Study|Non-compliance with study drug|0|||
147129704|NCT01358734|530642902|FG002|Overall Study|Non-compliance with study drug|1|||
147129705|NCT01358734|530642900|FG000|Overall Study|Other|2|||
147129706|NCT01358734|530642901|FG001|Overall Study|Other|5|||
147129707|NCT01358734|530642902|FG002|Overall Study|Other|4|||
147317299|NCT02611830|531327339|FG000|Maintenance Phase|Pregnancy|0|||
147317300|NCT02611830|531327340|FG001|Maintenance Phase|Pregnancy|0|||
147444798|NCT01357655|531792688|FG001|Overall Study|Adverse Event Unrelated to Study Drug|0|||
147444799|NCT01357655|531792687|FG000|Overall Study|Disease Progression|1|||
147444800|NCT01357655|531792688|FG001|Overall Study|Disease Progression|0|||
147444801|NCT01357655|531792687|FG000|Overall Study|Lost to Follow-up|2|||
147444802|NCT01357655|531792688|FG001|Overall Study|Lost to Follow-up|0|||
147444803|NCT01357655|531792687|FG000|Overall Study|Maximum Clinical Benefit|2|||
147129708|NCT01358734|530642900|FG000|Overall Study|Protocol Violation|0|||
147129709|NCT01358734|530642901|FG001|Overall Study|Protocol Violation|0|||
147129710|NCT01358734|530642902|FG002|Overall Study|Protocol Violation|2|||
147129711|NCT01822925|530642903|FG000|Overall Study|Adverse Event|1|||
147129712|NCT01822925|530642904|FG001|Overall Study|Adverse Event|1|||
147129713|NCT01822925|530642905|FG002|Overall Study|Adverse Event|1|||
147129714|NCT01822925|530642906|FG003|Overall Study|Adverse Event|1|||
147129715|NCT01822925|530642903|FG000|Overall Study|Lost to Follow-up|0|||
147129716|NCT01822925|530642904|FG001|Overall Study|Lost to Follow-up|1|||
147129717|NCT01822925|530642905|FG002|Overall Study|Lost to Follow-up|0|||
147129718|NCT01822925|530642906|FG003|Overall Study|Lost to Follow-up|0|||
147129719|NCT01822925|530642903|FG000|Overall Study|Protocol Violation|1|||
147129720|NCT01822925|530642904|FG001|Overall Study|Protocol Violation|0|||
147129721|NCT01822925|530642905|FG002|Overall Study|Protocol Violation|0|||
147129722|NCT01822925|530642906|FG003|Overall Study|Protocol Violation|1|||
147129723|NCT01822925|530642903|FG000|Overall Study|Withdrawal by Subject|2|||
147129724|NCT01822925|530642904|FG001|Overall Study|Withdrawal by Subject|0|||
147129725|NCT01822925|530642905|FG002|Overall Study|Withdrawal by Subject|2|||
147129726|NCT01822925|530642906|FG003|Overall Study|Withdrawal by Subject|2|||
147129727|NCT01822925|530642903|FG000|Overall Study|Taking prohibited medication|2|||
147129728|NCT01822925|530642904|FG001|Overall Study|Taking prohibited medication|0|||
147129729|NCT01822925|530642905|FG002|Overall Study|Taking prohibited medication|0|||
147129730|NCT01822925|530642906|FG003|Overall Study|Taking prohibited medication|1|||
147129731|NCT00553254|530642915|FG000|Overall Study|Death|3|||
147129732|NCT00553254|530642916|FG001|Overall Study|Death|6|||
147129733|NCT00553254|530642917|FG002|Overall Study|Death|25|||
147129734|NCT00553254|530642915|FG000|Overall Study|Lost to Follow-up|0|||
147129735|NCT00553254|530642916|FG001|Overall Study|Lost to Follow-up|0|||
147129736|NCT00553254|530642917|FG002|Overall Study|Lost to Follow-up|2|||
147129737|NCT00553254|530642915|FG000|Overall Study|Withdrawal by Subject|2|||
147129738|NCT00553254|530642916|FG001|Overall Study|Withdrawal by Subject|0|||
147129739|NCT00553254|530642917|FG002|Overall Study|Withdrawal by Subject|2|||
147129740|NCT00553254|530642915|FG000|Overall Study|Study terminated by Sponsor|0|||
147129741|NCT00553254|530642916|FG001|Overall Study|Study terminated by Sponsor|0|||
147129742|NCT00553254|530642917|FG002|Overall Study|Study terminated by Sponsor|1|||
147129743|NCT00553254|530642915|FG000|Overall Study|Other|1|||
147129744|NCT00553254|530642916|FG001|Overall Study|Other|0|||
147129745|NCT00553254|530642917|FG002|Overall Study|Other|13|||
147129746|NCT02314923|530642920|FG000|Overall Study|Death|0|||
147129747|NCT02314923|530642921|FG001|Overall Study|Death|0|||
147129748|NCT02314923|530642922|FG002|Overall Study|Death|0|||
147129749|NCT02314923|530642923|FG003|Overall Study|Death|1|||
147129750|NCT02314923|530642924|FG004|Overall Study|Death|0|||
147129751|NCT02314923|530642925|FG005|Overall Study|Death|0|||
147129752|NCT02314923|530642926|FG006|Overall Study|Death|0|||
147129753|NCT02314923|530642927|FG007|Overall Study|Death|0|||
147129754|NCT02314923|530642928|FG008|Overall Study|Death|0|||
147129755|NCT02314923|530642929|FG009|Overall Study|Death|0|||
147129756|NCT02314923|530642920|FG000|Overall Study|Lost to Follow-up|2|||
147129757|NCT02314923|530642921|FG001|Overall Study|Lost to Follow-up|3|||
147129758|NCT02314923|530642922|FG002|Overall Study|Lost to Follow-up|1|||
147129759|NCT02314923|530642923|FG003|Overall Study|Lost to Follow-up|0|||
147129760|NCT02314923|530642924|FG004|Overall Study|Lost to Follow-up|0|||
147129761|NCT02314923|530642925|FG005|Overall Study|Lost to Follow-up|0|||
147129762|NCT02314923|530642926|FG006|Overall Study|Lost to Follow-up|3|||
147129763|NCT02314923|530642927|FG007|Overall Study|Lost to Follow-up|4|||
147129764|NCT02314923|530642928|FG008|Overall Study|Lost to Follow-up|2|||
147129765|NCT02314923|530642929|FG009|Overall Study|Lost to Follow-up|0|||
147444804|NCT01357655|531792688|FG001|Overall Study|Maximum Clinical Benefit|0|||
147444805|NCT01357655|531792687|FG000|Overall Study|Reason Unspecified|1|||
147444806|NCT01357655|531792688|FG001|Overall Study|Reason Unspecified|0|||
147444807|NCT01357655|531792687|FG000|Overall Study|Study Drug Toxicity|11|||
147444808|NCT01357655|531792688|FG001|Overall Study|Study Drug Toxicity|0|||
147444809|NCT01357655|531792687|FG000|Overall Study|Subject Withdrew Consent|1|||
147444810|NCT01357655|531792688|FG001|Overall Study|Subject Withdrew Consent|0|||
147444811|NCT05003622|531792689|FG000|Overall Study|Progressive disease|2|||
147444812|NCT05003622|531792689|FG000|Overall Study|Withdrawal by Subject|1|||
147444813|NCT03803059|531792690|FG000|Overall Study|Protocol Violation|2|||
147444814|NCT03803059|531792690|FG000|Overall Study|Lost to Follow-up|1|||
147444815|NCT04066491|531792692|FG000|Overall Study|Randomized, not treated|0|||
147444816|NCT04066491|531792693|FG001|Overall Study|Randomized, not treated|0|||
147444817|NCT04066491|531792694|FG002|Overall Study|Randomized, not treated|2|||
147444818|NCT00402649|531794296|FG000|Overall Study|Lost to Follow-up|1|||
147444819|NCT00402649|531794296|FG000|Overall Study|Withdrawal by Subject|1|||
147129766|NCT02314923|530642920|FG000|Overall Study|Withdrawal by Subject|0|||
147129767|NCT02314923|530642921|FG001|Overall Study|Withdrawal by Subject|0|||
147129768|NCT02314923|530642922|FG002|Overall Study|Withdrawal by Subject|1|||
147129769|NCT02314923|530642923|FG003|Overall Study|Withdrawal by Subject|0|||
147235501|NCT00533897|531033711|FG006|Long Term Extension (LTE)|Adverse Event|2|||
147235502|NCT00533897|531033712|FG007|Long Term Extension (LTE)|Adverse Event|5|||
147235503|NCT00533897|531033705|FG000|Long Term Extension (LTE)|Pregnancy|0|||
147235504|NCT00533897|531033706|FG001|Long Term Extension (LTE)|Pregnancy|0|||
147235505|NCT00533897|531033707|FG002|Long Term Extension (LTE)|Pregnancy|0|||
147235506|NCT00533897|531033708|FG003|Long Term Extension (LTE)|Pregnancy|0|||
147235507|NCT00533897|531033709|FG004|Long Term Extension (LTE)|Pregnancy|0|||
147235508|NCT00533897|531033710|FG005|Long Term Extension (LTE)|Pregnancy|0|||
147235509|NCT00533897|531033711|FG006|Long Term Extension (LTE)|Pregnancy|0|||
147235510|NCT00533897|531033712|FG007|Long Term Extension (LTE)|Pregnancy|2|||
147235511|NCT00533897|531033705|FG000|Long Term Extension (LTE)|Lost to Follow-up|0|||
147235512|NCT00533897|531033706|FG001|Long Term Extension (LTE)|Lost to Follow-up|0|||
147235513|NCT00533897|531033707|FG002|Long Term Extension (LTE)|Lost to Follow-up|0|||
147235514|NCT00533897|531033708|FG003|Long Term Extension (LTE)|Lost to Follow-up|0|||
147235515|NCT00533897|531033709|FG004|Long Term Extension (LTE)|Lost to Follow-up|0|||
147235516|NCT00533897|531033710|FG005|Long Term Extension (LTE)|Lost to Follow-up|0|||
147235517|NCT00533897|531033711|FG006|Long Term Extension (LTE)|Lost to Follow-up|1|||
147235518|NCT00533897|531033712|FG007|Long Term Extension (LTE)|Lost to Follow-up|1|||
147235519|NCT00533897|531033705|FG000|Long Term Extension (LTE)|Other|0|||
147235520|NCT00533897|531033706|FG001|Long Term Extension (LTE)|Other|0|||
147235521|NCT00533897|531033707|FG002|Long Term Extension (LTE)|Other|0|||
147235522|NCT00533897|531033708|FG003|Long Term Extension (LTE)|Other|0|||
147235523|NCT00533897|531033709|FG004|Long Term Extension (LTE)|Other|0|||
147235524|NCT00533897|531033710|FG005|Long Term Extension (LTE)|Other|0|||
147235525|NCT00533897|531033711|FG006|Long Term Extension (LTE)|Other|1|||
147235526|NCT00533897|531033712|FG007|Long Term Extension (LTE)|Other|6|||
147235527|NCT00713323|531033715|FG000|Overall Study|Adverse Event|75|||
147235528|NCT00713323|531033715|FG000|Overall Study|Withdrawal by Subject|15|||
147235529|NCT00713323|531033715|FG000|Overall Study|Lost to Follow-up|11|||
147235530|NCT00713323|531033715|FG000|Overall Study|Lack of Efficacy|36|||
147235531|NCT00713323|531033715|FG000|Overall Study|Low creatine clearance at screening|1|||
147235532|NCT00713323|531033715|FG000|Overall Study|Withdrawn due to exclusion criteria 11|1|||
147235533|NCT00713323|531033715|FG000|Overall Study|Surgery cured allodynic pain|1|||
147235534|NCT00713323|531033715|FG000|Overall Study|Pain free|1|||
147235535|NCT00713323|531033715|FG000|Overall Study|Non-compliance|1|||
147235536|NCT00713323|531033715|FG000|Overall Study|Pain resolved|1|||
147235537|NCT00713323|531033715|FG000|Overall Study|Subject travelling to USA|1|||
147235538|NCT00713323|531033715|FG000|Overall Study|Subject travelling to Dominica Republic|1|||
147235539|NCT00713323|531033715|FG000|Overall Study|Treatment that may interact with Sativex|1|||
147235540|NCT00506662|531033717|FG000|Overall Study|Adverse Event|0|||
147235541|NCT00506662|531033718|FG001|Overall Study|Adverse Event|2|||
147235542|NCT00506662|531033717|FG000|Overall Study|Lack of Efficacy|1|||
147235543|NCT00506662|531033718|FG001|Overall Study|Lack of Efficacy|0|||
147235544|NCT00506662|531033717|FG000|Overall Study|Protocol Violation|2|||
147235545|NCT00506662|531033718|FG001|Overall Study|Protocol Violation|4|||
147235546|NCT00506662|531033717|FG000|Overall Study|Trial terminated|10|||
147235547|NCT00506662|531033718|FG001|Overall Study|Trial terminated|16|||
147235548|NCT00506662|531033717|FG000|Overall Study|Not recorded|4|||
147235549|NCT00506662|531033718|FG001|Overall Study|Not recorded|6|||
147235550|NCT00491075|531033719|FG000|Overall Study|Withdrawal by Subject|1|||
147235551|NCT00491075|531033719|FG000|Overall Study|Physician Decision|1|||
147235552|NCT01603355|531033720|FG000|Overall Study|Lack of Efficacy|2|||
147235553|NCT00246753|531033724|FG000|Overall Study|Withdrawal by Subject|2|||
147235554|NCT00246753|531033724|FG000|Overall Study|Physician Decision|2|||
147235555|NCT00246753|531033724|FG000|Overall Study|Adverse Event|2|||
147235556|NCT00246753|531033724|FG000|Overall Study|Unacceptable toxicity|2|||
147235557|NCT03019185|531033727|FG000|Overall Study|Lost to Follow-up|3|||
147235558|NCT03019185|531033728|FG001|Overall Study|Lost to Follow-up|0|||
147235559|NCT03019185|531033729|FG002|Overall Study|Lost to Follow-up|2|||
147235560|NCT03019185|531033727|FG000|Overall Study|Withdrawal by Subject|1|||
147129770|NCT02314923|530642924|FG004|Overall Study|Withdrawal by Subject|1|||
147129771|NCT02314923|530642925|FG005|Overall Study|Withdrawal by Subject|0|||
147129772|NCT02314923|530642926|FG006|Overall Study|Withdrawal by Subject|1|||
147129773|NCT02314923|530642927|FG007|Overall Study|Withdrawal by Subject|0|||
147235561|NCT03019185|531033728|FG001|Overall Study|Withdrawal by Subject|1|||
147235562|NCT03019185|531033729|FG002|Overall Study|Withdrawal by Subject|0|||
147235563|NCT03019185|531033727|FG000|Overall Study|Inability to continue due to increased serum creatinine|1|||
147235564|NCT03019185|531033728|FG001|Overall Study|Inability to continue due to increased serum creatinine|0|||
147235565|NCT03019185|531033729|FG002|Overall Study|Inability to continue due to increased serum creatinine|0|||
147235566|NCT03019185|531033727|FG000|Overall Study|ESKD Resulting in Kidney Transplant|1|||
147317301|NCT02611830|531327341|FG002|Maintenance Phase|Pregnancy|1|||
147129774|NCT02314923|530642928|FG008|Overall Study|Withdrawal by Subject|0|||
147129775|NCT02314923|530642929|FG009|Overall Study|Withdrawal by Subject|0|||
147129776|NCT02314923|530642920|FG000|Overall Study|Physician Decision|0|||
147129777|NCT02314923|530642921|FG001|Overall Study|Physician Decision|1|||
147129778|NCT02314923|530642922|FG002|Overall Study|Physician Decision|0|||
147129779|NCT02314923|530642923|FG003|Overall Study|Physician Decision|0|||
147317302|NCT02611830|531327342|FG003|Maintenance Phase|Pregnancy|0|||
147317303|NCT02611830|531327339|FG000|Maintenance Phase|Reason not specified|0|||
147317304|NCT02611830|531327340|FG001|Maintenance Phase|Reason not specified|1|||
147317305|NCT02611830|531327341|FG002|Maintenance Phase|Reason not specified|4|||
147129780|NCT02314923|530642924|FG004|Overall Study|Physician Decision|0|||
147129781|NCT02314923|530642925|FG005|Overall Study|Physician Decision|0|||
147129782|NCT02314923|530642926|FG006|Overall Study|Physician Decision|0|||
147129783|NCT02314923|530642927|FG007|Overall Study|Physician Decision|0|||
147129784|NCT02314923|530642928|FG008|Overall Study|Physician Decision|0|||
147129785|NCT02314923|530642929|FG009|Overall Study|Physician Decision|0|||
147129786|NCT02314923|530642920|FG000|Overall Study|Participant unavailable|0|||
147129787|NCT02314923|530642921|FG001|Overall Study|Participant unavailable|0|||
147129788|NCT02314923|530642922|FG002|Overall Study|Participant unavailable|0|||
147129789|NCT02314923|530642923|FG003|Overall Study|Participant unavailable|0|||
147129790|NCT02314923|530642924|FG004|Overall Study|Participant unavailable|0|||
147129791|NCT02314923|530642925|FG005|Overall Study|Participant unavailable|1|||
147129792|NCT02314923|530642926|FG006|Overall Study|Participant unavailable|0|||
147129793|NCT02314923|530642927|FG007|Overall Study|Participant unavailable|0|||
147235567|NCT03019185|531033728|FG001|Overall Study|ESKD Resulting in Kidney Transplant|0|||
147235568|NCT03019185|531033729|FG002|Overall Study|ESKD Resulting in Kidney Transplant|0|||
147235569|NCT02764333|531033730|FG000|Overall Study|Ineligible|1|||
147235570|NCT03355365|531033731|FG000|Year 1, First Intervention|Withdrawal by Subject|1|||
147235571|NCT03355365|531033732|FG001|Year 1, First Intervention|Withdrawal by Subject|0|||
147235572|NCT03355365|531033731|FG000|Year 1, First Intervention|Protocol Violation|1|||
147235573|NCT03355365|531033732|FG001|Year 1, First Intervention|Protocol Violation|0|||
147235574|NCT03355365|531033731|FG000|Year 1, First Intervention|pandemic travel limitation|1|||
147235575|NCT03355365|531033732|FG001|Year 1, First Intervention|pandemic travel limitation|0|||
147235576|NCT03355365|531033731|FG000|Year 2, Crossover Intervention|pandemic travel limitation|1|||
147235577|NCT03355365|531033732|FG001|Year 2, Crossover Intervention|pandemic travel limitation|0|||
147235578|NCT03355365|531033731|FG000|Year 2, Crossover Intervention|Adverse event as a result of long-COVID|1|||
147235579|NCT03355365|531033732|FG001|Year 2, Crossover Intervention|Adverse event as a result of long-COVID|0|||
147235580|NCT03355365|531033731|FG000|Year 2, Crossover Intervention|severe COVID|0|||
147235581|NCT03355365|531033732|FG001|Year 2, Crossover Intervention|severe COVID|1|||
147235582|NCT03355365|531033731|FG000|Year 2, Crossover Intervention|failure to isolate MSCs from bone marrow|0|||
147235583|NCT03355365|531033732|FG001|Year 2, Crossover Intervention|failure to isolate MSCs from bone marrow|1|||
147235584|NCT04622306|531033733|FG000|Couples Used First Assigned Condom Set|Withdrawal by Subject|2|||
147235585|NCT04622306|531033734|FG001|Couples Used First Assigned Condom Set|Withdrawal by Subject|2|||
147235586|NCT04622306|531033735|FG002|Couples Used First Assigned Condom Set|Withdrawal by Subject|0|||
147235587|NCT04622306|531033736|FG003|Couples Used First Assigned Condom Set|Withdrawal by Subject|0|||
147235588|NCT04622306|531033737|FG004|Couples Used First Assigned Condom Set|Withdrawal by Subject|2|||
147235589|NCT04622306|531033738|FG005|Couples Used First Assigned Condom Set|Withdrawal by Subject|5|||
147235590|NCT04622306|531033733|FG000|Couples Used Third Assigned Condom Set|Withdrawal by Subject|0|||
147235591|NCT04622306|531033734|FG001|Couples Used Third Assigned Condom Set|Withdrawal by Subject|0|||
147235592|NCT04622306|531033735|FG002|Couples Used Third Assigned Condom Set|Withdrawal by Subject|2|||
147235593|NCT04622306|531033736|FG003|Couples Used Third Assigned Condom Set|Withdrawal by Subject|3|||
147235594|NCT04622306|531033737|FG004|Couples Used Third Assigned Condom Set|Withdrawal by Subject|0|||
147235595|NCT04622306|531033738|FG005|Couples Used Third Assigned Condom Set|Withdrawal by Subject|0|||
147235596|NCT00617851|531033739|FG000|Overall Study|Death|0|||
147235597|NCT00617851|531033740|FG001|Overall Study|Death|0|||
147235598|NCT00617851|531033741|FG002|Overall Study|Death|0|||
147235599|NCT00617851|531033742|FG003|Overall Study|Death|1|||
147235600|NCT00617851|531033739|FG000|Overall Study|Withdrawal by Subject|14|||
147235601|NCT00617851|531033740|FG001|Overall Study|Withdrawal by Subject|7|||
147235602|NCT00617851|531033741|FG002|Overall Study|Withdrawal by Subject|12|||
147235603|NCT00617851|531033742|FG003|Overall Study|Withdrawal by Subject|4|||
147235604|NCT00617851|531033739|FG000|Overall Study|Lost to Follow-up|27|||
147235605|NCT00617851|531033740|FG001|Overall Study|Lost to Follow-up|29|||
147235606|NCT00617851|531033741|FG002|Overall Study|Lost to Follow-up|31|||
147235607|NCT00617851|531033742|FG003|Overall Study|Lost to Follow-up|19|||
147235608|NCT00617851|531033739|FG000|Overall Study|Inappropriate Enrollment|5|||
147235609|NCT00617851|531033740|FG001|Overall Study|Inappropriate Enrollment|4|||
147235610|NCT00617851|531033741|FG002|Overall Study|Inappropriate Enrollment|1|||
147235611|NCT00617851|531033742|FG003|Overall Study|Inappropriate Enrollment|1|||
147235612|NCT00617851|531033739|FG000|Overall Study|Unable to classify|1|||
147235613|NCT00617851|531033740|FG001|Overall Study|Unable to classify|0|||
147235614|NCT00617851|531033741|FG002|Overall Study|Unable to classify|1|||
147129794|NCT02314923|530642928|FG008|Overall Study|Participant unavailable|0|||
147129795|NCT02314923|530642929|FG009|Overall Study|Participant unavailable|0|||
147129796|NCT02314923|530642920|FG000|Overall Study|Screen failure|0|||
147129797|NCT02314923|530642921|FG001|Overall Study|Screen failure|0|||
147129798|NCT02314923|530642922|FG002|Overall Study|Screen failure|0|||
147129799|NCT02314923|530642923|FG003|Overall Study|Screen failure|0|||
147129800|NCT02314923|530642924|FG004|Overall Study|Screen failure|0|||
147129801|NCT02314923|530642925|FG005|Overall Study|Screen failure|0|||
147129802|NCT02314923|530642926|FG006|Overall Study|Screen failure|1|||
147129803|NCT02314923|530642927|FG007|Overall Study|Screen failure|0|||
147129804|NCT02314923|530642928|FG008|Overall Study|Screen failure|0|||
147129805|NCT02314923|530642929|FG009|Overall Study|Screen failure|0|||
147129806|NCT02314923|530642920|FG000|Overall Study|Participant relocation|1|||
147129807|NCT02314923|530642921|FG001|Overall Study|Participant relocation|0|||
147129808|NCT02314923|530642922|FG002|Overall Study|Participant relocation|0|||
147129809|NCT02314923|530642923|FG003|Overall Study|Participant relocation|0|||
147129810|NCT02314923|530642924|FG004|Overall Study|Participant relocation|0|||
147129811|NCT02314923|530642925|FG005|Overall Study|Participant relocation|0|||
147129812|NCT02314923|530642926|FG006|Overall Study|Participant relocation|0|||
147129813|NCT02314923|530642927|FG007|Overall Study|Participant relocation|1|||
147129814|NCT02314923|530642928|FG008|Overall Study|Participant relocation|0|||
147129815|NCT02314923|530642929|FG009|Overall Study|Participant relocation|0|||
147129816|NCT05134649|530642930|FG000|Overall Study|Lost to Follow-up|12|||
147129817|NCT05134649|530642930|FG000|Overall Study|Withdrawal by Subject|14|||
147235615|NCT00617851|531033742|FG003|Overall Study|Unable to classify|0|||
147235616|NCT01200524|531033743|FG000|Overall Study|Withdrawal by Subject|1|||
147235617|NCT01200524|531033744|FG001|Overall Study|Withdrawal by Subject|1|||
147235618|NCT01200524|531033745|FG002|Overall Study|Withdrawal by Subject|3|||
147235619|NCT01200524|531033743|FG000|Overall Study|Adverse Event|1|||
147235620|NCT01200524|531033744|FG001|Overall Study|Adverse Event|0|||
147235621|NCT01200524|531033745|FG002|Overall Study|Adverse Event|0|||
147235622|NCT01200524|531033743|FG000|Overall Study|Non availability of study nurse|0|||
147235623|NCT01200524|531033744|FG001|Overall Study|Non availability of study nurse|0|||
147235624|NCT01200524|531033745|FG002|Overall Study|Non availability of study nurse|1|||
147235625|NCT00491764|531033749|FG000|Overall Study|Adverse Event|1|||
147235626|NCT00491764|531033750|FG001|Overall Study|Adverse Event|2|||
147235627|NCT00491764|531033751|FG002|Overall Study|Adverse Event|4|||
147235628|NCT00491764|531033752|FG003|Overall Study|Adverse Event|4|||
147235629|NCT00491764|531033753|FG004|Overall Study|Adverse Event|0|||
147235630|NCT00491764|531033754|FG005|Overall Study|Adverse Event|1|||
147235631|NCT00491764|531033749|FG000|Overall Study|Lost to Follow-up|0|||
147235632|NCT00491764|531033750|FG001|Overall Study|Lost to Follow-up|1|||
147235633|NCT00491764|531033751|FG002|Overall Study|Lost to Follow-up|0|||
147235634|NCT00491764|531033752|FG003|Overall Study|Lost to Follow-up|1|||
147235635|NCT00491764|531033753|FG004|Overall Study|Lost to Follow-up|0|||
147235636|NCT00491764|531033754|FG005|Overall Study|Lost to Follow-up|3|||
147235637|NCT00491764|531033749|FG000|Overall Study|Withdrawal by Subject|2|||
147235638|NCT00491764|531033750|FG001|Overall Study|Withdrawal by Subject|3|||
147235639|NCT00491764|531033751|FG002|Overall Study|Withdrawal by Subject|1|||
147235640|NCT00491764|531033752|FG003|Overall Study|Withdrawal by Subject|2|||
147235641|NCT00491764|531033753|FG004|Overall Study|Withdrawal by Subject|2|||
147235642|NCT00491764|531033754|FG005|Overall Study|Withdrawal by Subject|4|||
147235643|NCT00491764|531033749|FG000|Overall Study|Non Compliance with the Protocol|1|||
147235644|NCT00491764|531033750|FG001|Overall Study|Non Compliance with the Protocol|0|||
147235645|NCT00491764|531033751|FG002|Overall Study|Non Compliance with the Protocol|0|||
147235646|NCT00491764|531033752|FG003|Overall Study|Non Compliance with the Protocol|0|||
147235647|NCT00491764|531033753|FG004|Overall Study|Non Compliance with the Protocol|0|||
147235648|NCT00491764|531033754|FG005|Overall Study|Non Compliance with the Protocol|0|||
147235649|NCT00491764|531033749|FG000|Overall Study|Did not Meet Protocol Eligibility|0|||
147235650|NCT00491764|531033750|FG001|Overall Study|Did not Meet Protocol Eligibility|1|||
147235651|NCT00491764|531033751|FG002|Overall Study|Did not Meet Protocol Eligibility|1|||
147235652|NCT00491764|531033752|FG003|Overall Study|Did not Meet Protocol Eligibility|0|||
147444820|NCT01199042|531794297|FG000|Sleep Laboratory (3 Nights)|Didn't meet inclusion/exclusion criteria|2|||
147129818|NCT05134649|530642930|FG000|Overall Study|Pregnancy|1|||
147129819|NCT05134649|530642930|FG000|Overall Study|Other, not specified|3|||
147129820|NCT01472185|530642937|FG000|Overall Study|Randomized but Not Treated|0|||
147129821|NCT01472185|530642938|FG001|Overall Study|Randomized but Not Treated|1|||
147235653|NCT00491764|531033753|FG004|Overall Study|Did not Meet Protocol Eligibility|1|||
147235654|NCT00491764|531033754|FG005|Overall Study|Did not Meet Protocol Eligibility|1|||
147129822|NCT01472185|530642937|FG000|Overall Study|Adverse Event Other than Hyperglycemia|3|||
147129823|NCT01472185|530642938|FG001|Overall Study|Adverse Event Other than Hyperglycemia|10|||
147235655|NCT00491764|531033749|FG000|Overall Study|Administrative|1|||
147235656|NCT00491764|531033750|FG001|Overall Study|Administrative|0|||
147129824|NCT01472185|530642937|FG000|Overall Study|Hyperglycemia|5|||
147235657|NCT00491764|531033751|FG002|Overall Study|Administrative|2|||
147444821|NCT01199042|531794297|FG000|At Home (3 Months)|Lost to Follow-up|1|||
147129825|NCT01472185|530642938|FG001|Overall Study|Hyperglycemia|2|||
147129826|NCT01472185|530642937|FG000|Overall Study|Investigator's Discretion|3|||
147129827|NCT01472185|530642938|FG001|Overall Study|Investigator's Discretion|1|||
147129828|NCT01472185|530642937|FG000|Overall Study|Lost to Follow-up|4|||
147129829|NCT01472185|530642938|FG001|Overall Study|Lost to Follow-up|1|||
147129830|NCT01472185|530642937|FG000|Overall Study|Protocol Violation|5|||
147129831|NCT01472185|530642938|FG001|Overall Study|Protocol Violation|1|||
147129832|NCT01472185|530642937|FG000|Overall Study|Subject Noncompliance|8|||
147129833|NCT01472185|530642938|FG001|Overall Study|Subject Noncompliance|15|||
147129834|NCT01472185|530642937|FG000|Overall Study|Subject Withdrew Consent|6|||
147129835|NCT01472185|530642938|FG001|Overall Study|Subject Withdrew Consent|3|||
147129836|NCT03232567|530642940|FG000|Overall Study|Withdrawal by Subject|0|||
147129837|NCT03232567|530642941|FG001|Overall Study|Withdrawal by Subject|1|||
147129838|NCT03232567|530642942|FG002|Overall Study|Withdrawal by Subject|0|||
147129839|NCT03232567|530642943|FG003|Overall Study|Withdrawal by Subject|0|||
147129840|NCT01153516|530642944|FG000|Overall Study|Both subjects refused surgery|2|||
147129841|NCT01153516|530642945|FG001|Overall Study|Both subjects refused surgery|0|||
147129842|NCT05837481|530642946|FG000|Overall Study|index procedure changed to an open surgical procedure that required general anesthesia.|0|||
147129843|NCT05837481|530642947|FG001|Overall Study|index procedure changed to an open surgical procedure that required general anesthesia.|1|||
147129844|NCT04581395|530642948|FG000|Overall Study|Protocol Violation|4|||
147129845|NCT04581395|530642949|FG001|Overall Study|Protocol Violation|3|||
147235658|NCT00491764|531033752|FG003|Overall Study|Administrative|1|||
147235659|NCT00491764|531033753|FG004|Overall Study|Administrative|0|||
147235660|NCT00491764|531033754|FG005|Overall Study|Administrative|0|||
147235661|NCT01601132|531033755|FG000|Overall Study|Patient withdrew consent|1|||
147235662|NCT01601132|531033755|FG000|Overall Study|Protocol deviation|1|||
147235663|NCT02110238|531033757|FG000|12 Week Pivotal Phase|Adverse Event|3|||
147235664|NCT02110238|531033758|FG001|12 Week Pivotal Phase|Adverse Event|0|||
147235665|NCT02110238|531033757|FG000|12 Week Pivotal Phase|Lack of Efficacy|2|||
147235666|NCT02110238|531033758|FG001|12 Week Pivotal Phase|Lack of Efficacy|3|||
147235667|NCT02110238|531033757|FG000|12 Week Pivotal Phase|Lost to Follow-up|2|||
147235668|NCT02110238|531033758|FG001|12 Week Pivotal Phase|Lost to Follow-up|0|||
147235669|NCT02110238|531033757|FG000|12 Week Pivotal Phase|Physician Decision|0|||
147235670|NCT02110238|531033758|FG001|12 Week Pivotal Phase|Physician Decision|2|||
147235671|NCT02110238|531033757|FG000|12 Week Pivotal Phase|Protocol Violation|0|||
147235672|NCT02110238|531033758|FG001|12 Week Pivotal Phase|Protocol Violation|1|||
147235673|NCT02110238|531033757|FG000|12 Week Pivotal Phase|Withdrawal by Subject|3|||
147235674|NCT02110238|531033758|FG001|12 Week Pivotal Phase|Withdrawal by Subject|3|||
147235675|NCT02110238|531033757|FG000|14 Week Blinded Extension Phase|Adverse Event|1|||
147235676|NCT02110238|531033758|FG001|14 Week Blinded Extension Phase|Adverse Event|1|||
147235677|NCT02110238|531033757|FG000|14 Week Blinded Extension Phase|Lack of Efficacy|2|||
147235678|NCT02110238|531033758|FG001|14 Week Blinded Extension Phase|Lack of Efficacy|4|||
147235679|NCT02110238|531033757|FG000|14 Week Blinded Extension Phase|Lost to Follow-up|3|||
147235680|NCT02110238|531033758|FG001|14 Week Blinded Extension Phase|Lost to Follow-up|1|||
147235681|NCT02110238|531033757|FG000|14 Week Blinded Extension Phase|Protocol Violation|2|||
147235682|NCT02110238|531033758|FG001|14 Week Blinded Extension Phase|Protocol Violation|3|||
147235683|NCT02110238|531033757|FG000|14 Week Blinded Extension Phase|Withdrawal by Subject|4|||
147235684|NCT02110238|531033758|FG001|14 Week Blinded Extension Phase|Withdrawal by Subject|3|||
147235685|NCT00697788|531033765|FG000|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
147235686|NCT00697788|531033766|FG001|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|2|||
147235687|NCT00697788|531033767|FG002|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
147235688|NCT00697788|531033768|FG003|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
147235689|NCT00697788|531033769|FG004|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
147129846|NCT04581395|530642950|FG002|Overall Study|Protocol Violation|2|||
147129847|NCT04581395|530642948|FG000|Overall Study|Physician Decision|0|||
147129848|NCT04581395|530642949|FG001|Overall Study|Physician Decision|1|||
147129849|NCT04581395|530642950|FG002|Overall Study|Physician Decision|0|||
147129850|NCT00815633|530642951|FG000|Overall Study|study terminated|1|||
147129851|NCT01605097|530642952|FG000|Overall Study|Protocol Violation|1|||
147129852|NCT02038647|530642953|FG000|Overall Study|Progressive Disease|50|||
147129853|NCT02038647|530642954|FG001|Overall Study|Progressive Disease|59|||
147129854|NCT02038647|530642953|FG000|Overall Study|Adverse Event|18|||
147129855|NCT02038647|530642954|FG001|Overall Study|Adverse Event|10|||
147129856|NCT02038647|530642953|FG000|Overall Study|Symptomatic Deterioration|7|||
147235690|NCT00697788|531033770|FG005|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
147235691|NCT00697788|531033771|FG006|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
147235692|NCT00697788|531033772|FG007|Dexmedetomidine 0.7 mcg/kg/hr Infusion|Physician Decision|0|||
147235693|NCT00697788|531033765|FG000|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
147235694|NCT00697788|531033766|FG001|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
147129857|NCT02038647|530642954|FG001|Overall Study|Symptomatic Deterioration|7|||
147235695|NCT00697788|531033767|FG002|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
147235696|NCT00697788|531033768|FG003|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
147444822|NCT01773109|531794298|FG000|Overall Study|Symptomatic Progression|2|||
147444823|NCT01773109|531794298|FG000|Overall Study|Death|1|||
147444824|NCT01239342|531794299|FG000|Overall Study|Adverse Event|1|||
147444825|NCT01239342|531794300|FG001|Overall Study|Adverse Event|0|||
147129858|NCT02038647|530642953|FG000|Overall Study|Withdrawal by Subject|5|||
147129859|NCT02038647|530642954|FG001|Overall Study|Withdrawal by Subject|2|||
147129860|NCT02038647|530642953|FG000|Overall Study|Not Reported|0|||
147129861|NCT02038647|530642954|FG001|Overall Study|Not Reported|1|||
147129862|NCT02038647|530642953|FG000|Overall Study|Ongoing at Datacut|9|||
147129863|NCT02038647|530642954|FG001|Overall Study|Ongoing at Datacut|10|||
147444826|NCT01239342|531794299|FG000|Overall Study|Withdrawal by Subject|1|||
147444827|NCT01239342|531794300|FG001|Overall Study|Withdrawal by Subject|5|||
147444828|NCT01239342|531794299|FG000|Overall Study|Reason Unknown|1|||
147444829|NCT01239342|531794300|FG001|Overall Study|Reason Unknown|1|||
147444830|NCT02325219|531794303|FG000|Controlled Period (Week 0 - 16)|Adverse Event|6|||
147444831|NCT02325219|531794304|FG001|Controlled Period (Week 0 - 16)|Adverse Event|1|||
147444832|NCT02325219|531794305|FG002|Controlled Period (Week 0 - 16)|Adverse Event|0|||
147444833|NCT02325219|531794306|FG003|Controlled Period (Week 0 - 16)|Adverse Event|0|||
147444834|NCT02325219|531794307|FG004|Controlled Period (Week 0 - 16)|Adverse Event|0|||
147444835|NCT02325219|531794303|FG000|Controlled Period (Week 0 - 16)|Withdrawal by Subject|6|||
147444836|NCT02325219|531794304|FG001|Controlled Period (Week 0 - 16)|Withdrawal by Subject|1|||
147444837|NCT02325219|531794305|FG002|Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
147444838|NCT02325219|531794306|FG003|Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
147444839|NCT02325219|531794307|FG004|Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
147444840|NCT02325219|531794303|FG000|Controlled Period (Week 0 - 16)|Other|0|||
147444841|NCT02325219|531794304|FG001|Controlled Period (Week 0 - 16)|Other|0|||
147444842|NCT02325219|531794305|FG002|Controlled Period (Week 0 - 16)|Other|1|||
147444843|NCT02325219|531794306|FG003|Controlled Period (Week 0 - 16)|Other|0|||
147444844|NCT02325219|531794307|FG004|Controlled Period (Week 0 - 16)|Other|0|||
147444845|NCT02325219|531794303|FG000|After Controlled Period (Week 16 - 52)|Adverse Event|0|||
147444846|NCT02325219|531794304|FG001|After Controlled Period (Week 16 - 52)|Adverse Event|0|||
147444847|NCT02325219|531794305|FG002|After Controlled Period (Week 16 - 52)|Adverse Event|0|||
147444848|NCT02325219|531794306|FG003|After Controlled Period (Week 16 - 52)|Adverse Event|0|||
147444849|NCT02325219|531794307|FG004|After Controlled Period (Week 16 - 52)|Adverse Event|1|||
147444850|NCT02325219|531794303|FG000|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|0|||
147444851|NCT02325219|531794304|FG001|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|2|||
147444852|NCT02325219|531794305|FG002|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|0|||
147444853|NCT02325219|531794306|FG003|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|0|||
147444854|NCT02325219|531794307|FG004|After Controlled Period (Week 16 - 52)|Withdrawal by Subject|0|||
147444855|NCT02325219|531794303|FG000|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
147444856|NCT02325219|531794304|FG001|After Controlled Period (Week 16 - 52)|Pregnancy|1|||
147444857|NCT02325219|531794305|FG002|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
147444858|NCT02325219|531794306|FG003|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
147444859|NCT02325219|531794307|FG004|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
147444860|NCT04036708|531794308|FG000|Overall Study|Lost to Follow-up|14|||
147444861|NCT04036708|531794309|FG001|Overall Study|Lost to Follow-up|4|||
147444862|NCT04036708|531794310|FG002|Overall Study|Lost to Follow-up|14|||
147444863|NCT04036708|531794311|FG003|Overall Study|Lost to Follow-up|4|||
147444864|NCT02918864|531794312|FG000|Overall Study|Withdrawal by Subject|1|||
147444865|NCT02918864|531794313|FG001|Overall Study|Withdrawal by Subject|1|||
147129864|NCT03078868|530642955|FG000|Overall Study|Physician Decision|3|||
147129865|NCT03038620|530642956|FG000|Overall Study|Lost to Follow-up|18|||
147129866|NCT03038620|530642957|FG001|Overall Study|Lost to Follow-up|23|||
147129867|NCT03038620|530642956|FG000|Overall Study|Withdrawal by Subject|0|||
147129868|NCT03038620|530642957|FG001|Overall Study|Withdrawal by Subject|15|||
147129869|NCT03038620|530642956|FG000|Overall Study|Uninterpretable Outcome (Imaging)|1|||
147129870|NCT03038620|530642957|FG001|Overall Study|Uninterpretable Outcome (Imaging)|0|||
147129871|NCT01968980|530642980|FG000|Overall Study|Death|0|||
147129872|NCT01968980|530642981|FG001|Overall Study|Death|1|||
147235697|NCT00697788|531033769|FG004|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|1|||
147444866|NCT02918864|531794312|FG000|Overall Study|Lost to Follow-up|3|||
147444867|NCT02918864|531794313|FG001|Overall Study|Lost to Follow-up|2|||
147444868|NCT04766021|531794314|FG000|Informed Consent/Screening Visit|Withdrawal by Subject|9|||
147569029|NCT01597245|532240126|FG005|Long Term Extension (Week 60 - Week 264)|Death|0|||
147569030|NCT01597245|532240127|FG006|Long Term Extension (Week 60 - Week 264)|Death|0|||
147569031|NCT01597245|532240128|FG007|Long Term Extension (Week 60 - Week 264)|Death|0|||
147569032|NCT01597245|532240129|FG008|Long Term Extension (Week 60 - Week 264)|Death|0|||
147569033|NCT01597245|532240130|FG009|Long Term Extension (Week 60 - Week 264)|Death|0|||
147569034|NCT01597245|532240131|FG010|Long Term Extension (Week 60 - Week 264)|Death|0|||
147129873|NCT01968980|530642980|FG000|Overall Study|Adverse Event|1|||
147129874|NCT01968980|530642981|FG001|Overall Study|Adverse Event|3|||
147235698|NCT00697788|531033770|FG005|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
147129875|NCT01968980|530642980|FG000|Overall Study|Does not meet entry criteria|1|||
147129876|NCT01968980|530642981|FG001|Overall Study|Does not meet entry criteria|3|||
147129877|NCT01968980|530642980|FG000|Overall Study|Withdrawal by Subject|13|||
147129878|NCT01968980|530642981|FG001|Overall Study|Withdrawal by Subject|5|||
147129879|NCT01968980|530642980|FG000|Overall Study|Other unspecified|1|||
147129880|NCT01968980|530642981|FG001|Overall Study|Other unspecified|2|||
147129881|NCT00265122|530642982|FG000|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|1|||
147129882|NCT00265122|530642983|FG001|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|1|||
147129883|NCT00265122|530642984|FG002|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|3|||
147129884|NCT00265122|530642985|FG003|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|0|||
147129885|NCT00265122|530642986|FG004|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|1|||
147129886|NCT00265122|530642987|FG005|Intervention Period 1 (Weeks 0 to 8):|Withdrawal by Subject|0|||
147129887|NCT00265122|530642982|FG000|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|1|||
147129888|NCT00265122|530642983|FG001|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0|||
147129889|NCT00265122|530642984|FG002|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0|||
147129890|NCT00265122|530642985|FG003|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|1|||
147129891|NCT00265122|530642986|FG004|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0|||
147129892|NCT00265122|530642987|FG005|Intervention Period 1 (Weeks 0 to 8):|Lost to Follow-up|0|||
147129893|NCT00265122|530642982|FG000|Intervention Period 1 (Weeks 0 to 8):|Other|0|||
147129894|NCT00265122|530642983|FG001|Intervention Period 1 (Weeks 0 to 8):|Other|1|||
147129895|NCT00265122|530642984|FG002|Intervention Period 1 (Weeks 0 to 8):|Other|2|||
147129896|NCT00265122|530642985|FG003|Intervention Period 1 (Weeks 0 to 8):|Other|1|||
147129897|NCT00265122|530642986|FG004|Intervention Period 1 (Weeks 0 to 8):|Other|0|||
147129898|NCT00265122|530642987|FG005|Intervention Period 1 (Weeks 0 to 8):|Other|0|||
147129899|NCT00265122|530642982|FG000|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|2|||
147129900|NCT00265122|530642983|FG001|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|1|||
147129901|NCT00265122|530642984|FG002|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|3|||
147129902|NCT00265122|530642985|FG003|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|1|||
147129903|NCT00265122|530642986|FG004|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|3|||
147129904|NCT00265122|530642987|FG005|Intervention Period 2 (Weeks 8 to 28):|Withdrawal by Subject|0|||
147129905|NCT00265122|530642982|FG000|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|1|||
147129906|NCT00265122|530642983|FG001|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|0|||
147129907|NCT00265122|530642984|FG002|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|0|||
147129908|NCT00265122|530642985|FG003|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|2|||
147129909|NCT00265122|530642986|FG004|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|2|||
147129910|NCT00265122|530642987|FG005|Intervention Period 2 (Weeks 8 to 28):|Lost to Follow-up|1|||
147129911|NCT00265122|530642982|FG000|Intervention Period 2 (Weeks 8 to 28):|Other|4|||
147129912|NCT00265122|530642983|FG001|Intervention Period 2 (Weeks 8 to 28):|Other|0|||
147129913|NCT00265122|530642984|FG002|Intervention Period 2 (Weeks 8 to 28):|Other|1|||
147129914|NCT00265122|530642985|FG003|Intervention Period 2 (Weeks 8 to 28):|Other|1|||
147129915|NCT00265122|530642986|FG004|Intervention Period 2 (Weeks 8 to 28):|Other|0|||
147129916|NCT00265122|530642987|FG005|Intervention Period 2 (Weeks 8 to 28):|Other|0|||
147129917|NCT04716894|530642988|FG000|Period 2: Itraconazole Alone|Not treated: positive alcohol test|1|||
147129918|NCT04716894|530642988|FG000|Period 2: Itraconazole Alone|COVID-19 related reason|1|||
147129919|NCT00982280|530643002|FG000|Observation Period|Not eligible to be dosed|19|||
147129920|NCT00982280|530643002|FG000|Titration and Optimal Dose Period|Adverse Event|5|||
147129921|NCT00982280|530643002|FG000|Titration and Optimal Dose Period|Lack of Efficacy|2|||
147129922|NCT00982280|530643002|FG000|Titration and Optimal Dose Period|Withdrawal by Subject|1|||
147129923|NCT00982280|530643002|FG000|Maintenance Period|Adverse Event|1|||
147129924|NCT01506726|530643003|FG000|Overall Study|Adverse Event|1|||
147129925|NCT01506726|530643004|FG001|Overall Study|Adverse Event|2|||
147129926|NCT02231580|530643005|FG000|Overall Study|Adverse Event|5|||
147129927|NCT02231580|530643006|FG001|Overall Study|Adverse Event|0|||
147129928|NCT04724837|530643007|FG000|Overall Study|Other|4|||
147129929|NCT04724837|530643008|FG001|Overall Study|Other|16|||
147129930|NCT04724837|530643009|FG002|Overall Study|Other|0|||
147129931|NCT04724837|530643007|FG000|Overall Study|Withdrawal by Subject|2|||
147129932|NCT04724837|530643008|FG001|Overall Study|Withdrawal by Subject|9|||
147129933|NCT04724837|530643009|FG002|Overall Study|Withdrawal by Subject|9|||
147129934|NCT04724837|530643007|FG000|Overall Study|Adverse Event|2|||
147129935|NCT04724837|530643008|FG001|Overall Study|Adverse Event|7|||
147129936|NCT04724837|530643009|FG002|Overall Study|Adverse Event|4|||
147129937|NCT04724837|530643007|FG000|Overall Study|Lost to Follow-up|0|||
147129938|NCT04724837|530643008|FG001|Overall Study|Lost to Follow-up|1|||
147129939|NCT04724837|530643009|FG002|Overall Study|Lost to Follow-up|3|||
147129940|NCT04724837|530643007|FG000|Overall Study|Physician Decision|1|||
147129941|NCT04724837|530643008|FG001|Overall Study|Physician Decision|2|||
147129942|NCT04724837|530643009|FG002|Overall Study|Physician Decision|0|||
147317306|NCT02611830|531327342|FG003|Maintenance Phase|Reason not specified|0|||
147129943|NCT04724837|530643007|FG000|Overall Study|Death|0|||
147129944|NCT04724837|530643008|FG001|Overall Study|Death|0|||
147317307|NCT03567993|531327345|FG000|Overall Study|Lost to Follow-up|4|||
147129945|NCT04724837|530643009|FG002|Overall Study|Death|1|||
147129946|NCT04724837|530643007|FG000|Overall Study|Failure to Meet Randomization Criteria|0|||
147129947|NCT04724837|530643008|FG001|Overall Study|Failure to Meet Randomization Criteria|1|||
147129948|NCT04724837|530643009|FG002|Overall Study|Failure to Meet Randomization Criteria|3|||
147129949|NCT04724837|530643007|FG000|Overall Study|Study Terminated by Sponsor|0|||
147129950|NCT04724837|530643008|FG001|Overall Study|Study Terminated by Sponsor|1|||
147129951|NCT04724837|530643009|FG002|Overall Study|Study Terminated by Sponsor|0|||
147129952|NCT03620981|530643010|FG000|Overall Study|Adverse Event|14|||
147129953|NCT03620981|530643011|FG001|Overall Study|Adverse Event|38|||
147129954|NCT03620981|530643012|FG002|Overall Study|Adverse Event|25|||
147129955|NCT03620981|530643010|FG000|Overall Study|Lack of Efficacy|2|||
147129956|NCT03620981|530643011|FG001|Overall Study|Lack of Efficacy|1|||
147129957|NCT03620981|530643012|FG002|Overall Study|Lack of Efficacy|1|||
147129958|NCT03620981|530643010|FG000|Overall Study|Physician Decision|7|||
147129959|NCT03620981|530643011|FG001|Overall Study|Physician Decision|4|||
147129960|NCT03620981|530643012|FG002|Overall Study|Physician Decision|4|||
147129961|NCT03620981|530643010|FG000|Overall Study|Protocol Violation|1|||
147129962|NCT03620981|530643011|FG001|Overall Study|Protocol Violation|2|||
147129963|NCT03620981|530643012|FG002|Overall Study|Protocol Violation|1|||
147129964|NCT03620981|530643010|FG000|Overall Study|Withdrawal by Legal Representative|2|||
147129965|NCT03620981|530643011|FG001|Overall Study|Withdrawal by Legal Representative|1|||
147129966|NCT03620981|530643012|FG002|Overall Study|Withdrawal by Legal Representative|1|||
147129967|NCT03620981|530643010|FG000|Overall Study|Withdrawal by Care Giver|2|||
147129968|NCT03620981|530643011|FG001|Overall Study|Withdrawal by Care Giver|0|||
147129969|NCT03620981|530643012|FG002|Overall Study|Withdrawal by Care Giver|1|||
147129970|NCT03620981|530643010|FG000|Overall Study|Non-compliance with Study Drug|1|||
147129971|NCT03620981|530643011|FG001|Overall Study|Non-compliance with Study Drug|1|||
147129972|NCT03620981|530643012|FG002|Overall Study|Non-compliance with Study Drug|0|||
147129973|NCT02420717|530643013|FG000|Overall Study|Did not receive all study medication|2|||
147129974|NCT02420717|530643014|FG001|Overall Study|Did not receive all study medication|0|||
147129975|NCT02420717|530643015|FG002|Overall Study|Did not receive all study medication|0|||
147129976|NCT04116489|530643016|FG000|Overall Study|Participant left facility and was no longer eligible|4|||
147129977|NCT04116489|530643016|FG000|Overall Study|Withdrawal by Subject|1|||
147129978|NCT03781570|530643017|FG000|Overall Study|Technical Issues (equipment failure)|31|||
147129979|NCT03781570|530643017|FG000|Overall Study|Withdrawal by Subject|7|||
147129980|NCT03781570|530643017|FG000|Overall Study|Physical Constraints|11|||
147129981|NCT01107496|530643018|FG000|Overall Study|Adverse Event|1|||
147129982|NCT01107496|530643019|FG001|Overall Study|Adverse Event|0|||
147129983|NCT01107496|530643018|FG000|Overall Study|Lack of Efficacy|1|||
147129984|NCT01107496|530643019|FG001|Overall Study|Lack of Efficacy|0|||
147129985|NCT01107496|530643018|FG000|Overall Study|Protocol Violation|0|||
147129986|NCT01107496|530643019|FG001|Overall Study|Protocol Violation|1|||
147129987|NCT01107496|530643018|FG000|Overall Study|Lost to Follow-up|0|||
147129988|NCT01107496|530643019|FG001|Overall Study|Lost to Follow-up|1|||
147129989|NCT01346592|530643020|FG000|Overall Study|Lost to Follow-up|62|||
147129990|NCT01346592|530643021|FG001|Overall Study|Lost to Follow-up|29|||
147129991|NCT01346592|530643022|FG002|Overall Study|Lost to Follow-up|29|||
147444869|NCT04766021|531794314|FG000|Informed Consent/Screening Visit|Met exclusion criteria|10|||
147444870|NCT00880399|531794322|FG000|Overall Study|Adverse Event|4|||
147129992|NCT01346592|530643020|FG000|Overall Study|Protocol Violation|2|||
147129993|NCT01346592|530643021|FG001|Overall Study|Protocol Violation|1|||
147129994|NCT01346592|530643022|FG002|Overall Study|Protocol Violation|0|||
147129995|NCT01346592|530643020|FG000|Overall Study|Death|1|||
147129996|NCT01346592|530643021|FG001|Overall Study|Death|3|||
147129997|NCT01346592|530643022|FG002|Overall Study|Death|4|||
147129998|NCT01346592|530643020|FG000|Overall Study|Adverse Event|0|||
147129999|NCT01346592|530643021|FG001|Overall Study|Adverse Event|1|||
147130000|NCT01346592|530643022|FG002|Overall Study|Adverse Event|0|||
147130001|NCT01346592|530643020|FG000|Overall Study|Withdrawal by Subject|77|||
147130002|NCT01346592|530643021|FG001|Overall Study|Withdrawal by Subject|51|||
147130003|NCT01346592|530643022|FG002|Overall Study|Withdrawal by Subject|38|||
147130004|NCT01346592|530643020|FG000|Overall Study|Inappropriate enrollment|3|||
147130005|NCT01346592|530643021|FG001|Overall Study|Inappropriate enrollment|1|||
147130006|NCT01346592|530643022|FG002|Overall Study|Inappropriate enrollment|1|||
147130007|NCT01346592|530643020|FG000|Overall Study|Administrative reason|1|||
147130008|NCT01346592|530643021|FG001|Overall Study|Administrative reason|0|||
147130009|NCT01346592|530643022|FG002|Overall Study|Administrative reason|0|||
147130010|NCT01346592|530643020|FG000|Overall Study|Unable to Classify|7|||
147130011|NCT01346592|530643021|FG001|Overall Study|Unable to Classify|3|||
147130012|NCT01346592|530643022|FG002|Overall Study|Unable to Classify|6|||
147130013|NCT05185453|530643029|FG000|Overall Study|Lost to Follow-up|13|||
147130014|NCT05185453|530643030|FG001|Overall Study|Lost to Follow-up|3|||
147130015|NCT04976777|530644458|FG000|Overall Study|COVID-19 Infection|1|||
147130016|NCT04976777|530644459|FG001|Overall Study|COVID-19 Infection|0|||
147130017|NCT02552225|530644460|FG000|Overall Study|Withdrawal by Subject|1|||
147130018|NCT02552225|530644461|FG001|Overall Study|Withdrawal by Subject|0|||
147444871|NCT00880399|531794323|FG001|Overall Study|Adverse Event|6|||
147130019|NCT01168596|530644462|FG000|Overall Study|Withdrawal by Subject|3|||
147130020|NCT01168596|530644463|FG001|Overall Study|Withdrawal by Subject|1|||
147130021|NCT00189423|530644464|FG000|Overall Study|Death|746|||
147130022|NCT00189423|530644465|FG001|Overall Study|Death|747|||
147130023|NCT00189423|530644464|FG000|Overall Study|Withdrawal by Subject|9|||
147130024|NCT00189423|530644465|FG001|Overall Study|Withdrawal by Subject|9|||
147130025|NCT00189423|530644464|FG000|Overall Study|Lost to Follow-up|10|||
147130026|NCT00189423|530644465|FG001|Overall Study|Lost to Follow-up|10|||
147130027|NCT00565747|530644475|FG000|Overall Study|No embryo transfer|67|||
147130028|NCT00565747|530644476|FG001|Overall Study|No embryo transfer|73|||
147130029|NCT00183248|530644477|FG000|Overall Study|Lost to Follow-up|0|||
147130030|NCT00183248|530644478|FG001|Overall Study|Lost to Follow-up|1|||
147130031|NCT00183248|530644477|FG000|Overall Study|Focal glomerulosclerosis proteinuria|1|||
147130032|NCT00183248|530644478|FG001|Overall Study|Focal glomerulosclerosis proteinuria|0|||
147130033|NCT04734210|530644481|FG000|Two-week Dosing Period (Days 1 - 14)|Withdrawal by Subject|1|||
147130034|NCT04734210|530644482|FG001|Two-week Dosing Period (Days 1 - 14)|Withdrawal by Subject|1|||
147130035|NCT04734210|530644483|FG002|Two-week Dosing Period (Days 1 - 14)|Withdrawal by Subject|0|||
147130036|NCT04734210|530644481|FG000|Two-week Dosing Period (Days 1 - 14)|Protocol Violation|1|||
147130037|NCT04734210|530644482|FG001|Two-week Dosing Period (Days 1 - 14)|Protocol Violation|0|||
147130038|NCT04734210|530644483|FG002|Two-week Dosing Period (Days 1 - 14)|Protocol Violation|0|||
147130039|NCT04734210|530644481|FG000|Two-week Dosing Period (Days 1 - 14)|Did not complete dosing with study drug but remained in the study for safety follow-up at Day 28.|1|||
147130040|NCT04734210|530644482|FG001|Two-week Dosing Period (Days 1 - 14)|Did not complete dosing with study drug but remained in the study for safety follow-up at Day 28.|0|||
147130041|NCT04734210|530644483|FG002|Two-week Dosing Period (Days 1 - 14)|Did not complete dosing with study drug but remained in the study for safety follow-up at Day 28.|0|||
147130042|NCT04734210|530644481|FG000|Two-week Dosing Period (Days 1 - 14)|Did not dose with study drug; missed Day 8 visit and did not return dosing diary. Lost to follow-up.|0|||
147130043|NCT04734210|530644482|FG001|Two-week Dosing Period (Days 1 - 14)|Did not dose with study drug; missed Day 8 visit and did not return dosing diary. Lost to follow-up.|0|||
147130044|NCT04734210|530644483|FG002|Two-week Dosing Period (Days 1 - 14)|Did not dose with study drug; missed Day 8 visit and did not return dosing diary. Lost to follow-up.|1|||
147130045|NCT02684461|530644484|FG000|Overall Study|Adverse Event|1|||
147130046|NCT02684461|530644485|FG001|Overall Study|Adverse Event|0|||
147130047|NCT02684461|530644486|FG002|Overall Study|Adverse Event|0|||
147130048|NCT02684461|530644484|FG000|Overall Study|Lack of Efficacy|1|||
147130049|NCT02684461|530644485|FG001|Overall Study|Lack of Efficacy|2|||
147130050|NCT02684461|530644486|FG002|Overall Study|Lack of Efficacy|0|||
147130051|NCT04507204|530644487|FG000|Overall Study|Adverse Event|8|||
147130052|NCT04507204|530644488|FG001|Overall Study|Adverse Event|13|||
147130053|NCT04507204|530644487|FG000|Overall Study|Death|0|||
147130054|NCT04507204|530644488|FG001|Overall Study|Death|1|||
147130055|NCT04507204|530644487|FG000|Overall Study|Lost to Follow-up|15|||
147130056|NCT04507204|530644488|FG001|Overall Study|Lost to Follow-up|14|||
147130057|NCT04507204|530644487|FG000|Overall Study|Poor Compliance with Protocol|2|||
147130058|NCT04507204|530644488|FG001|Overall Study|Poor Compliance with Protocol|4|||
147130059|NCT04507204|530644487|FG000|Overall Study|Other (e.g., PI judgment, moved out of state. etc.)|4|||
147130060|NCT04507204|530644488|FG001|Overall Study|Other (e.g., PI judgment, moved out of state. etc.)|3|||
147130061|NCT04507204|530644487|FG000|Overall Study|Withdrawal of Patient Consent|21|||
147130062|NCT04507204|530644488|FG001|Overall Study|Withdrawal of Patient Consent|13|||
147130063|NCT03580044|530644489|FG000|Overall Study|Death|2|||
147235699|NCT00697788|531033771|FG006|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
147235700|NCT00697788|531033772|FG007|Dexmedetomidine 1.6 mcg.kg.hr Infusion|Physician Decision|0|||
147235701|NCT03228433|531033773|FG000|Overall Study|Lost to Follow-up|1|||
147235702|NCT03228433|531033774|FG001|Overall Study|Lost to Follow-up|0|||
147235703|NCT03228433|531033775|FG002|Overall Study|Lost to Follow-up|0|||
147235704|NCT03228433|531033776|FG003|Overall Study|Lost to Follow-up|0|||
147235705|NCT03228433|531033777|FG004|Overall Study|Lost to Follow-up|0|||
147235706|NCT03228433|531033778|FG005|Overall Study|Lost to Follow-up|0|||
147235707|NCT03228433|531033773|FG000|Overall Study|Positive alcohol test|0|||
147235708|NCT03228433|531033774|FG001|Overall Study|Positive alcohol test|0|||
147235709|NCT03228433|531033775|FG002|Overall Study|Positive alcohol test|0|||
147235710|NCT03228433|531033776|FG003|Overall Study|Positive alcohol test|1|||
147235711|NCT03228433|531033777|FG004|Overall Study|Positive alcohol test|0|||
147235712|NCT03228433|531033778|FG005|Overall Study|Positive alcohol test|0|||
147235713|NCT01365052|531033788|FG000|Overall Study|Adverse Event|4|||
147235714|NCT01365052|531033789|FG001|Overall Study|Adverse Event|4|||
147235715|NCT00074984|531033790|FG000|Overall Study|Death|1|||
147235716|NCT00074984|531033791|FG001|Overall Study|Death|2|||
147235717|NCT00074984|531033790|FG000|Overall Study|Withdrawal by Subject|2|||
147235718|NCT00074984|531033791|FG001|Overall Study|Withdrawal by Subject|3|||
147235719|NCT00074984|531033790|FG000|Overall Study|Patient Withdrawn Per Protocol|0|||
147130064|NCT03580044|530644490|FG001|Overall Study|Death|1|||
147130065|NCT03580044|530644489|FG000|Overall Study|Withdrawal by Subject|1|||
147130066|NCT03580044|530644490|FG001|Overall Study|Withdrawal by Subject|1|||
147235720|NCT00074984|531033791|FG001|Overall Study|Patient Withdrawn Per Protocol|3|||
147130067|NCT02300233|530644502|FG000|Overall Study|Adverse Event or Serious Adverse Event|3|||
147130068|NCT02300233|530644503|FG001|Overall Study|Adverse Event or Serious Adverse Event|1|||
147130069|NCT02300233|530644504|FG002|Overall Study|Adverse Event or Serious Adverse Event|14|||
147130070|NCT02300233|530644502|FG000|Overall Study|Withdrawal by Subject|1|||
147130071|NCT02300233|530644503|FG001|Overall Study|Withdrawal by Subject|0|||
147130072|NCT02300233|530644504|FG002|Overall Study|Withdrawal by Subject|3|||
147130073|NCT02300233|530644502|FG000|Overall Study|Investigator Judgement|0|||
147130074|NCT02300233|530644503|FG001|Overall Study|Investigator Judgement|0|||
147130075|NCT02300233|530644504|FG002|Overall Study|Investigator Judgement|1|||
147130076|NCT02300233|530644502|FG000|Overall Study|Reason Not Specified|0|||
147130077|NCT02300233|530644503|FG001|Overall Study|Reason Not Specified|0|||
147130078|NCT02300233|530644504|FG002|Overall Study|Reason Not Specified|5|||
147130079|NCT02836249|530644505|FG000|Double-Blind Treatment Phase|Randomized but Never Treated|0|||
147130080|NCT02836249|530644506|FG001|Double-Blind Treatment Phase|Randomized but Never Treated|1|||
147130081|NCT02836249|530644507|FG002|Double-Blind Treatment Phase|Randomized but Never Treated|0|||
147130082|NCT02836249|530644508|FG003|Double-Blind Treatment Phase|Randomized but Never Treated|0|||
147130083|NCT02836249|530644505|FG000|Double-Blind Treatment Phase|Pregnancy|3|||
147130084|NCT02836249|530644506|FG001|Double-Blind Treatment Phase|Pregnancy|1|||
147130085|NCT02836249|530644507|FG002|Double-Blind Treatment Phase|Pregnancy|0|||
147130086|NCT02836249|530644508|FG003|Double-Blind Treatment Phase|Pregnancy|0|||
147130087|NCT02836249|530644505|FG000|Double-Blind Treatment Phase|Withdrew Consent|5|||
147130088|NCT02836249|530644506|FG001|Double-Blind Treatment Phase|Withdrew Consent|2|||
147130089|NCT02836249|530644507|FG002|Double-Blind Treatment Phase|Withdrew Consent|0|||
147130090|NCT02836249|530644508|FG003|Double-Blind Treatment Phase|Withdrew Consent|0|||
147130091|NCT02836249|530644505|FG000|Double-Blind Treatment Phase|Lost to Follow-up|0|||
147130092|NCT02836249|530644506|FG001|Double-Blind Treatment Phase|Lost to Follow-up|1|||
147130093|NCT02836249|530644507|FG002|Double-Blind Treatment Phase|Lost to Follow-up|0|||
147130094|NCT02836249|530644508|FG003|Double-Blind Treatment Phase|Lost to Follow-up|0|||
147130095|NCT02836249|530644505|FG000|Double-Blind Treatment Phase|Investigator's discretion|0|||
147130096|NCT02836249|530644506|FG001|Double-Blind Treatment Phase|Investigator's discretion|1|||
147130097|NCT02836249|530644507|FG002|Double-Blind Treatment Phase|Investigator's discretion|0|||
147130098|NCT02836249|530644508|FG003|Double-Blind Treatment Phase|Investigator's discretion|0|||
147130099|NCT02836249|530644505|FG000|Double-Blind Treatment Phase|Non-compliance with study drug|1|||
147130100|NCT02836249|530644506|FG001|Double-Blind Treatment Phase|Non-compliance with study drug|0|||
147130101|NCT02836249|530644507|FG002|Double-Blind Treatment Phase|Non-compliance with study drug|0|||
147235721|NCT03080454|531033792|FG000|Baseline|Adverse Event|2|||
147235722|NCT03080454|531033792|FG000|Anodal Doublestim (5 Days)|Adverse Event|1|||
147235723|NCT03080454|531033792|FG000|Anodal FU (7 Days)|Lost to Follow-up|4|||
147235724|NCT02202980|531033793|FG000|Overall Study|Lack of Efficacy|1|||
147235725|NCT02202980|531033794|FG001|Overall Study|Lack of Efficacy|0|||
147235726|NCT02202980|531033795|FG002|Overall Study|Lack of Efficacy|7|||
147235727|NCT02202980|531033796|FG003|Overall Study|Lack of Efficacy|0|||
147235728|NCT02202980|531033797|FG004|Overall Study|Lack of Efficacy|3|||
147235729|NCT02202980|531033798|FG005|Overall Study|Lack of Efficacy|1|||
147235730|NCT02202980|531033799|FG006|Overall Study|Lack of Efficacy|11|||
147235731|NCT02202980|531033800|FG007|Overall Study|Lack of Efficacy|2|||
147235732|NCT02202980|531033801|FG008|Overall Study|Lack of Efficacy|2|||
147235733|NCT02202980|531033802|FG009|Overall Study|Lack of Efficacy|0|||
147235734|NCT02202980|531033803|FG010|Overall Study|Lack of Efficacy|0|||
147130102|NCT02836249|530644508|FG003|Double-Blind Treatment Phase|Non-compliance with study drug|0|||
147130103|NCT02836249|530644505|FG000|Open-Label TAF Treatment Phase|Lost to Follow-up|0|||
147130104|NCT02836249|530644506|FG001|Open-Label TAF Treatment Phase|Lost to Follow-up|0|||
147130105|NCT02836249|530644507|FG002|Open-Label TAF Treatment Phase|Lost to Follow-up|6|||
147130106|NCT02836249|530644508|FG003|Open-Label TAF Treatment Phase|Lost to Follow-up|1|||
147130107|NCT02836249|530644505|FG000|Open-Label TAF Treatment Phase|Withdrew consent|0|||
147130108|NCT02836249|530644506|FG001|Open-Label TAF Treatment Phase|Withdrew consent|0|||
147130109|NCT02836249|530644507|FG002|Open-Label TAF Treatment Phase|Withdrew consent|4|||
147130110|NCT02836249|530644508|FG003|Open-Label TAF Treatment Phase|Withdrew consent|3|||
147130111|NCT02836249|530644505|FG000|Open-Label TAF Treatment Phase|Death|0|||
147130112|NCT02836249|530644506|FG001|Open-Label TAF Treatment Phase|Death|0|||
147130113|NCT02836249|530644507|FG002|Open-Label TAF Treatment Phase|Death|1|||
147130114|NCT02836249|530644508|FG003|Open-Label TAF Treatment Phase|Death|0|||
147235735|NCT02202980|531033804|FG011|Overall Study|Lack of Efficacy|3|||
147235736|NCT02202980|531033805|FG012|Overall Study|Lack of Efficacy|10|||
147235737|NCT02202980|531033806|FG013|Overall Study|Lack of Efficacy|0|||
147130115|NCT02836249|530644505|FG000|Open-Label TAF Treatment Phase|Lack of Efficacy|0|||
147130116|NCT02836249|530644506|FG001|Open-Label TAF Treatment Phase|Lack of Efficacy|0|||
147130117|NCT02836249|530644507|FG002|Open-Label TAF Treatment Phase|Lack of Efficacy|1|||
147130118|NCT02836249|530644508|FG003|Open-Label TAF Treatment Phase|Lack of Efficacy|0|||
147235738|NCT02202980|531033793|FG000|Overall Study|Protocol Violation|0|||
147235739|NCT02202980|531033794|FG001|Overall Study|Protocol Violation|0|||
147235740|NCT02202980|531033795|FG002|Overall Study|Protocol Violation|0|||
147235741|NCT02202980|531033796|FG003|Overall Study|Protocol Violation|3|||
147130119|NCT02836249|530644505|FG000|Open-Label TAF Treatment Phase|Pregnancy|0|||
147130120|NCT02836249|530644506|FG001|Open-Label TAF Treatment Phase|Pregnancy|0|||
147130121|NCT02836249|530644507|FG002|Open-Label TAF Treatment Phase|Pregnancy|1|||
147130122|NCT02836249|530644508|FG003|Open-Label TAF Treatment Phase|Pregnancy|0|||
147130123|NCT04752566|530644509|FG000|Overall Study|Protocol Violation|0|||
147130124|NCT04752566|530644510|FG001|Overall Study|Protocol Violation|1|||
147130125|NCT04752566|530644509|FG000|Overall Study|Death|1|||
147130126|NCT04752566|530644510|FG001|Overall Study|Death|0|||
147130127|NCT04752566|530644509|FG000|Overall Study|Adverse Event|1|||
147130128|NCT04752566|530644510|FG001|Overall Study|Adverse Event|0|||
147130129|NCT04752566|530644509|FG000|Overall Study|Withdrawal by Subject|2|||
147130130|NCT04752566|530644510|FG001|Overall Study|Withdrawal by Subject|0|||
147130131|NCT04752566|530644509|FG000|Overall Study|Physician Decision|1|||
147130132|NCT04752566|530644510|FG001|Overall Study|Physician Decision|1|||
147130133|NCT03331354|530644511|FG000|Overall Study|Withdrawal by Subject|1|||
147130134|NCT03331354|530644512|FG001|Overall Study|Withdrawal by Subject|3|||
147130135|NCT03331354|530644511|FG000|Overall Study|Lost to Follow-up|3|||
147130136|NCT03331354|530644512|FG001|Overall Study|Lost to Follow-up|3|||
147130137|NCT03331354|530644511|FG000|Overall Study|Found employment before initiated active intervention|0|||
147130138|NCT03331354|530644512|FG001|Overall Study|Found employment before initiated active intervention|4|||
147130139|NCT00928668|530644513|FG000|Overall Study|Adverse Event|1|||
147130140|NCT00928668|530644514|FG001|Overall Study|Adverse Event|0|||
147130141|NCT00928668|530644515|FG002|Overall Study|Adverse Event|0|||
147130142|NCT00928668|530644516|FG003|Overall Study|Adverse Event|0|||
147130143|NCT00928668|530644517|FG004|Overall Study|Adverse Event|0|||
147130144|NCT00928668|530644513|FG000|Overall Study|Protocol Violation|0|||
147130145|NCT00928668|530644514|FG001|Overall Study|Protocol Violation|0|||
147130146|NCT00928668|530644515|FG002|Overall Study|Protocol Violation|0|||
147130147|NCT00928668|530644516|FG003|Overall Study|Protocol Violation|0|||
147130148|NCT00928668|530644517|FG004|Overall Study|Protocol Violation|1|||
147130149|NCT00928668|530644513|FG000|Overall Study|Withdrawal by Subject|0|||
147130150|NCT00928668|530644514|FG001|Overall Study|Withdrawal by Subject|1|||
147130151|NCT00928668|530644515|FG002|Overall Study|Withdrawal by Subject|1|||
147130152|NCT00928668|530644516|FG003|Overall Study|Withdrawal by Subject|0|||
147130153|NCT00928668|530644517|FG004|Overall Study|Withdrawal by Subject|0|||
147130154|NCT00928668|530644513|FG000|Overall Study|Other reasons not listed above|0|||
147130155|NCT00928668|530644514|FG001|Overall Study|Other reasons not listed above|0|||
147130156|NCT00928668|530644515|FG002|Overall Study|Other reasons not listed above|0|||
147130157|NCT00928668|530644516|FG003|Overall Study|Other reasons not listed above|1|||
147130158|NCT00928668|530644517|FG004|Overall Study|Other reasons not listed above|0|||
147130159|NCT02958865|530644518|FG000|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
147130160|NCT02958865|530644519|FG001|Induction Period (Day 1 to Week 8)|Adverse Event|4|||
147130161|NCT02958865|530644520|FG002|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
147130162|NCT02958865|530644521|FG003|Induction Period (Day 1 to Week 8)|Adverse Event|5|||
147130163|NCT02958865|530644522|FG004|Induction Period (Day 1 to Week 8)|Adverse Event|1|||
147130164|NCT02958865|530644523|FG005|Induction Period (Day 1 to Week 8)|Adverse Event|2|||
147130165|NCT02958865|530644524|FG006|Induction Period (Day 1 to Week 8)|Adverse Event|1|||
147130166|NCT02958865|530644525|FG007|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
147130167|NCT02958865|530644526|FG008|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
147130168|NCT02958865|530644527|FG009|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
147130169|NCT02958865|530644528|FG010|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
147130170|NCT02958865|530644529|FG011|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
147130171|NCT02958865|530644530|FG012|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
147130172|NCT02958865|530644531|FG013|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
147130173|NCT02958865|530644532|FG014|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
147317308|NCT03567993|531327346|FG001|Overall Study|Lost to Follow-up|2|||
147317309|NCT03567993|531327345|FG000|Overall Study|Death|1|||
147317310|NCT03567993|531327346|FG001|Overall Study|Death|1|||
147317311|NCT03567993|531327345|FG000|Overall Study|Withdrawal by Subject|1|||
147317312|NCT03567993|531327346|FG001|Overall Study|Withdrawal by Subject|0|||
147130174|NCT02958865|530644533|FG015|Induction Period (Day 1 to Week 8)|Adverse Event|0|||
147317313|NCT02036515|531327347|FG000|Overall Study|Adverse Event|1|||
147317314|NCT02036515|531327348|FG001|Overall Study|Adverse Event|1|||
147130175|NCT02958865|530644518|FG000|Induction Period (Day 1 to Week 8)|Death|0|||
147130176|NCT02958865|530644519|FG001|Induction Period (Day 1 to Week 8)|Death|1|||
147130177|NCT02958865|530644520|FG002|Induction Period (Day 1 to Week 8)|Death|0|||
147130178|NCT02958865|530644521|FG003|Induction Period (Day 1 to Week 8)|Death|0|||
147130179|NCT02958865|530644522|FG004|Induction Period (Day 1 to Week 8)|Death|0|||
147130180|NCT02958865|530644523|FG005|Induction Period (Day 1 to Week 8)|Death|0|||
147130181|NCT02958865|530644524|FG006|Induction Period (Day 1 to Week 8)|Death|0|||
147130182|NCT02958865|530644525|FG007|Induction Period (Day 1 to Week 8)|Death|0|||
147130183|NCT02958865|530644526|FG008|Induction Period (Day 1 to Week 8)|Death|0|||
147130184|NCT02958865|530644527|FG009|Induction Period (Day 1 to Week 8)|Death|0|||
147130185|NCT02958865|530644528|FG010|Induction Period (Day 1 to Week 8)|Death|0|||
147317315|NCT02036515|531327349|FG002|Overall Study|Adverse Event|2|||
147235742|NCT02202980|531033797|FG004|Overall Study|Protocol Violation|3|||
147235743|NCT02202980|531033798|FG005|Overall Study|Protocol Violation|0|||
147444872|NCT00880399|531794324|FG002|Overall Study|Adverse Event|5|||
147444873|NCT00880399|531794322|FG000|Overall Study|Lack of Efficacy|1|||
147444874|NCT00880399|531794323|FG001|Overall Study|Lack of Efficacy|4|||
147444875|NCT00880399|531794324|FG002|Overall Study|Lack of Efficacy|2|||
147444876|NCT00880399|531794322|FG000|Overall Study|Protocol Violation|4|||
147444877|NCT00880399|531794323|FG001|Overall Study|Protocol Violation|4|||
147444878|NCT00880399|531794324|FG002|Overall Study|Protocol Violation|6|||
147444879|NCT00880399|531794322|FG000|Overall Study|Study closed/terminated|3|||
147444880|NCT00880399|531794323|FG001|Overall Study|Study closed/terminated|7|||
147444881|NCT00880399|531794324|FG002|Overall Study|Study closed/terminated|4|||
147235744|NCT02202980|531033799|FG006|Overall Study|Protocol Violation|0|||
147235745|NCT02202980|531033800|FG007|Overall Study|Protocol Violation|0|||
147235746|NCT02202980|531033801|FG008|Overall Study|Protocol Violation|0|||
147235747|NCT02202980|531033802|FG009|Overall Study|Protocol Violation|0|||
147235748|NCT02202980|531033803|FG010|Overall Study|Protocol Violation|0|||
147235749|NCT02202980|531033804|FG011|Overall Study|Protocol Violation|0|||
147235750|NCT02202980|531033805|FG012|Overall Study|Protocol Violation|0|||
147235751|NCT02202980|531033806|FG013|Overall Study|Protocol Violation|0|||
147235752|NCT02202980|531033793|FG000|Overall Study|Lost to Follow-up|0|||
147444882|NCT00880399|531794322|FG000|Overall Study|Lost to Follow-up|8|||
147444883|NCT00880399|531794323|FG001|Overall Study|Lost to Follow-up|5|||
147235753|NCT02202980|531033794|FG001|Overall Study|Lost to Follow-up|1|||
147317316|NCT02036515|531327347|FG000|Overall Study|Lost to Follow-up|0|||
147317317|NCT02036515|531327348|FG001|Overall Study|Lost to Follow-up|2|||
147444884|NCT00880399|531794324|FG002|Overall Study|Lost to Follow-up|3|||
147317318|NCT02036515|531327349|FG002|Overall Study|Lost to Follow-up|0|||
147317319|NCT02036515|531327347|FG000|Overall Study|Non-compliance with study drug|0|||
147317320|NCT02036515|531327348|FG001|Overall Study|Non-compliance with study drug|0|||
147444885|NCT00880399|531794322|FG000|Overall Study|Physician Decision|5|||
147444886|NCT00880399|531794323|FG001|Overall Study|Physician Decision|0|||
147444887|NCT00880399|531794324|FG002|Overall Study|Physician Decision|3|||
147444888|NCT00880399|531794322|FG000|Overall Study|Withdrawal by Subject|6|||
147444889|NCT00880399|531794323|FG001|Overall Study|Withdrawal by Subject|3|||
147444890|NCT00880399|531794324|FG002|Overall Study|Withdrawal by Subject|3|||
147444891|NCT01476475|531794325|FG000|Overall Study|Adverse Event|6|||
147444892|NCT01476475|531794326|FG001|Overall Study|Adverse Event|0|||
147444893|NCT01476475|531794325|FG000|Overall Study|Poor compliance to protocol|1|||
147235754|NCT02202980|531033795|FG002|Overall Study|Lost to Follow-up|1|||
147317321|NCT02036515|531327349|FG002|Overall Study|Non-compliance with study drug|2|||
147317322|NCT02036515|531327347|FG000|Overall Study|Screen failure|0|||
147317323|NCT02036515|531327348|FG001|Overall Study|Screen failure|2|||
147317324|NCT02036515|531327349|FG002|Overall Study|Screen failure|0|||
147317325|NCT02036515|531327347|FG000|Overall Study|Withdrawal by Subject|4|||
147317326|NCT02036515|531327348|FG001|Overall Study|Withdrawal by Subject|7|||
147317327|NCT02036515|531327349|FG002|Overall Study|Withdrawal by Subject|9|||
147317328|NCT02036515|531327347|FG000|Overall Study|Hyperglycemia|0|||
147317329|NCT02036515|531327348|FG001|Overall Study|Hyperglycemia|0|||
147317330|NCT02036515|531327349|FG002|Overall Study|Hyperglycemia|1|||
147317331|NCT01671748|531327356|FG000|4 Week run-in Phase|Withdrawal by Subject|1|||
147317332|NCT01671748|531327357|FG001|4 Week run-in Phase|Withdrawal by Subject|0|||
147317333|NCT01671748|531327356|FG000|4 Week run-in Phase|Adverse Event|1|||
147317334|NCT01671748|531327357|FG001|4 Week run-in Phase|Adverse Event|0|||
147317335|NCT01671748|531327356|FG000|4 Week run-in Phase|Not eligible|9|||
147317336|NCT01671748|531327357|FG001|4 Week run-in Phase|Not eligible|0|||
147317337|NCT02601937|531327358|FG000|Period 1: Dose Escalation Phase|Adverse Event|0|||
147317338|NCT02601937|531327359|FG001|Period 1: Dose Escalation Phase|Adverse Event|0|||
147317339|NCT02601937|531327360|FG002|Period 1: Dose Escalation Phase|Adverse Event|0|||
147444894|NCT01476475|531794326|FG001|Overall Study|Poor compliance to protocol|1|||
147444895|NCT01476475|531794325|FG000|Overall Study|Other reasons|4|||
147569035|NCT01597245|532240132|FG011|Long Term Extension (Week 60 - Week 264)|Death|0|||
147569036|NCT01597245|532240133|FG012|Long Term Extension (Week 60 - Week 264)|Death|0|||
147235755|NCT02202980|531033796|FG003|Overall Study|Lost to Follow-up|1|||
147235756|NCT02202980|531033797|FG004|Overall Study|Lost to Follow-up|0|||
147317340|NCT02601937|531327361|FG003|Period 1: Dose Escalation Phase|Adverse Event|0|||
147444896|NCT01476475|531794326|FG001|Overall Study|Other reasons|2|||
147444897|NCT00751400|531794327|FG000|Overall Study|Lost to Follow-up|10|||
147317341|NCT02601937|531327362|FG004|Period 1: Dose Escalation Phase|Adverse Event|0|||
147235757|NCT02202980|531033798|FG005|Overall Study|Lost to Follow-up|0|||
147235758|NCT02202980|531033799|FG006|Overall Study|Lost to Follow-up|0|||
147235759|NCT02202980|531033800|FG007|Overall Study|Lost to Follow-up|1|||
147235760|NCT02202980|531033801|FG008|Overall Study|Lost to Follow-up|1|||
147317342|NCT02601937|531327363|FG005|Period 1: Dose Escalation Phase|Adverse Event|1|||
147444898|NCT02576444|531794331|FG000|Overall Study|Death|1|||
147444899|NCT02576444|531794332|FG001|Overall Study|Death|1|||
147444900|NCT02576444|531794333|FG002|Overall Study|Death|0|||
147444901|NCT02576444|531794334|FG003|Overall Study|Death|0|||
147444902|NCT02576444|531794331|FG000|Overall Study|Withdrawal by Subject|0|||
147235761|NCT02202980|531033802|FG009|Overall Study|Lost to Follow-up|0|||
147235762|NCT02202980|531033803|FG010|Overall Study|Lost to Follow-up|0|||
147235763|NCT02202980|531033804|FG011|Overall Study|Lost to Follow-up|0|||
147235764|NCT02202980|531033805|FG012|Overall Study|Lost to Follow-up|1|||
147235765|NCT02202980|531033806|FG013|Overall Study|Lost to Follow-up|0|||
147235766|NCT02202980|531033793|FG000|Overall Study|Withdrew Consent|0|||
147235767|NCT02202980|531033794|FG001|Overall Study|Withdrew Consent|1|||
147235768|NCT02202980|531033795|FG002|Overall Study|Withdrew Consent|2|||
147235769|NCT02202980|531033796|FG003|Overall Study|Withdrew Consent|0|||
147235770|NCT02202980|531033797|FG004|Overall Study|Withdrew Consent|0|||
147235771|NCT02202980|531033798|FG005|Overall Study|Withdrew Consent|0|||
147235772|NCT02202980|531033799|FG006|Overall Study|Withdrew Consent|0|||
147235773|NCT02202980|531033800|FG007|Overall Study|Withdrew Consent|0|||
147235774|NCT02202980|531033801|FG008|Overall Study|Withdrew Consent|1|||
147235775|NCT02202980|531033802|FG009|Overall Study|Withdrew Consent|0|||
147235776|NCT02202980|531033803|FG010|Overall Study|Withdrew Consent|0|||
147235777|NCT02202980|531033804|FG011|Overall Study|Withdrew Consent|0|||
147235778|NCT02202980|531033805|FG012|Overall Study|Withdrew Consent|0|||
147235779|NCT02202980|531033806|FG013|Overall Study|Withdrew Consent|0|||
147235780|NCT04138810|531033810|FG000|Overall Study|Withdrawal by Subject|0|||
147235781|NCT04138810|531033811|FG001|Overall Study|Withdrawal by Subject|1|||
147235782|NCT04138810|531033810|FG000|Overall Study|Subject cancelled surgery|1|||
147235783|NCT04138810|531033811|FG001|Overall Study|Subject cancelled surgery|0|||
147235784|NCT02939079|531033820|FG000|Overall Study|Adverse Event|2|||
147235785|NCT02939079|531033821|FG001|Overall Study|Adverse Event|1|||
147235786|NCT02939079|531033820|FG000|Overall Study|Lost to Follow-up|0|||
147235787|NCT02939079|531033821|FG001|Overall Study|Lost to Follow-up|2|||
147235788|NCT02939079|531033820|FG000|Overall Study|Protocol Violation|1|||
147235789|NCT02939079|531033821|FG001|Overall Study|Protocol Violation|0|||
147235790|NCT02939079|531033820|FG000|Overall Study|Withdrawal by Subject|0|||
147235791|NCT02939079|531033821|FG001|Overall Study|Withdrawal by Subject|1|||
147235792|NCT02939079|531033820|FG000|Overall Study|relapse during the study|1|||
147235793|NCT02939079|531033821|FG001|Overall Study|relapse during the study|1|||
147235794|NCT04093414|531033822|FG000|3 Month Follow up|Physician Decision|0|||
147235795|NCT04093414|531033823|FG001|3 Month Follow up|Physician Decision|1|||
147235796|NCT04093414|531033822|FG000|6month Follow up|Physician Decision|1|||
147235797|NCT04093414|531033823|FG001|6month Follow up|Physician Decision|3|||
147235798|NCT04889222|531033824|FG000|Overall Study|Did not meet eligibility criteria|8|||
147235799|NCT04889222|531033824|FG000|Overall Study|Failure to place intravenous or arterial line|3|||
147317343|NCT02601937|531327364|FG006|Period 1: Dose Escalation Phase|Adverse Event|0|||
147317344|NCT02601937|531327365|FG007|Period 1: Dose Escalation Phase|Adverse Event|0|||
147317345|NCT02601937|531327366|FG008|Period 1: Dose Escalation Phase|Adverse Event|0|||
147317346|NCT02601937|531327367|FG009|Period 1: Dose Escalation Phase|Adverse Event|0|||
147317347|NCT02601937|531327368|FG010|Period 1: Dose Escalation Phase|Adverse Event|0|||
147235800|NCT04889222|531033824|FG000|Overall Study|Did not proceed due to time constraints|5|||
147235801|NCT00116428|531033825|FG000|Overall Study|Withdrawal by Subject|2|||
147235802|NCT00116428|531033826|FG001|Overall Study|Withdrawal by Subject|5|||
147235803|NCT00116428|531033825|FG000|Overall Study|Did not meet inclusion criteria|1|||
147235804|NCT00116428|531033826|FG001|Overall Study|Did not meet inclusion criteria|0|||
147235805|NCT00113087|531033827|FG000|Overall Study|Death or Transplant|14|||
147235806|NCT00113087|531033828|FG001|Overall Study|Death or Transplant|16|||
147235807|NCT00113087|531033827|FG000|Overall Study|Family or MD withdrew subject|10|||
147235808|NCT00113087|531033828|FG001|Overall Study|Family or MD withdrew subject|5|||
147235809|NCT03452228|531033829|FG000|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
147235810|NCT03452228|531033830|FG001|Double-Blind Treatment Period (12 Weeks)|Adverse Event|2|||
147235811|NCT03452228|531033831|FG002|Double-Blind Treatment Period (12 Weeks)|Adverse Event|0|||
147235812|NCT03452228|531033829|FG000|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|1|||
147235813|NCT03452228|531033830|FG001|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|1|||
147235814|NCT03452228|531033831|FG002|Double-Blind Treatment Period (12 Weeks)|Lost to Follow-up|0|||
147235815|NCT03452228|531033829|FG000|Double-Blind Treatment Period (12 Weeks)|Randomized but not treated|1|||
147235816|NCT03452228|531033830|FG001|Double-Blind Treatment Period (12 Weeks)|Randomized but not treated|0|||
147235817|NCT03452228|531033831|FG002|Double-Blind Treatment Period (12 Weeks)|Randomized but not treated|0|||
147317348|NCT02601937|531327358|FG000|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|1|||
147569037|NCT01597245|532240134|FG013|Long Term Extension (Week 60 - Week 264)|Death|0|||
147235818|NCT03452228|531033829|FG000|Single-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
147235819|NCT03452228|531033830|FG001|Single-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
147235820|NCT03452228|531033831|FG002|Single-Blind Treatment Period (12 Weeks)|Withdrawal by Subject|4|||
147235821|NCT00386607|531033832|FG000|Core|Adverse Event|40|||
147235822|NCT00386607|531033833|FG001|Core|Adverse Event|0|||
147569038|NCT01597245|532240135|FG014|Long Term Extension (Week 60 - Week 264)|Death|8|||
147569039|NCT01597245|532240136|FG015|Long Term Extension (Week 60 - Week 264)|Death|8|||
147235823|NCT00386607|531033832|FG000|Core|Abnormal laboratory value(s)|3|||
147235824|NCT00386607|531033833|FG001|Core|Abnormal laboratory value(s)|0|||
147130186|NCT02958865|530644529|FG011|Induction Period (Day 1 to Week 8)|Death|0|||
147130187|NCT02958865|530644530|FG012|Induction Period (Day 1 to Week 8)|Death|0|||
147130188|NCT02958865|530644531|FG013|Induction Period (Day 1 to Week 8)|Death|0|||
147130189|NCT02958865|530644532|FG014|Induction Period (Day 1 to Week 8)|Death|0|||
147130190|NCT02958865|530644533|FG015|Induction Period (Day 1 to Week 8)|Death|0|||
147130191|NCT02958865|530644518|FG000|Induction Period (Day 1 to Week 8)|Physician Decision|1|||
147130192|NCT02958865|530644519|FG001|Induction Period (Day 1 to Week 8)|Physician Decision|1|||
147130193|NCT02958865|530644520|FG002|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
147130194|NCT02958865|530644521|FG003|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
147130195|NCT02958865|530644522|FG004|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
147130196|NCT02958865|530644523|FG005|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
147130197|NCT02958865|530644524|FG006|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
147130198|NCT02958865|530644525|FG007|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
147130199|NCT02958865|530644526|FG008|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
147130200|NCT02958865|530644527|FG009|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
147130201|NCT02958865|530644528|FG010|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
147130202|NCT02958865|530644529|FG011|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
147130203|NCT02958865|530644530|FG012|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
147130204|NCT02958865|530644531|FG013|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
147130205|NCT02958865|530644532|FG014|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
147130206|NCT02958865|530644533|FG015|Induction Period (Day 1 to Week 8)|Physician Decision|0|||
147130207|NCT02958865|530644518|FG000|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|2|||
147130208|NCT02958865|530644519|FG001|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
147130209|NCT02958865|530644520|FG002|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|3|||
147130210|NCT02958865|530644521|FG003|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|1|||
147130211|NCT02958865|530644522|FG004|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|1|||
147130212|NCT02958865|530644523|FG005|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|1|||
147130213|NCT02958865|530644524|FG006|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|1|||
147130214|NCT02958865|530644525|FG007|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
147130215|NCT02958865|530644526|FG008|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
147130216|NCT02958865|530644527|FG009|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
147130217|NCT02958865|530644528|FG010|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
147130218|NCT02958865|530644529|FG011|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
147130219|NCT02958865|530644530|FG012|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
147130220|NCT02958865|530644531|FG013|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
147130221|NCT02958865|530644532|FG014|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
147130222|NCT02958865|530644533|FG015|Induction Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
147130223|NCT02958865|530644518|FG000|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
147130224|NCT02958865|530644519|FG001|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
147130225|NCT02958865|530644520|FG002|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
147130226|NCT02958865|530644521|FG003|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|1|||
147130227|NCT02958865|530644522|FG004|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
147130228|NCT02958865|530644523|FG005|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
147130229|NCT02958865|530644524|FG006|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|1|||
147130230|NCT02958865|530644525|FG007|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
147130231|NCT02958865|530644526|FG008|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
147130232|NCT02958865|530644527|FG009|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
147130233|NCT02958865|530644528|FG010|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
147130234|NCT02958865|530644529|FG011|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
147130235|NCT02958865|530644530|FG012|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
147130236|NCT02958865|530644531|FG013|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
147130237|NCT02958865|530644532|FG014|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
147317349|NCT02601937|531327359|FG001|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
147317350|NCT02601937|531327360|FG002|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
147317351|NCT02601937|531327361|FG003|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
147317352|NCT02601937|531327362|FG004|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
147317353|NCT02601937|531327363|FG005|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
147317354|NCT02601937|531327364|FG006|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|1|||
147317355|NCT02601937|531327365|FG007|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
147569040|NCT01597245|532240137|FG016|Long Term Extension (Week 60 - Week 264)|Death|0|||
147569041|NCT01597245|532240138|FG017|Long Term Extension (Week 60 - Week 264)|Death|0|||
147130238|NCT02958865|530644533|FG015|Induction Period (Day 1 to Week 8)|No longer meeting eligibility criteria|0|||
147130239|NCT02958865|530644518|FG000|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
147317356|NCT02601937|531327366|FG008|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
147317357|NCT02601937|531327367|FG009|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
147317358|NCT02601937|531327368|FG010|Period 1: Dose Escalation Phase|Patient refused further treatment of study drug|0|||
147317359|NCT02601937|531327358|FG000|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
147317360|NCT02601937|531327359|FG001|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
147317361|NCT02601937|531327360|FG002|Period 1: Dose Escalation Phase|Unacceptable toxicity|1|||
147317362|NCT02601937|531327361|FG003|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
147317363|NCT02601937|531327362|FG004|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
147317364|NCT02601937|531327363|FG005|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
147317365|NCT02601937|531327364|FG006|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
147317366|NCT02601937|531327365|FG007|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
147317367|NCT02601937|531327366|FG008|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
147317368|NCT02601937|531327367|FG009|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
147317369|NCT02601937|531327368|FG010|Period 1: Dose Escalation Phase|Unacceptable toxicity|0|||
147317370|NCT02601937|531327358|FG000|Period 1: Dose Escalation Phase|Progressive disease|7|||
147317371|NCT02601937|531327359|FG001|Period 1: Dose Escalation Phase|Progressive disease|6|||
147317372|NCT02601937|531327360|FG002|Period 1: Dose Escalation Phase|Progressive disease|5|||
147317373|NCT02601937|531327361|FG003|Period 1: Dose Escalation Phase|Progressive disease|6|||
147317374|NCT02601937|531327362|FG004|Period 1: Dose Escalation Phase|Progressive disease|6|||
147317375|NCT02601937|531327363|FG005|Period 1: Dose Escalation Phase|Progressive disease|4|||
147130240|NCT02958865|530644519|FG001|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
147130241|NCT02958865|530644520|FG002|Induction Period (Day 1 to Week 8)|Protocol Violation|1|||
147130242|NCT02958865|530644521|FG003|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
147130243|NCT02958865|530644522|FG004|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
147130244|NCT02958865|530644523|FG005|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
147130245|NCT02958865|530644524|FG006|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
147130246|NCT02958865|530644525|FG007|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
147130247|NCT02958865|530644526|FG008|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
147130248|NCT02958865|530644527|FG009|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
147130249|NCT02958865|530644528|FG010|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
147130250|NCT02958865|530644529|FG011|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
147130251|NCT02958865|530644530|FG012|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
147130252|NCT02958865|530644531|FG013|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
147130253|NCT02958865|530644532|FG014|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
147130254|NCT02958865|530644533|FG015|Induction Period (Day 1 to Week 8)|Protocol Violation|0|||
147130255|NCT02958865|530644518|FG000|Induction Period (Day 1 to Week 8)|Lack of Efficacy|1|||
147130256|NCT02958865|530644519|FG001|Induction Period (Day 1 to Week 8)|Lack of Efficacy|1|||
147130257|NCT02958865|530644520|FG002|Induction Period (Day 1 to Week 8)|Lack of Efficacy|1|||
147130258|NCT02958865|530644521|FG003|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
147130259|NCT02958865|530644522|FG004|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
147130260|NCT02958865|530644523|FG005|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
147130261|NCT02958865|530644524|FG006|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
147130262|NCT02958865|530644525|FG007|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
147130263|NCT02958865|530644526|FG008|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
147130264|NCT02958865|530644527|FG009|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
147130265|NCT02958865|530644528|FG010|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
147130266|NCT02958865|530644529|FG011|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
147130267|NCT02958865|530644530|FG012|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
147130268|NCT02958865|530644531|FG013|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
147130269|NCT02958865|530644532|FG014|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
147130270|NCT02958865|530644533|FG015|Induction Period (Day 1 to Week 8)|Lack of Efficacy|0|||
147130271|NCT02958865|530644518|FG000|Induction Period (Day 1 to Week 8)|Other|0|||
147130272|NCT02958865|530644519|FG001|Induction Period (Day 1 to Week 8)|Other|0|||
147130273|NCT02958865|530644520|FG002|Induction Period (Day 1 to Week 8)|Other|1|||
147130274|NCT02958865|530644521|FG003|Induction Period (Day 1 to Week 8)|Other|2|||
147130275|NCT02958865|530644522|FG004|Induction Period (Day 1 to Week 8)|Other|0|||
147130276|NCT02958865|530644523|FG005|Induction Period (Day 1 to Week 8)|Other|1|||
147130277|NCT02958865|530644524|FG006|Induction Period (Day 1 to Week 8)|Other|0|||
147130278|NCT02958865|530644525|FG007|Induction Period (Day 1 to Week 8)|Other|0|||
147130279|NCT02958865|530644526|FG008|Induction Period (Day 1 to Week 8)|Other|0|||
147130280|NCT02958865|530644527|FG009|Induction Period (Day 1 to Week 8)|Other|0|||
147130281|NCT02958865|530644528|FG010|Induction Period (Day 1 to Week 8)|Other|0|||
147130282|NCT02958865|530644529|FG011|Induction Period (Day 1 to Week 8)|Other|0|||
147130283|NCT02958865|530644530|FG012|Induction Period (Day 1 to Week 8)|Other|0|||
147130284|NCT02958865|530644531|FG013|Induction Period (Day 1 to Week 8)|Other|0|||
147130285|NCT02958865|530644532|FG014|Induction Period (Day 1 to Week 8)|Other|0|||
147130286|NCT02958865|530644533|FG015|Induction Period (Day 1 to Week 8)|Other|0|||
147130287|NCT02958865|530644518|FG000|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
147130288|NCT02958865|530644519|FG001|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
147130289|NCT02958865|530644520|FG002|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
147569042|NCT01597245|532240139|FG018|Long Term Extension (Week 60 - Week 264)|Death|0|||
147569043|NCT01597245|532240140|FG019|Long Term Extension (Week 60 - Week 264)|Death|0|||
147569044|NCT01597245|532240141|FG020|Long Term Extension (Week 60 - Week 264)|Death|0|||
147569045|NCT01597245|532240121|FG000|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
147569046|NCT01597245|532240122|FG001|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
147569047|NCT01597245|532240123|FG002|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
147569048|NCT01597245|532240124|FG003|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
147569049|NCT01597245|532240125|FG004|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
147569050|NCT01597245|532240126|FG005|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
147569051|NCT01597245|532240127|FG006|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
147569052|NCT01597245|532240128|FG007|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
147569053|NCT01597245|532240129|FG008|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
147569054|NCT01597245|532240130|FG009|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
147569055|NCT01597245|532240131|FG010|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
147569056|NCT01597245|532240132|FG011|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
147569057|NCT01597245|532240133|FG012|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
147569058|NCT01597245|532240134|FG013|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
147569059|NCT01597245|532240135|FG014|Long Term Extension (Week 60 - Week 264)|Protocol Violation|6|||
147569060|NCT01597245|532240136|FG015|Long Term Extension (Week 60 - Week 264)|Protocol Violation|6|||
147569061|NCT01597245|532240137|FG016|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
147569062|NCT01597245|532240138|FG017|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
147569063|NCT01597245|532240139|FG018|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
147569064|NCT01597245|532240140|FG019|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
147569065|NCT01597245|532240141|FG020|Long Term Extension (Week 60 - Week 264)|Protocol Violation|0|||
147569066|NCT01597245|532240121|FG000|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
147569067|NCT01597245|532240122|FG001|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
147569068|NCT01597245|532240123|FG002|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
147569069|NCT01597245|532240124|FG003|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
147569070|NCT01597245|532240125|FG004|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
147569071|NCT01597245|532240126|FG005|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
147569072|NCT01597245|532240127|FG006|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
147569073|NCT01597245|532240128|FG007|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
147569074|NCT01597245|532240129|FG008|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
147569075|NCT01597245|532240130|FG009|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
147569076|NCT01597245|532240131|FG010|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
147569077|NCT01597245|532240132|FG011|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
147569078|NCT01597245|532240133|FG012|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
147569079|NCT01597245|532240134|FG013|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
147569080|NCT01597245|532240135|FG014|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|4|||
147569081|NCT01597245|532240136|FG015|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|4|||
147569082|NCT01597245|532240137|FG016|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
147569083|NCT01597245|532240138|FG017|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
147569084|NCT01597245|532240139|FG018|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
147569085|NCT01597245|532240140|FG019|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
147569086|NCT01597245|532240141|FG020|Long Term Extension (Week 60 - Week 264)|Clinical Relapse|0|||
147569087|NCT01597245|532240121|FG000|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
147569088|NCT01597245|532240122|FG001|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
147569089|NCT01597245|532240123|FG002|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
147569090|NCT01597245|532240124|FG003|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
147569091|NCT01597245|532240125|FG004|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
147569092|NCT01597245|532240126|FG005|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
147569093|NCT01597245|532240127|FG006|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
147569094|NCT01597245|532240128|FG007|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
147569095|NCT01597245|532240129|FG008|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
147569096|NCT01597245|532240130|FG009|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
147569097|NCT01597245|532240131|FG010|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
147569098|NCT01597245|532240132|FG011|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
147569099|NCT01597245|532240133|FG012|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
147569100|NCT01597245|532240134|FG013|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
147651280|NCT01428115|532544662|FG000|Overall Study|Protocol Violation|3|||
147569101|NCT01597245|532240135|FG014|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|1|||
147569102|NCT01597245|532240136|FG015|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|1|||
147235825|NCT00386607|531033832|FG000|Core|Unsatisfactory therapeutic effect|23|||
147235826|NCT00386607|531033833|FG001|Core|Unsatisfactory therapeutic effect|0|||
147235827|NCT00386607|531033832|FG000|Core|Condition no longer requires study drug|4|||
147235828|NCT00386607|531033833|FG001|Core|Condition no longer requires study drug|0|||
147235829|NCT00386607|531033832|FG000|Core|Patient withdrew consent|15|||
147235830|NCT00386607|531033833|FG001|Core|Patient withdrew consent|0|||
147235831|NCT00386607|531033832|FG000|Core|Lost to Follow-up|23|||
147235832|NCT00386607|531033833|FG001|Core|Lost to Follow-up|0|||
147235833|NCT00386607|531033832|FG000|Core|Administrative problems|1|||
147235834|NCT00386607|531033833|FG001|Core|Administrative problems|0|||
147235835|NCT00386607|531033832|FG000|Core|Protocol Deviation|6|||
147235836|NCT00386607|531033833|FG001|Core|Protocol Deviation|0|||
147235837|NCT00386607|531033832|FG000|Extension|Adverse Event|0|||
147235838|NCT00386607|531033833|FG001|Extension|Adverse Event|6|||
147235839|NCT00386607|531033832|FG000|Extension|Abnormal laboratory value(s)|0|||
147235840|NCT00386607|531033833|FG001|Extension|Abnormal laboratory value(s)|1|||
147235841|NCT00386607|531033832|FG000|Extension|Administrative problems|0|||
147235842|NCT00386607|531033833|FG001|Extension|Administrative problems|1|||
147235843|NCT00386607|531033832|FG000|Extension|Lost to Follow-up|0|||
147235844|NCT00386607|531033833|FG001|Extension|Lost to Follow-up|3|||
147444903|NCT02576444|531794332|FG001|Overall Study|Withdrawal by Subject|0|||
147444904|NCT02576444|531794333|FG002|Overall Study|Withdrawal by Subject|2|||
147444905|NCT02576444|531794334|FG003|Overall Study|Withdrawal by Subject|0|||
147444906|NCT02576444|531794331|FG000|Overall Study|Adverse Event|0|||
147444907|NCT02576444|531794332|FG001|Overall Study|Adverse Event|0|||
147444908|NCT02576444|531794333|FG002|Overall Study|Adverse Event|1|||
147444909|NCT02576444|531794334|FG003|Overall Study|Adverse Event|0|||
147444910|NCT02576444|531794331|FG000|Overall Study|Physician Decision|0|||
147444911|NCT02576444|531794332|FG001|Overall Study|Physician Decision|0|||
147444912|NCT02576444|531794333|FG002|Overall Study|Physician Decision|1|||
147444913|NCT02576444|531794334|FG003|Overall Study|Physician Decision|0|||
147444914|NCT03370120|531794337|FG000|Overall Study|Adverse event, non-fatal|24|||
147444915|NCT03370120|531794337|FG000|Overall Study|Withdrawal by Subject|6|||
147444916|NCT03370120|531794337|FG000|Overall Study|Lost to Follow-up|1|||
147444917|NCT03370120|531794337|FG000|Overall Study|Lack of Efficacy|37|||
147444918|NCT03370120|531794337|FG000|Overall Study|Per sponsor's instructions|1|||
147444919|NCT03370120|531794337|FG000|Overall Study|Study was terminated by parent company UCB|2|||
147444920|NCT03370120|531794337|FG000|Overall Study|The study was ended by the promoter|3|||
147444921|NCT03370120|531794337|FG000|Overall Study|Discontinuation of drug development|3|||
147444922|NCT03370120|531794337|FG000|Overall Study|End of project|2|||
147444923|NCT03370120|531794337|FG000|Overall Study|Premature study closure|2|||
147444924|NCT03370120|531794337|FG000|Overall Study|Premature program termination|1|||
147444925|NCT03370120|531794337|FG000|Overall Study|Premature study termination|7|||
147444926|NCT03370120|531794337|FG000|Overall Study|Trial terminated by sponsor|2|||
147444927|NCT03370120|531794337|FG000|Overall Study|Trial discontinued by sponsor|2|||
147444928|NCT03370120|531794337|FG000|Overall Study|Study ended|15|||
147444929|NCT03370120|531794337|FG000|Overall Study|Clinical trial has been cancelled|1|||
147444930|NCT03370120|531794337|FG000|Overall Study|End of study per sponsor decision|2|||
147444931|NCT03370120|531794337|FG000|Overall Study|Promoter's decision|2|||
147444932|NCT03370120|531794337|FG000|Overall Study|The trial has been suspended|3|||
147444933|NCT03370120|531794337|FG000|Overall Study|Sponsor stopped PSL development based on data|3|||
147444934|NCT03370120|531794337|FG000|Overall Study|Early termination by order of sponsor|2|||
147444935|NCT03370120|531794337|FG000|Overall Study|Discontinuation of the study|5|||
147444936|NCT03370120|531794337|FG000|Overall Study|End of clinical trial discontinuation|1|||
147444937|NCT03370120|531794337|FG000|Overall Study|Because the clinical trial ended halfway|4|||
147444938|NCT03370120|531794337|FG000|Overall Study|Development discontinued|5|||
147444939|NCT03370120|531794337|FG000|Overall Study|Padsenovil program closed|3|||
147444940|NCT03370120|531794337|FG000|Overall Study|End of project|2|||
147444941|NCT03370120|531794337|FG000|Overall Study|Termination of project|1|||
147444942|NCT03370120|531794337|FG000|Overall Study|The study was interrupted by sponsor|4|||
147444943|NCT03370120|531794337|FG000|Overall Study|The protocol was interrupted by sponsor|1|||
147444944|NCT03370120|531794337|FG000|Overall Study|End of sponsor decision|1|||
147444945|NCT03370120|531794337|FG000|Overall Study|The study was terminated prematurely by study lead|1|||
147444946|NCT03370120|531794337|FG000|Overall Study|Early termination of studies|5|||
147444947|NCT03370120|531794337|FG000|Overall Study|This study is ended early|1|||
147444948|NCT03370120|531794337|FG000|Overall Study|End of padsevonil program|2|||
147444949|NCT03370120|531794337|FG000|Overall Study|Decision of sponsor|6|||
147444950|NCT03370120|531794337|FG000|Overall Study|Asked by the sponsor|3|||
147444951|NCT03370120|531794337|FG000|Overall Study|Sponsor decision to stop the protocol|1|||
147444952|NCT03370120|531794337|FG000|Overall Study|PI decision poor compliance from participant|1|||
147444953|NCT03370120|531794337|FG000|Overall Study|Promoter ended the study|3|||
147444954|NCT03370120|531794337|FG000|Overall Study|Premature study close by sponsor's decision|4|||
147444955|NCT03370120|531794337|FG000|Overall Study|Study terminated by sponsor|33|||
147235845|NCT00386607|531033832|FG000|Extension|Patient withdrew consent|0|||
147235846|NCT00386607|531033833|FG001|Extension|Patient withdrew consent|5|||
147235847|NCT00386607|531033832|FG000|Extension|Unsatisfactory therapeutic effect|0|||
147235848|NCT00386607|531033833|FG001|Extension|Unsatisfactory therapeutic effect|1|||
147235849|NCT00338104|531033836|FG000|Overall Study|Protocol Violation|2|||
147235850|NCT00338104|531033837|FG001|Overall Study|Protocol Violation|1|||
147235851|NCT00338104|531033838|FG002|Overall Study|Protocol Violation|3|||
147235852|NCT00633750|531033840|FG000|Overall Study|Adverse Event|2|||
147235853|NCT00633750|531033840|FG000|Overall Study|Withdrawal by Subject|3|||
147317376|NCT02601937|531327364|FG006|Period 1: Dose Escalation Phase|Progressive disease|6|||
147235854|NCT03000569|531033841|FG000|Overall Study|Withdrawal by Subject|1|||
147235855|NCT03000569|531033842|FG001|Overall Study|Withdrawal by Subject|0|||
147235856|NCT02298023|531033843|FG000|Overall Study|Withdrawal by Subject|1|||
147235857|NCT02298023|531033844|FG001|Overall Study|Withdrawal by Subject|0|||
147235858|NCT02298023|531033845|FG002|Overall Study|Withdrawal by Subject|0|||
147235859|NCT03320057|531035461|FG000|Overall Study|Lost to Follow-up|4|||
147235860|NCT03320057|531035462|FG001|Overall Study|Lost to Follow-up|17|||
147235861|NCT03320057|531035461|FG000|Overall Study|Did not take mifepristone or misoprostol|2|||
147235862|NCT03320057|531035462|FG001|Overall Study|Did not take mifepristone or misoprostol|0|||
147235863|NCT02323113|531035463|FG000|Overall Study|Adverse Event|3|||
147235864|NCT02323113|531035464|FG001|Overall Study|Adverse Event|3|||
147235865|NCT02323113|531035465|FG002|Overall Study|Adverse Event|2|||
147235866|NCT02323113|531035466|FG003|Overall Study|Adverse Event|5|||
147235867|NCT02323113|531035467|FG004|Overall Study|Adverse Event|8|||
147235868|NCT02323113|531035468|FG005|Overall Study|Adverse Event|3|||
147317377|NCT02601937|531327365|FG007|Period 1: Dose Escalation Phase|Progressive disease|0|||
147317378|NCT02601937|531327366|FG008|Period 1: Dose Escalation Phase|Progressive disease|0|||
147444956|NCT03370120|531794337|FG000|Overall Study|Sponsor prematurely terminated this study|2|||
147444957|NCT03370120|531794337|FG000|Overall Study|Sponsor decision to terminate study|63|||
147444958|NCT03370120|531794337|FG000|Overall Study|Program closure|3|||
147444959|NCT03370120|531794337|FG000|Overall Study|Study ended prematurely|1|||
147444960|NCT03370120|531794337|FG000|Overall Study|Study stopped by sponsor|2|||
147444961|NCT03370120|531794337|FG000|Overall Study|Program termination|55|||
147444962|NCT03370120|531794337|FG000|Overall Study|Sponsor decision|62|||
147444963|NCT03370120|531794337|FG000|Overall Study|Sponsor study closure|10|||
147444964|NCT04206020|531794338|FG000|Overall Study|Adverse Event|1|||
147444965|NCT04206020|531794339|FG001|Overall Study|Adverse Event|4|||
147444966|NCT04206020|531794338|FG000|Overall Study|Protocol Violation|2|||
147444967|NCT04206020|531794339|FG001|Overall Study|Protocol Violation|0|||
147444968|NCT04206020|531794338|FG000|Overall Study|Withdrawal by Subject|2|||
147444969|NCT04206020|531794339|FG001|Overall Study|Withdrawal by Subject|0|||
147444970|NCT04206020|531794338|FG000|Overall Study|Lost to Follow-up|2|||
147444971|NCT04206020|531794339|FG001|Overall Study|Lost to Follow-up|0|||
147444972|NCT04206020|531794338|FG000|Overall Study|Pregnancy|0|||
147444973|NCT04206020|531794339|FG001|Overall Study|Pregnancy|1|||
147444974|NCT04206020|531794338|FG000|Overall Study|Unable to attend visits|1|||
147444975|NCT04206020|531794339|FG001|Overall Study|Unable to attend visits|2|||
147444976|NCT02700412|531794340|FG000|Overall Study|Adverse Event|6|||
147444977|NCT02700412|531794340|FG000|Overall Study|Death|1|||
147444978|NCT02700412|531794340|FG000|Overall Study|Lack of Efficacy|19|||
147444979|NCT02700412|531794340|FG000|Overall Study|Protocol Violation|5|||
147444980|NCT02700412|531794340|FG000|Overall Study|Withdrawal by Subject|2|||
147444981|NCT04962022|531794342|FG000|Period 1|Withdrawal by Subject|1|||
147444982|NCT04962022|531794343|FG001|Period 1|Withdrawal by Subject|0|||
147444983|NCT04416555|531794346|FG000|Overall Study|Withdrawal by Subject|0|||
147444984|NCT04416555|531794347|FG001|Overall Study|Withdrawal by Subject|3|||
147444985|NCT00530270|531794348|FG000|Overall Study|Protocol Violation|1|||
147444986|NCT00530270|531794349|FG001|Overall Study|Protocol Violation|0|||
147444987|NCT01356407|531794360|FG000|Overall Study|Lost to Follow-up|2|||
147444988|NCT01356407|531794361|FG001|Overall Study|Lost to Follow-up|0|||
147444989|NCT01356407|531794360|FG000|Overall Study|Patient Withdrew Consent|2|||
147444990|NCT01356407|531794361|FG001|Overall Study|Patient Withdrew Consent|1|||
147444991|NCT01356407|531794360|FG000|Overall Study|Could not afford IMP administration|0|||
147444992|NCT01356407|531794361|FG001|Overall Study|Could not afford IMP administration|1|||
147444993|NCT01356407|531794360|FG000|Overall Study|Not complete Endoscopy|2|||
147444994|NCT01356407|531794361|FG001|Overall Study|Not complete Endoscopy|2|||
147444995|NCT01309659|531794364|FG000|Overall Study|Protocol Violation|0|||
147444996|NCT01309659|531794365|FG001|Overall Study|Protocol Violation|1|||
147444997|NCT02018822|531794366|FG000|Overall Study|filling replaced by crown|0|||
147444998|NCT02018822|531794367|FG001|Overall Study|filling replaced by crown|1|||
147444999|NCT02018822|531794368|FG002|Overall Study|filling replaced by crown|0|||
147445000|NCT02018822|531794366|FG000|Overall Study|Physician Decision|0|||
147445001|NCT02018822|531794367|FG001|Overall Study|Physician Decision|1|||
147445002|NCT02018822|531794368|FG002|Overall Study|Physician Decision|1|||
147445003|NCT02018822|531794366|FG000|Overall Study|Lost to Follow-up|6|||
147445004|NCT02018822|531794367|FG001|Overall Study|Lost to Follow-up|6|||
147445005|NCT02018822|531794368|FG002|Overall Study|Lost to Follow-up|5|||
147569103|NCT01597245|532240137|FG016|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
147569104|NCT01597245|532240138|FG017|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
147569105|NCT01597245|532240139|FG018|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
147569106|NCT01597245|532240140|FG019|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
147569107|NCT01597245|532240141|FG020|Long Term Extension (Week 60 - Week 264)|Sponsor Decision|0|||
147569108|NCT01597245|532240121|FG000|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
147569109|NCT01597245|532240122|FG001|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
147569110|NCT01597245|532240123|FG002|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
147569111|NCT01597245|532240124|FG003|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
147569112|NCT01597245|532240125|FG004|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
147569113|NCT01597245|532240126|FG005|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
147569114|NCT01597245|532240127|FG006|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
147569115|NCT01597245|532240128|FG007|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
147569116|NCT01597245|532240129|FG008|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
147569117|NCT01597245|532240130|FG009|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
147569118|NCT01597245|532240131|FG010|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
147569119|NCT01597245|532240132|FG011|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
147235869|NCT02323113|531035469|FG006|Overall Study|Adverse Event|6|||
147235870|NCT02323113|531035470|FG007|Overall Study|Adverse Event|0|||
147235871|NCT02323113|531035463|FG000|Overall Study|Progressive Disease|0|||
147235872|NCT02323113|531035464|FG001|Overall Study|Progressive Disease|1|||
147235873|NCT02323113|531035465|FG002|Overall Study|Progressive Disease|1|||
147235874|NCT02323113|531035466|FG003|Overall Study|Progressive Disease|0|||
147235875|NCT02323113|531035467|FG004|Overall Study|Progressive Disease|0|||
147235876|NCT02323113|531035468|FG005|Overall Study|Progressive Disease|3|||
147235877|NCT02323113|531035469|FG006|Overall Study|Progressive Disease|0|||
147317379|NCT02601937|531327367|FG009|Period 1: Dose Escalation Phase|Progressive disease|0|||
147317380|NCT02601937|531327368|FG010|Period 1: Dose Escalation Phase|Progressive disease|0|||
147317381|NCT02601937|531327358|FG000|Period 2: Dose Expansion Cohort|Adverse Event|0|||
147317382|NCT02601937|531327359|FG001|Period 2: Dose Expansion Cohort|Adverse Event|0|||
147317383|NCT02601937|531327360|FG002|Period 2: Dose Expansion Cohort|Adverse Event|0|||
147317384|NCT02601937|531327361|FG003|Period 2: Dose Expansion Cohort|Adverse Event|0|||
147317385|NCT02601937|531327362|FG004|Period 2: Dose Expansion Cohort|Adverse Event|0|||
147317386|NCT02601937|531327363|FG005|Period 2: Dose Expansion Cohort|Adverse Event|0|||
147317387|NCT02601937|531327364|FG006|Period 2: Dose Expansion Cohort|Adverse Event|0|||
147317388|NCT02601937|531327365|FG007|Period 2: Dose Expansion Cohort|Adverse Event|0|||
147317389|NCT02601937|531327366|FG008|Period 2: Dose Expansion Cohort|Adverse Event|0|||
147317390|NCT02601937|531327367|FG009|Period 2: Dose Expansion Cohort|Adverse Event|1|||
147317391|NCT02601937|531327368|FG010|Period 2: Dose Expansion Cohort|Adverse Event|0|||
147317392|NCT02601937|531327358|FG000|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
147317393|NCT02601937|531327359|FG001|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
147317394|NCT02601937|531327360|FG002|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
147317395|NCT02601937|531327361|FG003|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
147317396|NCT02601937|531327362|FG004|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
147569120|NCT01597245|532240133|FG012|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
147569121|NCT01597245|532240134|FG013|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|23|||
147569122|NCT01597245|532240135|FG014|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
147569123|NCT01597245|532240136|FG015|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
147569124|NCT01597245|532240137|FG016|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
147569125|NCT01597245|532240138|FG017|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
147569126|NCT01597245|532240139|FG018|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
147569127|NCT01597245|532240140|FG019|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
147130290|NCT02958865|530644521|FG003|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
147130291|NCT02958865|530644522|FG004|Induction Period (Day 1 to Week 8)|Lost to Follow-up|1|||
147130292|NCT02958865|530644523|FG005|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
147130293|NCT02958865|530644524|FG006|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
147130294|NCT02958865|530644525|FG007|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
147130295|NCT02958865|530644526|FG008|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
147130296|NCT02958865|530644527|FG009|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
147130297|NCT02958865|530644528|FG010|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
147130298|NCT02958865|530644529|FG011|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
147130299|NCT02958865|530644530|FG012|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
147130300|NCT02958865|530644531|FG013|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
147130301|NCT02958865|530644532|FG014|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
147130302|NCT02958865|530644533|FG015|Induction Period (Day 1 to Week 8)|Lost to Follow-up|0|||
147569128|NCT01597245|532240141|FG020|Long Term Extension (Week 60 - Week 264)|Switched from PBO to Ixe|0|||
147569129|NCT01597245|532240121|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
147569130|NCT01597245|532240122|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
147569131|NCT01597245|532240123|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
147569132|NCT01597245|532240124|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
147569133|NCT01597245|532240125|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
147569134|NCT01597245|532240126|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
147569135|NCT01597245|532240127|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
147569136|NCT01597245|532240128|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
147569137|NCT01597245|532240129|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
147569138|NCT01597245|532240130|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
147569139|NCT01597245|532240131|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
147569140|NCT01597245|532240132|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
147569141|NCT01597245|532240133|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
147569142|NCT01597245|532240134|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
147569143|NCT01597245|532240135|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
147569144|NCT01597245|532240136|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|0|||
147569145|NCT01597245|532240137|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|9|||
147569146|NCT01597245|532240138|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|5|||
147569147|NCT01597245|532240139|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|8|||
147569148|NCT01597245|532240140|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|63|||
147569149|NCT01597245|532240141|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Adverse Event|13|||
147569150|NCT01597245|532240121|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
147569151|NCT01597245|532240122|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
147569152|NCT01597245|532240123|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
147569153|NCT01597245|532240124|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
147569154|NCT01597245|532240125|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
147569155|NCT01597245|532240126|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
147569156|NCT01597245|532240127|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
147569157|NCT01597245|532240128|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
147569158|NCT01597245|532240129|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
147569159|NCT01597245|532240130|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
147569160|NCT01597245|532240131|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
147569161|NCT01597245|532240132|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
147569162|NCT01597245|532240133|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
147569163|NCT01597245|532240134|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
147569164|NCT01597245|532240135|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
147569165|NCT01597245|532240136|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
147569166|NCT01597245|532240137|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|0|||
147569167|NCT01597245|532240138|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|1|||
147569168|NCT01597245|532240139|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|1|||
147569169|NCT01597245|532240140|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|41|||
147569170|NCT01597245|532240141|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Withdrawal by Subject|13|||
147569171|NCT01597245|532240121|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
147569172|NCT01597245|532240122|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
147569173|NCT01597245|532240123|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
147569174|NCT01597245|532240124|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
147569175|NCT01597245|532240125|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
147569176|NCT01597245|532240126|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
147569177|NCT01597245|532240127|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
147569178|NCT01597245|532240128|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
147569179|NCT01597245|532240129|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
147569180|NCT01597245|532240130|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
147317397|NCT02601937|531327363|FG005|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
147317398|NCT02601937|531327364|FG006|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
147317399|NCT02601937|531327365|FG007|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|2|||
147317400|NCT02601937|531327366|FG008|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
147317401|NCT02601937|531327367|FG009|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
147317402|NCT02601937|531327368|FG010|Period 2: Dose Expansion Cohort|Patient refused further treatment of study drug|0|||
147317403|NCT02601937|531327358|FG000|Period 2: Dose Expansion Cohort|Physician Decision|0|||
147317404|NCT02601937|531327359|FG001|Period 2: Dose Expansion Cohort|Physician Decision|0|||
147317405|NCT02601937|531327360|FG002|Period 2: Dose Expansion Cohort|Physician Decision|0|||
147317406|NCT02601937|531327361|FG003|Period 2: Dose Expansion Cohort|Physician Decision|0|||
147569181|NCT01597245|532240131|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
147569182|NCT01597245|532240132|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
147569183|NCT01597245|532240133|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
147569184|NCT01597245|532240134|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
147569185|NCT01597245|532240135|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
147569186|NCT01597245|532240136|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
147569187|NCT01597245|532240137|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|2|||
147569188|NCT01597245|532240138|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
147569189|NCT01597245|532240139|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|0|||
147569190|NCT01597245|532240140|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|29|||
147569191|NCT01597245|532240141|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Lack of Efficacy|3|||
147569192|NCT01597245|532240121|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
147569193|NCT01597245|532240122|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
147569194|NCT01597245|532240123|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
147569195|NCT01597245|532240124|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
147569196|NCT01597245|532240125|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
147569197|NCT01597245|532240126|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
147569198|NCT01597245|532240127|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
147569199|NCT01597245|532240128|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
147569200|NCT01597245|532240129|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
147569201|NCT01597245|532240130|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
147569202|NCT01597245|532240131|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
147569203|NCT01597245|532240132|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
147569204|NCT01597245|532240133|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
147569205|NCT01597245|532240134|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
147569206|NCT01597245|532240135|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
147569207|NCT01597245|532240136|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
147569208|NCT01597245|532240137|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
147569209|NCT01597245|532240138|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|0|||
147569210|NCT01597245|532240139|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|1|||
147569211|NCT01597245|532240140|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|14|||
147569212|NCT01597245|532240141|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Lost to Follow-up|4|||
147569213|NCT01597245|532240121|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
147569214|NCT01597245|532240122|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
147569215|NCT01597245|532240123|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
147569216|NCT01597245|532240124|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
147569217|NCT01597245|532240125|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
147569218|NCT01597245|532240126|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
147569219|NCT01597245|532240127|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
147569220|NCT01597245|532240128|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
147569221|NCT01597245|532240129|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
147569222|NCT01597245|532240130|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
147569223|NCT01597245|532240131|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
147569224|NCT01597245|532240132|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
147569225|NCT01597245|532240133|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
147569226|NCT01597245|532240134|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
147569227|NCT01597245|532240135|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
147569228|NCT01597245|532240136|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
147569229|NCT01597245|532240137|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|1|||
147569230|NCT01597245|532240138|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
147569231|NCT01597245|532240139|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|0|||
147569232|NCT01597245|532240140|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|9|||
147569233|NCT01597245|532240141|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Physician Decision|1|||
147569234|NCT01597245|532240121|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
147569235|NCT01597245|532240122|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
147569236|NCT01597245|532240123|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
147569237|NCT01597245|532240124|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
147651281|NCT01428115|532544662|FG000|Overall Study|Withdrawal by Subject|4|||
147651282|NCT02620384|532544663|FG000|Overall Study|Adverse Event|2|||
147235878|NCT02323113|531035470|FG007|Overall Study|Progressive Disease|0|||
147235879|NCT02323113|531035463|FG000|Overall Study|Symptomatic Deterioration|0|||
147235880|NCT02323113|531035464|FG001|Overall Study|Symptomatic Deterioration|0|||
147235881|NCT02323113|531035465|FG002|Overall Study|Symptomatic Deterioration|1|||
147569238|NCT01597245|532240125|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
147569239|NCT01597245|532240126|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
147569240|NCT01597245|532240127|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
147569241|NCT01597245|532240128|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
147569242|NCT01597245|532240129|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
147569243|NCT01597245|532240130|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
147569244|NCT01597245|532240131|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
147569245|NCT01597245|532240132|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
147569246|NCT01597245|532240133|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
147569247|NCT01597245|532240134|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
147569248|NCT01597245|532240135|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
147569249|NCT01597245|532240136|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
147569250|NCT01597245|532240137|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|1|||
147569251|NCT01597245|532240138|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
147569252|NCT01597245|532240139|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|0|||
147569253|NCT01597245|532240140|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|6|||
147569254|NCT01597245|532240141|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Protocol Violation|2|||
147569255|NCT01597245|532240121|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
147569256|NCT01597245|532240122|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
147569257|NCT01597245|532240123|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
147569258|NCT01597245|532240124|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
147569259|NCT01597245|532240125|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
147569260|NCT01597245|532240126|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
147569261|NCT01597245|532240127|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
147569262|NCT01597245|532240128|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
147569263|NCT01597245|532240129|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
147569264|NCT01597245|532240130|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
147569265|NCT01597245|532240131|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
147569266|NCT01597245|532240132|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
147569267|NCT01597245|532240133|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
147569268|NCT01597245|532240134|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
147569269|NCT01597245|532240135|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
147569270|NCT01597245|532240136|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
147569271|NCT01597245|532240137|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|2|||
147569272|NCT01597245|532240138|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
147569273|NCT01597245|532240139|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
147569274|NCT01597245|532240140|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|3|||
147569275|NCT01597245|532240141|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Entry Criteria Not Met|0|||
147569276|NCT01597245|532240121|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
147569277|NCT01597245|532240122|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
147569278|NCT01597245|532240123|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
147569279|NCT01597245|532240124|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
147569280|NCT01597245|532240125|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
147569281|NCT01597245|532240126|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
147569282|NCT01597245|532240127|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
147569283|NCT01597245|532240128|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
147569284|NCT01597245|532240129|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
147569285|NCT01597245|532240130|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
147569286|NCT01597245|532240131|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
147569287|NCT01597245|532240132|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
147569288|NCT01597245|532240133|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
147569289|NCT01597245|532240134|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
147569290|NCT01597245|532240135|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
147569291|NCT01597245|532240136|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
147569292|NCT01597245|532240137|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|1|||
147569293|NCT01597245|532240138|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
147569294|NCT01597245|532240139|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
147569295|NCT01597245|532240140|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|1|||
147569296|NCT01597245|532240141|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Sponsor Decision|0|||
147651283|NCT02620384|532544664|FG001|Overall Study|Adverse Event|1|||
147235882|NCT02323113|531035466|FG003|Overall Study|Symptomatic Deterioration|0|||
147235883|NCT02323113|531035467|FG004|Overall Study|Symptomatic Deterioration|1|||
147651284|NCT02620384|532544663|FG000|Overall Study|Discharged prior to 2nd dose|2|||
147651285|NCT02620384|532544664|FG001|Overall Study|Discharged prior to 2nd dose|5|||
147235884|NCT02323113|531035468|FG005|Overall Study|Symptomatic Deterioration|0|||
147651286|NCT02620384|532544663|FG000|Overall Study|Drug shortage prevented 2nd dose|0|||
147651287|NCT02620384|532544664|FG001|Overall Study|Drug shortage prevented 2nd dose|1|||
147651288|NCT02071082|532544665|FG000|Overall Study|Enrolled and Never Treated|1|||
147651289|NCT02071082|532544666|FG001|Overall Study|Enrolled and Never Treated|1|||
147651290|NCT02071082|532544665|FG000|Overall Study|Adverse Event|0|||
147651291|NCT02071082|532544666|FG001|Overall Study|Adverse Event|1|||
147651292|NCT02071082|532544665|FG000|Overall Study|Withdrew Consent|0|||
147651293|NCT02071082|532544666|FG001|Overall Study|Withdrew Consent|4|||
147569297|NCT01597245|532240121|FG000|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
147569298|NCT01597245|532240122|FG001|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
147569299|NCT01597245|532240123|FG002|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
147569300|NCT01597245|532240124|FG003|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
147569301|NCT01597245|532240125|FG004|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
147569302|NCT01597245|532240126|FG005|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
147569303|NCT01597245|532240127|FG006|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
147569304|NCT01597245|532240128|FG007|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
147569305|NCT01597245|532240129|FG008|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
147569306|NCT01597245|532240130|FG009|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
147569307|NCT01597245|532240131|FG010|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
147569308|NCT01597245|532240132|FG011|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
147569309|NCT01597245|532240133|FG012|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
147651294|NCT02071082|532544665|FG000|Overall Study|Lost to Follow-up|1|||
147651295|NCT02071082|532544666|FG001|Overall Study|Lost to Follow-up|1|||
147569310|NCT01597245|532240134|FG013|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
147569311|NCT01597245|532240135|FG014|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
147569312|NCT01597245|532240136|FG015|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
147569313|NCT01597245|532240137|FG016|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
147569314|NCT01597245|532240138|FG017|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
147569315|NCT01597245|532240139|FG018|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
147651296|NCT00742027|532544667|FG000|Overall Study|Disease Progression|76|||
147651297|NCT00742027|532544667|FG000|Overall Study|New Cancer Therapy|19|||
147651298|NCT00742027|532544667|FG000|Overall Study|Withdrawal by Subject|18|||
147569316|NCT01597245|532240140|FG019|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|1|||
147651299|NCT00742027|532544667|FG000|Overall Study|Death|7|||
147651300|NCT00742027|532544667|FG000|Overall Study|Lost to Follow-up|4|||
147651301|NCT00742027|532544667|FG000|Overall Study|Follow up Phase Completed As Per Protocol|2|||
147651302|NCT00742027|532544667|FG000|Overall Study|Missing|2|||
147569317|NCT01597245|532240141|FG020|Post Treatment Follow-Up (12 - 24 Weeks)|Clinical Relapse|0|||
147569318|NCT00731783|532240142|FG000|One Month Follow-Up Visit|Lost to Follow-up|14|||
147569319|NCT00731783|532240143|FG001|One Month Follow-Up Visit|Lost to Follow-up|22|||
147569320|NCT00731783|532240142|FG000|Three Month Follow-Up Visit|Lost to Follow-up|7|||
147569321|NCT00731783|532240143|FG001|Three Month Follow-Up Visit|Lost to Follow-up|16|||
147569322|NCT00731783|532240142|FG000|Six Month Follow-Up Visit|Lost to Follow-up|6|||
147235885|NCT02323113|531035469|FG006|Overall Study|Symptomatic Deterioration|0|||
147235886|NCT02323113|531035470|FG007|Overall Study|Symptomatic Deterioration|0|||
147235887|NCT02323113|531035463|FG000|Overall Study|Unsatisfactory Therapeutic Response|1|||
147651303|NCT00742027|532544667|FG000|Overall Study|Administrative Problems|1|||
147651304|NCT00385827|532546431|FG000|Part 1|Adverse Event|1|||
147651305|NCT00385827|532546432|FG001|Part 1|Adverse Event|0|||
147651306|NCT00385827|532546433|FG002|Part 1|Adverse Event|0|||
147651307|NCT00385827|532546431|FG000|Part 1|Death|2|||
147651308|NCT00385827|532546432|FG001|Part 1|Death|0|||
147651309|NCT00385827|532546433|FG002|Part 1|Death|0|||
147651310|NCT00385827|532546431|FG000|Part 1|Lack of Efficacy|5|||
147651311|NCT00385827|532546432|FG001|Part 1|Lack of Efficacy|0|||
147651312|NCT00385827|532546433|FG002|Part 1|Lack of Efficacy|0|||
147651313|NCT00385827|532546431|FG000|Part 1|Other|1|||
147651314|NCT00385827|532546432|FG001|Part 1|Other|0|||
147651315|NCT00385827|532546433|FG002|Part 1|Other|0|||
147651316|NCT00385827|532546431|FG000|Part 2|Adverse Event|0|||
147651317|NCT00385827|532546432|FG001|Part 2|Adverse Event|6|||
147651318|NCT00385827|532546433|FG002|Part 2|Adverse Event|10|||
147651319|NCT00385827|532546431|FG000|Part 2|Death|0|||
147651320|NCT00385827|532546432|FG001|Part 2|Death|0|||
147651321|NCT00385827|532546433|FG002|Part 2|Death|2|||
147651322|NCT00385827|532546431|FG000|Part 2|Lack of Efficacy|0|||
147651323|NCT00385827|532546432|FG001|Part 2|Lack of Efficacy|14|||
147569323|NCT00731783|532240143|FG001|Six Month Follow-Up Visit|Lost to Follow-up|3|||
147651324|NCT00385827|532546433|FG002|Part 2|Lack of Efficacy|13|||
147235888|NCT02323113|531035464|FG001|Overall Study|Unsatisfactory Therapeutic Response|2|||
147235889|NCT02323113|531035465|FG002|Overall Study|Unsatisfactory Therapeutic Response|0|||
147651325|NCT00385827|532546431|FG000|Part 2|Randomized but not treated|0|||
147651326|NCT00385827|532546432|FG001|Part 2|Randomized but not treated|2|||
147651327|NCT00385827|532546433|FG002|Part 2|Randomized but not treated|2|||
147651328|NCT00385827|532546431|FG000|Part 2|Other|0|||
147130303|NCT02958865|530644518|FG000|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
147130304|NCT02958865|530644519|FG001|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
147130305|NCT02958865|530644520|FG002|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
147130306|NCT02958865|530644521|FG003|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
147130307|NCT02958865|530644522|FG004|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
147130308|NCT02958865|530644523|FG005|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
147130309|NCT02958865|530644524|FG006|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
147235890|NCT02323113|531035466|FG003|Overall Study|Unsatisfactory Therapeutic Response|0|||
147235891|NCT02323113|531035467|FG004|Overall Study|Unsatisfactory Therapeutic Response|0|||
147569324|NCT00731783|532240142|FG000|12 Month Follow-Up Visit|Lost to Follow-up|6|||
147569325|NCT00731783|532240143|FG001|12 Month Follow-Up Visit|Lost to Follow-up|7|||
147569326|NCT02267187|532241623|FG000|Overall Study|Physician Decision|2|||
147569327|NCT02267187|532241623|FG000|Overall Study|Screen fail|3|||
147569328|NCT02222818|532241624|FG000|Period 1|Eligibility criteria not met|0|||
147569329|NCT02222818|532241625|FG001|Period 1|Eligibility criteria not met|3|||
147569330|NCT00934050|532241626|FG000|Enrolled Prior to 15 Dec 2009|Adverse Event|1|||
147569331|NCT00934050|532241627|FG001|Enrolled Prior to 15 Dec 2009|Adverse Event|0|||
147569332|NCT00934050|532241628|FG002|Enrolled Prior to 15 Dec 2009|Adverse Event|0|||
147569333|NCT00934050|532241629|FG003|Enrolled Prior to 15 Dec 2009|Adverse Event|1|||
147569334|NCT00934050|532241630|FG004|Enrolled Prior to 15 Dec 2009|Adverse Event|0|||
147569335|NCT00934050|532241631|FG005|Enrolled Prior to 15 Dec 2009|Adverse Event|0|||
147569336|NCT00934050|532241626|FG000|Enrolled Prior to 15 Dec 2009|Sponsor Decision|11|||
147569337|NCT00934050|532241627|FG001|Enrolled Prior to 15 Dec 2009|Sponsor Decision|12|||
147569338|NCT00934050|532241628|FG002|Enrolled Prior to 15 Dec 2009|Sponsor Decision|11|||
147569339|NCT00934050|532241629|FG003|Enrolled Prior to 15 Dec 2009|Sponsor Decision|13|||
147569340|NCT00934050|532241630|FG004|Enrolled Prior to 15 Dec 2009|Sponsor Decision|0|||
147569341|NCT00934050|532241631|FG005|Enrolled Prior to 15 Dec 2009|Sponsor Decision|0|||
147569342|NCT00934050|532241626|FG000|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0|||
147235892|NCT02323113|531035468|FG005|Overall Study|Unsatisfactory Therapeutic Response|2|||
147235893|NCT02323113|531035469|FG006|Overall Study|Unsatisfactory Therapeutic Response|0|||
147235894|NCT02323113|531035470|FG007|Overall Study|Unsatisfactory Therapeutic Response|0|||
147235895|NCT02323113|531035463|FG000|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
147235896|NCT02323113|531035464|FG001|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|1|||
147235897|NCT02323113|531035465|FG002|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
147235898|NCT02323113|531035466|FG003|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
147235899|NCT02323113|531035467|FG004|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
147235900|NCT02323113|531035468|FG005|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
147235901|NCT02323113|531035469|FG006|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
147235902|NCT02323113|531035470|FG007|Overall Study|Study Drug was Held due to AE for >21 Days, Therefore Participant was Discontinued Per Protocol|0|||
147235903|NCT00403234|531035471|FG000|Overall Study|Withdrawal by Subject|0|||
147235904|NCT00403234|531035472|FG001|Overall Study|Withdrawal by Subject|1|||
147235905|NCT00403234|531035473|FG002|Overall Study|Withdrawal by Subject|0|||
147235906|NCT00403234|531035474|FG003|Overall Study|Withdrawal by Subject|0|||
147235907|NCT00403234|531035471|FG000|Overall Study|Adverse Event|1|||
147235908|NCT00403234|531035472|FG001|Overall Study|Adverse Event|0|||
147235909|NCT00403234|531035473|FG002|Overall Study|Adverse Event|1|||
147235910|NCT00403234|531035474|FG003|Overall Study|Adverse Event|0|||
147235911|NCT00316719|531035475|FG000|Overall Study|Adverse Event|0|||
147235912|NCT00316719|531035476|FG001|Overall Study|Adverse Event|6|||
147235913|NCT00316719|531035475|FG000|Overall Study|Consent withdrawn|2|||
147235914|NCT00316719|531035476|FG001|Overall Study|Consent withdrawn|0|||
147235915|NCT02468674|531035479|FG000|Overall Study|Adverse Event|0|||
147235916|NCT02468674|531035480|FG001|Overall Study|Adverse Event|0|||
147235917|NCT02468674|531035481|FG002|Overall Study|Adverse Event|0|||
147235918|NCT02468674|531035482|FG003|Overall Study|Adverse Event|1|||
147569343|NCT00934050|532241627|FG001|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0|||
147569344|NCT00934050|532241628|FG002|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|1|||
147569345|NCT00934050|532241629|FG003|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0|||
147569346|NCT00934050|532241630|FG004|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0|||
147569347|NCT00934050|532241631|FG005|Enrolled Prior to 15 Dec 2009|Withdrawal by Subject|0|||
147569348|NCT00934050|532241626|FG000|Enrolled After 15 Dec 2009|Adverse Event|0|||
147569349|NCT00934050|532241627|FG001|Enrolled After 15 Dec 2009|Adverse Event|0|||
147569350|NCT00934050|532241628|FG002|Enrolled After 15 Dec 2009|Adverse Event|0|||
147569351|NCT00934050|532241629|FG003|Enrolled After 15 Dec 2009|Adverse Event|0|||
147569352|NCT00934050|532241630|FG004|Enrolled After 15 Dec 2009|Adverse Event|3|||
147569353|NCT00934050|532241631|FG005|Enrolled After 15 Dec 2009|Adverse Event|0|||
147569354|NCT00934050|532241626|FG000|Enrolled After 15 Dec 2009|Death|0|||
147569355|NCT00934050|532241627|FG001|Enrolled After 15 Dec 2009|Death|0|||
147569356|NCT00934050|532241628|FG002|Enrolled After 15 Dec 2009|Death|0|||
147569357|NCT00934050|532241629|FG003|Enrolled After 15 Dec 2009|Death|0|||
147569358|NCT00934050|532241630|FG004|Enrolled After 15 Dec 2009|Death|0|||
147569359|NCT00934050|532241631|FG005|Enrolled After 15 Dec 2009|Death|1|||
147569360|NCT00934050|532241626|FG000|Enrolled After 15 Dec 2009|Lost to Follow-up|0|||
147569361|NCT00934050|532241627|FG001|Enrolled After 15 Dec 2009|Lost to Follow-up|0|||
147569362|NCT00934050|532241628|FG002|Enrolled After 15 Dec 2009|Lost to Follow-up|0|||
147569363|NCT00934050|532241629|FG003|Enrolled After 15 Dec 2009|Lost to Follow-up|0|||
147569364|NCT00934050|532241630|FG004|Enrolled After 15 Dec 2009|Lost to Follow-up|0|||
147569365|NCT00934050|532241631|FG005|Enrolled After 15 Dec 2009|Lost to Follow-up|1|||
147569366|NCT00934050|532241626|FG000|Enrolled After 15 Dec 2009|Withdrawal by Subject|0|||
147569367|NCT00934050|532241627|FG001|Enrolled After 15 Dec 2009|Withdrawal by Subject|0|||
147569368|NCT00934050|532241628|FG002|Enrolled After 15 Dec 2009|Withdrawal by Subject|0|||
147569369|NCT00934050|532241629|FG003|Enrolled After 15 Dec 2009|Withdrawal by Subject|0|||
147569370|NCT00934050|532241630|FG004|Enrolled After 15 Dec 2009|Withdrawal by Subject|4|||
147569371|NCT00934050|532241631|FG005|Enrolled After 15 Dec 2009|Withdrawal by Subject|2|||
147569372|NCT02149420|532241634|FG000|Core Study|Administrative problems|0|||
147569373|NCT02149420|532241635|FG001|Core Study|Administrative problems|1|||
147569374|NCT02149420|532241636|FG002|Core Study|Administrative problems|2|||
147569375|NCT02149420|532241634|FG000|Open Label VAY736 10 mg/kg Extension|Administrative problems|1|||
147569376|NCT02149420|532241635|FG001|Open Label VAY736 10 mg/kg Extension|Administrative problems|0|||
147569377|NCT02149420|532241636|FG002|Open Label VAY736 10 mg/kg Extension|Administrative problems|0|||
147569378|NCT03181594|532241637|FG000|Initial Study Protocol (12-month FU)|Lost to Follow-up|4|||
147569379|NCT03181594|532241637|FG000|Initial Study Protocol (12-month FU)|Withdrawal by Subject|3|||
147569380|NCT03181594|532241637|FG000|Initial Study Protocol (12-month FU)|Physician Decision|1|||
147569381|NCT03181594|532241637|FG000|Initial Study Protocol (12-month FU)|Death|1|||
147569382|NCT03181594|532241637|FG000|Long-term Extension (15-24 Month FU)|Lost to Follow-up|3|||
147569383|NCT03181594|532241637|FG000|Long-term Extension (15-24 Month FU)|Death|2|||
147569384|NCT00960297|532241640|FG000|Overall Study|Physician Decision|1|||
147569385|NCT00960297|532241640|FG000|Overall Study|Venous port infection|1|||
147569386|NCT00960297|532241640|FG000|Overall Study|Disease progression|1|||
147569387|NCT03247972|532241650|FG000|High Dose Statin Run-In Period (8 Weeks)|Withdrawal by Subject|4|||
147569388|NCT03247972|532241650|FG000|High Dose Statins + Evolocumab (8 Weeks)|Withdrawal by Subject|2|||
147569389|NCT03500341|532241651|FG000|Overall Study|Withdrawn prior to Completion|2|||
147569390|NCT02576938|532241654|FG000|Overall Study|Adverse Event|5|||
147569391|NCT02576938|532241655|FG001|Overall Study|Adverse Event|3|||
147569392|NCT02576938|532241656|FG002|Overall Study|Adverse Event|6|||
147569393|NCT02576938|532241654|FG000|Overall Study|Protocol Violation|1|||
147569394|NCT02576938|532241655|FG001|Overall Study|Protocol Violation|1|||
147569395|NCT02576938|532241656|FG002|Overall Study|Protocol Violation|1|||
147569396|NCT02576938|532241654|FG000|Overall Study|Withdrawal by Subject|3|||
147569397|NCT02576938|532241655|FG001|Overall Study|Withdrawal by Subject|2|||
147569398|NCT02576938|532241656|FG002|Overall Study|Withdrawal by Subject|4|||
147569399|NCT02576938|532241654|FG000|Overall Study|Lack of Efficacy|9|||
147569400|NCT02576938|532241655|FG001|Overall Study|Lack of Efficacy|4|||
147569401|NCT02576938|532241656|FG002|Overall Study|Lack of Efficacy|0|||
147569402|NCT02576938|532241654|FG000|Overall Study|Lost to Follow-up|2|||
147569403|NCT02576938|532241655|FG001|Overall Study|Lost to Follow-up|0|||
147569404|NCT02576938|532241656|FG002|Overall Study|Lost to Follow-up|1|||
147569405|NCT02576938|532241654|FG000|Overall Study|Physician Decision|0|||
147569406|NCT02576938|532241655|FG001|Overall Study|Physician Decision|1|||
147569407|NCT02576938|532241656|FG002|Overall Study|Physician Decision|0|||
147569408|NCT02576938|532241654|FG000|Overall Study|Met Exclusion Criteria|0|||
147569409|NCT02576938|532241655|FG001|Overall Study|Met Exclusion Criteria|1|||
147569410|NCT02576938|532241656|FG002|Overall Study|Met Exclusion Criteria|0|||
147569411|NCT00968812|532241657|FG000|Overall Study|Adverse Event|30|||
147569412|NCT00968812|532241658|FG001|Overall Study|Adverse Event|46|||
147569413|NCT00968812|532241659|FG002|Overall Study|Adverse Event|33|||
147569414|NCT00968812|532241657|FG000|Overall Study|Death|2|||
147569415|NCT00968812|532241658|FG001|Overall Study|Death|2|||
147569416|NCT00968812|532241659|FG002|Overall Study|Death|1|||
147569417|NCT00968812|532241657|FG000|Overall Study|Lack of Efficacy|9|||
147569418|NCT00968812|532241658|FG001|Overall Study|Lack of Efficacy|7|||
147569419|NCT00968812|532241659|FG002|Overall Study|Lack of Efficacy|16|||
147569420|NCT00968812|532241657|FG000|Overall Study|Lost to Follow-up|17|||
147569421|NCT00968812|532241658|FG001|Overall Study|Lost to Follow-up|12|||
147569422|NCT00968812|532241659|FG002|Overall Study|Lost to Follow-up|11|||
147569423|NCT00968812|532241657|FG000|Overall Study|Physician Decision|8|||
147569424|NCT00968812|532241658|FG001|Overall Study|Physician Decision|5|||
147569425|NCT00968812|532241659|FG002|Overall Study|Physician Decision|9|||
147569426|NCT00968812|532241657|FG000|Overall Study|Protocol Violation|7|||
147569427|NCT00968812|532241658|FG001|Overall Study|Protocol Violation|4|||
147569428|NCT00968812|532241659|FG002|Overall Study|Protocol Violation|3|||
147569429|NCT00968812|532241657|FG000|Overall Study|Withdrawal by Subject|17|||
147569430|NCT00968812|532241658|FG001|Overall Study|Withdrawal by Subject|23|||
147569431|NCT00968812|532241659|FG002|Overall Study|Withdrawal by Subject|25|||
147569432|NCT00968812|532241657|FG000|Overall Study|Creatinine or eGFR withdrawal criteria|9|||
147130310|NCT02958865|530644525|FG007|Chronic Period (Week 8 to Week 32)|Adverse Event|1|||
147130311|NCT02958865|530644526|FG008|Chronic Period (Week 8 to Week 32)|Adverse Event|1|||
147130312|NCT02958865|530644527|FG009|Chronic Period (Week 8 to Week 32)|Adverse Event|2|||
147130313|NCT02958865|530644528|FG010|Chronic Period (Week 8 to Week 32)|Adverse Event|0|||
147130314|NCT02958865|530644529|FG011|Chronic Period (Week 8 to Week 32)|Adverse Event|1|||
147130315|NCT02958865|530644530|FG012|Chronic Period (Week 8 to Week 32)|Adverse Event|4|||
147130316|NCT02958865|530644531|FG013|Chronic Period (Week 8 to Week 32)|Adverse Event|1|||
147130317|NCT02958865|530644532|FG014|Chronic Period (Week 8 to Week 32)|Adverse Event|1|||
147130318|NCT02958865|530644533|FG015|Chronic Period (Week 8 to Week 32)|Adverse Event|5|||
147130319|NCT02958865|530644518|FG000|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
147130320|NCT02958865|530644519|FG001|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
147130321|NCT02958865|530644520|FG002|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
147130322|NCT02958865|530644521|FG003|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
147235919|NCT02468674|531035483|FG004|Overall Study|Adverse Event|0|||
147235920|NCT02468674|531035484|FG005|Overall Study|Adverse Event|1|||
147235921|NCT02468674|531035485|FG006|Overall Study|Adverse Event|0|||
147235922|NCT02468674|531035486|FG007|Overall Study|Adverse Event|0|||
147235923|NCT02468674|531035487|FG008|Overall Study|Adverse Event|0|||
147235924|NCT02468674|531035479|FG000|Overall Study|Lost to Follow-up|1|||
147235925|NCT02468674|531035480|FG001|Overall Study|Lost to Follow-up|0|||
147235926|NCT02468674|531035481|FG002|Overall Study|Lost to Follow-up|0|||
147235927|NCT02468674|531035482|FG003|Overall Study|Lost to Follow-up|0|||
147235928|NCT02468674|531035483|FG004|Overall Study|Lost to Follow-up|0|||
147445006|NCT02285777|531794369|FG000|Overall Study|Withdrawal by Subject|1|||
147445007|NCT02285777|531794370|FG001|Overall Study|Withdrawal by Subject|1|||
147445008|NCT02285777|531794369|FG000|Overall Study|Lost to Follow-up|4|||
147445009|NCT02285777|531794370|FG001|Overall Study|Lost to Follow-up|2|||
147445010|NCT03201458|531794371|FG000|Overall Study|No longer eligible|2|||
147445011|NCT03201458|531794372|FG001|Overall Study|No longer eligible|5|||
147445012|NCT03201458|531794371|FG000|Overall Study|Health event before starting|1|||
147445013|NCT03201458|531794372|FG001|Overall Study|Health event before starting|0|||
147445014|NCT03201458|531794371|FG000|Overall Study|Physician Decision|1|||
147445015|NCT03201458|531794372|FG001|Overall Study|Physician Decision|0|||
147445016|NCT00715026|531794375|FG000|Overall Study|Withdrawal by Subject|5|||
147445017|NCT00715026|531794375|FG000|Overall Study|Lost to Follow-up|3|||
147445018|NCT00715026|531794375|FG000|Overall Study|Protocol Violation|1|||
147445019|NCT00715026|531794375|FG000|Overall Study|Surgery done on non-study consented hip|1|||
147445020|NCT00552175|531794376|FG000|Overall Study|Lack of Efficacy|2|||
147445021|NCT00552175|531794377|FG001|Overall Study|Lack of Efficacy|0|||
147445022|NCT00552175|531794378|FG002|Overall Study|Lack of Efficacy|1|||
147445023|NCT00552175|531794376|FG000|Overall Study|Adverse Event|9|||
147445024|NCT00552175|531794377|FG001|Overall Study|Adverse Event|9|||
147445025|NCT00552175|531794378|FG002|Overall Study|Adverse Event|10|||
147445026|NCT00552175|531794376|FG000|Overall Study|Withdrawal by Subject|2|||
147445027|NCT00552175|531794377|FG001|Overall Study|Withdrawal by Subject|2|||
147445028|NCT00552175|531794378|FG002|Overall Study|Withdrawal by Subject|1|||
147445029|NCT00552175|531794376|FG000|Overall Study|Lost to Follow-up|0|||
147445030|NCT00552175|531794377|FG001|Overall Study|Lost to Follow-up|0|||
147445031|NCT00552175|531794378|FG002|Overall Study|Lost to Follow-up|1|||
147445032|NCT00552175|531794376|FG000|Overall Study|Entry Criteria Not Met|1|||
147445033|NCT00552175|531794377|FG001|Overall Study|Entry Criteria Not Met|1|||
147445034|NCT00552175|531794378|FG002|Overall Study|Entry Criteria Not Met|0|||
147445035|NCT00552175|531794376|FG000|Overall Study|Reason Not Specified|3|||
147445036|NCT00552175|531794377|FG001|Overall Study|Reason Not Specified|1|||
147445037|NCT00552175|531794378|FG002|Overall Study|Reason Not Specified|1|||
147445038|NCT00750737|531794379|FG000|Overall Study|Withdrawal by Subject|3|||
147445039|NCT00750737|531794380|FG001|Overall Study|Withdrawal by Subject|3|||
147445040|NCT02614859|531794381|FG000|Overall Study|Physician Decision|0|||
147445041|NCT02614859|531794382|FG001|Overall Study|Physician Decision|1|||
147445042|NCT03972969|531794384|FG000|3-month Follow-up|Death|1|||
147445043|NCT03972969|531794385|FG001|3-month Follow-up|Death|1|||
147445044|NCT03972969|531794386|FG002|3-month Follow-up|Death|0|||
147445045|NCT03972969|531794384|FG000|6-month Follow-up|Death|1|||
147445046|NCT03972969|531794385|FG001|6-month Follow-up|Death|1|||
147445047|NCT03972969|531794386|FG002|6-month Follow-up|Death|1|||
147445048|NCT03972969|531794384|FG000|6-month Follow-up|Lost to Follow-up|2|||
147445049|NCT03972969|531794385|FG001|6-month Follow-up|Lost to Follow-up|2|||
147445050|NCT03972969|531794386|FG002|6-month Follow-up|Lost to Follow-up|2|||
147445051|NCT04607148|531794389|FG000|Overall Study|Withdrawal by Subject|0|||
147445052|NCT04607148|531794390|FG001|Overall Study|Withdrawal by Subject|4|||
147445053|NCT04607148|531794391|FG002|Overall Study|Withdrawal by Subject|2|||
147445054|NCT04607148|531794392|FG003|Overall Study|Withdrawal by Subject|8|||
147445055|NCT04607148|531794389|FG000|Overall Study|Study Terminated by Sponsor|14|||
147445056|NCT04607148|531794390|FG001|Overall Study|Study Terminated by Sponsor|59|||
147651329|NCT00385827|532546432|FG001|Part 2|Other|11|||
147651330|NCT00385827|532546433|FG002|Part 2|Other|21|||
147651331|NCT04227405|532546434|FG000|Enrollment - Time 1 PreTest|Schedule conflict /uninterested/Barriers|26|||
147130323|NCT02958865|530644522|FG004|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
147130324|NCT02958865|530644523|FG005|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
147130325|NCT02958865|530644524|FG006|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
147130326|NCT02958865|530644525|FG007|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
147130327|NCT02958865|530644526|FG008|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|2|||
147130328|NCT02958865|530644527|FG009|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|1|||
147130329|NCT02958865|530644528|FG010|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
147130330|NCT02958865|530644529|FG011|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|5|||
147130331|NCT02958865|530644530|FG012|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
147130332|NCT02958865|530644531|FG013|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|2|||
147130333|NCT02958865|530644532|FG014|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|0|||
147130334|NCT02958865|530644533|FG015|Chronic Period (Week 8 to Week 32)|Lack of Efficacy|8|||
147130335|NCT02958865|530644518|FG000|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
147130336|NCT02958865|530644519|FG001|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
147445057|NCT04607148|531794391|FG002|Overall Study|Study Terminated by Sponsor|9|||
147445058|NCT04607148|531794392|FG003|Overall Study|Study Terminated by Sponsor|39|||
147445059|NCT04607148|531794389|FG000|Overall Study|Sponsor Decision|0|||
147445060|NCT04607148|531794390|FG001|Overall Study|Sponsor Decision|0|||
147445061|NCT04607148|531794391|FG002|Overall Study|Sponsor Decision|1|||
147445062|NCT04607148|531794392|FG003|Overall Study|Sponsor Decision|0|||
147445063|NCT04607148|531794389|FG000|Overall Study|Non-Compliance With Study Drug|0|||
147445064|NCT04607148|531794390|FG001|Overall Study|Non-Compliance With Study Drug|1|||
147445065|NCT04607148|531794391|FG002|Overall Study|Non-Compliance With Study Drug|0|||
147445066|NCT04607148|531794392|FG003|Overall Study|Non-Compliance With Study Drug|0|||
147445067|NCT04607148|531794389|FG000|Overall Study|Lost to Follow-up|0|||
147445068|NCT04607148|531794390|FG001|Overall Study|Lost to Follow-up|2|||
147445069|NCT04607148|531794391|FG002|Overall Study|Lost to Follow-up|0|||
147445070|NCT04607148|531794392|FG003|Overall Study|Lost to Follow-up|0|||
147445071|NCT04607148|531794389|FG000|Overall Study|Death|0|||
147445072|NCT04607148|531794390|FG001|Overall Study|Death|3|||
147445073|NCT04607148|531794391|FG002|Overall Study|Death|0|||
147445074|NCT04607148|531794392|FG003|Overall Study|Death|1|||
147445075|NCT04607148|531794389|FG000|Overall Study|Adverse Event|0|||
147445076|NCT04607148|531794390|FG001|Overall Study|Adverse Event|1|||
147445077|NCT04607148|531794391|FG002|Overall Study|Adverse Event|0|||
147445078|NCT04607148|531794392|FG003|Overall Study|Adverse Event|0|||
147445079|NCT04251910|531794393|FG000|Overall Study|Covid 19 lockdown|0|||
147445080|NCT04251910|531794394|FG001|Overall Study|Covid 19 lockdown|5|||
147445081|NCT04251910|531794395|FG002|Overall Study|Covid 19 lockdown|0|||
147445082|NCT04251910|531794396|FG003|Overall Study|Covid 19 lockdown|4|||
147445083|NCT04251910|531794397|FG004|Overall Study|Covid 19 lockdown|0|||
147445084|NCT04251910|531794398|FG005|Overall Study|Covid 19 lockdown|0|||
147445085|NCT04251910|531794393|FG000|Overall Study|Assisted living facility was closed|0|||
147445086|NCT04251910|531794394|FG001|Overall Study|Assisted living facility was closed|0|||
147445087|NCT04251910|531794395|FG002|Overall Study|Assisted living facility was closed|0|||
147445088|NCT04251910|531794396|FG003|Overall Study|Assisted living facility was closed|0|||
147445089|NCT04251910|531794397|FG004|Overall Study|Assisted living facility was closed|1|||
147445090|NCT04251910|531794398|FG005|Overall Study|Assisted living facility was closed|0|||
147445091|NCT00916149|531794399|FG000|Overall Study|Lost to Follow-up|3|||
147445092|NCT00916149|531794400|FG001|Overall Study|Lost to Follow-up|2|||
147445093|NCT00916149|531794401|FG002|Overall Study|Lost to Follow-up|0|||
147445094|NCT00916149|531794399|FG000|Overall Study|Unable to place scalp EEG leads|1|||
147445095|NCT00916149|531794400|FG001|Overall Study|Unable to place scalp EEG leads|0|||
147445096|NCT00916149|531794401|FG002|Overall Study|Unable to place scalp EEG leads|0|||
147445097|NCT00841568|531794402|FG000|Overall Study|Adverse Event|1|||
147445098|NCT00841568|531794402|FG000|Overall Study|Death|1|||
147445099|NCT00841568|531794402|FG000|Overall Study|Withdrawal by Subject|2|||
147445100|NCT00841568|531794402|FG000|Overall Study|Creatinine over the withdrawal criteria|1|||
147445101|NCT03002155|531794403|FG000|Overall Study|Lost to Follow-up|1|||
147445102|NCT03002155|531794404|FG001|Overall Study|Lost to Follow-up|2|||
147445103|NCT03002155|531794403|FG000|Overall Study|Withdrawal by Subject|1|||
147445104|NCT03002155|531794404|FG001|Overall Study|Withdrawal by Subject|0|||
147445105|NCT03002155|531794403|FG000|Overall Study|Found to not meet inclusion criteria during baseline session data collection.|1|||
147445106|NCT03002155|531794404|FG001|Overall Study|Found to not meet inclusion criteria during baseline session data collection.|1|||
147445107|NCT00978029|531794405|FG000|Overall Study|Adverse Event|1|||
147445108|NCT00978029|531794406|FG001|Overall Study|Adverse Event|2|||
147445109|NCT00978029|531794407|FG002|Overall Study|Adverse Event|5|||
147445110|NCT00978029|531794405|FG000|Overall Study|Withdrawal by Subject|0|||
147445111|NCT00978029|531794406|FG001|Overall Study|Withdrawal by Subject|0|||
147445112|NCT00978029|531794407|FG002|Overall Study|Withdrawal by Subject|1|||
147445113|NCT00978029|531794405|FG000|Overall Study|Protocol Violation|0|||
147445114|NCT00978029|531794406|FG001|Overall Study|Protocol Violation|1|||
147317407|NCT02601937|531327362|FG004|Period 2: Dose Expansion Cohort|Physician Decision|0|||
147317408|NCT02601937|531327363|FG005|Period 2: Dose Expansion Cohort|Physician Decision|0|||
147317409|NCT02601937|531327364|FG006|Period 2: Dose Expansion Cohort|Physician Decision|0|||
147317410|NCT02601937|531327365|FG007|Period 2: Dose Expansion Cohort|Physician Decision|0|||
147317411|NCT02601937|531327366|FG008|Period 2: Dose Expansion Cohort|Physician Decision|0|||
147569433|NCT00968812|532241658|FG001|Overall Study|Creatinine or eGFR withdrawal criteria|13|||
147569434|NCT00968812|532241659|FG002|Overall Study|Creatinine or eGFR withdrawal criteria|7|||
147569435|NCT00968812|532241657|FG000|Overall Study|Noncompliance with study drug|4|||
147569436|NCT00968812|532241658|FG001|Overall Study|Noncompliance with study drug|1|||
147569437|NCT00968812|532241659|FG002|Overall Study|Noncompliance with study drug|6|||
147569438|NCT00968812|532241657|FG000|Overall Study|Unable to take rescue therapy|12|||
147569439|NCT00968812|532241658|FG001|Overall Study|Unable to take rescue therapy|12|||
147569440|NCT00968812|532241659|FG002|Overall Study|Unable to take rescue therapy|17|||
147569441|NCT00968812|532241657|FG000|Overall Study|Other|25|||
147569442|NCT00968812|532241658|FG001|Overall Study|Other|37|||
147569443|NCT00968812|532241659|FG002|Overall Study|Other|40|||
147569444|NCT00571064|532241662|FG000|Overall Study|Adverse Event|13|||
147569445|NCT00571064|532241662|FG000|Overall Study|Protocol Violation|4|||
147569446|NCT00571064|532241662|FG000|Overall Study|Withdrawal by Subject|2|||
147569447|NCT00571064|532241662|FG000|Overall Study|Other|2|||
147569448|NCT00003659|532241669|FG000|Overall Study|Withdrawal by Subject|3|||
147569449|NCT04022954|532241670|FG000|Consented to Completed Procedure|Consented Screen Failure|1|||
147569450|NCT04022954|532241670|FG000|Completed 12-month Follow-up|Lost to Follow-up|5|||
147569451|NCT04022954|532241670|FG000|Completed 12-month Follow-up|Withdrawal by Subject|3|||
147569452|NCT03017885|532241671|FG000|Overall Study|Adverse Event|2|||
147569453|NCT03017885|532241672|FG001|Overall Study|Adverse Event|0|||
147569454|NCT03017885|532241673|FG002|Overall Study|Adverse Event|0|||
147569455|NCT03017885|532241674|FG003|Overall Study|Adverse Event|0|||
147569456|NCT03017885|532241675|FG004|Overall Study|Adverse Event|0|||
147317412|NCT02601937|531327367|FG009|Period 2: Dose Expansion Cohort|Physician Decision|1|||
147317413|NCT02601937|531327368|FG010|Period 2: Dose Expansion Cohort|Physician Decision|1|||
147317414|NCT02601937|531327358|FG000|Period 2: Dose Expansion Cohort|Progressive disease|0|||
147569457|NCT03017885|532241676|FG005|Overall Study|Adverse Event|0|||
147569458|NCT03017885|532241671|FG000|Overall Study|Progression of disease|4|||
147569459|NCT03017885|532241672|FG001|Overall Study|Progression of disease|3|||
147569460|NCT03017885|532241673|FG002|Overall Study|Progression of disease|4|||
147569461|NCT03017885|532241674|FG003|Overall Study|Progression of disease|0|||
147569462|NCT03017885|532241675|FG004|Overall Study|Progression of disease|0|||
147235929|NCT02468674|531035484|FG005|Overall Study|Lost to Follow-up|0|||
147235930|NCT02468674|531035485|FG006|Overall Study|Lost to Follow-up|0|||
147235931|NCT02468674|531035486|FG007|Overall Study|Lost to Follow-up|1|||
147235932|NCT02468674|531035487|FG008|Overall Study|Lost to Follow-up|1|||
147235933|NCT02468674|531035479|FG000|Overall Study|Physician Decision|0|||
147235934|NCT02468674|531035480|FG001|Overall Study|Physician Decision|0|||
147235935|NCT02468674|531035481|FG002|Overall Study|Physician Decision|0|||
147235936|NCT02468674|531035482|FG003|Overall Study|Physician Decision|0|||
147235937|NCT02468674|531035483|FG004|Overall Study|Physician Decision|0|||
147235938|NCT02468674|531035484|FG005|Overall Study|Physician Decision|0|||
147235939|NCT02468674|531035485|FG006|Overall Study|Physician Decision|1|||
147235940|NCT02468674|531035486|FG007|Overall Study|Physician Decision|0|||
147235941|NCT02468674|531035487|FG008|Overall Study|Physician Decision|0|||
147235942|NCT02468674|531035479|FG000|Overall Study|Patient/Guardian Decision|0|||
147235943|NCT02468674|531035480|FG001|Overall Study|Patient/Guardian Decision|0|||
147235944|NCT02468674|531035481|FG002|Overall Study|Patient/Guardian Decision|0|||
147235945|NCT02468674|531035482|FG003|Overall Study|Patient/Guardian Decision|0|||
147235946|NCT02468674|531035483|FG004|Overall Study|Patient/Guardian Decision|1|||
147235947|NCT02468674|531035484|FG005|Overall Study|Patient/Guardian Decision|0|||
147235948|NCT02468674|531035485|FG006|Overall Study|Patient/Guardian Decision|0|||
147235949|NCT02468674|531035486|FG007|Overall Study|Patient/Guardian Decision|2|||
147235950|NCT02468674|531035487|FG008|Overall Study|Patient/Guardian Decision|1|||
147235951|NCT02468674|531035479|FG000|Overall Study|Protocol Deviation|0|||
147235952|NCT02468674|531035480|FG001|Overall Study|Protocol Deviation|0|||
147235953|NCT02468674|531035481|FG002|Overall Study|Protocol Deviation|0|||
147235954|NCT02468674|531035482|FG003|Overall Study|Protocol Deviation|0|||
147235955|NCT02468674|531035483|FG004|Overall Study|Protocol Deviation|0|||
147235956|NCT02468674|531035484|FG005|Overall Study|Protocol Deviation|0|||
147235957|NCT02468674|531035485|FG006|Overall Study|Protocol Deviation|0|||
147235958|NCT02468674|531035486|FG007|Overall Study|Protocol Deviation|1|||
147235959|NCT02468674|531035487|FG008|Overall Study|Protocol Deviation|1|||
147235960|NCT03281577|531035489|FG000|Overall Study|Adverse Event|0|||
147235961|NCT03281577|531035490|FG001|Overall Study|Adverse Event|0|||
147569463|NCT03017885|532241676|FG005|Overall Study|Progression of disease|0|||
147569464|NCT03017885|532241671|FG000|Overall Study|Other than listed|1|||
147569465|NCT03017885|532241672|FG001|Overall Study|Other than listed|2|||
147235962|NCT03281577|531035491|FG002|Overall Study|Adverse Event|0|||
147235963|NCT03281577|531035492|FG003|Overall Study|Adverse Event|1|||
147569466|NCT03017885|532241673|FG002|Overall Study|Other than listed|1|||
147569467|NCT03017885|532241674|FG003|Overall Study|Other than listed|0|||
147569468|NCT03017885|532241675|FG004|Overall Study|Other than listed|0|||
147569469|NCT03017885|532241676|FG005|Overall Study|Other than listed|0|||
147569470|NCT03017885|532241671|FG000|Overall Study|Lost to Follow-up|2|||
147569471|NCT03017885|532241672|FG001|Overall Study|Lost to Follow-up|0|||
147569472|NCT03017885|532241673|FG002|Overall Study|Lost to Follow-up|3|||
147569473|NCT03017885|532241674|FG003|Overall Study|Lost to Follow-up|0|||
147569474|NCT03017885|532241675|FG004|Overall Study|Lost to Follow-up|0|||
147569475|NCT03017885|532241676|FG005|Overall Study|Lost to Follow-up|0|||
147569476|NCT03017885|532241671|FG000|Overall Study|Change to other anti-cancer therapy|0|||
147235964|NCT03281577|531035489|FG000|Overall Study|Withdrawal by Subject|1|||
147235965|NCT03281577|531035490|FG001|Overall Study|Withdrawal by Subject|0|||
147235966|NCT03281577|531035491|FG002|Overall Study|Withdrawal by Subject|0|||
147569477|NCT03017885|532241672|FG001|Overall Study|Change to other anti-cancer therapy|0|||
147569478|NCT03017885|532241673|FG002|Overall Study|Change to other anti-cancer therapy|1|||
147569479|NCT03017885|532241674|FG003|Overall Study|Change to other anti-cancer therapy|0|||
147569480|NCT03017885|532241675|FG004|Overall Study|Change to other anti-cancer therapy|0|||
147569481|NCT03017885|532241676|FG005|Overall Study|Change to other anti-cancer therapy|0|||
147569482|NCT02258074|532241678|FG000|Overall Study|Withdrawal by Subject|1|||
147569483|NCT02258074|532241679|FG001|Overall Study|Withdrawal by Subject|0|||
147569484|NCT02258074|532241680|FG002|Overall Study|Withdrawal by Subject|0|||
147569485|NCT02258074|532241681|FG003|Overall Study|Withdrawal by Subject|0|||
147569486|NCT05446870|532241682|FG000|Overall Study|Death|6|||
147569487|NCT05446870|532241683|FG001|Overall Study|Death|5|||
147569488|NCT05446870|532241682|FG000|Overall Study|Lost to Follow-up|0|||
147569489|NCT05446870|532241683|FG001|Overall Study|Lost to Follow-up|1|||
147569490|NCT05446870|532241682|FG000|Overall Study|Physician Decision|52|||
147569491|NCT05446870|532241683|FG001|Overall Study|Physician Decision|53|||
147569492|NCT05446870|532241682|FG000|Overall Study|Withdrawal by Subject|3|||
147569493|NCT05446870|532241683|FG001|Overall Study|Withdrawal by Subject|3|||
147569494|NCT04108858|532241685|FG000|Overall Study|Adverse Event|1|||
147569495|NCT01005745|532241686|FG000|Overall Study|No TIL growth|1|||
147569496|NCT01005745|532241686|FG000|Overall Study|Disease progressed during TIL growth|3|||
147569497|NCT01005745|532241686|FG000|Overall Study|Death prior to treatment|1|||
147569498|NCT01005745|532241686|FG000|Overall Study|Inappropriate antidiuretic hormone|1|||
147569499|NCT01208337|532241694|FG000|Overall Study|Death|3|||
147569500|NCT03663179|532241695|FG000|Overall Study|Withdrawal by Subject|2|||
147569501|NCT03663179|532241696|FG001|Overall Study|Withdrawal by Subject|0|||
147569502|NCT03663179|532241695|FG000|Overall Study|Lost to Follow-up|1|||
147569503|NCT03663179|532241696|FG001|Overall Study|Lost to Follow-up|1|||
147569504|NCT03663179|532241695|FG000|Overall Study|Revealed exclusionary condition|1|||
147569505|NCT03663179|532241696|FG001|Overall Study|Revealed exclusionary condition|0|||
147569506|NCT01615198|532241700|FG000|Overall Study|Withdrawal by Subject|5|||
147569507|NCT01615198|532241701|FG001|Overall Study|Withdrawal by Subject|5|||
147569508|NCT01615198|532241700|FG000|Overall Study|Protocol deviation|1|||
147569509|NCT01615198|532241701|FG001|Overall Study|Protocol deviation|1|||
147569510|NCT01615198|532241700|FG000|Overall Study|Physician Decision|5|||
147569511|NCT01615198|532241701|FG001|Overall Study|Physician Decision|1|||
147569512|NCT01615198|532241700|FG000|Overall Study|Lost to Follow-up|1|||
147569513|NCT01615198|532241701|FG001|Overall Study|Lost to Follow-up|1|||
147569514|NCT01615198|532241700|FG000|Overall Study|Lack of Efficacy|1|||
147569515|NCT01615198|532241701|FG001|Overall Study|Lack of Efficacy|6|||
147569516|NCT01615198|532241700|FG000|Overall Study|Adverse Event|11|||
147569517|NCT01615198|532241701|FG001|Overall Study|Adverse Event|5|||
147569518|NCT01686438|532241702|FG000|Overall Study|Lost to Follow-up|8|||
147569519|NCT01686438|532241703|FG001|Overall Study|Lost to Follow-up|9|||
147569520|NCT01686438|532241704|FG002|Overall Study|Lost to Follow-up|10|||
147569521|NCT01686438|532241702|FG000|Overall Study|Adverse Event|0|||
147569522|NCT01686438|532241703|FG001|Overall Study|Adverse Event|0|||
147569523|NCT01686438|532241704|FG002|Overall Study|Adverse Event|1|||
147569524|NCT01686438|532241702|FG000|Overall Study|Protocol Violation|0|||
147569525|NCT01686438|532241703|FG001|Overall Study|Protocol Violation|0|||
147569526|NCT01686438|532241704|FG002|Overall Study|Protocol Violation|1|||
147569527|NCT01686438|532241702|FG000|Overall Study|Withdrawal by Subject|0|||
147569528|NCT01686438|532241703|FG001|Overall Study|Withdrawal by Subject|0|||
147569529|NCT01686438|532241704|FG002|Overall Study|Withdrawal by Subject|1|||
147569530|NCT00984126|532241705|FG000|Overall Study|Protocol Violation|0|||
147569531|NCT00984126|532241706|FG001|Overall Study|Protocol Violation|0|||
147569532|NCT00984126|532241707|FG002|Overall Study|Protocol Violation|1|||
147569533|NCT00984126|532241708|FG003|Overall Study|Protocol Violation|2|||
147569534|NCT00984126|532241705|FG000|Overall Study|Adverse Event|0|||
147235967|NCT03281577|531035492|FG003|Overall Study|Withdrawal by Subject|0|||
147569535|NCT00984126|532241706|FG001|Overall Study|Adverse Event|0|||
147569536|NCT00984126|532241707|FG002|Overall Study|Adverse Event|0|||
147569537|NCT00984126|532241708|FG003|Overall Study|Adverse Event|2|||
147569538|NCT00984126|532241705|FG000|Overall Study|Choose to join Pathfinder trial™ + other|7|||
147569539|NCT00984126|532241706|FG001|Overall Study|Choose to join Pathfinder trial™ + other|7|||
147569540|NCT00984126|532241707|FG002|Overall Study|Choose to join Pathfinder trial™ + other|3|||
147569541|NCT00984126|532241708|FG003|Overall Study|Choose to join Pathfinder trial™ + other|46|||
147569542|NCT00984126|532241705|FG000|Overall Study|Withdrawal criteria|0|||
147569543|NCT00984126|532241706|FG001|Overall Study|Withdrawal criteria|1|||
147569544|NCT00984126|532241707|FG002|Overall Study|Withdrawal criteria|3|||
147569545|NCT00984126|532241708|FG003|Overall Study|Withdrawal criteria|9|||
147569546|NCT01029340|532241712|FG000|Part B Treatment Period|Withdrawal by Subject|0|||
147569547|NCT01029340|532241713|FG001|Part B Treatment Period|Withdrawal by Subject|0|||
147569548|NCT01029340|532241714|FG002|Part B Treatment Period|Withdrawal by Subject|1|||
147569549|NCT01029340|532241715|FG003|Part B Treatment Period|Withdrawal by Subject|0|||
147569550|NCT01029340|532241716|FG004|Part B Treatment Period|Withdrawal by Subject|0|||
147569551|NCT01029340|532241717|FG005|Part B Treatment Period|Withdrawal by Subject|0|||
147569552|NCT01029340|532241712|FG000|Part B Treatment Period|Protocol Violation|0|||
147569553|NCT01029340|532241713|FG001|Part B Treatment Period|Protocol Violation|0|||
147569554|NCT01029340|532241714|FG002|Part B Treatment Period|Protocol Violation|1|||
147569555|NCT01029340|532241715|FG003|Part B Treatment Period|Protocol Violation|0|||
147569556|NCT01029340|532241716|FG004|Part B Treatment Period|Protocol Violation|0|||
147569557|NCT01029340|532241717|FG005|Part B Treatment Period|Protocol Violation|0|||
147569558|NCT01029340|532241712|FG000|Extension Period|Adverse Event|0|||
147569559|NCT01029340|532241713|FG001|Extension Period|Adverse Event|0|||
147569560|NCT01029340|532241714|FG002|Extension Period|Adverse Event|0|||
147569561|NCT01029340|532241715|FG003|Extension Period|Adverse Event|0|||
147569562|NCT01029340|532241716|FG004|Extension Period|Adverse Event|0|||
147569563|NCT01029340|532241717|FG005|Extension Period|Adverse Event|1|||
147569564|NCT01029340|532241712|FG000|Extension Period|starting another study|0|||
147569565|NCT01029340|532241713|FG001|Extension Period|starting another study|0|||
147569566|NCT01029340|532241714|FG002|Extension Period|starting another study|0|||
147569567|NCT01029340|532241715|FG003|Extension Period|starting another study|0|||
147569568|NCT01029340|532241716|FG004|Extension Period|starting another study|0|||
147569569|NCT01029340|532241717|FG005|Extension Period|starting another study|8|||
147569570|NCT01029340|532241712|FG000|Extension Period|non-compliance|0|||
147569571|NCT01029340|532241713|FG001|Extension Period|non-compliance|0|||
147569572|NCT01029340|532241714|FG002|Extension Period|non-compliance|0|||
147569573|NCT01029340|532241715|FG003|Extension Period|non-compliance|0|||
147569574|NCT01029340|532241716|FG004|Extension Period|non-compliance|0|||
147569575|NCT01029340|532241717|FG005|Extension Period|non-compliance|1|||
147569576|NCT01029340|532241712|FG000|Extension Period|Withdrawal by Subject|0|||
147569577|NCT01029340|532241713|FG001|Extension Period|Withdrawal by Subject|0|||
147569578|NCT01029340|532241714|FG002|Extension Period|Withdrawal by Subject|0|||
147569579|NCT01029340|532241715|FG003|Extension Period|Withdrawal by Subject|0|||
147569580|NCT01029340|532241716|FG004|Extension Period|Withdrawal by Subject|0|||
147569581|NCT01029340|532241717|FG005|Extension Period|Withdrawal by Subject|1|||
147569582|NCT01029340|532241712|FG000|Extension Period|Physician Decision|0|||
147569583|NCT01029340|532241713|FG001|Extension Period|Physician Decision|0|||
147569584|NCT01029340|532241714|FG002|Extension Period|Physician Decision|0|||
147569585|NCT01029340|532241715|FG003|Extension Period|Physician Decision|0|||
147569586|NCT01029340|532241716|FG004|Extension Period|Physician Decision|0|||
147569587|NCT01029340|532241717|FG005|Extension Period|Physician Decision|1|||
147569588|NCT01864174|532241718|FG000|Double Blind Treatment - All Treated|Removed due to site non-compliance|15|||
147569589|NCT01864174|532241719|FG001|Double Blind Treatment - All Treated|Removed due to site non-compliance|14|||
147569590|NCT01864174|532241718|FG000|Double Blind - Compliant Randomized|Adverse Event|6|||
147569591|NCT01864174|532241719|FG001|Double Blind - Compliant Randomized|Adverse Event|1|||
147569592|NCT01864174|532241718|FG000|Double Blind - Compliant Randomized|Subject Request to Discontinue Treatment|2|||
147569593|NCT01864174|532241719|FG001|Double Blind - Compliant Randomized|Subject Request to Discontinue Treatment|0|||
147569594|NCT01864174|532241718|FG000|Double Blind - Compliant Randomized|Subject Withdrew Consent|4|||
147569595|NCT01864174|532241719|FG001|Double Blind - Compliant Randomized|Subject Withdrew Consent|5|||
147317415|NCT02601937|531327359|FG001|Period 2: Dose Expansion Cohort|Progressive disease|0|||
147317416|NCT02601937|531327360|FG002|Period 2: Dose Expansion Cohort|Progressive disease|0|||
147317417|NCT02601937|531327361|FG003|Period 2: Dose Expansion Cohort|Progressive disease|0|||
147317418|NCT02601937|531327362|FG004|Period 2: Dose Expansion Cohort|Progressive disease|0|||
147317419|NCT02601937|531327363|FG005|Period 2: Dose Expansion Cohort|Progressive disease|0|||
147317420|NCT02601937|531327364|FG006|Period 2: Dose Expansion Cohort|Progressive disease|0|||
147317421|NCT02601937|531327365|FG007|Period 2: Dose Expansion Cohort|Progressive disease|16|||
147569596|NCT01864174|532241718|FG000|Double Blind - Compliant Randomized|Death|1|||
147569597|NCT01864174|532241719|FG001|Double Blind - Compliant Randomized|Death|0|||
147569598|NCT01864174|532241718|FG000|Double Blind - Compliant Randomized|Lost to Follow-up|3|||
147569599|NCT01864174|532241719|FG001|Double Blind - Compliant Randomized|Lost to Follow-up|10|||
147569600|NCT01864174|532241718|FG000|Double Blind - Compliant Randomized|Poor/Non-compliance|1|||
147130337|NCT02958865|530644520|FG002|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
147445115|NCT00978029|531794407|FG002|Overall Study|Protocol Violation|0|||
147130338|NCT02958865|530644521|FG003|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
147130339|NCT02958865|530644522|FG004|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
147130340|NCT02958865|530644523|FG005|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
147130341|NCT02958865|530644524|FG006|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
147130342|NCT02958865|530644525|FG007|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
147130343|NCT02958865|530644526|FG008|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
147130344|NCT02958865|530644527|FG009|Chronic Period (Week 8 to Week 32)|Pregnancy|1|||
147130345|NCT02958865|530644528|FG010|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
147130346|NCT02958865|530644529|FG011|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
147130347|NCT02958865|530644530|FG012|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
147130348|NCT02958865|530644531|FG013|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
147130349|NCT02958865|530644532|FG014|Chronic Period (Week 8 to Week 32)|Pregnancy|0|||
147130350|NCT02958865|530644533|FG015|Chronic Period (Week 8 to Week 32)|Pregnancy|1|||
147130351|NCT02958865|530644518|FG000|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
147130352|NCT02958865|530644519|FG001|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
147130353|NCT02958865|530644520|FG002|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
147130354|NCT02958865|530644521|FG003|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
147130355|NCT02958865|530644522|FG004|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
147130356|NCT02958865|530644523|FG005|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
147130357|NCT02958865|530644524|FG006|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
147130358|NCT02958865|530644525|FG007|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
147130359|NCT02958865|530644526|FG008|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
147130360|NCT02958865|530644527|FG009|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
147130361|NCT02958865|530644528|FG010|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|0|||
147130362|NCT02958865|530644529|FG011|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|1|||
147130363|NCT02958865|530644530|FG012|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|6|||
147130364|NCT02958865|530644531|FG013|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|3|||
147130365|NCT02958865|530644532|FG014|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|3|||
147130366|NCT02958865|530644533|FG015|Chronic Period (Week 8 to Week 32)|Withdrawal by Subject|2|||
147130367|NCT02958865|530644518|FG000|Chronic Period (Week 8 to Week 32)|Other|0|||
147235968|NCT01644565|531035493|FG000|Overall Study|Undisclosed Medical History|1|||
147235969|NCT01644565|531035494|FG001|Overall Study|Undisclosed Medical History|0|||
147569601|NCT01864174|532241719|FG001|Double Blind - Compliant Randomized|Poor/Non-compliance|0|||
147569602|NCT01864174|532241718|FG000|Double Blind - Compliant Randomized|Other|6|||
147569603|NCT01864174|532241719|FG001|Double Blind - Compliant Randomized|Other|10|||
147569604|NCT01864174|532241718|FG000|Off Treatment Follow-Up|Other|2|||
147569605|NCT01864174|532241719|FG001|Off Treatment Follow-Up|Other|0|||
147569606|NCT01864174|532241718|FG000|Off Treatment Follow-Up|Subject Withdrew Consent|1|||
147569607|NCT01864174|532241719|FG001|Off Treatment Follow-Up|Subject Withdrew Consent|0|||
147569608|NCT02648347|532241723|FG000|Overall Study|Death|174|||
147569609|NCT02648347|532241724|FG001|Overall Study|Death|167|||
147569610|NCT02648347|532241723|FG000|Overall Study|Withdrawal by Subject|16|||
147569611|NCT02648347|532241724|FG001|Overall Study|Withdrawal by Subject|9|||
147569612|NCT02648347|532241723|FG000|Overall Study|Lost to Follow-up|18|||
147569613|NCT02648347|532241724|FG001|Overall Study|Lost to Follow-up|21|||
147569614|NCT02648347|532241723|FG000|Overall Study|Missing|1|||
147569615|NCT02648347|532241724|FG001|Overall Study|Missing|0|||
147569616|NCT02739997|532241729|FG000|Overall Study|Death|1|||
147569617|NCT02739997|532241729|FG000|Overall Study|Withdrawal by Subject|1|||
147569618|NCT00468286|532241730|FG000|Overall Study|Adverse Event|1|||
147569619|NCT00468286|532241731|FG001|Overall Study|Adverse Event|6|||
147569620|NCT00468286|532241730|FG000|Overall Study|Protocol Violation|2|||
147569621|NCT00468286|532241731|FG001|Overall Study|Protocol Violation|2|||
147569622|NCT00468286|532241730|FG000|Overall Study|Withdrawal by Subject|4|||
147569623|NCT00468286|532241731|FG001|Overall Study|Withdrawal by Subject|3|||
147569624|NCT00468286|532241730|FG000|Overall Study|Physician Decision|0|||
147569625|NCT00468286|532241731|FG001|Overall Study|Physician Decision|1|||
147569626|NCT02196675|532241732|FG000|Overall Study|Withdrawal by Subject|1|||
147569627|NCT02196675|532241733|FG001|Overall Study|Withdrawal by Subject|0|||
147569628|NCT02196675|532241734|FG002|Overall Study|Withdrawal by Subject|0|||
147569629|NCT02196675|532241732|FG000|Overall Study|Intra-operative surgical exclusion|1|||
147569630|NCT02196675|532241733|FG001|Overall Study|Intra-operative surgical exclusion|1|||
147569631|NCT02196675|532241734|FG002|Overall Study|Intra-operative surgical exclusion|0|||
147569632|NCT02196675|532241732|FG000|Overall Study|Protocol Violation|0|||
147235970|NCT01644565|531035495|FG002|Overall Study|Undisclosed Medical History|0|||
147235971|NCT01644565|531035496|FG003|Overall Study|Undisclosed Medical History|0|||
147235972|NCT01644565|531035497|FG004|Overall Study|Undisclosed Medical History|0|||
147235973|NCT01644565|531035498|FG005|Overall Study|Undisclosed Medical History|0|||
147235974|NCT01644565|531035499|FG006|Overall Study|Undisclosed Medical History|0|||
147235975|NCT01644565|531035500|FG007|Overall Study|Undisclosed Medical History|0|||
147235976|NCT01644565|531035501|FG008|Overall Study|Undisclosed Medical History|0|||
147235977|NCT01644565|531035493|FG000|Overall Study|Lost to Follow-up|0|||
147317422|NCT02601937|531327366|FG008|Period 2: Dose Expansion Cohort|Progressive disease|17|||
147569633|NCT02196675|532241733|FG001|Overall Study|Protocol Violation|1|||
147569634|NCT02196675|532241734|FG002|Overall Study|Protocol Violation|0|||
147317423|NCT02601937|531327367|FG009|Period 2: Dose Expansion Cohort|Progressive disease|14|||
147317424|NCT02601937|531327368|FG010|Period 2: Dose Expansion Cohort|Progressive disease|4|||
147317425|NCT02601937|531327358|FG000|Period 2: Dose Expansion Cohort|Other|0|||
147317426|NCT02601937|531327359|FG001|Period 2: Dose Expansion Cohort|Other|0|||
147317427|NCT02601937|531327360|FG002|Period 2: Dose Expansion Cohort|Other|0|||
147130368|NCT02958865|530644519|FG001|Chronic Period (Week 8 to Week 32)|Other|0|||
147130369|NCT02958865|530644520|FG002|Chronic Period (Week 8 to Week 32)|Other|0|||
147130370|NCT02958865|530644521|FG003|Chronic Period (Week 8 to Week 32)|Other|0|||
147130371|NCT02958865|530644522|FG004|Chronic Period (Week 8 to Week 32)|Other|0|||
147130372|NCT02958865|530644523|FG005|Chronic Period (Week 8 to Week 32)|Other|0|||
147130373|NCT02958865|530644524|FG006|Chronic Period (Week 8 to Week 32)|Other|0|||
147317428|NCT02601937|531327361|FG003|Period 2: Dose Expansion Cohort|Other|0|||
147130374|NCT02958865|530644525|FG007|Chronic Period (Week 8 to Week 32)|Other|1|||
147130375|NCT02958865|530644526|FG008|Chronic Period (Week 8 to Week 32)|Other|0|||
147130376|NCT02958865|530644527|FG009|Chronic Period (Week 8 to Week 32)|Other|1|||
147130377|NCT02958865|530644528|FG010|Chronic Period (Week 8 to Week 32)|Other|0|||
147130378|NCT02958865|530644529|FG011|Chronic Period (Week 8 to Week 32)|Other|0|||
147130379|NCT02958865|530644530|FG012|Chronic Period (Week 8 to Week 32)|Other|1|||
147130380|NCT02958865|530644531|FG013|Chronic Period (Week 8 to Week 32)|Other|0|||
147130381|NCT02958865|530644532|FG014|Chronic Period (Week 8 to Week 32)|Other|0|||
147130382|NCT02958865|530644533|FG015|Chronic Period (Week 8 to Week 32)|Other|1|||
147130383|NCT02958865|530644518|FG000|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
147130384|NCT02958865|530644519|FG001|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
147130385|NCT02958865|530644520|FG002|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
147130386|NCT02958865|530644521|FG003|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
147235978|NCT01644565|531035494|FG001|Overall Study|Lost to Follow-up|0|||
147235979|NCT01644565|531035495|FG002|Overall Study|Lost to Follow-up|0|||
147235980|NCT01644565|531035496|FG003|Overall Study|Lost to Follow-up|1|||
147235981|NCT01644565|531035497|FG004|Overall Study|Lost to Follow-up|0|||
147235982|NCT01644565|531035498|FG005|Overall Study|Lost to Follow-up|0|||
147235983|NCT01644565|531035499|FG006|Overall Study|Lost to Follow-up|0|||
147235984|NCT01644565|531035500|FG007|Overall Study|Lost to Follow-up|2|||
147235985|NCT01644565|531035501|FG008|Overall Study|Lost to Follow-up|0|||
147235986|NCT01644565|531035493|FG000|Overall Study|Family emergency|0|||
147235987|NCT01644565|531035494|FG001|Overall Study|Family emergency|0|||
147235988|NCT01644565|531035495|FG002|Overall Study|Family emergency|0|||
147235989|NCT01644565|531035496|FG003|Overall Study|Family emergency|0|||
147235990|NCT01644565|531035497|FG004|Overall Study|Family emergency|1|||
147317429|NCT02601937|531327362|FG004|Period 2: Dose Expansion Cohort|Other|0|||
147317430|NCT02601937|531327363|FG005|Period 2: Dose Expansion Cohort|Other|0|||
147317431|NCT02601937|531327364|FG006|Period 2: Dose Expansion Cohort|Other|0|||
147317432|NCT02601937|531327365|FG007|Period 2: Dose Expansion Cohort|Other|0|||
147317433|NCT02601937|531327366|FG008|Period 2: Dose Expansion Cohort|Other|2|||
147317434|NCT02601937|531327367|FG009|Period 2: Dose Expansion Cohort|Other|2|||
147317435|NCT02601937|531327368|FG010|Period 2: Dose Expansion Cohort|Other|0|||
147317436|NCT02601937|531327358|FG000|Period 2: Dose Expansion Cohort|Death|0|||
147317437|NCT02601937|531327359|FG001|Period 2: Dose Expansion Cohort|Death|0|||
147317438|NCT02601937|531327360|FG002|Period 2: Dose Expansion Cohort|Death|0|||
147317439|NCT02601937|531327361|FG003|Period 2: Dose Expansion Cohort|Death|0|||
147317440|NCT02601937|531327362|FG004|Period 2: Dose Expansion Cohort|Death|0|||
147317441|NCT02601937|531327363|FG005|Period 2: Dose Expansion Cohort|Death|0|||
147317442|NCT02601937|531327364|FG006|Period 2: Dose Expansion Cohort|Death|0|||
147317443|NCT02601937|531327365|FG007|Period 2: Dose Expansion Cohort|Death|0|||
147317444|NCT02601937|531327366|FG008|Period 2: Dose Expansion Cohort|Death|1|||
147317445|NCT02601937|531327367|FG009|Period 2: Dose Expansion Cohort|Death|0|||
147317446|NCT02601937|531327368|FG010|Period 2: Dose Expansion Cohort|Death|0|||
147445116|NCT02830776|531794408|FG000|Overall Study|Lost to Follow-up|1|||
147445117|NCT01793142|531794409|FG000|Overall Study|Randomized not treated|7|||
147445118|NCT01820364|531794410|FG000|Part I: LGX818|Death|1|||
147445119|NCT01820364|531794411|FG001|Part I: LGX818|Death|0|||
147445120|NCT01820364|531794410|FG000|Part I: LGX818|Administrative Problems|3|||
147445121|NCT01820364|531794411|FG001|Part I: LGX818|Administrative Problems|0|||
147445122|NCT01820364|531794410|FG000|Part I: LGX818|Adverse Event|6|||
147445123|NCT01820364|531794411|FG001|Part I: LGX818|Adverse Event|0|||
147445124|NCT01820364|531794410|FG000|Part I: LGX818|Disease Progression|4|||
147445125|NCT01820364|531794411|FG001|Part I: LGX818|Disease Progression|0|||
147445126|NCT01820364|531794410|FG000|Part II: LGX818 + MEK162|Study Termination|0|||
147445127|NCT01820364|531794411|FG001|Part II: LGX818 + MEK162|Study Termination|1|||
147445128|NCT03451084|531794412|FG000|Overall Study|Withdrawal by Subject|2|||
147445129|NCT03451084|531794413|FG001|Overall Study|Withdrawal by Subject|1|||
147445130|NCT03451084|531794414|FG002|Overall Study|Withdrawal by Subject|2|||
147445131|NCT03451084|531794415|FG003|Overall Study|Withdrawal by Subject|1|||
147445132|NCT03451084|531794412|FG000|Overall Study|Disease recurrence|0|||
147445133|NCT03451084|531794413|FG001|Overall Study|Disease recurrence|2|||
147445134|NCT03451084|531794414|FG002|Overall Study|Disease recurrence|0|||
147445135|NCT03451084|531794415|FG003|Overall Study|Disease recurrence|0|||
147317447|NCT03615482|531329282|FG000|Overall Study|Death|1|||
147317448|NCT03615482|531329283|FG001|Overall Study|Death|0|||
147317449|NCT03615482|531329282|FG000|Overall Study|Lost to Follow-up|7|||
147317450|NCT03615482|531329283|FG001|Overall Study|Lost to Follow-up|7|||
147317451|NCT03615482|531329282|FG000|Overall Study|Physician Decision|2|||
147317452|NCT03615482|531329283|FG001|Overall Study|Physician Decision|3|||
147569635|NCT02196675|532241732|FG000|Overall Study|Death|0|||
147569636|NCT02196675|532241733|FG001|Overall Study|Death|0|||
147569637|NCT02196675|532241734|FG002|Overall Study|Death|1|||
147569638|NCT00359281|532241735|FG000|Overall Study|Adverse Event|1|||
147569639|NCT00359281|532241736|FG001|Overall Study|Adverse Event|0|||
147569640|NCT00359281|532241737|FG002|Overall Study|Adverse Event|0|||
147569641|NCT00359281|532241738|FG003|Overall Study|Adverse Event|0|||
147569642|NCT00359281|532241739|FG004|Overall Study|Adverse Event|0|||
147569643|NCT00359281|532241740|FG005|Overall Study|Adverse Event|0|||
147569644|NCT00359281|532241741|FG006|Overall Study|Adverse Event|1|||
147569645|NCT00359281|532241742|FG007|Overall Study|Adverse Event|0|||
147569646|NCT00359281|532241743|FG008|Overall Study|Adverse Event|0|||
147569647|NCT00359281|532241735|FG000|Overall Study|Withdrawal by Subject|0|||
147569648|NCT00359281|532241736|FG001|Overall Study|Withdrawal by Subject|0|||
147569649|NCT00359281|532241737|FG002|Overall Study|Withdrawal by Subject|0|||
147569650|NCT00359281|532241738|FG003|Overall Study|Withdrawal by Subject|0|||
147569651|NCT00359281|532241739|FG004|Overall Study|Withdrawal by Subject|0|||
147569652|NCT00359281|532241740|FG005|Overall Study|Withdrawal by Subject|0|||
147569653|NCT00359281|532241741|FG006|Overall Study|Withdrawal by Subject|1|||
147569654|NCT00359281|532241742|FG007|Overall Study|Withdrawal by Subject|0|||
147569655|NCT00359281|532241743|FG008|Overall Study|Withdrawal by Subject|0|||
147569656|NCT01474551|532241744|FG000|Overall Study|Death|1|||
147569657|NCT03686033|532241756|FG000|Treatment Period 2 (1 Day)|Adverse Event|0|||
147569658|NCT03686033|532241757|FG001|Treatment Period 2 (1 Day)|Adverse Event|0|||
147569659|NCT03686033|532241758|FG002|Treatment Period 2 (1 Day)|Adverse Event|0|||
147569660|NCT03686033|532241759|FG003|Treatment Period 2 (1 Day)|Adverse Event|0|||
147569661|NCT03686033|532241760|FG004|Treatment Period 2 (1 Day)|Adverse Event|1|||
147569662|NCT03686033|532241761|FG005|Treatment Period 2 (1 Day)|Adverse Event|0|||
147569663|NCT01854047|532241762|FG000|Overall Study|Lack of Efficacy|1|||
147569664|NCT01854047|532241763|FG001|Overall Study|Lack of Efficacy|0|||
147569665|NCT01854047|532241764|FG002|Overall Study|Lack of Efficacy|0|||
147569666|NCT01854047|532241765|FG003|Overall Study|Lack of Efficacy|0|||
147569667|NCT01854047|532241766|FG004|Overall Study|Lack of Efficacy|0|||
147569668|NCT01854047|532241762|FG000|Overall Study|Poor compliance to protocol|3|||
147569669|NCT01854047|532241763|FG001|Overall Study|Poor compliance to protocol|0|||
147569670|NCT01854047|532241764|FG002|Overall Study|Poor compliance to protocol|2|||
147569671|NCT01854047|532241765|FG003|Overall Study|Poor compliance to protocol|0|||
147569672|NCT01854047|532241766|FG004|Overall Study|Poor compliance to protocol|0|||
147569673|NCT01854047|532241762|FG000|Overall Study|Adverse Event|5|||
147569674|NCT01854047|532241763|FG001|Overall Study|Adverse Event|4|||
147569675|NCT01854047|532241764|FG002|Overall Study|Adverse Event|6|||
147569676|NCT01854047|532241765|FG003|Overall Study|Adverse Event|10|||
147569677|NCT01854047|532241766|FG004|Overall Study|Adverse Event|7|||
147569678|NCT01854047|532241762|FG000|Overall Study|Randomized but not treated|0|||
147569679|NCT01854047|532241763|FG001|Overall Study|Randomized but not treated|1|||
147569680|NCT01854047|532241764|FG002|Overall Study|Randomized but not treated|2|||
147569681|NCT01854047|532241765|FG003|Overall Study|Randomized but not treated|0|||
147569682|NCT01854047|532241766|FG004|Overall Study|Randomized but not treated|4|||
147317453|NCT03615482|531329282|FG000|Overall Study|Withdrawal by Subject|7|||
147317454|NCT03615482|531329283|FG001|Overall Study|Withdrawal by Subject|7|||
147569683|NCT01854047|532241762|FG000|Overall Study|Other than specified above|3|||
147569684|NCT01854047|532241763|FG001|Overall Study|Other than specified above|3|||
147569685|NCT01854047|532241764|FG002|Overall Study|Other than specified above|3|||
147569686|NCT01854047|532241765|FG003|Overall Study|Other than specified above|5|||
147569687|NCT01854047|532241766|FG004|Overall Study|Other than specified above|8|||
147569688|NCT01045161|532241767|FG000|Part A - 12 Weeks Double Blind Treatment|Withdrawal by Subject|8|||
147569689|NCT01045161|532241768|FG001|Part A - 12 Weeks Double Blind Treatment|Withdrawal by Subject|12|||
147569690|NCT01045161|532241769|FG002|Part A - 12 Weeks Double Blind Treatment|Withdrawal by Subject|6|||
147569691|NCT01045161|532241767|FG000|Part A - 12 Weeks Double Blind Treatment|Adverse Event|4|||
147569692|NCT01045161|532241768|FG001|Part A - 12 Weeks Double Blind Treatment|Adverse Event|3|||
147569693|NCT01045161|532241769|FG002|Part A - 12 Weeks Double Blind Treatment|Adverse Event|8|||
147569694|NCT01045161|532241767|FG000|Part A - 12 Weeks Double Blind Treatment|Lack of Efficacy|6|||
147569695|NCT01045161|532241768|FG001|Part A - 12 Weeks Double Blind Treatment|Lack of Efficacy|3|||
147569696|NCT01045161|532241769|FG002|Part A - 12 Weeks Double Blind Treatment|Lack of Efficacy|2|||
147569697|NCT01045161|532241767|FG000|Part A - 12 Weeks Double Blind Treatment|COPD Exacerbation|4|||
147317455|NCT01115998|531329295|FG000|Overall Study|Lost to Follow-up|6|||
147317456|NCT01115998|531329296|FG001|Overall Study|Lost to Follow-up|6|||
147569698|NCT01045161|532241768|FG001|Part A - 12 Weeks Double Blind Treatment|COPD Exacerbation|1|||
147569699|NCT01045161|532241769|FG002|Part A - 12 Weeks Double Blind Treatment|COPD Exacerbation|6|||
147569700|NCT01045161|532241767|FG000|Part A - 12 Weeks Double Blind Treatment|Other Reason|3|||
147130387|NCT02958865|530644522|FG004|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
147130388|NCT02958865|530644523|FG005|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
147130389|NCT02958865|530644524|FG006|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
147130390|NCT02958865|530644525|FG007|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
147130391|NCT02958865|530644526|FG008|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
147130392|NCT02958865|530644527|FG009|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
147130393|NCT02958865|530644528|FG010|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
147130394|NCT02958865|530644529|FG011|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
147130395|NCT02958865|530644530|FG012|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
147130396|NCT02958865|530644531|FG013|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|1|||
147130397|NCT02958865|530644532|FG014|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
147130398|NCT02958865|530644533|FG015|Chronic Period (Week 8 to Week 32)|Non-compliance with study drug|0|||
147130399|NCT02958865|530644518|FG000|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
147130400|NCT02958865|530644519|FG001|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
147130401|NCT02958865|530644520|FG002|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
147130402|NCT02958865|530644521|FG003|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
147130403|NCT02958865|530644522|FG004|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
147130404|NCT02958865|530644523|FG005|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
147130405|NCT02958865|530644524|FG006|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
147130406|NCT02958865|530644525|FG007|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
147130407|NCT02958865|530644526|FG008|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
147130408|NCT02958865|530644527|FG009|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
147130409|NCT02958865|530644528|FG010|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
147130410|NCT02958865|530644529|FG011|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
147130411|NCT02958865|530644530|FG012|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
147130412|NCT02958865|530644531|FG013|Chronic Period (Week 8 to Week 32)|Protocol Violation|1|||
147130413|NCT02958865|530644532|FG014|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
147130414|NCT02958865|530644533|FG015|Chronic Period (Week 8 to Week 32)|Protocol Violation|0|||
147130415|NCT02958865|530644518|FG000|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
147130416|NCT02958865|530644519|FG001|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
147130417|NCT02958865|530644520|FG002|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
147130418|NCT02958865|530644521|FG003|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
147130419|NCT02958865|530644522|FG004|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
147130420|NCT02958865|530644523|FG005|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
147130421|NCT02958865|530644524|FG006|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
147130422|NCT02958865|530644525|FG007|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
147130423|NCT02958865|530644526|FG008|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
147130424|NCT02958865|530644527|FG009|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|1|||
147130425|NCT02958865|530644528|FG010|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
147130426|NCT02958865|530644529|FG011|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
147130427|NCT02958865|530644530|FG012|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
147130428|NCT02958865|530644531|FG013|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
147130429|NCT02958865|530644532|FG014|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
147130430|NCT02958865|530644533|FG015|Chronic Period (Week 8 to Week 32)|No longer meeting eligibility criteria|0|||
147130431|NCT01767987|530644534|FG000|Overall Study|Physician Decision|4|||
147130432|NCT01767987|530644535|FG001|Overall Study|Physician Decision|1|||
147130433|NCT00654355|530644544|FG000|Overall Study|Lost to Follow-up|2|||
147130434|NCT00654355|530644545|FG001|Overall Study|Lost to Follow-up|2|||
147130435|NCT02284893|530644550|FG000|26 Week (Short Term)|Adverse Event|1|||
147130436|NCT02284893|530644551|FG001|26 Week (Short Term)|Adverse Event|9|||
147130437|NCT02284893|530644550|FG000|26 Week (Short Term)|Discontinuation by the subject|2|||
147130438|NCT02284893|530644551|FG001|26 Week (Short Term)|Discontinuation by the subject|2|||
147130439|NCT02284893|530644550|FG000|26 Week (Short Term)|Withrawal of the consent by the subject|7|||
147130440|NCT02284893|530644551|FG001|26 Week (Short Term)|Withrawal of the consent by the subject|10|||
147130441|NCT02284893|530644550|FG000|26 Week (Short Term)|Lost to Follow-up|3|||
147130442|NCT02284893|530644551|FG001|26 Week (Short Term)|Lost to Follow-up|1|||
147130443|NCT02284893|530644550|FG000|26 Week (Short Term)|Subject no longer meets study criteria|5|||
147130444|NCT02284893|530644551|FG001|26 Week (Short Term)|Subject no longer meets study criteria|8|||
147130445|NCT02284893|530644550|FG000|26 Week (Short Term)|Other|1|||
147130446|NCT02284893|530644551|FG001|26 Week (Short Term)|Other|1|||
147130447|NCT02284893|530644550|FG000|52 Week (Long Term)|Adverse Event|3|||
147130448|NCT02284893|530644551|FG001|52 Week (Long Term)|Adverse Event|1|||
147130449|NCT02284893|530644550|FG000|52 Week (Long Term)|Subject no longer meets study criteria|0|||
147235991|NCT01644565|531035498|FG005|Overall Study|Family emergency|0|||
147235992|NCT01644565|531035499|FG006|Overall Study|Family emergency|0|||
147130450|NCT02284893|530644551|FG001|52 Week (Long Term)|Subject no longer meets study criteria|1|||
147130451|NCT02284893|530644550|FG000|52 Week (Long Term)|Withrawal of the consent by the subject|4|||
147130452|NCT02284893|530644551|FG001|52 Week (Long Term)|Withrawal of the consent by the subject|6|||
147130453|NCT02284893|530644550|FG000|52 Week (Long Term)|Lost to Follow-up|2|||
147130454|NCT02284893|530644551|FG001|52 Week (Long Term)|Lost to Follow-up|2|||
147130455|NCT02284893|530644550|FG000|52 Week (Long Term)|Non-Compliance|2|||
147130456|NCT02284893|530644551|FG001|52 Week (Long Term)|Non-Compliance|3|||
147130457|NCT02757430|530644552|FG000|Overall Study|Physician Decision|6|||
147130458|NCT02757430|530644552|FG000|Overall Study|Inclusion/Exclusion criteria not met|3|||
147130459|NCT02757430|530644552|FG000|Overall Study|No informed consent|1|||
147130460|NCT02757430|530644552|FG000|Overall Study|No procedure performed|2|||
147130461|NCT02106832|530644559|FG000|Overall Study|Adverse Event|1|||
147130462|NCT02106832|530644560|FG001|Overall Study|Adverse Event|2|||
147130463|NCT02106832|530644561|FG002|Overall Study|Adverse Event|3|||
147130464|NCT02106832|530644562|FG003|Overall Study|Adverse Event|0|||
147130465|NCT02106832|530644559|FG000|Overall Study|Death|4|||
147130466|NCT02106832|530644560|FG001|Overall Study|Death|4|||
147130467|NCT02106832|530644561|FG002|Overall Study|Death|1|||
147130468|NCT02106832|530644562|FG003|Overall Study|Death|4|||
147130469|NCT02106832|530644559|FG000|Overall Study|Deterioration of general conditions|0|||
147130470|NCT02106832|530644560|FG001|Overall Study|Deterioration of general conditions|0|||
147130471|NCT02106832|530644561|FG002|Overall Study|Deterioration of general conditions|1|||
147130472|NCT02106832|530644562|FG003|Overall Study|Deterioration of general conditions|0|||
147130473|NCT02106832|530644559|FG000|Overall Study|Lost to Follow-up|0|||
147130474|NCT02106832|530644560|FG001|Overall Study|Lost to Follow-up|1|||
147130475|NCT02106832|530644561|FG002|Overall Study|Lost to Follow-up|1|||
147130476|NCT02106832|530644562|FG003|Overall Study|Lost to Follow-up|3|||
147130477|NCT02106832|530644559|FG000|Overall Study|Physician Decision|1|||
147130478|NCT02106832|530644560|FG001|Overall Study|Physician Decision|0|||
147130479|NCT02106832|530644561|FG002|Overall Study|Physician Decision|0|||
147130480|NCT02106832|530644562|FG003|Overall Study|Physician Decision|0|||
147130481|NCT02106832|530644559|FG000|Overall Study|Protocol Violation|0|||
147130482|NCT02106832|530644560|FG001|Overall Study|Protocol Violation|0|||
147130483|NCT02106832|530644561|FG002|Overall Study|Protocol Violation|0|||
147130484|NCT02106832|530644562|FG003|Overall Study|Protocol Violation|1|||
147130485|NCT02106832|530644559|FG000|Overall Study|Withdrawal by Subject|17|||
147130486|NCT02106832|530644560|FG001|Overall Study|Withdrawal by Subject|17|||
147130487|NCT02106832|530644561|FG002|Overall Study|Withdrawal by Subject|10|||
147130488|NCT02106832|530644562|FG003|Overall Study|Withdrawal by Subject|7|||
147130489|NCT02106832|530644559|FG000|Overall Study|Technical problems|0|||
147130490|NCT02106832|530644560|FG001|Overall Study|Technical problems|1|||
147130491|NCT02106832|530644561|FG002|Overall Study|Technical problems|0|||
147130492|NCT02106832|530644562|FG003|Overall Study|Technical problems|0|||
147130493|NCT00071032|530644575|FG000|Overall Study|Lost to Follow-up|1|||
147130494|NCT00071032|530644576|FG001|Overall Study|Lost to Follow-up|1|||
147130495|NCT00071032|530644575|FG000|Overall Study|Withdrawal by Subject|8|||
147130496|NCT00071032|530644576|FG001|Overall Study|Withdrawal by Subject|6|||
147130497|NCT00071032|530644575|FG000|Overall Study|Missing Primary Outcome|0|||
147235993|NCT01644565|531035500|FG007|Overall Study|Family emergency|0|||
147235994|NCT01644565|531035501|FG008|Overall Study|Family emergency|0|||
147235995|NCT01644565|531035493|FG000|Overall Study|Relocation|0|||
147235996|NCT01644565|531035494|FG001|Overall Study|Relocation|0|||
147235997|NCT01644565|531035495|FG002|Overall Study|Relocation|0|||
147235998|NCT01644565|531035496|FG003|Overall Study|Relocation|0|||
147235999|NCT01644565|531035497|FG004|Overall Study|Relocation|0|||
147236000|NCT01644565|531035498|FG005|Overall Study|Relocation|0|||
147236001|NCT01644565|531035499|FG006|Overall Study|Relocation|0|||
147236002|NCT01644565|531035500|FG007|Overall Study|Relocation|0|||
147236003|NCT01644565|531035501|FG008|Overall Study|Relocation|1|||
147236004|NCT01550289|531035502|FG000|Overall Study|Protocol Violation|1|||
147236005|NCT01550289|531035503|FG001|Overall Study|Protocol Violation|0|||
147236006|NCT01550289|531035502|FG000|Overall Study|Lost to Follow-up|1|||
147130498|NCT00071032|530644576|FG001|Overall Study|Missing Primary Outcome|1|||
147130499|NCT01903863|530644577|FG000|Overall Study|Physician Decision|2|||
147236007|NCT01550289|531035503|FG001|Overall Study|Lost to Follow-up|1|||
147569701|NCT01045161|532241768|FG001|Part A - 12 Weeks Double Blind Treatment|Other Reason|3|||
147130500|NCT01903863|530644578|FG001|Overall Study|Physician Decision|0|||
147130501|NCT03537508|530644583|FG000|Overall Study|Adverse Event|2|||
147130502|NCT03537508|530644584|FG001|Overall Study|Adverse Event|1|||
147236008|NCT01550289|531035502|FG000|Overall Study|Withdrawal by Subject|11|||
147236009|NCT01550289|531035503|FG001|Overall Study|Withdrawal by Subject|3|||
147236010|NCT02975336|531035504|FG000|DBPC (52 Weeks)|Adverse Event|16|||
147569702|NCT01045161|532241769|FG002|Part A - 12 Weeks Double Blind Treatment|Other Reason|3|||
147569703|NCT01045161|532241767|FG000|Part A - 12 Weeks Double Blind Treatment|Protocol Violation|3|||
147569704|NCT01045161|532241768|FG001|Part A - 12 Weeks Double Blind Treatment|Protocol Violation|4|||
147569705|NCT01045161|532241769|FG002|Part A - 12 Weeks Double Blind Treatment|Protocol Violation|3|||
147236011|NCT02975336|531035505|FG001|DBPC (52 Weeks)|Adverse Event|17|||
147236012|NCT02975336|531035506|FG002|DBPC (52 Weeks)|Adverse Event|13|||
147569706|NCT01045161|532241767|FG000|Part A - 12 Weeks Double Blind Treatment|Lost to Follow-up|3|||
147569707|NCT01045161|532241768|FG001|Part A - 12 Weeks Double Blind Treatment|Lost to Follow-up|3|||
147569708|NCT01045161|532241769|FG002|Part A - 12 Weeks Double Blind Treatment|Lost to Follow-up|2|||
147569709|NCT01045161|532241767|FG000|Part B - 40 Additional Weeks Open Label|Withdrawal by Subject|10|||
147569710|NCT01045161|532241768|FG001|Part B - 40 Additional Weeks Open Label|Withdrawal by Subject|7|||
147569711|NCT01045161|532241769|FG002|Part B - 40 Additional Weeks Open Label|Withdrawal by Subject|9|||
147569712|NCT01045161|532241767|FG000|Part B - 40 Additional Weeks Open Label|Adverse Event|10|||
147569713|NCT01045161|532241768|FG001|Part B - 40 Additional Weeks Open Label|Adverse Event|10|||
147569714|NCT01045161|532241769|FG002|Part B - 40 Additional Weeks Open Label|Adverse Event|7|||
147569715|NCT01045161|532241767|FG000|Part B - 40 Additional Weeks Open Label|Lack of Efficacy|3|||
147569716|NCT01045161|532241768|FG001|Part B - 40 Additional Weeks Open Label|Lack of Efficacy|5|||
147569717|NCT01045161|532241769|FG002|Part B - 40 Additional Weeks Open Label|Lack of Efficacy|5|||
147569718|NCT01045161|532241767|FG000|Part B - 40 Additional Weeks Open Label|COPD Exacerbation|1|||
147569719|NCT01045161|532241768|FG001|Part B - 40 Additional Weeks Open Label|COPD Exacerbation|5|||
147569720|NCT01045161|532241769|FG002|Part B - 40 Additional Weeks Open Label|COPD Exacerbation|1|||
147569721|NCT01045161|532241767|FG000|Part B - 40 Additional Weeks Open Label|Other Reason|4|||
147569722|NCT01045161|532241768|FG001|Part B - 40 Additional Weeks Open Label|Other Reason|2|||
147569723|NCT01045161|532241769|FG002|Part B - 40 Additional Weeks Open Label|Other Reason|1|||
147569724|NCT01045161|532241767|FG000|Part B - 40 Additional Weeks Open Label|Protocol Violation|3|||
147130503|NCT03537508|530644583|FG000|Overall Study|Protocol Violation|65|||
147130504|NCT03537508|530644584|FG001|Overall Study|Protocol Violation|48|||
147130505|NCT03537508|530644583|FG000|Overall Study|Lost to Follow-up|86|||
147130506|NCT03537508|530644584|FG001|Overall Study|Lost to Follow-up|60|||
147130507|NCT03537508|530644583|FG000|Overall Study|Withdrawal by parent/guardian|263|||
147130508|NCT03537508|530644584|FG001|Overall Study|Withdrawal by parent/guardian|149|||
147130509|NCT01972659|530644585|FG000|Overall Study|Protocol Violation|2|||
147130510|NCT01972659|530644586|FG001|Overall Study|Protocol Violation|2|||
147130511|NCT01972659|530644585|FG000|Overall Study|problems realted to acceleromyograph|2|||
147130512|NCT01972659|530644586|FG001|Overall Study|problems realted to acceleromyograph|1|||
147130513|NCT05715827|530644594|FG000|Overall Study|Physician Decision|0|||
147130514|NCT05715827|530644595|FG001|Overall Study|Physician Decision|1|||
147130515|NCT05715827|530644594|FG000|Overall Study|console communication error|0|||
147130516|NCT05715827|530644595|FG001|Overall Study|console communication error|1|||
147130517|NCT04569084|530644596|FG000|Overall Study|Adverse Event|10|||
147130518|NCT04569084|530644597|FG001|Overall Study|Adverse Event|14|||
147130519|NCT04569084|530644596|FG000|Overall Study|Death|2|||
147130520|NCT04569084|530644597|FG001|Overall Study|Death|3|||
147130521|NCT04569084|530644596|FG000|Overall Study|Lost to Follow-up|1|||
147130522|NCT04569084|530644597|FG001|Overall Study|Lost to Follow-up|1|||
147130523|NCT04569084|530644596|FG000|Overall Study|Physician Decision|3|||
147130524|NCT04569084|530644597|FG001|Overall Study|Physician Decision|3|||
147130525|NCT04569084|530644596|FG000|Overall Study|Protocol Violation|2|||
147130526|NCT04569084|530644597|FG001|Overall Study|Protocol Violation|1|||
147130527|NCT04569084|530644596|FG000|Overall Study|Withdrawal by Subject|20|||
147130528|NCT04569084|530644597|FG001|Overall Study|Withdrawal by Subject|21|||
147130529|NCT04569084|530644596|FG000|Overall Study|Study terminated by sponsor|26|||
147130530|NCT04569084|530644597|FG001|Overall Study|Study terminated by sponsor|23|||
147130531|NCT04569084|530644596|FG000|Overall Study|Other|3|||
147130532|NCT04569084|530644597|FG001|Overall Study|Other|5|||
147130533|NCT06022107|530644599|FG000|Overall Study|Did not complete baseline questionnaire / did not begin using intervention|4|||
147130534|NCT06022107|530644599|FG000|Overall Study|Dropped out of study for higher level of care|1|||
147130535|NCT06022107|530644599|FG000|Overall Study|Lost to Follow-up|2|||
147130536|NCT02333799|530645643|FG000|Treatment Period|Withdrawal by Subject|1|||
147130537|NCT02333799|530645643|FG000|Treatment Period|Death|6|||
147130538|NCT02333799|530645643|FG000|6 Month Follow Up Period|Physician Decision|1|||
147130539|NCT02333799|530645643|FG000|6 Month Follow Up Period|Death|1|||
147130540|NCT02333799|530645643|FG000|7 to 24 Month Follow Up Period|Lost to Follow-up|1|||
147130541|NCT02333799|530645643|FG000|7 to 24 Month Follow Up Period|Physician Decision|1|||
147130542|NCT05484895|530645644|FG000|Overall Study|Lost to Follow-up|63|||
147130543|NCT05484895|530645645|FG001|Overall Study|Lost to Follow-up|64|||
147130544|NCT00876447|530645649|FG000|Overall Study|Other miscellaneous reasons|3|||
147130545|NCT00876447|530645650|FG001|Overall Study|Other miscellaneous reasons|8|||
147130546|NCT00876447|530645649|FG000|Overall Study|Site closure|19|||
147130547|NCT00876447|530645650|FG001|Overall Study|Site closure|14|||
147130548|NCT00876447|530645649|FG000|Overall Study|Protocol Violation|9|||
147130549|NCT00876447|530645650|FG001|Overall Study|Protocol Violation|3|||
147130550|NCT00876447|530645649|FG000|Overall Study|Personal reasons|30|||
147130551|NCT00876447|530645650|FG001|Overall Study|Personal reasons|28|||
147130552|NCT00876447|530645649|FG000|Overall Study|Lost to Follow-up|6|||
147130553|NCT00876447|530645650|FG001|Overall Study|Lost to Follow-up|15|||
147130554|NCT00876447|530645649|FG000|Overall Study|Pregnancy|4|||
147130555|NCT00876447|530645650|FG001|Overall Study|Pregnancy|2|||
147130556|NCT00876447|530645649|FG000|Overall Study|Lack of Efficacy|5|||
147130557|NCT00876447|530645650|FG001|Overall Study|Lack of Efficacy|3|||
147130558|NCT00876447|530645649|FG000|Overall Study|Adverse Event|4|||
147130559|NCT00876447|530645650|FG001|Overall Study|Adverse Event|8|||
147130560|NCT02297516|530645653|FG000|Single Treatment Phase (6 Months)|Medical reason|1|||
147130561|NCT02297516|530645654|FG001|Single Treatment Phase (6 Months)|Medical reason|0|||
147130562|NCT02297516|530645653|FG000|Single Treatment Phase (6 Months)|Protocol Violation|0|||
147130563|NCT02297516|530645654|FG001|Single Treatment Phase (6 Months)|Protocol Violation|2|||
147130564|NCT02297516|530645653|FG000|Combination Treatment Phase (up to 18 m)|Withdrawal by Subject|0|||
147130565|NCT02297516|530645654|FG001|Combination Treatment Phase (up to 18 m)|Withdrawal by Subject|1|||
147130566|NCT00710593|530645655|FG000|Overall Study|Incarceration|1|||
147130567|NCT00710593|530645656|FG001|Overall Study|Incarceration|0|||
147130568|NCT00710593|530645655|FG000|Overall Study|Unable to complete Wk 48 within window|2|||
147130569|NCT00710593|530645656|FG001|Overall Study|Unable to complete Wk 48 within window|0|||
147130570|NCT00710593|530645655|FG000|Overall Study|Lost to Follow-up|3|||
147130571|NCT00710593|530645656|FG001|Overall Study|Lost to Follow-up|1|||
147130572|NCT00710593|530645655|FG000|Overall Study|Moved out of area|1|||
147130573|NCT00710593|530645656|FG001|Overall Study|Moved out of area|0|||
147130574|NCT00710593|530645655|FG000|Overall Study|Failure to adhere or complete study eval|1|||
147130575|NCT00710593|530645656|FG001|Overall Study|Failure to adhere or complete study eval|1|||
147130576|NCT00710593|530645655|FG000|Overall Study|Protocol Violation|1|||
147130577|NCT00710593|530645656|FG001|Overall Study|Protocol Violation|1|||
147130578|NCT00710593|530645655|FG000|Overall Study|Prem disc vaccine, completed all visits|6|||
147130579|NCT00710593|530645656|FG001|Overall Study|Prem disc vaccine, completed all visits|2|||
147130580|NCT04490278|530645657|FG000|Overall Study|Lost to Follow-up|6|||
147130581|NCT00366457|530645660|FG000|Overall Study|never began study therapy|2|||
147130582|NCT02829996|530645661|FG000|Overall Study|Withdrawal by Subject|1|||
147130583|NCT02829996|530645662|FG001|Overall Study|Withdrawal by Subject|0|||
147130584|NCT02829996|530645663|FG002|Overall Study|Withdrawal by Subject|0|||
147130585|NCT02829996|530645664|FG003|Overall Study|Withdrawal by Subject|0|||
147130586|NCT02829996|530645665|FG004|Overall Study|Withdrawal by Subject|0|||
147130587|NCT02538614|530645666|FG000|Overall Study|Progressive Disease|2|||
147130588|NCT01517984|530645678|FG000|Overall Study|Lost to Follow-up|0|||
147130589|NCT01517984|530645679|FG001|Overall Study|Lost to Follow-up|1|||
147130590|NCT01517984|530645680|FG002|Overall Study|Lost to Follow-up|0|||
147569725|NCT01045161|532241768|FG001|Part B - 40 Additional Weeks Open Label|Protocol Violation|6|||
147569726|NCT01045161|532241769|FG002|Part B - 40 Additional Weeks Open Label|Protocol Violation|3|||
147130591|NCT01517984|530645681|FG003|Overall Study|Lost to Follow-up|0|||
147130592|NCT01517984|530645678|FG000|Overall Study|Withdrawal by Subject|1|||
147130593|NCT01517984|530645679|FG001|Overall Study|Withdrawal by Subject|8|||
147130594|NCT01517984|530645680|FG002|Overall Study|Withdrawal by Subject|4|||
147130595|NCT01517984|530645681|FG003|Overall Study|Withdrawal by Subject|1|||
147130596|NCT01517984|530645678|FG000|Overall Study|Screen Failure|4|||
147130597|NCT01517984|530645679|FG001|Overall Study|Screen Failure|0|||
147130598|NCT01517984|530645680|FG002|Overall Study|Screen Failure|0|||
147130599|NCT01517984|530645681|FG003|Overall Study|Screen Failure|0|||
147569727|NCT01045161|532241767|FG000|Part B - 40 Additional Weeks Open Label|Lost to Follow-up|5|||
147569728|NCT01045161|532241768|FG001|Part B - 40 Additional Weeks Open Label|Lost to Follow-up|1|||
147569729|NCT01045161|532241769|FG002|Part B - 40 Additional Weeks Open Label|Lost to Follow-up|6|||
147569730|NCT04659603|532241775|FG000|Overall Study|Study terminated by sponsor|0|||
147569731|NCT04659603|532241776|FG001|Overall Study|Study terminated by sponsor|0|||
147569732|NCT04659603|532241777|FG002|Overall Study|Study terminated by sponsor|2|||
147569733|NCT04659603|532241775|FG000|Overall Study|Withdrawal by Subject|0|||
147569734|NCT04659603|532241776|FG001|Overall Study|Withdrawal by Subject|5|||
147569735|NCT04659603|532241777|FG002|Overall Study|Withdrawal by Subject|0|||
147569736|NCT04659603|532241775|FG000|Overall Study|Not related to Coronavirus disease 2019|0|||
147569737|NCT04659603|532241776|FG001|Overall Study|Not related to Coronavirus disease 2019|0|||
147569738|NCT04659603|532241777|FG002|Overall Study|Not related to Coronavirus disease 2019|1|||
147569739|NCT02374853|532241780|FG000|Overall Study|Surgery Cancelled|5|||
147569740|NCT02374853|532241781|FG001|Overall Study|Surgery Cancelled|11|||
147569741|NCT02281084|532241782|FG000|Overall Study|Death|21|||
147569742|NCT02281084|532241783|FG001|Overall Study|Death|18|||
147569743|NCT02281084|532241784|FG002|Overall Study|Death|3|||
147569744|NCT02281084|532241785|FG003|Overall Study|Death|5|||
147569745|NCT02281084|532241782|FG000|Overall Study|Adverse Event|1|||
147569746|NCT02281084|532241783|FG001|Overall Study|Adverse Event|0|||
147569747|NCT02281084|532241784|FG002|Overall Study|Adverse Event|0|||
147569748|NCT02281084|532241785|FG003|Overall Study|Adverse Event|0|||
147569749|NCT02281084|532241782|FG000|Overall Study|Withdrawal by Subject|2|||
147569750|NCT02281084|532241783|FG001|Overall Study|Withdrawal by Subject|2|||
147130600|NCT01517984|530645678|FG000|Overall Study|Ineligible for randomization|0|||
147130601|NCT01517984|530645679|FG001|Overall Study|Ineligible for randomization|14|||
147130602|NCT01517984|530645680|FG002|Overall Study|Ineligible for randomization|0|||
147569751|NCT02281084|532241784|FG002|Overall Study|Withdrawal by Subject|0|||
147130603|NCT01517984|530645681|FG003|Overall Study|Ineligible for randomization|0|||
147130604|NCT04903288|530645682|FG000|Extension Phase (48 Weeks)|Withdrawal by Subject|1|||
147130605|NCT04903288|530645682|FG000|Extension Phase (48 Weeks)|Ongoing in the Study|3|||
147130606|NCT04903288|530645682|FG000|Long-Term Extension Phase (60 Months)|Withdrawal by Subject|1|||
147130607|NCT04903288|530645682|FG000|Long-Term Extension Phase (60 Months)|Ongoing in the Study|6|||
147130608|NCT00904371|530645683|FG000|Overall Study|Adverse Event|2|||
147130609|NCT00904371|530645683|FG000|Overall Study|Lost to Follow-up|4|||
147130610|NCT00904371|530645683|FG000|Overall Study|Discontinued at target blood pressure|2|||
147130611|NCT00904371|530645683|FG000|Overall Study|Continued with Tritace|1|||
147130612|NCT04617860|530645686|FG000|Overall Study|Adverse Event|0|||
147130613|NCT04617860|530645687|FG001|Overall Study|Adverse Event|2|||
147130614|NCT04617860|530645688|FG002|Overall Study|Adverse Event|2|||
147130615|NCT04617860|530645686|FG000|Overall Study|Withdrawal by Subject|0|||
147130616|NCT04617860|530645687|FG001|Overall Study|Withdrawal by Subject|0|||
147130617|NCT04617860|530645688|FG002|Overall Study|Withdrawal by Subject|2|||
147130618|NCT04617860|530645686|FG000|Overall Study|Physician Decision|0|||
147130619|NCT04617860|530645687|FG001|Overall Study|Physician Decision|1|||
147130620|NCT04617860|530645688|FG002|Overall Study|Physician Decision|0|||
147130621|NCT04617860|530645686|FG000|Overall Study|Sponsor Decision|0|||
147130622|NCT04617860|530645687|FG001|Overall Study|Sponsor Decision|3|||
147130623|NCT04617860|530645688|FG002|Overall Study|Sponsor Decision|1|||
147130624|NCT04617860|530645686|FG000|Overall Study|Termination of Study by Sponsor|8|||
147130625|NCT04617860|530645687|FG001|Overall Study|Termination of Study by Sponsor|4|||
147569752|NCT02281084|532241785|FG003|Overall Study|Withdrawal by Subject|0|||
147569753|NCT02281084|532241782|FG000|Overall Study|Site Closure by Sponsor|5|||
147569754|NCT02281084|532241783|FG001|Overall Study|Site Closure by Sponsor|1|||
147569755|NCT02281084|532241784|FG002|Overall Study|Site Closure by Sponsor|2|||
147569756|NCT02281084|532241785|FG003|Overall Study|Site Closure by Sponsor|0|||
147569757|NCT03681470|532241786|FG000|Overall Study|Lack of Efficacy|3|||
147569758|NCT03681470|532241786|FG000|Overall Study|Lost to Follow-up|1|||
147569759|NCT03681470|532241786|FG000|Overall Study|Protocol Violation|3|||
147569760|NCT03681470|532241786|FG000|Overall Study|Withdrawal by Subject|1|||
147569761|NCT02305758|532241787|FG000|Overall Study|Death|27|||
147569762|NCT02305758|532241788|FG001|Overall Study|Death|27|||
147569763|NCT02305758|532241787|FG000|Overall Study|Withdrew consent|9|||
147569764|NCT02305758|532241788|FG001|Overall Study|Withdrew consent|2|||
147569765|NCT02305758|532241787|FG000|Overall Study|Lost to Follow-up|6|||
147569766|NCT02305758|532241788|FG001|Overall Study|Lost to Follow-up|1|||
147569767|NCT02305758|532241787|FG000|Overall Study|Study Terminated by Sponsor|21|||
147569768|NCT02305758|532241788|FG001|Overall Study|Study Terminated by Sponsor|34|||
147569769|NCT02305758|532241787|FG000|Overall Study|Other, not specified|2|||
147569770|NCT02305758|532241788|FG001|Overall Study|Other, not specified|1|||
147569771|NCT00811655|532241803|FG000|Overall Study|Physician Decision|1|||
147569772|NCT02820350|532241804|FG000|Overall Study|Withdrawal by Subject|3|||
147569773|NCT02820350|532241804|FG000|Overall Study|Death|4|||
147569774|NCT01754597|532241805|FG000|Overall Study|Dosage of NT-proBNP not performed|6|||
147569775|NCT01754597|532241806|FG001|Overall Study|Dosage of NT-proBNP not performed|5|||
147569776|NCT01802320|532241807|FG000|Overall Study|Death|1|||
147569777|NCT01802320|532241807|FG000|Overall Study|Withdrawal by Subject|1|||
147569778|NCT02674152|532243404|FG000|Overall Study|Personal Reasons|1|||
147569779|NCT02674152|532243405|FG001|Overall Study|Personal Reasons|0|||
147569780|NCT02674152|532243406|FG002|Overall Study|Personal Reasons|0|||
147569781|NCT02674152|532243407|FG003|Overall Study|Personal Reasons|1|||
147569782|NCT02674152|532243408|FG004|Overall Study|Personal Reasons|1|||
147569783|NCT02674152|532243404|FG000|Overall Study|Other adverse event or clinical progression|0|||
147569784|NCT02674152|532243405|FG001|Overall Study|Other adverse event or clinical progression|1|||
147569785|NCT02674152|532243406|FG002|Overall Study|Other adverse event or clinical progression|0|||
147569786|NCT02674152|532243407|FG003|Overall Study|Other adverse event or clinical progression|3|||
147569787|NCT02674152|532243408|FG004|Overall Study|Other adverse event or clinical progression|0|||
147569788|NCT02674152|532243404|FG000|Overall Study|Dose-limiting toxicity|0|||
147569789|NCT02674152|532243405|FG001|Overall Study|Dose-limiting toxicity|0|||
147569790|NCT02674152|532243406|FG002|Overall Study|Dose-limiting toxicity|0|||
147569791|NCT02674152|532243407|FG003|Overall Study|Dose-limiting toxicity|0|||
147569792|NCT02674152|532243408|FG004|Overall Study|Dose-limiting toxicity|1|||
147569793|NCT02674152|532243404|FG000|Overall Study|Progressive Disease|2|||
147569794|NCT02674152|532243405|FG001|Overall Study|Progressive Disease|1|||
147569795|NCT02674152|532243406|FG002|Overall Study|Progressive Disease|1|||
147569796|NCT02674152|532243407|FG003|Overall Study|Progressive Disease|13|||
147569797|NCT02674152|532243408|FG004|Overall Study|Progressive Disease|2|||
147569798|NCT02674152|532243404|FG000|Overall Study|Adverse Event|0|||
147569799|NCT02674152|532243405|FG001|Overall Study|Adverse Event|0|||
147569800|NCT02674152|532243406|FG002|Overall Study|Adverse Event|1|||
147569801|NCT02674152|532243407|FG003|Overall Study|Adverse Event|0|||
147569802|NCT02674152|532243408|FG004|Overall Study|Adverse Event|1|||
147569803|NCT05265624|532243409|FG000|Overall Study|Lost to Follow-up|3|||
147569804|NCT05265624|532243410|FG001|Overall Study|Lost to Follow-up|0|||
147569805|NCT05265624|532243409|FG000|Overall Study|Withdrawal by Subject|1|||
147569806|NCT05265624|532243410|FG001|Overall Study|Withdrawal by Subject|0|||
147569807|NCT00001703|532243411|FG000|Overall Study|progressed disease|2|||
147569808|NCT00001703|532243411|FG000|Overall Study|No evidence of disease|1|||
147569809|NCT00001703|532243411|FG000|Overall Study|recurrent disease|2|||
147569810|NCT03071575|532243412|FG000|Overall Study|Death|0|||
147569811|NCT03071575|532243413|FG001|Overall Study|Death|1|||
147569812|NCT03071575|532243412|FG000|Overall Study|Lost to Follow-up|5|||
147569813|NCT03071575|532243413|FG001|Overall Study|Lost to Follow-up|11|||
147569814|NCT03071575|532243412|FG000|Overall Study|Withdrawal by Subject|4|||
147569815|NCT03071575|532243413|FG001|Overall Study|Withdrawal by Subject|2|||
147569816|NCT00834795|532243418|FG000|Washout: 7 Days|Withdrawal by Subject|0|||
147569817|NCT00834795|532243419|FG001|Washout: 7 Days|Withdrawal by Subject|1|||
147569818|NCT00834795|532243418|FG000|Second Intervention|Adverse Event|1|||
147569819|NCT00834795|532243419|FG001|Second Intervention|Adverse Event|0|||
147569820|NCT00579345|532243420|FG000|Overall Study|Withdrawal by Subject|2|||
147569821|NCT00579345|532243421|FG001|Overall Study|Withdrawal by Subject|0|||
147569822|NCT00579345|532243422|FG002|Overall Study|Withdrawal by Subject|0|||
147569823|NCT00579345|532243423|FG003|Overall Study|Withdrawal by Subject|0|||
147569824|NCT00579345|532243424|FG004|Overall Study|Withdrawal by Subject|0|||
147569825|NCT00579345|532243425|FG005|Overall Study|Withdrawal by Subject|0|||
147569826|NCT00579345|532243426|FG006|Overall Study|Withdrawal by Subject|0|||
147569827|NCT00579345|532243427|FG007|Overall Study|Withdrawal by Subject|1|||
147569828|NCT00579345|532243420|FG000|Overall Study|Lost to Follow-up|1|||
147569829|NCT00579345|532243421|FG001|Overall Study|Lost to Follow-up|0|||
147569830|NCT00579345|532243422|FG002|Overall Study|Lost to Follow-up|0|||
147130626|NCT04617860|530645688|FG002|Overall Study|Termination of Study by Sponsor|13|||
147130627|NCT03898180|530645689|FG000|Overall Study|Death|178|||
147130628|NCT03898180|530645690|FG001|Overall Study|Death|173|||
147130629|NCT03898180|530645689|FG000|Overall Study|Physician Decision|1|||
147130630|NCT03898180|530645690|FG001|Overall Study|Physician Decision|0|||
147130631|NCT03898180|530645689|FG000|Overall Study|Sponsor Decision|3|||
147130632|NCT03898180|530645690|FG001|Overall Study|Sponsor Decision|0|||
147130633|NCT03898180|530645689|FG000|Overall Study|Lost to Follow-up|1|||
147130634|NCT03898180|530645690|FG001|Overall Study|Lost to Follow-up|0|||
147130635|NCT03898180|530645689|FG000|Overall Study|Withdrawal by Subject|5|||
147130636|NCT03898180|530645690|FG001|Overall Study|Withdrawal by Subject|4|||
147130637|NCT02507934|530645691|FG000|Overall Study|Lost to Follow-up|2|||
147130638|NCT02507934|530645692|FG001|Overall Study|Lost to Follow-up|0|||
147130639|NCT02507934|530645691|FG000|Overall Study|Withdrawal by Subject|2|||
147130640|NCT02507934|530645692|FG001|Overall Study|Withdrawal by Subject|0|||
147130641|NCT04392154|530645693|FG000|Primary Treatment Period (100 Weeks)|Adverse Event|3|||
147130642|NCT04392154|530645694|FG001|Primary Treatment Period (100 Weeks)|Adverse Event|46|||
147130643|NCT04392154|530645695|FG002|Primary Treatment Period (100 Weeks)|Adverse Event|0|||
147130644|NCT04392154|530645696|FG003|Primary Treatment Period (100 Weeks)|Adverse Event|0|||
147130645|NCT04392154|530645693|FG000|Primary Treatment Period (100 Weeks)|Due to epidemic/pandemic|0|||
147130646|NCT04392154|530645694|FG001|Primary Treatment Period (100 Weeks)|Due to epidemic/pandemic|1|||
147130647|NCT04392154|530645695|FG002|Primary Treatment Period (100 Weeks)|Due to epidemic/pandemic|0|||
147130648|NCT04392154|530645696|FG003|Primary Treatment Period (100 Weeks)|Due to epidemic/pandemic|0|||
147130649|NCT04392154|530645693|FG000|Primary Treatment Period (100 Weeks)|Lack of Efficacy|1|||
147130650|NCT04392154|530645694|FG001|Primary Treatment Period (100 Weeks)|Lack of Efficacy|47|||
147130651|NCT04392154|530645695|FG002|Primary Treatment Period (100 Weeks)|Lack of Efficacy|0|||
147130652|NCT04392154|530645696|FG003|Primary Treatment Period (100 Weeks)|Lack of Efficacy|0|||
147130653|NCT04392154|530645693|FG000|Primary Treatment Period (100 Weeks)|Lost to Follow-up|11|||
147130654|NCT04392154|530645694|FG001|Primary Treatment Period (100 Weeks)|Lost to Follow-up|61|||
147130655|NCT04392154|530645695|FG002|Primary Treatment Period (100 Weeks)|Lost to Follow-up|0|||
147130656|NCT04392154|530645696|FG003|Primary Treatment Period (100 Weeks)|Lost to Follow-up|0|||
147130657|NCT04392154|530645693|FG000|Primary Treatment Period (100 Weeks)|Geopolitical conflict|1|||
147130658|NCT04392154|530645694|FG001|Primary Treatment Period (100 Weeks)|Geopolitical conflict|1|||
147130659|NCT04392154|530645695|FG002|Primary Treatment Period (100 Weeks)|Geopolitical conflict|0|||
147317457|NCT02718417|531329297|FG000|Chemotherapy Phase (CP)|Adverse Event|9|||
147651332|NCT04227405|532546435|FG001|Enrollment - Time 1 PreTest|Schedule conflict /uninterested/Barriers|78|||
147651333|NCT04227405|532546434|FG000|Time 1 PreTest - Time 2 PostTest|Conflict schedule/uninterested/barriers|82|||
147130660|NCT04392154|530645696|FG003|Primary Treatment Period (100 Weeks)|Geopolitical conflict|0|||
147130661|NCT04392154|530645693|FG000|Primary Treatment Period (100 Weeks)|Physician Decision|1|||
147130662|NCT04392154|530645694|FG001|Primary Treatment Period (100 Weeks)|Physician Decision|5|||
147130663|NCT04392154|530645695|FG002|Primary Treatment Period (100 Weeks)|Physician Decision|0|||
147317458|NCT02718417|531329298|FG001|Chemotherapy Phase (CP)|Adverse Event|14|||
147569831|NCT00579345|532243423|FG003|Overall Study|Lost to Follow-up|0|||
147569832|NCT00579345|532243424|FG004|Overall Study|Lost to Follow-up|0|||
147569833|NCT00579345|532243425|FG005|Overall Study|Lost to Follow-up|0|||
147569834|NCT00579345|532243426|FG006|Overall Study|Lost to Follow-up|0|||
147569835|NCT00579345|532243427|FG007|Overall Study|Lost to Follow-up|0|||
147569836|NCT00579345|532243420|FG000|Overall Study|Adverse Event|0|||
147130664|NCT04392154|530645696|FG003|Primary Treatment Period (100 Weeks)|Physician Decision|0|||
147130665|NCT04392154|530645693|FG000|Primary Treatment Period (100 Weeks)|Pregnancy|1|||
147130666|NCT04392154|530645694|FG001|Primary Treatment Period (100 Weeks)|Pregnancy|8|||
147130667|NCT04392154|530645695|FG002|Primary Treatment Period (100 Weeks)|Pregnancy|0|||
147130668|NCT04392154|530645696|FG003|Primary Treatment Period (100 Weeks)|Pregnancy|0|||
147130669|NCT04392154|530645693|FG000|Primary Treatment Period (100 Weeks)|Protocol deviation|1|||
147130670|NCT04392154|530645694|FG001|Primary Treatment Period (100 Weeks)|Protocol deviation|12|||
147130671|NCT04392154|530645695|FG002|Primary Treatment Period (100 Weeks)|Protocol deviation|0|||
147130672|NCT04392154|530645696|FG003|Primary Treatment Period (100 Weeks)|Protocol deviation|0|||
147130673|NCT04392154|530645693|FG000|Primary Treatment Period (100 Weeks)|Withdrawal by Subject|18|||
147130674|NCT04392154|530645694|FG001|Primary Treatment Period (100 Weeks)|Withdrawal by Subject|138|||
147130675|NCT04392154|530645695|FG002|Primary Treatment Period (100 Weeks)|Withdrawal by Subject|0|||
147130676|NCT04392154|530645696|FG003|Primary Treatment Period (100 Weeks)|Withdrawal by Subject|0|||
147130677|NCT04392154|530645693|FG000|Primary Treatment Period (100 Weeks)|Sponsor Decision|1|||
147130678|NCT04392154|530645694|FG001|Primary Treatment Period (100 Weeks)|Sponsor Decision|14|||
147130679|NCT04392154|530645695|FG002|Primary Treatment Period (100 Weeks)|Sponsor Decision|0|||
147130680|NCT04392154|530645696|FG003|Primary Treatment Period (100 Weeks)|Sponsor Decision|0|||
147130681|NCT04392154|530645693|FG000|Primary Treatment Period (100 Weeks)|Site Closure|0|||
147130682|NCT04392154|530645694|FG001|Primary Treatment Period (100 Weeks)|Site Closure|4|||
147130683|NCT04392154|530645695|FG002|Primary Treatment Period (100 Weeks)|Site Closure|0|||
147130684|NCT04392154|530645696|FG003|Primary Treatment Period (100 Weeks)|Site Closure|0|||
147130685|NCT04392154|530645693|FG000|Open-Label Extension Addendum (32 Weeks)|Lost to Follow-up|0|||
147130686|NCT04392154|530645694|FG001|Open-Label Extension Addendum (32 Weeks)|Lost to Follow-up|0|||
147130687|NCT04392154|530645695|FG002|Open-Label Extension Addendum (32 Weeks)|Lost to Follow-up|0|||
147130688|NCT04392154|530645696|FG003|Open-Label Extension Addendum (32 Weeks)|Lost to Follow-up|1|||
147130689|NCT04392154|530645693|FG000|Open-Label Extension Addendum (32 Weeks)|Protocol Deviation|0|||
147130690|NCT04392154|530645694|FG001|Open-Label Extension Addendum (32 Weeks)|Protocol Deviation|0|||
147130691|NCT04392154|530645695|FG002|Open-Label Extension Addendum (32 Weeks)|Protocol Deviation|1|||
147130692|NCT04392154|530645696|FG003|Open-Label Extension Addendum (32 Weeks)|Protocol Deviation|0|||
147130693|NCT04392154|530645693|FG000|Open-Label Extension Addendum (32 Weeks)|Withdrawal by Subject|0|||
147130694|NCT04392154|530645694|FG001|Open-Label Extension Addendum (32 Weeks)|Withdrawal by Subject|0|||
147130695|NCT04392154|530645695|FG002|Open-Label Extension Addendum (32 Weeks)|Withdrawal by Subject|0|||
147130696|NCT04392154|530645696|FG003|Open-Label Extension Addendum (32 Weeks)|Withdrawal by Subject|1|||
147130697|NCT01559935|530645697|FG000|Car Phase|Toxicity|4|||
147130698|NCT01559935|530645697|FG000|Car Phase|Death|1|||
147130699|NCT01559935|530645697|FG000|Car Phase|Lack of Efficacy|2|||
147130700|NCT01559935|530645697|FG000|Car Phase|Lost to Follow-up|1|||
147130701|NCT01559935|530645697|FG000|Car Phase|Physician Decision|1|||
147130702|NCT01559935|530645697|FG000|Car Phase|Withdrawal by Subject|2|||
147130703|NCT01559935|530645697|FG000|Car Phase|Per protocol|1|||
147130704|NCT01559935|530645697|FG000|Car Phase|Insurance|1|||
147130705|NCT01559935|530645697|FG000|Car Phase|non-compliance|1|||
147130706|NCT01559935|530645697|FG000|BiRD Phase|Toxicity|1|||
147130707|NCT01559935|530645697|FG000|BiRD Phase|Lack of Efficacy|1|||
147130708|NCT01559935|530645697|FG000|BiRD Phase|Withdrawal by Subject|2|||
147130709|NCT01559935|530645697|FG000|Maintenance Phase|Remains on study|28|||
147130710|NCT01559935|530645697|FG000|Maintenance Phase|Toxicity|1|||
147130711|NCT01559935|530645697|FG000|Maintenance Phase|Lack of Efficacy|18|||
147130712|NCT01559935|530645697|FG000|Maintenance Phase|Withdrawal by Subject|5|||
147236013|NCT02975336|531035507|FG003|DBPC (52 Weeks)|Adverse Event|18|||
147236014|NCT02975336|531035508|FG004|DBPC (52 Weeks)|Adverse Event|0|||
147236015|NCT02975336|531035509|FG005|DBPC (52 Weeks)|Adverse Event|0|||
147236016|NCT02975336|531035510|FG006|DBPC (52 Weeks)|Adverse Event|0|||
147236017|NCT02975336|531035511|FG007|DBPC (52 Weeks)|Adverse Event|0|||
147236018|NCT02975336|531035504|FG000|DBPC (52 Weeks)|Lost to Follow-up|2|||
147236019|NCT02975336|531035505|FG001|DBPC (52 Weeks)|Lost to Follow-up|1|||
147236020|NCT02975336|531035506|FG002|DBPC (52 Weeks)|Lost to Follow-up|2|||
147236021|NCT02975336|531035507|FG003|DBPC (52 Weeks)|Lost to Follow-up|4|||
147236022|NCT02975336|531035508|FG004|DBPC (52 Weeks)|Lost to Follow-up|0|||
147236023|NCT02975336|531035509|FG005|DBPC (52 Weeks)|Lost to Follow-up|0|||
147236024|NCT02975336|531035510|FG006|DBPC (52 Weeks)|Lost to Follow-up|0|||
147130713|NCT01559935|530645697|FG000|Maintenance Phase|Non-compliance|2|||
147130714|NCT02661815|530645698|FG000|Overall Study|Withdrawal by Subject|1|||
147130715|NCT02661815|530645699|FG001|Overall Study|Withdrawal by Subject|0|||
147236025|NCT02975336|531035511|FG007|DBPC (52 Weeks)|Lost to Follow-up|0|||
147236026|NCT02975336|531035504|FG000|DBPC (52 Weeks)|Protocol Violation|4|||
147236027|NCT02975336|531035505|FG001|DBPC (52 Weeks)|Protocol Violation|1|||
147130716|NCT02661815|530645700|FG002|Overall Study|Withdrawal by Subject|0|||
147130717|NCT02661815|530645701|FG003|Overall Study|Withdrawal by Subject|0|||
147130718|NCT05805150|530645704|FG000|Period 2 (1 Week)|Should not have been enrolled. Participant was nursing (lactating).|0|||
147236028|NCT02975336|531035506|FG002|DBPC (52 Weeks)|Protocol Violation|3|||
147659419|NCT01064414|532576183|FG002|Core Period: Baseline to Week 26|Protocol Violation|1|||
147130719|NCT05805150|530645705|FG001|Period 2 (1 Week)|Should not have been enrolled. Participant was nursing (lactating).|1|||
147130720|NCT01983111|530645706|FG000|Overall Study|Withdrawal by Subject|8|||
147130721|NCT01983111|530645707|FG001|Overall Study|Withdrawal by Subject|6|||
147130722|NCT01983111|530645706|FG000|Overall Study|Adverse Event|4|||
147130723|NCT01983111|530645707|FG001|Overall Study|Adverse Event|0|||
147130724|NCT01983111|530645706|FG000|Overall Study|Protocol Violation|0|||
147130725|NCT01983111|530645707|FG001|Overall Study|Protocol Violation|1|||
147569837|NCT00579345|532243421|FG001|Overall Study|Adverse Event|0|||
147569838|NCT00579345|532243422|FG002|Overall Study|Adverse Event|1|||
147569839|NCT00579345|532243423|FG003|Overall Study|Adverse Event|0|||
147569840|NCT00579345|532243424|FG004|Overall Study|Adverse Event|0|||
147569841|NCT00579345|532243425|FG005|Overall Study|Adverse Event|0|||
147569842|NCT00579345|532243426|FG006|Overall Study|Adverse Event|0|||
147569843|NCT00579345|532243427|FG007|Overall Study|Adverse Event|0|||
147569844|NCT00579345|532243420|FG000|Overall Study|Protocol Violation|1|||
147569845|NCT00579345|532243421|FG001|Overall Study|Protocol Violation|0|||
147569846|NCT00579345|532243422|FG002|Overall Study|Protocol Violation|0|||
147569847|NCT00579345|532243423|FG003|Overall Study|Protocol Violation|0|||
147569848|NCT00579345|532243424|FG004|Overall Study|Protocol Violation|0|||
147569849|NCT00579345|532243425|FG005|Overall Study|Protocol Violation|0|||
147569850|NCT00579345|532243426|FG006|Overall Study|Protocol Violation|0|||
147569851|NCT00579345|532243427|FG007|Overall Study|Protocol Violation|1|||
147569852|NCT00579345|532243420|FG000|Overall Study|Death|1|||
147569853|NCT00579345|532243421|FG001|Overall Study|Death|1|||
147569854|NCT00579345|532243422|FG002|Overall Study|Death|1|||
147569855|NCT00579345|532243423|FG003|Overall Study|Death|1|||
147569856|NCT00579345|532243424|FG004|Overall Study|Death|0|||
147569857|NCT00579345|532243425|FG005|Overall Study|Death|0|||
147569858|NCT00579345|532243426|FG006|Overall Study|Death|0|||
147569859|NCT00579345|532243427|FG007|Overall Study|Death|0|||
147569860|NCT03447353|532243431|FG000|Overall Study|Failure at Screening Visit|2|||
147569861|NCT03447353|532243431|FG000|Overall Study|Lost to Follow-up|4|||
147569862|NCT03447353|532243431|FG000|Overall Study|Scheduling Conflicts|3|||
147569863|NCT03447353|532243431|FG000|Overall Study|Withdrew - Nausea Study V1, Sim Drive|1|||
147569864|NCT02057835|532243432|FG000|Overall Study|Withdrawal by Subject|0|||
147569865|NCT02057835|532243433|FG001|Overall Study|Withdrawal by Subject|2|||
147569866|NCT02057835|532243434|FG002|Overall Study|Withdrawal by Subject|0|||
147569867|NCT02057835|532243435|FG003|Overall Study|Withdrawal by Subject|0|||
147569868|NCT02057835|532243436|FG004|Overall Study|Withdrawal by Subject|0|||
147130726|NCT00105066|530645711|FG000|Overall Study|Adverse Event|2|||
147317459|NCT02718417|531329299|FG002|Chemotherapy Phase (CP)|Adverse Event|13|||
147317460|NCT02718417|531329297|FG000|Chemotherapy Phase (CP)|Death leading to discontinuation|5|||
147317461|NCT02718417|531329298|FG001|Chemotherapy Phase (CP)|Death leading to discontinuation|4|||
147317462|NCT02718417|531329299|FG002|Chemotherapy Phase (CP)|Death leading to discontinuation|1|||
147317463|NCT02718417|531329297|FG000|Chemotherapy Phase (CP)|Global deterioration of health status|3|||
147317464|NCT02718417|531329298|FG001|Chemotherapy Phase (CP)|Global deterioration of health status|2|||
147317465|NCT02718417|531329299|FG002|Chemotherapy Phase (CP)|Global deterioration of health status|1|||
147317466|NCT02718417|531329297|FG000|Chemotherapy Phase (CP)|No longer met eligibility criteria|4|||
147317467|NCT02718417|531329298|FG001|Chemotherapy Phase (CP)|No longer met eligibility criteria|2|||
147317468|NCT02718417|531329299|FG002|Chemotherapy Phase (CP)|No longer met eligibility criteria|1|||
147317469|NCT02718417|531329297|FG000|Chemotherapy Phase (CP)|Physician's decision|5|||
147317470|NCT02718417|531329298|FG001|Chemotherapy Phase (CP)|Physician's decision|0|||
147317471|NCT02718417|531329299|FG002|Chemotherapy Phase (CP)|Physician's decision|4|||
147317472|NCT02718417|531329297|FG000|Chemotherapy Phase (CP)|Progressive disease|11|||
147317473|NCT02718417|531329298|FG001|Chemotherapy Phase (CP)|Progressive disease|7|||
147317474|NCT02718417|531329299|FG002|Chemotherapy Phase (CP)|Progressive disease|10|||
147317475|NCT02718417|531329297|FG000|Chemotherapy Phase (CP)|Withdrawal by Subject|13|||
147317476|NCT02718417|531329298|FG001|Chemotherapy Phase (CP)|Withdrawal by Subject|8|||
147317477|NCT02718417|531329299|FG002|Chemotherapy Phase (CP)|Withdrawal by Subject|15|||
147651334|NCT04227405|532546435|FG001|Time 1 PreTest - Time 2 PostTest|Conflict schedule/uninterested/barriers|68|||
147130727|NCT00105066|530645712|FG001|Overall Study|Adverse Event|5|||
147130728|NCT01467466|530645713|FG000|Overall Study|Withdrawal by Subject|15|||
147317478|NCT02718417|531329297|FG000|Chemotherapy Phase (CP)|Other|2|||
147651335|NCT04227405|532546434|FG000|Time 2 PostTest - Time 3 Followup|Uninterested-Barriers to participation|68|||
147317479|NCT02718417|531329298|FG001|Chemotherapy Phase (CP)|Other|0|||
147317480|NCT02718417|531329299|FG002|Chemotherapy Phase (CP)|Other|1|||
147317481|NCT02718417|531329297|FG000|Maintenance Phase (MP)|Adverse Event|21|||
147569869|NCT02057835|532243437|FG005|Overall Study|Withdrawal by Subject|0|||
147569870|NCT02057835|532243438|FG006|Overall Study|Withdrawal by Subject|0|||
147569871|NCT02057835|532243439|FG007|Overall Study|Withdrawal by Subject|0|||
147569872|NCT02057835|532243440|FG008|Overall Study|Withdrawal by Subject|0|||
147569873|NCT02057835|532243441|FG009|Overall Study|Withdrawal by Subject|0|||
147569874|NCT04299087|532243442|FG000|Overall Study|Lost to Follow-up|2|||
147569875|NCT04299087|532243443|FG001|Overall Study|Lost to Follow-up|1|||
147569876|NCT03025087|532243444|FG000|Overall Study|Physician Decision|3|||
147569877|NCT03025087|532243445|FG001|Overall Study|Physician Decision|3|||
147569878|NCT03025087|532243446|FG002|Overall Study|Physician Decision|0|||
147569879|NCT03025087|532243447|FG003|Overall Study|Physician Decision|0|||
147569880|NCT03025087|532243448|FG004|Overall Study|Physician Decision|0|||
147569881|NCT03025087|532243444|FG000|Overall Study|Withdrawal by Subject|1|||
147569882|NCT03025087|532243445|FG001|Overall Study|Withdrawal by Subject|1|||
147569883|NCT03025087|532243446|FG002|Overall Study|Withdrawal by Subject|0|||
147569884|NCT03025087|532243447|FG003|Overall Study|Withdrawal by Subject|0|||
147569885|NCT03025087|532243448|FG004|Overall Study|Withdrawal by Subject|0|||
147569886|NCT03025087|532243444|FG000|Overall Study|Unable to complete MRI|2|||
147569887|NCT03025087|532243445|FG001|Overall Study|Unable to complete MRI|2|||
147569888|NCT03025087|532243446|FG002|Overall Study|Unable to complete MRI|0|||
147569889|NCT03025087|532243447|FG003|Overall Study|Unable to complete MRI|0|||
147569890|NCT03025087|532243448|FG004|Overall Study|Unable to complete MRI|0|||
147569891|NCT00508651|532243449|FG000|Overall Study|Lost to Follow-up|3|||
147569892|NCT00508651|532243450|FG001|Overall Study|Lost to Follow-up|1|||
147569893|NCT00508651|532243449|FG000|Overall Study|Withdrawal by Subject|1|||
147569894|NCT00508651|532243450|FG001|Overall Study|Withdrawal by Subject|1|||
147569895|NCT01376037|532243452|FG000|Overall Study|Lost to Follow-up|0|||
147569896|NCT01376037|532243453|FG001|Overall Study|Lost to Follow-up|2|||
147317482|NCT02718417|531329298|FG001|Maintenance Phase (MP)|Adverse Event|26|||
147317483|NCT02718417|531329299|FG002|Maintenance Phase (MP)|Adverse Event|0|||
147317484|NCT02718417|531329297|FG000|Maintenance Phase (MP)|Death leading to discontinuation|1|||
147317485|NCT02718417|531329298|FG001|Maintenance Phase (MP)|Death leading to discontinuation|1|||
147317486|NCT02718417|531329299|FG002|Maintenance Phase (MP)|Death leading to discontinuation|0|||
147317487|NCT02718417|531329297|FG000|Maintenance Phase (MP)|Global deterioration of health status|5|||
147317488|NCT02718417|531329298|FG001|Maintenance Phase (MP)|Global deterioration of health status|3|||
147317489|NCT02718417|531329299|FG002|Maintenance Phase (MP)|Global deterioration of health status|0|||
147317490|NCT02718417|531329297|FG000|Maintenance Phase (MP)|No longer met eligibility criteria|0|||
147317491|NCT02718417|531329298|FG001|Maintenance Phase (MP)|No longer met eligibility criteria|1|||
147317492|NCT02718417|531329299|FG002|Maintenance Phase (MP)|No longer met eligibility criteria|0|||
147317493|NCT02718417|531329297|FG000|Maintenance Phase (MP)|Physician's decision|6|||
147317494|NCT02718417|531329298|FG001|Maintenance Phase (MP)|Physician's decision|7|||
147317495|NCT02718417|531329299|FG002|Maintenance Phase (MP)|Physician's decision|0|||
147569897|NCT01111461|532243454|FG000|Overall Study|Adverse Event|32|||
147569898|NCT01111461|532243454|FG000|Overall Study|Participant choice|11|||
147569899|NCT01111461|532243454|FG000|Overall Study|Lost to Follow-up|1|||
147569900|NCT01111461|532243454|FG000|Overall Study|Withdrawal by Subject|1|||
147569901|NCT01111461|532243454|FG000|Overall Study|Other|6|||
147569902|NCT00834067|532243457|FG000|Washout of 21 Days|Protocol Violation|0|||
147569903|NCT00834067|532243458|FG001|Washout of 21 Days|Protocol Violation|1|||
147569904|NCT00440518|532243459|FG000|Randomized /Titration Period|Lack of Efficacy|1|||
147569905|NCT00440518|532243460|FG001|Randomized /Titration Period|Lack of Efficacy|0|||
147569906|NCT00440518|532243461|FG002|Randomized /Titration Period|Lack of Efficacy|1|||
147569907|NCT00440518|532243459|FG000|Randomized /Titration Period|Subject Withdrew Consent|4|||
147569908|NCT00440518|532243460|FG001|Randomized /Titration Period|Subject Withdrew Consent|1|||
147317496|NCT02718417|531329297|FG000|Maintenance Phase (MP)|Progressive disease|100|||
147569909|NCT00440518|532243461|FG002|Randomized /Titration Period|Subject Withdrew Consent|0|||
147569910|NCT00440518|532243459|FG000|Randomized /Titration Period|Protocol Deviation|1|||
147569911|NCT00440518|532243460|FG001|Randomized /Titration Period|Protocol Deviation|0|||
147569912|NCT00440518|532243461|FG002|Randomized /Titration Period|Protocol Deviation|0|||
147569913|NCT00440518|532243459|FG000|Randomized /Titration Period|Unsatisfactory Compliance|2|||
147569914|NCT00440518|532243460|FG001|Randomized /Titration Period|Unsatisfactory Compliance|3|||
147569915|NCT00440518|532243461|FG002|Randomized /Titration Period|Unsatisfactory Compliance|2|||
147569916|NCT00440518|532243459|FG000|Randomized /Titration Period|Other|1|||
147569917|NCT00440518|532243460|FG001|Randomized /Titration Period|Other|0|||
147569918|NCT00440518|532243461|FG002|Randomized /Titration Period|Other|0|||
147569919|NCT00440518|532243459|FG000|Randomized /Titration Period|Lost to Follow-up|2|||
147569920|NCT00440518|532243460|FG001|Randomized /Titration Period|Lost to Follow-up|2|||
147569921|NCT00440518|532243461|FG002|Randomized /Titration Period|Lost to Follow-up|1|||
147569922|NCT00440518|532243459|FG000|Randomized /Titration Period|Adverse Event|2|||
147317497|NCT02718417|531329298|FG001|Maintenance Phase (MP)|Progressive disease|88|||
147569923|NCT00440518|532243460|FG001|Randomized /Titration Period|Adverse Event|3|||
147569924|NCT00440518|532243461|FG002|Randomized /Titration Period|Adverse Event|0|||
147569925|NCT00440518|532243459|FG000|Maintenance and Safety Follow-up Periods|Adverse Event|3|||
147569926|NCT00440518|532243460|FG001|Maintenance and Safety Follow-up Periods|Adverse Event|4|||
147569927|NCT00440518|532243461|FG002|Maintenance and Safety Follow-up Periods|Adverse Event|2|||
147569928|NCT00440518|532243459|FG000|Maintenance and Safety Follow-up Periods|Lack of Efficacy|0|||
147569929|NCT00440518|532243460|FG001|Maintenance and Safety Follow-up Periods|Lack of Efficacy|1|||
147317498|NCT02718417|531329299|FG002|Maintenance Phase (MP)|Progressive disease|0|||
147569930|NCT00440518|532243461|FG002|Maintenance and Safety Follow-up Periods|Lack of Efficacy|1|||
147317499|NCT02718417|531329297|FG000|Maintenance Phase (MP)|Other|2|||
147317500|NCT02718417|531329298|FG001|Maintenance Phase (MP)|Other|1|||
147569931|NCT00440518|532243459|FG000|Maintenance and Safety Follow-up Periods|Subject Withdrew Consent|3|||
147569932|NCT00440518|532243460|FG001|Maintenance and Safety Follow-up Periods|Subject Withdrew Consent|2|||
147569933|NCT00440518|532243461|FG002|Maintenance and Safety Follow-up Periods|Subject Withdrew Consent|4|||
147569934|NCT00440518|532243459|FG000|Maintenance and Safety Follow-up Periods|Unsatisfactory Compliance|0|||
147569935|NCT00440518|532243460|FG001|Maintenance and Safety Follow-up Periods|Unsatisfactory Compliance|3|||
147569936|NCT00440518|532243461|FG002|Maintenance and Safety Follow-up Periods|Unsatisfactory Compliance|6|||
147569937|NCT00440518|532243459|FG000|Maintenance and Safety Follow-up Periods|Other|0|||
147569938|NCT00440518|532243460|FG001|Maintenance and Safety Follow-up Periods|Other|0|||
147569939|NCT00440518|532243461|FG002|Maintenance and Safety Follow-up Periods|Other|2|||
147569940|NCT00440518|532243459|FG000|Maintenance and Safety Follow-up Periods|Lost to Follow-up|1|||
147569941|NCT00440518|532243460|FG001|Maintenance and Safety Follow-up Periods|Lost to Follow-up|2|||
147569942|NCT00440518|532243461|FG002|Maintenance and Safety Follow-up Periods|Lost to Follow-up|0|||
147569943|NCT00561015|532243463|FG000|Overall Study|Adverse Event|0|||
147569944|NCT00561015|532243464|FG001|Overall Study|Adverse Event|0|||
147569945|NCT00561015|532243465|FG002|Overall Study|Adverse Event|0|||
147569946|NCT00561015|532243466|FG003|Overall Study|Adverse Event|0|||
147569947|NCT00561015|532243467|FG004|Overall Study|Adverse Event|1|||
147569948|NCT00561015|532243468|FG005|Overall Study|Adverse Event|0|||
147569949|NCT00561015|532243463|FG000|Overall Study|Lost to Follow-up|2|||
147569950|NCT00561015|532243464|FG001|Overall Study|Lost to Follow-up|0|||
147569951|NCT00561015|532243465|FG002|Overall Study|Lost to Follow-up|0|||
147569952|NCT00561015|532243466|FG003|Overall Study|Lost to Follow-up|1|||
147569953|NCT00561015|532243467|FG004|Overall Study|Lost to Follow-up|0|||
147569954|NCT00561015|532243468|FG005|Overall Study|Lost to Follow-up|3|||
147569955|NCT00561015|532243463|FG000|Overall Study|Participant non-compliance|2|||
147569956|NCT00561015|532243464|FG001|Overall Study|Participant non-compliance|0|||
147569957|NCT00561015|532243465|FG002|Overall Study|Participant non-compliance|0|||
147569958|NCT00561015|532243466|FG003|Overall Study|Participant non-compliance|0|||
147569959|NCT00561015|532243467|FG004|Overall Study|Participant non-compliance|0|||
147569960|NCT00561015|532243468|FG005|Overall Study|Participant non-compliance|0|||
147569961|NCT03570749|532243469|FG000|Overall Study|Ongoing|26|||
147569962|NCT03570749|532243470|FG001|Overall Study|Ongoing|25|||
147569963|NCT03570749|532243471|FG002|Overall Study|Ongoing|25|||
147569964|NCT03570749|532243472|FG003|Overall Study|Ongoing|26|||
147569965|NCT03570749|532243473|FG004|Overall Study|Ongoing|140|||
147569966|NCT03570749|532243474|FG005|Overall Study|Ongoing|142|||
147569967|NCT03570749|532243475|FG006|Overall Study|Ongoing|220|||
147569968|NCT03570749|532243469|FG000|Overall Study|Adverse Event|0|||
147569969|NCT03570749|532243470|FG001|Overall Study|Adverse Event|0|||
147569970|NCT03570749|532243471|FG002|Overall Study|Adverse Event|0|||
147569971|NCT03570749|532243472|FG003|Overall Study|Adverse Event|0|||
147569972|NCT03570749|532243473|FG004|Overall Study|Adverse Event|2|||
147569973|NCT03570749|532243474|FG005|Overall Study|Adverse Event|3|||
147569974|NCT03570749|532243475|FG006|Overall Study|Adverse Event|6|||
147569975|NCT03570749|532243469|FG000|Overall Study|Lack of Efficacy|0|||
147569976|NCT03570749|532243470|FG001|Overall Study|Lack of Efficacy|0|||
147569977|NCT03570749|532243471|FG002|Overall Study|Lack of Efficacy|0|||
147569978|NCT03570749|532243472|FG003|Overall Study|Lack of Efficacy|0|||
147569979|NCT03570749|532243473|FG004|Overall Study|Lack of Efficacy|8|||
147569980|NCT03570749|532243474|FG005|Overall Study|Lack of Efficacy|2|||
147569981|NCT03570749|532243475|FG006|Overall Study|Lack of Efficacy|7|||
147317501|NCT02718417|531329299|FG002|Maintenance Phase (MP)|Other|0|||
147317502|NCT02718417|531329297|FG000|Maintenance Phase (MP)|Withdrawal by Subject|17|||
147317503|NCT02718417|531329298|FG001|Maintenance Phase (MP)|Withdrawal by Subject|20|||
147569982|NCT03570749|532243469|FG000|Overall Study|Lost to Follow-up|0|||
147569983|NCT03570749|532243470|FG001|Overall Study|Lost to Follow-up|0|||
147569984|NCT03570749|532243471|FG002|Overall Study|Lost to Follow-up|0|||
147569985|NCT03570749|532243472|FG003|Overall Study|Lost to Follow-up|0|||
147569986|NCT03570749|532243473|FG004|Overall Study|Lost to Follow-up|5|||
147569987|NCT03570749|532243474|FG005|Overall Study|Lost to Follow-up|10|||
147569988|NCT03570749|532243475|FG006|Overall Study|Lost to Follow-up|10|||
147569989|NCT03570749|532243469|FG000|Overall Study|Pregnancy|0|||
147569990|NCT03570749|532243470|FG001|Overall Study|Pregnancy|0|||
147569991|NCT03570749|532243471|FG002|Overall Study|Pregnancy|0|||
147569992|NCT03570749|532243472|FG003|Overall Study|Pregnancy|0|||
147569993|NCT03570749|532243473|FG004|Overall Study|Pregnancy|0|||
147569994|NCT03570749|532243474|FG005|Overall Study|Pregnancy|1|||
147569995|NCT03570749|532243475|FG006|Overall Study|Pregnancy|1|||
147569996|NCT03570749|532243469|FG000|Overall Study|Screen Fail|0|||
147569997|NCT03570749|532243470|FG001|Overall Study|Screen Fail|0|||
147317504|NCT02718417|531329299|FG002|Maintenance Phase (MP)|Withdrawal by Subject|0|||
147569998|NCT03570749|532243471|FG002|Overall Study|Screen Fail|0|||
147569999|NCT03570749|532243472|FG003|Overall Study|Screen Fail|0|||
147570000|NCT03570749|532243473|FG004|Overall Study|Screen Fail|0|||
147570001|NCT03570749|532243474|FG005|Overall Study|Screen Fail|0|||
147570002|NCT03570749|532243475|FG006|Overall Study|Screen Fail|1|||
147570003|NCT03570749|532243469|FG000|Overall Study|Withdrawal by Subject|2|||
147570004|NCT03570749|532243470|FG001|Overall Study|Withdrawal by Subject|3|||
147570005|NCT03570749|532243471|FG002|Overall Study|Withdrawal by Subject|2|||
147570006|NCT03570749|532243472|FG003|Overall Study|Withdrawal by Subject|1|||
147570007|NCT03570749|532243473|FG004|Overall Study|Withdrawal by Subject|17|||
147570008|NCT03570749|532243474|FG005|Overall Study|Withdrawal by Subject|12|||
147570009|NCT03570749|532243475|FG006|Overall Study|Withdrawal by Subject|15|||
147570010|NCT03570749|532243469|FG000|Overall Study|Other|0|||
147570011|NCT03570749|532243470|FG001|Overall Study|Other|0|||
147570012|NCT03570749|532243471|FG002|Overall Study|Other|0|||
147570013|NCT03570749|532243472|FG003|Overall Study|Other|0|||
147570014|NCT03570749|532243473|FG004|Overall Study|Other|17|||
147570015|NCT03570749|532243474|FG005|Overall Study|Other|14|||
147570016|NCT03570749|532243475|FG006|Overall Study|Other|21|||
147570017|NCT03616535|532243476|FG000|Overall Study|Death|2|||
147570018|NCT03616535|532243477|FG001|Overall Study|Death|0|||
147570019|NCT03616535|532243478|FG002|Overall Study|Death|0|||
147570020|NCT03616535|532243479|FG003|Overall Study|Death|1|||
147570021|NCT03616535|532243476|FG000|Overall Study|Lost to Follow-up|2|||
147570022|NCT03616535|532243477|FG001|Overall Study|Lost to Follow-up|1|||
147570023|NCT03616535|532243478|FG002|Overall Study|Lost to Follow-up|0|||
147570024|NCT03616535|532243479|FG003|Overall Study|Lost to Follow-up|2|||
147570025|NCT03616535|532243476|FG000|Overall Study|Withdrawal by Subject|1|||
147570026|NCT03616535|532243477|FG001|Overall Study|Withdrawal by Subject|2|||
147570027|NCT03616535|532243478|FG002|Overall Study|Withdrawal by Subject|5|||
147570028|NCT03616535|532243479|FG003|Overall Study|Withdrawal by Subject|1|||
147570029|NCT03616535|532243476|FG000|Overall Study|Not specified or change in eligibility|2|||
147570030|NCT03616535|532243477|FG001|Overall Study|Not specified or change in eligibility|3|||
147570031|NCT03616535|532243478|FG002|Overall Study|Not specified or change in eligibility|3|||
147570032|NCT03616535|532243479|FG003|Overall Study|Not specified or change in eligibility|1|||
147570033|NCT02545283|532243480|FG000|Overall Study|Lost to Follow-up|2|||
147130729|NCT01467466|530645714|FG001|Overall Study|Withdrawal by Subject|18|||
147130730|NCT01467466|530645715|FG002|Overall Study|Withdrawal by Subject|13|||
147130731|NCT01467466|530645716|FG003|Overall Study|Withdrawal by Subject|11|||
147130732|NCT01467466|530645713|FG000|Overall Study|Revoked Consent Prior To Procedure|10|||
147130733|NCT01467466|530645714|FG001|Overall Study|Revoked Consent Prior To Procedure|9|||
147130734|NCT01467466|530645715|FG002|Overall Study|Revoked Consent Prior To Procedure|15|||
147130735|NCT01467466|530645716|FG003|Overall Study|Revoked Consent Prior To Procedure|5|||
147130736|NCT01467466|530645713|FG000|Overall Study|Procedure Cancelled|46|||
147236029|NCT02975336|531035507|FG003|DBPC (52 Weeks)|Protocol Violation|1|||
147570034|NCT02545283|532243481|FG001|Overall Study|Lost to Follow-up|4|||
147570035|NCT02545283|532243480|FG000|Overall Study|Withdrawal by Subject|5|||
147570036|NCT02545283|532243481|FG001|Overall Study|Withdrawal by Subject|9|||
147570037|NCT02545283|532243480|FG000|Overall Study|Death|109|||
147570038|NCT02545283|532243481|FG001|Overall Study|Death|211|||
147570039|NCT02545283|532243480|FG000|Overall Study|Did not complete due to 2 ineligibilities and physician's decision|0|||
147570040|NCT02545283|532243481|FG001|Overall Study|Did not complete due to 2 ineligibilities and physician's decision|3|||
147570041|NCT02545283|532243480|FG000|Overall Study|Study Terminated By Sponsor|33|||
147570042|NCT02545283|532243481|FG001|Overall Study|Study Terminated By Sponsor|71|||
147570043|NCT00804856|532243482|FG000|Overall Study|Progressive Disease|3|||
147236030|NCT02975336|531035508|FG004|DBPC (52 Weeks)|Protocol Violation|0|||
147236031|NCT02975336|531035509|FG005|DBPC (52 Weeks)|Protocol Violation|0|||
147236032|NCT02975336|531035510|FG006|DBPC (52 Weeks)|Protocol Violation|0|||
147236033|NCT02975336|531035511|FG007|DBPC (52 Weeks)|Protocol Violation|0|||
147236034|NCT02975336|531035504|FG000|DBPC (52 Weeks)|Lack of Efficacy|4|||
147236035|NCT02975336|531035505|FG001|DBPC (52 Weeks)|Lack of Efficacy|4|||
147236036|NCT02975336|531035506|FG002|DBPC (52 Weeks)|Lack of Efficacy|2|||
147236037|NCT02975336|531035507|FG003|DBPC (52 Weeks)|Lack of Efficacy|3|||
147236038|NCT02975336|531035508|FG004|DBPC (52 Weeks)|Lack of Efficacy|0|||
147236039|NCT02975336|531035509|FG005|DBPC (52 Weeks)|Lack of Efficacy|0|||
147236040|NCT02975336|531035510|FG006|DBPC (52 Weeks)|Lack of Efficacy|0|||
147236041|NCT02975336|531035511|FG007|DBPC (52 Weeks)|Lack of Efficacy|0|||
147570044|NCT00804856|532243483|FG001|Overall Study|Progressive Disease|2|||
147570045|NCT00804856|532243484|FG002|Overall Study|Progressive Disease|4|||
147570046|NCT00804856|532243485|FG003|Overall Study|Progressive Disease|6|||
147570047|NCT00804856|532243486|FG004|Overall Study|Progressive Disease|4|||
147570048|NCT00804856|532243487|FG005|Overall Study|Progressive Disease|1|||
147570049|NCT00804856|532243488|FG006|Overall Study|Progressive Disease|8|||
147570050|NCT00804856|532243489|FG007|Overall Study|Progressive Disease|2|||
147570051|NCT00804856|532243490|FG008|Overall Study|Progressive Disease|4|||
147570052|NCT00804856|532243491|FG009|Overall Study|Progressive Disease|5|||
147570053|NCT00804856|532243492|FG010|Overall Study|Progressive Disease|12|||
147570054|NCT00804856|532243493|FG011|Overall Study|Progressive Disease|2|||
147570055|NCT00804856|532243494|FG012|Overall Study|Progressive Disease|2|||
147570056|NCT00804856|532243495|FG013|Overall Study|Progressive Disease|26|||
147570057|NCT00804856|532243496|FG014|Overall Study|Progressive Disease|20|||
147570058|NCT00804856|532243482|FG000|Overall Study|Dose Limiting Toxicity (DLT)|0|||
147570059|NCT00804856|532243483|FG001|Overall Study|Dose Limiting Toxicity (DLT)|0|||
147570060|NCT00804856|532243484|FG002|Overall Study|Dose Limiting Toxicity (DLT)|0|||
147570061|NCT00804856|532243485|FG003|Overall Study|Dose Limiting Toxicity (DLT)|0|||
147570062|NCT00804856|532243486|FG004|Overall Study|Dose Limiting Toxicity (DLT)|1|||
147570063|NCT00804856|532243487|FG005|Overall Study|Dose Limiting Toxicity (DLT)|0|||
147570064|NCT00804856|532243488|FG006|Overall Study|Dose Limiting Toxicity (DLT)|0|||
147570065|NCT00804856|532243489|FG007|Overall Study|Dose Limiting Toxicity (DLT)|0|||
147570066|NCT00804856|532243490|FG008|Overall Study|Dose Limiting Toxicity (DLT)|0|||
147570067|NCT00804856|532243491|FG009|Overall Study|Dose Limiting Toxicity (DLT)|0|||
147570068|NCT00804856|532243492|FG010|Overall Study|Dose Limiting Toxicity (DLT)|0|||
147570069|NCT00804856|532243493|FG011|Overall Study|Dose Limiting Toxicity (DLT)|0|||
147570070|NCT00804856|532243494|FG012|Overall Study|Dose Limiting Toxicity (DLT)|0|||
147570071|NCT00804856|532243495|FG013|Overall Study|Dose Limiting Toxicity (DLT)|0|||
147570072|NCT00804856|532243496|FG014|Overall Study|Dose Limiting Toxicity (DLT)|1|||
147570073|NCT00804856|532243482|FG000|Overall Study|Other Adverse Event|1|||
147570074|NCT00804856|532243483|FG001|Overall Study|Other Adverse Event|1|||
147570075|NCT00804856|532243484|FG002|Overall Study|Other Adverse Event|1|||
147570076|NCT00804856|532243485|FG003|Overall Study|Other Adverse Event|2|||
147570077|NCT00804856|532243486|FG004|Overall Study|Other Adverse Event|2|||
147570078|NCT00804856|532243487|FG005|Overall Study|Other Adverse Event|1|||
147570079|NCT00804856|532243488|FG006|Overall Study|Other Adverse Event|3|||
147570080|NCT00804856|532243489|FG007|Overall Study|Other Adverse Event|0|||
147570081|NCT00804856|532243490|FG008|Overall Study|Other Adverse Event|0|||
147570082|NCT00804856|532243491|FG009|Overall Study|Other Adverse Event|1|||
147570083|NCT00804856|532243492|FG010|Overall Study|Other Adverse Event|5|||
147570084|NCT00804856|532243493|FG011|Overall Study|Other Adverse Event|2|||
147570085|NCT00804856|532243494|FG012|Overall Study|Other Adverse Event|0|||
147570086|NCT00804856|532243495|FG013|Overall Study|Other Adverse Event|6|||
147570087|NCT00804856|532243496|FG014|Overall Study|Other Adverse Event|13|||
147570088|NCT00804856|532243482|FG000|Overall Study|Non compliance with protocol|0|||
147570089|NCT00804856|532243483|FG001|Overall Study|Non compliance with protocol|0|||
147570090|NCT00804856|532243484|FG002|Overall Study|Non compliance with protocol|0|||
147570091|NCT00804856|532243485|FG003|Overall Study|Non compliance with protocol|0|||
147570092|NCT00804856|532243486|FG004|Overall Study|Non compliance with protocol|0|||
147570093|NCT00804856|532243487|FG005|Overall Study|Non compliance with protocol|0|||
147570094|NCT00804856|532243488|FG006|Overall Study|Non compliance with protocol|0|||
147570095|NCT00804856|532243489|FG007|Overall Study|Non compliance with protocol|0|||
147570096|NCT00804856|532243490|FG008|Overall Study|Non compliance with protocol|0|||
147570097|NCT00804856|532243491|FG009|Overall Study|Non compliance with protocol|0|||
147570098|NCT00804856|532243492|FG010|Overall Study|Non compliance with protocol|0|||
147570099|NCT00804856|532243493|FG011|Overall Study|Non compliance with protocol|0|||
147570100|NCT00804856|532243494|FG012|Overall Study|Non compliance with protocol|0|||
147570101|NCT00804856|532243495|FG013|Overall Study|Non compliance with protocol|2|||
147570102|NCT00804856|532243496|FG014|Overall Study|Non compliance with protocol|0|||
147570103|NCT00804856|532243482|FG000|Overall Study|Refused to continue medication|0|||
147570104|NCT00804856|532243483|FG001|Overall Study|Refused to continue medication|0|||
147570105|NCT00804856|532243484|FG002|Overall Study|Refused to continue medication|0|||
147570106|NCT00804856|532243485|FG003|Overall Study|Refused to continue medication|1|||
147570107|NCT00804856|532243486|FG004|Overall Study|Refused to continue medication|1|||
147570108|NCT00804856|532243487|FG005|Overall Study|Refused to continue medication|0|||
147570109|NCT00804856|532243488|FG006|Overall Study|Refused to continue medication|0|||
147570110|NCT00804856|532243489|FG007|Overall Study|Refused to continue medication|0|||
147570111|NCT00804856|532243490|FG008|Overall Study|Refused to continue medication|0|||
147570112|NCT00804856|532243491|FG009|Overall Study|Refused to continue medication|0|||
147570113|NCT00804856|532243492|FG010|Overall Study|Refused to continue medication|3|||
147570114|NCT00804856|532243493|FG011|Overall Study|Refused to continue medication|0|||
147570115|NCT00804856|532243494|FG012|Overall Study|Refused to continue medication|1|||
147570116|NCT00804856|532243495|FG013|Overall Study|Refused to continue medication|1|||
147570117|NCT00804856|532243496|FG014|Overall Study|Refused to continue medication|5|||
147570118|NCT00804856|532243482|FG000|Overall Study|Other reason than listed above|0|||
147570119|NCT00804856|532243483|FG001|Overall Study|Other reason than listed above|0|||
147570120|NCT00804856|532243484|FG002|Overall Study|Other reason than listed above|0|||
147570121|NCT00804856|532243485|FG003|Overall Study|Other reason than listed above|0|||
147570122|NCT00804856|532243486|FG004|Overall Study|Other reason than listed above|0|||
147570123|NCT00804856|532243487|FG005|Overall Study|Other reason than listed above|1|||
147570124|NCT00804856|532243488|FG006|Overall Study|Other reason than listed above|0|||
147570125|NCT00804856|532243489|FG007|Overall Study|Other reason than listed above|0|||
147570126|NCT00804856|532243490|FG008|Overall Study|Other reason than listed above|1|||
147570127|NCT00804856|532243491|FG009|Overall Study|Other reason than listed above|0|||
147570128|NCT00804856|532243492|FG010|Overall Study|Other reason than listed above|3|||
147570129|NCT00804856|532243493|FG011|Overall Study|Other reason than listed above|1|||
147570130|NCT00804856|532243494|FG012|Overall Study|Other reason than listed above|1|||
147651336|NCT04227405|532546435|FG001|Time 2 PostTest - Time 3 Followup|Uninterested-Barriers to participation|48|||
147570131|NCT00804856|532243495|FG013|Overall Study|Other reason than listed above|10|||
147570132|NCT00804856|532243496|FG014|Overall Study|Other reason than listed above|3|||
147570133|NCT00455312|532243497|FG000|Overall Study|Death|0|||
147570134|NCT00455312|532243498|FG001|Overall Study|Death|1|||
147570135|NCT03343535|532243499|FG000|Overall Study|Lost to Follow-up|1|||
147570136|NCT03343535|532243499|FG000|Overall Study|Subject Discontinued Due to Re-transplant|1|||
147570137|NCT03343535|532243499|FG000|Overall Study|Death|12|||
147570138|NCT03868891|532243500|FG000|Overall Study|Adverse Event|1|||
147570139|NCT03868891|532243501|FG001|Overall Study|Adverse Event|0|||
147570140|NCT03868891|532243500|FG000|Overall Study|Lost to Follow-up|2|||
147570141|NCT03868891|532243501|FG001|Overall Study|Lost to Follow-up|1|||
147570142|NCT03868891|532243500|FG000|Overall Study|COVID-19 Restrictions|1|||
147570143|NCT03868891|532243501|FG001|Overall Study|COVID-19 Restrictions|2|||
147570144|NCT01518972|532243502|FG000|Overall Study|Lost to Follow-up|2|||
147570145|NCT01518972|532243503|FG001|Overall Study|Lost to Follow-up|1|||
147570146|NCT01518972|532243502|FG000|Overall Study|Withdrawal by Subject|1|||
147570147|NCT01518972|532243503|FG001|Overall Study|Withdrawal by Subject|0|||
147570148|NCT01518972|532243502|FG000|Overall Study|Moved from area|1|||
147570149|NCT01518972|532243503|FG001|Overall Study|Moved from area|0|||
147570150|NCT01518972|532243502|FG000|Overall Study|Transportation problems|1|||
147570151|NCT01518972|532243503|FG001|Overall Study|Transportation problems|0|||
147570152|NCT01518972|532243502|FG000|Overall Study|Exclusionary medical condition|1|||
147570153|NCT01518972|532243503|FG001|Overall Study|Exclusionary medical condition|0|||
147570154|NCT01518972|532243502|FG000|Overall Study|Missed safety visits|0|||
147570155|NCT01518972|532243503|FG001|Overall Study|Missed safety visits|1|||
147570156|NCT01518972|532243502|FG000|Overall Study|Exclusionary medication|0|||
147570157|NCT01518972|532243503|FG001|Overall Study|Exclusionary medication|1|||
147570158|NCT01518972|532243502|FG000|Overall Study|Declined medication starting on day 12|0|||
147570159|NCT01518972|532243503|FG001|Overall Study|Declined medication starting on day 12|1|||
147570160|NCT02159950|532243508|FG000|Overall Study|Adverse Event|0|||
147570161|NCT02159950|532243509|FG001|Overall Study|Adverse Event|1|||
147570162|NCT02159950|532243508|FG000|Overall Study|Progression|0|||
147570163|NCT02159950|532243509|FG001|Overall Study|Progression|1|||
147570164|NCT02009163|532243515|FG000|Open-label Period (Non-randomized)|Failure to Meet Randomization Criteria|48|||
147570165|NCT02009163|532243516|FG001|Open-label Period (Non-randomized)|Failure to Meet Randomization Criteria|0|||
147570166|NCT02009163|532243517|FG002|Open-label Period (Non-randomized)|Failure to Meet Randomization Criteria|0|||
147570167|NCT02009163|532243515|FG000|Open-label Period (Non-randomized)|Withdrawal by Subject|29|||
147570168|NCT02009163|532243516|FG001|Open-label Period (Non-randomized)|Withdrawal by Subject|0|||
147570169|NCT02009163|532243517|FG002|Open-label Period (Non-randomized)|Withdrawal by Subject|0|||
147570170|NCT02009163|532243515|FG000|Open-label Period (Non-randomized)|Adverse Event|22|||
147570171|NCT02009163|532243516|FG001|Open-label Period (Non-randomized)|Adverse Event|0|||
147570172|NCT02009163|532243517|FG002|Open-label Period (Non-randomized)|Adverse Event|0|||
147570173|NCT02009163|532243515|FG000|Open-label Period (Non-randomized)|Lost to Follow-up|20|||
147570174|NCT02009163|532243516|FG001|Open-label Period (Non-randomized)|Lost to Follow-up|0|||
147570175|NCT02009163|532243517|FG002|Open-label Period (Non-randomized)|Lost to Follow-up|0|||
147570176|NCT02009163|532243515|FG000|Open-label Period (Non-randomized)|Protocol Violation|10|||
147570177|NCT02009163|532243516|FG001|Open-label Period (Non-randomized)|Protocol Violation|0|||
147570178|NCT02009163|532243517|FG002|Open-label Period (Non-randomized)|Protocol Violation|0|||
147570179|NCT02009163|532243515|FG000|Open-label Period (Non-randomized)|Pregnancy|1|||
147570180|NCT02009163|532243516|FG001|Open-label Period (Non-randomized)|Pregnancy|0|||
147570181|NCT02009163|532243517|FG002|Open-label Period (Non-randomized)|Pregnancy|0|||
147236042|NCT02975336|531035504|FG000|DBPC (52 Weeks)|Withdrawal by Subject|1|||
147236043|NCT02975336|531035505|FG001|DBPC (52 Weeks)|Withdrawal by Subject|0|||
147236044|NCT02975336|531035506|FG002|DBPC (52 Weeks)|Withdrawal by Subject|1|||
147236045|NCT02975336|531035507|FG003|DBPC (52 Weeks)|Withdrawal by Subject|3|||
147236046|NCT02975336|531035508|FG004|DBPC (52 Weeks)|Withdrawal by Subject|0|||
147236047|NCT02975336|531035509|FG005|DBPC (52 Weeks)|Withdrawal by Subject|0|||
147236048|NCT02975336|531035510|FG006|DBPC (52 Weeks)|Withdrawal by Subject|0|||
147236049|NCT02975336|531035511|FG007|DBPC (52 Weeks)|Withdrawal by Subject|0|||
147236050|NCT02975336|531035504|FG000|DBPC (52 Weeks)|Premature termination of the study|5|||
147236051|NCT02975336|531035505|FG001|DBPC (52 Weeks)|Premature termination of the study|6|||
147236052|NCT02975336|531035506|FG002|DBPC (52 Weeks)|Premature termination of the study|6|||
147317505|NCT02718417|531329297|FG000|Maintenance Phase (MP)|Study terminated by sponsor|114|||
147317506|NCT02718417|531329298|FG001|Maintenance Phase (MP)|Study terminated by sponsor|140|||
147570182|NCT02009163|532243515|FG000|Open-label Period (Non-randomized)|Other|13|||
147570183|NCT02009163|532243516|FG001|Open-label Period (Non-randomized)|Other|0|||
147570184|NCT02009163|532243517|FG002|Open-label Period (Non-randomized)|Other|0|||
147570185|NCT02009163|532243515|FG000|Randomized-withdrawal Period|Withdrawal by Subject|0|||
147570186|NCT02009163|532243516|FG001|Randomized-withdrawal Period|Withdrawal by Subject|25|||
147570187|NCT02009163|532243517|FG002|Randomized-withdrawal Period|Withdrawal by Subject|9|||
147570188|NCT02009163|532243515|FG000|Randomized-withdrawal Period|Lost to Follow-up|0|||
147570189|NCT02009163|532243516|FG001|Randomized-withdrawal Period|Lost to Follow-up|13|||
147317507|NCT02718417|531329299|FG002|Maintenance Phase (MP)|Study terminated by sponsor|0|||
147317508|NCT02718417|531329297|FG000|Observation Phase (OP)|Adverse Event|0|||
147317509|NCT02718417|531329298|FG001|Observation Phase (OP)|Adverse Event|0|||
147317510|NCT02718417|531329299|FG002|Observation Phase (OP)|Adverse Event|1|||
147317511|NCT02718417|531329297|FG000|Observation Phase (OP)|Death leading to discontinuation|0|||
147317512|NCT02718417|531329298|FG001|Observation Phase (OP)|Death leading to discontinuation|0|||
147317513|NCT02718417|531329299|FG002|Observation Phase (OP)|Death leading to discontinuation|2|||
147317514|NCT02718417|531329297|FG000|Observation Phase (OP)|Lost to Follow-up|0|||
147317515|NCT02718417|531329298|FG001|Observation Phase (OP)|Lost to Follow-up|0|||
147317516|NCT02718417|531329299|FG002|Observation Phase (OP)|Lost to Follow-up|1|||
147317517|NCT02718417|531329297|FG000|Observation Phase (OP)|Physician Decision|0|||
147317518|NCT02718417|531329298|FG001|Observation Phase (OP)|Physician Decision|0|||
147317519|NCT02718417|531329299|FG002|Observation Phase (OP)|Physician Decision|9|||
147317520|NCT02718417|531329297|FG000|Observation Phase (OP)|Progressive disease|0|||
147317521|NCT02718417|531329298|FG001|Observation Phase (OP)|Progressive disease|0|||
147317522|NCT02718417|531329299|FG002|Observation Phase (OP)|Progressive disease|92|||
147317523|NCT02718417|531329297|FG000|Observation Phase (OP)|Study terminated by sponsor|0|||
147317524|NCT02718417|531329298|FG001|Observation Phase (OP)|Study terminated by sponsor|0|||
147317525|NCT02718417|531329299|FG002|Observation Phase (OP)|Study terminated by sponsor|135|||
147317526|NCT02718417|531329297|FG000|Observation Phase (OP)|Withdrawal by Subject|0|||
147317527|NCT02718417|531329298|FG001|Observation Phase (OP)|Withdrawal by Subject|0|||
147317528|NCT02718417|531329299|FG002|Observation Phase (OP)|Withdrawal by Subject|34|||
147317529|NCT02718417|531329297|FG000|Observation Phase (OP)|Global deterioration of health status|0|||
147317530|NCT02718417|531329298|FG001|Observation Phase (OP)|Global deterioration of health status|0|||
147317531|NCT02718417|531329299|FG002|Observation Phase (OP)|Global deterioration of health status|1|||
147317532|NCT02718417|531329297|FG000|Observation Phase (OP)|Other|0|||
147317533|NCT02718417|531329298|FG001|Observation Phase (OP)|Other|0|||
147317534|NCT02718417|531329299|FG002|Observation Phase (OP)|Other|7|||
147317535|NCT02718417|531329297|FG000|Follow-up Phase|Adverse Event|3|||
147317536|NCT02718417|531329298|FG001|Follow-up Phase|Adverse Event|1|||
147317537|NCT02718417|531329299|FG002|Follow-up Phase|Adverse Event|1|||
147317538|NCT02718417|531329297|FG000|Follow-up Phase|Other|4|||
147317539|NCT02718417|531329298|FG001|Follow-up Phase|Other|6|||
147317540|NCT02718417|531329299|FG002|Follow-up Phase|Other|4|||
147317541|NCT02718417|531329297|FG000|Follow-up Phase|Withdrawal by Subject|19|||
147317542|NCT02718417|531329298|FG001|Follow-up Phase|Withdrawal by Subject|17|||
147317543|NCT02718417|531329299|FG002|Follow-up Phase|Withdrawal by Subject|5|||
147317544|NCT02718417|531329297|FG000|Follow-up Phase|Study terminated by sponsor|100|||
147317545|NCT02718417|531329298|FG001|Follow-up Phase|Study terminated by sponsor|138|||
147317546|NCT02718417|531329299|FG002|Follow-up Phase|Study terminated by sponsor|6|||
147317547|NCT02718417|531329297|FG000|Follow-up Phase|Lost to Follow-up|2|||
147317548|NCT02718417|531329298|FG001|Follow-up Phase|Lost to Follow-up|3|||
147317549|NCT02718417|531329299|FG002|Follow-up Phase|Lost to Follow-up|0|||
147317550|NCT02718417|531329297|FG000|Follow-up Phase|Death leading to discontinuation|7|||
147317551|NCT02718417|531329298|FG001|Follow-up Phase|Death leading to discontinuation|7|||
147317552|NCT02718417|531329299|FG002|Follow-up Phase|Death leading to discontinuation|3|||
147317553|NCT02718417|531329297|FG000|Long-term Follow-up Phase|Death leading to discontinuation|20|||
147317554|NCT02718417|531329298|FG001|Long-term Follow-up Phase|Death leading to discontinuation|17|||
147317555|NCT02718417|531329299|FG002|Long-term Follow-up Phase|Death leading to discontinuation|11|||
147317556|NCT02718417|531329297|FG000|Long-term Follow-up Phase|Lost to Follow-up|8|||
147570190|NCT02009163|532243517|FG002|Randomized-withdrawal Period|Lost to Follow-up|6|||
147570191|NCT02009163|532243515|FG000|Randomized-withdrawal Period|Adverse Event|0|||
147570192|NCT02009163|532243516|FG001|Randomized-withdrawal Period|Adverse Event|0|||
147570193|NCT02009163|532243517|FG002|Randomized-withdrawal Period|Adverse Event|6|||
147570194|NCT02009163|532243515|FG000|Randomized-withdrawal Period|Relapse Criteria Met|0|||
147570195|NCT02009163|532243516|FG001|Randomized-withdrawal Period|Relapse Criteria Met|40|||
147570196|NCT02009163|532243517|FG002|Randomized-withdrawal Period|Relapse Criteria Met|5|||
147570197|NCT02009163|532243515|FG000|Randomized-withdrawal Period|Protocol Violation|0|||
147570198|NCT02009163|532243516|FG001|Randomized-withdrawal Period|Protocol Violation|1|||
147570199|NCT02009163|532243517|FG002|Randomized-withdrawal Period|Protocol Violation|2|||
147570200|NCT02009163|532243515|FG000|Randomized-withdrawal Period|Pregnancy|0|||
147570201|NCT02009163|532243516|FG001|Randomized-withdrawal Period|Pregnancy|0|||
147570202|NCT02009163|532243517|FG002|Randomized-withdrawal Period|Pregnancy|2|||
147317557|NCT02718417|531329298|FG001|Long-term Follow-up Phase|Lost to Follow-up|4|||
147317558|NCT02718417|531329299|FG002|Long-term Follow-up Phase|Lost to Follow-up|3|||
147317559|NCT02718417|531329297|FG000|Long-term Follow-up Phase|Study terminated by sponsor|105|||
147317560|NCT02718417|531329298|FG001|Long-term Follow-up Phase|Study terminated by sponsor|80|||
147317561|NCT02718417|531329299|FG002|Long-term Follow-up Phase|Study terminated by sponsor|112|||
147317562|NCT02718417|531329297|FG000|Long-term Follow-up Phase|Withdrawal by Subject|6|||
147317563|NCT02718417|531329298|FG001|Long-term Follow-up Phase|Withdrawal by Subject|9|||
147317564|NCT02718417|531329299|FG002|Long-term Follow-up Phase|Withdrawal by Subject|9|||
147570203|NCT02009163|532243515|FG000|Randomized-withdrawal Period|Other|0|||
147570204|NCT02009163|532243516|FG001|Randomized-withdrawal Period|Other|9|||
147570205|NCT02009163|532243517|FG002|Randomized-withdrawal Period|Other|5|||
147570206|NCT02453386|532243520|FG000|Overall Study|Adverse Event|22|||
147570207|NCT02453386|532243521|FG001|Overall Study|Adverse Event|30|||
147317565|NCT02718417|531329297|FG000|Long-term Follow-up Phase|Other|0|||
147570208|NCT02453386|532243522|FG002|Overall Study|Adverse Event|15|||
147570209|NCT02453386|532243520|FG000|Overall Study|Protocol Violation|1|||
147570210|NCT02453386|532243521|FG001|Overall Study|Protocol Violation|0|||
147570211|NCT02453386|532243522|FG002|Overall Study|Protocol Violation|1|||
147570212|NCT02453386|532243520|FG000|Overall Study|Withdrawal by Subject|10|||
147570213|NCT02453386|532243521|FG001|Overall Study|Withdrawal by Subject|9|||
147570214|NCT02453386|532243522|FG002|Overall Study|Withdrawal by Subject|9|||
147570215|NCT02453386|532243520|FG000|Overall Study|Sponsor Terminated Study|14|||
147570216|NCT02453386|532243521|FG001|Overall Study|Sponsor Terminated Study|8|||
147570217|NCT02453386|532243522|FG002|Overall Study|Sponsor Terminated Study|11|||
147570218|NCT02453386|532243520|FG000|Overall Study|Subject Terminated by Sponsor|1|||
147570219|NCT02453386|532243521|FG001|Overall Study|Subject Terminated by Sponsor|1|||
147570220|NCT02453386|532243522|FG002|Overall Study|Subject Terminated by Sponsor|1|||
147570221|NCT02453386|532243520|FG000|Overall Study|Sponsor Terminated by Investigator|0|||
147570222|NCT02453386|532243521|FG001|Overall Study|Sponsor Terminated by Investigator|1|||
147570223|NCT02453386|532243522|FG002|Overall Study|Sponsor Terminated by Investigator|2|||
147570224|NCT02453386|532243520|FG000|Overall Study|Lost to Follow-up|0|||
147570225|NCT02453386|532243521|FG001|Overall Study|Lost to Follow-up|0|||
147570226|NCT02453386|532243522|FG002|Overall Study|Lost to Follow-up|1|||
147570227|NCT02453386|532243520|FG000|Overall Study|Other|1|||
147570228|NCT02453386|532243521|FG001|Overall Study|Other|0|||
147570229|NCT02453386|532243522|FG002|Overall Study|Other|1|||
147570230|NCT02601625|532243523|FG000|Overall Study|Lost to Follow-up|0|||
147570231|NCT02601625|532243524|FG001|Overall Study|Lost to Follow-up|0|||
147570232|NCT02601625|532243525|FG002|Overall Study|Lost to Follow-up|1|||
147570233|NCT02601625|532243526|FG003|Overall Study|Lost to Follow-up|1|||
147570234|NCT00838279|532243531|FG000|Washout|Protocol Violation|1|||
147570235|NCT00838279|532243532|FG001|Washout|Protocol Violation|0|||
147570236|NCT00838279|532243531|FG000|Washout|Withdrawal by Subject|0|||
147570237|NCT00838279|532243532|FG001|Washout|Withdrawal by Subject|1|||
147570238|NCT01415986|532243533|FG000|Overall Study|Lost to Follow-up|1|||
147570239|NCT03792477|532243536|FG000|Overall Study|Adverse Event|0|||
147570240|NCT03792477|532243537|FG001|Overall Study|Adverse Event|0|||
147570241|NCT03792477|532243538|FG002|Overall Study|Adverse Event|0|||
147570242|NCT03792477|532243539|FG003|Overall Study|Adverse Event|1|||
147570243|NCT03792477|532243540|FG004|Overall Study|Adverse Event|0|||
147570244|NCT03792477|532243536|FG000|Overall Study|Lost to Follow-up|0|||
147317566|NCT02718417|531329298|FG001|Long-term Follow-up Phase|Other|2|||
147570245|NCT03792477|532243537|FG001|Overall Study|Lost to Follow-up|0|||
147570246|NCT03792477|532243538|FG002|Overall Study|Lost to Follow-up|2|||
147570247|NCT03792477|532243539|FG003|Overall Study|Lost to Follow-up|0|||
147570248|NCT03792477|532243540|FG004|Overall Study|Lost to Follow-up|0|||
147570249|NCT03792477|532243536|FG000|Overall Study|Other|0|||
147570250|NCT03792477|532243537|FG001|Overall Study|Other|0|||
147570251|NCT03792477|532243538|FG002|Overall Study|Other|0|||
147570252|NCT03792477|532243539|FG003|Overall Study|Other|0|||
147570253|NCT03792477|532243540|FG004|Overall Study|Other|1|||
147130737|NCT01467466|530645714|FG001|Overall Study|Procedure Cancelled|45|||
147130738|NCT01467466|530645715|FG002|Overall Study|Procedure Cancelled|25|||
147130739|NCT01467466|530645716|FG003|Overall Study|Procedure Cancelled|29|||
147130740|NCT01467466|530645713|FG000|Overall Study|No Endpoint Blood Draw|38|||
147130741|NCT01467466|530645714|FG001|Overall Study|No Endpoint Blood Draw|32|||
147130742|NCT01467466|530645715|FG002|Overall Study|No Endpoint Blood Draw|51|||
147130743|NCT01467466|530645716|FG003|Overall Study|No Endpoint Blood Draw|43|||
147130744|NCT03261505|530645717|FG000|Overall Study|Withdrawal by Subject|2|||
147130745|NCT03261505|530645718|FG001|Overall Study|Withdrawal by Subject|3|||
147130746|NCT03261505|530645719|FG002|Overall Study|Withdrawal by Subject|4|||
147130747|NCT03261505|530645720|FG003|Overall Study|Withdrawal by Subject|3|||
147130748|NCT03261505|530645717|FG000|Overall Study|unrelated surgery preventing the subject participating the study|0|||
147130749|NCT03261505|530645718|FG001|Overall Study|unrelated surgery preventing the subject participating the study|0|||
147130750|NCT03261505|530645719|FG002|Overall Study|unrelated surgery preventing the subject participating the study|1|||
147130751|NCT03261505|530645720|FG003|Overall Study|unrelated surgery preventing the subject participating the study|0|||
147130752|NCT03261505|530645717|FG000|Overall Study|Claustrophobic or can not provide proof of diagnosis|0|||
147130753|NCT03261505|530645718|FG001|Overall Study|Claustrophobic or can not provide proof of diagnosis|0|||
147130754|NCT03261505|530645719|FG002|Overall Study|Claustrophobic or can not provide proof of diagnosis|2|||
147130755|NCT03261505|530645720|FG003|Overall Study|Claustrophobic or can not provide proof of diagnosis|0|||
147317567|NCT02718417|531329299|FG002|Long-term Follow-up Phase|Other|0|||
147570254|NCT00840411|532243542|FG000|First Intervention|Adverse Event|1|||
147570255|NCT00840411|532243543|FG001|First Intervention|Adverse Event|0|||
147570256|NCT00840411|532243542|FG000|Washout|Withdrawal by Subject|1|||
147130756|NCT03261505|530645717|FG000|Overall Study|the subject can not concentrate to complete the questionnaire|1|||
147130757|NCT03261505|530645718|FG001|Overall Study|the subject can not concentrate to complete the questionnaire|0|||
147130758|NCT03261505|530645719|FG002|Overall Study|the subject can not concentrate to complete the questionnaire|0|||
147130759|NCT03261505|530645720|FG003|Overall Study|the subject can not concentrate to complete the questionnaire|0|||
147130760|NCT03773484|530645731|FG000|Post-intervention|5 clinicians were excluded from analysis due to lack of prescribing data|5|||
147130761|NCT04079738|530645732|FG000|Study Treatment|Death|1|||
147130762|NCT04079738|530645733|FG001|Study Treatment|Death|0|||
147130763|NCT04079738|530645734|FG002|Study Treatment|Death|0|||
147130764|NCT04079738|530645735|FG003|Study Treatment|Death|0|||
147130765|NCT04079738|530645732|FG000|Study Treatment|Adverse Event|2|||
147130766|NCT04079738|530645733|FG001|Study Treatment|Adverse Event|0|||
147130767|NCT04079738|530645734|FG002|Study Treatment|Adverse Event|0|||
147130768|NCT04079738|530645735|FG003|Study Treatment|Adverse Event|0|||
147130769|NCT04079738|530645732|FG000|Study Treatment|withdrawal before treatment|1|||
147570257|NCT00840411|532243543|FG001|Washout|Withdrawal by Subject|0|||
147570258|NCT04419311|532243544|FG000|Overall Study|Lost to Follow-up|1|||
147570259|NCT04419311|532243545|FG001|Overall Study|Lost to Follow-up|0|||
147570260|NCT00465270|532243546|FG000|Overall Study|Death|7|||
147570261|NCT00465270|532243547|FG001|Overall Study|Death|11|||
147570262|NCT00465270|532243546|FG000|Overall Study|Withdrawal by Subject|34|||
147570263|NCT00465270|532243547|FG001|Overall Study|Withdrawal by Subject|78|||
147570264|NCT00465270|532243546|FG000|Overall Study|Lost to Follow-up|60|||
147570265|NCT00465270|532243547|FG001|Overall Study|Lost to Follow-up|67|||
147570266|NCT00465270|532243546|FG000|Overall Study|Investigator request|3|||
147570267|NCT00465270|532243547|FG001|Overall Study|Investigator request|4|||
147570268|NCT03122457|532243549|FG000|Overall Study|Withdrawal by Subject|6|||
147570269|NCT02388191|532243550|FG000|Overall Study|Patient did not receive IUD|1|||
147570270|NCT02388191|532243551|FG001|Overall Study|Patient did not receive IUD|0|||
147570271|NCT01921062|532243552|FG000|Overall Study|Withdrawal by Subject|0|||
147570272|NCT01921062|532243553|FG001|Overall Study|Withdrawal by Subject|7|||
147570273|NCT01921062|532243552|FG000|Overall Study|Adverse Event|5|||
147130770|NCT04079738|530645733|FG001|Study Treatment|withdrawal before treatment|0|||
147130771|NCT04079738|530645734|FG002|Study Treatment|withdrawal before treatment|0|||
147130772|NCT04079738|530645735|FG003|Study Treatment|withdrawal before treatment|0|||
147236053|NCT02975336|531035507|FG003|DBPC (52 Weeks)|Premature termination of the study|4|||
147130773|NCT04079738|530645732|FG000|Study Treatment|symptomatic deterioration|2|||
147130774|NCT04079738|530645733|FG001|Study Treatment|symptomatic deterioration|0|||
147236054|NCT02975336|531035508|FG004|DBPC (52 Weeks)|Premature termination of the study|0|||
147236055|NCT02975336|531035509|FG005|DBPC (52 Weeks)|Premature termination of the study|0|||
147236056|NCT02975336|531035510|FG006|DBPC (52 Weeks)|Premature termination of the study|0|||
147236057|NCT02975336|531035511|FG007|DBPC (52 Weeks)|Premature termination of the study|0|||
147236058|NCT02975336|531035504|FG000|LTE (104 Weeks)|Adverse Event|0|||
147236059|NCT02975336|531035505|FG001|LTE (104 Weeks)|Adverse Event|0|||
147236060|NCT02975336|531035506|FG002|LTE (104 Weeks)|Adverse Event|0|||
147236061|NCT02975336|531035507|FG003|LTE (104 Weeks)|Adverse Event|0|||
147236062|NCT02975336|531035508|FG004|LTE (104 Weeks)|Adverse Event|7|||
147236063|NCT02975336|531035509|FG005|LTE (104 Weeks)|Adverse Event|4|||
147236064|NCT02975336|531035510|FG006|LTE (104 Weeks)|Adverse Event|2|||
147236065|NCT02975336|531035511|FG007|LTE (104 Weeks)|Adverse Event|0|||
147317568|NCT01023308|531329300|FG000|Overall Study|Abnormal test proceedure results|3|||
147317569|NCT01023308|531329301|FG001|Overall Study|Abnormal test proceedure results|8|||
147317570|NCT01023308|531329300|FG000|Overall Study|Administrative problems|2|||
147317571|NCT01023308|531329301|FG001|Overall Study|Administrative problems|1|||
147317572|NCT01023308|531329300|FG000|Overall Study|Adverse Event|130|||
147317573|NCT01023308|531329301|FG001|Overall Study|Adverse Event|66|||
147317574|NCT01023308|531329300|FG000|Overall Study|Death|21|||
147317575|NCT01023308|531329301|FG001|Overall Study|Death|17|||
147317576|NCT01023308|531329300|FG000|Overall Study|Disease progression|82|||
147317577|NCT01023308|531329301|FG001|Overall Study|Disease progression|153|||
147317578|NCT01023308|531329300|FG000|Overall Study|New Cancer therapy|4|||
147317579|NCT01023308|531329301|FG001|Overall Study|New Cancer therapy|7|||
147317580|NCT01023308|531329300|FG000|Overall Study|Protocol Violation|3|||
147317581|NCT01023308|531329301|FG001|Overall Study|Protocol Violation|4|||
147236066|NCT02975336|531035504|FG000|LTE (104 Weeks)|Lost to Follow-up|0|||
147236067|NCT02975336|531035505|FG001|LTE (104 Weeks)|Lost to Follow-up|0|||
147236068|NCT02975336|531035506|FG002|LTE (104 Weeks)|Lost to Follow-up|0|||
147236069|NCT02975336|531035507|FG003|LTE (104 Weeks)|Lost to Follow-up|0|||
147317582|NCT01023308|531329300|FG000|Overall Study|Untreated|5|||
147317583|NCT01023308|531329301|FG001|Overall Study|Untreated|5|||
147317584|NCT01023308|531329300|FG000|Overall Study|Lost to Follow-up|1|||
147570274|NCT01921062|532243553|FG001|Overall Study|Adverse Event|6|||
147570275|NCT01921062|532243552|FG000|Overall Study|Protocol Violation|0|||
147570276|NCT01921062|532243553|FG001|Overall Study|Protocol Violation|1|||
147570277|NCT01921062|532243552|FG000|Overall Study|VMIQ score > 72|4|||
147570278|NCT01921062|532243553|FG001|Overall Study|VMIQ score > 72|1|||
147570279|NCT01921062|532243552|FG000|Overall Study|Logistic error|0|||
147570280|NCT01921062|532243553|FG001|Overall Study|Logistic error|1|||
147570281|NCT01911676|532243554|FG000|Period 1 of Study|Withdrawal by Subject|4|||
147570282|NCT01911676|532243555|FG001|Period 1 of Study|Withdrawal by Subject|2|||
147570283|NCT01911676|532243556|FG002|Period 1 of Study|Withdrawal by Subject|1|||
147570284|NCT01911676|532243557|FG003|Period 1 of Study|Withdrawal by Subject|2|||
147570285|NCT01911676|532243554|FG000|Period 1 of Study|Physician Decision|2|||
147570286|NCT01911676|532243555|FG001|Period 1 of Study|Physician Decision|0|||
147570287|NCT01911676|532243556|FG002|Period 1 of Study|Physician Decision|0|||
147570288|NCT01911676|532243557|FG003|Period 1 of Study|Physician Decision|1|||
147570289|NCT01911676|532243554|FG000|Period 2 of Study|Physician Decision|2|||
147570290|NCT01911676|532243555|FG001|Period 2 of Study|Physician Decision|0|||
147570291|NCT01911676|532243556|FG002|Period 2 of Study|Physician Decision|0|||
147570292|NCT01911676|532243557|FG003|Period 2 of Study|Physician Decision|1|||
147570293|NCT01911676|532243554|FG000|Period 2 of Study|Lost to Follow-up|0|||
147570294|NCT01911676|532243555|FG001|Period 2 of Study|Lost to Follow-up|0|||
147570295|NCT01911676|532243556|FG002|Period 2 of Study|Lost to Follow-up|0|||
147570296|NCT01911676|532243557|FG003|Period 2 of Study|Lost to Follow-up|1|||
147570297|NCT00657553|532243560|FG000|Overall Study|low accrual, no analysis run|5|||
147570298|NCT00657553|532243561|FG001|Overall Study|low accrual, no analysis run|5|||
147570299|NCT03173547|532243562|FG000|Overall Study|Adverse Event|2|||
147570300|NCT03173547|532243563|FG001|Overall Study|Adverse Event|0|||
147570301|NCT03173547|532243562|FG000|Overall Study|Withdrawal by Subject|2|||
147570302|NCT03173547|532243563|FG001|Overall Study|Withdrawal by Subject|2|||
147570303|NCT01169558|532243564|FG000|Overall Study|Disease progression|98|||
147570304|NCT01169558|532243564|FG000|Overall Study|Adverse Event|25|||
147570305|NCT01169558|532243564|FG000|Overall Study|Withdrawal of Consent|8|||
147570306|NCT01169558|532243564|FG000|Overall Study|Medical Decision|7|||
147570307|NCT01169558|532243564|FG000|Overall Study|Stable Disease|4|||
147570308|NCT01169558|532243564|FG000|Overall Study|Lost to Follow-up|4|||
147570309|NCT01169558|532243564|FG000|Overall Study|Need for Surgery|4|||
147570310|NCT01169558|532243564|FG000|Overall Study|Non-compliance|2|||
147570311|NCT01169558|532243564|FG000|Overall Study|Protocol Violation|2|||
147570312|NCT01169558|532243564|FG000|Overall Study|Partial response|2|||
147570313|NCT03482882|532243569|FG000|Overall Study|Adverse Event|3|||
147570314|NCT03482882|532243569|FG000|Overall Study|Lost to Follow-up|1|||
147570315|NCT03482882|532243569|FG000|Overall Study|Protocol Violation|2|||
147570316|NCT03482882|532243569|FG000|Overall Study|Not further specified|1|||
147570317|NCT01110005|532243572|FG000|Overall Study|ineligible|1|||
147570318|NCT01110005|532243573|FG001|Overall Study|ineligible|2|||
147570319|NCT01110005|532243572|FG000|Overall Study|missing consent|3|||
147236070|NCT02975336|531035508|FG004|LTE (104 Weeks)|Lost to Follow-up|0|||
147236071|NCT02975336|531035509|FG005|LTE (104 Weeks)|Lost to Follow-up|1|||
147236072|NCT02975336|531035510|FG006|LTE (104 Weeks)|Lost to Follow-up|0|||
147236073|NCT02975336|531035511|FG007|LTE (104 Weeks)|Lost to Follow-up|0|||
147236074|NCT02975336|531035504|FG000|LTE (104 Weeks)|Lack of Efficacy|0|||
147570320|NCT01110005|532243573|FG001|Overall Study|missing consent|2|||
147570321|NCT01110005|532243572|FG000|Overall Study|Withdrawal by Subject|0|||
147570322|NCT01110005|532243573|FG001|Overall Study|Withdrawal by Subject|1|||
147570323|NCT01136174|532243574|FG000|Overall Study|Adverse Event|0|||
147570324|NCT01136174|532243575|FG001|Overall Study|Adverse Event|0|||
147236075|NCT02975336|531035505|FG001|LTE (104 Weeks)|Lack of Efficacy|0|||
147236076|NCT02975336|531035506|FG002|LTE (104 Weeks)|Lack of Efficacy|0|||
147236077|NCT02975336|531035507|FG003|LTE (104 Weeks)|Lack of Efficacy|0|||
147236078|NCT02975336|531035508|FG004|LTE (104 Weeks)|Lack of Efficacy|0|||
147236079|NCT02975336|531035509|FG005|LTE (104 Weeks)|Lack of Efficacy|1|||
147236080|NCT02975336|531035510|FG006|LTE (104 Weeks)|Lack of Efficacy|2|||
147236081|NCT02975336|531035511|FG007|LTE (104 Weeks)|Lack of Efficacy|0|||
147236082|NCT02975336|531035504|FG000|LTE (104 Weeks)|Other|0|||
147236083|NCT02975336|531035505|FG001|LTE (104 Weeks)|Other|0|||
147236084|NCT02975336|531035506|FG002|LTE (104 Weeks)|Other|0|||
147236085|NCT02975336|531035507|FG003|LTE (104 Weeks)|Other|0|||
147236086|NCT02975336|531035508|FG004|LTE (104 Weeks)|Other|55|||
147570325|NCT01136174|532243576|FG002|Overall Study|Adverse Event|0|||
147570326|NCT01136174|532243577|FG003|Overall Study|Adverse Event|4|||
147236087|NCT02975336|531035509|FG005|LTE (104 Weeks)|Other|63|||
147236088|NCT02975336|531035510|FG006|LTE (104 Weeks)|Other|76|||
147236089|NCT02975336|531035511|FG007|LTE (104 Weeks)|Other|72|||
147570327|NCT00819741|532243580|FG000|Overall Study|Adverse Event|5|||
147570328|NCT00819741|532243581|FG001|Overall Study|Adverse Event|2|||
147570329|NCT00819741|532243580|FG000|Overall Study|Lack of Efficacy|0|||
147570330|NCT00819741|532243581|FG001|Overall Study|Lack of Efficacy|2|||
147570331|NCT00819741|532243580|FG000|Overall Study|Lost to Follow-up|3|||
147236090|NCT01897454|531035512|FG000|Overall Study|Withdrawal by Subject|1|||
147236091|NCT04015336|531035513|FG000|Overall Study|Participant signed consent and was later deemed a screen failure. Participant was not treated|1|||
147570332|NCT00819741|532243581|FG001|Overall Study|Lost to Follow-up|1|||
147570333|NCT00819741|532243580|FG000|Overall Study|Protocol Violation|3|||
147570334|NCT00819741|532243581|FG001|Overall Study|Protocol Violation|4|||
147570335|NCT00819741|532243580|FG000|Overall Study|Withdrawal by Subject|2|||
147570336|NCT00819741|532243581|FG001|Overall Study|Withdrawal by Subject|2|||
147570337|NCT00819741|532243580|FG000|Overall Study|Unclassified|6|||
147570338|NCT00819741|532243581|FG001|Overall Study|Unclassified|0|||
147570339|NCT00819741|532243580|FG000|Overall Study|Reasons unknown|3|||
147570340|NCT00819741|532243581|FG001|Overall Study|Reasons unknown|3|||
147570341|NCT00119015|532243582|FG000|Open-Label Phase (2 Weeks)|Did not have residual symptoms|48|||
147570342|NCT00119015|532243583|FG001|Open-Label Phase (2 Weeks)|Did not have residual symptoms|0|||
147570343|NCT00119015|532243584|FG002|Open-Label Phase (2 Weeks)|Did not have residual symptoms|0|||
147570344|NCT05604170|532245129|FG000|Overall Study|Lack of Efficacy|5|||
147570345|NCT05604170|532245129|FG000|Overall Study|Adverse Event|6|||
147570346|NCT05604170|532245129|FG000|Overall Study|Physician Decision|6|||
147570347|NCT05604170|532245129|FG000|Overall Study|Lost to Follow-up|6|||
147570348|NCT05604170|532245129|FG000|Overall Study|Withdrawal by Subject|11|||
147570349|NCT05604170|532245129|FG000|Overall Study|Early study termination by sponsor|77|||
147570350|NCT05604170|532245129|FG000|Overall Study|Other|6|||
147570351|NCT03697109|532245130|FG000|Open-label (OL) Phase|Adverse Event|24|||
147570352|NCT03697109|532245131|FG001|Open-label (OL) Phase|Adverse Event|0|||
147570353|NCT03697109|532245132|FG002|Open-label (OL) Phase|Adverse Event|0|||
147570354|NCT03697109|532245130|FG000|Open-label (OL) Phase|Lost to Follow-up|2|||
147570355|NCT03697109|532245131|FG001|Open-label (OL) Phase|Lost to Follow-up|0|||
147570356|NCT03697109|532245132|FG002|Open-label (OL) Phase|Lost to Follow-up|0|||
147570357|NCT03697109|532245130|FG000|Open-label (OL) Phase|Lack of Efficacy|6|||
147570358|NCT03697109|532245131|FG001|Open-label (OL) Phase|Lack of Efficacy|0|||
147570359|NCT03697109|532245132|FG002|Open-label (OL) Phase|Lack of Efficacy|0|||
147570360|NCT03697109|532245130|FG000|Open-label (OL) Phase|Withdrawal by Subject|21|||
147570361|NCT03697109|532245131|FG001|Open-label (OL) Phase|Withdrawal by Subject|0|||
147570362|NCT03697109|532245132|FG002|Open-label (OL) Phase|Withdrawal by Subject|0|||
147570363|NCT03697109|532245130|FG000|Open-label (OL) Phase|Physician Decision|2|||
147570364|NCT03697109|532245131|FG001|Open-label (OL) Phase|Physician Decision|0|||
147570365|NCT03697109|532245132|FG002|Open-label (OL) Phase|Physician Decision|0|||
147570366|NCT03697109|532245130|FG000|Open-label (OL) Phase|Death|2|||
147570367|NCT03697109|532245131|FG001|Open-label (OL) Phase|Death|0|||
147570368|NCT03697109|532245132|FG002|Open-label (OL) Phase|Death|0|||
147570369|NCT03697109|532245130|FG000|Randomized-withdrawal (RW) Phase|Adverse Event|0|||
147570370|NCT03697109|532245131|FG001|Randomized-withdrawal (RW) Phase|Adverse Event|1|||
147570371|NCT03697109|532245132|FG002|Randomized-withdrawal (RW) Phase|Adverse Event|0|||
147570372|NCT03697109|532245130|FG000|Randomized-withdrawal (RW) Phase|Lack of Efficacy|0|||
147570373|NCT03697109|532245131|FG001|Randomized-withdrawal (RW) Phase|Lack of Efficacy|1|||
147570374|NCT03697109|532245132|FG002|Randomized-withdrawal (RW) Phase|Lack of Efficacy|0|||
147570375|NCT03697109|532245130|FG000|Randomized-withdrawal (RW) Phase|Withdrawal by Subject|0|||
147570376|NCT03697109|532245131|FG001|Randomized-withdrawal (RW) Phase|Withdrawal by Subject|1|||
147570377|NCT03697109|532245132|FG002|Randomized-withdrawal (RW) Phase|Withdrawal by Subject|1|||
147570378|NCT03032172|532245133|FG000|Treatment Period|Adverse Event|0|||
147570379|NCT03032172|532245134|FG001|Treatment Period|Adverse Event|1|||
147570380|NCT03032172|532245135|FG002|Treatment Period|Adverse Event|0|||
147570381|NCT03032172|532245136|FG003|Treatment Period|Adverse Event|0|||
147570382|NCT03032172|532245137|FG004|Treatment Period|Adverse Event|0|||
147570383|NCT03032172|532245138|FG005|Treatment Period|Adverse Event|0|||
147570384|NCT03032172|532245139|FG006|Treatment Period|Adverse Event|0|||
147130775|NCT04079738|530645734|FG002|Study Treatment|symptomatic deterioration|0|||
147570385|NCT03032172|532245140|FG007|Treatment Period|Adverse Event|0|||
147570386|NCT03032172|532245133|FG000|Treatment Period|Lack of Efficacy|0|||
147570387|NCT03032172|532245134|FG001|Treatment Period|Lack of Efficacy|1|||
147570388|NCT03032172|532245135|FG002|Treatment Period|Lack of Efficacy|0|||
147570389|NCT03032172|532245136|FG003|Treatment Period|Lack of Efficacy|0|||
147570390|NCT03032172|532245137|FG004|Treatment Period|Lack of Efficacy|0|||
147130776|NCT04079738|530645735|FG003|Study Treatment|symptomatic deterioration|0|||
147130777|NCT04079738|530645732|FG000|Study Treatment|Disease Progression|1|||
147130778|NCT04079738|530645733|FG001|Study Treatment|Disease Progression|0|||
147130779|NCT04079738|530645734|FG002|Study Treatment|Disease Progression|0|||
147130780|NCT04079738|530645735|FG003|Study Treatment|Disease Progression|0|||
147130781|NCT04079738|530645732|FG000|Study Treatment|withdrawal after treatment|1|||
147130782|NCT04079738|530645733|FG001|Study Treatment|withdrawal after treatment|0|||
147130783|NCT04079738|530645734|FG002|Study Treatment|withdrawal after treatment|0|||
147130784|NCT04079738|530645735|FG003|Study Treatment|withdrawal after treatment|0|||
147130785|NCT04079738|530645732|FG000|Follow up|Withdrawal by Subject|3|||
147130786|NCT04079738|530645733|FG001|Follow up|Withdrawal by Subject|0|||
147130787|NCT04079738|530645734|FG002|Follow up|Withdrawal by Subject|0|||
147130788|NCT04079738|530645735|FG003|Follow up|Withdrawal by Subject|0|||
147130789|NCT04079738|530645732|FG000|Follow up|Death|5|||
147130790|NCT04079738|530645733|FG001|Follow up|Death|0|||
147130791|NCT04079738|530645734|FG002|Follow up|Death|0|||
147130792|NCT04079738|530645735|FG003|Follow up|Death|0|||
147317585|NCT01023308|531329301|FG001|Overall Study|Lost to Follow-up|0|||
147570391|NCT03032172|532245138|FG005|Treatment Period|Lack of Efficacy|0|||
147570392|NCT03032172|532245139|FG006|Treatment Period|Lack of Efficacy|0|||
147570393|NCT03032172|532245140|FG007|Treatment Period|Lack of Efficacy|0|||
147570394|NCT03032172|532245133|FG000|Treatment Period|Non-compliance With Study Drug|0|||
147130793|NCT05552859|530645736|FG000|Overall Study|Study was terminated by the Sponsor due to poor recruitment/severe recruitment delay|30|||
147130794|NCT05552859|530645737|FG001|Overall Study|Study was terminated by the Sponsor due to poor recruitment/severe recruitment delay|30|||
147130795|NCT04251533|530645738|FG000|Overall Study|Progressive disease|33|||
147130796|NCT04251533|530645739|FG001|Overall Study|Progressive disease|29|||
147130797|NCT04251533|530645740|FG002|Overall Study|Progressive disease|22|||
147130798|NCT04251533|530645738|FG000|Overall Study|Death|5|||
147130799|NCT04251533|530645739|FG001|Overall Study|Death|1|||
147130800|NCT04251533|530645740|FG002|Overall Study|Death|3|||
147130801|NCT04251533|530645738|FG000|Overall Study|Physician Decision|3|||
147130802|NCT04251533|530645739|FG001|Overall Study|Physician Decision|2|||
147130803|NCT04251533|530645740|FG002|Overall Study|Physician Decision|4|||
147130804|NCT04251533|530645738|FG000|Overall Study|Participant decision|1|||
147570395|NCT03032172|532245134|FG001|Treatment Period|Non-compliance With Study Drug|1|||
147570396|NCT03032172|532245135|FG002|Treatment Period|Non-compliance With Study Drug|0|||
147570397|NCT03032172|532245136|FG003|Treatment Period|Non-compliance With Study Drug|0|||
147570398|NCT03032172|532245137|FG004|Treatment Period|Non-compliance With Study Drug|0|||
147570399|NCT03032172|532245138|FG005|Treatment Period|Non-compliance With Study Drug|0|||
147570400|NCT03032172|532245139|FG006|Treatment Period|Non-compliance With Study Drug|0|||
147570401|NCT03032172|532245140|FG007|Treatment Period|Non-compliance With Study Drug|0|||
147570402|NCT03032172|532245133|FG000|Treatment Period|Reason Not Specified|0|||
147570403|NCT03032172|532245134|FG001|Treatment Period|Reason Not Specified|4|||
147570404|NCT03032172|532245135|FG002|Treatment Period|Reason Not Specified|1|||
147570405|NCT03032172|532245136|FG003|Treatment Period|Reason Not Specified|0|||
147570406|NCT03032172|532245137|FG004|Treatment Period|Reason Not Specified|0|||
147570407|NCT03032172|532245138|FG005|Treatment Period|Reason Not Specified|0|||
147570408|NCT03032172|532245139|FG006|Treatment Period|Reason Not Specified|0|||
147570409|NCT03032172|532245140|FG007|Treatment Period|Reason Not Specified|0|||
147570410|NCT03032172|532245133|FG000|Treatment Period|Physician Decision|0|||
147570411|NCT03032172|532245134|FG001|Treatment Period|Physician Decision|2|||
147570412|NCT03032172|532245135|FG002|Treatment Period|Physician Decision|1|||
147570413|NCT03032172|532245136|FG003|Treatment Period|Physician Decision|0|||
147570414|NCT03032172|532245137|FG004|Treatment Period|Physician Decision|0|||
147570415|NCT03032172|532245138|FG005|Treatment Period|Physician Decision|0|||
147570416|NCT03032172|532245139|FG006|Treatment Period|Physician Decision|0|||
147570417|NCT03032172|532245140|FG007|Treatment Period|Physician Decision|0|||
147570418|NCT03032172|532245133|FG000|Treatment Period|Discontinued, but Recorded as Completed Open-label Treatment by the Investigator|0|||
147570419|NCT03032172|532245134|FG001|Treatment Period|Discontinued, but Recorded as Completed Open-label Treatment by the Investigator|1|||
147570420|NCT03032172|532245135|FG002|Treatment Period|Discontinued, but Recorded as Completed Open-label Treatment by the Investigator|2|||
147570421|NCT03032172|532245136|FG003|Treatment Period|Discontinued, but Recorded as Completed Open-label Treatment by the Investigator|1|||
147570422|NCT03032172|532245137|FG004|Treatment Period|Discontinued, but Recorded as Completed Open-label Treatment by the Investigator|0|||
147570423|NCT03032172|532245138|FG005|Treatment Period|Discontinued, but Recorded as Completed Open-label Treatment by the Investigator|0|||
147570424|NCT03032172|532245139|FG006|Treatment Period|Discontinued, but Recorded as Completed Open-label Treatment by the Investigator|0|||
147570425|NCT03032172|532245140|FG007|Treatment Period|Discontinued, but Recorded as Completed Open-label Treatment by the Investigator|0|||
147570426|NCT03032172|532245133|FG000|Treatment Period|Withdrawal by Subject|2|||
147651337|NCT04985942|532546436|FG000|Overall Study|Adverse Event|14|||
147651338|NCT04985942|532546437|FG001|Overall Study|Adverse Event|2|||
147130805|NCT04251533|530645739|FG001|Overall Study|Participant decision|3|||
147130806|NCT04251533|530645740|FG002|Overall Study|Participant decision|1|||
147130807|NCT04251533|530645738|FG000|Overall Study|Adverse Event|2|||
147130808|NCT04251533|530645739|FG001|Overall Study|Adverse Event|1|||
147570427|NCT03032172|532245134|FG001|Treatment Period|Withdrawal by Subject|0|||
147570428|NCT03032172|532245135|FG002|Treatment Period|Withdrawal by Subject|3|||
147570429|NCT03032172|532245136|FG003|Treatment Period|Withdrawal by Subject|0|||
147570430|NCT03032172|532245137|FG004|Treatment Period|Withdrawal by Subject|0|||
147570431|NCT03032172|532245138|FG005|Treatment Period|Withdrawal by Subject|0|||
147570432|NCT03032172|532245139|FG006|Treatment Period|Withdrawal by Subject|0|||
147570433|NCT03032172|532245140|FG007|Treatment Period|Withdrawal by Subject|0|||
147570434|NCT03032172|532245133|FG000|Open-label Extension Period|Death|0|||
147570435|NCT03032172|532245134|FG001|Open-label Extension Period|Death|0|||
147570436|NCT03032172|532245135|FG002|Open-label Extension Period|Death|0|||
147570437|NCT03032172|532245136|FG003|Open-label Extension Period|Death|0|||
147570438|NCT03032172|532245137|FG004|Open-label Extension Period|Death|0|||
147570439|NCT03032172|532245138|FG005|Open-label Extension Period|Death|0|||
147570440|NCT03032172|532245139|FG006|Open-label Extension Period|Death|0|||
147570441|NCT03032172|532245140|FG007|Open-label Extension Period|Death|2|||
147570442|NCT03032172|532245133|FG000|Open-label Extension Period|Reason Not Specified|0|||
147570443|NCT03032172|532245134|FG001|Open-label Extension Period|Reason Not Specified|0|||
147570444|NCT03032172|532245135|FG002|Open-label Extension Period|Reason Not Specified|0|||
147570445|NCT03032172|532245136|FG003|Open-label Extension Period|Reason Not Specified|0|||
147130809|NCT04251533|530645740|FG002|Overall Study|Adverse Event|1|||
147130810|NCT01889251|530645745|FG000|Overall Study|Adverse Event|1|||
147570446|NCT03032172|532245137|FG004|Open-label Extension Period|Reason Not Specified|0|||
147570447|NCT03032172|532245138|FG005|Open-label Extension Period|Reason Not Specified|5|||
147570448|NCT03032172|532245139|FG006|Open-label Extension Period|Reason Not Specified|3|||
147570449|NCT03032172|532245140|FG007|Open-label Extension Period|Reason Not Specified|0|||
147570450|NCT03032172|532245133|FG000|Open-label Extension Period|Pregnancy|0|||
147570451|NCT03032172|532245134|FG001|Open-label Extension Period|Pregnancy|0|||
147570452|NCT03032172|532245135|FG002|Open-label Extension Period|Pregnancy|0|||
147570453|NCT03032172|532245136|FG003|Open-label Extension Period|Pregnancy|0|||
147570454|NCT03032172|532245137|FG004|Open-label Extension Period|Pregnancy|0|||
147570455|NCT03032172|532245138|FG005|Open-label Extension Period|Pregnancy|0|||
147570456|NCT03032172|532245139|FG006|Open-label Extension Period|Pregnancy|1|||
147570457|NCT03032172|532245140|FG007|Open-label Extension Period|Pregnancy|0|||
147570458|NCT03032172|532245133|FG000|Open-label Extension Period|Withdrawal by Subject|0|||
147570459|NCT03032172|532245134|FG001|Open-label Extension Period|Withdrawal by Subject|0|||
147570460|NCT03032172|532245135|FG002|Open-label Extension Period|Withdrawal by Subject|0|||
147570461|NCT03032172|532245136|FG003|Open-label Extension Period|Withdrawal by Subject|0|||
147570462|NCT03032172|532245137|FG004|Open-label Extension Period|Withdrawal by Subject|1|||
147570463|NCT03032172|532245138|FG005|Open-label Extension Period|Withdrawal by Subject|7|||
147570464|NCT03032172|532245139|FG006|Open-label Extension Period|Withdrawal by Subject|11|||
147570465|NCT03032172|532245140|FG007|Open-label Extension Period|Withdrawal by Subject|4|||
147570466|NCT06284525|532245141|FG000|Overall Study|Withdrawal by Subject|1|||
147570467|NCT02436005|532245144|FG000|Second Intervention|Adverse Event|0|||
147570468|NCT02436005|532245145|FG001|Second Intervention|Adverse Event|1|||
147570469|NCT00583453|532245146|FG000|Overall Study|discontinued intervention|0|||
147570470|NCT00583453|532245147|FG001|Overall Study|discontinued intervention|2|||
147570471|NCT00905606|532245148|FG000|Period 1|Adverse Event|0|||
147570472|NCT00905606|532245149|FG001|Period 1|Adverse Event|1|||
147570473|NCT00905606|532245148|FG000|Washout|Withdrawal by Subject|1|||
147570474|NCT00905606|532245149|FG001|Washout|Withdrawal by Subject|0|||
147570475|NCT03635320|532245150|FG000|Overall Study|not implanted the device|1|||
147570476|NCT03635320|532245151|FG001|Overall Study|not implanted the device|2|||
147570477|NCT03635320|532245150|FG000|Overall Study|Withdrawal by Subject|11|||
147570478|NCT03635320|532245151|FG001|Overall Study|Withdrawal by Subject|6|||
147570479|NCT01558635|532245155|FG000|Overall Study|Death|1|||
147570480|NCT01558635|532245155|FG000|Overall Study|Withdrawal by Subject|2|||
147570481|NCT01558635|532245155|FG000|Overall Study|Physician Decision|1|||
147570482|NCT01558635|532245155|FG000|Overall Study|Subject received other treatment|1|||
147570483|NCT01558635|532245155|FG000|Overall Study|Reveal XT was explanted|1|||
147651339|NCT04985942|532546436|FG000|Overall Study|Lack of Efficacy|0|||
147651340|NCT04985942|532546437|FG001|Overall Study|Lack of Efficacy|3|||
147236092|NCT00591344|531035514|FG000|Overall Study|Transportation issues|1|||
147236093|NCT00591344|531035515|FG001|Overall Study|Transportation issues|0|||
147236094|NCT00591344|531035514|FG000|Overall Study|Moved out of state|1|||
147236095|NCT00591344|531035515|FG001|Overall Study|Moved out of state|0|||
147236096|NCT00591344|531035514|FG000|Overall Study|Medical complications|1|||
147236097|NCT00591344|531035515|FG001|Overall Study|Medical complications|3|||
147236098|NCT00591344|531035514|FG000|Overall Study|Underwent DBS|2|||
147236099|NCT00591344|531035515|FG001|Overall Study|Underwent DBS|2|||
147236100|NCT00591344|531035514|FG000|Overall Study|Death|0|||
147236101|NCT00591344|531035515|FG001|Overall Study|Death|1|||
147236102|NCT00591344|531035514|FG000|Overall Study|Lost to Follow-up|0|||
147236103|NCT00591344|531035515|FG001|Overall Study|Lost to Follow-up|1|||
147236104|NCT00591344|531035514|FG000|Overall Study|Did not want to come off medication|0|||
147236105|NCT00591344|531035515|FG001|Overall Study|Did not want to come off medication|1|||
147236106|NCT04515394|531035524|FG000|Overall Study|Participant did not receive treatment|1|||
147236107|NCT00413244|531035525|FG000|Overall Study|Withdrawal by Subject|10|||
147236108|NCT00413244|531035526|FG001|Overall Study|Withdrawal by Subject|1|||
147236109|NCT01058655|531035528|FG000|Overall Study|Withdrawal by Subject|1|||
147236110|NCT01058655|531035529|FG001|Overall Study|Withdrawal by Subject|0|||
147236111|NCT01058655|531035530|FG002|Overall Study|Withdrawal by Subject|3|||
147236112|NCT01058655|531035531|FG003|Overall Study|Withdrawal by Subject|4|||
147236113|NCT01058655|531035528|FG000|Overall Study|Prolonged Treatment Delay|0|||
147236114|NCT01058655|531035529|FG001|Overall Study|Prolonged Treatment Delay|0|||
147236115|NCT01058655|531035530|FG002|Overall Study|Prolonged Treatment Delay|0|||
147236116|NCT01058655|531035531|FG003|Overall Study|Prolonged Treatment Delay|2|||
147236117|NCT01058655|531035528|FG000|Overall Study|Symptomatic Deterioration|0|||
147236118|NCT01058655|531035529|FG001|Overall Study|Symptomatic Deterioration|0|||
147236119|NCT01058655|531035530|FG002|Overall Study|Symptomatic Deterioration|0|||
147236120|NCT01058655|531035531|FG003|Overall Study|Symptomatic Deterioration|1|||
147445136|NCT03451084|531794412|FG000|Overall Study|Lack of Efficacy|0|||
147236121|NCT01058655|531035528|FG000|Overall Study|Clinical Progression (non-RECIST)|1|||
147570484|NCT04994535|532245156|FG000|Overall Study|Lost to Follow-up|7|||
147570485|NCT04994535|532245157|FG001|Overall Study|Lost to Follow-up|7|||
147570486|NCT04994535|532245156|FG000|Overall Study|Withdrawal by Subject|10|||
147570487|NCT04994535|532245157|FG001|Overall Study|Withdrawal by Subject|7|||
147570488|NCT04994535|532245156|FG000|Overall Study|Other|1|||
147130811|NCT01889251|530645746|FG001|Overall Study|Adverse Event|0|||
147130812|NCT05852470|530645748|FG000|Overall Study|Withdrawal by Subject|0|||
147130813|NCT05852470|530645749|FG001|Overall Study|Withdrawal by Subject|1|||
147130814|NCT06071104|530645750|FG000|Overall Study|Non-ocular and non-device related adverse event|1|||
147130815|NCT03636022|530645753|FG000|Overall Study|Withdrawal by Subject|1|||
147130816|NCT03636022|530645754|FG001|Overall Study|Withdrawal by Subject|3|||
147130817|NCT00642759|530645758|FG000|Overall Study|Protocol Violation|1|||
147130818|NCT03612570|530645759|FG000|Overall Study|Lost to Follow-up|1|||
147130819|NCT05212168|530645760|FG000|Overall Study|Lost to Follow-up|0|||
147130820|NCT05212168|530645761|FG001|Overall Study|Lost to Follow-up|3|||
147130821|NCT05212168|530645760|FG000|Overall Study|Study terminated by sponsor|30|||
147130822|NCT05212168|530645761|FG001|Overall Study|Study terminated by sponsor|27|||
147130823|NCT05212168|530645760|FG000|Overall Study|Other|4|||
147130824|NCT05212168|530645761|FG001|Overall Study|Other|7|||
147130825|NCT03274466|530645762|FG000|Overall Study|Withdrawal by Subject|7|||
147130826|NCT03274466|530645763|FG001|Overall Study|Withdrawal by Subject|3|||
147130827|NCT03274466|530645762|FG000|Overall Study|Protocol Specified Withdrawal|5|||
147130828|NCT03274466|530645763|FG001|Overall Study|Protocol Specified Withdrawal|11|||
147130829|NCT03274466|530645762|FG000|Overall Study|Lost to Follow-up|5|||
147130830|NCT03274466|530645763|FG001|Overall Study|Lost to Follow-up|7|||
147130831|NCT03274466|530645762|FG000|Overall Study|Subject Non-compliance|0|||
147130832|NCT03274466|530645763|FG001|Overall Study|Subject Non-compliance|1|||
147130833|NCT03274466|530645762|FG000|Overall Study|Adverse Event|3|||
147130834|NCT03274466|530645763|FG001|Overall Study|Adverse Event|3|||
147130835|NCT03274466|530645762|FG000|Overall Study|Physician Decision|0|||
147570489|NCT04994535|532245157|FG001|Overall Study|Other|1|||
147570490|NCT01158118|532245158|FG000|Overall Study|Screen failure|1|||
147570491|NCT01158118|532245159|FG001|Overall Study|Screen failure|0|||
147570492|NCT01158118|532245158|FG000|Overall Study|Donor match was a screen failure|0|||
147570493|NCT01158118|532245159|FG001|Overall Study|Donor match was a screen failure|1|||
147570494|NCT01158118|532245158|FG000|Overall Study|Suffered stroke prior to transplant|0|||
147570495|NCT01158118|532245159|FG001|Overall Study|Suffered stroke prior to transplant|1|||
147570496|NCT01158118|532245158|FG000|Overall Study|Death|0|||
147570497|NCT01158118|532245159|FG001|Overall Study|Death|1|||
147570498|NCT00905840|532245162|FG000|Overall Study|Lost to Follow-up|11|||
147570499|NCT00905840|532245162|FG000|Overall Study|Death|3|||
147570500|NCT00905840|532245162|FG000|Overall Study|Withdrawal by Subject|1|||
147570501|NCT00905840|532245162|FG000|Overall Study|Adverse Event|1|||
147570502|NCT01667679|532245168|FG000|Treatment Period 1 (<=12 Weeks)|Failure to Treat Migraine Headache|2|||
147570503|NCT01667679|532245169|FG001|Treatment Period 1 (<=12 Weeks)|Failure to Treat Migraine Headache|6|||
147570504|NCT01667679|532245168|FG000|Treatment Period 1 (<=12 Weeks)|Dosed Incorrectly|2|||
147570505|NCT01667679|532245169|FG001|Treatment Period 1 (<=12 Weeks)|Dosed Incorrectly|0|||
147570506|NCT01667679|532245168|FG000|Treatment Period 1 (<=12 Weeks)|Lack of Efficacy|2|||
147570507|NCT01667679|532245169|FG001|Treatment Period 1 (<=12 Weeks)|Lack of Efficacy|0|||
147570508|NCT01667679|532245168|FG000|Treatment Period 1 (<=12 Weeks)|Could Not Tolerate Diary|1|||
147570509|NCT01667679|532245169|FG001|Treatment Period 1 (<=12 Weeks)|Could Not Tolerate Diary|0|||
147570510|NCT01667679|532245168|FG000|Treatment Period 1 (<=12 Weeks)|Withdrawal by Subject|6|||
147570511|NCT01667679|532245169|FG001|Treatment Period 1 (<=12 Weeks)|Withdrawal by Subject|13|||
147570512|NCT01667679|532245168|FG000|Treatment Period 1 (<=12 Weeks)|Adverse Event|3|||
147570513|NCT01667679|532245169|FG001|Treatment Period 1 (<=12 Weeks)|Adverse Event|3|||
147570514|NCT01667679|532245168|FG000|Treatment Period 1 (<=12 Weeks)|Lost to Follow-up|0|||
147570515|NCT01667679|532245169|FG001|Treatment Period 1 (<=12 Weeks)|Lost to Follow-up|2|||
147570516|NCT01667679|532245168|FG000|Treatment Period 1 (<=12 Weeks)|Protocol Violation|0|||
147570517|NCT01667679|532245169|FG001|Treatment Period 1 (<=12 Weeks)|Protocol Violation|2|||
147570518|NCT01667679|532245168|FG000|Treatment Period 1 (<=12 Weeks)|Non-compliance|0|||
147570519|NCT01667679|532245169|FG001|Treatment Period 1 (<=12 Weeks)|Non-compliance|3|||
147570520|NCT01667679|532245168|FG000|Treatment Period 1 (<=12 Weeks)|Moved Out of State|0|||
147570521|NCT01667679|532245169|FG001|Treatment Period 1 (<=12 Weeks)|Moved Out of State|1|||
147570522|NCT01667679|532245168|FG000|Treatment Period 2 (<=12 Weeks)|Withdrawal by Subject|6|||
147570523|NCT01667679|532245169|FG001|Treatment Period 2 (<=12 Weeks)|Withdrawal by Subject|4|||
147570524|NCT01667679|532245168|FG000|Treatment Period 2 (<=12 Weeks)|Non-compliance with Electronic Diary|2|||
147570525|NCT01667679|532245169|FG001|Treatment Period 2 (<=12 Weeks)|Non-compliance with Electronic Diary|0|||
147570526|NCT01667679|532245168|FG000|Treatment Period 2 (<=12 Weeks)|Lost to Follow-up|8|||
147570527|NCT01667679|532245169|FG001|Treatment Period 2 (<=12 Weeks)|Lost to Follow-up|10|||
147570528|NCT01667679|532245168|FG000|Treatment Period 2 (<=12 Weeks)|Non-compliance|3|||
147570529|NCT01667679|532245169|FG001|Treatment Period 2 (<=12 Weeks)|Non-compliance|4|||
147570530|NCT01667679|532245168|FG000|Treatment Period 2 (<=12 Weeks)|Sponsor Decision|1|||
147570531|NCT01667679|532245169|FG001|Treatment Period 2 (<=12 Weeks)|Sponsor Decision|0|||
147651341|NCT04985942|532546436|FG000|Overall Study|Lost to Follow-up|1|||
147651342|NCT04985942|532546437|FG001|Overall Study|Lost to Follow-up|1|||
147130836|NCT03274466|530645763|FG001|Overall Study|Physician Decision|1|||
147130837|NCT03274466|530645762|FG000|Overall Study|Protocol Violation|3|||
147130838|NCT03274466|530645763|FG001|Overall Study|Protocol Violation|3|||
147595956|NCT00359632|532338754|FG000|Overall Study|Non-compliance with visit schedule|1|||
147130839|NCT00618787|530645767|FG000|Overall Study|Adverse Event|0|||
147130840|NCT00618787|530645768|FG001|Overall Study|Adverse Event|1|||
147130841|NCT00618787|530645767|FG000|Overall Study|Withdrawal by Subject|2|||
147130842|NCT00618787|530645768|FG001|Overall Study|Withdrawal by Subject|1|||
147130843|NCT00618787|530645767|FG000|Overall Study|Lost to Follow-up|1|||
147130844|NCT00618787|530645768|FG001|Overall Study|Lost to Follow-up|0|||
147130845|NCT01107886|530645769|FG000|Overall Study|Lost to Follow-up|15|||
147130846|NCT01107886|530645770|FG001|Overall Study|Lost to Follow-up|13|||
147130847|NCT01107886|530645769|FG000|Overall Study|Withdrawal by Subject|180|||
147130848|NCT01107886|530645770|FG001|Overall Study|Withdrawal by Subject|196|||
147130849|NCT01107886|530645769|FG000|Overall Study|Administrative withdrawal of consent|7|||
147130850|NCT01107886|530645770|FG001|Overall Study|Administrative withdrawal of consent|5|||
147130851|NCT01994876|530645771|FG000|Test Period 1|Withdrawal by Subject|0|||
147130852|NCT01994876|530645772|FG001|Test Period 1|Withdrawal by Subject|1|||
147130853|NCT01994876|530645771|FG000|Test Period 1|Adverse Event|0|||
147130854|NCT01994876|530645772|FG001|Test Period 1|Adverse Event|1|||
147130855|NCT01994876|530645771|FG000|Test Period 2|Adverse Event|1|||
147130856|NCT01994876|530645772|FG001|Test Period 2|Adverse Event|0|||
147130857|NCT01994876|530645771|FG000|Test Period 2|Protocol Violation|0|||
147130858|NCT01994876|530645772|FG001|Test Period 2|Protocol Violation|1|||
147130859|NCT01346176|530645773|FG000|Recruited|Protocol Violation|1|||
147130860|NCT01346176|530645774|FG001|Recruited|Protocol Violation|0|||
147130861|NCT01346176|530645775|FG002|Recruited|Protocol Violation|0|||
147130862|NCT01346176|530645773|FG000|Completed Advance Directive|Death|3|||
147130863|NCT01346176|530645774|FG001|Completed Advance Directive|Death|2|||
147130864|NCT01346176|530645775|FG002|Completed Advance Directive|Death|2|||
147130865|NCT01346176|530645773|FG000|Completed Advance Directive|Became Ineligible|3|||
147130866|NCT01346176|530645774|FG001|Completed Advance Directive|Became Ineligible|0|||
147130867|NCT01346176|530645775|FG002|Completed Advance Directive|Became Ineligible|1|||
147130868|NCT01346176|530645773|FG000|Completed Advance Directive|Other reason did not complete AD|7|||
147130869|NCT01346176|530645774|FG001|Completed Advance Directive|Other reason did not complete AD|12|||
147130870|NCT01346176|530645775|FG002|Completed Advance Directive|Other reason did not complete AD|7|||
147130871|NCT01346176|530645773|FG000|Completed Satisfaction Survey|Death|3|||
147130872|NCT01346176|530645774|FG001|Completed Satisfaction Survey|Death|0|||
147130873|NCT01346176|530645775|FG002|Completed Satisfaction Survey|Death|2|||
147130874|NCT01346176|530645773|FG000|Completed Satisfaction Survey|Lost to Follow-up|3|||
147130875|NCT01346176|530645774|FG001|Completed Satisfaction Survey|Lost to Follow-up|4|||
147130876|NCT01346176|530645775|FG002|Completed Satisfaction Survey|Lost to Follow-up|4|||
147130877|NCT05819398|530645776|FG000|Overall Study|Withdrawal by Subject|11|||
147130878|NCT05819398|530645777|FG001|Overall Study|Withdrawal by Subject|7|||
147130879|NCT05819398|530645778|FG002|Overall Study|Withdrawal by Subject|6|||
147130880|NCT05819398|530645779|FG003|Overall Study|Withdrawal by Subject|6|||
147130881|NCT05819398|530645776|FG000|Overall Study|Lost to Follow-up|0|||
147130882|NCT05819398|530645777|FG001|Overall Study|Lost to Follow-up|2|||
147130883|NCT05819398|530645778|FG002|Overall Study|Lost to Follow-up|0|||
147130884|NCT05819398|530645779|FG003|Overall Study|Lost to Follow-up|1|||
147130885|NCT05819398|530645776|FG000|Overall Study|Adverse Event|1|||
147130886|NCT05819398|530645777|FG001|Overall Study|Adverse Event|3|||
147130887|NCT05819398|530645778|FG002|Overall Study|Adverse Event|4|||
147130888|NCT05819398|530645779|FG003|Overall Study|Adverse Event|5|||
147130889|NCT05819398|530645776|FG000|Overall Study|Other than listed|0|||
147130890|NCT05819398|530645777|FG001|Overall Study|Other than listed|2|||
147130891|NCT05819398|530645778|FG002|Overall Study|Other than listed|2|||
147130892|NCT05819398|530645779|FG003|Overall Study|Other than listed|0|||
147130893|NCT05819398|530645776|FG000|Overall Study|Lack of Efficacy|0|||
147130894|NCT05819398|530645777|FG001|Overall Study|Lack of Efficacy|1|||
147130895|NCT05819398|530645778|FG002|Overall Study|Lack of Efficacy|0|||
147130896|NCT05819398|530645779|FG003|Overall Study|Lack of Efficacy|0|||
147130897|NCT05819398|530645776|FG000|Overall Study|Study terminated by sponsor|20|||
147130898|NCT05819398|530645777|FG001|Overall Study|Study terminated by sponsor|18|||
147130899|NCT05819398|530645778|FG002|Overall Study|Study terminated by sponsor|20|||
147130900|NCT05819398|530645779|FG003|Overall Study|Study terminated by sponsor|22|||
147130901|NCT04795531|530648814|FG000|Overall Study|Withdrawal by Subject|4|||
147130902|NCT04795531|530648815|FG001|Overall Study|Withdrawal by Subject|4|||
147130903|NCT04795531|530648814|FG000|Overall Study|Lost to Follow-up|0|||
147130904|NCT04795531|530648815|FG001|Overall Study|Lost to Follow-up|1|||
147130905|NCT04795531|530648814|FG000|Overall Study|Physician Decision|0|||
147130906|NCT04795531|530648815|FG001|Overall Study|Physician Decision|2|||
147130907|NCT04795531|530648814|FG000|Overall Study|Death|2|||
147130908|NCT04795531|530648815|FG001|Overall Study|Death|1|||
147130909|NCT04887831|530648816|FG000|Overall Study|Death|26|||
147130910|NCT04887831|530648817|FG001|Overall Study|Death|26|||
147130911|NCT04887831|530648816|FG000|Overall Study|Lost to Follow-up|0|||
147236122|NCT01058655|531035529|FG001|Overall Study|Clinical Progression (non-RECIST)|0|||
147236123|NCT01058655|531035530|FG002|Overall Study|Clinical Progression (non-RECIST)|0|||
147236124|NCT01058655|531035531|FG003|Overall Study|Clinical Progression (non-RECIST)|7|||
147130912|NCT04887831|530648817|FG001|Overall Study|Lost to Follow-up|1|||
147130913|NCT04887831|530648816|FG000|Overall Study|Withdrawal by Subject|2|||
147130914|NCT04887831|530648817|FG001|Overall Study|Withdrawal by Subject|1|||
147130915|NCT04887831|530648816|FG000|Overall Study|Study Terminated by Sponsor|18|||
147130916|NCT04887831|530648817|FG001|Overall Study|Study Terminated by Sponsor|17|||
147130917|NCT04887831|530648816|FG000|Overall Study|Other|1|||
147130918|NCT04887831|530648817|FG001|Overall Study|Other|0|||
147130919|NCT03396445|530648818|FG000|Treatment Period|Death|2|||
147130920|NCT03396445|530648819|FG001|Treatment Period|Death|2|||
147130921|NCT03396445|530648820|FG002|Treatment Period|Death|1|||
147130922|NCT03396445|530648821|FG003|Treatment Period|Death|1|||
147130923|NCT03396445|530648822|FG004|Treatment Period|Death|3|||
147130924|NCT03396445|530648823|FG005|Treatment Period|Death|2|||
147130925|NCT03396445|530648824|FG006|Treatment Period|Death|5|||
147130926|NCT03396445|530648825|FG007|Treatment Period|Death|3|||
147130927|NCT03396445|530648826|FG008|Treatment Period|Death|3|||
147130928|NCT03396445|530648827|FG009|Treatment Period|Death|3|||
147130929|NCT03396445|530648828|FG010|Treatment Period|Death|7|||
147130930|NCT03396445|530648829|FG011|Treatment Period|Death|12|||
147130931|NCT03396445|530648830|FG012|Treatment Period|Death|28|||
147130932|NCT03396445|530648831|FG013|Treatment Period|Death|14|||
147130933|NCT03396445|530648832|FG014|Treatment Period|Death|10|||
147130934|NCT03396445|530648833|FG015|Treatment Period|Death|8|||
147130935|NCT03396445|530648834|FG016|Treatment Period|Death|18|||
147130936|NCT03396445|530648835|FG017|Treatment Period|Death|0|||
147130937|NCT03396445|530648836|FG018|Treatment Period|Death|0|||
147130938|NCT03396445|530648837|FG019|Treatment Period|Death|0|||
147317586|NCT01023308|531329300|FG000|Overall Study|Withdrawal by Subject|34|||
147317587|NCT01023308|531329301|FG001|Overall Study|Withdrawal by Subject|18|||
147317588|NCT01646320|531329304|FG000|Short-term Period (Day 1 to Week 24)|Adverse Event|3|||
147317589|NCT01646320|531329305|FG001|Short-term Period (Day 1 to Week 24)|Adverse Event|0|||
147317590|NCT01646320|531329304|FG000|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|0|||
147317591|NCT01646320|531329305|FG001|Short-term Period (Day 1 to Week 24)|No longer meets study criteria|1|||
147317592|NCT01646320|531329304|FG000|Short-term Period (Day 1 to Week 24)|Not reported|2|||
147317593|NCT01646320|531329305|FG001|Short-term Period (Day 1 to Week 24)|Not reported|2|||
147317594|NCT01646320|531329304|FG000|Short-term Period (Day 1 to Week 24)|Other|1|||
147317595|NCT01646320|531329305|FG001|Short-term Period (Day 1 to Week 24)|Other|0|||
147317596|NCT01646320|531329304|FG000|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4|||
147570532|NCT01667679|532245168|FG000|Treatment Period 2 (<=12 Weeks)|Failure to Treat Migraine Headache|1|||
147570533|NCT01667679|532245169|FG001|Treatment Period 2 (<=12 Weeks)|Failure to Treat Migraine Headache|0|||
147570534|NCT01667679|532245168|FG000|Treatment Period 2 (<=12 Weeks)|Adverse Event|1|||
147130939|NCT03396445|530648838|FG020|Treatment Period|Death|0|||
147130940|NCT03396445|530648839|FG021|Treatment Period|Death|0|||
147130941|NCT03396445|530648840|FG022|Treatment Period|Death|0|||
147130942|NCT03396445|530648841|FG023|Treatment Period|Death|0|||
147130943|NCT03396445|530648842|FG024|Treatment Period|Death|0|||
147130944|NCT03396445|530648843|FG025|Treatment Period|Death|0|||
147130945|NCT03396445|530648818|FG000|Treatment Period|Lost to Follow-up|0|||
147130946|NCT03396445|530648819|FG001|Treatment Period|Lost to Follow-up|0|||
147130947|NCT03396445|530648820|FG002|Treatment Period|Lost to Follow-up|0|||
147130948|NCT03396445|530648821|FG003|Treatment Period|Lost to Follow-up|0|||
147130949|NCT03396445|530648822|FG004|Treatment Period|Lost to Follow-up|0|||
147130950|NCT03396445|530648823|FG005|Treatment Period|Lost to Follow-up|0|||
147130951|NCT03396445|530648824|FG006|Treatment Period|Lost to Follow-up|0|||
147130952|NCT03396445|530648825|FG007|Treatment Period|Lost to Follow-up|0|||
147130953|NCT03396445|530648826|FG008|Treatment Period|Lost to Follow-up|0|||
147130954|NCT03396445|530648827|FG009|Treatment Period|Lost to Follow-up|0|||
147130955|NCT03396445|530648828|FG010|Treatment Period|Lost to Follow-up|0|||
147130956|NCT03396445|530648829|FG011|Treatment Period|Lost to Follow-up|0|||
147130957|NCT03396445|530648830|FG012|Treatment Period|Lost to Follow-up|1|||
147130958|NCT03396445|530648831|FG013|Treatment Period|Lost to Follow-up|0|||
147130959|NCT03396445|530648832|FG014|Treatment Period|Lost to Follow-up|1|||
147130960|NCT03396445|530648833|FG015|Treatment Period|Lost to Follow-up|0|||
147130961|NCT03396445|530648834|FG016|Treatment Period|Lost to Follow-up|0|||
147130962|NCT03396445|530648835|FG017|Treatment Period|Lost to Follow-up|0|||
147130963|NCT03396445|530648836|FG018|Treatment Period|Lost to Follow-up|0|||
147130964|NCT03396445|530648837|FG019|Treatment Period|Lost to Follow-up|0|||
147130965|NCT03396445|530648838|FG020|Treatment Period|Lost to Follow-up|0|||
147130966|NCT03396445|530648839|FG021|Treatment Period|Lost to Follow-up|0|||
147130967|NCT03396445|530648840|FG022|Treatment Period|Lost to Follow-up|0|||
147130968|NCT03396445|530648841|FG023|Treatment Period|Lost to Follow-up|0|||
147130969|NCT03396445|530648842|FG024|Treatment Period|Lost to Follow-up|0|||
147130970|NCT03396445|530648843|FG025|Treatment Period|Lost to Follow-up|0|||
147130971|NCT03396445|530648818|FG000|Treatment Period|Physician Decision|0|||
147130972|NCT03396445|530648819|FG001|Treatment Period|Physician Decision|0|||
147130973|NCT03396445|530648820|FG002|Treatment Period|Physician Decision|0|||
147130974|NCT03396445|530648821|FG003|Treatment Period|Physician Decision|0|||
147130975|NCT03396445|530648822|FG004|Treatment Period|Physician Decision|1|||
147130976|NCT03396445|530648823|FG005|Treatment Period|Physician Decision|0|||
147130977|NCT03396445|530648824|FG006|Treatment Period|Physician Decision|0|||
147130978|NCT03396445|530648825|FG007|Treatment Period|Physician Decision|0|||
147130979|NCT03396445|530648826|FG008|Treatment Period|Physician Decision|0|||
147130980|NCT03396445|530648827|FG009|Treatment Period|Physician Decision|1|||
147130981|NCT03396445|530648828|FG010|Treatment Period|Physician Decision|0|||
147130982|NCT03396445|530648829|FG011|Treatment Period|Physician Decision|0|||
147130983|NCT03396445|530648830|FG012|Treatment Period|Physician Decision|0|||
147130984|NCT03396445|530648831|FG013|Treatment Period|Physician Decision|0|||
147130985|NCT03396445|530648832|FG014|Treatment Period|Physician Decision|0|||
147130986|NCT03396445|530648833|FG015|Treatment Period|Physician Decision|0|||
147130987|NCT03396445|530648834|FG016|Treatment Period|Physician Decision|0|||
147130988|NCT03396445|530648835|FG017|Treatment Period|Physician Decision|0|||
147130989|NCT03396445|530648836|FG018|Treatment Period|Physician Decision|0|||
147130990|NCT03396445|530648837|FG019|Treatment Period|Physician Decision|0|||
147130991|NCT03396445|530648838|FG020|Treatment Period|Physician Decision|0|||
147130992|NCT03396445|530648839|FG021|Treatment Period|Physician Decision|0|||
147130993|NCT03396445|530648840|FG022|Treatment Period|Physician Decision|0|||
147130994|NCT03396445|530648841|FG023|Treatment Period|Physician Decision|0|||
147130995|NCT03396445|530648842|FG024|Treatment Period|Physician Decision|0|||
147130996|NCT03396445|530648843|FG025|Treatment Period|Physician Decision|0|||
147130997|NCT03396445|530648818|FG000|Treatment Period|Randomized by Mistake without Study Treatment|0|||
147130998|NCT03396445|530648819|FG001|Treatment Period|Randomized by Mistake without Study Treatment|0|||
147130999|NCT03396445|530648820|FG002|Treatment Period|Randomized by Mistake without Study Treatment|0|||
147131000|NCT03396445|530648821|FG003|Treatment Period|Randomized by Mistake without Study Treatment|0|||
147131001|NCT03396445|530648822|FG004|Treatment Period|Randomized by Mistake without Study Treatment|0|||
147131002|NCT03396445|530648823|FG005|Treatment Period|Randomized by Mistake without Study Treatment|0|||
147131003|NCT03396445|530648824|FG006|Treatment Period|Randomized by Mistake without Study Treatment|0|||
147131004|NCT03396445|530648825|FG007|Treatment Period|Randomized by Mistake without Study Treatment|0|||
147131005|NCT03396445|530648826|FG008|Treatment Period|Randomized by Mistake without Study Treatment|0|||
147131006|NCT03396445|530648827|FG009|Treatment Period|Randomized by Mistake without Study Treatment|0|||
147131007|NCT03396445|530648828|FG010|Treatment Period|Randomized by Mistake without Study Treatment|0|||
147131008|NCT03396445|530648829|FG011|Treatment Period|Randomized by Mistake without Study Treatment|0|||
147131009|NCT03396445|530648830|FG012|Treatment Period|Randomized by Mistake without Study Treatment|1|||
147131010|NCT03396445|530648831|FG013|Treatment Period|Randomized by Mistake without Study Treatment|0|||
147131011|NCT03396445|530648832|FG014|Treatment Period|Randomized by Mistake without Study Treatment|1|||
147131012|NCT03396445|530648833|FG015|Treatment Period|Randomized by Mistake without Study Treatment|0|||
147131013|NCT03396445|530648834|FG016|Treatment Period|Randomized by Mistake without Study Treatment|0|||
147131014|NCT03396445|530648835|FG017|Treatment Period|Randomized by Mistake without Study Treatment|0|||
147131015|NCT03396445|530648836|FG018|Treatment Period|Randomized by Mistake without Study Treatment|0|||
147131016|NCT03396445|530648837|FG019|Treatment Period|Randomized by Mistake without Study Treatment|0|||
147131017|NCT03396445|530648838|FG020|Treatment Period|Randomized by Mistake without Study Treatment|0|||
147317597|NCT01646320|531329305|FG001|Short-term Period (Day 1 to Week 24)|Lost to Follow-up|4|||
147317598|NCT01646320|531329304|FG000|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|2|||
147317599|NCT01646320|531329305|FG001|Short-term Period (Day 1 to Week 24)|Withdrawal by Subject|0|||
147317600|NCT01646320|531329304|FG000|Long-term Period (Weeks 24 to 52)|Subject no longer meets study criteria|2|||
147317601|NCT01646320|531329305|FG001|Long-term Period (Weeks 24 to 52)|Subject no longer meets study criteria|0|||
147317602|NCT01646320|531329304|FG000|Long-term Period (Weeks 24 to 52)|Withdrawal by Subject|0|||
147317603|NCT01646320|531329305|FG001|Long-term Period (Weeks 24 to 52)|Withdrawal by Subject|2|||
147317604|NCT01646320|531329304|FG000|Long-term Period (Weeks 24 to 52)|Adverse Event|4|||
147317605|NCT01646320|531329305|FG001|Long-term Period (Weeks 24 to 52)|Adverse Event|2|||
147317606|NCT01646320|531329304|FG000|Long-term Period (Weeks 24 to 52)|Lack of Efficacy|0|||
147317607|NCT01646320|531329305|FG001|Long-term Period (Weeks 24 to 52)|Lack of Efficacy|1|||
147317608|NCT01646320|531329304|FG000|Long-term Period (Weeks 24 to 52)|Lost to Follow-up|0|||
147445137|NCT03451084|531794413|FG001|Overall Study|Lack of Efficacy|3|||
147570535|NCT01667679|532245169|FG001|Treatment Period 2 (<=12 Weeks)|Adverse Event|0|||
147570536|NCT01667679|532245168|FG000|Treatment Period 2 (<=12 Weeks)|Significant Improvement in Migraine|0|||
147570537|NCT01667679|532245169|FG001|Treatment Period 2 (<=12 Weeks)|Significant Improvement in Migraine|1|||
147570538|NCT01667679|532245168|FG000|Treatment Period 2 (<=12 Weeks)|Partially Dosed|0|||
147570539|NCT01667679|532245169|FG001|Treatment Period 2 (<=12 Weeks)|Partially Dosed|1|||
147131018|NCT03396445|530648839|FG021|Treatment Period|Randomized by Mistake without Study Treatment|0|||
147131019|NCT03396445|530648840|FG022|Treatment Period|Randomized by Mistake without Study Treatment|0|||
147131020|NCT03396445|530648841|FG023|Treatment Period|Randomized by Mistake without Study Treatment|0|||
147131021|NCT03396445|530648842|FG024|Treatment Period|Randomized by Mistake without Study Treatment|0|||
147317609|NCT01646320|531329305|FG001|Long-term Period (Weeks 24 to 52)|Lost to Follow-up|2|||
147651343|NCT04985942|532546436|FG000|Overall Study|Protocol Violation|1|||
147131022|NCT03396445|530648843|FG025|Treatment Period|Randomized by Mistake without Study Treatment|0|||
147131023|NCT03396445|530648818|FG000|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|1|||
147131024|NCT03396445|530648819|FG001|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|1|||
147131025|NCT03396445|530648820|FG002|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|5|||
147131026|NCT03396445|530648821|FG003|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|2|||
147131027|NCT03396445|530648822|FG004|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|5|||
147131028|NCT03396445|530648823|FG005|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
147131029|NCT03396445|530648824|FG006|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|9|||
147131030|NCT03396445|530648825|FG007|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
147131031|NCT03396445|530648826|FG008|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
147131032|NCT03396445|530648827|FG009|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
147131033|NCT03396445|530648828|FG010|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
147131034|NCT03396445|530648829|FG011|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
147131035|NCT03396445|530648830|FG012|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
147131036|NCT03396445|530648831|FG013|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
147131037|NCT03396445|530648832|FG014|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
147131038|NCT03396445|530648833|FG015|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
147131039|NCT03396445|530648834|FG016|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
147131040|NCT03396445|530648835|FG017|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
147131041|NCT03396445|530648836|FG018|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
147131042|NCT03396445|530648837|FG019|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
147131043|NCT03396445|530648838|FG020|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
147131044|NCT03396445|530648839|FG021|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
147131045|NCT03396445|530648840|FG022|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
147131046|NCT03396445|530648841|FG023|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
147131047|NCT03396445|530648842|FG024|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
147131048|NCT03396445|530648843|FG025|Treatment Period|Progressive Disease, Switched Over to Boserolimab + Pembrolizumab Combination Treatment|0|||
147131049|NCT03396445|530648818|FG000|Treatment Period|Withdrawal by Subject|0|||
147131050|NCT03396445|530648819|FG001|Treatment Period|Withdrawal by Subject|0|||
147131051|NCT03396445|530648820|FG002|Treatment Period|Withdrawal by Subject|0|||
147131052|NCT03396445|530648821|FG003|Treatment Period|Withdrawal by Subject|0|||
147131053|NCT03396445|530648822|FG004|Treatment Period|Withdrawal by Subject|0|||
147131054|NCT03396445|530648823|FG005|Treatment Period|Withdrawal by Subject|0|||
147131055|NCT03396445|530648824|FG006|Treatment Period|Withdrawal by Subject|0|||
147131056|NCT03396445|530648825|FG007|Treatment Period|Withdrawal by Subject|0|||
147131057|NCT03396445|530648826|FG008|Treatment Period|Withdrawal by Subject|0|||
147131058|NCT03396445|530648827|FG009|Treatment Period|Withdrawal by Subject|0|||
147131059|NCT03396445|530648828|FG010|Treatment Period|Withdrawal by Subject|0|||
147131060|NCT03396445|530648829|FG011|Treatment Period|Withdrawal by Subject|0|||
147131061|NCT03396445|530648830|FG012|Treatment Period|Withdrawal by Subject|0|||
147131062|NCT03396445|530648831|FG013|Treatment Period|Withdrawal by Subject|0|||
147131063|NCT03396445|530648832|FG014|Treatment Period|Withdrawal by Subject|1|||
147131064|NCT03396445|530648833|FG015|Treatment Period|Withdrawal by Subject|0|||
147131065|NCT03396445|530648834|FG016|Treatment Period|Withdrawal by Subject|1|||
147131066|NCT03396445|530648835|FG017|Treatment Period|Withdrawal by Subject|0|||
147131067|NCT03396445|530648836|FG018|Treatment Period|Withdrawal by Subject|0|||
147131068|NCT03396445|530648837|FG019|Treatment Period|Withdrawal by Subject|0|||
147131069|NCT03396445|530648838|FG020|Treatment Period|Withdrawal by Subject|0|||
147131070|NCT03396445|530648839|FG021|Treatment Period|Withdrawal by Subject|0|||
147131071|NCT03396445|530648840|FG022|Treatment Period|Withdrawal by Subject|0|||
147131072|NCT03396445|530648841|FG023|Treatment Period|Withdrawal by Subject|0|||
147131073|NCT03396445|530648842|FG024|Treatment Period|Withdrawal by Subject|0|||
147131074|NCT03396445|530648843|FG025|Treatment Period|Withdrawal by Subject|0|||
147317610|NCT02892409|531329306|FG000|Overall Study|Adverse Event|1|||
147570540|NCT01667679|532245168|FG000|Treatment Period 2 (<=12 Weeks)|Brought in before 12 Weeks/5 Migraines|0|||
147570541|NCT01667679|532245169|FG001|Treatment Period 2 (<=12 Weeks)|Brought in before 12 Weeks/5 Migraines|1|||
147570542|NCT01667679|532245168|FG000|Treatment Period 2 (<=12 Weeks)|Refused Last Day of Visit 4 Procedures|0|||
147570543|NCT01667679|532245169|FG001|Treatment Period 2 (<=12 Weeks)|Refused Last Day of Visit 4 Procedures|1|||
147131075|NCT03396445|530648818|FG000|Switch-over Period|Death|0|||
147131076|NCT03396445|530648819|FG001|Switch-over Period|Death|0|||
147131077|NCT03396445|530648820|FG002|Switch-over Period|Death|0|||
147131078|NCT03396445|530648821|FG003|Switch-over Period|Death|0|||
147131079|NCT03396445|530648822|FG004|Switch-over Period|Death|0|||
147131080|NCT03396445|530648823|FG005|Switch-over Period|Death|0|||
147131081|NCT03396445|530648824|FG006|Switch-over Period|Death|0|||
147131082|NCT03396445|530648825|FG007|Switch-over Period|Death|0|||
147131083|NCT03396445|530648826|FG008|Switch-over Period|Death|0|||
147131084|NCT03396445|530648827|FG009|Switch-over Period|Death|0|||
147131085|NCT03396445|530648828|FG010|Switch-over Period|Death|0|||
147131086|NCT03396445|530648829|FG011|Switch-over Period|Death|0|||
147131087|NCT03396445|530648830|FG012|Switch-over Period|Death|0|||
147131088|NCT03396445|530648831|FG013|Switch-over Period|Death|0|||
147131089|NCT03396445|530648832|FG014|Switch-over Period|Death|0|||
147131090|NCT03396445|530648833|FG015|Switch-over Period|Death|0|||
147131091|NCT03396445|530648834|FG016|Switch-over Period|Death|0|||
147131092|NCT03396445|530648835|FG017|Switch-over Period|Death|0|||
147131093|NCT03396445|530648836|FG018|Switch-over Period|Death|1|||
147131094|NCT03396445|530648837|FG019|Switch-over Period|Death|2|||
147131095|NCT03396445|530648838|FG020|Switch-over Period|Death|2|||
147131096|NCT03396445|530648839|FG021|Switch-over Period|Death|1|||
147131097|NCT03396445|530648840|FG022|Switch-over Period|Death|2|||
147131098|NCT03396445|530648841|FG023|Switch-over Period|Death|0|||
147131099|NCT03396445|530648842|FG024|Switch-over Period|Death|1|||
147131100|NCT03396445|530648843|FG025|Switch-over Period|Death|6|||
147131101|NCT03396445|530648818|FG000|Switch-over Period|Lost to Follow-up|0|||
147131102|NCT03396445|530648819|FG001|Switch-over Period|Lost to Follow-up|0|||
147131103|NCT03396445|530648820|FG002|Switch-over Period|Lost to Follow-up|0|||
147131104|NCT03396445|530648821|FG003|Switch-over Period|Lost to Follow-up|0|||
147131105|NCT03396445|530648822|FG004|Switch-over Period|Lost to Follow-up|0|||
147131106|NCT03396445|530648823|FG005|Switch-over Period|Lost to Follow-up|0|||
147131107|NCT03396445|530648824|FG006|Switch-over Period|Lost to Follow-up|0|||
147131108|NCT03396445|530648825|FG007|Switch-over Period|Lost to Follow-up|0|||
147131109|NCT03396445|530648826|FG008|Switch-over Period|Lost to Follow-up|0|||
147131110|NCT03396445|530648827|FG009|Switch-over Period|Lost to Follow-up|0|||
147131111|NCT03396445|530648828|FG010|Switch-over Period|Lost to Follow-up|0|||
147131112|NCT03396445|530648829|FG011|Switch-over Period|Lost to Follow-up|0|||
147131113|NCT03396445|530648830|FG012|Switch-over Period|Lost to Follow-up|0|||
147131114|NCT03396445|530648831|FG013|Switch-over Period|Lost to Follow-up|0|||
147131115|NCT03396445|530648832|FG014|Switch-over Period|Lost to Follow-up|0|||
147131116|NCT03396445|530648833|FG015|Switch-over Period|Lost to Follow-up|0|||
147131117|NCT03396445|530648834|FG016|Switch-over Period|Lost to Follow-up|0|||
147131118|NCT03396445|530648835|FG017|Switch-over Period|Lost to Follow-up|0|||
147131119|NCT03396445|530648836|FG018|Switch-over Period|Lost to Follow-up|0|||
147131120|NCT03396445|530648837|FG019|Switch-over Period|Lost to Follow-up|0|||
147131121|NCT03396445|530648838|FG020|Switch-over Period|Lost to Follow-up|0|||
147131122|NCT03396445|530648839|FG021|Switch-over Period|Lost to Follow-up|0|||
147131123|NCT03396445|530648840|FG022|Switch-over Period|Lost to Follow-up|0|||
147131124|NCT03396445|530648841|FG023|Switch-over Period|Lost to Follow-up|1|||
147131125|NCT03396445|530648842|FG024|Switch-over Period|Lost to Follow-up|0|||
147131126|NCT03396445|530648843|FG025|Switch-over Period|Lost to Follow-up|0|||
147131127|NCT04622592|530648844|FG000|Overall Study|Death|0|||
147131128|NCT04622592|530648845|FG001|Overall Study|Death|0|||
147131129|NCT04622592|530648846|FG002|Overall Study|Death|1|||
147236125|NCT01058655|531035528|FG000|Overall Study|Death|0|||
147236126|NCT01058655|531035529|FG001|Overall Study|Death|1|||
147236127|NCT01058655|531035530|FG002|Overall Study|Death|1|||
147236128|NCT01058655|531035531|FG003|Overall Study|Death|0|||
147236129|NCT01058655|531035528|FG000|Overall Study|Disease Progression|1|||
147236130|NCT01058655|531035529|FG001|Overall Study|Disease Progression|2|||
147236131|NCT01058655|531035530|FG002|Overall Study|Disease Progression|4|||
147236132|NCT01058655|531035531|FG003|Overall Study|Disease Progression|24|||
147236133|NCT01058655|531035528|FG000|Overall Study|Other|0|||
147131130|NCT04622592|530648847|FG003|Overall Study|Death|0|||
147131131|NCT04622592|530648848|FG004|Overall Study|Death|0|||
147236134|NCT01058655|531035529|FG001|Overall Study|Other|0|||
147131132|NCT04622592|530648849|FG005|Overall Study|Death|0|||
147131133|NCT04622592|530648850|FG006|Overall Study|Death|0|||
147236135|NCT01058655|531035530|FG002|Overall Study|Other|0|||
147131134|NCT04622592|530648851|FG007|Overall Study|Death|1|||
147131135|NCT04622592|530648844|FG000|Overall Study|Lost to Follow-up|0|||
147131136|NCT04622592|530648845|FG001|Overall Study|Lost to Follow-up|0|||
147131137|NCT04622592|530648846|FG002|Overall Study|Lost to Follow-up|0|||
147131138|NCT04622592|530648847|FG003|Overall Study|Lost to Follow-up|3|||
147131139|NCT04622592|530648848|FG004|Overall Study|Lost to Follow-up|1|||
147131140|NCT04622592|530648849|FG005|Overall Study|Lost to Follow-up|0|||
147131141|NCT04622592|530648850|FG006|Overall Study|Lost to Follow-up|2|||
147131142|NCT04622592|530648851|FG007|Overall Study|Lost to Follow-up|2|||
147131143|NCT04622592|530648844|FG000|Overall Study|Physician Decision|0|||
147236136|NCT01058655|531035531|FG003|Overall Study|Other|4|||
147236137|NCT00619177|531035534|FG000|Overall Study|Adverse Event|18|||
147131144|NCT04622592|530648845|FG001|Overall Study|Physician Decision|0|||
147131145|NCT04622592|530648846|FG002|Overall Study|Physician Decision|0|||
147131146|NCT04622592|530648847|FG003|Overall Study|Physician Decision|0|||
147131147|NCT04622592|530648848|FG004|Overall Study|Physician Decision|1|||
147131148|NCT04622592|530648849|FG005|Overall Study|Physician Decision|0|||
147131149|NCT04622592|530648850|FG006|Overall Study|Physician Decision|0|||
147131150|NCT04622592|530648851|FG007|Overall Study|Physician Decision|0|||
147131151|NCT04622592|530648844|FG000|Overall Study|Withdrawal by Subject|1|||
147131152|NCT04622592|530648845|FG001|Overall Study|Withdrawal by Subject|0|||
147131153|NCT04622592|530648846|FG002|Overall Study|Withdrawal by Subject|2|||
147131154|NCT04622592|530648847|FG003|Overall Study|Withdrawal by Subject|0|||
147131155|NCT04622592|530648848|FG004|Overall Study|Withdrawal by Subject|0|||
147131156|NCT04622592|530648849|FG005|Overall Study|Withdrawal by Subject|0|||
147131157|NCT04622592|530648850|FG006|Overall Study|Withdrawal by Subject|1|||
147131158|NCT04622592|530648851|FG007|Overall Study|Withdrawal by Subject|4|||
147131159|NCT04622592|530648844|FG000|Overall Study|Other than specified above|0|||
147131160|NCT04622592|530648845|FG001|Overall Study|Other than specified above|0|||
147131161|NCT04622592|530648846|FG002|Overall Study|Other than specified above|1|||
147131162|NCT04622592|530648847|FG003|Overall Study|Other than specified above|0|||
147131163|NCT04622592|530648848|FG004|Overall Study|Other than specified above|0|||
147131164|NCT04622592|530648849|FG005|Overall Study|Other than specified above|0|||
147131165|NCT04622592|530648850|FG006|Overall Study|Other than specified above|0|||
147131166|NCT04622592|530648851|FG007|Overall Study|Other than specified above|0|||
147131167|NCT01664624|530648852|FG000|Overall Study|Adverse Event|0|||
147131168|NCT01664624|530648853|FG001|Overall Study|Adverse Event|1|||
147131169|NCT01664624|530648854|FG002|Overall Study|Adverse Event|0|||
147131170|NCT01664624|530648855|FG003|Overall Study|Adverse Event|0|||
147131171|NCT00573768|530648859|FG000|Overall Study|Adverse Event|1|||
147131172|NCT00573768|530648860|FG001|Overall Study|Adverse Event|1|||
147131173|NCT00573768|530648861|FG002|Overall Study|Adverse Event|2|||
147131174|NCT00573768|530648859|FG000|Overall Study|Protocol Violation|1|||
147131175|NCT00573768|530648860|FG001|Overall Study|Protocol Violation|0|||
147131176|NCT00573768|530648861|FG002|Overall Study|Protocol Violation|1|||
147131177|NCT00573768|530648859|FG000|Overall Study|Withdrawal by Subject|0|||
147131178|NCT00573768|530648860|FG001|Overall Study|Withdrawal by Subject|1|||
147131179|NCT00573768|530648861|FG002|Overall Study|Withdrawal by Subject|0|||
147131180|NCT00573768|530648859|FG000|Overall Study|Lost to Follow-up|0|||
147131181|NCT00573768|530648860|FG001|Overall Study|Lost to Follow-up|0|||
147131182|NCT00573768|530648861|FG002|Overall Study|Lost to Follow-up|1|||
147317611|NCT02892409|531329307|FG001|Overall Study|Adverse Event|0|||
147317612|NCT02892409|531329306|FG000|Overall Study|Withdrawal by Subject|2|||
147317613|NCT02892409|531329307|FG001|Overall Study|Withdrawal by Subject|1|||
147317614|NCT01440049|531329310|FG000|Overall Study|Adverse Event|5|||
147317615|NCT02748512|531329314|FG000|Overall Study|Lost to Follow-up|1|||
147570544|NCT03872128|532245173|FG000|Overall Study|Dropped out before treatment|1|||
147570545|NCT03872128|532245174|FG001|Overall Study|Dropped out before treatment|0|||
147317616|NCT02748512|531329315|FG001|Overall Study|Lost to Follow-up|1|||
147317617|NCT02411591|531329319|FG000|Overall Study|Adverse Event|0|||
147317618|NCT02411591|531329320|FG001|Overall Study|Adverse Event|4|||
147317619|NCT02411591|531329321|FG002|Overall Study|Adverse Event|2|||
147317620|NCT02411591|531329319|FG000|Overall Study|Withdrawal by Subject|0|||
147317621|NCT02411591|531329320|FG001|Overall Study|Withdrawal by Subject|3|||
147317622|NCT02411591|531329321|FG002|Overall Study|Withdrawal by Subject|0|||
147317623|NCT02411591|531329319|FG000|Overall Study|Physician Decision|0|||
147317624|NCT02411591|531329320|FG001|Overall Study|Physician Decision|3|||
147317625|NCT02411591|531329321|FG002|Overall Study|Physician Decision|1|||
147317626|NCT02491892|531329322|FG000|Overall Study|Adverse Event|1|||
147317627|NCT02491892|531329323|FG001|Overall Study|Adverse Event|1|||
147317628|NCT02491892|531329322|FG000|Overall Study|Death|1|||
147317629|NCT02491892|531329323|FG001|Overall Study|Death|1|||
147317630|NCT02491892|531329322|FG000|Overall Study|Lack of Efficacy|37|||
147317631|NCT02491892|531329323|FG001|Overall Study|Lack of Efficacy|36|||
147317632|NCT02491892|531329322|FG000|Overall Study|Refused Treatment|1|||
147317633|NCT02491892|531329323|FG001|Overall Study|Refused Treatment|0|||
147570546|NCT03872128|532245175|FG002|Overall Study|Dropped out before treatment|4|||
147317634|NCT02491892|531329322|FG000|Overall Study|Lost to Follow-up|1|||
147131183|NCT03502200|530648871|FG000|Overall Study|Adverse Event|1|||
147131184|NCT03502200|530648872|FG001|Overall Study|Adverse Event|0|||
147131185|NCT03502200|530648871|FG000|Overall Study|Lost to Follow-up|36|||
147131186|NCT03502200|530648872|FG001|Overall Study|Lost to Follow-up|38|||
147317635|NCT02491892|531329323|FG001|Overall Study|Lost to Follow-up|0|||
147317636|NCT04496167|531329325|FG000|Overall Study|Adverse Event|6|||
147131187|NCT03502200|530648871|FG000|Overall Study|Study Team Decision|1|||
147131188|NCT03502200|530648872|FG001|Overall Study|Study Team Decision|1|||
147131189|NCT03502200|530648871|FG000|Overall Study|Withdrawal by Subject|5|||
147131190|NCT03502200|530648872|FG001|Overall Study|Withdrawal by Subject|7|||
147131191|NCT03502200|530648871|FG000|Overall Study|Death|0|||
147131192|NCT03502200|530648872|FG001|Overall Study|Death|2|||
147317637|NCT04496167|531329326|FG001|Overall Study|Adverse Event|2|||
147317638|NCT04496167|531329325|FG000|Overall Study|Withdrawal by Subject|7|||
147317639|NCT04496167|531329326|FG001|Overall Study|Withdrawal by Subject|6|||
147131193|NCT00855335|530648873|FG000|Overall Study|Lost to Follow-up|0|||
147131194|NCT00855335|530648874|FG001|Overall Study|Lost to Follow-up|0|||
147131195|NCT00855335|530648875|FG002|Overall Study|Lost to Follow-up|3|||
147131196|NCT00855335|530648876|FG003|Overall Study|Lost to Follow-up|1|||
147131197|NCT00855335|530648877|FG004|Overall Study|Lost to Follow-up|0|||
147131198|NCT00855335|530648873|FG000|Overall Study|Withdrawal by Subject|0|||
147131199|NCT00855335|530648874|FG001|Overall Study|Withdrawal by Subject|0|||
147131200|NCT00855335|530648875|FG002|Overall Study|Withdrawal by Subject|0|||
147131201|NCT00855335|530648876|FG003|Overall Study|Withdrawal by Subject|1|||
147131202|NCT00855335|530648877|FG004|Overall Study|Withdrawal by Subject|0|||
147131203|NCT00855335|530648873|FG000|Overall Study|Adverse Event|2|||
147131204|NCT00855335|530648874|FG001|Overall Study|Adverse Event|0|||
147131205|NCT00855335|530648875|FG002|Overall Study|Adverse Event|0|||
147131206|NCT00855335|530648876|FG003|Overall Study|Adverse Event|0|||
147131207|NCT00855335|530648877|FG004|Overall Study|Adverse Event|0|||
147131208|NCT00855335|530648873|FG000|Overall Study|Physician Decision|1|||
147131209|NCT00855335|530648874|FG001|Overall Study|Physician Decision|1|||
147131210|NCT00855335|530648875|FG002|Overall Study|Physician Decision|0|||
147131211|NCT00855335|530648876|FG003|Overall Study|Physician Decision|0|||
147131212|NCT00855335|530648877|FG004|Overall Study|Physician Decision|0|||
147131213|NCT00855335|530648873|FG000|Overall Study|Other|2|||
147131214|NCT00855335|530648874|FG001|Overall Study|Other|1|||
147131215|NCT00855335|530648875|FG002|Overall Study|Other|2|||
147131216|NCT00855335|530648876|FG003|Overall Study|Other|5|||
147131217|NCT00855335|530648877|FG004|Overall Study|Other|1|||
147131218|NCT02526290|530648884|FG000|Overall Study|Adverse Event|3|||
147651344|NCT04985942|532546437|FG001|Overall Study|Protocol Violation|1|||
147131219|NCT02526290|530648884|FG000|Overall Study|Withdrawal by Subject|4|||
147131220|NCT02526290|530648884|FG000|Overall Study|Physician Decision|1|||
147131221|NCT02082977|530648885|FG000|Part 1 (Up to 3.2 Years)|Death|1|||
147131222|NCT02082977|530648886|FG001|Part 1 (Up to 3.2 Years)|Death|0|||
147131223|NCT02082977|530648887|FG002|Part 1 (Up to 3.2 Years)|Death|0|||
147131224|NCT02082977|530648888|FG003|Part 1 (Up to 3.2 Years)|Death|0|||
147131225|NCT02082977|530648889|FG004|Part 1 (Up to 3.2 Years)|Death|0|||
147131226|NCT02082977|530648890|FG005|Part 1 (Up to 3.2 Years)|Death|1|||
147131227|NCT02082977|530648891|FG006|Part 1 (Up to 3.2 Years)|Death|2|||
147131228|NCT02082977|530648892|FG007|Part 1 (Up to 3.2 Years)|Death|0|||
147131229|NCT02082977|530648893|FG008|Part 1 (Up to 3.2 Years)|Death|1|||
147131230|NCT02082977|530648894|FG009|Part 1 (Up to 3.2 Years)|Death|0|||
147131231|NCT02082977|530648885|FG000|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
147131232|NCT02082977|530648886|FG001|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
147131233|NCT02082977|530648887|FG002|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
147131234|NCT02082977|530648888|FG003|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
147131235|NCT02082977|530648889|FG004|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
147131236|NCT02082977|530648890|FG005|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
147131237|NCT02082977|530648891|FG006|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
147131238|NCT02082977|530648892|FG007|Part 1 (Up to 3.2 Years)|Study closed/terminated|2|||
147131239|NCT02082977|530648893|FG008|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
147131240|NCT02082977|530648894|FG009|Part 1 (Up to 3.2 Years)|Study closed/terminated|0|||
147131241|NCT02082977|530648885|FG000|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
147131242|NCT02082977|530648886|FG001|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
147131243|NCT02082977|530648887|FG002|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
147131244|NCT02082977|530648888|FG003|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
147131245|NCT02082977|530648889|FG004|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
147445138|NCT03451084|531794414|FG002|Overall Study|Lack of Efficacy|0|||
147445139|NCT03451084|531794415|FG003|Overall Study|Lack of Efficacy|1|||
147131246|NCT02082977|530648890|FG005|Part 1 (Up to 3.2 Years)|Lost to Follow-up|1|||
147131247|NCT02082977|530648891|FG006|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
147131248|NCT02082977|530648892|FG007|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
147131249|NCT02082977|530648893|FG008|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
147131250|NCT02082977|530648894|FG009|Part 1 (Up to 3.2 Years)|Lost to Follow-up|0|||
147131251|NCT02082977|530648885|FG000|Part 1 (Up to 3.2 Years)|Physician Decision|0|||
147131252|NCT02082977|530648886|FG001|Part 1 (Up to 3.2 Years)|Physician Decision|0|||
147131253|NCT02082977|530648887|FG002|Part 1 (Up to 3.2 Years)|Physician Decision|0|||
147131254|NCT02082977|530648888|FG003|Part 1 (Up to 3.2 Years)|Physician Decision|0|||
147131255|NCT02082977|530648889|FG004|Part 1 (Up to 3.2 Years)|Physician Decision|1|||
147131256|NCT02082977|530648890|FG005|Part 1 (Up to 3.2 Years)|Physician Decision|1|||
147131257|NCT02082977|530648891|FG006|Part 1 (Up to 3.2 Years)|Physician Decision|4|||
147131258|NCT02082977|530648892|FG007|Part 1 (Up to 3.2 Years)|Physician Decision|1|||
147131259|NCT02082977|530648893|FG008|Part 1 (Up to 3.2 Years)|Physician Decision|2|||
147131260|NCT02082977|530648894|FG009|Part 1 (Up to 3.2 Years)|Physician Decision|0|||
147131261|NCT02082977|530648885|FG000|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
147131262|NCT02082977|530648886|FG001|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
147131263|NCT02082977|530648887|FG002|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
147131264|NCT02082977|530648888|FG003|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
147131265|NCT02082977|530648889|FG004|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
147131266|NCT02082977|530648890|FG005|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
147131267|NCT02082977|530648891|FG006|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
147131268|NCT02082977|530648892|FG007|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|2|||
147131269|NCT02082977|530648893|FG008|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
147131270|NCT02082977|530648894|FG009|Part 1 (Up to 3.2 Years)|Withdrawal by Subject|0|||
147131271|NCT00049543|530648895|FG000|Overall Study|still on treatment|2|||
147131272|NCT00049543|530648896|FG001|Overall Study|still on treatment|9|||
147131273|NCT04138056|530648901|FG000|Primary Study|Lost to Follow-up|3|||
147131274|NCT04138056|530648902|FG001|Primary Study|Lost to Follow-up|4|||
147131275|NCT04138056|530648903|FG002|Primary Study|Lost to Follow-up|1|||
147131276|NCT04138056|530648904|FG003|Primary Study|Lost to Follow-up|1|||
147131277|NCT04138056|530648905|FG004|Primary Study|Lost to Follow-up|4|||
147131278|NCT04138056|530648901|FG000|Primary Study|ELIGIBILITY CRITERIA NOT FULFILLED (INCLUSION AND EXCLUSION CRITERIA)|3|||
147131279|NCT04138056|530648902|FG001|Primary Study|ELIGIBILITY CRITERIA NOT FULFILLED (INCLUSION AND EXCLUSION CRITERIA)|4|||
147131280|NCT04138056|530648903|FG002|Primary Study|ELIGIBILITY CRITERIA NOT FULFILLED (INCLUSION AND EXCLUSION CRITERIA)|2|||
147131281|NCT04138056|530648904|FG003|Primary Study|ELIGIBILITY CRITERIA NOT FULFILLED (INCLUSION AND EXCLUSION CRITERIA)|1|||
147131282|NCT04138056|530648905|FG004|Primary Study|ELIGIBILITY CRITERIA NOT FULFILLED (INCLUSION AND EXCLUSION CRITERIA)|0|||
147131283|NCT04138056|530648901|FG000|Extension Study|Lost to Follow-up|1|||
147131284|NCT04138056|530648902|FG001|Extension Study|Lost to Follow-up|2|||
147131285|NCT04138056|530648903|FG002|Extension Study|Lost to Follow-up|1|||
147131286|NCT04138056|530648904|FG003|Extension Study|Lost to Follow-up|0|||
147131287|NCT04138056|530648905|FG004|Extension Study|Lost to Follow-up|1|||
147131288|NCT02706392|530648910|FG000|Overall Study|Death|1|||
147131289|NCT02706392|530648911|FG001|Overall Study|Death|0|||
147131290|NCT02706392|530648912|FG002|Overall Study|Death|2|||
147131291|NCT02706392|530648913|FG003|Overall Study|Death|2|||
147131292|NCT02706392|530648914|FG004|Overall Study|Death|5|||
147131293|NCT02706392|530648915|FG005|Overall Study|Death|2|||
147131294|NCT01276106|530648925|FG000|Overall Study|Adverse Event|3|||
147131295|NCT01276106|530648926|FG001|Overall Study|Adverse Event|3|||
147131296|NCT01276106|530648927|FG002|Overall Study|Adverse Event|11|||
147131297|NCT01276106|530648928|FG003|Overall Study|Adverse Event|3|||
147131298|NCT01276106|530648925|FG000|Overall Study|Withdrawal by Subject|6|||
147131299|NCT01276106|530648926|FG001|Overall Study|Withdrawal by Subject|3|||
147131300|NCT01276106|530648927|FG002|Overall Study|Withdrawal by Subject|1|||
147131301|NCT01276106|530648928|FG003|Overall Study|Withdrawal by Subject|6|||
147131302|NCT01276106|530648925|FG000|Overall Study|Lack of Efficacy|0|||
147131303|NCT01276106|530648926|FG001|Overall Study|Lack of Efficacy|1|||
147131304|NCT01276106|530648927|FG002|Overall Study|Lack of Efficacy|0|||
147131305|NCT01276106|530648928|FG003|Overall Study|Lack of Efficacy|1|||
147131306|NCT01276106|530648925|FG000|Overall Study|Lost to Follow-up|2|||
147131307|NCT01276106|530648926|FG001|Overall Study|Lost to Follow-up|1|||
147570547|NCT03872128|532245173|FG000|Overall Study|Lost to Follow-up|2|||
147570548|NCT03872128|532245174|FG001|Overall Study|Lost to Follow-up|5|||
147131308|NCT01276106|530648927|FG002|Overall Study|Lost to Follow-up|1|||
147131309|NCT01276106|530648928|FG003|Overall Study|Lost to Follow-up|0|||
147131310|NCT01276106|530648925|FG000|Overall Study|Physician Decision|0|||
147570549|NCT03872128|532245175|FG002|Overall Study|Lost to Follow-up|8|||
147570550|NCT03419403|532245184|FG000|Overall Study|Withdrawal by Subject|5|||
147570551|NCT03419403|532245185|FG001|Overall Study|Withdrawal by Subject|2|||
147570552|NCT03419403|532245186|FG002|Overall Study|Withdrawal by Subject|5|||
147131311|NCT01276106|530648926|FG001|Overall Study|Physician Decision|0|||
147131312|NCT01276106|530648927|FG002|Overall Study|Physician Decision|1|||
147131313|NCT01276106|530648928|FG003|Overall Study|Physician Decision|1|||
147131314|NCT01276106|530648925|FG000|Overall Study|Protocol Violation|1|||
147131315|NCT01276106|530648926|FG001|Overall Study|Protocol Violation|1|||
147131316|NCT01276106|530648927|FG002|Overall Study|Protocol Violation|0|||
147131317|NCT01276106|530648928|FG003|Overall Study|Protocol Violation|2|||
147131318|NCT01276106|530648925|FG000|Overall Study|Insufficient therapeutic effects|0|||
147236138|NCT00619177|531035534|FG000|Overall Study|Lost to Follow-up|2|||
147236139|NCT00619177|531035534|FG000|Overall Study|Lack of Efficacy|1|||
147236140|NCT00619177|531035534|FG000|Overall Study|Missing termination information|481|||
147236141|NCT00619177|531035534|FG000|Overall Study|Not specified reasons|6|||
147236142|NCT01609231|531035535|FG000|Overall Study|Adverse Event|1|||
147236143|NCT01609231|531035536|FG001|Overall Study|Adverse Event|3|||
147236144|NCT01609231|531035535|FG000|Overall Study|Physician Decision|1|||
147236145|NCT01609231|531035536|FG001|Overall Study|Physician Decision|0|||
147236146|NCT01609231|531035535|FG000|Overall Study|Withdrawal by Subject|1|||
147236147|NCT01609231|531035536|FG001|Overall Study|Withdrawal by Subject|0|||
147236148|NCT01180647|531035537|FG000|Overall Study|Lost to Follow-up|5|||
147236149|NCT01180647|531035538|FG001|Overall Study|Lost to Follow-up|6|||
147236150|NCT02761733|531035550|FG000|Overall Study|Death|3|||
147236151|NCT02761733|531035551|FG001|Overall Study|Death|5|||
147236152|NCT02761733|531035552|FG002|Overall Study|Death|1|||
147131319|NCT01276106|530648926|FG001|Overall Study|Insufficient therapeutic effects|0|||
147131320|NCT01276106|530648927|FG002|Overall Study|Insufficient therapeutic effects|2|||
147131321|NCT01276106|530648928|FG003|Overall Study|Insufficient therapeutic effects|0|||
147131322|NCT01242514|530648931|FG000|Overall Study|e.g., project closure|1042|||
147131323|NCT01242514|530648932|FG001|Overall Study|e.g., project closure|305|||
147131324|NCT01242514|530648933|FG002|Overall Study|e.g., project closure|171|||
147131325|NCT01242514|530648931|FG000|Overall Study|Subject decision|33|||
147131326|NCT01242514|530648932|FG001|Overall Study|Subject decision|8|||
147131327|NCT01242514|530648933|FG002|Overall Study|Subject decision|2|||
147131328|NCT01242514|530648931|FG000|Overall Study|Severe non-compliance to protocol|5|||
147131329|NCT01242514|530648932|FG001|Overall Study|Severe non-compliance to protocol|2|||
147131330|NCT01242514|530648933|FG002|Overall Study|Severe non-compliance to protocol|1|||
147131331|NCT01242514|530648931|FG000|Overall Study|Lack of therapeutic response|99|||
147131332|NCT01242514|530648932|FG001|Overall Study|Lack of therapeutic response|16|||
147131333|NCT01242514|530648933|FG002|Overall Study|Lack of therapeutic response|10|||
147131334|NCT01242514|530648931|FG000|Overall Study|Dev. of study specific discont. criteria|21|||
147131335|NCT01242514|530648932|FG001|Overall Study|Dev. of study specific discont. criteria|3|||
147131336|NCT01242514|530648933|FG002|Overall Study|Dev. of study specific discont. criteria|5|||
147131337|NCT01242514|530648931|FG000|Overall Study|Lost to Follow-up|14|||
147131338|NCT01242514|530648932|FG001|Overall Study|Lost to Follow-up|5|||
147131339|NCT01242514|530648933|FG002|Overall Study|Lost to Follow-up|4|||
147131340|NCT01242514|530648931|FG000|Overall Study|Adverse Event|129|||
147131341|NCT01242514|530648932|FG001|Overall Study|Adverse Event|18|||
147131342|NCT01242514|530648933|FG002|Overall Study|Adverse Event|19|||
147131343|NCT00862940|530648935|FG000|Overall Study|Adverse Event|15|||
147131344|NCT00862940|530648936|FG001|Overall Study|Adverse Event|12|||
147131345|NCT00862940|530648935|FG000|Overall Study|Lack of Efficacy|1|||
147131346|NCT00862940|530648936|FG001|Overall Study|Lack of Efficacy|3|||
147131347|NCT00862940|530648935|FG000|Overall Study|Protocol Violation|2|||
147131348|NCT00862940|530648936|FG001|Overall Study|Protocol Violation|5|||
147131349|NCT00862940|530648935|FG000|Overall Study|Withdrawal by Subject|4|||
147131350|NCT00862940|530648936|FG001|Overall Study|Withdrawal by Subject|6|||
147131351|NCT00862940|530648935|FG000|Overall Study|Non-compliance|4|||
147131352|NCT00862940|530648936|FG001|Overall Study|Non-compliance|0|||
147131353|NCT00862940|530648935|FG000|Overall Study|Lost to Follow-up|0|||
147131354|NCT00862940|530648936|FG001|Overall Study|Lost to Follow-up|1|||
147131355|NCT00862940|530648935|FG000|Overall Study|Administrative or other reason(s)|4|||
147131356|NCT00862940|530648936|FG001|Overall Study|Administrative or other reason(s)|3|||
147131357|NCT00787150|530648937|FG000|Overall Study|Adverse Event|4|||
147131358|NCT00787150|530648938|FG001|Overall Study|Adverse Event|4|||
147131359|NCT00787150|530648939|FG002|Overall Study|Adverse Event|4|||
147131360|NCT00787150|530648937|FG000|Overall Study|Physician Decision|1|||
147131361|NCT00787150|530648938|FG001|Overall Study|Physician Decision|2|||
147131362|NCT00787150|530648939|FG002|Overall Study|Physician Decision|1|||
147131363|NCT00787150|530648937|FG000|Overall Study|Withdrawal by Subject|2|||
147131364|NCT00787150|530648938|FG001|Overall Study|Withdrawal by Subject|1|||
147131365|NCT00787150|530648939|FG002|Overall Study|Withdrawal by Subject|0|||
147131366|NCT00787150|530648937|FG000|Overall Study|Dosing incorrect study durg|2|||
147131367|NCT00787150|530648938|FG001|Overall Study|Dosing incorrect study durg|0|||
147131368|NCT00787150|530648939|FG002|Overall Study|Dosing incorrect study durg|0|||
147131369|NCT00879398|530648940|FG000|Overall Study|Visit Stop|399|||
147131370|NCT00879398|530648940|FG000|Overall Study|Lack of Efficacy|64|||
147131371|NCT00879398|530648940|FG000|Overall Study|Adverse Event|41|||
147131372|NCT00879398|530648940|FG000|Overall Study|Other Reasons|171|||
147131373|NCT01380080|530648942|FG000|Overall Study|Death|36|||
147131374|NCT01380080|530648943|FG001|Overall Study|Death|44|||
147131375|NCT01380080|530648942|FG000|Overall Study|Site is closing|28|||
147131376|NCT01380080|530648943|FG001|Overall Study|Site is closing|31|||
147570553|NCT03419403|532245187|FG003|Overall Study|Withdrawal by Subject|1|||
147570554|NCT03419403|532245184|FG000|Overall Study|Progressive disease (per protocol)|0|||
147570555|NCT03419403|532245185|FG001|Overall Study|Progressive disease (per protocol)|2|||
147570556|NCT03419403|532245186|FG002|Overall Study|Progressive disease (per protocol)|2|||
147570557|NCT03419403|532245187|FG003|Overall Study|Progressive disease (per protocol)|0|||
147131377|NCT01380080|530648942|FG000|Overall Study|Not able to get to clinic|7|||
147131378|NCT01380080|530648943|FG001|Overall Study|Not able to get to clinic|1|||
147131379|NCT01380080|530648942|FG000|Overall Study|Not willing to adhere to requirements|6|||
147131380|NCT01380080|530648943|FG001|Overall Study|Not willing to adhere to requirements|2|||
147131381|NCT01380080|530648942|FG000|Overall Study|Withdrawal by Subject|5|||
147570558|NCT03419403|532245184|FG000|Overall Study|Other, not specified|6|||
147131382|NCT01380080|530648943|FG001|Overall Study|Withdrawal by Subject|2|||
147131383|NCT01380080|530648942|FG000|Overall Study|Lost to Follow-up|3|||
147131384|NCT01380080|530648943|FG001|Overall Study|Lost to Follow-up|3|||
147131385|NCT05901636|530648944|FG000|Overall Study|Lost to Follow-up|0|||
147131386|NCT05901636|530648945|FG001|Overall Study|Lost to Follow-up|1|||
147131387|NCT05901636|530648946|FG002|Overall Study|Lost to Follow-up|0|||
147131388|NCT05901636|530648947|FG003|Overall Study|Lost to Follow-up|1|||
147131389|NCT05901636|530648948|FG004|Overall Study|Lost to Follow-up|1|||
147131390|NCT05901636|530648949|FG005|Overall Study|Lost to Follow-up|3|||
147131391|NCT05901636|530648950|FG006|Overall Study|Lost to Follow-up|1|||
147131392|NCT05901636|530648944|FG000|Overall Study|Non- Compliance With Study Schedule|0|||
147131393|NCT05901636|530648945|FG001|Overall Study|Non- Compliance With Study Schedule|0|||
147131394|NCT05901636|530648946|FG002|Overall Study|Non- Compliance With Study Schedule|2|||
147131395|NCT05901636|530648947|FG003|Overall Study|Non- Compliance With Study Schedule|1|||
147131396|NCT05901636|530648948|FG004|Overall Study|Non- Compliance With Study Schedule|0|||
147131397|NCT05901636|530648949|FG005|Overall Study|Non- Compliance With Study Schedule|0|||
147131398|NCT05901636|530648950|FG006|Overall Study|Non- Compliance With Study Schedule|2|||
147131399|NCT05901636|530648944|FG000|Overall Study|Withdrawal by Subject|1|||
147131400|NCT05901636|530648945|FG001|Overall Study|Withdrawal by Subject|1|||
147131401|NCT05901636|530648946|FG002|Overall Study|Withdrawal by Subject|0|||
147131402|NCT05901636|530648947|FG003|Overall Study|Withdrawal by Subject|0|||
147131403|NCT05901636|530648948|FG004|Overall Study|Withdrawal by Subject|1|||
147131404|NCT05901636|530648949|FG005|Overall Study|Withdrawal by Subject|1|||
147131405|NCT05901636|530648950|FG006|Overall Study|Withdrawal by Subject|0|||
147131406|NCT05901636|530648944|FG000|Overall Study|Other|0|||
147131407|NCT05901636|530648945|FG001|Overall Study|Other|0|||
147131408|NCT05901636|530648946|FG002|Overall Study|Other|1|||
147131409|NCT05901636|530648947|FG003|Overall Study|Other|1|||
147131410|NCT05901636|530648948|FG004|Overall Study|Other|0|||
147131411|NCT05901636|530648949|FG005|Overall Study|Other|0|||
147131412|NCT05901636|530648950|FG006|Overall Study|Other|0|||
147131413|NCT02303821|530648951|FG000|Overall Study|Withdrawal by Subject|0|||
147131414|NCT02303821|530648952|FG001|Overall Study|Withdrawal by Subject|0|||
147131415|NCT02303821|530648953|FG002|Overall Study|Withdrawal by Subject|0|||
147131416|NCT02303821|530648954|FG003|Overall Study|Withdrawal by Subject|0|||
147131417|NCT02303821|530648955|FG004|Overall Study|Withdrawal by Subject|0|||
147131418|NCT02303821|530648956|FG005|Overall Study|Withdrawal by Subject|0|||
147131419|NCT02303821|530648957|FG006|Overall Study|Withdrawal by Subject|0|||
147131420|NCT02303821|530648958|FG007|Overall Study|Withdrawal by Subject|2|||
147131421|NCT02303821|530648951|FG000|Overall Study|Death|0|||
147131422|NCT02303821|530648952|FG001|Overall Study|Death|2|||
147131423|NCT02303821|530648953|FG002|Overall Study|Death|0|||
147131424|NCT02303821|530648954|FG003|Overall Study|Death|0|||
147131425|NCT02303821|530648955|FG004|Overall Study|Death|0|||
147131426|NCT02303821|530648956|FG005|Overall Study|Death|3|||
147131427|NCT02303821|530648957|FG006|Overall Study|Death|41|||
147131428|NCT02303821|530648958|FG007|Overall Study|Death|29|||
147131429|NCT02303821|530648951|FG000|Overall Study|Lost to Follow-up|0|||
147131430|NCT02303821|530648952|FG001|Overall Study|Lost to Follow-up|0|||
147131431|NCT02303821|530648953|FG002|Overall Study|Lost to Follow-up|0|||
147131432|NCT02303821|530648954|FG003|Overall Study|Lost to Follow-up|0|||
147131433|NCT02303821|530648955|FG004|Overall Study|Lost to Follow-up|0|||
147131434|NCT02303821|530648956|FG005|Overall Study|Lost to Follow-up|0|||
147131435|NCT02303821|530648957|FG006|Overall Study|Lost to Follow-up|1|||
147131436|NCT02303821|530648958|FG007|Overall Study|Lost to Follow-up|0|||
147131437|NCT02303821|530648951|FG000|Overall Study|Withdrawal prior to Carfilzomib dosing|0|||
147131438|NCT02303821|530648952|FG001|Overall Study|Withdrawal prior to Carfilzomib dosing|0|||
147131439|NCT02303821|530648953|FG002|Overall Study|Withdrawal prior to Carfilzomib dosing|0|||
147131440|NCT02303821|530648954|FG003|Overall Study|Withdrawal prior to Carfilzomib dosing|0|||
147131441|NCT02303821|530648955|FG004|Overall Study|Withdrawal prior to Carfilzomib dosing|0|||
147131442|NCT02303821|530648956|FG005|Overall Study|Withdrawal prior to Carfilzomib dosing|0|||
147131443|NCT02303821|530648957|FG006|Overall Study|Withdrawal prior to Carfilzomib dosing|1|||
147131444|NCT02303821|530648958|FG007|Overall Study|Withdrawal prior to Carfilzomib dosing|0|||
147131445|NCT02303821|530648951|FG000|Overall Study|Decision by sponsor|0|||
147131446|NCT02303821|530648952|FG001|Overall Study|Decision by sponsor|0|||
147131447|NCT02303821|530648953|FG002|Overall Study|Decision by sponsor|0|||
147131448|NCT02303821|530648954|FG003|Overall Study|Decision by sponsor|0|||
147131449|NCT02303821|530648955|FG004|Overall Study|Decision by sponsor|0|||
147131450|NCT02303821|530648956|FG005|Overall Study|Decision by sponsor|1|||
147131451|NCT02303821|530648957|FG006|Overall Study|Decision by sponsor|0|||
147236153|NCT02761733|531035553|FG003|Overall Study|Death|1|||
147236154|NCT02761733|531035550|FG000|Overall Study|Lost to Follow-up|6|||
147236155|NCT02761733|531035551|FG001|Overall Study|Lost to Follow-up|7|||
147236156|NCT02761733|531035552|FG002|Overall Study|Lost to Follow-up|0|||
147236157|NCT02761733|531035553|FG003|Overall Study|Lost to Follow-up|3|||
147131452|NCT02303821|530648958|FG007|Overall Study|Decision by sponsor|0|||
147131453|NCT02303821|530648951|FG000|Overall Study|Protocol-specified criteria|0|||
147131454|NCT02303821|530648952|FG001|Overall Study|Protocol-specified criteria|1|||
147131455|NCT02303821|530648953|FG002|Overall Study|Protocol-specified criteria|0|||
147131456|NCT02303821|530648954|FG003|Overall Study|Protocol-specified criteria|0|||
147131457|NCT02303821|530648955|FG004|Overall Study|Protocol-specified criteria|0|||
147131458|NCT02303821|530648956|FG005|Overall Study|Protocol-specified criteria|1|||
147131459|NCT02303821|530648957|FG006|Overall Study|Protocol-specified criteria|0|||
147236158|NCT02761733|531035550|FG000|Overall Study|Physician Decision|4|||
147236159|NCT02761733|531035551|FG001|Overall Study|Physician Decision|0|||
147570559|NCT03419403|532245185|FG001|Overall Study|Other, not specified|4|||
147570560|NCT03419403|532245186|FG002|Overall Study|Other, not specified|5|||
147570561|NCT03419403|532245187|FG003|Overall Study|Other, not specified|1|||
147570562|NCT03419403|532245184|FG000|Overall Study|Left study due to COVID-19 restrictions|1|||
147570563|NCT03419403|532245185|FG001|Overall Study|Left study due to COVID-19 restrictions|1|||
147570564|NCT03419403|532245186|FG002|Overall Study|Left study due to COVID-19 restrictions|0|||
147570565|NCT03419403|532245187|FG003|Overall Study|Left study due to COVID-19 restrictions|0|||
147570566|NCT03552393|532245190|FG000|Core Period|Kidney Transplant|1|||
147570567|NCT03552393|532245190|FG000|Core Period|Prohibited Medication|1|||
147570568|NCT03552393|532245190|FG000|Safety Extension Period|Kidney Transplant|4|||
147570569|NCT01289262|532245192|FG000|Overall Study|Lost to Follow-up|29|||
147570570|NCT01289262|532245193|FG001|Overall Study|Lost to Follow-up|16|||
147570571|NCT01289262|532245192|FG000|Overall Study|Exclusion due to expanded Kerr incision|4|||
147570572|NCT01289262|532245193|FG001|Overall Study|Exclusion due to expanded Kerr incision|3|||
147570573|NCT04887415|532245194|FG000|Overall Study|Lost to Follow-up|2|||
147131460|NCT02303821|530648958|FG007|Overall Study|Protocol-specified criteria|0|||
147131461|NCT00210132|530648959|FG000|Overall Study|Protocol Violation|1|||
147131462|NCT00210132|530648960|FG001|Overall Study|Protocol Violation|4|||
147131463|NCT02711202|530648961|FG000|Overall Study|Adverse Event|3|||
147131464|NCT02711202|530648962|FG001|Overall Study|Adverse Event|0|||
147131465|NCT02711202|530648961|FG000|Overall Study|graft loss|1|||
147131466|NCT02711202|530648962|FG001|Overall Study|graft loss|0|||
147131467|NCT00432965|530648963|FG000|Overall Study|Lost to Follow-up|22|||
147131468|NCT00432965|530648964|FG001|Overall Study|Lost to Follow-up|19|||
147131469|NCT00432965|530648963|FG000|Overall Study|Withdrawal by Subject|13|||
147236160|NCT02761733|531035552|FG002|Overall Study|Physician Decision|0|||
147236161|NCT02761733|531035553|FG003|Overall Study|Physician Decision|0|||
147236162|NCT02761733|531035550|FG000|Overall Study|Withdrawal by Subject|2|||
147236163|NCT02761733|531035551|FG001|Overall Study|Withdrawal by Subject|0|||
147236164|NCT02761733|531035552|FG002|Overall Study|Withdrawal by Subject|0|||
147236165|NCT02761733|531035553|FG003|Overall Study|Withdrawal by Subject|0|||
147236166|NCT02761733|531035550|FG000|Overall Study|Discharged from Study Site|10|||
147236167|NCT02761733|531035551|FG001|Overall Study|Discharged from Study Site|9|||
147236168|NCT02761733|531035552|FG002|Overall Study|Discharged from Study Site|25|||
147236169|NCT02761733|531035553|FG003|Overall Study|Discharged from Study Site|11|||
147236170|NCT02761733|531035550|FG000|Overall Study|Cognitive Impairment|5|||
147236171|NCT02761733|531035551|FG001|Overall Study|Cognitive Impairment|0|||
147236172|NCT02761733|531035552|FG002|Overall Study|Cognitive Impairment|1|||
147236173|NCT02761733|531035553|FG003|Overall Study|Cognitive Impairment|0|||
147236174|NCT02713204|531035554|FG000|Baseline (Day 1) up to Week 12|Adverse Event|1|||
147236175|NCT02713204|531035555|FG001|Baseline (Day 1) up to Week 12|Adverse Event|0|||
147236176|NCT02713204|531035556|FG002|Baseline (Day 1) up to Week 12|Adverse Event|1|||
147236177|NCT02713204|531035557|FG003|Baseline (Day 1) up to Week 12|Adverse Event|0|||
147236178|NCT02713204|531035558|FG004|Baseline (Day 1) up to Week 12|Adverse Event|0|||
147236179|NCT02713204|531035559|FG005|Baseline (Day 1) up to Week 12|Adverse Event|0|||
147236180|NCT02713204|531035560|FG006|Baseline (Day 1) up to Week 12|Adverse Event|0|||
147236181|NCT02713204|531035561|FG007|Baseline (Day 1) up to Week 12|Adverse Event|0|||
147236182|NCT02713204|531035554|FG000|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
147236183|NCT02713204|531035555|FG001|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
147236184|NCT02713204|531035556|FG002|Baseline (Day 1) up to Week 12|Withdrawal by Subject|1|||
147236185|NCT02713204|531035557|FG003|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
147236186|NCT02713204|531035558|FG004|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
147236187|NCT02713204|531035559|FG005|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
147236188|NCT02713204|531035560|FG006|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
147236189|NCT02713204|531035561|FG007|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
147236190|NCT02713204|531035554|FG000|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
147236191|NCT02713204|531035555|FG001|Baseline (Day 1) up to Week 12|Lost to Follow-up|1|||
147236192|NCT02713204|531035556|FG002|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
147236193|NCT02713204|531035557|FG003|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
147236194|NCT02713204|531035558|FG004|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
147236195|NCT02713204|531035559|FG005|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
147236196|NCT02713204|531035560|FG006|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
147236197|NCT02713204|531035561|FG007|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
147236198|NCT02713204|531035554|FG000|From Week 12 up to Week 36|Adverse Event|1|||
147570574|NCT04608188|532245195|FG000|Overall Study|Withdrawal by Subject|4|||
147570575|NCT04608188|532245196|FG001|Overall Study|Withdrawal by Subject|8|||
147570576|NCT01250912|532245200|FG000|Overall Study|Lost to Follow-up|1|||
147570577|NCT05646251|532245203|FG000|Overall Study|Physician Decision|1|||
147651345|NCT04985942|532546436|FG000|Overall Study|Withdrawal by Subject|5|||
147236199|NCT02713204|531035555|FG001|From Week 12 up to Week 36|Adverse Event|0|||
147236200|NCT02713204|531035556|FG002|From Week 12 up to Week 36|Adverse Event|0|||
147131470|NCT00432965|530648964|FG001|Overall Study|Withdrawal by Subject|13|||
147131471|NCT00432965|530648963|FG000|Overall Study|Physician Decision|14|||
147131472|NCT00432965|530648964|FG001|Overall Study|Physician Decision|13|||
147131473|NCT00432965|530648963|FG000|Overall Study|Lack of Efficacy|8|||
147131474|NCT00432965|530648964|FG001|Overall Study|Lack of Efficacy|13|||
147131475|NCT00432965|530648963|FG000|Overall Study|Non-compliance|7|||
147131476|NCT00432965|530648964|FG001|Overall Study|Non-compliance|0|||
147131477|NCT00432965|530648963|FG000|Overall Study|Adverse Event|22|||
147131478|NCT00432965|530648964|FG001|Overall Study|Adverse Event|19|||
147131479|NCT00432965|530648963|FG000|Overall Study|Death|3|||
147131480|NCT00432965|530648964|FG001|Overall Study|Death|4|||
147131481|NCT00432965|530648963|FG000|Overall Study|Exclusionary Methods|1|||
147131482|NCT00432965|530648964|FG001|Overall Study|Exclusionary Methods|2|||
147131483|NCT00432965|530648963|FG000|Overall Study|Incomplete Data|4|||
147131484|NCT00432965|530648964|FG001|Overall Study|Incomplete Data|3|||
147131485|NCT01344226|530648967|FG000|Overall Study|Protocol Violation|2|||
147131486|NCT01344226|530648967|FG000|Overall Study|Withdrawal by Subject|3|||
147131487|NCT01344226|530648967|FG000|Overall Study|Lack of Efficacy|3|||
147131488|NCT03909971|530648974|FG000|Overall Study|Participant transition to rollover study|26|||
147131489|NCT03909971|530648975|FG001|Overall Study|Participant transition to rollover study|9|||
147131490|NCT03909971|530648974|FG000|Overall Study|Global Deterioration of Health Status|2|||
147131491|NCT03909971|530648975|FG001|Overall Study|Global Deterioration of Health Status|2|||
147131492|NCT03909971|530648974|FG000|Overall Study|Progressive Disease|28|||
147131493|NCT03909971|530648975|FG001|Overall Study|Progressive Disease|21|||
147131494|NCT03909971|530648974|FG000|Overall Study|Death|6|||
147131495|NCT03909971|530648975|FG001|Overall Study|Death|6|||
147131496|NCT03909971|530648974|FG000|Overall Study|Adverse Event|1|||
147131497|NCT03909971|530648975|FG001|Overall Study|Adverse Event|2|||
147131498|NCT03909971|530648974|FG000|Overall Study|Withdrawal by Subject|2|||
147131499|NCT03909971|530648975|FG001|Overall Study|Withdrawal by Subject|1|||
147131500|NCT03909971|530648974|FG000|Overall Study|Participant was unwilling to come to site visit|0|||
147131501|NCT03909971|530648975|FG001|Overall Study|Participant was unwilling to come to site visit|1|||
147131502|NCT03909971|530648974|FG000|Overall Study|No longer benefit from Lorlatinib|2|||
147131503|NCT03909971|530648975|FG001|Overall Study|No longer benefit from Lorlatinib|0|||
147131504|NCT05177354|530648976|FG000|Implant to 30-day Visit|Physician Decision|1|||
147131505|NCT05177354|530648976|FG000|Implant to 30-day Visit|Withdrawal by Subject|1|||
147131506|NCT05177354|530648976|FG000|Implant to 30-day Visit|Lack of compliance to the protocol including phone calls & optimisation visits.|1|||
147131507|NCT05177354|530648976|FG000|30-day Visit to 3-Month Visit|Adverse Event|1|||
147131508|NCT03734536|530648977|FG000|Overall Study|Withdrew Consent|1|||
147131509|NCT03734536|530648978|FG001|Overall Study|Withdrew Consent|5|||
147131510|NCT03734536|530648977|FG000|Overall Study|Lost to Follow-up|10|||
147131511|NCT03734536|530648978|FG001|Overall Study|Lost to Follow-up|7|||
147131512|NCT06028464|530648982|FG000|Washout|Positive drug test.|1|||
147131513|NCT03448393|530648983|FG000|Dose Escalation|Not Treated - participant did not receive cell infusion.|0|||
147131514|NCT03448393|530648984|FG001|Dose Escalation|Not Treated - participant did not receive cell infusion.|0|||
147131515|NCT03448393|530648985|FG002|Dose Escalation|Not Treated - participant did not receive cell infusion.|1|||
147131516|NCT03448393|530648986|FG003|Dose Escalation|Not Treated - participant did not receive cell infusion.|0|||
147131517|NCT03448393|530648987|FG004|Dose Escalation|Not Treated - participant did not receive cell infusion.|0|||
147131518|NCT03448393|530648988|FG005|Dose Escalation|Not Treated - participant did not receive cell infusion.|0|||
147131519|NCT03448393|530648989|FG006|Dose Escalation|Not Treated - participant did not receive cell infusion.|0|||
147131520|NCT03448393|530648990|FG007|Dose Escalation|Not Treated - participant did not receive cell infusion.|0|||
147131521|NCT03448393|530648991|FG008|Dose Escalation|Not Treated - participant did not receive cell infusion.|8|||
147131522|NCT03448393|530648983|FG000|Dose Expansion|Not treated - screen failure|0|||
147131523|NCT03448393|530648984|FG001|Dose Expansion|Not treated - screen failure|0|||
147131524|NCT03448393|530648985|FG002|Dose Expansion|Not treated - screen failure|0|||
147131525|NCT03448393|530648986|FG003|Dose Expansion|Not treated - screen failure|0|||
147131526|NCT03448393|530648987|FG004|Dose Expansion|Not treated - screen failure|0|||
147131527|NCT03448393|530648988|FG005|Dose Expansion|Not treated - screen failure|0|||
147131528|NCT03448393|530648989|FG006|Dose Expansion|Not treated - screen failure|0|||
147131529|NCT03448393|530648990|FG007|Dose Expansion|Not treated - screen failure|0|||
147131530|NCT03448393|530648991|FG008|Dose Expansion|Not treated - screen failure|7|||
147131531|NCT01587196|530648992|FG000|Overall Study|Lost to Follow-up|50|||
147131532|NCT01587196|530648992|FG000|Overall Study|Withdrawal by Subject|4|||
147131533|NCT00643279|530648997|FG000|Overall Study|Death|13|||
147131534|NCT00643279|530648998|FG001|Overall Study|Death|11|||
147131535|NCT00643279|530648997|FG000|Overall Study|Withdrawal by Subject|3|||
147131536|NCT00643279|530648998|FG001|Overall Study|Withdrawal by Subject|0|||
147131537|NCT00643279|530648997|FG000|Overall Study|Lost to Follow-up|0|||
147131538|NCT00643279|530648998|FG001|Overall Study|Lost to Follow-up|1|||
147131539|NCT00643279|530648997|FG000|Overall Study|Physician Decision|0|||
147131540|NCT00643279|530648998|FG001|Overall Study|Physician Decision|1|||
147131541|NCT04846868|530648999|FG000|Overall Study|Adverse Event|12|||
147131542|NCT04846868|530649000|FG001|Overall Study|Adverse Event|11|||
147131543|NCT04846868|530648999|FG000|Overall Study|Protocol deviation|6|||
147131544|NCT04846868|530649000|FG001|Overall Study|Protocol deviation|2|||
147445140|NCT03451084|531794412|FG000|Overall Study|Death|1|||
147445141|NCT03451084|531794413|FG001|Overall Study|Death|0|||
147445142|NCT03451084|531794414|FG002|Overall Study|Death|2|||
147445143|NCT03451084|531794415|FG003|Overall Study|Death|0|||
147445144|NCT03451084|531794412|FG000|Overall Study|Physician Decision|0|||
147445145|NCT03451084|531794413|FG001|Overall Study|Physician Decision|0|||
147445146|NCT03451084|531794414|FG002|Overall Study|Physician Decision|2|||
147445147|NCT03451084|531794415|FG003|Overall Study|Physician Decision|2|||
147445148|NCT03451084|531794412|FG000|Overall Study|Disease progression (n=4), study closed by sponsor (n=1)|3|||
147445149|NCT03451084|531794413|FG001|Overall Study|Disease progression (n=4), study closed by sponsor (n=1)|0|||
147445150|NCT03451084|531794414|FG002|Overall Study|Disease progression (n=4), study closed by sponsor (n=1)|0|||
147445151|NCT03451084|531794415|FG003|Overall Study|Disease progression (n=4), study closed by sponsor (n=1)|2|||
147445152|NCT01087775|531794416|FG000|Overall Study|failed inclusion criteria|2|||
147445153|NCT03029143|531794417|FG000|Lead-in Period (6 Weeks)|Pretreatment Event/Adverse Event|8|||
147445154|NCT03029143|531794418|FG001|Lead-in Period (6 Weeks)|Pretreatment Event/Adverse Event|0|||
147445155|NCT03029143|531794419|FG002|Lead-in Period (6 Weeks)|Pretreatment Event/Adverse Event|0|||
147445156|NCT03029143|531794417|FG000|Lead-in Period (6 Weeks)|Significant Protocol Deviation|12|||
147445157|NCT03029143|531794418|FG001|Lead-in Period (6 Weeks)|Significant Protocol Deviation|0|||
147445158|NCT03029143|531794419|FG002|Lead-in Period (6 Weeks)|Significant Protocol Deviation|0|||
147445159|NCT03029143|531794417|FG000|Lead-in Period (6 Weeks)|Lost to Follow-up|1|||
147445160|NCT03029143|531794418|FG001|Lead-in Period (6 Weeks)|Lost to Follow-up|0|||
147445161|NCT03029143|531794419|FG002|Lead-in Period (6 Weeks)|Lost to Follow-up|0|||
147445162|NCT03029143|531794417|FG000|Lead-in Period (6 Weeks)|Voluntary Withdrawal|6|||
147445163|NCT03029143|531794418|FG001|Lead-in Period (6 Weeks)|Voluntary Withdrawal|0|||
147445164|NCT03029143|531794419|FG002|Lead-in Period (6 Weeks)|Voluntary Withdrawal|0|||
147445165|NCT03029143|531794417|FG000|Lead-in Period (6 Weeks)|Randomized but not Treated|142|||
147445166|NCT03029143|531794418|FG001|Lead-in Period (6 Weeks)|Randomized but not Treated|0|||
147445167|NCT03029143|531794419|FG002|Lead-in Period (6 Weeks)|Randomized but not Treated|0|||
147445168|NCT03029143|531794417|FG000|Randomized Treatment Period (24 Weeks)|Pretreatment Event/Adverse Event|0|||
147445169|NCT03029143|531794418|FG001|Randomized Treatment Period (24 Weeks)|Pretreatment Event/Adverse Event|3|||
147445170|NCT03029143|531794419|FG002|Randomized Treatment Period (24 Weeks)|Pretreatment Event/Adverse Event|9|||
147445171|NCT03029143|531794417|FG000|Randomized Treatment Period (24 Weeks)|Significant Protocol Deviation|0|||
147445172|NCT03029143|531794418|FG001|Randomized Treatment Period (24 Weeks)|Significant Protocol Deviation|1|||
147445173|NCT03029143|531794419|FG002|Randomized Treatment Period (24 Weeks)|Significant Protocol Deviation|3|||
147445174|NCT03029143|531794417|FG000|Randomized Treatment Period (24 Weeks)|Lost to Follow-up|0|||
147445175|NCT03029143|531794418|FG001|Randomized Treatment Period (24 Weeks)|Lost to Follow-up|1|||
147445176|NCT03029143|531794419|FG002|Randomized Treatment Period (24 Weeks)|Lost to Follow-up|3|||
147445177|NCT03029143|531794417|FG000|Randomized Treatment Period (24 Weeks)|Voluntary Withdrawal|0|||
147445178|NCT03029143|531794418|FG001|Randomized Treatment Period (24 Weeks)|Voluntary Withdrawal|10|||
147445179|NCT03029143|531794419|FG002|Randomized Treatment Period (24 Weeks)|Voluntary Withdrawal|1|||
147445180|NCT03029143|531794417|FG000|Randomized Treatment Period (24 Weeks)|Lack of Efficacy|0|||
147445181|NCT03029143|531794418|FG001|Randomized Treatment Period (24 Weeks)|Lack of Efficacy|6|||
147445182|NCT03029143|531794419|FG002|Randomized Treatment Period (24 Weeks)|Lack of Efficacy|7|||
147445183|NCT03029143|531794417|FG000|Randomized Treatment Period (24 Weeks)|Reason not Specified|0|||
147445184|NCT03029143|531794418|FG001|Randomized Treatment Period (24 Weeks)|Reason not Specified|2|||
147445185|NCT03029143|531794419|FG002|Randomized Treatment Period (24 Weeks)|Reason not Specified|1|||
147445186|NCT05289570|531794422|FG000|Overall Study|Physician Decision|1|||
147445187|NCT04544475|531794432|FG000|Overall Study|Withdrawal by Subject|1|||
147445188|NCT04544475|531794433|FG001|Overall Study|Withdrawal by Subject|3|||
147445189|NCT00808236|531794434|FG000|Overall Study|Was not resuscitated|50|||
147131545|NCT04846868|530648999|FG000|Overall Study|Perceived lack of efficacy|3|||
147131546|NCT04846868|530649000|FG001|Overall Study|Perceived lack of efficacy|2|||
147317640|NCT04496167|531329325|FG000|Overall Study|Lost to Follow-up|3|||
147317641|NCT04496167|531329326|FG001|Overall Study|Lost to Follow-up|5|||
147317642|NCT04496167|531329325|FG000|Overall Study|Not Treated|1|||
147317643|NCT04496167|531329326|FG001|Overall Study|Not Treated|2|||
147317644|NCT04496167|531329325|FG000|Overall Study|Other Than Specified|1|||
147317645|NCT04496167|531329326|FG001|Overall Study|Other Than Specified|1|||
147317646|NCT00598481|531329329|FG000|Treatment|Physician Decision|1|||
147317647|NCT00918749|531329332|FG000|Overall Study|Adverse Event|1|||
147317648|NCT00918749|531329333|FG001|Overall Study|Adverse Event|0|||
147317649|NCT00918749|531329334|FG002|Overall Study|Adverse Event|1|||
147317650|NCT00918749|531329332|FG000|Overall Study|Lost to Follow-up|0|||
147317651|NCT00918749|531329333|FG001|Overall Study|Lost to Follow-up|0|||
147317652|NCT00918749|531329334|FG002|Overall Study|Lost to Follow-up|1|||
147131547|NCT04846868|530648999|FG000|Overall Study|Change of residence|2|||
147317653|NCT00918749|531329332|FG000|Overall Study|Withdrawal by Subject|5|||
147131548|NCT04846868|530649000|FG001|Overall Study|Change of residence|3|||
147317654|NCT00918749|531329333|FG001|Overall Study|Withdrawal by Subject|3|||
147317655|NCT00918749|531329334|FG002|Overall Study|Withdrawal by Subject|5|||
147570578|NCT05646251|532245204|FG001|Overall Study|Physician Decision|0|||
147570579|NCT05646251|532245205|FG002|Overall Study|Physician Decision|2|||
147131549|NCT04846868|530648999|FG000|Overall Study|Burden of study procedures|1|||
147131550|NCT04846868|530649000|FG001|Overall Study|Burden of study procedures|1|||
147131551|NCT04846868|530648999|FG000|Overall Study|No reason available|2|||
147131552|NCT04846868|530649000|FG001|Overall Study|No reason available|5|||
147131553|NCT04846868|530648999|FG000|Overall Study|Other reason listed|20|||
147131554|NCT04846868|530649000|FG001|Overall Study|Other reason listed|10|||
147445190|NCT00808236|531794435|FG001|Overall Study|Was not resuscitated|56|||
147445191|NCT00808236|531794434|FG000|Overall Study|Pre-defined exclusion|13|||
147445192|NCT00808236|531794435|FG001|Overall Study|Pre-defined exclusion|3|||
147445193|NCT00808236|531794434|FG000|Overall Study|Lost to Follow-up|1|||
147445194|NCT00808236|531794435|FG001|Overall Study|Lost to Follow-up|1|||
147445195|NCT00808236|531794434|FG000|Overall Study|Physician Decision|0|||
147445196|NCT00808236|531794435|FG001|Overall Study|Physician Decision|1|||
147445197|NCT00808236|531794434|FG000|Overall Study|Death|18|||
147445198|NCT00808236|531794435|FG001|Overall Study|Death|30|||
147445199|NCT05376215|531794436|FG000|Overall Study|Withdrawal by Subject|2|||
147445200|NCT05376215|531794437|FG001|Overall Study|Withdrawal by Subject|1|||
147445201|NCT05376215|531794436|FG000|Overall Study|Lost to Follow-up|0|||
147445202|NCT05376215|531794437|FG001|Overall Study|Lost to Follow-up|1|||
147445203|NCT01301950|531794440|FG000|Overall Study|Surgery was cancelled by patient|0|||
147445204|NCT01301950|531794441|FG001|Overall Study|Surgery was cancelled by patient|1|||
147445205|NCT04041284|531794442|FG000|DB Phase (12 Weeks)|Adverse Event|0|||
147445206|NCT04041284|531794443|FG001|DB Phase (12 Weeks)|Adverse Event|3|||
147445207|NCT04041284|531794442|FG000|DB Phase (12 Weeks)|Withdrawal by Subject|6|||
147445208|NCT04041284|531794443|FG001|DB Phase (12 Weeks)|Withdrawal by Subject|4|||
147445209|NCT04041284|531794442|FG000|DB Phase (12 Weeks)|Protocol deviation|3|||
147445210|NCT04041284|531794443|FG001|DB Phase (12 Weeks)|Protocol deviation|3|||
147445211|NCT04041284|531794442|FG000|DB Phase (12 Weeks)|Lost to Follow-up|1|||
147445212|NCT04041284|531794443|FG001|DB Phase (12 Weeks)|Lost to Follow-up|0|||
147445213|NCT04041284|531794442|FG000|DB Phase (12 Weeks)|Lack of Efficacy|1|||
147445214|NCT04041284|531794443|FG001|DB Phase (12 Weeks)|Lack of Efficacy|1|||
147445215|NCT04041284|531794442|FG000|DB Phase (12 Weeks)|Other than specified|1|||
147445216|NCT04041284|531794443|FG001|DB Phase (12 Weeks)|Other than specified|0|||
147445217|NCT04041284|531794442|FG000|OL Phase (12 Weeks)|Withdrawal by Subject|5|||
147445218|NCT04041284|531794443|FG001|OL Phase (12 Weeks)|Withdrawal by Subject|5|||
147445219|NCT04041284|531794442|FG000|OL Phase (12 Weeks)|Protocol deviation|0|||
147445220|NCT04041284|531794443|FG001|OL Phase (12 Weeks)|Protocol deviation|1|||
147445221|NCT04041284|531794442|FG000|OL Phase (12 Weeks)|Pregnancy|1|||
147445222|NCT04041284|531794443|FG001|OL Phase (12 Weeks)|Pregnancy|1|||
147445223|NCT04041284|531794442|FG000|OL Phase (12 Weeks)|Other than specified|6|||
147445224|NCT04041284|531794443|FG001|OL Phase (12 Weeks)|Other than specified|2|||
147445225|NCT00964743|531794444|FG000|Overall Study|Neither patient completed 8 weeks of tre|2|||
147445226|NCT01549002|531794445|FG000|Overall Study|Excessive pain|0|||
147445227|NCT01549002|531794446|FG001|Overall Study|Excessive pain|2|||
147445228|NCT01549002|531794445|FG000|Overall Study|Moderate sedation required|0|||
147445229|NCT01549002|531794446|FG001|Overall Study|Moderate sedation required|2|||
147445230|NCT03709654|531795771|FG000|Overall Study|Lost to Follow-up|1|||
147445231|NCT03709654|531795772|FG001|Overall Study|Lost to Follow-up|1|||
147445232|NCT03709654|531795771|FG000|Overall Study|Withdrawal by Subject|1|||
147570580|NCT01218867|532245206|FG000|Overall Study|Death during treatment|0|||
147570581|NCT01218867|532245207|FG001|Overall Study|Death during treatment|0|||
147570582|NCT01218867|532245208|FG002|Overall Study|Death during treatment|0|||
147570583|NCT01218867|532245209|FG003|Overall Study|Death during treatment|0|||
147570584|NCT01218867|532245210|FG004|Overall Study|Death during treatment|0|||
147570585|NCT01218867|532245211|FG005|Overall Study|Death during treatment|0|||
147570586|NCT01218867|532245212|FG006|Overall Study|Death during treatment|1|||
147131555|NCT04846868|530648999|FG000|Overall Study|Not treated|0|||
147131556|NCT04846868|530649000|FG001|Overall Study|Not treated|1|||
147131557|NCT04116853|530649001|FG000|Overall Study|Adverse Event|1|||
147131558|NCT04116853|530649002|FG001|Overall Study|Adverse Event|3|||
147131559|NCT04116853|530649001|FG000|Overall Study|Lost to Follow-up|2|||
147445233|NCT03709654|531795772|FG001|Overall Study|Withdrawal by Subject|1|||
147445234|NCT03709654|531795771|FG000|Overall Study|Adverse Event|1|||
147445235|NCT03709654|531795772|FG001|Overall Study|Adverse Event|0|||
147445236|NCT01902966|531795773|FG000|Overall Study|Death|1|||
147445237|NCT01902966|531795773|FG000|Overall Study|Physician Decision|1|||
147570587|NCT01218867|532245213|FG007|Overall Study|Death during treatment|0|||
147570588|NCT01218867|532245214|FG008|Overall Study|Death during treatment|0|||
147570589|NCT01218867|532245215|FG009|Overall Study|Death during treatment|0|||
147445238|NCT01902966|531795773|FG000|Overall Study|Withdrawal by Subject|1|||
147445239|NCT01230307|531795774|FG000|Overall Study|LVAD Placement|0|||
147445240|NCT01230307|531795775|FG001|Overall Study|LVAD Placement|2|||
147445241|NCT01230242|531795779|FG000|Overall Study|Physician Decision|2|||
147570590|NCT01218867|532245216|FG010|Overall Study|Death during treatment|0|||
147131560|NCT04116853|530649002|FG001|Overall Study|Lost to Follow-up|0|||
147445242|NCT01230242|531795779|FG000|Overall Study|Withdrawal by Subject|1|||
147131561|NCT04116853|530649001|FG000|Overall Study|Incarceration|0|||
147131562|NCT04116853|530649002|FG001|Overall Study|Incarceration|1|||
147131563|NCT04116853|530649001|FG000|Overall Study|Pregnancy|1|||
147131564|NCT04116853|530649002|FG001|Overall Study|Pregnancy|1|||
147131565|NCT04116853|530649001|FG000|Overall Study|Began Other Weight Loss program|4|||
147131566|NCT04116853|530649002|FG001|Overall Study|Began Other Weight Loss program|8|||
147131567|NCT04116853|530649001|FG000|Overall Study|Began Anti-Obesity Medication|3|||
147131568|NCT04116853|530649002|FG001|Overall Study|Began Anti-Obesity Medication|3|||
147131569|NCT04116853|530649001|FG000|Overall Study|Protocol Violation|0|||
147131570|NCT04116853|530649002|FG001|Overall Study|Protocol Violation|1|||
147131571|NCT04522973|530649003|FG000|Overall Study|Lost to Follow-up|4|||
147131572|NCT04522973|530649003|FG000|Overall Study|Could not adhere to study schedule|1|||
147131573|NCT01649869|530649004|FG000|Overall Study|Family member illness|1|||
147131574|NCT01649869|530649005|FG001|Overall Study|Family member illness|0|||
147131575|NCT01649869|530649004|FG000|Overall Study|Required treatment outside protocol|1|||
147131576|NCT01649869|530649005|FG001|Overall Study|Required treatment outside protocol|0|||
147131577|NCT01649869|530649004|FG000|Overall Study|Severe hearing loss borderline eligible|0|||
147131578|NCT01649869|530649005|FG001|Overall Study|Severe hearing loss borderline eligible|1|||
147131579|NCT02776735|530649006|FG000|Overall Study|Adverse Event|0|||
147131580|NCT02776735|530649007|FG001|Overall Study|Adverse Event|0|||
147131581|NCT02776735|530649008|FG002|Overall Study|Adverse Event|0|||
147131582|NCT02776735|530649009|FG003|Overall Study|Adverse Event|1|||
147131583|NCT02776735|530649010|FG004|Overall Study|Adverse Event|0|||
147131584|NCT02776735|530649011|FG005|Overall Study|Adverse Event|1|||
147570591|NCT03233724|532245220|FG000|Phase I Dose Escalation|Removed from protocol prior to treatment due to rapidly progressive esophageal obstruction.|0|||
147570592|NCT03233724|532245221|FG001|Phase I Dose Escalation|Removed from protocol prior to treatment due to rapidly progressive esophageal obstruction.|0|||
147570593|NCT03233724|532245222|FG002|Phase I Dose Escalation|Removed from protocol prior to treatment due to rapidly progressive esophageal obstruction.|0|||
147570594|NCT03233724|532245223|FG003|Phase I Dose Escalation|Removed from protocol prior to treatment due to rapidly progressive esophageal obstruction.|0|||
147570595|NCT03233724|532245224|FG004|Phase I Dose Escalation|Removed from protocol prior to treatment due to rapidly progressive esophageal obstruction.|1|||
147570596|NCT03233724|532245220|FG000|Phase I Dose Escalation|Best interest of participant|1|||
147570597|NCT03233724|532245221|FG001|Phase I Dose Escalation|Best interest of participant|1|||
147131585|NCT02776735|530649006|FG000|Overall Study|Lost to Follow-up|0|||
147131586|NCT02776735|530649007|FG001|Overall Study|Lost to Follow-up|0|||
147131587|NCT02776735|530649008|FG002|Overall Study|Lost to Follow-up|0|||
147131588|NCT02776735|530649009|FG003|Overall Study|Lost to Follow-up|1|||
147131589|NCT02776735|530649010|FG004|Overall Study|Lost to Follow-up|0|||
147131590|NCT02776735|530649011|FG005|Overall Study|Lost to Follow-up|0|||
147131591|NCT02776735|530649006|FG000|Overall Study|Withdrawal by parent/guardian|0|||
147131592|NCT02776735|530649007|FG001|Overall Study|Withdrawal by parent/guardian|0|||
147131593|NCT02776735|530649008|FG002|Overall Study|Withdrawal by parent/guardian|2|||
147131594|NCT02776735|530649009|FG003|Overall Study|Withdrawal by parent/guardian|2|||
147131595|NCT02776735|530649010|FG004|Overall Study|Withdrawal by parent/guardian|0|||
147131596|NCT02776735|530649011|FG005|Overall Study|Withdrawal by parent/guardian|0|||
147131597|NCT02776735|530649006|FG000|Overall Study|Withdrawal by Subject|1|||
147131598|NCT02776735|530649007|FG001|Overall Study|Withdrawal by Subject|0|||
147131599|NCT02776735|530649008|FG002|Overall Study|Withdrawal by Subject|0|||
147131600|NCT02776735|530649009|FG003|Overall Study|Withdrawal by Subject|0|||
147131601|NCT02776735|530649010|FG004|Overall Study|Withdrawal by Subject|0|||
147131602|NCT02776735|530649011|FG005|Overall Study|Withdrawal by Subject|1|||
147131603|NCT02776735|530649006|FG000|Overall Study|Other|0|||
147131604|NCT02776735|530649007|FG001|Overall Study|Other|0|||
147131605|NCT02776735|530649008|FG002|Overall Study|Other|3|||
147131606|NCT02776735|530649009|FG003|Overall Study|Other|0|||
147131607|NCT02776735|530649010|FG004|Overall Study|Other|0|||
147131608|NCT02776735|530649011|FG005|Overall Study|Other|0|||
147131609|NCT05847686|530650687|FG000|Overall Study|Withdrawal by Subject|3|||
147131610|NCT03021486|530650688|FG000|Overall Study|Withdrawal by Subject|1|||
147131611|NCT03021486|530650689|FG001|Overall Study|Withdrawal by Subject|1|||
147131612|NCT03021486|530650690|FG002|Overall Study|Withdrawal by Subject|3|||
147570598|NCT03233724|532245222|FG002|Phase I Dose Escalation|Best interest of participant|1|||
147131613|NCT03021486|530650688|FG000|Overall Study|Did not develop an RASS score of at least >= 1|7|||
147131614|NCT03021486|530650689|FG001|Overall Study|Did not develop an RASS score of at least >= 1|5|||
147131615|NCT03021486|530650690|FG002|Overall Study|Did not develop an RASS score of at least >= 1|6|||
147131616|NCT03309202|530650693|FG000|Overall Study|Lost to Follow-up|1|||
147317656|NCT00918749|531329332|FG000|Overall Study|No Study Medication Taken|1|||
147131617|NCT03309202|530650694|FG001|Overall Study|Lost to Follow-up|0|||
147131618|NCT03309202|530650695|FG002|Overall Study|Lost to Follow-up|0|||
147131619|NCT03309202|530650696|FG003|Overall Study|Lost to Follow-up|0|||
147131620|NCT01209767|530650697|FG000|Overall Study|Withdrawal by Subject|1|||
147131621|NCT01209767|530650697|FG000|Overall Study|Lost to Follow-up|3|||
147131622|NCT01702298|530650698|FG000|Overall Study|Withdrawal by Subject|1|||
147131623|NCT00583219|530650702|FG000|Phase 2|Withdrawal by Subject|1|||
147131624|NCT02090764|530650703|FG000|Overall Study|Adverse Event|1|||
147131625|NCT02090764|530650704|FG001|Overall Study|Adverse Event|3|||
147131626|NCT02090764|530650703|FG000|Overall Study|Lack of Efficacy|0|||
147131627|NCT02090764|530650704|FG001|Overall Study|Lack of Efficacy|13|||
147131628|NCT02090764|530650703|FG000|Overall Study|Withdrawal by Subject|2|||
147131629|NCT02090764|530650704|FG001|Overall Study|Withdrawal by Subject|1|||
147131630|NCT02090764|530650703|FG000|Overall Study|Intercurrent illness and other|1|||
147131631|NCT02090764|530650704|FG001|Overall Study|Intercurrent illness and other|1|||
147131632|NCT02090764|530650703|FG000|Overall Study|Lost to Follow-up|2|||
147131633|NCT02090764|530650704|FG001|Overall Study|Lost to Follow-up|2|||
147131634|NCT02037529|530650705|FG000|Overall Study|Withdrawal by Subject|1|||
147131635|NCT02037529|530650706|FG001|Overall Study|Withdrawal by Subject|3|||
147131636|NCT02037529|530650705|FG000|Overall Study|Adverse Event|0|||
147131637|NCT02037529|530650706|FG001|Overall Study|Adverse Event|1|||
147131638|NCT02131766|530650707|FG000|Overall Study|Withdrawal by Subject|4|||
147131639|NCT00718315|530650709|FG000|Overall Study|Adverse Event|1|||
147131640|NCT00718315|530650710|FG001|Overall Study|Adverse Event|2|||
147131641|NCT00718315|530650711|FG002|Overall Study|Adverse Event|3|||
147131642|NCT00718315|530650709|FG000|Overall Study|Death|6|||
147131643|NCT00718315|530650710|FG001|Overall Study|Death|6|||
147131644|NCT00718315|530650711|FG002|Overall Study|Death|5|||
147131645|NCT00718315|530650709|FG000|Overall Study|Lost to Follow-up|2|||
147131646|NCT00718315|530650710|FG001|Overall Study|Lost to Follow-up|3|||
147131647|NCT00718315|530650711|FG002|Overall Study|Lost to Follow-up|4|||
147131648|NCT00718315|530650709|FG000|Overall Study|Protocol Violation|5|||
147131649|NCT00718315|530650710|FG001|Overall Study|Protocol Violation|5|||
147131650|NCT00718315|530650711|FG002|Overall Study|Protocol Violation|3|||
147131651|NCT00718315|530650709|FG000|Overall Study|Erlotinib dose decreased|4|||
147131652|NCT00718315|530650710|FG001|Overall Study|Erlotinib dose decreased|3|||
147131653|NCT00718315|530650711|FG002|Overall Study|Erlotinib dose decreased|1|||
147131654|NCT00718315|530650709|FG000|Overall Study|Use of Minocyclin|1|||
147131655|NCT00718315|530650710|FG001|Overall Study|Use of Minocyclin|1|||
147131656|NCT00718315|530650711|FG002|Overall Study|Use of Minocyclin|1|||
147131657|NCT00718315|530650709|FG000|Overall Study|Disease progression|0|||
147131658|NCT00718315|530650710|FG001|Overall Study|Disease progression|1|||
147131659|NCT00718315|530650711|FG002|Overall Study|Disease progression|1|||
147131660|NCT00718315|530650709|FG000|Overall Study|Other|0|||
147131661|NCT00718315|530650710|FG001|Overall Study|Other|0|||
147131662|NCT00718315|530650711|FG002|Overall Study|Other|1|||
147131663|NCT00718315|530650709|FG000|Overall Study|Use of ATB and Corticoids|0|||
147131664|NCT00718315|530650710|FG001|Overall Study|Use of ATB and Corticoids|1|||
147131665|NCT00718315|530650711|FG002|Overall Study|Use of ATB and Corticoids|2|||
147131666|NCT00806585|530650713|FG000|Overall Study|Study terminated by Sponsor|0|||
147131667|NCT00806585|530650714|FG001|Overall Study|Study terminated by Sponsor|0|||
147131668|NCT00806585|530650715|FG002|Overall Study|Study terminated by Sponsor|1|||
147131669|NCT00806585|530650716|FG003|Overall Study|Study terminated by Sponsor|2|||
147131670|NCT00806585|530650717|FG004|Overall Study|Study terminated by Sponsor|0|||
147131671|NCT00806585|530650713|FG000|Overall Study|Protocol Violation|3|||
147131672|NCT00806585|530650714|FG001|Overall Study|Protocol Violation|1|||
147131673|NCT00806585|530650715|FG002|Overall Study|Protocol Violation|2|||
147131674|NCT00806585|530650716|FG003|Overall Study|Protocol Violation|0|||
147131675|NCT00806585|530650717|FG004|Overall Study|Protocol Violation|0|||
147131676|NCT00806585|530650713|FG000|Overall Study|Physician Decision|0|||
147131677|NCT00806585|530650714|FG001|Overall Study|Physician Decision|2|||
147131678|NCT00806585|530650715|FG002|Overall Study|Physician Decision|3|||
147131679|NCT00806585|530650716|FG003|Overall Study|Physician Decision|0|||
147131680|NCT00806585|530650717|FG004|Overall Study|Physician Decision|1|||
147131681|NCT00806585|530650713|FG000|Overall Study|Lost to Follow-up|2|||
147131682|NCT00806585|530650714|FG001|Overall Study|Lost to Follow-up|1|||
147131683|NCT00806585|530650715|FG002|Overall Study|Lost to Follow-up|2|||
147131684|NCT00806585|530650716|FG003|Overall Study|Lost to Follow-up|2|||
147131685|NCT00806585|530650717|FG004|Overall Study|Lost to Follow-up|5|||
147131686|NCT00806585|530650713|FG000|Overall Study|Lack of Efficacy|1|||
147131687|NCT00806585|530650714|FG001|Overall Study|Lack of Efficacy|0|||
147131688|NCT00806585|530650715|FG002|Overall Study|Lack of Efficacy|0|||
147131689|NCT00806585|530650716|FG003|Overall Study|Lack of Efficacy|0|||
147131690|NCT00806585|530650717|FG004|Overall Study|Lack of Efficacy|0|||
147131691|NCT00806585|530650713|FG000|Overall Study|Adverse Event|1|||
147131692|NCT00806585|530650714|FG001|Overall Study|Adverse Event|5|||
147131693|NCT00806585|530650715|FG002|Overall Study|Adverse Event|3|||
147131694|NCT00806585|530650716|FG003|Overall Study|Adverse Event|4|||
147131695|NCT00806585|530650717|FG004|Overall Study|Adverse Event|2|||
147131696|NCT00806585|530650713|FG000|Overall Study|Withdrawal by Subject|10|||
147131697|NCT00806585|530650714|FG001|Overall Study|Withdrawal by Subject|8|||
147131698|NCT00806585|530650715|FG002|Overall Study|Withdrawal by Subject|9|||
147131699|NCT00806585|530650716|FG003|Overall Study|Withdrawal by Subject|3|||
147131700|NCT00806585|530650717|FG004|Overall Study|Withdrawal by Subject|11|||
147131701|NCT00806585|530650713|FG000|Overall Study|Completion status unknown|15|||
147131702|NCT00806585|530650714|FG001|Overall Study|Completion status unknown|14|||
147445243|NCT02256540|531795780|FG000|Overall Study|Withdrawal by Subject|0|||
147445244|NCT02256540|531795781|FG001|Overall Study|Withdrawal by Subject|1|||
147445245|NCT02256540|531795782|FG002|Overall Study|Withdrawal by Subject|1|||
147445246|NCT02256540|531795780|FG000|Overall Study|Back pain preventing exercise|0|||
147445247|NCT02256540|531795781|FG001|Overall Study|Back pain preventing exercise|0|||
147445248|NCT02256540|531795782|FG002|Overall Study|Back pain preventing exercise|1|||
147445249|NCT03923426|531795783|FG000|Overall Study|Other|19|||
147445250|NCT03923426|531795783|FG000|Overall Study|Lost to Follow-up|16|||
147445251|NCT03923426|531795783|FG000|Overall Study|Death|107|||
147445252|NCT03923426|531795783|FG000|Overall Study|Incomplete response to question|13|||
147445253|NCT01918007|531795784|FG000|Overall Study|Baseline oximetry not acceptable|11|||
147445254|NCT01918007|531795785|FG001|Overall Study|Baseline oximetry not acceptable|7|||
147445255|NCT01918007|531795784|FG000|Overall Study|Follow-up oximetry not acceptable|10|||
147445256|NCT01918007|531795785|FG001|Overall Study|Follow-up oximetry not acceptable|7|||
147445257|NCT01918007|531795784|FG000|Overall Study|Lost to Follow-up|4|||
147445258|NCT01918007|531795785|FG001|Overall Study|Lost to Follow-up|7|||
147445259|NCT01140451|531795787|FG000|Overall Study|Withdrawal by Subject|26|||
147445260|NCT01140451|531795788|FG001|Overall Study|Withdrawal by Subject|33|||
147445261|NCT01140451|531795787|FG000|Overall Study|Adverse Event|2|||
147445262|NCT01140451|531795788|FG001|Overall Study|Adverse Event|6|||
147445263|NCT01140451|531795787|FG000|Overall Study|Physician Decision|5|||
147445264|NCT01140451|531795788|FG001|Overall Study|Physician Decision|3|||
147445265|NCT01140451|531795787|FG000|Overall Study|Lost to Follow-up|2|||
147131703|NCT00806585|530650715|FG002|Overall Study|Completion status unknown|12|||
147131704|NCT00806585|530650716|FG003|Overall Study|Completion status unknown|4|||
147131705|NCT00806585|530650717|FG004|Overall Study|Completion status unknown|12|||
147131706|NCT00673920|530650724|FG000|Baseline up to Week 48|Withdrew consent|1|||
147131707|NCT00673920|530650725|FG001|Baseline up to Week 48|Withdrew consent|0|||
147131708|NCT00673920|530650726|FG002|Baseline up to Week 48|Withdrew consent|2|||
147131709|NCT00673920|530650727|FG003|Baseline up to Week 48|Withdrew consent|0|||
147131710|NCT00673920|530650728|FG004|Baseline up to Week 48|Withdrew consent|0|||
147131711|NCT00673920|530650729|FG005|Baseline up to Week 48|Withdrew consent|0|||
147131712|NCT00673920|530650730|FG006|Baseline up to Week 48|Withdrew consent|0|||
147131713|NCT00673920|530650731|FG007|Baseline up to Week 48|Withdrew consent|0|||
147131714|NCT00673920|530650724|FG000|Baseline up to Week 48|Refused treatment|1|||
147131715|NCT00673920|530650725|FG001|Baseline up to Week 48|Refused treatment|0|||
147131716|NCT00673920|530650726|FG002|Baseline up to Week 48|Refused treatment|0|||
147131717|NCT00673920|530650727|FG003|Baseline up to Week 48|Refused treatment|0|||
147131718|NCT00673920|530650728|FG004|Baseline up to Week 48|Refused treatment|0|||
147131719|NCT00673920|530650729|FG005|Baseline up to Week 48|Refused treatment|0|||
147131720|NCT00673920|530650730|FG006|Baseline up to Week 48|Refused treatment|0|||
147131721|NCT00673920|530650731|FG007|Baseline up to Week 48|Refused treatment|0|||
147131722|NCT00673920|530650724|FG000|Baseline up to Week 48|Insufficient therapeutic response|2|||
147131723|NCT00673920|530650725|FG001|Baseline up to Week 48|Insufficient therapeutic response|1|||
147131724|NCT00673920|530650726|FG002|Baseline up to Week 48|Insufficient therapeutic response|0|||
147131725|NCT00673920|530650727|FG003|Baseline up to Week 48|Insufficient therapeutic response|0|||
147131726|NCT00673920|530650728|FG004|Baseline up to Week 48|Insufficient therapeutic response|0|||
147131727|NCT00673920|530650729|FG005|Baseline up to Week 48|Insufficient therapeutic response|0|||
147131728|NCT00673920|530650730|FG006|Baseline up to Week 48|Insufficient therapeutic response|0|||
147131729|NCT00673920|530650731|FG007|Baseline up to Week 48|Insufficient therapeutic response|0|||
147131730|NCT00673920|530650724|FG000|Baseline up to Week 48|Protocol Violation|0|||
147131731|NCT00673920|530650725|FG001|Baseline up to Week 48|Protocol Violation|0|||
147131732|NCT00673920|530650726|FG002|Baseline up to Week 48|Protocol Violation|1|||
147131733|NCT00673920|530650727|FG003|Baseline up to Week 48|Protocol Violation|0|||
147131734|NCT00673920|530650728|FG004|Baseline up to Week 48|Protocol Violation|0|||
147131735|NCT00673920|530650729|FG005|Baseline up to Week 48|Protocol Violation|0|||
147131736|NCT00673920|530650730|FG006|Baseline up to Week 48|Protocol Violation|0|||
147131737|NCT00673920|530650731|FG007|Baseline up to Week 48|Protocol Violation|0|||
147131738|NCT00673920|530650724|FG000|Baseline up to Week 48|Violation of selection criteria at entry|0|||
147131739|NCT00673920|530650725|FG001|Baseline up to Week 48|Violation of selection criteria at entry|0|||
147131740|NCT00673920|530650726|FG002|Baseline up to Week 48|Violation of selection criteria at entry|1|||
147131741|NCT00673920|530650727|FG003|Baseline up to Week 48|Violation of selection criteria at entry|0|||
147131742|NCT00673920|530650728|FG004|Baseline up to Week 48|Violation of selection criteria at entry|0|||
147131743|NCT00673920|530650729|FG005|Baseline up to Week 48|Violation of selection criteria at entry|0|||
147131744|NCT00673920|530650730|FG006|Baseline up to Week 48|Violation of selection criteria at entry|0|||
147131745|NCT00673920|530650731|FG007|Baseline up to Week 48|Violation of selection criteria at entry|0|||
147131746|NCT00673920|530650724|FG000|Baseline up to Week 48|Administrative/Other|0|||
147131747|NCT00673920|530650725|FG001|Baseline up to Week 48|Administrative/Other|1|||
147131748|NCT00673920|530650726|FG002|Baseline up to Week 48|Administrative/Other|2|||
147131749|NCT00673920|530650727|FG003|Baseline up to Week 48|Administrative/Other|0|||
147445266|NCT01140451|531795788|FG001|Overall Study|Lost to Follow-up|0|||
147445267|NCT01140451|531795787|FG000|Overall Study|Participants Planning Pregnancy|3|||
147131750|NCT00673920|530650728|FG004|Baseline up to Week 48|Administrative/Other|0|||
147131751|NCT00673920|530650729|FG005|Baseline up to Week 48|Administrative/Other|0|||
147131752|NCT00673920|530650730|FG006|Baseline up to Week 48|Administrative/Other|0|||
147131753|NCT00673920|530650731|FG007|Baseline up to Week 48|Administrative/Other|0|||
147131754|NCT00673920|530650724|FG000|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
147131755|NCT00673920|530650725|FG001|Baseline up to Week 48|Adverse event/intercurrent illness|1|||
147131756|NCT00673920|530650726|FG002|Baseline up to Week 48|Adverse event/intercurrent illness|1|||
147131757|NCT00673920|530650727|FG003|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
147131758|NCT00673920|530650728|FG004|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
147131759|NCT00673920|530650729|FG005|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
147131760|NCT00673920|530650730|FG006|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
147131761|NCT00673920|530650731|FG007|Baseline up to Week 48|Adverse event/intercurrent illness|0|||
147131762|NCT00673920|530650724|FG000|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
147131763|NCT00673920|530650725|FG001|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
147131764|NCT00673920|530650726|FG002|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
147131765|NCT00673920|530650727|FG003|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
147131766|NCT00673920|530650728|FG004|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
147131767|NCT00673920|530650729|FG005|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
147131768|NCT00673920|530650730|FG006|Week 24 to Week 48|Adverse event/intercurrent illness|1|||
147131769|NCT00673920|530650731|FG007|Week 24 to Week 48|Adverse event/intercurrent illness|0|||
147131770|NCT00673920|530650724|FG000|Week 24 to Week 48|Failure to return|0|||
147131771|NCT00673920|530650725|FG001|Week 24 to Week 48|Failure to return|0|||
147131772|NCT00673920|530650726|FG002|Week 24 to Week 48|Failure to return|0|||
147131773|NCT00673920|530650727|FG003|Week 24 to Week 48|Failure to return|0|||
147131774|NCT00673920|530650728|FG004|Week 24 to Week 48|Failure to return|0|||
147131775|NCT00673920|530650729|FG005|Week 24 to Week 48|Failure to return|1|||
147131776|NCT00673920|530650730|FG006|Week 24 to Week 48|Failure to return|0|||
147570599|NCT03233724|532245223|FG003|Phase I Dose Escalation|Best interest of participant|0|||
147570600|NCT03233724|532245224|FG004|Phase I Dose Escalation|Best interest of participant|0|||
147570601|NCT03233724|532245220|FG000|Phase I Dose Escalation|Physician Decision|0|||
147570602|NCT03233724|532245221|FG001|Phase I Dose Escalation|Physician Decision|0|||
147570603|NCT03233724|532245222|FG002|Phase I Dose Escalation|Physician Decision|1|||
147570604|NCT03233724|532245223|FG003|Phase I Dose Escalation|Physician Decision|0|||
147570605|NCT03233724|532245224|FG004|Phase I Dose Escalation|Physician Decision|0|||
147570606|NCT03233724|532245220|FG000|Phase I Dose Escalation|Delay >3 weeks on treatment|0|||
147570607|NCT03233724|532245221|FG001|Phase I Dose Escalation|Delay >3 weeks on treatment|0|||
147570608|NCT03233724|532245222|FG002|Phase I Dose Escalation|Delay >3 weeks on treatment|1|||
147570609|NCT03233724|532245223|FG003|Phase I Dose Escalation|Delay >3 weeks on treatment|0|||
147570610|NCT03233724|532245224|FG004|Phase I Dose Escalation|Delay >3 weeks on treatment|0|||
147570611|NCT00651820|532245227|FG000|Overall Study|Lost to Follow-up|2|||
147570612|NCT00773253|532245228|FG000|First Intervention (Week 0-24)|Frontalis Test Negative|0|||
147570613|NCT00773253|532245229|FG001|First Intervention (Week 0-24)|Frontalis Test Negative|1|||
147570614|NCT01566721|532245230|FG000|Treatment Period|Withdrawal by Subject|35|||
147570615|NCT01566721|532245231|FG001|Treatment Period|Withdrawal by Subject|9|||
147570616|NCT01566721|532245230|FG000|Treatment Period|Disease Progression/Recurrence|37|||
147570617|NCT01566721|532245231|FG001|Treatment Period|Disease Progression/Recurrence|13|||
147570618|NCT01566721|532245230|FG000|Treatment Period|Investigator/Sponsor Decision|6|||
147570619|NCT01566721|532245231|FG001|Treatment Period|Investigator/Sponsor Decision|3|||
147570620|NCT01566721|532245230|FG000|Treatment Period|Other|13|||
147570621|NCT01566721|532245231|FG001|Treatment Period|Other|2|||
147570622|NCT01566721|532245230|FG000|Treatment Period|Lack of Compliance|5|||
147570623|NCT01566721|532245231|FG001|Treatment Period|Lack of Compliance|1|||
147570624|NCT01566721|532245230|FG000|Treatment Period|Adverse Event|100|||
147570625|NCT01566721|532245231|FG001|Treatment Period|Adverse Event|30|||
147570626|NCT01566721|532245230|FG000|Treatment Period|Pregnancy|1|||
147570627|NCT01566721|532245231|FG001|Treatment Period|Pregnancy|0|||
147570628|NCT01566721|532245230|FG000|Safety Follow-up|Physician Decision|6|||
147570629|NCT01566721|532245231|FG001|Safety Follow-up|Physician Decision|4|||
147570630|NCT01566721|532245230|FG000|Safety Follow-up|Lost to Follow-up|101|||
147570631|NCT01566721|532245231|FG001|Safety Follow-up|Lost to Follow-up|48|||
147570632|NCT01566721|532245230|FG000|Safety Follow-up|Withdrawal by Subject|155|||
147570633|NCT01566721|532245231|FG001|Safety Follow-up|Withdrawal by Subject|49|||
147570634|NCT01566721|532245230|FG000|Safety Follow-up|Death|28|||
147570635|NCT01566721|532245231|FG001|Safety Follow-up|Death|4|||
147131777|NCT00673920|530650731|FG007|Week 24 to Week 48|Failure to return|0|||
147570636|NCT01566721|532245230|FG000|Safety Follow-up|Non-compliance|7|||
147570637|NCT01566721|532245231|FG001|Safety Follow-up|Non-compliance|3|||
147570638|NCT01566721|532245230|FG000|Safety Follow-up|Protocol Violation|7|||
147570639|NCT01566721|532245231|FG001|Safety Follow-up|Protocol Violation|0|||
147570640|NCT01566721|532245230|FG000|Safety Follow-up|Site closure|2|||
147570641|NCT01566721|532245231|FG001|Safety Follow-up|Site closure|3|||
147570642|NCT01566721|532245230|FG000|Safety Follow-up|Erroneous reporting or late reporting|2|||
147131778|NCT00673920|530650724|FG000|Week 24 to Week 48|Insufficient therapeutic response|0|||
147131779|NCT00673920|530650725|FG001|Week 24 to Week 48|Insufficient therapeutic response|0|||
147131780|NCT00673920|530650726|FG002|Week 24 to Week 48|Insufficient therapeutic response|0|||
147131781|NCT00673920|530650727|FG003|Week 24 to Week 48|Insufficient therapeutic response|0|||
147131782|NCT00673920|530650728|FG004|Week 24 to Week 48|Insufficient therapeutic response|0|||
147131783|NCT00673920|530650729|FG005|Week 24 to Week 48|Insufficient therapeutic response|1|||
147131784|NCT00673920|530650730|FG006|Week 24 to Week 48|Insufficient therapeutic response|0|||
147131785|NCT00673920|530650731|FG007|Week 24 to Week 48|Insufficient therapeutic response|0|||
147131786|NCT00673920|530650724|FG000|Week 24 to Week 48|Death|0|||
147131787|NCT00673920|530650725|FG001|Week 24 to Week 48|Death|0|||
147131788|NCT00673920|530650726|FG002|Week 24 to Week 48|Death|0|||
147131789|NCT00673920|530650727|FG003|Week 24 to Week 48|Death|0|||
147131790|NCT00673920|530650728|FG004|Week 24 to Week 48|Death|0|||
147131791|NCT00673920|530650729|FG005|Week 24 to Week 48|Death|1|||
147131792|NCT00673920|530650730|FG006|Week 24 to Week 48|Death|0|||
147131793|NCT00673920|530650731|FG007|Week 24 to Week 48|Death|0|||
147131794|NCT00673920|530650724|FG000|Week 24 to Week 48|Adminstrative/Other|0|||
147131795|NCT00673920|530650725|FG001|Week 24 to Week 48|Adminstrative/Other|0|||
147131796|NCT00673920|530650726|FG002|Week 24 to Week 48|Adminstrative/Other|0|||
147131797|NCT00673920|530650727|FG003|Week 24 to Week 48|Adminstrative/Other|1|||
147131798|NCT00673920|530650728|FG004|Week 24 to Week 48|Adminstrative/Other|0|||
147131799|NCT00673920|530650729|FG005|Week 24 to Week 48|Adminstrative/Other|0|||
147131800|NCT00673920|530650730|FG006|Week 24 to Week 48|Adminstrative/Other|0|||
147131801|NCT00673920|530650731|FG007|Week 24 to Week 48|Adminstrative/Other|0|||
147131802|NCT00833690|530650735|FG000|Overall Study|Withdrawal by Subject|1|||
147131803|NCT00833690|530650736|FG001|Overall Study|Withdrawal by Subject|0|||
147131804|NCT00833690|530650737|FG002|Overall Study|Withdrawal by Subject|0|||
147131805|NCT00833690|530650735|FG000|Overall Study|Discontinued study drug|3|||
147131806|NCT00833690|530650736|FG001|Overall Study|Discontinued study drug|2|||
147131807|NCT00833690|530650737|FG002|Overall Study|Discontinued study drug|0|||
147131808|NCT04562116|530650745|FG000|Overall Study|Lost to Follow-up|1|||
147131809|NCT04562116|530650745|FG000|Overall Study|Withdrawal by Subject|3|||
147131810|NCT04462471|530650748|FG000|Overall Study|Adverse Event|0|||
147131811|NCT04462471|530650749|FG001|Overall Study|Adverse Event|1|||
147131812|NCT04462471|530650750|FG002|Overall Study|Adverse Event|0|||
147131813|NCT04462471|530650751|FG003|Overall Study|Adverse Event|0|||
147131814|NCT04462471|530650748|FG000|Overall Study|Disease progression|1|||
147131815|NCT04462471|530650749|FG001|Overall Study|Disease progression|0|||
147131816|NCT04462471|530650750|FG002|Overall Study|Disease progression|0|||
147131817|NCT04462471|530650751|FG003|Overall Study|Disease progression|0|||
147131818|NCT03097289|530650752|FG000|Overall Study|Adverse Event|1|||
147131819|NCT03097289|530650752|FG000|Overall Study|Equipment failure|2|||
147131820|NCT03097289|530650752|FG000|Overall Study|Collected platelet product unusable|3|||
147131821|NCT00619866|530650753|FG000|Weeks 1 - 12|Adverse Event|0|||
147131822|NCT00619866|530650754|FG001|Weeks 1 - 12|Adverse Event|1|||
147131823|NCT00619866|530650755|FG002|Weeks 1 - 12|Adverse Event|2|||
147131824|NCT00619866|530650756|FG003|Weeks 1 - 12|Adverse Event|0|||
147131825|NCT00619866|530650757|FG004|Weeks 1 - 12|Adverse Event|0|||
147131826|NCT00619866|530650753|FG000|Weeks 1 - 12|Non-compliance|0|||
147131827|NCT00619866|530650754|FG001|Weeks 1 - 12|Non-compliance|0|||
147131828|NCT00619866|530650755|FG002|Weeks 1 - 12|Non-compliance|1|||
147131829|NCT00619866|530650756|FG003|Weeks 1 - 12|Non-compliance|0|||
147131830|NCT00619866|530650757|FG004|Weeks 1 - 12|Non-compliance|0|||
147131831|NCT00619866|530650753|FG000|Weeks 1 - 12|Withdrawal by Subject|7|||
147131832|NCT00619866|530650754|FG001|Weeks 1 - 12|Withdrawal by Subject|2|||
147131833|NCT00619866|530650755|FG002|Weeks 1 - 12|Withdrawal by Subject|4|||
147131834|NCT00619866|530650756|FG003|Weeks 1 - 12|Withdrawal by Subject|0|||
147131835|NCT00619866|530650757|FG004|Weeks 1 - 12|Withdrawal by Subject|0|||
147131836|NCT00619866|530650753|FG000|Weeks 1 - 12|Lack of Efficacy|3|||
147131837|NCT00619866|530650754|FG001|Weeks 1 - 12|Lack of Efficacy|2|||
147131838|NCT00619866|530650755|FG002|Weeks 1 - 12|Lack of Efficacy|1|||
147236201|NCT02713204|531035557|FG003|From Week 12 up to Week 36|Adverse Event|1|||
147236202|NCT02713204|531035558|FG004|From Week 12 up to Week 36|Adverse Event|1|||
147131839|NCT00619866|530650756|FG003|Weeks 1 - 12|Lack of Efficacy|0|||
147236203|NCT02713204|531035559|FG005|From Week 12 up to Week 36|Adverse Event|0|||
147131840|NCT00619866|530650757|FG004|Weeks 1 - 12|Lack of Efficacy|0|||
147131841|NCT00619866|530650753|FG000|Weeks 1 - 12|Lost to Follow-up|4|||
147131842|NCT00619866|530650754|FG001|Weeks 1 - 12|Lost to Follow-up|0|||
147131843|NCT00619866|530650755|FG002|Weeks 1 - 12|Lost to Follow-up|2|||
147131844|NCT00619866|530650756|FG003|Weeks 1 - 12|Lost to Follow-up|0|||
147131845|NCT00619866|530650757|FG004|Weeks 1 - 12|Lost to Follow-up|0|||
147131846|NCT00619866|530650753|FG000|Weeks 1 - 12|Sponsor Decision|0|||
147131847|NCT00619866|530650754|FG001|Weeks 1 - 12|Sponsor Decision|1|||
147131848|NCT00619866|530650755|FG002|Weeks 1 - 12|Sponsor Decision|0|||
147131849|NCT00619866|530650756|FG003|Weeks 1 - 12|Sponsor Decision|0|||
147131850|NCT00619866|530650757|FG004|Weeks 1 - 12|Sponsor Decision|0|||
147236204|NCT02713204|531035560|FG006|From Week 12 up to Week 36|Adverse Event|2|||
147131851|NCT00619866|530650753|FG000|Weeks 13 - 24|Adverse Event|0|||
147131852|NCT00619866|530650754|FG001|Weeks 13 - 24|Adverse Event|0|||
147131853|NCT00619866|530650755|FG002|Weeks 13 - 24|Adverse Event|2|||
147131854|NCT00619866|530650756|FG003|Weeks 13 - 24|Adverse Event|1|||
147131855|NCT00619866|530650757|FG004|Weeks 13 - 24|Adverse Event|0|||
147131856|NCT00619866|530650753|FG000|Weeks 13 - 24|Protocol Deviation|0|||
147131857|NCT00619866|530650754|FG001|Weeks 13 - 24|Protocol Deviation|0|||
147131858|NCT00619866|530650755|FG002|Weeks 13 - 24|Protocol Deviation|0|||
147131859|NCT00619866|530650756|FG003|Weeks 13 - 24|Protocol Deviation|1|||
147131860|NCT00619866|530650757|FG004|Weeks 13 - 24|Protocol Deviation|0|||
147131861|NCT00619866|530650753|FG000|Weeks 13 - 24|Withdrawal by Subject|0|||
147131862|NCT00619866|530650754|FG001|Weeks 13 - 24|Withdrawal by Subject|3|||
147131863|NCT00619866|530650755|FG002|Weeks 13 - 24|Withdrawal by Subject|2|||
147131864|NCT00619866|530650756|FG003|Weeks 13 - 24|Withdrawal by Subject|2|||
147131865|NCT00619866|530650757|FG004|Weeks 13 - 24|Withdrawal by Subject|2|||
147131866|NCT00619866|530650753|FG000|Weeks 13 - 24|Non-compliance|0|||
147131867|NCT00619866|530650754|FG001|Weeks 13 - 24|Non-compliance|1|||
147131868|NCT00619866|530650755|FG002|Weeks 13 - 24|Non-compliance|1|||
147131869|NCT00619866|530650756|FG003|Weeks 13 - 24|Non-compliance|0|||
147131870|NCT00619866|530650757|FG004|Weeks 13 - 24|Non-compliance|0|||
147131871|NCT00619866|530650753|FG000|Weeks 13 - 24|Lost to Follow-up|0|||
147131872|NCT00619866|530650754|FG001|Weeks 13 - 24|Lost to Follow-up|3|||
147131873|NCT00619866|530650755|FG002|Weeks 13 - 24|Lost to Follow-up|0|||
147131874|NCT00619866|530650756|FG003|Weeks 13 - 24|Lost to Follow-up|0|||
147131875|NCT00619866|530650757|FG004|Weeks 13 - 24|Lost to Follow-up|0|||
147131876|NCT00485173|530650761|FG000|Overall Study|Death|4|||
147131877|NCT00485173|530650762|FG001|Overall Study|Death|3|||
147131878|NCT00485173|530650761|FG000|Overall Study|Lost to Follow-up|32|||
147131879|NCT00485173|530650762|FG001|Overall Study|Lost to Follow-up|61|||
147131880|NCT00829244|530650763|FG000|Overall Study|Adverse Event|1|||
147131881|NCT00829244|530650764|FG001|Overall Study|Adverse Event|3|||
147131882|NCT00829244|530650763|FG000|Overall Study|Protocol Violation|1|||
147131883|NCT00829244|530650764|FG001|Overall Study|Protocol Violation|0|||
147131884|NCT00829244|530650763|FG000|Overall Study|Lack of ovarian response to stimulation|9|||
147131885|NCT00829244|530650764|FG001|Overall Study|Lack of ovarian response to stimulation|5|||
147131886|NCT00829244|530650763|FG000|Overall Study|Ovarian hyperstimulation syndrome (OHSS)|1|||
147131887|NCT00829244|530650764|FG001|Overall Study|Ovarian hyperstimulation syndrome (OHSS)|6|||
147131888|NCT00829244|530650763|FG000|Overall Study|No fertilization|2|||
147131889|NCT00829244|530650764|FG001|Overall Study|No fertilization|2|||
147131890|NCT00829244|530650763|FG000|Overall Study|All embryos discarded|0|||
147131891|NCT00829244|530650764|FG001|Overall Study|All embryos discarded|3|||
147131892|NCT00829244|530650763|FG000|Overall Study|No embryo cleavage|0|||
147131893|NCT00829244|530650764|FG001|Overall Study|No embryo cleavage|2|||
147131894|NCT02302222|530650781|FG000|Overall Study|Physician Decision|0|||
147131895|NCT02302222|530650782|FG001|Overall Study|Physician Decision|4|||
147131896|NCT02302222|530650781|FG000|Overall Study|Lost to Follow-up|1|||
147131897|NCT02302222|530650782|FG001|Overall Study|Lost to Follow-up|0|||
147131898|NCT02302222|530650781|FG000|Overall Study|Treatment discontinued before day 5|0|||
147131899|NCT02302222|530650782|FG001|Overall Study|Treatment discontinued before day 5|1|||
147131900|NCT02302222|530650781|FG000|Overall Study|Withdrawn prior to any treatment|0|||
147131901|NCT02302222|530650782|FG001|Overall Study|Withdrawn prior to any treatment|1|||
147131902|NCT03193801|530650783|FG000|Overall Study|Physician Decision|2|||
147131903|NCT03193801|530650783|FG000|Overall Study|Withdrawal by Subject|1|||
147131904|NCT03138564|530650784|FG000|Overall Study|Death of patient prior to the Week 2 assessment|14|||
147131905|NCT03138564|530650785|FG001|Overall Study|Death of patient prior to the Week 2 assessment|2|||
147131906|NCT03138564|530650784|FG000|Overall Study|Lost to Follow-up|16|||
147131907|NCT03138564|530650785|FG001|Overall Study|Lost to Follow-up|2|||
147131908|NCT03138564|530650784|FG000|Overall Study|Withdrawal by Subject|48|||
147131909|NCT03138564|530650785|FG001|Overall Study|Withdrawal by Subject|4|||
147131910|NCT03138564|530650784|FG000|Overall Study|No longer met eligibility criteria|2|||
147131911|NCT03138564|530650785|FG001|Overall Study|No longer met eligibility criteria|0|||
147131912|NCT03138564|530650784|FG000|Overall Study|Withdrawal by investigator due to no availability of SPIRIT champion in the clinic|4|||
147131913|NCT03138564|530650785|FG001|Overall Study|Withdrawal by investigator due to no availability of SPIRIT champion in the clinic|0|||
147131914|NCT03138564|530650784|FG000|Overall Study|Patient died before surrogate completed Week 2 assessment|12|||
147131915|NCT03138564|530650785|FG001|Overall Study|Patient died before surrogate completed Week 2 assessment|0|||
147131916|NCT03138564|530650784|FG000|Overall Study|Surrogate declined to complete the Week 2 assessment but did not withdraw from study|0|||
147131917|NCT03138564|530650785|FG001|Overall Study|Surrogate declined to complete the Week 2 assessment but did not withdraw from study|1|||
147131918|NCT03138564|530650784|FG000|Overall Study|Death of surrogate prior to Week 2 assessment|1|||
147131919|NCT03138564|530650785|FG001|Overall Study|Death of surrogate prior to Week 2 assessment|0|||
147131920|NCT03330847|530650789|FG000|Overall Study|Patients ongoing study|62|||
147131921|NCT03330847|530650790|FG001|Overall Study|Patients ongoing study|65|||
147131922|NCT03330847|530650791|FG002|Overall Study|Patients ongoing study|15|||
147131923|NCT05211596|530650794|FG000|Baseline to 6 Months|Lost to Follow-up|11|||
147131924|NCT05211596|530650794|FG000|Baseline to 6 Months|Death|1|||
147570643|NCT01566721|532245231|FG001|Safety Follow-up|Erroneous reporting or late reporting|0|||
147570644|NCT01566721|532245230|FG000|Safety Follow-up|Missing|7|||
147570645|NCT01566721|532245231|FG001|Safety Follow-up|Missing|2|||
147570646|NCT01566721|532245230|FG000|Safety Follow-up|Disease progression /disease recurrence|223|||
147570647|NCT01566721|532245231|FG001|Safety Follow-up|Disease progression /disease recurrence|90|||
147570648|NCT01566721|532245230|FG000|Safety Follow-up|Sponsor decision|1|||
147570649|NCT01566721|532245231|FG001|Safety Follow-up|Sponsor decision|0|||
147570650|NCT01566721|532245230|FG000|Safety Follow-up|Adverse Event|8|||
147570651|NCT01566721|532245231|FG001|Safety Follow-up|Adverse Event|4|||
147570652|NCT00446563|532245232|FG000|Overall Study|Adverse Event|4|||
147570653|NCT00446563|532245233|FG001|Overall Study|Adverse Event|3|||
147570654|NCT00446563|532245232|FG000|Overall Study|Abnormal laboratory value(s)|0|||
147570655|NCT00446563|532245233|FG001|Overall Study|Abnormal laboratory value(s)|1|||
147570656|NCT00446563|532245232|FG000|Overall Study|Abnormal test procedure result(s)|1|||
147570657|NCT00446563|532245233|FG001|Overall Study|Abnormal test procedure result(s)|0|||
147570658|NCT00446563|532245232|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
147570659|NCT00446563|532245233|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
147570660|NCT00446563|532245232|FG000|Overall Study|Withdrawal by Subject|2|||
147570661|NCT00446563|532245233|FG001|Overall Study|Withdrawal by Subject|1|||
147570662|NCT00446563|532245232|FG000|Overall Study|Administrative problems|0|||
147570663|NCT00446563|532245233|FG001|Overall Study|Administrative problems|1|||
147570664|NCT02911701|532245234|FG000|Overall Study|Withdrawal by Subject|2|||
147570665|NCT02911701|532245235|FG001|Overall Study|Withdrawal by Subject|4|||
147570666|NCT02911701|532245234|FG000|Overall Study|Adverse Event|1|||
147570667|NCT02911701|532245235|FG001|Overall Study|Adverse Event|0|||
147570668|NCT01302548|532245236|FG000|Overall Study|Lost to Follow-up|2|||
147651346|NCT04985942|532546437|FG001|Overall Study|Withdrawal by Subject|4|||
147651347|NCT03536663|532546440|FG000|Endexo|Protocol Violation|1|||
147131925|NCT05211596|530650794|FG000|Baseline to 6 Months|Withdrawal by Subject|1|||
147131926|NCT05211596|530650794|FG000|6 Months to 18 Months|Lost to Follow-up|9|||
147131927|NCT02769481|530650795|FG000|Overall Study|Protocol Violation|1|||
147131928|NCT02769481|530650796|FG001|Overall Study|Protocol Violation|0|||
147131929|NCT02769481|530650795|FG000|Overall Study|Adverse Event|3|||
147131930|NCT02769481|530650796|FG001|Overall Study|Adverse Event|6|||
147131931|NCT02769481|530650795|FG000|Overall Study|Entry Criteria Not Met|1|||
147131932|NCT02769481|530650796|FG001|Overall Study|Entry Criteria Not Met|2|||
147131933|NCT02769481|530650795|FG000|Overall Study|Withdrawal by Subject|14|||
147131934|NCT02769481|530650796|FG001|Overall Study|Withdrawal by Subject|16|||
147131935|NCT02769481|530650795|FG000|Overall Study|Lost to Follow-up|9|||
147131936|NCT02769481|530650796|FG001|Overall Study|Lost to Follow-up|9|||
147131937|NCT02769481|530650795|FG000|Overall Study|Physician Decision|0|||
147131938|NCT02769481|530650796|FG001|Overall Study|Physician Decision|1|||
147131939|NCT02769481|530650795|FG000|Overall Study|Terminated by Sponsor|1|||
147131940|NCT02769481|530650796|FG001|Overall Study|Terminated by Sponsor|0|||
147131941|NCT02769481|530650795|FG000|Overall Study|Death|0|||
147131942|NCT02769481|530650796|FG001|Overall Study|Death|1|||
147131943|NCT02769481|530650795|FG000|Overall Study|Undefined|4|||
147131944|NCT02769481|530650796|FG001|Overall Study|Undefined|1|||
147131945|NCT06272383|530650797|FG000|Overall Study|The investigational drugs were going to expire and to use the pilot data for the definitive trial|6|||
147236205|NCT02713204|531035561|FG007|From Week 12 up to Week 36|Adverse Event|1|||
147236206|NCT02713204|531035554|FG000|From Week 12 up to Week 36|Death|0|||
147236207|NCT02713204|531035555|FG001|From Week 12 up to Week 36|Death|0|||
147236208|NCT02713204|531035556|FG002|From Week 12 up to Week 36|Death|0|||
147236209|NCT02713204|531035557|FG003|From Week 12 up to Week 36|Death|1|||
147236210|NCT02713204|531035558|FG004|From Week 12 up to Week 36|Death|0|||
147236211|NCT02713204|531035559|FG005|From Week 12 up to Week 36|Death|1|||
147236212|NCT02713204|531035560|FG006|From Week 12 up to Week 36|Death|0|||
147236213|NCT02713204|531035561|FG007|From Week 12 up to Week 36|Death|3|||
147236214|NCT02713204|531035554|FG000|From Week 12 up to Week 36|Lost to Follow-up|0|||
147236215|NCT02713204|531035555|FG001|From Week 12 up to Week 36|Lost to Follow-up|0|||
147236216|NCT02713204|531035556|FG002|From Week 12 up to Week 36|Lost to Follow-up|0|||
147236217|NCT02713204|531035557|FG003|From Week 12 up to Week 36|Lost to Follow-up|2|||
147236218|NCT02713204|531035558|FG004|From Week 12 up to Week 36|Lost to Follow-up|0|||
147236219|NCT02713204|531035559|FG005|From Week 12 up to Week 36|Lost to Follow-up|0|||
147236220|NCT02713204|531035560|FG006|From Week 12 up to Week 36|Lost to Follow-up|0|||
147236221|NCT02713204|531035561|FG007|From Week 12 up to Week 36|Lost to Follow-up|0|||
147236222|NCT02713204|531035554|FG000|From Week 12 up to Week 36|Participant Re-located|0|||
147236223|NCT02713204|531035555|FG001|From Week 12 up to Week 36|Participant Re-located|0|||
147570669|NCT01302548|532245237|FG001|Overall Study|Lost to Follow-up|1|||
147570670|NCT02409355|532245240|FG000|Overall Study|Withdrawal by Subject|1|||
147570671|NCT02409355|532245241|FG001|Overall Study|Withdrawal by Subject|0|||
147570672|NCT02409355|532245240|FG000|Overall Study|Death|1|||
147570673|NCT02409355|532245241|FG001|Overall Study|Death|1|||
147570674|NCT02409355|532245240|FG000|Overall Study|Study terminated by Sponsor|2|||
147570675|NCT02409355|532245241|FG001|Overall Study|Study terminated by Sponsor|3|||
147236224|NCT02713204|531035556|FG002|From Week 12 up to Week 36|Participant Re-located|0|||
147131946|NCT06272383|530650798|FG001|Overall Study|The investigational drugs were going to expire and to use the pilot data for the definitive trial|4|||
147131947|NCT04398706|530650799|FG000|Overall Study|Adverse Event|0|||
147131948|NCT04398706|530650800|FG001|Overall Study|Adverse Event|0|||
147131949|NCT04398706|530650801|FG002|Overall Study|Adverse Event|0|||
147131950|NCT04398706|530650802|FG003|Overall Study|Adverse Event|0|||
147131951|NCT04398706|530650803|FG004|Overall Study|Adverse Event|0|||
147131952|NCT04398706|530650804|FG005|Overall Study|Adverse Event|1|||
147131953|NCT04398706|530650805|FG006|Overall Study|Adverse Event|1|||
147131954|NCT04398706|530650806|FG007|Overall Study|Adverse Event|0|||
147131955|NCT04398706|530650799|FG000|Overall Study|Lost to Follow-up|0|||
147131956|NCT04398706|530650800|FG001|Overall Study|Lost to Follow-up|1|||
147131957|NCT04398706|530650801|FG002|Overall Study|Lost to Follow-up|2|||
147131958|NCT04398706|530650802|FG003|Overall Study|Lost to Follow-up|1|||
147131959|NCT04398706|530650803|FG004|Overall Study|Lost to Follow-up|6|||
147131960|NCT04398706|530650804|FG005|Overall Study|Lost to Follow-up|3|||
147131961|NCT04398706|530650805|FG006|Overall Study|Lost to Follow-up|8|||
147131962|NCT04398706|530650806|FG007|Overall Study|Lost to Follow-up|2|||
147131963|NCT04398706|530650799|FG000|Overall Study|Withdrawal by parent/guardian|0|||
147131964|NCT04398706|530650800|FG001|Overall Study|Withdrawal by parent/guardian|2|||
147131965|NCT04398706|530650801|FG002|Overall Study|Withdrawal by parent/guardian|1|||
147131966|NCT04398706|530650802|FG003|Overall Study|Withdrawal by parent/guardian|2|||
147131967|NCT04398706|530650803|FG004|Overall Study|Withdrawal by parent/guardian|19|||
147131968|NCT04398706|530650804|FG005|Overall Study|Withdrawal by parent/guardian|23|||
147131969|NCT04398706|530650805|FG006|Overall Study|Withdrawal by parent/guardian|13|||
147131970|NCT04398706|530650806|FG007|Overall Study|Withdrawal by parent/guardian|11|||
147131971|NCT04398706|530650799|FG000|Overall Study|Protocol deviation|0|||
147131972|NCT04398706|530650800|FG001|Overall Study|Protocol deviation|1|||
147131973|NCT04398706|530650801|FG002|Overall Study|Protocol deviation|0|||
147131974|NCT04398706|530650802|FG003|Overall Study|Protocol deviation|0|||
147131975|NCT04398706|530650803|FG004|Overall Study|Protocol deviation|6|||
147131976|NCT04398706|530650804|FG005|Overall Study|Protocol deviation|4|||
147131977|NCT04398706|530650805|FG006|Overall Study|Protocol deviation|6|||
147131978|NCT04398706|530650806|FG007|Overall Study|Protocol deviation|3|||
147131979|NCT03716830|530652122|FG000|Overall Study|Withdrawal by Subject|2|||
147131980|NCT03716830|530652123|FG001|Overall Study|Withdrawal by Subject|2|||
147131981|NCT03716830|530652124|FG002|Overall Study|Withdrawal by Subject|6|||
147131982|NCT03716830|530652125|FG003|Overall Study|Withdrawal by Subject|5|||
147131983|NCT03716830|530652122|FG000|Overall Study|Adverse Event|1|||
147131984|NCT03716830|530652123|FG001|Overall Study|Adverse Event|2|||
147131985|NCT03716830|530652124|FG002|Overall Study|Adverse Event|0|||
147131986|NCT03716830|530652125|FG003|Overall Study|Adverse Event|1|||
147131987|NCT03716830|530652122|FG000|Overall Study|Lost to Follow-up|1|||
147131988|NCT03716830|530652123|FG001|Overall Study|Lost to Follow-up|1|||
147131989|NCT03716830|530652124|FG002|Overall Study|Lost to Follow-up|0|||
147131990|NCT03716830|530652125|FG003|Overall Study|Lost to Follow-up|0|||
147131991|NCT05489328|530652126|FG000|Overall Study|Lost to Follow-up|0|||
147131992|NCT05489328|530652127|FG001|Overall Study|Lost to Follow-up|0|||
147131993|NCT05489328|530652128|FG002|Overall Study|Lost to Follow-up|1|||
147131994|NCT05489328|530652129|FG003|Overall Study|Lost to Follow-up|0|||
147131995|NCT05489328|530652130|FG004|Overall Study|Lost to Follow-up|2|||
147131996|NCT05489328|530652131|FG005|Overall Study|Lost to Follow-up|0|||
147131997|NCT05489328|530652132|FG006|Overall Study|Lost to Follow-up|0|||
147131998|NCT05489328|530652133|FG007|Overall Study|Lost to Follow-up|1|||
147131999|NCT05489328|530652134|FG008|Overall Study|Lost to Follow-up|0|||
147132000|NCT05489328|530652126|FG000|Overall Study|Withdrawal by Subject|0|||
147132001|NCT05489328|530652127|FG001|Overall Study|Withdrawal by Subject|0|||
147132002|NCT05489328|530652128|FG002|Overall Study|Withdrawal by Subject|0|||
147132003|NCT05489328|530652129|FG003|Overall Study|Withdrawal by Subject|0|||
147132004|NCT05489328|530652130|FG004|Overall Study|Withdrawal by Subject|0|||
147132005|NCT05489328|530652131|FG005|Overall Study|Withdrawal by Subject|0|||
147132006|NCT05489328|530652132|FG006|Overall Study|Withdrawal by Subject|1|||
147132007|NCT05489328|530652133|FG007|Overall Study|Withdrawal by Subject|1|||
147132008|NCT05489328|530652134|FG008|Overall Study|Withdrawal by Subject|0|||
147132009|NCT05489328|530652126|FG000|Overall Study|Other|0|||
147132010|NCT05489328|530652127|FG001|Overall Study|Other|0|||
147132011|NCT05489328|530652128|FG002|Overall Study|Other|0|||
147132012|NCT05489328|530652129|FG003|Overall Study|Other|0|||
147132013|NCT05489328|530652130|FG004|Overall Study|Other|0|||
147132014|NCT05489328|530652131|FG005|Overall Study|Other|0|||
147132015|NCT05489328|530652132|FG006|Overall Study|Other|0|||
147132016|NCT05489328|530652133|FG007|Overall Study|Other|1|||
147132017|NCT05489328|530652134|FG008|Overall Study|Other|1|||
147132018|NCT01083602|530652135|FG000|Overall Study|Adverse Event|11|||
147132019|NCT01083602|530652135|FG000|Overall Study|New Cancer Therapy|2|||
147132020|NCT01083602|530652135|FG000|Overall Study|Death|1|||
147132021|NCT01083602|530652135|FG000|Overall Study|Withdrawal by Subject|5|||
147132022|NCT01083602|530652135|FG000|Overall Study|Lack of Efficacy|36|||
147132023|NCT01657370|530652136|FG000|Overall Study|Withdrawal by Subject|0|||
147570676|NCT02605928|532245242|FG000|Overall Study|Model tuning phase|28|||
147132024|NCT01657370|530652137|FG001|Overall Study|Withdrawal by Subject|0|||
147132025|NCT01657370|530652138|FG002|Overall Study|Withdrawal by Subject|1|||
147132026|NCT01657370|530652139|FG003|Overall Study|Withdrawal by Subject|0|||
147132027|NCT01657370|530652140|FG004|Overall Study|Withdrawal by Subject|0|||
147132028|NCT01657370|530652141|FG005|Overall Study|Withdrawal by Subject|1|||
147132029|NCT01657370|530652136|FG000|Overall Study|Physician Decision|2|||
147132030|NCT01657370|530652137|FG001|Overall Study|Physician Decision|3|||
147132031|NCT01657370|530652138|FG002|Overall Study|Physician Decision|1|||
147132032|NCT01657370|530652139|FG003|Overall Study|Physician Decision|2|||
147132033|NCT01657370|530652140|FG004|Overall Study|Physician Decision|5|||
147132034|NCT01657370|530652141|FG005|Overall Study|Physician Decision|0|||
147132035|NCT01657370|530652136|FG000|Overall Study|Lack of Qualifying Event|1|||
147132036|NCT01657370|530652137|FG001|Overall Study|Lack of Qualifying Event|0|||
147132037|NCT01657370|530652138|FG002|Overall Study|Lack of Qualifying Event|3|||
147132038|NCT01657370|530652139|FG003|Overall Study|Lack of Qualifying Event|2|||
147132039|NCT01657370|530652140|FG004|Overall Study|Lack of Qualifying Event|1|||
147132040|NCT01657370|530652141|FG005|Overall Study|Lack of Qualifying Event|2|||
147132041|NCT01657370|530652136|FG000|Overall Study|Adverse Event|0|||
147132042|NCT01657370|530652137|FG001|Overall Study|Adverse Event|0|||
147132043|NCT01657370|530652138|FG002|Overall Study|Adverse Event|0|||
147132044|NCT01657370|530652139|FG003|Overall Study|Adverse Event|0|||
147132045|NCT01657370|530652140|FG004|Overall Study|Adverse Event|1|||
147132046|NCT01657370|530652141|FG005|Overall Study|Adverse Event|0|||
147132047|NCT01657370|530652136|FG000|Overall Study|Protocol Violation|1|||
147132048|NCT01657370|530652137|FG001|Overall Study|Protocol Violation|1|||
147132049|NCT01657370|530652138|FG002|Overall Study|Protocol Violation|1|||
147132050|NCT01657370|530652139|FG003|Overall Study|Protocol Violation|1|||
147132051|NCT01657370|530652140|FG004|Overall Study|Protocol Violation|0|||
147132052|NCT01657370|530652141|FG005|Overall Study|Protocol Violation|0|||
147132053|NCT01657370|530652136|FG000|Overall Study|Lost to Follow-up|2|||
147132054|NCT01657370|530652137|FG001|Overall Study|Lost to Follow-up|0|||
147132055|NCT01657370|530652138|FG002|Overall Study|Lost to Follow-up|1|||
147132056|NCT01657370|530652139|FG003|Overall Study|Lost to Follow-up|0|||
147132057|NCT01657370|530652140|FG004|Overall Study|Lost to Follow-up|0|||
147132058|NCT01657370|530652141|FG005|Overall Study|Lost to Follow-up|1|||
147132059|NCT01323192|530652142|FG000|Overall Study|Adverse Event|6|||
147132060|NCT01323192|530652143|FG001|Overall Study|Adverse Event|1|||
147132061|NCT01323192|530652142|FG000|Overall Study|Withdrawal by Subject|3|||
147132062|NCT01323192|530652143|FG001|Overall Study|Withdrawal by Subject|1|||
147132063|NCT01323192|530652142|FG000|Overall Study|Noncompliance with study medication|0|||
147132064|NCT01323192|530652143|FG001|Overall Study|Noncompliance with study medication|3|||
147132065|NCT01323192|530652142|FG000|Overall Study|Nonmedical reasons|0|||
147132066|NCT01323192|530652143|FG001|Overall Study|Nonmedical reasons|1|||
147132067|NCT02276040|530652149|FG000|Overall Study|Physician Decision|15|||
147132068|NCT02835690|530652150|FG000|Overall Study|Death|12|||
147132069|NCT02835690|530652151|FG001|Overall Study|Death|11|||
147132070|NCT02835690|530652152|FG002|Overall Study|Death|13|||
147132071|NCT02835690|530652150|FG000|Overall Study|Transferred to Extension Study|2|||
147132072|NCT02835690|530652151|FG001|Overall Study|Transferred to Extension Study|2|||
147132073|NCT02835690|530652152|FG002|Overall Study|Transferred to Extension Study|1|||
147132074|NCT02835690|530652150|FG000|Overall Study|Did Not Continue on Extension Study|0|||
147132075|NCT02835690|530652151|FG001|Overall Study|Did Not Continue on Extension Study|0|||
147132076|NCT02835690|530652152|FG002|Overall Study|Did Not Continue on Extension Study|1|||
147132077|NCT02835690|530652150|FG000|Overall Study|Not Treated|0|||
147132078|NCT02835690|530652151|FG001|Overall Study|Not Treated|2|||
147132079|NCT02835690|530652152|FG002|Overall Study|Not Treated|0|||
147132080|NCT03674281|530652153|FG000|Overall Study|screen failure|2|||
147132081|NCT03674281|530652154|FG001|Overall Study|screen failure|0|||
147132082|NCT03674281|530652155|FG002|Overall Study|screen failure|0|||
147132083|NCT03674281|530652153|FG000|Overall Study|Withdrawal by Subject|1|||
147132084|NCT03674281|530652154|FG001|Overall Study|Withdrawal by Subject|3|||
147132085|NCT03674281|530652155|FG002|Overall Study|Withdrawal by Subject|3|||
147132086|NCT00582907|530652156|FG000|1st Course|Withdrawal by Subject|1|||
147132087|NCT00582907|530652157|FG001|1st Course|Withdrawal by Subject|0|||
147132088|NCT00582907|530652158|FG002|1st Course|Withdrawal by Subject|0|||
147132089|NCT00582907|530652159|FG003|1st Course|Withdrawal by Subject|0|||
147132090|NCT00582907|530652156|FG000|1st Course|Lost to Follow-up|0|||
147132091|NCT00582907|530652157|FG001|1st Course|Lost to Follow-up|0|||
147132092|NCT00582907|530652158|FG002|1st Course|Lost to Follow-up|0|||
147132093|NCT00582907|530652159|FG003|1st Course|Lost to Follow-up|1|||
147317657|NCT00918749|531329333|FG001|Overall Study|No Study Medication Taken|0|||
147132094|NCT00582907|530652156|FG000|2nd Course|Lack of Efficacy|1|||
147132095|NCT00582907|530652157|FG001|2nd Course|Lack of Efficacy|0|||
147132096|NCT00582907|530652158|FG002|2nd Course|Lack of Efficacy|0|||
147132097|NCT00582907|530652159|FG003|2nd Course|Lack of Efficacy|0|||
147132098|NCT01441960|530652160|FG000|First Neuromuscular Blocking Agent:|Technical error or incomplete ECT series|6|||
147132099|NCT01441960|530652161|FG001|First Neuromuscular Blocking Agent:|Technical error or incomplete ECT series|5|||
147132100|NCT01441960|530652160|FG000|First Neuromuscular Blocking Agent:|Protocol Violation|1|||
147132101|NCT01441960|530652161|FG001|First Neuromuscular Blocking Agent:|Protocol Violation|1|||
147132102|NCT01441960|530652160|FG000|First Neuromuscular Blocking Agent:|Withdrawal by Subject|1|||
147132103|NCT01441960|530652161|FG001|First Neuromuscular Blocking Agent:|Withdrawal by Subject|0|||
147132104|NCT00415636|530652164|FG000|Overall Study|Symptomatic deterioration|1|||
147132105|NCT00415636|530652165|FG001|Overall Study|Symptomatic deterioration|0|||
147132106|NCT00415636|530652166|FG002|Overall Study|Symptomatic deterioration|1|||
147132107|NCT00415636|530652167|FG003|Overall Study|Symptomatic deterioration|2|||
147132108|NCT00415636|530652168|FG004|Overall Study|Symptomatic deterioration|0|||
147132109|NCT00415636|530652169|FG005|Overall Study|Symptomatic deterioration|1|||
147132110|NCT00415636|530652164|FG000|Overall Study|Adverse Event|0|||
147132111|NCT00415636|530652165|FG001|Overall Study|Adverse Event|0|||
147132112|NCT00415636|530652166|FG002|Overall Study|Adverse Event|0|||
147132113|NCT00415636|530652167|FG003|Overall Study|Adverse Event|1|||
147132114|NCT00415636|530652168|FG004|Overall Study|Adverse Event|1|||
147132115|NCT00415636|530652169|FG005|Overall Study|Adverse Event|0|||
147132116|NCT00415636|530652164|FG000|Overall Study|Withdrawal by Subject|0|||
147132117|NCT00415636|530652165|FG001|Overall Study|Withdrawal by Subject|0|||
147236225|NCT02713204|531035557|FG003|From Week 12 up to Week 36|Participant Re-located|0|||
147236226|NCT02713204|531035558|FG004|From Week 12 up to Week 36|Participant Re-located|1|||
147236227|NCT02713204|531035559|FG005|From Week 12 up to Week 36|Participant Re-located|0|||
147236228|NCT02713204|531035560|FG006|From Week 12 up to Week 36|Participant Re-located|0|||
147236229|NCT02713204|531035561|FG007|From Week 12 up to Week 36|Participant Re-located|0|||
147236230|NCT03800173|531035565|FG000|Overall Study|Lost to Follow-up|0|||
147236231|NCT03800173|531035566|FG001|Overall Study|Lost to Follow-up|0|||
147236232|NCT03800173|531035567|FG002|Overall Study|Lost to Follow-up|0|||
147236233|NCT03800173|531035568|FG003|Overall Study|Lost to Follow-up|0|||
147236234|NCT03800173|531035569|FG004|Overall Study|Lost to Follow-up|1|||
147236235|NCT01903031|531035584|FG000|Overall Study|Not Able to Attend Clinic|1|||
147236236|NCT01903031|531035585|FG001|Overall Study|Not Able to Attend Clinic|1|||
147236237|NCT01903031|531035586|FG002|Overall Study|Not Able to Attend Clinic|0|||
147236238|NCT01903031|531035584|FG000|Overall Study|Missed Day 21 Primary Endpoint Visit|1|||
147236239|NCT01903031|531035585|FG001|Overall Study|Missed Day 21 Primary Endpoint Visit|0|||
147236240|NCT01903031|531035586|FG002|Overall Study|Missed Day 21 Primary Endpoint Visit|0|||
147236241|NCT01903031|531035584|FG000|Overall Study|Adverse Event|0|||
147236242|NCT01903031|531035585|FG001|Overall Study|Adverse Event|1|||
147236243|NCT01903031|531035586|FG002|Overall Study|Adverse Event|0|||
147236244|NCT01903031|531035584|FG000|Overall Study|Withdrawal by Subject|0|||
147236245|NCT01903031|531035585|FG001|Overall Study|Withdrawal by Subject|1|||
147236246|NCT01903031|531035586|FG002|Overall Study|Withdrawal by Subject|1|||
147236247|NCT01903031|531035584|FG000|Overall Study|Protocol Violation|0|||
147236248|NCT01903031|531035585|FG001|Overall Study|Protocol Violation|0|||
147236249|NCT01903031|531035586|FG002|Overall Study|Protocol Violation|2|||
147236250|NCT01903031|531035584|FG000|Overall Study|Lost to Follow-up|0|||
147236251|NCT01903031|531035585|FG001|Overall Study|Lost to Follow-up|0|||
147236252|NCT01903031|531035586|FG002|Overall Study|Lost to Follow-up|1|||
147236253|NCT01903031|531035584|FG000|Overall Study|NuvaRing removed prior to Day 21 visit|0|||
147236254|NCT01903031|531035585|FG001|Overall Study|NuvaRing removed prior to Day 21 visit|0|||
147236255|NCT01903031|531035586|FG002|Overall Study|NuvaRing removed prior to Day 21 visit|1|||
147236256|NCT01811225|531035587|FG000|Treatment Period 1|Adverse Event|2|||
147236257|NCT01811225|531035588|FG001|Treatment Period 1|Adverse Event|3|||
147236258|NCT01811225|531035587|FG000|Treatment Period 1|Lost to Follow-up|12|||
147236259|NCT01811225|531035588|FG001|Treatment Period 1|Lost to Follow-up|8|||
147236260|NCT01811225|531035587|FG000|Treatment Period 1|transporation|1|||
147236261|NCT01811225|531035588|FG001|Treatment Period 1|transporation|0|||
147236262|NCT01811225|531035587|FG000|Treatment Period 1|unable to remain smoke free overnight|10|||
147236263|NCT01811225|531035588|FG001|Treatment Period 1|unable to remain smoke free overnight|6|||
147236264|NCT01811225|531035587|FG000|Treatment Period 2|Lost to Follow-up|1|||
147236265|NCT01811225|531035588|FG001|Treatment Period 2|Lost to Follow-up|2|||
147236266|NCT01811225|531035587|FG000|Treatment Period 2|unable to remain smoke free overnight|3|||
147236267|NCT01811225|531035588|FG001|Treatment Period 2|unable to remain smoke free overnight|4|||
147651348|NCT03252145|532546445|FG000|Overall Study|Withdrawal by Subject|1|||
147236268|NCT00287365|531035589|FG000|Overall Study|sample not acquired|13|||
147236269|NCT00569270|531035590|FG000|Period: First Intervention|Protocol Violation|0|||
147236270|NCT00569270|531035591|FG001|Period: First Intervention|Protocol Violation|1|||
147236271|NCT00447005|531035593|FG000|Overall Study|Adverse Event|1|||
147236272|NCT00447005|531035593|FG000|Overall Study|Lack of Efficacy|11|||
147236273|NCT00492531|531035594|FG000|Overall Study|Withdrawn(More than one reason selected)|22|||
147236274|NCT00492531|531035595|FG001|Overall Study|Withdrawn(More than one reason selected)|23|||
147236275|NCT01187433|531035603|FG000|Overall Study|Protocol Violation|6|||
147236276|NCT01187433|531035604|FG001|Overall Study|Protocol Violation|2|||
147236277|NCT01187433|531035603|FG000|Overall Study|Withdrawal by Subject|5|||
147236278|NCT01187433|531035604|FG001|Overall Study|Withdrawal by Subject|2|||
147236279|NCT00302107|531035605|FG000|Overall Study|Lost to Follow-up|6|||
147236280|NCT00302107|531035606|FG001|Overall Study|Lost to Follow-up|5|||
147236281|NCT00302107|531035605|FG000|Overall Study|Protocol Violation|1|||
147236282|NCT00302107|531035606|FG001|Overall Study|Protocol Violation|0|||
147236283|NCT00302107|531035605|FG000|Overall Study|Relocation|0|||
147236284|NCT00302107|531035606|FG001|Overall Study|Relocation|1|||
147236285|NCT00302107|531035605|FG000|Overall Study|Withdrawal by Subject|0|||
147236286|NCT00302107|531035606|FG001|Overall Study|Withdrawal by Subject|3|||
147236287|NCT00302107|531035605|FG000|Overall Study|Adverse Event|1|||
147236288|NCT00302107|531035606|FG001|Overall Study|Adverse Event|0|||
147236289|NCT00437983|531035607|FG000|Overall Study|Adverse Event|6|||
147236290|NCT00437983|531035608|FG001|Overall Study|Adverse Event|6|||
147236291|NCT00437983|531035607|FG000|Overall Study|Protocol Violation|2|||
147236292|NCT00437983|531035608|FG001|Overall Study|Protocol Violation|1|||
147236293|NCT00437983|531035607|FG000|Overall Study|Withdrawal by Subject|5|||
147236294|NCT00437983|531035608|FG001|Overall Study|Withdrawal by Subject|6|||
147236295|NCT01790932|531035609|FG000|Overall Study|Disease Progression|41|||
147236296|NCT01790932|531035609|FG000|Overall Study|Adverse Event|7|||
147236297|NCT01790932|531035609|FG000|Overall Study|Physician Decision|1|||
147236298|NCT01790932|531035609|FG000|Overall Study|Withdrawal by Subject|1|||
147236299|NCT04223973|531035612|FG000|Overall Study|Patients 'withdrawal due to Covid 19 impact on study recruitment/follow-up on site|5|||
147236300|NCT04223973|531035613|FG001|Overall Study|Patients 'withdrawal due to Covid 19 impact on study recruitment/follow-up on site|0|||
147236301|NCT04223973|531035612|FG000|Overall Study|Adverse Event|4|||
147236302|NCT04223973|531035613|FG001|Overall Study|Adverse Event|0|||
147236303|NCT04223973|531035612|FG000|Overall Study|patients reported product dysfunctions and decided to stop the study|3|||
147236304|NCT04223973|531035613|FG001|Overall Study|patients reported product dysfunctions and decided to stop the study|0|||
147236305|NCT04223973|531035612|FG000|Overall Study|Physician Decision|1|||
147236306|NCT04223973|531035613|FG001|Overall Study|Physician Decision|1|||
147236307|NCT04223973|531035612|FG000|Overall Study|Withdrawal by Subject|0|||
147236308|NCT04223973|531035613|FG001|Overall Study|Withdrawal by Subject|1|||
147236309|NCT00594659|531035621|FG000|Overall Study|Lost to Follow-up|13|||
147236310|NCT00594659|531035622|FG001|Overall Study|Lost to Follow-up|9|||
147236311|NCT00594659|531035623|FG002|Overall Study|Lost to Follow-up|7|||
147236312|NCT00300274|531035624|FG000|Overall Study|Withdrawal by Subject|12|||
147236313|NCT00300274|531035625|FG001|Overall Study|Withdrawal by Subject|3|||
147236314|NCT00300274|531035626|FG002|Overall Study|Withdrawal by Subject|14|||
147236315|NCT00300274|531035624|FG000|Overall Study|Lost to Follow-up|3|||
147236316|NCT00300274|531035625|FG001|Overall Study|Lost to Follow-up|4|||
147236317|NCT00300274|531035626|FG002|Overall Study|Lost to Follow-up|5|||
147236318|NCT00300274|531035624|FG000|Overall Study|Death|31|||
147236319|NCT00300274|531035625|FG001|Overall Study|Death|20|||
147236320|NCT00300274|531035626|FG002|Overall Study|Death|25|||
147236321|NCT00300274|531035624|FG000|Overall Study|Re-transplant|0|||
147236322|NCT00300274|531035625|FG001|Overall Study|Re-transplant|0|||
147236323|NCT00300274|531035626|FG002|Overall Study|Re-transplant|1|||
147236324|NCT00242216|531035627|FG000|Overall Study|Lost to Follow-up|12|||
147236325|NCT00242216|531035628|FG001|Overall Study|Lost to Follow-up|17|||
147236326|NCT00242216|531035627|FG000|Overall Study|Death|4|||
147236327|NCT00242216|531035628|FG001|Overall Study|Death|2|||
147236328|NCT00242216|531035627|FG000|Overall Study|Lack of Efficacy|1|||
147236329|NCT00242216|531035628|FG001|Overall Study|Lack of Efficacy|2|||
147236330|NCT00242216|531035627|FG000|Overall Study|no medicaiton dispensed|1|||
147236331|NCT00242216|531035628|FG001|Overall Study|no medicaiton dispensed|1|||
147236332|NCT00678080|531035630|FG000|Overall Study|Physician Decision|2|||
147236333|NCT00678080|531035631|FG001|Overall Study|Physician Decision|0|||
147236334|NCT00678080|531035630|FG000|Overall Study|Lost to Follow-up|1|||
147236335|NCT00678080|531035631|FG001|Overall Study|Lost to Follow-up|0|||
147236336|NCT00678080|531035630|FG000|Overall Study|Withdrawal by Subject|0|||
147236337|NCT00678080|531035631|FG001|Overall Study|Withdrawal by Subject|1|||
147236338|NCT04439201|531035641|FG000|Overall Study|Ineligible|2|||
147236339|NCT04439201|531035641|FG000|Overall Study|Never start protocol therapy|1|||
147236340|NCT04439201|531035641|FG000|Overall Study|Ineligible and never start protocol therapy|1|||
147236341|NCT04439201|531035641|FG000|Overall Study|Mutation status not confirmed|4|||
147236342|NCT04439201|531035641|FG000|Overall Study|Adverse Event|1|||
147236343|NCT04439201|531035641|FG000|Overall Study|Death|7|||
147570677|NCT02605928|532245242|FG000|Overall Study|Lack of Efficacy|5|||
147236344|NCT04439201|531035641|FG000|Overall Study|Withdrawal by Subject|2|||
147570678|NCT02530905|532245245|FG000|Open Label Extension Period (132 Weeks)|Withdrawal by Subject|0|||
147570679|NCT02530905|532245246|FG001|Open Label Extension Period (132 Weeks)|Withdrawal by Subject|0|||
147236345|NCT04439201|531035641|FG000|Overall Study|Disease progression|20|||
147236346|NCT04439201|531035641|FG000|Overall Study|Alternative therapy|1|||
147236347|NCT04439201|531035641|FG000|Overall Study|Physician Decision|1|||
147236348|NCT05154578|531037297|FG000|Overall Study|Withdrawal by Subject|2|||
147236349|NCT05154578|531037298|FG001|Overall Study|Withdrawal by Subject|3|||
147236350|NCT05154578|531037299|FG002|Overall Study|Withdrawal by Subject|2|||
147236351|NCT05154578|531037300|FG003|Overall Study|Withdrawal by Subject|4|||
147236352|NCT05154578|531037301|FG004|Overall Study|Withdrawal by Subject|0|||
147236353|NCT05154578|531037297|FG000|Overall Study|Lost to Follow-up|0|||
147236354|NCT05154578|531037298|FG001|Overall Study|Lost to Follow-up|1|||
147317658|NCT00918749|531329334|FG002|Overall Study|No Study Medication Taken|0|||
147317659|NCT00136916|531329335|FG000|Overall Study|Never received study treatment|3|||
147317660|NCT00136916|531329336|FG001|Overall Study|Never received study treatment|5|||
147317661|NCT00136916|531329335|FG000|Overall Study|Death|1|||
147317662|NCT00136916|531329336|FG001|Overall Study|Death|3|||
147317663|NCT00136916|531329335|FG000|Overall Study|Adverse Event|27|||
147317664|NCT00136916|531329336|FG001|Overall Study|Adverse Event|8|||
147317665|NCT00136916|531329335|FG000|Overall Study|Laboratory abnormality|0|||
147317666|NCT00136916|531329336|FG001|Overall Study|Laboratory abnormality|1|||
147317667|NCT00136916|531329335|FG000|Overall Study|Lack of Efficacy|13|||
147317668|NCT00136916|531329336|FG001|Overall Study|Lack of Efficacy|3|||
147317669|NCT00136916|531329335|FG000|Overall Study|Lost to Follow-up|12|||
147317670|NCT00136916|531329336|FG001|Overall Study|Lost to Follow-up|14|||
147317671|NCT00136916|531329335|FG000|Overall Study|Withdrawal by Subject|44|||
147317672|NCT00136916|531329336|FG001|Overall Study|Withdrawal by Subject|46|||
147317673|NCT00136916|531329335|FG000|Overall Study|Other|22|||
147317674|NCT00136916|531329336|FG001|Overall Study|Other|24|||
147317675|NCT00136916|531329335|FG000|Overall Study|Discontinued in follow up period|3|||
147317676|NCT00136916|531329336|FG001|Overall Study|Discontinued in follow up period|0|||
147317677|NCT02397460|531329337|FG000|Treatment Period 2|Adverse Event|0|||
147317678|NCT02397460|531329338|FG001|Treatment Period 2|Adverse Event|0|||
147317679|NCT02397460|531329339|FG002|Treatment Period 2|Adverse Event|0|||
147317680|NCT02397460|531329340|FG003|Treatment Period 2|Adverse Event|0|||
147317681|NCT02397460|531329341|FG004|Treatment Period 2|Adverse Event|0|||
147317682|NCT02397460|531329342|FG005|Treatment Period 2|Adverse Event|0|||
147317683|NCT02397460|531329343|FG006|Treatment Period 2|Adverse Event|0|||
147317684|NCT02397460|531329344|FG007|Treatment Period 2|Adverse Event|1|||
147317685|NCT02397460|531329337|FG000|Treatment Period 4|Adverse Event|0|||
147317686|NCT02397460|531329338|FG001|Treatment Period 4|Adverse Event|1|||
147317687|NCT02397460|531329339|FG002|Treatment Period 4|Adverse Event|0|||
147317688|NCT02397460|531329340|FG003|Treatment Period 4|Adverse Event|0|||
147317689|NCT02397460|531329341|FG004|Treatment Period 4|Adverse Event|0|||
147317690|NCT02397460|531329342|FG005|Treatment Period 4|Adverse Event|0|||
147317691|NCT02397460|531329343|FG006|Treatment Period 4|Adverse Event|0|||
147317692|NCT02397460|531329344|FG007|Treatment Period 4|Adverse Event|0|||
147317693|NCT02397460|531329337|FG000|Treatment Period 4|Physician Decision|0|||
147317694|NCT02397460|531329338|FG001|Treatment Period 4|Physician Decision|0|||
147317695|NCT02397460|531329339|FG002|Treatment Period 4|Physician Decision|0|||
147317696|NCT02397460|531329340|FG003|Treatment Period 4|Physician Decision|0|||
147317697|NCT02397460|531329341|FG004|Treatment Period 4|Physician Decision|1|||
147317698|NCT02397460|531329342|FG005|Treatment Period 4|Physician Decision|0|||
147317699|NCT02397460|531329343|FG006|Treatment Period 4|Physician Decision|0|||
147317700|NCT02397460|531329344|FG007|Treatment Period 4|Physician Decision|0|||
147317701|NCT02213055|531329346|FG000|Overall Study|Protocol was not Followed at Enrollment|5|||
147317702|NCT02213055|531329347|FG001|Overall Study|Protocol was not Followed at Enrollment|0|||
147317703|NCT02213055|531329346|FG000|Overall Study|Protocol was not Followed during Study|1|||
147317704|NCT02213055|531329347|FG001|Overall Study|Protocol was not Followed during Study|0|||
147317705|NCT02213055|531329346|FG000|Overall Study|Documentation Issue at Enrollment|1|||
147317706|NCT02213055|531329347|FG001|Overall Study|Documentation Issue at Enrollment|0|||
147317707|NCT02213055|531329346|FG000|Overall Study|Documentation Issue during Study|10|||
147317708|NCT02213055|531329347|FG001|Overall Study|Documentation Issue during Study|0|||
147317709|NCT02213055|531329346|FG000|Overall Study|Did not have Live Lice|8|||
147317710|NCT02213055|531329347|FG001|Overall Study|Did not have Live Lice|0|||
147317711|NCT02213055|531329346|FG000|Overall Study|Had another Treatment during the Study|3|||
147317712|NCT02213055|531329347|FG001|Overall Study|Had another Treatment during the Study|0|||
147317713|NCT02213055|531329346|FG000|Overall Study|Did not meet Inclusion Criteria|6|||
147317714|NCT02213055|531329347|FG001|Overall Study|Did not meet Inclusion Criteria|0|||
147317715|NCT02213055|531329346|FG000|Overall Study|Did not Return to School|5|||
147317716|NCT02213055|531329347|FG001|Overall Study|Did not Return to School|0|||
147317717|NCT00231894|531329348|FG000|Overall Study|Withdrawal by Subject|1|||
147317718|NCT00231894|531329349|FG001|Overall Study|Withdrawal by Subject|1|||
147317719|NCT02025205|531329351|FG000|Overall Study|Withdrawal by Subject|1|||
147317720|NCT02025205|531329352|FG001|Overall Study|Withdrawal by Subject|1|||
147317721|NCT02025205|531329351|FG000|Overall Study|Protocol Violation|2|||
147317722|NCT02025205|531329352|FG001|Overall Study|Protocol Violation|1|||
147317723|NCT02025205|531329351|FG000|Overall Study|Death|0|||
147317724|NCT02025205|531329352|FG001|Overall Study|Death|1|||
147317725|NCT01767129|531329353|FG000|Treatment Period 1 (14 Days)|Adverse Event|1|||
147317726|NCT01767129|531329354|FG001|Treatment Period 1 (14 Days)|Adverse Event|0|||
147317727|NCT01024751|531329355|FG000|Enrolled Participants|Ineligible at baseline|3|||
147317728|NCT01024751|531329356|FG001|Enrolled Participants|Ineligible at baseline|4|||
147317729|NCT01024751|531329355|FG000|Eligible Participants|Withdrawal by Subject|0|||
147317730|NCT01024751|531329356|FG001|Eligible Participants|Withdrawal by Subject|1|||
147317731|NCT01024751|531329355|FG000|Eligible Participants|Lost to Follow-up|0|||
147317732|NCT01024751|531329356|FG001|Eligible Participants|Lost to Follow-up|1|||
147317733|NCT01024751|531329355|FG000|Eligible Participants|Ineligible|0|||
147236355|NCT05154578|531037299|FG002|Overall Study|Lost to Follow-up|0|||
147236356|NCT05154578|531037300|FG003|Overall Study|Lost to Follow-up|3|||
147236357|NCT05154578|531037301|FG004|Overall Study|Lost to Follow-up|0|||
147236358|NCT05154578|531037297|FG000|Overall Study|Adverse Event|0|||
147236359|NCT05154578|531037298|FG001|Overall Study|Adverse Event|0|||
147236360|NCT05154578|531037299|FG002|Overall Study|Adverse Event|0|||
147236361|NCT05154578|531037300|FG003|Overall Study|Adverse Event|1|||
147236362|NCT05154578|531037301|FG004|Overall Study|Adverse Event|0|||
147236363|NCT05154578|531037297|FG000|Overall Study|Relocated to another province|0|||
147236364|NCT05154578|531037298|FG001|Overall Study|Relocated to another province|0|||
147236365|NCT05154578|531037299|FG002|Overall Study|Relocated to another province|1|||
147236366|NCT05154578|531037300|FG003|Overall Study|Relocated to another province|0|||
147236367|NCT05154578|531037301|FG004|Overall Study|Relocated to another province|1|||
147236368|NCT05154578|531037297|FG000|Overall Study|Baby loss|0|||
147236369|NCT05154578|531037298|FG001|Overall Study|Baby loss|1|||
147236370|NCT05154578|531037299|FG002|Overall Study|Baby loss|0|||
147236371|NCT05154578|531037300|FG003|Overall Study|Baby loss|0|||
147236372|NCT05154578|531037301|FG004|Overall Study|Baby loss|0|||
147236373|NCT00894166|531037309|FG000|Overall Study|Withdrew or Lost to Follow-Up|61|||
147236374|NCT00894166|531037310|FG001|Overall Study|Withdrew or Lost to Follow-Up|63|||
147236375|NCT00894166|531037311|FG002|Overall Study|Withdrew or Lost to Follow-Up|62|||
147236376|NCT00894166|531037312|FG003|Overall Study|Withdrew or Lost to Follow-Up|68|||
147236377|NCT00894166|531037313|FG004|Overall Study|Withdrew or Lost to Follow-Up|24|||
147236378|NCT00894166|531037314|FG005|Overall Study|Withdrew or Lost to Follow-Up|16|||
147236379|NCT00894166|531037315|FG006|Overall Study|Withdrew or Lost to Follow-Up|16|||
147236380|NCT00894166|531037316|FG007|Overall Study|Withdrew or Lost to Follow-Up|34|||
147236381|NCT00894166|531037309|FG000|Overall Study|Death|0|||
147236382|NCT00894166|531037310|FG001|Overall Study|Death|0|||
147236383|NCT00894166|531037311|FG002|Overall Study|Death|0|||
147236384|NCT00894166|531037312|FG003|Overall Study|Death|1|||
147236385|NCT00894166|531037313|FG004|Overall Study|Death|0|||
147236386|NCT00894166|531037314|FG005|Overall Study|Death|0|||
147236387|NCT00894166|531037315|FG006|Overall Study|Death|0|||
147236388|NCT00894166|531037316|FG007|Overall Study|Death|0|||
147236389|NCT05350410|531037317|FG000|Overall Study|Withdrawal by Subject|1|||
147236390|NCT00142935|531037321|FG000|Overall Study|Other reason|1|||
147236391|NCT00142935|531037322|FG001|Overall Study|Other reason|1|||
147236392|NCT00142935|531037323|FG002|Overall Study|Other reason|1|||
147236393|NCT00142935|531037321|FG000|Overall Study|Lost to Follow-up|2|||
147236394|NCT00142935|531037322|FG001|Overall Study|Lost to Follow-up|5|||
147236395|NCT00142935|531037323|FG002|Overall Study|Lost to Follow-up|5|||
147236396|NCT00142935|531037321|FG000|Overall Study|Death|0|||
147236397|NCT00142935|531037322|FG001|Overall Study|Death|2|||
147236398|NCT00142935|531037323|FG002|Overall Study|Death|1|||
147236399|NCT01180985|531037324|FG000|Period 2 (7 +/- 1 Days)|Lost to Follow-up|1|||
147236400|NCT01180985|531037325|FG001|Period 2 (7 +/- 1 Days)|Lost to Follow-up|0|||
147236401|NCT00705289|531037326|FG000|Overall Study|Subject or treating physician's choice|131|||
147236402|NCT01030536|531037327|FG000|Overall Study|Withdrawal by Subject|0|||
147236403|NCT01030536|531037328|FG001|Overall Study|Withdrawal by Subject|0|||
147236404|NCT01030536|531037329|FG002|Overall Study|Withdrawal by Subject|1|||
147236405|NCT01030536|531037330|FG003|Overall Study|Withdrawal by Subject|0|||
147236406|NCT01030536|531037331|FG004|Overall Study|Withdrawal by Subject|0|||
147236407|NCT01030536|531037327|FG000|Overall Study|undefined|1|||
147236408|NCT01030536|531037328|FG001|Overall Study|undefined|0|||
147236409|NCT01030536|531037329|FG002|Overall Study|undefined|1|||
147236410|NCT01030536|531037330|FG003|Overall Study|undefined|1|||
147236411|NCT01030536|531037331|FG004|Overall Study|undefined|0|||
147236412|NCT01030536|531037327|FG000|Overall Study|Adverse Event|0|||
147236413|NCT01030536|531037328|FG001|Overall Study|Adverse Event|3|||
147236414|NCT01030536|531037329|FG002|Overall Study|Adverse Event|1|||
147236415|NCT01030536|531037330|FG003|Overall Study|Adverse Event|0|||
147236416|NCT01030536|531037331|FG004|Overall Study|Adverse Event|1|||
147236417|NCT01030536|531037327|FG000|Overall Study|Progressive disease|6|||
147236418|NCT01030536|531037328|FG001|Overall Study|Progressive disease|2|||
147236419|NCT01030536|531037329|FG002|Overall Study|Progressive disease|3|||
147236420|NCT01030536|531037330|FG003|Overall Study|Progressive disease|2|||
147236421|NCT01030536|531037331|FG004|Overall Study|Progressive disease|0|||
147236422|NCT01030536|531037327|FG000|Overall Study|Death|0|||
147236423|NCT01030536|531037328|FG001|Overall Study|Death|1|||
147236424|NCT01030536|531037329|FG002|Overall Study|Death|0|||
147236425|NCT01030536|531037330|FG003|Overall Study|Death|0|||
147236426|NCT01030536|531037331|FG004|Overall Study|Death|0|||
147236427|NCT00129272|531037332|FG000|Overall Study|Lost to Follow-up|12|||
147236428|NCT00129272|531037333|FG001|Overall Study|Lost to Follow-up|11|||
147236429|NCT00129272|531037332|FG000|Overall Study|Withdrawal by Subject|5|||
147236430|NCT00129272|531037333|FG001|Overall Study|Withdrawal by Subject|11|||
147236431|NCT02601027|531037337|FG000|Registration to Surgery|Withdrawal by Subject|20|||
147236432|NCT02601027|531037338|FG001|Registration to Surgery|Withdrawal by Subject|10|||
147236433|NCT01419626|531037339|FG000|Overall Study|Protocol Violation|3|||
147236434|NCT01419626|531037340|FG001|Overall Study|Protocol Violation|2|||
147570680|NCT02530905|532245247|FG002|Open Label Extension Period (132 Weeks)|Withdrawal by Subject|1|||
147570681|NCT01231906|532245249|FG000|Overall Study|Lack of Efficacy|75|||
147570682|NCT01231906|532245250|FG001|Overall Study|Lack of Efficacy|68|||
147570683|NCT01231906|532245249|FG000|Overall Study|Lost to Follow-up|1|||
147570684|NCT01231906|532245250|FG001|Overall Study|Lost to Follow-up|0|||
147570685|NCT01231906|532245249|FG000|Overall Study|Physician Decision|34|||
147236435|NCT01419626|531037341|FG002|Overall Study|Protocol Violation|2|||
147236436|NCT01419626|531037339|FG000|Overall Study|Withdrawal by Subject|1|||
147236437|NCT01419626|531037340|FG001|Overall Study|Withdrawal by Subject|0|||
147236438|NCT01419626|531037341|FG002|Overall Study|Withdrawal by Subject|0|||
147570686|NCT01231906|532245250|FG001|Overall Study|Physician Decision|24|||
147236439|NCT01419626|531037339|FG000|Overall Study|Lost to Follow-up|0|||
147236440|NCT01419626|531037340|FG001|Overall Study|Lost to Follow-up|1|||
147236441|NCT01419626|531037341|FG002|Overall Study|Lost to Follow-up|1|||
147236442|NCT01146912|531037342|FG000|Overall Study|Already received influenza vaccination|817|||
147236443|NCT01146912|531037343|FG001|Overall Study|Already received influenza vaccination|822|||
147236444|NCT01146912|531037344|FG002|Overall Study|Already received influenza vaccination|13|||
147236445|NCT01146912|531037345|FG003|Overall Study|Already received influenza vaccination|15|||
147236446|NCT01146912|531037346|FG004|Overall Study|Already received influenza vaccination|41|||
147236447|NCT01146912|531037347|FG005|Overall Study|Already received influenza vaccination|61|||
147236448|NCT01146912|531037348|FG006|Overall Study|Already received influenza vaccination|56|||
147570687|NCT01231906|532245249|FG000|Overall Study|Withdrawal by Subject|0|||
147236449|NCT01146912|531037349|FG007|Overall Study|Already received influenza vaccination|0|||
147236450|NCT01146912|531037342|FG000|Overall Study|< 14 weeks gestational age|0|||
147236451|NCT01146912|531037343|FG001|Overall Study|< 14 weeks gestational age|0|||
147236452|NCT01146912|531037344|FG002|Overall Study|< 14 weeks gestational age|3|||
147236453|NCT01146912|531037345|FG003|Overall Study|< 14 weeks gestational age|2|||
147236454|NCT01146912|531037346|FG004|Overall Study|< 14 weeks gestational age|0|||
147236455|NCT01146912|531037347|FG005|Overall Study|< 14 weeks gestational age|0|||
147236456|NCT01146912|531037348|FG006|Overall Study|< 14 weeks gestational age|0|||
147236457|NCT01146912|531037349|FG007|Overall Study|< 14 weeks gestational age|0|||
147236458|NCT01146912|531037342|FG000|Overall Study|Duplicate patient|0|||
147236459|NCT01146912|531037343|FG001|Overall Study|Duplicate patient|0|||
147236460|NCT01146912|531037344|FG002|Overall Study|Duplicate patient|1|||
147236461|NCT01146912|531037345|FG003|Overall Study|Duplicate patient|0|||
147236462|NCT01146912|531037346|FG004|Overall Study|Duplicate patient|0|||
147236463|NCT01146912|531037347|FG005|Overall Study|Duplicate patient|0|||
147236464|NCT01146912|531037348|FG006|Overall Study|Duplicate patient|0|||
147236465|NCT01146912|531037349|FG007|Overall Study|Duplicate patient|0|||
147236466|NCT02248701|531037352|FG000|Overall Study|Withdrawal by Subject|2|||
147236467|NCT02248701|531037353|FG001|Overall Study|Withdrawal by Subject|1|||
147236468|NCT02248701|531037352|FG000|Overall Study|Physician Decision|0|||
147236469|NCT02248701|531037353|FG001|Overall Study|Physician Decision|1|||
147236470|NCT02248701|531037352|FG000|Overall Study|Adverse Event|1|||
147236471|NCT02248701|531037353|FG001|Overall Study|Adverse Event|0|||
147236472|NCT02248701|531037352|FG000|Overall Study|VA mandated stop on all in person visits for VA sponsored research nationally|1|||
147236473|NCT02248701|531037353|FG001|Overall Study|VA mandated stop on all in person visits for VA sponsored research nationally|0|||
147236474|NCT01145625|531037354|FG000|Overall Study|Lost to Follow-up|8|||
147236475|NCT01145625|531037355|FG001|Overall Study|Lost to Follow-up|9|||
147236476|NCT01145625|531037354|FG000|Overall Study|Adverse Event|6|||
147236477|NCT01145625|531037355|FG001|Overall Study|Adverse Event|4|||
147236478|NCT01145625|531037354|FG000|Overall Study|Protocol Violation|3|||
147236479|NCT01145625|531037355|FG001|Overall Study|Protocol Violation|1|||
147236480|NCT01145625|531037354|FG000|Overall Study|Withdrawal by Subject|7|||
147236481|NCT01145625|531037355|FG001|Overall Study|Withdrawal by Subject|16|||
147236482|NCT01145625|531037354|FG000|Overall Study|Pregnancy|0|||
147236483|NCT01145625|531037355|FG001|Overall Study|Pregnancy|1|||
147236484|NCT04289623|531037356|FG000|Wave 1 Emails|Email was not delivered|268|||
147236485|NCT04289623|531037357|FG001|Wave 1 Emails|Email was not delivered|257|||
147236486|NCT04289623|531037358|FG002|Wave 1 Emails|Email was not delivered|0|||
147236487|NCT04289623|531037359|FG003|Wave 1 Emails|Email was not delivered|0|||
147236488|NCT04289623|531037360|FG004|Wave 1 Emails|Email was not delivered|0|||
147236489|NCT04289623|531037361|FG005|Wave 1 Emails|Email was not delivered|0|||
147236490|NCT01952145|531037362|FG000|Overall Study|Protocol Violation|2|||
147236491|NCT01952145|531037363|FG001|Overall Study|Protocol Violation|1|||
147570688|NCT01231906|532245250|FG001|Overall Study|Withdrawal by Subject|4|||
147570689|NCT01231906|532245249|FG000|Overall Study|Ineligible|10|||
147236492|NCT01952145|531037362|FG000|Overall Study|Death|0|||
147236493|NCT01952145|531037363|FG001|Overall Study|Death|1|||
147236494|NCT01952145|531037362|FG000|Overall Study|Adverse Event|9|||
147236495|NCT01952145|531037363|FG001|Overall Study|Adverse Event|0|||
147236496|NCT01952145|531037362|FG000|Overall Study|Withdrawal Criteria|16|||
147236497|NCT01952145|531037363|FG001|Overall Study|Withdrawal Criteria|11|||
147236498|NCT01952145|531037362|FG000|Overall Study|Unclassified|1|||
147236499|NCT01952145|531037363|FG001|Overall Study|Unclassified|1|||
147236500|NCT03863197|531037365|FG000|Overall Study|Lost to Follow-up|2|||
147236501|NCT03863197|531037366|FG001|Overall Study|Lost to Follow-up|3|||
147236502|NCT03863197|531037365|FG000|Overall Study|Withdrawal by Subject|4|||
147236503|NCT03863197|531037366|FG001|Overall Study|Withdrawal by Subject|0|||
147236504|NCT03863197|531037365|FG000|Overall Study|Did not receive intervention (inability to cooperate with assessment or cancellation due to Covid)|2|||
147236505|NCT03863197|531037366|FG001|Overall Study|Did not receive intervention (inability to cooperate with assessment or cancellation due to Covid)|0|||
147236506|NCT01065597|531037367|FG000|Overall Study|Adverse Event|1|||
147236507|NCT01622231|531037368|FG000|Overall Study|Physician Decision|1|||
147236508|NCT01622231|531037368|FG000|Overall Study|Withdrawal by Subject|1|||
147236509|NCT04545554|531037371|FG000|Overall Study|Withdrawal by Subject|0|||
147236510|NCT04545554|531037372|FG001|Overall Study|Withdrawal by Subject|0|||
147236511|NCT04545554|531037373|FG002|Overall Study|Withdrawal by Subject|0|||
147236512|NCT04545554|531037374|FG003|Overall Study|Withdrawal by Subject|1|||
147236513|NCT04545554|531037375|FG004|Overall Study|Withdrawal by Subject|0|||
147236514|NCT04545554|531037376|FG005|Overall Study|Withdrawal by Subject|0|||
147236515|NCT00494299|531037377|FG000|Overall Study|Adverse Event|93|||
147236516|NCT00494299|531037378|FG001|Overall Study|Adverse Event|13|||
147236517|NCT00494299|531037377|FG000|Overall Study|Lost to Follow-up|1|||
147236518|NCT00494299|531037378|FG001|Overall Study|Lost to Follow-up|0|||
147236519|NCT00494299|531037377|FG000|Overall Study|Physician Decision|0|||
147236520|NCT00494299|531037378|FG001|Overall Study|Physician Decision|2|||
147236521|NCT00494299|531037377|FG000|Overall Study|Protocol Violation|1|||
147236522|NCT00494299|531037378|FG001|Overall Study|Protocol Violation|2|||
147236523|NCT00494299|531037377|FG000|Overall Study|Withdrawal by Subject|8|||
147236524|NCT00494299|531037378|FG001|Overall Study|Withdrawal by Subject|3|||
147236525|NCT00494299|531037377|FG000|Overall Study|Disease Progression, Recurrence/Relapse|109|||
147236526|NCT00494299|531037378|FG001|Overall Study|Disease Progression, Recurrence/Relapse|185|||
147236527|NCT00494299|531037377|FG000|Overall Study|Participant Did Not Take Study Drug|0|||
147236528|NCT00494299|531037378|FG001|Overall Study|Participant Did Not Take Study Drug|2|||
147236529|NCT00494299|531037377|FG000|Overall Study|Site Closed by Sponsor|6|||
147236530|NCT00494299|531037378|FG001|Overall Study|Site Closed by Sponsor|0|||
147236531|NCT00494299|531037377|FG000|Overall Study|Protocol Driven Decision Point|11|||
147236532|NCT00494299|531037378|FG001|Overall Study|Protocol Driven Decision Point|22|||
147236533|NCT01986907|531037379|FG000|Overall Study|Adverse Event|11|||
147236534|NCT01986907|531037379|FG000|Overall Study|Unsatisfactory therapeutic effect|24|||
147236535|NCT01986907|531037379|FG000|Overall Study|Protocol Violation|4|||
147236536|NCT01986907|531037379|FG000|Overall Study|Withdrawal by Subject|76|||
147236537|NCT01986907|531037379|FG000|Overall Study|Lost to Follow-up|38|||
147236538|NCT01986907|531037379|FG000|Overall Study|Death|9|||
147236539|NCT02635776|531037380|FG000|Overall Study|Physician Decision|1|||
147236540|NCT02635776|531037381|FG001|Overall Study|Physician Decision|0|||
147651349|NCT03252145|532546446|FG001|Overall Study|Withdrawal by Subject|0|||
147651350|NCT03252145|532546445|FG000|Overall Study|Complicating Disease|1|||
147651351|NCT03252145|532546446|FG001|Overall Study|Complicating Disease|2|||
147651352|NCT03488563|532546447|FG000|Overall Study|Lost to Follow-up|7|||
147651353|NCT03488563|532546448|FG001|Overall Study|Lost to Follow-up|6|||
147651354|NCT03488563|532546449|FG002|Overall Study|Lost to Follow-up|7|||
147651355|NCT03488563|532546447|FG000|Overall Study|Withdrawal by Subject|8|||
147651356|NCT03488563|532546448|FG001|Overall Study|Withdrawal by Subject|7|||
147236541|NCT02635776|531037380|FG000|Overall Study|Adverse Event|51|||
147236542|NCT02635776|531037381|FG001|Overall Study|Adverse Event|3|||
147236543|NCT02635776|531037380|FG000|Overall Study|Withdrawal by Subject|41|||
147236544|NCT02635776|531037381|FG001|Overall Study|Withdrawal by Subject|7|||
147236545|NCT02635776|531037380|FG000|Overall Study|Lost to Follow-up|4|||
147236546|NCT02635776|531037381|FG001|Overall Study|Lost to Follow-up|0|||
147236547|NCT02635776|531037380|FG000|Overall Study|Other reasons|5|||
147236548|NCT02635776|531037381|FG001|Overall Study|Other reasons|1|||
147236549|NCT00788073|531037382|FG000|STX209 Then Placebo|Adverse Event|1|||
147236550|NCT00788073|531037383|FG001|STX209 Then Placebo|Adverse Event|0|||
147236551|NCT00788073|531037382|FG000|STX209 Then Placebo|Lost to Follow-up|0|||
147236552|NCT00788073|531037383|FG001|STX209 Then Placebo|Lost to Follow-up|1|||
147236553|NCT00788073|531037382|FG000|STX209 Then Placebo|Withdrawal by Subject|0|||
147236554|NCT00788073|531037383|FG001|STX209 Then Placebo|Withdrawal by Subject|1|||
147651357|NCT03488563|532546449|FG002|Overall Study|Withdrawal by Subject|7|||
147651358|NCT03488563|532546447|FG000|Overall Study|Physician Decision|0|||
147236555|NCT00788073|531037382|FG000|STX209 Then Placebo|unable to return due to travel|0|||
147236556|NCT00788073|531037383|FG001|STX209 Then Placebo|unable to return due to travel|1|||
147236557|NCT00788073|531037382|FG000|Placebo Then STX209|Adverse Event|2|||
147236558|NCT00788073|531037383|FG001|Placebo Then STX209|Adverse Event|0|||
147236559|NCT00788073|531037382|FG000|Placebo Then STX209|Protocol Violation|0|||
147236560|NCT00788073|531037383|FG001|Placebo Then STX209|Protocol Violation|1|||
147236561|NCT03608254|531037384|FG000|Overall Study|Blood sampling was not completed for 2 participants.|2|||
147249858|NCT01018186|531083794|FG001|2-week Run-in Period|Physician Decision|0|||
147249859|NCT01018186|531083795|FG002|2-week Run-in Period|Physician Decision|0|||
147249860|NCT01018186|531083796|FG003|2-week Run-in Period|Physician Decision|0|||
147249861|NCT01018186|531083793|FG000|2-week Run-in Period|Withdrawal by Subject|11|||
147236562|NCT03608254|531037384|FG000|Overall Study|One participant chose not to consume the entire 12-ounce dose of watermelon juice.|1|||
147236563|NCT03208127|531037385|FG000|Overall Study|Death|1|||
147236564|NCT00660673|531037386|FG000|Overall Study|Adverse Event|84|||
147236565|NCT00660673|531037386|FG000|Overall Study|Lack of Efficacy|7|||
147236566|NCT00660673|531037386|FG000|Overall Study|Withdrawal by Subject|22|||
147236567|NCT00660673|531037386|FG000|Overall Study|Administrative|2|||
147236568|NCT00660673|531037386|FG000|Overall Study|Protocol Violation|2|||
147236569|NCT03685123|531037387|FG000|Weight Loss Phase|Withdrawal by Subject|1|||
147236570|NCT03685123|531037388|FG001|Weight Loss Phase|Withdrawal by Subject|0|||
147236571|NCT03685123|531037389|FG002|Weight Loss Phase|Withdrawal by Subject|0|||
147236572|NCT03685123|531037387|FG000|Weight Loss Phase|Did not obtain weight loss goal|3|||
147236573|NCT03685123|531037388|FG001|Weight Loss Phase|Did not obtain weight loss goal|0|||
147236574|NCT03685123|531037389|FG002|Weight Loss Phase|Did not obtain weight loss goal|0|||
147236575|NCT03685123|531037387|FG000|Weight Loss Phase|Lost to Follow-up|1|||
147236576|NCT03685123|531037388|FG001|Weight Loss Phase|Lost to Follow-up|0|||
147236577|NCT03685123|531037389|FG002|Weight Loss Phase|Lost to Follow-up|0|||
147236578|NCT03685123|531037387|FG000|Weight Loss Phase|PI removal due to subject lack of compliance|1|||
147236579|NCT03685123|531037388|FG001|Weight Loss Phase|PI removal due to subject lack of compliance|0|||
147236580|NCT03685123|531037389|FG002|Weight Loss Phase|PI removal due to subject lack of compliance|0|||
147236581|NCT03685123|531037387|FG000|Weight Maintenance Phase|Covid Pandemic|0|||
147236582|NCT03685123|531037388|FG001|Weight Maintenance Phase|Covid Pandemic|4|||
147236583|NCT03685123|531037389|FG002|Weight Maintenance Phase|Covid Pandemic|5|||
147236584|NCT03685123|531037387|FG000|Weight Maintenance Phase|Withdrawal by Subject|0|||
147236585|NCT03685123|531037388|FG001|Weight Maintenance Phase|Withdrawal by Subject|0|||
147236586|NCT03685123|531037389|FG002|Weight Maintenance Phase|Withdrawal by Subject|3|||
147236587|NCT00400764|531037391|FG000|Phase Ib|Adverse Event|1|||
147236588|NCT00400764|531037392|FG001|Phase Ib|Adverse Event|0|||
147236589|NCT00400764|531037393|FG002|Phase Ib|Adverse Event|0|||
147236590|NCT00400764|531037394|FG003|Phase Ib|Adverse Event|0|||
147236591|NCT00400764|531037395|FG004|Phase Ib|Adverse Event|0|||
147236592|NCT00400764|531037391|FG000|Phase Ib|Death|1|||
147236593|NCT00400764|531037392|FG001|Phase Ib|Death|0|||
147236594|NCT00400764|531037393|FG002|Phase Ib|Death|0|||
147236595|NCT00400764|531037394|FG003|Phase Ib|Death|0|||
147236596|NCT00400764|531037395|FG004|Phase Ib|Death|0|||
147236597|NCT00400764|531037391|FG000|Phase Ib|Disease Progression|4|||
147236598|NCT00400764|531037392|FG001|Phase Ib|Disease Progression|4|||
147236599|NCT00400764|531037393|FG002|Phase Ib|Disease Progression|0|||
147236600|NCT00400764|531037394|FG003|Phase Ib|Disease Progression|0|||
147236601|NCT00400764|531037395|FG004|Phase Ib|Disease Progression|0|||
147236602|NCT00400764|531037391|FG000|Phase II|Death|0|||
147236603|NCT00400764|531037392|FG001|Phase II|Death|0|||
147236604|NCT00400764|531037393|FG002|Phase II|Death|1|||
147236605|NCT00400764|531037394|FG003|Phase II|Death|2|||
147236606|NCT00400764|531037395|FG004|Phase II|Death|0|||
147236607|NCT00400764|531037391|FG000|Phase II|Lost to Follow-up|0|||
147236608|NCT00400764|531037392|FG001|Phase II|Lost to Follow-up|0|||
147236609|NCT00400764|531037393|FG002|Phase II|Lost to Follow-up|1|||
147236610|NCT00400764|531037394|FG003|Phase II|Lost to Follow-up|0|||
147236611|NCT00400764|531037395|FG004|Phase II|Lost to Follow-up|0|||
147236612|NCT00400764|531037391|FG000|Phase II|Physician Decision|0|||
147236613|NCT00400764|531037392|FG001|Phase II|Physician Decision|0|||
147236614|NCT00400764|531037393|FG002|Phase II|Physician Decision|1|||
147236615|NCT00400764|531037394|FG003|Phase II|Physician Decision|1|||
147236616|NCT00400764|531037395|FG004|Phase II|Physician Decision|0|||
147236617|NCT00400764|531037391|FG000|Phase II|Sponsor's decision to terminate|0|||
147236618|NCT00400764|531037392|FG001|Phase II|Sponsor's decision to terminate|0|||
147236619|NCT00400764|531037393|FG002|Phase II|Sponsor's decision to terminate|18|||
147236620|NCT00400764|531037394|FG003|Phase II|Sponsor's decision to terminate|22|||
147236621|NCT00400764|531037395|FG004|Phase II|Sponsor's decision to terminate|11|||
147236622|NCT00400764|531037391|FG000|Phase II|Patient began new, non-protocol, therapy|0|||
147236623|NCT00400764|531037392|FG001|Phase II|Patient began new, non-protocol, therapy|0|||
147570690|NCT01231906|532245250|FG001|Overall Study|Ineligible|3|||
147570691|NCT01231906|532245249|FG000|Overall Study|No treatment|1|||
147236624|NCT00400764|531037393|FG002|Phase II|Patient began new, non-protocol, therapy|1|||
147236625|NCT00400764|531037394|FG003|Phase II|Patient began new, non-protocol, therapy|0|||
147236626|NCT00400764|531037395|FG004|Phase II|Patient began new, non-protocol, therapy|0|||
147236627|NCT00400764|531037391|FG000|Phase II|Withdrawal by Subject|0|||
147236628|NCT00400764|531037392|FG001|Phase II|Withdrawal by Subject|0|||
147236629|NCT00400764|531037393|FG002|Phase II|Withdrawal by Subject|1|||
147236630|NCT00400764|531037394|FG003|Phase II|Withdrawal by Subject|1|||
147236631|NCT00400764|531037395|FG004|Phase II|Withdrawal by Subject|0|||
147236632|NCT00621959|531037399|FG000|Overall Study|Adverse Event|4|||
147236633|NCT00621959|531037400|FG001|Overall Study|Adverse Event|2|||
147236634|NCT00621959|531037399|FG000|Overall Study|Lack of Efficacy|1|||
147236635|NCT00621959|531037400|FG001|Overall Study|Lack of Efficacy|1|||
147236636|NCT00621959|531037399|FG000|Overall Study|Lost to Follow-up|0|||
147236637|NCT00621959|531037400|FG001|Overall Study|Lost to Follow-up|2|||
147236638|NCT00621959|531037399|FG000|Overall Study|Withdrawal by Subject|1|||
147236639|NCT00621959|531037400|FG001|Overall Study|Withdrawal by Subject|1|||
147236640|NCT00621959|531037399|FG000|Overall Study|Other|1|||
147236641|NCT00621959|531037400|FG001|Overall Study|Other|3|||
147236642|NCT01758523|531037401|FG000|Overall Study|Adverse Event|2|||
147236643|NCT01758523|531037402|FG001|Overall Study|Adverse Event|1|||
147236644|NCT01758523|531037401|FG000|Overall Study|Lack of Efficacy|4|||
147236645|NCT01758523|531037402|FG001|Overall Study|Lack of Efficacy|2|||
147236646|NCT01758523|531037401|FG000|Overall Study|Lost to Follow-up|3|||
147236647|NCT01758523|531037402|FG001|Overall Study|Lost to Follow-up|4|||
147236648|NCT01758523|531037401|FG000|Overall Study|Withdrawal by Subject|12|||
147236649|NCT01758523|531037402|FG001|Overall Study|Withdrawal by Subject|7|||
147236650|NCT01893203|531037403|FG000|Overall Study|Withdrawal by Subject|1|||
147236651|NCT00722800|531037404|FG000|Overall Study|Withdrawal by Subject|1|||
147236652|NCT00722800|531037405|FG001|Overall Study|Withdrawal by Subject|0|||
147236653|NCT00722800|531037404|FG000|Overall Study|Physician Decision|1|||
147236654|NCT00722800|531037405|FG001|Overall Study|Physician Decision|0|||
147236655|NCT02925117|531037408|FG000|Period 1 (Weeks 0 - 16)|Adverse Event|1|||
147236656|NCT02925117|531037409|FG001|Period 1 (Weeks 0 - 16)|Adverse Event|3|||
147236657|NCT02925117|531037410|FG002|Period 1 (Weeks 0 - 16)|Adverse Event|1|||
147236658|NCT02925117|531037411|FG003|Period 1 (Weeks 0 - 16)|Adverse Event|2|||
147236659|NCT02925117|531037412|FG004|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
147236660|NCT02925117|531037413|FG005|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
147236661|NCT02925117|531037414|FG006|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
147236662|NCT02925117|531037415|FG007|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
147236663|NCT02925117|531037416|FG008|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
147236664|NCT02925117|531037417|FG009|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
147236665|NCT02925117|531037418|FG010|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
147236666|NCT02925117|531037419|FG011|Period 1 (Weeks 0 - 16)|Adverse Event|0|||
147236667|NCT02925117|531037408|FG000|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|10|||
147236668|NCT02925117|531037409|FG001|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|3|||
147236669|NCT02925117|531037410|FG002|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|3|||
147236670|NCT02925117|531037411|FG003|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
147236671|NCT02925117|531037412|FG004|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
147236672|NCT02925117|531037413|FG005|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
147236673|NCT02925117|531037414|FG006|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
147236674|NCT02925117|531037415|FG007|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
147236675|NCT02925117|531037416|FG008|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
147236676|NCT02925117|531037417|FG009|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
147236677|NCT02925117|531037418|FG010|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
147236678|NCT02925117|531037419|FG011|Period 1 (Weeks 0 - 16)|Withdrawal by Subject|0|||
147236679|NCT02925117|531037408|FG000|Period 1 (Weeks 0 - 16)|Lost to Follow-up|2|||
147236680|NCT02925117|531037409|FG001|Period 1 (Weeks 0 - 16)|Lost to Follow-up|1|||
147236681|NCT02925117|531037410|FG002|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
147236682|NCT02925117|531037411|FG003|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
147236683|NCT02925117|531037412|FG004|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
147236684|NCT02925117|531037413|FG005|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
147236685|NCT02925117|531037414|FG006|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
147236686|NCT02925117|531037415|FG007|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
147236687|NCT02925117|531037416|FG008|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
147236688|NCT02925117|531037417|FG009|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
147236689|NCT02925117|531037418|FG010|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
147236690|NCT02925117|531037419|FG011|Period 1 (Weeks 0 - 16)|Lost to Follow-up|0|||
147236691|NCT02925117|531037408|FG000|Period 1 (Weeks 0 - 16)|Other|5|||
147236692|NCT02925117|531037409|FG001|Period 1 (Weeks 0 - 16)|Other|4|||
147236693|NCT02925117|531037410|FG002|Period 1 (Weeks 0 - 16)|Other|1|||
147236694|NCT02925117|531037411|FG003|Period 1 (Weeks 0 - 16)|Other|1|||
147317734|NCT01024751|531329356|FG001|Eligible Participants|Ineligible|1|||
147317735|NCT01628510|531329362|FG000|Overall Study|Withdrawal by Subject|0|||
147236695|NCT02925117|531037412|FG004|Period 1 (Weeks 0 - 16)|Other|0|||
147236696|NCT02925117|531037413|FG005|Period 1 (Weeks 0 - 16)|Other|0|||
147317736|NCT01628510|531329363|FG001|Overall Study|Withdrawal by Subject|4|||
147317737|NCT01628510|531329362|FG000|Overall Study|Death|3|||
147317738|NCT01628510|531329363|FG001|Overall Study|Death|1|||
147236697|NCT02925117|531037414|FG006|Period 1 (Weeks 0 - 16)|Other|0|||
147317739|NCT01656759|531329364|FG000|Overall Study|Protocol Violation|2|||
147317740|NCT01656759|531329365|FG001|Overall Study|Protocol Violation|3|||
147236698|NCT02925117|531037415|FG007|Period 1 (Weeks 0 - 16)|Other|0|||
147236699|NCT02925117|531037416|FG008|Period 1 (Weeks 0 - 16)|Other|0|||
147236700|NCT02925117|531037417|FG009|Period 1 (Weeks 0 - 16)|Other|0|||
147236701|NCT02925117|531037418|FG010|Period 1 (Weeks 0 - 16)|Other|0|||
147236702|NCT02925117|531037419|FG011|Period 1 (Weeks 0 - 16)|Other|0|||
147236703|NCT02925117|531037408|FG000|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
147236704|NCT02925117|531037409|FG001|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
147236705|NCT02925117|531037410|FG002|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
147236706|NCT02925117|531037411|FG003|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
147236707|NCT02925117|531037412|FG004|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
147317741|NCT04707391|531329366|FG000|Overall Study|Adverse Event|5|||
147236708|NCT02925117|531037413|FG005|Period 2 (Weeks 16 - 88)|Adverse Event|1|||
147236709|NCT02925117|531037414|FG006|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
147236710|NCT02925117|531037415|FG007|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
147236711|NCT02925117|531037416|FG008|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
147236712|NCT02925117|531037417|FG009|Period 2 (Weeks 16 - 88)|Adverse Event|0|||
147236713|NCT02925117|531037418|FG010|Period 2 (Weeks 16 - 88)|Adverse Event|3|||
147236714|NCT02925117|531037419|FG011|Period 2 (Weeks 16 - 88)|Adverse Event|2|||
147236715|NCT02925117|531037408|FG000|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0|||
147236716|NCT02925117|531037409|FG001|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0|||
147236717|NCT02925117|531037410|FG002|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0|||
147236718|NCT02925117|531037411|FG003|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0|||
147236719|NCT02925117|531037412|FG004|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|0|||
147236720|NCT02925117|531037413|FG005|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|1|||
147236721|NCT02925117|531037414|FG006|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|4|||
147236722|NCT02925117|531037415|FG007|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|3|||
147236723|NCT02925117|531037416|FG008|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|2|||
147236724|NCT02925117|531037417|FG009|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|2|||
147236725|NCT02925117|531037418|FG010|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|2|||
147236726|NCT02925117|531037419|FG011|Period 2 (Weeks 16 - 88)|Withdrawal by Subject|2|||
147236727|NCT02925117|531037408|FG000|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
147236728|NCT02925117|531037409|FG001|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
147236729|NCT02925117|531037410|FG002|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
147236730|NCT02925117|531037411|FG003|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
147236731|NCT02925117|531037412|FG004|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1|||
147236732|NCT02925117|531037413|FG005|Period 2 (Weeks 16 - 88)|Lost to Follow-up|2|||
147236733|NCT02925117|531037414|FG006|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1|||
147236734|NCT02925117|531037415|FG007|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1|||
147236735|NCT02925117|531037416|FG008|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1|||
147236736|NCT02925117|531037417|FG009|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
147236737|NCT02925117|531037418|FG010|Period 2 (Weeks 16 - 88)|Lost to Follow-up|0|||
147236738|NCT02925117|531037419|FG011|Period 2 (Weeks 16 - 88)|Lost to Follow-up|1|||
147236739|NCT02925117|531037408|FG000|Period 2 (Weeks 16 - 88)|Other|0|||
147236740|NCT02925117|531037409|FG001|Period 2 (Weeks 16 - 88)|Other|0|||
147236741|NCT02925117|531037410|FG002|Period 2 (Weeks 16 - 88)|Other|0|||
147236742|NCT02925117|531037411|FG003|Period 2 (Weeks 16 - 88)|Other|0|||
147236743|NCT02925117|531037412|FG004|Period 2 (Weeks 16 - 88)|Other|1|||
147236744|NCT02925117|531037413|FG005|Period 2 (Weeks 16 - 88)|Other|1|||
147236745|NCT02925117|531037414|FG006|Period 2 (Weeks 16 - 88)|Other|1|||
147236746|NCT02925117|531037415|FG007|Period 2 (Weeks 16 - 88)|Other|1|||
147236747|NCT02925117|531037416|FG008|Period 2 (Weeks 16 - 88)|Other|3|||
147236748|NCT02925117|531037417|FG009|Period 2 (Weeks 16 - 88)|Other|4|||
147236749|NCT02925117|531037418|FG010|Period 2 (Weeks 16 - 88)|Other|3|||
147236750|NCT02925117|531037419|FG011|Period 2 (Weeks 16 - 88)|Other|0|||
147236751|NCT02130297|531037424|FG000|Overall Study|Lost to Follow-up|4|||
147236752|NCT00347360|531037425|FG000|Overall Study|Adverse Event|1|||
147236753|NCT00347360|531037426|FG001|Overall Study|Adverse Event|2|||
147236754|NCT00347360|531037427|FG002|Overall Study|Adverse Event|0|||
147236755|NCT00347360|531037428|FG003|Overall Study|Adverse Event|4|||
147236756|NCT00347360|531037429|FG004|Overall Study|Adverse Event|1|||
147236757|NCT00347360|531037430|FG005|Overall Study|Adverse Event|2|||
147236758|NCT00347360|531037431|FG006|Overall Study|Adverse Event|2|||
147236759|NCT00347360|531037432|FG007|Overall Study|Adverse Event|0|||
147236760|NCT00347360|531037433|FG008|Overall Study|Adverse Event|2|||
147236761|NCT00347360|531037434|FG009|Overall Study|Adverse Event|3|||
147236762|NCT00347360|531037435|FG010|Overall Study|Adverse Event|3|||
147236763|NCT00347360|531037436|FG011|Overall Study|Adverse Event|1|||
147236764|NCT00347360|531037437|FG012|Overall Study|Adverse Event|3|||
147236765|NCT00347360|531037438|FG013|Overall Study|Adverse Event|2|||
147236766|NCT00347360|531037439|FG014|Overall Study|Adverse Event|2|||
147236767|NCT00347360|531037425|FG000|Overall Study|Lost to Follow-up|0|||
147236768|NCT00347360|531037426|FG001|Overall Study|Lost to Follow-up|0|||
147236769|NCT00347360|531037427|FG002|Overall Study|Lost to Follow-up|0|||
147236770|NCT00347360|531037428|FG003|Overall Study|Lost to Follow-up|2|||
147236771|NCT00347360|531037429|FG004|Overall Study|Lost to Follow-up|1|||
147236772|NCT00347360|531037430|FG005|Overall Study|Lost to Follow-up|1|||
147236773|NCT00347360|531037431|FG006|Overall Study|Lost to Follow-up|0|||
147236774|NCT00347360|531037432|FG007|Overall Study|Lost to Follow-up|1|||
147236775|NCT00347360|531037433|FG008|Overall Study|Lost to Follow-up|1|||
147236776|NCT00347360|531037434|FG009|Overall Study|Lost to Follow-up|2|||
147236777|NCT00347360|531037435|FG010|Overall Study|Lost to Follow-up|0|||
147236778|NCT00347360|531037436|FG011|Overall Study|Lost to Follow-up|0|||
147236779|NCT00347360|531037437|FG012|Overall Study|Lost to Follow-up|1|||
147236780|NCT00347360|531037438|FG013|Overall Study|Lost to Follow-up|0|||
147236781|NCT00347360|531037439|FG014|Overall Study|Lost to Follow-up|0|||
147236782|NCT00347360|531037425|FG000|Overall Study|Protocol Violation|2|||
147236783|NCT00347360|531037426|FG001|Overall Study|Protocol Violation|3|||
147236784|NCT00347360|531037427|FG002|Overall Study|Protocol Violation|1|||
147317742|NCT04707391|531329367|FG001|Overall Study|Adverse Event|8|||
147317743|NCT04707391|531329366|FG000|Overall Study|Lost to Follow-up|44|||
147317744|NCT04707391|531329367|FG001|Overall Study|Lost to Follow-up|31|||
147317745|NCT04707391|531329366|FG000|Overall Study|Protocol Violation|1|||
147317746|NCT04707391|531329367|FG001|Overall Study|Protocol Violation|5|||
147317747|NCT04707391|531329366|FG000|Overall Study|Withdrawal by Subject|27|||
147236785|NCT00347360|531037428|FG003|Overall Study|Protocol Violation|2|||
147236786|NCT00347360|531037429|FG004|Overall Study|Protocol Violation|1|||
147317748|NCT04707391|531329367|FG001|Overall Study|Withdrawal by Subject|25|||
147317749|NCT04707391|531329366|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|8|||
147317750|NCT04707391|531329367|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|8|||
147317751|NCT04707391|531329366|FG000|Overall Study|Other|0|||
147445268|NCT01140451|531795788|FG001|Overall Study|Participants Planning Pregnancy|0|||
147236787|NCT00347360|531037430|FG005|Overall Study|Protocol Violation|2|||
147236788|NCT00347360|531037431|FG006|Overall Study|Protocol Violation|0|||
147236789|NCT00347360|531037432|FG007|Overall Study|Protocol Violation|0|||
147236790|NCT00347360|531037433|FG008|Overall Study|Protocol Violation|1|||
147236791|NCT00347360|531037434|FG009|Overall Study|Protocol Violation|2|||
147236792|NCT00347360|531037435|FG010|Overall Study|Protocol Violation|0|||
147236793|NCT00347360|531037436|FG011|Overall Study|Protocol Violation|0|||
147236794|NCT00347360|531037437|FG012|Overall Study|Protocol Violation|0|||
147236795|NCT00347360|531037438|FG013|Overall Study|Protocol Violation|1|||
147236796|NCT00347360|531037439|FG014|Overall Study|Protocol Violation|0|||
147236797|NCT00347360|531037425|FG000|Overall Study|Withdrawal by Subject|0|||
147236798|NCT00347360|531037426|FG001|Overall Study|Withdrawal by Subject|1|||
147236799|NCT00347360|531037427|FG002|Overall Study|Withdrawal by Subject|2|||
147236800|NCT00347360|531037428|FG003|Overall Study|Withdrawal by Subject|4|||
147236801|NCT00347360|531037429|FG004|Overall Study|Withdrawal by Subject|1|||
147236802|NCT00347360|531037430|FG005|Overall Study|Withdrawal by Subject|2|||
147236803|NCT00347360|531037431|FG006|Overall Study|Withdrawal by Subject|1|||
147236804|NCT00347360|531037432|FG007|Overall Study|Withdrawal by Subject|1|||
147236805|NCT00347360|531037433|FG008|Overall Study|Withdrawal by Subject|1|||
147236806|NCT00347360|531037434|FG009|Overall Study|Withdrawal by Subject|1|||
147236807|NCT00347360|531037435|FG010|Overall Study|Withdrawal by Subject|0|||
147236808|NCT00347360|531037436|FG011|Overall Study|Withdrawal by Subject|3|||
147236809|NCT00347360|531037437|FG012|Overall Study|Withdrawal by Subject|4|||
147236810|NCT00347360|531037438|FG013|Overall Study|Withdrawal by Subject|2|||
147236811|NCT00347360|531037439|FG014|Overall Study|Withdrawal by Subject|1|||
147236812|NCT00347360|531037425|FG000|Overall Study|Lack of Efficacy|1|||
147236813|NCT00347360|531037426|FG001|Overall Study|Lack of Efficacy|1|||
147236814|NCT00347360|531037427|FG002|Overall Study|Lack of Efficacy|3|||
147236815|NCT00347360|531037428|FG003|Overall Study|Lack of Efficacy|1|||
147236816|NCT00347360|531037429|FG004|Overall Study|Lack of Efficacy|0|||
147236817|NCT00347360|531037430|FG005|Overall Study|Lack of Efficacy|1|||
147236818|NCT00347360|531037431|FG006|Overall Study|Lack of Efficacy|0|||
147236819|NCT00347360|531037432|FG007|Overall Study|Lack of Efficacy|1|||
147236820|NCT00347360|531037433|FG008|Overall Study|Lack of Efficacy|1|||
147236821|NCT00347360|531037434|FG009|Overall Study|Lack of Efficacy|0|||
147236822|NCT00347360|531037435|FG010|Overall Study|Lack of Efficacy|0|||
147236823|NCT00347360|531037436|FG011|Overall Study|Lack of Efficacy|0|||
147236824|NCT00347360|531037437|FG012|Overall Study|Lack of Efficacy|0|||
147236825|NCT00347360|531037438|FG013|Overall Study|Lack of Efficacy|0|||
147236826|NCT00347360|531037439|FG014|Overall Study|Lack of Efficacy|0|||
147236827|NCT00347360|531037425|FG000|Overall Study|Reason not listed/blank|1|||
147236828|NCT00347360|531037426|FG001|Overall Study|Reason not listed/blank|0|||
147236829|NCT00347360|531037427|FG002|Overall Study|Reason not listed/blank|0|||
147445269|NCT00441974|531795789|FG000|Overall Study|Adverse Event|6|||
147445270|NCT00441974|531795789|FG000|Overall Study|Consent Withdrawn|35|||
147445271|NCT00441974|531795789|FG000|Overall Study|Lost to Follow-up|80|||
147445272|NCT00441974|531795789|FG000|Overall Study|Protocol Violation|7|||
147570692|NCT01231906|532245250|FG001|Overall Study|No treatment|2|||
147570693|NCT04646213|532245251|FG000|Overall Study|Physician Decision|3|||
147570694|NCT04646213|532245251|FG000|Overall Study|Withdrawal by Subject|2|||
147570695|NCT02441309|532245254|FG000|Overall Study|Disease progression|2|||
147236830|NCT00347360|531037428|FG003|Overall Study|Reason not listed/blank|0|||
147236831|NCT00347360|531037429|FG004|Overall Study|Reason not listed/blank|0|||
147236832|NCT00347360|531037430|FG005|Overall Study|Reason not listed/blank|0|||
147236833|NCT00347360|531037431|FG006|Overall Study|Reason not listed/blank|1|||
147236834|NCT00347360|531037432|FG007|Overall Study|Reason not listed/blank|0|||
147236835|NCT00347360|531037433|FG008|Overall Study|Reason not listed/blank|0|||
147317752|NCT04707391|531329367|FG001|Overall Study|Other|2|||
147236836|NCT00347360|531037434|FG009|Overall Study|Reason not listed/blank|0|||
147236837|NCT00347360|531037435|FG010|Overall Study|Reason not listed/blank|0|||
147236838|NCT00347360|531037436|FG011|Overall Study|Reason not listed/blank|0|||
147236839|NCT00347360|531037437|FG012|Overall Study|Reason not listed/blank|0|||
147236840|NCT00347360|531037438|FG013|Overall Study|Reason not listed/blank|1|||
147236841|NCT00347360|531037439|FG014|Overall Study|Reason not listed/blank|0|||
147570696|NCT02441309|532245255|FG001|Overall Study|Disease progression|1|||
147236842|NCT00347360|531037425|FG000|Overall Study|Per sponsors instruction|0|||
147236843|NCT00347360|531037426|FG001|Overall Study|Per sponsors instruction|1|||
147236844|NCT00347360|531037427|FG002|Overall Study|Per sponsors instruction|0|||
147236845|NCT00347360|531037428|FG003|Overall Study|Per sponsors instruction|0|||
147236846|NCT00347360|531037429|FG004|Overall Study|Per sponsors instruction|0|||
147236847|NCT00347360|531037430|FG005|Overall Study|Per sponsors instruction|0|||
147236848|NCT00347360|531037431|FG006|Overall Study|Per sponsors instruction|0|||
147236849|NCT00347360|531037432|FG007|Overall Study|Per sponsors instruction|0|||
147236850|NCT00347360|531037433|FG008|Overall Study|Per sponsors instruction|0|||
147236851|NCT00347360|531037434|FG009|Overall Study|Per sponsors instruction|0|||
147236852|NCT00347360|531037435|FG010|Overall Study|Per sponsors instruction|0|||
147236853|NCT00347360|531037436|FG011|Overall Study|Per sponsors instruction|0|||
147236854|NCT00347360|531037437|FG012|Overall Study|Per sponsors instruction|0|||
147236855|NCT00347360|531037438|FG013|Overall Study|Per sponsors instruction|0|||
147236856|NCT00347360|531037439|FG014|Overall Study|Per sponsors instruction|0|||
147236857|NCT00347360|531037425|FG000|Overall Study|P.I. recommended due to blood pressure|0|||
147236858|NCT00347360|531037426|FG001|Overall Study|P.I. recommended due to blood pressure|0|||
147236859|NCT00347360|531037427|FG002|Overall Study|P.I. recommended due to blood pressure|0|||
147236860|NCT00347360|531037428|FG003|Overall Study|P.I. recommended due to blood pressure|0|||
147236861|NCT00347360|531037429|FG004|Overall Study|P.I. recommended due to blood pressure|1|||
147236862|NCT00347360|531037430|FG005|Overall Study|P.I. recommended due to blood pressure|0|||
147236863|NCT00347360|531037431|FG006|Overall Study|P.I. recommended due to blood pressure|0|||
147236864|NCT00347360|531037432|FG007|Overall Study|P.I. recommended due to blood pressure|0|||
147236865|NCT00347360|531037433|FG008|Overall Study|P.I. recommended due to blood pressure|0|||
147132118|NCT00415636|530652166|FG002|Overall Study|Withdrawal by Subject|0|||
147132119|NCT00415636|530652167|FG003|Overall Study|Withdrawal by Subject|0|||
147132120|NCT00415636|530652168|FG004|Overall Study|Withdrawal by Subject|1|||
147132121|NCT00415636|530652169|FG005|Overall Study|Withdrawal by Subject|0|||
147132122|NCT00415636|530652164|FG000|Overall Study|Disease progression|0|||
147132123|NCT00415636|530652165|FG001|Overall Study|Disease progression|0|||
147132124|NCT00415636|530652166|FG002|Overall Study|Disease progression|0|||
147132125|NCT00415636|530652167|FG003|Overall Study|Disease progression|3|||
147132126|NCT00415636|530652168|FG004|Overall Study|Disease progression|0|||
147132127|NCT00415636|530652169|FG005|Overall Study|Disease progression|1|||
147132128|NCT01263119|530652170|FG000|Period 1|Protocol Violation|2|||
147132129|NCT01263119|530652170|FG000|Period 2|Adverse Event|2|||
147236866|NCT00347360|531037434|FG009|Overall Study|P.I. recommended due to blood pressure|0|||
147236867|NCT00347360|531037435|FG010|Overall Study|P.I. recommended due to blood pressure|0|||
147236868|NCT00347360|531037436|FG011|Overall Study|P.I. recommended due to blood pressure|0|||
147236869|NCT00347360|531037437|FG012|Overall Study|P.I. recommended due to blood pressure|0|||
147236870|NCT00347360|531037438|FG013|Overall Study|P.I. recommended due to blood pressure|0|||
147236871|NCT00347360|531037439|FG014|Overall Study|P.I. recommended due to blood pressure|0|||
147236872|NCT00347360|531037425|FG000|Overall Study|Subject did not meet end of study ABPM|0|||
147236873|NCT00347360|531037426|FG001|Overall Study|Subject did not meet end of study ABPM|0|||
147236874|NCT00347360|531037427|FG002|Overall Study|Subject did not meet end of study ABPM|0|||
147132130|NCT02138825|530652171|FG000|Main Study Treatment|Adverse Event|11|||
147132131|NCT02138825|530652172|FG001|Main Study Treatment|Adverse Event|3|||
147132132|NCT02138825|530652171|FG000|Main Study Treatment|Death|1|||
147132133|NCT02138825|530652172|FG001|Main Study Treatment|Death|2|||
147132134|NCT02138825|530652171|FG000|Main Study Treatment|Protocol Violation|2|||
147236875|NCT00347360|531037428|FG003|Overall Study|Subject did not meet end of study ABPM|0|||
147236876|NCT00347360|531037429|FG004|Overall Study|Subject did not meet end of study ABPM|0|||
147236877|NCT00347360|531037430|FG005|Overall Study|Subject did not meet end of study ABPM|0|||
147236878|NCT00347360|531037431|FG006|Overall Study|Subject did not meet end of study ABPM|1|||
147236879|NCT00347360|531037432|FG007|Overall Study|Subject did not meet end of study ABPM|0|||
147236880|NCT00347360|531037433|FG008|Overall Study|Subject did not meet end of study ABPM|0|||
147236881|NCT00347360|531037434|FG009|Overall Study|Subject did not meet end of study ABPM|0|||
147236882|NCT00347360|531037435|FG010|Overall Study|Subject did not meet end of study ABPM|1|||
147236883|NCT00347360|531037436|FG011|Overall Study|Subject did not meet end of study ABPM|0|||
147236884|NCT00347360|531037437|FG012|Overall Study|Subject did not meet end of study ABPM|1|||
147236885|NCT00347360|531037438|FG013|Overall Study|Subject did not meet end of study ABPM|1|||
147236886|NCT00347360|531037439|FG014|Overall Study|Subject did not meet end of study ABPM|0|||
147236887|NCT00347360|531037425|FG000|Overall Study|Abnormal lab values|0|||
147236888|NCT00347360|531037426|FG001|Overall Study|Abnormal lab values|0|||
147236889|NCT00347360|531037427|FG002|Overall Study|Abnormal lab values|0|||
147236890|NCT00347360|531037428|FG003|Overall Study|Abnormal lab values|0|||
147236891|NCT00347360|531037429|FG004|Overall Study|Abnormal lab values|0|||
147236892|NCT00347360|531037430|FG005|Overall Study|Abnormal lab values|0|||
147236893|NCT00347360|531037431|FG006|Overall Study|Abnormal lab values|1|||
147236894|NCT00347360|531037432|FG007|Overall Study|Abnormal lab values|0|||
147236895|NCT00347360|531037433|FG008|Overall Study|Abnormal lab values|0|||
147236896|NCT00347360|531037434|FG009|Overall Study|Abnormal lab values|0|||
147132135|NCT02138825|530652172|FG001|Main Study Treatment|Protocol Violation|2|||
147132136|NCT02138825|530652171|FG000|Main Study Treatment|Sponsor decision|12|||
147132137|NCT02138825|530652172|FG001|Main Study Treatment|Sponsor decision|18|||
147132138|NCT02138825|530652171|FG000|Main Study Treatment|Study terminated by sponsor|10|||
147132139|NCT02138825|530652172|FG001|Main Study Treatment|Study terminated by sponsor|9|||
147132140|NCT02138825|530652171|FG000|Main Study Treatment|Withdrawal by Subject|3|||
147132141|NCT02138825|530652172|FG001|Main Study Treatment|Withdrawal by Subject|1|||
147132142|NCT02138825|530652171|FG000|Main Study Treatment|Medical decision|1|||
147132143|NCT02138825|530652172|FG001|Main Study Treatment|Medical decision|0|||
147132144|NCT02138825|530652171|FG000|Long-term Extension|Study termination by sponsor|32|||
147132145|NCT02138825|530652172|FG001|Long-term Extension|Study termination by sponsor|38|||
147132146|NCT02138825|530652171|FG000|Safety Follow-up|Adverse Event|4|||
147132147|NCT02138825|530652172|FG001|Safety Follow-up|Adverse Event|3|||
147132148|NCT02138825|530652171|FG000|Safety Follow-up|Death|11|||
147317753|NCT03246672|531329369|FG000|Overall Study|Lost to Follow-up|2|||
147132149|NCT02138825|530652172|FG001|Safety Follow-up|Death|5|||
147132150|NCT02138825|530652171|FG000|Safety Follow-up|Withdrawal by Subject|5|||
147132151|NCT02138825|530652172|FG001|Safety Follow-up|Withdrawal by Subject|3|||
147317754|NCT01932996|531329370|FG000|Overall Study|Protocol Violation|2|||
147317755|NCT01932996|531329371|FG001|Overall Study|Protocol Violation|0|||
147317756|NCT02500316|531329375|FG000|Overall Study|Adverse Event|3|||
147570697|NCT02441309|532245256|FG002|Overall Study|Disease progression|2|||
147570698|NCT02441309|532245254|FG000|Overall Study|Adverse Event|0|||
147570699|NCT02441309|532245255|FG001|Overall Study|Adverse Event|1|||
147570700|NCT02441309|532245256|FG002|Overall Study|Adverse Event|0|||
147570701|NCT02441309|532245254|FG000|Overall Study|Withdrawal by Subject|1|||
147570702|NCT02441309|532245255|FG001|Overall Study|Withdrawal by Subject|0|||
147570703|NCT02441309|532245256|FG002|Overall Study|Withdrawal by Subject|1|||
147570704|NCT00415363|532245257|FG000|Overall Study|Withdrawal by Subject|4|||
147570705|NCT00415363|532245258|FG001|Overall Study|Withdrawal by Subject|4|||
147570706|NCT00415363|532245257|FG000|Overall Study|Adverse Event|4|||
147570707|NCT00415363|532245258|FG001|Overall Study|Adverse Event|4|||
147132152|NCT02138825|530652171|FG000|Safety Follow-up|clinic worsening|1|||
147132153|NCT02138825|530652172|FG001|Safety Follow-up|clinic worsening|0|||
147132154|NCT02138825|530652171|FG000|Safety Follow-up|withdrawal by PI|1|||
147132155|NCT02138825|530652172|FG001|Safety Follow-up|withdrawal by PI|0|||
147132156|NCT02138825|530652171|FG000|Safety Follow-up|logistical difficulties|0|||
147132157|NCT02138825|530652172|FG001|Safety Follow-up|logistical difficulties|1|||
147132158|NCT02138825|530652171|FG000|Safety Follow-up|progressive disease|0|||
147132159|NCT02138825|530652172|FG001|Safety Follow-up|progressive disease|2|||
147132160|NCT02138825|530652171|FG000|Safety Follow-up|too unwell to attend the visit|0|||
147132161|NCT02138825|530652172|FG001|Safety Follow-up|too unwell to attend the visit|1|||
147132162|NCT02138825|530652171|FG000|Safety Follow-up|treatment unblinded|0|||
147132163|NCT02138825|530652172|FG001|Safety Follow-up|treatment unblinded|1|||
147132164|NCT02138825|530652171|FG000|Safety Follow-up|withdrawn due to lung transplant|0|||
147132165|NCT02138825|530652172|FG001|Safety Follow-up|withdrawn due to lung transplant|1|||
147132166|NCT05201807|530652175|FG000|Overall Study|Adverse Event|1|||
147132167|NCT05201807|530652175|FG000|Overall Study|COVID-19 Related|1|||
147132168|NCT02367456|530652183|FG000|Overall Study|Death|8|||
147132169|NCT02367456|530652184|FG001|Overall Study|Death|24|||
147132170|NCT02367456|530652185|FG002|Overall Study|Death|17|||
147132171|NCT02367456|530652183|FG000|Overall Study|Lost to Follow-up|1|||
147132172|NCT02367456|530652184|FG001|Overall Study|Lost to Follow-up|3|||
147132173|NCT02367456|530652185|FG002|Overall Study|Lost to Follow-up|1|||
147132174|NCT02367456|530652183|FG000|Overall Study|Other reason|3|||
147132175|NCT02367456|530652184|FG001|Overall Study|Other reason|3|||
147132176|NCT02367456|530652185|FG002|Overall Study|Other reason|9|||
147132177|NCT02367456|530652183|FG000|Overall Study|Study Participation Terminated by Sponsor|0|||
147132178|NCT02367456|530652184|FG001|Overall Study|Study Participation Terminated by Sponsor|0|||
147132179|NCT02367456|530652185|FG002|Overall Study|Study Participation Terminated by Sponsor|3|||
147132180|NCT02862574|530652186|FG000|Double-Blind Treatment Period|Adverse Event|0|||
147132181|NCT02862574|530652187|FG001|Double-Blind Treatment Period|Adverse Event|1|||
147132182|NCT02862574|530652188|FG002|Double-Blind Treatment Period|Adverse Event|0|||
147132183|NCT02862574|530652186|FG000|Double-Blind Treatment Period|Study Terminated by Sponsor|3|||
147132184|NCT02862574|530652187|FG001|Double-Blind Treatment Period|Study Terminated by Sponsor|1|||
147132185|NCT02862574|530652188|FG002|Double-Blind Treatment Period|Study Terminated by Sponsor|4|||
147132186|NCT02862574|530652186|FG000|Open-Label Treatment Period|Study Terminated by Sponsor|2|||
147317757|NCT02500316|531329375|FG000|Overall Study|Lost to Follow-up|2|||
147570708|NCT00415363|532245257|FG000|Overall Study|Lost to Follow-up|2|||
147132187|NCT02862574|530652187|FG001|Open-Label Treatment Period|Study Terminated by Sponsor|3|||
147132188|NCT02862574|530652188|FG002|Open-Label Treatment Period|Study Terminated by Sponsor|1|||
147132189|NCT04573972|530652189|FG000|Overall Study|Dyad partner did not join study or did not walk >0 steps|32|||
147132190|NCT04573972|530652190|FG001|Overall Study|Dyad partner did not join study or did not walk >0 steps|14|||
147132191|NCT03746015|530652193|FG000|Overall Study|Withdrawal of Consent|1|||
147317758|NCT02500316|531329375|FG000|Overall Study|Protocol Violation|1|||
147132192|NCT03746015|530652194|FG001|Overall Study|Withdrawal of Consent|0|||
147132193|NCT03746015|530652195|FG002|Overall Study|Withdrawal of Consent|0|||
147132194|NCT03510273|530652200|FG000|Overall Study|Withdrawal by Subject|2|||
147132195|NCT03510273|530652200|FG000|Overall Study|Care outside study, ineligible to cont.|3|||
147132196|NCT03510273|530652200|FG000|Overall Study|Moved away from study area|4|||
147132197|NCT02589938|530652203|FG000|Overall Study|Withdrawal by Subject|11|||
147132198|NCT02589938|530652204|FG001|Overall Study|Withdrawal by Subject|5|||
147132199|NCT02589938|530652205|FG002|Overall Study|Withdrawal by Subject|6|||
147132200|NCT02589938|530652203|FG000|Overall Study|Lost to Follow-up|3|||
147132201|NCT02589938|530652204|FG001|Overall Study|Lost to Follow-up|3|||
147132202|NCT02589938|530652205|FG002|Overall Study|Lost to Follow-up|3|||
147132203|NCT02589938|530652203|FG000|Overall Study|Death|1|||
147132204|NCT02589938|530652204|FG001|Overall Study|Death|0|||
147132205|NCT02589938|530652205|FG002|Overall Study|Death|1|||
147132206|NCT02589938|530652203|FG000|Overall Study|Protocol Violation|6|||
147132207|NCT02589938|530652204|FG001|Overall Study|Protocol Violation|2|||
147132208|NCT02589938|530652205|FG002|Overall Study|Protocol Violation|3|||
147132209|NCT02589938|530652203|FG000|Overall Study|Physician Decision|1|||
147132210|NCT02589938|530652204|FG001|Overall Study|Physician Decision|0|||
147132211|NCT02589938|530652205|FG002|Overall Study|Physician Decision|0|||
147132212|NCT02589938|530652203|FG000|Overall Study|Other: includes Patient found to be ineligible, distance, no benefit, lost insurance|2|||
147132213|NCT02589938|530652204|FG001|Overall Study|Other: includes Patient found to be ineligible, distance, no benefit, lost insurance|3|||
147132214|NCT02589938|530652205|FG002|Overall Study|Other: includes Patient found to be ineligible, distance, no benefit, lost insurance|4|||
147132215|NCT01121757|530652206|FG000|First Drug|Death|1|||
147132216|NCT01121757|530652207|FG001|First Drug|Death|0|||
147132217|NCT01121757|530652206|FG000|First Drug|Disease Progression|0|||
147132218|NCT01121757|530652207|FG001|First Drug|Disease Progression|2|||
147132219|NCT01121757|530652206|FG000|Combination|Physician Decision|0|||
147132220|NCT01121757|530652207|FG001|Combination|Physician Decision|1|||
147132221|NCT01121757|530652206|FG000|Combination|Disease Progression|2|||
147132222|NCT01121757|530652207|FG001|Combination|Disease Progression|0|||
147132223|NCT04222673|530652208|FG000|Overall Study|Lost to Follow-up|5|||
147132224|NCT03213509|530652212|FG000|Overall Study|Did not consent for verbal autopsy|4|||
147132225|NCT03213509|530652213|FG001|Overall Study|Did not consent for verbal autopsy|5|||
147132226|NCT02297412|530652214|FG000|Overall Study|Canceled|1|||
147132227|NCT02297412|530652215|FG001|Overall Study|Canceled|1|||
147132228|NCT04583618|530652225|FG000|Overall Study|Adverse Event|0|||
147132229|NCT04583618|530652226|FG001|Overall Study|Adverse Event|0|||
147132230|NCT04583618|530652227|FG002|Overall Study|Adverse Event|1|||
147132231|NCT04583618|530652228|FG003|Overall Study|Adverse Event|0|||
147132232|NCT04583618|530652229|FG004|Overall Study|Adverse Event|0|||
147132233|NCT04583618|530652225|FG000|Overall Study|Protocol deviation|1|||
147132234|NCT04583618|530652226|FG001|Overall Study|Protocol deviation|1|||
147132235|NCT04583618|530652227|FG002|Overall Study|Protocol deviation|1|||
147132236|NCT04583618|530652228|FG003|Overall Study|Protocol deviation|0|||
147132237|NCT04583618|530652229|FG004|Overall Study|Protocol deviation|0|||
147132238|NCT04583618|530652225|FG000|Overall Study|Withdrawal by Subject|2|||
147132239|NCT04583618|530652226|FG001|Overall Study|Withdrawal by Subject|1|||
147132240|NCT04583618|530652227|FG002|Overall Study|Withdrawal by Subject|3|||
147132241|NCT04583618|530652228|FG003|Overall Study|Withdrawal by Subject|1|||
147132242|NCT04583618|530652229|FG004|Overall Study|Withdrawal by Subject|1|||
147132243|NCT04583618|530652225|FG000|Overall Study|Lost to Follow-up|0|||
147132244|NCT04583618|530652226|FG001|Overall Study|Lost to Follow-up|1|||
147132245|NCT04583618|530652227|FG002|Overall Study|Lost to Follow-up|3|||
147132246|NCT04583618|530652228|FG003|Overall Study|Lost to Follow-up|1|||
147132247|NCT04583618|530652229|FG004|Overall Study|Lost to Follow-up|1|||
147132248|NCT00016354|530652234|FG000|Overall Study|Lack of Efficacy|0|||
147132249|NCT00016354|530652235|FG001|Overall Study|Lack of Efficacy|0|||
147132250|NCT00016354|530652236|FG002|Overall Study|Lack of Efficacy|0|||
147132251|NCT00016354|530652237|FG003|Overall Study|Lack of Efficacy|0|||
147132252|NCT00016354|530652238|FG004|Overall Study|Lack of Efficacy|0|||
147132253|NCT00016354|530652239|FG005|Overall Study|Lack of Efficacy|0|||
147132254|NCT00016354|530652240|FG006|Overall Study|Lack of Efficacy|0|||
147236897|NCT00347360|531037435|FG010|Overall Study|Abnormal lab values|0|||
147132255|NCT00016354|530652241|FG007|Overall Study|Lack of Efficacy|1|||
147132256|NCT03110562|530652242|FG000|Initial Treatment Period|Disease Progression|1|||
147132257|NCT03110562|530652243|FG001|Initial Treatment Period|Disease Progression|1|||
147132258|NCT03110562|530652244|FG002|Initial Treatment Period|Disease Progression|0|||
147132259|NCT03110562|530652245|FG003|Initial Treatment Period|Disease Progression|0|||
147132260|NCT03110562|530652242|FG000|Initial Treatment Period|Withdrawal by Subject|39|||
147132261|NCT03110562|530652243|FG001|Initial Treatment Period|Withdrawal by Subject|41|||
147132262|NCT03110562|530652244|FG002|Initial Treatment Period|Withdrawal by Subject|0|||
147132263|NCT03110562|530652245|FG003|Initial Treatment Period|Withdrawal by Subject|0|||
147132264|NCT03110562|530652242|FG000|Initial Treatment Period|Adverse Event|1|||
147132265|NCT03110562|530652243|FG001|Initial Treatment Period|Adverse Event|0|||
147236898|NCT00347360|531037436|FG011|Overall Study|Abnormal lab values|0|||
147236899|NCT00347360|531037437|FG012|Overall Study|Abnormal lab values|0|||
147132266|NCT03110562|530652244|FG002|Initial Treatment Period|Adverse Event|0|||
147132267|NCT03110562|530652245|FG003|Initial Treatment Period|Adverse Event|0|||
147132268|NCT03110562|530652242|FG000|Initial Treatment Period|Death|74|||
147132269|NCT03110562|530652243|FG001|Initial Treatment Period|Death|82|||
147132270|NCT03110562|530652244|FG002|Initial Treatment Period|Death|0|||
147132271|NCT03110562|530652245|FG003|Initial Treatment Period|Death|0|||
147132272|NCT03110562|530652242|FG000|Initial Treatment Period|Lost to Follow-up|13|||
147132273|NCT03110562|530652243|FG001|Initial Treatment Period|Lost to Follow-up|8|||
147132274|NCT03110562|530652244|FG002|Initial Treatment Period|Lost to Follow-up|0|||
147132275|NCT03110562|530652245|FG003|Initial Treatment Period|Lost to Follow-up|0|||
147132276|NCT03110562|530652242|FG000|Initial Treatment Period|Protocol Deviation|1|||
147132277|NCT03110562|530652243|FG001|Initial Treatment Period|Protocol Deviation|0|||
147132278|NCT03110562|530652244|FG002|Initial Treatment Period|Protocol Deviation|0|||
147132279|NCT03110562|530652245|FG003|Initial Treatment Period|Protocol Deviation|0|||
147132280|NCT03110562|530652242|FG000|Initial Treatment Period|Physician Decision|2|||
147132281|NCT03110562|530652243|FG001|Initial Treatment Period|Physician Decision|1|||
147132282|NCT03110562|530652244|FG002|Initial Treatment Period|Physician Decision|0|||
147132283|NCT03110562|530652245|FG003|Initial Treatment Period|Physician Decision|0|||
147132284|NCT03110562|530652242|FG000|Initial Treatment Period|Participants withdrawn due to company goals|59|||
147132285|NCT03110562|530652243|FG001|Initial Treatment Period|Participants withdrawn due to company goals|67|||
147132286|NCT03110562|530652244|FG002|Initial Treatment Period|Participants withdrawn due to company goals|0|||
147132287|NCT03110562|530652245|FG003|Initial Treatment Period|Participants withdrawn due to company goals|0|||
147132288|NCT03110562|530652242|FG000|Initial Treatment Period|Other|5|||
147132289|NCT03110562|530652243|FG001|Initial Treatment Period|Other|4|||
147132290|NCT03110562|530652244|FG002|Initial Treatment Period|Other|0|||
147132291|NCT03110562|530652245|FG003|Initial Treatment Period|Other|0|||
147132292|NCT03110562|530652242|FG000|Initial Treatment Period|Randomized but never treated|0|||
147132293|NCT03110562|530652243|FG001|Initial Treatment Period|Randomized but never treated|3|||
147132294|NCT03110562|530652244|FG002|Initial Treatment Period|Randomized but never treated|0|||
147132295|NCT03110562|530652245|FG003|Initial Treatment Period|Randomized but never treated|0|||
147132296|NCT03110562|530652242|FG000|Crossover Period|Disease Progression|0|||
147132297|NCT03110562|530652243|FG001|Crossover Period|Disease Progression|0|||
147132298|NCT03110562|530652244|FG002|Crossover Period|Disease Progression|1|||
147132299|NCT03110562|530652245|FG003|Crossover Period|Disease Progression|0|||
147132300|NCT03110562|530652242|FG000|Crossover Period|Withdrawal by Subject|0|||
147132301|NCT03110562|530652243|FG001|Crossover Period|Withdrawal by Subject|0|||
147132302|NCT03110562|530652244|FG002|Crossover Period|Withdrawal by Subject|8|||
147132303|NCT03110562|530652245|FG003|Crossover Period|Withdrawal by Subject|6|||
147132304|NCT03110562|530652242|FG000|Crossover Period|Death|0|||
147132305|NCT03110562|530652243|FG001|Crossover Period|Death|0|||
147132306|NCT03110562|530652244|FG002|Crossover Period|Death|37|||
147132307|NCT03110562|530652245|FG003|Crossover Period|Death|3|||
147132308|NCT03110562|530652242|FG000|Crossover Period|Lost to Follow-up|0|||
147132309|NCT03110562|530652243|FG001|Crossover Period|Lost to Follow-up|0|||
147132310|NCT03110562|530652244|FG002|Crossover Period|Lost to Follow-up|0|||
147132311|NCT03110562|530652245|FG003|Crossover Period|Lost to Follow-up|1|||
147132312|NCT03110562|530652242|FG000|Crossover Period|Other|0|||
147132313|NCT03110562|530652243|FG001|Crossover Period|Other|0|||
147132314|NCT03110562|530652244|FG002|Crossover Period|Other|1|||
147132315|NCT03110562|530652245|FG003|Crossover Period|Other|1|||
147132316|NCT03110562|530652242|FG000|Crossover Period|Participants withdrawn due to company goals|0|||
147132317|NCT03110562|530652243|FG001|Crossover Period|Participants withdrawn due to company goals|0|||
147132318|NCT03110562|530652244|FG002|Crossover Period|Participants withdrawn due to company goals|19|||
147132319|NCT03110562|530652245|FG003|Crossover Period|Participants withdrawn due to company goals|3|||
147132320|NCT03189719|530652249|FG000|Overall Study|Death|325|||
147651359|NCT03488563|532546448|FG001|Overall Study|Physician Decision|0|||
147651360|NCT03488563|532546449|FG002|Overall Study|Physician Decision|1|||
147132321|NCT03189719|530652250|FG001|Overall Study|Death|361|||
147132322|NCT03189719|530652249|FG000|Overall Study|Physician Decision|1|||
147132323|NCT03189719|530652250|FG001|Overall Study|Physician Decision|0|||
147132324|NCT03189719|530652249|FG000|Overall Study|Sponsor Decision|40|||
147132325|NCT03189719|530652250|FG001|Overall Study|Sponsor Decision|12|||
147132326|NCT03189719|530652249|FG000|Overall Study|Withdrawal by Subject|7|||
147132327|NCT03189719|530652250|FG001|Overall Study|Withdrawal by Subject|3|||
147132328|NCT03012880|530652251|FG000|Overall Study|Withdrawal by Subject|1|||
147132329|NCT03012880|530652252|FG001|Overall Study|Withdrawal by Subject|0|||
147132330|NCT03012880|530652251|FG000|Overall Study|Ineligible|1|||
147317759|NCT02500316|531329375|FG000|Overall Study|Withdrawal by Subject|15|||
147317760|NCT02500316|531329375|FG000|Overall Study|Final height achieved|5|||
147132331|NCT03012880|530652252|FG001|Overall Study|Ineligible|0|||
147132332|NCT01355627|530652253|FG000|Overall Study|Request By the Patient to Discontinue|5|||
147132333|NCT01355627|530652254|FG001|Overall Study|Request By the Patient to Discontinue|7|||
147132334|NCT01355627|530652253|FG000|Overall Study|Lost to Follow-up|8|||
147132335|NCT01355627|530652254|FG001|Overall Study|Lost to Follow-up|7|||
147132336|NCT01355627|530652253|FG000|Overall Study|Fatal Adverse Event|19|||
147132337|NCT01355627|530652254|FG001|Overall Study|Fatal Adverse Event|23|||
147132338|NCT01355627|530652253|FG000|Overall Study|Other|1|||
147132339|NCT01355627|530652254|FG001|Overall Study|Other|1|||
147132340|NCT05239221|530652258|FG000|Overall Study|Adverse Event|0|||
147132341|NCT05239221|530652259|FG001|Overall Study|Adverse Event|0|||
147132342|NCT05239221|530652260|FG002|Overall Study|Adverse Event|0|||
147132343|NCT05239221|530652261|FG003|Overall Study|Adverse Event|0|||
147132344|NCT05239221|530652262|FG004|Overall Study|Adverse Event|0|||
147132345|NCT05239221|530652263|FG005|Overall Study|Adverse Event|0|||
147132346|NCT05239221|530652264|FG006|Overall Study|Adverse Event|1|||
147132347|NCT05239221|530652265|FG007|Overall Study|Adverse Event|0|||
147132348|NCT05239221|530652266|FG008|Overall Study|Adverse Event|0|||
147132349|NCT05239221|530652267|FG009|Overall Study|Adverse Event|0|||
147132350|NCT05239221|530652268|FG010|Overall Study|Adverse Event|1|||
147132351|NCT05239221|530652269|FG011|Overall Study|Adverse Event|1|||
147132352|NCT05239221|530652270|FG012|Overall Study|Adverse Event|0|||
147132353|NCT05239221|530652271|FG013|Overall Study|Adverse Event|0|||
147132354|NCT05239221|530652272|FG014|Overall Study|Adverse Event|0|||
147132355|NCT05239221|530652273|FG015|Overall Study|Adverse Event|0|||
147132356|NCT05239221|530652258|FG000|Overall Study|Withdrawal by Subject|0|||
147132357|NCT05239221|530652259|FG001|Overall Study|Withdrawal by Subject|0|||
147132358|NCT05239221|530652260|FG002|Overall Study|Withdrawal by Subject|0|||
147132359|NCT05239221|530652261|FG003|Overall Study|Withdrawal by Subject|0|||
147132360|NCT05239221|530652262|FG004|Overall Study|Withdrawal by Subject|0|||
147132361|NCT05239221|530652263|FG005|Overall Study|Withdrawal by Subject|0|||
147132362|NCT05239221|530652264|FG006|Overall Study|Withdrawal by Subject|0|||
147132363|NCT05239221|530652265|FG007|Overall Study|Withdrawal by Subject|0|||
147132364|NCT05239221|530652266|FG008|Overall Study|Withdrawal by Subject|0|||
147132365|NCT05239221|530652267|FG009|Overall Study|Withdrawal by Subject|0|||
147132366|NCT05239221|530652268|FG010|Overall Study|Withdrawal by Subject|1|||
147132367|NCT05239221|530652269|FG011|Overall Study|Withdrawal by Subject|0|||
147132368|NCT05239221|530652270|FG012|Overall Study|Withdrawal by Subject|0|||
147132369|NCT05239221|530652271|FG013|Overall Study|Withdrawal by Subject|0|||
147132370|NCT05239221|530652272|FG014|Overall Study|Withdrawal by Subject|0|||
147132371|NCT05239221|530652273|FG015|Overall Study|Withdrawal by Subject|1|||
147132372|NCT02581930|530652274|FG000|Overall Study|Withdrawal by Subject|1|||
147132373|NCT02581930|530652274|FG000|Overall Study|patient declined further treatment|1|||
147132374|NCT01400412|530652275|FG000|Overall Study|Lost to Follow-up|4|||
147132375|NCT01400412|530652276|FG001|Overall Study|Lost to Follow-up|7|||
147132376|NCT01400412|530652275|FG000|Overall Study|Withdrawal by Subject|3|||
147132377|NCT01400412|530652276|FG001|Overall Study|Withdrawal by Subject|4|||
147132378|NCT01400412|530652275|FG000|Overall Study|Unable to complete|3|||
147132379|NCT01400412|530652276|FG001|Overall Study|Unable to complete|3|||
147132380|NCT01400412|530652275|FG000|Overall Study|Never started study treatment|0|||
147132381|NCT01400412|530652276|FG001|Overall Study|Never started study treatment|3|||
147132382|NCT04043286|530654537|FG000|Overall Study|Withdrawal by Subject|2|||
147132383|NCT04043286|530654538|FG001|Overall Study|Withdrawal by Subject|2|||
147132384|NCT00805389|530654539|FG000|Overall Study|Adverse Event|0|||
147132385|NCT00805389|530654540|FG001|Overall Study|Adverse Event|0|||
147132386|NCT00805389|530654541|FG002|Overall Study|Adverse Event|1|||
147132387|NCT00805389|530654542|FG003|Overall Study|Adverse Event|2|||
147132388|NCT00805389|530654543|FG004|Overall Study|Adverse Event|0|||
147132389|NCT00805389|530654539|FG000|Overall Study|Lost to Follow-up|4|||
147132390|NCT00805389|530654540|FG001|Overall Study|Lost to Follow-up|3|||
147132391|NCT00805389|530654541|FG002|Overall Study|Lost to Follow-up|6|||
147132392|NCT00805389|530654542|FG003|Overall Study|Lost to Follow-up|10|||
147132393|NCT00805389|530654543|FG004|Overall Study|Lost to Follow-up|9|||
147651361|NCT03488563|532546447|FG000|Overall Study|Protocol Violation|3|||
147651362|NCT03488563|532546448|FG001|Overall Study|Protocol Violation|2|||
147651363|NCT03488563|532546449|FG002|Overall Study|Protocol Violation|6|||
147132394|NCT00805389|530654539|FG000|Overall Study|Protocol Violation|0|||
147132395|NCT00805389|530654540|FG001|Overall Study|Protocol Violation|0|||
147132396|NCT00805389|530654541|FG002|Overall Study|Protocol Violation|1|||
147132397|NCT00805389|530654542|FG003|Overall Study|Protocol Violation|0|||
147132398|NCT00805389|530654543|FG004|Overall Study|Protocol Violation|0|||
147132399|NCT00805389|530654539|FG000|Overall Study|Withdrawal by Subject|3|||
147132400|NCT00805389|530654540|FG001|Overall Study|Withdrawal by Subject|2|||
147132401|NCT00805389|530654541|FG002|Overall Study|Withdrawal by Subject|4|||
147132402|NCT00805389|530654542|FG003|Overall Study|Withdrawal by Subject|5|||
147132403|NCT00805389|530654543|FG004|Overall Study|Withdrawal by Subject|4|||
147132404|NCT03698279|530654544|FG000|Overall Study|Withdrawal by parent/guardian|1|||
147132405|NCT03698279|530654545|FG001|Overall Study|Withdrawal by parent/guardian|1|||
147132406|NCT03698279|530654546|FG002|Overall Study|Withdrawal by parent/guardian|1|||
147132407|NCT03698279|530654547|FG003|Overall Study|Withdrawal by parent/guardian|1|||
147132408|NCT03698279|530654548|FG004|Overall Study|Withdrawal by parent/guardian|0|||
147132409|NCT03698279|530654549|FG005|Overall Study|Withdrawal by parent/guardian|0|||
147132410|NCT03698279|530654544|FG000|Overall Study|Protocol deviation|1|||
147132411|NCT03698279|530654545|FG001|Overall Study|Protocol deviation|0|||
147132412|NCT03698279|530654546|FG002|Overall Study|Protocol deviation|1|||
147132413|NCT03698279|530654547|FG003|Overall Study|Protocol deviation|0|||
147132414|NCT03698279|530654548|FG004|Overall Study|Protocol deviation|0|||
147132415|NCT03698279|530654549|FG005|Overall Study|Protocol deviation|0|||
147132416|NCT03698279|530654544|FG000|Overall Study|Withdrawal by Subject|0|||
147132417|NCT03698279|530654545|FG001|Overall Study|Withdrawal by Subject|0|||
147132418|NCT03698279|530654546|FG002|Overall Study|Withdrawal by Subject|1|||
147132419|NCT03698279|530654547|FG003|Overall Study|Withdrawal by Subject|0|||
147132420|NCT03698279|530654548|FG004|Overall Study|Withdrawal by Subject|0|||
147132421|NCT03698279|530654549|FG005|Overall Study|Withdrawal by Subject|0|||
147132422|NCT03698279|530654544|FG000|Overall Study|Lost to Follow-up|3|||
147132423|NCT03698279|530654545|FG001|Overall Study|Lost to Follow-up|1|||
147132424|NCT03698279|530654546|FG002|Overall Study|Lost to Follow-up|4|||
147132425|NCT03698279|530654547|FG003|Overall Study|Lost to Follow-up|5|||
147132426|NCT03698279|530654548|FG004|Overall Study|Lost to Follow-up|0|||
147132427|NCT03698279|530654549|FG005|Overall Study|Lost to Follow-up|0|||
147132428|NCT04388826|530654551|FG000|Overall Study|Lost to Follow-up|3|||
147132429|NCT04388826|530654552|FG001|Overall Study|Lost to Follow-up|2|||
147132430|NCT04388826|530654551|FG000|Overall Study|Adverse Event|1|||
147132431|NCT04388826|530654552|FG001|Overall Study|Adverse Event|0|||
147132432|NCT04047446|530654553|FG000|Overall Study|Physician Decision|1|||
147132433|NCT04047446|530654554|FG001|Overall Study|Physician Decision|0|||
147132434|NCT00329420|530654555|FG000|Re-induction Phase|Lack of Efficacy|0|||
147132435|NCT00329420|530654556|FG001|Re-induction Phase|Lack of Efficacy|1|||
147132436|NCT00329420|530654557|FG002|Re-induction Phase|Lack of Efficacy|0|||
147132437|NCT00329420|530654555|FG000|Re-induction Phase|Withdrawal of Consent|0|||
147132438|NCT00329420|530654556|FG001|Re-induction Phase|Withdrawal of Consent|0|||
147132439|NCT00329420|530654557|FG002|Re-induction Phase|Withdrawal of Consent|1|||
147132440|NCT00329420|530654555|FG000|Re-induction Phase|Did not respond to re-induction|6|||
147132441|NCT00329420|530654556|FG001|Re-induction Phase|Did not respond to re-induction|5|||
147132442|NCT00329420|530654557|FG002|Re-induction Phase|Did not respond to re-induction|7|||
147132443|NCT00329420|530654555|FG000|4-weekly Dosing Phase (Responders Only)|Adverse Event|2|||
147132444|NCT00329420|530654556|FG001|4-weekly Dosing Phase (Responders Only)|Adverse Event|1|||
147132445|NCT00329420|530654557|FG002|4-weekly Dosing Phase (Responders Only)|Adverse Event|1|||
147132446|NCT00329420|530654555|FG000|4-weekly Dosing Phase (Responders Only)|Lack of Efficacy|1|||
147132447|NCT00329420|530654556|FG001|4-weekly Dosing Phase (Responders Only)|Lack of Efficacy|1|||
147132448|NCT00329420|530654557|FG002|4-weekly Dosing Phase (Responders Only)|Lack of Efficacy|0|||
147132449|NCT00329420|530654555|FG000|4-weekly Dosing Phase (Responders Only)|Withdrawal of Consent|1|||
147236900|NCT00347360|531037438|FG013|Overall Study|Abnormal lab values|0|||
147236901|NCT00347360|531037439|FG014|Overall Study|Abnormal lab values|0|||
147236902|NCT00347360|531037425|FG000|Overall Study|PI recommended early withdrawal|0|||
147236903|NCT00347360|531037426|FG001|Overall Study|PI recommended early withdrawal|0|||
147236904|NCT00347360|531037427|FG002|Overall Study|PI recommended early withdrawal|0|||
147236905|NCT00347360|531037428|FG003|Overall Study|PI recommended early withdrawal|0|||
147236906|NCT00347360|531037429|FG004|Overall Study|PI recommended early withdrawal|0|||
147236907|NCT00347360|531037430|FG005|Overall Study|PI recommended early withdrawal|0|||
147236908|NCT00347360|531037431|FG006|Overall Study|PI recommended early withdrawal|0|||
147236909|NCT00347360|531037432|FG007|Overall Study|PI recommended early withdrawal|0|||
147236910|NCT00347360|531037433|FG008|Overall Study|PI recommended early withdrawal|0|||
147236911|NCT00347360|531037434|FG009|Overall Study|PI recommended early withdrawal|1|||
147236912|NCT00347360|531037435|FG010|Overall Study|PI recommended early withdrawal|0|||
147236913|NCT00347360|531037436|FG011|Overall Study|PI recommended early withdrawal|0|||
147236914|NCT00347360|531037437|FG012|Overall Study|PI recommended early withdrawal|0|||
147236915|NCT00347360|531037438|FG013|Overall Study|PI recommended early withdrawal|0|||
147236916|NCT00347360|531037439|FG014|Overall Study|PI recommended early withdrawal|0|||
147236917|NCT00347360|531037425|FG000|Overall Study|Did not meet criteria before ABPM|0|||
147236918|NCT00347360|531037426|FG001|Overall Study|Did not meet criteria before ABPM|0|||
147236919|NCT00347360|531037427|FG002|Overall Study|Did not meet criteria before ABPM|0|||
147236920|NCT00347360|531037428|FG003|Overall Study|Did not meet criteria before ABPM|0|||
147236921|NCT00347360|531037429|FG004|Overall Study|Did not meet criteria before ABPM|0|||
147236922|NCT00347360|531037430|FG005|Overall Study|Did not meet criteria before ABPM|0|||
147236923|NCT00347360|531037431|FG006|Overall Study|Did not meet criteria before ABPM|0|||
147236924|NCT00347360|531037432|FG007|Overall Study|Did not meet criteria before ABPM|0|||
147236925|NCT00347360|531037433|FG008|Overall Study|Did not meet criteria before ABPM|0|||
147236926|NCT00347360|531037434|FG009|Overall Study|Did not meet criteria before ABPM|0|||
147236927|NCT00347360|531037435|FG010|Overall Study|Did not meet criteria before ABPM|1|||
147132450|NCT00329420|530654556|FG001|4-weekly Dosing Phase (Responders Only)|Withdrawal of Consent|0|||
147132451|NCT00329420|530654557|FG002|4-weekly Dosing Phase (Responders Only)|Withdrawal of Consent|0|||
147132452|NCT00892008|530654560|FG000|Overall Study|Death|5|||
147132453|NCT00892008|530654560|FG000|Overall Study|Lack of Efficacy|3|||
147132454|NCT00892008|530654560|FG000|Overall Study|Lost to Follow-up|142|||
147651364|NCT03488563|532546447|FG000|Overall Study|Subject did not meet minimum number of migraines per month|1|||
147132455|NCT00892008|530654560|FG000|Overall Study|Other|378|||
147132456|NCT00892008|530654560|FG000|Overall Study|Adverse Event|37|||
147132457|NCT02410772|530654564|FG000|Overall Study|Death|3|||
147132458|NCT02410772|530654565|FG001|Overall Study|Death|4|||
147132459|NCT02410772|530654566|FG002|Overall Study|Death|8|||
147132460|NCT02410772|530654564|FG000|Overall Study|Lost to Follow-up|31|||
147132461|NCT02410772|530654565|FG001|Overall Study|Lost to Follow-up|23|||
147132462|NCT02410772|530654566|FG002|Overall Study|Lost to Follow-up|22|||
147132463|NCT02410772|530654564|FG000|Overall Study|Pregnancy|8|||
147132464|NCT02410772|530654565|FG001|Overall Study|Pregnancy|4|||
147132465|NCT02410772|530654566|FG002|Overall Study|Pregnancy|5|||
147132466|NCT02410772|530654564|FG000|Overall Study|Protocol Violation|8|||
147132467|NCT02410772|530654565|FG001|Overall Study|Protocol Violation|8|||
147132468|NCT02410772|530654566|FG002|Overall Study|Protocol Violation|4|||
147132469|NCT02410772|530654564|FG000|Overall Study|Baseline Drug Resistance|49|||
147132470|NCT02410772|530654565|FG001|Overall Study|Baseline Drug Resistance|40|||
147132471|NCT02410772|530654566|FG002|Overall Study|Baseline Drug Resistance|51|||
147132472|NCT02410772|530654564|FG000|Overall Study|No positive Mycobacterium tuberculosis culture|4|||
147132473|NCT02410772|530654565|FG001|Overall Study|No positive Mycobacterium tuberculosis culture|6|||
147132474|NCT02410772|530654566|FG002|Overall Study|No positive Mycobacterium tuberculosis culture|3|||
147132475|NCT02410772|530654564|FG000|Overall Study|Reinfection with a new strain of MTB|0|||
147132476|NCT02410772|530654565|FG001|Overall Study|Reinfection with a new strain of MTB|1|||
147132477|NCT02410772|530654566|FG002|Overall Study|Reinfection with a new strain of MTB|0|||
147132478|NCT05067335|530654571|FG000|Double-blind Period: Day 1 - Month 6|Adverse Event|1|||
147132479|NCT05067335|530654572|FG001|Double-blind Period: Day 1 - Month 6|Adverse Event|2|||
147132480|NCT05067335|530654573|FG002|Double-blind Period: Day 1 - Month 6|Adverse Event|0|||
147132481|NCT05067335|530654574|FG003|Double-blind Period: Day 1 - Month 6|Adverse Event|0|||
147132482|NCT05067335|530654571|FG000|Double-blind Period: Day 1 - Month 6|Protocol Violation|1|||
147132483|NCT05067335|530654572|FG001|Double-blind Period: Day 1 - Month 6|Protocol Violation|1|||
147132484|NCT05067335|530654573|FG002|Double-blind Period: Day 1 - Month 6|Protocol Violation|0|||
147132485|NCT05067335|530654574|FG003|Double-blind Period: Day 1 - Month 6|Protocol Violation|0|||
147132486|NCT05067335|530654571|FG000|Double-blind Period: Day 1 - Month 6|Withdrawal by Subject|6|||
147132487|NCT05067335|530654572|FG001|Double-blind Period: Day 1 - Month 6|Withdrawal by Subject|10|||
147132488|NCT05067335|530654573|FG002|Double-blind Period: Day 1 - Month 6|Withdrawal by Subject|0|||
147132489|NCT05067335|530654574|FG003|Double-blind Period: Day 1 - Month 6|Withdrawal by Subject|0|||
147132490|NCT05067335|530654571|FG000|Double-blind Period: Day 1 - Month 6|Patient Voluntary Withdrawal|1|||
147132491|NCT05067335|530654572|FG001|Double-blind Period: Day 1 - Month 6|Patient Voluntary Withdrawal|0|||
147132492|NCT05067335|530654573|FG002|Double-blind Period: Day 1 - Month 6|Patient Voluntary Withdrawal|0|||
147132493|NCT05067335|530654574|FG003|Double-blind Period: Day 1 - Month 6|Patient Voluntary Withdrawal|0|||
147132494|NCT05067335|530654571|FG000|Double-blind Period: Day 1 - Month 6|The Patient Withdrew Early Due To Their Own Reasons|0|||
147132495|NCT05067335|530654572|FG001|Double-blind Period: Day 1 - Month 6|The Patient Withdrew Early Due To Their Own Reasons|1|||
147132496|NCT05067335|530654573|FG002|Double-blind Period: Day 1 - Month 6|The Patient Withdrew Early Due To Their Own Reasons|0|||
147236928|NCT00347360|531037436|FG011|Overall Study|Did not meet criteria before ABPM|0|||
147236929|NCT00347360|531037437|FG012|Overall Study|Did not meet criteria before ABPM|0|||
147236930|NCT00347360|531037438|FG013|Overall Study|Did not meet criteria before ABPM|0|||
147236931|NCT00347360|531037439|FG014|Overall Study|Did not meet criteria before ABPM|0|||
147236932|NCT00347360|531037425|FG000|Overall Study|Randomized in error|0|||
147236933|NCT00347360|531037426|FG001|Overall Study|Randomized in error|0|||
147236934|NCT00347360|531037427|FG002|Overall Study|Randomized in error|0|||
147236935|NCT00347360|531037428|FG003|Overall Study|Randomized in error|0|||
147236936|NCT00347360|531037429|FG004|Overall Study|Randomized in error|0|||
147236937|NCT00347360|531037430|FG005|Overall Study|Randomized in error|0|||
147236938|NCT00347360|531037431|FG006|Overall Study|Randomized in error|0|||
147236939|NCT00347360|531037432|FG007|Overall Study|Randomized in error|0|||
147236940|NCT00347360|531037433|FG008|Overall Study|Randomized in error|0|||
147236941|NCT00347360|531037434|FG009|Overall Study|Randomized in error|0|||
147236942|NCT00347360|531037435|FG010|Overall Study|Randomized in error|0|||
147236943|NCT00347360|531037436|FG011|Overall Study|Randomized in error|1|||
147236944|NCT00347360|531037437|FG012|Overall Study|Randomized in error|0|||
147236945|NCT00347360|531037438|FG013|Overall Study|Randomized in error|0|||
147236946|NCT00347360|531037439|FG014|Overall Study|Randomized in error|0|||
147236947|NCT00347360|531037425|FG000|Overall Study|Failed inclusion criteria #4|0|||
147236948|NCT00347360|531037426|FG001|Overall Study|Failed inclusion criteria #4|0|||
147132497|NCT05067335|530654574|FG003|Double-blind Period: Day 1 - Month 6|The Patient Withdrew Early Due To Their Own Reasons|0|||
147236949|NCT00347360|531037427|FG002|Overall Study|Failed inclusion criteria #4|0|||
147236950|NCT00347360|531037428|FG003|Overall Study|Failed inclusion criteria #4|0|||
147236951|NCT00347360|531037429|FG004|Overall Study|Failed inclusion criteria #4|0|||
147236952|NCT00347360|531037430|FG005|Overall Study|Failed inclusion criteria #4|0|||
147236953|NCT00347360|531037431|FG006|Overall Study|Failed inclusion criteria #4|0|||
147236954|NCT00347360|531037432|FG007|Overall Study|Failed inclusion criteria #4|0|||
147132498|NCT05067335|530654571|FG000|Open-label Period: Month 7 - 12|Adverse Event|0|||
147132499|NCT05067335|530654572|FG001|Open-label Period: Month 7 - 12|Adverse Event|0|||
147132500|NCT05067335|530654573|FG002|Open-label Period: Month 7 - 12|Adverse Event|3|||
147132501|NCT05067335|530654574|FG003|Open-label Period: Month 7 - 12|Adverse Event|2|||
147132502|NCT05067335|530654571|FG000|Open-label Period: Month 7 - 12|Lost to Follow-up|0|||
147132503|NCT05067335|530654572|FG001|Open-label Period: Month 7 - 12|Lost to Follow-up|0|||
147132504|NCT05067335|530654573|FG002|Open-label Period: Month 7 - 12|Lost to Follow-up|1|||
147132505|NCT05067335|530654574|FG003|Open-label Period: Month 7 - 12|Lost to Follow-up|0|||
147132506|NCT05067335|530654571|FG000|Open-label Period: Month 7 - 12|Withdrawal by Subject|0|||
147132507|NCT05067335|530654572|FG001|Open-label Period: Month 7 - 12|Withdrawal by Subject|0|||
147132508|NCT05067335|530654573|FG002|Open-label Period: Month 7 - 12|Withdrawal by Subject|0|||
147132509|NCT05067335|530654574|FG003|Open-label Period: Month 7 - 12|Withdrawal by Subject|3|||
147132510|NCT05067335|530654571|FG000|Open-label Period: Month 7 - 12|Subject Was Unable To Comply With Study Procedures Due To Prolonged Withdrawal From Medication|0|||
147132511|NCT05067335|530654572|FG001|Open-label Period: Month 7 - 12|Subject Was Unable To Comply With Study Procedures Due To Prolonged Withdrawal From Medication|0|||
147132512|NCT05067335|530654573|FG002|Open-label Period: Month 7 - 12|Subject Was Unable To Comply With Study Procedures Due To Prolonged Withdrawal From Medication|1|||
147132513|NCT05067335|530654574|FG003|Open-label Period: Month 7 - 12|Subject Was Unable To Comply With Study Procedures Due To Prolonged Withdrawal From Medication|0|||
147132514|NCT05067335|530654571|FG000|Open-label Period: Month 7 - 12|Did not receive Open-label IMP at Month 6 and then discontinued|0|||
147132515|NCT05067335|530654572|FG001|Open-label Period: Month 7 - 12|Did not receive Open-label IMP at Month 6 and then discontinued|0|||
147132516|NCT05067335|530654573|FG002|Open-label Period: Month 7 - 12|Did not receive Open-label IMP at Month 6 and then discontinued|1|||
147132517|NCT05067335|530654574|FG003|Open-label Period: Month 7 - 12|Did not receive Open-label IMP at Month 6 and then discontinued|0|||
147132518|NCT02724839|530654575|FG000|Overall Study|Withdrawal by Subject|1|||
147132519|NCT02724839|530654576|FG001|Overall Study|Withdrawal by Subject|1|||
147132520|NCT02724839|530654577|FG002|Overall Study|Withdrawal by Subject|0|||
147132521|NCT02724839|530654575|FG000|Overall Study|Lost to Follow-up|0|||
147132522|NCT02724839|530654576|FG001|Overall Study|Lost to Follow-up|3|||
147132523|NCT02724839|530654577|FG002|Overall Study|Lost to Follow-up|2|||
147132524|NCT02724839|530654575|FG000|Overall Study|Physician Decision|0|||
147132525|NCT02724839|530654576|FG001|Overall Study|Physician Decision|0|||
147132526|NCT02724839|530654577|FG002|Overall Study|Physician Decision|3|||
147132527|NCT01645176|530654579|FG000|Overall Study|Lack of Efficacy|4|||
147132528|NCT01645176|530654579|FG000|Overall Study|did not complete final MRI|1|||
147132529|NCT05878067|530654580|FG000|Overall Study|Lost to Follow-up|2|||
147132530|NCT00949533|530654583|FG000|Overall Study|Lost to Follow-up|0|||
147132531|NCT00949533|530654584|FG001|Overall Study|Lost to Follow-up|1|||
147132532|NCT01198587|530654587|FG000|Overall Study|Lost to Follow-up|8|||
147132533|NCT01198587|530654588|FG001|Overall Study|Lost to Follow-up|0|||
147132534|NCT01198587|530654589|FG002|Overall Study|Lost to Follow-up|9|||
147132535|NCT01198587|530654590|FG003|Overall Study|Lost to Follow-up|0|||
147132536|NCT01493089|530654591|FG000|Overall Study|Protocol Violation|2|||
147132537|NCT01493089|530654592|FG001|Overall Study|Protocol Violation|2|||
147132538|NCT01493089|530654591|FG000|Overall Study|Withdrawal by Subject|1|||
147132539|NCT01493089|530654592|FG001|Overall Study|Withdrawal by Subject|0|||
147132540|NCT01493089|530654591|FG000|Overall Study|Physician Decision|0|||
147132541|NCT01493089|530654592|FG001|Overall Study|Physician Decision|1|||
147132542|NCT02234362|530654593|FG000|Overall Study|Not eligible after first screening visit|17|||
147132543|NCT02234362|530654593|FG000|Overall Study|Lost to Follow-up|6|||
147132544|NCT02234362|530654593|FG000|Overall Study|Withdrawal by Subject|3|||
147132545|NCT00560417|530654601|FG000|Overall Study|Adverse Event|3|||
147132546|NCT00560417|530654602|FG001|Overall Study|Adverse Event|2|||
147132547|NCT00560417|530654601|FG000|Overall Study|Entry Criteria Not Met|1|||
147132548|NCT00560417|530654602|FG001|Overall Study|Entry Criteria Not Met|0|||
147132549|NCT00560417|530654601|FG000|Overall Study|Lost to Follow-up|0|||
147132550|NCT00560417|530654602|FG001|Overall Study|Lost to Follow-up|1|||
147132551|NCT00560417|530654601|FG000|Overall Study|Physician Decision|2|||
147132552|NCT00560417|530654602|FG001|Overall Study|Physician Decision|6|||
147132553|NCT00560417|530654601|FG000|Overall Study|Protocol Violation|6|||
147132554|NCT00560417|530654602|FG001|Overall Study|Protocol Violation|5|||
147132555|NCT00560417|530654601|FG000|Overall Study|Sponsor Decision|2|||
147132556|NCT00560417|530654602|FG001|Overall Study|Sponsor Decision|0|||
147132557|NCT00560417|530654601|FG000|Overall Study|Withdrawal by Subject|3|||
147132558|NCT00560417|530654602|FG001|Overall Study|Withdrawal by Subject|3|||
147570709|NCT00415363|532245258|FG001|Overall Study|Lost to Follow-up|1|||
147132559|NCT01870869|530654605|FG000|Overall Study|Implanted with nonstudy device|1|||
147132560|NCT01870869|530654606|FG001|Overall Study|Implanted with nonstudy device|3|||
147570710|NCT00415363|532245257|FG000|Overall Study|Physician Decision|3|||
147132561|NCT01870869|530654607|FG002|Overall Study|Implanted with nonstudy device|14|||
147132562|NCT01870869|530654608|FG003|Overall Study|Implanted with nonstudy device|4|||
147132563|NCT01870869|530654605|FG000|Overall Study|Death|0|||
147236955|NCT00347360|531037433|FG008|Overall Study|Failed inclusion criteria #4|0|||
147236956|NCT00347360|531037434|FG009|Overall Study|Failed inclusion criteria #4|0|||
147570711|NCT00415363|532245258|FG001|Overall Study|Physician Decision|1|||
147132564|NCT01870869|530654606|FG001|Overall Study|Death|0|||
147132565|NCT01870869|530654607|FG002|Overall Study|Death|7|||
147132566|NCT01870869|530654608|FG003|Overall Study|Death|1|||
147132567|NCT01870869|530654605|FG000|Overall Study|Subject choice|6|||
147132568|NCT01870869|530654606|FG001|Overall Study|Subject choice|2|||
147132569|NCT01870869|530654607|FG002|Overall Study|Subject choice|22|||
147132570|NCT01870869|530654608|FG003|Overall Study|Subject choice|8|||
147132571|NCT01870869|530654605|FG000|Overall Study|Lost to Follow-up|10|||
147132572|NCT01870869|530654606|FG001|Overall Study|Lost to Follow-up|2|||
147132573|NCT01870869|530654607|FG002|Overall Study|Lost to Follow-up|25|||
147132574|NCT01870869|530654608|FG003|Overall Study|Lost to Follow-up|3|||
147132575|NCT01870869|530654605|FG000|Overall Study|Reason not Specified|1|||
147132576|NCT01870869|530654606|FG001|Overall Study|Reason not Specified|2|||
147132577|NCT01870869|530654607|FG002|Overall Study|Reason not Specified|20|||
147132578|NCT01870869|530654608|FG003|Overall Study|Reason not Specified|4|||
147132579|NCT01870869|530654605|FG000|Overall Study|Not evaluable|10|||
147132580|NCT01870869|530654606|FG001|Overall Study|Not evaluable|5|||
147132581|NCT01870869|530654607|FG002|Overall Study|Not evaluable|42|||
147132582|NCT01870869|530654608|FG003|Overall Study|Not evaluable|10|||
147132583|NCT00557193|530654609|FG000|Induction|Adverse Event|2|||
147132584|NCT00557193|530654610|FG001|Induction|Adverse Event|0|||
147132585|NCT00557193|530654611|FG002|Induction|Adverse Event|0|||
147132586|NCT00557193|530654612|FG003|Induction|Adverse Event|0|||
147132587|NCT00557193|530654613|FG004|Induction|Adverse Event|0|||
147132588|NCT00557193|530654614|FG005|Induction|Adverse Event|0|||
147132589|NCT00557193|530654609|FG000|Induction|Death|6|||
147132590|NCT00557193|530654610|FG001|Induction|Death|0|||
147132591|NCT00557193|530654611|FG002|Induction|Death|0|||
147132592|NCT00557193|530654612|FG003|Induction|Death|0|||
147132593|NCT00557193|530654613|FG004|Induction|Death|0|||
147132594|NCT00557193|530654614|FG005|Induction|Death|0|||
147132595|NCT00557193|530654609|FG000|Induction|Physician Decision|3|||
147132596|NCT00557193|530654610|FG001|Induction|Physician Decision|0|||
147132597|NCT00557193|530654611|FG002|Induction|Physician Decision|0|||
147132598|NCT00557193|530654612|FG003|Induction|Physician Decision|0|||
147132599|NCT00557193|530654613|FG004|Induction|Physician Decision|0|||
147132600|NCT00557193|530654614|FG005|Induction|Physician Decision|0|||
147132601|NCT00557193|530654609|FG000|Induction|Withdrawal by Subject|1|||
147132602|NCT00557193|530654610|FG001|Induction|Withdrawal by Subject|0|||
147132603|NCT00557193|530654611|FG002|Induction|Withdrawal by Subject|0|||
147132604|NCT00557193|530654612|FG003|Induction|Withdrawal by Subject|0|||
147132605|NCT00557193|530654613|FG004|Induction|Withdrawal by Subject|0|||
147132606|NCT00557193|530654614|FG005|Induction|Withdrawal by Subject|0|||
147132607|NCT00557193|530654609|FG000|Induction|Refusal of Further Protocol Therapy|2|||
147132608|NCT00557193|530654610|FG001|Induction|Refusal of Further Protocol Therapy|0|||
147132609|NCT00557193|530654611|FG002|Induction|Refusal of Further Protocol Therapy|0|||
147132610|NCT00557193|530654612|FG003|Induction|Refusal of Further Protocol Therapy|0|||
147132611|NCT00557193|530654613|FG004|Induction|Refusal of Further Protocol Therapy|0|||
147132612|NCT00557193|530654614|FG005|Induction|Refusal of Further Protocol Therapy|0|||
147132613|NCT00557193|530654609|FG000|Induction|Ineligible|8|||
147132614|NCT00557193|530654610|FG001|Induction|Ineligible|0|||
147132615|NCT00557193|530654611|FG002|Induction|Ineligible|0|||
147132616|NCT00557193|530654612|FG003|Induction|Ineligible|0|||
147132617|NCT00557193|530654613|FG004|Induction|Ineligible|0|||
147132618|NCT00557193|530654614|FG005|Induction|Ineligible|0|||
147132619|NCT00557193|530654609|FG000|Induction|Inevaluable for post Induction|2|||
147132620|NCT00557193|530654610|FG001|Induction|Inevaluable for post Induction|0|||
147132621|NCT00557193|530654611|FG002|Induction|Inevaluable for post Induction|0|||
147132622|NCT00557193|530654612|FG003|Induction|Inevaluable for post Induction|0|||
147132623|NCT00557193|530654613|FG004|Induction|Inevaluable for post Induction|0|||
147132624|NCT00557193|530654614|FG005|Induction|Inevaluable for post Induction|0|||
147132625|NCT00557193|530654609|FG000|Induction|Unable to receive Lestaurtinib-Not in US|2|||
147132626|NCT00557193|530654610|FG001|Induction|Unable to receive Lestaurtinib-Not in US|0|||
147132627|NCT00557193|530654611|FG002|Induction|Unable to receive Lestaurtinib-Not in US|0|||
147132628|NCT00557193|530654612|FG003|Induction|Unable to receive Lestaurtinib-Not in US|0|||
147132629|NCT00557193|530654613|FG004|Induction|Unable to receive Lestaurtinib-Not in US|0|||
147236957|NCT00347360|531037435|FG010|Overall Study|Failed inclusion criteria #4|0|||
147236958|NCT00347360|531037436|FG011|Overall Study|Failed inclusion criteria #4|1|||
147132630|NCT00557193|530654614|FG005|Induction|Unable to receive Lestaurtinib-Not in US|0|||
147132631|NCT00557193|530654609|FG000|Post Induction Therapy by Tx Assignment|Adverse Event|0|||
147132632|NCT00557193|530654610|FG001|Post Induction Therapy by Tx Assignment|Adverse Event|1|||
147132633|NCT00557193|530654611|FG002|Post Induction Therapy by Tx Assignment|Adverse Event|2|||
147132634|NCT00557193|530654612|FG003|Post Induction Therapy by Tx Assignment|Adverse Event|1|||
147132635|NCT00557193|530654613|FG004|Post Induction Therapy by Tx Assignment|Adverse Event|0|||
147132636|NCT00557193|530654614|FG005|Post Induction Therapy by Tx Assignment|Adverse Event|3|||
147132637|NCT00557193|530654609|FG000|Post Induction Therapy by Tx Assignment|Death|0|||
147132638|NCT00557193|530654610|FG001|Post Induction Therapy by Tx Assignment|Death|0|||
147132639|NCT00557193|530654611|FG002|Post Induction Therapy by Tx Assignment|Death|2|||
147570712|NCT00415363|532245257|FG000|Overall Study|Death|16|||
147132640|NCT00557193|530654612|FG003|Post Induction Therapy by Tx Assignment|Death|0|||
147132641|NCT00557193|530654613|FG004|Post Induction Therapy by Tx Assignment|Death|2|||
147132642|NCT00557193|530654614|FG005|Post Induction Therapy by Tx Assignment|Death|2|||
147132643|NCT00557193|530654609|FG000|Post Induction Therapy by Tx Assignment|Physician Decision|0|||
147132644|NCT00557193|530654610|FG001|Post Induction Therapy by Tx Assignment|Physician Decision|3|||
147132645|NCT00557193|530654611|FG002|Post Induction Therapy by Tx Assignment|Physician Decision|5|||
147132646|NCT00557193|530654612|FG003|Post Induction Therapy by Tx Assignment|Physician Decision|1|||
147132647|NCT00557193|530654613|FG004|Post Induction Therapy by Tx Assignment|Physician Decision|2|||
147132648|NCT00557193|530654614|FG005|Post Induction Therapy by Tx Assignment|Physician Decision|2|||
147132649|NCT00557193|530654609|FG000|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|0|||
147132650|NCT00557193|530654610|FG001|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|1|||
147132651|NCT00557193|530654611|FG002|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|0|||
147132652|NCT00557193|530654612|FG003|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|2|||
147132653|NCT00557193|530654613|FG004|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|2|||
147132654|NCT00557193|530654614|FG005|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol|5|||
147132655|NCT00557193|530654609|FG000|Post Induction Therapy by Tx Assignment|Relapse|0|||
147132656|NCT00557193|530654610|FG001|Post Induction Therapy by Tx Assignment|Relapse|5|||
147132657|NCT00557193|530654611|FG002|Post Induction Therapy by Tx Assignment|Relapse|16|||
147132658|NCT00557193|530654612|FG003|Post Induction Therapy by Tx Assignment|Relapse|3|||
147132659|NCT00557193|530654613|FG004|Post Induction Therapy by Tx Assignment|Relapse|1|||
147132660|NCT00557193|530654614|FG005|Post Induction Therapy by Tx Assignment|Relapse|20|||
147132661|NCT00557193|530654609|FG000|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0|||
147132662|NCT00557193|530654610|FG001|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0|||
147132663|NCT00557193|530654611|FG002|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|1|||
147132664|NCT00557193|530654612|FG003|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0|||
147132665|NCT00557193|530654613|FG004|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0|||
147132666|NCT00557193|530654614|FG005|Post Induction Therapy by Tx Assignment|Developed second malignant neoplasm|0|||
147132667|NCT00557193|530654609|FG000|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0|||
147132668|NCT00557193|530654610|FG001|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0|||
147132669|NCT00557193|530654611|FG002|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|2|||
147132670|NCT00557193|530654612|FG003|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0|||
147132671|NCT00557193|530654613|FG004|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0|||
147132672|NCT00557193|530654614|FG005|Post Induction Therapy by Tx Assignment|Patient Moved to Another Institution|0|||
147132673|NCT00557193|530654609|FG000|Post Induction Therapy by Tx Assignment|Induction Failure|0|||
147132674|NCT00557193|530654610|FG001|Post Induction Therapy by Tx Assignment|Induction Failure|0|||
147132675|NCT00557193|530654611|FG002|Post Induction Therapy by Tx Assignment|Induction Failure|4|||
147132676|NCT00557193|530654612|FG003|Post Induction Therapy by Tx Assignment|Induction Failure|0|||
147132677|NCT00557193|530654613|FG004|Post Induction Therapy by Tx Assignment|Induction Failure|0|||
147132678|NCT00557193|530654614|FG005|Post Induction Therapy by Tx Assignment|Induction Failure|5|||
147132679|NCT00261833|530654615|FG000|Overall Study|Death|1|||
147132680|NCT00261833|530654616|FG001|Overall Study|Death|3|||
147132681|NCT00261833|530654615|FG000|Overall Study|Adverse Event|1|||
147132682|NCT00261833|530654616|FG001|Overall Study|Adverse Event|4|||
147132683|NCT00261833|530654615|FG000|Overall Study|Withdrawal by Subject|5|||
147132684|NCT00261833|530654616|FG001|Overall Study|Withdrawal by Subject|7|||
147132685|NCT00261833|530654615|FG000|Overall Study|Protocol Violation|0|||
147132686|NCT00261833|530654616|FG001|Overall Study|Protocol Violation|1|||
147132687|NCT00261833|530654615|FG000|Overall Study|Suspicion of pulmonary cancer|0|||
147132688|NCT00261833|530654616|FG001|Overall Study|Suspicion of pulmonary cancer|1|||
147132689|NCT00261833|530654615|FG000|Overall Study|Lung transplantation|1|||
147132690|NCT00261833|530654616|FG001|Overall Study|Lung transplantation|1|||
147132691|NCT00261833|530654615|FG000|Overall Study|Missing reason|1|||
147132692|NCT00261833|530654616|FG001|Overall Study|Missing reason|0|||
147132693|NCT00261833|530654615|FG000|Overall Study|Not interested in being participant|0|||
147132694|NCT00261833|530654616|FG001|Overall Study|Not interested in being participant|1|||
147132695|NCT00622726|530654617|FG000|March, 2008 to August, 2010|Death|5|||
147132696|NCT00622726|530654618|FG001|March, 2008 to August, 2010|Death|2|||
147132697|NCT00622726|530654617|FG000|August, 2010 to April, 2013|Death|1|||
147570713|NCT00415363|532245258|FG001|Overall Study|Death|12|||
147570714|NCT00415363|532245257|FG000|Overall Study|Progressive disease|26|||
147570715|NCT00415363|532245258|FG001|Overall Study|Progressive disease|32|||
147570716|NCT02658084|532245263|FG000|Overall Study|Withdrawal by Subject|1|||
147570717|NCT02658084|532245264|FG001|Overall Study|Withdrawal by Subject|0|||
147132698|NCT00622726|530654618|FG001|August, 2010 to April, 2013|Death|5|||
147570718|NCT02658084|532245263|FG000|Overall Study|Study Termination|1|||
147570719|NCT02658084|532245264|FG001|Overall Study|Study Termination|0|||
147445273|NCT00661531|531795795|FG000|Overall Study|Withdrawal by Subject|3|||
147445274|NCT03134599|531795796|FG000|Week 1|Lost to Follow-up|0|||
147132699|NCT01948427|530654621|FG000|Overall Study|Serious Adverse Event|3|||
147132700|NCT01948427|530654622|FG001|Overall Study|Serious Adverse Event|0|||
147132701|NCT01948427|530654623|FG002|Overall Study|Serious Adverse Event|0|||
147132702|NCT01948427|530654624|FG003|Overall Study|Serious Adverse Event|0|||
147132703|NCT01948427|530654625|FG004|Overall Study|Serious Adverse Event|1|||
147132704|NCT01948427|530654621|FG000|Overall Study|Investigator Request|0|||
147132705|NCT01948427|530654622|FG001|Overall Study|Investigator Request|8|||
147132706|NCT01948427|530654623|FG002|Overall Study|Investigator Request|0|||
147132707|NCT01948427|530654624|FG003|Overall Study|Investigator Request|0|||
147132708|NCT01948427|530654625|FG004|Overall Study|Investigator Request|6|||
147132709|NCT01948427|530654621|FG000|Overall Study|Lost to Follow-up|1|||
147132710|NCT01948427|530654622|FG001|Overall Study|Lost to Follow-up|0|||
147132711|NCT01948427|530654623|FG002|Overall Study|Lost to Follow-up|0|||
147132712|NCT01948427|530654624|FG003|Overall Study|Lost to Follow-up|0|||
147132713|NCT01948427|530654625|FG004|Overall Study|Lost to Follow-up|4|||
147132714|NCT01948427|530654621|FG000|Overall Study|Withdrawal by Subject|2|||
147132715|NCT01948427|530654622|FG001|Overall Study|Withdrawal by Subject|0|||
147132716|NCT01948427|530654623|FG002|Overall Study|Withdrawal by Subject|0|||
147132717|NCT01948427|530654624|FG003|Overall Study|Withdrawal by Subject|0|||
147132718|NCT01948427|530654625|FG004|Overall Study|Withdrawal by Subject|1|||
147132719|NCT01948427|530654621|FG000|Overall Study|Other, Not Specified|1|||
147132720|NCT01948427|530654622|FG001|Overall Study|Other, Not Specified|9|||
147132721|NCT01948427|530654623|FG002|Overall Study|Other, Not Specified|0|||
147132722|NCT01948427|530654624|FG003|Overall Study|Other, Not Specified|0|||
147132723|NCT01948427|530654625|FG004|Overall Study|Other, Not Specified|2|||
147132724|NCT00402987|530654626|FG000|Overall Study|Lack of Efficacy|0|||
147132725|NCT00402987|530654627|FG001|Overall Study|Lack of Efficacy|0|||
147132726|NCT00402987|530654628|FG002|Overall Study|Lack of Efficacy|1|||
147132727|NCT00402987|530654629|FG003|Overall Study|Lack of Efficacy|0|||
147132728|NCT02434081|530654630|FG000|Overall Study|Death (never started treatment)|2|||
147132729|NCT02434081|530654630|FG000|Overall Study|Death|2|||
147132730|NCT02434081|530654630|FG000|Overall Study|Progression|20|||
147132731|NCT02434081|530654630|FG000|Overall Study|Adverse Event|20|||
147132732|NCT02434081|530654630|FG000|Overall Study|Physician Decision|2|||
147132733|NCT02434081|530654630|FG000|Overall Study|Withdrawal by Subject|1|||
147132734|NCT02434081|530654630|FG000|Overall Study|Patient did not receive treatment for more than six weeks|1|||
147132735|NCT00419744|530654631|FG000|Overall Study|Adverse Event|39|||
147132736|NCT00419744|530654632|FG001|Overall Study|Adverse Event|40|||
147132737|NCT00419744|530654633|FG002|Overall Study|Adverse Event|50|||
147132738|NCT00419744|530654631|FG000|Overall Study|Withdrawal by Subject|45|||
147132739|NCT00419744|530654632|FG001|Overall Study|Withdrawal by Subject|49|||
147132740|NCT00419744|530654633|FG002|Overall Study|Withdrawal by Subject|52|||
147132741|NCT00419744|530654631|FG000|Overall Study|Lost to Follow-up|8|||
147132742|NCT00419744|530654632|FG001|Overall Study|Lost to Follow-up|10|||
147132743|NCT00419744|530654633|FG002|Overall Study|Lost to Follow-up|6|||
147132744|NCT00419744|530654631|FG000|Overall Study|Protocol Violation|4|||
147132745|NCT00419744|530654632|FG001|Overall Study|Protocol Violation|7|||
147132746|NCT00419744|530654633|FG002|Overall Study|Protocol Violation|8|||
147132747|NCT00419744|530654631|FG000|Overall Study|Randomized in error|9|||
147132748|NCT00419744|530654632|FG001|Overall Study|Randomized in error|6|||
147132749|NCT00419744|530654633|FG002|Overall Study|Randomized in error|7|||
147132750|NCT00419744|530654631|FG000|Overall Study|Moving out of state|2|||
147132751|NCT00419744|530654632|FG001|Overall Study|Moving out of state|0|||
147132752|NCT00419744|530654633|FG002|Overall Study|Moving out of state|1|||
147132753|NCT00419744|530654631|FG000|Overall Study|Physician Decision|10|||
147132754|NCT00419744|530654632|FG001|Overall Study|Physician Decision|5|||
147132755|NCT00419744|530654633|FG002|Overall Study|Physician Decision|6|||
147132756|NCT00419744|530654631|FG000|Overall Study|Spirometry mouthpiece issues|0|||
147132757|NCT00419744|530654632|FG001|Overall Study|Spirometry mouthpiece issues|1|||
147132758|NCT00419744|530654633|FG002|Overall Study|Spirometry mouthpiece issues|2|||
147132759|NCT00419744|530654631|FG000|Overall Study|Incorrect medication kit dispensed|0|||
147445275|NCT03134599|531795797|FG001|Week 1|Lost to Follow-up|0|||
147445276|NCT03134599|531795798|FG002|Week 1|Lost to Follow-up|0|||
147570720|NCT03290781|532245266|FG000|Overall Study|Adverse Event|5|||
147132760|NCT00419744|530654632|FG001|Overall Study|Incorrect medication kit dispensed|0|||
147132761|NCT00419744|530654633|FG002|Overall Study|Incorrect medication kit dispensed|1|||
147445277|NCT03134599|531795799|FG003|Week 1|Lost to Follow-up|0|||
147132762|NCT02448381|530654638|FG000|Overall Study|Adverse Event|2|||
147132763|NCT02448381|530654639|FG001|Overall Study|Adverse Event|0|||
147132764|NCT02448381|530654638|FG000|Overall Study|Lost to Follow-up|16|||
147132765|NCT02448381|530654639|FG001|Overall Study|Lost to Follow-up|9|||
147132766|NCT02448381|530654638|FG000|Overall Study|Physician Decision|1|||
147445278|NCT03134599|531795800|FG004|Week 1|Lost to Follow-up|1|||
147132767|NCT02448381|530654639|FG001|Overall Study|Physician Decision|1|||
147132768|NCT02448381|530654638|FG000|Overall Study|Pregnancy|1|||
147445279|NCT03134599|531795801|FG005|Week 1|Lost to Follow-up|0|||
147132769|NCT02448381|530654639|FG001|Overall Study|Pregnancy|0|||
147132770|NCT02448381|530654638|FG000|Overall Study|Withdrawal by Subject|13|||
147132771|NCT02448381|530654639|FG001|Overall Study|Withdrawal by Subject|9|||
147132772|NCT02448381|530654638|FG000|Overall Study|Noncompliance with Study Procedures|2|||
147132773|NCT02448381|530654639|FG001|Overall Study|Noncompliance with Study Procedures|0|||
147132774|NCT01500317|530654642|FG000|Overall Study|Withdrawal by Subject|3|||
147132775|NCT01500317|530654643|FG001|Overall Study|Withdrawal by Subject|2|||
147132776|NCT01500317|530654644|FG002|Overall Study|Withdrawal by Subject|0|||
147132777|NCT00976456|530654645|FG000|Overall Study|Adverse Event|17|||
147132778|NCT00976456|530654646|FG001|Overall Study|Adverse Event|22|||
147132779|NCT00976456|530654645|FG000|Overall Study|Death|7|||
147132780|NCT00976456|530654646|FG001|Overall Study|Death|9|||
147132781|NCT00976456|530654645|FG000|Overall Study|Lack of Efficacy|5|||
147132782|NCT00976456|530654646|FG001|Overall Study|Lack of Efficacy|2|||
147132783|NCT00976456|530654645|FG000|Overall Study|Withdrawal by Subject|3|||
147132784|NCT00976456|530654646|FG001|Overall Study|Withdrawal by Subject|1|||
147132785|NCT00976456|530654645|FG000|Overall Study|screening failure, unknown|11|||
147132786|NCT00976456|530654646|FG001|Overall Study|screening failure, unknown|4|||
147132787|NCT04856527|530654648|FG000|Overall Study|Unable to complete experimental task|2|||
147132788|NCT04856527|530654649|FG001|Overall Study|Unable to complete experimental task|0|||
147132789|NCT01463527|530654652|FG000|Overall Study|Protocol Violation|1|||
147132790|NCT01463527|530654653|FG001|Overall Study|Protocol Violation|1|||
147132791|NCT01463527|530654652|FG000|Overall Study|Crying >20% of sedation|5|||
147132792|NCT01463527|530654653|FG001|Overall Study|Crying >20% of sedation|6|||
147132793|NCT01493414|530654654|FG000|Overall Study|Adverse Event|405|||
147132794|NCT01493414|530654654|FG000|Overall Study|Disease progression|204|||
147132795|NCT01493414|530654654|FG000|Overall Study|Death|101|||
147132796|NCT01493414|530654654|FG000|Overall Study|Physician Decision|93|||
147132797|NCT01493414|530654654|FG000|Overall Study|Withdrawal by Subject|79|||
147132798|NCT01493414|530654654|FG000|Overall Study|Protocol deviation|27|||
147132799|NCT01493414|530654654|FG000|Overall Study|Administrative problems|25|||
147132800|NCT01493414|530654654|FG000|Overall Study|Lost to Follow-up|16|||
147132801|NCT05448950|530654657|FG000|Overall Study|Death|2|||
147132802|NCT05448950|530654657|FG000|Overall Study|Withdrawal by Subject|1|||
147132803|NCT05448950|530654657|FG000|Overall Study|AVG abandoned|4|||
147132804|NCT01728246|530654658|FG000|Overall Study|Participant needed rescue medication|1|||
147132805|NCT01728246|530654659|FG001|Overall Study|Participant needed rescue medication|5|||
147445280|NCT03134599|531795796|FG000|Week 2|Lost to Follow-up|1|||
147445281|NCT03134599|531795797|FG001|Week 2|Lost to Follow-up|0|||
147445282|NCT03134599|531795798|FG002|Week 2|Lost to Follow-up|0|||
147445283|NCT03134599|531795799|FG003|Week 2|Lost to Follow-up|1|||
147445284|NCT03134599|531795800|FG004|Week 2|Lost to Follow-up|1|||
147445285|NCT03134599|531795801|FG005|Week 2|Lost to Follow-up|0|||
147570721|NCT03290781|532245267|FG001|Overall Study|Adverse Event|7|||
147570722|NCT03290781|532245268|FG002|Overall Study|Adverse Event|4|||
147570723|NCT03290781|532245269|FG003|Overall Study|Adverse Event|1|||
147132806|NCT01728246|530654658|FG000|Overall Study|Protocol Violation|1|||
147132807|NCT01728246|530654659|FG001|Overall Study|Protocol Violation|0|||
147132808|NCT01728246|530654658|FG000|Overall Study|Withdrawal by Subject|2|||
147132809|NCT01728246|530654659|FG001|Overall Study|Withdrawal by Subject|3|||
147132810|NCT01728246|530654658|FG000|Overall Study|Lost to Follow-up|23|||
147132811|NCT01728246|530654659|FG001|Overall Study|Lost to Follow-up|22|||
147132812|NCT01728246|530654658|FG000|Overall Study|Lack of Efficacy|1|||
147132813|NCT01728246|530654659|FG001|Overall Study|Lack of Efficacy|1|||
147132814|NCT01728246|530654658|FG000|Overall Study|Adverse Event|8|||
147132815|NCT01728246|530654659|FG001|Overall Study|Adverse Event|5|||
147132816|NCT01143402|530654660|FG000|Overall Study|Rapid clinical decline|1|||
147132817|NCT01143402|530654661|FG001|Overall Study|Rapid clinical decline|1|||
147132818|NCT01143402|530654662|FG002|Overall Study|Rapid clinical decline|0|||
147132819|NCT01143402|530654660|FG000|Overall Study|Not Treated|0|||
147132820|NCT01143402|530654661|FG001|Overall Study|Not Treated|0|||
147132821|NCT01143402|530654662|FG002|Overall Study|Not Treated|1|||
147132822|NCT01959932|530654666|FG000|Overall Study|Withdrawal by Subject|1|||
147132823|NCT01959932|530654667|FG001|Overall Study|Withdrawal by Subject|0|||
147132824|NCT01959932|530654668|FG002|Overall Study|Withdrawal by Subject|0|||
147132825|NCT00397540|530654669|FG000|Overall Study|short follow-up duration < 12 months|1|||
147445286|NCT03134599|531795796|FG000|Week 3|Lost to Follow-up|0|||
147132826|NCT00397540|530654670|FG001|Overall Study|short follow-up duration < 12 months|0|||
147132827|NCT01656161|530654671|FG000|Overall Study|Death|3|||
147132828|NCT01656161|530654671|FG000|Overall Study|Adverse Event|2|||
147236959|NCT00347360|531037437|FG012|Overall Study|Failed inclusion criteria #4|0|||
147570724|NCT03290781|532245270|FG004|Overall Study|Adverse Event|0|||
147132829|NCT01656161|530654671|FG000|Overall Study|Protocol Violation|1|||
147132830|NCT01656161|530654671|FG000|Overall Study|Withdrawal by Subject|1|||
147132831|NCT00776230|530654674|FG000|Overall Study|Lost to Follow-up|2|||
147132832|NCT00776230|530654675|FG001|Overall Study|Lost to Follow-up|1|||
147445287|NCT03134599|531795797|FG001|Week 3|Lost to Follow-up|0|||
147445288|NCT03134599|531795798|FG002|Week 3|Lost to Follow-up|0|||
147570725|NCT03290781|532245271|FG005|Overall Study|Adverse Event|0|||
147132833|NCT00776230|530654676|FG002|Overall Study|Lost to Follow-up|5|||
147132834|NCT00776230|530654674|FG000|Overall Study|Not vaccinated at Day 0|1|||
147132835|NCT00776230|530654675|FG001|Overall Study|Not vaccinated at Day 0|0|||
147132836|NCT00776230|530654676|FG002|Overall Study|Not vaccinated at Day 0|0|||
147132837|NCT00776230|530654674|FG000|Overall Study|Withdrawal by Subject|0|||
147132838|NCT00776230|530654675|FG001|Overall Study|Withdrawal by Subject|1|||
147132839|NCT00776230|530654676|FG002|Overall Study|Withdrawal by Subject|0|||
147132840|NCT00776230|530654674|FG000|Overall Study|Subject missed Visit 4|0|||
147132841|NCT00776230|530654675|FG001|Overall Study|Subject missed Visit 4|1|||
147132842|NCT00776230|530654676|FG002|Overall Study|Subject missed Visit 4|0|||
147132843|NCT01215851|530654677|FG000|Treatment Period|Adverse Event|1|||
147132844|NCT01215851|530654678|FG001|Treatment Period|Adverse Event|1|||
147132845|NCT01215851|530654679|FG002|Treatment Period|Adverse Event|1|||
147132846|NCT01215851|530654680|FG003|Treatment Period|Adverse Event|3|||
147132847|NCT01215851|530654681|FG004|Treatment Period|Adverse Event|0|||
147132848|NCT01215851|530654682|FG005|Treatment Period|Adverse Event|1|||
147132849|NCT01215851|530654677|FG000|Follow up Period|Lost to Follow-up|0|||
147132850|NCT01215851|530654678|FG001|Follow up Period|Lost to Follow-up|0|||
147132851|NCT01215851|530654679|FG002|Follow up Period|Lost to Follow-up|0|||
147132852|NCT01215851|530654680|FG003|Follow up Period|Lost to Follow-up|0|||
147132853|NCT01215851|530654681|FG004|Follow up Period|Lost to Follow-up|0|||
147132854|NCT01215851|530654682|FG005|Follow up Period|Lost to Follow-up|1|||
147132855|NCT04532749|530654687|FG000|DB Treatment Phase (Day 1 to Day 43)|Adverse Event|1|||
147132856|NCT04532749|530654688|FG001|DB Treatment Phase (Day 1 to Day 43)|Adverse Event|6|||
147132857|NCT04532749|530654687|FG000|DB Treatment Phase (Day 1 to Day 43)|Lack of Efficacy|2|||
147132858|NCT04532749|530654688|FG001|DB Treatment Phase (Day 1 to Day 43)|Lack of Efficacy|5|||
147132859|NCT04532749|530654687|FG000|DB Treatment Phase (Day 1 to Day 43)|Withdrawal by Subject|2|||
147132860|NCT04532749|530654688|FG001|DB Treatment Phase (Day 1 to Day 43)|Withdrawal by Subject|0|||
147132861|NCT04532749|530654687|FG000|DB Treatment Phase (Day 1 to Day 43)|Lost to Follow-up|0|||
147132862|NCT04532749|530654688|FG001|DB Treatment Phase (Day 1 to Day 43)|Lost to Follow-up|1|||
147132863|NCT04532749|530654687|FG000|DB Treatment Phase (Day 1 to Day 43)|Protocol Violation|0|||
147132864|NCT04532749|530654688|FG001|DB Treatment Phase (Day 1 to Day 43)|Protocol Violation|1|||
147132865|NCT04532749|530654687|FG000|DB Treatment Phase (Day 1 to Day 43)|Study Terminated by Sponsor|0|||
147132866|NCT04532749|530654688|FG001|DB Treatment Phase (Day 1 to Day 43)|Study Terminated by Sponsor|1|||
147132867|NCT04532749|530654687|FG000|DB Treatment Phase (Day 1 to Day 43)|Other|1|||
147132868|NCT04532749|530654688|FG001|DB Treatment Phase (Day 1 to Day 43)|Other|2|||
147132869|NCT04532749|530654687|FG000|Follow-up Phase (Day 44 to Day 57)|Withdrawal by Subject|0|||
147132870|NCT04532749|530654688|FG001|Follow-up Phase (Day 44 to Day 57)|Withdrawal by Subject|3|||
147132871|NCT04532749|530654687|FG000|Follow-up Phase (Day 44 to Day 57)|Adverse Event|0|||
147132872|NCT04532749|530654688|FG001|Follow-up Phase (Day 44 to Day 57)|Adverse Event|1|||
147132873|NCT04532749|530654687|FG000|Follow-up Phase (Day 44 to Day 57)|Other|1|||
147132874|NCT04532749|530654688|FG001|Follow-up Phase (Day 44 to Day 57)|Other|2|||
147132875|NCT04756531|530654693|FG000|Overall Study|Adverse Event|0|||
147132876|NCT04756531|530654694|FG001|Overall Study|Adverse Event|0|||
147132877|NCT04756531|530654695|FG002|Overall Study|Adverse Event|0|||
147132878|NCT04756531|530654696|FG003|Overall Study|Adverse Event|0|||
147132879|NCT04756531|530654697|FG004|Overall Study|Adverse Event|1|||
147132880|NCT04756531|530654698|FG005|Overall Study|Adverse Event|0|||
147132881|NCT04756531|530654699|FG006|Overall Study|Adverse Event|0|||
147132882|NCT04756531|530654700|FG007|Overall Study|Adverse Event|0|||
147132883|NCT04756531|530654701|FG008|Overall Study|Adverse Event|0|||
147132884|NCT04756531|530654702|FG009|Overall Study|Adverse Event|0|||
147132885|NCT04756531|530654703|FG010|Overall Study|Adverse Event|0|||
147132886|NCT04756531|530654704|FG011|Overall Study|Adverse Event|0|||
147132887|NCT04756531|530654705|FG012|Overall Study|Adverse Event|0|||
147132888|NCT04756531|530654706|FG013|Overall Study|Adverse Event|0|||
147132889|NCT04756531|530654707|FG014|Overall Study|Adverse Event|0|||
147132890|NCT04756531|530654708|FG015|Overall Study|Adverse Event|0|||
147132891|NCT04756531|530654709|FG016|Overall Study|Adverse Event|0|||
147132892|NCT04756531|530654710|FG017|Overall Study|Adverse Event|0|||
147570726|NCT03290781|532245272|FG006|Overall Study|Adverse Event|0|||
147570727|NCT03290781|532245266|FG000|Overall Study|Death|0|||
147570728|NCT03290781|532245267|FG001|Overall Study|Death|0|||
147570729|NCT03290781|532245268|FG002|Overall Study|Death|1|||
147570730|NCT03290781|532245269|FG003|Overall Study|Death|0|||
147132893|NCT04756531|530654693|FG000|Overall Study|Withdrawal by Subject|0|||
147236960|NCT00347360|531037438|FG013|Overall Study|Failed inclusion criteria #4|0|||
147570731|NCT03290781|532245270|FG004|Overall Study|Death|1|||
147132894|NCT04756531|530654694|FG001|Overall Study|Withdrawal by Subject|0|||
147132895|NCT04756531|530654695|FG002|Overall Study|Withdrawal by Subject|0|||
147132896|NCT04756531|530654696|FG003|Overall Study|Withdrawal by Subject|0|||
147132897|NCT04756531|530654697|FG004|Overall Study|Withdrawal by Subject|0|||
147132898|NCT04756531|530654698|FG005|Overall Study|Withdrawal by Subject|0|||
147132899|NCT04756531|530654699|FG006|Overall Study|Withdrawal by Subject|1|||
147570732|NCT03290781|532245271|FG005|Overall Study|Death|0|||
147132900|NCT04756531|530654700|FG007|Overall Study|Withdrawal by Subject|0|||
147132901|NCT04756531|530654701|FG008|Overall Study|Withdrawal by Subject|0|||
147132902|NCT04756531|530654702|FG009|Overall Study|Withdrawal by Subject|0|||
147132903|NCT04756531|530654703|FG010|Overall Study|Withdrawal by Subject|0|||
147132904|NCT04756531|530654704|FG011|Overall Study|Withdrawal by Subject|0|||
147132905|NCT04756531|530654705|FG012|Overall Study|Withdrawal by Subject|0|||
147132906|NCT04756531|530654706|FG013|Overall Study|Withdrawal by Subject|0|||
147132907|NCT04756531|530654707|FG014|Overall Study|Withdrawal by Subject|0|||
147132908|NCT04756531|530654708|FG015|Overall Study|Withdrawal by Subject|0|||
147132909|NCT04756531|530654709|FG016|Overall Study|Withdrawal by Subject|0|||
147132910|NCT04756531|530654710|FG017|Overall Study|Withdrawal by Subject|0|||
147132911|NCT05643495|530654711|FG000|Overall Study|Adverse Event|0|||
147132912|NCT05643495|530654712|FG001|Overall Study|Adverse Event|1|||
147132913|NCT05643495|530654711|FG000|Overall Study|Withdrawal of consent (not due to AE)|1|||
147132914|NCT05643495|530654712|FG001|Overall Study|Withdrawal of consent (not due to AE)|1|||
147132915|NCT04237584|530654713|FG000|R1- Lead-in ARB Treatment (12 Weeks)|Adverse Event|0|||
147132916|NCT04237584|530654714|FG001|R1- Lead-in ARB Treatment (12 Weeks)|Adverse Event|0|||
147132917|NCT04237584|530654715|FG002|R1- Lead-in ARB Treatment (12 Weeks)|Adverse Event|1|||
147132918|NCT04237584|530654716|FG003|R1- Lead-in ARB Treatment (12 Weeks)|Adverse Event|1|||
147132919|NCT04237584|530654713|FG000|R1- Lead-in ARB Treatment (12 Weeks)|Did not meet R2 entry criteria|1|||
147132920|NCT04237584|530654714|FG001|R1- Lead-in ARB Treatment (12 Weeks)|Did not meet R2 entry criteria|1|||
147132921|NCT04237584|530654715|FG002|R1- Lead-in ARB Treatment (12 Weeks)|Did not meet R2 entry criteria|0|||
147132922|NCT04237584|530654716|FG003|R1- Lead-in ARB Treatment (12 Weeks)|Did not meet R2 entry criteria|1|||
147132923|NCT04237584|530654713|FG000|R1- Lead-in ARB Treatment (12 Weeks)|Randomized R2 (no cycles given)|0|||
147132924|NCT04237584|530654714|FG001|R1- Lead-in ARB Treatment (12 Weeks)|Randomized R2 (no cycles given)|0|||
147132925|NCT04237584|530654715|FG002|R1- Lead-in ARB Treatment (12 Weeks)|Randomized R2 (no cycles given)|2|||
147132926|NCT04237584|530654716|FG003|R1- Lead-in ARB Treatment (12 Weeks)|Randomized R2 (no cycles given)|0|||
147132927|NCT04237584|530654713|FG000|R2- ARB Treatment With Ra-223 or Placebo|Sponsor Decision|4|||
147132928|NCT04237584|530654714|FG001|R2- ARB Treatment With Ra-223 or Placebo|Sponsor Decision|4|||
147132929|NCT04237584|530654715|FG002|R2- ARB Treatment With Ra-223 or Placebo|Sponsor Decision|2|||
147132930|NCT04237584|530654716|FG003|R2- ARB Treatment With Ra-223 or Placebo|Sponsor Decision|3|||
147132931|NCT04237584|530654713|FG000|R2- ARB Treatment With Ra-223 or Placebo|Physician Decision|0|||
147132932|NCT04237584|530654714|FG001|R2- ARB Treatment With Ra-223 or Placebo|Physician Decision|0|||
147132933|NCT04237584|530654715|FG002|R2- ARB Treatment With Ra-223 or Placebo|Physician Decision|1|||
147132934|NCT04237584|530654716|FG003|R2- ARB Treatment With Ra-223 or Placebo|Physician Decision|0|||
147132935|NCT01334918|530655806|FG000|Overall Study|Did not receive study drug|6|||
147132936|NCT01334918|530655807|FG001|Overall Study|Did not receive study drug|0|||
147132937|NCT01334918|530655806|FG000|Overall Study|Adverse Event|2|||
147132938|NCT01334918|530655807|FG001|Overall Study|Adverse Event|0|||
147132939|NCT01334918|530655806|FG000|Overall Study|Withdrawal by Subject|0|||
147132940|NCT01334918|530655807|FG001|Overall Study|Withdrawal by Subject|1|||
147132941|NCT00529633|530655808|FG000|Overall Study|Withdrawal by Subject|1|||
147132942|NCT00529633|530655809|FG001|Overall Study|Withdrawal by Subject|1|||
147132943|NCT02777086|530655811|FG000|Overall Study|Lost to Follow-up|96|||
147132944|NCT02777086|530655812|FG001|Overall Study|Lost to Follow-up|99|||
147132945|NCT01133665|530655813|FG000|Overall Study|Physician Decision|2|||
147132946|NCT01819272|530655814|FG000|Overall Study|Adverse Event|1|||
147132947|NCT01819272|530655815|FG001|Overall Study|Adverse Event|0|||
147132948|NCT01819272|530655816|FG002|Overall Study|Adverse Event|0|||
147132949|NCT01819272|530655817|FG003|Overall Study|Adverse Event|2|||
147132950|NCT01819272|530655818|FG004|Overall Study|Adverse Event|0|||
147132951|NCT01819272|530655819|FG005|Overall Study|Adverse Event|0|||
147132952|NCT01819272|530655814|FG000|Overall Study|Lost to Follow-up|3|||
147132953|NCT01819272|530655815|FG001|Overall Study|Lost to Follow-up|0|||
147132954|NCT01819272|530655816|FG002|Overall Study|Lost to Follow-up|1|||
147132955|NCT01819272|530655817|FG003|Overall Study|Lost to Follow-up|0|||
147132956|NCT01819272|530655818|FG004|Overall Study|Lost to Follow-up|0|||
147132957|NCT01819272|530655819|FG005|Overall Study|Lost to Follow-up|3|||
147132958|NCT01819272|530655814|FG000|Overall Study|Protocol Violation|0|||
147132959|NCT01819272|530655815|FG001|Overall Study|Protocol Violation|0|||
147132960|NCT01819272|530655816|FG002|Overall Study|Protocol Violation|0|||
147132961|NCT01819272|530655817|FG003|Overall Study|Protocol Violation|1|||
147132962|NCT01819272|530655818|FG004|Overall Study|Protocol Violation|2|||
147132963|NCT01819272|530655819|FG005|Overall Study|Protocol Violation|3|||
147132964|NCT01819272|530655814|FG000|Overall Study|Physician Decision|0|||
147132965|NCT01819272|530655815|FG001|Overall Study|Physician Decision|1|||
147132966|NCT01819272|530655816|FG002|Overall Study|Physician Decision|0|||
147132967|NCT01819272|530655817|FG003|Overall Study|Physician Decision|0|||
147132968|NCT01819272|530655818|FG004|Overall Study|Physician Decision|0|||
147132969|NCT01819272|530655819|FG005|Overall Study|Physician Decision|0|||
147132970|NCT01819272|530655814|FG000|Overall Study|Withdrawal of Consent|0|||
147445289|NCT03134599|531795799|FG003|Week 3|Lost to Follow-up|1|||
147132971|NCT01819272|530655815|FG001|Overall Study|Withdrawal of Consent|1|||
147132972|NCT01819272|530655816|FG002|Overall Study|Withdrawal of Consent|2|||
147132973|NCT01819272|530655817|FG003|Overall Study|Withdrawal of Consent|1|||
147132974|NCT01819272|530655818|FG004|Overall Study|Withdrawal of Consent|0|||
147132975|NCT01819272|530655819|FG005|Overall Study|Withdrawal of Consent|1|||
147132976|NCT01819272|530655814|FG000|Overall Study|Loss of Glucose Control|2|||
147132977|NCT01819272|530655815|FG001|Overall Study|Loss of Glucose Control|1|||
147132978|NCT01819272|530655816|FG002|Overall Study|Loss of Glucose Control|0|||
147132979|NCT01819272|530655817|FG003|Overall Study|Loss of Glucose Control|1|||
147132980|NCT01819272|530655818|FG004|Overall Study|Loss of Glucose Control|2|||
147132981|NCT01819272|530655819|FG005|Overall Study|Loss of Glucose Control|0|||
147132982|NCT01784029|530655820|FG000|Overall Study|Lost to Follow-up|19|||
147132983|NCT01784029|530655821|FG001|Overall Study|Lost to Follow-up|20|||
147132984|NCT01784029|530655822|FG002|Overall Study|Lost to Follow-up|22|||
147132985|NCT00069641|530655825|FG000|Overall Study|Death|1|||
147132986|NCT00069641|530655826|FG001|Overall Study|Death|0|||
147132987|NCT00069641|530655827|FG002|Overall Study|Death|1|||
147132988|NCT03186638|530655828|FG000|Overall Study|Withdrawal by Subject|4|||
147132989|NCT03186638|530655829|FG001|Overall Study|Withdrawal by Subject|4|||
147132990|NCT03186638|530655828|FG000|Overall Study|Withdrawn due to medical problem|3|||
147132991|NCT03186638|530655829|FG001|Overall Study|Withdrawn due to medical problem|2|||
147132992|NCT03186638|530655828|FG000|Overall Study|Lost to Follow-up|1|||
147132993|NCT03186638|530655829|FG001|Overall Study|Lost to Follow-up|0|||
147132994|NCT02239926|530655830|FG000|Overall Study|Withdrawal by Subject|0|||
147132995|NCT02239926|530655831|FG001|Overall Study|Withdrawal by Subject|1|||
147132996|NCT02704208|530655832|FG000|Overall Study|Lost to Follow-up|42|||
147132997|NCT02704208|530655833|FG001|Overall Study|Lost to Follow-up|37|||
147132998|NCT00560508|530655834|FG000|12 Week Double-blind Period|Adverse Event|3|||
147132999|NCT00560508|530655835|FG001|12 Week Double-blind Period|Adverse Event|2|||
147133000|NCT00560508|530655834|FG000|12 Week Double-blind Period|Protocol Violation|1|||
147133001|NCT00560508|530655835|FG001|12 Week Double-blind Period|Protocol Violation|0|||
147133002|NCT00560508|530655834|FG000|12 Week Double-blind Period|Withdrawal by Subject|1|||
147133003|NCT00560508|530655835|FG001|12 Week Double-blind Period|Withdrawal by Subject|1|||
147133004|NCT00560508|530655834|FG000|52-week Open-label Period Pramipexole ER|Adverse Event|6|||
147133005|NCT00560508|530655835|FG001|52-week Open-label Period Pramipexole ER|Adverse Event|6|||
147133006|NCT00560508|530655834|FG000|52-week Open-label Period Pramipexole ER|Lack of Efficacy|1|||
147133007|NCT00560508|530655835|FG001|52-week Open-label Period Pramipexole ER|Lack of Efficacy|1|||
147133008|NCT00560508|530655834|FG000|52-week Open-label Period Pramipexole ER|Withdrawal by Subject|0|||
147133009|NCT00560508|530655835|FG001|52-week Open-label Period Pramipexole ER|Withdrawal by Subject|3|||
147133010|NCT00560508|530655834|FG000|52-week Open-label Period Pramipexole ER|Other reason - investigator's judgement|1|||
147133011|NCT00560508|530655835|FG001|52-week Open-label Period Pramipexole ER|Other reason - investigator's judgement|1|||
147133012|NCT03983421|530655837|FG000|Overall Study|Lost to Follow-up|1|||
147133013|NCT03386773|530655838|FG000|Overall Study|Lost to Follow-up|24|||
147133014|NCT03386773|530655839|FG001|Overall Study|Lost to Follow-up|33|||
147133015|NCT03386773|530655838|FG000|Overall Study|Withdrawal by Subject|3|||
147133016|NCT03386773|530655839|FG001|Overall Study|Withdrawal by Subject|2|||
147133017|NCT03639610|530655840|FG000|Overall Study|Adverse Event|7|||
147133018|NCT03639610|530655841|FG001|Overall Study|Adverse Event|1|||
147133019|NCT03639610|530655842|FG002|Overall Study|Adverse Event|0|||
147133020|NCT03639610|530655840|FG000|Overall Study|Physician Decision|3|||
147133021|NCT03639610|530655841|FG001|Overall Study|Physician Decision|1|||
147133022|NCT03639610|530655842|FG002|Overall Study|Physician Decision|0|||
147133023|NCT03639610|530655840|FG000|Overall Study|Disease progression|8|||
147133024|NCT03639610|530655841|FG001|Overall Study|Disease progression|5|||
147133025|NCT03639610|530655842|FG002|Overall Study|Disease progression|3|||
147133026|NCT03639610|530655840|FG000|Overall Study|Study terminated by sponsor|2|||
147133027|NCT03639610|530655841|FG001|Overall Study|Study terminated by sponsor|1|||
147133028|NCT03639610|530655842|FG002|Overall Study|Study terminated by sponsor|1|||
147133029|NCT03639610|530655840|FG000|Overall Study|Patient request to stop treatment|1|||
147133030|NCT03639610|530655841|FG001|Overall Study|Patient request to stop treatment|2|||
147133031|NCT03639610|530655842|FG002|Overall Study|Patient request to stop treatment|0|||
147133032|NCT01959529|530655843|FG000|Overall Study|Adverse event (not hypoglycaemia)|0|||
147133033|NCT01959529|530655844|FG001|Overall Study|Adverse event (not hypoglycaemia)|1|||
147236961|NCT00347360|531037439|FG014|Overall Study|Failed inclusion criteria #4|0|||
147236962|NCT00347360|531037425|FG000|Overall Study|Prolonged duration between visits|0|||
147570733|NCT03290781|532245272|FG006|Overall Study|Death|0|||
147570734|NCT03290781|532245266|FG000|Overall Study|Withdrawal by Subject|6|||
147133034|NCT01959529|530655843|FG000|Overall Study|Lost to Follow-up|4|||
147133035|NCT01959529|530655844|FG001|Overall Study|Lost to Follow-up|1|||
147133036|NCT01959529|530655843|FG000|Overall Study|Other|70|||
147133037|NCT01959529|530655844|FG001|Overall Study|Other|68|||
147133038|NCT01959529|530655843|FG000|Overall Study|Hypoglycaemia|1|||
147133039|NCT01959529|530655844|FG001|Overall Study|Hypoglycaemia|1|||
147570735|NCT03290781|532245267|FG001|Overall Study|Withdrawal by Subject|5|||
147133040|NCT01959529|530655843|FG000|Overall Study|Lack of glycaemic control|1|||
147133041|NCT01959529|530655844|FG001|Overall Study|Lack of glycaemic control|1|||
147570736|NCT03290781|532245268|FG002|Overall Study|Withdrawal by Subject|9|||
147570737|NCT03290781|532245269|FG003|Overall Study|Withdrawal by Subject|10|||
147570738|NCT03290781|532245270|FG004|Overall Study|Withdrawal by Subject|1|||
147570739|NCT03290781|532245271|FG005|Overall Study|Withdrawal by Subject|2|||
147570740|NCT03290781|532245272|FG006|Overall Study|Withdrawal by Subject|0|||
147570741|NCT03290781|532245266|FG000|Overall Study|Physician Decision|0|||
147570742|NCT03290781|532245267|FG001|Overall Study|Physician Decision|1|||
147570743|NCT03290781|532245268|FG002|Overall Study|Physician Decision|0|||
147570744|NCT03290781|532245269|FG003|Overall Study|Physician Decision|0|||
147570745|NCT03290781|532245270|FG004|Overall Study|Physician Decision|0|||
147570746|NCT03290781|532245271|FG005|Overall Study|Physician Decision|0|||
147570747|NCT03290781|532245272|FG006|Overall Study|Physician Decision|0|||
147570748|NCT03290781|532245266|FG000|Overall Study|Site Terminated by Sponsor|1|||
147570749|NCT03290781|532245267|FG001|Overall Study|Site Terminated by Sponsor|0|||
147570750|NCT03290781|532245268|FG002|Overall Study|Site Terminated by Sponsor|2|||
147570751|NCT03290781|532245269|FG003|Overall Study|Site Terminated by Sponsor|1|||
147570752|NCT03290781|532245270|FG004|Overall Study|Site Terminated by Sponsor|0|||
147570753|NCT03290781|532245271|FG005|Overall Study|Site Terminated by Sponsor|0|||
147570754|NCT03290781|532245272|FG006|Overall Study|Site Terminated by Sponsor|0|||
147570755|NCT03290781|532245266|FG000|Overall Study|Lost to Follow-up|0|||
147570756|NCT03290781|532245267|FG001|Overall Study|Lost to Follow-up|0|||
147570757|NCT03290781|532245268|FG002|Overall Study|Lost to Follow-up|0|||
147570758|NCT03290781|532245269|FG003|Overall Study|Lost to Follow-up|1|||
147570759|NCT03290781|532245270|FG004|Overall Study|Lost to Follow-up|0|||
147570760|NCT03290781|532245271|FG005|Overall Study|Lost to Follow-up|0|||
147570761|NCT03290781|532245272|FG006|Overall Study|Lost to Follow-up|0|||
147570762|NCT03290781|532245266|FG000|Overall Study|Protocol Deviation|2|||
147570763|NCT03290781|532245267|FG001|Overall Study|Protocol Deviation|0|||
147570764|NCT03290781|532245268|FG002|Overall Study|Protocol Deviation|0|||
147570765|NCT03290781|532245269|FG003|Overall Study|Protocol Deviation|1|||
147570766|NCT03290781|532245270|FG004|Overall Study|Protocol Deviation|0|||
147570767|NCT03290781|532245271|FG005|Overall Study|Protocol Deviation|0|||
147570768|NCT03290781|532245272|FG006|Overall Study|Protocol Deviation|0|||
147570769|NCT03290781|532245266|FG000|Overall Study|Disease Relapse|32|||
147570770|NCT03290781|532245267|FG001|Overall Study|Disease Relapse|5|||
147570771|NCT03290781|532245268|FG002|Overall Study|Disease Relapse|38|||
147570772|NCT03290781|532245269|FG003|Overall Study|Disease Relapse|7|||
147570773|NCT03290781|532245270|FG004|Overall Study|Disease Relapse|3|||
147570774|NCT03290781|532245271|FG005|Overall Study|Disease Relapse|1|||
147570775|NCT03290781|532245272|FG006|Overall Study|Disease Relapse|4|||
147570776|NCT03290781|532245266|FG000|Overall Study|Other|3|||
147570777|NCT03290781|532245267|FG001|Overall Study|Other|0|||
147570778|NCT03290781|532245268|FG002|Overall Study|Other|2|||
147570779|NCT03290781|532245269|FG003|Overall Study|Other|2|||
147570780|NCT03290781|532245270|FG004|Overall Study|Other|0|||
147570781|NCT03290781|532245271|FG005|Overall Study|Other|0|||
147570782|NCT03290781|532245272|FG006|Overall Study|Other|0|||
147570783|NCT02957942|532245273|FG000|Overall Study|Withdrawal by Subject|0|||
147570784|NCT02957942|532245274|FG001|Overall Study|Withdrawal by Subject|1|||
147570785|NCT02957942|532245273|FG000|Overall Study|Practicing experiment protocol|0|||
147570786|NCT02957942|532245274|FG001|Overall Study|Practicing experiment protocol|6|||
147570787|NCT01588236|532245283|FG000|Overall Study|Adverse Event|5|||
147133042|NCT02164864|530655845|FG000|Overall Study|Trial disease worsening|7|||
147133043|NCT02164864|530655846|FG001|Overall Study|Trial disease worsening|5|||
147133044|NCT02164864|530655847|FG002|Overall Study|Trial disease worsening|1|||
147133045|NCT02164864|530655845|FG000|Overall Study|Other pre-existing disease worsening|6|||
147133046|NCT02164864|530655846|FG001|Overall Study|Other pre-existing disease worsening|4|||
147133047|NCT02164864|530655847|FG002|Overall Study|Other pre-existing disease worsening|9|||
147133048|NCT02164864|530655845|FG000|Overall Study|Other Adverse Event (AE)|52|||
147133049|NCT02164864|530655846|FG001|Overall Study|Other Adverse Event (AE)|32|||
147133050|NCT02164864|530655847|FG002|Overall Study|Other Adverse Event (AE)|49|||
147236963|NCT00347360|531037426|FG001|Overall Study|Prolonged duration between visits|0|||
147570788|NCT01588236|532245284|FG001|Overall Study|Adverse Event|4|||
147570789|NCT01588236|532245285|FG002|Overall Study|Adverse Event|1|||
147570790|NCT01588236|532245283|FG000|Overall Study|Lost to Follow-up|8|||
147570791|NCT01588236|532245284|FG001|Overall Study|Lost to Follow-up|13|||
147570792|NCT01588236|532245285|FG002|Overall Study|Lost to Follow-up|6|||
147570793|NCT01588236|532245283|FG000|Overall Study|Physician Decision|1|||
147236964|NCT00347360|531037427|FG002|Overall Study|Prolonged duration between visits|0|||
147236965|NCT00347360|531037428|FG003|Overall Study|Prolonged duration between visits|0|||
147570794|NCT01588236|532245284|FG001|Overall Study|Physician Decision|2|||
147570795|NCT01588236|532245285|FG002|Overall Study|Physician Decision|0|||
147570796|NCT01588236|532245283|FG000|Overall Study|Protocol Violation|0|||
147570797|NCT01588236|532245284|FG001|Overall Study|Protocol Violation|1|||
147570798|NCT01588236|532245285|FG002|Overall Study|Protocol Violation|1|||
147570799|NCT01588236|532245283|FG000|Overall Study|Withdrawal by Subject|14|||
147570800|NCT01588236|532245284|FG001|Overall Study|Withdrawal by Subject|16|||
147570801|NCT01588236|532245285|FG002|Overall Study|Withdrawal by Subject|18|||
147133051|NCT02164864|530655845|FG000|Overall Study|Protocol Violation|2|||
147133052|NCT02164864|530655846|FG001|Overall Study|Protocol Violation|4|||
147133053|NCT02164864|530655847|FG002|Overall Study|Protocol Violation|1|||
147133054|NCT02164864|530655845|FG000|Overall Study|Lost to Follow-up|4|||
147133055|NCT02164864|530655846|FG001|Overall Study|Lost to Follow-up|3|||
147133056|NCT02164864|530655847|FG002|Overall Study|Lost to Follow-up|2|||
147133057|NCT02164864|530655845|FG000|Overall Study|Consent withdrawn, not due to AE|21|||
147133058|NCT02164864|530655846|FG001|Overall Study|Consent withdrawn, not due to AE|8|||
147133059|NCT02164864|530655847|FG002|Overall Study|Consent withdrawn, not due to AE|56|||
147133060|NCT02164864|530655845|FG000|Overall Study|Other than stated|3|||
147133061|NCT02164864|530655846|FG001|Overall Study|Other than stated|4|||
147133062|NCT02164864|530655847|FG002|Overall Study|Other than stated|14|||
147133063|NCT00652834|530655848|FG000|Overall Study|Withdrawal by Subject|3|||
147133064|NCT00652834|530655848|FG000|Overall Study|Lost to Follow-up|2|||
147133065|NCT02569853|530655849|FG000|Overall Study|Adverse Event|2|||
147133066|NCT02569853|530655850|FG001|Overall Study|Adverse Event|0|||
147133067|NCT02569853|530655849|FG000|Overall Study|Withdrawal by Subject|3|||
147133068|NCT02569853|530655850|FG001|Overall Study|Withdrawal by Subject|2|||
147133069|NCT02569853|530655849|FG000|Overall Study|Lost to Follow-up|3|||
147133070|NCT02569853|530655850|FG001|Overall Study|Lost to Follow-up|3|||
147133071|NCT02569853|530655849|FG000|Overall Study|Protocol Violation|1|||
147133072|NCT02569853|530655850|FG001|Overall Study|Protocol Violation|1|||
147133073|NCT02569853|530655849|FG000|Overall Study|Did not experience migraine attack|10|||
147133074|NCT02569853|530655850|FG001|Overall Study|Did not experience migraine attack|7|||
147133075|NCT02569853|530655849|FG000|Overall Study|Physician Decision|1|||
147133076|NCT02569853|530655850|FG001|Overall Study|Physician Decision|1|||
147133077|NCT01668004|530655851|FG000|Overall Study|Adverse Event|7|||
147133078|NCT01668004|530655851|FG000|Overall Study|Withdrawal by Subject|2|||
147133079|NCT01668004|530655851|FG000|Overall Study|Lost to Follow-up|5|||
147133080|NCT01668004|530655851|FG000|Overall Study|Lack of Efficacy|9|||
147133081|NCT01668004|530655851|FG000|Overall Study|Non-compliance with treatment|2|||
147133082|NCT00335829|530655855|FG000|Overall Study|Withdrawal by Subject|1|||
147133083|NCT00335829|530655855|FG000|Overall Study|Lost to Follow-up|1|||
147133084|NCT00335829|530655855|FG000|Overall Study|Adverse Event|1|||
147133085|NCT00854360|530655856|FG000|Overall Study|Adverse Event|0|||
147133086|NCT00854360|530655857|FG001|Overall Study|Adverse Event|1|||
147133087|NCT00854360|530655858|FG002|Overall Study|Adverse Event|2|||
147133088|NCT00854360|530655859|FG003|Overall Study|Adverse Event|6|||
147133089|NCT00854360|530655856|FG000|Overall Study|Withdrawal by Subject|0|||
147133090|NCT00854360|530655857|FG001|Overall Study|Withdrawal by Subject|0|||
147133091|NCT00854360|530655858|FG002|Overall Study|Withdrawal by Subject|0|||
147133092|NCT00854360|530655859|FG003|Overall Study|Withdrawal by Subject|1|||
147133093|NCT00854360|530655856|FG000|Overall Study|Pregnancy|0|||
147133094|NCT00854360|530655857|FG001|Overall Study|Pregnancy|1|||
147133095|NCT00854360|530655858|FG002|Overall Study|Pregnancy|0|||
147133096|NCT00854360|530655859|FG003|Overall Study|Pregnancy|0|||
147133097|NCT00854360|530655856|FG000|Overall Study|Lack of Efficacy|2|||
147133098|NCT00854360|530655857|FG001|Overall Study|Lack of Efficacy|1|||
147133099|NCT00854360|530655858|FG002|Overall Study|Lack of Efficacy|0|||
147133100|NCT00854360|530655859|FG003|Overall Study|Lack of Efficacy|0|||
147133101|NCT00854360|530655856|FG000|Overall Study|Other|0|||
147133102|NCT00854360|530655857|FG001|Overall Study|Other|0|||
147133103|NCT00854360|530655858|FG002|Overall Study|Other|0|||
147133104|NCT00854360|530655859|FG003|Overall Study|Other|3|||
147133105|NCT00754572|530655860|FG000|Overall Study|Adverse Event|19|||
147133106|NCT00754572|530655860|FG000|Overall Study|Other|39|||
147133107|NCT00754572|530655860|FG000|Overall Study|Protocol Violation|3|||
147133108|NCT00754572|530655860|FG000|Overall Study|Withdrawal by Subject|3|||
147133109|NCT00754572|530655860|FG000|Overall Study|Lack of Efficacy|2|||
147133110|NCT00754572|530655860|FG000|Overall Study|Death|1|||
147133111|NCT00754572|530655860|FG000|Overall Study|Administrative Reason|3|||
147236966|NCT00347360|531037429|FG004|Overall Study|Prolonged duration between visits|0|||
147236967|NCT00347360|531037430|FG005|Overall Study|Prolonged duration between visits|0|||
147236968|NCT00347360|531037431|FG006|Overall Study|Prolonged duration between visits|0|||
147236969|NCT00347360|531037432|FG007|Overall Study|Prolonged duration between visits|0|||
147236970|NCT00347360|531037433|FG008|Overall Study|Prolonged duration between visits|0|||
147133112|NCT00754572|530655860|FG000|Overall Study|Lost to Follow-up|1|||
147133113|NCT02006927|530655863|FG000|Overall Study|Adverse Event|2|||
147133114|NCT02006927|530655863|FG000|Overall Study|Withdrawal by Subject|1|||
147133115|NCT02735200|530655866|FG000|Overall Study|Lost to Follow-up|0|||
147236971|NCT00347360|531037434|FG009|Overall Study|Prolonged duration between visits|0|||
147445290|NCT03134599|531795800|FG004|Week 3|Lost to Follow-up|0|||
147133116|NCT02735200|530655867|FG001|Overall Study|Lost to Follow-up|5|||
147133117|NCT02735200|530655866|FG000|Overall Study|Withdrawal by Subject|8|||
147133118|NCT02735200|530655867|FG001|Overall Study|Withdrawal by Subject|0|||
147133119|NCT02746809|530655868|FG000|Enrollment|Inclusion Exclusion not met|9|||
147133120|NCT02746809|530655868|FG000|Enrollment|Withdrawal by Subject|1|||
147133121|NCT02746809|530655868|FG000|Enrollment|Expected Enrollment Met|2|||
147133122|NCT02746809|530655868|FG000|Procedure|Death|1|||
147651365|NCT03488563|532546448|FG001|Overall Study|Subject did not meet minimum number of migraines per month|0|||
147651366|NCT03488563|532546449|FG002|Overall Study|Subject did not meet minimum number of migraines per month|0|||
147651367|NCT03488563|532546447|FG000|Overall Study|Use of prohibited medication|2|||
147651368|NCT03488563|532546448|FG001|Overall Study|Use of prohibited medication|0|||
147651369|NCT03488563|532546449|FG002|Overall Study|Use of prohibited medication|0|||
147651370|NCT03488563|532546447|FG000|Overall Study|Adverse Event|1|||
147651371|NCT03488563|532546448|FG001|Overall Study|Adverse Event|0|||
147651372|NCT03488563|532546449|FG002|Overall Study|Adverse Event|1|||
147651373|NCT03488563|532546447|FG000|Overall Study|Subject returned for ET visit|0|||
147651374|NCT03488563|532546448|FG001|Overall Study|Subject returned for ET visit|1|||
147651375|NCT03488563|532546449|FG002|Overall Study|Subject returned for ET visit|0|||
147651376|NCT03488563|532546447|FG000|Overall Study|Sponsor's decision|0|||
147651377|NCT03488563|532546448|FG001|Overall Study|Sponsor's decision|0|||
147651378|NCT03488563|532546449|FG002|Overall Study|Sponsor's decision|1|||
147651379|NCT00582426|532546456|FG000|Overall Study|Lost to Follow-up|0|||
147651380|NCT00582426|532546457|FG001|Overall Study|Lost to Follow-up|2|||
147651381|NCT00582426|532546456|FG000|Overall Study|Adverse Event|4|||
147651382|NCT00582426|532546457|FG001|Overall Study|Adverse Event|2|||
147651383|NCT00582426|532546456|FG000|Overall Study|Protocol Violation|6|||
147651384|NCT00582426|532546457|FG001|Overall Study|Protocol Violation|2|||
147651385|NCT00582426|532546456|FG000|Overall Study|Death|4|||
147651386|NCT00582426|532546457|FG001|Overall Study|Death|3|||
147651387|NCT00582426|532546456|FG000|Overall Study|Withdrawal by Subject|3|||
147651388|NCT00582426|532546457|FG001|Overall Study|Withdrawal by Subject|2|||
147651389|NCT00582426|532546456|FG000|Overall Study|Disease Progression|2|||
147651390|NCT00582426|532546457|FG001|Overall Study|Disease Progression|2|||
147651391|NCT00582426|532546456|FG000|Overall Study|Use of illicit drugs|1|||
147651392|NCT00582426|532546457|FG001|Overall Study|Use of illicit drugs|0|||
147651393|NCT02626000|532546460|FG000|Overall Study|Decision by Sponsor|1|||
147651394|NCT02626000|532546460|FG000|Overall Study|Death|29|||
147651395|NCT02164318|532546461|FG000|Overall Study|Withdrawal by Subject|0|||
147133123|NCT02746809|530655868|FG000|1-Month|Death|5|||
147133124|NCT02746809|530655868|FG000|6-Month|Death|2|||
147133125|NCT02746809|530655868|FG000|6-Month|Withdrawal by Subject|1|||
147133126|NCT02746809|530655868|FG000|12-Month|Death|3|||
147133127|NCT02746809|530655868|FG000|12-Month|Withdrawal by Subject|2|||
147133128|NCT02746809|530655868|FG000|24-Month|Death|1|||
147133129|NCT02746809|530655868|FG000|24-Month|Withdrawal by Subject|1|||
147133130|NCT02746809|530655868|FG000|36-Month|Death|8|||
147133131|NCT02746809|530655868|FG000|36-Month|Withdrawal by Subject|1|||
147133132|NCT02746809|530655868|FG000|48-Month|Death|7|||
147133133|NCT02746809|530655868|FG000|48-Month|Withdrawal by Subject|1|||
147133134|NCT02746809|530655868|FG000|60-Month|Death|1|||
147133135|NCT02746809|530655868|FG000|60-Month|Lost to Follow-up|2|||
147133136|NCT01164007|530655871|FG000|Overall Study|Adverse Event|5|||
147133137|NCT01164007|530655871|FG000|Overall Study|Progression of Disease|30|||
147133138|NCT01164007|530655871|FG000|Overall Study|Protocol Violation|1|||
147133139|NCT01164007|530655871|FG000|Overall Study|Withdrawal by Subject|1|||
147133140|NCT01164007|530655871|FG000|Overall Study|Medical Decision|3|||
147133141|NCT00894387|530655872|FG000|Overall Study|Adverse Event|44|||
147133142|NCT00894387|530655873|FG001|Overall Study|Adverse Event|45|||
147133143|NCT00894387|530655872|FG000|Overall Study|Abnormal Laboratory values|2|||
147133144|NCT00894387|530655873|FG001|Overall Study|Abnormal Laboratory values|2|||
147133145|NCT00894387|530655872|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
147133146|NCT00894387|530655873|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
147133147|NCT00894387|530655872|FG000|Overall Study|Lost to Follow-up|3|||
147133148|NCT00894387|530655873|FG001|Overall Study|Lost to Follow-up|5|||
147133149|NCT00894387|530655872|FG000|Overall Study|Administrative problems|2|||
147133150|NCT00894387|530655873|FG001|Overall Study|Administrative problems|2|||
147133151|NCT00894387|530655872|FG000|Overall Study|Death|77|||
147133152|NCT00894387|530655873|FG001|Overall Study|Death|76|||
147133153|NCT00894387|530655872|FG000|Overall Study|Protocol Deviation|4|||
147133154|NCT00894387|530655873|FG001|Overall Study|Protocol Deviation|0|||
147133155|NCT00894387|530655872|FG000|Overall Study|Patient's request|25|||
147133156|NCT00894387|530655873|FG001|Overall Study|Patient's request|30|||
147651396|NCT02164318|532546462|FG001|Overall Study|Withdrawal by Subject|1|||
147651397|NCT02164318|532546463|FG002|Overall Study|Withdrawal by Subject|0|||
147651398|NCT02164318|532546464|FG003|Overall Study|Withdrawal by Subject|1|||
147651399|NCT00662311|532546465|FG000|Overall Study|Respiratory Infection|1|||
147651400|NCT00662311|532546466|FG001|Overall Study|Respiratory Infection|0|||
147133157|NCT00894387|530655872|FG000|Overall Study|Other (Missing)|5|||
147133158|NCT00894387|530655873|FG001|Overall Study|Other (Missing)|3|||
147317761|NCT02500316|531329375|FG000|Overall Study|Due to war activity|1|||
147651401|NCT00662311|532546467|FG002|Overall Study|Respiratory Infection|0|||
147651402|NCT01964989|532546470|FG000|Overall Study|Protocol Violation|3|||
147133159|NCT00894387|530655872|FG000|Overall Study|Mis-randomized|13|||
147133160|NCT00894387|530655873|FG001|Overall Study|Mis-randomized|9|||
147133161|NCT00894387|530655872|FG000|Overall Study|GCP non-compliance|0|||
147133162|NCT00894387|530655873|FG001|Overall Study|GCP non-compliance|2|||
147317762|NCT01406717|531329376|FG000|Overall Study|Subject non-compliance|4|||
147317763|NCT01406717|531329377|FG001|Overall Study|Subject non-compliance|3|||
147317764|NCT01406717|531329376|FG000|Overall Study|Protocol Violation|5|||
147317765|NCT01406717|531329377|FG001|Overall Study|Protocol Violation|1|||
147317766|NCT01406717|531329376|FG000|Overall Study|Lost to Follow-up|14|||
147317767|NCT01406717|531329377|FG001|Overall Study|Lost to Follow-up|8|||
147317768|NCT01406717|531329376|FG000|Overall Study|Withdrawal by Subject|19|||
147317769|NCT01406717|531329377|FG001|Overall Study|Withdrawal by Subject|15|||
147317770|NCT01406717|531329376|FG000|Overall Study|Adverse Event|1|||
147317771|NCT01406717|531329377|FG001|Overall Study|Adverse Event|2|||
147317772|NCT01406717|531329376|FG000|Overall Study|Lack of Efficacy|0|||
147317773|NCT01406717|531329377|FG001|Overall Study|Lack of Efficacy|1|||
147317774|NCT01406717|531329376|FG000|Overall Study|Non-completion of visit activity|0|||
147317775|NCT01406717|531329377|FG001|Overall Study|Non-completion of visit activity|1|||
147317776|NCT03257995|531329378|FG000|Overall Study|Adverse Event|0|||
147317777|NCT03257995|531329379|FG001|Overall Study|Adverse Event|1|||
147317778|NCT03257995|531329380|FG002|Overall Study|Adverse Event|0|||
147317779|NCT03257995|531329381|FG003|Overall Study|Adverse Event|0|||
147317780|NCT03257995|531329382|FG004|Overall Study|Adverse Event|0|||
147317781|NCT03257995|531329383|FG005|Overall Study|Adverse Event|0|||
147317782|NCT03257995|531329378|FG000|Overall Study|Protocol deviation|0|||
147317783|NCT03257995|531329379|FG001|Overall Study|Protocol deviation|0|||
147317784|NCT03257995|531329380|FG002|Overall Study|Protocol deviation|0|||
147317785|NCT03257995|531329381|FG003|Overall Study|Protocol deviation|0|||
147317786|NCT03257995|531329382|FG004|Overall Study|Protocol deviation|0|||
147317787|NCT03257995|531329383|FG005|Overall Study|Protocol deviation|2|||
147317788|NCT02040090|531329384|FG000|Overall Study|Adverse Event|2|||
147317789|NCT02040090|531329385|FG001|Overall Study|Adverse Event|0|||
147317790|NCT02040090|531329384|FG000|Overall Study|Physician Decision|1|||
147317791|NCT02040090|531329385|FG001|Overall Study|Physician Decision|0|||
147317792|NCT02040090|531329384|FG000|Overall Study|Withdrawal by Subject|0|||
147317793|NCT02040090|531329385|FG001|Overall Study|Withdrawal by Subject|1|||
147317794|NCT02040090|531329384|FG000|Overall Study|Lost to Follow-up|0|||
147317795|NCT02040090|531329385|FG001|Overall Study|Lost to Follow-up|1|||
147317796|NCT02584855|531329393|FG000|Open-Label Treatment Period|Lack of Efficacy|61|||
147317797|NCT02584855|531329394|FG001|Open-Label Treatment Period|Lack of Efficacy|0|||
147317798|NCT02584855|531329395|FG002|Open-Label Treatment Period|Lack of Efficacy|0|||
147317799|NCT02584855|531329396|FG003|Open-Label Treatment Period|Lack of Efficacy|0|||
147317800|NCT02584855|531329397|FG004|Open-Label Treatment Period|Lack of Efficacy|0|||
147317801|NCT02584855|531329398|FG005|Open-Label Treatment Period|Lack of Efficacy|0|||
147317802|NCT02584855|531329393|FG000|Open-Label Treatment Period|Withdrawal by Subject|21|||
147317803|NCT02584855|531329394|FG001|Open-Label Treatment Period|Withdrawal by Subject|0|||
147317804|NCT02584855|531329395|FG002|Open-Label Treatment Period|Withdrawal by Subject|0|||
147317805|NCT02584855|531329396|FG003|Open-Label Treatment Period|Withdrawal by Subject|0|||
147133163|NCT00744861|530655874|FG000|Feasibility Stage 1|Withdrawal by Subject|1|||
147133164|NCT00744861|530655875|FG001|Feasibility Stage 1|Withdrawal by Subject|1|||
147133165|NCT00744861|530655876|FG002|Feasibility Stage 1|Withdrawal by Subject|0|||
147133166|NCT00744861|530655877|FG003|Feasibility Stage 1|Withdrawal by Subject|0|||
147133167|NCT00744861|530655874|FG000|Feasibility Stage 1|Pregnancy|0|||
147317806|NCT02584855|531329397|FG004|Open-Label Treatment Period|Withdrawal by Subject|0|||
147317807|NCT02584855|531329398|FG005|Open-Label Treatment Period|Withdrawal by Subject|0|||
147317808|NCT02584855|531329393|FG000|Open-Label Treatment Period|Adverse Event|14|||
147317809|NCT02584855|531329394|FG001|Open-Label Treatment Period|Adverse Event|0|||
147317810|NCT02584855|531329395|FG002|Open-Label Treatment Period|Adverse Event|0|||
147317811|NCT02584855|531329396|FG003|Open-Label Treatment Period|Adverse Event|0|||
147317812|NCT02584855|531329397|FG004|Open-Label Treatment Period|Adverse Event|0|||
147317813|NCT02584855|531329398|FG005|Open-Label Treatment Period|Adverse Event|0|||
147317814|NCT02584855|531329393|FG000|Open-Label Treatment Period|Death|2|||
147317815|NCT02584855|531329394|FG001|Open-Label Treatment Period|Death|0|||
147317816|NCT02584855|531329395|FG002|Open-Label Treatment Period|Death|0|||
147317817|NCT02584855|531329396|FG003|Open-Label Treatment Period|Death|0|||
147317818|NCT02584855|531329397|FG004|Open-Label Treatment Period|Death|0|||
147317819|NCT02584855|531329398|FG005|Open-Label Treatment Period|Death|0|||
147317820|NCT02584855|531329393|FG000|Open-Label Treatment Period|Lost to Follow-up|1|||
147317821|NCT02584855|531329394|FG001|Open-Label Treatment Period|Lost to Follow-up|0|||
147317822|NCT02584855|531329395|FG002|Open-Label Treatment Period|Lost to Follow-up|0|||
147317823|NCT02584855|531329396|FG003|Open-Label Treatment Period|Lost to Follow-up|0|||
147445291|NCT03134599|531795801|FG005|Week 3|Lost to Follow-up|1|||
147445292|NCT01265615|531795802|FG000|Overall Study|Protocol Violation|2|||
147133168|NCT00744861|530655875|FG001|Feasibility Stage 1|Pregnancy|1|||
147317824|NCT02584855|531329397|FG004|Open-Label Treatment Period|Lost to Follow-up|0|||
147317825|NCT02584855|531329398|FG005|Open-Label Treatment Period|Lost to Follow-up|0|||
147317826|NCT02584855|531329393|FG000|Open-Label Treatment Period|Protocol Violation|1|||
147317827|NCT02584855|531329394|FG001|Open-Label Treatment Period|Protocol Violation|0|||
147317828|NCT02584855|531329395|FG002|Open-Label Treatment Period|Protocol Violation|0|||
147317829|NCT02584855|531329396|FG003|Open-Label Treatment Period|Protocol Violation|0|||
147133169|NCT00744861|530655876|FG002|Feasibility Stage 1|Pregnancy|0|||
147133170|NCT00744861|530655877|FG003|Feasibility Stage 1|Pregnancy|0|||
147133171|NCT00744861|530655874|FG000|Pivotal Stage 2|Adverse Event|0|||
147133172|NCT00744861|530655875|FG001|Pivotal Stage 2|Adverse Event|0|||
147133173|NCT00744861|530655876|FG002|Pivotal Stage 2|Adverse Event|6|||
147133174|NCT00744861|530655877|FG003|Pivotal Stage 2|Adverse Event|11|||
147133175|NCT00744861|530655874|FG000|Pivotal Stage 2|Death|0|||
147133176|NCT00744861|530655875|FG001|Pivotal Stage 2|Death|0|||
147133177|NCT00744861|530655876|FG002|Pivotal Stage 2|Death|0|||
147133178|NCT00744861|530655877|FG003|Pivotal Stage 2|Death|1|||
147133179|NCT00744861|530655874|FG000|Pivotal Stage 2|Lost to Follow-up|0|||
147133180|NCT00744861|530655875|FG001|Pivotal Stage 2|Lost to Follow-up|0|||
147133181|NCT00744861|530655876|FG002|Pivotal Stage 2|Lost to Follow-up|13|||
147133182|NCT00744861|530655877|FG003|Pivotal Stage 2|Lost to Follow-up|14|||
147133183|NCT00744861|530655874|FG000|Pivotal Stage 2|Physician Decision|0|||
147133184|NCT00744861|530655875|FG001|Pivotal Stage 2|Physician Decision|0|||
147133185|NCT00744861|530655876|FG002|Pivotal Stage 2|Physician Decision|3|||
147133186|NCT00744861|530655877|FG003|Pivotal Stage 2|Physician Decision|1|||
147133187|NCT00744861|530655874|FG000|Pivotal Stage 2|Protocol Violation|0|||
147133188|NCT00744861|530655875|FG001|Pivotal Stage 2|Protocol Violation|0|||
147133189|NCT00744861|530655876|FG002|Pivotal Stage 2|Protocol Violation|0|||
147133190|NCT00744861|530655877|FG003|Pivotal Stage 2|Protocol Violation|1|||
147133191|NCT00744861|530655874|FG000|Pivotal Stage 2|Withdrawal by Subject|0|||
147133192|NCT00744861|530655875|FG001|Pivotal Stage 2|Withdrawal by Subject|0|||
147133193|NCT00744861|530655876|FG002|Pivotal Stage 2|Withdrawal by Subject|20|||
147133194|NCT00744861|530655877|FG003|Pivotal Stage 2|Withdrawal by Subject|14|||
147133195|NCT00744861|530655874|FG000|Pivotal Stage 2|Study Terminated by Sponsor|0|||
147133196|NCT00744861|530655875|FG001|Pivotal Stage 2|Study Terminated by Sponsor|0|||
147133197|NCT00744861|530655876|FG002|Pivotal Stage 2|Study Terminated by Sponsor|60|||
147133198|NCT00744861|530655877|FG003|Pivotal Stage 2|Study Terminated by Sponsor|63|||
147133199|NCT02493764|530655878|FG000|Overall Study|Adverse Event|2|||
147133200|NCT02493764|530655879|FG001|Overall Study|Adverse Event|2|||
147133201|NCT02493764|530655878|FG000|Overall Study|Death|44|||
147133202|NCT02493764|530655879|FG001|Overall Study|Death|58|||
147133203|NCT02493764|530655878|FG000|Overall Study|Lost to Follow-up|2|||
147133204|NCT02493764|530655879|FG001|Overall Study|Lost to Follow-up|1|||
147133205|NCT02493764|530655878|FG000|Overall Study|Protocol Violation|6|||
147133206|NCT02493764|530655879|FG001|Overall Study|Protocol Violation|7|||
147133207|NCT02493764|530655878|FG000|Overall Study|Physician Decision|1|||
147133208|NCT02493764|530655879|FG001|Overall Study|Physician Decision|1|||
147133209|NCT02493764|530655878|FG000|Overall Study|Participant moved|17|||
147133210|NCT02493764|530655879|FG001|Overall Study|Participant moved|5|||
147133211|NCT02493764|530655878|FG000|Overall Study|Withdrawal parent/guardian|0|||
147133212|NCT02493764|530655879|FG001|Overall Study|Withdrawal parent/guardian|1|||
147133213|NCT02493764|530655878|FG000|Overall Study|Withdrawal by Subject|11|||
147133214|NCT02493764|530655879|FG001|Overall Study|Withdrawal by Subject|7|||
147133215|NCT01561976|530655880|FG000|Period 1|Adverse Event|0|||
147133216|NCT01561976|530655881|FG001|Period 1|Adverse Event|0|||
147133217|NCT01561976|530655882|FG002|Period 1|Adverse Event|1|||
147133218|NCT01561976|530655883|FG003|Period 1|Adverse Event|0|||
147133219|NCT01561976|530655884|FG004|Period 1|Adverse Event|0|||
147133220|NCT01561976|530655885|FG005|Period 1|Adverse Event|0|||
147133221|NCT01561976|530655880|FG000|Washout Period 1 (7 Days)|Adverse Event|0|||
147133222|NCT01561976|530655881|FG001|Washout Period 1 (7 Days)|Adverse Event|0|||
147133223|NCT01561976|530655882|FG002|Washout Period 1 (7 Days)|Adverse Event|0|||
147133224|NCT01561976|530655883|FG003|Washout Period 1 (7 Days)|Adverse Event|1|||
147133225|NCT01561976|530655884|FG004|Washout Period 1 (7 Days)|Adverse Event|0|||
147133226|NCT01561976|530655885|FG005|Washout Period 1 (7 Days)|Adverse Event|0|||
147133227|NCT01561976|530655880|FG000|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
147133228|NCT01561976|530655881|FG001|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
147133229|NCT01561976|530655882|FG002|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
147133230|NCT01561976|530655883|FG003|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
147133231|NCT01561976|530655884|FG004|Washout Period 1 (7 Days)|Withdrawal by Subject|0|||
147133232|NCT01561976|530655885|FG005|Washout Period 1 (7 Days)|Withdrawal by Subject|1|||
147133233|NCT01561976|530655880|FG000|Washout Period 2 (7 Days)|Non-compliance|1|||
147133234|NCT01561976|530655881|FG001|Washout Period 2 (7 Days)|Non-compliance|0|||
147133235|NCT01561976|530655882|FG002|Washout Period 2 (7 Days)|Non-compliance|1|||
147133236|NCT01561976|530655883|FG003|Washout Period 2 (7 Days)|Non-compliance|0|||
147133237|NCT01561976|530655884|FG004|Washout Period 2 (7 Days)|Non-compliance|0|||
147133238|NCT01561976|530655885|FG005|Washout Period 2 (7 Days)|Non-compliance|0|||
147133239|NCT01977222|530655888|FG000|Overall Study|Withdrawal by Subject|1|||
147133240|NCT04165824|530655889|FG000|Overall Study|Adverse Event|23|||
147133241|NCT04165824|530655889|FG000|Overall Study|Physician Decision|1|||
147133242|NCT04165824|530655889|FG000|Overall Study|Withdrawal by Subject|17|||
147133243|NCT04165824|530655889|FG000|Overall Study|Other|5|||
147133244|NCT04403919|530655890|FG000|Overall Study|Lost to Follow-up|0|||
147133245|NCT04403919|530655891|FG001|Overall Study|Lost to Follow-up|0|||
147133246|NCT04403919|530655892|FG002|Overall Study|Lost to Follow-up|0|||
147651403|NCT01964989|532546471|FG001|Overall Study|Protocol Violation|4|||
147133247|NCT04403919|530655893|FG003|Overall Study|Lost to Follow-up|1|||
147133248|NCT04846231|530655897|FG000|Overall Study|Lost to Follow-up|1|||
147133249|NCT04846231|530655898|FG001|Overall Study|Lost to Follow-up|0|||
147651404|NCT01964989|532546470|FG000|Overall Study|Administrative Reason|103|||
147651405|NCT01964989|532546471|FG001|Overall Study|Administrative Reason|95|||
147133250|NCT04846231|530655899|FG002|Overall Study|Lost to Follow-up|0|||
147133251|NCT04846231|530655900|FG003|Overall Study|Lost to Follow-up|0|||
147133252|NCT04846231|530655901|FG004|Overall Study|Lost to Follow-up|0|||
147133253|NCT04846231|530655902|FG005|Overall Study|Lost to Follow-up|0|||
147133254|NCT04846231|530655903|FG006|Overall Study|Lost to Follow-up|0|||
147133255|NCT04846231|530655904|FG007|Overall Study|Lost to Follow-up|1|||
147133256|NCT04846231|530655897|FG000|Overall Study|Withdrawal by Subject|0|||
147133257|NCT04846231|530655898|FG001|Overall Study|Withdrawal by Subject|1|||
147133258|NCT04846231|530655899|FG002|Overall Study|Withdrawal by Subject|2|||
147133259|NCT04846231|530655900|FG003|Overall Study|Withdrawal by Subject|1|||
147133260|NCT04846231|530655901|FG004|Overall Study|Withdrawal by Subject|0|||
147133261|NCT04846231|530655902|FG005|Overall Study|Withdrawal by Subject|0|||
147133262|NCT04846231|530655903|FG006|Overall Study|Withdrawal by Subject|0|||
147133263|NCT04846231|530655904|FG007|Overall Study|Withdrawal by Subject|0|||
147133264|NCT04846231|530655897|FG000|Overall Study|Protocol Violation|0|||
147133265|NCT04846231|530655898|FG001|Overall Study|Protocol Violation|1|||
147133266|NCT04846231|530655899|FG002|Overall Study|Protocol Violation|0|||
147133267|NCT04846231|530655900|FG003|Overall Study|Protocol Violation|0|||
147133268|NCT04846231|530655901|FG004|Overall Study|Protocol Violation|0|||
147133269|NCT04846231|530655902|FG005|Overall Study|Protocol Violation|0|||
147133270|NCT04846231|530655903|FG006|Overall Study|Protocol Violation|0|||
147317830|NCT02584855|531329397|FG004|Open-Label Treatment Period|Protocol Violation|0|||
147317831|NCT02584855|531329398|FG005|Open-Label Treatment Period|Protocol Violation|0|||
147317832|NCT02584855|531329393|FG000|Open-Label Treatment Period|No PI Available|2|||
147317833|NCT02584855|531329394|FG001|Open-Label Treatment Period|No PI Available|0|||
147317834|NCT02584855|531329395|FG002|Open-Label Treatment Period|No PI Available|0|||
147317835|NCT02584855|531329396|FG003|Open-Label Treatment Period|No PI Available|0|||
147317836|NCT02584855|531329397|FG004|Open-Label Treatment Period|No PI Available|0|||
147317837|NCT02584855|531329398|FG005|Open-Label Treatment Period|No PI Available|0|||
147317838|NCT02584855|531329393|FG000|Open-Label Treatment Period|Sponsor Decision|1|||
147317839|NCT02584855|531329394|FG001|Open-Label Treatment Period|Sponsor Decision|0|||
147317840|NCT02584855|531329395|FG002|Open-Label Treatment Period|Sponsor Decision|0|||
147317841|NCT02584855|531329396|FG003|Open-Label Treatment Period|Sponsor Decision|0|||
147317842|NCT02584855|531329397|FG004|Open-Label Treatment Period|Sponsor Decision|0|||
147317843|NCT02584855|531329398|FG005|Open-Label Treatment Period|Sponsor Decision|0|||
147317844|NCT02584855|531329393|FG000|Double-Blind Withdrawal Period|Withdrawal by Subject|0|||
147317845|NCT02584855|531329394|FG001|Double-Blind Withdrawal Period|Withdrawal by Subject|0|||
147317846|NCT02584855|531329395|FG002|Double-Blind Withdrawal Period|Withdrawal by Subject|2|||
147317847|NCT02584855|531329396|FG003|Double-Blind Withdrawal Period|Withdrawal by Subject|0|||
147317848|NCT02584855|531329397|FG004|Double-Blind Withdrawal Period|Withdrawal by Subject|0|||
147317849|NCT02584855|531329398|FG005|Double-Blind Withdrawal Period|Withdrawal by Subject|0|||
147317850|NCT02584855|531329393|FG000|Double-Blind Withdrawal Period|Adverse Event|0|||
147317851|NCT02584855|531329394|FG001|Double-Blind Withdrawal Period|Adverse Event|4|||
147317852|NCT02584855|531329395|FG002|Double-Blind Withdrawal Period|Adverse Event|0|||
147317853|NCT02584855|531329396|FG003|Double-Blind Withdrawal Period|Adverse Event|1|||
147317854|NCT02584855|531329397|FG004|Double-Blind Withdrawal Period|Adverse Event|0|||
147317855|NCT02584855|531329398|FG005|Double-Blind Withdrawal Period|Adverse Event|0|||
147651406|NCT01964989|532546470|FG000|Overall Study|Adverse Event|0|||
147651407|NCT01964989|532546471|FG001|Overall Study|Adverse Event|1|||
147133271|NCT04846231|530655904|FG007|Overall Study|Protocol Violation|0|||
147133272|NCT04846231|530655897|FG000|Overall Study|Adverse Event|0|||
147133273|NCT04846231|530655898|FG001|Overall Study|Adverse Event|0|||
147133274|NCT04846231|530655899|FG002|Overall Study|Adverse Event|0|||
147133275|NCT04846231|530655900|FG003|Overall Study|Adverse Event|0|||
147317856|NCT02584855|531329393|FG000|Double-Blind Withdrawal Period|Lack of Efficacy|0|||
147317857|NCT02584855|531329394|FG001|Double-Blind Withdrawal Period|Lack of Efficacy|10|||
147317858|NCT02584855|531329395|FG002|Double-Blind Withdrawal Period|Lack of Efficacy|0|||
147317859|NCT02584855|531329396|FG003|Double-Blind Withdrawal Period|Lack of Efficacy|0|||
147317860|NCT02584855|531329397|FG004|Double-Blind Withdrawal Period|Lack of Efficacy|0|||
147317861|NCT02584855|531329398|FG005|Double-Blind Withdrawal Period|Lack of Efficacy|0|||
147317862|NCT02584855|531329393|FG000|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0|||
147651408|NCT01964989|532546470|FG000|Overall Study|Death|1|||
147651409|NCT01964989|532546471|FG001|Overall Study|Death|3|||
147133276|NCT04846231|530655901|FG004|Overall Study|Adverse Event|0|||
147133277|NCT04846231|530655902|FG005|Overall Study|Adverse Event|0|||
147133278|NCT04846231|530655903|FG006|Overall Study|Adverse Event|1|||
147133279|NCT04846231|530655904|FG007|Overall Study|Adverse Event|1|||
147133280|NCT02980107|530655905|FG000|Overall Study|Withdrawal by Subject|51|||
147133281|NCT02980107|530655906|FG001|Overall Study|Withdrawal by Subject|62|||
147651410|NCT01964989|532546470|FG000|Overall Study|Withdrawal by Subject|156|||
147651411|NCT01964989|532546471|FG001|Overall Study|Withdrawal by Subject|160|||
147651412|NCT01964989|532546470|FG000|Overall Study|Lost to Follow-up|254|||
147651413|NCT01964989|532546471|FG001|Overall Study|Lost to Follow-up|232|||
147651414|NCT01964989|532546470|FG000|Overall Study|Other|267|||
147651415|NCT01964989|532546471|FG001|Overall Study|Other|252|||
147651416|NCT02499263|532546472|FG000|Overall Study|Lost to Follow-up|9|||
147651417|NCT02499263|532546472|FG000|Overall Study|Participant's withdrawal of consent|4|||
147651418|NCT02499263|532546472|FG000|Overall Study|Lack of Efficacy|22|||
147651419|NCT02499263|532546472|FG000|Overall Study|investigator's judgment|12|||
147651420|NCT02499263|532546472|FG000|Overall Study|Adverse Events/Serious Adverse Events|11|||
147651421|NCT02499263|532546472|FG000|Overall Study|Participant's decision|3|||
147651422|NCT02499263|532546472|FG000|Overall Study|Pregnancy|1|||
147651423|NCT04126317|532546473|FG000|Overall Study|Adverse Event|0|||
147651424|NCT04126317|532546474|FG001|Overall Study|Adverse Event|1|||
147651425|NCT04126317|532546473|FG000|Overall Study|Withdrawal by Subject|4|||
147133282|NCT02303262|530655907|FG000|Overall Study|Withdrawal by Subject|2|||
147133283|NCT01038323|530655914|FG000|Overall Study|Withdrawal by Subject|3|||
147133284|NCT01038323|530655915|FG001|Overall Study|Withdrawal by Subject|2|||
147133285|NCT01038323|530655916|FG002|Overall Study|Withdrawal by Subject|4|||
147133286|NCT02257528|530655917|FG000|Overall Study|Never received study treatment|1|||
147133287|NCT00404248|530655918|FG000|Overall Study|pts declining status|0|||
147133288|NCT00404248|530655919|FG001|Overall Study|pts declining status|1|||
147133289|NCT00404248|530655920|FG002|Overall Study|pts declining status|0|||
147133290|NCT00404248|530655921|FG003|Overall Study|pts declining status|0|||
147133291|NCT00404248|530655922|FG004|Overall Study|pts declining status|0|||
147133292|NCT00404248|530655923|FG005|Overall Study|pts declining status|0|||
147133293|NCT00404248|530655924|FG006|Overall Study|pts declining status|0|||
147133294|NCT00404248|530655925|FG007|Overall Study|pts declining status|0|||
147133295|NCT00404248|530655926|FG008|Overall Study|pts declining status|0|||
147133296|NCT00789555|530655927|FG000|Overall Study|Protocol Amendment|78|||
147133297|NCT00789555|530655928|FG001|Overall Study|Protocol Amendment|76|||
147133298|NCT00789555|530655929|FG002|Overall Study|Protocol Amendment|80|||
147133299|NCT00789555|530655927|FG000|Overall Study|Adverse Event|17|||
147133300|NCT00789555|530655928|FG001|Overall Study|Adverse Event|7|||
147133301|NCT00789555|530655929|FG002|Overall Study|Adverse Event|10|||
147133302|NCT00789555|530655927|FG000|Overall Study|Lost to Follow-up|9|||
147133303|NCT00789555|530655928|FG001|Overall Study|Lost to Follow-up|10|||
147133304|NCT00789555|530655929|FG002|Overall Study|Lost to Follow-up|18|||
147133305|NCT00789555|530655927|FG000|Overall Study|Patient decision unnrelated to adv event|38|||
147133306|NCT00789555|530655928|FG001|Overall Study|Patient decision unnrelated to adv event|29|||
147133307|NCT00789555|530655929|FG002|Overall Study|Patient decision unnrelated to adv event|26|||
147133308|NCT00789555|530655927|FG000|Overall Study|Treatment failure|11|||
147133309|NCT00789555|530655928|FG001|Overall Study|Treatment failure|8|||
147133310|NCT00789555|530655929|FG002|Overall Study|Treatment failure|12|||
147133311|NCT00789555|530655927|FG000|Overall Study|Protocol Violation|6|||
147133312|NCT00789555|530655928|FG001|Overall Study|Protocol Violation|9|||
147133313|NCT00789555|530655929|FG002|Overall Study|Protocol Violation|13|||
147133314|NCT00698841|530655930|FG000|Overall Study|Withdrawal by Subject|2|||
147133315|NCT00698841|530655930|FG000|Overall Study|Adverse Event|3|||
147651426|NCT04126317|532546474|FG001|Overall Study|Withdrawal by Subject|1|||
147651427|NCT00424593|532546475|FG000|Acute Double-Blind Period|Adverse Event|16|||
147651428|NCT00424593|532546476|FG001|Acute Double-Blind Period|Adverse Event|7|||
147651429|NCT00424593|532546475|FG000|Acute Double-Blind Period|Withdrawal by Subject|11|||
147651430|NCT00424593|532546476|FG001|Acute Double-Blind Period|Withdrawal by Subject|10|||
147651431|NCT00424593|532546475|FG000|Acute Double-Blind Period|Protocol Violation|2|||
147651432|NCT00424593|532546476|FG001|Acute Double-Blind Period|Protocol Violation|2|||
147651433|NCT00424593|532546475|FG000|Acute Double-Blind Period|Physician Decision|1|||
147651434|NCT00424593|532546476|FG001|Acute Double-Blind Period|Physician Decision|2|||
147651435|NCT00424593|532546475|FG000|Acute Double-Blind Period|Lost to Follow-up|1|||
147651436|NCT00424593|532546476|FG001|Acute Double-Blind Period|Lost to Follow-up|1|||
147133316|NCT00698841|530655930|FG000|Overall Study|Disease progression|7|||
147133317|NCT00698841|530655930|FG000|Overall Study|Failure to meet eligibility criteria|2|||
147133318|NCT00698841|530655930|FG000|Overall Study|Study drug toxicity|2|||
147133319|NCT00698841|530655930|FG000|Overall Study|Other|2|||
147133320|NCT04696146|530657149|FG000|Overall Study|Transplant Cancelled and did not proceed with study|0|||
147133321|NCT04696146|530657150|FG001|Overall Study|Transplant Cancelled and did not proceed with study|4|||
147133322|NCT04696146|530657149|FG000|Overall Study|Off hours issue with product|1|||
147317863|NCT02584855|531329394|FG001|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|1|||
147317864|NCT02584855|531329395|FG002|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0|||
147651437|NCT00424593|532546475|FG000|Acute Double-Blind Period|Lack of Efficacy|0|||
147651438|NCT00424593|532546476|FG001|Acute Double-Blind Period|Lack of Efficacy|1|||
147133323|NCT04696146|530657150|FG001|Overall Study|Off hours issue with product|0|||
147133324|NCT01576783|530657154|FG000|Overall Study|Change in Medical Care|1|||
147133325|NCT01576783|530657155|FG001|Overall Study|Change in Medical Care|0|||
147133326|NCT01576783|530657154|FG000|Overall Study|Lost to Follow-up|14|||
147133327|NCT01576783|530657155|FG001|Overall Study|Lost to Follow-up|16|||
147133328|NCT01576783|530657154|FG000|Overall Study|Withdrawal by Subject|5|||
147133329|NCT01576783|530657155|FG001|Overall Study|Withdrawal by Subject|1|||
147133330|NCT01897493|530657156|FG000|Period 1 (Day 1 Through Day 6 Predose)|Withdrawal by Subject|1|||
147133331|NCT01732536|530657160|FG000|Overall Study|Withdrawal by Subject|1|||
147133332|NCT01732536|530657161|FG001|Overall Study|Withdrawal by Subject|1|||
147133333|NCT05111145|530657164|FG000|Overall Study|Commercial drug is available for participant|76|||
147133334|NCT05111145|530657164|FG000|Overall Study|Participant enrolled in another qualified Vertex study|10|||
147133335|NCT01276704|530657167|FG000|Overall Study|Lost to Follow-up|2|||
147133336|NCT01276704|530657168|FG001|Overall Study|Lost to Follow-up|3|||
147133337|NCT01276704|530657167|FG000|Overall Study|Non-compliant|2|||
147133338|NCT01276704|530657168|FG001|Overall Study|Non-compliant|2|||
147133339|NCT01276704|530657167|FG000|Overall Study|Withdrawal by Subject|7|||
147133340|NCT01276704|530657168|FG001|Overall Study|Withdrawal by Subject|1|||
147133341|NCT01276704|530657167|FG000|Overall Study|Physician Decision|3|||
147133342|NCT01276704|530657168|FG001|Overall Study|Physician Decision|5|||
147133343|NCT01359956|530657169|FG000|Overall Study|Death|58|||
147133344|NCT01359956|530657170|FG001|Overall Study|Death|60|||
147133345|NCT01359956|530657171|FG002|Overall Study|Death|66|||
147133346|NCT01359956|530657172|FG003|Overall Study|Death|57|||
147133347|NCT01359956|530657169|FG000|Overall Study|Lost to Follow-up|3|||
147133348|NCT01359956|530657170|FG001|Overall Study|Lost to Follow-up|4|||
147133349|NCT01359956|530657171|FG002|Overall Study|Lost to Follow-up|1|||
147133350|NCT01359956|530657172|FG003|Overall Study|Lost to Follow-up|1|||
147133351|NCT03728933|530657173|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
147133352|NCT03728933|530657174|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
147133353|NCT03728933|530657175|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
147133354|NCT03728933|530657173|FG000|Overall Study|Withdrawal by Subject|0|||
147133355|NCT03728933|530657174|FG001|Overall Study|Withdrawal by Subject|0|||
147133356|NCT03728933|530657175|FG002|Overall Study|Withdrawal by Subject|1|||
147133357|NCT03728933|530657173|FG000|Overall Study|Lost to Follow-up|0|||
147133358|NCT03728933|530657174|FG001|Overall Study|Lost to Follow-up|1|||
147133359|NCT03728933|530657175|FG002|Overall Study|Lost to Follow-up|0|||
147133360|NCT03728933|530657173|FG000|Overall Study|Adverse Event|1|||
147133361|NCT03728933|530657174|FG001|Overall Study|Adverse Event|0|||
147133362|NCT03728933|530657175|FG002|Overall Study|Adverse Event|0|||
147133363|NCT00370292|530657176|FG000|Overall Study|Disease Progression|4|||
147133364|NCT00370292|530657176|FG000|Overall Study|Adverse Event|7|||
147133365|NCT00370292|530657176|FG000|Overall Study|Physician Decision|2|||
147133366|NCT00276419|530657177|FG000|First Intervention|Adverse Event|1|||
147133367|NCT00276419|530657178|FG001|First Intervention|Adverse Event|0|||
147133368|NCT00276419|530657177|FG000|First Intervention|Withdrawal by Subject|0|||
147570802|NCT01588236|532245283|FG000|Overall Study|Exclusion Criteria met during study|2|||
147570803|NCT01588236|532245284|FG001|Overall Study|Exclusion Criteria met during study|1|||
147570804|NCT01588236|532245285|FG002|Overall Study|Exclusion Criteria met during study|0|||
147570805|NCT01588236|532245283|FG000|Overall Study|sponsor decision|1|||
147570806|NCT01588236|532245284|FG001|Overall Study|sponsor decision|6|||
147570807|NCT01588236|532245285|FG002|Overall Study|sponsor decision|2|||
147570808|NCT04115293|532246785|FG000|Overall Study|Adverse Event|0|||
147570809|NCT04115293|532246786|FG001|Overall Study|Adverse Event|2|||
147570810|NCT04115293|532246785|FG000|Overall Study|Withdrawal by Subject|2|||
147570811|NCT04115293|532246786|FG001|Overall Study|Withdrawal by Subject|1|||
147570812|NCT04115293|532246785|FG000|Overall Study|Physician Decision|1|||
147570813|NCT04115293|532246786|FG001|Overall Study|Physician Decision|0|||
147570814|NCT04115293|532246785|FG000|Overall Study|Death|1|||
147570815|NCT04115293|532246786|FG001|Overall Study|Death|1|||
147570816|NCT02571907|532246787|FG000|Overall Study|Death|4|||
147570817|NCT02571907|532246787|FG000|Overall Study|Lost to Follow-up|3|||
147133369|NCT00276419|530657178|FG001|First Intervention|Withdrawal by Subject|2|||
147133370|NCT03801525|530657179|FG000|Overall Study|Adverse Event|17|||
147570818|NCT02571907|532246787|FG000|Overall Study|Withdrawal by Subject|3|||
147133371|NCT03801525|530657180|FG001|Overall Study|Adverse Event|1|||
147133372|NCT03801525|530657181|FG002|Overall Study|Adverse Event|0|||
147133373|NCT03801525|530657179|FG000|Overall Study|Conditions Requiring Therapeutic Intervention Not Permitted by The Protocol|1|||
147133374|NCT03801525|530657180|FG001|Overall Study|Conditions Requiring Therapeutic Intervention Not Permitted by The Protocol|0|||
147133375|NCT03801525|530657181|FG002|Overall Study|Conditions Requiring Therapeutic Intervention Not Permitted by The Protocol|0|||
147133376|NCT03801525|530657179|FG000|Overall Study|Death|29|||
147133377|NCT03801525|530657180|FG001|Overall Study|Death|1|||
147133378|NCT03801525|530657181|FG002|Overall Study|Death|4|||
147133379|NCT03801525|530657179|FG000|Overall Study|Disease Progression|6|||
147133380|NCT03801525|530657180|FG001|Overall Study|Disease Progression|0|||
147133381|NCT03801525|530657181|FG002|Overall Study|Disease Progression|1|||
147570819|NCT02286739|532246788|FG000|Overall Study|Verasense type posterior stabilizing (PS)|37|||
147570820|NCT02286739|532246789|FG001|Overall Study|Verasense type posterior stabilizing (PS)|16|||
147133382|NCT03801525|530657179|FG000|Overall Study|Inability to Comply With Study Requirements|1|||
147133383|NCT03801525|530657180|FG001|Overall Study|Inability to Comply With Study Requirements|1|||
147133384|NCT03801525|530657181|FG002|Overall Study|Inability to Comply With Study Requirements|0|||
147133385|NCT03801525|530657179|FG000|Overall Study|Investigator Decision|18|||
147133386|NCT03801525|530657180|FG001|Overall Study|Investigator Decision|1|||
147133387|NCT03801525|530657181|FG002|Overall Study|Investigator Decision|0|||
147133388|NCT03801525|530657179|FG000|Overall Study|Minimal Residual Disease (MRD) Negativity and Tumor Response|14|||
147133389|NCT03801525|530657180|FG001|Overall Study|Minimal Residual Disease (MRD) Negativity and Tumor Response|0|||
147133390|NCT03801525|530657181|FG002|Overall Study|Minimal Residual Disease (MRD) Negativity and Tumor Response|0|||
147133391|NCT03801525|530657179|FG000|Overall Study|Sponsor Discontinuation of the Study|24|||
147133392|NCT03801525|530657180|FG001|Overall Study|Sponsor Discontinuation of the Study|49|||
147133393|NCT03801525|530657181|FG002|Overall Study|Sponsor Discontinuation of the Study|43|||
147133394|NCT03801525|530657179|FG000|Overall Study|Started Non-protocol Anti-cancer Therapy|2|||
147133395|NCT03801525|530657180|FG001|Overall Study|Started Non-protocol Anti-cancer Therapy|1|||
147133396|NCT03801525|530657181|FG002|Overall Study|Started Non-protocol Anti-cancer Therapy|3|||
147133397|NCT03801525|530657179|FG000|Overall Study|Withdrawal of Subject Consent|38|||
147133398|NCT03801525|530657180|FG001|Overall Study|Withdrawal of Subject Consent|2|||
147133399|NCT03801525|530657181|FG002|Overall Study|Withdrawal of Subject Consent|1|||
147133400|NCT03801525|530657179|FG000|Overall Study|Reason not Specified|4|||
147133401|NCT03801525|530657180|FG001|Overall Study|Reason not Specified|0|||
147133402|NCT03801525|530657181|FG002|Overall Study|Reason not Specified|4|||
147133403|NCT03545672|530657184|FG000|Overall Study|Uncertain diagnosis|2|||
147133404|NCT03545672|530657185|FG001|Overall Study|Uncertain diagnosis|1|||
147133405|NCT03545672|530657184|FG000|Overall Study|Protocol Violation|2|||
147133406|NCT03545672|530657185|FG001|Overall Study|Protocol Violation|2|||
147133407|NCT01628913|530657186|FG000|Overall Study|Adverse Event|12|||
147133408|NCT01628913|530657187|FG001|Overall Study|Adverse Event|5|||
147133409|NCT01628913|530657186|FG000|Overall Study|Disease Progression|11|||
147133410|NCT01628913|530657187|FG001|Overall Study|Disease Progression|14|||
147133411|NCT01628913|530657186|FG000|Overall Study|Protocol Violation|1|||
147133412|NCT01628913|530657187|FG001|Overall Study|Protocol Violation|0|||
147133413|NCT01628913|530657186|FG000|Overall Study|Death|1|||
147133414|NCT01628913|530657187|FG001|Overall Study|Death|0|||
147133415|NCT01628913|530657186|FG000|Overall Study|study terminated by Sponsor|4|||
147133416|NCT01628913|530657187|FG001|Overall Study|study terminated by Sponsor|9|||
147133417|NCT01628913|530657186|FG000|Overall Study|Withdrawal by Subject|1|||
147133418|NCT01628913|530657187|FG001|Overall Study|Withdrawal by Subject|0|||
147133419|NCT01628913|530657186|FG000|Overall Study|Physician Decision|1|||
147133420|NCT01628913|530657187|FG001|Overall Study|Physician Decision|3|||
147133421|NCT02271880|530657190|FG000|Overall Study|Premature discontinuation of study|3|||
147133422|NCT02271880|530657191|FG001|Overall Study|Premature discontinuation of study|4|||
147133423|NCT00474903|530657192|FG000|Overall Study|Protocol Violation|1|||
147317865|NCT02584855|531329396|FG003|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0|||
147317866|NCT02584855|531329397|FG004|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0|||
147317867|NCT02584855|531329398|FG005|Double-Blind Withdrawal Period|Declined Transfer to a Different Site|0|||
147317868|NCT02584855|531329393|FG000|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
147317869|NCT02584855|531329394|FG001|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
147317870|NCT02584855|531329395|FG002|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
147133424|NCT00474903|530657193|FG001|Overall Study|Protocol Violation|5|||
147133425|NCT00474903|530657194|FG002|Overall Study|Protocol Violation|2|||
147133426|NCT00399529|530657195|FG000|Overall Study|Off Study Prior to Treatment|2|||
147133427|NCT01170663|530657196|FG000|Overall Study|Lost to Follow-up|3|||
147133428|NCT01170663|530657197|FG001|Overall Study|Lost to Follow-up|9|||
147133429|NCT01170663|530657196|FG000|Overall Study|Withdrawal of consent without follow-up|11|||
147133430|NCT01170663|530657197|FG001|Overall Study|Withdrawal of consent without follow-up|11|||
147133431|NCT00742625|530657198|FG000|Remission Induction|Progression|6|||
147133432|NCT00742625|530657198|FG000|Remission Induction|Failed induction|8|||
147133433|NCT00742625|530657198|FG000|Remission Induction|Adverse Event|3|||
147133434|NCT00742625|530657198|FG000|Remission Induction|Death|10|||
147133435|NCT00742625|530657198|FG000|Remission Induction|Refusal|5|||
147133436|NCT00742625|530657198|FG000|Remission Induction|Non protocol treatment|17|||
147133437|NCT00742625|530657198|FG000|Remission Induction|Other, not specified|5|||
147133438|NCT00742625|530657198|FG000|Consolidation|Progression|5|||
147133439|NCT00742625|530657198|FG000|Consolidation|Adverse Event|1|||
147133440|NCT00742625|530657198|FG000|Consolidation|Death|1|||
147133441|NCT00742625|530657198|FG000|Consolidation|Refused|1|||
147133442|NCT00742625|530657198|FG000|Consolidation|Non protocol therapy|13|||
147317871|NCT02584855|531329396|FG003|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
147133443|NCT02519842|530657202|FG000|Base Study: Cycle 1|Screening Failure|1|||
147133444|NCT02519842|530657203|FG001|Base Study: Cycle 1|Screening Failure|1|||
147133445|NCT02519842|530657204|FG002|Base Study: Cycle 1|Screening Failure|0|||
147133446|NCT02519842|530657202|FG000|Base Study: Cycle 1|Adverse Event|1|||
147133447|NCT02519842|530657203|FG001|Base Study: Cycle 1|Adverse Event|0|||
147133448|NCT02519842|530657204|FG002|Base Study: Cycle 1|Adverse Event|0|||
147133449|NCT02519842|530657202|FG000|Base Study: Cycle 1|Withdrawn by Parent/Guardian|0|||
147133450|NCT02519842|530657203|FG001|Base Study: Cycle 1|Withdrawn by Parent/Guardian|1|||
147133451|NCT02519842|530657204|FG002|Base Study: Cycle 1|Withdrawn by Parent/Guardian|0|||
147133452|NCT02519842|530657202|FG000|Base Study: Cycle 1|Non-compliance with Study Drug|0|||
147133453|NCT02519842|530657203|FG001|Base Study: Cycle 1|Non-compliance with Study Drug|1|||
147133454|NCT02519842|530657204|FG002|Base Study: Cycle 1|Non-compliance with Study Drug|0|||
147133455|NCT02519842|530657202|FG000|Optional Extension: Cycles 2-6|Physician Decision|0|||
147133456|NCT02519842|530657203|FG001|Optional Extension: Cycles 2-6|Physician Decision|0|||
147133457|NCT02519842|530657204|FG002|Optional Extension: Cycles 2-6|Physician Decision|5|||
147133458|NCT02519842|530657202|FG000|Optional Extension: Cycles 2-6|Adverse Event|0|||
147133459|NCT02519842|530657203|FG001|Optional Extension: Cycles 2-6|Adverse Event|0|||
147133460|NCT02519842|530657204|FG002|Optional Extension: Cycles 2-6|Adverse Event|1|||
147133461|NCT02519842|530657202|FG000|Optional Extension: Cycles 2-6|Withdrawal by Parent/Guardian|0|||
147133462|NCT02519842|530657203|FG001|Optional Extension: Cycles 2-6|Withdrawal by Parent/Guardian|0|||
147133463|NCT02519842|530657204|FG002|Optional Extension: Cycles 2-6|Withdrawal by Parent/Guardian|3|||
147133464|NCT02519842|530657202|FG000|Optional Extension: Cycles 2-6|Withdrawal by Subject|0|||
147133465|NCT02519842|530657203|FG001|Optional Extension: Cycles 2-6|Withdrawal by Subject|0|||
147133466|NCT02519842|530657204|FG002|Optional Extension: Cycles 2-6|Withdrawal by Subject|1|||
147133467|NCT02519842|530657202|FG000|Optional Extension: Cycles 2-6|Death|0|||
147133468|NCT02519842|530657203|FG001|Optional Extension: Cycles 2-6|Death|0|||
147133469|NCT02519842|530657204|FG002|Optional Extension: Cycles 2-6|Death|1|||
147133470|NCT02519842|530657202|FG000|Optional Extension: Cycles 2-6|Did Not Respond to Chemotherapy|0|||
147133471|NCT02519842|530657203|FG001|Optional Extension: Cycles 2-6|Did Not Respond to Chemotherapy|0|||
147133472|NCT02519842|530657204|FG002|Optional Extension: Cycles 2-6|Did Not Respond to Chemotherapy|2|||
147445293|NCT01265615|531795803|FG001|Overall Study|Protocol Violation|2|||
147317872|NCT02584855|531329397|FG004|Post Treatment Follow-up Period|Withdrawal by Subject|7|||
147317873|NCT02584855|531329398|FG005|Post Treatment Follow-up Period|Withdrawal by Subject|0|||
147317874|NCT02584855|531329393|FG000|Post Treatment Follow-up Period|Protocol Violation|0|||
147317875|NCT02584855|531329394|FG001|Post Treatment Follow-up Period|Protocol Violation|0|||
147317876|NCT02584855|531329395|FG002|Post Treatment Follow-up Period|Protocol Violation|0|||
147317877|NCT02584855|531329396|FG003|Post Treatment Follow-up Period|Protocol Violation|0|||
147317878|NCT02584855|531329397|FG004|Post Treatment Follow-up Period|Protocol Violation|1|||
147317879|NCT02584855|531329398|FG005|Post Treatment Follow-up Period|Protocol Violation|0|||
147317880|NCT02337478|531329399|FG000|Overall Study|Lack of Efficacy|5|||
147317881|NCT00895843|531329400|FG000|Overall Study|Protocol Violation|12|||
147317882|NCT00895843|531329401|FG001|Overall Study|Protocol Violation|12|||
147570821|NCT02286739|532246788|FG000|Overall Study|No Verasense type documented|0|||
147570822|NCT02286739|532246789|FG001|Overall Study|No Verasense type documented|23|||
147570823|NCT02286739|532246788|FG000|Overall Study|Adverse Event|1|||
147570824|NCT02286739|532246789|FG001|Overall Study|Adverse Event|2|||
147317883|NCT02906202|531329421|FG000|Overall Study|Discontinued after mobilization due to pregnancy|1|||
147317884|NCT01987830|531329422|FG000|Overall Study|Never received baseline scan|1|||
147317885|NCT00057811|531329426|FG000|Overall Study|Lack of Efficacy|1|||
147317886|NCT00057811|531329427|FG001|Overall Study|Lack of Efficacy|4|||
147317887|NCT00057811|531329426|FG000|Overall Study|Physician Decision|1|||
147317888|NCT00057811|531329427|FG001|Overall Study|Physician Decision|0|||
147317889|NCT00057811|531329426|FG000|Overall Study|Withdrawal by Subject|3|||
147317890|NCT00057811|531329427|FG001|Overall Study|Withdrawal by Subject|4|||
147317891|NCT00057811|531329426|FG000|Overall Study|Ineligible|4|||
147317892|NCT00057811|531329427|FG001|Overall Study|Ineligible|2|||
147317893|NCT00057811|531329426|FG000|Overall Study|Inevaluable|1|||
147317894|NCT00057811|531329427|FG001|Overall Study|Inevaluable|2|||
147317895|NCT04131907|531329428|FG000|Overall Study|Adverse Event|2|||
147317896|NCT04131907|531329429|FG001|Overall Study|Adverse Event|0|||
147317897|NCT04131907|531329430|FG002|Overall Study|Adverse Event|0|||
147317898|NCT04131907|531329428|FG000|Overall Study|Physician Decision|4|||
147570825|NCT02286739|532246788|FG000|Overall Study|Lost to follow-up (LTFU), Patient withdrawal or Physician decision but not specified|86|||
147570826|NCT02286739|532246789|FG001|Overall Study|Lost to follow-up (LTFU), Patient withdrawal or Physician decision but not specified|112|||
147651439|NCT00424593|532546475|FG000|Dose-Blind Extension Period|Withdrawal by Subject|19|||
147133473|NCT02519842|530657202|FG000|Optional Extension: Cycles 2-6|Completed Chemotherapy|0|||
147133474|NCT02519842|530657203|FG001|Optional Extension: Cycles 2-6|Completed Chemotherapy|0|||
147133475|NCT02519842|530657204|FG002|Optional Extension: Cycles 2-6|Completed Chemotherapy|13|||
147133476|NCT02519842|530657202|FG000|Optional Extension: Cycles 2-6|Enrollment Terminated at Site|0|||
147317899|NCT04131907|531329429|FG001|Overall Study|Physician Decision|22|||
147317900|NCT04131907|531329430|FG002|Overall Study|Physician Decision|0|||
147570827|NCT02635750|532246794|FG000|Part 1, Period 2|Adverse Event|1|||
147570828|NCT02635750|532246795|FG001|Part 1, Period 2|Adverse Event|0|||
147317901|NCT04131907|531329428|FG000|Overall Study|Withdrawal by Subject|2|||
147445294|NCT01265615|531795804|FG002|Overall Study|Protocol Violation|4|||
147570829|NCT02635750|532246796|FG002|Part 1, Period 2|Adverse Event|0|||
147133477|NCT02519842|530657203|FG001|Optional Extension: Cycles 2-6|Enrollment Terminated at Site|0|||
147133478|NCT02519842|530657204|FG002|Optional Extension: Cycles 2-6|Enrollment Terminated at Site|1|||
147133479|NCT02519842|530657202|FG000|Optional Extension: Cycles 2-6|Cycle Eligibility Criteria Not Met|0|||
147133480|NCT02519842|530657203|FG001|Optional Extension: Cycles 2-6|Cycle Eligibility Criteria Not Met|0|||
147133481|NCT02519842|530657204|FG002|Optional Extension: Cycles 2-6|Cycle Eligibility Criteria Not Met|2|||
147133482|NCT01612676|530657208|FG000|Overall Study|Adverse Event|2|||
147133483|NCT01612676|530657209|FG001|Overall Study|Adverse Event|3|||
147133484|NCT01612676|530657210|FG002|Overall Study|Adverse Event|1|||
147133485|NCT01612676|530657211|FG003|Overall Study|Adverse Event|3|||
147133486|NCT01612676|530657208|FG000|Overall Study|Protocol Violation|0|||
147133487|NCT01612676|530657209|FG001|Overall Study|Protocol Violation|1|||
147133488|NCT01612676|530657210|FG002|Overall Study|Protocol Violation|0|||
147133489|NCT01612676|530657211|FG003|Overall Study|Protocol Violation|0|||
147133490|NCT04064905|530657215|FG000|Overall Study|Lost to Follow-up|0|||
147133491|NCT04064905|530657216|FG001|Overall Study|Lost to Follow-up|3|||
147133492|NCT04064905|530657217|FG002|Overall Study|Lost to Follow-up|1|||
147133493|NCT04064905|530657218|FG003|Overall Study|Lost to Follow-up|4|||
147133494|NCT04064905|530657219|FG004|Overall Study|Lost to Follow-up|2|||
147133495|NCT01448616|530657220|FG000|Lead-In (Observational Phase)|Collected no genital swabs|3|||
147133496|NCT01448616|530657221|FG001|Lead-In (Observational Phase)|Collected no genital swabs|0|||
147133497|NCT01448616|530657222|FG002|Lead-In (Observational Phase)|Collected no genital swabs|0|||
147133498|NCT01448616|530657223|FG003|Lead-In (Observational Phase)|Collected no genital swabs|0|||
147133499|NCT01448616|530657220|FG000|Lead-In (Observational Phase)|Collected <90% of required swabs|6|||
147570830|NCT02642653|532246800|FG000|Overall Study|Adverse Event|2|||
147133500|NCT01448616|530657221|FG001|Lead-In (Observational Phase)|Collected <90% of required swabs|0|||
147133501|NCT01448616|530657222|FG002|Lead-In (Observational Phase)|Collected <90% of required swabs|0|||
147133502|NCT01448616|530657223|FG003|Lead-In (Observational Phase)|Collected <90% of required swabs|0|||
147133503|NCT01448616|530657220|FG000|Study Drug (Treatment Phase)|Adverse Event|0|||
147133504|NCT01448616|530657221|FG001|Study Drug (Treatment Phase)|Adverse Event|1|||
147133505|NCT01448616|530657222|FG002|Study Drug (Treatment Phase)|Adverse Event|1|||
147133506|NCT01448616|530657223|FG003|Study Drug (Treatment Phase)|Adverse Event|0|||
147133507|NCT01448616|530657220|FG000|Study Drug (Treatment Phase)|Never initiated study drug|0|||
147133508|NCT01448616|530657221|FG001|Study Drug (Treatment Phase)|Never initiated study drug|0|||
147133509|NCT01448616|530657222|FG002|Study Drug (Treatment Phase)|Never initiated study drug|1|||
147133510|NCT01448616|530657223|FG003|Study Drug (Treatment Phase)|Never initiated study drug|2|||
147570831|NCT02642653|532246801|FG001|Overall Study|Adverse Event|0|||
147570832|NCT02875392|532246802|FG000|Overall Study|The subjects did not inform their Hepatobiliary disorders; hence, their data did not analyze|7|||
147317902|NCT04131907|531329429|FG001|Overall Study|Withdrawal by Subject|0|||
147317903|NCT04131907|531329430|FG002|Overall Study|Withdrawal by Subject|1|||
147570833|NCT02875392|532246803|FG001|Overall Study|The subjects did not inform their Hepatobiliary disorders; hence, their data did not analyze|8|||
147133511|NCT01448616|530657220|FG000|Study Drug (Treatment Phase)|Withdrawal by Subject|0|||
147133512|NCT01448616|530657221|FG001|Study Drug (Treatment Phase)|Withdrawal by Subject|1|||
147133513|NCT01448616|530657222|FG002|Study Drug (Treatment Phase)|Withdrawal by Subject|2|||
147133514|NCT01448616|530657223|FG003|Study Drug (Treatment Phase)|Withdrawal by Subject|2|||
147133515|NCT00431964|530657224|FG000|Overall Study|Adverse Event|1|||
147133516|NCT00431964|530657225|FG001|Overall Study|Adverse Event|0|||
147133517|NCT00431964|530657224|FG000|Overall Study|Lost to Follow-up|1|||
147133518|NCT00431964|530657225|FG001|Overall Study|Lost to Follow-up|2|||
147570834|NCT00834717|532246809|FG000|First Intervention|Adverse Event|1|||
147570835|NCT00834717|532246810|FG001|First Intervention|Adverse Event|0|||
147570836|NCT00834717|532246809|FG000|First Intervention|Withdrawal by Subject|0|||
147570837|NCT00834717|532246810|FG001|First Intervention|Withdrawal by Subject|1|||
147570838|NCT01701674|532246811|FG000|Overall Study|Unable to safely complete treatment|1|||
147570839|NCT00834522|532246814|FG000|Washout|Adverse Event|1|||
147570840|NCT00834522|532246815|FG001|Washout|Adverse Event|0|||
147570841|NCT00834522|532246814|FG000|Washout|Withdrawal by Subject|2|||
147570842|NCT00834522|532246815|FG001|Washout|Withdrawal by Subject|1|||
147570843|NCT04516967|532246816|FG000|Core Phase|Adverse Event|2|||
147570844|NCT04516967|532246817|FG001|Core Phase|Adverse Event|1|||
147570845|NCT04516967|532246818|FG002|Core Phase|Adverse Event|0|||
147570846|NCT04516967|532246816|FG000|Core Phase|Physician Decision|1|||
147570847|NCT04516967|532246817|FG001|Core Phase|Physician Decision|1|||
147570848|NCT04516967|532246818|FG002|Core Phase|Physician Decision|0|||
147570849|NCT04516967|532246816|FG000|Core Phase|Lack of Efficacy|7|||
147133519|NCT00431964|530657224|FG000|Overall Study|Physician Decision|2|||
147133520|NCT00431964|530657225|FG001|Overall Study|Physician Decision|2|||
147317904|NCT04131907|531329428|FG000|Overall Study|Treatment failure|2|||
147317905|NCT04131907|531329429|FG001|Overall Study|Treatment failure|0|||
147317906|NCT04131907|531329430|FG002|Overall Study|Treatment failure|1|||
147570850|NCT04516967|532246817|FG001|Core Phase|Lack of Efficacy|18|||
147570851|NCT04516967|532246818|FG002|Core Phase|Lack of Efficacy|0|||
147570852|NCT03165994|532246819|FG000|Overall Study|Confirmed Radiographic Disease Progression|4|||
147570853|NCT03165994|532246819|FG000|Overall Study|Death|2|||
147133521|NCT00431964|530657224|FG000|Overall Study|Withdrawal by Subject|2|||
147133522|NCT00431964|530657225|FG001|Overall Study|Withdrawal by Subject|1|||
147133523|NCT00431964|530657224|FG000|Overall Study|Parental Consent Withdrawn|0|||
147133524|NCT00431964|530657225|FG001|Overall Study|Parental Consent Withdrawn|2|||
147133525|NCT00431964|530657224|FG000|Overall Study|Due to Unstable Health|0|||
147317907|NCT03428815|531329433|FG000|Overall Study|Lost to Follow-up|2|||
147317908|NCT03428815|531329434|FG001|Overall Study|Lost to Follow-up|2|||
147133526|NCT00431964|530657225|FG001|Overall Study|Due to Unstable Health|1|||
147133527|NCT02170064|530657226|FG000|Overall Study|Withdrawal by Subject|5|||
147133528|NCT02170064|530657227|FG001|Overall Study|Withdrawal by Subject|1|||
147133529|NCT02170064|530657228|FG002|Overall Study|Withdrawal by Subject|1|||
147133530|NCT02170064|530657226|FG000|Overall Study|Physician Decision|1|||
147133531|NCT02170064|530657227|FG001|Overall Study|Physician Decision|1|||
147133532|NCT02170064|530657228|FG002|Overall Study|Physician Decision|0|||
147133533|NCT04211363|530657229|FG000|Overall Study|Adverse Event|5|||
147133534|NCT04211363|530657230|FG001|Overall Study|Adverse Event|2|||
147133535|NCT04211363|530657229|FG000|Overall Study|Physician Decision|0|||
147133536|NCT04211363|530657230|FG001|Overall Study|Physician Decision|1|||
147133537|NCT04211363|530657229|FG000|Overall Study|Protocol Violation|1|||
147133538|NCT04211363|530657230|FG001|Overall Study|Protocol Violation|0|||
147133539|NCT04211363|530657229|FG000|Overall Study|Pregnancy|1|||
147133540|NCT04211363|530657230|FG001|Overall Study|Pregnancy|0|||
147133541|NCT04211363|530657229|FG000|Overall Study|Lost to Follow-up|12|||
147133542|NCT04211363|530657230|FG001|Overall Study|Lost to Follow-up|4|||
147133543|NCT04211363|530657229|FG000|Overall Study|Withdrawal by Subject|11|||
147133544|NCT04211363|530657230|FG001|Overall Study|Withdrawal by Subject|11|||
147133545|NCT04211363|530657229|FG000|Overall Study|Other|1|||
147133546|NCT04211363|530657230|FG001|Overall Study|Other|2|||
147133547|NCT03961308|530657231|FG000|Overall Study|Withdrawal by Subject|1|||
147133548|NCT03961308|530657232|FG001|Overall Study|Withdrawal by Subject|0|||
147133549|NCT03961308|530657231|FG000|Overall Study|Other|1|||
147133550|NCT03961308|530657232|FG001|Overall Study|Other|0|||
147133551|NCT03961308|530657231|FG000|Overall Study|Lost to Follow-up|0|||
147133552|NCT03961308|530657232|FG001|Overall Study|Lost to Follow-up|1|||
147133553|NCT03961308|530657231|FG000|Overall Study|Adverse Event|0|||
147133554|NCT03961308|530657232|FG001|Overall Study|Adverse Event|1|||
147133555|NCT00659425|530657235|FG000|Overall Study|Disease progression|1|||
147133556|NCT00659425|530657236|FG001|Overall Study|Disease progression|0|||
147133557|NCT00659425|530657237|FG002|Overall Study|Disease progression|0|||
147133558|NCT00659425|530657238|FG003|Overall Study|Disease progression|1|||
147133559|NCT00659425|530657239|FG004|Overall Study|Disease progression|0|||
147133560|NCT00659425|530657240|FG005|Overall Study|Disease progression|2|||
147133561|NCT00659425|530657241|FG006|Overall Study|Disease progression|4|||
147133562|NCT00659425|530657242|FG007|Overall Study|Disease progression|3|||
147133563|NCT00659425|530657243|FG008|Overall Study|Disease progression|5|||
147133564|NCT00659425|530657244|FG009|Overall Study|Disease progression|3|||
147133565|NCT00659425|530657235|FG000|Overall Study|Death|0|||
147133566|NCT00659425|530657236|FG001|Overall Study|Death|0|||
147133567|NCT00659425|530657237|FG002|Overall Study|Death|0|||
147133568|NCT00659425|530657238|FG003|Overall Study|Death|1|||
147133569|NCT00659425|530657239|FG004|Overall Study|Death|0|||
147133570|NCT00659425|530657240|FG005|Overall Study|Death|0|||
147133571|NCT00659425|530657241|FG006|Overall Study|Death|1|||
147133572|NCT00659425|530657242|FG007|Overall Study|Death|0|||
147133573|NCT00659425|530657243|FG008|Overall Study|Death|0|||
147133574|NCT00659425|530657244|FG009|Overall Study|Death|0|||
147133575|NCT00659425|530657235|FG000|Overall Study|Adverse Event|0|||
147133576|NCT00659425|530657236|FG001|Overall Study|Adverse Event|0|||
147133577|NCT00659425|530657237|FG002|Overall Study|Adverse Event|0|||
147133578|NCT00659425|530657238|FG003|Overall Study|Adverse Event|0|||
147133579|NCT00659425|530657239|FG004|Overall Study|Adverse Event|0|||
147133580|NCT00659425|530657240|FG005|Overall Study|Adverse Event|1|||
147133581|NCT00659425|530657241|FG006|Overall Study|Adverse Event|0|||
147133582|NCT00659425|530657242|FG007|Overall Study|Adverse Event|3|||
147133583|NCT00659425|530657243|FG008|Overall Study|Adverse Event|1|||
147133584|NCT00659425|530657244|FG009|Overall Study|Adverse Event|4|||
147445295|NCT01265615|531795805|FG003|Overall Study|Protocol Violation|3|||
147133585|NCT00659425|530657235|FG000|Overall Study|Investigator Discretion|0|||
147133586|NCT00659425|530657236|FG001|Overall Study|Investigator Discretion|0|||
147133587|NCT00659425|530657237|FG002|Overall Study|Investigator Discretion|0|||
147133588|NCT00659425|530657238|FG003|Overall Study|Investigator Discretion|0|||
147133589|NCT00659425|530657239|FG004|Overall Study|Investigator Discretion|0|||
147133590|NCT00659425|530657240|FG005|Overall Study|Investigator Discretion|1|||
147133591|NCT00659425|530657241|FG006|Overall Study|Investigator Discretion|0|||
147133592|NCT00659425|530657242|FG007|Overall Study|Investigator Discretion|3|||
147133593|NCT00659425|530657243|FG008|Overall Study|Investigator Discretion|0|||
147133594|NCT00659425|530657244|FG009|Overall Study|Investigator Discretion|0|||
147133595|NCT00659425|530657235|FG000|Overall Study|Other|0|||
147133596|NCT00659425|530657236|FG001|Overall Study|Other|1|||
147133597|NCT00659425|530657237|FG002|Overall Study|Other|1|||
147133598|NCT00659425|530657238|FG003|Overall Study|Other|2|||
147133599|NCT00659425|530657239|FG004|Overall Study|Other|4|||
147133600|NCT00659425|530657240|FG005|Overall Study|Other|0|||
147133601|NCT00659425|530657241|FG006|Overall Study|Other|3|||
147133602|NCT00659425|530657242|FG007|Overall Study|Other|2|||
147133603|NCT00659425|530657243|FG008|Overall Study|Other|0|||
147133604|NCT00659425|530657244|FG009|Overall Study|Other|6|||
147133605|NCT03358030|530657245|FG000|Overall Study|Adverse Event or Serious Adverse Event (SAE)|2|||
147133606|NCT03358030|530657246|FG001|Overall Study|Adverse Event or Serious Adverse Event (SAE)|0|||
147133607|NCT03358030|530657247|FG002|Overall Study|Adverse Event or Serious Adverse Event (SAE)|5|||
147133608|NCT03358030|530657248|FG003|Overall Study|Adverse Event or Serious Adverse Event (SAE)|1|||
147133609|NCT03358030|530657245|FG000|Overall Study|Ineligibility|0|||
147133610|NCT03358030|530657246|FG001|Overall Study|Ineligibility|0|||
147133611|NCT03358030|530657247|FG002|Overall Study|Ineligibility|0|||
147133612|NCT03358030|530657248|FG003|Overall Study|Ineligibility|2|||
147133613|NCT03358030|530657245|FG000|Overall Study|Voluntary Withdrawal|1|||
147133614|NCT03358030|530657246|FG001|Overall Study|Voluntary Withdrawal|1|||
147133615|NCT03358030|530657247|FG002|Overall Study|Voluntary Withdrawal|3|||
147133616|NCT03358030|530657248|FG003|Overall Study|Voluntary Withdrawal|1|||
147133617|NCT03358030|530657245|FG000|Overall Study|Other|0|||
147133618|NCT03358030|530657246|FG001|Overall Study|Other|0|||
147133619|NCT03358030|530657247|FG002|Overall Study|Other|1|||
147133620|NCT03358030|530657248|FG003|Overall Study|Other|0|||
147133621|NCT03342560|530657249|FG000|Overall Study|Lost to Follow-up|2|||
147133622|NCT02604511|530657250|FG000|Overall Study|Adverse Event|3|||
147133623|NCT02604511|530657250|FG000|Overall Study|Disease Progression|4|||
147133624|NCT02604511|530657250|FG000|Overall Study|Withdrawal by Subject|3|||
147133625|NCT02604511|530657250|FG000|Overall Study|Participant ineligible|1|||
147133626|NCT02604511|530657250|FG000|Overall Study|Intercurrent illness|1|||
147133627|NCT03770286|530657251|FG000|Overall Study|Lost to Follow-up|6|||
147133628|NCT03770286|530657252|FG001|Overall Study|Lost to Follow-up|4|||
147133629|NCT03770286|530657253|FG002|Overall Study|Lost to Follow-up|3|||
147133630|NCT03770286|530657251|FG000|Overall Study|Protocol Violation|1|||
147133631|NCT03770286|530657252|FG001|Overall Study|Protocol Violation|0|||
147133632|NCT03770286|530657253|FG002|Overall Study|Protocol Violation|2|||
147133633|NCT01729039|530657256|FG000|Overall Study|disqualified|2|||
147133634|NCT01729039|530657257|FG001|Overall Study|disqualified|5|||
147133635|NCT01729039|530657256|FG000|Overall Study|Withdrawal by Subject|8|||
147133636|NCT01729039|530657257|FG001|Overall Study|Withdrawal by Subject|7|||
147133637|NCT04646005|530657258|FG000|Overall Study|Adverse Event|1|||
147133638|NCT04646005|530657258|FG000|Overall Study|Progressive Disease|71|||
147133639|NCT04646005|530657258|FG000|Overall Study|Death|20|||
147133640|NCT04646005|530657258|FG000|Overall Study|Withdrawal by Subject|12|||
147133641|NCT04646005|530657258|FG000|Overall Study|Sponsor Request|9|||
147133642|NCT05788991|530657259|FG000|Overall Study|Not treated with study medication|1|||
147133643|NCT05788991|530657260|FG001|Overall Study|Not treated with study medication|3|||
147133644|NCT05788991|530657259|FG000|Overall Study|Withdrawal by Subject|1|||
147133645|NCT05788991|530657260|FG001|Overall Study|Withdrawal by Subject|0|||
147133646|NCT05788991|530657259|FG000|Overall Study|Lack of Efficacy|0|||
147133647|NCT05788991|530657260|FG001|Overall Study|Lack of Efficacy|1|||
147133648|NCT05788991|530657259|FG000|Overall Study|Protocol Violation|1|||
147133649|NCT05788991|530657260|FG001|Overall Study|Protocol Violation|2|||
147651440|NCT00424593|532546476|FG001|Dose-Blind Extension Period|Withdrawal by Subject|0|||
147651441|NCT00424593|532546475|FG000|Dose-Blind Extension Period|Adverse Event|18|||
147133650|NCT04464473|530657261|FG000|Overall Study|New piercing could not be removed for scanning|0|||
147133651|NCT04464473|530657262|FG001|Overall Study|New piercing could not be removed for scanning|0|||
147133652|NCT04464473|530657263|FG002|Overall Study|New piercing could not be removed for scanning|0|||
147133653|NCT04464473|530657264|FG003|Overall Study|New piercing could not be removed for scanning|1|||
147133654|NCT04464473|530657265|FG004|Overall Study|New piercing could not be removed for scanning|0|||
147133655|NCT04464473|530657266|FG005|Overall Study|New piercing could not be removed for scanning|0|||
147133656|NCT04464473|530657261|FG000|Overall Study|Adverse Event|0|||
147133657|NCT04464473|530657262|FG001|Overall Study|Adverse Event|0|||
147133658|NCT04464473|530657263|FG002|Overall Study|Adverse Event|0|||
147133659|NCT04464473|530657264|FG003|Overall Study|Adverse Event|1|||
147133660|NCT04464473|530657265|FG004|Overall Study|Adverse Event|0|||
147133661|NCT04464473|530657266|FG005|Overall Study|Adverse Event|0|||
147133662|NCT04464473|530657261|FG000|Overall Study|Lost to Follow-up|0|||
147133663|NCT04464473|530657262|FG001|Overall Study|Lost to Follow-up|0|||
147445296|NCT01399788|531795815|FG000|First Intervention Period|Adverse Event|1|||
147133664|NCT04464473|530657263|FG002|Overall Study|Lost to Follow-up|0|||
147133665|NCT04464473|530657264|FG003|Overall Study|Lost to Follow-up|1|||
147133666|NCT04464473|530657265|FG004|Overall Study|Lost to Follow-up|0|||
147133667|NCT04464473|530657266|FG005|Overall Study|Lost to Follow-up|0|||
147133668|NCT03802396|530657267|FG000|Overall Study|Withdrawal by Subject|2|||
147133669|NCT03802396|530657268|FG001|Overall Study|Withdrawal by Subject|0|||
147133670|NCT03802396|530657267|FG000|Overall Study|Surgery Cancelled|1|||
147133671|NCT03802396|530657268|FG001|Overall Study|Surgery Cancelled|0|||
147133672|NCT02661672|530657272|FG000|Overall Study|Lost to Follow-up|1|||
147133673|NCT02661672|530657272|FG000|Overall Study|Death|4|||
147133674|NCT02114177|530658870|FG000|Overall Study|Lost to Follow-up|1|||
147133675|NCT02114177|530658871|FG001|Overall Study|Lost to Follow-up|2|||
147133676|NCT02114177|530658870|FG000|Overall Study|Withdrawal by Subject|6|||
147133677|NCT02114177|530658871|FG001|Overall Study|Withdrawal by Subject|1|||
147133678|NCT02114177|530658870|FG000|Overall Study|Other|2|||
147133679|NCT02114177|530658871|FG001|Overall Study|Other|1|||
147133680|NCT02986074|530658872|FG000|First Trial Period|Adverse Event|1|||
147133681|NCT02986074|530658873|FG001|First Trial Period|Adverse Event|0|||
147133682|NCT02986074|530658874|FG002|First Trial Period|Adverse Event|0|||
147133683|NCT02986074|530658875|FG003|First Trial Period|Adverse Event|0|||
147133684|NCT02986074|530658872|FG000|Follow up Period|system explant|0|||
147133685|NCT02986074|530658873|FG001|Follow up Period|system explant|0|||
147133686|NCT02986074|530658874|FG002|Follow up Period|system explant|1|||
147317909|NCT03428815|531329433|FG000|Overall Study|suspension of study activities due to Covid-19 pandemic|5|||
147317910|NCT03428815|531329434|FG001|Overall Study|suspension of study activities due to Covid-19 pandemic|2|||
147317911|NCT03428815|531329433|FG000|Overall Study|Intermittent fitting issues that affected reliability of data|3|||
147317912|NCT03428815|531329434|FG001|Overall Study|Intermittent fitting issues that affected reliability of data|1|||
147317913|NCT02404493|531329435|FG000|Overall Study|Adverse Event|1|||
147317914|NCT02404493|531329436|FG001|Overall Study|Adverse Event|1|||
147317915|NCT01700348|531329437|FG000|Overall Study|Withdrawal by Subject|22|||
147317916|NCT01700348|531329437|FG000|Overall Study|Lost to Follow-up|1|||
147317917|NCT03958630|531329440|FG000|Overall Study|Withdrawal by Subject|0|||
147317918|NCT03958630|531329441|FG001|Overall Study|Withdrawal by Subject|0|||
147317919|NCT03958630|531329442|FG002|Overall Study|Withdrawal by Subject|1|||
147317920|NCT03958630|531329440|FG000|Overall Study|Withdrawn due to the 2019 pandemic|0|||
147317921|NCT03958630|531329441|FG001|Overall Study|Withdrawn due to the 2019 pandemic|0|||
147317922|NCT03958630|531329442|FG002|Overall Study|Withdrawn due to the 2019 pandemic|1|||
147317923|NCT04157686|531329445|FG000|Overall Study|Adverse Event|1|||
147317924|NCT04157686|531329446|FG001|Overall Study|Adverse Event|0|||
147317925|NCT04157686|531329447|FG002|Overall Study|Adverse Event|1|||
147317926|NCT04157686|531329448|FG003|Overall Study|Adverse Event|0|||
147317927|NCT04157686|531329449|FG004|Overall Study|Adverse Event|1|||
147317928|NCT04157686|531329450|FG005|Overall Study|Adverse Event|0|||
147317929|NCT04157686|531329451|FG006|Overall Study|Adverse Event|0|||
147317930|NCT04157686|531329452|FG007|Overall Study|Adverse Event|0|||
147317931|NCT04157686|531329445|FG000|Overall Study|Pregnancy|0|||
147317932|NCT04157686|531329446|FG001|Overall Study|Pregnancy|1|||
147317933|NCT04157686|531329447|FG002|Overall Study|Pregnancy|3|||
147133687|NCT02986074|530658875|FG003|Follow up Period|system explant|2|||
147133688|NCT02986074|530658872|FG000|Follow up Period|Physician Decision|0|||
147133689|NCT02986074|530658873|FG001|Follow up Period|Physician Decision|0|||
147133690|NCT02986074|530658874|FG002|Follow up Period|Physician Decision|0|||
147133691|NCT02986074|530658875|FG003|Follow up Period|Physician Decision|1|||
147133692|NCT02415556|530658876|FG000|Overall Study|Adverse Event|3|||
147133693|NCT02415556|530658877|FG001|Overall Study|Adverse Event|4|||
147133694|NCT02415556|530658878|FG002|Overall Study|Adverse Event|2|||
147133695|NCT02415556|530658879|FG003|Overall Study|Adverse Event|4|||
147133696|NCT02415556|530658876|FG000|Overall Study|Lost to Follow-up|4|||
147133697|NCT02415556|530658877|FG001|Overall Study|Lost to Follow-up|5|||
147133698|NCT02415556|530658878|FG002|Overall Study|Lost to Follow-up|4|||
147133699|NCT02415556|530658879|FG003|Overall Study|Lost to Follow-up|1|||
147133700|NCT02415556|530658876|FG000|Overall Study|Withdrawal by Subject|13|||
147133701|NCT02415556|530658877|FG001|Overall Study|Withdrawal by Subject|4|||
147133702|NCT02415556|530658878|FG002|Overall Study|Withdrawal by Subject|14|||
147133703|NCT02415556|530658879|FG003|Overall Study|Withdrawal by Subject|12|||
147133704|NCT02415556|530658876|FG000|Overall Study|Physician Decision|1|||
147133705|NCT02415556|530658877|FG001|Overall Study|Physician Decision|3|||
147133706|NCT02415556|530658878|FG002|Overall Study|Physician Decision|1|||
147133707|NCT02415556|530658879|FG003|Overall Study|Physician Decision|2|||
147133708|NCT02415556|530658876|FG000|Overall Study|Censored - study completion|4|||
147133709|NCT02415556|530658877|FG001|Overall Study|Censored - study completion|5|||
147133710|NCT02415556|530658878|FG002|Overall Study|Censored - study completion|1|||
147133711|NCT02415556|530658879|FG003|Overall Study|Censored - study completion|0|||
147133712|NCT02415556|530658876|FG000|Overall Study|Family-related issues|0|||
147133713|NCT02415556|530658877|FG001|Overall Study|Family-related issues|0|||
147133714|NCT02415556|530658878|FG002|Overall Study|Family-related issues|0|||
147133715|NCT02415556|530658879|FG003|Overall Study|Family-related issues|1|||
147133716|NCT01146613|530658880|FG000|Overall Study|Lost to Follow-up|3|||
147133717|NCT01146613|530658881|FG001|Overall Study|Lost to Follow-up|8|||
147133718|NCT01146613|530658880|FG000|Overall Study|Lack of Efficacy|0|||
147133719|NCT01146613|530658881|FG001|Overall Study|Lack of Efficacy|1|||
147133720|NCT01146613|530658880|FG000|Overall Study|Death|1|||
147133721|NCT01146613|530658881|FG001|Overall Study|Death|0|||
147133722|NCT01146613|530658880|FG000|Overall Study|Physician Decision|1|||
147317934|NCT04157686|531329448|FG003|Overall Study|Pregnancy|0|||
147133723|NCT01146613|530658881|FG001|Overall Study|Physician Decision|0|||
147133724|NCT01146613|530658880|FG000|Overall Study|Withdrawal by Subject|0|||
147445297|NCT01399788|531795816|FG001|First Intervention Period|Adverse Event|0|||
147445298|NCT02919436|531795817|FG000|Overall Study|Did not undergo surgery|16|||
147445299|NCT02919436|531795818|FG001|Overall Study|Did not undergo surgery|20|||
147445300|NCT02919436|531795817|FG000|Overall Study|Enrolled before trial registration|44|||
147133725|NCT01146613|530658881|FG001|Overall Study|Withdrawal by Subject|3|||
147445301|NCT02919436|531795818|FG001|Overall Study|Enrolled before trial registration|33|||
147133726|NCT01146613|530658880|FG000|Overall Study|schedule conflict|1|||
147133727|NCT01146613|530658881|FG001|Overall Study|schedule conflict|0|||
147133728|NCT01146613|530658880|FG000|Overall Study|Outpatient detox|1|||
147133729|NCT01146613|530658881|FG001|Overall Study|Outpatient detox|0|||
147133730|NCT00320606|530658882|FG000|Overall Study|Adverse Event|1|||
147133731|NCT00320606|530658882|FG000|Overall Study|Protocol Violation|1|||
147133732|NCT00320606|530658882|FG000|Overall Study|Withdrawal by Subject|1|||
147133733|NCT03984825|530658883|FG000|Treatment Period 1 (Day 1 to 10)|Sponsor decision|2|||
147133734|NCT03984825|530658883|FG000|Treatment Period 2 (Day 11 to 21)|Physician Decision|1|||
147133735|NCT03984825|530658883|FG000|Treatment Period 2 (Day 11 to 21)|Adverse Event|3|||
147445302|NCT00283595|531795820|FG000|Overall Study|Withdrawal by Subject|1|||
147445303|NCT00283595|531795821|FG001|Overall Study|Withdrawal by Subject|2|||
147445304|NCT01389752|531795822|FG000|Study Period 1|Sponsor decision|0|||
147445305|NCT01389752|531795823|FG001|Study Period 1|Sponsor decision|2|||
147445306|NCT01389752|531795822|FG000|Study Period 2|Sponsor decision|1|||
147445307|NCT01389752|531795823|FG001|Study Period 2|Sponsor decision|0|||
147445308|NCT03259074|531795824|FG000|Overall Study|Adverse Event|9|||
147445309|NCT03259074|531795825|FG001|Overall Study|Adverse Event|12|||
147445310|NCT03259074|531795826|FG002|Overall Study|Adverse Event|8|||
147445311|NCT03259074|531795824|FG000|Overall Study|Death|1|||
147445312|NCT03259074|531795825|FG001|Overall Study|Death|1|||
147445313|NCT03259074|531795826|FG002|Overall Study|Death|3|||
147445314|NCT03259074|531795824|FG000|Overall Study|Lost to Follow-up|2|||
147445315|NCT03259074|531795825|FG001|Overall Study|Lost to Follow-up|4|||
147445316|NCT03259074|531795826|FG002|Overall Study|Lost to Follow-up|3|||
147445317|NCT03259074|531795824|FG000|Overall Study|New Therapy For Study Indication|1|||
147445318|NCT03259074|531795825|FG001|Overall Study|New Therapy For Study Indication|2|||
147445319|NCT03259074|531795826|FG002|Overall Study|New Therapy For Study Indication|2|||
147570854|NCT03165994|532246819|FG000|Overall Study|Non-Compliance With Study Treatment or Procedure Requirements|3|||
147570855|NCT03165994|532246819|FG000|Overall Study|Physician Decision, other than adverse event (AE)|9|||
147570856|NCT03165994|532246819|FG000|Overall Study|Participant or Legal Representative Withdraws Consent|1|||
147570857|NCT03165994|532246819|FG000|Overall Study|Miscellaneous|1|||
147570858|NCT00519194|532246820|FG000|Overall Study|Withdrawal by Subject|9|||
147133736|NCT02115321|530658886|FG000|Overall Study|Death|1|||
147133737|NCT02115321|530658887|FG001|Overall Study|Death|0|||
147133738|NCT02639390|530658888|FG000|Overall Study|Subject unable to comply with treatment schedule.|0|||
147133739|NCT02639390|530658889|FG001|Overall Study|Subject unable to comply with treatment schedule.|2|||
147133740|NCT01908140|530658890|FG000|Overall Study|Other or Progressive Disease|5|||
147133741|NCT01908140|530658891|FG001|Overall Study|Other or Progressive Disease|12|||
147133742|NCT01908140|530658890|FG000|Overall Study|Lack of Efficacy|7|||
147133743|NCT01908140|530658891|FG001|Overall Study|Lack of Efficacy|5|||
147133744|NCT01908140|530658890|FG000|Overall Study|Withdrawal by Subject|23|||
147445320|NCT03259074|531795824|FG000|Overall Study|Physician Decision|4|||
147445321|NCT03259074|531795825|FG001|Overall Study|Physician Decision|12|||
147445322|NCT03259074|531795826|FG002|Overall Study|Physician Decision|10|||
147445323|NCT03259074|531795824|FG000|Overall Study|Pregnancy|1|||
147133745|NCT01908140|530658891|FG001|Overall Study|Withdrawal by Subject|24|||
147133746|NCT01908140|530658890|FG000|Overall Study|Lost to Follow-up|1|||
147445324|NCT03259074|531795825|FG001|Overall Study|Pregnancy|1|||
147445325|NCT03259074|531795826|FG002|Overall Study|Pregnancy|0|||
147445326|NCT03259074|531795824|FG000|Overall Study|Progressive Disease|1|||
147445327|NCT03259074|531795825|FG001|Overall Study|Progressive Disease|0|||
147445328|NCT03259074|531795826|FG002|Overall Study|Progressive Disease|0|||
147445329|NCT03259074|531795824|FG000|Overall Study|Protocol Deviation|1|||
147445330|NCT03259074|531795825|FG001|Overall Study|Protocol Deviation|1|||
147445331|NCT03259074|531795826|FG002|Overall Study|Protocol Deviation|3|||
147445332|NCT03259074|531795824|FG000|Overall Study|Subject/Guardian Decision|13|||
147133747|NCT01908140|530658891|FG001|Overall Study|Lost to Follow-up|6|||
147236972|NCT00347360|531037435|FG010|Overall Study|Prolonged duration between visits|0|||
147445333|NCT03259074|531795825|FG001|Overall Study|Subject/Guardian Decision|16|||
147133748|NCT01908140|530658890|FG000|Overall Study|Protocol Violation|8|||
147133749|NCT01908140|530658891|FG001|Overall Study|Protocol Violation|9|||
147445334|NCT03259074|531795826|FG002|Overall Study|Subject/Guardian Decision|14|||
147133750|NCT01908140|530658890|FG000|Overall Study|Adverse Event|22|||
147133751|NCT01908140|530658891|FG001|Overall Study|Adverse Event|23|||
147133752|NCT00698828|530658894|FG000|Overall Study|Adverse Event|3|||
147445335|NCT00053417|531795837|FG000|Overall Study|Adverse Event|1|||
147445336|NCT00053417|531795838|FG001|Overall Study|Adverse Event|0|||
147445337|NCT00053417|531795839|FG002|Overall Study|Adverse Event|1|||
147445338|NCT00053417|531795840|FG003|Overall Study|Adverse Event|5|||
147570859|NCT00519194|532246820|FG000|Overall Study|Death|9|||
147133753|NCT00698828|530658895|FG001|Overall Study|Adverse Event|4|||
147133754|NCT00698828|530658896|FG002|Overall Study|Adverse Event|4|||
147133755|NCT00698828|530658894|FG000|Overall Study|Death|0|||
147133756|NCT00698828|530658895|FG001|Overall Study|Death|0|||
147133757|NCT00698828|530658896|FG002|Overall Study|Death|1|||
147133758|NCT00698828|530658894|FG000|Overall Study|Exacerbation of COPD|1|||
147133759|NCT00698828|530658895|FG001|Overall Study|Exacerbation of COPD|3|||
147133760|NCT00698828|530658896|FG002|Overall Study|Exacerbation of COPD|0|||
147133761|NCT00698828|530658894|FG000|Overall Study|Exacerbation of COPD (Not treated)|1|||
147133762|NCT00698828|530658895|FG001|Overall Study|Exacerbation of COPD (Not treated)|0|||
147133763|NCT00698828|530658896|FG002|Overall Study|Exacerbation of COPD (Not treated)|0|||
147133764|NCT00698828|530658894|FG000|Overall Study|Investigator/Sponsor decision|1|||
147133765|NCT00698828|530658895|FG001|Overall Study|Investigator/Sponsor decision|0|||
147133766|NCT00698828|530658896|FG002|Overall Study|Investigator/Sponsor decision|2|||
147133767|NCT00698828|530658894|FG000|Overall Study|Lost to Follow-up|1|||
147133768|NCT00698828|530658895|FG001|Overall Study|Lost to Follow-up|1|||
147133769|NCT00698828|530658896|FG002|Overall Study|Lost to Follow-up|0|||
147133770|NCT00698828|530658894|FG000|Overall Study|Withdrew consent|0|||
147133771|NCT00698828|530658895|FG001|Overall Study|Withdrew consent|7|||
147133772|NCT00698828|530658896|FG002|Overall Study|Withdrew consent|4|||
147133773|NCT00698828|530658894|FG000|Overall Study|Withdrew consent (not treated)|2|||
147133774|NCT00698828|530658895|FG001|Overall Study|Withdrew consent (not treated)|0|||
147133775|NCT00698828|530658896|FG002|Overall Study|Withdrew consent (not treated)|0|||
147133776|NCT02013609|530658897|FG000|Overall Study|Withdrawal by Subject|9|||
147133777|NCT02013609|530658897|FG000|Overall Study|Lost to Follow-up|3|||
147133778|NCT02013609|530658897|FG000|Overall Study|Adverse Event|3|||
147133779|NCT02013609|530658897|FG000|Overall Study|Met Withdrawal Criteria|3|||
147133780|NCT01816295|530658898|FG000|Double Blind Phase|Adverse Event|11|||
147133781|NCT01816295|530658899|FG001|Double Blind Phase|Adverse Event|8|||
147133782|NCT01816295|530658898|FG000|Double Blind Phase|Entry Criteria Not Met|0|||
147133783|NCT01816295|530658899|FG001|Double Blind Phase|Entry Criteria Not Met|2|||
147133784|NCT01816295|530658898|FG000|Double Blind Phase|Lost to Follow-up|3|||
147133785|NCT01816295|530658899|FG001|Double Blind Phase|Lost to Follow-up|5|||
147133786|NCT01816295|530658898|FG000|Double Blind Phase|Physician Decision|2|||
147133787|NCT01816295|530658899|FG001|Double Blind Phase|Physician Decision|2|||
147133788|NCT01816295|530658898|FG000|Double Blind Phase|Protocol Violation|17|||
147133789|NCT01816295|530658899|FG001|Double Blind Phase|Protocol Violation|11|||
147133790|NCT01816295|530658898|FG000|Double Blind Phase|Sponsor Decision|8|||
147133791|NCT01816295|530658899|FG001|Double Blind Phase|Sponsor Decision|8|||
147133792|NCT01816295|530658898|FG000|Double Blind Phase|Withdrawal by Subject|22|||
147133793|NCT01816295|530658899|FG001|Double Blind Phase|Withdrawal by Subject|20|||
147133794|NCT01816295|530658898|FG000|OLE Phase|Adverse Event|17|||
147133795|NCT01816295|530658899|FG001|OLE Phase|Adverse Event|15|||
147133796|NCT01816295|530658898|FG000|OLE Phase|Death|1|||
147133797|NCT01816295|530658899|FG001|OLE Phase|Death|0|||
147133798|NCT01816295|530658898|FG000|OLE Phase|Entry Criteria Not Met|3|||
147133799|NCT01816295|530658899|FG001|OLE Phase|Entry Criteria Not Met|5|||
147133800|NCT01816295|530658898|FG000|OLE Phase|Lost to Follow-up|5|||
147133801|NCT01816295|530658899|FG001|OLE Phase|Lost to Follow-up|5|||
147133802|NCT01816295|530658898|FG000|OLE Phase|Physician Decision|3|||
147133803|NCT01816295|530658899|FG001|OLE Phase|Physician Decision|1|||
147133804|NCT01816295|530658898|FG000|OLE Phase|Protocol Violation|4|||
147133805|NCT01816295|530658899|FG001|OLE Phase|Protocol Violation|4|||
147133806|NCT01816295|530658898|FG000|OLE Phase|Sponsor Decision|7|||
147133807|NCT01816295|530658899|FG001|OLE Phase|Sponsor Decision|9|||
147133808|NCT01816295|530658898|FG000|OLE Phase|Withdrawal by Subject|10|||
147133809|NCT01816295|530658899|FG001|OLE Phase|Withdrawal by Subject|10|||
147133810|NCT01816295|530658898|FG000|OLE Phase|Lack of Efficacy|3|||
147133811|NCT01816295|530658899|FG001|OLE Phase|Lack of Efficacy|7|||
147133812|NCT01119287|530658900|FG000|Overall Study|Patient Decision, not related to AE|0|||
147133813|NCT01119287|530658901|FG001|Overall Study|Patient Decision, not related to AE|0|||
147133814|NCT01119287|530658902|FG002|Overall Study|Patient Decision, not related to AE|2|||
147133815|NCT01119287|530658903|FG003|Overall Study|Patient Decision, not related to AE|2|||
147133816|NCT01119287|530658904|FG004|Overall Study|Patient Decision, not related to AE|1|||
147133817|NCT01119287|530658905|FG005|Overall Study|Patient Decision, not related to AE|0|||
147133818|NCT01076010|530658908|FG000|Overall Study|Death|15|||
147133819|NCT01076010|530658909|FG001|Overall Study|Death|1|||
147133820|NCT01076010|530658910|FG002|Overall Study|Death|0|||
147133821|NCT01076010|530658908|FG000|Overall Study|Adverse Event|7|||
147133822|NCT01076010|530658909|FG001|Overall Study|Adverse Event|2|||
147133823|NCT01076010|530658910|FG002|Overall Study|Adverse Event|0|||
147133824|NCT01076010|530658908|FG000|Overall Study|Progressive disease|90|||
147133825|NCT01076010|530658909|FG001|Overall Study|Progressive disease|30|||
147133826|NCT01076010|530658910|FG002|Overall Study|Progressive disease|1|||
147133827|NCT01076010|530658908|FG000|Overall Study|Lack of Efficacy|4|||
147236973|NCT00347360|531037436|FG011|Overall Study|Prolonged duration between visits|0|||
147133828|NCT01076010|530658909|FG001|Overall Study|Lack of Efficacy|0|||
147236974|NCT00347360|531037437|FG012|Overall Study|Prolonged duration between visits|1|||
147133829|NCT01076010|530658910|FG002|Overall Study|Lack of Efficacy|0|||
147133830|NCT01076010|530658908|FG000|Overall Study|Treatment Interruption for > 2 Weeks|0|||
147133831|NCT01076010|530658909|FG001|Overall Study|Treatment Interruption for > 2 Weeks|1|||
147133832|NCT01076010|530658910|FG002|Overall Study|Treatment Interruption for > 2 Weeks|0|||
147133833|NCT01076010|530658908|FG000|Overall Study|Significant Surgical Procedure|0|||
147133834|NCT01076010|530658909|FG001|Overall Study|Significant Surgical Procedure|1|||
147133835|NCT01076010|530658910|FG002|Overall Study|Significant Surgical Procedure|0|||
147133836|NCT01076010|530658908|FG000|Overall Study|Protocol Violation|0|||
147133837|NCT01076010|530658909|FG001|Overall Study|Protocol Violation|1|||
147133838|NCT01076010|530658910|FG002|Overall Study|Protocol Violation|0|||
147133839|NCT01076010|530658908|FG000|Overall Study|Noncompliance|1|||
147133840|NCT01076010|530658909|FG001|Overall Study|Noncompliance|1|||
147133841|NCT01076010|530658910|FG002|Overall Study|Noncompliance|0|||
147133842|NCT01076010|530658908|FG000|Overall Study|Withdrawal by Subject|3|||
147133843|NCT01076010|530658909|FG001|Overall Study|Withdrawal by Subject|0|||
147133844|NCT01076010|530658910|FG002|Overall Study|Withdrawal by Subject|1|||
147133845|NCT01076010|530658908|FG000|Overall Study|Other|5|||
147133846|NCT01076010|530658909|FG001|Overall Study|Other|2|||
147133847|NCT01076010|530658910|FG002|Overall Study|Other|0|||
147133848|NCT01156844|530658911|FG000|Overall Study|Adverse Event|0|||
147133849|NCT01156844|530658912|FG001|Overall Study|Adverse Event|0|||
147133850|NCT01156844|530658913|FG002|Overall Study|Adverse Event|1|||
147133851|NCT01156844|530658914|FG003|Overall Study|Adverse Event|1|||
147133852|NCT01156844|530658911|FG000|Overall Study|Abnormal test procedure result(s)|0|||
147133853|NCT01156844|530658912|FG001|Overall Study|Abnormal test procedure result(s)|1|||
147133854|NCT01156844|530658913|FG002|Overall Study|Abnormal test procedure result(s)|2|||
147133855|NCT01156844|530658914|FG003|Overall Study|Abnormal test procedure result(s)|2|||
147133856|NCT01156844|530658911|FG000|Overall Study|Withdrawal by Subject|0|||
147133857|NCT01156844|530658912|FG001|Overall Study|Withdrawal by Subject|0|||
147133858|NCT01156844|530658913|FG002|Overall Study|Withdrawal by Subject|2|||
147133859|NCT01156844|530658914|FG003|Overall Study|Withdrawal by Subject|2|||
147133860|NCT01156844|530658911|FG000|Overall Study|Lost to Follow-up|0|||
147133861|NCT01156844|530658912|FG001|Overall Study|Lost to Follow-up|0|||
147133862|NCT01156844|530658913|FG002|Overall Study|Lost to Follow-up|1|||
147133863|NCT01156844|530658914|FG003|Overall Study|Lost to Follow-up|0|||
147133864|NCT01156844|530658911|FG000|Overall Study|Administrative problems|0|||
147133865|NCT01156844|530658912|FG001|Overall Study|Administrative problems|1|||
147133866|NCT01156844|530658913|FG002|Overall Study|Administrative problems|0|||
147133867|NCT01156844|530658914|FG003|Overall Study|Administrative problems|1|||
147133868|NCT01156844|530658911|FG000|Overall Study|Protocol deviation|2|||
147133869|NCT01156844|530658912|FG001|Overall Study|Protocol deviation|0|||
147133870|NCT01156844|530658913|FG002|Overall Study|Protocol deviation|0|||
147133871|NCT01156844|530658914|FG003|Overall Study|Protocol deviation|0|||
147133872|NCT00945659|530658916|FG000|Overall Study|Lost to Follow-up|7|||
147133873|NCT00945659|530658917|FG001|Overall Study|Lost to Follow-up|20|||
147133874|NCT00945659|530658918|FG002|Overall Study|Lost to Follow-up|17|||
147133875|NCT04067011|530658919|FG000|Overall Study|Not Treated|8|||
147133876|NCT04067011|530658920|FG001|Overall Study|Not Treated|7|||
147133877|NCT04067011|530658921|FG002|Overall Study|Not Treated|5|||
147133878|NCT04067011|530658919|FG000|Overall Study|Adverse Event|2|||
147133879|NCT04067011|530658920|FG001|Overall Study|Adverse Event|1|||
147133880|NCT04067011|530658921|FG002|Overall Study|Adverse Event|0|||
147133881|NCT04067011|530658919|FG000|Overall Study|Withdrawal by Subject|6|||
147133882|NCT04067011|530658920|FG001|Overall Study|Withdrawal by Subject|2|||
147133883|NCT04067011|530658921|FG002|Overall Study|Withdrawal by Subject|1|||
147133884|NCT04067011|530658919|FG000|Overall Study|Lost to Follow-up|0|||
147133885|NCT04067011|530658920|FG001|Overall Study|Lost to Follow-up|0|||
147133886|NCT04067011|530658921|FG002|Overall Study|Lost to Follow-up|1|||
147133887|NCT04067011|530658919|FG000|Overall Study|Physician Decision|1|||
147133888|NCT04067011|530658920|FG001|Overall Study|Physician Decision|1|||
147133889|NCT04067011|530658921|FG002|Overall Study|Physician Decision|0|||
147133890|NCT04067011|530658919|FG000|Overall Study|Other Reasons|2|||
147133891|NCT04067011|530658920|FG001|Overall Study|Other Reasons|0|||
147133892|NCT04067011|530658921|FG002|Overall Study|Other Reasons|1|||
147133893|NCT04067011|530658919|FG000|Overall Study|Missing|0|||
147133894|NCT04067011|530658920|FG001|Overall Study|Missing|2|||
147133895|NCT04067011|530658921|FG002|Overall Study|Missing|0|||
147133896|NCT05209386|530658922|FG000|Overall Study|Withdrawal by Subject|8|||
147133897|NCT05209386|530658922|FG000|Overall Study|Period of sEEG implant insufficient to collect complete behavioral task|24|||
147133898|NCT05200845|530658924|FG000|Overall Study|stopped collecting pilot data for metabolic chamber|1|||
147133899|NCT05200845|530658925|FG001|Overall Study|stopped collecting pilot data for metabolic chamber|1|||
147133900|NCT05200845|530658926|FG002|Overall Study|stopped collecting pilot data for metabolic chamber|2|||
147133901|NCT05200845|530658927|FG003|Overall Study|stopped collecting pilot data for metabolic chamber|0|||
147133902|NCT05200845|530658924|FG000|Overall Study|Withdrawal by Subject|0|||
147133903|NCT05200845|530658925|FG001|Overall Study|Withdrawal by Subject|1|||
147133904|NCT05200845|530658926|FG002|Overall Study|Withdrawal by Subject|1|||
147133905|NCT05200845|530658927|FG003|Overall Study|Withdrawal by Subject|0|||
147133906|NCT02412670|530658928|FG000|Overall Study|Adverse Event|4|||
147133907|NCT02412670|530658929|FG001|Overall Study|Adverse Event|1|||
147133908|NCT02412670|530658928|FG000|Overall Study|Physician Decision|1|||
147133909|NCT02412670|530658929|FG001|Overall Study|Physician Decision|0|||
147133910|NCT02412670|530658928|FG000|Overall Study|Withdrawal by Subject|1|||
147133911|NCT02412670|530658929|FG001|Overall Study|Withdrawal by Subject|0|||
147133912|NCT02412670|530658928|FG000|Overall Study|Ineligible|1|||
147133913|NCT02412670|530658929|FG001|Overall Study|Ineligible|0|||
147133914|NCT00565409|530658932|FG000|Period 1 Open Label|Adverse Event|17|||
147133915|NCT00565409|530658933|FG001|Period 1 Open Label|Adverse Event|0|||
147133916|NCT00565409|530658934|FG002|Period 1 Open Label|Adverse Event|0|||
147133917|NCT00565409|530658935|FG003|Period 1 Open Label|Adverse Event|0|||
147133918|NCT00565409|530658932|FG000|Period 1 Open Label|Death|2|||
147133919|NCT00565409|530658933|FG001|Period 1 Open Label|Death|0|||
147133920|NCT00565409|530658934|FG002|Period 1 Open Label|Death|0|||
147133921|NCT00565409|530658935|FG003|Period 1 Open Label|Death|0|||
147133922|NCT00565409|530658932|FG000|Period 1 Open Label|Lost to Follow-up|1|||
147133923|NCT00565409|530658933|FG001|Period 1 Open Label|Lost to Follow-up|0|||
147133924|NCT00565409|530658934|FG002|Period 1 Open Label|Lost to Follow-up|0|||
147133925|NCT00565409|530658935|FG003|Period 1 Open Label|Lost to Follow-up|0|||
147133926|NCT00565409|530658932|FG000|Period 1 Open Label|Other|21|||
147133927|NCT00565409|530658933|FG001|Period 1 Open Label|Other|0|||
147133928|NCT00565409|530658934|FG002|Period 1 Open Label|Other|0|||
147133929|NCT00565409|530658935|FG003|Period 1 Open Label|Other|0|||
147133930|NCT00565409|530658932|FG000|Period 1 Open Label|Protocol Violation|14|||
147133931|NCT00565409|530658933|FG001|Period 1 Open Label|Protocol Violation|0|||
147133932|NCT00565409|530658934|FG002|Period 1 Open Label|Protocol Violation|0|||
147133933|NCT00565409|530658935|FG003|Period 1 Open Label|Protocol Violation|0|||
147133934|NCT00565409|530658932|FG000|Period 1 Open Label|Unsatisfactory Response-Efficacy|22|||
147133935|NCT00565409|530658933|FG001|Period 1 Open Label|Unsatisfactory Response-Efficacy|0|||
147133936|NCT00565409|530658934|FG002|Period 1 Open Label|Unsatisfactory Response-Efficacy|0|||
147133937|NCT00565409|530658935|FG003|Period 1 Open Label|Unsatisfactory Response-Efficacy|0|||
147133938|NCT00565409|530658932|FG000|Period 1 Open Label|no conclusion of participation record|1|||
147133939|NCT00565409|530658933|FG001|Period 1 Open Label|no conclusion of participation record|0|||
147133940|NCT00565409|530658934|FG002|Period 1 Open Label|no conclusion of participation record|0|||
147133941|NCT00565409|530658935|FG003|Period 1 Open Label|no conclusion of participation record|0|||
147133942|NCT00565409|530658932|FG000|After Period 1, Prior to Period 2|did not meet criteria|152|||
147133943|NCT00565409|530658933|FG001|After Period 1, Prior to Period 2|did not meet criteria|0|||
147133944|NCT00565409|530658934|FG002|After Period 1, Prior to Period 2|did not meet criteria|0|||
147236975|NCT00347360|531037438|FG013|Overall Study|Prolonged duration between visits|0|||
147236976|NCT00347360|531037439|FG014|Overall Study|Prolonged duration between visits|0|||
147236977|NCT00347360|531037425|FG000|Overall Study|Subject left town, ran out of study drug|0|||
147570860|NCT00519194|532246820|FG000|Overall Study|Lost to Follow-up|3|||
147570861|NCT01175018|532246827|FG000|Overall Study|Adverse Event|3|||
147570862|NCT01175018|532246828|FG001|Overall Study|Adverse Event|1|||
147570863|NCT03285594|532246829|FG000|Overall Study|At the Participant's Own Request|10|||
147570864|NCT03285594|532246830|FG001|Overall Study|At the Participant's Own Request|5|||
147570865|NCT03285594|532246831|FG002|Overall Study|At the Participant's Own Request|21|||
147570866|NCT03285594|532246829|FG000|Overall Study|Adverse Event|2|||
147570867|NCT03285594|532246830|FG001|Overall Study|Adverse Event|2|||
147570868|NCT03285594|532246831|FG002|Overall Study|Adverse Event|6|||
147570869|NCT03285594|532246829|FG000|Overall Study|Poor Compliance to Protocol|0|||
147570870|NCT03285594|532246830|FG001|Overall Study|Poor Compliance to Protocol|0|||
147570871|NCT03285594|532246831|FG002|Overall Study|Poor Compliance to Protocol|1|||
147570872|NCT03285594|532246829|FG000|Overall Study|Lost to Follow-up|0|||
147570873|NCT03285594|532246830|FG001|Overall Study|Lost to Follow-up|0|||
147570874|NCT03285594|532246831|FG002|Overall Study|Lost to Follow-up|1|||
147570875|NCT03285594|532246829|FG000|Overall Study|Reason Not Specified|3|||
147133945|NCT00565409|530658935|FG003|After Period 1, Prior to Period 2|did not meet criteria|0|||
147133946|NCT00565409|530658932|FG000|Period 2 Double-Blind|Adverse Event|0|||
147133947|NCT00565409|530658933|FG001|Period 2 Double-Blind|Adverse Event|7|||
147133948|NCT00565409|530658934|FG002|Period 2 Double-Blind|Adverse Event|4|||
147133949|NCT00565409|530658935|FG003|Period 2 Double-Blind|Adverse Event|5|||
147133950|NCT00565409|530658932|FG000|Period 2 Double-Blind|Death|0|||
147133951|NCT00565409|530658933|FG001|Period 2 Double-Blind|Death|2|||
147133952|NCT00565409|530658934|FG002|Period 2 Double-Blind|Death|0|||
147133953|NCT00565409|530658935|FG003|Period 2 Double-Blind|Death|0|||
147133954|NCT00565409|530658932|FG000|Period 2 Double-Blind|Protocol Violation|0|||
147133955|NCT00565409|530658933|FG001|Period 2 Double-Blind|Protocol Violation|4|||
147133956|NCT00565409|530658934|FG002|Period 2 Double-Blind|Protocol Violation|6|||
147133957|NCT00565409|530658935|FG003|Period 2 Double-Blind|Protocol Violation|2|||
147133958|NCT00565409|530658932|FG000|Period 2 Double-Blind|Lost to Follow-up|0|||
147236978|NCT00347360|531037426|FG001|Overall Study|Subject left town, ran out of study drug|0|||
147317935|NCT04157686|531329449|FG004|Overall Study|Pregnancy|0|||
147570876|NCT03285594|532246830|FG001|Overall Study|Reason Not Specified|4|||
147570877|NCT03285594|532246831|FG002|Overall Study|Reason Not Specified|8|||
147133959|NCT00565409|530658933|FG001|Period 2 Double-Blind|Lost to Follow-up|0|||
147133960|NCT00565409|530658934|FG002|Period 2 Double-Blind|Lost to Follow-up|1|||
147133961|NCT00565409|530658935|FG003|Period 2 Double-Blind|Lost to Follow-up|0|||
147133962|NCT00565409|530658932|FG000|Period 2 Double-Blind|Other|0|||
147133963|NCT00565409|530658933|FG001|Period 2 Double-Blind|Other|4|||
147133964|NCT00565409|530658934|FG002|Period 2 Double-Blind|Other|5|||
147133965|NCT00565409|530658935|FG003|Period 2 Double-Blind|Other|9|||
147133966|NCT00565409|530658932|FG000|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|0|||
147133967|NCT00565409|530658933|FG001|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|4|||
147133968|NCT00565409|530658934|FG002|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|11|||
147133969|NCT00565409|530658935|FG003|Period 2 Double-Blind|Unsatisfactory Response-Efficacy|43|||
147133970|NCT02284191|530658939|FG000|Overall Study|Withdrawal by Subject|1|||
147133971|NCT02284191|530658940|FG001|Overall Study|Withdrawal by Subject|3|||
147133972|NCT02284191|530658939|FG000|Overall Study|Lost to Follow-up|1|||
147133973|NCT02284191|530658940|FG001|Overall Study|Lost to Follow-up|0|||
147133974|NCT02257684|530658943|FG000|Overall Study|Adverse Event|2|||
147133975|NCT02257684|530658943|FG000|Overall Study|Lack of Efficacy|1|||
147133976|NCT02257684|530658943|FG000|Overall Study|Sponsor's Decision|1|||
147133977|NCT01570387|530658944|FG000|Overall Study|Adverse Event|1|||
147133978|NCT01570387|530658945|FG001|Overall Study|Adverse Event|0|||
147133979|NCT01570387|530658946|FG002|Overall Study|Adverse Event|0|||
147133980|NCT01570387|530658947|FG003|Overall Study|Adverse Event|0|||
147133981|NCT01570387|530658944|FG000|Overall Study|Death|0|||
147133982|NCT01570387|530658945|FG001|Overall Study|Death|0|||
147133983|NCT01570387|530658946|FG002|Overall Study|Death|0|||
147133984|NCT01570387|530658947|FG003|Overall Study|Death|1|||
147133985|NCT01570387|530658944|FG000|Overall Study|Withdrawal by Subject|0|||
147133986|NCT01570387|530658945|FG001|Overall Study|Withdrawal by Subject|0|||
147133987|NCT01570387|530658946|FG002|Overall Study|Withdrawal by Subject|0|||
147133988|NCT01570387|530658947|FG003|Overall Study|Withdrawal by Subject|1|||
147133989|NCT02943473|530658948|FG000|Overall Study|enrolled but not dosed|1|||
147133990|NCT02943473|530658948|FG000|Overall Study|screen failure|1|||
147651442|NCT00424593|532546476|FG001|Dose-Blind Extension Period|Adverse Event|0|||
147651443|NCT00424593|532546475|FG000|Dose-Blind Extension Period|Lack of Efficacy|9|||
147651444|NCT00424593|532546476|FG001|Dose-Blind Extension Period|Lack of Efficacy|0|||
147651445|NCT00424593|532546475|FG000|Dose-Blind Extension Period|Protocol Violation|9|||
147651446|NCT00424593|532546476|FG001|Dose-Blind Extension Period|Protocol Violation|0|||
147651447|NCT00424593|532546475|FG000|Dose-Blind Extension Period|Lost to Follow-up|6|||
147651448|NCT00424593|532546476|FG001|Dose-Blind Extension Period|Lost to Follow-up|0|||
147651449|NCT00424593|532546475|FG000|Dose-Blind Extension Period|Physician Decision|3|||
147651450|NCT00424593|532546476|FG001|Dose-Blind Extension Period|Physician Decision|0|||
147651451|NCT05114564|532546479|FG000|First Intervention|Vision with study contact lens subjectively unacceptable|1|||
147651452|NCT05114564|532546480|FG001|First Intervention|Vision with study contact lens subjectively unacceptable|0|||
147651453|NCT05114564|532546479|FG000|First Intervention|Adverse Event|0|||
147651454|NCT05114564|532546480|FG001|First Intervention|Adverse Event|1|||
147651455|NCT00493311|532546481|FG000|Overall Study|Need for rescue medication|2|||
147651456|NCT00493311|532546482|FG001|Overall Study|Need for rescue medication|2|||
147651457|NCT02779075|532546483|FG000|Overall Study|Withdrawal by Subject|1|||
147651458|NCT02779075|532546484|FG001|Overall Study|Withdrawal by Subject|3|||
147651459|NCT02779075|532546483|FG000|Overall Study|IV lost during 2nd study|1|||
147651460|NCT02779075|532546484|FG001|Overall Study|IV lost during 2nd study|0|||
147651461|NCT02791438|532546492|FG000|Treatment Period|Adverse Event|1|||
147651462|NCT02791438|532546493|FG001|Treatment Period|Adverse Event|0|||
147651463|NCT02791438|532546492|FG000|Treatment Period|Withdrawal by Subject|0|||
147651464|NCT02791438|532546493|FG001|Treatment Period|Withdrawal by Subject|1|||
147651465|NCT02791438|532546492|FG000|Treatment Period|Withdrawal by Parent/Guardian|2|||
147133991|NCT02943473|530658948|FG000|Overall Study|Physician Decision|4|||
147133992|NCT01567722|530658955|FG000|Overall Study|Not being able to get tissue for Central Pathology Review prior to the protocol closure date|1|||
147133993|NCT01567722|530658956|FG001|Overall Study|Not being able to get tissue for Central Pathology Review prior to the protocol closure date|0|||
147133994|NCT01567722|530658957|FG002|Overall Study|Not being able to get tissue for Central Pathology Review prior to the protocol closure date|0|||
147651466|NCT02791438|532546493|FG001|Treatment Period|Withdrawal by Parent/Guardian|0|||
147651467|NCT01603394|532546494|FG000|Overall Study|Adverse Event|1|||
147133995|NCT01567722|530658955|FG000|Overall Study|Insufficient tissue available to satisfy the protocol requirements|2|||
147133996|NCT01567722|530658956|FG001|Overall Study|Insufficient tissue available to satisfy the protocol requirements|0|||
147651468|NCT02669667|532546495|FG000|Overall Study|Lost to Follow-up|0|||
147133997|NCT01567722|530658957|FG002|Overall Study|Insufficient tissue available to satisfy the protocol requirements|0|||
147133998|NCT01567722|530658955|FG000|Overall Study|Protocol closure by the OCG|2|||
147133999|NCT01567722|530658956|FG001|Overall Study|Protocol closure by the OCG|0|||
147134000|NCT01567722|530658957|FG002|Overall Study|Protocol closure by the OCG|0|||
147134001|NCT01567722|530658955|FG000|Overall Study|Not enough tissue left for the tissue scrolls|1|||
147134002|NCT01567722|530658956|FG001|Overall Study|Not enough tissue left for the tissue scrolls|0|||
147317936|NCT04157686|531329450|FG005|Overall Study|Pregnancy|0|||
147134003|NCT01567722|530658957|FG002|Overall Study|Not enough tissue left for the tissue scrolls|0|||
147134004|NCT00654732|530658962|FG000|Overall Study|Adverse Event|4|||
147134005|NCT00654732|530658963|FG001|Overall Study|Adverse Event|6|||
147134006|NCT01734902|530658966|FG000|Overall Study|Other than listed|0|||
147134007|NCT01734902|530658967|FG001|Overall Study|Other than listed|2|||
147134008|NCT00060944|530658970|FG000|Overall Study|Adverse Event|12|||
147134009|NCT00060944|530658971|FG001|Overall Study|Adverse Event|10|||
147134010|NCT00060944|530658970|FG000|Overall Study|Death|2|||
147134011|NCT00060944|530658971|FG001|Overall Study|Death|3|||
147134012|NCT00060944|530658970|FG000|Overall Study|Withdrawal by Subject|18|||
147134013|NCT00060944|530658971|FG001|Overall Study|Withdrawal by Subject|5|||
147134014|NCT00060944|530658970|FG000|Overall Study|Disease Progression|93|||
147134015|NCT00060944|530658971|FG001|Overall Study|Disease Progression|94|||
147134016|NCT00060944|530658970|FG000|Overall Study|Lost to Follow-up|1|||
147134017|NCT00060944|530658971|FG001|Overall Study|Lost to Follow-up|0|||
147134018|NCT00060944|530658970|FG000|Overall Study|Subject Ineligible To Continue|2|||
147134019|NCT00060944|530658971|FG001|Overall Study|Subject Ineligible To Continue|1|||
147134020|NCT00060944|530658970|FG000|Overall Study|Treatment Switch|0|||
147134021|NCT00060944|530658971|FG001|Overall Study|Treatment Switch|13|||
147134022|NCT00060944|530658970|FG000|Overall Study|Other|2|||
147134023|NCT00060944|530658971|FG001|Overall Study|Other|4|||
147134024|NCT00060944|530658970|FG000|Overall Study|randomized but not treated|6|||
147134025|NCT00060944|530658971|FG001|Overall Study|randomized but not treated|4|||
147134026|NCT02536664|530658976|FG000|Overall Study|Inadequate completion of documentation|2|||
147134027|NCT02536664|530658977|FG001|Overall Study|Inadequate completion of documentation|4|||
147134028|NCT02536664|530658976|FG000|Overall Study|Progression|13|||
147134029|NCT02536664|530658977|FG001|Overall Study|Progression|18|||
147134030|NCT02536664|530658976|FG000|Overall Study|Death due to lymphoma|2|||
147134031|NCT02536664|530658977|FG001|Overall Study|Death due to lymphoma|1|||
147134032|NCT02536664|530658976|FG000|Overall Study|Death due to other reason|3|||
147134033|NCT02536664|530658977|FG001|Overall Study|Death due to other reason|2|||
147134034|NCT02536664|530658976|FG000|Overall Study|Intolerability|8|||
147134035|NCT02536664|530658977|FG001|Overall Study|Intolerability|6|||
147134036|NCT02536664|530658976|FG000|Overall Study|Withdrawal by Subject|8|||
147134037|NCT02536664|530658977|FG001|Overall Study|Withdrawal by Subject|5|||
147134038|NCT02536664|530658976|FG000|Overall Study|Other|18|||
147134039|NCT02536664|530658977|FG001|Overall Study|Other|24|||
147134040|NCT02536664|530658976|FG000|Overall Study|Missing|53|||
147134041|NCT02536664|530658977|FG001|Overall Study|Missing|20|||
147134042|NCT03383666|530658978|FG000|Overall Study|Withdrawal by Subject|2|||
147134043|NCT03383666|530658978|FG000|Overall Study|Lost to Follow-up|2|||
147134044|NCT02359903|530658979|FG000|Overall Study|Adverse Event|0|||
147134045|NCT02359903|530658980|FG001|Overall Study|Adverse Event|2|||
147134046|NCT03507127|530658988|FG000|Overall Study|Withdrawal by Subject|1|||
147134047|NCT03507127|530658989|FG001|Overall Study|Withdrawal by Subject|0|||
147134048|NCT03507127|530658988|FG000|Overall Study|Unable to meet smoking abstinence criterion|1|||
147134049|NCT03507127|530658989|FG001|Overall Study|Unable to meet smoking abstinence criterion|1|||
147134050|NCT00746811|530658994|FG000|First Intervention (6 Weeks)|Adverse Event|1|||
147134051|NCT00746811|530658995|FG001|First Intervention (6 Weeks)|Adverse Event|0|||
147134052|NCT02505425|530658999|FG000|Overall Study|Lost to Follow-up|41|||
147134053|NCT02505425|530659000|FG001|Overall Study|Lost to Follow-up|61|||
147134054|NCT02505425|530659001|FG002|Overall Study|Lost to Follow-up|31|||
147134055|NCT02505425|530659002|FG003|Overall Study|Lost to Follow-up|19|||
147134056|NCT02505425|530658999|FG000|Overall Study|Withdrawal by Subject|39|||
147134057|NCT02505425|530659000|FG001|Overall Study|Withdrawal by Subject|9|||
147134058|NCT02505425|530659001|FG002|Overall Study|Withdrawal by Subject|19|||
147134059|NCT02505425|530659002|FG003|Overall Study|Withdrawal by Subject|7|||
147134060|NCT02505425|530658999|FG000|Overall Study|Death|8|||
147134061|NCT02505425|530659000|FG001|Overall Study|Death|12|||
147134062|NCT02505425|530659001|FG002|Overall Study|Death|0|||
147134063|NCT02505425|530659002|FG003|Overall Study|Death|0|||
147134064|NCT02031302|530659003|FG000|Overall Study|Death|115|||
147134065|NCT02031302|530659004|FG001|Overall Study|Death|0|||
147134066|NCT02031302|530659003|FG000|Overall Study|Not treated with study valve system|18|||
147134067|NCT02031302|530659004|FG001|Overall Study|Not treated with study valve system|0|||
147134068|NCT02031302|530659003|FG000|Overall Study|Missed Follow Up|27|||
147134069|NCT02031302|530659004|FG001|Overall Study|Missed Follow Up|0|||
147134070|NCT02031302|530659003|FG000|Overall Study|Lost to Follow-up|4|||
147134071|NCT02031302|530659004|FG001|Overall Study|Lost to Follow-up|0|||
147134072|NCT02293551|530659011|FG000|Part A and B Period 2|Withdrawal by Subject|0|||
147317937|NCT04157686|531329451|FG006|Overall Study|Pregnancy|3|||
147134073|NCT02293551|530659012|FG001|Part A and B Period 2|Withdrawal by Subject|0|||
147134074|NCT02293551|530659013|FG002|Part A and B Period 2|Withdrawal by Subject|0|||
147134075|NCT02293551|530659014|FG003|Part A and B Period 2|Withdrawal by Subject|0|||
147134076|NCT02293551|530659015|FG004|Part A and B Period 2|Withdrawal by Subject|0|||
147134077|NCT02293551|530659016|FG005|Part A and B Period 2|Withdrawal by Subject|1|||
147134078|NCT02293551|530659011|FG000|Part A and B Period 3|Withdrawal by Subject|0|||
147134079|NCT02293551|530659012|FG001|Part A and B Period 3|Withdrawal by Subject|0|||
147134080|NCT02293551|530659013|FG002|Part A and B Period 3|Withdrawal by Subject|0|||
147134081|NCT02293551|530659014|FG003|Part A and B Period 3|Withdrawal by Subject|2|||
147134082|NCT02293551|530659015|FG004|Part A and B Period 3|Withdrawal by Subject|0|||
147134083|NCT02293551|530659016|FG005|Part A and B Period 3|Withdrawal by Subject|1|||
147134084|NCT02293551|530659011|FG000|Part A and Part B Period 4|Withdrawal by Subject|0|||
147134085|NCT02293551|530659012|FG001|Part A and Part B Period 4|Withdrawal by Subject|0|||
147134086|NCT02293551|530659013|FG002|Part A and Part B Period 4|Withdrawal by Subject|0|||
147134087|NCT02293551|530659014|FG003|Part A and Part B Period 4|Withdrawal by Subject|2|||
147134088|NCT02293551|530659015|FG004|Part A and Part B Period 4|Withdrawal by Subject|0|||
147134089|NCT02293551|530659016|FG005|Part A and Part B Period 4|Withdrawal by Subject|1|||
147134090|NCT02936323|530659017|FG000|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
147134091|NCT02936323|530659018|FG001|Phase 1 Dose Escalation|Informed Consent Withdrawn|1|||
147134092|NCT02936323|530659019|FG002|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
147134093|NCT02936323|530659020|FG003|Phase 1 Dose Escalation|Informed Consent Withdrawn|1|||
147134094|NCT02936323|530659021|FG004|Phase 1 Dose Escalation|Informed Consent Withdrawn|1|||
147134095|NCT02936323|530659022|FG005|Phase 1 Dose Escalation|Informed Consent Withdrawn|1|||
147134096|NCT02936323|530659023|FG006|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
147134097|NCT02936323|530659024|FG007|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
147134098|NCT02936323|530659025|FG008|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
147134099|NCT02936323|530659026|FG009|Phase 1 Dose Escalation|Informed Consent Withdrawn|0|||
147134100|NCT02936323|530659017|FG000|Phase 1 Dose Escalation|Death|2|||
147134101|NCT02936323|530659018|FG001|Phase 1 Dose Escalation|Death|1|||
147134102|NCT02936323|530659019|FG002|Phase 1 Dose Escalation|Death|3|||
147134103|NCT02936323|530659020|FG003|Phase 1 Dose Escalation|Death|1|||
147134104|NCT02936323|530659021|FG004|Phase 1 Dose Escalation|Death|2|||
147134105|NCT02936323|530659022|FG005|Phase 1 Dose Escalation|Death|3|||
147134106|NCT02936323|530659023|FG006|Phase 1 Dose Escalation|Death|3|||
147134107|NCT02936323|530659024|FG007|Phase 1 Dose Escalation|Death|0|||
147134108|NCT02936323|530659025|FG008|Phase 1 Dose Escalation|Death|0|||
147134109|NCT02936323|530659026|FG009|Phase 1 Dose Escalation|Death|0|||
147134110|NCT02936323|530659017|FG000|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
147134111|NCT02936323|530659018|FG001|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
147134112|NCT02936323|530659019|FG002|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
147651469|NCT02669667|532546496|FG001|Overall Study|Lost to Follow-up|0|||
147651470|NCT02669667|532546497|FG002|Overall Study|Lost to Follow-up|0|||
147651471|NCT02669667|532546498|FG003|Overall Study|Lost to Follow-up|0|||
147651472|NCT02669667|532546499|FG004|Overall Study|Lost to Follow-up|0|||
147651473|NCT02669667|532546500|FG005|Overall Study|Lost to Follow-up|1|||
147651474|NCT02669667|532546501|FG006|Overall Study|Lost to Follow-up|0|||
147651475|NCT01215435|532546502|FG000|Overall Study|Adverse Event|1|||
147651476|NCT01215435|532546503|FG001|Overall Study|Adverse Event|0|||
147651477|NCT01215435|532546502|FG000|Overall Study|Protocol Violation|2|||
147651478|NCT01215435|532546503|FG001|Overall Study|Protocol Violation|0|||
147651479|NCT01215435|532546502|FG000|Overall Study|Withdrawal Criteria|8|||
147651480|NCT01215435|532546503|FG001|Overall Study|Withdrawal Criteria|11|||
147651481|NCT01215435|532546502|FG000|Overall Study|Lost to Follow-up|3|||
147651482|NCT01215435|532546503|FG001|Overall Study|Lost to Follow-up|0|||
147651483|NCT01215435|532546502|FG000|Overall Study|Unclassified|5|||
147651484|NCT01215435|532546503|FG001|Overall Study|Unclassified|5|||
147651485|NCT00840034|532546504|FG000|Acute Treatment Phase|Adverse Event|6|||
147651486|NCT00840034|532546505|FG001|Acute Treatment Phase|Adverse Event|8|||
147651487|NCT00840034|532546504|FG000|Acute Treatment Phase|Lack of Efficacy|2|||
147651488|NCT00840034|532546505|FG001|Acute Treatment Phase|Lack of Efficacy|0|||
147651489|NCT00840034|532546504|FG000|Acute Treatment Phase|Lost to Follow-up|5|||
147651490|NCT00840034|532546505|FG001|Acute Treatment Phase|Lost to Follow-up|12|||
147651491|NCT00840034|532546504|FG000|Acute Treatment Phase|Physician Decision|0|||
147134113|NCT02936323|530659020|FG003|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
147134114|NCT02936323|530659021|FG004|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
147134115|NCT02936323|530659022|FG005|Phase 1 Dose Escalation|Study Discontinued at Site|1|||
147134116|NCT02936323|530659023|FG006|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
147134117|NCT02936323|530659024|FG007|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
147134118|NCT02936323|530659025|FG008|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
147134119|NCT02936323|530659026|FG009|Phase 1 Dose Escalation|Study Discontinued at Site|0|||
147134120|NCT02936323|530659017|FG000|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
147134121|NCT02936323|530659018|FG001|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
147651492|NCT00840034|532546505|FG001|Acute Treatment Phase|Physician Decision|1|||
147651493|NCT00840034|532546504|FG000|Acute Treatment Phase|Protocol Violation|2|||
147651494|NCT00840034|532546505|FG001|Acute Treatment Phase|Protocol Violation|4|||
147134122|NCT02936323|530659019|FG002|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
147134123|NCT02936323|530659020|FG003|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
147134124|NCT02936323|530659021|FG004|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
147317938|NCT04157686|531329452|FG007|Overall Study|Pregnancy|0|||
147651495|NCT00840034|532546504|FG000|Acute Treatment Phase|Withdrawal by Subject|6|||
147134125|NCT02936323|530659022|FG005|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
147134126|NCT02936323|530659023|FG006|Phase 2a Dose Expansion|Informed Consent Withdrawn|0|||
147134127|NCT02936323|530659024|FG007|Phase 2a Dose Expansion|Informed Consent Withdrawn|11|||
147134128|NCT02936323|530659025|FG008|Phase 2a Dose Expansion|Informed Consent Withdrawn|4|||
147134129|NCT02936323|530659026|FG009|Phase 2a Dose Expansion|Informed Consent Withdrawn|2|||
147134130|NCT02936323|530659017|FG000|Phase 2a Dose Expansion|Physician Decision|0|||
147134131|NCT02936323|530659018|FG001|Phase 2a Dose Expansion|Physician Decision|0|||
147134132|NCT02936323|530659019|FG002|Phase 2a Dose Expansion|Physician Decision|0|||
147134133|NCT02936323|530659020|FG003|Phase 2a Dose Expansion|Physician Decision|0|||
147134134|NCT02936323|530659021|FG004|Phase 2a Dose Expansion|Physician Decision|0|||
147134135|NCT02936323|530659022|FG005|Phase 2a Dose Expansion|Physician Decision|0|||
147134136|NCT02936323|530659023|FG006|Phase 2a Dose Expansion|Physician Decision|0|||
147134137|NCT02936323|530659024|FG007|Phase 2a Dose Expansion|Physician Decision|0|||
147134138|NCT02936323|530659025|FG008|Phase 2a Dose Expansion|Physician Decision|0|||
147134139|NCT02936323|530659026|FG009|Phase 2a Dose Expansion|Physician Decision|1|||
147134140|NCT02936323|530659017|FG000|Phase 2a Dose Expansion|Lost to Follow-up|0|||
147134141|NCT02936323|530659018|FG001|Phase 2a Dose Expansion|Lost to Follow-up|0|||
147134142|NCT02936323|530659019|FG002|Phase 2a Dose Expansion|Lost to Follow-up|0|||
147134143|NCT02936323|530659020|FG003|Phase 2a Dose Expansion|Lost to Follow-up|0|||
147134144|NCT02936323|530659021|FG004|Phase 2a Dose Expansion|Lost to Follow-up|0|||
147134145|NCT02936323|530659022|FG005|Phase 2a Dose Expansion|Lost to Follow-up|0|||
147134146|NCT02936323|530659023|FG006|Phase 2a Dose Expansion|Lost to Follow-up|0|||
147134147|NCT02936323|530659024|FG007|Phase 2a Dose Expansion|Lost to Follow-up|2|||
147134148|NCT02936323|530659025|FG008|Phase 2a Dose Expansion|Lost to Follow-up|1|||
147134149|NCT02936323|530659026|FG009|Phase 2a Dose Expansion|Lost to Follow-up|0|||
147134150|NCT02936323|530659017|FG000|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
147134151|NCT02936323|530659018|FG001|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
147134152|NCT02936323|530659019|FG002|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
147134153|NCT02936323|530659020|FG003|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
147134154|NCT02936323|530659021|FG004|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
147134155|NCT02936323|530659022|FG005|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
147134156|NCT02936323|530659023|FG006|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
147134157|NCT02936323|530659024|FG007|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
147134158|NCT02936323|530659025|FG008|Phase 2a Dose Expansion|Change(s) to patient's condition|0|||
147134159|NCT02936323|530659026|FG009|Phase 2a Dose Expansion|Change(s) to patient's condition|1|||
147134160|NCT02936323|530659017|FG000|Phase 2a Dose Expansion|Death|0|||
147134161|NCT02936323|530659018|FG001|Phase 2a Dose Expansion|Death|0|||
147134162|NCT02936323|530659019|FG002|Phase 2a Dose Expansion|Death|0|||
147134163|NCT02936323|530659020|FG003|Phase 2a Dose Expansion|Death|0|||
147134164|NCT02936323|530659021|FG004|Phase 2a Dose Expansion|Death|0|||
147134165|NCT02936323|530659022|FG005|Phase 2a Dose Expansion|Death|0|||
147134166|NCT02936323|530659023|FG006|Phase 2a Dose Expansion|Death|0|||
147134167|NCT02936323|530659024|FG007|Phase 2a Dose Expansion|Death|4|||
147134168|NCT02936323|530659025|FG008|Phase 2a Dose Expansion|Death|8|||
147134169|NCT02936323|530659026|FG009|Phase 2a Dose Expansion|Death|10|||
147134170|NCT02781558|530659027|FG000|Overall Study|Lost to Follow-up|2|||
147134171|NCT02781558|530659028|FG001|Overall Study|Lost to Follow-up|2|||
147134172|NCT02781558|530659027|FG000|Overall Study|Adverse Event|1|||
147134173|NCT02781558|530659028|FG001|Overall Study|Adverse Event|0|||
147134174|NCT00545779|530659031|FG000|Overall Study|Violation of selection criteria at entry|8|||
147134175|NCT00545779|530659031|FG000|Overall Study|Other protocol violation|1|||
147134176|NCT00545779|530659031|FG000|Overall Study|Did not cooperate|7|||
147134177|NCT00545779|530659031|FG000|Overall Study|Withdrawal by Subject|20|||
147134178|NCT00545779|530659031|FG000|Overall Study|Adverse Event/intercurrent illness|5|||
147134179|NCT00545779|530659031|FG000|Overall Study|Failure to return|3|||
147134180|NCT01542788|530659032|FG000|Overall Study|Randomized but Not Treated|2|||
147134181|NCT01542788|530659033|FG001|Overall Study|Randomized but Not Treated|0|||
147134182|NCT01542788|530659032|FG000|Overall Study|Lack of Efficacy|41|||
147134183|NCT01542788|530659033|FG001|Overall Study|Lack of Efficacy|71|||
147134184|NCT01542788|530659032|FG000|Overall Study|Lost to Follow-up|5|||
147134185|NCT01542788|530659033|FG001|Overall Study|Lost to Follow-up|0|||
147134186|NCT01542788|530659032|FG000|Overall Study|Death|3|||
147236979|NCT00347360|531037427|FG002|Overall Study|Subject left town, ran out of study drug|0|||
147236980|NCT00347360|531037428|FG003|Overall Study|Subject left town, ran out of study drug|0|||
147134187|NCT01542788|530659033|FG001|Overall Study|Death|0|||
147134188|NCT01542788|530659032|FG000|Overall Study|Protocol Violation|2|||
147134189|NCT01542788|530659033|FG001|Overall Study|Protocol Violation|0|||
147236981|NCT00347360|531037429|FG004|Overall Study|Subject left town, ran out of study drug|0|||
147134190|NCT01542788|530659032|FG000|Overall Study|Physician Decision|1|||
147134191|NCT01542788|530659033|FG001|Overall Study|Physician Decision|0|||
147236982|NCT00347360|531037430|FG005|Overall Study|Subject left town, ran out of study drug|0|||
147236983|NCT00347360|531037431|FG006|Overall Study|Subject left town, ran out of study drug|0|||
147134192|NCT01542788|530659032|FG000|Overall Study|Withdrawal by Subject|1|||
147134193|NCT01542788|530659033|FG001|Overall Study|Withdrawal by Subject|0|||
147134194|NCT03586973|530659035|FG000|Overall Study|Death|15|||
147134195|NCT03586973|530659036|FG001|Overall Study|Death|8|||
147134196|NCT03586973|530659035|FG000|Overall Study|Site Terminated by Sponsor|3|||
147134197|NCT03586973|530659036|FG001|Overall Study|Site Terminated by Sponsor|6|||
147134198|NCT03586973|530659035|FG000|Overall Study|Withdrawal by Subject|1|||
147134199|NCT03586973|530659036|FG001|Overall Study|Withdrawal by Subject|0|||
147134200|NCT03586973|530659035|FG000|Overall Study|Lost to Follow-up|1|||
147134201|NCT03586973|530659036|FG001|Overall Study|Lost to Follow-up|0|||
147134202|NCT01150357|530659037|FG000|Dose Response Phase (Phase 1)|Protocol Violation|0|||
147134203|NCT01150357|530659038|FG001|Dose Response Phase (Phase 1)|Protocol Violation|1|||
147134204|NCT01150357|530659039|FG002|Dose Response Phase (Phase 1)|Protocol Violation|1|||
147134205|NCT01150357|530659037|FG000|Dose Response Phase (Phase 1)|Unsatisfactory therapeutic effect|1|||
147134206|NCT01150357|530659038|FG001|Dose Response Phase (Phase 1)|Unsatisfactory therapeutic effect|0|||
147134207|NCT01150357|530659039|FG002|Dose Response Phase (Phase 1)|Unsatisfactory therapeutic effect|0|||
147134208|NCT01150357|530659037|FG000|Dose Response Phase (Phase 1)|Adverse Event|0|||
147134209|NCT01150357|530659038|FG001|Dose Response Phase (Phase 1)|Adverse Event|0|||
147134210|NCT01150357|530659039|FG002|Dose Response Phase (Phase 1)|Adverse Event|1|||
147134211|NCT01150357|530659037|FG000|Dose Response Phase (Phase 1)|Withdrawal by Participants|0|||
147134212|NCT01150357|530659038|FG001|Dose Response Phase (Phase 1)|Withdrawal by Participants|2|||
147134213|NCT01150357|530659039|FG002|Dose Response Phase (Phase 1)|Withdrawal by Participants|1|||
147134214|NCT01150357|530659037|FG000|Placebo-controlled Withdrawal (Phase 2)|Adverse Event|0|||
147134215|NCT01150357|530659038|FG001|Placebo-controlled Withdrawal (Phase 2)|Adverse Event|0|||
147134216|NCT01150357|530659039|FG002|Placebo-controlled Withdrawal (Phase 2)|Adverse Event|2|||
147134217|NCT01150357|530659037|FG000|Placebo-controlled Withdrawal (Phase 2)|Withdrawal by Subject|2|||
147134218|NCT01150357|530659038|FG001|Placebo-controlled Withdrawal (Phase 2)|Withdrawal by Subject|0|||
147134219|NCT01150357|530659039|FG002|Placebo-controlled Withdrawal (Phase 2)|Withdrawal by Subject|0|||
147134220|NCT01150357|530659037|FG000|Placebo-controlled Withdrawal (Phase 2)|Lost to Follow-up|1|||
147134221|NCT01150357|530659038|FG001|Placebo-controlled Withdrawal (Phase 2)|Lost to Follow-up|0|||
147134222|NCT01150357|530659039|FG002|Placebo-controlled Withdrawal (Phase 2)|Lost to Follow-up|0|||
147134223|NCT01770743|530660466|FG000|Overall Study|Adverse Event|1|||
147134224|NCT01770743|530660467|FG001|Overall Study|Adverse Event|0|||
147134225|NCT01770743|530660468|FG002|Overall Study|Adverse Event|0|||
147134226|NCT01770743|530660469|FG003|Overall Study|Adverse Event|0|||
147134227|NCT01770743|530660470|FG004|Overall Study|Adverse Event|0|||
147134228|NCT01770743|530660466|FG000|Overall Study|Withdrawal by Subject|0|||
147134229|NCT01770743|530660467|FG001|Overall Study|Withdrawal by Subject|0|||
147134230|NCT01770743|530660468|FG002|Overall Study|Withdrawal by Subject|1|||
147134231|NCT01770743|530660469|FG003|Overall Study|Withdrawal by Subject|1|||
147134232|NCT01770743|530660470|FG004|Overall Study|Withdrawal by Subject|1|||
147134233|NCT01770743|530660466|FG000|Overall Study|Lost to Follow-up|0|||
147134234|NCT01770743|530660467|FG001|Overall Study|Lost to Follow-up|2|||
147134235|NCT01770743|530660468|FG002|Overall Study|Lost to Follow-up|0|||
147134236|NCT01770743|530660469|FG003|Overall Study|Lost to Follow-up|0|||
147134237|NCT01770743|530660470|FG004|Overall Study|Lost to Follow-up|1|||
147134238|NCT01770743|530660466|FG000|Overall Study|Sponsor Terminated Subject|1|||
147134239|NCT01770743|530660467|FG001|Overall Study|Sponsor Terminated Subject|0|||
147134240|NCT01770743|530660468|FG002|Overall Study|Sponsor Terminated Subject|0|||
147134241|NCT01770743|530660469|FG003|Overall Study|Sponsor Terminated Subject|1|||
147134242|NCT01770743|530660470|FG004|Overall Study|Sponsor Terminated Subject|0|||
147134243|NCT01770743|530660466|FG000|Overall Study|Moving Out of State|0|||
147134244|NCT01770743|530660467|FG001|Overall Study|Moving Out of State|1|||
147134245|NCT01770743|530660468|FG002|Overall Study|Moving Out of State|0|||
147134246|NCT01770743|530660469|FG003|Overall Study|Moving Out of State|0|||
147236984|NCT00347360|531037432|FG007|Overall Study|Subject left town, ran out of study drug|0|||
147236985|NCT00347360|531037433|FG008|Overall Study|Subject left town, ran out of study drug|0|||
147236986|NCT00347360|531037434|FG009|Overall Study|Subject left town, ran out of study drug|0|||
147236987|NCT00347360|531037435|FG010|Overall Study|Subject left town, ran out of study drug|0|||
147236988|NCT00347360|531037436|FG011|Overall Study|Subject left town, ran out of study drug|0|||
147236989|NCT00347360|531037437|FG012|Overall Study|Subject left town, ran out of study drug|0|||
147134247|NCT01770743|530660470|FG004|Overall Study|Moving Out of State|0|||
147134248|NCT01585025|530660471|FG000|Overall Study|Withdrawal by Subject|0|||
147134249|NCT01585025|530660472|FG001|Overall Study|Withdrawal by Subject|3|||
147134250|NCT01585025|530660473|FG002|Overall Study|Withdrawal by Subject|4|||
147134251|NCT02336815|530660474|FG000|Overall Study|Disease Progression|45|||
147134252|NCT02336815|530660475|FG001|Overall Study|Disease Progression|70|||
147134253|NCT02336815|530660474|FG000|Overall Study|Adverse Event|18|||
147134254|NCT02336815|530660475|FG001|Overall Study|Adverse Event|39|||
147236990|NCT00347360|531037438|FG013|Overall Study|Subject left town, ran out of study drug|1|||
147134255|NCT02336815|530660474|FG000|Overall Study|Physician Decision|11|||
147134256|NCT02336815|530660475|FG001|Overall Study|Physician Decision|4|||
147134257|NCT02336815|530660474|FG000|Overall Study|Withdrawal by Subject|3|||
147236991|NCT00347360|531037439|FG014|Overall Study|Subject left town, ran out of study drug|0|||
147134258|NCT02336815|530660475|FG001|Overall Study|Withdrawal by Subject|2|||
147134259|NCT02336815|530660474|FG000|Overall Study|Lost to Follow-up|1|||
147134260|NCT02336815|530660475|FG001|Overall Study|Lost to Follow-up|3|||
147134261|NCT02336815|530660474|FG000|Overall Study|Other|1|||
147134262|NCT02336815|530660475|FG001|Overall Study|Other|5|||
147134263|NCT00952705|530660476|FG000|Overall Study|Lost to Follow-up|24|||
147134264|NCT00952705|530660477|FG001|Overall Study|Lost to Follow-up|8|||
147134265|NCT00952705|530660478|FG002|Overall Study|Lost to Follow-up|9|||
147134266|NCT00952705|530660476|FG000|Overall Study|Withdrawal by Subject|2|||
147134267|NCT00952705|530660477|FG001|Overall Study|Withdrawal by Subject|1|||
147134268|NCT00952705|530660478|FG002|Overall Study|Withdrawal by Subject|1|||
147134269|NCT00952705|530660476|FG000|Overall Study|Death|2|||
147134270|NCT00952705|530660477|FG001|Overall Study|Death|0|||
147134271|NCT00952705|530660478|FG002|Overall Study|Death|0|||
147134272|NCT00952705|530660476|FG000|Overall Study|Incarcerated post dose|5|||
147134273|NCT00952705|530660477|FG001|Overall Study|Incarcerated post dose|0|||
147134274|NCT00952705|530660478|FG002|Overall Study|Incarcerated post dose|0|||
147134275|NCT00952705|530660476|FG000|Overall Study|Exclusion criteria not met pre dose|0|||
147134276|NCT00952705|530660477|FG001|Overall Study|Exclusion criteria not met pre dose|1|||
147134277|NCT00952705|530660478|FG002|Overall Study|Exclusion criteria not met pre dose|0|||
147134278|NCT00140140|530660479|FG000|Overall Study|Unacceptable toxicity|1|||
147134279|NCT00140140|530660480|FG001|Overall Study|Unacceptable toxicity|1|||
147134280|NCT00140140|530660481|FG002|Overall Study|Unacceptable toxicity|2|||
147134281|NCT00140140|530660479|FG000|Overall Study|Physician Decision|1|||
147134282|NCT00140140|530660480|FG001|Overall Study|Physician Decision|1|||
147134283|NCT00140140|530660481|FG002|Overall Study|Physician Decision|0|||
147134284|NCT03376516|530660482|FG000|Overall Study|Not treated|1|||
147134285|NCT03376516|530660482|FG000|Overall Study|Consent withdrawn|1|||
147134286|NCT01581684|530660483|FG000|Overall Study|Other reason not defined|0|||
147134287|NCT01581684|530660484|FG001|Overall Study|Other reason not defined|0|||
147134288|NCT01581684|530660485|FG002|Overall Study|Other reason not defined|0|||
147134289|NCT01581684|530660486|FG003|Overall Study|Other reason not defined|0|||
147134290|NCT01581684|530660487|FG004|Overall Study|Other reason not defined|0|||
147134291|NCT01581684|530660488|FG005|Overall Study|Other reason not defined|0|||
147134292|NCT01581684|530660489|FG006|Overall Study|Other reason not defined|0|||
147134293|NCT01581684|530660490|FG007|Overall Study|Other reason not defined|0|||
147134294|NCT01581684|530660491|FG008|Overall Study|Other reason not defined|1|||
147134295|NCT01581684|530660492|FG009|Overall Study|Other reason not defined|0|||
147134296|NCT00598650|530660493|FG000|Overall Study|Withdrawal by Subject|3|||
147134297|NCT00598650|530660493|FG000|Overall Study|Adverse Event|18|||
147134298|NCT00598650|530660493|FG000|Overall Study|No treatment for 3 weeks|1|||
147134299|NCT00598650|530660493|FG000|Overall Study|Not eligible|1|||
147134300|NCT00598650|530660493|FG000|Overall Study|Prohibited Concomitant Medication|2|||
147134301|NCT00598650|530660493|FG000|Overall Study|Physician Decision|2|||
147134302|NCT01128569|530660496|FG000|Washout Period 1|Adverse Event|0|||
147134303|NCT01128569|530660497|FG001|Washout Period 1|Adverse Event|0|||
147134304|NCT01128569|530660498|FG002|Washout Period 1|Adverse Event|1|||
147134305|NCT01128569|530660499|FG003|Washout Period 1|Adverse Event|0|||
147134306|NCT01128569|530660500|FG004|Washout Period 1|Adverse Event|0|||
147134307|NCT01128569|530660501|FG005|Washout Period 1|Adverse Event|0|||
147134308|NCT01128569|530660496|FG000|Treatment Period 2|Withdrawal by Subject|0|||
147134309|NCT01128569|530660497|FG001|Treatment Period 2|Withdrawal by Subject|1|||
147134310|NCT01128569|530660498|FG002|Treatment Period 2|Withdrawal by Subject|0|||
147134311|NCT01128569|530660499|FG003|Treatment Period 2|Withdrawal by Subject|0|||
147134312|NCT01128569|530660500|FG004|Treatment Period 2|Withdrawal by Subject|0|||
147134313|NCT01128569|530660501|FG005|Treatment Period 2|Withdrawal by Subject|0|||
147134314|NCT01865487|530660505|FG000|Overall Study|Lost to Follow-up|0|||
147317939|NCT04157686|531329445|FG000|Overall Study|Lost to Follow-up|1|||
147317940|NCT04157686|531329446|FG001|Overall Study|Lost to Follow-up|2|||
147317941|NCT04157686|531329447|FG002|Overall Study|Lost to Follow-up|8|||
147317942|NCT04157686|531329448|FG003|Overall Study|Lost to Follow-up|6|||
147317943|NCT04157686|531329449|FG004|Overall Study|Lost to Follow-up|6|||
147317944|NCT04157686|531329450|FG005|Overall Study|Lost to Follow-up|3|||
147317945|NCT04157686|531329451|FG006|Overall Study|Lost to Follow-up|7|||
147317946|NCT04157686|531329452|FG007|Overall Study|Lost to Follow-up|9|||
147317947|NCT04157686|531329445|FG000|Overall Study|Lack of Efficacy|0|||
147317948|NCT04157686|531329446|FG001|Overall Study|Lack of Efficacy|0|||
147134315|NCT01865487|530660506|FG001|Overall Study|Lost to Follow-up|0|||
147134316|NCT01865487|530660507|FG002|Overall Study|Lost to Follow-up|0|||
147134317|NCT01865487|530660508|FG003|Overall Study|Lost to Follow-up|1|||
147134318|NCT01865487|530660509|FG004|Overall Study|Lost to Follow-up|0|||
147134319|NCT01865487|530660510|FG005|Overall Study|Lost to Follow-up|0|||
147134320|NCT01865487|530660511|FG006|Overall Study|Lost to Follow-up|1|||
147134321|NCT01865487|530660512|FG007|Overall Study|Lost to Follow-up|0|||
147134322|NCT01865487|530660513|FG008|Overall Study|Lost to Follow-up|0|||
147134323|NCT01865487|530660514|FG009|Overall Study|Lost to Follow-up|0|||
147134324|NCT01865487|530660505|FG000|Overall Study|Withdrawal by Subject|0|||
147134325|NCT01865487|530660506|FG001|Overall Study|Withdrawal by Subject|0|||
147317949|NCT04157686|531329447|FG002|Overall Study|Lack of Efficacy|0|||
147134326|NCT01865487|530660507|FG002|Overall Study|Withdrawal by Subject|0|||
147134327|NCT01865487|530660508|FG003|Overall Study|Withdrawal by Subject|0|||
147134328|NCT01865487|530660509|FG004|Overall Study|Withdrawal by Subject|1|||
147134329|NCT01865487|530660510|FG005|Overall Study|Withdrawal by Subject|0|||
147134330|NCT01865487|530660511|FG006|Overall Study|Withdrawal by Subject|0|||
147134331|NCT01865487|530660512|FG007|Overall Study|Withdrawal by Subject|0|||
147134332|NCT01865487|530660513|FG008|Overall Study|Withdrawal by Subject|0|||
147134333|NCT01865487|530660514|FG009|Overall Study|Withdrawal by Subject|0|||
147134334|NCT01213082|530660515|FG000|Overall Study|Lost to Follow-up|6|||
147134335|NCT01213082|530660516|FG001|Overall Study|Lost to Follow-up|7|||
147134336|NCT01213082|530660517|FG002|Overall Study|Lost to Follow-up|4|||
147134337|NCT01213082|530660515|FG000|Overall Study|Physician Decision|0|||
147134338|NCT01213082|530660516|FG001|Overall Study|Physician Decision|0|||
147134339|NCT01213082|530660517|FG002|Overall Study|Physician Decision|1|||
147134340|NCT01627691|530660521|FG000|Overall Study|Death|11|||
147134341|NCT01627691|530660521|FG000|Overall Study|Lost to Follow-up|3|||
147134342|NCT01627691|530660521|FG000|Overall Study|Withdrawal by Subject|1|||
147134343|NCT01627691|530660521|FG000|Overall Study|Missed the visit|3|||
147134344|NCT01307449|530660523|FG000|Overall Study|Adverse Event|1|||
147134345|NCT01307449|530660524|FG001|Overall Study|Adverse Event|0|||
147134346|NCT01307449|530660525|FG002|Overall Study|Adverse Event|0|||
147134347|NCT01307449|530660526|FG003|Overall Study|Adverse Event|0|||
147134348|NCT03218917|530660527|FG000|Overall Study|Adverse Event|3|||
147134349|NCT03218917|530660528|FG001|Overall Study|Adverse Event|3|||
147134350|NCT03218917|530660529|FG002|Overall Study|Adverse Event|2|||
147134351|NCT03218917|530660527|FG000|Overall Study|Subject withdrew consent|2|||
147134352|NCT03218917|530660528|FG001|Overall Study|Subject withdrew consent|4|||
147134353|NCT03218917|530660529|FG002|Overall Study|Subject withdrew consent|10|||
147134354|NCT03218917|530660527|FG000|Overall Study|Physician Decision|0|||
147134355|NCT03218917|530660528|FG001|Overall Study|Physician Decision|1|||
147134356|NCT03218917|530660529|FG002|Overall Study|Physician Decision|1|||
147134357|NCT03218917|530660527|FG000|Overall Study|Lost to Follow-up|1|||
147134358|NCT03218917|530660528|FG001|Overall Study|Lost to Follow-up|0|||
147134359|NCT03218917|530660529|FG002|Overall Study|Lost to Follow-up|0|||
147134360|NCT03218917|530660527|FG000|Overall Study|Reason Missing|0|||
147134361|NCT03218917|530660528|FG001|Overall Study|Reason Missing|2|||
147134362|NCT03218917|530660529|FG002|Overall Study|Reason Missing|0|||
147134363|NCT03218917|530660527|FG000|Overall Study|Death|0|||
147134364|NCT03218917|530660528|FG001|Overall Study|Death|1|||
147134365|NCT03218917|530660529|FG002|Overall Study|Death|0|||
147134366|NCT03218917|530660527|FG000|Overall Study|Non-Compliance with Study Drug|0|||
147134367|NCT03218917|530660528|FG001|Overall Study|Non-Compliance with Study Drug|1|||
147134368|NCT03218917|530660529|FG002|Overall Study|Non-Compliance with Study Drug|0|||
147134369|NCT03440008|530660532|FG000|Overall Study|Cessation of research visits due to COVID-19, PI was transferred to a crisis-response department|25|||
147134370|NCT03440008|530660533|FG001|Overall Study|Cessation of research visits due to COVID-19, PI was transferred to a crisis-response department|7|||
147134371|NCT03440008|530660532|FG000|Overall Study|Withdrawal by Subject|1|||
147134372|NCT03440008|530660533|FG001|Overall Study|Withdrawal by Subject|0|||
147134373|NCT00760552|530660541|FG000|Overall Study|Death|2|||
147134374|NCT00760552|530660542|FG001|Overall Study|Death|0|||
147134375|NCT00760552|530660541|FG000|Overall Study|Lost to Follow-up|11|||
147134376|NCT00760552|530660542|FG001|Overall Study|Lost to Follow-up|10|||
147134377|NCT03323164|530660548|FG000|Overall Study|Poor quality imaging/scans|2|||
147134378|NCT03323164|530660549|FG001|Overall Study|Poor quality imaging/scans|2|||
147134379|NCT01823289|530660550|FG000|Overall Study|Lost to Follow-up|5|||
147134380|NCT01823289|530660550|FG000|Overall Study|Adverse Event|5|||
147134381|NCT01823289|530660550|FG000|Overall Study|Lack of Efficacy|1|||
147134382|NCT01823289|530660550|FG000|Overall Study|Physician Decision|9|||
147134383|NCT01823289|530660550|FG000|Overall Study|Administered contraindicated medicine|1|||
147134384|NCT01823289|530660550|FG000|Overall Study|Transaminase increased more than 3 times|1|||
147134385|NCT01823289|530660550|FG000|Overall Study|Drug affected efficacy and safety|1|||
147134386|NCT01823289|530660550|FG000|Overall Study|Creatinine clearance<30milliliter/minute|1|||
147134387|NCT01736917|530660551|FG000|Overall Study|Adverse Event|1|||
147134388|NCT01736917|530660551|FG000|Overall Study|Protocol Violation|10|||
147134389|NCT01911260|530660554|FG000|Supplementation Period|transference or evasion of school|7|||
147134390|NCT01911260|530660555|FG001|Supplementation Period|transference or evasion of school|9|||
147134391|NCT01911260|530660556|FG002|Supplementation Period|transference or evasion of school|7|||
147134392|NCT01911260|530660557|FG003|Supplementation Period|transference or evasion of school|6|||
147134393|NCT01911260|530660554|FG000|Supplementation Period|Adverse Event|2|||
147134394|NCT01911260|530660555|FG001|Supplementation Period|Adverse Event|0|||
147134395|NCT01911260|530660556|FG002|Supplementation Period|Adverse Event|1|||
147134396|NCT01911260|530660557|FG003|Supplementation Period|Adverse Event|0|||
147134397|NCT01911260|530660554|FG000|Supplementation Period|refused to receive supplement|1|||
147134398|NCT01911260|530660555|FG001|Supplementation Period|refused to receive supplement|0|||
147134399|NCT01911260|530660556|FG002|Supplementation Period|refused to receive supplement|1|||
147134400|NCT01911260|530660557|FG003|Supplementation Period|refused to receive supplement|0|||
147134401|NCT01911260|530660554|FG000|Supplementation Period|less than 12 weeks supplementation|0|||
147134402|NCT01911260|530660555|FG001|Supplementation Period|less than 12 weeks supplementation|3|||
147134403|NCT01911260|530660556|FG002|Supplementation Period|less than 12 weeks supplementation|1|||
147134404|NCT01911260|530660557|FG003|Supplementation Period|less than 12 weeks supplementation|2|||
147134405|NCT01911260|530660554|FG000|Follow-up Period|transference or evasion of school|13|||
147134406|NCT01911260|530660555|FG001|Follow-up Period|transference or evasion of school|20|||
147134407|NCT01911260|530660556|FG002|Follow-up Period|transference or evasion of school|15|||
147134408|NCT01911260|530660557|FG003|Follow-up Period|transference or evasion of school|12|||
147134409|NCT00956293|530660560|FG000|Main Period (Pre-randomization)|Not specified (data missing)|0|||
147134410|NCT00956293|530660561|FG001|Main Period (Pre-randomization)|Not specified (data missing)|0|||
147134411|NCT00956293|530660562|FG002|Main Period (Pre-randomization)|Not specified (data missing)|1|||
147134412|NCT00956293|530660560|FG000|Main Period (Pre-randomization)|Death|0|||
147134413|NCT00956293|530660561|FG001|Main Period (Pre-randomization)|Death|0|||
147134414|NCT00956293|530660562|FG002|Main Period (Pre-randomization)|Death|1|||
147445339|NCT00053417|531795837|FG000|Overall Study|Non-Compliance|0|||
147445340|NCT00053417|531795838|FG001|Overall Study|Non-Compliance|0|||
147445341|NCT00053417|531795839|FG002|Overall Study|Non-Compliance|0|||
147445342|NCT00053417|531795840|FG003|Overall Study|Non-Compliance|1|||
147134415|NCT00956293|530660560|FG000|Main Period (Pre-randomization)|Protocol Violation|0|||
147134416|NCT00956293|530660561|FG001|Main Period (Pre-randomization)|Protocol Violation|0|||
147134417|NCT00956293|530660562|FG002|Main Period (Pre-randomization)|Protocol Violation|1|||
147134418|NCT00956293|530660560|FG000|Main Period (Pre-randomization)|Abnormal test procedure result|0|||
147445343|NCT00053417|531795837|FG000|Overall Study|Withdrawal by Subject|0|||
147445344|NCT00053417|531795838|FG001|Overall Study|Withdrawal by Subject|1|||
147445345|NCT00053417|531795839|FG002|Overall Study|Withdrawal by Subject|0|||
147445346|NCT00053417|531795840|FG003|Overall Study|Withdrawal by Subject|0|||
147445347|NCT00053417|531795837|FG000|Overall Study|Lost to Follow-up|1|||
147445348|NCT00053417|531795838|FG001|Overall Study|Lost to Follow-up|1|||
147445349|NCT00053417|531795839|FG002|Overall Study|Lost to Follow-up|0|||
147445350|NCT00053417|531795840|FG003|Overall Study|Lost to Follow-up|0|||
147445351|NCT00705783|531795843|FG000|Conversion Phase|Sponsor Discontinued Study|54|||
147445352|NCT00705783|531795844|FG001|Conversion Phase|Sponsor Discontinued Study|0|||
147445353|NCT00705783|531795845|FG002|Conversion Phase|Sponsor Discontinued Study|0|||
147445354|NCT00705783|531795843|FG000|Conversion Phase|Lost to Follow-up|13|||
147445355|NCT00705783|531795844|FG001|Conversion Phase|Lost to Follow-up|0|||
147445356|NCT00705783|531795845|FG002|Conversion Phase|Lost to Follow-up|0|||
147445357|NCT00705783|531795843|FG000|Conversion Phase|Met Withdrawal Criteria|4|||
147445358|NCT00705783|531795844|FG001|Conversion Phase|Met Withdrawal Criteria|0|||
147445359|NCT00705783|531795845|FG002|Conversion Phase|Met Withdrawal Criteria|0|||
147445360|NCT00705783|531795843|FG000|Conversion Phase|Withdrawn by Investigator|4|||
147445361|NCT00705783|531795844|FG001|Conversion Phase|Withdrawn by Investigator|0|||
147445362|NCT00705783|531795845|FG002|Conversion Phase|Withdrawn by Investigator|0|||
147445363|NCT00705783|531795843|FG000|Conversion Phase|Withdrew Consent|24|||
147445364|NCT00705783|531795844|FG001|Conversion Phase|Withdrew Consent|0|||
147445365|NCT00705783|531795845|FG002|Conversion Phase|Withdrew Consent|0|||
147445366|NCT00705783|531795843|FG000|Conversion Phase|Protocol Deviation|2|||
147445367|NCT00705783|531795844|FG001|Conversion Phase|Protocol Deviation|0|||
147445368|NCT00705783|531795845|FG002|Conversion Phase|Protocol Deviation|0|||
147445369|NCT00705783|531795843|FG000|Conversion Phase|Adverse Event|11|||
147445370|NCT00705783|531795844|FG001|Conversion Phase|Adverse Event|0|||
147445371|NCT00705783|531795845|FG002|Conversion Phase|Adverse Event|0|||
147445372|NCT00705783|531795843|FG000|Conversion Phase|Lack of Efficacy with Adverse Event|13|||
147445373|NCT00705783|531795844|FG001|Conversion Phase|Lack of Efficacy with Adverse Event|0|||
147445374|NCT00705783|531795845|FG002|Conversion Phase|Lack of Efficacy with Adverse Event|0|||
147445375|NCT00705783|531795843|FG000|Conversion Phase|Lack of Efficacy without Adverse Event|8|||
147445376|NCT00705783|531795844|FG001|Conversion Phase|Lack of Efficacy without Adverse Event|0|||
147445377|NCT00705783|531795845|FG002|Conversion Phase|Lack of Efficacy without Adverse Event|0|||
147445378|NCT00705783|531795843|FG000|Oral Stabilization Phase|Sponsor Discontinue Study|42|||
147445379|NCT00705783|531795844|FG001|Oral Stabilization Phase|Sponsor Discontinue Study|0|||
147445380|NCT00705783|531795845|FG002|Oral Stabilization Phase|Sponsor Discontinue Study|0|||
147134419|NCT00956293|530660561|FG001|Main Period (Pre-randomization)|Abnormal test procedure result|0|||
147134420|NCT00956293|530660562|FG002|Main Period (Pre-randomization)|Abnormal test procedure result|2|||
147134421|NCT00956293|530660560|FG000|Main Period (Pre-randomization)|Administrative problems|0|||
147134422|NCT00956293|530660561|FG001|Main Period (Pre-randomization)|Administrative problems|0|||
147445381|NCT00705783|531795843|FG000|Oral Stabilization Phase|Lost to Follow-up|7|||
147445382|NCT00705783|531795844|FG001|Oral Stabilization Phase|Lost to Follow-up|0|||
147445383|NCT00705783|531795845|FG002|Oral Stabilization Phase|Lost to Follow-up|0|||
147445384|NCT00705783|531795843|FG000|Oral Stabilization Phase|Met Withdrawal Criteria|19|||
147445385|NCT00705783|531795844|FG001|Oral Stabilization Phase|Met Withdrawal Criteria|0|||
147651496|NCT00840034|532546505|FG001|Acute Treatment Phase|Withdrawal by Subject|11|||
147651497|NCT00840034|532546504|FG000|Taper Phase|Adverse Event|1|||
147134423|NCT00956293|530660562|FG002|Main Period (Pre-randomization)|Administrative problems|6|||
147134424|NCT00956293|530660560|FG000|Main Period (Pre-randomization)|Graft loss|0|||
147134425|NCT00956293|530660561|FG001|Main Period (Pre-randomization)|Graft loss|0|||
147134426|NCT00956293|530660562|FG002|Main Period (Pre-randomization)|Graft loss|7|||
147134427|NCT00956293|530660560|FG000|Main Period (Pre-randomization)|Withdrawal by Subject|0|||
147134428|NCT00956293|530660561|FG001|Main Period (Pre-randomization)|Withdrawal by Subject|0|||
147134429|NCT00956293|530660562|FG002|Main Period (Pre-randomization)|Withdrawal by Subject|12|||
147134430|NCT00956293|530660560|FG000|Main Period (Pre-randomization)|Lack of Efficacy|0|||
147134431|NCT00956293|530660561|FG001|Main Period (Pre-randomization)|Lack of Efficacy|0|||
147134432|NCT00956293|530660562|FG002|Main Period (Pre-randomization)|Lack of Efficacy|20|||
147134433|NCT00956293|530660560|FG000|Main Period (Pre-randomization)|Adverse Event|0|||
147134434|NCT00956293|530660561|FG001|Main Period (Pre-randomization)|Adverse Event|0|||
147134435|NCT00956293|530660562|FG002|Main Period (Pre-randomization)|Adverse Event|36|||
147134436|NCT00956293|530660560|FG000|Main Period (Pre-randomization)|Abnormal laboratory value|0|||
147134437|NCT00956293|530660561|FG001|Main Period (Pre-randomization)|Abnormal laboratory value|0|||
147134438|NCT00956293|530660562|FG002|Main Period (Pre-randomization)|Abnormal laboratory value|44|||
147134439|NCT00956293|530660560|FG000|Main Period (Randomization)|Abnormal laboratory value|0|||
147134440|NCT00956293|530660561|FG001|Main Period (Randomization)|Abnormal laboratory value|2|||
147134441|NCT00956293|530660562|FG002|Main Period (Randomization)|Abnormal laboratory value|0|||
147317950|NCT04157686|531329448|FG003|Overall Study|Lack of Efficacy|0|||
147317951|NCT04157686|531329449|FG004|Overall Study|Lack of Efficacy|0|||
147317952|NCT04157686|531329450|FG005|Overall Study|Lack of Efficacy|2|||
147317953|NCT04157686|531329451|FG006|Overall Study|Lack of Efficacy|0|||
147317954|NCT04157686|531329452|FG007|Overall Study|Lack of Efficacy|1|||
147134442|NCT00956293|530660560|FG000|Main Period (Randomization)|Lack of Efficacy|1|||
147134443|NCT00956293|530660561|FG001|Main Period (Randomization)|Lack of Efficacy|10|||
147134444|NCT00956293|530660562|FG002|Main Period (Randomization)|Lack of Efficacy|0|||
147317955|NCT04157686|531329445|FG000|Overall Study|Withdrawal by Subject|10|||
147317956|NCT04157686|531329446|FG001|Overall Study|Withdrawal by Subject|10|||
147317957|NCT04157686|531329447|FG002|Overall Study|Withdrawal by Subject|12|||
147317958|NCT04157686|531329448|FG003|Overall Study|Withdrawal by Subject|20|||
147317959|NCT04157686|531329449|FG004|Overall Study|Withdrawal by Subject|12|||
147317960|NCT04157686|531329450|FG005|Overall Study|Withdrawal by Subject|11|||
147317961|NCT04157686|531329451|FG006|Overall Study|Withdrawal by Subject|18|||
147317962|NCT04157686|531329452|FG007|Overall Study|Withdrawal by Subject|24|||
147317963|NCT04157686|531329445|FG000|Overall Study|Physician Decision|0|||
147317964|NCT04157686|531329446|FG001|Overall Study|Physician Decision|0|||
147317965|NCT04157686|531329447|FG002|Overall Study|Physician Decision|1|||
147317966|NCT04157686|531329448|FG003|Overall Study|Physician Decision|0|||
147317967|NCT04157686|531329449|FG004|Overall Study|Physician Decision|1|||
147317968|NCT04157686|531329450|FG005|Overall Study|Physician Decision|0|||
147317969|NCT04157686|531329451|FG006|Overall Study|Physician Decision|3|||
147317970|NCT04157686|531329452|FG007|Overall Study|Physician Decision|0|||
147317971|NCT04157686|531329445|FG000|Overall Study|Death|0|||
147317972|NCT04157686|531329446|FG001|Overall Study|Death|0|||
147317973|NCT04157686|531329447|FG002|Overall Study|Death|0|||
147317974|NCT04157686|531329448|FG003|Overall Study|Death|2|||
147317975|NCT04157686|531329449|FG004|Overall Study|Death|0|||
147570878|NCT02558491|532246832|FG000|First Invention|Withdrawal by Subject|3|||
147570879|NCT02558491|532246833|FG001|First Invention|Withdrawal by Subject|1|||
147134445|NCT00956293|530660560|FG000|Main Period (Randomization)|Adverse Event|0|||
147134446|NCT00956293|530660561|FG001|Main Period (Randomization)|Adverse Event|15|||
147317976|NCT04157686|531329450|FG005|Overall Study|Death|0|||
147317977|NCT04157686|531329451|FG006|Overall Study|Death|0|||
147317978|NCT04157686|531329452|FG007|Overall Study|Death|0|||
147317979|NCT04157686|531329445|FG000|Overall Study|Protocol Violation|0|||
147317980|NCT04157686|531329446|FG001|Overall Study|Protocol Violation|0|||
147317981|NCT04157686|531329447|FG002|Overall Study|Protocol Violation|0|||
147317982|NCT04157686|531329448|FG003|Overall Study|Protocol Violation|0|||
147317983|NCT04157686|531329449|FG004|Overall Study|Protocol Violation|1|||
147317984|NCT04157686|531329450|FG005|Overall Study|Protocol Violation|0|||
147570880|NCT02558491|532246832|FG000|First Invention|Data collection issues|1|||
147570881|NCT02558491|532246833|FG001|First Invention|Data collection issues|0|||
147570882|NCT02558491|532246832|FG000|First Invention|Stopping criteria|0|||
147134447|NCT00956293|530660562|FG002|Main Period (Randomization)|Adverse Event|0|||
147134448|NCT00956293|530660560|FG000|Follow-up Period|Follow-up period was terminated.|20|||
147134449|NCT00956293|530660561|FG001|Follow-up Period|Follow-up period was terminated.|32|||
147317985|NCT04157686|531329451|FG006|Overall Study|Protocol Violation|0|||
147317986|NCT04157686|531329452|FG007|Overall Study|Protocol Violation|0|||
147317987|NCT04157686|531329445|FG000|Overall Study|COVID-19, Family Reasons etc.|0|||
147317988|NCT04157686|531329446|FG001|Overall Study|COVID-19, Family Reasons etc.|2|||
147317989|NCT04157686|531329447|FG002|Overall Study|COVID-19, Family Reasons etc.|4|||
147317990|NCT04157686|531329448|FG003|Overall Study|COVID-19, Family Reasons etc.|1|||
147317991|NCT04157686|531329449|FG004|Overall Study|COVID-19, Family Reasons etc.|4|||
147317992|NCT04157686|531329450|FG005|Overall Study|COVID-19, Family Reasons etc.|6|||
147445386|NCT00705783|531795845|FG002|Oral Stabilization Phase|Met Withdrawal Criteria|0|||
147445387|NCT00705783|531795843|FG000|Oral Stabilization Phase|Withdrawn by Investigator|12|||
147445388|NCT00705783|531795844|FG001|Oral Stabilization Phase|Withdrawn by Investigator|0|||
147445389|NCT00705783|531795845|FG002|Oral Stabilization Phase|Withdrawn by Investigator|0|||
147445390|NCT00705783|531795843|FG000|Oral Stabilization Phase|Withdrew Consent|29|||
147445391|NCT00705783|531795844|FG001|Oral Stabilization Phase|Withdrew Consent|0|||
147445392|NCT00705783|531795845|FG002|Oral Stabilization Phase|Withdrew Consent|0|||
147445393|NCT00705783|531795843|FG000|Oral Stabilization Phase|Adverse Event|14|||
147445394|NCT00705783|531795844|FG001|Oral Stabilization Phase|Adverse Event|0|||
147445395|NCT00705783|531795845|FG002|Oral Stabilization Phase|Adverse Event|0|||
147570883|NCT02558491|532246833|FG001|First Invention|Stopping criteria|1|||
147570884|NCT02558491|532246832|FG000|First Invention|Changed parameters during trial|1|||
147134450|NCT00956293|530660562|FG002|Follow-up Period|Follow-up period was terminated.|0|||
147134451|NCT01240863|530660563|FG000|Open-label Titration Period|Adverse Event|47|||
147134452|NCT01240863|530660564|FG001|Open-label Titration Period|Adverse Event|0|||
147134453|NCT01240863|530660565|FG002|Open-label Titration Period|Adverse Event|0|||
147134454|NCT01240863|530660563|FG000|Open-label Titration Period|Lack of Efficacy|19|||
147134455|NCT01240863|530660564|FG001|Open-label Titration Period|Lack of Efficacy|0|||
147134456|NCT01240863|530660565|FG002|Open-label Titration Period|Lack of Efficacy|0|||
147134457|NCT01240863|530660563|FG000|Open-label Titration Period|Withdrawal by Subject|9|||
147134458|NCT01240863|530660564|FG001|Open-label Titration Period|Withdrawal by Subject|0|||
147134459|NCT01240863|530660565|FG002|Open-label Titration Period|Withdrawal by Subject|0|||
147134460|NCT01240863|530660563|FG000|Open-label Titration Period|Protocol Violation|7|||
147134461|NCT01240863|530660564|FG001|Open-label Titration Period|Protocol Violation|0|||
147134462|NCT01240863|530660565|FG002|Open-label Titration Period|Protocol Violation|0|||
147134463|NCT01240863|530660563|FG000|Open-label Titration Period|Noncompliance to study drug admin|3|||
147134464|NCT01240863|530660564|FG001|Open-label Titration Period|Noncompliance to study drug admin|0|||
147134465|NCT01240863|530660565|FG002|Open-label Titration Period|Noncompliance to study drug admin|0|||
147134466|NCT01240863|530660563|FG000|Open-label Titration Period|Noncompliance to study procedures|3|||
147134467|NCT01240863|530660564|FG001|Open-label Titration Period|Noncompliance to study procedures|0|||
147134468|NCT01240863|530660565|FG002|Open-label Titration Period|Noncompliance to study procedures|0|||
147134469|NCT01240863|530660563|FG000|Open-label Titration Period|Dropped out prior to dosing|2|||
147134470|NCT01240863|530660564|FG001|Open-label Titration Period|Dropped out prior to dosing|0|||
147134471|NCT01240863|530660565|FG002|Open-label Titration Period|Dropped out prior to dosing|0|||
147134472|NCT01240863|530660563|FG000|Open-label Titration Period|Other|7|||
147134473|NCT01240863|530660564|FG001|Open-label Titration Period|Other|0|||
147134474|NCT01240863|530660565|FG002|Open-label Titration Period|Other|0|||
147134475|NCT01240863|530660563|FG000|Double-blind Treatment Period (12 Weeks)|Adverse Event|0|||
147134476|NCT01240863|530660564|FG001|Double-blind Treatment Period (12 Weeks)|Adverse Event|4|||
147134477|NCT01240863|530660565|FG002|Double-blind Treatment Period (12 Weeks)|Adverse Event|10|||
147134478|NCT01240863|530660563|FG000|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
147134479|NCT01240863|530660564|FG001|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|17|||
147134480|NCT01240863|530660565|FG002|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|5|||
147134481|NCT01240863|530660563|FG000|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
147134482|NCT01240863|530660564|FG001|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|3|||
147134483|NCT01240863|530660565|FG002|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|5|||
147134484|NCT01240863|530660563|FG000|Double-blind Treatment Period (12 Weeks)|Protocol Violation|0|||
147134485|NCT01240863|530660564|FG001|Double-blind Treatment Period (12 Weeks)|Protocol Violation|9|||
147134486|NCT01240863|530660565|FG002|Double-blind Treatment Period (12 Weeks)|Protocol Violation|14|||
147134487|NCT01240863|530660563|FG000|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|0|||
147134488|NCT01240863|530660564|FG001|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|9|||
147134489|NCT01240863|530660565|FG002|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|11|||
147134490|NCT01240863|530660563|FG000|Double-blind Treatment Period (12 Weeks)|Noncompliance to study procedures|0|||
147134491|NCT01240863|530660564|FG001|Double-blind Treatment Period (12 Weeks)|Noncompliance to study procedures|2|||
147134492|NCT01240863|530660565|FG002|Double-blind Treatment Period (12 Weeks)|Noncompliance to study procedures|2|||
147134493|NCT01240863|530660563|FG000|Double-blind Treatment Period (12 Weeks)|Other|0|||
147134494|NCT01240863|530660564|FG001|Double-blind Treatment Period (12 Weeks)|Other|1|||
147134495|NCT01240863|530660565|FG002|Double-blind Treatment Period (12 Weeks)|Other|5|||
147134496|NCT01240863|530660563|FG000|Double-blind Treatment Period (12 Weeks)|Physician Decision|0|||
147134497|NCT01240863|530660564|FG001|Double-blind Treatment Period (12 Weeks)|Physician Decision|1|||
147134498|NCT01240863|530660565|FG002|Double-blind Treatment Period (12 Weeks)|Physician Decision|0|||
147134499|NCT01816984|530660567|FG000|Overall Study|declining health status|1|||
147445396|NCT00705783|531795843|FG000|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|7|||
147570885|NCT02558491|532246833|FG001|First Invention|Changed parameters during trial|0|||
147570886|NCT02558491|532246832|FG000|Second Intervention|Withdrawal by Subject|1|||
147570887|NCT02558491|532246833|FG001|Second Intervention|Withdrawal by Subject|0|||
147570888|NCT02558491|532246832|FG000|Second Intervention|Stopping Criteria|1|||
147134500|NCT05899829|530660568|FG000|Part 1 (Up to Day 22)|Enrolled but did not receive study treatment|4|||
147134501|NCT05899829|530660569|FG001|Part 1 (Up to Day 22)|Enrolled but did not receive study treatment|0|||
147134502|NCT05899829|530660568|FG000|Part 2 (up to Day 21)|Enrolled but did not receive study treatment|0|||
147134503|NCT05899829|530660569|FG001|Part 2 (up to Day 21)|Enrolled but did not receive study treatment|6|||
147134504|NCT00867035|530660570|FG000|Baseline to 1 Hour|Withdrawal by Subject|1|||
147134505|NCT00867035|530660571|FG001|Baseline to 1 Hour|Withdrawal by Subject|1|||
147134506|NCT00867035|530660570|FG000|Baseline to 1 Week|Withdrawal by Subject|1|||
147134507|NCT00867035|530660571|FG001|Baseline to 1 Week|Withdrawal by Subject|0|||
147134508|NCT02993263|530660572|FG000|Overall Study|Equipment Software failed and results were lost.|323|||
147134509|NCT01405196|530660575|FG000|Overall Study|Study Terminated by Sponsor|0|||
147134510|NCT01405196|530660576|FG001|Overall Study|Study Terminated by Sponsor|0|||
147134511|NCT01405196|530660577|FG002|Overall Study|Study Terminated by Sponsor|9|||
147134512|NCT01405196|530660578|FG003|Overall Study|Study Terminated by Sponsor|0|||
147134513|NCT01405196|530660575|FG000|Overall Study|Other|2|||
147134514|NCT01405196|530660576|FG001|Overall Study|Other|2|||
147134515|NCT01405196|530660577|FG002|Overall Study|Other|5|||
147134516|NCT01405196|530660578|FG003|Overall Study|Other|0|||
147134517|NCT01405196|530660575|FG000|Overall Study|Withdrawal by Subject|4|||
147134518|NCT01405196|530660576|FG001|Overall Study|Withdrawal by Subject|6|||
147134519|NCT01405196|530660577|FG002|Overall Study|Withdrawal by Subject|3|||
147134520|NCT01405196|530660578|FG003|Overall Study|Withdrawal by Subject|6|||
147134521|NCT01405196|530660575|FG000|Overall Study|Adverse Event|2|||
147134522|NCT01405196|530660576|FG001|Overall Study|Adverse Event|2|||
147134523|NCT01405196|530660577|FG002|Overall Study|Adverse Event|0|||
147134524|NCT01405196|530660578|FG003|Overall Study|Adverse Event|2|||
147134525|NCT01405196|530660575|FG000|Overall Study|Death|1|||
147134526|NCT01405196|530660576|FG001|Overall Study|Death|0|||
147134527|NCT01405196|530660577|FG002|Overall Study|Death|3|||
147134528|NCT01405196|530660578|FG003|Overall Study|Death|0|||
147134529|NCT01405196|530660575|FG000|Overall Study|Lost to Follow-up|2|||
147134530|NCT01405196|530660576|FG001|Overall Study|Lost to Follow-up|2|||
147134531|NCT01405196|530660577|FG002|Overall Study|Lost to Follow-up|3|||
147134532|NCT01405196|530660578|FG003|Overall Study|Lost to Follow-up|1|||
147134533|NCT04704193|530660581|FG000|Overall Study|Withdrawal by Subject|1|||
147134534|NCT00542178|530660582|FG000|Overall Study|did not complete year 4 follow-up|75|||
147134535|NCT00542178|530660583|FG001|Overall Study|did not complete year 4 follow-up|80|||
147134536|NCT00542178|530660584|FG002|Overall Study|did not complete year 4 follow-up|74|||
147134537|NCT00542178|530660585|FG003|Overall Study|did not complete year 4 follow-up|62|||
147134538|NCT00542178|530660586|FG004|Overall Study|did not complete year 4 follow-up|64|||
147134539|NCT00542178|530660587|FG005|Overall Study|did not complete year 4 follow-up|89|||
147134540|NCT00542178|530660588|FG006|Overall Study|did not complete year 4 follow-up|87|||
147134541|NCT00542178|530660589|FG007|Overall Study|did not complete year 4 follow-up|85|||
147134542|NCT02611037|530660592|FG000|Overall Study|Withdrawal prior to treatment|2|||
147134543|NCT02611037|530660593|FG001|Overall Study|Withdrawal prior to treatment|0|||
147134544|NCT00829998|530660594|FG000|Washout|Adverse Event|0|||
147134545|NCT00829998|530660595|FG001|Washout|Adverse Event|1|||
147134546|NCT05270863|530660598|FG000|Visit 2 First Intervention|Randomization error|0|||
147134547|NCT05270863|530660599|FG001|Visit 2 First Intervention|Randomization error|0|||
147134548|NCT05270863|530660600|FG002|Visit 2 First Intervention|Randomization error|0|||
147134549|NCT05270863|530660601|FG003|Visit 2 First Intervention|Randomization error|1|||
147134550|NCT05270863|530660602|FG004|Visit 2 First Intervention|Randomization error|0|||
147134551|NCT05270863|530660603|FG005|Visit 2 First Intervention|Randomization error|0|||
147134552|NCT05270863|530660598|FG000|First Washout|Withdrawal by Subject|0|||
147570889|NCT02558491|532246833|FG001|Second Intervention|Stopping Criteria|0|||
147134553|NCT05270863|530660599|FG001|First Washout|Withdrawal by Subject|0|||
147134554|NCT05270863|530660600|FG002|First Washout|Withdrawal by Subject|0|||
147134555|NCT05270863|530660601|FG003|First Washout|Withdrawal by Subject|0|||
147134556|NCT05270863|530660602|FG004|First Washout|Withdrawal by Subject|1|||
147134557|NCT05270863|530660603|FG005|First Washout|Withdrawal by Subject|1|||
147134558|NCT05270863|530660598|FG000|First Washout|Lost to Follow-up|0|||
147134559|NCT05270863|530660599|FG001|First Washout|Lost to Follow-up|0|||
147570890|NCT00834431|532246834|FG000|First Intervention|Adverse Event|0|||
147570891|NCT00834431|532246835|FG001|First Intervention|Adverse Event|1|||
147570892|NCT00834431|532246834|FG000|Washout of 7 Days|Withdrawal by Subject|0|||
147570893|NCT00834431|532246835|FG001|Washout of 7 Days|Withdrawal by Subject|1|||
147570894|NCT03733444|532246838|FG000|Overall Study|Adverse Event|8|||
147570895|NCT03733444|532246839|FG001|Overall Study|Adverse Event|10|||
147570896|NCT03733444|532246840|FG002|Overall Study|Adverse Event|5|||
147570897|NCT03733444|532246838|FG000|Overall Study|Death|20|||
147570898|NCT03733444|532246839|FG001|Overall Study|Death|19|||
147134560|NCT05270863|530660600|FG002|First Washout|Lost to Follow-up|0|||
147134561|NCT05270863|530660601|FG003|First Washout|Lost to Follow-up|0|||
147570899|NCT03733444|532246840|FG002|Overall Study|Death|11|||
147134562|NCT05270863|530660602|FG004|First Washout|Lost to Follow-up|0|||
147570900|NCT03733444|532246838|FG000|Overall Study|Lost to Follow-up|3|||
147570901|NCT03733444|532246839|FG001|Overall Study|Lost to Follow-up|0|||
147134563|NCT05270863|530660603|FG005|First Washout|Lost to Follow-up|1|||
147134564|NCT05270863|530660598|FG000|Visit 3 Second Intervention|Inclusion Criteria|1|||
147134565|NCT05270863|530660599|FG001|Visit 3 Second Intervention|Inclusion Criteria|0|||
147134566|NCT05270863|530660600|FG002|Visit 3 Second Intervention|Inclusion Criteria|1|||
147134567|NCT05270863|530660601|FG003|Visit 3 Second Intervention|Inclusion Criteria|0|||
147134568|NCT05270863|530660602|FG004|Visit 3 Second Intervention|Inclusion Criteria|0|||
147134569|NCT05270863|530660603|FG005|Visit 3 Second Intervention|Inclusion Criteria|0|||
147134570|NCT05270863|530660598|FG000|Second Washout|Withdrawal by Subject|1|||
147134571|NCT05270863|530660599|FG001|Second Washout|Withdrawal by Subject|1|||
147134572|NCT05270863|530660600|FG002|Second Washout|Withdrawal by Subject|0|||
147134573|NCT05270863|530660601|FG003|Second Washout|Withdrawal by Subject|0|||
147134574|NCT05270863|530660602|FG004|Second Washout|Withdrawal by Subject|0|||
147134575|NCT05270863|530660603|FG005|Second Washout|Withdrawal by Subject|0|||
147134576|NCT05270863|530660598|FG000|Second Washout|Lost to Follow-up|0|||
147134577|NCT05270863|530660599|FG001|Second Washout|Lost to Follow-up|0|||
147134578|NCT05270863|530660600|FG002|Second Washout|Lost to Follow-up|0|||
147134579|NCT05270863|530660601|FG003|Second Washout|Lost to Follow-up|1|||
147134580|NCT05270863|530660602|FG004|Second Washout|Lost to Follow-up|0|||
147134581|NCT05270863|530660603|FG005|Second Washout|Lost to Follow-up|0|||
147134582|NCT04712669|530660604|FG000|Double Blind Phase|Adverse Event|4|||
147134583|NCT04712669|530660605|FG001|Double Blind Phase|Adverse Event|4|||
147134584|NCT04712669|530660606|FG002|Double Blind Phase|Adverse Event|3|||
147317993|NCT04157686|531329451|FG006|Overall Study|COVID-19, Family Reasons etc.|0|||
147570902|NCT03733444|532246840|FG002|Overall Study|Lost to Follow-up|1|||
147570903|NCT03733444|532246838|FG000|Overall Study|Lack of Efficacy|0|||
147570904|NCT03733444|532246839|FG001|Overall Study|Lack of Efficacy|1|||
147570905|NCT03733444|532246840|FG002|Overall Study|Lack of Efficacy|1|||
147570906|NCT03733444|532246838|FG000|Overall Study|Physician Decision|2|||
147570907|NCT03733444|532246839|FG001|Overall Study|Physician Decision|1|||
147570908|NCT03733444|532246840|FG002|Overall Study|Physician Decision|0|||
147570909|NCT03733444|532246838|FG000|Overall Study|Protocol Violation|2|||
147570910|NCT03733444|532246839|FG001|Overall Study|Protocol Violation|1|||
147570911|NCT03733444|532246840|FG002|Overall Study|Protocol Violation|0|||
147570912|NCT03733444|532246838|FG000|Overall Study|Protocol Specified Withdrawal Criteria Met|1|||
147570913|NCT03733444|532246839|FG001|Overall Study|Protocol Specified Withdrawal Criteria Met|1|||
147570914|NCT03733444|532246840|FG002|Overall Study|Protocol Specified Withdrawal Criteria Met|2|||
147134585|NCT04712669|530660607|FG003|Double Blind Phase|Adverse Event|0|||
147134586|NCT04712669|530660608|FG004|Double Blind Phase|Adverse Event|0|||
147317994|NCT04157686|531329452|FG007|Overall Study|COVID-19, Family Reasons etc.|1|||
147317995|NCT03038672|531331571|FG000|Initial Treatment|Unacceptable chemistry|0|||
147317996|NCT03038672|531331572|FG001|Initial Treatment|Unacceptable chemistry|1|||
147317997|NCT03038672|531331571|FG000|Initial Treatment|Progression prior to treatment|1|||
147317998|NCT03038672|531331572|FG001|Initial Treatment|Progression prior to treatment|0|||
147317999|NCT03038672|531331571|FG000|Initial Treatment|No treatment per protocol|1|||
147318000|NCT03038672|531331572|FG001|Initial Treatment|No treatment per protocol|0|||
147318001|NCT04423393|531331573|FG000|Overall Study|Withdrawal by Subject|0|||
147318002|NCT04423393|531331574|FG001|Overall Study|Withdrawal by Subject|0|||
147318003|NCT04423393|531331575|FG002|Overall Study|Withdrawal by Subject|0|||
147318004|NCT04423393|531331576|FG003|Overall Study|Withdrawal by Subject|0|||
147318005|NCT04423393|531331577|FG004|Overall Study|Withdrawal by Subject|0|||
147318006|NCT04423393|531331578|FG005|Overall Study|Withdrawal by Subject|1|||
147318007|NCT04423393|531331579|FG006|Overall Study|Withdrawal by Subject|0|||
147318008|NCT04423393|531331580|FG007|Overall Study|Withdrawal by Subject|0|||
147318009|NCT04423393|531331581|FG008|Overall Study|Withdrawal by Subject|0|||
147318010|NCT04423393|531331582|FG009|Overall Study|Withdrawal by Subject|0|||
147318011|NCT04423393|531331583|FG010|Overall Study|Withdrawal by Subject|0|||
147318012|NCT04423393|531331584|FG011|Overall Study|Withdrawal by Subject|0|||
147318013|NCT04423393|531331585|FG012|Overall Study|Withdrawal by Subject|0|||
147318014|NCT04423393|531331586|FG013|Overall Study|Withdrawal by Subject|1|||
147318015|NCT04423393|531331587|FG014|Overall Study|Withdrawal by Subject|0|||
147318016|NCT04423393|531331588|FG015|Overall Study|Withdrawal by Subject|0|||
147318017|NCT04423393|531331589|FG016|Overall Study|Withdrawal by Subject|0|||
147318018|NCT04423393|531331590|FG017|Overall Study|Withdrawal by Subject|0|||
147318019|NCT04423393|531331573|FG000|Overall Study|Sponsor Decision|0|||
147318020|NCT04423393|531331574|FG001|Overall Study|Sponsor Decision|0|||
147318021|NCT04423393|531331575|FG002|Overall Study|Sponsor Decision|0|||
147318022|NCT04423393|531331576|FG003|Overall Study|Sponsor Decision|0|||
147134587|NCT04712669|530660609|FG005|Double Blind Phase|Adverse Event|0|||
147134588|NCT04712669|530660610|FG006|Double Blind Phase|Adverse Event|0|||
147570915|NCT03733444|532246838|FG000|Overall Study|Study Terminated by Sponsor|203|||
147570916|NCT03733444|532246839|FG001|Overall Study|Study Terminated by Sponsor|209|||
147570917|NCT03733444|532246840|FG002|Overall Study|Study Terminated by Sponsor|221|||
147570918|NCT03733444|532246838|FG000|Overall Study|Withdrawal by Subject|19|||
147134589|NCT04712669|530660611|FG007|Double Blind Phase|Adverse Event|0|||
147318023|NCT04423393|531331577|FG004|Overall Study|Sponsor Decision|0|||
147318024|NCT04423393|531331578|FG005|Overall Study|Sponsor Decision|0|||
147236992|NCT00347360|531037425|FG000|Overall Study|Subject refuse to sign updated consent|0|||
147236993|NCT00347360|531037426|FG001|Overall Study|Subject refuse to sign updated consent|0|||
147236994|NCT00347360|531037427|FG002|Overall Study|Subject refuse to sign updated consent|0|||
147236995|NCT00347360|531037428|FG003|Overall Study|Subject refuse to sign updated consent|0|||
147236996|NCT00347360|531037429|FG004|Overall Study|Subject refuse to sign updated consent|0|||
147236997|NCT00347360|531037430|FG005|Overall Study|Subject refuse to sign updated consent|0|||
147236998|NCT00347360|531037431|FG006|Overall Study|Subject refuse to sign updated consent|0|||
147236999|NCT00347360|531037432|FG007|Overall Study|Subject refuse to sign updated consent|0|||
147237000|NCT00347360|531037433|FG008|Overall Study|Subject refuse to sign updated consent|0|||
147237001|NCT00347360|531037434|FG009|Overall Study|Subject refuse to sign updated consent|0|||
147237002|NCT00347360|531037435|FG010|Overall Study|Subject refuse to sign updated consent|0|||
147237003|NCT00347360|531037436|FG011|Overall Study|Subject refuse to sign updated consent|0|||
147237004|NCT00347360|531037437|FG012|Overall Study|Subject refuse to sign updated consent|0|||
147237005|NCT00347360|531037438|FG013|Overall Study|Subject refuse to sign updated consent|0|||
147237006|NCT00347360|531037439|FG014|Overall Study|Subject refuse to sign updated consent|1|||
147237007|NCT00347360|531037425|FG000|Overall Study|Visits conflicted with new job|0|||
147570919|NCT03733444|532246839|FG001|Overall Study|Withdrawal by Subject|18|||
147570920|NCT03733444|532246840|FG002|Overall Study|Withdrawal by Subject|16|||
147570921|NCT03733444|532246838|FG000|Overall Study|Miscellaneous|1|||
147570922|NCT03733444|532246839|FG001|Overall Study|Miscellaneous|0|||
147570923|NCT03733444|532246840|FG002|Overall Study|Miscellaneous|1|||
147570924|NCT03733444|532246838|FG000|Overall Study|Not Treated|1|||
147570925|NCT03733444|532246839|FG001|Overall Study|Not Treated|2|||
147570926|NCT03733444|532246840|FG002|Overall Study|Not Treated|1|||
147570927|NCT03637764|532246841|FG000|Overall Study|Adverse Event|2|||
147570928|NCT03637764|532246842|FG001|Overall Study|Adverse Event|0|||
147570929|NCT03637764|532246843|FG002|Overall Study|Adverse Event|0|||
147570930|NCT03637764|532246844|FG003|Overall Study|Adverse Event|1|||
147570931|NCT03637764|532246841|FG000|Overall Study|Progressive Disease|23|||
147570932|NCT03637764|532246842|FG001|Overall Study|Progressive Disease|23|||
147570933|NCT03637764|532246843|FG002|Overall Study|Progressive Disease|18|||
147570934|NCT03637764|532246844|FG003|Overall Study|Progressive Disease|31|||
147570935|NCT03637764|532246841|FG000|Overall Study|Withdrawal by Subject|1|||
147570936|NCT03637764|532246842|FG001|Overall Study|Withdrawal by Subject|3|||
147570937|NCT03637764|532246843|FG002|Overall Study|Withdrawal by Subject|0|||
147570938|NCT03637764|532246844|FG003|Overall Study|Withdrawal by Subject|1|||
147570939|NCT00835263|532246845|FG000|Second Intervention|Adverse Event|1|||
147570940|NCT00835263|532246846|FG001|Second Intervention|Adverse Event|0|||
147570941|NCT01020474|532246847|FG000|Overall Study|Adverse Event|4|||
147570942|NCT01020474|532246848|FG001|Overall Study|Adverse Event|4|||
147570943|NCT01020474|532246847|FG000|Overall Study|Protocol Violation|0|||
147570944|NCT01020474|532246848|FG001|Overall Study|Protocol Violation|2|||
147570945|NCT01020474|532246847|FG000|Overall Study|Withdrawal by Subject|5|||
147570946|NCT01020474|532246848|FG001|Overall Study|Withdrawal by Subject|7|||
147570947|NCT01020474|532246847|FG000|Overall Study|Other Reasons|1|||
147570948|NCT01020474|532246848|FG001|Overall Study|Other Reasons|1|||
147570949|NCT01020474|532246847|FG000|Overall Study|Insufficient Clinical Response|0|||
147570950|NCT01020474|532246848|FG001|Overall Study|Insufficient Clinical Response|3|||
147570951|NCT03987191|532246849|FG000|Overall Study|COVID-19 related research disruption|0|||
147570952|NCT03987191|532246850|FG001|Overall Study|COVID-19 related research disruption|2|||
147570953|NCT02838420|532246853|FG000|Overall Study|Ongoing in Study|113|||
147651498|NCT00840034|532546505|FG001|Taper Phase|Adverse Event|0|||
147651499|NCT00840034|532546504|FG000|Taper Phase|Lost to Follow-up|1|||
147237008|NCT00347360|531037426|FG001|Overall Study|Visits conflicted with new job|0|||
147237009|NCT00347360|531037427|FG002|Overall Study|Visits conflicted with new job|0|||
147237010|NCT00347360|531037428|FG003|Overall Study|Visits conflicted with new job|0|||
147237011|NCT00347360|531037429|FG004|Overall Study|Visits conflicted with new job|0|||
147237012|NCT00347360|531037430|FG005|Overall Study|Visits conflicted with new job|0|||
147237013|NCT00347360|531037431|FG006|Overall Study|Visits conflicted with new job|1|||
147237014|NCT00347360|531037432|FG007|Overall Study|Visits conflicted with new job|0|||
147237015|NCT00347360|531037433|FG008|Overall Study|Visits conflicted with new job|0|||
147237016|NCT00347360|531037434|FG009|Overall Study|Visits conflicted with new job|0|||
147570954|NCT02838420|532246854|FG001|Overall Study|Ongoing in Study|45|||
147570955|NCT02838420|532246853|FG000|Overall Study|Lost to Follow-up|1|||
147570956|NCT02838420|532246854|FG001|Overall Study|Lost to Follow-up|0|||
147570957|NCT02838420|532246853|FG000|Overall Study|Withdrawal by Subject|3|||
147570958|NCT02838420|532246854|FG001|Overall Study|Withdrawal by Subject|4|||
147570959|NCT02838420|532246853|FG000|Overall Study|Death|8|||
147570960|NCT02838420|532246854|FG001|Overall Study|Death|13|||
147570961|NCT00796653|532246855|FG000|Overall Study|Adverse Event|19|||
147570962|NCT00796653|532246856|FG001|Overall Study|Adverse Event|16|||
147570963|NCT00796653|532246857|FG002|Overall Study|Adverse Event|16|||
147570964|NCT00796653|532246858|FG003|Overall Study|Adverse Event|16|||
147570965|NCT00796653|532246855|FG000|Overall Study|Lost to Follow-up|2|||
147570966|NCT00796653|532246856|FG001|Overall Study|Lost to Follow-up|1|||
147134590|NCT04712669|530660604|FG000|Double Blind Phase|Physician Decision|1|||
147134591|NCT04712669|530660605|FG001|Double Blind Phase|Physician Decision|0|||
147134592|NCT04712669|530660606|FG002|Double Blind Phase|Physician Decision|0|||
147134593|NCT04712669|530660607|FG003|Double Blind Phase|Physician Decision|0|||
147134594|NCT04712669|530660608|FG004|Double Blind Phase|Physician Decision|0|||
147134595|NCT04712669|530660609|FG005|Double Blind Phase|Physician Decision|0|||
147134596|NCT04712669|530660610|FG006|Double Blind Phase|Physician Decision|0|||
147134597|NCT04712669|530660611|FG007|Double Blind Phase|Physician Decision|0|||
147134598|NCT04712669|530660604|FG000|Double Blind Phase|Withdrawal by Subject|3|||
147134599|NCT04712669|530660605|FG001|Double Blind Phase|Withdrawal by Subject|6|||
147570967|NCT00796653|532246857|FG002|Overall Study|Lost to Follow-up|2|||
147570968|NCT00796653|532246858|FG003|Overall Study|Lost to Follow-up|3|||
147570969|NCT00796653|532246855|FG000|Overall Study|Withdrawal by Subject|16|||
147570970|NCT00796653|532246856|FG001|Overall Study|Withdrawal by Subject|8|||
147570971|NCT00796653|532246857|FG002|Overall Study|Withdrawal by Subject|8|||
147570972|NCT00796653|532246858|FG003|Overall Study|Withdrawal by Subject|13|||
147318025|NCT04423393|531331579|FG006|Overall Study|Sponsor Decision|0|||
147318026|NCT04423393|531331580|FG007|Overall Study|Sponsor Decision|0|||
147318027|NCT04423393|531331581|FG008|Overall Study|Sponsor Decision|0|||
147318028|NCT04423393|531331582|FG009|Overall Study|Sponsor Decision|0|||
147318029|NCT04423393|531331583|FG010|Overall Study|Sponsor Decision|0|||
147318030|NCT04423393|531331584|FG011|Overall Study|Sponsor Decision|0|||
147318031|NCT04423393|531331585|FG012|Overall Study|Sponsor Decision|0|||
147318032|NCT04423393|531331586|FG013|Overall Study|Sponsor Decision|1|||
147318033|NCT04423393|531331587|FG014|Overall Study|Sponsor Decision|0|||
147318034|NCT04423393|531331588|FG015|Overall Study|Sponsor Decision|0|||
147318035|NCT04423393|531331589|FG016|Overall Study|Sponsor Decision|0|||
147445397|NCT00705783|531795844|FG001|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
147445398|NCT00705783|531795845|FG002|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
147445399|NCT00705783|531795843|FG000|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|4|||
147318036|NCT04423393|531331590|FG017|Overall Study|Sponsor Decision|0|||
147318037|NCT05220501|531331591|FG000|Overall Study|Withdrawal by Subject|11|||
147318038|NCT05220501|531331592|FG001|Overall Study|Withdrawal by Subject|21|||
147570973|NCT00796653|532246855|FG000|Overall Study|Lack of Efficacy|8|||
147570974|NCT00796653|532246856|FG001|Overall Study|Lack of Efficacy|1|||
147570975|NCT00796653|532246857|FG002|Overall Study|Lack of Efficacy|3|||
147570976|NCT00796653|532246858|FG003|Overall Study|Lack of Efficacy|2|||
147570977|NCT00796653|532246855|FG000|Overall Study|Non compliance with protocol|2|||
147570978|NCT00796653|532246856|FG001|Overall Study|Non compliance with protocol|2|||
147570979|NCT00796653|532246857|FG002|Overall Study|Non compliance with protocol|0|||
147570980|NCT00796653|532246858|FG003|Overall Study|Non compliance with protocol|2|||
147570981|NCT00796653|532246855|FG000|Overall Study|Other reason not described above|4|||
147570982|NCT00796653|532246856|FG001|Overall Study|Other reason not described above|9|||
147570983|NCT00796653|532246857|FG002|Overall Study|Other reason not described above|7|||
147570984|NCT00796653|532246858|FG003|Overall Study|Other reason not described above|4|||
147570985|NCT01940341|532246861|FG000|Period 1: Double-blind Phase|Withdrew Consent|7|||
147570986|NCT01940341|532246862|FG001|Period 1: Double-blind Phase|Withdrew Consent|4|||
147570987|NCT01940341|532246863|FG002|Period 1: Double-blind Phase|Withdrew Consent|0|||
147570988|NCT01940341|532246864|FG003|Period 1: Double-blind Phase|Withdrew Consent|0|||
147570989|NCT01940341|532246861|FG000|Period 1: Double-blind Phase|Lost to Follow-up|8|||
147570990|NCT01940341|532246862|FG001|Period 1: Double-blind Phase|Lost to Follow-up|1|||
147570991|NCT01940341|532246863|FG002|Period 1: Double-blind Phase|Lost to Follow-up|0|||
147570992|NCT01940341|532246864|FG003|Period 1: Double-blind Phase|Lost to Follow-up|0|||
147570993|NCT01940341|532246861|FG000|Period 1: Double-blind Phase|Adverse Event|4|||
147651500|NCT00840034|532546505|FG001|Taper Phase|Lost to Follow-up|1|||
147134600|NCT04712669|530660606|FG002|Double Blind Phase|Withdrawal by Subject|0|||
147134601|NCT04712669|530660607|FG003|Double Blind Phase|Withdrawal by Subject|0|||
147134602|NCT04712669|530660608|FG004|Double Blind Phase|Withdrawal by Subject|0|||
147318039|NCT05220501|531331593|FG002|Overall Study|Withdrawal by Subject|32|||
147445400|NCT00705783|531795844|FG001|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
147570994|NCT01940341|532246862|FG001|Period 1: Double-blind Phase|Adverse Event|2|||
147570995|NCT01940341|532246863|FG002|Period 1: Double-blind Phase|Adverse Event|0|||
147570996|NCT01940341|532246864|FG003|Period 1: Double-blind Phase|Adverse Event|0|||
147651501|NCT00840034|532546504|FG000|Taper Phase|Withdrawal by Subject|1|||
147134603|NCT04712669|530660609|FG005|Double Blind Phase|Withdrawal by Subject|0|||
147318040|NCT05220501|531331591|FG000|Overall Study|Awaiting biopsy at time of interim analysis. Study closed. Primary endpoint met|5|||
147570997|NCT01940341|532246861|FG000|Period 1: Double-blind Phase|Investigator's Discretion|3|||
147570998|NCT01940341|532246862|FG001|Period 1: Double-blind Phase|Investigator's Discretion|1|||
147570999|NCT01940341|532246863|FG002|Period 1: Double-blind Phase|Investigator's Discretion|0|||
147571000|NCT01940341|532246864|FG003|Period 1: Double-blind Phase|Investigator's Discretion|0|||
147651502|NCT00840034|532546505|FG001|Taper Phase|Withdrawal by Subject|1|||
147134604|NCT04712669|530660610|FG006|Double Blind Phase|Withdrawal by Subject|0|||
147134605|NCT04712669|530660611|FG007|Double Blind Phase|Withdrawal by Subject|0|||
147571001|NCT01940341|532246861|FG000|Period 1: Double-blind Phase|Non-compliance with Study Drug|1|||
147571002|NCT01940341|532246862|FG001|Period 1: Double-blind Phase|Non-compliance with Study Drug|1|||
147571003|NCT01940341|532246863|FG002|Period 1: Double-blind Phase|Non-compliance with Study Drug|0|||
147571004|NCT01940341|532246864|FG003|Period 1: Double-blind Phase|Non-compliance with Study Drug|0|||
147571005|NCT01940341|532246861|FG000|Period 1: Double-blind Phase|Death|0|||
147571006|NCT01940341|532246862|FG001|Period 1: Double-blind Phase|Death|1|||
147571007|NCT01940341|532246863|FG002|Period 1: Double-blind Phase|Death|0|||
147571008|NCT01940341|532246864|FG003|Period 1: Double-blind Phase|Death|0|||
147571009|NCT01940341|532246861|FG000|Period 1: Double-blind Phase|Pregnancy|0|||
147571010|NCT01940341|532246862|FG001|Period 1: Double-blind Phase|Pregnancy|1|||
147571011|NCT01940341|532246863|FG002|Period 1: Double-blind Phase|Pregnancy|0|||
147571012|NCT01940341|532246864|FG003|Period 1: Double-blind Phase|Pregnancy|0|||
147571013|NCT01940341|532246861|FG000|Period 1: Double-blind Phase|Protocol Specified Criteria for Withdrawal|1|||
147571014|NCT01940341|532246862|FG001|Period 1: Double-blind Phase|Protocol Specified Criteria for Withdrawal|0|||
147571015|NCT01940341|532246863|FG002|Period 1: Double-blind Phase|Protocol Specified Criteria for Withdrawal|0|||
147571016|NCT01940341|532246864|FG003|Period 1: Double-blind Phase|Protocol Specified Criteria for Withdrawal|0|||
147571017|NCT01940341|532246861|FG000|Period 1: Double-blind Phase|Randomized but Never Treated|0|||
147571018|NCT01940341|532246862|FG001|Period 1: Double-blind Phase|Randomized but Never Treated|1|||
147571019|NCT01940341|532246863|FG002|Period 1: Double-blind Phase|Randomized but Never Treated|0|||
147571020|NCT01940341|532246864|FG003|Period 1: Double-blind Phase|Randomized but Never Treated|0|||
147571021|NCT01940341|532246861|FG000|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|0|||
147571022|NCT01940341|532246862|FG001|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|0|||
147571023|NCT01940341|532246863|FG002|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|17|||
147571024|NCT01940341|532246864|FG003|Period 2: Open-Label TAF Extension Phase|Withdrew Consent|4|||
147571025|NCT01940341|532246861|FG000|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|0|||
147571026|NCT01940341|532246862|FG001|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|0|||
147571027|NCT01940341|532246863|FG002|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|3|||
147571028|NCT01940341|532246864|FG003|Period 2: Open-Label TAF Extension Phase|Investigator's Discretion|4|||
147571029|NCT01940341|532246861|FG000|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|0|||
147571030|NCT01940341|532246862|FG001|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|0|||
147571031|NCT01940341|532246863|FG002|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|6|||
147571032|NCT01940341|532246864|FG003|Period 2: Open-Label TAF Extension Phase|Lost to Follow-up|0|||
147571033|NCT01940341|532246861|FG000|Period 2: Open-Label TAF Extension Phase|Protocol Specified Criteria for Withdrawal|0|||
147571034|NCT01940341|532246862|FG001|Period 2: Open-Label TAF Extension Phase|Protocol Specified Criteria for Withdrawal|0|||
147571035|NCT01940341|532246863|FG002|Period 2: Open-Label TAF Extension Phase|Protocol Specified Criteria for Withdrawal|3|||
147571036|NCT01940341|532246864|FG003|Period 2: Open-Label TAF Extension Phase|Protocol Specified Criteria for Withdrawal|1|||
147571037|NCT01940341|532246861|FG000|Period 2: Open-Label TAF Extension Phase|Adverse Event|0|||
147571038|NCT01940341|532246862|FG001|Period 2: Open-Label TAF Extension Phase|Adverse Event|0|||
147571039|NCT01940341|532246863|FG002|Period 2: Open-Label TAF Extension Phase|Adverse Event|2|||
147571040|NCT01940341|532246864|FG003|Period 2: Open-Label TAF Extension Phase|Adverse Event|0|||
147571041|NCT01940341|532246861|FG000|Period 2: Open-Label TAF Extension Phase|Death|0|||
147571042|NCT01940341|532246862|FG001|Period 2: Open-Label TAF Extension Phase|Death|0|||
147571043|NCT01940341|532246863|FG002|Period 2: Open-Label TAF Extension Phase|Death|1|||
147571044|NCT01940341|532246864|FG003|Period 2: Open-Label TAF Extension Phase|Death|0|||
147571045|NCT01940341|532246861|FG000|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
147571046|NCT01940341|532246862|FG001|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
147571047|NCT01940341|532246863|FG002|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|1|||
147571048|NCT01940341|532246864|FG003|Period 2: Open-Label TAF Extension Phase|HbsAg Seroconversion|0|||
147571049|NCT01940341|532246861|FG000|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|0|||
147571050|NCT01940341|532246862|FG001|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|0|||
147571051|NCT01940341|532246863|FG002|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|0|||
147571052|NCT01940341|532246864|FG003|Period 2: Open-Label TAF Extension Phase|Non-compliance with Study Drug|1|||
147571053|NCT01940341|532246861|FG000|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
147571054|NCT01940341|532246862|FG001|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
147571055|NCT01940341|532246863|FG002|Period 2: Open-Label TAF Extension Phase|Pregnancy|0|||
147571056|NCT01940341|532246864|FG003|Period 2: Open-Label TAF Extension Phase|Pregnancy|1|||
147571057|NCT01940341|532246861|FG000|Period 2: Open-Label TAF Extension Phase|Progressive Disease|0|||
147571058|NCT01940341|532246862|FG001|Period 2: Open-Label TAF Extension Phase|Progressive Disease|0|||
147571059|NCT01940341|532246863|FG002|Period 2: Open-Label TAF Extension Phase|Progressive Disease|1|||
147571060|NCT01940341|532246864|FG003|Period 2: Open-Label TAF Extension Phase|Progressive Disease|0|||
147571061|NCT02414152|532246865|FG000|Overall Study|Withdrawal by Subject|1|||
147571062|NCT02414152|532246865|FG000|Overall Study|Lack of Efficacy|1|||
147571063|NCT01576042|532246869|FG000|Overall Study|Physician Decision|2|||
147571064|NCT01576042|532246870|FG001|Overall Study|Physician Decision|0|||
147134606|NCT04712669|530660604|FG000|Double Blind Phase|Termination by Sponsor|0|||
147134607|NCT04712669|530660605|FG001|Double Blind Phase|Termination by Sponsor|0|||
147134608|NCT04712669|530660606|FG002|Double Blind Phase|Termination by Sponsor|1|||
147134609|NCT04712669|530660607|FG003|Double Blind Phase|Termination by Sponsor|0|||
147134610|NCT04712669|530660608|FG004|Double Blind Phase|Termination by Sponsor|0|||
147134611|NCT04712669|530660609|FG005|Double Blind Phase|Termination by Sponsor|0|||
147237017|NCT00347360|531037435|FG010|Overall Study|Visits conflicted with new job|0|||
147237018|NCT00347360|531037436|FG011|Overall Study|Visits conflicted with new job|0|||
147237019|NCT00347360|531037437|FG012|Overall Study|Visits conflicted with new job|0|||
147237020|NCT00347360|531037438|FG013|Overall Study|Visits conflicted with new job|0|||
147237021|NCT00347360|531037439|FG014|Overall Study|Visits conflicted with new job|0|||
147237022|NCT01449539|531037441|FG000|Overall Study|Withdrawal by Subject|3|||
147237023|NCT01449539|531037441|FG000|Overall Study|Toxicity not study related|1|||
147237024|NCT01387789|531037444|FG000|Overall Study|Adverse Event|5|||
147237025|NCT01387789|531037444|FG000|Overall Study|Lack of Efficacy|2|||
147237026|NCT01387789|531037444|FG000|Overall Study|Lost to Follow-up|1|||
147237027|NCT02187744|531037445|FG000|Study|Participant refused further follow-up|1|||
147237028|NCT02187744|531037446|FG001|Study|Participant refused further follow-up|0|||
147237029|NCT02187744|531037445|FG000|Study|Other|2|||
147237030|NCT02187744|531037446|FG001|Study|Other|1|||
147237031|NCT02187744|531037445|FG000|Study|Lost to Follow-up|0|||
147237032|NCT02187744|531037446|FG001|Study|Lost to Follow-up|2|||
147237033|NCT02187744|531037445|FG000|Study|Related adverse event, not serious|0|||
147237034|NCT02187744|531037446|FG001|Study|Related adverse event, not serious|2|||
147237035|NCT02187744|531037445|FG000|Study|Death|1|||
147237036|NCT02187744|531037446|FG001|Study|Death|0|||
147237037|NCT02187744|531037445|FG000|Study|Related adverse event, serious non-fatal|0|||
147237038|NCT02187744|531037446|FG001|Study|Related adverse event, serious non-fatal|1|||
147237039|NCT02187744|531037445|FG000|Treatment|Death|1|||
147237040|NCT02187744|531037446|FG001|Treatment|Death|0|||
147237041|NCT02187744|531037445|FG000|Treatment|Related adverse event, serious non-fatal|0|||
147237042|NCT02187744|531037446|FG001|Treatment|Related adverse event, serious non-fatal|1|||
147237043|NCT02187744|531037445|FG000|Treatment|Related adverse event, not serious|0|||
147237044|NCT02187744|531037446|FG001|Treatment|Related adverse event, not serious|2|||
147237045|NCT02187744|531037445|FG000|Treatment|Lost to Follow-up|0|||
147237046|NCT02187744|531037446|FG001|Treatment|Lost to Follow-up|1|||
147237047|NCT02187744|531037445|FG000|Treatment|Other|2|||
147237048|NCT02187744|531037446|FG001|Treatment|Other|0|||
147237049|NCT02187744|531037445|FG000|Treatment|Participant refused continued treatment|1|||
147237050|NCT02187744|531037446|FG001|Treatment|Participant refused continued treatment|1|||
147237051|NCT00508755|531037451|FG000|Overall Study|Withdrawal by Subject|1|||
147237052|NCT00945893|531037452|FG000|Overall Study|Lost to Follow-up|2|||
147237053|NCT00945893|531037453|FG001|Overall Study|Lost to Follow-up|8|||
147237054|NCT00945893|531037452|FG000|Overall Study|Withdrawal of consent|1|||
147237055|NCT00945893|531037453|FG001|Overall Study|Withdrawal of consent|2|||
147237056|NCT03113071|531037454|FG000|Overall Study|Withdrawal by Subject|1|||
147237057|NCT03113071|531037455|FG001|Overall Study|Withdrawal by Subject|0|||
147237058|NCT01602120|531037456|FG000|Overall Study|Adverse Event|3|||
147237059|NCT01602120|531037457|FG001|Overall Study|Adverse Event|6|||
147237060|NCT01602120|531037458|FG002|Overall Study|Adverse Event|0|||
147237061|NCT01602120|531037459|FG003|Overall Study|Adverse Event|2|||
147237062|NCT01602120|531037456|FG000|Overall Study|Death|0|||
147237063|NCT01602120|531037457|FG001|Overall Study|Death|4|||
147237064|NCT01602120|531037458|FG002|Overall Study|Death|0|||
147237065|NCT01602120|531037459|FG003|Overall Study|Death|0|||
147237066|NCT01602120|531037456|FG000|Overall Study|Lost to Follow-up|0|||
147237067|NCT01602120|531037457|FG001|Overall Study|Lost to Follow-up|1|||
147237068|NCT01602120|531037458|FG002|Overall Study|Lost to Follow-up|0|||
147237069|NCT01602120|531037459|FG003|Overall Study|Lost to Follow-up|1|||
147237070|NCT01602120|531037456|FG000|Overall Study|Protocol Violation|1|||
147237071|NCT01602120|531037457|FG001|Overall Study|Protocol Violation|1|||
147237072|NCT01602120|531037458|FG002|Overall Study|Protocol Violation|0|||
147237073|NCT01602120|531037459|FG003|Overall Study|Protocol Violation|0|||
147134612|NCT04712669|530660610|FG006|Double Blind Phase|Termination by Sponsor|0|||
147134613|NCT04712669|530660611|FG007|Double Blind Phase|Termination by Sponsor|0|||
147134614|NCT04712669|530660604|FG000|Open Label Phase|Adverse Event|0|||
147134615|NCT04712669|530660605|FG001|Open Label Phase|Adverse Event|0|||
147237074|NCT01602120|531037456|FG000|Overall Study|Non-compliance|0|||
147237075|NCT01602120|531037457|FG001|Overall Study|Non-compliance|3|||
147237076|NCT01602120|531037458|FG002|Overall Study|Non-compliance|0|||
147237077|NCT01602120|531037459|FG003|Overall Study|Non-compliance|1|||
147237078|NCT01602120|531037456|FG000|Overall Study|Withdrawal by Subject|8|||
147237079|NCT01602120|531037457|FG001|Overall Study|Withdrawal by Subject|17|||
147237080|NCT01602120|531037458|FG002|Overall Study|Withdrawal by Subject|0|||
147237081|NCT01602120|531037459|FG003|Overall Study|Withdrawal by Subject|3|||
147237082|NCT01602120|531037456|FG000|Overall Study|Study Terminated by Sponsor|12|||
147237083|NCT01602120|531037457|FG001|Overall Study|Study Terminated by Sponsor|24|||
147237084|NCT01602120|531037458|FG002|Overall Study|Study Terminated by Sponsor|17|||
147651503|NCT03383692|532546516|FG000|Overall Study|Progressive disease as per RECIST|3|||
147651504|NCT03383692|532546517|FG001|Overall Study|Progressive disease as per RECIST|3|||
147651505|NCT03383692|532546516|FG000|Overall Study|Clinical progression|0|||
147651506|NCT03383692|532546517|FG001|Overall Study|Clinical progression|1|||
147651507|NCT03383692|532546516|FG000|Overall Study|Adverse Event|3|||
147651508|NCT03383692|532546517|FG001|Overall Study|Adverse Event|0|||
147651509|NCT01156051|532546524|FG000|Overall Study|Lost to Follow-up|1|||
147651510|NCT01156051|532546525|FG001|Overall Study|Lost to Follow-up|0|||
147651511|NCT01156051|532546524|FG000|Overall Study|patient not compliant with protocol|0|||
147651512|NCT01156051|532546525|FG001|Overall Study|patient not compliant with protocol|1|||
147651513|NCT00793546|532546527|FG000|Overall Study|Death|3|||
147651514|NCT00793546|532546528|FG001|Overall Study|Death|0|||
147651515|NCT00793546|532546527|FG000|Overall Study|Lost to Follow-up|1|||
147651516|NCT00793546|532546528|FG001|Overall Study|Lost to Follow-up|0|||
147651517|NCT00793546|532546527|FG000|Overall Study|Withdrawal by Subject|1|||
147651518|NCT00793546|532546528|FG001|Overall Study|Withdrawal by Subject|1|||
147651519|NCT00793546|532546527|FG000|Overall Study|Study Terminated by Sponsor|8|||
147651520|NCT00793546|532546528|FG001|Overall Study|Study Terminated by Sponsor|27|||
147651521|NCT00793546|532546527|FG000|Overall Study|Other|1|||
147651522|NCT00793546|532546528|FG001|Overall Study|Other|0|||
147651523|NCT02101359|532546529|FG000|Overall Study|Not included|23|||
147651524|NCT02101359|532546530|FG001|Overall Study|Not included|13|||
147651525|NCT02101359|532546529|FG000|Overall Study|Withdrawal by Subject|5|||
147651526|NCT02101359|532546530|FG001|Overall Study|Withdrawal by Subject|4|||
147651527|NCT02101359|532546529|FG000|Overall Study|Lost to Follow-up|1|||
147651528|NCT02101359|532546530|FG001|Overall Study|Lost to Follow-up|0|||
147651529|NCT02101359|532546529|FG000|Overall Study|Protocol Violation|0|||
147651530|NCT02101359|532546530|FG001|Overall Study|Protocol Violation|2|||
147651531|NCT00494221|532546531|FG000|Overall Study|Death|15|||
147651532|NCT00494221|532546532|FG001|Overall Study|Death|9|||
147651533|NCT00494221|532546533|FG002|Overall Study|Death|14|||
147651534|NCT00494221|532546531|FG000|Overall Study|Withdrawal by Subject|1|||
147651535|NCT00494221|532546532|FG001|Overall Study|Withdrawal by Subject|2|||
147651536|NCT00494221|532546533|FG002|Overall Study|Withdrawal by Subject|0|||
147651537|NCT03755518|532546538|FG000|Overall Study|Lack of Efficacy|10|||
147651538|NCT03755518|532546538|FG000|Overall Study|Adverse Event|7|||
147651539|NCT03755518|532546538|FG000|Overall Study|Study Terminated by Sponsor|5|||
147651540|NCT03755518|532546538|FG000|Overall Study|Death|1|||
147651541|NCT03755518|532546538|FG000|Overall Study|Withdrawal by Subject|3|||
147651542|NCT03755518|532546538|FG000|Overall Study|Progressive Disease|4|||
147651543|NCT03755518|532546538|FG000|Overall Study|Bone Marrow Transplant|4|||
147651544|NCT03755518|532546538|FG000|Overall Study|Physicians Decision|1|||
147651545|NCT03755518|532546538|FG000|Overall Study|Relapse|1|||
147651546|NCT03755518|532546538|FG000|Overall Study|Withdrawal by Investigator for Non Compliance|1|||
147651547|NCT03755518|532546538|FG000|Overall Study|Withdrawal by PI|1|||
147651548|NCT03172364|532546539|FG000|Overall Study|Adverse Event|1|||
147651549|NCT03172364|532546540|FG001|Overall Study|Adverse Event|1|||
147651550|NCT03172364|532546539|FG000|Overall Study|Protocol Violation|1|||
147651551|NCT03172364|532546540|FG001|Overall Study|Protocol Violation|0|||
147651552|NCT01714609|532546541|FG000|Overall Study|Protocol Violation|1|||
147651553|NCT01714609|532546542|FG001|Overall Study|Protocol Violation|0|||
147651554|NCT02732327|532546543|FG000|Overall Study|Protocol Violation|0|||
147651555|NCT02732327|532546544|FG001|Overall Study|Protocol Violation|1|||
147651556|NCT02306694|532546545|FG000|Overall Study|Withdrawal by Subject|3|||
147651557|NCT02306694|532546545|FG000|Overall Study|Lost to Follow-up|1|||
147134616|NCT04712669|530660606|FG002|Open Label Phase|Adverse Event|0|||
147134617|NCT04712669|530660607|FG003|Open Label Phase|Adverse Event|1|||
147134618|NCT04712669|530660608|FG004|Open Label Phase|Adverse Event|1|||
147134619|NCT04712669|530660609|FG005|Open Label Phase|Adverse Event|3|||
147134620|NCT04712669|530660610|FG006|Open Label Phase|Adverse Event|1|||
147134621|NCT04712669|530660611|FG007|Open Label Phase|Adverse Event|2|||
147134622|NCT04712669|530660604|FG000|Open Label Phase|Death|0|||
147134623|NCT04712669|530660605|FG001|Open Label Phase|Death|0|||
147651558|NCT00603382|532546546|FG000|Overall Study|Adverse Event|0|||
147651559|NCT00603382|532546547|FG001|Overall Study|Adverse Event|1|||
147134624|NCT04712669|530660606|FG002|Open Label Phase|Death|0|||
147651560|NCT00603382|532546548|FG002|Overall Study|Adverse Event|1|||
147651561|NCT00603382|532546549|FG003|Overall Study|Adverse Event|2|||
147651562|NCT00603382|532546550|FG004|Overall Study|Adverse Event|1|||
147237085|NCT01602120|531037459|FG003|Overall Study|Study Terminated by Sponsor|44|||
147651563|NCT00603382|532546551|FG005|Overall Study|Adverse Event|2|||
147134625|NCT04712669|530660607|FG003|Open Label Phase|Death|1|||
147134626|NCT04712669|530660608|FG004|Open Label Phase|Death|0|||
147237086|NCT01602120|531037456|FG000|Overall Study|Physician Decision|2|||
147651564|NCT00603382|532546546|FG000|Overall Study|Lack of Efficacy|14|||
147651565|NCT00603382|532546547|FG001|Overall Study|Lack of Efficacy|9|||
147651566|NCT00603382|532546548|FG002|Overall Study|Lack of Efficacy|3|||
147651567|NCT00603382|532546549|FG003|Overall Study|Lack of Efficacy|6|||
147651568|NCT00603382|532546550|FG004|Overall Study|Lack of Efficacy|6|||
147134627|NCT04712669|530660609|FG005|Open Label Phase|Death|0|||
147134628|NCT04712669|530660610|FG006|Open Label Phase|Death|0|||
147134629|NCT04712669|530660611|FG007|Open Label Phase|Death|0|||
147134630|NCT04712669|530660604|FG000|Open Label Phase|Lack of Efficacy|0|||
147134631|NCT04712669|530660605|FG001|Open Label Phase|Lack of Efficacy|0|||
147134632|NCT04712669|530660606|FG002|Open Label Phase|Lack of Efficacy|0|||
147134633|NCT04712669|530660607|FG003|Open Label Phase|Lack of Efficacy|0|||
147134634|NCT04712669|530660608|FG004|Open Label Phase|Lack of Efficacy|1|||
147134635|NCT04712669|530660609|FG005|Open Label Phase|Lack of Efficacy|0|||
147134636|NCT04712669|530660610|FG006|Open Label Phase|Lack of Efficacy|0|||
147134637|NCT04712669|530660611|FG007|Open Label Phase|Lack of Efficacy|0|||
147134638|NCT04712669|530660604|FG000|Open Label Phase|Lost to Follow-up|0|||
147134639|NCT04712669|530660605|FG001|Open Label Phase|Lost to Follow-up|0|||
147134640|NCT04712669|530660606|FG002|Open Label Phase|Lost to Follow-up|0|||
147134641|NCT04712669|530660607|FG003|Open Label Phase|Lost to Follow-up|0|||
147134642|NCT04712669|530660608|FG004|Open Label Phase|Lost to Follow-up|0|||
147134643|NCT04712669|530660609|FG005|Open Label Phase|Lost to Follow-up|0|||
147134644|NCT04712669|530660610|FG006|Open Label Phase|Lost to Follow-up|1|||
147134645|NCT04712669|530660611|FG007|Open Label Phase|Lost to Follow-up|1|||
147134646|NCT04712669|530660604|FG000|Open Label Phase|Physician Decision|0|||
147134647|NCT04712669|530660605|FG001|Open Label Phase|Physician Decision|0|||
147134648|NCT04712669|530660606|FG002|Open Label Phase|Physician Decision|0|||
147134649|NCT04712669|530660607|FG003|Open Label Phase|Physician Decision|1|||
147134650|NCT04712669|530660608|FG004|Open Label Phase|Physician Decision|0|||
147134651|NCT04712669|530660609|FG005|Open Label Phase|Physician Decision|0|||
147134652|NCT04712669|530660610|FG006|Open Label Phase|Physician Decision|0|||
147134653|NCT04712669|530660611|FG007|Open Label Phase|Physician Decision|0|||
147571065|NCT03769025|532246876|FG000|Overall Study|Withdrawal by Subject|1|||
147134654|NCT04712669|530660604|FG000|Open Label Phase|Withdrawal by Subject|0|||
147134655|NCT04712669|530660605|FG001|Open Label Phase|Withdrawal by Subject|0|||
147134656|NCT04712669|530660606|FG002|Open Label Phase|Withdrawal by Subject|0|||
147134657|NCT04712669|530660607|FG003|Open Label Phase|Withdrawal by Subject|1|||
147134658|NCT04712669|530660608|FG004|Open Label Phase|Withdrawal by Subject|5|||
147134659|NCT04712669|530660609|FG005|Open Label Phase|Withdrawal by Subject|5|||
147134660|NCT04712669|530660610|FG006|Open Label Phase|Withdrawal by Subject|0|||
147134661|NCT04712669|530660611|FG007|Open Label Phase|Withdrawal by Subject|4|||
147134662|NCT04712669|530660604|FG000|Open Label Phase|Termination by Sponsor|0|||
147134663|NCT04712669|530660605|FG001|Open Label Phase|Termination by Sponsor|0|||
147134664|NCT04712669|530660606|FG002|Open Label Phase|Termination by Sponsor|0|||
147134665|NCT04712669|530660607|FG003|Open Label Phase|Termination by Sponsor|11|||
147134666|NCT04712669|530660608|FG004|Open Label Phase|Termination by Sponsor|9|||
147134667|NCT04712669|530660609|FG005|Open Label Phase|Termination by Sponsor|14|||
147571066|NCT03769025|532246877|FG001|Overall Study|Withdrawal by Subject|1|||
147571067|NCT03769025|532246876|FG000|Overall Study|Lost to Follow-up|4|||
147134668|NCT04712669|530660610|FG006|Open Label Phase|Termination by Sponsor|0|||
147134669|NCT04712669|530660611|FG007|Open Label Phase|Termination by Sponsor|14|||
147134670|NCT04577404|530660612|FG000|Overall Study|Adverse Event|31|||
147134671|NCT04577404|530660612|FG000|Overall Study|Death|1|||
147134672|NCT04577404|530660612|FG000|Overall Study|Lack of Efficacy|3|||
147134673|NCT04577404|530660612|FG000|Overall Study|Physician Decision|7|||
147134674|NCT04577404|530660612|FG000|Overall Study|Withdrawal by Subject|21|||
147134675|NCT04577404|530660612|FG000|Overall Study|Switched to commercial oral Edaravon etc.|12|||
147134676|NCT00652743|530662512|FG000|Months 12-18|Lost to Follow-up|1|||
147134677|NCT00652743|530662513|FG001|Months 12-18|Lost to Follow-up|2|||
147134678|NCT00652743|530662514|FG002|Months 12-18|Lost to Follow-up|7|||
147134679|NCT00652743|530662512|FG000|Months 24-30|Other|5|||
147134680|NCT00652743|530662513|FG001|Months 24-30|Other|1|||
147134681|NCT00652743|530662514|FG002|Months 24-30|Other|11|||
147134682|NCT00652743|530662512|FG000|Months 36-42|Serious Adverse Events|0|||
147134683|NCT00652743|530662513|FG001|Months 36-42|Serious Adverse Events|1|||
147134684|NCT00652743|530662514|FG002|Months 36-42|Serious Adverse Events|1|||
147134685|NCT00652743|530662512|FG000|Months 36-42|Withdrawal by Subject|1|||
147134686|NCT00652743|530662513|FG001|Months 36-42|Withdrawal by Subject|1|||
147571068|NCT03769025|532246877|FG001|Overall Study|Lost to Follow-up|3|||
147571069|NCT03123471|532246888|FG000|Placebo-controlled Phase|Adverse Event|3|||
147134687|NCT00652743|530662514|FG002|Months 36-42|Withdrawal by Subject|0|||
147134688|NCT00652743|530662512|FG000|Months 36-42|Lost to Follow-up|0|||
147571070|NCT03123471|532246889|FG001|Placebo-controlled Phase|Adverse Event|8|||
147134689|NCT00652743|530662513|FG001|Months 36-42|Lost to Follow-up|1|||
147134690|NCT00652743|530662514|FG002|Months 36-42|Lost to Follow-up|0|||
147134691|NCT00652743|530662512|FG000|Months 36-42|Migrated/moved from study area|1|||
147134692|NCT00652743|530662513|FG001|Months 36-42|Migrated/moved from study area|0|||
147134693|NCT00652743|530662514|FG002|Months 36-42|Migrated/moved from study area|0|||
147134694|NCT00652743|530662512|FG000|Months 36-42|Other|4|||
147134695|NCT00652743|530662513|FG001|Months 36-42|Other|2|||
147134696|NCT00652743|530662514|FG002|Months 36-42|Other|8|||
147134697|NCT00503984|530662519|FG000|Overall Study|Protocol Violation|0|||
147134698|NCT00503984|530662520|FG001|Overall Study|Protocol Violation|1|||
147134699|NCT00503984|530662521|FG002|Overall Study|Protocol Violation|0|||
147134700|NCT00503984|530662522|FG003|Overall Study|Protocol Violation|0|||
147134701|NCT00503984|530662523|FG004|Overall Study|Protocol Violation|0|||
147134702|NCT00503984|530662524|FG005|Overall Study|Protocol Violation|0|||
147134703|NCT00503984|530662519|FG000|Overall Study|Adverse Event|0|||
147134704|NCT00503984|530662520|FG001|Overall Study|Adverse Event|1|||
147134705|NCT00503984|530662521|FG002|Overall Study|Adverse Event|0|||
147134706|NCT00503984|530662522|FG003|Overall Study|Adverse Event|0|||
147571071|NCT03123471|532246888|FG000|Placebo-controlled Phase|Lack of Efficacy|3|||
147571072|NCT03123471|532246889|FG001|Placebo-controlled Phase|Lack of Efficacy|4|||
147571073|NCT03123471|532246888|FG000|Placebo-controlled Phase|Withdrawal by Subject|6|||
147571074|NCT03123471|532246889|FG001|Placebo-controlled Phase|Withdrawal by Subject|16|||
147571075|NCT03123471|532246888|FG000|Placebo-controlled Phase|Non-compliance with Study Drug|3|||
147571076|NCT03123471|532246889|FG001|Placebo-controlled Phase|Non-compliance with Study Drug|0|||
147571077|NCT03123471|532246888|FG000|Placebo-controlled Phase|Lost to Follow-up|1|||
147571078|NCT03123471|532246889|FG001|Placebo-controlled Phase|Lost to Follow-up|3|||
147571079|NCT03123471|532246888|FG000|Placebo-controlled Phase|Protocol Deviation|2|||
147571080|NCT03123471|532246889|FG001|Placebo-controlled Phase|Protocol Deviation|1|||
147571081|NCT03123471|532246888|FG000|Placebo-controlled Phase|Miscellaneous|0|||
147571082|NCT03123471|532246889|FG001|Placebo-controlled Phase|Miscellaneous|1|||
147571083|NCT03123471|532246888|FG000|Apremilast Extension Phase|Lost to Follow-up|2|||
147571084|NCT03123471|532246889|FG001|Apremilast Extension Phase|Lost to Follow-up|5|||
147571085|NCT03123471|532246888|FG000|Apremilast Extension Phase|Adverse Event|1|||
147571086|NCT03123471|532246889|FG001|Apremilast Extension Phase|Adverse Event|5|||
147571087|NCT03123471|532246888|FG000|Apremilast Extension Phase|Lack of Efficacy|2|||
147571088|NCT03123471|532246889|FG001|Apremilast Extension Phase|Lack of Efficacy|8|||
147571089|NCT03123471|532246888|FG000|Apremilast Extension Phase|Withdrawal by Subject|3|||
147571090|NCT03123471|532246889|FG001|Apremilast Extension Phase|Withdrawal by Subject|7|||
147571091|NCT05341622|532246890|FG000|Overall Study|Death|0|||
147571092|NCT05341622|532246891|FG001|Overall Study|Death|0|||
147571093|NCT05341622|532246892|FG002|Overall Study|Death|0|||
147571094|NCT05341622|532246893|FG003|Overall Study|Death|0|||
147571095|NCT05341622|532246894|FG004|Overall Study|Death|1|||
147571096|NCT05341622|532246895|FG005|Overall Study|Death|0|||
147571097|NCT05341622|532246896|FG006|Overall Study|Death|0|||
147571098|NCT05341622|532246897|FG007|Overall Study|Death|1|||
147571099|NCT05341622|532246890|FG000|Overall Study|Invalid Address|0|||
147571100|NCT05341622|532246891|FG001|Overall Study|Invalid Address|1|||
147571101|NCT05341622|532246892|FG002|Overall Study|Invalid Address|0|||
147571102|NCT05341622|532246893|FG003|Overall Study|Invalid Address|0|||
147571103|NCT05341622|532246894|FG004|Overall Study|Invalid Address|0|||
147571104|NCT05341622|532246895|FG005|Overall Study|Invalid Address|0|||
147571105|NCT05341622|532246896|FG006|Overall Study|Invalid Address|0|||
147571106|NCT05341622|532246897|FG007|Overall Study|Invalid Address|0|||
147571107|NCT05341622|532246890|FG000|Overall Study|Ineligible|26|||
147571108|NCT05341622|532246891|FG001|Overall Study|Ineligible|21|||
147571109|NCT05341622|532246892|FG002|Overall Study|Ineligible|28|||
147571110|NCT05341622|532246893|FG003|Overall Study|Ineligible|24|||
147571111|NCT05341622|532246894|FG004|Overall Study|Ineligible|29|||
147571112|NCT05341622|532246895|FG005|Overall Study|Ineligible|31|||
147571113|NCT05341622|532246896|FG006|Overall Study|Ineligible|28|||
147571114|NCT05341622|532246897|FG007|Overall Study|Ineligible|26|||
147571115|NCT03801707|532246908|FG000|Overall Study|Removed from study due to reaching the study target of 30 transplant from hepatitis C viremic donors|6|||
147571116|NCT00787254|532246909|FG000|Overall Study|Adverse Event|24|||
147571117|NCT00787254|532246910|FG001|Overall Study|Adverse Event|23|||
147571118|NCT00787254|532246909|FG000|Overall Study|Protocol Violation|26|||
147571119|NCT00787254|532246910|FG001|Overall Study|Protocol Violation|23|||
147651569|NCT00603382|532546551|FG005|Overall Study|Lack of Efficacy|11|||
147651570|NCT00603382|532546546|FG000|Overall Study|Protocol Violation|1|||
147651571|NCT00603382|532546547|FG001|Overall Study|Protocol Violation|0|||
147651572|NCT00603382|532546548|FG002|Overall Study|Protocol Violation|1|||
147651573|NCT00603382|532546549|FG003|Overall Study|Protocol Violation|2|||
147134707|NCT00503984|530662523|FG004|Overall Study|Adverse Event|0|||
147571120|NCT00787254|532246909|FG000|Overall Study|Withdrawal by Subject|16|||
147571121|NCT00787254|532246910|FG001|Overall Study|Withdrawal by Subject|11|||
147571122|NCT00787254|532246909|FG000|Overall Study|Lack of Efficacy|4|||
147571123|NCT00787254|532246910|FG001|Overall Study|Lack of Efficacy|15|||
147571124|NCT00787254|532246909|FG000|Overall Study|NSAIDs discontinuation|1|||
147134708|NCT00503984|530662524|FG005|Overall Study|Adverse Event|0|||
147134709|NCT00503984|530662519|FG000|Overall Study|Death|0|||
147571125|NCT00787254|532246910|FG001|Overall Study|NSAIDs discontinuation|2|||
147571126|NCT00787254|532246909|FG000|Overall Study|Institution closed|1|||
147571127|NCT00787254|532246910|FG001|Overall Study|Institution closed|0|||
147571128|NCT00787254|532246909|FG000|Overall Study|Physician Decision|4|||
147651574|NCT00603382|532546550|FG004|Overall Study|Protocol Violation|1|||
147571129|NCT00787254|532246910|FG001|Overall Study|Physician Decision|8|||
147651575|NCT00603382|532546551|FG005|Overall Study|Protocol Violation|0|||
147134710|NCT00503984|530662520|FG001|Overall Study|Death|0|||
147134711|NCT00503984|530662521|FG002|Overall Study|Death|0|||
147134712|NCT00503984|530662522|FG003|Overall Study|Death|0|||
147571130|NCT03761173|532246913|FG000|Overall Study|Lost to Follow-up|93|||
147318041|NCT05220501|531331592|FG001|Overall Study|Awaiting biopsy at time of interim analysis. Study closed. Primary endpoint met|16|||
147318042|NCT05220501|531331593|FG002|Overall Study|Awaiting biopsy at time of interim analysis. Study closed. Primary endpoint met|39|||
147318043|NCT02692235|531331594|FG000|Overall Study|Withdrawal by Subject|2|||
147318044|NCT02692235|531331595|FG001|Overall Study|Withdrawal by Subject|1|||
147318045|NCT02692235|531331594|FG000|Overall Study|Adverse Event|1|||
147318046|NCT02692235|531331595|FG001|Overall Study|Adverse Event|2|||
147318047|NCT00107380|531331597|FG000|Overall Study|Adverse Event|7|||
147318048|NCT00107380|531331597|FG000|Overall Study|Refusal Unrelated to Adverse Event|7|||
147318049|NCT00107380|531331597|FG000|Overall Study|Progression/relapse|4|||
147318050|NCT00107380|531331597|FG000|Overall Study|Death|3|||
147318051|NCT00107380|531331597|FG000|Overall Study|Other - not protocol specified|7|||
147318052|NCT00107380|531331597|FG000|Overall Study|Ineligible|2|||
147318053|NCT03673098|531331598|FG000|Overall Study|Lost to Follow-up|2|||
147318054|NCT03673098|531331599|FG001|Overall Study|Lost to Follow-up|3|||
147318055|NCT03673098|531331598|FG000|Overall Study|Withdrawal by Subject|6|||
147318056|NCT03673098|531331599|FG001|Overall Study|Withdrawal by Subject|1|||
147318057|NCT03673098|531331598|FG000|Overall Study|Could not participate due to scheduling conflicts or health issues|2|||
147318058|NCT03673098|531331599|FG001|Overall Study|Could not participate due to scheduling conflicts or health issues|0|||
147318059|NCT01268059|531331600|FG000|Overall Study|Lost to Follow-up|0|||
147318060|NCT01268059|531331601|FG001|Overall Study|Lost to Follow-up|1|||
147318061|NCT01268059|531331602|FG002|Overall Study|Lost to Follow-up|0|||
147318062|NCT01268059|531331603|FG003|Overall Study|Lost to Follow-up|0|||
147318063|NCT01268059|531331600|FG000|Overall Study|Withdrawal by Subject|7|||
147318064|NCT01268059|531331601|FG001|Overall Study|Withdrawal by Subject|4|||
147318065|NCT01268059|531331602|FG002|Overall Study|Withdrawal by Subject|0|||
147318066|NCT01268059|531331603|FG003|Overall Study|Withdrawal by Subject|0|||
147318067|NCT01268059|531331600|FG000|Overall Study|Death|20|||
147318068|NCT01268059|531331601|FG001|Overall Study|Death|30|||
147318069|NCT01268059|531331602|FG002|Overall Study|Death|3|||
147318070|NCT01268059|531331603|FG003|Overall Study|Death|5|||
147318071|NCT01268059|531331600|FG000|Overall Study|Progression of disease|1|||
147318072|NCT01268059|531331601|FG001|Overall Study|Progression of disease|0|||
147318073|NCT01268059|531331602|FG002|Overall Study|Progression of disease|0|||
147318074|NCT01268059|531331603|FG003|Overall Study|Progression of disease|0|||
147318075|NCT03660943|531331604|FG000|Overall Study|Adverse Event|5|||
147318076|NCT03660943|531331605|FG001|Overall Study|Adverse Event|3|||
147318077|NCT03660943|531331604|FG000|Overall Study|Death|0|||
147318078|NCT03660943|531331605|FG001|Overall Study|Death|2|||
147318079|NCT03660943|531331604|FG000|Overall Study|Lost to Follow-up|7|||
147318080|NCT03660943|531331605|FG001|Overall Study|Lost to Follow-up|3|||
147318081|NCT03660943|531331604|FG000|Overall Study|Protocol Violation|3|||
147318082|NCT03660943|531331605|FG001|Overall Study|Protocol Violation|5|||
147318083|NCT03660943|531331604|FG000|Overall Study|Withdrawal by Subject|8|||
147318084|NCT03660943|531331605|FG001|Overall Study|Withdrawal by Subject|15|||
147318085|NCT03660943|531331604|FG000|Overall Study|Lack of Efficacy|9|||
147318086|NCT03660943|531331605|FG001|Overall Study|Lack of Efficacy|12|||
147318087|NCT03660943|531331604|FG000|Overall Study|WITHDRAWAL FOR OTHER TREATMENT; UNABLE TO COMPLETE INJECTION PROCEDURES|4|||
147318088|NCT03660943|531331605|FG001|Overall Study|WITHDRAWAL FOR OTHER TREATMENT; UNABLE TO COMPLETE INJECTION PROCEDURES|13|||
147318089|NCT03850444|531331606|FG000|Overall Study|Adverse Event|16|||
147318090|NCT03850444|531331607|FG001|Overall Study|Adverse Event|10|||
147318091|NCT03850444|531331606|FG000|Overall Study|Death|87|||
147318092|NCT03850444|531331607|FG001|Overall Study|Death|107|||
147318093|NCT03850444|531331606|FG000|Overall Study|Lost to Follow-up|1|||
147571131|NCT03761173|532246913|FG000|Overall Study|Withdrawal by Subject|74|||
147571132|NCT03761173|532246913|FG000|Overall Study|Death|45|||
147237087|NCT01602120|531037457|FG001|Overall Study|Physician Decision|3|||
147237088|NCT01602120|531037458|FG002|Overall Study|Physician Decision|0|||
147237089|NCT01602120|531037459|FG003|Overall Study|Physician Decision|0|||
147237090|NCT01602120|531037456|FG000|Overall Study|Unspecified Reason|3|||
147237091|NCT01602120|531037457|FG001|Overall Study|Unspecified Reason|1|||
147237092|NCT01602120|531037458|FG002|Overall Study|Unspecified Reason|0|||
147237093|NCT01602120|531037459|FG003|Overall Study|Unspecified Reason|2|||
147237094|NCT03298867|531037469|FG000|Double-Masked 24-Week Treatment Period|Adverse Event|1|||
147237095|NCT03298867|531037470|FG001|Double-Masked 24-Week Treatment Period|Adverse Event|1|||
147237096|NCT03298867|531037469|FG000|Double-Masked 24-Week Treatment Period|Withdrawal by Subject|1|||
147237097|NCT03298867|531037470|FG001|Double-Masked 24-Week Treatment Period|Withdrawal by Subject|1|||
147318094|NCT03850444|531331607|FG001|Overall Study|Lost to Follow-up|1|||
147318095|NCT03850444|531331606|FG000|Overall Study|Withdrawal by Subject|1|||
147318096|NCT03850444|531331607|FG001|Overall Study|Withdrawal by Subject|5|||
147318097|NCT03850444|531331606|FG000|Overall Study|Participation in study terminated by Sponsor|23|||
147318098|NCT03850444|531331607|FG001|Overall Study|Participation in study terminated by Sponsor|11|||
147571133|NCT03761173|532246913|FG000|Overall Study|Withdrawal for Other Reasons|29|||
147571134|NCT03761173|532246913|FG000|Overall Study|Protocol Violation|1|||
147237098|NCT03298867|531037469|FG000|48-Week Follow-Up Period (Weeks 24-72)|Relapsed/Entered OPTIC-X|1|||
147134713|NCT00503984|530662523|FG004|Overall Study|Death|1|||
147134714|NCT00503984|530662524|FG005|Overall Study|Death|0|||
147134715|NCT01246960|530662525|FG000|Overall Study|Lost to Follow-up|3|||
147134716|NCT01246960|530662526|FG001|Overall Study|Lost to Follow-up|1|||
147134717|NCT01246960|530662525|FG000|Overall Study|Withdrawal (by participant or physician)|3|||
147134718|NCT01246960|530662526|FG001|Overall Study|Withdrawal (by participant or physician)|3|||
147134719|NCT02122380|530662529|FG000|First Intervention (30 Days)|Adverse Event|1|||
147134720|NCT02122380|530662530|FG001|First Intervention (30 Days)|Adverse Event|0|||
147134721|NCT02122380|530662529|FG000|First Intervention (30 Days)|Physician Decision|0|||
147134722|NCT02122380|530662530|FG001|First Intervention (30 Days)|Physician Decision|1|||
147134723|NCT02122380|530662529|FG000|Washout (8 Weeks)|Lost to Follow-up|1|||
147134724|NCT02122380|530662530|FG001|Washout (8 Weeks)|Lost to Follow-up|0|||
147134725|NCT02122380|530662529|FG000|Washout (8 Weeks)|No Longer Met Inclusion Criteria|0|||
147134726|NCT02122380|530662530|FG001|Washout (8 Weeks)|No Longer Met Inclusion Criteria|2|||
147134727|NCT02122380|530662529|FG000|Second Intervention (30 Days)|2 did not complete all of inpatient day|0|||
147134728|NCT02122380|530662530|FG001|Second Intervention (30 Days)|2 did not complete all of inpatient day|2|||
147134729|NCT04102007|530662532|FG000|Overall Study|Adverse Event|4|||
147134730|NCT04102007|530662532|FG000|Overall Study|Lost to Follow-up|3|||
147134731|NCT04102007|530662532|FG000|Overall Study|Withdrawal by Subject|12|||
147134732|NCT04102007|530662532|FG000|Overall Study|Eligibility Violation|5|||
147134733|NCT04102007|530662532|FG000|Overall Study|Lack of Efficacy|6|||
147134734|NCT04102007|530662532|FG000|Overall Study|Protocol Deviation|5|||
147134735|NCT04102007|530662532|FG000|Overall Study|Protocol Compliance|1|||
147134736|NCT04102007|530662532|FG000|Overall Study|Withdrew Treatment|2|||
147134737|NCT04102007|530662532|FG000|Overall Study|Pregnancy|1|||
147134738|NCT05173974|530662533|FG000|Period 2 (Visit 3, 1 Day)|Baseline bite was not eligible|0|||
147134739|NCT05173974|530662534|FG001|Period 2 (Visit 3, 1 Day)|Baseline bite was not eligible|0|||
147134740|NCT05173974|530662535|FG002|Period 2 (Visit 3, 1 Day)|Baseline bite was not eligible|0|||
147134741|NCT05173974|530662536|FG003|Period 2 (Visit 3, 1 Day)|Baseline bite was not eligible|1|||
147134742|NCT05173974|530662533|FG000|Period 4 (Visit 5, 1 Day)|Baseline bite was not eligible|0|||
147134743|NCT05173974|530662534|FG001|Period 4 (Visit 5, 1 Day)|Baseline bite was not eligible|1|||
147134744|NCT05173974|530662535|FG002|Period 4 (Visit 5, 1 Day)|Baseline bite was not eligible|0|||
147134745|NCT05173974|530662536|FG003|Period 4 (Visit 5, 1 Day)|Baseline bite was not eligible|0|||
147134746|NCT03289143|530662537|FG000|Overall Study|Caregiver Unavailability|1|||
147134747|NCT03289143|530662538|FG001|Overall Study|Caregiver Unavailability|1|||
147134748|NCT03289143|530662539|FG002|Overall Study|Caregiver Unavailability|0|||
147134749|NCT03289143|530662540|FG003|Overall Study|Caregiver Unavailability|0|||
147134750|NCT03289143|530662537|FG000|Overall Study|Research Department Closure|0|||
147134751|NCT03289143|530662538|FG001|Overall Study|Research Department Closure|0|||
147134752|NCT03289143|530662539|FG002|Overall Study|Research Department Closure|1|||
147134753|NCT03289143|530662540|FG003|Overall Study|Research Department Closure|0|||
147134754|NCT03289143|530662537|FG000|Overall Study|Caregiver and Participant Withdrew Consent|0|||
147134755|NCT03289143|530662538|FG001|Overall Study|Caregiver and Participant Withdrew Consent|0|||
147134756|NCT03289143|530662539|FG002|Overall Study|Caregiver and Participant Withdrew Consent|1|||
147134757|NCT03289143|530662540|FG003|Overall Study|Caregiver and Participant Withdrew Consent|0|||
147134758|NCT03289143|530662537|FG000|Overall Study|Medical Monitor Decision|1|||
147134759|NCT03289143|530662538|FG001|Overall Study|Medical Monitor Decision|0|||
147134760|NCT03289143|530662539|FG002|Overall Study|Medical Monitor Decision|0|||
147134761|NCT03289143|530662540|FG003|Overall Study|Medical Monitor Decision|0|||
147134762|NCT03289143|530662537|FG000|Overall Study|Participant Non-Compliance|0|||
147134763|NCT03289143|530662538|FG001|Overall Study|Participant Non-Compliance|0|||
147134764|NCT03289143|530662539|FG002|Overall Study|Participant Non-Compliance|1|||
147134765|NCT03289143|530662540|FG003|Overall Study|Participant Non-Compliance|0|||
147134766|NCT03289143|530662537|FG000|Overall Study|Drug Interrupted for Too Long Due to Prohibited Med|0|||
147134767|NCT03289143|530662538|FG001|Overall Study|Drug Interrupted for Too Long Due to Prohibited Med|0|||
147134768|NCT03289143|530662539|FG002|Overall Study|Drug Interrupted for Too Long Due to Prohibited Med|1|||
147134769|NCT03289143|530662540|FG003|Overall Study|Drug Interrupted for Too Long Due to Prohibited Med|0|||
147134770|NCT03289143|530662537|FG000|Overall Study|Participant Non Compliance With Concomitant Medications|0|||
147651576|NCT00603382|532546546|FG000|Overall Study|Lost to Follow-up|0|||
147651577|NCT00603382|532546547|FG001|Overall Study|Lost to Follow-up|1|||
147134771|NCT03289143|530662538|FG001|Overall Study|Participant Non Compliance With Concomitant Medications|0|||
147134772|NCT03289143|530662539|FG002|Overall Study|Participant Non Compliance With Concomitant Medications|1|||
147134773|NCT03289143|530662540|FG003|Overall Study|Participant Non Compliance With Concomitant Medications|0|||
147134774|NCT03289143|530662537|FG000|Overall Study|Caregiver Passed Away|1|||
147134775|NCT03289143|530662538|FG001|Overall Study|Caregiver Passed Away|0|||
147134776|NCT03289143|530662539|FG002|Overall Study|Caregiver Passed Away|0|||
147134777|NCT03289143|530662540|FG003|Overall Study|Caregiver Passed Away|0|||
147134778|NCT03289143|530662537|FG000|Overall Study|Physician Decision|0|||
147134779|NCT03289143|530662538|FG001|Overall Study|Physician Decision|2|||
147134780|NCT03289143|530662539|FG002|Overall Study|Physician Decision|2|||
147134781|NCT03289143|530662540|FG003|Overall Study|Physician Decision|2|||
147571135|NCT00316186|532246914|FG000|Overall Study|Adverse Event|6|||
147571136|NCT00316186|532246914|FG000|Overall Study|Disease Progression|4|||
147571137|NCT00316186|532246914|FG000|Overall Study|Lost to Follow-up|1|||
147571138|NCT00316186|532246914|FG000|Overall Study|Other|1|||
147571139|NCT00594035|532248781|FG000|Overall Study|Lost to Follow-up|1|||
147571140|NCT00594035|532248782|FG001|Overall Study|Lost to Follow-up|1|||
147571141|NCT00594035|532248781|FG000|Overall Study|Withdrawal by Subject|1|||
147571142|NCT00594035|532248782|FG001|Overall Study|Withdrawal by Subject|0|||
147571143|NCT00594035|532248781|FG000|Overall Study|Subject transferred to nursing home|0|||
147571144|NCT00594035|532248782|FG001|Overall Study|Subject transferred to nursing home|1|||
147571145|NCT00594035|532248781|FG000|Overall Study|Subject couldn't return due to job|0|||
147571146|NCT00594035|532248782|FG001|Overall Study|Subject couldn't return due to job|1|||
147571147|NCT00795821|532248785|FG000|Acute Treatment Phase|Adverse Event|23|||
147134782|NCT03289143|530662537|FG000|Overall Study|Protocol Deviation|2|||
147134783|NCT03289143|530662538|FG001|Overall Study|Protocol Deviation|1|||
147134784|NCT03289143|530662539|FG002|Overall Study|Protocol Deviation|3|||
147134785|NCT03289143|530662540|FG003|Overall Study|Protocol Deviation|1|||
147134786|NCT03289143|530662537|FG000|Overall Study|Study Terminated By Sponsor|101|||
147134787|NCT03289143|530662538|FG001|Overall Study|Study Terminated By Sponsor|75|||
147134788|NCT03289143|530662539|FG002|Overall Study|Study Terminated By Sponsor|100|||
147134789|NCT03289143|530662540|FG003|Overall Study|Study Terminated By Sponsor|69|||
147134790|NCT03289143|530662537|FG000|Overall Study|Withdrawal by Subject|14|||
147134791|NCT03289143|530662538|FG001|Overall Study|Withdrawal by Subject|6|||
147134792|NCT03289143|530662539|FG002|Overall Study|Withdrawal by Subject|14|||
147134793|NCT03289143|530662540|FG003|Overall Study|Withdrawal by Subject|12|||
147134794|NCT03289143|530662537|FG000|Overall Study|Adverse Event|10|||
147134795|NCT03289143|530662538|FG001|Overall Study|Adverse Event|7|||
147134796|NCT03289143|530662539|FG002|Overall Study|Adverse Event|6|||
147134797|NCT03289143|530662540|FG003|Overall Study|Adverse Event|5|||
147134798|NCT03289143|530662537|FG000|Overall Study|Death|2|||
147134799|NCT03289143|530662538|FG001|Overall Study|Death|0|||
147134800|NCT03289143|530662539|FG002|Overall Study|Death|2|||
147134801|NCT03289143|530662540|FG003|Overall Study|Death|1|||
147134802|NCT03289143|530662537|FG000|Overall Study|Lost to Follow-up|2|||
147134803|NCT03289143|530662538|FG001|Overall Study|Lost to Follow-up|1|||
147134804|NCT03289143|530662539|FG002|Overall Study|Lost to Follow-up|1|||
147134805|NCT03289143|530662540|FG003|Overall Study|Lost to Follow-up|0|||
147134806|NCT03289143|530662537|FG000|Overall Study|Participant No Longer Has Study Partner|0|||
147134807|NCT03289143|530662538|FG001|Overall Study|Participant No Longer Has Study Partner|0|||
147134808|NCT03289143|530662539|FG002|Overall Study|Participant No Longer Has Study Partner|0|||
147134809|NCT03289143|530662540|FG003|Overall Study|Participant No Longer Has Study Partner|1|||
147134810|NCT03289143|530662537|FG000|Overall Study|Withdrawal by Caregiver|0|||
147134811|NCT03289143|530662538|FG001|Overall Study|Withdrawal by Caregiver|1|||
147134812|NCT03289143|530662539|FG002|Overall Study|Withdrawal by Caregiver|0|||
147134813|NCT03289143|530662540|FG003|Overall Study|Withdrawal by Caregiver|0|||
147134814|NCT03289143|530662537|FG000|Overall Study|Caregiver Passed Away & Family Moved Out of State|0|||
147237099|NCT03298867|531037470|FG001|48-Week Follow-Up Period (Weeks 24-72)|Relapsed/Entered OPTIC-X|9|||
147237100|NCT03298867|531037469|FG000|48-Week Follow-Up Period (Weeks 24-72)|Relapsed/Did not enter OPTIC-X|0|||
147237101|NCT03298867|531037470|FG001|48-Week Follow-Up Period (Weeks 24-72)|Relapsed/Did not enter OPTIC-X|1|||
147237102|NCT03298867|531037469|FG000|48-Week Follow-Up Period (Weeks 24-72)|Physician Decision|0|||
147237103|NCT03298867|531037470|FG001|48-Week Follow-Up Period (Weeks 24-72)|Physician Decision|1|||
147237104|NCT03298867|531037469|FG000|48-Week Follow-Up Period (Weeks 24-72)|Withdrawal by Subject|0|||
147237105|NCT03298867|531037470|FG001|48-Week Follow-Up Period (Weeks 24-72)|Withdrawal by Subject|2|||
147237106|NCT03298867|531037469|FG000|48-Week Follow-Up Period (Weeks 24-72)|Other, Not Specified|0|||
147237107|NCT03298867|531037470|FG001|48-Week Follow-Up Period (Weeks 24-72)|Other, Not Specified|1|||
147237108|NCT03298867|531037469|FG000|48-Week Follow-Up Period (Weeks 24-72)|Mis-classified as Responders|0|||
147237109|NCT03298867|531037470|FG001|48-Week Follow-Up Period (Weeks 24-72)|Mis-classified as Responders|2|||
147237110|NCT03298867|531037469|FG000|48-Week Follow-Up Contact (Weeks 96-120)|Lost to Follow-up|0|||
147318099|NCT01021878|531331608|FG000|Overall Study|Lost to Follow-up|4|||
147318100|NCT01021878|531331609|FG001|Overall Study|Lost to Follow-up|3|||
147318101|NCT01021878|531331608|FG000|Overall Study|Death|0|||
147318102|NCT01021878|531331609|FG001|Overall Study|Death|1|||
147318103|NCT01021878|531331608|FG000|Overall Study|Adverse Event|6|||
147571148|NCT00795821|532248786|FG001|Acute Treatment Phase|Adverse Event|4|||
147571149|NCT00795821|532248785|FG000|Acute Treatment Phase|Death|1|||
147571150|NCT00795821|532248786|FG001|Acute Treatment Phase|Death|0|||
147134815|NCT03289143|530662538|FG001|Overall Study|Caregiver Passed Away & Family Moved Out of State|0|||
147134816|NCT03289143|530662539|FG002|Overall Study|Caregiver Passed Away & Family Moved Out of State|1|||
147134817|NCT03289143|530662540|FG003|Overall Study|Caregiver Passed Away & Family Moved Out of State|0|||
147134818|NCT03289143|530662537|FG000|Overall Study|Absence of Consistent and Reliable Caregiver|0|||
147134819|NCT03289143|530662538|FG001|Overall Study|Absence of Consistent and Reliable Caregiver|0|||
147134820|NCT03289143|530662539|FG002|Overall Study|Absence of Consistent and Reliable Caregiver|0|||
147571151|NCT00795821|532248785|FG000|Acute Treatment Phase|Lack of Efficacy|5|||
147445401|NCT00705783|531795845|FG002|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
147445402|NCT00705783|531795843|FG000|Depot Stabilization Phase|Sponsor Discontinued Study|86|||
147445403|NCT00705783|531795844|FG001|Depot Stabilization Phase|Sponsor Discontinued Study|0|||
147445404|NCT00705783|531795845|FG002|Depot Stabilization Phase|Sponsor Discontinued Study|0|||
147445405|NCT00705783|531795843|FG000|Depot Stabilization Phase|Lost to Follow-up|11|||
147445406|NCT00705783|531795844|FG001|Depot Stabilization Phase|Lost to Follow-up|0|||
147445407|NCT00705783|531795845|FG002|Depot Stabilization Phase|Lost to Follow-up|0|||
147445408|NCT00705783|531795843|FG000|Depot Stabilization Phase|Met Withdrawal Criteria|8|||
147445409|NCT00705783|531795844|FG001|Depot Stabilization Phase|Met Withdrawal Criteria|0|||
147445410|NCT00705783|531795845|FG002|Depot Stabilization Phase|Met Withdrawal Criteria|0|||
147445411|NCT00705783|531795843|FG000|Depot Stabilization Phase|Withdrawn by Investigator|9|||
147445412|NCT00705783|531795844|FG001|Depot Stabilization Phase|Withdrawn by Investigator|0|||
147445413|NCT00705783|531795845|FG002|Depot Stabilization Phase|Withdrawn by Investigator|0|||
147445414|NCT00705783|531795843|FG000|Depot Stabilization Phase|Withdrew Consent|29|||
147318104|NCT01021878|531331609|FG001|Overall Study|Adverse Event|5|||
147318105|NCT01021878|531331608|FG000|Overall Study|Transplantation|6|||
147318106|NCT01021878|531331609|FG001|Overall Study|Transplantation|1|||
147318107|NCT01155726|531331610|FG000|Period 1, 3 Days (Masked)|Inconvenience|1|||
147318108|NCT01155726|531331611|FG001|Period 1, 3 Days (Masked)|Inconvenience|0|||
147318109|NCT01155726|531331612|FG002|Period 1, 3 Days (Masked)|Inconvenience|2|||
147318110|NCT01155726|531331613|FG003|Period 1, 3 Days (Masked)|Inconvenience|0|||
147318111|NCT05305040|531331614|FG000|Overall Study|Not Dosed|37|||
147318112|NCT05305040|531331615|FG001|Overall Study|Not Dosed|37|||
147318113|NCT05305040|531331614|FG000|Overall Study|Study Closure|34|||
147318114|NCT05305040|531331615|FG001|Overall Study|Study Closure|46|||
147318115|NCT05305040|531331614|FG000|Overall Study|Death|14|||
147318116|NCT05305040|531331615|FG001|Overall Study|Death|13|||
147318117|NCT05305040|531331614|FG000|Overall Study|Withdrawal by Subject|15|||
147318118|NCT05305040|531331615|FG001|Overall Study|Withdrawal by Subject|10|||
147318119|NCT05305040|531331614|FG000|Overall Study|Other|13|||
147318120|NCT05305040|531331615|FG001|Overall Study|Other|10|||
147318121|NCT05305040|531331614|FG000|Overall Study|Primary Malignancy Relapse|3|||
147318122|NCT05305040|531331615|FG001|Overall Study|Primary Malignancy Relapse|4|||
147318123|NCT05305040|531331614|FG000|Overall Study|Adverse Event|3|||
147318124|NCT05305040|531331615|FG001|Overall Study|Adverse Event|3|||
147318125|NCT05305040|531331614|FG000|Overall Study|Lost to Follow-up|2|||
147318126|NCT05305040|531331615|FG001|Overall Study|Lost to Follow-up|1|||
147318127|NCT05305040|531331614|FG000|Overall Study|Graft versus host disease|2|||
147318128|NCT05305040|531331615|FG001|Overall Study|Graft versus host disease|0|||
147318129|NCT05305040|531331614|FG000|Overall Study|Investigator's Decision|1|||
147318130|NCT05305040|531331615|FG001|Overall Study|Investigator's Decision|1|||
147318131|NCT05305040|531331614|FG000|Overall Study|COVID-19 Reasons|1|||
147318132|NCT05305040|531331615|FG001|Overall Study|COVID-19 Reasons|0|||
147318133|NCT01195675|531331616|FG000|Overall Study|Adverse Event|1|||
147651578|NCT00603382|532546548|FG002|Overall Study|Lost to Follow-up|1|||
147651579|NCT00603382|532546549|FG003|Overall Study|Lost to Follow-up|1|||
147134821|NCT03289143|530662540|FG003|Overall Study|Absence of Consistent and Reliable Caregiver|1|||
147134822|NCT00730756|530662541|FG000|Overall Study|Adverse Event|2|||
147134823|NCT00730756|530662542|FG001|Overall Study|Adverse Event|0|||
147134824|NCT00730756|530662541|FG000|Overall Study|Lack of Efficacy|1|||
147134825|NCT00730756|530662542|FG001|Overall Study|Lack of Efficacy|1|||
147134826|NCT00730756|530662541|FG000|Overall Study|Protocol Deviation|1|||
147134827|NCT00730756|530662542|FG001|Overall Study|Protocol Deviation|2|||
147134828|NCT00730756|530662541|FG000|Overall Study|Lost to Follow-up|0|||
147134829|NCT00730756|530662542|FG001|Overall Study|Lost to Follow-up|1|||
147134830|NCT00730756|530662541|FG000|Overall Study|Withdrew Consent|0|||
147134831|NCT00730756|530662542|FG001|Overall Study|Withdrew Consent|1|||
147134832|NCT00948688|530662543|FG000|Period 1: 200 mg Vorinostat|Adverse Event|1|||
147134833|NCT00948688|530662544|FG001|Period 1: 200 mg Vorinostat|Adverse Event|0|||
147134834|NCT00948688|530662543|FG000|Period 1: 200 mg Vorinostat|Protocol Violation|1|||
147318134|NCT01195675|531331616|FG000|Overall Study|Withdrawal by Subject|2|||
147318135|NCT02424344|531331617|FG000|Overall Study|Lack of Efficacy|0|||
147318136|NCT02424344|531331618|FG001|Overall Study|Lack of Efficacy|1|||
147318137|NCT02424344|531331617|FG000|Overall Study|Withdrawal by Subject|2|||
147318138|NCT02424344|531331618|FG001|Overall Study|Withdrawal by Subject|1|||
147318139|NCT02424344|531331617|FG000|Overall Study|Lost to Follow-up|1|||
147318140|NCT02424344|531331618|FG001|Overall Study|Lost to Follow-up|0|||
147318141|NCT02424344|531331617|FG000|Overall Study|Adverse Event|4|||
147445415|NCT00705783|531795844|FG001|Depot Stabilization Phase|Withdrew Consent|0|||
147445416|NCT00705783|531795845|FG002|Depot Stabilization Phase|Withdrew Consent|0|||
147134835|NCT00948688|530662544|FG001|Period 1: 200 mg Vorinostat|Protocol Violation|0|||
147134836|NCT00948688|530662543|FG000|Period 2: 100 mg Vorinostat|Adverse Event|0|||
147134837|NCT00948688|530662544|FG001|Period 2: 100 mg Vorinostat|Adverse Event|1|||
147134838|NCT00524121|530662547|FG000|Overall Study|Disease progression|6|||
147134839|NCT00524121|530662547|FG000|Overall Study|Adverse Event|4|||
147318142|NCT02424344|531331618|FG001|Overall Study|Adverse Event|8|||
147318143|NCT01174550|531331619|FG000|Overall Study|Death|75|||
147318144|NCT01174550|531331620|FG001|Overall Study|Death|74|||
147318145|NCT01174550|531331619|FG000|Overall Study|Lost to Follow-up|652|||
147318146|NCT01174550|531331620|FG001|Overall Study|Lost to Follow-up|510|||
147318147|NCT01174550|531331619|FG000|Overall Study|Withdrawal by Subject|543|||
147318148|NCT01174550|531331620|FG001|Overall Study|Withdrawal by Subject|289|||
147318149|NCT01536262|531331621|FG000|Overall Study|Adverse Event|6|||
147318150|NCT01536262|531331622|FG001|Overall Study|Adverse Event|1|||
147318151|NCT01536262|531331623|FG002|Overall Study|Adverse Event|2|||
147134840|NCT00524121|530662547|FG000|Overall Study|Patient refused|2|||
147318152|NCT01536262|531331621|FG000|Overall Study|Withdrawal by Subject|1|||
147318153|NCT01536262|531331622|FG001|Overall Study|Withdrawal by Subject|1|||
147318154|NCT01536262|531331623|FG002|Overall Study|Withdrawal by Subject|0|||
147318155|NCT01536262|531331621|FG000|Overall Study|Other than stated above|1|||
147318156|NCT01536262|531331622|FG001|Overall Study|Other than stated above|0|||
147318157|NCT01536262|531331623|FG002|Overall Study|Other than stated above|0|||
147318158|NCT05257837|531331627|FG000|Overall Study|Excluded (did not find the guns)|4|||
147318159|NCT05257837|531331628|FG001|Overall Study|Excluded (did not find the guns)|2|||
147318160|NCT05257837|531331629|FG002|Overall Study|Excluded (did not find the guns)|4|||
147318161|NCT05257837|531331630|FG003|Overall Study|Excluded (did not find the guns)|0|||
147318162|NCT01781611|531331631|FG000|Overall Study|Adverse Event|4|||
147318163|NCT01781611|531331632|FG001|Overall Study|Adverse Event|0|||
147318164|NCT03639675|531331633|FG000|Overall Study|Withdrawal by Subject|1|||
147318165|NCT02459587|531331634|FG000|3-Month Follow-up Assessment|Death|0|||
147318166|NCT02459587|531331635|FG001|3-Month Follow-up Assessment|Death|2|||
147318167|NCT02459587|531331634|FG000|3-Month Follow-up Assessment|Withdrawal by Subject|3|||
147318168|NCT02459587|531331635|FG001|3-Month Follow-up Assessment|Withdrawal by Subject|3|||
147318169|NCT02459587|531331634|FG000|3-Month Follow-up Assessment|Lost to Follow-up|27|||
147318170|NCT02459587|531331635|FG001|3-Month Follow-up Assessment|Lost to Follow-up|22|||
147318171|NCT02459587|531331634|FG000|3-Month Follow-up Assessment|Researcher withdrew|2|||
147318172|NCT02459587|531331635|FG001|3-Month Follow-up Assessment|Researcher withdrew|4|||
147318173|NCT02459587|531331634|FG000|6-month Follow-up Assessment|Death|2|||
147318174|NCT02459587|531331635|FG001|6-month Follow-up Assessment|Death|1|||
147318175|NCT02459587|531331634|FG000|6-month Follow-up Assessment|Withdrawal by Subject|1|||
147318176|NCT02459587|531331635|FG001|6-month Follow-up Assessment|Withdrawal by Subject|2|||
147318177|NCT02459587|531331634|FG000|6-month Follow-up Assessment|Lost to Follow-up|21|||
147318178|NCT02459587|531331635|FG001|6-month Follow-up Assessment|Lost to Follow-up|22|||
147318179|NCT02459587|531331634|FG000|12-month Follow-up Assessment|Death|2|||
147318180|NCT02459587|531331635|FG001|12-month Follow-up Assessment|Death|0|||
147318181|NCT02459587|531331634|FG000|12-month Follow-up Assessment|Withdrawal by Subject|2|||
147318182|NCT02459587|531331635|FG001|12-month Follow-up Assessment|Withdrawal by Subject|4|||
147318183|NCT02459587|531331634|FG000|12-month Follow-up Assessment|Lost to Follow-up|18|||
147318184|NCT02459587|531331635|FG001|12-month Follow-up Assessment|Lost to Follow-up|22|||
147318185|NCT02459587|531331634|FG000|12-month Follow-up Assessment|Researcher withdrew|0|||
147318186|NCT02459587|531331635|FG001|12-month Follow-up Assessment|Researcher withdrew|1|||
147318187|NCT05343455|531331638|FG000|Overall Study|Withdrawal by Subject|4|||
147134841|NCT00524121|530662547|FG000|Overall Study|Other|1|||
147134842|NCT00524121|530662547|FG000|Overall Study|Death|1|||
147134843|NCT00524121|530662547|FG000|Overall Study|Not treated (became ineligible)|4|||
147134844|NCT00524121|530662547|FG000|Overall Study|Not treated (changed mind)|1|||
147134845|NCT01840943|530662548|FG000|Overall Study|Withdrawal by Subject|5|||
147134846|NCT01840943|530662549|FG001|Overall Study|Withdrawal by Subject|6|||
147134847|NCT01840943|530662548|FG000|Overall Study|Physician Decision|4|||
147134848|NCT01840943|530662549|FG001|Overall Study|Physician Decision|2|||
147134849|NCT01840943|530662548|FG000|Overall Study|Lost to Follow-up|4|||
147134850|NCT01840943|530662549|FG001|Overall Study|Lost to Follow-up|4|||
147318188|NCT05343455|531331639|FG001|Overall Study|Withdrawal by Subject|9|||
147651580|NCT00603382|532546550|FG004|Overall Study|Lost to Follow-up|0|||
147134851|NCT01446874|530662550|FG000|Overall Study|Not eligible|1|||
147318189|NCT05343455|531331640|FG002|Overall Study|Withdrawal by Subject|7|||
147318190|NCT05343455|531331638|FG000|Overall Study|Adverse Event|2|||
147318191|NCT05343455|531331639|FG001|Overall Study|Adverse Event|1|||
147318192|NCT05343455|531331640|FG002|Overall Study|Adverse Event|2|||
147318193|NCT05343455|531331638|FG000|Overall Study|Lost to Follow-up|1|||
147318194|NCT05343455|531331639|FG001|Overall Study|Lost to Follow-up|1|||
147318195|NCT05343455|531331640|FG002|Overall Study|Lost to Follow-up|3|||
147318196|NCT05343455|531331638|FG000|Overall Study|Pregnancy|1|||
147318197|NCT05343455|531331639|FG001|Overall Study|Pregnancy|0|||
147134852|NCT01446874|530662551|FG001|Overall Study|Not eligible|0|||
147134853|NCT01446874|530662552|FG002|Overall Study|Not eligible|0|||
147134854|NCT01446874|530662550|FG000|Overall Study|No surgery/No qualifying surgery|1|||
147134855|NCT01446874|530662551|FG001|Overall Study|No surgery/No qualifying surgery|0|||
147318198|NCT05343455|531331640|FG002|Overall Study|Pregnancy|0|||
147318199|NCT05343455|531331638|FG000|Overall Study|Physician Decision|0|||
147318200|NCT05343455|531331639|FG001|Overall Study|Physician Decision|0|||
147318201|NCT05343455|531331640|FG002|Overall Study|Physician Decision|1|||
147318202|NCT05343455|531331638|FG000|Overall Study|Protocol Violation|0|||
147318203|NCT05343455|531331639|FG001|Overall Study|Protocol Violation|1|||
147318204|NCT05343455|531331640|FG002|Overall Study|Protocol Violation|1|||
147318205|NCT03468426|531331641|FG000|Overall Study|Progressive disease|3|||
147318206|NCT03468426|531331642|FG001|Overall Study|Progressive disease|0|||
147318207|NCT03468426|531331643|FG002|Overall Study|Progressive disease|4|||
147318208|NCT03468426|531331644|FG003|Overall Study|Progressive disease|20|||
147318209|NCT03468426|531331645|FG004|Overall Study|Progressive disease|23|||
147318210|NCT03468426|531331646|FG005|Overall Study|Progressive disease|15|||
147318211|NCT03468426|531331647|FG006|Overall Study|Progressive disease|24|||
147318212|NCT03468426|531331648|FG007|Overall Study|Progressive disease|27|||
147318213|NCT03468426|531331649|FG008|Overall Study|Progressive disease|13|||
147318214|NCT03468426|531331650|FG009|Overall Study|Progressive disease|13|||
147318215|NCT03468426|531331651|FG010|Overall Study|Progressive disease|0|||
147318216|NCT03468426|531331641|FG000|Overall Study|Other adverse event or clinical progression|0|||
147318217|NCT03468426|531331642|FG001|Overall Study|Other adverse event or clinical progression|1|||
147318218|NCT03468426|531331643|FG002|Overall Study|Other adverse event or clinical progression|3|||
147318219|NCT03468426|531331644|FG003|Overall Study|Other adverse event or clinical progression|14|||
147318220|NCT03468426|531331645|FG004|Overall Study|Other adverse event or clinical progression|10|||
147318221|NCT03468426|531331646|FG005|Overall Study|Other adverse event or clinical progression|8|||
147318222|NCT03468426|531331647|FG006|Overall Study|Other adverse event or clinical progression|5|||
147318223|NCT03468426|531331648|FG007|Overall Study|Other adverse event or clinical progression|4|||
147318224|NCT03468426|531331649|FG008|Overall Study|Other adverse event or clinical progression|6|||
147318225|NCT03468426|531331650|FG009|Overall Study|Other adverse event or clinical progression|11|||
147318226|NCT03468426|531331651|FG010|Overall Study|Other adverse event or clinical progression|0|||
147318227|NCT03468426|531331641|FG000|Overall Study|Refused to continue taking trial medication|0|||
147318228|NCT03468426|531331642|FG001|Overall Study|Refused to continue taking trial medication|0|||
147318229|NCT03468426|531331643|FG002|Overall Study|Refused to continue taking trial medication|0|||
147318230|NCT03468426|531331644|FG003|Overall Study|Refused to continue taking trial medication|2|||
147134856|NCT01446874|530662552|FG002|Overall Study|No surgery/No qualifying surgery|12|||
147134857|NCT01446874|530662550|FG000|Overall Study|Non-compliance|0|||
147134858|NCT01446874|530662551|FG001|Overall Study|Non-compliance|4|||
147134859|NCT01446874|530662552|FG002|Overall Study|Non-compliance|0|||
147134860|NCT01446874|530662550|FG000|Overall Study|Antibiotics for pre-op infection|0|||
147134861|NCT01446874|530662551|FG001|Overall Study|Antibiotics for pre-op infection|0|||
147134862|NCT01446874|530662552|FG002|Overall Study|Antibiotics for pre-op infection|2|||
147134863|NCT01446874|530662550|FG000|Overall Study|Withdrawal by Subject|0|||
147134864|NCT01446874|530662551|FG001|Overall Study|Withdrawal by Subject|0|||
147134865|NCT01446874|530662552|FG002|Overall Study|Withdrawal by Subject|4|||
147134866|NCT01135992|530662553|FG000|Overall Study|Adverse Event|1|||
147134867|NCT01135992|530662553|FG000|Overall Study|Lack of Efficacy|1|||
147134868|NCT01135992|530662553|FG000|Overall Study|Protocol Violation|2|||
147134869|NCT01135992|530662553|FG000|Overall Study|Withdrawal criteria|10|||
147134870|NCT01135992|530662553|FG000|Overall Study|Unclassified|7|||
147134871|NCT01977898|530662554|FG000|Overall Study|Non functioning catheter|1|||
147134872|NCT01977898|530662555|FG001|Overall Study|Non functioning catheter|1|||
147318231|NCT03468426|531331645|FG004|Overall Study|Refused to continue taking trial medication|0|||
147318232|NCT03468426|531331646|FG005|Overall Study|Refused to continue taking trial medication|3|||
147318233|NCT03468426|531331647|FG006|Overall Study|Refused to continue taking trial medication|0|||
147318234|NCT03468426|531331648|FG007|Overall Study|Refused to continue taking trial medication|0|||
147318235|NCT03468426|531331649|FG008|Overall Study|Refused to continue taking trial medication|1|||
147318236|NCT03468426|531331650|FG009|Overall Study|Refused to continue taking trial medication|0|||
147318237|NCT03468426|531331651|FG010|Overall Study|Refused to continue taking trial medication|0|||
147318238|NCT03468426|531331641|FG000|Overall Study|Other than listed|0|||
147571152|NCT00795821|532248786|FG001|Acute Treatment Phase|Lack of Efficacy|2|||
147571153|NCT00795821|532248785|FG000|Acute Treatment Phase|Lost to Follow-up|9|||
147571154|NCT00795821|532248786|FG001|Acute Treatment Phase|Lost to Follow-up|12|||
147571155|NCT00795821|532248785|FG000|Acute Treatment Phase|Physician Decision|1|||
147571156|NCT00795821|532248786|FG001|Acute Treatment Phase|Physician Decision|1|||
147571157|NCT00795821|532248785|FG000|Acute Treatment Phase|Protocol Violation|1|||
147134873|NCT01049373|530662561|FG000|Overall Study|Protocol Violation|9|||
147134874|NCT01049373|530662562|FG001|Overall Study|Protocol Violation|9|||
147134875|NCT01049373|530662561|FG000|Overall Study|Withdrawal by Subject|8|||
147134876|NCT01049373|530662562|FG001|Overall Study|Withdrawal by Subject|5|||
147318239|NCT03468426|531331642|FG001|Overall Study|Other than listed|1|||
147318240|NCT03468426|531331643|FG002|Overall Study|Other than listed|0|||
147318241|NCT03468426|531331644|FG003|Overall Study|Other than listed|0|||
147318242|NCT03468426|531331645|FG004|Overall Study|Other than listed|2|||
147318243|NCT03468426|531331646|FG005|Overall Study|Other than listed|2|||
147571158|NCT00795821|532248786|FG001|Acute Treatment Phase|Protocol Violation|2|||
147571159|NCT00795821|532248785|FG000|Acute Treatment Phase|Withdrawal by Subject|16|||
147134877|NCT01049373|530662561|FG000|Overall Study|Adverse Event|3|||
147134878|NCT01049373|530662562|FG001|Overall Study|Adverse Event|3|||
147134879|NCT01049373|530662561|FG000|Overall Study|Lost to Follow-up|9|||
147134880|NCT01049373|530662562|FG001|Overall Study|Lost to Follow-up|4|||
147134881|NCT01049373|530662561|FG000|Overall Study|no evaluable study values|9|||
147134882|NCT01049373|530662562|FG001|Overall Study|no evaluable study values|21|||
147134883|NCT01049373|530662561|FG000|Overall Study|Other|1|||
147134884|NCT01049373|530662562|FG001|Overall Study|Other|1|||
147134885|NCT01049373|530662561|FG000|Overall Study|Non-cooperation|0|||
147134886|NCT01049373|530662562|FG001|Overall Study|Non-cooperation|1|||
147134887|NCT01693367|530662563|FG000|Overall Study|Withdrawal by Subject|1|||
147134888|NCT01693367|530662564|FG001|Overall Study|Withdrawal by Subject|1|||
147134889|NCT01693367|530662563|FG000|Overall Study|Physician Decision|0|||
147134890|NCT01693367|530662564|FG001|Overall Study|Physician Decision|1|||
147134891|NCT03610048|530662565|FG000|Overall Study|Study terminated by sponsor|84|||
147134892|NCT03610048|530662565|FG000|Overall Study|Adverse Event|32|||
147134893|NCT03610048|530662565|FG000|Overall Study|Withdrawal by Subject|31|||
147134894|NCT03610048|530662565|FG000|Overall Study|Lost to Follow-up|8|||
147134895|NCT03610048|530662565|FG000|Overall Study|Other|4|||
147134896|NCT03610048|530662565|FG000|Overall Study|Physician Decision|1|||
147134897|NCT03610048|530662565|FG000|Overall Study|Pregnancy|1|||
147134898|NCT01155050|530662566|FG000|Overall Study|Lost to Follow-up|15|||
147134899|NCT01155050|530662567|FG001|Overall Study|Lost to Follow-up|20|||
147134900|NCT01155050|530662568|FG002|Overall Study|Lost to Follow-up|19|||
147134901|NCT01155050|530662569|FG003|Overall Study|Lost to Follow-up|22|||
147134902|NCT02136914|530662570|FG000|Overall Study|Sponsor's Decision to Stop the Study|7|||
147134903|NCT02136914|530662571|FG001|Overall Study|Sponsor's Decision to Stop the Study|7|||
147134904|NCT02136914|530662570|FG000|Overall Study|Withdrawal by Subject|3|||
147134905|NCT02136914|530662571|FG001|Overall Study|Withdrawal by Subject|10|||
147134906|NCT02136914|530662570|FG000|Overall Study|Subject Unwilling to Proceed|7|||
147134907|NCT02136914|530662571|FG001|Overall Study|Subject Unwilling to Proceed|2|||
147134908|NCT02136914|530662570|FG000|Overall Study|Lost to Follow-up|1|||
147134909|NCT02136914|530662571|FG001|Overall Study|Lost to Follow-up|1|||
147134910|NCT02136914|530662570|FG000|Overall Study|Did Not Receive Study Drug|2|||
147134911|NCT02136914|530662571|FG001|Overall Study|Did Not Receive Study Drug|0|||
147134912|NCT02136914|530662570|FG000|Overall Study|Lack of Efficacy|1|||
147134913|NCT02136914|530662571|FG001|Overall Study|Lack of Efficacy|0|||
147134914|NCT02136914|530662570|FG000|Overall Study|Death|0|||
147134915|NCT02136914|530662571|FG001|Overall Study|Death|1|||
147134916|NCT00329030|530662574|FG000|Overall Study|Withdrawal by Subject|1|||
147134917|NCT00329030|530662575|FG001|Overall Study|Withdrawal by Subject|3|||
147134918|NCT00329030|530662574|FG000|Overall Study|Progressive Disease|6|||
147134919|NCT00329030|530662575|FG001|Overall Study|Progressive Disease|2|||
147134920|NCT00329030|530662574|FG000|Overall Study|Ineligible Pathology|1|||
147134921|NCT00329030|530662575|FG001|Overall Study|Ineligible Pathology|1|||
147134922|NCT00325143|530662576|FG000|Overall Study|Lost to follow-up(complete vacc. course)|13|||
147134923|NCT00325143|530662576|FG000|Overall Study|Migrated/moved from study area|1|||
147134924|NCT00325143|530662576|FG000|Overall Study|Lost to follow-up(incompl. vacc. course)|4|||
147134925|NCT00325143|530662576|FG000|Overall Study|Withdrawal by Subject|8|||
147134926|NCT02286895|530662577|FG000|Assessed for Measles Seroconversion|Protocol Violation|1|||
147134927|NCT02286895|530662578|FG001|Assessed for Measles Seroconversion|Protocol Violation|4|||
147134928|NCT02286895|530662577|FG000|Assessed for Measles Seroconversion|Missing measurement|6|||
147134929|NCT02286895|530662578|FG001|Assessed for Measles Seroconversion|Missing measurement|3|||
147134930|NCT02286895|530662577|FG000|Assessed for Measles Seroconversion|Baseline measure non-negative|41|||
147134931|NCT02286895|530662578|FG001|Assessed for Measles Seroconversion|Baseline measure non-negative|32|||
147318244|NCT03468426|531331647|FG006|Overall Study|Other than listed|0|||
147571160|NCT00795821|532248786|FG001|Acute Treatment Phase|Withdrawal by Subject|10|||
147571161|NCT00795821|532248785|FG000|Long-term Extension Phase|Adverse Event|25|||
147571162|NCT00795821|532248786|FG001|Long-term Extension Phase|Adverse Event|32|||
147571163|NCT00795821|532248785|FG000|Long-term Extension Phase|Lack of Efficacy|16|||
147134932|NCT03036852|530662579|FG000|Overall Study|Death|2|||
147134933|NCT03036852|530662579|FG000|Overall Study|Lack of Efficacy|2|||
147134934|NCT03036852|530662579|FG000|Overall Study|Adverse Event|1|||
147134935|NCT03036852|530662579|FG000|Overall Study|Lost to Follow-up|1|||
147134936|NCT00399035|530662582|FG000|Overall Study|Death|289|||
147134937|NCT00399035|530662583|FG001|Overall Study|Death|141|||
147134938|NCT00399035|530662584|FG002|Overall Study|Death|234|||
147134939|NCT00399035|530662582|FG000|Overall Study|Lost to Follow-up|2|||
147134940|NCT00399035|530662583|FG001|Overall Study|Lost to Follow-up|1|||
147134941|NCT00399035|530662584|FG002|Overall Study|Lost to Follow-up|5|||
147134942|NCT00399035|530662582|FG000|Overall Study|Withdrawal by Subject|19|||
147134943|NCT00399035|530662583|FG001|Overall Study|Withdrawal by Subject|15|||
147134944|NCT00399035|530662584|FG002|Overall Study|Withdrawal by Subject|12|||
147134945|NCT00399035|530662582|FG000|Overall Study|Incorrect enrolment/eligib not fulfilled|1|||
147134946|NCT00399035|530662583|FG001|Overall Study|Incorrect enrolment/eligib not fulfilled|0|||
147134947|NCT00399035|530662584|FG002|Overall Study|Incorrect enrolment/eligib not fulfilled|1|||
147134948|NCT00399035|530662582|FG000|Overall Study|Severe non-compliance with protocol|2|||
147571164|NCT00795821|532248786|FG001|Long-term Extension Phase|Lack of Efficacy|12|||
147571165|NCT00795821|532248785|FG000|Long-term Extension Phase|Lost to Follow-up|20|||
147651581|NCT00603382|532546551|FG005|Overall Study|Lost to Follow-up|1|||
147651582|NCT00603382|532546546|FG000|Overall Study|Physician Decision|0|||
147134949|NCT00399035|530662583|FG001|Overall Study|Severe non-compliance with protocol|1|||
147134950|NCT00399035|530662584|FG002|Overall Study|Severe non-compliance with protocol|0|||
147571166|NCT00795821|532248786|FG001|Long-term Extension Phase|Lost to Follow-up|16|||
147571167|NCT00795821|532248785|FG000|Long-term Extension Phase|Physician Decision|1|||
147571168|NCT00795821|532248786|FG001|Long-term Extension Phase|Physician Decision|2|||
147571169|NCT00795821|532248785|FG000|Long-term Extension Phase|Protocol Violation|3|||
147571170|NCT00795821|532248786|FG001|Long-term Extension Phase|Protocol Violation|5|||
147571171|NCT00795821|532248785|FG000|Long-term Extension Phase|Withdrawal by Subject|25|||
147571172|NCT00795821|532248786|FG001|Long-term Extension Phase|Withdrawal by Subject|25|||
147571173|NCT00795821|532248785|FG000|Taper Phase|Adverse Event|2|||
147651583|NCT00603382|532546547|FG001|Overall Study|Physician Decision|0|||
147134951|NCT02949011|530662591|FG000|Overall Study|Adverse Event|6|||
147134952|NCT02949011|530662592|FG001|Overall Study|Adverse Event|7|||
147134953|NCT02949011|530662593|FG002|Overall Study|Adverse Event|3|||
147134954|NCT02949011|530662591|FG000|Overall Study|Failed Inclusion/Exclusion Criteria|0|||
147134955|NCT02949011|530662592|FG001|Overall Study|Failed Inclusion/Exclusion Criteria|0|||
147134956|NCT02949011|530662593|FG002|Overall Study|Failed Inclusion/Exclusion Criteria|3|||
147134957|NCT02949011|530662591|FG000|Overall Study|Protocol Deviation|5|||
147134958|NCT02949011|530662592|FG001|Overall Study|Protocol Deviation|3|||
147134959|NCT02949011|530662593|FG002|Overall Study|Protocol Deviation|3|||
147134960|NCT02949011|530662591|FG000|Overall Study|Lack of Efficacy|0|||
147134961|NCT02949011|530662592|FG001|Overall Study|Lack of Efficacy|2|||
147134962|NCT02949011|530662593|FG002|Overall Study|Lack of Efficacy|0|||
147134963|NCT02949011|530662591|FG000|Overall Study|Withdrawal by Subject|13|||
147134964|NCT02949011|530662592|FG001|Overall Study|Withdrawal by Subject|13|||
147134965|NCT02949011|530662593|FG002|Overall Study|Withdrawal by Subject|21|||
147134966|NCT02949011|530662591|FG000|Overall Study|Lost to Follow-up|7|||
147134967|NCT02949011|530662592|FG001|Overall Study|Lost to Follow-up|5|||
147134968|NCT02949011|530662593|FG002|Overall Study|Lost to Follow-up|5|||
147134969|NCT02949011|530662591|FG000|Overall Study|Death|0|||
147134970|NCT02949011|530662592|FG001|Overall Study|Death|0|||
147134971|NCT02949011|530662593|FG002|Overall Study|Death|1|||
147134972|NCT02949011|530662591|FG000|Overall Study|Miscellaneous|2|||
147134973|NCT02949011|530662592|FG001|Overall Study|Miscellaneous|4|||
147134974|NCT02949011|530662593|FG002|Overall Study|Miscellaneous|6|||
147134975|NCT02441218|530662594|FG000|Overall Study|Death|503|||
147134976|NCT02441218|530662595|FG001|Overall Study|Death|553|||
147134977|NCT02441218|530662594|FG000|Overall Study|Withdrawal by Subject|73|||
147134978|NCT02441218|530662595|FG001|Overall Study|Withdrawal by Subject|58|||
147134979|NCT02441218|530662594|FG000|Overall Study|Lost to Follow-up|2|||
147134980|NCT02441218|530662595|FG001|Overall Study|Lost to Follow-up|1|||
147134981|NCT01541371|530662596|FG000|Overall Study|Withdrawal by Subject|14|||
147134982|NCT01541371|530662596|FG000|Overall Study|Lost to Follow-up|21|||
147134983|NCT01541371|530662596|FG000|Overall Study|Adverse Event|15|||
147237111|NCT03298867|531037470|FG001|48-Week Follow-Up Contact (Weeks 96-120)|Lost to Follow-up|1|||
147237112|NCT05136690|531037471|FG000|Period 1|Withdrawal by Subject|0|||
147237113|NCT05136690|531037472|FG001|Period 1|Withdrawal by Subject|1|||
147237114|NCT05136690|531037471|FG000|Period 2|Lost to Follow-up|0|||
147237115|NCT05136690|531037472|FG001|Period 2|Lost to Follow-up|3|||
147237116|NCT05136690|531037471|FG000|Period 2|Withdrawal by Subject|0|||
147237117|NCT05136690|531037472|FG001|Period 2|Withdrawal by Subject|1|||
147237118|NCT03730012|531037473|FG000|Overall Study|Adverse Event|0|||
147237119|NCT03730012|531037474|FG001|Overall Study|Adverse Event|1|||
147237120|NCT03730012|531037473|FG000|Overall Study|Lack of Efficacy|1|||
147237121|NCT03730012|531037474|FG001|Overall Study|Lack of Efficacy|5|||
147237122|NCT03730012|531037473|FG000|Overall Study|Withdrawal by Subject|0|||
147237123|NCT03730012|531037474|FG001|Overall Study|Withdrawal by Subject|1|||
147237124|NCT03730012|531037473|FG000|Overall Study|Miscellaneous|2|||
147237125|NCT03730012|531037474|FG001|Overall Study|Miscellaneous|1|||
147651584|NCT00603382|532546548|FG002|Overall Study|Physician Decision|2|||
147134984|NCT01541371|530662596|FG000|Overall Study|Lack of Efficacy|12|||
147134985|NCT01541371|530662596|FG000|Overall Study|Protocol Violation|6|||
147134986|NCT01541371|530662596|FG000|Overall Study|Study medication non-compliance|3|||
147134987|NCT01541371|530662596|FG000|Overall Study|Other|6|||
147134988|NCT00163189|530662599|FG000|Overall Study|Other|6|||
147134989|NCT00163189|530662599|FG000|Overall Study|Lost to Follow-up|1|||
147134990|NCT00163189|530662599|FG000|Overall Study|Protocol Violation|2|||
147134991|NCT00163189|530662599|FG000|Overall Study|Death|3|||
147134992|NCT00163189|530662599|FG000|Overall Study|Adverse Event|6|||
147134993|NCT00163189|530662599|FG000|Overall Study|Lack of Efficacy|7|||
147134994|NCT00163189|530662599|FG000|Overall Study|Study terminated by sponsor|11|||
147134995|NCT00163189|530662599|FG000|Overall Study|Withdrawal by Subject|11|||
147134996|NCT00163189|530662599|FG000|Overall Study|Did not meet continuation criterion|16|||
147134997|NCT03435380|530662600|FG000|Overall Study|Death|1|||
147237126|NCT06956170|531038796|FG000|Overall Study|Death|2|||
147571174|NCT00795821|532248786|FG001|Taper Phase|Adverse Event|0|||
147571175|NCT00795821|532248785|FG000|Taper Phase|Lost to Follow-up|1|||
147318245|NCT03468426|531331648|FG007|Overall Study|Other than listed|0|||
147318246|NCT03468426|531331649|FG008|Overall Study|Other than listed|4|||
147318247|NCT03468426|531331650|FG009|Overall Study|Other than listed|4|||
147445417|NCT00705783|531795843|FG000|Depot Stabilization Phase|Adverse Event|17|||
147445418|NCT00705783|531795844|FG001|Depot Stabilization Phase|Adverse Event|0|||
147445419|NCT00705783|531795845|FG002|Depot Stabilization Phase|Adverse Event|0|||
147445420|NCT00705783|531795843|FG000|Depot Stabilization Phase|Lack of Efficacy with Adverse Event|12|||
147445421|NCT00705783|531795844|FG001|Depot Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
147445422|NCT00705783|531795845|FG002|Depot Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
147445423|NCT00705783|531795843|FG000|Depot Stabilization Phase|Lack of Efficacy without Adverse Event|1|||
147445424|NCT00705783|531795844|FG001|Depot Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
147445425|NCT00705783|531795845|FG002|Depot Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
147445426|NCT00705783|531795843|FG000|Depot Maintenance Phase|Sponsor Discontinued Study|0|||
147445427|NCT00705783|531795844|FG001|Depot Maintenance Phase|Sponsor Discontinued Study|179|||
147445428|NCT00705783|531795845|FG002|Depot Maintenance Phase|Sponsor Discontinued Study|58|||
147445429|NCT00705783|531795843|FG000|Depot Maintenance Phase|Lost to Follow-up|0|||
147445430|NCT00705783|531795844|FG001|Depot Maintenance Phase|Lost to Follow-up|5|||
147445431|NCT00705783|531795845|FG002|Depot Maintenance Phase|Lost to Follow-up|3|||
147445432|NCT00705783|531795843|FG000|Depot Maintenance Phase|Met Withdrawal Criteria|0|||
147445433|NCT00705783|531795844|FG001|Depot Maintenance Phase|Met Withdrawal Criteria|2|||
147445434|NCT00705783|531795845|FG002|Depot Maintenance Phase|Met Withdrawal Criteria|2|||
147445435|NCT00705783|531795843|FG000|Depot Maintenance Phase|Withdrawn by Investigator|0|||
147445436|NCT00705783|531795844|FG001|Depot Maintenance Phase|Withdrawn by Investigator|8|||
147445437|NCT00705783|531795845|FG002|Depot Maintenance Phase|Withdrawn by Investigator|6|||
147445438|NCT00705783|531795843|FG000|Depot Maintenance Phase|Withdrew Consent|0|||
147445439|NCT00705783|531795844|FG001|Depot Maintenance Phase|Withdrew Consent|14|||
147445440|NCT00705783|531795845|FG002|Depot Maintenance Phase|Withdrew Consent|4|||
147571176|NCT00795821|532248786|FG001|Taper Phase|Lost to Follow-up|0|||
147318248|NCT03468426|531331651|FG010|Overall Study|Other than listed|1|||
147318249|NCT03468426|531331641|FG000|Overall Study|Dose Limiting Toxicity (DLT)|0|||
147318250|NCT03468426|531331642|FG001|Overall Study|Dose Limiting Toxicity (DLT)|0|||
147318251|NCT03468426|531331643|FG002|Overall Study|Dose Limiting Toxicity (DLT)|1|||
147318252|NCT03468426|531331644|FG003|Overall Study|Dose Limiting Toxicity (DLT)|0|||
147318253|NCT03468426|531331645|FG004|Overall Study|Dose Limiting Toxicity (DLT)|0|||
147318254|NCT03468426|531331646|FG005|Overall Study|Dose Limiting Toxicity (DLT)|0|||
147318255|NCT03468426|531331647|FG006|Overall Study|Dose Limiting Toxicity (DLT)|0|||
147318256|NCT03468426|531331648|FG007|Overall Study|Dose Limiting Toxicity (DLT)|0|||
147318257|NCT03468426|531331649|FG008|Overall Study|Dose Limiting Toxicity (DLT)|0|||
147318258|NCT03468426|531331650|FG009|Overall Study|Dose Limiting Toxicity (DLT)|0|||
147318259|NCT03468426|531331651|FG010|Overall Study|Dose Limiting Toxicity (DLT)|0|||
147318260|NCT03468426|531331641|FG000|Overall Study|missing reason|0|||
147318261|NCT03468426|531331642|FG001|Overall Study|missing reason|0|||
147318262|NCT03468426|531331643|FG002|Overall Study|missing reason|0|||
147318263|NCT03468426|531331644|FG003|Overall Study|missing reason|0|||
147318264|NCT03468426|531331645|FG004|Overall Study|missing reason|0|||
147318265|NCT03468426|531331646|FG005|Overall Study|missing reason|0|||
147318266|NCT03468426|531331647|FG006|Overall Study|missing reason|0|||
147318267|NCT03468426|531331648|FG007|Overall Study|missing reason|0|||
147318268|NCT03468426|531331649|FG008|Overall Study|missing reason|0|||
147318269|NCT03468426|531331650|FG009|Overall Study|missing reason|1|||
147318270|NCT03468426|531331651|FG010|Overall Study|missing reason|0|||
147318271|NCT02139982|531331652|FG000|Overall Study|Lack of Efficacy|0|||
147318272|NCT02139982|531331653|FG001|Overall Study|Lack of Efficacy|1|||
147318273|NCT02139982|531331654|FG002|Overall Study|Lack of Efficacy|0|||
147318274|NCT02139982|531331655|FG003|Overall Study|Lack of Efficacy|1|||
147318275|NCT02139982|531331656|FG004|Overall Study|Lack of Efficacy|0|||
147318276|NCT02139982|531331657|FG005|Overall Study|Lack of Efficacy|0|||
147318277|NCT02139982|531331658|FG006|Overall Study|Lack of Efficacy|0|||
147318278|NCT02139982|531331659|FG007|Overall Study|Lack of Efficacy|0|||
147318279|NCT02139982|531331660|FG008|Overall Study|Lack of Efficacy|0|||
147318280|NCT02139982|531331661|FG009|Overall Study|Lack of Efficacy|0|||
147318281|NCT04466618|531331666|FG000|Overall Study|Withdrawal by Subject|0|||
147571177|NCT00795821|532248785|FG000|Taper Phase|Physician Decision|2|||
147571178|NCT00795821|532248786|FG001|Taper Phase|Physician Decision|0|||
147571179|NCT00795821|532248785|FG000|Taper Phase|Withdrawal by Subject|4|||
147318282|NCT04466618|531331667|FG001|Overall Study|Withdrawal by Subject|1|||
147318283|NCT00109928|531331668|FG000|Overall Study|Adverse Event|2|||
147318284|NCT00109928|531331668|FG000|Overall Study|Progression|6|||
147318285|NCT00109928|531331668|FG000|Overall Study|Death|2|||
147445441|NCT00705783|531795843|FG000|Depot Maintenance Phase|Protocol Deviation|0|||
147571180|NCT00795821|532248786|FG001|Taper Phase|Withdrawal by Subject|0|||
147318286|NCT00109928|531331668|FG000|Overall Study|not protocol specified|2|||
147318287|NCT00109928|531331668|FG000|Overall Study|not eligible|1|||
147318288|NCT01734850|531331673|FG000|Overall Study|Continued to Week 48 but recommenced ART|3|||
147571181|NCT00712959|532248793|FG000|Overall Study|Protocol Violation|3|||
147571182|NCT00712959|532248794|FG001|Overall Study|Protocol Violation|1|||
147571183|NCT00712959|532248793|FG000|Overall Study|Lost to Follow-up|13|||
147134998|NCT03435380|530662601|FG001|Overall Study|Death|2|||
147134999|NCT03435380|530662602|FG002|Overall Study|Death|1|||
147135000|NCT03435380|530662600|FG000|Overall Study|Lost to Follow-up|12|||
147135001|NCT03435380|530662601|FG001|Overall Study|Lost to Follow-up|8|||
147135002|NCT03435380|530662602|FG002|Overall Study|Lost to Follow-up|6|||
147135003|NCT03435380|530662600|FG000|Overall Study|Physician Decision|1|||
147135004|NCT03435380|530662601|FG001|Overall Study|Physician Decision|0|||
147135005|NCT03435380|530662602|FG002|Overall Study|Physician Decision|0|||
147135006|NCT03435380|530662600|FG000|Overall Study|Withdrawal by Subject|0|||
147135007|NCT03435380|530662601|FG001|Overall Study|Withdrawal by Subject|1|||
147135008|NCT03435380|530662602|FG002|Overall Study|Withdrawal by Subject|1|||
147135009|NCT03435380|530662600|FG000|Overall Study|Ineligible|0|||
147135010|NCT03435380|530662601|FG001|Overall Study|Ineligible|1|||
147135011|NCT03435380|530662602|FG002|Overall Study|Ineligible|1|||
147135012|NCT03338400|530662603|FG000|Overall Study|Lost to Follow-up|1|||
147135013|NCT03338400|530662604|FG001|Overall Study|Lost to Follow-up|2|||
147135014|NCT01531998|530662609|FG000|Overall Study|Withdrawal by Subject|3|||
147135015|NCT01130337|530662615|FG000|Overall Study|Withdrawal by Subject|3|||
147135016|NCT01130337|530662615|FG000|Overall Study|Principal investigator decision|1|||
147135017|NCT01130337|530662615|FG000|Overall Study|Death|1|||
147135018|NCT01130337|530662615|FG000|Overall Study|Disease progression|1|||
147135019|NCT01130337|530662615|FG000|Overall Study|Toxicity, AE/intercurrent disease|7|||
147135020|NCT01130337|530662615|FG000|Overall Study|Surgical resection (R2)|1|||
147135021|NCT03886493|530662616|FG000|Overall Study|Adverse Event|1|||
147135022|NCT00181844|530662617|FG000|Signed Consent|Withdrawal by Subject|5|||
147135023|NCT00181844|530662617|FG000|Signed Consent|Did not meet entrance criteria|7|||
147135024|NCT00181844|530662617|FG000|Exposed to Study Medication|Adverse Event|10|||
147135025|NCT00181844|530662617|FG000|Exposed to Study Medication|Lack of Efficacy|2|||
147135026|NCT00181844|530662617|FG000|Exposed to Study Medication|Non-compliance|2|||
147135027|NCT00181844|530662617|FG000|Exposed to Study Medication|Withdrawal by Subject|1|||
147135028|NCT00181844|530662617|FG000|Exposed to Study Medication|Difficulty meeting study schedule|2|||
147135029|NCT00107276|530662618|FG000|Overall Study|Progression|46|||
147135030|NCT00107276|530662618|FG000|Overall Study|Adverse Event|6|||
147135031|NCT00107276|530662618|FG000|Overall Study|M.D. decision|2|||
147135032|NCT00107276|530662618|FG000|Overall Study|Patient refusal|1|||
147135033|NCT00107276|530662618|FG000|Overall Study|Death|1|||
147135034|NCT00107276|530662618|FG000|Overall Study|Ineligible|16|||
147135035|NCT03179761|530662619|FG000|Overall Study|Death|2|||
147135036|NCT03179761|530662620|FG001|Overall Study|Death|5|||
147135037|NCT03179761|530662619|FG000|Overall Study|Lost to Follow-up|2|||
147135038|NCT03179761|530662620|FG001|Overall Study|Lost to Follow-up|2|||
147135039|NCT03179761|530662619|FG000|Overall Study|Protocol Violation|1|||
147135040|NCT03179761|530662620|FG001|Overall Study|Protocol Violation|0|||
147135041|NCT03179761|530662619|FG000|Overall Study|Withdrawal by Subject|1|||
147135042|NCT03179761|530662620|FG001|Overall Study|Withdrawal by Subject|4|||
147135043|NCT03179761|530662619|FG000|Overall Study|Investigator Request|0|||
147237127|NCT06956170|531038797|FG001|Overall Study|Death|1|||
147237128|NCT06956170|531038796|FG000|Overall Study|Withdrawal by Subject|1|||
147237129|NCT06956170|531038797|FG001|Overall Study|Withdrawal by Subject|0|||
147237130|NCT06956170|531038796|FG000|Overall Study|Ongoing|7|||
147237131|NCT06956170|531038797|FG001|Overall Study|Ongoing|10|||
147237132|NCT00885846|531038798|FG000|Overall Study|Withdrawal by Subject|2|||
147237133|NCT00885846|531038799|FG001|Overall Study|Withdrawal by Subject|5|||
147237134|NCT00885846|531038800|FG002|Overall Study|Withdrawal by Subject|2|||
147237135|NCT01540838|531038801|FG000|Overall Study|Open nasogastric tube|9|||
147237136|NCT01540838|531038802|FG001|Overall Study|Open nasogastric tube|7|||
147237137|NCT01540838|531038801|FG000|Overall Study|Treatment doses missing|8|||
147237138|NCT01540838|531038802|FG001|Overall Study|Treatment doses missing|12|||
147237139|NCT01540838|531038801|FG000|Overall Study|Additional antibiotic treatment|1|||
147237140|NCT01540838|531038802|FG001|Overall Study|Additional antibiotic treatment|2|||
147237141|NCT01540838|531038801|FG000|Overall Study|Died before treatment initiation|1|||
147237142|NCT01540838|531038802|FG001|Overall Study|Died before treatment initiation|1|||
147237143|NCT01540838|531038801|FG000|Overall Study|Not BM. Other treatment|3|||
147237144|NCT01540838|531038802|FG001|Overall Study|Not BM. Other treatment|1|||
147237145|NCT02130570|531038803|FG000|Overall Study|Death|3|||
147237146|NCT02130570|531038804|FG001|Overall Study|Death|5|||
147237147|NCT02130570|531038803|FG000|Overall Study|Withdrawal by Subject|6|||
147237148|NCT02130570|531038804|FG001|Overall Study|Withdrawal by Subject|3|||
147237149|NCT02130570|531038803|FG000|Overall Study|Part of practice that discontinued study|0|||
147237150|NCT02130570|531038804|FG001|Overall Study|Part of practice that discontinued study|5|||
147237151|NCT00493025|531038807|FG000|Overall Study|Physician Decision|19|||
147237152|NCT00071396|531038815|FG000|Overall Study|Withdrawal by Subject|1|||
147135044|NCT03179761|530662620|FG001|Overall Study|Investigator Request|2|||
147135045|NCT04661033|530662621|FG000|Overall Study|Adverse Event|0|||
147135046|NCT04661033|530662622|FG001|Overall Study|Adverse Event|0|||
147237153|NCT00071396|531038815|FG000|Overall Study|Physician Decision|2|||
147135047|NCT04661033|530662623|FG002|Overall Study|Adverse Event|1|||
147135048|NCT04661033|530662624|FG003|Overall Study|Adverse Event|0|||
147135049|NCT04661033|530662621|FG000|Overall Study|Switch of cohort due to retreatment criteria met|1|||
147135050|NCT04661033|530662622|FG001|Overall Study|Switch of cohort due to retreatment criteria met|0|||
147135051|NCT04661033|530662623|FG002|Overall Study|Switch of cohort due to retreatment criteria met|0|||
147135052|NCT04661033|530662624|FG003|Overall Study|Switch of cohort due to retreatment criteria met|0|||
147135053|NCT04661033|530662621|FG000|Overall Study|As per Principal Investigator (PI) decision|1|||
147135054|NCT04661033|530662622|FG001|Overall Study|As per Principal Investigator (PI) decision|0|||
147135055|NCT04661033|530662623|FG002|Overall Study|As per Principal Investigator (PI) decision|0|||
147237154|NCT03082261|531038816|FG000|Overall Study|Death|4|||
147237155|NCT03082261|531038816|FG000|Overall Study|Implant of dorsal root ganglion stimulation (DRG) device|1|||
147571184|NCT00712959|532248794|FG001|Overall Study|Lost to Follow-up|2|||
147571185|NCT00712959|532248793|FG000|Overall Study|Withdrawal by Subject|3|||
147571186|NCT00712959|532248794|FG001|Overall Study|Withdrawal by Subject|0|||
147571187|NCT02255149|532248795|FG000|Overall Study|Lost to Follow-up|2|||
147571188|NCT02255149|532248795|FG000|Overall Study|Withdrawal by Subject|1|||
147571189|NCT02255149|532248795|FG000|Overall Study|Withdrawal by PI|1|||
147571190|NCT02255149|532248795|FG000|Overall Study|Implant Failure|1|||
147571191|NCT02301975|532248805|FG000|Overall Study|Adverse Event|8|||
147571192|NCT02301975|532248806|FG001|Overall Study|Adverse Event|3|||
147571193|NCT02301975|532248807|FG002|Overall Study|Adverse Event|2|||
147571194|NCT02301975|532248805|FG000|Overall Study|Lack of Efficacy|1|||
147571195|NCT02301975|532248806|FG001|Overall Study|Lack of Efficacy|1|||
147571196|NCT02301975|532248807|FG002|Overall Study|Lack of Efficacy|1|||
147571197|NCT02301975|532248805|FG000|Overall Study|Protocol Violation|3|||
147571198|NCT02301975|532248806|FG001|Overall Study|Protocol Violation|5|||
147571199|NCT02301975|532248807|FG002|Overall Study|Protocol Violation|3|||
147571200|NCT02301975|532248805|FG000|Overall Study|Lost to Follow-up|0|||
147571201|NCT02301975|532248806|FG001|Overall Study|Lost to Follow-up|2|||
147571202|NCT02301975|532248807|FG002|Overall Study|Lost to Follow-up|2|||
147571203|NCT02301975|532248805|FG000|Overall Study|Physician Decision|4|||
147571204|NCT02301975|532248806|FG001|Overall Study|Physician Decision|2|||
147571205|NCT02301975|532248807|FG002|Overall Study|Physician Decision|3|||
147571206|NCT02301975|532248805|FG000|Overall Study|Withdrawal by Subject|15|||
147571207|NCT02301975|532248806|FG001|Overall Study|Withdrawal by Subject|12|||
147571208|NCT02301975|532248807|FG002|Overall Study|Withdrawal by Subject|11|||
147571209|NCT04278560|532248809|FG000|Overall Study|Adverse Event|1|||
147571210|NCT04278560|532248810|FG001|Overall Study|Adverse Event|2|||
147571211|NCT04278560|532248809|FG000|Overall Study|Withdrawal by Subject|0|||
147571212|NCT04278560|532248810|FG001|Overall Study|Withdrawal by Subject|1|||
147571213|NCT00163657|532248811|FG000|Overall Study|Death|12|||
147571214|NCT00163657|532248812|FG001|Overall Study|Death|14|||
147571215|NCT00163657|532248813|FG002|Overall Study|Death|19|||
147571216|NCT00163657|532248811|FG000|Overall Study|graft loss|4|||
147571217|NCT00163657|532248812|FG001|Overall Study|graft loss|1|||
147571218|NCT00163657|532248813|FG002|Overall Study|graft loss|2|||
147571219|NCT00163657|532248811|FG000|Overall Study|Withdrawal by Subject|2|||
147571220|NCT00163657|532248812|FG001|Overall Study|Withdrawal by Subject|3|||
147571221|NCT00163657|532248813|FG002|Overall Study|Withdrawal by Subject|2|||
147571222|NCT00163657|532248811|FG000|Overall Study|Physician Decision|0|||
147571223|NCT00163657|532248812|FG001|Overall Study|Physician Decision|1|||
147571224|NCT00163657|532248813|FG002|Overall Study|Physician Decision|1|||
147571225|NCT00163657|532248811|FG000|Overall Study|Non Compliance|1|||
147571226|NCT00163657|532248812|FG001|Overall Study|Non Compliance|0|||
147571227|NCT00163657|532248813|FG002|Overall Study|Non Compliance|0|||
147571228|NCT00163657|532248811|FG000|Overall Study|Lost to Follow-up|1|||
147571229|NCT00163657|532248812|FG001|Overall Study|Lost to Follow-up|3|||
147571230|NCT00163657|532248813|FG002|Overall Study|Lost to Follow-up|10|||
147571231|NCT00163657|532248811|FG000|Overall Study|Other reason|0|||
147571232|NCT00163657|532248812|FG001|Overall Study|Other reason|1|||
147571233|NCT00163657|532248813|FG002|Overall Study|Other reason|3|||
147571234|NCT01319383|532248814|FG000|Overall Study|No ex vivo or in vivo response|4|||
147571235|NCT01319383|532248815|FG001|Overall Study|No ex vivo or in vivo response|0|||
147571236|NCT01319383|532248814|FG000|Overall Study|Physician Decision|3|||
147571237|NCT01319383|532248815|FG001|Overall Study|Physician Decision|0|||
147571238|NCT01319383|532248814|FG000|Overall Study|Lack of Efficacy|5|||
147571239|NCT01319383|532248815|FG001|Overall Study|Lack of Efficacy|9|||
147237156|NCT03082261|531038816|FG000|Overall Study|Insurance denial|1|||
147571240|NCT01319383|532248814|FG000|Overall Study|No in vivo response to interval doses|0|||
147571241|NCT01319383|532248815|FG001|Overall Study|No in vivo response to interval doses|1|||
147571242|NCT01531894|532248820|FG000|Overall Study|Physician Decision|8|||
147571243|NCT01531894|532248820|FG000|Overall Study|Death|1|||
147571244|NCT03086460|532248821|FG000|Study Participants|Lost to Follow-up|2|||
147571245|NCT03086460|532248821|FG000|Study Participants|Protocol Violation|1|||
147571246|NCT03086460|532248821|FG000|Study Participants|Withdrawal by Subject|6|||
147571247|NCT03086460|532248821|FG000|Treatment A|Lost to Follow-up|1|||
147571248|NCT03086460|532248821|FG000|Treatment A|Protocol Violation|1|||
147571249|NCT03086460|532248821|FG000|Treatment A|Withdrawal by Subject|2|||
147318289|NCT01734850|531331674|FG001|Overall Study|Continued to Week 48 but recommenced ART|2|||
147318290|NCT01734850|531331675|FG002|Overall Study|Continued to Week 48 but recommenced ART|3|||
147318291|NCT01734850|531331673|FG000|Overall Study|Not infused due to manufacturing failure|0|||
147318292|NCT01734850|531331674|FG001|Overall Study|Not infused due to manufacturing failure|0|||
147318293|NCT01734850|531331675|FG002|Overall Study|Not infused due to manufacturing failure|1|||
147318294|NCT00750893|531331676|FG000|Overall Study|Adverse Event|5|||
147318295|NCT00750893|531331676|FG000|Overall Study|Withdrawal by Subject|10|||
147318296|NCT00750893|531331676|FG000|Overall Study|Lost to Follow-up|510|||
147318297|NCT00750893|531331676|FG000|Overall Study|Other|17|||
147318298|NCT00661258|531331677|FG000|Overall Study|Death|1|||
147318299|NCT00661258|531331678|FG001|Overall Study|Death|0|||
147318300|NCT00661258|531331677|FG000|Overall Study|caught by police and in detox center|2|||
147318301|NCT00661258|531331678|FG001|Overall Study|caught by police and in detox center|1|||
147318302|NCT01083160|531331679|FG000|Overall Study|Adverse Event|1|||
147318303|NCT01951092|531331680|FG000|Overall Study|Lost to Follow-up|10|||
147318304|NCT01951092|531331680|FG000|Overall Study|Incarceration|1|||
147318305|NCT01951092|531331680|FG000|Overall Study|Transfer of Care|1|||
147318306|NCT01712789|531331681|FG000|Overall Study|Lack of Efficacy|2|||
147318307|NCT01712789|531331681|FG000|Overall Study|Lost to Follow-up|1|||
147318308|NCT01712789|531331681|FG000|Overall Study|Progressive Disease|504|||
147318309|NCT01712789|531331681|FG000|Overall Study|Death|57|||
147318310|NCT01712789|531331681|FG000|Overall Study|Adverse Event|52|||
147571250|NCT03086460|532248821|FG000|Treatment C|Withdrawal by Subject|2|||
147571251|NCT03086460|532248821|FG000|Treatment E|Lost to Follow-up|1|||
147571252|NCT03086460|532248821|FG000|Treatment E|Withdrawal by Subject|3|||
147571253|NCT03600805|532248830|FG000|Overall Study|Adverse Event|2|||
147571254|NCT03600805|532248831|FG001|Overall Study|Adverse Event|1|||
147571255|NCT03600805|532248832|FG002|Overall Study|Adverse Event|1|||
147571256|NCT03600805|532248833|FG003|Overall Study|Adverse Event|7|||
147571257|NCT03600805|532248830|FG000|Overall Study|Lack of Efficacy|2|||
147135056|NCT04661033|530662624|FG003|Overall Study|As per Principal Investigator (PI) decision|0|||
147135057|NCT04661033|530662621|FG000|Overall Study|Early discontinuation as per PI|1|||
147135058|NCT04661033|530662622|FG001|Overall Study|Early discontinuation as per PI|0|||
147135059|NCT04661033|530662623|FG002|Overall Study|Early discontinuation as per PI|0|||
147135060|NCT04661033|530662624|FG003|Overall Study|Early discontinuation as per PI|0|||
147135061|NCT03498716|530662633|FG000|Overall Study|Withdrawal by Subject|88|||
147135062|NCT03498716|530662634|FG001|Overall Study|Withdrawal by Subject|73|||
147135063|NCT03498716|530662633|FG000|Overall Study|Study Terminated By Sponsor|933|||
147135064|NCT03498716|530662634|FG001|Overall Study|Study Terminated By Sponsor|927|||
147135065|NCT03498716|530662633|FG000|Overall Study|Lost to Follow-up|15|||
147135066|NCT03498716|530662634|FG001|Overall Study|Lost to Follow-up|26|||
147135067|NCT03498716|530662633|FG000|Overall Study|Disease Relapse|0|||
147135068|NCT03498716|530662634|FG001|Overall Study|Disease Relapse|1|||
147135069|NCT03498716|530662633|FG000|Overall Study|Death|58|||
147135070|NCT03498716|530662634|FG001|Overall Study|Death|72|||
147135071|NCT03498716|530662633|FG000|Overall Study|Physician Decision|4|||
147571258|NCT03600805|532248831|FG001|Overall Study|Lack of Efficacy|1|||
147135072|NCT03498716|530662634|FG001|Overall Study|Physician Decision|2|||
147135073|NCT03139448|530662638|FG000|Overall Study|Lack of Efficacy|6|||
147135074|NCT03139448|530662639|FG001|Overall Study|Lack of Efficacy|7|||
147135075|NCT03139448|530662638|FG000|Overall Study|Location of procedure changed|2|||
147135076|NCT03139448|530662639|FG001|Overall Study|Location of procedure changed|8|||
147135077|NCT03139448|530662638|FG000|Overall Study|Withdrawal by Subject|3|||
147135078|NCT03139448|530662639|FG001|Overall Study|Withdrawal by Subject|6|||
147318311|NCT01712789|531331681|FG000|Overall Study|Miscellaneous|31|||
147318312|NCT01712789|531331681|FG000|Overall Study|Withdrawal by Subject|21|||
147318313|NCT01712789|531331681|FG000|Overall Study|Transition to Commercial Treatment|8|||
147318314|NCT01712789|531331681|FG000|Overall Study|Participants Did Not Receive Study Drug|6|||
147318315|NCT01708187|531331682|FG000|Overall Study|Lost to Follow-up|0|||
147318316|NCT01708187|531331683|FG001|Overall Study|Lost to Follow-up|1|||
147318317|NCT01152554|531331685|FG000|Overall Study|Withdrawal by Subject|73|||
147318318|NCT01152554|531331686|FG001|Overall Study|Withdrawal by Subject|28|||
147318319|NCT01152554|531331685|FG000|Overall Study|Eligiblity criteria not fulfilled|0|||
147318320|NCT01152554|531331686|FG001|Overall Study|Eligiblity criteria not fulfilled|1|||
147318321|NCT01152554|531331685|FG000|Overall Study|Adverse Event|67|||
147318322|NCT01152554|531331686|FG001|Overall Study|Adverse Event|14|||
147318323|NCT01152554|531331685|FG000|Overall Study|Severe non-compliance to protocol|36|||
147318324|NCT01152554|531331686|FG001|Overall Study|Severe non-compliance to protocol|14|||
147318325|NCT01152554|531331685|FG000|Overall Study|Condition under investigation worsened|5|||
147571259|NCT03600805|532248832|FG002|Overall Study|Lack of Efficacy|0|||
147318326|NCT01152554|531331686|FG001|Overall Study|Condition under investigation worsened|2|||
147318327|NCT01152554|531331685|FG000|Overall Study|Lack of Efficacy|20|||
147571260|NCT03600805|532248833|FG003|Overall Study|Lack of Efficacy|0|||
147135079|NCT03139448|530662638|FG000|Overall Study|Screen fail|1|||
147135080|NCT03139448|530662639|FG001|Overall Study|Screen fail|3|||
147135081|NCT03139448|530662638|FG000|Overall Study|Physician Decision|0|||
147135082|NCT03139448|530662639|FG001|Overall Study|Physician Decision|2|||
147135083|NCT01987557|530662640|FG000|Overall Study|Protocol Violation|1|||
147135084|NCT01987557|530662641|FG001|Overall Study|Protocol Violation|0|||
147135085|NCT01987557|530662642|FG002|Overall Study|Protocol Violation|1|||
147135086|NCT01987557|530662640|FG000|Overall Study|Withdrawal by Subject|2|||
147135087|NCT01987557|530662641|FG001|Overall Study|Withdrawal by Subject|1|||
147135088|NCT01987557|530662642|FG002|Overall Study|Withdrawal by Subject|2|||
147237157|NCT03082261|531038816|FG000|Overall Study|Peripheral lead added|1|||
147237158|NCT03082261|531038816|FG000|Overall Study|Withdrawal by Subject|40|||
147237159|NCT03082261|531038816|FG000|Overall Study|Subject did not meet screening inclusion/exclusion criteria|2|||
147237160|NCT03082261|531038816|FG000|Overall Study|Subject implanted with device other than study device|1|||
147135089|NCT01987557|530662640|FG000|Overall Study|Adverse Event|0|||
147237161|NCT03082261|531038816|FG000|Overall Study|Lost to Follow-up|14|||
147237162|NCT03082261|531038816|FG000|Overall Study|Subject moved to a different state|1|||
147237163|NCT03082261|531038816|FG000|Overall Study|Subject non-compliance|2|||
147135090|NCT01987557|530662641|FG001|Overall Study|Adverse Event|2|||
147135091|NCT01987557|530662642|FG002|Overall Study|Adverse Event|0|||
147135092|NCT01854528|530662648|FG000|Overall Study|Adverse Event|0|||
147135093|NCT01854528|530662649|FG001|Overall Study|Adverse Event|4|||
147135094|NCT01854528|530662648|FG000|Overall Study|Withdrawal by Subject|0|||
147135095|NCT01854528|530662649|FG001|Overall Study|Withdrawal by Subject|2|||
147135096|NCT01854528|530662648|FG000|Overall Study|Virologic Failure|0|||
147135097|NCT01854528|530662649|FG001|Overall Study|Virologic Failure|9|||
147135098|NCT00518180|530662650|FG000|Overall Study|Withdrawal by Subject|29|||
147135099|NCT00518180|530662651|FG001|Overall Study|Withdrawal by Subject|30|||
147135100|NCT00518180|530662652|FG002|Overall Study|Withdrawal by Subject|42|||
147135101|NCT00518180|530662650|FG000|Overall Study|Lost to Follow-up|30|||
147135102|NCT00518180|530662651|FG001|Overall Study|Lost to Follow-up|28|||
147135103|NCT00518180|530662652|FG002|Overall Study|Lost to Follow-up|34|||
147135104|NCT00518180|530662650|FG000|Overall Study|Administrative reason|0|||
147135105|NCT00518180|530662651|FG001|Overall Study|Administrative reason|2|||
147135106|NCT00518180|530662652|FG002|Overall Study|Administrative reason|2|||
147318328|NCT01152554|531331686|FG001|Overall Study|Lack of Efficacy|3|||
147318329|NCT01152554|531331685|FG000|Overall Study|Study-specific withdrawal criteria|17|||
147318330|NCT01152554|531331686|FG001|Overall Study|Study-specific withdrawal criteria|8|||
147318331|NCT01152554|531331685|FG000|Overall Study|Lost to Follow-up|87|||
147318332|NCT01152554|531331686|FG001|Overall Study|Lost to Follow-up|32|||
147318333|NCT01152554|531331685|FG000|Overall Study|Other|28|||
147318334|NCT01152554|531331686|FG001|Overall Study|Other|8|||
147318335|NCT01152554|531331685|FG000|Overall Study|Death|1|||
147318336|NCT01152554|531331686|FG001|Overall Study|Death|1|||
147318337|NCT02117544|531331687|FG000|Period 1|Lost to follow-up (prior to treatment)|2|||
147318338|NCT02117544|531331688|FG001|Period 1|Lost to follow-up (prior to treatment)|0|||
147318339|NCT03486899|531331689|FG000|Overall Study|Lost to Follow-up|4|||
147318340|NCT03486899|531331690|FG001|Overall Study|Lost to Follow-up|1|||
147318341|NCT03486899|531331691|FG002|Overall Study|Lost to Follow-up|4|||
147318342|NCT03486899|531331692|FG003|Overall Study|Lost to Follow-up|3|||
147318343|NCT03486899|531331689|FG000|Overall Study|Death|1|||
147318344|NCT03486899|531331690|FG001|Overall Study|Death|0|||
147318345|NCT03486899|531331691|FG002|Overall Study|Death|0|||
147318346|NCT03486899|531331692|FG003|Overall Study|Death|1|||
147318347|NCT03486899|531331689|FG000|Overall Study|Adverse Event|0|||
147318348|NCT03486899|531331690|FG001|Overall Study|Adverse Event|2|||
147318349|NCT03486899|531331691|FG002|Overall Study|Adverse Event|0|||
147318350|NCT03486899|531331692|FG003|Overall Study|Adverse Event|2|||
147318351|NCT03486899|531331689|FG000|Overall Study|Withdrawal by Subject|3|||
147318352|NCT03486899|531331690|FG001|Overall Study|Withdrawal by Subject|7|||
147318353|NCT03486899|531331691|FG002|Overall Study|Withdrawal by Subject|4|||
147318354|NCT03486899|531331692|FG003|Overall Study|Withdrawal by Subject|3|||
147318355|NCT03486899|531331689|FG000|Overall Study|Other Reasons|0|||
147318356|NCT03486899|531331690|FG001|Overall Study|Other Reasons|1|||
147237164|NCT03082261|531038816|FG000|Overall Study|Subject participation terminated by investigator|9|||
147237165|NCT03082261|531038816|FG000|Overall Study|Subject participation terminated by sponsor|4|||
147237166|NCT03082261|531038816|FG000|Overall Study|System explant|19|||
147318357|NCT03486899|531331691|FG002|Overall Study|Other Reasons|0|||
147135107|NCT00518180|530662650|FG000|Overall Study|Protocol Violation|5|||
147135108|NCT00518180|530662651|FG001|Overall Study|Protocol Violation|7|||
147237167|NCT03082261|531038816|FG000|Overall Study|Unable to place lead(s)|2|||
147318358|NCT03486899|531331692|FG003|Overall Study|Other Reasons|1|||
147318359|NCT01439711|531331693|FG000|Overall Study|Ineligible|13|||
147318360|NCT01439711|531331693|FG000|Overall Study|Cancel|3|||
147318361|NCT01439711|531331693|FG000|Overall Study|Progression Prior to Beginning Tx|1|||
147318362|NCT01439711|531331693|FG000|Overall Study|Adverse Event|5|||
147318363|NCT01439711|531331693|FG000|Overall Study|Withdrawal by Subject|3|||
147318364|NCT01439711|531331693|FG000|Overall Study|Progression During Active Tx|3|||
147318365|NCT01439711|531331693|FG000|Overall Study|Noncompliance|3|||
147135109|NCT00518180|530662652|FG002|Overall Study|Protocol Violation|4|||
147135110|NCT00518180|530662650|FG000|Overall Study|Unable to classify|0|||
147135111|NCT00518180|530662651|FG001|Overall Study|Unable to classify|2|||
147135112|NCT00518180|530662652|FG002|Overall Study|Unable to classify|0|||
147135113|NCT00518180|530662650|FG000|Overall Study|Adverse Event|1|||
147135114|NCT00518180|530662651|FG001|Overall Study|Adverse Event|0|||
147135115|NCT00518180|530662652|FG002|Overall Study|Adverse Event|0|||
147135116|NCT04881760|530662659|FG000|Overall Study|Adverse Event|0|||
147135117|NCT04881760|530662660|FG001|Overall Study|Adverse Event|1|||
147135118|NCT04881760|530662661|FG002|Overall Study|Adverse Event|1|||
147135119|NCT04881760|530662662|FG003|Overall Study|Adverse Event|0|||
147135120|NCT04881760|530662663|FG004|Overall Study|Adverse Event|1|||
147135121|NCT04881760|530662664|FG005|Overall Study|Adverse Event|1|||
147135122|NCT04881760|530662665|FG006|Overall Study|Adverse Event|2|||
147135123|NCT04881760|530662659|FG000|Overall Study|Death|0|||
147135124|NCT04881760|530662660|FG001|Overall Study|Death|0|||
147135125|NCT04881760|530662661|FG002|Overall Study|Death|0|||
147135126|NCT04881760|530662662|FG003|Overall Study|Death|1|||
147135127|NCT04881760|530662663|FG004|Overall Study|Death|0|||
147135128|NCT04881760|530662664|FG005|Overall Study|Death|0|||
147135129|NCT04881760|530662665|FG006|Overall Study|Death|0|||
147135130|NCT04881760|530662659|FG000|Overall Study|Lost to Follow-up|5|||
147135131|NCT04881760|530662660|FG001|Overall Study|Lost to Follow-up|7|||
147135132|NCT04881760|530662661|FG002|Overall Study|Lost to Follow-up|5|||
147135133|NCT04881760|530662662|FG003|Overall Study|Lost to Follow-up|1|||
147135134|NCT04881760|530662663|FG004|Overall Study|Lost to Follow-up|2|||
147135135|NCT04881760|530662664|FG005|Overall Study|Lost to Follow-up|4|||
147135136|NCT04881760|530662665|FG006|Overall Study|Lost to Follow-up|4|||
147135137|NCT04881760|530662659|FG000|Overall Study|Withdrawal by Subject|13|||
147135138|NCT04881760|530662660|FG001|Overall Study|Withdrawal by Subject|1|||
147135139|NCT04881760|530662661|FG002|Overall Study|Withdrawal by Subject|1|||
147135140|NCT04881760|530662662|FG003|Overall Study|Withdrawal by Subject|4|||
147135141|NCT04881760|530662663|FG004|Overall Study|Withdrawal by Subject|2|||
147135142|NCT04881760|530662664|FG005|Overall Study|Withdrawal by Subject|1|||
147135143|NCT04881760|530662665|FG006|Overall Study|Withdrawal by Subject|2|||
147135144|NCT04881760|530662659|FG000|Overall Study|Randomized but Never Treated|0|||
147135145|NCT04881760|530662660|FG001|Overall Study|Randomized but Never Treated|0|||
147135146|NCT04881760|530662661|FG002|Overall Study|Randomized but Never Treated|0|||
147135147|NCT04881760|530662662|FG003|Overall Study|Randomized but Never Treated|1|||
147135148|NCT04881760|530662663|FG004|Overall Study|Randomized but Never Treated|0|||
147135149|NCT04881760|530662664|FG005|Overall Study|Randomized but Never Treated|0|||
147135150|NCT04881760|530662665|FG006|Overall Study|Randomized but Never Treated|0|||
147135151|NCT04881760|530662659|FG000|Overall Study|Inadvertent Enrollment|2|||
147135152|NCT04881760|530662660|FG001|Overall Study|Inadvertent Enrollment|0|||
147135153|NCT04881760|530662661|FG002|Overall Study|Inadvertent Enrollment|0|||
147135154|NCT04881760|530662662|FG003|Overall Study|Inadvertent Enrollment|0|||
147135155|NCT04881760|530662663|FG004|Overall Study|Inadvertent Enrollment|0|||
147135156|NCT04881760|530662664|FG005|Overall Study|Inadvertent Enrollment|0|||
147135157|NCT04881760|530662665|FG006|Overall Study|Inadvertent Enrollment|0|||
147135158|NCT04881760|530662659|FG000|Overall Study|Site Closure|0|||
147135159|NCT04881760|530662660|FG001|Overall Study|Site Closure|0|||
147135160|NCT04881760|530662661|FG002|Overall Study|Site Closure|0|||
147135161|NCT04881760|530662662|FG003|Overall Study|Site Closure|1|||
147135162|NCT04881760|530662663|FG004|Overall Study|Site Closure|0|||
147135163|NCT04881760|530662664|FG005|Overall Study|Site Closure|0|||
147135164|NCT04881760|530662665|FG006|Overall Study|Site Closure|0|||
147135165|NCT00636181|530662668|FG000|Overall Study|Withdrawal by Subject|8|||
147135166|NCT00636181|530662669|FG001|Overall Study|Withdrawal by Subject|6|||
147135167|NCT00636181|530662670|FG002|Overall Study|Withdrawal by Subject|10|||
147135168|NCT04549454|530662678|FG000|T1 to T2|Lost to Follow-up|22|||
147135169|NCT04549454|530662679|FG001|T1 to T2|Lost to Follow-up|26|||
147135170|NCT04549454|530662678|FG000|T1 to T3|Lost to Follow-up|31|||
147135171|NCT04549454|530662679|FG001|T1 to T3|Lost to Follow-up|36|||
147135172|NCT05076045|530662681|FG000|Washout (1 Week)|Withdrawal by Subject|1|||
147135173|NCT05076045|530662682|FG001|Washout (1 Week)|Withdrawal by Subject|3|||
147135174|NCT02561962|530662687|FG000|Overall Study|Withdrawal by Subject|1|||
147135175|NCT02561962|530662688|FG001|Overall Study|Withdrawal by Subject|0|||
147135176|NCT02561962|530662689|FG002|Overall Study|Withdrawal by Subject|0|||
147135177|NCT02561962|530662690|FG003|Overall Study|Withdrawal by Subject|0|||
147135178|NCT02561962|530662691|FG004|Overall Study|Withdrawal by Subject|1|||
147135179|NCT02561962|530662692|FG005|Overall Study|Withdrawal by Subject|1|||
147135180|NCT02561962|530662693|FG006|Overall Study|Withdrawal by Subject|2|||
147135181|NCT02561962|530662694|FG007|Overall Study|Withdrawal by Subject|1|||
147135182|NCT02561962|530662695|FG008|Overall Study|Withdrawal by Subject|0|||
147135183|NCT02561962|530662687|FG000|Overall Study|Decision by sponsor|0|||
147135184|NCT02561962|530662688|FG001|Overall Study|Decision by sponsor|0|||
147135185|NCT02561962|530662689|FG002|Overall Study|Decision by sponsor|0|||
147135186|NCT02561962|530662690|FG003|Overall Study|Decision by sponsor|0|||
147135187|NCT02561962|530662691|FG004|Overall Study|Decision by sponsor|1|||
147135188|NCT02561962|530662692|FG005|Overall Study|Decision by sponsor|1|||
147135189|NCT02561962|530662693|FG006|Overall Study|Decision by sponsor|0|||
147135190|NCT02561962|530662694|FG007|Overall Study|Decision by sponsor|3|||
147135191|NCT02561962|530662695|FG008|Overall Study|Decision by sponsor|0|||
147135192|NCT02561962|530662687|FG000|Overall Study|Lost to Follow-up|0|||
147135193|NCT02561962|530662688|FG001|Overall Study|Lost to Follow-up|0|||
147135194|NCT02561962|530662689|FG002|Overall Study|Lost to Follow-up|0|||
147135195|NCT02561962|530662690|FG003|Overall Study|Lost to Follow-up|0|||
147135196|NCT02561962|530662691|FG004|Overall Study|Lost to Follow-up|0|||
147135197|NCT02561962|530662692|FG005|Overall Study|Lost to Follow-up|1|||
147135198|NCT02561962|530662693|FG006|Overall Study|Lost to Follow-up|0|||
147135199|NCT02561962|530662694|FG007|Overall Study|Lost to Follow-up|0|||
147135200|NCT02561962|530662695|FG008|Overall Study|Lost to Follow-up|0|||
147237168|NCT03082261|531038816|FG000|Overall Study|Unsuccessful trial evaluation period|19|||
147237169|NCT01032174|531038819|FG000|Overall Study|Adverse Event|0|||
147237170|NCT01032174|531038820|FG001|Overall Study|Adverse Event|1|||
147237171|NCT01281137|531038821|FG000|Baseline Population|No samples assayed (excluded from all analyses)|0|||
147237172|NCT01281137|531038822|FG001|Baseline Population|No samples assayed (excluded from all analyses)|1|||
147237173|NCT01281137|531038821|FG000|Analysis Population (Baseline)|baseline sample only so excluded from longitudinal analysis|4|||
147237174|NCT01281137|531038822|FG001|Analysis Population (Baseline)|baseline sample only so excluded from longitudinal analysis|9|||
147237175|NCT01281137|531038821|FG000|Analysis Population (9 Months)|5 from the baseline analysis population did not have samples assayed for the analysis at month 9.|0|||
147237176|NCT01281137|531038822|FG001|Analysis Population (9 Months)|5 from the baseline analysis population did not have samples assayed for the analysis at month 9.|5|||
147237177|NCT01281137|531038821|FG000|Analysis Population (10.5 Months)|1 from the baseline analysis population did not have a sample assayed for analysis at month 10.5|1|||
147237178|NCT01281137|531038822|FG001|Analysis Population (10.5 Months)|1 from the baseline analysis population did not have a sample assayed for analysis at month 10.5|0|||
147237179|NCT01281137|531038821|FG000|Analysis Population (12 Months)|3 from the baseline analysis population did not have a sample assayed for analysis at month 12|1|||
147237180|NCT01281137|531038822|FG001|Analysis Population (12 Months)|3 from the baseline analysis population did not have a sample assayed for analysis at month 12|2|||
147237181|NCT01313312|531038826|FG000|Overall Study|Adverse Event|5|||
147237182|NCT01313312|531038826|FG000|Overall Study|Withdrawal by Subject|18|||
147237183|NCT01313312|531038826|FG000|Overall Study|Lack of Efficacy|3|||
147237184|NCT01313312|531038826|FG000|Overall Study|Investigator Decision|1|||
147237185|NCT01313312|531038826|FG000|Overall Study|Observational Phase|1|||
147237186|NCT01313312|531038826|FG000|Overall Study|Subject Withdrawn Early in Error|4|||
147237187|NCT01313312|531038826|FG000|Overall Study|Did Not Receive Treatment with Dysport®|4|||
147237188|NCT04295772|531038827|FG000|Overall Study|Protocol Violation|1|||
147237189|NCT04295772|531038828|FG001|Overall Study|Protocol Violation|0|||
147237190|NCT04295772|531038827|FG000|Overall Study|Ongoing for safety monitoring|14|||
147237191|NCT04295772|531038828|FG001|Overall Study|Ongoing for safety monitoring|1|||
147237192|NCT04295772|531038827|FG000|Overall Study|Excluded from results due to informed consent issue|2|||
147237193|NCT04295772|531038828|FG001|Overall Study|Excluded from results due to informed consent issue|0|||
147237194|NCT02846324|531038829|FG000|Overall Study|Other|1|||
147237195|NCT02846324|531038830|FG001|Overall Study|Other|0|||
147237196|NCT02846324|531038831|FG002|Overall Study|Other|0|||
147237197|NCT02846324|531038832|FG003|Overall Study|Other|0|||
147237198|NCT02846324|531038829|FG000|Overall Study|Withdrawal by Subject|1|||
147237199|NCT02846324|531038830|FG001|Overall Study|Withdrawal by Subject|0|||
147237200|NCT02846324|531038831|FG002|Overall Study|Withdrawal by Subject|4|||
147237201|NCT02846324|531038832|FG003|Overall Study|Withdrawal by Subject|0|||
147237202|NCT00932126|531038836|FG000|Overall Study|Adverse Event|0|||
147237203|NCT00932126|531038837|FG001|Overall Study|Adverse Event|0|||
147237204|NCT00932126|531038838|FG002|Overall Study|Adverse Event|0|||
147237205|NCT00932126|531038839|FG003|Overall Study|Adverse Event|0|||
147237206|NCT00932126|531038840|FG004|Overall Study|Adverse Event|0|||
147237207|NCT00932126|531038841|FG005|Overall Study|Adverse Event|0|||
147237208|NCT00932126|531038842|FG006|Overall Study|Adverse Event|1|||
147237209|NCT00932126|531038843|FG007|Overall Study|Adverse Event|2|||
147237210|NCT00932126|531038836|FG000|Overall Study|Protocol Violation|0|||
147237211|NCT00932126|531038837|FG001|Overall Study|Protocol Violation|0|||
147237212|NCT00932126|531038838|FG002|Overall Study|Protocol Violation|0|||
147237213|NCT00932126|531038839|FG003|Overall Study|Protocol Violation|0|||
147237214|NCT00932126|531038840|FG004|Overall Study|Protocol Violation|1|||
147237215|NCT00932126|531038841|FG005|Overall Study|Protocol Violation|0|||
147237216|NCT00932126|531038842|FG006|Overall Study|Protocol Violation|0|||
147237217|NCT00932126|531038843|FG007|Overall Study|Protocol Violation|0|||
147237218|NCT00932126|531038836|FG000|Overall Study|Withdrawal by Subject|0|||
147237219|NCT00932126|531038837|FG001|Overall Study|Withdrawal by Subject|0|||
147237220|NCT00932126|531038838|FG002|Overall Study|Withdrawal by Subject|1|||
147237221|NCT00932126|531038839|FG003|Overall Study|Withdrawal by Subject|0|||
147237222|NCT00932126|531038840|FG004|Overall Study|Withdrawal by Subject|0|||
147237223|NCT00932126|531038841|FG005|Overall Study|Withdrawal by Subject|0|||
147237224|NCT00932126|531038842|FG006|Overall Study|Withdrawal by Subject|0|||
147237225|NCT00932126|531038843|FG007|Overall Study|Withdrawal by Subject|1|||
147237226|NCT00932126|531038836|FG000|Overall Study|Objective progression or relapse|3|||
147318366|NCT01439711|531331693|FG000|Overall Study|No MRI|9|||
147135201|NCT02735421|530664325|FG000|Part A (Randomized): up to 24 Weeks|Adverse Event|2|||
147135202|NCT02735421|530664325|FG000|Part A (Randomized): up to 24 Weeks|Withdrawal by Subject|6|||
147135203|NCT02735421|530664325|FG000|Part A (Randomized): up to 24 Weeks|Lost to Follow-up|3|||
147135204|NCT02735421|530664325|FG000|Part A (Randomized): up to 24 Weeks|Inadequate compliance to treatment|1|||
147651585|NCT00603382|532546549|FG003|Overall Study|Physician Decision|0|||
147651586|NCT00603382|532546550|FG004|Overall Study|Physician Decision|1|||
147651587|NCT00603382|532546551|FG005|Overall Study|Physician Decision|3|||
147651588|NCT00603382|532546546|FG000|Overall Study|Withdrawal by Subject|3|||
147651589|NCT00603382|532546547|FG001|Overall Study|Withdrawal by Subject|3|||
147651590|NCT00603382|532546548|FG002|Overall Study|Withdrawal by Subject|1|||
147651591|NCT00603382|532546549|FG003|Overall Study|Withdrawal by Subject|1|||
147651592|NCT00603382|532546550|FG004|Overall Study|Withdrawal by Subject|0|||
147651593|NCT00603382|532546551|FG005|Overall Study|Withdrawal by Subject|1|||
147651594|NCT00583102|532546552|FG000|Overall Study|Adverse Event|3|||
147651595|NCT01180049|532546557|FG000|Overall Study|Other|9|||
147651596|NCT01180049|532546558|FG001|Overall Study|Other|7|||
147651597|NCT01180049|532546557|FG000|Overall Study|Lost to Follow-up|8|||
147651598|NCT01180049|532546558|FG001|Overall Study|Lost to Follow-up|6|||
147651599|NCT01180049|532546557|FG000|Overall Study|Death|36|||
147135205|NCT02735421|530664325|FG000|Part A (Randomized): up to 24 Weeks|Pregnancy|1|||
147135206|NCT02735421|530664325|FG000|Part 2 (Open Label): up to 48 Weeks|Withdrawal by Subject|1|||
147135207|NCT02735421|530664325|FG000|Part 2 (Open Label): up to 48 Weeks|Lost to Follow-up|3|||
147135208|NCT01492426|530664326|FG000|Treatment|Death|0|||
147135209|NCT01492426|530664327|FG001|Treatment|Death|1|||
147135210|NCT01492426|530664326|FG000|Treatment|Other|1|||
147135211|NCT01492426|530664327|FG001|Treatment|Other|0|||
147135212|NCT01492426|530664326|FG000|Treatment|Adverse Event|25|||
147237227|NCT00932126|531038837|FG001|Overall Study|Objective progression or relapse|3|||
147237228|NCT00932126|531038838|FG002|Overall Study|Objective progression or relapse|2|||
147237229|NCT00932126|531038839|FG003|Overall Study|Objective progression or relapse|3|||
147237230|NCT00932126|531038840|FG004|Overall Study|Objective progression or relapse|3|||
147237231|NCT00932126|531038841|FG005|Overall Study|Objective progression or relapse|3|||
147237232|NCT00932126|531038842|FG006|Overall Study|Objective progression or relapse|3|||
147237233|NCT00932126|531038843|FG007|Overall Study|Objective progression or relapse|5|||
147237234|NCT00932126|531038836|FG000|Overall Study|Other|0|||
147237235|NCT00932126|531038837|FG001|Overall Study|Other|0|||
147237236|NCT00932126|531038838|FG002|Overall Study|Other|0|||
147237237|NCT00932126|531038839|FG003|Overall Study|Other|0|||
147237238|NCT00932126|531038840|FG004|Overall Study|Other|1|||
147237239|NCT00932126|531038841|FG005|Overall Study|Other|0|||
147237240|NCT00932126|531038842|FG006|Overall Study|Other|1|||
147237241|NCT00932126|531038843|FG007|Overall Study|Other|2|||
147237242|NCT02716805|531038844|FG000|Overall Study|Progressive disease|2|||
147237243|NCT02716805|531038845|FG001|Overall Study|Progressive disease|0|||
147237244|NCT02716805|531038846|FG002|Overall Study|Progressive disease|0|||
147237245|NCT02716805|531038847|FG003|Overall Study|Progressive disease|0|||
147237246|NCT00066365|531038848|FG000|Overall Study|Adverse Event|1|||
147237247|NCT00066365|531038849|FG001|Overall Study|Adverse Event|0|||
147237248|NCT00066365|531038848|FG000|Overall Study|Lack of Efficacy|15|||
147237249|NCT00066365|531038849|FG001|Overall Study|Lack of Efficacy|12|||
147237250|NCT00066365|531038848|FG000|Overall Study|Physician Decision|1|||
147237251|NCT00066365|531038849|FG001|Overall Study|Physician Decision|0|||
147237252|NCT00066365|531038848|FG000|Overall Study|No viable tumor after 1 cycle of therapy|2|||
147237253|NCT00066365|531038849|FG001|Overall Study|No viable tumor after 1 cycle of therapy|0|||
147237254|NCT00066365|531038848|FG000|Overall Study|Ineligible|4|||
147237255|NCT00066365|531038849|FG001|Overall Study|Ineligible|2|||
147237256|NCT00467857|531038852|FG000|Overall Study|Adverse Event|1|||
147237257|NCT00467857|531038853|FG001|Overall Study|Adverse Event|0|||
147237258|NCT00467857|531038852|FG000|Overall Study|Withdrew consent|2|||
147237259|NCT00467857|531038853|FG001|Overall Study|Withdrew consent|0|||
147237260|NCT00467857|531038852|FG000|Overall Study|Death|0|||
147237261|NCT00467857|531038853|FG001|Overall Study|Death|1|||
147237262|NCT00467857|531038852|FG000|Overall Study|Discharged from court service|0|||
147237263|NCT00467857|531038853|FG001|Overall Study|Discharged from court service|1|||
147237264|NCT00467857|531038852|FG000|Overall Study|Emergency care required|0|||
147237265|NCT00467857|531038853|FG001|Overall Study|Emergency care required|1|||
147237266|NCT00467857|531038852|FG000|Overall Study|Did not meet inclusion/exclusion criteri|0|||
147237267|NCT00467857|531038853|FG001|Overall Study|Did not meet inclusion/exclusion criteri|2|||
147237268|NCT00467857|531038852|FG000|Overall Study|Discontinuation reason missing|0|||
147237269|NCT00467857|531038853|FG001|Overall Study|Discontinuation reason missing|3|||
147237270|NCT03576495|531038855|FG000|Period 1 (0 Months)|Lost to Follow-up|51|||
147237271|NCT03576495|531038856|FG001|Period 1 (0 Months)|Lost to Follow-up|40|||
147651600|NCT01180049|532546558|FG001|Overall Study|Death|35|||
147651601|NCT01738191|532546559|FG000|Overall Study|Withdrawal by Subject|4|||
147651602|NCT01738191|532546560|FG001|Overall Study|Withdrawal by Subject|1|||
147135213|NCT01492426|530664327|FG001|Treatment|Adverse Event|25|||
147237272|NCT04203797|531038858|FG000|Overall Study|Adverse Event|1|||
147237273|NCT04203797|531038859|FG001|Overall Study|Adverse Event|0|||
147651603|NCT02483572|532546561|FG000|Overall Study|Withdrawal by Subject|1|||
147651604|NCT02483572|532546562|FG001|Overall Study|Withdrawal by Subject|0|||
147651605|NCT02483572|532546561|FG000|Overall Study|Lost to Follow-up|1|||
147651606|NCT02483572|532546562|FG001|Overall Study|Lost to Follow-up|0|||
147651607|NCT02483572|532546561|FG000|Overall Study|Physician Decision|0|||
147651608|NCT02483572|532546562|FG001|Overall Study|Physician Decision|1|||
147651609|NCT00350779|532546563|FG000|Overall Study|Adverse Event|4|||
147651610|NCT00350779|532546564|FG001|Overall Study|Adverse Event|2|||
147651611|NCT00350779|532546563|FG000|Overall Study|Lack of Efficacy|0|||
147651612|NCT00350779|532546564|FG001|Overall Study|Lack of Efficacy|4|||
147651613|NCT00350779|532546563|FG000|Overall Study|Lost to Follow-up|2|||
147651614|NCT00350779|532546564|FG001|Overall Study|Lost to Follow-up|0|||
147651615|NCT00350779|532546563|FG000|Overall Study|Physician Decision|2|||
147651616|NCT00350779|532546564|FG001|Overall Study|Physician Decision|4|||
147651617|NCT00350779|532546563|FG000|Overall Study|Protocol Violation|3|||
147135214|NCT01492426|530664326|FG000|Treatment|Lack of Efficacy|38|||
147135215|NCT01492426|530664327|FG001|Treatment|Lack of Efficacy|5|||
147135216|NCT01492426|530664326|FG000|Treatment|Participant withdrew consent|1|||
147135217|NCT01492426|530664327|FG001|Treatment|Participant withdrew consent|2|||
147135218|NCT01492426|530664326|FG000|Treatment|Poor compliance/noncompliance|1|||
147135219|NCT01492426|530664327|FG001|Treatment|Poor compliance/noncompliance|0|||
147135220|NCT01492426|530664326|FG000|Treatment|Subject requested discontinue study drug|7|||
147135221|NCT01492426|530664327|FG001|Treatment|Subject requested discontinue study drug|3|||
147135222|NCT01492426|530664326|FG000|Treatment|Lost to Follow-up|9|||
147135223|NCT01492426|530664327|FG001|Treatment|Lost to Follow-up|4|||
147135224|NCT01492426|530664326|FG000|Treatment|Participant does not meet study criteria|1|||
147135225|NCT01492426|530664327|FG001|Treatment|Participant does not meet study criteria|0|||
147135226|NCT01492426|530664326|FG000|Follow-Up|Protocol Requires no Follow-Up|2|||
147135227|NCT01492426|530664327|FG001|Follow-Up|Protocol Requires no Follow-Up|1|||
147135228|NCT01492426|530664326|FG000|Follow-Up|Death|1|||
147135229|NCT01492426|530664327|FG001|Follow-Up|Death|0|||
147135230|NCT01492426|530664326|FG000|Follow-Up|Other|4|||
147135231|NCT01492426|530664327|FG001|Follow-Up|Other|2|||
147135232|NCT01492426|530664326|FG000|Follow-Up|Participant Withdrew Consent|6|||
147135233|NCT01492426|530664327|FG001|Follow-Up|Participant Withdrew Consent|1|||
147135234|NCT01492426|530664326|FG000|Follow-Up|Lost to Follow-up|12|||
147135235|NCT01492426|530664327|FG001|Follow-Up|Lost to Follow-up|6|||
147135236|NCT03549338|530664328|FG000|Overall Study|Progressive Disease|1|||
147135237|NCT03549338|530664329|FG001|Overall Study|Progressive Disease|0|||
147135238|NCT03549338|530664330|FG002|Overall Study|Progressive Disease|0|||
147135239|NCT03549338|530664328|FG000|Overall Study|Clinical Progression|0|||
147135240|NCT03549338|530664329|FG001|Overall Study|Clinical Progression|1|||
147135241|NCT03549338|530664330|FG002|Overall Study|Clinical Progression|0|||
147135242|NCT00269113|530664331|FG000|Overall Study|Adverse Event|14|||
147135243|NCT00269113|530664332|FG001|Overall Study|Adverse Event|7|||
147135244|NCT00269113|530664331|FG000|Overall Study|Lack of Efficacy|35|||
147135245|NCT00269113|530664332|FG001|Overall Study|Lack of Efficacy|18|||
147135246|NCT00269113|530664331|FG000|Overall Study|Early Improvement|2|||
147135247|NCT00269113|530664332|FG001|Overall Study|Early Improvement|0|||
147135248|NCT00269113|530664331|FG000|Overall Study|Withdrawal by Subject|0|||
147135249|NCT00269113|530664332|FG001|Overall Study|Withdrawal by Subject|2|||
147135250|NCT00269113|530664331|FG000|Overall Study|Death|6|||
147135251|NCT00269113|530664332|FG001|Overall Study|Death|2|||
147135252|NCT00269113|530664331|FG000|Overall Study|Lost to Follow-up|2|||
147135253|NCT00269113|530664332|FG001|Overall Study|Lost to Follow-up|1|||
147135254|NCT00269113|530664331|FG000|Overall Study|Protocol Violation|15|||
147135255|NCT00269113|530664332|FG001|Overall Study|Protocol Violation|5|||
147135256|NCT00269113|530664331|FG000|Overall Study|Other|0|||
147135257|NCT00269113|530664332|FG001|Overall Study|Other|2|||
147135258|NCT01173679|530664333|FG000|Overall Study|Death|1|||
147135259|NCT02026011|530664334|FG000|Allocation 1 (First Set of Medication)|Side Effects|6|||
147135260|NCT02026011|530664335|FG001|Allocation 1 (First Set of Medication)|Side Effects|0|||
147445442|NCT00705783|531795844|FG001|Depot Maintenance Phase|Protocol Deviation|2|||
147135261|NCT02026011|530664334|FG000|Allocation 1 (First Set of Medication)|Withdrawal by Subject|1|||
147135262|NCT02026011|530664335|FG001|Allocation 1 (First Set of Medication)|Withdrawal by Subject|2|||
147135263|NCT02026011|530664334|FG000|Allocation 1 (First Set of Medication)|Investigator Withdrawal|1|||
147135264|NCT02026011|530664335|FG001|Allocation 1 (First Set of Medication)|Investigator Withdrawal|0|||
147445443|NCT00705783|531795845|FG002|Depot Maintenance Phase|Protocol Deviation|0|||
147651618|NCT00350779|532546564|FG001|Overall Study|Protocol Violation|1|||
147651619|NCT00350779|532546563|FG000|Overall Study|Withdrawal by Subject|9|||
147651620|NCT00350779|532546564|FG001|Overall Study|Withdrawal by Subject|8|||
147135265|NCT02026011|530664334|FG000|Allocation 2 (Second Set of Medication)|Withdrawal by Subject|1|||
147135266|NCT02026011|530664335|FG001|Allocation 2 (Second Set of Medication)|Withdrawal by Subject|2|||
147135267|NCT05010070|530664336|FG000|Overall Study|Lost to Follow-up|1|||
147318367|NCT02408549|531331694|FG000|Overall Study|Adverse Event|15|||
147318368|NCT02408549|531331694|FG000|Overall Study|Death|4|||
147651621|NCT00350779|532546563|FG000|Overall Study|Patient Moved|2|||
147135268|NCT05010070|530664336|FG000|Overall Study|Withdrawal by Subject|1|||
147135269|NCT00939107|530664337|FG000|Overall Study|Lost to Follow-up|14|||
147135270|NCT00939107|530664338|FG001|Overall Study|Lost to Follow-up|12|||
147135271|NCT00529243|530664339|FG000|Overall Study|Adverse Event|1|||
147135272|NCT00529243|530664339|FG000|Overall Study|Death|1|||
147135273|NCT00529243|530664339|FG000|Overall Study|Relocated|1|||
147135274|NCT00639457|530664340|FG000|Overall Study|Withdrawal by Subject|2|||
147135275|NCT00639457|530664341|FG001|Overall Study|Withdrawal by Subject|3|||
147135276|NCT03235050|530664342|FG000|Overall Study|Adverse Event|0|||
147135277|NCT03235050|530664343|FG001|Overall Study|Adverse Event|0|||
147135278|NCT03235050|530664344|FG002|Overall Study|Adverse Event|1|||
147135279|NCT03235050|530664345|FG003|Overall Study|Adverse Event|4|||
147135280|NCT03235050|530664346|FG004|Overall Study|Adverse Event|1|||
147135281|NCT03235050|530664342|FG000|Overall Study|Death|0|||
147135282|NCT03235050|530664343|FG001|Overall Study|Death|0|||
147135283|NCT03235050|530664344|FG002|Overall Study|Death|0|||
147135284|NCT03235050|530664345|FG003|Overall Study|Death|2|||
147135285|NCT03235050|530664346|FG004|Overall Study|Death|1|||
147135286|NCT03235050|530664342|FG000|Overall Study|Lost to Follow-up|1|||
147135287|NCT03235050|530664343|FG001|Overall Study|Lost to Follow-up|2|||
147135288|NCT03235050|530664344|FG002|Overall Study|Lost to Follow-up|1|||
147135289|NCT03235050|530664345|FG003|Overall Study|Lost to Follow-up|2|||
147135290|NCT03235050|530664346|FG004|Overall Study|Lost to Follow-up|0|||
147135291|NCT03235050|530664342|FG000|Overall Study|Withdrawal by Subject|3|||
147135292|NCT03235050|530664343|FG001|Overall Study|Withdrawal by Subject|2|||
147135293|NCT03235050|530664344|FG002|Overall Study|Withdrawal by Subject|2|||
147135294|NCT03235050|530664345|FG003|Overall Study|Withdrawal by Subject|5|||
147135295|NCT03235050|530664346|FG004|Overall Study|Withdrawal by Subject|7|||
147135296|NCT03235050|530664342|FG000|Overall Study|Other reasons|0|||
147135297|NCT03235050|530664343|FG001|Overall Study|Other reasons|1|||
147135298|NCT03235050|530664344|FG002|Overall Study|Other reasons|0|||
147135299|NCT03235050|530664345|FG003|Overall Study|Other reasons|1|||
147135300|NCT03235050|530664346|FG004|Overall Study|Other reasons|2|||
147135301|NCT00105534|530664350|FG000|Overall Study|Adverse Event|2|||
147135302|NCT00105534|530664351|FG001|Overall Study|Adverse Event|5|||
147135303|NCT00105534|530664350|FG000|Overall Study|Protocol Violation|1|||
147135304|NCT00105534|530664351|FG001|Overall Study|Protocol Violation|4|||
147135305|NCT00105534|530664350|FG000|Overall Study|Withdrawal by Subject|6|||
147135306|NCT00105534|530664351|FG001|Overall Study|Withdrawal by Subject|6|||
147135307|NCT00105534|530664350|FG000|Overall Study|Lost to Follow-up|5|||
147135308|NCT00105534|530664351|FG001|Overall Study|Lost to Follow-up|1|||
147135309|NCT00105534|530664350|FG000|Overall Study|Lack of Efficacy|7|||
147135310|NCT00105534|530664351|FG001|Overall Study|Lack of Efficacy|15|||
147135311|NCT00105534|530664350|FG000|Overall Study|Treatment unmasked|1|||
147135312|NCT00105534|530664351|FG001|Overall Study|Treatment unmasked|0|||
147135313|NCT00105534|530664350|FG000|Overall Study|Other Reason|0|||
147135314|NCT00105534|530664351|FG001|Overall Study|Other Reason|2|||
147135315|NCT02935192|530664352|FG000|Overall Study|Withdrawal by Subject|8|||
147135316|NCT02935192|530664353|FG001|Overall Study|Withdrawal by Subject|4|||
147571261|NCT03600805|532248830|FG000|Overall Study|Withdrawal by Subject|1|||
147571262|NCT03600805|532248831|FG001|Overall Study|Withdrawal by Subject|0|||
147571263|NCT03600805|532248832|FG002|Overall Study|Withdrawal by Subject|0|||
147571264|NCT03600805|532248833|FG003|Overall Study|Withdrawal by Subject|1|||
147571265|NCT03600805|532248830|FG000|Overall Study|Other unspecified|14|||
147571266|NCT03600805|532248831|FG001|Overall Study|Other unspecified|6|||
147571267|NCT03600805|532248832|FG002|Overall Study|Other unspecified|7|||
147571268|NCT03600805|532248833|FG003|Overall Study|Other unspecified|11|||
147571269|NCT06195579|532248834|FG000|Overall Study|Withdrawal by Subject|1|||
147571270|NCT03123094|532248836|FG000|Overall Study|Withdrawal by Subject|0|||
147571271|NCT03123094|532248837|FG001|Overall Study|Withdrawal by Subject|2|||
147571272|NCT03123094|532248838|FG002|Overall Study|Withdrawal by Subject|1|||
147571273|NCT03123094|532248839|FG003|Overall Study|Withdrawal by Subject|0|||
147571274|NCT03123094|532248840|FG004|Overall Study|Withdrawal by Subject|1|||
147571275|NCT01735994|532248841|FG000|Overall Study|Withdrawal by Subject|6|||
147571276|NCT01735994|532248842|FG001|Overall Study|Withdrawal by Subject|4|||
147571277|NCT01735994|532248841|FG000|Overall Study|Injury|2|||
147571278|NCT01735994|532248842|FG001|Overall Study|Injury|0|||
147571279|NCT01735994|532248841|FG000|Overall Study|Kicked off team|5|||
147571280|NCT01735994|532248842|FG001|Overall Study|Kicked off team|0|||
147571281|NCT01735994|532248841|FG000|Overall Study|Lost to Follow-up|50|||
147571282|NCT01735994|532248842|FG001|Overall Study|Lost to Follow-up|62|||
147571283|NCT00604162|532248843|FG000|Overall Study|Physician Decision|3|||
147571284|NCT00604162|532248843|FG000|Overall Study|Withdrawal by Subject|1|||
147571285|NCT00736190|532248845|FG000|Overall Study|Pregnancy|1|||
147571286|NCT00736190|532248845|FG000|Overall Study|Withdrawal by Subject|1|||
147571287|NCT00736190|532248845|FG000|Overall Study|Adverse Event|1|||
147135317|NCT02465931|530664355|FG000|Overall Study|Lost to Follow-up|9|||
147135318|NCT02465931|530664356|FG001|Overall Study|Lost to Follow-up|11|||
147135319|NCT02465931|530664355|FG000|Overall Study|Protocol Violation|1|||
147135320|NCT02465931|530664356|FG001|Overall Study|Protocol Violation|0|||
147135321|NCT02465931|530664355|FG000|Overall Study|Withdrawal by Subject|1|||
147135322|NCT02465931|530664356|FG001|Overall Study|Withdrawal by Subject|0|||
147135323|NCT00492557|530664357|FG000|Overall Study|Subject request|12|||
147135324|NCT00492557|530664358|FG001|Overall Study|Subject request|11|||
147135325|NCT00492557|530664357|FG000|Overall Study|Protocol Violation|7|||
147135326|NCT00492557|530664358|FG001|Overall Study|Protocol Violation|8|||
147135327|NCT00492557|530664357|FG000|Overall Study|Other|2|||
147135328|NCT00492557|530664358|FG001|Overall Study|Other|2|||
147135329|NCT00492557|530664357|FG000|Overall Study|Death|1|||
147135330|NCT00492557|530664358|FG001|Overall Study|Death|1|||
147135331|NCT00492557|530664357|FG000|Overall Study|Adverse Event|1|||
147135332|NCT00492557|530664358|FG001|Overall Study|Adverse Event|0|||
147135333|NCT00492557|530664357|FG000|Overall Study|Failed to return|1|||
147135334|NCT00492557|530664358|FG001|Overall Study|Failed to return|0|||
147135335|NCT00492557|530664357|FG000|Overall Study|Lost to Follow-up|0|||
147135336|NCT00492557|530664358|FG001|Overall Study|Lost to Follow-up|1|||
147135337|NCT03423121|530664363|FG000|Overall Study|Lost to Follow-up|2|||
147135338|NCT03423121|530664364|FG001|Overall Study|Lost to Follow-up|6|||
147135339|NCT03423121|530664363|FG000|Overall Study|Adverse Event|1|||
147135340|NCT03423121|530664364|FG001|Overall Study|Adverse Event|0|||
147135341|NCT01354223|530664365|FG000|Overall Study|Withdrawal by Subject|3|||
147135342|NCT01354223|530664366|FG001|Overall Study|Withdrawal by Subject|1|||
147135343|NCT01126190|530664367|FG000|Double-Blind Phase|Death|0|||
147135344|NCT01126190|530664368|FG001|Double-Blind Phase|Death|1|||
147135345|NCT01126190|530664369|FG002|Double-Blind Phase|Death|0|||
147135346|NCT01126190|530664367|FG000|Double-Blind Phase|Adverse Event|1|||
147135347|NCT01126190|530664368|FG001|Double-Blind Phase|Adverse Event|2|||
147135348|NCT01126190|530664369|FG002|Double-Blind Phase|Adverse Event|0|||
147135349|NCT01126190|530664367|FG000|Double-Blind Phase|Withdrawal by Subject|2|||
147135350|NCT01126190|530664368|FG001|Double-Blind Phase|Withdrawal by Subject|5|||
147135351|NCT01126190|530664369|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
147135352|NCT01126190|530664367|FG000|Double-Blind Phase|Request of Investigator|1|||
147135353|NCT01126190|530664368|FG001|Double-Blind Phase|Request of Investigator|0|||
147135354|NCT01126190|530664369|FG002|Double-Blind Phase|Request of Investigator|0|||
147237274|NCT04203797|531038858|FG000|Overall Study|Did not complete End of Study follow-up|1|||
147237275|NCT04203797|531038859|FG001|Overall Study|Did not complete End of Study follow-up|0|||
147237276|NCT00579098|531038861|FG000|Overall Study|Lost to Follow-up|2|||
147237277|NCT00579098|531038862|FG001|Overall Study|Lost to Follow-up|0|||
147237278|NCT00579098|531038861|FG000|Overall Study|Adverse Event|2|||
147237279|NCT00579098|531038862|FG001|Overall Study|Adverse Event|3|||
147237280|NCT00579098|531038861|FG000|Overall Study|Withdrawal by Subject|2|||
147237281|NCT00579098|531038862|FG001|Overall Study|Withdrawal by Subject|3|||
147237282|NCT00579098|531038861|FG000|Overall Study|AF returned after ablation|3|||
147237283|NCT00579098|531038862|FG001|Overall Study|AF returned after ablation|2|||
147237284|NCT01254331|531038863|FG000|Initial Phase|Adverse Event|3|||
147237285|NCT01254331|531038863|FG000|Initial Phase|Withdrawal by Subject|1|||
147237286|NCT01254331|531038863|FG000|Initial Phase|Pregnancy|1|||
147237287|NCT01254331|531038863|FG000|Extension Phase|Lack of Efficacy|1|||
147237288|NCT01254331|531038863|FG000|Extension Phase|Lost to Follow-up|3|||
147237289|NCT00516074|531038867|FG000|Overall Study|Adverse Event|0|||
147237290|NCT00516074|531038868|FG001|Overall Study|Adverse Event|1|||
147237291|NCT00516074|531038867|FG000|Overall Study|Subject Decision|4|||
147237292|NCT00516074|531038868|FG001|Overall Study|Subject Decision|2|||
147237293|NCT00516074|531038867|FG000|Overall Study|Loss of Glucose Control|2|||
147237294|NCT00516074|531038868|FG001|Overall Study|Loss of Glucose Control|0|||
147237295|NCT05213481|531038869|FG000|Overall Study|Adverse Event|3|||
147237296|NCT05213481|531038869|FG000|Overall Study|Lost to Follow-up|1|||
147237297|NCT03822182|531038873|FG000|Overall Study|Protocol Violation|0|||
147237298|NCT03822182|531038874|FG001|Overall Study|Protocol Violation|1|||
147237299|NCT03822182|531038875|FG002|Overall Study|Protocol Violation|1|||
147237300|NCT01612858|531038877|FG000|Overall Study|Withdrawal by Subject|5|||
147237301|NCT01612858|531038878|FG001|Overall Study|Withdrawal by Subject|1|||
147237302|NCT01484275|531038879|FG000|Overall Study|Study terminated by sponsor|28|||
147237303|NCT01484275|531038880|FG001|Overall Study|Study terminated by sponsor|32|||
147237304|NCT01484275|531038879|FG000|Overall Study|Other|10|||
147237305|NCT01484275|531038880|FG001|Overall Study|Other|0|||
147237306|NCT01484275|531038879|FG000|Overall Study|Death|3|||
147237307|NCT01484275|531038880|FG001|Overall Study|Death|4|||
147651622|NCT00350779|532546564|FG001|Overall Study|Patient Moved|1|||
147135355|NCT01126190|530664367|FG000|Double-Blind Phase|Treatment Failure/Disease Progression|0|||
147135356|NCT01126190|530664368|FG001|Double-Blind Phase|Treatment Failure/Disease Progression|4|||
147237308|NCT01484275|531038879|FG000|Overall Study|Withdrawal by Subject|1|||
147237309|NCT01484275|531038880|FG001|Overall Study|Withdrawal by Subject|5|||
147135357|NCT01126190|530664369|FG002|Double-Blind Phase|Treatment Failure/Disease Progression|0|||
147135358|NCT01126190|530664367|FG000|Double-Blind Phase|Non-compliance|1|||
147237310|NCT01484275|531038879|FG000|Overall Study|Lost to Follow-up|1|||
147237311|NCT01484275|531038880|FG001|Overall Study|Lost to Follow-up|1|||
147237312|NCT00657358|531038883|FG000|Overall Study|Lack of Efficacy|6|||
147237313|NCT00913380|531038889|FG000|Clinical Outcomes|Lost to Follow-up|6|||
147135359|NCT01126190|530664368|FG001|Double-Blind Phase|Non-compliance|0|||
147135360|NCT01126190|530664369|FG002|Double-Blind Phase|Non-compliance|0|||
147135361|NCT01126190|530664367|FG000|Double-Blind Phase|Lost to Follow-up|1|||
147135362|NCT01126190|530664368|FG001|Double-Blind Phase|Lost to Follow-up|3|||
147135363|NCT01126190|530664369|FG002|Double-Blind Phase|Lost to Follow-up|0|||
147135364|NCT01126190|530664367|FG000|Open-Label Phase|Death|0|||
147135365|NCT01126190|530664368|FG001|Open-Label Phase|Death|0|||
147135366|NCT01126190|530664369|FG002|Open-Label Phase|Death|1|||
147135367|NCT01126190|530664367|FG000|Open-Label Phase|Adverse Event|0|||
147237314|NCT00913380|531038890|FG001|Clinical Outcomes|Lost to Follow-up|6|||
147651623|NCT00350779|532546563|FG000|Overall Study|Non-compliance with study procedures|0|||
147237315|NCT01788228|531038895|FG000|Overall Study|Migrated/moved from study area|1|||
147237316|NCT01788228|531038896|FG001|Overall Study|Migrated/moved from study area|0|||
147237317|NCT01972568|531038897|FG000|Overall Study|Other events|3|||
147237318|NCT01972568|531038898|FG001|Overall Study|Other events|0|||
147237319|NCT01972568|531038899|FG002|Overall Study|Other events|0|||
147237320|NCT01972568|531038897|FG000|Overall Study|Lack of Efficacy|0|||
147237321|NCT01972568|531038898|FG001|Overall Study|Lack of Efficacy|1|||
147237322|NCT01972568|531038899|FG002|Overall Study|Lack of Efficacy|2|||
147237323|NCT01972568|531038897|FG000|Overall Study|Protocol Violation|1|||
147237324|NCT01972568|531038898|FG001|Overall Study|Protocol Violation|2|||
147237325|NCT01972568|531038899|FG002|Overall Study|Protocol Violation|2|||
147237326|NCT01972568|531038897|FG000|Overall Study|Withdrawal by Subject|6|||
147237327|NCT01972568|531038898|FG001|Overall Study|Withdrawal by Subject|3|||
147237328|NCT01972568|531038899|FG002|Overall Study|Withdrawal by Subject|7|||
147237329|NCT01972568|531038897|FG000|Overall Study|Lost to Follow-up|1|||
147237330|NCT01972568|531038898|FG001|Overall Study|Lost to Follow-up|0|||
147237331|NCT01972568|531038899|FG002|Overall Study|Lost to Follow-up|0|||
147237332|NCT01972568|531038897|FG000|Overall Study|Adverse Event|5|||
147237333|NCT01972568|531038898|FG001|Overall Study|Adverse Event|6|||
147237334|NCT01972568|531038899|FG002|Overall Study|Adverse Event|5|||
147237335|NCT00957580|531038900|FG000|Overall Study|Ongoing at data cut-off|0|||
147237336|NCT00957580|531038901|FG001|Overall Study|Ongoing at data cut-off|1|||
147237337|NCT00957580|531038902|FG002|Overall Study|Ongoing at data cut-off|0|||
147237338|NCT00957580|531038900|FG000|Overall Study|Enrolled but not treated|0|||
147237339|NCT00957580|531038901|FG001|Overall Study|Enrolled but not treated|1|||
147237340|NCT00957580|531038902|FG002|Overall Study|Enrolled but not treated|0|||
147237341|NCT02699593|531038905|FG000|Period 1|Unsatisfactory Visual Response|0|||
147237342|NCT02699593|531038906|FG001|Period 1|Unsatisfactory Visual Response|1|||
147237343|NCT02699593|531038905|FG000|Period 1|Torn Contact Len|4|||
147237344|NCT02699593|531038906|FG001|Period 1|Torn Contact Len|3|||
147237345|NCT02699593|531038905|FG000|Period 1|Protocol Violation|0|||
147237346|NCT02699593|531038906|FG001|Period 1|Protocol Violation|1|||
147237347|NCT02699593|531038905|FG000|Period 1|Withdrawal by Subject|0|||
147237348|NCT02699593|531038906|FG001|Period 1|Withdrawal by Subject|1|||
147237349|NCT02699593|531038905|FG000|Period 1|Adverse Event|1|||
147237350|NCT02699593|531038906|FG001|Period 1|Adverse Event|1|||
147237351|NCT02699593|531038905|FG000|Period 2|Adverse Event|1|||
147237352|NCT02699593|531038906|FG001|Period 2|Adverse Event|1|||
147237353|NCT02699593|531038905|FG000|Period 2|Lost Contact Lens|0|||
147237354|NCT02699593|531038906|FG001|Period 2|Lost Contact Lens|1|||
147237355|NCT02699593|531038905|FG000|Period 2|Torn Contact Lens|1|||
147237356|NCT02699593|531038906|FG001|Period 2|Torn Contact Lens|0|||
147237357|NCT01696071|531038919|FG000|Treatment Period 2: 4 Weeks|Adverse Event|1|||
147237358|NCT01696071|531038920|FG001|Treatment Period 2: 4 Weeks|Adverse Event|0|||
147237359|NCT02764697|531038921|FG000|Overall Study|Lack of Efficacy|3|||
147237360|NCT01995825|531040565|FG000|Overall Study|Withdrawal by Subject|1|||
147237361|NCT01995825|531040566|FG001|Overall Study|Withdrawal by Subject|0|||
147237362|NCT01798004|531040567|FG000|Overall Study|Death|2|||
147237363|NCT01798004|531040567|FG000|Overall Study|Lack of Efficacy|8|||
147237364|NCT01798004|531040567|FG000|Overall Study|Physician Decision|25|||
147135368|NCT01126190|530664368|FG001|Open-Label Phase|Adverse Event|0|||
147135369|NCT01126190|530664369|FG002|Open-Label Phase|Adverse Event|4|||
147237365|NCT01798004|531040567|FG000|Overall Study|Withdrawal by Subject|4|||
147237366|NCT01798004|531040567|FG000|Overall Study|Ineligible|4|||
147237367|NCT01798004|531040567|FG000|Overall Study|Patient/parent refusal|7|||
147237368|NCT01798004|531040567|FG000|Overall Study|Initiation of other non-protocol therapy|5|||
147237369|NCT01798004|531040567|FG000|Overall Study|Enrollment another COG therapeutic trial|32|||
147237370|NCT04680052|531040568|FG000|Overall Study|Ongoing|244|||
147237371|NCT04680052|531040569|FG001|Overall Study|Ongoing|229|||
147237372|NCT04680052|531040570|FG002|Overall Study|Ongoing|39|||
147237373|NCT04680052|531040571|FG003|Overall Study|Ongoing|46|||
147237374|NCT04680052|531040568|FG000|Overall Study|Death|15|||
147135370|NCT01126190|530664367|FG000|Open-Label Phase|Withdrawal by Subject|0|||
147237375|NCT04680052|531040569|FG001|Overall Study|Death|22|||
147237376|NCT04680052|531040570|FG002|Overall Study|Death|7|||
147237377|NCT04680052|531040571|FG003|Overall Study|Death|1|||
147237378|NCT04680052|531040568|FG000|Overall Study|Lost to Follow-up|3|||
147135371|NCT01126190|530664368|FG001|Open-Label Phase|Withdrawal by Subject|0|||
147237379|NCT04680052|531040569|FG001|Overall Study|Lost to Follow-up|2|||
147651624|NCT00350779|532546564|FG001|Overall Study|Non-compliance with study procedures|1|||
147651625|NCT00528372|532546565|FG000|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|2|||
147651626|NCT00528372|532546566|FG001|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
147651627|NCT00528372|532546567|FG002|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
147651628|NCT00528372|532546568|FG003|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
147651629|NCT00528372|532546569|FG004|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
147651630|NCT00528372|532546570|FG005|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
147651631|NCT00528372|532546571|FG006|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
147651632|NCT00528372|532546572|FG007|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
147135372|NCT01126190|530664369|FG002|Open-Label Phase|Withdrawal by Subject|6|||
147135373|NCT01114737|530664370|FG000|Randomized Treatment Period|Withdrawal by Subject|1|||
147135374|NCT01114737|530664371|FG001|Randomized Treatment Period|Withdrawal by Subject|0|||
147135375|NCT01114737|530664370|FG000|Randomized Treatment Period|Lost to Follow-up|1|||
147135376|NCT01114737|530664371|FG001|Randomized Treatment Period|Lost to Follow-up|1|||
147135377|NCT01114737|530664370|FG000|Randomized Treatment Period|Pregnancy|1|||
147135378|NCT01114737|530664371|FG001|Randomized Treatment Period|Pregnancy|0|||
147135379|NCT01114737|530664370|FG000|Open-Label Treatment Period|Withdrawal by Subject|1|||
147135380|NCT01114737|530664371|FG001|Open-Label Treatment Period|Withdrawal by Subject|1|||
147135381|NCT01114737|530664370|FG000|Open-Label Treatment Period|Lost to Follow-up|3|||
147135382|NCT01114737|530664371|FG001|Open-Label Treatment Period|Lost to Follow-up|1|||
147135383|NCT01114737|530664370|FG000|Open-Label Treatment Period|Difficult Personal Events|1|||
147135384|NCT01114737|530664371|FG001|Open-Label Treatment Period|Difficult Personal Events|0|||
147135385|NCT02660229|530664375|FG000|Overall Study|Adverse Event|2|||
147135386|NCT02660229|530664376|FG001|Overall Study|Adverse Event|0|||
147135387|NCT02660229|530664375|FG000|Overall Study|Withdrawal by Subject|0|||
147135388|NCT02660229|530664376|FG001|Overall Study|Withdrawal by Subject|1|||
147135389|NCT01466491|530664377|FG000|Overall Study|Protocol Violation|0|||
147135390|NCT01466491|530664378|FG001|Overall Study|Protocol Violation|3|||
147135391|NCT01466491|530664379|FG002|Overall Study|Protocol Violation|2|||
147445444|NCT00705783|531795843|FG000|Depot Maintenance Phase|Adverse Event without Impending Relapse|0|||
147445445|NCT00705783|531795844|FG001|Depot Maintenance Phase|Adverse Event without Impending Relapse|9|||
147445446|NCT00705783|531795845|FG002|Depot Maintenance Phase|Adverse Event without Impending Relapse|5|||
147445447|NCT00705783|531795843|FG000|Depot Maintenance Phase|Impending Relapse with Adverse Event|0|||
147445448|NCT00705783|531795844|FG001|Depot Maintenance Phase|Impending Relapse with Adverse Event|11|||
147445449|NCT00705783|531795845|FG002|Depot Maintenance Phase|Impending Relapse with Adverse Event|13|||
147445450|NCT00705783|531795843|FG000|Depot Maintenance Phase|Impending Relapse without Adverse Event|0|||
147445451|NCT00705783|531795844|FG001|Depot Maintenance Phase|Impending Relapse without Adverse Event|16|||
147445452|NCT00705783|531795845|FG002|Depot Maintenance Phase|Impending Relapse without Adverse Event|40|||
147445453|NCT02184195|531795849|FG000|Overall Study|Patient decision|5|||
147445454|NCT02184195|531795850|FG001|Overall Study|Patient decision|2|||
147445455|NCT02184195|531795849|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
147445456|NCT02184195|531795850|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
147445457|NCT02184195|531795849|FG000|Overall Study|Death|67|||
147445458|NCT02184195|531795850|FG001|Overall Study|Death|44|||
147445459|NCT02184195|531795849|FG000|Overall Study|Lost to Follow-up|1|||
147445460|NCT02184195|531795850|FG001|Overall Study|Lost to Follow-up|5|||
147651633|NCT00528372|532546573|FG008|Short-term (ST) Period (Day 1-Week 24)|Lack of Efficacy|0|||
147651634|NCT00528372|532546565|FG000|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0|||
147651635|NCT00528372|532546566|FG001|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|2|||
147651636|NCT00528372|532546567|FG002|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|2|||
147651637|NCT00528372|532546568|FG003|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|6|||
147651638|NCT00528372|532546569|FG004|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0|||
147651639|NCT00528372|532546570|FG005|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|3|||
147651640|NCT00528372|532546571|FG006|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|3|||
147651641|NCT00528372|532546572|FG007|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0|||
147651642|NCT00528372|532546573|FG008|Short-term (ST) Period (Day 1-Week 24)|Adverse Event|0|||
147135392|NCT01466491|530664380|FG003|Overall Study|Protocol Violation|0|||
147135393|NCT01466491|530664377|FG000|Overall Study|Missing Data|0|||
147135394|NCT01466491|530664378|FG001|Overall Study|Missing Data|0|||
147445461|NCT02184195|531795849|FG000|Overall Study|Other|0|||
147651643|NCT00528372|532546565|FG000|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|1|||
147135395|NCT01466491|530664379|FG002|Overall Study|Missing Data|1|||
147135396|NCT01466491|530664380|FG003|Overall Study|Missing Data|0|||
147135397|NCT02727322|530664381|FG000|Overall Study|Withdrawal by Subject|1|||
147135398|NCT02727322|530664382|FG001|Overall Study|Withdrawal by Subject|1|||
147135399|NCT02727322|530664381|FG000|Overall Study|Protocol Violation|1|||
147445462|NCT02184195|531795850|FG001|Overall Study|Other|3|||
147445463|NCT02285998|531795851|FG000|Overall Study|Adverse Event|9|||
147445464|NCT02285998|531795852|FG001|Overall Study|Adverse Event|8|||
147445465|NCT02285998|531795851|FG000|Overall Study|Physician Decision|1|||
147445466|NCT02285998|531795852|FG001|Overall Study|Physician Decision|2|||
147135400|NCT02727322|530664382|FG001|Overall Study|Protocol Violation|0|||
147135401|NCT02852967|530664383|FG000|Overall Study|Adverse Event|3|||
147135402|NCT02852967|530664384|FG001|Overall Study|Adverse Event|1|||
147135403|NCT02852967|530664385|FG002|Overall Study|Adverse Event|0|||
147135404|NCT02852967|530664386|FG003|Overall Study|Adverse Event|1|||
147135405|NCT02852967|530664387|FG004|Overall Study|Adverse Event|0|||
147135406|NCT02852967|530664383|FG000|Overall Study|Death|1|||
147135407|NCT02852967|530664384|FG001|Overall Study|Death|0|||
147135408|NCT02852967|530664385|FG002|Overall Study|Death|0|||
147135409|NCT02852967|530664386|FG003|Overall Study|Death|0|||
147135410|NCT02852967|530664387|FG004|Overall Study|Death|0|||
147135411|NCT02852967|530664383|FG000|Overall Study|Lost to Follow-up|1|||
147135412|NCT02852967|530664384|FG001|Overall Study|Lost to Follow-up|2|||
147135413|NCT02852967|530664385|FG002|Overall Study|Lost to Follow-up|3|||
147135414|NCT02852967|530664386|FG003|Overall Study|Lost to Follow-up|4|||
147135415|NCT02852967|530664387|FG004|Overall Study|Lost to Follow-up|4|||
147135416|NCT02852967|530664383|FG000|Overall Study|Withdrawal by Subject|6|||
147135417|NCT02852967|530664384|FG001|Overall Study|Withdrawal by Subject|12|||
147135418|NCT02852967|530664385|FG002|Overall Study|Withdrawal by Subject|7|||
147135419|NCT02852967|530664386|FG003|Overall Study|Withdrawal by Subject|10|||
147135420|NCT02852967|530664387|FG004|Overall Study|Withdrawal by Subject|10|||
147135421|NCT02852967|530664383|FG000|Overall Study|SAE|0|||
147135422|NCT02852967|530664384|FG001|Overall Study|SAE|0|||
147135423|NCT02852967|530664385|FG002|Overall Study|SAE|0|||
147135424|NCT02852967|530664386|FG003|Overall Study|SAE|3|||
147135425|NCT02852967|530664387|FG004|Overall Study|SAE|0|||
147135426|NCT02852967|530664383|FG000|Overall Study|Elevated Liver Enzymes|2|||
147135427|NCT02852967|530664384|FG001|Overall Study|Elevated Liver Enzymes|0|||
147135428|NCT02852967|530664385|FG002|Overall Study|Elevated Liver Enzymes|0|||
147135429|NCT02852967|530664386|FG003|Overall Study|Elevated Liver Enzymes|2|||
147135430|NCT02852967|530664387|FG004|Overall Study|Elevated Liver Enzymes|2|||
147135431|NCT02852967|530664383|FG000|Overall Study|Physician Decision|0|||
147135432|NCT02852967|530664384|FG001|Overall Study|Physician Decision|0|||
147135433|NCT02852967|530664385|FG002|Overall Study|Physician Decision|0|||
147135434|NCT02852967|530664386|FG003|Overall Study|Physician Decision|1|||
147135435|NCT02852967|530664387|FG004|Overall Study|Physician Decision|0|||
147135436|NCT02852967|530664383|FG000|Overall Study|Lack of Efficacy|0|||
147135437|NCT02852967|530664384|FG001|Overall Study|Lack of Efficacy|1|||
147135438|NCT02852967|530664385|FG002|Overall Study|Lack of Efficacy|0|||
147135439|NCT02852967|530664386|FG003|Overall Study|Lack of Efficacy|0|||
147135440|NCT02852967|530664387|FG004|Overall Study|Lack of Efficacy|0|||
147318369|NCT02408549|531331694|FG000|Overall Study|Lack of Efficacy|17|||
147318370|NCT02408549|531331694|FG000|Overall Study|Protocol Violation|4|||
147318371|NCT02408549|531331694|FG000|Overall Study|Lost to Follow-up|6|||
147318372|NCT02408549|531331694|FG000|Overall Study|Consent withdrawn|30|||
147318373|NCT02408549|531331694|FG000|Overall Study|Neurology research program closing at site|1|||
147318374|NCT02408549|531331694|FG000|Overall Study|Site closure|1|||
147318375|NCT02408549|531331694|FG000|Overall Study|Pregnancy|1|||
147318376|NCT02408549|531331694|FG000|Overall Study|Withdrawal of consent due to business trip|1|||
147135441|NCT02852967|530664383|FG000|Overall Study|Non-compliance|0|||
147135442|NCT02852967|530664384|FG001|Overall Study|Non-compliance|0|||
147135443|NCT02852967|530664385|FG002|Overall Study|Non-compliance|1|||
147135444|NCT02852967|530664386|FG003|Overall Study|Non-compliance|1|||
147135445|NCT02852967|530664387|FG004|Overall Study|Non-compliance|0|||
147135446|NCT02852967|530664383|FG000|Overall Study|Dispensing Drug Violation|0|||
147135447|NCT02852967|530664384|FG001|Overall Study|Dispensing Drug Violation|0|||
147135448|NCT02852967|530664385|FG002|Overall Study|Dispensing Drug Violation|1|||
147135449|NCT02852967|530664386|FG003|Overall Study|Dispensing Drug Violation|0|||
147135450|NCT02852967|530664387|FG004|Overall Study|Dispensing Drug Violation|0|||
147135451|NCT02852967|530664383|FG000|Overall Study|Inclusion/Exclusion Violation|1|||
147135452|NCT02852967|530664384|FG001|Overall Study|Inclusion/Exclusion Violation|0|||
147135453|NCT02852967|530664385|FG002|Overall Study|Inclusion/Exclusion Violation|0|||
147135454|NCT02852967|530664386|FG003|Overall Study|Inclusion/Exclusion Violation|0|||
147135455|NCT02852967|530664387|FG004|Overall Study|Inclusion/Exclusion Violation|0|||
147318377|NCT02408549|531331694|FG000|Overall Study|Subject moved to another place, far from site|1|||
147135456|NCT01123148|530664388|FG000|Overall Study|Coughing caused unacceptable EEG quality|1|||
147135457|NCT01123148|530664388|FG000|Overall Study|Didn't meet milestone criteria|1|||
147135458|NCT03046446|530664389|FG000|Overall Study|Lack of Efficacy|7|||
147135459|NCT03046446|530664389|FG000|Overall Study|Adverse Event|6|||
147135460|NCT03046446|530664389|FG000|Overall Study|Lost to Follow-up|3|||
147135461|NCT03046446|530664389|FG000|Overall Study|Withdrawal by Subject|14|||
147135462|NCT03046446|530664389|FG000|Overall Study|Withdrawn by Investigator/Sponsor|3|||
147135463|NCT03046446|530664389|FG000|Overall Study|Disease Progression (see caveats)|25|||
147135464|NCT03046446|530664389|FG000|Overall Study|Non OA related knee surgery|1|||
147135465|NCT02808897|530664390|FG000|Overall Study|Lost to Follow-up|9|||
147135466|NCT02808897|530664391|FG001|Overall Study|Lost to Follow-up|11|||
147135467|NCT01496287|530664392|FG000|Overall Study|Lost to Follow-up|1|||
147318378|NCT02408549|531331694|FG000|Overall Study|Study terminated at site|1|||
147651644|NCT00528372|532546566|FG001|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|2|||
147571288|NCT03128723|532248849|FG000|Overall Study|Withdrawal by Subject|2|||
147571289|NCT02909907|532248851|FG000|Overall Study|Withdrawal by Subject|0|||
147571290|NCT02909907|532248852|FG001|Overall Study|Withdrawal by Subject|1|||
147571291|NCT00395694|532248856|FG000|Escalation Phase + Maintenance Phase|Adverse Event|1|||
147571292|NCT00395694|532248857|FG001|Escalation Phase + Maintenance Phase|Adverse Event|2|||
147135468|NCT01496287|530664392|FG000|Overall Study|Incomplete anesthesia|5|||
147135469|NCT03012334|530664393|FG000|Period 1|Withdrawal by Subject|0|||
147135470|NCT03012334|530664394|FG001|Period 1|Withdrawal by Subject|0|||
147135471|NCT03012334|530664395|FG002|Period 1|Withdrawal by Subject|0|||
147135472|NCT03012334|530664396|FG003|Period 1|Withdrawal by Subject|0|||
147135473|NCT03012334|530664397|FG004|Period 1|Withdrawal by Subject|0|||
147135474|NCT03012334|530664398|FG005|Period 1|Withdrawal by Subject|0|||
147135475|NCT03012334|530664399|FG006|Period 1|Withdrawal by Subject|0|||
147135476|NCT03012334|530664400|FG007|Period 1|Withdrawal by Subject|0|||
147135477|NCT03012334|530664401|FG008|Period 1|Withdrawal by Subject|0|||
147135478|NCT03012334|530664402|FG009|Period 1|Withdrawal by Subject|1|||
147571293|NCT00395694|532248856|FG000|Continuation Phase|Adverse Event|1|||
147571294|NCT00395694|532248857|FG001|Continuation Phase|Adverse Event|0|||
147651645|NCT00528372|532546567|FG002|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|7|||
147651646|NCT00528372|532546568|FG003|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|1|||
147135479|NCT03012334|530664393|FG000|Period 2|Withdrawal by Subject|0|||
147135480|NCT03012334|530664394|FG001|Period 2|Withdrawal by Subject|1|||
147135481|NCT03012334|530664395|FG002|Period 2|Withdrawal by Subject|0|||
147135482|NCT03012334|530664396|FG003|Period 2|Withdrawal by Subject|0|||
147135483|NCT03012334|530664397|FG004|Period 2|Withdrawal by Subject|0|||
147135484|NCT03012334|530664398|FG005|Period 2|Withdrawal by Subject|0|||
147135485|NCT03012334|530664399|FG006|Period 2|Withdrawal by Subject|0|||
147651647|NCT00528372|532546569|FG004|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|6|||
147135486|NCT03012334|530664400|FG007|Period 2|Withdrawal by Subject|0|||
147135487|NCT03012334|530664401|FG008|Period 2|Withdrawal by Subject|0|||
147135488|NCT03012334|530664402|FG009|Period 2|Withdrawal by Subject|0|||
147135489|NCT03012334|530664393|FG000|Period 2|Protocol Violation|0|||
147135490|NCT03012334|530664394|FG001|Period 2|Protocol Violation|0|||
147135491|NCT03012334|530664395|FG002|Period 2|Protocol Violation|1|||
147135492|NCT03012334|530664396|FG003|Period 2|Protocol Violation|0|||
147135493|NCT03012334|530664397|FG004|Period 2|Protocol Violation|0|||
147135494|NCT03012334|530664398|FG005|Period 2|Protocol Violation|0|||
147135495|NCT03012334|530664399|FG006|Period 2|Protocol Violation|0|||
147135496|NCT03012334|530664400|FG007|Period 2|Protocol Violation|1|||
147135497|NCT03012334|530664401|FG008|Period 2|Protocol Violation|0|||
147135498|NCT03012334|530664402|FG009|Period 2|Protocol Violation|0|||
147135499|NCT03012334|530664393|FG000|Period 4|Non-Compliance|0|||
147135500|NCT03012334|530664394|FG001|Period 4|Non-Compliance|0|||
147135501|NCT03012334|530664395|FG002|Period 4|Non-Compliance|0|||
147135502|NCT03012334|530664396|FG003|Period 4|Non-Compliance|0|||
147135503|NCT03012334|530664397|FG004|Period 4|Non-Compliance|0|||
147135504|NCT03012334|530664398|FG005|Period 4|Non-Compliance|0|||
147135505|NCT03012334|530664399|FG006|Period 4|Non-Compliance|1|||
147135506|NCT03012334|530664400|FG007|Period 4|Non-Compliance|0|||
147237380|NCT04680052|531040570|FG002|Overall Study|Lost to Follow-up|0|||
147237381|NCT04680052|531040571|FG003|Overall Study|Lost to Follow-up|1|||
147237382|NCT04680052|531040568|FG000|Overall Study|Withdrawal by Subject|11|||
147237383|NCT04680052|531040569|FG001|Overall Study|Withdrawal by Subject|19|||
147237384|NCT04680052|531040570|FG002|Overall Study|Withdrawal by Subject|7|||
147237385|NCT04680052|531040571|FG003|Overall Study|Withdrawal by Subject|5|||
147237386|NCT04680052|531040568|FG000|Overall Study|Missing|0|||
147237387|NCT04680052|531040569|FG001|Overall Study|Missing|1|||
147237388|NCT04680052|531040570|FG002|Overall Study|Missing|0|||
147237389|NCT04680052|531040571|FG003|Overall Study|Missing|0|||
147237390|NCT04680052|531040568|FG000|Overall Study|Hypersensitivity to Rituximab; Did Not Receive Treatment|0|||
147445467|NCT02285998|531795851|FG000|Overall Study|Lost to Follow-up|176|||
147445468|NCT02285998|531795852|FG001|Overall Study|Lost to Follow-up|172|||
147445469|NCT02285998|531795851|FG000|Overall Study|Withdrawal by Subject|53|||
147445470|NCT02285998|531795852|FG001|Overall Study|Withdrawal by Subject|61|||
147445471|NCT02285998|531795851|FG000|Overall Study|Other Reasons|7|||
147571295|NCT00395694|532248856|FG000|Continuation Phase|Lack of Efficacy|12|||
147571296|NCT00395694|532248857|FG001|Continuation Phase|Lack of Efficacy|11|||
147135507|NCT03012334|530664401|FG008|Period 4|Non-Compliance|0|||
147135508|NCT03012334|530664402|FG009|Period 4|Non-Compliance|0|||
147135509|NCT03012334|530664393|FG000|Period 4|Adverse Event|0|||
147135510|NCT03012334|530664394|FG001|Period 4|Adverse Event|0|||
147135511|NCT03012334|530664395|FG002|Period 4|Adverse Event|0|||
147135512|NCT03012334|530664396|FG003|Period 4|Adverse Event|0|||
147135513|NCT03012334|530664397|FG004|Period 4|Adverse Event|0|||
147135514|NCT03012334|530664398|FG005|Period 4|Adverse Event|0|||
147135515|NCT03012334|530664399|FG006|Period 4|Adverse Event|0|||
147135516|NCT03012334|530664400|FG007|Period 4|Adverse Event|0|||
147135517|NCT03012334|530664401|FG008|Period 4|Adverse Event|1|||
147445472|NCT02285998|531795852|FG001|Overall Study|Other Reasons|10|||
147135518|NCT03012334|530664402|FG009|Period 4|Adverse Event|0|||
147135519|NCT00800735|530664403|FG000|Overall Study|Administrative/Other|2|||
147135520|NCT00800735|530664403|FG000|Overall Study|Insufficient Therapeutic Response|2|||
147135521|NCT00800735|530664403|FG000|Overall Study|Violation of Selection Criteria at Entry|7|||
147135522|NCT00800735|530664403|FG000|Overall Study|Withdrew Consent|3|||
147135523|NCT01936831|530664409|FG000|Step 2: Arm Randomization|Withdrawal by Subject|0|||
147135524|NCT01936831|530664410|FG001|Step 2: Arm Randomization|Withdrawal by Subject|0|||
147135525|NCT01936831|530664411|FG002|Step 2: Arm Randomization|Withdrawal by Subject|0|||
147135526|NCT01936831|530664412|FG003|Step 2: Arm Randomization|Withdrawal by Subject|0|||
147135527|NCT01936831|530664413|FG004|Step 2: Arm Randomization|Withdrawal by Subject|0|||
147135528|NCT01936831|530664414|FG005|Step 2: Arm Randomization|Withdrawal by Subject|1|||
147135529|NCT01936831|530664415|FG006|Step 2: Arm Randomization|Withdrawal by Subject|0|||
147135530|NCT01936831|530664416|FG007|Step 2: Arm Randomization|Withdrawal by Subject|0|||
147135531|NCT01936831|530664417|FG008|Step 2: Arm Randomization|Withdrawal by Subject|0|||
147135532|NCT00454116|530664419|FG000|Overall Study|Adverse Event|5|||
147135533|NCT00454116|530664420|FG001|Overall Study|Adverse Event|11|||
147135534|NCT00454116|530664421|FG002|Overall Study|Adverse Event|9|||
147135535|NCT00454116|530664419|FG000|Overall Study|Condition under investigation worsened|17|||
147135536|NCT00454116|530664420|FG001|Overall Study|Condition under investigation worsened|13|||
147135537|NCT00454116|530664421|FG002|Overall Study|Condition under investigation worsened|18|||
147135538|NCT00454116|530664419|FG000|Overall Study|Withdrawal by Subject|3|||
147135539|NCT00454116|530664420|FG001|Overall Study|Withdrawal by Subject|3|||
147135540|NCT00454116|530664421|FG002|Overall Study|Withdrawal by Subject|1|||
147135541|NCT00454116|530664419|FG000|Overall Study|Other|2|||
147135542|NCT00454116|530664420|FG001|Overall Study|Other|2|||
147135543|NCT00454116|530664421|FG002|Overall Study|Other|0|||
147135544|NCT02431325|530664424|FG000|Overall Study|Adverse Event|3|||
147135545|NCT02431325|530664425|FG001|Overall Study|Adverse Event|0|||
147571297|NCT00395694|532248856|FG000|Continuation Phase|Withdrawal Due to Wishes of Family|1|||
147135546|NCT02431325|530664424|FG000|Overall Study|Lost to Follow-up|0|||
147135547|NCT02431325|530664425|FG001|Overall Study|Lost to Follow-up|1|||
147135548|NCT02431325|530664424|FG000|Overall Study|Withdrawal by Subject|1|||
147135549|NCT02431325|530664425|FG001|Overall Study|Withdrawal by Subject|2|||
147135550|NCT02431325|530664424|FG000|Overall Study|Declined to take study medication|1|||
147135551|NCT02431325|530664425|FG001|Overall Study|Declined to take study medication|0|||
147135552|NCT02431325|530664424|FG000|Overall Study|Withdrew before starting study medication|1|||
147135553|NCT02431325|530664425|FG001|Overall Study|Withdrew before starting study medication|0|||
147135554|NCT02431325|530664424|FG000|Overall Study|Placebo shortage|2|||
147135555|NCT02431325|530664425|FG001|Overall Study|Placebo shortage|0|||
147445473|NCT00545298|531795853|FG000|Overall Study|Issues with Standard of Care|2|||
147445474|NCT00545298|531795854|FG001|Overall Study|Issues with Standard of Care|0|||
147445475|NCT00545298|531795855|FG002|Overall Study|Issues with Standard of Care|1|||
147445476|NCT00974675|531795863|FG000|Overall Study|Adverse Event|2|||
147445477|NCT00974675|531795864|FG001|Overall Study|Adverse Event|1|||
147135556|NCT01917318|530664426|FG000|First Treatment|Withdrawal by Subject|0|||
147135557|NCT01917318|530664427|FG001|First Treatment|Withdrawal by Subject|1|||
147135558|NCT01008618|530664428|FG000|Period 1 (Titration Period)|Physician Decision|2|||
147135559|NCT01008618|530664429|FG001|Period 1 (Titration Period)|Physician Decision|0|||
147135560|NCT01008618|530664430|FG002|Period 1 (Titration Period)|Physician Decision|0|||
147135561|NCT01008618|530664428|FG000|Period 1 (Titration Period)|Adverse Event|33|||
147135562|NCT01008618|530664429|FG001|Period 1 (Titration Period)|Adverse Event|0|||
147135563|NCT01008618|530664430|FG002|Period 1 (Titration Period)|Adverse Event|0|||
147135564|NCT01008618|530664428|FG000|Period 1 (Titration Period)|Withdrawal by Subject|11|||
147135565|NCT01008618|530664429|FG001|Period 1 (Titration Period)|Withdrawal by Subject|0|||
147135566|NCT01008618|530664430|FG002|Period 1 (Titration Period)|Withdrawal by Subject|0|||
147135567|NCT01008618|530664428|FG000|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|20|||
147135568|NCT01008618|530664429|FG001|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0|||
147445478|NCT00974675|531795865|FG002|Overall Study|Adverse Event|1|||
147445479|NCT00974675|531795866|FG003|Overall Study|Adverse Event|1|||
147445480|NCT00974675|531795863|FG000|Overall Study|Physician Decision|0|||
147445481|NCT00974675|531795864|FG001|Overall Study|Physician Decision|0|||
147445482|NCT00974675|531795865|FG002|Overall Study|Physician Decision|1|||
147135569|NCT01008618|530664430|FG002|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0|||
147135570|NCT01008618|530664428|FG000|Period 1 (Titration Period)|Aggravated symptom|2|||
147135571|NCT01008618|530664429|FG001|Period 1 (Titration Period)|Aggravated symptom|0|||
147135572|NCT01008618|530664430|FG002|Period 1 (Titration Period)|Aggravated symptom|0|||
147135573|NCT01008618|530664428|FG000|Period 2 (Double-Blind Period)|Adverse Event|0|||
147135574|NCT01008618|530664429|FG001|Period 2 (Double-Blind Period)|Adverse Event|11|||
147135575|NCT01008618|530664430|FG002|Period 2 (Double-Blind Period)|Adverse Event|2|||
147135576|NCT01008618|530664428|FG000|Period 2 (Double-Blind Period)|Withdrawal by Subject|0|||
147135577|NCT01008618|530664429|FG001|Period 2 (Double-Blind Period)|Withdrawal by Subject|3|||
147135578|NCT01008618|530664430|FG002|Period 2 (Double-Blind Period)|Withdrawal by Subject|2|||
147135579|NCT01008618|530664428|FG000|Period 2 (Double-Blind Period)|Physician Decision|0|||
147135580|NCT01008618|530664429|FG001|Period 2 (Double-Blind Period)|Physician Decision|1|||
147135581|NCT01008618|530664430|FG002|Period 2 (Double-Blind Period)|Physician Decision|0|||
147135582|NCT01008618|530664428|FG000|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|0|||
147135583|NCT01008618|530664429|FG001|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|0|||
147135584|NCT01008618|530664430|FG002|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|3|||
147135585|NCT01008618|530664428|FG000|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0|||
147135586|NCT01008618|530664429|FG001|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0|||
147135587|NCT01008618|530664430|FG002|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|1|||
147135588|NCT01008618|530664428|FG000|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|0|||
147135589|NCT01008618|530664429|FG001|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|21|||
147135590|NCT01008618|530664430|FG002|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|29|||
147135591|NCT01008618|530664428|FG000|Period 2 (Double-Blind Period)|Not appropriate for this study|0|||
147135592|NCT01008618|530664429|FG001|Period 2 (Double-Blind Period)|Not appropriate for this study|0|||
147135593|NCT01008618|530664430|FG002|Period 2 (Double-Blind Period)|Not appropriate for this study|1|||
147135594|NCT02927795|530664433|FG000|Overall Study|Non-evaluable PF10 quest. at visit 2|19|||
147135595|NCT02927795|530664433|FG000|Overall Study|Not Treated|4|||
147135596|NCT02581891|530664434|FG000|Overall Study|Adverse Event|4|||
147135597|NCT02581891|530664435|FG001|Overall Study|Adverse Event|6|||
147135598|NCT02581891|530664434|FG000|Overall Study|Death|3|||
147135599|NCT02581891|530664435|FG001|Overall Study|Death|4|||
147135600|NCT02581891|530664434|FG000|Overall Study|Lost to Follow-up|1|||
147135601|NCT02581891|530664435|FG001|Overall Study|Lost to Follow-up|2|||
147135602|NCT02581891|530664434|FG000|Overall Study|Physician Decision|0|||
147135603|NCT02581891|530664435|FG001|Overall Study|Physician Decision|1|||
147135604|NCT02581891|530664434|FG000|Overall Study|Withdrawal by Subject|4|||
147135605|NCT02581891|530664435|FG001|Overall Study|Withdrawal by Subject|5|||
147135606|NCT02581891|530664434|FG000|Overall Study|Other Reasons|3|||
147135607|NCT02581891|530664435|FG001|Overall Study|Other Reasons|1|||
147135608|NCT02581891|530664434|FG000|Overall Study|Discontinued during followup|1|||
147135609|NCT02581891|530664435|FG001|Overall Study|Discontinued during followup|0|||
147135610|NCT01534481|530664441|FG000|Overall Study|Lost to Follow-up|29|||
147135611|NCT01534481|530664442|FG001|Overall Study|Lost to Follow-up|24|||
147135612|NCT01534481|530664441|FG000|Overall Study|Incomplete Follow-up or No Study Data|6|||
147135613|NCT01534481|530664442|FG001|Overall Study|Incomplete Follow-up or No Study Data|3|||
147135614|NCT05525910|530664443|FG000|Period 4|Per sponsor due to study timelines|0|||
147135615|NCT05525910|530664444|FG001|Period 4|Per sponsor due to study timelines|0|||
147135616|NCT05525910|530664445|FG002|Period 4|Per sponsor due to study timelines|1|||
147135617|NCT05525910|530664446|FG003|Period 4|Per sponsor due to study timelines|1|||
147135618|NCT05525910|530664447|FG004|Period 4|Per sponsor due to study timelines|1|||
147135619|NCT01812057|530664454|FG000|Overall Study|Protocol Violation|1|||
147135620|NCT01812057|530664455|FG001|Overall Study|Protocol Violation|0|||
147135621|NCT01812057|530664454|FG000|Overall Study|Physician Decision|1|||
147571298|NCT00395694|532248857|FG001|Continuation Phase|Withdrawal Due to Wishes of Family|0|||
147571299|NCT00395694|532248856|FG000|Continuation Phase|Poor Compliance|1|||
147571300|NCT00395694|532248857|FG001|Continuation Phase|Poor Compliance|0|||
147571301|NCT00395694|532248856|FG000|Continuation Phase|Withdrawal by Subject|0|||
147571302|NCT00395694|532248857|FG001|Continuation Phase|Withdrawal by Subject|2|||
147571303|NCT02699866|532248860|FG000|Overall Study|Withdrawal by Subject|3|||
147571304|NCT02699866|532248860|FG000|Overall Study|Physician Decision|2|||
147571305|NCT02699866|532248860|FG000|Overall Study|Adverse Event|3|||
147571306|NCT02849457|532248861|FG000|Enrolled, Pre-randomized Period|Excluded prior to randomization due to discovery of exclusion criteria, e.g. prenatal mTOR inhibitor|0|||
147135622|NCT01812057|530664455|FG001|Overall Study|Physician Decision|0|||
147135623|NCT01880957|530664460|FG000|Overall Study|Diagnosis: Unipolar Depression|12|||
147135624|NCT01880957|530664461|FG001|Overall Study|Diagnosis: Unipolar Depression|0|||
147135625|NCT01880957|530664460|FG000|Overall Study|Lost to Follow-up|11|||
147135626|NCT01880957|530664461|FG001|Overall Study|Lost to Follow-up|0|||
147135627|NCT01880957|530664460|FG000|Overall Study|Poor Tolerance to Lithium/Declined Treatment|5|||
147135628|NCT01880957|530664461|FG001|Overall Study|Poor Tolerance to Lithium/Declined Treatment|0|||
147135629|NCT02951780|530664462|FG000|Period 1|Adverse Event|0|||
147135630|NCT02951780|530664463|FG001|Period 1|Adverse Event|0|||
147135631|NCT02951780|530664464|FG002|Period 1|Adverse Event|0|||
147135632|NCT02951780|530664465|FG003|Period 1|Adverse Event|1|||
147135633|NCT02951780|530664466|FG004|Period 1|Adverse Event|0|||
147135634|NCT02951780|530664467|FG005|Period 1|Adverse Event|0|||
147445483|NCT00974675|531795866|FG003|Overall Study|Physician Decision|0|||
147651648|NCT00528372|532546570|FG005|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|4|||
147135635|NCT02951780|530664468|FG006|Period 1|Adverse Event|0|||
147135636|NCT02951780|530664469|FG007|Period 1|Adverse Event|0|||
147135637|NCT02951780|530664470|FG008|Period 1|Adverse Event|0|||
147135638|NCT02951780|530664462|FG000|Period 1|Scheduling Conflicts|0|||
147135639|NCT02951780|530664463|FG001|Period 1|Scheduling Conflicts|0|||
147445484|NCT00974675|531795863|FG000|Overall Study|Participant on holiday; unable to attend|0|||
147445485|NCT00974675|531795864|FG001|Overall Study|Participant on holiday; unable to attend|0|||
147445486|NCT00974675|531795865|FG002|Overall Study|Participant on holiday; unable to attend|0|||
147445487|NCT00974675|531795866|FG003|Overall Study|Participant on holiday; unable to attend|1|||
147135640|NCT02951780|530664464|FG002|Period 1|Scheduling Conflicts|0|||
147135641|NCT02951780|530664465|FG003|Period 1|Scheduling Conflicts|0|||
147135642|NCT02951780|530664466|FG004|Period 1|Scheduling Conflicts|0|||
147445488|NCT01394627|531795867|FG000|First Intervention (1 Day)|poor intravenous access|0|||
147445489|NCT01394627|531795868|FG001|First Intervention (1 Day)|poor intravenous access|1|||
147445490|NCT01394627|531795867|FG000|Washout (1-3 Months)|concurrent enrollment in another study|1|||
147445491|NCT01394627|531795868|FG001|Washout (1-3 Months)|concurrent enrollment in another study|0|||
147445492|NCT04744207|531795869|FG000|Treatment|Withdrawal by Subject|2|||
147445493|NCT04744207|531795870|FG001|Treatment|Withdrawal by Subject|0|||
147445494|NCT04744207|531795869|FG000|Treatment|Adverse Event|1|||
147445495|NCT04744207|531795870|FG001|Treatment|Adverse Event|2|||
147445496|NCT03223428|531795872|FG000|Overall Study|No longer taking Xermelo|27|||
147445497|NCT03223428|531795872|FG000|Overall Study|Declined Consent|1|||
147445498|NCT03223428|531795872|FG000|Overall Study|Non-responders|56|||
147445499|NCT03223428|531795872|FG000|Overall Study|Withdrawal by Subject|14|||
147445500|NCT00777101|531795874|FG000|Overall Study|Death|48|||
147445501|NCT00777101|531795875|FG001|Overall Study|Death|43|||
147445502|NCT00777101|531795874|FG000|Overall Study|Withdrawal by Subject|11|||
147445503|NCT00777101|531795875|FG001|Overall Study|Withdrawal by Subject|6|||
147445504|NCT00777101|531795874|FG000|Overall Study|Lost to Follow-up|2|||
147571307|NCT02849457|532248862|FG001|Enrolled, Pre-randomized Period|Excluded prior to randomization due to discovery of exclusion criteria, e.g. prenatal mTOR inhibitor|0|||
147571308|NCT02849457|532248863|FG002|Enrolled, Pre-randomized Period|Excluded prior to randomization due to discovery of exclusion criteria, e.g. prenatal mTOR inhibitor|12|||
147571309|NCT02849457|532248864|FG003|Enrolled, Pre-randomized Period|Excluded prior to randomization due to discovery of exclusion criteria, e.g. prenatal mTOR inhibitor|0|||
147571310|NCT04238754|532248868|FG000|Washout - 1 Week|Lost to Follow-up|1|||
147571311|NCT04238754|532248869|FG001|Washout - 1 Week|Lost to Follow-up|0|||
147571312|NCT01294917|532248872|FG000|Overall Study|Relocation|5|||
147571313|NCT01294917|532248872|FG000|Overall Study|Inconvenience|1|||
147571314|NCT03406156|532248874|FG000|Overall Study|Death|9|||
147571315|NCT03406156|532248875|FG001|Overall Study|Death|3|||
147571316|NCT03406156|532248874|FG000|Overall Study|Withdrawal by Subject|1|||
147571317|NCT03406156|532248875|FG001|Overall Study|Withdrawal by Subject|2|||
147571318|NCT03406156|532248874|FG000|Overall Study|COVID-19 infection|1|||
147571319|NCT03406156|532248875|FG001|Overall Study|COVID-19 infection|0|||
147571320|NCT03406156|532248874|FG000|Overall Study|Non-compliance with study procedures|1|||
147571321|NCT03406156|532248875|FG001|Overall Study|Non-compliance with study procedures|1|||
147571322|NCT03406156|532248874|FG000|Overall Study|Lost to Follow-up|0|||
147571323|NCT03406156|532248875|FG001|Overall Study|Lost to Follow-up|2|||
147571324|NCT03406156|532248874|FG000|Overall Study|Other, not specified|72|||
147571325|NCT03406156|532248875|FG001|Overall Study|Other, not specified|28|||
147571326|NCT00835536|532248878|FG000|Washout of 5 Weeks|Withdrawal by Subject|1|||
147571327|NCT00835536|532248879|FG001|Washout of 5 Weeks|Withdrawal by Subject|0|||
147571328|NCT01686477|532248880|FG000|Feeding Intervention|Death|1|||
147571329|NCT01686477|532248881|FG001|Feeding Intervention|Death|0|||
147571330|NCT01686477|532248882|FG002|Feeding Intervention|Death|1|||
147571331|NCT01686477|532248880|FG000|Feeding Intervention|Withdrawal by Subject|0|||
147571332|NCT01686477|532248881|FG001|Feeding Intervention|Withdrawal by Subject|6|||
147571333|NCT01686477|532248882|FG002|Feeding Intervention|Withdrawal by Subject|0|||
147571334|NCT01686477|532248880|FG000|Feeding Intervention|Physician Decision|1|||
147571335|NCT01686477|532248881|FG001|Feeding Intervention|Physician Decision|2|||
147571336|NCT01686477|532248882|FG002|Feeding Intervention|Physician Decision|0|||
147571337|NCT01686477|532248880|FG000|Feeding Intervention|Met pre-defined safety threshold|1|||
147571338|NCT01686477|532248881|FG001|Feeding Intervention|Met pre-defined safety threshold|0|||
147571339|NCT01686477|532248882|FG002|Feeding Intervention|Met pre-defined safety threshold|1|||
147571340|NCT01686477|532248880|FG000|Feeding Intervention|Transfer to a non-participating hospital|0|||
147571341|NCT01686477|532248881|FG001|Feeding Intervention|Transfer to a non-participating hospital|1|||
147135643|NCT02951780|530664467|FG005|Period 1|Scheduling Conflicts|0|||
147135644|NCT02951780|530664468|FG006|Period 1|Scheduling Conflicts|0|||
147135645|NCT02951780|530664469|FG007|Period 1|Scheduling Conflicts|1|||
147571342|NCT01686477|532248882|FG002|Feeding Intervention|Transfer to a non-participating hospital|1|||
147571343|NCT01686477|532248880|FG000|Primary Outcome Term Scan|Withdrawal by Subject|6|||
147571344|NCT01686477|532248881|FG001|Primary Outcome Term Scan|Withdrawal by Subject|5|||
147571345|NCT01686477|532248882|FG002|Primary Outcome Term Scan|Withdrawal by Subject|5|||
147445505|NCT00777101|531795875|FG001|Overall Study|Lost to Follow-up|1|||
147571346|NCT01686477|532248880|FG000|Primary Outcome Term Scan|Lost to Follow-up|1|||
147571347|NCT01686477|532248881|FG001|Primary Outcome Term Scan|Lost to Follow-up|1|||
147571348|NCT01686477|532248882|FG002|Primary Outcome Term Scan|Lost to Follow-up|1|||
147135646|NCT02951780|530664470|FG008|Period 1|Scheduling Conflicts|0|||
147135647|NCT02951780|530664462|FG000|Period 2|Scheduling Conflicts|0|||
147135648|NCT02951780|530664463|FG001|Period 2|Scheduling Conflicts|0|||
147135649|NCT02951780|530664464|FG002|Period 2|Scheduling Conflicts|0|||
147135650|NCT02951780|530664465|FG003|Period 2|Scheduling Conflicts|0|||
147135651|NCT02951780|530664466|FG004|Period 2|Scheduling Conflicts|0|||
147135652|NCT02951780|530664467|FG005|Period 2|Scheduling Conflicts|0|||
147135653|NCT02951780|530664468|FG006|Period 2|Scheduling Conflicts|0|||
147571349|NCT01686477|532248880|FG000|Primary Outcome Term Scan|Scanner unavailable to measure primary outcome|2|||
147571350|NCT01686477|532248881|FG001|Primary Outcome Term Scan|Scanner unavailable to measure primary outcome|0|||
147571351|NCT01686477|532248882|FG002|Primary Outcome Term Scan|Scanner unavailable to measure primary outcome|0|||
147571352|NCT01686477|532248880|FG000|Term Plus 6 Week Scan (End of Study)|Withdrawal by Subject|7|||
147571353|NCT01686477|532248881|FG001|Term Plus 6 Week Scan (End of Study)|Withdrawal by Subject|12|||
147571354|NCT01686477|532248882|FG002|Term Plus 6 Week Scan (End of Study)|Withdrawal by Subject|5|||
147571355|NCT01686477|532248880|FG000|Term Plus 6 Week Scan (End of Study)|Lost to Follow-up|0|||
147571356|NCT01686477|532248881|FG001|Term Plus 6 Week Scan (End of Study)|Lost to Follow-up|2|||
147571357|NCT01686477|532248882|FG002|Term Plus 6 Week Scan (End of Study)|Lost to Follow-up|0|||
147571358|NCT01249651|532248887|FG000|Overall Study|Withdrawal by Subject|4|||
147571359|NCT01249651|532248887|FG000|Overall Study|Adverse Event|1|||
147571360|NCT01249651|532248887|FG000|Overall Study|Protocol Violation|1|||
147571361|NCT01249651|532248887|FG000|Overall Study|Sponsor Decision|1|||
147571362|NCT00813592|532248888|FG000|Overall Study|Disease assessment was not completed per|2|||
147571363|NCT03873272|532248891|FG000|Overall Study|Withdrawal by Subject|2|||
147571364|NCT03873272|532248892|FG001|Overall Study|Withdrawal by Subject|0|||
147571365|NCT03873272|532248893|FG002|Overall Study|Withdrawal by Subject|1|||
147571366|NCT03873272|532248891|FG000|Overall Study|Death|0|||
147571367|NCT03873272|532248892|FG001|Overall Study|Death|2|||
147571368|NCT03873272|532248893|FG002|Overall Study|Death|1|||
147571369|NCT04544410|532248894|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
147571370|NCT04544410|532248895|FG001|Double-blind Treatment Period|Withdrawal by Subject|2|||
147571371|NCT04544410|532248894|FG000|Double-blind Treatment Period|Adverse Event|1|||
147571372|NCT04544410|532248895|FG001|Double-blind Treatment Period|Adverse Event|0|||
147571373|NCT04544410|532248894|FG000|Double-blind Treatment Period|Lost to Follow-up|1|||
147571374|NCT04544410|532248895|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
147571375|NCT04544410|532248894|FG000|Double-blind Treatment Period|Protocol Violation|1|||
147571376|NCT04544410|532248895|FG001|Double-blind Treatment Period|Protocol Violation|0|||
147571377|NCT04544410|532248894|FG000|Open-Label Treatment Period|Study Terminated|15|||
147571378|NCT04544410|532248895|FG001|Open-Label Treatment Period|Study Terminated|19|||
147571379|NCT04544410|532248894|FG000|Open-Label Treatment Period|Withdrawal by Subject|6|||
147571380|NCT04544410|532248895|FG001|Open-Label Treatment Period|Withdrawal by Subject|5|||
147571381|NCT04544410|532248894|FG000|Open-Label Treatment Period|Adverse Event|0|||
147571382|NCT04544410|532248895|FG001|Open-Label Treatment Period|Adverse Event|1|||
147571383|NCT04544410|532248894|FG000|Open-Label Treatment Period|Physician Decision|1|||
147571384|NCT04544410|532248895|FG001|Open-Label Treatment Period|Physician Decision|0|||
147571385|NCT04544410|532248894|FG000|Open-Label Treatment Period|Other|0|||
147571386|NCT04544410|532248895|FG001|Open-Label Treatment Period|Other|1|||
147571387|NCT02430480|532248896|FG000|Overall Study|Death|1|||
147571388|NCT02430480|532248896|FG000|Overall Study|Anesthesia concerns|1|||
147571389|NCT02430480|532248896|FG000|Overall Study|Progressed on treatment|1|||
147571390|NCT04493684|532248897|FG000|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|1|||
147571391|NCT04493684|532248898|FG001|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
147571392|NCT04493684|532248899|FG002|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|1|||
147571393|NCT04493684|532248900|FG003|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
147571394|NCT04493684|532248901|FG004|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
147571395|NCT04493684|532248902|FG005|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|1|||
147571396|NCT04493684|532248903|FG006|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
147571397|NCT04493684|532248904|FG007|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
147571398|NCT04493684|532248905|FG008|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
147571399|NCT04493684|532248906|FG009|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
147571400|NCT04493684|532248907|FG010|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
147571401|NCT04493684|532248908|FG011|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
147571402|NCT04493684|532248909|FG012|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
147651649|NCT00528372|532546571|FG006|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|6|||
147651650|NCT00528372|532546572|FG007|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|2|||
147318379|NCT01232556|531331698|FG000|Overall Study|Withdrawal by Subject|21|||
147318380|NCT01232556|531331699|FG001|Overall Study|Withdrawal by Subject|17|||
147571403|NCT04493684|532248910|FG013|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
147651651|NCT00528372|532546573|FG008|Short-term (ST) Period (Day 1-Week 24)|Withdrawal by Subject|4|||
147135654|NCT02951780|530664469|FG007|Period 2|Scheduling Conflicts|1|||
147135655|NCT02951780|530664470|FG008|Period 2|Scheduling Conflicts|0|||
147135656|NCT02289469|530664473|FG000|Overall Study|Unable to match a control|6|||
147135657|NCT02289469|530664474|FG001|Overall Study|Unable to match a control|0|||
147135658|NCT03508050|530664475|FG000|Overall Study|Pleural adhesions|1|||
147135659|NCT03508050|530664476|FG001|Overall Study|Pleural adhesions|0|||
147135660|NCT03508050|530664475|FG000|Overall Study|Mucus plug|1|||
147135661|NCT03508050|530664476|FG001|Overall Study|Mucus plug|0|||
147135662|NCT03508050|530664475|FG000|Overall Study|Negative biopsy, surgery cancelled|3|||
147135663|NCT03508050|530664476|FG001|Overall Study|Negative biopsy, surgery cancelled|1|||
147135664|NCT03508050|530664475|FG000|Overall Study|Sustained desaturation|0|||
147445506|NCT00777101|531795874|FG000|Overall Study|Discontinuation of Study by Sponsor|1|||
147445507|NCT00777101|531795875|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
147445508|NCT00777101|531795874|FG000|Overall Study|Failed to Return|0|||
147445509|NCT00777101|531795875|FG001|Overall Study|Failed to Return|1|||
147135665|NCT03508050|530664476|FG001|Overall Study|Sustained desaturation|1|||
147135666|NCT01082614|530664477|FG000|Overall Study|Adverse Event|1|||
147135667|NCT01082614|530664478|FG001|Overall Study|Adverse Event|4|||
147135668|NCT01082614|530664477|FG000|Overall Study|Equipment Malfunction|0|||
147135669|NCT01082614|530664478|FG001|Overall Study|Equipment Malfunction|1|||
147135670|NCT01082614|530664477|FG000|Overall Study|Physician Decision|2|||
147135671|NCT01082614|530664478|FG001|Overall Study|Physician Decision|0|||
147135672|NCT03710889|530664479|FG000|Overall Study|Adverse Event|2|||
147445510|NCT02230384|531795876|FG000|Phase 1|Lost to Follow-up|1|||
147445511|NCT02230384|531795877|FG001|Phase 1|Lost to Follow-up|0|||
147445512|NCT02230384|531795876|FG000|Phase 1|Physician Decision|0|||
147445513|NCT02230384|531795877|FG001|Phase 1|Physician Decision|1|||
147135673|NCT03710889|530664479|FG000|Overall Study|Protocol Deviation|1|||
147135674|NCT00421148|530664480|FG000|Overall Study|Lost to Follow-up|0|||
147135675|NCT00421148|530664481|FG001|Overall Study|Lost to Follow-up|0|||
147135676|NCT00421148|530664482|FG002|Overall Study|Lost to Follow-up|0|||
147135677|NCT00421148|530664483|FG003|Overall Study|Lost to Follow-up|0|||
147135678|NCT00421148|530664484|FG004|Overall Study|Lost to Follow-up|0|||
147135679|NCT00421148|530664485|FG005|Overall Study|Lost to Follow-up|0|||
147135680|NCT00421148|530664486|FG006|Overall Study|Lost to Follow-up|0|||
147135681|NCT00421148|530664487|FG007|Overall Study|Lost to Follow-up|0|||
147135682|NCT00421148|530664488|FG008|Overall Study|Lost to Follow-up|0|||
147135683|NCT00421148|530664489|FG009|Overall Study|Lost to Follow-up|0|||
147135684|NCT00421148|530664490|FG010|Overall Study|Lost to Follow-up|0|||
147135685|NCT00421148|530664491|FG011|Overall Study|Lost to Follow-up|0|||
147135686|NCT00421148|530664492|FG012|Overall Study|Lost to Follow-up|0|||
147135687|NCT00421148|530664493|FG013|Overall Study|Lost to Follow-up|0|||
147571404|NCT04493684|532248911|FG014|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
147571405|NCT04493684|532248912|FG015|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
147571406|NCT04493684|532248913|FG016|Part 1:Treatment Period 1-Up to 9 Weeks|Withdrawal by Subject|0|||
147571407|NCT04493684|532248897|FG000|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|1|||
147571408|NCT04493684|532248898|FG001|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
147135688|NCT00421148|530664494|FG014|Overall Study|Lost to Follow-up|0|||
147135689|NCT00421148|530664495|FG015|Overall Study|Lost to Follow-up|0|||
147135690|NCT00421148|530664496|FG016|Overall Study|Lost to Follow-up|0|||
147135691|NCT00421148|530664497|FG017|Overall Study|Lost to Follow-up|1|||
147135692|NCT00421148|530664498|FG018|Overall Study|Lost to Follow-up|0|||
147135693|NCT00421148|530664499|FG019|Overall Study|Lost to Follow-up|0|||
147135694|NCT00421148|530664480|FG000|Overall Study|Withdrawal by Subject|0|||
147135695|NCT00421148|530664481|FG001|Overall Study|Withdrawal by Subject|0|||
147135696|NCT00421148|530664482|FG002|Overall Study|Withdrawal by Subject|0|||
147135697|NCT00421148|530664483|FG003|Overall Study|Withdrawal by Subject|0|||
147571409|NCT04493684|532248899|FG002|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
147571410|NCT04493684|532248900|FG003|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
147571411|NCT04493684|532248901|FG004|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
147571412|NCT04493684|532248902|FG005|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
147571413|NCT04493684|532248903|FG006|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
147651652|NCT00528372|532546565|FG000|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|5|||
147135698|NCT00421148|530664484|FG004|Overall Study|Withdrawal by Subject|0|||
147445514|NCT02230384|531795876|FG000|Phase 2 - Switch|Withdrawal by Subject|0|||
147651653|NCT00528372|532546566|FG001|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|1|||
147445515|NCT02230384|531795877|FG001|Phase 2 - Switch|Withdrawal by Subject|1|||
147135699|NCT00421148|530664485|FG005|Overall Study|Withdrawal by Subject|0|||
147445516|NCT02230384|531795876|FG000|Phase 2 - Switch|Lost to Follow-up|1|||
147445517|NCT02230384|531795877|FG001|Phase 2 - Switch|Lost to Follow-up|0|||
147135700|NCT00421148|530664486|FG006|Overall Study|Withdrawal by Subject|0|||
147135701|NCT00421148|530664487|FG007|Overall Study|Withdrawal by Subject|0|||
147135702|NCT00421148|530664488|FG008|Overall Study|Withdrawal by Subject|0|||
147135703|NCT00421148|530664489|FG009|Overall Study|Withdrawal by Subject|0|||
147135704|NCT00421148|530664490|FG010|Overall Study|Withdrawal by Subject|0|||
147135705|NCT00421148|530664491|FG011|Overall Study|Withdrawal by Subject|0|||
147135706|NCT00421148|530664492|FG012|Overall Study|Withdrawal by Subject|0|||
147135707|NCT00421148|530664493|FG013|Overall Study|Withdrawal by Subject|0|||
147135708|NCT00421148|530664494|FG014|Overall Study|Withdrawal by Subject|0|||
147135709|NCT00421148|530664495|FG015|Overall Study|Withdrawal by Subject|0|||
147135710|NCT00421148|530664496|FG016|Overall Study|Withdrawal by Subject|0|||
147571414|NCT04493684|532248904|FG007|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
147571415|NCT04493684|532248905|FG008|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
147571416|NCT04493684|532248906|FG009|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
147571417|NCT04493684|532248907|FG010|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
147571418|NCT04493684|532248908|FG011|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
147571419|NCT04493684|532248909|FG012|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
147571420|NCT04493684|532248910|FG013|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
147571421|NCT04493684|532248911|FG014|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
147571422|NCT04493684|532248912|FG015|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
147571423|NCT04493684|532248913|FG016|Part 1:Treatment Period 2-Up to 9 Weeks|Physician Decision|0|||
147571424|NCT04493684|532248897|FG000|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
147571425|NCT04493684|532248898|FG001|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
147571426|NCT04493684|532248899|FG002|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
147571427|NCT04493684|532248900|FG003|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
147571428|NCT04493684|532248901|FG004|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
147571429|NCT04493684|532248902|FG005|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
147571430|NCT04493684|532248903|FG006|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|1|||
147571431|NCT04493684|532248904|FG007|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
147571432|NCT04493684|532248905|FG008|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
147571433|NCT04493684|532248906|FG009|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
147571434|NCT04493684|532248907|FG010|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
147571435|NCT04493684|532248908|FG011|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
147571436|NCT04493684|532248909|FG012|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
147571437|NCT04493684|532248910|FG013|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
147571438|NCT04493684|532248911|FG014|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
147571439|NCT04493684|532248912|FG015|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
147571440|NCT04493684|532248913|FG016|Part 1:Treatment Period 2-Up to 9 Weeks|Protocol Deviation|0|||
147571441|NCT04493684|532248897|FG000|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|1|||
147571442|NCT04493684|532248898|FG001|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
147571443|NCT04493684|532248899|FG002|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
147571444|NCT04493684|532248900|FG003|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
147571445|NCT04493684|532248901|FG004|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
147571446|NCT04493684|532248902|FG005|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
147571447|NCT04493684|532248903|FG006|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
147571448|NCT04493684|532248904|FG007|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
147571449|NCT04493684|532248905|FG008|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
147571450|NCT04493684|532248906|FG009|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
147571451|NCT04493684|532248907|FG010|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
147571452|NCT04493684|532248908|FG011|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
147571453|NCT04493684|532248909|FG012|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
147571454|NCT04493684|532248910|FG013|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
147571455|NCT04493684|532248911|FG014|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
147571456|NCT04493684|532248912|FG015|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
147571457|NCT04493684|532248913|FG016|Part 1:Treatment Period 3-Up to 9 Weeks|Adverse Event|0|||
147571458|NCT04493684|532248897|FG000|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
147571459|NCT04493684|532248898|FG001|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
147571460|NCT04493684|532248899|FG002|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
147571461|NCT04493684|532248900|FG003|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
147571462|NCT04493684|532248901|FG004|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
147571463|NCT04493684|532248902|FG005|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|1|||
147571464|NCT04493684|532248903|FG006|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
147571465|NCT04493684|532248904|FG007|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
147571466|NCT04493684|532248905|FG008|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
147571467|NCT04493684|532248906|FG009|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
147571468|NCT04493684|532248907|FG010|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
147571469|NCT04493684|532248908|FG011|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
147135711|NCT00421148|530664497|FG017|Overall Study|Withdrawal by Subject|1|||
147135712|NCT00421148|530664498|FG018|Overall Study|Withdrawal by Subject|0|||
147135713|NCT00421148|530664499|FG019|Overall Study|Withdrawal by Subject|0|||
147135714|NCT00421148|530664480|FG000|Overall Study|Protocol Violation|0|||
147135715|NCT00421148|530664481|FG001|Overall Study|Protocol Violation|0|||
147135716|NCT00421148|530664482|FG002|Overall Study|Protocol Violation|0|||
147135717|NCT00421148|530664483|FG003|Overall Study|Protocol Violation|0|||
147135718|NCT00421148|530664484|FG004|Overall Study|Protocol Violation|0|||
147135719|NCT00421148|530664485|FG005|Overall Study|Protocol Violation|1|||
147135720|NCT00421148|530664486|FG006|Overall Study|Protocol Violation|0|||
147135721|NCT00421148|530664487|FG007|Overall Study|Protocol Violation|0|||
147135722|NCT00421148|530664488|FG008|Overall Study|Protocol Violation|0|||
147135723|NCT00421148|530664489|FG009|Overall Study|Protocol Violation|0|||
147135724|NCT00421148|530664490|FG010|Overall Study|Protocol Violation|0|||
147135725|NCT00421148|530664491|FG011|Overall Study|Protocol Violation|0|||
147135726|NCT00421148|530664492|FG012|Overall Study|Protocol Violation|0|||
147135727|NCT00421148|530664493|FG013|Overall Study|Protocol Violation|0|||
147237391|NCT04680052|531040569|FG001|Overall Study|Hypersensitivity to Rituximab; Did Not Receive Treatment|1|||
147237392|NCT04680052|531040570|FG002|Overall Study|Hypersensitivity to Rituximab; Did Not Receive Treatment|0|||
147237393|NCT04680052|531040571|FG003|Overall Study|Hypersensitivity to Rituximab; Did Not Receive Treatment|0|||
147237394|NCT04680052|531040568|FG000|Overall Study|Physician Decision|0|||
147237395|NCT04680052|531040569|FG001|Overall Study|Physician Decision|1|||
147237396|NCT04680052|531040570|FG002|Overall Study|Physician Decision|0|||
147237397|NCT04680052|531040571|FG003|Overall Study|Physician Decision|0|||
147237398|NCT01367002|531040572|FG000|Overall Study|Withdrawal by Subject|1|||
147237399|NCT01367002|531040573|FG001|Overall Study|Withdrawal by Subject|0|||
147237400|NCT01367002|531040572|FG000|Overall Study|Physician Decision|0|||
147237401|NCT01367002|531040573|FG001|Overall Study|Physician Decision|2|||
147237402|NCT01516437|531040574|FG000|Overall Study|Reason not specified|0|||
147237403|NCT01516437|531040575|FG001|Overall Study|Reason not specified|0|||
147237404|NCT01516437|531040576|FG002|Overall Study|Reason not specified|1|||
147237405|NCT01516437|531040577|FG003|Overall Study|Reason not specified|1|||
147237406|NCT01385566|531040581|FG000|Overall Study|Lost to Follow-up|1|||
147237407|NCT01385566|531040582|FG001|Overall Study|Lost to Follow-up|0|||
147237408|NCT01385566|531040583|FG002|Overall Study|Lost to Follow-up|0|||
147571470|NCT04493684|532248909|FG012|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
147571471|NCT04493684|532248910|FG013|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
147237409|NCT01385566|531040584|FG003|Overall Study|Lost to Follow-up|0|||
147237410|NCT01385566|531040585|FG004|Overall Study|Lost to Follow-up|0|||
147237411|NCT01385566|531040586|FG005|Overall Study|Lost to Follow-up|0|||
147237412|NCT01385566|531040581|FG000|Overall Study|Withdrawal by Subject|0|||
147237413|NCT01385566|531040582|FG001|Overall Study|Withdrawal by Subject|0|||
147237414|NCT01385566|531040583|FG002|Overall Study|Withdrawal by Subject|0|||
147571472|NCT04493684|532248911|FG014|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
147571473|NCT04493684|532248912|FG015|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
147571474|NCT04493684|532248913|FG016|Part 1:Treatment Period 3-Up to 9 Weeks|Physician Decision|0|||
147571475|NCT04493684|532248897|FG000|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
147571476|NCT04493684|532248898|FG001|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
147571477|NCT04493684|532248899|FG002|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
147571478|NCT04493684|532248900|FG003|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
147571479|NCT04493684|532248901|FG004|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
147571480|NCT04493684|532248902|FG005|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
147571481|NCT04493684|532248903|FG006|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
147571482|NCT04493684|532248904|FG007|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
147571483|NCT04493684|532248905|FG008|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
147571484|NCT04493684|532248906|FG009|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
147571485|NCT04493684|532248907|FG010|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
147571486|NCT04493684|532248908|FG011|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|1|||
147571487|NCT04493684|532248909|FG012|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
147571488|NCT04493684|532248910|FG013|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
147571489|NCT04493684|532248911|FG014|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
147571490|NCT04493684|532248912|FG015|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
147571491|NCT04493684|532248913|FG016|Part 2:Treatment Period 1-Up to 5 Weeks|Withdrawal by Subject|0|||
147571492|NCT04493684|532248897|FG000|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
147571493|NCT04493684|532248898|FG001|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
147135728|NCT00421148|530664494|FG014|Overall Study|Protocol Violation|0|||
147135729|NCT00421148|530664495|FG015|Overall Study|Protocol Violation|0|||
147135730|NCT00421148|530664496|FG016|Overall Study|Protocol Violation|0|||
147237415|NCT01385566|531040584|FG003|Overall Study|Withdrawal by Subject|1|||
147237416|NCT01385566|531040585|FG004|Overall Study|Withdrawal by Subject|0|||
147237417|NCT01385566|531040586|FG005|Overall Study|Withdrawal by Subject|0|||
147237418|NCT00825682|531040587|FG000|Overall Study|personal reasons/ inconvenience|13|||
147237419|NCT00825682|531040588|FG001|Overall Study|personal reasons/ inconvenience|5|||
147237420|NCT00560105|531040595|FG000|Overall Study|musculoskeletal chest discomfort with us|1|||
147571494|NCT04493684|532248899|FG002|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
147571495|NCT04493684|532248900|FG003|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
147571496|NCT04493684|532248901|FG004|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
147571497|NCT04493684|532248902|FG005|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
147571498|NCT04493684|532248903|FG006|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
147571499|NCT04493684|532248904|FG007|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
147571500|NCT04493684|532248905|FG008|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
147571501|NCT04493684|532248906|FG009|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
147571502|NCT04493684|532248907|FG010|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
147571503|NCT04493684|532248908|FG011|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
147571504|NCT04493684|532248909|FG012|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
147571505|NCT04493684|532248910|FG013|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
147571506|NCT04493684|532248911|FG014|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
147571507|NCT04493684|532248912|FG015|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|1|||
147571508|NCT04493684|532248913|FG016|Part 3:Treatment Period 1-Up to 4 Weeks|Physician Decision|0|||
147571509|NCT04493684|532248897|FG000|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
147571510|NCT04493684|532248898|FG001|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
147571511|NCT04493684|532248899|FG002|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
147571512|NCT04493684|532248900|FG003|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
147571513|NCT04493684|532248901|FG004|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
147571514|NCT04493684|532248902|FG005|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
147571515|NCT04493684|532248903|FG006|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
147571516|NCT04493684|532248904|FG007|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
147571517|NCT04493684|532248905|FG008|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
147135731|NCT00421148|530664497|FG017|Overall Study|Protocol Violation|0|||
147135732|NCT00421148|530664498|FG018|Overall Study|Protocol Violation|1|||
147135733|NCT00421148|530664499|FG019|Overall Study|Protocol Violation|0|||
147135734|NCT01538199|530664500|FG000|Overall Study|Lost to Follow-up|1|||
147135735|NCT01538199|530664501|FG001|Overall Study|Lost to Follow-up|2|||
147135736|NCT01538199|530664502|FG002|Overall Study|Lost to Follow-up|1|||
147135737|NCT01538199|530664503|FG003|Overall Study|Lost to Follow-up|0|||
147135738|NCT01538199|530664500|FG000|Overall Study|participant did not have time|1|||
147135739|NCT01538199|530664501|FG001|Overall Study|participant did not have time|0|||
147135740|NCT01538199|530664502|FG002|Overall Study|participant did not have time|0|||
147135741|NCT01538199|530664503|FG003|Overall Study|participant did not have time|2|||
147135742|NCT01538199|530664500|FG000|Overall Study|Lack of Efficacy|0|||
147135743|NCT01538199|530664501|FG001|Overall Study|Lack of Efficacy|1|||
147135744|NCT01538199|530664502|FG002|Overall Study|Lack of Efficacy|0|||
147135745|NCT01538199|530664503|FG003|Overall Study|Lack of Efficacy|0|||
147135746|NCT02081586|530664504|FG000|Overall Study|Lost to Follow-up|0|||
147135747|NCT02081586|530664505|FG001|Overall Study|Lost to Follow-up|1|||
147135748|NCT02081586|530664506|FG002|Overall Study|Lost to Follow-up|0|||
147135749|NCT02081586|530664507|FG003|Overall Study|Lost to Follow-up|1|||
147135750|NCT02081586|530664504|FG000|Overall Study|Head injury not related to study|0|||
147135751|NCT02081586|530664505|FG001|Overall Study|Head injury not related to study|0|||
147135752|NCT02081586|530664506|FG002|Overall Study|Head injury not related to study|1|||
147135753|NCT02081586|530664507|FG003|Overall Study|Head injury not related to study|0|||
147135754|NCT02121509|530664513|FG000|Washout Period (35 Days)|Adverse Event|1|||
147135755|NCT02121509|530664514|FG001|Washout Period (35 Days)|Adverse Event|1|||
147135756|NCT02121509|530664515|FG002|Washout Period (35 Days)|Adverse Event|0|||
147135757|NCT02121509|530664516|FG003|Washout Period (35 Days)|Adverse Event|0|||
147237421|NCT00560105|531040596|FG001|Overall Study|musculoskeletal chest discomfort with us|2|||
147571518|NCT04493684|532248906|FG009|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
147571519|NCT04493684|532248907|FG010|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
147571520|NCT04493684|532248908|FG011|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
147571521|NCT04493684|532248909|FG012|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
147135758|NCT02121509|530664513|FG000|Washout Period (35 Days)|Withdrawal by Subject|0|||
147237422|NCT02400333|531040597|FG000|Overall Study|Withdrawal by Subject|0|||
147237423|NCT02400333|531040598|FG001|Overall Study|Withdrawal by Subject|1|||
147237424|NCT02400333|531040599|FG002|Overall Study|Withdrawal by Subject|0|||
147237425|NCT02400333|531040600|FG003|Overall Study|Withdrawal by Subject|1|||
147237426|NCT02400333|531040597|FG000|Overall Study|Protocol Violation|1|||
147237427|NCT02400333|531040598|FG001|Overall Study|Protocol Violation|0|||
147237428|NCT02400333|531040599|FG002|Overall Study|Protocol Violation|2|||
147237429|NCT02400333|531040600|FG003|Overall Study|Protocol Violation|1|||
147237430|NCT00094172|531040608|FG000|Overall Study|Adverse Event|0|||
147237431|NCT00094172|531040609|FG001|Overall Study|Adverse Event|1|||
147135759|NCT02121509|530664514|FG001|Washout Period (35 Days)|Withdrawal by Subject|3|||
147237432|NCT00094172|531040608|FG000|Overall Study|Lost to Follow-up|2|||
147237433|NCT00094172|531040609|FG001|Overall Study|Lost to Follow-up|0|||
147237434|NCT00094172|531040608|FG000|Overall Study|Protocol Violation|0|||
147237435|NCT00094172|531040609|FG001|Overall Study|Protocol Violation|1|||
147237436|NCT00094172|531040608|FG000|Overall Study|Withdrawal by Subject|10|||
147237437|NCT00094172|531040609|FG001|Overall Study|Withdrawal by Subject|5|||
147237438|NCT00094172|531040608|FG000|Overall Study|Primary endpoint met.|1|||
147237439|NCT00094172|531040609|FG001|Overall Study|Primary endpoint met.|0|||
147571522|NCT04493684|532248910|FG013|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
147571523|NCT04493684|532248911|FG014|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
147571524|NCT04493684|532248912|FG015|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|1|||
147571525|NCT04493684|532248913|FG016|Part 3:Treatment Period 2-Up to 4 Weeks|Physician Decision|0|||
147571526|NCT01963728|532248914|FG000|Overall Study|Study terminated early|0|||
147571527|NCT01963728|532248915|FG001|Overall Study|Study terminated early|1|||
147571528|NCT05152576|532248918|FG000|Overall Study|Lost to Follow-up|3|||
147571529|NCT05152576|532248919|FG001|Overall Study|Lost to Follow-up|0|||
147571530|NCT05152576|532248920|FG002|Overall Study|Lost to Follow-up|0|||
147571531|NCT05152576|532248921|FG003|Overall Study|Lost to Follow-up|1|||
147571532|NCT05152576|532248918|FG000|Overall Study|Withdrawal by Subject|0|||
147571533|NCT05152576|532248919|FG001|Overall Study|Withdrawal by Subject|1|||
147571534|NCT05152576|532248920|FG002|Overall Study|Withdrawal by Subject|0|||
147571535|NCT05152576|532248921|FG003|Overall Study|Withdrawal by Subject|1|||
147571536|NCT05152576|532248918|FG000|Overall Study|Other|2|||
147571537|NCT05152576|532248919|FG001|Overall Study|Other|0|||
147571538|NCT05152576|532248920|FG002|Overall Study|Other|0|||
147571539|NCT05152576|532248921|FG003|Overall Study|Other|0|||
147571540|NCT00859430|532248922|FG000|First Intervention|Withdrawal by Subject|0|||
147571541|NCT00859430|532248923|FG001|First Intervention|Withdrawal by Subject|1|||
147571542|NCT01660243|532250342|FG000|Overall Study|Adverse Event|1|||
147571543|NCT01660243|532250343|FG001|Overall Study|Adverse Event|0|||
147571544|NCT01660243|532250344|FG002|Overall Study|Adverse Event|1|||
147571545|NCT01660243|532250345|FG003|Overall Study|Adverse Event|0|||
147571546|NCT01660243|532250342|FG000|Overall Study|Unable to visit clinic to obtain study drug due to hospitalization|1|||
147571547|NCT01660243|532250343|FG001|Overall Study|Unable to visit clinic to obtain study drug due to hospitalization|0|||
147571548|NCT01660243|532250344|FG002|Overall Study|Unable to visit clinic to obtain study drug due to hospitalization|0|||
147571549|NCT01660243|532250345|FG003|Overall Study|Unable to visit clinic to obtain study drug due to hospitalization|0|||
147571550|NCT01660243|532250342|FG000|Overall Study|Subject was noncompliant with study drug after experiencing AEs; was not discontinued due to the AEs|0|||
147571551|NCT01660243|532250343|FG001|Overall Study|Subject was noncompliant with study drug after experiencing AEs; was not discontinued due to the AEs|0|||
147571552|NCT01660243|532250344|FG002|Overall Study|Subject was noncompliant with study drug after experiencing AEs; was not discontinued due to the AEs|1|||
147571553|NCT01660243|532250345|FG003|Overall Study|Subject was noncompliant with study drug after experiencing AEs; was not discontinued due to the AEs|0|||
147571554|NCT01660243|532250342|FG000|Overall Study|Randomization error|0|||
147571555|NCT01660243|532250343|FG001|Overall Study|Randomization error|0|||
147571556|NCT01660243|532250344|FG002|Overall Study|Randomization error|0|||
147571557|NCT01660243|532250345|FG003|Overall Study|Randomization error|1|||
147571558|NCT02328040|532250363|FG000|First Intervention (2 Days)|Withdrawal by Subject|1|||
147571559|NCT02328040|532250364|FG001|First Intervention (2 Days)|Withdrawal by Subject|1|||
147571560|NCT03049748|532250365|FG000|Overall Study|Lost to Follow-up|1|||
147571561|NCT03049748|532250366|FG001|Overall Study|Lost to Follow-up|0|||
147571562|NCT03049748|532250365|FG000|Overall Study|Death|3|||
147571563|NCT03049748|532250366|FG001|Overall Study|Death|0|||
147571564|NCT03049748|532250365|FG000|Overall Study|Withdrawal by Subject|0|||
147571565|NCT03049748|532250366|FG001|Overall Study|Withdrawal by Subject|3|||
147571566|NCT03049748|532250365|FG000|Overall Study|Protocol Violation|0|||
147571567|NCT03049748|532250366|FG001|Overall Study|Protocol Violation|2|||
147571568|NCT03049748|532250365|FG000|Overall Study|Moved out of state (relocation)|0|||
147571569|NCT03049748|532250366|FG001|Overall Study|Moved out of state (relocation)|1|||
147571570|NCT02682238|532250375|FG000|Overall Study|Lost to Follow-up|0|||
147571571|NCT02682238|532250376|FG001|Overall Study|Lost to Follow-up|2|||
147571572|NCT02682238|532250375|FG000|Overall Study|Withdrawal by Subject|1|||
147571573|NCT02682238|532250376|FG001|Overall Study|Withdrawal by Subject|0|||
147571574|NCT02682238|532250375|FG000|Overall Study|Adverse Event|1|||
147571575|NCT02682238|532250376|FG001|Overall Study|Adverse Event|0|||
147571576|NCT02682238|532250375|FG000|Overall Study|Non-compliance with Study Drug|1|||
147571577|NCT02682238|532250376|FG001|Overall Study|Non-compliance with Study Drug|0|||
147651654|NCT00528372|532546567|FG002|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|2|||
147651655|NCT00528372|532546568|FG003|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|3|||
147237440|NCT00094172|531040608|FG000|Overall Study|Started other MS therapy due to disease|1|||
147237441|NCT00094172|531040609|FG001|Overall Study|Started other MS therapy due to disease|0|||
147237442|NCT00289133|531040614|FG000|Overall Study|Non-study device implanted|12|||
147571578|NCT02682238|532250375|FG000|Overall Study|Non-compliance with Protocol|0|||
147237443|NCT00289133|531040615|FG001|Overall Study|Non-study device implanted|0|||
147445518|NCT02230384|531795876|FG000|Phase 2 - Switch|Adverse Event|2|||
147237444|NCT00289133|531040614|FG000|Overall Study|Protocol Violation|32|||
147135760|NCT02121509|530664515|FG002|Washout Period (35 Days)|Withdrawal by Subject|0|||
147135761|NCT02121509|530664516|FG003|Washout Period (35 Days)|Withdrawal by Subject|0|||
147135762|NCT02121509|530664513|FG000|Washout Period (35 Days)|elevated AST and ALT levels|1|||
147135763|NCT02121509|530664514|FG001|Washout Period (35 Days)|elevated AST and ALT levels|0|||
147135764|NCT02121509|530664515|FG002|Washout Period (35 Days)|elevated AST and ALT levels|0|||
147135765|NCT02121509|530664516|FG003|Washout Period (35 Days)|elevated AST and ALT levels|0|||
147571579|NCT02682238|532250376|FG001|Overall Study|Non-compliance with Protocol|2|||
147571580|NCT01370317|532250377|FG000|Overall Study|Participant withdrew consent|1|||
147571581|NCT01370317|532250378|FG001|Overall Study|Participant withdrew consent|0|||
147571582|NCT01370317|532250377|FG000|Overall Study|Protocol deviation|0|||
147571583|NCT01370317|532250378|FG001|Overall Study|Protocol deviation|1|||
147571584|NCT00075478|532250379|FG000|Overall Study|not eligible|1|||
147571585|NCT00075478|532250380|FG001|Overall Study|not eligible|0|||
147571586|NCT00075478|532250379|FG000|Overall Study|Physician Decision|0|||
147571587|NCT00075478|532250380|FG001|Overall Study|Physician Decision|1|||
147571588|NCT02075463|532250383|FG000|Overall Study|Adverse Event|3|||
147571589|NCT02075463|532250383|FG000|Overall Study|Par. reached stopping criteria|4|||
147571590|NCT02075463|532250383|FG000|Overall Study|Withdrawal by Subject|1|||
147571591|NCT00673660|532250384|FG000|Overall Study|Lost to Follow-up|107|||
147571592|NCT01527006|532250385|FG000|Core Study|Adverse Event|0|||
147571593|NCT01527006|532250386|FG001|Core Study|Adverse Event|2|||
147571594|NCT01527006|532250385|FG000|Core Study|Lost to Follow-up|0|||
147571595|NCT01527006|532250386|FG001|Core Study|Lost to Follow-up|1|||
147571596|NCT01527006|532250385|FG000|Core Study|Subject Choice|1|||
147571597|NCT01527006|532250386|FG001|Core Study|Subject Choice|0|||
147571598|NCT01527006|532250385|FG000|Core Study|Inadequate Therapeutic Effect|1|||
147571599|NCT01527006|532250386|FG001|Core Study|Inadequate Therapeutic Effect|0|||
147571600|NCT01527006|532250385|FG000|Core Study|Withdrawal by Subject|0|||
147571601|NCT01527006|532250386|FG001|Core Study|Withdrawal by Subject|1|||
147571602|NCT01527006|532250385|FG000|Core Study|Other|0|||
147571603|NCT01527006|532250386|FG001|Core Study|Other|2|||
147571604|NCT01527006|532250385|FG000|Extension Phase|Adverse Event|4|||
147571605|NCT01527006|532250386|FG001|Extension Phase|Adverse Event|2|||
147571606|NCT01527006|532250385|FG000|Extension Phase|Lost to Follow-up|0|||
147571607|NCT01527006|532250386|FG001|Extension Phase|Lost to Follow-up|1|||
147571608|NCT01527006|532250385|FG000|Extension Phase|Subject Choice|1|||
147571609|NCT01527006|532250386|FG001|Extension Phase|Subject Choice|1|||
147571610|NCT01527006|532250385|FG000|Extension Phase|Inadequate therapeutic effect|1|||
147571611|NCT01527006|532250386|FG001|Extension Phase|Inadequate therapeutic effect|1|||
147571612|NCT01527006|532250385|FG000|Extension Phase|Other|0|||
147571613|NCT01527006|532250386|FG001|Extension Phase|Other|3|||
147571614|NCT00834340|532250388|FG000|Washout|Adverse Event|1|||
147571615|NCT00834340|532250389|FG001|Washout|Adverse Event|0|||
147571616|NCT00834340|532250388|FG000|Washout|Withdrawal by Subject|1|||
147571617|NCT00834340|532250389|FG001|Washout|Withdrawal by Subject|0|||
147571618|NCT00392665|532250390|FG000|Overall Study|Death|16|||
147571619|NCT00392665|532250391|FG001|Overall Study|Death|14|||
147571620|NCT00392665|532250390|FG000|Overall Study|Lost to Follow-up|1|||
147571621|NCT00392665|532250391|FG001|Overall Study|Lost to Follow-up|1|||
147571622|NCT03673670|532250394|FG000|Treatment Period 1 (3 Days)|Withdrawal by Subject|1|||
147571623|NCT03673670|532250395|FG001|Treatment Period 1 (3 Days)|Withdrawal by Subject|0|||
147571624|NCT03673670|532250396|FG002|Treatment Period 1 (3 Days)|Withdrawal by Subject|0|||
147135766|NCT01978145|530666229|FG000|Treatment Period 1|Adverse Event|1|||
147135767|NCT01978145|530666230|FG001|Treatment Period 1|Adverse Event|9|||
147135768|NCT01978145|530666229|FG000|Treatment Period 1|Physician Decision|1|||
147135769|NCT01978145|530666230|FG001|Treatment Period 1|Physician Decision|0|||
147237445|NCT00289133|531040615|FG001|Overall Study|Protocol Violation|38|||
147571625|NCT03673670|532250397|FG003|Treatment Period 1 (3 Days)|Withdrawal by Subject|0|||
147571626|NCT03673670|532250398|FG004|Treatment Period 1 (3 Days)|Withdrawal by Subject|0|||
147571627|NCT03673670|532250399|FG005|Treatment Period 1 (3 Days)|Withdrawal by Subject|0|||
147571628|NCT03673670|532250394|FG000|Treatment Period 1 (3 Days)|Physician Decision|0|||
147571629|NCT03673670|532250395|FG001|Treatment Period 1 (3 Days)|Physician Decision|0|||
147571630|NCT03673670|532250396|FG002|Treatment Period 1 (3 Days)|Physician Decision|1|||
147571631|NCT03673670|532250397|FG003|Treatment Period 1 (3 Days)|Physician Decision|0|||
147571632|NCT03673670|532250398|FG004|Treatment Period 1 (3 Days)|Physician Decision|0|||
147571633|NCT03673670|532250399|FG005|Treatment Period 1 (3 Days)|Physician Decision|0|||
147571634|NCT03673670|532250394|FG000|Treatment Period 1 (3 Days)|Adverse Event|0|||
147135770|NCT01978145|530666229|FG000|Treatment Period 1|Withdrawal by Subject|5|||
147135771|NCT01978145|530666230|FG001|Treatment Period 1|Withdrawal by Subject|4|||
147571635|NCT03673670|532250395|FG001|Treatment Period 1 (3 Days)|Adverse Event|0|||
147571636|NCT03673670|532250396|FG002|Treatment Period 1 (3 Days)|Adverse Event|0|||
147571637|NCT03673670|532250397|FG003|Treatment Period 1 (3 Days)|Adverse Event|0|||
147571638|NCT03673670|532250398|FG004|Treatment Period 1 (3 Days)|Adverse Event|0|||
147571639|NCT03673670|532250399|FG005|Treatment Period 1 (3 Days)|Adverse Event|1|||
147571640|NCT03673670|532250394|FG000|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0|||
147571641|NCT03673670|532250395|FG001|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0|||
147135772|NCT01978145|530666229|FG000|Treatment Period 1|Par. reached defined stopping criteria|2|||
147135773|NCT01978145|530666230|FG001|Treatment Period 1|Par. reached defined stopping criteria|3|||
147135774|NCT01978145|530666229|FG000|Washout Period 1|Adverse Event|0|||
147135775|NCT01978145|530666230|FG001|Washout Period 1|Adverse Event|1|||
147135776|NCT01978145|530666229|FG000|Washout Period 1|Withdrawal by Subject|1|||
147135777|NCT01978145|530666230|FG001|Washout Period 1|Withdrawal by Subject|1|||
147135778|NCT01978145|530666229|FG000|Washout Period 1|Par. reached defined stopping criteria|0|||
147135779|NCT01978145|530666230|FG001|Washout Period 1|Par. reached defined stopping criteria|1|||
147135780|NCT01978145|530666229|FG000|Treatment Period 2|Adverse Event|3|||
147135781|NCT01978145|530666230|FG001|Treatment Period 2|Adverse Event|3|||
147135782|NCT01978145|530666229|FG000|Treatment Period 2|Protocol Violation|0|||
147571642|NCT03673670|532250396|FG002|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0|||
147571643|NCT03673670|532250397|FG003|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0|||
147571644|NCT03673670|532250398|FG004|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|0|||
147571645|NCT03673670|532250399|FG005|Treatment Period 1 (3 Days)|Alpha 1 antitrypsin deficiency|1|||
147571646|NCT03673670|532250394|FG000|Treatment Period 2 (3 Days)|Adverse Event|0|||
147571647|NCT03673670|532250395|FG001|Treatment Period 2 (3 Days)|Adverse Event|0|||
147571648|NCT03673670|532250396|FG002|Treatment Period 2 (3 Days)|Adverse Event|1|||
147571649|NCT03673670|532250397|FG003|Treatment Period 2 (3 Days)|Adverse Event|0|||
147571650|NCT03673670|532250398|FG004|Treatment Period 2 (3 Days)|Adverse Event|1|||
147571651|NCT03673670|532250399|FG005|Treatment Period 2 (3 Days)|Adverse Event|0|||
147571652|NCT03673670|532250394|FG000|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0|||
147571653|NCT03673670|532250395|FG001|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0|||
147571654|NCT03673670|532250396|FG002|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0|||
147571655|NCT03673670|532250397|FG003|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0|||
147571656|NCT03673670|532250398|FG004|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|1|||
147571657|NCT03673670|532250399|FG005|Washout Period 2 (7-14 Days)|Pre-dose FEV1 not 20% baseline|0|||
147571658|NCT03673670|532250394|FG000|Treatment Period 3 (3 Days)|Adverse Event|0|||
147135783|NCT01978145|530666230|FG001|Treatment Period 2|Protocol Violation|1|||
147135784|NCT01978145|530666229|FG000|Treatment Period 2|Lost to Follow-up|1|||
147135785|NCT01978145|530666230|FG001|Treatment Period 2|Lost to Follow-up|1|||
147135786|NCT01978145|530666229|FG000|Treatment Period 2|Withdrawal by Subject|7|||
147135787|NCT01978145|530666230|FG001|Treatment Period 2|Withdrawal by Subject|4|||
147135788|NCT01978145|530666229|FG000|Treatment Period 2|Par. reached defined stopping criteria|8|||
147135789|NCT01978145|530666230|FG001|Treatment Period 2|Par. reached defined stopping criteria|5|||
147135790|NCT00322049|530666231|FG000|Overall Study|Moved out of area|0|||
147135791|NCT00322049|530666232|FG001|Overall Study|Moved out of area|0|||
147135792|NCT00322049|530666233|FG002|Overall Study|Moved out of area|0|||
147135793|NCT00322049|530666234|FG003|Overall Study|Moved out of area|1|||
147135794|NCT00322049|530666231|FG000|Overall Study|Infected with Dengue during study|0|||
147135795|NCT00322049|530666232|FG001|Overall Study|Infected with Dengue during study|1|||
147135796|NCT00322049|530666233|FG002|Overall Study|Infected with Dengue during study|0|||
147135797|NCT00322049|530666234|FG003|Overall Study|Infected with Dengue during study|0|||
147135798|NCT01250054|530666235|FG000|Period 2, One Week of Wear|Unacceptable subjective vision|1|||
147135799|NCT01250054|530666236|FG001|Period 2, One Week of Wear|Unacceptable subjective vision|0|||
147135800|NCT00755807|530666243|FG000|Acute Phase|Adverse Event|16|||
147135801|NCT00755807|530666244|FG001|Acute Phase|Adverse Event|5|||
147135802|NCT00755807|530666243|FG000|Acute Phase|Protocol Violation|1|||
147135803|NCT00755807|530666244|FG001|Acute Phase|Protocol Violation|3|||
147135804|NCT00755807|530666243|FG000|Acute Phase|Withdrawal by Subject|1|||
147135805|NCT00755807|530666244|FG001|Acute Phase|Withdrawal by Subject|2|||
147135806|NCT00755807|530666243|FG000|Acute Phase|Lack of Efficacy|0|||
147135807|NCT00755807|530666244|FG001|Acute Phase|Lack of Efficacy|1|||
147135808|NCT00755807|530666243|FG000|Acute Phase|Physician Decision|0|||
147135809|NCT00755807|530666244|FG001|Acute Phase|Physician Decision|1|||
147135810|NCT00755807|530666243|FG000|Open-label Extension Phase|Adverse Event|7|||
147135811|NCT00755807|530666244|FG001|Open-label Extension Phase|Adverse Event|7|||
147135812|NCT00755807|530666243|FG000|Open-label Extension Phase|Protocol Violation|5|||
147135813|NCT00755807|530666244|FG001|Open-label Extension Phase|Protocol Violation|2|||
147135814|NCT00755807|530666243|FG000|Open-label Extension Phase|Lack of Efficacy|3|||
147135815|NCT00755807|530666244|FG001|Open-label Extension Phase|Lack of Efficacy|3|||
147571659|NCT03673670|532250395|FG001|Treatment Period 3 (3 Days)|Adverse Event|0|||
147571660|NCT03673670|532250396|FG002|Treatment Period 3 (3 Days)|Adverse Event|0|||
147571661|NCT03673670|532250397|FG003|Treatment Period 3 (3 Days)|Adverse Event|0|||
147571662|NCT03673670|532250398|FG004|Treatment Period 3 (3 Days)|Adverse Event|1|||
147651656|NCT00528372|532546569|FG004|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|3|||
147135816|NCT00755807|530666243|FG000|Open-label Extension Phase|Withdrawal by Subject|1|||
147135817|NCT00755807|530666244|FG001|Open-label Extension Phase|Withdrawal by Subject|3|||
147135818|NCT00755807|530666243|FG000|Open-label Extension Phase|Lost to Follow-up|2|||
147135819|NCT00755807|530666244|FG001|Open-label Extension Phase|Lost to Follow-up|0|||
147135820|NCT00755807|530666243|FG000|Open-label Extension Phase|Sponsor Decision|0|||
147135821|NCT00755807|530666244|FG001|Open-label Extension Phase|Sponsor Decision|1|||
147135822|NCT02921789|530666245|FG000|Overall Study|Adverse Event|0|||
147135823|NCT02921789|530666246|FG001|Overall Study|Adverse Event|1|||
147135824|NCT02921789|530666245|FG000|Overall Study|Lost to Follow-up|1|||
147135825|NCT02921789|530666246|FG001|Overall Study|Lost to Follow-up|0|||
147135826|NCT02921789|530666245|FG000|Overall Study|Protocol Deviation|2|||
147135827|NCT02921789|530666246|FG001|Overall Study|Protocol Deviation|0|||
147135828|NCT02921789|530666245|FG000|Overall Study|Withdrawal by Subject|2|||
147135829|NCT02921789|530666246|FG001|Overall Study|Withdrawal by Subject|1|||
147135830|NCT02921789|530666245|FG000|Overall Study|Miscellaneous|3|||
147135831|NCT02921789|530666246|FG001|Overall Study|Miscellaneous|2|||
147135832|NCT01621178|530666247|FG000|Overall Study|Adverse Event|5|||
147135833|NCT01621178|530666248|FG001|Overall Study|Adverse Event|2|||
147135834|NCT01621178|530666249|FG002|Overall Study|Adverse Event|8|||
147135835|NCT01621178|530666247|FG000|Overall Study|Death|6|||
147135836|NCT01621178|530666248|FG001|Overall Study|Death|7|||
147135837|NCT01621178|530666249|FG002|Overall Study|Death|2|||
147135838|NCT01621178|530666247|FG000|Overall Study|Lost to Follow-up|1|||
147135839|NCT01621178|530666248|FG001|Overall Study|Lost to Follow-up|2|||
147135840|NCT01621178|530666249|FG002|Overall Study|Lost to Follow-up|1|||
147135841|NCT01621178|530666247|FG000|Overall Study|Withdrawal by Subject|14|||
147135842|NCT01621178|530666248|FG001|Overall Study|Withdrawal by Subject|17|||
147135843|NCT01621178|530666249|FG002|Overall Study|Withdrawal by Subject|18|||
147135844|NCT01621178|530666247|FG000|Overall Study|Physician Decision|5|||
147135845|NCT01621178|530666248|FG001|Overall Study|Physician Decision|2|||
147135846|NCT01621178|530666249|FG002|Overall Study|Physician Decision|7|||
147135847|NCT02896257|530666250|FG000|Providers|Without eligible patients|21|||
147135848|NCT02896257|530666251|FG001|Providers|Without eligible patients|28|||
147135849|NCT02896257|530666250|FG000|Patients|PFT entry criteria not met|43|||
147135850|NCT02896257|530666251|FG001|Patients|PFT entry criteria not met|50|||
147135851|NCT02896257|530666250|FG000|Patients|No capacity to review|8|||
147135852|NCT02896257|530666251|FG001|Patients|No capacity to review|11|||
147135853|NCT02896257|530666250|FG000|Patients|Appointment rescheduled/cancelled|5|||
147135854|NCT02896257|530666251|FG001|Patients|Appointment rescheduled/cancelled|7|||
147135855|NCT02896257|530666250|FG000|Patients|PCP not assigned a clinic|4|||
147135856|NCT02896257|530666251|FG001|Patients|PCP not assigned a clinic|0|||
147135857|NCT02896257|530666250|FG000|Patients|No history of COPD|0|||
147135858|NCT02896257|530666251|FG001|Patients|No history of COPD|1|||
147135859|NCT02896257|530666250|FG000|Patients|Deceased between review and index date|0|||
147135860|NCT02896257|530666251|FG001|Patients|Deceased between review and index date|1|||
147135861|NCT02896257|530666250|FG000|Patients|No ICS Rx upon review|1|||
147135862|NCT02896257|530666251|FG001|Patients|No ICS Rx upon review|1|||
147135863|NCT02896257|530666250|FG000|Patients|Protocol Violation|2|||
147135864|NCT02896257|530666251|FG001|Patients|Protocol Violation|1|||
147135865|NCT02896257|530666250|FG000|Patients|Hospice care|0|||
147135866|NCT02896257|530666251|FG001|Patients|Hospice care|1|||
147135867|NCT04778592|530666252|FG000|Overall Study|Adverse Event|1|||
147135868|NCT04778592|530666253|FG001|Overall Study|Adverse Event|2|||
147135869|NCT04778592|530666252|FG000|Overall Study|Withdrawal by Subject|1|||
147135870|NCT04778592|530666253|FG001|Overall Study|Withdrawal by Subject|2|||
147135871|NCT03423602|530666254|FG000|Overall Study|Death|1|||
147135872|NCT03423602|530666254|FG000|Overall Study|Lost to Follow-up|6|||
147135873|NCT03423602|530666254|FG000|Overall Study|Protocol Violation|1|||
147135874|NCT03423602|530666254|FG000|Overall Study|Withdrawal by Subject|4|||
147135875|NCT01192126|530666255|FG000|First Intervention (1 Week)|Unacceptable Distance Visual Acuity|1|||
147135876|NCT01192126|530666256|FG001|First Intervention (1 Week)|Unacceptable Distance Visual Acuity|0|||
147135877|NCT01192126|530666255|FG000|First Intervention (1 Week)|Lost to Follow-up|1|||
147135878|NCT01192126|530666256|FG001|First Intervention (1 Week)|Lost to Follow-up|1|||
147135879|NCT02580877|530666260|FG000|Overall Study|Withdrawal by Subject|1|||
147135880|NCT02580877|530666261|FG001|Overall Study|Withdrawal by Subject|3|||
147135881|NCT02580877|530666260|FG000|Overall Study|Adverse Event|0|||
147135882|NCT02580877|530666261|FG001|Overall Study|Adverse Event|1|||
147135883|NCT02903823|530666262|FG000|Overall Study|Physician Decision|5|||
147135884|NCT02903823|530666262|FG000|Overall Study|Could not advance catheter|1|||
147135885|NCT02903823|530666262|FG000|Overall Study|Catheter dislodgement|1|||
147135886|NCT01823107|530666263|FG000|Overall Study|Withdrawal by Subject|1|||
147135887|NCT00256126|530666264|FG000|Overall Study|Adverse Event|1|||
147135888|NCT00256126|530666265|FG001|Overall Study|Adverse Event|0|||
147135889|NCT00256126|530666264|FG000|Overall Study|Other|1|||
147135890|NCT00256126|530666265|FG001|Overall Study|Other|2|||
147135891|NCT02154061|530666266|FG000|Overall Study|Pregnancy|1|||
147318381|NCT01232556|531331698|FG000|Overall Study|Death|97|||
147135892|NCT02154061|530666267|FG001|Overall Study|Pregnancy|0|||
147135893|NCT02154061|530666266|FG000|Overall Study|enrolled but not vaccinated|1|||
147135894|NCT02154061|530666267|FG001|Overall Study|enrolled but not vaccinated|0|||
147135895|NCT02133573|530666268|FG000|Overall Study|Withdrawal by Maternal Subjects|2|||
147135896|NCT02133573|530666269|FG001|Overall Study|Withdrawal by Maternal Subjects|1|||
147135897|NCT02133573|530666268|FG000|Overall Study|Child Deaths|3|||
147135898|NCT02133573|530666269|FG001|Overall Study|Child Deaths|5|||
147318382|NCT01232556|531331699|FG001|Overall Study|Death|97|||
147571663|NCT03673670|532250399|FG005|Treatment Period 3 (3 Days)|Adverse Event|0|||
147571664|NCT03437265|532250402|FG000|Overall Study|Protocol Violation|6|||
147571665|NCT02294786|532250403|FG000|Overall Study|Withdrawal by Subject|0|||
147571666|NCT02294786|532250404|FG001|Overall Study|Withdrawal by Subject|1|||
147571667|NCT02294786|532250403|FG000|Overall Study|Physician Decision|6|||
147571668|NCT02294786|532250404|FG001|Overall Study|Physician Decision|7|||
147571669|NCT02294786|532250403|FG000|Overall Study|Lost to Follow-up|1|||
147571670|NCT02294786|532250404|FG001|Overall Study|Lost to Follow-up|2|||
147571671|NCT02294786|532250403|FG000|Overall Study|Protocol Violation|1|||
147571672|NCT02294786|532250404|FG001|Overall Study|Protocol Violation|0|||
147571673|NCT02294786|532250403|FG000|Overall Study|Adverse Event|1|||
147571674|NCT02294786|532250404|FG001|Overall Study|Adverse Event|1|||
147571675|NCT02294786|532250403|FG000|Overall Study|Death|2|||
147571676|NCT02294786|532250404|FG001|Overall Study|Death|3|||
147571677|NCT01778010|532250405|FG000|Overall Study|Withdrawal by Subject|2|||
147571678|NCT01778010|532250405|FG000|Overall Study|abnormal ECG before meds|1|||
147571679|NCT01778010|532250405|FG000|Overall Study|Arrested|1|||
147571680|NCT01778010|532250405|FG000|Overall Study|rash while on placebo|1|||
147571681|NCT02159183|532250413|FG000|Analysis After the 36 Months Follow-up|Protocol Violation|2|||
147571682|NCT02159183|532250414|FG001|Analysis After the 36 Months Follow-up|Protocol Violation|1|||
147571683|NCT02159183|532250413|FG000|Analysis After the 36 Months Follow-up|Adverse Event|1|||
147571684|NCT02159183|532250414|FG001|Analysis After the 36 Months Follow-up|Adverse Event|0|||
147571685|NCT02159183|532250413|FG000|Analysis After the 36 Months Follow-up|Death|0|||
147651657|NCT00528372|532546570|FG005|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|2|||
147651658|NCT00528372|532546571|FG006|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|2|||
147651659|NCT00528372|532546572|FG007|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|3|||
147651660|NCT00528372|532546573|FG008|Short-term (ST) Period (Day 1-Week 24)|Lost to Follow-up|1|||
147651661|NCT00528372|532546565|FG000|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
147135899|NCT02133573|530666268|FG000|Overall Study|Child Declined Follow Ups|2|||
147135900|NCT02133573|530666269|FG001|Overall Study|Child Declined Follow Ups|1|||
147135901|NCT02133573|530666268|FG000|Overall Study|Child missing primary endpoint score due to child's inability to test|2|||
147135902|NCT02133573|530666269|FG001|Overall Study|Child missing primary endpoint score due to child's inability to test|1|||
147135903|NCT01832727|530666273|FG000|Overall Study|Adverse Event|4|||
147135904|NCT01832727|530666274|FG001|Overall Study|Adverse Event|6|||
147135905|NCT01832727|530666275|FG002|Overall Study|Adverse Event|1|||
147135906|NCT01832727|530666276|FG003|Overall Study|Adverse Event|0|||
147135907|NCT01832727|530666277|FG004|Overall Study|Adverse Event|1|||
147135908|NCT01832727|530666278|FG005|Overall Study|Adverse Event|1|||
147135909|NCT01832727|530666279|FG006|Overall Study|Adverse Event|2|||
147135910|NCT01832727|530666280|FG007|Overall Study|Adverse Event|1|||
147135911|NCT01832727|530666281|FG008|Overall Study|Adverse Event|9|||
147135912|NCT01832727|530666273|FG000|Overall Study|Disease progression|3|||
147135913|NCT01832727|530666274|FG001|Overall Study|Disease progression|0|||
147135914|NCT01832727|530666275|FG002|Overall Study|Disease progression|2|||
147135915|NCT01832727|530666276|FG003|Overall Study|Disease progression|1|||
147135916|NCT01832727|530666277|FG004|Overall Study|Disease progression|3|||
147135917|NCT01832727|530666278|FG005|Overall Study|Disease progression|3|||
147135918|NCT01832727|530666279|FG006|Overall Study|Disease progression|6|||
147135919|NCT01832727|530666280|FG007|Overall Study|Disease progression|2|||
147135920|NCT01832727|530666281|FG008|Overall Study|Disease progression|7|||
147135921|NCT01832727|530666273|FG000|Overall Study|Lost to Follow-up|0|||
147135922|NCT01832727|530666274|FG001|Overall Study|Lost to Follow-up|0|||
147135923|NCT01832727|530666275|FG002|Overall Study|Lost to Follow-up|0|||
147135924|NCT01832727|530666276|FG003|Overall Study|Lost to Follow-up|1|||
147135925|NCT01832727|530666277|FG004|Overall Study|Lost to Follow-up|0|||
147318383|NCT01232556|531331698|FG000|Overall Study|Lost to Follow-up|0|||
147318384|NCT01232556|531331699|FG001|Overall Study|Lost to Follow-up|2|||
147318385|NCT01232556|531331698|FG000|Overall Study|Terminated by Sponsor|35|||
147318386|NCT01232556|531331699|FG001|Overall Study|Terminated by Sponsor|51|||
147318387|NCT01232556|531331698|FG000|Overall Study|Other|6|||
147318388|NCT01232556|531331699|FG001|Overall Study|Other|4|||
147318389|NCT02448719|531331700|FG000|Overall Study|Withdrawal by Subject|0|||
147318390|NCT02448719|531331701|FG001|Overall Study|Withdrawal by Subject|0|||
147318391|NCT02448719|531331702|FG002|Overall Study|Withdrawal by Subject|0|||
147318392|NCT02448719|531331703|FG003|Overall Study|Withdrawal by Subject|0|||
147318393|NCT02448719|531331704|FG004|Overall Study|Withdrawal by Subject|1|||
147571686|NCT02159183|532250414|FG001|Analysis After the 36 Months Follow-up|Death|1|||
147571687|NCT02159183|532250413|FG000|Analysis of Primary Endpoint (12 Mts)|Adverse Event|1|||
147135926|NCT01832727|530666278|FG005|Overall Study|Lost to Follow-up|0|||
147135927|NCT01832727|530666279|FG006|Overall Study|Lost to Follow-up|0|||
147135928|NCT01832727|530666280|FG007|Overall Study|Lost to Follow-up|0|||
147135929|NCT01832727|530666281|FG008|Overall Study|Lost to Follow-up|0|||
147318394|NCT02448719|531331705|FG005|Overall Study|Withdrawal by Subject|0|||
147318395|NCT02448719|531331706|FG006|Overall Study|Withdrawal by Subject|0|||
147571688|NCT02159183|532250414|FG001|Analysis of Primary Endpoint (12 Mts)|Adverse Event|0|||
147571689|NCT02159183|532250413|FG000|Analysis of Primary Endpoint (12 Mts)|Protocol Violation|2|||
147571690|NCT02159183|532250414|FG001|Analysis of Primary Endpoint (12 Mts)|Protocol Violation|1|||
147571691|NCT01244620|532250418|FG000|Overall Study|Study terminated|4|||
147571692|NCT01244620|532250419|FG001|Overall Study|Study terminated|4|||
147135930|NCT01832727|530666273|FG000|Overall Study|Physician Decision|1|||
147135931|NCT01832727|530666274|FG001|Overall Study|Physician Decision|0|||
147135932|NCT01832727|530666275|FG002|Overall Study|Physician Decision|0|||
147135933|NCT01832727|530666276|FG003|Overall Study|Physician Decision|1|||
147135934|NCT01832727|530666277|FG004|Overall Study|Physician Decision|0|||
147135935|NCT01832727|530666278|FG005|Overall Study|Physician Decision|1|||
147135936|NCT01832727|530666279|FG006|Overall Study|Physician Decision|0|||
147135937|NCT01832727|530666280|FG007|Overall Study|Physician Decision|0|||
147135938|NCT01832727|530666281|FG008|Overall Study|Physician Decision|0|||
147135939|NCT01832727|530666273|FG000|Overall Study|Withdrawal by Subject|1|||
147135940|NCT01832727|530666274|FG001|Overall Study|Withdrawal by Subject|1|||
147135941|NCT01832727|530666275|FG002|Overall Study|Withdrawal by Subject|0|||
147135942|NCT01832727|530666276|FG003|Overall Study|Withdrawal by Subject|1|||
147135943|NCT01832727|530666277|FG004|Overall Study|Withdrawal by Subject|0|||
147135944|NCT01832727|530666278|FG005|Overall Study|Withdrawal by Subject|1|||
147571693|NCT01244620|532250420|FG002|Overall Study|Study terminated|4|||
147135945|NCT01832727|530666279|FG006|Overall Study|Withdrawal by Subject|0|||
147135946|NCT01832727|530666280|FG007|Overall Study|Withdrawal by Subject|2|||
147135947|NCT01832727|530666281|FG008|Overall Study|Withdrawal by Subject|1|||
147135948|NCT01832727|530666273|FG000|Overall Study|Study terminated by sponsor|0|||
147135949|NCT01832727|530666274|FG001|Overall Study|Study terminated by sponsor|0|||
147135950|NCT01832727|530666275|FG002|Overall Study|Study terminated by sponsor|0|||
147135951|NCT01832727|530666276|FG003|Overall Study|Study terminated by sponsor|0|||
147135952|NCT01832727|530666277|FG004|Overall Study|Study terminated by sponsor|0|||
147135953|NCT01832727|530666278|FG005|Overall Study|Study terminated by sponsor|0|||
147135954|NCT01832727|530666279|FG006|Overall Study|Study terminated by sponsor|0|||
147135955|NCT01832727|530666280|FG007|Overall Study|Study terminated by sponsor|1|||
147135956|NCT01832727|530666281|FG008|Overall Study|Study terminated by sponsor|1|||
147135957|NCT04436744|530666286|FG000|Overall Study|Adverse Event|1|||
147135958|NCT04436744|530666287|FG001|Overall Study|Adverse Event|1|||
147135959|NCT04436744|530666286|FG000|Overall Study|Death|1|||
147135960|NCT04436744|530666287|FG001|Overall Study|Death|0|||
147135961|NCT04436744|530666286|FG000|Overall Study|Lost to Follow-up|0|||
147135962|NCT04436744|530666287|FG001|Overall Study|Lost to Follow-up|2|||
147135963|NCT04436744|530666286|FG000|Overall Study|Physician Decision|0|||
147135964|NCT04436744|530666287|FG001|Overall Study|Physician Decision|1|||
147135965|NCT04436744|530666286|FG000|Overall Study|Progressive Disease|0|||
147135966|NCT04436744|530666287|FG001|Overall Study|Progressive Disease|4|||
147135967|NCT04436744|530666286|FG000|Overall Study|Protocol Deviation|1|||
147571694|NCT01244620|532250421|FG003|Overall Study|Study terminated|4|||
147571695|NCT00840073|532250423|FG000|Second Intervention|Missed 72 hour blood draw|1|||
147571696|NCT00840073|532250424|FG001|Second Intervention|Missed 72 hour blood draw|1|||
147571697|NCT01663233|532250425|FG000|Overall Study|Withdrawal by Subject|3|||
147571698|NCT01663233|532250426|FG001|Overall Study|Withdrawal by Subject|2|||
147571699|NCT01663233|532250425|FG000|Overall Study|Protocol Deviation|1|||
147571700|NCT01663233|532250426|FG001|Overall Study|Protocol Deviation|4|||
147571701|NCT01663233|532250425|FG000|Overall Study|Lost to Follow-up|0|||
147571702|NCT01663233|532250426|FG001|Overall Study|Lost to Follow-up|1|||
147571703|NCT02321098|532250427|FG000|12 Weeks Treament|Lost to Follow-up|1|||
147571704|NCT02321098|532250428|FG001|12 Weeks Treament|Lost to Follow-up|1|||
147571705|NCT02321098|532250429|FG002|12 Weeks Treament|Lost to Follow-up|0|||
147571706|NCT02321098|532250427|FG000|Additional 15 Months Treatment|Lack of Efficacy|0|||
147571707|NCT02321098|532250428|FG001|Additional 15 Months Treatment|Lack of Efficacy|0|||
147571708|NCT02321098|532250429|FG002|Additional 15 Months Treatment|Lack of Efficacy|6|||
147135968|NCT04436744|530666287|FG001|Overall Study|Protocol Deviation|1|||
147135969|NCT04436744|530666286|FG000|Overall Study|Withdrawal by Subject|1|||
147571709|NCT02321098|532250427|FG000|Additional 15 Months Treatment|Lost to Follow-up|0|||
147571710|NCT02321098|532250428|FG001|Additional 15 Months Treatment|Lost to Follow-up|0|||
147571711|NCT02321098|532250429|FG002|Additional 15 Months Treatment|Lost to Follow-up|1|||
147571712|NCT02321098|532250427|FG000|Additional 15 Months Treatment|Withdrawal by Subject|0|||
147571713|NCT02321098|532250428|FG001|Additional 15 Months Treatment|Withdrawal by Subject|0|||
147571714|NCT02321098|532250429|FG002|Additional 15 Months Treatment|Withdrawal by Subject|1|||
147571715|NCT01788423|532250432|FG000|Overall Study|See Comments in Completed (above)|0|||
147135970|NCT04436744|530666287|FG001|Overall Study|Withdrawal by Subject|2|||
147135971|NCT01133847|530666288|FG000|Active Treatment Phase (Weeks 1-16)|Withdrawal by Subject|5|||
147135972|NCT01133847|530666289|FG001|Active Treatment Phase (Weeks 1-16)|Withdrawal by Subject|1|||
147135973|NCT01133847|530666290|FG002|Active Treatment Phase (Weeks 1-16)|Withdrawal by Subject|3|||
147135974|NCT01133847|530666288|FG000|Follow-Up Phase|Lost to Follow-up|1|||
147135975|NCT01133847|530666289|FG001|Follow-Up Phase|Lost to Follow-up|3|||
147135976|NCT01133847|530666290|FG002|Follow-Up Phase|Lost to Follow-up|7|||
147135977|NCT02961244|530666293|FG000|Overall Study|Protocol Violation|0|||
147135978|NCT02961244|530666294|FG001|Overall Study|Protocol Violation|1|||
147135979|NCT02961244|530666293|FG000|Overall Study|Withdrawal by Subject|1|||
147571716|NCT01788423|532250433|FG001|Overall Study|See Comments in Completed (above)|4|||
147571717|NCT01788423|532250434|FG002|Overall Study|See Comments in Completed (above)|5|||
147571718|NCT03249454|532250435|FG000|Overall Study|Withdrawal by Subject|0|||
147571719|NCT03249454|532250436|FG001|Overall Study|Withdrawal by Subject|0|||
147571720|NCT03249454|532250437|FG002|Overall Study|Withdrawal by Subject|0|||
147571721|NCT03249454|532250438|FG003|Overall Study|Withdrawal by Subject|0|||
147571722|NCT03249454|532250439|FG004|Overall Study|Withdrawal by Subject|0|||
147571723|NCT03249454|532250440|FG005|Overall Study|Withdrawal by Subject|0|||
147571724|NCT03249454|532250441|FG006|Overall Study|Withdrawal by Subject|0|||
147571725|NCT03249454|532250442|FG007|Overall Study|Withdrawal by Subject|0|||
147135980|NCT02961244|530666294|FG001|Overall Study|Withdrawal by Subject|2|||
147135981|NCT02961244|530666293|FG000|Overall Study|Surgery plan change after study approval|0|||
147135982|NCT02961244|530666294|FG001|Overall Study|Surgery plan change after study approval|2|||
147135983|NCT02961244|530666293|FG000|Overall Study|Lost to Follow-up|0|||
147135984|NCT02961244|530666294|FG001|Overall Study|Lost to Follow-up|2|||
147135985|NCT02961244|530666293|FG000|Overall Study|İnadequate data|0|||
147135986|NCT02961244|530666294|FG001|Overall Study|İnadequate data|2|||
147135987|NCT03789292|530666295|FG000|Treatment Period I (Week 0 to Week 26)|Adverse Event|7|||
147135988|NCT03789292|530666296|FG001|Treatment Period I (Week 0 to Week 26)|Adverse Event|8|||
147135989|NCT03789292|530666297|FG002|Treatment Period I (Week 0 to Week 26)|Adverse Event|0|||
147135990|NCT03789292|530666295|FG000|Treatment Period I (Week 0 to Week 26)|Lost to Follow-up|2|||
147135991|NCT03789292|530666296|FG001|Treatment Period I (Week 0 to Week 26)|Lost to Follow-up|0|||
147135992|NCT03789292|530666297|FG002|Treatment Period I (Week 0 to Week 26)|Lost to Follow-up|0|||
147135993|NCT03789292|530666295|FG000|Treatment Period I (Week 0 to Week 26)|Physician Decision|1|||
147135994|NCT03789292|530666296|FG001|Treatment Period I (Week 0 to Week 26)|Physician Decision|0|||
147135995|NCT03789292|530666297|FG002|Treatment Period I (Week 0 to Week 26)|Physician Decision|0|||
147135996|NCT03789292|530666295|FG000|Treatment Period I (Week 0 to Week 26)|Protocol Violation|1|||
147135997|NCT03789292|530666296|FG001|Treatment Period I (Week 0 to Week 26)|Protocol Violation|1|||
147135998|NCT03789292|530666297|FG002|Treatment Period I (Week 0 to Week 26)|Protocol Violation|0|||
147135999|NCT03789292|530666295|FG000|Treatment Period I (Week 0 to Week 26)|Withdrawal by Subject|9|||
147136000|NCT03789292|530666296|FG001|Treatment Period I (Week 0 to Week 26)|Withdrawal by Subject|8|||
147136001|NCT03789292|530666297|FG002|Treatment Period I (Week 0 to Week 26)|Withdrawal by Subject|0|||
147136002|NCT03789292|530666295|FG000|Treatment Period I (Week 0 to Week 26)|Significant dose delay|1|||
147136003|NCT03789292|530666296|FG001|Treatment Period I (Week 0 to Week 26)|Significant dose delay|0|||
147136004|NCT03789292|530666297|FG002|Treatment Period I (Week 0 to Week 26)|Significant dose delay|0|||
147136005|NCT03789292|530666295|FG000|Treatment Period I (Week 0 to Week 26)|Patient decision|0|||
147136006|NCT03789292|530666296|FG001|Treatment Period I (Week 0 to Week 26)|Patient decision|2|||
147136007|NCT03789292|530666297|FG002|Treatment Period I (Week 0 to Week 26)|Patient decision|0|||
147136008|NCT03789292|530666295|FG000|Treatment Period II (Week 26 to Week 52)|Adverse Event|3|||
147136009|NCT03789292|530666296|FG001|Treatment Period II (Week 26 to Week 52)|Adverse Event|3|||
147136010|NCT03789292|530666297|FG002|Treatment Period II (Week 26 to Week 52)|Adverse Event|6|||
147136011|NCT03789292|530666295|FG000|Treatment Period II (Week 26 to Week 52)|Lost to Follow-up|0|||
147136012|NCT03789292|530666296|FG001|Treatment Period II (Week 26 to Week 52)|Lost to Follow-up|0|||
147136013|NCT03789292|530666297|FG002|Treatment Period II (Week 26 to Week 52)|Lost to Follow-up|1|||
147136014|NCT03789292|530666295|FG000|Treatment Period II (Week 26 to Week 52)|Physician Decision|1|||
147571726|NCT03249454|532250443|FG008|Overall Study|Withdrawal by Subject|0|||
147571727|NCT03249454|532250444|FG009|Overall Study|Withdrawal by Subject|1|||
147651662|NCT00528372|532546566|FG001|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
147651663|NCT00528372|532546567|FG002|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
147651664|NCT00528372|532546568|FG003|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|2|||
147136015|NCT03789292|530666296|FG001|Treatment Period II (Week 26 to Week 52)|Physician Decision|0|||
147136016|NCT03789292|530666297|FG002|Treatment Period II (Week 26 to Week 52)|Physician Decision|0|||
147136017|NCT03789292|530666295|FG000|Treatment Period II (Week 26 to Week 52)|Withdrawal by Subject|9|||
147136018|NCT03789292|530666296|FG001|Treatment Period II (Week 26 to Week 52)|Withdrawal by Subject|2|||
147136019|NCT03789292|530666297|FG002|Treatment Period II (Week 26 to Week 52)|Withdrawal by Subject|2|||
147136020|NCT03789292|530666295|FG000|Treatment Period II (Week 26 to Week 52)|Significant dose delay|1|||
147136021|NCT03789292|530666296|FG001|Treatment Period II (Week 26 to Week 52)|Significant dose delay|0|||
147136022|NCT03789292|530666297|FG002|Treatment Period II (Week 26 to Week 52)|Significant dose delay|0|||
147136023|NCT03789292|530666295|FG000|Treatment Period II (Week 26 to Week 52)|Could not visit the site due to COVID-19 pandemic|2|||
147571728|NCT03249454|532250445|FG010|Overall Study|Withdrawal by Subject|1|||
147571729|NCT01913405|532250446|FG000|Overall Study|Withdrawal by Subject|1|||
147445519|NCT02230384|531795877|FG001|Phase 2 - Switch|Adverse Event|0|||
147136024|NCT03789292|530666296|FG001|Treatment Period II (Week 26 to Week 52)|Could not visit the site due to COVID-19 pandemic|1|||
147136025|NCT03789292|530666297|FG002|Treatment Period II (Week 26 to Week 52)|Could not visit the site due to COVID-19 pandemic|0|||
147571730|NCT01913405|532250446|FG000|Overall Study|Adverse Event|1|||
147571731|NCT00705666|532250451|FG000|Overall Study|No post-treatment questionnaire|279|||
147571732|NCT00705666|532250451|FG000|Overall Study|Withdrawal by Subject|21|||
147571733|NCT00705666|532250451|FG000|Overall Study|Physician Decision|7|||
147136026|NCT00967616|530666298|FG000|Overall Study|Adverse Event or Serious Adverse Event|2|||
147136027|NCT00967616|530666299|FG001|Overall Study|Adverse Event or Serious Adverse Event|17|||
147136028|NCT00967616|530666298|FG000|Overall Study|Death|0|||
147136029|NCT00967616|530666299|FG001|Overall Study|Death|3|||
147136030|NCT00967616|530666298|FG000|Overall Study|Withdrawal by Subject|8|||
147136031|NCT00967616|530666299|FG001|Overall Study|Withdrawal by Subject|4|||
147136032|NCT00967616|530666298|FG000|Overall Study|Progressive Disease|31|||
147136033|NCT00967616|530666299|FG001|Overall Study|Progressive Disease|18|||
147136034|NCT00967616|530666298|FG000|Overall Study|Other|8|||
147136035|NCT00967616|530666299|FG001|Overall Study|Other|8|||
147136036|NCT00967616|530666298|FG000|Overall Study|Protocol Violation|1|||
147136037|NCT00967616|530666299|FG001|Overall Study|Protocol Violation|0|||
147136038|NCT01696643|530666300|FG000|Overall Study|Adverse Event|15|||
147136039|NCT01696643|530666301|FG001|Overall Study|Adverse Event|7|||
147136040|NCT01696643|530666300|FG000|Overall Study|Death|1|||
147136041|NCT01696643|530666301|FG001|Overall Study|Death|2|||
147136042|NCT01696643|530666300|FG000|Overall Study|Lack of Efficacy|3|||
147136043|NCT01696643|530666301|FG001|Overall Study|Lack of Efficacy|0|||
147136044|NCT01696643|530666300|FG000|Overall Study|Lost to Follow-up|67|||
147136045|NCT01696643|530666301|FG001|Overall Study|Lost to Follow-up|67|||
147136046|NCT01696643|530666300|FG000|Overall Study|Physician Decision|3|||
147136047|NCT01696643|530666301|FG001|Overall Study|Physician Decision|2|||
147136048|NCT01696643|530666300|FG000|Overall Study|Pregnancy|0|||
147136049|NCT01696643|530666301|FG001|Overall Study|Pregnancy|1|||
147136050|NCT01696643|530666300|FG000|Overall Study|Protocol Violation|7|||
147136051|NCT01696643|530666301|FG001|Overall Study|Protocol Violation|7|||
147136052|NCT01696643|530666300|FG000|Overall Study|Study Terminated by Sponsor|286|||
147136053|NCT01696643|530666301|FG001|Overall Study|Study Terminated by Sponsor|294|||
147136054|NCT01696643|530666300|FG000|Overall Study|Withdrawal by Subject|142|||
147136055|NCT01696643|530666301|FG001|Overall Study|Withdrawal by Subject|149|||
147136056|NCT01696643|530666300|FG000|Overall Study|Participant on Restricted Bed Rest|1|||
147136057|NCT01696643|530666301|FG001|Overall Study|Participant on Restricted Bed Rest|0|||
147136058|NCT01696643|530666300|FG000|Overall Study|Site Error|2|||
147136059|NCT01696643|530666301|FG001|Overall Study|Site Error|1|||
147136060|NCT01696643|530666300|FG000|Overall Study|Participant Incarcerated|0|||
147136061|NCT01696643|530666301|FG001|Overall Study|Participant Incarcerated|1|||
147136062|NCT01696643|530666300|FG000|Overall Study|Medical Monitor Decision|0|||
147136063|NCT01696643|530666301|FG001|Overall Study|Medical Monitor Decision|2|||
147136064|NCT01696643|530666300|FG000|Overall Study|Participant Did Not Receive Study Drug|2|||
147136065|NCT01696643|530666301|FG001|Overall Study|Participant Did Not Receive Study Drug|2|||
147136066|NCT00575666|530666302|FG000|Overall Study|Withdrawal by Subject|3|||
147136067|NCT00575666|530666303|FG001|Overall Study|Withdrawal by Subject|2|||
147136068|NCT00575666|530666302|FG000|Overall Study|Physician Decision|1|||
147136069|NCT00575666|530666303|FG001|Overall Study|Physician Decision|1|||
147136070|NCT00508482|530666304|FG000|Over 4 Weeks of Treatment|Changed mind, didn't want to participate|9|||
147136071|NCT00508482|530666305|FG001|Over 4 Weeks of Treatment|Changed mind, didn't want to participate|7|||
147136072|NCT00508482|530666306|FG002|Over 4 Weeks of Treatment|Changed mind, didn't want to participate|4|||
147136073|NCT00508482|530666304|FG000|Over 4 Weeks of Treatment|Lost to Follow-up|12|||
147136074|NCT00508482|530666305|FG001|Over 4 Weeks of Treatment|Lost to Follow-up|10|||
147136075|NCT00508482|530666306|FG002|Over 4 Weeks of Treatment|Lost to Follow-up|16|||
147136076|NCT00508482|530666304|FG000|at the 4th Week of Follow-up|Lost to Follow-up|20|||
147136077|NCT00508482|530666305|FG001|at the 4th Week of Follow-up|Lost to Follow-up|6|||
147136078|NCT00508482|530666306|FG002|at the 4th Week of Follow-up|Lost to Follow-up|1|||
147571734|NCT00705666|532250451|FG000|Overall Study|Lost to Follow-up|5|||
147571735|NCT00705666|532250451|FG000|Overall Study|Death|1|||
147571736|NCT00705666|532250451|FG000|Overall Study|Adverse Event|4|||
147571737|NCT00705666|532250451|FG000|Overall Study|Other|12|||
147571738|NCT00705666|532250451|FG000|Overall Study|Other|2|||
147136079|NCT02850978|530666313|FG000|Overall Study|Uncollectable CRF|27|||
147571739|NCT00705666|532250451|FG000|Overall Study|Lack of data|3|||
147445520|NCT00961220|531795878|FG000|Overall Study|Adverse Event|3|||
147136080|NCT02850978|530666313|FG000|Overall Study|No visit since the first visit|35|||
147136081|NCT02850978|530666313|FG000|Overall Study|Adverse Event|81|||
147136082|NCT02850978|530666313|FG000|Overall Study|Lack of Efficacy|40|||
147136083|NCT02850978|530666313|FG000|Overall Study|Improvement in condition|34|||
147136084|NCT02850978|530666313|FG000|Overall Study|Lost to Follow-up|121|||
147136085|NCT02850978|530666313|FG000|Overall Study|Reason not listed|88|||
147136086|NCT00570713|530666314|FG000|Overall Study|Adverse Event|16|||
147136087|NCT00570713|530666315|FG001|Overall Study|Adverse Event|9|||
147136088|NCT00570713|530666314|FG000|Overall Study|Death|7|||
147136089|NCT00570713|530666315|FG001|Overall Study|Death|7|||
147136090|NCT00570713|530666314|FG000|Overall Study|Lack of Efficacy|40|||
147136091|NCT00570713|530666315|FG001|Overall Study|Lack of Efficacy|49|||
147571740|NCT00705666|532250451|FG000|Overall Study|Untreated|5|||
147571741|NCT02105272|532250452|FG000|Overall Study|Adverse Event|1|||
147571742|NCT02105272|532250453|FG001|Overall Study|Adverse Event|2|||
147571743|NCT02105272|532250452|FG000|Overall Study|Physician Decision|0|||
147571744|NCT02105272|532250453|FG001|Overall Study|Physician Decision|1|||
147571745|NCT02105272|532250452|FG000|Overall Study|Protocol Violation|2|||
147571746|NCT02105272|532250453|FG001|Overall Study|Protocol Violation|0|||
147571747|NCT02105272|532250452|FG000|Overall Study|Withdrawal by Subject|2|||
147571748|NCT02105272|532250453|FG001|Overall Study|Withdrawal by Subject|0|||
147571749|NCT02964039|532250464|FG000|Overall Study|Medical reason unrelated to study participation|1|||
147571750|NCT02964039|532250465|FG001|Overall Study|Medical reason unrelated to study participation|0|||
147571751|NCT02964039|532250466|FG002|Overall Study|Medical reason unrelated to study participation|3|||
147571752|NCT02964039|532250464|FG000|Overall Study|Research shutdown due to pandemic|2|||
147571753|NCT02964039|532250465|FG001|Overall Study|Research shutdown due to pandemic|0|||
147571754|NCT02964039|532250466|FG002|Overall Study|Research shutdown due to pandemic|1|||
147571755|NCT02964039|532250464|FG000|Overall Study|Withdrawal by Subject|0|||
147571756|NCT02964039|532250465|FG001|Overall Study|Withdrawal by Subject|1|||
147571757|NCT02964039|532250466|FG002|Overall Study|Withdrawal by Subject|0|||
147571758|NCT02964039|532250464|FG000|Overall Study|Lost to Follow-up|1|||
147571759|NCT02964039|532250465|FG001|Overall Study|Lost to Follow-up|0|||
147571760|NCT02964039|532250466|FG002|Overall Study|Lost to Follow-up|1|||
147571761|NCT05479058|532250467|FG000|Overall Study|Withdrawal by Subject|1|||
147136092|NCT00570713|530666314|FG000|Overall Study|Physician Decision|2|||
147136093|NCT00570713|530666315|FG001|Overall Study|Physician Decision|2|||
147136094|NCT00570713|530666314|FG000|Overall Study|Withdrawal by Subject|3|||
147136095|NCT00570713|530666315|FG001|Overall Study|Withdrawal by Subject|3|||
147136096|NCT00570713|530666314|FG000|Overall Study|Discontinuation of Study by the Sponsor|10|||
147136097|NCT00570713|530666315|FG001|Overall Study|Discontinuation of Study by the Sponsor|7|||
147136098|NCT04016714|530666316|FG000|Overall Study|Death|1|||
147136099|NCT04016714|530666317|FG001|Overall Study|Death|0|||
147136100|NCT04016714|530666316|FG000|Overall Study|Lost to Follow-up|3|||
147136101|NCT04016714|530666317|FG001|Overall Study|Lost to Follow-up|1|||
147136102|NCT04016714|530666316|FG000|Overall Study|Physician Decision|3|||
147136103|NCT04016714|530666317|FG001|Overall Study|Physician Decision|3|||
147136104|NCT04016714|530666316|FG000|Overall Study|Withdrawal by Parent/Guardian|16|||
147136105|NCT04016714|530666317|FG001|Overall Study|Withdrawal by Parent/Guardian|12|||
147136106|NCT01677988|530666322|FG000|Overall Study|Lack of Efficacy|2|||
147136107|NCT01822665|530666326|FG000|Overall Study|Adverse Event|3|||
147136108|NCT01822665|530666326|FG000|Overall Study|Other Reason|5|||
147136109|NCT04540367|530666327|FG000|Overall Study|Withdrawal by Subject|0|||
147136110|NCT04540367|530666328|FG001|Overall Study|Withdrawal by Subject|0|||
147136111|NCT04540367|530666329|FG002|Overall Study|Withdrawal by Subject|0|||
147136112|NCT04540367|530666330|FG003|Overall Study|Withdrawal by Subject|2|||
147136113|NCT04540367|530666327|FG000|Overall Study|COVID-19 Contact Tracing Protocols prevented completion of study activities|0|||
147136114|NCT04540367|530666328|FG001|Overall Study|COVID-19 Contact Tracing Protocols prevented completion of study activities|0|||
147136115|NCT04540367|530666329|FG002|Overall Study|COVID-19 Contact Tracing Protocols prevented completion of study activities|4|||
147136116|NCT04540367|530666330|FG003|Overall Study|COVID-19 Contact Tracing Protocols prevented completion of study activities|1|||
147136117|NCT04540367|530666327|FG000|Overall Study|Adverse Event|0|||
147136118|NCT04540367|530666328|FG001|Overall Study|Adverse Event|0|||
147136119|NCT04540367|530666329|FG002|Overall Study|Adverse Event|1|||
147136120|NCT04540367|530666330|FG003|Overall Study|Adverse Event|1|||
147136121|NCT00907621|530666336|FG000|Overall Study|Lost to Follow-up|6|||
147136122|NCT00907621|530666337|FG001|Overall Study|Lost to Follow-up|3|||
147136123|NCT00907621|530666336|FG000|Overall Study|intercurrent febrile illness|1|||
147571762|NCT05479058|532250468|FG001|Overall Study|Withdrawal by Subject|1|||
147571763|NCT05479058|532250467|FG000|Overall Study|Study terminated by sponsor|10|||
147571764|NCT05479058|532250468|FG001|Overall Study|Study terminated by sponsor|10|||
147571765|NCT05630885|532250469|FG000|Study Completion|Took prohibited medications|2|||
147136124|NCT00907621|530666337|FG001|Overall Study|intercurrent febrile illness|1|||
147136125|NCT00902330|530666340|FG000|Overall Study|Too overwhelmed by treatment|2|||
147136126|NCT00902330|530666341|FG001|Overall Study|Too overwhelmed by treatment|5|||
147136127|NCT00902330|530666340|FG000|Overall Study|Adverse Event|1|||
147136128|NCT00902330|530666341|FG001|Overall Study|Adverse Event|0|||
147571766|NCT05630885|532250470|FG001|Study Completion|Took prohibited medications|0|||
147571767|NCT05630885|532250469|FG000|Study Completion|Non-compliance with study drug|1|||
147571768|NCT05630885|532250470|FG001|Study Completion|Non-compliance with study drug|0|||
147571769|NCT05630885|532250469|FG000|Study Completion|Adverse Event|1|||
147571770|NCT05630885|532250470|FG001|Study Completion|Adverse Event|0|||
147571771|NCT05630885|532250469|FG000|Efficacy Analysis Population Set|Took prohibited medications|3|||
147136129|NCT00902330|530666340|FG000|Overall Study|No post baseline data|1|||
147136130|NCT00902330|530666341|FG001|Overall Study|No post baseline data|0|||
147136131|NCT00165789|530666342|FG000|Overall Study|Adverse Event|0|||
147136132|NCT00165789|530666343|FG001|Overall Study|Adverse Event|3|||
147136133|NCT00165789|530666344|FG002|Overall Study|Adverse Event|0|||
147136134|NCT00165789|530666345|FG003|Overall Study|Adverse Event|12|||
147136135|NCT00165789|530666342|FG000|Overall Study|Withdrawal by Subject|0|||
147445521|NCT00961220|531795878|FG000|Overall Study|Lack of Efficacy|1|||
147136136|NCT00165789|530666343|FG001|Overall Study|Withdrawal by Subject|1|||
147136137|NCT00165789|530666344|FG002|Overall Study|Withdrawal by Subject|1|||
147136138|NCT00165789|530666345|FG003|Overall Study|Withdrawal by Subject|2|||
147136139|NCT01816048|530666346|FG000|Overall Study|Adverse Event|1|||
147136140|NCT01816048|530666346|FG000|Overall Study|Death|1|||
147136141|NCT01816048|530666346|FG000|Overall Study|Withdrawal by Subject|1|||
147136142|NCT01816048|530666346|FG000|Overall Study|Disease Progression|3|||
147136143|NCT04290624|530666347|FG000|Overall Study|Adverse Event|1|||
147136144|NCT04290624|530666348|FG001|Overall Study|Adverse Event|0|||
147136145|NCT01847443|530666349|FG000|Study Period 1|Withdrawal by Subject|0|||
147136146|NCT01847443|530666350|FG001|Study Period 1|Withdrawal by Subject|1|||
147136147|NCT01847443|530666351|FG002|Study Period 1|Withdrawal by Subject|0|||
147136148|NCT01847443|530666352|FG003|Study Period 1|Withdrawal by Subject|0|||
147136149|NCT01847443|530666349|FG000|Washout Period Before Study Period 2|Adverse Event|1|||
147136150|NCT01847443|530666350|FG001|Washout Period Before Study Period 2|Adverse Event|1|||
147136151|NCT01847443|530666351|FG002|Washout Period Before Study Period 2|Adverse Event|0|||
147136152|NCT01847443|530666352|FG003|Washout Period Before Study Period 2|Adverse Event|0|||
147136153|NCT01847443|530666349|FG000|Washout Period Before Study Period 2|Other reason|1|||
147136154|NCT01847443|530666350|FG001|Washout Period Before Study Period 2|Other reason|0|||
147136155|NCT01847443|530666351|FG002|Washout Period Before Study Period 2|Other reason|0|||
147136156|NCT01847443|530666352|FG003|Washout Period Before Study Period 2|Other reason|0|||
147136157|NCT01847443|530666349|FG000|Washout Period Before Study Period 3|Other reason|1|||
147136158|NCT01847443|530666350|FG001|Washout Period Before Study Period 3|Other reason|0|||
147136159|NCT01847443|530666351|FG002|Washout Period Before Study Period 3|Other reason|0|||
147136160|NCT01847443|530666352|FG003|Washout Period Before Study Period 3|Other reason|0|||
147136161|NCT01847443|530666349|FG000|Washout Period Before Study Period 4|Withdrawal by Subject|1|||
147136162|NCT01847443|530666350|FG001|Washout Period Before Study Period 4|Withdrawal by Subject|0|||
147136163|NCT01847443|530666351|FG002|Washout Period Before Study Period 4|Withdrawal by Subject|0|||
147136164|NCT01847443|530666352|FG003|Washout Period Before Study Period 4|Withdrawal by Subject|0|||
147136165|NCT01847443|530666349|FG000|Washout Period Before Study Period 4|Positive alcohol test|1|||
147136166|NCT01847443|530666350|FG001|Washout Period Before Study Period 4|Positive alcohol test|0|||
147136167|NCT01847443|530666351|FG002|Washout Period Before Study Period 4|Positive alcohol test|0|||
147136168|NCT01847443|530666352|FG003|Washout Period Before Study Period 4|Positive alcohol test|0|||
147136169|NCT03571971|530666353|FG000|Overall Study|Lost to Follow-up|2|||
147136170|NCT03571971|530666354|FG001|Overall Study|Lost to Follow-up|2|||
147136171|NCT03571971|530666353|FG000|Overall Study|Protocol Violation|2|||
147136172|NCT03571971|530666354|FG001|Overall Study|Protocol Violation|3|||
147136173|NCT03571971|530666353|FG000|Overall Study|Withdrawal by Subject|2|||
147136174|NCT03571971|530666354|FG001|Overall Study|Withdrawal by Subject|0|||
147445522|NCT00961220|531795878|FG000|Overall Study|No IV access for O6BG|1|||
147445523|NCT00961220|531795878|FG000|Overall Study|O6BG no longer supplied|1|||
147571772|NCT05630885|532250470|FG001|Efficacy Analysis Population Set|Took prohibited medications|1|||
147571773|NCT05630885|532250469|FG000|Efficacy Analysis Population Set|Prematurely discontinued study treatment before week 22|8|||
147136175|NCT03571971|530666353|FG000|Overall Study|Incomplete primary outcome data|2|||
147136176|NCT03571971|530666354|FG001|Overall Study|Incomplete primary outcome data|0|||
147136177|NCT04067492|530666355|FG000|Overall Study|Lost to Follow-up|0|||
147136178|NCT04067492|530666356|FG001|Overall Study|Lost to Follow-up|0|||
147136179|NCT04067492|530666357|FG002|Overall Study|Lost to Follow-up|0|||
147136180|NCT04067492|530666358|FG003|Overall Study|Lost to Follow-up|0|||
147136181|NCT04067492|530666359|FG004|Overall Study|Lost to Follow-up|0|||
147136182|NCT04067492|530666360|FG005|Overall Study|Lost to Follow-up|1|||
147136183|NCT04067492|530666355|FG000|Overall Study|closure of city borders because of COVID-19 quarantine|0|||
147136184|NCT04067492|530666356|FG001|Overall Study|closure of city borders because of COVID-19 quarantine|1|||
147136185|NCT04067492|530666357|FG002|Overall Study|closure of city borders because of COVID-19 quarantine|0|||
147136186|NCT04067492|530666358|FG003|Overall Study|closure of city borders because of COVID-19 quarantine|0|||
147136187|NCT04067492|530666359|FG004|Overall Study|closure of city borders because of COVID-19 quarantine|0|||
147136188|NCT04067492|530666360|FG005|Overall Study|closure of city borders because of COVID-19 quarantine|0|||
147136189|NCT04067492|530666355|FG000|Overall Study|COVID-19 epidemiological situation|0|||
147136190|NCT04067492|530666356|FG001|Overall Study|COVID-19 epidemiological situation|0|||
147136191|NCT04067492|530666357|FG002|Overall Study|COVID-19 epidemiological situation|0|||
147136192|NCT04067492|530666358|FG003|Overall Study|COVID-19 epidemiological situation|1|||
147136193|NCT04067492|530666359|FG004|Overall Study|COVID-19 epidemiological situation|0|||
147136194|NCT04067492|530666360|FG005|Overall Study|COVID-19 epidemiological situation|0|||
147136195|NCT00656370|530666365|FG000|Overall Study|Screen Failures|7|||
147136196|NCT00656370|530666365|FG000|Overall Study|Alternates|3|||
147136197|NCT03402841|530666371|FG000|Overall Study|Withdrawal by Subject|3|||
147136198|NCT03402841|530666371|FG000|Overall Study|Lost to Follow-up|2|||
147136199|NCT03402841|530666371|FG000|Overall Study|Death|146|||
147136200|NCT03984188|530666374|FG000|Overall Study|Death|2|||
147136201|NCT03984188|530666375|FG001|Overall Study|Death|4|||
147136202|NCT03984188|530666374|FG000|Overall Study|Physician Decision|0|||
147136203|NCT03984188|530666375|FG001|Overall Study|Physician Decision|2|||
147136204|NCT03984188|530666374|FG000|Overall Study|Lost to Follow-up|3|||
147136205|NCT03984188|530666375|FG001|Overall Study|Lost to Follow-up|2|||
147136206|NCT03984188|530666374|FG000|Overall Study|Withdrawal by Subject|6|||
147136207|NCT03984188|530666375|FG001|Overall Study|Withdrawal by Subject|0|||
147136208|NCT03384875|530666376|FG000|Overall Study|Death|1|||
147136209|NCT03384875|530666377|FG001|Overall Study|Death|1|||
147136210|NCT03384875|530666378|FG002|Overall Study|Death|0|||
147136211|NCT03384875|530666376|FG000|Overall Study|Reason not provided|1|||
147136212|NCT03384875|530666377|FG001|Overall Study|Reason not provided|0|||
147136213|NCT03384875|530666378|FG002|Overall Study|Reason not provided|0|||
147136214|NCT01047007|530668120|FG000|Overall Study|Adverse Event|0|||
147136215|NCT01047007|530668121|FG001|Overall Study|Adverse Event|2|||
147136216|NCT01047007|530668122|FG002|Overall Study|Adverse Event|1|||
147136217|NCT01047007|530668123|FG003|Overall Study|Adverse Event|0|||
147136218|NCT01047007|530668120|FG000|Overall Study|Progressive Disease|2|||
147136219|NCT01047007|530668121|FG001|Overall Study|Progressive Disease|4|||
147136220|NCT01047007|530668122|FG002|Overall Study|Progressive Disease|1|||
147136221|NCT01047007|530668123|FG003|Overall Study|Progressive Disease|0|||
147136222|NCT04099277|530668124|FG000|Overall Study|Physician Decision|1|||
147136223|NCT04099277|530668124|FG000|Overall Study|Withdrawal by Subject|1|||
147136224|NCT03759600|530668133|FG000|Overall Study|Adverse Event|2|||
147136225|NCT03759600|530668133|FG000|Overall Study|Progressive Disease|15|||
147136226|NCT03759600|530668133|FG000|Overall Study|Site Terminated by Sponsor|3|||
147136227|NCT03257358|530668134|FG000|Overall Study|Adverse Event|25|||
147136228|NCT03257358|530668135|FG001|Overall Study|Adverse Event|12|||
147136229|NCT03257358|530668134|FG000|Overall Study|Lack of Efficacy|1|||
147136230|NCT03257358|530668135|FG001|Overall Study|Lack of Efficacy|1|||
147237446|NCT00289133|531040614|FG000|Overall Study|Withdrawal by Subject|9|||
147136231|NCT03257358|530668134|FG000|Overall Study|Lost to Follow-up|12|||
147136232|NCT03257358|530668135|FG001|Overall Study|Lost to Follow-up|4|||
147237447|NCT00289133|531040615|FG001|Overall Study|Withdrawal by Subject|10|||
147237448|NCT00289133|531040614|FG000|Overall Study|Death|5|||
147237449|NCT00289133|531040615|FG001|Overall Study|Death|10|||
147237450|NCT00289133|531040614|FG000|Overall Study|Lost to Follow-up - Hurricane Katri|73|||
147237451|NCT00289133|531040615|FG001|Overall Study|Lost to Follow-up - Hurricane Katri|74|||
147237452|NCT00289133|531040614|FG000|Overall Study|Physician Decision|41|||
147237453|NCT00289133|531040615|FG001|Overall Study|Physician Decision|45|||
147237454|NCT00289133|531040614|FG000|Overall Study|Revision|8|||
147237455|NCT00289133|531040615|FG001|Overall Study|Revision|6|||
147237456|NCT00289133|531040614|FG000|Overall Study|Lost to Follow-up|92|||
147237457|NCT00289133|531040615|FG001|Overall Study|Lost to Follow-up|115|||
147237458|NCT00541931|531040620|FG000|Overall Study|Adverse Event|1|||
147237459|NCT00541931|531040621|FG001|Overall Study|Adverse Event|0|||
147237460|NCT00541931|531040620|FG000|Overall Study|Lost to Follow-up|3|||
147237461|NCT00541931|531040621|FG001|Overall Study|Lost to Follow-up|3|||
147237462|NCT00541931|531040620|FG000|Overall Study|Withdrawal by Subject|1|||
147237463|NCT00541931|531040621|FG001|Overall Study|Withdrawal by Subject|0|||
147237464|NCT00541931|531040620|FG000|Overall Study|Transportation Issue|0|||
147237465|NCT00541931|531040621|FG001|Overall Study|Transportation Issue|1|||
147237466|NCT01947582|531040626|FG000|Overall Study|Withdrawal by Subject|1|||
147237467|NCT00064337|531040627|FG000|PBSCC or Induction/PBSCC|Not protocol-specified|7|||
147237468|NCT00064337|531040627|FG000|PBSCC or Induction/PBSCC|Adverse Event|6|||
147237469|NCT00064337|531040627|FG000|PBSCC or Induction/PBSCC|Progression|3|||
147237470|NCT00064337|531040627|FG000|PBSCC or Induction/PBSCC|Patient Refusal|2|||
147237471|NCT00064337|531040627|FG000|PBSCC or Induction/PBSCC|Death|2|||
147237472|NCT00064337|531040627|FG000|Transplant|Adverse Event|9|||
147237473|NCT00064337|531040627|FG000|Transplant|Not protocol-specified|5|||
147237474|NCT00064337|531040627|FG000|Transplant|Death|3|||
147595957|NCT00359632|532338755|FG001|Overall Study|Non-compliance with visit schedule|0|||
147136233|NCT03257358|530668134|FG000|Overall Study|Non-compliance with fingolimod treatment|4|||
147237475|NCT00064337|531040627|FG000|Transplant|Patient Refusal|2|||
147237476|NCT00064337|531040627|FG000|Transplant|Progression|2|||
147237477|NCT00064337|531040627|FG000|Maintenance|Adverse Event|3|||
147136234|NCT03257358|530668135|FG001|Overall Study|Non-compliance with fingolimod treatment|2|||
147237478|NCT00064337|531040627|FG000|Maintenance|Progression|2|||
147237479|NCT00064337|531040627|FG000|Maintenance|On treatment at time of analysis|2|||
147237480|NCT00064337|531040627|FG000|Maintenance|Not protocol-specified|2|||
147237481|NCT00064337|531040627|FG000|Maintenance|Death|1|||
147237482|NCT00612040|531040628|FG000|Overall Study|Adverse Event|0|||
147136235|NCT03257358|530668134|FG000|Overall Study|Physician Decision|2|||
147136236|NCT03257358|530668135|FG001|Overall Study|Physician Decision|2|||
147136237|NCT03257358|530668134|FG000|Overall Study|Protocol Violation|5|||
147136238|NCT03257358|530668135|FG001|Overall Study|Protocol Violation|3|||
147136239|NCT03257358|530668134|FG000|Overall Study|Technical problems|4|||
147136240|NCT03257358|530668135|FG001|Overall Study|Technical problems|1|||
147136241|NCT03257358|530668134|FG000|Overall Study|Withdrawal by Subject|8|||
147136242|NCT03257358|530668135|FG001|Overall Study|Withdrawal by Subject|3|||
147237483|NCT00612040|531040629|FG001|Overall Study|Adverse Event|2|||
147237484|NCT00612040|531040630|FG002|Overall Study|Adverse Event|1|||
147136243|NCT03257358|530668134|FG000|Overall Study|Withdrawal of informed consent|9|||
147136244|NCT03257358|530668135|FG001|Overall Study|Withdrawal of informed consent|5|||
147136245|NCT03257358|530668134|FG000|Overall Study|New therapy for study indication|1|||
147136246|NCT03257358|530668135|FG001|Overall Study|New therapy for study indication|0|||
147136247|NCT03257358|530668134|FG000|Overall Study|No longer requires treatment|0|||
147136248|NCT03257358|530668135|FG001|Overall Study|No longer requires treatment|1|||
147136249|NCT00305877|530668136|FG000|Overall Study|Lack of Efficacy|6|||
147136250|NCT00305877|530668137|FG001|Overall Study|Lack of Efficacy|9|||
147136251|NCT00305877|530668136|FG000|Overall Study|Adverse Event|9|||
147136252|NCT00305877|530668137|FG001|Overall Study|Adverse Event|14|||
147136253|NCT00305877|530668136|FG000|Overall Study|Death|0|||
147136254|NCT00305877|530668137|FG001|Overall Study|Death|1|||
147136255|NCT00305877|530668136|FG000|Overall Study|Withdrawal by Subject|4|||
147136256|NCT00305877|530668137|FG001|Overall Study|Withdrawal by Subject|2|||
147136257|NCT00305877|530668136|FG000|Overall Study|Physician Decision|1|||
147136258|NCT00305877|530668137|FG001|Overall Study|Physician Decision|1|||
147136259|NCT00305877|530668136|FG000|Overall Study|Never start treatment|2|||
147136260|NCT00305877|530668137|FG001|Overall Study|Never start treatment|5|||
147136261|NCT00305877|530668136|FG000|Overall Study|Ineligible|2|||
147136262|NCT00305877|530668137|FG001|Overall Study|Ineligible|1|||
147136263|NCT00305877|530668136|FG000|Overall Study|Transportation issue with daily RT|0|||
147136264|NCT00305877|530668137|FG001|Overall Study|Transportation issue with daily RT|1|||
147136265|NCT01248793|530668138|FG000|Overall Study|Lost to Follow-up|0|||
147136266|NCT01248793|530668139|FG001|Overall Study|Lost to Follow-up|1|||
147136267|NCT01248793|530668138|FG000|Overall Study|Adverse Event|1|||
147136268|NCT01248793|530668139|FG001|Overall Study|Adverse Event|1|||
147136269|NCT01248793|530668138|FG000|Overall Study|Protocol Violation|0|||
147136270|NCT01248793|530668139|FG001|Overall Study|Protocol Violation|1|||
147136271|NCT01248793|530668138|FG000|Overall Study|Withdrawal by Subject|3|||
147136272|NCT01248793|530668139|FG001|Overall Study|Withdrawal by Subject|3|||
147136273|NCT02332187|530668140|FG000|Overall Study|Withdrawal by Subject|2|||
147136274|NCT02332187|530668141|FG001|Overall Study|Withdrawal by Subject|2|||
147136275|NCT02332187|530668140|FG000|Overall Study|Adverse Event|0|||
147136276|NCT02332187|530668141|FG001|Overall Study|Adverse Event|1|||
147136277|NCT00355030|530668148|FG000|Study Period 1 Treatment|Adverse Event|1|||
147136278|NCT00355030|530668149|FG001|Study Period 1 Treatment|Adverse Event|1|||
147136279|NCT00355030|530668148|FG000|Study Period 1 Treatment|Lost to Follow-up|3|||
147136280|NCT00355030|530668149|FG001|Study Period 1 Treatment|Lost to Follow-up|0|||
147136281|NCT00355030|530668148|FG000|Study Period 1 Treatment|Withdrawal by Subject|4|||
147136282|NCT00355030|530668149|FG001|Study Period 1 Treatment|Withdrawal by Subject|1|||
147136283|NCT00355030|530668148|FG000|Study Period 1 Treatment|Parent/Caregiver Decision|1|||
147136284|NCT00355030|530668149|FG001|Study Period 1 Treatment|Parent/Caregiver Decision|2|||
147136285|NCT00355030|530668148|FG000|Study Period 1 Treatment|Physician Decision|0|||
147136286|NCT00355030|530668149|FG001|Study Period 1 Treatment|Physician Decision|1|||
147136287|NCT00355030|530668148|FG000|Study Period 1 Treatment|Sponsor Decision|34|||
147136288|NCT00355030|530668149|FG001|Study Period 1 Treatment|Sponsor Decision|32|||
147136289|NCT00355030|530668148|FG000|Study Period 1 Treatment|Protocol Entry Criterion Not Met|0|||
147136290|NCT00355030|530668149|FG001|Study Period 1 Treatment|Protocol Entry Criterion Not Met|1|||
147136291|NCT00355030|530668148|FG000|Study Period 1 Treatment|Other|2|||
147136292|NCT00355030|530668149|FG001|Study Period 1 Treatment|Other|6|||
147136293|NCT00355030|530668148|FG000|Study Period 2 Long Term Follow-Up|Lost to Follow-up|0|||
147136294|NCT00355030|530668149|FG001|Study Period 2 Long Term Follow-Up|Lost to Follow-up|1|||
147136295|NCT00355030|530668148|FG000|Study Period 2 Long Term Follow-Up|Withdrawal by Subject|1|||
147136296|NCT00355030|530668149|FG001|Study Period 2 Long Term Follow-Up|Withdrawal by Subject|1|||
147136297|NCT00339040|530668150|FG000|Stage I|Not able to attend clinic|1|||
147136298|NCT00339040|530668151|FG001|Stage I|Not able to attend clinic|0|||
147445524|NCT00961220|531795878|FG000|Overall Study|Complete Response prior to 12 courses|1|||
147445525|NCT00282334|531795882|FG000|Overall Study|Withdrawal by Subject|8|||
147571774|NCT05630885|532250470|FG001|Efficacy Analysis Population Set|Prematurely discontinued study treatment before week 22|1|||
147571775|NCT01103713|532250471|FG000|Overall Study|Lost to Follow-up|2|||
147571776|NCT01103713|532250471|FG000|Overall Study|Withdrawal by Subject|8|||
147571777|NCT01103713|532250471|FG000|Overall Study|Study terminated by sponsor|2|||
147571778|NCT01103713|532250471|FG000|Overall Study|Other|1|||
147571779|NCT01929863|532250474|FG000|Period 1:Intervention Period 1 (7 Days)|Adverse Event|1|||
147136299|NCT00339040|530668150|FG000|Stage I|Protocol Violation|1|||
147136300|NCT00339040|530668151|FG001|Stage I|Protocol Violation|1|||
147136301|NCT00339040|530668150|FG000|Stage II|Lost to Follow-up|3|||
147136302|NCT00339040|530668151|FG001|Stage II|Lost to Follow-up|0|||
147136303|NCT00339040|530668150|FG000|Stage II|Withdrawal by Subject|1|||
147136304|NCT00339040|530668151|FG001|Stage II|Withdrawal by Subject|2|||
147136305|NCT00339040|530668150|FG000|Stage II|Protocol Violation|3|||
147136306|NCT00339040|530668151|FG001|Stage II|Protocol Violation|0|||
147136307|NCT00339040|530668150|FG000|Stage II|Not able to attend clinic|1|||
147136308|NCT00339040|530668151|FG001|Stage II|Not able to attend clinic|0|||
147136309|NCT00339040|530668150|FG000|Stage II|Site closing|2|||
147571780|NCT01929863|532250475|FG001|Period 1:Intervention Period 1 (7 Days)|Adverse Event|0|||
147571781|NCT01929863|532250474|FG000|Period 1:Intervention Period 1 (7 Days)|Withdrawal by Subject|0|||
147571782|NCT01929863|532250475|FG001|Period 1:Intervention Period 1 (7 Days)|Withdrawal by Subject|1|||
147571783|NCT01929863|532250474|FG000|Period 3:Intervention Period 2 (7 Days)|Adverse Event|0|||
147571784|NCT01929863|532250475|FG001|Period 3:Intervention Period 2 (7 Days)|Adverse Event|1|||
147571785|NCT00251979|532250476|FG000|Overall Study|Protocol Violation|3|||
147571786|NCT00251979|532250477|FG001|Overall Study|Protocol Violation|5|||
147571787|NCT00251979|532250476|FG000|Overall Study|Adverse Event|11|||
147571788|NCT00251979|532250477|FG001|Overall Study|Adverse Event|17|||
147571789|NCT00251979|532250476|FG000|Overall Study|Withdrawal by Subject|13|||
147571790|NCT00251979|532250477|FG001|Overall Study|Withdrawal by Subject|7|||
147571791|NCT00251979|532250476|FG000|Overall Study|Lost to Follow-up|8|||
147571792|NCT00251979|532250477|FG001|Overall Study|Lost to Follow-up|6|||
147571793|NCT00251979|532250476|FG000|Overall Study|Death|3|||
147571794|NCT00251979|532250477|FG001|Overall Study|Death|5|||
147571795|NCT01878292|532250483|FG000|Randomized|Protocol Violation|1|||
147571796|NCT01878292|532250484|FG001|Randomized|Protocol Violation|0|||
147571797|NCT01878292|532250485|FG002|Randomized|Protocol Violation|0|||
147571798|NCT01878292|532250483|FG000|Randomized|Lost to Follow-up|1|||
147571799|NCT01878292|532250484|FG001|Randomized|Lost to Follow-up|0|||
147571800|NCT01878292|532250485|FG002|Randomized|Lost to Follow-up|0|||
147571801|NCT01878292|532250483|FG000|Randomized|Adverse Event|1|||
147571802|NCT01878292|532250484|FG001|Randomized|Adverse Event|0|||
147571803|NCT01878292|532250485|FG002|Randomized|Adverse Event|0|||
147571804|NCT01878292|532250483|FG000|Double-blind Treatment Period|Other Reasons|2|||
147571805|NCT01878292|532250484|FG001|Double-blind Treatment Period|Other Reasons|0|||
147571806|NCT01878292|532250485|FG002|Double-blind Treatment Period|Other Reasons|0|||
147571807|NCT01878292|532250483|FG000|Double-blind Treatment Period|Lost to Follow-up|6|||
147571808|NCT01878292|532250484|FG001|Double-blind Treatment Period|Lost to Follow-up|3|||
147571809|NCT01878292|532250485|FG002|Double-blind Treatment Period|Lost to Follow-up|1|||
147136310|NCT00339040|530668151|FG001|Stage II|Site closing|0|||
147136311|NCT02391311|530668154|FG000|Overall Study|Lost to Follow-up|2|||
147136312|NCT02391311|530668155|FG001|Overall Study|Lost to Follow-up|1|||
147136313|NCT02391311|530668154|FG000|Overall Study|deemed ineligible after baseline|1|||
147136314|NCT02391311|530668155|FG001|Overall Study|deemed ineligible after baseline|1|||
147136315|NCT03183063|530668156|FG000|Overall Study|Withdrawal by Subject|2|||
147136316|NCT03183063|530668157|FG001|Overall Study|Withdrawal by Subject|0|||
147136317|NCT03183063|530668158|FG002|Overall Study|Withdrawal by Subject|0|||
147136318|NCT03183063|530668156|FG000|Overall Study|Physician Decision|3|||
147136319|NCT03183063|530668157|FG001|Overall Study|Physician Decision|4|||
147136320|NCT03183063|530668158|FG002|Overall Study|Physician Decision|4|||
147136321|NCT00688467|530668159|FG000|Treatment Period 1|Adverse Event|2|||
147136322|NCT00688467|530668160|FG001|Treatment Period 1|Adverse Event|1|||
147136323|NCT00688467|530668159|FG000|Treatment Period 1|Did not meet protocol eligibility|0|||
147136324|NCT00688467|530668160|FG001|Treatment Period 1|Did not meet protocol eligibility|1|||
147136325|NCT00688467|530668159|FG000|Treatment Period 2|Protocol Violation|0|||
147136326|NCT00688467|530668160|FG001|Treatment Period 2|Protocol Violation|1|||
147136327|NCT00688467|530668159|FG000|Treatment Period 2|Adverse Event|0|||
147136328|NCT00688467|530668160|FG001|Treatment Period 2|Adverse Event|1|||
147136329|NCT00690794|530668165|FG000|Overall Study|Adverse Event|12|||
147136330|NCT00690794|530668166|FG001|Overall Study|Adverse Event|10|||
147136331|NCT00690794|530668165|FG000|Overall Study|Lost to Follow-up|1|||
147136332|NCT00690794|530668166|FG001|Overall Study|Lost to Follow-up|4|||
147136333|NCT00690794|530668165|FG000|Overall Study|Withdrawal by Subject|0|||
147136334|NCT00690794|530668166|FG001|Overall Study|Withdrawal by Subject|9|||
147136335|NCT00690794|530668165|FG000|Overall Study|Protocol Violation|6|||
147136336|NCT00690794|530668166|FG001|Overall Study|Protocol Violation|7|||
147571810|NCT01878292|532250483|FG000|Double-blind Treatment Period|Withdrawal by Subject|9|||
147571811|NCT01878292|532250484|FG001|Double-blind Treatment Period|Withdrawal by Subject|7|||
147136337|NCT00690794|530668165|FG000|Overall Study|Noncompliance|1|||
147136338|NCT00690794|530668166|FG001|Overall Study|Noncompliance|2|||
147136339|NCT00690794|530668165|FG000|Overall Study|Other not specified|1|||
147571812|NCT01878292|532250485|FG002|Double-blind Treatment Period|Withdrawal by Subject|8|||
147571813|NCT01878292|532250483|FG000|Double-blind Treatment Period|Protocol Violation|3|||
147571814|NCT01878292|532250484|FG001|Double-blind Treatment Period|Protocol Violation|4|||
147651665|NCT00528372|532546569|FG004|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
147136340|NCT00690794|530668166|FG001|Overall Study|Other not specified|3|||
147136341|NCT01073293|530668167|FG000|Overall Study|Lost to Follow-up|0|||
147136342|NCT01073293|530668168|FG001|Overall Study|Lost to Follow-up|1|||
147136343|NCT01073293|530668167|FG000|Overall Study|Withdrawal by Subject|5|||
147571815|NCT01878292|532250485|FG002|Double-blind Treatment Period|Protocol Violation|2|||
147571816|NCT01878292|532250483|FG000|Double-blind Treatment Period|Lack of Efficacy|5|||
147571817|NCT01878292|532250484|FG001|Double-blind Treatment Period|Lack of Efficacy|3|||
147571818|NCT01878292|532250485|FG002|Double-blind Treatment Period|Lack of Efficacy|0|||
147571819|NCT01878292|532250483|FG000|Double-blind Treatment Period|Adverse Event|4|||
147445526|NCT00282334|531795883|FG001|Overall Study|Withdrawal by Subject|5|||
147445527|NCT00825162|531795894|FG000|Overall Study|Withdrawal by Subject|11|||
147445528|NCT00825162|531795895|FG001|Overall Study|Withdrawal by Subject|13|||
147445529|NCT00825162|531795896|FG002|Overall Study|Withdrawal by Subject|3|||
147445530|NCT00825162|531795894|FG000|Overall Study|Lost to Follow-up|9|||
147445531|NCT00825162|531795895|FG001|Overall Study|Lost to Follow-up|6|||
147445532|NCT00825162|531795896|FG002|Overall Study|Lost to Follow-up|3|||
147445533|NCT00825162|531795894|FG000|Overall Study|Physician Decision|2|||
147445534|NCT00825162|531795895|FG001|Overall Study|Physician Decision|0|||
147445535|NCT00825162|531795896|FG002|Overall Study|Physician Decision|0|||
147445536|NCT00825162|531795894|FG000|Overall Study|Move away from the study area|1|||
147445537|NCT00825162|531795895|FG001|Overall Study|Move away from the study area|0|||
147445538|NCT00825162|531795896|FG002|Overall Study|Move away from the study area|0|||
147445539|NCT00825162|531795894|FG000|Overall Study|Unable to attend the study visit|5|||
147445540|NCT00825162|531795895|FG001|Overall Study|Unable to attend the study visit|2|||
147445541|NCT00825162|531795896|FG002|Overall Study|Unable to attend the study visit|0|||
147445542|NCT03317795|531795905|FG000|Overall Study|IUD Expulsion|1|||
147445543|NCT03317795|531795906|FG001|Overall Study|IUD Expulsion|0|||
147445544|NCT03317795|531795905|FG000|Overall Study|Lost to Follow-up|1|||
147445545|NCT03317795|531795906|FG001|Overall Study|Lost to Follow-up|3|||
147445546|NCT03317795|531795905|FG000|Overall Study|Treatment change|0|||
147445547|NCT03317795|531795906|FG001|Overall Study|Treatment change|3|||
147445548|NCT03317795|531795905|FG000|Overall Study|Intolerance of medication|0|||
147445549|NCT03317795|531795906|FG001|Overall Study|Intolerance of medication|1|||
147445550|NCT00939783|531795907|FG000|Overall Study|Death|6|||
147445551|NCT00939783|531795907|FG000|Overall Study|Adverse Event|39|||
147445552|NCT00939783|531795907|FG000|Overall Study|Study Terminated by Sponsor|498|||
147445553|NCT00939783|531795907|FG000|Overall Study|Withdrawal by Subject|78|||
147445554|NCT00939783|531795907|FG000|Overall Study|Other|16|||
147445555|NCT00939783|531795907|FG000|Overall Study|Lost to Follow-up|8|||
147445556|NCT00939783|531795907|FG000|Overall Study|Protocol Violation|3|||
147445557|NCT00939783|531795907|FG000|Overall Study|Enrolled but not treated|1|||
147445558|NCT00501007|531795911|FG000|Overall Study|Inclusion criteria not met.|29|||
147445559|NCT00501007|531795912|FG001|Overall Study|Inclusion criteria not met.|25|||
147445560|NCT03917823|531795913|FG000|Overall Study|Lost to Follow-up|1|||
147445561|NCT03917823|531795914|FG001|Overall Study|Lost to Follow-up|1|||
147445562|NCT03917823|531795913|FG000|Overall Study|Withdrawal by Subject|0|||
147445563|NCT03917823|531795914|FG001|Overall Study|Withdrawal by Subject|1|||
147445564|NCT00135668|531795915|FG000|Overall Study - Randomized to be Dosed|Discontinued pre-operatively|1|||
147445565|NCT00135668|531795916|FG001|Overall Study - Randomized to be Dosed|Discontinued pre-operatively|0|||
147445566|NCT00135668|531795917|FG002|Overall Study - Randomized to be Dosed|Discontinued pre-operatively|2|||
147445567|NCT00135668|531795918|FG003|Overall Study - Randomized to be Dosed|Discontinued pre-operatively|0|||
147445568|NCT02424253|531795921|FG000|Overall Study|Other, unspecified|1|||
147445569|NCT02424253|531795922|FG001|Overall Study|Other, unspecified|0|||
147445570|NCT02424253|531795921|FG000|Overall Study|Compliance problems|1|||
147445571|NCT02424253|531795922|FG001|Overall Study|Compliance problems|0|||
147445572|NCT02424253|531795921|FG000|Overall Study|Physician Decision|2|||
147445573|NCT02424253|531795922|FG001|Overall Study|Physician Decision|0|||
147445574|NCT02424253|531795921|FG000|Overall Study|Lack of Efficacy|0|||
147445575|NCT02424253|531795922|FG001|Overall Study|Lack of Efficacy|7|||
147445576|NCT02424253|531795921|FG000|Overall Study|Adverse Event|2|||
147445577|NCT02424253|531795922|FG001|Overall Study|Adverse Event|0|||
147445578|NCT02424253|531795921|FG000|Overall Study|Consent withdrawn by subject|4|||
147445579|NCT02424253|531795922|FG001|Overall Study|Consent withdrawn by subject|1|||
147571820|NCT01878292|532250484|FG001|Double-blind Treatment Period|Adverse Event|9|||
147571821|NCT01878292|532250485|FG002|Double-blind Treatment Period|Adverse Event|8|||
147237485|NCT00612040|531040628|FG000|Overall Study|Protocol Violation|1|||
147237486|NCT00612040|531040629|FG001|Overall Study|Protocol Violation|2|||
147237487|NCT00612040|531040630|FG002|Overall Study|Protocol Violation|1|||
147237488|NCT00612040|531040628|FG000|Overall Study|Lack of Efficacy|2|||
147237489|NCT00612040|531040629|FG001|Overall Study|Lack of Efficacy|1|||
147237490|NCT00612040|531040630|FG002|Overall Study|Lack of Efficacy|0|||
147237491|NCT00612040|531040628|FG000|Overall Study|Unclassified|2|||
147237492|NCT00612040|531040629|FG001|Overall Study|Unclassified|2|||
147571822|NCT01878292|532250483|FG000|Double-blind Down-Taper Period|Withdrawal by Subject|5|||
147237493|NCT00612040|531040630|FG002|Overall Study|Unclassified|5|||
147237494|NCT00827502|531040633|FG000|Overall Study|randomized but not treated|11|||
147445580|NCT02424253|531795921|FG000|Overall Study|Lost to Follow-up|1|||
147445581|NCT02424253|531795922|FG001|Overall Study|Lost to Follow-up|1|||
147445582|NCT00781911|531795923|FG000|Overall Study|Adverse Event|4|||
147445583|NCT00781911|531795924|FG001|Overall Study|Adverse Event|4|||
147445584|NCT00781911|531795923|FG000|Overall Study|Withdrawal by Subject|1|||
147445585|NCT00781911|531795924|FG001|Overall Study|Withdrawal by Subject|2|||
147445586|NCT00781911|531795923|FG000|Overall Study|Physician Decision|0|||
147445587|NCT00781911|531795924|FG001|Overall Study|Physician Decision|2|||
147445588|NCT00781911|531795923|FG000|Overall Study|Sponsor Decision|1|||
147595958|NCT01875471|532338756|FG000|Overall Study|Adverse Event|0|||
147136344|NCT01073293|530668168|FG001|Overall Study|Withdrawal by Subject|10|||
147136345|NCT00305448|530668169|FG000|Overall Study|Protocol Violation|0|||
147136346|NCT00305448|530668170|FG001|Overall Study|Protocol Violation|1|||
147136347|NCT00305448|530668171|FG002|Overall Study|Protocol Violation|0|||
147136348|NCT00305448|530668169|FG000|Overall Study|Withdrawal by Subject|2|||
147136349|NCT00305448|530668170|FG001|Overall Study|Withdrawal by Subject|0|||
147136350|NCT00305448|530668171|FG002|Overall Study|Withdrawal by Subject|1|||
147136351|NCT00305448|530668169|FG000|Overall Study|Adverse Event|1|||
147136352|NCT00305448|530668170|FG001|Overall Study|Adverse Event|0|||
147136353|NCT00305448|530668171|FG002|Overall Study|Adverse Event|1|||
147136354|NCT00305448|530668169|FG000|Overall Study|Disease Progression|27|||
147136355|NCT00305448|530668170|FG001|Overall Study|Disease Progression|31|||
147136356|NCT00305448|530668171|FG002|Overall Study|Disease Progression|28|||
147136357|NCT00305448|530668169|FG000|Overall Study|Subjective Disease Progression|1|||
147136358|NCT00305448|530668170|FG001|Overall Study|Subjective Disease Progression|2|||
147136359|NCT00305448|530668171|FG002|Overall Study|Subjective Disease Progression|2|||
147136360|NCT00305448|530668169|FG000|Overall Study|Tumor Marker Elevation|0|||
147136361|NCT00305448|530668170|FG001|Overall Study|Tumor Marker Elevation|0|||
147136362|NCT00305448|530668171|FG002|Overall Study|Tumor Marker Elevation|1|||
147136363|NCT01343888|530668172|FG000|Overall Study|Adverse Event|12|||
147136364|NCT01343888|530668173|FG001|Overall Study|Adverse Event|22|||
147136365|NCT01343888|530668174|FG002|Overall Study|Adverse Event|5|||
147136366|NCT01343888|530668172|FG000|Overall Study|Lack of Efficacy|9|||
147136367|NCT01343888|530668173|FG001|Overall Study|Lack of Efficacy|9|||
147136368|NCT01343888|530668174|FG002|Overall Study|Lack of Efficacy|13|||
147136369|NCT01343888|530668172|FG000|Overall Study|Lost to Follow-up|0|||
147136370|NCT01343888|530668173|FG001|Overall Study|Lost to Follow-up|2|||
147136371|NCT01343888|530668174|FG002|Overall Study|Lost to Follow-up|1|||
147136372|NCT01343888|530668172|FG000|Overall Study|Protocol Violation|0|||
147136373|NCT01343888|530668173|FG001|Overall Study|Protocol Violation|2|||
147136374|NCT01343888|530668174|FG002|Overall Study|Protocol Violation|0|||
147136375|NCT01343888|530668172|FG000|Overall Study|Withdrawal by Subject|4|||
147136376|NCT01343888|530668173|FG001|Overall Study|Withdrawal by Subject|4|||
147136377|NCT01343888|530668174|FG002|Overall Study|Withdrawal by Subject|2|||
147136378|NCT01343888|530668172|FG000|Overall Study|other than stated above|0|||
147136379|NCT01343888|530668173|FG001|Overall Study|other than stated above|0|||
147136380|NCT01343888|530668174|FG002|Overall Study|other than stated above|1|||
147136381|NCT00077974|530668175|FG000|Overall Study|Adverse Event|22|||
147136382|NCT00077974|530668175|FG000|Overall Study|Protocol Violation|1|||
147136383|NCT00077974|530668175|FG000|Overall Study|Withdrawal by Subject|3|||
147136384|NCT00077974|530668175|FG000|Overall Study|Lack of Efficacy|76|||
147136385|NCT00077974|530668175|FG000|Overall Study|Decision of Sponsor|2|||
147136386|NCT04108273|530668187|FG000|Overall Study|COVID Pandemic|1|||
147136387|NCT04108273|530668188|FG001|Overall Study|COVID Pandemic|0|||
147136388|NCT00506142|530668189|FG000|Overall Study|Adverse Event|8|||
147136389|NCT00506142|530668190|FG001|Overall Study|Adverse Event|7|||
147136390|NCT00506142|530668189|FG000|Overall Study|Lack of Efficacy|21|||
147136391|NCT00506142|530668190|FG001|Overall Study|Lack of Efficacy|7|||
147136392|NCT00506142|530668189|FG000|Overall Study|Withdrawal by Subject|4|||
147136393|NCT00506142|530668190|FG001|Overall Study|Withdrawal by Subject|5|||
147136394|NCT00506142|530668189|FG000|Overall Study|Physician Decision|1|||
147136395|NCT00506142|530668190|FG001|Overall Study|Physician Decision|0|||
147136396|NCT00506142|530668189|FG000|Overall Study|New health condition|1|||
147136397|NCT00506142|530668190|FG001|Overall Study|New health condition|0|||
147136398|NCT03500211|530668195|FG000|Overall Study|Withdrawal by Subject|1|||
147136399|NCT03500211|530668196|FG001|Overall Study|Withdrawal by Subject|1|||
147571823|NCT01878292|532250484|FG001|Double-blind Down-Taper Period|Withdrawal by Subject|8|||
147571824|NCT01878292|532250485|FG002|Double-blind Down-Taper Period|Withdrawal by Subject|4|||
147571825|NCT01983969|532250487|FG000|Overall Study|Disease Progression|0|||
147571826|NCT01983969|532250488|FG001|Overall Study|Disease Progression|1|||
147571827|NCT01983969|532250489|FG002|Overall Study|Disease Progression|0|||
147571828|NCT00268203|532250490|FG000|Overall Study|Lost to Follow-up|92|||
147571829|NCT00268203|532250490|FG000|Overall Study|Withdrawal by Subject|9|||
147136400|NCT04460183|530668197|FG000|Overall Study|Lost to Follow-up|3|||
147136401|NCT04460183|530668198|FG001|Overall Study|Lost to Follow-up|1|||
147136402|NCT04460183|530668197|FG000|Overall Study|Withdrawal by Subject|1|||
147136403|NCT04460183|530668198|FG001|Overall Study|Withdrawal by Subject|0|||
147136404|NCT00487981|530668199|FG000|Overall Study|Hypothyroidism diagnosis|1|||
147136405|NCT02808429|530668204|FG000|Overall Study|Lost to Follow-up|1|||
147136406|NCT02808429|530668205|FG001|Overall Study|Lost to Follow-up|0|||
147136407|NCT02808429|530668206|FG002|Overall Study|Lost to Follow-up|0|||
147136408|NCT02808429|530668204|FG000|Overall Study|Protocol Violation|0|||
147136409|NCT02808429|530668205|FG001|Overall Study|Protocol Violation|1|||
147136410|NCT02808429|530668206|FG002|Overall Study|Protocol Violation|0|||
147136411|NCT02808429|530668204|FG000|Overall Study|Premature study termination by sponsor|2|||
147136412|NCT02808429|530668205|FG001|Overall Study|Premature study termination by sponsor|0|||
147136413|NCT02808429|530668206|FG002|Overall Study|Premature study termination by sponsor|1|||
147571830|NCT00268203|532250490|FG000|Overall Study|Received Other NHL Therapy|7|||
147571831|NCT00268203|532250490|FG000|Overall Study|Progressive Disease|359|||
147571832|NCT00268203|532250490|FG000|Overall Study|Death|84|||
147571833|NCT00268203|532250490|FG000|Overall Study|Reason Not Specified|34|||
147571834|NCT00268203|532250490|FG000|Overall Study|Completed 2 Years of Follow-up|62|||
147571835|NCT00950989|532250491|FG000|Overall Study|Death|0|||
147571836|NCT00950989|532250492|FG001|Overall Study|Death|0|||
147571837|NCT00950989|532250493|FG002|Overall Study|Death|1|||
147571838|NCT00950989|532250494|FG003|Overall Study|Death|0|||
147571839|NCT00950989|532250491|FG000|Overall Study|Administrative Decision|0|||
147571840|NCT00950989|532250492|FG001|Overall Study|Administrative Decision|1|||
147136414|NCT02808429|530668204|FG000|Overall Study|Relocation|0|||
147136415|NCT02808429|530668205|FG001|Overall Study|Relocation|0|||
147571841|NCT00950989|532250493|FG002|Overall Study|Administrative Decision|0|||
147571842|NCT00950989|532250494|FG003|Overall Study|Administrative Decision|0|||
147571843|NCT00950989|532250491|FG000|Overall Study|Disease Progression|0|||
147136416|NCT02808429|530668206|FG002|Overall Study|Relocation|1|||
147136417|NCT00856609|530668210|FG000|Overall Study|Adverse Event|1|||
147136418|NCT00856609|530668211|FG001|Overall Study|Adverse Event|0|||
147136419|NCT01788943|530668212|FG000|Overall Study|Withdrawal by Subject|1|||
147136420|NCT01788943|530668213|FG001|Overall Study|Withdrawal by Subject|0|||
147136421|NCT00783432|530668214|FG000|Overall Study|Adverse Event|22|||
147136422|NCT00783432|530668215|FG001|Overall Study|Adverse Event|17|||
147136423|NCT00783432|530668214|FG000|Overall Study|Lack of Efficacy|20|||
147136424|NCT00783432|530668215|FG001|Overall Study|Lack of Efficacy|21|||
147445589|NCT00781911|531795924|FG001|Overall Study|Sponsor Decision|0|||
147445590|NCT05885737|531795928|FG000|DB Period|Adverse Event|4|||
147445591|NCT05885737|531795929|FG001|DB Period|Adverse Event|4|||
147445592|NCT05885737|531795928|FG000|DB Period|Lost to Follow-up|0|||
147445593|NCT05885737|531795929|FG001|DB Period|Lost to Follow-up|1|||
147445594|NCT05885737|531795928|FG000|DB Period|Physician Decision|2|||
147445595|NCT05885737|531795929|FG001|DB Period|Physician Decision|0|||
147445596|NCT05885737|531795928|FG000|DB Period|Withdrawal by Subject|12|||
147445597|NCT05885737|531795929|FG001|DB Period|Withdrawal by Subject|6|||
147445598|NCT05885737|531795928|FG000|DB Period|Other: Unspecified|2|||
147445599|NCT05885737|531795929|FG001|DB Period|Other: Unspecified|2|||
147445600|NCT05885737|531795928|FG000|OLE Period|Adverse Event|3|||
147445601|NCT05885737|531795929|FG001|OLE Period|Adverse Event|2|||
147445602|NCT05885737|531795928|FG000|OLE Period|Physician Decision|1|||
147445603|NCT05885737|531795929|FG001|OLE Period|Physician Decision|0|||
147445604|NCT05885737|531795928|FG000|OLE Period|Withdrawal by Subject|5|||
147445605|NCT05885737|531795929|FG001|OLE Period|Withdrawal by Subject|5|||
147445606|NCT05885737|531795928|FG000|OLE Period|Other: Unspecified|2|||
147445607|NCT05885737|531795929|FG001|OLE Period|Other: Unspecified|1|||
147445608|NCT02037295|531797407|FG000|Phase 2: Vancomycin and Placebo|Withdrawal by Subject|1|||
147445609|NCT02037295|531797408|FG001|Phase 2: Vancomycin and Placebo|Withdrawal by Subject|0|||
147445610|NCT02037295|531797409|FG002|Phase 2: Vancomycin and Placebo|Withdrawal by Subject|0|||
147445611|NCT02037295|531797410|FG003|Phase 2: Vancomycin and Placebo|Withdrawal by Subject|1|||
147445612|NCT02004262|531797413|FG000|Overall Study|Death|67|||
147445613|NCT02004262|531797414|FG001|Overall Study|Death|64|||
147445614|NCT02004262|531797415|FG002|Overall Study|Death|66|||
147445615|NCT02004262|531797416|FG003|Overall Study|Death|28|||
147445616|NCT02004262|531797417|FG004|Overall Study|Death|29|||
147445617|NCT02004262|531797418|FG005|Overall Study|Death|22|||
147571844|NCT00950989|532250492|FG001|Overall Study|Disease Progression|0|||
147571845|NCT00950989|532250493|FG002|Overall Study|Disease Progression|1|||
147136425|NCT00783432|530668214|FG000|Overall Study|Lost to Follow-up|11|||
147136426|NCT00783432|530668215|FG001|Overall Study|Lost to Follow-up|6|||
147136427|NCT00783432|530668214|FG000|Overall Study|Withdrawal by Subject|23|||
147136428|NCT00783432|530668215|FG001|Overall Study|Withdrawal by Subject|20|||
147445618|NCT02004262|531797413|FG000|Overall Study|Withdrawal by Subject|1|||
147445619|NCT02004262|531797414|FG001|Overall Study|Withdrawal by Subject|0|||
147571846|NCT00950989|532250494|FG003|Overall Study|Disease Progression|0|||
147136429|NCT00783432|530668214|FG000|Overall Study|subject moved|3|||
147136430|NCT00783432|530668215|FG001|Overall Study|subject moved|5|||
147136431|NCT00783432|530668214|FG000|Overall Study|Protocol Violation|6|||
147136432|NCT00783432|530668215|FG001|Overall Study|Protocol Violation|9|||
147445620|NCT02004262|531797415|FG002|Overall Study|Withdrawal by Subject|4|||
147445621|NCT02004262|531797416|FG003|Overall Study|Withdrawal by Subject|0|||
147445622|NCT02004262|531797417|FG004|Overall Study|Withdrawal by Subject|1|||
147445623|NCT02004262|531797418|FG005|Overall Study|Withdrawal by Subject|3|||
147445624|NCT02004262|531797413|FG000|Overall Study|Lost to Follow-up|1|||
147445625|NCT02004262|531797414|FG001|Overall Study|Lost to Follow-up|1|||
147445626|NCT02004262|531797415|FG002|Overall Study|Lost to Follow-up|0|||
147445627|NCT02004262|531797416|FG003|Overall Study|Lost to Follow-up|0|||
147571847|NCT00950989|532250491|FG000|Overall Study|Withdrawal by Subject|2|||
147571848|NCT00950989|532250492|FG001|Overall Study|Withdrawal by Subject|1|||
147571849|NCT00950989|532250493|FG002|Overall Study|Withdrawal by Subject|0|||
147136433|NCT01436110|530668216|FG000|Overall Study|Lack of Efficacy|23|||
147445628|NCT02004262|531797417|FG004|Overall Study|Lost to Follow-up|0|||
147571850|NCT00950989|532250494|FG003|Overall Study|Withdrawal by Subject|0|||
147136434|NCT01436110|530668217|FG001|Overall Study|Lack of Efficacy|14|||
147136435|NCT01436110|530668218|FG002|Overall Study|Lack of Efficacy|9|||
147136436|NCT01436110|530668216|FG000|Overall Study|Withdrawal by Subject|6|||
147136437|NCT01436110|530668217|FG001|Overall Study|Withdrawal by Subject|8|||
147136438|NCT01436110|530668218|FG002|Overall Study|Withdrawal by Subject|4|||
147136439|NCT01436110|530668216|FG000|Overall Study|Adverse Event|2|||
147136440|NCT01436110|530668217|FG001|Overall Study|Adverse Event|1|||
147136441|NCT01436110|530668218|FG002|Overall Study|Adverse Event|2|||
147136442|NCT01436110|530668216|FG000|Overall Study|Physician Decision|3|||
147136443|NCT01436110|530668217|FG001|Overall Study|Physician Decision|1|||
147136444|NCT01436110|530668218|FG002|Overall Study|Physician Decision|1|||
147136445|NCT01436110|530668216|FG000|Overall Study|Lost to Follow-up|1|||
147136446|NCT01436110|530668217|FG001|Overall Study|Lost to Follow-up|1|||
147136447|NCT01436110|530668218|FG002|Overall Study|Lost to Follow-up|3|||
147136448|NCT01436110|530668216|FG000|Overall Study|Protocol Violation|3|||
147136449|NCT01436110|530668217|FG001|Overall Study|Protocol Violation|1|||
147136450|NCT01436110|530668218|FG002|Overall Study|Protocol Violation|1|||
147136451|NCT01436110|530668216|FG000|Overall Study|Did Not Receive Trial Medication|1|||
147136452|NCT01436110|530668217|FG001|Overall Study|Did Not Receive Trial Medication|0|||
147136453|NCT01436110|530668218|FG002|Overall Study|Did Not Receive Trial Medication|3|||
147136454|NCT03273907|530668219|FG000|Overall Study|Death|1|||
147136455|NCT03273907|530668219|FG000|Overall Study|Lost to Follow-up|4|||
147136456|NCT03273907|530668219|FG000|Overall Study|Withdrawal by Subject|2|||
147136457|NCT03273907|530668219|FG000|Overall Study|COVID 19|2|||
147136458|NCT01088503|530668220|FG000|Overall Study|Withdrawal by Subject|118|||
147136459|NCT01088503|530668221|FG001|Overall Study|Withdrawal by Subject|327|||
147136460|NCT01088503|530668222|FG002|Overall Study|Withdrawal by Subject|10|||
147136461|NCT01088503|530668220|FG000|Overall Study|Death|64|||
147136462|NCT01088503|530668221|FG001|Overall Study|Death|358|||
147136463|NCT01088503|530668222|FG002|Overall Study|Death|7|||
147136464|NCT00110214|530668223|FG000|Overall Study|Never started treatment|21|||
147136465|NCT00110214|530668224|FG001|Overall Study|Never started treatment|20|||
147136466|NCT00110214|530668223|FG000|Overall Study|Disease progression or death|260|||
147136467|NCT00110214|530668224|FG001|Overall Study|Disease progression or death|151|||
147136468|NCT00110214|530668223|FG000|Overall Study|Adverse Event|115|||
147136469|NCT00110214|530668224|FG001|Overall Study|Adverse Event|192|||
147136470|NCT00110214|530668223|FG000|Overall Study|Refused further treatment|52|||
147136471|NCT00110214|530668224|FG001|Overall Study|Refused further treatment|65|||
147136472|NCT00110214|530668223|FG000|Overall Study|Other (not specified)|61|||
147136473|NCT00110214|530668224|FG001|Overall Study|Other (not specified)|75|||
147136474|NCT01847092|530668225|FG000|Overall Study|Adverse Event|12|||
147136475|NCT01847092|530668226|FG001|Overall Study|Adverse Event|3|||
147136476|NCT01847092|530668225|FG000|Overall Study|Withdrawal by Subject|5|||
147136477|NCT01847092|530668226|FG001|Overall Study|Withdrawal by Subject|5|||
147136478|NCT01847092|530668225|FG000|Overall Study|Protocol Specified|8|||
147136479|NCT01847092|530668226|FG001|Overall Study|Protocol Specified|0|||
147136480|NCT01847092|530668225|FG000|Overall Study|Physician Decision|1|||
147136481|NCT01847092|530668226|FG001|Overall Study|Physician Decision|1|||
147136482|NCT01847092|530668225|FG000|Overall Study|Protocol Violation|0|||
147136483|NCT01847092|530668226|FG001|Overall Study|Protocol Violation|2|||
147136484|NCT03604497|530668228|FG000|Overall Study|Protocol Violation|52|||
147136485|NCT00811954|530668229|FG000|Overall Study|Death|10|||
147136486|NCT00811954|530668230|FG001|Overall Study|Death|6|||
147136487|NCT00811954|530668231|FG002|Overall Study|Death|13|||
147136488|NCT00811954|530668229|FG000|Overall Study|Lost to Follow-up|29|||
147136489|NCT00811954|530668230|FG001|Overall Study|Lost to Follow-up|23|||
147136490|NCT00811954|530668231|FG002|Overall Study|Lost to Follow-up|34|||
147136491|NCT00811954|530668229|FG000|Overall Study|Not able to get to clinic|28|||
147136492|NCT00811954|530668230|FG001|Overall Study|Not able to get to clinic|35|||
147136493|NCT00811954|530668231|FG002|Overall Study|Not able to get to clinic|30|||
147136494|NCT00811954|530668229|FG000|Overall Study|Not willing to adhere to requirements|12|||
147136495|NCT00811954|530668230|FG001|Overall Study|Not willing to adhere to requirements|2|||
147445629|NCT02004262|531797418|FG005|Overall Study|Lost to Follow-up|0|||
147136496|NCT00811954|530668231|FG002|Overall Study|Not willing to adhere to requirements|16|||
147136497|NCT00811954|530668229|FG000|Overall Study|Withdraw consent prior study completion|4|||
147136498|NCT00811954|530668230|FG001|Overall Study|Withdraw consent prior study completion|6|||
147136499|NCT00811954|530668231|FG002|Overall Study|Withdraw consent prior study completion|5|||
147136500|NCT00811954|530668229|FG000|Overall Study|Site Closure|4|||
147136501|NCT00811954|530668230|FG001|Overall Study|Site Closure|0|||
147136502|NCT00811954|530668231|FG002|Overall Study|Site Closure|1|||
147136503|NCT00811954|530668229|FG000|Overall Study|Severe Debilitation|2|||
147136504|NCT00811954|530668230|FG001|Overall Study|Severe Debilitation|0|||
147136505|NCT00811954|530668231|FG002|Overall Study|Severe Debilitation|1|||
147136506|NCT00811954|530668229|FG000|Overall Study|Complete Protocol: No follow-up|0|||
147136507|NCT00811954|530668230|FG001|Overall Study|Complete Protocol: No follow-up|0|||
147136508|NCT00811954|530668231|FG002|Overall Study|Complete Protocol: No follow-up|1|||
147136509|NCT01016067|530668232|FG000|Overall Study|Lost to Follow-up|1|||
147571851|NCT00950989|532250491|FG000|Overall Study|Adverse Event|2|||
147571852|NCT00950989|532250492|FG001|Overall Study|Adverse Event|1|||
147136510|NCT01016067|530668233|FG001|Overall Study|Lost to Follow-up|2|||
147136511|NCT01016067|530668232|FG000|Overall Study|Physician Decision|1|||
147136512|NCT01016067|530668233|FG001|Overall Study|Physician Decision|1|||
147136513|NCT01016067|530668232|FG000|Overall Study|Withdrew due to Relocation|0|||
147136514|NCT01016067|530668233|FG001|Overall Study|Withdrew due to Relocation|1|||
147136515|NCT00186628|530668235|FG000|Overall Study|Death|2|||
147136516|NCT00186628|530668235|FG000|Overall Study|Withdrawal by subject (before treatment)|1|||
147136517|NCT03434834|530668238|FG000|Overall Study|unable to swallow OCT probe|16|||
147136518|NCT01657305|530668242|FG000|Overall Study|Lack of Wound Closure at Day 28|15|||
147136519|NCT01657305|530668242|FG000|Overall Study|Withdrawal by Subject|4|||
147136520|NCT01657305|530668242|FG000|Overall Study|Adverse Event|1|||
147136521|NCT01657305|530668242|FG000|Overall Study|Lost to Follow-up|1|||
147136522|NCT01657305|530668242|FG000|Overall Study|Did not Adhere to Protocol/Procedures|4|||
147136523|NCT00696878|530668244|FG000|Overall Study|Adverse Event|8|||
147136524|NCT00696878|530668244|FG000|Overall Study|Withdrawal by Subject|87|||
147136525|NCT00696878|530668244|FG000|Overall Study|Stop Treat Cycle 3 not for Adverse Event|18|||
147136526|NCT00696878|530668244|FG000|Overall Study|Pregnant prior to Treat Cycle 3|304|||
147136527|NCT00696878|530668244|FG000|Overall Study|Trial stopped|32|||
147136528|NCT00696878|530668244|FG000|Overall Study|Other reason (not specified)|55|||
147136529|NCT01378117|530668246|FG000|Overall Study|withdrawal|2|||
147136530|NCT01378117|530668247|FG001|Overall Study|withdrawal|1|||
147136531|NCT01378117|530668248|FG002|Overall Study|withdrawal|2|||
147136532|NCT01378117|530668246|FG000|Overall Study|discharged before med given|2|||
147136533|NCT01378117|530668247|FG001|Overall Study|discharged before med given|0|||
147136534|NCT01378117|530668248|FG002|Overall Study|discharged before med given|1|||
147136535|NCT01374425|530668250|FG000|Overall Study|Radiographic Disease Progression|86|||
147136536|NCT01374425|530668251|FG001|Overall Study|Radiographic Disease Progression|81|||
147136537|NCT01374425|530668250|FG000|Overall Study|Clinical Disease Progression|9|||
147136538|NCT01374425|530668251|FG001|Overall Study|Clinical Disease Progression|6|||
147136539|NCT01374425|530668250|FG000|Overall Study|Adverse Event|29|||
147136540|NCT01374425|530668251|FG001|Overall Study|Adverse Event|18|||
147136541|NCT01374425|530668250|FG000|Overall Study|Death (Progression of Disease)|1|||
147136542|NCT01374425|530668251|FG001|Overall Study|Death (Progression of Disease)|0|||
147136543|NCT01374425|530668250|FG000|Overall Study|Death (Adverse Event)|2|||
147136544|NCT01374425|530668251|FG001|Overall Study|Death (Adverse Event)|4|||
147136545|NCT01374425|530668250|FG000|Overall Study|Withdrawal by Subject|6|||
147136546|NCT01374425|530668251|FG001|Overall Study|Withdrawal by Subject|7|||
147136547|NCT01374425|530668250|FG000|Overall Study|Refused Treatment|10|||
147136548|NCT01374425|530668251|FG001|Overall Study|Refused Treatment|24|||
147136549|NCT01374425|530668250|FG000|Overall Study|Protocol Violation|2|||
147136550|NCT01374425|530668251|FG001|Overall Study|Protocol Violation|3|||
147136551|NCT01374425|530668250|FG000|Overall Study|Sponsor Decision|0|||
147136552|NCT01374425|530668251|FG001|Overall Study|Sponsor Decision|1|||
147136553|NCT01374425|530668250|FG000|Overall Study|Lost to Follow-up|2|||
147136554|NCT01374425|530668251|FG001|Overall Study|Lost to Follow-up|1|||
147136555|NCT01374425|530668250|FG000|Overall Study|Other|41|||
147136556|NCT01374425|530668251|FG001|Overall Study|Other|43|||
147136557|NCT00546481|530668252|FG000|Correction Phase (CERA or Epoetin Beta)|Protocol Violation|1|||
147136558|NCT00546481|530668253|FG001|Correction Phase (CERA or Epoetin Beta)|Protocol Violation|0|||
147136559|NCT00546481|530668254|FG002|Correction Phase (CERA or Epoetin Beta)|Protocol Violation|0|||
147136560|NCT00546481|530668252|FG000|Correction Phase (CERA or Epoetin Beta)|Withdrawal by Subject|1|||
147136561|NCT00546481|530668253|FG001|Correction Phase (CERA or Epoetin Beta)|Withdrawal by Subject|3|||
147136562|NCT00546481|530668254|FG002|Correction Phase (CERA or Epoetin Beta)|Withdrawal by Subject|0|||
147136563|NCT00546481|530668252|FG000|Correction Phase (CERA or Epoetin Beta)|Lack of Efficacy|1|||
147136564|NCT00546481|530668253|FG001|Correction Phase (CERA or Epoetin Beta)|Lack of Efficacy|0|||
147136565|NCT00546481|530668254|FG002|Correction Phase (CERA or Epoetin Beta)|Lack of Efficacy|0|||
147136566|NCT00546481|530668252|FG000|Correction Phase (CERA or Epoetin Beta)|Kidney transplantation|2|||
147136567|NCT00546481|530668253|FG001|Correction Phase (CERA or Epoetin Beta)|Kidney transplantation|0|||
147445630|NCT02004262|531797413|FG000|Overall Study|Study Terminated by Sponsor|4|||
147136568|NCT00546481|530668254|FG002|Correction Phase (CERA or Epoetin Beta)|Kidney transplantation|0|||
147136569|NCT00546481|530668252|FG000|Correction Phase (CERA or Epoetin Beta)|Lost to Follow-up|1|||
147136570|NCT00546481|530668253|FG001|Correction Phase (CERA or Epoetin Beta)|Lost to Follow-up|1|||
147136571|NCT00546481|530668254|FG002|Correction Phase (CERA or Epoetin Beta)|Lost to Follow-up|0|||
147136572|NCT00546481|530668252|FG000|Correction Phase (CERA or Epoetin Beta)|RBC transfusion|0|||
147136573|NCT00546481|530668253|FG001|Correction Phase (CERA or Epoetin Beta)|RBC transfusion|1|||
147136574|NCT00546481|530668254|FG002|Correction Phase (CERA or Epoetin Beta)|RBC transfusion|0|||
147136575|NCT00546481|530668252|FG000|Maintenance Phase (CERA)|Withdrawal by Subject|0|||
147136576|NCT00546481|530668253|FG001|Maintenance Phase (CERA)|Withdrawal by Subject|0|||
147136577|NCT00546481|530668254|FG002|Maintenance Phase (CERA)|Withdrawal by Subject|2|||
147136578|NCT00546481|530668252|FG000|Maintenance Phase (CERA)|Kidney transplantation|0|||
147445631|NCT02004262|531797414|FG001|Overall Study|Study Terminated by Sponsor|3|||
147571853|NCT00950989|532250493|FG002|Overall Study|Adverse Event|1|||
147571854|NCT00950989|532250494|FG003|Overall Study|Adverse Event|0|||
147571855|NCT00730691|532250495|FG000|Overall Study|Adverse Event|4|||
147571856|NCT00730691|532250496|FG001|Overall Study|Adverse Event|8|||
147571857|NCT00730691|532250497|FG002|Overall Study|Adverse Event|11|||
147571858|NCT00730691|532250498|FG003|Overall Study|Adverse Event|11|||
147571859|NCT00730691|532250499|FG004|Overall Study|Adverse Event|23|||
147571860|NCT00730691|532250495|FG000|Overall Study|Lack of Efficacy|4|||
147571861|NCT00730691|532250496|FG001|Overall Study|Lack of Efficacy|4|||
147571862|NCT00730691|532250497|FG002|Overall Study|Lack of Efficacy|2|||
147571863|NCT00730691|532250498|FG003|Overall Study|Lack of Efficacy|1|||
147571864|NCT00730691|532250499|FG004|Overall Study|Lack of Efficacy|1|||
147571865|NCT00730691|532250495|FG000|Overall Study|Non-compliance with Study Drug|6|||
147136579|NCT00546481|530668253|FG001|Maintenance Phase (CERA)|Kidney transplantation|0|||
147136580|NCT00546481|530668254|FG002|Maintenance Phase (CERA)|Kidney transplantation|1|||
147136581|NCT00546481|530668252|FG000|Maintenance Phase (CERA)|Other Reason|0|||
147136582|NCT00546481|530668253|FG001|Maintenance Phase (CERA)|Other Reason|0|||
147136583|NCT00546481|530668254|FG002|Maintenance Phase (CERA)|Other Reason|1|||
147136584|NCT00950651|530668257|FG000|Overall Study|Adverse Event|17|||
147136585|NCT00950651|530668258|FG001|Overall Study|Adverse Event|20|||
147136586|NCT00950651|530668257|FG000|Overall Study|Death|1|||
147136587|NCT00950651|530668258|FG001|Overall Study|Death|0|||
147136588|NCT00950651|530668257|FG000|Overall Study|Lack of Efficacy|2|||
147136589|NCT00950651|530668258|FG001|Overall Study|Lack of Efficacy|2|||
147136590|NCT00950651|530668257|FG000|Overall Study|Protocol Violation|3|||
147136591|NCT00950651|530668258|FG001|Overall Study|Protocol Violation|4|||
147136592|NCT00950651|530668257|FG000|Overall Study|Withdrawal by Subject|8|||
147136593|NCT00950651|530668258|FG001|Overall Study|Withdrawal by Subject|9|||
147136594|NCT02761642|530668259|FG000|Overall Study|Did not Receive Study Treatment|3|||
147136595|NCT02761642|530668259|FG000|Overall Study|Adverse Event|13|||
147136596|NCT02761642|530668259|FG000|Overall Study|Withdrawal by Subject|2|||
147136597|NCT02761642|530668259|FG000|Overall Study|Non-compliant|7|||
147136598|NCT02761642|530668259|FG000|Overall Study|Death|3|||
147136599|NCT02761642|530668259|FG000|Overall Study|Lack of Efficacy|20|||
147136600|NCT02761642|530668259|FG000|Overall Study|Physician Decision|1|||
147136601|NCT02761642|530668259|FG000|Overall Study|Reason Unspecified|21|||
147136602|NCT03783780|530668260|FG000|Overall Study|Withdrawn prior to completion|1|||
147136603|NCT02765399|530668265|FG000|Overall Study|Nausea|1|||
147136604|NCT02765399|530668266|FG001|Overall Study|Nausea|0|||
147136605|NCT00120627|530668271|FG000|Overall Study|Withdrawal by Subject|5|||
147136606|NCT00120627|530668272|FG001|Overall Study|Withdrawal by Subject|5|||
147136607|NCT00271544|530668273|FG000|Overall Study|Subjects did not receive a 4196 lead|7|||
147136608|NCT00271544|530668273|FG000|Overall Study|Model 4196 lead not attempted|9|||
147136609|NCT00271544|530668273|FG000|Overall Study|Implant not attempted|4|||
147136610|NCT03950856|530668277|FG000|Overall Study|Death|1|||
147136611|NCT03950856|530668278|FG001|Overall Study|Death|2|||
147136612|NCT03950856|530668279|FG002|Overall Study|Death|0|||
147136613|NCT03950856|530668280|FG003|Overall Study|Death|0|||
147136614|NCT03950856|530668277|FG000|Overall Study|Lost to Follow-up|5|||
147136615|NCT03950856|530668278|FG001|Overall Study|Lost to Follow-up|6|||
147136616|NCT03950856|530668279|FG002|Overall Study|Lost to Follow-up|8|||
147136617|NCT03950856|530668280|FG003|Overall Study|Lost to Follow-up|2|||
147136618|NCT03950856|530668277|FG000|Overall Study|Protocol Violation|2|||
147136619|NCT03950856|530668278|FG001|Overall Study|Protocol Violation|0|||
147136620|NCT03950856|530668279|FG002|Overall Study|Protocol Violation|0|||
147136621|NCT03950856|530668280|FG003|Overall Study|Protocol Violation|1|||
147136622|NCT03950856|530668277|FG000|Overall Study|Withdrawal by Subject|4|||
147136623|NCT03950856|530668278|FG001|Overall Study|Withdrawal by Subject|1|||
147136624|NCT03950856|530668279|FG002|Overall Study|Withdrawal by Subject|3|||
147136625|NCT03950856|530668280|FG003|Overall Study|Withdrawal by Subject|1|||
147136626|NCT03950856|530668277|FG000|Overall Study|Unable to phone|7|||
147136627|NCT03950856|530668278|FG001|Overall Study|Unable to phone|6|||
147136628|NCT03950856|530668279|FG002|Overall Study|Unable to phone|7|||
147136629|NCT03950856|530668280|FG003|Overall Study|Unable to phone|2|||
147136630|NCT03247829|530669844|FG000|Overall Study|Death|3|||
147136631|NCT03247829|530669845|FG001|Overall Study|Death|4|||
147136632|NCT03247829|530669844|FG000|Overall Study|Enter Hospice Care|1|||
147136633|NCT03247829|530669845|FG001|Overall Study|Enter Hospice Care|0|||
147136634|NCT03247829|530669844|FG000|Overall Study|LVAD System Replaced / Exchange|1|||
147136635|NCT03247829|530669845|FG001|Overall Study|LVAD System Replaced / Exchange|0|||
147136636|NCT03247829|530669844|FG000|Overall Study|LVAD Explant|1|||
147136637|NCT03247829|530669845|FG001|Overall Study|LVAD Explant|1|||
147571866|NCT00730691|532250496|FG001|Overall Study|Non-compliance with Study Drug|1|||
147571867|NCT00730691|532250497|FG002|Overall Study|Non-compliance with Study Drug|6|||
147571868|NCT00730691|532250498|FG003|Overall Study|Non-compliance with Study Drug|3|||
147571869|NCT00730691|532250499|FG004|Overall Study|Non-compliance with Study Drug|3|||
147136638|NCT03247829|530669844|FG000|Overall Study|Transplant|1|||
147136639|NCT03247829|530669845|FG001|Overall Study|Transplant|1|||
147136640|NCT00272792|530669847|FG000|Part 1: Responsiveness|Lost to Follow-up|1|||
147571870|NCT00730691|532250495|FG000|Overall Study|Protocol Deviations|3|||
147136641|NCT00272792|530669848|FG001|Part 1: Responsiveness|Lost to Follow-up|0|||
147136642|NCT00272792|530669847|FG000|Part 2: Blinded, Placebo Control Period|Withdrawal by Subject|0|||
147571871|NCT00730691|532250496|FG001|Overall Study|Protocol Deviations|5|||
147571872|NCT00730691|532250497|FG002|Overall Study|Protocol Deviations|3|||
147571873|NCT00730691|532250498|FG003|Overall Study|Protocol Deviations|7|||
147571874|NCT00730691|532250499|FG004|Overall Study|Protocol Deviations|5|||
147571875|NCT00730691|532250495|FG000|Overall Study|Withdrawal of Consent|7|||
147571876|NCT00730691|532250496|FG001|Overall Study|Withdrawal of Consent|9|||
147571877|NCT00730691|532250497|FG002|Overall Study|Withdrawal of Consent|3|||
147136643|NCT00272792|530669848|FG001|Part 2: Blinded, Placebo Control Period|Withdrawal by Subject|2|||
147136644|NCT00272792|530669847|FG000|Part 2: Blinded, Placebo Control Period|Lack of Efficacy|1|||
147136645|NCT00272792|530669848|FG001|Part 2: Blinded, Placebo Control Period|Lack of Efficacy|0|||
147136646|NCT00272792|530669847|FG000|Part 2: Blinded, Placebo Control Period|Patient Uncooperative|0|||
147136647|NCT00272792|530669848|FG001|Part 2: Blinded, Placebo Control Period|Patient Uncooperative|1|||
147136648|NCT00427011|530669851|FG000|Overall Study|Adverse Event|10|||
147136649|NCT00427011|530669851|FG000|Overall Study|Withdrawal by Subject|1|||
147136650|NCT00427011|530669851|FG000|Overall Study|Lack of Efficacy|2|||
147136651|NCT00427011|530669851|FG000|Overall Study|Other|12|||
147136652|NCT00288015|530669852|FG000|Bevacizumab Treatment Cycles 1-2|Withdrawal by Subject|1|||
147136653|NCT00288015|530669852|FG000|Bevacizumab Treatment Cycles 1-2|Physician Decision|1|||
147136654|NCT00288015|530669852|FG000|First Response Assessment|Withdrawal by Subject|1|||
147136655|NCT00288015|530669852|FG000|First Response Assessment|Death|1|||
147136656|NCT00288015|530669852|FG000|First Response Assessment|Physician Decision|2|||
147136657|NCT00288015|530669852|FG000|Continued Bevacizumab Cycle 3+|Disease progressed|7|||
147136658|NCT00288015|530669852|FG000|Follow up for Survival x 2 Years|Death|13|||
147136659|NCT00288015|530669852|FG000|Follow up for Survival x 2 Years|Lost to Follow-up|4|||
147136660|NCT00288015|530669852|FG000|Follow up for Survival x 2 Years|Other|9|||
147136661|NCT00443703|530669853|FG000|Overall Study|Never Treated|3|||
147136662|NCT00443703|530669854|FG001|Overall Study|Never Treated|1|||
147136663|NCT00443703|530669853|FG000|Overall Study|Adverse Event|7|||
147136664|NCT00443703|530669854|FG001|Overall Study|Adverse Event|3|||
147136665|NCT00443703|530669853|FG000|Overall Study|Lack of Efficacy|3|||
147136666|NCT00443703|530669854|FG001|Overall Study|Lack of Efficacy|1|||
147136667|NCT00443703|530669853|FG000|Overall Study|Lost to Follow-up|0|||
147136668|NCT00443703|530669854|FG001|Overall Study|Lost to Follow-up|4|||
147136669|NCT00443703|530669853|FG000|Overall Study|Physician Decision|4|||
147136670|NCT00443703|530669854|FG001|Overall Study|Physician Decision|2|||
147136671|NCT00443703|530669853|FG000|Overall Study|Protocol Violation|1|||
147136672|NCT00443703|530669854|FG001|Overall Study|Protocol Violation|1|||
147136673|NCT00443703|530669853|FG000|Overall Study|Withdrawal by Subject|9|||
147136674|NCT00443703|530669854|FG001|Overall Study|Withdrawal by Subject|6|||
147136675|NCT00443703|530669853|FG000|Overall Study|Progressive Disease|1|||
147136676|NCT00443703|530669854|FG001|Overall Study|Progressive Disease|0|||
147136677|NCT01669902|530669859|FG000|Overall Study|Adverse Event|11|||
147136678|NCT01669902|530669859|FG000|Overall Study|Lack of Efficacy|10|||
147571878|NCT00730691|532250498|FG003|Overall Study|Withdrawal of Consent|6|||
147571879|NCT00730691|532250499|FG004|Overall Study|Withdrawal of Consent|3|||
147571880|NCT00730691|532250495|FG000|Overall Study|Lost to Follow-up|11|||
147571881|NCT00730691|532250496|FG001|Overall Study|Lost to Follow-up|8|||
147136679|NCT01669902|530669859|FG000|Overall Study|Other|8|||
147136680|NCT00457392|530669860|FG000|Overall Study|Objective Progression or Relapse|229|||
147136681|NCT00457392|530669861|FG001|Overall Study|Objective Progression or Relapse|296|||
147136682|NCT00457392|530669860|FG000|Overall Study|Death|106|||
147136683|NCT00457392|530669861|FG001|Overall Study|Death|106|||
147136684|NCT00457392|530669860|FG000|Overall Study|Adverse Event|84|||
147136685|NCT00457392|530669861|FG001|Overall Study|Adverse Event|41|||
147136686|NCT00457392|530669860|FG000|Overall Study|Global Deterioration of Health Status|22|||
147136687|NCT00457392|530669861|FG001|Overall Study|Global Deterioration of Health Status|8|||
147136688|NCT00457392|530669860|FG000|Overall Study|Withdrawal by Subject|14|||
147136689|NCT00457392|530669861|FG001|Overall Study|Withdrawal by Subject|8|||
147136690|NCT00457392|530669860|FG000|Overall Study|Lost to Follow-up|6|||
147136691|NCT00457392|530669861|FG001|Overall Study|Lost to Follow-up|7|||
147136692|NCT00457392|530669860|FG000|Overall Study|Protocol Violation|4|||
147136693|NCT00457392|530669861|FG001|Overall Study|Protocol Violation|3|||
147571882|NCT00730691|532250497|FG002|Overall Study|Lost to Follow-up|13|||
147136694|NCT00457392|530669860|FG000|Overall Study|Other|7|||
147571883|NCT00730691|532250498|FG003|Overall Study|Lost to Follow-up|15|||
147136695|NCT00457392|530669861|FG001|Overall Study|Other|4|||
147136696|NCT00457392|530669860|FG000|Overall Study|Study Terminated by Sponsor|1|||
147571884|NCT00730691|532250499|FG004|Overall Study|Lost to Follow-up|13|||
147571885|NCT00730691|532250495|FG000|Overall Study|Other|1|||
147571886|NCT00730691|532250496|FG001|Overall Study|Other|1|||
147136697|NCT00457392|530669861|FG001|Overall Study|Study Terminated by Sponsor|4|||
147136698|NCT00457392|530669860|FG000|Overall Study|Randomized, Not Treated|7|||
147136699|NCT00457392|530669861|FG001|Overall Study|Randomized, Not Treated|3|||
147136700|NCT00980148|530669862|FG000|Overall Study|Discharged from facility|89|||
147136701|NCT00980148|530669863|FG001|Overall Study|Discharged from facility|96|||
147136702|NCT00980148|530669862|FG000|Overall Study|Received other antichlamydia treatment|20|||
147136703|NCT00980148|530669863|FG001|Overall Study|Received other antichlamydia treatment|14|||
147136704|NCT00980148|530669862|FG000|Overall Study|Negative for chlamydia at enrollment|12|||
147136705|NCT00980148|530669863|FG001|Overall Study|Negative for chlamydia at enrollment|9|||
147136706|NCT00980148|530669862|FG000|Overall Study|Various other reasons|8|||
147136707|NCT00980148|530669863|FG001|Overall Study|Various other reasons|9|||
147136708|NCT01747915|530669864|FG000|Overall Study|Other|1|||
147571887|NCT00730691|532250497|FG002|Overall Study|Other|1|||
147571888|NCT00730691|532250498|FG003|Overall Study|Other|2|||
147571889|NCT00730691|532250499|FG004|Overall Study|Other|2|||
147571890|NCT05776901|532252277|FG000|Overall Study|Covid delays and grant termination without continuation.|3|||
147571891|NCT00682461|532252279|FG000|Overall Study|Adverse Event|5|||
147571892|NCT00682461|532252280|FG001|Overall Study|Adverse Event|7|||
147571893|NCT00682461|532252279|FG000|Overall Study|Lost to Follow-up|8|||
147571894|NCT00682461|532252280|FG001|Overall Study|Lost to Follow-up|5|||
147571895|NCT00682461|532252279|FG000|Overall Study|Withdrawal by Subject|12|||
147571896|NCT00682461|532252280|FG001|Overall Study|Withdrawal by Subject|19|||
147571897|NCT00835705|532252281|FG000|First Intervention|Difficulty with vein|1|||
147571898|NCT00835705|532252282|FG001|First Intervention|Difficulty with vein|0|||
147571899|NCT00835705|532252281|FG000|Second Intervention|Difficulty with vein|1|||
147571900|NCT00835705|532252282|FG001|Second Intervention|Difficulty with vein|0|||
147571901|NCT00665925|532252283|FG000|Overall Study|Lack of Efficacy|10|||
147571902|NCT00665925|532252284|FG001|Overall Study|Lack of Efficacy|8|||
147571903|NCT00665925|532252285|FG002|Overall Study|Lack of Efficacy|9|||
147571904|NCT00665925|532252286|FG003|Overall Study|Lack of Efficacy|8|||
147571905|NCT00665925|532252283|FG000|Overall Study|Lost to Follow-up|1|||
147571906|NCT00665925|532252284|FG001|Overall Study|Lost to Follow-up|2|||
147571907|NCT00665925|532252285|FG002|Overall Study|Lost to Follow-up|2|||
147571908|NCT00665925|532252286|FG003|Overall Study|Lost to Follow-up|2|||
147571909|NCT00665925|532252283|FG000|Overall Study|Withdrawal by Subject|2|||
147571910|NCT00665925|532252284|FG001|Overall Study|Withdrawal by Subject|2|||
147571911|NCT00665925|532252285|FG002|Overall Study|Withdrawal by Subject|3|||
147571912|NCT00665925|532252286|FG003|Overall Study|Withdrawal by Subject|2|||
147136709|NCT01747915|530669865|FG001|Overall Study|Other|1|||
147136710|NCT01747915|530669866|FG002|Overall Study|Other|1|||
147136711|NCT01747915|530669864|FG000|Overall Study|Adverse Event|8|||
147136712|NCT01747915|530669865|FG001|Overall Study|Adverse Event|5|||
147136713|NCT01747915|530669866|FG002|Overall Study|Adverse Event|2|||
147136714|NCT01747915|530669864|FG000|Overall Study|Death|0|||
147136715|NCT01747915|530669865|FG001|Overall Study|Death|0|||
147136716|NCT01747915|530669866|FG002|Overall Study|Death|1|||
147136717|NCT01747915|530669864|FG000|Overall Study|Lack of Efficacy|0|||
147136718|NCT01747915|530669865|FG001|Overall Study|Lack of Efficacy|1|||
147136719|NCT01747915|530669866|FG002|Overall Study|Lack of Efficacy|0|||
147136720|NCT01747915|530669864|FG000|Overall Study|Lost to Follow-up|1|||
147136721|NCT01747915|530669865|FG001|Overall Study|Lost to Follow-up|0|||
147136722|NCT01747915|530669866|FG002|Overall Study|Lost to Follow-up|0|||
147136723|NCT01747915|530669864|FG000|Overall Study|Withdrawal by Subject|4|||
147136724|NCT01747915|530669865|FG001|Overall Study|Withdrawal by Subject|4|||
147136725|NCT01747915|530669866|FG002|Overall Study|Withdrawal by Subject|1|||
147136726|NCT01747915|530669864|FG000|Overall Study|Protocol Violation|1|||
147136727|NCT01747915|530669865|FG001|Overall Study|Protocol Violation|0|||
147136728|NCT01747915|530669866|FG002|Overall Study|Protocol Violation|0|||
147136729|NCT01747915|530669864|FG000|Overall Study|Pregnancy|0|||
147136730|NCT01747915|530669865|FG001|Overall Study|Pregnancy|0|||
147571913|NCT00665925|532252283|FG000|Overall Study|Physician Decision|0|||
147571914|NCT00665925|532252284|FG001|Overall Study|Physician Decision|0|||
147571915|NCT00665925|532252285|FG002|Overall Study|Physician Decision|1|||
147571916|NCT00665925|532252286|FG003|Overall Study|Physician Decision|2|||
147571917|NCT00665925|532252283|FG000|Overall Study|Severe Non-Compliance to Protocol|0|||
147571918|NCT00665925|532252284|FG001|Overall Study|Severe Non-Compliance to Protocol|0|||
147136731|NCT01747915|530669866|FG002|Overall Study|Pregnancy|1|||
147136732|NCT01462929|530669867|FG000|Overall Study|Adverse Event|3|||
147136733|NCT01462929|530669868|FG001|Overall Study|Adverse Event|3|||
147136734|NCT01462929|530669869|FG002|Overall Study|Adverse Event|4|||
147136735|NCT01462929|530669867|FG000|Overall Study|Withdrawal by Subject|2|||
147136736|NCT01462929|530669868|FG001|Overall Study|Withdrawal by Subject|1|||
147571919|NCT00665925|532252285|FG002|Overall Study|Severe Non-Compliance to Protocol|1|||
147571920|NCT00665925|532252286|FG003|Overall Study|Severe Non-Compliance to Protocol|1|||
147571921|NCT00665925|532252283|FG000|Overall Study|Adverse Event|1|||
147571922|NCT00665925|532252284|FG001|Overall Study|Adverse Event|5|||
147571923|NCT00665925|532252285|FG002|Overall Study|Adverse Event|10|||
147571924|NCT00665925|532252286|FG003|Overall Study|Adverse Event|5|||
147571925|NCT00665925|532252283|FG000|Overall Study|Enrolled by mistake|0|||
147136737|NCT01462929|530669869|FG002|Overall Study|Withdrawal by Subject|0|||
147136738|NCT01462929|530669867|FG000|Overall Study|Lack of Efficacy|0|||
147136739|NCT01462929|530669868|FG001|Overall Study|Lack of Efficacy|0|||
147571926|NCT00665925|532252284|FG001|Overall Study|Enrolled by mistake|0|||
147571927|NCT00665925|532252285|FG002|Overall Study|Enrolled by mistake|0|||
147571928|NCT00665925|532252286|FG003|Overall Study|Enrolled by mistake|1|||
147571929|NCT00665925|532252283|FG000|Overall Study|Due to exclusion criteria|1|||
147571930|NCT00665925|532252284|FG001|Overall Study|Due to exclusion criteria|0|||
147571931|NCT00665925|532252285|FG002|Overall Study|Due to exclusion criteria|0|||
147136740|NCT01462929|530669869|FG002|Overall Study|Lack of Efficacy|1|||
147136741|NCT01309204|530669872|FG000|Overall Study|Adverse Event|48|||
147136742|NCT01309204|530669873|FG001|Overall Study|Adverse Event|58|||
147136743|NCT01309204|530669872|FG000|Overall Study|Lost to Follow-up|2|||
147136744|NCT01309204|530669873|FG001|Overall Study|Lost to Follow-up|2|||
147136745|NCT01309204|530669872|FG000|Overall Study|Subject's decision unrelated to an AE|9|||
147136746|NCT01309204|530669873|FG001|Overall Study|Subject's decision unrelated to an AE|10|||
147136747|NCT01309204|530669872|FG000|Overall Study|Inadequate control of IOP|4|||
147136748|NCT01309204|530669873|FG001|Overall Study|Inadequate control of IOP|4|||
147136749|NCT01309204|530669872|FG000|Overall Study|Other|4|||
147136750|NCT01309204|530669873|FG001|Overall Study|Other|1|||
147136751|NCT00925002|530669876|FG000|Overall Study|Other|1|||
147136752|NCT00925002|530669877|FG001|Overall Study|Other|4|||
147136753|NCT00925002|530669878|FG002|Overall Study|Other|0|||
147136754|NCT00925002|530669876|FG000|Overall Study|Death|1|||
147136755|NCT00925002|530669877|FG001|Overall Study|Death|1|||
147136756|NCT00925002|530669878|FG002|Overall Study|Death|5|||
147445632|NCT02004262|531797415|FG002|Overall Study|Study Terminated by Sponsor|2|||
147445633|NCT02004262|531797416|FG003|Overall Study|Study Terminated by Sponsor|1|||
147445634|NCT02004262|531797417|FG004|Overall Study|Study Terminated by Sponsor|1|||
147136757|NCT00925002|530669876|FG000|Overall Study|Adverse Event|3|||
147136758|NCT00925002|530669877|FG001|Overall Study|Adverse Event|1|||
147136759|NCT00925002|530669878|FG002|Overall Study|Adverse Event|2|||
147136760|NCT00925002|530669876|FG000|Overall Study|Participant withdrew consent|1|||
147136761|NCT00925002|530669877|FG001|Overall Study|Participant withdrew consent|3|||
147136762|NCT00925002|530669878|FG002|Overall Study|Participant withdrew consent|3|||
147136763|NCT00002766|530669879|FG000|Overall Study|Withdrawal by Subject|0|||
147136764|NCT00002766|530669880|FG001|Overall Study|Withdrawal by Subject|1|||
147136765|NCT00002766|530669879|FG000|Overall Study|Patient Not Treated|1|||
147136766|NCT00002766|530669880|FG001|Overall Study|Patient Not Treated|2|||
147136767|NCT00002766|530669879|FG000|Overall Study|Adverse Event|1|||
147136768|NCT00002766|530669880|FG001|Overall Study|Adverse Event|1|||
147136769|NCT00002766|530669879|FG000|Overall Study|Protocol Violation|1|||
147136770|NCT00002766|530669880|FG001|Overall Study|Protocol Violation|0|||
147136771|NCT00328172|530669883|FG000|Overall Study|Adverse Event|3|||
147136772|NCT00328172|530669884|FG001|Overall Study|Adverse Event|2|||
147136773|NCT00328172|530669885|FG002|Overall Study|Adverse Event|1|||
147136774|NCT00328172|530669886|FG003|Overall Study|Adverse Event|2|||
147136775|NCT00328172|530669887|FG004|Overall Study|Adverse Event|1|||
147136776|NCT00328172|530669883|FG000|Overall Study|Protocol Violation|0|||
147136777|NCT00328172|530669884|FG001|Overall Study|Protocol Violation|1|||
147136778|NCT00328172|530669885|FG002|Overall Study|Protocol Violation|1|||
147136779|NCT00328172|530669886|FG003|Overall Study|Protocol Violation|0|||
147136780|NCT00328172|530669887|FG004|Overall Study|Protocol Violation|0|||
147136781|NCT00328172|530669883|FG000|Overall Study|Lost to Follow-up|1|||
147136782|NCT00328172|530669884|FG001|Overall Study|Lost to Follow-up|1|||
147136783|NCT00328172|530669885|FG002|Overall Study|Lost to Follow-up|2|||
147136784|NCT00328172|530669886|FG003|Overall Study|Lost to Follow-up|1|||
147136785|NCT00328172|530669887|FG004|Overall Study|Lost to Follow-up|1|||
147136786|NCT00328172|530669883|FG000|Overall Study|Withdrawal by Subject|1|||
147136787|NCT00328172|530669884|FG001|Overall Study|Withdrawal by Subject|1|||
147136788|NCT00328172|530669885|FG002|Overall Study|Withdrawal by Subject|1|||
147136789|NCT00328172|530669886|FG003|Overall Study|Withdrawal by Subject|6|||
147136790|NCT00328172|530669887|FG004|Overall Study|Withdrawal by Subject|0|||
147136791|NCT00328172|530669883|FG000|Overall Study|Lack of Efficacy|14|||
147136792|NCT00328172|530669884|FG001|Overall Study|Lack of Efficacy|9|||
147237495|NCT00827502|531040633|FG000|Overall Study|Adverse Event|1|||
147571932|NCT00665925|532252286|FG003|Overall Study|Due to exclusion criteria|0|||
147571933|NCT04035187|532252287|FG000|Overall Study|Withdrawal by Subject|2|||
147571934|NCT04035187|532252288|FG001|Overall Study|Withdrawal by Subject|1|||
147571935|NCT04035187|532252289|FG002|Overall Study|Withdrawal by Subject|0|||
147136793|NCT00328172|530669885|FG002|Overall Study|Lack of Efficacy|4|||
147136794|NCT00328172|530669886|FG003|Overall Study|Lack of Efficacy|4|||
147136795|NCT00328172|530669887|FG004|Overall Study|Lack of Efficacy|3|||
147136796|NCT00328172|530669883|FG000|Overall Study|Other reason (not specified)|3|||
147136797|NCT00328172|530669884|FG001|Overall Study|Other reason (not specified)|0|||
147136798|NCT00328172|530669885|FG002|Overall Study|Other reason (not specified)|1|||
147136799|NCT00328172|530669886|FG003|Overall Study|Other reason (not specified)|0|||
147445635|NCT02004262|531797418|FG005|Overall Study|Study Terminated by Sponsor|5|||
147445636|NCT01146873|531797419|FG000|Overall Study|Transfer out|0|||
147136800|NCT00328172|530669887|FG004|Overall Study|Other reason (not specified)|0|||
147136801|NCT00558636|530669888|FG000|Treatment|Adverse Event|9|||
147136802|NCT00558636|530669889|FG001|Treatment|Adverse Event|2|||
147136803|NCT00558636|530669888|FG000|Treatment|Withdrawal by Subject|2|||
147571936|NCT04035187|532252290|FG003|Overall Study|Withdrawal by Subject|0|||
147571937|NCT04035187|532252287|FG000|Overall Study|Participant lived out of state and due to COVID-19 pandemic could not travel to study site.|0|||
147136804|NCT00558636|530669889|FG001|Treatment|Withdrawal by Subject|0|||
147136805|NCT00558636|530669888|FG000|Treatment|Premature termination of the study|35|||
147136806|NCT00558636|530669889|FG001|Treatment|Premature termination of the study|37|||
147136807|NCT00558636|530669888|FG000|Treatment|Disease progression|1|||
147136808|NCT00558636|530669889|FG001|Treatment|Disease progression|5|||
147136809|NCT00558636|530669888|FG000|Follow-up|Premature termination of the study|12|||
147136810|NCT00558636|530669889|FG001|Follow-up|Premature termination of the study|7|||
147136811|NCT01990742|530669890|FG000|Overall Study|Withdrawal by facility|407|||
147136812|NCT01990742|530669891|FG001|Overall Study|Withdrawal by facility|1083|||
147136813|NCT01990742|530669890|FG000|Overall Study|Facility closed|0|||
147136814|NCT01990742|530669891|FG001|Overall Study|Facility closed|270|||
147136815|NCT03443687|530669892|FG000|Overall Study|Lost to Follow-up|3|||
147136816|NCT03443687|530669893|FG001|Overall Study|Lost to Follow-up|5|||
147136817|NCT03443687|530669892|FG000|Overall Study|Withdrawal by Subject|1|||
147136818|NCT03443687|530669893|FG001|Overall Study|Withdrawal by Subject|0|||
147136819|NCT03443687|530669892|FG000|Overall Study|Discontinued intervention|1|||
147136820|NCT03443687|530669893|FG001|Overall Study|Discontinued intervention|1|||
147136821|NCT03848416|530669900|FG000|Overall Study|Withdrawal by Subject|1|||
147136822|NCT03848416|530669901|FG001|Overall Study|Withdrawal by Subject|0|||
147136823|NCT03848416|530669902|FG002|Overall Study|Withdrawal by Subject|0|||
147136824|NCT03848416|530669900|FG000|Overall Study|Death|0|||
147136825|NCT03848416|530669901|FG001|Overall Study|Death|0|||
147136826|NCT03848416|530669902|FG002|Overall Study|Death|1|||
147136827|NCT01331681|530669904|FG000|Overall Study|Adverse Event|10|||
147136828|NCT01331681|530669905|FG001|Overall Study|Adverse Event|13|||
147136829|NCT01331681|530669906|FG002|Overall Study|Adverse Event|10|||
147136830|NCT01331681|530669904|FG000|Overall Study|Death|6|||
147136831|NCT01331681|530669905|FG001|Overall Study|Death|6|||
147136832|NCT01331681|530669906|FG002|Overall Study|Death|2|||
147571938|NCT04035187|532252288|FG001|Overall Study|Participant lived out of state and due to COVID-19 pandemic could not travel to study site.|1|||
147571939|NCT04035187|532252289|FG002|Overall Study|Participant lived out of state and due to COVID-19 pandemic could not travel to study site.|0|||
147571940|NCT04035187|532252290|FG003|Overall Study|Participant lived out of state and due to COVID-19 pandemic could not travel to study site.|1|||
147571941|NCT01987765|532252299|FG000|Overall Study|Protocol Violation|65|||
147571942|NCT01987765|532252299|FG000|Overall Study|Lost to Follow-up|37|||
147571943|NCT03502811|532252302|FG000|Overall Study|Death|157|||
147571944|NCT03502811|532252302|FG000|Overall Study|Withdrawal by Subject|105|||
147571945|NCT03502811|532252302|FG000|Overall Study|Lost to Follow-up|26|||
147571946|NCT03502811|532252302|FG000|Overall Study|No Visits (Missed)|31|||
147571947|NCT01492439|532252303|FG000|Overall Study|Withdrew from RTE|4|||
147571948|NCT01492439|532252304|FG001|Overall Study|Withdrew from RTE|9|||
147571949|NCT05014828|532252305|FG000|Overall Study|Study Completed by Sponsor|16|||
147571950|NCT05014828|532252306|FG001|Overall Study|Study Completed by Sponsor|16|||
147571951|NCT05014828|532252307|FG002|Overall Study|Study Completed by Sponsor|3|||
147571952|NCT05014828|532252308|FG003|Overall Study|Study Completed by Sponsor|3|||
147571953|NCT05014828|532252305|FG000|Overall Study|Death|11|||
147571954|NCT05014828|532252306|FG001|Overall Study|Death|6|||
147571955|NCT05014828|532252307|FG002|Overall Study|Death|0|||
147571956|NCT05014828|532252308|FG003|Overall Study|Death|0|||
147136833|NCT01331681|530669904|FG000|Overall Study|Lack of Efficacy|0|||
147136834|NCT01331681|530669905|FG001|Overall Study|Lack of Efficacy|1|||
147136835|NCT01331681|530669906|FG002|Overall Study|Lack of Efficacy|0|||
147136836|NCT01331681|530669904|FG000|Overall Study|Withdrawal by Subject|12|||
147136837|NCT01331681|530669905|FG001|Overall Study|Withdrawal by Subject|8|||
147136838|NCT01331681|530669906|FG002|Overall Study|Withdrawal by Subject|15|||
147136839|NCT01331681|530669904|FG000|Overall Study|Protocol Violation|1|||
147136840|NCT01331681|530669905|FG001|Overall Study|Protocol Violation|1|||
147136841|NCT01331681|530669906|FG002|Overall Study|Protocol Violation|0|||
147136842|NCT01331681|530669904|FG000|Overall Study|Lost to Follow-up|2|||
147136843|NCT01331681|530669905|FG001|Overall Study|Lost to Follow-up|4|||
147237496|NCT00827502|531040633|FG000|Overall Study|Lost to Follow-up|4|||
147237497|NCT00827502|531040633|FG000|Overall Study|Withdrawal by Subject|5|||
147571957|NCT05014828|532252305|FG000|Overall Study|Lost to Follow-up|0|||
147571958|NCT05014828|532252306|FG001|Overall Study|Lost to Follow-up|0|||
147651666|NCT00528372|532546570|FG005|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|1|||
147445637|NCT01146873|531797420|FG001|Overall Study|Transfer out|6|||
147571959|NCT05014828|532252307|FG002|Overall Study|Lost to Follow-up|2|||
147136844|NCT01331681|530669906|FG002|Overall Study|Lost to Follow-up|1|||
147136845|NCT01331681|530669904|FG000|Overall Study|Physician Decision|2|||
147136846|NCT01331681|530669905|FG001|Overall Study|Physician Decision|0|||
147136847|NCT01331681|530669906|FG002|Overall Study|Physician Decision|4|||
147136848|NCT01331681|530669904|FG000|Overall Study|Therapeutic procedure required|1|||
147136849|NCT01331681|530669905|FG001|Overall Study|Therapeutic procedure required|0|||
147136850|NCT01331681|530669906|FG002|Overall Study|Therapeutic procedure required|0|||
147136851|NCT01331681|530669904|FG000|Overall Study|Sponsor decision|1|||
147136852|NCT01331681|530669905|FG001|Overall Study|Sponsor decision|1|||
147136853|NCT01331681|530669906|FG002|Overall Study|Sponsor decision|0|||
147136854|NCT01331681|530669904|FG000|Overall Study|Switching to other therapy|0|||
147136855|NCT01331681|530669905|FG001|Overall Study|Switching to other therapy|0|||
147136856|NCT01331681|530669906|FG002|Overall Study|Switching to other therapy|1|||
147136857|NCT01331681|530669904|FG000|Overall Study|Not Received Study Treatment|0|||
147136858|NCT01331681|530669905|FG001|Overall Study|Not Received Study Treatment|0|||
147136859|NCT01331681|530669906|FG002|Overall Study|Not Received Study Treatment|2|||
147136860|NCT00658541|530669911|FG000|Washout Period of 7 Days|Withdrawal by Subject|1|||
147136861|NCT00658541|530669912|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
147136862|NCT00658541|530669911|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
147136863|NCT00658541|530669912|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
147136864|NCT04828707|530669913|FG000|Overall Study|Lost to Follow-up|3|||
147136865|NCT04828707|530669914|FG001|Overall Study|Lost to Follow-up|2|||
147136866|NCT04828707|530669913|FG000|Overall Study|Withdrawal by Subject|2|||
147136867|NCT04828707|530669914|FG001|Overall Study|Withdrawal by Subject|1|||
147136868|NCT01188967|530669916|FG000|Overall Study|Withdrawal by Subject|1|||
147136869|NCT01188967|530669917|FG001|Overall Study|Withdrawal by Subject|1|||
147136870|NCT01188967|530669916|FG000|Overall Study|Physician Decision|1|||
147136871|NCT01188967|530669917|FG001|Overall Study|Physician Decision|1|||
147136872|NCT01188967|530669916|FG000|Overall Study|Lost to Follow-up|3|||
147136873|NCT01188967|530669917|FG001|Overall Study|Lost to Follow-up|2|||
147136874|NCT00523978|530669920|FG000|Overall Study|Withdrawal by Subject|3|||
147136875|NCT00523978|530669921|FG001|Overall Study|Withdrawal by Subject|7|||
147136876|NCT00523978|530669920|FG000|Overall Study|Screen Failures|5|||
147136877|NCT00523978|530669921|FG001|Overall Study|Screen Failures|1|||
147136878|NCT00523978|530669920|FG000|Overall Study|Death|1|||
147136879|NCT00523978|530669921|FG001|Overall Study|Death|0|||
147136880|NCT02553629|530669922|FG000|Overall Study|Logistic reasons|3|||
147136881|NCT02553629|530669923|FG001|Overall Study|Logistic reasons|6|||
147136882|NCT04577781|530669924|FG000|Overall Study|Adverse Event|2|||
147136883|NCT04577781|530669925|FG001|Overall Study|Adverse Event|2|||
147136884|NCT04577781|530669924|FG000|Overall Study|Physician Decision|1|||
147136885|NCT04577781|530669925|FG001|Overall Study|Physician Decision|0|||
147136886|NCT04103450|530669929|FG000|Overall Study|Adverse Event|4|||
147136887|NCT04103450|530669930|FG001|Overall Study|Adverse Event|2|||
147136888|NCT04103450|530669929|FG000|Overall Study|Lack of Efficacy|3|||
147136889|NCT04103450|530669930|FG001|Overall Study|Lack of Efficacy|0|||
147136890|NCT04103450|530669929|FG000|Overall Study|Withdrawal by Subject|5|||
147136891|NCT04103450|530669930|FG001|Overall Study|Withdrawal by Subject|3|||
147136892|NCT04103450|530669929|FG000|Overall Study|Lost to Follow-up|1|||
147136893|NCT04103450|530669930|FG001|Overall Study|Lost to Follow-up|2|||
147136894|NCT04103450|530669929|FG000|Overall Study|Physician Decision|1|||
147136895|NCT04103450|530669930|FG001|Overall Study|Physician Decision|2|||
147136896|NCT04103450|530669929|FG000|Overall Study|Protocol Violation|1|||
147136897|NCT04103450|530669930|FG001|Overall Study|Protocol Violation|0|||
147136898|NCT04103450|530669929|FG000|Overall Study|Other|1|||
147136899|NCT04103450|530669930|FG001|Overall Study|Other|1|||
147136900|NCT02259114|530669931|FG000|Overall Study|Progressive Disease|14|||
147136901|NCT02259114|530669932|FG001|Overall Study|Progressive Disease|2|||
147136902|NCT02259114|530669933|FG002|Overall Study|Progressive Disease|10|||
147136903|NCT02259114|530669934|FG003|Overall Study|Progressive Disease|2|||
147136904|NCT02259114|530669935|FG004|Overall Study|Progressive Disease|5|||
147136905|NCT02259114|530669931|FG000|Overall Study|Adverse Event|2|||
147136906|NCT02259114|530669932|FG001|Overall Study|Adverse Event|1|||
147136907|NCT02259114|530669933|FG002|Overall Study|Adverse Event|0|||
147136908|NCT02259114|530669934|FG003|Overall Study|Adverse Event|0|||
147136909|NCT02259114|530669935|FG004|Overall Study|Adverse Event|1|||
147136910|NCT02259114|530669931|FG000|Overall Study|Death|3|||
147136911|NCT02259114|530669932|FG001|Overall Study|Death|0|||
147136912|NCT02259114|530669933|FG002|Overall Study|Death|1|||
147136913|NCT02259114|530669934|FG003|Overall Study|Death|0|||
147136914|NCT02259114|530669935|FG004|Overall Study|Death|0|||
147136915|NCT02259114|530669931|FG000|Overall Study|Treatment Delay >2 wks: Adverse Event|0|||
147136916|NCT02259114|530669932|FG001|Overall Study|Treatment Delay >2 wks: Adverse Event|0|||
147571960|NCT05014828|532252308|FG003|Overall Study|Lost to Follow-up|0|||
147136917|NCT02259114|530669933|FG002|Overall Study|Treatment Delay >2 wks: Adverse Event|1|||
147136918|NCT02259114|530669934|FG003|Overall Study|Treatment Delay >2 wks: Adverse Event|0|||
147136919|NCT02259114|530669935|FG004|Overall Study|Treatment Delay >2 wks: Adverse Event|0|||
147136920|NCT02259114|530669931|FG000|Overall Study|Withdrawal by Subject|0|||
147136921|NCT02259114|530669932|FG001|Overall Study|Withdrawal by Subject|0|||
147136922|NCT02259114|530669933|FG002|Overall Study|Withdrawal by Subject|1|||
147136923|NCT02259114|530669934|FG003|Overall Study|Withdrawal by Subject|1|||
147136924|NCT02259114|530669935|FG004|Overall Study|Withdrawal by Subject|0|||
147136925|NCT02259114|530669931|FG000|Overall Study|Treatment Delay >2 wks: Toxicity|1|||
147136926|NCT02259114|530669932|FG001|Overall Study|Treatment Delay >2 wks: Toxicity|1|||
147136927|NCT02259114|530669933|FG002|Overall Study|Treatment Delay >2 wks: Toxicity|0|||
147136928|NCT02259114|530669934|FG003|Overall Study|Treatment Delay >2 wks: Toxicity|0|||
147136929|NCT02259114|530669935|FG004|Overall Study|Treatment Delay >2 wks: Toxicity|0|||
147136930|NCT02259114|530669931|FG000|Overall Study|Not Treated|1|||
147136931|NCT02259114|530669932|FG001|Overall Study|Not Treated|0|||
147136932|NCT02259114|530669933|FG002|Overall Study|Not Treated|0|||
147136933|NCT02259114|530669934|FG003|Overall Study|Not Treated|0|||
147136934|NCT02259114|530669935|FG004|Overall Study|Not Treated|0|||
147136935|NCT00244621|530669938|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
147136936|NCT00244621|530669939|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
147445638|NCT03200366|531797423|FG000|Patient Navigation Intervention Given|Death|0|||
147571961|NCT05014828|532252305|FG000|Overall Study|Miscellaneous.|0|||
147571962|NCT05014828|532252306|FG001|Overall Study|Miscellaneous.|1|||
147571963|NCT05014828|532252307|FG002|Overall Study|Miscellaneous.|0|||
147571964|NCT05014828|532252308|FG003|Overall Study|Miscellaneous.|0|||
147571965|NCT00824291|532252311|FG000|Overall Study|Adverse Event|15|||
147571966|NCT00824291|532252312|FG001|Overall Study|Adverse Event|6|||
147571967|NCT00824291|532252311|FG000|Overall Study|Discontinuation of Study by Sponsor|1|||
147571968|NCT00824291|532252312|FG001|Overall Study|Discontinuation of Study by Sponsor|2|||
147571969|NCT00824291|532252311|FG000|Overall Study|Lost to Follow-up|11|||
147571970|NCT00824291|532252312|FG001|Overall Study|Lost to Follow-up|9|||
147571971|NCT00824291|532252311|FG000|Overall Study|Non-compliance|1|||
147571972|NCT00824291|532252312|FG001|Overall Study|Non-compliance|1|||
147571973|NCT00824291|532252311|FG000|Overall Study|Protocol Violation|4|||
147571974|NCT00824291|532252312|FG001|Overall Study|Protocol Violation|1|||
147571975|NCT00824291|532252311|FG000|Overall Study|Withdrawal by Subject|14|||
147571976|NCT00824291|532252312|FG001|Overall Study|Withdrawal by Subject|8|||
147571977|NCT00824291|532252311|FG000|Overall Study|Lack of Efficacy|7|||
147571978|NCT00824291|532252312|FG001|Overall Study|Lack of Efficacy|8|||
147571979|NCT00824291|532252311|FG000|Overall Study|Participant on prohibited medication|1|||
147571980|NCT00824291|532252312|FG001|Overall Study|Participant on prohibited medication|0|||
147571981|NCT00933686|532252313|FG000|Overall Study|Protocol Violation|0|||
147571982|NCT00933686|532252314|FG001|Overall Study|Protocol Violation|1|||
147571983|NCT00933686|532252313|FG000|Overall Study|Lost to Follow-up|2|||
147571984|NCT00933686|532252314|FG001|Overall Study|Lost to Follow-up|2|||
147571985|NCT00933686|532252313|FG000|Overall Study|Withdrawal by Subject|6|||
147571986|NCT00933686|532252314|FG001|Overall Study|Withdrawal by Subject|5|||
147571987|NCT00933686|532252313|FG000|Overall Study|Adverse Event|1|||
147571988|NCT00933686|532252314|FG001|Overall Study|Adverse Event|1|||
147571989|NCT00933686|532252313|FG000|Overall Study|Physician Decision|1|||
147571990|NCT00933686|532252314|FG001|Overall Study|Physician Decision|0|||
147571991|NCT00933686|532252313|FG000|Overall Study|Failure to show up at endpoint visits|0|||
147571992|NCT00933686|532252314|FG001|Overall Study|Failure to show up at endpoint visits|2|||
147571993|NCT00123734|532252315|FG000|Overall Study|Death|3|||
147571994|NCT00123734|532252315|FG000|Overall Study|Lost to Follow-up|3|||
147571995|NCT00123734|532252315|FG000|Overall Study|Dropout|1|||
147571996|NCT00123734|532252315|FG000|Overall Study|Withdrawal by Subject|1|||
147571997|NCT00113386|532252316|FG000|Overall Study|Withdrawal by Subject|1|||
147571998|NCT00113386|532252317|FG001|Overall Study|Withdrawal by Subject|0|||
147571999|NCT00113386|532252316|FG000|Overall Study|Physician Decision|0|||
147572000|NCT00113386|532252317|FG001|Overall Study|Physician Decision|1|||
147572001|NCT00113386|532252316|FG000|Overall Study|Toxicity|3|||
147572002|NCT00113386|532252317|FG001|Overall Study|Toxicity|0|||
147572003|NCT00113386|532252316|FG000|Overall Study|Ineligible|1|||
147572004|NCT00113386|532252317|FG001|Overall Study|Ineligible|2|||
147572005|NCT00113386|532252316|FG000|Overall Study|Unknown - Lost to Follow-Up|2|||
147572006|NCT00113386|532252317|FG001|Overall Study|Unknown - Lost to Follow-Up|1|||
147572007|NCT01648582|532252318|FG000|Overall Study|Adverse Event|6|||
147572008|NCT01648582|532252319|FG001|Overall Study|Adverse Event|11|||
147572009|NCT01648582|532252320|FG002|Overall Study|Adverse Event|2|||
147572010|NCT01648582|532252318|FG000|Overall Study|Lost to Follow-up|9|||
147572011|NCT01648582|532252319|FG001|Overall Study|Lost to Follow-up|6|||
147572012|NCT01648582|532252320|FG002|Overall Study|Lost to Follow-up|8|||
147572013|NCT01648582|532252318|FG000|Overall Study|Protocol Violation|1|||
147572014|NCT01648582|532252319|FG001|Overall Study|Protocol Violation|2|||
147572015|NCT01648582|532252320|FG002|Overall Study|Protocol Violation|1|||
147572016|NCT01648582|532252318|FG000|Overall Study|Withdrawal by Subject|15|||
147136937|NCT00244621|530669940|FG002|Double-blind Treatment Period|Lost to Follow-up|1|||
147136938|NCT00244621|530669938|FG000|Double-blind Treatment Period|Withdrawal by Subject|0|||
147136939|NCT00244621|530669939|FG001|Double-blind Treatment Period|Withdrawal by Subject|1|||
147136940|NCT00244621|530669940|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
147572017|NCT01648582|532252319|FG001|Overall Study|Withdrawal by Subject|17|||
147572018|NCT01648582|532252320|FG002|Overall Study|Withdrawal by Subject|17|||
147572019|NCT01648582|532252318|FG000|Overall Study|Physician Decision|0|||
147572020|NCT01648582|532252319|FG001|Overall Study|Physician Decision|1|||
147572021|NCT01648582|532252320|FG002|Overall Study|Physician Decision|3|||
147572022|NCT01648582|532252318|FG000|Overall Study|Death|1|||
147572023|NCT01648582|532252319|FG001|Overall Study|Death|0|||
147572024|NCT01648582|532252320|FG002|Overall Study|Death|0|||
147136941|NCT00244621|530669938|FG000|Double-blind Treatment Period|Lack of Efficacy|0|||
147572025|NCT01648582|532252318|FG000|Overall Study|Sponsor Decision|0|||
147572026|NCT01648582|532252319|FG001|Overall Study|Sponsor Decision|1|||
147572027|NCT01648582|532252320|FG002|Overall Study|Sponsor Decision|1|||
147572028|NCT04408794|532252321|FG000|Overall Study|Adverse Event|43|||
147572029|NCT04408794|532252321|FG000|Overall Study|Infrequent study drug usage|43|||
147136942|NCT00244621|530669939|FG001|Double-blind Treatment Period|Lack of Efficacy|1|||
147136943|NCT00244621|530669940|FG002|Double-blind Treatment Period|Lack of Efficacy|0|||
147136944|NCT00244621|530669938|FG000|Double-blind Treatment Period|Multiple Reasons|2|||
147136945|NCT00244621|530669939|FG001|Double-blind Treatment Period|Multiple Reasons|1|||
147136946|NCT00244621|530669940|FG002|Double-blind Treatment Period|Multiple Reasons|1|||
147136947|NCT00244621|530669938|FG000|Open-label Treatment Period|Lost to Follow-up|0|||
147136948|NCT00244621|530669939|FG001|Open-label Treatment Period|Lost to Follow-up|1|||
147136949|NCT00244621|530669940|FG002|Open-label Treatment Period|Lost to Follow-up|0|||
147136950|NCT00244621|530669938|FG000|Open-label Treatment Period|Withdrawal by Subject|1|||
147136951|NCT00244621|530669939|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
147136952|NCT00244621|530669940|FG002|Open-label Treatment Period|Withdrawal by Subject|0|||
147136953|NCT00244621|530669938|FG000|Open-label Treatment Period|Adverse Event|0|||
147651667|NCT00528372|532546571|FG006|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
147136954|NCT00244621|530669939|FG001|Open-label Treatment Period|Adverse Event|0|||
147136955|NCT00244621|530669940|FG002|Open-label Treatment Period|Adverse Event|1|||
147136956|NCT00244621|530669938|FG000|Open-label Treatment Period|Moved abroad|0|||
147136957|NCT00244621|530669939|FG001|Open-label Treatment Period|Moved abroad|0|||
147136958|NCT00244621|530669940|FG002|Open-label Treatment Period|Moved abroad|1|||
147136959|NCT01847755|530669944|FG000|Overall Study|Adverse Event|2|||
147136960|NCT01847755|530669944|FG000|Overall Study|Withdrawal by Subject|2|||
147136961|NCT01847755|530669944|FG000|Overall Study|Physician Decision|1|||
147136962|NCT01193101|530669945|FG000|Overall Study|Adverse Event|0|||
147136963|NCT01193101|530669946|FG001|Overall Study|Adverse Event|1|||
147136964|NCT01193101|530669947|FG002|Overall Study|Adverse Event|1|||
147136965|NCT01193101|530669948|FG003|Overall Study|Adverse Event|3|||
147136966|NCT01193101|530669945|FG000|Overall Study|Lack of Efficacy|3|||
147136967|NCT01193101|530669946|FG001|Overall Study|Lack of Efficacy|1|||
147136968|NCT01193101|530669947|FG002|Overall Study|Lack of Efficacy|0|||
147136969|NCT01193101|530669948|FG003|Overall Study|Lack of Efficacy|8|||
147136970|NCT01193101|530669945|FG000|Overall Study|Withdrawal by Subject|2|||
147136971|NCT01193101|530669946|FG001|Overall Study|Withdrawal by Subject|4|||
147136972|NCT01193101|530669947|FG002|Overall Study|Withdrawal by Subject|1|||
147136973|NCT01193101|530669948|FG003|Overall Study|Withdrawal by Subject|1|||
147136974|NCT01193101|530669945|FG000|Overall Study|Administrative problems|0|||
147136975|NCT01193101|530669946|FG001|Overall Study|Administrative problems|0|||
147136976|NCT01193101|530669947|FG002|Overall Study|Administrative problems|1|||
147136977|NCT01193101|530669948|FG003|Overall Study|Administrative problems|0|||
147136978|NCT01193101|530669945|FG000|Overall Study|Abnormal test procedure results|0|||
147136979|NCT01193101|530669946|FG001|Overall Study|Abnormal test procedure results|1|||
147136980|NCT01193101|530669947|FG002|Overall Study|Abnormal test procedure results|0|||
147136981|NCT01193101|530669948|FG003|Overall Study|Abnormal test procedure results|0|||
147136982|NCT02347085|530669949|FG000|Overall Study|Adverse Event|2|||
147237498|NCT02478632|531040638|FG000|Early Switch Phase (Up to Week 52)|Withdrawal from parent study|4|||
147237499|NCT02478632|531040639|FG001|Early Switch Phase (Up to Week 52)|Withdrawal from parent study|5|||
147237500|NCT02478632|531040638|FG000|Late Switch Phase (Week 52 to Week 148)|Withdrawal from parent study|2|||
147237501|NCT02478632|531040639|FG001|Late Switch Phase (Week 52 to Week 148)|Withdrawal from parent study|3|||
147572030|NCT04408794|532252321|FG000|Overall Study|Lack of Efficacy|61|||
147572031|NCT04408794|532252321|FG000|Overall Study|Lost to Follow-up|33|||
147572032|NCT04408794|532252321|FG000|Overall Study|Non-compliance|6|||
147572033|NCT04408794|532252321|FG000|Overall Study|Physician Decision|1|||
147572034|NCT04408794|532252321|FG000|Overall Study|Pregnancy|6|||
147572035|NCT04408794|532252321|FG000|Overall Study|Protocol Deviation|9|||
147572036|NCT04408794|532252321|FG000|Overall Study|Sheehan-STS Result|1|||
147651668|NCT00528372|532546572|FG007|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
147136983|NCT02347085|530669949|FG000|Overall Study|Lack of Efficacy|1|||
147237502|NCT02478632|531040638|FG000|Late Switch Phase (Week 52 to Week 148)|Prohibited medication use|5|||
147572037|NCT04408794|532252321|FG000|Overall Study|Withdrawal by Subject|57|||
147136984|NCT02347085|530669949|FG000|Overall Study|Withdrawal by Subject|4|||
147136985|NCT02347085|530669949|FG000|Overall Study|Lost to Follow-up|1|||
147136986|NCT02347085|530669949|FG000|Overall Study|Protocol Criteria|2|||
147136987|NCT02271529|530669950|FG000|Overall Study|Withdrawal by Subject|1|||
147136988|NCT01077063|530669955|FG000|Overall Study|Adverse Event|3|||
147136989|NCT01077063|530669956|FG001|Overall Study|Adverse Event|0|||
147136990|NCT01077063|530669955|FG000|Overall Study|Death|1|||
147136991|NCT01077063|530669956|FG001|Overall Study|Death|1|||
147136992|NCT01077063|530669955|FG000|Overall Study|Withdrawal by Subject|0|||
147136993|NCT01077063|530669956|FG001|Overall Study|Withdrawal by Subject|2|||
147237503|NCT02478632|531040639|FG001|Late Switch Phase (Week 52 to Week 148)|Prohibited medication use|1|||
147572038|NCT04408794|532252321|FG000|Overall Study|Terminated study prematurely due to COVID-19 - Adverse Event|2|||
147572039|NCT04408794|532252321|FG000|Overall Study|Never Treated Migraine|5|||
147572040|NCT01444378|532252326|FG000|Overall Study|Lost to Follow-up|1|||
147572041|NCT01444378|532252326|FG000|Overall Study|Withdrawal by Subject|1|||
147572042|NCT01444378|532252326|FG000|Overall Study|Death|3|||
147572043|NCT01444378|532252326|FG000|Overall Study|Administrative Closure Of The Study|2|||
147572044|NCT01444378|532252326|FG000|Overall Study|Missed Visits|10|||
147572045|NCT00556322|532252327|FG000|Overall Study|Insufficient therapeutic response|158|||
147572046|NCT00556322|532252328|FG001|Overall Study|Insufficient therapeutic response|168|||
147572047|NCT00556322|532252327|FG000|Overall Study|Adverse Event|7|||
147572048|NCT00556322|532252328|FG001|Overall Study|Adverse Event|4|||
147572049|NCT00556322|532252327|FG000|Overall Study|Other|4|||
147572050|NCT00556322|532252328|FG001|Overall Study|Other|1|||
147572051|NCT00556322|532252327|FG000|Overall Study|Lost to Follow-up|5|||
147572052|NCT00556322|532252328|FG001|Overall Study|Lost to Follow-up|3|||
147136994|NCT03768427|530669957|FG000|Overall Study|Death|0|||
147136995|NCT03768427|530669958|FG001|Overall Study|Death|0|||
147136996|NCT03768427|530669959|FG002|Overall Study|Death|1|||
147136997|NCT03768427|530669960|FG003|Overall Study|Death|0|||
147136998|NCT03768427|530669957|FG000|Overall Study|Lost to Follow-up|2|||
147136999|NCT03768427|530669958|FG001|Overall Study|Lost to Follow-up|0|||
147137000|NCT03768427|530669959|FG002|Overall Study|Lost to Follow-up|0|||
147137001|NCT03768427|530669960|FG003|Overall Study|Lost to Follow-up|0|||
147137002|NCT03768427|530669957|FG000|Overall Study|Physician Decision|3|||
147137003|NCT03768427|530669958|FG001|Overall Study|Physician Decision|2|||
147137004|NCT03768427|530669959|FG002|Overall Study|Physician Decision|4|||
147137005|NCT03768427|530669960|FG003|Overall Study|Physician Decision|4|||
147137006|NCT03768427|530669957|FG000|Overall Study|Withdrawal by Subject|7|||
147137007|NCT03768427|530669958|FG001|Overall Study|Withdrawal by Subject|2|||
147137008|NCT03768427|530669959|FG002|Overall Study|Withdrawal by Subject|6|||
147137009|NCT03768427|530669960|FG003|Overall Study|Withdrawal by Subject|7|||
147137010|NCT01644643|530669963|FG000|Overall Study|Death|1|||
147137011|NCT01644643|530669964|FG001|Overall Study|Death|0|||
147137012|NCT01644643|530669965|FG002|Overall Study|Death|3|||
147137013|NCT01644643|530669966|FG003|Overall Study|Death|3|||
147137014|NCT01644643|530669963|FG000|Overall Study|Lost to Follow-up|0|||
147137015|NCT01644643|530669964|FG001|Overall Study|Lost to Follow-up|0|||
147137016|NCT01644643|530669965|FG002|Overall Study|Lost to Follow-up|0|||
147137017|NCT01644643|530669966|FG003|Overall Study|Lost to Follow-up|4|||
147137018|NCT01644643|530669963|FG000|Overall Study|Withdrawal by Subject|1|||
147137019|NCT01644643|530669964|FG001|Overall Study|Withdrawal by Subject|0|||
147137020|NCT01644643|530669965|FG002|Overall Study|Withdrawal by Subject|2|||
147137021|NCT01644643|530669966|FG003|Overall Study|Withdrawal by Subject|1|||
147137022|NCT01644643|530669963|FG000|Overall Study|Other Eligibility criteria|0|||
147137023|NCT01644643|530669964|FG001|Overall Study|Other Eligibility criteria|0|||
147137024|NCT01644643|530669965|FG002|Overall Study|Other Eligibility criteria|0|||
147137025|NCT01644643|530669966|FG003|Overall Study|Other Eligibility criteria|2|||
147137026|NCT02756403|530669967|FG000|Overall Study|Unable to swallow medication|0|||
147137027|NCT02756403|530669968|FG001|Overall Study|Unable to swallow medication|1|||
147137028|NCT02756403|530669969|FG002|Overall Study|Unable to swallow medication|1|||
147137029|NCT02756403|530669970|FG003|Overall Study|Unable to swallow medication|1|||
147137030|NCT02756403|530669967|FG000|Overall Study|Did not complete Procedure|0|||
147137031|NCT02756403|530669968|FG001|Overall Study|Did not complete Procedure|1|||
147137032|NCT02756403|530669969|FG002|Overall Study|Did not complete Procedure|0|||
147137033|NCT02756403|530669970|FG003|Overall Study|Did not complete Procedure|0|||
147137034|NCT02756403|530669967|FG000|Overall Study|Changed Mind About Procedure|0|||
147445639|NCT03200366|531797424|FG001|Patient Navigation Intervention Given|Death|2|||
147572053|NCT00556322|532252327|FG000|Overall Study|Withdrawal by Subject|19|||
147572054|NCT00556322|532252328|FG001|Overall Study|Withdrawal by Subject|7|||
147572055|NCT00556322|532252327|FG000|Overall Study|Protocol Violation|5|||
147572056|NCT00556322|532252328|FG001|Overall Study|Protocol Violation|1|||
147572057|NCT00556322|532252327|FG000|Overall Study|Ongoing at data cutoff|3|||
147572058|NCT00556322|532252328|FG001|Overall Study|Ongoing at data cutoff|5|||
147572059|NCT00556322|532252327|FG000|Overall Study|Death|20|||
147572060|NCT00556322|532252328|FG001|Overall Study|Death|14|||
147572061|NCT03261167|532252331|FG000|Double Blind(Treatment cyc1,Upto Week48)|Adverse Event|0|||
147572062|NCT03261167|532252332|FG001|Double Blind(Treatment cyc1,Upto Week48)|Adverse Event|3|||
147137035|NCT02756403|530669968|FG001|Overall Study|Changed Mind About Procedure|0|||
147137036|NCT02756403|530669969|FG002|Overall Study|Changed Mind About Procedure|1|||
147137037|NCT02756403|530669970|FG003|Overall Study|Changed Mind About Procedure|0|||
147137038|NCT02756403|530669967|FG000|Overall Study|Protocol Violation|0|||
147137039|NCT02756403|530669968|FG001|Overall Study|Protocol Violation|1|||
147137040|NCT02756403|530669969|FG002|Overall Study|Protocol Violation|0|||
147137041|NCT02756403|530669970|FG003|Overall Study|Protocol Violation|1|||
147237504|NCT00002651|531040640|FG000|Induction|Adverse Event|44|||
147572063|NCT03261167|532252331|FG000|Double Blind(Treatment cyc1,Upto Week48)|Withdrawal by Subject|3|||
147572064|NCT03261167|532252332|FG001|Double Blind(Treatment cyc1,Upto Week48)|Withdrawal by Subject|1|||
147595959|NCT01875471|532338757|FG001|Overall Study|Adverse Event|1|||
147237505|NCT00002651|531040641|FG001|Induction|Adverse Event|0|||
147137042|NCT00527618|530669971|FG000|Week 1-12 (First Intervention)|Lost to Follow-up|3|||
147137043|NCT00527618|530669972|FG001|Week 1-12 (First Intervention)|Lost to Follow-up|1|||
147137044|NCT00527618|530669971|FG000|Week 1-12 (First Intervention)|Adverse Event|0|||
147137045|NCT00527618|530669972|FG001|Week 1-12 (First Intervention)|Adverse Event|1|||
147572065|NCT03261167|532252331|FG000|Open-label(Treatment cycle2,Upto Week48)|Protocol defined stopping criteria|1|||
147572066|NCT03261167|532252332|FG001|Open-label(Treatment cycle2,Upto Week48)|Protocol defined stopping criteria|0|||
147572067|NCT03261167|532252331|FG000|Open-label(Treatment cycle2,Upto Week48)|Withdrawal by Subject|1|||
147572068|NCT03261167|532252332|FG001|Open-label(Treatment cycle2,Upto Week48)|Withdrawal by Subject|0|||
147137046|NCT00527618|530669971|FG000|Week 13-14 (Washout)|Lost to Follow-up|1|||
147137047|NCT00527618|530669972|FG001|Week 13-14 (Washout)|Lost to Follow-up|0|||
147137048|NCT00527618|530669971|FG000|Week 15-18 (Second Intervention)|Lost to Follow-up|0|||
147137049|NCT00527618|530669972|FG001|Week 15-18 (Second Intervention)|Lost to Follow-up|1|||
147137050|NCT00527618|530669971|FG000|Week 15-18 (Second Intervention)|Censored on initiation of HAART|0|||
147137051|NCT00527618|530669972|FG001|Week 15-18 (Second Intervention)|Censored on initiation of HAART|1|||
147137052|NCT00527618|530669971|FG000|Week 15-18 (Second Intervention)|Withdrawal by Subject|0|||
147137053|NCT00527618|530669972|FG001|Week 15-18 (Second Intervention)|Withdrawal by Subject|1|||
147137054|NCT01490918|530669975|FG000|Overall Study|Lost to Follow-up|2|||
147137055|NCT01490918|530669976|FG001|Overall Study|Lost to Follow-up|1|||
147137056|NCT01490918|530669977|FG002|Overall Study|Lost to Follow-up|0|||
147137057|NCT01490918|530669975|FG000|Overall Study|Withdrawal by Subject|7|||
147137058|NCT01490918|530669976|FG001|Overall Study|Withdrawal by Subject|8|||
147137059|NCT01490918|530669977|FG002|Overall Study|Withdrawal by Subject|3|||
147137060|NCT01490918|530669975|FG000|Overall Study|Adverse Event|0|||
147137061|NCT01490918|530669976|FG001|Overall Study|Adverse Event|0|||
147137062|NCT01490918|530669977|FG002|Overall Study|Adverse Event|1|||
147572069|NCT03261167|532252331|FG000|Open-label(Treatment cycle3,Upto Week48)|Withdrawal by Subject|1|||
147572070|NCT03261167|532252332|FG001|Open-label(Treatment cycle3,Upto Week48)|Withdrawal by Subject|1|||
147572071|NCT03256695|532252335|FG000|Overall Study|Adverse Event|8|||
147137063|NCT01490918|530669975|FG000|Overall Study|other cause|4|||
147137064|NCT01490918|530669976|FG001|Overall Study|other cause|5|||
147137065|NCT01490918|530669977|FG002|Overall Study|other cause|8|||
147137066|NCT00776789|530669978|FG000|Overall Study|Consent refusal|2|||
147137067|NCT00776789|530669979|FG001|Overall Study|Consent refusal|2|||
147137068|NCT00776789|530669978|FG000|Overall Study|Poor quality video|1|||
147137069|NCT00776789|530669979|FG001|Overall Study|Poor quality video|1|||
147137070|NCT00648037|530669982|FG000|Overall Study|Not Treated|1|||
147137071|NCT00648037|530669982|FG000|Overall Study|Withdrawal by Subject|1|||
147137072|NCT00648037|530669982|FG000|Overall Study|Adverse Event|11|||
147137073|NCT00648037|530669982|FG000|Overall Study|Relapse|2|||
147137074|NCT00648037|530669982|FG000|Overall Study|Other|1|||
147137075|NCT02967679|530669983|FG000|Overall Study|Adverse Event|1|||
147137076|NCT03391882|530669989|FG000|Study Overall|Adverse Event|3|||
147137077|NCT03391882|530669990|FG001|Study Overall|Adverse Event|6|||
147137078|NCT03391882|530669991|FG002|Study Overall|Adverse Event|1|||
147137079|NCT03391882|530669992|FG003|Study Overall|Adverse Event|1|||
147137080|NCT03391882|530669993|FG004|Study Overall|Adverse Event|3|||
147137081|NCT03391882|530669994|FG005|Study Overall|Adverse Event|1|||
147137082|NCT03391882|530669989|FG000|Study Overall|Lack of Efficacy|13|||
147137083|NCT03391882|530669990|FG001|Study Overall|Lack of Efficacy|9|||
147137084|NCT03391882|530669991|FG002|Study Overall|Lack of Efficacy|0|||
147137085|NCT03391882|530669992|FG003|Study Overall|Lack of Efficacy|0|||
147137086|NCT03391882|530669993|FG004|Study Overall|Lack of Efficacy|0|||
147137087|NCT03391882|530669994|FG005|Study Overall|Lack of Efficacy|0|||
147137088|NCT03391882|530669989|FG000|Study Overall|Withdrawal by Subject|3|||
147137089|NCT03391882|530669990|FG001|Study Overall|Withdrawal by Subject|3|||
147137090|NCT03391882|530669991|FG002|Study Overall|Withdrawal by Subject|2|||
147137091|NCT03391882|530669992|FG003|Study Overall|Withdrawal by Subject|2|||
147137092|NCT03391882|530669993|FG004|Study Overall|Withdrawal by Subject|1|||
147137093|NCT03391882|530669994|FG005|Study Overall|Withdrawal by Subject|3|||
147137094|NCT03391882|530669989|FG000|Study Overall|EARLY TERM AT SPONSOR REQUEST|0|||
147445640|NCT03200366|531797425|FG002|Patient Navigation Intervention Given|Death|0|||
147445641|NCT03200366|531797423|FG000|Patient Navigation Intervention Given|Lost to Follow-up|0|||
147445642|NCT03200366|531797424|FG001|Patient Navigation Intervention Given|Lost to Follow-up|25|||
147572072|NCT03256695|532252335|FG000|Overall Study|Death|2|||
147137095|NCT03391882|530669990|FG001|Study Overall|EARLY TERM AT SPONSOR REQUEST|1|||
147445643|NCT03200366|531797425|FG002|Patient Navigation Intervention Given|Lost to Follow-up|0|||
147572073|NCT03256695|532252335|FG000|Overall Study|Withdrawal by Subject|14|||
147137096|NCT03391882|530669991|FG002|Study Overall|EARLY TERM AT SPONSOR REQUEST|0|||
147137097|NCT03391882|530669992|FG003|Study Overall|EARLY TERM AT SPONSOR REQUEST|0|||
147137098|NCT03391882|530669993|FG004|Study Overall|EARLY TERM AT SPONSOR REQUEST|0|||
147137099|NCT03391882|530669994|FG005|Study Overall|EARLY TERM AT SPONSOR REQUEST|0|||
147137100|NCT03391882|530669989|FG000|Study Overall|Protocol Violation|1|||
147137101|NCT03391882|530669990|FG001|Study Overall|Protocol Violation|0|||
147137102|NCT03391882|530669991|FG002|Study Overall|Protocol Violation|0|||
147137103|NCT03391882|530669992|FG003|Study Overall|Protocol Violation|0|||
147137104|NCT03391882|530669993|FG004|Study Overall|Protocol Violation|0|||
147137105|NCT03391882|530669994|FG005|Study Overall|Protocol Violation|0|||
147137106|NCT03391882|530669989|FG000|Part A - Titration Phase|Adverse Event|3|||
147137107|NCT03391882|530669990|FG001|Part A - Titration Phase|Adverse Event|6|||
147137108|NCT03391882|530669991|FG002|Part A - Titration Phase|Adverse Event|0|||
147137109|NCT03391882|530669992|FG003|Part A - Titration Phase|Adverse Event|0|||
147137110|NCT03391882|530669993|FG004|Part A - Titration Phase|Adverse Event|0|||
147137111|NCT03391882|530669994|FG005|Part A - Titration Phase|Adverse Event|0|||
147572074|NCT03256695|532252335|FG000|Overall Study|Non-compliance with study drug|1|||
147137112|NCT03391882|530669989|FG000|Part A - Titration Phase|Lack of Efficacy|12|||
147137113|NCT03391882|530669990|FG001|Part A - Titration Phase|Lack of Efficacy|6|||
147137114|NCT03391882|530669991|FG002|Part A - Titration Phase|Lack of Efficacy|0|||
147137115|NCT03391882|530669992|FG003|Part A - Titration Phase|Lack of Efficacy|0|||
147137116|NCT03391882|530669993|FG004|Part A - Titration Phase|Lack of Efficacy|0|||
147137117|NCT03391882|530669994|FG005|Part A - Titration Phase|Lack of Efficacy|0|||
147137118|NCT03391882|530669989|FG000|Part A - Titration Phase|Withdrawal by Subject|3|||
147137119|NCT03391882|530669990|FG001|Part A - Titration Phase|Withdrawal by Subject|3|||
147137120|NCT03391882|530669991|FG002|Part A - Titration Phase|Withdrawal by Subject|0|||
147137121|NCT03391882|530669992|FG003|Part A - Titration Phase|Withdrawal by Subject|0|||
147137122|NCT03391882|530669993|FG004|Part A - Titration Phase|Withdrawal by Subject|0|||
147137123|NCT03391882|530669994|FG005|Part A - Titration Phase|Withdrawal by Subject|0|||
147237506|NCT00002651|531040642|FG002|Induction|Adverse Event|0|||
147572075|NCT03256695|532252335|FG000|Overall Study|Lost to Follow-up|3|||
147572076|NCT03256695|532252335|FG000|Overall Study|Lack of Efficacy|3|||
147651669|NCT00528372|532546573|FG008|Short-term (ST) Period (Day 1-Week 24)|Poor or noncompliance|0|||
147651670|NCT00528372|532546565|FG000|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|1|||
147651671|NCT00528372|532546566|FG001|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
147651672|NCT00528372|532546567|FG002|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|1|||
147651673|NCT00528372|532546568|FG003|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
147651674|NCT00528372|532546569|FG004|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
147651675|NCT00528372|532546570|FG005|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|1|||
147651676|NCT00528372|532546571|FG006|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
147651677|NCT00528372|532546572|FG007|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
147651678|NCT00528372|532546573|FG008|Short-term (ST) Period (Day 1-Week 24)|Administration reason by sponsor|0|||
147651679|NCT00528372|532546565|FG000|Short-term (ST) Period (Day 1-Week 24)|Other|3|||
147651680|NCT00528372|532546566|FG001|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
147651681|NCT00528372|532546567|FG002|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
147651682|NCT00528372|532546568|FG003|Short-term (ST) Period (Day 1-Week 24)|Other|1|||
147237507|NCT00002651|531040640|FG000|Induction|Refusal unrelated to adverse event|50|||
147572077|NCT03256695|532252335|FG000|Overall Study|Protocol Violation|5|||
147572078|NCT03256695|532252335|FG000|Overall Study|Other than specified|3|||
147572079|NCT00318461|532252336|FG000|Double-Blind, 6 Months|Adverse Event|11|||
147572080|NCT00318461|532252337|FG001|Double-Blind, 6 Months|Adverse Event|23|||
147572081|NCT00318461|532252338|FG002|Double-Blind, 6 Months|Adverse Event|29|||
147572082|NCT00318461|532252339|FG003|Double-Blind, 6 Months|Adverse Event|2|||
147572083|NCT00318461|532252340|FG004|Double-Blind, 6 Months|Adverse Event|8|||
147572084|NCT00318461|532252336|FG000|Double-Blind, 6 Months|Lack of Efficacy|19|||
147572085|NCT00318461|532252337|FG001|Double-Blind, 6 Months|Lack of Efficacy|8|||
147572086|NCT00318461|532252338|FG002|Double-Blind, 6 Months|Lack of Efficacy|13|||
147572087|NCT00318461|532252339|FG003|Double-Blind, 6 Months|Lack of Efficacy|29|||
147572088|NCT00318461|532252340|FG004|Double-Blind, 6 Months|Lack of Efficacy|9|||
147572089|NCT00318461|532252336|FG000|Double-Blind, 6 Months|Protocol Violation|2|||
147572090|NCT00318461|532252337|FG001|Double-Blind, 6 Months|Protocol Violation|4|||
147572091|NCT00318461|532252338|FG002|Double-Blind, 6 Months|Protocol Violation|4|||
147572092|NCT00318461|532252339|FG003|Double-Blind, 6 Months|Protocol Violation|4|||
147572093|NCT00318461|532252340|FG004|Double-Blind, 6 Months|Protocol Violation|5|||
147572094|NCT00318461|532252336|FG000|Double-Blind, 6 Months|Lost to follow up|0|||
147572095|NCT00318461|532252337|FG001|Double-Blind, 6 Months|Lost to follow up|1|||
147572096|NCT00318461|532252338|FG002|Double-Blind, 6 Months|Lost to follow up|0|||
147572097|NCT00318461|532252339|FG003|Double-Blind, 6 Months|Lost to follow up|0|||
147651683|NCT00528372|532546569|FG004|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
147137124|NCT03391882|530669989|FG000|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|0|||
147137125|NCT03391882|530669990|FG001|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|1|||
147237508|NCT00002651|531040641|FG001|Induction|Refusal unrelated to adverse event|0|||
147572098|NCT00318461|532252340|FG004|Double-Blind, 6 Months|Lost to follow up|0|||
147572099|NCT00318461|532252336|FG000|Double-Blind, 6 Months|Poor compliance/Non-compliance|0|||
147572100|NCT00318461|532252337|FG001|Double-Blind, 6 Months|Poor compliance/Non-compliance|1|||
147572101|NCT00318461|532252338|FG002|Double-Blind, 6 Months|Poor compliance/Non-compliance|0|||
147572102|NCT00318461|532252339|FG003|Double-Blind, 6 Months|Poor compliance/Non-compliance|0|||
147572103|NCT00318461|532252340|FG004|Double-Blind, 6 Months|Poor compliance/Non-compliance|0|||
147651684|NCT00528372|532546570|FG005|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
147651685|NCT00528372|532546571|FG006|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
147651686|NCT00528372|532546572|FG007|Short-term (ST) Period (Day 1-Week 24)|Other|1|||
147651687|NCT00528372|532546573|FG008|Short-term (ST) Period (Day 1-Week 24)|Other|0|||
147651688|NCT00528372|532546565|FG000|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|6|||
147651689|NCT00528372|532546566|FG001|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|6|||
147651690|NCT00528372|532546567|FG002|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|1|||
147651691|NCT00528372|532546568|FG003|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|7|||
147651692|NCT00528372|532546569|FG004|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|7|||
147651693|NCT00528372|532546570|FG005|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|7|||
147651694|NCT00528372|532546571|FG006|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|2|||
147651695|NCT00528372|532546572|FG007|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|0|||
147651696|NCT00528372|532546573|FG008|Long-term (LT) Period (Weeks 24-102)|Lack of Efficacy|0|||
147651697|NCT00528372|532546565|FG000|Long-term (LT) Period (Weeks 24-102)|Adverse Event|3|||
147651698|NCT00528372|532546566|FG001|Long-term (LT) Period (Weeks 24-102)|Adverse Event|1|||
147651699|NCT00528372|532546567|FG002|Long-term (LT) Period (Weeks 24-102)|Adverse Event|1|||
147651700|NCT00528372|532546568|FG003|Long-term (LT) Period (Weeks 24-102)|Adverse Event|0|||
147651701|NCT00528372|532546569|FG004|Long-term (LT) Period (Weeks 24-102)|Adverse Event|2|||
147651702|NCT00528372|532546570|FG005|Long-term (LT) Period (Weeks 24-102)|Adverse Event|3|||
147651703|NCT00528372|532546571|FG006|Long-term (LT) Period (Weeks 24-102)|Adverse Event|4|||
147651704|NCT00528372|532546572|FG007|Long-term (LT) Period (Weeks 24-102)|Adverse Event|0|||
147651705|NCT00528372|532546573|FG008|Long-term (LT) Period (Weeks 24-102)|Adverse Event|0|||
147651706|NCT00528372|532546565|FG000|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|6|||
147651707|NCT00528372|532546566|FG001|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|6|||
147651708|NCT00528372|532546567|FG002|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|3|||
147651709|NCT00528372|532546568|FG003|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|3|||
147651710|NCT00528372|532546569|FG004|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|7|||
147651711|NCT00528372|532546570|FG005|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|0|||
147651712|NCT00528372|532546571|FG006|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|4|||
147651713|NCT00528372|532546572|FG007|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|2|||
147651714|NCT00528372|532546573|FG008|Long-term (LT) Period (Weeks 24-102)|Withdrawal by Subject|4|||
147651715|NCT00528372|532546565|FG000|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|3|||
147651716|NCT00528372|532546566|FG001|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|2|||
147651717|NCT00528372|532546567|FG002|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|1|||
147651718|NCT00528372|532546568|FG003|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|1|||
147651719|NCT00528372|532546569|FG004|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|0|||
147651720|NCT00528372|532546570|FG005|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|4|||
147651721|NCT00528372|532546571|FG006|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|2|||
147651722|NCT00528372|532546572|FG007|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|3|||
147651723|NCT00528372|532546573|FG008|Long-term (LT) Period (Weeks 24-102)|Lost to Follow-up|1|||
147651724|NCT00528372|532546565|FG000|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0|||
147651725|NCT00528372|532546566|FG001|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1|||
147651726|NCT00528372|532546567|FG002|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1|||
147651727|NCT00528372|532546568|FG003|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1|||
147651728|NCT00528372|532546569|FG004|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0|||
147651729|NCT00528372|532546570|FG005|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0|||
147651730|NCT00528372|532546571|FG006|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|1|||
147651731|NCT00528372|532546572|FG007|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0|||
147651732|NCT00528372|532546573|FG008|Long-term (LT) Period (Weeks 24-102)|Poor compliance or noncompliance|0|||
147651733|NCT00528372|532546565|FG000|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
147651734|NCT00528372|532546566|FG001|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
147651735|NCT00528372|532546567|FG002|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
147651736|NCT00528372|532546568|FG003|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
147651737|NCT00528372|532546569|FG004|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|2|||
147651738|NCT00528372|532546570|FG005|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|1|||
147651739|NCT00528372|532546571|FG006|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
147651740|NCT00528372|532546572|FG007|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
147651741|NCT00528372|532546573|FG008|Long-term (LT) Period (Weeks 24-102)|No longer met study criteria|0|||
147651742|NCT00528372|532546565|FG000|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
147651743|NCT00528372|532546566|FG001|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|1|||
147651744|NCT00528372|532546567|FG002|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
147651745|NCT00528372|532546568|FG003|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
147651746|NCT00528372|532546569|FG004|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
147651747|NCT00528372|532546570|FG005|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
147651748|NCT00528372|532546571|FG006|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|1|||
147651749|NCT00528372|532546572|FG007|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|0|||
147651750|NCT00528372|532546573|FG008|Long-term (LT) Period (Weeks 24-102)|Administrative reason by sponsor|1|||
147651751|NCT00528372|532546565|FG000|Long-term (LT) Period (Weeks 24-102)|Other|2|||
147651752|NCT00528372|532546566|FG001|Long-term (LT) Period (Weeks 24-102)|Other|2|||
147651753|NCT00528372|532546567|FG002|Long-term (LT) Period (Weeks 24-102)|Other|1|||
147651754|NCT00528372|532546568|FG003|Long-term (LT) Period (Weeks 24-102)|Other|2|||
147651755|NCT00528372|532546569|FG004|Long-term (LT) Period (Weeks 24-102)|Other|3|||
147651756|NCT00528372|532546570|FG005|Long-term (LT) Period (Weeks 24-102)|Other|0|||
147651757|NCT00528372|532546571|FG006|Long-term (LT) Period (Weeks 24-102)|Other|3|||
147651758|NCT00528372|532546572|FG007|Long-term (LT) Period (Weeks 24-102)|Other|1|||
147651759|NCT00528372|532546573|FG008|Long-term (LT) Period (Weeks 24-102)|Other|0|||
147651760|NCT02432144|532546578|FG000|Overall Study|Participant Non-Compliance|1|||
147651761|NCT01483599|532546580|FG000|Controlled Period (CP) (up to Week 16)|Adverse Event|2|||
147651762|NCT01483599|532546581|FG001|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
147651763|NCT01483599|532546582|FG002|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
147651764|NCT01483599|532546583|FG003|Controlled Period (CP) (up to Week 16)|Adverse Event|1|||
147651765|NCT01483599|532546584|FG004|Controlled Period (CP) (up to Week 16)|Adverse Event|1|||
147651766|NCT01483599|532546585|FG005|Controlled Period (CP) (up to Week 16)|Adverse Event|4|||
147651767|NCT01483599|532546586|FG006|Controlled Period (CP) (up to Week 16)|Adverse Event|3|||
147651768|NCT01483599|532546587|FG007|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
147651769|NCT01483599|532546588|FG008|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
147651770|NCT01483599|532546589|FG009|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
147651771|NCT01483599|532546590|FG010|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
147651772|NCT01483599|532546591|FG011|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
147651773|NCT01483599|532546592|FG012|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
147651774|NCT01483599|532546593|FG013|Controlled Period (CP) (up to Week 16)|Adverse Event|0|||
147651775|NCT01483599|532546580|FG000|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
147651776|NCT01483599|532546581|FG001|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|1|||
147651777|NCT01483599|532546582|FG002|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
147651778|NCT01483599|532546583|FG003|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|1|||
147651779|NCT01483599|532546584|FG004|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
147651780|NCT01483599|532546585|FG005|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
147651781|NCT01483599|532546586|FG006|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|1|||
147651782|NCT01483599|532546587|FG007|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
147651783|NCT01483599|532546588|FG008|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
147651784|NCT01483599|532546589|FG009|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
147651785|NCT01483599|532546590|FG010|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
147651786|NCT01483599|532546591|FG011|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
147651787|NCT01483599|532546592|FG012|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
147651788|NCT01483599|532546593|FG013|Controlled Period (CP) (up to Week 16)|Lost to Follow-up|0|||
147651789|NCT01483599|532546580|FG000|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|1|||
147651790|NCT01483599|532546581|FG001|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
147651791|NCT01483599|532546582|FG002|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
147651792|NCT01483599|532546583|FG003|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
147651793|NCT01483599|532546584|FG004|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
147651794|NCT01483599|532546585|FG005|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
147651795|NCT01483599|532546586|FG006|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
147651796|NCT01483599|532546587|FG007|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
147651797|NCT01483599|532546588|FG008|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
147651798|NCT01483599|532546589|FG009|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
147651799|NCT01483599|532546590|FG010|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
147651800|NCT01483599|532546591|FG011|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
147651801|NCT01483599|532546592|FG012|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
147651802|NCT01483599|532546593|FG013|Controlled Period (CP) (up to Week 16)|Lack of Efficacy|0|||
147651803|NCT01483599|532546580|FG000|Controlled Period (CP) (up to Week 16)|Other|0|||
147651804|NCT01483599|532546581|FG001|Controlled Period (CP) (up to Week 16)|Other|2|||
147651805|NCT01483599|532546582|FG002|Controlled Period (CP) (up to Week 16)|Other|0|||
147651806|NCT01483599|532546583|FG003|Controlled Period (CP) (up to Week 16)|Other|1|||
147651807|NCT01483599|532546584|FG004|Controlled Period (CP) (up to Week 16)|Other|1|||
147237509|NCT00002651|531040642|FG002|Induction|Refusal unrelated to adverse event|0|||
147237510|NCT00002651|531040640|FG000|Induction|Progression/relapse|274|||
147449488|NCT00440947|531809509|FG004|36-Week Induction Phase|Took Exclusionary Medications|0|||
147651808|NCT01483599|532546585|FG005|Controlled Period (CP) (up to Week 16)|Other|0|||
147651809|NCT01483599|532546586|FG006|Controlled Period (CP) (up to Week 16)|Other|0|||
147572104|NCT00318461|532252336|FG000|Double-Blind, 6 Months|Consent withdrawn|0|||
147572105|NCT00318461|532252337|FG001|Double-Blind, 6 Months|Consent withdrawn|3|||
147572106|NCT00318461|532252338|FG002|Double-Blind, 6 Months|Consent withdrawn|4|||
147572107|NCT00318461|532252339|FG003|Double-Blind, 6 Months|Consent withdrawn|10|||
147572108|NCT00318461|532252340|FG004|Double-Blind, 6 Months|Consent withdrawn|4|||
147572109|NCT00318461|532252336|FG000|Double-Blind, 6 Months|Subject decision/No wish to continue|0|||
147572110|NCT00318461|532252337|FG001|Double-Blind, 6 Months|Subject decision/No wish to continue|2|||
147572111|NCT00318461|532252338|FG002|Double-Blind, 6 Months|Subject decision/No wish to continue|1|||
147572112|NCT00318461|532252339|FG003|Double-Blind, 6 Months|Subject decision/No wish to continue|0|||
147572113|NCT00318461|532252340|FG004|Double-Blind, 6 Months|Subject decision/No wish to continue|2|||
147572114|NCT00318461|532252336|FG000|Double-Blind, 6 Months|Move|0|||
147572115|NCT00318461|532252337|FG001|Double-Blind, 6 Months|Move|1|||
147572116|NCT00318461|532252338|FG002|Double-Blind, 6 Months|Move|0|||
147572117|NCT00318461|532252339|FG003|Double-Blind, 6 Months|Move|0|||
147572118|NCT00318461|532252340|FG004|Double-Blind, 6 Months|Move|0|||
147572119|NCT00318461|532252336|FG000|Double-Blind, 6 Months|Tendency to low blood glucose levels|0|||
147572120|NCT00318461|532252337|FG001|Double-Blind, 6 Months|Tendency to low blood glucose levels|0|||
147572121|NCT00318461|532252338|FG002|Double-Blind, 6 Months|Tendency to low blood glucose levels|0|||
147572122|NCT00318461|532252339|FG003|Double-Blind, 6 Months|Tendency to low blood glucose levels|0|||
147572123|NCT00318461|532252340|FG004|Double-Blind, 6 Months|Tendency to low blood glucose levels|1|||
147572124|NCT00318461|532252336|FG000|Double-Blind, 6 Months|FPG exceeds limits/too high|1|||
147572125|NCT00318461|532252337|FG001|Double-Blind, 6 Months|FPG exceeds limits/too high|0|||
147572126|NCT00318461|532252338|FG002|Double-Blind, 6 Months|FPG exceeds limits/too high|0|||
147572127|NCT00318461|532252339|FG003|Double-Blind, 6 Months|FPG exceeds limits/too high|2|||
147572128|NCT00318461|532252340|FG004|Double-Blind, 6 Months|FPG exceeds limits/too high|0|||
147572129|NCT00318461|532252336|FG000|Double-Blind, 6 Months|Work commitment|0|||
147572130|NCT00318461|532252337|FG001|Double-Blind, 6 Months|Work commitment|0|||
147572131|NCT00318461|532252338|FG002|Double-Blind, 6 Months|Work commitment|0|||
147572132|NCT00318461|532252339|FG003|Double-Blind, 6 Months|Work commitment|0|||
147572133|NCT00318461|532252340|FG004|Double-Blind, 6 Months|Work commitment|1|||
147572134|NCT00318461|532252336|FG000|Double-Blind, 6 Months|Investigator decision|0|||
147572135|NCT00318461|532252337|FG001|Double-Blind, 6 Months|Investigator decision|0|||
147572136|NCT00318461|532252338|FG002|Double-Blind, 6 Months|Investigator decision|0|||
147572137|NCT00318461|532252339|FG003|Double-Blind, 6 Months|Investigator decision|0|||
147572138|NCT00318461|532252340|FG004|Double-Blind, 6 Months|Investigator decision|1|||
147572139|NCT00318461|532252336|FG000|Double-Blind, 6 Months|Lack of time|1|||
147572140|NCT00318461|532252337|FG001|Double-Blind, 6 Months|Lack of time|0|||
147572141|NCT00318461|532252338|FG002|Double-Blind, 6 Months|Lack of time|0|||
147572142|NCT00318461|532252339|FG003|Double-Blind, 6 Months|Lack of time|0|||
147572143|NCT00318461|532252340|FG004|Double-Blind, 6 Months|Lack of time|0|||
147572144|NCT00318461|532252336|FG000|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0|||
147572145|NCT00318461|532252337|FG001|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0|||
147572146|NCT00318461|532252338|FG002|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0|||
147572147|NCT00318461|532252339|FG003|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|0|||
147572148|NCT00318461|532252340|FG004|Double-Blind, 6 Months|Hypoglycaemia/Hypoglycemia|2|||
147572149|NCT00318461|532252336|FG000|Double-Blind, 6 Months|Hyperglicaemia|0|||
147572150|NCT00318461|532252337|FG001|Double-Blind, 6 Months|Hyperglicaemia|0|||
147572151|NCT00318461|532252338|FG002|Double-Blind, 6 Months|Hyperglicaemia|0|||
147572152|NCT00318461|532252339|FG003|Double-Blind, 6 Months|Hyperglicaemia|1|||
147572153|NCT00318461|532252340|FG004|Double-Blind, 6 Months|Hyperglicaemia|0|||
147572154|NCT00318461|532252336|FG000|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0|||
147572155|NCT00318461|532252337|FG001|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0|||
147572156|NCT00318461|532252338|FG002|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0|||
147572157|NCT00318461|532252339|FG003|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|0|||
147572158|NCT00318461|532252340|FG004|Double-Blind, 6 Months|metformin titrated <1500 mg or >2000 mg|1|||
147572159|NCT00318461|532252336|FG000|Double-Blind, 6 Months|Fear of experiencing AE again|0|||
147572160|NCT00318461|532252337|FG001|Double-Blind, 6 Months|Fear of experiencing AE again|1|||
147572161|NCT00318461|532252338|FG002|Double-Blind, 6 Months|Fear of experiencing AE again|0|||
147572162|NCT00318461|532252339|FG003|Double-Blind, 6 Months|Fear of experiencing AE again|0|||
147572163|NCT00318461|532252340|FG004|Double-Blind, 6 Months|Fear of experiencing AE again|0|||
147572164|NCT00318461|532252336|FG000|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|19|||
147572165|NCT00318461|532252337|FG001|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|14|||
147137126|NCT03391882|530669991|FG002|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|0|||
147237511|NCT00002651|531040641|FG001|Induction|Progression/relapse|0|||
147572166|NCT00318461|532252338|FG002|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|27|||
147572167|NCT00318461|532252339|FG003|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|11|||
147572168|NCT00318461|532252340|FG004|Open-Label Extension, 18 Months|Withdrawals between 6 and 24 months|22|||
147572169|NCT00318461|532252336|FG000|Open-Label Extension, 18 Months|Adverse Event|11|||
147572170|NCT00318461|532252337|FG001|Open-Label Extension, 18 Months|Adverse Event|8|||
147137127|NCT03391882|530669992|FG003|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|0|||
147137128|NCT03391882|530669993|FG004|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|0|||
147137129|NCT03391882|530669994|FG005|Part A - Titration Phase|EARLY TERM AT SPONSOR REQUEST|0|||
147137130|NCT03391882|530669989|FG000|Post Part A / Pre Part B|Lack of Efficacy|1|||
147137131|NCT03391882|530669990|FG001|Post Part A / Pre Part B|Lack of Efficacy|3|||
147137132|NCT03391882|530669991|FG002|Post Part A / Pre Part B|Lack of Efficacy|0|||
147137133|NCT03391882|530669992|FG003|Post Part A / Pre Part B|Lack of Efficacy|0|||
147137134|NCT03391882|530669993|FG004|Post Part A / Pre Part B|Lack of Efficacy|0|||
147137135|NCT03391882|530669994|FG005|Post Part A / Pre Part B|Lack of Efficacy|0|||
147137136|NCT03391882|530669989|FG000|Post Part A / Pre Part B|Protocol Violation|1|||
147137137|NCT03391882|530669990|FG001|Post Part A / Pre Part B|Protocol Violation|0|||
147137138|NCT03391882|530669991|FG002|Post Part A / Pre Part B|Protocol Violation|0|||
147137139|NCT03391882|530669992|FG003|Post Part A / Pre Part B|Protocol Violation|0|||
147137140|NCT03391882|530669993|FG004|Post Part A / Pre Part B|Protocol Violation|0|||
147137141|NCT03391882|530669994|FG005|Post Part A / Pre Part B|Protocol Violation|0|||
147137142|NCT03391882|530669989|FG000|Part B - Treatment Phase|Adverse Event|0|||
147137143|NCT03391882|530669990|FG001|Part B - Treatment Phase|Adverse Event|0|||
147137144|NCT03391882|530669991|FG002|Part B - Treatment Phase|Adverse Event|1|||
147137145|NCT03391882|530669992|FG003|Part B - Treatment Phase|Adverse Event|1|||
147137146|NCT03391882|530669993|FG004|Part B - Treatment Phase|Adverse Event|3|||
147137147|NCT03391882|530669994|FG005|Part B - Treatment Phase|Adverse Event|1|||
147137148|NCT03391882|530669989|FG000|Part B - Treatment Phase|Withdrawal by Subject|0|||
147137149|NCT03391882|530669990|FG001|Part B - Treatment Phase|Withdrawal by Subject|0|||
147137150|NCT03391882|530669991|FG002|Part B - Treatment Phase|Withdrawal by Subject|2|||
147137151|NCT03391882|530669992|FG003|Part B - Treatment Phase|Withdrawal by Subject|2|||
147137152|NCT03391882|530669993|FG004|Part B - Treatment Phase|Withdrawal by Subject|1|||
147137153|NCT03391882|530669994|FG005|Part B - Treatment Phase|Withdrawal by Subject|3|||
147137154|NCT00543985|530669995|FG000|Overall Study|Withdrawal by Subject|4|||
147137155|NCT01280968|530669996|FG000|Overall Study|Lost to Follow-up|8|||
147137156|NCT01280968|530669997|FG001|Overall Study|Lost to Follow-up|2|||
147137157|NCT01280968|530669996|FG000|Overall Study|Unable to Follow Experimental Protocol|2|||
147137158|NCT01280968|530669997|FG001|Overall Study|Unable to Follow Experimental Protocol|0|||
147137159|NCT01280968|530669996|FG000|Overall Study|Commuting Problems|2|||
147137160|NCT01280968|530669997|FG001|Overall Study|Commuting Problems|0|||
147137161|NCT01280968|530669996|FG000|Overall Study|Anxiety|2|||
147137162|NCT01280968|530669997|FG001|Overall Study|Anxiety|0|||
147137163|NCT01280968|530669996|FG000|Overall Study|Adverse Event|1|||
147137164|NCT01280968|530669997|FG001|Overall Study|Adverse Event|0|||
147137165|NCT01280968|530669996|FG000|Overall Study|Scheduling Conflicts|1|||
147572171|NCT00318461|532252338|FG002|Open-Label Extension, 18 Months|Adverse Event|6|||
147572172|NCT00318461|532252339|FG003|Open-Label Extension, 18 Months|Adverse Event|1|||
147572173|NCT00318461|532252340|FG004|Open-Label Extension, 18 Months|Adverse Event|6|||
147572174|NCT00318461|532252336|FG000|Open-Label Extension, 18 Months|Lack of Efficacy|41|||
147572175|NCT00318461|532252337|FG001|Open-Label Extension, 18 Months|Lack of Efficacy|33|||
147572176|NCT00318461|532252338|FG002|Open-Label Extension, 18 Months|Lack of Efficacy|37|||
147572177|NCT00318461|532252339|FG003|Open-Label Extension, 18 Months|Lack of Efficacy|27|||
147572178|NCT00318461|532252340|FG004|Open-Label Extension, 18 Months|Lack of Efficacy|63|||
147572179|NCT00318461|532252336|FG000|Open-Label Extension, 18 Months|Protocol Violation|7|||
147572180|NCT00318461|532252337|FG001|Open-Label Extension, 18 Months|Protocol Violation|5|||
147572181|NCT00318461|532252338|FG002|Open-Label Extension, 18 Months|Protocol Violation|3|||
147572182|NCT00318461|532252339|FG003|Open-Label Extension, 18 Months|Protocol Violation|4|||
147572183|NCT00318461|532252340|FG004|Open-Label Extension, 18 Months|Protocol Violation|6|||
147572184|NCT01848938|532252349|FG000|Overall Study|Lost to Follow-up|1|||
147572185|NCT01848938|532252350|FG001|Overall Study|Lost to Follow-up|1|||
147572186|NCT01757392|532252351|FG000|Overall Study|Withdrawal by Subject|1|||
147137166|NCT01280968|530669997|FG001|Overall Study|Scheduling Conflicts|1|||
147137167|NCT01280968|530669996|FG000|Overall Study|Pre-existing Neurological Condition|1|||
147137168|NCT01280968|530669997|FG001|Overall Study|Pre-existing Neurological Condition|0|||
147137169|NCT01280968|530669996|FG000|Overall Study|Unable to Smoke in Supine Position|1|||
147137170|NCT01280968|530669997|FG001|Overall Study|Unable to Smoke in Supine Position|0|||
147237512|NCT00002651|531040642|FG002|Induction|Progression/relapse|0|||
147237513|NCT00002651|531040640|FG000|Induction|Death|62|||
147237514|NCT00002651|531040641|FG001|Induction|Death|0|||
147237515|NCT00002651|531040642|FG002|Induction|Death|0|||
147237516|NCT00002651|531040640|FG000|Induction|Other|823|||
147572187|NCT01757392|532252351|FG000|Overall Study|Screen Fail|3|||
147572188|NCT00207090|532252356|FG000|Overall Study|Study drug toxicity|3|||
147572189|NCT00207090|532252356|FG000|Overall Study|Chest wall mass larger|1|||
147572190|NCT00207090|532252356|FG000|Overall Study|Disease progression/relapse|2|||
147572191|NCT00207090|532252356|FG000|Overall Study|Physician Decision|1|||
147237517|NCT00002651|531040641|FG001|Induction|Other|0|||
147237518|NCT00002651|531040642|FG002|Induction|Other|0|||
147572192|NCT00841698|532252359|FG000|First Intervention|Withdrawal by Subject|1|||
147572193|NCT00841698|532252360|FG001|First Intervention|Withdrawal by Subject|0|||
147572194|NCT01348789|532252365|FG000|Overall Study|Protocol Violation|2|||
147572195|NCT01348789|532252365|FG000|Overall Study|Withdrawal by Subject|2|||
147572196|NCT00323882|532252366|FG000|Overall Study|Adverse Event|2|||
147572197|NCT00323882|532252367|FG001|Overall Study|Adverse Event|1|||
147572198|NCT00323882|532252368|FG002|Overall Study|Adverse Event|1|||
147572199|NCT00323882|532252369|FG003|Overall Study|Adverse Event|1|||
147572200|NCT00323882|532252370|FG004|Overall Study|Adverse Event|3|||
147572201|NCT00323882|532252366|FG000|Overall Study|Disease Progression|6|||
147572202|NCT00323882|532252367|FG001|Overall Study|Disease Progression|4|||
147572203|NCT00323882|532252368|FG002|Overall Study|Disease Progression|10|||
147572204|NCT00323882|532252369|FG003|Overall Study|Disease Progression|5|||
147572205|NCT00323882|532252370|FG004|Overall Study|Disease Progression|22|||
147572206|NCT00323882|532252366|FG000|Overall Study|Death|0|||
147572207|NCT00323882|532252367|FG001|Overall Study|Death|1|||
147572208|NCT00323882|532252368|FG002|Overall Study|Death|1|||
147572209|NCT00323882|532252369|FG003|Overall Study|Death|0|||
147572210|NCT00323882|532252370|FG004|Overall Study|Death|5|||
147572211|NCT00323882|532252366|FG000|Overall Study|Lost to Follow-up|0|||
147572212|NCT00323882|532252367|FG001|Overall Study|Lost to Follow-up|0|||
147572213|NCT00323882|532252368|FG002|Overall Study|Lost to Follow-up|1|||
147572214|NCT00323882|532252369|FG003|Overall Study|Lost to Follow-up|0|||
147572215|NCT00323882|532252370|FG004|Overall Study|Lost to Follow-up|1|||
147572216|NCT00323882|532252366|FG000|Overall Study|Other|0|||
147572217|NCT00323882|532252367|FG001|Overall Study|Other|0|||
147572218|NCT00323882|532252368|FG002|Overall Study|Other|0|||
147572219|NCT00323882|532252369|FG003|Overall Study|Other|1|||
147572220|NCT00323882|532252370|FG004|Overall Study|Other|1|||
147572221|NCT00429416|532252377|FG000|Overall Study|Death|1|||
147572222|NCT00830024|532252378|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
147651810|NCT01483599|532546587|FG007|Controlled Period (CP) (up to Week 16)|Other|0|||
147651811|NCT01483599|532546588|FG008|Controlled Period (CP) (up to Week 16)|Other|0|||
147137171|NCT00038948|530669998|FG000|Overall Study|Adverse Event|131|||
147137172|NCT00038948|530669999|FG001|Overall Study|Adverse Event|43|||
147137173|NCT00038948|530669998|FG000|Overall Study|Lost to Follow-up|4|||
147137174|NCT00038948|530669999|FG001|Overall Study|Lost to Follow-up|4|||
147137175|NCT00038948|530669998|FG000|Overall Study|Nonmedical event|5|||
147137176|NCT00038948|530669999|FG001|Overall Study|Nonmedical event|7|||
147137177|NCT00038948|530669998|FG000|Overall Study|Withdrawal by Subject|23|||
147137178|NCT00038948|530669999|FG001|Overall Study|Withdrawal by Subject|10|||
147137179|NCT00038948|530669998|FG000|Overall Study|Protocol Violation|3|||
147137180|NCT00038948|530669999|FG001|Overall Study|Protocol Violation|7|||
147137181|NCT00038948|530669998|FG000|Overall Study|Lack of Efficacy|3|||
147137182|NCT00038948|530669999|FG001|Overall Study|Lack of Efficacy|6|||
147137183|NCT02670473|530670000|FG000|Overall Study|Withdrawal by Subject|1|||
147137184|NCT01404234|530670001|FG000|Overall Study|Withdrawal by Subject|2|||
147651812|NCT01483599|532546589|FG009|Controlled Period (CP) (up to Week 16)|Other|0|||
147651813|NCT01483599|532546590|FG010|Controlled Period (CP) (up to Week 16)|Other|0|||
147137185|NCT01214837|530670002|FG000|Overall Study|Death|0|||
147137186|NCT01214837|530670003|FG001|Overall Study|Death|0|||
147137187|NCT01214837|530670004|FG002|Overall Study|Death|1|||
147137188|NCT01214837|530670002|FG000|Overall Study|Adverse Event|1|||
147137189|NCT01214837|530670003|FG001|Overall Study|Adverse Event|2|||
147572223|NCT00830024|532252379|FG001|Washout: 7 Days|Withdrawal by Subject|0|||
147572224|NCT02619682|532252380|FG000|Overall Study|Withdrawal by Subject|3|||
147572225|NCT02619682|532252380|FG000|Overall Study|Lack of Efficacy|8|||
147572226|NCT02619682|532252380|FG000|Overall Study|new secondary cancer|1|||
147572227|NCT02619682|532252380|FG000|Overall Study|post surgery complications|2|||
147572228|NCT03600376|532252381|FG000|Overall Study|Adverse Event|1|||
147572229|NCT03600376|532252382|FG001|Overall Study|Adverse Event|1|||
147572230|NCT03600376|532252381|FG000|Overall Study|Transferred to other facility|1|||
147572231|NCT03600376|532252382|FG001|Overall Study|Transferred to other facility|0|||
147572232|NCT03600376|532252381|FG000|Overall Study|Investigator Decision|0|||
147572233|NCT03600376|532252382|FG001|Overall Study|Investigator Decision|4|||
147572234|NCT03600376|532252381|FG000|Overall Study|Determined to be ineligible for study|0|||
147572235|NCT03600376|532252382|FG001|Overall Study|Determined to be ineligible for study|1|||
147572236|NCT02358538|532252383|FG000|Through Week 26|Adverse Event|0|||
147572237|NCT02358538|532252384|FG001|Through Week 26|Adverse Event|1|||
147572238|NCT02358538|532252385|FG002|Through Week 26|Adverse Event|1|||
147572239|NCT02358538|532252386|FG003|Through Week 26|Adverse Event|2|||
147572240|NCT02358538|532252383|FG000|Through Week 26|Lack of Efficacy|1|||
147572241|NCT02358538|532252384|FG001|Through Week 26|Lack of Efficacy|1|||
147572242|NCT02358538|532252385|FG002|Through Week 26|Lack of Efficacy|3|||
147572243|NCT02358538|532252386|FG003|Through Week 26|Lack of Efficacy|3|||
147572244|NCT02358538|532252383|FG000|Through Week 26|Withdrawal by Subject|1|||
147318396|NCT02448719|531331707|FG007|Overall Study|Withdrawal by Subject|0|||
147137190|NCT01214837|530670004|FG002|Overall Study|Adverse Event|1|||
147137191|NCT01214837|530670002|FG000|Overall Study|Withdrawal by Subject|27|||
147572245|NCT02358538|532252384|FG001|Through Week 26|Withdrawal by Subject|0|||
147137192|NCT01214837|530670003|FG001|Overall Study|Withdrawal by Subject|36|||
147137193|NCT01214837|530670004|FG002|Overall Study|Withdrawal by Subject|28|||
147137194|NCT01214837|530670002|FG000|Overall Study|Lost to Follow-up|20|||
147137195|NCT01214837|530670003|FG001|Overall Study|Lost to Follow-up|15|||
147137196|NCT01214837|530670004|FG002|Overall Study|Lost to Follow-up|21|||
147137197|NCT01214837|530670002|FG000|Overall Study|Inappropriate Enrolment|0|||
147137198|NCT01214837|530670003|FG001|Overall Study|Inappropriate Enrolment|1|||
147137199|NCT01214837|530670004|FG002|Overall Study|Inappropriate Enrolment|2|||
147137200|NCT01214837|530670002|FG000|Overall Study|Administrative Reason|2|||
147137201|NCT01214837|530670003|FG001|Overall Study|Administrative Reason|6|||
147137202|NCT01214837|530670004|FG002|Overall Study|Administrative Reason|4|||
147137203|NCT01214837|530670002|FG000|Overall Study|Protocol Violation|3|||
147137204|NCT01214837|530670003|FG001|Overall Study|Protocol Violation|1|||
147137205|NCT01214837|530670004|FG002|Overall Study|Protocol Violation|5|||
147137206|NCT01214837|530670002|FG000|Overall Study|Unable to Classify|1|||
147137207|NCT01214837|530670003|FG001|Overall Study|Unable to Classify|3|||
147137208|NCT01214837|530670004|FG002|Overall Study|Unable to Classify|0|||
147137209|NCT00887159|530671855|FG000|Overall Study|Disease progression|6|||
147137210|NCT00887159|530671856|FG001|Overall Study|Disease progression|39|||
147137211|NCT00887159|530671857|FG002|Overall Study|Disease progression|33|||
147137212|NCT00887159|530671855|FG000|Overall Study|Adverse Event|3|||
147137213|NCT00887159|530671856|FG001|Overall Study|Adverse Event|4|||
147137214|NCT00887159|530671857|FG002|Overall Study|Adverse Event|17|||
147137215|NCT00887159|530671855|FG000|Overall Study|Death|2|||
147137216|NCT00887159|530671856|FG001|Overall Study|Death|2|||
147137217|NCT00887159|530671857|FG002|Overall Study|Death|0|||
147137218|NCT00887159|530671855|FG000|Overall Study|Withdrawal by Subject|4|||
147137219|NCT00887159|530671856|FG001|Overall Study|Withdrawal by Subject|4|||
147137220|NCT00887159|530671857|FG002|Overall Study|Withdrawal by Subject|2|||
147137221|NCT00887159|530671855|FG000|Overall Study|Alternative therapy|2|||
147137222|NCT00887159|530671856|FG001|Overall Study|Alternative therapy|0|||
147137223|NCT00887159|530671857|FG002|Overall Study|Alternative therapy|0|||
147137224|NCT00887159|530671855|FG000|Overall Study|Physician Decision|1|||
147137225|NCT00887159|530671856|FG001|Overall Study|Physician Decision|1|||
147137226|NCT00887159|530671857|FG002|Overall Study|Physician Decision|0|||
147137227|NCT00887159|530671855|FG000|Overall Study|Sympomatic deterioration|1|||
147137228|NCT00887159|530671856|FG001|Overall Study|Sympomatic deterioration|0|||
147137229|NCT00887159|530671857|FG002|Overall Study|Sympomatic deterioration|0|||
147318397|NCT02448719|531331708|FG008|Overall Study|Withdrawal by Subject|0|||
147318398|NCT02448719|531331709|FG009|Overall Study|Withdrawal by Subject|0|||
147137230|NCT00887159|530671855|FG000|Overall Study|Treatment delayed|1|||
147137231|NCT00887159|530671856|FG001|Overall Study|Treatment delayed|1|||
147137232|NCT00887159|530671857|FG002|Overall Study|Treatment delayed|0|||
147137233|NCT00887159|530671855|FG000|Overall Study|Pt had PD but was SD when re-measured|0|||
147137234|NCT00887159|530671856|FG001|Overall Study|Pt had PD but was SD when re-measured|1|||
147137235|NCT00887159|530671857|FG002|Overall Study|Pt had PD but was SD when re-measured|0|||
147137236|NCT00887159|530671855|FG000|Overall Study|Received more tx instead of observation|1|||
147137237|NCT00887159|530671856|FG001|Overall Study|Received more tx instead of observation|0|||
147137238|NCT00887159|530671857|FG002|Overall Study|Received more tx instead of observation|0|||
147137239|NCT00887159|530671855|FG000|Overall Study|Ineligible|5|||
147137240|NCT00887159|530671856|FG001|Overall Study|Ineligible|1|||
147137241|NCT00887159|530671857|FG002|Overall Study|Ineligible|0|||
147137242|NCT00887159|530671855|FG000|Overall Study|Never started assigned therapy|3|||
147137243|NCT00887159|530671856|FG001|Overall Study|Never started assigned therapy|3|||
147137244|NCT00887159|530671857|FG002|Overall Study|Never started assigned therapy|4|||
147137245|NCT06164691|530671860|FG000|Overall Study|Withdrawal by Subject|2|||
147137246|NCT06164691|530671861|FG001|Overall Study|Withdrawal by Subject|0|||
147137247|NCT06164691|530671862|FG002|Overall Study|Withdrawal by Subject|0|||
147137248|NCT00812955|530671863|FG000|Overall Study|Adverse Event|7|||
147137249|NCT00812955|530671864|FG001|Overall Study|Adverse Event|6|||
147137250|NCT00812955|530671865|FG002|Overall Study|Adverse Event|3|||
147137251|NCT00812955|530671866|FG003|Overall Study|Adverse Event|4|||
147137252|NCT00812955|530671863|FG000|Overall Study|Lost to Follow-up|2|||
147445644|NCT03200366|531797423|FG000|Patient Navigation Intervention Given|Not attempted/missed by nurse|0|||
147445645|NCT03200366|531797424|FG001|Patient Navigation Intervention Given|Not attempted/missed by nurse|1|||
147445646|NCT03200366|531797425|FG002|Patient Navigation Intervention Given|Not attempted/missed by nurse|0|||
147137253|NCT00812955|530671864|FG001|Overall Study|Lost to Follow-up|1|||
147137254|NCT00812955|530671865|FG002|Overall Study|Lost to Follow-up|1|||
147137255|NCT00812955|530671866|FG003|Overall Study|Lost to Follow-up|2|||
147137256|NCT00812955|530671863|FG000|Overall Study|Withdrawal by Subject|1|||
147137257|NCT00812955|530671864|FG001|Overall Study|Withdrawal by Subject|0|||
147137258|NCT00812955|530671865|FG002|Overall Study|Withdrawal by Subject|1|||
147137259|NCT00812955|530671866|FG003|Overall Study|Withdrawal by Subject|2|||
147137260|NCT00812955|530671863|FG000|Overall Study|randomized in error|0|||
147137261|NCT00812955|530671864|FG001|Overall Study|randomized in error|0|||
147137262|NCT00812955|530671865|FG002|Overall Study|randomized in error|1|||
147137263|NCT00812955|530671866|FG003|Overall Study|randomized in error|0|||
147137264|NCT01673646|530671871|FG000|Overall Study|Adverse Event|2|||
147137265|NCT01673646|530671872|FG001|Overall Study|Adverse Event|1|||
147137266|NCT01673646|530671873|FG002|Overall Study|Adverse Event|1|||
147137267|NCT01673646|530671871|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
147137268|NCT01673646|530671872|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
147137269|NCT01673646|530671873|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
147137270|NCT01673646|530671871|FG000|Overall Study|Condition no longer requires study drug|0|||
147137271|NCT01673646|530671872|FG001|Overall Study|Condition no longer requires study drug|1|||
147137272|NCT01673646|530671873|FG002|Overall Study|Condition no longer requires study drug|0|||
147137273|NCT01673646|530671871|FG000|Overall Study|Withdrawal by Subject|0|||
147137274|NCT01673646|530671872|FG001|Overall Study|Withdrawal by Subject|2|||
147137275|NCT01673646|530671873|FG002|Overall Study|Withdrawal by Subject|2|||
147137276|NCT01673646|530671871|FG000|Overall Study|Completed Core/did not enter Ext.|2|||
147137277|NCT01673646|530671872|FG001|Overall Study|Completed Core/did not enter Ext.|1|||
147137278|NCT01673646|530671873|FG002|Overall Study|Completed Core/did not enter Ext.|1|||
147137279|NCT01063348|530671874|FG000|Overall Study|Lost to Follow-up|3|||
147137280|NCT01063348|530671875|FG001|Overall Study|Lost to Follow-up|10|||
147137281|NCT00269087|530671876|FG000|Overall Study|Adverse Event|20|||
147137282|NCT00269087|530671876|FG000|Overall Study|Withdrawal by Subject|1|||
147137283|NCT00269087|530671876|FG000|Overall Study|Exacerbation of COPD|13|||
147137284|NCT00461708|530671881|FG000|Overall Study|Adverse Event|17|||
147137285|NCT00461708|530671882|FG001|Overall Study|Adverse Event|7|||
147137286|NCT00461708|530671881|FG000|Overall Study|Lack of Efficacy|68|||
147137287|NCT00461708|530671882|FG001|Overall Study|Lack of Efficacy|20|||
147137288|NCT00461708|530671881|FG000|Overall Study|Physician Decision|10|||
147137289|NCT00461708|530671882|FG001|Overall Study|Physician Decision|4|||
147137290|NCT00461708|530671881|FG000|Overall Study|Withdrawal by Subject|8|||
147137291|NCT00461708|530671882|FG001|Overall Study|Withdrawal by Subject|2|||
147137292|NCT00461708|530671881|FG000|Overall Study|Other|4|||
147137293|NCT00461708|530671882|FG001|Overall Study|Other|4|||
147137294|NCT00461708|530671881|FG000|Overall Study|Death|8|||
147137295|NCT00461708|530671882|FG001|Overall Study|Death|1|||
147137296|NCT00501644|530671883|FG000|Overall Study|Adverse Event|4|||
147137297|NCT00501644|530671883|FG000|Overall Study|Withdrawal by Subject|1|||
147137298|NCT02394561|530671884|FG000|CORE Phase|Adverse Event|7|||
147237519|NCT00002651|531040640|FG000|Induction|not eligible|90|||
147237520|NCT00002651|531040641|FG001|Induction|not eligible|0|||
147237521|NCT00002651|531040642|FG002|Induction|not eligible|0|||
147237522|NCT00002651|531040640|FG000|Consolidation and Randomization|Adverse Event|0|||
147237523|NCT00002651|531040641|FG001|Consolidation and Randomization|Adverse Event|36|||
147237524|NCT00002651|531040642|FG002|Consolidation and Randomization|Adverse Event|14|||
147237525|NCT00002651|531040640|FG000|Consolidation and Randomization|Refusal unrelated to adverse event|0|||
147237526|NCT00002651|531040641|FG001|Consolidation and Randomization|Refusal unrelated to adverse event|53|||
147237527|NCT00002651|531040642|FG002|Consolidation and Randomization|Refusal unrelated to adverse event|75|||
147237528|NCT00002651|531040640|FG000|Consolidation and Randomization|Progression/relapse|0|||
147237529|NCT00002651|531040641|FG001|Consolidation and Randomization|Progression/relapse|295|||
147237530|NCT00002651|531040642|FG002|Consolidation and Randomization|Progression/relapse|298|||
147237531|NCT00002651|531040640|FG000|Consolidation and Randomization|Death|0|||
147237532|NCT00002651|531040641|FG001|Consolidation and Randomization|Death|38|||
147237533|NCT00002651|531040642|FG002|Consolidation and Randomization|Death|48|||
147237534|NCT00002651|531040640|FG000|Consolidation and Randomization|Other|0|||
147237535|NCT00002651|531040641|FG001|Consolidation and Randomization|Other|314|||
147237536|NCT00002651|531040642|FG002|Consolidation and Randomization|Other|313|||
147237537|NCT00002651|531040640|FG000|Consolidation and Randomization|not eligible|0|||
147237538|NCT00002651|531040641|FG001|Consolidation and Randomization|not eligible|102|||
147237539|NCT00002651|531040642|FG002|Consolidation and Randomization|not eligible|112|||
147237540|NCT03750955|531040643|FG000|Hygiene Phase of 2 Weeks|Withdrawal by Subject|2|||
147237541|NCT03750955|531040644|FG001|Hygiene Phase of 2 Weeks|Withdrawal by Subject|2|||
147237542|NCT03750955|531040643|FG000|Hygiene Phase of 2 Weeks|Not eligible at Baseline (start of gingivitis induction phase)|1|||
147237543|NCT03750955|531040644|FG001|Hygiene Phase of 2 Weeks|Not eligible at Baseline (start of gingivitis induction phase)|1|||
147137299|NCT02394561|530671885|FG001|CORE Phase|Adverse Event|9|||
147137300|NCT02394561|530671884|FG000|CORE Phase|Death|0|||
147137301|NCT02394561|530671885|FG001|CORE Phase|Death|1|||
147137302|NCT02394561|530671884|FG000|CORE Phase|Pregnancy|1|||
147137303|NCT02394561|530671885|FG001|CORE Phase|Pregnancy|0|||
147137304|NCT02394561|530671884|FG000|CORE Phase|Lost to Follow-up|1|||
147137305|NCT02394561|530671885|FG001|CORE Phase|Lost to Follow-up|0|||
147137306|NCT02394561|530671884|FG000|CORE Phase|Physician Decision|1|||
147137307|NCT02394561|530671885|FG001|CORE Phase|Physician Decision|1|||
147572246|NCT02358538|532252385|FG002|Through Week 26|Withdrawal by Subject|0|||
147137308|NCT02394561|530671884|FG000|CORE Phase|Withdrawal by Subject|2|||
147572247|NCT02358538|532252386|FG003|Through Week 26|Withdrawal by Subject|0|||
147572248|NCT02358538|532252383|FG000|Through Week 26|Non-Compliance|0|||
147137309|NCT02394561|530671885|FG001|CORE Phase|Withdrawal by Subject|2|||
147572249|NCT02358538|532252384|FG001|Through Week 26|Non-Compliance|0|||
147572250|NCT02358538|532252385|FG002|Through Week 26|Non-Compliance|1|||
147572251|NCT02358538|532252386|FG003|Through Week 26|Non-Compliance|0|||
147572252|NCT02358538|532252383|FG000|Through Week 26|Family did not see benefit from IP|1|||
147572253|NCT02358538|532252384|FG001|Through Week 26|Family did not see benefit from IP|0|||
147572254|NCT02358538|532252385|FG002|Through Week 26|Family did not see benefit from IP|0|||
147572255|NCT02358538|532252386|FG003|Through Week 26|Family did not see benefit from IP|0|||
147572256|NCT02358538|532252383|FG000|52 Week Extension Period|Lack of Efficacy|0|||
147572257|NCT02358538|532252384|FG001|52 Week Extension Period|Lack of Efficacy|0|||
147572258|NCT02358538|532252385|FG002|52 Week Extension Period|Lack of Efficacy|2|||
147572259|NCT02358538|532252386|FG003|52 Week Extension Period|Lack of Efficacy|4|||
147572260|NCT06999265|532252387|FG000|Overall Study|Lost to Follow-up|1|||
147572261|NCT06999265|532252388|FG001|Overall Study|Lost to Follow-up|1|||
147572262|NCT02178787|532252389|FG000|Overall Study|Lost to Follow-up|1|||
147572263|NCT02178787|532252390|FG001|Overall Study|Lost to Follow-up|0|||
147572264|NCT02178787|532252389|FG000|Overall Study|Withdrawal by Subject|0|||
147572265|NCT02178787|532252390|FG001|Overall Study|Withdrawal by Subject|2|||
147572266|NCT02178787|532252389|FG000|Overall Study|No TCD window|3|||
147572267|NCT02178787|532252390|FG001|Overall Study|No TCD window|7|||
147572268|NCT02178787|532252389|FG000|Overall Study|Physician Decision|1|||
147572269|NCT02178787|532252390|FG001|Overall Study|Physician Decision|0|||
147572270|NCT02554890|532252391|FG000|Double-blind|Adverse Event|45|||
147572271|NCT02554890|532252392|FG001|Double-blind|Adverse Event|51|||
147572272|NCT02554890|532252391|FG000|Double-blind|Death|6|||
147572273|NCT02554890|532252392|FG001|Double-blind|Death|4|||
147572274|NCT02554890|532252391|FG000|Double-blind|Protocol Violation|1|||
147572275|NCT02554890|532252392|FG001|Double-blind|Protocol Violation|1|||
147572276|NCT02554890|532252391|FG000|Double-blind|Physician Decision|4|||
147572277|NCT02554890|532252392|FG001|Double-blind|Physician Decision|3|||
147572278|NCT02554890|532252391|FG000|Double-blind|Subject/Guardian decision|21|||
147572279|NCT02554890|532252392|FG001|Double-blind|Subject/Guardian decision|16|||
147572280|NCT02554890|532252391|FG000|Double-blind|Lost to Follow-up|7|||
147572281|NCT02554890|532252392|FG001|Double-blind|Lost to Follow-up|5|||
147572282|NCT02554890|532252391|FG000|Double-blind|Technical problems|1|||
147572283|NCT02554890|532252392|FG001|Double-blind|Technical problems|0|||
147572284|NCT02554890|532252391|FG000|Double-blind|Withdrawal by Subject|5|||
147572285|NCT02554890|532252392|FG001|Double-blind|Withdrawal by Subject|6|||
147572286|NCT02554890|532252391|FG000|Double-blind|Noncompliance with study treatment|6|||
147572287|NCT02554890|532252392|FG001|Double-blind|Noncompliance with study treatment|5|||
147572288|NCT02554890|532252391|FG000|Open-label|Adverse Event|0|||
147572289|NCT02554890|532252392|FG001|Open-label|Adverse Event|30|||
147572290|NCT02554890|532252391|FG000|Open-label|Death|0|||
147572291|NCT02554890|532252392|FG001|Open-label|Death|1|||
147445647|NCT03200366|531797423|FG000|Patient Navigation Intervention Given|Colonoscopy already re-scheduled and completed|0|||
147445648|NCT03200366|531797424|FG001|Patient Navigation Intervention Given|Colonoscopy already re-scheduled and completed|2|||
147572292|NCT02554890|532252391|FG000|Open-label|Physician Decision|0|||
147572293|NCT02554890|532252392|FG001|Open-label|Physician Decision|1|||
147572294|NCT02554890|532252391|FG000|Open-label|Subject/Guardian decision|0|||
147572295|NCT02554890|532252392|FG001|Open-label|Subject/Guardian decision|11|||
147572296|NCT02554890|532252391|FG000|Open-label|Lost to Follow-up|0|||
147572297|NCT02554890|532252392|FG001|Open-label|Lost to Follow-up|7|||
147572298|NCT02554890|532252391|FG000|Open-label|Technical problems|0|||
147572299|NCT02554890|532252392|FG001|Open-label|Technical problems|1|||
147572300|NCT02554890|532252391|FG000|Open-label|Withdrawal by Subject|0|||
147572301|NCT02554890|532252392|FG001|Open-label|Withdrawal by Subject|1|||
147572302|NCT03649477|532252398|FG000|Overall Study|Adverse Event|2|||
147572303|NCT03649477|532252399|FG001|Overall Study|Adverse Event|0|||
147572304|NCT03649477|532252400|FG002|Overall Study|Adverse Event|0|||
147572305|NCT01030133|532252401|FG000|Overall Study|failed to experience pain at level 7/10|2|||
147572306|NCT01030133|532252402|FG001|Overall Study|failed to experience pain at level 7/10|2|||
147572307|NCT01750294|532253695|FG000|Overall Study|Withdrawal by Subject|1|||
147572308|NCT01750294|532253695|FG000|Overall Study|Safety Endpoint|1|||
147572309|NCT01116739|532253696|FG000|Overall Study|Child had 2 years of HS|110|||
147572310|NCT01116739|532253697|FG001|Overall Study|Child had 2 years of HS|128|||
147572311|NCT01116739|532253696|FG000|Overall Study|Withdrawal by Subject|6|||
147318399|NCT02448719|531331710|FG010|Overall Study|Withdrawal by Subject|0|||
147318400|NCT01473420|531331713|FG000|Titration Period (18 Weeks)|Adverse Event|4|||
147572312|NCT01116739|532253697|FG001|Overall Study|Withdrawal by Subject|0|||
147572313|NCT01116739|532253696|FG000|Overall Study|child too young|2|||
147572314|NCT01116739|532253697|FG001|Overall Study|child too young|6|||
147572315|NCT01116739|532253696|FG000|Overall Study|child not enrolled in head start|10|||
147572316|NCT01116739|532253697|FG001|Overall Study|child not enrolled in head start|2|||
147572317|NCT01116739|532253696|FG000|Overall Study|enrolled caregiver not legal guardian|2|||
147572318|NCT01116739|532253697|FG001|Overall Study|enrolled caregiver not legal guardian|0|||
147572319|NCT01624233|532253698|FG000|Period 2 - Induction|Adverse Event|1|||
147572320|NCT01624233|532253698|FG000|Period 3 - Maintenance|Adverse Event|2|||
147572321|NCT01624233|532253698|FG000|Period 3 - Maintenance|Lack of Efficacy|1|||
147572322|NCT01624233|532253698|FG000|Period 3 - Maintenance|Physician Decision|2|||
147572323|NCT01624233|532253698|FG000|Period 3 - Maintenance|Withdrawal by Subject|2|||
147137310|NCT02394561|530671884|FG000|CORE Phase|Lack of Efficacy|1|||
147137311|NCT02394561|530671885|FG001|CORE Phase|Lack of Efficacy|6|||
147137312|NCT02394561|530671884|FG000|Extension Phase|Adverse Event|6|||
147137313|NCT02394561|530671885|FG001|Extension Phase|Adverse Event|1|||
147137314|NCT02394561|530671884|FG000|Extension Phase|Death|0|||
147137315|NCT02394561|530671885|FG001|Extension Phase|Death|1|||
147137316|NCT02394561|530671884|FG000|Extension Phase|Protocol Violation|1|||
147137317|NCT02394561|530671885|FG001|Extension Phase|Protocol Violation|0|||
147137318|NCT02394561|530671884|FG000|Extension Phase|Lost to Follow-up|1|||
147137319|NCT02394561|530671885|FG001|Extension Phase|Lost to Follow-up|0|||
147137320|NCT02394561|530671884|FG000|Extension Phase|Physician Decision|0|||
147137321|NCT02394561|530671885|FG001|Extension Phase|Physician Decision|2|||
147137322|NCT02394561|530671884|FG000|Extension Phase|Withdrawal by Subject|0|||
147137323|NCT02394561|530671885|FG001|Extension Phase|Withdrawal by Subject|5|||
147137324|NCT02394561|530671884|FG000|Extension Phase|Lack of Efficacy|3|||
147137325|NCT02394561|530671885|FG001|Extension Phase|Lack of Efficacy|3|||
147137326|NCT01464879|530671886|FG000|Overall Study|Physician Decision|1|||
147137327|NCT01464879|530671886|FG000|Overall Study|Non-compliance|1|||
147137328|NCT03937479|530671891|FG000|Overall Study|Adverse Event|2|||
147137329|NCT03937479|530671892|FG001|Overall Study|Adverse Event|3|||
147137330|NCT03937479|530671893|FG002|Overall Study|Adverse Event|0|||
147137331|NCT03937479|530671894|FG003|Overall Study|Adverse Event|0|||
147137332|NCT03937479|530671895|FG004|Overall Study|Adverse Event|1|||
147137333|NCT03937479|530671891|FG000|Overall Study|Withdrawal by Subject|3|||
147137334|NCT03937479|530671892|FG001|Overall Study|Withdrawal by Subject|5|||
147137335|NCT03937479|530671893|FG002|Overall Study|Withdrawal by Subject|2|||
147137336|NCT03937479|530671894|FG003|Overall Study|Withdrawal by Subject|2|||
147137337|NCT03937479|530671895|FG004|Overall Study|Withdrawal by Subject|1|||
147137338|NCT03937479|530671891|FG000|Overall Study|Protocol Violation|5|||
147137339|NCT03937479|530671892|FG001|Overall Study|Protocol Violation|6|||
147137340|NCT03937479|530671893|FG002|Overall Study|Protocol Violation|4|||
147137341|NCT03937479|530671894|FG003|Overall Study|Protocol Violation|3|||
147137342|NCT03937479|530671895|FG004|Overall Study|Protocol Violation|2|||
147137343|NCT03937479|530671891|FG000|Overall Study|Lost to Follow-up|0|||
147137344|NCT03937479|530671892|FG001|Overall Study|Lost to Follow-up|1|||
147137345|NCT03937479|530671893|FG002|Overall Study|Lost to Follow-up|0|||
147137346|NCT03937479|530671894|FG003|Overall Study|Lost to Follow-up|1|||
147137347|NCT03937479|530671895|FG004|Overall Study|Lost to Follow-up|0|||
147137348|NCT03937479|530671891|FG000|Overall Study|Physician Decision|0|||
147137349|NCT03937479|530671892|FG001|Overall Study|Physician Decision|0|||
147137350|NCT03937479|530671893|FG002|Overall Study|Physician Decision|1|||
147137351|NCT03937479|530671894|FG003|Overall Study|Physician Decision|0|||
147137352|NCT03937479|530671895|FG004|Overall Study|Physician Decision|1|||
147137353|NCT02712788|530671896|FG000|Overall Study|Physician Decision|1|||
147137354|NCT02712788|530671897|FG001|Overall Study|Physician Decision|0|||
147137355|NCT02712788|530671896|FG000|Overall Study|Protocol Violation|1|||
147572324|NCT01624233|532253698|FG000|Period 4 - Drug Free Period|Relapsed|61|||
147572325|NCT01624233|532253698|FG000|Period 5 - Retreatment Period|Adverse Event|5|||
147572326|NCT01624233|532253698|FG000|Period 5 - Retreatment Period|Lack of Efficacy|1|||
147572327|NCT01624233|532253698|FG000|Period 5 - Retreatment Period|Physician Decision|1|||
147572328|NCT01624233|532253698|FG000|Period 5 - Retreatment Period|Withdrawal by Subject|3|||
147572329|NCT01624233|532253698|FG000|Period 6: Follow-up|Adverse Event|3|||
147572330|NCT01624233|532253698|FG000|Period 6: Follow-up|Lack of Efficacy|2|||
147572331|NCT01624233|532253698|FG000|Period 6: Follow-up|Physician Decision|1|||
147651814|NCT01483599|532546591|FG011|Controlled Period (CP) (up to Week 16)|Other|0|||
147651815|NCT01483599|532546592|FG012|Controlled Period (CP) (up to Week 16)|Other|0|||
147651816|NCT01483599|532546593|FG013|Controlled Period (CP) (up to Week 16)|Other|0|||
147651817|NCT01483599|532546580|FG000|After Controlled Period(Week 16-Week 40)|Death|0|||
147651818|NCT01483599|532546581|FG001|After Controlled Period(Week 16-Week 40)|Death|0|||
147445649|NCT03200366|531797425|FG002|Patient Navigation Intervention Given|Colonoscopy already re-scheduled and completed|0|||
147651819|NCT01483599|532546582|FG002|After Controlled Period(Week 16-Week 40)|Death|0|||
147651820|NCT01483599|532546583|FG003|After Controlled Period(Week 16-Week 40)|Death|0|||
147137356|NCT02712788|530671897|FG001|Overall Study|Protocol Violation|0|||
147137357|NCT00940602|530671901|FG000|Overall Study|Administrative problems|1|||
147237544|NCT01705730|531040645|FG000|Overall Study|Lack of Efficacy|1|||
147572332|NCT01624233|532253698|FG000|Period 6: Follow-up|Withdrawal by Subject|3|||
147137358|NCT00940602|530671902|FG001|Overall Study|Administrative problems|1|||
147572333|NCT05090839|532253699|FG000|Overall Study|Lost to Follow-up|2|||
147137359|NCT00940602|530671901|FG000|Overall Study|Patient/guardian decision|13|||
147137360|NCT00940602|530671902|FG001|Overall Study|Patient/guardian decision|28|||
147137361|NCT00940602|530671901|FG000|Overall Study|Physician Decision|8|||
147137362|NCT00940602|530671902|FG001|Overall Study|Physician Decision|5|||
147137363|NCT00940602|530671901|FG000|Overall Study|Pregnancy|1|||
147137364|NCT00940602|530671902|FG001|Overall Study|Pregnancy|0|||
147137365|NCT00940602|530671901|FG000|Overall Study|Protocol Deviation (untreated)|1|||
147137366|NCT00940602|530671902|FG001|Overall Study|Protocol Deviation (untreated)|0|||
147137367|NCT00940602|530671901|FG000|Overall Study|Disease progression|8|||
147137368|NCT00940602|530671902|FG001|Overall Study|Disease progression|2|||
147137369|NCT00940602|530671901|FG000|Overall Study|Death|38|||
147137370|NCT00940602|530671902|FG001|Overall Study|Death|19|||
147137371|NCT00940602|530671901|FG000|Overall Study|Lost to Follow-up|3|||
147137372|NCT00940602|530671902|FG001|Overall Study|Lost to Follow-up|1|||
147137373|NCT00940602|530671901|FG000|Overall Study|Patient withdrew consent|26|||
147137374|NCT00940602|530671902|FG001|Overall Study|Patient withdrew consent|13|||
147137375|NCT00940602|530671901|FG000|Overall Study|Adverse Event|7|||
147137376|NCT00940602|530671902|FG001|Overall Study|Adverse Event|2|||
147137377|NCT00940602|530671901|FG000|Overall Study|Study terminated by Sponsor = trial was to continue for 3 years from date the last patient enrolled|43|||
147137378|NCT00940602|530671902|FG001|Overall Study|Study terminated by Sponsor = trial was to continue for 3 years from date the last patient enrolled|5|||
147137379|NCT01463033|530671903|FG000|Overall Study|Lost to Follow-up|4|||
147137380|NCT01463033|530671904|FG001|Overall Study|Lost to Follow-up|4|||
147137381|NCT01463033|530671903|FG000|Overall Study|Death|3|||
147137382|NCT01463033|530671904|FG001|Overall Study|Death|2|||
147137383|NCT01368614|530671908|FG000|Screening Period|Screen Failure|58|||
147137384|NCT01368614|530671909|FG001|Screening Period|Screen Failure|0|||
147137385|NCT01368614|530671910|FG002|Screening Period|Screen Failure|0|||
147137386|NCT01368614|530671911|FG003|Screening Period|Screen Failure|0|||
147137387|NCT01368614|530671908|FG000|Study Period|Withdrawal by Subject|0|||
147137388|NCT01368614|530671909|FG001|Study Period|Withdrawal by Subject|1|||
147137389|NCT01368614|530671910|FG002|Study Period|Withdrawal by Subject|1|||
147137390|NCT01368614|530671911|FG003|Study Period|Withdrawal by Subject|3|||
147137391|NCT01368614|530671908|FG000|Study Period|Lost to Follow-up|0|||
147137392|NCT01368614|530671909|FG001|Study Period|Lost to Follow-up|0|||
147137393|NCT01368614|530671910|FG002|Study Period|Lost to Follow-up|1|||
147137394|NCT01368614|530671911|FG003|Study Period|Lost to Follow-up|0|||
147137395|NCT01904721|530671914|FG000|Overall Study|Other Reasons|0|||
147137396|NCT01904721|530671915|FG001|Overall Study|Other Reasons|0|||
147137397|NCT01904721|530671916|FG002|Overall Study|Other Reasons|1|||
147137398|NCT01904721|530671917|FG003|Overall Study|Other Reasons|1|||
147137399|NCT01904721|530671918|FG004|Overall Study|Other Reasons|2|||
147137400|NCT01904721|530671919|FG005|Overall Study|Other Reasons|2|||
147137401|NCT01904721|530671920|FG006|Overall Study|Other Reasons|2|||
147137402|NCT01904721|530671914|FG000|Overall Study|Personal Reasons|0|||
147137403|NCT01904721|530671915|FG001|Overall Study|Personal Reasons|0|||
147137404|NCT01904721|530671916|FG002|Overall Study|Personal Reasons|0|||
147137405|NCT01904721|530671917|FG003|Overall Study|Personal Reasons|0|||
147137406|NCT01904721|530671918|FG004|Overall Study|Personal Reasons|2|||
147137407|NCT01904721|530671919|FG005|Overall Study|Personal Reasons|3|||
147137408|NCT01904721|530671920|FG006|Overall Study|Personal Reasons|3|||
147137409|NCT01904721|530671914|FG000|Overall Study|Lost to Follow-up|0|||
147137410|NCT01904721|530671915|FG001|Overall Study|Lost to Follow-up|0|||
147137411|NCT01904721|530671916|FG002|Overall Study|Lost to Follow-up|0|||
147137412|NCT01904721|530671917|FG003|Overall Study|Lost to Follow-up|0|||
147137413|NCT01904721|530671918|FG004|Overall Study|Lost to Follow-up|1|||
147572334|NCT05090839|532253700|FG001|Overall Study|Lost to Follow-up|3|||
147137414|NCT01904721|530671919|FG005|Overall Study|Lost to Follow-up|3|||
147137415|NCT01904721|530671920|FG006|Overall Study|Lost to Follow-up|1|||
147137416|NCT01904721|530671914|FG000|Overall Study|Lack of Efficacy|0|||
147137417|NCT01904721|530671915|FG001|Overall Study|Lack of Efficacy|0|||
147137418|NCT01904721|530671916|FG002|Overall Study|Lack of Efficacy|0|||
147137419|NCT01904721|530671917|FG003|Overall Study|Lack of Efficacy|0|||
147137420|NCT01904721|530671918|FG004|Overall Study|Lack of Efficacy|0|||
147137421|NCT01904721|530671919|FG005|Overall Study|Lack of Efficacy|0|||
147137422|NCT01904721|530671920|FG006|Overall Study|Lack of Efficacy|1|||
147137423|NCT01904721|530671914|FG000|Overall Study|Adverse Event|0|||
147137424|NCT01904721|530671915|FG001|Overall Study|Adverse Event|0|||
147137425|NCT01904721|530671916|FG002|Overall Study|Adverse Event|0|||
147137426|NCT01904721|530671917|FG003|Overall Study|Adverse Event|0|||
147137427|NCT01904721|530671918|FG004|Overall Study|Adverse Event|3|||
147572335|NCT05090839|532253701|FG002|Overall Study|Lost to Follow-up|1|||
147137428|NCT01904721|530671919|FG005|Overall Study|Adverse Event|1|||
147137429|NCT01904721|530671920|FG006|Overall Study|Adverse Event|0|||
147137430|NCT01957865|530671921|FG000|Overall Study|Found HIV negative|0|||
147137431|NCT01957865|530671922|FG001|Overall Study|Found HIV negative|0|||
147137432|NCT01957865|530671923|FG002|Overall Study|Found HIV negative|1|||
147137433|NCT01957865|530671921|FG000|Overall Study|Lost to Follow-up|0|||
147137434|NCT01957865|530671922|FG001|Overall Study|Lost to Follow-up|2|||
147137435|NCT01957865|530671923|FG002|Overall Study|Lost to Follow-up|2|||
147137436|NCT00811720|530671924|FG000|All Randomised Patients|Did not receive placebo/nalmefene|2|||
147137437|NCT00811720|530671925|FG001|All Randomised Patients|Did not receive placebo/nalmefene|4|||
147137438|NCT00811720|530671924|FG000|All Treated Patients|Adverse Event|20|||
147137439|NCT00811720|530671925|FG001|All Treated Patients|Adverse Event|62|||
147137440|NCT00811720|530671924|FG000|All Treated Patients|Lack of Efficacy|22|||
147137441|NCT00811720|530671925|FG001|All Treated Patients|Lack of Efficacy|18|||
147137442|NCT00811720|530671924|FG000|All Treated Patients|Non-compliance|0|||
147137443|NCT00811720|530671925|FG001|All Treated Patients|Non-compliance|14|||
147137444|NCT00811720|530671924|FG000|All Treated Patients|Protocol Violation|9|||
147137445|NCT00811720|530671925|FG001|All Treated Patients|Protocol Violation|16|||
147137446|NCT00811720|530671924|FG000|All Treated Patients|Withdrawal by Subject|28|||
147137447|NCT00811720|530671925|FG001|All Treated Patients|Withdrawal by Subject|34|||
147137448|NCT00811720|530671924|FG000|All Treated Patients|Lost to Follow-up|10|||
147137449|NCT00811720|530671925|FG001|All Treated Patients|Lost to Follow-up|16|||
147137450|NCT00811720|530671924|FG000|All Treated Patients|Other Reason|7|||
147137451|NCT00811720|530671925|FG001|All Treated Patients|Other Reason|4|||
147137452|NCT02750930|530671926|FG000|Overall Study|Study closed/terminated|8|||
147137453|NCT00553631|530671927|FG000|Overall Study|Withdrawal by Subject|0|||
147137454|NCT00553631|530671928|FG001|Overall Study|Withdrawal by Subject|1|||
147137455|NCT00553631|530671927|FG000|Overall Study|Lost to Follow-up|1|||
147137456|NCT00553631|530671928|FG001|Overall Study|Lost to Follow-up|0|||
147572336|NCT05090839|532253702|FG003|Overall Study|Lost to Follow-up|1|||
147572337|NCT05710718|532253703|FG000|Overall Study|Withdrawal by Subject|5|||
147572338|NCT05710718|532253704|FG001|Overall Study|Withdrawal by Subject|1|||
147572339|NCT05710718|532253703|FG000|Overall Study|Lost to Follow-up|0|||
147572340|NCT05710718|532253704|FG001|Overall Study|Lost to Follow-up|1|||
147572341|NCT05710718|532253703|FG000|Overall Study|Death|0|||
147572342|NCT05710718|532253704|FG001|Overall Study|Death|1|||
147572343|NCT01528696|532253706|FG000|Overall Study|See detailed description|18|||
147137457|NCT00114127|530671930|FG000|Overall Study|Adverse Event|2|||
147137458|NCT00114127|530671931|FG001|Overall Study|Adverse Event|1|||
147137459|NCT00114127|530671930|FG000|Overall Study|Lost to Follow-up|1|||
147137460|NCT00114127|530671931|FG001|Overall Study|Lost to Follow-up|0|||
147137461|NCT00114127|530671930|FG000|Overall Study|Withdrawal by Subject|1|||
147137462|NCT00114127|530671931|FG001|Overall Study|Withdrawal by Subject|3|||
147137463|NCT03188263|530671932|FG000|Overall Study|Withdrawal by Subject|3|||
147137464|NCT03188263|530671933|FG001|Overall Study|Withdrawal by Subject|0|||
147137465|NCT03188263|530671932|FG000|Overall Study|Physician Decision|1|||
147137466|NCT03188263|530671933|FG001|Overall Study|Physician Decision|0|||
147137467|NCT00699413|530671934|FG000|Overall Study|Withdrawal by Subject|0|||
147137468|NCT00699413|530671935|FG001|Overall Study|Withdrawal by Subject|2|||
147137469|NCT00699413|530671934|FG000|Overall Study|Study terminated by sponsor|4|||
147137470|NCT00699413|530671935|FG001|Overall Study|Study terminated by sponsor|2|||
147137471|NCT02779777|530671936|FG000|Overall Study|Disease Progression|1|||
147137472|NCT02779777|530671937|FG001|Overall Study|Disease Progression|0|||
147137473|NCT02779777|530671938|FG002|Overall Study|Disease Progression|0|||
147137474|NCT02779777|530671936|FG000|Overall Study|Adverse Event|3|||
147137475|NCT02779777|530671937|FG001|Overall Study|Adverse Event|1|||
147137476|NCT02779777|530671938|FG002|Overall Study|Adverse Event|0|||
147137477|NCT02779777|530671936|FG000|Overall Study|Physician Decision|9|||
147137478|NCT02779777|530671937|FG001|Overall Study|Physician Decision|0|||
147137479|NCT02779777|530671938|FG002|Overall Study|Physician Decision|1|||
147137480|NCT02779777|530671936|FG000|Overall Study|Withdrawal by Subject|1|||
147137481|NCT02779777|530671937|FG001|Overall Study|Withdrawal by Subject|0|||
147137482|NCT02779777|530671938|FG002|Overall Study|Withdrawal by Subject|0|||
147137483|NCT00881894|530671939|FG000|Overall Study|Consent withdrawn|0|||
147137484|NCT00881894|530671940|FG001|Overall Study|Consent withdrawn|1|||
147137485|NCT00881894|530671939|FG000|Overall Study|Other reasons for premature termination|1|||
147137486|NCT00881894|530671940|FG001|Overall Study|Other reasons for premature termination|2|||
147137487|NCT00469833|530671941|FG000|Overall Study|No IV access|2|||
147137488|NCT01253369|530671942|FG000|Overall Study|Adverse Event|4|||
147137489|NCT01253369|530671942|FG000|Overall Study|Withdrawal by Subject|2|||
147137490|NCT01253369|530671942|FG000|Overall Study|Death|1|||
147137491|NCT01253369|530671942|FG000|Overall Study|Progressive disease|23|||
147137492|NCT01253369|530671942|FG000|Overall Study|Not Evaluable|3|||
147137493|NCT03289533|530671943|FG000|Overall Study|Death|12|||
147137494|NCT03289533|530671943|FG000|Overall Study|Terminated from study by sponsor|10|||
147237545|NCT01705730|531040645|FG000|Overall Study|Adverse Event|3|||
147237546|NCT01705730|531040645|FG000|Overall Study|Lost to Follow-up|1|||
147237547|NCT01705730|531040645|FG000|Overall Study|Reason not Specified|4|||
147237548|NCT01773733|531040646|FG000|Overall Study|Adverse Event|3286|||
147237549|NCT01773733|531040647|FG001|Overall Study|Adverse Event|540|||
147237550|NCT01773733|531040646|FG000|Overall Study|Pregnancy|28|||
147237551|NCT01773733|531040647|FG001|Overall Study|Pregnancy|0|||
147237552|NCT01773733|531040646|FG000|Overall Study|Other different categories of not compl|55415|||
147237553|NCT01773733|531040647|FG001|Overall Study|Other different categories of not compl|7781|||
147237554|NCT00880542|531040652|FG000|Treatment Period (Sorafenib+Ifosfamide)|Adverse Event|1|||
147237555|NCT00880542|531040652|FG000|Treatment Period (Sorafenib+Ifosfamide)|disease progression|2|||
147572344|NCT01528696|532253707|FG001|Overall Study|See detailed description|19|||
147137495|NCT00539240|530671944|FG000|Overall Study|Withdrawal by Subject|0|||
147137496|NCT00539240|530671945|FG001|Overall Study|Withdrawal by Subject|2|||
147137497|NCT00539240|530671946|FG002|Overall Study|Withdrawal by Subject|0|||
147137498|NCT00539240|530671944|FG000|Overall Study|Protocol Violation|1|||
147137499|NCT00539240|530671945|FG001|Overall Study|Protocol Violation|1|||
147137500|NCT00539240|530671946|FG002|Overall Study|Protocol Violation|4|||
147137501|NCT00539240|530671944|FG000|Overall Study|Lost to Follow-up|2|||
147137502|NCT00539240|530671945|FG001|Overall Study|Lost to Follow-up|3|||
147137503|NCT00539240|530671946|FG002|Overall Study|Lost to Follow-up|1|||
147137504|NCT00539240|530671944|FG000|Overall Study|Adverse Event|3|||
147137505|NCT00539240|530671945|FG001|Overall Study|Adverse Event|1|||
147137506|NCT00539240|530671946|FG002|Overall Study|Adverse Event|10|||
147137507|NCT01284959|530671948|FG000|Overall Study|Withdrawal by Subject|1|||
147137508|NCT01284959|530671949|FG001|Overall Study|Withdrawal by Subject|0|||
147137509|NCT01284959|530671950|FG002|Overall Study|Withdrawal by Subject|0|||
147137510|NCT01284959|530671948|FG000|Overall Study|Adverse Event|0|||
147137511|NCT01284959|530671949|FG001|Overall Study|Adverse Event|0|||
147137512|NCT01284959|530671950|FG002|Overall Study|Adverse Event|1|||
147137513|NCT01055613|530671951|FG000|Overall Study|No Longer Meets Eligibility Criteria|3|||
147318401|NCT01473420|531331714|FG001|Titration Period (18 Weeks)|Adverse Event|6|||
147318402|NCT01473420|531331713|FG000|Titration Period (18 Weeks)|Did not meet criteria|32|||
147318403|NCT01473420|531331714|FG001|Titration Period (18 Weeks)|Did not meet criteria|32|||
147318404|NCT01473420|531331713|FG000|Maintenance Period (16 Weeks)|Adverse Event|3|||
147318405|NCT01473420|531331714|FG001|Maintenance Period (16 Weeks)|Adverse Event|2|||
147318406|NCT01473420|531331713|FG000|Maintenance Period (16 Weeks)|Physician Decision|1|||
147318407|NCT01473420|531331714|FG001|Maintenance Period (16 Weeks)|Physician Decision|2|||
147318408|NCT01473420|531331713|FG000|Maintenance Period (16 Weeks)|Did not meet criteria|0|||
147318409|NCT01473420|531331714|FG001|Maintenance Period (16 Weeks)|Did not meet criteria|2|||
147318410|NCT01473420|531331713|FG000|Maintenance Period (16 Weeks)|Kidney transplant|3|||
147318411|NCT01473420|531331714|FG001|Maintenance Period (16 Weeks)|Kidney transplant|1|||
147318412|NCT01473420|531331713|FG000|Maintenance Period (16 Weeks)|Lost to Follow-up|1|||
147318413|NCT01473420|531331714|FG001|Maintenance Period (16 Weeks)|Lost to Follow-up|2|||
147318414|NCT01473420|531331713|FG000|Maintenance Period (16 Weeks)|Withdrawal by Subject|4|||
147318415|NCT01473420|531331714|FG001|Maintenance Period (16 Weeks)|Withdrawal by Subject|6|||
147318416|NCT01473420|531331713|FG000|Maintenance Period (16 Weeks)|Site closure|3|||
147318417|NCT01473420|531331714|FG001|Maintenance Period (16 Weeks)|Site closure|1|||
147318418|NCT01473420|531331713|FG000|Maintenance Period (16 Weeks)|Started Peritoneal Dialysis|1|||
147318419|NCT01473420|531331714|FG001|Maintenance Period (16 Weeks)|Started Peritoneal Dialysis|0|||
147318420|NCT01473420|531331713|FG000|Maintenance Period (16 Weeks)|Long term hospitalization|0|||
147318421|NCT01473420|531331714|FG001|Maintenance Period (16 Weeks)|Long term hospitalization|1|||
147318422|NCT01473420|531331713|FG000|Maintenance Period (16 Weeks)|Sponsor's Decision|1|||
147318423|NCT01473420|531331714|FG001|Maintenance Period (16 Weeks)|Sponsor's Decision|0|||
147651821|NCT01483599|532546584|FG004|After Controlled Period(Week 16-Week 40)|Death|0|||
147651822|NCT01483599|532546585|FG005|After Controlled Period(Week 16-Week 40)|Death|0|||
147651823|NCT01483599|532546586|FG006|After Controlled Period(Week 16-Week 40)|Death|0|||
147651824|NCT01483599|532546587|FG007|After Controlled Period(Week 16-Week 40)|Death|0|||
147651825|NCT01483599|532546588|FG008|After Controlled Period(Week 16-Week 40)|Death|1|||
147137514|NCT01055613|530671952|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
147137515|NCT01055613|530671951|FG000|Overall Study|Unacceptable lens fit|1|||
147237556|NCT00880542|531040652|FG000|REP: Surgical Resection|progressive disease|1|||
147237557|NCT00762385|531040653|FG000|First Intervention|Lens Issue|1|||
147237558|NCT00762385|531040654|FG001|First Intervention|Lens Issue|1|||
147237559|NCT00762385|531040653|FG000|First Intervention|Lost to Follow-up|0|||
147237560|NCT00762385|531040654|FG001|First Intervention|Lost to Follow-up|2|||
147237561|NCT00762385|531040653|FG000|First Intervention|Ineligible|1|||
147237562|NCT00762385|531040654|FG001|First Intervention|Ineligible|0|||
147237563|NCT00762385|531040653|FG000|First Intervention|Protocol Violation|0|||
147237564|NCT00762385|531040654|FG001|First Intervention|Protocol Violation|1|||
147237565|NCT00762385|531040653|FG000|Second Intervention|Protocol Violation|3|||
147237566|NCT00762385|531040654|FG001|Second Intervention|Protocol Violation|3|||
147237567|NCT01781975|531040655|FG000|Overall Study|Death|1|||
147237568|NCT01781975|531040656|FG001|Overall Study|Death|0|||
147237569|NCT01781975|531040655|FG000|Overall Study|Withdrawal by Subject|1|||
147237570|NCT01781975|531040656|FG001|Overall Study|Withdrawal by Subject|1|||
147237571|NCT02329080|531040657|FG000|Overall Study|Adverse Event|1|||
147237572|NCT02329080|531040657|FG000|Overall Study|Death|4|||
147237573|NCT02329080|531040657|FG000|Overall Study|Lack of Efficacy|22|||
147237574|NCT02329080|531040657|FG000|Overall Study|Lost to Follow-up|1|||
147237575|NCT02329080|531040657|FG000|Overall Study|Physician Decision|2|||
147237576|NCT02329080|531040657|FG000|Overall Study|Partial response|4|||
147237577|NCT02329080|531040657|FG000|Overall Study|Complete response|4|||
147237578|NCT04545060|531040658|FG000|Overall Study|Adverse Event|0|||
147237579|NCT04545060|531040659|FG001|Overall Study|Adverse Event|1|||
147237580|NCT04545060|531040658|FG000|Overall Study|Death|0|||
147237581|NCT04545060|531040659|FG001|Overall Study|Death|5|||
147237582|NCT04545060|531040658|FG000|Overall Study|Lost to Follow-up|10|||
147237583|NCT04545060|531040659|FG001|Overall Study|Lost to Follow-up|13|||
147237584|NCT04545060|531040658|FG000|Overall Study|Physician Decision|3|||
147572345|NCT01056484|532253708|FG000|Randomized Controlled Trial|Withdrawal by Subject|6|||
147572346|NCT01056484|532253709|FG001|Randomized Controlled Trial|Withdrawal by Subject|1|||
147572347|NCT01056484|532253708|FG000|Randomized Controlled Trial|Physician Decision|1|||
147572348|NCT01056484|532253709|FG001|Randomized Controlled Trial|Physician Decision|0|||
147318424|NCT01473420|531331713|FG000|Maintenance Period (16 Weeks)|Elevated Hemoglobin|1|||
147318425|NCT01473420|531331714|FG001|Maintenance Period (16 Weeks)|Elevated Hemoglobin|0|||
147318426|NCT04172987|531331717|FG000|Lead In Period|Adverse Event|1|||
147318427|NCT04172987|531331717|FG000|Lead In Period|Protocol Violation|1|||
147318428|NCT04172987|531331717|FG000|Period 1|Physician Decision|1|||
147318429|NCT04172987|531331717|FG000|Period 2|Adverse Event|5|||
147318430|NCT04172987|531331717|FG000|Period 2|Dosing Termination by Sponsor|4|||
147318431|NCT01603121|531331720|FG000|Second Intervention, 10 Hours|Adverse Event|1|||
147318432|NCT01603121|531331721|FG001|Second Intervention, 10 Hours|Adverse Event|0|||
147572349|NCT01056484|532253708|FG000|Follow up - Non-randomized|Withdrawal by Subject|0|||
147572350|NCT01056484|532253709|FG001|Follow up - Non-randomized|Withdrawal by Subject|2|||
147318433|NCT00577720|531331722|FG000|Overall Study|Adverse Event|2|||
147318434|NCT00577720|531331723|FG001|Overall Study|Adverse Event|1|||
147318435|NCT00577720|531331724|FG002|Overall Study|Adverse Event|0|||
147318436|NCT00577720|531331725|FG003|Overall Study|Adverse Event|4|||
147318437|NCT00577720|531331722|FG000|Overall Study|Lost to Follow-up|0|||
147318438|NCT00577720|531331723|FG001|Overall Study|Lost to Follow-up|0|||
147318439|NCT00577720|531331724|FG002|Overall Study|Lost to Follow-up|1|||
147318440|NCT00577720|531331725|FG003|Overall Study|Lost to Follow-up|0|||
147318441|NCT00577720|531331722|FG000|Overall Study|Protocol Violation|0|||
147318442|NCT00577720|531331723|FG001|Overall Study|Protocol Violation|0|||
147318443|NCT00577720|531331724|FG002|Overall Study|Protocol Violation|0|||
147318444|NCT00577720|531331725|FG003|Overall Study|Protocol Violation|1|||
147318445|NCT00577720|531331722|FG000|Overall Study|Withdrawal by Subject|2|||
147318446|NCT00577720|531331723|FG001|Overall Study|Withdrawal by Subject|0|||
147318447|NCT00577720|531331724|FG002|Overall Study|Withdrawal by Subject|0|||
147318448|NCT00577720|531331725|FG003|Overall Study|Withdrawal by Subject|2|||
147318449|NCT00738530|531331731|FG000|Overall Study|Death|220|||
147318450|NCT00738530|531331732|FG001|Overall Study|Death|224|||
147318451|NCT00738530|531331731|FG000|Overall Study|Lost to Follow-up|8|||
147318452|NCT00738530|531331732|FG001|Overall Study|Lost to Follow-up|6|||
147318453|NCT00738530|531331731|FG000|Overall Study|Withdrawal by Subject|6|||
147318454|NCT00738530|531331732|FG001|Overall Study|Withdrawal by Subject|8|||
147318455|NCT04179461|531331733|FG000|Overall Study|Lost to Follow-up|4|||
147318456|NCT03100838|531331734|FG000|Overall Study|Adverse Event|1|||
147318457|NCT03100838|531331735|FG001|Overall Study|Adverse Event|0|||
147318458|NCT03100838|531331736|FG002|Overall Study|Adverse Event|0|||
147318459|NCT03100838|531331737|FG003|Overall Study|Adverse Event|0|||
147318460|NCT03100838|531331734|FG000|Overall Study|Physician Decision|1|||
147318461|NCT03100838|531331735|FG001|Overall Study|Physician Decision|1|||
147318462|NCT03100838|531331736|FG002|Overall Study|Physician Decision|1|||
147318463|NCT03100838|531331737|FG003|Overall Study|Physician Decision|1|||
147318464|NCT03100838|531331734|FG000|Overall Study|Pregnancy|0|||
147318465|NCT03100838|531331735|FG001|Overall Study|Pregnancy|1|||
147318466|NCT03100838|531331736|FG002|Overall Study|Pregnancy|0|||
147318467|NCT03100838|531331737|FG003|Overall Study|Pregnancy|0|||
147318468|NCT03100838|531331734|FG000|Overall Study|Lost to Follow-up|0|||
147318469|NCT03100838|531331735|FG001|Overall Study|Lost to Follow-up|0|||
147318470|NCT03100838|531331736|FG002|Overall Study|Lost to Follow-up|1|||
147318471|NCT03100838|531331737|FG003|Overall Study|Lost to Follow-up|0|||
147318472|NCT01347645|531331738|FG000|Overall Study|Death|1|||
147318473|NCT01347645|531331739|FG001|Overall Study|Death|5|||
147572351|NCT00835575|532253711|FG000|Washout of 14 Days|Withdrawal by Subject|1|||
147572352|NCT00835575|532253712|FG001|Washout of 14 Days|Withdrawal by Subject|0|||
147572353|NCT03606174|532253717|FG000|Overall Study|Death|37|||
147572354|NCT03606174|532253718|FG001|Overall Study|Death|15|||
147572355|NCT03606174|532253719|FG002|Overall Study|Death|15|||
147318474|NCT01347645|531331740|FG002|Overall Study|Death|2|||
147318475|NCT01347645|531331741|FG003|Overall Study|Death|7|||
147318476|NCT01347645|531331742|FG004|Overall Study|Death|7|||
147318477|NCT01347645|531331738|FG000|Overall Study|Lost to Follow-up|1|||
147651826|NCT01483599|532546589|FG009|After Controlled Period(Week 16-Week 40)|Death|0|||
147318478|NCT01347645|531331739|FG001|Overall Study|Lost to Follow-up|1|||
147318479|NCT01347645|531331740|FG002|Overall Study|Lost to Follow-up|0|||
147318480|NCT01347645|531331741|FG003|Overall Study|Lost to Follow-up|1|||
147318481|NCT01347645|531331742|FG004|Overall Study|Lost to Follow-up|1|||
147318482|NCT01347645|531331738|FG000|Overall Study|Study termination by Sponsor due to E7820 plus irinotecan being potentially inferior to FOLFIRI|0|||
147318483|NCT01347645|531331739|FG001|Overall Study|Study termination by Sponsor due to E7820 plus irinotecan being potentially inferior to FOLFIRI|2|||
147318484|NCT01347645|531331740|FG002|Overall Study|Study termination by Sponsor due to E7820 plus irinotecan being potentially inferior to FOLFIRI|1|||
147318485|NCT01347645|531331741|FG003|Overall Study|Study termination by Sponsor due to E7820 plus irinotecan being potentially inferior to FOLFIRI|22|||
147572356|NCT03606174|532253720|FG003|Overall Study|Death|7|||
147572357|NCT03606174|532253721|FG004|Overall Study|Death|35|||
147572358|NCT03606174|532253722|FG005|Overall Study|Death|12|||
147572359|NCT03606174|532253723|FG006|Overall Study|Death|35|||
147572360|NCT03606174|532253724|FG007|Overall Study|Death|8|||
147572361|NCT03606174|532253725|FG008|Overall Study|Death|5|||
147318486|NCT01347645|531331742|FG004|Overall Study|Study termination by Sponsor due to E7820 plus irinotecan being potentially inferior to FOLFIRI|20|||
147318487|NCT01347645|531331738|FG000|Overall Study|Other|1|||
147318488|NCT01347645|531331739|FG001|Overall Study|Other|0|||
147318489|NCT01347645|531331740|FG002|Overall Study|Other|0|||
147318490|NCT01347645|531331741|FG003|Overall Study|Other|0|||
147318491|NCT01347645|531331742|FG004|Overall Study|Other|1|||
147318492|NCT01347645|531331738|FG000|Overall Study|Withdrawal by Subject|0|||
147318493|NCT01347645|531331739|FG001|Overall Study|Withdrawal by Subject|0|||
147318494|NCT01347645|531331740|FG002|Overall Study|Withdrawal by Subject|0|||
147318495|NCT01347645|531331741|FG003|Overall Study|Withdrawal by Subject|3|||
147318496|NCT01347645|531331742|FG004|Overall Study|Withdrawal by Subject|3|||
147318497|NCT01347645|531331738|FG000|Overall Study|Physician Decision|0|||
147318498|NCT01347645|531331739|FG001|Overall Study|Physician Decision|0|||
147318499|NCT01347645|531331740|FG002|Overall Study|Physician Decision|0|||
147318500|NCT01347645|531331741|FG003|Overall Study|Physician Decision|0|||
147318501|NCT01347645|531331742|FG004|Overall Study|Physician Decision|1|||
147318502|NCT01347645|531331738|FG000|Overall Study|Adverse Event|0|||
147318503|NCT01347645|531331739|FG001|Overall Study|Adverse Event|0|||
147318504|NCT01347645|531331740|FG002|Overall Study|Adverse Event|0|||
147318505|NCT01347645|531331741|FG003|Overall Study|Adverse Event|1|||
147318506|NCT01347645|531331742|FG004|Overall Study|Adverse Event|1|||
147318507|NCT00184028|531331743|FG000|Overall Study|Death|1|||
147318508|NCT00184028|531331743|FG000|Overall Study|Lack of Efficacy|4|||
147318509|NCT00184028|531331743|FG000|Overall Study|Adverse Event|2|||
147318510|NCT00184028|531331743|FG000|Overall Study|Withdrawal by Subject|1|||
147318511|NCT00184028|531331743|FG000|Overall Study|Non-compliance|2|||
147318512|NCT01141660|531331744|FG000|Overall Study|Physician Decision|0|||
147318513|NCT01141660|531331745|FG001|Overall Study|Physician Decision|12|||
147318514|NCT00209027|531331747|FG000|Overall Study|study terminated|10|||
147318515|NCT00209027|531331748|FG001|Overall Study|study terminated|0|||
147318516|NCT03785340|531331749|FG000|Overall Study|Lost to Follow-up|2|||
147318517|NCT03785340|531331750|FG001|Overall Study|Lost to Follow-up|0|||
147318518|NCT03785340|531331749|FG000|Overall Study|Adverse Event|1|||
147318519|NCT03785340|531331750|FG001|Overall Study|Adverse Event|0|||
147318520|NCT04963062|531331751|FG000|Overall Study|withdrew by the study team|4|||
147318521|NCT04963062|531331752|FG001|Overall Study|withdrew by the study team|2|||
147318522|NCT01349660|531331761|FG000|Overall Study|Still Receiving Study Treatment|0|||
147572362|NCT03606174|532253726|FG009|Overall Study|Death|3|||
147318523|NCT01349660|531331762|FG001|Overall Study|Still Receiving Study Treatment|0|||
147318524|NCT01349660|531331763|FG002|Overall Study|Still Receiving Study Treatment|1|||
147318525|NCT01349660|531331761|FG000|Overall Study|Disease Progression|2|||
147318526|NCT01349660|531331762|FG001|Overall Study|Disease Progression|4|||
147572363|NCT03606174|532253727|FG010|Overall Study|Death|0|||
147572364|NCT03606174|532253717|FG000|Overall Study|Lost to Follow-up|0|||
147318527|NCT01349660|531331763|FG002|Overall Study|Disease Progression|50|||
147318528|NCT01349660|531331761|FG000|Overall Study|Adverse Event|1|||
147318529|NCT01349660|531331762|FG001|Overall Study|Adverse Event|1|||
147318530|NCT01349660|531331763|FG002|Overall Study|Adverse Event|12|||
147318531|NCT01349660|531331761|FG000|Overall Study|Withdrawal by Subject|2|||
147318532|NCT01349660|531331762|FG001|Overall Study|Withdrawal by Subject|0|||
147318533|NCT01349660|531331763|FG002|Overall Study|Withdrawal by Subject|9|||
147318534|NCT01349660|531331761|FG000|Overall Study|Death|1|||
147318535|NCT01349660|531331762|FG001|Overall Study|Death|1|||
147318536|NCT01349660|531331763|FG002|Overall Study|Death|0|||
147318537|NCT01349660|531331761|FG000|Overall Study|Non-Permitted Interventions|0|||
147318538|NCT01349660|531331762|FG001|Overall Study|Non-Permitted Interventions|0|||
147318539|NCT01349660|531331763|FG002|Overall Study|Non-Permitted Interventions|2|||
147572365|NCT03606174|532253718|FG001|Overall Study|Lost to Follow-up|0|||
147572366|NCT03606174|532253719|FG002|Overall Study|Lost to Follow-up|0|||
147318540|NCT01349660|531331761|FG000|Overall Study|Study Compliance|0|||
147318541|NCT01349660|531331762|FG001|Overall Study|Study Compliance|0|||
147318542|NCT01349660|531331763|FG002|Overall Study|Study Compliance|1|||
147318543|NCT01349660|531331761|FG000|Overall Study|Declining Performance Status|0|||
147318544|NCT01349660|531331762|FG001|Overall Study|Declining Performance Status|0|||
147318545|NCT01349660|531331763|FG002|Overall Study|Declining Performance Status|1|||
147318546|NCT00556374|531331766|FG000|Overall Study|Withdrawal by Subject|235|||
147318547|NCT00556374|531331767|FG001|Overall Study|Withdrawal by Subject|205|||
147318548|NCT00556374|531331766|FG000|Overall Study|Death|158|||
147318549|NCT00556374|531331767|FG001|Overall Study|Death|127|||
147318550|NCT00556374|531331766|FG000|Overall Study|Lost to Follow-up|24|||
147318551|NCT00556374|531331767|FG001|Overall Study|Lost to Follow-up|17|||
147318552|NCT00556374|531331766|FG000|Overall Study|Continuing into Zoledronic Acid Substudy|50|||
147318553|NCT00556374|531331767|FG001|Overall Study|Continuing into Zoledronic Acid Substudy|0|||
147572367|NCT03606174|532253720|FG003|Overall Study|Lost to Follow-up|0|||
147572368|NCT03606174|532253721|FG004|Overall Study|Lost to Follow-up|1|||
147572369|NCT03606174|532253722|FG005|Overall Study|Lost to Follow-up|1|||
147137516|NCT01055613|530671952|FG001|Overall Study|Unacceptable lens fit|0|||
147137517|NCT01055613|530671951|FG000|Overall Study|Discomfort|2|||
147137518|NCT01055613|530671952|FG001|Overall Study|Discomfort|1|||
147137519|NCT01055613|530671951|FG000|Overall Study|Lost to Follow-up|1|||
147137520|NCT01055613|530671952|FG001|Overall Study|Lost to Follow-up|1|||
147137521|NCT01055613|530671951|FG000|Overall Study|Protocol Violation|1|||
147137522|NCT01055613|530671952|FG001|Overall Study|Protocol Violation|1|||
147137523|NCT01055613|530671951|FG000|Overall Study|Subject Disinterest|1|||
147137524|NCT01055613|530671952|FG001|Overall Study|Subject Disinterest|1|||
147137525|NCT00363311|530671953|FG000|Overall Study|Adverse Event|6|||
147137526|NCT00363311|530671954|FG001|Overall Study|Adverse Event|4|||
147137527|NCT00363311|530671953|FG000|Overall Study|Lost to Follow-up|3|||
147137528|NCT00363311|530671954|FG001|Overall Study|Lost to Follow-up|0|||
147137529|NCT00363311|530671953|FG000|Overall Study|Protocol Violation|1|||
147137530|NCT00363311|530671954|FG001|Overall Study|Protocol Violation|2|||
147137531|NCT00363311|530671953|FG000|Overall Study|Withdrawal by Subject|12|||
147137532|NCT00363311|530671954|FG001|Overall Study|Withdrawal by Subject|6|||
147137533|NCT00363311|530671953|FG000|Overall Study|Physician Decision|1|||
147137534|NCT00363311|530671954|FG001|Overall Study|Physician Decision|1|||
147137535|NCT00363311|530671953|FG000|Overall Study|Sponsor Terminated Study|2|||
147137536|NCT00363311|530671954|FG001|Overall Study|Sponsor Terminated Study|2|||
147137537|NCT00363311|530671953|FG000|Overall Study|Disease Progression|46|||
147137538|NCT00363311|530671954|FG001|Overall Study|Disease Progression|26|||
147137539|NCT00363311|530671953|FG000|Overall Study|Non-Compliance|1|||
147137540|NCT00363311|530671954|FG001|Overall Study|Non-Compliance|1|||
147137541|NCT00363311|530671953|FG000|Overall Study|Participant Refused Biopsy|1|||
147137542|NCT00363311|530671954|FG001|Overall Study|Participant Refused Biopsy|0|||
147137543|NCT00363311|530671953|FG000|Overall Study|Prostate Volume/PSA Doubled|1|||
147137544|NCT00363311|530671954|FG001|Overall Study|Prostate Volume/PSA Doubled|0|||
147137545|NCT00363311|530671953|FG000|Overall Study|Participant Opted for Treatment|1|||
147137546|NCT00363311|530671954|FG001|Overall Study|Participant Opted for Treatment|0|||
147137547|NCT00363311|530671953|FG000|Overall Study|Participant Moved to Another Country|1|||
147137548|NCT00363311|530671954|FG001|Overall Study|Participant Moved to Another Country|0|||
147137549|NCT00363311|530671953|FG000|Overall Study|Participant Withdrew Waiting for Surgery|0|||
147137550|NCT00363311|530671954|FG001|Overall Study|Participant Withdrew Waiting for Surgery|1|||
147137551|NCT00363311|530671953|FG000|Overall Study|Withdrawn per Instructions of Monitor|0|||
147137552|NCT00363311|530671954|FG001|Overall Study|Withdrawn per Instructions of Monitor|1|||
147137553|NCT00363311|530671953|FG000|Overall Study|Participant Moved to Louisiana|0|||
147137554|NCT00363311|530671954|FG001|Overall Study|Participant Moved to Louisiana|1|||
147137555|NCT02103062|530671959|FG000|Overall Study|Adverse Event|1|||
147137556|NCT02103062|530671960|FG001|Overall Study|Adverse Event|2|||
147237585|NCT04545060|531040659|FG001|Overall Study|Physician Decision|0|||
147237586|NCT04545060|531040658|FG000|Overall Study|Withdrawal by Subject|17|||
147237587|NCT04545060|531040659|FG001|Overall Study|Withdrawal by Subject|22|||
147237588|NCT00973674|531040660|FG000|Overall Study|Protocol Violation|2|||
147237589|NCT00973674|531040661|FG001|Overall Study|Protocol Violation|0|||
147237590|NCT00839852|531040662|FG000|Overall Study|Adverse Event|10|||
147237591|NCT00839852|531040662|FG000|Overall Study|Insufficient Therapeutic Response|3|||
147237592|NCT00839852|531040662|FG000|Overall Study|Protocol Violation|9|||
147237593|NCT00839852|531040662|FG000|Overall Study|Withdrawal of Consent|16|||
147237594|NCT00839852|531040662|FG000|Overall Study|Lost to Follow-up|7|||
147237595|NCT00839852|531040662|FG000|Overall Study|Lack of Compliance While in Jail|1|||
147237596|NCT00839852|531040662|FG000|Overall Study|Pregnancy|1|||
147237597|NCT01206166|531040671|FG000|Overall Study|No evaluable data|2|||
147237598|NCT01206166|531040672|FG001|Overall Study|No evaluable data|3|||
147237599|NCT00810355|531040678|FG000|Overall Study|Lost to Follow-up|13|||
147237600|NCT00810355|531040679|FG001|Overall Study|Lost to Follow-up|17|||
147237601|NCT00810355|531040680|FG002|Overall Study|Lost to Follow-up|11|||
147237602|NCT00810355|531040678|FG000|Overall Study|Withdrawal by Subject|1|||
147237603|NCT00810355|531040679|FG001|Overall Study|Withdrawal by Subject|0|||
147237604|NCT00810355|531040680|FG002|Overall Study|Withdrawal by Subject|0|||
147237605|NCT00003487|531040681|FG000|Overall Study|Not evaluable|2|||
147237606|NCT04154930|531040684|FG000|Overall Study|Withdrawal by Subject|15|||
147237607|NCT04154930|531040685|FG001|Overall Study|Withdrawal by Subject|6|||
147237608|NCT04154930|531040684|FG000|Overall Study|Withdrew consent- Covid-19 related|2|||
147237609|NCT04154930|531040685|FG001|Overall Study|Withdrew consent- Covid-19 related|1|||
147237610|NCT04154930|531040684|FG000|Overall Study|Lost to Follow-up|14|||
147237611|NCT04154930|531040685|FG001|Overall Study|Lost to Follow-up|6|||
147237612|NCT04154930|531040684|FG000|Overall Study|Other|6|||
147318554|NCT00847301|531331768|FG000|Overall Study|Adverse Event|35|||
147137557|NCT02103062|530671959|FG000|Overall Study|Progressive Disease|17|||
147137558|NCT02103062|530671960|FG001|Overall Study|Progressive Disease|20|||
147137559|NCT02103062|530671959|FG000|Overall Study|Death|0|||
147137560|NCT02103062|530671960|FG001|Overall Study|Death|1|||
147137561|NCT01182298|530671961|FG000|Overall Study|Lack of Efficacy|4|||
147237613|NCT04154930|531040685|FG001|Overall Study|Other|0|||
147237614|NCT02628938|531040686|FG000|Overall Study|Did not attend the follow up recall|2|||
147572370|NCT03606174|532253723|FG006|Overall Study|Lost to Follow-up|0|||
147137562|NCT01182298|530671961|FG000|Overall Study|Withdrawal by Subject|2|||
147137563|NCT02629861|530671963|FG000|Overall Study|Adverse Event|7|||
147137564|NCT02629861|530671964|FG001|Overall Study|Adverse Event|5|||
147137565|NCT02629861|530671965|FG002|Overall Study|Adverse Event|4|||
147137566|NCT02629861|530671963|FG000|Overall Study|Withdrawal by Subject|5|||
147137567|NCT02629861|530671964|FG001|Overall Study|Withdrawal by Subject|8|||
147137568|NCT02629861|530671965|FG002|Overall Study|Withdrawal by Subject|13|||
147137569|NCT02629861|530671963|FG000|Overall Study|Protocol Violation|2|||
147137570|NCT02629861|530671964|FG001|Overall Study|Protocol Violation|3|||
147137571|NCT02629861|530671965|FG002|Overall Study|Protocol Violation|7|||
147137572|NCT02629861|530671963|FG000|Overall Study|Lost to Follow-up|12|||
147137573|NCT02629861|530671964|FG001|Overall Study|Lost to Follow-up|9|||
147137574|NCT02629861|530671965|FG002|Overall Study|Lost to Follow-up|4|||
147137575|NCT02629861|530671963|FG000|Overall Study|Other|1|||
147137576|NCT02629861|530671964|FG001|Overall Study|Other|1|||
147137577|NCT02629861|530671965|FG002|Overall Study|Other|0|||
147137578|NCT02629861|530671963|FG000|Overall Study|Pregnancy|2|||
147137579|NCT02629861|530671964|FG001|Overall Study|Pregnancy|1|||
147137580|NCT02629861|530671965|FG002|Overall Study|Pregnancy|0|||
147137581|NCT00730886|530671966|FG000|Overall Study|Lost to Follow-up|1|||
147137582|NCT00730886|530671967|FG001|Overall Study|Lost to Follow-up|0|||
147137583|NCT00730886|530671966|FG000|Overall Study|Physician Decision|1|||
147137584|NCT00730886|530671967|FG001|Overall Study|Physician Decision|0|||
147137585|NCT01991483|530671968|FG000|Dose Level 600 mg|Withdrawal by Subject|0|||
147137586|NCT01991483|530671969|FG001|Dose Level 600 mg|Withdrawal by Subject|0|||
147137587|NCT01991483|530671970|FG002|Dose Level 600 mg|Withdrawal by Subject|1|||
147137588|NCT01991483|530671971|FG003|Dose Level 600 mg|Withdrawal by Subject|0|||
147137589|NCT01991483|530671968|FG000|Dose Level 600 mg|Physician Decision|0|||
147137590|NCT01991483|530671969|FG001|Dose Level 600 mg|Physician Decision|0|||
147137591|NCT01991483|530671970|FG002|Dose Level 600 mg|Physician Decision|1|||
147137592|NCT01991483|530671971|FG003|Dose Level 600 mg|Physician Decision|0|||
147137593|NCT01991483|530671968|FG000|Dose Level 1000 mg|Protocol Violation|0|||
147137594|NCT01991483|530671969|FG001|Dose Level 1000 mg|Protocol Violation|0|||
147137595|NCT01991483|530671970|FG002|Dose Level 1000 mg|Protocol Violation|0|||
147137596|NCT01991483|530671971|FG003|Dose Level 1000 mg|Protocol Violation|1|||
147137597|NCT02030821|530671974|FG000|Overall Study|Physician Decision|2|||
147137598|NCT02030821|530671975|FG001|Overall Study|Physician Decision|2|||
147137599|NCT02030821|530671976|FG002|Overall Study|Physician Decision|5|||
147137600|NCT02030821|530671977|FG003|Overall Study|Physician Decision|2|||
147137601|NCT00716274|530671983|FG000|Study Period II (16-Weeks)|Entry Criteria Not Met|2|||
147137602|NCT00716274|530671984|FG001|Study Period II (16-Weeks)|Entry Criteria Not Met|0|||
147137603|NCT00716274|530671985|FG002|Study Period II (16-Weeks)|Entry Criteria Not Met|0|||
147572371|NCT03606174|532253724|FG007|Overall Study|Lost to Follow-up|0|||
147137604|NCT00716274|530671986|FG003|Study Period II (16-Weeks)|Entry Criteria Not Met|0|||
147137605|NCT00716274|530671987|FG004|Study Period II (16-Weeks)|Entry Criteria Not Met|0|||
147137606|NCT00716274|530671988|FG005|Study Period II (16-Weeks)|Entry Criteria Not Met|0|||
147137607|NCT00716274|530671983|FG000|Study Period II (16-Weeks)|Protocol Violation|0|||
147137608|NCT00716274|530671984|FG001|Study Period II (16-Weeks)|Protocol Violation|3|||
147137609|NCT00716274|530671985|FG002|Study Period II (16-Weeks)|Protocol Violation|0|||
147137610|NCT00716274|530671986|FG003|Study Period II (16-Weeks)|Protocol Violation|0|||
147137611|NCT00716274|530671987|FG004|Study Period II (16-Weeks)|Protocol Violation|0|||
147137612|NCT00716274|530671988|FG005|Study Period II (16-Weeks)|Protocol Violation|1|||
147137613|NCT00716274|530671983|FG000|Study Period II (16-Weeks)|Withdrawal by Subject|1|||
147137614|NCT00716274|530671984|FG001|Study Period II (16-Weeks)|Withdrawal by Subject|0|||
147137615|NCT00716274|530671985|FG002|Study Period II (16-Weeks)|Withdrawal by Subject|0|||
147137616|NCT00716274|530671986|FG003|Study Period II (16-Weeks)|Withdrawal by Subject|0|||
147137617|NCT00716274|530671987|FG004|Study Period II (16-Weeks)|Withdrawal by Subject|0|||
147137618|NCT00716274|530671988|FG005|Study Period II (16-Weeks)|Withdrawal by Subject|0|||
147572372|NCT03606174|532253725|FG008|Overall Study|Lost to Follow-up|0|||
147572373|NCT03606174|532253726|FG009|Overall Study|Lost to Follow-up|0|||
147572374|NCT03606174|532253727|FG010|Overall Study|Lost to Follow-up|0|||
147572375|NCT03606174|532253717|FG000|Overall Study|Withdrawal by Subject|6|||
147572376|NCT03606174|532253718|FG001|Overall Study|Withdrawal by Subject|0|||
147137619|NCT00716274|530671983|FG000|Study Period II (16-Weeks)|Physician Decision|3|||
147137620|NCT00716274|530671984|FG001|Study Period II (16-Weeks)|Physician Decision|1|||
147137621|NCT00716274|530671985|FG002|Study Period II (16-Weeks)|Physician Decision|0|||
147137622|NCT00716274|530671986|FG003|Study Period II (16-Weeks)|Physician Decision|0|||
147137623|NCT00716274|530671987|FG004|Study Period II (16-Weeks)|Physician Decision|0|||
147137624|NCT00716274|530671988|FG005|Study Period II (16-Weeks)|Physician Decision|1|||
147137625|NCT00716274|530671983|FG000|Study Period II (16-Weeks)|Parent/Caregiver Decision|3|||
147137626|NCT00716274|530671984|FG001|Study Period II (16-Weeks)|Parent/Caregiver Decision|3|||
147237615|NCT02628938|531040687|FG001|Overall Study|Did not attend the follow up recall|2|||
147572377|NCT03606174|532253719|FG002|Overall Study|Withdrawal by Subject|0|||
147572378|NCT03606174|532253720|FG003|Overall Study|Withdrawal by Subject|1|||
147572379|NCT03606174|532253721|FG004|Overall Study|Withdrawal by Subject|2|||
147137627|NCT00716274|530671985|FG002|Study Period II (16-Weeks)|Parent/Caregiver Decision|0|||
147137628|NCT00716274|530671986|FG003|Study Period II (16-Weeks)|Parent/Caregiver Decision|0|||
147137629|NCT00716274|530671987|FG004|Study Period II (16-Weeks)|Parent/Caregiver Decision|0|||
147137630|NCT00716274|530671988|FG005|Study Period II (16-Weeks)|Parent/Caregiver Decision|0|||
147137631|NCT00716274|530671983|FG000|Study Period II (16-Weeks)|Lost to Follow-up|0|||
147137632|NCT00716274|530671984|FG001|Study Period II (16-Weeks)|Lost to Follow-up|2|||
147137633|NCT00716274|530671985|FG002|Study Period II (16-Weeks)|Lost to Follow-up|0|||
147137634|NCT00716274|530671986|FG003|Study Period II (16-Weeks)|Lost to Follow-up|0|||
147137635|NCT00716274|530671987|FG004|Study Period II (16-Weeks)|Lost to Follow-up|0|||
147137636|NCT00716274|530671988|FG005|Study Period II (16-Weeks)|Lost to Follow-up|0|||
147137637|NCT00716274|530671983|FG000|Study Period III (16-Weeks)|Withdrawal by Subject|0|||
147137638|NCT00716274|530671984|FG001|Study Period III (16-Weeks)|Withdrawal by Subject|0|||
147137639|NCT00716274|530671985|FG002|Study Period III (16-Weeks)|Withdrawal by Subject|2|||
147137640|NCT00716274|530671986|FG003|Study Period III (16-Weeks)|Withdrawal by Subject|0|||
147137641|NCT00716274|530671987|FG004|Study Period III (16-Weeks)|Withdrawal by Subject|0|||
147137642|NCT00716274|530671988|FG005|Study Period III (16-Weeks)|Withdrawal by Subject|0|||
147137643|NCT00716274|530671983|FG000|Study Period III (16-Weeks)|Physician Decision|0|||
147137644|NCT00716274|530671984|FG001|Study Period III (16-Weeks)|Physician Decision|0|||
147137645|NCT00716274|530671985|FG002|Study Period III (16-Weeks)|Physician Decision|0|||
147137646|NCT00716274|530671986|FG003|Study Period III (16-Weeks)|Physician Decision|0|||
147137647|NCT00716274|530671987|FG004|Study Period III (16-Weeks)|Physician Decision|1|||
147137648|NCT00716274|530671988|FG005|Study Period III (16-Weeks)|Physician Decision|0|||
147137649|NCT00716274|530671983|FG000|Study Period III (16-Weeks)|Parent Caregiver Decision|0|||
147137650|NCT00716274|530671984|FG001|Study Period III (16-Weeks)|Parent Caregiver Decision|0|||
147137651|NCT00716274|530671985|FG002|Study Period III (16-Weeks)|Parent Caregiver Decision|0|||
147137652|NCT00716274|530671986|FG003|Study Period III (16-Weeks)|Parent Caregiver Decision|1|||
147137653|NCT00716274|530671987|FG004|Study Period III (16-Weeks)|Parent Caregiver Decision|1|||
147137654|NCT00716274|530671988|FG005|Study Period III (16-Weeks)|Parent Caregiver Decision|0|||
147137655|NCT00716274|530671983|FG000|Study Period III (16-Weeks)|Adverse Event|0|||
147137656|NCT00716274|530671984|FG001|Study Period III (16-Weeks)|Adverse Event|0|||
147137657|NCT00716274|530671985|FG002|Study Period III (16-Weeks)|Adverse Event|0|||
147137658|NCT00716274|530671986|FG003|Study Period III (16-Weeks)|Adverse Event|0|||
147137659|NCT00716274|530671987|FG004|Study Period III (16-Weeks)|Adverse Event|1|||
147137660|NCT00716274|530671988|FG005|Study Period III (16-Weeks)|Adverse Event|0|||
147137661|NCT04021290|530671994|FG000|Randomized Phase (Day1 to Week 52)|Adverse Event|4|||
147137662|NCT04021290|530671995|FG001|Randomized Phase (Day1 to Week 52)|Adverse Event|3|||
147137663|NCT04021290|530671996|FG002|Randomized Phase (Day1 to Week 52)|Adverse Event|0|||
147137664|NCT04021290|530671994|FG000|Randomized Phase (Day1 to Week 52)|Lack of Efficacy|0|||
147137665|NCT04021290|530671995|FG001|Randomized Phase (Day1 to Week 52)|Lack of Efficacy|3|||
147137666|NCT04021290|530671996|FG002|Randomized Phase (Day1 to Week 52)|Lack of Efficacy|0|||
147137667|NCT04021290|530671994|FG000|Randomized Phase (Day1 to Week 52)|Lost to Follow-up|2|||
147137668|NCT04021290|530671995|FG001|Randomized Phase (Day1 to Week 52)|Lost to Follow-up|1|||
147137669|NCT04021290|530671996|FG002|Randomized Phase (Day1 to Week 52)|Lost to Follow-up|0|||
147137670|NCT04021290|530671994|FG000|Randomized Phase (Day1 to Week 52)|Death|1|||
147137671|NCT04021290|530671995|FG001|Randomized Phase (Day1 to Week 52)|Death|0|||
147137672|NCT04021290|530671996|FG002|Randomized Phase (Day1 to Week 52)|Death|0|||
147137673|NCT04021290|530671994|FG000|Randomized Phase (Day1 to Week 52)|Physician Decision|1|||
147137674|NCT04021290|530671995|FG001|Randomized Phase (Day1 to Week 52)|Physician Decision|2|||
147137675|NCT04021290|530671996|FG002|Randomized Phase (Day1 to Week 52)|Physician Decision|0|||
147137676|NCT04021290|530671994|FG000|Randomized Phase (Day1 to Week 52)|Withdrawal by Subject|1|||
147137677|NCT04021290|530671995|FG001|Randomized Phase (Day1 to Week 52)|Withdrawal by Subject|5|||
147137678|NCT04021290|530671996|FG002|Randomized Phase (Day1 to Week 52)|Withdrawal by Subject|0|||
147137679|NCT04021290|530671994|FG000|Randomized Phase (Day1 to Week 52)|Transferred to continuation phase|96|||
147137680|NCT04021290|530671995|FG001|Randomized Phase (Day1 to Week 52)|Transferred to continuation phase|0|||
147137681|NCT04021290|530671996|FG002|Randomized Phase (Day1 to Week 52)|Transferred to continuation phase|0|||
147137682|NCT04021290|530671994|FG000|Randomized Phase (Day1 to Week 52)|Protocol Deviation|5|||
147137683|NCT04021290|530671995|FG001|Randomized Phase (Day1 to Week 52)|Protocol Deviation|4|||
147137684|NCT04021290|530671996|FG002|Randomized Phase (Day1 to Week 52)|Protocol Deviation|0|||
147137685|NCT04021290|530671994|FG000|Continuation Phase (Week 52 to Week 132)|Physician Decision|0|||
147137686|NCT04021290|530671995|FG001|Continuation Phase (Week 52 to Week 132)|Physician Decision|0|||
147137687|NCT04021290|530671996|FG002|Continuation Phase (Week 52 to Week 132)|Physician Decision|1|||
147137688|NCT04021290|530671994|FG000|Continuation Phase (Week 52 to Week 132)|Lost to Follow-up|0|||
147572380|NCT03606174|532253722|FG005|Overall Study|Withdrawal by Subject|1|||
147572381|NCT03606174|532253723|FG006|Overall Study|Withdrawal by Subject|4|||
147572382|NCT03606174|532253724|FG007|Overall Study|Withdrawal by Subject|0|||
147572383|NCT03606174|532253725|FG008|Overall Study|Withdrawal by Subject|0|||
147572384|NCT03606174|532253726|FG009|Overall Study|Withdrawal by Subject|0|||
147572385|NCT03606174|532253727|FG010|Overall Study|Withdrawal by Subject|1|||
147137689|NCT04021290|530671995|FG001|Continuation Phase (Week 52 to Week 132)|Lost to Follow-up|0|||
147137690|NCT04021290|530671996|FG002|Continuation Phase (Week 52 to Week 132)|Lost to Follow-up|1|||
147137691|NCT04021290|530671994|FG000|Continuation Phase (Week 52 to Week 132)|Lack of Efficacy|0|||
147137692|NCT04021290|530671995|FG001|Continuation Phase (Week 52 to Week 132)|Lack of Efficacy|0|||
147137693|NCT04021290|530671996|FG002|Continuation Phase (Week 52 to Week 132)|Lack of Efficacy|1|||
147137694|NCT04021290|530671994|FG000|Continuation Phase (Week 52 to Week 132)|Adverse Event|0|||
147137695|NCT04021290|530671995|FG001|Continuation Phase (Week 52 to Week 132)|Adverse Event|0|||
147137696|NCT04021290|530671996|FG002|Continuation Phase (Week 52 to Week 132)|Adverse Event|2|||
147137697|NCT01174563|530672006|FG000|Overall Study|Progressive Disease|45|||
147137698|NCT01174563|530672006|FG000|Overall Study|Death|5|||
147137699|NCT01174563|530672006|FG000|Overall Study|Investigator's Discretion|5|||
147137700|NCT01174563|530672006|FG000|Overall Study|Participant Withdrew Consent|3|||
147137701|NCT01174563|530672006|FG000|Overall Study|Rash Adverse Event|1|||
147137702|NCT01174563|530672006|FG000|Overall Study|Sponsor's decision|1|||
147137703|NCT00444106|530672007|FG000|Overall Study|Lost to Follow-up|2|||
147137704|NCT00444106|530672008|FG001|Overall Study|Lost to Follow-up|1|||
147137705|NCT00444106|530672009|FG002|Overall Study|Lost to Follow-up|0|||
147137706|NCT00444106|530672007|FG000|Overall Study|Abnormal Test Procedure Results|0|||
147137707|NCT00444106|530672008|FG001|Overall Study|Abnormal Test Procedure Results|0|||
147137708|NCT00444106|530672009|FG002|Overall Study|Abnormal Test Procedure Results|1|||
147137709|NCT01634152|530672010|FG000|Overall Study|Adverse Event|2|||
147137710|NCT01634152|530672011|FG001|Overall Study|Adverse Event|0|||
147137711|NCT01634152|530672012|FG002|Overall Study|Adverse Event|2|||
147137712|NCT01634152|530672010|FG000|Overall Study|Consent withdrawn not due to AE|1|||
147137713|NCT01634152|530672011|FG001|Overall Study|Consent withdrawn not due to AE|0|||
147137714|NCT01634152|530672012|FG002|Overall Study|Consent withdrawn not due to AE|1|||
147137715|NCT01634152|530672010|FG000|Overall Study|Not treated|0|||
147137716|NCT01634152|530672011|FG001|Overall Study|Not treated|1|||
147137717|NCT01634152|530672012|FG002|Overall Study|Not treated|0|||
147137718|NCT01634152|530672010|FG000|Overall Study|Other reason not defined above|1|||
147137719|NCT01634152|530672011|FG001|Overall Study|Other reason not defined above|0|||
147137720|NCT01634152|530672012|FG002|Overall Study|Other reason not defined above|1|||
147137721|NCT01152437|530672016|FG000|Overall Study|Other Adverse Event|8|||
147137722|NCT01152437|530672017|FG001|Overall Study|Other Adverse Event|1|||
147137723|NCT01152437|530672018|FG002|Overall Study|Other Adverse Event|7|||
147137724|NCT01152437|530672016|FG000|Overall Study|Not treated|0|||
147137725|NCT01152437|530672017|FG001|Overall Study|Not treated|1|||
147137726|NCT01152437|530672018|FG002|Overall Study|Not treated|2|||
147137727|NCT01152437|530672016|FG000|Overall Study|Progressive disease|27|||
147137728|NCT01152437|530672017|FG001|Overall Study|Progressive disease|13|||
147137729|NCT01152437|530672018|FG002|Overall Study|Progressive disease|32|||
147137730|NCT01152437|530672016|FG000|Overall Study|Refusal to continue taking trial medicat|1|||
147137731|NCT01152437|530672017|FG001|Overall Study|Refusal to continue taking trial medicat|0|||
147137732|NCT01152437|530672018|FG002|Overall Study|Refusal to continue taking trial medicat|2|||
147137733|NCT00279214|530672023|FG000|Overall Study|Physician Decision|3|||
147137734|NCT00279214|530672024|FG001|Overall Study|Physician Decision|2|||
147137735|NCT01897532|530672025|FG000|Discontinuation From Treatment|Not Treated|7|||
147137736|NCT01897532|530672026|FG001|Discontinuation From Treatment|Not Treated|5|||
147137737|NCT01897532|530672025|FG000|Discontinuation From Treatment|Other reason than specified|196|||
147137738|NCT01897532|530672026|FG001|Discontinuation From Treatment|Other reason than specified|176|||
147137739|NCT01897532|530672025|FG000|Discontinuation From Treatment|Withdrawal by Subject|333|||
147137740|NCT01897532|530672026|FG001|Discontinuation From Treatment|Withdrawal by Subject|281|||
147137741|NCT01897532|530672025|FG000|Discontinuation From Treatment|Non compliance|24|||
147137742|NCT01897532|530672026|FG001|Discontinuation From Treatment|Non compliance|15|||
147137743|NCT01897532|530672025|FG000|Discontinuation From Treatment|Adverse event/ CV outcome event|402|||
147137744|NCT01897532|530672026|FG001|Discontinuation From Treatment|Adverse event/ CV outcome event|362|||
147137745|NCT01897532|530672025|FG000|Discontinuation From Trial|Not Treated|7|||
147137746|NCT01897532|530672026|FG001|Discontinuation From Trial|Not Treated|5|||
147137747|NCT01897532|530672025|FG000|Discontinuation From Trial|Patient lost to follow-up for MACE|55|||
147137748|NCT01897532|530672026|FG001|Discontinuation From Trial|Patient lost to follow-up for MACE|36|||
147137749|NCT00953706|530672029|FG000|Part A (16-Week Double-Blind Treatment)|Adverse Event|2|||
147137750|NCT00953706|530672030|FG001|Part A (16-Week Double-Blind Treatment)|Adverse Event|3|||
147137751|NCT00953706|530672031|FG002|Part A (16-Week Double-Blind Treatment)|Adverse Event|0|||
147137752|NCT00953706|530672032|FG003|Part A (16-Week Double-Blind Treatment)|Adverse Event|0|||
147137753|NCT00953706|530672029|FG000|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|0|||
147137754|NCT00953706|530672030|FG001|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|1|||
147137755|NCT00953706|530672031|FG002|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|0|||
147237616|NCT02628938|531040688|FG002|Overall Study|Did not attend the follow up recall|1|||
147237617|NCT02628938|531040686|FG000|Overall Study|Failure to comply with the instructions|3|||
147237618|NCT02628938|531040687|FG001|Overall Study|Failure to comply with the instructions|0|||
147137756|NCT00953706|530672032|FG003|Part A (16-Week Double-Blind Treatment)|Lost to Follow-up|0|||
147137757|NCT00953706|530672029|FG000|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|0|||
147137758|NCT00953706|530672030|FG001|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|2|||
147137759|NCT00953706|530672031|FG002|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|0|||
147137760|NCT00953706|530672032|FG003|Part A (16-Week Double-Blind Treatment)|Noncompliance with Study Requirements|0|||
147137761|NCT00953706|530672029|FG000|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|0|||
147137762|NCT00953706|530672030|FG001|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|1|||
147137763|NCT00953706|530672031|FG002|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|0|||
147137764|NCT00953706|530672032|FG003|Part A (16-Week Double-Blind Treatment)|Required Prohibited Medication|0|||
147137765|NCT00953706|530672029|FG000|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|0|||
147137766|NCT00953706|530672030|FG001|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|1|||
147137767|NCT00953706|530672031|FG002|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|0|||
147137768|NCT00953706|530672032|FG003|Part A (16-Week Double-Blind Treatment)|Sponsor Decision|0|||
147137769|NCT00953706|530672029|FG000|Part B (96-Week Open-Label Extension)|Adverse Event|0|||
147137770|NCT00953706|530672030|FG001|Part B (96-Week Open-Label Extension)|Adverse Event|0|||
147137771|NCT00953706|530672031|FG002|Part B (96-Week Open-Label Extension)|Adverse Event|0|||
147137772|NCT00953706|530672032|FG003|Part B (96-Week Open-Label Extension)|Adverse Event|2|||
147137773|NCT00953706|530672029|FG000|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|0|||
147137774|NCT00953706|530672030|FG001|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|0|||
147137775|NCT00953706|530672031|FG002|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|0|||
147137776|NCT00953706|530672032|FG003|Part B (96-Week Open-Label Extension)|Noncompliance with Study Requirements|1|||
147137777|NCT00953706|530672029|FG000|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|0|||
147137778|NCT00953706|530672030|FG001|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|0|||
147137779|NCT00953706|530672031|FG002|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|0|||
147137780|NCT00953706|530672032|FG003|Part B (96-Week Open-Label Extension)|Required Prohibited Medication|1|||
147137781|NCT00953706|530672029|FG000|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|0|||
147137782|NCT00953706|530672030|FG001|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|0|||
147137783|NCT00953706|530672031|FG002|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|4|||
147137784|NCT00953706|530672032|FG003|Part B (96-Week Open-Label Extension)|Study Termination by Sponsor|25|||
147137785|NCT00953706|530672029|FG000|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|0|||
147137786|NCT00953706|530672030|FG001|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|0|||
147137787|NCT00953706|530672031|FG002|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|1|||
147137788|NCT00953706|530672032|FG003|Part B (96-Week Open-Label Extension)|Withdrawal by Subject|2|||
147137789|NCT00953706|530672029|FG000|Part B (96-Week Open-Label Extension)|Other|0|||
147137790|NCT00953706|530672030|FG001|Part B (96-Week Open-Label Extension)|Other|0|||
147137791|NCT00953706|530672031|FG002|Part B (96-Week Open-Label Extension)|Other|0|||
147137792|NCT00953706|530672032|FG003|Part B (96-Week Open-Label Extension)|Other|2|||
147137793|NCT01088906|530672033|FG000|Overall Study|Inclusion error|1|||
147137794|NCT01088906|530672033|FG000|Overall Study|Did not receive study treatment|3|||
147137795|NCT01088906|530672033|FG000|Overall Study|Missing data|1|||
147137796|NCT00457626|530672034|FG000|Overall Study|Adverse Event|3|||
147137797|NCT00457626|530672034|FG000|Overall Study|Administrative Problems|2|||
147137798|NCT00457626|530672034|FG000|Overall Study|Participant's Condition No Longer Requires Study Drug|1|||
147137799|NCT01783444|530673712|FG000|Treatment Phase|Adverse Event|9|||
147137800|NCT01783444|530673713|FG001|Treatment Phase|Adverse Event|20|||
147137801|NCT01783444|530673714|FG002|Treatment Phase|Adverse Event|19|||
147137802|NCT01783444|530673712|FG000|Treatment Phase|Disease Progression|76|||
147137803|NCT01783444|530673713|FG001|Treatment Phase|Disease Progression|66|||
147137804|NCT01783444|530673714|FG002|Treatment Phase|Disease Progression|64|||
147137805|NCT01783444|530673712|FG000|Treatment Phase|Death|2|||
147137806|NCT01783444|530673713|FG001|Treatment Phase|Death|2|||
147137807|NCT01783444|530673714|FG002|Treatment Phase|Death|2|||
147137808|NCT01783444|530673712|FG000|Treatment Phase|Protocol Violation|1|||
147137809|NCT01783444|530673713|FG001|Treatment Phase|Protocol Violation|1|||
147137810|NCT01783444|530673714|FG002|Treatment Phase|Protocol Violation|2|||
147137811|NCT01783444|530673712|FG000|Treatment Phase|Withdrawal by Subject|6|||
147137812|NCT01783444|530673713|FG001|Treatment Phase|Withdrawal by Subject|8|||
147137813|NCT01783444|530673714|FG002|Treatment Phase|Withdrawal by Subject|9|||
147137814|NCT01783444|530673712|FG000|Treatment Phase|Administrative problems|2|||
147137815|NCT01783444|530673713|FG001|Treatment Phase|Administrative problems|0|||
147137816|NCT01783444|530673714|FG002|Treatment Phase|Administrative problems|1|||
147137817|NCT01783444|530673712|FG000|Treatment Phase|Physician Decision|8|||
147137818|NCT01783444|530673713|FG001|Treatment Phase|Physician Decision|6|||
147137819|NCT01783444|530673714|FG002|Treatment Phase|Physician Decision|5|||
147237619|NCT02628938|531040688|FG002|Overall Study|Failure to comply with the instructions|3|||
147237620|NCT02058693|531040689|FG000|Phase 1|Withdrawal by Subject|3|||
147237621|NCT02058693|531040690|FG001|Phase 1|Withdrawal by Subject|2|||
147651827|NCT01483599|532546590|FG010|After Controlled Period(Week 16-Week 40)|Death|0|||
147137820|NCT01783444|530673712|FG000|Post-Treatment Efficacy Follow-Up Phase|Disease Progression|7|||
147137821|NCT01783444|530673713|FG001|Post-Treatment Efficacy Follow-Up Phase|Disease Progression|8|||
147137822|NCT01783444|530673714|FG002|Post-Treatment Efficacy Follow-Up Phase|Disease Progression|11|||
147137823|NCT01783444|530673712|FG000|Post-Treatment Efficacy Follow-Up Phase|Death|9|||
147137824|NCT01783444|530673713|FG001|Post-Treatment Efficacy Follow-Up Phase|Death|7|||
147137825|NCT01783444|530673714|FG002|Post-Treatment Efficacy Follow-Up Phase|Death|5|||
147137826|NCT01783444|530673712|FG000|Post-Treatment Efficacy Follow-Up Phase|Withdrawal by Subject|4|||
147137827|NCT01783444|530673713|FG001|Post-Treatment Efficacy Follow-Up Phase|Withdrawal by Subject|8|||
147137828|NCT01783444|530673714|FG002|Post-Treatment Efficacy Follow-Up Phase|Withdrawal by Subject|8|||
147137829|NCT01783444|530673712|FG000|Post-Treatment Efficacy Follow-Up Phase|Administrative Problems|0|||
147137830|NCT01783444|530673713|FG001|Post-Treatment Efficacy Follow-Up Phase|Administrative Problems|1|||
147137831|NCT01783444|530673714|FG002|Post-Treatment Efficacy Follow-Up Phase|Administrative Problems|0|||
147137832|NCT01783444|530673712|FG000|Post-Treatment Efficacy Follow-Up Phase|New cancer therapy|7|||
147137833|NCT01783444|530673713|FG001|Post-Treatment Efficacy Follow-Up Phase|New cancer therapy|16|||
147137834|NCT01783444|530673714|FG002|Post-Treatment Efficacy Follow-Up Phase|New cancer therapy|15|||
147137835|NCT01783444|530673712|FG000|Post-Treatment Efficacy Follow-Up Phase|Followup phase completed as per protocol|69|||
147137836|NCT01783444|530673713|FG001|Post-Treatment Efficacy Follow-Up Phase|Followup phase completed as per protocol|53|||
147137837|NCT01783444|530673714|FG002|Post-Treatment Efficacy Follow-Up Phase|Followup phase completed as per protocol|52|||
147137838|NCT00552071|530673715|FG000|Overall Study|Adverse Event|1|||
147137839|NCT00552071|530673716|FG001|Overall Study|Adverse Event|0|||
147137840|NCT00552071|530673715|FG000|Overall Study|Lack of Efficacy|1|||
147137841|NCT00552071|530673716|FG001|Overall Study|Lack of Efficacy|0|||
147137842|NCT00552071|530673715|FG000|Overall Study|Physician Decision|1|||
147137843|NCT00552071|530673716|FG001|Overall Study|Physician Decision|0|||
147137844|NCT00552071|530673715|FG000|Overall Study|Pregnancy|1|||
147137845|NCT00552071|530673716|FG001|Overall Study|Pregnancy|0|||
147137846|NCT00552071|530673715|FG000|Overall Study|Death|0|||
147137847|NCT00552071|530673716|FG001|Overall Study|Death|1|||
147137848|NCT00552071|530673715|FG000|Overall Study|Withdrawal by Subject|0|||
147137849|NCT00552071|530673716|FG001|Overall Study|Withdrawal by Subject|1|||
147137850|NCT00937495|530673721|FG000|Overall Study|Protocol Violation|2|||
147137851|NCT00441272|530673722|FG000|Overall Study|Study terminated prior to enrollment|25|||
147137852|NCT00441272|530673723|FG001|Overall Study|Study terminated prior to enrollment|25|||
147137853|NCT00954447|530673724|FG000|Overall Study|Adverse Event|33|||
147137854|NCT00954447|530673725|FG001|Overall Study|Adverse Event|25|||
147137855|NCT00954447|530673724|FG000|Overall Study|Lack of Efficacy|17|||
147137856|NCT00954447|530673725|FG001|Overall Study|Lack of Efficacy|3|||
147137857|NCT00954447|530673724|FG000|Overall Study|Protocol Violation|5|||
147137858|NCT00954447|530673725|FG001|Overall Study|Protocol Violation|7|||
147137859|NCT00954447|530673724|FG000|Overall Study|Lost to Follow-up|8|||
147137860|NCT00954447|530673725|FG001|Overall Study|Lost to Follow-up|14|||
147137861|NCT00954447|530673724|FG000|Overall Study|Withdrawal by Subject|26|||
147137862|NCT00954447|530673725|FG001|Overall Study|Withdrawal by Subject|21|||
147137863|NCT00954447|530673724|FG000|Overall Study|Other|21|||
147137864|NCT00954447|530673725|FG001|Overall Study|Other|18|||
147137865|NCT04592341|530673726|FG000|Overall Study|Physician Decision|5|||
147137866|NCT04592341|530673726|FG000|Overall Study|Study Terminated by Sponsor|5|||
147137867|NCT04592341|530673726|FG000|Overall Study|Withdrawal by Subject|53|||
147137868|NCT04592341|530673726|FG000|Overall Study|Lost to Follow-up|3|||
147137869|NCT04592341|530673726|FG000|Overall Study|Death|1|||
147137870|NCT04592341|530673726|FG000|Overall Study|Adverse Event|5|||
147137871|NCT04592341|530673726|FG000|Overall Study|other|4|||
147137872|NCT00692003|530673727|FG000|Overall Study|Sponsor Decision|5|||
147137873|NCT00692003|530673728|FG001|Overall Study|Sponsor Decision|1|||
147137874|NCT01535287|530673731|FG000|Overall Study|drug not prepared in time|5|||
147137875|NCT01535287|530673732|FG001|Overall Study|drug not prepared in time|6|||
147137876|NCT00517699|530673733|FG000|Overall Study|Withdrawal by Subject|1|||
147137877|NCT00517699|530673733|FG000|Overall Study|Lack of Efficacy|1|||
147137878|NCT00517699|530673733|FG000|Overall Study|Administrative error|1|||
147137879|NCT00517699|530673733|FG000|Overall Study|Study terminated by Sponsor|2|||
147137880|NCT03341637|530673734|FG000|Overall Study|Lost to Follow-up|1|||
147137881|NCT03341637|530673735|FG001|Overall Study|Lost to Follow-up|0|||
147137882|NCT03341637|530673734|FG000|Overall Study|Withdrawal by Subject|3|||
147137883|NCT03341637|530673735|FG001|Overall Study|Withdrawal by Subject|3|||
147137884|NCT03341637|530673734|FG000|Overall Study|Reason not Specified|1|||
147137885|NCT03341637|530673735|FG001|Overall Study|Reason not Specified|1|||
147137886|NCT01815424|530673746|FG000|Week 0 to 16|Adverse Event|1|||
147137887|NCT01815424|530673747|FG001|Week 0 to 16|Adverse Event|3|||
147137888|NCT01815424|530673748|FG002|Week 0 to 16|Adverse Event|3|||
147137889|NCT01815424|530673749|FG003|Week 0 to 16|Adverse Event|0|||
147137890|NCT01815424|530673750|FG004|Week 0 to 16|Adverse Event|0|||
147137891|NCT01815424|530673746|FG000|Week 0 to 16|Does Not Meet Entrance Criteria|2|||
147137892|NCT01815424|530673747|FG001|Week 0 to 16|Does Not Meet Entrance Criteria|0|||
147237622|NCT02058693|531040689|FG000|Phase 1|Adverse Event|0|||
147137893|NCT01815424|530673748|FG002|Week 0 to 16|Does Not Meet Entrance Criteria|0|||
147137894|NCT01815424|530673749|FG003|Week 0 to 16|Does Not Meet Entrance Criteria|0|||
147137895|NCT01815424|530673750|FG004|Week 0 to 16|Does Not Meet Entrance Criteria|0|||
147137896|NCT01815424|530673746|FG000|Week 0 to 16|Lost to Follow-up|0|||
147137897|NCT01815424|530673747|FG001|Week 0 to 16|Lost to Follow-up|1|||
147137898|NCT01815424|530673748|FG002|Week 0 to 16|Lost to Follow-up|0|||
147137899|NCT01815424|530673749|FG003|Week 0 to 16|Lost to Follow-up|0|||
147137900|NCT01815424|530673750|FG004|Week 0 to 16|Lost to Follow-up|0|||
147137901|NCT01815424|530673746|FG000|Week 0 to 16|Withdrawal by Subject|0|||
147137902|NCT01815424|530673747|FG001|Week 0 to 16|Withdrawal by Subject|0|||
147137903|NCT01815424|530673748|FG002|Week 0 to 16|Withdrawal by Subject|1|||
147137904|NCT01815424|530673749|FG003|Week 0 to 16|Withdrawal by Subject|0|||
147137905|NCT01815424|530673750|FG004|Week 0 to 16|Withdrawal by Subject|0|||
147137906|NCT01815424|530673746|FG000|Week 0 to 16|Other|1|||
147137907|NCT01815424|530673747|FG001|Week 0 to 16|Other|0|||
147137908|NCT01815424|530673748|FG002|Week 0 to 16|Other|3|||
147137909|NCT01815424|530673749|FG003|Week 0 to 16|Other|0|||
147137910|NCT01815424|530673750|FG004|Week 0 to 16|Other|0|||
147137911|NCT01815424|530673746|FG000|Week 0 to 16|Protocol Violation|1|||
147137912|NCT01815424|530673747|FG001|Week 0 to 16|Protocol Violation|0|||
147137913|NCT01815424|530673748|FG002|Week 0 to 16|Protocol Violation|0|||
147137914|NCT01815424|530673749|FG003|Week 0 to 16|Protocol Violation|0|||
147137915|NCT01815424|530673750|FG004|Week 0 to 16|Protocol Violation|0|||
147137916|NCT01815424|530673746|FG000|Week 0 to 16|Insufficient Clinical Response|2|||
147137917|NCT01815424|530673747|FG001|Week 0 to 16|Insufficient Clinical Response|0|||
147137918|NCT01815424|530673748|FG002|Week 0 to 16|Insufficient Clinical Response|4|||
147137919|NCT01815424|530673749|FG003|Week 0 to 16|Insufficient Clinical Response|0|||
147137920|NCT01815424|530673750|FG004|Week 0 to 16|Insufficient Clinical Response|0|||
147137921|NCT01815424|530673746|FG000|Week 16 to 52|Other|0|||
147137922|NCT01815424|530673747|FG001|Week 16 to 52|Other|1|||
147137923|NCT01815424|530673748|FG002|Week 16 to 52|Other|0|||
147137924|NCT01815424|530673749|FG003|Week 16 to 52|Other|0|||
147137925|NCT01815424|530673750|FG004|Week 16 to 52|Other|0|||
147137926|NCT01815424|530673746|FG000|Week 16 to 52|Adverse Event|0|||
147137927|NCT01815424|530673747|FG001|Week 16 to 52|Adverse Event|0|||
147137928|NCT01815424|530673748|FG002|Week 16 to 52|Adverse Event|0|||
147137929|NCT01815424|530673749|FG003|Week 16 to 52|Adverse Event|0|||
147572386|NCT03606174|532253717|FG000|Overall Study|Study Terminated by Sponsor|5|||
147137930|NCT01815424|530673750|FG004|Week 16 to 52|Adverse Event|1|||
147137931|NCT01815424|530673746|FG000|Week 16 to 52|Insufficient Clinical Response|1|||
147137932|NCT01815424|530673747|FG001|Week 16 to 52|Insufficient Clinical Response|0|||
147137933|NCT01815424|530673748|FG002|Week 16 to 52|Insufficient Clinical Response|0|||
147137934|NCT01815424|530673749|FG003|Week 16 to 52|Insufficient Clinical Response|1|||
147137935|NCT01815424|530673750|FG004|Week 16 to 52|Insufficient Clinical Response|1|||
147137936|NCT01815424|530673746|FG000|Week 16 to 52|Lost to Follow-up|0|||
147137937|NCT01815424|530673747|FG001|Week 16 to 52|Lost to Follow-up|2|||
147137938|NCT01815424|530673748|FG002|Week 16 to 52|Lost to Follow-up|0|||
147137939|NCT01815424|530673749|FG003|Week 16 to 52|Lost to Follow-up|2|||
147137940|NCT01815424|530673750|FG004|Week 16 to 52|Lost to Follow-up|1|||
147137941|NCT01815424|530673746|FG000|Week 16 to 52|Withdrawal by Subject|1|||
147137942|NCT01815424|530673747|FG001|Week 16 to 52|Withdrawal by Subject|2|||
147137943|NCT01815424|530673748|FG002|Week 16 to 52|Withdrawal by Subject|0|||
147137944|NCT01815424|530673749|FG003|Week 16 to 52|Withdrawal by Subject|0|||
147137945|NCT01815424|530673750|FG004|Week 16 to 52|Withdrawal by Subject|0|||
147137946|NCT04723355|530673751|FG000|Overall Study|Issues with leads off, substantial ECG signal artefacts, and ECG data upload errors|50|||
147137947|NCT04723355|530673751|FG000|Overall Study|Errors in the informed consent form|2|||
147137948|NCT03374358|530673752|FG000|Overall Study|Withdrawal by Subject|0|||
147137949|NCT03374358|530673753|FG001|Overall Study|Withdrawal by Subject|2|||
147137950|NCT01127633|530673754|FG000|Overall Study|Adverse Event|74|||
147572387|NCT03606174|532253718|FG001|Overall Study|Study Terminated by Sponsor|7|||
147137951|NCT01127633|530673755|FG001|Overall Study|Adverse Event|73|||
147237623|NCT02058693|531040690|FG001|Phase 1|Adverse Event|1|||
147237624|NCT02058693|531040689|FG000|Phase 1|Lack of Efficacy|1|||
147572388|NCT03606174|532253719|FG002|Overall Study|Study Terminated by Sponsor|3|||
147137952|NCT01127633|530673754|FG000|Overall Study|Death|40|||
147137953|NCT01127633|530673755|FG001|Overall Study|Death|43|||
147137954|NCT01127633|530673754|FG000|Overall Study|Lost to Follow-up|4|||
147137955|NCT01127633|530673755|FG001|Overall Study|Lost to Follow-up|0|||
147137956|NCT01127633|530673754|FG000|Overall Study|Parent/Caregiver Decision|246|||
147137957|NCT01127633|530673755|FG001|Overall Study|Parent/Caregiver Decision|228|||
147137958|NCT01127633|530673754|FG000|Overall Study|Physician Decision|60|||
147137959|NCT01127633|530673755|FG001|Overall Study|Physician Decision|45|||
147137960|NCT01127633|530673754|FG000|Overall Study|Withdrawal by Subject|57|||
147137961|NCT01127633|530673755|FG001|Overall Study|Withdrawal by Subject|72|||
147137962|NCT01127633|530673754|FG000|Overall Study|Sponsor Decision|163|||
147137963|NCT01127633|530673755|FG001|Overall Study|Sponsor Decision|195|||
147237625|NCT02058693|531040690|FG001|Phase 1|Lack of Efficacy|0|||
147572389|NCT03606174|532253720|FG003|Overall Study|Study Terminated by Sponsor|0|||
147137964|NCT01127633|530673754|FG000|Overall Study|Protocol Violation|8|||
147137965|NCT01127633|530673755|FG001|Overall Study|Protocol Violation|16|||
147137966|NCT01127633|530673754|FG000|Overall Study|Abnormal Lab/ECG Result|0|||
147137967|NCT01127633|530673755|FG001|Overall Study|Abnormal Lab/ECG Result|1|||
147137968|NCT01127633|530673754|FG000|Overall Study|Not treated|1|||
147137969|NCT01127633|530673755|FG001|Overall Study|Not treated|0|||
147137970|NCT02805790|530673757|FG000|Second Intervention (4 Weeks)|Physician Decision|0|||
147137971|NCT02805790|530673758|FG001|Second Intervention (4 Weeks)|Physician Decision|1|||
147137972|NCT01639469|530673763|FG000|Overall Study|Death|4|||
147137973|NCT01639469|530673764|FG001|Overall Study|Death|2|||
147137974|NCT01639469|530673763|FG000|Overall Study|Lost to Follow-up|1|||
147137975|NCT01639469|530673764|FG001|Overall Study|Lost to Follow-up|1|||
147137976|NCT00420381|530673765|FG000|Overall Study|Protocol Violation|1|||
147137977|NCT02078752|530673766|FG000|Overall Study|Death|0|||
147137978|NCT02078752|530673767|FG001|Overall Study|Death|3|||
147137979|NCT02078752|530673768|FG002|Overall Study|Death|0|||
147137980|NCT02078752|530673769|FG003|Overall Study|Death|0|||
147137981|NCT02078752|530673770|FG004|Overall Study|Death|0|||
147137982|NCT02078752|530673771|FG005|Overall Study|Death|1|||
147137983|NCT02078752|530673772|FG006|Overall Study|Death|0|||
147137984|NCT02078752|530673773|FG007|Overall Study|Death|1|||
147137985|NCT02078752|530673774|FG008|Overall Study|Death|0|||
147137986|NCT02078752|530673775|FG009|Overall Study|Death|4|||
147137987|NCT02078752|530673766|FG000|Overall Study|Lost to Follow-up|1|||
147137988|NCT02078752|530673767|FG001|Overall Study|Lost to Follow-up|0|||
147137989|NCT02078752|530673768|FG002|Overall Study|Lost to Follow-up|0|||
147137990|NCT02078752|530673769|FG003|Overall Study|Lost to Follow-up|1|||
147137991|NCT02078752|530673770|FG004|Overall Study|Lost to Follow-up|0|||
147137992|NCT02078752|530673771|FG005|Overall Study|Lost to Follow-up|0|||
147137993|NCT02078752|530673772|FG006|Overall Study|Lost to Follow-up|0|||
147137994|NCT02078752|530673773|FG007|Overall Study|Lost to Follow-up|0|||
147137995|NCT02078752|530673774|FG008|Overall Study|Lost to Follow-up|0|||
147137996|NCT02078752|530673775|FG009|Overall Study|Lost to Follow-up|0|||
147137997|NCT02078752|530673766|FG000|Overall Study|Withdrawal by Subject|1|||
147137998|NCT02078752|530673767|FG001|Overall Study|Withdrawal by Subject|1|||
147137999|NCT02078752|530673768|FG002|Overall Study|Withdrawal by Subject|1|||
147138000|NCT02078752|530673769|FG003|Overall Study|Withdrawal by Subject|1|||
147138001|NCT02078752|530673770|FG004|Overall Study|Withdrawal by Subject|0|||
147138002|NCT02078752|530673771|FG005|Overall Study|Withdrawal by Subject|3|||
147138003|NCT02078752|530673772|FG006|Overall Study|Withdrawal by Subject|2|||
147138004|NCT02078752|530673773|FG007|Overall Study|Withdrawal by Subject|1|||
147138005|NCT02078752|530673774|FG008|Overall Study|Withdrawal by Subject|0|||
147138006|NCT02078752|530673775|FG009|Overall Study|Withdrawal by Subject|1|||
147138007|NCT02078752|530673766|FG000|Overall Study|Other|0|||
147138008|NCT02078752|530673767|FG001|Overall Study|Other|3|||
147138009|NCT02078752|530673768|FG002|Overall Study|Other|0|||
147138010|NCT02078752|530673769|FG003|Overall Study|Other|0|||
147138011|NCT02078752|530673770|FG004|Overall Study|Other|1|||
147138012|NCT02078752|530673771|FG005|Overall Study|Other|0|||
147138013|NCT02078752|530673772|FG006|Overall Study|Other|0|||
147138014|NCT02078752|530673773|FG007|Overall Study|Other|1|||
147138015|NCT02078752|530673774|FG008|Overall Study|Other|0|||
147318555|NCT00847301|531331768|FG000|Overall Study|Switch to other anticoagulants|16|||
147572390|NCT03606174|532253721|FG004|Overall Study|Study Terminated by Sponsor|11|||
147572391|NCT03606174|532253722|FG005|Overall Study|Study Terminated by Sponsor|6|||
147572392|NCT03606174|532253723|FG006|Overall Study|Study Terminated by Sponsor|12|||
147318556|NCT00847301|531331768|FG000|Overall Study|Lost to Follow-up|1|||
147318557|NCT00847301|531331768|FG000|Overall Study|No prescription after hospital discharge|1|||
147318558|NCT00847301|531331768|FG000|Overall Study|Other reason not defined above|1|||
147318559|NCT00996580|531331769|FG000|Overall Study|Adverse Event|466|||
147318560|NCT00996580|531331769|FG000|Overall Study|Lost to Follow-up|480|||
147572393|NCT03606174|532253724|FG007|Overall Study|Study Terminated by Sponsor|1|||
147572394|NCT03606174|532253725|FG008|Overall Study|Study Terminated by Sponsor|3|||
147572395|NCT03606174|532253726|FG009|Overall Study|Study Terminated by Sponsor|1|||
147138016|NCT02078752|530673775|FG009|Overall Study|Other|0|||
147138017|NCT02078752|530673766|FG000|Overall Study|Study terminated by sponsor|0|||
147138018|NCT02078752|530673767|FG001|Overall Study|Study terminated by sponsor|0|||
147138019|NCT02078752|530673768|FG002|Overall Study|Study terminated by sponsor|0|||
147138020|NCT02078752|530673769|FG003|Overall Study|Study terminated by sponsor|0|||
147138021|NCT02078752|530673770|FG004|Overall Study|Study terminated by sponsor|0|||
147138022|NCT02078752|530673771|FG005|Overall Study|Study terminated by sponsor|0|||
147318561|NCT00996580|531331769|FG000|Overall Study|Noncompliance with the protocol|137|||
147138023|NCT02078752|530673772|FG006|Overall Study|Study terminated by sponsor|0|||
147138024|NCT02078752|530673773|FG007|Overall Study|Study terminated by sponsor|0|||
147138025|NCT02078752|530673774|FG008|Overall Study|Study terminated by sponsor|0|||
147138026|NCT02078752|530673775|FG009|Overall Study|Study terminated by sponsor|5|||
147138027|NCT00775268|530673786|FG000|Baseline|Drug not synthesize dose|1|||
147318562|NCT00996580|531331769|FG000|Overall Study|Physician Decision|5|||
147572396|NCT03606174|532253727|FG010|Overall Study|Study Terminated by Sponsor|2|||
147572397|NCT03606174|532253717|FG000|Overall Study|Miscellaneous|1|||
147572398|NCT03606174|532253718|FG001|Overall Study|Miscellaneous|1|||
147572399|NCT03606174|532253719|FG002|Overall Study|Miscellaneous|0|||
147572400|NCT03606174|532253720|FG003|Overall Study|Miscellaneous|1|||
147572401|NCT03606174|532253721|FG004|Overall Study|Miscellaneous|4|||
147572402|NCT03606174|532253722|FG005|Overall Study|Miscellaneous|7|||
147572403|NCT03606174|532253723|FG006|Overall Study|Miscellaneous|5|||
147572404|NCT03606174|532253724|FG007|Overall Study|Miscellaneous|0|||
147572405|NCT03606174|532253725|FG008|Overall Study|Miscellaneous|0|||
147572406|NCT03606174|532253726|FG009|Overall Study|Miscellaneous|0|||
147572407|NCT03606174|532253727|FG010|Overall Study|Miscellaneous|1|||
147572408|NCT02241551|532253730|FG000|Overall Study|Adverse Event|1|||
147572409|NCT02241551|532253731|FG001|Overall Study|Adverse Event|0|||
147572410|NCT03246503|532253732|FG000|Overall Study|Lost to Follow-up|23|||
147572411|NCT03246503|532253732|FG000|Overall Study|Withdrawal by Subject|20|||
147572412|NCT03246503|532253732|FG000|Overall Study|Physician Decision|5|||
147572413|NCT03246503|532253732|FG000|Overall Study|Received phtototherapy prior to study visit=4, blood specimen not obtained =1|5|||
147572414|NCT01896934|532253740|FG000|Overall Study|Adverse Event|1|||
147572415|NCT01896934|532253740|FG000|Overall Study|Withdrawal by Subject|1|||
147572416|NCT02197416|532253741|FG000|Overall Study|Other reasons|0|||
147572417|NCT02197416|532253742|FG001|Overall Study|Other reasons|2|||
147572418|NCT02197416|532253743|FG002|Overall Study|Other reasons|5|||
147572419|NCT02197416|532253741|FG000|Overall Study|Withdrawal by Subject|0|||
147572420|NCT02197416|532253742|FG001|Overall Study|Withdrawal by Subject|2|||
147572421|NCT02197416|532253743|FG002|Overall Study|Withdrawal by Subject|1|||
147572422|NCT02197416|532253741|FG000|Overall Study|Protocol Violation|1|||
147572423|NCT02197416|532253742|FG001|Overall Study|Protocol Violation|0|||
147572424|NCT02197416|532253743|FG002|Overall Study|Protocol Violation|1|||
147572425|NCT02197416|532253741|FG000|Overall Study|Adverse Event|0|||
147572426|NCT02197416|532253742|FG001|Overall Study|Adverse Event|0|||
147572427|NCT02197416|532253743|FG002|Overall Study|Adverse Event|1|||
147572428|NCT00716625|532253744|FG000|Overall Study|Safety was not Assessable|1|||
147572429|NCT04590027|532253745|FG000|Overall Study|Lost to Follow-up|17|||
147572430|NCT04590027|532253746|FG001|Overall Study|Lost to Follow-up|14|||
147572431|NCT04590027|532253745|FG000|Overall Study|Protocol Violation|0|||
147572432|NCT04590027|532253746|FG001|Overall Study|Protocol Violation|3|||
147572433|NCT01383486|532253747|FG000|Overall Study|Lost to Follow-up|10|||
147572434|NCT01383486|532253747|FG000|Overall Study|Incomplete information for analysis|2|||
147572435|NCT01383486|532253747|FG000|Overall Study|Did not take any product|6|||
147572436|NCT03276754|532253749|FG000|Overall Study|Withdrawal of informed consent|4|||
147572437|NCT03276754|532253749|FG000|Overall Study|Presence of any immunosuppressive condition|8|||
147572438|NCT03276754|532253749|FG000|Overall Study|Lost to Follow-up|27|||
147572439|NCT03276754|532253749|FG000|Overall Study|No data reported at Month 24|31|||
147572440|NCT03276754|532253749|FG000|Overall Study|Death|39|||
147572441|NCT00927069|532253752|FG000|Week 0 to Week 12|Worsening of psoriasis|1|||
147572442|NCT00927069|532253753|FG001|Week 0 to Week 12|Worsening of psoriasis|1|||
147572443|NCT00927069|532253754|FG002|Week 0 to Week 12|Worsening of psoriasis|0|||
147138028|NCT00775268|530673787|FG001|Baseline|Drug not synthesize dose|0|||
147138029|NCT00775268|530673786|FG000|Baseline|Not treated-ineligible per CT|0|||
147138030|NCT00775268|530673787|FG001|Baseline|Not treated-ineligible per CT|1|||
147138031|NCT00775268|530673786|FG000|After 2 Cycles|Participant refused to be scanned further|1|||
147138032|NCT00775268|530673787|FG001|After 2 Cycles|Participant refused to be scanned further|0|||
147138033|NCT00775268|530673786|FG000|After Completion|Participant missed scan appointment|1|||
147138034|NCT00775268|530673787|FG001|After Completion|Participant missed scan appointment|0|||
147138035|NCT00825994|530673788|FG000|Overall Study|Withdrawal by Subject|2|||
147138036|NCT00825994|530673788|FG000|Overall Study|Lost to Follow-up|1|||
147138037|NCT00825994|530673788|FG000|Overall Study|Protocol Violation|1|||
147138038|NCT00825994|530673788|FG000|Overall Study|Placebo Responder at V2|1|||
147138039|NCT00616642|530673792|FG000|Overall Study|Withdrawal by Subject|0|||
147138040|NCT00616642|530673793|FG001|Overall Study|Withdrawal by Subject|1|||
147572444|NCT00927069|532253755|FG003|Week 0 to Week 12|Worsening of psoriasis|0|||
147572445|NCT00927069|532253752|FG000|Week 12 to Week 24|Lack of Efficacy|0|||
147572446|NCT00927069|532253753|FG001|Week 12 to Week 24|Lack of Efficacy|0|||
147138041|NCT01881009|530673799|FG000|Summer Camp Session (6 Days)|Unable to wear device|0|||
147572447|NCT00927069|532253754|FG002|Week 12 to Week 24|Lack of Efficacy|2|||
147651828|NCT01483599|532546591|FG011|After Controlled Period(Week 16-Week 40)|Death|0|||
147138042|NCT01881009|530673800|FG001|Summer Camp Session (6 Days)|Unable to wear device|1|||
147138043|NCT05518461|530673802|FG000|Overall Study|Lost to Follow-up|25|||
147318563|NCT00996580|531331769|FG000|Overall Study|Pregnancy|68|||
147572448|NCT00927069|532253755|FG003|Week 12 to Week 24|Lack of Efficacy|3|||
147572449|NCT00927069|532253752|FG000|Week 12 to Week 24|Lost to Follow-up|0|||
147572450|NCT00927069|532253753|FG001|Week 12 to Week 24|Lost to Follow-up|0|||
147138044|NCT03326063|530673804|FG000|Overall Study|COVID pandemic: subject recalled to her country|1|||
147572451|NCT00927069|532253754|FG002|Week 12 to Week 24|Lost to Follow-up|1|||
147572452|NCT00927069|532253755|FG003|Week 12 to Week 24|Lost to Follow-up|0|||
147572453|NCT00927069|532253752|FG000|Week 12 to Week 24|Withdrawal by Subject|1|||
147572454|NCT00927069|532253753|FG001|Week 12 to Week 24|Withdrawal by Subject|0|||
147138045|NCT03326063|530673805|FG001|Overall Study|COVID pandemic: subject recalled to her country|0|||
147138046|NCT01876381|530673806|FG000|Overall Study|Lack of Efficacy|5|||
147572455|NCT00927069|532253754|FG002|Week 12 to Week 24|Withdrawal by Subject|0|||
147138047|NCT01876381|530673806|FG000|Overall Study|Physician Decision|1|||
147138048|NCT01876381|530673806|FG000|Overall Study|Withdrawal by Subject|1|||
147138049|NCT00332696|530673807|FG000|Overall Study|Death|24|||
147138050|NCT00332696|530673808|FG001|Overall Study|Death|14|||
147138051|NCT00332696|530673807|FG000|Overall Study|Insufficient therapeutic effect|4|||
147138052|NCT00332696|530673808|FG001|Overall Study|Insufficient therapeutic effect|11|||
147138053|NCT00332696|530673807|FG000|Overall Study|Adverse Event|1|||
147138054|NCT00332696|530673808|FG001|Overall Study|Adverse Event|2|||
147138055|NCT00332696|530673807|FG000|Overall Study|Condition does not justify treatment|0|||
147138056|NCT00332696|530673808|FG001|Overall Study|Condition does not justify treatment|2|||
147138057|NCT00332696|530673807|FG000|Overall Study|Lost to Follow-up|0|||
147138058|NCT00332696|530673808|FG001|Overall Study|Lost to Follow-up|1|||
147138059|NCT00332696|530673807|FG000|Overall Study|Withdrawal by Subject|1|||
147138060|NCT00332696|530673808|FG001|Overall Study|Withdrawal by Subject|0|||
147138061|NCT00382174|530673809|FG000|Overall Study|Lost to Follow-up|1|||
147138062|NCT00382174|530673810|FG001|Overall Study|Lost to Follow-up|4|||
147138063|NCT00382174|530673811|FG002|Overall Study|Lost to Follow-up|5|||
147138064|NCT00382174|530673809|FG000|Overall Study|Adverse Event|1|||
147138065|NCT00382174|530673810|FG001|Overall Study|Adverse Event|4|||
147138066|NCT00382174|530673811|FG002|Overall Study|Adverse Event|5|||
147138067|NCT00382174|530673809|FG000|Overall Study|Withdrawal by Subject|1|||
147138068|NCT00382174|530673810|FG001|Overall Study|Withdrawal by Subject|4|||
147572456|NCT00927069|532253755|FG003|Week 12 to Week 24|Withdrawal by Subject|0|||
147572457|NCT00927069|532253752|FG000|Week 12 to Week 24|Had a vaccination, removed from study|1|||
147572458|NCT00927069|532253753|FG001|Week 12 to Week 24|Had a vaccination, removed from study|0|||
147138069|NCT00382174|530673811|FG002|Overall Study|Withdrawal by Subject|5|||
147138070|NCT00382174|530673809|FG000|Overall Study|Non compliance|1|||
147138071|NCT00382174|530673810|FG001|Overall Study|Non compliance|0|||
147138072|NCT00382174|530673811|FG002|Overall Study|Non compliance|1|||
147138073|NCT00382174|530673809|FG000|Overall Study|Physician Decision|0|||
147138074|NCT00382174|530673810|FG001|Overall Study|Physician Decision|2|||
147138075|NCT00382174|530673811|FG002|Overall Study|Physician Decision|2|||
147138076|NCT00382174|530673809|FG000|Overall Study|Failed to meet criteria|0|||
147138077|NCT00382174|530673810|FG001|Overall Study|Failed to meet criteria|1|||
147138078|NCT00382174|530673811|FG002|Overall Study|Failed to meet criteria|1|||
147138079|NCT00382174|530673809|FG000|Overall Study|Wounds merged|0|||
147138080|NCT00382174|530673810|FG001|Overall Study|Wounds merged|2|||
147138081|NCT00382174|530673811|FG002|Overall Study|Wounds merged|2|||
147138082|NCT02750514|530673812|FG000|Track 1|Disease progression|20|||
147138083|NCT02750514|530673813|FG001|Track 1|Disease progression|1|||
147138084|NCT02750514|530673814|FG002|Track 1|Disease progression|0|||
147138085|NCT02750514|530673815|FG003|Track 1|Disease progression|1|||
147138086|NCT02750514|530673816|FG004|Track 1|Disease progression|0|||
147138087|NCT02750514|530673812|FG000|Track 1|Adverse event unrelated to study drug|1|||
147572459|NCT00927069|532253754|FG002|Week 12 to Week 24|Had a vaccination, removed from study|0|||
147572460|NCT00927069|532253755|FG003|Week 12 to Week 24|Had a vaccination, removed from study|0|||
147572461|NCT02911792|532253756|FG000|Overall Study|Lost to Follow-up|3|||
147572462|NCT02911792|532253757|FG001|Overall Study|Lost to Follow-up|3|||
147572463|NCT02911792|532253758|FG002|Overall Study|Lost to Follow-up|3|||
147572464|NCT02911792|532253759|FG003|Overall Study|Lost to Follow-up|3|||
147572465|NCT00796328|532253762|FG000|Overall Study|experienced hypotension requiring tx|6|||
147572466|NCT03199963|532253766|FG000|Blinded Phase - Overall Study|Withdrawal by Subject|5|||
147572467|NCT03199963|532253767|FG001|Blinded Phase - Overall Study|Withdrawal by Subject|5|||
147572468|NCT03199963|532253766|FG000|Blinded Phase - Overall Study|Lost to Follow-up|9|||
147572469|NCT03199963|532253767|FG001|Blinded Phase - Overall Study|Lost to Follow-up|2|||
147572470|NCT03199963|532253766|FG000|Blinded Phase - Overall Study|Adverse Event|10|||
147572471|NCT03199963|532253767|FG001|Blinded Phase - Overall Study|Adverse Event|5|||
147572472|NCT03199963|532253766|FG000|Blinded Phase - Overall Study|Study was terminated early by the Sponsor for administrative reasons.|109|||
147651829|NCT01483599|532546592|FG012|After Controlled Period(Week 16-Week 40)|Death|0|||
147138088|NCT02750514|530673813|FG001|Track 1|Adverse event unrelated to study drug|0|||
147138089|NCT02750514|530673814|FG002|Track 1|Adverse event unrelated to study drug|0|||
147138090|NCT02750514|530673815|FG003|Track 1|Adverse event unrelated to study drug|0|||
147572473|NCT03199963|532253767|FG001|Blinded Phase - Overall Study|Study was terminated early by the Sponsor for administrative reasons.|54|||
147651830|NCT01483599|532546593|FG013|After Controlled Period(Week 16-Week 40)|Death|0|||
147651831|NCT01483599|532546580|FG000|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
147572474|NCT03199963|532253766|FG000|Optional Open-Label Phase - BHR-700|Study terminated early by Sponsor for administrative reasons; data contribution was negligible.|7|||
147138091|NCT02750514|530673816|FG004|Track 1|Adverse event unrelated to study drug|0|||
147138092|NCT02750514|530673812|FG000|Track 1|Study drug toxicity|4|||
147138093|NCT02750514|530673813|FG001|Track 1|Study drug toxicity|1|||
147138094|NCT02750514|530673814|FG002|Track 1|Study drug toxicity|0|||
147572475|NCT03199963|532253767|FG001|Optional Open-Label Phase - BHR-700|Study terminated early by Sponsor for administrative reasons; data contribution was negligible.|5|||
147572476|NCT03199963|532253766|FG000|Optional Open-Label Phase - BHR-700|Adverse Event|0|||
147572477|NCT03199963|532253767|FG001|Optional Open-Label Phase - BHR-700|Adverse Event|1|||
147572478|NCT00466167|532253768|FG000|Overall Study|Adverse Event|8|||
147572479|NCT00466167|532253769|FG001|Overall Study|Adverse Event|8|||
147572480|NCT00466167|532253770|FG002|Overall Study|Adverse Event|7|||
147572481|NCT00466167|532253768|FG000|Overall Study|Lack of Efficacy|2|||
147572482|NCT00466167|532253769|FG001|Overall Study|Lack of Efficacy|0|||
147572483|NCT00466167|532253770|FG002|Overall Study|Lack of Efficacy|3|||
147572484|NCT00466167|532253768|FG000|Overall Study|Protocol Violation|1|||
147572485|NCT00466167|532253769|FG001|Overall Study|Protocol Violation|1|||
147572486|NCT00466167|532253770|FG002|Overall Study|Protocol Violation|2|||
147572487|NCT00466167|532253768|FG000|Overall Study|Lost to Follow-up|3|||
147572488|NCT00466167|532253769|FG001|Overall Study|Lost to Follow-up|2|||
147572489|NCT00466167|532253770|FG002|Overall Study|Lost to Follow-up|2|||
147572490|NCT00466167|532253768|FG000|Overall Study|Withdrawal by Subject|4|||
147572491|NCT00466167|532253769|FG001|Overall Study|Withdrawal by Subject|1|||
147572492|NCT00466167|532253770|FG002|Overall Study|Withdrawal by Subject|6|||
147572493|NCT00466167|532253768|FG000|Overall Study|patient did not meet inclusion criteria|1|||
147572494|NCT00466167|532253769|FG001|Overall Study|patient did not meet inclusion criteria|0|||
147138095|NCT02750514|530673815|FG003|Track 1|Study drug toxicity|1|||
147138096|NCT02750514|530673816|FG004|Track 1|Study drug toxicity|0|||
147138097|NCT02750514|530673812|FG000|Track 1|Participant request to discontinue|1|||
147138098|NCT02750514|530673813|FG001|Track 1|Participant request to discontinue|0|||
147138099|NCT02750514|530673814|FG002|Track 1|Participant request to discontinue|0|||
147138100|NCT02750514|530673815|FG003|Track 1|Participant request to discontinue|0|||
147138101|NCT02750514|530673816|FG004|Track 1|Participant request to discontinue|0|||
147138102|NCT02750514|530673812|FG000|Track 1|Other reasons|1|||
147138103|NCT02750514|530673813|FG001|Track 1|Other reasons|0|||
147138104|NCT02750514|530673814|FG002|Track 1|Other reasons|0|||
147138105|NCT02750514|530673815|FG003|Track 1|Other reasons|0|||
147138106|NCT02750514|530673816|FG004|Track 1|Other reasons|0|||
147138107|NCT02750514|530673812|FG000|Track 2|Disease progression|4|||
147138108|NCT02750514|530673813|FG001|Track 2|Disease progression|5|||
147138109|NCT02750514|530673814|FG002|Track 2|Disease progression|2|||
147138110|NCT02750514|530673815|FG003|Track 2|Disease progression|5|||
147138111|NCT02750514|530673816|FG004|Track 2|Disease progression|0|||
147138112|NCT02750514|530673812|FG000|Track 2|Adverse event unrelated to study drug|1|||
147138113|NCT02750514|530673813|FG001|Track 2|Adverse event unrelated to study drug|0|||
147138114|NCT02750514|530673814|FG002|Track 2|Adverse event unrelated to study drug|0|||
147138115|NCT02750514|530673815|FG003|Track 2|Adverse event unrelated to study drug|0|||
147138116|NCT02750514|530673816|FG004|Track 2|Adverse event unrelated to study drug|0|||
147138117|NCT02750514|530673812|FG000|Track 2|Study drug toxicity|1|||
147138118|NCT02750514|530673813|FG001|Track 2|Study drug toxicity|2|||
147138119|NCT02750514|530673814|FG002|Track 2|Study drug toxicity|0|||
147138120|NCT02750514|530673815|FG003|Track 2|Study drug toxicity|2|||
147138121|NCT02750514|530673816|FG004|Track 2|Study drug toxicity|0|||
147138122|NCT02750514|530673812|FG000|Track 2|Participant withdrew consent|0|||
147138123|NCT02750514|530673813|FG001|Track 2|Participant withdrew consent|1|||
147138124|NCT02750514|530673814|FG002|Track 2|Participant withdrew consent|0|||
147138125|NCT02750514|530673815|FG003|Track 2|Participant withdrew consent|0|||
147572495|NCT00466167|532253770|FG002|Overall Study|patient did not meet inclusion criteria|1|||
147572496|NCT00466167|532253768|FG000|Overall Study|Not treated|1|||
147572497|NCT00466167|532253769|FG001|Overall Study|Not treated|0|||
147572498|NCT00466167|532253770|FG002|Overall Study|Not treated|0|||
147572499|NCT00107991|532253773|FG000|Eligibility Assessment|Disease not severe enough|7|||
147572500|NCT00107991|532253773|FG000|Eligibility Assessment|Unwilling to participate|7|||
147572501|NCT00107991|532253773|FG000|Eligibility Assessment|Positive purified protein derivative|4|||
147572502|NCT00107991|532253773|FG000|Eligibility Assessment|Abnormal labs|2|||
147572503|NCT00107991|532253773|FG000|Eligibility Assessment|Ongoing treatment with antibiotics|1|||
147572504|NCT00107991|532253773|FG000|Eligibility Assessment|chronic uncontrolled asthma|1|||
147572505|NCT00107991|532253773|FG000|Eligibility Assessment|hx of alcohol abuse in past 12 months|1|||
147572506|NCT00107991|532253773|FG000|12 Week Treatment Period|Lack of Efficacy|2|||
147572507|NCT00107991|532253773|FG000|12 Week Treatment Period|Adverse Event|1|||
147138126|NCT02750514|530673816|FG004|Track 2|Participant withdrew consent|0|||
147138127|NCT02750514|530673812|FG000|Track 3|Disease progression|0|||
147138128|NCT02750514|530673813|FG001|Track 3|Disease progression|24|||
147572508|NCT00107991|532253773|FG000|12 Week Treatment Period|Protocol Violation|1|||
147138129|NCT02750514|530673814|FG002|Track 3|Disease progression|13|||
147138130|NCT02750514|530673815|FG003|Track 3|Disease progression|14|||
147138131|NCT02750514|530673816|FG004|Track 3|Disease progression|0|||
147572509|NCT00107991|532253773|FG000|12 Week Treatment Period|Incarcerated|1|||
147572510|NCT00107991|532253773|FG000|18-Week Post Treatment Assessment|Adverse Event|2|||
147572511|NCT01535222|532253774|FG000|Overall Study|Inclusion/exclusion|0|||
147572512|NCT01535222|532253775|FG001|Overall Study|Inclusion/exclusion|0|||
147572513|NCT01535222|532253776|FG002|Overall Study|Inclusion/exclusion|1|||
147572514|NCT01535222|532253777|FG003|Overall Study|Inclusion/exclusion|0|||
147572515|NCT01535222|532253778|FG004|Overall Study|Inclusion/exclusion|0|||
147572516|NCT01535222|532253779|FG005|Overall Study|Inclusion/exclusion|0|||
147572517|NCT03669861|532253780|FG000|Overall Study|Disease Flare|5|||
147572518|NCT03669861|532253780|FG000|Overall Study|Lack of Efficacy|2|||
147572519|NCT02760927|532253781|FG000|Overall Study|Tube Slippage from Device|1|||
147572520|NCT03930732|532253782|FG000|Overall Study|Adverse Event|9|||
147572521|NCT03930732|532253783|FG001|Overall Study|Adverse Event|7|||
147572522|NCT03930732|532253782|FG000|Overall Study|Poor compliance to protocol|0|||
147572523|NCT03930732|532253783|FG001|Overall Study|Poor compliance to protocol|1|||
147572524|NCT03930732|532253782|FG000|Overall Study|Withdrawal by Subject|23|||
147572525|NCT03930732|532253783|FG001|Overall Study|Withdrawal by Subject|11|||
147572526|NCT03930732|532253782|FG000|Overall Study|Other reason related to Coronavirus Disease-2019 (COVID-19)|0|||
147572527|NCT03930732|532253783|FG001|Overall Study|Other reason related to Coronavirus Disease-2019 (COVID-19)|1|||
147572528|NCT03930732|532253782|FG000|Overall Study|Other reason not related to COVID-19|5|||
147572529|NCT03930732|532253783|FG001|Overall Study|Other reason not related to COVID-19|8|||
147572530|NCT02645409|532253792|FG000|Overall Study|Withdrawal by Subject|3|||
147572531|NCT02645409|532253793|FG001|Overall Study|Withdrawal by Subject|0|||
147572532|NCT02645409|532253792|FG000|Overall Study|Physician Decision|1|||
147572533|NCT02645409|532253793|FG001|Overall Study|Physician Decision|0|||
147572534|NCT02089685|532253796|FG000|Overall Study|Adverse Event|1|||
147572535|NCT02089685|532253797|FG001|Overall Study|Adverse Event|0|||
147572536|NCT02089685|532253798|FG002|Overall Study|Adverse Event|0|||
147572537|NCT02089685|532253799|FG003|Overall Study|Adverse Event|0|||
147572538|NCT02089685|532253800|FG004|Overall Study|Adverse Event|1|||
147572539|NCT02089685|532253801|FG005|Overall Study|Adverse Event|0|||
147572540|NCT02089685|532253796|FG000|Overall Study|Clinical Progression|4|||
147572541|NCT02089685|532253797|FG001|Overall Study|Clinical Progression|0|||
147572542|NCT02089685|532253798|FG002|Overall Study|Clinical Progression|0|||
147651832|NCT01483599|532546581|FG001|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
147651833|NCT01483599|532546582|FG002|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
147138132|NCT02750514|530673812|FG000|Track 3|Adverse event unrelated to study drug|0|||
147138133|NCT02750514|530673813|FG001|Track 3|Adverse event unrelated to study drug|1|||
147138134|NCT02750514|530673814|FG002|Track 3|Adverse event unrelated to study drug|1|||
147138135|NCT02750514|530673815|FG003|Track 3|Adverse event unrelated to study drug|1|||
147138136|NCT02750514|530673816|FG004|Track 3|Adverse event unrelated to study drug|0|||
147138137|NCT02750514|530673812|FG000|Track 3|Study drug toxicity|0|||
147138138|NCT02750514|530673813|FG001|Track 3|Study drug toxicity|3|||
147138139|NCT02750514|530673814|FG002|Track 3|Study drug toxicity|0|||
147138140|NCT02750514|530673815|FG003|Track 3|Study drug toxicity|1|||
147138141|NCT02750514|530673816|FG004|Track 3|Study drug toxicity|0|||
147237626|NCT02058693|531040689|FG000|Phase 1|Physician Decision|1|||
147237627|NCT02058693|531040690|FG001|Phase 1|Physician Decision|1|||
147237628|NCT02058693|531040689|FG000|Phase 2|Withdrawal by Subject|0|||
147237629|NCT02058693|531040690|FG001|Phase 2|Withdrawal by Subject|2|||
147237630|NCT00241358|531040691|FG000|Overall Study|Determined to be not ineligible|0|||
147237631|NCT00241358|531040692|FG001|Overall Study|Determined to be not ineligible|1|||
147237632|NCT00241358|531040693|FG002|Overall Study|Determined to be not ineligible|1|||
147237633|NCT03855228|531040694|FG000|Overall Study|Adverse Event|2|||
147237634|NCT03855228|531040695|FG001|Overall Study|Adverse Event|4|||
147237635|NCT03855228|531040696|FG002|Overall Study|Adverse Event|4|||
147237636|NCT03855228|531040697|FG003|Overall Study|Adverse Event|8|||
147237637|NCT03855228|531040694|FG000|Overall Study|Treatment Failure|1|||
147237638|NCT03855228|531040695|FG001|Overall Study|Treatment Failure|2|||
147237639|NCT03855228|531040696|FG002|Overall Study|Treatment Failure|1|||
147237640|NCT03855228|531040697|FG003|Overall Study|Treatment Failure|8|||
147237641|NCT03855228|531040694|FG000|Overall Study|Lost to Follow-up|0|||
147237642|NCT03855228|531040695|FG001|Overall Study|Lost to Follow-up|0|||
147572543|NCT02089685|532253799|FG003|Overall Study|Clinical Progression|5|||
147138142|NCT02750514|530673812|FG000|Track 3|Participant request to discontinue|0|||
147138143|NCT02750514|530673813|FG001|Track 3|Participant request to discontinue|2|||
147138144|NCT02750514|530673814|FG002|Track 3|Participant request to discontinue|0|||
147138145|NCT02750514|530673815|FG003|Track 3|Participant request to discontinue|0|||
147237643|NCT03855228|531040696|FG002|Overall Study|Lost to Follow-up|0|||
147237644|NCT03855228|531040697|FG003|Overall Study|Lost to Follow-up|1|||
147237645|NCT03855228|531040694|FG000|Overall Study|Protocol Violation|0|||
147572544|NCT02089685|532253800|FG004|Overall Study|Clinical Progression|1|||
147572545|NCT02089685|532253801|FG005|Overall Study|Clinical Progression|2|||
147572546|NCT02089685|532253796|FG000|Overall Study|Excluded Medication|1|||
147237646|NCT03855228|531040695|FG001|Overall Study|Protocol Violation|1|||
147237647|NCT03855228|531040696|FG002|Overall Study|Protocol Violation|2|||
147237648|NCT03855228|531040697|FG003|Overall Study|Protocol Violation|1|||
147572547|NCT02089685|532253797|FG001|Overall Study|Excluded Medication|0|||
147572548|NCT02089685|532253798|FG002|Overall Study|Excluded Medication|0|||
147237649|NCT03855228|531040694|FG000|Overall Study|Did Not Meet Entry Requirements|0|||
147138146|NCT02750514|530673816|FG004|Track 3|Participant request to discontinue|0|||
147138147|NCT02750514|530673812|FG000|Track 3|Participant withdrew consent|0|||
147138148|NCT02750514|530673813|FG001|Track 3|Participant withdrew consent|3|||
147138149|NCT02750514|530673814|FG002|Track 3|Participant withdrew consent|1|||
147138150|NCT02750514|530673815|FG003|Track 3|Participant withdrew consent|0|||
147138151|NCT02750514|530673816|FG004|Track 3|Participant withdrew consent|0|||
147138152|NCT02750514|530673812|FG000|Track 3|Other reasons|0|||
147138153|NCT02750514|530673813|FG001|Track 3|Other reasons|3|||
147138154|NCT02750514|530673814|FG002|Track 3|Other reasons|0|||
147138155|NCT02750514|530673815|FG003|Track 3|Other reasons|0|||
147138156|NCT02750514|530673816|FG004|Track 3|Other reasons|0|||
147572549|NCT02089685|532253799|FG003|Overall Study|Excluded Medication|11|||
147572550|NCT02089685|532253800|FG004|Overall Study|Excluded Medication|2|||
147572551|NCT02089685|532253801|FG005|Overall Study|Excluded Medication|1|||
147572552|NCT02089685|532253796|FG000|Overall Study|Progressive disease|13|||
147572553|NCT02089685|532253797|FG001|Overall Study|Progressive disease|10|||
147572554|NCT02089685|532253798|FG002|Overall Study|Progressive disease|3|||
147138157|NCT02750514|530673812|FG000|Track 4|Study drug toxicity|0|||
147237650|NCT03855228|531040695|FG001|Overall Study|Did Not Meet Entry Requirements|2|||
147237651|NCT03855228|531040696|FG002|Overall Study|Did Not Meet Entry Requirements|1|||
147237652|NCT03855228|531040697|FG003|Overall Study|Did Not Meet Entry Requirements|1|||
147237653|NCT00843856|531040698|FG000|Overall Study|Lost to Follow-up|1|||
147237654|NCT00843856|531040699|FG001|Overall Study|Lost to Follow-up|2|||
147237655|NCT00590135|531040700|FG000|Overall Study|Primary endpoint measure not obtainable|59|||
147237656|NCT00806351|531040718|FG000|Overall Study|Death|5|||
147237657|NCT00806351|531040719|FG001|Overall Study|Death|4|||
147237658|NCT02059408|531040720|FG000|Overall Study|Did not get tested|0|||
147237659|NCT02059408|531040721|FG001|Overall Study|Did not get tested|330|||
147237660|NCT02059408|531040722|FG002|Overall Study|Did not get tested|358|||
147237661|NCT01681472|531040726|FG000|Overall Study|Adverse Event|0|||
147237662|NCT01681472|531040727|FG001|Overall Study|Adverse Event|1|||
147237663|NCT01681472|531040728|FG002|Overall Study|Adverse Event|0|||
147237664|NCT01681472|531040729|FG003|Overall Study|Adverse Event|0|||
147237665|NCT01999179|531040730|FG000|Overall Study|Adverse Event|1|||
147237666|NCT01999179|531040730|FG000|Overall Study|Lost to Follow-up|1|||
147237667|NCT01999179|531040730|FG000|Overall Study|Change in Therapy|3|||
147237668|NCT01999179|531040730|FG000|Overall Study|New catheter|2|||
147237669|NCT01752985|531040731|FG000|Treatment Period|Subject request to discontinue treatment|1|||
147237670|NCT01752985|531040732|FG001|Treatment Period|Subject request to discontinue treatment|0|||
147237671|NCT01752985|531040733|FG002|Treatment Period|Subject request to discontinue treatment|1|||
147237672|NCT01752985|531040731|FG000|Treatment Period|Subject no longer meets study criteria|0|||
147237673|NCT01752985|531040732|FG001|Treatment Period|Subject no longer meets study criteria|1|||
147237674|NCT01752985|531040733|FG002|Treatment Period|Subject no longer meets study criteria|1|||
147237675|NCT01752985|531040731|FG000|Treatment Period|Adverse Event|2|||
147237676|NCT01752985|531040732|FG001|Treatment Period|Adverse Event|1|||
147237677|NCT01752985|531040733|FG002|Treatment Period|Adverse Event|2|||
147237678|NCT01752985|531040731|FG000|Treatment Period|Withdrawal by Subject|1|||
147237679|NCT01752985|531040732|FG001|Treatment Period|Withdrawal by Subject|1|||
147237680|NCT01752985|531040733|FG002|Treatment Period|Withdrawal by Subject|0|||
147237681|NCT01752985|531040731|FG000|Treatment Period|Lost to Follow-up|0|||
147237682|NCT01752985|531040732|FG001|Treatment Period|Lost to Follow-up|0|||
147237683|NCT01752985|531040733|FG002|Treatment Period|Lost to Follow-up|1|||
147445650|NCT03200366|531797423|FG000|Patient Navigation Intervention Given|Declined navigation intervention|0|||
147445651|NCT03200366|531797424|FG001|Patient Navigation Intervention Given|Declined navigation intervention|1|||
147572555|NCT02089685|532253799|FG003|Overall Study|Progressive disease|51|||
147572556|NCT02089685|532253800|FG004|Overall Study|Progressive disease|17|||
147138158|NCT02750514|530673813|FG001|Track 4|Study drug toxicity|6|||
147138159|NCT02750514|530673814|FG002|Track 4|Study drug toxicity|0|||
147138160|NCT02750514|530673815|FG003|Track 4|Study drug toxicity|5|||
147138161|NCT02750514|530673816|FG004|Track 4|Study drug toxicity|0|||
147237684|NCT05147428|531040734|FG000|Overall Study|Removed prior to mailing|289|||
147237685|NCT05147428|531040735|FG001|Overall Study|Removed prior to mailing|306|||
147237686|NCT05147428|531040736|FG002|Overall Study|Removed prior to mailing|270|||
147237687|NCT05147428|531040734|FG000|Overall Study|Died or disenrolled during blackout period|239|||
147237688|NCT05147428|531040735|FG001|Overall Study|Died or disenrolled during blackout period|278|||
147237689|NCT05147428|531040736|FG002|Overall Study|Died or disenrolled during blackout period|273|||
147237690|NCT01687998|531042486|FG000|Overall Study|Withdrawal by Subject|49|||
147237691|NCT01687998|531042487|FG001|Overall Study|Withdrawal by Subject|51|||
147237692|NCT01687998|531042486|FG000|Overall Study|Known to be Alive at Study End|54|||
147237693|NCT01687998|531042487|FG001|Overall Study|Known to be Alive at Study End|62|||
147237694|NCT01687998|531042486|FG000|Overall Study|Lost to Follow-up|9|||
147237695|NCT01687998|531042487|FG001|Overall Study|Lost to Follow-up|7|||
147237696|NCT00443261|531042488|FG000|Overall Study|Death|1|||
147237697|NCT01663532|531042489|FG000|Overall Study|Lost to Follow-up|9|||
147572557|NCT02089685|532253801|FG005|Overall Study|Progressive disease|12|||
147572558|NCT02089685|532253796|FG000|Overall Study|Follow up ended by sponsor|2|||
147138162|NCT02750514|530673812|FG000|Track 4|Participant request to discontinue|0|||
147138163|NCT02750514|530673813|FG001|Track 4|Participant request to discontinue|1|||
147138164|NCT02750514|530673814|FG002|Track 4|Participant request to discontinue|0|||
147138165|NCT02750514|530673815|FG003|Track 4|Participant request to discontinue|1|||
147138166|NCT02750514|530673816|FG004|Track 4|Participant request to discontinue|0|||
147138167|NCT02750514|530673812|FG000|Track 4|Participant withdrew consent|0|||
147138168|NCT02750514|530673813|FG001|Track 4|Participant withdrew consent|1|||
147138169|NCT02750514|530673814|FG002|Track 4|Participant withdrew consent|0|||
147138170|NCT02750514|530673815|FG003|Track 4|Participant withdrew consent|0|||
147138171|NCT02750514|530673816|FG004|Track 4|Participant withdrew consent|0|||
147138172|NCT02750514|530673812|FG000|Track 4|Other reasons|0|||
147138173|NCT02750514|530673813|FG001|Track 4|Other reasons|5|||
147138174|NCT02750514|530673814|FG002|Track 4|Other reasons|0|||
147138175|NCT02750514|530673815|FG003|Track 4|Other reasons|3|||
147138176|NCT02750514|530673816|FG004|Track 4|Other reasons|0|||
147138177|NCT02750514|530673812|FG000|Track 4|Disease progression|0|||
147138178|NCT02750514|530673813|FG001|Track 4|Disease progression|33|||
147138179|NCT02750514|530673814|FG002|Track 4|Disease progression|0|||
147138180|NCT02750514|530673815|FG003|Track 4|Disease progression|32|||
147138181|NCT02750514|530673816|FG004|Track 4|Disease progression|0|||
147138182|NCT02750514|530673812|FG000|Track 4|Adverse event unrelated to study drug|0|||
147138183|NCT02750514|530673813|FG001|Track 4|Adverse event unrelated to study drug|5|||
147138184|NCT02750514|530673814|FG002|Track 4|Adverse event unrelated to study drug|0|||
147138185|NCT02750514|530673815|FG003|Track 4|Adverse event unrelated to study drug|0|||
147138186|NCT02750514|530673816|FG004|Track 4|Adverse event unrelated to study drug|0|||
147138187|NCT02750514|530673812|FG000|Track 4|Death|0|||
147138188|NCT02750514|530673813|FG001|Track 4|Death|0|||
147138189|NCT02750514|530673814|FG002|Track 4|Death|0|||
147138190|NCT02750514|530673815|FG003|Track 4|Death|1|||
147138191|NCT02750514|530673816|FG004|Track 4|Death|0|||
147138192|NCT02750514|530673812|FG000|Track 5|Disease progression|0|||
147138193|NCT02750514|530673813|FG001|Track 5|Disease progression|0|||
147138194|NCT02750514|530673814|FG002|Track 5|Disease progression|0|||
147138195|NCT02750514|530673815|FG003|Track 5|Disease progression|0|||
147138196|NCT02750514|530673816|FG004|Track 5|Disease progression|34|||
147138197|NCT02750514|530673812|FG000|Track 5|Adverse event unrelated to study drug|0|||
147138198|NCT02750514|530673813|FG001|Track 5|Adverse event unrelated to study drug|0|||
147138199|NCT02750514|530673814|FG002|Track 5|Adverse event unrelated to study drug|0|||
147138200|NCT02750514|530673815|FG003|Track 5|Adverse event unrelated to study drug|0|||
147138201|NCT02750514|530673816|FG004|Track 5|Adverse event unrelated to study drug|2|||
147138202|NCT02750514|530673812|FG000|Track 5|Study drug toxicity|0|||
147138203|NCT02750514|530673813|FG001|Track 5|Study drug toxicity|0|||
147138204|NCT02750514|530673814|FG002|Track 5|Study drug toxicity|0|||
147138205|NCT02750514|530673815|FG003|Track 5|Study drug toxicity|0|||
147138206|NCT02750514|530673816|FG004|Track 5|Study drug toxicity|2|||
147138207|NCT02750514|530673812|FG000|Track 5|Participant request to discontinue|0|||
147138208|NCT02750514|530673813|FG001|Track 5|Participant request to discontinue|0|||
147138209|NCT02750514|530673814|FG002|Track 5|Participant request to discontinue|0|||
147138210|NCT02750514|530673815|FG003|Track 5|Participant request to discontinue|0|||
147138211|NCT02750514|530673816|FG004|Track 5|Participant request to discontinue|3|||
147138212|NCT02750514|530673812|FG000|Track 5|Other reasons|0|||
147138213|NCT02750514|530673813|FG001|Track 5|Other reasons|0|||
147138214|NCT02750514|530673814|FG002|Track 5|Other reasons|0|||
147138215|NCT02750514|530673815|FG003|Track 5|Other reasons|0|||
147138216|NCT02750514|530673816|FG004|Track 5|Other reasons|2|||
147138217|NCT02230189|530673817|FG000|Overall Study|Withdrawal by Subject|3|||
147138218|NCT02230189|530673818|FG001|Overall Study|Withdrawal by Subject|0|||
147138219|NCT02230189|530673819|FG002|Overall Study|Withdrawal by Subject|1|||
147138220|NCT02230189|530673817|FG000|Overall Study|Lost to Follow-up|1|||
147138221|NCT02230189|530673818|FG001|Overall Study|Lost to Follow-up|0|||
147138222|NCT02230189|530673819|FG002|Overall Study|Lost to Follow-up|0|||
147138223|NCT02230189|530673817|FG000|Overall Study|Physician Decision|1|||
147138224|NCT02230189|530673818|FG001|Overall Study|Physician Decision|0|||
147138225|NCT02230189|530673819|FG002|Overall Study|Physician Decision|0|||
147138226|NCT03894891|530673822|FG000|Overall Study|Withdrawal by Subject|1|||
147138227|NCT03894891|530673822|FG000|Overall Study|Completed protocol treatment per protocol|5|||
147138228|NCT00800982|530673824|FG000|Overall Study|Lost to Follow-up|1|||
147138229|NCT00800982|530673825|FG001|Overall Study|Lost to Follow-up|2|||
147138230|NCT00800982|530673824|FG000|Overall Study|Withdrawal by Subject|0|||
147138231|NCT00800982|530673825|FG001|Overall Study|Withdrawal by Subject|1|||
147138232|NCT00800982|530673824|FG000|Overall Study|Patient moved out of state|1|||
147138233|NCT00800982|530673825|FG001|Overall Study|Patient moved out of state|0|||
147138234|NCT01824290|530673826|FG000|Period 1: Double Blind|Entry Criteria Not Met|1|||
147138235|NCT01824290|530673827|FG001|Period 1: Double Blind|Entry Criteria Not Met|0|||
147138236|NCT01824290|530673828|FG002|Period 1: Double Blind|Entry Criteria Not Met|0|||
147138237|NCT01824290|530673829|FG003|Period 1: Double Blind|Entry Criteria Not Met|0|||
147138238|NCT01824290|530673826|FG000|Period 1: Double Blind|Parent/Caregiver Decision|1|||
147237698|NCT01663532|531042490|FG001|Overall Study|Lost to Follow-up|10|||
147138239|NCT01824290|530673827|FG001|Period 1: Double Blind|Parent/Caregiver Decision|1|||
147138240|NCT01824290|530673828|FG002|Period 1: Double Blind|Parent/Caregiver Decision|0|||
147138241|NCT01824290|530673829|FG003|Period 1: Double Blind|Parent/Caregiver Decision|0|||
147138242|NCT01824290|530673826|FG000|Period 1: Double Blind|Investigator Reported Clinical Worsening|1|||
147138243|NCT01824290|530673827|FG001|Period 1: Double Blind|Investigator Reported Clinical Worsening|1|||
147138244|NCT01824290|530673828|FG002|Period 1: Double Blind|Investigator Reported Clinical Worsening|0|||
147138245|NCT01824290|530673829|FG003|Period 1: Double Blind|Investigator Reported Clinical Worsening|0|||
147138246|NCT01824290|530673826|FG000|Period 2: Open-Label Treatment|Adverse Event|0|||
147138247|NCT01824290|530673827|FG001|Period 2: Open-Label Treatment|Adverse Event|0|||
147138248|NCT01824290|530673828|FG002|Period 2: Open-Label Treatment|Adverse Event|0|||
147138249|NCT01824290|530673829|FG003|Period 2: Open-Label Treatment|Adverse Event|1|||
147138250|NCT01824290|530673826|FG000|Period 2: Open-Label Treatment|Parent/caregiver Decision|0|||
147138251|NCT01824290|530673827|FG001|Period 2: Open-Label Treatment|Parent/caregiver Decision|0|||
147138252|NCT01824290|530673828|FG002|Period 2: Open-Label Treatment|Parent/caregiver Decision|1|||
147138253|NCT01824290|530673829|FG003|Period 2: Open-Label Treatment|Parent/caregiver Decision|1|||
147138254|NCT01824290|530673826|FG000|Period 2: Open-Label Treatment|Withdrawal by Subject|0|||
147138255|NCT01824290|530673827|FG001|Period 2: Open-Label Treatment|Withdrawal by Subject|0|||
147138256|NCT01824290|530673828|FG002|Period 2: Open-Label Treatment|Withdrawal by Subject|2|||
147138257|NCT01824290|530673829|FG003|Period 2: Open-Label Treatment|Withdrawal by Subject|1|||
147138258|NCT01595529|530673832|FG000|Overall Study|Adverse Event|2|||
147138259|NCT01595529|530673833|FG001|Overall Study|Adverse Event|0|||
147138260|NCT01595529|530673832|FG000|Overall Study|Subject Non-Compliant|2|||
147138261|NCT01595529|530673833|FG001|Overall Study|Subject Non-Compliant|0|||
147138262|NCT01595529|530673832|FG000|Overall Study|Lost to Follow-up|8|||
147138263|NCT01595529|530673833|FG001|Overall Study|Lost to Follow-up|14|||
147138264|NCT01595529|530673832|FG000|Overall Study|Protocol Violation|1|||
147138265|NCT01595529|530673833|FG001|Overall Study|Protocol Violation|2|||
147138266|NCT01595529|530673832|FG000|Overall Study|Physician Decision|1|||
147138267|NCT01595529|530673833|FG001|Overall Study|Physician Decision|0|||
147138268|NCT01595529|530673832|FG000|Overall Study|Consent Withdrawn/Voluntary Withdrawal|3|||
147138269|NCT01595529|530673833|FG001|Overall Study|Consent Withdrawn/Voluntary Withdrawal|3|||
147138270|NCT01595529|530673832|FG000|Overall Study|Administrative Decision|1|||
147138271|NCT01595529|530673833|FG001|Overall Study|Administrative Decision|0|||
147138272|NCT01595529|530673832|FG000|Overall Study|Entry Failure/Screening Failure|6|||
147138273|NCT01595529|530673833|FG001|Overall Study|Entry Failure/Screening Failure|1|||
147138274|NCT00959907|530673838|FG000|Overall Study|Protocol Violation|0|||
147138275|NCT00959907|530673839|FG001|Overall Study|Protocol Violation|1|||
147138276|NCT00959907|530673838|FG000|Overall Study|Adverse Event|1|||
147138277|NCT00959907|530673839|FG001|Overall Study|Adverse Event|0|||
147138278|NCT00959907|530673838|FG000|Overall Study|Withdrawal by Subject|2|||
147138279|NCT00959907|530673839|FG001|Overall Study|Withdrawal by Subject|0|||
147138280|NCT03958331|530673840|FG000|Overall Study|Withdrawal by Subject|3|||
147138281|NCT03958331|530673841|FG001|Overall Study|Withdrawal by Subject|1|||
147138282|NCT03958331|530673842|FG002|Overall Study|Withdrawal by Subject|5|||
147138283|NCT03958331|530673840|FG000|Overall Study|Weaned from medicine|2|||
147138284|NCT03958331|530673841|FG001|Overall Study|Weaned from medicine|0|||
147138285|NCT03958331|530673842|FG002|Overall Study|Weaned from medicine|0|||
147138286|NCT03958331|530673840|FG000|Overall Study|Withdrawn by study staff due to non-compliance with study procedures|2|||
147138287|NCT03958331|530673841|FG001|Overall Study|Withdrawn by study staff due to non-compliance with study procedures|1|||
147138288|NCT03958331|530673842|FG002|Overall Study|Withdrawn by study staff due to non-compliance with study procedures|12|||
147138289|NCT04422431|530673845|FG000|Treatment Period (48 Weeks)|Adverse Event|3|||
147138290|NCT04422431|530673845|FG000|Treatment Period (48 Weeks)|Withdrawal by Subject|1|||
147138291|NCT04422431|530673845|FG000|Treatment Period (48 Weeks)|Other than specified|1|||
147138292|NCT04422431|530673845|FG000|Extension Period (48 Weeks)|Withdrawal by Subject|1|||
147138293|NCT04422431|530673845|FG000|Extension Period (48 Weeks)|Lost to Follow-up|1|||
147138294|NCT04422431|530673845|FG000|Extension Period (48 Weeks)|Other than specified|2|||
147138295|NCT02015039|530673846|FG000|Overall Study|Not eligible|0|||
147138296|NCT02015039|530673847|FG001|Overall Study|Not eligible|1|||
147138297|NCT01900665|530673848|FG000|Placebo Controlled Period|Death|9|||
147138298|NCT01900665|530673849|FG001|Placebo Controlled Period|Death|16|||
147138299|NCT01900665|530673848|FG000|Placebo Controlled Period|Adverse Event|48|||
147138300|NCT01900665|530673849|FG001|Placebo Controlled Period|Adverse Event|39|||
147138301|NCT01900665|530673848|FG000|Placebo Controlled Period|Protocol Violation|1|||
147138302|NCT01900665|530673849|FG001|Placebo Controlled Period|Protocol Violation|7|||
147138303|NCT01900665|530673848|FG000|Placebo Controlled Period|Withdrawal by Subject|33|||
147138304|NCT01900665|530673849|FG001|Placebo Controlled Period|Withdrawal by Subject|45|||
147138305|NCT01900665|530673848|FG000|Placebo Controlled Period|Physician Decision|11|||
147138306|NCT01900665|530673849|FG001|Placebo Controlled Period|Physician Decision|7|||
147138307|NCT01900665|530673848|FG000|Placebo Controlled Period|Lost to Follow-up|3|||
147138308|NCT01900665|530673849|FG001|Placebo Controlled Period|Lost to Follow-up|0|||
147138309|NCT01900665|530673848|FG000|Placebo Controlled Period|Caregiver Decision|33|||
147138310|NCT01900665|530673849|FG001|Placebo Controlled Period|Caregiver Decision|41|||
147138311|NCT01900665|530673848|FG000|Placebo Controlled Period|Entry Criteria Not Met|5|||
147138312|NCT01900665|530673849|FG001|Placebo Controlled Period|Entry Criteria Not Met|9|||
147138313|NCT01900665|530673848|FG000|Open Label Period|Adverse Event|16|||
147138314|NCT01900665|530673849|FG001|Open Label Period|Adverse Event|20|||
147138315|NCT01900665|530673848|FG000|Open Label Period|Death|5|||
147138316|NCT01900665|530673849|FG001|Open Label Period|Death|6|||
147138317|NCT01900665|530673848|FG000|Open Label Period|Lost to Follow-up|1|||
147138318|NCT01900665|530673849|FG001|Open Label Period|Lost to Follow-up|1|||
147138319|NCT01900665|530673848|FG000|Open Label Period|Parent/Caregiver Decision|33|||
147138320|NCT01900665|530673849|FG001|Open Label Period|Parent/Caregiver Decision|34|||
147138321|NCT01900665|530673848|FG000|Open Label Period|Physician Decision|4|||
147138322|NCT01900665|530673849|FG001|Open Label Period|Physician Decision|4|||
147138323|NCT01900665|530673848|FG000|Open Label Period|Protocol Violation|0|||
147138324|NCT01900665|530673849|FG001|Open Label Period|Protocol Violation|1|||
147138325|NCT01900665|530673848|FG000|Open Label Period|Sponsor Decision|802|||
147138326|NCT01900665|530673849|FG001|Open Label Period|Sponsor Decision|765|||
147138327|NCT01900665|530673848|FG000|Open Label Period|Withdrawal by Subject|20|||
147138328|NCT01900665|530673849|FG001|Open Label Period|Withdrawal by Subject|28|||
147138329|NCT04046939|530673850|FG000|Primary Assessment Period|Adverse Event|1|||
147138330|NCT04046939|530673851|FG001|Primary Assessment Period|Adverse Event|0|||
147138331|NCT04046939|530673852|FG002|Primary Assessment Period|Adverse Event|0|||
147138332|NCT04046939|530673853|FG003|Primary Assessment Period|Adverse Event|0|||
147138333|NCT04046939|530673850|FG000|Primary Assessment Period|Withdrawal by Subject|1|||
147138334|NCT04046939|530673851|FG001|Primary Assessment Period|Withdrawal by Subject|0|||
147138335|NCT04046939|530673852|FG002|Primary Assessment Period|Withdrawal by Subject|1|||
147138336|NCT04046939|530673853|FG003|Primary Assessment Period|Withdrawal by Subject|0|||
147138337|NCT04046939|530673850|FG000|Primary Assessment Period|Physician Decision|0|||
147138338|NCT04046939|530673851|FG001|Primary Assessment Period|Physician Decision|0|||
147138339|NCT04046939|530673852|FG002|Primary Assessment Period|Physician Decision|1|||
147138340|NCT04046939|530673853|FG003|Primary Assessment Period|Physician Decision|0|||
147138341|NCT04046939|530673850|FG000|Eosinophil Recovery Period|Withdrawal by Subject|1|||
147138342|NCT04046939|530673851|FG001|Eosinophil Recovery Period|Withdrawal by Subject|0|||
147138343|NCT04046939|530673852|FG002|Eosinophil Recovery Period|Withdrawal by Subject|0|||
147138344|NCT04046939|530673853|FG003|Eosinophil Recovery Period|Withdrawal by Subject|1|||
147138345|NCT05414175|530673859|FG000|Overall Study|Withdrawal by Subject|1|||
147138346|NCT05414175|530673859|FG000|Overall Study|Other Reasons|1|||
147138347|NCT00027560|530673860|FG000|Overall Study|Withdrawal by Subject|1|||
147138348|NCT03559270|530673864|FG000|Overall Study|Adverse Event|6|||
147138349|NCT03559270|530673865|FG001|Overall Study|Adverse Event|5|||
147138350|NCT03559270|530673866|FG002|Overall Study|Adverse Event|3|||
147138351|NCT03559270|530673867|FG003|Overall Study|Adverse Event|0|||
147138352|NCT03559270|530673864|FG000|Overall Study|Lack of Efficacy|34|||
147138353|NCT03559270|530673865|FG001|Overall Study|Lack of Efficacy|52|||
147138354|NCT03559270|530673866|FG002|Overall Study|Lack of Efficacy|37|||
147138355|NCT03559270|530673867|FG003|Overall Study|Lack of Efficacy|2|||
147138356|NCT03559270|530673864|FG000|Overall Study|Death|0|||
147138357|NCT03559270|530673865|FG001|Overall Study|Death|2|||
147138358|NCT03559270|530673866|FG002|Overall Study|Death|0|||
147138359|NCT03559270|530673867|FG003|Overall Study|Death|0|||
147138360|NCT03559270|530673864|FG000|Overall Study|Lost to Follow-up|16|||
147138361|NCT03559270|530673865|FG001|Overall Study|Lost to Follow-up|4|||
147138362|NCT03559270|530673866|FG002|Overall Study|Lost to Follow-up|12|||
147138363|NCT03559270|530673867|FG003|Overall Study|Lost to Follow-up|3|||
147138364|NCT03559270|530673864|FG000|Overall Study|Sponsor Decision|38|||
147138365|NCT03559270|530673865|FG001|Overall Study|Sponsor Decision|31|||
147138366|NCT03559270|530673866|FG002|Overall Study|Sponsor Decision|35|||
147138367|NCT03559270|530673867|FG003|Overall Study|Sponsor Decision|18|||
147138368|NCT03559270|530673864|FG000|Overall Study|Withdrawal by Subject|19|||
147138369|NCT03559270|530673865|FG001|Overall Study|Withdrawal by Subject|21|||
147138370|NCT03559270|530673866|FG002|Overall Study|Withdrawal by Subject|18|||
147138371|NCT03559270|530673867|FG003|Overall Study|Withdrawal by Subject|7|||
147138372|NCT03559270|530673864|FG000|Overall Study|Physician Decision|3|||
147138373|NCT03559270|530673865|FG001|Overall Study|Physician Decision|2|||
147237699|NCT01663532|531042489|FG000|Overall Study|Adverse Event|7|||
147572559|NCT02089685|532253797|FG001|Overall Study|Follow up ended by sponsor|2|||
147572560|NCT02089685|532253798|FG002|Overall Study|Follow up ended by sponsor|0|||
147572561|NCT02089685|532253799|FG003|Overall Study|Follow up ended by sponsor|70|||
147237700|NCT01663532|531042490|FG001|Overall Study|Adverse Event|13|||
147572562|NCT02089685|532253800|FG004|Overall Study|Follow up ended by sponsor|26|||
147138374|NCT03559270|530673866|FG002|Overall Study|Physician Decision|1|||
147138375|NCT03559270|530673867|FG003|Overall Study|Physician Decision|0|||
147138376|NCT03559270|530673864|FG000|Overall Study|Pregnancy|0|||
147138377|NCT03559270|530673865|FG001|Overall Study|Pregnancy|1|||
147138378|NCT03559270|530673866|FG002|Overall Study|Pregnancy|0|||
147138379|NCT03559270|530673867|FG003|Overall Study|Pregnancy|0|||
147138380|NCT03559270|530673864|FG000|Overall Study|Protocol Violation|1|||
147572563|NCT02089685|532253801|FG005|Overall Study|Follow up ended by sponsor|26|||
147572564|NCT02089685|532253796|FG000|Overall Study|Withdrawal by Subject|0|||
147572565|NCT02089685|532253797|FG001|Overall Study|Withdrawal by Subject|2|||
147572566|NCT02089685|532253798|FG002|Overall Study|Withdrawal by Subject|0|||
147572567|NCT02089685|532253799|FG003|Overall Study|Withdrawal by Subject|8|||
147572568|NCT02089685|532253800|FG004|Overall Study|Withdrawal by Subject|1|||
147572569|NCT02089685|532253801|FG005|Overall Study|Withdrawal by Subject|1|||
147572570|NCT02089685|532253796|FG000|Overall Study|Status not recorded|1|||
147572571|NCT02089685|532253797|FG001|Overall Study|Status not recorded|0|||
147572572|NCT02089685|532253798|FG002|Overall Study|Status not recorded|0|||
147572573|NCT02089685|532253799|FG003|Overall Study|Status not recorded|0|||
147572574|NCT02089685|532253800|FG004|Overall Study|Status not recorded|1|||
147572575|NCT02089685|532253801|FG005|Overall Study|Status not recorded|0|||
147572576|NCT02089685|532253796|FG000|Overall Study|Death|0|||
147572577|NCT02089685|532253797|FG001|Overall Study|Death|0|||
147572578|NCT02089685|532253798|FG002|Overall Study|Death|0|||
147572579|NCT02089685|532253799|FG003|Overall Study|Death|7|||
147572580|NCT02089685|532253800|FG004|Overall Study|Death|2|||
147572581|NCT02089685|532253801|FG005|Overall Study|Death|5|||
147572582|NCT02089685|532253796|FG000|Overall Study|Lost to Follow-up|0|||
147572583|NCT02089685|532253797|FG001|Overall Study|Lost to Follow-up|0|||
147572584|NCT02089685|532253798|FG002|Overall Study|Lost to Follow-up|0|||
147572585|NCT02089685|532253799|FG003|Overall Study|Lost to Follow-up|1|||
147572586|NCT02089685|532253800|FG004|Overall Study|Lost to Follow-up|0|||
147572587|NCT02089685|532253801|FG005|Overall Study|Lost to Follow-up|0|||
147572588|NCT02089685|532253796|FG000|Overall Study|Physician Decision|0|||
147572589|NCT02089685|532253797|FG001|Overall Study|Physician Decision|0|||
147572590|NCT02089685|532253798|FG002|Overall Study|Physician Decision|0|||
147572591|NCT02089685|532253799|FG003|Overall Study|Physician Decision|0|||
147572592|NCT02089685|532253800|FG004|Overall Study|Physician Decision|0|||
147572593|NCT02089685|532253801|FG005|Overall Study|Physician Decision|4|||
147572594|NCT02089685|532253796|FG000|Overall Study|Screen failure|1|||
147572595|NCT02089685|532253797|FG001|Overall Study|Screen failure|0|||
147572596|NCT02089685|532253798|FG002|Overall Study|Screen failure|0|||
147572597|NCT02089685|532253799|FG003|Overall Study|Screen failure|0|||
147572598|NCT02089685|532253800|FG004|Overall Study|Screen failure|0|||
147572599|NCT02089685|532253801|FG005|Overall Study|Screen failure|0|||
147572600|NCT03084471|532253809|FG000|Overall Study|Development of study specific discontinuation criteria|2|||
147572601|NCT03084471|532253809|FG000|Overall Study|Condition under investigation worsened|84|||
147572602|NCT03084471|532253809|FG000|Overall Study|Lack of therapeutic response|2|||
147572603|NCT03084471|532253809|FG000|Overall Study|Protocol Violation|1|||
147572604|NCT03084471|532253809|FG000|Overall Study|Adverse Event|73|||
147572605|NCT03084471|532253809|FG000|Overall Study|Withdrawal by Subject|12|||
147572606|NCT03084471|532253809|FG000|Overall Study|Disease relapse|181|||
147572607|NCT03084471|532253809|FG000|Overall Study|Subjective disease progression|359|||
147572608|NCT03084471|532253809|FG000|Overall Study|Other (as recorded)|33|||
147572609|NCT03084471|532253809|FG000|Overall Study|Patients who were still on study treatment at Data Cutoff|120|||
147572610|NCT00505622|532253810|FG000|Overall Study|Adverse Event|5|||
147572611|NCT00505622|532253811|FG001|Overall Study|Adverse Event|6|||
147572612|NCT00505622|532253812|FG002|Overall Study|Adverse Event|4|||
147572613|NCT00505622|532253810|FG000|Overall Study|Protocol Violation|1|||
147572614|NCT00505622|532253811|FG001|Overall Study|Protocol Violation|1|||
147572615|NCT00505622|532253812|FG002|Overall Study|Protocol Violation|0|||
147572616|NCT00505622|532253810|FG000|Overall Study|Withdrawal by Subject|0|||
147572617|NCT00505622|532253811|FG001|Overall Study|Withdrawal by Subject|3|||
147572618|NCT00505622|532253812|FG002|Overall Study|Withdrawal by Subject|2|||
147572619|NCT00505622|532253810|FG000|Overall Study|Study termination by sponsor|115|||
147572620|NCT00505622|532253811|FG001|Overall Study|Study termination by sponsor|98|||
147572621|NCT00505622|532253812|FG002|Overall Study|Study termination by sponsor|90|||
147572622|NCT00835692|532253815|FG000|First Intervention|Withdrawal by Subject|1|||
147572623|NCT00835692|532253816|FG001|First Intervention|Withdrawal by Subject|0|||
147572624|NCT04078022|532253819|FG000|Vaccination Phase|Withdrawal prior to challenge|2|||
147572625|NCT04078022|532253820|FG001|Vaccination Phase|Withdrawal prior to challenge|3|||
147572626|NCT00191815|532253821|FG000|Overall Study|Adverse Event|2|||
147572627|NCT00191815|532253821|FG000|Overall Study|Disease progression or relapse|24|||
147572628|NCT00191815|532253821|FG000|Overall Study|Death|2|||
147572629|NCT00191815|532253821|FG000|Overall Study|Protocol Violation|3|||
147572630|NCT00191815|532253821|FG000|Overall Study|Physician Decision|2|||
147572631|NCT00191815|532253821|FG000|Overall Study|Withdrawal by Subject|7|||
147572632|NCT03808376|532253822|FG000|Overall Study|Withdrawal by Subject|10|||
147572633|NCT03644550|532253823|FG000|Overall Study|Withdrawal by Subject|3|||
147572634|NCT03644550|532253823|FG000|Overall Study|Progressive disease|15|||
147572635|NCT03804983|532253824|FG000|Overall Study|Adverse Event|0|||
147572636|NCT03804983|532253825|FG001|Overall Study|Adverse Event|1|||
147572637|NCT03804983|532253824|FG000|Overall Study|Family Obligation|1|||
147572638|NCT03804983|532253825|FG001|Overall Study|Family Obligation|0|||
147572639|NCT02152163|532253826|FG000|Overall Study|Physician Decision|12|||
147572640|NCT02152163|532253827|FG001|Overall Study|Physician Decision|13|||
147572641|NCT01097577|532253831|FG000|Overall Study|Adverse Event|0|||
147572642|NCT01097577|532253832|FG001|Overall Study|Adverse Event|1|||
147572643|NCT03114891|532253843|FG000|First Treatment Round|Lost to Follow-up|0|||
147572644|NCT03114891|532253844|FG001|First Treatment Round|Lost to Follow-up|1|||
147572645|NCT03114891|532253845|FG002|First Treatment Round|Lost to Follow-up|1|||
147572646|NCT03114891|532253846|FG003|First Treatment Round|Lost to Follow-up|0|||
147572647|NCT03114891|532253843|FG000|First Treatment Round|Withdrawal by Subject|0|||
147572648|NCT03114891|532253844|FG001|First Treatment Round|Withdrawal by Subject|2|||
147572649|NCT03114891|532253845|FG002|First Treatment Round|Withdrawal by Subject|0|||
147572650|NCT03114891|532253846|FG003|First Treatment Round|Withdrawal by Subject|1|||
147572651|NCT03114891|532253843|FG000|3 Week Break|Lost to Follow-up|1|||
147572652|NCT03114891|532253844|FG001|3 Week Break|Lost to Follow-up|0|||
147572653|NCT03114891|532253845|FG002|3 Week Break|Lost to Follow-up|0|||
147572654|NCT03114891|532253846|FG003|3 Week Break|Lost to Follow-up|1|||
147572655|NCT03114891|532253843|FG000|3 Week Break|Withdrawal by Subject|0|||
147572656|NCT03114891|532253844|FG001|3 Week Break|Withdrawal by Subject|1|||
147572657|NCT03114891|532253845|FG002|3 Week Break|Withdrawal by Subject|0|||
147572658|NCT03114891|532253846|FG003|3 Week Break|Withdrawal by Subject|0|||
147572659|NCT03114891|532253843|FG000|Second Treatment Round|Lost to Follow-up|1|||
147572660|NCT03114891|532253844|FG001|Second Treatment Round|Lost to Follow-up|0|||
147572661|NCT03114891|532253845|FG002|Second Treatment Round|Lost to Follow-up|0|||
147572662|NCT03114891|532253846|FG003|Second Treatment Round|Lost to Follow-up|0|||
147572663|NCT03114891|532253843|FG000|Second Treatment Round|Physician Decision|1|||
147138381|NCT03559270|530673865|FG001|Overall Study|Protocol Violation|0|||
147138382|NCT03559270|530673866|FG002|Overall Study|Protocol Violation|2|||
147138383|NCT03559270|530673867|FG003|Overall Study|Protocol Violation|0|||
147138384|NCT01856322|530675404|FG000|Overall Study|off study due to lack of accrual|0|||
147138385|NCT01856322|530675405|FG001|Overall Study|off study due to lack of accrual|0|||
147138386|NCT01856322|530675406|FG002|Overall Study|off study due to lack of accrual|3|||
147138387|NCT02393859|530675408|FG000|Overall Study|Decision by Sponsor|2|||
147138388|NCT02393859|530675409|FG001|Overall Study|Decision by Sponsor|4|||
147138389|NCT02393859|530675408|FG000|Overall Study|Withdrawal by Subject|11|||
147138390|NCT02393859|530675409|FG001|Overall Study|Withdrawal by Subject|6|||
147138391|NCT02393859|530675408|FG000|Overall Study|Death|27|||
147445652|NCT03200366|531797425|FG002|Patient Navigation Intervention Given|Declined navigation intervention|0|||
147445653|NCT03200366|531797423|FG000|6 Month Post-Baseline Interview|Death|1|||
147445654|NCT03200366|531797424|FG001|6 Month Post-Baseline Interview|Death|1|||
147445655|NCT03200366|531797425|FG002|6 Month Post-Baseline Interview|Death|1|||
147138392|NCT02393859|530675409|FG001|Overall Study|Death|10|||
147138393|NCT02393859|530675408|FG000|Overall Study|Lost to Follow-up|1|||
147138394|NCT02393859|530675409|FG001|Overall Study|Lost to Follow-up|1|||
147138395|NCT00856323|530675412|FG000|Overall Study|Withdrawal by Subject|2|||
147138396|NCT01119443|530675413|FG000|Crossover Period 1 (5 Days)|Adverse Event|0|||
147138397|NCT01119443|530675414|FG001|Crossover Period 1 (5 Days)|Adverse Event|1|||
147138398|NCT02329743|530675415|FG000|Overall Study|Adverse Event|1|||
147138399|NCT02329743|530675416|FG001|Overall Study|Adverse Event|1|||
147138400|NCT02329743|530675417|FG002|Overall Study|Adverse Event|3|||
147138401|NCT02329743|530675415|FG000|Overall Study|Lost to Follow-up|1|||
147445656|NCT03200366|531797423|FG000|6 Month Post-Baseline Interview|Lost to Follow-up|27|||
147445657|NCT03200366|531797424|FG001|6 Month Post-Baseline Interview|Lost to Follow-up|21|||
147445658|NCT03200366|531797425|FG002|6 Month Post-Baseline Interview|Lost to Follow-up|17|||
147572664|NCT03114891|532253844|FG001|Second Treatment Round|Physician Decision|0|||
147572665|NCT03114891|532253845|FG002|Second Treatment Round|Physician Decision|0|||
147572666|NCT03114891|532253846|FG003|Second Treatment Round|Physician Decision|0|||
147572667|NCT05511935|532255708|FG000|Overall Study|Lost to Follow-up|9|||
147572668|NCT05511935|532255709|FG001|Overall Study|Lost to Follow-up|27|||
147572669|NCT00373256|532255710|FG000|Overall Study|Adverse Event (AE)|1|||
147572670|NCT00373256|532255711|FG001|Overall Study|Adverse Event (AE)|5|||
147572671|NCT00373256|532255710|FG000|Overall Study|Lost to Follow-up|2|||
147572672|NCT00373256|532255711|FG001|Overall Study|Lost to Follow-up|1|||
147572673|NCT00373256|532255710|FG000|Overall Study|Death|9|||
147572674|NCT00373256|532255711|FG001|Overall Study|Death|8|||
147572675|NCT00373256|532255710|FG000|Overall Study|Objective Progression or Relapse|111|||
147572676|NCT00373256|532255711|FG001|Overall Study|Objective Progression or Relapse|104|||
147572677|NCT00373256|532255710|FG000|Overall Study|Refused Treatment-Reason Other Than AE|4|||
147572678|NCT00373256|532255711|FG001|Overall Study|Refused Treatment-Reason Other Than AE|7|||
147572679|NCT00373256|532255710|FG000|Overall Study|Other|73|||
147138402|NCT02329743|530675416|FG001|Overall Study|Lost to Follow-up|0|||
147138403|NCT02329743|530675417|FG002|Overall Study|Lost to Follow-up|1|||
147318564|NCT00996580|531331769|FG000|Overall Study|Protocol Violation|16|||
147445659|NCT03200366|531797423|FG000|6 Month Post-Baseline Interview|Withdrawal by Subject|1|||
147572680|NCT00373256|532255711|FG001|Overall Study|Other|107|||
147572681|NCT00373256|532255710|FG000|Overall Study|Protocol Violation|0|||
147572682|NCT00373256|532255711|FG001|Overall Study|Protocol Violation|2|||
147138404|NCT02329743|530675415|FG000|Overall Study|Withdrawal by Subject|4|||
147572683|NCT00373256|532255710|FG000|Overall Study|Study Terminated by Sponsor|41|||
147138405|NCT02329743|530675416|FG001|Overall Study|Withdrawal by Subject|4|||
147138406|NCT02329743|530675417|FG002|Overall Study|Withdrawal by Subject|1|||
147138407|NCT02329743|530675415|FG000|Overall Study|Other|0|||
147138408|NCT02329743|530675416|FG001|Overall Study|Other|2|||
147138409|NCT02329743|530675417|FG002|Overall Study|Other|3|||
147138410|NCT01428219|530675418|FG000|Overall Study|25 patients enrolled, 3 were not treated|3|||
147138411|NCT02071771|530675419|FG000|Period 1: First 10 Days|Unacceptable lens fit|1|||
147138412|NCT02071771|530675420|FG001|Period 1: First 10 Days|Unacceptable lens fit|0|||
147138413|NCT02071771|530675419|FG000|Period 1: First 10 Days|Unavailable lens power|1|||
147138414|NCT02071771|530675420|FG001|Period 1: First 10 Days|Unavailable lens power|0|||
147138415|NCT01833494|530675428|FG000|Overall Study|Adverse Event|24|||
147138416|NCT01833494|530675428|FG000|Overall Study|Physician Decision|6|||
147138417|NCT01833494|530675428|FG000|Overall Study|Withdrawal by Subject|6|||
147138418|NCT01833494|530675428|FG000|Overall Study|Decrease in serum phosphorus|4|||
147138419|NCT01833494|530675428|FG000|Overall Study|Decrease in serum calcium|4|||
147138420|NCT01833494|530675428|FG000|Overall Study|Increase in serum ferritin|1|||
147138421|NCT01694433|530675433|FG000|Overall Study|Adverse Event|7|||
147138422|NCT01694433|530675434|FG001|Overall Study|Adverse Event|0|||
147138423|NCT01694433|530675433|FG000|Overall Study|Physician Decision|1|||
147138424|NCT01694433|530675434|FG001|Overall Study|Physician Decision|0|||
147138425|NCT01694433|530675433|FG000|Overall Study|Withdrawal by Subject|3|||
147138426|NCT01694433|530675434|FG001|Overall Study|Withdrawal by Subject|4|||
147138427|NCT00374595|530675437|FG000|Overall Study|Death|23|||
147138428|NCT00374595|530675437|FG000|Overall Study|Withdrawal by Subject|39|||
147138429|NCT00374595|530675437|FG000|Overall Study|Lost to Follow-up|3|||
147138430|NCT00374595|530675437|FG000|Overall Study|too much time commitment|1|||
147138431|NCT00374595|530675437|FG000|Overall Study|transfer care to other clinical site|1|||
147138432|NCT00374595|530675437|FG000|Overall Study|relocation|3|||
147138433|NCT03745768|530675438|FG000|Overall Study|discontinued study|2|||
147138434|NCT03745768|530675439|FG001|Overall Study|discontinued study|0|||
147138435|NCT00443118|530675440|FG000|Overall Study|unknown primary outcome|3|||
147138436|NCT00443118|530675441|FG001|Overall Study|unknown primary outcome|1|||
147138437|NCT00443118|530675442|FG002|Overall Study|unknown primary outcome|0|||
147138438|NCT00443118|530675440|FG000|Overall Study|Withdrawal by Subject|1|||
147138439|NCT00443118|530675441|FG001|Overall Study|Withdrawal by Subject|0|||
147138440|NCT00443118|530675442|FG002|Overall Study|Withdrawal by Subject|0|||
147138441|NCT04512001|530675443|FG000|Week 0 to Week 24|Adverse Event|14|||
147138442|NCT04512001|530675444|FG001|Week 0 to Week 24|Adverse Event|10|||
147138443|NCT04512001|530675445|FG002|Week 0 to Week 24|Adverse Event|0|||
147138444|NCT04512001|530675446|FG003|Week 0 to Week 24|Adverse Event|0|||
147138445|NCT04512001|530675447|FG004|Week 0 to Week 24|Adverse Event|0|||
147138446|NCT04512001|530675443|FG000|Week 0 to Week 24|Death|0|||
147138447|NCT04512001|530675444|FG001|Week 0 to Week 24|Death|2|||
147138448|NCT04512001|530675445|FG002|Week 0 to Week 24|Death|0|||
147138449|NCT04512001|530675446|FG003|Week 0 to Week 24|Death|0|||
147138450|NCT04512001|530675447|FG004|Week 0 to Week 24|Death|0|||
147138451|NCT04512001|530675443|FG000|Week 0 to Week 24|Withdrawal by Subject|16|||
147138452|NCT04512001|530675444|FG001|Week 0 to Week 24|Withdrawal by Subject|9|||
147138453|NCT04512001|530675445|FG002|Week 0 to Week 24|Withdrawal by Subject|0|||
147138454|NCT04512001|530675446|FG003|Week 0 to Week 24|Withdrawal by Subject|0|||
147138455|NCT04512001|530675447|FG004|Week 0 to Week 24|Withdrawal by Subject|0|||
147138456|NCT04512001|530675443|FG000|Week 0 to Week 24|Discontinued treatment prior to Week 24|4|||
147138457|NCT04512001|530675444|FG001|Week 0 to Week 24|Discontinued treatment prior to Week 24|4|||
147138458|NCT04512001|530675445|FG002|Week 0 to Week 24|Discontinued treatment prior to Week 24|0|||
147138459|NCT04512001|530675446|FG003|Week 0 to Week 24|Discontinued treatment prior to Week 24|0|||
147138460|NCT04512001|530675447|FG004|Week 0 to Week 24|Discontinued treatment prior to Week 24|0|||
147138461|NCT04512001|530675443|FG000|Week 0 to Week 24|Withdrawal By Sponsor's Decision|1|||
147138462|NCT04512001|530675444|FG001|Week 0 to Week 24|Withdrawal By Sponsor's Decision|0|||
147138463|NCT04512001|530675445|FG002|Week 0 to Week 24|Withdrawal By Sponsor's Decision|0|||
147138464|NCT04512001|530675446|FG003|Week 0 to Week 24|Withdrawal By Sponsor's Decision|0|||
147138465|NCT04512001|530675447|FG004|Week 0 to Week 24|Withdrawal By Sponsor's Decision|0|||
147138466|NCT04512001|530675443|FG000|Week 0 to Week 24|Subject Did Not Meet Eligibility But Was Randomized|0|||
147138467|NCT04512001|530675444|FG001|Week 0 to Week 24|Subject Did Not Meet Eligibility But Was Randomized|1|||
147138468|NCT04512001|530675445|FG002|Week 0 to Week 24|Subject Did Not Meet Eligibility But Was Randomized|0|||
147138469|NCT04512001|530675446|FG003|Week 0 to Week 24|Subject Did Not Meet Eligibility But Was Randomized|0|||
147138470|NCT04512001|530675447|FG004|Week 0 to Week 24|Subject Did Not Meet Eligibility But Was Randomized|0|||
147138471|NCT04512001|530675443|FG000|Week 24 to Week 63|Adverse Event|0|||
147138472|NCT04512001|530675444|FG001|Week 24 to Week 63|Adverse Event|0|||
147318565|NCT00996580|531331769|FG000|Overall Study|Sponsor requested participant withdrawal|35|||
147318566|NCT00996580|531331769|FG000|Overall Study|Withdrawal by Subject|217|||
147138473|NCT04512001|530675445|FG002|Week 24 to Week 63|Adverse Event|13|||
147138474|NCT04512001|530675446|FG003|Week 24 to Week 63|Adverse Event|8|||
147138475|NCT04512001|530675447|FG004|Week 24 to Week 63|Adverse Event|6|||
147138476|NCT04512001|530675443|FG000|Week 24 to Week 63|Lost to Follow-up|0|||
147138477|NCT04512001|530675444|FG001|Week 24 to Week 63|Lost to Follow-up|0|||
147138478|NCT04512001|530675445|FG002|Week 24 to Week 63|Lost to Follow-up|1|||
147138479|NCT04512001|530675446|FG003|Week 24 to Week 63|Lost to Follow-up|1|||
147138480|NCT04512001|530675447|FG004|Week 24 to Week 63|Lost to Follow-up|1|||
147138481|NCT04512001|530675443|FG000|Week 24 to Week 63|Death|0|||
147138482|NCT04512001|530675444|FG001|Week 24 to Week 63|Death|0|||
147138483|NCT04512001|530675445|FG002|Week 24 to Week 63|Death|0|||
147138484|NCT04512001|530675446|FG003|Week 24 to Week 63|Death|1|||
147138485|NCT04512001|530675447|FG004|Week 24 to Week 63|Death|1|||
147138486|NCT04512001|530675443|FG000|Week 24 to Week 63|Withdrawal by Subject|0|||
147138487|NCT04512001|530675444|FG001|Week 24 to Week 63|Withdrawal by Subject|0|||
147138488|NCT04512001|530675445|FG002|Week 24 to Week 63|Withdrawal by Subject|6|||
147138489|NCT04512001|530675446|FG003|Week 24 to Week 63|Withdrawal by Subject|4|||
147138490|NCT04512001|530675447|FG004|Week 24 to Week 63|Withdrawal by Subject|6|||
147138491|NCT04512001|530675443|FG000|Week 24 to Week 63|Miscellaneous|0|||
147138492|NCT04512001|530675444|FG001|Week 24 to Week 63|Miscellaneous|0|||
147138493|NCT04512001|530675445|FG002|Week 24 to Week 63|Miscellaneous|3|||
147138494|NCT04512001|530675446|FG003|Week 24 to Week 63|Miscellaneous|2|||
147138495|NCT04512001|530675447|FG004|Week 24 to Week 63|Miscellaneous|1|||
147138496|NCT02776683|530675448|FG000|Pre-switch Period|Protocol Violation|1|||
147138497|NCT02776683|530675449|FG001|Pre-switch Period|Protocol Violation|0|||
147138498|NCT02776683|530675448|FG000|Pre-switch Period|Adverse Event|21|||
147138499|NCT02776683|530675449|FG001|Pre-switch Period|Adverse Event|0|||
147138500|NCT02776683|530675448|FG000|Pre-switch Period|Withdrawal by Subject|9|||
147138501|NCT02776683|530675449|FG001|Pre-switch Period|Withdrawal by Subject|0|||
147138502|NCT02776683|530675448|FG000|Pre-switch Period|Physician Decision|7|||
147138503|NCT02776683|530675449|FG001|Pre-switch Period|Physician Decision|0|||
147138504|NCT02776683|530675448|FG000|Pre-switch Period|Progressive disease|39|||
147138505|NCT02776683|530675449|FG001|Pre-switch Period|Progressive disease|0|||
147138506|NCT02776683|530675448|FG000|Pre-switch Period|Other than listed|3|||
147138507|NCT02776683|530675449|FG001|Pre-switch Period|Other than listed|0|||
147138508|NCT02776683|530675448|FG000|Post-switch Period|Adverse Event|0|||
147138509|NCT02776683|530675449|FG001|Post-switch Period|Adverse Event|3|||
147138510|NCT02776683|530675448|FG000|Post-switch Period|Withdrawal by Subject|0|||
147138511|NCT02776683|530675449|FG001|Post-switch Period|Withdrawal by Subject|2|||
147138512|NCT02776683|530675448|FG000|Post-switch Period|Physician Decision|0|||
147138513|NCT02776683|530675449|FG001|Post-switch Period|Physician Decision|3|||
147138514|NCT02776683|530675448|FG000|Post-switch Period|Progressive disease|0|||
147138515|NCT02776683|530675449|FG001|Post-switch Period|Progressive disease|20|||
147138516|NCT02776683|530675448|FG000|Post-switch Period|Other than listed|0|||
147138517|NCT02776683|530675449|FG001|Post-switch Period|Other than listed|15|||
147138518|NCT04232943|530675450|FG000|Overall Study|Enrolled but Treatment not Administered|2|||
147138519|NCT04232943|530675451|FG001|Overall Study|Enrolled but Treatment not Administered|3|||
147138520|NCT04232943|530675452|FG002|Overall Study|Enrolled but Treatment not Administered|2|||
147138521|NCT04232943|530675450|FG000|Overall Study|Withdrawal by Subject|1|||
147138522|NCT04232943|530675451|FG001|Overall Study|Withdrawal by Subject|1|||
147138523|NCT04232943|530675452|FG002|Overall Study|Withdrawal by Subject|0|||
147138524|NCT01664247|530675457|FG000|Overall Study|Adverse Event|5|||
147138525|NCT01664247|530675458|FG001|Overall Study|Adverse Event|3|||
147138526|NCT01664247|530675457|FG000|Overall Study|Protocol Violation|3|||
147138527|NCT01664247|530675458|FG001|Overall Study|Protocol Violation|5|||
147138528|NCT01664247|530675457|FG000|Overall Study|Withdrawal Criteria|1|||
147138529|NCT01664247|530675458|FG001|Overall Study|Withdrawal Criteria|4|||
147138530|NCT01664247|530675457|FG000|Overall Study|Unclassified|5|||
147138531|NCT01664247|530675458|FG001|Overall Study|Unclassified|29|||
147138532|NCT01000506|530675461|FG000|Overall Study|Adverse Event|6|||
147138533|NCT01000506|530675462|FG001|Overall Study|Adverse Event|5|||
147138534|NCT01000506|530675463|FG002|Overall Study|Adverse Event|8|||
147138535|NCT01000506|530675464|FG003|Overall Study|Adverse Event|9|||
147138536|NCT01000506|530675461|FG000|Overall Study|Lack of Efficacy|8|||
147138537|NCT01000506|530675462|FG001|Overall Study|Lack of Efficacy|6|||
147138538|NCT01000506|530675463|FG002|Overall Study|Lack of Efficacy|4|||
147572684|NCT00373256|532255711|FG001|Overall Study|Study Terminated by Sponsor|13|||
147572685|NCT00334815|532255712|FG000|Overall Study|Adverse Event|3|||
147572686|NCT00334815|532255713|FG001|Overall Study|Adverse Event|2|||
147572687|NCT00334815|532255712|FG000|Overall Study|Death|0|||
147572688|NCT00334815|532255713|FG001|Overall Study|Death|2|||
147572689|NCT00334815|532255712|FG000|Overall Study|Progression|1|||
147572690|NCT00334815|532255713|FG001|Overall Study|Progression|0|||
147572691|NCT00334815|532255712|FG000|Overall Study|ineligible|1|||
147572692|NCT00334815|532255713|FG001|Overall Study|ineligible|1|||
147572693|NCT00334815|532255712|FG000|Overall Study|patient refused treatment|0|||
147138539|NCT01000506|530675464|FG003|Overall Study|Lack of Efficacy|4|||
147138540|NCT01000506|530675461|FG000|Overall Study|Protocol Violation|1|||
147138541|NCT01000506|530675462|FG001|Overall Study|Protocol Violation|1|||
147138542|NCT01000506|530675463|FG002|Overall Study|Protocol Violation|0|||
147138543|NCT01000506|530675464|FG003|Overall Study|Protocol Violation|0|||
147138544|NCT01000506|530675461|FG000|Overall Study|Lost to Follow-up|1|||
147572694|NCT00334815|532255713|FG001|Overall Study|patient refused treatment|1|||
147138545|NCT01000506|530675462|FG001|Overall Study|Lost to Follow-up|1|||
147138546|NCT01000506|530675463|FG002|Overall Study|Lost to Follow-up|4|||
147138547|NCT01000506|530675464|FG003|Overall Study|Lost to Follow-up|0|||
147138548|NCT01000506|530675461|FG000|Overall Study|Physician Decision|1|||
147138549|NCT01000506|530675462|FG001|Overall Study|Physician Decision|3|||
147138550|NCT01000506|530675463|FG002|Overall Study|Physician Decision|3|||
147138551|NCT01000506|530675464|FG003|Overall Study|Physician Decision|3|||
147138552|NCT01000506|530675461|FG000|Overall Study|Withdrawal by Subject|11|||
147572695|NCT00334815|532255712|FG000|Overall Study|Physician Decision|2|||
147138553|NCT01000506|530675462|FG001|Overall Study|Withdrawal by Subject|8|||
147138554|NCT01000506|530675463|FG002|Overall Study|Withdrawal by Subject|2|||
147138555|NCT01000506|530675464|FG003|Overall Study|Withdrawal by Subject|7|||
147138556|NCT03064074|530675465|FG000|Overall Study|Physician Decision|0|||
147138557|NCT03064074|530675466|FG001|Overall Study|Physician Decision|0|||
147138558|NCT03064074|530675467|FG002|Overall Study|Physician Decision|0|||
147138559|NCT03064074|530675468|FG003|Overall Study|Physician Decision|1|||
147138560|NCT02216526|530675474|FG000|Overall Study|Adverse Event|1|||
147138561|NCT02216526|530675475|FG001|Overall Study|Adverse Event|1|||
147138562|NCT02216526|530675476|FG002|Overall Study|Adverse Event|0|||
147138563|NCT02216526|530675474|FG000|Overall Study|Death|0|||
147138564|NCT02216526|530675475|FG001|Overall Study|Death|1|||
147138565|NCT02216526|530675476|FG002|Overall Study|Death|3|||
147138566|NCT02216526|530675474|FG000|Overall Study|Protocol Violation|2|||
147138567|NCT02216526|530675475|FG001|Overall Study|Protocol Violation|0|||
147138568|NCT02216526|530675476|FG002|Overall Study|Protocol Violation|2|||
147138569|NCT02216526|530675474|FG000|Overall Study|Hospitalization|2|||
147138570|NCT02216526|530675475|FG001|Overall Study|Hospitalization|1|||
147138571|NCT02216526|530675476|FG002|Overall Study|Hospitalization|3|||
147138572|NCT01882465|530675477|FG000|Period 1|Lens Discomfort|0|||
147138573|NCT01882465|530675478|FG001|Period 1|Lens Discomfort|0|||
147138574|NCT01882465|530675479|FG002|Period 1|Lens Discomfort|0|||
147138575|NCT01882465|530675480|FG003|Period 1|Lens Discomfort|1|||
147138576|NCT01882465|530675481|FG004|Period 1|Lens Discomfort|0|||
147138577|NCT01882465|530675482|FG005|Period 1|Lens Discomfort|0|||
147138578|NCT01882465|530675483|FG006|Period 1|Lens Discomfort|0|||
147138579|NCT01882465|530675477|FG000|Period 1|Withdrawal by Subject|0|||
147138580|NCT01882465|530675478|FG001|Period 1|Withdrawal by Subject|0|||
147138581|NCT01882465|530675479|FG002|Period 1|Withdrawal by Subject|0|||
147138582|NCT01882465|530675480|FG003|Period 1|Withdrawal by Subject|0|||
147138583|NCT01882465|530675481|FG004|Period 1|Withdrawal by Subject|0|||
147138584|NCT01882465|530675482|FG005|Period 1|Withdrawal by Subject|0|||
147138585|NCT01882465|530675483|FG006|Period 1|Withdrawal by Subject|1|||
147138586|NCT01882465|530675477|FG000|Period 2|Protocol Violation|0|||
147138587|NCT01882465|530675478|FG001|Period 2|Protocol Violation|0|||
147138588|NCT01882465|530675479|FG002|Period 2|Protocol Violation|0|||
147138589|NCT01882465|530675480|FG003|Period 2|Protocol Violation|0|||
147138590|NCT01882465|530675481|FG004|Period 2|Protocol Violation|1|||
147138591|NCT01882465|530675482|FG005|Period 2|Protocol Violation|0|||
147138592|NCT01882465|530675483|FG006|Period 2|Protocol Violation|0|||
147138593|NCT03824392|530675484|FG000|Overall Study|Adverse Event|1|||
147138594|NCT03824392|530675485|FG001|Overall Study|Adverse Event|0|||
147138595|NCT03824392|530675486|FG002|Overall Study|Adverse Event|0|||
147138596|NCT03824392|530675487|FG003|Overall Study|Adverse Event|0|||
147138597|NCT03824392|530675484|FG000|Overall Study|Investigator Decision|0|||
147138598|NCT03824392|530675485|FG001|Overall Study|Investigator Decision|1|||
147138599|NCT03824392|530675486|FG002|Overall Study|Investigator Decision|0|||
147138600|NCT03824392|530675487|FG003|Overall Study|Investigator Decision|0|||
147138601|NCT03824392|530675484|FG000|Overall Study|Participant Unable to Participate Due to COVID-19 Quarantine Restrictions|2|||
147138602|NCT03824392|530675485|FG001|Overall Study|Participant Unable to Participate Due to COVID-19 Quarantine Restrictions|1|||
147138603|NCT03824392|530675486|FG002|Overall Study|Participant Unable to Participate Due to COVID-19 Quarantine Restrictions|3|||
147138604|NCT03824392|530675487|FG003|Overall Study|Participant Unable to Participate Due to COVID-19 Quarantine Restrictions|1|||
147138605|NCT00532844|530675489|FG000|Treatment Period - Day 1 to Day 14|Withdrawal of consent|0|||
147138606|NCT00532844|530675490|FG001|Treatment Period - Day 1 to Day 14|Withdrawal of consent|1|||
147138607|NCT00532844|530675489|FG000|Treatment Period - Day 15 to Day 28|Pregnancy|1|||
147138608|NCT00532844|530675490|FG001|Treatment Period - Day 15 to Day 28|Pregnancy|0|||
147138609|NCT00532844|530675489|FG000|Treatment Period - Day 15 to Day 28|Personal reasons|1|||
147138610|NCT00532844|530675490|FG001|Treatment Period - Day 15 to Day 28|Personal reasons|0|||
147138611|NCT00532844|530675489|FG000|Treatment Period - Day 15 to Day 28|Adverse Event|1|||
147138612|NCT00532844|530675490|FG001|Treatment Period - Day 15 to Day 28|Adverse Event|0|||
147138613|NCT00532844|530675489|FG000|Treatment Period - Day 15 to Day 28|withdrawal of consent|1|||
147138614|NCT00532844|530675490|FG001|Treatment Period - Day 15 to Day 28|withdrawal of consent|0|||
147138615|NCT04389866|530675493|FG000|Overall Study|Patient with COVID-19 exposure concerns 03Dec2020|1|||
147138616|NCT04389866|530675494|FG001|Overall Study|Patient with COVID-19 exposure concerns 03Dec2020|1|||
147138617|NCT04940130|530675500|FG000|Overall Study|Travel|1|||
147138618|NCT04940130|530675501|FG001|Overall Study|Travel|0|||
147138619|NCT04940130|530675502|FG002|Overall Study|Travel|2|||
147318567|NCT00996580|531331769|FG000|Overall Study|Other|29|||
147651834|NCT01483599|532546583|FG003|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
147651835|NCT01483599|532546584|FG004|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
147651836|NCT01483599|532546585|FG005|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
147651837|NCT01483599|532546586|FG006|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
147651838|NCT01483599|532546587|FG007|After Controlled Period(Week 16-Week 40)|Adverse Event|1|||
147651839|NCT01483599|532546588|FG008|After Controlled Period(Week 16-Week 40)|Adverse Event|1|||
147651840|NCT01483599|532546589|FG009|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
147651841|NCT01483599|532546590|FG010|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
147651842|NCT01483599|532546591|FG011|After Controlled Period(Week 16-Week 40)|Adverse Event|0|||
147651843|NCT01483599|532546592|FG012|After Controlled Period(Week 16-Week 40)|Adverse Event|1|||
147651844|NCT01483599|532546593|FG013|After Controlled Period(Week 16-Week 40)|Adverse Event|1|||
147651845|NCT01483599|532546580|FG000|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
147651846|NCT01483599|532546581|FG001|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
147651847|NCT01483599|532546582|FG002|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
147651848|NCT01483599|532546583|FG003|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
147651849|NCT01483599|532546584|FG004|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
147651850|NCT01483599|532546585|FG005|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
147651851|NCT01483599|532546586|FG006|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
147651852|NCT01483599|532546587|FG007|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
147651853|NCT01483599|532546588|FG008|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|1|||
147651854|NCT01483599|532546589|FG009|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
147651855|NCT01483599|532546590|FG010|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
147651856|NCT01483599|532546591|FG011|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|1|||
147651857|NCT01483599|532546592|FG012|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|0|||
147138620|NCT04940130|530675500|FG000|Overall Study|Parent/Guardian withdrew consent|0|||
147138621|NCT04940130|530675501|FG001|Overall Study|Parent/Guardian withdrew consent|1|||
147138622|NCT04940130|530675502|FG002|Overall Study|Parent/Guardian withdrew consent|7|||
147138623|NCT04940130|530675500|FG000|Overall Study|Adverse Event|0|||
147138624|NCT04940130|530675501|FG001|Overall Study|Adverse Event|0|||
147138625|NCT04940130|530675502|FG002|Overall Study|Adverse Event|2|||
147138626|NCT04940130|530675500|FG000|Overall Study|Disease progression/treatment failure|0|||
147138627|NCT04940130|530675501|FG001|Overall Study|Disease progression/treatment failure|0|||
147138628|NCT04940130|530675502|FG002|Overall Study|Disease progression/treatment failure|1|||
147138629|NCT04940130|530675500|FG000|Overall Study|Participant refusal|0|||
147138630|NCT04940130|530675501|FG001|Overall Study|Participant refusal|0|||
147138631|NCT04940130|530675502|FG002|Overall Study|Participant refusal|1|||
147138632|NCT02240121|530675503|FG000|Overall Study|Protocol Violation|1|||
147138633|NCT02240121|530675504|FG001|Overall Study|Protocol Violation|2|||
147138634|NCT02240121|530675503|FG000|Overall Study|Physician Decision|0|||
147138635|NCT02240121|530675504|FG001|Overall Study|Physician Decision|1|||
147138636|NCT02240121|530675503|FG000|Overall Study|Change in protocol interpretation|1|||
147138637|NCT02240121|530675504|FG001|Overall Study|Change in protocol interpretation|0|||
147138638|NCT02240121|530675503|FG000|Overall Study|Lack of Efficacy|2|||
147138639|NCT02240121|530675504|FG001|Overall Study|Lack of Efficacy|3|||
147138640|NCT02240121|530675503|FG000|Overall Study|Site closed|1|||
147138641|NCT02240121|530675504|FG001|Overall Study|Site closed|1|||
147138642|NCT02240121|530675503|FG000|Overall Study|Pregnancy|1|||
147138643|NCT02240121|530675504|FG001|Overall Study|Pregnancy|0|||
147138644|NCT02240121|530675503|FG000|Overall Study|Adverse Event|2|||
147138645|NCT02240121|530675504|FG001|Overall Study|Adverse Event|4|||
147138646|NCT02240121|530675503|FG000|Overall Study|Withdrawal by Subject|6|||
147138647|NCT02240121|530675504|FG001|Overall Study|Withdrawal by Subject|2|||
147138648|NCT02240121|530675503|FG000|Overall Study|Lost to Follow-up|3|||
147138649|NCT02240121|530675504|FG001|Overall Study|Lost to Follow-up|4|||
147237701|NCT01663532|531042489|FG000|Overall Study|Met Withdrawal Criteria|7|||
147237702|NCT01663532|531042490|FG001|Overall Study|Met Withdrawal Criteria|6|||
147237703|NCT01663532|531042489|FG000|Overall Study|Physician Decision|1|||
147572696|NCT00334815|532255713|FG001|Overall Study|Physician Decision|4|||
147572697|NCT03121586|532255714|FG000|Overall Study|Study terminated by sponsor|0|||
147572698|NCT03121586|532255715|FG001|Overall Study|Study terminated by sponsor|0|||
147572699|NCT03121586|532255716|FG002|Overall Study|Study terminated by sponsor|99|||
147572700|NCT03121586|532255714|FG000|Overall Study|Withdrawal by Subject|37|||
147572701|NCT03121586|532255715|FG001|Overall Study|Withdrawal by Subject|14|||
147572702|NCT03121586|532255716|FG002|Overall Study|Withdrawal by Subject|9|||
147572703|NCT03121586|532255714|FG000|Overall Study|Not further specified|6|||
147138650|NCT02240121|530675503|FG000|Overall Study|Other than specified|1|||
147138651|NCT02240121|530675504|FG001|Overall Study|Other than specified|3|||
147138652|NCT00251693|530675508|FG000|Overall Study|Adverse Event|17|||
147138653|NCT00251693|530675509|FG001|Overall Study|Adverse Event|9|||
147138654|NCT00251693|530675510|FG002|Overall Study|Adverse Event|9|||
147138655|NCT00251693|530675508|FG000|Overall Study|Protocol Violation|2|||
147138656|NCT00251693|530675509|FG001|Overall Study|Protocol Violation|0|||
147138657|NCT00251693|530675510|FG002|Overall Study|Protocol Violation|2|||
147138658|NCT00251693|530675508|FG000|Overall Study|Lost to Follow-up|12|||
147138659|NCT00251693|530675509|FG001|Overall Study|Lost to Follow-up|7|||
147138660|NCT00251693|530675510|FG002|Overall Study|Lost to Follow-up|8|||
147138661|NCT00251693|530675508|FG000|Overall Study|Withdrawal by Subject|11|||
147138662|NCT00251693|530675509|FG001|Overall Study|Withdrawal by Subject|17|||
147138663|NCT00251693|530675510|FG002|Overall Study|Withdrawal by Subject|14|||
147138664|NCT00251693|530675508|FG000|Overall Study|Lack of Efficacy|0|||
147138665|NCT00251693|530675509|FG001|Overall Study|Lack of Efficacy|1|||
147138666|NCT00251693|530675510|FG002|Overall Study|Lack of Efficacy|0|||
147138667|NCT00251693|530675508|FG000|Overall Study|Inclusion/exclusion criteria not met|5|||
147138668|NCT00251693|530675509|FG001|Overall Study|Inclusion/exclusion criteria not met|3|||
147138669|NCT00251693|530675510|FG002|Overall Study|Inclusion/exclusion criteria not met|8|||
147138670|NCT00251693|530675508|FG000|Overall Study|Noncompliant|0|||
147138671|NCT00251693|530675509|FG001|Overall Study|Noncompliant|0|||
147138672|NCT00251693|530675510|FG002|Overall Study|Noncompliant|2|||
147138673|NCT00251693|530675508|FG000|Overall Study|Possible Barrett's esophagus|3|||
147138674|NCT00251693|530675509|FG001|Overall Study|Possible Barrett's esophagus|5|||
147138675|NCT00251693|530675510|FG002|Overall Study|Possible Barrett's esophagus|2|||
147138676|NCT00251693|530675508|FG000|Overall Study|Subject request/subject unavailable|1|||
147138677|NCT00251693|530675509|FG001|Overall Study|Subject request/subject unavailable|2|||
147138678|NCT00251693|530675510|FG002|Overall Study|Subject request/subject unavailable|0|||
147138679|NCT00251693|530675508|FG000|Overall Study|Abnormal laboratory findings|0|||
147138680|NCT00251693|530675509|FG001|Overall Study|Abnormal laboratory findings|0|||
147138681|NCT00251693|530675510|FG002|Overall Study|Abnormal laboratory findings|1|||
147138682|NCT01030822|530675511|FG000|Overall Study|Moved/migrated from study area|6|||
147138683|NCT01030822|530675512|FG001|Overall Study|Moved/migrated from study area|7|||
147138684|NCT01030822|530675513|FG002|Overall Study|Moved/migrated from study area|3|||
147138685|NCT01030822|530675511|FG000|Overall Study|Withdrawal by Subject|16|||
147138686|NCT01030822|530675512|FG001|Overall Study|Withdrawal by Subject|13|||
147138687|NCT01030822|530675513|FG002|Overall Study|Withdrawal by Subject|16|||
147138688|NCT01030822|530675511|FG000|Overall Study|Lost to Follow-up|9|||
147138689|NCT01030822|530675512|FG001|Overall Study|Lost to Follow-up|4|||
147138690|NCT01030822|530675513|FG002|Overall Study|Lost to Follow-up|7|||
147138691|NCT00401843|530675514|FG000|Overall Study|Achieved Complete Response|1|||
147138692|NCT00401843|530675515|FG001|Overall Study|Achieved Complete Response|5|||
147138693|NCT00401843|530675516|FG002|Overall Study|Achieved Complete Response|11|||
147138694|NCT00401843|530675514|FG000|Overall Study|Adverse Event|7|||
147138695|NCT00401843|530675515|FG001|Overall Study|Adverse Event|26|||
147138696|NCT00401843|530675516|FG002|Overall Study|Adverse Event|27|||
147138697|NCT00401843|530675514|FG000|Overall Study|Death|0|||
147138698|NCT00401843|530675515|FG001|Overall Study|Death|8|||
147138699|NCT00401843|530675516|FG002|Overall Study|Death|10|||
147572704|NCT03121586|532255715|FG001|Overall Study|Not further specified|11|||
147572705|NCT03121586|532255716|FG002|Overall Study|Not further specified|10|||
147572706|NCT03121586|532255714|FG000|Overall Study|Adverse Event|16|||
147572707|NCT03121586|532255715|FG001|Overall Study|Adverse Event|5|||
147572708|NCT03121586|532255716|FG002|Overall Study|Adverse Event|6|||
147572709|NCT03121586|532255714|FG000|Overall Study|Protocol Violation|0|||
147572710|NCT03121586|532255715|FG001|Overall Study|Protocol Violation|5|||
147572711|NCT03121586|532255716|FG002|Overall Study|Protocol Violation|0|||
147572712|NCT03121586|532255714|FG000|Overall Study|Lack of Efficacy|3|||
147572713|NCT03121586|532255715|FG001|Overall Study|Lack of Efficacy|3|||
147572714|NCT03121586|532255716|FG002|Overall Study|Lack of Efficacy|1|||
147572715|NCT03121586|532255714|FG000|Overall Study|Physician Decision|2|||
147572716|NCT03121586|532255715|FG001|Overall Study|Physician Decision|2|||
147572717|NCT03121586|532255716|FG002|Overall Study|Physician Decision|0|||
147572718|NCT03121586|532255714|FG000|Overall Study|Noncompliance with study drug|5|||
147572719|NCT03121586|532255715|FG001|Overall Study|Noncompliance with study drug|3|||
147138700|NCT00401843|530675514|FG000|Overall Study|Disease progression|10|||
147138701|NCT00401843|530675515|FG001|Overall Study|Disease progression|60|||
147138702|NCT00401843|530675516|FG002|Overall Study|Disease progression|49|||
147138703|NCT00401843|530675514|FG000|Overall Study|End of Study|1|||
147138704|NCT00401843|530675515|FG001|Overall Study|End of Study|1|||
147138705|NCT00401843|530675516|FG002|Overall Study|End of Study|2|||
147138706|NCT00401843|530675514|FG000|Overall Study|Lost to Follow-up|0|||
147138707|NCT00401843|530675515|FG001|Overall Study|Lost to Follow-up|0|||
147138708|NCT00401843|530675516|FG002|Overall Study|Lost to Follow-up|2|||
147138709|NCT00401843|530675514|FG000|Overall Study|Other Unspecified|0|||
147138710|NCT00401843|530675515|FG001|Overall Study|Other Unspecified|3|||
147237704|NCT01663532|531042490|FG001|Overall Study|Physician Decision|1|||
147445660|NCT03200366|531797424|FG001|6 Month Post-Baseline Interview|Withdrawal by Subject|1|||
147572720|NCT03121586|532255716|FG002|Overall Study|Noncompliance with study drug|5|||
147138711|NCT00401843|530675516|FG002|Overall Study|Other Unspecified|5|||
147138712|NCT00401843|530675514|FG000|Overall Study|Physician Decision|0|||
147572721|NCT03121586|532255714|FG000|Overall Study|Lost to Follow-up|4|||
147572722|NCT03121586|532255715|FG001|Overall Study|Lost to Follow-up|2|||
147138713|NCT00401843|530675515|FG001|Overall Study|Physician Decision|16|||
147138714|NCT00401843|530675516|FG002|Overall Study|Physician Decision|10|||
147138715|NCT00401843|530675514|FG000|Overall Study|Protocol Violation|0|||
147138716|NCT00401843|530675515|FG001|Overall Study|Protocol Violation|0|||
147138717|NCT00401843|530675516|FG002|Overall Study|Protocol Violation|1|||
147138718|NCT00401843|530675514|FG000|Overall Study|Withdrawal by Subject|1|||
147138719|NCT00401843|530675515|FG001|Overall Study|Withdrawal by Subject|5|||
147138720|NCT00401843|530675516|FG002|Overall Study|Withdrawal by Subject|5|||
147138721|NCT00401843|530675514|FG000|Overall Study|Withdrawal of consent to study agent|1|||
147138722|NCT00401843|530675515|FG001|Overall Study|Withdrawal of consent to study agent|15|||
147138723|NCT00401843|530675516|FG002|Overall Study|Withdrawal of consent to study agent|17|||
147138724|NCT00401843|530675514|FG000|Overall Study|Randomized but not Treated|0|||
147572723|NCT03121586|532255716|FG002|Overall Study|Lost to Follow-up|0|||
147572724|NCT03121586|532255714|FG000|Overall Study|Death|2|||
147572725|NCT03121586|532255715|FG001|Overall Study|Death|0|||
147572726|NCT03121586|532255716|FG002|Overall Study|Death|0|||
147572727|NCT06381102|532255717|FG000|Washout 5 Days|Withdrawal by Subject|0|||
147572728|NCT06381102|532255718|FG001|Washout 5 Days|Withdrawal by Subject|2|||
147572729|NCT00446966|532255723|FG000|Overall Study|Lost to Follow-up|10|||
147572730|NCT00446966|532255724|FG001|Overall Study|Lost to Follow-up|7|||
147572731|NCT01440803|532255725|FG000|Overall Study|Met study stopping rule|2|||
147572732|NCT01440803|532255726|FG001|Overall Study|Met study stopping rule|1|||
147572733|NCT01440803|532255725|FG000|Overall Study|Lost to Follow-up|0|||
147572734|NCT01440803|532255726|FG001|Overall Study|Lost to Follow-up|2|||
147572735|NCT01440803|532255725|FG000|Overall Study|Withdrawal by Subject|0|||
147572736|NCT01440803|532255726|FG001|Overall Study|Withdrawal by Subject|1|||
147572737|NCT00443651|532255727|FG000|Overall Study|Death|1|||
147572738|NCT00443651|532255728|FG001|Overall Study|Death|5|||
147572739|NCT00443651|532255727|FG000|Overall Study|Adverse Event|5|||
147572740|NCT00443651|532255728|FG001|Overall Study|Adverse Event|6|||
147572741|NCT00443651|532255727|FG000|Overall Study|Lost to Follow-up|18|||
147138725|NCT00401843|530675515|FG001|Overall Study|Randomized but not Treated|2|||
147138726|NCT00401843|530675516|FG002|Overall Study|Randomized but not Treated|3|||
147138727|NCT00401843|530675514|FG000|Overall Study|Received incorrect treatment|0|||
147138728|NCT00401843|530675515|FG001|Overall Study|Received incorrect treatment|3|||
147138729|NCT00401843|530675516|FG002|Overall Study|Received incorrect treatment|0|||
147138730|NCT01508910|530675517|FG000|Treatment|Death|2|||
147138731|NCT01508910|530675518|FG001|Treatment|Death|3|||
147138732|NCT01508910|530675519|FG002|Treatment|Death|2|||
147138733|NCT01508910|530675520|FG003|Treatment|Death|0|||
147138734|NCT01508910|530675517|FG000|Treatment|Lost to Follow-up|0|||
147138735|NCT01508910|530675518|FG001|Treatment|Lost to Follow-up|0|||
147138736|NCT01508910|530675519|FG002|Treatment|Lost to Follow-up|2|||
147138737|NCT01508910|530675520|FG003|Treatment|Lost to Follow-up|1|||
147138738|NCT01508910|530675517|FG000|Treatment|Withdrawal by Subject|0|||
147138739|NCT01508910|530675518|FG001|Treatment|Withdrawal by Subject|1|||
147138740|NCT01508910|530675519|FG002|Treatment|Withdrawal by Subject|6|||
147138741|NCT01508910|530675520|FG003|Treatment|Withdrawal by Subject|1|||
147138742|NCT01508910|530675517|FG000|Treatment|Sponsor Decision|0|||
147138743|NCT01508910|530675518|FG001|Treatment|Sponsor Decision|0|||
147138744|NCT01508910|530675519|FG002|Treatment|Sponsor Decision|0|||
147138745|NCT01508910|530675520|FG003|Treatment|Sponsor Decision|1|||
147138746|NCT01932788|530675533|FG000|Overall Study|Protocol Violation|18|||
147138747|NCT01932788|530675534|FG001|Overall Study|Protocol Violation|0|||
147138748|NCT01932788|530675533|FG000|Overall Study|Lost to Follow-up|18|||
147572742|NCT00443651|532255728|FG001|Overall Study|Lost to Follow-up|12|||
147572743|NCT00443651|532255727|FG000|Overall Study|Patient's/Guardian's Decision|58|||
147572744|NCT00443651|532255728|FG001|Overall Study|Patient's/Guardian's Decision|30|||
147572745|NCT00443651|532255727|FG000|Overall Study|Physician Decision|13|||
147572746|NCT00443651|532255728|FG001|Overall Study|Physician Decision|4|||
147138749|NCT01932788|530675534|FG001|Overall Study|Lost to Follow-up|46|||
147138750|NCT01932788|530675533|FG000|Overall Study|Lack of Efficacy|2|||
147138751|NCT01932788|530675534|FG001|Overall Study|Lack of Efficacy|0|||
147237705|NCT01663532|531042489|FG000|Overall Study|Withdrawal by Subject|35|||
147572747|NCT00443651|532255727|FG000|Overall Study|Pregnancy|0|||
147572748|NCT00443651|532255728|FG001|Overall Study|Pregnancy|1|||
147572749|NCT01564394|532255729|FG000|Overall Study|Withdrawal by Subject|6|||
147572750|NCT01564394|532255730|FG001|Overall Study|Withdrawal by Subject|10|||
147138752|NCT01932788|530675533|FG000|Overall Study|Withdrawal by Subject|0|||
147138753|NCT01932788|530675534|FG001|Overall Study|Withdrawal by Subject|5|||
147138754|NCT01171677|530675535|FG000|Overall Study|Withdrawal by Subject|0|||
147138755|NCT01171677|530675536|FG001|Overall Study|Withdrawal by Subject|3|||
147138756|NCT01171677|530675535|FG000|Overall Study|Adverse Event|1|||
147138757|NCT01171677|530675536|FG001|Overall Study|Adverse Event|0|||
147138758|NCT01171677|530675535|FG000|Overall Study|completed <70% IntenSati classes|5|||
147572751|NCT00859521|532255731|FG000|Washout|Withdrawal by Subject|0|||
147572752|NCT00859521|532255732|FG001|Washout|Withdrawal by Subject|1|||
147138759|NCT01171677|530675536|FG001|Overall Study|completed <70% IntenSati classes|0|||
147572753|NCT01609257|532255733|FG000|Overall Study|Lost to Follow-up|2|||
147138760|NCT03092479|530675541|FG000|Overall Study|Lost to Follow-up|3|||
147138761|NCT03092479|530675542|FG001|Overall Study|Lost to Follow-up|2|||
147138762|NCT03092479|530675541|FG000|Overall Study|Withdrawal by Subject|4|||
147138763|NCT03092479|530675542|FG001|Overall Study|Withdrawal by Subject|0|||
147138764|NCT03913130|530675545|FG000|Overall Study|Sponsor Decision|1|||
147138765|NCT05653700|530675546|FG000|Overall Study|Non Responders|9|||
147572754|NCT01609257|532255734|FG001|Overall Study|Lost to Follow-up|1|||
147572755|NCT01609257|532255733|FG000|Overall Study|Voluntary Withdrawal by Subject|0|||
147138766|NCT05653700|530675547|FG001|Overall Study|Non Responders|0|||
147572756|NCT01609257|532255734|FG001|Overall Study|Voluntary Withdrawal by Subject|1|||
147572757|NCT01609257|532255733|FG000|Overall Study|Non-compliance/Protocol deviation|4|||
147572758|NCT01609257|532255734|FG001|Overall Study|Non-compliance/Protocol deviation|6|||
147572759|NCT02125461|532255735|FG000|Overall Study|Withdrawal by Subject|30|||
147572760|NCT02125461|532255736|FG001|Overall Study|Withdrawal by Subject|16|||
147572761|NCT02125461|532255735|FG000|Overall Study|Lost to Follow-up|8|||
147572762|NCT02125461|532255736|FG001|Overall Study|Lost to Follow-up|3|||
147572763|NCT02125461|532255735|FG000|Overall Study|Death|260|||
147572764|NCT02125461|532255736|FG001|Overall Study|Death|149|||
147572765|NCT02125461|532255735|FG000|Overall Study|Missing Termination Reason|0|||
147138767|NCT01085214|530675550|FG000|Overall Study|Alternate treatment required|1|||
147138768|NCT02317627|530675565|FG000|Overall Study|Withdrawal by Subject|0|||
147138769|NCT02317627|530675566|FG001|Overall Study|Withdrawal by Subject|1|||
147138770|NCT02317627|530675567|FG002|Overall Study|Withdrawal by Subject|1|||
147138771|NCT02317627|530675565|FG000|Overall Study|Lost to Follow-up|2|||
147138772|NCT02317627|530675566|FG001|Overall Study|Lost to Follow-up|0|||
147138773|NCT02317627|530675567|FG002|Overall Study|Lost to Follow-up|0|||
147138774|NCT02317627|530675565|FG000|Overall Study|Stopped by Investigator|0|||
147138775|NCT02317627|530675566|FG001|Overall Study|Stopped by Investigator|1|||
147138776|NCT02317627|530675567|FG002|Overall Study|Stopped by Investigator|0|||
147138777|NCT02317627|530675565|FG000|Overall Study|Adverse Event|0|||
147138778|NCT02317627|530675566|FG001|Overall Study|Adverse Event|2|||
147138779|NCT02317627|530675567|FG002|Overall Study|Adverse Event|3|||
147138780|NCT02317627|530675565|FG000|Overall Study|Non-compliance with study drug|0|||
147138781|NCT02317627|530675566|FG001|Overall Study|Non-compliance with study drug|1|||
147138782|NCT02317627|530675567|FG002|Overall Study|Non-compliance with study drug|0|||
147572766|NCT02125461|532255736|FG001|Overall Study|Missing Termination Reason|1|||
147572767|NCT02888756|532255738|FG000|Analytical Treatment Interruption|Physician Decision|10|||
147138783|NCT04749914|530675568|FG000|Period 1|Adverse Event|1|||
147138784|NCT04749914|530675569|FG001|Period 1|Adverse Event|0|||
147138785|NCT04749914|530675570|FG002|Period 1|Adverse Event|0|||
147572768|NCT02888756|532255739|FG001|Analytical Treatment Interruption|Physician Decision|6|||
147572769|NCT02888756|532255740|FG002|Analytical Treatment Interruption|Physician Decision|5|||
147572770|NCT01547286|532255749|FG000|Overall Study|Did not meet all eligibility criteria|1|||
147572771|NCT01547286|532255749|FG000|Overall Study|Physician Decision|1|||
147572772|NCT03415308|532255753|FG000|Overall Study|Lost to Follow-up|0|||
147572773|NCT03415308|532255754|FG001|Overall Study|Lost to Follow-up|0|||
147572774|NCT03415308|532255755|FG002|Overall Study|Lost to Follow-up|1|||
147572775|NCT03415308|532255753|FG000|Overall Study|Scheduling Conflicts|0|||
147572776|NCT03415308|532255754|FG001|Overall Study|Scheduling Conflicts|0|||
147572777|NCT03415308|532255755|FG002|Overall Study|Scheduling Conflicts|7|||
147572778|NCT01471353|532255756|FG000|Overall Study|remain on study|3|||
147572779|NCT00836472|532255757|FG000|Washout|Adverse Event|1|||
147572780|NCT00836472|532255758|FG001|Washout|Adverse Event|2|||
147572781|NCT00836472|532255757|FG000|Washout|Withdrawal by Subject|1|||
147572782|NCT00836472|532255758|FG001|Washout|Withdrawal by Subject|1|||
147572783|NCT01695239|532255759|FG000|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|1|||
147572784|NCT01695239|532255760|FG001|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|1|||
147572785|NCT01695239|532255761|FG002|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|3|||
147572786|NCT01695239|532255762|FG003|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|4|||
147572787|NCT01695239|532255763|FG004|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
147572788|NCT01695239|532255764|FG005|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
147572789|NCT01695239|532255765|FG006|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
147138786|NCT04749914|530675571|FG003|Period 1|Adverse Event|0|||
147445661|NCT03200366|531797425|FG002|6 Month Post-Baseline Interview|Withdrawal by Subject|0|||
147445662|NCT03200366|531797423|FG000|6 Month Post-Baseline Interview|Refused 6 month interview but continued in study|1|||
147572790|NCT01695239|532255766|FG007|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
147572791|NCT01695239|532255767|FG008|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
147572792|NCT01695239|532255768|FG009|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
147138787|NCT04749914|530675568|FG000|Period 1|Withdrawal by Subject|1|||
147138788|NCT04749914|530675569|FG001|Period 1|Withdrawal by Subject|0|||
147572793|NCT01695239|532255769|FG010|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
147572794|NCT01695239|532255770|FG011|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
147138789|NCT04749914|530675570|FG002|Period 1|Withdrawal by Subject|1|||
147138790|NCT04749914|530675571|FG003|Period 1|Withdrawal by Subject|0|||
147138791|NCT00403130|530675572|FG000|2 Years From Start of Treatment|Not Eligible|3|||
147138792|NCT00403130|530675572|FG000|2 Years From Start of Treatment|Lost to Follow up|1|||
147138793|NCT00403130|530675572|FG000|2 Years From Start of Treatment|Withdrawal by Subject|1|||
147138794|NCT00403130|530675572|FG000|Survival Follow-up up to 6 Years|Lost to Follow-up|10|||
147138795|NCT00806260|530675573|FG000|Period 1 (1 Day)|Adverse Event|0|||
147138796|NCT00806260|530675574|FG001|Period 1 (1 Day)|Adverse Event|0|||
147138797|NCT00806260|530675575|FG002|Period 1 (1 Day)|Adverse Event|0|||
147138798|NCT00806260|530675576|FG003|Period 1 (1 Day)|Adverse Event|0|||
147138799|NCT00806260|530675577|FG004|Period 1 (1 Day)|Adverse Event|3|||
147138800|NCT00806260|530675578|FG005|Period 1 (1 Day)|Adverse Event|0|||
147138801|NCT00806260|530675573|FG000|Period 2|Adverse Event|0|||
147138802|NCT00806260|530675574|FG001|Period 2|Adverse Event|0|||
147138803|NCT00806260|530675575|FG002|Period 2|Adverse Event|0|||
147138804|NCT00806260|530675576|FG003|Period 2|Adverse Event|1|||
147138805|NCT00806260|530675577|FG004|Period 2|Adverse Event|0|||
147138806|NCT00806260|530675578|FG005|Period 2|Adverse Event|0|||
147651858|NCT01483599|532546593|FG013|After Controlled Period(Week 16-Week 40)|Lost to Follow-up|1|||
147651859|NCT01483599|532546580|FG000|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
147651860|NCT01483599|532546581|FG001|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
147651861|NCT01483599|532546582|FG002|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
147651862|NCT01483599|532546583|FG003|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
147651863|NCT01483599|532546584|FG004|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
147651864|NCT01483599|532546585|FG005|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
147651865|NCT01483599|532546586|FG006|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
147651866|NCT01483599|532546587|FG007|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
147651867|NCT01483599|532546588|FG008|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|1|||
147651868|NCT01483599|532546589|FG009|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
147651869|NCT01483599|532546590|FG010|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|2|||
147651870|NCT01483599|532546591|FG011|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
147651871|NCT01483599|532546592|FG012|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|0|||
147651872|NCT01483599|532546593|FG013|After Controlled Period(Week 16-Week 40)|Withdrawal by Subject|1|||
147651873|NCT01483599|532546580|FG000|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
147651874|NCT01483599|532546581|FG001|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
147651875|NCT01483599|532546582|FG002|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
147651876|NCT01483599|532546583|FG003|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
147651877|NCT01483599|532546584|FG004|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
147651878|NCT01483599|532546585|FG005|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
147651879|NCT01483599|532546586|FG006|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
147651880|NCT01483599|532546587|FG007|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
147651881|NCT01483599|532546588|FG008|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|5|||
147651882|NCT01483599|532546589|FG009|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
147651883|NCT01483599|532546590|FG010|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
147651884|NCT01483599|532546591|FG011|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|0|||
147651885|NCT01483599|532546592|FG012|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|1|||
147651886|NCT01483599|532546593|FG013|After Controlled Period(Week 16-Week 40)|Lack of Efficacy|4|||
147651887|NCT01483599|532546580|FG000|After Controlled Period(Week 16-Week 40)|Other|0|||
147651888|NCT01483599|532546581|FG001|After Controlled Period(Week 16-Week 40)|Other|0|||
147651889|NCT01483599|532546582|FG002|After Controlled Period(Week 16-Week 40)|Other|0|||
147651890|NCT01483599|532546583|FG003|After Controlled Period(Week 16-Week 40)|Other|0|||
147651891|NCT01483599|532546584|FG004|After Controlled Period(Week 16-Week 40)|Other|0|||
147651892|NCT01483599|532546585|FG005|After Controlled Period(Week 16-Week 40)|Other|0|||
147651893|NCT01483599|532546586|FG006|After Controlled Period(Week 16-Week 40)|Other|0|||
147651894|NCT01483599|532546587|FG007|After Controlled Period(Week 16-Week 40)|Other|1|||
147651895|NCT01483599|532546588|FG008|After Controlled Period(Week 16-Week 40)|Other|0|||
147651896|NCT01483599|532546589|FG009|After Controlled Period(Week 16-Week 40)|Other|4|||
147651897|NCT01483599|532546590|FG010|After Controlled Period(Week 16-Week 40)|Other|0|||
147651898|NCT01483599|532546591|FG011|After Controlled Period(Week 16-Week 40)|Other|0|||
147651899|NCT01483599|532546592|FG012|After Controlled Period(Week 16-Week 40)|Other|1|||
147651900|NCT01483599|532546593|FG013|After Controlled Period(Week 16-Week 40)|Other|0|||
147651901|NCT02109445|532546594|FG000|Overall Study|Symptomatic deterioration|2|||
147138807|NCT00806260|530675573|FG000|Period 2|Protocol Violation|1|||
147138808|NCT00806260|530675574|FG001|Period 2|Protocol Violation|0|||
147237706|NCT01663532|531042490|FG001|Overall Study|Withdrawal by Subject|17|||
147651902|NCT02109445|532546594|FG000|Overall Study|Adverse Event|1|||
147651903|NCT00958412|532546595|FG000|Overall Study|Study prematurely terminated|18|||
147138809|NCT00806260|530675575|FG002|Period 2|Protocol Violation|1|||
147138810|NCT00806260|530675576|FG003|Period 2|Protocol Violation|0|||
147138811|NCT00806260|530675577|FG004|Period 2|Protocol Violation|0|||
147138812|NCT00806260|530675578|FG005|Period 2|Protocol Violation|0|||
147138813|NCT00806260|530675573|FG000|Period 2|Need to take concomitant medication|1|||
147651904|NCT00966355|532546596|FG000|Overall Study|non-variceal bleeding on endoscopy|68|||
147651905|NCT00966355|532546597|FG001|Overall Study|non-variceal bleeding on endoscopy|70|||
147651906|NCT00966355|532546598|FG002|Overall Study|non-variceal bleeding on endoscopy|71|||
147651907|NCT00966355|532546596|FG000|Overall Study|newly diagnosed advanced HCC|11|||
147651908|NCT00966355|532546597|FG001|Overall Study|newly diagnosed advanced HCC|12|||
147651909|NCT00966355|532546598|FG002|Overall Study|newly diagnosed advanced HCC|10|||
147651910|NCT00966355|532546596|FG000|Overall Study|Lost to Follow-up|5|||
147651911|NCT00966355|532546597|FG001|Overall Study|Lost to Follow-up|4|||
147651912|NCT00966355|532546598|FG002|Overall Study|Lost to Follow-up|3|||
147651913|NCT02552888|532546599|FG000|Overall Study|Lost to Follow-up|1|||
147651914|NCT02552888|532546600|FG001|Overall Study|Lost to Follow-up|1|||
147651915|NCT03630705|532548234|FG000|Overall Study|Withdrawal by Parent/Guardian|9|||
147651916|NCT03630705|532548235|FG001|Overall Study|Withdrawal by Parent/Guardian|6|||
147651917|NCT03630705|532548236|FG002|Overall Study|Withdrawal by Parent/Guardian|2|||
147651918|NCT03630705|532548237|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
147651919|NCT03630705|532548234|FG000|Overall Study|Lost to Follow-up|1|||
147651920|NCT03630705|532548235|FG001|Overall Study|Lost to Follow-up|2|||
147651921|NCT03630705|532548236|FG002|Overall Study|Lost to Follow-up|0|||
147651922|NCT03630705|532548237|FG003|Overall Study|Lost to Follow-up|0|||
147651923|NCT02688764|532548240|FG000|Overall Study|Adverse Event|3|||
147651924|NCT02688764|532548241|FG001|Overall Study|Adverse Event|3|||
147651925|NCT02688764|532548240|FG000|Overall Study|AE/Kidney transplant|1|||
147651926|NCT02688764|532548241|FG001|Overall Study|AE/Kidney transplant|0|||
147651927|NCT02688764|532548240|FG000|Overall Study|AE/Lack of efficacy|1|||
147651928|NCT02688764|532548241|FG001|Overall Study|AE/Lack of efficacy|0|||
147651929|NCT02688764|532548240|FG000|Overall Study|AE/Non-compl.|1|||
147651930|NCT02688764|532548241|FG001|Overall Study|AE/Non-compl.|0|||
147651931|NCT02688764|532548240|FG000|Overall Study|AE/Non-compl./Withd. parent|0|||
147651932|NCT02688764|532548241|FG001|Overall Study|AE/Non-compl./Withd. parent|1|||
147651933|NCT02688764|532548240|FG000|Overall Study|AE/Other|0|||
147651934|NCT02688764|532548241|FG001|Overall Study|AE/Other|1|||
147651935|NCT02688764|532548240|FG000|Overall Study|AE/Physician decision|1|||
147651936|NCT02688764|532548241|FG001|Overall Study|AE/Physician decision|0|||
147651937|NCT02688764|532548240|FG000|Overall Study|AE/Withd. parent|3|||
147651938|NCT02688764|532548241|FG001|Overall Study|AE/Withd. parent|0|||
147651939|NCT02688764|532548240|FG000|Overall Study|AE/Withd. parent/Withd. subject|1|||
147651940|NCT02688764|532548241|FG001|Overall Study|AE/Withd. parent/Withd. subject|1|||
147651941|NCT02688764|532548240|FG000|Overall Study|AE/Withd. subject|1|||
147651942|NCT02688764|532548241|FG001|Overall Study|AE/Withd. subject|0|||
147651943|NCT02688764|532548240|FG000|Overall Study|Kidney transplant|10|||
147651944|NCT02688764|532548241|FG001|Overall Study|Kidney transplant|4|||
147651945|NCT02688764|532548240|FG000|Overall Study|Lack of Efficacy|3|||
147138814|NCT00806260|530675574|FG001|Period 2|Need to take concomitant medication|0|||
147138815|NCT00806260|530675575|FG002|Period 2|Need to take concomitant medication|0|||
147138816|NCT00806260|530675576|FG003|Period 2|Need to take concomitant medication|0|||
147138817|NCT00806260|530675577|FG004|Period 2|Need to take concomitant medication|0|||
147138818|NCT00806260|530675578|FG005|Period 2|Need to take concomitant medication|0|||
147138819|NCT00806260|530675573|FG000|Period 2|sponsor request|0|||
147138820|NCT00806260|530675574|FG001|Period 2|sponsor request|0|||
147138821|NCT00806260|530675575|FG002|Period 2|sponsor request|1|||
147138822|NCT00806260|530675576|FG003|Period 2|sponsor request|1|||
147138823|NCT00806260|530675577|FG004|Period 2|sponsor request|0|||
147138824|NCT00806260|530675578|FG005|Period 2|sponsor request|0|||
147138825|NCT00806260|530675573|FG000|Period 3|Protocol Violation|0|||
147138826|NCT00806260|530675574|FG001|Period 3|Protocol Violation|1|||
147138827|NCT00806260|530675575|FG002|Period 3|Protocol Violation|1|||
147138828|NCT00806260|530675576|FG003|Period 3|Protocol Violation|0|||
147138829|NCT00806260|530675577|FG004|Period 3|Protocol Violation|0|||
147138830|NCT00806260|530675578|FG005|Period 3|Protocol Violation|0|||
147138831|NCT00806260|530675573|FG000|Period 3|Pregnancy|1|||
147138832|NCT00806260|530675574|FG001|Period 3|Pregnancy|0|||
147138833|NCT00806260|530675575|FG002|Period 3|Pregnancy|0|||
147138834|NCT00806260|530675576|FG003|Period 3|Pregnancy|0|||
147138835|NCT00806260|530675577|FG004|Period 3|Pregnancy|0|||
147651946|NCT02688764|532548241|FG001|Overall Study|Lack of Efficacy|2|||
147138836|NCT00806260|530675578|FG005|Period 3|Pregnancy|0|||
147138837|NCT00237042|530675579|FG000|Treatment|Became ineligible post-randomization|0|||
147138838|NCT00237042|530675580|FG001|Treatment|Became ineligible post-randomization|1|||
147138839|NCT00237042|530675581|FG002|Treatment|Became ineligible post-randomization|16|||
147651947|NCT02688764|532548240|FG000|Overall Study|Lack of efficacy/Physician decision|0|||
147651948|NCT02688764|532548241|FG001|Overall Study|Lack of efficacy/Physician decision|1|||
147651949|NCT02688764|532548240|FG000|Overall Study|Non-compliance with study drug|4|||
147651950|NCT02688764|532548241|FG001|Overall Study|Non-compliance with study drug|0|||
147651951|NCT02688764|532548240|FG000|Overall Study|Non-compl./Physician decision|2|||
147651952|NCT02688764|532548241|FG001|Overall Study|Non-compl./Physician decision|0|||
147138840|NCT00237042|530675579|FG000|Treatment|Moved out of state|1|||
147651953|NCT02688764|532548240|FG000|Overall Study|Non-compl./Ph. decision/Withd. subject|1|||
147572795|NCT01695239|532255771|FG012|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
147572796|NCT01695239|532255772|FG013|Double-Blind (DB) Treatment Period|Entry Criteria Not Met|0|||
147572797|NCT01695239|532255759|FG000|Double-Blind (DB) Treatment Period|Adverse Event|2|||
147572798|NCT01695239|532255760|FG001|Double-Blind (DB) Treatment Period|Adverse Event|2|||
147572799|NCT01695239|532255761|FG002|Double-Blind (DB) Treatment Period|Adverse Event|2|||
147572800|NCT01695239|532255762|FG003|Double-Blind (DB) Treatment Period|Adverse Event|3|||
147572801|NCT01695239|532255763|FG004|Double-Blind (DB) Treatment Period|Adverse Event|0|||
147572802|NCT01695239|532255764|FG005|Double-Blind (DB) Treatment Period|Adverse Event|0|||
147572803|NCT01695239|532255765|FG006|Double-Blind (DB) Treatment Period|Adverse Event|0|||
147572804|NCT01695239|532255766|FG007|Double-Blind (DB) Treatment Period|Adverse Event|0|||
147572805|NCT01695239|532255767|FG008|Double-Blind (DB) Treatment Period|Adverse Event|0|||
147572806|NCT01695239|532255768|FG009|Double-Blind (DB) Treatment Period|Adverse Event|0|||
147572807|NCT01695239|532255769|FG010|Double-Blind (DB) Treatment Period|Adverse Event|0|||
147572808|NCT01695239|532255770|FG011|Double-Blind (DB) Treatment Period|Adverse Event|0|||
147572809|NCT01695239|532255771|FG012|Double-Blind (DB) Treatment Period|Adverse Event|0|||
147572810|NCT01695239|532255772|FG013|Double-Blind (DB) Treatment Period|Adverse Event|0|||
147572811|NCT01695239|532255759|FG000|Double-Blind (DB) Treatment Period|Lack of Efficacy|4|||
147572812|NCT01695239|532255760|FG001|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
147572813|NCT01695239|532255761|FG002|Double-Blind (DB) Treatment Period|Lack of Efficacy|2|||
147572814|NCT01695239|532255762|FG003|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
147572815|NCT01695239|532255763|FG004|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
147572816|NCT01695239|532255764|FG005|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
147572817|NCT01695239|532255765|FG006|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
147572818|NCT01695239|532255766|FG007|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
147572819|NCT01695239|532255767|FG008|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
147572820|NCT01695239|532255768|FG009|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
147572821|NCT01695239|532255769|FG010|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
147572822|NCT01695239|532255770|FG011|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
147572823|NCT01695239|532255771|FG012|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
147572824|NCT01695239|532255772|FG013|Double-Blind (DB) Treatment Period|Lack of Efficacy|0|||
147572825|NCT01695239|532255759|FG000|Double-Blind (DB) Treatment Period|Withdrawal by Subject|3|||
147572826|NCT01695239|532255760|FG001|Double-Blind (DB) Treatment Period|Withdrawal by Subject|1|||
147572827|NCT01695239|532255761|FG002|Double-Blind (DB) Treatment Period|Withdrawal by Subject|1|||
147138841|NCT00237042|530675580|FG001|Treatment|Moved out of state|1|||
147138842|NCT00237042|530675581|FG002|Treatment|Moved out of state|1|||
147138843|NCT00237042|530675579|FG000|Treatment|Completed no treatment|5|||
147138844|NCT00237042|530675580|FG001|Treatment|Completed no treatment|5|||
147138845|NCT00237042|530675581|FG002|Treatment|Completed no treatment|21|||
147138846|NCT00237042|530675579|FG000|Short Term (6 Month) Follow up|Lost to Follow-up|9|||
147138847|NCT00237042|530675580|FG001|Short Term (6 Month) Follow up|Lost to Follow-up|8|||
147138848|NCT00237042|530675581|FG002|Short Term (6 Month) Follow up|Lost to Follow-up|11|||
147138849|NCT00237042|530675579|FG000|Long Term (12 Month) Follow up|Lost to Follow-up|11|||
147138850|NCT00237042|530675580|FG001|Long Term (12 Month) Follow up|Lost to Follow-up|9|||
147138851|NCT00237042|530675581|FG002|Long Term (12 Month) Follow up|Lost to Follow-up|9|||
147138852|NCT01074931|530675582|FG000|Overall Study|Economic reasons|1|||
147138853|NCT01074931|530675582|FG000|Overall Study|Death|5|||
147138854|NCT03132467|530675583|FG000|Overall Study|Adverse Event|2|||
147138855|NCT03132467|530675583|FG000|Overall Study|Withdrawal by Subject|2|||
147138856|NCT05223673|530675584|FG000|Overall Study|Protocol Violation|1|||
147138857|NCT05223673|530675584|FG000|Overall Study|Study termination|6|||
147138858|NCT04790279|530677319|FG000|Overall Study|Did not meet medication start criteria|27|||
147138859|NCT04790279|530677320|FG001|Overall Study|Did not meet medication start criteria|15|||
147138860|NCT04790279|530677319|FG000|Overall Study|Required long acting antihypertensive intrapartum|1|||
147138861|NCT04790279|530677320|FG001|Overall Study|Required long acting antihypertensive intrapartum|0|||
147138862|NCT04790279|530677319|FG000|Overall Study|Protocol Violation|8|||
147138863|NCT04790279|530677320|FG001|Overall Study|Protocol Violation|3|||
147138864|NCT04790279|530677319|FG000|Overall Study|Developed complication requiring alternative regimen|0|||
147138865|NCT04790279|530677320|FG001|Overall Study|Developed complication requiring alternative regimen|1|||
147138866|NCT00678288|530677337|FG000|Overall Study|Adverse Event|0|||
147138867|NCT00678288|530677338|FG001|Overall Study|Adverse Event|2|||
147445663|NCT03200366|531797424|FG001|6 Month Post-Baseline Interview|Refused 6 month interview but continued in study|0|||
147572828|NCT01695239|532255762|FG003|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
147572829|NCT01695239|532255763|FG004|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
147572830|NCT01695239|532255764|FG005|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
147572831|NCT01695239|532255765|FG006|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
147572832|NCT01695239|532255766|FG007|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
147572833|NCT01695239|532255767|FG008|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
147572834|NCT01695239|532255768|FG009|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
147138868|NCT00678288|530677337|FG000|Overall Study|Withdrawal by Subject|1|||
147138869|NCT00678288|530677338|FG001|Overall Study|Withdrawal by Subject|1|||
147138870|NCT00678288|530677337|FG000|Overall Study|Study terminated by the sponsor|2|||
147138871|NCT00678288|530677338|FG001|Overall Study|Study terminated by the sponsor|0|||
147138872|NCT00678288|530677337|FG000|Overall Study|Not compliant with study medication|0|||
147138873|NCT00678288|530677338|FG001|Overall Study|Not compliant with study medication|1|||
147138874|NCT00678288|530677337|FG000|Overall Study|Switch to commercial drug|0|||
147138875|NCT00678288|530677338|FG001|Overall Study|Switch to commercial drug|1|||
147138876|NCT00678288|530677337|FG000|Overall Study|Reason not reported|1|||
147572835|NCT01695239|532255769|FG010|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
147572836|NCT01695239|532255770|FG011|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
147572837|NCT01695239|532255771|FG012|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
147572838|NCT01695239|532255772|FG013|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
147572839|NCT01695239|532255759|FG000|Double-Blind (DB) Treatment Period|Sponsor Decision|3|||
147572840|NCT01695239|532255760|FG001|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
147572841|NCT01695239|532255761|FG002|Double-Blind (DB) Treatment Period|Sponsor Decision|1|||
147572842|NCT01695239|532255762|FG003|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
147572843|NCT01695239|532255763|FG004|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
147572844|NCT01695239|532255764|FG005|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
147572845|NCT01695239|532255765|FG006|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
147572846|NCT01695239|532255766|FG007|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
147572847|NCT01695239|532255767|FG008|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
147572848|NCT01695239|532255768|FG009|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
147572849|NCT01695239|532255769|FG010|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
147572850|NCT01695239|532255770|FG011|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
147572851|NCT01695239|532255771|FG012|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
147572852|NCT01695239|532255772|FG013|Double-Blind (DB) Treatment Period|Sponsor Decision|0|||
147572853|NCT01695239|532255759|FG000|Double-Blind (DB) Treatment Period|Lost to Follow-up|1|||
147572854|NCT01695239|532255760|FG001|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
147572855|NCT01695239|532255761|FG002|Double-Blind (DB) Treatment Period|Lost to Follow-up|1|||
147572856|NCT01695239|532255762|FG003|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
147572857|NCT01695239|532255763|FG004|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
147572858|NCT01695239|532255764|FG005|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
147138877|NCT00678288|530677338|FG001|Overall Study|Reason not reported|0|||
147138878|NCT00678288|530677337|FG000|Overall Study|Disease progression/recurrence/relapse|6|||
147138879|NCT00678288|530677338|FG001|Overall Study|Disease progression/recurrence/relapse|1|||
147138880|NCT04472650|530677347|FG000|Washout Period (Minimum 14 Days)|Adverse Event|1|||
147138881|NCT04472650|530677348|FG001|Washout Period (Minimum 14 Days)|Adverse Event|0|||
147138882|NCT02549989|530677351|FG000|Overall Study|Adverse Event|4|||
147138883|NCT02549989|530677351|FG000|Overall Study|Death|1|||
147138884|NCT02549989|530677351|FG000|Overall Study|Lack of Efficacy|19|||
147138885|NCT02549989|530677351|FG000|Overall Study|Withdrawal by Subject|3|||
147138886|NCT02628444|530677355|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|1|||
147138887|NCT02628444|530677356|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
147138888|NCT02628444|530677357|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
147138889|NCT02628444|530677358|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
147138890|NCT02628444|530677359|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
147138891|NCT02628444|530677360|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
147138892|NCT02628444|530677361|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
147138893|NCT02628444|530677362|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
147138894|NCT02628444|530677363|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Adverse event (AE) intensity less than (<) Grade 1|0|||
147138895|NCT02628444|530677355|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
147138896|NCT02628444|530677356|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|4|||
147138897|NCT02628444|530677357|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|3|||
147138898|NCT02628444|530677358|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
147138899|NCT02628444|530677359|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
147138900|NCT02628444|530677360|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
147138901|NCT02628444|530677361|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
147237707|NCT01663532|531042489|FG000|Overall Study|Lack of Efficacy|15|||
147237708|NCT01663532|531042490|FG001|Overall Study|Lack of Efficacy|60|||
147237709|NCT03539081|531042493|FG000|Overall Study|Withdrawal by Subject|2|||
147572859|NCT01695239|532255765|FG006|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
147572860|NCT01695239|532255766|FG007|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
147572861|NCT01695239|532255767|FG008|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
147572862|NCT01695239|532255768|FG009|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
147651954|NCT02688764|532548241|FG001|Overall Study|Non-compl./Ph. decision/Withd. subject|1|||
147138902|NCT02628444|530677362|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
147138903|NCT02628444|530677363|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Serious AE (SAE)|0|||
147138904|NCT02628444|530677355|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|21|||
147138905|NCT02628444|530677356|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|16|||
147138906|NCT02628444|530677357|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|25|||
147138907|NCT02628444|530677358|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
147138908|NCT02628444|530677359|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
147138909|NCT02628444|530677360|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
147138910|NCT02628444|530677361|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
147138911|NCT02628444|530677362|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
147138912|NCT02628444|530677363|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Voluntary withdrawal not due to AE|0|||
147138913|NCT02628444|530677355|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|9|||
147138914|NCT02628444|530677356|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|16|||
147138915|NCT02628444|530677357|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|9|||
147138916|NCT02628444|530677358|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
147138917|NCT02628444|530677359|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
147138918|NCT02628444|530677360|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
147138919|NCT02628444|530677361|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
147138920|NCT02628444|530677362|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
147138921|NCT02628444|530677363|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Non-compliance with protocol|0|||
147138922|NCT02628444|530677355|FG000|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|5|||
147138923|NCT02628444|530677356|FG001|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|3|||
147138924|NCT02628444|530677357|FG002|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|5|||
147138925|NCT02628444|530677358|FG003|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
147138926|NCT02628444|530677359|FG004|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
147138927|NCT02628444|530677360|FG005|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
147138928|NCT02628444|530677361|FG006|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
147138929|NCT02628444|530677362|FG007|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
147138930|NCT02628444|530677363|FG008|Stage-I(24M:12M Treatment+12M Follow-up)|Lost to Follow-up|0|||
147138931|NCT02628444|530677355|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
147138932|NCT02628444|530677356|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
147138933|NCT02628444|530677357|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
147138934|NCT02628444|530677358|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|1|||
147138935|NCT02628444|530677359|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
147138936|NCT02628444|530677360|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
147138937|NCT02628444|530677361|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
147138938|NCT02628444|530677362|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
147138939|NCT02628444|530677363|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|Other AE|0|||
147138940|NCT02628444|530677355|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|0|||
147138941|NCT02628444|530677356|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|0|||
147138942|NCT02628444|530677357|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|0|||
147138943|NCT02628444|530677358|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|83|||
147138944|NCT02628444|530677359|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|83|||
147138945|NCT02628444|530677360|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|83|||
147138946|NCT02628444|530677361|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|81|||
147138947|NCT02628444|530677362|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|84|||
147138948|NCT02628444|530677363|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|Non-compliance with protocol|85|||
147138949|NCT02628444|530677355|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|0|||
147138950|NCT02628444|530677356|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|0|||
147138951|NCT02628444|530677357|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|0|||
147138952|NCT02628444|530677358|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|5|||
147138953|NCT02628444|530677359|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|6|||
147138954|NCT02628444|530677360|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|10|||
147138955|NCT02628444|530677361|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|12|||
147445664|NCT03200366|531797425|FG002|6 Month Post-Baseline Interview|Refused 6 month interview but continued in study|0|||
147445665|NCT03200366|531797423|FG000|6 Month Post-Baseline Interview|Not attempted/missed by data collectors|0|||
147445666|NCT03200366|531797424|FG001|6 Month Post-Baseline Interview|Not attempted/missed by data collectors|0|||
147445667|NCT03200366|531797425|FG002|6 Month Post-Baseline Interview|Not attempted/missed by data collectors|1|||
147445668|NCT03200366|531797423|FG000|9 Month Post-Baseline Interview|Death|1|||
147445669|NCT03200366|531797424|FG001|9 Month Post-Baseline Interview|Death|1|||
147572863|NCT01695239|532255769|FG010|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
147572864|NCT01695239|532255770|FG011|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
147572865|NCT01695239|532255771|FG012|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
147572866|NCT01695239|532255772|FG013|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
147138956|NCT02628444|530677362|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|11|||
147138957|NCT02628444|530677363|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|Voluntary withdrawal not due to AE|9|||
147138958|NCT02628444|530677355|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
147138959|NCT02628444|530677356|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
147138960|NCT02628444|530677357|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
147138961|NCT02628444|530677358|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
147138962|NCT02628444|530677359|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|3|||
147138963|NCT02628444|530677360|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
147138964|NCT02628444|530677361|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|0|||
147138965|NCT02628444|530677362|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|2|||
147138966|NCT02628444|530677363|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|SAE|3|||
147138967|NCT02628444|530677355|FG000|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|0|||
147138968|NCT02628444|530677356|FG001|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|0|||
147138969|NCT02628444|530677357|FG002|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|0|||
147138970|NCT02628444|530677358|FG003|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|1|||
147138971|NCT02628444|530677359|FG004|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|1|||
147138972|NCT02628444|530677360|FG005|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|2|||
147138973|NCT02628444|530677361|FG006|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|3|||
147138974|NCT02628444|530677362|FG007|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|1|||
147138975|NCT02628444|530677363|FG008|STAGE-II(18M:12M Treatment+6M Follow-up)|Lost to Follow-up|2|||
147138976|NCT02079909|530677364|FG000|Overall Study|Adverse Event|23|||
147138977|NCT02079909|530677365|FG001|Overall Study|Adverse Event|23|||
147138978|NCT02079909|530677366|FG002|Overall Study|Adverse Event|7|||
147138979|NCT02079909|530677364|FG000|Overall Study|Withdrawal by Subject|9|||
147572867|NCT01695239|532255759|FG000|Double-Blind (DB) Treatment Period|Protocol Violation|1|||
147572868|NCT01695239|532255760|FG001|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
147138980|NCT02079909|530677365|FG001|Overall Study|Withdrawal by Subject|17|||
147138981|NCT02079909|530677366|FG002|Overall Study|Withdrawal by Subject|4|||
147572869|NCT01695239|532255761|FG002|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
147572870|NCT01695239|532255762|FG003|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
147572871|NCT01695239|532255763|FG004|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
147572872|NCT01695239|532255764|FG005|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
147572873|NCT01695239|532255765|FG006|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
147572874|NCT01695239|532255766|FG007|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
147572875|NCT01695239|532255767|FG008|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
147572876|NCT01695239|532255768|FG009|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
147572877|NCT01695239|532255769|FG010|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
147572878|NCT01695239|532255770|FG011|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
147572879|NCT01695239|532255771|FG012|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
147138982|NCT02079909|530677364|FG000|Overall Study|Lost to Follow-up|2|||
147138983|NCT02079909|530677365|FG001|Overall Study|Lost to Follow-up|3|||
147138984|NCT02079909|530677366|FG002|Overall Study|Lost to Follow-up|1|||
147138985|NCT02079909|530677364|FG000|Overall Study|Death|2|||
147138986|NCT02079909|530677365|FG001|Overall Study|Death|2|||
147445670|NCT03200366|531797425|FG002|9 Month Post-Baseline Interview|Death|1|||
147445671|NCT03200366|531797423|FG000|9 Month Post-Baseline Interview|Lost to Follow-up|23|||
147572880|NCT01695239|532255772|FG013|Double-Blind (DB) Treatment Period|Protocol Violation|0|||
147572881|NCT01695239|532255759|FG000|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
147572882|NCT01695239|532255760|FG001|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
147138987|NCT02079909|530677366|FG002|Overall Study|Death|0|||
147138988|NCT02079909|530677364|FG000|Overall Study|Lack of Efficacy|0|||
147138989|NCT02079909|530677365|FG001|Overall Study|Lack of Efficacy|0|||
147138990|NCT02079909|530677366|FG002|Overall Study|Lack of Efficacy|1|||
147138991|NCT02079909|530677364|FG000|Overall Study|Protocol Violation|0|||
147138992|NCT02079909|530677365|FG001|Overall Study|Protocol Violation|1|||
147138993|NCT02079909|530677366|FG002|Overall Study|Protocol Violation|1|||
147237710|NCT03539081|531042494|FG001|Overall Study|Withdrawal by Subject|3|||
147237711|NCT03539081|531042495|FG002|Overall Study|Withdrawal by Subject|0|||
147237712|NCT03539081|531042493|FG000|Overall Study|MSNA testing not done due to nerve recording not being able to be done due to restless legs|1|||
147237713|NCT03539081|531042494|FG001|Overall Study|MSNA testing not done due to nerve recording not being able to be done due to restless legs|0|||
147237714|NCT03539081|531042495|FG002|Overall Study|MSNA testing not done due to nerve recording not being able to be done due to restless legs|0|||
147237715|NCT02025621|531042496|FG000|Overall Study|Withdrawal by Subject|1|||
147237716|NCT02025621|531042497|FG001|Overall Study|Withdrawal by Subject|0|||
147237717|NCT02025621|531042496|FG000|Overall Study|Death|0|||
147138994|NCT02079909|530677364|FG000|Overall Study|Physician Decision|0|||
147138995|NCT02079909|530677365|FG001|Overall Study|Physician Decision|1|||
147138996|NCT02079909|530677366|FG002|Overall Study|Physician Decision|1|||
147138997|NCT02079909|530677364|FG000|Overall Study|Relocation etc.|2|||
147138998|NCT02079909|530677365|FG001|Overall Study|Relocation etc.|2|||
147138999|NCT02079909|530677366|FG002|Overall Study|Relocation etc.|3|||
147318568|NCT05708846|531331770|FG000|Overall Study|Death|5|||
147651955|NCT02688764|532548240|FG000|Overall Study|Non-compl./Withd. subject|0|||
147651956|NCT02688764|532548241|FG001|Overall Study|Non-compl./Withd. subject|2|||
147651957|NCT02688764|532548240|FG000|Overall Study|Phosphorus level outside safe range|0|||
147651958|NCT02688764|532548241|FG001|Overall Study|Phosphorus level outside safe range|1|||
147651959|NCT02688764|532548240|FG000|Overall Study|Phosphorus >7 mg/dL - Withd. by sponsor|1|||
147651960|NCT02688764|532548241|FG001|Overall Study|Phosphorus >7 mg/dL - Withd. by sponsor|0|||
147651961|NCT02688764|532548240|FG000|Overall Study|Study drug taste/Withd. parent|1|||
147651962|NCT02688764|532548241|FG001|Overall Study|Study drug taste/Withd. parent|0|||
147651963|NCT02688764|532548240|FG000|Overall Study|Subject moving out|2|||
147651964|NCT02688764|532548241|FG001|Overall Study|Subject moving out|0|||
147651965|NCT02688764|532548240|FG000|Overall Study|Subject taken off dialysis|1|||
147651966|NCT02688764|532548241|FG001|Overall Study|Subject taken off dialysis|0|||
147651967|NCT02688764|532548240|FG000|Overall Study|Withdrawal by parent|3|||
147651968|NCT02688764|532548241|FG001|Overall Study|Withdrawal by parent|0|||
147651969|NCT02113007|532548242|FG000|Overall Study|Progressive disease|2|||
147651970|NCT00885378|532548243|FG000|Overall Study|Lack of Efficacy|2|||
147651971|NCT00885378|532548244|FG001|Overall Study|Lack of Efficacy|2|||
147651972|NCT00885378|532548243|FG000|Overall Study|Withdrawal by Subject|1|||
147651973|NCT00885378|532548244|FG001|Overall Study|Withdrawal by Subject|2|||
147651974|NCT00885378|532548243|FG000|Overall Study|Lost to Follow-up|1|||
147651975|NCT00885378|532548244|FG001|Overall Study|Lost to Follow-up|2|||
147651976|NCT00885378|532548243|FG000|Overall Study|Poor/Noncompliance|2|||
147651977|NCT00885378|532548244|FG001|Overall Study|Poor/Noncompliance|2|||
147651978|NCT00885378|532548243|FG000|Overall Study|Protocol Violation|2|||
147651979|NCT00885378|532548244|FG001|Overall Study|Protocol Violation|0|||
147651980|NCT04076319|532548245|FG000|Overall Study|Withdrawal by Subject|2|||
147651981|NCT04076319|532548246|FG001|Overall Study|Withdrawal by Subject|0|||
147651982|NCT04076319|532548245|FG000|Overall Study|Death|1|||
147651983|NCT04076319|532548246|FG001|Overall Study|Death|0|||
147651984|NCT01054222|532548247|FG000|Overall Study|Lack of Efficacy|1|||
147651985|NCT01054222|532548247|FG000|Overall Study|Lost to Follow-up|4|||
147651986|NCT01054222|532548247|FG000|Overall Study|Withdrawal by Subject|6|||
147651987|NCT00824655|532548248|FG000|Toddler Dose (12 Months of Age)|Adverse Event|1|||
147651988|NCT00824655|532548249|FG001|Toddler Dose (12 Months of Age)|Adverse Event|0|||
147651989|NCT00824655|532548248|FG000|Toddler Dose (12 Months of Age)|Parent/legal guardian request|1|||
147651990|NCT00824655|532548249|FG001|Toddler Dose (12 Months of Age)|Parent/legal guardian request|0|||
147651991|NCT03504189|532548250|FG000|Overall Study|Withdrawal by Subject|1|||
147651992|NCT03504189|532548250|FG000|Overall Study|Screening Failure|1|||
147651993|NCT03504189|532548250|FG000|Overall Study|Device Failure|2|||
147651994|NCT03091738|532548251|FG000|Overall Study|Adverse Event|1|||
147651995|NCT03091738|532548251|FG000|Overall Study|Lost to Follow-up|1|||
147651996|NCT01467271|532548257|FG000|Overall Study|Death|84|||
147651997|NCT01467271|532548257|FG000|Overall Study|Lost to Follow-up|83|||
147651998|NCT01467271|532548257|FG000|Overall Study|Retraction of patient's consent|21|||
147651999|NCT01467271|532548257|FG000|Overall Study|Other reason|14|||
147652000|NCT03084302|532548262|FG000|Overall Study|Miscarriage, twin pregnancy, congenital abnormality|9|||
147652001|NCT03084302|532548262|FG000|Overall Study|No valid objective monitor data|6|||
147652002|NCT01411319|532548263|FG000|Overall Study|Lost to Follow-up|1|||
147652003|NCT00660595|532548284|FG000|Overall Study|Lost to Follow-up|0|||
147652004|NCT00660595|532548285|FG001|Overall Study|Lost to Follow-up|1|||
147652005|NCT00660595|532548284|FG000|Overall Study|Did not consent to participate in study|12|||
147652006|NCT00660595|532548285|FG001|Overall Study|Did not consent to participate in study|8|||
147652007|NCT00660595|532548284|FG000|Overall Study|Participant left hospital|1|||
147652008|NCT00660595|532548285|FG001|Overall Study|Participant left hospital|0|||
147652009|NCT00660595|532548284|FG000|Overall Study|Non Specified reasons|5|||
147139000|NCT00720356|530677369|FG000|Registration to Study|Determined to have methylated MGMT|67|||
147139001|NCT00720356|530677369|FG000|Reached 1st Response/2 Cycles|Progressive Disease|1|||
147139002|NCT00720356|530677369|FG000|Reached 1st Response/2 Cycles|Withdrawal by Subject|1|||
147139003|NCT00720356|530677369|FG000|Went on to be Treated Cycle 3|Adverse Event|1|||
147318569|NCT05708846|531331770|FG000|Overall Study|Withdrawal by Subject|20|||
147652010|NCT00660595|532548285|FG001|Overall Study|Non Specified reasons|0|||
147652011|NCT01148459|532548286|FG000|Overall Study|Serious Adverse Event|5|||
147652012|NCT01148459|532548287|FG001|Overall Study|Serious Adverse Event|4|||
147652013|NCT01148459|532548286|FG000|Overall Study|Withdrawal by Subject|1|||
147652014|NCT01148459|532548287|FG001|Overall Study|Withdrawal by Subject|0|||
147652015|NCT01148459|532548286|FG000|Overall Study|Migrated/moved from study area|3|||
147652016|NCT01148459|532548287|FG001|Overall Study|Migrated/moved from study area|6|||
147652017|NCT01148459|532548286|FG000|Overall Study|Lost to Follow-up|2|||
147652018|NCT01148459|532548287|FG001|Overall Study|Lost to Follow-up|0|||
147139004|NCT00720356|530677369|FG000|Went on to be Treated Cycle 3|Physician Decision|1|||
147139005|NCT00720356|530677369|FG000|Follow up Until Death|Withdrawal by Subject|1|||
147139006|NCT00720356|530677369|FG000|Follow up Until Death|Alive at last data collection|4|||
147139007|NCT02237001|530677372|FG000|Overall Study|Lost to Follow-up|2|||
147139008|NCT02237001|530677372|FG000|Overall Study|Withdrawal by Subject|1|||
147139009|NCT02237001|530677372|FG000|Overall Study|Eligibility criteria/Late Screen Failure|3|||
147139010|NCT02237001|530677372|FG000|Overall Study|Re-operation|4|||
147572883|NCT01695239|532255761|FG002|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
147572884|NCT01695239|532255762|FG003|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
147572885|NCT01695239|532255763|FG004|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
147572886|NCT01695239|532255764|FG005|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
147572887|NCT01695239|532255765|FG006|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
147572888|NCT01695239|532255766|FG007|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|9|||
147572889|NCT01695239|532255767|FG008|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
147572890|NCT01695239|532255768|FG009|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
147572891|NCT01695239|532255769|FG010|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
147572892|NCT01695239|532255770|FG011|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
147572893|NCT01695239|532255771|FG012|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
147572894|NCT01695239|532255772|FG013|Placebo Washout (Week 24 Up To Week 32)|Lack of Efficacy|0|||
147572895|NCT01695239|532255759|FG000|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
147572896|NCT01695239|532255760|FG001|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
147572897|NCT01695239|532255761|FG002|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
147572898|NCT01695239|532255762|FG003|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
147572899|NCT01695239|532255763|FG004|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
147572900|NCT01695239|532255764|FG005|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
147572901|NCT01695239|532255765|FG006|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
147572902|NCT01695239|532255766|FG007|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|1|||
147572903|NCT01695239|532255767|FG008|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
147572904|NCT01695239|532255768|FG009|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
147139011|NCT02237001|530677372|FG000|Overall Study|Incarceration|1|||
147139012|NCT01713582|530677373|FG000|Overall Study|Disease progression|3|||
147572905|NCT01695239|532255769|FG010|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
147572906|NCT01695239|532255770|FG011|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
147572907|NCT01695239|532255771|FG012|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
147572908|NCT01695239|532255772|FG013|Placebo Washout (Week 24 Up To Week 32)|Adverse Event|0|||
147572909|NCT01695239|532255759|FG000|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
147572910|NCT01695239|532255760|FG001|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
147572911|NCT01695239|532255761|FG002|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
147572912|NCT01695239|532255762|FG003|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
147572913|NCT01695239|532255763|FG004|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
147572914|NCT01695239|532255764|FG005|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
147139013|NCT01713582|530677374|FG001|Overall Study|Disease progression|3|||
147139014|NCT01713582|530677375|FG002|Overall Study|Disease progression|3|||
147139015|NCT01713582|530677376|FG003|Overall Study|Disease progression|2|||
147139016|NCT01713582|530677377|FG004|Overall Study|Disease progression|3|||
147139017|NCT01713582|530677378|FG005|Overall Study|Disease progression|3|||
147139018|NCT01713582|530677379|FG006|Overall Study|Disease progression|3|||
147139019|NCT01713582|530677380|FG007|Overall Study|Disease progression|3|||
147139020|NCT01713582|530677381|FG008|Overall Study|Disease progression|3|||
147139021|NCT01713582|530677382|FG009|Overall Study|Disease progression|11|||
147139022|NCT01713582|530677383|FG010|Overall Study|Disease progression|10|||
147139023|NCT01713582|530677384|FG011|Overall Study|Disease progression|5|||
147139024|NCT01713582|530677385|FG012|Overall Study|Disease progression|3|||
147139025|NCT01713582|530677386|FG013|Overall Study|Disease progression|3|||
147139026|NCT01713582|530677387|FG014|Overall Study|Disease progression|6|||
147139027|NCT01713582|530677388|FG015|Overall Study|Disease progression|6|||
147139028|NCT01713582|530677389|FG016|Overall Study|Disease progression|5|||
147139029|NCT01713582|530677390|FG017|Overall Study|Disease progression|2|||
147139030|NCT01713582|530677391|FG018|Overall Study|Disease progression|3|||
147139031|NCT01713582|530677392|FG019|Overall Study|Disease progression|5|||
147139032|NCT01713582|530677393|FG020|Overall Study|Disease progression|15|||
147139033|NCT01713582|530677373|FG000|Overall Study|Death|0|||
147139034|NCT01713582|530677374|FG001|Overall Study|Death|0|||
147139035|NCT01713582|530677375|FG002|Overall Study|Death|0|||
147139036|NCT01713582|530677376|FG003|Overall Study|Death|1|||
147139037|NCT01713582|530677377|FG004|Overall Study|Death|1|||
147139038|NCT01713582|530677378|FG005|Overall Study|Death|3|||
147139039|NCT01713582|530677379|FG006|Overall Study|Death|3|||
147139040|NCT01713582|530677380|FG007|Overall Study|Death|2|||
147139041|NCT01713582|530677381|FG008|Overall Study|Death|3|||
147139042|NCT01713582|530677382|FG009|Overall Study|Death|4|||
147139043|NCT01713582|530677383|FG010|Overall Study|Death|3|||
147139044|NCT01713582|530677384|FG011|Overall Study|Death|0|||
147572915|NCT01695239|532255765|FG006|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
147572916|NCT01695239|532255766|FG007|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|1|||
147572917|NCT01695239|532255767|FG008|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
147572918|NCT01695239|532255768|FG009|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
147572919|NCT01695239|532255769|FG010|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
147572920|NCT01695239|532255770|FG011|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
147572921|NCT01695239|532255771|FG012|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
147572922|NCT01695239|532255772|FG013|Placebo Washout (Week 24 Up To Week 32)|Entry Criteria Not Met|0|||
147572923|NCT01695239|532255759|FG000|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
147572924|NCT01695239|532255760|FG001|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
147572925|NCT01695239|532255761|FG002|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
147572926|NCT01695239|532255762|FG003|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
147139045|NCT01713582|530677385|FG012|Overall Study|Death|0|||
147139046|NCT01713582|530677386|FG013|Overall Study|Death|0|||
147139047|NCT01713582|530677387|FG014|Overall Study|Death|0|||
147139048|NCT01713582|530677388|FG015|Overall Study|Death|0|||
147139049|NCT01713582|530677389|FG016|Overall Study|Death|0|||
147139050|NCT01713582|530677390|FG017|Overall Study|Death|0|||
147139051|NCT01713582|530677391|FG018|Overall Study|Death|0|||
147139052|NCT01713582|530677392|FG019|Overall Study|Death|0|||
147139053|NCT01713582|530677393|FG020|Overall Study|Death|0|||
147139054|NCT01713582|530677373|FG000|Overall Study|Adverse event-related|0|||
147139055|NCT01713582|530677374|FG001|Overall Study|Adverse event-related|0|||
147139056|NCT01713582|530677375|FG002|Overall Study|Adverse event-related|0|||
147139057|NCT01713582|530677376|FG003|Overall Study|Adverse event-related|0|||
147139058|NCT01713582|530677377|FG004|Overall Study|Adverse event-related|0|||
147139059|NCT01713582|530677378|FG005|Overall Study|Adverse event-related|0|||
147139060|NCT01713582|530677379|FG006|Overall Study|Adverse event-related|0|||
147139061|NCT01713582|530677380|FG007|Overall Study|Adverse event-related|0|||
147139062|NCT01713582|530677381|FG008|Overall Study|Adverse event-related|0|||
147139063|NCT01713582|530677382|FG009|Overall Study|Adverse event-related|1|||
147139064|NCT01713582|530677383|FG010|Overall Study|Adverse event-related|1|||
147139065|NCT01713582|530677384|FG011|Overall Study|Adverse event-related|0|||
147139066|NCT01713582|530677385|FG012|Overall Study|Adverse event-related|0|||
147139067|NCT01713582|530677386|FG013|Overall Study|Adverse event-related|0|||
147139068|NCT01713582|530677387|FG014|Overall Study|Adverse event-related|0|||
147139069|NCT01713582|530677388|FG015|Overall Study|Adverse event-related|0|||
147139070|NCT01713582|530677389|FG016|Overall Study|Adverse event-related|0|||
147139071|NCT01713582|530677390|FG017|Overall Study|Adverse event-related|0|||
147139072|NCT01713582|530677391|FG018|Overall Study|Adverse event-related|1|||
147139073|NCT01713582|530677392|FG019|Overall Study|Adverse event-related|0|||
147139074|NCT01713582|530677393|FG020|Overall Study|Adverse event-related|0|||
147139075|NCT01713582|530677373|FG000|Overall Study|Adverse event-unrelated|0|||
147139076|NCT01713582|530677374|FG001|Overall Study|Adverse event-unrelated|0|||
147139077|NCT01713582|530677375|FG002|Overall Study|Adverse event-unrelated|0|||
147139078|NCT01713582|530677376|FG003|Overall Study|Adverse event-unrelated|0|||
147139079|NCT01713582|530677377|FG004|Overall Study|Adverse event-unrelated|0|||
147139080|NCT01713582|530677378|FG005|Overall Study|Adverse event-unrelated|1|||
147139081|NCT01713582|530677379|FG006|Overall Study|Adverse event-unrelated|1|||
147139082|NCT01713582|530677380|FG007|Overall Study|Adverse event-unrelated|1|||
147139083|NCT01713582|530677381|FG008|Overall Study|Adverse event-unrelated|0|||
147572927|NCT01695239|532255763|FG004|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
147572928|NCT01695239|532255764|FG005|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
147572929|NCT01695239|532255765|FG006|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
147572930|NCT01695239|532255766|FG007|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
147572931|NCT01695239|532255767|FG008|Extension Long-Term Extension Periods|Lack of Efficacy|37|||
147139084|NCT01713582|530677382|FG009|Overall Study|Adverse event-unrelated|0|||
147139085|NCT01713582|530677383|FG010|Overall Study|Adverse event-unrelated|0|||
147139086|NCT01713582|530677384|FG011|Overall Study|Adverse event-unrelated|0|||
147572932|NCT01695239|532255768|FG009|Extension Long-Term Extension Periods|Lack of Efficacy|31|||
147572933|NCT01695239|532255769|FG010|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
147572934|NCT01695239|532255770|FG011|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
147572935|NCT01695239|532255771|FG012|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
147572936|NCT01695239|532255772|FG013|Extension Long-Term Extension Periods|Lack of Efficacy|0|||
147139087|NCT01713582|530677385|FG012|Overall Study|Adverse event-unrelated|0|||
147139088|NCT01713582|530677386|FG013|Overall Study|Adverse event-unrelated|1|||
147139089|NCT01713582|530677387|FG014|Overall Study|Adverse event-unrelated|1|||
147139090|NCT01713582|530677388|FG015|Overall Study|Adverse event-unrelated|0|||
147139091|NCT01713582|530677389|FG016|Overall Study|Adverse event-unrelated|0|||
147572937|NCT01695239|532255759|FG000|Extension Long-Term Extension Periods|Adverse Event|0|||
147652019|NCT01148459|532548286|FG000|Overall Study|Refusal|1|||
147139092|NCT01713582|530677390|FG017|Overall Study|Adverse event-unrelated|0|||
147237718|NCT02025621|531042497|FG001|Overall Study|Death|1|||
147139093|NCT01713582|530677391|FG018|Overall Study|Adverse event-unrelated|0|||
147139094|NCT01713582|530677392|FG019|Overall Study|Adverse event-unrelated|0|||
147139095|NCT01713582|530677393|FG020|Overall Study|Adverse event-unrelated|0|||
147139096|NCT01713582|530677373|FG000|Overall Study|Withdrawal of consent|0|||
147139097|NCT01713582|530677374|FG001|Overall Study|Withdrawal of consent|0|||
147139098|NCT01713582|530677375|FG002|Overall Study|Withdrawal of consent|1|||
147139099|NCT01713582|530677376|FG003|Overall Study|Withdrawal of consent|0|||
147572938|NCT01695239|532255760|FG001|Extension Long-Term Extension Periods|Adverse Event|0|||
147139100|NCT01713582|530677377|FG004|Overall Study|Withdrawal of consent|0|||
147139101|NCT01713582|530677378|FG005|Overall Study|Withdrawal of consent|1|||
147139102|NCT01713582|530677379|FG006|Overall Study|Withdrawal of consent|0|||
147139103|NCT01713582|530677380|FG007|Overall Study|Withdrawal of consent|0|||
147139104|NCT01713582|530677381|FG008|Overall Study|Withdrawal of consent|0|||
147139105|NCT01713582|530677382|FG009|Overall Study|Withdrawal of consent|1|||
147139106|NCT01713582|530677383|FG010|Overall Study|Withdrawal of consent|0|||
147139107|NCT01713582|530677384|FG011|Overall Study|Withdrawal of consent|0|||
147139108|NCT01713582|530677385|FG012|Overall Study|Withdrawal of consent|0|||
147139109|NCT01713582|530677386|FG013|Overall Study|Withdrawal of consent|0|||
147139110|NCT01713582|530677387|FG014|Overall Study|Withdrawal of consent|0|||
147139111|NCT01713582|530677388|FG015|Overall Study|Withdrawal of consent|0|||
147237719|NCT02025621|531042496|FG000|Overall Study|No longer eligible|10|||
147572939|NCT01695239|532255761|FG002|Extension Long-Term Extension Periods|Adverse Event|0|||
147572940|NCT01695239|532255762|FG003|Extension Long-Term Extension Periods|Adverse Event|0|||
147572941|NCT01695239|532255763|FG004|Extension Long-Term Extension Periods|Adverse Event|0|||
147572942|NCT01695239|532255764|FG005|Extension Long-Term Extension Periods|Adverse Event|0|||
147572943|NCT01695239|532255765|FG006|Extension Long-Term Extension Periods|Adverse Event|0|||
147572944|NCT01695239|532255766|FG007|Extension Long-Term Extension Periods|Adverse Event|0|||
147572945|NCT01695239|532255767|FG008|Extension Long-Term Extension Periods|Adverse Event|15|||
147572946|NCT01695239|532255768|FG009|Extension Long-Term Extension Periods|Adverse Event|21|||
147572947|NCT01695239|532255769|FG010|Extension Long-Term Extension Periods|Adverse Event|0|||
147572948|NCT01695239|532255770|FG011|Extension Long-Term Extension Periods|Adverse Event|0|||
147572949|NCT01695239|532255771|FG012|Extension Long-Term Extension Periods|Adverse Event|0|||
147572950|NCT01695239|532255772|FG013|Extension Long-Term Extension Periods|Adverse Event|0|||
147572951|NCT01695239|532255759|FG000|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
147572952|NCT01695239|532255760|FG001|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
147572953|NCT01695239|532255761|FG002|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
147572954|NCT01695239|532255762|FG003|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
147572955|NCT01695239|532255763|FG004|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
147572956|NCT01695239|532255764|FG005|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
147572957|NCT01695239|532255765|FG006|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
147572958|NCT01695239|532255766|FG007|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
147572959|NCT01695239|532255767|FG008|Extension Long-Term Extension Periods|Withdrawal by Subject|6|||
147572960|NCT01695239|532255768|FG009|Extension Long-Term Extension Periods|Withdrawal by Subject|7|||
147572961|NCT01695239|532255769|FG010|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
147572962|NCT01695239|532255770|FG011|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
147572963|NCT01695239|532255771|FG012|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
147572964|NCT01695239|532255772|FG013|Extension Long-Term Extension Periods|Withdrawal by Subject|0|||
147572965|NCT01695239|532255759|FG000|Extension Long-Term Extension Periods|Physician Decision|0|||
147572966|NCT01695239|532255760|FG001|Extension Long-Term Extension Periods|Physician Decision|0|||
147572967|NCT01695239|532255761|FG002|Extension Long-Term Extension Periods|Physician Decision|0|||
147572968|NCT01695239|532255762|FG003|Extension Long-Term Extension Periods|Physician Decision|0|||
147572969|NCT01695239|532255763|FG004|Extension Long-Term Extension Periods|Physician Decision|0|||
147572970|NCT01695239|532255764|FG005|Extension Long-Term Extension Periods|Physician Decision|0|||
147572971|NCT01695239|532255765|FG006|Extension Long-Term Extension Periods|Physician Decision|0|||
147652020|NCT01148459|532548287|FG001|Overall Study|Refusal|0|||
147139112|NCT01713582|530677389|FG016|Overall Study|Withdrawal of consent|0|||
147237720|NCT02025621|531042497|FG001|Overall Study|No longer eligible|15|||
147237721|NCT02025621|531042496|FG000|Overall Study|Surgery initiated before infusion|3|||
147237722|NCT02025621|531042497|FG001|Overall Study|Surgery initiated before infusion|3|||
147237723|NCT00739674|531042498|FG000|Overall Study|Screening failures|19|||
147237724|NCT00739674|531042499|FG001|Overall Study|Screening failures|17|||
147237725|NCT00739674|531042498|FG000|Overall Study|Site 212 removal|19|||
147237726|NCT00739674|531042499|FG001|Overall Study|Site 212 removal|13|||
147237727|NCT00739674|531042498|FG000|Overall Study|No follow-up data|33|||
147237728|NCT00739674|531042499|FG001|Overall Study|No follow-up data|18|||
147139113|NCT01713582|530677390|FG017|Overall Study|Withdrawal of consent|0|||
147139114|NCT01713582|530677391|FG018|Overall Study|Withdrawal of consent|1|||
147139115|NCT01713582|530677392|FG019|Overall Study|Withdrawal of consent|0|||
147139116|NCT01713582|530677393|FG020|Overall Study|Withdrawal of consent|0|||
147318570|NCT00641186|531331771|FG000|Overall Study|Adverse Event|3|||
147139117|NCT01713582|530677373|FG000|Overall Study|Lack of Efficacy|0|||
147139118|NCT01713582|530677374|FG001|Overall Study|Lack of Efficacy|0|||
147139119|NCT01713582|530677375|FG002|Overall Study|Lack of Efficacy|0|||
147139120|NCT01713582|530677376|FG003|Overall Study|Lack of Efficacy|0|||
147139121|NCT01713582|530677377|FG004|Overall Study|Lack of Efficacy|0|||
147139122|NCT01713582|530677378|FG005|Overall Study|Lack of Efficacy|0|||
147139123|NCT01713582|530677379|FG006|Overall Study|Lack of Efficacy|0|||
147139124|NCT01713582|530677380|FG007|Overall Study|Lack of Efficacy|0|||
147139125|NCT01713582|530677381|FG008|Overall Study|Lack of Efficacy|0|||
147139126|NCT01713582|530677382|FG009|Overall Study|Lack of Efficacy|1|||
147139127|NCT01713582|530677383|FG010|Overall Study|Lack of Efficacy|2|||
147139128|NCT01713582|530677384|FG011|Overall Study|Lack of Efficacy|0|||
147139129|NCT01713582|530677385|FG012|Overall Study|Lack of Efficacy|0|||
147139130|NCT01713582|530677386|FG013|Overall Study|Lack of Efficacy|0|||
147139131|NCT01713582|530677387|FG014|Overall Study|Lack of Efficacy|0|||
147139132|NCT01713582|530677388|FG015|Overall Study|Lack of Efficacy|0|||
147139133|NCT01713582|530677389|FG016|Overall Study|Lack of Efficacy|0|||
147139134|NCT01713582|530677390|FG017|Overall Study|Lack of Efficacy|0|||
147139135|NCT01713582|530677391|FG018|Overall Study|Lack of Efficacy|0|||
147139136|NCT01713582|530677392|FG019|Overall Study|Lack of Efficacy|0|||
147139137|NCT01713582|530677393|FG020|Overall Study|Lack of Efficacy|0|||
147139138|NCT01713582|530677373|FG000|Overall Study|Withdrawal by Subject|0|||
147139139|NCT01713582|530677374|FG001|Overall Study|Withdrawal by Subject|0|||
147139140|NCT01713582|530677375|FG002|Overall Study|Withdrawal by Subject|0|||
147139141|NCT01713582|530677376|FG003|Overall Study|Withdrawal by Subject|0|||
147139142|NCT01713582|530677377|FG004|Overall Study|Withdrawal by Subject|0|||
147139143|NCT01713582|530677378|FG005|Overall Study|Withdrawal by Subject|0|||
147139144|NCT01713582|530677379|FG006|Overall Study|Withdrawal by Subject|0|||
147139145|NCT01713582|530677380|FG007|Overall Study|Withdrawal by Subject|0|||
147139146|NCT01713582|530677381|FG008|Overall Study|Withdrawal by Subject|0|||
147572972|NCT01695239|532255766|FG007|Extension Long-Term Extension Periods|Physician Decision|0|||
147572973|NCT01695239|532255767|FG008|Extension Long-Term Extension Periods|Physician Decision|3|||
147572974|NCT01695239|532255768|FG009|Extension Long-Term Extension Periods|Physician Decision|0|||
147572975|NCT01695239|532255769|FG010|Extension Long-Term Extension Periods|Physician Decision|0|||
147572976|NCT01695239|532255770|FG011|Extension Long-Term Extension Periods|Physician Decision|0|||
147572977|NCT01695239|532255771|FG012|Extension Long-Term Extension Periods|Physician Decision|0|||
147572978|NCT01695239|532255772|FG013|Extension Long-Term Extension Periods|Physician Decision|0|||
147572979|NCT01695239|532255759|FG000|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
147572980|NCT01695239|532255760|FG001|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
147572981|NCT01695239|532255761|FG002|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
147572982|NCT01695239|532255762|FG003|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
147572983|NCT01695239|532255763|FG004|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
147572984|NCT01695239|532255764|FG005|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
147572985|NCT01695239|532255765|FG006|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
147572986|NCT01695239|532255766|FG007|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
147572987|NCT01695239|532255767|FG008|Extension Long-Term Extension Periods|Lost to Follow-up|2|||
147572988|NCT01695239|532255768|FG009|Extension Long-Term Extension Periods|Lost to Follow-up|1|||
147572989|NCT01695239|532255769|FG010|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
147572990|NCT01695239|532255770|FG011|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
147572991|NCT01695239|532255771|FG012|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
147572992|NCT01695239|532255772|FG013|Extension Long-Term Extension Periods|Lost to Follow-up|0|||
147572993|NCT01695239|532255759|FG000|Extension Long-Term Extension Periods|Sponsor Decision|0|||
147139147|NCT01713582|530677382|FG009|Overall Study|Withdrawal by Subject|0|||
147139148|NCT01713582|530677383|FG010|Overall Study|Withdrawal by Subject|0|||
147139149|NCT01713582|530677384|FG011|Overall Study|Withdrawal by Subject|0|||
147139150|NCT01713582|530677385|FG012|Overall Study|Withdrawal by Subject|0|||
147139151|NCT01713582|530677386|FG013|Overall Study|Withdrawal by Subject|0|||
147139152|NCT01713582|530677387|FG014|Overall Study|Withdrawal by Subject|0|||
147139153|NCT01713582|530677388|FG015|Overall Study|Withdrawal by Subject|0|||
147139154|NCT01713582|530677389|FG016|Overall Study|Withdrawal by Subject|0|||
147139155|NCT01713582|530677390|FG017|Overall Study|Withdrawal by Subject|1|||
147572994|NCT01695239|532255760|FG001|Extension Long-Term Extension Periods|Sponsor Decision|0|||
147572995|NCT01695239|532255761|FG002|Extension Long-Term Extension Periods|Sponsor Decision|0|||
147139156|NCT01713582|530677391|FG018|Overall Study|Withdrawal by Subject|0|||
147572996|NCT01695239|532255762|FG003|Extension Long-Term Extension Periods|Sponsor Decision|0|||
147572997|NCT01695239|532255763|FG004|Extension Long-Term Extension Periods|Sponsor Decision|0|||
147139157|NCT01713582|530677392|FG019|Overall Study|Withdrawal by Subject|0|||
147139158|NCT01713582|530677393|FG020|Overall Study|Withdrawal by Subject|0|||
147139159|NCT01713582|530677373|FG000|Overall Study|Stopped to receive bone marrow graft|0|||
147139160|NCT01713582|530677374|FG001|Overall Study|Stopped to receive bone marrow graft|0|||
147139161|NCT01713582|530677375|FG002|Overall Study|Stopped to receive bone marrow graft|0|||
147139162|NCT01713582|530677376|FG003|Overall Study|Stopped to receive bone marrow graft|0|||
147139163|NCT01713582|530677377|FG004|Overall Study|Stopped to receive bone marrow graft|0|||
147139164|NCT01713582|530677378|FG005|Overall Study|Stopped to receive bone marrow graft|0|||
147139165|NCT01713582|530677379|FG006|Overall Study|Stopped to receive bone marrow graft|0|||
147139166|NCT01713582|530677380|FG007|Overall Study|Stopped to receive bone marrow graft|0|||
147139167|NCT01713582|530677381|FG008|Overall Study|Stopped to receive bone marrow graft|0|||
147139168|NCT01713582|530677382|FG009|Overall Study|Stopped to receive bone marrow graft|0|||
147139169|NCT01713582|530677383|FG010|Overall Study|Stopped to receive bone marrow graft|0|||
147139170|NCT01713582|530677384|FG011|Overall Study|Stopped to receive bone marrow graft|0|||
147139171|NCT01713582|530677385|FG012|Overall Study|Stopped to receive bone marrow graft|0|||
147139172|NCT01713582|530677386|FG013|Overall Study|Stopped to receive bone marrow graft|0|||
147139173|NCT01713582|530677387|FG014|Overall Study|Stopped to receive bone marrow graft|0|||
147139174|NCT01713582|530677388|FG015|Overall Study|Stopped to receive bone marrow graft|0|||
147139175|NCT01713582|530677389|FG016|Overall Study|Stopped to receive bone marrow graft|1|||
147139176|NCT01713582|530677390|FG017|Overall Study|Stopped to receive bone marrow graft|0|||
147139177|NCT01713582|530677391|FG018|Overall Study|Stopped to receive bone marrow graft|0|||
147139178|NCT01713582|530677392|FG019|Overall Study|Stopped to receive bone marrow graft|0|||
147139179|NCT01713582|530677393|FG020|Overall Study|Stopped to receive bone marrow graft|0|||
147139180|NCT01713582|530677373|FG000|Overall Study|Disease progression and adverse event|0|||
147139181|NCT01713582|530677374|FG001|Overall Study|Disease progression and adverse event|0|||
147139182|NCT01713582|530677375|FG002|Overall Study|Disease progression and adverse event|0|||
147139183|NCT01713582|530677376|FG003|Overall Study|Disease progression and adverse event|0|||
147139184|NCT01713582|530677377|FG004|Overall Study|Disease progression and adverse event|0|||
147139185|NCT01713582|530677378|FG005|Overall Study|Disease progression and adverse event|0|||
147139186|NCT01713582|530677379|FG006|Overall Study|Disease progression and adverse event|0|||
147139187|NCT01713582|530677380|FG007|Overall Study|Disease progression and adverse event|0|||
147139188|NCT01713582|530677381|FG008|Overall Study|Disease progression and adverse event|0|||
147139189|NCT01713582|530677382|FG009|Overall Study|Disease progression and adverse event|0|||
147139190|NCT01713582|530677383|FG010|Overall Study|Disease progression and adverse event|0|||
147139191|NCT01713582|530677384|FG011|Overall Study|Disease progression and adverse event|0|||
147139192|NCT01713582|530677385|FG012|Overall Study|Disease progression and adverse event|0|||
147139193|NCT01713582|530677386|FG013|Overall Study|Disease progression and adverse event|0|||
147139194|NCT01713582|530677387|FG014|Overall Study|Disease progression and adverse event|0|||
147139195|NCT01713582|530677388|FG015|Overall Study|Disease progression and adverse event|0|||
147139196|NCT01713582|530677389|FG016|Overall Study|Disease progression and adverse event|1|||
147139197|NCT01713582|530677390|FG017|Overall Study|Disease progression and adverse event|0|||
147139198|NCT01713582|530677391|FG018|Overall Study|Disease progression and adverse event|0|||
147139199|NCT01713582|530677392|FG019|Overall Study|Disease progression and adverse event|0|||
147139200|NCT01713582|530677393|FG020|Overall Study|Disease progression and adverse event|0|||
147139201|NCT04776161|530677394|FG000|Overall Study|Withdrew after randomization but prior to intervention|1|||
147139202|NCT04776161|530677395|FG001|Overall Study|Withdrew after randomization but prior to intervention|3|||
147139203|NCT04776161|530677396|FG002|Overall Study|Withdrew after randomization but prior to intervention|2|||
147139204|NCT04776161|530677394|FG000|Overall Study|Withdrawal by Subject|1|||
147139205|NCT04776161|530677395|FG001|Overall Study|Withdrawal by Subject|0|||
147139206|NCT04776161|530677396|FG002|Overall Study|Withdrawal by Subject|1|||
147139207|NCT04776161|530677394|FG000|Overall Study|Adverse Event|0|||
147139208|NCT04776161|530677395|FG001|Overall Study|Adverse Event|1|||
147139209|NCT04776161|530677396|FG002|Overall Study|Adverse Event|1|||
147139210|NCT00342628|530677399|FG000|Overall Study|Withdrawal by Subject|19|||
147139211|NCT00342628|530677400|FG001|Overall Study|Withdrawal by Subject|19|||
147139212|NCT00342628|530677401|FG002|Overall Study|Withdrawal by Subject|18|||
147139213|NCT00342628|530677399|FG000|Overall Study|Death|1|||
147139214|NCT00342628|530677400|FG001|Overall Study|Death|1|||
147139215|NCT00342628|530677401|FG002|Overall Study|Death|0|||
147139216|NCT00342628|530677399|FG000|Overall Study|moved residence|0|||
147139217|NCT00342628|530677400|FG001|Overall Study|moved residence|1|||
147139218|NCT00342628|530677401|FG002|Overall Study|moved residence|1|||
147139219|NCT03427814|530677402|FG000|Overall Study|Withdrawal by Subject|4|||
147139220|NCT03427814|530677403|FG001|Overall Study|Withdrawal by Subject|4|||
147139221|NCT03427814|530677402|FG000|Overall Study|Lost to Follow-up|0|||
147139222|NCT03427814|530677403|FG001|Overall Study|Lost to Follow-up|2|||
147139223|NCT03427814|530677402|FG000|Overall Study|Death|42|||
147139224|NCT03427814|530677403|FG001|Overall Study|Death|31|||
147139225|NCT03427814|530677402|FG000|Overall Study|Sponsor's Decision|1|||
147139226|NCT03427814|530677403|FG001|Overall Study|Sponsor's Decision|0|||
147139227|NCT03427814|530677402|FG000|Overall Study|Investigator's Decision|1|||
147572998|NCT01695239|532255764|FG005|Extension Long-Term Extension Periods|Sponsor Decision|0|||
147139228|NCT03427814|530677403|FG001|Overall Study|Investigator's Decision|2|||
147139229|NCT03427814|530677402|FG000|Overall Study|Disease progression|1|||
147139230|NCT03427814|530677403|FG001|Overall Study|Disease progression|0|||
147139231|NCT03427814|530677402|FG000|Overall Study|Treatment Completed|0|||
147139232|NCT03427814|530677403|FG001|Overall Study|Treatment Completed|1|||
147139233|NCT03427814|530677402|FG000|Overall Study|Sponsor's Decision to End study|21|||
147139234|NCT03427814|530677403|FG001|Overall Study|Sponsor's Decision to End study|25|||
147139235|NCT03427814|530677402|FG000|Overall Study|Transfer to Long Term Extension Study|1|||
147139236|NCT03427814|530677403|FG001|Overall Study|Transfer to Long Term Extension Study|0|||
147139237|NCT03846427|530677404|FG000|Overall Study|Death|13|||
147139238|NCT03846427|530677404|FG000|Overall Study|Withdrawal by Subject|3|||
147139239|NCT03846427|530677404|FG000|Overall Study|Physician Decision|1|||
147139240|NCT01334554|530677405|FG000|Overall Study|Adverse Event|4|||
147139241|NCT01334554|530677406|FG001|Overall Study|Adverse Event|2|||
147139242|NCT01944020|530677408|FG000|Overall Study|Withdrawal by Subject|5|||
147139243|NCT01944020|530677409|FG001|Overall Study|Withdrawal by Subject|0|||
147139244|NCT01979614|530677410|FG000|Overall Study|Adverse Event|1|||
147139245|NCT01979614|530677411|FG001|Overall Study|Adverse Event|1|||
147572999|NCT01695239|532255765|FG006|Extension Long-Term Extension Periods|Sponsor Decision|0|||
147573000|NCT01695239|532255766|FG007|Extension Long-Term Extension Periods|Sponsor Decision|0|||
147573001|NCT01695239|532255767|FG008|Extension Long-Term Extension Periods|Sponsor Decision|2|||
147573002|NCT01695239|532255768|FG009|Extension Long-Term Extension Periods|Sponsor Decision|1|||
147573003|NCT01695239|532255769|FG010|Extension Long-Term Extension Periods|Sponsor Decision|0|||
147573004|NCT01695239|532255770|FG011|Extension Long-Term Extension Periods|Sponsor Decision|0|||
147573005|NCT01695239|532255771|FG012|Extension Long-Term Extension Periods|Sponsor Decision|0|||
147573006|NCT01695239|532255772|FG013|Extension Long-Term Extension Periods|Sponsor Decision|0|||
147573007|NCT01695239|532255759|FG000|Extension Long-Term Extension Periods|Death|0|||
147573008|NCT01695239|532255760|FG001|Extension Long-Term Extension Periods|Death|0|||
147573009|NCT01695239|532255761|FG002|Extension Long-Term Extension Periods|Death|0|||
147573010|NCT01695239|532255762|FG003|Extension Long-Term Extension Periods|Death|0|||
147573011|NCT01695239|532255763|FG004|Extension Long-Term Extension Periods|Death|0|||
147573012|NCT01695239|532255764|FG005|Extension Long-Term Extension Periods|Death|0|||
147573013|NCT01695239|532255765|FG006|Extension Long-Term Extension Periods|Death|0|||
147573014|NCT01695239|532255766|FG007|Extension Long-Term Extension Periods|Death|0|||
147573015|NCT01695239|532255767|FG008|Extension Long-Term Extension Periods|Death|1|||
147573016|NCT01695239|532255768|FG009|Extension Long-Term Extension Periods|Death|0|||
147573017|NCT01695239|532255769|FG010|Extension Long-Term Extension Periods|Death|0|||
147573018|NCT01695239|532255770|FG011|Extension Long-Term Extension Periods|Death|0|||
147573019|NCT01695239|532255771|FG012|Extension Long-Term Extension Periods|Death|0|||
147573020|NCT01695239|532255772|FG013|Extension Long-Term Extension Periods|Death|0|||
147573021|NCT01695239|532255759|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
147573022|NCT01695239|532255760|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
147139246|NCT00661830|530677412|FG000|Overall Study|Death|37|||
147139247|NCT00661830|530677413|FG001|Overall Study|Death|33|||
147139248|NCT00661830|530677412|FG000|Overall Study|Lost to Follow-up|1|||
147139249|NCT00661830|530677413|FG001|Overall Study|Lost to Follow-up|3|||
147139250|NCT00661830|530677412|FG000|Overall Study|Withdrawal by Subject|1|||
147139251|NCT00661830|530677413|FG001|Overall Study|Withdrawal by Subject|1|||
147139252|NCT00661830|530677412|FG000|Overall Study|Other reason|1|||
147139253|NCT00661830|530677413|FG001|Overall Study|Other reason|5|||
147139254|NCT00488514|530677414|FG000|Overall Study|Adverse Event|41|||
147139255|NCT00488514|530677414|FG000|Overall Study|Lost to Follow-up|44|||
147139256|NCT00488514|530677414|FG000|Overall Study|Protocol Violation|32|||
147139257|NCT00488514|530677414|FG000|Overall Study|Withdrawal by Subject|106|||
147139258|NCT00488514|530677414|FG000|Overall Study|Lack of Efficacy|28|||
147139259|NCT00488514|530677414|FG000|Overall Study|Did not meet criteria for treatment|30|||
147139260|NCT00488514|530677414|FG000|Overall Study|Postive drug screen|1|||
147139261|NCT00488514|530677414|FG000|Overall Study|Withdrawn per medical monitor decision|2|||
147139262|NCT00488514|530677414|FG000|Overall Study|Investigator decision|1|||
147139263|NCT00488514|530677414|FG000|Overall Study|Participant had too few migraines|5|||
147139264|NCT00488514|530677414|FG000|Overall Study|Increase in number of migraines|2|||
147139265|NCT00488514|530677414|FG000|Overall Study|Increased use of concomitant medication|1|||
147139266|NCT04971967|530677419|FG000|Overall Study|Lost to Follow-up|6|||
147139267|NCT04971967|530677420|FG001|Overall Study|Lost to Follow-up|7|||
147139268|NCT00938912|530677423|FG000|Overall Study|Withdrawal by Subject|28|||
147573023|NCT01695239|532255761|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
147573024|NCT01695239|532255762|FG003|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
147573025|NCT01695239|532255763|FG004|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
147573026|NCT01695239|532255764|FG005|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
147139269|NCT00938912|530677423|FG000|Overall Study|Lost to Follow-up|4|||
147139270|NCT00938912|530677423|FG000|Overall Study|Lack of Efficacy|43|||
147139271|NCT00938912|530677423|FG000|Overall Study|Adverse event, non-fatal|24|||
147139272|NCT00938912|530677423|FG000|Overall Study|Adverse event, fatal|1|||
147139273|NCT00938912|530677423|FG000|Overall Study|Participant self adjusted antiepileptic medication|1|||
147139274|NCT00938912|530677423|FG000|Overall Study|Participant had a creatinine clearance less than 30 mL/min|1|||
147139275|NCT00938912|530677423|FG000|Overall Study|Participant needed prohibit medication|1|||
147139276|NCT00938912|530677423|FG000|Overall Study|Participant was scheduled for lobal resection|1|||
147139277|NCT00938912|530677423|FG000|Overall Study|Did not meet Eligibility criteria|1|||
147139278|NCT00938912|530677423|FG000|Overall Study|Participant relocated not related to AE|1|||
147139279|NCT00938912|530677423|FG000|Overall Study|Participant moved to another city|1|||
147318571|NCT02218489|531331772|FG000|Overall Study|Withdrawal by Subject|4|||
147318572|NCT02218489|531331773|FG001|Overall Study|Withdrawal by Subject|3|||
147318573|NCT02218489|531331772|FG000|Overall Study|Lost to Follow-up|1|||
147318574|NCT02218489|531331773|FG001|Overall Study|Lost to Follow-up|0|||
147573027|NCT01695239|532255765|FG006|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
147573028|NCT01695239|532255766|FG007|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
147573029|NCT01695239|532255767|FG008|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
147573030|NCT01695239|532255768|FG009|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
147573031|NCT01695239|532255769|FG010|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
147573032|NCT01695239|532255770|FG011|Post-Treatment Follow-Up Period|Withdrawal by Subject|1|||
147573033|NCT01695239|532255771|FG012|Post-Treatment Follow-Up Period|Withdrawal by Subject|6|||
147573034|NCT01695239|532255772|FG013|Post-Treatment Follow-Up Period|Withdrawal by Subject|3|||
147573035|NCT01695239|532255759|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
147573036|NCT01695239|532255760|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
147573037|NCT01695239|532255761|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
147573038|NCT01695239|532255762|FG003|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
147573039|NCT01695239|532255763|FG004|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
147573040|NCT01695239|532255764|FG005|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
147573041|NCT01695239|532255765|FG006|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
147573042|NCT01695239|532255766|FG007|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
147573043|NCT01695239|532255767|FG008|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
147573044|NCT01695239|532255768|FG009|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
147573045|NCT01695239|532255769|FG010|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
147573046|NCT01695239|532255770|FG011|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
147573047|NCT01695239|532255771|FG012|Post-Treatment Follow-Up Period|Lost to Follow-up|1|||
147573048|NCT01695239|532255772|FG013|Post-Treatment Follow-Up Period|Lost to Follow-up|1|||
147573049|NCT01695239|532255759|FG000|Post-Treatment Follow-Up Period|Physician Decision|0|||
147573050|NCT01695239|532255760|FG001|Post-Treatment Follow-Up Period|Physician Decision|0|||
147573051|NCT01695239|532255761|FG002|Post-Treatment Follow-Up Period|Physician Decision|0|||
147573052|NCT01695239|532255762|FG003|Post-Treatment Follow-Up Period|Physician Decision|0|||
147139280|NCT00938912|530677423|FG000|Overall Study|Participant experienced break through seizures|1|||
147139281|NCT00938912|530677423|FG000|Overall Study|No longer wished to participate in the study|1|||
147318575|NCT00519636|531331774|FG000|Treatment Period 1|Adverse Event|1|||
147318576|NCT00519636|531331775|FG001|Treatment Period 1|Adverse Event|0|||
147318577|NCT00519636|531331776|FG002|Treatment Period 1|Adverse Event|1|||
147318578|NCT00519636|531331777|FG003|Treatment Period 1|Adverse Event|0|||
147318579|NCT00519636|531331774|FG000|Treatment Period 1|Sponsor request due to missed visit|1|||
147318580|NCT00519636|531331775|FG001|Treatment Period 1|Sponsor request due to missed visit|0|||
147318581|NCT00519636|531331776|FG002|Treatment Period 1|Sponsor request due to missed visit|0|||
147318582|NCT00519636|531331777|FG003|Treatment Period 1|Sponsor request due to missed visit|0|||
147318583|NCT00519636|531331774|FG000|Washout Period|Adverse Event|2|||
147318584|NCT00519636|531331775|FG001|Washout Period|Adverse Event|1|||
147573053|NCT01695239|532255763|FG004|Post-Treatment Follow-Up Period|Physician Decision|0|||
147573054|NCT01695239|532255764|FG005|Post-Treatment Follow-Up Period|Physician Decision|0|||
147573055|NCT01695239|532255765|FG006|Post-Treatment Follow-Up Period|Physician Decision|0|||
147573056|NCT01695239|532255766|FG007|Post-Treatment Follow-Up Period|Physician Decision|0|||
147573057|NCT01695239|532255767|FG008|Post-Treatment Follow-Up Period|Physician Decision|0|||
147573058|NCT01695239|532255768|FG009|Post-Treatment Follow-Up Period|Physician Decision|0|||
147139282|NCT00938912|530677423|FG000|Overall Study|Protocol Deviation|2|||
147237729|NCT00739674|531042498|FG000|Overall Study|Dietician consultation >30 days|1|||
147237730|NCT00739674|531042499|FG001|Overall Study|Dietician consultation >30 days|9|||
147237731|NCT00739674|531042498|FG000|Overall Study|Adverse Event|22|||
147237732|NCT00739674|531042499|FG001|Overall Study|Adverse Event|13|||
147237733|NCT00739674|531042498|FG000|Overall Study|Death|1|||
147237734|NCT00739674|531042499|FG001|Overall Study|Death|0|||
147237735|NCT00739674|531042498|FG000|Overall Study|Lack of Efficacy|1|||
147237736|NCT00739674|531042499|FG001|Overall Study|Lack of Efficacy|0|||
147237737|NCT00739674|531042498|FG000|Overall Study|Lost to Follow-up|52|||
147237738|NCT00739674|531042499|FG001|Overall Study|Lost to Follow-up|30|||
147237739|NCT00739674|531042498|FG000|Overall Study|Protocol Violation|5|||
147237740|NCT00739674|531042499|FG001|Overall Study|Protocol Violation|5|||
147237741|NCT00739674|531042498|FG000|Overall Study|Withdrawal by Subject|9|||
147237742|NCT00739674|531042499|FG001|Overall Study|Withdrawal by Subject|9|||
147237743|NCT00739674|531042498|FG000|Overall Study|Reason missing|2|||
147318585|NCT00519636|531331776|FG002|Washout Period|Adverse Event|1|||
147318586|NCT00519636|531331777|FG003|Washout Period|Adverse Event|0|||
147318587|NCT00519636|531331774|FG000|Washout Period|Lost to Follow-up|1|||
147139283|NCT01475721|530677424|FG000|Overall Study|Death|3|||
147139284|NCT01475721|530677425|FG001|Overall Study|Death|6|||
147139285|NCT01475721|530677424|FG000|Overall Study|Withdrawal by Subject|8|||
147139286|NCT01475721|530677425|FG001|Overall Study|Withdrawal by Subject|8|||
147139287|NCT00803738|530677426|FG000|Overall Study|Adverse Event|3|||
147139288|NCT00803738|530677427|FG001|Overall Study|Adverse Event|5|||
147573059|NCT01695239|532255769|FG010|Post-Treatment Follow-Up Period|Physician Decision|0|||
147573060|NCT01695239|532255770|FG011|Post-Treatment Follow-Up Period|Physician Decision|0|||
147139289|NCT00803738|530677426|FG000|Overall Study|Lost to Follow-up|4|||
147139290|NCT00803738|530677427|FG001|Overall Study|Lost to Follow-up|4|||
147139291|NCT00803738|530677426|FG000|Overall Study|Protocol Violation|18|||
147139292|NCT00803738|530677427|FG001|Overall Study|Protocol Violation|10|||
147139293|NCT00803738|530677426|FG000|Overall Study|Withdrawal by Subject|1|||
147139294|NCT00803738|530677427|FG001|Overall Study|Withdrawal by Subject|4|||
147139295|NCT00803738|530677426|FG000|Overall Study|Lack of Efficacy|10|||
147139296|NCT00803738|530677427|FG001|Overall Study|Lack of Efficacy|16|||
147139297|NCT00803738|530677426|FG000|Overall Study|Negative Baseline Culture of Candida|56|||
147139298|NCT00803738|530677427|FG001|Overall Study|Negative Baseline Culture of Candida|63|||
147139299|NCT00803738|530677426|FG000|Overall Study|Positive Results for STD or abnormal PAP|2|||
147139300|NCT00803738|530677427|FG001|Overall Study|Positive Results for STD or abnormal PAP|8|||
147139301|NCT01048242|530677428|FG000|Overall Study|See study flow chart|4|||
147139302|NCT01048242|530677429|FG001|Overall Study|See study flow chart|2|||
147139303|NCT02364037|530677430|FG000|Overall Study|Withdrawal by Subject|7|||
147445672|NCT03200366|531797424|FG001|9 Month Post-Baseline Interview|Lost to Follow-up|18|||
147445673|NCT03200366|531797425|FG002|9 Month Post-Baseline Interview|Lost to Follow-up|9|||
147445674|NCT03200366|531797423|FG000|9 Month Post-Baseline Interview|Withdrawal by PI|0|||
147445675|NCT03200366|531797424|FG001|9 Month Post-Baseline Interview|Withdrawal by PI|0|||
147445676|NCT03200366|531797425|FG002|9 Month Post-Baseline Interview|Withdrawal by PI|1|||
147445677|NCT03200366|531797423|FG000|9 Month Post-Baseline Interview|Refused interview|0|||
147445678|NCT03200366|531797424|FG001|9 Month Post-Baseline Interview|Refused interview|2|||
147445679|NCT03200366|531797425|FG002|9 Month Post-Baseline Interview|Refused interview|0|||
147445680|NCT04677959|531797426|FG000|Overall Study|Adverse Event|1|||
147445681|NCT04677959|531797427|FG001|Overall Study|Adverse Event|9|||
147445682|NCT04677959|531797426|FG000|Overall Study|Withdrawal by Subject|2|||
147445683|NCT04677959|531797427|FG001|Overall Study|Withdrawal by Subject|15|||
147445684|NCT04677959|531797426|FG000|Overall Study|Withdrawal by parent/guardian|0|||
147445685|NCT04677959|531797427|FG001|Overall Study|Withdrawal by parent/guardian|1|||
147445686|NCT04677959|531797426|FG000|Overall Study|Non-compliance with study drug|0|||
147445687|NCT04677959|531797427|FG001|Overall Study|Non-compliance with study drug|2|||
147445688|NCT04677959|531797426|FG000|Overall Study|Protocol deviation|0|||
147445689|NCT04677959|531797427|FG001|Overall Study|Protocol deviation|11|||
147445690|NCT04677959|531797426|FG000|Overall Study|Lost to Follow-up|9|||
147445691|NCT04677959|531797427|FG001|Overall Study|Lost to Follow-up|13|||
147573061|NCT01695239|532255771|FG012|Post-Treatment Follow-Up Period|Physician Decision|2|||
147573062|NCT01695239|532255772|FG013|Post-Treatment Follow-Up Period|Physician Decision|0|||
147573063|NCT01695239|532255759|FG000|Post-Treatment Follow-Up Period|Protocol Violation|0|||
147573064|NCT01695239|532255760|FG001|Post-Treatment Follow-Up Period|Protocol Violation|0|||
147139304|NCT02364037|530677431|FG001|Overall Study|Withdrawal by Subject|4|||
147139305|NCT02364037|530677430|FG000|Overall Study|Lost to Follow-up|37|||
147139306|NCT02364037|530677431|FG001|Overall Study|Lost to Follow-up|49|||
147139307|NCT01772550|530677432|FG000|Overall Study|Unable to insert IV in antecubital vein|1|||
147139308|NCT01772550|530677433|FG001|Overall Study|Unable to insert IV in antecubital vein|1|||
147139309|NCT01772550|530677434|FG002|Overall Study|Unable to insert IV in antecubital vein|5|||
147139310|NCT01772550|530677432|FG000|Overall Study|Adverse Event|0|||
147139311|NCT01772550|530677433|FG001|Overall Study|Adverse Event|0|||
147139312|NCT01772550|530677434|FG002|Overall Study|Adverse Event|1|||
147139313|NCT00559104|530677435|FG000|Overall Study|Lack of Efficacy|9|||
147139314|NCT00559104|530677436|FG001|Overall Study|Lack of Efficacy|0|||
147139315|NCT00387088|530677437|FG000|Overall Study|Adverse Event|143|||
147139316|NCT00387088|530677438|FG001|Overall Study|Adverse Event|156|||
147139317|NCT00387088|530677437|FG000|Overall Study|Protocol Violation|47|||
147573065|NCT01695239|532255761|FG002|Post-Treatment Follow-Up Period|Protocol Violation|0|||
147139318|NCT00387088|530677438|FG001|Overall Study|Protocol Violation|35|||
147139319|NCT00387088|530677437|FG000|Overall Study|Withdrawal by Subject|20|||
147139320|NCT00387088|530677438|FG001|Overall Study|Withdrawal by Subject|35|||
147318588|NCT00519636|531331775|FG001|Washout Period|Lost to Follow-up|0|||
147139321|NCT00387088|530677437|FG000|Overall Study|Lack of Efficacy|28|||
147139322|NCT00387088|530677438|FG001|Overall Study|Lack of Efficacy|67|||
147445692|NCT04677959|531797426|FG000|Overall Study|Other than specified|0|||
147445693|NCT04677959|531797427|FG001|Overall Study|Other than specified|8|||
147445694|NCT00732303|531797428|FG000|Overall Study|Study Terminated|2|||
147445695|NCT00264875|531797429|FG000|Overall Study|Adverse Event|6|||
147139323|NCT00387088|530677437|FG000|Overall Study|Lost to Follow-up|22|||
147139324|NCT00387088|530677438|FG001|Overall Study|Lost to Follow-up|28|||
147139325|NCT00387088|530677437|FG000|Overall Study|Other|58|||
147139326|NCT00387088|530677438|FG001|Overall Study|Other|52|||
147139327|NCT02897115|530677443|FG000|Overall Study|Early termination of study by sponsor|11|||
147139328|NCT02897115|530677444|FG001|Overall Study|Early termination of study by sponsor|8|||
147139329|NCT03432494|530677446|FG000|Overall Study|Death|1|||
147139330|NCT03432494|530677446|FG000|Overall Study|Noncompliance|1|||
147139331|NCT00856635|530677447|FG000|Overall Study|Lost to Follow-up|2|||
147139332|NCT00856635|530677448|FG001|Overall Study|Lost to Follow-up|5|||
147139333|NCT00856635|530677447|FG000|Overall Study|Pregnancy|1|||
147139334|NCT00856635|530677448|FG001|Overall Study|Pregnancy|0|||
147139335|NCT00856635|530677447|FG000|Overall Study|Withdrawal by Subject|3|||
147139336|NCT00856635|530677448|FG001|Overall Study|Withdrawal by Subject|1|||
147139337|NCT00856635|530677447|FG000|Overall Study|Serious Adverse Event|1|||
147139338|NCT00856635|530677448|FG001|Overall Study|Serious Adverse Event|0|||
147139339|NCT00856635|530677447|FG000|Overall Study|Other|1|||
147139340|NCT00856635|530677448|FG001|Overall Study|Other|0|||
147139341|NCT00856635|530677447|FG000|Overall Study|Discontinued at Randomization|2|||
147139342|NCT00856635|530677448|FG001|Overall Study|Discontinued at Randomization|2|||
147139343|NCT01244035|530677450|FG000|Part 1: Period 1|Adverse Event|0|||
147139344|NCT01244035|530677451|FG001|Part 1: Period 1|Adverse Event|0|||
147139345|NCT01244035|530677452|FG002|Part 1: Period 1|Adverse Event|0|||
147139346|NCT01244035|530677453|FG003|Part 1: Period 1|Adverse Event|0|||
147139347|NCT01244035|530677454|FG004|Part 1: Period 1|Adverse Event|0|||
147139348|NCT01244035|530677455|FG005|Part 1: Period 1|Adverse Event|1|||
147139349|NCT01244035|530677450|FG000|Part 1: Period 1|Withdrawal by Subject|0|||
147139350|NCT01244035|530677451|FG001|Part 1: Period 1|Withdrawal by Subject|2|||
147139351|NCT01244035|530677452|FG002|Part 1: Period 1|Withdrawal by Subject|0|||
147139352|NCT01244035|530677453|FG003|Part 1: Period 1|Withdrawal by Subject|0|||
147139353|NCT01244035|530677454|FG004|Part 1: Period 1|Withdrawal by Subject|0|||
147139354|NCT01244035|530677455|FG005|Part 1: Period 1|Withdrawal by Subject|0|||
147139355|NCT01244035|530677450|FG000|Part 1: Period 1|Fulfilled Stopping Criteria|1|||
147139356|NCT01244035|530677451|FG001|Part 1: Period 1|Fulfilled Stopping Criteria|0|||
147139357|NCT01244035|530677452|FG002|Part 1: Period 1|Fulfilled Stopping Criteria|2|||
147139358|NCT01244035|530677453|FG003|Part 1: Period 1|Fulfilled Stopping Criteria|0|||
147139359|NCT01244035|530677454|FG004|Part 1: Period 1|Fulfilled Stopping Criteria|1|||
147139360|NCT01244035|530677455|FG005|Part 1: Period 1|Fulfilled Stopping Criteria|1|||
147139361|NCT01244035|530677450|FG000|Part 1: Period 2|Fulfilled Stopping Criteria|0|||
147139362|NCT01244035|530677451|FG001|Part 1: Period 2|Fulfilled Stopping Criteria|0|||
147139363|NCT01244035|530677452|FG002|Part 1: Period 2|Fulfilled Stopping Criteria|1|||
147139364|NCT01244035|530677453|FG003|Part 1: Period 2|Fulfilled Stopping Criteria|0|||
147139365|NCT01244035|530677454|FG004|Part 1: Period 2|Fulfilled Stopping Criteria|0|||
147139366|NCT01244035|530677455|FG005|Part 1: Period 2|Fulfilled Stopping Criteria|0|||
147139367|NCT01244035|530677450|FG000|Part 1: Period 3|Adverse Event|0|||
147139368|NCT01244035|530677451|FG001|Part 1: Period 3|Adverse Event|0|||
147139369|NCT01244035|530677452|FG002|Part 1: Period 3|Adverse Event|0|||
147139370|NCT01244035|530677453|FG003|Part 1: Period 3|Adverse Event|0|||
147139371|NCT01244035|530677454|FG004|Part 1: Period 3|Adverse Event|0|||
147139372|NCT01244035|530677455|FG005|Part 1: Period 3|Adverse Event|1|||
147139373|NCT01244035|530677450|FG000|Part 1: Period 3|Withdrawal by Subject|0|||
147139374|NCT01244035|530677451|FG001|Part 1: Period 3|Withdrawal by Subject|0|||
147139375|NCT01244035|530677452|FG002|Part 1: Period 3|Withdrawal by Subject|0|||
147139376|NCT01244035|530677453|FG003|Part 1: Period 3|Withdrawal by Subject|0|||
147139377|NCT01244035|530677454|FG004|Part 1: Period 3|Withdrawal by Subject|1|||
147139378|NCT01244035|530677455|FG005|Part 1: Period 3|Withdrawal by Subject|0|||
147139379|NCT01244035|530677450|FG000|Part 1: Period 3|Protocol Deviation|0|||
147139380|NCT01244035|530677451|FG001|Part 1: Period 3|Protocol Deviation|1|||
147139381|NCT01244035|530677452|FG002|Part 1: Period 3|Protocol Deviation|0|||
147139382|NCT01244035|530677453|FG003|Part 1: Period 3|Protocol Deviation|0|||
147139383|NCT01244035|530677454|FG004|Part 1: Period 3|Protocol Deviation|0|||
147139384|NCT01244035|530677455|FG005|Part 1: Period 3|Protocol Deviation|0|||
147139385|NCT02383862|530677457|FG000|3 Month Follow up|Lost to Follow-up|23|||
147139386|NCT02383862|530677458|FG001|3 Month Follow up|Lost to Follow-up|21|||
147237744|NCT00739674|531042499|FG001|Overall Study|Reason missing|0|||
147573066|NCT01695239|532255762|FG003|Post-Treatment Follow-Up Period|Protocol Violation|0|||
147573067|NCT01695239|532255763|FG004|Post-Treatment Follow-Up Period|Protocol Violation|0|||
147573068|NCT01695239|532255764|FG005|Post-Treatment Follow-Up Period|Protocol Violation|0|||
147573069|NCT01695239|532255765|FG006|Post-Treatment Follow-Up Period|Protocol Violation|0|||
147573070|NCT01695239|532255766|FG007|Post-Treatment Follow-Up Period|Protocol Violation|0|||
147573071|NCT01695239|532255767|FG008|Post-Treatment Follow-Up Period|Protocol Violation|0|||
147139387|NCT00347932|530677459|FG000|Overall Study|Adverse Event|4|||
147237745|NCT00739674|531042498|FG000|Overall Study|Clinic closed|6|||
147237746|NCT00739674|531042499|FG001|Overall Study|Clinic closed|4|||
147237747|NCT00739674|531042498|FG000|Overall Study|Patient moved|3|||
147139388|NCT00347932|530677460|FG001|Overall Study|Adverse Event|5|||
147139389|NCT00347932|530677459|FG000|Overall Study|Lack of Efficacy|3|||
147139390|NCT00347932|530677460|FG001|Overall Study|Lack of Efficacy|14|||
147139391|NCT00347932|530677459|FG000|Overall Study|Lost to Follow-up|10|||
147573072|NCT01695239|532255768|FG009|Post-Treatment Follow-Up Period|Protocol Violation|0|||
147573073|NCT01695239|532255769|FG010|Post-Treatment Follow-Up Period|Protocol Violation|0|||
147573074|NCT01695239|532255770|FG011|Post-Treatment Follow-Up Period|Protocol Violation|0|||
147573075|NCT01695239|532255771|FG012|Post-Treatment Follow-Up Period|Protocol Violation|0|||
147573076|NCT01695239|532255772|FG013|Post-Treatment Follow-Up Period|Protocol Violation|1|||
147573077|NCT03913377|532255775|FG000|Period 1|Test Article no longer available|0|||
147573078|NCT03913377|532255776|FG001|Period 1|Test Article no longer available|1|||
147573079|NCT03913377|532255777|FG002|Period 1|Test Article no longer available|0|||
147573080|NCT03913377|532255775|FG000|Period 1|No Longer Meets Eligibility Criteria|0|||
147573081|NCT03913377|532255776|FG001|Period 1|No Longer Meets Eligibility Criteria|0|||
147573082|NCT03913377|532255777|FG002|Period 1|No Longer Meets Eligibility Criteria|1|||
147573083|NCT05239195|532255778|FG000|Overall Study|After enrollment, discovered to be a person experiencing incarceration.|2|||
147573084|NCT05239195|532255779|FG001|Overall Study|After enrollment, discovered to be a person experiencing incarceration.|1|||
147573085|NCT03552484|532255782|FG000|Overall Study|Death|6|||
147573086|NCT03552484|532255783|FG001|Overall Study|Death|4|||
147573087|NCT03552484|532255782|FG000|Overall Study|Lost to Follow-up|0|||
147573088|NCT03552484|532255783|FG001|Overall Study|Lost to Follow-up|16|||
147573089|NCT03499353|532255784|FG000|Treatment|Adverse Event|3|||
147573090|NCT03499353|532255784|FG000|Treatment|Progressive Disease|10|||
147573091|NCT03499353|532255784|FG000|Treatment|Other|1|||
147573092|NCT03499353|532255784|FG000|Treatment|Withdrawal by Subject|2|||
147573093|NCT03499353|532255784|FG000|Long-Term Follow-up|Death|2|||
147573094|NCT03499353|532255784|FG000|Long-Term Follow-up|Study Terminated By Sponsor|55|||
147573095|NCT03499353|532255784|FG000|Long-Term Follow-up|Withdrawal by Subject|1|||
147573096|NCT01015287|532255787|FG000|Overall Study|Death|21|||
147573097|NCT01015287|532255788|FG001|Overall Study|Death|16|||
147573098|NCT01015287|532255787|FG000|Overall Study|Adverse Event|1|||
147573099|NCT01015287|532255788|FG001|Overall Study|Adverse Event|0|||
147573100|NCT01015287|532255787|FG000|Overall Study|Sponsor Decision|3|||
147573101|NCT01015287|532255788|FG001|Overall Study|Sponsor Decision|7|||
147573102|NCT01015287|532255787|FG000|Overall Study|Physician Decision|19|||
147573103|NCT01015287|532255788|FG001|Overall Study|Physician Decision|21|||
147573104|NCT01015287|532255787|FG000|Overall Study|Withdrawal by Subject|14|||
147573105|NCT01015287|532255788|FG001|Overall Study|Withdrawal by Subject|19|||
147573106|NCT01015287|532255787|FG000|Overall Study|Entry Criteria not Met|11|||
147139392|NCT00347932|530677460|FG001|Overall Study|Lost to Follow-up|9|||
147139393|NCT00347932|530677459|FG000|Overall Study|Withdrawal by Subject|10|||
147139394|NCT00347932|530677460|FG001|Overall Study|Withdrawal by Subject|16|||
147139395|NCT00347932|530677459|FG000|Overall Study|Did not meet inclusion criteria|4|||
147139396|NCT00347932|530677460|FG001|Overall Study|Did not meet inclusion criteria|8|||
147139397|NCT00400517|530677461|FG000|Overall Study|Withdrawal by Subject|1|||
147139398|NCT00400517|530677461|FG000|Overall Study|Physician Decision|1|||
147139399|NCT01023217|530677462|FG000|Overall Study|Withdrawal by Subject|1|||
147139400|NCT01023217|530677463|FG001|Overall Study|Withdrawal by Subject|0|||
147139401|NCT01106157|530677464|FG000|Overall Study|Withdrawal by Subject|1|||
147139402|NCT01106157|530677465|FG001|Overall Study|Withdrawal by Subject|0|||
147139403|NCT02298868|530677469|FG000|Overall Study|Adverse Event|1|||
147139404|NCT02298868|530677469|FG000|Overall Study|Death|1|||
147139405|NCT02298868|530677469|FG000|Overall Study|Patient underwent transplant|1|||
147139406|NCT02141672|530677470|FG000|Overall Study|Adverse Event|0|||
147139407|NCT02141672|530677471|FG001|Overall Study|Adverse Event|1|||
147139408|NCT02141672|530677472|FG002|Overall Study|Adverse Event|0|||
147139409|NCT02141672|530677470|FG000|Overall Study|Death|10|||
147139410|NCT02141672|530677471|FG001|Overall Study|Death|2|||
147139411|NCT02141672|530677472|FG002|Overall Study|Death|1|||
147139412|NCT02141672|530677470|FG000|Overall Study|Lack of Efficacy|0|||
147139413|NCT02141672|530677471|FG001|Overall Study|Lack of Efficacy|0|||
147139414|NCT02141672|530677472|FG002|Overall Study|Lack of Efficacy|2|||
147139415|NCT02141672|530677470|FG000|Overall Study|Lost to Follow-up|1|||
147139416|NCT02141672|530677471|FG001|Overall Study|Lost to Follow-up|1|||
147139417|NCT02141672|530677472|FG002|Overall Study|Lost to Follow-up|3|||
147139418|NCT02141672|530677470|FG000|Overall Study|Physician Decision|1|||
147139419|NCT02141672|530677471|FG001|Overall Study|Physician Decision|2|||
147139420|NCT02141672|530677472|FG002|Overall Study|Physician Decision|5|||
147139421|NCT02141672|530677470|FG000|Overall Study|Protocol Violation|0|||
147318589|NCT00519636|531331776|FG002|Washout Period|Lost to Follow-up|0|||
147318590|NCT00519636|531331777|FG003|Washout Period|Lost to Follow-up|0|||
147318591|NCT00519636|531331774|FG000|Washout Period|Protocol Violation|0|||
147573107|NCT01015287|532255788|FG001|Overall Study|Entry Criteria not Met|14|||
147139422|NCT02141672|530677471|FG001|Overall Study|Protocol Violation|0|||
147139423|NCT02141672|530677472|FG002|Overall Study|Protocol Violation|1|||
147139424|NCT02141672|530677470|FG000|Overall Study|Withdrawal by Subject|3|||
147139425|NCT02141672|530677471|FG001|Overall Study|Withdrawal by Subject|2|||
147139426|NCT02141672|530677472|FG002|Overall Study|Withdrawal by Subject|5|||
147318592|NCT00519636|531331775|FG001|Washout Period|Protocol Violation|0|||
147573108|NCT01015287|532255787|FG000|Overall Study|Lost to Follow-up|2|||
147573109|NCT01015287|532255788|FG001|Overall Study|Lost to Follow-up|1|||
147139427|NCT02141672|530677470|FG000|Overall Study|refused to follow-up|1|||
147139428|NCT02141672|530677471|FG001|Overall Study|refused to follow-up|0|||
147139429|NCT02141672|530677472|FG002|Overall Study|refused to follow-up|1|||
147139430|NCT01194245|530677473|FG000|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|5|||
147139431|NCT01194245|530677474|FG001|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0|||
147139432|NCT01194245|530677475|FG002|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0|||
147139433|NCT01194245|530677476|FG003|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0|||
147139434|NCT01194245|530677477|FG004|Titration Period (4 to 6 Weeks)|Withdrawal by Subject|0|||
147139435|NCT01194245|530677473|FG000|Titration Period (4 to 6 Weeks)|Physician Decision|3|||
147139436|NCT01194245|530677474|FG001|Titration Period (4 to 6 Weeks)|Physician Decision|0|||
147139437|NCT01194245|530677475|FG002|Titration Period (4 to 6 Weeks)|Physician Decision|0|||
147139438|NCT01194245|530677476|FG003|Titration Period (4 to 6 Weeks)|Physician Decision|0|||
147139439|NCT01194245|530677477|FG004|Titration Period (4 to 6 Weeks)|Physician Decision|0|||
147139440|NCT01194245|530677473|FG000|Titration Period (4 to 6 Weeks)|Titration Failure|3|||
147139441|NCT01194245|530677474|FG001|Titration Period (4 to 6 Weeks)|Titration Failure|0|||
147139442|NCT01194245|530677475|FG002|Titration Period (4 to 6 Weeks)|Titration Failure|0|||
147139443|NCT01194245|530677476|FG003|Titration Period (4 to 6 Weeks)|Titration Failure|0|||
147139444|NCT01194245|530677477|FG004|Titration Period (4 to 6 Weeks)|Titration Failure|0|||
147139445|NCT01194245|530677473|FG000|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|7|||
147139446|NCT01194245|530677474|FG001|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0|||
147139447|NCT01194245|530677475|FG002|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0|||
147139448|NCT01194245|530677476|FG003|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0|||
147139449|NCT01194245|530677477|FG004|Titration Period (4 to 6 Weeks)|Did Not Meet Randomization Criteria|0|||
147139450|NCT01194245|530677473|FG000|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
147139451|NCT01194245|530677474|FG001|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
147139452|NCT01194245|530677475|FG002|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
147139453|NCT01194245|530677476|FG003|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
147139454|NCT01194245|530677477|FG004|Treatment Period 1 (Weeks 0 to 12)|Lost to Follow-up|1|||
147139455|NCT01194245|530677473|FG000|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
147139456|NCT01194245|530677474|FG001|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
147139457|NCT01194245|530677475|FG002|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|1|||
147139458|NCT01194245|530677476|FG003|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|1|||
147139459|NCT01194245|530677477|FG004|Treatment Period 1 (Weeks 0 to 12)|Withdrawal by Subject|1|||
147139460|NCT01118780|530677478|FG000|Overall Study|Adverse Event|15|||
147139461|NCT01118780|530677479|FG001|Overall Study|Adverse Event|15|||
147139462|NCT01118780|530677478|FG000|Overall Study|Death|1|||
147139463|NCT01118780|530677479|FG001|Overall Study|Death|0|||
147139464|NCT01118780|530677478|FG000|Overall Study|Lack of Efficacy|2|||
147139465|NCT01118780|530677479|FG001|Overall Study|Lack of Efficacy|6|||
147139466|NCT01118780|530677478|FG000|Overall Study|Physician Decision|2|||
147139467|NCT01118780|530677479|FG001|Overall Study|Physician Decision|0|||
147139468|NCT01118780|530677478|FG000|Overall Study|Protocol Violation|3|||
147139469|NCT01118780|530677479|FG001|Overall Study|Protocol Violation|6|||
147139470|NCT01118780|530677478|FG000|Overall Study|Withdrawal by Subject|13|||
147139471|NCT01118780|530677479|FG001|Overall Study|Withdrawal by Subject|8|||
147139472|NCT03962855|530677480|FG000|Overall Study|Death|0|||
147139473|NCT03962855|530677481|FG001|Overall Study|Death|1|||
147139474|NCT03962855|530677480|FG000|Overall Study|Lost to Follow-up|0|||
147139475|NCT03962855|530677481|FG001|Overall Study|Lost to Follow-up|1|||
147139476|NCT03962855|530677480|FG000|Overall Study|Adverse Event|0|||
147139477|NCT03962855|530677481|FG001|Overall Study|Adverse Event|1|||
147237748|NCT00739674|531042499|FG001|Overall Study|Patient moved|2|||
147237749|NCT00739674|531042498|FG000|Overall Study|Non compliant|4|||
147237750|NCT00739674|531042499|FG001|Overall Study|Non compliant|0|||
147237751|NCT00739674|531042498|FG000|Overall Study|Unable to attend visit|3|||
147237752|NCT00739674|531042499|FG001|Overall Study|Unable to attend visit|1|||
147237753|NCT00739674|531042498|FG000|Overall Study|Home monitoring off meds|1|||
147237754|NCT00739674|531042499|FG001|Overall Study|Home monitoring off meds|0|||
147237755|NCT00739674|531042498|FG000|Overall Study|Erectile dysfunction|0|||
147237756|NCT00739674|531042499|FG001|Overall Study|Erectile dysfunction|1|||
147237757|NCT04805541|531042501|FG000|Overall Study|Unable to be retinally photographed with good quality.|35|||
147237758|NCT00283400|531042504|FG000|Overall Study|Withdrawal by Subject|1|||
147237759|NCT00283400|531042505|FG001|Overall Study|Withdrawal by Subject|1|||
147237760|NCT00283400|531042506|FG002|Overall Study|Withdrawal by Subject|0|||
147237761|NCT00283400|531042507|FG003|Overall Study|Withdrawal by Subject|0|||
147139478|NCT03962855|530677480|FG000|Overall Study|Physician Decision|0|||
147237762|NCT00283400|531042504|FG000|Overall Study|Death|1|||
147237763|NCT00283400|531042505|FG001|Overall Study|Death|0|||
147237764|NCT00283400|531042506|FG002|Overall Study|Death|1|||
147237765|NCT00283400|531042507|FG003|Overall Study|Death|0|||
147139479|NCT03962855|530677481|FG001|Overall Study|Physician Decision|2|||
147139480|NCT02457247|530677482|FG000|Period 1|Pretreatment Event/Adverse Event|0|||
147237766|NCT02195583|531042512|FG000|Overall Study|Lost to Follow-up|1|||
147139481|NCT02457247|530677483|FG001|Period 1|Pretreatment Event/Adverse Event|1|||
147139482|NCT02457247|530677484|FG002|Period 1|Pretreatment Event/Adverse Event|0|||
147139483|NCT02457247|530677485|FG003|Period 1|Pretreatment Event/Adverse Event|0|||
147139484|NCT02457247|530677482|FG000|Period 1|Significant Protocol Deviation|1|||
147139485|NCT02457247|530677483|FG001|Period 1|Significant Protocol Deviation|1|||
147139486|NCT02457247|530677484|FG002|Period 1|Significant Protocol Deviation|0|||
147139487|NCT02457247|530677485|FG003|Period 1|Significant Protocol Deviation|0|||
147139488|NCT02457247|530677482|FG000|Period 1|Voluntary Withdrawal|1|||
147139489|NCT02457247|530677483|FG001|Period 1|Voluntary Withdrawal|0|||
147139490|NCT02457247|530677484|FG002|Period 1|Voluntary Withdrawal|0|||
147139491|NCT02457247|530677485|FG003|Period 1|Voluntary Withdrawal|0|||
147139492|NCT02457247|530677482|FG000|Period 2|Pretreatment Event/Adverse Event|0|||
147139493|NCT02457247|530677483|FG001|Period 2|Pretreatment Event/Adverse Event|1|||
147139494|NCT02457247|530677484|FG002|Period 2|Pretreatment Event/Adverse Event|0|||
147139495|NCT02457247|530677485|FG003|Period 2|Pretreatment Event/Adverse Event|0|||
147139496|NCT02457247|530677482|FG000|Period 2|Significant Protocol Deviation|1|||
147139497|NCT02457247|530677483|FG001|Period 2|Significant Protocol Deviation|0|||
147139498|NCT02457247|530677484|FG002|Period 2|Significant Protocol Deviation|0|||
147237767|NCT02195583|531042512|FG000|Overall Study|Withdrawal by Subject|4|||
147318593|NCT00519636|531331776|FG002|Washout Period|Protocol Violation|1|||
147318594|NCT00519636|531331777|FG003|Washout Period|Protocol Violation|2|||
147318595|NCT00519636|531331774|FG000|Washout Period|Withdrawal by Subject|1|||
147318596|NCT00519636|531331775|FG001|Washout Period|Withdrawal by Subject|0|||
147318597|NCT00519636|531331776|FG002|Washout Period|Withdrawal by Subject|1|||
147318598|NCT00519636|531331777|FG003|Washout Period|Withdrawal by Subject|0|||
147318599|NCT00519636|531331774|FG000|Washout Period|Failed to meet continuation criteria|14|||
147318600|NCT00519636|531331775|FG001|Washout Period|Failed to meet continuation criteria|11|||
147318601|NCT00519636|531331776|FG002|Washout Period|Failed to meet continuation criteria|9|||
147318602|NCT00519636|531331777|FG003|Washout Period|Failed to meet continuation criteria|3|||
147318603|NCT00519636|531331774|FG000|Washout Period|Out of pollen area > 48 hours|1|||
147318604|NCT00519636|531331775|FG001|Washout Period|Out of pollen area > 48 hours|0|||
147318605|NCT00519636|531331776|FG002|Washout Period|Out of pollen area > 48 hours|0|||
147318606|NCT00519636|531331777|FG003|Washout Period|Out of pollen area > 48 hours|0|||
147318607|NCT00519636|531331774|FG000|Washout Period|Participating in study at another site|1|||
147318608|NCT00519636|531331775|FG001|Washout Period|Participating in study at another site|0|||
147318609|NCT00519636|531331776|FG002|Washout Period|Participating in study at another site|0|||
147318610|NCT00519636|531331777|FG003|Washout Period|Participating in study at another site|0|||
147318611|NCT00519636|531331774|FG000|Washout Period|Non-compliant|0|||
147445696|NCT00264875|531797429|FG000|Overall Study|Lost to Follow-up|6|||
147445697|NCT00264875|531797429|FG000|Overall Study|Protocol Violation|11|||
147573110|NCT01015287|532255787|FG000|Overall Study|Protocol Violation|1|||
147573111|NCT01015287|532255788|FG001|Overall Study|Protocol Violation|1|||
147139499|NCT02457247|530677485|FG003|Period 2|Significant Protocol Deviation|0|||
147139500|NCT02457247|530677482|FG000|Period 2|Lost to Follow-up|0|||
147139501|NCT02457247|530677483|FG001|Period 2|Lost to Follow-up|1|||
147139502|NCT02457247|530677484|FG002|Period 2|Lost to Follow-up|0|||
147237768|NCT02195583|531042512|FG000|Overall Study|Adverse Event|2|||
147237769|NCT02195583|531042512|FG000|Overall Study|Other Reason|2|||
147237770|NCT01560403|531042513|FG000|Overall Study|Lost to Follow-up|0|||
147237771|NCT01560403|531042514|FG001|Overall Study|Lost to Follow-up|1|||
147237772|NCT00354744|531042515|FG000|Overall Study|Adverse Event|2|||
147237773|NCT00354744|531042515|FG000|Overall Study|Death|2|||
147237774|NCT00354744|531042515|FG000|Overall Study|Lack of Efficacy|11|||
147237775|NCT00354744|531042515|FG000|Overall Study|Lost to Follow-up|2|||
147237776|NCT00354744|531042515|FG000|Overall Study|Physician Decision|11|||
147237777|NCT00354744|531042515|FG000|Overall Study|Withdrawal by Subject|14|||
147237778|NCT00983437|531042516|FG000|Overall Study|Adverse Event|9|||
147237779|NCT00983437|531042516|FG000|Overall Study|Lack of Efficacy|1|||
147237780|NCT00983437|531042516|FG000|Overall Study|Withdrawal by Subject|8|||
147237781|NCT00983437|531042516|FG000|Overall Study|Noncompliance to Study Procedures|1|||
147237782|NCT00983437|531042516|FG000|Overall Study|Lost to Follow-up|2|||
147237783|NCT00983437|531042516|FG000|Overall Study|Other Reason|26|||
147237784|NCT01020981|531042517|FG000|Overall Study|Did not return mailed survey|74|||
147237785|NCT01020981|531042518|FG001|Overall Study|Did not return mailed survey|58|||
147237786|NCT01020981|531042517|FG000|Overall Study|Survey returned undeliverable|8|||
147237787|NCT01020981|531042518|FG001|Overall Study|Survey returned undeliverable|32|||
147237788|NCT01020981|531042517|FG000|Overall Study|Participant declined to complete survey|2|||
147237789|NCT01020981|531042518|FG001|Overall Study|Participant declined to complete survey|0|||
147237790|NCT03372096|531042524|FG000|Overall Study|Study Closed|8|||
147237791|NCT00040365|531042525|FG000|Overall Study|Death|1|||
147237792|NCT00040365|531042525|FG000|Overall Study|Progressive disease|7|||
147139503|NCT02457247|530677485|FG003|Period 2|Lost to Follow-up|0|||
147318612|NCT00519636|531331775|FG001|Washout Period|Non-compliant|1|||
147318613|NCT00519636|531331776|FG002|Washout Period|Non-compliant|0|||
147573112|NCT01592240|532255789|FG000|Overall Study|Adverse Event|1|||
147573113|NCT01592240|532255790|FG001|Overall Study|Adverse Event|0|||
147139504|NCT02457247|530677482|FG000|Period 2|Voluntary Withdrawal|1|||
147139505|NCT02457247|530677483|FG001|Period 2|Voluntary Withdrawal|1|||
147139506|NCT02457247|530677484|FG002|Period 2|Voluntary Withdrawal|0|||
147139507|NCT02457247|530677485|FG003|Period 2|Voluntary Withdrawal|0|||
147139508|NCT02954887|530677486|FG000|Overall Study|Withdrawal by Subject|3|||
147139509|NCT02954887|530677486|FG000|Overall Study|Lack of Efficacy|3|||
147139510|NCT02954887|530677486|FG000|Overall Study|Other|1|||
147139511|NCT02803203|530677487|FG000|Overall Study|Adverse Event|4|||
147139512|NCT02803203|530677487|FG000|Overall Study|Death|4|||
147139513|NCT02803203|530677487|FG000|Overall Study|Progressive disease|29|||
147139514|NCT02803203|530677487|FG000|Overall Study|Withdrawal by Subject|8|||
147139515|NCT02803203|530677487|FG000|Overall Study|Complete resection of target disease|2|||
147139516|NCT02803203|530677487|FG000|Overall Study|Switched to commercial Osi|1|||
147573114|NCT01592240|532255791|FG002|Overall Study|Adverse Event|0|||
147573115|NCT01592240|532255792|FG003|Overall Study|Adverse Event|1|||
147573116|NCT01592240|532255793|FG004|Overall Study|Adverse Event|1|||
147573117|NCT01592240|532255794|FG005|Overall Study|Adverse Event|0|||
147139517|NCT02803203|530677487|FG000|Overall Study|Participant moved away|1|||
147139518|NCT00600067|530677491|FG000|Overall Study|Adverse Event|0|||
147139519|NCT00600067|530677492|FG001|Overall Study|Adverse Event|1|||
147139520|NCT00600067|530677491|FG000|Overall Study|Lost to Follow-up|2|||
147139521|NCT00600067|530677492|FG001|Overall Study|Lost to Follow-up|3|||
147139522|NCT00600067|530677491|FG000|Overall Study|protocol non-compliance|0|||
147139523|NCT00600067|530677492|FG001|Overall Study|protocol non-compliance|3|||
147139524|NCT00600067|530677491|FG000|Overall Study|Lack of Efficacy|1|||
147139525|NCT00600067|530677492|FG001|Overall Study|Lack of Efficacy|0|||
147139526|NCT01220401|530677495|FG000|Overall Study|Withdrawal by Subject|2|||
147573118|NCT01592240|532255795|FG006|Overall Study|Adverse Event|0|||
147573119|NCT01592240|532255789|FG000|Overall Study|Death|0|||
147573120|NCT01592240|532255790|FG001|Overall Study|Death|1|||
147573121|NCT01592240|532255791|FG002|Overall Study|Death|0|||
147573122|NCT01592240|532255792|FG003|Overall Study|Death|0|||
147573123|NCT01592240|532255793|FG004|Overall Study|Death|0|||
147139527|NCT01220401|530677495|FG000|Overall Study|Protocol Violation|1|||
147139528|NCT00833027|530677497|FG000|Overall Study|Adverse Event|33|||
147573124|NCT01592240|532255794|FG005|Overall Study|Death|0|||
147573125|NCT01592240|532255795|FG006|Overall Study|Death|0|||
147573126|NCT01592240|532255789|FG000|Overall Study|Lost to Follow-up|1|||
147573127|NCT01592240|532255790|FG001|Overall Study|Lost to Follow-up|3|||
147573128|NCT01592240|532255791|FG002|Overall Study|Lost to Follow-up|1|||
147573129|NCT01592240|532255792|FG003|Overall Study|Lost to Follow-up|0|||
147573130|NCT01592240|532255793|FG004|Overall Study|Lost to Follow-up|3|||
147573131|NCT01592240|532255794|FG005|Overall Study|Lost to Follow-up|2|||
147573132|NCT01592240|532255795|FG006|Overall Study|Lost to Follow-up|0|||
147573133|NCT01592240|532255789|FG000|Overall Study|Protocol Violation|0|||
147573134|NCT01592240|532255790|FG001|Overall Study|Protocol Violation|0|||
147573135|NCT01592240|532255791|FG002|Overall Study|Protocol Violation|0|||
147573136|NCT01592240|532255792|FG003|Overall Study|Protocol Violation|0|||
147573137|NCT01592240|532255793|FG004|Overall Study|Protocol Violation|0|||
147573138|NCT01592240|532255794|FG005|Overall Study|Protocol Violation|1|||
147573139|NCT01592240|532255795|FG006|Overall Study|Protocol Violation|0|||
147573140|NCT01592240|532255789|FG000|Overall Study|Withdrawal by Subject|0|||
147573141|NCT01592240|532255790|FG001|Overall Study|Withdrawal by Subject|4|||
147573142|NCT01592240|532255791|FG002|Overall Study|Withdrawal by Subject|4|||
147573143|NCT01592240|532255792|FG003|Overall Study|Withdrawal by Subject|1|||
147573144|NCT01592240|532255793|FG004|Overall Study|Withdrawal by Subject|3|||
147139529|NCT00833027|530677497|FG000|Overall Study|Death|1|||
147139530|NCT00833027|530677497|FG000|Overall Study|Lack of Efficacy|12|||
147139531|NCT00833027|530677497|FG000|Overall Study|Lost to Follow-up|24|||
147139532|NCT00833027|530677497|FG000|Overall Study|Protocol Violation|115|||
147139533|NCT00833027|530677497|FG000|Overall Study|Withdrawal by Subject|16|||
147139534|NCT00833027|530677497|FG000|Overall Study|Missing|10|||
147318614|NCT00519636|531331777|FG003|Washout Period|Non-compliant|0|||
147139535|NCT03069716|530677498|FG000|Run-in Period (2 Weeks)|Adverse Event|1|||
147139536|NCT03069716|530677499|FG001|Run-in Period (2 Weeks)|Adverse Event|0|||
147139537|NCT03069716|530677500|FG002|Run-in Period (2 Weeks)|Adverse Event|0|||
147139538|NCT03069716|530677498|FG000|Run-in Period (2 Weeks)|Protocol Violation|1|||
147139539|NCT03069716|530677499|FG001|Run-in Period (2 Weeks)|Protocol Violation|0|||
147139540|NCT03069716|530677500|FG002|Run-in Period (2 Weeks)|Protocol Violation|0|||
147139541|NCT03069716|530677498|FG000|Run-in Period (2 Weeks)|Withdrawal by Subject|5|||
147573145|NCT01592240|532255794|FG005|Overall Study|Withdrawal by Subject|0|||
147573146|NCT01592240|532255795|FG006|Overall Study|Withdrawal by Subject|2|||
147573147|NCT01592240|532255789|FG000|Overall Study|Other|0|||
147573148|NCT01592240|532255790|FG001|Overall Study|Other|3|||
147573149|NCT01592240|532255791|FG002|Overall Study|Other|1|||
147573150|NCT01592240|532255792|FG003|Overall Study|Other|1|||
147573151|NCT01592240|532255793|FG004|Overall Study|Other|0|||
147573152|NCT01592240|532255794|FG005|Overall Study|Other|0|||
147573153|NCT01592240|532255795|FG006|Overall Study|Other|1|||
147573154|NCT01592240|532255789|FG000|Overall Study|Did Not Meet Entrance Criteria|1|||
147139542|NCT03069716|530677499|FG001|Run-in Period (2 Weeks)|Withdrawal by Subject|0|||
147139543|NCT03069716|530677500|FG002|Run-in Period (2 Weeks)|Withdrawal by Subject|0|||
147139544|NCT03069716|530677498|FG000|Randomized Treatment|Withdrawal by Subject|0|||
147139545|NCT03069716|530677499|FG001|Randomized Treatment|Withdrawal by Subject|2|||
147139546|NCT03069716|530677500|FG002|Randomized Treatment|Withdrawal by Subject|0|||
147139547|NCT01985022|530677503|FG000|Overall Study|Lost to Follow-up|0|||
147139548|NCT01985022|530677504|FG001|Overall Study|Lost to Follow-up|1|||
147139549|NCT01985022|530677503|FG000|Overall Study|Protocol Violation|0|||
147139550|NCT01985022|530677504|FG001|Overall Study|Protocol Violation|1|||
147139551|NCT01985022|530677503|FG000|Overall Study|Withdrawal by Subject|4|||
147139552|NCT01985022|530677504|FG001|Overall Study|Withdrawal by Subject|1|||
147139553|NCT02573948|530677507|FG000|Longitudinal Cohort|Death|9|||
147139554|NCT02573948|530677507|FG000|Longitudinal Cohort|Lost to Follow-up|22|||
147139555|NCT02573948|530677507|FG000|Longitudinal Cohort|Incarcerated|25|||
147139556|NCT01673126|530677508|FG000|Overall Study|change of diagnosis|4|||
147139557|NCT01673126|530677509|FG001|Overall Study|change of diagnosis|3|||
147139558|NCT01913327|530677520|FG000|Overall Study|Withdrawal by Subject|0|||
147139559|NCT01913327|530677521|FG001|Overall Study|Withdrawal by Subject|1|||
147139560|NCT01333722|530679143|FG000|Overall Study|Lack of Efficacy|0|||
147139561|NCT01333722|530679144|FG001|Overall Study|Lack of Efficacy|2|||
147139562|NCT01333722|530679143|FG000|Overall Study|Withdrawal by Subject|0|||
147139563|NCT01333722|530679144|FG001|Overall Study|Withdrawal by Subject|1|||
147139564|NCT00784368|530679147|FG000|Overall Study|Physician Decision|0|||
147139565|NCT00784368|530679148|FG001|Overall Study|Physician Decision|0|||
147139566|NCT00784368|530679149|FG002|Overall Study|Physician Decision|6|||
147139567|NCT00784368|530679147|FG000|Overall Study|Lack of Efficacy|2|||
147139568|NCT00784368|530679148|FG001|Overall Study|Lack of Efficacy|0|||
147139569|NCT00784368|530679149|FG002|Overall Study|Lack of Efficacy|1|||
147139570|NCT00784368|530679147|FG000|Overall Study|Adverse Event|6|||
147139571|NCT00784368|530679148|FG001|Overall Study|Adverse Event|9|||
147139572|NCT00784368|530679149|FG002|Overall Study|Adverse Event|2|||
147139573|NCT00784368|530679147|FG000|Overall Study|Diagnosis of fever|0|||
147139574|NCT00784368|530679148|FG001|Overall Study|Diagnosis of fever|0|||
147139575|NCT00784368|530679149|FG002|Overall Study|Diagnosis of fever|1|||
147139576|NCT00784368|530679147|FG000|Overall Study|Worsening of complications|0|||
147139577|NCT00784368|530679148|FG001|Overall Study|Worsening of complications|0|||
147139578|NCT00784368|530679149|FG002|Overall Study|Worsening of complications|1|||
147139579|NCT00784368|530679147|FG000|Overall Study|Worsening of symptoms|0|||
147139580|NCT00784368|530679148|FG001|Overall Study|Worsening of symptoms|1|||
147139581|NCT00784368|530679149|FG002|Overall Study|Worsening of symptoms|0|||
147139582|NCT00784368|530679147|FG000|Overall Study|Withdrawal of informed consent|0|||
147139583|NCT00784368|530679148|FG001|Overall Study|Withdrawal of informed consent|1|||
147139584|NCT00784368|530679149|FG002|Overall Study|Withdrawal of informed consent|0|||
147139585|NCT00628446|530679152|FG000|Overall Study|Lost to Follow-up|3|||
147139586|NCT00628446|530679152|FG000|Overall Study|Withdrawal by Subject|1|||
147139587|NCT00628446|530679152|FG000|Overall Study|Protocol Violation|3|||
147139588|NCT00756275|530679153|FG000|Overall Study|Lost to Follow-up|25|||
147139589|NCT00756275|530679154|FG001|Overall Study|Lost to Follow-up|21|||
147139590|NCT00756275|530679153|FG000|Overall Study|Withdrawal by Subject|4|||
147139591|NCT00756275|530679154|FG001|Overall Study|Withdrawal by Subject|7|||
147139592|NCT00682929|530679157|FG000|Overall Study|Adverse Event|4|||
147139593|NCT00682929|530679158|FG001|Overall Study|Adverse Event|1|||
147139594|NCT00682929|530679159|FG002|Overall Study|Adverse Event|1|||
147139595|NCT00682929|530679157|FG000|Overall Study|Withdrawal by Subject|1|||
147139596|NCT00682929|530679158|FG001|Overall Study|Withdrawal by Subject|2|||
147139597|NCT00682929|530679159|FG002|Overall Study|Withdrawal by Subject|1|||
147139598|NCT00682929|530679157|FG000|Overall Study|dosing compliance < 80%|0|||
147139599|NCT00682929|530679158|FG001|Overall Study|dosing compliance < 80%|2|||
147139600|NCT00682929|530679159|FG002|Overall Study|dosing compliance < 80%|0|||
147139601|NCT00682929|530679157|FG000|Overall Study|lag in DEA renewal|1|||
147139602|NCT00682929|530679158|FG001|Overall Study|lag in DEA renewal|0|||
147139603|NCT00682929|530679159|FG002|Overall Study|lag in DEA renewal|0|||
147139604|NCT00592631|530679166|FG000|Overall Study|Lost to Follow-up|0|||
147139605|NCT00592631|530679167|FG001|Overall Study|Lost to Follow-up|2|||
147139606|NCT03389308|530679168|FG000|Overall Study|Withdrawal by Subject|5|||
147139607|NCT03389308|530679168|FG000|Overall Study|Lost to Follow-up|3|||
147139608|NCT03389308|530679168|FG000|Overall Study|Adverse Event|2|||
147139609|NCT03389308|530679168|FG000|Overall Study|Sponsor Request|2|||
147139610|NCT03198767|530679170|FG000|Overall Study|Protocol Violation|0|||
147139611|NCT03198767|530679171|FG001|Overall Study|Protocol Violation|0|||
147139612|NCT03198767|530679172|FG002|Overall Study|Protocol Violation|0|||
147139613|NCT03198767|530679173|FG003|Overall Study|Protocol Violation|6|||
147139614|NCT03198767|530679174|FG004|Overall Study|Protocol Violation|0|||
147139615|NCT03198767|530679175|FG005|Overall Study|Protocol Violation|0|||
147139616|NCT03198767|530679176|FG006|Overall Study|Protocol Violation|0|||
147139617|NCT02651116|530679179|FG000|Overall Study|Adverse Event|0|||
147139618|NCT02651116|530679180|FG001|Overall Study|Adverse Event|1|||
147139619|NCT02651116|530679179|FG000|Overall Study|No Longer Willing To Participate In Study|1|||
147139620|NCT02651116|530679180|FG001|Overall Study|No Longer Willing To Participate In Study|0|||
147139621|NCT00041470|530679188|FG000|Overall Study|Loss of Funding|38|||
147139622|NCT00739310|530679189|FG000|Overall Study|Poor adherance to prescribed therapy|4|||
147139623|NCT00739310|530679189|FG000|Overall Study|Withdrawal by Subject|1|||
147139624|NCT00739310|530679189|FG000|Overall Study|Lost to Follow-up|2|||
147139625|NCT01061385|530679190|FG000|Overall Study|Lost to Follow-up|1|||
147139626|NCT01061385|530679191|FG001|Overall Study|Lost to Follow-up|0|||
147139627|NCT01061385|530679190|FG000|Overall Study|subject decision not related to AE|0|||
147139628|NCT01061385|530679191|FG001|Overall Study|subject decision not related to AE|1|||
147139629|NCT02948582|530679200|FG000|Washout Period 1|Adverse Event|0|||
147139630|NCT02948582|530679201|FG001|Washout Period 1|Adverse Event|2|||
147139631|NCT02948582|530679202|FG002|Washout Period 1|Adverse Event|0|||
147139632|NCT02948582|530679203|FG003|Washout Period 1|Adverse Event|0|||
147139633|NCT02948582|530679204|FG004|Washout Period 1|Adverse Event|0|||
147139634|NCT02948582|530679205|FG005|Washout Period 1|Adverse Event|0|||
147139635|NCT02948582|530679200|FG000|Washout Period 1|Protocol Violation|0|||
147139636|NCT02948582|530679201|FG001|Washout Period 1|Protocol Violation|0|||
147139637|NCT02948582|530679202|FG002|Washout Period 1|Protocol Violation|0|||
147139638|NCT02948582|530679203|FG003|Washout Period 1|Protocol Violation|0|||
147139639|NCT02948582|530679204|FG004|Washout Period 1|Protocol Violation|0|||
147139640|NCT02948582|530679205|FG005|Washout Period 1|Protocol Violation|1|||
147139641|NCT02948582|530679200|FG000|Washout Period 2|Adverse Event|0|||
147139642|NCT02948582|530679201|FG001|Washout Period 2|Adverse Event|1|||
147139643|NCT02948582|530679202|FG002|Washout Period 2|Adverse Event|0|||
147139644|NCT02948582|530679203|FG003|Washout Period 2|Adverse Event|0|||
147139645|NCT02948582|530679204|FG004|Washout Period 2|Adverse Event|0|||
147139646|NCT02948582|530679205|FG005|Washout Period 2|Adverse Event|0|||
147139647|NCT02948582|530679200|FG000|Washout Period 2|personal reasons|0|||
147139648|NCT02948582|530679201|FG001|Washout Period 2|personal reasons|0|||
147139649|NCT02948582|530679202|FG002|Washout Period 2|personal reasons|0|||
147139650|NCT02948582|530679203|FG003|Washout Period 2|personal reasons|1|||
147139651|NCT02948582|530679204|FG004|Washout Period 2|personal reasons|0|||
147139652|NCT02948582|530679205|FG005|Washout Period 2|personal reasons|0|||
147139653|NCT02948582|530679200|FG000|Washout Period 4|Adverse Event|1|||
147139654|NCT02948582|530679201|FG001|Washout Period 4|Adverse Event|0|||
147139655|NCT02948582|530679202|FG002|Washout Period 4|Adverse Event|1|||
147139656|NCT02948582|530679203|FG003|Washout Period 4|Adverse Event|0|||
147139657|NCT02948582|530679204|FG004|Washout Period 4|Adverse Event|0|||
147139658|NCT02948582|530679205|FG005|Washout Period 4|Adverse Event|0|||
147139659|NCT04419467|530679206|FG000|Overall Study|Not treated with IP|0|||
147139660|NCT04419467|530679207|FG001|Overall Study|Not treated with IP|0|||
147139661|NCT04419467|530679208|FG002|Overall Study|Not treated with IP|2|||
147139662|NCT04419467|530679206|FG000|Overall Study|Adverse Event|0|||
147139663|NCT04419467|530679207|FG001|Overall Study|Adverse Event|2|||
147139664|NCT04419467|530679208|FG002|Overall Study|Adverse Event|0|||
147139665|NCT04419467|530679206|FG000|Overall Study|Death|1|||
147139666|NCT04419467|530679207|FG001|Overall Study|Death|0|||
147139667|NCT04419467|530679208|FG002|Overall Study|Death|0|||
147139668|NCT04419467|530679206|FG000|Overall Study|Lost to Follow-up|0|||
147139669|NCT04419467|530679207|FG001|Overall Study|Lost to Follow-up|1|||
147139670|NCT04419467|530679208|FG002|Overall Study|Lost to Follow-up|2|||
147139671|NCT04419467|530679206|FG000|Overall Study|Withdrawal by Subject|0|||
147139672|NCT04419467|530679207|FG001|Overall Study|Withdrawal by Subject|0|||
147139673|NCT04419467|530679208|FG002|Overall Study|Withdrawal by Subject|4|||
147139674|NCT04419467|530679206|FG000|Overall Study|Pandemic related|0|||
147139675|NCT04419467|530679207|FG001|Overall Study|Pandemic related|0|||
147139676|NCT04419467|530679208|FG002|Overall Study|Pandemic related|1|||
147139677|NCT04419467|530679206|FG000|Overall Study|Reason not known|1|||
147139678|NCT04419467|530679207|FG001|Overall Study|Reason not known|0|||
147139679|NCT04419467|530679208|FG002|Overall Study|Reason not known|0|||
147139680|NCT04571060|530679230|FG000|Overall Study|Lost to Follow-up from Randomization to Treatment|17|||
147139681|NCT04571060|530679231|FG001|Overall Study|Lost to Follow-up from Randomization to Treatment|9|||
147139682|NCT04571060|530679230|FG000|Overall Study|Never treated migraine|47|||
147139683|NCT04571060|530679231|FG001|Overall Study|Never treated migraine|36|||
147139684|NCT04571060|530679230|FG000|Overall Study|Protocol Violation|4|||
147139685|NCT04571060|530679231|FG001|Overall Study|Protocol Violation|2|||
147139686|NCT04571060|530679230|FG000|Overall Study|Withdrawal by Subject|6|||
147139687|NCT04571060|530679231|FG001|Overall Study|Withdrawal by Subject|2|||
147139688|NCT04571060|530679230|FG000|Overall Study|Lost to Follow-up from Treatment to End of Study|7|||
147139689|NCT04571060|530679231|FG001|Overall Study|Lost to Follow-up from Treatment to End of Study|0|||
147139690|NCT00087698|530679238|FG000|Overall Study|Lack of Efficacy, Progressive Disease|14|||
147139691|NCT00087698|530679238|FG000|Overall Study|Death from Other Causes|3|||
147139692|NCT00087698|530679238|FG000|Overall Study|Adverse Event|4|||
147139693|NCT00087698|530679238|FG000|Overall Study|Withdrawal by Subject|4|||
147139694|NCT00087698|530679238|FG000|Overall Study|Lack of Efficacy, Physician Perception|3|||
147139695|NCT00087698|530679238|FG000|Overall Study|Protocol Entry Criteria Not Met|2|||
147139696|NCT00087698|530679238|FG000|Overall Study|Clinical Relapse|1|||
147139697|NCT00087698|530679238|FG000|Overall Study|Death from Study Disease|2|||
147139698|NCT00087698|530679238|FG000|Overall Study|Death from Study Drug Toxicity|2|||
147139699|NCT00087698|530679238|FG000|Overall Study|Protocol Violation|1|||
147139700|NCT03943290|530679242|FG000|Overall Study|Sponsor Terminated Study|6|||
147139701|NCT03943290|530679243|FG001|Overall Study|Sponsor Terminated Study|1|||
147139702|NCT03943290|530679244|FG002|Overall Study|Sponsor Terminated Study|11|||
147139703|NCT03943290|530679245|FG003|Overall Study|Sponsor Terminated Study|6|||
147139704|NCT03943290|530679246|FG004|Overall Study|Sponsor Terminated Study|7|||
147139705|NCT03943290|530679247|FG005|Overall Study|Sponsor Terminated Study|6|||
147139706|NCT03943290|530679248|FG006|Overall Study|Sponsor Terminated Study|6|||
147139707|NCT03943290|530679249|FG007|Overall Study|Sponsor Terminated Study|7|||
147139708|NCT03943290|530679250|FG008|Overall Study|Sponsor Terminated Study|8|||
147139709|NCT03943290|530679242|FG000|Overall Study|Lost to Follow-up|1|||
147139710|NCT03943290|530679243|FG001|Overall Study|Lost to Follow-up|0|||
147139711|NCT03943290|530679244|FG002|Overall Study|Lost to Follow-up|1|||
147139712|NCT03943290|530679245|FG003|Overall Study|Lost to Follow-up|0|||
147139713|NCT03943290|530679246|FG004|Overall Study|Lost to Follow-up|0|||
147139714|NCT03943290|530679247|FG005|Overall Study|Lost to Follow-up|0|||
147139715|NCT03943290|530679248|FG006|Overall Study|Lost to Follow-up|0|||
147139716|NCT03943290|530679249|FG007|Overall Study|Lost to Follow-up|1|||
147139717|NCT03943290|530679250|FG008|Overall Study|Lost to Follow-up|0|||
147139718|NCT03943290|530679242|FG000|Overall Study|Withdrawal by Subject|0|||
147139719|NCT03943290|530679243|FG001|Overall Study|Withdrawal by Subject|0|||
147139720|NCT03943290|530679244|FG002|Overall Study|Withdrawal by Subject|1|||
147139721|NCT03943290|530679245|FG003|Overall Study|Withdrawal by Subject|0|||
147139722|NCT03943290|530679246|FG004|Overall Study|Withdrawal by Subject|0|||
147139723|NCT03943290|530679247|FG005|Overall Study|Withdrawal by Subject|0|||
147139724|NCT03943290|530679248|FG006|Overall Study|Withdrawal by Subject|0|||
147139725|NCT03943290|530679249|FG007|Overall Study|Withdrawal by Subject|0|||
147139726|NCT03943290|530679250|FG008|Overall Study|Withdrawal by Subject|0|||
147139727|NCT04179305|530679254|FG000|Overall Study|Death|1|||
147139728|NCT04179305|530679255|FG001|Overall Study|Death|1|||
147139729|NCT04179305|530679256|FG002|Overall Study|Death|0|||
147139730|NCT04179305|530679257|FG003|Overall Study|Death|0|||
147139731|NCT04179305|530679254|FG000|Overall Study|Lost to Follow-up|1|||
147139732|NCT04179305|530679255|FG001|Overall Study|Lost to Follow-up|1|||
147139733|NCT04179305|530679256|FG002|Overall Study|Lost to Follow-up|0|||
147139734|NCT04179305|530679257|FG003|Overall Study|Lost to Follow-up|0|||
147139735|NCT04179305|530679254|FG000|Overall Study|Withdrawal by Subject|0|||
147139736|NCT04179305|530679255|FG001|Overall Study|Withdrawal by Subject|1|||
147139737|NCT04179305|530679256|FG002|Overall Study|Withdrawal by Subject|0|||
147139738|NCT04179305|530679257|FG003|Overall Study|Withdrawal by Subject|0|||
147139739|NCT04179305|530679254|FG000|Overall Study|Did not have scan|1|||
147139740|NCT04179305|530679255|FG001|Overall Study|Did not have scan|0|||
147139741|NCT04179305|530679256|FG002|Overall Study|Did not have scan|0|||
147139742|NCT04179305|530679257|FG003|Overall Study|Did not have scan|0|||
147139743|NCT04179305|530679254|FG000|Overall Study|In hospice care|3|||
147139744|NCT04179305|530679255|FG001|Overall Study|In hospice care|0|||
147139745|NCT04179305|530679256|FG002|Overall Study|In hospice care|0|||
147139746|NCT04179305|530679257|FG003|Overall Study|In hospice care|0|||
147139747|NCT03192137|530679260|FG000|Overall Study|Adverse Event|10|||
147139748|NCT03192137|530679261|FG001|Overall Study|Adverse Event|11|||
147139749|NCT03192137|530679260|FG000|Overall Study|Physician Decision|1|||
147139750|NCT03192137|530679261|FG001|Overall Study|Physician Decision|0|||
147139751|NCT03192137|530679260|FG000|Overall Study|Lack of Efficacy|20|||
147139752|NCT03192137|530679261|FG001|Overall Study|Lack of Efficacy|37|||
147139753|NCT03192137|530679260|FG000|Overall Study|Withdrawal by Subject|3|||
147139754|NCT03192137|530679261|FG001|Overall Study|Withdrawal by Subject|3|||
147139755|NCT03192137|530679260|FG000|Overall Study|Protocol Violation|4|||
147139756|NCT03192137|530679261|FG001|Overall Study|Protocol Violation|3|||
147139757|NCT03192137|530679260|FG000|Overall Study|Surgery Cancelled|4|||
147139758|NCT03192137|530679261|FG001|Overall Study|Surgery Cancelled|1|||
147139759|NCT03192137|530679260|FG000|Overall Study|Other - Various Administrative Reasons|8|||
147139760|NCT03192137|530679261|FG001|Overall Study|Other - Various Administrative Reasons|3|||
147139761|NCT02737501|530679264|FG000|Randomized Phase|Died|41|||
147139762|NCT02737501|530679265|FG001|Randomized Phase|Died|29|||
147139763|NCT02737501|530679266|FG002|Randomized Phase|Died|0|||
147139764|NCT02737501|530679264|FG000|Randomized Phase|Withdrawal by Subject|16|||
147139765|NCT02737501|530679265|FG001|Randomized Phase|Withdrawal by Subject|6|||
147139766|NCT02737501|530679266|FG002|Randomized Phase|Withdrawal by Subject|0|||
147139767|NCT02737501|530679264|FG000|Randomized Phase|Lost to Follow-up|0|||
147139768|NCT02737501|530679265|FG001|Randomized Phase|Lost to Follow-up|1|||
147139769|NCT02737501|530679266|FG002|Randomized Phase|Lost to Follow-up|0|||
147139770|NCT02737501|530679264|FG000|Randomized Phase|Site Terminated by Sponsor|58|||
147139771|NCT02737501|530679265|FG001|Randomized Phase|Site Terminated by Sponsor|16|||
147139772|NCT02737501|530679266|FG002|Randomized Phase|Site Terminated by Sponsor|0|||
147139773|NCT02737501|530679264|FG000|Randomized Phase|Reason not Specified|1|||
147139774|NCT02737501|530679265|FG001|Randomized Phase|Reason not Specified|1|||
147139775|NCT02737501|530679266|FG002|Randomized Phase|Reason not Specified|0|||
147139776|NCT02737501|530679264|FG000|Randomized Phase|Never Treated|1|||
147139777|NCT02737501|530679265|FG001|Randomized Phase|Never Treated|1|||
147139778|NCT02737501|530679266|FG002|Randomized Phase|Never Treated|0|||
147139779|NCT02737501|530679264|FG000|Crossover Phase|Died|0|||
147139780|NCT02737501|530679265|FG001|Crossover Phase|Died|0|||
147139781|NCT02737501|530679266|FG002|Crossover Phase|Died|22|||
147139782|NCT02737501|530679264|FG000|Crossover Phase|Withdrew Consent|0|||
147139783|NCT02737501|530679265|FG001|Crossover Phase|Withdrew Consent|0|||
147139784|NCT02737501|530679266|FG002|Crossover Phase|Withdrew Consent|9|||
147139785|NCT02737501|530679264|FG000|Crossover Phase|Physician Decision|0|||
147139786|NCT02737501|530679265|FG001|Crossover Phase|Physician Decision|0|||
147139787|NCT02737501|530679266|FG002|Crossover Phase|Physician Decision|1|||
147139788|NCT02737501|530679264|FG000|Crossover Phase|Site Terminated by Sponsor|0|||
147139789|NCT02737501|530679265|FG001|Crossover Phase|Site Terminated by Sponsor|0|||
147139790|NCT02737501|530679266|FG002|Crossover Phase|Site Terminated by Sponsor|23|||
147139791|NCT01261975|530679267|FG000|Overall Study|Surgical complication|1|||
147139792|NCT01070979|530679270|FG000|Overall Study|Adverse Event|2|||
147139793|NCT01070979|530679271|FG001|Overall Study|Adverse Event|3|||
147139794|NCT01070979|530679272|FG002|Overall Study|Adverse Event|3|||
147139795|NCT01070979|530679270|FG000|Overall Study|Lost to Follow-up|2|||
147139796|NCT01070979|530679271|FG001|Overall Study|Lost to Follow-up|1|||
147139797|NCT01070979|530679272|FG002|Overall Study|Lost to Follow-up|1|||
147139798|NCT01070979|530679270|FG000|Overall Study|Protocol Violation|0|||
147139799|NCT01070979|530679271|FG001|Overall Study|Protocol Violation|2|||
147139800|NCT01070979|530679272|FG002|Overall Study|Protocol Violation|6|||
147139801|NCT01070979|530679270|FG000|Overall Study|Surgery, moving, personal, abn. labs|4|||
147139802|NCT01070979|530679271|FG001|Overall Study|Surgery, moving, personal, abn. labs|4|||
147139803|NCT01070979|530679272|FG002|Overall Study|Surgery, moving, personal, abn. labs|2|||
147139804|NCT01070979|530679270|FG000|Overall Study|Withdrawal by Subject|3|||
147139805|NCT01070979|530679271|FG001|Overall Study|Withdrawal by Subject|1|||
147139806|NCT01070979|530679272|FG002|Overall Study|Withdrawal by Subject|1|||
147139807|NCT01070979|530679270|FG000|Overall Study|No study drug taken|0|||
147139808|NCT01070979|530679271|FG001|Overall Study|No study drug taken|1|||
147139809|NCT01070979|530679272|FG002|Overall Study|No study drug taken|0|||
147139810|NCT00142792|530679273|FG000|Overall Study|Death|0|||
147139811|NCT00142792|530679274|FG001|Overall Study|Death|0|||
147139812|NCT00142792|530679275|FG002|Overall Study|Death|1|||
147139813|NCT00142792|530679273|FG000|Overall Study|Withdrawal by Subject|3|||
147573155|NCT01592240|532255790|FG001|Overall Study|Did Not Meet Entrance Criteria|0|||
147573156|NCT01592240|532255791|FG002|Overall Study|Did Not Meet Entrance Criteria|1|||
147573157|NCT01592240|532255792|FG003|Overall Study|Did Not Meet Entrance Criteria|0|||
147573158|NCT01592240|532255793|FG004|Overall Study|Did Not Meet Entrance Criteria|0|||
147573159|NCT01592240|532255794|FG005|Overall Study|Did Not Meet Entrance Criteria|0|||
147573160|NCT01592240|532255795|FG006|Overall Study|Did Not Meet Entrance Criteria|0|||
147573161|NCT01117623|532255796|FG000|Overall Study|Adverse Event|0|||
147573162|NCT01117623|532255797|FG001|Overall Study|Adverse Event|2|||
147573163|NCT01117623|532255798|FG002|Overall Study|Adverse Event|4|||
147573164|NCT01117623|532255799|FG003|Overall Study|Adverse Event|0|||
147573165|NCT01117623|532255800|FG004|Overall Study|Adverse Event|2|||
147573166|NCT01117623|532255801|FG005|Overall Study|Adverse Event|0|||
147573167|NCT01117623|532255802|FG006|Overall Study|Adverse Event|0|||
147573168|NCT01117623|532255803|FG007|Overall Study|Adverse Event|2|||
147573169|NCT01117623|532255796|FG000|Overall Study|Disease progression, recurrence, relapse|3|||
147573170|NCT01117623|532255797|FG001|Overall Study|Disease progression, recurrence, relapse|6|||
147573171|NCT01117623|532255798|FG002|Overall Study|Disease progression, recurrence, relapse|5|||
147573172|NCT01117623|532255799|FG003|Overall Study|Disease progression, recurrence, relapse|6|||
147573173|NCT01117623|532255800|FG004|Overall Study|Disease progression, recurrence, relapse|8|||
147573174|NCT01117623|532255801|FG005|Overall Study|Disease progression, recurrence, relapse|14|||
147573175|NCT01117623|532255802|FG006|Overall Study|Disease progression, recurrence, relapse|5|||
147573176|NCT01117623|532255803|FG007|Overall Study|Disease progression, recurrence, relapse|22|||
147139814|NCT00142792|530679274|FG001|Overall Study|Withdrawal by Subject|2|||
147139815|NCT00142792|530679275|FG002|Overall Study|Withdrawal by Subject|3|||
147139816|NCT00142792|530679273|FG000|Overall Study|Lost to Follow-up|8|||
147139817|NCT00142792|530679274|FG001|Overall Study|Lost to Follow-up|11|||
147139818|NCT00142792|530679275|FG002|Overall Study|Lost to Follow-up|7|||
147139819|NCT00142792|530679273|FG000|Overall Study|No category|1|||
147139820|NCT00142792|530679274|FG001|Overall Study|No category|2|||
147139821|NCT00142792|530679275|FG002|Overall Study|No category|1|||
147139822|NCT00437268|530679276|FG000|Overall Study|Adverse Event|1|||
147139823|NCT00437268|530679277|FG001|Overall Study|Adverse Event|1|||
147139824|NCT00437268|530679276|FG000|Overall Study|Withdrawal by Subject|2|||
147237793|NCT00040365|531042525|FG000|Overall Study|Lost to Follow-up|3|||
147237794|NCT00680017|531042526|FG000|Overall Study|Adverse Event|13|||
147573177|NCT01117623|532255796|FG000|Overall Study|Withdrawal by Subject|0|||
147573178|NCT01117623|532255797|FG001|Overall Study|Withdrawal by Subject|0|||
147652021|NCT01148459|532548286|FG000|Overall Study|Failure to comply with study procedures|0|||
147652022|NCT01148459|532548287|FG001|Overall Study|Failure to comply with study procedures|1|||
147652023|NCT02985021|532548288|FG000|Overall Study|Inability to comply with study procedures|1|||
147652024|NCT04854057|532548289|FG000|Overall Study|Adverse Event|0|||
147652025|NCT04854057|532548290|FG001|Overall Study|Adverse Event|1|||
147652026|NCT01951573|532548299|FG000|Washout Period|Adverse Event|0|||
147652027|NCT01951573|532548300|FG001|Washout Period|Adverse Event|1|||
147652028|NCT04399889|532548301|FG000|Overall Study|Death|5|||
147652029|NCT04399889|532548302|FG001|Overall Study|Death|1|||
147652030|NCT04399889|532548303|FG002|Overall Study|Death|1|||
147652031|NCT01152996|532548307|FG000|Overall Study|Withdrawal by Subject|142|||
147652032|NCT01152996|532548307|FG000|Overall Study|Adverse Event|115|||
147652033|NCT01152996|532548307|FG000|Overall Study|Lost to Follow-up|112|||
147652034|NCT01152996|532548307|FG000|Overall Study|Lack of Efficacy|68|||
147652035|NCT01152996|532548307|FG000|Overall Study|Noncompliance|41|||
147652036|NCT01152996|532548307|FG000|Overall Study|Other|36|||
147652037|NCT01152996|532548307|FG000|Overall Study|Protocol Violation|22|||
147652038|NCT01152996|532548307|FG000|Overall Study|Elevated liver enzymes|1|||
147652039|NCT03077607|532548308|FG000|Period 1 (15 Days)|Adverse Event|1|||
147652040|NCT03077607|532548309|FG001|Period 1 (15 Days)|Adverse Event|0|||
147652041|NCT03077607|532548308|FG000|Period 1 (15 Days)|Death|1|||
147652042|NCT03077607|532548309|FG001|Period 1 (15 Days)|Death|0|||
147652043|NCT03077607|532548308|FG000|Period 2 (Arm A:21 Days; Arm B:23 Days)|Death|1|||
147652044|NCT03077607|532548309|FG001|Period 2 (Arm A:21 Days; Arm B:23 Days)|Death|0|||
147652045|NCT03077607|532548308|FG000|Period 2 (Arm A:21 Days; Arm B:23 Days)|Adverse Event|2|||
147652046|NCT03077607|532548309|FG001|Period 2 (Arm A:21 Days; Arm B:23 Days)|Adverse Event|2|||
147652047|NCT00460239|532548310|FG000|Overall Study|Physician Decision|0|||
147652048|NCT00460239|532548311|FG001|Overall Study|Physician Decision|1|||
147652049|NCT00460239|532548312|FG002|Overall Study|Physician Decision|0|||
147652050|NCT00460239|532548313|FG003|Overall Study|Physician Decision|0|||
147652051|NCT00460239|532548314|FG004|Overall Study|Physician Decision|0|||
147652052|NCT00460239|532548315|FG005|Overall Study|Physician Decision|2|||
147652053|NCT00460239|532548316|FG006|Overall Study|Physician Decision|0|||
147573179|NCT01117623|532255798|FG002|Overall Study|Withdrawal by Subject|2|||
147139825|NCT00437268|530679277|FG001|Overall Study|Withdrawal by Subject|2|||
147139826|NCT00437268|530679276|FG000|Overall Study|Progressive disease|9|||
147139827|NCT00437268|530679277|FG001|Overall Study|Progressive disease|9|||
147139828|NCT00437268|530679276|FG000|Overall Study|Physician Decision|1|||
147139829|NCT00437268|530679277|FG001|Overall Study|Physician Decision|0|||
147139830|NCT00437268|530679276|FG000|Overall Study|Death|0|||
147139831|NCT00437268|530679277|FG001|Overall Study|Death|1|||
147139832|NCT00444925|530679282|FG000|Randomized to Double-blind Treatment|Never returned after randomization|3|||
147139833|NCT00444925|530679283|FG001|Randomized to Double-blind Treatment|Never returned after randomization|6|||
147139834|NCT00444925|530679284|FG002|Randomized to Double-blind Treatment|Never returned after randomization|6|||
147237795|NCT00680017|531042527|FG001|Overall Study|Adverse Event|7|||
147573180|NCT01117623|532255799|FG003|Overall Study|Withdrawal by Subject|0|||
147573181|NCT01117623|532255800|FG004|Overall Study|Withdrawal by Subject|0|||
147573182|NCT01117623|532255801|FG005|Overall Study|Withdrawal by Subject|1|||
147573183|NCT01117623|532255802|FG006|Overall Study|Withdrawal by Subject|1|||
147573184|NCT01117623|532255803|FG007|Overall Study|Withdrawal by Subject|1|||
147573185|NCT01117623|532255796|FG000|Overall Study|Non-compliance with study medication|0|||
147573186|NCT01117623|532255797|FG001|Overall Study|Non-compliance with study medication|0|||
147573187|NCT01117623|532255798|FG002|Overall Study|Non-compliance with study medication|0|||
147573188|NCT01117623|532255799|FG003|Overall Study|Non-compliance with study medication|0|||
147573189|NCT01117623|532255800|FG004|Overall Study|Non-compliance with study medication|0|||
147573190|NCT01117623|532255801|FG005|Overall Study|Non-compliance with study medication|0|||
147573191|NCT01117623|532255802|FG006|Overall Study|Non-compliance with study medication|0|||
147573192|NCT01117623|532255803|FG007|Overall Study|Non-compliance with study medication|1|||
147652054|NCT00460239|532548317|FG007|Overall Study|Physician Decision|0|||
147652055|NCT00460239|532548318|FG008|Overall Study|Physician Decision|0|||
147652056|NCT00460239|532548310|FG000|Overall Study|Withdrawal by Subject|0|||
147652057|NCT00460239|532548311|FG001|Overall Study|Withdrawal by Subject|0|||
147652058|NCT00460239|532548312|FG002|Overall Study|Withdrawal by Subject|0|||
147652059|NCT00460239|532548313|FG003|Overall Study|Withdrawal by Subject|0|||
147652060|NCT00460239|532548314|FG004|Overall Study|Withdrawal by Subject|0|||
147652061|NCT00460239|532548315|FG005|Overall Study|Withdrawal by Subject|1|||
147652062|NCT00460239|532548316|FG006|Overall Study|Withdrawal by Subject|0|||
147652063|NCT00460239|532548317|FG007|Overall Study|Withdrawal by Subject|0|||
147652064|NCT00460239|532548318|FG008|Overall Study|Withdrawal by Subject|0|||
147652065|NCT05259917|532548341|FG000|Overall Study|Protocol Violation|0|||
147652066|NCT05259917|532548342|FG001|Overall Study|Protocol Violation|0|||
147652067|NCT05259917|532548343|FG002|Overall Study|Protocol Violation|1|||
147652068|NCT05259917|532548344|FG003|Overall Study|Protocol Violation|0|||
147652069|NCT05259917|532548345|FG004|Overall Study|Protocol Violation|0|||
147652070|NCT05259917|532548346|FG005|Overall Study|Protocol Violation|0|||
147652071|NCT05259917|532548341|FG000|Overall Study|Lost to Follow-up|0|||
147573193|NCT01117623|532255796|FG000|Overall Study|Invest. text: completed all planned txs|0|||
147573194|NCT01117623|532255797|FG001|Overall Study|Invest. text: completed all planned txs|0|||
147573195|NCT01117623|532255798|FG002|Overall Study|Invest. text: completed all planned txs|0|||
147573196|NCT01117623|532255799|FG003|Overall Study|Invest. text: completed all planned txs|0|||
147573197|NCT01117623|532255800|FG004|Overall Study|Invest. text: completed all planned txs|0|||
147573198|NCT01117623|532255801|FG005|Overall Study|Invest. text: completed all planned txs|1|||
147573199|NCT01117623|532255802|FG006|Overall Study|Invest. text: completed all planned txs|0|||
147573200|NCT01117623|532255803|FG007|Overall Study|Invest. text: completed all planned txs|0|||
147573201|NCT00469898|532255811|FG000|Overall Study|Adverse Event|7|||
147573202|NCT00469898|532255811|FG000|Overall Study|Withdrawal by Subject|4|||
147573203|NCT00469898|532255811|FG000|Overall Study|Death|4|||
147573204|NCT00469898|532255811|FG000|Overall Study|Disease progression|9|||
147573205|NCT00469898|532255811|FG000|Overall Study|Decreased performance status|1|||
147573206|NCT01205035|532255816|FG000|Overall Study|Withdrawal by Subject|1|||
147573207|NCT01205035|532255817|FG001|Overall Study|Withdrawal by Subject|0|||
147573208|NCT01205035|532255816|FG000|Overall Study|Physician Decision|1|||
147573209|NCT01205035|532255817|FG001|Overall Study|Physician Decision|0|||
147573210|NCT02751424|532255818|FG000|Part 2|Adverse Event|0|||
147573211|NCT02751424|532255819|FG001|Part 2|Adverse Event|0|||
147573212|NCT02751424|532255820|FG002|Part 2|Adverse Event|0|||
147573213|NCT02751424|532255821|FG003|Part 2|Adverse Event|0|||
147573214|NCT02751424|532255822|FG004|Part 2|Adverse Event|0|||
147573215|NCT02751424|532255823|FG005|Part 2|Adverse Event|0|||
147573216|NCT02751424|532255824|FG006|Part 2|Adverse Event|0|||
147573217|NCT02751424|532255825|FG007|Part 2|Adverse Event|5|||
147573218|NCT02751424|532255826|FG008|Part 2|Adverse Event|0|||
147573219|NCT01204294|532255827|FG000|Overall Study|Adverse Event|2|||
147573220|NCT01204294|532255828|FG001|Overall Study|Adverse Event|6|||
147573221|NCT01204294|532255829|FG002|Overall Study|Adverse Event|0|||
147573222|NCT01204294|532255830|FG003|Overall Study|Adverse Event|7|||
147573223|NCT01204294|532255831|FG004|Overall Study|Adverse Event|1|||
147573224|NCT01204294|532255832|FG005|Overall Study|Adverse Event|4|||
147573225|NCT01204294|532255833|FG006|Overall Study|Adverse Event|0|||
147573226|NCT01204294|532255827|FG000|Overall Study|Protocol Violation|1|||
147573227|NCT01204294|532255828|FG001|Overall Study|Protocol Violation|0|||
147573228|NCT01204294|532255829|FG002|Overall Study|Protocol Violation|2|||
147573229|NCT01204294|532255830|FG003|Overall Study|Protocol Violation|1|||
147573230|NCT01204294|532255831|FG004|Overall Study|Protocol Violation|0|||
147573231|NCT01204294|532255832|FG005|Overall Study|Protocol Violation|0|||
147573232|NCT01204294|532255833|FG006|Overall Study|Protocol Violation|0|||
147573233|NCT01204294|532255827|FG000|Overall Study|Withdrawal by Subject|0|||
147573234|NCT01204294|532255828|FG001|Overall Study|Withdrawal by Subject|2|||
147573235|NCT01204294|532255829|FG002|Overall Study|Withdrawal by Subject|2|||
147573236|NCT01204294|532255830|FG003|Overall Study|Withdrawal by Subject|1|||
147573237|NCT01204294|532255831|FG004|Overall Study|Withdrawal by Subject|1|||
147573238|NCT01204294|532255832|FG005|Overall Study|Withdrawal by Subject|1|||
147573239|NCT01204294|532255833|FG006|Overall Study|Withdrawal by Subject|2|||
147573240|NCT01204294|532255827|FG000|Overall Study|Lack of Efficacy|0|||
147573241|NCT01204294|532255828|FG001|Overall Study|Lack of Efficacy|0|||
147573242|NCT01204294|532255829|FG002|Overall Study|Lack of Efficacy|0|||
147573243|NCT01204294|532255830|FG003|Overall Study|Lack of Efficacy|2|||
147573244|NCT01204294|532255831|FG004|Overall Study|Lack of Efficacy|0|||
147573245|NCT01204294|532255832|FG005|Overall Study|Lack of Efficacy|0|||
147573246|NCT01204294|532255833|FG006|Overall Study|Lack of Efficacy|0|||
147139835|NCT00444925|530679282|FG000|Double-blind Treatment Period|Death|2|||
147139836|NCT00444925|530679283|FG001|Double-blind Treatment Period|Death|0|||
147139837|NCT00444925|530679284|FG002|Double-blind Treatment Period|Death|0|||
147139838|NCT00444925|530679282|FG000|Double-blind Treatment Period|Adverse Event|6|||
147139839|NCT00444925|530679283|FG001|Double-blind Treatment Period|Adverse Event|28|||
147139840|NCT00444925|530679284|FG002|Double-blind Treatment Period|Adverse Event|44|||
147445698|NCT00264875|531797429|FG000|Overall Study|Withdrawal by Subject|7|||
147445699|NCT01074190|531797430|FG000|Overall Study|Emergency Cesarean Delivery|1|||
147573247|NCT01204294|532255827|FG000|Overall Study|Other (house moving)|0|||
147445700|NCT01074190|531797431|FG001|Overall Study|Emergency Cesarean Delivery|2|||
147445701|NCT01074190|531797432|FG002|Overall Study|Emergency Cesarean Delivery|1|||
147573248|NCT01204294|532255828|FG001|Overall Study|Other (house moving)|0|||
147573249|NCT01204294|532255829|FG002|Overall Study|Other (house moving)|1|||
147573250|NCT01204294|532255830|FG003|Overall Study|Other (house moving)|0|||
147573251|NCT01204294|532255831|FG004|Overall Study|Other (house moving)|0|||
147573252|NCT01204294|532255832|FG005|Overall Study|Other (house moving)|0|||
147573253|NCT01204294|532255833|FG006|Overall Study|Other (house moving)|0|||
147573254|NCT00245063|532255834|FG000|Overall Study|Adverse Event|6|||
147573255|NCT00245063|532255835|FG001|Overall Study|Adverse Event|5|||
147573256|NCT00245063|532255834|FG000|Overall Study|Death|1|||
147573257|NCT00245063|532255835|FG001|Overall Study|Death|0|||
147573258|NCT01839279|532255836|FG000|Overall Study|Adverse Event|4|||
147573259|NCT01839279|532255837|FG001|Overall Study|Adverse Event|1|||
147573260|NCT01839279|532255838|FG002|Overall Study|Adverse Event|1|||
147139841|NCT00444925|530679282|FG000|Double-blind Treatment Period|Lack of Efficacy|5|||
147139842|NCT00444925|530679283|FG001|Double-blind Treatment Period|Lack of Efficacy|5|||
147139843|NCT00444925|530679284|FG002|Double-blind Treatment Period|Lack of Efficacy|13|||
147139844|NCT00444925|530679282|FG000|Double-blind Treatment Period|Lost to Follow-up|4|||
147139845|NCT00444925|530679283|FG001|Double-blind Treatment Period|Lost to Follow-up|8|||
147139846|NCT00444925|530679284|FG002|Double-blind Treatment Period|Lost to Follow-up|5|||
147139847|NCT00444925|530679282|FG000|Double-blind Treatment Period|Withdrawal by Subject|6|||
147139848|NCT00444925|530679283|FG001|Double-blind Treatment Period|Withdrawal by Subject|8|||
147139849|NCT00444925|530679284|FG002|Double-blind Treatment Period|Withdrawal by Subject|7|||
147139850|NCT00444925|530679282|FG000|Double-blind Treatment Period|Other|7|||
147139851|NCT00444925|530679283|FG001|Double-blind Treatment Period|Other|7|||
147573261|NCT01839279|532255836|FG000|Overall Study|Withdrawal by Subject|4|||
147573262|NCT01839279|532255837|FG001|Overall Study|Withdrawal by Subject|1|||
147573263|NCT01839279|532255838|FG002|Overall Study|Withdrawal by Subject|1|||
147573264|NCT01839279|532255836|FG000|Overall Study|Classified as 'Other'|5|||
147139852|NCT00444925|530679284|FG002|Double-blind Treatment Period|Other|12|||
147139853|NCT01342094|530679287|FG000|Overall Study|Adverse Event|5|||
147139854|NCT01342094|530679288|FG001|Overall Study|Adverse Event|0|||
147139855|NCT01342094|530679287|FG000|Overall Study|Not meeting inclusion/exclusion criteria|0|||
147139856|NCT01342094|530679288|FG001|Overall Study|Not meeting inclusion/exclusion criteria|1|||
147139857|NCT01342094|530679287|FG000|Overall Study|Withdrawal by Subject|0|||
147139858|NCT01342094|530679288|FG001|Overall Study|Withdrawal by Subject|2|||
147139859|NCT02806414|530679289|FG000|Overall Study|Lost to Follow-up|2|||
147139860|NCT00810277|530681358|FG000|Overall Study|Adverse Event|1|||
147139861|NCT04551898|530681361|FG000|Overall Study|Participant randomized but did not receive study drug|0|||
147139862|NCT04551898|530681362|FG001|Overall Study|Participant randomized but did not receive study drug|1|||
147139863|NCT04551898|530681363|FG002|Overall Study|Participant randomized but did not receive study drug|3|||
147139864|NCT04551898|530681364|FG003|Overall Study|Participant randomized but did not receive study drug|1|||
147139865|NCT04551898|530681361|FG000|Overall Study|Withdrawal by Subject|5|||
147139866|NCT04551898|530681362|FG001|Overall Study|Withdrawal by Subject|1|||
147139867|NCT04551898|530681363|FG002|Overall Study|Withdrawal by Subject|2|||
147139868|NCT04551898|530681364|FG003|Overall Study|Withdrawal by Subject|2|||
147139869|NCT04551898|530681361|FG000|Overall Study|Lost to Follow-up|2|||
147139870|NCT04551898|530681362|FG001|Overall Study|Lost to Follow-up|1|||
147139871|NCT04551898|530681363|FG002|Overall Study|Lost to Follow-up|2|||
147139872|NCT04551898|530681364|FG003|Overall Study|Lost to Follow-up|2|||
147139873|NCT04551898|530681361|FG000|Overall Study|Death|1|||
147139874|NCT04551898|530681362|FG001|Overall Study|Death|0|||
147139875|NCT04551898|530681363|FG002|Overall Study|Death|0|||
147139876|NCT04551898|530681364|FG003|Overall Study|Death|0|||
147139877|NCT04551898|530681361|FG000|Overall Study|Incorrectly randomized and screen failed due to administrative error|0|||
147139878|NCT04551898|530681362|FG001|Overall Study|Incorrectly randomized and screen failed due to administrative error|0|||
147139879|NCT04551898|530681363|FG002|Overall Study|Incorrectly randomized and screen failed due to administrative error|1|||
147139880|NCT04551898|530681364|FG003|Overall Study|Incorrectly randomized and screen failed due to administrative error|0|||
147139881|NCT00456755|530681373|FG000|Overall Study|Lost to Follow-up|2|||
147139882|NCT00456755|530681374|FG001|Overall Study|Lost to Follow-up|1|||
147573265|NCT01839279|532255837|FG001|Overall Study|Classified as 'Other'|0|||
147573266|NCT01839279|532255838|FG002|Overall Study|Classified as 'Other'|0|||
147139883|NCT04072835|530681379|FG000|Overall Study|Overall trial ended|603|||
147139884|NCT04072835|530681379|FG000|Overall Study|Ablation|97|||
147139885|NCT04072835|530681379|FG000|Overall Study|Withdrawal of consent|66|||
147139886|NCT04072835|530681379|FG000|Overall Study|Physician Decision|50|||
147139887|NCT04072835|530681379|FG000|Overall Study|Lost to Follow-up|39|||
147139888|NCT04072835|530681379|FG000|Overall Study|Participant no longer meets the inclusion/exclusion criteria|38|||
147139889|NCT04072835|530681379|FG000|Overall Study|Participant wanted to try other therapy or treatment|34|||
147139890|NCT04072835|530681379|FG000|Overall Study|Adverse Event|25|||
147139891|NCT04072835|530681379|FG000|Overall Study|Participant non-compliance / Protocol violation(s)|25|||
147139892|NCT04072835|530681379|FG000|Overall Study|Death|11|||
147139893|NCT04072835|530681379|FG000|Overall Study|Participant felt the drug did not work|8|||
147139894|NCT04072835|530681379|FG000|Overall Study|Participant tolerability|5|||
147139895|NCT04072835|530681379|FG000|Overall Study|Missing|5|||
147139896|NCT04072835|530681379|FG000|Overall Study|Participant withdrawn due to COVID-19 situation|4|||
147139897|NCT04072835|530681379|FG000|Overall Study|Pregnancy|3|||
147573267|NCT00840216|532255842|FG000|Washout: 7 Days|Withdrawal by Subject|1|||
147237796|NCT00680017|531042526|FG000|Overall Study|Withdrawal by Subject|2|||
147237797|NCT00680017|531042527|FG001|Overall Study|Withdrawal by Subject|5|||
147573268|NCT00840216|532255843|FG001|Washout: 7 Days|Withdrawal by Subject|0|||
147139898|NCT01336712|530681380|FG000|Overall Study|Death|2|||
147139899|NCT01336712|530681380|FG000|Overall Study|Lack of Efficacy|1|||
147139900|NCT00399568|530681381|FG000|Overall Study|Adverse Event|1|||
147139901|NCT00399568|530681382|FG001|Overall Study|Adverse Event|2|||
147139902|NCT00399568|530681381|FG000|Overall Study|Withdrawal by Subject|7|||
147139903|NCT00399568|530681382|FG001|Overall Study|Withdrawal by Subject|3|||
147139904|NCT00399568|530681381|FG000|Overall Study|Protocol non-compliance|2|||
147139905|NCT00399568|530681382|FG001|Overall Study|Protocol non-compliance|2|||
147139906|NCT00399568|530681381|FG000|Overall Study|Lost to Follow-up|2|||
147139907|NCT00399568|530681382|FG001|Overall Study|Lost to Follow-up|2|||
147139908|NCT02477527|530681385|FG000|Overall Study|Lost to Follow-up|2|||
147139909|NCT02477527|530681385|FG000|Overall Study|Withdrawal by Subject|1|||
147139910|NCT02477527|530681385|FG000|Overall Study|Screen Failure|3|||
147139911|NCT04567524|530681386|FG000|Overall Study|Adverse Event|1|||
147139912|NCT04567524|530681387|FG001|Overall Study|Adverse Event|1|||
147139913|NCT04567524|530681388|FG002|Overall Study|Adverse Event|0|||
147139914|NCT04567524|530681389|FG003|Overall Study|Adverse Event|0|||
147652072|NCT05259917|532548342|FG001|Overall Study|Lost to Follow-up|0|||
147652073|NCT05259917|532548343|FG002|Overall Study|Lost to Follow-up|1|||
147652074|NCT05259917|532548344|FG003|Overall Study|Lost to Follow-up|0|||
147652075|NCT05259917|532548345|FG004|Overall Study|Lost to Follow-up|0|||
147652076|NCT05259917|532548346|FG005|Overall Study|Lost to Follow-up|1|||
147652077|NCT05259917|532548341|FG000|Overall Study|Physician Decision|0|||
147652078|NCT05259917|532548342|FG001|Overall Study|Physician Decision|1|||
147652079|NCT05259917|532548343|FG002|Overall Study|Physician Decision|0|||
147652080|NCT05259917|532548344|FG003|Overall Study|Physician Decision|0|||
147652081|NCT05259917|532548345|FG004|Overall Study|Physician Decision|0|||
147652082|NCT05259917|532548346|FG005|Overall Study|Physician Decision|0|||
147652083|NCT05259917|532548341|FG000|Overall Study|Withdrawal by Subject|0|||
147652084|NCT05259917|532548342|FG001|Overall Study|Withdrawal by Subject|1|||
147652085|NCT05259917|532548343|FG002|Overall Study|Withdrawal by Subject|0|||
147652086|NCT05259917|532548344|FG003|Overall Study|Withdrawal by Subject|0|||
147652087|NCT05259917|532548345|FG004|Overall Study|Withdrawal by Subject|1|||
147652088|NCT05259917|532548346|FG005|Overall Study|Withdrawal by Subject|1|||
147652089|NCT05259917|532548341|FG000|Overall Study|Trial Termination by Sponsor|7|||
147652090|NCT05259917|532548342|FG001|Overall Study|Trial Termination by Sponsor|2|||
147652091|NCT05259917|532548343|FG002|Overall Study|Trial Termination by Sponsor|3|||
147139915|NCT04567524|530681386|FG000|Overall Study|Withdrawal by Subject|2|||
147139916|NCT04567524|530681387|FG001|Overall Study|Withdrawal by Subject|0|||
147139917|NCT04567524|530681388|FG002|Overall Study|Withdrawal by Subject|0|||
147139918|NCT04567524|530681389|FG003|Overall Study|Withdrawal by Subject|1|||
147139919|NCT01147393|530681390|FG000|Dose Level 1|Dose limiting Toxicity|2|||
147139920|NCT01147393|530681390|FG000|Dose Level -1|Dose Limited Toxicity|1|||
147139921|NCT00570323|530681395|FG000|Started Treatment After Randomization|Withdrawal by Subject|0|||
147139922|NCT00570323|530681396|FG001|Started Treatment After Randomization|Withdrawal by Subject|1|||
147139923|NCT00570323|530681395|FG000|Started Treatment After Randomization|Protocol Violation|1|||
147139924|NCT00570323|530681396|FG001|Started Treatment After Randomization|Protocol Violation|0|||
147139925|NCT00570323|530681395|FG000|Started Treatment After Randomization|Physician Decision|1|||
147139926|NCT00570323|530681396|FG001|Started Treatment After Randomization|Physician Decision|0|||
147139927|NCT00570323|530681395|FG000|Complete Study After Start|Lost to Follow-up|0|||
147139928|NCT00570323|530681396|FG001|Complete Study After Start|Lost to Follow-up|1|||
147139929|NCT00570323|530681395|FG000|Complete Study After Start|Withdrawal by Subject|2|||
147139930|NCT00570323|530681396|FG001|Complete Study After Start|Withdrawal by Subject|0|||
147139931|NCT00570323|530681395|FG000|Complete Study After Start|Physician Decision|1|||
147139932|NCT00570323|530681396|FG001|Complete Study After Start|Physician Decision|0|||
147139933|NCT04263766|530681397|FG000|Overall Study|Withdrawal by Subject|6|||
147139934|NCT04263766|530681398|FG001|Overall Study|Withdrawal by Subject|4|||
147139935|NCT04263766|530681397|FG000|Overall Study|Lack of Efficacy|1|||
147139936|NCT04263766|530681398|FG001|Overall Study|Lack of Efficacy|3|||
147139937|NCT02639247|530681401|FG000|Overall Study|Lost to Follow-up|2|||
147139938|NCT02639247|530681402|FG001|Overall Study|Lost to Follow-up|1|||
147139939|NCT02639247|530681401|FG000|Overall Study|Death|2|||
147139940|NCT02639247|530681402|FG001|Overall Study|Death|0|||
147139941|NCT02639247|530681401|FG000|Overall Study|Withdrew Consent|0|||
147139942|NCT02639247|530681402|FG001|Overall Study|Withdrew Consent|1|||
147139943|NCT02639247|530681401|FG000|Overall Study|Protocol Violation|1|||
147139944|NCT02639247|530681402|FG001|Overall Study|Protocol Violation|0|||
147139945|NCT01891396|530681404|FG000|Overall Study|Withdrawal by Subject|4|||
147139946|NCT01891396|530681405|FG001|Overall Study|Withdrawal by Subject|4|||
147139947|NCT01891396|530681406|FG002|Overall Study|Withdrawal by Subject|3|||
147652092|NCT05259917|532548344|FG003|Overall Study|Trial Termination by Sponsor|5|||
147652093|NCT05259917|532548345|FG004|Overall Study|Trial Termination by Sponsor|11|||
147139948|NCT01891396|530681404|FG000|Overall Study|Lost to Follow-up|0|||
147139949|NCT01891396|530681405|FG001|Overall Study|Lost to Follow-up|1|||
147139950|NCT01891396|530681406|FG002|Overall Study|Lost to Follow-up|0|||
147318615|NCT00519636|531331774|FG000|Washout Period|Per doctors request|0|||
147139951|NCT03462758|530681407|FG000|Overall Study|Chose no or other method of contraception|20|||
147139952|NCT03462758|530681408|FG001|Overall Study|Chose no or other method of contraception|23|||
147652094|NCT05259917|532548346|FG005|Overall Study|Trial Termination by Sponsor|4|||
147652095|NCT05259917|532548341|FG000|Overall Study|Other|1|||
147652096|NCT05259917|532548342|FG001|Overall Study|Other|0|||
147573269|NCT01058668|532255844|FG000|Double-blind Treatment Phase|Adverse Event|8|||
147573270|NCT01058668|532255845|FG001|Double-blind Treatment Phase|Adverse Event|15|||
147573271|NCT01058668|532255846|FG002|Double-blind Treatment Phase|Adverse Event|25|||
147573272|NCT01058668|532255844|FG000|Double-blind Treatment Phase|Insufficient Therapeutic Response|15|||
147573273|NCT01058668|532255845|FG001|Double-blind Treatment Phase|Insufficient Therapeutic Response|2|||
147573274|NCT01058668|532255846|FG002|Double-blind Treatment Phase|Insufficient Therapeutic Response|5|||
147573275|NCT01058668|532255844|FG000|Double-blind Treatment Phase|Protocol Violation|1|||
147573276|NCT01058668|532255845|FG001|Double-blind Treatment Phase|Protocol Violation|1|||
147573277|NCT01058668|532255846|FG002|Double-blind Treatment Phase|Protocol Violation|2|||
147573278|NCT01058668|532255844|FG000|Double-blind Treatment Phase|Withdrawal of Consent|14|||
147573279|NCT01058668|532255845|FG001|Double-blind Treatment Phase|Withdrawal of Consent|18|||
147573280|NCT01058668|532255846|FG002|Double-blind Treatment Phase|Withdrawal of Consent|17|||
147573281|NCT01058668|532255844|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
147573282|NCT01058668|532255845|FG001|Double-blind Treatment Phase|Lost to Follow-up|1|||
147573283|NCT01058668|532255846|FG002|Double-blind Treatment Phase|Lost to Follow-up|1|||
147573284|NCT01058668|532255844|FG000|Double-blind Treatment Phase|Other Unspecified|1|||
147573285|NCT01058668|532255845|FG001|Double-blind Treatment Phase|Other Unspecified|1|||
147573286|NCT01058668|532255846|FG002|Double-blind Treatment Phase|Other Unspecified|0|||
147573287|NCT00316277|532255847|FG000|Phase 1 (12 Weeks)|Lost to Follow-up|88|||
147573288|NCT00316277|532255848|FG001|Phase 1 (12 Weeks)|Lost to Follow-up|75|||
147573289|NCT00316277|532255847|FG000|Phase 1 (12 Weeks)|Investigator-initiated termination|2|||
147573290|NCT00316277|532255848|FG001|Phase 1 (12 Weeks)|Investigator-initiated termination|0|||
147573291|NCT00316277|532255847|FG000|Phase 1 (12 Weeks)|Eligible for Phase 2|220|||
147573292|NCT00316277|532255848|FG001|Phase 1 (12 Weeks)|Eligible for Phase 2|225|||
147573293|NCT00316277|532255847|FG000|Phase 2 (24 Weeks)|Lost to Follow-up prior to wk 13|19|||
147139953|NCT03462758|530681407|FG000|Overall Study|Lost to follow-up before IUD placement|14|||
147139954|NCT03462758|530681408|FG001|Overall Study|Lost to follow-up before IUD placement|12|||
147139955|NCT03462758|530681407|FG000|Overall Study|Unsuccessful IUD placement attempt|3|||
147139956|NCT03462758|530681408|FG001|Overall Study|Unsuccessful IUD placement attempt|3|||
147139957|NCT03462758|530681407|FG000|Overall Study|Medical contraindication|2|||
147139958|NCT03462758|530681408|FG001|Overall Study|Medical contraindication|2|||
147139959|NCT03462758|530681407|FG000|Overall Study|Lost to follow-up after IUD placement|17|||
147139960|NCT03462758|530681408|FG001|Overall Study|Lost to follow-up after IUD placement|14|||
147139961|NCT02820844|530681409|FG000|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|1|||
147139962|NCT02820844|530681410|FG001|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|3|||
147237798|NCT00680017|531042526|FG000|Overall Study|Lost to Follow-up|2|||
147139963|NCT02820844|530681411|FG002|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|0|||
147139964|NCT02820844|530681412|FG003|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|0|||
147139965|NCT02820844|530681413|FG004|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|0|||
147139966|NCT02820844|530681414|FG005|Double-blinded (Up to 48 Weeks)|Withdrawal by Subject|0|||
147139967|NCT02820844|530681409|FG000|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|1|||
147139968|NCT02820844|530681410|FG001|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|2|||
147139969|NCT02820844|530681411|FG002|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|0|||
147139970|NCT02820844|530681412|FG003|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|0|||
147139971|NCT02820844|530681413|FG004|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|0|||
147139972|NCT02820844|530681414|FG005|Double-blinded (Up to 48 Weeks)|Reached stopping criteria|0|||
147139973|NCT02820844|530681409|FG000|Double-blinded (Up to 48 Weeks)|Protocol Violation|0|||
147139974|NCT02820844|530681410|FG001|Double-blinded (Up to 48 Weeks)|Protocol Violation|3|||
147139975|NCT02820844|530681411|FG002|Double-blinded (Up to 48 Weeks)|Protocol Violation|0|||
147139976|NCT02820844|530681412|FG003|Double-blinded (Up to 48 Weeks)|Protocol Violation|0|||
147139977|NCT02820844|530681413|FG004|Double-blinded (Up to 48 Weeks)|Protocol Violation|0|||
147573294|NCT00316277|532255848|FG001|Phase 2 (24 Weeks)|Lost to Follow-up prior to wk 13|18|||
147573295|NCT00316277|532255847|FG000|Phase 2 (24 Weeks)|Discontinued intervention (jailed)|0|||
147573296|NCT00316277|532255848|FG001|Phase 2 (24 Weeks)|Discontinued intervention (jailed)|1|||
147573297|NCT00848536|532255851|FG000|Overall Study|Adverse Event|2|||
147573298|NCT00848536|532255852|FG001|Overall Study|Adverse Event|2|||
147573299|NCT00848536|532255851|FG000|Overall Study|Withdrawal by Subject|0|||
147573300|NCT00848536|532255852|FG001|Overall Study|Withdrawal by Subject|1|||
147573301|NCT00848536|532255851|FG000|Overall Study|Protocol Violation|0|||
147573302|NCT00848536|532255852|FG001|Overall Study|Protocol Violation|1|||
147573303|NCT00848536|532255851|FG000|Overall Study|Noncompliance|1|||
147573304|NCT00848536|532255852|FG001|Overall Study|Noncompliance|0|||
147573305|NCT00848536|532255851|FG000|Overall Study|Inadequate Control of IOP|1|||
147139978|NCT02820844|530681414|FG005|Double-blinded (Up to 48 Weeks)|Protocol Violation|0|||
147139979|NCT02820844|530681409|FG000|Double-blinded (Up to 48 Weeks)|Adverse Event|2|||
147573306|NCT00848536|532255852|FG001|Overall Study|Inadequate Control of IOP|1|||
147573307|NCT00848536|532255851|FG000|Overall Study|Patient Moved|0|||
147573308|NCT00848536|532255852|FG001|Overall Study|Patient Moved|2|||
147573309|NCT01370733|532255853|FG000|Overall Study|Withdrawal by Subject|8|||
147652097|NCT05259917|532548343|FG002|Overall Study|Other|2|||
147139980|NCT02820844|530681410|FG001|Double-blinded (Up to 48 Weeks)|Adverse Event|1|||
147139981|NCT02820844|530681411|FG002|Double-blinded (Up to 48 Weeks)|Adverse Event|0|||
147139982|NCT02820844|530681412|FG003|Double-blinded (Up to 48 Weeks)|Adverse Event|0|||
147573310|NCT01370733|532255854|FG001|Overall Study|Withdrawal by Subject|8|||
147573311|NCT01370733|532255853|FG000|Overall Study|Lost to Follow-up|3|||
147573312|NCT01370733|532255854|FG001|Overall Study|Lost to Follow-up|0|||
147139983|NCT02820844|530681413|FG004|Double-blinded (Up to 48 Weeks)|Adverse Event|0|||
147139984|NCT02820844|530681414|FG005|Double-blinded (Up to 48 Weeks)|Adverse Event|0|||
147139985|NCT02820844|530681409|FG000|Double-blinded (Up to 48 Weeks)|Investigator discretion|1|||
147139986|NCT02820844|530681410|FG001|Double-blinded (Up to 48 Weeks)|Investigator discretion|0|||
147139987|NCT02820844|530681411|FG002|Double-blinded (Up to 48 Weeks)|Investigator discretion|0|||
147139988|NCT02820844|530681412|FG003|Double-blinded (Up to 48 Weeks)|Investigator discretion|0|||
147139989|NCT02820844|530681413|FG004|Double-blinded (Up to 48 Weeks)|Investigator discretion|0|||
147573313|NCT01370733|532255853|FG000|Overall Study|Adverse Event|2|||
147573314|NCT01370733|532255854|FG001|Overall Study|Adverse Event|4|||
147573315|NCT01370733|532255853|FG000|Overall Study|Lack of Efficacy|3|||
147573316|NCT01370733|532255854|FG001|Overall Study|Lack of Efficacy|5|||
147573317|NCT01370733|532255853|FG000|Overall Study|Physician Decision|0|||
147139990|NCT02820844|530681414|FG005|Double-blinded (Up to 48 Weeks)|Investigator discretion|0|||
147573318|NCT01370733|532255854|FG001|Overall Study|Physician Decision|2|||
147573319|NCT01370733|532255853|FG000|Overall Study|Protocol Violation|1|||
147573320|NCT01370733|532255854|FG001|Overall Study|Protocol Violation|3|||
147139991|NCT02820844|530681409|FG000|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|0|||
147139992|NCT02820844|530681410|FG001|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|0|||
147139993|NCT02820844|530681411|FG002|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|1|||
147139994|NCT02820844|530681412|FG003|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|2|||
147139995|NCT02820844|530681413|FG004|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|0|||
147139996|NCT02820844|530681414|FG005|Open-label(2nd Treatment-Up to 48 Weeks)|Adverse Event|0|||
147139997|NCT02820844|530681409|FG000|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0|||
147139998|NCT02820844|530681410|FG001|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0|||
147139999|NCT02820844|530681411|FG002|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|1|||
147140000|NCT02820844|530681412|FG003|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0|||
147140001|NCT02820844|530681413|FG004|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0|||
147140002|NCT02820844|530681414|FG005|Open-label(2nd Treatment-Up to 48 Weeks)|Investigator discretion|0|||
147140003|NCT02820844|530681409|FG000|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
147140004|NCT02820844|530681410|FG001|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
147140005|NCT02820844|530681411|FG002|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|7|||
147140006|NCT02820844|530681412|FG003|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|2|||
147140007|NCT02820844|530681413|FG004|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
147140008|NCT02820844|530681414|FG005|Open-label(2nd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
147237799|NCT00680017|531042527|FG001|Overall Study|Lost to Follow-up|0|||
147237800|NCT02555683|531042531|FG000|Overall Study|Physician Decision|1|||
147237801|NCT02555683|531042532|FG001|Overall Study|Physician Decision|0|||
147237802|NCT02555683|531042533|FG002|Overall Study|Physician Decision|2|||
147237803|NCT02555683|531042531|FG000|Overall Study|Lost to Follow-up|2|||
147237804|NCT02555683|531042532|FG001|Overall Study|Lost to Follow-up|1|||
147237805|NCT02555683|531042533|FG002|Overall Study|Lost to Follow-up|2|||
147237806|NCT02555683|531042531|FG000|Overall Study|Technical Problems|1|||
147237807|NCT02555683|531042532|FG001|Overall Study|Technical Problems|1|||
147237808|NCT02555683|531042533|FG002|Overall Study|Technical Problems|0|||
147318616|NCT00519636|531331775|FG001|Washout Period|Per doctors request|1|||
147318617|NCT00519636|531331776|FG002|Washout Period|Per doctors request|0|||
147573321|NCT06539676|532255855|FG000|Overall Study|Early study termination|1|||
147573322|NCT06539676|532255856|FG001|Overall Study|Early study termination|0|||
147573323|NCT06539676|532255857|FG002|Overall Study|Early study termination|6|||
147573324|NCT03214588|532255858|FG000|Overall Study|Adverse Event|1|||
147573325|NCT03214588|532255859|FG001|Overall Study|Adverse Event|0|||
147573326|NCT03214588|532255860|FG002|Overall Study|Adverse Event|2|||
147573327|NCT03214588|532255858|FG000|Overall Study|Reason Not Specified|0|||
147573328|NCT03214588|532255859|FG001|Overall Study|Reason Not Specified|1|||
147652098|NCT05259917|532548344|FG003|Overall Study|Other|0|||
147140009|NCT02820844|530681409|FG000|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0|||
147237809|NCT02555683|531042531|FG000|Overall Study|Protocol deviation|0|||
147237810|NCT02555683|531042532|FG001|Overall Study|Protocol deviation|1|||
147237811|NCT02555683|531042533|FG002|Overall Study|Protocol deviation|0|||
147237812|NCT02555683|531042531|FG000|Overall Study|Lack of Efficacy|2|||
147573329|NCT03214588|532255860|FG002|Overall Study|Reason Not Specified|0|||
147573330|NCT00700739|532255863|FG000|Overall Study|Lost to Follow-up|4|||
147573331|NCT00700739|532255864|FG001|Overall Study|Lost to Follow-up|4|||
147573332|NCT00185458|532255866|FG000|Contraception Phase|Adverse Event|37|||
147573333|NCT00185458|532255866|FG000|Contraception Phase|Lost to Follow-up|10|||
147652099|NCT05259917|532548345|FG004|Overall Study|Other|0|||
147652100|NCT05259917|532548346|FG005|Overall Study|Other|0|||
147652101|NCT00592592|532548347|FG000|Overall Study|Patient found ineligible upon chart review|1|||
147237813|NCT02555683|531042532|FG001|Overall Study|Lack of Efficacy|0|||
147573334|NCT00185458|532255866|FG000|Contraception Phase|Protocol Violation|2|||
147573335|NCT00185458|532255866|FG000|Contraception Phase|Physician Decision|2|||
147573336|NCT00185458|532255866|FG000|Contraception Phase|Withdrawal by Subject|7|||
147573337|NCT00185458|532255866|FG000|HRT Phase|Adverse Event|18|||
147573338|NCT00185458|532255866|FG000|HRT Phase|Lost to Follow-up|4|||
147573339|NCT00185458|532255866|FG000|HRT Phase|Protocol Violation|2|||
147573340|NCT00185458|532255866|FG000|HRT Phase|Withdrawal by Subject|3|||
147573341|NCT03503318|532255867|FG000|Overall Study|Death|1|||
147573342|NCT03503318|532255868|FG001|Overall Study|Death|0|||
147573343|NCT03503318|532255869|FG002|Overall Study|Death|4|||
147573344|NCT03503318|532255867|FG000|Overall Study|Adverse Event|3|||
147573345|NCT03503318|532255868|FG001|Overall Study|Adverse Event|4|||
147573346|NCT03503318|532255869|FG002|Overall Study|Adverse Event|2|||
147573347|NCT03503318|532255867|FG000|Overall Study|Withdrawal by Subject|12|||
147573348|NCT03503318|532255868|FG001|Overall Study|Withdrawal by Subject|17|||
147573349|NCT03503318|532255869|FG002|Overall Study|Withdrawal by Subject|16|||
147573350|NCT03503318|532255867|FG000|Overall Study|Protocol Violation|5|||
147573351|NCT03503318|532255868|FG001|Overall Study|Protocol Violation|0|||
147573352|NCT03503318|532255869|FG002|Overall Study|Protocol Violation|3|||
147573353|NCT03503318|532255867|FG000|Overall Study|Lost to Follow-up|17|||
147573354|NCT03503318|532255868|FG001|Overall Study|Lost to Follow-up|15|||
147573355|NCT03503318|532255869|FG002|Overall Study|Lost to Follow-up|12|||
147573356|NCT03503318|532255867|FG000|Overall Study|Other than specified|1|||
147573357|NCT03503318|532255868|FG001|Overall Study|Other than specified|3|||
147573358|NCT03503318|532255869|FG002|Overall Study|Other than specified|3|||
147573359|NCT00424047|532255874|FG000|Blinded Treatment (Up to 03 Aug 2005)|Adverse Event|18|||
147573360|NCT00424047|532255875|FG001|Blinded Treatment (Up to 03 Aug 2005)|Adverse Event|12|||
147573361|NCT00424047|532255874|FG000|Blinded Treatment (Up to 03 Aug 2005)|Progression of disease|67|||
147573362|NCT00424047|532255875|FG001|Blinded Treatment (Up to 03 Aug 2005)|Progression of disease|122|||
147573363|NCT00424047|532255874|FG000|Blinded Treatment (Up to 03 Aug 2005)|Lack of therapeutic effect|1|||
147573364|NCT00424047|532255875|FG001|Blinded Treatment (Up to 03 Aug 2005)|Lack of therapeutic effect|3|||
147573365|NCT00424047|532255874|FG000|Blinded Treatment (Up to 03 Aug 2005)|Withdrawal by Subject|23|||
147573366|NCT00424047|532255875|FG001|Blinded Treatment (Up to 03 Aug 2005)|Withdrawal by Subject|8|||
147573367|NCT00424047|532255874|FG000|Blinded Treatment (Up to 03 Aug 2005)|Death|11|||
147573368|NCT00424047|532255875|FG001|Blinded Treatment (Up to 03 Aug 2005)|Death|10|||
147573369|NCT00424047|532255874|FG000|Blinded Treatment (Up to 03 Aug 2005)|Other|2|||
147573370|NCT00424047|532255875|FG001|Blinded Treatment (Up to 03 Aug 2005)|Other|1|||
147573371|NCT00424047|532255874|FG000|On Study at Time of Unblinding|Adverse Event|22|||
147573372|NCT00424047|532255875|FG001|On Study at Time of Unblinding|Adverse Event|12|||
147573373|NCT00424047|532255874|FG000|On Study at Time of Unblinding|Progression of disease|92|||
147573374|NCT00424047|532255875|FG001|On Study at Time of Unblinding|Progression of disease|128|||
147573375|NCT00424047|532255874|FG000|On Study at Time of Unblinding|Lack of Efficacy|1|||
147573376|NCT00424047|532255875|FG001|On Study at Time of Unblinding|Lack of Efficacy|3|||
147573377|NCT00424047|532255874|FG000|On Study at Time of Unblinding|Withdrawal by Subject|24|||
147573378|NCT00424047|532255875|FG001|On Study at Time of Unblinding|Withdrawal by Subject|9|||
147573379|NCT00424047|532255874|FG000|On Study at Time of Unblinding|Death|11|||
147573380|NCT00424047|532255875|FG001|On Study at Time of Unblinding|Death|11|||
147573381|NCT00424047|532255874|FG000|On Study at Time of Unblinding|Other|5|||
147573382|NCT00424047|532255875|FG001|On Study at Time of Unblinding|Other|4|||
147573383|NCT00424047|532255874|FG000|Long Term Extension (Up to 25 Jun 2013)|Adverse Event|1|||
147652102|NCT03585712|532548348|FG000|Treatment Period 1|Protocol Violation|1|||
147652103|NCT03585712|532548349|FG001|Treatment Period 1|Protocol Violation|0|||
147652104|NCT03585712|532548350|FG002|Treatment Period 1|Protocol Violation|0|||
147652105|NCT03585712|532548348|FG000|Treatment Periods 2 and 3|Protocol Violation|0|||
147140010|NCT02820844|530681410|FG001|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0|||
147140011|NCT02820844|530681411|FG002|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0|||
147140012|NCT02820844|530681412|FG003|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0|||
147140013|NCT02820844|530681413|FG004|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|2|||
147140014|NCT02820844|530681414|FG005|Open-label(3rd Treatment-Up to 48 Weeks)|Reached stopping criteria|0|||
147140015|NCT02820844|530681409|FG000|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
147140016|NCT02820844|530681410|FG001|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
147140017|NCT02820844|530681411|FG002|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
147140018|NCT02820844|530681412|FG003|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
147140019|NCT02820844|530681413|FG004|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|0|||
147140020|NCT02820844|530681414|FG005|Open-label(3rd Treatment-Up to 48 Weeks)|Withdrawal by Subject|1|||
147573384|NCT00424047|532255875|FG001|Long Term Extension (Up to 25 Jun 2013)|Adverse Event|0|||
147573385|NCT00424047|532255874|FG000|Long Term Extension (Up to 25 Jun 2013)|Death|0|||
147573386|NCT00424047|532255875|FG001|Long Term Extension (Up to 25 Jun 2013)|Death|1|||
147573387|NCT00424047|532255874|FG000|Long Term Extension (Up to 25 Jun 2013)|Other|12|||
147573388|NCT00424047|532255875|FG001|Long Term Extension (Up to 25 Jun 2013)|Other|4|||
147573389|NCT00424047|532255874|FG000|Long Term Extension (Up to 25 Jun 2013)|Progression of Disease|7|||
147573390|NCT00424047|532255875|FG001|Long Term Extension (Up to 25 Jun 2013)|Progression of Disease|3|||
147573391|NCT00424047|532255874|FG000|Long Term Extension (Up to 25 Jun 2013)|Withdrawal by Subject|1|||
147573392|NCT00424047|532255875|FG001|Long Term Extension (Up to 25 Jun 2013)|Withdrawal by Subject|0|||
147573393|NCT01010503|532255877|FG000|Overall Study|Adverse Event|1|||
147573394|NCT01010503|532255877|FG000|Overall Study|Death|1|||
147573395|NCT01154231|532255878|FG000|Overall Study|Safety Unassessable, No Drug Admin.|1|||
147573396|NCT01154231|532255878|FG000|Overall Study|No Info. After 1st Day, No Drug Admin.|1|||
147573397|NCT01952691|532257388|FG000|Overall Study|Lost to Follow-up|2|||
147573398|NCT00199901|532257389|FG000|Overall Study|Protocol Violation|2|||
147573399|NCT00199901|532257390|FG001|Overall Study|Protocol Violation|0|||
147573400|NCT00199901|532257389|FG000|Overall Study|Withdrawal by Subject|1|||
147573401|NCT00199901|532257390|FG001|Overall Study|Withdrawal by Subject|0|||
147573402|NCT00199901|532257389|FG000|Overall Study|Progressive Disease|24|||
147573403|NCT00199901|532257390|FG001|Overall Study|Progressive Disease|24|||
147573404|NCT01958294|532257400|FG000|Overall Study|Clinical Circumstances|2|||
147573405|NCT02566850|532257401|FG000|Overall Study|Protocol Violation|1|||
147573406|NCT03599193|532257402|FG000|Overall Study|Adverse Event|0|||
147573407|NCT03599193|532257403|FG001|Overall Study|Adverse Event|2|||
147140021|NCT02266147|530681416|FG000|PART 1: Dose Escalation|Physician Decision|0|||
147140022|NCT02266147|530681417|FG001|PART 1: Dose Escalation|Physician Decision|0|||
147140023|NCT02266147|530681418|FG002|PART 1: Dose Escalation|Physician Decision|1|||
147140024|NCT02266147|530681419|FG003|PART 1: Dose Escalation|Physician Decision|0|||
147140025|NCT02266147|530681416|FG000|PART 1: Dose Escalation|Lack of Efficacy|0|||
147140026|NCT02266147|530681417|FG001|PART 1: Dose Escalation|Lack of Efficacy|2|||
147140027|NCT02266147|530681418|FG002|PART 1: Dose Escalation|Lack of Efficacy|1|||
147140028|NCT02266147|530681419|FG003|PART 1: Dose Escalation|Lack of Efficacy|1|||
147140029|NCT02266147|530681416|FG000|PART 1: Dose Escalation|Study Terminated by Sponsor|0|||
147140030|NCT02266147|530681417|FG001|PART 1: Dose Escalation|Study Terminated by Sponsor|0|||
147140031|NCT02266147|530681418|FG002|PART 1: Dose Escalation|Study Terminated by Sponsor|1|||
147140032|NCT02266147|530681419|FG003|PART 1: Dose Escalation|Study Terminated by Sponsor|3|||
147140033|NCT02266147|530681416|FG000|PART 1: Dose Escalation|Other|1|||
147140034|NCT02266147|530681417|FG001|PART 1: Dose Escalation|Other|1|||
147140035|NCT02266147|530681418|FG002|PART 1: Dose Escalation|Other|0|||
147140036|NCT02266147|530681419|FG003|PART 1: Dose Escalation|Other|0|||
147140037|NCT02266147|530681416|FG000|PART 2: Dose Expansion|Lack of Efficacy|1|||
147140038|NCT02266147|530681417|FG001|PART 2: Dose Expansion|Lack of Efficacy|0|||
147140039|NCT02266147|530681418|FG002|PART 2: Dose Expansion|Lack of Efficacy|0|||
147140040|NCT02266147|530681419|FG003|PART 2: Dose Expansion|Lack of Efficacy|1|||
147140041|NCT02266147|530681416|FG000|PART 2: Dose Expansion|Study Terminated by Sponsor|6|||
147140042|NCT02266147|530681417|FG001|PART 2: Dose Expansion|Study Terminated by Sponsor|0|||
147140043|NCT02266147|530681418|FG002|PART 2: Dose Expansion|Study Terminated by Sponsor|0|||
147140044|NCT02266147|530681419|FG003|PART 2: Dose Expansion|Study Terminated by Sponsor|8|||
147140045|NCT00573391|530681420|FG000|Overall Study|study stopped|2|||
147140046|NCT00573391|530681421|FG001|Overall Study|study stopped|2|||
147140047|NCT00573391|530681420|FG000|Overall Study|Death|1|||
147140048|NCT00573391|530681421|FG001|Overall Study|Death|0|||
147140049|NCT00413660|530681424|FG000|Up To Week 12|Adverse Event|1|||
147140050|NCT00413660|530681425|FG001|Up To Week 12|Adverse Event|3|||
147140051|NCT00413660|530681426|FG002|Up To Week 12|Adverse Event|1|||
147140052|NCT00413660|530681427|FG003|Up To Week 12|Adverse Event|4|||
147140053|NCT00413660|530681428|FG004|Up To Week 12|Adverse Event|6|||
147140054|NCT00413660|530681429|FG005|Up To Week 12|Adverse Event|4|||
147140055|NCT00413660|530681430|FG006|Up To Week 12|Adverse Event|1|||
147140056|NCT00413660|530681431|FG007|Up To Week 12|Adverse Event|0|||
147140057|NCT00413660|530681432|FG008|Up To Week 12|Adverse Event|0|||
147140058|NCT00413660|530681433|FG009|Up To Week 12|Adverse Event|0|||
147140059|NCT00413660|530681434|FG010|Up To Week 12|Adverse Event|0|||
147237814|NCT02555683|531042533|FG002|Overall Study|Lack of Efficacy|0|||
147573408|NCT03599193|532257402|FG000|Overall Study|Withdrawal by Subject|1|||
147573409|NCT03599193|532257403|FG001|Overall Study|Withdrawal by Subject|0|||
147140060|NCT00413660|530681424|FG000|Up To Week 12|Lack of Efficacy|2|||
147140061|NCT00413660|530681425|FG001|Up To Week 12|Lack of Efficacy|0|||
147140062|NCT00413660|530681426|FG002|Up To Week 12|Lack of Efficacy|0|||
147237815|NCT02555683|531042531|FG000|Overall Study|Death|0|||
147237816|NCT02555683|531042532|FG001|Overall Study|Death|1|||
147237817|NCT02555683|531042533|FG002|Overall Study|Death|2|||
147140063|NCT00413660|530681427|FG003|Up To Week 12|Lack of Efficacy|0|||
147140064|NCT00413660|530681428|FG004|Up To Week 12|Lack of Efficacy|0|||
147140065|NCT00413660|530681429|FG005|Up To Week 12|Lack of Efficacy|0|||
147140066|NCT00413660|530681430|FG006|Up To Week 12|Lack of Efficacy|5|||
147140067|NCT00413660|530681431|FG007|Up To Week 12|Lack of Efficacy|0|||
147573410|NCT03599193|532257402|FG000|Overall Study|Protocol Violation|1|||
147573411|NCT03599193|532257403|FG001|Overall Study|Protocol Violation|0|||
147140068|NCT00413660|530681432|FG008|Up To Week 12|Lack of Efficacy|0|||
147140069|NCT00413660|530681433|FG009|Up To Week 12|Lack of Efficacy|0|||
147140070|NCT00413660|530681434|FG010|Up To Week 12|Lack of Efficacy|0|||
147140071|NCT00413660|530681424|FG000|Up To Week 12|Lost to Follow-up|0|||
147140072|NCT00413660|530681425|FG001|Up To Week 12|Lost to Follow-up|1|||
147140073|NCT00413660|530681426|FG002|Up To Week 12|Lost to Follow-up|0|||
147140074|NCT00413660|530681427|FG003|Up To Week 12|Lost to Follow-up|0|||
147140075|NCT00413660|530681428|FG004|Up To Week 12|Lost to Follow-up|1|||
147140076|NCT00413660|530681429|FG005|Up To Week 12|Lost to Follow-up|0|||
147140077|NCT00413660|530681430|FG006|Up To Week 12|Lost to Follow-up|0|||
147140078|NCT00413660|530681431|FG007|Up To Week 12|Lost to Follow-up|0|||
147140079|NCT00413660|530681432|FG008|Up To Week 12|Lost to Follow-up|0|||
147140080|NCT00413660|530681433|FG009|Up To Week 12|Lost to Follow-up|0|||
147140081|NCT00413660|530681434|FG010|Up To Week 12|Lost to Follow-up|0|||
147140082|NCT00413660|530681424|FG000|Up To Week 12|Withdrawal by Subject|0|||
147140083|NCT00413660|530681425|FG001|Up To Week 12|Withdrawal by Subject|2|||
147140084|NCT00413660|530681426|FG002|Up To Week 12|Withdrawal by Subject|0|||
147140085|NCT00413660|530681427|FG003|Up To Week 12|Withdrawal by Subject|2|||
147140086|NCT00413660|530681428|FG004|Up To Week 12|Withdrawal by Subject|0|||
147140087|NCT00413660|530681429|FG005|Up To Week 12|Withdrawal by Subject|2|||
147140088|NCT00413660|530681430|FG006|Up To Week 12|Withdrawal by Subject|2|||
147140089|NCT00413660|530681431|FG007|Up To Week 12|Withdrawal by Subject|0|||
147140090|NCT00413660|530681432|FG008|Up To Week 12|Withdrawal by Subject|0|||
147140091|NCT00413660|530681433|FG009|Up To Week 12|Withdrawal by Subject|0|||
147140092|NCT00413660|530681434|FG010|Up To Week 12|Withdrawal by Subject|0|||
147140093|NCT00413660|530681424|FG000|Up To Week 12|Randomized, Not Treated|1|||
147140094|NCT00413660|530681425|FG001|Up To Week 12|Randomized, Not Treated|0|||
147140095|NCT00413660|530681426|FG002|Up To Week 12|Randomized, Not Treated|0|||
147140096|NCT00413660|530681427|FG003|Up To Week 12|Randomized, Not Treated|1|||
147140097|NCT00413660|530681428|FG004|Up To Week 12|Randomized, Not Treated|0|||
147140098|NCT00413660|530681429|FG005|Up To Week 12|Randomized, Not Treated|0|||
147140099|NCT00413660|530681430|FG006|Up To Week 12|Randomized, Not Treated|0|||
147140100|NCT00413660|530681431|FG007|Up To Week 12|Randomized, Not Treated|0|||
147140101|NCT00413660|530681432|FG008|Up To Week 12|Randomized, Not Treated|0|||
147140102|NCT00413660|530681433|FG009|Up To Week 12|Randomized, Not Treated|0|||
147140103|NCT00413660|530681434|FG010|Up To Week 12|Randomized, Not Treated|0|||
147140104|NCT00413660|530681424|FG000|Up To Week 12|Other|3|||
147140105|NCT00413660|530681425|FG001|Up To Week 12|Other|1|||
147140106|NCT00413660|530681426|FG002|Up To Week 12|Other|6|||
147140107|NCT00413660|530681427|FG003|Up To Week 12|Other|1|||
147140108|NCT00413660|530681428|FG004|Up To Week 12|Other|2|||
147140109|NCT00413660|530681429|FG005|Up To Week 12|Other|4|||
147140110|NCT00413660|530681430|FG006|Up To Week 12|Other|3|||
147140111|NCT00413660|530681431|FG007|Up To Week 12|Other|0|||
147140112|NCT00413660|530681432|FG008|Up To Week 12|Other|0|||
147140113|NCT00413660|530681433|FG009|Up To Week 12|Other|0|||
147140114|NCT00413660|530681434|FG010|Up To Week 12|Other|0|||
147140115|NCT00413660|530681424|FG000|Post Week 12|Adverse Event|2|||
147140116|NCT00413660|530681425|FG001|Post Week 12|Adverse Event|0|||
147140117|NCT00413660|530681426|FG002|Post Week 12|Adverse Event|2|||
147237818|NCT02555683|531042531|FG000|Overall Study|Adverse Event|1|||
147652106|NCT03585712|532548349|FG001|Treatment Periods 2 and 3|Protocol Violation|1|||
147652107|NCT03585712|532548350|FG002|Treatment Periods 2 and 3|Protocol Violation|1|||
147652108|NCT03585712|532548348|FG000|Treatment Periods 2 and 3|Withdrawal by Subject|0|||
147652109|NCT03585712|532548349|FG001|Treatment Periods 2 and 3|Withdrawal by Subject|2|||
147652110|NCT03585712|532548350|FG002|Treatment Periods 2 and 3|Withdrawal by Subject|0|||
147652111|NCT03585712|532548348|FG000|Treatment Periods 2 and 3|Physician Decision|0|||
147652112|NCT03585712|532548349|FG001|Treatment Periods 2 and 3|Physician Decision|0|||
147652113|NCT03585712|532548350|FG002|Treatment Periods 2 and 3|Physician Decision|2|||
147652114|NCT02886884|532548351|FG000|Follow-up|Withdrawal by Subject|0|||
147652115|NCT02886884|532548352|FG001|Follow-up|Withdrawal by Subject|0|||
147652116|NCT02886884|532548353|FG002|Follow-up|Withdrawal by Subject|0|||
147140118|NCT00413660|530681427|FG003|Post Week 12|Adverse Event|1|||
147140119|NCT00413660|530681428|FG004|Post Week 12|Adverse Event|4|||
147140120|NCT00413660|530681429|FG005|Post Week 12|Adverse Event|2|||
147140121|NCT00413660|530681430|FG006|Post Week 12|Adverse Event|2|||
147140122|NCT00413660|530681431|FG007|Post Week 12|Adverse Event|0|||
147140123|NCT00413660|530681432|FG008|Post Week 12|Adverse Event|0|||
147140124|NCT00413660|530681433|FG009|Post Week 12|Adverse Event|0|||
147140125|NCT00413660|530681434|FG010|Post Week 12|Adverse Event|0|||
147140126|NCT00413660|530681424|FG000|Post Week 12|Lack of Efficacy|0|||
147140127|NCT00413660|530681425|FG001|Post Week 12|Lack of Efficacy|0|||
147140128|NCT00413660|530681426|FG002|Post Week 12|Lack of Efficacy|1|||
147140129|NCT00413660|530681427|FG003|Post Week 12|Lack of Efficacy|0|||
147140130|NCT00413660|530681428|FG004|Post Week 12|Lack of Efficacy|0|||
147140131|NCT00413660|530681429|FG005|Post Week 12|Lack of Efficacy|0|||
147237819|NCT02555683|531042532|FG001|Overall Study|Adverse Event|0|||
147652117|NCT02886884|532548354|FG003|Follow-up|Withdrawal by Subject|1|||
147652118|NCT02697734|532548360|FG000|Core Phase - up to Week 48|Withdrawal by Subject|4|||
147573412|NCT03599193|532257402|FG000|Overall Study|Lost to Follow-up|0|||
147140132|NCT00413660|530681430|FG006|Post Week 12|Lack of Efficacy|0|||
147140133|NCT00413660|530681431|FG007|Post Week 12|Lack of Efficacy|0|||
147140134|NCT00413660|530681432|FG008|Post Week 12|Lack of Efficacy|0|||
147140135|NCT00413660|530681433|FG009|Post Week 12|Lack of Efficacy|1|||
147140136|NCT00413660|530681434|FG010|Post Week 12|Lack of Efficacy|0|||
147140137|NCT00413660|530681424|FG000|Post Week 12|Lost to Follow-up|0|||
147140138|NCT00413660|530681425|FG001|Post Week 12|Lost to Follow-up|1|||
147140139|NCT00413660|530681426|FG002|Post Week 12|Lost to Follow-up|1|||
147140140|NCT00413660|530681427|FG003|Post Week 12|Lost to Follow-up|0|||
147140141|NCT00413660|530681428|FG004|Post Week 12|Lost to Follow-up|0|||
147140142|NCT00413660|530681429|FG005|Post Week 12|Lost to Follow-up|0|||
147140143|NCT00413660|530681430|FG006|Post Week 12|Lost to Follow-up|0|||
147140144|NCT00413660|530681431|FG007|Post Week 12|Lost to Follow-up|0|||
147140145|NCT00413660|530681432|FG008|Post Week 12|Lost to Follow-up|0|||
147140146|NCT00413660|530681433|FG009|Post Week 12|Lost to Follow-up|0|||
147140147|NCT00413660|530681434|FG010|Post Week 12|Lost to Follow-up|0|||
147140148|NCT00413660|530681424|FG000|Post Week 12|Withdrawal by Subject|0|||
147140149|NCT00413660|530681425|FG001|Post Week 12|Withdrawal by Subject|1|||
147140150|NCT00413660|530681426|FG002|Post Week 12|Withdrawal by Subject|1|||
147140151|NCT00413660|530681427|FG003|Post Week 12|Withdrawal by Subject|0|||
147140152|NCT00413660|530681428|FG004|Post Week 12|Withdrawal by Subject|1|||
147140153|NCT00413660|530681429|FG005|Post Week 12|Withdrawal by Subject|0|||
147140154|NCT00413660|530681430|FG006|Post Week 12|Withdrawal by Subject|0|||
147140155|NCT00413660|530681431|FG007|Post Week 12|Withdrawal by Subject|0|||
147140156|NCT00413660|530681432|FG008|Post Week 12|Withdrawal by Subject|0|||
147140157|NCT00413660|530681433|FG009|Post Week 12|Withdrawal by Subject|0|||
147140158|NCT00413660|530681434|FG010|Post Week 12|Withdrawal by Subject|1|||
147140159|NCT00413660|530681424|FG000|Post Week 12|Other|1|||
147140160|NCT00413660|530681425|FG001|Post Week 12|Other|2|||
147140161|NCT00413660|530681426|FG002|Post Week 12|Other|3|||
147140162|NCT00413660|530681427|FG003|Post Week 12|Other|0|||
147140163|NCT00413660|530681428|FG004|Post Week 12|Other|1|||
147140164|NCT00413660|530681429|FG005|Post Week 12|Other|1|||
147140165|NCT00413660|530681430|FG006|Post Week 12|Other|1|||
147140166|NCT00413660|530681431|FG007|Post Week 12|Other|0|||
147140167|NCT00413660|530681432|FG008|Post Week 12|Other|0|||
147140168|NCT00413660|530681433|FG009|Post Week 12|Other|0|||
147140169|NCT00413660|530681434|FG010|Post Week 12|Other|0|||
147140170|NCT03896477|530681435|FG000|Overall Study|Met Ineligibility Criteria During the Study|1|||
147140171|NCT03896477|530681436|FG001|Overall Study|Met Ineligibility Criteria During the Study|1|||
147140172|NCT03896477|530681437|FG002|Overall Study|Met Ineligibility Criteria During the Study|2|||
147140173|NCT03896477|530681435|FG000|Overall Study|Parent Requested Withdrawal|8|||
147140174|NCT03896477|530681436|FG001|Overall Study|Parent Requested Withdrawal|12|||
147140175|NCT03896477|530681437|FG002|Overall Study|Parent Requested Withdrawal|9|||
147140176|NCT03896477|530681435|FG000|Overall Study|Adverse Event|0|||
147140177|NCT03896477|530681436|FG001|Overall Study|Adverse Event|0|||
147140178|NCT03896477|530681437|FG002|Overall Study|Adverse Event|1|||
147140179|NCT03896477|530681435|FG000|Overall Study|Death|1|||
147140180|NCT03896477|530681436|FG001|Overall Study|Death|0|||
147140181|NCT03896477|530681437|FG002|Overall Study|Death|0|||
147140182|NCT03896477|530681435|FG000|Overall Study|Other|5|||
147140183|NCT03896477|530681436|FG001|Overall Study|Other|6|||
147140184|NCT03896477|530681437|FG002|Overall Study|Other|7|||
147140185|NCT03896477|530681435|FG000|Overall Study|Lost to Follow-up|2|||
147140186|NCT03896477|530681436|FG001|Overall Study|Lost to Follow-up|1|||
147140187|NCT03896477|530681437|FG002|Overall Study|Lost to Follow-up|1|||
147140188|NCT01791517|530681439|FG000|Phase I: Period 1|Withdrawal by Subject|0|||
147140189|NCT01791517|530681440|FG001|Phase I: Period 1|Withdrawal by Subject|1|||
147140190|NCT01791517|530681441|FG002|Phase I: Period 1|Withdrawal by Subject|1|||
147140191|NCT01791517|530681442|FG003|Phase I: Period 1|Withdrawal by Subject|0|||
147140192|NCT01791517|530681443|FG004|Phase I: Period 1|Withdrawal by Subject|1|||
147140193|NCT01791517|530681444|FG005|Phase I: Period 1|Withdrawal by Subject|1|||
147140194|NCT01791517|530681445|FG006|Phase I: Period 1|Withdrawal by Subject|0|||
147140195|NCT01791517|530681446|FG007|Phase I: Period 1|Withdrawal by Subject|0|||
147140196|NCT01791517|530681447|FG008|Phase I: Period 1|Withdrawal by Subject|0|||
147140197|NCT01791517|530681448|FG009|Phase I: Period 1|Withdrawal by Subject|0|||
147140198|NCT01791517|530681449|FG010|Phase I: Period 1|Withdrawal by Subject|0|||
147237820|NCT02555683|531042533|FG002|Overall Study|Adverse Event|1|||
147237821|NCT02555683|531042531|FG000|Overall Study|Subject/guardian decision|12|||
147140199|NCT01791517|530681450|FG011|Phase I: Period 1|Withdrawal by Subject|0|||
147140200|NCT01791517|530681439|FG000|Phase I: Period 1|Adverse Event|0|||
147140201|NCT01791517|530681440|FG001|Phase I: Period 1|Adverse Event|0|||
147140202|NCT01791517|530681441|FG002|Phase I: Period 1|Adverse Event|1|||
147237822|NCT02555683|531042532|FG001|Overall Study|Subject/guardian decision|12|||
147573413|NCT03599193|532257403|FG001|Overall Study|Lost to Follow-up|1|||
147140203|NCT01791517|530681442|FG003|Phase I: Period 1|Adverse Event|1|||
147140204|NCT01791517|530681443|FG004|Phase I: Period 1|Adverse Event|0|||
147140205|NCT01791517|530681444|FG005|Phase I: Period 1|Adverse Event|0|||
147237823|NCT02555683|531042533|FG002|Overall Study|Subject/guardian decision|22|||
147237824|NCT02555683|531042531|FG000|Overall Study|Death post Treatment/safety period|0|||
147237825|NCT02555683|531042532|FG001|Overall Study|Death post Treatment/safety period|1|||
147237826|NCT02555683|531042533|FG002|Overall Study|Death post Treatment/safety period|0|||
147237827|NCT01397890|531042535|FG000|Overall Study|Withdrawal by Subject|7|||
147237828|NCT01397890|531042536|FG001|Overall Study|Withdrawal by Subject|11|||
147237829|NCT01397890|531042535|FG000|Overall Study|Eligibility Criteria Not Fulfilled|7|||
147237830|NCT01397890|531042536|FG001|Overall Study|Eligibility Criteria Not Fulfilled|6|||
147237831|NCT01397890|531042535|FG000|Overall Study|Death|2|||
147237832|NCT01397890|531042536|FG001|Overall Study|Death|3|||
147237833|NCT01397890|531042535|FG000|Overall Study|Lost to Follow-up|1|||
147237834|NCT01397890|531042536|FG001|Overall Study|Lost to Follow-up|4|||
147237835|NCT01397890|531042535|FG000|Overall Study|Condition under Investigation Worsened|1|||
147237836|NCT01397890|531042536|FG001|Overall Study|Condition under Investigation Worsened|3|||
147237837|NCT01397890|531042535|FG000|Overall Study|Adverse Event|1|||
147237838|NCT01397890|531042536|FG001|Overall Study|Adverse Event|2|||
147237839|NCT01397890|531042535|FG000|Overall Study|Severe Non-Compliance to Protocol|2|||
147237840|NCT01397890|531042536|FG001|Overall Study|Severe Non-Compliance to Protocol|1|||
147237841|NCT01397890|531042535|FG000|Overall Study|Others|2|||
147237842|NCT01397890|531042536|FG001|Overall Study|Others|1|||
147237843|NCT02924571|531042537|FG000|Overall Study|Lost to Follow-up|1|||
147237844|NCT02924571|531042538|FG001|Overall Study|Lost to Follow-up|1|||
147237845|NCT02924571|531042539|FG002|Overall Study|Lost to Follow-up|0|||
147237846|NCT00434954|531042543|FG000|Overall Study|Adverse Event|17|||
147237847|NCT00434954|531042544|FG001|Overall Study|Adverse Event|2|||
147237848|NCT00434954|531042543|FG000|Overall Study|Entry criteria not met|14|||
147237849|NCT00434954|531042544|FG001|Overall Study|Entry criteria not met|16|||
147237850|NCT00434954|531042543|FG000|Overall Study|Lost to Follow-up|0|||
147237851|NCT00434954|531042544|FG001|Overall Study|Lost to Follow-up|1|||
147318618|NCT00519636|531331777|FG003|Washout Period|Per doctors request|0|||
147318619|NCT00519636|531331774|FG000|Washout Period|Subject randomized in error|0|||
147318620|NCT00519636|531331775|FG001|Washout Period|Subject randomized in error|0|||
147318621|NCT00519636|531331776|FG002|Washout Period|Subject randomized in error|1|||
147573414|NCT00798603|532257404|FG000|Overall Study|Still on treatment as of 11/6/2012|1|||
147573415|NCT00798603|532257404|FG000|Overall Study|Withdrawal by Subject|10|||
147573416|NCT00798603|532257404|FG000|Overall Study|Adverse Event|22|||
147573417|NCT00798603|532257404|FG000|Overall Study|Physician Decision|1|||
147573418|NCT00798603|532257404|FG000|Overall Study|Lack of insurance coverage|1|||
147573419|NCT04372238|532257407|FG000|Overall Study|Duplicate|3|||
147573420|NCT04372238|532257408|FG001|Overall Study|Duplicate|3|||
147573421|NCT04372238|532257407|FG000|Overall Study|Did not consent for data linkage|6|||
147573422|NCT04372238|532257408|FG001|Overall Study|Did not consent for data linkage|10|||
147573423|NCT04241458|532257409|FG000|Overall Study|Withdrawal by Subject|0|||
147573424|NCT04241458|532257410|FG001|Overall Study|Withdrawal by Subject|0|||
147573425|NCT04241458|532257411|FG002|Overall Study|Withdrawal by Subject|0|||
147573426|NCT04241458|532257412|FG003|Overall Study|Withdrawal by Subject|0|||
147573427|NCT04241458|532257413|FG004|Overall Study|Withdrawal by Subject|1|||
147573428|NCT06144424|532257414|FG000|Overall Study|Withdrawal by Subject|2|||
147573429|NCT06144424|532257415|FG001|Overall Study|Withdrawal by Subject|0|||
147573430|NCT06144424|532257414|FG000|Overall Study|Incarceration|1|||
147573431|NCT06144424|532257415|FG001|Overall Study|Incarceration|0|||
147573432|NCT02832063|532257416|FG000|Overall Study|Adverse Event|2|||
147573433|NCT02832063|532257417|FG001|Overall Study|Adverse Event|1|||
147573434|NCT02832063|532257416|FG000|Overall Study|Physician Decision|5|||
147573435|NCT02832063|532257417|FG001|Overall Study|Physician Decision|7|||
147573436|NCT02832063|532257416|FG000|Overall Study|Lost to Follow-up|15|||
147573437|NCT02832063|532257417|FG001|Overall Study|Lost to Follow-up|8|||
147573438|NCT02832063|532257416|FG000|Overall Study|Withdrawal by Subject|10|||
147573439|NCT02832063|532257417|FG001|Overall Study|Withdrawal by Subject|21|||
147573440|NCT02832063|532257416|FG000|Overall Study|Other|2|||
147573441|NCT02832063|532257417|FG001|Overall Study|Other|1|||
147573442|NCT03733730|532257418|FG000|Overall Study|Lost to Follow-up|1|||
147573443|NCT03733730|532257419|FG001|Overall Study|Lost to Follow-up|32|||
147573444|NCT03733730|532257418|FG000|Overall Study|Other|1|||
147573445|NCT03733730|532257419|FG001|Overall Study|Other|0|||
147573446|NCT03733730|532257418|FG000|Overall Study|Adverse Event|0|||
147573447|NCT03733730|532257419|FG001|Overall Study|Adverse Event|4|||
147573448|NCT03733730|532257418|FG000|Overall Study|Death|0|||
147573449|NCT03733730|532257419|FG001|Overall Study|Death|5|||
147573450|NCT03733730|532257418|FG000|Overall Study|Withdrawal by Subject|0|||
147573451|NCT03733730|532257419|FG001|Overall Study|Withdrawal by Subject|8|||
147573452|NCT00772603|532257420|FG000|Overall Study|Withdrawal by Subject|11|||
147573453|NCT00772603|532257421|FG001|Overall Study|Withdrawal by Subject|10|||
147573454|NCT00772603|532257422|FG002|Overall Study|Withdrawal by Subject|6|||
147573455|NCT00772603|532257420|FG000|Overall Study|Adverse Event|37|||
147573456|NCT00772603|532257421|FG001|Overall Study|Adverse Event|18|||
147573457|NCT00772603|532257422|FG002|Overall Study|Adverse Event|10|||
147573458|NCT00772603|532257420|FG000|Overall Study|Subject Non-compliance|1|||
147573459|NCT00772603|532257421|FG001|Overall Study|Subject Non-compliance|6|||
147573460|NCT00772603|532257422|FG002|Overall Study|Subject Non-compliance|4|||
147573461|NCT00772603|532257420|FG000|Overall Study|Protocol Violation|0|||
147573462|NCT00772603|532257421|FG001|Overall Study|Protocol Violation|1|||
147573463|NCT00772603|532257422|FG002|Overall Study|Protocol Violation|1|||
147573464|NCT00772603|532257420|FG000|Overall Study|Lost to Follow-up|1|||
147652119|NCT02697734|532548361|FG001|Core Phase - up to Week 48|Withdrawal by Subject|0|||
147652120|NCT02697734|532548360|FG000|Core Phase - up to Week 48|Adverse Event|1|||
147652121|NCT02697734|532548361|FG001|Core Phase - up to Week 48|Adverse Event|2|||
147652122|NCT02697734|532548360|FG000|Core Phase - up to Week 48|Physician Decision|1|||
147652123|NCT02697734|532548361|FG001|Core Phase - up to Week 48|Physician Decision|0|||
147652124|NCT02697734|532548360|FG000|Optional Extension Phase|Adverse Event|5|||
147652125|NCT02697734|532548361|FG001|Optional Extension Phase|Adverse Event|1|||
147652126|NCT02697734|532548360|FG000|Optional Extension Phase|Physician Decision|0|||
147652127|NCT02697734|532548361|FG001|Optional Extension Phase|Physician Decision|1|||
147652128|NCT02324699|532548362|FG000|Overall Study|study terminated|1|||
147652129|NCT03970200|532548363|FG000|Overall Study|Death|2|||
147652130|NCT03970200|532548364|FG001|Overall Study|Death|2|||
147652131|NCT03970200|532548365|FG002|Overall Study|Death|1|||
147652132|NCT03970200|532548363|FG000|Overall Study|Subject re-enrolled into Upper GI|0|||
147652133|NCT03970200|532548364|FG001|Overall Study|Subject re-enrolled into Upper GI|0|||
147652134|NCT03970200|532548365|FG002|Overall Study|Subject re-enrolled into Upper GI|1|||
147652135|NCT01607346|532548366|FG000|Overall Study|Adverse Event|3|||
147652136|NCT01098162|532548367|FG000|Overall Study|Adverse Event|37|||
147652137|NCT01098162|532548367|FG000|Overall Study|Lack of Efficacy|4|||
147652138|NCT01098162|532548367|FG000|Overall Study|Wish of Patient|7|||
147652139|NCT01098162|532548367|FG000|Overall Study|Lost to Follow-up|9|||
147573465|NCT00772603|532257421|FG001|Overall Study|Lost to Follow-up|5|||
147573466|NCT00772603|532257422|FG002|Overall Study|Lost to Follow-up|2|||
147573467|NCT00772603|532257420|FG000|Overall Study|Physician Decision|0|||
147573468|NCT00772603|532257421|FG001|Overall Study|Physician Decision|0|||
147573469|NCT00772603|532257422|FG002|Overall Study|Physician Decision|1|||
147573470|NCT00772603|532257420|FG000|Overall Study|Other|2|||
147573471|NCT00772603|532257421|FG001|Overall Study|Other|0|||
147573472|NCT00772603|532257422|FG002|Overall Study|Other|2|||
147573473|NCT00081653|532257424|FG000|Overall Study|Adverse Event|23|||
147573474|NCT00081653|532257425|FG001|Overall Study|Adverse Event|17|||
147573475|NCT00081653|532257424|FG000|Overall Study|Lost to Follow-up|2|||
147573476|NCT00081653|532257425|FG001|Overall Study|Lost to Follow-up|4|||
147573477|NCT00081653|532257424|FG000|Overall Study|Refused Treatment|18|||
147573478|NCT00081653|532257425|FG001|Overall Study|Refused Treatment|14|||
147573479|NCT00081653|532257424|FG000|Overall Study|Low bone mineral density|1|||
147573480|NCT00081653|532257425|FG001|Overall Study|Low bone mineral density|0|||
147573481|NCT00081653|532257424|FG000|Overall Study|Bone loss|2|||
147573482|NCT00081653|532257425|FG001|Overall Study|Bone loss|0|||
147573483|NCT00081653|532257424|FG000|Overall Study|Participant leaving country|1|||
147573484|NCT00081653|532257425|FG001|Overall Study|Participant leaving country|0|||
147573485|NCT00081653|532257424|FG000|Overall Study|Loss of bone mass|0|||
147573486|NCT00081653|532257425|FG001|Overall Study|Loss of bone mass|2|||
147573487|NCT02663349|532257426|FG000|Overall Study|Withdrawal by Subject|6|||
147573488|NCT00928057|532257428|FG000|Overall Study|Adverse Event|1|||
147652140|NCT01098162|532548367|FG000|Overall Study|Lack of Efficacy & Wish of Patient|5|||
147652141|NCT01098162|532548367|FG000|Overall Study|Adverse Event & Lack of Efficacy|6|||
147652142|NCT01098162|532548367|FG000|Overall Study|Adverse Event & Wish of Patient|13|||
147652143|NCT01098162|532548367|FG000|Overall Study|Adverse Event & Lost to Follow-up|2|||
147140206|NCT01791517|530681445|FG006|Phase I: Period 1|Adverse Event|0|||
147140207|NCT01791517|530681446|FG007|Phase I: Period 1|Adverse Event|0|||
147573489|NCT00928057|532257429|FG001|Overall Study|Adverse Event|2|||
147573490|NCT00928057|532257428|FG000|Overall Study|Withdrawal by Subject|1|||
147573491|NCT00928057|532257429|FG001|Overall Study|Withdrawal by Subject|0|||
147573492|NCT00928057|532257428|FG000|Overall Study|Lost to Follow-up|0|||
147573493|NCT00928057|532257429|FG001|Overall Study|Lost to Follow-up|1|||
147140208|NCT01791517|530681447|FG008|Phase I: Period 1|Adverse Event|0|||
147140209|NCT01791517|530681448|FG009|Phase I: Period 1|Adverse Event|0|||
147573494|NCT00928057|532257428|FG000|Overall Study|Protocol Violation|0|||
147573495|NCT00928057|532257429|FG001|Overall Study|Protocol Violation|1|||
147573496|NCT02451696|532257430|FG000|Overall Study|Surgery postponed|1|||
147573497|NCT02451696|532257431|FG001|Overall Study|Surgery postponed|0|||
147573498|NCT01557751|532257432|FG000|Overall Study|Physician Decision|3|||
147573499|NCT03674892|532257434|FG000|Overall Study|Lack of Efficacy|5|||
147573500|NCT03674892|532257434|FG000|Overall Study|Lost to Follow-up|3|||
147573501|NCT03674892|532257434|FG000|Overall Study|Migraine|2|||
147573502|NCT03674892|532257434|FG000|Overall Study|Excessive Tearing|1|||
147573503|NCT03674892|532257434|FG000|Overall Study|Increased Eye Pain|1|||
147652144|NCT01098162|532548367|FG000|Overall Study|AE & Lack of Efficacy & Wish of Patient|1|||
147652145|NCT01098162|532548367|FG000|Overall Study|Wish of Patient & Lost to Follow-up|1|||
147652146|NCT01098162|532548367|FG000|Overall Study|Other Reason|1|||
147652147|NCT01098162|532548367|FG000|Overall Study|Reason Unknown|26|||
147652148|NCT01605825|532548368|FG000|Overall Study|Adverse Event|4|||
147652149|NCT01605825|532548369|FG001|Overall Study|Adverse Event|2|||
147652150|NCT01605825|532548368|FG000|Overall Study|Withdrawal by Subject|0|||
147652151|NCT01605825|532548369|FG001|Overall Study|Withdrawal by Subject|1|||
147652152|NCT01605825|532548368|FG000|Overall Study|Non-Compliance -Investigational Drug|3|||
147652153|NCT01605825|532548369|FG001|Overall Study|Non-Compliance -Investigational Drug|0|||
147652154|NCT01605825|532548368|FG000|Overall Study|Non-Compliance with Protocol|3|||
147652155|NCT01605825|532548369|FG001|Overall Study|Non-Compliance with Protocol|0|||
147652156|NCT00830518|532548370|FG000|Overall Study|Progressive Disease|18|||
147652157|NCT00830518|532548371|FG001|Overall Study|Progressive Disease|8|||
147652158|NCT00830518|532548370|FG000|Overall Study|Symptomatic Deterioration|4|||
147652159|NCT00830518|532548371|FG001|Overall Study|Symptomatic Deterioration|1|||
147652160|NCT00830518|532548370|FG000|Overall Study|Adverse Event|14|||
147652161|NCT00830518|532548371|FG001|Overall Study|Adverse Event|1|||
147652162|NCT00830518|532548370|FG000|Overall Study|Withdrawal by Patient|2|||
147652163|NCT00830518|532548371|FG001|Overall Study|Withdrawal by Patient|0|||
147652164|NCT00830518|532548370|FG000|Overall Study|Reason not Specified|8|||
147652165|NCT00830518|532548371|FG001|Overall Study|Reason not Specified|1|||
147652166|NCT02155322|532548374|FG000|Overall Study|Adverse Event|1|||
147652167|NCT02155322|532548374|FG000|Overall Study|Physician Decision|1|||
147652168|NCT02155322|532548374|FG000|Overall Study|Relapse/Recurrence|8|||
147652169|NCT02155322|532548374|FG000|Overall Study|Withdrawal by Subject|4|||
147652170|NCT00586898|532548386|FG000|Overall Study|Adverse Event|1|||
147652171|NCT00586898|532548386|FG000|Overall Study|Patiemt Non-compliance|1|||
147652172|NCT00586898|532548386|FG000|Overall Study|Evaluable for Toxicity Only|5|||
147652173|NCT00636961|532548387|FG000|Period 1|Administrative problems|1|||
147652174|NCT00636961|532548388|FG001|Period 1|Administrative problems|1|||
147652175|NCT00636961|532548387|FG000|Period 2|Adverse Event|1|||
147652176|NCT00636961|532548388|FG001|Period 2|Adverse Event|0|||
147652177|NCT02179749|532548392|FG000|Overall Study|Adverse Event|0|||
147652178|NCT02179749|532548393|FG001|Overall Study|Adverse Event|0|||
147652179|NCT02179749|532548394|FG002|Overall Study|Adverse Event|1|||
147140210|NCT01791517|530681449|FG010|Phase I: Period 1|Adverse Event|0|||
147140211|NCT01791517|530681450|FG011|Phase I: Period 1|Adverse Event|0|||
147140212|NCT01791517|530681439|FG000|Phase I: Period 1|Unsatisfactory Lens Fitting|1|||
147140213|NCT01791517|530681440|FG001|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
147140214|NCT01791517|530681441|FG002|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
147140215|NCT01791517|530681442|FG003|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
147140216|NCT01791517|530681443|FG004|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
147140217|NCT01791517|530681444|FG005|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
147140218|NCT01791517|530681445|FG006|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
147140219|NCT01791517|530681446|FG007|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
147140220|NCT01791517|530681447|FG008|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
147140221|NCT01791517|530681448|FG009|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
147140222|NCT01791517|530681449|FG010|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
147140223|NCT01791517|530681450|FG011|Phase I: Period 1|Unsatisfactory Lens Fitting|0|||
147140224|NCT01791517|530681439|FG000|Phase I: Period 1|Protocol Violation|0|||
147140225|NCT01791517|530681440|FG001|Phase I: Period 1|Protocol Violation|1|||
147140226|NCT01791517|530681441|FG002|Phase I: Period 1|Protocol Violation|0|||
147140227|NCT01791517|530681442|FG003|Phase I: Period 1|Protocol Violation|0|||
147140228|NCT01791517|530681443|FG004|Phase I: Period 1|Protocol Violation|0|||
147140229|NCT01791517|530681444|FG005|Phase I: Period 1|Protocol Violation|0|||
147140230|NCT01791517|530681445|FG006|Phase I: Period 1|Protocol Violation|0|||
147140231|NCT01791517|530681446|FG007|Phase I: Period 1|Protocol Violation|0|||
147140232|NCT01791517|530681447|FG008|Phase I: Period 1|Protocol Violation|0|||
147140233|NCT01791517|530681448|FG009|Phase I: Period 1|Protocol Violation|0|||
147140234|NCT01791517|530681449|FG010|Phase I: Period 1|Protocol Violation|0|||
147140235|NCT01791517|530681450|FG011|Phase I: Period 1|Protocol Violation|0|||
147140236|NCT01791517|530681439|FG000|Phase I: Period 1|Lost to Follow-up|0|||
147140237|NCT01791517|530681440|FG001|Phase I: Period 1|Lost to Follow-up|0|||
147140238|NCT01791517|530681441|FG002|Phase I: Period 1|Lost to Follow-up|0|||
147652180|NCT02179749|532548392|FG000|Overall Study|Withdrawal by Subject|0|||
147652181|NCT02179749|532548393|FG001|Overall Study|Withdrawal by Subject|0|||
147652182|NCT02179749|532548394|FG002|Overall Study|Withdrawal by Subject|1|||
147652183|NCT01841567|532548395|FG000|Overall Study|Adverse Event|3|||
147652184|NCT01573754|532548400|FG000|Overall Study|Noncompliance or remission not achieved|3|||
147140239|NCT01791517|530681442|FG003|Phase I: Period 1|Lost to Follow-up|1|||
147140240|NCT01791517|530681443|FG004|Phase I: Period 1|Lost to Follow-up|0|||
147140241|NCT01791517|530681444|FG005|Phase I: Period 1|Lost to Follow-up|0|||
147140242|NCT01791517|530681445|FG006|Phase I: Period 1|Lost to Follow-up|1|||
147140243|NCT01791517|530681446|FG007|Phase I: Period 1|Lost to Follow-up|0|||
147652185|NCT01573754|532548401|FG001|Overall Study|Noncompliance or remission not achieved|15|||
147652186|NCT01994902|532548402|FG000|Test Period 1|Withdrawal by Subject|3|||
147652187|NCT01994902|532548403|FG001|Test Period 1|Withdrawal by Subject|0|||
147652188|NCT01994902|532548402|FG000|Test Period 1|device deficiency with adverse event|0|||
147652189|NCT01994902|532548403|FG001|Test Period 1|device deficiency with adverse event|1|||
147652190|NCT01994902|532548402|FG000|Test Period 1|Adverse Event|2|||
147652191|NCT01994902|532548403|FG001|Test Period 1|Adverse Event|1|||
147652192|NCT01994902|532548402|FG000|Test Period 1|Lack of Efficacy|0|||
147652193|NCT01994902|532548403|FG001|Test Period 1|Lack of Efficacy|1|||
147652194|NCT01994902|532548402|FG000|Test Period 1|bag too small|1|||
147652195|NCT01994902|532548403|FG001|Test Period 1|bag too small|0|||
147652196|NCT01994902|532548402|FG000|Test Period 2|Withdrawal by Subject|0|||
147652197|NCT01994902|532548403|FG001|Test Period 2|Withdrawal by Subject|2|||
147652198|NCT01994902|532548402|FG000|Test Period 2|Lack of Efficacy|0|||
147140244|NCT01791517|530681447|FG008|Phase I: Period 1|Lost to Follow-up|1|||
147140245|NCT01791517|530681448|FG009|Phase I: Period 1|Lost to Follow-up|1|||
147140246|NCT01791517|530681449|FG010|Phase I: Period 1|Lost to Follow-up|0|||
147140247|NCT01791517|530681450|FG011|Phase I: Period 1|Lost to Follow-up|0|||
147140248|NCT01791517|530681439|FG000|Phase I: Period 1|Lens Handling DIfficulties|0|||
147140249|NCT01791517|530681440|FG001|Phase I: Period 1|Lens Handling DIfficulties|0|||
147652199|NCT01994902|532548403|FG001|Test Period 2|Lack of Efficacy|1|||
147652200|NCT01994902|532548402|FG000|Test Period 2|Other|0|||
147652201|NCT01994902|532548403|FG001|Test Period 2|Other|3|||
147140250|NCT01791517|530681441|FG002|Phase I: Period 1|Lens Handling DIfficulties|0|||
147140251|NCT01791517|530681442|FG003|Phase I: Period 1|Lens Handling DIfficulties|0|||
147140252|NCT01791517|530681443|FG004|Phase I: Period 1|Lens Handling DIfficulties|0|||
147140253|NCT01791517|530681444|FG005|Phase I: Period 1|Lens Handling DIfficulties|0|||
147140254|NCT01791517|530681445|FG006|Phase I: Period 1|Lens Handling DIfficulties|0|||
147140255|NCT01791517|530681446|FG007|Phase I: Period 1|Lens Handling DIfficulties|0|||
147140256|NCT01791517|530681447|FG008|Phase I: Period 1|Lens Handling DIfficulties|0|||
147140257|NCT01791517|530681448|FG009|Phase I: Period 1|Lens Handling DIfficulties|0|||
147140258|NCT01791517|530681449|FG010|Phase I: Period 1|Lens Handling DIfficulties|0|||
147140259|NCT01791517|530681450|FG011|Phase I: Period 1|Lens Handling DIfficulties|1|||
147140260|NCT01791517|530681439|FG000|Phase I: Period 2|Unsatisfactory Lens Fit|1|||
147140261|NCT01791517|530681440|FG001|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
147140262|NCT01791517|530681441|FG002|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
147140263|NCT01791517|530681442|FG003|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
147140264|NCT01791517|530681443|FG004|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
147140265|NCT01791517|530681444|FG005|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
147140266|NCT01791517|530681445|FG006|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
147140267|NCT01791517|530681446|FG007|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
147140268|NCT01791517|530681447|FG008|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
147140269|NCT01791517|530681448|FG009|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
147140270|NCT01791517|530681449|FG010|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
147140271|NCT01791517|530681450|FG011|Phase I: Period 2|Unsatisfactory Lens Fit|0|||
147140272|NCT01791517|530681439|FG000|Phase I: Period 2|Protocol Violation|0|||
147140273|NCT01791517|530681440|FG001|Phase I: Period 2|Protocol Violation|0|||
147140274|NCT01791517|530681441|FG002|Phase I: Period 2|Protocol Violation|0|||
147140275|NCT01791517|530681442|FG003|Phase I: Period 2|Protocol Violation|1|||
147140276|NCT01791517|530681443|FG004|Phase I: Period 2|Protocol Violation|0|||
147140277|NCT01791517|530681444|FG005|Phase I: Period 2|Protocol Violation|0|||
147140278|NCT01791517|530681445|FG006|Phase I: Period 2|Protocol Violation|0|||
147140279|NCT01791517|530681446|FG007|Phase I: Period 2|Protocol Violation|0|||
147140280|NCT01791517|530681447|FG008|Phase I: Period 2|Protocol Violation|0|||
147140281|NCT01791517|530681448|FG009|Phase I: Period 2|Protocol Violation|0|||
147140282|NCT01791517|530681449|FG010|Phase I: Period 2|Protocol Violation|0|||
147652202|NCT04378569|532550220|FG000|Overall Study|Adverse Event|0|||
147652203|NCT04378569|532550221|FG001|Overall Study|Adverse Event|0|||
147652204|NCT04378569|532550222|FG002|Overall Study|Adverse Event|2|||
147652205|NCT04378569|532550223|FG003|Overall Study|Adverse Event|0|||
147652206|NCT04378569|532550224|FG004|Overall Study|Adverse Event|3|||
147652207|NCT04378569|532550225|FG005|Overall Study|Adverse Event|3|||
147652208|NCT04378569|532550220|FG000|Overall Study|Lost to Follow-up|0|||
147652209|NCT04378569|532550221|FG001|Overall Study|Lost to Follow-up|3|||
147140283|NCT01791517|530681450|FG011|Phase I: Period 2|Protocol Violation|0|||
147652210|NCT04378569|532550222|FG002|Overall Study|Lost to Follow-up|1|||
147652211|NCT04378569|532550223|FG003|Overall Study|Lost to Follow-up|0|||
147140284|NCT01791517|530681439|FG000|Phase I: Period 2|Withdrawal by Subject|0|||
147140285|NCT01791517|530681440|FG001|Phase I: Period 2|Withdrawal by Subject|0|||
147140286|NCT01791517|530681441|FG002|Phase I: Period 2|Withdrawal by Subject|0|||
147140287|NCT01791517|530681442|FG003|Phase I: Period 2|Withdrawal by Subject|0|||
147140288|NCT01791517|530681443|FG004|Phase I: Period 2|Withdrawal by Subject|0|||
147140289|NCT01791517|530681444|FG005|Phase I: Period 2|Withdrawal by Subject|0|||
147140290|NCT01791517|530681445|FG006|Phase I: Period 2|Withdrawal by Subject|0|||
147140291|NCT01791517|530681446|FG007|Phase I: Period 2|Withdrawal by Subject|0|||
147140292|NCT01791517|530681447|FG008|Phase I: Period 2|Withdrawal by Subject|0|||
147652212|NCT04378569|532550224|FG004|Overall Study|Lost to Follow-up|1|||
147652213|NCT04378569|532550225|FG005|Overall Study|Lost to Follow-up|1|||
147652214|NCT04378569|532550220|FG000|Overall Study|Protocol Violation|0|||
147652215|NCT04378569|532550221|FG001|Overall Study|Protocol Violation|0|||
147140293|NCT01791517|530681448|FG009|Phase I: Period 2|Withdrawal by Subject|1|||
147573504|NCT03674892|532257434|FG000|Overall Study|Increased Facial Pain|1|||
147573505|NCT03674892|532257434|FG000|Overall Study|Sinus Irritation|1|||
147573506|NCT03674892|532257434|FG000|Overall Study|Sinus Infection|1|||
147573507|NCT05099380|532257435|FG000|Overall Study|Subject enrolled in error|1|||
147573508|NCT05099380|532257436|FG001|Overall Study|Subject enrolled in error|0|||
147573509|NCT05099380|532257435|FG000|Overall Study|Study Procedure|1|||
147573510|NCT05099380|532257436|FG001|Overall Study|Study Procedure|0|||
147573511|NCT05099380|532257435|FG000|Overall Study|Protocol Violation|1|||
147573512|NCT05099380|532257436|FG001|Overall Study|Protocol Violation|0|||
147573513|NCT05099380|532257435|FG000|Overall Study|Adverse Event|1|||
147573514|NCT05099380|532257436|FG001|Overall Study|Adverse Event|1|||
147140294|NCT01791517|530681449|FG010|Phase I: Period 2|Withdrawal by Subject|1|||
147140295|NCT01791517|530681450|FG011|Phase I: Period 2|Withdrawal by Subject|0|||
147140296|NCT01791517|530681439|FG000|Phase I: Period 2|Unsatisfactory Visual Response|0|||
147140297|NCT01791517|530681440|FG001|Phase I: Period 2|Unsatisfactory Visual Response|0|||
147140298|NCT01791517|530681441|FG002|Phase I: Period 2|Unsatisfactory Visual Response|0|||
147140299|NCT01791517|530681442|FG003|Phase I: Period 2|Unsatisfactory Visual Response|0|||
147140300|NCT01791517|530681443|FG004|Phase I: Period 2|Unsatisfactory Visual Response|0|||
147140301|NCT01791517|530681444|FG005|Phase I: Period 2|Unsatisfactory Visual Response|0|||
147140302|NCT01791517|530681445|FG006|Phase I: Period 2|Unsatisfactory Visual Response|0|||
147140303|NCT01791517|530681446|FG007|Phase I: Period 2|Unsatisfactory Visual Response|0|||
147140304|NCT01791517|530681447|FG008|Phase I: Period 2|Unsatisfactory Visual Response|0|||
147140305|NCT01791517|530681448|FG009|Phase I: Period 2|Unsatisfactory Visual Response|0|||
147140306|NCT01791517|530681449|FG010|Phase I: Period 2|Unsatisfactory Visual Response|1|||
147573515|NCT05099380|532257435|FG000|Overall Study|Subject no longer meets eligibility criteria|1|||
147573516|NCT05099380|532257436|FG001|Overall Study|Subject no longer meets eligibility criteria|0|||
147652216|NCT04378569|532550222|FG002|Overall Study|Protocol Violation|0|||
147652217|NCT04378569|532550223|FG003|Overall Study|Protocol Violation|0|||
147140307|NCT01791517|530681450|FG011|Phase I: Period 2|Unsatisfactory Visual Response|0|||
147140308|NCT01791517|530681439|FG000|Phase I: Period 2|Lens Discomfort|0|||
147140309|NCT01791517|530681440|FG001|Phase I: Period 2|Lens Discomfort|0|||
147140310|NCT01791517|530681441|FG002|Phase I: Period 2|Lens Discomfort|0|||
147140311|NCT01791517|530681442|FG003|Phase I: Period 2|Lens Discomfort|0|||
147140312|NCT01791517|530681443|FG004|Phase I: Period 2|Lens Discomfort|0|||
147140313|NCT01791517|530681444|FG005|Phase I: Period 2|Lens Discomfort|1|||
147140314|NCT01791517|530681445|FG006|Phase I: Period 2|Lens Discomfort|0|||
147140315|NCT01791517|530681446|FG007|Phase I: Period 2|Lens Discomfort|0|||
147140316|NCT01791517|530681447|FG008|Phase I: Period 2|Lens Discomfort|0|||
147140317|NCT01791517|530681448|FG009|Phase I: Period 2|Lens Discomfort|0|||
147140318|NCT01791517|530681449|FG010|Phase I: Period 2|Lens Discomfort|0|||
147140319|NCT01791517|530681450|FG011|Phase I: Period 2|Lens Discomfort|0|||
147140320|NCT01791517|530681439|FG000|Phase I: Period 2|Lost to Follow-up|0|||
147140321|NCT01791517|530681440|FG001|Phase I: Period 2|Lost to Follow-up|3|||
147140322|NCT01791517|530681441|FG002|Phase I: Period 2|Lost to Follow-up|2|||
147140323|NCT01791517|530681442|FG003|Phase I: Period 2|Lost to Follow-up|0|||
147140324|NCT01791517|530681443|FG004|Phase I: Period 2|Lost to Follow-up|0|||
147140325|NCT01791517|530681444|FG005|Phase I: Period 2|Lost to Follow-up|0|||
147140326|NCT01791517|530681445|FG006|Phase I: Period 2|Lost to Follow-up|0|||
147140327|NCT01791517|530681446|FG007|Phase I: Period 2|Lost to Follow-up|0|||
147140328|NCT01791517|530681447|FG008|Phase I: Period 2|Lost to Follow-up|0|||
147140329|NCT01791517|530681448|FG009|Phase I: Period 2|Lost to Follow-up|0|||
147140330|NCT01791517|530681449|FG010|Phase I: Period 2|Lost to Follow-up|0|||
147140331|NCT01791517|530681450|FG011|Phase I: Period 2|Lost to Follow-up|0|||
147140332|NCT01791517|530681439|FG000|Phase I: Period 3|Lens Discomfort|0|||
147140333|NCT01791517|530681440|FG001|Phase I: Period 3|Lens Discomfort|0|||
147140334|NCT01791517|530681441|FG002|Phase I: Period 3|Lens Discomfort|0|||
147140335|NCT01791517|530681442|FG003|Phase I: Period 3|Lens Discomfort|0|||
147140336|NCT01791517|530681443|FG004|Phase I: Period 3|Lens Discomfort|0|||
147140337|NCT01791517|530681444|FG005|Phase I: Period 3|Lens Discomfort|0|||
147140338|NCT01791517|530681445|FG006|Phase I: Period 3|Lens Discomfort|0|||
147140339|NCT01791517|530681446|FG007|Phase I: Period 3|Lens Discomfort|0|||
147140340|NCT01791517|530681447|FG008|Phase I: Period 3|Lens Discomfort|0|||
147140341|NCT01791517|530681448|FG009|Phase I: Period 3|Lens Discomfort|0|||
147140342|NCT01791517|530681449|FG010|Phase I: Period 3|Lens Discomfort|0|||
147140343|NCT01791517|530681450|FG011|Phase I: Period 3|Lens Discomfort|1|||
147652218|NCT04378569|532550224|FG004|Overall Study|Protocol Violation|0|||
147652219|NCT04378569|532550225|FG005|Overall Study|Protocol Violation|1|||
147652220|NCT04378569|532550220|FG000|Overall Study|Withdrawal by Subject|0|||
147140344|NCT01791517|530681439|FG000|Phase I: Period 3|Lost to Follow-up|0|||
147140345|NCT01791517|530681440|FG001|Phase I: Period 3|Lost to Follow-up|1|||
147140346|NCT01791517|530681441|FG002|Phase I: Period 3|Lost to Follow-up|0|||
147140347|NCT01791517|530681442|FG003|Phase I: Period 3|Lost to Follow-up|0|||
147140348|NCT01791517|530681443|FG004|Phase I: Period 3|Lost to Follow-up|1|||
147140349|NCT01791517|530681444|FG005|Phase I: Period 3|Lost to Follow-up|0|||
147652221|NCT04378569|532550221|FG001|Overall Study|Withdrawal by Subject|6|||
147140350|NCT01791517|530681445|FG006|Phase I: Period 3|Lost to Follow-up|0|||
147237852|NCT00434954|531042543|FG000|Overall Study|Physician Decision|6|||
147140351|NCT01791517|530681446|FG007|Phase I: Period 3|Lost to Follow-up|0|||
147140352|NCT01791517|530681447|FG008|Phase I: Period 3|Lost to Follow-up|0|||
147140353|NCT01791517|530681448|FG009|Phase I: Period 3|Lost to Follow-up|0|||
147140354|NCT01791517|530681449|FG010|Phase I: Period 3|Lost to Follow-up|0|||
147140355|NCT01791517|530681450|FG011|Phase I: Period 3|Lost to Follow-up|0|||
147140356|NCT01791517|530681439|FG000|Phase I: Period 3|Adverse Event|0|||
147140357|NCT01791517|530681440|FG001|Phase I: Period 3|Adverse Event|0|||
147140358|NCT01791517|530681441|FG002|Phase I: Period 3|Adverse Event|0|||
147140359|NCT01791517|530681442|FG003|Phase I: Period 3|Adverse Event|1|||
147140360|NCT01791517|530681443|FG004|Phase I: Period 3|Adverse Event|0|||
147140361|NCT01791517|530681444|FG005|Phase I: Period 3|Adverse Event|0|||
147140362|NCT01791517|530681445|FG006|Phase I: Period 3|Adverse Event|0|||
147140363|NCT01791517|530681446|FG007|Phase I: Period 3|Adverse Event|0|||
147140364|NCT01791517|530681447|FG008|Phase I: Period 3|Adverse Event|0|||
147140365|NCT01791517|530681448|FG009|Phase I: Period 3|Adverse Event|0|||
147140366|NCT01791517|530681449|FG010|Phase I: Period 3|Adverse Event|0|||
147140367|NCT01791517|530681450|FG011|Phase I: Period 3|Adverse Event|0|||
147140368|NCT01791517|530681439|FG000|Phase II|Lost to Follow-up|1|||
147140369|NCT01791517|530681440|FG001|Phase II|Lost to Follow-up|0|||
147140370|NCT01791517|530681441|FG002|Phase II|Lost to Follow-up|1|||
147140371|NCT01791517|530681442|FG003|Phase II|Lost to Follow-up|0|||
147140372|NCT01791517|530681443|FG004|Phase II|Lost to Follow-up|1|||
147140373|NCT01791517|530681444|FG005|Phase II|Lost to Follow-up|2|||
147140374|NCT01791517|530681445|FG006|Phase II|Lost to Follow-up|0|||
147140375|NCT01791517|530681446|FG007|Phase II|Lost to Follow-up|1|||
147140376|NCT01791517|530681447|FG008|Phase II|Lost to Follow-up|1|||
147140377|NCT01791517|530681448|FG009|Phase II|Lost to Follow-up|1|||
147140378|NCT01791517|530681449|FG010|Phase II|Lost to Follow-up|0|||
147140379|NCT01791517|530681450|FG011|Phase II|Lost to Follow-up|0|||
147140380|NCT01791517|530681439|FG000|Phase II|Withdrawal by Subject|1|||
147140381|NCT01791517|530681440|FG001|Phase II|Withdrawal by Subject|0|||
147140382|NCT01791517|530681441|FG002|Phase II|Withdrawal by Subject|0|||
147140383|NCT01791517|530681442|FG003|Phase II|Withdrawal by Subject|0|||
147140384|NCT01791517|530681443|FG004|Phase II|Withdrawal by Subject|0|||
147140385|NCT01791517|530681444|FG005|Phase II|Withdrawal by Subject|2|||
147140386|NCT01791517|530681445|FG006|Phase II|Withdrawal by Subject|0|||
147140387|NCT01791517|530681446|FG007|Phase II|Withdrawal by Subject|1|||
147140388|NCT01791517|530681447|FG008|Phase II|Withdrawal by Subject|0|||
147140389|NCT01791517|530681448|FG009|Phase II|Withdrawal by Subject|0|||
147140390|NCT01791517|530681449|FG010|Phase II|Withdrawal by Subject|1|||
147140391|NCT01791517|530681450|FG011|Phase II|Withdrawal by Subject|0|||
147140392|NCT01791517|530681439|FG000|Phase II|Lack of Efficacy|0|||
147140393|NCT01791517|530681440|FG001|Phase II|Lack of Efficacy|0|||
147140394|NCT01791517|530681441|FG002|Phase II|Lack of Efficacy|0|||
147140395|NCT01791517|530681442|FG003|Phase II|Lack of Efficacy|0|||
147140396|NCT01791517|530681443|FG004|Phase II|Lack of Efficacy|1|||
147140397|NCT01791517|530681444|FG005|Phase II|Lack of Efficacy|0|||
147140398|NCT01791517|530681445|FG006|Phase II|Lack of Efficacy|0|||
147140399|NCT01791517|530681446|FG007|Phase II|Lack of Efficacy|0|||
147140400|NCT01791517|530681447|FG008|Phase II|Lack of Efficacy|0|||
147140401|NCT01791517|530681448|FG009|Phase II|Lack of Efficacy|0|||
147140402|NCT01791517|530681449|FG010|Phase II|Lack of Efficacy|0|||
147140403|NCT01791517|530681450|FG011|Phase II|Lack of Efficacy|0|||
147237853|NCT00434954|531042544|FG001|Overall Study|Physician Decision|3|||
147573517|NCT02842853|532257437|FG000|Overall Study|Non-compliance with the protocol|3|||
147573518|NCT02842853|532257438|FG001|Overall Study|Non-compliance with the protocol|7|||
147573519|NCT02842853|532257439|FG002|Overall Study|Non-compliance with the protocol|2|||
147573520|NCT02842853|532257440|FG003|Overall Study|Non-compliance with the protocol|5|||
147573521|NCT02842853|532257437|FG000|Overall Study|Subject met exclusion criteria|0|||
147573522|NCT02842853|532257438|FG001|Overall Study|Subject met exclusion criteria|1|||
147573523|NCT02842853|532257439|FG002|Overall Study|Subject met exclusion criteria|0|||
147573524|NCT02842853|532257440|FG003|Overall Study|Subject met exclusion criteria|0|||
147140404|NCT01791517|530681439|FG000|Phase II|Adverse Event|0|||
147237854|NCT00434954|531042543|FG000|Overall Study|Protocol Violation|36|||
147140405|NCT01791517|530681440|FG001|Phase II|Adverse Event|0|||
147237855|NCT00434954|531042544|FG001|Overall Study|Protocol Violation|27|||
147573525|NCT02842853|532257437|FG000|Overall Study|Withdrawal by Subject|11|||
147573526|NCT02842853|532257438|FG001|Overall Study|Withdrawal by Subject|13|||
147573527|NCT02842853|532257439|FG002|Overall Study|Withdrawal by Subject|9|||
147652222|NCT04378569|532550222|FG002|Overall Study|Withdrawal by Subject|7|||
147140406|NCT01791517|530681441|FG002|Phase II|Adverse Event|0|||
147140407|NCT01791517|530681442|FG003|Phase II|Adverse Event|0|||
147140408|NCT01791517|530681443|FG004|Phase II|Adverse Event|0|||
147140409|NCT01791517|530681444|FG005|Phase II|Adverse Event|0|||
147140410|NCT01791517|530681445|FG006|Phase II|Adverse Event|2|||
147140411|NCT01791517|530681446|FG007|Phase II|Adverse Event|1|||
147140412|NCT01791517|530681447|FG008|Phase II|Adverse Event|0|||
147140413|NCT01791517|530681448|FG009|Phase II|Adverse Event|1|||
147573528|NCT02842853|532257440|FG003|Overall Study|Withdrawal by Subject|8|||
147140414|NCT01791517|530681449|FG010|Phase II|Adverse Event|0|||
147140415|NCT01791517|530681450|FG011|Phase II|Adverse Event|0|||
147573529|NCT02842853|532257437|FG000|Overall Study|Lost to Follow-up|9|||
147573530|NCT02842853|532257438|FG001|Overall Study|Lost to Follow-up|13|||
147573531|NCT02842853|532257439|FG002|Overall Study|Lost to Follow-up|10|||
147573532|NCT02842853|532257440|FG003|Overall Study|Lost to Follow-up|11|||
147573533|NCT04089553|532257441|FG000|Overall Study|Death|1|||
147573534|NCT04089553|532257442|FG001|Overall Study|Death|1|||
147573535|NCT04089553|532257441|FG000|Overall Study|Progressive disease - objective (AZD4635)|13|||
147573536|NCT04089553|532257442|FG001|Overall Study|Progressive disease - objective (AZD4635)|20|||
147237856|NCT00434954|531042543|FG000|Overall Study|Sponsor decision|1|||
147237857|NCT00434954|531042544|FG001|Overall Study|Sponsor decision|0|||
147237858|NCT00434954|531042543|FG000|Overall Study|Subject decision|8|||
147237859|NCT00434954|531042544|FG001|Overall Study|Subject decision|22|||
147573537|NCT04089553|532257441|FG000|Overall Study|Withdrawal by Subject|3|||
147573538|NCT04089553|532257442|FG001|Overall Study|Withdrawal by Subject|3|||
147573539|NCT04089553|532257441|FG000|Overall Study|Physician Decision|1|||
147573540|NCT04089553|532257442|FG001|Overall Study|Physician Decision|0|||
147573541|NCT04089553|532257441|FG000|Overall Study|Progressive disease - subjective (AZD4635)|6|||
147573542|NCT04089553|532257442|FG001|Overall Study|Progressive disease - subjective (AZD4635)|3|||
147573543|NCT04089553|532257441|FG000|Overall Study|Other|1|||
147573544|NCT04089553|532257442|FG001|Overall Study|Other|0|||
147573545|NCT04089553|532257441|FG000|Overall Study|Adverse Event|1|||
147573546|NCT04089553|532257442|FG001|Overall Study|Adverse Event|1|||
147573547|NCT01175135|532257450|FG000|Overall Study|Adverse Event|2|||
147573548|NCT01175135|532257451|FG001|Overall Study|Adverse Event|5|||
147573549|NCT01175135|532257452|FG002|Overall Study|Adverse Event|3|||
147573550|NCT01175135|532257453|FG003|Overall Study|Adverse Event|4|||
147573551|NCT01175135|532257450|FG000|Overall Study|Death|1|||
147573552|NCT01175135|532257451|FG001|Overall Study|Death|0|||
147573553|NCT01175135|532257452|FG002|Overall Study|Death|0|||
147573554|NCT01175135|532257453|FG003|Overall Study|Death|0|||
147573555|NCT01175135|532257450|FG000|Overall Study|Lack of Efficacy|4|||
147573556|NCT01175135|532257451|FG001|Overall Study|Lack of Efficacy|5|||
147573557|NCT01175135|532257452|FG002|Overall Study|Lack of Efficacy|0|||
147573558|NCT01175135|532257453|FG003|Overall Study|Lack of Efficacy|5|||
147573559|NCT01175135|532257450|FG000|Overall Study|Lost to Follow-up|1|||
147573560|NCT01175135|532257451|FG001|Overall Study|Lost to Follow-up|2|||
147573561|NCT01175135|532257452|FG002|Overall Study|Lost to Follow-up|0|||
147573562|NCT01175135|532257453|FG003|Overall Study|Lost to Follow-up|0|||
147573563|NCT01175135|532257450|FG000|Overall Study|Protocol Violation|1|||
147652223|NCT04378569|532550223|FG003|Overall Study|Withdrawal by Subject|4|||
147652224|NCT04378569|532550224|FG004|Overall Study|Withdrawal by Subject|5|||
147140416|NCT01791517|530681439|FG000|Phase II|Lens Handling Difficulties|0|||
147140417|NCT01791517|530681440|FG001|Phase II|Lens Handling Difficulties|0|||
147140418|NCT01791517|530681441|FG002|Phase II|Lens Handling Difficulties|0|||
147140419|NCT01791517|530681442|FG003|Phase II|Lens Handling Difficulties|0|||
147140420|NCT01791517|530681443|FG004|Phase II|Lens Handling Difficulties|0|||
147140421|NCT01791517|530681444|FG005|Phase II|Lens Handling Difficulties|0|||
147140422|NCT01791517|530681445|FG006|Phase II|Lens Handling Difficulties|0|||
147140423|NCT01791517|530681446|FG007|Phase II|Lens Handling Difficulties|0|||
147140424|NCT01791517|530681447|FG008|Phase II|Lens Handling Difficulties|1|||
147140425|NCT01791517|530681448|FG009|Phase II|Lens Handling Difficulties|0|||
147140426|NCT01791517|530681449|FG010|Phase II|Lens Handling Difficulties|0|||
147140427|NCT01791517|530681450|FG011|Phase II|Lens Handling Difficulties|0|||
147140428|NCT01791517|530681439|FG000|Phase II|Unsatisfactory Lens Fitting|0|||
147140429|NCT01791517|530681440|FG001|Phase II|Unsatisfactory Lens Fitting|0|||
147140430|NCT01791517|530681441|FG002|Phase II|Unsatisfactory Lens Fitting|0|||
147140431|NCT01791517|530681442|FG003|Phase II|Unsatisfactory Lens Fitting|0|||
147140432|NCT01791517|530681443|FG004|Phase II|Unsatisfactory Lens Fitting|0|||
147140433|NCT01791517|530681444|FG005|Phase II|Unsatisfactory Lens Fitting|0|||
147140434|NCT01791517|530681445|FG006|Phase II|Unsatisfactory Lens Fitting|0|||
147140435|NCT01791517|530681446|FG007|Phase II|Unsatisfactory Lens Fitting|0|||
147573564|NCT01175135|532257451|FG001|Overall Study|Protocol Violation|1|||
147573565|NCT01175135|532257452|FG002|Overall Study|Protocol Violation|0|||
147573566|NCT01175135|532257453|FG003|Overall Study|Protocol Violation|0|||
147573567|NCT01175135|532257450|FG000|Overall Study|Withdrawal by Subject|4|||
147573568|NCT01175135|532257451|FG001|Overall Study|Withdrawal by Subject|8|||
147573569|NCT01175135|532257452|FG002|Overall Study|Withdrawal by Subject|5|||
147652225|NCT04378569|532550225|FG005|Overall Study|Withdrawal by Subject|4|||
147140436|NCT01791517|530681447|FG008|Phase II|Unsatisfactory Lens Fitting|0|||
147140437|NCT01791517|530681448|FG009|Phase II|Unsatisfactory Lens Fitting|1|||
147237860|NCT03417219|531042553|FG000|Overall Study|Lost to Follow-up|0|||
147237861|NCT03417219|531042554|FG001|Overall Study|Lost to Follow-up|3|||
147237862|NCT03345914|531042555|FG000|Overall Study|Transition to another study at week 16|80|||
147237863|NCT03345914|531042556|FG001|Overall Study|Transition to another study at week 16|86|||
147573570|NCT01175135|532257453|FG003|Overall Study|Withdrawal by Subject|5|||
147573571|NCT01175135|532257450|FG000|Overall Study|Other|3|||
147573572|NCT01175135|532257451|FG001|Overall Study|Other|1|||
147573573|NCT01175135|532257452|FG002|Overall Study|Other|3|||
147140438|NCT01791517|530681449|FG010|Phase II|Unsatisfactory Lens Fitting|0|||
147140439|NCT01791517|530681450|FG011|Phase II|Unsatisfactory Lens Fitting|0|||
147140440|NCT01791517|530681439|FG000|Phase II|Pre-Existing Ocular Issue|0|||
147140441|NCT01791517|530681440|FG001|Phase II|Pre-Existing Ocular Issue|0|||
147140442|NCT01791517|530681441|FG002|Phase II|Pre-Existing Ocular Issue|0|||
147140443|NCT01791517|530681442|FG003|Phase II|Pre-Existing Ocular Issue|0|||
147140444|NCT01791517|530681443|FG004|Phase II|Pre-Existing Ocular Issue|0|||
147140445|NCT01791517|530681444|FG005|Phase II|Pre-Existing Ocular Issue|0|||
147140446|NCT01791517|530681445|FG006|Phase II|Pre-Existing Ocular Issue|0|||
147140447|NCT01791517|530681446|FG007|Phase II|Pre-Existing Ocular Issue|0|||
147140448|NCT01791517|530681447|FG008|Phase II|Pre-Existing Ocular Issue|0|||
147140449|NCT01791517|530681448|FG009|Phase II|Pre-Existing Ocular Issue|0|||
147140450|NCT01791517|530681449|FG010|Phase II|Pre-Existing Ocular Issue|0|||
147140451|NCT01791517|530681450|FG011|Phase II|Pre-Existing Ocular Issue|1|||
147140452|NCT00589797|530681451|FG000|Overall Study|Death|1|||
147140453|NCT00589797|530681452|FG001|Overall Study|Death|0|||
147140454|NCT00589797|530681451|FG000|Overall Study|Lost to Follow-up|12|||
147140455|NCT00589797|530681452|FG001|Overall Study|Lost to Follow-up|9|||
147140456|NCT00589797|530681451|FG000|Overall Study|Physician Decision|8|||
147140457|NCT00589797|530681452|FG001|Overall Study|Physician Decision|3|||
147140458|NCT00589797|530681451|FG000|Overall Study|Withdrawal by Subject|6|||
147140459|NCT00589797|530681452|FG001|Overall Study|Withdrawal by Subject|5|||
147140460|NCT00589797|530681451|FG000|Overall Study|Non-Randomized Training Subjects|46|||
147140461|NCT00589797|530681452|FG001|Overall Study|Non-Randomized Training Subjects|6|||
147140462|NCT03230318|530681457|FG000|Overall Study|Radiographic disease progression|72|||
147140463|NCT03230318|530681458|FG001|Overall Study|Radiographic disease progression|19|||
147140464|NCT03230318|530681457|FG000|Overall Study|Clinical progression|17|||
147140465|NCT03230318|530681458|FG001|Overall Study|Clinical progression|7|||
147140466|NCT03230318|530681457|FG000|Overall Study|Adverse Event|5|||
147140467|NCT03230318|530681458|FG001|Overall Study|Adverse Event|3|||
147140468|NCT03230318|530681457|FG000|Overall Study|Physician Decision|2|||
147140469|NCT03230318|530681458|FG001|Overall Study|Physician Decision|3|||
147140470|NCT03230318|530681457|FG000|Overall Study|Death|3|||
147140471|NCT03230318|530681458|FG001|Overall Study|Death|2|||
147140472|NCT03230318|530681457|FG000|Overall Study|Lost to Follow-up|1|||
147140473|NCT03230318|530681458|FG001|Overall Study|Lost to Follow-up|0|||
147140474|NCT03230318|530681457|FG000|Overall Study|Withdrawal by Subject|1|||
147140475|NCT03230318|530681458|FG001|Overall Study|Withdrawal by Subject|3|||
147140476|NCT03230318|530681457|FG000|Overall Study|Other|3|||
147140477|NCT03230318|530681458|FG001|Overall Study|Other|7|||
147140478|NCT04011735|530681460|FG000|Overall Study|Withdrawal by Subject|1|||
147140479|NCT04011735|530681461|FG001|Overall Study|Withdrawal by Subject|0|||
147140480|NCT04011735|530681462|FG002|Overall Study|Withdrawal by Subject|1|||
147140481|NCT04011735|530681460|FG000|Overall Study|Met exclusion criteria after study entry|0|||
147140482|NCT04011735|530681461|FG001|Overall Study|Met exclusion criteria after study entry|1|||
147140483|NCT04011735|530681462|FG002|Overall Study|Met exclusion criteria after study entry|0|||
147140484|NCT01459666|530681464|FG000|Overall Study|PI left institution|5|||
147140485|NCT01459666|530681465|FG001|Overall Study|PI left institution|4|||
147140486|NCT01492088|530681466|FG000|Overall Study|Withdrawal by Patient|0|||
147140487|NCT01492088|530681467|FG001|Overall Study|Withdrawal by Patient|2|||
147140488|NCT01492088|530681468|FG002|Overall Study|Withdrawal by Patient|0|||
147140489|NCT01492088|530681466|FG000|Overall Study|Death|1|||
147140490|NCT01492088|530681467|FG001|Overall Study|Death|6|||
147140491|NCT01492088|530681468|FG002|Overall Study|Death|2|||
147140492|NCT01492088|530681466|FG000|Overall Study|Completed Post Treatment Followup (PTFU)|2|||
147140493|NCT01492088|530681467|FG001|Overall Study|Completed Post Treatment Followup (PTFU)|0|||
147140494|NCT01492088|530681468|FG002|Overall Study|Completed Post Treatment Followup (PTFU)|1|||
147140495|NCT01492088|530681466|FG000|Overall Study|Alive at Last Follow-up|0|||
147140496|NCT01492088|530681467|FG001|Overall Study|Alive at Last Follow-up|6|||
147140497|NCT01492088|530681468|FG002|Overall Study|Alive at Last Follow-up|11|||
147140498|NCT00533429|530681469|FG000|Overall Study|Adverse Event|3|||
147140499|NCT00533429|530681470|FG001|Overall Study|Adverse Event|1|||
147237864|NCT03345914|531042557|FG002|Overall Study|Transition to another study at week 16|78|||
147237865|NCT03345914|531042555|FG000|Overall Study|Transition to OLE during follow-up|37|||
147237866|NCT03345914|531042556|FG001|Overall Study|Transition to OLE during follow-up|33|||
147237867|NCT03345914|531042557|FG002|Overall Study|Transition to OLE during follow-up|39|||
147140500|NCT00533429|530681469|FG000|Overall Study|Death|1|||
147140501|NCT00533429|530681470|FG001|Overall Study|Death|0|||
147140502|NCT00533429|530681469|FG000|Overall Study|Withdrawal by Subject|2|||
147140503|NCT00533429|530681470|FG001|Overall Study|Withdrawal by Subject|0|||
147237868|NCT03345914|531042555|FG000|Overall Study|Physician Decision|0|||
147237869|NCT03345914|531042556|FG001|Overall Study|Physician Decision|1|||
147237870|NCT03345914|531042557|FG002|Overall Study|Physician Decision|1|||
147140504|NCT00533429|530681469|FG000|Overall Study|Progressive Disease|12|||
147140505|NCT00533429|530681470|FG001|Overall Study|Progressive Disease|13|||
147140506|NCT00533429|530681469|FG000|Overall Study|Symptomatic deterioration|1|||
147140507|NCT00533429|530681470|FG001|Overall Study|Symptomatic deterioration|2|||
147140508|NCT02379052|530681471|FG000|Overall Study|Protocol Violation|0|||
147140509|NCT02379052|530681472|FG001|Overall Study|Protocol Violation|1|||
147140510|NCT02379052|530681471|FG000|Overall Study|Adverse Event|0|||
147140511|NCT02379052|530681472|FG001|Overall Study|Adverse Event|1|||
147140512|NCT02379052|530681471|FG000|Overall Study|Physician Decision|1|||
147140513|NCT02379052|530681472|FG001|Overall Study|Physician Decision|1|||
147140514|NCT02379052|530681471|FG000|Overall Study|Withdrawal by Subject|2|||
147140515|NCT02379052|530681472|FG001|Overall Study|Withdrawal by Subject|0|||
147140516|NCT02379052|530681471|FG000|Overall Study|Lost to Follow-up|2|||
147140517|NCT02379052|530681472|FG001|Overall Study|Lost to Follow-up|1|||
147140518|NCT02379052|530681471|FG000|Overall Study|Did Not Meet Inc./ Exclusion Criteria|1|||
147140519|NCT02379052|530681472|FG001|Overall Study|Did Not Meet Inc./ Exclusion Criteria|0|||
147140520|NCT02379052|530681471|FG000|Overall Study|Subject was Incarcerated|0|||
147140521|NCT02379052|530681472|FG001|Overall Study|Subject was Incarcerated|1|||
147140522|NCT00127855|530681473|FG000|Primary Vaccination Course|Adverse Event|0|||
147140523|NCT00127855|530681474|FG001|Primary Vaccination Course|Adverse Event|0|||
147140524|NCT00127855|530681475|FG002|Primary Vaccination Course|Adverse Event|1|||
147140525|NCT00127855|530681476|FG003|Primary Vaccination Course|Adverse Event|0|||
147140526|NCT00127855|530681477|FG004|Primary Vaccination Course|Adverse Event|0|||
147140527|NCT00127855|530681473|FG000|Primary Vaccination Course|Withdrawal by Subject|1|||
147140528|NCT00127855|530681474|FG001|Primary Vaccination Course|Withdrawal by Subject|0|||
147140529|NCT00127855|530681475|FG002|Primary Vaccination Course|Withdrawal by Subject|0|||
147140530|NCT00127855|530681476|FG003|Primary Vaccination Course|Withdrawal by Subject|0|||
147140531|NCT00127855|530681477|FG004|Primary Vaccination Course|Withdrawal by Subject|1|||
147140532|NCT00127855|530681473|FG000|Primary Vaccination Course|Lost to Follow-up|1|||
147140533|NCT00127855|530681474|FG001|Primary Vaccination Course|Lost to Follow-up|1|||
147140534|NCT00127855|530681475|FG002|Primary Vaccination Course|Lost to Follow-up|1|||
147140535|NCT00127855|530681476|FG003|Primary Vaccination Course|Lost to Follow-up|0|||
147140536|NCT00127855|530681477|FG004|Primary Vaccination Course|Lost to Follow-up|2|||
147140537|NCT00127855|530681473|FG000|Primary Vaccination Course|Other|0|||
147140538|NCT00127855|530681474|FG001|Primary Vaccination Course|Other|0|||
147140539|NCT00127855|530681475|FG002|Primary Vaccination Course|Other|0|||
147140540|NCT00127855|530681476|FG003|Primary Vaccination Course|Other|0|||
147140541|NCT00127855|530681477|FG004|Primary Vaccination Course|Other|1|||
147140542|NCT02343302|530681478|FG000|Overall Study|Physician Decision|1|||
147140543|NCT02343302|530681479|FG001|Overall Study|Physician Decision|1|||
147140544|NCT01887717|530681480|FG000|Overall Study|Withdrawal by Subject|1|||
147140545|NCT01887717|530681481|FG001|Overall Study|Withdrawal by Subject|7|||
147140546|NCT01887717|530681480|FG000|Overall Study|Physician Decision|0|||
147140547|NCT01887717|530681481|FG001|Overall Study|Physician Decision|2|||
147140548|NCT01887717|530681480|FG000|Overall Study|Administrative reasons|5|||
147140549|NCT01887717|530681481|FG001|Overall Study|Administrative reasons|2|||
147140550|NCT02655887|530681484|FG000|Overall Study|Lost to Follow-up|3|||
147140551|NCT02655887|530681484|FG000|Overall Study|Death|4|||
147140552|NCT02655887|530681484|FG000|Overall Study|Withdrawal by Subject|3|||
147140553|NCT02655887|530681484|FG000|Overall Study|Missed 12-month follow-up visit|4|||
147140554|NCT01299389|530681485|FG000|Double-blind|Adverse Event|45|||
147140555|NCT01299389|530681486|FG001|Double-blind|Adverse Event|27|||
147140556|NCT01299389|530681487|FG002|Double-blind|Adverse Event|0|||
147140557|NCT01299389|530681488|FG003|Double-blind|Adverse Event|0|||
147140558|NCT01299389|530681485|FG000|Double-blind|Lack of Efficacy|45|||
147140559|NCT01299389|530681486|FG001|Double-blind|Lack of Efficacy|21|||
147140560|NCT01299389|530681487|FG002|Double-blind|Lack of Efficacy|0|||
147140561|NCT01299389|530681488|FG003|Double-blind|Lack of Efficacy|0|||
147140562|NCT01299389|530681485|FG000|Double-blind|Lost to Follow-up|2|||
147140563|NCT01299389|530681486|FG001|Double-blind|Lost to Follow-up|1|||
147140564|NCT01299389|530681487|FG002|Double-blind|Lost to Follow-up|0|||
147140565|NCT01299389|530681488|FG003|Double-blind|Lost to Follow-up|0|||
147140566|NCT01299389|530681485|FG000|Double-blind|Withdrawal by Subject|16|||
147140567|NCT01299389|530681486|FG001|Double-blind|Withdrawal by Subject|13|||
147140568|NCT01299389|530681487|FG002|Double-blind|Withdrawal by Subject|0|||
147140569|NCT01299389|530681488|FG003|Double-blind|Withdrawal by Subject|0|||
147140570|NCT01299389|530681485|FG000|Double-blind|Other|1|||
147140571|NCT01299389|530681486|FG001|Double-blind|Other|1|||
147140572|NCT01299389|530681487|FG002|Double-blind|Other|0|||
147140573|NCT01299389|530681488|FG003|Double-blind|Other|0|||
147140574|NCT01299389|530681485|FG000|Double-blind|"fail to meet study population criteria"|0|||
147140575|NCT01299389|530681486|FG001|Double-blind|"fail to meet study population criteria"|1|||
147140576|NCT01299389|530681487|FG002|Double-blind|"fail to meet study population criteria"|0|||
147140577|NCT01299389|530681488|FG003|Double-blind|"fail to meet study population criteria"|0|||
147140578|NCT01299389|530681485|FG000|Post-observational|Other|0|||
147140579|NCT01299389|530681486|FG001|Post-observational|Other|0|||
147140580|NCT01299389|530681487|FG002|Post-observational|Other|12|||
147237871|NCT03345914|531042555|FG000|Overall Study|Withdrawal by Subject|5|||
147237872|NCT03345914|531042556|FG001|Overall Study|Withdrawal by Subject|1|||
147237873|NCT03345914|531042557|FG002|Overall Study|Withdrawal by Subject|2|||
147237874|NCT03345914|531042555|FG000|Overall Study|Other|1|||
147140581|NCT01299389|530681488|FG003|Post-observational|Other|6|||
147140582|NCT02834819|530681489|FG000|Overall Study|Did not complete 7 day follow up call.|5|||
147140583|NCT02834819|530681490|FG001|Overall Study|Did not complete 7 day follow up call.|0|||
147140584|NCT04245709|530681491|FG000|Overall Study|Adverse Event|13|||
147140585|NCT04245709|530681491|FG000|Overall Study|Risk of travel during COVID19 pandemic|1|||
147140586|NCT03637491|530681492|FG000|Overall Study|Death|9|||
147140587|NCT03637491|530681493|FG001|Overall Study|Death|9|||
147140588|NCT03637491|530681494|FG002|Overall Study|Death|5|||
147140589|NCT03637491|530681495|FG003|Overall Study|Death|3|||
147140590|NCT03637491|530681492|FG000|Overall Study|Lost to Follow-up|0|||
147140591|NCT03637491|530681493|FG001|Overall Study|Lost to Follow-up|1|||
147140592|NCT03637491|530681494|FG002|Overall Study|Lost to Follow-up|0|||
147140593|NCT03637491|530681495|FG003|Overall Study|Lost to Follow-up|1|||
147140594|NCT03637491|530681492|FG000|Overall Study|Study Terminated By Sponsor|0|||
147140595|NCT03637491|530681493|FG001|Overall Study|Study Terminated By Sponsor|2|||
147140596|NCT03637491|530681494|FG002|Overall Study|Study Terminated By Sponsor|1|||
147140597|NCT03637491|530681495|FG003|Overall Study|Study Terminated By Sponsor|0|||
147140598|NCT03637491|530681492|FG000|Overall Study|Withdrawal by Subject|1|||
147140599|NCT03637491|530681493|FG001|Overall Study|Withdrawal by Subject|0|||
147140600|NCT03637491|530681494|FG002|Overall Study|Withdrawal by Subject|1|||
147140601|NCT03637491|530681495|FG003|Overall Study|Withdrawal by Subject|2|||
147140602|NCT00889707|530681501|FG000|Overall Study|Adverse Event|1|||
147140603|NCT00889707|530681502|FG001|Overall Study|Adverse Event|0|||
147140604|NCT00889707|530681501|FG000|Overall Study|Withdrawal by Subject|4|||
147140605|NCT00889707|530681502|FG001|Overall Study|Withdrawal by Subject|3|||
147140606|NCT00889707|530681501|FG000|Overall Study|Lost to Follow-up|0|||
147140607|NCT00889707|530681502|FG001|Overall Study|Lost to Follow-up|2|||
147140608|NCT00889707|530681501|FG000|Overall Study|Lack of Efficacy|2|||
147140609|NCT00889707|530681502|FG001|Overall Study|Lack of Efficacy|5|||
147140610|NCT02185534|530681503|FG000|First Period|Withdrawal by Subject|0|||
147140611|NCT02185534|530681504|FG001|First Period|Withdrawal by Subject|0|||
147140612|NCT02185534|530681505|FG002|First Period|Withdrawal by Subject|0|||
147140613|NCT02185534|530681506|FG003|First Period|Withdrawal by Subject|1|||
147140614|NCT02185534|530681507|FG004|First Period|Withdrawal by Subject|0|||
147140615|NCT02185534|530681508|FG005|First Period|Withdrawal by Subject|0|||
147140616|NCT02185534|530681503|FG000|First Washout Period|Withdrawal by Subject|1|||
147140617|NCT02185534|530681504|FG001|First Washout Period|Withdrawal by Subject|0|||
147140618|NCT02185534|530681505|FG002|First Washout Period|Withdrawal by Subject|0|||
147140619|NCT02185534|530681506|FG003|First Washout Period|Withdrawal by Subject|0|||
147140620|NCT02185534|530681507|FG004|First Washout Period|Withdrawal by Subject|1|||
147140621|NCT02185534|530681508|FG005|First Washout Period|Withdrawal by Subject|0|||
147140622|NCT02185534|530681503|FG000|First Washout Period|Protocol Violation|0|||
147140623|NCT02185534|530681504|FG001|First Washout Period|Protocol Violation|0|||
147140624|NCT02185534|530681505|FG002|First Washout Period|Protocol Violation|0|||
147140625|NCT02185534|530681506|FG003|First Washout Period|Protocol Violation|0|||
147140626|NCT02185534|530681507|FG004|First Washout Period|Protocol Violation|0|||
147140627|NCT02185534|530681508|FG005|First Washout Period|Protocol Violation|1|||
147140628|NCT03465722|530681509|FG000|Overall Study|Withdrawal by Subject|21|||
147140629|NCT03465722|530681510|FG001|Overall Study|Withdrawal by Subject|14|||
147140630|NCT03465722|530681509|FG000|Overall Study|Death|89|||
147140631|NCT03465722|530681510|FG001|Overall Study|Death|87|||
147140632|NCT03465722|530681509|FG000|Overall Study|Lost to Follow-up|5|||
147140633|NCT03465722|530681510|FG001|Overall Study|Lost to Follow-up|3|||
147140634|NCT03465722|530681509|FG000|Overall Study|Administrative/Other|33|||
147140635|NCT03465722|530681510|FG001|Overall Study|Administrative/Other|32|||
147573574|NCT01175135|532257453|FG003|Overall Study|Other|0|||
147573575|NCT01175135|532257450|FG000|Overall Study|Randomized But Not Treated|0|||
147573576|NCT01175135|532257451|FG001|Overall Study|Randomized But Not Treated|0|||
147573577|NCT01175135|532257452|FG002|Overall Study|Randomized But Not Treated|1|||
147573578|NCT01175135|532257453|FG003|Overall Study|Randomized But Not Treated|0|||
147573579|NCT01572662|532257454|FG000|Overall Study|Withdrawal by Subject|1|||
147140636|NCT03465722|530681509|FG000|Overall Study|Not treated|1|||
147140637|NCT03465722|530681510|FG001|Overall Study|Not treated|2|||
147140638|NCT03465722|530681509|FG000|Overall Study|Sponsor decision|91|||
147140639|NCT03465722|530681510|FG001|Overall Study|Sponsor decision|98|||
147140640|NCT02041299|530681514|FG000|Overall Study|Adverse Event|9|||
147140641|NCT02041299|530681515|FG001|Overall Study|Adverse Event|3|||
147140642|NCT02041299|530681514|FG000|Overall Study|Lost to Follow-up|4|||
147140643|NCT02041299|530681515|FG001|Overall Study|Lost to Follow-up|1|||
147140644|NCT02041299|530681514|FG000|Overall Study|Physician Decision|1|||
147140645|NCT02041299|530681515|FG001|Overall Study|Physician Decision|1|||
147140646|NCT02041299|530681514|FG000|Overall Study|Withdrawal by Subject|13|||
147140647|NCT02041299|530681515|FG001|Overall Study|Withdrawal by Subject|7|||
147140648|NCT02041299|530681514|FG000|Overall Study|Protocol Violation|11|||
147140649|NCT02041299|530681515|FG001|Overall Study|Protocol Violation|4|||
147140650|NCT02041299|530681514|FG000|Overall Study|Termination of the study|7|||
147573580|NCT01572662|532257455|FG001|Overall Study|Withdrawal by Subject|0|||
147140651|NCT02041299|530681515|FG001|Overall Study|Termination of the study|3|||
147140652|NCT02041299|530681514|FG000|Overall Study|Required bone marrow transplant|0|||
147140653|NCT02041299|530681515|FG001|Overall Study|Required bone marrow transplant|1|||
147140654|NCT02041299|530681514|FG000|Overall Study|Patient stopped dosing on unknown date|1|||
147140655|NCT02041299|530681515|FG001|Overall Study|Patient stopped dosing on unknown date|0|||
147140656|NCT02389465|530681516|FG000|Overall Study|Lost to Follow-up|1|||
147140657|NCT02389465|530681517|FG001|Overall Study|Lost to Follow-up|3|||
147140658|NCT02389465|530681518|FG002|Overall Study|Lost to Follow-up|3|||
147140659|NCT02389465|530681519|FG003|Overall Study|Lost to Follow-up|0|||
147140660|NCT02389465|530681516|FG000|Overall Study|Physician Decision|0|||
147140661|NCT02389465|530681517|FG001|Overall Study|Physician Decision|0|||
147140662|NCT02389465|530681518|FG002|Overall Study|Physician Decision|0|||
147140663|NCT02389465|530681519|FG003|Overall Study|Physician Decision|1|||
147140664|NCT02389465|530681516|FG000|Overall Study|Withdrawal by Subject|0|||
147140665|NCT02389465|530681517|FG001|Overall Study|Withdrawal by Subject|1|||
147140666|NCT02389465|530681518|FG002|Overall Study|Withdrawal by Subject|2|||
147140667|NCT02389465|530681519|FG003|Overall Study|Withdrawal by Subject|2|||
147140668|NCT01635998|530681520|FG000|Overall Study|Death|1|||
147140669|NCT01635998|530681521|FG001|Overall Study|Death|1|||
147140670|NCT01635998|530681520|FG000|Overall Study|Lost to Follow-up|2|||
147140671|NCT01635998|530681521|FG001|Overall Study|Lost to Follow-up|1|||
147140672|NCT01635998|530681520|FG000|Overall Study|Withdrawal by Subject|1|||
147140673|NCT01635998|530681521|FG001|Overall Study|Withdrawal by Subject|5|||
147140674|NCT00846846|530681522|FG000|Overall Study|Death|56|||
147140675|NCT00846846|530681522|FG000|Overall Study|Withdrawal by Subject|19|||
147140676|NCT01925768|530681523|FG000|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1|||
147140677|NCT01925768|530681524|FG001|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
147140678|NCT01925768|530681523|FG000|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1|||
147140679|NCT01925768|530681524|FG001|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|2|||
147140680|NCT01925768|530681523|FG000|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|5|||
147140681|NCT01925768|530681524|FG001|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|10|||
147140682|NCT01925768|530681523|FG000|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|3|||
147140683|NCT01925768|530681524|FG001|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|6|||
147140684|NCT01925768|530681523|FG000|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|1|||
147140685|NCT01925768|530681524|FG001|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|4|||
147140686|NCT01925768|530681523|FG000|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with study drug|0|||
147140687|NCT01925768|530681524|FG001|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with study drug|1|||
147140688|NCT01925768|530681523|FG000|ActiveTreatment/Extension (Weeks 24-104)|Lack of Efficacy|6|||
147140689|NCT01925768|530681524|FG001|ActiveTreatment/Extension (Weeks 24-104)|Lack of Efficacy|6|||
147140690|NCT01925768|530681523|FG000|ActiveTreatment/Extension (Weeks 24-104)|Withdrawal by Subject|7|||
147140691|NCT01925768|530681524|FG001|ActiveTreatment/Extension (Weeks 24-104)|Withdrawal by Subject|9|||
147140692|NCT01925768|530681523|FG000|ActiveTreatment/Extension (Weeks 24-104)|Lost to Follow-up|2|||
147140693|NCT01925768|530681524|FG001|ActiveTreatment/Extension (Weeks 24-104)|Lost to Follow-up|1|||
147140694|NCT01925768|530681523|FG000|ActiveTreatment/Extension (Weeks 24-104)|Death|0|||
147140695|NCT01925768|530681524|FG001|ActiveTreatment/Extension (Weeks 24-104)|Death|1|||
147140696|NCT01925768|530681523|FG000|ActiveTreatment/Extension (Weeks 24-104)|Adverse Event|5|||
147140697|NCT01925768|530681524|FG001|ActiveTreatment/Extension (Weeks 24-104)|Adverse Event|1|||
147140698|NCT04339413|530681528|FG000|Overall Study|Reason Not Specified|2|||
147140699|NCT04339413|530681529|FG001|Overall Study|Reason Not Specified|7|||
147140700|NCT04339413|530681528|FG000|Overall Study|Study Terminated by Sponsor|30|||
147140701|NCT04339413|530681529|FG001|Overall Study|Study Terminated by Sponsor|33|||
147140702|NCT04339413|530681528|FG000|Overall Study|Progressive Disease|9|||
147140703|NCT04339413|530681529|FG001|Overall Study|Progressive Disease|6|||
147140704|NCT04339413|530681528|FG000|Overall Study|Withdrawal by Subject|9|||
147140705|NCT04339413|530681529|FG001|Overall Study|Withdrawal by Subject|10|||
147140706|NCT04339413|530681528|FG000|Overall Study|Physician Decision|3|||
147237875|NCT03345914|531042556|FG001|Overall Study|Other|1|||
147237876|NCT03345914|531042557|FG002|Overall Study|Other|1|||
147237877|NCT03345914|531042555|FG000|Overall Study|Ongoing|0|||
147237878|NCT03345914|531042556|FG001|Overall Study|Ongoing|0|||
147237879|NCT03345914|531042557|FG002|Overall Study|Ongoing|1|||
147237880|NCT02609828|531042558|FG000|Overall Study|Adverse Event|8|||
147445702|NCT01074190|531797430|FG000|Overall Study|Protocol Violation|2|||
147140707|NCT04339413|530681529|FG001|Overall Study|Physician Decision|1|||
147140708|NCT04339413|530681528|FG000|Overall Study|Death|2|||
147445703|NCT01074190|531797431|FG001|Overall Study|Protocol Violation|1|||
147445704|NCT01074190|531797432|FG002|Overall Study|Protocol Violation|0|||
147445705|NCT01074190|531797430|FG000|Overall Study|Delivered in under 90 minutes|0|||
147652226|NCT04378569|532550220|FG000|Overall Study|Lack of response|0|||
147140709|NCT04339413|530681529|FG001|Overall Study|Death|0|||
147140710|NCT04339413|530681528|FG000|Overall Study|Adverse Event|3|||
147140711|NCT04339413|530681529|FG001|Overall Study|Adverse Event|0|||
147237881|NCT02609828|531042559|FG001|Overall Study|Adverse Event|1|||
147237882|NCT02609828|531042560|FG002|Overall Study|Adverse Event|0|||
147140712|NCT04819113|530681530|FG000|Overall Study|Withdrawal by parent/guardian|3|||
147140713|NCT04819113|530681530|FG000|Overall Study|Lost to Follow-up|1|||
147140714|NCT04819113|530681530|FG000|Overall Study|Withdrawn before vaccination|2|||
147140715|NCT00532129|530682817|FG000|Treatment Period|Adverse event/Serious adverse event|25|||
147140716|NCT00532129|530682817|FG000|Treatment Period|Physician Decision|15|||
147140717|NCT00532129|530682817|FG000|Treatment Period|Disease progression|3|||
147573581|NCT01572662|532257454|FG000|Overall Study|Physician Decision|0|||
147573582|NCT01572662|532257455|FG001|Overall Study|Physician Decision|1|||
147140718|NCT00532129|530682817|FG000|Treatment Period|Protocol Violation|1|||
147140719|NCT00532129|530682817|FG000|Treatment Period|Other|5|||
147140720|NCT00532129|530682817|FG000|Follow-up Period|Adverse event/Serious adverse event|1|||
147140721|NCT00532129|530682817|FG000|Follow-up Period|Disease progression|57|||
147140722|NCT00532129|530682817|FG000|Follow-up Period|Lost to Follow-up|1|||
147140723|NCT00532129|530682817|FG000|Follow-up Period|Other|6|||
147140724|NCT03145064|530682818|FG000|Overall Study|Death|24|||
147140725|NCT03145064|530682818|FG000|Overall Study|Lost to Follow-up|3|||
147573583|NCT03364192|532257456|FG000|Overall Study|Ineligible|10|||
147573584|NCT03364192|532257456|FG000|Overall Study|Withdrawal by Subject|5|||
147573585|NCT03364192|532257456|FG000|Overall Study|Lost to Follow-up|1|||
147573586|NCT04547192|532257459|FG000|Period 1: 0-14 Weeks|Incomplete Data|7|||
147140726|NCT03145064|530682818|FG000|Overall Study|Withdrawal by Subject|6|||
147140727|NCT03145064|530682818|FG000|Overall Study|Study ended by sponsor once primary/ secondary analysis was complete and participants discontinued|4|||
147140728|NCT03145064|530682818|FG000|Overall Study|Other: Transferred to Long term Extension (LTE) study BGB-3111-LTE1 (NCT04170283)|4|||
147140729|NCT01396187|530682819|FG000|Overall Study|Adverse Event|0|||
147140730|NCT01396187|530682820|FG001|Overall Study|Adverse Event|1|||
147140731|NCT01396187|530682821|FG002|Overall Study|Adverse Event|0|||
147140732|NCT01396187|530682822|FG003|Overall Study|Adverse Event|0|||
147140733|NCT01396187|530682823|FG004|Overall Study|Adverse Event|0|||
147140734|NCT01396187|530682819|FG000|Overall Study|Withdrawal by Subject|0|||
147140735|NCT01396187|530682820|FG001|Overall Study|Withdrawal by Subject|1|||
147140736|NCT01396187|530682821|FG002|Overall Study|Withdrawal by Subject|1|||
147140737|NCT01396187|530682822|FG003|Overall Study|Withdrawal by Subject|0|||
147140738|NCT01396187|530682823|FG004|Overall Study|Withdrawal by Subject|0|||
147140739|NCT01396187|530682819|FG000|Overall Study|Other|1|||
147140740|NCT01396187|530682820|FG001|Overall Study|Other|1|||
147140741|NCT01396187|530682821|FG002|Overall Study|Other|0|||
147140742|NCT01396187|530682822|FG003|Overall Study|Other|0|||
147140743|NCT01396187|530682823|FG004|Overall Study|Other|1|||
147140744|NCT01898286|530682824|FG000|Overall Study|Withdrawal by Subject|1|||
147140745|NCT01898286|530682824|FG000|Overall Study|Protocol Violation|1|||
147140746|NCT01898286|530682824|FG000|Overall Study|Lost to Follow-up|1|||
147140747|NCT02257242|530682825|FG000|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|1|||
147140748|NCT02257242|530682826|FG001|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
147140749|NCT02257242|530682827|FG002|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
147140750|NCT02257242|530682828|FG003|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
147140751|NCT02257242|530682829|FG004|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
147140752|NCT02257242|530682830|FG005|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
147573587|NCT04547192|532257460|FG001|Period 1: 0-14 Weeks|Incomplete Data|2|||
147573588|NCT04547192|532257461|FG002|Period 1: 0-14 Weeks|Incomplete Data|5|||
147573589|NCT04547192|532257462|FG003|Period 1: 0-14 Weeks|Incomplete Data|1|||
147140753|NCT02257242|530682831|FG006|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
147140754|NCT02257242|530682832|FG007|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
147140755|NCT02257242|530682833|FG008|Overall Study|1 subject removed from study before any treatment due to temporary unavailability of study drug|0|||
147140756|NCT00551031|530682837|FG000|Overall Study|Adverse Event|0|||
147237883|NCT02609828|531042561|FG003|Overall Study|Adverse Event|6|||
147237884|NCT02609828|531042558|FG000|Overall Study|Death|15|||
147237885|NCT02609828|531042559|FG001|Overall Study|Death|1|||
147573590|NCT04547192|532257459|FG000|Period 2: 14-28 Weeks|Incomplete Data|0|||
147573591|NCT04547192|532257460|FG001|Period 2: 14-28 Weeks|Incomplete Data|1|||
147573592|NCT04547192|532257461|FG002|Period 2: 14-28 Weeks|Incomplete Data|1|||
147573593|NCT04547192|532257462|FG003|Period 2: 14-28 Weeks|Incomplete Data|0|||
147237886|NCT02609828|531042560|FG002|Overall Study|Death|1|||
147573594|NCT04547192|532257459|FG000|Period 3: 28-42 Weeks|Incomplete Data|2|||
147573595|NCT04547192|532257460|FG001|Period 3: 28-42 Weeks|Incomplete Data|0|||
147140757|NCT00551031|530682838|FG001|Overall Study|Adverse Event|1|||
147140758|NCT00551031|530682839|FG002|Overall Study|Adverse Event|0|||
147140759|NCT00551031|530682840|FG003|Overall Study|Adverse Event|0|||
147237887|NCT02609828|531042561|FG003|Overall Study|Death|19|||
147573596|NCT04547192|532257461|FG002|Period 3: 28-42 Weeks|Incomplete Data|6|||
147573597|NCT04547192|532257462|FG003|Period 3: 28-42 Weeks|Incomplete Data|0|||
147573598|NCT04547192|532257459|FG000|Period 4: 42-56 Weeks|Incomplete Data|2|||
147140760|NCT00551031|530682841|FG004|Overall Study|Adverse Event|0|||
147140761|NCT00551031|530682837|FG000|Overall Study|Protocol Violation|1|||
147140762|NCT00551031|530682838|FG001|Overall Study|Protocol Violation|1|||
147140763|NCT00551031|530682839|FG002|Overall Study|Protocol Violation|0|||
147140764|NCT00551031|530682840|FG003|Overall Study|Protocol Violation|0|||
147140765|NCT00551031|530682841|FG004|Overall Study|Protocol Violation|0|||
147140766|NCT00551031|530682837|FG000|Overall Study|Lost to Follow-up|0|||
147140767|NCT00551031|530682838|FG001|Overall Study|Lost to Follow-up|1|||
147140768|NCT00551031|530682839|FG002|Overall Study|Lost to Follow-up|0|||
147140769|NCT00551031|530682840|FG003|Overall Study|Lost to Follow-up|1|||
147140770|NCT00551031|530682841|FG004|Overall Study|Lost to Follow-up|1|||
147140771|NCT00551031|530682837|FG000|Overall Study|Withdrawal by Subject|0|||
147140772|NCT00551031|530682838|FG001|Overall Study|Withdrawal by Subject|4|||
147140773|NCT00551031|530682839|FG002|Overall Study|Withdrawal by Subject|1|||
147140774|NCT00551031|530682840|FG003|Overall Study|Withdrawal by Subject|2|||
147140775|NCT00551031|530682841|FG004|Overall Study|Withdrawal by Subject|0|||
147140776|NCT00551031|530682837|FG000|Overall Study|Serious Adverse Event|0|||
147140777|NCT00551031|530682838|FG001|Overall Study|Serious Adverse Event|2|||
147140778|NCT00551031|530682839|FG002|Overall Study|Serious Adverse Event|1|||
147140779|NCT00551031|530682840|FG003|Overall Study|Serious Adverse Event|0|||
147140780|NCT00551031|530682841|FG004|Overall Study|Serious Adverse Event|0|||
147140781|NCT00551031|530682837|FG000|Overall Study|Did not receive vaccine|1|||
147140782|NCT00551031|530682838|FG001|Overall Study|Did not receive vaccine|2|||
147140783|NCT00551031|530682839|FG002|Overall Study|Did not receive vaccine|0|||
147140784|NCT00551031|530682840|FG003|Overall Study|Did not receive vaccine|0|||
147140785|NCT00551031|530682841|FG004|Overall Study|Did not receive vaccine|0|||
147140786|NCT02964273|530682843|FG000|Phase A: Double-blind Period (12 Months)|Adverse Events|1|||
147140787|NCT02964273|530682844|FG001|Phase A: Double-blind Period (12 Months)|Adverse Events|0|||
147140788|NCT02964273|530682845|FG002|Phase A: Double-blind Period (12 Months)|Adverse Events|0|||
147140789|NCT02964273|530682846|FG003|Phase A: Double-blind Period (12 Months)|Adverse Events|0|||
147140790|NCT02964273|530682843|FG000|Phase A: Double-blind Period (12 Months)|Physician Decision|0|||
147140791|NCT02964273|530682844|FG001|Phase A: Double-blind Period (12 Months)|Physician Decision|2|||
147140792|NCT02964273|530682845|FG002|Phase A: Double-blind Period (12 Months)|Physician Decision|0|||
147140793|NCT02964273|530682846|FG003|Phase A: Double-blind Period (12 Months)|Physician Decision|0|||
147140794|NCT02964273|530682843|FG000|Phase A: Double-blind Period (12 Months)|Withdrawal by Subject|3|||
147140795|NCT02964273|530682844|FG001|Phase A: Double-blind Period (12 Months)|Withdrawal by Subject|1|||
147140796|NCT02964273|530682845|FG002|Phase A: Double-blind Period (12 Months)|Withdrawal by Subject|0|||
147140797|NCT02964273|530682846|FG003|Phase A: Double-blind Period (12 Months)|Withdrawal by Subject|0|||
147140798|NCT02964273|530682843|FG000|Phase B: Open-label Period (24 Months)|Adverse Events|0|||
147140799|NCT02964273|530682844|FG001|Phase B: Open-label Period (24 Months)|Adverse Events|0|||
147140800|NCT02964273|530682845|FG002|Phase B: Open-label Period (24 Months)|Adverse Events|0|||
147140801|NCT02964273|530682846|FG003|Phase B: Open-label Period (24 Months)|Adverse Events|2|||
147140802|NCT02964273|530682843|FG000|Phase B: Open-label Period (24 Months)|Withdrawal by Subject|0|||
147140803|NCT02964273|530682844|FG001|Phase B: Open-label Period (24 Months)|Withdrawal by Subject|0|||
147140804|NCT02964273|530682845|FG002|Phase B: Open-label Period (24 Months)|Withdrawal by Subject|4|||
147140805|NCT02964273|530682846|FG003|Phase B: Open-label Period (24 Months)|Withdrawal by Subject|3|||
147140806|NCT02964273|530682843|FG000|Phase B: Open-label Period (24 Months)|Reason Not Specified|0|||
147140807|NCT02964273|530682844|FG001|Phase B: Open-label Period (24 Months)|Reason Not Specified|0|||
147140808|NCT02964273|530682845|FG002|Phase B: Open-label Period (24 Months)|Reason Not Specified|2|||
147140809|NCT02964273|530682846|FG003|Phase B: Open-label Period (24 Months)|Reason Not Specified|1|||
147140810|NCT01453036|530682847|FG000|Overall Study|Lost to Follow-up|26|||
147140811|NCT01453036|530682848|FG001|Overall Study|Lost to Follow-up|115|||
147140812|NCT01453036|530682849|FG002|Overall Study|Lost to Follow-up|31|||
147140813|NCT00841776|530682851|FG000|Overall Study|Lack of Efficacy|0|||
147140814|NCT00841776|530682852|FG001|Overall Study|Lack of Efficacy|1|||
147573599|NCT04547192|532257460|FG001|Period 4: 42-56 Weeks|Incomplete Data|0|||
147573600|NCT04547192|532257461|FG002|Period 4: 42-56 Weeks|Incomplete Data|0|||
147573601|NCT04547192|532257462|FG003|Period 4: 42-56 Weeks|Incomplete Data|0|||
147573602|NCT04547192|532257459|FG000|Period 5: 56-70 Weeks|Incomplete Data|0|||
147573603|NCT04547192|532257460|FG001|Period 5: 56-70 Weeks|Incomplete Data|0|||
147573604|NCT04547192|532257461|FG002|Period 5: 56-70 Weeks|Incomplete Data|1|||
147140815|NCT00841776|530682851|FG000|Overall Study|Lost to Follow-up|2|||
147140816|NCT00841776|530682852|FG001|Overall Study|Lost to Follow-up|1|||
147140817|NCT00841776|530682851|FG000|Overall Study|Withdrawal by Subject|0|||
147140818|NCT00841776|530682852|FG001|Overall Study|Withdrawal by Subject|1|||
147140819|NCT04245449|530682853|FG000|Overall Study|COVID shutdown|7|||
147140820|NCT03688919|530682862|FG000|Overall Study|Lost to Follow-up|2|||
147140821|NCT03688919|530682863|FG001|Overall Study|Lost to Follow-up|1|||
147140822|NCT03688919|530682862|FG000|Overall Study|withdrawn by study team due to poor data validity|1|||
147140823|NCT03688919|530682863|FG001|Overall Study|withdrawn by study team due to poor data validity|0|||
147237888|NCT02609828|531042558|FG000|Overall Study|Insufficient clinical response|2|||
147140824|NCT00920556|530682870|FG000|Overall Study|Adverse Event|16|||
147140825|NCT00920556|530682870|FG000|Overall Study|Physician Decision|7|||
147140826|NCT00920556|530682870|FG000|Overall Study|Withdrawal by Subject|1|||
147140827|NCT00003631|530682871|FG000|Overall Study|Patient not treated|1|||
147140828|NCT00003631|530682872|FG001|Overall Study|Patient not treated|0|||
147140829|NCT00003631|530682873|FG002|Overall Study|Patient not treated|1|||
147140830|NCT00003631|530682871|FG000|Overall Study|Protocol Violation|1|||
147140831|NCT00003631|530682872|FG001|Overall Study|Protocol Violation|0|||
147140832|NCT00003631|530682873|FG002|Overall Study|Protocol Violation|0|||
147140833|NCT00003631|530682871|FG000|Overall Study|Adverse Event|1|||
147140834|NCT00003631|530682872|FG001|Overall Study|Adverse Event|1|||
147140835|NCT00003631|530682873|FG002|Overall Study|Adverse Event|5|||
147140836|NCT00003631|530682871|FG000|Overall Study|Death|0|||
147140837|NCT00003631|530682872|FG001|Overall Study|Death|0|||
147140838|NCT00003631|530682873|FG002|Overall Study|Death|1|||
147140839|NCT00003631|530682871|FG000|Overall Study|Evaluable for toxicity only|0|||
147140840|NCT00003631|530682872|FG001|Overall Study|Evaluable for toxicity only|0|||
147140841|NCT00003631|530682873|FG002|Overall Study|Evaluable for toxicity only|2|||
147140842|NCT01853462|530682878|FG000|Overall Study|Withdrawal by Subject|1|||
147140843|NCT01853462|530682879|FG001|Overall Study|Withdrawal by Subject|1|||
147140844|NCT00955474|530682881|FG000|Overall Study|Physician Decision|7|||
147140845|NCT00955474|530682882|FG001|Overall Study|Physician Decision|5|||
147140846|NCT03386435|530682885|FG000|Overall Study|Protocol Violation|5|||
147140847|NCT03386435|530682886|FG001|Overall Study|Protocol Violation|7|||
147140848|NCT04068922|530682887|FG000|Overall Study|Lost to Follow-up|5|||
147140849|NCT04068922|530682887|FG000|Overall Study|Withdrawal by Subject|7|||
147140850|NCT04068922|530682887|FG000|Overall Study|Adverse Event|1|||
147140851|NCT00625586|530682888|FG000|Overall Study|Adverse Event|1|||
147140852|NCT00625586|530682888|FG000|Overall Study|Progressive disease|1|||
147140853|NCT03542266|530682889|FG000|Treatment Phase|Withdrawal by Subject|1|||
147140854|NCT03542266|530682889|FG000|Treatment Phase|Adverse Event|1|||
147140855|NCT03542266|530682889|FG000|Treatment Phase|PD|1|||
147140856|NCT00657267|530682902|FG000|Overall Study|Progressive disease|45|||
147140857|NCT00657267|530682902|FG000|Overall Study|Adverse Event|9|||
147140858|NCT02382991|530682903|FG000|Overall Study|Adverse Event|1|||
147140859|NCT02382991|530682904|FG001|Overall Study|Adverse Event|2|||
147140860|NCT02382991|530682903|FG000|Overall Study|Lost to Follow-up|1|||
147140861|NCT02382991|530682904|FG001|Overall Study|Lost to Follow-up|0|||
147140862|NCT02382991|530682903|FG000|Overall Study|Withdrawal by Subject|0|||
147140863|NCT02382991|530682904|FG001|Overall Study|Withdrawal by Subject|1|||
147140864|NCT00786422|530682906|FG000|Rivaroxaban Treatment|Death|2|||
147140865|NCT00786422|530682906|FG000|Rivaroxaban Treatment|Final visit earlier than planned|3|||
147140866|NCT00786422|530682906|FG000|Rivaroxaban Treatment|Lack of Efficacy|1|||
147140867|NCT00786422|530682906|FG000|Rivaroxaban Treatment|Physician Decision|1|||
147140868|NCT00786422|530682906|FG000|Rivaroxaban Treatment|Withdrawal by Subject|1|||
147140869|NCT00786422|530682906|FG000|Rivaroxaban Treatment|Non-compliance with study drug treatment|1|||
147140870|NCT00786422|530682906|FG000|Rivaroxaban Treatment|Adverse Event|2|||
147140871|NCT00786422|530682906|FG000|Follow-up Period|Death|1|||
147140872|NCT00786422|530682906|FG000|Follow-up Period|End-of-study done up to 4 days early|2|||
147140873|NCT03484429|530682907|FG000|Overall Study|Withdrawal by Subject|1|||
147140874|NCT03484429|530682908|FG001|Overall Study|Withdrawal by Subject|0|||
147140875|NCT03484429|530682907|FG000|Overall Study|Adverse Event|2|||
147140876|NCT03484429|530682908|FG001|Overall Study|Adverse Event|0|||
147140877|NCT04466384|530682909|FG000|First Phase|Protocol Violation|1|||
147140878|NCT04466384|530682910|FG001|First Phase|Protocol Violation|0|||
147140879|NCT04466384|530682909|FG000|First Phase|Missing data|1|||
147140880|NCT04466384|530682910|FG001|First Phase|Missing data|0|||
147140881|NCT04466384|530682909|FG000|Cross Over Phase|Physician Decision|1|||
147140882|NCT04466384|530682910|FG001|Cross Over Phase|Physician Decision|0|||
147140883|NCT04466384|530682909|FG000|Cross Over Phase|Withdrawal by Subject|0|||
147140884|NCT04466384|530682910|FG001|Cross Over Phase|Withdrawal by Subject|1|||
147140885|NCT00943761|530682911|FG000|Overall Study|Lost to Follow-up|2|||
147140886|NCT00943761|530682912|FG001|Overall Study|Lost to Follow-up|0|||
147140887|NCT00943761|530682911|FG000|Overall Study|Withdrawal by Subject|2|||
147318622|NCT00519636|531331777|FG003|Washout Period|Subject randomized in error|0|||
147140888|NCT00943761|530682912|FG001|Overall Study|Withdrawal by Subject|1|||
147140889|NCT02268383|530682913|FG000|Overall Study|Death|12|||
147140890|NCT02268383|530682913|FG000|Overall Study|Lost to Follow-up|2|||
147652227|NCT04378569|532550221|FG001|Overall Study|Lack of response|0|||
147140891|NCT02268383|530682913|FG000|Overall Study|Withdrawal by Subject|9|||
147140892|NCT02268383|530682913|FG000|Overall Study|Presence of ≥1% blasts in peripheral blood|1|||
147140893|NCT02268383|530682913|FG000|Overall Study|Protocol deviation|3|||
147140894|NCT02268383|530682913|FG000|Overall Study|Sponsor decision|22|||
147140895|NCT02268383|530682913|FG000|Overall Study|Not reported|12|||
147140896|NCT04162470|530682914|FG000|Overall Study|Withdrawn due to sponsor's decision|24|||
147140897|NCT03382912|530682915|FG000|Overall Study|Physician Decision|0|||
147140898|NCT03382912|530682916|FG001|Overall Study|Physician Decision|1|||
147140899|NCT03382912|530682915|FG000|Overall Study|Sponsor Decision|6|||
147140900|NCT03382912|530682916|FG001|Overall Study|Sponsor Decision|6|||
147140901|NCT03382912|530682915|FG000|Overall Study|Withdrawal by Subject|0|||
147140902|NCT03382912|530682916|FG001|Overall Study|Withdrawal by Subject|5|||
147140903|NCT04570384|530682917|FG000|Overall Study|Adverse Event|2|||
147140904|NCT04570384|530682918|FG001|Overall Study|Adverse Event|1|||
147140905|NCT04570384|530682917|FG000|Overall Study|Death|2|||
147140906|NCT04570384|530682918|FG001|Overall Study|Death|5|||
147140907|NCT04570384|530682917|FG000|Overall Study|Lost to Follow-up|1|||
147140908|NCT04570384|530682918|FG001|Overall Study|Lost to Follow-up|0|||
147140909|NCT04570384|530682917|FG000|Overall Study|Other|1|||
147140910|NCT04570384|530682918|FG001|Overall Study|Other|0|||
147140911|NCT04570384|530682917|FG000|Overall Study|Protocol Violation|0|||
147140912|NCT04570384|530682918|FG001|Overall Study|Protocol Violation|1|||
147140913|NCT04570384|530682917|FG000|Overall Study|Sponsor Decision|1|||
147140914|NCT04570384|530682918|FG001|Overall Study|Sponsor Decision|0|||
147140915|NCT04570384|530682917|FG000|Overall Study|Withdrawal by Subject|4|||
147140916|NCT04570384|530682918|FG001|Overall Study|Withdrawal by Subject|2|||
147140917|NCT00326001|530682919|FG000|Overall Study|Adverse Event|4|||
147140918|NCT00326001|530682920|FG001|Overall Study|Adverse Event|5|||
147140919|NCT00326001|530682919|FG000|Overall Study|Physician Decision|3|||
147140920|NCT00326001|530682920|FG001|Overall Study|Physician Decision|3|||
147140921|NCT03265145|530682921|FG000|Overall Study|Protocol Violation|2|||
147140922|NCT03265145|530682922|FG001|Overall Study|Protocol Violation|0|||
147140923|NCT03265145|530682921|FG000|Overall Study|Adverse Event|1|||
147140924|NCT03265145|530682922|FG001|Overall Study|Adverse Event|0|||
147140925|NCT03265145|530682921|FG000|Overall Study|Withdrawal by Subject|23|||
147140926|NCT03265145|530682922|FG001|Overall Study|Withdrawal by Subject|19|||
147140927|NCT03265145|530682921|FG000|Overall Study|Death|12|||
147140928|NCT03265145|530682922|FG001|Overall Study|Death|12|||
147140929|NCT03265145|530682921|FG000|Overall Study|Lost to Follow-up|13|||
147140930|NCT03265145|530682922|FG001|Overall Study|Lost to Follow-up|9|||
147140931|NCT03265145|530682921|FG000|Overall Study|missing end of study form, could not definitely count as completion or discontinuation|0|||
147140932|NCT03265145|530682922|FG001|Overall Study|missing end of study form, could not definitely count as completion or discontinuation|1|||
147140933|NCT03265145|530682921|FG000|Overall Study|Switched back to previous medication|1|||
147140934|NCT03265145|530682922|FG001|Overall Study|Switched back to previous medication|0|||
147140935|NCT03265145|530682921|FG000|Overall Study|Did not want to take medication|1|||
147140936|NCT03265145|530682922|FG001|Overall Study|Did not want to take medication|0|||
147140937|NCT03265145|530682921|FG000|Overall Study|Subject could not afford medication|0|||
147140938|NCT03265145|530682922|FG001|Overall Study|Subject could not afford medication|1|||
147140939|NCT03265145|530682921|FG000|Overall Study|Site closed|2|||
147140940|NCT03265145|530682922|FG001|Overall Study|Site closed|3|||
147140941|NCT03265145|530682921|FG000|Overall Study|Incorrectly randomized|16|||
147140942|NCT03265145|530682922|FG001|Overall Study|Incorrectly randomized|6|||
147140943|NCT03265145|530682921|FG000|Overall Study|Entered into Electronic Data Capture in error|0|||
147140944|NCT03265145|530682922|FG001|Overall Study|Entered into Electronic Data Capture in error|1|||
147140945|NCT03265145|530682921|FG000|Overall Study|Physician Decision|0|||
147140946|NCT03265145|530682922|FG001|Overall Study|Physician Decision|3|||
147140947|NCT03265145|530682921|FG000|Overall Study|Subject transferred to another facility|0|||
147140948|NCT03265145|530682922|FG001|Overall Study|Subject transferred to another facility|1|||
147140949|NCT04409834|530682923|FG000|Overall Study|Death|55|||
147140950|NCT04409834|530682924|FG001|Overall Study|Death|62|||
147140951|NCT02112656|530682925|FG000|Overall Study|Death|78|||
147140952|NCT02112656|530682926|FG001|Overall Study|Death|82|||
147140953|NCT02112656|530682925|FG000|Overall Study|Withdrawal by Subject|9|||
147140954|NCT02112656|530682926|FG001|Overall Study|Withdrawal by Subject|11|||
147140955|NCT02112656|530682925|FG000|Overall Study|Lost to Follow-up|2|||
147140956|NCT02112656|530682926|FG001|Overall Study|Lost to Follow-up|4|||
147140957|NCT02112656|530682925|FG000|Overall Study|Noncompliance|1|||
147140958|NCT02112656|530682926|FG001|Overall Study|Noncompliance|2|||
147140959|NCT04749745|530682927|FG000|Overall Study|Withdrawal by Subject|1|||
147140960|NCT04749745|530682928|FG001|Overall Study|Withdrawal by Subject|0|||
147140961|NCT01365455|530682933|FG000|Induction Period|Adverse Event|5|||
147318623|NCT00519636|531331774|FG000|Washout Period|Prohibited medications|0|||
147140962|NCT01365455|530682934|FG001|Induction Period|Adverse Event|3|||
147140963|NCT01365455|530682935|FG002|Induction Period|Adverse Event|4|||
147140964|NCT01365455|530682936|FG003|Induction Period|Adverse Event|0|||
147140965|NCT01365455|530682937|FG004|Induction Period|Adverse Event|0|||
147140966|NCT01365455|530682933|FG000|Induction Period|Lack of Efficacy|1|||
147140967|NCT01365455|530682934|FG001|Induction Period|Lack of Efficacy|1|||
147140968|NCT01365455|530682935|FG002|Induction Period|Lack of Efficacy|0|||
147140969|NCT01365455|530682936|FG003|Induction Period|Lack of Efficacy|0|||
147140970|NCT01365455|530682937|FG004|Induction Period|Lack of Efficacy|0|||
147140971|NCT01365455|530682933|FG000|Induction Period|Pregnancy|0|||
147140972|NCT01365455|530682934|FG001|Induction Period|Pregnancy|1|||
147140973|NCT01365455|530682935|FG002|Induction Period|Pregnancy|0|||
147140974|NCT01365455|530682936|FG003|Induction Period|Pregnancy|0|||
147140975|NCT01365455|530682937|FG004|Induction Period|Pregnancy|0|||
147140976|NCT01365455|530682933|FG000|Induction Period|Protocol deviation|0|||
147140977|NCT01365455|530682934|FG001|Induction Period|Protocol deviation|1|||
147140978|NCT01365455|530682935|FG002|Induction Period|Protocol deviation|1|||
147140979|NCT01365455|530682936|FG003|Induction Period|Protocol deviation|0|||
147140980|NCT01365455|530682937|FG004|Induction Period|Protocol deviation|0|||
147140981|NCT01365455|530682933|FG000|Induction Period|Subject/guardian decision|9|||
147140982|NCT01365455|530682934|FG001|Induction Period|Subject/guardian decision|1|||
147140983|NCT01365455|530682935|FG002|Induction Period|Subject/guardian decision|8|||
147573605|NCT04547192|532257462|FG003|Period 5: 56-70 Weeks|Incomplete Data|0|||
147140984|NCT01365455|530682936|FG003|Induction Period|Subject/guardian decision|0|||
147140985|NCT01365455|530682937|FG004|Induction Period|Subject/guardian decision|0|||
147140986|NCT01365455|530682933|FG000|Induction Period|Lost to Follow-up|0|||
147140987|NCT01365455|530682934|FG001|Induction Period|Lost to Follow-up|0|||
147140988|NCT01365455|530682935|FG002|Induction Period|Lost to Follow-up|3|||
147573606|NCT00935012|532257465|FG000|Overall Study|Death|19|||
147573607|NCT00935012|532257465|FG000|Overall Study|Withdrawal by Subject|3|||
147573608|NCT00935012|532257465|FG000|Overall Study|Other|5|||
147573609|NCT00935012|532257465|FG000|Overall Study|Adverse Event|2|||
147573610|NCT01442155|532257466|FG000|Overall Study|Complete remission|35|||
147573611|NCT01442155|532257466|FG000|Overall Study|Recurrence|26|||
147573612|NCT01442155|532257466|FG000|Overall Study|Adverse Event|2|||
147573613|NCT01442155|532257466|FG000|Overall Study|Lost to Follow-up|2|||
147573614|NCT01590563|532257473|FG000|Overall Study|simple uterine hyperplasia - not related|1|||
147573615|NCT02699463|532257478|FG000|Overall Study|Lost to Follow-up|11|||
147573616|NCT02699463|532257479|FG001|Overall Study|Lost to Follow-up|8|||
147573617|NCT02699463|532257478|FG000|Overall Study|Withdrawal by Subject|4|||
147573618|NCT02699463|532257479|FG001|Overall Study|Withdrawal by Subject|1|||
147573619|NCT02294981|532257480|FG000|Overall Study|Lost to Follow-up|1|||
147573620|NCT00909038|532257483|FG000|Overall Study|Protocol Violation|187|||
147573621|NCT00909038|532257483|FG000|Overall Study|Non-evaluable Subjects|230|||
147573622|NCT00909753|532257486|FG000|Period: Washout of 28 Days|Protocol Violation|2|||
147573623|NCT00909753|532257487|FG001|Period: Washout of 28 Days|Protocol Violation|3|||
147573624|NCT00909753|532257486|FG000|Period: Second Intervention|Protocol Violation|1|||
147573625|NCT00909753|532257487|FG001|Period: Second Intervention|Protocol Violation|0|||
147573626|NCT01895335|532257488|FG000|Overall Study|Adverse Event|106|||
147573627|NCT01895335|532257488|FG000|Overall Study|Lack of Efficacy|53|||
147140989|NCT01365455|530682936|FG003|Induction Period|Lost to Follow-up|0|||
147140990|NCT01365455|530682937|FG004|Induction Period|Lost to Follow-up|0|||
147140991|NCT01365455|530682933|FG000|Maintenance Period|Adverse Event|12|||
147140992|NCT01365455|530682934|FG001|Maintenance Period|Adverse Event|5|||
147140993|NCT01365455|530682935|FG002|Maintenance Period|Adverse Event|1|||
147140994|NCT01365455|530682936|FG003|Maintenance Period|Adverse Event|2|||
147140995|NCT01365455|530682937|FG004|Maintenance Period|Adverse Event|4|||
147140996|NCT01365455|530682933|FG000|Maintenance Period|Lack of Efficacy|10|||
147140997|NCT01365455|530682934|FG001|Maintenance Period|Lack of Efficacy|2|||
147140998|NCT01365455|530682935|FG002|Maintenance Period|Lack of Efficacy|0|||
147140999|NCT01365455|530682936|FG003|Maintenance Period|Lack of Efficacy|2|||
147141000|NCT01365455|530682937|FG004|Maintenance Period|Lack of Efficacy|2|||
147141001|NCT01365455|530682933|FG000|Maintenance Period|Lost to Follow-up|2|||
147141002|NCT01365455|530682934|FG001|Maintenance Period|Lost to Follow-up|4|||
147141003|NCT01365455|530682935|FG002|Maintenance Period|Lost to Follow-up|0|||
147141004|NCT01365455|530682936|FG003|Maintenance Period|Lost to Follow-up|0|||
147141005|NCT01365455|530682937|FG004|Maintenance Period|Lost to Follow-up|3|||
147141006|NCT01365455|530682933|FG000|Maintenance Period|Non-compliance with study treatment|0|||
147141007|NCT01365455|530682934|FG001|Maintenance Period|Non-compliance with study treatment|0|||
147141008|NCT01365455|530682935|FG002|Maintenance Period|Non-compliance with study treatment|0|||
147141009|NCT01365455|530682936|FG003|Maintenance Period|Non-compliance with study treatment|1|||
147141010|NCT01365455|530682937|FG004|Maintenance Period|Non-compliance with study treatment|0|||
147237889|NCT02609828|531042559|FG001|Overall Study|Insufficient clinical response|1|||
147573628|NCT01895335|532257488|FG000|Overall Study|Poor Compliance to Protocol|11|||
147573629|NCT01895335|532257488|FG000|Overall Study|Included But Not treated|1|||
147573630|NCT01895335|532257488|FG000|Overall Study|Other than Specified Above|44|||
147573631|NCT01647828|532257489|FG000|Overall Study|Death|3|||
147573632|NCT01647828|532257490|FG001|Overall Study|Death|4|||
147573633|NCT01647828|532257491|FG002|Overall Study|Death|4|||
147652228|NCT04378569|532550222|FG002|Overall Study|Lack of response|1|||
147141011|NCT01365455|530682933|FG000|Maintenance Period|Physician Decision|0|||
147573634|NCT01647828|532257492|FG003|Overall Study|Death|5|||
147573635|NCT01647828|532257493|FG004|Overall Study|Death|6|||
147573636|NCT01647828|532257494|FG005|Overall Study|Death|3|||
147573637|NCT01647828|532257495|FG006|Overall Study|Death|10|||
147141012|NCT01365455|530682934|FG001|Maintenance Period|Physician Decision|1|||
147141013|NCT01365455|530682935|FG002|Maintenance Period|Physician Decision|0|||
147141014|NCT01365455|530682936|FG003|Maintenance Period|Physician Decision|0|||
147141015|NCT01365455|530682937|FG004|Maintenance Period|Physician Decision|1|||
147141016|NCT01365455|530682933|FG000|Maintenance Period|Pregnancy|0|||
147652229|NCT04378569|532550223|FG003|Overall Study|Lack of response|0|||
147652230|NCT04378569|532550224|FG004|Overall Study|Lack of response|1|||
147652231|NCT04378569|532550225|FG005|Overall Study|Lack of response|1|||
147652232|NCT01048944|532550226|FG000|Overall Study|Protocol Violation|8|||
147652233|NCT01048944|532550227|FG001|Overall Study|Protocol Violation|10|||
147652234|NCT01048944|532550228|FG002|Overall Study|Protocol Violation|10|||
147652235|NCT01048944|532550229|FG003|Overall Study|Protocol Violation|2|||
147652236|NCT01844817|532550230|FG000|Enrolled and Randomized|Withdrawal by Subject|2|||
147652237|NCT01844817|532550231|FG001|Enrolled and Randomized|Withdrawal by Subject|3|||
147652238|NCT01844817|532550230|FG000|Treatment|Progressive Disease|27|||
147652239|NCT01844817|532550231|FG001|Treatment|Progressive Disease|36|||
147652240|NCT01844817|532550230|FG000|Treatment|Adverse Event|17|||
147652241|NCT01844817|532550231|FG001|Treatment|Adverse Event|9|||
147652242|NCT01844817|532550230|FG000|Treatment|Withdrawal by Subject|10|||
147652243|NCT01844817|532550231|FG001|Treatment|Withdrawal by Subject|6|||
147652244|NCT01844817|532550230|FG000|Treatment|Death|10|||
147652245|NCT01844817|532550231|FG001|Treatment|Death|8|||
147652246|NCT01844817|532550230|FG000|Treatment|Lost to Follow-up|0|||
147652247|NCT01844817|532550231|FG001|Treatment|Lost to Follow-up|1|||
147652248|NCT01844817|532550230|FG000|Treatment|Other|0|||
147652249|NCT01844817|532550231|FG001|Treatment|Other|3|||
147573638|NCT01647828|532257496|FG007|Overall Study|Death|60|||
147573639|NCT01647828|532257497|FG008|Overall Study|Death|71|||
147573640|NCT01647828|532257489|FG000|Overall Study|Withdrawal by Subject|2|||
147573641|NCT01647828|532257490|FG001|Overall Study|Withdrawal by Subject|0|||
147573642|NCT01647828|532257491|FG002|Overall Study|Withdrawal by Subject|0|||
147573643|NCT01647828|532257492|FG003|Overall Study|Withdrawal by Subject|1|||
147573644|NCT01647828|532257493|FG004|Overall Study|Withdrawal by Subject|0|||
147573645|NCT01647828|532257494|FG005|Overall Study|Withdrawal by Subject|0|||
147573646|NCT01647828|532257495|FG006|Overall Study|Withdrawal by Subject|1|||
147573647|NCT01647828|532257496|FG007|Overall Study|Withdrawal by Subject|0|||
147573648|NCT01647828|532257497|FG008|Overall Study|Withdrawal by Subject|2|||
147573649|NCT01647828|532257489|FG000|Overall Study|Study terminated by Sponsor|0|||
147573650|NCT01647828|532257490|FG001|Overall Study|Study terminated by Sponsor|0|||
147573651|NCT01647828|532257491|FG002|Overall Study|Study terminated by Sponsor|0|||
147573652|NCT01647828|532257492|FG003|Overall Study|Study terminated by Sponsor|0|||
147573653|NCT01647828|532257493|FG004|Overall Study|Study terminated by Sponsor|0|||
147573654|NCT01647828|532257494|FG005|Overall Study|Study terminated by Sponsor|0|||
147573655|NCT01647828|532257495|FG006|Overall Study|Study terminated by Sponsor|1|||
147573656|NCT01647828|532257496|FG007|Overall Study|Study terminated by Sponsor|26|||
147573657|NCT01647828|532257497|FG008|Overall Study|Study terminated by Sponsor|16|||
147573658|NCT01647828|532257489|FG000|Overall Study|Lost to Follow-up|0|||
147573659|NCT01647828|532257490|FG001|Overall Study|Lost to Follow-up|0|||
147573660|NCT01647828|532257491|FG002|Overall Study|Lost to Follow-up|0|||
147573661|NCT01647828|532257492|FG003|Overall Study|Lost to Follow-up|0|||
147573662|NCT01647828|532257493|FG004|Overall Study|Lost to Follow-up|0|||
147573663|NCT01647828|532257494|FG005|Overall Study|Lost to Follow-up|0|||
147573664|NCT01647828|532257495|FG006|Overall Study|Lost to Follow-up|0|||
147573665|NCT01647828|532257496|FG007|Overall Study|Lost to Follow-up|2|||
147573666|NCT01647828|532257497|FG008|Overall Study|Lost to Follow-up|0|||
147573667|NCT00205777|532257500|FG000|Core Study (Up to 3 Years)|Adverse Event|260|||
147573668|NCT00205777|532257501|FG001|Core Study (Up to 3 Years)|Adverse Event|267|||
147573669|NCT00205777|532257502|FG002|Core Study (Up to 3 Years)|Adverse Event|252|||
147573670|NCT00205777|532257503|FG003|Core Study (Up to 3 Years)|Adverse Event|232|||
147573671|NCT00205777|532257504|FG004|Core Study (Up to 3 Years)|Adverse Event|0|||
147573672|NCT00205777|532257505|FG005|Core Study (Up to 3 Years)|Adverse Event|0|||
147573673|NCT00205777|532257500|FG000|Core Study (Up to 3 Years)|Death|9|||
147652250|NCT01128400|532550232|FG000|Overall Study|Lost to Follow-up|1|||
147652251|NCT01128400|532550233|FG001|Overall Study|Lost to Follow-up|0|||
147573674|NCT00205777|532257501|FG001|Core Study (Up to 3 Years)|Death|7|||
147573675|NCT00205777|532257502|FG002|Core Study (Up to 3 Years)|Death|14|||
147573676|NCT00205777|532257503|FG003|Core Study (Up to 3 Years)|Death|7|||
147573677|NCT00205777|532257504|FG004|Core Study (Up to 3 Years)|Death|0|||
147573678|NCT00205777|532257505|FG005|Core Study (Up to 3 Years)|Death|0|||
147652252|NCT01128400|532550234|FG002|Overall Study|Lost to Follow-up|1|||
147141017|NCT01365455|530682934|FG001|Maintenance Period|Pregnancy|4|||
147141018|NCT01365455|530682935|FG002|Maintenance Period|Pregnancy|0|||
147141019|NCT01365455|530682936|FG003|Maintenance Period|Pregnancy|0|||
147141020|NCT01365455|530682937|FG004|Maintenance Period|Pregnancy|2|||
147573679|NCT00205777|532257500|FG000|Core Study (Up to 3 Years)|Failed to return|40|||
147573680|NCT00205777|532257501|FG001|Core Study (Up to 3 Years)|Failed to return|25|||
147652253|NCT01128400|532550232|FG000|Overall Study|Screening failure|1|||
147141021|NCT01365455|530682933|FG000|Maintenance Period|Protocol deviation|1|||
147573681|NCT00205777|532257502|FG002|Core Study (Up to 3 Years)|Failed to return|27|||
147573682|NCT00205777|532257503|FG003|Core Study (Up to 3 Years)|Failed to return|27|||
147652254|NCT01128400|532550233|FG001|Overall Study|Screening failure|0|||
147652255|NCT01128400|532550234|FG002|Overall Study|Screening failure|0|||
147652256|NCT01128400|532550232|FG000|Overall Study|were not invited to participate on taste|0|||
147141022|NCT01365455|530682934|FG001|Maintenance Period|Protocol deviation|1|||
147141023|NCT01365455|530682935|FG002|Maintenance Period|Protocol deviation|0|||
147141024|NCT01365455|530682936|FG003|Maintenance Period|Protocol deviation|0|||
147141025|NCT01365455|530682937|FG004|Maintenance Period|Protocol deviation|0|||
147141026|NCT01365455|530682933|FG000|Maintenance Period|Subject/guardian decision|4|||
147141027|NCT01365455|530682934|FG001|Maintenance Period|Subject/guardian decision|6|||
147141028|NCT01365455|530682935|FG002|Maintenance Period|Subject/guardian decision|2|||
147141029|NCT01365455|530682936|FG003|Maintenance Period|Subject/guardian decision|4|||
147141030|NCT01365455|530682937|FG004|Maintenance Period|Subject/guardian decision|1|||
147141031|NCT03965403|530682938|FG000|Overall Study|Subject not meeting eligibility criteria|1|||
147141032|NCT03718325|530684394|FG000|Overall Study|Externalized leads were removed independent of the research protocol|2|||
147141033|NCT03718325|530684395|FG001|Overall Study|Externalized leads were removed independent of the research protocol|0|||
147141034|NCT03718325|530684396|FG002|Overall Study|Externalized leads were removed independent of the research protocol|0|||
147141035|NCT03718325|530684394|FG000|Overall Study|Lost to follow-up because of research pause caused by the COVID-19 pandemic|1|||
147141036|NCT03718325|530684395|FG001|Overall Study|Lost to follow-up because of research pause caused by the COVID-19 pandemic|0|||
147141037|NCT03718325|530684396|FG002|Overall Study|Lost to follow-up because of research pause caused by the COVID-19 pandemic|0|||
147141038|NCT03073525|530684397|FG000|Overall Study|Withdrawal by Subject|0|||
147141039|NCT03073525|530684398|FG001|Overall Study|Withdrawal by Subject|0|||
147141040|NCT03073525|530684399|FG002|Overall Study|Withdrawal by Subject|3|||
147141041|NCT01976299|530684400|FG000|Overall Study|Withdrawal by Subject|3|||
147141042|NCT01976299|530684401|FG001|Overall Study|Withdrawal by Subject|1|||
147573683|NCT00205777|532257504|FG004|Core Study (Up to 3 Years)|Failed to return|0|||
147573684|NCT00205777|532257505|FG005|Core Study (Up to 3 Years)|Failed to return|0|||
147573685|NCT00205777|532257500|FG000|Core Study (Up to 3 Years)|Other Event|49|||
147573686|NCT00205777|532257501|FG001|Core Study (Up to 3 Years)|Other Event|52|||
147573687|NCT00205777|532257502|FG002|Core Study (Up to 3 Years)|Other Event|41|||
147573688|NCT00205777|532257503|FG003|Core Study (Up to 3 Years)|Other Event|58|||
147573689|NCT00205777|532257504|FG004|Core Study (Up to 3 Years)|Other Event|0|||
147573690|NCT00205777|532257505|FG005|Core Study (Up to 3 Years)|Other Event|0|||
147573691|NCT00205777|532257500|FG000|Core Study (Up to 3 Years)|Withdrawal by Subject|144|||
147573692|NCT00205777|532257501|FG001|Core Study (Up to 3 Years)|Withdrawal by Subject|169|||
147573693|NCT00205777|532257502|FG002|Core Study (Up to 3 Years)|Withdrawal by Subject|149|||
147573694|NCT00205777|532257503|FG003|Core Study (Up to 3 Years)|Withdrawal by Subject|162|||
147573695|NCT00205777|532257504|FG004|Core Study (Up to 3 Years)|Withdrawal by Subject|0|||
147573696|NCT00205777|532257505|FG005|Core Study (Up to 3 Years)|Withdrawal by Subject|0|||
147573697|NCT00205777|532257500|FG000|Core Study (Up to 3 Years)|Protocol Violation|53|||
147573698|NCT00205777|532257501|FG001|Core Study (Up to 3 Years)|Protocol Violation|55|||
147573699|NCT00205777|532257502|FG002|Core Study (Up to 3 Years)|Protocol Violation|50|||
147573700|NCT00205777|532257503|FG003|Core Study (Up to 3 Years)|Protocol Violation|42|||
147573701|NCT00205777|532257504|FG004|Core Study (Up to 3 Years)|Protocol Violation|0|||
147573702|NCT00205777|532257505|FG005|Core Study (Up to 3 Years)|Protocol Violation|0|||
147573703|NCT00205777|532257500|FG000|Core Study (Up to 3 Years)|Lack of Efficacy|52|||
147573704|NCT00205777|532257501|FG001|Core Study (Up to 3 Years)|Lack of Efficacy|52|||
147573705|NCT00205777|532257502|FG002|Core Study (Up to 3 Years)|Lack of Efficacy|39|||
147573706|NCT00205777|532257503|FG003|Core Study (Up to 3 Years)|Lack of Efficacy|75|||
147573707|NCT00205777|532257504|FG004|Core Study (Up to 3 Years)|Lack of Efficacy|0|||
147573708|NCT00205777|532257505|FG005|Core Study (Up to 3 Years)|Lack of Efficacy|0|||
147573709|NCT00205777|532257500|FG000|Core Study (Up to 3 Years)|Randomized but not treated|21|||
147573710|NCT00205777|532257501|FG001|Core Study (Up to 3 Years)|Randomized but not treated|32|||
147573711|NCT00205777|532257502|FG002|Core Study (Up to 3 Years)|Randomized but not treated|35|||
147573712|NCT00205777|532257503|FG003|Core Study (Up to 3 Years)|Randomized but not treated|29|||
147573713|NCT00205777|532257504|FG004|Core Study (Up to 3 Years)|Randomized but not treated|0|||
147573714|NCT00205777|532257505|FG005|Core Study (Up to 3 Years)|Randomized but not treated|0|||
147573715|NCT00205777|532257500|FG000|Completed Core Study, Entered SE I|Withdrawal by Subject|180|||
147573716|NCT00205777|532257501|FG001|Completed Core Study, Entered SE I|Withdrawal by Subject|158|||
147573717|NCT00205777|532257502|FG002|Completed Core Study, Entered SE I|Withdrawal by Subject|160|||
147573718|NCT00205777|532257503|FG003|Completed Core Study, Entered SE I|Withdrawal by Subject|174|||
147573719|NCT00205777|532257504|FG004|Completed Core Study, Entered SE I|Withdrawal by Subject|0|||
147573720|NCT00205777|532257505|FG005|Completed Core Study, Entered SE I|Withdrawal by Subject|0|||
147573721|NCT00205777|532257500|FG000|Completed Core Study, Entered SE I|Other Event|52|||
147573722|NCT00205777|532257501|FG001|Completed Core Study, Entered SE I|Other Event|46|||
147573723|NCT00205777|532257502|FG002|Completed Core Study, Entered SE I|Other Event|47|||
147573724|NCT00205777|532257503|FG003|Completed Core Study, Entered SE I|Other Event|50|||
147573725|NCT00205777|532257504|FG004|Completed Core Study, Entered SE I|Other Event|0|||
147573726|NCT00205777|532257505|FG005|Completed Core Study, Entered SE I|Other Event|0|||
147141043|NCT01976299|530684400|FG000|Overall Study|Death|4|||
147141044|NCT01976299|530684401|FG001|Overall Study|Death|2|||
147141045|NCT01976299|530684400|FG000|Overall Study|Lost to Follow-up|7|||
147141046|NCT01976299|530684401|FG001|Overall Study|Lost to Follow-up|1|||
147573727|NCT00205777|532257500|FG000|Study Extension I|Adverse Event|57|||
147573728|NCT00205777|532257501|FG001|Study Extension I|Adverse Event|0|||
147141047|NCT01976299|530684400|FG000|Overall Study|See clarification above in comments|9|||
147141048|NCT01976299|530684401|FG001|Overall Study|See clarification above in comments|2|||
147141049|NCT03692403|530684402|FG000|Overall Study|Withdrawal by Subject|1|||
147141050|NCT03692403|530684403|FG001|Overall Study|Withdrawal by Subject|0|||
147141051|NCT03692403|530684404|FG002|Overall Study|Withdrawal by Subject|1|||
147141052|NCT03692403|530684405|FG003|Overall Study|Withdrawal by Subject|0|||
147141053|NCT03692403|530684402|FG000|Overall Study|Adverse Event|0|||
147141054|NCT03692403|530684403|FG001|Overall Study|Adverse Event|0|||
147141055|NCT03692403|530684404|FG002|Overall Study|Adverse Event|0|||
147141056|NCT03692403|530684405|FG003|Overall Study|Adverse Event|1|||
147141057|NCT03692403|530684402|FG000|Overall Study|Pregnancy|0|||
147141058|NCT03692403|530684403|FG001|Overall Study|Pregnancy|1|||
147141059|NCT03692403|530684404|FG002|Overall Study|Pregnancy|0|||
147141060|NCT03692403|530684405|FG003|Overall Study|Pregnancy|0|||
147141061|NCT03692403|530684402|FG000|Overall Study|Other|0|||
147141062|NCT03692403|530684403|FG001|Overall Study|Other|0|||
147141063|NCT03692403|530684404|FG002|Overall Study|Other|1|||
147141064|NCT03692403|530684405|FG003|Overall Study|Other|0|||
147141065|NCT02848092|530684407|FG000|1-month Post-training Follow-up|Lost to Follow-up|8|||
147141066|NCT02848092|530684408|FG001|1-month Post-training Follow-up|Lost to Follow-up|3|||
147141067|NCT02848092|530684407|FG000|1-month Post-training Follow-up|Adverse Event|2|||
147141068|NCT02848092|530684408|FG001|1-month Post-training Follow-up|Adverse Event|1|||
147141069|NCT02848092|530684407|FG000|1-month Post-training Follow-up|Withdrawal by Subject|1|||
147141070|NCT02848092|530684408|FG001|1-month Post-training Follow-up|Withdrawal by Subject|0|||
147141071|NCT02848092|530684407|FG000|1-month Post-training Follow-up|received new diagnosis of epilepsy|1|||
147141072|NCT02848092|530684408|FG001|1-month Post-training Follow-up|received new diagnosis of epilepsy|0|||
147141073|NCT02848092|530684407|FG000|1-month Post-training Follow-up|fatigue|0|||
147141074|NCT02848092|530684408|FG001|1-month Post-training Follow-up|fatigue|1|||
147141075|NCT02848092|530684407|FG000|6-month Post-training Follow-up|Lost to Follow-up|9|||
147141076|NCT02848092|530684408|FG001|6-month Post-training Follow-up|Lost to Follow-up|3|||
147141077|NCT02848092|530684407|FG000|6-month Post-training Follow-up|Adverse Event|1|||
147141078|NCT02848092|530684408|FG001|6-month Post-training Follow-up|Adverse Event|1|||
147141079|NCT02848092|530684407|FG000|6-month Post-training Follow-up|Withdrawal by Subject|1|||
147141080|NCT02848092|530684408|FG001|6-month Post-training Follow-up|Withdrawal by Subject|0|||
147141081|NCT02848092|530684407|FG000|6-month Post-training Follow-up|frustrated with task|1|||
147141082|NCT02848092|530684408|FG001|6-month Post-training Follow-up|frustrated with task|0|||
147141083|NCT02848092|530684407|FG000|6-month Post-training Follow-up|new diagnosis of epilepsy|1|||
147141084|NCT02848092|530684408|FG001|6-month Post-training Follow-up|new diagnosis of epilepsy|0|||
147141085|NCT02848092|530684407|FG000|12-month Naturalistic Driving|Did not have DriveCam installed in car|3|||
147141086|NCT02848092|530684408|FG001|12-month Naturalistic Driving|Did not have DriveCam installed in car|2|||
147141087|NCT01349673|530684415|FG000|Overall Study|Progression Of Disease Past 40 cm|1|||
147141088|NCT01349673|530684415|FG000|Overall Study|No Longer Qualified For Study|1|||
147141089|NCT01349673|530684415|FG000|Overall Study|Site Closure|10|||
147141090|NCT01349673|530684415|FG000|Overall Study|Withdrawal by Subject|21|||
147141091|NCT01349673|530684415|FG000|Overall Study|Lost to Follow-up|6|||
147141092|NCT01349673|530684415|FG000|Overall Study|Adverse Event|17|||
147141093|NCT01349673|530684415|FG000|Overall Study|Study Terminated By Sponsor|50|||
147141094|NCT01349673|530684415|FG000|Overall Study|Lack of Efficacy|8|||
147141095|NCT01665911|530684416|FG000|Overall Study|Protocol Violation|4|||
147141096|NCT01665911|530684416|FG000|Overall Study|Withdrawal by Subject|1|||
147141097|NCT01665911|530684416|FG000|Overall Study|Adverse Event|1|||
147141098|NCT01724216|530684423|FG000|Overall Study|Scan was not completed|1|||
147141099|NCT00564733|530684424|FG000|Overall Study|Withdrawal by Subject|4|||
147141100|NCT00564733|530684424|FG000|Overall Study|Ineligible|5|||
147141101|NCT01484496|530684427|FG000|Period 1|Protocol Violation|3|||
147573729|NCT00205777|532257502|FG002|Study Extension I|Adverse Event|0|||
147573730|NCT00205777|532257503|FG003|Study Extension I|Adverse Event|61|||
147573731|NCT00205777|532257504|FG004|Study Extension I|Adverse Event|58|||
147573732|NCT00205777|532257505|FG005|Study Extension I|Adverse Event|0|||
147573733|NCT00205777|532257500|FG000|Study Extension I|Death|5|||
147573734|NCT00205777|532257501|FG001|Study Extension I|Death|0|||
147573735|NCT00205777|532257502|FG002|Study Extension I|Death|0|||
147573736|NCT00205777|532257503|FG003|Study Extension I|Death|1|||
147141102|NCT01484496|530684428|FG001|Period 1|Protocol Violation|4|||
147141103|NCT01484496|530684429|FG002|Period 1|Protocol Violation|0|||
147141104|NCT01484496|530684430|FG003|Period 1|Protocol Violation|0|||
147141105|NCT01484496|530684427|FG000|Period 1|Physician Decision|5|||
147141106|NCT01484496|530684428|FG001|Period 1|Physician Decision|1|||
147141107|NCT01484496|530684429|FG002|Period 1|Physician Decision|0|||
147141108|NCT01484496|530684430|FG003|Period 1|Physician Decision|0|||
147141109|NCT01484496|530684427|FG000|Period 1|Lack of Efficacy|10|||
147141110|NCT01484496|530684428|FG001|Period 1|Lack of Efficacy|15|||
147141111|NCT01484496|530684429|FG002|Period 1|Lack of Efficacy|0|||
147141112|NCT01484496|530684430|FG003|Period 1|Lack of Efficacy|0|||
147141113|NCT01484496|530684427|FG000|Period 1|Adverse Event|25|||
147141114|NCT01484496|530684428|FG001|Period 1|Adverse Event|40|||
147141115|NCT01484496|530684429|FG002|Period 1|Adverse Event|0|||
147141116|NCT01484496|530684430|FG003|Period 1|Adverse Event|0|||
147141117|NCT01484496|530684427|FG000|Period 1|Withdrawal by Subject|15|||
147141118|NCT01484496|530684428|FG001|Period 1|Withdrawal by Subject|12|||
147141119|NCT01484496|530684429|FG002|Period 1|Withdrawal by Subject|0|||
147141120|NCT01484496|530684430|FG003|Period 1|Withdrawal by Subject|0|||
147141121|NCT01484496|530684427|FG000|Period 1|Lost to Follow-up|2|||
147141122|NCT01484496|530684428|FG001|Period 1|Lost to Follow-up|6|||
147141123|NCT01484496|530684429|FG002|Period 1|Lost to Follow-up|0|||
147141124|NCT01484496|530684430|FG003|Period 1|Lost to Follow-up|0|||
147141125|NCT01484496|530684427|FG000|Period 1|Positive Pregnancy|1|||
147141126|NCT01484496|530684428|FG001|Period 1|Positive Pregnancy|6|||
147141127|NCT01484496|530684429|FG002|Period 1|Positive Pregnancy|0|||
147141128|NCT01484496|530684430|FG003|Period 1|Positive Pregnancy|0|||
147141129|NCT01484496|530684427|FG000|Period 1|Treatment Failure|3|||
147141130|NCT01484496|530684428|FG001|Period 1|Treatment Failure|6|||
147141131|NCT01484496|530684429|FG002|Period 1|Treatment Failure|0|||
147141132|NCT01484496|530684430|FG003|Period 1|Treatment Failure|0|||
147141133|NCT01484496|530684427|FG000|Period 1|Lack of Compliance|2|||
147141134|NCT01484496|530684428|FG001|Period 1|Lack of Compliance|1|||
147141135|NCT01484496|530684429|FG002|Period 1|Lack of Compliance|0|||
147141136|NCT01484496|530684430|FG003|Period 1|Lack of Compliance|0|||
147141137|NCT01484496|530684427|FG000|Period 1|Unable to Visit Site|0|||
147141138|NCT01484496|530684428|FG001|Period 1|Unable to Visit Site|2|||
147141139|NCT01484496|530684429|FG002|Period 1|Unable to Visit Site|0|||
147141140|NCT01484496|530684430|FG003|Period 1|Unable to Visit Site|0|||
147141141|NCT01484496|530684427|FG000|Period 2|Lack of Efficacy|0|||
147141142|NCT01484496|530684428|FG001|Period 2|Lack of Efficacy|0|||
147141143|NCT01484496|530684429|FG002|Period 2|Lack of Efficacy|1|||
147141144|NCT01484496|530684430|FG003|Period 2|Lack of Efficacy|3|||
147141145|NCT01484496|530684427|FG000|Period 2|Adverse Event|0|||
147141146|NCT01484496|530684428|FG001|Period 2|Adverse Event|0|||
147141147|NCT01484496|530684429|FG002|Period 2|Adverse Event|5|||
147141148|NCT01484496|530684430|FG003|Period 2|Adverse Event|13|||
147141149|NCT01484496|530684427|FG000|Period 2|Other|0|||
147141150|NCT01484496|530684428|FG001|Period 2|Other|0|||
147141151|NCT01484496|530684429|FG002|Period 2|Other|9|||
147141152|NCT01484496|530684430|FG003|Period 2|Other|6|||
147141153|NCT00506779|530684431|FG000|Overall Study|Withdrawal by Subject|1|||
147141154|NCT00506779|530684432|FG001|Overall Study|Withdrawal by Subject|0|||
147141155|NCT00506779|530684433|FG002|Overall Study|Withdrawal by Subject|1|||
147141156|NCT00506779|530684434|FG003|Overall Study|Withdrawal by Subject|0|||
147141157|NCT00506779|530684431|FG000|Overall Study|Adverse Event|0|||
147141158|NCT00506779|530684432|FG001|Overall Study|Adverse Event|1|||
147573737|NCT00205777|532257504|FG004|Study Extension I|Death|2|||
147573738|NCT00205777|532257505|FG005|Study Extension I|Death|0|||
147573739|NCT00205777|532257500|FG000|Study Extension I|Withdrawal by Subject|99|||
147573740|NCT00205777|532257501|FG001|Study Extension I|Withdrawal by Subject|0|||
147573741|NCT00205777|532257502|FG002|Study Extension I|Withdrawal by Subject|0|||
147573742|NCT00205777|532257503|FG003|Study Extension I|Withdrawal by Subject|106|||
147573743|NCT00205777|532257504|FG004|Study Extension I|Withdrawal by Subject|89|||
147573744|NCT00205777|532257505|FG005|Study Extension I|Withdrawal by Subject|0|||
147573745|NCT00205777|532257500|FG000|Study Extension I|Protocol Violation|4|||
147573746|NCT00205777|532257501|FG001|Study Extension I|Protocol Violation|0|||
147573747|NCT00205777|532257502|FG002|Study Extension I|Protocol Violation|0|||
147573748|NCT00205777|532257503|FG003|Study Extension I|Protocol Violation|8|||
147573749|NCT00205777|532257504|FG004|Study Extension I|Protocol Violation|8|||
147573750|NCT00205777|532257505|FG005|Study Extension I|Protocol Violation|0|||
147573751|NCT00205777|532257500|FG000|Study Extension I|Lack of Efficacy|0|||
147141159|NCT00506779|530684433|FG002|Overall Study|Adverse Event|1|||
147141160|NCT00506779|530684434|FG003|Overall Study|Adverse Event|1|||
147141161|NCT01645735|530684435|FG000|Overall Study|Physician Decision|2|||
147141162|NCT01645735|530684436|FG001|Overall Study|Physician Decision|0|||
147141163|NCT01645735|530684435|FG000|Overall Study|Withdrawal by Subject|1|||
147141164|NCT01645735|530684436|FG001|Overall Study|Withdrawal by Subject|0|||
147573752|NCT00205777|532257501|FG001|Study Extension I|Lack of Efficacy|0|||
147141165|NCT01645735|530684435|FG000|Overall Study|Protocol Violation|1|||
147141166|NCT01645735|530684436|FG001|Overall Study|Protocol Violation|0|||
147141167|NCT01645735|530684435|FG000|Overall Study|Adverse Event|0|||
147141168|NCT01645735|530684436|FG001|Overall Study|Adverse Event|1|||
147141169|NCT01456130|530684438|FG000|Overall Study|Adverse Event|4|||
147141170|NCT01456130|530684438|FG000|Overall Study|Voluntary Withdrawal|1|||
147141171|NCT01456130|530684438|FG000|Overall Study|Lack of Efficacy|4|||
147573753|NCT00205777|532257502|FG002|Study Extension I|Lack of Efficacy|0|||
147573754|NCT00205777|532257503|FG003|Study Extension I|Lack of Efficacy|1|||
147141172|NCT01456130|530684438|FG000|Overall Study|Other|1|||
147141173|NCT04908683|530684443|FG000|Overall Study|Failure to meet continuation criteria|34|||
147141174|NCT04908683|530684444|FG001|Overall Study|Failure to meet continuation criteria|22|||
147141175|NCT04908683|530684443|FG000|Overall Study|Initiated prohibited medication|3|||
147141176|NCT04908683|530684444|FG001|Overall Study|Initiated prohibited medication|0|||
147141177|NCT04908683|530684443|FG000|Overall Study|Randomized by mistake|1|||
147141178|NCT04908683|530684444|FG001|Overall Study|Randomized by mistake|0|||
147141179|NCT04908683|530684443|FG000|Overall Study|Lost to Follow-up|679|||
147141180|NCT04908683|530684444|FG001|Overall Study|Lost to Follow-up|341|||
147141181|NCT04908683|530684443|FG000|Overall Study|Participant met eligibility criteria but were not needed|3|||
147141182|NCT04908683|530684444|FG001|Overall Study|Participant met eligibility criteria but were not needed|1|||
147141183|NCT04908683|530684443|FG000|Overall Study|Physician Decision|44|||
147141184|NCT04908683|530684444|FG001|Overall Study|Physician Decision|35|||
147141185|NCT04908683|530684443|FG000|Overall Study|Technical problems|12|||
147141186|NCT04908683|530684444|FG001|Overall Study|Technical problems|9|||
147141187|NCT04908683|530684443|FG000|Overall Study|Withdrawal by legally authorized representative|1|||
147141188|NCT04908683|530684444|FG001|Overall Study|Withdrawal by legally authorized representative|0|||
147141189|NCT04908683|530684443|FG000|Overall Study|Protocol Violation|2|||
147141190|NCT04908683|530684444|FG001|Overall Study|Protocol Violation|0|||
147141191|NCT04908683|530684443|FG000|Overall Study|Withdrawal by Subject|1188|||
147141192|NCT04908683|530684444|FG001|Overall Study|Withdrawal by Subject|570|||
147141193|NCT04908683|530684443|FG000|Overall Study|Site Closure by Sponsor|6|||
147141194|NCT04908683|530684444|FG001|Overall Study|Site Closure by Sponsor|3|||
147141195|NCT04908683|530684443|FG000|Overall Study|Adverse Event|21|||
147141196|NCT04908683|530684444|FG001|Overall Study|Adverse Event|11|||
147141197|NCT04908683|530684443|FG000|Overall Study|Death|101|||
147141198|NCT04908683|530684444|FG001|Overall Study|Death|61|||
147141199|NCT04908683|530684443|FG000|Overall Study|Sponsor's decision|14398|||
147141200|NCT04908683|530684444|FG001|Overall Study|Sponsor's decision|7205|||
147141201|NCT04908683|530684443|FG000|Overall Study|Other|92|||
147141202|NCT04908683|530684444|FG001|Overall Study|Other|50|||
147141203|NCT04908683|530684443|FG000|Overall Study|Randomized not vaccinated|108|||
147141204|NCT04908683|530684444|FG001|Overall Study|Randomized not vaccinated|52|||
147141205|NCT02831855|530684445|FG000|Open Label Phase (24 Weeks)|Adverse Event|39|||
147141206|NCT02831855|530684446|FG001|Open Label Phase (24 Weeks)|Adverse Event|0|||
147141207|NCT02831855|530684447|FG002|Open Label Phase (24 Weeks)|Adverse Event|0|||
147141208|NCT02831855|530684445|FG000|Open Label Phase (24 Weeks)|Lost to Follow-up|8|||
147141209|NCT02831855|530684446|FG001|Open Label Phase (24 Weeks)|Lost to Follow-up|0|||
147141210|NCT02831855|530684447|FG002|Open Label Phase (24 Weeks)|Lost to Follow-up|0|||
147141211|NCT02831855|530684445|FG000|Open Label Phase (24 Weeks)|Insufficient Clinical Response|7|||
147141212|NCT02831855|530684446|FG001|Open Label Phase (24 Weeks)|Insufficient Clinical Response|0|||
147141213|NCT02831855|530684447|FG002|Open Label Phase (24 Weeks)|Insufficient Clinical Response|0|||
147141214|NCT02831855|530684445|FG000|Open Label Phase (24 Weeks)|Medication error,no linked adverse event|2|||
147141215|NCT02831855|530684446|FG001|Open Label Phase (24 Weeks)|Medication error,no linked adverse event|0|||
147141216|NCT02831855|530684447|FG002|Open Label Phase (24 Weeks)|Medication error,no linked adverse event|0|||
147141217|NCT02831855|530684445|FG000|Open Label Phase (24 Weeks)|Protocol Violation|5|||
147141218|NCT02831855|530684446|FG001|Open Label Phase (24 Weeks)|Protocol Violation|0|||
147141219|NCT02831855|530684447|FG002|Open Label Phase (24 Weeks)|Protocol Violation|0|||
147141220|NCT02831855|530684445|FG000|Open Label Phase (24 Weeks)|Withdrawal by Subject|6|||
147141221|NCT02831855|530684446|FG001|Open Label Phase (24 Weeks)|Withdrawal by Subject|0|||
147141222|NCT02831855|530684447|FG002|Open Label Phase (24 Weeks)|Withdrawal by Subject|0|||
147141223|NCT02831855|530684445|FG000|Open Label Phase (24 Weeks)|Other|4|||
147141224|NCT02831855|530684446|FG001|Open Label Phase (24 Weeks)|Other|0|||
147141225|NCT02831855|530684447|FG002|Open Label Phase (24 Weeks)|Other|0|||
147141226|NCT02831855|530684445|FG000|Double Blind Phase (24 Weeks)|Adverse Event|0|||
147141227|NCT02831855|530684446|FG001|Double Blind Phase (24 Weeks)|Adverse Event|6|||
147141228|NCT02831855|530684447|FG002|Double Blind Phase (24 Weeks)|Adverse Event|6|||
147141229|NCT02831855|530684445|FG000|Double Blind Phase (24 Weeks)|Death|0|||
147141230|NCT02831855|530684446|FG001|Double Blind Phase (24 Weeks)|Death|0|||
147141231|NCT02831855|530684447|FG002|Double Blind Phase (24 Weeks)|Death|2|||
147141232|NCT02831855|530684445|FG000|Double Blind Phase (24 Weeks)|Lost to Follow-up|0|||
147141233|NCT02831855|530684446|FG001|Double Blind Phase (24 Weeks)|Lost to Follow-up|1|||
147141234|NCT02831855|530684447|FG002|Double Blind Phase (24 Weeks)|Lost to Follow-up|1|||
147141235|NCT02831855|530684445|FG000|Double Blind Phase (24 Weeks)|Screen Failure|0|||
147141236|NCT02831855|530684446|FG001|Double Blind Phase (24 Weeks)|Screen Failure|1|||
147141237|NCT02831855|530684447|FG002|Double Blind Phase (24 Weeks)|Screen Failure|0|||
147141238|NCT02831855|530684445|FG000|Double Blind Phase (24 Weeks)|Withdrawal by Subject|0|||
147141239|NCT02831855|530684446|FG001|Double Blind Phase (24 Weeks)|Withdrawal by Subject|5|||
147141240|NCT02831855|530684447|FG002|Double Blind Phase (24 Weeks)|Withdrawal by Subject|2|||
147141241|NCT02831855|530684445|FG000|Double Blind Phase (24 Weeks)|Other|0|||
147141242|NCT02831855|530684446|FG001|Double Blind Phase (24 Weeks)|Other|2|||
147141243|NCT02831855|530684447|FG002|Double Blind Phase (24 Weeks)|Other|5|||
147141244|NCT02831855|530684445|FG000|Double Blind Phase (24 Weeks)|Insufficient Clinical Response|0|||
147141245|NCT02831855|530684446|FG001|Double Blind Phase (24 Weeks)|Insufficient Clinical Response|6|||
147141246|NCT02831855|530684447|FG002|Double Blind Phase (24 Weeks)|Insufficient Clinical Response|1|||
147141247|NCT02831855|530684445|FG000|Double Blind Phase (24 Weeks)|Protocol Violation|0|||
147141248|NCT02831855|530684446|FG001|Double Blind Phase (24 Weeks)|Protocol Violation|5|||
147141249|NCT02831855|530684447|FG002|Double Blind Phase (24 Weeks)|Protocol Violation|2|||
147141250|NCT02831855|530684445|FG000|Double Blind Phase (24 Weeks)|Randomized but not Treated|0|||
147141251|NCT02831855|530684446|FG001|Double Blind Phase (24 Weeks)|Randomized but not Treated|3|||
147141252|NCT02831855|530684447|FG002|Double Blind Phase (24 Weeks)|Randomized but not Treated|0|||
147141253|NCT02688192|530684448|FG000|Overall Study|Lost to Follow-up|11|||
147141254|NCT02688192|530684449|FG001|Overall Study|Lost to Follow-up|5|||
147141255|NCT02688192|530684448|FG000|Overall Study|Physician Decision|1|||
147141256|NCT02688192|530684449|FG001|Overall Study|Physician Decision|0|||
147141257|NCT00075764|530684450|FG000|Overall Study|Adverse Event|5|||
147141258|NCT00075764|530684451|FG001|Overall Study|Adverse Event|12|||
147141259|NCT00075764|530684450|FG000|Overall Study|Death|4|||
147141260|NCT00075764|530684451|FG001|Overall Study|Death|8|||
147141261|NCT00075764|530684450|FG000|Overall Study|Withdrawal by Subject|28|||
147141262|NCT00075764|530684451|FG001|Overall Study|Withdrawal by Subject|18|||
147141263|NCT00075764|530684450|FG000|Overall Study|Progression|269|||
147141264|NCT00075764|530684451|FG001|Overall Study|Progression|274|||
147141265|NCT00075764|530684450|FG000|Overall Study|Still on treatment|8|||
147141266|NCT00075764|530684451|FG001|Overall Study|Still on treatment|15|||
147141267|NCT00075764|530684450|FG000|Overall Study|Delinquent|4|||
147141268|NCT00075764|530684451|FG001|Overall Study|Delinquent|2|||
147141269|NCT00075764|530684450|FG000|Overall Study|Not protocol specified|27|||
147141270|NCT00075764|530684451|FG001|Overall Study|Not protocol specified|19|||
147141271|NCT00075764|530684450|FG000|Overall Study|Under review|0|||
147141272|NCT00075764|530684451|FG001|Overall Study|Under review|1|||
147141273|NCT02817594|530684455|FG000|Overall Study|Withdrawal by Subject|1|||
147141274|NCT02817594|530684455|FG000|Overall Study|Other|1|||
147141275|NCT02817594|530684455|FG000|Overall Study|Did Not Receive Treatment|1|||
147141276|NCT02010593|530684456|FG000|Overall Study|Lost to Follow-up|1|||
147141277|NCT02010593|530684457|FG001|Overall Study|Lost to Follow-up|0|||
147141278|NCT02010593|530684456|FG000|Overall Study|Physician Decision|1|||
147141279|NCT02010593|530684457|FG001|Overall Study|Physician Decision|0|||
147141280|NCT02010593|530684456|FG000|Overall Study|Unable to adhere to visit schedule|0|||
147141281|NCT02010593|530684457|FG001|Overall Study|Unable to adhere to visit schedule|2|||
147141282|NCT01773967|530684458|FG000|Overall Study|Lost to Follow-up|15|||
147141283|NCT01773967|530684459|FG001|Overall Study|Lost to Follow-up|13|||
147141284|NCT01135459|530684460|FG000|Overall Study|Adverse Event|8|||
147141285|NCT01135459|530684461|FG001|Overall Study|Adverse Event|10|||
147141286|NCT01135459|530684460|FG000|Overall Study|Lack of Efficacy|3|||
147141287|NCT01135459|530684461|FG001|Overall Study|Lack of Efficacy|1|||
147141288|NCT01135459|530684460|FG000|Overall Study|Withdrawal by Subject|2|||
147141289|NCT01135459|530684461|FG001|Overall Study|Withdrawal by Subject|3|||
147141290|NCT01135459|530684460|FG000|Overall Study|Protocol Violation|5|||
147141291|NCT01135459|530684461|FG001|Overall Study|Protocol Violation|3|||
147141292|NCT01135459|530684460|FG000|Overall Study|Lost to Follow-up|2|||
147141293|NCT01135459|530684461|FG001|Overall Study|Lost to Follow-up|1|||
147141294|NCT01135459|530684460|FG000|Overall Study|Non-compliance to study procedures|0|||
147141295|NCT01135459|530684461|FG001|Overall Study|Non-compliance to study procedures|1|||
147141296|NCT01135459|530684460|FG000|Overall Study|Other than specified|1|||
147141297|NCT01135459|530684461|FG001|Overall Study|Other than specified|1|||
147141298|NCT02236572|530684463|FG000|Overall Study|Withdrawal by Subject|1|||
147141299|NCT02236572|530684463|FG000|Overall Study|Protocol Violation|1|||
147141300|NCT02236572|530684463|FG000|Overall Study|Lost to Follow-up|1|||
147141301|NCT01057693|530684464|FG000|Single-Blind Phase (Up to Week 6)|Adverse Event|45|||
147141302|NCT01057693|530684465|FG001|Single-Blind Phase (Up to Week 6)|Adverse Event|0|||
147141303|NCT01057693|530684466|FG002|Single-Blind Phase (Up to Week 6)|Adverse Event|0|||
147141304|NCT01057693|530684464|FG000|Single-Blind Phase (Up to Week 6)|Lack of Efficacy|7|||
147141305|NCT01057693|530684465|FG001|Single-Blind Phase (Up to Week 6)|Lack of Efficacy|0|||
147141306|NCT01057693|530684466|FG002|Single-Blind Phase (Up to Week 6)|Lack of Efficacy|0|||
147141307|NCT01057693|530684464|FG000|Single-Blind Phase (Up to Week 6)|Lost to Follow-up|14|||
147141308|NCT01057693|530684465|FG001|Single-Blind Phase (Up to Week 6)|Lost to Follow-up|0|||
147141309|NCT01057693|530684466|FG002|Single-Blind Phase (Up to Week 6)|Lost to Follow-up|0|||
147141310|NCT01057693|530684464|FG000|Single-Blind Phase (Up to Week 6)|Protocol Violation|9|||
147445706|NCT01074190|531797431|FG001|Overall Study|Delivered in under 90 minutes|2|||
147445707|NCT01074190|531797432|FG002|Overall Study|Delivered in under 90 minutes|1|||
147141311|NCT01057693|530684465|FG001|Single-Blind Phase (Up to Week 6)|Protocol Violation|0|||
147141312|NCT01057693|530684466|FG002|Single-Blind Phase (Up to Week 6)|Protocol Violation|0|||
147141313|NCT01057693|530684464|FG000|Single-Blind Phase (Up to Week 6)|Withdrawal by Subject|22|||
147141314|NCT01057693|530684465|FG001|Single-Blind Phase (Up to Week 6)|Withdrawal by Subject|0|||
147141315|NCT01057693|530684466|FG002|Single-Blind Phase (Up to Week 6)|Withdrawal by Subject|0|||
147141316|NCT01057693|530684464|FG000|Single-Blind Phase (Up to Week 6)|Other|2|||
147141317|NCT01057693|530684465|FG001|Single-Blind Phase (Up to Week 6)|Other|0|||
147141318|NCT01057693|530684466|FG002|Single-Blind Phase (Up to Week 6)|Other|0|||
147141319|NCT01057693|530684464|FG000|Between Single-Blind and Double-Blind|Adverse Event|5|||
147141320|NCT01057693|530684465|FG001|Between Single-Blind and Double-Blind|Adverse Event|0|||
147141321|NCT01057693|530684466|FG002|Between Single-Blind and Double-Blind|Adverse Event|0|||
147141322|NCT01057693|530684464|FG000|Between Single-Blind and Double-Blind|Lack of Efficacy|247|||
147141323|NCT01057693|530684465|FG001|Between Single-Blind and Double-Blind|Lack of Efficacy|0|||
147141324|NCT01057693|530684466|FG002|Between Single-Blind and Double-Blind|Lack of Efficacy|0|||
147141325|NCT01057693|530684464|FG000|Between Single-Blind and Double-Blind|Lost to Follow-up|1|||
147141326|NCT01057693|530684465|FG001|Between Single-Blind and Double-Blind|Lost to Follow-up|0|||
147141327|NCT01057693|530684466|FG002|Between Single-Blind and Double-Blind|Lost to Follow-up|0|||
147141328|NCT01057693|530684464|FG000|Between Single-Blind and Double-Blind|Protocol Violation|7|||
147141329|NCT01057693|530684465|FG001|Between Single-Blind and Double-Blind|Protocol Violation|0|||
147141330|NCT01057693|530684466|FG002|Between Single-Blind and Double-Blind|Protocol Violation|0|||
147141331|NCT01057693|530684464|FG000|Between Single-Blind and Double-Blind|Withdrawal by Subject|4|||
147141332|NCT01057693|530684465|FG001|Between Single-Blind and Double-Blind|Withdrawal by Subject|0|||
147141333|NCT01057693|530684466|FG002|Between Single-Blind and Double-Blind|Withdrawal by Subject|0|||
147141334|NCT01057693|530684464|FG000|Between Single-Blind and Double-Blind|Other|6|||
147141335|NCT01057693|530684465|FG001|Between Single-Blind and Double-Blind|Other|0|||
147141336|NCT01057693|530684466|FG002|Between Single-Blind and Double-Blind|Other|0|||
147141337|NCT01057693|530684464|FG000|Double-Blind Phase (Week 7 to Week 19)|Adverse Event|0|||
147141338|NCT01057693|530684465|FG001|Double-Blind Phase (Week 7 to Week 19)|Adverse Event|8|||
147141339|NCT01057693|530684466|FG002|Double-Blind Phase (Week 7 to Week 19)|Adverse Event|11|||
147141340|NCT01057693|530684464|FG000|Double-Blind Phase (Week 7 to Week 19)|Lack of Efficacy|0|||
147141341|NCT01057693|530684465|FG001|Double-Blind Phase (Week 7 to Week 19)|Lack of Efficacy|3|||
147141342|NCT01057693|530684466|FG002|Double-Blind Phase (Week 7 to Week 19)|Lack of Efficacy|8|||
147141343|NCT01057693|530684464|FG000|Double-Blind Phase (Week 7 to Week 19)|Lost to Follow-up|0|||
147141344|NCT01057693|530684465|FG001|Double-Blind Phase (Week 7 to Week 19)|Lost to Follow-up|2|||
147141345|NCT01057693|530684466|FG002|Double-Blind Phase (Week 7 to Week 19)|Lost to Follow-up|5|||
147141346|NCT01057693|530684464|FG000|Double-Blind Phase (Week 7 to Week 19)|Protocol Violation|0|||
147141347|NCT01057693|530684465|FG001|Double-Blind Phase (Week 7 to Week 19)|Protocol Violation|0|||
147141348|NCT01057693|530684466|FG002|Double-Blind Phase (Week 7 to Week 19)|Protocol Violation|4|||
147141349|NCT01057693|530684464|FG000|Double-Blind Phase (Week 7 to Week 19)|Withdrawal by Subject|0|||
147141350|NCT01057693|530684465|FG001|Double-Blind Phase (Week 7 to Week 19)|Withdrawal by Subject|8|||
147141351|NCT01057693|530684466|FG002|Double-Blind Phase (Week 7 to Week 19)|Withdrawal by Subject|6|||
147237890|NCT02609828|531042560|FG002|Overall Study|Insufficient clinical response|0|||
147573755|NCT00205777|532257504|FG004|Study Extension I|Lack of Efficacy|2|||
147573756|NCT00205777|532257505|FG005|Study Extension I|Lack of Efficacy|0|||
147573757|NCT00205777|532257500|FG000|Study Extension I|Failed to return|15|||
147573758|NCT00205777|532257501|FG001|Study Extension I|Failed to return|0|||
147573759|NCT00205777|532257502|FG002|Study Extension I|Failed to return|0|||
147573760|NCT00205777|532257503|FG003|Study Extension I|Failed to return|17|||
147573761|NCT00205777|532257504|FG004|Study Extension I|Failed to return|13|||
147573762|NCT00205777|532257505|FG005|Study Extension I|Failed to return|0|||
147573763|NCT00205777|532257500|FG000|Study Extension I|Other Event|34|||
147573764|NCT00205777|532257501|FG001|Study Extension I|Other Event|0|||
147573765|NCT00205777|532257502|FG002|Study Extension I|Other Event|0|||
147573766|NCT00205777|532257503|FG003|Study Extension I|Other Event|34|||
147573767|NCT00205777|532257504|FG004|Study Extension I|Other Event|29|||
147573768|NCT00205777|532257505|FG005|Study Extension I|Other Event|0|||
147573769|NCT00205777|532257500|FG000|Study Extension I|Withdrawn as per protocol|0|||
147573770|NCT00205777|532257501|FG001|Study Extension I|Withdrawn as per protocol|0|||
147573771|NCT00205777|532257502|FG002|Study Extension I|Withdrawn as per protocol|1070|||
147573772|NCT00205777|532257503|FG003|Study Extension I|Withdrawn as per protocol|0|||
147237891|NCT02609828|531042561|FG003|Overall Study|Insufficient clinical response|0|||
147237892|NCT02609828|531042558|FG000|Overall Study|Lost to Follow-up|0|||
147237893|NCT02609828|531042559|FG001|Overall Study|Lost to Follow-up|0|||
147237894|NCT02609828|531042560|FG002|Overall Study|Lost to Follow-up|0|||
147237895|NCT02609828|531042561|FG003|Overall Study|Lost to Follow-up|1|||
147237896|NCT02609828|531042558|FG000|Overall Study|Protocol Violation|2|||
147237897|NCT02609828|531042559|FG001|Overall Study|Protocol Violation|0|||
147237898|NCT02609828|531042560|FG002|Overall Study|Protocol Violation|0|||
147237899|NCT02609828|531042561|FG003|Overall Study|Protocol Violation|1|||
147237900|NCT02609828|531042558|FG000|Overall Study|Withdrawal by Subject|12|||
147237901|NCT02609828|531042559|FG001|Overall Study|Withdrawal by Subject|1|||
147237902|NCT02609828|531042560|FG002|Overall Study|Withdrawal by Subject|0|||
147237903|NCT02609828|531042561|FG003|Overall Study|Withdrawal by Subject|10|||
147237904|NCT02609828|531042558|FG000|Overall Study|Other|3|||
147237905|NCT02609828|531042559|FG001|Overall Study|Other|0|||
147237906|NCT02609828|531042560|FG002|Overall Study|Other|0|||
147237907|NCT02609828|531042561|FG003|Overall Study|Other|6|||
147237908|NCT02609828|531042558|FG000|Overall Study|Randomized but not treated|1|||
147237909|NCT02609828|531042559|FG001|Overall Study|Randomized but not treated|0|||
147573773|NCT00205777|532257504|FG004|Study Extension I|Withdrawn as per protocol|0|||
147237910|NCT02609828|531042560|FG002|Overall Study|Randomized but not treated|0|||
147318624|NCT00519636|531331775|FG001|Washout Period|Prohibited medications|0|||
147318625|NCT00519636|531331776|FG002|Washout Period|Prohibited medications|1|||
147318626|NCT00519636|531331777|FG003|Washout Period|Prohibited medications|0|||
147318627|NCT00519636|531331774|FG000|Treatment Period 2|Failed To Meet Continuation Criteria|0|||
147318628|NCT00519636|531331775|FG001|Treatment Period 2|Failed To Meet Continuation Criteria|0|||
147318629|NCT00519636|531331776|FG002|Treatment Period 2|Failed To Meet Continuation Criteria|0|||
147318630|NCT00519636|531331777|FG003|Treatment Period 2|Failed To Meet Continuation Criteria|1|||
147318631|NCT00519636|531331774|FG000|Treatment Period 2|Subject randomized in error|0|||
147318632|NCT00519636|531331775|FG001|Treatment Period 2|Subject randomized in error|1|||
147318633|NCT00519636|531331776|FG002|Treatment Period 2|Subject randomized in error|0|||
147318634|NCT00519636|531331777|FG003|Treatment Period 2|Subject randomized in error|0|||
147141352|NCT01057693|530684464|FG000|Double-Blind Phase (Week 7 to Week 19)|Other|0|||
147141353|NCT01057693|530684465|FG001|Double-Blind Phase (Week 7 to Week 19)|Other|1|||
147141354|NCT01057693|530684466|FG002|Double-Blind Phase (Week 7 to Week 19)|Other|0|||
147141355|NCT01057693|530684464|FG000|Double-Blind Phase (Week 7 to Week 19)|Randomized, Not Treated|0|||
147141356|NCT01057693|530684465|FG001|Double-Blind Phase (Week 7 to Week 19)|Randomized, Not Treated|0|||
147141357|NCT01057693|530684466|FG002|Double-Blind Phase (Week 7 to Week 19)|Randomized, Not Treated|2|||
147141358|NCT02413996|530684467|FG000|Overall Study|not comfortable with the intervention|9|||
147141359|NCT02413996|530684468|FG001|Overall Study|not comfortable with the intervention|2|||
147141360|NCT00709319|530684469|FG000|Overall Study|Death|4|||
147141361|NCT00709319|530684469|FG000|Overall Study|Withdrawal by Subject|2|||
147141362|NCT00090779|530684473|FG000|Step 1|Withdrawal by Subject|4|||
147141363|NCT00090779|530684474|FG001|Step 1|Withdrawal by Subject|2|||
147141364|NCT00090779|530684473|FG000|Step 1|Lost to Follow-up|3|||
147141365|NCT00090779|530684474|FG001|Step 1|Lost to Follow-up|2|||
147141366|NCT00090779|530684473|FG000|Step 1|Death|0|||
147141367|NCT00090779|530684474|FG001|Step 1|Death|2|||
147141368|NCT00090779|530684473|FG000|Step 1|Physician Decision|1|||
147141369|NCT00090779|530684474|FG001|Step 1|Physician Decision|0|||
147141370|NCT00090779|530684473|FG000|Step 1|Pregnancy|1|||
147141371|NCT00090779|530684474|FG001|Step 1|Pregnancy|0|||
147141372|NCT00090779|530684473|FG000|Step 1|Non-compliance to study requirements|0|||
147141373|NCT00090779|530684474|FG001|Step 1|Non-compliance to study requirements|1|||
147141374|NCT00090779|530684473|FG000|Step 1|Subject relocated|2|||
147141375|NCT00090779|530684474|FG001|Step 1|Subject relocated|8|||
147141376|NCT00090779|530684473|FG000|Step 2|Off study per study closure|6|||
147141377|NCT00090779|530684474|FG001|Step 2|Off study per study closure|16|||
147141378|NCT00090779|530684473|FG000|Step 2|Subject relocated|0|||
147141379|NCT00090779|530684474|FG001|Step 2|Subject relocated|1|||
147141380|NCT00090779|530684473|FG000|Step 2|Non-compliance to study requirements|0|||
147141381|NCT00090779|530684474|FG001|Step 2|Non-compliance to study requirements|1|||
147141382|NCT00090779|530684473|FG000|Step 3|Initiation of ART and off extended study|3|||
147141383|NCT00090779|530684474|FG001|Step 3|Initiation of ART and off extended study|2|||
147141384|NCT00090779|530684473|FG000|Step 3|Off extended study due to study closure|4|||
147141385|NCT00090779|530684474|FG001|Step 3|Off extended study due to study closure|3|||
147141386|NCT04860869|530684481|FG000|Overall Study|Withdrawal by Subject|1|||
147141387|NCT04860869|530684482|FG001|Overall Study|Withdrawal by Subject|0|||
147141388|NCT00590967|530684486|FG000|Overall Study|Withdrawal by Subject|1|||
147141389|NCT00590967|530684487|FG001|Overall Study|Withdrawal by Subject|1|||
147141390|NCT00590967|530684486|FG000|Overall Study|Ineligible|1|||
147141391|NCT00590967|530684487|FG001|Overall Study|Ineligible|0|||
147141392|NCT00590967|530684486|FG000|Overall Study|Poor performance status|0|||
147141393|NCT00590967|530684487|FG001|Overall Study|Poor performance status|1|||
147141394|NCT00590967|530684486|FG000|Overall Study|Non-compliant|0|||
147141395|NCT00590967|530684487|FG001|Overall Study|Non-compliant|2|||
147141396|NCT00590967|530684486|FG000|Overall Study|Did not sign consent form|0|||
147141397|NCT00590967|530684487|FG001|Overall Study|Did not sign consent form|1|||
147141398|NCT00590967|530684486|FG000|Overall Study|Did not receive chemo per protocol|1|||
147141399|NCT00590967|530684487|FG001|Overall Study|Did not receive chemo per protocol|0|||
147141400|NCT01881789|530684488|FG000|Overall Study|Withdrawal by Subject|0|||
147141401|NCT01881789|530684489|FG001|Overall Study|Withdrawal by Subject|2|||
147141402|NCT01881789|530684490|FG002|Overall Study|Withdrawal by Subject|1|||
147141403|NCT01881789|530684491|FG003|Overall Study|Withdrawal by Subject|0|||
147141404|NCT01881789|530684492|FG004|Overall Study|Withdrawal by Subject|1|||
147141405|NCT01881789|530684493|FG005|Overall Study|Withdrawal by Subject|1|||
147141406|NCT01881789|530684488|FG000|Overall Study|Study Terminated by Sponsor|0|||
147318635|NCT00519636|531331774|FG000|Treatment Period 2|Per doctors request|0|||
147141407|NCT01881789|530684489|FG001|Overall Study|Study Terminated by Sponsor|0|||
147141408|NCT01881789|530684490|FG002|Overall Study|Study Terminated by Sponsor|0|||
147141409|NCT01881789|530684491|FG003|Overall Study|Study Terminated by Sponsor|0|||
147141410|NCT01881789|530684492|FG004|Overall Study|Study Terminated by Sponsor|0|||
147141411|NCT01881789|530684493|FG005|Overall Study|Study Terminated by Sponsor|1|||
147141412|NCT01881789|530684488|FG000|Overall Study|Other|3|||
147318636|NCT00519636|531331775|FG001|Treatment Period 2|Per doctors request|0|||
147318637|NCT00519636|531331776|FG002|Treatment Period 2|Per doctors request|1|||
147141413|NCT01881789|530684489|FG001|Overall Study|Other|5|||
147141414|NCT01881789|530684490|FG002|Overall Study|Other|2|||
147141415|NCT01881789|530684491|FG003|Overall Study|Other|3|||
147141416|NCT01881789|530684492|FG004|Overall Study|Other|1|||
147141417|NCT01881789|530684493|FG005|Overall Study|Other|1|||
147141418|NCT01151020|530684494|FG000|Overall Study|Death|25|||
147141419|NCT01151020|530684494|FG000|Overall Study|Conversion to open repair|1|||
147141420|NCT01151020|530684494|FG000|Overall Study|Lost to Follow-up|4|||
147141421|NCT01151020|530684494|FG000|Overall Study|Withdrawal by Subject|22|||
147141422|NCT01151020|530684494|FG000|Overall Study|Patients did not receive the device|2|||
147141423|NCT00442416|530684495|FG000|Overall Study|Adverse Event|4|||
147141424|NCT00442416|530684496|FG001|Overall Study|Adverse Event|1|||
147141425|NCT00442416|530684495|FG000|Overall Study|Death|1|||
147141426|NCT00442416|530684496|FG001|Overall Study|Death|0|||
147141427|NCT00442416|530684495|FG000|Overall Study|Lack of Efficacy|2|||
147141428|NCT00442416|530684496|FG001|Overall Study|Lack of Efficacy|0|||
147141429|NCT00442416|530684495|FG000|Overall Study|Protocol Violation|2|||
147141430|NCT00442416|530684496|FG001|Overall Study|Protocol Violation|3|||
147141431|NCT00442416|530684495|FG000|Overall Study|Withdrew consent|1|||
147141432|NCT00442416|530684496|FG001|Overall Study|Withdrew consent|2|||
147141433|NCT00442416|530684495|FG000|Overall Study|Administrative/Other|27|||
147141434|NCT00442416|530684496|FG001|Overall Study|Administrative/Other|33|||
147141435|NCT01737762|530684499|FG000|Overall Study|Adverse Event|2|||
147141436|NCT01737762|530684500|FG001|Overall Study|Adverse Event|2|||
147141437|NCT01737762|530684499|FG000|Overall Study|Lost to Follow-up|1|||
147141438|NCT01737762|530684500|FG001|Overall Study|Lost to Follow-up|0|||
147141439|NCT01737762|530684499|FG000|Overall Study|Withdrawal by Subject|2|||
147141440|NCT01737762|530684500|FG001|Overall Study|Withdrawal by Subject|2|||
147141441|NCT01737762|530684499|FG000|Overall Study|Progressive disease|1|||
147141442|NCT01737762|530684500|FG001|Overall Study|Progressive disease|2|||
147141443|NCT01737762|530684499|FG000|Overall Study|Physician Decision|1|||
147141444|NCT01737762|530684500|FG001|Overall Study|Physician Decision|1|||
147141445|NCT01737762|530684499|FG000|Overall Study|Moved from area|2|||
147141446|NCT01737762|530684500|FG001|Overall Study|Moved from area|1|||
147141447|NCT01737762|530684499|FG000|Overall Study|Trial termination|11|||
147141448|NCT01737762|530684500|FG001|Overall Study|Trial termination|9|||
147141449|NCT00503425|530684501|FG000|Overall Study|Participant files lost|6|||
147141450|NCT00503425|530684501|FG000|Overall Study|Adverse Event|5|||
147141451|NCT00503425|530684501|FG000|Overall Study|Lack of Efficacy|25|||
147141452|NCT00503425|530684501|FG000|Overall Study|Withdrawal by Subject|8|||
147141453|NCT00503425|530684501|FG000|Overall Study|Lost to Follow-up|3|||
147141454|NCT00503425|530684501|FG000|Overall Study|Death|3|||
147141455|NCT00503425|530684501|FG000|Overall Study|Missing Data/Unknown|4|||
147141456|NCT02148263|530684502|FG000|Overall Study|Withdrawal by Subject|3|||
147141457|NCT02148263|530684503|FG001|Overall Study|Withdrawal by Subject|2|||
147141458|NCT00003869|530684504|FG000|Overall Study|Adverse Event|14|||
147141459|NCT00003869|530684505|FG001|Overall Study|Adverse Event|3|||
147141460|NCT00003869|530684504|FG000|Overall Study|Withdrawal by Subject|21|||
147141461|NCT00003869|530684505|FG001|Overall Study|Withdrawal by Subject|3|||
147141462|NCT00003869|530684504|FG000|Overall Study|Death|1|||
147141463|NCT00003869|530684505|FG001|Overall Study|Death|2|||
147141464|NCT00003869|530684504|FG000|Overall Study|Alternative treatmnt, medical problems|5|||
147141465|NCT00003869|530684505|FG001|Overall Study|Alternative treatmnt, medical problems|4|||
147141466|NCT01964378|530684506|FG000|Overall Study|Disc. due to death before first dosing|0|||
147141467|NCT01964378|530684507|FG001|Overall Study|Disc. due to death before first dosing|1|||
147141468|NCT01964378|530684506|FG000|Overall Study|Disc. due to AE before first dosing|1|||
147141469|NCT01964378|530684507|FG001|Overall Study|Disc. due to AE before first dosing|0|||
147141470|NCT01964378|530684506|FG000|Overall Study|Death|3|||
147573774|NCT00205777|532257505|FG005|Study Extension I|Withdrawn as per protocol|0|||
147318638|NCT00519636|531331777|FG003|Treatment Period 2|Per doctors request|0|||
147318639|NCT00519636|531331774|FG000|Treatment Period 2|Subject misrandomized|0|||
147573775|NCT00205777|532257500|FG000|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|273|||
147318640|NCT00519636|531331775|FG001|Treatment Period 2|Subject misrandomized|0|||
147318641|NCT00519636|531331776|FG002|Treatment Period 2|Subject misrandomized|0|||
147573776|NCT00205777|532257501|FG001|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|0|||
147318642|NCT00519636|531331777|FG003|Treatment Period 2|Subject misrandomized|1|||
147573777|NCT00205777|532257502|FG002|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|0|||
147573778|NCT00205777|532257503|FG003|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|240|||
147141471|NCT01964378|530684507|FG001|Overall Study|Death|2|||
147141472|NCT01964378|530684506|FG000|Overall Study|Adverse Event|12|||
147141473|NCT01964378|530684507|FG001|Overall Study|Adverse Event|5|||
147141474|NCT01964378|530684506|FG000|Overall Study|Lack of Efficacy|0|||
147141475|NCT01964378|530684507|FG001|Overall Study|Lack of Efficacy|1|||
147141476|NCT01964378|530684506|FG000|Overall Study|Protocol Violation|0|||
147141477|NCT01964378|530684507|FG001|Overall Study|Protocol Violation|1|||
147141478|NCT01964378|530684506|FG000|Overall Study|Lost to Follow-up|0|||
147141479|NCT01964378|530684507|FG001|Overall Study|Lost to Follow-up|1|||
147141480|NCT01964378|530684506|FG000|Overall Study|Withdrawal by Subject|7|||
147141481|NCT01964378|530684507|FG001|Overall Study|Withdrawal by Subject|5|||
147141482|NCT01964378|530684506|FG000|Overall Study|Inclusion/exclusion criteria not met|1|||
147141483|NCT01964378|530684507|FG001|Overall Study|Inclusion/exclusion criteria not met|3|||
147141484|NCT01964378|530684506|FG000|Overall Study|Other|1|||
147141485|NCT01964378|530684507|FG001|Overall Study|Other|2|||
147141486|NCT00326599|530684508|FG000|Overall Study|Withdrawal by Subject|1|||
147141487|NCT00326599|530684509|FG001|Overall Study|Withdrawal by Subject|0|||
147141488|NCT00326599|530684510|FG002|Overall Study|Withdrawal by Subject|5|||
147141489|NCT00326599|530684511|FG003|Overall Study|Withdrawal by Subject|2|||
147141490|NCT00326599|530684508|FG000|Overall Study|Adverse Event|1|||
147141491|NCT00326599|530684509|FG001|Overall Study|Adverse Event|0|||
147141492|NCT00326599|530684510|FG002|Overall Study|Adverse Event|32|||
147141493|NCT00326599|530684511|FG003|Overall Study|Adverse Event|3|||
147141494|NCT00326599|530684508|FG000|Overall Study|Disease Progression|3|||
147141495|NCT00326599|530684509|FG001|Overall Study|Disease Progression|1|||
147141496|NCT00326599|530684510|FG002|Overall Study|Disease Progression|13|||
147141497|NCT00326599|530684511|FG003|Overall Study|Disease Progression|11|||
147141498|NCT00326599|530684508|FG000|Overall Study|Alternate Treatment|1|||
147141499|NCT00326599|530684509|FG001|Overall Study|Alternate Treatment|0|||
147141500|NCT00326599|530684510|FG002|Overall Study|Alternate Treatment|0|||
147141501|NCT00326599|530684511|FG003|Overall Study|Alternate Treatment|0|||
147573779|NCT00205777|532257504|FG004|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|258|||
147573780|NCT00205777|532257505|FG005|Completed SE I, Entered Extension SE II|No-consent/eligible/SEII continuing site|0|||
147573781|NCT00205777|532257500|FG000|Study Extension II|Adverse Event|0|||
147573782|NCT00205777|532257501|FG001|Study Extension II|Adverse Event|0|||
147573783|NCT00205777|532257502|FG002|Study Extension II|Adverse Event|0|||
147573784|NCT00205777|532257503|FG003|Study Extension II|Adverse Event|14|||
147573785|NCT00205777|532257504|FG004|Study Extension II|Adverse Event|0|||
147573786|NCT00205777|532257505|FG005|Study Extension II|Adverse Event|30|||
147573787|NCT00205777|532257500|FG000|Study Extension II|Death|0|||
147573788|NCT00205777|532257501|FG001|Study Extension II|Death|0|||
147573789|NCT00205777|532257502|FG002|Study Extension II|Death|0|||
147573790|NCT00205777|532257503|FG003|Study Extension II|Death|2|||
147573791|NCT00205777|532257504|FG004|Study Extension II|Death|0|||
147573792|NCT00205777|532257505|FG005|Study Extension II|Death|5|||
147573793|NCT00205777|532257500|FG000|Study Extension II|Withdrawal by Subject|0|||
147573794|NCT00205777|532257501|FG001|Study Extension II|Withdrawal by Subject|0|||
147573795|NCT00205777|532257502|FG002|Study Extension II|Withdrawal by Subject|0|||
147573796|NCT00205777|532257503|FG003|Study Extension II|Withdrawal by Subject|35|||
147573797|NCT00205777|532257504|FG004|Study Extension II|Withdrawal by Subject|0|||
147573798|NCT00205777|532257505|FG005|Study Extension II|Withdrawal by Subject|59|||
147573799|NCT00205777|532257500|FG000|Study Extension II|Protocol Violation|0|||
147573800|NCT00205777|532257501|FG001|Study Extension II|Protocol Violation|0|||
147573801|NCT00205777|532257502|FG002|Study Extension II|Protocol Violation|0|||
147573802|NCT00205777|532257503|FG003|Study Extension II|Protocol Violation|1|||
147573803|NCT00205777|532257504|FG004|Study Extension II|Protocol Violation|0|||
147573804|NCT00205777|532257505|FG005|Study Extension II|Protocol Violation|10|||
147573805|NCT00205777|532257500|FG000|Study Extension II|Lack of Efficacy|0|||
147573806|NCT00205777|532257501|FG001|Study Extension II|Lack of Efficacy|0|||
147573807|NCT00205777|532257502|FG002|Study Extension II|Lack of Efficacy|0|||
147573808|NCT00205777|532257503|FG003|Study Extension II|Lack of Efficacy|0|||
147573809|NCT00205777|532257504|FG004|Study Extension II|Lack of Efficacy|0|||
147573810|NCT00205777|532257505|FG005|Study Extension II|Lack of Efficacy|1|||
147573811|NCT00205777|532257500|FG000|Study Extension II|Failed to return|0|||
147573812|NCT00205777|532257501|FG001|Study Extension II|Failed to return|0|||
147573813|NCT00205777|532257502|FG002|Study Extension II|Failed to return|0|||
147573814|NCT00205777|532257503|FG003|Study Extension II|Failed to return|14|||
147141502|NCT00326599|530684508|FG000|Overall Study|Death|0|||
147141503|NCT00326599|530684509|FG001|Overall Study|Death|0|||
147237911|NCT02609828|531042561|FG003|Overall Study|Randomized but not treated|0|||
147237912|NCT00319553|531042562|FG000|Overall Study|Protocol Violation|1|||
147573815|NCT00205777|532257504|FG004|Study Extension II|Failed to return|0|||
147573816|NCT00205777|532257505|FG005|Study Extension II|Failed to return|26|||
147573817|NCT00205777|532257500|FG000|Study Extension II|Other Event|0|||
147573818|NCT00205777|532257501|FG001|Study Extension II|Other Event|0|||
147141504|NCT00326599|530684510|FG002|Overall Study|Death|1|||
147141505|NCT00326599|530684511|FG003|Overall Study|Death|2|||
147237913|NCT00319553|531042563|FG001|Overall Study|Protocol Violation|2|||
147141506|NCT00326599|530684508|FG000|Overall Study|Other Unspecified Reason|0|||
147141507|NCT00326599|530684509|FG001|Overall Study|Other Unspecified Reason|0|||
147141508|NCT00326599|530684510|FG002|Overall Study|Other Unspecified Reason|2|||
147141509|NCT00326599|530684511|FG003|Overall Study|Other Unspecified Reason|1|||
147573819|NCT00205777|532257502|FG002|Study Extension II|Other Event|0|||
147573820|NCT00205777|532257503|FG003|Study Extension II|Other Event|12|||
147573821|NCT00205777|532257504|FG004|Study Extension II|Other Event|0|||
147573822|NCT00205777|532257505|FG005|Study Extension II|Other Event|20|||
147573823|NCT00205777|532257500|FG000|Study Extension II|Enrolled but not treated|0|||
147141510|NCT03364231|530684512|FG000|Overall Study|Adverse Event|1|||
147141511|NCT03364231|530684513|FG001|Overall Study|Adverse Event|4|||
147141512|NCT03364231|530684512|FG000|Overall Study|Death|1|||
147141513|NCT03364231|530684513|FG001|Overall Study|Death|0|||
147141514|NCT03364231|530684512|FG000|Overall Study|Investigator Decision|2|||
147141515|NCT03364231|530684513|FG001|Overall Study|Investigator Decision|2|||
147141516|NCT03364231|530684512|FG000|Overall Study|Sponsor Discontinuation of the Study|2|||
147141517|NCT03364231|530684513|FG001|Overall Study|Sponsor Discontinuation of the Study|1|||
147141518|NCT03364231|530684512|FG000|Overall Study|Withdrawal of Subject Consent|1|||
147141519|NCT03364231|530684513|FG001|Overall Study|Withdrawal of Subject Consent|0|||
147141520|NCT03364231|530684512|FG000|Overall Study|Reason Not Specified|1|||
147141521|NCT03364231|530684513|FG001|Overall Study|Reason Not Specified|0|||
147237914|NCT00319553|531042562|FG000|Overall Study|Lost to Follow-up|2|||
147237915|NCT00319553|531042563|FG001|Overall Study|Lost to Follow-up|1|||
147237916|NCT00319553|531042562|FG000|Overall Study|Withdrawal by Subject|1|||
147573824|NCT00205777|532257501|FG001|Study Extension II|Enrolled but not treated|0|||
147573825|NCT00205777|532257502|FG002|Study Extension II|Enrolled but not treated|0|||
147141522|NCT03364231|530684512|FG000|Overall Study|Disease Progression|0|||
147573826|NCT00205777|532257503|FG003|Study Extension II|Enrolled but not treated|71|||
147573827|NCT00205777|532257504|FG004|Study Extension II|Enrolled but not treated|0|||
147141523|NCT03364231|530684513|FG001|Overall Study|Disease Progression|6|||
147141524|NCT02012218|530684522|FG000|Overall Study|Withdrawal by Subject|1|||
147141525|NCT02012218|530684523|FG001|Overall Study|Withdrawal by Subject|0|||
147141526|NCT02012218|530684524|FG002|Overall Study|Withdrawal by Subject|1|||
147141527|NCT02012218|530684525|FG003|Overall Study|Withdrawal by Subject|1|||
147141528|NCT02012218|530684526|FG004|Overall Study|Withdrawal by Subject|1|||
147141529|NCT02012218|530684522|FG000|Overall Study|Adverse Event|1|||
147141530|NCT02012218|530684523|FG001|Overall Study|Adverse Event|0|||
147141531|NCT02012218|530684524|FG002|Overall Study|Adverse Event|0|||
147141532|NCT02012218|530684525|FG003|Overall Study|Adverse Event|1|||
147141533|NCT02012218|530684526|FG004|Overall Study|Adverse Event|0|||
147141534|NCT02012218|530684522|FG000|Overall Study|Lost to Follow-up|0|||
147141535|NCT02012218|530684523|FG001|Overall Study|Lost to Follow-up|1|||
147141536|NCT02012218|530684524|FG002|Overall Study|Lost to Follow-up|1|||
147141537|NCT02012218|530684525|FG003|Overall Study|Lost to Follow-up|0|||
147141538|NCT02012218|530684526|FG004|Overall Study|Lost to Follow-up|0|||
147141539|NCT02012218|530684522|FG000|Overall Study|Protocol Specified|1|||
147573828|NCT00205777|532257505|FG005|Study Extension II|Enrolled but not treated|131|||
147573829|NCT01794845|532257508|FG000|Overall Study|Withdrawal by Subject|1|||
147573830|NCT02139826|532257509|FG000|Overall Study|Adverse Event|1|||
147573831|NCT00436163|532257512|FG000|Overall Study|Lost to Follow-up|2|||
147573832|NCT00436163|532257512|FG000|Overall Study|Adverse Event|1|||
147573833|NCT03719040|532257513|FG000|Overall Study|Withdrawal by Subject|177|||
147141540|NCT02012218|530684523|FG001|Overall Study|Protocol Specified|0|||
147237917|NCT00319553|531042563|FG001|Overall Study|Withdrawal by Subject|1|||
147237918|NCT01896102|531042564|FG000|Overall Study|Death|1|||
147237919|NCT01896102|531042564|FG000|Overall Study|Participant to receive allogenic transplant|2|||
147237920|NCT00753766|531042565|FG000|Overall Study|Physician Decision|1|||
147237921|NCT00753766|531042566|FG001|Overall Study|Physician Decision|0|||
147237922|NCT02805972|531042571|FG000|Washout Period|Lost to Follow-up|3|||
147237923|NCT02805972|531042572|FG001|Washout Period|Lost to Follow-up|0|||
147237924|NCT00939640|531042581|FG000|Overall Study|Physician Decision|1|||
147237925|NCT00239590|531042582|FG000|Randomized|Lost to Follow-up|0|||
147237926|NCT00239590|531042583|FG001|Randomized|Lost to Follow-up|1|||
147237927|NCT00239590|531042582|FG000|Randomized|Withdrawal by Subject|0|||
147237928|NCT00239590|531042583|FG001|Randomized|Withdrawal by Subject|1|||
147237929|NCT00239590|531042582|FG000|Completed Study Protocol|Adverse Event|1|||
147237930|NCT00239590|531042583|FG001|Completed Study Protocol|Adverse Event|1|||
147237931|NCT00239590|531042582|FG000|Completed Study Protocol|Withdrawal by Subject|0|||
147237932|NCT00239590|531042583|FG001|Completed Study Protocol|Withdrawal by Subject|1|||
147237933|NCT02121522|531042585|FG000|Overall Study|Adverse Event|1|||
147573834|NCT03719040|532257513|FG000|Overall Study|Lost to Follow-up|26|||
147573835|NCT06647173|532257514|FG000|Overall Study|Lost to Follow-up|24|||
147573836|NCT01841554|532257515|FG000|Overall Study|Death|7|||
147573837|NCT01841554|532257515|FG000|Overall Study|No Implantation|1|||
147573838|NCT01841554|532257515|FG000|Overall Study|Discontinued Follow Up|5|||
147573839|NCT01841554|532257515|FG000|Overall Study|Study exit due to secondary intervention|6|||
147141541|NCT02012218|530684524|FG002|Overall Study|Protocol Specified|0|||
147573840|NCT01473953|532257518|FG000|Overall Study|Other|1|||
147141542|NCT02012218|530684525|FG003|Overall Study|Protocol Specified|0|||
147141543|NCT02012218|530684526|FG004|Overall Study|Protocol Specified|0|||
147141544|NCT02012218|530684522|FG000|Overall Study|Protocol Deviation|1|||
147141545|NCT02012218|530684523|FG001|Overall Study|Protocol Deviation|0|||
147141546|NCT02012218|530684524|FG002|Overall Study|Protocol Deviation|0|||
147237934|NCT00892047|531042591|FG000|Overall Study|Adverse Event|2|||
147237935|NCT00892047|531042592|FG001|Overall Study|Adverse Event|2|||
147237936|NCT00892047|531042591|FG000|Overall Study|subject burden|2|||
147237937|NCT00892047|531042592|FG001|Overall Study|subject burden|3|||
147141547|NCT02012218|530684525|FG003|Overall Study|Protocol Deviation|0|||
147141548|NCT02012218|530684526|FG004|Overall Study|Protocol Deviation|0|||
147141549|NCT05005273|530684527|FG000|Overall Study|Study Terminated|1|||
147141550|NCT05005273|530684528|FG001|Overall Study|Study Terminated|0|||
147141551|NCT04267926|530686201|FG000|Overall Study|abnormal labs. No longer eligible|0|||
147141552|NCT04267926|530686202|FG001|Overall Study|abnormal labs. No longer eligible|0|||
147141553|NCT04267926|530686203|FG002|Overall Study|abnormal labs. No longer eligible|1|||
147141554|NCT04267926|530686201|FG000|Overall Study|Iron infusion for fatigue. No longer eligible for study.|1|||
147141555|NCT04267926|530686202|FG001|Overall Study|Iron infusion for fatigue. No longer eligible for study.|0|||
147141556|NCT04267926|530686203|FG002|Overall Study|Iron infusion for fatigue. No longer eligible for study.|0|||
147141557|NCT02489318|530686206|FG000|Randomized|Withdrawal by Subject|0|||
147141558|NCT02489318|530686207|FG001|Randomized|Withdrawal by Subject|1|||
147141559|NCT02489318|530686206|FG000|Treated|Adverse Event|19|||
147141560|NCT02489318|530686207|FG001|Treated|Adverse Event|62|||
147141561|NCT02489318|530686206|FG000|Treated|Death|13|||
147141562|NCT02489318|530686207|FG001|Treated|Death|11|||
147141563|NCT02489318|530686206|FG000|Treated|Physician Decision|4|||
147141564|NCT02489318|530686207|FG001|Treated|Physician Decision|6|||
147141565|NCT02489318|530686206|FG000|Treated|Protocol Violation|1|||
147141566|NCT02489318|530686207|FG001|Treated|Protocol Violation|2|||
147141567|NCT02489318|530686206|FG000|Treated|Withdrawal by Subject|37|||
147141568|NCT02489318|530686207|FG001|Treated|Withdrawal by Subject|36|||
147141569|NCT02489318|530686206|FG000|Treated|Other: Progressive Disease|245|||
147141570|NCT02489318|530686207|FG001|Treated|Other: Progressive Disease|138|||
147141571|NCT02489318|530686206|FG000|Treated|Other|0|||
147141572|NCT02489318|530686207|FG001|Treated|Other|2|||
147141573|NCT02489318|530686206|FG000|Treated|Ongoing|0|||
147141574|NCT02489318|530686207|FG001|Treated|Ongoing|267|||
147141575|NCT01306643|530686208|FG000|Overall Study|Adverse Event|5|||
147141576|NCT01306643|530686208|FG000|Overall Study|Disease Progression|7|||
147141577|NCT01306643|530686208|FG000|Overall Study|Other: Change in Eligibility Status|1|||
147141578|NCT03801928|530686209|FG000|Overall Study|Adverse Event|1|||
147141579|NCT03801928|530686210|FG001|Overall Study|Adverse Event|0|||
147141580|NCT03801928|530686211|FG002|Overall Study|Adverse Event|1|||
147141581|NCT03801928|530686212|FG003|Overall Study|Adverse Event|2|||
147141582|NCT03801928|530686213|FG004|Overall Study|Adverse Event|0|||
147141583|NCT03801928|530686214|FG005|Overall Study|Adverse Event|2|||
147141584|NCT03801928|530686209|FG000|Overall Study|Lack of Efficacy|0|||
147141585|NCT03801928|530686210|FG001|Overall Study|Lack of Efficacy|0|||
147141586|NCT03801928|530686211|FG002|Overall Study|Lack of Efficacy|1|||
147141587|NCT03801928|530686212|FG003|Overall Study|Lack of Efficacy|0|||
147141588|NCT03801928|530686213|FG004|Overall Study|Lack of Efficacy|0|||
147141589|NCT03801928|530686214|FG005|Overall Study|Lack of Efficacy|0|||
147141590|NCT03801928|530686209|FG000|Overall Study|Lost to Follow-up|5|||
147141591|NCT03801928|530686210|FG001|Overall Study|Lost to Follow-up|1|||
147141592|NCT03801928|530686211|FG002|Overall Study|Lost to Follow-up|1|||
147141593|NCT03801928|530686212|FG003|Overall Study|Lost to Follow-up|4|||
147141594|NCT03801928|530686213|FG004|Overall Study|Lost to Follow-up|4|||
147141595|NCT03801928|530686214|FG005|Overall Study|Lost to Follow-up|2|||
147141596|NCT03801928|530686209|FG000|Overall Study|Withdrawal by Subject|0|||
147141597|NCT03801928|530686210|FG001|Overall Study|Withdrawal by Subject|0|||
147141598|NCT03801928|530686211|FG002|Overall Study|Withdrawal by Subject|2|||
147141599|NCT03801928|530686212|FG003|Overall Study|Withdrawal by Subject|1|||
147141600|NCT03801928|530686213|FG004|Overall Study|Withdrawal by Subject|0|||
147141601|NCT03801928|530686214|FG005|Overall Study|Withdrawal by Subject|0|||
147141602|NCT03801928|530686209|FG000|Overall Study|Other|0|||
147141603|NCT03801928|530686210|FG001|Overall Study|Other|2|||
147141604|NCT03801928|530686211|FG002|Overall Study|Other|0|||
147141605|NCT03801928|530686212|FG003|Overall Study|Other|1|||
147141606|NCT03801928|530686213|FG004|Overall Study|Other|0|||
147141607|NCT03801928|530686214|FG005|Overall Study|Other|1|||
147141608|NCT02370368|530686217|FG000|Overall Study|Adverse Event|1|||
147141609|NCT02370368|530686218|FG001|Overall Study|Adverse Event|2|||
147141610|NCT02370368|530686217|FG000|Overall Study|Withdrawal by Subject|5|||
147141611|NCT02370368|530686218|FG001|Overall Study|Withdrawal by Subject|4|||
147141612|NCT05197049|530686219|FG000|Overall Study|Death|0|||
147141613|NCT05197049|530686220|FG001|Overall Study|Death|1|||
147141614|NCT05197049|530686221|FG002|Overall Study|Death|0|||
147573841|NCT01473953|532257519|FG001|Overall Study|Other|0|||
147141615|NCT05197049|530686219|FG000|Overall Study|Lost to Follow-up|3|||
147141616|NCT05197049|530686220|FG001|Overall Study|Lost to Follow-up|1|||
147141617|NCT05197049|530686221|FG002|Overall Study|Lost to Follow-up|0|||
147141618|NCT05197049|530686219|FG000|Overall Study|Withdrawal by Subject|15|||
147141619|NCT05197049|530686220|FG001|Overall Study|Withdrawal by Subject|3|||
147141620|NCT05197049|530686221|FG002|Overall Study|Withdrawal by Subject|1|||
147141621|NCT05197049|530686219|FG000|Overall Study|GCP non-compliance|1|||
147141622|NCT05197049|530686220|FG001|Overall Study|GCP non-compliance|2|||
147141623|NCT05197049|530686221|FG002|Overall Study|GCP non-compliance|0|||
147141624|NCT00579553|530686222|FG000|Overall Study|Lost to Follow-up|16|||
147141625|NCT00579553|530686223|FG001|Overall Study|Lost to Follow-up|13|||
147141626|NCT03748641|530686224|FG000|Overall Study|Ongoing|155|||
147141627|NCT03748641|530686225|FG001|Overall Study|Ongoing|148|||
147141628|NCT03748641|530686226|FG002|Overall Study|Ongoing|66|||
147141629|NCT03748641|530686227|FG003|Overall Study|Ongoing|79|||
147141630|NCT03748641|530686228|FG004|Overall Study|Ongoing|84|||
147141631|NCT03748641|530686224|FG000|Overall Study|Death|54|||
147141632|NCT03748641|530686225|FG001|Overall Study|Death|59|||
147141633|NCT03748641|530686226|FG002|Overall Study|Death|51|||
147141634|NCT03748641|530686227|FG003|Overall Study|Death|42|||
147141635|NCT03748641|530686228|FG004|Overall Study|Death|9|||
147141636|NCT03748641|530686224|FG000|Overall Study|Lost to Follow-up|0|||
147141637|NCT03748641|530686225|FG001|Overall Study|Lost to Follow-up|2|||
147141638|NCT03748641|530686226|FG002|Overall Study|Lost to Follow-up|1|||
147141639|NCT03748641|530686227|FG003|Overall Study|Lost to Follow-up|0|||
147141640|NCT03748641|530686228|FG004|Overall Study|Lost to Follow-up|0|||
147141641|NCT03748641|530686224|FG000|Overall Study|Withdrawal by Subject|3|||
147141642|NCT03748641|530686225|FG001|Overall Study|Withdrawal by Subject|2|||
147141643|NCT03748641|530686226|FG002|Overall Study|Withdrawal by Subject|5|||
147141644|NCT03748641|530686227|FG003|Overall Study|Withdrawal by Subject|3|||
147141645|NCT03748641|530686228|FG004|Overall Study|Withdrawal by Subject|2|||
147141646|NCT04834726|530686229|FG000|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|82|||
147141647|NCT04834726|530686230|FG001|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|422|||
147141648|NCT04834726|530686231|FG002|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|404|||
147141649|NCT04834726|530686232|FG003|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|415|||
147141650|NCT04834726|530686233|FG004|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|428|||
147141651|NCT04834726|530686234|FG005|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|462|||
147141652|NCT04834726|530686235|FG006|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|447|||
147141653|NCT04834726|530686236|FG007|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|449|||
147237938|NCT00892047|531042591|FG000|Overall Study|Lack of Efficacy|0|||
147573842|NCT01473953|532257520|FG002|Overall Study|Other|0|||
147573843|NCT01473953|532257521|FG003|Overall Study|Other|0|||
147573844|NCT01473953|532257522|FG004|Overall Study|Other|0|||
147573845|NCT00312897|532257523|FG000|Overall Study|Adverse Event|1|||
147573846|NCT00312897|532257524|FG001|Overall Study|Adverse Event|0|||
147573847|NCT00312897|532257523|FG000|Overall Study|Lost to Follow-up|2|||
147237939|NCT00892047|531042592|FG001|Overall Study|Lack of Efficacy|2|||
147573848|NCT00312897|532257524|FG001|Overall Study|Lost to Follow-up|0|||
147573849|NCT00312897|532257523|FG000|Overall Study|Physician Decision|1|||
147573850|NCT00312897|532257524|FG001|Overall Study|Physician Decision|0|||
147573851|NCT00312897|532257523|FG000|Overall Study|Withdrawal by Subject|1|||
147573852|NCT00312897|532257524|FG001|Overall Study|Withdrawal by Subject|3|||
147573853|NCT00312897|532257523|FG000|Overall Study|Pregnancy|1|||
147573854|NCT00312897|532257524|FG001|Overall Study|Pregnancy|0|||
147573855|NCT00312897|532257523|FG000|Overall Study|discontinued prior to getting treatment|0|||
147573856|NCT00312897|532257524|FG001|Overall Study|discontinued prior to getting treatment|3|||
147573857|NCT03100344|532257527|FG000|Overall Study|Adverse Event|0|||
147573858|NCT03100344|532257528|FG001|Overall Study|Adverse Event|3|||
147573859|NCT03100344|532257529|FG002|Overall Study|Adverse Event|2|||
147573860|NCT03100344|532257530|FG003|Overall Study|Adverse Event|3|||
147573861|NCT03100344|532257527|FG000|Overall Study|Lack of Efficacy|2|||
147573862|NCT03100344|532257528|FG001|Overall Study|Lack of Efficacy|0|||
147573863|NCT03100344|532257529|FG002|Overall Study|Lack of Efficacy|0|||
147573864|NCT03100344|532257530|FG003|Overall Study|Lack of Efficacy|0|||
147573865|NCT03100344|532257527|FG000|Overall Study|Protocol Violation|1|||
147573866|NCT03100344|532257528|FG001|Overall Study|Protocol Violation|0|||
147573867|NCT03100344|532257529|FG002|Overall Study|Protocol Violation|0|||
147573868|NCT03100344|532257530|FG003|Overall Study|Protocol Violation|0|||
147573869|NCT03100344|532257527|FG000|Overall Study|Withdrawal by Subject|10|||
147573870|NCT03100344|532257528|FG001|Overall Study|Withdrawal by Subject|7|||
147573871|NCT03100344|532257529|FG002|Overall Study|Withdrawal by Subject|4|||
147573872|NCT03100344|532257530|FG003|Overall Study|Withdrawal by Subject|8|||
147141654|NCT04834726|530686237|FG008|Overall Study|Excluded for receiving one or more vaccine doses prior to outreach|400|||
147141655|NCT03606486|530686240|FG000|Overall Study|Unable to collect sample|5|||
147141656|NCT02503085|530686253|FG000|Period 2: Washout (3 to 7 Days)|Adverse Event|1|||
147237940|NCT05306977|531042593|FG000|Overall Study|Withdrawal by Subject|1|||
147573873|NCT03100344|532257527|FG000|Overall Study|Lost to Follow-up|1|||
147573874|NCT03100344|532257528|FG001|Overall Study|Lost to Follow-up|1|||
147573875|NCT03100344|532257529|FG002|Overall Study|Lost to Follow-up|1|||
147652257|NCT01128400|532550233|FG001|Overall Study|were not invited to participate on taste|0|||
147141657|NCT02503085|530686254|FG001|Period 2: Washout (3 to 7 Days)|Adverse Event|0|||
147141658|NCT02503085|530686255|FG002|Period 2: Washout (3 to 7 Days)|Adverse Event|1|||
147141659|NCT02503085|530686256|FG003|Period 2: Washout (3 to 7 Days)|Adverse Event|0|||
147141660|NCT01162473|530686261|FG000|Overall Study|Adverse Event|2|||
147573876|NCT03100344|532257530|FG003|Overall Study|Lost to Follow-up|1|||
147573877|NCT04633564|532257531|FG000|Period 1|Adverse Event|28|||
147573878|NCT04633564|532257532|FG001|Period 1|Adverse Event|19|||
147141661|NCT01162473|530686262|FG001|Overall Study|Adverse Event|1|||
147141662|NCT01162473|530686261|FG000|Overall Study|Withdrawal by Subject|0|||
147141663|NCT01162473|530686262|FG001|Overall Study|Withdrawal by Subject|4|||
147141664|NCT01144416|530686263|FG000|Intervention Period|Adverse Event|5|||
147141665|NCT01144416|530686264|FG001|Intervention Period|Adverse Event|6|||
147141666|NCT01144416|530686263|FG000|Intervention Period|Insufficient ovarian response|11|||
147141667|NCT01144416|530686264|FG001|Intervention Period|Insufficient ovarian response|17|||
147141668|NCT01144416|530686263|FG000|Intervention Period|Risk of OHSS|0|||
147141669|NCT01144416|530686264|FG001|Intervention Period|Risk of OHSS|1|||
147141670|NCT01144416|530686263|FG000|Intervention Period|Too high ovarian response|4|||
147141671|NCT01144416|530686264|FG001|Intervention Period|Too high ovarian response|2|||
147141672|NCT01144416|530686263|FG000|Intervention Period|No/too few/bad oocytes|7|||
147141673|NCT01144416|530686264|FG001|Intervention Period|No/too few/bad oocytes|5|||
147141674|NCT01144416|530686263|FG000|Intervention Period|No or abnormal fertilization|25|||
147141675|NCT01144416|530686264|FG001|Intervention Period|No or abnormal fertilization|10|||
147141676|NCT01144416|530686263|FG000|Intervention Period|No/too few/bad quality embryos|3|||
147141677|NCT01144416|530686264|FG001|Intervention Period|No/too few/bad quality embryos|3|||
147141678|NCT01144416|530686263|FG000|Intervention Period|Other|7|||
147141679|NCT01144416|530686264|FG001|Intervention Period|Other|5|||
147141680|NCT00124072|530686265|FG000|Overall Study|Lost to Follow-up for Mortality|0|||
147141681|NCT00124072|530686266|FG001|Overall Study|Lost to Follow-up for Mortality|3|||
147141682|NCT00124072|530686267|FG002|Overall Study|Lost to Follow-up for Mortality|2|||
147141683|NCT00124072|530686268|FG003|Overall Study|Lost to Follow-up for Mortality|2|||
147141684|NCT00124072|530686265|FG000|Overall Study|Lost to Follow-up for Morbidity|15|||
147141685|NCT00124072|530686266|FG001|Overall Study|Lost to Follow-up for Morbidity|25|||
147141686|NCT00124072|530686267|FG002|Overall Study|Lost to Follow-up for Morbidity|19|||
147141687|NCT00124072|530686268|FG003|Overall Study|Lost to Follow-up for Morbidity|18|||
147141688|NCT00124072|530686265|FG000|Overall Study|Death|499|||
147141689|NCT00124072|530686266|FG001|Overall Study|Death|484|||
147141690|NCT00124072|530686267|FG002|Overall Study|Death|471|||
147141691|NCT00124072|530686268|FG003|Overall Study|Death|480|||
147141692|NCT03328832|530686269|FG000|Overall Study|Lost to Follow-up|0|||
147141693|NCT03328832|530686270|FG001|Overall Study|Lost to Follow-up|1|||
147141694|NCT04872569|530686273|FG000|Overall Study|Withdrawal by Subject|2|||
147141695|NCT04417257|530686276|FG000|Pilot Phase 2|Adverse Event|2|||
147141696|NCT04417257|530686277|FG001|Pilot Phase 2|Adverse Event|0|||
147141697|NCT04417257|530686276|FG000|Pilot Phase 2|Death|14|||
147141698|NCT04417257|530686277|FG001|Pilot Phase 2|Death|11|||
147141699|NCT04417257|530686276|FG000|Pilot Phase 2|Lost to Follow-up|3|||
147141700|NCT04417257|530686277|FG001|Pilot Phase 2|Lost to Follow-up|5|||
147141701|NCT04417257|530686276|FG000|Pilot Phase 2|Withdrawal by Subject|7|||
147141702|NCT04417257|530686277|FG001|Pilot Phase 2|Withdrawal by Subject|6|||
147141703|NCT04417257|530686276|FG000|Pilot Phase 2|Hepatic impairment|1|||
147141704|NCT04417257|530686277|FG001|Pilot Phase 2|Hepatic impairment|0|||
147141705|NCT04417257|530686276|FG000|Pilot Phase 2|Unblinding|1|||
147141706|NCT04417257|530686277|FG001|Pilot Phase 2|Unblinding|0|||
147141707|NCT04417257|530686276|FG000|Pilot Phase 2|All other|0|||
147141708|NCT04417257|530686277|FG001|Pilot Phase 2|All other|2|||
147141709|NCT04417257|530686276|FG000|Phase 3 Extension|Death|3|||
147141710|NCT04417257|530686277|FG001|Phase 3 Extension|Death|1|||
147141711|NCT04417257|530686276|FG000|Phase 3 Extension|Lost to Follow-up|4|||
147141712|NCT04417257|530686277|FG001|Phase 3 Extension|Lost to Follow-up|2|||
147141713|NCT04417257|530686276|FG000|Phase 3 Extension|Patient withdrawal|2|||
147141714|NCT04417257|530686277|FG001|Phase 3 Extension|Patient withdrawal|2|||
147141715|NCT04417257|530686276|FG000|Phase 3 Extension|Study terminated by sponsor due to futility criteria reached|3|||
147141716|NCT04417257|530686277|FG001|Phase 3 Extension|Study terminated by sponsor due to futility criteria reached|1|||
147141717|NCT04951622|530686278|FG000|DB Phase: Day 1 (Week 0) to Week 24|Adverse Event|7|||
147141718|NCT04951622|530686279|FG001|DB Phase: Day 1 (Week 0) to Week 24|Adverse Event|5|||
147141719|NCT04951622|530686280|FG002|DB Phase: Day 1 (Week 0) to Week 24|Adverse Event|0|||
147141720|NCT04951622|530686281|FG003|DB Phase: Day 1 (Week 0) to Week 24|Adverse Event|0|||
147141721|NCT04951622|530686282|FG004|DB Phase: Day 1 (Week 0) to Week 24|Adverse Event|0|||
147141722|NCT04951622|530686278|FG000|DB Phase: Day 1 (Week 0) to Week 24|Protocol Violation|2|||
147141723|NCT04951622|530686279|FG001|DB Phase: Day 1 (Week 0) to Week 24|Protocol Violation|2|||
147141724|NCT04951622|530686280|FG002|DB Phase: Day 1 (Week 0) to Week 24|Protocol Violation|0|||
147141725|NCT04951622|530686281|FG003|DB Phase: Day 1 (Week 0) to Week 24|Protocol Violation|0|||
147141726|NCT04951622|530686282|FG004|DB Phase: Day 1 (Week 0) to Week 24|Protocol Violation|0|||
147141727|NCT04951622|530686278|FG000|DB Phase: Day 1 (Week 0) to Week 24|Death|2|||
147141728|NCT04951622|530686279|FG001|DB Phase: Day 1 (Week 0) to Week 24|Death|1|||
147141729|NCT04951622|530686280|FG002|DB Phase: Day 1 (Week 0) to Week 24|Death|0|||
147141730|NCT04951622|530686281|FG003|DB Phase: Day 1 (Week 0) to Week 24|Death|0|||
147141731|NCT04951622|530686282|FG004|DB Phase: Day 1 (Week 0) to Week 24|Death|0|||
147141732|NCT04951622|530686278|FG000|DB Phase: Day 1 (Week 0) to Week 24|Disease relapse|0|||
147141733|NCT04951622|530686279|FG001|DB Phase: Day 1 (Week 0) to Week 24|Disease relapse|1|||
147141734|NCT04951622|530686280|FG002|DB Phase: Day 1 (Week 0) to Week 24|Disease relapse|0|||
147141735|NCT04951622|530686281|FG003|DB Phase: Day 1 (Week 0) to Week 24|Disease relapse|0|||
147141736|NCT04951622|530686282|FG004|DB Phase: Day 1 (Week 0) to Week 24|Disease relapse|0|||
147141737|NCT04951622|530686278|FG000|DB Phase: Day 1 (Week 0) to Week 24|Progressive Disease|1|||
147141738|NCT04951622|530686279|FG001|DB Phase: Day 1 (Week 0) to Week 24|Progressive Disease|1|||
147141739|NCT04951622|530686280|FG002|DB Phase: Day 1 (Week 0) to Week 24|Progressive Disease|0|||
147141740|NCT04951622|530686281|FG003|DB Phase: Day 1 (Week 0) to Week 24|Progressive Disease|0|||
147141741|NCT04951622|530686282|FG004|DB Phase: Day 1 (Week 0) to Week 24|Progressive Disease|0|||
147141742|NCT04951622|530686278|FG000|DB Phase: Day 1 (Week 0) to Week 24|Withdrawal by Subject|0|||
147141743|NCT04951622|530686279|FG001|DB Phase: Day 1 (Week 0) to Week 24|Withdrawal by Subject|1|||
147141744|NCT04951622|530686280|FG002|DB Phase: Day 1 (Week 0) to Week 24|Withdrawal by Subject|0|||
147141745|NCT04951622|530686281|FG003|DB Phase: Day 1 (Week 0) to Week 24|Withdrawal by Subject|0|||
147141746|NCT04951622|530686282|FG004|DB Phase: Day 1 (Week 0) to Week 24|Withdrawal by Subject|0|||
147141747|NCT04951622|530686278|FG000|DB Phase: Day 1 (Week 0) to Week 24|Lack of Efficacy|2|||
147141748|NCT04951622|530686279|FG001|DB Phase: Day 1 (Week 0) to Week 24|Lack of Efficacy|0|||
147141749|NCT04951622|530686280|FG002|DB Phase: Day 1 (Week 0) to Week 24|Lack of Efficacy|0|||
147141750|NCT04951622|530686281|FG003|DB Phase: Day 1 (Week 0) to Week 24|Lack of Efficacy|0|||
147141751|NCT04951622|530686282|FG004|DB Phase: Day 1 (Week 0) to Week 24|Lack of Efficacy|0|||
147141752|NCT04951622|530686278|FG000|DB Phase: Day 1 (Week 0) to Week 24|Randomized by mistake|1|||
147141753|NCT04951622|530686279|FG001|DB Phase: Day 1 (Week 0) to Week 24|Randomized by mistake|0|||
147141754|NCT04951622|530686280|FG002|DB Phase: Day 1 (Week 0) to Week 24|Randomized by mistake|0|||
147141755|NCT04951622|530686281|FG003|DB Phase: Day 1 (Week 0) to Week 24|Randomized by mistake|0|||
147141756|NCT04951622|530686282|FG004|DB Phase: Day 1 (Week 0) to Week 24|Randomized by mistake|0|||
147141757|NCT04951622|530686278|FG000|DB Phase: Day 1 (Week 0) to Week 24|Subject refused further study treatment|1|||
147141758|NCT04951622|530686279|FG001|DB Phase: Day 1 (Week 0) to Week 24|Subject refused further study treatment|0|||
147141759|NCT04951622|530686280|FG002|DB Phase: Day 1 (Week 0) to Week 24|Subject refused further study treatment|0|||
147141760|NCT04951622|530686281|FG003|DB Phase: Day 1 (Week 0) to Week 24|Subject refused further study treatment|0|||
147141761|NCT04951622|530686282|FG004|DB Phase: Day 1 (Week 0) to Week 24|Subject refused further study treatment|0|||
147141762|NCT04951622|530686278|FG000|DB Phase: Day 1 (Week 0) to Week 24|Other|0|||
147141763|NCT04951622|530686279|FG001|DB Phase: Day 1 (Week 0) to Week 24|Other|1|||
147141764|NCT04951622|530686280|FG002|DB Phase: Day 1 (Week 0) to Week 24|Other|0|||
147141765|NCT04951622|530686281|FG003|DB Phase: Day 1 (Week 0) to Week 24|Other|0|||
147141766|NCT04951622|530686282|FG004|DB Phase: Day 1 (Week 0) to Week 24|Other|0|||
147141767|NCT04951622|530686278|FG000|DB Phase: Day 1 (Week 0) to Week 24|Pregnancy|1|||
147141768|NCT04951622|530686279|FG001|DB Phase: Day 1 (Week 0) to Week 24|Pregnancy|0|||
147141769|NCT04951622|530686280|FG002|DB Phase: Day 1 (Week 0) to Week 24|Pregnancy|0|||
147141770|NCT04951622|530686281|FG003|DB Phase: Day 1 (Week 0) to Week 24|Pregnancy|0|||
147141771|NCT04951622|530686282|FG004|DB Phase: Day 1 (Week 0) to Week 24|Pregnancy|0|||
147141772|NCT04951622|530686278|FG000|DB Phase: Day 1 (Week 0) to Week 24|Failure to meet randomization criteria|0|||
147141773|NCT04951622|530686279|FG001|DB Phase: Day 1 (Week 0) to Week 24|Failure to meet randomization criteria|1|||
147141774|NCT04951622|530686280|FG002|DB Phase: Day 1 (Week 0) to Week 24|Failure to meet randomization criteria|0|||
147141775|NCT04951622|530686281|FG003|DB Phase: Day 1 (Week 0) to Week 24|Failure to meet randomization criteria|0|||
147141776|NCT04951622|530686282|FG004|DB Phase: Day 1 (Week 0) to Week 24|Failure to meet randomization criteria|0|||
147141777|NCT04951622|530686278|FG000|OLE: Week 24 (OLE Day 1) up to 2 Years|Adverse Event|0|||
147141778|NCT04951622|530686279|FG001|OLE: Week 24 (OLE Day 1) up to 2 Years|Adverse Event|0|||
147141779|NCT04951622|530686280|FG002|OLE: Week 24 (OLE Day 1) up to 2 Years|Adverse Event|5|||
147141780|NCT04951622|530686281|FG003|OLE: Week 24 (OLE Day 1) up to 2 Years|Adverse Event|0|||
147141781|NCT04951622|530686282|FG004|OLE: Week 24 (OLE Day 1) up to 2 Years|Adverse Event|2|||
147141782|NCT04951622|530686278|FG000|OLE: Week 24 (OLE Day 1) up to 2 Years|Death|0|||
147141783|NCT04951622|530686279|FG001|OLE: Week 24 (OLE Day 1) up to 2 Years|Death|0|||
147141784|NCT04951622|530686280|FG002|OLE: Week 24 (OLE Day 1) up to 2 Years|Death|0|||
147141785|NCT04951622|530686281|FG003|OLE: Week 24 (OLE Day 1) up to 2 Years|Death|1|||
147141786|NCT04951622|530686282|FG004|OLE: Week 24 (OLE Day 1) up to 2 Years|Death|1|||
147141787|NCT04951622|530686278|FG000|OLE: Week 24 (OLE Day 1) up to 2 Years|Withdrawal by Subject|0|||
147141788|NCT04951622|530686279|FG001|OLE: Week 24 (OLE Day 1) up to 2 Years|Withdrawal by Subject|0|||
147141789|NCT04951622|530686280|FG002|OLE: Week 24 (OLE Day 1) up to 2 Years|Withdrawal by Subject|1|||
147141790|NCT04951622|530686281|FG003|OLE: Week 24 (OLE Day 1) up to 2 Years|Withdrawal by Subject|5|||
147141791|NCT04951622|530686282|FG004|OLE: Week 24 (OLE Day 1) up to 2 Years|Withdrawal by Subject|1|||
147141792|NCT04951622|530686278|FG000|OLE: Week 24 (OLE Day 1) up to 2 Years|Lack of Efficacy|0|||
147573879|NCT04633564|532257531|FG000|Period 1|Death|8|||
147573880|NCT04633564|532257532|FG001|Period 1|Death|7|||
147573881|NCT04633564|532257531|FG000|Period 1|Lost to Follow-up|3|||
147573882|NCT04633564|532257532|FG001|Period 1|Lost to Follow-up|5|||
147573883|NCT04633564|532257531|FG000|Period 1|Physician Decision|4|||
147573884|NCT04633564|532257532|FG001|Period 1|Physician Decision|12|||
147573885|NCT04633564|532257531|FG000|Period 1|Protocol Violation|0|||
147573886|NCT04633564|532257532|FG001|Period 1|Protocol Violation|1|||
147141793|NCT04951622|530686279|FG001|OLE: Week 24 (OLE Day 1) up to 2 Years|Lack of Efficacy|0|||
147141794|NCT04951622|530686280|FG002|OLE: Week 24 (OLE Day 1) up to 2 Years|Lack of Efficacy|3|||
147141795|NCT04951622|530686281|FG003|OLE: Week 24 (OLE Day 1) up to 2 Years|Lack of Efficacy|7|||
147141796|NCT04951622|530686282|FG004|OLE: Week 24 (OLE Day 1) up to 2 Years|Lack of Efficacy|0|||
147141797|NCT04951622|530686278|FG000|OLE: Week 24 (OLE Day 1) up to 2 Years|Lost to Follow-up|0|||
147141798|NCT04951622|530686279|FG001|OLE: Week 24 (OLE Day 1) up to 2 Years|Lost to Follow-up|0|||
147141799|NCT04951622|530686280|FG002|OLE: Week 24 (OLE Day 1) up to 2 Years|Lost to Follow-up|1|||
147141800|NCT04951622|530686281|FG003|OLE: Week 24 (OLE Day 1) up to 2 Years|Lost to Follow-up|0|||
147141801|NCT04951622|530686282|FG004|OLE: Week 24 (OLE Day 1) up to 2 Years|Lost to Follow-up|0|||
147141802|NCT04951622|530686278|FG000|OLE: Week 24 (OLE Day 1) up to 2 Years|Physician Decision|0|||
147141803|NCT04951622|530686279|FG001|OLE: Week 24 (OLE Day 1) up to 2 Years|Physician Decision|0|||
147141804|NCT04951622|530686280|FG002|OLE: Week 24 (OLE Day 1) up to 2 Years|Physician Decision|1|||
147141805|NCT04951622|530686281|FG003|OLE: Week 24 (OLE Day 1) up to 2 Years|Physician Decision|1|||
147141806|NCT04951622|530686282|FG004|OLE: Week 24 (OLE Day 1) up to 2 Years|Physician Decision|0|||
147141807|NCT04951622|530686278|FG000|OLE: Week 24 (OLE Day 1) up to 2 Years|Ongoing|0|||
147141808|NCT04951622|530686279|FG001|OLE: Week 24 (OLE Day 1) up to 2 Years|Ongoing|0|||
147141809|NCT04951622|530686280|FG002|OLE: Week 24 (OLE Day 1) up to 2 Years|Ongoing|77|||
147141810|NCT04951622|530686281|FG003|OLE: Week 24 (OLE Day 1) up to 2 Years|Ongoing|74|||
147141811|NCT04951622|530686282|FG004|OLE: Week 24 (OLE Day 1) up to 2 Years|Ongoing|15|||
147141812|NCT04951622|530686278|FG000|OLE: Week 24 (OLE Day 1) up to 2 Years|Met eligibility criteria but discontinued during the screening period (not treated)|0|||
147141813|NCT04951622|530686279|FG001|OLE: Week 24 (OLE Day 1) up to 2 Years|Met eligibility criteria but discontinued during the screening period (not treated)|0|||
147141814|NCT04951622|530686280|FG002|OLE: Week 24 (OLE Day 1) up to 2 Years|Met eligibility criteria but discontinued during the screening period (not treated)|0|||
147141815|NCT04951622|530686281|FG003|OLE: Week 24 (OLE Day 1) up to 2 Years|Met eligibility criteria but discontinued during the screening period (not treated)|0|||
147141816|NCT04951622|530686282|FG004|OLE: Week 24 (OLE Day 1) up to 2 Years|Met eligibility criteria but discontinued during the screening period (not treated)|1|||
147141817|NCT00714948|530686290|FG000|Overall Study|Adverse Event|2|||
147141818|NCT02708680|530686291|FG000|Overall Study|Withdrawal by Subject|4|||
147141819|NCT02708680|530686292|FG001|Overall Study|Withdrawal by Subject|12|||
147141820|NCT02708680|530686293|FG002|Overall Study|Withdrawal by Subject|12|||
147141821|NCT02708680|530686291|FG000|Overall Study|Death|4|||
147141822|NCT02708680|530686292|FG001|Overall Study|Death|19|||
147141823|NCT02708680|530686293|FG002|Overall Study|Death|21|||
147141824|NCT02708680|530686291|FG000|Overall Study|Lost to Follow-up|0|||
147141825|NCT02708680|530686292|FG001|Overall Study|Lost to Follow-up|3|||
147141826|NCT02708680|530686293|FG002|Overall Study|Lost to Follow-up|3|||
147141827|NCT02708680|530686291|FG000|Overall Study|Study Terminated By Sponsor|0|||
147141828|NCT02708680|530686292|FG001|Overall Study|Study Terminated By Sponsor|5|||
147141829|NCT02708680|530686293|FG002|Overall Study|Study Terminated By Sponsor|4|||
147141830|NCT02708680|530686291|FG000|Overall Study|Other than Specified|0|||
147141831|NCT02708680|530686292|FG001|Overall Study|Other than Specified|0|||
147141832|NCT02708680|530686293|FG002|Overall Study|Other than Specified|1|||
147141833|NCT02708680|530686291|FG000|Overall Study|Discontinued Treatment but Remained in Follow-up|0|||
147141834|NCT02708680|530686292|FG001|Overall Study|Discontinued Treatment but Remained in Follow-up|1|||
147141835|NCT02708680|530686293|FG002|Overall Study|Discontinued Treatment but Remained in Follow-up|0|||
147141836|NCT01342926|530686294|FG000|Overall Study|Adverse Event|5|||
147141837|NCT01342926|530686295|FG001|Overall Study|Adverse Event|8|||
147141838|NCT01342926|530686296|FG002|Overall Study|Adverse Event|10|||
147141839|NCT01342926|530686297|FG003|Overall Study|Adverse Event|7|||
147141840|NCT01342926|530686294|FG000|Overall Study|Lost to Follow-up|0|||
147141841|NCT01342926|530686295|FG001|Overall Study|Lost to Follow-up|1|||
147141842|NCT01342926|530686296|FG002|Overall Study|Lost to Follow-up|1|||
147141843|NCT01342926|530686297|FG003|Overall Study|Lost to Follow-up|0|||
147141844|NCT01342926|530686294|FG000|Overall Study|Investigator Discretion|2|||
147318643|NCT00519636|531331774|FG000|Post Study Period|Subject randomized in error|0|||
147318644|NCT00519636|531331775|FG001|Post Study Period|Subject randomized in error|0|||
147318645|NCT00519636|531331776|FG002|Post Study Period|Subject randomized in error|0|||
147318646|NCT00519636|531331777|FG003|Post Study Period|Subject randomized in error|1|||
147318647|NCT01254890|531331780|FG000|Overall Study|Ineligible|0|||
147318648|NCT01254890|531331781|FG001|Overall Study|Ineligible|3|||
147318649|NCT01254890|531331780|FG000|Overall Study|Withdrawal by Subject|1|||
147318650|NCT01254890|531331781|FG001|Overall Study|Withdrawal by Subject|2|||
147141845|NCT01342926|530686295|FG001|Overall Study|Investigator Discretion|2|||
147141846|NCT01342926|530686296|FG002|Overall Study|Investigator Discretion|0|||
147141847|NCT01342926|530686297|FG003|Overall Study|Investigator Discretion|0|||
147141848|NCT01342926|530686294|FG000|Overall Study|Withdrawal by Subject|2|||
147318651|NCT01254890|531331780|FG000|Overall Study|Disease Progression|0|||
147652258|NCT01128400|532550234|FG002|Overall Study|were not invited to participate on taste|15|||
147141849|NCT01342926|530686295|FG001|Overall Study|Withdrawal by Subject|4|||
147141850|NCT01342926|530686296|FG002|Overall Study|Withdrawal by Subject|3|||
147141851|NCT01342926|530686297|FG003|Overall Study|Withdrawal by Subject|5|||
147141852|NCT03390504|530686302|FG000|Overall Study|Lost to Follow-up|2|||
147141853|NCT03390504|530686303|FG001|Overall Study|Lost to Follow-up|4|||
147141854|NCT03390504|530686304|FG002|Overall Study|Lost to Follow-up|0|||
147141855|NCT03390504|530686305|FG003|Overall Study|Lost to Follow-up|1|||
147141856|NCT03390504|530686302|FG000|Overall Study|Withdrawal by Subject|3|||
147141857|NCT03390504|530686303|FG001|Overall Study|Withdrawal by Subject|15|||
147141858|NCT03390504|530686304|FG002|Overall Study|Withdrawal by Subject|5|||
147141859|NCT03390504|530686305|FG003|Overall Study|Withdrawal by Subject|2|||
147141860|NCT03390504|530686302|FG000|Overall Study|Other|1|||
147141861|NCT03390504|530686303|FG001|Overall Study|Other|2|||
147318652|NCT01254890|531331781|FG001|Overall Study|Disease Progression|5|||
147141862|NCT03390504|530686304|FG002|Overall Study|Other|2|||
147141863|NCT03390504|530686305|FG003|Overall Study|Other|6|||
147141864|NCT00980538|530686306|FG000|Overall Study|Lost to Follow-up|20|||
147141865|NCT00980538|530686306|FG000|Overall Study|Sponsor's Decision|4|||
147141866|NCT00980538|530686306|FG000|Overall Study|Participant/Legal Representative Withdrew Consent/Assent|34|||
147141867|NCT00980538|530686306|FG000|Overall Study|Adverse Event/HIV-Related Event/Cutaneous Event/Rash|12|||
147141868|NCT00980538|530686306|FG000|Overall Study|Switch to Commercially Available Medication|25|||
147141869|NCT00980538|530686306|FG000|Overall Study|Participant Non-Compliant|9|||
147141870|NCT00980538|530686306|FG000|Overall Study|Investigator no Longer Thinks Participant Benefits from the ETR Treatment|9|||
147141871|NCT00980538|530686306|FG000|Overall Study|Participant Ineligible to Continue the Trial|6|||
147141872|NCT00980538|530686306|FG000|Overall Study|Other|60|||
147141873|NCT00980538|530686306|FG000|Overall Study|Other|1|||
147141874|NCT01544348|530686307|FG000|Overall Study|Lost to Follow-up|1|||
147141875|NCT01544348|530686308|FG001|Overall Study|Lost to Follow-up|0|||
147141876|NCT01544348|530686309|FG002|Overall Study|Lost to Follow-up|0|||
147141877|NCT01544348|530686310|FG003|Overall Study|Lost to Follow-up|0|||
147141878|NCT01544348|530686311|FG004|Overall Study|Lost to Follow-up|0|||
147141879|NCT01544348|530686312|FG005|Overall Study|Lost to Follow-up|0|||
147141880|NCT01544348|530686313|FG006|Overall Study|Lost to Follow-up|1|||
147141881|NCT01544348|530686314|FG007|Overall Study|Lost to Follow-up|0|||
147141882|NCT01544348|530686307|FG000|Overall Study|Withdrawal by Subject|1|||
147141883|NCT01544348|530686308|FG001|Overall Study|Withdrawal by Subject|0|||
147141884|NCT01544348|530686309|FG002|Overall Study|Withdrawal by Subject|0|||
147141885|NCT01544348|530686310|FG003|Overall Study|Withdrawal by Subject|0|||
147141886|NCT01544348|530686311|FG004|Overall Study|Withdrawal by Subject|1|||
147141887|NCT01544348|530686312|FG005|Overall Study|Withdrawal by Subject|2|||
147141888|NCT01544348|530686313|FG006|Overall Study|Withdrawal by Subject|1|||
147141889|NCT01544348|530686314|FG007|Overall Study|Withdrawal by Subject|0|||
147141890|NCT01544348|530686307|FG000|Overall Study|Physician Decision|0|||
147141891|NCT01544348|530686308|FG001|Overall Study|Physician Decision|0|||
147141892|NCT01544348|530686309|FG002|Overall Study|Physician Decision|0|||
147141893|NCT01544348|530686310|FG003|Overall Study|Physician Decision|0|||
147141894|NCT01544348|530686311|FG004|Overall Study|Physician Decision|0|||
147141895|NCT01544348|530686312|FG005|Overall Study|Physician Decision|1|||
147141896|NCT01544348|530686313|FG006|Overall Study|Physician Decision|0|||
147141897|NCT01544348|530686314|FG007|Overall Study|Physician Decision|0|||
147141898|NCT01445847|530686315|FG000|Overall Study|Protocol Violation|13|||
147141899|NCT01445847|530686316|FG001|Overall Study|Protocol Violation|14|||
147141900|NCT01445847|530686315|FG000|Overall Study|Missed Data|1|||
147141901|NCT01445847|530686316|FG001|Overall Study|Missed Data|0|||
147141902|NCT00707993|530686317|FG000|Overall Study|Adverse Event|16|||
147141903|NCT00707993|530686318|FG001|Overall Study|Adverse Event|20|||
147141904|NCT00707993|530686317|FG000|Overall Study|Protocol Violation|4|||
147141905|NCT00707993|530686318|FG001|Overall Study|Protocol Violation|7|||
147141906|NCT00707993|530686317|FG000|Overall Study|Lost to Follow-up|0|||
147141907|NCT00707993|530686318|FG001|Overall Study|Lost to Follow-up|4|||
147141908|NCT00707993|530686317|FG000|Overall Study|Withdrawal by Subject|12|||
147141909|NCT00707993|530686318|FG001|Overall Study|Withdrawal by Subject|16|||
147141910|NCT00707993|530686317|FG000|Overall Study|Hyperglycemic Rescue|55|||
147141911|NCT00707993|530686318|FG001|Overall Study|Hyperglycemic Rescue|47|||
147141912|NCT00707993|530686317|FG000|Overall Study|Other|2|||
147141913|NCT00707993|530686318|FG001|Overall Study|Other|0|||
147141914|NCT03654274|530686319|FG000|Overall Study|Adverse Event|19|||
147141915|NCT03654274|530686320|FG001|Overall Study|Adverse Event|23|||
147141916|NCT03654274|530686321|FG002|Overall Study|Adverse Event|24|||
147141917|NCT03654274|530686319|FG000|Overall Study|Protocol Deviation|0|||
147141918|NCT03654274|530686320|FG001|Overall Study|Protocol Deviation|2|||
147141919|NCT03654274|530686321|FG002|Overall Study|Protocol Deviation|0|||
147141920|NCT03654274|530686319|FG000|Overall Study|Lost to Follow-up|8|||
147141921|NCT03654274|530686320|FG001|Overall Study|Lost to Follow-up|6|||
147141922|NCT03654274|530686321|FG002|Overall Study|Lost to Follow-up|5|||
147141923|NCT03654274|530686319|FG000|Overall Study|Withdrawal by Subject|46|||
147141924|NCT03654274|530686320|FG001|Overall Study|Withdrawal by Subject|25|||
147141925|NCT03654274|530686321|FG002|Overall Study|Withdrawal by Subject|33|||
147141926|NCT03654274|530686319|FG000|Overall Study|Lack of Efficacy|4|||
147141927|NCT03654274|530686320|FG001|Overall Study|Lack of Efficacy|5|||
147141928|NCT03654274|530686321|FG002|Overall Study|Lack of Efficacy|7|||
147141929|NCT03654274|530686319|FG000|Overall Study|Pregnancy|2|||
147141930|NCT03654274|530686320|FG001|Overall Study|Pregnancy|2|||
147141931|NCT03654274|530686321|FG002|Overall Study|Pregnancy|1|||
147141932|NCT03654274|530686319|FG000|Overall Study|Other|27|||
147573887|NCT04633564|532257531|FG000|Period 1|Withdrawal by Subject|10|||
147573888|NCT04633564|532257532|FG001|Period 1|Withdrawal by Subject|8|||
147573889|NCT04633564|532257531|FG000|Period 1|Progressive disease|47|||
147573890|NCT04633564|532257532|FG001|Period 1|Progressive disease|51|||
147141933|NCT03654274|530686320|FG001|Overall Study|Other|29|||
147141934|NCT03654274|530686321|FG002|Overall Study|Other|32|||
147141935|NCT03654274|530686319|FG000|Overall Study|Participants Who Consented to Week 52 and Completed at Week 52|0|||
147141936|NCT03654274|530686320|FG001|Overall Study|Participants Who Consented to Week 52 and Completed at Week 52|0|||
147141937|NCT03654274|530686321|FG002|Overall Study|Participants Who Consented to Week 52 and Completed at Week 52|1|||
147141938|NCT01102491|530686324|FG000|Overall Study|Protocol Violation|11|||
147141939|NCT01102491|530686325|FG001|Overall Study|Protocol Violation|12|||
147141940|NCT01265992|530686326|FG000|Overall Study|Lost to Follow-up|1|||
147141941|NCT01265992|530686326|FG000|Overall Study|Withdrawal by Subject|1|||
147141942|NCT01265992|530686326|FG000|Overall Study|Adverse Event|1|||
147141943|NCT01265992|530686326|FG000|Overall Study|Administrative reasons|2|||
147141944|NCT01265992|530686326|FG000|Overall Study|Stopped treatment|3|||
147141945|NCT01265992|530686326|FG000|Overall Study|Did not receive treatment|1|||
147141946|NCT01837680|530686327|FG000|Overall Study|Lost to Follow-up|2|||
147141947|NCT01837680|530686328|FG001|Overall Study|Lost to Follow-up|2|||
147141948|NCT01837680|530686327|FG000|Overall Study|lack of insurance|0|||
147141949|NCT01837680|530686328|FG001|Overall Study|lack of insurance|2|||
147141950|NCT01837680|530686327|FG000|Overall Study|allergic reaction|6|||
147141951|NCT01837680|530686328|FG001|Overall Study|allergic reaction|0|||
147141952|NCT01837680|530686327|FG000|Overall Study|switched to oral hypoglycemic or diet|2|||
147141953|NCT01837680|530686328|FG001|Overall Study|switched to oral hypoglycemic or diet|4|||
147141954|NCT03008070|530686329|FG000|Overall Study|Adverse Event|3|||
147141955|NCT03008070|530686330|FG001|Overall Study|Adverse Event|3|||
147141956|NCT03008070|530686331|FG002|Overall Study|Adverse Event|3|||
147141957|NCT03008070|530686329|FG000|Overall Study|Lost to Follow-up|1|||
147141958|NCT03008070|530686330|FG001|Overall Study|Lost to Follow-up|1|||
147141959|NCT03008070|530686331|FG002|Overall Study|Lost to Follow-up|0|||
147141960|NCT03008070|530686329|FG000|Overall Study|Non compliance|0|||
147141961|NCT03008070|530686330|FG001|Overall Study|Non compliance|1|||
147141962|NCT03008070|530686331|FG002|Overall Study|Non compliance|1|||
147141963|NCT03008070|530686329|FG000|Overall Study|Withdrawal by patient and adverse event non fatal|0|||
147141964|NCT03008070|530686330|FG001|Overall Study|Withdrawal by patient and adverse event non fatal|1|||
147141965|NCT03008070|530686331|FG002|Overall Study|Withdrawal by patient and adverse event non fatal|0|||
147141966|NCT03008070|530686329|FG000|Overall Study|Withdrawal by Subject|2|||
147141967|NCT03008070|530686330|FG001|Overall Study|Withdrawal by Subject|0|||
147141968|NCT03008070|530686331|FG002|Overall Study|Withdrawal by Subject|1|||
147141969|NCT03008070|530686329|FG000|Overall Study|Use of prohibited drug|0|||
147141970|NCT03008070|530686330|FG001|Overall Study|Use of prohibited drug|0|||
147141971|NCT03008070|530686331|FG002|Overall Study|Use of prohibited drug|2|||
147141972|NCT03960684|530686332|FG000|Overall Study|Did not proceed to surgery with MSS|1|||
147141973|NCT02151786|530686333|FG000|Overall Study|Unavailability of Case Report Form|26|||
147141974|NCT02151786|530686333|FG000|Overall Study|Outside the Contract Period|1|||
147141975|NCT02151786|530686333|FG000|Overall Study|Randomized, not Treated|1|||
147141976|NCT02151786|530686333|FG000|Overall Study|Unavailability of Information|8|||
147141977|NCT03761056|530686337|FG000|Overall Study|Death|8|||
147141978|NCT03761056|530686337|FG000|Overall Study|Enrolled but never treated|2|||
147141979|NCT03761056|530686337|FG000|Overall Study|Withdrawal of consent from further follow-up|2|||
147141980|NCT03761056|530686337|FG000|Overall Study|Investigator decision|1|||
147141981|NCT03941483|530686338|FG000|Overall Study|Miscellaneous|2|||
147141982|NCT03941483|530686339|FG001|Overall Study|Miscellaneous|3|||
147141983|NCT03941483|530686340|FG002|Overall Study|Miscellaneous|0|||
147141984|NCT03941483|530686338|FG000|Overall Study|Study Terminated by Sponsor|1|||
147237941|NCT00306189|531042594|FG000|Overall Study|Physician Decision|0|||
147237942|NCT00306189|531042595|FG001|Overall Study|Physician Decision|0|||
147573891|NCT04633564|532257531|FG000|Period 1|Terminated by Sponsor|8|||
147573892|NCT04633564|532257532|FG001|Period 1|Terminated by Sponsor|6|||
147141985|NCT03941483|530686339|FG001|Overall Study|Study Terminated by Sponsor|0|||
147141986|NCT03941483|530686340|FG002|Overall Study|Study Terminated by Sponsor|0|||
147141987|NCT03941483|530686338|FG000|Overall Study|Withdrawal by Subject|1|||
147141988|NCT03941483|530686339|FG001|Overall Study|Withdrawal by Subject|4|||
147141989|NCT03941483|530686340|FG002|Overall Study|Withdrawal by Subject|1|||
147141990|NCT03941483|530686338|FG000|Overall Study|Lost to Follow-up|2|||
147141991|NCT03941483|530686339|FG001|Overall Study|Lost to Follow-up|1|||
147141992|NCT03941483|530686340|FG002|Overall Study|Lost to Follow-up|8|||
147141993|NCT03941483|530686338|FG000|Overall Study|Death|3|||
147141994|NCT03941483|530686339|FG001|Overall Study|Death|2|||
147141995|NCT03941483|530686340|FG002|Overall Study|Death|6|||
147141996|NCT02685826|530686342|FG000|Overall Study|Adverse Event|2|||
147141997|NCT02685826|530686343|FG001|Overall Study|Adverse Event|0|||
147141998|NCT02685826|530686344|FG002|Overall Study|Adverse Event|1|||
147141999|NCT02685826|530686342|FG000|Overall Study|Progressive Disease|2|||
147142000|NCT02685826|530686343|FG001|Overall Study|Progressive Disease|1|||
147142001|NCT02685826|530686344|FG002|Overall Study|Progressive Disease|0|||
147142002|NCT02685826|530686342|FG000|Overall Study|Withdrawal by Subject|2|||
147142003|NCT02685826|530686343|FG001|Overall Study|Withdrawal by Subject|0|||
147142004|NCT02685826|530686344|FG002|Overall Study|Withdrawal by Subject|0|||
147142005|NCT02685826|530686342|FG000|Overall Study|Full Clinical Hold by FDA|19|||
147142006|NCT02685826|530686343|FG001|Overall Study|Full Clinical Hold by FDA|9|||
147142007|NCT02685826|530686344|FG002|Overall Study|Full Clinical Hold by FDA|20|||
147142008|NCT03154476|530686345|FG000|Overall Study|Lost to Follow-up|4|||
147142009|NCT03154476|530686346|FG001|Overall Study|Lost to Follow-up|4|||
147142010|NCT01444430|530686347|FG000|Overall Study|Withdrawal by Subject|53|||
147142011|NCT01444430|530686348|FG001|Overall Study|Withdrawal by Subject|72|||
147142012|NCT01444430|530686347|FG000|Overall Study|Death|6|||
147142013|NCT01444430|530686348|FG001|Overall Study|Death|8|||
147142014|NCT01444430|530686347|FG000|Overall Study|Lost to Follow-up|2|||
147142015|NCT01444430|530686348|FG001|Overall Study|Lost to Follow-up|0|||
147142016|NCT01444430|530686347|FG000|Overall Study|CRF termination module not completed.|0|||
147142017|NCT01444430|530686348|FG001|Overall Study|CRF termination module not completed.|1|||
147142018|NCT03816176|530686349|FG000|Overall Study|Miscellaneous|5|||
147142019|NCT03816176|530686349|FG000|Overall Study|Lack of Efficacy|4|||
147142020|NCT03816176|530686349|FG000|Overall Study|Adverse Event|3|||
147142021|NCT00972023|530687407|FG000|Overall Study|Withdrawal by Subject|1|||
147142022|NCT02595879|530687408|FG000|Expansion Cohort|Did not complete treatment regimen|1|||
147142023|NCT02595879|530687409|FG001|Expansion Cohort|Did not complete treatment regimen|0|||
147573893|NCT04633564|532257531|FG000|Period 2|Adverse Event|3|||
147142024|NCT00600106|530687410|FG000|Overall Study|Withdrawal by Subject|1|||
147142025|NCT00600106|530687411|FG001|Overall Study|Withdrawal by Subject|1|||
147142026|NCT01465386|530687421|FG000|Overall Study|Lack of Efficacy|3|||
147142027|NCT01465386|530687421|FG000|Overall Study|Adverse Event|1|||
147142028|NCT02479880|530687424|FG000|Overall Study|Study Terminated by Sponsor|13|||
147142029|NCT02479880|530687425|FG001|Overall Study|Study Terminated by Sponsor|12|||
147142030|NCT02479880|530687424|FG000|Overall Study|Pregnancy|0|||
147142031|NCT02479880|530687425|FG001|Overall Study|Pregnancy|1|||
147142032|NCT00355368|530687426|FG000|Overall Study|Protocol Violation|8|||
147573894|NCT04633564|532257532|FG001|Period 2|Adverse Event|4|||
147573895|NCT04633564|532257531|FG000|Period 2|Death|0|||
147573896|NCT04633564|532257532|FG001|Period 2|Death|2|||
147573897|NCT04633564|532257531|FG000|Period 2|Lost to Follow-up|0|||
147573898|NCT04633564|532257532|FG001|Period 2|Lost to Follow-up|1|||
147573899|NCT04633564|532257531|FG000|Period 2|Physician Decision|2|||
147573900|NCT04633564|532257532|FG001|Period 2|Physician Decision|4|||
147573901|NCT04633564|532257531|FG000|Period 2|Withdrawal by Subject|5|||
147573902|NCT04633564|532257532|FG001|Period 2|Withdrawal by Subject|1|||
147573903|NCT04633564|532257531|FG000|Period 2|Progressive Disease|74|||
147573904|NCT04633564|532257532|FG001|Period 2|Progressive Disease|82|||
147573905|NCT04633564|532257531|FG000|Period 2|Terminated by Sponsor|9|||
147573906|NCT04633564|532257532|FG001|Period 2|Terminated by Sponsor|3|||
147573907|NCT02011945|532257533|FG000|Overall Study|Participant requested to Discontinue|0|||
147573908|NCT02011945|532257534|FG001|Overall Study|Participant requested to Discontinue|1|||
147573909|NCT02011945|532257535|FG002|Overall Study|Participant requested to Discontinue|1|||
147142033|NCT00355368|530687427|FG001|Overall Study|Protocol Violation|7|||
147142034|NCT00355368|530687426|FG000|Overall Study|cardiac arrest prior to intubation|2|||
147573910|NCT02011945|532257533|FG000|Overall Study|Adverse Event unrelated to Drug|0|||
147237943|NCT00306189|531042596|FG002|Overall Study|Physician Decision|0|||
147237944|NCT00306189|531042597|FG003|Overall Study|Physician Decision|1|||
147237945|NCT00306189|531042594|FG000|Overall Study|Adverse Event|3|||
147237946|NCT00306189|531042595|FG001|Overall Study|Adverse Event|3|||
147237947|NCT00306189|531042596|FG002|Overall Study|Adverse Event|2|||
147237948|NCT00306189|531042597|FG003|Overall Study|Adverse Event|2|||
147237949|NCT00306189|531042594|FG000|Overall Study|Withdrawal by Subject|4|||
147318653|NCT01824472|531331782|FG000|Overall Study|Lost to Follow-up|0|||
147573911|NCT02011945|532257534|FG001|Overall Study|Adverse Event unrelated to Drug|2|||
147573912|NCT02011945|532257535|FG002|Overall Study|Adverse Event unrelated to Drug|1|||
147573913|NCT02011945|532257533|FG000|Overall Study|Study Drug Toxicity|0|||
147573914|NCT02011945|532257534|FG001|Overall Study|Study Drug Toxicity|0|||
147573915|NCT02011945|532257535|FG002|Overall Study|Study Drug Toxicity|1|||
147142035|NCT00355368|530687427|FG001|Overall Study|cardiac arrest prior to intubation|2|||
147142036|NCT01279044|530687428|FG000|PHASE 2 - Randmonized Controlled Trial|Withdrawal by Subject|0|||
147142037|NCT01279044|530687429|FG001|PHASE 2 - Randmonized Controlled Trial|Withdrawal by Subject|3|||
147142038|NCT01279044|530687430|FG002|PHASE 2 - Randmonized Controlled Trial|Withdrawal by Subject|2|||
147142039|NCT01279044|530687428|FG000|PHASE 2 - Randmonized Controlled Trial|Lost to Follow-up|0|||
147142040|NCT01279044|530687429|FG001|PHASE 2 - Randmonized Controlled Trial|Lost to Follow-up|8|||
147142041|NCT01279044|530687430|FG002|PHASE 2 - Randmonized Controlled Trial|Lost to Follow-up|0|||
147237950|NCT00306189|531042595|FG001|Overall Study|Withdrawal by Subject|2|||
147237951|NCT00306189|531042596|FG002|Overall Study|Withdrawal by Subject|8|||
147573916|NCT02011945|532257533|FG000|Overall Study|Treatment Failure|0|||
147573917|NCT02011945|532257534|FG001|Overall Study|Treatment Failure|7|||
147573918|NCT02011945|532257535|FG002|Overall Study|Treatment Failure|6|||
147573919|NCT02011945|532257533|FG000|Overall Study|No Longer Meets Study Criteria|1|||
147573920|NCT02011945|532257534|FG001|Overall Study|No Longer Meets Study Criteria|0|||
147142042|NCT01279044|530687428|FG000|PHASE 2 - Randmonized Controlled Trial|Death|0|||
147142043|NCT01279044|530687429|FG001|PHASE 2 - Randmonized Controlled Trial|Death|0|||
147573921|NCT02011945|532257535|FG002|Overall Study|No Longer Meets Study Criteria|0|||
147573922|NCT02011945|532257533|FG000|Overall Study|Proceeded to stem cell transplant|0|||
147573923|NCT02011945|532257534|FG001|Overall Study|Proceeded to stem cell transplant|0|||
147573924|NCT02011945|532257535|FG002|Overall Study|Proceeded to stem cell transplant|1|||
147573925|NCT02011945|532257533|FG000|Overall Study|Sub-Optimal Response to dasatinib|1|||
147573926|NCT02011945|532257534|FG001|Overall Study|Sub-Optimal Response to dasatinib|0|||
147573927|NCT02011945|532257535|FG002|Overall Study|Sub-Optimal Response to dasatinib|0|||
147573928|NCT00902538|532257536|FG000|1-Single-blind, Run-in, Single-Treatment|Adverse Event|49|||
147573929|NCT00902538|532257537|FG001|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0|||
147573930|NCT00902538|532257538|FG002|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0|||
147142044|NCT01279044|530687430|FG002|PHASE 2 - Randmonized Controlled Trial|Death|1|||
147142045|NCT01408277|530687431|FG000|Overall Study|Adverse Event|3|||
147142046|NCT01408277|530687432|FG001|Overall Study|Adverse Event|4|||
147142047|NCT01408277|530687431|FG000|Overall Study|Lost to Follow-up|1|||
147142048|NCT01408277|530687432|FG001|Overall Study|Lost to Follow-up|0|||
147142049|NCT01408277|530687431|FG000|Overall Study|Withdrawal by Subject|2|||
147142050|NCT01408277|530687432|FG001|Overall Study|Withdrawal by Subject|0|||
147142051|NCT01408277|530687431|FG000|Overall Study|Protocol Violation|2|||
147142052|NCT01408277|530687432|FG001|Overall Study|Protocol Violation|0|||
147142053|NCT02840253|530687433|FG000|Overall Study|Unsuccessful block|4|||
147142054|NCT03783962|530687434|FG000|Overall Study|Lost to Follow-up|3|||
147142055|NCT03783962|530687435|FG001|Overall Study|Lost to Follow-up|6|||
147142056|NCT03783962|530687434|FG000|Overall Study|Protocol Violation|0|||
147142057|NCT03783962|530687435|FG001|Overall Study|Protocol Violation|1|||
147142058|NCT02763059|530687438|FG000|Overall Study|Lost to Follow-up|4|||
147142059|NCT02763059|530687439|FG001|Overall Study|Lost to Follow-up|1|||
147142060|NCT02763059|530687440|FG002|Overall Study|Lost to Follow-up|6|||
147142061|NCT02763059|530687438|FG000|Overall Study|Withdrawal by Subject|1|||
147142062|NCT02763059|530687439|FG001|Overall Study|Withdrawal by Subject|0|||
147142063|NCT02763059|530687440|FG002|Overall Study|Withdrawal by Subject|3|||
147142064|NCT03369665|530687441|FG000|Overall Study|Adverse Event|3|||
147142065|NCT03369665|530687441|FG000|Overall Study|Lost to Follow-up|7|||
147142066|NCT03369665|530687441|FG000|Overall Study|Withdrawal by Subject|15|||
147142067|NCT03369665|530687441|FG000|Overall Study|Progression Disease|2|||
147142068|NCT03369665|530687441|FG000|Overall Study|Not classified|3|||
147652259|NCT01128400|532550232|FG000|Overall Study|Excluded due to sinus problems|0|||
147652260|NCT01128400|532550233|FG001|Overall Study|Excluded due to sinus problems|1|||
147652261|NCT01128400|532550234|FG002|Overall Study|Excluded due to sinus problems|0|||
147142069|NCT01775553|530687444|FG000|Overall Study|Adverse Event|1|||
147142070|NCT01775553|530687444|FG000|Overall Study|Disease Progression|12|||
147142071|NCT03810014|530687445|FG000|Overall Study|Pregnancy|2|||
147652262|NCT02362425|532550235|FG000|Phase 1 (up to 6 Months)|Withdrawal by Subject|2|||
147652263|NCT02362425|532550236|FG001|Phase 1 (up to 6 Months)|Withdrawal by Subject|0|||
147142072|NCT03810014|530687446|FG001|Overall Study|Pregnancy|2|||
147142073|NCT03810014|530687447|FG002|Overall Study|Pregnancy|0|||
147142074|NCT03810014|530687448|FG003|Overall Study|Pregnancy|2|||
147142075|NCT02534883|530687453|FG000|Overall Study|Early Termination|8|||
147142076|NCT02534883|530687454|FG001|Overall Study|Early Termination|3|||
147142077|NCT00886769|530687455|FG000|Overall Study|Unsatisfactory therapeutic effect|6|||
147142078|NCT00886769|530687456|FG001|Overall Study|Unsatisfactory therapeutic effect|37|||
147142079|NCT00414076|530687457|FG000|Overall Study|Progression|1|||
147142080|NCT00414076|530687458|FG001|Overall Study|Progression|2|||
147142081|NCT00414076|530687457|FG000|Overall Study|Withdrawal by Subject|1|||
147318654|NCT01824472|531331783|FG001|Overall Study|Lost to Follow-up|0|||
147573931|NCT00902538|532257539|FG003|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0|||
147573932|NCT00902538|532257540|FG004|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0|||
147652264|NCT02362425|532550237|FG002|Phase 1 (up to 6 Months)|Withdrawal by Subject|0|||
147652265|NCT02362425|532550238|FG003|Phase 1 (up to 6 Months)|Withdrawal by Subject|0|||
147142082|NCT00414076|530687458|FG001|Overall Study|Withdrawal by Subject|3|||
147142083|NCT00414076|530687457|FG000|Overall Study|Adverse Event|1|||
147142084|NCT00414076|530687458|FG001|Overall Study|Adverse Event|0|||
147142085|NCT00778336|530687459|FG000|Index Procedure-Discharge|Death|6|||
147142086|NCT00778336|530687460|FG001|Index Procedure-Discharge|Death|3|||
147142087|NCT00778336|530687461|FG002|Index Procedure-Discharge|Death|2|||
147142088|NCT00778336|530687462|FG003|Index Procedure-Discharge|Death|0|||
147142089|NCT00778336|530687459|FG000|3 Month Follow Up|Lost to Follow-up|15|||
147142090|NCT00778336|530687460|FG001|3 Month Follow Up|Lost to Follow-up|20|||
147142091|NCT00778336|530687461|FG002|3 Month Follow Up|Lost to Follow-up|3|||
147142092|NCT00778336|530687462|FG003|3 Month Follow Up|Lost to Follow-up|0|||
147142093|NCT00778336|530687459|FG000|3 Month Follow Up|Death|8|||
147573933|NCT00902538|532257541|FG005|1-Single-blind, Run-in, Single-Treatment|Adverse Event|0|||
147142094|NCT00778336|530687460|FG001|3 Month Follow Up|Death|3|||
147142095|NCT00778336|530687461|FG002|3 Month Follow Up|Death|2|||
147142096|NCT00778336|530687462|FG003|3 Month Follow Up|Death|0|||
147142097|NCT03670355|530687463|FG000|Overall Study|Adverse Event|1|||
147142098|NCT03670355|530687464|FG001|Overall Study|Adverse Event|0|||
147142099|NCT03670355|530687463|FG000|Overall Study|Unable to comply with study procedures|0|||
147142100|NCT03670355|530687464|FG001|Overall Study|Unable to comply with study procedures|1|||
147142101|NCT03670355|530687463|FG000|Overall Study|Participant refused|0|||
147142102|NCT03670355|530687464|FG001|Overall Study|Participant refused|1|||
147142103|NCT03517436|530687465|FG000|Overall Study|Death|3|||
147142104|NCT03517436|530687465|FG000|Overall Study|Withdrawal by Subject|4|||
147142105|NCT03517436|530687465|FG000|Overall Study|Did not receive study valve.|1|||
147142106|NCT04181827|530687466|FG000|Overall Study|Ongoing|124|||
147142107|NCT04181827|530687467|FG001|Overall Study|Ongoing|157|||
147142108|NCT04181827|530687466|FG000|Overall Study|Death|82|||
147142109|NCT04181827|530687467|FG001|Overall Study|Death|50|||
147142110|NCT04181827|530687466|FG000|Overall Study|Lost to Follow-up|0|||
147142111|NCT04181827|530687467|FG001|Overall Study|Lost to Follow-up|1|||
147142112|NCT04181827|530687466|FG000|Overall Study|Withdrawal by Subject|5|||
147142113|NCT04181827|530687467|FG001|Overall Study|Withdrawal by Subject|0|||
147142114|NCT04587869|530687468|FG000|Overall Study|Death|1|||
147142115|NCT04587869|530687469|FG001|Overall Study|Death|0|||
147142116|NCT04587869|530687468|FG000|Overall Study|Lost to Follow-up|27|||
147142117|NCT04587869|530687469|FG001|Overall Study|Lost to Follow-up|34|||
147573934|NCT00902538|532257536|FG000|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|30|||
147573935|NCT00902538|532257537|FG001|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0|||
147573936|NCT00902538|532257538|FG002|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0|||
147142118|NCT04587869|530687468|FG000|Overall Study|Grant Termination|13|||
147142119|NCT04587869|530687469|FG001|Overall Study|Grant Termination|25|||
147142120|NCT04587869|530687468|FG000|Overall Study|too busy|2|||
147142121|NCT04587869|530687469|FG001|Overall Study|too busy|0|||
147142122|NCT04587869|530687468|FG000|Overall Study|Withdrawal by Subject|2|||
147142123|NCT04587869|530687469|FG001|Overall Study|Withdrawal by Subject|2|||
147142124|NCT04587869|530687468|FG000|Overall Study|Other|1|||
147142125|NCT04587869|530687469|FG001|Overall Study|Other|0|||
147142126|NCT04538664|530687474|FG000|Overall Study|Withdrawal by Subject|5|||
147142127|NCT04538664|530687475|FG001|Overall Study|Withdrawal by Subject|9|||
147142128|NCT04538664|530687474|FG000|Overall Study|Lost to Follow-up|2|||
147142129|NCT04538664|530687475|FG001|Overall Study|Lost to Follow-up|1|||
147142130|NCT04538664|530687474|FG000|Overall Study|Ongoing|106|||
147142131|NCT04538664|530687475|FG001|Overall Study|Ongoing|115|||
147142132|NCT03929913|530687476|FG000|Overall Study|Death|4|||
147142133|NCT03929913|530687476|FG000|Overall Study|Lost to Follow-up|1|||
147142134|NCT03929913|530687476|FG000|Overall Study|Failed Procedure|2|||
147142135|NCT00642707|530687477|FG000|Overall Study|Adverse Event|0|||
147142136|NCT00642707|530687478|FG001|Overall Study|Adverse Event|0|||
147142137|NCT00642707|530687479|FG002|Overall Study|Adverse Event|0|||
147142138|NCT00642707|530687480|FG003|Overall Study|Adverse Event|2|||
147142139|NCT00642707|530687477|FG000|Overall Study|Withdrawal by Subject|1|||
147142140|NCT00642707|530687478|FG001|Overall Study|Withdrawal by Subject|0|||
147142141|NCT00642707|530687479|FG002|Overall Study|Withdrawal by Subject|0|||
147142142|NCT00642707|530687480|FG003|Overall Study|Withdrawal by Subject|0|||
147142143|NCT02891226|530687481|FG000|Period 1 (Weeks 0 to 12)|Adverse Event|4|||
147142144|NCT02891226|530687482|FG001|Period 1 (Weeks 0 to 12)|Adverse Event|1|||
147573937|NCT00902538|532257539|FG003|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0|||
147573938|NCT00902538|532257540|FG004|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0|||
147142145|NCT02891226|530687483|FG002|Period 1 (Weeks 0 to 12)|Adverse Event|3|||
147142146|NCT02891226|530687484|FG003|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
147142147|NCT02891226|530687485|FG004|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
147142148|NCT02891226|530687486|FG005|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
147142149|NCT02891226|530687487|FG006|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
147142150|NCT02891226|530687488|FG007|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
147142151|NCT02891226|530687489|FG008|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
147142152|NCT02891226|530687490|FG009|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
147142153|NCT02891226|530687491|FG010|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
147142154|NCT02891226|530687492|FG011|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
147142155|NCT02891226|530687493|FG012|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
147142156|NCT02891226|530687494|FG013|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
147142157|NCT02891226|530687495|FG014|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
147237952|NCT00306189|531042597|FG003|Overall Study|Withdrawal by Subject|1|||
147142158|NCT02891226|530687496|FG015|Period 1 (Weeks 0 to 12)|Adverse Event|0|||
147237953|NCT00306189|531042594|FG000|Overall Study|Ineligibility determined|1|||
147142159|NCT02891226|530687481|FG000|Period 1 (Weeks 0 to 12)|Lost to Follow-up|1|||
147142160|NCT02891226|530687482|FG001|Period 1 (Weeks 0 to 12)|Lost to Follow-up|1|||
147237954|NCT00306189|531042595|FG001|Overall Study|Ineligibility determined|1|||
147142161|NCT02891226|530687483|FG002|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
147142162|NCT02891226|530687484|FG003|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
147142163|NCT02891226|530687485|FG004|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
147142164|NCT02891226|530687486|FG005|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
147142165|NCT02891226|530687487|FG006|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
147142166|NCT02891226|530687488|FG007|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
147142167|NCT02891226|530687489|FG008|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
147142168|NCT02891226|530687490|FG009|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
147142169|NCT02891226|530687491|FG010|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
147142170|NCT02891226|530687492|FG011|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
147142171|NCT02891226|530687493|FG012|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
147142172|NCT02891226|530687494|FG013|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
147142173|NCT02891226|530687495|FG014|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
147142174|NCT02891226|530687496|FG015|Period 1 (Weeks 0 to 12)|Lost to Follow-up|0|||
147142175|NCT02891226|530687481|FG000|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
147142176|NCT02891226|530687482|FG001|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
147142177|NCT02891226|530687483|FG002|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
147142178|NCT02891226|530687484|FG003|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|2|||
147142179|NCT02891226|530687485|FG004|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
147142180|NCT02891226|530687486|FG005|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
147142181|NCT02891226|530687487|FG006|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
147142182|NCT02891226|530687488|FG007|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
147142183|NCT02891226|530687489|FG008|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
147142184|NCT02891226|530687490|FG009|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
147142185|NCT02891226|530687491|FG010|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
147142186|NCT02891226|530687492|FG011|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
147142187|NCT02891226|530687493|FG012|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
147142188|NCT02891226|530687494|FG013|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
147142189|NCT02891226|530687495|FG014|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
147142190|NCT02891226|530687496|FG015|Period 1 (Weeks 0 to 12)|Withdrawal by Subject|0|||
147142191|NCT02891226|530687481|FG000|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
147142192|NCT02891226|530687482|FG001|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
147142193|NCT02891226|530687483|FG002|Period 1 (Weeks 0 to 12)|Enrollment Failure|1|||
147142194|NCT02891226|530687484|FG003|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
147142195|NCT02891226|530687485|FG004|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
147142196|NCT02891226|530687486|FG005|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
147142197|NCT02891226|530687487|FG006|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
147142198|NCT02891226|530687488|FG007|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
147142199|NCT02891226|530687489|FG008|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
147142200|NCT02891226|530687490|FG009|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
147142201|NCT02891226|530687491|FG010|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
147142202|NCT02891226|530687492|FG011|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
147142203|NCT02891226|530687493|FG012|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
147142204|NCT02891226|530687494|FG013|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
147142205|NCT02891226|530687495|FG014|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
147142206|NCT02891226|530687496|FG015|Period 1 (Weeks 0 to 12)|Enrollment Failure|0|||
147142207|NCT02891226|530687481|FG000|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
147142208|NCT02891226|530687482|FG001|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
147142209|NCT02891226|530687483|FG002|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
147142210|NCT02891226|530687484|FG003|Period 1 (Weeks 0 to 12)|Sponsor Decision|1|||
147142211|NCT02891226|530687485|FG004|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
147142212|NCT02891226|530687486|FG005|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
147142213|NCT02891226|530687487|FG006|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
147142214|NCT02891226|530687488|FG007|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
147142215|NCT02891226|530687489|FG008|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
147142216|NCT02891226|530687490|FG009|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
147142217|NCT02891226|530687491|FG010|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
147573939|NCT00902538|532257541|FG005|1-Single-blind, Run-in, Single-Treatment|Withdrawal by Subject|0|||
147573940|NCT00902538|532257536|FG000|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|22|||
147573941|NCT00902538|532257537|FG001|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0|||
147573942|NCT00902538|532257538|FG002|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0|||
147573943|NCT00902538|532257539|FG003|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0|||
147142218|NCT02891226|530687492|FG011|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
147142219|NCT02891226|530687493|FG012|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
147142220|NCT02891226|530687494|FG013|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
147142221|NCT02891226|530687495|FG014|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
147142222|NCT02891226|530687496|FG015|Period 1 (Weeks 0 to 12)|Sponsor Decision|0|||
147142223|NCT02891226|530687481|FG000|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
147142224|NCT02891226|530687482|FG001|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
147142225|NCT02891226|530687483|FG002|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
147318655|NCT01824472|531331784|FG002|Overall Study|Lost to Follow-up|1|||
147142226|NCT02891226|530687484|FG003|Period 1 (Weeks 0 to 12)|Lack of Efficacy|1|||
147142227|NCT02891226|530687485|FG004|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
147142228|NCT02891226|530687486|FG005|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
147142229|NCT02891226|530687487|FG006|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
147142230|NCT02891226|530687488|FG007|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
147142231|NCT02891226|530687489|FG008|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
147142232|NCT02891226|530687490|FG009|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
147142233|NCT02891226|530687491|FG010|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
147142234|NCT02891226|530687492|FG011|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
147142235|NCT02891226|530687493|FG012|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
147142236|NCT02891226|530687494|FG013|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
147142237|NCT02891226|530687495|FG014|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
147142238|NCT02891226|530687496|FG015|Period 1 (Weeks 0 to 12)|Lack of Efficacy|0|||
147142239|NCT02891226|530687481|FG000|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
147142240|NCT02891226|530687482|FG001|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
147142241|NCT02891226|530687483|FG002|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
147142242|NCT02891226|530687484|FG003|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
147142243|NCT02891226|530687485|FG004|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
147142244|NCT02891226|530687486|FG005|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
147142245|NCT02891226|530687487|FG006|Period 2 (Weeks 12 to 52)|Adverse Event|1|||
147142246|NCT02891226|530687488|FG007|Period 2 (Weeks 12 to 52)|Adverse Event|1|||
147142247|NCT02891226|530687489|FG008|Period 2 (Weeks 12 to 52)|Adverse Event|3|||
147142248|NCT02891226|530687490|FG009|Period 2 (Weeks 12 to 52)|Adverse Event|7|||
147142249|NCT02891226|530687491|FG010|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
147142250|NCT02891226|530687492|FG011|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
147142251|NCT02891226|530687493|FG012|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
147142252|NCT02891226|530687494|FG013|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
147142253|NCT02891226|530687495|FG014|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
147142254|NCT02891226|530687496|FG015|Period 2 (Weeks 12 to 52)|Adverse Event|0|||
147142255|NCT02891226|530687481|FG000|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
147142256|NCT02891226|530687482|FG001|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
147142257|NCT02891226|530687483|FG002|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
147142258|NCT02891226|530687484|FG003|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
147142259|NCT02891226|530687485|FG004|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
147142260|NCT02891226|530687486|FG005|Period 2 (Weeks 12 to 52)|Lost to Follow-up|1|||
147142261|NCT02891226|530687487|FG006|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
147142262|NCT02891226|530687488|FG007|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
147142263|NCT02891226|530687489|FG008|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
147142264|NCT02891226|530687490|FG009|Period 2 (Weeks 12 to 52)|Lost to Follow-up|1|||
147142265|NCT02891226|530687491|FG010|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
147142266|NCT02891226|530687492|FG011|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
147142267|NCT02891226|530687493|FG012|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
147142268|NCT02891226|530687494|FG013|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
147142269|NCT02891226|530687495|FG014|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
147445708|NCT01074190|531797430|FG000|Overall Study|Subject withdrew consent|1|||
147445709|NCT01074190|531797431|FG001|Overall Study|Subject withdrew consent|1|||
147573944|NCT00902538|532257540|FG004|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0|||
147573945|NCT00902538|532257541|FG005|1-Single-blind, Run-in, Single-Treatment|Protocol Violation|0|||
147573946|NCT00902538|532257536|FG000|1-Single-blind, Run-in, Single-Treatment|Other Reason|13|||
147573947|NCT00902538|532257537|FG001|1-Single-blind, Run-in, Single-Treatment|Other Reason|0|||
147573948|NCT00902538|532257538|FG002|1-Single-blind, Run-in, Single-Treatment|Other Reason|0|||
147573949|NCT00902538|532257539|FG003|1-Single-blind, Run-in, Single-Treatment|Other Reason|0|||
147573950|NCT00902538|532257540|FG004|1-Single-blind, Run-in, Single-Treatment|Other Reason|0|||
147573951|NCT00902538|532257541|FG005|1-Single-blind, Run-in, Single-Treatment|Other Reason|0|||
147573952|NCT00902538|532257536|FG000|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|4|||
147573953|NCT00902538|532257537|FG001|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0|||
147573954|NCT00902538|532257538|FG002|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0|||
147573955|NCT00902538|532257539|FG003|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0|||
147573956|NCT00902538|532257540|FG004|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0|||
147573957|NCT00902538|532257541|FG005|1-Single-blind, Run-in, Single-Treatment|Lost to Follow-up|0|||
147573958|NCT00902538|532257536|FG000|2-Randomized Double-blind 3 Treatments|Adverse Event|4|||
147573959|NCT00902538|532257537|FG001|2-Randomized Double-blind 3 Treatments|Adverse Event|2|||
147573960|NCT00902538|532257538|FG002|2-Randomized Double-blind 3 Treatments|Adverse Event|3|||
147573961|NCT00902538|532257539|FG003|2-Randomized Double-blind 3 Treatments|Adverse Event|0|||
147573962|NCT00902538|532257540|FG004|2-Randomized Double-blind 3 Treatments|Adverse Event|0|||
147573963|NCT00902538|532257541|FG005|2-Randomized Double-blind 3 Treatments|Adverse Event|0|||
147573964|NCT00902538|532257536|FG000|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|1|||
147573965|NCT00902538|532257537|FG001|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|2|||
147445710|NCT01074190|531797432|FG002|Overall Study|Subject withdrew consent|1|||
147573966|NCT00902538|532257538|FG002|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|1|||
147142270|NCT02891226|530687496|FG015|Period 2 (Weeks 12 to 52)|Lost to Follow-up|0|||
147142271|NCT02891226|530687481|FG000|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
147142272|NCT02891226|530687482|FG001|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
147142273|NCT02891226|530687483|FG002|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
147142274|NCT02891226|530687484|FG003|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
147142275|NCT02891226|530687485|FG004|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
147142276|NCT02891226|530687486|FG005|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
147142277|NCT02891226|530687487|FG006|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|1|||
147142278|NCT02891226|530687488|FG007|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|2|||
147142279|NCT02891226|530687489|FG008|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|1|||
147142280|NCT02891226|530687490|FG009|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|6|||
147142281|NCT02891226|530687491|FG010|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
147142282|NCT02891226|530687492|FG011|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
147142283|NCT02891226|530687493|FG012|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
147142284|NCT02891226|530687494|FG013|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
147142285|NCT02891226|530687495|FG014|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
147142286|NCT02891226|530687496|FG015|Period 2 (Weeks 12 to 52)|Withdrawal by Subject|0|||
147142287|NCT02891226|530687481|FG000|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
147142288|NCT02891226|530687482|FG001|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
147142289|NCT02891226|530687483|FG002|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
147142290|NCT02891226|530687484|FG003|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
147142291|NCT02891226|530687485|FG004|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|1|||
147142292|NCT02891226|530687486|FG005|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
147142293|NCT02891226|530687487|FG006|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
147142294|NCT02891226|530687488|FG007|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
147142295|NCT02891226|530687489|FG008|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
147142296|NCT02891226|530687490|FG009|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
147142297|NCT02891226|530687491|FG010|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
147142298|NCT02891226|530687492|FG011|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
147142299|NCT02891226|530687493|FG012|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
147142300|NCT02891226|530687494|FG013|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
147142301|NCT02891226|530687495|FG014|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
147142302|NCT02891226|530687496|FG015|Period 2 (Weeks 12 to 52)|PI decision due to Lack of Efficacy|0|||
147142303|NCT02891226|530687481|FG000|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
147142304|NCT02891226|530687482|FG001|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
147142305|NCT02891226|530687483|FG002|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
147142306|NCT02891226|530687484|FG003|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
147142307|NCT02891226|530687485|FG004|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
147142308|NCT02891226|530687486|FG005|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
147142309|NCT02891226|530687487|FG006|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|1|||
147142310|NCT02891226|530687488|FG007|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
147142311|NCT02891226|530687489|FG008|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
147142312|NCT02891226|530687490|FG009|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
147142313|NCT02891226|530687491|FG010|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
147142314|NCT02891226|530687492|FG011|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
147142315|NCT02891226|530687493|FG012|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
147142316|NCT02891226|530687494|FG013|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
147142317|NCT02891226|530687495|FG014|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
147573967|NCT00902538|532257539|FG003|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|0|||
147142318|NCT02891226|530687496|FG015|Period 2 (Weeks 12 to 52)|PI and Sponsor Decision due to Subject Safety|0|||
147142319|NCT02891226|530687481|FG000|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
147142320|NCT02891226|530687482|FG001|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
147142321|NCT02891226|530687483|FG002|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
147142322|NCT02891226|530687484|FG003|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
147142323|NCT02891226|530687485|FG004|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
147142324|NCT02891226|530687486|FG005|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
147142325|NCT02891226|530687487|FG006|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
147142326|NCT02891226|530687488|FG007|Period 2 (Weeks 12 to 52)|Lack of Efficacy|1|||
147142327|NCT02891226|530687489|FG008|Period 2 (Weeks 12 to 52)|Lack of Efficacy|1|||
147142328|NCT02891226|530687490|FG009|Period 2 (Weeks 12 to 52)|Lack of Efficacy|1|||
147445711|NCT01500278|531797439|FG000|Week 0 - Week 12|Lack of Efficacy|0|||
147573968|NCT00902538|532257540|FG004|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|0|||
147573969|NCT00902538|532257541|FG005|2-Randomized Double-blind 3 Treatments|Withdrawal by Subject|0|||
147573970|NCT00902538|532257536|FG000|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|1|||
147573971|NCT00902538|532257537|FG001|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0|||
147573972|NCT00902538|532257538|FG002|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|2|||
147573973|NCT00902538|532257539|FG003|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0|||
147573974|NCT00902538|532257540|FG004|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0|||
147573975|NCT00902538|532257541|FG005|2-Randomized Double-blind 3 Treatments|Lost to Follow-up|0|||
147573976|NCT00902538|532257536|FG000|2-Randomized Double-blind 3 Treatments|Other|2|||
147573977|NCT00902538|532257537|FG001|2-Randomized Double-blind 3 Treatments|Other|1|||
147573978|NCT00902538|532257538|FG002|2-Randomized Double-blind 3 Treatments|Other|0|||
147573979|NCT00902538|532257539|FG003|2-Randomized Double-blind 3 Treatments|Other|0|||
147573980|NCT00902538|532257540|FG004|2-Randomized Double-blind 3 Treatments|Other|0|||
147573981|NCT00902538|532257541|FG005|2-Randomized Double-blind 3 Treatments|Other|0|||
147573982|NCT00902538|532257536|FG000|2-Randomized Double-blind 3 Treatments|Protocol Violation|1|||
147573983|NCT00902538|532257537|FG001|2-Randomized Double-blind 3 Treatments|Protocol Violation|1|||
147573984|NCT00902538|532257538|FG002|2-Randomized Double-blind 3 Treatments|Protocol Violation|2|||
147573985|NCT00902538|532257539|FG003|2-Randomized Double-blind 3 Treatments|Protocol Violation|0|||
147573986|NCT00902538|532257540|FG004|2-Randomized Double-blind 3 Treatments|Protocol Violation|0|||
147573987|NCT00902538|532257541|FG005|2-Randomized Double-blind 3 Treatments|Protocol Violation|0|||
147142329|NCT02891226|530687491|FG010|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
147142330|NCT02891226|530687492|FG011|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
147142331|NCT02891226|530687493|FG012|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
147142332|NCT02891226|530687494|FG013|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
147142333|NCT02891226|530687495|FG014|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
147142334|NCT02891226|530687496|FG015|Period 2 (Weeks 12 to 52)|Lack of Efficacy|0|||
147573988|NCT00902538|532257536|FG000|3-Single-blind, Single Treatment|Adverse Event|0|||
147142335|NCT02891226|530687481|FG000|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
147142336|NCT02891226|530687482|FG001|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
147142337|NCT02891226|530687483|FG002|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
147142338|NCT02891226|530687484|FG003|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
147142339|NCT02891226|530687485|FG004|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
147142340|NCT02891226|530687486|FG005|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
147142341|NCT02891226|530687487|FG006|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
147142342|NCT02891226|530687488|FG007|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|1|||
147142343|NCT02891226|530687489|FG008|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
147142344|NCT02891226|530687490|FG009|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
147142345|NCT02891226|530687491|FG010|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
147142346|NCT02891226|530687492|FG011|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
147142347|NCT02891226|530687493|FG012|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
147142348|NCT02891226|530687494|FG013|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
147142349|NCT02891226|530687495|FG014|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
147142350|NCT02891226|530687496|FG015|Period 2 (Weeks 12 to 52)|PI Decision due to Lack of Efficacy|0|||
147142351|NCT02891226|530687481|FG000|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
147142352|NCT02891226|530687482|FG001|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
147142353|NCT02891226|530687483|FG002|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
147142354|NCT02891226|530687484|FG003|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
147142355|NCT02891226|530687485|FG004|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
147142356|NCT02891226|530687486|FG005|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
147142357|NCT02891226|530687487|FG006|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
147142358|NCT02891226|530687488|FG007|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
147142359|NCT02891226|530687489|FG008|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|1|||
147142360|NCT02891226|530687490|FG009|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
147142361|NCT02891226|530687491|FG010|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
147142362|NCT02891226|530687492|FG011|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
147142363|NCT02891226|530687493|FG012|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
147142364|NCT02891226|530687494|FG013|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
147142365|NCT02891226|530687495|FG014|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
147445712|NCT01500278|531797440|FG001|Week 0 - Week 12|Lack of Efficacy|1|||
147445713|NCT01500278|531797439|FG000|Week 0 - Week 12|Protocol Violation|10|||
147573989|NCT00902538|532257537|FG001|3-Single-blind, Single Treatment|Adverse Event|5|||
147573990|NCT00902538|532257538|FG002|3-Single-blind, Single Treatment|Adverse Event|0|||
147573991|NCT00902538|532257539|FG003|3-Single-blind, Single Treatment|Adverse Event|0|||
147573992|NCT00902538|532257540|FG004|3-Single-blind, Single Treatment|Adverse Event|0|||
147573993|NCT00902538|532257541|FG005|3-Single-blind, Single Treatment|Adverse Event|0|||
147573994|NCT00902538|532257536|FG000|3-Single-blind, Single Treatment|Protocol Violation|0|||
147573995|NCT00902538|532257537|FG001|3-Single-blind, Single Treatment|Protocol Violation|5|||
147573996|NCT00902538|532257538|FG002|3-Single-blind, Single Treatment|Protocol Violation|0|||
147142366|NCT02891226|530687496|FG015|Period 2 (Weeks 12 to 52)|Endoscopic Procedure was not Evaluated|0|||
147142367|NCT02891226|530687481|FG000|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
147142368|NCT02891226|530687482|FG001|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
147142369|NCT02891226|530687483|FG002|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
147142370|NCT02891226|530687484|FG003|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
147142371|NCT02891226|530687485|FG004|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
147142372|NCT02891226|530687486|FG005|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
147142373|NCT02891226|530687487|FG006|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
147142374|NCT02891226|530687488|FG007|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
147142375|NCT02891226|530687489|FG008|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
147142376|NCT02891226|530687490|FG009|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|1|||
147142377|NCT02891226|530687491|FG010|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
147142378|NCT02891226|530687492|FG011|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
147142379|NCT02891226|530687493|FG012|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
147142380|NCT02891226|530687494|FG013|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
147142381|NCT02891226|530687495|FG014|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
147142382|NCT02891226|530687496|FG015|Period 2 (Weeks 12 to 52)|Lack of Efficacy and Withdrew from Study|0|||
147142383|NCT02891226|530687481|FG000|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
147142384|NCT02891226|530687482|FG001|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
147142385|NCT02891226|530687483|FG002|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
147142386|NCT02891226|530687484|FG003|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
147142387|NCT02891226|530687485|FG004|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
147142388|NCT02891226|530687486|FG005|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
147142389|NCT02891226|530687487|FG006|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
147142390|NCT02891226|530687488|FG007|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
147142391|NCT02891226|530687489|FG008|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
147142392|NCT02891226|530687490|FG009|Period 2 (Weeks 12 to 52)|Sponsor Decision|1|||
147142393|NCT02891226|530687491|FG010|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
147142394|NCT02891226|530687492|FG011|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
147142395|NCT02891226|530687493|FG012|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
147142396|NCT02891226|530687494|FG013|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
147142397|NCT02891226|530687495|FG014|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
147142398|NCT02891226|530687496|FG015|Period 2 (Weeks 12 to 52)|Sponsor Decision|0|||
147142399|NCT02891226|530687481|FG000|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
147142400|NCT02891226|530687482|FG001|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
147142401|NCT02891226|530687483|FG002|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
147142402|NCT02891226|530687484|FG003|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
147142403|NCT02891226|530687485|FG004|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
147142404|NCT02891226|530687486|FG005|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
147142405|NCT02891226|530687487|FG006|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
147142406|NCT02891226|530687488|FG007|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
147142407|NCT02891226|530687489|FG008|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
147142408|NCT02891226|530687490|FG009|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
147142409|NCT02891226|530687491|FG010|Period 3 (Weeks 52 to 208)|Adverse Event|5|||
147142410|NCT02891226|530687492|FG011|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
147142411|NCT02891226|530687493|FG012|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
147142412|NCT02891226|530687494|FG013|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
147142413|NCT02891226|530687495|FG014|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
147142414|NCT02891226|530687496|FG015|Period 3 (Weeks 52 to 208)|Adverse Event|0|||
147142415|NCT02891226|530687481|FG000|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
147142416|NCT02891226|530687482|FG001|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
147142417|NCT02891226|530687483|FG002|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
147142418|NCT02891226|530687484|FG003|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
147142419|NCT02891226|530687485|FG004|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
147142420|NCT02891226|530687486|FG005|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
147318656|NCT01824472|531331782|FG000|Overall Study|Withdrawal by Subject|1|||
147318657|NCT01824472|531331783|FG001|Overall Study|Withdrawal by Subject|5|||
147142421|NCT02891226|530687487|FG006|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
147142422|NCT02891226|530687488|FG007|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
147142423|NCT02891226|530687489|FG008|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
147573997|NCT00902538|532257539|FG003|3-Single-blind, Single Treatment|Protocol Violation|0|||
147142424|NCT02891226|530687490|FG009|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
147142425|NCT02891226|530687491|FG010|Period 3 (Weeks 52 to 208)|Lost to Follow-up|1|||
147142426|NCT02891226|530687492|FG011|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
147142427|NCT02891226|530687493|FG012|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
147142428|NCT02891226|530687494|FG013|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
147573998|NCT00902538|532257540|FG004|3-Single-blind, Single Treatment|Protocol Violation|0|||
147573999|NCT00902538|532257541|FG005|3-Single-blind, Single Treatment|Protocol Violation|0|||
147142429|NCT02891226|530687495|FG014|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
147142430|NCT02891226|530687496|FG015|Period 3 (Weeks 52 to 208)|Lost to Follow-up|0|||
147142431|NCT02891226|530687481|FG000|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
147142432|NCT02891226|530687482|FG001|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
147142433|NCT02891226|530687483|FG002|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
147142434|NCT02891226|530687484|FG003|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
147142435|NCT02891226|530687485|FG004|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
147142436|NCT02891226|530687486|FG005|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
147142437|NCT02891226|530687487|FG006|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
147142438|NCT02891226|530687488|FG007|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
147142439|NCT02891226|530687489|FG008|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
147142440|NCT02891226|530687490|FG009|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
147142441|NCT02891226|530687491|FG010|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|14|||
147142442|NCT02891226|530687492|FG011|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
147142443|NCT02891226|530687493|FG012|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
147142444|NCT02891226|530687494|FG013|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
147142445|NCT02891226|530687495|FG014|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
147142446|NCT02891226|530687496|FG015|Period 3 (Weeks 52 to 208)|Withdrawal by Subject|0|||
147142447|NCT02891226|530687481|FG000|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
147142448|NCT02891226|530687482|FG001|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
147142449|NCT02891226|530687483|FG002|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
147142450|NCT02891226|530687484|FG003|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
147142451|NCT02891226|530687485|FG004|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
147142452|NCT02891226|530687486|FG005|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
147142453|NCT02891226|530687487|FG006|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
147142454|NCT02891226|530687488|FG007|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
147142455|NCT02891226|530687489|FG008|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
147142456|NCT02891226|530687490|FG009|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
147142457|NCT02891226|530687491|FG010|Period 3 (Weeks 52 to 208)|Roll over to AMAX|108|||
147142458|NCT02891226|530687492|FG011|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
147142459|NCT02891226|530687493|FG012|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
147142460|NCT02891226|530687494|FG013|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
147142461|NCT02891226|530687495|FG014|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
147142462|NCT02891226|530687496|FG015|Period 3 (Weeks 52 to 208)|Roll over to AMAX|0|||
147142463|NCT02891226|530687481|FG000|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
147142464|NCT02891226|530687482|FG001|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
147142465|NCT02891226|530687483|FG002|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
147142466|NCT02891226|530687484|FG003|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
147142467|NCT02891226|530687485|FG004|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
147142468|NCT02891226|530687486|FG005|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
147142469|NCT02891226|530687487|FG006|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
147142470|NCT02891226|530687488|FG007|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
147142471|NCT02891226|530687489|FG008|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
147142472|NCT02891226|530687490|FG009|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
147142473|NCT02891226|530687491|FG010|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|2|||
147142474|NCT02891226|530687492|FG011|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
147142475|NCT02891226|530687493|FG012|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
147142476|NCT02891226|530687494|FG013|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
147142477|NCT02891226|530687495|FG014|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
147142478|NCT02891226|530687496|FG015|Period 3 (Weeks 52 to 208)|Decided to not Participate in Extension Period (Week 104-208)|0|||
147142479|NCT02891226|530687481|FG000|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
147142480|NCT02891226|530687482|FG001|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
147142481|NCT02891226|530687483|FG002|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
147237955|NCT00306189|531042596|FG002|Overall Study|Ineligibility determined|1|||
147574000|NCT00902538|532257536|FG000|3-Single-blind, Single Treatment|Withdrawal by Subject|0|||
147574001|NCT00902538|532257537|FG001|3-Single-blind, Single Treatment|Withdrawal by Subject|4|||
147574002|NCT00902538|532257538|FG002|3-Single-blind, Single Treatment|Withdrawal by Subject|0|||
147574003|NCT00902538|532257539|FG003|3-Single-blind, Single Treatment|Withdrawal by Subject|0|||
147574004|NCT00902538|532257540|FG004|3-Single-blind, Single Treatment|Withdrawal by Subject|0|||
147574005|NCT00902538|532257541|FG005|3-Single-blind, Single Treatment|Withdrawal by Subject|0|||
147574006|NCT00902538|532257536|FG000|3-Single-blind, Single Treatment|Lost to Follow-up|0|||
147574007|NCT00902538|532257537|FG001|3-Single-blind, Single Treatment|Lost to Follow-up|1|||
147574008|NCT00902538|532257538|FG002|3-Single-blind, Single Treatment|Lost to Follow-up|0|||
147574009|NCT00902538|532257539|FG003|3-Single-blind, Single Treatment|Lost to Follow-up|0|||
147142482|NCT02891226|530687484|FG003|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
147142483|NCT02891226|530687485|FG004|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
147142484|NCT02891226|530687486|FG005|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
147574010|NCT00902538|532257540|FG004|3-Single-blind, Single Treatment|Lost to Follow-up|0|||
147142485|NCT02891226|530687487|FG006|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
147142486|NCT02891226|530687488|FG007|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
147142487|NCT02891226|530687489|FG008|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
147142488|NCT02891226|530687490|FG009|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
147142489|NCT02891226|530687491|FG010|Period 3 (Weeks 52 to 208)|Lack of Efficacy|3|||
147142490|NCT02891226|530687492|FG011|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
147142491|NCT02891226|530687493|FG012|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
147142492|NCT02891226|530687494|FG013|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
147142493|NCT02891226|530687495|FG014|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
147142494|NCT02891226|530687496|FG015|Period 3 (Weeks 52 to 208)|Lack of Efficacy|0|||
147142495|NCT02891226|530687481|FG000|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
147142496|NCT02891226|530687482|FG001|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
147142497|NCT02891226|530687483|FG002|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
147142498|NCT02891226|530687484|FG003|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
147142499|NCT02891226|530687485|FG004|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
147142500|NCT02891226|530687486|FG005|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
147142501|NCT02891226|530687487|FG006|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
147142502|NCT02891226|530687488|FG007|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
147142503|NCT02891226|530687489|FG008|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
147142504|NCT02891226|530687490|FG009|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
147142505|NCT02891226|530687491|FG010|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|2|||
147142506|NCT02891226|530687492|FG011|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
147142507|NCT02891226|530687493|FG012|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
147142508|NCT02891226|530687494|FG013|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
147142509|NCT02891226|530687495|FG014|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
147142510|NCT02891226|530687496|FG015|Period 3 (Weeks 52 to 208)|PI Decision as Subject Not Responding to Study Drug|0|||
147142511|NCT02891226|530687481|FG000|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
147142512|NCT02891226|530687482|FG001|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
147142513|NCT02891226|530687483|FG002|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
147142514|NCT02891226|530687484|FG003|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
147142515|NCT02891226|530687485|FG004|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
147142516|NCT02891226|530687486|FG005|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
147142517|NCT02891226|530687487|FG006|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
147142518|NCT02891226|530687488|FG007|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
147142519|NCT02891226|530687489|FG008|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
147142520|NCT02891226|530687490|FG009|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
147142521|NCT02891226|530687491|FG010|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|2|||
147142522|NCT02891226|530687492|FG011|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
147142523|NCT02891226|530687493|FG012|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
147142524|NCT02891226|530687494|FG013|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
147142525|NCT02891226|530687495|FG014|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
147142526|NCT02891226|530687496|FG015|Period 3 (Weeks 52 to 208)|Non-Compliance With Study Visit Schedule|0|||
147142527|NCT02891226|530687481|FG000|Follow-up Period|Withdrawal by Subject|0|||
147142528|NCT02891226|530687482|FG001|Follow-up Period|Withdrawal by Subject|0|||
147142529|NCT02891226|530687483|FG002|Follow-up Period|Withdrawal by Subject|0|||
147574011|NCT00902538|532257541|FG005|3-Single-blind, Single Treatment|Lost to Follow-up|0|||
147574012|NCT00902538|532257536|FG000|4-Randomized Double-blind 2 Treatments|Adverse Event|0|||
147574013|NCT00902538|532257537|FG001|4-Randomized Double-blind 2 Treatments|Adverse Event|0|||
147574014|NCT00902538|532257538|FG002|4-Randomized Double-blind 2 Treatments|Adverse Event|0|||
147574015|NCT00902538|532257539|FG003|4-Randomized Double-blind 2 Treatments|Adverse Event|3|||
147574016|NCT00902538|532257540|FG004|4-Randomized Double-blind 2 Treatments|Adverse Event|1|||
147574017|NCT00902538|532257541|FG005|4-Randomized Double-blind 2 Treatments|Adverse Event|1|||
147574018|NCT00902538|532257536|FG000|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0|||
147574019|NCT00902538|532257537|FG001|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0|||
147574020|NCT00902538|532257538|FG002|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0|||
147574021|NCT00902538|532257539|FG003|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|3|||
147574022|NCT00902538|532257540|FG004|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|1|||
147142530|NCT02891226|530687484|FG003|Follow-up Period|Withdrawal by Subject|0|||
147142531|NCT02891226|530687485|FG004|Follow-up Period|Withdrawal by Subject|0|||
147142532|NCT02891226|530687486|FG005|Follow-up Period|Withdrawal by Subject|0|||
147142533|NCT02891226|530687487|FG006|Follow-up Period|Withdrawal by Subject|0|||
147142534|NCT02891226|530687488|FG007|Follow-up Period|Withdrawal by Subject|0|||
147142535|NCT02891226|530687489|FG008|Follow-up Period|Withdrawal by Subject|0|||
147142536|NCT02891226|530687490|FG009|Follow-up Period|Withdrawal by Subject|0|||
147142537|NCT02891226|530687491|FG010|Follow-up Period|Withdrawal by Subject|0|||
147445714|NCT01500278|531797440|FG001|Week 0 - Week 12|Protocol Violation|16|||
147142538|NCT02891226|530687492|FG011|Follow-up Period|Withdrawal by Subject|1|||
147142539|NCT02891226|530687493|FG012|Follow-up Period|Withdrawal by Subject|0|||
147142540|NCT02891226|530687494|FG013|Follow-up Period|Withdrawal by Subject|0|||
147142541|NCT02891226|530687495|FG014|Follow-up Period|Withdrawal by Subject|1|||
147142542|NCT02891226|530687496|FG015|Follow-up Period|Withdrawal by Subject|1|||
147142543|NCT03381287|530687503|FG000|Overall Study|Withdrawal by Subject|0|||
147142544|NCT03381287|530687504|FG001|Overall Study|Withdrawal by Subject|1|||
147142545|NCT03381287|530687505|FG002|Overall Study|Withdrawal by Subject|0|||
147142546|NCT03381287|530687506|FG003|Overall Study|Withdrawal by Subject|0|||
147142547|NCT03381287|530687503|FG000|Overall Study|Adverse Event|0|||
147142548|NCT03381287|530687504|FG001|Overall Study|Adverse Event|0|||
147142549|NCT03381287|530687505|FG002|Overall Study|Adverse Event|0|||
147142550|NCT03381287|530687506|FG003|Overall Study|Adverse Event|1|||
147142551|NCT03381287|530687503|FG000|Overall Study|Physician Decision|0|||
147142552|NCT03381287|530687504|FG001|Overall Study|Physician Decision|0|||
147142553|NCT03381287|530687505|FG002|Overall Study|Physician Decision|0|||
147142554|NCT03381287|530687506|FG003|Overall Study|Physician Decision|1|||
147142555|NCT02454530|530687509|FG000|Overall Study|Other|8|||
147142556|NCT02454530|530687510|FG001|Overall Study|Other|13|||
147142557|NCT02454530|530687509|FG000|Overall Study|Missing information|56|||
147142558|NCT02454530|530687510|FG001|Overall Study|Missing information|69|||
147142559|NCT02454530|530687509|FG000|Overall Study|Death|2|||
147142560|NCT02454530|530687510|FG001|Overall Study|Death|41|||
147142561|NCT02454530|530687509|FG000|Overall Study|Lost to Follow-up|4|||
147142562|NCT02454530|530687510|FG001|Overall Study|Lost to Follow-up|4|||
147142563|NCT02137070|530687512|FG000|Overall Study|Adverse Event|12|||
147142564|NCT02137070|530687513|FG001|Overall Study|Adverse Event|3|||
147142565|NCT02137070|530687512|FG000|Overall Study|Death|2|||
147142566|NCT02137070|530687513|FG001|Overall Study|Death|0|||
147142567|NCT02137070|530687512|FG000|Overall Study|Lost to Follow-up|24|||
147142568|NCT02137070|530687513|FG001|Overall Study|Lost to Follow-up|9|||
147142569|NCT02137070|530687512|FG000|Overall Study|Physician Decision|0|||
147142570|NCT02137070|530687513|FG001|Overall Study|Physician Decision|1|||
147142571|NCT02137070|530687512|FG000|Overall Study|Protocol Violation|18|||
147142572|NCT02137070|530687513|FG001|Overall Study|Protocol Violation|4|||
147142573|NCT02137070|530687512|FG000|Overall Study|Withdrawal by Subject|18|||
147142574|NCT02137070|530687513|FG001|Overall Study|Withdrawal by Subject|1|||
147142575|NCT03533660|530687514|FG000|Overall Study|Withdrawal by Subject|2|||
147142576|NCT03533660|530687515|FG001|Overall Study|Withdrawal by Subject|2|||
147142577|NCT03533660|530687514|FG000|Overall Study|Death|2|||
147142578|NCT03533660|530687515|FG001|Overall Study|Death|4|||
147142579|NCT03533660|530687514|FG000|Overall Study|Adverse Event|0|||
147142580|NCT03533660|530687515|FG001|Overall Study|Adverse Event|2|||
147142581|NCT00996658|530687516|FG000|Overall Study|Adverse Event|2|||
147142582|NCT00996658|530687517|FG001|Overall Study|Adverse Event|5|||
147142583|NCT00996658|530687516|FG000|Overall Study|Protocol Violation|0|||
147142584|NCT00996658|530687517|FG001|Overall Study|Protocol Violation|1|||
147142585|NCT00996658|530687516|FG000|Overall Study|Lost to Follow-up|2|||
147142586|NCT00996658|530687517|FG001|Overall Study|Lost to Follow-up|5|||
147142587|NCT00996658|530687516|FG000|Overall Study|Non-compliance issues|3|||
147142588|NCT00996658|530687517|FG001|Overall Study|Non-compliance issues|3|||
147445715|NCT01500278|531797439|FG000|Week 0 - Week 12|Lost to Follow-up|1|||
147142589|NCT00996658|530687516|FG000|Overall Study|Other|9|||
147142590|NCT00996658|530687517|FG001|Overall Study|Other|7|||
147142591|NCT04487080|530687527|FG000|Overall Study|Withdrawal by Subject|19|||
147237956|NCT00306189|531042597|FG003|Overall Study|Ineligibility determined|1|||
147445716|NCT01500278|531797440|FG001|Week 0 - Week 12|Lost to Follow-up|1|||
147142592|NCT04487080|530687528|FG001|Overall Study|Withdrawal by Subject|18|||
147142593|NCT04487080|530687529|FG002|Overall Study|Withdrawal by Subject|13|||
147142594|NCT04487080|530687527|FG000|Overall Study|Lost to Follow-up|3|||
147142595|NCT04487080|530687528|FG001|Overall Study|Lost to Follow-up|1|||
147142596|NCT04487080|530687529|FG002|Overall Study|Lost to Follow-up|0|||
147142597|NCT04487080|530687527|FG000|Overall Study|Ongoing|313|||
147142598|NCT04487080|530687528|FG001|Overall Study|Ongoing|297|||
147142599|NCT04487080|530687529|FG002|Overall Study|Ongoing|149|||
147142600|NCT02842086|530687530|FG000|Overall Study|Randomized but Never Treated|6|||
147142601|NCT02842086|530687531|FG001|Overall Study|Randomized but Never Treated|6|||
147142602|NCT02842086|530687530|FG000|Overall Study|Still in Double-Blind Phase|7|||
147142603|NCT02842086|530687531|FG001|Overall Study|Still in Double-Blind Phase|3|||
147142604|NCT02842086|530687530|FG000|Overall Study|Adverse Event|18|||
147142605|NCT02842086|530687531|FG001|Overall Study|Adverse Event|20|||
147142606|NCT02842086|530687530|FG000|Overall Study|Death|3|||
147142607|NCT02842086|530687531|FG001|Overall Study|Death|3|||
147142608|NCT02842086|530687530|FG000|Overall Study|Investigator's Discretion|9|||
147142609|NCT02842086|530687531|FG001|Overall Study|Investigator's Discretion|13|||
147142610|NCT02842086|530687530|FG000|Overall Study|Non-Compliance with Study Drug|9|||
147142611|NCT02842086|530687531|FG001|Overall Study|Non-Compliance with Study Drug|8|||
147142612|NCT02842086|530687530|FG000|Overall Study|Protocol Violation|8|||
147142613|NCT02842086|530687531|FG001|Overall Study|Protocol Violation|4|||
147142614|NCT02842086|530687530|FG000|Overall Study|Withdrew Consent|205|||
147142615|NCT02842086|530687531|FG001|Overall Study|Withdrew Consent|194|||
147142616|NCT02842086|530687530|FG000|Overall Study|Lost to Follow-up|274|||
147142617|NCT02842086|530687531|FG001|Overall Study|Lost to Follow-up|236|||
147142618|NCT02842086|530687530|FG000|Overall Study|HIV-1 Infection|5|||
147142619|NCT02842086|530687531|FG001|Overall Study|HIV-1 Infection|6|||
147142620|NCT03451851|530687532|FG000|PCP: Week 0 -16|Adverse Event|1|||
147142621|NCT03451851|530687533|FG001|PCP: Week 0 -16|Adverse Event|0|||
147142622|NCT03451851|530687534|FG002|PCP: Week 0 -16|Adverse Event|0|||
147142623|NCT03451851|530687535|FG003|PCP: Week 0 -16|Adverse Event|0|||
147142624|NCT03451851|530687536|FG004|PCP: Week 0 -16|Adverse Event|0|||
147142625|NCT03451851|530687537|FG005|PCP: Week 0 -16|Adverse Event|0|||
147142626|NCT03451851|530687538|FG006|PCP: Week 0 -16|Adverse Event|1|||
147142627|NCT03451851|530687539|FG007|PCP: Week 0 -16|Adverse Event|0|||
147142628|NCT03451851|530687532|FG000|PCP: Week 0 -16|Withdrawal by Subject|0|||
147142629|NCT03451851|530687533|FG001|PCP: Week 0 -16|Withdrawal by Subject|0|||
147142630|NCT03451851|530687534|FG002|PCP: Week 0 -16|Withdrawal by Subject|1|||
147142631|NCT03451851|530687535|FG003|PCP: Week 0 -16|Withdrawal by Subject|0|||
147142632|NCT03451851|530687536|FG004|PCP: Week 0 -16|Withdrawal by Subject|0|||
147142633|NCT03451851|530687537|FG005|PCP: Week 0 -16|Withdrawal by Subject|0|||
147142634|NCT03451851|530687538|FG006|PCP: Week 0 -16|Withdrawal by Subject|0|||
147142635|NCT03451851|530687539|FG007|PCP: Week 0 -16|Withdrawal by Subject|0|||
147142636|NCT03451851|530687532|FG000|PCP: Week 0 -16|Withdrawal by Parent/Guardian|0|||
147142637|NCT03451851|530687533|FG001|PCP: Week 0 -16|Withdrawal by Parent/Guardian|0|||
147142638|NCT03451851|530687534|FG002|PCP: Week 0 -16|Withdrawal by Parent/Guardian|2|||
147142639|NCT03451851|530687535|FG003|PCP: Week 0 -16|Withdrawal by Parent/Guardian|0|||
147142640|NCT03451851|530687536|FG004|PCP: Week 0 -16|Withdrawal by Parent/Guardian|0|||
147142641|NCT03451851|530687537|FG005|PCP: Week 0 -16|Withdrawal by Parent/Guardian|0|||
147142642|NCT03451851|530687538|FG006|PCP: Week 0 -16|Withdrawal by Parent/Guardian|0|||
147142643|NCT03451851|530687539|FG007|PCP: Week 0 -16|Withdrawal by Parent/Guardian|0|||
147142644|NCT03451851|530687532|FG000|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|0|||
147142645|NCT03451851|530687533|FG001|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|0|||
147142646|NCT03451851|530687534|FG002|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|0|||
147142647|NCT03451851|530687535|FG003|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|0|||
147142648|NCT03451851|530687536|FG004|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|3|||
147142649|NCT03451851|530687537|FG005|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|1|||
147142650|NCT03451851|530687538|FG006|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|0|||
147142651|NCT03451851|530687539|FG007|Withdrawal and Retreament: Week 16-52|Other Withdrawal by Parent/Guardian|0|||
147142652|NCT03451851|530687532|FG000|Withdrawal and Retreament: Week 16-52|Other Unspecified|0|||
147142653|NCT03451851|530687533|FG001|Withdrawal and Retreament: Week 16-52|Other Unspecified|0|||
147142654|NCT03451851|530687534|FG002|Withdrawal and Retreament: Week 16-52|Other Unspecified|0|||
147142655|NCT03451851|530687535|FG003|Withdrawal and Retreament: Week 16-52|Other Unspecified|0|||
147142656|NCT03451851|530687536|FG004|Withdrawal and Retreament: Week 16-52|Other Unspecified|1|||
147142657|NCT03451851|530687537|FG005|Withdrawal and Retreament: Week 16-52|Other Unspecified|0|||
147142658|NCT03451851|530687538|FG006|Withdrawal and Retreament: Week 16-52|Other Unspecified|0|||
147142659|NCT03451851|530687539|FG007|Withdrawal and Retreament: Week 16-52|Other Unspecified|0|||
147237957|NCT00306189|531042594|FG000|Overall Study|Other|1|||
147237958|NCT00306189|531042595|FG001|Overall Study|Other|0|||
147237959|NCT00306189|531042596|FG002|Overall Study|Other|0|||
147237960|NCT00306189|531042597|FG003|Overall Study|Other|0|||
147142660|NCT03451851|530687532|FG000|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|0|||
147142661|NCT03451851|530687533|FG001|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|0|||
147142662|NCT03451851|530687534|FG002|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|0|||
147142663|NCT03451851|530687535|FG003|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|0|||
147142664|NCT03451851|530687536|FG004|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|2|||
147142665|NCT03451851|530687537|FG005|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|0|||
147142666|NCT03451851|530687538|FG006|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|0|||
147142667|NCT03451851|530687539|FG007|Withdrawal and Retreament: Week 16-52|Other- completed safety follow up|0|||
147142668|NCT03581292|530687540|FG000|Overall Study|Physician Decision|9|||
147237961|NCT02993757|531042598|FG000|Overall Study|Non compliance with the protocol|155|||
147237962|NCT02993757|531042599|FG001|Overall Study|Non compliance with the protocol|170|||
147142669|NCT03581292|530687541|FG001|Overall Study|Physician Decision|5|||
147142670|NCT03581292|530687540|FG000|Overall Study|Withdrawal by Subject|3|||
147142671|NCT03581292|530687541|FG001|Overall Study|Withdrawal by Subject|0|||
147142672|NCT03581292|530687540|FG000|Overall Study|Withdrawal before Therapy Start|1|||
147142673|NCT03581292|530687541|FG001|Overall Study|Withdrawal before Therapy Start|0|||
147142674|NCT07214935|530687542|FG000|Overall Study|Adverse Event|1|||
147142675|NCT07214935|530687543|FG001|Overall Study|Adverse Event|1|||
147142676|NCT07214935|530687544|FG002|Overall Study|Adverse Event|1|||
147142677|NCT07214935|530687545|FG003|Overall Study|Adverse Event|0|||
147142678|NCT07214935|530687542|FG000|Overall Study|Lost to Follow-up|0|||
147142679|NCT07214935|530687543|FG001|Overall Study|Lost to Follow-up|1|||
147142680|NCT07214935|530687544|FG002|Overall Study|Lost to Follow-up|0|||
147142681|NCT07214935|530687545|FG003|Overall Study|Lost to Follow-up|0|||
147142682|NCT07214935|530687542|FG000|Overall Study|Participant did not meet all eligibility criteria, ADMISSION DRUG SCREEN POSITIVE|1|||
147142683|NCT07214935|530687543|FG001|Overall Study|Participant did not meet all eligibility criteria, ADMISSION DRUG SCREEN POSITIVE|0|||
147142684|NCT07214935|530687544|FG002|Overall Study|Participant did not meet all eligibility criteria, ADMISSION DRUG SCREEN POSITIVE|0|||
147142685|NCT07214935|530687545|FG003|Overall Study|Participant did not meet all eligibility criteria, ADMISSION DRUG SCREEN POSITIVE|0|||
147142686|NCT07214935|530687542|FG000|Overall Study|Participant discontinued prior to first dosing|0|||
147142687|NCT07214935|530687543|FG001|Overall Study|Participant discontinued prior to first dosing|0|||
147142688|NCT07214935|530687544|FG002|Overall Study|Participant discontinued prior to first dosing|0|||
147142689|NCT07214935|530687545|FG003|Overall Study|Participant discontinued prior to first dosing|1|||
147142690|NCT04609553|530688988|FG000|Overall Study|Lost to Follow-up|27|||
147142691|NCT04609553|530688989|FG001|Overall Study|Lost to Follow-up|31|||
147142692|NCT04609553|530688990|FG002|Overall Study|Lost to Follow-up|24|||
147142693|NCT04609553|530688988|FG000|Overall Study|Discontinued|12|||
147142694|NCT04609553|530688989|FG001|Overall Study|Discontinued|10|||
147142695|NCT04609553|530688990|FG002|Overall Study|Discontinued|9|||
147142696|NCT01147965|530688994|FG000|Overall Study|Progressive Disease|3|||
147142697|NCT01147965|530688995|FG001|Overall Study|Progressive Disease|3|||
147142698|NCT01147965|530688996|FG002|Overall Study|Progressive Disease|5|||
147142699|NCT01147965|530688997|FG003|Overall Study|Progressive Disease|9|||
147142700|NCT01147965|530688998|FG004|Overall Study|Progressive Disease|5|||
147142701|NCT01147965|530688999|FG005|Overall Study|Progressive Disease|5|||
147142702|NCT01147965|530688994|FG000|Overall Study|Death|0|||
147142703|NCT01147965|530688995|FG001|Overall Study|Death|0|||
147142704|NCT01147965|530688996|FG002|Overall Study|Death|1|||
147142705|NCT01147965|530688997|FG003|Overall Study|Death|1|||
147142706|NCT01147965|530688998|FG004|Overall Study|Death|0|||
147142707|NCT01147965|530688999|FG005|Overall Study|Death|2|||
147142708|NCT01147965|530688994|FG000|Overall Study|Withdrawal by Subject|0|||
147142709|NCT01147965|530688995|FG001|Overall Study|Withdrawal by Subject|0|||
147142710|NCT01147965|530688996|FG002|Overall Study|Withdrawal by Subject|1|||
147142711|NCT01147965|530688997|FG003|Overall Study|Withdrawal by Subject|1|||
147142712|NCT01147965|530688998|FG004|Overall Study|Withdrawal by Subject|0|||
147142713|NCT01147965|530688999|FG005|Overall Study|Withdrawal by Subject|0|||
147142714|NCT01147965|530688994|FG000|Overall Study|Administration Of Alternative Therapy|0|||
147142715|NCT01147965|530688995|FG001|Overall Study|Administration Of Alternative Therapy|0|||
147142716|NCT01147965|530688996|FG002|Overall Study|Administration Of Alternative Therapy|0|||
147142717|NCT01147965|530688997|FG003|Overall Study|Administration Of Alternative Therapy|0|||
147142718|NCT01147965|530688998|FG004|Overall Study|Administration Of Alternative Therapy|0|||
147142719|NCT01147965|530688999|FG005|Overall Study|Administration Of Alternative Therapy|1|||
147142720|NCT01147965|530688994|FG000|Overall Study|Other|0|||
147142721|NCT01147965|530688995|FG001|Overall Study|Other|0|||
147142722|NCT01147965|530688996|FG002|Overall Study|Other|0|||
147142723|NCT01147965|530688997|FG003|Overall Study|Other|3|||
147142724|NCT01147965|530688998|FG004|Overall Study|Other|1|||
147142725|NCT01147965|530688999|FG005|Overall Study|Other|0|||
147142726|NCT01650831|530689002|FG000|Overall Study|Screen failure|1|||
147142727|NCT02522429|530689003|FG000|Overall Study|Lost to Follow-up|8|||
147142728|NCT02522429|530689003|FG000|Overall Study|Adverse Event|2|||
147142729|NCT02522429|530689003|FG000|Overall Study|Death|1|||
147142730|NCT02522429|530689003|FG000|Overall Study|Patient exceeded inclusion criteria after enrollment but prior to undergoing study procedures|1|||
147142731|NCT05554146|530689006|FG000|Overall Study|Adverse Event|0|||
147142732|NCT05554146|530689007|FG001|Overall Study|Adverse Event|1|||
147142733|NCT05554146|530689008|FG002|Overall Study|Adverse Event|0|||
147142734|NCT05554146|530689009|FG003|Overall Study|Adverse Event|0|||
147142735|NCT05554146|530689006|FG000|Overall Study|Protocol Violation|0|||
147142736|NCT05554146|530689007|FG001|Overall Study|Protocol Violation|1|||
147142737|NCT05554146|530689008|FG002|Overall Study|Protocol Violation|0|||
147142738|NCT05554146|530689009|FG003|Overall Study|Protocol Violation|0|||
147142739|NCT05554146|530689006|FG000|Overall Study|No longer interested in participating|0|||
147142740|NCT05554146|530689007|FG001|Overall Study|No longer interested in participating|0|||
147142741|NCT05554146|530689008|FG002|Overall Study|No longer interested in participating|1|||
147142742|NCT05554146|530689009|FG003|Overall Study|No longer interested in participating|0|||
147142743|NCT05554146|530689006|FG000|Overall Study|Lost to Follow-up|1|||
147142744|NCT05554146|530689007|FG001|Overall Study|Lost to Follow-up|0|||
147142745|NCT05554146|530689008|FG002|Overall Study|Lost to Follow-up|0|||
147142746|NCT05554146|530689009|FG003|Overall Study|Lost to Follow-up|0|||
147142747|NCT04988295|530689010|FG000|Overall Study|Withdrawal by Subject|9|||
147142748|NCT04988295|530689011|FG001|Overall Study|Withdrawal by Subject|29|||
147142749|NCT04988295|530689012|FG002|Overall Study|Withdrawal by Subject|6|||
147142750|NCT04988295|530689013|FG003|Overall Study|Withdrawal by Subject|0|||
147142751|NCT04988295|530689010|FG000|Overall Study|Lost to Follow-up|1|||
147142752|NCT04988295|530689011|FG001|Overall Study|Lost to Follow-up|0|||
147142753|NCT04988295|530689012|FG002|Overall Study|Lost to Follow-up|0|||
147142754|NCT04988295|530689013|FG003|Overall Study|Lost to Follow-up|0|||
147142755|NCT04988295|530689010|FG000|Overall Study|Study participation ongoing|186|||
147142756|NCT04988295|530689011|FG001|Overall Study|Study participation ongoing|169|||
147142757|NCT04988295|530689012|FG002|Overall Study|Study participation ongoing|99|||
147142758|NCT04988295|530689013|FG003|Overall Study|Study participation ongoing|119|||
147142759|NCT02197572|530689016|FG000|Overall Study|Progressive Disease|28|||
147142760|NCT02197572|530689016|FG000|Overall Study|Withdrawal by Subject|9|||
147142761|NCT02197572|530689016|FG000|Overall Study|Adverse Event|3|||
147142762|NCT02197572|530689016|FG000|Overall Study|Reason Not Specified|4|||
147142763|NCT03458325|530689020|FG000|Overall Study|Withdrawal by Subject|1|||
147142764|NCT00175916|530689021|FG000|Overall Study|Death|19|||
147142765|NCT00175916|530689021|FG000|Overall Study|Adverse Event|81|||
147142766|NCT00175916|530689021|FG000|Overall Study|Lack of Efficacy|354|||
147142767|NCT00175916|530689021|FG000|Overall Study|Lost to Follow-up|17|||
147142768|NCT00175916|530689021|FG000|Overall Study|Subject Choice|98|||
147142769|NCT00175916|530689021|FG000|Overall Study|Lack of compliance|8|||
147142770|NCT00175916|530689021|FG000|Overall Study|Patient cannot record seizures|1|||
147142771|NCT00175916|530689021|FG000|Overall Study|Sponsor decision|17|||
147142772|NCT00175916|530689021|FG000|Overall Study|Vigabatrin intake|1|||
147142773|NCT00175916|530689021|FG000|Overall Study|Suicidal behaviour|1|||
147142774|NCT00175916|530689021|FG000|Overall Study|Withdrawal by Subject|1|||
147142775|NCT00175916|530689021|FG000|Overall Study|Seizure - free|4|||
147142776|NCT00175916|530689021|FG000|Overall Study|Administrative reason|1|||
147142777|NCT00175916|530689021|FG000|Overall Study|Pregnancy|1|||
147142778|NCT00175916|530689021|FG000|Overall Study|Patient's request|2|||
147142779|NCT00175916|530689021|FG000|Overall Study|Treating physiciant's choice|1|||
147142780|NCT00175916|530689021|FG000|Overall Study|Moved overseas|1|||
147142781|NCT00175916|530689021|FG000|Overall Study|Loss of job and economic burden|1|||
147142782|NCT00175916|530689021|FG000|Overall Study|Site was closed|9|||
147142783|NCT00175916|530689021|FG000|Overall Study|Patient went to prison|1|||
147142784|NCT04024436|530689022|FG000|Overall Study|Death|10|||
147142785|NCT04024436|530689023|FG001|Overall Study|Death|14|||
147142786|NCT04024436|530689024|FG002|Overall Study|Death|2|||
147142787|NCT04024436|530689025|FG003|Overall Study|Death|7|||
147142788|NCT04024436|530689022|FG000|Overall Study|Loss to follow up|1|||
147142789|NCT04024436|530689023|FG001|Overall Study|Loss to follow up|0|||
147142790|NCT04024436|530689024|FG002|Overall Study|Loss to follow up|0|||
147142791|NCT04024436|530689025|FG003|Overall Study|Loss to follow up|1|||
147142792|NCT04024436|530689022|FG000|Overall Study|Withdrawal of consent|2|||
147142793|NCT04024436|530689023|FG001|Overall Study|Withdrawal of consent|0|||
147142794|NCT04024436|530689024|FG002|Overall Study|Withdrawal of consent|0|||
147142795|NCT04024436|530689025|FG003|Overall Study|Withdrawal of consent|1|||
147142796|NCT04024436|530689022|FG000|Overall Study|Study termination by sponsor|4|||
147142797|NCT04024436|530689023|FG001|Overall Study|Study termination by sponsor|6|||
147142798|NCT04024436|530689024|FG002|Overall Study|Study termination by sponsor|2|||
147142799|NCT04024436|530689025|FG003|Overall Study|Study termination by sponsor|11|||
147142800|NCT04024436|530689022|FG000|Overall Study|Reason Not Specified|0|||
147142801|NCT04024436|530689023|FG001|Overall Study|Reason Not Specified|1|||
147142802|NCT04024436|530689024|FG002|Overall Study|Reason Not Specified|0|||
147142803|NCT04024436|530689025|FG003|Overall Study|Reason Not Specified|2|||
147142804|NCT01169337|530689026|FG000|Overall Study|Lack of Efficacy|5|||
147142805|NCT01169337|530689027|FG001|Overall Study|Lack of Efficacy|7|||
147142806|NCT01169337|530689028|FG002|Overall Study|Lack of Efficacy|0|||
147142807|NCT01169337|530689026|FG000|Overall Study|Adverse Event|12|||
147142808|NCT01169337|530689027|FG001|Overall Study|Adverse Event|18|||
147142809|NCT01169337|530689028|FG002|Overall Study|Adverse Event|0|||
147142810|NCT01169337|530689026|FG000|Overall Study|Death|2|||
147142811|NCT01169337|530689027|FG001|Overall Study|Death|0|||
147142812|NCT01169337|530689028|FG002|Overall Study|Death|0|||
147142813|NCT01169337|530689026|FG000|Overall Study|Withdrawal by Subject|11|||
147142814|NCT01169337|530689027|FG001|Overall Study|Withdrawal by Subject|11|||
147142815|NCT01169337|530689028|FG002|Overall Study|Withdrawal by Subject|6|||
147142816|NCT01169337|530689026|FG000|Overall Study|Noncompliance|2|||
147142817|NCT01169337|530689027|FG001|Overall Study|Noncompliance|0|||
147142818|NCT01169337|530689028|FG002|Overall Study|Noncompliance|0|||
147142819|NCT01169337|530689026|FG000|Overall Study|Other complicating disease|1|||
147142820|NCT01169337|530689027|FG001|Overall Study|Other complicating disease|1|||
147142821|NCT01169337|530689028|FG002|Overall Study|Other complicating disease|0|||
147237963|NCT02993757|531042598|FG000|Overall Study|Lost to Follow-up|1|||
147142822|NCT01169337|530689026|FG000|Overall Study|Physician Decision|1|||
147142823|NCT01169337|530689027|FG001|Overall Study|Physician Decision|5|||
147142824|NCT01169337|530689028|FG002|Overall Study|Physician Decision|0|||
147142825|NCT01169337|530689026|FG000|Overall Study|Alternative therapy|0|||
147445717|NCT01500278|531797439|FG000|Week 0 - Week 12|Withdrawal by Subject|7|||
147445718|NCT01500278|531797440|FG001|Week 0 - Week 12|Withdrawal by Subject|2|||
147142826|NCT01169337|530689027|FG001|Overall Study|Alternative therapy|2|||
147142827|NCT01169337|530689028|FG002|Overall Study|Alternative therapy|0|||
147142828|NCT01169337|530689026|FG000|Overall Study|Changed hospital|0|||
147142829|NCT01169337|530689027|FG001|Overall Study|Changed hospital|1|||
147142830|NCT01169337|530689028|FG002|Overall Study|Changed hospital|0|||
147142831|NCT01169337|530689026|FG000|Overall Study|Never started treatment|0|||
147142832|NCT01169337|530689027|FG001|Overall Study|Never started treatment|2|||
147142833|NCT01169337|530689028|FG002|Overall Study|Never started treatment|0|||
147142834|NCT01169337|530689026|FG000|Overall Study|Reason not reported|1|||
147142835|NCT01169337|530689027|FG001|Overall Study|Reason not reported|0|||
147142836|NCT01169337|530689028|FG002|Overall Study|Reason not reported|0|||
147142837|NCT01169337|530689026|FG000|Overall Study|Continuing lenalidomide|9|||
147142838|NCT01169337|530689027|FG001|Overall Study|Continuing lenalidomide|43|||
147142839|NCT01169337|530689028|FG002|Overall Study|Continuing lenalidomide|0|||
147142840|NCT00540592|530689029|FG000|Overall Study|Adverse Event|0|||
147142841|NCT00540592|530689030|FG001|Overall Study|Adverse Event|1|||
147142842|NCT00540592|530689031|FG002|Overall Study|Adverse Event|0|||
147142843|NCT00540592|530689032|FG003|Overall Study|Adverse Event|0|||
147142844|NCT00540592|530689033|FG004|Overall Study|Adverse Event|1|||
147142845|NCT00540592|530689034|FG005|Overall Study|Adverse Event|0|||
147142846|NCT00540592|530689035|FG006|Overall Study|Adverse Event|0|||
147142847|NCT00540592|530689036|FG007|Overall Study|Adverse Event|1|||
147142848|NCT00540592|530689037|FG008|Overall Study|Adverse Event|1|||
147142849|NCT00540592|530689038|FG009|Overall Study|Adverse Event|2|||
147142850|NCT00540592|530689029|FG000|Overall Study|Lost to Follow-up|2|||
147142851|NCT00540592|530689030|FG001|Overall Study|Lost to Follow-up|0|||
147142852|NCT00540592|530689031|FG002|Overall Study|Lost to Follow-up|0|||
147142853|NCT00540592|530689032|FG003|Overall Study|Lost to Follow-up|0|||
147142854|NCT00540592|530689033|FG004|Overall Study|Lost to Follow-up|0|||
147142855|NCT00540592|530689034|FG005|Overall Study|Lost to Follow-up|0|||
147142856|NCT00540592|530689035|FG006|Overall Study|Lost to Follow-up|0|||
147142857|NCT00540592|530689036|FG007|Overall Study|Lost to Follow-up|0|||
147142858|NCT00540592|530689037|FG008|Overall Study|Lost to Follow-up|0|||
147142859|NCT00540592|530689038|FG009|Overall Study|Lost to Follow-up|0|||
147142860|NCT00540592|530689029|FG000|Overall Study|Withdrawal by Subject|0|||
147142861|NCT00540592|530689030|FG001|Overall Study|Withdrawal by Subject|0|||
147237964|NCT02993757|531042599|FG001|Overall Study|Lost to Follow-up|0|||
147142862|NCT00540592|530689031|FG002|Overall Study|Withdrawal by Subject|1|||
147142863|NCT00540592|530689032|FG003|Overall Study|Withdrawal by Subject|1|||
147142864|NCT00540592|530689033|FG004|Overall Study|Withdrawal by Subject|0|||
147142865|NCT00540592|530689034|FG005|Overall Study|Withdrawal by Subject|0|||
147142866|NCT00540592|530689035|FG006|Overall Study|Withdrawal by Subject|0|||
147142867|NCT00540592|530689036|FG007|Overall Study|Withdrawal by Subject|0|||
147142868|NCT00540592|530689037|FG008|Overall Study|Withdrawal by Subject|0|||
147142869|NCT00540592|530689038|FG009|Overall Study|Withdrawal by Subject|0|||
147142870|NCT02168101|530689041|FG000|Overall Study|Death|2|||
147142871|NCT02168101|530689042|FG001|Overall Study|Death|2|||
147142872|NCT02168101|530689043|FG002|Overall Study|Death|1|||
147142873|NCT05507567|530689044|FG000|Randomised and Received Challenge Virus|Lost to Follow-up|0|||
147142874|NCT05507567|530689045|FG001|Randomised and Received Challenge Virus|Lost to Follow-up|0|||
147142875|NCT05507567|530689046|FG002|Randomised and Received Challenge Virus|Lost to Follow-up|1|||
147142876|NCT05507567|530689044|FG000|Randomised and Received Challenge Virus|Physician Decision|1|||
147142877|NCT05507567|530689045|FG001|Randomised and Received Challenge Virus|Physician Decision|0|||
147142878|NCT05507567|530689046|FG002|Randomised and Received Challenge Virus|Physician Decision|0|||
147237965|NCT02993757|531042598|FG000|Overall Study|Voluntary withdraw not due adverse event|8|||
147445719|NCT01500278|531797439|FG000|Week 0 - Week 12|Protocol violation on screening X-ray|1|||
147237966|NCT02993757|531042599|FG001|Overall Study|Voluntary withdraw not due adverse event|8|||
147574023|NCT00902538|532257541|FG005|4-Randomized Double-blind 2 Treatments|Withdrawal by Subject|0|||
147574024|NCT00902538|532257536|FG000|4-Randomized Double-blind 2 Treatments|Protocol Violation|0|||
147237967|NCT00190671|531042600|FG000|Overall Study|Satisfactory Response|4|||
147237968|NCT00190671|531042601|FG001|Overall Study|Satisfactory Response|7|||
147142879|NCT05507567|530689044|FG000|Randomised and Received Challenge Virus|Did not complete quarantine|1|||
147142880|NCT05507567|530689045|FG001|Randomised and Received Challenge Virus|Did not complete quarantine|0|||
147142881|NCT05507567|530689046|FG002|Randomised and Received Challenge Virus|Did not complete quarantine|0|||
147142882|NCT05507567|530689044|FG000|From Challenge Virus to End of Study|Withdrawal by Subject|0|||
147142883|NCT05507567|530689045|FG001|From Challenge Virus to End of Study|Withdrawal by Subject|2|||
147237969|NCT00190671|531042600|FG000|Overall Study|Lack of Efficacy|19|||
147142884|NCT05507567|530689046|FG002|From Challenge Virus to End of Study|Withdrawal by Subject|0|||
147142885|NCT03901963|530689047|FG000|Overall Study|Lost to Follow-up|1|||
147142886|NCT03901963|530689048|FG001|Overall Study|Lost to Follow-up|1|||
147142887|NCT03901963|530689047|FG000|Overall Study|Physician Decision|1|||
147142888|NCT03901963|530689048|FG001|Overall Study|Physician Decision|2|||
147142889|NCT03901963|530689047|FG000|Overall Study|Protocol Violation|1|||
147142890|NCT03901963|530689048|FG001|Overall Study|Protocol Violation|1|||
147142891|NCT03901963|530689047|FG000|Overall Study|Withdrawal by Subject|4|||
147142892|NCT03901963|530689048|FG001|Overall Study|Withdrawal by Subject|11|||
147142893|NCT03901963|530689047|FG000|Overall Study|Ongoing|84|||
147142894|NCT03901963|530689048|FG001|Overall Study|Ongoing|73|||
147142895|NCT03901963|530689047|FG000|Overall Study|Randomized but not treated|3|||
147142896|NCT03901963|530689048|FG001|Overall Study|Randomized but not treated|3|||
147652266|NCT02362425|532550235|FG000|Phase 1 (up to 6 Months)|Medicinal contraindication|1|||
147652267|NCT02362425|532550236|FG001|Phase 1 (up to 6 Months)|Medicinal contraindication|0|||
147142897|NCT01722994|530689051|FG000|Overall Study|Missing data|25|||
147142898|NCT01722994|530689052|FG001|Overall Study|Missing data|17|||
147142899|NCT01206140|530689056|FG000|Overall Study|Deemed ineligible due to incorrect diag.|1|||
147142900|NCT01206140|530689057|FG001|Overall Study|Deemed ineligible due to incorrect diag.|0|||
147142901|NCT01803880|530689058|FG000|Overall Study|Adverse Event|1|||
147142902|NCT01803880|530689059|FG001|Overall Study|Adverse Event|0|||
147142903|NCT01803880|530689060|FG002|Overall Study|Adverse Event|0|||
147142904|NCT01803880|530689058|FG000|Overall Study|Withdrawal by Subject|1|||
147142905|NCT01803880|530689059|FG001|Overall Study|Withdrawal by Subject|1|||
147142906|NCT01803880|530689060|FG002|Overall Study|Withdrawal by Subject|4|||
147142907|NCT01803880|530689058|FG000|Overall Study|Physician Decision|0|||
147142908|NCT01803880|530689059|FG001|Overall Study|Physician Decision|0|||
147142909|NCT01803880|530689060|FG002|Overall Study|Physician Decision|1|||
147142910|NCT01803880|530689058|FG000|Overall Study|Unable to return for follow-up visits|0|||
147142911|NCT01803880|530689059|FG001|Overall Study|Unable to return for follow-up visits|1|||
147142912|NCT01803880|530689060|FG002|Overall Study|Unable to return for follow-up visits|2|||
147142913|NCT01803880|530689058|FG000|Overall Study|Lost to Follow-up|1|||
147142914|NCT01803880|530689059|FG001|Overall Study|Lost to Follow-up|2|||
147142915|NCT01803880|530689060|FG002|Overall Study|Lost to Follow-up|3|||
147142916|NCT01803880|530689058|FG000|Overall Study|Protocol Violation|1|||
147142917|NCT01803880|530689059|FG001|Overall Study|Protocol Violation|0|||
147142918|NCT01803880|530689060|FG002|Overall Study|Protocol Violation|0|||
147142919|NCT01803880|530689058|FG000|Overall Study|Early study termination|0|||
147142920|NCT01803880|530689059|FG001|Overall Study|Early study termination|6|||
147142921|NCT01803880|530689060|FG002|Overall Study|Early study termination|5|||
147142922|NCT01803880|530689058|FG000|Overall Study|Incomplete data entry by sites|2|||
147142923|NCT01803880|530689059|FG001|Overall Study|Incomplete data entry by sites|0|||
147142924|NCT01803880|530689060|FG002|Overall Study|Incomplete data entry by sites|0|||
147142925|NCT05226598|530689062|FG000|Overall Study|Death|186|||
147142926|NCT05226598|530689063|FG001|Overall Study|Death|191|||
147142927|NCT05226598|530689062|FG000|Overall Study|Withdrawal by Subject|6|||
147142928|NCT05226598|530689063|FG001|Overall Study|Withdrawal by Subject|6|||
147142929|NCT05226598|530689062|FG000|Overall Study|Ongoing|174|||
147142930|NCT05226598|530689063|FG001|Overall Study|Ongoing|176|||
147142931|NCT02959463|530689064|FG000|Overall Study|Adverse Event|1|||
147142932|NCT02959463|530689065|FG001|Overall Study|Adverse Event|1|||
147142933|NCT02959463|530689064|FG000|Overall Study|Death|1|||
147142934|NCT02959463|530689065|FG001|Overall Study|Death|0|||
147142935|NCT02959463|530689064|FG000|Overall Study|Withdrawal by Subject|1|||
147142936|NCT02959463|530689065|FG001|Overall Study|Withdrawal by Subject|0|||
147142937|NCT01672879|530689066|FG000|Blinded Phase (Up to 240 Weeks)|Study Terminated by Sponsor|43|||
147142938|NCT01672879|530689067|FG001|Blinded Phase (Up to 240 Weeks)|Study Terminated by Sponsor|55|||
147142939|NCT01672879|530689068|FG002|Blinded Phase (Up to 240 Weeks)|Study Terminated by Sponsor|61|||
147142940|NCT01672879|530689066|FG000|Blinded Phase (Up to 240 Weeks)|Withdrew Consent|14|||
147142941|NCT01672879|530689067|FG001|Blinded Phase (Up to 240 Weeks)|Withdrew Consent|7|||
147142942|NCT01672879|530689068|FG002|Blinded Phase (Up to 240 Weeks)|Withdrew Consent|6|||
147142943|NCT01672879|530689066|FG000|Blinded Phase (Up to 240 Weeks)|Adverse Event|5|||
147142944|NCT01672879|530689067|FG001|Blinded Phase (Up to 240 Weeks)|Adverse Event|2|||
147142945|NCT01672879|530689068|FG002|Blinded Phase (Up to 240 Weeks)|Adverse Event|7|||
147142946|NCT01672879|530689066|FG000|Blinded Phase (Up to 240 Weeks)|Lost to Follow-up|4|||
147142947|NCT01672879|530689067|FG001|Blinded Phase (Up to 240 Weeks)|Lost to Follow-up|3|||
147142948|NCT01672879|530689068|FG002|Blinded Phase (Up to 240 Weeks)|Lost to Follow-up|1|||
147142949|NCT01672879|530689066|FG000|Blinded Phase (Up to 240 Weeks)|Investigator's Discretion|5|||
147142950|NCT01672879|530689067|FG001|Blinded Phase (Up to 240 Weeks)|Investigator's Discretion|0|||
147142951|NCT01672879|530689068|FG002|Blinded Phase (Up to 240 Weeks)|Investigator's Discretion|2|||
147142952|NCT01672879|530689066|FG000|Blinded Phase (Up to 240 Weeks)|Death|0|||
147318658|NCT01824472|531331784|FG002|Overall Study|Withdrawal by Subject|3|||
147142953|NCT01672879|530689067|FG001|Blinded Phase (Up to 240 Weeks)|Death|2|||
147142954|NCT01672879|530689068|FG002|Blinded Phase (Up to 240 Weeks)|Death|0|||
147318659|NCT01824472|531331782|FG000|Overall Study|Ineligible post randomization&screening|0|||
147652268|NCT02362425|532550237|FG002|Phase 1 (up to 6 Months)|Medicinal contraindication|0|||
147652269|NCT02362425|532550238|FG003|Phase 1 (up to 6 Months)|Medicinal contraindication|0|||
147652270|NCT02362425|532550235|FG000|Phase 1 (up to 6 Months)|Screening failure|1|||
147652271|NCT02362425|532550236|FG001|Phase 1 (up to 6 Months)|Screening failure|0|||
147652272|NCT02362425|532550237|FG002|Phase 1 (up to 6 Months)|Screening failure|0|||
147652273|NCT02362425|532550238|FG003|Phase 1 (up to 6 Months)|Screening failure|0|||
147652274|NCT02362425|532550235|FG000|Phase 1 (up to 6 Months)|Confirmatory genetic testing negative|3|||
147652275|NCT02362425|532550236|FG001|Phase 1 (up to 6 Months)|Confirmatory genetic testing negative|0|||
147652276|NCT02362425|532550237|FG002|Phase 1 (up to 6 Months)|Confirmatory genetic testing negative|0|||
147652277|NCT02362425|532550238|FG003|Phase 1 (up to 6 Months)|Confirmatory genetic testing negative|0|||
147652278|NCT02362425|532550235|FG000|Phase 1 (up to 6 Months)|Study closure|9|||
147652279|NCT02362425|532550236|FG001|Phase 1 (up to 6 Months)|Study closure|0|||
147652280|NCT02362425|532550237|FG002|Phase 1 (up to 6 Months)|Study closure|0|||
147652281|NCT02362425|532550238|FG003|Phase 1 (up to 6 Months)|Study closure|0|||
147652282|NCT02362425|532550235|FG000|Phase 2 (up to 6 Months, Randomized)|Adverse Event|0|||
147652283|NCT02362425|532550236|FG001|Phase 2 (up to 6 Months, Randomized)|Adverse Event|0|||
147652284|NCT02362425|532550237|FG002|Phase 2 (up to 6 Months, Randomized)|Adverse Event|0|||
147652285|NCT02362425|532550238|FG003|Phase 2 (up to 6 Months, Randomized)|Adverse Event|2|||
147652286|NCT02362425|532550235|FG000|Phase 2 (up to 6 Months, Randomized)|Withdrawal by Subject|0|||
147652287|NCT02362425|532550236|FG001|Phase 2 (up to 6 Months, Randomized)|Withdrawal by Subject|0|||
147652288|NCT02362425|532550237|FG002|Phase 2 (up to 6 Months, Randomized)|Withdrawal by Subject|0|||
147652289|NCT02362425|532550238|FG003|Phase 2 (up to 6 Months, Randomized)|Withdrawal by Subject|1|||
147652290|NCT02362425|532550235|FG000|Phase 2 (up to 6 Months, Randomized)|Discontinued study drug due to procedure|0|||
147652291|NCT02362425|532550236|FG001|Phase 2 (up to 6 Months, Randomized)|Discontinued study drug due to procedure|0|||
147652292|NCT02362425|532550237|FG002|Phase 2 (up to 6 Months, Randomized)|Discontinued study drug due to procedure|1|||
147652293|NCT02362425|532550238|FG003|Phase 2 (up to 6 Months, Randomized)|Discontinued study drug due to procedure|0|||
147652294|NCT04750278|532550241|FG000|Overall Study|Death|9|||
147652295|NCT04750278|532550242|FG001|Overall Study|Death|10|||
147652296|NCT04750278|532550243|FG002|Overall Study|Death|10|||
147652297|NCT04750278|532550241|FG000|Overall Study|Withdrawal by Subject|4|||
147652298|NCT04750278|532550242|FG001|Overall Study|Withdrawal by Subject|1|||
147652299|NCT04750278|532550243|FG002|Overall Study|Withdrawal by Subject|2|||
147652300|NCT04750278|532550241|FG000|Overall Study|Lost to Follow-up|1|||
147652301|NCT04750278|532550242|FG001|Overall Study|Lost to Follow-up|1|||
147652302|NCT04750278|532550243|FG002|Overall Study|Lost to Follow-up|1|||
147652303|NCT04750278|532550241|FG000|Overall Study|Pregnancy|1|||
147652304|NCT04750278|532550242|FG001|Overall Study|Pregnancy|0|||
147652305|NCT04750278|532550243|FG002|Overall Study|Pregnancy|0|||
147652306|NCT04750278|532550241|FG000|Overall Study|Withdrawal by Legally Authorized Representative|0|||
147652307|NCT04750278|532550242|FG001|Overall Study|Withdrawal by Legally Authorized Representative|1|||
147652308|NCT04750278|532550243|FG002|Overall Study|Withdrawal by Legally Authorized Representative|0|||
147652309|NCT04750278|532550241|FG000|Overall Study|Non-compliance|0|||
147652310|NCT04750278|532550242|FG001|Overall Study|Non-compliance|0|||
147652311|NCT04750278|532550243|FG002|Overall Study|Non-compliance|1|||
147652312|NCT04750278|532550241|FG000|Overall Study|Transfer to Outside Facility|0|||
147652313|NCT04750278|532550242|FG001|Overall Study|Transfer to Outside Facility|2|||
147652314|NCT04750278|532550243|FG002|Overall Study|Transfer to Outside Facility|1|||
147142955|NCT01672879|530689066|FG000|Blinded Phase (Up to 240 Weeks)|Missing|1|||
147142956|NCT01672879|530689067|FG001|Blinded Phase (Up to 240 Weeks)|Missing|0|||
147142957|NCT01672879|530689068|FG002|Blinded Phase (Up to 240 Weeks)|Missing|0|||
147142958|NCT01672879|530689066|FG000|Blinded Phase (Up to 240 Weeks)|Randomized but Never Treated|0|||
147142959|NCT01672879|530689067|FG001|Blinded Phase (Up to 240 Weeks)|Randomized but Never Treated|0|||
147142960|NCT01672879|530689068|FG002|Blinded Phase (Up to 240 Weeks)|Randomized but Never Treated|1|||
147142961|NCT01672879|530689066|FG000|Blinded Phase (Up to 240 Weeks)|Met Protocol-Specified Reason(s)|15|||
147142962|NCT01672879|530689067|FG001|Blinded Phase (Up to 240 Weeks)|Met Protocol-Specified Reason(s)|17|||
147142963|NCT01672879|530689068|FG002|Blinded Phase (Up to 240 Weeks)|Met Protocol-Specified Reason(s)|8|||
147142964|NCT01672879|530689066|FG000|Open-Label Phase (Up to 240 Weeks)|Study Terminated by Sponsor|8|||
147142965|NCT01672879|530689067|FG001|Open-Label Phase (Up to 240 Weeks)|Study Terminated by Sponsor|16|||
147142966|NCT01672879|530689068|FG002|Open-Label Phase (Up to 240 Weeks)|Study Terminated by Sponsor|6|||
147237970|NCT00190671|531042601|FG001|Overall Study|Lack of Efficacy|24|||
147237971|NCT00190671|531042600|FG000|Overall Study|Death from Study Disease|1|||
147237972|NCT00190671|531042601|FG001|Overall Study|Death from Study Disease|1|||
147652315|NCT04750278|532550241|FG000|Overall Study|Staff Inadvertently Failed to Follow up with Subject Visits|0|||
147652316|NCT04750278|532550242|FG001|Overall Study|Staff Inadvertently Failed to Follow up with Subject Visits|1|||
147142967|NCT01672879|530689066|FG000|Open-Label Phase (Up to 240 Weeks)|Adverse Event|5|||
147142968|NCT01672879|530689067|FG001|Open-Label Phase (Up to 240 Weeks)|Adverse Event|1|||
147142969|NCT01672879|530689068|FG002|Open-Label Phase (Up to 240 Weeks)|Adverse Event|1|||
147237973|NCT00190671|531042600|FG000|Overall Study|Adverse Event|3|||
147142970|NCT01672879|530689066|FG000|Open-Label Phase (Up to 240 Weeks)|Investigator's Discretion|1|||
147142971|NCT01672879|530689067|FG001|Open-Label Phase (Up to 240 Weeks)|Investigator's Discretion|0|||
147142972|NCT01672879|530689068|FG002|Open-Label Phase (Up to 240 Weeks)|Investigator's Discretion|1|||
147142973|NCT01672879|530689066|FG000|Open-Label Phase (Up to 240 Weeks)|Progressive Disease|1|||
147142974|NCT01672879|530689067|FG001|Open-Label Phase (Up to 240 Weeks)|Progressive Disease|0|||
147142975|NCT01672879|530689068|FG002|Open-Label Phase (Up to 240 Weeks)|Progressive Disease|0|||
147142976|NCT05384834|530689073|FG000|Overall Study|Lost to Follow-up|43|||
147142977|NCT05384834|530689073|FG000|Overall Study|Withdrawal by Subject|5|||
147142978|NCT03951766|530689074|FG000|Treatment Phase|Lost to Follow-up|1|||
147142979|NCT03951766|530689074|FG000|Follow-up Phase|Lost to Follow-up|10|||
147237974|NCT00190671|531042601|FG001|Overall Study|Adverse Event|2|||
147237975|NCT00190671|531042600|FG000|Overall Study|Clinical Relapse|0|||
147237976|NCT00190671|531042601|FG001|Overall Study|Clinical Relapse|1|||
147237977|NCT00190671|531042600|FG000|Overall Study|Death from Study-Drug Toxicity|0|||
147237978|NCT00190671|531042601|FG001|Overall Study|Death from Study-Drug Toxicity|2|||
147237979|NCT00190671|531042600|FG000|Overall Study|Death from Other Causes|0|||
147237980|NCT00190671|531042601|FG001|Overall Study|Death from Other Causes|2|||
147237981|NCT00190671|531042600|FG000|Overall Study|Protocol Violation|0|||
147237982|NCT00190671|531042601|FG001|Overall Study|Protocol Violation|1|||
147237983|NCT00190671|531042600|FG000|Overall Study|Withdrawal by Subject|0|||
147237984|NCT00190671|531042601|FG001|Overall Study|Withdrawal by Subject|2|||
147237985|NCT04502433|531042602|FG000|Overall Study|Death|2|||
147237986|NCT04502433|531042603|FG001|Overall Study|Death|4|||
147237987|NCT04502433|531042602|FG000|Overall Study|Lost to Follow-up|1|||
147237988|NCT04502433|531042603|FG001|Overall Study|Lost to Follow-up|0|||
147318660|NCT01824472|531331783|FG001|Overall Study|Ineligible post randomization&screening|2|||
147318661|NCT01824472|531331784|FG002|Overall Study|Ineligible post randomization&screening|0|||
147318662|NCT01815736|531331785|FG000|Randomized Treatment Phase-Up to Week 96|Withdrew Consent|11|||
147318663|NCT01815736|531331786|FG001|Randomized Treatment Phase-Up to Week 96|Withdrew Consent|17|||
147318664|NCT01815736|531331785|FG000|Randomized Treatment Phase-Up to Week 96|Lost to Follow-up|10|||
147318665|NCT01815736|531331786|FG001|Randomized Treatment Phase-Up to Week 96|Lost to Follow-up|9|||
147318666|NCT01815736|531331785|FG000|Randomized Treatment Phase-Up to Week 96|Investigator's Discretion|11|||
147318667|NCT01815736|531331786|FG001|Randomized Treatment Phase-Up to Week 96|Investigator's Discretion|2|||
147318668|NCT01815736|531331785|FG000|Randomized Treatment Phase-Up to Week 96|Adverse Event|7|||
147318669|NCT01815736|531331786|FG001|Randomized Treatment Phase-Up to Week 96|Adverse Event|4|||
147574025|NCT00902538|532257537|FG001|4-Randomized Double-blind 2 Treatments|Protocol Violation|0|||
147574026|NCT00902538|532257538|FG002|4-Randomized Double-blind 2 Treatments|Protocol Violation|0|||
147142980|NCT01871545|530689075|FG000|Overall Study|Death|2|||
147142981|NCT01871545|530689076|FG001|Overall Study|Death|0|||
147142982|NCT01871545|530689075|FG000|Overall Study|Lack of Efficacy|11|||
147142983|NCT01871545|530689076|FG001|Overall Study|Lack of Efficacy|2|||
147142984|NCT01871545|530689075|FG000|Overall Study|Physician Decision|4|||
147142985|NCT01871545|530689076|FG001|Overall Study|Physician Decision|0|||
147142986|NCT01871545|530689075|FG000|Overall Study|Withdrawal by Subject|0|||
147142987|NCT01871545|530689076|FG001|Overall Study|Withdrawal by Subject|1|||
147142988|NCT01523743|530689077|FG000|Period 1|Adverse Event|1|||
147142989|NCT01523743|530689078|FG001|Period 1|Adverse Event|0|||
147142990|NCT01523743|530689077|FG000|Period 1|Withdrawal by Subject|6|||
147142991|NCT01523743|530689078|FG001|Period 1|Withdrawal by Subject|2|||
147142992|NCT01523743|530689077|FG000|Period 1|Lost to Follow-up|1|||
147142993|NCT01523743|530689078|FG001|Period 1|Lost to Follow-up|0|||
147142994|NCT01523743|530689077|FG000|Period 1|Lack of Efficacy|1|||
147142995|NCT01523743|530689078|FG001|Period 1|Lack of Efficacy|0|||
147142996|NCT01523743|530689077|FG000|Period 1|Felt unable to empty bladder|1|||
147142997|NCT01523743|530689078|FG001|Period 1|Felt unable to empty bladder|0|||
147142998|NCT01523743|530689077|FG000|Period 2|Withdrawal by Subject|0|||
147142999|NCT01523743|530689078|FG001|Period 2|Withdrawal by Subject|2|||
147143000|NCT01523743|530689077|FG000|Period 2|Adverse Event|1|||
147143001|NCT01523743|530689078|FG001|Period 2|Adverse Event|0|||
147143002|NCT05710640|530689081|FG000|Overall Study|Physician Decision|0|||
147143003|NCT05710640|530689082|FG001|Overall Study|Physician Decision|1|||
147143004|NCT05710640|530689081|FG000|Overall Study|Withdrawal by Subject|1|||
147143005|NCT05710640|530689082|FG001|Overall Study|Withdrawal by Subject|0|||
147143006|NCT05710640|530689081|FG000|Overall Study|Withdrew prior to first device stimulation|1|||
147143007|NCT05710640|530689082|FG001|Overall Study|Withdrew prior to first device stimulation|0|||
147143008|NCT04188509|530689083|FG000|Overall Study|Adverse Event|2|||
147237989|NCT04502433|531042602|FG000|Overall Study|Physician Decision|0|||
147237990|NCT04502433|531042603|FG001|Overall Study|Physician Decision|1|||
147237991|NCT00672646|531042606|FG000|Overall Study|Lost to Follow-up|0|||
147237992|NCT00672646|531042607|FG001|Overall Study|Lost to Follow-up|1|||
147237993|NCT00672646|531042608|FG002|Overall Study|Lost to Follow-up|2|||
147143009|NCT04188509|530689083|FG000|Overall Study|Lost to Follow-up|1|||
147143010|NCT04188509|530689083|FG000|Overall Study|Withdrawal of Consent|1|||
147143011|NCT04188509|530689083|FG000|Overall Study|Discretion of Investigator|1|||
147237994|NCT00672646|531042606|FG000|Overall Study|Withdrawal by Subject|0|||
147143012|NCT04188509|530689083|FG000|Overall Study|Noncompliance|3|||
147143013|NCT04188509|530689083|FG000|Overall Study|Sponsor Decision|127|||
147143014|NCT04188509|530689083|FG000|Overall Study|Other|2|||
147143015|NCT04847843|530689084|FG000|Overall Study|Scheduling Conflicts|6|||
147143016|NCT04847843|530689085|FG001|Overall Study|Scheduling Conflicts|9|||
147143017|NCT04847843|530689084|FG000|Overall Study|Withdrawal by Subject|1|||
147143018|NCT04847843|530689085|FG001|Overall Study|Withdrawal by Subject|0|||
147143019|NCT04847843|530689084|FG000|Overall Study|Lost to Follow-up|1|||
147143020|NCT04847843|530689085|FG001|Overall Study|Lost to Follow-up|1|||
147143021|NCT04847843|530689084|FG000|Overall Study|Pregnancy|0|||
147143022|NCT04847843|530689085|FG001|Overall Study|Pregnancy|2|||
147143023|NCT04847843|530689084|FG000|Overall Study|Discovered not eligible - recent cancer diagnosis|0|||
147143024|NCT04847843|530689085|FG001|Overall Study|Discovered not eligible - recent cancer diagnosis|1|||
147143025|NCT02734004|530689086|FG000|Overall Study|Death|36|||
147143026|NCT02734004|530689087|FG001|Overall Study|Death|24|||
147143027|NCT02734004|530689088|FG002|Overall Study|Death|26|||
147143028|NCT02734004|530689089|FG003|Overall Study|Death|35|||
147143029|NCT02734004|530689090|FG004|Overall Study|Death|13|||
147143030|NCT02734004|530689091|FG005|Overall Study|Death|17|||
147143031|NCT02734004|530689092|FG006|Overall Study|Death|20|||
147143032|NCT02734004|530689086|FG000|Overall Study|Lost to Follow-up|1|||
147143033|NCT02734004|530689087|FG001|Overall Study|Lost to Follow-up|1|||
147143034|NCT02734004|530689088|FG002|Overall Study|Lost to Follow-up|0|||
147143035|NCT02734004|530689089|FG003|Overall Study|Lost to Follow-up|0|||
147143036|NCT02734004|530689090|FG004|Overall Study|Lost to Follow-up|1|||
147143037|NCT02734004|530689091|FG005|Overall Study|Lost to Follow-up|0|||
147143038|NCT02734004|530689092|FG006|Overall Study|Lost to Follow-up|0|||
147143039|NCT02734004|530689086|FG000|Overall Study|Withdrawal by Subject|3|||
147143040|NCT02734004|530689087|FG001|Overall Study|Withdrawal by Subject|1|||
147143041|NCT02734004|530689088|FG002|Overall Study|Withdrawal by Subject|1|||
147143042|NCT02734004|530689089|FG003|Overall Study|Withdrawal by Subject|1|||
147143043|NCT02734004|530689090|FG004|Overall Study|Withdrawal by Subject|3|||
147143044|NCT02734004|530689091|FG005|Overall Study|Withdrawal by Subject|0|||
147143045|NCT02734004|530689092|FG006|Overall Study|Withdrawal by Subject|2|||
147143046|NCT02734004|530689086|FG000|Overall Study|Other|0|||
147143047|NCT02734004|530689087|FG001|Overall Study|Other|8|||
147143048|NCT02734004|530689088|FG002|Overall Study|Other|7|||
147143049|NCT02734004|530689089|FG003|Overall Study|Other|4|||
147143050|NCT02734004|530689090|FG004|Overall Study|Other|34|||
147143051|NCT02734004|530689091|FG005|Overall Study|Other|14|||
147143052|NCT02734004|530689092|FG006|Overall Study|Other|10|||
147143053|NCT05615220|530689093|FG000|Open label stabilization Part (12 weeks)|Failure to meet responder criteria|36|||
147143054|NCT05615220|530689094|FG001|Open label stabilization Part (12 weeks)|Failure to meet responder criteria|0|||
147143055|NCT05615220|530689095|FG002|Open label stabilization Part (12 weeks)|Failure to meet responder criteria|0|||
147143056|NCT05615220|530689093|FG000|Open label stabilization Part (12 weeks)|Study end once relapsed goal met|21|||
147143057|NCT05615220|530689094|FG001|Open label stabilization Part (12 weeks)|Study end once relapsed goal met|0|||
147143058|NCT05615220|530689095|FG002|Open label stabilization Part (12 weeks)|Study end once relapsed goal met|0|||
147143059|NCT05615220|530689093|FG000|Open label stabilization Part (12 weeks)|Adverse Event|33|||
147143060|NCT05615220|530689094|FG001|Open label stabilization Part (12 weeks)|Adverse Event|0|||
147143061|NCT05615220|530689095|FG002|Open label stabilization Part (12 weeks)|Adverse Event|0|||
147143062|NCT05615220|530689093|FG000|Open label stabilization Part (12 weeks)|Withdrawal by Subject|6|||
147143063|NCT05615220|530689094|FG001|Open label stabilization Part (12 weeks)|Withdrawal by Subject|0|||
147143064|NCT05615220|530689095|FG002|Open label stabilization Part (12 weeks)|Withdrawal by Subject|0|||
147143065|NCT05615220|530689093|FG000|Open label stabilization Part (12 weeks)|Non-compliance with study drug|1|||
147143066|NCT05615220|530689094|FG001|Open label stabilization Part (12 weeks)|Non-compliance with study drug|0|||
147143067|NCT05615220|530689095|FG002|Open label stabilization Part (12 weeks)|Non-compliance with study drug|0|||
147237995|NCT00672646|531042607|FG001|Overall Study|Withdrawal by Subject|0|||
147237996|NCT00672646|531042608|FG002|Overall Study|Withdrawal by Subject|1|||
147237997|NCT00289783|531042609|FG000|Primary Phase|Adverse Event|10|||
147237998|NCT00289783|531042610|FG001|Primary Phase|Adverse Event|1|||
147237999|NCT00289783|531042609|FG000|Primary Phase|Protocol Violation|27|||
147238000|NCT00289783|531042610|FG001|Primary Phase|Protocol Violation|6|||
147238001|NCT00289783|531042609|FG000|Primary Phase|Withdrawal by Subject|93|||
147238002|NCT00289783|531042610|FG001|Primary Phase|Withdrawal by Subject|40|||
147238003|NCT00289783|531042609|FG000|Primary Phase|Lost to Follow-up|60|||
147238004|NCT00289783|531042610|FG001|Primary Phase|Lost to Follow-up|14|||
147238005|NCT00289783|531042609|FG000|Primary Phase|Migration from the study area|26|||
147143068|NCT05615220|530689093|FG000|Open label stabilization Part (12 weeks)|Physician Decision|1|||
147143069|NCT05615220|530689094|FG001|Open label stabilization Part (12 weeks)|Physician Decision|0|||
147143070|NCT05615220|530689095|FG002|Open label stabilization Part (12 weeks)|Physician Decision|0|||
147143071|NCT05615220|530689093|FG000|Open label stabilization Part (12 weeks)|Lost to Follow-up|3|||
147238006|NCT00289783|531042610|FG001|Primary Phase|Migration from the study area|10|||
147238007|NCT00289783|531042609|FG000|Primary Phase|Other|32|||
147238008|NCT00289783|531042610|FG001|Primary Phase|Other|12|||
147143072|NCT05615220|530689094|FG001|Open label stabilization Part (12 weeks)|Lost to Follow-up|0|||
147143073|NCT05615220|530689095|FG002|Open label stabilization Part (12 weeks)|Lost to Follow-up|0|||
147143074|NCT05615220|530689093|FG000|Open label stabilization Part (12 weeks)|Protocol Deviation|1|||
147143075|NCT05615220|530689094|FG001|Open label stabilization Part (12 weeks)|Protocol Deviation|0|||
147143076|NCT05615220|530689095|FG002|Open label stabilization Part (12 weeks)|Protocol Deviation|0|||
147143077|NCT05615220|530689093|FG000|Open label stabilization Part (12 weeks)|Other|6|||
147143078|NCT05615220|530689094|FG001|Open label stabilization Part (12 weeks)|Other|0|||
147143079|NCT05615220|530689095|FG002|Open label stabilization Part (12 weeks)|Other|0|||
147143080|NCT05615220|530689093|FG000|Open label stabilization Part (12 weeks)|Lack of Efficacy|4|||
147143081|NCT05615220|530689094|FG001|Open label stabilization Part (12 weeks)|Lack of Efficacy|0|||
147143082|NCT05615220|530689095|FG002|Open label stabilization Part (12 weeks)|Lack of Efficacy|0|||
147143083|NCT05615220|530689093|FG000|Double Blind R/WD Part (12-24 weeks)|Relapsed|0|||
147143084|NCT05615220|530689094|FG001|Double Blind R/WD Part (12-24 weeks)|Relapsed|21|||
147143085|NCT05615220|530689095|FG002|Double Blind R/WD Part (12-24 weeks)|Relapsed|36|||
147143086|NCT05615220|530689093|FG000|Double Blind R/WD Part (12-24 weeks)|Adverse Event|0|||
147143087|NCT05615220|530689094|FG001|Double Blind R/WD Part (12-24 weeks)|Adverse Event|1|||
147143088|NCT05615220|530689095|FG002|Double Blind R/WD Part (12-24 weeks)|Adverse Event|1|||
147143089|NCT05615220|530689093|FG000|Double Blind R/WD Part (12-24 weeks)|Withdrawal by Subject|0|||
147143090|NCT05615220|530689094|FG001|Double Blind R/WD Part (12-24 weeks)|Withdrawal by Subject|1|||
147143091|NCT05615220|530689095|FG002|Double Blind R/WD Part (12-24 weeks)|Withdrawal by Subject|0|||
147143092|NCT05615220|530689093|FG000|Double Blind R/WD Part (12-24 weeks)|Study end once relapsed goal met|0|||
147143093|NCT05615220|530689094|FG001|Double Blind R/WD Part (12-24 weeks)|Study end once relapsed goal met|6|||
147143094|NCT05615220|530689095|FG002|Double Blind R/WD Part (12-24 weeks)|Study end once relapsed goal met|2|||
147143095|NCT05615220|530689093|FG000|Double Blind R/WD Part (12-24 weeks)|Other|0|||
147143096|NCT05615220|530689094|FG001|Double Blind R/WD Part (12-24 weeks)|Other|1|||
147143097|NCT05615220|530689095|FG002|Double Blind R/WD Part (12-24 weeks)|Other|1|||
147143098|NCT01282866|530689104|FG000|Overall Study|Adverse Event|1|||
147143099|NCT01541865|530689106|FG000|Overall Study|Lost to Follow-up|11|||
147143100|NCT01541865|530689106|FG000|Overall Study|Withdrawal by Subject|9|||
147143101|NCT01541865|530689106|FG000|Overall Study|Adverse Event|1|||
147143102|NCT01541865|530689106|FG000|Overall Study|Protocol Violation|1|||
147143103|NCT01393899|530689110|FG000|Overall Study|Study terminated by sponsor|1|||
147143104|NCT01393899|530689111|FG001|Overall Study|Study terminated by sponsor|0|||
147143105|NCT01393899|530689112|FG002|Overall Study|Study terminated by sponsor|1|||
147652317|NCT04750278|532550243|FG002|Overall Study|Staff Inadvertently Failed to Follow up with Subject Visits|0|||
147652318|NCT04750278|532550241|FG000|Overall Study|Patient Hospitalized Secondary to Unrelated SAE and Did Not Have Study Medication|0|||
147652319|NCT04750278|532550242|FG001|Overall Study|Patient Hospitalized Secondary to Unrelated SAE and Did Not Have Study Medication|0|||
147652320|NCT04750278|532550243|FG002|Overall Study|Patient Hospitalized Secondary to Unrelated SAE and Did Not Have Study Medication|1|||
147652321|NCT03026283|532550244|FG000|CCTA Diagnosis|CCTA not performed as planned|9|||
147652322|NCT03026283|532550245|FG001|CCTA Diagnosis|CCTA not performed as planned|0|||
147652323|NCT03026283|532550246|FG002|CCTA Diagnosis|CCTA not performed as planned|0|||
147652324|NCT03026283|532550247|FG003|CCTA Diagnosis|CCTA not performed as planned|0|||
147652325|NCT03026283|532550248|FG004|CCTA Diagnosis|CCTA not performed as planned|0|||
147652326|NCT03026283|532550249|FG005|CCTA Diagnosis|CCTA not performed as planned|0|||
147652327|NCT03026283|532550250|FG006|CCTA Diagnosis|CCTA not performed as planned|0|||
147652328|NCT03026283|532550251|FG007|CCTA Diagnosis|CCTA not performed as planned|0|||
147652329|NCT03026283|532550244|FG000|CCTA Diagnosis|Withdrawal by Subject|5|||
147652330|NCT03026283|532550245|FG001|CCTA Diagnosis|Withdrawal by Subject|0|||
147652331|NCT03026283|532550246|FG002|CCTA Diagnosis|Withdrawal by Subject|0|||
147652332|NCT03026283|532550247|FG003|CCTA Diagnosis|Withdrawal by Subject|0|||
147143106|NCT01393899|530689110|FG000|Overall Study|Other|1|||
147143107|NCT01393899|530689111|FG001|Overall Study|Other|0|||
147143108|NCT01393899|530689112|FG002|Overall Study|Other|0|||
147143109|NCT01393899|530689110|FG000|Overall Study|Withdrawal by Subject|2|||
147143110|NCT01393899|530689111|FG001|Overall Study|Withdrawal by Subject|2|||
147238009|NCT00289783|531042609|FG000|Fourth Dose Phase|Adverse Event|1|||
147238010|NCT00289783|531042610|FG001|Fourth Dose Phase|Adverse Event|0|||
147238011|NCT00289783|531042609|FG000|Fourth Dose Phase|Withdrawal by Subject|10|||
147445720|NCT01500278|531797440|FG001|Week 0 - Week 12|Protocol violation on screening X-ray|0|||
147143111|NCT01393899|530689112|FG002|Overall Study|Withdrawal by Subject|1|||
147143112|NCT01393899|530689110|FG000|Overall Study|Lost to Follow-up|0|||
147143113|NCT01393899|530689111|FG001|Overall Study|Lost to Follow-up|0|||
147143114|NCT01393899|530689112|FG002|Overall Study|Lost to Follow-up|1|||
147143115|NCT01393899|530689110|FG000|Overall Study|Does not meet entrance criteria|1|||
147143116|NCT01393899|530689111|FG001|Overall Study|Does not meet entrance criteria|0|||
147238012|NCT00289783|531042610|FG001|Fourth Dose Phase|Withdrawal by Subject|1|||
147445721|NCT01500278|531797439|FG000|Week 0 - Week 12|Patient decision|1|||
147445722|NCT01500278|531797440|FG001|Week 0 - Week 12|Patient decision|0|||
147445723|NCT01500278|531797439|FG000|Week 0 - Week 12|Exclusion criteria not met|1|||
147143117|NCT01393899|530689112|FG002|Overall Study|Does not meet entrance criteria|1|||
147143118|NCT01393899|530689110|FG000|Overall Study|Lack of Efficacy|26|||
147143119|NCT01393899|530689111|FG001|Overall Study|Lack of Efficacy|21|||
147143120|NCT01393899|530689112|FG002|Overall Study|Lack of Efficacy|16|||
147143121|NCT01393899|530689110|FG000|Overall Study|Adverse Event|1|||
147143122|NCT01393899|530689111|FG001|Overall Study|Adverse Event|5|||
147143123|NCT01393899|530689112|FG002|Overall Study|Adverse Event|3|||
147143124|NCT00049257|530689115|FG000|Carboplatin, Paclitaxel|Withdrawal by Subject|10|||
147143125|NCT00049257|530689115|FG000|Carboplatin, Paclitaxel|Lost to Follow-up|1|||
147143126|NCT00049257|530689115|FG000|Carboplatin, Paclitaxel|Death|2|||
147143127|NCT00049257|530689115|FG000|Follow-up Period for Survival Status|Lost to Follow-up|4|||
147143128|NCT04721158|530689116|FG000|Overall Study|Lost to Follow-up|4|||
147143129|NCT04721158|530689116|FG000|Overall Study|Device did not connect|1|||
147143130|NCT00132301|530689117|FG000|Overall Study|Death|7|||
147143131|NCT00132301|530689118|FG001|Overall Study|Death|6|||
147143132|NCT00132301|530689117|FG000|Overall Study|Withdrawal by Subject|5|||
147143133|NCT00132301|530689118|FG001|Overall Study|Withdrawal by Subject|2|||
147143134|NCT00132301|530689117|FG000|Overall Study|Physician Decision|1|||
147143135|NCT00132301|530689118|FG001|Overall Study|Physician Decision|1|||
147143136|NCT00132301|530689117|FG000|Overall Study|Lost to Follow-up|5|||
147143137|NCT00132301|530689118|FG001|Overall Study|Lost to Follow-up|3|||
147143138|NCT00132301|530689117|FG000|Overall Study|Other|1|||
147143139|NCT00132301|530689118|FG001|Overall Study|Other|1|||
147143140|NCT00132301|530689117|FG000|Overall Study|Excluded by Data Monitoring Committee|1|||
147143141|NCT00132301|530689118|FG001|Overall Study|Excluded by Data Monitoring Committee|0|||
147143142|NCT04108208|530689126|FG000|Overall Study|Withdrawal by Subject|2|||
147143143|NCT04108208|530689127|FG001|Overall Study|Withdrawal by Subject|6|||
147143144|NCT04108208|530689126|FG000|Overall Study|other-ongoing|20|||
147143145|NCT04108208|530689127|FG001|Overall Study|other-ongoing|40|||
147143146|NCT04108208|530689126|FG000|Overall Study|Death|1|||
147143147|NCT04108208|530689127|FG001|Overall Study|Death|4|||
147143148|NCT04108208|530689126|FG000|Overall Study|Lost to Follow-up|2|||
147143149|NCT04108208|530689127|FG001|Overall Study|Lost to Follow-up|0|||
147143150|NCT01402869|530689133|FG000|Overall Study|Required Tooth Extraction|0|||
147143151|NCT01402869|530689134|FG001|Overall Study|Required Tooth Extraction|0|||
147143152|NCT01402869|530689135|FG002|Overall Study|Required Tooth Extraction|1|||
147143153|NCT01142388|530690808|FG000|Overall Study|Lack of Efficacy|21|||
147143154|NCT01142388|530690809|FG001|Overall Study|Lack of Efficacy|31|||
147143155|NCT01142388|530690808|FG000|Overall Study|Adverse Event|9|||
147143156|NCT01142388|530690809|FG001|Overall Study|Adverse Event|5|||
147143157|NCT01142388|530690808|FG000|Overall Study|Death|3|||
147143158|NCT01142388|530690809|FG001|Overall Study|Death|2|||
147143159|NCT01142388|530690808|FG000|Overall Study|Withdrawal by Subject|5|||
147143160|NCT01142388|530690809|FG001|Overall Study|Withdrawal by Subject|3|||
147143161|NCT01142388|530690808|FG000|Overall Study|Alternative therapy|1|||
147143162|NCT01142388|530690809|FG001|Overall Study|Alternative therapy|0|||
147143163|NCT01142388|530690808|FG000|Overall Study|Other complications|0|||
147143164|NCT01142388|530690809|FG001|Overall Study|Other complications|2|||
147143165|NCT01142388|530690808|FG000|Overall Study|Other|1|||
147143166|NCT01142388|530690809|FG001|Overall Study|Other|1|||
147143167|NCT01142388|530690808|FG000|Overall Study|Never started therapy|7|||
147143168|NCT01142388|530690809|FG001|Overall Study|Never started therapy|3|||
147143169|NCT05730725|530690810|FG000|Overall Study|Withdrawal by Subject|3|||
147143170|NCT05730725|530690811|FG001|Overall Study|Withdrawal by Subject|0|||
147143171|NCT05730725|530690812|FG002|Overall Study|Withdrawal by Subject|0|||
147143172|NCT05730725|530690813|FG003|Overall Study|Withdrawal by Subject|1|||
147143173|NCT05730725|530690810|FG000|Overall Study|Not Reported|1|||
147143174|NCT05730725|530690811|FG001|Overall Study|Not Reported|1|||
147143175|NCT05730725|530690812|FG002|Overall Study|Not Reported|1|||
147143176|NCT05730725|530690813|FG003|Overall Study|Not Reported|1|||
147143177|NCT05265728|530690814|FG000|Overall Study|Adverse Event|1|||
147143178|NCT05265728|530690814|FG000|Overall Study|Study Terminated by Sponsor|5|||
147143179|NCT05265728|530690814|FG000|Overall Study|Withdrawal by Subject|2|||
147143180|NCT03687957|530690815|FG000|Overall Study|Withdrawal by Subject|0|||
147143181|NCT03687957|530690816|FG001|Overall Study|Withdrawal by Subject|0|||
147143182|NCT03687957|530690817|FG002|Overall Study|Withdrawal by Subject|0|||
147143183|NCT03687957|530690818|FG003|Overall Study|Withdrawal by Subject|2|||
147143184|NCT03687957|530690819|FG004|Overall Study|Withdrawal by Subject|0|||
147143185|NCT03687957|530690820|FG005|Overall Study|Withdrawal by Subject|0|||
147143186|NCT03687957|530690821|FG006|Overall Study|Withdrawal by Subject|3|||
147143187|NCT03687957|530690822|FG007|Overall Study|Withdrawal by Subject|1|||
147143188|NCT03687957|530690823|FG008|Overall Study|Withdrawal by Subject|1|||
147143189|NCT03687957|530690824|FG009|Overall Study|Withdrawal by Subject|0|||
147143190|NCT03687957|530690815|FG000|Overall Study|Disease progression|0|||
147143191|NCT03687957|530690816|FG001|Overall Study|Disease progression|1|||
147143192|NCT03687957|530690817|FG002|Overall Study|Disease progression|1|||
147143193|NCT03687957|530690818|FG003|Overall Study|Disease progression|2|||
147143194|NCT03687957|530690819|FG004|Overall Study|Disease progression|2|||
147143195|NCT03687957|530690820|FG005|Overall Study|Disease progression|0|||
147143196|NCT03687957|530690821|FG006|Overall Study|Disease progression|2|||
147143197|NCT03687957|530690822|FG007|Overall Study|Disease progression|1|||
147143198|NCT03687957|530690823|FG008|Overall Study|Disease progression|0|||
147143199|NCT03687957|530690824|FG009|Overall Study|Disease progression|0|||
147143200|NCT03687957|530690815|FG000|Overall Study|Physician Decision|0|||
147143201|NCT03687957|530690816|FG001|Overall Study|Physician Decision|0|||
147143202|NCT03687957|530690817|FG002|Overall Study|Physician Decision|0|||
147143203|NCT03687957|530690818|FG003|Overall Study|Physician Decision|2|||
147143204|NCT03687957|530690819|FG004|Overall Study|Physician Decision|1|||
147143205|NCT03687957|530690820|FG005|Overall Study|Physician Decision|0|||
147143206|NCT03687957|530690821|FG006|Overall Study|Physician Decision|1|||
147143207|NCT03687957|530690822|FG007|Overall Study|Physician Decision|0|||
147143208|NCT03687957|530690823|FG008|Overall Study|Physician Decision|0|||
147143209|NCT03687957|530690824|FG009|Overall Study|Physician Decision|0|||
147143210|NCT03687957|530690815|FG000|Overall Study|New malignancy|0|||
147143211|NCT03687957|530690816|FG001|Overall Study|New malignancy|0|||
147143212|NCT03687957|530690817|FG002|Overall Study|New malignancy|0|||
147143213|NCT03687957|530690818|FG003|Overall Study|New malignancy|0|||
147652333|NCT03026283|532550248|FG004|CCTA Diagnosis|Withdrawal by Subject|0|||
147143214|NCT03687957|530690819|FG004|Overall Study|New malignancy|1|||
147143215|NCT03687957|530690820|FG005|Overall Study|New malignancy|0|||
147143216|NCT03687957|530690821|FG006|Overall Study|New malignancy|0|||
147143217|NCT03687957|530690822|FG007|Overall Study|New malignancy|0|||
147143218|NCT03687957|530690823|FG008|Overall Study|New malignancy|0|||
147143219|NCT03687957|530690824|FG009|Overall Study|New malignancy|0|||
147143220|NCT03687957|530690815|FG000|Overall Study|Adverse Event|0|||
147143221|NCT03687957|530690816|FG001|Overall Study|Adverse Event|0|||
147143222|NCT03687957|530690817|FG002|Overall Study|Adverse Event|0|||
147143223|NCT03687957|530690818|FG003|Overall Study|Adverse Event|0|||
147143224|NCT03687957|530690819|FG004|Overall Study|Adverse Event|0|||
147143225|NCT03687957|530690820|FG005|Overall Study|Adverse Event|2|||
147143226|NCT03687957|530690821|FG006|Overall Study|Adverse Event|0|||
147143227|NCT03687957|530690822|FG007|Overall Study|Adverse Event|3|||
147143228|NCT03687957|530690823|FG008|Overall Study|Adverse Event|0|||
147143229|NCT03687957|530690824|FG009|Overall Study|Adverse Event|0|||
147143230|NCT03687957|530690815|FG000|Overall Study|Patient went on hospice|0|||
147143231|NCT03687957|530690816|FG001|Overall Study|Patient went on hospice|0|||
147143232|NCT03687957|530690817|FG002|Overall Study|Patient went on hospice|0|||
147143233|NCT03687957|530690818|FG003|Overall Study|Patient went on hospice|0|||
147143234|NCT03687957|530690819|FG004|Overall Study|Patient went on hospice|0|||
147652334|NCT03026283|532550249|FG005|CCTA Diagnosis|Withdrawal by Subject|0|||
147652335|NCT03026283|532550250|FG006|CCTA Diagnosis|Withdrawal by Subject|0|||
147652336|NCT03026283|532550251|FG007|CCTA Diagnosis|Withdrawal by Subject|0|||
147143235|NCT03687957|530690820|FG005|Overall Study|Patient went on hospice|0|||
147143236|NCT03687957|530690821|FG006|Overall Study|Patient went on hospice|1|||
147445724|NCT01500278|531797440|FG001|Week 0 - Week 12|Exclusion criteria not met|0|||
147652337|NCT03026283|532550244|FG000|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
147143237|NCT03687957|530690822|FG007|Overall Study|Patient went on hospice|0|||
147143238|NCT03687957|530690823|FG008|Overall Study|Patient went on hospice|0|||
147143239|NCT03687957|530690824|FG009|Overall Study|Patient went on hospice|0|||
147143240|NCT03687957|530690815|FG000|Overall Study|Death|0|||
147143241|NCT03687957|530690816|FG001|Overall Study|Death|0|||
147143242|NCT03687957|530690817|FG002|Overall Study|Death|0|||
147143243|NCT03687957|530690818|FG003|Overall Study|Death|0|||
147143244|NCT03687957|530690819|FG004|Overall Study|Death|0|||
147143245|NCT03687957|530690820|FG005|Overall Study|Death|0|||
147143246|NCT03687957|530690821|FG006|Overall Study|Death|0|||
147143247|NCT03687957|530690822|FG007|Overall Study|Death|1|||
147143248|NCT03687957|530690823|FG008|Overall Study|Death|0|||
147143249|NCT03687957|530690824|FG009|Overall Study|Death|0|||
147143250|NCT03052608|530690828|FG000|Treatment Phase|Adverse Event|10|||
147143251|NCT03052608|530690829|FG001|Treatment Phase|Adverse Event|12|||
147143252|NCT03052608|530690828|FG000|Treatment Phase|Death|6|||
147143253|NCT03052608|530690829|FG001|Treatment Phase|Death|4|||
147143254|NCT03052608|530690828|FG000|Treatment Phase|Withdrawal by Subject|4|||
147143255|NCT03052608|530690829|FG001|Treatment Phase|Withdrawal by Subject|12|||
147143256|NCT03052608|530690828|FG000|Treatment Phase|Global Deterioration of Health Status|0|||
147143257|NCT03052608|530690829|FG001|Treatment Phase|Global Deterioration of Health Status|3|||
147143258|NCT03052608|530690828|FG000|Treatment Phase|Subject decided to continue study treatment as per clinical practice in another hospital.|0|||
147143259|NCT03052608|530690829|FG001|Treatment Phase|Subject decided to continue study treatment as per clinical practice in another hospital.|1|||
147143260|NCT03052608|530690828|FG000|Treatment Phase|Subject didn't receive study treatment.|0|||
147143261|NCT03052608|530690829|FG001|Treatment Phase|Subject didn't receive study treatment.|1|||
147143262|NCT03052608|530690828|FG000|Treatment Phase|Ongoing|103|||
147143263|NCT03052608|530690829|FG001|Treatment Phase|Ongoing|31|||
147143264|NCT03052608|530690828|FG000|Long-Term Follow-up Phase|Death|23|||
147143265|NCT03052608|530690829|FG001|Long-Term Follow-up Phase|Death|28|||
147143266|NCT03052608|530690828|FG000|Long-Term Follow-up Phase|Lost to Follow-up|0|||
147143267|NCT03052608|530690829|FG001|Long-Term Follow-up Phase|Lost to Follow-up|2|||
147143268|NCT03052608|530690828|FG000|Long-Term Follow-up Phase|Withdrawal by Subject|4|||
147143269|NCT03052608|530690829|FG001|Long-Term Follow-up Phase|Withdrawal by Subject|18|||
147143270|NCT03052608|530690828|FG000|Long-Term Follow-up Phase|Ongoing|122|||
147143271|NCT03052608|530690829|FG001|Long-Term Follow-up Phase|Ongoing|99|||
147143272|NCT04667949|530690830|FG000|Overall Study|Adverse Event|0|||
147143273|NCT04667949|530690831|FG001|Overall Study|Adverse Event|2|||
147143274|NCT04667949|530690830|FG000|Overall Study|Lost to Follow-up|0|||
147143275|NCT04667949|530690831|FG001|Overall Study|Lost to Follow-up|1|||
147143276|NCT04667949|530690830|FG000|Overall Study|Physician Decision|0|||
147143277|NCT04667949|530690831|FG001|Overall Study|Physician Decision|2|||
147143278|NCT04667949|530690830|FG000|Overall Study|Subject decision|1|||
147143279|NCT04667949|530690831|FG001|Overall Study|Subject decision|7|||
147143280|NCT02213926|530690832|FG000|Overall Study|Death|59|||
147143281|NCT02213926|530690832|FG000|Overall Study|Withdrawal by Subject|10|||
147143282|NCT02213926|530690832|FG000|Overall Study|study terminated by sponsor|51|||
147143283|NCT02213926|530690832|FG000|Overall Study|Lost to Follow-up|3|||
147143284|NCT02213926|530690832|FG000|Overall Study|SITE CLOSURE - PI RETIREMENT|1|||
147143285|NCT01273038|530690833|FG000|Second Intervention (14 Days)|Adverse Event|0|||
147143286|NCT01273038|530690834|FG001|Second Intervention (14 Days)|Adverse Event|1|||
147143287|NCT01273038|530690833|FG000|Second Intervention (14 Days)|Withdrawal by Subject|0|||
147143288|NCT01273038|530690834|FG001|Second Intervention (14 Days)|Withdrawal by Subject|1|||
147143289|NCT05887908|530690835|FG000|Overall Study|Adverse Event|6|||
147143290|NCT05887908|530690836|FG001|Overall Study|Adverse Event|1|||
147143291|NCT05887908|530690837|FG002|Overall Study|Adverse Event|1|||
147143292|NCT05887908|530690835|FG000|Overall Study|Physician Decision|4|||
147143293|NCT05887908|530690836|FG001|Overall Study|Physician Decision|1|||
147143294|NCT05887908|530690837|FG002|Overall Study|Physician Decision|0|||
147143295|NCT05887908|530690835|FG000|Overall Study|Withdrawal by Subject|3|||
147143296|NCT05887908|530690836|FG001|Overall Study|Withdrawal by Subject|2|||
147143297|NCT05887908|530690837|FG002|Overall Study|Withdrawal by Subject|3|||
147143298|NCT05887908|530690835|FG000|Overall Study|Ineligibility after the start of the study|4|||
147143299|NCT05887908|530690836|FG001|Overall Study|Ineligibility after the start of the study|1|||
147143300|NCT05887908|530690837|FG002|Overall Study|Ineligibility after the start of the study|0|||
147143301|NCT05887908|530690835|FG000|Overall Study|Subject non-compliance|4|||
147143302|NCT05887908|530690836|FG001|Overall Study|Subject non-compliance|0|||
147143303|NCT05887908|530690837|FG002|Overall Study|Subject non-compliance|4|||
147143304|NCT05887908|530690835|FG000|Overall Study|Grew only a Gram-negative organism resistant to imipenem and/or meropenem|0|||
147143305|NCT05887908|530690836|FG001|Overall Study|Grew only a Gram-negative organism resistant to imipenem and/or meropenem|0|||
147143306|NCT05887908|530690837|FG002|Overall Study|Grew only a Gram-negative organism resistant to imipenem and/or meropenem|1|||
147143307|NCT05887908|530690835|FG000|Overall Study|Pregnancy|0|||
147143308|NCT05887908|530690836|FG001|Overall Study|Pregnancy|1|||
147143309|NCT05887908|530690837|FG002|Overall Study|Pregnancy|0|||
147143310|NCT05887908|530690835|FG000|Overall Study|Required Use of Prohibited Concomitant Medications|1|||
147143311|NCT05887908|530690836|FG001|Overall Study|Required Use of Prohibited Concomitant Medications|0|||
147143312|NCT05887908|530690837|FG002|Overall Study|Required Use of Prohibited Concomitant Medications|0|||
147143313|NCT05887908|530690835|FG000|Overall Study|Significant prolongation of the QT/QTc interval|0|||
147143314|NCT05887908|530690836|FG001|Overall Study|Significant prolongation of the QT/QTc interval|1|||
147143315|NCT05887908|530690837|FG002|Overall Study|Significant prolongation of the QT/QTc interval|0|||
147143316|NCT05887908|530690835|FG000|Overall Study|Other Reason|3|||
147143317|NCT05887908|530690836|FG001|Overall Study|Other Reason|3|||
147143318|NCT05887908|530690837|FG002|Overall Study|Other Reason|3|||
147143319|NCT02630693|530690840|FG000|Overall Study|No receive treatment|0|||
147143320|NCT02630693|530690841|FG001|Overall Study|No receive treatment|1|||
147143321|NCT04423939|530690842|FG000|Overall Study|Still on study (but completed primary endpoint)|8|||
147143322|NCT04423939|530690843|FG001|Overall Study|Still on study (but completed primary endpoint)|8|||
147143323|NCT04423939|530690842|FG000|Overall Study|Death|3|||
147143324|NCT04423939|530690843|FG001|Overall Study|Death|0|||
147143325|NCT04423939|530690842|FG000|Overall Study|Withdrawal by Subject|3|||
147143326|NCT04423939|530690843|FG001|Overall Study|Withdrawal by Subject|0|||
147143327|NCT04423939|530690842|FG000|Overall Study|Caregiver to patient who died|0|||
147143328|NCT04423939|530690843|FG001|Overall Study|Caregiver to patient who died|3|||
147238013|NCT00289783|531042609|FG000|Fourth Dose Phase|Lost to Follow-up|53|||
147143329|NCT04423939|530690842|FG000|Overall Study|Caregiver to patient who withdrew|0|||
147143330|NCT04423939|530690843|FG001|Overall Study|Caregiver to patient who withdrew|3|||
147143331|NCT01134614|530690844|FG000|Overall Study|Still on treatment as of March 2013|21|||
147143332|NCT01134614|530690845|FG001|Overall Study|Still on treatment as of March 2013|13|||
147143333|NCT01134614|530690844|FG000|Overall Study|Progressive disease|60|||
147143334|NCT01134614|530690845|FG001|Overall Study|Progressive disease|54|||
147143335|NCT01134614|530690844|FG000|Overall Study|Adverse Event|26|||
147143336|NCT01134614|530690845|FG001|Overall Study|Adverse Event|39|||
147143337|NCT01134614|530690844|FG000|Overall Study|Death|5|||
147238014|NCT00289783|531042610|FG001|Fourth Dose Phase|Lost to Follow-up|12|||
147143338|NCT01134614|530690845|FG001|Overall Study|Death|8|||
147143339|NCT01134614|530690844|FG000|Overall Study|Withdrawal by Subject|3|||
147143340|NCT01134614|530690845|FG001|Overall Study|Withdrawal by Subject|2|||
147143341|NCT01134614|530690844|FG000|Overall Study|Alternative therapy|2|||
147143342|NCT01134614|530690845|FG001|Overall Study|Alternative therapy|0|||
147143343|NCT01134614|530690844|FG000|Overall Study|Complicating disease|2|||
147143344|NCT01134614|530690845|FG001|Overall Study|Complicating disease|1|||
147143345|NCT01134614|530690844|FG000|Overall Study|Physician's decision|0|||
147143346|NCT01134614|530690845|FG001|Overall Study|Physician's decision|1|||
147143347|NCT01134614|530690844|FG000|Overall Study|Never started treatment|4|||
147143348|NCT01134614|530690845|FG001|Overall Study|Never started treatment|1|||
147143349|NCT01134614|530690844|FG000|Overall Study|Pt received tx not allowed on study|0|||
147143350|NCT01134614|530690845|FG001|Overall Study|Pt received tx not allowed on study|1|||
147143351|NCT01134614|530690844|FG000|Overall Study|Symptomatic deterioration|0|||
147143352|NCT01134614|530690845|FG001|Overall Study|Symptomatic deterioration|1|||
147143353|NCT01134614|530690844|FG000|Overall Study|Patient in hospice care|0|||
147143354|NCT01134614|530690845|FG001|Overall Study|Patient in hospice care|1|||
147143355|NCT01766037|530690848|FG000|Overall Study|Adverse Event|1|||
147143356|NCT01766037|530690849|FG001|Overall Study|Adverse Event|0|||
147143357|NCT01766037|530690848|FG000|Overall Study|Lack of Efficacy|1|||
147143358|NCT01766037|530690849|FG001|Overall Study|Lack of Efficacy|0|||
147143359|NCT01766037|530690848|FG000|Overall Study|Lost to Follow-up|0|||
147143360|NCT01766037|530690849|FG001|Overall Study|Lost to Follow-up|10|||
147143361|NCT01766037|530690848|FG000|Overall Study|Physician Decision|0|||
147143362|NCT01766037|530690849|FG001|Overall Study|Physician Decision|1|||
147143363|NCT01766037|530690848|FG000|Overall Study|Withdrawal by Subject|18|||
147143364|NCT01766037|530690849|FG001|Overall Study|Withdrawal by Subject|16|||
147143365|NCT01766037|530690848|FG000|Overall Study|Moved from area|5|||
147143366|NCT01766037|530690849|FG001|Overall Study|Moved from area|0|||
147143367|NCT01766037|530690848|FG000|Overall Study|medical - unrelated|1|||
147143368|NCT01766037|530690849|FG001|Overall Study|medical - unrelated|2|||
147143369|NCT01766037|530690848|FG000|Overall Study|nausea / discomfort|3|||
147143370|NCT01766037|530690849|FG001|Overall Study|nausea / discomfort|0|||
147143371|NCT04503551|530690850|FG000|Overall Study|Withdrawal by Subject|5|||
147143372|NCT04503551|530690851|FG001|Overall Study|Withdrawal by Subject|3|||
147143373|NCT04503551|530690850|FG000|Overall Study|Physician Decision|1|||
147143374|NCT04503551|530690851|FG001|Overall Study|Physician Decision|0|||
147143375|NCT04503551|530690850|FG000|Overall Study|Death|0|||
147143376|NCT04503551|530690851|FG001|Overall Study|Death|1|||
147143377|NCT04503551|530690850|FG000|Overall Study|Lost to Follow-up|1|||
147143378|NCT04503551|530690851|FG001|Overall Study|Lost to Follow-up|2|||
147143379|NCT04503551|530690850|FG000|Overall Study|Ongoing at Week 52|99|||
147143380|NCT04503551|530690851|FG001|Overall Study|Ongoing at Week 52|62|||
147143381|NCT04158375|530690859|FG000|Overall Study|Withdrawal by Subject|0|||
147143382|NCT04158375|530690860|FG001|Overall Study|Withdrawal by Subject|3|||
147143383|NCT04158375|530690861|FG002|Overall Study|Withdrawal by Subject|0|||
147143384|NCT01152788|530690862|FG000|Overall Study|Withdrawal by Subject|0|||
147143385|NCT01152788|530690863|FG001|Overall Study|Withdrawal by Subject|3|||
147143386|NCT01152788|530690862|FG000|Overall Study|No treatment|0|||
147143387|NCT01152788|530690863|FG001|Overall Study|No treatment|1|||
147143388|NCT01272037|530690871|FG000|Overall Study|Death|25|||
147143389|NCT01272037|530690872|FG001|Overall Study|Death|28|||
147143390|NCT01272037|530690871|FG000|Overall Study|Adverse Event|12|||
147143391|NCT01272037|530690872|FG001|Overall Study|Adverse Event|7|||
147143392|NCT01272037|530690871|FG000|Overall Study|Withdrawal by Subject|175|||
147143393|NCT01272037|530690872|FG001|Overall Study|Withdrawal by Subject|93|||
147143394|NCT01272037|530690871|FG000|Overall Study|Disease progression|70|||
147143395|NCT01272037|530690872|FG001|Overall Study|Disease progression|111|||
147143396|NCT01272037|530690871|FG000|Overall Study|Other reason|42|||
147238015|NCT00289783|531042609|FG000|Fourth Dose Phase|Migration from the study area|1|||
147238016|NCT00289783|531042610|FG001|Fourth Dose Phase|Migration from the study area|1|||
147445725|NCT01500278|531797439|FG000|Week 0 - Week 12|Investigator decision|1|||
147445726|NCT01500278|531797440|FG001|Week 0 - Week 12|Investigator decision|0|||
147143397|NCT01272037|530690872|FG001|Overall Study|Other reason|41|||
147143398|NCT01272037|530690871|FG000|Overall Study|Delinquent data|24|||
147143399|NCT01272037|530690872|FG001|Overall Study|Delinquent data|19|||
147143400|NCT01272037|530690871|FG000|Overall Study|Reason under review|33|||
147143401|NCT01272037|530690872|FG001|Overall Study|Reason under review|29|||
147143402|NCT01272037|530690871|FG000|Overall Study|On treatment|626|||
147143403|NCT01272037|530690872|FG001|Overall Study|On treatment|632|||
147143404|NCT01890265|530690873|FG000|Overall Study|Other (Unspecified reason)|0|||
147143405|NCT01890265|530690874|FG001|Overall Study|Other (Unspecified reason)|1|||
147143406|NCT01890265|530690875|FG002|Overall Study|Other (Unspecified reason)|0|||
147143407|NCT01890265|530690876|FG003|Overall Study|Other (Unspecified reason)|0|||
147238017|NCT00289783|531042609|FG000|Fourth Dose Phase|Other|22|||
147143408|NCT01890265|530690877|FG004|Overall Study|Other (Unspecified reason)|0|||
147143409|NCT01890265|530690878|FG005|Overall Study|Other (Unspecified reason)|0|||
147143410|NCT01890265|530690873|FG000|Overall Study|Progressive disease|6|||
147143411|NCT01890265|530690874|FG001|Overall Study|Progressive disease|6|||
147143412|NCT01890265|530690875|FG002|Overall Study|Progressive disease|0|||
147143413|NCT01890265|530690876|FG003|Overall Study|Progressive disease|0|||
147143414|NCT01890265|530690877|FG004|Overall Study|Progressive disease|0|||
147143415|NCT01890265|530690878|FG005|Overall Study|Progressive disease|0|||
147143416|NCT01890265|530690873|FG000|Overall Study|Adverse Event|2|||
147143417|NCT01890265|530690874|FG001|Overall Study|Adverse Event|1|||
147143418|NCT01890265|530690875|FG002|Overall Study|Adverse Event|0|||
147143419|NCT01890265|530690876|FG003|Overall Study|Adverse Event|0|||
147143420|NCT01890265|530690877|FG004|Overall Study|Adverse Event|0|||
147143421|NCT01890265|530690878|FG005|Overall Study|Adverse Event|0|||
147143422|NCT01890265|530690873|FG000|Overall Study|Death|2|||
147143423|NCT01890265|530690874|FG001|Overall Study|Death|3|||
147143424|NCT01890265|530690875|FG002|Overall Study|Death|1|||
147143425|NCT01890265|530690876|FG003|Overall Study|Death|0|||
147143426|NCT01890265|530690877|FG004|Overall Study|Death|0|||
147143427|NCT01890265|530690878|FG005|Overall Study|Death|0|||
147143428|NCT01890265|530690873|FG000|Overall Study|Withdrawal by Subject|0|||
147143429|NCT01890265|530690874|FG001|Overall Study|Withdrawal by Subject|2|||
147143430|NCT01890265|530690875|FG002|Overall Study|Withdrawal by Subject|3|||
147143431|NCT01890265|530690876|FG003|Overall Study|Withdrawal by Subject|0|||
147143432|NCT01890265|530690877|FG004|Overall Study|Withdrawal by Subject|2|||
147143433|NCT01890265|530690878|FG005|Overall Study|Withdrawal by Subject|0|||
147143434|NCT04585269|530690881|FG000|Intervention|Withdrawal by Subject|9|||
147143435|NCT04585269|530690882|FG001|Intervention|Withdrawal by Subject|0|||
147143436|NCT04585269|530690881|FG000|Intervention|Unable to schedule|15|||
147143437|NCT04585269|530690882|FG001|Intervention|Unable to schedule|0|||
147143438|NCT04585269|530690881|FG000|Intervention|Started but did not finish (<4 sessions)|24|||
147143439|NCT04585269|530690882|FG001|Intervention|Started but did not finish (<4 sessions)|0|||
147143440|NCT04585269|530690881|FG000|FU Time 2 (3 months)|Death|2|||
147143441|NCT04585269|530690882|FG001|FU Time 2 (3 months)|Death|2|||
147143442|NCT04585269|530690881|FG000|FU Time 2 (3 months)|Lost to Follow-up|14|||
147143443|NCT04585269|530690882|FG001|FU Time 2 (3 months)|Lost to Follow-up|17|||
147143444|NCT04585269|530690881|FG000|FU Time 2 (3 months)|Withdrawal by Subject|4|||
147143445|NCT04585269|530690882|FG001|FU Time 2 (3 months)|Withdrawal by Subject|0|||
147143446|NCT04585269|530690881|FG000|FU Time 3 (6 months) Primary outcomes|Death|4|||
147143447|NCT04585269|530690882|FG001|FU Time 3 (6 months) Primary outcomes|Death|1|||
147143448|NCT04585269|530690881|FG000|FU Time 3 (6 months) Primary outcomes|Lost to Follow-up|16|||
147143449|NCT04585269|530690882|FG001|FU Time 3 (6 months) Primary outcomes|Lost to Follow-up|24|||
147143450|NCT04585269|530690881|FG000|FU Time 3 (6 months) Primary outcomes|Physician Decision|2|||
147143451|NCT04585269|530690882|FG001|FU Time 3 (6 months) Primary outcomes|Physician Decision|0|||
147143452|NCT03462719|530690885|FG000|Overall Study|Withdrawal by Subject|4|||
147143453|NCT03462719|530690886|FG001|Overall Study|Withdrawal by Subject|3|||
147143454|NCT03462719|530690885|FG000|Overall Study|Ongoing|87|||
147143455|NCT03462719|530690886|FG001|Overall Study|Ongoing|72|||
147143456|NCT04271540|530690887|FG000|Overall Study|Lost to Follow-up|1|||
147143457|NCT04271540|530690887|FG000|Overall Study|Screen Fail|5|||
147143458|NCT03307785|530690888|FG000|Main Study: Part A: Up to 28.5 Months|Disease progression|2|||
147143459|NCT03307785|530690889|FG001|Main Study: Part A: Up to 28.5 Months|Disease progression|0|||
147143460|NCT03307785|530690890|FG002|Main Study: Part A: Up to 28.5 Months|Disease progression|0|||
147143461|NCT03307785|530690891|FG003|Main Study: Part A: Up to 28.5 Months|Disease progression|0|||
147143462|NCT03307785|530690892|FG004|Main Study: Part A: Up to 28.5 Months|Disease progression|0|||
147143463|NCT03307785|530690893|FG005|Main Study: Part A: Up to 28.5 Months|Disease progression|0|||
147143464|NCT03307785|530690894|FG006|Main Study: Part A: Up to 28.5 Months|Disease progression|0|||
147143465|NCT03307785|530690895|FG007|Main Study: Part A: Up to 28.5 Months|Disease progression|0|||
147143466|NCT03307785|530690896|FG008|Main Study: Part A: Up to 28.5 Months|Disease progression|0|||
147143467|NCT03307785|530690897|FG009|Main Study: Part A: Up to 28.5 Months|Disease progression|0|||
147143468|NCT03307785|530690898|FG010|Main Study: Part A: Up to 28.5 Months|Disease progression|0|||
147143469|NCT03307785|530690899|FG011|Main Study: Part A: Up to 28.5 Months|Disease progression|0|||
147143470|NCT03307785|530690900|FG012|Main Study: Part A: Up to 28.5 Months|Disease progression|0|||
147143471|NCT03307785|530690888|FG000|Main Study: Part A: Up to 28.5 Months|Withdrawal by Subject|7|||
147143472|NCT03307785|530690889|FG001|Main Study: Part A: Up to 28.5 Months|Withdrawal by Subject|1|||
147143473|NCT03307785|530690890|FG002|Main Study: Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
147238018|NCT00289783|531042610|FG001|Fourth Dose Phase|Other|10|||
147238019|NCT00660699|531042611|FG000|Overall Study|Withdrawal by Subject|2|||
147238020|NCT06934993|531042614|FG000|Overall Study|Withdrawal by Subject|29|||
147143474|NCT03307785|530690891|FG003|Main Study: Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
147143475|NCT03307785|530690892|FG004|Main Study: Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
147143476|NCT03307785|530690893|FG005|Main Study: Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
147143477|NCT03307785|530690894|FG006|Main Study: Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
147238021|NCT06934993|531042614|FG000|Overall Study|elevated postoperative creatinine level|11|||
147238022|NCT06934993|531042614|FG000|Overall Study|Death|3|||
147574027|NCT00902538|532257539|FG003|4-Randomized Double-blind 2 Treatments|Protocol Violation|3|||
147143478|NCT03307785|530690895|FG007|Main Study: Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
147143479|NCT03307785|530690896|FG008|Main Study: Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
147143480|NCT03307785|530690897|FG009|Main Study: Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
147143481|NCT03307785|530690898|FG010|Main Study: Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
147143482|NCT03307785|530690899|FG011|Main Study: Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
147143483|NCT03307785|530690900|FG012|Main Study: Part A: Up to 28.5 Months|Withdrawal by Subject|0|||
147143484|NCT03307785|530690888|FG000|Main Study: Part A: Up to 28.5 Months|Death|4|||
147143485|NCT03307785|530690889|FG001|Main Study: Part A: Up to 28.5 Months|Death|4|||
147143486|NCT03307785|530690890|FG002|Main Study: Part A: Up to 28.5 Months|Death|0|||
147143487|NCT03307785|530690891|FG003|Main Study: Part A: Up to 28.5 Months|Death|0|||
147143488|NCT03307785|530690892|FG004|Main Study: Part A: Up to 28.5 Months|Death|0|||
147143489|NCT03307785|530690893|FG005|Main Study: Part A: Up to 28.5 Months|Death|0|||
147143490|NCT03307785|530690894|FG006|Main Study: Part A: Up to 28.5 Months|Death|0|||
147143491|NCT03307785|530690895|FG007|Main Study: Part A: Up to 28.5 Months|Death|0|||
147143492|NCT03307785|530690896|FG008|Main Study: Part A: Up to 28.5 Months|Death|0|||
147143493|NCT03307785|530690897|FG009|Main Study: Part A: Up to 28.5 Months|Death|0|||
147143494|NCT03307785|530690898|FG010|Main Study: Part A: Up to 28.5 Months|Death|0|||
147143495|NCT03307785|530690899|FG011|Main Study: Part A: Up to 28.5 Months|Death|0|||
147143496|NCT03307785|530690900|FG012|Main Study: Part A: Up to 28.5 Months|Death|0|||
147143497|NCT03307785|530690888|FG000|Main Study: Part A: Up to 28.5 Months|Physician Decision|3|||
147143498|NCT03307785|530690889|FG001|Main Study: Part A: Up to 28.5 Months|Physician Decision|1|||
147143499|NCT03307785|530690890|FG002|Main Study: Part A: Up to 28.5 Months|Physician Decision|0|||
147143500|NCT03307785|530690891|FG003|Main Study: Part A: Up to 28.5 Months|Physician Decision|0|||
147143501|NCT03307785|530690892|FG004|Main Study: Part A: Up to 28.5 Months|Physician Decision|0|||
147143502|NCT03307785|530690893|FG005|Main Study: Part A: Up to 28.5 Months|Physician Decision|0|||
147143503|NCT03307785|530690894|FG006|Main Study: Part A: Up to 28.5 Months|Physician Decision|0|||
147238023|NCT03128047|531042615|FG000|Overall Study|Withdrawal by Subject|1|||
147238024|NCT01153347|531044061|FG000|Overall Study|Withdrawal by Subject|7|||
147238025|NCT01153347|531044062|FG001|Overall Study|Withdrawal by Subject|7|||
147238026|NCT01153347|531044063|FG002|Overall Study|Withdrawal by Subject|7|||
147238027|NCT01153347|531044064|FG003|Overall Study|Withdrawal by Subject|7|||
147238028|NCT01153347|531044061|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
147238029|NCT01153347|531044062|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
147238030|NCT01153347|531044063|FG002|Overall Study|Eligibility criteria not fulfilled|2|||
147238031|NCT01153347|531044064|FG003|Overall Study|Eligibility criteria not fulfilled|1|||
147574028|NCT00902538|532257540|FG004|4-Randomized Double-blind 2 Treatments|Protocol Violation|0|||
147574029|NCT00902538|532257541|FG005|4-Randomized Double-blind 2 Treatments|Protocol Violation|0|||
147574030|NCT00830258|532258986|FG000|First Intervention|Adverse Event|1|||
147574031|NCT00830258|532258987|FG001|First Intervention|Adverse Event|0|||
147574032|NCT00830258|532258986|FG000|Washout: 7 Days|Protocol Violation|1|||
147574033|NCT00830258|532258987|FG001|Washout: 7 Days|Protocol Violation|0|||
147574034|NCT03206749|532258990|FG000|Overall Study|Withdrawal of consent|5|||
147574035|NCT03206749|532258991|FG001|Overall Study|Withdrawal of consent|3|||
147574036|NCT03206749|532258992|FG002|Overall Study|Withdrawal of consent|6|||
147574037|NCT03206749|532258990|FG000|Overall Study|Lost to Follow-up|0|||
147574038|NCT03206749|532258991|FG001|Overall Study|Lost to Follow-up|0|||
147574039|NCT03206749|532258992|FG002|Overall Study|Lost to Follow-up|1|||
147574040|NCT02752074|532258993|FG000|Overall Study|Lost to Follow-up|1|||
147574041|NCT02752074|532258994|FG001|Overall Study|Lost to Follow-up|4|||
147574042|NCT02752074|532258993|FG000|Overall Study|Death|146|||
147574043|NCT02752074|532258994|FG001|Overall Study|Death|129|||
147574044|NCT02752074|532258993|FG000|Overall Study|Withdrawal by Subject|9|||
147574045|NCT02752074|532258994|FG001|Overall Study|Withdrawal by Subject|10|||
147574046|NCT00488774|532258995|FG000|Overall Study|Withdrawal of consent|2|||
147574047|NCT00488774|532258996|FG001|Overall Study|Withdrawal of consent|2|||
147574048|NCT00488774|532258997|FG002|Overall Study|Withdrawal of consent|2|||
147238032|NCT01153347|531044061|FG000|Overall Study|Adverse Event|3|||
147238033|NCT01153347|531044062|FG001|Overall Study|Adverse Event|9|||
147238034|NCT01153347|531044063|FG002|Overall Study|Adverse Event|21|||
147238035|NCT01153347|531044064|FG003|Overall Study|Adverse Event|7|||
147238036|NCT01153347|531044061|FG000|Overall Study|Severe non-compliance to protocol|6|||
147238037|NCT01153347|531044062|FG001|Overall Study|Severe non-compliance to protocol|7|||
147574049|NCT00488774|532258998|FG003|Overall Study|Withdrawal of consent|0|||
147574050|NCT00488774|532258995|FG000|Overall Study|Other|6|||
147143504|NCT03307785|530690895|FG007|Main Study: Part A: Up to 28.5 Months|Physician Decision|0|||
147238038|NCT01153347|531044063|FG002|Overall Study|Severe non-compliance to protocol|4|||
147238039|NCT01153347|531044064|FG003|Overall Study|Severe non-compliance to protocol|3|||
147238040|NCT01153347|531044061|FG000|Overall Study|Condition under investigation worsened|1|||
147574051|NCT00488774|532258996|FG001|Overall Study|Other|3|||
147574052|NCT00488774|532258997|FG002|Overall Study|Other|2|||
147574053|NCT00488774|532258998|FG003|Overall Study|Other|2|||
147574054|NCT00488774|532258995|FG000|Overall Study|Lost to Follow-up|0|||
147143505|NCT03307785|530690896|FG008|Main Study: Part A: Up to 28.5 Months|Physician Decision|0|||
147143506|NCT03307785|530690897|FG009|Main Study: Part A: Up to 28.5 Months|Physician Decision|0|||
147143507|NCT03307785|530690898|FG010|Main Study: Part A: Up to 28.5 Months|Physician Decision|0|||
147143508|NCT03307785|530690899|FG011|Main Study: Part A: Up to 28.5 Months|Physician Decision|0|||
147143509|NCT03307785|530690900|FG012|Main Study: Part A: Up to 28.5 Months|Physician Decision|0|||
147143510|NCT03307785|530690888|FG000|MainStudy: PartB: Up to Approx.66months|Disease progression|0|||
147143511|NCT03307785|530690889|FG001|MainStudy: PartB: Up to Approx.66months|Disease progression|0|||
147143512|NCT03307785|530690890|FG002|MainStudy: PartB: Up to Approx.66months|Disease progression|2|||
147143513|NCT03307785|530690891|FG003|MainStudy: PartB: Up to Approx.66months|Disease progression|0|||
147143514|NCT03307785|530690892|FG004|MainStudy: PartB: Up to Approx.66months|Disease progression|0|||
147143515|NCT03307785|530690893|FG005|MainStudy: PartB: Up to Approx.66months|Disease progression|0|||
147143516|NCT03307785|530690894|FG006|MainStudy: PartB: Up to Approx.66months|Disease progression|0|||
147143517|NCT03307785|530690895|FG007|MainStudy: PartB: Up to Approx.66months|Disease progression|0|||
147143518|NCT03307785|530690896|FG008|MainStudy: PartB: Up to Approx.66months|Disease progression|0|||
147143519|NCT03307785|530690897|FG009|MainStudy: PartB: Up to Approx.66months|Disease progression|0|||
147143520|NCT03307785|530690898|FG010|MainStudy: PartB: Up to Approx.66months|Disease progression|0|||
147143521|NCT03307785|530690899|FG011|MainStudy: PartB: Up to Approx.66months|Disease progression|0|||
147143522|NCT03307785|530690900|FG012|MainStudy: PartB: Up to Approx.66months|Disease progression|0|||
147143523|NCT03307785|530690888|FG000|MainStudy: PartB: Up to Approx.66months|Death|0|||
147143524|NCT03307785|530690889|FG001|MainStudy: PartB: Up to Approx.66months|Death|0|||
147143525|NCT03307785|530690890|FG002|MainStudy: PartB: Up to Approx.66months|Death|7|||
147143526|NCT03307785|530690891|FG003|MainStudy: PartB: Up to Approx.66months|Death|0|||
147143527|NCT03307785|530690892|FG004|MainStudy: PartB: Up to Approx.66months|Death|0|||
147143528|NCT03307785|530690893|FG005|MainStudy: PartB: Up to Approx.66months|Death|0|||
147143529|NCT03307785|530690894|FG006|MainStudy: PartB: Up to Approx.66months|Death|0|||
147143530|NCT03307785|530690895|FG007|MainStudy: PartB: Up to Approx.66months|Death|0|||
147143531|NCT03307785|530690896|FG008|MainStudy: PartB: Up to Approx.66months|Death|0|||
147143532|NCT03307785|530690897|FG009|MainStudy: PartB: Up to Approx.66months|Death|0|||
147143533|NCT03307785|530690898|FG010|MainStudy: PartB: Up to Approx.66months|Death|0|||
147143534|NCT03307785|530690899|FG011|MainStudy: PartB: Up to Approx.66months|Death|0|||
147143535|NCT03307785|530690900|FG012|MainStudy: PartB: Up to Approx.66months|Death|0|||
147143536|NCT03307785|530690888|FG000|MainStudy: PartB: Up to Approx.66months|Withdrawal by Subject|0|||
147143537|NCT03307785|530690889|FG001|MainStudy: PartB: Up to Approx.66months|Withdrawal by Subject|0|||
147143538|NCT03307785|530690890|FG002|MainStudy: PartB: Up to Approx.66months|Withdrawal by Subject|2|||
147143539|NCT03307785|530690891|FG003|MainStudy: PartB: Up to Approx.66months|Withdrawal by Subject|0|||
147143540|NCT03307785|530690892|FG004|MainStudy: PartB: Up to Approx.66months|Withdrawal by Subject|0|||
147143541|NCT03307785|530690893|FG005|MainStudy: PartB: Up to Approx.66months|Withdrawal by Subject|0|||
147143542|NCT03307785|530690894|FG006|MainStudy: PartB: Up to Approx.66months|Withdrawal by Subject|0|||
147143543|NCT03307785|530690895|FG007|MainStudy: PartB: Up to Approx.66months|Withdrawal by Subject|0|||
147143544|NCT03307785|530690896|FG008|MainStudy: PartB: Up to Approx.66months|Withdrawal by Subject|0|||
147143545|NCT03307785|530690897|FG009|MainStudy: PartB: Up to Approx.66months|Withdrawal by Subject|0|||
147143546|NCT03307785|530690898|FG010|MainStudy: PartB: Up to Approx.66months|Withdrawal by Subject|0|||
147143547|NCT03307785|530690899|FG011|MainStudy: PartB: Up to Approx.66months|Withdrawal by Subject|0|||
147143548|NCT03307785|530690900|FG012|MainStudy: PartB: Up to Approx.66months|Withdrawal by Subject|0|||
147143549|NCT03307785|530690888|FG000|MainStudy: PartB: Up to Approx.66months|Transitioned to PACT phase|0|||
147143550|NCT03307785|530690889|FG001|MainStudy: PartB: Up to Approx.66months|Transitioned to PACT phase|0|||
147143551|NCT03307785|530690890|FG002|MainStudy: PartB: Up to Approx.66months|Transitioned to PACT phase|2|||
147143552|NCT03307785|530690891|FG003|MainStudy: PartB: Up to Approx.66months|Transitioned to PACT phase|0|||
147143553|NCT03307785|530690892|FG004|MainStudy: PartB: Up to Approx.66months|Transitioned to PACT phase|0|||
147143554|NCT03307785|530690893|FG005|MainStudy: PartB: Up to Approx.66months|Transitioned to PACT phase|0|||
147143555|NCT03307785|530690894|FG006|MainStudy: PartB: Up to Approx.66months|Transitioned to PACT phase|0|||
147143556|NCT03307785|530690895|FG007|MainStudy: PartB: Up to Approx.66months|Transitioned to PACT phase|0|||
147143557|NCT03307785|530690896|FG008|MainStudy: PartB: Up to Approx.66months|Transitioned to PACT phase|0|||
147143558|NCT03307785|530690897|FG009|MainStudy: PartB: Up to Approx.66months|Transitioned to PACT phase|0|||
147143559|NCT03307785|530690898|FG010|MainStudy: PartB: Up to Approx.66months|Transitioned to PACT phase|0|||
147143560|NCT03307785|530690899|FG011|MainStudy: PartB: Up to Approx.66months|Transitioned to PACT phase|0|||
147143561|NCT03307785|530690900|FG012|MainStudy: PartB: Up to Approx.66months|Transitioned to PACT phase|0|||
147143562|NCT03307785|530690888|FG000|MainStudy: PartB: Up to Approx.66months|Physician Decision|0|||
147143563|NCT03307785|530690889|FG001|MainStudy: PartB: Up to Approx.66months|Physician Decision|0|||
147238041|NCT01153347|531044062|FG001|Overall Study|Condition under investigation worsened|1|||
147238042|NCT01153347|531044063|FG002|Overall Study|Condition under investigation worsened|0|||
147238043|NCT01153347|531044064|FG003|Overall Study|Condition under investigation worsened|0|||
147238044|NCT01153347|531044061|FG000|Overall Study|Lack of Efficacy|2|||
147143564|NCT03307785|530690890|FG002|MainStudy: PartB: Up to Approx.66months|Physician Decision|1|||
147143565|NCT03307785|530690891|FG003|MainStudy: PartB: Up to Approx.66months|Physician Decision|0|||
147143566|NCT03307785|530690892|FG004|MainStudy: PartB: Up to Approx.66months|Physician Decision|0|||
147143567|NCT03307785|530690893|FG005|MainStudy: PartB: Up to Approx.66months|Physician Decision|0|||
147143568|NCT03307785|530690894|FG006|MainStudy: PartB: Up to Approx.66months|Physician Decision|0|||
147143569|NCT03307785|530690895|FG007|MainStudy: PartB: Up to Approx.66months|Physician Decision|0|||
147143570|NCT03307785|530690896|FG008|MainStudy: PartB: Up to Approx.66months|Physician Decision|0|||
147143571|NCT03307785|530690897|FG009|MainStudy: PartB: Up to Approx.66months|Physician Decision|0|||
147143572|NCT03307785|530690898|FG010|MainStudy: PartB: Up to Approx.66months|Physician Decision|0|||
147143573|NCT03307785|530690899|FG011|MainStudy: PartB: Up to Approx.66months|Physician Decision|0|||
147143574|NCT03307785|530690900|FG012|MainStudy: PartB: Up to Approx.66months|Physician Decision|0|||
147143575|NCT03307785|530690888|FG000|MainStudy: PartC:Up to Approx.60months|Physician Decision|0|||
147143576|NCT03307785|530690889|FG001|MainStudy: PartC:Up to Approx.60months|Physician Decision|0|||
147143577|NCT03307785|530690890|FG002|MainStudy: PartC:Up to Approx.60months|Physician Decision|0|||
147143578|NCT03307785|530690891|FG003|MainStudy: PartC:Up to Approx.60months|Physician Decision|3|||
147143579|NCT03307785|530690892|FG004|MainStudy: PartC:Up to Approx.60months|Physician Decision|1|||
147143580|NCT03307785|530690893|FG005|MainStudy: PartC:Up to Approx.60months|Physician Decision|0|||
147143581|NCT03307785|530690894|FG006|MainStudy: PartC:Up to Approx.60months|Physician Decision|0|||
147143582|NCT03307785|530690895|FG007|MainStudy: PartC:Up to Approx.60months|Physician Decision|0|||
147143583|NCT03307785|530690896|FG008|MainStudy: PartC:Up to Approx.60months|Physician Decision|0|||
147143584|NCT03307785|530690897|FG009|MainStudy: PartC:Up to Approx.60months|Physician Decision|0|||
147143585|NCT03307785|530690898|FG010|MainStudy: PartC:Up to Approx.60months|Physician Decision|0|||
147143586|NCT03307785|530690899|FG011|MainStudy: PartC:Up to Approx.60months|Physician Decision|0|||
147143587|NCT03307785|530690900|FG012|MainStudy: PartC:Up to Approx.60months|Physician Decision|0|||
147143588|NCT03307785|530690888|FG000|MainStudy: PartC:Up to Approx.60months|Death|0|||
147143589|NCT03307785|530690889|FG001|MainStudy: PartC:Up to Approx.60months|Death|0|||
147143590|NCT03307785|530690890|FG002|MainStudy: PartC:Up to Approx.60months|Death|0|||
147143591|NCT03307785|530690891|FG003|MainStudy: PartC:Up to Approx.60months|Death|2|||
147143592|NCT03307785|530690892|FG004|MainStudy: PartC:Up to Approx.60months|Death|5|||
147143593|NCT03307785|530690893|FG005|MainStudy: PartC:Up to Approx.60months|Death|0|||
147143594|NCT03307785|530690894|FG006|MainStudy: PartC:Up to Approx.60months|Death|0|||
147143595|NCT03307785|530690895|FG007|MainStudy: PartC:Up to Approx.60months|Death|0|||
147143596|NCT03307785|530690896|FG008|MainStudy: PartC:Up to Approx.60months|Death|0|||
147143597|NCT03307785|530690897|FG009|MainStudy: PartC:Up to Approx.60months|Death|0|||
147143598|NCT03307785|530690898|FG010|MainStudy: PartC:Up to Approx.60months|Death|0|||
147143599|NCT03307785|530690899|FG011|MainStudy: PartC:Up to Approx.60months|Death|0|||
147143600|NCT03307785|530690900|FG012|MainStudy: PartC:Up to Approx.60months|Death|0|||
147143601|NCT03307785|530690888|FG000|MainStudy: PartC:Up to Approx.60months|Withdrawal by Subject|0|||
147143602|NCT03307785|530690889|FG001|MainStudy: PartC:Up to Approx.60months|Withdrawal by Subject|0|||
147143603|NCT03307785|530690890|FG002|MainStudy: PartC:Up to Approx.60months|Withdrawal by Subject|0|||
147143604|NCT03307785|530690891|FG003|MainStudy: PartC:Up to Approx.60months|Withdrawal by Subject|1|||
147143605|NCT03307785|530690892|FG004|MainStudy: PartC:Up to Approx.60months|Withdrawal by Subject|0|||
147143606|NCT03307785|530690893|FG005|MainStudy: PartC:Up to Approx.60months|Withdrawal by Subject|0|||
147143607|NCT03307785|530690894|FG006|MainStudy: PartC:Up to Approx.60months|Withdrawal by Subject|0|||
147143608|NCT03307785|530690895|FG007|MainStudy: PartC:Up to Approx.60months|Withdrawal by Subject|0|||
147143609|NCT03307785|530690896|FG008|MainStudy: PartC:Up to Approx.60months|Withdrawal by Subject|0|||
147143610|NCT03307785|530690897|FG009|MainStudy: PartC:Up to Approx.60months|Withdrawal by Subject|0|||
147143611|NCT03307785|530690898|FG010|MainStudy: PartC:Up to Approx.60months|Withdrawal by Subject|0|||
147143612|NCT03307785|530690899|FG011|MainStudy: PartC:Up to Approx.60months|Withdrawal by Subject|0|||
147143613|NCT03307785|530690900|FG012|MainStudy: PartC:Up to Approx.60months|Withdrawal by Subject|0|||
147143614|NCT03307785|530690888|FG000|MainStudy: PartC:Up to Approx.60months|Went on Another Clinical Trial|0|||
147143615|NCT03307785|530690889|FG001|MainStudy: PartC:Up to Approx.60months|Went on Another Clinical Trial|0|||
147143616|NCT03307785|530690890|FG002|MainStudy: PartC:Up to Approx.60months|Went on Another Clinical Trial|0|||
147143617|NCT03307785|530690891|FG003|MainStudy: PartC:Up to Approx.60months|Went on Another Clinical Trial|0|||
147143618|NCT03307785|530690892|FG004|MainStudy: PartC:Up to Approx.60months|Went on Another Clinical Trial|1|||
147143619|NCT03307785|530690893|FG005|MainStudy: PartC:Up to Approx.60months|Went on Another Clinical Trial|0|||
147143620|NCT03307785|530690894|FG006|MainStudy: PartC:Up to Approx.60months|Went on Another Clinical Trial|0|||
147143621|NCT03307785|530690895|FG007|MainStudy: PartC:Up to Approx.60months|Went on Another Clinical Trial|0|||
147143622|NCT03307785|530690896|FG008|MainStudy: PartC:Up to Approx.60months|Went on Another Clinical Trial|0|||
147143623|NCT03307785|530690897|FG009|MainStudy: PartC:Up to Approx.60months|Went on Another Clinical Trial|0|||
147574055|NCT00488774|532258996|FG001|Overall Study|Lost to Follow-up|0|||
147143624|NCT03307785|530690898|FG010|MainStudy: PartC:Up to Approx.60months|Went on Another Clinical Trial|0|||
147574056|NCT00488774|532258997|FG002|Overall Study|Lost to Follow-up|1|||
147574057|NCT00488774|532258998|FG003|Overall Study|Lost to Follow-up|1|||
147652338|NCT03026283|532550245|FG001|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|3|||
147652339|NCT03026283|532550246|FG002|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
147652340|NCT03026283|532550247|FG003|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
147652341|NCT03026283|532550248|FG004|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
147652342|NCT03026283|532550249|FG005|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
147652343|NCT03026283|532550250|FG006|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
147652344|NCT03026283|532550251|FG007|Optimal Medical Care/FFR-CT Diagnosis|Screen Failure: Enrollment Criteria|0|||
147238045|NCT01153347|531044062|FG001|Overall Study|Lack of Efficacy|2|||
147238046|NCT01153347|531044063|FG002|Overall Study|Lack of Efficacy|0|||
147238047|NCT01153347|531044064|FG003|Overall Study|Lack of Efficacy|4|||
147652345|NCT03026283|532550244|FG000|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
147652346|NCT03026283|532550245|FG001|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
147652347|NCT03026283|532550246|FG002|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|15|||
147652348|NCT03026283|532550247|FG003|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
147652349|NCT03026283|532550248|FG004|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
147652350|NCT03026283|532550249|FG005|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
147652351|NCT03026283|532550250|FG006|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
147652352|NCT03026283|532550251|FG007|Optimal Medical Care/FFR-CT Diagnosis|FFRCT Nondiagnostic|0|||
147143625|NCT03307785|530690899|FG011|MainStudy: PartC:Up to Approx.60months|Went on Another Clinical Trial|0|||
147143626|NCT03307785|530690900|FG012|MainStudy: PartC:Up to Approx.60months|Went on Another Clinical Trial|0|||
147143627|NCT03307785|530690888|FG000|MainStudy:PartD:Up to Approx. 62.5months|Physician Decision|0|||
147143628|NCT03307785|530690889|FG001|MainStudy:PartD:Up to Approx. 62.5months|Physician Decision|0|||
147143629|NCT03307785|530690890|FG002|MainStudy:PartD:Up to Approx. 62.5months|Physician Decision|0|||
147143630|NCT03307785|530690891|FG003|MainStudy:PartD:Up to Approx. 62.5months|Physician Decision|0|||
147143631|NCT03307785|530690892|FG004|MainStudy:PartD:Up to Approx. 62.5months|Physician Decision|0|||
147143632|NCT03307785|530690893|FG005|MainStudy:PartD:Up to Approx. 62.5months|Physician Decision|2|||
147143633|NCT03307785|530690894|FG006|MainStudy:PartD:Up to Approx. 62.5months|Physician Decision|0|||
147143634|NCT03307785|530690895|FG007|MainStudy:PartD:Up to Approx. 62.5months|Physician Decision|0|||
147143635|NCT03307785|530690896|FG008|MainStudy:PartD:Up to Approx. 62.5months|Physician Decision|0|||
147143636|NCT03307785|530690897|FG009|MainStudy:PartD:Up to Approx. 62.5months|Physician Decision|0|||
147143637|NCT03307785|530690898|FG010|MainStudy:PartD:Up to Approx. 62.5months|Physician Decision|0|||
147143638|NCT03307785|530690899|FG011|MainStudy:PartD:Up to Approx. 62.5months|Physician Decision|0|||
147143639|NCT03307785|530690900|FG012|MainStudy:PartD:Up to Approx. 62.5months|Physician Decision|0|||
147143640|NCT03307785|530690888|FG000|MainStudy:PartD:Up to Approx. 62.5months|Death|0|||
147143641|NCT03307785|530690889|FG001|MainStudy:PartD:Up to Approx. 62.5months|Death|0|||
147143642|NCT03307785|530690890|FG002|MainStudy:PartD:Up to Approx. 62.5months|Death|0|||
147143643|NCT03307785|530690891|FG003|MainStudy:PartD:Up to Approx. 62.5months|Death|0|||
147143644|NCT03307785|530690892|FG004|MainStudy:PartD:Up to Approx. 62.5months|Death|0|||
147143645|NCT03307785|530690893|FG005|MainStudy:PartD:Up to Approx. 62.5months|Death|1|||
147143646|NCT03307785|530690894|FG006|MainStudy:PartD:Up to Approx. 62.5months|Death|0|||
147143647|NCT03307785|530690895|FG007|MainStudy:PartD:Up to Approx. 62.5months|Death|0|||
147143648|NCT03307785|530690896|FG008|MainStudy:PartD:Up to Approx. 62.5months|Death|0|||
147143649|NCT03307785|530690897|FG009|MainStudy:PartD:Up to Approx. 62.5months|Death|0|||
147143650|NCT03307785|530690898|FG010|MainStudy:PartD:Up to Approx. 62.5months|Death|0|||
147143651|NCT03307785|530690899|FG011|MainStudy:PartD:Up to Approx. 62.5months|Death|0|||
147652353|NCT03026283|532550244|FG000|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
147652354|NCT03026283|532550245|FG001|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
147143652|NCT03307785|530690900|FG012|MainStudy:PartD:Up to Approx. 62.5months|Death|0|||
147143653|NCT03307785|530690888|FG000|MainStudy:PartD:Up to Approx. 62.5months|Withdrawal by Subject|0|||
147143654|NCT03307785|530690889|FG001|MainStudy:PartD:Up to Approx. 62.5months|Withdrawal by Subject|0|||
147143655|NCT03307785|530690890|FG002|MainStudy:PartD:Up to Approx. 62.5months|Withdrawal by Subject|0|||
147143656|NCT03307785|530690891|FG003|MainStudy:PartD:Up to Approx. 62.5months|Withdrawal by Subject|0|||
147143657|NCT03307785|530690892|FG004|MainStudy:PartD:Up to Approx. 62.5months|Withdrawal by Subject|0|||
147143658|NCT03307785|530690893|FG005|MainStudy:PartD:Up to Approx. 62.5months|Withdrawal by Subject|1|||
147143659|NCT03307785|530690894|FG006|MainStudy:PartD:Up to Approx. 62.5months|Withdrawal by Subject|0|||
147143660|NCT03307785|530690895|FG007|MainStudy:PartD:Up to Approx. 62.5months|Withdrawal by Subject|0|||
147143661|NCT03307785|530690896|FG008|MainStudy:PartD:Up to Approx. 62.5months|Withdrawal by Subject|0|||
147143662|NCT03307785|530690897|FG009|MainStudy:PartD:Up to Approx. 62.5months|Withdrawal by Subject|0|||
147238048|NCT01153347|531044061|FG000|Overall Study|Study-specific withdrawal criteria|4|||
147238049|NCT01153347|531044062|FG001|Overall Study|Study-specific withdrawal criteria|3|||
147238050|NCT01153347|531044063|FG002|Overall Study|Study-specific withdrawal criteria|1|||
147652355|NCT03026283|532550246|FG002|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
147652356|NCT03026283|532550247|FG003|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|8|||
147445727|NCT01500278|531797439|FG000|Week 0 - Week 12|Prior history of serious disease|1|||
147143663|NCT03307785|530690898|FG010|MainStudy:PartD:Up to Approx. 62.5months|Withdrawal by Subject|0|||
147143664|NCT03307785|530690899|FG011|MainStudy:PartD:Up to Approx. 62.5months|Withdrawal by Subject|0|||
147143665|NCT03307785|530690900|FG012|MainStudy:PartD:Up to Approx. 62.5months|Withdrawal by Subject|0|||
147143666|NCT03307785|530690888|FG000|MainStudy:PartD:Up to Approx. 62.5months|Transitioned to PACT phase|0|||
147143667|NCT03307785|530690889|FG001|MainStudy:PartD:Up to Approx. 62.5months|Transitioned to PACT phase|0|||
147143668|NCT03307785|530690890|FG002|MainStudy:PartD:Up to Approx. 62.5months|Transitioned to PACT phase|0|||
147143669|NCT03307785|530690891|FG003|MainStudy:PartD:Up to Approx. 62.5months|Transitioned to PACT phase|0|||
147143670|NCT03307785|530690892|FG004|MainStudy:PartD:Up to Approx. 62.5months|Transitioned to PACT phase|0|||
147143671|NCT03307785|530690893|FG005|MainStudy:PartD:Up to Approx. 62.5months|Transitioned to PACT phase|1|||
147143672|NCT03307785|530690894|FG006|MainStudy:PartD:Up to Approx. 62.5months|Transitioned to PACT phase|0|||
147143673|NCT03307785|530690895|FG007|MainStudy:PartD:Up to Approx. 62.5months|Transitioned to PACT phase|0|||
147143674|NCT03307785|530690896|FG008|MainStudy:PartD:Up to Approx. 62.5months|Transitioned to PACT phase|0|||
147143675|NCT03307785|530690897|FG009|MainStudy:PartD:Up to Approx. 62.5months|Transitioned to PACT phase|0|||
147143676|NCT03307785|530690898|FG010|MainStudy:PartD:Up to Approx. 62.5months|Transitioned to PACT phase|0|||
147143677|NCT03307785|530690899|FG011|MainStudy:PartD:Up to Approx. 62.5months|Transitioned to PACT phase|0|||
147143678|NCT03307785|530690900|FG012|MainStudy:PartD:Up to Approx. 62.5months|Transitioned to PACT phase|0|||
147143679|NCT03307785|530690888|FG000|MainStudy:PartD:Up to Approx. 62.5months|Completed EOT and Began New Study|0|||
147143680|NCT03307785|530690889|FG001|MainStudy:PartD:Up to Approx. 62.5months|Completed EOT and Began New Study|0|||
147143681|NCT03307785|530690890|FG002|MainStudy:PartD:Up to Approx. 62.5months|Completed EOT and Began New Study|0|||
147143682|NCT03307785|530690891|FG003|MainStudy:PartD:Up to Approx. 62.5months|Completed EOT and Began New Study|0|||
147143683|NCT03307785|530690892|FG004|MainStudy:PartD:Up to Approx. 62.5months|Completed EOT and Began New Study|0|||
147143684|NCT03307785|530690893|FG005|MainStudy:PartD:Up to Approx. 62.5months|Completed EOT and Began New Study|1|||
147143685|NCT03307785|530690894|FG006|MainStudy:PartD:Up to Approx. 62.5months|Completed EOT and Began New Study|0|||
147143686|NCT03307785|530690895|FG007|MainStudy:PartD:Up to Approx. 62.5months|Completed EOT and Began New Study|0|||
147143687|NCT03307785|530690896|FG008|MainStudy:PartD:Up to Approx. 62.5months|Completed EOT and Began New Study|0|||
147238051|NCT01153347|531044064|FG003|Overall Study|Study-specific withdrawal criteria|2|||
147238052|NCT01153347|531044061|FG000|Overall Study|Lost to Follow-up|4|||
147238053|NCT01153347|531044062|FG001|Overall Study|Lost to Follow-up|9|||
147238054|NCT01153347|531044063|FG002|Overall Study|Lost to Follow-up|11|||
147238055|NCT01153347|531044064|FG003|Overall Study|Lost to Follow-up|8|||
147238056|NCT01153347|531044061|FG000|Overall Study|Other|5|||
147238057|NCT01153347|531044062|FG001|Overall Study|Other|5|||
147574058|NCT05523895|532258999|FG000|Overall Study|Adverse Event|2|||
147574059|NCT05523895|532259000|FG001|Overall Study|Adverse Event|1|||
147574060|NCT05523895|532259001|FG002|Overall Study|Adverse Event|1|||
147574061|NCT05523895|532258999|FG000|Overall Study|Lost to Follow-up|0|||
147574062|NCT05523895|532259000|FG001|Overall Study|Lost to Follow-up|1|||
147574063|NCT05523895|532259001|FG002|Overall Study|Lost to Follow-up|2|||
147574064|NCT05523895|532258999|FG000|Overall Study|Noncompliance with study drug|1|||
147574065|NCT05523895|532259000|FG001|Overall Study|Noncompliance with study drug|1|||
147574066|NCT05523895|532259001|FG002|Overall Study|Noncompliance with study drug|1|||
147574067|NCT05523895|532258999|FG000|Overall Study|Protocol Violation|0|||
147574068|NCT05523895|532259000|FG001|Overall Study|Protocol Violation|2|||
147574069|NCT05523895|532259001|FG002|Overall Study|Protocol Violation|0|||
147574070|NCT05523895|532258999|FG000|Overall Study|Withdrawal by Subject|1|||
147574071|NCT05523895|532259000|FG001|Overall Study|Withdrawal by Subject|3|||
147574072|NCT05523895|532259001|FG002|Overall Study|Withdrawal by Subject|1|||
147574073|NCT05523895|532258999|FG000|Overall Study|Not further specified|0|||
147574074|NCT05523895|532259000|FG001|Overall Study|Not further specified|3|||
147574075|NCT05523895|532259001|FG002|Overall Study|Not further specified|1|||
147574076|NCT01959672|532259004|FG000|Overall Study|Death|1|||
147574077|NCT05041361|532259005|FG000|Overall Study|Lost to Follow-up|1|||
147574078|NCT05041361|532259006|FG001|Overall Study|Lost to Follow-up|3|||
147574079|NCT01919112|532259007|FG000|Secondary Analysis-day 30|Death|1|||
147574080|NCT01919112|532259008|FG001|Secondary Analysis-day 30|Death|1|||
147574081|NCT01919112|532259009|FG002|Secondary Analysis-day 30|Death|1|||
147574082|NCT01919112|532259007|FG000|Secondary Analysis-day 30|Lost to Follow-up|1|||
147574083|NCT01919112|532259008|FG001|Secondary Analysis-day 30|Lost to Follow-up|0|||
147574084|NCT01919112|532259009|FG002|Secondary Analysis-day 30|Lost to Follow-up|0|||
147574085|NCT04692155|532259012|FG000|Overall Study|Death|1|||
147574086|NCT02554877|532259013|FG000|Overall Study|Adverse Event|2|||
147574087|NCT02554877|532259014|FG001|Overall Study|Adverse Event|0|||
147574088|NCT02554877|532259015|FG002|Overall Study|Adverse Event|0|||
147574089|NCT02554877|532259016|FG003|Overall Study|Adverse Event|1|||
147574090|NCT02554877|532259013|FG000|Overall Study|Lost to Follow-up|1|||
147574091|NCT02554877|532259014|FG001|Overall Study|Lost to Follow-up|1|||
147574092|NCT02554877|532259015|FG002|Overall Study|Lost to Follow-up|1|||
147574093|NCT02554877|532259016|FG003|Overall Study|Lost to Follow-up|2|||
147574094|NCT02554877|532259013|FG000|Overall Study|Did not meet entrance criteria|0|||
147143688|NCT03307785|530690897|FG009|MainStudy:PartD:Up to Approx. 62.5months|Completed EOT and Began New Study|0|||
147574095|NCT02554877|532259014|FG001|Overall Study|Did not meet entrance criteria|0|||
147574096|NCT02554877|532259015|FG002|Overall Study|Did not meet entrance criteria|1|||
147574097|NCT02554877|532259016|FG003|Overall Study|Did not meet entrance criteria|0|||
147574098|NCT02554877|532259013|FG000|Overall Study|No longer met eligibility criteria|1|||
147574099|NCT02554877|532259014|FG001|Overall Study|No longer met eligibility criteria|0|||
147574100|NCT02554877|532259015|FG002|Overall Study|No longer met eligibility criteria|1|||
147574101|NCT02554877|532259016|FG003|Overall Study|No longer met eligibility criteria|1|||
147574102|NCT02554877|532259013|FG000|Overall Study|Protocol Violation|3|||
147574103|NCT02554877|532259014|FG001|Overall Study|Protocol Violation|1|||
147574104|NCT02554877|532259015|FG002|Overall Study|Protocol Violation|1|||
147574105|NCT02554877|532259016|FG003|Overall Study|Protocol Violation|0|||
147574106|NCT02554877|532259013|FG000|Overall Study|Other|1|||
147574107|NCT02554877|532259014|FG001|Overall Study|Other|3|||
147574108|NCT02554877|532259015|FG002|Overall Study|Other|0|||
147574109|NCT02554877|532259016|FG003|Overall Study|Other|3|||
147574110|NCT02554877|532259013|FG000|Overall Study|Insufficient clinical response|4|||
147574111|NCT02554877|532259014|FG001|Overall Study|Insufficient clinical response|0|||
147574112|NCT02554877|532259015|FG002|Overall Study|Insufficient clinical response|0|||
147574113|NCT02554877|532259016|FG003|Overall Study|Insufficient clinical response|0|||
147574114|NCT02554877|532259013|FG000|Overall Study|No longer willing to participate|0|||
147574115|NCT02554877|532259014|FG001|Overall Study|No longer willing to participate|2|||
147574116|NCT02554877|532259015|FG002|Overall Study|No longer willing to participate|2|||
147574117|NCT02554877|532259016|FG003|Overall Study|No longer willing to participate|0|||
147574118|NCT00274651|532259017|FG000|Overall Study|Adverse Event|6|||
147574119|NCT00274651|532259018|FG001|Overall Study|Adverse Event|3|||
147574120|NCT00274651|532259017|FG000|Overall Study|Lack of Efficacy|13|||
147574121|NCT00274651|532259018|FG001|Overall Study|Lack of Efficacy|6|||
147574122|NCT00274651|532259017|FG000|Overall Study|Death|1|||
147574123|NCT00274651|532259018|FG001|Overall Study|Death|3|||
147574124|NCT00274651|532259017|FG000|Overall Study|Withdrawal by Subject|0|||
147574125|NCT00274651|532259018|FG001|Overall Study|Withdrawal by Subject|1|||
147574126|NCT00274651|532259017|FG000|Overall Study|Physician Decision|8|||
147574127|NCT00274651|532259018|FG001|Overall Study|Physician Decision|7|||
147574128|NCT03446768|532259019|FG000|Overall Study|Withdrawal by Subject|0|||
147574129|NCT03446768|532259020|FG001|Overall Study|Withdrawal by Subject|1|||
147574130|NCT02488239|532259023|FG000|Overall Study|Death|3|||
147574131|NCT02488239|532259023|FG000|Overall Study|Withdrawal by Subject|3|||
147574132|NCT02488239|532259023|FG000|Overall Study|Physician Decision|2|||
147574133|NCT02488239|532259023|FG000|Overall Study|Consent ineligible|1|||
147574134|NCT02488239|532259023|FG000|Overall Study|Did not undergo implant procedure|1|||
147574135|NCT04345653|532259027|FG000|Overall Study|Withdrawal by Subject|2|||
147574136|NCT03480763|532259032|FG000|Overall Study|Withdrawal by Subject|18|||
147574137|NCT03480763|532259033|FG001|Overall Study|Withdrawal by Subject|10|||
147574138|NCT03480763|532259032|FG000|Overall Study|Lost to Follow-up|4|||
147574139|NCT03480763|532259033|FG001|Overall Study|Lost to Follow-up|7|||
147574140|NCT03480763|532259032|FG000|Overall Study|non-study pneumococcal vaccine|1|||
147574141|NCT03480763|532259033|FG001|Overall Study|non-study pneumococcal vaccine|0|||
147574142|NCT03480763|532259032|FG000|Overall Study|oncological treatment|0|||
147574143|NCT03480763|532259033|FG001|Overall Study|oncological treatment|2|||
147574144|NCT03480763|532259032|FG000|Overall Study|pain with vaccination|1|||
147574145|NCT03480763|532259033|FG001|Overall Study|pain with vaccination|0|||
147574146|NCT00418938|532259034|FG000|Overall Study|Reimbursement|1|||
147574147|NCT00418938|532259035|FG001|Overall Study|Reimbursement|0|||
147574148|NCT00418938|532259034|FG000|Overall Study|Administrative decision|3|||
147574149|NCT00418938|532259035|FG001|Overall Study|Administrative decision|3|||
147574150|NCT00418938|532259034|FG000|Overall Study|Withdrawal by Subject|16|||
147574151|NCT00418938|532259035|FG001|Overall Study|Withdrawal by Subject|15|||
147574152|NCT00418938|532259034|FG000|Overall Study|Lost to Follow-up|1|||
147574153|NCT00418938|532259035|FG001|Overall Study|Lost to Follow-up|3|||
147574154|NCT00418938|532259034|FG000|Overall Study|Adverse Event|1|||
147574155|NCT00418938|532259035|FG001|Overall Study|Adverse Event|1|||
147574156|NCT00418938|532259034|FG000|Overall Study|On-going|1|||
147574157|NCT00418938|532259035|FG001|Overall Study|On-going|1|||
147574158|NCT00418938|532259034|FG000|Overall Study|Ineligibility Determined|1|||
147574159|NCT00418938|532259035|FG001|Overall Study|Ineligibility Determined|0|||
147143689|NCT03307785|530690898|FG010|MainStudy:PartD:Up to Approx. 62.5months|Completed EOT and Began New Study|0|||
147574160|NCT00115063|532259038|FG000|Overall Study|Lost to Follow-up|98|||
147574161|NCT00115063|532259039|FG001|Overall Study|Lost to Follow-up|104|||
147574162|NCT00115063|532259038|FG000|Overall Study|Death|1|||
147574163|NCT00115063|532259039|FG001|Overall Study|Death|0|||
147574164|NCT01316055|532259040|FG000|Overall Study|Lost to Follow-up|1|||
147574165|NCT01316055|532259041|FG001|Overall Study|Lost to Follow-up|0|||
147574166|NCT01316055|532259042|FG002|Overall Study|Lost to Follow-up|0|||
147574167|NCT00003470|532259043|FG000|Overall Study|Not evaluable|6|||
147574168|NCT00748566|532259047|FG000|Overall Study|Adverse Event|49|||
147574169|NCT00748566|532259047|FG000|Overall Study|Death|1|||
147143690|NCT03307785|530690899|FG011|MainStudy:PartD:Up to Approx. 62.5months|Completed EOT and Began New Study|0|||
147143691|NCT03307785|530690900|FG012|MainStudy:PartD:Up to Approx. 62.5months|Completed EOT and Began New Study|0|||
147143692|NCT03307785|530690888|FG000|Main Study: Part E: Up to 4.4 Months|Death|0|||
147143693|NCT03307785|530690889|FG001|Main Study: Part E: Up to 4.4 Months|Death|0|||
147143694|NCT03307785|530690890|FG002|Main Study: Part E: Up to 4.4 Months|Death|0|||
147143695|NCT03307785|530690891|FG003|Main Study: Part E: Up to 4.4 Months|Death|0|||
147143696|NCT03307785|530690892|FG004|Main Study: Part E: Up to 4.4 Months|Death|0|||
147143697|NCT03307785|530690893|FG005|Main Study: Part E: Up to 4.4 Months|Death|0|||
147143698|NCT03307785|530690894|FG006|Main Study: Part E: Up to 4.4 Months|Death|1|||
147143699|NCT03307785|530690895|FG007|Main Study: Part E: Up to 4.4 Months|Death|0|||
147143700|NCT03307785|530690896|FG008|Main Study: Part E: Up to 4.4 Months|Death|0|||
147143701|NCT03307785|530690897|FG009|Main Study: Part E: Up to 4.4 Months|Death|0|||
147143702|NCT03307785|530690898|FG010|Main Study: Part E: Up to 4.4 Months|Death|0|||
147143703|NCT03307785|530690899|FG011|Main Study: Part E: Up to 4.4 Months|Death|0|||
147143704|NCT03307785|530690900|FG012|Main Study: Part E: Up to 4.4 Months|Death|0|||
147143705|NCT03307785|530690888|FG000|Main Study: Part E: Up to 4.4 Months|Physician Decision|0|||
147143706|NCT03307785|530690889|FG001|Main Study: Part E: Up to 4.4 Months|Physician Decision|0|||
147143707|NCT03307785|530690890|FG002|Main Study: Part E: Up to 4.4 Months|Physician Decision|0|||
147143708|NCT03307785|530690891|FG003|Main Study: Part E: Up to 4.4 Months|Physician Decision|0|||
147143709|NCT03307785|530690892|FG004|Main Study: Part E: Up to 4.4 Months|Physician Decision|0|||
147143710|NCT03307785|530690893|FG005|Main Study: Part E: Up to 4.4 Months|Physician Decision|0|||
147143711|NCT03307785|530690894|FG006|Main Study: Part E: Up to 4.4 Months|Physician Decision|1|||
147143712|NCT03307785|530690895|FG007|Main Study: Part E: Up to 4.4 Months|Physician Decision|0|||
147143713|NCT03307785|530690896|FG008|Main Study: Part E: Up to 4.4 Months|Physician Decision|0|||
147143714|NCT03307785|530690897|FG009|Main Study: Part E: Up to 4.4 Months|Physician Decision|0|||
147143715|NCT03307785|530690898|FG010|Main Study: Part E: Up to 4.4 Months|Physician Decision|0|||
147143716|NCT03307785|530690899|FG011|Main Study: Part E: Up to 4.4 Months|Physician Decision|0|||
147143717|NCT03307785|530690900|FG012|Main Study: Part E: Up to 4.4 Months|Physician Decision|0|||
147143718|NCT03307785|530690888|FG000|Main Study: Part F: Up to 3.5 Months|Physician Decision|0|||
147143719|NCT03307785|530690889|FG001|Main Study: Part F: Up to 3.5 Months|Physician Decision|0|||
147143720|NCT03307785|530690890|FG002|Main Study: Part F: Up to 3.5 Months|Physician Decision|0|||
147143721|NCT03307785|530690891|FG003|Main Study: Part F: Up to 3.5 Months|Physician Decision|0|||
147143722|NCT03307785|530690892|FG004|Main Study: Part F: Up to 3.5 Months|Physician Decision|0|||
147143723|NCT03307785|530690893|FG005|Main Study: Part F: Up to 3.5 Months|Physician Decision|0|||
147143724|NCT03307785|530690894|FG006|Main Study: Part F: Up to 3.5 Months|Physician Decision|0|||
147143725|NCT03307785|530690895|FG007|Main Study: Part F: Up to 3.5 Months|Physician Decision|1|||
147143726|NCT03307785|530690896|FG008|Main Study: Part F: Up to 3.5 Months|Physician Decision|0|||
147143727|NCT03307785|530690897|FG009|Main Study: Part F: Up to 3.5 Months|Physician Decision|0|||
147143728|NCT03307785|530690898|FG010|Main Study: Part F: Up to 3.5 Months|Physician Decision|0|||
147143729|NCT03307785|530690899|FG011|Main Study: Part F: Up to 3.5 Months|Physician Decision|0|||
147143730|NCT03307785|530690900|FG012|Main Study: Part F: Up to 3.5 Months|Physician Decision|0|||
147143731|NCT03307785|530690888|FG000|PACT Phase: Up to 19 Months|Death|0|||
147143732|NCT03307785|530690889|FG001|PACT Phase: Up to 19 Months|Death|0|||
147143733|NCT03307785|530690890|FG002|PACT Phase: Up to 19 Months|Death|0|||
147143734|NCT03307785|530690891|FG003|PACT Phase: Up to 19 Months|Death|0|||
147143735|NCT03307785|530690892|FG004|PACT Phase: Up to 19 Months|Death|0|||
147143736|NCT03307785|530690893|FG005|PACT Phase: Up to 19 Months|Death|0|||
147143737|NCT03307785|530690894|FG006|PACT Phase: Up to 19 Months|Death|0|||
147143738|NCT03307785|530690895|FG007|PACT Phase: Up to 19 Months|Death|0|||
147143739|NCT03307785|530690896|FG008|PACT Phase: Up to 19 Months|Death|0|||
147143740|NCT03307785|530690897|FG009|PACT Phase: Up to 19 Months|Death|0|||
147143741|NCT03307785|530690898|FG010|PACT Phase: Up to 19 Months|Death|0|||
147143742|NCT03307785|530690899|FG011|PACT Phase: Up to 19 Months|Death|0|||
147143743|NCT03307785|530690900|FG012|PACT Phase: Up to 19 Months|Death|1|||
147143744|NCT05526521|530690904|FG000|Overall Study|Withdrawal by Subject|0|||
147238058|NCT01153347|531044063|FG002|Overall Study|Other|4|||
147238059|NCT01153347|531044064|FG003|Overall Study|Other|0|||
147238060|NCT01153347|531044061|FG000|Overall Study|Death|1|||
147238061|NCT01153347|531044062|FG001|Overall Study|Death|0|||
147238062|NCT01153347|531044063|FG002|Overall Study|Death|0|||
147238063|NCT01153347|531044064|FG003|Overall Study|Death|0|||
147238064|NCT05096221|531044065|FG000|Part 2|Physician Decision|0|||
147238065|NCT05096221|531044066|FG001|Part 2|Physician Decision|1|||
147238066|NCT04678661|531044069|FG000|Overall Study|Study paused to address technical issues related to the app. Participants removed from study .|17|||
147143745|NCT05526521|530690905|FG001|Overall Study|Withdrawal by Subject|1|||
147143746|NCT05526521|530690906|FG002|Overall Study|Withdrawal by Subject|0|||
147143747|NCT05526521|530690907|FG003|Overall Study|Withdrawal by Subject|0|||
147238067|NCT04678661|531044070|FG001|Overall Study|Study paused to address technical issues related to the app. Participants removed from study .|0|||
147238068|NCT04678661|531044069|FG000|Overall Study|Protocol Violation|2|||
147238069|NCT04678661|531044070|FG001|Overall Study|Protocol Violation|0|||
147574170|NCT00748566|532259047|FG000|Overall Study|Lack of Efficacy|12|||
147574171|NCT00748566|532259047|FG000|Overall Study|Lost to Follow-up|1|||
147574172|NCT00748566|532259047|FG000|Overall Study|Protocol Violation|13|||
147574173|NCT00748566|532259047|FG000|Overall Study|Withdrawal by Subject|22|||
147574174|NCT00748566|532259047|FG000|Overall Study|Study terminated by sponsor|5|||
147143748|NCT03919929|530690908|FG000|Overall Study|Withdrawal by Subject|0|||
147143749|NCT03919929|530690909|FG001|Overall Study|Withdrawal by Subject|4|||
147143750|NCT03919929|530690908|FG000|Overall Study|Screen Failure|0|||
147143751|NCT03919929|530690909|FG001|Overall Study|Screen Failure|5|||
147143752|NCT00100802|530690913|FG000|Overall Study|Adverse Event|9|||
147143753|NCT00100802|530690913|FG000|Overall Study|Death|1|||
147143754|NCT00100802|530690913|FG000|Overall Study|Lack of Efficacy|47|||
147143755|NCT00100802|530690913|FG000|Overall Study|Physician Decision|5|||
147143756|NCT00100802|530690913|FG000|Overall Study|Protocol Violation|1|||
147143757|NCT00100802|530690913|FG000|Overall Study|Withdrawal by Subject|5|||
147143758|NCT00100802|530690913|FG000|Overall Study|Ineligible|12|||
147143759|NCT00325130|530690945|FG000|Overall Study|Lost to Follow-up|6|||
147143760|NCT00325130|530690946|FG001|Overall Study|Lost to Follow-up|14|||
147143761|NCT00325130|530690945|FG000|Overall Study|Withdrawal by Subject|12|||
147143762|NCT00325130|530690946|FG001|Overall Study|Withdrawal by Subject|14|||
147143763|NCT00325130|530690945|FG000|Overall Study|Protocol Deviation|0|||
147143764|NCT00325130|530690946|FG001|Overall Study|Protocol Deviation|1|||
147143765|NCT00325130|530690945|FG000|Overall Study|Moved|0|||
147143766|NCT00325130|530690946|FG001|Overall Study|Moved|1|||
147143767|NCT00325130|530690945|FG000|Overall Study|Patient Discontinued for Other|1|||
147143768|NCT00325130|530690946|FG001|Overall Study|Patient Discontinued for Other|0|||
147143769|NCT00928187|530690950|FG000|Overall Study|Death|1|||
147143770|NCT00928187|530690951|FG001|Overall Study|Death|2|||
147143771|NCT00928187|530690952|FG002|Overall Study|Death|3|||
147143772|NCT00928187|530690950|FG000|Overall Study|Lost to Follow-up|1|||
147143773|NCT00928187|530690951|FG001|Overall Study|Lost to Follow-up|2|||
147143774|NCT00928187|530690952|FG002|Overall Study|Lost to Follow-up|1|||
147143775|NCT00928187|530690950|FG000|Overall Study|Withdrawal by Subject|0|||
147143776|NCT00928187|530690951|FG001|Overall Study|Withdrawal by Subject|1|||
147143777|NCT00928187|530690952|FG002|Overall Study|Withdrawal by Subject|1|||
147143778|NCT00928187|530690950|FG000|Overall Study|Protocol Violation|0|||
147143779|NCT00928187|530690951|FG001|Overall Study|Protocol Violation|1|||
147143780|NCT00928187|530690952|FG002|Overall Study|Protocol Violation|0|||
147143781|NCT02524145|530690956|FG000|Overall Study|Withdrawal by Subject|2|||
147143782|NCT02524145|530690957|FG001|Overall Study|Withdrawal by Subject|2|||
147143783|NCT02524145|530690958|FG002|Overall Study|Withdrawal by Subject|3|||
147143784|NCT00620373|530691703|FG000|Overall Study|Unverified cancer status|33|||
147143785|NCT01897727|530691704|FG000|Overall Study|Exclusion: central sleep apnea|0|||
147143786|NCT01897727|530691705|FG001|Overall Study|Exclusion: central sleep apnea|1|||
147143787|NCT01061723|530691706|FG000|Overall Study|Adverse Event|0|||
147143788|NCT01061723|530691707|FG001|Overall Study|Adverse Event|2|||
147143789|NCT01061723|530691708|FG002|Overall Study|Adverse Event|5|||
147143790|NCT01061723|530691709|FG003|Overall Study|Adverse Event|5|||
147143791|NCT01061723|530691710|FG004|Overall Study|Adverse Event|2|||
147143792|NCT01061723|530691711|FG005|Overall Study|Adverse Event|6|||
147143793|NCT01061723|530691706|FG000|Overall Study|Lack of Efficacy|2|||
147143794|NCT01061723|530691707|FG001|Overall Study|Lack of Efficacy|3|||
147143795|NCT01061723|530691708|FG002|Overall Study|Lack of Efficacy|4|||
147143796|NCT01061723|530691709|FG003|Overall Study|Lack of Efficacy|2|||
147143797|NCT01061723|530691710|FG004|Overall Study|Lack of Efficacy|1|||
147143798|NCT01061723|530691711|FG005|Overall Study|Lack of Efficacy|1|||
147143799|NCT01061723|530691706|FG000|Overall Study|Randomized but not treated|0|||
147143800|NCT01061723|530691707|FG001|Overall Study|Randomized but not treated|0|||
147143801|NCT01061723|530691708|FG002|Overall Study|Randomized but not treated|0|||
147574175|NCT00748566|532259047|FG000|Overall Study|Other|9|||
147143802|NCT01061723|530691709|FG003|Overall Study|Randomized but not treated|0|||
147143803|NCT01061723|530691710|FG004|Overall Study|Randomized but not treated|0|||
147143804|NCT01061723|530691711|FG005|Overall Study|Randomized but not treated|1|||
147143805|NCT01061723|530691706|FG000|Overall Study|Other than specified above|2|||
147143806|NCT01061723|530691707|FG001|Overall Study|Other than specified above|1|||
147143807|NCT01061723|530691708|FG002|Overall Study|Other than specified above|1|||
147143808|NCT01061723|530691709|FG003|Overall Study|Other than specified above|1|||
147574176|NCT01442376|532259050|FG000|Overall Study|Adverse Event|0|||
147143809|NCT01061723|530691710|FG004|Overall Study|Other than specified above|0|||
147143810|NCT01061723|530691711|FG005|Overall Study|Other than specified above|1|||
147143811|NCT00293813|530691712|FG000|Overall Study|Physician Decision|0|||
147143812|NCT00293813|530691713|FG001|Overall Study|Physician Decision|1|||
147143813|NCT00293813|530691714|FG002|Overall Study|Physician Decision|0|||
147143814|NCT00293813|530691712|FG000|Overall Study|Adverse Event|3|||
147143815|NCT00293813|530691713|FG001|Overall Study|Adverse Event|1|||
147143816|NCT00293813|530691714|FG002|Overall Study|Adverse Event|1|||
147574177|NCT01442376|532259051|FG001|Overall Study|Adverse Event|3|||
147574178|NCT01442376|532259052|FG002|Overall Study|Adverse Event|2|||
147574179|NCT01442376|532259050|FG000|Overall Study|Death|0|||
147143817|NCT00293813|530691712|FG000|Overall Study|Withdrawal by Subject|7|||
147143818|NCT00293813|530691713|FG001|Overall Study|Withdrawal by Subject|4|||
147143819|NCT00293813|530691714|FG002|Overall Study|Withdrawal by Subject|4|||
147143820|NCT00293813|530691712|FG000|Overall Study|Lost to Follow-up|3|||
147143821|NCT00293813|530691713|FG001|Overall Study|Lost to Follow-up|2|||
147143822|NCT00293813|530691714|FG002|Overall Study|Lost to Follow-up|3|||
147143823|NCT00293813|530691712|FG000|Overall Study|Noncompliance|0|||
147143824|NCT00293813|530691713|FG001|Overall Study|Noncompliance|1|||
147143825|NCT00293813|530691714|FG002|Overall Study|Noncompliance|0|||
147143826|NCT00460655|530691719|FG000|Double-Blind Phase (12 Weeks)|Adverse Event|3|||
147143827|NCT00460655|530691720|FG001|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
147143828|NCT00460655|530691721|FG002|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
147143829|NCT00460655|530691722|FG003|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
147143830|NCT00460655|530691719|FG000|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|3|||
147143831|NCT00460655|530691720|FG001|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
147143832|NCT00460655|530691721|FG002|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
147143833|NCT00460655|530691722|FG003|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
147143834|NCT00460655|530691719|FG000|Double-Blind Phase (12 Weeks)|Protocol Violation|0|||
147143835|NCT00460655|530691720|FG001|Double-Blind Phase (12 Weeks)|Protocol Violation|1|||
147143836|NCT00460655|530691721|FG002|Double-Blind Phase (12 Weeks)|Protocol Violation|0|||
147143837|NCT00460655|530691722|FG003|Double-Blind Phase (12 Weeks)|Protocol Violation|0|||
147143838|NCT00460655|530691719|FG000|Open-Label Phase (36 Weeks)|Adverse Event|0|||
147143839|NCT00460655|530691720|FG001|Open-Label Phase (36 Weeks)|Adverse Event|0|||
147143840|NCT00460655|530691721|FG002|Open-Label Phase (36 Weeks)|Adverse Event|1|||
147143841|NCT00460655|530691722|FG003|Open-Label Phase (36 Weeks)|Adverse Event|6|||
147143842|NCT00460655|530691719|FG000|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
147143843|NCT00460655|530691720|FG001|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
147143844|NCT00460655|530691721|FG002|Open-Label Phase (36 Weeks)|Withdrawal by Subject|6|||
147143845|NCT00460655|530691722|FG003|Open-Label Phase (36 Weeks)|Withdrawal by Subject|2|||
147143846|NCT00460655|530691719|FG000|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|0|||
147143847|NCT00460655|530691720|FG001|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|0|||
147143848|NCT00460655|530691721|FG002|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|0|||
147143849|NCT00460655|530691722|FG003|Open-Label Phase (36 Weeks)|Meeting the Exclusion Criteria|1|||
147143850|NCT00910910|530691723|FG000|Overall Study|Adverse Event|63|||
147143851|NCT00910910|530691724|FG001|Overall Study|Adverse Event|35|||
147143852|NCT00910910|530691723|FG000|Overall Study|PD without histologic change|27|||
147143853|NCT00910910|530691724|FG001|Overall Study|PD without histologic change|23|||
147143854|NCT00910910|530691723|FG000|Overall Study|PD with histologic change|0|||
147143855|NCT00910910|530691724|FG001|Overall Study|PD with histologic change|2|||
147143856|NCT00910910|530691723|FG000|Overall Study|Withdrawal by Subject|7|||
147143857|NCT00910910|530691724|FG001|Overall Study|Withdrawal by Subject|5|||
147143858|NCT00910910|530691723|FG000|Overall Study|Lost to Follow-up|2|||
147143859|NCT00910910|530691724|FG001|Overall Study|Lost to Follow-up|2|||
147143860|NCT00910910|530691723|FG000|Overall Study|Death|9|||
147143861|NCT00910910|530691724|FG001|Overall Study|Death|3|||
147143862|NCT00910910|530691723|FG000|Overall Study|Protocol Violation|2|||
147238070|NCT04678661|531044069|FG000|Overall Study|Withdrawal by Subject|1|||
147574180|NCT01442376|532259051|FG001|Overall Study|Death|1|||
147143863|NCT00910910|530691724|FG001|Overall Study|Protocol Violation|2|||
147143864|NCT00910910|530691723|FG000|Overall Study|Completed 13 cycles of treatment|0|||
147143865|NCT00910910|530691724|FG001|Overall Study|Completed 13 cycles of treatment|118|||
147143866|NCT00910910|530691723|FG000|Overall Study|Other|114|||
147143867|NCT00910910|530691724|FG001|Overall Study|Other|32|||
147143868|NCT00910910|530691723|FG000|Overall Study|Untreated before cycle 1|1|||
147143869|NCT00910910|530691724|FG001|Overall Study|Untreated before cycle 1|2|||
147143870|NCT01973231|530691725|FG000|Overall Study|Protocol Violation|1|||
147143871|NCT01973231|530691726|FG001|Overall Study|Protocol Violation|1|||
147143872|NCT01973231|530691725|FG000|Overall Study|Lost to Follow-up|1|||
147143873|NCT01973231|530691726|FG001|Overall Study|Lost to Follow-up|1|||
147143874|NCT01973231|530691725|FG000|Overall Study|unclassified|2|||
147143875|NCT01973231|530691726|FG001|Overall Study|unclassified|1|||
147143876|NCT01973231|530691725|FG000|Overall Study|Withdrawal by Subject|7|||
147143877|NCT01973231|530691726|FG001|Overall Study|Withdrawal by Subject|9|||
147574181|NCT01442376|532259052|FG002|Overall Study|Death|1|||
147143878|NCT05338710|530691728|FG000|Overall Study|Withdrawal by Subject|3|||
147143879|NCT01194219|530691729|FG000|Placebo-Controlled Phase Weeks 0-16|Adverse Event|23|||
147143880|NCT01194219|530691730|FG001|Placebo-Controlled Phase Weeks 0-16|Adverse Event|5|||
147143881|NCT01194219|530691731|FG002|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
147143882|NCT01194219|530691732|FG003|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
147143883|NCT01194219|530691733|FG004|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
147143884|NCT01194219|530691734|FG005|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
147143885|NCT01194219|530691735|FG006|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
147143886|NCT01194219|530691736|FG007|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
147143887|NCT01194219|530691737|FG008|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
147143888|NCT01194219|530691738|FG009|Placebo-Controlled Phase Weeks 0-16|Adverse Event|0|||
147143889|NCT01194219|530691729|FG000|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|2|||
147143890|NCT01194219|530691730|FG001|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|7|||
147143891|NCT01194219|530691731|FG002|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
147143892|NCT01194219|530691732|FG003|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
147143893|NCT01194219|530691733|FG004|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
147143894|NCT01194219|530691734|FG005|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
147143895|NCT01194219|530691735|FG006|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
147143896|NCT01194219|530691736|FG007|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
147143897|NCT01194219|530691737|FG008|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
147143898|NCT01194219|530691738|FG009|Placebo-Controlled Phase Weeks 0-16|Lack of Efficacy|0|||
147143899|NCT01194219|530691729|FG000|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|7|||
147143900|NCT01194219|530691730|FG001|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
147143901|NCT01194219|530691731|FG002|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
147143902|NCT01194219|530691732|FG003|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
147143903|NCT01194219|530691733|FG004|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
147143904|NCT01194219|530691734|FG005|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
147143905|NCT01194219|530691735|FG006|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
147143906|NCT01194219|530691736|FG007|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
147143907|NCT01194219|530691737|FG008|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
147143908|NCT01194219|530691738|FG009|Placebo-Controlled Phase Weeks 0-16|Noncompliance with study drug|0|||
147143909|NCT01194219|530691729|FG000|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|12|||
147143910|NCT01194219|530691730|FG001|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|9|||
147143911|NCT01194219|530691731|FG002|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
147143912|NCT01194219|530691732|FG003|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
147143913|NCT01194219|530691733|FG004|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
147143914|NCT01194219|530691734|FG005|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
147143915|NCT01194219|530691735|FG006|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
147143916|NCT01194219|530691736|FG007|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
147143917|NCT01194219|530691737|FG008|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
147143918|NCT01194219|530691738|FG009|Placebo-Controlled Phase Weeks 0-16|Withdrawal by Subject|0|||
147143919|NCT01194219|530691729|FG000|Placebo-Controlled Phase Weeks 0-16|Death|0|||
147143920|NCT01194219|530691730|FG001|Placebo-Controlled Phase Weeks 0-16|Death|1|||
147143921|NCT01194219|530691731|FG002|Placebo-Controlled Phase Weeks 0-16|Death|0|||
147143922|NCT01194219|530691732|FG003|Placebo-Controlled Phase Weeks 0-16|Death|0|||
147143923|NCT01194219|530691733|FG004|Placebo-Controlled Phase Weeks 0-16|Death|0|||
147143924|NCT01194219|530691734|FG005|Placebo-Controlled Phase Weeks 0-16|Death|0|||
147143925|NCT01194219|530691735|FG006|Placebo-Controlled Phase Weeks 0-16|Death|0|||
147143926|NCT01194219|530691736|FG007|Placebo-Controlled Phase Weeks 0-16|Death|0|||
147143927|NCT01194219|530691737|FG008|Placebo-Controlled Phase Weeks 0-16|Death|0|||
147143928|NCT01194219|530691738|FG009|Placebo-Controlled Phase Weeks 0-16|Death|0|||
147143929|NCT01194219|530691729|FG000|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|7|||
147143930|NCT01194219|530691730|FG001|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|9|||
147143931|NCT01194219|530691731|FG002|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
147143932|NCT01194219|530691732|FG003|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
147143933|NCT01194219|530691733|FG004|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
147143934|NCT01194219|530691734|FG005|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
147143935|NCT01194219|530691735|FG006|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
147143936|NCT01194219|530691736|FG007|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
147143937|NCT01194219|530691737|FG008|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
147143938|NCT01194219|530691738|FG009|Placebo-Controlled Phase Weeks 0-16|Lost to Follow-up|0|||
147143939|NCT01194219|530691729|FG000|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|7|||
147143940|NCT01194219|530691730|FG001|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|1|||
147143941|NCT01194219|530691731|FG002|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
147143942|NCT01194219|530691732|FG003|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
147238071|NCT04678661|531044070|FG001|Overall Study|Withdrawal by Subject|0|||
147574182|NCT01442376|532259050|FG000|Overall Study|Withdrawal of consent|0|||
147238072|NCT04678661|531044069|FG000|Overall Study|Lost to Follow-up|2|||
147238073|NCT04678661|531044070|FG001|Overall Study|Lost to Follow-up|0|||
147238074|NCT04678661|531044069|FG000|Overall Study|Death|2|||
147238075|NCT04678661|531044070|FG001|Overall Study|Death|0|||
147238076|NCT01086033|531044071|FG000|Overall Study|Lack of efficacy/Exacerbation of RA|86|||
147574183|NCT01442376|532259051|FG001|Overall Study|Withdrawal of consent|0|||
147574184|NCT01442376|532259052|FG002|Overall Study|Withdrawal of consent|1|||
147574185|NCT01442376|532259050|FG000|Overall Study|Patients not treated|2|||
147574186|NCT01442376|532259051|FG001|Overall Study|Patients not treated|3|||
147574187|NCT01442376|532259052|FG002|Overall Study|Patients not treated|1|||
147574188|NCT01442376|532259050|FG000|Overall Study|Not eligible for subsequent cycles|1|||
147143943|NCT01194219|530691733|FG004|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
147143944|NCT01194219|530691734|FG005|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
147143945|NCT01194219|530691735|FG006|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
147143946|NCT01194219|530691736|FG007|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
147143947|NCT01194219|530691737|FG008|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
147143948|NCT01194219|530691738|FG009|Placebo-Controlled Phase Weeks 0-16|Protocol Violation|0|||
147143949|NCT01194219|530691729|FG000|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|1|||
147143950|NCT01194219|530691730|FG001|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|1|||
147143951|NCT01194219|530691731|FG002|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
147143952|NCT01194219|530691732|FG003|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
147143953|NCT01194219|530691733|FG004|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
147143954|NCT01194219|530691734|FG005|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
147143955|NCT01194219|530691735|FG006|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
147143956|NCT01194219|530691736|FG007|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
147143957|NCT01194219|530691737|FG008|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
147143958|NCT01194219|530691738|FG009|Placebo-Controlled Phase Weeks 0-16|Miscellaneous|0|||
147143959|NCT01194219|530691729|FG000|Maintenance Phase Weeks16-32|Adverse Event|0|||
147143960|NCT01194219|530691730|FG001|Maintenance Phase Weeks16-32|Adverse Event|0|||
147143961|NCT01194219|530691731|FG002|Maintenance Phase Weeks16-32|Adverse Event|8|||
147143962|NCT01194219|530691732|FG003|Maintenance Phase Weeks16-32|Adverse Event|9|||
147143963|NCT01194219|530691733|FG004|Maintenance Phase Weeks16-32|Adverse Event|0|||
147143964|NCT01194219|530691734|FG005|Maintenance Phase Weeks16-32|Adverse Event|0|||
147143965|NCT01194219|530691735|FG006|Maintenance Phase Weeks16-32|Adverse Event|0|||
147143966|NCT01194219|530691736|FG007|Maintenance Phase Weeks16-32|Adverse Event|0|||
147143967|NCT01194219|530691737|FG008|Maintenance Phase Weeks16-32|Adverse Event|0|||
147143968|NCT01194219|530691738|FG009|Maintenance Phase Weeks16-32|Adverse Event|0|||
147143969|NCT01194219|530691729|FG000|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
147143970|NCT01194219|530691730|FG001|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
147143971|NCT01194219|530691731|FG002|Maintenance Phase Weeks16-32|Lack of Efficacy|37|||
147143972|NCT01194219|530691732|FG003|Maintenance Phase Weeks16-32|Lack of Efficacy|15|||
147143973|NCT01194219|530691733|FG004|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
147143974|NCT01194219|530691734|FG005|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
147143975|NCT01194219|530691735|FG006|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
147143976|NCT01194219|530691736|FG007|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
147143977|NCT01194219|530691737|FG008|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
147143978|NCT01194219|530691738|FG009|Maintenance Phase Weeks16-32|Lack of Efficacy|0|||
147143979|NCT01194219|530691729|FG000|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
147143980|NCT01194219|530691730|FG001|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
147143981|NCT01194219|530691731|FG002|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|2|||
147143982|NCT01194219|530691732|FG003|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|1|||
147143983|NCT01194219|530691733|FG004|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
147143984|NCT01194219|530691734|FG005|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
147143985|NCT01194219|530691735|FG006|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
147143986|NCT01194219|530691736|FG007|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
147574189|NCT01442376|532259051|FG001|Overall Study|Not eligible for subsequent cycles|2|||
147574190|NCT01442376|532259052|FG002|Overall Study|Not eligible for subsequent cycles|0|||
147574191|NCT00863330|532259053|FG000|Overall Study|study terminated early due to administra|6|||
147574192|NCT04404725|532259054|FG000|First Intervention|Withdrawal by Subject|0|||
147574193|NCT04404725|532259055|FG001|First Intervention|Withdrawal by Subject|2|||
147574194|NCT04404725|532259054|FG000|Second Intervention|Adverse Event|1|||
147574195|NCT04404725|532259055|FG001|Second Intervention|Adverse Event|1|||
147574196|NCT04404725|532259054|FG000|Second Intervention|Withdrawal by Subject|0|||
147574197|NCT04404725|532259055|FG001|Second Intervention|Withdrawal by Subject|1|||
147574198|NCT01075516|532259056|FG000|Overall Study|Death|5|||
147143987|NCT01194219|530691737|FG008|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
147143988|NCT01194219|530691738|FG009|Maintenance Phase Weeks16-32|Non-compliance with Study Drug|0|||
147143989|NCT01194219|530691729|FG000|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
147143990|NCT01194219|530691730|FG001|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
147143991|NCT01194219|530691731|FG002|Maintenance Phase Weeks16-32|Withdrawal by Subject|12|||
147143992|NCT01194219|530691732|FG003|Maintenance Phase Weeks16-32|Withdrawal by Subject|3|||
147143993|NCT01194219|530691733|FG004|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
147143994|NCT01194219|530691734|FG005|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
147143995|NCT01194219|530691735|FG006|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
147143996|NCT01194219|530691736|FG007|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
147143997|NCT01194219|530691737|FG008|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
147574199|NCT01075516|532259057|FG001|Overall Study|Death|9|||
147574200|NCT01075516|532259056|FG000|Overall Study|Lost to Follow-up|10|||
147574201|NCT01075516|532259057|FG001|Overall Study|Lost to Follow-up|2|||
147574202|NCT01075516|532259056|FG000|Overall Study|Withdrawal by Subject|3|||
147574203|NCT01075516|532259057|FG001|Overall Study|Withdrawal by Subject|5|||
147574204|NCT02252016|532259058|FG000|Overall Study|Lost to Follow-up|2|||
147574205|NCT02252016|532259059|FG001|Overall Study|Lost to Follow-up|1|||
147574206|NCT02252016|532259058|FG000|Overall Study|Physician Decision|1|||
147574207|NCT02252016|532259059|FG001|Overall Study|Physician Decision|0|||
147574208|NCT02252016|532259058|FG000|Overall Study|Withdrawal by Subject|0|||
147574209|NCT02252016|532259059|FG001|Overall Study|Withdrawal by Subject|2|||
147574210|NCT01825798|532259061|FG000|Overall Study|Adverse Event|1|||
147574211|NCT01825798|532259062|FG001|Overall Study|Adverse Event|5|||
147574212|NCT01825798|532259061|FG000|Overall Study|Lost to Follow-up|1|||
147574213|NCT01825798|532259062|FG001|Overall Study|Lost to Follow-up|0|||
147574214|NCT00834873|532259068|FG000|First Intervention|Adverse Event|0|||
147574215|NCT00834873|532259069|FG001|First Intervention|Adverse Event|1|||
147574216|NCT02055547|532259071|FG000|Overall Study|Protocol Violation|0|||
147574217|NCT02055547|532259072|FG001|Overall Study|Protocol Violation|0|||
147574218|NCT02055547|532259073|FG002|Overall Study|Protocol Violation|1|||
147574219|NCT02055547|532259074|FG003|Overall Study|Protocol Violation|0|||
147574220|NCT02055547|532259075|FG004|Overall Study|Protocol Violation|0|||
147574221|NCT02055547|532259076|FG005|Overall Study|Protocol Violation|0|||
147574222|NCT02055547|532259077|FG006|Overall Study|Protocol Violation|1|||
147574223|NCT02055547|532259078|FG007|Overall Study|Protocol Violation|0|||
147574224|NCT02055547|532259079|FG008|Overall Study|Protocol Violation|0|||
147574225|NCT02055547|532259080|FG009|Overall Study|Protocol Violation|0|||
147574226|NCT02055547|532259081|FG010|Overall Study|Protocol Violation|0|||
147574227|NCT02055547|532259082|FG011|Overall Study|Protocol Violation|0|||
147143998|NCT01194219|530691738|FG009|Maintenance Phase Weeks16-32|Withdrawal by Subject|0|||
147143999|NCT01194219|530691729|FG000|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
147144000|NCT01194219|530691730|FG001|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
147144001|NCT01194219|530691731|FG002|Maintenance Phase Weeks16-32|Lost to Follow-up|9|||
147144002|NCT01194219|530691732|FG003|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
147144003|NCT01194219|530691733|FG004|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
147144004|NCT01194219|530691734|FG005|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
147144005|NCT01194219|530691735|FG006|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
147144006|NCT01194219|530691736|FG007|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
147144007|NCT01194219|530691737|FG008|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
147144008|NCT01194219|530691738|FG009|Maintenance Phase Weeks16-32|Lost to Follow-up|0|||
147144009|NCT01194219|530691729|FG000|Maintenance Phase Weeks16-32|Protocol Violation|0|||
147144010|NCT01194219|530691730|FG001|Maintenance Phase Weeks16-32|Protocol Violation|0|||
147144011|NCT01194219|530691731|FG002|Maintenance Phase Weeks16-32|Protocol Violation|0|||
147144012|NCT01194219|530691732|FG003|Maintenance Phase Weeks16-32|Protocol Violation|1|||
147144013|NCT01194219|530691733|FG004|Maintenance Phase Weeks16-32|Protocol Violation|0|||
147144014|NCT01194219|530691734|FG005|Maintenance Phase Weeks16-32|Protocol Violation|0|||
147144015|NCT01194219|530691735|FG006|Maintenance Phase Weeks16-32|Protocol Violation|0|||
147144016|NCT01194219|530691736|FG007|Maintenance Phase Weeks16-32|Protocol Violation|0|||
147144017|NCT01194219|530691737|FG008|Maintenance Phase Weeks16-32|Protocol Violation|0|||
147144018|NCT01194219|530691738|FG009|Maintenance Phase Weeks16-32|Protocol Violation|0|||
147144019|NCT01194219|530691729|FG000|Maintenance Phase Weeks16-32|Other|0|||
147144020|NCT01194219|530691730|FG001|Maintenance Phase Weeks16-32|Other|0|||
147144021|NCT01194219|530691731|FG002|Maintenance Phase Weeks16-32|Other|2|||
147144022|NCT01194219|530691732|FG003|Maintenance Phase Weeks16-32|Other|1|||
147144023|NCT01194219|530691733|FG004|Maintenance Phase Weeks16-32|Other|0|||
147144024|NCT01194219|530691734|FG005|Maintenance Phase Weeks16-32|Other|0|||
147144025|NCT01194219|530691735|FG006|Maintenance Phase Weeks16-32|Other|0|||
147144026|NCT01194219|530691736|FG007|Maintenance Phase Weeks16-32|Other|0|||
147144027|NCT01194219|530691737|FG008|Maintenance Phase Weeks16-32|Other|0|||
147144028|NCT01194219|530691738|FG009|Maintenance Phase Weeks16-32|Other|0|||
147144029|NCT01194219|530691729|FG000|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
147574228|NCT02055547|532259083|FG012|Overall Study|Protocol Violation|0|||
147144030|NCT01194219|530691730|FG001|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
147238077|NCT01086033|531044071|FG000|Overall Study|Lost to Follow-up|86|||
147238078|NCT01086033|531044071|FG000|Overall Study|Adverse Event|42|||
147574229|NCT02055547|532259084|FG013|Overall Study|Protocol Violation|0|||
147574230|NCT02055547|532259085|FG014|Overall Study|Protocol Violation|0|||
147574231|NCT02055547|532259086|FG015|Overall Study|Protocol Violation|0|||
147574232|NCT02055547|532259087|FG016|Overall Study|Protocol Violation|0|||
147574233|NCT02055547|532259088|FG017|Overall Study|Protocol Violation|0|||
147574234|NCT02055547|532259089|FG018|Overall Study|Protocol Violation|0|||
147574235|NCT02055547|532259071|FG000|Overall Study|Physician Decision|0|||
147574236|NCT02055547|532259072|FG001|Overall Study|Physician Decision|1|||
147144031|NCT01194219|530691731|FG002|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
147144032|NCT01194219|530691732|FG003|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
147144033|NCT01194219|530691733|FG004|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
147238079|NCT01086033|531044071|FG000|Overall Study|Withdrawal by Subject|41|||
147574237|NCT02055547|532259073|FG002|Overall Study|Physician Decision|1|||
147574238|NCT02055547|532259074|FG003|Overall Study|Physician Decision|0|||
147144034|NCT01194219|530691734|FG005|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|1|||
147144035|NCT01194219|530691735|FG006|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|6|||
147144036|NCT01194219|530691736|FG007|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|5|||
147144037|NCT01194219|530691737|FG008|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
147144038|NCT01194219|530691738|FG009|Randomized Withdrawal Phase-Weeks 32-52|Adverse Event|0|||
147144039|NCT01194219|530691729|FG000|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
147144040|NCT01194219|530691730|FG001|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
147144041|NCT01194219|530691731|FG002|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
147144042|NCT01194219|530691732|FG003|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
147144043|NCT01194219|530691733|FG004|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|1|||
147144044|NCT01194219|530691734|FG005|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|1|||
147144045|NCT01194219|530691735|FG006|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|35|||
147144046|NCT01194219|530691736|FG007|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|33|||
147144047|NCT01194219|530691737|FG008|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
147144048|NCT01194219|530691738|FG009|Randomized Withdrawal Phase-Weeks 32-52|Lack of Efficacy|0|||
147144049|NCT01194219|530691729|FG000|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
147144050|NCT01194219|530691730|FG001|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
147144051|NCT01194219|530691731|FG002|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
147144052|NCT01194219|530691732|FG003|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
147144053|NCT01194219|530691733|FG004|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|1|||
147144054|NCT01194219|530691734|FG005|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
147144055|NCT01194219|530691735|FG006|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|2|||
147144056|NCT01194219|530691736|FG007|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
147144057|NCT01194219|530691737|FG008|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
147144058|NCT01194219|530691738|FG009|Randomized Withdrawal Phase-Weeks 32-52|Non-compliance with Study Drug|0|||
147144059|NCT01194219|530691729|FG000|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
147144060|NCT01194219|530691730|FG001|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
147144061|NCT01194219|530691731|FG002|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
147144062|NCT01194219|530691732|FG003|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
147144063|NCT01194219|530691733|FG004|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|1|||
147144064|NCT01194219|530691734|FG005|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
147144065|NCT01194219|530691735|FG006|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|12|||
147144066|NCT01194219|530691736|FG007|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|6|||
147144067|NCT01194219|530691737|FG008|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
147144068|NCT01194219|530691738|FG009|Randomized Withdrawal Phase-Weeks 32-52|Withdrawal by Subject|0|||
147144069|NCT01194219|530691729|FG000|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
147144070|NCT01194219|530691730|FG001|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
147144071|NCT01194219|530691731|FG002|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
147144072|NCT01194219|530691732|FG003|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
147144073|NCT01194219|530691733|FG004|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|1|||
147144074|NCT01194219|530691734|FG005|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|2|||
147144075|NCT01194219|530691735|FG006|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|5|||
147144076|NCT01194219|530691736|FG007|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
147144077|NCT01194219|530691737|FG008|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
147144078|NCT01194219|530691738|FG009|Randomized Withdrawal Phase-Weeks 32-52|Lost to Follow-up|0|||
147144079|NCT01194219|530691729|FG000|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
147144080|NCT01194219|530691730|FG001|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
147144081|NCT01194219|530691731|FG002|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
147144082|NCT01194219|530691732|FG003|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
147144083|NCT01194219|530691733|FG004|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
147144084|NCT01194219|530691734|FG005|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
147144085|NCT01194219|530691735|FG006|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
147144086|NCT01194219|530691736|FG007|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|1|||
147144087|NCT01194219|530691737|FG008|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
147574239|NCT02055547|532259075|FG004|Overall Study|Physician Decision|1|||
147574240|NCT02055547|532259076|FG005|Overall Study|Physician Decision|0|||
147574241|NCT02055547|532259077|FG006|Overall Study|Physician Decision|0|||
147574242|NCT02055547|532259078|FG007|Overall Study|Physician Decision|0|||
147574243|NCT02055547|532259079|FG008|Overall Study|Physician Decision|0|||
147574244|NCT02055547|532259080|FG009|Overall Study|Physician Decision|1|||
147574245|NCT02055547|532259081|FG010|Overall Study|Physician Decision|1|||
147574246|NCT02055547|532259082|FG011|Overall Study|Physician Decision|0|||
147144088|NCT01194219|530691738|FG009|Randomized Withdrawal Phase-Weeks 32-52|Protocol Violation|0|||
147445728|NCT01500278|531797440|FG001|Week 0 - Week 12|Prior history of serious disease|0|||
147445729|NCT01500278|531797439|FG000|Week 0 - Week 12|Sponsor decision|1|||
147144089|NCT01194219|530691729|FG000|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
147144090|NCT01194219|530691730|FG001|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
147144091|NCT01194219|530691731|FG002|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
147144092|NCT01194219|530691732|FG003|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
147144093|NCT01194219|530691733|FG004|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
147144094|NCT01194219|530691734|FG005|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
147144095|NCT01194219|530691735|FG006|Randomized Withdrawal Phase-Weeks 32-52|Other|1|||
147144096|NCT01194219|530691736|FG007|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
147144097|NCT01194219|530691737|FG008|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
147144098|NCT01194219|530691738|FG009|Randomized Withdrawal Phase-Weeks 32-52|Other|0|||
147144099|NCT01194219|530691729|FG000|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
147144100|NCT01194219|530691730|FG001|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
147144101|NCT01194219|530691731|FG002|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
147144102|NCT01194219|530691732|FG003|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
147144103|NCT01194219|530691733|FG004|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
147144104|NCT01194219|530691734|FG005|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
147144105|NCT01194219|530691735|FG006|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
147144106|NCT01194219|530691736|FG007|Long-Term Extension Weeks 52 to 260|Adverse Event|0|||
147144107|NCT01194219|530691737|FG008|Long-Term Extension Weeks 52 to 260|Adverse Event|25|||
147144108|NCT01194219|530691738|FG009|Long-Term Extension Weeks 52 to 260|Adverse Event|14|||
147144109|NCT01194219|530691729|FG000|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
147144110|NCT01194219|530691730|FG001|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
147144111|NCT01194219|530691731|FG002|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
147144112|NCT01194219|530691732|FG003|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
147144113|NCT01194219|530691733|FG004|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
147144114|NCT01194219|530691734|FG005|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
147144115|NCT01194219|530691735|FG006|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
147144116|NCT01194219|530691736|FG007|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|0|||
147144117|NCT01194219|530691737|FG008|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|81|||
147144118|NCT01194219|530691738|FG009|Long-Term Extension Weeks 52 to 260|Lack of Efficacy|49|||
147144119|NCT01194219|530691729|FG000|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
147144120|NCT01194219|530691730|FG001|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
147144121|NCT01194219|530691731|FG002|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
147144122|NCT01194219|530691732|FG003|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
147144123|NCT01194219|530691733|FG004|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
147144124|NCT01194219|530691734|FG005|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
147144125|NCT01194219|530691735|FG006|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
147144126|NCT01194219|530691736|FG007|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|0|||
147144127|NCT01194219|530691737|FG008|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|9|||
147144128|NCT01194219|530691738|FG009|Long-Term Extension Weeks 52 to 260|Noncompliance with IP|4|||
147144129|NCT01194219|530691729|FG000|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
147144130|NCT01194219|530691730|FG001|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
147144131|NCT01194219|530691731|FG002|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
147144132|NCT01194219|530691732|FG003|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
147144133|NCT01194219|530691733|FG004|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
147144134|NCT01194219|530691734|FG005|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
147144135|NCT01194219|530691735|FG006|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
147144136|NCT01194219|530691736|FG007|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|0|||
147144137|NCT01194219|530691737|FG008|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|66|||
147144138|NCT01194219|530691738|FG009|Long-Term Extension Weeks 52 to 260|Withdrawal by Subject|32|||
147144139|NCT01194219|530691729|FG000|Long-Term Extension Weeks 52 to 260|Death|0|||
147144140|NCT01194219|530691730|FG001|Long-Term Extension Weeks 52 to 260|Death|0|||
147144141|NCT01194219|530691731|FG002|Long-Term Extension Weeks 52 to 260|Death|0|||
147144142|NCT01194219|530691732|FG003|Long-Term Extension Weeks 52 to 260|Death|0|||
147144143|NCT01194219|530691733|FG004|Long-Term Extension Weeks 52 to 260|Death|0|||
147574247|NCT02055547|532259083|FG012|Overall Study|Physician Decision|0|||
147574248|NCT02055547|532259084|FG013|Overall Study|Physician Decision|0|||
147144144|NCT01194219|530691734|FG005|Long-Term Extension Weeks 52 to 260|Death|0|||
147144145|NCT01194219|530691735|FG006|Long-Term Extension Weeks 52 to 260|Death|0|||
147574249|NCT02055547|532259085|FG014|Overall Study|Physician Decision|0|||
147144146|NCT01194219|530691736|FG007|Long-Term Extension Weeks 52 to 260|Death|0|||
147144147|NCT01194219|530691737|FG008|Long-Term Extension Weeks 52 to 260|Death|1|||
147144148|NCT01194219|530691738|FG009|Long-Term Extension Weeks 52 to 260|Death|1|||
147144149|NCT01194219|530691729|FG000|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
147144150|NCT01194219|530691730|FG001|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
147144151|NCT01194219|530691731|FG002|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
147144152|NCT01194219|530691732|FG003|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
147238080|NCT01086033|531044071|FG000|Overall Study|Other|14|||
147574250|NCT02055547|532259086|FG015|Overall Study|Physician Decision|0|||
147144153|NCT01194219|530691733|FG004|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
147144154|NCT01194219|530691734|FG005|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
147144155|NCT01194219|530691735|FG006|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
147144156|NCT01194219|530691736|FG007|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|0|||
147144157|NCT01194219|530691737|FG008|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|24|||
147144158|NCT01194219|530691738|FG009|Long-Term Extension Weeks 52 to 260|Lost to Follow-up|10|||
147144159|NCT01194219|530691729|FG000|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
147144160|NCT01194219|530691730|FG001|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
147144161|NCT01194219|530691731|FG002|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
147144162|NCT01194219|530691732|FG003|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
147144163|NCT01194219|530691733|FG004|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
147144164|NCT01194219|530691734|FG005|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
147144165|NCT01194219|530691735|FG006|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
147144166|NCT01194219|530691736|FG007|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
147144167|NCT01194219|530691737|FG008|Long-Term Extension Weeks 52 to 260|Protocol Violation|3|||
147144168|NCT01194219|530691738|FG009|Long-Term Extension Weeks 52 to 260|Protocol Violation|0|||
147144169|NCT01194219|530691729|FG000|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
147144170|NCT01194219|530691730|FG001|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
147144171|NCT01194219|530691731|FG002|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
147144172|NCT01194219|530691732|FG003|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
147144173|NCT01194219|530691733|FG004|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
147144174|NCT01194219|530691734|FG005|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
147144175|NCT01194219|530691735|FG006|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
147144176|NCT01194219|530691736|FG007|Long-Term Extension Weeks 52 to 260|Miscellaneous|0|||
147144177|NCT01194219|530691737|FG008|Long-Term Extension Weeks 52 to 260|Miscellaneous|11|||
147144178|NCT01194219|530691738|FG009|Long-Term Extension Weeks 52 to 260|Miscellaneous|2|||
147144179|NCT01081951|530691739|FG000|Overall Study|Death|54|||
147144180|NCT01081951|530691740|FG001|Overall Study|Death|47|||
147144181|NCT01081951|530691739|FG000|Overall Study|Withdrawal by Subject|2|||
147144182|NCT01081951|530691740|FG001|Overall Study|Withdrawal by Subject|6|||
147144183|NCT01081951|530691739|FG000|Overall Study|Allocated treatment but did not take it|0|||
147144184|NCT01081951|530691740|FG001|Overall Study|Allocated treatment but did not take it|1|||
147144185|NCT01081951|530691739|FG000|Overall Study|Lost to Follow-up|0|||
147144186|NCT01081951|530691740|FG001|Overall Study|Lost to Follow-up|1|||
147144187|NCT01671956|530691744|FG000|Overall Study|Disease progression|0|||
147144188|NCT01671956|530691745|FG001|Overall Study|Disease progression|1|||
147144189|NCT01671956|530691744|FG000|Overall Study|Withdrawal by Subject|1|||
147144190|NCT01671956|530691745|FG001|Overall Study|Withdrawal by Subject|1|||
147144191|NCT01671956|530691744|FG000|Overall Study|Adverse Event|1|||
147144192|NCT01671956|530691745|FG001|Overall Study|Adverse Event|0|||
147144193|NCT04266912|530691757|FG000|Overall Study|Withdrawal by Subject|1|||
147144194|NCT04266912|530691758|FG001|Overall Study|Withdrawal by Subject|0|||
147144195|NCT04266912|530691759|FG002|Overall Study|Withdrawal by Subject|0|||
147144196|NCT04266912|530691760|FG003|Overall Study|Withdrawal by Subject|0|||
147144197|NCT04266912|530691757|FG000|Overall Study|Progression|6|||
147144198|NCT04266912|530691758|FG001|Overall Study|Progression|6|||
147144199|NCT04266912|530691759|FG002|Overall Study|Progression|0|||
147144200|NCT04266912|530691760|FG003|Overall Study|Progression|10|||
147144201|NCT05696444|530691761|FG000|Treatment|Physician Decision|0|||
147144202|NCT05696444|530691762|FG001|Treatment|Physician Decision|1|||
147144203|NCT05696444|530691763|FG002|Treatment|Physician Decision|0|||
147144204|NCT05696444|530691761|FG000|30 Days|Death|1|||
147144205|NCT05696444|530691762|FG001|30 Days|Death|1|||
147144206|NCT05696444|530691763|FG002|30 Days|Death|0|||
147144207|NCT05696444|530691761|FG000|30 Days|Missed Visit|1|||
147144208|NCT05696444|530691762|FG001|30 Days|Missed Visit|1|||
147144209|NCT05696444|530691763|FG002|30 Days|Missed Visit|1|||
147144210|NCT05200572|530691764|FG000|Overall Study|Withdrawal by Subject|14|||
147144211|NCT00316706|530692863|FG000|Overall Study|Lost to Follow-up|38|||
147144212|NCT00316706|530692864|FG001|Overall Study|Lost to Follow-up|48|||
147144213|NCT03640325|530692870|FG000|Overall Study|Withdrawal by Subject|4|||
147144214|NCT03640325|530692871|FG001|Overall Study|Withdrawal by Subject|1|||
147144215|NCT03640325|530692872|FG002|Overall Study|Withdrawal by Subject|0|||
147238081|NCT01086033|531044071|FG000|Overall Study|Other|13|||
147238082|NCT01086033|531044071|FG000|Overall Study|AE and Withdrew Consent|5|||
147144216|NCT03640325|530692870|FG000|Overall Study|Lost to Follow-up|4|||
147144217|NCT03640325|530692871|FG001|Overall Study|Lost to Follow-up|5|||
147144218|NCT03640325|530692872|FG002|Overall Study|Lost to Follow-up|21|||
147144219|NCT03640325|530692870|FG000|Overall Study|Death|5|||
147144220|NCT03640325|530692871|FG001|Overall Study|Death|5|||
147144221|NCT03640325|530692872|FG002|Overall Study|Death|0|||
147144222|NCT03493451|530692873|FG000|Overall Study|Death|11|||
147144223|NCT03493451|530692874|FG001|Overall Study|Death|26|||
147144224|NCT03493451|530692875|FG002|Overall Study|Death|3|||
147144225|NCT03493451|530692873|FG000|Overall Study|Lost to Follow-up|1|||
147238083|NCT01086033|531044071|FG000|Overall Study|Withdrew Consent and Lack of Efficacy|5|||
147652357|NCT03026283|532550248|FG004|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|11|||
147652358|NCT03026283|532550249|FG005|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
147652359|NCT03026283|532550250|FG006|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
147652360|NCT03026283|532550251|FG007|Optimal Care/Stress Test/ICA|Referring MD ordered diagnostic cath|0|||
147652361|NCT03026283|532550244|FG000|Optimal Care/Stress Test/ICA|Lost to Follow-up|0|||
147652362|NCT03026283|532550245|FG001|Optimal Care/Stress Test/ICA|Lost to Follow-up|0|||
147652363|NCT03026283|532550246|FG002|Optimal Care/Stress Test/ICA|Lost to Follow-up|0|||
147652364|NCT03026283|532550247|FG003|Optimal Care/Stress Test/ICA|Lost to Follow-up|9|||
147144226|NCT03493451|530692874|FG001|Overall Study|Lost to Follow-up|4|||
147144227|NCT03493451|530692875|FG002|Overall Study|Lost to Follow-up|1|||
147144228|NCT03493451|530692873|FG000|Overall Study|Withdrawal by Subject|1|||
147652365|NCT03026283|532550248|FG004|Optimal Care/Stress Test/ICA|Lost to Follow-up|2|||
147144229|NCT03493451|530692874|FG001|Overall Study|Withdrawal by Subject|1|||
147144230|NCT03493451|530692875|FG002|Overall Study|Withdrawal by Subject|2|||
147144231|NCT03493451|530692873|FG000|Overall Study|Progressive Disease|1|||
147144232|NCT03493451|530692874|FG001|Overall Study|Progressive Disease|0|||
147144233|NCT03493451|530692875|FG002|Overall Study|Progressive Disease|0|||
147144234|NCT03493451|530692873|FG000|Overall Study|Transferred to long term extension study|8|||
147144235|NCT03493451|530692874|FG001|Overall Study|Transferred to long term extension study|13|||
147144236|NCT03493451|530692875|FG002|Overall Study|Transferred to long term extension study|5|||
147144237|NCT01133756|530692878|FG000|Overall Study|Adverse Event|1|||
147144238|NCT01133756|530692879|FG001|Overall Study|Adverse Event|2|||
147144239|NCT01133756|530692880|FG002|Overall Study|Adverse Event|1|||
147144240|NCT01133756|530692878|FG000|Overall Study|Investigator Decision|1|||
147144241|NCT01133756|530692879|FG001|Overall Study|Investigator Decision|0|||
147144242|NCT01133756|530692880|FG002|Overall Study|Investigator Decision|0|||
147144243|NCT01133756|530692878|FG000|Overall Study|Withdrawal by Subject|0|||
147144244|NCT01133756|530692879|FG001|Overall Study|Withdrawal by Subject|1|||
147144245|NCT01133756|530692880|FG002|Overall Study|Withdrawal by Subject|0|||
147144246|NCT01133756|530692878|FG000|Overall Study|Progression of Disease|0|||
147144247|NCT01133756|530692879|FG001|Overall Study|Progression of Disease|0|||
147144248|NCT01133756|530692880|FG002|Overall Study|Progression of Disease|1|||
147144249|NCT01566149|530692881|FG000|Overall Study|Adverse Event|0|||
147144250|NCT01566149|530692882|FG001|Overall Study|Adverse Event|1|||
147144251|NCT01566149|530692881|FG000|Overall Study|Non-compliance with study medication|2|||
147144252|NCT01566149|530692882|FG001|Overall Study|Non-compliance with study medication|0|||
147144253|NCT01566149|530692881|FG000|Overall Study|Protocol Violation|0|||
147144254|NCT01566149|530692882|FG001|Overall Study|Protocol Violation|1|||
147144255|NCT01566149|530692881|FG000|Overall Study|Withdrawal by Subject|1|||
147144256|NCT01566149|530692882|FG001|Overall Study|Withdrawal by Subject|0|||
147144257|NCT03941873|530692896|FG000|Overall Study|Death|0|||
147144258|NCT03941873|530692897|FG001|Overall Study|Death|12|||
147144259|NCT03941873|530692898|FG002|Overall Study|Death|2|||
147144260|NCT03941873|530692899|FG003|Overall Study|Death|53|||
147144261|NCT03941873|530692896|FG000|Overall Study|Withdrawal by Subject|1|||
147144262|NCT03941873|530692897|FG001|Overall Study|Withdrawal by Subject|1|||
147144263|NCT03941873|530692898|FG002|Overall Study|Withdrawal by Subject|0|||
147144264|NCT03941873|530692899|FG003|Overall Study|Withdrawal by Subject|5|||
147144265|NCT03941873|530692896|FG000|Overall Study|Lost to Follow-up|1|||
147144266|NCT03941873|530692897|FG001|Overall Study|Lost to Follow-up|2|||
147144267|NCT03941873|530692898|FG002|Overall Study|Lost to Follow-up|0|||
147144268|NCT03941873|530692899|FG003|Overall Study|Lost to Follow-up|0|||
147144269|NCT03941873|530692896|FG000|Overall Study|Sponsor Decision|0|||
147144270|NCT03941873|530692897|FG001|Overall Study|Sponsor Decision|6|||
147144271|NCT03941873|530692898|FG002|Overall Study|Sponsor Decision|0|||
147144272|NCT03941873|530692899|FG003|Overall Study|Sponsor Decision|15|||
147144273|NCT03276728|530692900|FG000|Overall Study|Lost to Follow-up|0|||
147144274|NCT03276728|530692901|FG001|Overall Study|Lost to Follow-up|0|||
147144275|NCT03276728|530692902|FG002|Overall Study|Lost to Follow-up|2|||
147144276|NCT03276728|530692903|FG003|Overall Study|Lost to Follow-up|2|||
147144277|NCT03276728|530692904|FG004|Overall Study|Lost to Follow-up|0|||
147144278|NCT03276728|530692905|FG005|Overall Study|Lost to Follow-up|0|||
147652366|NCT03026283|532550249|FG005|Optimal Care/Stress Test/ICA|Lost to Follow-up|2|||
147144279|NCT03276728|530692906|FG006|Overall Study|Lost to Follow-up|0|||
147144280|NCT03276728|530692907|FG007|Overall Study|Lost to Follow-up|0|||
147144281|NCT03276728|530692900|FG000|Overall Study|Withdrawal by Subject|0|||
147144282|NCT03276728|530692901|FG001|Overall Study|Withdrawal by Subject|0|||
147144283|NCT03276728|530692902|FG002|Overall Study|Withdrawal by Subject|0|||
147652367|NCT03026283|532550250|FG006|Optimal Care/Stress Test/ICA|Lost to Follow-up|0|||
147144284|NCT03276728|530692903|FG003|Overall Study|Withdrawal by Subject|3|||
147144285|NCT03276728|530692904|FG004|Overall Study|Withdrawal by Subject|0|||
147144286|NCT03276728|530692905|FG005|Overall Study|Withdrawal by Subject|0|||
147144287|NCT03276728|530692906|FG006|Overall Study|Withdrawal by Subject|0|||
147144288|NCT03276728|530692907|FG007|Overall Study|Withdrawal by Subject|0|||
147144289|NCT03276728|530692900|FG000|Overall Study|Decision by sponsor|0|||
147144290|NCT03276728|530692901|FG001|Overall Study|Decision by sponsor|0|||
147238084|NCT01086033|531044071|FG000|Overall Study|Withdrew consent and Other Reason|4|||
147445730|NCT01500278|531797440|FG001|Week 0 - Week 12|Sponsor decision|0|||
147445731|NCT01500278|531797439|FG000|Week 0 - Week 12|Personal reason|0|||
147574251|NCT02055547|532259087|FG016|Overall Study|Physician Decision|0|||
147574252|NCT02055547|532259088|FG017|Overall Study|Physician Decision|0|||
147144291|NCT03276728|530692902|FG002|Overall Study|Decision by sponsor|0|||
147144292|NCT03276728|530692903|FG003|Overall Study|Decision by sponsor|0|||
147144293|NCT03276728|530692904|FG004|Overall Study|Decision by sponsor|1|||
147144294|NCT03276728|530692905|FG005|Overall Study|Decision by sponsor|0|||
147144295|NCT03276728|530692906|FG006|Overall Study|Decision by sponsor|2|||
147144296|NCT03276728|530692907|FG007|Overall Study|Decision by sponsor|1|||
147144297|NCT02982772|530692910|FG000|Intervention|Lost to Follow-up|19|||
147144298|NCT02982772|530692911|FG001|Intervention|Lost to Follow-up|13|||
147144299|NCT02982772|530692910|FG000|1M Follow-Up|Lost to Follow-up|21|||
147144300|NCT02982772|530692911|FG001|1M Follow-Up|Lost to Follow-up|18|||
147144301|NCT02982772|530692910|FG000|3M Follow-Up|Lost to Follow-up|17|||
147144302|NCT02982772|530692911|FG001|3M Follow-Up|Lost to Follow-up|11|||
147144303|NCT02982772|530692910|FG000|6M Follow-Up|Lost to Follow-up|11|||
147144304|NCT02982772|530692911|FG001|6M Follow-Up|Lost to Follow-up|9|||
147144305|NCT02982772|530692910|FG000|12M Follow-Up|Lost to Follow-up|11|||
147144306|NCT02982772|530692911|FG001|12M Follow-Up|Lost to Follow-up|5|||
147144307|NCT01234480|530692912|FG000|Overall Study|Pregnancy|88|||
147144308|NCT01234480|530692912|FG000|Overall Study|>36/Normal History|50|||
147144309|NCT01234480|530692912|FG000|Overall Study|Age|3|||
147144310|NCT01234480|530692912|FG000|Overall Study|HPV Vaccine History|28|||
147144311|NCT01234480|530692912|FG000|Overall Study|HPV Vaccine after Enrollment|17|||
147144312|NCT01234480|530692912|FG000|Overall Study|Hysterectomy|2|||
147144313|NCT01234480|530692912|FG000|Overall Study|Hysterectomy post enrollment|1|||
147144314|NCT01234480|530692912|FG000|Overall Study|Inclusion/Exclusion Violation|3|||
147144315|NCT01234480|530692912|FG000|Overall Study|Informed Consent Form Violation|30|||
147144316|NCT01234480|530692912|FG000|Overall Study|Incorrect Visit|3|||
147144317|NCT01234480|530692912|FG000|Overall Study|No Florida Lab License|20|||
147144318|NCT01234480|530692912|FG000|Overall Study|Out of Window|42|||
147144319|NCT01234480|530692912|FG000|Overall Study|Sample Processing/Storage|92|||
147144320|NCT01234480|530692912|FG000|Overall Study|Site Amendment prohibited colposcopy|11|||
147144321|NCT01234480|530692912|FG000|Overall Study|Site/Subject non-compliance|44|||
147144322|NCT01234480|530692912|FG000|Overall Study|Missing Sample|9|||
147144323|NCT02974140|530692913|FG000|Overall Study|Adverse Event|2|||
147144324|NCT02974140|530692913|FG000|Overall Study|Lost to Follow-up|1|||
147144325|NCT02974140|530692913|FG000|Overall Study|Study Terminated by Sponsor|36|||
147144326|NCT00617084|530692914|FG000|Overall Study|Withdrawal by Subject|5|||
147144327|NCT00617084|530692915|FG001|Overall Study|Withdrawal by Subject|7|||
147144328|NCT00617084|530692914|FG000|Overall Study|Missed 12 Months visit|16|||
147144329|NCT00617084|530692915|FG001|Overall Study|Missed 12 Months visit|19|||
147144330|NCT03370419|530692916|FG000|Overall Study|Lost to Follow-up|16|||
147144331|NCT01693250|530692927|FG000|Overall Study|Lost to Follow-up|2|||
147144332|NCT01693250|530692928|FG001|Overall Study|Lost to Follow-up|2|||
147144333|NCT02297815|530692933|FG000|Overall Study|Lost to Follow-up|236|||
147144334|NCT02297815|530692934|FG001|Overall Study|Lost to Follow-up|140|||
147144335|NCT03650413|530692935|FG000|Overall Study|Adverse Event|1|||
147144336|NCT03650413|530692935|FG000|Overall Study|Lack of Efficacy|17|||
147144337|NCT03650413|530692935|FG000|Overall Study|Other|9|||
147144338|NCT03650413|530692935|FG000|Overall Study|Physician Decision|2|||
147144339|NCT03650413|530692935|FG000|Overall Study|Study Terminated By Sponsor|16|||
147144340|NCT03650413|530692935|FG000|Overall Study|Withdrawal by Subject|16|||
147144341|NCT00310375|530692936|FG000|Primary Reporting Phase|Adverse Event|28|||
147144342|NCT00310375|530692937|FG001|Primary Reporting Phase|Adverse Event|22|||
147144343|NCT00310375|530692938|FG002|Primary Reporting Phase|Adverse Event|0|||
147144344|NCT00310375|530692936|FG000|Primary Reporting Phase|Lack of Efficacy|24|||
147144345|NCT00310375|530692937|FG001|Primary Reporting Phase|Lack of Efficacy|19|||
147144346|NCT00310375|530692938|FG002|Primary Reporting Phase|Lack of Efficacy|0|||
147144347|NCT00310375|530692936|FG000|Primary Reporting Phase|Pregnancy|2|||
147144348|NCT00310375|530692937|FG001|Primary Reporting Phase|Pregnancy|2|||
147144349|NCT00310375|530692938|FG002|Primary Reporting Phase|Pregnancy|0|||
147144350|NCT00310375|530692936|FG000|Primary Reporting Phase|Withdrawal by Subject|10|||
147144351|NCT00310375|530692937|FG001|Primary Reporting Phase|Withdrawal by Subject|7|||
147144352|NCT00310375|530692938|FG002|Primary Reporting Phase|Withdrawal by Subject|0|||
147144353|NCT00310375|530692936|FG000|Primary Reporting Phase|Protocol Violation|8|||
147144354|NCT00310375|530692937|FG001|Primary Reporting Phase|Protocol Violation|5|||
147144355|NCT00310375|530692938|FG002|Primary Reporting Phase|Protocol Violation|0|||
147144356|NCT00310375|530692936|FG000|Primary Reporting Phase|Change in Par medical condition|2|||
147144357|NCT00310375|530692937|FG001|Primary Reporting Phase|Change in Par medical condition|0|||
147144358|NCT00310375|530692938|FG002|Primary Reporting Phase|Change in Par medical condition|0|||
147574253|NCT02055547|532259089|FG018|Overall Study|Physician Decision|0|||
147144359|NCT00310375|530692936|FG000|Primary Reporting Phase|Transaminase >5 upper limit of normal|2|||
147238085|NCT01086033|531044071|FG000|Overall Study|AE and Lack of Efficacy|4|||
147238086|NCT01086033|531044071|FG000|Overall Study|Death|1|||
147144360|NCT00310375|530692937|FG001|Primary Reporting Phase|Transaminase >5 upper limit of normal|1|||
147144361|NCT00310375|530692938|FG002|Primary Reporting Phase|Transaminase >5 upper limit of normal|0|||
147144362|NCT00310375|530692936|FG000|Primary Reporting Phase|Physician Decision|5|||
147144363|NCT00310375|530692937|FG001|Primary Reporting Phase|Physician Decision|3|||
147144364|NCT00310375|530692938|FG002|Primary Reporting Phase|Physician Decision|0|||
147144365|NCT00310375|530692936|FG000|Primary Reporting Phase|Request of the sponsor|2|||
147144366|NCT00310375|530692937|FG001|Primary Reporting Phase|Request of the sponsor|2|||
147144367|NCT00310375|530692938|FG002|Primary Reporting Phase|Request of the sponsor|0|||
147144368|NCT00310375|530692936|FG000|Primary Reporting Phase|Failed to return|1|||
147144369|NCT00310375|530692937|FG001|Primary Reporting Phase|Failed to return|3|||
147144370|NCT00310375|530692938|FG002|Primary Reporting Phase|Failed to return|0|||
147144371|NCT00310375|530692936|FG000|Primary Reporting Phase|Participant request unrelated to study|1|||
147144372|NCT00310375|530692937|FG001|Primary Reporting Phase|Participant request unrelated to study|2|||
147144373|NCT00310375|530692938|FG002|Primary Reporting Phase|Participant request unrelated to study|0|||
147144374|NCT00310375|530692936|FG000|Primary Reporting Phase|Going for temporal lobectomy|1|||
147144375|NCT00310375|530692937|FG001|Primary Reporting Phase|Going for temporal lobectomy|0|||
147144376|NCT00310375|530692938|FG002|Primary Reporting Phase|Going for temporal lobectomy|0|||
147144377|NCT00310375|530692936|FG000|Primary Reporting Phase|Missed study drug >5 days|1|||
147144378|NCT00310375|530692937|FG001|Primary Reporting Phase|Missed study drug >5 days|0|||
147144379|NCT00310375|530692938|FG002|Primary Reporting Phase|Missed study drug >5 days|0|||
147144380|NCT00310375|530692936|FG000|Primary Reporting Phase|Site closure|3|||
147144381|NCT00310375|530692937|FG001|Primary Reporting Phase|Site closure|0|||
147144382|NCT00310375|530692938|FG002|Primary Reporting Phase|Site closure|0|||
147144383|NCT00310375|530692936|FG000|Primary Reporting Phase|Missed study drug for 2 months|1|||
147144384|NCT00310375|530692937|FG001|Primary Reporting Phase|Missed study drug for 2 months|0|||
147144385|NCT00310375|530692938|FG002|Primary Reporting Phase|Missed study drug for 2 months|0|||
147144386|NCT00310375|530692936|FG000|Primary Reporting Phase|Par. switched to commercial product|0|||
147144387|NCT00310375|530692937|FG001|Primary Reporting Phase|Par. switched to commercial product|1|||
147144388|NCT00310375|530692938|FG002|Primary Reporting Phase|Par. switched to commercial product|0|||
147144389|NCT00310375|530692936|FG000|Primary Reporting Phase|Request of Ethics Committee|0|||
147144390|NCT00310375|530692937|FG001|Primary Reporting Phase|Request of Ethics Committee|1|||
147144391|NCT00310375|530692938|FG002|Primary Reporting Phase|Request of Ethics Committee|0|||
147144392|NCT00310375|530692936|FG000|Safety Follow-up Continuation Phase|Lost to Follow-up|0|||
147144393|NCT00310375|530692937|FG001|Safety Follow-up Continuation Phase|Lost to Follow-up|0|||
147144394|NCT00310375|530692938|FG002|Safety Follow-up Continuation Phase|Lost to Follow-up|1|||
147144395|NCT03726658|530692940|FG000|Overall Study|Lost to Follow-up|0|||
147144396|NCT03726658|530692941|FG001|Overall Study|Lost to Follow-up|0|||
147144397|NCT03726658|530692942|FG002|Overall Study|Lost to Follow-up|2|||
147144398|NCT03726658|530692943|FG003|Overall Study|Lost to Follow-up|0|||
147144399|NCT03726658|530692944|FG004|Overall Study|Lost to Follow-up|0|||
147144400|NCT03726658|530692945|FG005|Overall Study|Lost to Follow-up|1|||
147144401|NCT03726658|530692946|FG006|Overall Study|Lost to Follow-up|1|||
147144402|NCT03726658|530692940|FG000|Overall Study|Withdrawal by Subject|1|||
147144403|NCT03726658|530692941|FG001|Overall Study|Withdrawal by Subject|0|||
147144404|NCT03726658|530692942|FG002|Overall Study|Withdrawal by Subject|0|||
147144405|NCT03726658|530692943|FG003|Overall Study|Withdrawal by Subject|0|||
147144406|NCT03726658|530692944|FG004|Overall Study|Withdrawal by Subject|6|||
147144407|NCT03726658|530692945|FG005|Overall Study|Withdrawal by Subject|4|||
147144408|NCT03726658|530692946|FG006|Overall Study|Withdrawal by Subject|2|||
147144409|NCT03726658|530692940|FG000|Overall Study|Pregnancy|0|||
147144410|NCT03726658|530692941|FG001|Overall Study|Pregnancy|0|||
147144411|NCT03726658|530692942|FG002|Overall Study|Pregnancy|0|||
147144412|NCT03726658|530692943|FG003|Overall Study|Pregnancy|0|||
147144413|NCT03726658|530692944|FG004|Overall Study|Pregnancy|0|||
147144414|NCT03726658|530692945|FG005|Overall Study|Pregnancy|0|||
147144415|NCT03726658|530692946|FG006|Overall Study|Pregnancy|1|||
147144416|NCT03726658|530692940|FG000|Overall Study|Not Reported|0|||
147144417|NCT03726658|530692941|FG001|Overall Study|Not Reported|0|||
147574254|NCT02055547|532259071|FG000|Overall Study|Adverse Event|0|||
147574255|NCT02055547|532259072|FG001|Overall Study|Adverse Event|0|||
147574256|NCT02055547|532259073|FG002|Overall Study|Adverse Event|0|||
147574257|NCT02055547|532259074|FG003|Overall Study|Adverse Event|0|||
147574258|NCT02055547|532259075|FG004|Overall Study|Adverse Event|0|||
147144418|NCT03726658|530692942|FG002|Overall Study|Not Reported|0|||
147144419|NCT03726658|530692943|FG003|Overall Study|Not Reported|0|||
147144420|NCT03726658|530692944|FG004|Overall Study|Not Reported|0|||
147144421|NCT03726658|530692945|FG005|Overall Study|Not Reported|0|||
147144422|NCT03726658|530692946|FG006|Overall Study|Not Reported|1|||
147144423|NCT00412958|530692947|FG000|Overall Study|Withdrawal by Subject|3|||
147144424|NCT00412958|530692948|FG001|Overall Study|Withdrawal by Subject|0|||
147144425|NCT00412958|530692949|FG002|Overall Study|Withdrawal by Subject|0|||
147574259|NCT02055547|532259076|FG005|Overall Study|Adverse Event|0|||
147144426|NCT00412958|530692950|FG003|Overall Study|Withdrawal by Subject|1|||
147574260|NCT02055547|532259077|FG006|Overall Study|Adverse Event|1|||
147144427|NCT00412958|530692947|FG000|Overall Study|Adverse Event|0|||
147144428|NCT00412958|530692948|FG001|Overall Study|Adverse Event|1|||
147144429|NCT00412958|530692949|FG002|Overall Study|Adverse Event|0|||
147144430|NCT00412958|530692950|FG003|Overall Study|Adverse Event|0|||
147144431|NCT00412958|530692947|FG000|Overall Study|Lost to Follow-up|0|||
147144432|NCT00412958|530692948|FG001|Overall Study|Lost to Follow-up|1|||
147144433|NCT00412958|530692949|FG002|Overall Study|Lost to Follow-up|0|||
147144434|NCT00412958|530692950|FG003|Overall Study|Lost to Follow-up|0|||
147144435|NCT00412958|530692947|FG000|Overall Study|Death|0|||
147144436|NCT00412958|530692948|FG001|Overall Study|Death|1|||
147144437|NCT00412958|530692949|FG002|Overall Study|Death|0|||
147144438|NCT00412958|530692950|FG003|Overall Study|Death|0|||
147144439|NCT00412958|530692947|FG000|Overall Study|Transport issue|0|||
147144440|NCT00412958|530692948|FG001|Overall Study|Transport issue|1|||
147144441|NCT00412958|530692949|FG002|Overall Study|Transport issue|0|||
147144442|NCT00412958|530692950|FG003|Overall Study|Transport issue|0|||
147144443|NCT01318135|530692951|FG000|Enrolled - Long-Term Extension Study|Adverse Event|1|||
147144444|NCT01318135|530692952|FG001|Enrolled - Long-Term Extension Study|Adverse Event|0|||
147144445|NCT01318135|530692953|FG002|Enrolled - Long-Term Extension Study|Adverse Event|0|||
147144446|NCT01318135|530692954|FG003|Enrolled - Long-Term Extension Study|Adverse Event|0|||
147144447|NCT01318135|530692955|FG004|Enrolled - Long-Term Extension Study|Adverse Event|0|||
147144448|NCT01318135|530692956|FG005|Enrolled - Long-Term Extension Study|Adverse Event|0|||
147144449|NCT01318135|530692957|FG006|Enrolled - Long-Term Extension Study|Adverse Event|0|||
147144450|NCT01318135|530692958|FG007|Enrolled - Long-Term Extension Study|Adverse Event|0|||
147144451|NCT01318135|530692951|FG000|Enrolled - Long-Term Extension Study|Treatment Complications|1|||
147144452|NCT01318135|530692952|FG001|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
147144453|NCT01318135|530692953|FG002|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
147144454|NCT01318135|530692954|FG003|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
147144455|NCT01318135|530692955|FG004|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
147144456|NCT01318135|530692956|FG005|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
147144457|NCT01318135|530692957|FG006|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
147144458|NCT01318135|530692958|FG007|Enrolled - Long-Term Extension Study|Treatment Complications|0|||
147144459|NCT01318135|530692951|FG000|Entered - Long-Term Extension Study|Adverse Event|9|||
147144460|NCT01318135|530692952|FG001|Entered - Long-Term Extension Study|Adverse Event|3|||
147144461|NCT01318135|530692953|FG002|Entered - Long-Term Extension Study|Adverse Event|4|||
147144462|NCT01318135|530692954|FG003|Entered - Long-Term Extension Study|Adverse Event|3|||
147144463|NCT01318135|530692955|FG004|Entered - Long-Term Extension Study|Adverse Event|4|||
147144464|NCT01318135|530692956|FG005|Entered - Long-Term Extension Study|Adverse Event|2|||
147144465|NCT01318135|530692957|FG006|Entered - Long-Term Extension Study|Adverse Event|0|||
147144466|NCT01318135|530692958|FG007|Entered - Long-Term Extension Study|Adverse Event|0|||
147144467|NCT01318135|530692951|FG000|Entered - Long-Term Extension Study|Protocol Violation|1|||
147144468|NCT01318135|530692952|FG001|Entered - Long-Term Extension Study|Protocol Violation|1|||
147144469|NCT01318135|530692953|FG002|Entered - Long-Term Extension Study|Protocol Violation|0|||
147144470|NCT01318135|530692954|FG003|Entered - Long-Term Extension Study|Protocol Violation|0|||
147144471|NCT01318135|530692955|FG004|Entered - Long-Term Extension Study|Protocol Violation|1|||
147144472|NCT01318135|530692956|FG005|Entered - Long-Term Extension Study|Protocol Violation|0|||
147144473|NCT01318135|530692957|FG006|Entered - Long-Term Extension Study|Protocol Violation|0|||
147144474|NCT01318135|530692958|FG007|Entered - Long-Term Extension Study|Protocol Violation|0|||
147144475|NCT01318135|530692951|FG000|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
147144476|NCT01318135|530692952|FG001|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
147144477|NCT01318135|530692953|FG002|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
147144478|NCT01318135|530692954|FG003|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
147144479|NCT01318135|530692955|FG004|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
147144480|NCT01318135|530692956|FG005|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
147144481|NCT01318135|530692957|FG006|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
147144482|NCT01318135|530692958|FG007|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
147144483|NCT01318135|530692951|FG000|Entered - Long-Term Extension Study|Lack of Efficacy|5|||
147144484|NCT01318135|530692952|FG001|Entered - Long-Term Extension Study|Lack of Efficacy|7|||
147144485|NCT01318135|530692953|FG002|Entered - Long-Term Extension Study|Lack of Efficacy|2|||
147144486|NCT01318135|530692954|FG003|Entered - Long-Term Extension Study|Lack of Efficacy|3|||
147144487|NCT01318135|530692955|FG004|Entered - Long-Term Extension Study|Lack of Efficacy|2|||
147144488|NCT01318135|530692956|FG005|Entered - Long-Term Extension Study|Lack of Efficacy|2|||
147144489|NCT01318135|530692957|FG006|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
147144490|NCT01318135|530692958|FG007|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
147144491|NCT01318135|530692951|FG000|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
147144492|NCT01318135|530692952|FG001|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
147144493|NCT01318135|530692953|FG002|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
147144494|NCT01318135|530692954|FG003|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
147445732|NCT01500278|531797440|FG001|Week 0 - Week 12|Personal reason|1|||
147144495|NCT01318135|530692955|FG004|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
147144496|NCT01318135|530692956|FG005|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
147144497|NCT01318135|530692957|FG006|Entered - Long-Term Extension Study|Use of Excluded Medications|0|||
147144498|NCT01318135|530692958|FG007|Entered - Long-Term Extension Study|Use of Excluded Medications|1|||
147238087|NCT01086033|531044071|FG000|Overall Study|AE and Lost to Follow-up|1|||
147238088|NCT01086033|531044071|FG000|Overall Study|AE and Other Reason|1|||
147238089|NCT01086033|531044071|FG000|Overall Study|AE, Withdrew Consent & Lack of Efficacy|1|||
147238090|NCT03094169|531044072|FG000|Overall Study|Lack of Efficacy|0|||
147238091|NCT03094169|531044073|FG001|Overall Study|Lack of Efficacy|0|||
147238092|NCT03094169|531044074|FG002|Overall Study|Lack of Efficacy|0|||
147238093|NCT03094169|531044075|FG003|Overall Study|Lack of Efficacy|0|||
147238094|NCT03094169|531044076|FG004|Overall Study|Lack of Efficacy|0|||
147238095|NCT03094169|531044077|FG005|Overall Study|Lack of Efficacy|0|||
147238096|NCT03094169|531044078|FG006|Overall Study|Lack of Efficacy|0|||
147238097|NCT03094169|531044079|FG007|Overall Study|Lack of Efficacy|21|||
147574261|NCT02055547|532259078|FG007|Overall Study|Adverse Event|0|||
147574262|NCT02055547|532259079|FG008|Overall Study|Adverse Event|1|||
147144499|NCT03782064|530692963|FG000|Overall Study|Lack of Efficacy|2|||
147144500|NCT03782064|530692963|FG000|Overall Study|Progression Prior to Starting Treatment|3|||
147144501|NCT00363142|530692964|FG000|Overall Study|Adverse Event|2|||
147144502|NCT00363142|530692965|FG001|Overall Study|Adverse Event|0|||
147144503|NCT00363142|530692964|FG000|Overall Study|Lack of Efficacy|0|||
147144504|NCT00363142|530692965|FG001|Overall Study|Lack of Efficacy|1|||
147144505|NCT00363142|530692964|FG000|Overall Study|Lost to Follow-up|1|||
147144506|NCT00363142|530692965|FG001|Overall Study|Lost to Follow-up|0|||
147144507|NCT00363142|530692964|FG000|Overall Study|Non-compliance|1|||
147144508|NCT00363142|530692965|FG001|Overall Study|Non-compliance|1|||
147144509|NCT00363142|530692964|FG000|Overall Study|Withdrawal by Subject|3|||
147144510|NCT00363142|530692965|FG001|Overall Study|Withdrawal by Subject|1|||
147144511|NCT00049322|530692969|FG000|Overall Study|disease burden|0|||
147144512|NCT00049322|530692970|FG001|Overall Study|disease burden|3|||
147144513|NCT00049322|530692969|FG000|Overall Study|Adverse Event|1|||
147144514|NCT00049322|530692970|FG001|Overall Study|Adverse Event|0|||
147144515|NCT00049322|530692969|FG000|Overall Study|refused angio|0|||
147144516|NCT00049322|530692970|FG001|Overall Study|refused angio|3|||
147144517|NCT03994211|530692971|FG000|Core Phase|Adverse Event|0|||
147144518|NCT03994211|530692972|FG001|Core Phase|Adverse Event|1|||
147144519|NCT03994211|530692973|FG002|Core Phase|Adverse Event|0|||
147144520|NCT03994211|530692971|FG000|Extension Phase|Adverse Event|0|||
147144521|NCT03994211|530692972|FG001|Extension Phase|Adverse Event|0|||
147144522|NCT03994211|530692973|FG002|Extension Phase|Adverse Event|1|||
147144523|NCT03994211|530692971|FG000|Extension Phase|Physician Decision|0|||
147144524|NCT03994211|530692972|FG001|Extension Phase|Physician Decision|0|||
147144525|NCT03994211|530692973|FG002|Extension Phase|Physician Decision|1|||
147144526|NCT03994211|530692971|FG000|Extension Phase|Progressive Disease|0|||
147144527|NCT03994211|530692972|FG001|Extension Phase|Progressive Disease|0|||
147144528|NCT03994211|530692973|FG002|Extension Phase|Progressive Disease|20|||
147144529|NCT03994211|530692971|FG000|Extension Phase|Withdrawal by Subject|0|||
147144530|NCT03994211|530692972|FG001|Extension Phase|Withdrawal by Subject|0|||
147144531|NCT03994211|530692973|FG002|Extension Phase|Withdrawal by Subject|2|||
147144532|NCT02625220|530692974|FG000|Overall Study|Adverse Event|2|||
147144533|NCT02625220|530692974|FG000|Overall Study|Lost to Follow-up|2|||
147144534|NCT02625220|530692974|FG000|Overall Study|Protocol Violation|1|||
147144535|NCT02625220|530692974|FG000|Overall Study|Study discontinued at site|2|||
147144536|NCT01140867|530692975|FG000|Overall Study|Adverse Event|22|||
147144537|NCT01140867|530692975|FG000|Overall Study|Lack of Efficacy|3|||
147144538|NCT01140867|530692975|FG000|Overall Study|Lost to Follow-up|2|||
147144539|NCT01140867|530692975|FG000|Overall Study|Withdrawal by Subject|1|||
147144540|NCT01140867|530692975|FG000|Overall Study|Protocol Violation|1|||
147144541|NCT01140867|530692975|FG000|Overall Study|Uncooperative patient|2|||
147144542|NCT01140867|530692975|FG000|Overall Study|Medication Noncompliance|2|||
147144543|NCT01926444|530692976|FG000|Overall Study|Colonoscopy not performed|0|||
147574263|NCT02055547|532259080|FG009|Overall Study|Adverse Event|0|||
147144544|NCT01926444|530692977|FG001|Overall Study|Colonoscopy not performed|0|||
147144545|NCT01926444|530692978|FG002|Overall Study|Colonoscopy not performed|4|||
147144546|NCT01926444|530692979|FG003|Overall Study|Colonoscopy not performed|2|||
147144547|NCT03035864|530692983|FG000|Treatment Period|Adverse Event|1|||
147144548|NCT03035864|530692984|FG001|Treatment Period|Adverse Event|0|||
147144549|NCT03035864|530692983|FG000|Treatment Period|Other|3|||
147144550|NCT03035864|530692984|FG001|Treatment Period|Other|1|||
147574264|NCT02055547|532259081|FG010|Overall Study|Adverse Event|0|||
147144551|NCT03035864|530692983|FG000|Follow-up Period|Adverse Event|1|||
147144552|NCT03035864|530692984|FG001|Follow-up Period|Adverse Event|0|||
147238098|NCT03094169|531044072|FG000|Overall Study|Adverse Event|0|||
147238099|NCT03094169|531044073|FG001|Overall Study|Adverse Event|0|||
147144553|NCT03035864|530692983|FG000|Follow-up Period|Lost to Follow-up|6|||
147144554|NCT03035864|530692984|FG001|Follow-up Period|Lost to Follow-up|2|||
147238100|NCT03094169|531044074|FG002|Overall Study|Adverse Event|0|||
147144555|NCT03035864|530692983|FG000|Follow-up Period|Physician Decision|1|||
147144556|NCT03035864|530692984|FG001|Follow-up Period|Physician Decision|0|||
147144557|NCT03035864|530692983|FG000|Follow-up Period|Other|3|||
147144558|NCT03035864|530692984|FG001|Follow-up Period|Other|2|||
147144559|NCT02720523|530692985|FG000|Period 1: Placebo-controlled Period|Adverse Event|0|||
147144560|NCT02720523|530692986|FG001|Period 1: Placebo-controlled Period|Adverse Event|0|||
147144561|NCT02720523|530692987|FG002|Period 1: Placebo-controlled Period|Adverse Event|1|||
147144562|NCT02720523|530692988|FG003|Period 1: Placebo-controlled Period|Adverse Event|5|||
147144563|NCT02720523|530692989|FG004|Period 1: Placebo-controlled Period|Adverse Event|0|||
147144564|NCT02720523|530692990|FG005|Period 1: Placebo-controlled Period|Adverse Event|0|||
147144565|NCT02720523|530692991|FG006|Period 1: Placebo-controlled Period|Adverse Event|0|||
147144566|NCT02720523|530692985|FG000|Period 1: Placebo-controlled Period|Withdrawal by Subject|1|||
147144567|NCT02720523|530692986|FG001|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
147144568|NCT02720523|530692987|FG002|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
147144569|NCT02720523|530692988|FG003|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
147144570|NCT02720523|530692989|FG004|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
147144571|NCT02720523|530692990|FG005|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
147144572|NCT02720523|530692991|FG006|Period 1: Placebo-controlled Period|Withdrawal by Subject|0|||
147144573|NCT02720523|530692985|FG000|Period 1: Placebo-controlled Period|Lack of Efficacy|1|||
147144574|NCT02720523|530692986|FG001|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
147144575|NCT02720523|530692987|FG002|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
147144576|NCT02720523|530692988|FG003|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
147144577|NCT02720523|530692989|FG004|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
147144578|NCT02720523|530692990|FG005|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
147144579|NCT02720523|530692991|FG006|Period 1: Placebo-controlled Period|Lack of Efficacy|0|||
147144580|NCT02720523|530692985|FG000|Period 1: Placebo-controlled Period|Other|0|||
147144581|NCT02720523|530692986|FG001|Period 1: Placebo-controlled Period|Other|0|||
147144582|NCT02720523|530692987|FG002|Period 1: Placebo-controlled Period|Other|1|||
147144583|NCT02720523|530692988|FG003|Period 1: Placebo-controlled Period|Other|1|||
147144584|NCT02720523|530692989|FG004|Period 1: Placebo-controlled Period|Other|0|||
147144585|NCT02720523|530692990|FG005|Period 1: Placebo-controlled Period|Other|0|||
147144586|NCT02720523|530692991|FG006|Period 1: Placebo-controlled Period|Other|0|||
147144587|NCT02720523|530692985|FG000|Period 2: Long-term Extension Period|Ongoing|0|||
147144588|NCT02720523|530692986|FG001|Period 2: Long-term Extension Period|Ongoing|0|||
147144589|NCT02720523|530692987|FG002|Period 2: Long-term Extension Period|Ongoing|0|||
147144590|NCT02720523|530692988|FG003|Period 2: Long-term Extension Period|Ongoing|0|||
147144591|NCT02720523|530692989|FG004|Period 2: Long-term Extension Period|Ongoing|57|||
147144592|NCT02720523|530692990|FG005|Period 2: Long-term Extension Period|Ongoing|54|||
147144593|NCT02720523|530692991|FG006|Period 2: Long-term Extension Period|Ongoing|45|||
147144594|NCT02720523|530692985|FG000|Period 2: Long-term Extension Period|Adverse Event|0|||
147144595|NCT02720523|530692986|FG001|Period 2: Long-term Extension Period|Adverse Event|0|||
147144596|NCT02720523|530692987|FG002|Period 2: Long-term Extension Period|Adverse Event|0|||
147144597|NCT02720523|530692988|FG003|Period 2: Long-term Extension Period|Adverse Event|0|||
147144598|NCT02720523|530692989|FG004|Period 2: Long-term Extension Period|Adverse Event|4|||
147144599|NCT02720523|530692990|FG005|Period 2: Long-term Extension Period|Adverse Event|7|||
147144600|NCT02720523|530692991|FG006|Period 2: Long-term Extension Period|Adverse Event|11|||
147144601|NCT02720523|530692985|FG000|Period 2: Long-term Extension Period|Withdrawal by Subject|0|||
147144602|NCT02720523|530692986|FG001|Period 2: Long-term Extension Period|Withdrawal by Subject|0|||
147144603|NCT02720523|530692987|FG002|Period 2: Long-term Extension Period|Withdrawal by Subject|0|||
147144604|NCT02720523|530692988|FG003|Period 2: Long-term Extension Period|Withdrawal by Subject|0|||
147144605|NCT02720523|530692989|FG004|Period 2: Long-term Extension Period|Withdrawal by Subject|2|||
147144606|NCT02720523|530692990|FG005|Period 2: Long-term Extension Period|Withdrawal by Subject|1|||
147144607|NCT02720523|530692991|FG006|Period 2: Long-term Extension Period|Withdrawal by Subject|1|||
147144608|NCT02720523|530692985|FG000|Period 2: Long-term Extension Period|Other|0|||
147144609|NCT02720523|530692986|FG001|Period 2: Long-term Extension Period|Other|0|||
147144610|NCT02720523|530692987|FG002|Period 2: Long-term Extension Period|Other|0|||
147144611|NCT02720523|530692988|FG003|Period 2: Long-term Extension Period|Other|0|||
147144612|NCT02720523|530692989|FG004|Period 2: Long-term Extension Period|Other|2|||
147144613|NCT02720523|530692990|FG005|Period 2: Long-term Extension Period|Other|0|||
147144614|NCT02720523|530692991|FG006|Period 2: Long-term Extension Period|Other|3|||
147144615|NCT00577707|530692996|FG000|Overall Study|Withdrawal by Subject|3|||
147144616|NCT03299244|530692997|FG000|Overall Study|Withdrawal by Subject|34|||
147144617|NCT03299244|530692998|FG001|Overall Study|Withdrawal by Subject|29|||
147144618|NCT03299244|530692997|FG000|Overall Study|Decision by Sponsor|4|||
147238101|NCT03094169|531044075|FG003|Overall Study|Adverse Event|0|||
147144619|NCT03299244|530692998|FG001|Overall Study|Decision by Sponsor|5|||
147238102|NCT03094169|531044076|FG004|Overall Study|Adverse Event|0|||
147238103|NCT03094169|531044077|FG005|Overall Study|Adverse Event|0|||
147238104|NCT03094169|531044078|FG006|Overall Study|Adverse Event|0|||
147238105|NCT03094169|531044079|FG007|Overall Study|Adverse Event|2|||
147574265|NCT02055547|532259082|FG011|Overall Study|Adverse Event|0|||
147574266|NCT02055547|532259083|FG012|Overall Study|Adverse Event|0|||
147144620|NCT03299244|530692997|FG000|Overall Study|Death|9|||
147144621|NCT03299244|530692998|FG001|Overall Study|Death|4|||
147144622|NCT03146663|530692999|FG000|Overall Study|Did not receive study treatment|1|||
147144623|NCT03146663|530693000|FG001|Overall Study|Did not receive study treatment|1|||
147144624|NCT00980460|530693001|FG000|Overall Study|Death|0|||
147144625|NCT00980460|530693002|FG001|Overall Study|Death|0|||
147144626|NCT00980460|530693003|FG002|Overall Study|Death|1|||
147144627|NCT00980460|530693004|FG003|Overall Study|Death|2|||
147144628|NCT00980460|530693005|FG004|Overall Study|Death|1|||
147144629|NCT00980460|530693001|FG000|Overall Study|Lack of Efficacy|0|||
147144630|NCT00980460|530693002|FG001|Overall Study|Lack of Efficacy|0|||
147144631|NCT00980460|530693003|FG002|Overall Study|Lack of Efficacy|10|||
147144632|NCT00980460|530693004|FG003|Overall Study|Lack of Efficacy|6|||
147144633|NCT00980460|530693005|FG004|Overall Study|Lack of Efficacy|8|||
147144634|NCT00980460|530693001|FG000|Overall Study|Lost to Follow-up|0|||
147144635|NCT00980460|530693002|FG001|Overall Study|Lost to Follow-up|0|||
147144636|NCT00980460|530693003|FG002|Overall Study|Lost to Follow-up|0|||
147144637|NCT00980460|530693004|FG003|Overall Study|Lost to Follow-up|1|||
147144638|NCT00980460|530693005|FG004|Overall Study|Lost to Follow-up|0|||
147144639|NCT00980460|530693001|FG000|Overall Study|Physician Decision|0|||
147144640|NCT00980460|530693002|FG001|Overall Study|Physician Decision|0|||
147144641|NCT00980460|530693003|FG002|Overall Study|Physician Decision|11|||
147144642|NCT00980460|530693004|FG003|Overall Study|Physician Decision|5|||
147144643|NCT00980460|530693005|FG004|Overall Study|Physician Decision|3|||
147144644|NCT00980460|530693001|FG000|Overall Study|Withdrawal by Subject|0|||
147144645|NCT00980460|530693002|FG001|Overall Study|Withdrawal by Subject|0|||
147144646|NCT00980460|530693003|FG002|Overall Study|Withdrawal by Subject|1|||
147144647|NCT00980460|530693004|FG003|Overall Study|Withdrawal by Subject|0|||
147144648|NCT00980460|530693005|FG004|Overall Study|Withdrawal by Subject|0|||
147144649|NCT00980460|530693001|FG000|Overall Study|Ineligible|0|||
147144650|NCT00980460|530693002|FG001|Overall Study|Ineligible|2|||
147144651|NCT00980460|530693003|FG002|Overall Study|Ineligible|3|||
147144652|NCT00980460|530693004|FG003|Overall Study|Ineligible|1|||
147144653|NCT00980460|530693005|FG004|Overall Study|Ineligible|4|||
147144654|NCT00980460|530693001|FG000|Overall Study|Refusal of further therapy|0|||
147144655|NCT00980460|530693002|FG001|Overall Study|Refusal of further therapy|2|||
147144656|NCT00980460|530693003|FG002|Overall Study|Refusal of further therapy|3|||
147144657|NCT00980460|530693004|FG003|Overall Study|Refusal of further therapy|2|||
147144658|NCT00980460|530693005|FG004|Overall Study|Refusal of further therapy|0|||
147144659|NCT00980460|530693001|FG000|Overall Study|No therapy within 42 days of resection|0|||
147144660|NCT00980460|530693002|FG001|Overall Study|No therapy within 42 days of resection|0|||
147144661|NCT00980460|530693003|FG002|Overall Study|No therapy within 42 days of resection|3|||
147144662|NCT00980460|530693004|FG003|Overall Study|No therapy within 42 days of resection|1|||
147144663|NCT00980460|530693005|FG004|Overall Study|No therapy within 42 days of resection|0|||
147144664|NCT00980460|530693001|FG000|Overall Study|No transplant by protocol timepoints|0|||
147144665|NCT00980460|530693002|FG001|Overall Study|No transplant by protocol timepoints|0|||
147144666|NCT00980460|530693003|FG002|Overall Study|No transplant by protocol timepoints|3|||
147144667|NCT00980460|530693004|FG003|Overall Study|No transplant by protocol timepoints|0|||
147144668|NCT00980460|530693005|FG004|Overall Study|No transplant by protocol timepoints|0|||
147144669|NCT00283803|530694249|FG000|Overall Study|Physician Decision|9|||
147144670|NCT00283803|530694249|FG000|Overall Study|Withdrawal by Subject|4|||
147144671|NCT01127607|530694250|FG000|Phase II (Between Subjects)|Lost to Follow-up|0|||
147144672|NCT01127607|530694251|FG001|Phase II (Between Subjects)|Lost to Follow-up|2|||
147144673|NCT01127607|530694250|FG000|Phase II (Between Subjects)|Withdrawal by Subject|1|||
147144674|NCT01127607|530694251|FG001|Phase II (Between Subjects)|Withdrawal by Subject|0|||
147144675|NCT00662831|530694253|FG000|Overall Study|Death|4|||
147144676|NCT00662831|530694254|FG001|Overall Study|Death|1|||
147144677|NCT00662831|530694253|FG000|Overall Study|Lack of Efficacy|6|||
147144678|NCT00662831|530694254|FG001|Overall Study|Lack of Efficacy|6|||
147144679|NCT00662831|530694253|FG000|Overall Study|Lost to Follow-up|1|||
147144680|NCT00662831|530694254|FG001|Overall Study|Lost to Follow-up|0|||
147574267|NCT02055547|532259084|FG013|Overall Study|Adverse Event|0|||
147144681|NCT00662831|530694253|FG000|Overall Study|Withdrawal by Subject|2|||
147144682|NCT00662831|530694254|FG001|Overall Study|Withdrawal by Subject|1|||
147144683|NCT00662831|530694253|FG000|Overall Study|Other|62|||
147144684|NCT00662831|530694254|FG001|Overall Study|Other|31|||
147144685|NCT00662831|530694253|FG000|Overall Study|Protocol Violation|8|||
147144686|NCT00662831|530694254|FG001|Overall Study|Protocol Violation|4|||
147144687|NCT00662831|530694253|FG000|Overall Study|Adverse Event|23|||
147144688|NCT00662831|530694254|FG001|Overall Study|Adverse Event|16|||
147144689|NCT00294671|530694255|FG000|Overall Study|Lack of Efficacy|11|||
147144690|NCT00294671|530694256|FG001|Overall Study|Lack of Efficacy|23|||
147144691|NCT00294671|530694255|FG000|Overall Study|Liver transplant|7|||
147144692|NCT00294671|530694256|FG001|Overall Study|Liver transplant|9|||
147574268|NCT02055547|532259085|FG014|Overall Study|Adverse Event|0|||
147144693|NCT00294671|530694255|FG000|Overall Study|Drug related adverse event (AE)|4|||
147144694|NCT00294671|530694256|FG001|Overall Study|Drug related adverse event (AE)|2|||
147144695|NCT00294671|530694255|FG000|Overall Study|Non-drug related AE|3|||
147144696|NCT00294671|530694256|FG001|Overall Study|Non-drug related AE|2|||
147144697|NCT00294671|530694255|FG000|Overall Study|Lost to Follow-up|1|||
147144698|NCT00294671|530694256|FG001|Overall Study|Lost to Follow-up|3|||
147144699|NCT00294671|530694255|FG000|Overall Study|Non-compliance|1|||
147144700|NCT00294671|530694256|FG001|Overall Study|Non-compliance|0|||
147144701|NCT00294671|530694255|FG000|Overall Study|Death|0|||
147144702|NCT00294671|530694256|FG001|Overall Study|Death|1|||
147144703|NCT01734785|530694257|FG000|Open-Label Period|Adverse Event|0|||
147144704|NCT01734785|530694258|FG001|Open-Label Period|Adverse Event|0|||
147144705|NCT01734785|530694259|FG002|Open-Label Period|Adverse Event|0|||
147144706|NCT01734785|530694260|FG003|Open-Label Period|Adverse Event|9|||
147144707|NCT01734785|530694257|FG000|Open-Label Period|Lack of Efficacy|0|||
147144708|NCT01734785|530694258|FG001|Open-Label Period|Lack of Efficacy|0|||
147144709|NCT01734785|530694259|FG002|Open-Label Period|Lack of Efficacy|0|||
147144710|NCT01734785|530694260|FG003|Open-Label Period|Lack of Efficacy|1|||
147144711|NCT01734785|530694257|FG000|Open-Label Period|Protocol Violation|0|||
147144712|NCT01734785|530694258|FG001|Open-Label Period|Protocol Violation|0|||
147144713|NCT01734785|530694259|FG002|Open-Label Period|Protocol Violation|0|||
147144714|NCT01734785|530694260|FG003|Open-Label Period|Protocol Violation|13|||
147144715|NCT01734785|530694257|FG000|Open-Label Period|Lost to Follow-up|0|||
147144716|NCT01734785|530694258|FG001|Open-Label Period|Lost to Follow-up|0|||
147144717|NCT01734785|530694259|FG002|Open-Label Period|Lost to Follow-up|0|||
147144718|NCT01734785|530694260|FG003|Open-Label Period|Lost to Follow-up|14|||
147144719|NCT01734785|530694257|FG000|Open-Label Period|Withdrawal by Subject|0|||
147144720|NCT01734785|530694258|FG001|Open-Label Period|Withdrawal by Subject|0|||
147144721|NCT01734785|530694259|FG002|Open-Label Period|Withdrawal by Subject|0|||
147144722|NCT01734785|530694260|FG003|Open-Label Period|Withdrawal by Subject|12|||
147144723|NCT01734785|530694257|FG000|Open-Label Period|Other Reasons|0|||
147144724|NCT01734785|530694258|FG001|Open-Label Period|Other Reasons|0|||
147144725|NCT01734785|530694259|FG002|Open-Label Period|Other Reasons|0|||
147144726|NCT01734785|530694260|FG003|Open-Label Period|Other Reasons|224|||
147144727|NCT01734785|530694257|FG000|Double-Blind Period|Adverse Event|0|||
147144728|NCT01734785|530694258|FG001|Double-Blind Period|Adverse Event|3|||
147144729|NCT01734785|530694259|FG002|Double-Blind Period|Adverse Event|2|||
147144730|NCT01734785|530694260|FG003|Double-Blind Period|Adverse Event|0|||
147144731|NCT01734785|530694257|FG000|Double-Blind Period|Lack of Efficacy|0|||
147144732|NCT01734785|530694258|FG001|Double-Blind Period|Lack of Efficacy|1|||
147144733|NCT01734785|530694259|FG002|Double-Blind Period|Lack of Efficacy|0|||
147144734|NCT01734785|530694260|FG003|Double-Blind Period|Lack of Efficacy|0|||
147144735|NCT01734785|530694257|FG000|Double-Blind Period|Protocol Violation|0|||
147144736|NCT01734785|530694258|FG001|Double-Blind Period|Protocol Violation|1|||
147144737|NCT01734785|530694259|FG002|Double-Blind Period|Protocol Violation|1|||
147144738|NCT01734785|530694260|FG003|Double-Blind Period|Protocol Violation|0|||
147144739|NCT01734785|530694257|FG000|Double-Blind Period|Lost to Follow-up|2|||
147144740|NCT01734785|530694258|FG001|Double-Blind Period|Lost to Follow-up|4|||
147144741|NCT01734785|530694259|FG002|Double-Blind Period|Lost to Follow-up|2|||
147144742|NCT01734785|530694260|FG003|Double-Blind Period|Lost to Follow-up|0|||
147144743|NCT01734785|530694257|FG000|Double-Blind Period|Withdrawal by Subject|2|||
147144744|NCT01734785|530694258|FG001|Double-Blind Period|Withdrawal by Subject|0|||
147144745|NCT01734785|530694259|FG002|Double-Blind Period|Withdrawal by Subject|0|||
147144746|NCT01734785|530694260|FG003|Double-Blind Period|Withdrawal by Subject|0|||
147144747|NCT01734785|530694257|FG000|Double-Blind Period|Not treated|1|||
147144748|NCT01734785|530694258|FG001|Double-Blind Period|Not treated|0|||
147144749|NCT01734785|530694259|FG002|Double-Blind Period|Not treated|0|||
147144750|NCT01734785|530694260|FG003|Double-Blind Period|Not treated|0|||
147144751|NCT01961297|530694266|FG000|Overall Study|unconfirmed diagnosis of SD|2|||
147144752|NCT01961297|530694267|FG001|Overall Study|unconfirmed diagnosis of SD|1|||
147144753|NCT02482298|530694268|FG000|Overall Study|Withdrawal by Subject|2|||
147445733|NCT01500278|531797439|FG000|Week 0 - Week 12|Other serious disease|0|||
147445734|NCT01500278|531797440|FG001|Week 0 - Week 12|Other serious disease|1|||
147144754|NCT02482298|530694269|FG001|Overall Study|Withdrawal by Subject|1|||
147144755|NCT02482298|530694270|FG002|Overall Study|Withdrawal by Subject|2|||
147144756|NCT02482298|530694268|FG000|Overall Study|Did Not Fulfill Randomization Criteria|0|||
147144757|NCT02482298|530694269|FG001|Overall Study|Did Not Fulfill Randomization Criteria|1|||
147144758|NCT02482298|530694270|FG002|Overall Study|Did Not Fulfill Randomization Criteria|0|||
147144759|NCT02482298|530694268|FG000|Overall Study|Dev. of Study-Spec. Withdrawal Criteria|0|||
147144760|NCT02482298|530694269|FG001|Overall Study|Dev. of Study-Spec. Withdrawal Criteria|0|||
147144761|NCT02482298|530694270|FG002|Overall Study|Dev. of Study-Spec. Withdrawal Criteria|1|||
147144762|NCT02482298|530694268|FG000|Overall Study|Lost to Follow-up|0|||
147144763|NCT02482298|530694269|FG001|Overall Study|Lost to Follow-up|1|||
147144764|NCT02482298|530694270|FG002|Overall Study|Lost to Follow-up|0|||
147144765|NCT01582009|530694273|FG000|Overall Study|Withdrawal by Subject|1|||
147144766|NCT01582009|530694273|FG000|Overall Study|Physician Decision|1|||
147144767|NCT03050450|530694276|FG000|Overall Study|Physician Decision|1|||
147144768|NCT03050450|530694277|FG001|Overall Study|Physician Decision|0|||
147144769|NCT03050450|530694278|FG002|Overall Study|Physician Decision|0|||
147144770|NCT03050450|530694279|FG003|Overall Study|Physician Decision|0|||
147144771|NCT03050450|530694280|FG004|Overall Study|Physician Decision|0|||
147144772|NCT03592771|530694281|FG000|Overall Study|Adverse Event|2|||
147144773|NCT03592771|530694282|FG001|Overall Study|Adverse Event|0|||
147144774|NCT03592771|530694283|FG002|Overall Study|Adverse Event|1|||
147144775|NCT03592771|530694281|FG000|Overall Study|Death|0|||
147144776|NCT03592771|530694282|FG001|Overall Study|Death|1|||
147144777|NCT03592771|530694283|FG002|Overall Study|Death|1|||
147144778|NCT03592771|530694281|FG000|Overall Study|Lost to Follow-up|5|||
147144779|NCT03592771|530694282|FG001|Overall Study|Lost to Follow-up|11|||
147144780|NCT03592771|530694283|FG002|Overall Study|Lost to Follow-up|15|||
147144781|NCT03592771|530694281|FG000|Overall Study|Withdrawal by Subject|0|||
147144782|NCT03592771|530694282|FG001|Overall Study|Withdrawal by Subject|2|||
147144783|NCT03592771|530694283|FG002|Overall Study|Withdrawal by Subject|0|||
147144784|NCT00735553|530694284|FG000|Overall Study|Study prematurely terminated|77|||
147144785|NCT02705105|530694285|FG000|Treatment|Objective Disease Progression|1|||
147144786|NCT02705105|530694286|FG001|Treatment|Objective Disease Progression|50|||
147144787|NCT02705105|530694285|FG000|Treatment|Withdrawal by Subject|3|||
147144788|NCT02705105|530694286|FG001|Treatment|Withdrawal by Subject|5|||
147144789|NCT02705105|530694285|FG000|Treatment|Adverse Event|0|||
147144790|NCT02705105|530694286|FG001|Treatment|Adverse Event|17|||
147144791|NCT02705105|530694285|FG000|Treatment|Clinical Disease Progression|0|||
147144792|NCT02705105|530694286|FG001|Treatment|Clinical Disease Progression|32|||
147144793|NCT02705105|530694285|FG000|Treatment|Physician Decision|0|||
147144794|NCT02705105|530694286|FG001|Treatment|Physician Decision|3|||
147144795|NCT02705105|530694285|FG000|Treatment|Ongoing w/ Treatment at time of data cut|0|||
147144796|NCT02705105|530694286|FG001|Treatment|Ongoing w/ Treatment at time of data cut|2|||
147144797|NCT02705105|530694285|FG000|Follow-Up|Death|3|||
147144798|NCT02705105|530694286|FG001|Follow-Up|Death|68|||
147144799|NCT02705105|530694285|FG000|Follow-Up|Withdrawal by Subject|1|||
147144800|NCT02705105|530694286|FG001|Follow-Up|Withdrawal by Subject|14|||
147144801|NCT02705105|530694285|FG000|Follow-Up|Study Terminated|0|||
147144802|NCT02705105|530694286|FG001|Follow-Up|Study Terminated|26|||
147144803|NCT02705105|530694285|FG000|Follow-Up|Discontinued per Amendment 3|0|||
147144804|NCT02705105|530694286|FG001|Follow-Up|Discontinued per Amendment 3|2|||
147144805|NCT04556591|530694288|FG000|Overall Study|Lost to Follow-up|1|||
147144806|NCT04556591|530694289|FG001|Overall Study|Lost to Follow-up|0|||
147144807|NCT04556591|530694288|FG000|Overall Study|Ineligible after medical record review; documentation for SCI not sufficient|2|||
147144808|NCT04556591|530694289|FG001|Overall Study|Ineligible after medical record review; documentation for SCI not sufficient|0|||
147144809|NCT03332173|530694290|FG000|Overall Study|Death|7|||
147144810|NCT03332173|530694290|FG000|Overall Study|Withdrawal by Subject|6|||
147144811|NCT03332173|530694290|FG000|Overall Study|Lost to Follow-up|2|||
147144812|NCT03332173|530694290|FG000|Overall Study|Transferred to long-term extension study|29|||
147144813|NCT01485796|530694291|FG000|Period 1: Epoch 1 (Ramp-up)|Withdrawal by Subject|1|||
147144814|NCT01485796|530694291|FG000|Period 2: Epoch 2|Withdrawal by Subject|6|||
147144815|NCT01485796|530694291|FG000|Period 2: Epoch 2|Adverse Event|3|||
147144816|NCT01485796|530694291|FG000|Period 2: Epoch 2|Switch to safety follow-up|26|||
147144817|NCT01485796|530694291|FG000|Overall Trial (Incl. Safety Follow-up)|Withdrawal by Subject in Epoch 1|1|||
147144818|NCT01485796|530694291|FG000|Overall Trial (Incl. Safety Follow-up)|Withdrawal by Subject in Epoch 2|6|||
147144819|NCT01485796|530694291|FG000|Overall Trial (Incl. Safety Follow-up)|Adverse Event in Epoch 2|3|||
147144820|NCT01485796|530694291|FG000|Overall Trial (Incl. Safety Follow-up)|Withdrawal During Safety-Follow-up|2|||
147144821|NCT04830215|530694292|FG000|Overall Study|Adverse Event|6|||
147144822|NCT04830215|530694292|FG000|Overall Study|Failure to Meet Continuation Criteria|1|||
147144823|NCT04830215|530694292|FG000|Overall Study|Withdrawal by Subject|3|||
147144824|NCT04830215|530694292|FG000|Overall Study|Protocol Deviation|1|||
147144825|NCT00211172|530694295|FG000|Overall Study|Died or lost health plan eligibility|39|||
147144826|NCT00211172|530694296|FG001|Overall Study|Died or lost health plan eligibility|32|||
147144827|NCT00770562|530694299|FG000|Overall Study|Did not take treatment|1|||
147144828|NCT00770562|530694300|FG001|Overall Study|Did not take treatment|1|||
147144829|NCT01643408|530694301|FG000|Overall Study|Adverse Event|12|||
147144830|NCT01643408|530694301|FG000|Overall Study|Other|2|||
147144831|NCT00292045|530694305|FG000|Core Study (Through Week 13)|Adverse Event|1|||
147144832|NCT00292045|530694305|FG000|Core Study (Through Week 13)|Withdrawal by Subject|1|||
147144833|NCT04474197|530694306|FG000|Overall Study|Withdrawal of consent (not due to adverse event)|0|||
147652368|NCT03026283|532550251|FG007|Optimal Care/Stress Test/ICA|Lost to Follow-up|0|||
147144834|NCT04474197|530694307|FG001|Overall Study|Withdrawal of consent (not due to adverse event)|1|||
147144835|NCT04474197|530694308|FG002|Overall Study|Withdrawal of consent (not due to adverse event)|0|||
147144836|NCT04474197|530694309|FG003|Overall Study|Withdrawal of consent (not due to adverse event)|0|||
147144837|NCT00606411|530694310|FG000|Overall Study|Adverse Event|1|||
147144838|NCT00606411|530694311|FG001|Overall Study|Adverse Event|2|||
147144839|NCT00606411|530694310|FG000|Overall Study|Lack of Adherence|1|||
147144840|NCT00606411|530694311|FG001|Overall Study|Lack of Adherence|1|||
147144841|NCT00606411|530694310|FG000|Overall Study|Lack of Efficacy|1|||
147574269|NCT02055547|532259086|FG015|Overall Study|Adverse Event|0|||
147574270|NCT02055547|532259087|FG016|Overall Study|Adverse Event|0|||
147574271|NCT02055547|532259088|FG017|Overall Study|Adverse Event|0|||
147574272|NCT02055547|532259089|FG018|Overall Study|Adverse Event|0|||
147144842|NCT00606411|530694311|FG001|Overall Study|Lack of Efficacy|1|||
147144843|NCT00606411|530694310|FG000|Overall Study|Withdrawal by Subject|2|||
147144844|NCT00606411|530694311|FG001|Overall Study|Withdrawal by Subject|0|||
147144845|NCT00606411|530694310|FG000|Overall Study|Lost to Follow-up|1|||
147144846|NCT00606411|530694311|FG001|Overall Study|Lost to Follow-up|2|||
147144847|NCT00606411|530694310|FG000|Overall Study|Move out of state|0|||
147144848|NCT00606411|530694311|FG001|Overall Study|Move out of state|1|||
147144849|NCT00624468|530694313|FG000|Double-blind Period|Early Termination Initiated by Sponsor|13|||
147144850|NCT00624468|530694314|FG001|Double-blind Period|Early Termination Initiated by Sponsor|12|||
147144851|NCT00624468|530694315|FG002|Double-blind Period|Early Termination Initiated by Sponsor|0|||
147144852|NCT00624468|530694316|FG003|Double-blind Period|Early Termination Initiated by Sponsor|0|||
147144853|NCT00624468|530694313|FG000|Double-blind Period|Withdrew Prematurely|1|||
147144854|NCT00624468|530694314|FG001|Double-blind Period|Withdrew Prematurely|1|||
147144855|NCT00624468|530694315|FG002|Double-blind Period|Withdrew Prematurely|0|||
147144856|NCT00624468|530694316|FG003|Double-blind Period|Withdrew Prematurely|0|||
147144857|NCT00624468|530694313|FG000|Safety Follow-up (SFU) Period|Lost to Follow-up|0|||
147144858|NCT00624468|530694314|FG001|Safety Follow-up (SFU) Period|Lost to Follow-up|0|||
147144859|NCT00624468|530694315|FG002|Safety Follow-up (SFU) Period|Lost to Follow-up|1|||
147144860|NCT00624468|530694316|FG003|Safety Follow-up (SFU) Period|Lost to Follow-up|2|||
147144861|NCT00624468|530694313|FG000|Safety Follow-up (SFU) Period|Other|0|||
147144862|NCT00624468|530694314|FG001|Safety Follow-up (SFU) Period|Other|0|||
147144863|NCT00624468|530694315|FG002|Safety Follow-up (SFU) Period|Other|1|||
147144864|NCT00624468|530694316|FG003|Safety Follow-up (SFU) Period|Other|1|||
147144865|NCT00635349|530694318|FG000|Overall Study|Other|8|||
147144866|NCT00635349|530694319|FG001|Overall Study|Other|6|||
147144867|NCT00635349|530694318|FG000|Overall Study|Protocol Violation|18|||
147144868|NCT00635349|530694319|FG001|Overall Study|Protocol Violation|22|||
147144869|NCT00635349|530694318|FG000|Overall Study|Withdrawal by Subject|3|||
147144870|NCT00635349|530694319|FG001|Overall Study|Withdrawal by Subject|8|||
147144871|NCT00635349|530694318|FG000|Overall Study|Lost to Follow-up|4|||
147144872|NCT00635349|530694319|FG001|Overall Study|Lost to Follow-up|3|||
147144873|NCT00635349|530694318|FG000|Overall Study|Adverse Event|11|||
147144874|NCT00635349|530694319|FG001|Overall Study|Adverse Event|9|||
147144875|NCT02569476|530694322|FG000|Overall Study|Roll over to Long-Term Extension Study|73|||
147144876|NCT02569476|530694322|FG000|Overall Study|Death|33|||
147144877|NCT02569476|530694322|FG000|Overall Study|Withdrawal by Subject|9|||
147144878|NCT02569476|530694322|FG000|Overall Study|Progressive disease at study withdrawal and death by end of study|1|||
147144879|NCT02569476|530694322|FG000|Overall Study|Palliative care|1|||
147144880|NCT02569476|530694322|FG000|Overall Study|Transitioned to Long Term Follow Up Study|1|||
147144881|NCT02569476|530694322|FG000|Overall Study|Transitioned to Long Term Extension Study|1|||
147144882|NCT01071954|530694323|FG000|Overall Study|Noncompliance|4|||
147144883|NCT01071954|530694323|FG000|Overall Study|Adverse Event|1|||
147144884|NCT01071954|530694323|FG000|Overall Study|Withdrawal by Subject|11|||
147144885|NCT01071954|530694323|FG000|Overall Study|Requirement for Alternative Therapy|5|||
147144886|NCT01071954|530694323|FG000|Overall Study|Administrative Decision|5|||
147144887|NCT01071954|530694323|FG000|Overall Study|Protocol Specified Criteria|1|||
147144888|NCT00703963|530694324|FG000|Overall Study|Withdrawal by Subject|7|||
147144889|NCT00703963|530694325|FG001|Overall Study|Withdrawal by Subject|13|||
147144890|NCT00703963|530694324|FG000|Overall Study|Physician Decision|0|||
147144891|NCT00703963|530694325|FG001|Overall Study|Physician Decision|1|||
147144892|NCT01340664|530694326|FG000|Overall Study|Adverse Event|0|||
147144893|NCT01340664|530694327|FG001|Overall Study|Adverse Event|1|||
147144894|NCT01340664|530694328|FG002|Overall Study|Adverse Event|7|||
147144895|NCT01340664|530694326|FG000|Overall Study|Lost to Follow-up|2|||
147144896|NCT01340664|530694327|FG001|Overall Study|Lost to Follow-up|0|||
147144897|NCT01340664|530694328|FG002|Overall Study|Lost to Follow-up|2|||
147144898|NCT01340664|530694326|FG000|Overall Study|Withdrawal by Subject|2|||
147144899|NCT01340664|530694327|FG001|Overall Study|Withdrawal by Subject|4|||
147144900|NCT01340664|530694328|FG002|Overall Study|Withdrawal by Subject|0|||
147144901|NCT01340664|530694326|FG000|Overall Study|Glycemic withdrawal criteria|2|||
147144902|NCT01340664|530694327|FG001|Overall Study|Glycemic withdrawal criteria|0|||
147144903|NCT01340664|530694328|FG002|Overall Study|Glycemic withdrawal criteria|0|||
147144904|NCT01340664|530694326|FG000|Overall Study|Creatinine or eGFR withdrawal criteria|0|||
147144905|NCT01340664|530694327|FG001|Overall Study|Creatinine or eGFR withdrawal criteria|1|||
147144906|NCT01340664|530694328|FG002|Overall Study|Creatinine or eGFR withdrawal criteria|2|||
147144907|NCT01340664|530694326|FG000|Overall Study|Other|1|||
147144908|NCT01340664|530694327|FG001|Overall Study|Other|2|||
147574273|NCT02055547|532259071|FG000|Overall Study|Withdrawal by Subject|0|||
147144909|NCT01340664|530694328|FG002|Overall Study|Other|2|||
147144910|NCT02528942|530694334|FG000|Overall Study|Did not meet imaging criteria|9|||
147144911|NCT02528942|530694334|FG000|Overall Study|Lost to Follow-up|25|||
147144912|NCT04599803|530694335|FG000|Overall Study|Withdrawal by Subject|5|||
147144913|NCT04599803|530694335|FG000|Overall Study|Lost to Follow-up|26|||
147144914|NCT00881530|530694336|FG000|Overall Study|Adverse Event|5|||
147144915|NCT00881530|530694337|FG001|Overall Study|Adverse Event|1|||
147144916|NCT00881530|530694338|FG002|Overall Study|Adverse Event|1|||
147144917|NCT00881530|530694339|FG003|Overall Study|Adverse Event|4|||
147144918|NCT00881530|530694340|FG004|Overall Study|Adverse Event|10|||
147144919|NCT00881530|530694341|FG005|Overall Study|Adverse Event|2|||
147144920|NCT00881530|530694336|FG000|Overall Study|Lack of Efficacy|1|||
147144921|NCT00881530|530694337|FG001|Overall Study|Lack of Efficacy|0|||
147144922|NCT00881530|530694338|FG002|Overall Study|Lack of Efficacy|0|||
147144923|NCT00881530|530694339|FG003|Overall Study|Lack of Efficacy|0|||
147144924|NCT00881530|530694340|FG004|Overall Study|Lack of Efficacy|1|||
147144925|NCT00881530|530694341|FG005|Overall Study|Lack of Efficacy|1|||
147144926|NCT00881530|530694336|FG000|Overall Study|Not compliant with the protocol|0|||
147144927|NCT00881530|530694337|FG001|Overall Study|Not compliant with the protocol|0|||
147144928|NCT00881530|530694338|FG002|Overall Study|Not compliant with the protocol|0|||
147144929|NCT00881530|530694339|FG003|Overall Study|Not compliant with the protocol|0|||
147144930|NCT00881530|530694340|FG004|Overall Study|Not compliant with the protocol|2|||
147144931|NCT00881530|530694341|FG005|Overall Study|Not compliant with the protocol|0|||
147144932|NCT00881530|530694336|FG000|Overall Study|Lost to Follow-up|0|||
147144933|NCT00881530|530694337|FG001|Overall Study|Lost to Follow-up|1|||
147144934|NCT00881530|530694338|FG002|Overall Study|Lost to Follow-up|1|||
147144935|NCT00881530|530694339|FG003|Overall Study|Lost to Follow-up|3|||
147144936|NCT00881530|530694340|FG004|Overall Study|Lost to Follow-up|1|||
147144937|NCT00881530|530694341|FG005|Overall Study|Lost to Follow-up|0|||
147144938|NCT00881530|530694336|FG000|Overall Study|Refused to continue medication|7|||
147144939|NCT00881530|530694337|FG001|Overall Study|Refused to continue medication|2|||
147144940|NCT00881530|530694338|FG002|Overall Study|Refused to continue medication|1|||
147144941|NCT00881530|530694339|FG003|Overall Study|Refused to continue medication|2|||
147144942|NCT00881530|530694340|FG004|Overall Study|Refused to continue medication|0|||
147144943|NCT00881530|530694341|FG005|Overall Study|Refused to continue medication|0|||
147144944|NCT00881530|530694336|FG000|Overall Study|Other reason not defined above|1|||
147144945|NCT00881530|530694337|FG001|Overall Study|Other reason not defined above|1|||
147144946|NCT00881530|530694338|FG002|Overall Study|Other reason not defined above|2|||
147144947|NCT00881530|530694339|FG003|Overall Study|Other reason not defined above|0|||
147144948|NCT00881530|530694340|FG004|Overall Study|Other reason not defined above|0|||
147144949|NCT00881530|530694341|FG005|Overall Study|Other reason not defined above|2|||
147144950|NCT00763256|530694342|FG000|Overall Study|Didn't return for appointments|7|||
147144951|NCT00763256|530694343|FG001|Overall Study|Didn't return for appointments|10|||
147144952|NCT01637584|530694344|FG000|Overall Study|Withdrawal by Subject|1|||
147144953|NCT01637584|530694345|FG001|Overall Study|Withdrawal by Subject|3|||
147144954|NCT04396795|530694346|FG000|Month 1|Lost to Follow-up|2|||
147144955|NCT04396795|530694347|FG001|Month 1|Lost to Follow-up|3|||
147144956|NCT04396795|530694346|FG000|Month 3|Lost to Follow-up|1|||
147144957|NCT04396795|530694347|FG001|Month 3|Lost to Follow-up|3|||
147144958|NCT04396795|530694346|FG000|Month 6|Lost to Follow-up|3|||
147144959|NCT04396795|530694347|FG001|Month 6|Lost to Follow-up|3|||
147144960|NCT02366923|530694348|FG000|Overall Study|Withdrawal by Subject|1|||
147144961|NCT02366923|530694348|FG000|Overall Study|Positive Slit Lamp Findings|2|||
147144962|NCT02366923|530694348|FG000|Overall Study|High Astigmatism|3|||
147144963|NCT00995436|530694352|FG000|Overall Study|Withdrawal by Subject|2|||
147144964|NCT00995436|530694353|FG001|Overall Study|Withdrawal by Subject|5|||
147144965|NCT00995436|530694354|FG002|Overall Study|Withdrawal by Subject|0|||
147144966|NCT01232127|530694355|FG000|Period 1: Days 1-10|Discontinued due to dosing error|1|||
147144967|NCT01232127|530694356|FG001|Period 1: Days 1-10|Discontinued due to dosing error|0|||
147144968|NCT01232127|530694357|FG002|Period 1: Days 1-10|Discontinued due to dosing error|0|||
147144969|NCT02725476|530694358|FG000|Overall Study|Physician Decision|2|||
147144970|NCT02725476|530694359|FG001|Overall Study|Physician Decision|0|||
147144971|NCT02725476|530694358|FG000|Overall Study|Adverse Event|1|||
147144972|NCT02725476|530694359|FG001|Overall Study|Adverse Event|1|||
147144973|NCT00289289|530694360|FG000|Overall Study|Withdrawal by Subject|5|||
147238106|NCT03094169|531044072|FG000|Overall Study|Withdrawal by Subject|0|||
147238107|NCT03094169|531044073|FG001|Overall Study|Withdrawal by Subject|0|||
147238108|NCT03094169|531044074|FG002|Overall Study|Withdrawal by Subject|0|||
147238109|NCT03094169|531044075|FG003|Overall Study|Withdrawal by Subject|0|||
147238110|NCT03094169|531044076|FG004|Overall Study|Withdrawal by Subject|0|||
147238111|NCT03094169|531044077|FG005|Overall Study|Withdrawal by Subject|0|||
147238112|NCT03094169|531044078|FG006|Overall Study|Withdrawal by Subject|1|||
147144974|NCT00289289|530694361|FG001|Overall Study|Withdrawal by Subject|3|||
147144975|NCT00289289|530694362|FG002|Overall Study|Withdrawal by Subject|15|||
147144976|NCT00289289|530694360|FG000|Overall Study|Lost to Follow-up|1|||
147144977|NCT00289289|530694361|FG001|Overall Study|Lost to Follow-up|0|||
147238113|NCT03094169|531044079|FG007|Overall Study|Withdrawal by Subject|1|||
147144978|NCT00289289|530694362|FG002|Overall Study|Lost to Follow-up|1|||
147144979|NCT00289289|530694360|FG000|Overall Study|Death|4|||
147144980|NCT00289289|530694361|FG001|Overall Study|Death|2|||
147144981|NCT00289289|530694362|FG002|Overall Study|Death|5|||
147144982|NCT00289289|530694360|FG000|Overall Study|No implant attempted|0|||
147144983|NCT00289289|530694361|FG001|Overall Study|No implant attempted|0|||
147144984|NCT00289289|530694362|FG002|Overall Study|No implant attempted|1|||
147144985|NCT00289289|530694360|FG000|Overall Study|Physician Decision|1|||
147144986|NCT00289289|530694361|FG001|Overall Study|Physician Decision|0|||
147144987|NCT00289289|530694362|FG002|Overall Study|Physician Decision|6|||
147144988|NCT00289289|530694360|FG000|Overall Study|Non-study device implanted|2|||
147144989|NCT00289289|530694361|FG001|Overall Study|Non-study device implanted|1|||
147144990|NCT00289289|530694362|FG002|Overall Study|Non-study device implanted|3|||
147144991|NCT00289289|530694360|FG000|Overall Study|Did not meet inclusion/exclusion|0|||
147144992|NCT00289289|530694361|FG001|Overall Study|Did not meet inclusion/exclusion|0|||
147144993|NCT00289289|530694362|FG002|Overall Study|Did not meet inclusion/exclusion|6|||
147144994|NCT00289289|530694360|FG000|Overall Study|Other Exit Reason|6|||
147144995|NCT00289289|530694361|FG001|Overall Study|Other Exit Reason|4|||
147144996|NCT00289289|530694362|FG002|Overall Study|Other Exit Reason|12|||
147144997|NCT01445613|530694363|FG000|30-day Follow-up|Withdrawal by Subject|6|||
147144998|NCT01445613|530694363|FG000|30-day Follow-up|Physician Decision|3|||
147144999|NCT01445613|530694363|FG000|30-day Follow-up|Missed visit|23|||
147145000|NCT01445613|530694363|FG000|30-day Follow-up|Death|3|||
147145001|NCT01445613|530694363|FG000|1-year Follow-up|Withdrawal by Subject|12|||
147145002|NCT01445613|530694363|FG000|1-year Follow-up|Missed visit|29|||
147145003|NCT01445613|530694363|FG000|1-year Follow-up|Lost to Follow-up|2|||
147145004|NCT01445613|530694363|FG000|1-year Follow-up|Death|30|||
147145005|NCT01445613|530694363|FG000|1-year Follow-up|Physician Decision|2|||
147145006|NCT01445613|530694363|FG000|1-year Follow-up|Received a non-study stent|2|||
147145007|NCT03666988|530694364|FG000|Part 1 (Up to 28 Months)|Adverse Event|0|||
147145008|NCT03666988|530694365|FG001|Part 1 (Up to 28 Months)|Adverse Event|1|||
147145009|NCT03666988|530694366|FG002|Part 1 (Up to 28 Months)|Adverse Event|3|||
147145010|NCT03666988|530694367|FG003|Part 1 (Up to 28 Months)|Adverse Event|0|||
147145011|NCT03666988|530694368|FG004|Part 1 (Up to 28 Months)|Adverse Event|0|||
147145012|NCT03666988|530694369|FG005|Part 1 (Up to 28 Months)|Adverse Event|0|||
147145013|NCT03666988|530694364|FG000|Part 1 (Up to 28 Months)|Other|0|||
147145014|NCT03666988|530694365|FG001|Part 1 (Up to 28 Months)|Other|1|||
147145015|NCT03666988|530694366|FG002|Part 1 (Up to 28 Months)|Other|1|||
147145016|NCT03666988|530694367|FG003|Part 1 (Up to 28 Months)|Other|0|||
147145017|NCT03666988|530694368|FG004|Part 1 (Up to 28 Months)|Other|0|||
147145018|NCT03666988|530694369|FG005|Part 1 (Up to 28 Months)|Other|0|||
147145019|NCT03666988|530694364|FG000|Part 1 (Up to 28 Months)|Disease Progression|2|||
147145020|NCT03666988|530694365|FG001|Part 1 (Up to 28 Months)|Disease Progression|14|||
147145021|NCT03666988|530694366|FG002|Part 1 (Up to 28 Months)|Disease Progression|7|||
147145022|NCT03666988|530694367|FG003|Part 1 (Up to 28 Months)|Disease Progression|0|||
147145023|NCT03666988|530694368|FG004|Part 1 (Up to 28 Months)|Disease Progression|0|||
147145024|NCT03666988|530694369|FG005|Part 1 (Up to 28 Months)|Disease Progression|0|||
147145025|NCT03666988|530694364|FG000|Part 1 (Up to 28 Months)|Physician Decision|0|||
147145026|NCT03666988|530694365|FG001|Part 1 (Up to 28 Months)|Physician Decision|0|||
147145027|NCT03666988|530694366|FG002|Part 1 (Up to 28 Months)|Physician Decision|1|||
147145028|NCT03666988|530694367|FG003|Part 1 (Up to 28 Months)|Physician Decision|0|||
147145029|NCT03666988|530694368|FG004|Part 1 (Up to 28 Months)|Physician Decision|0|||
147145030|NCT03666988|530694369|FG005|Part 1 (Up to 28 Months)|Physician Decision|0|||
147145031|NCT03666988|530694364|FG000|Part 1 (Up to 28 Months)|Withdrawal by Subject|1|||
147145032|NCT03666988|530694365|FG001|Part 1 (Up to 28 Months)|Withdrawal by Subject|0|||
147145033|NCT03666988|530694366|FG002|Part 1 (Up to 28 Months)|Withdrawal by Subject|0|||
147145034|NCT03666988|530694367|FG003|Part 1 (Up to 28 Months)|Withdrawal by Subject|0|||
147145035|NCT03666988|530694368|FG004|Part 1 (Up to 28 Months)|Withdrawal by Subject|0|||
147145036|NCT03666988|530694369|FG005|Part 1 (Up to 28 Months)|Withdrawal by Subject|0|||
147145037|NCT05588440|530694372|FG000|Overall Study|Sponsor Decision|2|||
147145038|NCT05588440|530694373|FG001|Overall Study|Sponsor Decision|0|||
147145039|NCT05588440|530694374|FG002|Overall Study|Sponsor Decision|1|||
147145040|NCT05588440|530694372|FG000|Overall Study|Death|1|||
147145041|NCT05588440|530694373|FG001|Overall Study|Death|1|||
147145042|NCT05588440|530694374|FG002|Overall Study|Death|1|||
147145043|NCT05588440|530694372|FG000|Overall Study|Screen Fail|0|||
147145044|NCT05588440|530694373|FG001|Overall Study|Screen Fail|1|||
147145045|NCT05588440|530694374|FG002|Overall Study|Screen Fail|1|||
147145046|NCT05588440|530694372|FG000|Overall Study|Withdrawal by Subject|0|||
147145047|NCT05588440|530694373|FG001|Overall Study|Withdrawal by Subject|0|||
147145048|NCT05588440|530694374|FG002|Overall Study|Withdrawal by Subject|1|||
147145049|NCT02142803|530694375|FG000|Registration to Initiation of Therapy|Withdrawal by Subject|0|||
147145050|NCT02142803|530694376|FG001|Registration to Initiation of Therapy|Withdrawal by Subject|0|||
147145051|NCT02142803|530694377|FG002|Registration to Initiation of Therapy|Withdrawal by Subject|0|||
147145052|NCT02142803|530694378|FG003|Registration to Initiation of Therapy|Withdrawal by Subject|1|||
147145053|NCT01154452|530694379|FG000|Phase Ib|Not Treated|1|||
147145054|NCT01154452|530694380|FG001|Phase Ib|Not Treated|0|||
147238114|NCT03094169|531044072|FG000|Overall Study|Trial Termination|0|||
147145055|NCT01154452|530694381|FG002|Phase Ib|Not Treated|0|||
147145056|NCT01154452|530694382|FG003|Phase Ib|Not Treated|0|||
147145057|NCT01154452|530694379|FG000|Phase Ib|Adverse Event|2|||
147145058|NCT01154452|530694380|FG001|Phase Ib|Adverse Event|1|||
147145059|NCT01154452|530694381|FG002|Phase Ib|Adverse Event|0|||
147145060|NCT01154452|530694382|FG003|Phase Ib|Adverse Event|0|||
147145061|NCT01154452|530694379|FG000|Phase II|Withdrawal by Subject|0|||
147145062|NCT01154452|530694380|FG001|Phase II|Withdrawal by Subject|0|||
147145063|NCT01154452|530694381|FG002|Phase II|Withdrawal by Subject|1|||
147145064|NCT01154452|530694382|FG003|Phase II|Withdrawal by Subject|2|||
147145065|NCT01154452|530694379|FG000|Phase II|Adverse Event|0|||
147145066|NCT01154452|530694380|FG001|Phase II|Adverse Event|0|||
147145067|NCT01154452|530694381|FG002|Phase II|Adverse Event|4|||
147145068|NCT01154452|530694382|FG003|Phase II|Adverse Event|4|||
147145069|NCT03706430|530694383|FG000|Overall Study|No A-Line placed|5|||
147145070|NCT03706430|530694383|FG000|Overall Study|Subject had gel nail polish|1|||
147145071|NCT03706430|530694383|FG000|Overall Study|Nail length causing difficulties with sensor|1|||
147145072|NCT03706430|530694383|FG000|Overall Study|Cancelled Case|6|||
147145073|NCT03706430|530694383|FG000|Overall Study|Physician Decision|2|||
147145074|NCT00145626|530694384|FG000|Overall Study|Did not have NK infusions|2|||
147145075|NCT00145626|530694384|FG000|Overall Study|Turned 2 years old before treatment|1|||
147145076|NCT00145626|530694384|FG000|Overall Study|Death|1|||
147145077|NCT00145626|530694384|FG000|Overall Study|Withdrawal by Subject|1|||
147145078|NCT01392573|530694385|FG000|Overall Study|Adverse Event|1|||
147145079|NCT01392573|530694386|FG001|Overall Study|Adverse Event|3|||
147145080|NCT01392573|530694385|FG000|Overall Study|Lack of Efficacy|1|||
147145081|NCT01392573|530694386|FG001|Overall Study|Lack of Efficacy|2|||
147145082|NCT01392573|530694385|FG000|Overall Study|Protocol Violation|0|||
147145083|NCT01392573|530694386|FG001|Overall Study|Protocol Violation|2|||
147145084|NCT01392573|530694385|FG000|Overall Study|Withdrawal Criteria|13|||
147145085|NCT01392573|530694386|FG001|Overall Study|Withdrawal Criteria|15|||
147145086|NCT01392573|530694385|FG000|Overall Study|Site closure|8|||
147145087|NCT01392573|530694386|FG001|Overall Study|Site closure|7|||
147145088|NCT01392573|530694385|FG000|Overall Study|Unclassified|9|||
147145089|NCT01392573|530694386|FG001|Overall Study|Unclassified|6|||
147145090|NCT00436436|530694387|FG000|Overall Study|Progression|4|||
147145091|NCT00436436|530694387|FG000|Overall Study|Adverse Event|2|||
147145092|NCT00436436|530694387|FG000|Overall Study|Death|6|||
147145093|NCT02709720|530694388|FG000|Overall Study|Non-compliance with inclusion criteria|1|||
147145094|NCT02709720|530694388|FG000|Overall Study|Protocol Violation|1|||
147145095|NCT02709720|530694388|FG000|Overall Study|Not take study medication|1|||
147145096|NCT00200967|530694389|FG000|First Treatment Period|Withdrawal by Subject|5|||
147145097|NCT00200967|530694390|FG001|First Treatment Period|Withdrawal by Subject|1|||
147145098|NCT00200967|530694389|FG000|First Treatment Period|Pregnancy|1|||
147145099|NCT00200967|530694390|FG001|First Treatment Period|Pregnancy|0|||
147145100|NCT00200967|530694389|FG000|Wash-out Period|Lost to Follow-up|0|||
147145101|NCT00200967|530694390|FG001|Wash-out Period|Lost to Follow-up|1|||
147145102|NCT00200967|530694389|FG000|Second Treatment Period|Withdrawal by Subject|1|||
147145103|NCT00200967|530694390|FG001|Second Treatment Period|Withdrawal by Subject|2|||
147574274|NCT02055547|532259072|FG001|Overall Study|Withdrawal by Subject|0|||
147574275|NCT02055547|532259073|FG002|Overall Study|Withdrawal by Subject|0|||
147145104|NCT00200967|530694389|FG000|Run-out Period|Lost to Follow-up|1|||
147145105|NCT00200967|530694390|FG001|Run-out Period|Lost to Follow-up|0|||
147238115|NCT03094169|531044073|FG001|Overall Study|Trial Termination|0|||
147238116|NCT03094169|531044074|FG002|Overall Study|Trial Termination|0|||
147238117|NCT03094169|531044075|FG003|Overall Study|Trial Termination|0|||
147238118|NCT03094169|531044076|FG004|Overall Study|Trial Termination|0|||
147238119|NCT03094169|531044077|FG005|Overall Study|Trial Termination|0|||
147238120|NCT03094169|531044078|FG006|Overall Study|Trial Termination|0|||
147238121|NCT03094169|531044079|FG007|Overall Study|Trial Termination|1|||
147238122|NCT04645953|531044080|FG000|Overall Study|Lost to Follow-up|2|||
147238123|NCT04645953|531044081|FG001|Overall Study|Lost to Follow-up|1|||
147238124|NCT04645953|531044082|FG002|Overall Study|Lost to Follow-up|1|||
147238125|NCT04645953|531044080|FG000|Overall Study|Withdrawal by Subject|0|||
147238126|NCT04645953|531044081|FG001|Overall Study|Withdrawal by Subject|1|||
147238127|NCT04645953|531044082|FG002|Overall Study|Withdrawal by Subject|0|||
147238128|NCT04645953|531044080|FG000|Overall Study|Physician Decision|0|||
147574276|NCT02055547|532259074|FG003|Overall Study|Withdrawal by Subject|0|||
147145106|NCT05823974|530696846|FG000|Overall Study|Lost to Follow-up|0|||
147145107|NCT05823974|530696847|FG001|Overall Study|Lost to Follow-up|3|||
147145108|NCT05823974|530696848|FG002|Overall Study|Lost to Follow-up|1|||
147145109|NCT05823974|530696849|FG003|Overall Study|Lost to Follow-up|0|||
147145110|NCT05823974|530696850|FG004|Overall Study|Lost to Follow-up|1|||
147145111|NCT05823974|530696851|FG005|Overall Study|Lost to Follow-up|0|||
147238129|NCT04645953|531044081|FG001|Overall Study|Physician Decision|1|||
147145112|NCT05823974|530696852|FG006|Overall Study|Lost to Follow-up|1|||
147145113|NCT05823974|530696853|FG007|Overall Study|Lost to Follow-up|0|||
147145114|NCT05823974|530696854|FG008|Overall Study|Lost to Follow-up|0|||
147238130|NCT04645953|531044082|FG002|Overall Study|Physician Decision|0|||
147238131|NCT04645953|531044080|FG000|Overall Study|Discontinued Prior to Dosing|0|||
147574277|NCT02055547|532259075|FG004|Overall Study|Withdrawal by Subject|0|||
147574278|NCT02055547|532259076|FG005|Overall Study|Withdrawal by Subject|1|||
147574279|NCT02055547|532259077|FG006|Overall Study|Withdrawal by Subject|0|||
147574280|NCT02055547|532259078|FG007|Overall Study|Withdrawal by Subject|0|||
147145115|NCT05823974|530696855|FG009|Overall Study|Lost to Follow-up|1|||
147145116|NCT05823974|530696856|FG010|Overall Study|Lost to Follow-up|1|||
147145117|NCT05823974|530696857|FG011|Overall Study|Lost to Follow-up|0|||
147145118|NCT05823974|530696858|FG012|Overall Study|Lost to Follow-up|1|||
147145119|NCT05823974|530696859|FG013|Overall Study|Lost to Follow-up|2|||
147145120|NCT05823974|530696860|FG014|Overall Study|Lost to Follow-up|1|||
147145121|NCT05823974|530696861|FG015|Overall Study|Lost to Follow-up|1|||
147145122|NCT05823974|530696862|FG016|Overall Study|Lost to Follow-up|1|||
147145123|NCT05823974|530696863|FG017|Overall Study|Lost to Follow-up|0|||
147145124|NCT05823974|530696864|FG018|Overall Study|Lost to Follow-up|0|||
147145125|NCT05823974|530696865|FG019|Overall Study|Lost to Follow-up|2|||
147145126|NCT05823974|530696866|FG020|Overall Study|Lost to Follow-up|0|||
147145127|NCT05823974|530696846|FG000|Overall Study|Physician Decision|0|||
147145128|NCT05823974|530696847|FG001|Overall Study|Physician Decision|0|||
147145129|NCT05823974|530696848|FG002|Overall Study|Physician Decision|0|||
147145130|NCT05823974|530696849|FG003|Overall Study|Physician Decision|0|||
147145131|NCT05823974|530696850|FG004|Overall Study|Physician Decision|0|||
147145132|NCT05823974|530696851|FG005|Overall Study|Physician Decision|0|||
147145133|NCT05823974|530696852|FG006|Overall Study|Physician Decision|0|||
147145134|NCT05823974|530696853|FG007|Overall Study|Physician Decision|0|||
147145135|NCT05823974|530696854|FG008|Overall Study|Physician Decision|0|||
147145136|NCT05823974|530696855|FG009|Overall Study|Physician Decision|0|||
147145137|NCT05823974|530696856|FG010|Overall Study|Physician Decision|0|||
147145138|NCT05823974|530696857|FG011|Overall Study|Physician Decision|0|||
147145139|NCT05823974|530696858|FG012|Overall Study|Physician Decision|0|||
147145140|NCT05823974|530696859|FG013|Overall Study|Physician Decision|0|||
147145141|NCT05823974|530696860|FG014|Overall Study|Physician Decision|0|||
147145142|NCT05823974|530696861|FG015|Overall Study|Physician Decision|1|||
147145143|NCT05823974|530696862|FG016|Overall Study|Physician Decision|0|||
147145144|NCT05823974|530696863|FG017|Overall Study|Physician Decision|1|||
147145145|NCT05823974|530696864|FG018|Overall Study|Physician Decision|1|||
147145146|NCT05823974|530696865|FG019|Overall Study|Physician Decision|0|||
147145147|NCT05823974|530696866|FG020|Overall Study|Physician Decision|0|||
147145148|NCT05823974|530696846|FG000|Overall Study|Withdrawal by Subject|1|||
147145149|NCT05823974|530696847|FG001|Overall Study|Withdrawal by Subject|1|||
147145150|NCT05823974|530696848|FG002|Overall Study|Withdrawal by Subject|2|||
147145151|NCT05823974|530696849|FG003|Overall Study|Withdrawal by Subject|0|||
147145152|NCT05823974|530696850|FG004|Overall Study|Withdrawal by Subject|2|||
147145153|NCT05823974|530696851|FG005|Overall Study|Withdrawal by Subject|3|||
147145154|NCT05823974|530696852|FG006|Overall Study|Withdrawal by Subject|1|||
147145155|NCT05823974|530696853|FG007|Overall Study|Withdrawal by Subject|1|||
147145156|NCT05823974|530696854|FG008|Overall Study|Withdrawal by Subject|2|||
147145157|NCT05823974|530696855|FG009|Overall Study|Withdrawal by Subject|1|||
147145158|NCT05823974|530696856|FG010|Overall Study|Withdrawal by Subject|1|||
147145159|NCT05823974|530696857|FG011|Overall Study|Withdrawal by Subject|0|||
147145160|NCT05823974|530696858|FG012|Overall Study|Withdrawal by Subject|0|||
147145161|NCT05823974|530696859|FG013|Overall Study|Withdrawal by Subject|1|||
147145162|NCT05823974|530696860|FG014|Overall Study|Withdrawal by Subject|1|||
147145163|NCT05823974|530696861|FG015|Overall Study|Withdrawal by Subject|3|||
147145164|NCT05823974|530696862|FG016|Overall Study|Withdrawal by Subject|0|||
147145165|NCT05823974|530696863|FG017|Overall Study|Withdrawal by Subject|2|||
147145166|NCT05823974|530696864|FG018|Overall Study|Withdrawal by Subject|2|||
147145167|NCT05823974|530696865|FG019|Overall Study|Withdrawal by Subject|0|||
147145168|NCT05823974|530696866|FG020|Overall Study|Withdrawal by Subject|1|||
147145169|NCT05823974|530696846|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
147574281|NCT02055547|532259079|FG008|Overall Study|Withdrawal by Subject|1|||
147574282|NCT02055547|532259080|FG009|Overall Study|Withdrawal by Subject|0|||
147574283|NCT02055547|532259081|FG010|Overall Study|Withdrawal by Subject|0|||
147145170|NCT05823974|530696847|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
147145171|NCT05823974|530696848|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
147145172|NCT05823974|530696849|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
147145173|NCT05823974|530696850|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
147145174|NCT05823974|530696851|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
147145175|NCT05823974|530696852|FG006|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
147445735|NCT01500278|531797439|FG000|Week 0 - Week 12|Adverse event (AE), not fatal|7|||
147145176|NCT05823974|530696853|FG007|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
147145177|NCT05823974|530696854|FG008|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
147145178|NCT05823974|530696855|FG009|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
147145179|NCT05823974|530696856|FG010|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
147145180|NCT05823974|530696857|FG011|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
147145181|NCT05823974|530696858|FG012|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
147574284|NCT02055547|532259082|FG011|Overall Study|Withdrawal by Subject|0|||
147145182|NCT05823974|530696859|FG013|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
147145183|NCT05823974|530696860|FG014|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
147145184|NCT05823974|530696861|FG015|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
147145185|NCT05823974|530696862|FG016|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
147145186|NCT05823974|530696863|FG017|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
147145187|NCT05823974|530696864|FG018|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
147145188|NCT05823974|530696865|FG019|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
147145189|NCT05823974|530696866|FG020|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
147145190|NCT05823974|530696846|FG000|Overall Study|Other|0|||
147145191|NCT05823974|530696847|FG001|Overall Study|Other|1|||
147145192|NCT05823974|530696848|FG002|Overall Study|Other|1|||
147145193|NCT05823974|530696849|FG003|Overall Study|Other|1|||
147145194|NCT05823974|530696850|FG004|Overall Study|Other|0|||
147145195|NCT05823974|530696851|FG005|Overall Study|Other|1|||
147145196|NCT05823974|530696852|FG006|Overall Study|Other|1|||
147145197|NCT05823974|530696853|FG007|Overall Study|Other|1|||
147145198|NCT05823974|530696854|FG008|Overall Study|Other|1|||
147145199|NCT05823974|530696855|FG009|Overall Study|Other|0|||
147145200|NCT05823974|530696856|FG010|Overall Study|Other|0|||
147145201|NCT05823974|530696857|FG011|Overall Study|Other|0|||
147145202|NCT05823974|530696858|FG012|Overall Study|Other|2|||
147145203|NCT05823974|530696859|FG013|Overall Study|Other|1|||
147145204|NCT05823974|530696860|FG014|Overall Study|Other|0|||
147145205|NCT05823974|530696861|FG015|Overall Study|Other|1|||
147145206|NCT05823974|530696862|FG016|Overall Study|Other|0|||
147145207|NCT05823974|530696863|FG017|Overall Study|Other|0|||
147145208|NCT05823974|530696864|FG018|Overall Study|Other|0|||
147145209|NCT05823974|530696865|FG019|Overall Study|Other|0|||
147145210|NCT05823974|530696866|FG020|Overall Study|Other|0|||
147145211|NCT01238991|530696871|FG000|Overall Study|Adverse Event|1|||
147145212|NCT01238991|530696872|FG001|Overall Study|Adverse Event|0|||
147145213|NCT01238991|530696873|FG002|Overall Study|Adverse Event|3|||
147145214|NCT01238991|530696874|FG003|Overall Study|Adverse Event|1|||
147145215|NCT01238991|530696875|FG004|Overall Study|Adverse Event|1|||
147238132|NCT04645953|531044081|FG001|Overall Study|Discontinued Prior to Dosing|0|||
147238133|NCT04645953|531044082|FG002|Overall Study|Discontinued Prior to Dosing|2|||
147238134|NCT00864721|531044083|FG000|Overall Study|Patient request|11|||
147145216|NCT01238991|530696876|FG005|Overall Study|Adverse Event|0|||
147145217|NCT01238991|530696877|FG006|Overall Study|Adverse Event|1|||
147145218|NCT01238991|530696878|FG007|Overall Study|Adverse Event|1|||
147145219|NCT01238991|530696879|FG008|Overall Study|Adverse Event|0|||
147145220|NCT01238991|530696880|FG009|Overall Study|Adverse Event|0|||
147145221|NCT01238991|530696871|FG000|Overall Study|Death|0|||
147145222|NCT01238991|530696872|FG001|Overall Study|Death|0|||
147145223|NCT01238991|530696873|FG002|Overall Study|Death|0|||
147145224|NCT01238991|530696874|FG003|Overall Study|Death|1|||
147145225|NCT01238991|530696875|FG004|Overall Study|Death|0|||
147145226|NCT01238991|530696876|FG005|Overall Study|Death|0|||
147145227|NCT01238991|530696877|FG006|Overall Study|Death|0|||
147145228|NCT01238991|530696878|FG007|Overall Study|Death|0|||
147145229|NCT01238991|530696879|FG008|Overall Study|Death|0|||
147145230|NCT01238991|530696880|FG009|Overall Study|Death|0|||
147145231|NCT01238991|530696871|FG000|Overall Study|Lack of Efficacy|0|||
147145232|NCT01238991|530696872|FG001|Overall Study|Lack of Efficacy|0|||
147145233|NCT01238991|530696873|FG002|Overall Study|Lack of Efficacy|1|||
147145234|NCT01238991|530696874|FG003|Overall Study|Lack of Efficacy|0|||
147145235|NCT01238991|530696875|FG004|Overall Study|Lack of Efficacy|0|||
147145236|NCT01238991|530696876|FG005|Overall Study|Lack of Efficacy|0|||
147145237|NCT01238991|530696877|FG006|Overall Study|Lack of Efficacy|0|||
147238135|NCT00864721|531044083|FG000|Overall Study|Hospitalized|1|||
147238136|NCT00864721|531044083|FG000|Overall Study|Drug hold/delay more than 4 weeks|1|||
147238137|NCT00864721|531044083|FG000|Overall Study|Adverse Event|21|||
147238138|NCT03741062|531044086|FG000|Overall Study|Protocol Violation|1|||
147238139|NCT03741062|531044087|FG001|Overall Study|Protocol Violation|0|||
147145238|NCT01238991|530696878|FG007|Overall Study|Lack of Efficacy|0|||
147145239|NCT01238991|530696879|FG008|Overall Study|Lack of Efficacy|1|||
147145240|NCT01238991|530696880|FG009|Overall Study|Lack of Efficacy|0|||
147145241|NCT01238991|530696871|FG000|Overall Study|Withdrawal by Subject|0|||
147238140|NCT02763462|531044090|FG000|Overall Study|Protocol Violation|6|||
147238141|NCT00261807|531044091|FG000|Overall Study|Lost to Follow-up|2|||
147238142|NCT00261807|531044091|FG000|Overall Study|Adverse Event|2|||
147238143|NCT00261807|531044091|FG000|Overall Study|Death|1|||
147574285|NCT02055547|532259083|FG012|Overall Study|Withdrawal by Subject|0|||
147145242|NCT01238991|530696872|FG001|Overall Study|Withdrawal by Subject|0|||
147145243|NCT01238991|530696873|FG002|Overall Study|Withdrawal by Subject|1|||
147145244|NCT01238991|530696874|FG003|Overall Study|Withdrawal by Subject|0|||
147145245|NCT01238991|530696875|FG004|Overall Study|Withdrawal by Subject|0|||
147145246|NCT01238991|530696876|FG005|Overall Study|Withdrawal by Subject|0|||
147145247|NCT01238991|530696877|FG006|Overall Study|Withdrawal by Subject|0|||
147145248|NCT01238991|530696878|FG007|Overall Study|Withdrawal by Subject|0|||
147574286|NCT02055547|532259084|FG013|Overall Study|Withdrawal by Subject|1|||
147574287|NCT02055547|532259085|FG014|Overall Study|Withdrawal by Subject|0|||
147574288|NCT02055547|532259086|FG015|Overall Study|Withdrawal by Subject|1|||
147574289|NCT02055547|532259087|FG016|Overall Study|Withdrawal by Subject|0|||
147574290|NCT02055547|532259088|FG017|Overall Study|Withdrawal by Subject|0|||
147574291|NCT02055547|532259089|FG018|Overall Study|Withdrawal by Subject|0|||
147574292|NCT02055547|532259071|FG000|Overall Study|Lost to Follow-up|0|||
147145249|NCT01238991|530696879|FG008|Overall Study|Withdrawal by Subject|0|||
147145250|NCT01238991|530696880|FG009|Overall Study|Withdrawal by Subject|0|||
147145251|NCT01238991|530696871|FG000|Overall Study|Study Terminated by Sponsor|0|||
147145252|NCT01238991|530696872|FG001|Overall Study|Study Terminated by Sponsor|0|||
147145253|NCT01238991|530696873|FG002|Overall Study|Study Terminated by Sponsor|0|||
147145254|NCT01238991|530696874|FG003|Overall Study|Study Terminated by Sponsor|0|||
147145255|NCT01238991|530696875|FG004|Overall Study|Study Terminated by Sponsor|1|||
147145256|NCT01238991|530696876|FG005|Overall Study|Study Terminated by Sponsor|0|||
147145257|NCT01238991|530696877|FG006|Overall Study|Study Terminated by Sponsor|7|||
147145258|NCT01238991|530696878|FG007|Overall Study|Study Terminated by Sponsor|4|||
147145259|NCT01238991|530696879|FG008|Overall Study|Study Terminated by Sponsor|2|||
147145260|NCT01238991|530696880|FG009|Overall Study|Study Terminated by Sponsor|2|||
147145261|NCT01238991|530696871|FG000|Overall Study|Caregiver's request|0|||
147145262|NCT01238991|530696872|FG001|Overall Study|Caregiver's request|0|||
147145263|NCT01238991|530696873|FG002|Overall Study|Caregiver's request|0|||
147145264|NCT01238991|530696874|FG003|Overall Study|Caregiver's request|0|||
147145265|NCT01238991|530696875|FG004|Overall Study|Caregiver's request|0|||
147145266|NCT01238991|530696876|FG005|Overall Study|Caregiver's request|0|||
147145267|NCT01238991|530696877|FG006|Overall Study|Caregiver's request|0|||
147145268|NCT01238991|530696878|FG007|Overall Study|Caregiver's request|0|||
147145269|NCT01238991|530696879|FG008|Overall Study|Caregiver's request|1|||
147145270|NCT01238991|530696880|FG009|Overall Study|Caregiver's request|0|||
147145271|NCT01238991|530696871|FG000|Overall Study|Admission to a nursing home|1|||
147145272|NCT01238991|530696872|FG001|Overall Study|Admission to a nursing home|0|||
147145273|NCT01238991|530696873|FG002|Overall Study|Admission to a nursing home|1|||
147145274|NCT01238991|530696874|FG003|Overall Study|Admission to a nursing home|0|||
147145275|NCT01238991|530696875|FG004|Overall Study|Admission to a nursing home|0|||
147145276|NCT01238991|530696876|FG005|Overall Study|Admission to a nursing home|0|||
147145277|NCT01238991|530696877|FG006|Overall Study|Admission to a nursing home|0|||
147145278|NCT01238991|530696878|FG007|Overall Study|Admission to a nursing home|0|||
147145279|NCT01238991|530696879|FG008|Overall Study|Admission to a nursing home|0|||
147145280|NCT01238991|530696880|FG009|Overall Study|Admission to a nursing home|0|||
147145281|NCT02222688|530696884|FG000|Overall Study|Withdrawal by Subject|0|||
147145282|NCT02222688|530696885|FG001|Overall Study|Withdrawal by Subject|0|||
147145283|NCT02222688|530696886|FG002|Overall Study|Withdrawal by Subject|0|||
147145284|NCT02222688|530696887|FG003|Overall Study|Withdrawal by Subject|2|||
147145285|NCT02222688|530696888|FG004|Overall Study|Withdrawal by Subject|1|||
147145286|NCT02222688|530696889|FG005|Overall Study|Withdrawal by Subject|0|||
147145287|NCT02222688|530696890|FG006|Overall Study|Withdrawal by Subject|1|||
147145288|NCT02222688|530696884|FG000|Overall Study|Disease progression|1|||
147145289|NCT02222688|530696885|FG001|Overall Study|Disease progression|0|||
147145290|NCT02222688|530696886|FG002|Overall Study|Disease progression|0|||
147145291|NCT02222688|530696887|FG003|Overall Study|Disease progression|0|||
147145292|NCT02222688|530696888|FG004|Overall Study|Disease progression|0|||
147145293|NCT02222688|530696889|FG005|Overall Study|Disease progression|0|||
147145294|NCT02222688|530696890|FG006|Overall Study|Disease progression|0|||
147145295|NCT02013778|530696900|FG000|Overall Study|Death|4|||
147145296|NCT02013778|530696900|FG000|Overall Study|Withdrawal by Subject|1|||
147145297|NCT02013778|530696900|FG000|Overall Study|Physician Decision|1|||
147145298|NCT02013778|530696900|FG000|Overall Study|Adverse Event|1|||
147145299|NCT03308968|530696901|FG000|Double-Blind Period (12 Weeks)|Adverse Event|3|||
147145300|NCT03308968|530696902|FG001|Double-Blind Period (12 Weeks)|Adverse Event|1|||
147145301|NCT03308968|530696903|FG002|Double-Blind Period (12 Weeks)|Adverse Event|4|||
147145302|NCT03308968|530696901|FG000|Double-Blind Period (12 Weeks)|Withdrawal by Subject|2|||
147145303|NCT03308968|530696902|FG001|Double-Blind Period (12 Weeks)|Withdrawal by Subject|2|||
147145304|NCT03308968|530696903|FG002|Double-Blind Period (12 Weeks)|Withdrawal by Subject|3|||
147145305|NCT03308968|530696901|FG000|Double-Blind Period (12 Weeks)|Protocol Violation|6|||
147574293|NCT02055547|532259072|FG001|Overall Study|Lost to Follow-up|0|||
147574294|NCT02055547|532259073|FG002|Overall Study|Lost to Follow-up|1|||
147145306|NCT03308968|530696902|FG001|Double-Blind Period (12 Weeks)|Protocol Violation|0|||
147145307|NCT03308968|530696903|FG002|Double-Blind Period (12 Weeks)|Protocol Violation|2|||
147145308|NCT03308968|530696901|FG000|Double-Blind Period (12 Weeks)|Non-compliance to study procedures|1|||
147145309|NCT03308968|530696902|FG001|Double-Blind Period (12 Weeks)|Non-compliance to study procedures|1|||
147145310|NCT03308968|530696903|FG002|Double-Blind Period (12 Weeks)|Non-compliance to study procedures|0|||
147145311|NCT03308968|530696901|FG000|Double-Blind Period (12 Weeks)|Lost to Follow-up|1|||
147145312|NCT03308968|530696902|FG001|Double-Blind Period (12 Weeks)|Lost to Follow-up|0|||
147145313|NCT03308968|530696903|FG002|Double-Blind Period (12 Weeks)|Lost to Follow-up|0|||
147145314|NCT03308968|530696901|FG000|Double-Blind Period (12 Weeks)|Lack of Efficacy|1|||
147574295|NCT02055547|532259074|FG003|Overall Study|Lost to Follow-up|0|||
147145315|NCT03308968|530696902|FG001|Double-Blind Period (12 Weeks)|Lack of Efficacy|1|||
147145316|NCT03308968|530696903|FG002|Double-Blind Period (12 Weeks)|Lack of Efficacy|0|||
147145317|NCT03308968|530696901|FG000|Double-Blind Period (12 Weeks)|Other than specified|1|||
147145318|NCT03308968|530696902|FG001|Double-Blind Period (12 Weeks)|Other than specified|0|||
147145319|NCT03308968|530696903|FG002|Double-Blind Period (12 Weeks)|Other than specified|2|||
147145320|NCT03308968|530696901|FG000|Open-Label Period (12 Weeks)|Other than specified|1|||
147145321|NCT03308968|530696902|FG001|Open-Label Period (12 Weeks)|Other than specified|2|||
147145322|NCT03308968|530696903|FG002|Open-Label Period (12 Weeks)|Other than specified|1|||
147145323|NCT03308968|530696901|FG000|Open-Label Period (12 Weeks)|Adverse Event|4|||
147145324|NCT03308968|530696902|FG001|Open-Label Period (12 Weeks)|Adverse Event|1|||
147145325|NCT03308968|530696903|FG002|Open-Label Period (12 Weeks)|Adverse Event|1|||
147145326|NCT03308968|530696901|FG000|Open-Label Period (12 Weeks)|Withdrawal by Subject|5|||
147145327|NCT03308968|530696902|FG001|Open-Label Period (12 Weeks)|Withdrawal by Subject|5|||
147145328|NCT03308968|530696903|FG002|Open-Label Period (12 Weeks)|Withdrawal by Subject|7|||
147145329|NCT03308968|530696901|FG000|Open-Label Period (12 Weeks)|Protocol Violation|0|||
147145330|NCT03308968|530696902|FG001|Open-Label Period (12 Weeks)|Protocol Violation|1|||
147145331|NCT03308968|530696903|FG002|Open-Label Period (12 Weeks)|Protocol Violation|1|||
147145332|NCT03308968|530696901|FG000|Open-Label Period (12 Weeks)|Non-compliance to study procedures|0|||
147145333|NCT03308968|530696902|FG001|Open-Label Period (12 Weeks)|Non-compliance to study procedures|0|||
147145334|NCT03308968|530696903|FG002|Open-Label Period (12 Weeks)|Non-compliance to study procedures|1|||
147145335|NCT03308968|530696901|FG000|Open-Label Period (12 Weeks)|Lost to Follow-up|0|||
147145336|NCT03308968|530696902|FG001|Open-Label Period (12 Weeks)|Lost to Follow-up|1|||
147145337|NCT03308968|530696903|FG002|Open-Label Period (12 Weeks)|Lost to Follow-up|1|||
147145338|NCT03308968|530696901|FG000|Open-Label Period (12 Weeks)|Lack of Efficacy|1|||
147145339|NCT03308968|530696902|FG001|Open-Label Period (12 Weeks)|Lack of Efficacy|2|||
147145340|NCT03308968|530696903|FG002|Open-Label Period (12 Weeks)|Lack of Efficacy|0|||
147145341|NCT03037476|530696906|FG000|Overall Study|Lost to Follow-up|63|||
147145342|NCT03037476|530696907|FG001|Overall Study|Lost to Follow-up|46|||
147145343|NCT02141633|530696908|FG000|Overall Study|Physician Decision|1|||
147145344|NCT02141633|530696909|FG001|Overall Study|Physician Decision|0|||
147145345|NCT03053440|530696912|FG000|Overall Study|Sponsor's Decision to End the Study|20|||
147145346|NCT03053440|530696913|FG001|Overall Study|Sponsor's Decision to End the Study|13|||
147145347|NCT03053440|530696912|FG000|Overall Study|Death|18|||
147145348|NCT03053440|530696913|FG001|Overall Study|Death|14|||
147145349|NCT03053440|530696912|FG000|Overall Study|Withdrawal by Subject|9|||
147145350|NCT03053440|530696913|FG001|Overall Study|Withdrawal by Subject|8|||
147145351|NCT03053440|530696912|FG000|Overall Study|Lost to Follow-up|1|||
147145352|NCT03053440|530696913|FG001|Overall Study|Lost to Follow-up|0|||
147145353|NCT03053440|530696912|FG000|Overall Study|Enrolled in Long-term Extension Study|48|||
147145354|NCT03053440|530696913|FG001|Overall Study|Enrolled in Long-term Extension Study|66|||
147145355|NCT03053440|530696912|FG000|Overall Study|Physician Decision|2|||
147145356|NCT03053440|530696913|FG001|Overall Study|Physician Decision|1|||
147145357|NCT03053440|530696912|FG000|Overall Study|Participant Randomized but died before dosing|1|||
147145358|NCT03053440|530696913|FG001|Overall Study|Participant Randomized but died before dosing|0|||
147145359|NCT01188551|530696914|FG000|Overall Study|Pharmacy issues|1|||
147145360|NCT01188551|530696915|FG001|Overall Study|Pharmacy issues|0|||
147145361|NCT01188551|530696916|FG002|Overall Study|Pharmacy issues|0|||
147145362|NCT01188551|530696917|FG003|Overall Study|Pharmacy issues|0|||
147145363|NCT00391053|530696918|FG000|Overall Study|Serious Adverse Events|1|||
147145364|NCT00391053|530696919|FG001|Overall Study|Serious Adverse Events|0|||
147145365|NCT00391053|530696920|FG002|Overall Study|Serious Adverse Events|1|||
147145366|NCT00391053|530696921|FG003|Overall Study|Serious Adverse Events|4|||
147145367|NCT00391053|530696918|FG000|Overall Study|Protocol Violation|2|||
147145368|NCT00391053|530696919|FG001|Overall Study|Protocol Violation|0|||
147145369|NCT00391053|530696920|FG002|Overall Study|Protocol Violation|0|||
147145370|NCT00391053|530696921|FG003|Overall Study|Protocol Violation|0|||
147145371|NCT00391053|530696918|FG000|Overall Study|Lost to Follow-up|1|||
147145372|NCT00391053|530696919|FG001|Overall Study|Lost to Follow-up|0|||
147145373|NCT00391053|530696920|FG002|Overall Study|Lost to Follow-up|0|||
147145374|NCT00391053|530696921|FG003|Overall Study|Lost to Follow-up|5|||
147145375|NCT00391053|530696918|FG000|Overall Study|Withdrawal by Subject|5|||
147145376|NCT00391053|530696919|FG001|Overall Study|Withdrawal by Subject|1|||
147145377|NCT00391053|530696920|FG002|Overall Study|Withdrawal by Subject|1|||
147145378|NCT00391053|530696921|FG003|Overall Study|Withdrawal by Subject|1|||
147145379|NCT02140970|530696923|FG000|Overall Study|Lost to Follow-up|1|||
147145380|NCT02140970|530696924|FG001|Overall Study|Lost to Follow-up|2|||
147145381|NCT02140970|530696923|FG000|Overall Study|Misplaced consent, subject withdrawn|1|||
147145382|NCT02140970|530696924|FG001|Overall Study|Misplaced consent, subject withdrawn|0|||
147145383|NCT02140970|530696923|FG000|Overall Study|Did not meet inclusion criteria|0|||
147145384|NCT02140970|530696924|FG001|Overall Study|Did not meet inclusion criteria|1|||
147145385|NCT05069597|530696925|FG000|Treatment Period (Day 1 to Day 85)|Withdrawal by Subject|0|||
147145386|NCT05069597|530696926|FG001|Treatment Period (Day 1 to Day 85)|Withdrawal by Subject|1|||
147145387|NCT02553928|530696927|FG000|Overall Study|Adverse Event|2|||
147145388|NCT02553928|530696928|FG001|Overall Study|Adverse Event|1|||
147145389|NCT02553928|530696927|FG000|Overall Study|Lost to Follow-up|0|||
147145390|NCT02553928|530696928|FG001|Overall Study|Lost to Follow-up|1|||
147145391|NCT02553928|530696927|FG000|Overall Study|Administrative reason(s)|0|||
147145392|NCT02553928|530696928|FG001|Overall Study|Administrative reason(s)|1|||
147145393|NCT02526212|530696929|FG000|Overall Study|Incarceration|1|||
147145394|NCT02526212|530696930|FG001|Overall Study|Incarceration|0|||
147145395|NCT02526212|530696929|FG000|Overall Study|Lost to Follow-up|1|||
147145396|NCT02526212|530696930|FG001|Overall Study|Lost to Follow-up|0|||
147145397|NCT02526212|530696929|FG000|Overall Study|Death|0|||
147145398|NCT02526212|530696930|FG001|Overall Study|Death|1|||
147145399|NCT00040742|530696931|FG000|Overall Study|Death|0|||
147145400|NCT00040742|530696932|FG001|Overall Study|Death|0|||
147145401|NCT00040742|530696933|FG002|Overall Study|Death|1|||
147145402|NCT00040742|530696934|FG003|Overall Study|Death|0|||
147145403|NCT00040742|530696931|FG000|Overall Study|Adverse Event|15|||
147145404|NCT00040742|530696932|FG001|Overall Study|Adverse Event|16|||
147145405|NCT00040742|530696933|FG002|Overall Study|Adverse Event|21|||
147145406|NCT00040742|530696934|FG003|Overall Study|Adverse Event|9|||
147145407|NCT00040742|530696931|FG000|Overall Study|Withdrawal by Subject|7|||
147145408|NCT00040742|530696932|FG001|Overall Study|Withdrawal by Subject|15|||
147145409|NCT00040742|530696933|FG002|Overall Study|Withdrawal by Subject|10|||
147145410|NCT00040742|530696934|FG003|Overall Study|Withdrawal by Subject|13|||
147145411|NCT00040742|530696931|FG000|Overall Study|Chemotoxicity|4|||
147145412|NCT00040742|530696932|FG001|Overall Study|Chemotoxicity|3|||
147145413|NCT00040742|530696933|FG002|Overall Study|Chemotoxicity|5|||
147145414|NCT00040742|530696934|FG003|Overall Study|Chemotoxicity|2|||
147145415|NCT00040742|530696931|FG000|Overall Study|Incomplete Forms|6|||
147145416|NCT00040742|530696932|FG001|Overall Study|Incomplete Forms|10|||
147145417|NCT00040742|530696933|FG002|Overall Study|Incomplete Forms|4|||
147145418|NCT00040742|530696934|FG003|Overall Study|Incomplete Forms|5|||
147145419|NCT00040742|530696931|FG000|Overall Study|Other medical|7|||
147145420|NCT00040742|530696932|FG001|Overall Study|Other medical|5|||
147145421|NCT00040742|530696933|FG002|Overall Study|Other medical|5|||
147145422|NCT00040742|530696934|FG003|Overall Study|Other medical|5|||
147145423|NCT01434654|530696935|FG000|Overall Study|Withdrawal by Subject|1|||
147145424|NCT01434654|530696936|FG001|Overall Study|Withdrawal by Subject|0|||
147145425|NCT01434654|530696935|FG000|Overall Study|Lost to Follow-up|1|||
147145426|NCT01434654|530696936|FG001|Overall Study|Lost to Follow-up|0|||
147145427|NCT00645840|530696937|FG000|Overall Study|Protocol Violation|3|||
147145428|NCT00402324|530696938|FG000|Overall Study|Lost to Follow-up|11|||
147145429|NCT00402324|530696939|FG001|Overall Study|Lost to Follow-up|11|||
147145430|NCT00402324|530696938|FG000|Overall Study|Protocol Entry Criteria Not Met|5|||
147145431|NCT00402324|530696939|FG001|Overall Study|Protocol Entry Criteria Not Met|4|||
147145432|NCT00402324|530696938|FG000|Overall Study|Protocol Violation|8|||
147145433|NCT00402324|530696939|FG001|Overall Study|Protocol Violation|7|||
147145434|NCT00402324|530696938|FG000|Overall Study|Withdrawal by Subject|5|||
147145435|NCT00402324|530696939|FG001|Overall Study|Withdrawal by Subject|2|||
147145436|NCT00402324|530696938|FG000|Overall Study|Physician Decision|2|||
147145437|NCT00402324|530696939|FG001|Overall Study|Physician Decision|4|||
147145438|NCT00402324|530696938|FG000|Overall Study|Sponsor Decision|4|||
147145439|NCT00402324|530696939|FG001|Overall Study|Sponsor Decision|5|||
147145440|NCT00402324|530696938|FG000|Overall Study|Lack of Efficacy|1|||
147145441|NCT00402324|530696939|FG001|Overall Study|Lack of Efficacy|4|||
147145442|NCT00402324|530696938|FG000|Overall Study|Adverse Event|6|||
147145443|NCT00402324|530696939|FG001|Overall Study|Adverse Event|4|||
147145444|NCT00402324|530696938|FG000|Overall Study|Death|1|||
147145445|NCT00402324|530696939|FG001|Overall Study|Death|0|||
147145446|NCT01823198|530696940|FG000|Overall Study|Physician Decision|0|||
147145447|NCT01823198|530696941|FG001|Overall Study|Physician Decision|1|||
147145448|NCT01823198|530696942|FG002|Overall Study|Physician Decision|0|||
147574296|NCT02055547|532259075|FG004|Overall Study|Lost to Follow-up|0|||
147574297|NCT02055547|532259076|FG005|Overall Study|Lost to Follow-up|0|||
147574298|NCT02055547|532259077|FG006|Overall Study|Lost to Follow-up|0|||
147574299|NCT02055547|532259078|FG007|Overall Study|Lost to Follow-up|0|||
147145449|NCT01823198|530696943|FG003|Overall Study|Physician Decision|0|||
147145450|NCT01823198|530696944|FG004|Overall Study|Physician Decision|0|||
147145451|NCT01823198|530696945|FG005|Overall Study|Physician Decision|3|||
147145452|NCT01823198|530696946|FG006|Overall Study|Physician Decision|3|||
147145453|NCT01119066|530696947|FG000|Overall Study|Withdrawal by Subject|4|||
147145454|NCT01119066|530696948|FG001|Overall Study|Withdrawal by Subject|6|||
147145455|NCT01119066|530696949|FG002|Overall Study|Withdrawal by Subject|0|||
147145456|NCT01119066|530696950|FG003|Overall Study|Withdrawal by Subject|0|||
147145457|NCT01119066|530696947|FG000|Overall Study|Concern regarding adequacy of transplant cell dose|2|||
147574300|NCT02055547|532259079|FG008|Overall Study|Lost to Follow-up|0|||
147145458|NCT01119066|530696948|FG001|Overall Study|Concern regarding adequacy of transplant cell dose|1|||
147145459|NCT01119066|530696949|FG002|Overall Study|Concern regarding adequacy of transplant cell dose|0|||
147145460|NCT01119066|530696950|FG003|Overall Study|Concern regarding adequacy of transplant cell dose|0|||
147574301|NCT02055547|532259080|FG009|Overall Study|Lost to Follow-up|0|||
147145461|NCT01119066|530696947|FG000|Overall Study|Relapse identified before transplant|1|||
147145462|NCT01119066|530696948|FG001|Overall Study|Relapse identified before transplant|0|||
147145463|NCT01119066|530696949|FG002|Overall Study|Relapse identified before transplant|0|||
147145464|NCT01119066|530696950|FG003|Overall Study|Relapse identified before transplant|0|||
147145465|NCT01119066|530696947|FG000|Overall Study|Intercurrent medication condition rendered patient ineligible|0|||
147145466|NCT01119066|530696948|FG001|Overall Study|Intercurrent medication condition rendered patient ineligible|3|||
147145467|NCT01119066|530696949|FG002|Overall Study|Intercurrent medication condition rendered patient ineligible|0|||
147145468|NCT01119066|530696950|FG003|Overall Study|Intercurrent medication condition rendered patient ineligible|0|||
147145469|NCT01119066|530696947|FG000|Overall Study|Relapse identified before transplant|0|||
147145470|NCT01119066|530696948|FG001|Overall Study|Relapse identified before transplant|4|||
147145471|NCT01119066|530696949|FG002|Overall Study|Relapse identified before transplant|0|||
147145472|NCT01119066|530696950|FG003|Overall Study|Relapse identified before transplant|0|||
147238144|NCT00261807|531044091|FG000|Overall Study|Protocol Violation|2|||
147238145|NCT01706146|531044092|FG000|Overall Study|Withdrawal by Subject|1|||
147574302|NCT02055547|532259081|FG010|Overall Study|Lost to Follow-up|0|||
147574303|NCT02055547|532259082|FG011|Overall Study|Lost to Follow-up|0|||
147238146|NCT01706146|531044092|FG000|Overall Study|Adverse Event|3|||
147238147|NCT01706146|531044092|FG000|Overall Study|Developed AF and need for antiplatelets|2|||
147238148|NCT00675948|531044094|FG000|Overall Study|Adverse Event|23|||
147238149|NCT00675948|531044095|FG001|Overall Study|Adverse Event|1|||
147238150|NCT00675948|531044094|FG000|Overall Study|Lack of Efficacy|3|||
147238151|NCT00675948|531044095|FG001|Overall Study|Lack of Efficacy|0|||
147238152|NCT00675948|531044094|FG000|Overall Study|Withdrawal by Subject|7|||
147238153|NCT00675948|531044095|FG001|Overall Study|Withdrawal by Subject|0|||
147238154|NCT00675948|531044094|FG000|Overall Study|Lost to Follow-up|2|||
147238155|NCT00675948|531044095|FG001|Overall Study|Lost to Follow-up|0|||
147238156|NCT00675948|531044094|FG000|Overall Study|Protocol Violation|1|||
147238157|NCT00675948|531044095|FG001|Overall Study|Protocol Violation|0|||
147238158|NCT00675948|531044094|FG000|Overall Study|Pain under control|1|||
147238159|NCT00675948|531044095|FG001|Overall Study|Pain under control|0|||
147238160|NCT00675948|531044094|FG000|Overall Study|Sponsor decision|0|||
147238161|NCT00675948|531044095|FG001|Overall Study|Sponsor decision|1|||
147238162|NCT00675948|531044094|FG000|Overall Study|Patient died|1|||
147238163|NCT00675948|531044095|FG001|Overall Study|Patient died|0|||
147238164|NCT00675948|531044094|FG000|Overall Study|Patient unable to comply with diaries|1|||
147238165|NCT00675948|531044095|FG001|Overall Study|Patient unable to comply with diaries|0|||
147238166|NCT00675948|531044094|FG000|Overall Study|Patient feels unable to take medication|0|||
147238167|NCT00675948|531044095|FG001|Overall Study|Patient feels unable to take medication|1|||
147238168|NCT02527161|531044096|FG000|Overall Study|Failed MRI|52|||
147238169|NCT02527161|531044096|FG000|Overall Study|Withdrawal by Subject|19|||
147238170|NCT02527161|531044096|FG000|Overall Study|Delay in or unfit for surgery|16|||
147238171|NCT02527161|531044096|FG000|Overall Study|MRI contraindication|6|||
147238172|NCT02527161|531044096|FG000|Overall Study|Consent violation|4|||
147238173|NCT02527161|531044096|FG000|Overall Study|Only Recruited to Part A|27|||
147238174|NCT02527161|531044096|FG000|Overall Study|Physician Decision|1|||
147238175|NCT02527161|531044096|FG000|Overall Study|Adverse Event|1|||
147238176|NCT02527161|531044096|FG000|Overall Study|Lost to Follow-up|6|||
147238177|NCT02100514|531044097|FG000|Treatment Period|Adverse Event|0|||
147238178|NCT02100514|531044098|FG001|Treatment Period|Adverse Event|5|||
147238179|NCT02100514|531044099|FG002|Treatment Period|Adverse Event|0|||
147238180|NCT02100514|531044100|FG003|Treatment Period|Adverse Event|0|||
147238181|NCT02100514|531044101|FG004|Treatment Period|Adverse Event|0|||
147238182|NCT02100514|531044097|FG000|Treatment Period|Death|2|||
147238183|NCT02100514|531044098|FG001|Treatment Period|Death|2|||
147238184|NCT02100514|531044099|FG002|Treatment Period|Death|0|||
147238185|NCT02100514|531044100|FG003|Treatment Period|Death|0|||
147238186|NCT02100514|531044101|FG004|Treatment Period|Death|0|||
147238187|NCT02100514|531044097|FG000|Treatment Period|Lost to Follow-up|5|||
147238188|NCT02100514|531044098|FG001|Treatment Period|Lost to Follow-up|17|||
147238189|NCT02100514|531044099|FG002|Treatment Period|Lost to Follow-up|0|||
147238190|NCT02100514|531044100|FG003|Treatment Period|Lost to Follow-up|0|||
147238191|NCT02100514|531044101|FG004|Treatment Period|Lost to Follow-up|0|||
147238192|NCT02100514|531044097|FG000|Treatment Period|Did Not Meet Entrance Criteria|0|||
147238193|NCT02100514|531044098|FG001|Treatment Period|Did Not Meet Entrance Criteria|1|||
147238194|NCT02100514|531044099|FG002|Treatment Period|Did Not Meet Entrance Criteria|0|||
147238195|NCT02100514|531044100|FG003|Treatment Period|Did Not Meet Entrance Criteria|0|||
147238196|NCT02100514|531044101|FG004|Treatment Period|Did Not Meet Entrance Criteria|0|||
147238197|NCT02100514|531044097|FG000|Treatment Period|Protocol Violation|1|||
147238198|NCT02100514|531044098|FG001|Treatment Period|Protocol Violation|1|||
147238199|NCT02100514|531044099|FG002|Treatment Period|Protocol Violation|0|||
147574304|NCT02055547|532259083|FG012|Overall Study|Lost to Follow-up|0|||
147238200|NCT02100514|531044100|FG003|Treatment Period|Protocol Violation|0|||
147238201|NCT02100514|531044101|FG004|Treatment Period|Protocol Violation|0|||
147238202|NCT02100514|531044097|FG000|Treatment Period|Withdrawal by Subject|12|||
147145473|NCT02441101|530696951|FG000|Overall Study|Withdrawal by Subject|1|||
147145474|NCT02441101|530696952|FG001|Overall Study|Withdrawal by Subject|0|||
147145475|NCT02441101|530696951|FG000|Overall Study|Lost to Follow-up|1|||
147145476|NCT02441101|530696952|FG001|Overall Study|Lost to Follow-up|0|||
147145477|NCT02441101|530696951|FG000|Overall Study|PI relocated and study terminated|1|||
147145478|NCT02441101|530696952|FG001|Overall Study|PI relocated and study terminated|0|||
147145479|NCT03012828|530696953|FG000|Overall Study|Lost to Follow-up|1|||
147145480|NCT03012828|530696954|FG001|Overall Study|Lost to Follow-up|0|||
147145481|NCT03012828|530696955|FG002|Overall Study|Lost to Follow-up|1|||
147145482|NCT03012828|530696956|FG003|Overall Study|Lost to Follow-up|0|||
147145483|NCT03012828|530696957|FG004|Overall Study|Lost to Follow-up|1|||
147145484|NCT03012828|530696958|FG005|Overall Study|Lost to Follow-up|0|||
147145485|NCT03012828|530696953|FG000|Overall Study|Withdrawal by Subject|0|||
147145486|NCT03012828|530696954|FG001|Overall Study|Withdrawal by Subject|0|||
147145487|NCT03012828|530696955|FG002|Overall Study|Withdrawal by Subject|1|||
147145488|NCT03012828|530696956|FG003|Overall Study|Withdrawal by Subject|0|||
147145489|NCT03012828|530696957|FG004|Overall Study|Withdrawal by Subject|0|||
147145490|NCT03012828|530696958|FG005|Overall Study|Withdrawal by Subject|1|||
147145491|NCT03012828|530696953|FG000|Overall Study|Non-compliance with protocol|0|||
147145492|NCT03012828|530696954|FG001|Overall Study|Non-compliance with protocol|0|||
147145493|NCT03012828|530696955|FG002|Overall Study|Non-compliance with protocol|0|||
147145494|NCT03012828|530696956|FG003|Overall Study|Non-compliance with protocol|0|||
147238203|NCT02100514|531044098|FG001|Treatment Period|Withdrawal by Subject|37|||
147238204|NCT02100514|531044099|FG002|Treatment Period|Withdrawal by Subject|0|||
147238205|NCT02100514|531044100|FG003|Treatment Period|Withdrawal by Subject|0|||
147238206|NCT02100514|531044101|FG004|Treatment Period|Withdrawal by Subject|0|||
147238207|NCT02100514|531044097|FG000|Treatment Period|Other|9|||
147238208|NCT02100514|531044098|FG001|Treatment Period|Other|11|||
147238209|NCT02100514|531044099|FG002|Treatment Period|Other|0|||
147238210|NCT02100514|531044100|FG003|Treatment Period|Other|0|||
147238211|NCT02100514|531044101|FG004|Treatment Period|Other|0|||
147238212|NCT02100514|531044097|FG000|Extension Period|Withdrew consent|0|||
147238213|NCT02100514|531044098|FG001|Extension Period|Withdrew consent|0|||
147238214|NCT02100514|531044099|FG002|Extension Period|Withdrew consent|2|||
147238215|NCT02100514|531044100|FG003|Extension Period|Withdrew consent|0|||
147238216|NCT02100514|531044101|FG004|Extension Period|Withdrew consent|0|||
147238217|NCT00762229|531044102|FG000|Overall Study|Lost to Follow-up|1|||
147238218|NCT00762229|531044103|FG001|Overall Study|Lost to Follow-up|1|||
147238219|NCT00762229|531044102|FG000|Overall Study|did not recveive intervention|0|||
147445736|NCT01500278|531797440|FG001|Week 0 - Week 12|Adverse event (AE), not fatal|8|||
147445737|NCT01500278|531797439|FG000|Week 13 - Week 104|Lack of Efficacy|11|||
147445738|NCT01500278|531797440|FG001|Week 13 - Week 104|Lack of Efficacy|12|||
147238220|NCT00762229|531044103|FG001|Overall Study|did not recveive intervention|1|||
147238221|NCT01751178|531044108|FG000|Overall Study|Adverse Event|2|||
147238222|NCT01751178|531044109|FG001|Overall Study|Adverse Event|0|||
147238223|NCT01751178|531044110|FG002|Overall Study|Adverse Event|0|||
147238224|NCT01751178|531044108|FG000|Overall Study|Other Reason (unknown)|1|||
147238225|NCT01751178|531044109|FG001|Overall Study|Other Reason (unknown)|0|||
147238226|NCT01751178|531044110|FG002|Overall Study|Other Reason (unknown)|2|||
147238227|NCT02747875|531044114|FG000|Overall Study|Physician Decision|1|||
147238228|NCT02747875|531044115|FG001|Overall Study|Physician Decision|0|||
147238229|NCT02747875|531044114|FG000|Overall Study|Adverse Event|0|||
147238230|NCT02747875|531044115|FG001|Overall Study|Adverse Event|1|||
147238231|NCT04891978|531044119|FG000|Baseline|Protocol Violation|2|||
147238232|NCT04891978|531044120|FG001|Baseline|Protocol Violation|1|||
147238233|NCT04891978|531044121|FG002|Baseline|Protocol Violation|0|||
147574305|NCT02055547|532259084|FG013|Overall Study|Lost to Follow-up|0|||
147574306|NCT02055547|532259085|FG014|Overall Study|Lost to Follow-up|0|||
147574307|NCT02055547|532259086|FG015|Overall Study|Lost to Follow-up|0|||
147145495|NCT03012828|530696957|FG004|Overall Study|Non-compliance with protocol|1|||
147145496|NCT03012828|530696958|FG005|Overall Study|Non-compliance with protocol|0|||
147145497|NCT03012828|530696953|FG000|Overall Study|Delay to last visit would delay DBL|0|||
147145498|NCT03012828|530696954|FG001|Overall Study|Delay to last visit would delay DBL|0|||
147145499|NCT03012828|530696955|FG002|Overall Study|Delay to last visit would delay DBL|0|||
147145500|NCT03012828|530696956|FG003|Overall Study|Delay to last visit would delay DBL|0|||
147145501|NCT03012828|530696957|FG004|Overall Study|Delay to last visit would delay DBL|0|||
147145502|NCT03012828|530696958|FG005|Overall Study|Delay to last visit would delay DBL|1|||
147145503|NCT01509846|530696959|FG000|Received Vaccination 2|Withdrawal by Subject|0|||
147145504|NCT01509846|530696960|FG001|Received Vaccination 2|Withdrawal by Subject|0|||
147238234|NCT04891978|531044119|FG000|Baseline|Missing AIRQ|1|||
147238235|NCT04891978|531044120|FG001|Baseline|Missing AIRQ|0|||
147238236|NCT04891978|531044121|FG002|Baseline|Missing AIRQ|0|||
147238237|NCT04891978|531044119|FG000|Baseline|Did not attend a baseline visit|0|||
147238238|NCT04891978|531044120|FG001|Baseline|Did not attend a baseline visit|0|||
147238239|NCT04891978|531044121|FG002|Baseline|Did not attend a baseline visit|9|||
147238240|NCT01776840|531044122|FG000|Overall Study|Lost to Follow-up|12|||
147238241|NCT01776840|531044123|FG001|Overall Study|Lost to Follow-up|7|||
147574308|NCT02055547|532259087|FG016|Overall Study|Lost to Follow-up|0|||
147574309|NCT02055547|532259088|FG017|Overall Study|Lost to Follow-up|0|||
147574310|NCT02055547|532259089|FG018|Overall Study|Lost to Follow-up|0|||
147574311|NCT02911025|532259090|FG000|Overall Study|Lost to Follow-up|3|||
147145505|NCT01509846|530696961|FG002|Received Vaccination 2|Withdrawal by Subject|1|||
147145506|NCT01509846|530696962|FG003|Received Vaccination 2|Withdrawal by Subject|0|||
147145507|NCT01509846|530696963|FG004|Received Vaccination 2|Withdrawal by Subject|0|||
147145508|NCT01509846|530696959|FG000|Received Vaccination 2|Illness|0|||
147145509|NCT01509846|530696960|FG001|Received Vaccination 2|Illness|0|||
147145510|NCT01509846|530696961|FG002|Received Vaccination 2|Illness|0|||
147145511|NCT01509846|530696962|FG003|Received Vaccination 2|Illness|0|||
147145512|NCT01509846|530696963|FG004|Received Vaccination 2|Illness|1|||
147145513|NCT01509846|530696959|FG000|Received Vaccination 2|Not vaccinated per protocol|5|||
147145514|NCT01509846|530696960|FG001|Received Vaccination 2|Not vaccinated per protocol|0|||
147145515|NCT01509846|530696961|FG002|Received Vaccination 2|Not vaccinated per protocol|0|||
147238242|NCT01776840|531044122|FG000|Overall Study|Withdrawal by Subject|32|||
147238243|NCT01776840|531044123|FG001|Overall Study|Withdrawal by Subject|48|||
147238244|NCT01776840|531044122|FG000|Overall Study|Sponsor decision|89|||
147238245|NCT01776840|531044123|FG001|Overall Study|Sponsor decision|87|||
147238246|NCT03641339|531044124|FG000|Overall Study|Physician Decision|1|||
147238247|NCT03641339|531044125|FG001|Overall Study|Physician Decision|0|||
147238248|NCT03641339|531044126|FG002|Overall Study|Physician Decision|0|||
147238249|NCT03641339|531044127|FG003|Overall Study|Physician Decision|0|||
147238250|NCT03641339|531044128|FG004|Overall Study|Physician Decision|0|||
147238251|NCT03641339|531044129|FG005|Overall Study|Physician Decision|0|||
147238252|NCT03641339|531044124|FG000|Overall Study|Withdrawal by Subject|0|||
147238253|NCT03641339|531044125|FG001|Overall Study|Withdrawal by Subject|2|||
147238254|NCT03641339|531044126|FG002|Overall Study|Withdrawal by Subject|0|||
147238255|NCT03641339|531044127|FG003|Overall Study|Withdrawal by Subject|2|||
147238256|NCT03641339|531044128|FG004|Overall Study|Withdrawal by Subject|0|||
147238257|NCT03641339|531044129|FG005|Overall Study|Withdrawal by Subject|1|||
147238258|NCT02589405|531044132|FG000|Overall Study|Adverse Event|3|||
147238259|NCT02589405|531044132|FG000|Overall Study|Withdrawal by Subject|1|||
147238260|NCT00446251|531044136|FG000|Overall Study|On-study Transplants|2|||
147238261|NCT00446251|531044136|FG000|Overall Study|Rituximab Infusion Reaction|2|||
147238262|NCT00446251|531044136|FG000|Overall Study|Lost to Follow-up|1|||
147238263|NCT02264639|531044141|FG000|Overall Study|Death (after completing single-dose phase)|1|||
147238264|NCT02264639|531044142|FG001|Overall Study|Death (after completing single-dose phase)|0|||
147238265|NCT02264639|531044143|FG002|Overall Study|Death (after completing single-dose phase)|0|||
147238266|NCT02264639|531044144|FG003|Overall Study|Death (after completing single-dose phase)|0|||
147238267|NCT02264639|531044145|FG004|Overall Study|Death (after completing single-dose phase)|0|||
147238268|NCT02264639|531044141|FG000|Overall Study|Withdrawal by subject (during multiple-dose phase)|1|||
147238269|NCT02264639|531044142|FG001|Overall Study|Withdrawal by subject (during multiple-dose phase)|0|||
147238270|NCT02264639|531044143|FG002|Overall Study|Withdrawal by subject (during multiple-dose phase)|0|||
147238271|NCT02264639|531044144|FG003|Overall Study|Withdrawal by subject (during multiple-dose phase)|0|||
147238272|NCT02264639|531044145|FG004|Overall Study|Withdrawal by subject (during multiple-dose phase)|0|||
147238273|NCT02264639|531044141|FG000|Overall Study|Pregnancy (during multiple-dose phase)|0|||
147238274|NCT02264639|531044142|FG001|Overall Study|Pregnancy (during multiple-dose phase)|0|||
147238275|NCT02264639|531044143|FG002|Overall Study|Pregnancy (during multiple-dose phase)|1|||
147238276|NCT02264639|531044144|FG003|Overall Study|Pregnancy (during multiple-dose phase)|0|||
147238277|NCT02264639|531044145|FG004|Overall Study|Pregnancy (during multiple-dose phase)|0|||
147238278|NCT02264639|531044141|FG000|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|0|||
147238279|NCT02264639|531044142|FG001|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|0|||
147238280|NCT02264639|531044143|FG002|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|0|||
147238281|NCT02264639|531044144|FG003|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|0|||
147238282|NCT02264639|531044145|FG004|Overall Study|Major Intercurrent Illness (during multiple-dose phase)|1|||
147238283|NCT02693119|531044153|FG000|Open-Label Period|Withdrawal by Subject|0|||
147238284|NCT02693119|531044154|FG001|Open-Label Period|Withdrawal by Subject|1|||
147238285|NCT02319837|531044155|FG000|Study Treatment Phase|Centrally confirmed radiographic progression|26|||
147238286|NCT02319837|531044156|FG001|Study Treatment Phase|Centrally confirmed radiographic progression|66|||
147238287|NCT02319837|531044157|FG002|Study Treatment Phase|Centrally confirmed radiographic progression|37|||
147238288|NCT02319837|531044155|FG000|Study Treatment Phase|PSA progression notification from sponsor|2|||
147238289|NCT02319837|531044156|FG001|Study Treatment Phase|PSA progression notification from sponsor|20|||
147238290|NCT02319837|531044157|FG002|Study Treatment Phase|PSA progression notification from sponsor|5|||
147574312|NCT02923349|532259094|FG000|Overall Study|Other|1|||
147574313|NCT02923349|532259095|FG001|Overall Study|Other|2|||
147574314|NCT02923349|532259096|FG002|Overall Study|Other|4|||
147145516|NCT01509846|530696962|FG003|Received Vaccination 2|Not vaccinated per protocol|0|||
147238291|NCT02319837|531044155|FG000|Study Treatment Phase|Adverse Event|73|||
147238292|NCT02319837|531044156|FG001|Study Treatment Phase|Adverse Event|36|||
147574315|NCT02923349|532259097|FG003|Overall Study|Other|1|||
147238293|NCT02319837|531044157|FG002|Study Treatment Phase|Adverse Event|63|||
147238294|NCT02319837|531044155|FG000|Study Treatment Phase|Development of castration resistance|0|||
147238295|NCT02319837|531044156|FG001|Study Treatment Phase|Development of castration resistance|2|||
147238296|NCT02319837|531044157|FG002|Study Treatment Phase|Development of castration resistance|0|||
147238297|NCT02319837|531044155|FG000|Study Treatment Phase|Withdrawal by Subject|26|||
147574316|NCT02923349|532259098|FG004|Overall Study|Other|3|||
147574317|NCT02923349|532259099|FG005|Overall Study|Other|0|||
147574318|NCT02923349|532259100|FG006|Overall Study|Other|1|||
147574319|NCT02923349|532259094|FG000|Overall Study|Withdrawal by Subject|2|||
147574320|NCT02923349|532259095|FG001|Overall Study|Withdrawal by Subject|2|||
147574321|NCT02923349|532259096|FG002|Overall Study|Withdrawal by Subject|8|||
147574322|NCT02923349|532259097|FG003|Overall Study|Withdrawal by Subject|10|||
147574323|NCT02923349|532259098|FG004|Overall Study|Withdrawal by Subject|12|||
147574324|NCT02923349|532259099|FG005|Overall Study|Withdrawal by Subject|3|||
147574325|NCT02923349|532259100|FG006|Overall Study|Withdrawal by Subject|0|||
147574326|NCT02923349|532259094|FG000|Overall Study|Physician Decision|0|||
147574327|NCT02923349|532259095|FG001|Overall Study|Physician Decision|0|||
147145517|NCT01509846|530696963|FG004|Received Vaccination 2|Not vaccinated per protocol|2|||
147145518|NCT01509846|530696959|FG000|Received Vaccination 3|Withdrawal by Subject|0|||
147145519|NCT01509846|530696960|FG001|Received Vaccination 3|Withdrawal by Subject|1|||
147145520|NCT01509846|530696961|FG002|Received Vaccination 3|Withdrawal by Subject|0|||
147145521|NCT01509846|530696962|FG003|Received Vaccination 3|Withdrawal by Subject|0|||
147145522|NCT01509846|530696963|FG004|Received Vaccination 3|Withdrawal by Subject|0|||
147145523|NCT01509846|530696959|FG000|Received Vaccination 3|Pregnancy|0|||
147145524|NCT01509846|530696960|FG001|Received Vaccination 3|Pregnancy|0|||
147145525|NCT01509846|530696961|FG002|Received Vaccination 3|Pregnancy|0|||
147145526|NCT01509846|530696962|FG003|Received Vaccination 3|Pregnancy|1|||
147574328|NCT02923349|532259096|FG002|Overall Study|Physician Decision|0|||
147574329|NCT02923349|532259097|FG003|Overall Study|Physician Decision|1|||
147574330|NCT02923349|532259098|FG004|Overall Study|Physician Decision|1|||
147574331|NCT02923349|532259099|FG005|Overall Study|Physician Decision|0|||
147145527|NCT01509846|530696963|FG004|Received Vaccination 3|Pregnancy|0|||
147145528|NCT01509846|530696959|FG000|Received Vaccination 3|Lost to Follow-up|0|||
147145529|NCT01509846|530696960|FG001|Received Vaccination 3|Lost to Follow-up|0|||
147145530|NCT01509846|530696961|FG002|Received Vaccination 3|Lost to Follow-up|1|||
147145531|NCT01509846|530696962|FG003|Received Vaccination 3|Lost to Follow-up|0|||
147145532|NCT01509846|530696963|FG004|Received Vaccination 3|Lost to Follow-up|0|||
147145533|NCT03900728|530696964|FG000|Overall Study|No text responses|0|||
147145534|NCT03900728|530696965|FG001|Overall Study|No text responses|0|||
147145535|NCT03900728|530696966|FG002|Overall Study|No text responses|4|||
147145536|NCT02544750|530696968|FG000|Overall Study|Physician Decision|3|||
147145537|NCT02544750|530696969|FG001|Overall Study|Physician Decision|1|||
147145538|NCT02544750|530696968|FG000|Overall Study|Other reasons|69|||
147145539|NCT02544750|530696969|FG001|Overall Study|Other reasons|39|||
147145540|NCT02544750|530696968|FG000|Overall Study|Met withdrawal criteria|2|||
147145541|NCT02544750|530696969|FG001|Overall Study|Met withdrawal criteria|2|||
147145542|NCT02544750|530696968|FG000|Overall Study|Transition To Commercial Product|1|||
147145543|NCT02544750|530696969|FG001|Overall Study|Transition To Commercial Product|0|||
147145544|NCT02544750|530696968|FG000|Overall Study|Withdrawal by Parent/Guardian|8|||
147145545|NCT02544750|530696969|FG001|Overall Study|Withdrawal by Parent/Guardian|7|||
147574332|NCT02923349|532259100|FG006|Overall Study|Physician Decision|2|||
147574333|NCT02923349|532259094|FG000|Overall Study|Lost to Follow-up|0|||
147574334|NCT02923349|532259095|FG001|Overall Study|Lost to Follow-up|0|||
147574335|NCT02923349|532259096|FG002|Overall Study|Lost to Follow-up|3|||
147574336|NCT02923349|532259097|FG003|Overall Study|Lost to Follow-up|0|||
147574337|NCT02923349|532259098|FG004|Overall Study|Lost to Follow-up|1|||
147574338|NCT02923349|532259099|FG005|Overall Study|Lost to Follow-up|1|||
147574339|NCT02923349|532259100|FG006|Overall Study|Lost to Follow-up|0|||
147574340|NCT02923349|532259094|FG000|Overall Study|Death|1|||
147574341|NCT02923349|532259095|FG001|Overall Study|Death|0|||
147145546|NCT02544750|530696968|FG000|Overall Study|Adverse Event|8|||
147145547|NCT02544750|530696969|FG001|Overall Study|Adverse Event|10|||
147238298|NCT02319837|531044156|FG001|Study Treatment Phase|Withdrawal by Subject|32|||
147238299|NCT02319837|531044157|FG002|Study Treatment Phase|Withdrawal by Subject|25|||
147238300|NCT02319837|531044155|FG000|Study Treatment Phase|Protocol Violation|2|||
147574342|NCT02923349|532259096|FG002|Overall Study|Death|2|||
147145548|NCT02544750|530696968|FG000|Overall Study|Withdrawal by Subject|10|||
147145549|NCT02544750|530696969|FG001|Overall Study|Withdrawal by Subject|4|||
147145550|NCT02544750|530696968|FG000|Overall Study|Lost to Follow-up|1|||
147145551|NCT02544750|530696969|FG001|Overall Study|Lost to Follow-up|0|||
147238301|NCT02319837|531044156|FG001|Study Treatment Phase|Protocol Violation|2|||
147574343|NCT02923349|532259097|FG003|Overall Study|Death|4|||
147574344|NCT02923349|532259098|FG004|Overall Study|Death|2|||
147574345|NCT02923349|532259099|FG005|Overall Study|Death|3|||
147574346|NCT02923349|532259100|FG006|Overall Study|Death|0|||
147574347|NCT01120028|532259103|FG000|Period 1: Alemtuzumab or Basiliximab|Withdrawal by Subject|0|||
147574348|NCT01120028|532259104|FG001|Period 1: Alemtuzumab or Basiliximab|Withdrawal by Subject|5|||
147145552|NCT02484443|530696972|FG000|Overall Study|Lack of Efficacy|28|||
147145553|NCT02484443|530696972|FG000|Overall Study|Physician Decision|2|||
147145554|NCT02484443|530696972|FG000|Overall Study|Ineligible|2|||
147145555|NCT02969915|530696973|FG000|Overall Study|Death|104|||
147145556|NCT02969915|530696974|FG001|Overall Study|Death|125|||
147145557|NCT02969915|530696973|FG000|Overall Study|Lost to Follow-up|108|||
147145558|NCT02969915|530696974|FG001|Overall Study|Lost to Follow-up|112|||
147145559|NCT02969915|530696973|FG000|Overall Study|Censored due to COVID-19|481|||
147145560|NCT02969915|530696974|FG001|Overall Study|Censored due to COVID-19|471|||
147145561|NCT02595866|530696975|FG000|Overall Study|Adverse Event|2|||
147145562|NCT02595866|530696976|FG001|Overall Study|Adverse Event|5|||
147145563|NCT02595866|530696975|FG000|Overall Study|Complicating Disease/Intercurrent Illness|1|||
147145564|NCT02595866|530696976|FG001|Overall Study|Complicating Disease/Intercurrent Illness|1|||
147145565|NCT02595866|530696975|FG000|Overall Study|Death|0|||
147145566|NCT02595866|530696976|FG001|Overall Study|Death|1|||
147145567|NCT02595866|530696975|FG000|Overall Study|Incarceration|1|||
147145568|NCT02595866|530696976|FG001|Overall Study|Incarceration|0|||
147145569|NCT02595866|530696975|FG000|Overall Study|Lack of Efficacy|17|||
147145570|NCT02595866|530696976|FG001|Overall Study|Lack of Efficacy|7|||
147145571|NCT02595866|530696975|FG000|Overall Study|Physician Decision|4|||
147145572|NCT02595866|530696976|FG001|Overall Study|Physician Decision|3|||
147145573|NCT02595866|530696975|FG000|Overall Study|Switched to Alternative Treatment|1|||
147145574|NCT02595866|530696976|FG001|Overall Study|Switched to Alternative Treatment|0|||
147574349|NCT01120028|532259105|FG002|Period 1: Alemtuzumab or Basiliximab|Withdrawal by Subject|0|||
147574350|NCT01120028|532259106|FG003|Period 1: Alemtuzumab or Basiliximab|Withdrawal by Subject|0|||
147574351|NCT01120028|532259103|FG000|Period 1: Alemtuzumab or Basiliximab|Not transplanted|14|||
147574352|NCT01120028|532259104|FG001|Period 1: Alemtuzumab or Basiliximab|Not transplanted|18|||
147574353|NCT01120028|532259105|FG002|Period 1: Alemtuzumab or Basiliximab|Not transplanted|0|||
147574354|NCT01120028|532259106|FG003|Period 1: Alemtuzumab or Basiliximab|Not transplanted|0|||
147574355|NCT03250117|532259107|FG000|Ropinirole Implant 12 Weeks|At request of Sponsor, regulatory agencies, or the IRB|1|||
147574356|NCT03250117|532259108|FG001|Ropinirole Implant 12 Weeks|At request of Sponsor, regulatory agencies, or the IRB|0|||
147574357|NCT03250117|532259109|FG002|Ropinirole Implant 12 Weeks|At request of Sponsor, regulatory agencies, or the IRB|0|||
147574358|NCT03250117|532259110|FG003|Ropinirole Implant 12 Weeks|At request of Sponsor, regulatory agencies, or the IRB|0|||
147574359|NCT04063878|532259111|FG000|Overall Study|Withdrawal by Subject|2|||
147145575|NCT02595866|530696975|FG000|Overall Study|Study Terminated|0|||
147574360|NCT04063878|532259111|FG000|Overall Study|Subject not fulfilling study eligibility criteria|14|||
147574361|NCT02751827|532259112|FG000|Overall Study|Only patient treated by TKI without anti-angiogenic action. He was excluded due to selection bias.|0|||
147574362|NCT02751827|532259113|FG001|Overall Study|Only patient treated by TKI without anti-angiogenic action. He was excluded due to selection bias.|0|||
147574363|NCT02751827|532259114|FG002|Overall Study|Only patient treated by TKI without anti-angiogenic action. He was excluded due to selection bias.|1|||
147574364|NCT01248728|532259115|FG000|Overall Study|Adverse Event|1|||
147574365|NCT01248728|532259116|FG001|Overall Study|Adverse Event|1|||
147574366|NCT01248728|532259115|FG000|Overall Study|Withdrawal by Subject|2|||
147574367|NCT01248728|532259116|FG001|Overall Study|Withdrawal by Subject|1|||
147574368|NCT01248728|532259115|FG000|Overall Study|Lack of Efficacy|1|||
147574369|NCT01248728|532259116|FG001|Overall Study|Lack of Efficacy|0|||
147574370|NCT01838681|532259117|FG000|Period A|Adverse Event|39|||
147574371|NCT01838681|532259118|FG001|Period A|Adverse Event|0|||
147574372|NCT01838681|532259119|FG002|Period A|Adverse Event|0|||
147574373|NCT01838681|532259120|FG003|Period A|Adverse Event|0|||
147574374|NCT01838681|532259117|FG000|Period A|Lack of Efficacy|21|||
147574375|NCT01838681|532259118|FG001|Period A|Lack of Efficacy|0|||
147145576|NCT02595866|530696976|FG001|Overall Study|Study Terminated|4|||
147145577|NCT02595866|530696975|FG000|Overall Study|Withdrawal by Subject|6|||
147145578|NCT02595866|530696976|FG001|Overall Study|Withdrawal by Subject|1|||
147145579|NCT02520388|530696977|FG000|Overall Study|Physician Decision|1|||
147145580|NCT02520388|530696978|FG001|Overall Study|Physician Decision|0|||
147145581|NCT02520388|530696977|FG000|Overall Study|Subject or parent/guardian request|0|||
147145582|NCT02520388|530696978|FG001|Overall Study|Subject or parent/guardian request|6|||
147145583|NCT02520388|530696977|FG000|Overall Study|Adverse Event|1|||
147145584|NCT02520388|530696978|FG001|Overall Study|Adverse Event|4|||
147145585|NCT02520388|530696977|FG000|Overall Study|Lost to Follow-up|3|||
147574376|NCT01838681|532259119|FG002|Period A|Lack of Efficacy|0|||
147145586|NCT02520388|530696978|FG001|Overall Study|Lost to Follow-up|2|||
147145587|NCT02520388|530696977|FG000|Overall Study|Other (reason not defined)|4|||
147145588|NCT02520388|530696978|FG001|Overall Study|Other (reason not defined)|4|||
147145589|NCT03162796|530696981|FG000|Placebo Controlled Period: Week 0 - 24|Other|0|||
147145590|NCT03162796|530696982|FG001|Placebo Controlled Period: Week 0 - 24|Other|1|||
147574377|NCT01838681|532259120|FG003|Period A|Lack of Efficacy|0|||
147145591|NCT03162796|530696983|FG002|Placebo Controlled Period: Week 0 - 24|Other|1|||
147145592|NCT03162796|530696981|FG000|Placebo Controlled Period: Week 0 - 24|Initiated prohibited medication|1|||
147145593|NCT03162796|530696982|FG001|Placebo Controlled Period: Week 0 - 24|Initiated prohibited medication|0|||
147145594|NCT03162796|530696983|FG002|Placebo Controlled Period: Week 0 - 24|Initiated prohibited medication|0|||
147574378|NCT01838681|532259117|FG000|Period A|Early response|148|||
147145595|NCT03162796|530696981|FG000|Placebo Controlled Period: Week 0 - 24|Death|1|||
147145596|NCT03162796|530696982|FG001|Placebo Controlled Period: Week 0 - 24|Death|0|||
147145597|NCT03162796|530696983|FG002|Placebo Controlled Period: Week 0 - 24|Death|0|||
147145598|NCT03162796|530696981|FG000|Placebo Controlled Period: Week 0 - 24|Lost to Follow-up|1|||
147145599|NCT03162796|530696982|FG001|Placebo Controlled Period: Week 0 - 24|Lost to Follow-up|0|||
147145600|NCT03162796|530696983|FG002|Placebo Controlled Period: Week 0 - 24|Lost to Follow-up|0|||
147145601|NCT03162796|530696981|FG000|Placebo Controlled Period: Week 0 - 24|Withdrawal by Subject|3|||
147145602|NCT03162796|530696982|FG001|Placebo Controlled Period: Week 0 - 24|Withdrawal by Subject|0|||
147145603|NCT03162796|530696983|FG002|Placebo Controlled Period: Week 0 - 24|Withdrawal by Subject|1|||
147145604|NCT03162796|530696981|FG000|Placebo Controlled Period: Week 0 - 24|Lack of Efficacy|4|||
147145605|NCT03162796|530696982|FG001|Placebo Controlled Period: Week 0 - 24|Lack of Efficacy|0|||
147145606|NCT03162796|530696983|FG002|Placebo Controlled Period: Week 0 - 24|Lack of Efficacy|0|||
147145607|NCT03162796|530696981|FG000|Placebo Controlled Period: Week 0 - 24|Adverse Event|2|||
147145608|NCT03162796|530696982|FG001|Placebo Controlled Period: Week 0 - 24|Adverse Event|3|||
147145609|NCT03162796|530696983|FG002|Placebo Controlled Period: Week 0 - 24|Adverse Event|1|||
147145610|NCT03162796|530696981|FG000|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|0|||
147145611|NCT03162796|530696982|FG001|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|2|||
147145612|NCT03162796|530696983|FG002|Active Treatment Period: Week 24 - 52|Withdrawal by Subject|0|||
147145613|NCT03162796|530696981|FG000|Active Treatment Period: Week 24 - 52|Lack of Efficacy|4|||
147145614|NCT03162796|530696982|FG001|Active Treatment Period: Week 24 - 52|Lack of Efficacy|3|||
147145615|NCT03162796|530696983|FG002|Active Treatment Period: Week 24 - 52|Lack of Efficacy|1|||
147145616|NCT03162796|530696981|FG000|Active Treatment Period: Week 24 - 52|Adverse Event|3|||
147145617|NCT03162796|530696982|FG001|Active Treatment Period: Week 24 - 52|Adverse Event|2|||
147145618|NCT03162796|530696983|FG002|Active Treatment Period: Week 24 - 52|Adverse Event|0|||
147145619|NCT03162796|530696981|FG000|Safety Follow-up: Week 52 - 60|Withdrawal by Subject|1|||
147145620|NCT03162796|530696982|FG001|Safety Follow-up: Week 52 - 60|Withdrawal by Subject|2|||
147145621|NCT03162796|530696983|FG002|Safety Follow-up: Week 52 - 60|Withdrawal by Subject|1|||
147145622|NCT02342288|530696984|FG000|Overall Study|no protocol anesthesiologist available|3|||
147145623|NCT02342288|530696985|FG001|Overall Study|no protocol anesthesiologist available|2|||
147145624|NCT02342288|530696984|FG000|Overall Study|anesthesia leak in system|1|||
147145625|NCT02342288|530696985|FG001|Overall Study|anesthesia leak in system|0|||
147145626|NCT02342288|530696984|FG000|Overall Study|Withdrawal by Subject|1|||
147574379|NCT01838681|532259118|FG001|Period A|Early response|0|||
147145627|NCT02342288|530696985|FG001|Overall Study|Withdrawal by Subject|0|||
147145628|NCT02342288|530696984|FG000|Overall Study|coordinator contaminated with blood|0|||
147238302|NCT02319837|531044157|FG002|Study Treatment Phase|Protocol Violation|1|||
147238303|NCT02319837|531044155|FG000|Study Treatment Phase|Lost to Follow-up|0|||
147238304|NCT02319837|531044156|FG001|Study Treatment Phase|Lost to Follow-up|1|||
147238305|NCT02319837|531044157|FG002|Study Treatment Phase|Lost to Follow-up|0|||
147238306|NCT02319837|531044155|FG000|Study Treatment Phase|PI decision/disease progression by local conventional scan/PSA, and other miscellaneous reasons|17|||
147238307|NCT02319837|531044156|FG001|Study Treatment Phase|PI decision/disease progression by local conventional scan/PSA, and other miscellaneous reasons|41|||
147238308|NCT02319837|531044157|FG002|Study Treatment Phase|PI decision/disease progression by local conventional scan/PSA, and other miscellaneous reasons|26|||
147238309|NCT02319837|531044155|FG000|Study Treatment Phase|Other|0|||
147238310|NCT02319837|531044156|FG001|Study Treatment Phase|Other|1|||
147238311|NCT02319837|531044157|FG002|Study Treatment Phase|Other|0|||
147238312|NCT02319837|531044155|FG000|Study Treatment Phase|Ongoing; still in treatment phase as of primary completion date (PCD) cutoff date 31 Jan 2023|207|||
147238313|NCT02319837|531044156|FG001|Study Treatment Phase|Ongoing; still in treatment phase as of primary completion date (PCD) cutoff date 31 Jan 2023|153|||
147238314|NCT02319837|531044157|FG002|Study Treatment Phase|Ongoing; still in treatment phase as of primary completion date (PCD) cutoff date 31 Jan 2023|197|||
147238315|NCT02319837|531044155|FG000|Study Treatment Phase|Participants did not receive treatment.|2|||
147238316|NCT02319837|531044156|FG001|Study Treatment Phase|Participants did not receive treatment.|4|||
147238317|NCT02319837|531044157|FG002|Study Treatment Phase|Participants did not receive treatment.|1|||
147238318|NCT02319837|531044155|FG000|Long-Term Follow-Up Phase|Ongoing; participants still in long-time follow-up phase as of the PCD cutoff date (31 January 2023)|67|||
147238319|NCT02319837|531044156|FG001|Long-Term Follow-Up Phase|Ongoing; participants still in long-time follow-up phase as of the PCD cutoff date (31 January 2023)|104|||
147238320|NCT02319837|531044157|FG002|Long-Term Follow-Up Phase|Ongoing; participants still in long-time follow-up phase as of the PCD cutoff date (31 January 2023)|62|||
147238321|NCT02319837|531044155|FG000|Long-Term Follow-Up Phase|PI decision, site closure and other miscellaneous reasons|5|||
147238322|NCT02319837|531044156|FG001|Long-Term Follow-Up Phase|PI decision, site closure and other miscellaneous reasons|8|||
147238323|NCT02319837|531044157|FG002|Long-Term Follow-Up Phase|PI decision, site closure and other miscellaneous reasons|12|||
147238324|NCT02319837|531044155|FG000|Long-Term Follow-Up Phase|Withdrawal by Subject|40|||
147238325|NCT02319837|531044156|FG001|Long-Term Follow-Up Phase|Withdrawal by Subject|36|||
147238326|NCT02319837|531044157|FG002|Long-Term Follow-Up Phase|Withdrawal by Subject|38|||
147238327|NCT02319837|531044155|FG000|Long-Term Follow-Up Phase|Lost to Follow-up|3|||
147145629|NCT02342288|530696985|FG001|Overall Study|coordinator contaminated with blood|1|||
147145630|NCT02342288|530696984|FG000|Overall Study|subject cannot tolerate numbing drops|0|||
147145631|NCT02342288|530696985|FG001|Overall Study|subject cannot tolerate numbing drops|1|||
147145632|NCT02342288|530696984|FG000|Overall Study|coordinator not available|0|||
147145633|NCT02342288|530696985|FG001|Overall Study|coordinator not available|2|||
147145634|NCT02375373|530696986|FG000|Overall Study|Withdrawal by Subject|11|||
147145635|NCT00407602|530696987|FG000|Overall Study|Death - unrelated to device|1|||
147145636|NCT00407602|530696987|FG000|Overall Study|Device explanted|5|||
147145637|NCT00407602|530696987|FG000|Overall Study|Withdrawal by Subject|1|||
147145638|NCT00431444|530696988|FG000|Overall Study|Protocol Violation|1|||
147145639|NCT00431444|530696989|FG001|Overall Study|Protocol Violation|4|||
147145640|NCT00431444|530696988|FG000|Overall Study|Adverse Event|2|||
147145641|NCT00431444|530696989|FG001|Overall Study|Adverse Event|1|||
147145642|NCT00431444|530696988|FG000|Overall Study|Withdrawal by Subject|1|||
147145643|NCT00431444|530696989|FG001|Overall Study|Withdrawal by Subject|1|||
147145644|NCT00431444|530696988|FG000|Overall Study|Lost to Follow-up|1|||
147145645|NCT00431444|530696989|FG001|Overall Study|Lost to Follow-up|0|||
147145646|NCT00431444|530696988|FG000|Overall Study|Administrative Problems|0|||
147145647|NCT00431444|530696989|FG001|Overall Study|Administrative Problems|1|||
147145648|NCT02517398|530697008|FG000|Overall Study|Death|2|||
147145649|NCT02517398|530697009|FG001|Overall Study|Death|3|||
147145650|NCT02517398|530697010|FG002|Overall Study|Death|4|||
147145651|NCT02517398|530697011|FG003|Overall Study|Death|2|||
147145652|NCT02517398|530697012|FG004|Overall Study|Death|3|||
147145653|NCT02517398|530697013|FG005|Overall Study|Death|8|||
147145654|NCT02517398|530697014|FG006|Overall Study|Death|3|||
147145655|NCT02517398|530697015|FG007|Overall Study|Death|2|||
147145656|NCT02517398|530697016|FG008|Overall Study|Death|6|||
147145657|NCT02517398|530697017|FG009|Overall Study|Death|24|||
147145658|NCT02517398|530697018|FG010|Overall Study|Death|53|||
147145659|NCT02517398|530697019|FG011|Overall Study|Death|25|||
147145660|NCT02517398|530697020|FG012|Overall Study|Death|73|||
147145661|NCT02517398|530697021|FG013|Overall Study|Death|29|||
147145662|NCT02517398|530697022|FG014|Overall Study|Death|26|||
147145663|NCT02517398|530697023|FG015|Overall Study|Death|23|||
147145664|NCT02517398|530697024|FG016|Overall Study|Death|26|||
147145665|NCT02517398|530697025|FG017|Overall Study|Death|25|||
147145666|NCT02517398|530697026|FG018|Overall Study|Death|22|||
147145667|NCT02517398|530697027|FG019|Overall Study|Death|7|||
147145668|NCT02517398|530697028|FG020|Overall Study|Death|26|||
147145669|NCT02517398|530697029|FG021|Overall Study|Death|30|||
147145670|NCT02517398|530697030|FG022|Overall Study|Death|20|||
147145671|NCT02517398|530697008|FG000|Overall Study|Other|0|||
147145672|NCT02517398|530697009|FG001|Overall Study|Other|0|||
147145673|NCT02517398|530697010|FG002|Overall Study|Other|0|||
147145674|NCT02517398|530697011|FG003|Overall Study|Other|1|||
147145675|NCT02517398|530697012|FG004|Overall Study|Other|0|||
147145676|NCT02517398|530697013|FG005|Overall Study|Other|0|||
147145677|NCT02517398|530697014|FG006|Overall Study|Other|0|||
147145678|NCT02517398|530697015|FG007|Overall Study|Other|0|||
147145679|NCT02517398|530697016|FG008|Overall Study|Other|0|||
147145680|NCT02517398|530697017|FG009|Overall Study|Other|1|||
147145681|NCT02517398|530697018|FG010|Overall Study|Other|0|||
147145682|NCT02517398|530697019|FG011|Overall Study|Other|0|||
147145683|NCT02517398|530697020|FG012|Overall Study|Other|0|||
147145684|NCT02517398|530697021|FG013|Overall Study|Other|1|||
147145685|NCT02517398|530697022|FG014|Overall Study|Other|0|||
147145686|NCT02517398|530697023|FG015|Overall Study|Other|1|||
147145687|NCT02517398|530697024|FG016|Overall Study|Other|1|||
147145688|NCT02517398|530697025|FG017|Overall Study|Other|0|||
147145689|NCT02517398|530697026|FG018|Overall Study|Other|0|||
147145690|NCT02517398|530697027|FG019|Overall Study|Other|1|||
147145691|NCT02517398|530697028|FG020|Overall Study|Other|0|||
147145692|NCT02517398|530697029|FG021|Overall Study|Other|0|||
147145693|NCT02517398|530697030|FG022|Overall Study|Other|0|||
147145694|NCT02517398|530697008|FG000|Overall Study|Lost to Follow-up|0|||
147145695|NCT02517398|530697009|FG001|Overall Study|Lost to Follow-up|0|||
147145696|NCT02517398|530697010|FG002|Overall Study|Lost to Follow-up|0|||
147145697|NCT02517398|530697011|FG003|Overall Study|Lost to Follow-up|0|||
147145698|NCT02517398|530697012|FG004|Overall Study|Lost to Follow-up|0|||
147145699|NCT02517398|530697013|FG005|Overall Study|Lost to Follow-up|0|||
147145700|NCT02517398|530697014|FG006|Overall Study|Lost to Follow-up|0|||
147145701|NCT02517398|530697015|FG007|Overall Study|Lost to Follow-up|0|||
147145702|NCT02517398|530697016|FG008|Overall Study|Lost to Follow-up|0|||
147145703|NCT02517398|530697017|FG009|Overall Study|Lost to Follow-up|1|||
147145704|NCT02517398|530697018|FG010|Overall Study|Lost to Follow-up|0|||
147145705|NCT02517398|530697019|FG011|Overall Study|Lost to Follow-up|2|||
147145706|NCT02517398|530697020|FG012|Overall Study|Lost to Follow-up|2|||
147145707|NCT02517398|530697021|FG013|Overall Study|Lost to Follow-up|0|||
147145708|NCT02517398|530697022|FG014|Overall Study|Lost to Follow-up|1|||
147145709|NCT02517398|530697023|FG015|Overall Study|Lost to Follow-up|1|||
147145710|NCT02517398|530697024|FG016|Overall Study|Lost to Follow-up|0|||
147145711|NCT02517398|530697025|FG017|Overall Study|Lost to Follow-up|3|||
147145712|NCT02517398|530697026|FG018|Overall Study|Lost to Follow-up|1|||
147145713|NCT02517398|530697027|FG019|Overall Study|Lost to Follow-up|0|||
147145714|NCT02517398|530697028|FG020|Overall Study|Lost to Follow-up|1|||
147145715|NCT02517398|530697029|FG021|Overall Study|Lost to Follow-up|0|||
147145716|NCT02517398|530697030|FG022|Overall Study|Lost to Follow-up|2|||
147145717|NCT02517398|530697008|FG000|Overall Study|Withdrew Consent|0|||
147145718|NCT02517398|530697009|FG001|Overall Study|Withdrew Consent|0|||
147145719|NCT02517398|530697010|FG002|Overall Study|Withdrew Consent|0|||
147145720|NCT02517398|530697011|FG003|Overall Study|Withdrew Consent|0|||
147145721|NCT02517398|530697012|FG004|Overall Study|Withdrew Consent|0|||
147145722|NCT02517398|530697013|FG005|Overall Study|Withdrew Consent|0|||
147145723|NCT02517398|530697014|FG006|Overall Study|Withdrew Consent|1|||
147145724|NCT02517398|530697015|FG007|Overall Study|Withdrew Consent|0|||
147145725|NCT02517398|530697016|FG008|Overall Study|Withdrew Consent|0|||
147145726|NCT02517398|530697017|FG009|Overall Study|Withdrew Consent|2|||
147145727|NCT02517398|530697018|FG010|Overall Study|Withdrew Consent|7|||
147574380|NCT01838681|532259119|FG002|Period A|Early response|0|||
147145728|NCT02517398|530697019|FG011|Overall Study|Withdrew Consent|1|||
147145729|NCT02517398|530697020|FG012|Overall Study|Withdrew Consent|5|||
147145730|NCT02517398|530697021|FG013|Overall Study|Withdrew Consent|4|||
147145731|NCT02517398|530697022|FG014|Overall Study|Withdrew Consent|2|||
147145732|NCT02517398|530697023|FG015|Overall Study|Withdrew Consent|5|||
147145733|NCT02517398|530697024|FG016|Overall Study|Withdrew Consent|4|||
147145734|NCT02517398|530697025|FG017|Overall Study|Withdrew Consent|2|||
147145735|NCT02517398|530697026|FG018|Overall Study|Withdrew Consent|3|||
147145736|NCT02517398|530697027|FG019|Overall Study|Withdrew Consent|2|||
147145737|NCT02517398|530697028|FG020|Overall Study|Withdrew Consent|9|||
147145738|NCT02517398|530697029|FG021|Overall Study|Withdrew Consent|3|||
147145739|NCT02517398|530697030|FG022|Overall Study|Withdrew Consent|1|||
147145740|NCT03554018|530697035|FG000|Overall Study|Lost to Follow-up|3|||
147145741|NCT03554018|530697036|FG001|Overall Study|Lost to Follow-up|7|||
147145742|NCT02131662|530697037|FG000|Overall Study|Protocol Violation|1|||
147145743|NCT02131662|530697038|FG001|Overall Study|Protocol Violation|0|||
147145744|NCT02131662|530697039|FG002|Overall Study|Protocol Violation|0|||
147145745|NCT02131662|530697040|FG003|Overall Study|Protocol Violation|0|||
147145746|NCT02131662|530697041|FG004|Overall Study|Protocol Violation|0|||
147145747|NCT02131662|530697037|FG000|Overall Study|Other|2|||
147145748|NCT02131662|530697038|FG001|Overall Study|Other|4|||
147145749|NCT02131662|530697039|FG002|Overall Study|Other|3|||
147145750|NCT02131662|530697040|FG003|Overall Study|Other|3|||
147145751|NCT02131662|530697041|FG004|Overall Study|Other|4|||
147145752|NCT02131662|530697037|FG000|Overall Study|Adverse Event|0|||
147145753|NCT02131662|530697038|FG001|Overall Study|Adverse Event|1|||
147145754|NCT02131662|530697039|FG002|Overall Study|Adverse Event|1|||
147145755|NCT02131662|530697040|FG003|Overall Study|Adverse Event|1|||
147145756|NCT02131662|530697041|FG004|Overall Study|Adverse Event|3|||
147145757|NCT02131662|530697037|FG000|Overall Study|Pregnancy|0|||
147145758|NCT02131662|530697038|FG001|Overall Study|Pregnancy|1|||
147145759|NCT02131662|530697039|FG002|Overall Study|Pregnancy|0|||
147145760|NCT02131662|530697040|FG003|Overall Study|Pregnancy|1|||
147145761|NCT02131662|530697041|FG004|Overall Study|Pregnancy|0|||
147145762|NCT02131662|530697037|FG000|Overall Study|Wish for pregnancy|0|||
147145763|NCT02131662|530697038|FG001|Overall Study|Wish for pregnancy|0|||
147145764|NCT02131662|530697039|FG002|Overall Study|Wish for pregnancy|0|||
147145765|NCT02131662|530697040|FG003|Overall Study|Wish for pregnancy|0|||
147145766|NCT02131662|530697041|FG004|Overall Study|Wish for pregnancy|1|||
147145767|NCT02131662|530697037|FG000|Overall Study|Lack of Efficacy|1|||
147145768|NCT02131662|530697038|FG001|Overall Study|Lack of Efficacy|0|||
147145769|NCT02131662|530697039|FG002|Overall Study|Lack of Efficacy|0|||
147574381|NCT01838681|532259120|FG003|Period A|Early response|0|||
147574382|NCT01838681|532259117|FG000|Period A|Withdrawal by Subject|70|||
147574383|NCT01838681|532259118|FG001|Period A|Withdrawal by Subject|0|||
147145770|NCT02131662|530697040|FG003|Overall Study|Lack of Efficacy|0|||
147145771|NCT02131662|530697041|FG004|Overall Study|Lack of Efficacy|1|||
147145772|NCT02131662|530697037|FG000|Overall Study|Withdrawal by Subject|1|||
147145773|NCT02131662|530697038|FG001|Overall Study|Withdrawal by Subject|5|||
147574384|NCT01838681|532259119|FG002|Period A|Withdrawal by Subject|0|||
147145774|NCT02131662|530697039|FG002|Overall Study|Withdrawal by Subject|1|||
147145775|NCT02131662|530697040|FG003|Overall Study|Withdrawal by Subject|5|||
147238328|NCT02319837|531044156|FG001|Long-Term Follow-Up Phase|Lost to Follow-up|3|||
147238329|NCT02319837|531044157|FG002|Long-Term Follow-Up Phase|Lost to Follow-up|4|||
147238330|NCT02319837|531044155|FG000|Long-Term Follow-Up Phase|Death|33|||
147145776|NCT02131662|530697041|FG004|Overall Study|Withdrawal by Subject|6|||
147145777|NCT02131662|530697037|FG000|Overall Study|Lost to Follow-up|1|||
147145778|NCT02131662|530697038|FG001|Overall Study|Lost to Follow-up|3|||
147145779|NCT02131662|530697039|FG002|Overall Study|Lost to Follow-up|0|||
147145780|NCT02131662|530697040|FG003|Overall Study|Lost to Follow-up|9|||
147145781|NCT02131662|530697041|FG004|Overall Study|Lost to Follow-up|0|||
147145782|NCT02131662|530697037|FG000|Overall Study|Not treated|2|||
147145783|NCT02131662|530697038|FG001|Overall Study|Not treated|0|||
147145784|NCT02131662|530697039|FG002|Overall Study|Not treated|2|||
147145785|NCT02131662|530697040|FG003|Overall Study|Not treated|2|||
147574385|NCT01838681|532259120|FG003|Period A|Withdrawal by Subject|0|||
147145786|NCT02131662|530697041|FG004|Overall Study|Not treated|3|||
147145787|NCT00130039|530697047|FG000|Overall Study|Withdrawal by Subject|15|||
147145788|NCT00130039|530697048|FG001|Overall Study|Withdrawal by Subject|11|||
147145789|NCT00130039|530697047|FG000|Overall Study|Lost to Follow-up|3|||
147145790|NCT00130039|530697048|FG001|Overall Study|Lost to Follow-up|1|||
147145791|NCT00130039|530697047|FG000|Overall Study|Adverse Event|4|||
147145792|NCT00130039|530697048|FG001|Overall Study|Adverse Event|2|||
147145793|NCT00130039|530697047|FG000|Overall Study|Physician Decision|3|||
147145794|NCT00130039|530697048|FG001|Overall Study|Physician Decision|0|||
147145795|NCT00130039|530697047|FG000|Overall Study|clinical events without follow up MRI|5|||
147145796|NCT00130039|530697048|FG001|Overall Study|clinical events without follow up MRI|4|||
147145797|NCT01928433|530697049|FG000|Overall Study|Adverse Event|5|||
147145798|NCT01928433|530697050|FG001|Overall Study|Adverse Event|2|||
147145799|NCT01928433|530697051|FG002|Overall Study|Adverse Event|5|||
147145800|NCT01928433|530697049|FG000|Overall Study|Protocol Violation|0|||
147145801|NCT01928433|530697050|FG001|Overall Study|Protocol Violation|0|||
147145802|NCT01928433|530697051|FG002|Overall Study|Protocol Violation|2|||
147145803|NCT01928433|530697049|FG000|Overall Study|Lack of Efficacy|5|||
147145804|NCT01928433|530697050|FG001|Overall Study|Lack of Efficacy|4|||
147145805|NCT01928433|530697051|FG002|Overall Study|Lack of Efficacy|4|||
147145806|NCT01928433|530697049|FG000|Overall Study|Withdrawal by Subject|0|||
147145807|NCT01928433|530697050|FG001|Overall Study|Withdrawal by Subject|4|||
147145808|NCT01928433|530697051|FG002|Overall Study|Withdrawal by Subject|0|||
147145809|NCT01928433|530697049|FG000|Overall Study|Negative screening urine culture|7|||
147145810|NCT01928433|530697050|FG001|Overall Study|Negative screening urine culture|6|||
147145811|NCT01928433|530697051|FG002|Overall Study|Negative screening urine culture|10|||
147145812|NCT01928433|530697049|FG000|Overall Study|Lost to Follow-up|0|||
147145813|NCT01928433|530697050|FG001|Overall Study|Lost to Follow-up|2|||
147145814|NCT01928433|530697051|FG002|Overall Study|Lost to Follow-up|3|||
147145815|NCT01928433|530697049|FG000|Overall Study|Other reasons|3|||
147145816|NCT01928433|530697050|FG001|Overall Study|Other reasons|3|||
147145817|NCT01928433|530697051|FG002|Overall Study|Other reasons|4|||
147145818|NCT01740687|530697052|FG000|Overall Study|Lost to Follow-up|11|||
147145819|NCT01740687|530697052|FG000|Overall Study|Withdrawal by Subject|2|||
147145820|NCT01740687|530697052|FG000|Overall Study|other reason|22|||
147145821|NCT01740687|530697052|FG000|Overall Study|treatment not received|2|||
147145822|NCT01016132|530697054|FG000|Overall Study|Discomfort|1|||
147145823|NCT01198574|530697056|FG000|Overall Study|Resigned from schools|4|||
147145824|NCT01198574|530697057|FG001|Overall Study|Resigned from schools|1|||
147145825|NCT01198574|530697058|FG002|Overall Study|Resigned from schools|1|||
147145826|NCT01198574|530697059|FG003|Overall Study|Resigned from schools|4|||
147145827|NCT00556439|530697060|FG000|Study Entry to Week 12|Lack of Efficacy|5|||
147145828|NCT00556439|530697061|FG001|Study Entry to Week 12|Lack of Efficacy|0|||
147145829|NCT00556439|530697062|FG002|Study Entry to Week 12|Lack of Efficacy|6|||
147145830|NCT00556439|530697063|FG003|Study Entry to Week 12|Lack of Efficacy|0|||
147145831|NCT00556439|530697060|FG000|Study Entry to Week 12|Physician Decision|1|||
147145832|NCT00556439|530697061|FG001|Study Entry to Week 12|Physician Decision|0|||
147145833|NCT00556439|530697062|FG002|Study Entry to Week 12|Physician Decision|0|||
147145834|NCT00556439|530697063|FG003|Study Entry to Week 12|Physician Decision|0|||
147145835|NCT00556439|530697060|FG000|Study Entry to Week 12|Withdrawal by Subject|1|||
147145836|NCT00556439|530697061|FG001|Study Entry to Week 12|Withdrawal by Subject|0|||
147145837|NCT00556439|530697062|FG002|Study Entry to Week 12|Withdrawal by Subject|1|||
147145838|NCT00556439|530697063|FG003|Study Entry to Week 12|Withdrawal by Subject|0|||
147145839|NCT00556439|530697060|FG000|Study Entry to Week 12|Recurrent infection|1|||
147145840|NCT00556439|530697061|FG001|Study Entry to Week 12|Recurrent infection|0|||
147145841|NCT00556439|530697062|FG002|Study Entry to Week 12|Recurrent infection|0|||
147145842|NCT00556439|530697063|FG003|Study Entry to Week 12|Recurrent infection|0|||
147145843|NCT00556439|530697060|FG000|Study Entry to Week 12|Malignancy|0|||
147145844|NCT00556439|530697061|FG001|Study Entry to Week 12|Malignancy|0|||
147145845|NCT00556439|530697062|FG002|Study Entry to Week 12|Malignancy|1|||
147145846|NCT00556439|530697063|FG003|Study Entry to Week 12|Malignancy|0|||
147145847|NCT00556439|530697060|FG000|After Week 12 (Randomized Study Period)|Withdrawal by Subject|1|||
147145848|NCT00556439|530697061|FG001|After Week 12 (Randomized Study Period)|Withdrawal by Subject|3|||
147145849|NCT00556439|530697062|FG002|After Week 12 (Randomized Study Period)|Withdrawal by Subject|0|||
147145850|NCT00556439|530697063|FG003|After Week 12 (Randomized Study Period)|Withdrawal by Subject|0|||
147145851|NCT00556439|530697060|FG000|After Week 12 (Randomized Study Period)|Physician Decision|1|||
147145852|NCT00556439|530697061|FG001|After Week 12 (Randomized Study Period)|Physician Decision|0|||
147145853|NCT00556439|530697062|FG002|After Week 12 (Randomized Study Period)|Physician Decision|0|||
147145854|NCT00556439|530697063|FG003|After Week 12 (Randomized Study Period)|Physician Decision|0|||
147145855|NCT00556439|530697060|FG000|After Week 12 (Randomized Study Period)|Malignancy|0|||
147145856|NCT00556439|530697061|FG001|After Week 12 (Randomized Study Period)|Malignancy|1|||
147145857|NCT00556439|530697062|FG002|After Week 12 (Randomized Study Period)|Malignancy|0|||
147145858|NCT00556439|530697063|FG003|After Week 12 (Randomized Study Period)|Malignancy|1|||
147145859|NCT00556439|530697060|FG000|After Week 12 (Randomized Study Period)|Severe infection|1|||
147238331|NCT02319837|531044156|FG001|Long-Term Follow-Up Phase|Death|54|||
147238332|NCT02319837|531044157|FG002|Long-Term Follow-Up Phase|Death|42|||
147238333|NCT00702689|531044158|FG000|Overall Study|Withdrawal by Subject|4|||
147238334|NCT00702689|531044158|FG000|Overall Study|Recurrent malignancy|1|||
147238335|NCT00702689|531044158|FG000|Overall Study|Adverse Event|1|||
147238336|NCT00369824|531044161|FG000|Overall Study|Adverse Event|0|||
147238337|NCT00369824|531044162|FG001|Overall Study|Adverse Event|2|||
147238338|NCT00369824|531044163|FG002|Overall Study|Adverse Event|0|||
147238339|NCT00369824|531044164|FG003|Overall Study|Adverse Event|0|||
147238340|NCT00369824|531044165|FG004|Overall Study|Adverse Event|1|||
147238341|NCT00369824|531044166|FG005|Overall Study|Adverse Event|0|||
147238342|NCT00369824|531044161|FG000|Overall Study|Protocol Violation|0|||
147238343|NCT00369824|531044162|FG001|Overall Study|Protocol Violation|1|||
147238344|NCT00369824|531044163|FG002|Overall Study|Protocol Violation|0|||
147318670|NCT01815736|531331785|FG000|Randomized Treatment Phase-Up to Week 96|Death|4|||
147318671|NCT01815736|531331786|FG001|Randomized Treatment Phase-Up to Week 96|Death|0|||
147318672|NCT01815736|531331785|FG000|Randomized Treatment Phase-Up to Week 96|Lack of Efficacy|1|||
147318673|NCT01815736|531331786|FG001|Randomized Treatment Phase-Up to Week 96|Lack of Efficacy|0|||
147318674|NCT01815736|531331785|FG000|Randomized Treatment Phase-Up to Week 96|Pregnancy|1|||
147318675|NCT01815736|531331786|FG001|Randomized Treatment Phase-Up to Week 96|Pregnancy|0|||
147318676|NCT01815736|531331785|FG000|Randomized Treatment Phase-Up to Week 96|Participants randomized and never treated|4|||
147318677|NCT01815736|531331786|FG001|Randomized Treatment Phase-Up to Week 96|Participants randomized and never treated|3|||
147318678|NCT01815736|531331785|FG000|Extension Treatment Phase- After Week 96|Investigator's Discretion|31|||
147318679|NCT01815736|531331786|FG001|Extension Treatment Phase- After Week 96|Investigator's Discretion|15|||
147318680|NCT01815736|531331785|FG000|Extension Treatment Phase- After Week 96|Lost to Follow-up|13|||
147318681|NCT01815736|531331786|FG001|Extension Treatment Phase- After Week 96|Lost to Follow-up|9|||
147318682|NCT01815736|531331785|FG000|Extension Treatment Phase- After Week 96|Withdrew Consent|5|||
147318683|NCT01815736|531331786|FG001|Extension Treatment Phase- After Week 96|Withdrew Consent|1|||
147318684|NCT01815736|531331785|FG000|Extension Treatment Phase- After Week 96|Adverse Event|1|||
147318685|NCT01815736|531331786|FG001|Extension Treatment Phase- After Week 96|Adverse Event|1|||
147318686|NCT01815736|531331785|FG000|Extension Treatment Phase- After Week 96|Death|1|||
147318687|NCT01815736|531331786|FG001|Extension Treatment Phase- After Week 96|Death|0|||
147318688|NCT03363659|531331787|FG000|Overall Study|Adverse Event|1|||
147318689|NCT03363659|531331787|FG000|Overall Study|Screen fail|1|||
147318690|NCT03363659|531331787|FG000|Overall Study|Withdrawal by Subject|1|||
147318691|NCT03872388|531331788|FG000|Overall Study|Disease Progression|0|||
147318692|NCT03872388|531331789|FG001|Overall Study|Disease Progression|0|||
147318693|NCT03872388|531331790|FG002|Overall Study|Disease Progression|0|||
147318694|NCT03872388|531331791|FG003|Overall Study|Disease Progression|0|||
147318695|NCT03872388|531331792|FG004|Overall Study|Disease Progression|0|||
147318696|NCT03872388|531331793|FG005|Overall Study|Disease Progression|0|||
147145860|NCT00556439|530697061|FG001|After Week 12 (Randomized Study Period)|Severe infection|0|||
147145861|NCT00556439|530697062|FG002|After Week 12 (Randomized Study Period)|Severe infection|0|||
147145862|NCT00556439|530697063|FG003|After Week 12 (Randomized Study Period)|Severe infection|0|||
147145863|NCT02100423|530697064|FG000|Overall Study|Death|1|||
147145864|NCT02100423|530697064|FG000|Overall Study|Withdrawal by Subject|3|||
147145865|NCT02100423|530697064|FG000|Overall Study|Adverse Event|1|||
147145866|NCT02100423|530697064|FG000|Overall Study|Physician Decision|1|||
147145867|NCT03744910|530699159|FG000|Overall Study|Withdrew Consent|1|||
147145868|NCT03744910|530699160|FG001|Overall Study|Withdrew Consent|8|||
147145869|NCT03744910|530699159|FG000|Overall Study|Physician Decision|5|||
147145870|NCT03744910|530699160|FG001|Overall Study|Physician Decision|4|||
147145871|NCT03744910|530699159|FG000|Overall Study|Sponsor Decision (due to study termination)|68|||
147145872|NCT03744910|530699160|FG001|Overall Study|Sponsor Decision (due to study termination)|71|||
147145873|NCT03744910|530699159|FG000|Overall Study|Lost to Follow-up|0|||
147145874|NCT03744910|530699160|FG001|Overall Study|Lost to Follow-up|1|||
147145875|NCT03744910|530699159|FG000|Overall Study|Other-unspecified|4|||
147145876|NCT03744910|530699160|FG001|Overall Study|Other-unspecified|1|||
147145877|NCT02744612|530699161|FG000|Overall Study|Withdrawal by Subject|0|||
147145878|NCT02744612|530699162|FG001|Overall Study|Withdrawal by Subject|2|||
147145879|NCT02220855|530699164|FG000|Overall Study|Adverse Event|8|||
147318697|NCT03872388|531331794|FG006|Overall Study|Disease Progression|1|||
147318698|NCT03872388|531331795|FG007|Overall Study|Disease Progression|1|||
147145880|NCT02220855|530699164|FG000|Overall Study|Disease Progression|5|||
147145881|NCT02220855|530699164|FG000|Overall Study|Withdrawal by Subject|1|||
147145882|NCT03280303|530699165|FG000|Overall Study|Death|505|||
147238345|NCT00369824|531044164|FG003|Overall Study|Protocol Violation|1|||
147238346|NCT00369824|531044165|FG004|Overall Study|Protocol Violation|1|||
147238347|NCT00369824|531044166|FG005|Overall Study|Protocol Violation|0|||
147238348|NCT00369824|531044161|FG000|Overall Study|Withdrawal by Subject|9|||
147238349|NCT00369824|531044162|FG001|Overall Study|Withdrawal by Subject|5|||
147145883|NCT03280303|530699165|FG000|Overall Study|Study terminated by sponsor|383|||
147145884|NCT03280303|530699165|FG000|Overall Study|Other|148|||
147145885|NCT03280303|530699165|FG000|Overall Study|No longer willing to participate in study|101|||
147145886|NCT03280303|530699165|FG000|Overall Study|Lost to follow up|39|||
147145887|NCT03280303|530699165|FG000|Overall Study|Adverse Event|20|||
147145888|NCT03419897|530699166|FG000|Overall Study|Death|180|||
147145889|NCT03419897|530699166|FG000|Overall Study|Lost to Follow-up|1|||
147145890|NCT03419897|530699166|FG000|Overall Study|Withdrawal by Subject|6|||
147145891|NCT03419897|530699166|FG000|Overall Study|Sponsor Decision|61|||
147145892|NCT03419897|530699166|FG000|Overall Study|Physician Decision|1|||
147145893|NCT01945216|530699169|FG000|Overall Study|Case report forms (CRF) uncollected|52|||
147145894|NCT01945216|530699169|FG000|Overall Study|Protocol Violation|42|||
147145895|NCT01945216|530699169|FG000|Overall Study|CRF not assured by investigators|5|||
147145896|NCT01905943|530699173|FG000|Overall Study|Withdrawal of consent|90|||
147145897|NCT01905943|530699173|FG000|Overall Study|Lost to Follow-up|16|||
147145898|NCT01905943|530699173|FG000|Overall Study|Investigator discretion|7|||
147145899|NCT01905943|530699173|FG000|Overall Study|Death|186|||
147145900|NCT01905943|530699173|FG000|Overall Study|Adverse Event|3|||
147145901|NCT01905943|530699173|FG000|Overall Study|Other|12|||
147145902|NCT02574078|530699174|FG000|Pre-Treatment Period|Participant no longer meets study criteria|0|||
147145903|NCT02574078|530699175|FG001|Pre-Treatment Period|Participant no longer meets study criteria|0|||
147145904|NCT02574078|530699176|FG002|Pre-Treatment Period|Participant no longer meets study criteria|0|||
147145905|NCT02574078|530699177|FG003|Pre-Treatment Period|Participant no longer meets study criteria|0|||
147145906|NCT02574078|530699178|FG004|Pre-Treatment Period|Participant no longer meets study criteria|0|||
147145907|NCT02574078|530699179|FG005|Pre-Treatment Period|Participant no longer meets study criteria|1|||
147145908|NCT02574078|530699180|FG006|Pre-Treatment Period|Participant no longer meets study criteria|2|||
147145909|NCT02574078|530699181|FG007|Pre-Treatment Period|Participant no longer meets study criteria|0|||
147145910|NCT02574078|530699182|FG008|Pre-Treatment Period|Participant no longer meets study criteria|1|||
147145911|NCT02574078|530699183|FG009|Pre-Treatment Period|Participant no longer meets study criteria|0|||
147145912|NCT02574078|530699184|FG010|Pre-Treatment Period|Participant no longer meets study criteria|0|||
147145913|NCT02574078|530699185|FG011|Pre-Treatment Period|Participant no longer meets study criteria|0|||
147145914|NCT02574078|530699186|FG012|Pre-Treatment Period|Participant no longer meets study criteria|0|||
147145915|NCT02574078|530699174|FG000|Pre-Treatment Period|Participant withdrew consent|0|||
147145916|NCT02574078|530699175|FG001|Pre-Treatment Period|Participant withdrew consent|0|||
147145917|NCT02574078|530699176|FG002|Pre-Treatment Period|Participant withdrew consent|0|||
147145918|NCT02574078|530699177|FG003|Pre-Treatment Period|Participant withdrew consent|0|||
147145919|NCT02574078|530699178|FG004|Pre-Treatment Period|Participant withdrew consent|0|||
147145920|NCT02574078|530699179|FG005|Pre-Treatment Period|Participant withdrew consent|0|||
147145921|NCT02574078|530699180|FG006|Pre-Treatment Period|Participant withdrew consent|0|||
147145922|NCT02574078|530699181|FG007|Pre-Treatment Period|Participant withdrew consent|3|||
147145923|NCT02574078|530699182|FG008|Pre-Treatment Period|Participant withdrew consent|0|||
147145924|NCT02574078|530699183|FG009|Pre-Treatment Period|Participant withdrew consent|0|||
147145925|NCT02574078|530699184|FG010|Pre-Treatment Period|Participant withdrew consent|2|||
147145926|NCT02574078|530699185|FG011|Pre-Treatment Period|Participant withdrew consent|0|||
147145927|NCT02574078|530699186|FG012|Pre-Treatment Period|Participant withdrew consent|0|||
147145928|NCT02574078|530699174|FG000|Pre-Treatment Period|Other reasons|0|||
147238350|NCT00369824|531044163|FG002|Overall Study|Withdrawal by Subject|5|||
147238351|NCT00369824|531044164|FG003|Overall Study|Withdrawal by Subject|4|||
147238352|NCT00369824|531044165|FG004|Overall Study|Withdrawal by Subject|6|||
147238353|NCT00369824|531044166|FG005|Overall Study|Withdrawal by Subject|2|||
147238354|NCT00369824|531044161|FG000|Overall Study|Lost to Follow-up|6|||
147238355|NCT00369824|531044162|FG001|Overall Study|Lost to Follow-up|11|||
147238356|NCT00369824|531044163|FG002|Overall Study|Lost to Follow-up|7|||
147238357|NCT00369824|531044164|FG003|Overall Study|Lost to Follow-up|8|||
147238358|NCT00369824|531044165|FG004|Overall Study|Lost to Follow-up|9|||
147238359|NCT00369824|531044166|FG005|Overall Study|Lost to Follow-up|6|||
147238360|NCT00369824|531044161|FG000|Overall Study|Other|0|||
147238361|NCT00369824|531044162|FG001|Overall Study|Other|0|||
147238362|NCT00369824|531044163|FG002|Overall Study|Other|0|||
147238363|NCT00369824|531044164|FG003|Overall Study|Other|2|||
147238364|NCT00369824|531044165|FG004|Overall Study|Other|1|||
147238365|NCT00369824|531044166|FG005|Overall Study|Other|3|||
147238366|NCT02106975|531044167|FG000|Overall Study|Death|25|||
147238367|NCT02106975|531044168|FG001|Overall Study|Death|39|||
147238368|NCT01611155|531044169|FG000|Overall Study|Adverse Event|1|||
147574386|NCT01838681|532259117|FG000|Period A|Protocol Violation|16|||
147574387|NCT01838681|532259118|FG001|Period A|Protocol Violation|0|||
147574388|NCT01838681|532259119|FG002|Period A|Protocol Violation|0|||
147145929|NCT02574078|530699175|FG001|Pre-Treatment Period|Other reasons|0|||
147145930|NCT02574078|530699176|FG002|Pre-Treatment Period|Other reasons|0|||
147145931|NCT02574078|530699177|FG003|Pre-Treatment Period|Other reasons|0|||
147238369|NCT01611155|531044170|FG001|Overall Study|Adverse Event|1|||
147238370|NCT01611155|531044169|FG000|Overall Study|Refused further treatment|6|||
147238371|NCT01611155|531044170|FG001|Overall Study|Refused further treatment|4|||
147238372|NCT01611155|531044169|FG000|Overall Study|Disease progression|1|||
147238373|NCT01611155|531044170|FG001|Overall Study|Disease progression|0|||
147445739|NCT01500278|531797439|FG000|Week 13 - Week 104|Protocol Violation|6|||
147145932|NCT02574078|530699178|FG004|Pre-Treatment Period|Other reasons|0|||
147145933|NCT02574078|530699179|FG005|Pre-Treatment Period|Other reasons|0|||
147145934|NCT02574078|530699180|FG006|Pre-Treatment Period|Other reasons|2|||
147145935|NCT02574078|530699181|FG007|Pre-Treatment Period|Other reasons|0|||
147145936|NCT02574078|530699182|FG008|Pre-Treatment Period|Other reasons|0|||
147145937|NCT02574078|530699183|FG009|Pre-Treatment Period|Other reasons|0|||
147145938|NCT02574078|530699184|FG010|Pre-Treatment Period|Other reasons|2|||
147145939|NCT02574078|530699185|FG011|Pre-Treatment Period|Other reasons|0|||
147145940|NCT02574078|530699186|FG012|Pre-Treatment Period|Other reasons|0|||
147145941|NCT02574078|530699174|FG000|Pre-Treatment Period|Poor/non-compliance|0|||
147145942|NCT02574078|530699175|FG001|Pre-Treatment Period|Poor/non-compliance|0|||
147145943|NCT02574078|530699176|FG002|Pre-Treatment Period|Poor/non-compliance|0|||
147145944|NCT02574078|530699177|FG003|Pre-Treatment Period|Poor/non-compliance|0|||
147145945|NCT02574078|530699178|FG004|Pre-Treatment Period|Poor/non-compliance|0|||
147145946|NCT02574078|530699179|FG005|Pre-Treatment Period|Poor/non-compliance|0|||
147145947|NCT02574078|530699180|FG006|Pre-Treatment Period|Poor/non-compliance|0|||
147145948|NCT02574078|530699181|FG007|Pre-Treatment Period|Poor/non-compliance|0|||
147145949|NCT02574078|530699182|FG008|Pre-Treatment Period|Poor/non-compliance|0|||
147145950|NCT02574078|530699183|FG009|Pre-Treatment Period|Poor/non-compliance|0|||
147145951|NCT02574078|530699184|FG010|Pre-Treatment Period|Poor/non-compliance|0|||
147145952|NCT02574078|530699185|FG011|Pre-Treatment Period|Poor/non-compliance|1|||
147145953|NCT02574078|530699186|FG012|Pre-Treatment Period|Poor/non-compliance|0|||
147145954|NCT02574078|530699174|FG000|Treatment Period|Disease progression|6|||
147145955|NCT02574078|530699175|FG001|Treatment Period|Disease progression|4|||
147145956|NCT02574078|530699176|FG002|Treatment Period|Disease progression|7|||
147145957|NCT02574078|530699177|FG003|Treatment Period|Disease progression|18|||
147145958|NCT02574078|530699178|FG004|Treatment Period|Disease progression|16|||
147145959|NCT02574078|530699179|FG005|Treatment Period|Disease progression|26|||
147145960|NCT02574078|530699180|FG006|Treatment Period|Disease progression|5|||
147145961|NCT02574078|530699181|FG007|Treatment Period|Disease progression|9|||
147145962|NCT02574078|530699182|FG008|Treatment Period|Disease progression|8|||
147145963|NCT02574078|530699183|FG009|Treatment Period|Disease progression|5|||
147145964|NCT02574078|530699184|FG010|Treatment Period|Disease progression|20|||
147145965|NCT02574078|530699185|FG011|Treatment Period|Disease progression|29|||
147145966|NCT02574078|530699186|FG012|Treatment Period|Disease progression|2|||
147145967|NCT02574078|530699174|FG000|Treatment Period|Study drug toxicity|1|||
147145968|NCT02574078|530699175|FG001|Treatment Period|Study drug toxicity|1|||
147145969|NCT02574078|530699176|FG002|Treatment Period|Study drug toxicity|0|||
147145970|NCT02574078|530699177|FG003|Treatment Period|Study drug toxicity|5|||
147145971|NCT02574078|530699178|FG004|Treatment Period|Study drug toxicity|3|||
147145972|NCT02574078|530699179|FG005|Treatment Period|Study drug toxicity|1|||
147145973|NCT02574078|530699180|FG006|Treatment Period|Study drug toxicity|2|||
147145974|NCT02574078|530699181|FG007|Treatment Period|Study drug toxicity|0|||
147145975|NCT02574078|530699182|FG008|Treatment Period|Study drug toxicity|2|||
147145976|NCT02574078|530699183|FG009|Treatment Period|Study drug toxicity|1|||
147145977|NCT02574078|530699184|FG010|Treatment Period|Study drug toxicity|16|||
147145978|NCT02574078|530699185|FG011|Treatment Period|Study drug toxicity|2|||
147145979|NCT02574078|530699186|FG012|Treatment Period|Study drug toxicity|4|||
147145980|NCT02574078|530699174|FG000|Treatment Period|Death|2|||
147145981|NCT02574078|530699175|FG001|Treatment Period|Death|0|||
147145982|NCT02574078|530699176|FG002|Treatment Period|Death|0|||
147145983|NCT02574078|530699177|FG003|Treatment Period|Death|0|||
147145984|NCT02574078|530699178|FG004|Treatment Period|Death|1|||
147145985|NCT02574078|530699179|FG005|Treatment Period|Death|1|||
147145986|NCT02574078|530699180|FG006|Treatment Period|Death|1|||
147145987|NCT02574078|530699181|FG007|Treatment Period|Death|1|||
147145988|NCT02574078|530699182|FG008|Treatment Period|Death|7|||
147145989|NCT02574078|530699183|FG009|Treatment Period|Death|1|||
147145990|NCT02574078|530699184|FG010|Treatment Period|Death|0|||
147145991|NCT02574078|530699185|FG011|Treatment Period|Death|2|||
147145992|NCT02574078|530699186|FG012|Treatment Period|Death|1|||
147145993|NCT02574078|530699174|FG000|Treatment Period|Adverse event unrelated to drug|0|||
147145994|NCT02574078|530699175|FG001|Treatment Period|Adverse event unrelated to drug|0|||
147145995|NCT02574078|530699176|FG002|Treatment Period|Adverse event unrelated to drug|1|||
147145996|NCT02574078|530699177|FG003|Treatment Period|Adverse event unrelated to drug|0|||
147145997|NCT02574078|530699178|FG004|Treatment Period|Adverse event unrelated to drug|2|||
147145998|NCT02574078|530699179|FG005|Treatment Period|Adverse event unrelated to drug|3|||
147145999|NCT02574078|530699180|FG006|Treatment Period|Adverse event unrelated to drug|0|||
147146000|NCT02574078|530699181|FG007|Treatment Period|Adverse event unrelated to drug|0|||
147146001|NCT02574078|530699182|FG008|Treatment Period|Adverse event unrelated to drug|1|||
147146002|NCT02574078|530699183|FG009|Treatment Period|Adverse event unrelated to drug|2|||
147146003|NCT02574078|530699184|FG010|Treatment Period|Adverse event unrelated to drug|4|||
147146004|NCT02574078|530699185|FG011|Treatment Period|Adverse event unrelated to drug|1|||
147146005|NCT02574078|530699186|FG012|Treatment Period|Adverse event unrelated to drug|0|||
147318699|NCT01929993|531333542|FG000|Overall Study|Protocol Violation|4|||
147146006|NCT02574078|530699174|FG000|Treatment Period|Administrative reason by Sponsor|0|||
147574389|NCT01838681|532259120|FG003|Period A|Protocol Violation|0|||
147574390|NCT01838681|532259117|FG000|Period A|Non-compliance with IMP|6|||
147574391|NCT01838681|532259118|FG001|Period A|Non-compliance with IMP|0|||
147574392|NCT01838681|532259119|FG002|Period A|Non-compliance with IMP|0|||
147574393|NCT01838681|532259120|FG003|Period A|Non-compliance with IMP|0|||
147574394|NCT01838681|532259117|FG000|Period A|Lost to Follow-up|4|||
147574395|NCT01838681|532259118|FG001|Period A|Lost to Follow-up|0|||
147574396|NCT01838681|532259119|FG002|Period A|Lost to Follow-up|0|||
147574397|NCT01838681|532259120|FG003|Period A|Lost to Follow-up|0|||
147574398|NCT01838681|532259117|FG000|Period A|Withdrawal before treatment|4|||
147574399|NCT01838681|532259118|FG001|Period A|Withdrawal before treatment|0|||
147574400|NCT01838681|532259119|FG002|Period A|Withdrawal before treatment|0|||
147574401|NCT01838681|532259120|FG003|Period A|Withdrawal before treatment|0|||
147574402|NCT01838681|532259117|FG000|Period A|Administrative or other reasons|17|||
147574403|NCT01838681|532259118|FG001|Period A|Administrative or other reasons|0|||
147574404|NCT01838681|532259119|FG002|Period A|Administrative or other reasons|0|||
147574405|NCT01838681|532259120|FG003|Period A|Administrative or other reasons|0|||
147574406|NCT01838681|532259117|FG000|Period B/A+|Adverse Event|0|||
147574407|NCT01838681|532259118|FG001|Period B/A+|Adverse Event|13|||
147574408|NCT01838681|532259119|FG002|Period B/A+|Adverse Event|27|||
147574409|NCT01838681|532259120|FG003|Period B/A+|Adverse Event|16|||
147574410|NCT01838681|532259117|FG000|Period B/A+|Lack of Efficacy|0|||
147574411|NCT01838681|532259118|FG001|Period B/A+|Lack of Efficacy|9|||
147574412|NCT01838681|532259119|FG002|Period B/A+|Lack of Efficacy|11|||
147574413|NCT01838681|532259120|FG003|Period B/A+|Lack of Efficacy|6|||
147574414|NCT01838681|532259117|FG000|Period B/A+|Withdrawal by Subject|0|||
147574415|NCT01838681|532259118|FG001|Period B/A+|Withdrawal by Subject|28|||
147574416|NCT01838681|532259119|FG002|Period B/A+|Withdrawal by Subject|35|||
147574417|NCT01838681|532259120|FG003|Period B/A+|Withdrawal by Subject|47|||
147574418|NCT01838681|532259117|FG000|Period B/A+|Protocol Violation|0|||
147574419|NCT01838681|532259118|FG001|Period B/A+|Protocol Violation|1|||
147574420|NCT01838681|532259119|FG002|Period B/A+|Protocol Violation|4|||
147574421|NCT01838681|532259120|FG003|Period B/A+|Protocol Violation|6|||
147574422|NCT01838681|532259117|FG000|Period B/A+|Non-compliance with IMP|0|||
147574423|NCT01838681|532259118|FG001|Period B/A+|Non-compliance with IMP|2|||
147574424|NCT01838681|532259119|FG002|Period B/A+|Non-compliance with IMP|3|||
147574425|NCT01838681|532259120|FG003|Period B/A+|Non-compliance with IMP|3|||
147574426|NCT01838681|532259117|FG000|Period B/A+|Lost to Follow-up|0|||
147574427|NCT01838681|532259118|FG001|Period B/A+|Lost to Follow-up|2|||
147574428|NCT01838681|532259119|FG002|Period B/A+|Lost to Follow-up|5|||
147574429|NCT01838681|532259120|FG003|Period B/A+|Lost to Follow-up|11|||
147574430|NCT01838681|532259117|FG000|Period B/A+|Withdrawal before treatment|0|||
147574431|NCT01838681|532259118|FG001|Period B/A+|Withdrawal before treatment|1|||
147574432|NCT01838681|532259119|FG002|Period B/A+|Withdrawal before treatment|0|||
147574433|NCT01838681|532259120|FG003|Period B/A+|Withdrawal before treatment|0|||
147574434|NCT01838681|532259117|FG000|Period B/A+|Administrative or other reasons|0|||
147574435|NCT01838681|532259118|FG001|Period B/A+|Administrative or other reasons|6|||
147146007|NCT02574078|530699175|FG001|Treatment Period|Administrative reason by Sponsor|1|||
147146008|NCT02574078|530699176|FG002|Treatment Period|Administrative reason by Sponsor|0|||
147146009|NCT02574078|530699177|FG003|Treatment Period|Administrative reason by Sponsor|0|||
147146010|NCT02574078|530699178|FG004|Treatment Period|Administrative reason by Sponsor|0|||
147146011|NCT02574078|530699179|FG005|Treatment Period|Administrative reason by Sponsor|0|||
147146012|NCT02574078|530699180|FG006|Treatment Period|Administrative reason by Sponsor|1|||
147146013|NCT02574078|530699181|FG007|Treatment Period|Administrative reason by Sponsor|0|||
147318700|NCT01929993|531333543|FG001|Overall Study|Protocol Violation|6|||
147574436|NCT01838681|532259119|FG002|Period B/A+|Administrative or other reasons|10|||
147574437|NCT01838681|532259120|FG003|Period B/A+|Administrative or other reasons|28|||
147574438|NCT00796562|532259121|FG000|Overall Study|Death|49|||
147574439|NCT04198363|532259125|FG000|Overall Study|Adverse Event|1|||
147574440|NCT04198363|532259126|FG001|Overall Study|Adverse Event|1|||
147574441|NCT04198363|532259125|FG000|Overall Study|Voluntary Withdrawal by Subject|0|||
147146014|NCT02574078|530699182|FG008|Treatment Period|Administrative reason by Sponsor|0|||
147318701|NCT01929993|531333542|FG000|Overall Study|Absent CIN, invasion present or artifact|26|||
147318702|NCT01929993|531333543|FG001|Overall Study|Absent CIN, invasion present or artifact|22|||
147574442|NCT04198363|532259126|FG001|Overall Study|Voluntary Withdrawal by Subject|1|||
147574443|NCT04198363|532259125|FG000|Overall Study|Reason not Specified|1|||
147574444|NCT04198363|532259126|FG001|Overall Study|Reason not Specified|0|||
147574445|NCT03067987|532259128|FG000|Overall Study|Lost to Follow-up|7|||
147574446|NCT03067987|532259129|FG001|Overall Study|Lost to Follow-up|10|||
147574447|NCT03067987|532259128|FG000|Overall Study|Protocol Violation|1|||
147574448|NCT03067987|532259129|FG001|Overall Study|Protocol Violation|2|||
147574449|NCT03067987|532259128|FG000|Overall Study|Withdrawal by Subject|2|||
147574450|NCT03067987|532259129|FG001|Overall Study|Withdrawal by Subject|1|||
147574451|NCT04827394|532259130|FG000|Overall Study|Physician Decision|0|||
147574452|NCT04827394|532259131|FG001|Overall Study|Physician Decision|2|||
147574453|NCT01404988|532259132|FG000|Overall Study|Death|2|||
147574454|NCT01404988|532259133|FG001|Overall Study|Death|0|||
147574455|NCT01404988|532259134|FG002|Overall Study|Death|2|||
147574456|NCT01404988|532259132|FG000|Overall Study|Adverse Event|1|||
147574457|NCT01404988|532259133|FG001|Overall Study|Adverse Event|0|||
147574458|NCT01404988|532259134|FG002|Overall Study|Adverse Event|0|||
147574459|NCT01404988|532259132|FG000|Overall Study|Withdrawal by Subject|2|||
147574460|NCT01404988|532259133|FG001|Overall Study|Withdrawal by Subject|2|||
147574461|NCT01404988|532259134|FG002|Overall Study|Withdrawal by Subject|0|||
147574462|NCT01404988|532259132|FG000|Overall Study|Lost to Follow-up|1|||
147574463|NCT01404988|532259133|FG001|Overall Study|Lost to Follow-up|2|||
147574464|NCT01404988|532259134|FG002|Overall Study|Lost to Follow-up|1|||
147574465|NCT00829764|532259135|FG000|First Intervention|Adverse Event|1|||
147574466|NCT00829764|532259136|FG001|First Intervention|Adverse Event|0|||
147146015|NCT02574078|530699183|FG009|Treatment Period|Administrative reason by Sponsor|0|||
147146016|NCT02574078|530699184|FG010|Treatment Period|Administrative reason by Sponsor|0|||
147146017|NCT02574078|530699185|FG011|Treatment Period|Administrative reason by Sponsor|0|||
147146018|NCT02574078|530699186|FG012|Treatment Period|Administrative reason by Sponsor|3|||
147146019|NCT02574078|530699174|FG000|Treatment Period|Other reasons|1|||
147146020|NCT02574078|530699175|FG001|Treatment Period|Other reasons|0|||
147146021|NCT02574078|530699176|FG002|Treatment Period|Other reasons|1|||
147146022|NCT02574078|530699177|FG003|Treatment Period|Other reasons|3|||
147146023|NCT02574078|530699178|FG004|Treatment Period|Other reasons|3|||
147146024|NCT02574078|530699179|FG005|Treatment Period|Other reasons|1|||
147146025|NCT02574078|530699180|FG006|Treatment Period|Other reasons|2|||
147146026|NCT02574078|530699181|FG007|Treatment Period|Other reasons|1|||
147238374|NCT01611155|531044169|FG000|Overall Study|Withdrawal by Subject|1|||
147238375|NCT01611155|531044170|FG001|Overall Study|Withdrawal by Subject|0|||
147238376|NCT01611155|531044169|FG000|Overall Study|Alternative treatment|0|||
147238377|NCT01611155|531044170|FG001|Overall Study|Alternative treatment|1|||
147238378|NCT01611155|531044169|FG000|Overall Study|Ineligible patient|0|||
147238379|NCT01611155|531044170|FG001|Overall Study|Ineligible patient|1|||
147238380|NCT00087607|531044171|FG000|Overall Study|Adverse Event|14|||
147238381|NCT00087607|531044172|FG001|Overall Study|Adverse Event|24|||
147238382|NCT00087607|531044171|FG000|Overall Study|Death|0|||
147238383|NCT00087607|531044172|FG001|Overall Study|Death|1|||
147238384|NCT00087607|531044171|FG000|Overall Study|Insufficient Therapeutic Response|53|||
147238385|NCT00087607|531044172|FG001|Overall Study|Insufficient Therapeutic Response|42|||
147238386|NCT00087607|531044171|FG000|Overall Study|Failure to return|21|||
147238387|NCT00087607|531044172|FG001|Overall Study|Failure to return|17|||
147238388|NCT00087607|531044171|FG000|Overall Study|Withdrew Consent|12|||
147238389|NCT00087607|531044172|FG001|Overall Study|Withdrew Consent|16|||
147238390|NCT00087607|531044171|FG000|Overall Study|Administrative|12|||
147238391|NCT00087607|531044172|FG001|Overall Study|Administrative|12|||
147238392|NCT00087607|531044171|FG000|Overall Study|Refused Treatment|5|||
147238393|NCT00087607|531044172|FG001|Overall Study|Refused Treatment|7|||
147238394|NCT00087607|531044171|FG000|Overall Study|Other Protocol Violation|5|||
147238395|NCT00087607|531044172|FG001|Overall Study|Other Protocol Violation|2|||
147238396|NCT00087607|531044171|FG000|Overall Study|Violation of Selection Criteria at Entry|0|||
147238397|NCT00087607|531044172|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
147238398|NCT02015754|531044173|FG000|Overall Study|Disease progression|5|||
147238399|NCT02015754|531044173|FG000|Overall Study|Change in treatment modality|5|||
147238400|NCT02015754|531044173|FG000|Overall Study|Lost to Follow-up|1|||
147238401|NCT02369016|531044174|FG000|Overall Study|AE associated with clinical disease progression|2|||
147238402|NCT02369016|531044175|FG001|Overall Study|AE associated with clinical disease progression|1|||
147238403|NCT02369016|531044174|FG000|Overall Study|AE not associated with clinical diseaseprogression|4|||
147238404|NCT02369016|531044175|FG001|Overall Study|AE not associated with clinical diseaseprogression|1|||
147238405|NCT02369016|531044174|FG000|Overall Study|Progressive disease - clinical progression|1|||
147238406|NCT02369016|531044175|FG001|Overall Study|Progressive disease - clinical progression|4|||
147238407|NCT02369016|531044174|FG000|Overall Study|withdrawal by patient|4|||
147238408|NCT02369016|531044175|FG001|Overall Study|withdrawal by patient|0|||
147238409|NCT02369016|531044174|FG000|Overall Study|Progressive disease - radiological progression|6|||
147238410|NCT02369016|531044175|FG001|Overall Study|Progressive disease - radiological progression|2|||
147238411|NCT02229383|531044176|FG000|Overall Study|Adverse Event|7|||
147238412|NCT02229383|531044177|FG001|Overall Study|Adverse Event|4|||
147238413|NCT02229383|531044176|FG000|Overall Study|Death|0|||
147238414|NCT02229383|531044177|FG001|Overall Study|Death|1|||
147238415|NCT02229383|531044176|FG000|Overall Study|Lost to Follow-up|5|||
147238416|NCT02229383|531044177|FG001|Overall Study|Lost to Follow-up|3|||
147238417|NCT02229383|531044176|FG000|Overall Study|Withdrawal by Subject|4|||
147238418|NCT02229383|531044177|FG001|Overall Study|Withdrawal by Subject|6|||
147238419|NCT02229383|531044176|FG000|Overall Study|Did not receive treatment|1|||
147238420|NCT02229383|531044177|FG001|Overall Study|Did not receive treatment|0|||
147238421|NCT02229383|531044176|FG000|Overall Study|Other|3|||
147238422|NCT02229383|531044177|FG001|Overall Study|Other|8|||
147238423|NCT05248867|531044182|FG000|Double-blind Period|Lost to Follow-up|0|||
147238424|NCT05248867|531044183|FG001|Double-blind Period|Lost to Follow-up|3|||
147238425|NCT05248867|531044184|FG002|Double-blind Period|Lost to Follow-up|0|||
147574467|NCT00829764|532259135|FG000|First Intervention|Withdrawal by Subject|1|||
147574468|NCT00829764|532259136|FG001|First Intervention|Withdrawal by Subject|1|||
147574469|NCT04594252|532259137|FG000|Overall Study|Adverse Event|0|||
147146027|NCT02574078|530699182|FG008|Treatment Period|Other reasons|3|||
147146028|NCT02574078|530699183|FG009|Treatment Period|Other reasons|1|||
147146029|NCT02574078|530699184|FG010|Treatment Period|Other reasons|1|||
147146030|NCT02574078|530699185|FG011|Treatment Period|Other reasons|3|||
147146031|NCT02574078|530699186|FG012|Treatment Period|Other reasons|1|||
147146032|NCT02574078|530699174|FG000|Treatment Period|Participant request to stop drug|0|||
147146033|NCT02574078|530699175|FG001|Treatment Period|Participant request to stop drug|0|||
147146034|NCT02574078|530699176|FG002|Treatment Period|Participant request to stop drug|0|||
147146035|NCT02574078|530699177|FG003|Treatment Period|Participant request to stop drug|2|||
147146036|NCT02574078|530699178|FG004|Treatment Period|Participant request to stop drug|4|||
147146037|NCT02574078|530699179|FG005|Treatment Period|Participant request to stop drug|0|||
147146038|NCT02574078|530699180|FG006|Treatment Period|Participant request to stop drug|1|||
147146039|NCT02574078|530699181|FG007|Treatment Period|Participant request to stop drug|0|||
147146040|NCT02574078|530699182|FG008|Treatment Period|Participant request to stop drug|3|||
147146041|NCT02574078|530699183|FG009|Treatment Period|Participant request to stop drug|2|||
147146042|NCT02574078|530699184|FG010|Treatment Period|Participant request to stop drug|2|||
147146043|NCT02574078|530699185|FG011|Treatment Period|Participant request to stop drug|4|||
147146044|NCT02574078|530699186|FG012|Treatment Period|Participant request to stop drug|1|||
147146045|NCT02574078|530699174|FG000|Treatment Period|Participant withdrew consent|0|||
147146046|NCT02574078|530699175|FG001|Treatment Period|Participant withdrew consent|0|||
147146047|NCT02574078|530699176|FG002|Treatment Period|Participant withdrew consent|0|||
147146048|NCT02574078|530699177|FG003|Treatment Period|Participant withdrew consent|0|||
147146049|NCT02574078|530699178|FG004|Treatment Period|Participant withdrew consent|1|||
147146050|NCT02574078|530699179|FG005|Treatment Period|Participant withdrew consent|1|||
147574470|NCT04594252|532259138|FG001|Overall Study|Adverse Event|2|||
147146051|NCT02574078|530699180|FG006|Treatment Period|Participant withdrew consent|0|||
147146052|NCT02574078|530699181|FG007|Treatment Period|Participant withdrew consent|1|||
147146053|NCT02574078|530699182|FG008|Treatment Period|Participant withdrew consent|0|||
147146054|NCT02574078|530699183|FG009|Treatment Period|Participant withdrew consent|2|||
147146055|NCT02574078|530699184|FG010|Treatment Period|Participant withdrew consent|1|||
147146056|NCT02574078|530699185|FG011|Treatment Period|Participant withdrew consent|4|||
147146057|NCT02574078|530699186|FG012|Treatment Period|Participant withdrew consent|1|||
147146058|NCT02574078|530699174|FG000|Treatment Period|Participant no longer meets criteria|0|||
147146059|NCT02574078|530699175|FG001|Treatment Period|Participant no longer meets criteria|0|||
147146060|NCT02574078|530699176|FG002|Treatment Period|Participant no longer meets criteria|0|||
147146061|NCT02574078|530699177|FG003|Treatment Period|Participant no longer meets criteria|0|||
147146062|NCT02574078|530699178|FG004|Treatment Period|Participant no longer meets criteria|1|||
147146063|NCT02574078|530699179|FG005|Treatment Period|Participant no longer meets criteria|0|||
147146064|NCT02574078|530699180|FG006|Treatment Period|Participant no longer meets criteria|0|||
147146065|NCT02574078|530699181|FG007|Treatment Period|Participant no longer meets criteria|0|||
147146066|NCT02574078|530699182|FG008|Treatment Period|Participant no longer meets criteria|0|||
147146067|NCT02574078|530699183|FG009|Treatment Period|Participant no longer meets criteria|1|||
147146068|NCT02574078|530699184|FG010|Treatment Period|Participant no longer meets criteria|1|||
147146069|NCT02574078|530699185|FG011|Treatment Period|Participant no longer meets criteria|1|||
147146070|NCT02574078|530699186|FG012|Treatment Period|Participant no longer meets criteria|0|||
147146071|NCT02574078|530699174|FG000|Treatment Period|Lost to Follow-up|0|||
147146072|NCT02574078|530699175|FG001|Treatment Period|Lost to Follow-up|0|||
147146073|NCT02574078|530699176|FG002|Treatment Period|Lost to Follow-up|0|||
147146074|NCT02574078|530699177|FG003|Treatment Period|Lost to Follow-up|0|||
147146075|NCT02574078|530699178|FG004|Treatment Period|Lost to Follow-up|0|||
147146076|NCT02574078|530699179|FG005|Treatment Period|Lost to Follow-up|0|||
147146077|NCT02574078|530699180|FG006|Treatment Period|Lost to Follow-up|0|||
147146078|NCT02574078|530699181|FG007|Treatment Period|Lost to Follow-up|0|||
147146079|NCT02574078|530699182|FG008|Treatment Period|Lost to Follow-up|0|||
147146080|NCT02574078|530699183|FG009|Treatment Period|Lost to Follow-up|1|||
147146081|NCT02574078|530699184|FG010|Treatment Period|Lost to Follow-up|0|||
147146082|NCT02574078|530699185|FG011|Treatment Period|Lost to Follow-up|1|||
147146083|NCT02574078|530699186|FG012|Treatment Period|Lost to Follow-up|0|||
147146084|NCT02574078|530699174|FG000|Treatment Period|Maximum clinical benefit|0|||
147146085|NCT02574078|530699175|FG001|Treatment Period|Maximum clinical benefit|0|||
147146086|NCT02574078|530699176|FG002|Treatment Period|Maximum clinical benefit|0|||
147146087|NCT02574078|530699177|FG003|Treatment Period|Maximum clinical benefit|0|||
147574471|NCT00477594|532259139|FG000|Year 1 and Year 2|Adverse Event|4|||
147146088|NCT02574078|530699178|FG004|Treatment Period|Maximum clinical benefit|0|||
147146089|NCT02574078|530699179|FG005|Treatment Period|Maximum clinical benefit|0|||
147146090|NCT02574078|530699180|FG006|Treatment Period|Maximum clinical benefit|0|||
147146091|NCT02574078|530699181|FG007|Treatment Period|Maximum clinical benefit|0|||
147146092|NCT02574078|530699182|FG008|Treatment Period|Maximum clinical benefit|0|||
147146093|NCT02574078|530699183|FG009|Treatment Period|Maximum clinical benefit|1|||
147574472|NCT00477594|532259140|FG001|Year 1 and Year 2|Adverse Event|2|||
147574473|NCT00477594|532259139|FG000|Year 1 and Year 2|Physician Decision|2|||
147574474|NCT00477594|532259140|FG001|Year 1 and Year 2|Physician Decision|1|||
147146094|NCT02574078|530699184|FG010|Treatment Period|Maximum clinical benefit|0|||
147146095|NCT02574078|530699185|FG011|Treatment Period|Maximum clinical benefit|0|||
147146096|NCT02574078|530699186|FG012|Treatment Period|Maximum clinical benefit|0|||
147146097|NCT05935878|530699187|FG000|Overall Study|Death|1|||
147318703|NCT03531905|531333548|FG000|Overall Study|Withdrawal by Subject|3|||
147318704|NCT03531905|531333549|FG001|Overall Study|Withdrawal by Subject|3|||
147318705|NCT03531905|531333550|FG002|Overall Study|Withdrawal by Subject|2|||
147318706|NCT03531905|531333548|FG000|Overall Study|Lost to Follow-up|2|||
147318707|NCT03531905|531333549|FG001|Overall Study|Lost to Follow-up|2|||
147318708|NCT03531905|531333550|FG002|Overall Study|Lost to Follow-up|1|||
147318709|NCT03531905|531333548|FG000|Overall Study|Participant was out of town|1|||
147318710|NCT03531905|531333549|FG001|Overall Study|Participant was out of town|0|||
147318711|NCT03531905|531333550|FG002|Overall Study|Participant was out of town|0|||
147318712|NCT03531905|531333548|FG000|Overall Study|Could not speak with the participant|1|||
147318713|NCT03531905|531333549|FG001|Overall Study|Could not speak with the participant|0|||
147318714|NCT03531905|531333550|FG002|Overall Study|Could not speak with the participant|0|||
147445740|NCT01500278|531797440|FG001|Week 13 - Week 104|Protocol Violation|6|||
147445741|NCT01500278|531797439|FG000|Week 13 - Week 104|Lost to Follow-up|6|||
147574475|NCT00477594|532259139|FG000|Year 1 and Year 2|Withdrawal by Subject|2|||
147574476|NCT00477594|532259140|FG001|Year 1 and Year 2|Withdrawal by Subject|1|||
147574477|NCT00477594|532259139|FG000|Year 1 and Year 2|Other|1|||
147574478|NCT00477594|532259140|FG001|Year 1 and Year 2|Other|0|||
147574479|NCT00477594|532259139|FG000|Year 3|Adverse Event|1|||
147574480|NCT00477594|532259140|FG001|Year 3|Adverse Event|0|||
147574481|NCT00477594|532259139|FG000|Year 3|Withdrawal by Subject|1|||
147146098|NCT05935878|530699188|FG001|Overall Study|Death|2|||
147146099|NCT05935878|530699187|FG000|Overall Study|Withdrawal by Subject|5|||
147146100|NCT05935878|530699188|FG001|Overall Study|Withdrawal by Subject|5|||
147146101|NCT05935878|530699187|FG000|Overall Study|Revision of implant|1|||
147318715|NCT01036087|531333551|FG000|Overall Study|Adverse Event|2|||
147318716|NCT01036087|531333551|FG000|Overall Study|Lack of Efficacy|1|||
147318717|NCT01625338|531333557|FG000|Overall Study|Enrolled but not Treated|0|||
147574482|NCT00477594|532259140|FG001|Year 3|Withdrawal by Subject|0|||
147574483|NCT00477594|532259139|FG000|Follow-up Period|Withdrawal by Subject|2|||
147574484|NCT00477594|532259140|FG001|Follow-up Period|Withdrawal by Subject|1|||
147574485|NCT00477594|532259139|FG000|Follow-up Period|Other|1|||
147318718|NCT01625338|531333558|FG001|Overall Study|Enrolled but not Treated|0|||
147318719|NCT01625338|531333559|FG002|Overall Study|Enrolled but not Treated|1|||
147318720|NCT01625338|531333557|FG000|Overall Study|Efficacy Failure|27|||
147318721|NCT01625338|531333558|FG001|Overall Study|Efficacy Failure|39|||
147445742|NCT01500278|531797440|FG001|Week 13 - Week 104|Lost to Follow-up|5|||
147574486|NCT00477594|532259140|FG001|Follow-up Period|Other|0|||
147574487|NCT00640341|532261199|FG000|Overall Study|Adverse Event|0|||
147146102|NCT05935878|530699188|FG001|Overall Study|Revision of implant|1|||
147318722|NCT01625338|531333559|FG002|Overall Study|Efficacy Failure|31|||
147574488|NCT00640341|532261200|FG001|Overall Study|Adverse Event|0|||
147574489|NCT00640341|532261201|FG002|Overall Study|Adverse Event|1|||
147574490|NCT00640341|532261199|FG000|Overall Study|Positive Slit Lamp Findings|0|||
147574491|NCT00640341|532261200|FG001|Overall Study|Positive Slit Lamp Findings|0|||
147574492|NCT00640341|532261201|FG002|Overall Study|Positive Slit Lamp Findings|1|||
147574493|NCT00640341|532261199|FG000|Overall Study|Study Related Symptoms/Complaints|2|||
147574494|NCT00640341|532261200|FG001|Overall Study|Study Related Symptoms/Complaints|1|||
147574495|NCT00640341|532261201|FG002|Overall Study|Study Related Symptoms/Complaints|2|||
147574496|NCT00640341|532261199|FG000|Overall Study|Inability to Maintain Wearing Schedule|1|||
147574497|NCT00640341|532261200|FG001|Overall Study|Inability to Maintain Wearing Schedule|1|||
147574498|NCT00640341|532261201|FG002|Overall Study|Inability to Maintain Wearing Schedule|0|||
147574499|NCT00640341|532261199|FG000|Overall Study|Failure to Follow Subject Instructions|1|||
147574500|NCT00640341|532261200|FG001|Overall Study|Failure to Follow Subject Instructions|0|||
147574501|NCT00640341|532261201|FG002|Overall Study|Failure to Follow Subject Instructions|0|||
147574502|NCT00640341|532261199|FG000|Overall Study|Lost to Follow-up|2|||
147574503|NCT00640341|532261200|FG001|Overall Study|Lost to Follow-up|0|||
147574504|NCT00640341|532261201|FG002|Overall Study|Lost to Follow-up|0|||
147574505|NCT00640341|532261199|FG000|Overall Study|Withdrawal by Subject|4|||
147574506|NCT00640341|532261200|FG001|Overall Study|Withdrawal by Subject|0|||
147574507|NCT00640341|532261201|FG002|Overall Study|Withdrawal by Subject|1|||
147574508|NCT00640341|532261199|FG000|Overall Study|Unacceptable Lens Movement|1|||
147574509|NCT00640341|532261200|FG001|Overall Study|Unacceptable Lens Movement|0|||
147574510|NCT00640341|532261201|FG002|Overall Study|Unacceptable Lens Movement|0|||
147574511|NCT00640341|532261199|FG000|Overall Study|Poor fit/Uncomfortable|4|||
147574512|NCT00640341|532261200|FG001|Overall Study|Poor fit/Uncomfortable|0|||
147574513|NCT00640341|532261201|FG002|Overall Study|Poor fit/Uncomfortable|0|||
147574514|NCT00640341|532261199|FG000|Overall Study|Ineligable at Baseline|5|||
147574515|NCT00640341|532261200|FG001|Overall Study|Ineligable at Baseline|3|||
147238426|NCT05248867|531044185|FG003|Double-blind Period|Lost to Follow-up|0|||
147238427|NCT05248867|531044186|FG004|Double-blind Period|Lost to Follow-up|0|||
147238428|NCT05248867|531044187|FG005|Double-blind Period|Lost to Follow-up|0|||
147238429|NCT05248867|531044182|FG000|Double-blind Period|Withdrawal by Subject|5|||
147238430|NCT05248867|531044183|FG001|Double-blind Period|Withdrawal by Subject|14|||
147238431|NCT05248867|531044184|FG002|Double-blind Period|Withdrawal by Subject|0|||
147238432|NCT05248867|531044185|FG003|Double-blind Period|Withdrawal by Subject|0|||
147238433|NCT05248867|531044186|FG004|Double-blind Period|Withdrawal by Subject|0|||
147238434|NCT05248867|531044187|FG005|Double-blind Period|Withdrawal by Subject|0|||
147238435|NCT05248867|531044182|FG000|Double-blind Period|Withdrawal by Subject due to Adverse Event|0|||
147238436|NCT05248867|531044183|FG001|Double-blind Period|Withdrawal by Subject due to Adverse Event|3|||
147238437|NCT05248867|531044184|FG002|Double-blind Period|Withdrawal by Subject due to Adverse Event|0|||
147238438|NCT05248867|531044185|FG003|Double-blind Period|Withdrawal by Subject due to Adverse Event|0|||
147238439|NCT05248867|531044186|FG004|Double-blind Period|Withdrawal by Subject due to Adverse Event|0|||
147238440|NCT05248867|531044187|FG005|Double-blind Period|Withdrawal by Subject due to Adverse Event|0|||
147238441|NCT05248867|531044182|FG000|Double-blind Period|Other, not specified|3|||
147238442|NCT05248867|531044183|FG001|Double-blind Period|Other, not specified|8|||
147238443|NCT05248867|531044184|FG002|Double-blind Period|Other, not specified|0|||
147238444|NCT05248867|531044185|FG003|Double-blind Period|Other, not specified|0|||
147238445|NCT05248867|531044186|FG004|Double-blind Period|Other, not specified|0|||
147238446|NCT05248867|531044187|FG005|Double-blind Period|Other, not specified|0|||
147238447|NCT05248867|531044182|FG000|Open-label Period|Withdrawal by Subject|0|||
147238448|NCT05248867|531044183|FG001|Open-label Period|Withdrawal by Subject|0|||
147238449|NCT05248867|531044184|FG002|Open-label Period|Withdrawal by Subject|3|||
147238450|NCT05248867|531044185|FG003|Open-label Period|Withdrawal by Subject|1|||
147238451|NCT05248867|531044186|FG004|Open-label Period|Withdrawal by Subject|7|||
147238452|NCT05248867|531044187|FG005|Open-label Period|Withdrawal by Subject|9|||
147238453|NCT05248867|531044182|FG000|Open-label Period|Withdrawal by Subject due to Adverse Event|0|||
147238454|NCT05248867|531044183|FG001|Open-label Period|Withdrawal by Subject due to Adverse Event|0|||
147238455|NCT05248867|531044184|FG002|Open-label Period|Withdrawal by Subject due to Adverse Event|0|||
147238456|NCT05248867|531044185|FG003|Open-label Period|Withdrawal by Subject due to Adverse Event|1|||
147238457|NCT05248867|531044186|FG004|Open-label Period|Withdrawal by Subject due to Adverse Event|0|||
147238458|NCT05248867|531044187|FG005|Open-label Period|Withdrawal by Subject due to Adverse Event|0|||
147238459|NCT05248867|531044182|FG000|Open-label Period|Lost to Follow-up|0|||
147238460|NCT05248867|531044183|FG001|Open-label Period|Lost to Follow-up|0|||
147238461|NCT05248867|531044184|FG002|Open-label Period|Lost to Follow-up|0|||
147238462|NCT05248867|531044185|FG003|Open-label Period|Lost to Follow-up|0|||
147238463|NCT05248867|531044186|FG004|Open-label Period|Lost to Follow-up|5|||
147238464|NCT05248867|531044187|FG005|Open-label Period|Lost to Follow-up|2|||
147238465|NCT05248867|531044182|FG000|Open-label Period|COVID-19 Infection|0|||
147238466|NCT05248867|531044183|FG001|Open-label Period|COVID-19 Infection|0|||
147238467|NCT05248867|531044184|FG002|Open-label Period|COVID-19 Infection|0|||
147238468|NCT05248867|531044185|FG003|Open-label Period|COVID-19 Infection|0|||
147318723|NCT01625338|531333557|FG000|Overall Study|Lost to Follow-up|3|||
147318724|NCT01625338|531333558|FG001|Overall Study|Lost to Follow-up|3|||
147318725|NCT01625338|531333559|FG002|Overall Study|Lost to Follow-up|2|||
147318726|NCT01625338|531333557|FG000|Overall Study|Investigator Decision|0|||
147318727|NCT01625338|531333558|FG001|Overall Study|Investigator Decision|2|||
147318728|NCT01625338|531333559|FG002|Overall Study|Investigator Decision|1|||
147318729|NCT01625338|531333557|FG000|Overall Study|Subject Withdrew Consent|1|||
147318730|NCT01625338|531333558|FG001|Overall Study|Subject Withdrew Consent|0|||
147318731|NCT01625338|531333559|FG002|Overall Study|Subject Withdrew Consent|2|||
147318732|NCT01625338|531333557|FG000|Overall Study|Adverse Event|1|||
147318733|NCT01625338|531333558|FG001|Overall Study|Adverse Event|0|||
147318734|NCT01625338|531333559|FG002|Overall Study|Adverse Event|1|||
147318735|NCT01625338|531333557|FG000|Overall Study|Study Discontinued by Sponsor|0|||
147318736|NCT01625338|531333558|FG001|Overall Study|Study Discontinued by Sponsor|0|||
147318737|NCT01625338|531333559|FG002|Overall Study|Study Discontinued by Sponsor|1|||
147574516|NCT00640341|532261201|FG002|Overall Study|Ineligable at Baseline|2|||
147574517|NCT00640341|532261199|FG000|Overall Study|Adverse event and positive slit lamp|1|||
147574518|NCT00640341|532261200|FG001|Overall Study|Adverse event and positive slit lamp|0|||
147318738|NCT01349907|531333566|FG000|Overall Study|Adverse Event|37|||
147318739|NCT01349907|531333567|FG001|Overall Study|Adverse Event|11|||
147318740|NCT01349907|531333566|FG000|Overall Study|Treatment failure|13|||
147318741|NCT01349907|531333567|FG001|Overall Study|Treatment failure|4|||
147318742|NCT01349907|531333566|FG000|Overall Study|Lost to Follow-up|25|||
147318743|NCT01349907|531333567|FG001|Overall Study|Lost to Follow-up|6|||
147318744|NCT01349907|531333566|FG000|Overall Study|Withdrawal by Subject|30|||
147238469|NCT05248867|531044186|FG004|Open-label Period|COVID-19 Infection|1|||
147238470|NCT05248867|531044187|FG005|Open-label Period|COVID-19 Infection|0|||
147238471|NCT05248867|531044182|FG000|Open-label Period|Other, not specified|0|||
147238472|NCT05248867|531044183|FG001|Open-label Period|Other, not specified|0|||
147574519|NCT00640341|532261201|FG002|Overall Study|Adverse event and positive slit lamp|0|||
147652369|NCT03026283|532550244|FG000|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
147652370|NCT03026283|532550245|FG001|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
147652371|NCT03026283|532550246|FG002|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
147652372|NCT03026283|532550247|FG003|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|2|||
147652373|NCT03026283|532550248|FG004|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
147652374|NCT03026283|532550249|FG005|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|7|||
147652375|NCT03026283|532550250|FG006|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
147652376|NCT03026283|532550251|FG007|Optimal Care/Stress Test/ICA|Referring MD ordered stress test|0|||
147652377|NCT03026283|532550244|FG000|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
147652378|NCT03026283|532550245|FG001|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
147652379|NCT03026283|532550246|FG002|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
147238473|NCT05248867|531044184|FG002|Open-label Period|Other, not specified|0|||
147238474|NCT05248867|531044185|FG003|Open-label Period|Other, not specified|0|||
147238475|NCT05248867|531044186|FG004|Open-label Period|Other, not specified|4|||
147238476|NCT05248867|531044187|FG005|Open-label Period|Other, not specified|0|||
147238477|NCT01453361|531044196|FG000|Overall Study|Disease Progression|6|||
147238478|NCT01453361|531044196|FG000|Overall Study|Screen-Failures|10|||
147238479|NCT01594281|531046066|FG000|Interventional Core Phase|Protocol Deviation|1|||
147238480|NCT01594281|531046067|FG001|Interventional Core Phase|Protocol Deviation|0|||
147238481|NCT01594281|531046068|FG002|Interventional Core Phase|Protocol Deviation|0|||
147238482|NCT01594281|531046066|FG000|Interventional Core Phase|Subject Withdrew Consent|0|||
147238483|NCT01594281|531046067|FG001|Interventional Core Phase|Subject Withdrew Consent|1|||
147238484|NCT01594281|531046068|FG002|Interventional Core Phase|Subject Withdrew Consent|1|||
147238485|NCT01594281|531046066|FG000|Interventional Core Phase|Death|1|||
147238486|NCT01594281|531046067|FG001|Interventional Core Phase|Death|1|||
147238487|NCT01594281|531046068|FG002|Interventional Core Phase|Death|2|||
147238488|NCT01594281|531046066|FG000|Interventional Core Phase|Lost to Follow-up|1|||
147238489|NCT01594281|531046067|FG001|Interventional Core Phase|Lost to Follow-up|4|||
147238490|NCT01594281|531046068|FG002|Interventional Core Phase|Lost to Follow-up|1|||
147238491|NCT01594281|531046066|FG000|Interventional Core Phase|Adverse Event|4|||
147238492|NCT01594281|531046067|FG001|Interventional Core Phase|Adverse Event|4|||
147238493|NCT01594281|531046068|FG002|Interventional Core Phase|Adverse Event|4|||
147238494|NCT01594281|531046066|FG000|Non-Interventional Follow Up Phase|Lost to Follow-up|2|||
147238495|NCT01594281|531046067|FG001|Non-Interventional Follow Up Phase|Lost to Follow-up|2|||
147238496|NCT01594281|531046068|FG002|Non-Interventional Follow Up Phase|Lost to Follow-up|0|||
147238497|NCT01594281|531046066|FG000|Non-Interventional Follow Up Phase|Administrative Problems|0|||
147238498|NCT01594281|531046067|FG001|Non-Interventional Follow Up Phase|Administrative Problems|0|||
147238499|NCT01594281|531046068|FG002|Non-Interventional Follow Up Phase|Administrative Problems|1|||
147238500|NCT01594281|531046066|FG000|Non-Interventional Follow Up Phase|Subject Withdrew Consent|1|||
147238501|NCT01594281|531046067|FG001|Non-Interventional Follow Up Phase|Subject Withdrew Consent|0|||
147238502|NCT01594281|531046068|FG002|Non-Interventional Follow Up Phase|Subject Withdrew Consent|1|||
147238503|NCT02550106|531046070|FG000|Overall Study|Adverse Event|1|||
147238504|NCT02550106|531046070|FG000|Overall Study|Lack of Efficacy|3|||
147238505|NCT02550106|531046070|FG000|Overall Study|Protocol Violation|6|||
147238506|NCT02550106|531046070|FG000|Overall Study|Withdrawal by Subject|2|||
147238507|NCT01709513|531046071|FG000|Overall Study|Randomized but not treated|0|||
147238508|NCT01709513|531046072|FG001|Overall Study|Randomized but not treated|1|||
147238509|NCT01709513|531046073|FG002|Overall Study|Randomized but not treated|0|||
147238510|NCT01709513|531046071|FG000|Overall Study|Adverse Event|16|||
147238511|NCT01709513|531046072|FG001|Overall Study|Adverse Event|31|||
147238512|NCT01709513|531046073|FG002|Overall Study|Adverse Event|23|||
147238513|NCT01709513|531046071|FG000|Overall Study|Poor compliance to protocol|2|||
147238514|NCT01709513|531046072|FG001|Overall Study|Poor compliance to protocol|0|||
147238515|NCT01709513|531046073|FG002|Overall Study|Poor compliance to protocol|0|||
147238516|NCT01709513|531046071|FG000|Overall Study|Other|3|||
147238517|NCT01709513|531046072|FG001|Overall Study|Other|11|||
147238518|NCT01709513|531046073|FG002|Overall Study|Other|7|||
147238519|NCT01034631|531046074|FG000|Phase I|Symptomatic Deterioration before Treatme|3|||
147238520|NCT01034631|531046075|FG001|Phase I|Symptomatic Deterioration before Treatme|0|||
147238521|NCT01034631|531046076|FG002|Phase I|Symptomatic Deterioration before Treatme|0|||
147238522|NCT01034631|531046074|FG000|Phase II|Not Evaluable per protocol|0|||
147238523|NCT01034631|531046075|FG001|Phase II|Not Evaluable per protocol|0|||
147238524|NCT01034631|531046076|FG002|Phase II|Not Evaluable per protocol|2|||
147238525|NCT01034631|531046074|FG000|Phase II|Determined Ineligible per protocol|0|||
147238526|NCT01034631|531046075|FG001|Phase II|Determined Ineligible per protocol|1|||
147238527|NCT01034631|531046076|FG002|Phase II|Determined Ineligible per protocol|0|||
147238528|NCT01193530|531046079|FG000|Overall Study|Withdrawal by Subject|2|||
147238529|NCT01193530|531046080|FG001|Overall Study|Withdrawal by Subject|2|||
147238530|NCT01193530|531046079|FG000|Overall Study|Began Contraindicated Therapy|1|||
147445743|NCT01500278|531797439|FG000|Week 13 - Week 104|Withdrawal by Subject|22|||
147445744|NCT01500278|531797440|FG001|Week 13 - Week 104|Withdrawal by Subject|13|||
147445745|NCT01500278|531797439|FG000|Week 13 - Week 104|Week 24 Non-Responder|20|||
147445746|NCT01500278|531797440|FG001|Week 13 - Week 104|Week 24 Non-Responder|16|||
147445747|NCT01500278|531797439|FG000|Week 13 - Week 104|Non/bad compliance|7|||
147445748|NCT01500278|531797440|FG001|Week 13 - Week 104|Non/bad compliance|5|||
147445749|NCT01500278|531797439|FG000|Week 13 - Week 104|Recurrent infections|1|||
147445750|NCT01500278|531797440|FG001|Week 13 - Week 104|Recurrent infections|0|||
147445751|NCT01500278|531797439|FG000|Week 13 - Week 104|False positive test|1|||
147445752|NCT01500278|531797440|FG001|Week 13 - Week 104|False positive test|2|||
147445753|NCT01500278|531797439|FG000|Week 13 - Week 104|Sponsor request|4|||
147445754|NCT01500278|531797440|FG001|Week 13 - Week 104|Sponsor request|0|||
147445755|NCT01500278|531797439|FG000|Week 13 - Week 104|Withdrawn in error|1|||
147445756|NCT01500278|531797440|FG001|Week 13 - Week 104|Withdrawn in error|0|||
147445757|NCT01500278|531797439|FG000|Week 13 - Week 104|Exclusion criteria not met|1|||
147445758|NCT01500278|531797440|FG001|Week 13 - Week 104|Exclusion criteria not met|0|||
147445759|NCT01500278|531797439|FG000|Week 13 - Week 104|Protocol deviation|1|||
147445760|NCT01500278|531797440|FG001|Week 13 - Week 104|Protocol deviation|0|||
147445761|NCT01500278|531797439|FG000|Week 13 - Week 104|Principal investigator retiring|1|||
147445762|NCT01500278|531797440|FG001|Week 13 - Week 104|Principal investigator retiring|0|||
147445763|NCT01500278|531797439|FG000|Week 13 - Week 104|Patient declined Safety Follow Up Visit|1|||
147445764|NCT01500278|531797440|FG001|Week 13 - Week 104|Patient declined Safety Follow Up Visit|0|||
147445765|NCT01500278|531797439|FG000|Week 13 - Week 104|Abnormal questionable chest X-ray|0|||
147445766|NCT01500278|531797440|FG001|Week 13 - Week 104|Abnormal questionable chest X-ray|2|||
147445767|NCT01500278|531797439|FG000|Week 13 - Week 104|Relocation|0|||
147445768|NCT01500278|531797440|FG001|Week 13 - Week 104|Relocation|1|||
147445769|NCT01500278|531797439|FG000|Week 13 - Week 104|Sponsor decision|0|||
147445770|NCT01500278|531797440|FG001|Week 13 - Week 104|Sponsor decision|2|||
147445771|NCT01500278|531797439|FG000|Week 13 - Week 104|Medical monitor decision|0|||
147445772|NCT01500278|531797440|FG001|Week 13 - Week 104|Medical monitor decision|2|||
147445773|NCT01500278|531797439|FG000|Week 13 - Week 104|Personal reason|0|||
147445774|NCT01500278|531797440|FG001|Week 13 - Week 104|Personal reason|1|||
147445775|NCT01500278|531797439|FG000|Week 13 - Week 104|Not completed|0|||
147445776|NCT01500278|531797440|FG001|Week 13 - Week 104|Not completed|1|||
147445777|NCT01500278|531797439|FG000|Week 13 - Week 104|Death|2|||
147445778|NCT01500278|531797440|FG001|Week 13 - Week 104|Death|4|||
147445779|NCT01500278|531797439|FG000|Week 13 - Week 104|Adverse Event|54|||
147445780|NCT01500278|531797440|FG001|Week 13 - Week 104|Adverse Event|54|||
147445781|NCT04718974|531797444|FG000|Overall Study|Death|0|||
147445782|NCT04718974|531797445|FG001|Overall Study|Death|2|||
147445783|NCT04718974|531797444|FG000|Overall Study|Lost to Follow-up|10|||
147445784|NCT04718974|531797445|FG001|Overall Study|Lost to Follow-up|20|||
147445785|NCT04718974|531797444|FG000|Overall Study|Transferred out|2|||
147445786|NCT04718974|531797445|FG001|Overall Study|Transferred out|4|||
147146103|NCT05935878|530699187|FG000|Overall Study|Mobile bearing dislocation|0|||
147146104|NCT05935878|530699188|FG001|Overall Study|Mobile bearing dislocation|1|||
147146105|NCT00958360|530699197|FG000|Overall Study|Withdrawal by Subject|3|||
147146106|NCT00958360|530699198|FG001|Overall Study|Withdrawal by Subject|1|||
147146107|NCT00958360|530699197|FG000|Overall Study|Death|6|||
147146108|NCT00958360|530699198|FG001|Overall Study|Death|7|||
147146109|NCT00958360|530699197|FG000|Overall Study|Physician Decision|2|||
147146110|NCT00958360|530699198|FG001|Overall Study|Physician Decision|1|||
147146111|NCT00958360|530699197|FG000|Overall Study|Lost to Follow-up|0|||
147146112|NCT00958360|530699198|FG001|Overall Study|Lost to Follow-up|1|||
147445787|NCT01709435|531797446|FG000|Overall Study|Adverse Event|1|||
147445788|NCT01709435|531797447|FG001|Overall Study|Adverse Event|1|||
147445789|NCT01709435|531797448|FG002|Overall Study|Adverse Event|1|||
147445790|NCT01709435|531797449|FG003|Overall Study|Adverse Event|0|||
147445791|NCT01709435|531797450|FG004|Overall Study|Adverse Event|0|||
147445792|NCT01709435|531797451|FG005|Overall Study|Adverse Event|1|||
147445793|NCT01709435|531797446|FG000|Overall Study|Lack of Efficacy|5|||
147445794|NCT01709435|531797447|FG001|Overall Study|Lack of Efficacy|7|||
147574520|NCT03578809|532261202|FG000|Overall Study|Death|0|||
147574521|NCT03578809|532261203|FG001|Overall Study|Death|2|||
147574522|NCT03578809|532261204|FG002|Overall Study|Death|0|||
147574523|NCT03578809|532261205|FG003|Overall Study|Death|1|||
147574524|NCT03578809|532261202|FG000|Overall Study|Lost to Follow-up|0|||
147574525|NCT03578809|532261203|FG001|Overall Study|Lost to Follow-up|1|||
147574526|NCT03578809|532261204|FG002|Overall Study|Lost to Follow-up|0|||
147574527|NCT03578809|532261205|FG003|Overall Study|Lost to Follow-up|0|||
147574528|NCT03578809|532261202|FG000|Overall Study|Withdrawal by Subject|3|||
147146113|NCT03107052|530699199|FG000|Overall Study|Adverse Event|6|||
147146114|NCT03107052|530699200|FG001|Overall Study|Adverse Event|1|||
147146115|NCT03107052|530699201|FG002|Overall Study|Adverse Event|2|||
147445795|NCT01709435|531797448|FG002|Overall Study|Lack of Efficacy|2|||
147574529|NCT03578809|532261203|FG001|Overall Study|Withdrawal by Subject|5|||
147574530|NCT03578809|532261204|FG002|Overall Study|Withdrawal by Subject|2|||
147574531|NCT03578809|532261205|FG003|Overall Study|Withdrawal by Subject|0|||
147574532|NCT03578809|532261202|FG000|Overall Study|Other|3|||
147574533|NCT03578809|532261203|FG001|Overall Study|Other|6|||
147574534|NCT03578809|532261204|FG002|Overall Study|Other|2|||
147574535|NCT03578809|532261205|FG003|Overall Study|Other|8|||
147146116|NCT03107052|530699199|FG000|Overall Study|Withdrawal by Subject|9|||
147146117|NCT03107052|530699200|FG001|Overall Study|Withdrawal by Subject|5|||
147146118|NCT03107052|530699201|FG002|Overall Study|Withdrawal by Subject|8|||
147146119|NCT03107052|530699199|FG000|Overall Study|Protocol Violation|6|||
147146120|NCT03107052|530699200|FG001|Overall Study|Protocol Violation|0|||
147146121|NCT03107052|530699201|FG002|Overall Study|Protocol Violation|3|||
147146122|NCT03107052|530699199|FG000|Overall Study|Lost to Follow-up|4|||
147146123|NCT03107052|530699200|FG001|Overall Study|Lost to Follow-up|0|||
147146124|NCT03107052|530699201|FG002|Overall Study|Lost to Follow-up|1|||
147146125|NCT03107052|530699199|FG000|Overall Study|Lack of Efficacy|23|||
147146126|NCT03107052|530699200|FG001|Overall Study|Lack of Efficacy|7|||
147146127|NCT03107052|530699201|FG002|Overall Study|Lack of Efficacy|4|||
147146128|NCT03107052|530699199|FG000|Overall Study|Other than specified|4|||
147146129|NCT03107052|530699200|FG001|Overall Study|Other than specified|2|||
147146130|NCT03107052|530699201|FG002|Overall Study|Other than specified|0|||
147146131|NCT03107052|530699199|FG000|Overall Study|Study terminated due to futility|67|||
147146132|NCT03107052|530699200|FG001|Overall Study|Study terminated due to futility|31|||
147146133|NCT03107052|530699201|FG002|Overall Study|Study terminated due to futility|23|||
147146134|NCT03015363|530699202|FG000|Overall Study|Physician Decision|14|||
147146135|NCT03015363|530699202|FG000|Overall Study|Withdrawal by Subject|3|||
147146136|NCT00500357|530699203|FG000|Overall Study|Death|1|||
147146137|NCT02263326|530699204|FG000|Overall Study|Lost to Follow-up|1|||
147146138|NCT02263326|530699205|FG001|Overall Study|Lost to Follow-up|1|||
147146139|NCT00078806|530699206|FG000|Part 1A|Adverse Event|2|||
147146140|NCT00078806|530699207|FG001|Part 1A|Adverse Event|0|||
147146141|NCT00078806|530699208|FG002|Part 1A|Adverse Event|0|||
147146142|NCT00078806|530699209|FG003|Part 1A|Adverse Event|0|||
147146143|NCT00078806|530699206|FG000|Part 1A|Lack of Efficacy|7|||
147146144|NCT00078806|530699207|FG001|Part 1A|Lack of Efficacy|0|||
147146145|NCT00078806|530699208|FG002|Part 1A|Lack of Efficacy|0|||
147146146|NCT00078806|530699209|FG003|Part 1A|Lack of Efficacy|0|||
147146147|NCT00078806|530699206|FG000|Part 1A|Other|1|||
147146148|NCT00078806|530699207|FG001|Part 1A|Other|0|||
147146149|NCT00078806|530699208|FG002|Part 1A|Other|0|||
147146150|NCT00078806|530699209|FG003|Part 1A|Other|0|||
147146151|NCT00078806|530699206|FG000|Part 1B|Adverse Event|1|||
147146152|NCT00078806|530699207|FG001|Part 1B|Adverse Event|0|||
147146153|NCT00078806|530699208|FG002|Part 1B|Adverse Event|0|||
147146154|NCT00078806|530699209|FG003|Part 1B|Adverse Event|0|||
147146155|NCT00078806|530699206|FG000|Part 1B|Lack of Efficacy|7|||
147146156|NCT00078806|530699207|FG001|Part 1B|Lack of Efficacy|0|||
147146157|NCT00078806|530699208|FG002|Part 1B|Lack of Efficacy|0|||
147146158|NCT00078806|530699209|FG003|Part 1B|Lack of Efficacy|0|||
147146159|NCT00078806|530699206|FG000|Part 2|Adverse Event|0|||
147146160|NCT00078806|530699207|FG001|Part 2|Adverse Event|1|||
147146161|NCT00078806|530699208|FG002|Part 2|Adverse Event|0|||
147146162|NCT00078806|530699209|FG003|Part 2|Adverse Event|0|||
147146163|NCT01893411|530699212|FG000|Overall Study|Protocol Violation|1|||
147146164|NCT01893411|530699213|FG001|Overall Study|Protocol Violation|0|||
147146165|NCT01893411|530699214|FG002|Overall Study|Protocol Violation|0|||
147146166|NCT01893411|530699212|FG000|Overall Study|Physician Decision|1|||
147146167|NCT01893411|530699213|FG001|Overall Study|Physician Decision|1|||
147146168|NCT01893411|530699214|FG002|Overall Study|Physician Decision|2|||
147146169|NCT01893411|530699212|FG000|Overall Study|Lack of Efficacy|2|||
147146170|NCT01893411|530699213|FG001|Overall Study|Lack of Efficacy|1|||
147146171|NCT01893411|530699214|FG002|Overall Study|Lack of Efficacy|0|||
147146172|NCT01893411|530699212|FG000|Overall Study|Other|3|||
147146173|NCT01893411|530699213|FG001|Overall Study|Other|1|||
147146174|NCT01893411|530699214|FG002|Overall Study|Other|3|||
147146175|NCT01893411|530699212|FG000|Overall Study|Adverse Event|1|||
147146176|NCT01893411|530699213|FG001|Overall Study|Adverse Event|0|||
147146177|NCT01893411|530699214|FG002|Overall Study|Adverse Event|0|||
147146178|NCT01893411|530699212|FG000|Overall Study|Withdrawal by Subject|7|||
147146179|NCT01893411|530699213|FG001|Overall Study|Withdrawal by Subject|4|||
147146180|NCT01893411|530699214|FG002|Overall Study|Withdrawal by Subject|3|||
147146181|NCT01893411|530699212|FG000|Overall Study|Lost to Follow-up|2|||
147146182|NCT01893411|530699213|FG001|Overall Study|Lost to Follow-up|0|||
147146183|NCT01893411|530699214|FG002|Overall Study|Lost to Follow-up|1|||
147146184|NCT02397915|530699215|FG000|Period 1|Protocol Violation|0|||
147146185|NCT02397915|530699216|FG001|Period 1|Protocol Violation|1|||
147146186|NCT02397915|530699217|FG002|Period 1|Protocol Violation|0|||
147146187|NCT02397915|530699218|FG003|Period 1|Protocol Violation|0|||
147574536|NCT02488109|532261206|FG000|Treatment in Hospital|Withdrawal by Subject|0|||
147146188|NCT02397915|530699215|FG000|Period 1|Physician Decision|1|||
147146189|NCT02397915|530699216|FG001|Period 1|Physician Decision|0|||
147146190|NCT02397915|530699217|FG002|Period 1|Physician Decision|0|||
147146191|NCT02397915|530699218|FG003|Period 1|Physician Decision|0|||
147146192|NCT00368745|530699219|FG000|Double-blind Treatment Period|Adverse Event|6|||
147146193|NCT00368745|530699220|FG001|Double-blind Treatment Period|Adverse Event|6|||
147146194|NCT00368745|530699219|FG000|Double-blind Treatment Period|Lack of Efficacy|7|||
147146195|NCT00368745|530699220|FG001|Double-blind Treatment Period|Lack of Efficacy|16|||
147146196|NCT00368745|530699219|FG000|Double-blind Treatment Period|Lost to Follow-up|1|||
147146197|NCT00368745|530699220|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
147146198|NCT00368745|530699219|FG000|Double-blind Treatment Period|Withdrawal by Subject|5|||
147146199|NCT00368745|530699220|FG001|Double-blind Treatment Period|Withdrawal by Subject|3|||
147146200|NCT00368745|530699219|FG000|Double-blind Treatment Period|Other|7|||
147146201|NCT00368745|530699220|FG001|Double-blind Treatment Period|Other|6|||
147146202|NCT03292874|530699221|FG000|Overall Study|Due to pandemic|5|||
147146203|NCT00161616|530699222|FG000|Overall Study|Withdrawal by Subject|6|||
147146204|NCT00161616|530699223|FG001|Overall Study|Withdrawal by Subject|5|||
147146205|NCT00161616|530699222|FG000|Overall Study|Physician Decision|1|||
147146206|NCT00161616|530699223|FG001|Overall Study|Physician Decision|0|||
147146207|NCT00161616|530699222|FG000|Overall Study|Death|1|||
147146208|NCT00161616|530699223|FG001|Overall Study|Death|1|||
147146209|NCT00161616|530699222|FG000|Overall Study|Lost to Follow-up|17|||
147146210|NCT00161616|530699223|FG001|Overall Study|Lost to Follow-up|13|||
147146211|NCT00161616|530699222|FG000|Overall Study|Protocol deviation|1|||
147146212|NCT00161616|530699223|FG001|Overall Study|Protocol deviation|0|||
147146213|NCT00933608|530699225|FG000|Overall Study|Adverse Event|4|||
147146214|NCT00933608|530699226|FG001|Overall Study|Adverse Event|2|||
147146215|NCT00933608|530699225|FG000|Overall Study|Physician Decision|1|||
147146216|NCT00933608|530699226|FG001|Overall Study|Physician Decision|0|||
147146217|NCT02719691|530699229|FG000|Overall Study|Physician Decision|0|||
147146218|NCT02719691|530699230|FG001|Overall Study|Physician Decision|0|||
147146219|NCT02719691|530699231|FG002|Overall Study|Physician Decision|1|||
147146220|NCT02719691|530699232|FG003|Overall Study|Physician Decision|0|||
147146221|NCT02719691|530699233|FG004|Overall Study|Physician Decision|0|||
147146222|NCT02719691|530699234|FG005|Overall Study|Physician Decision|0|||
147146223|NCT02719691|530699235|FG006|Overall Study|Physician Decision|0|||
147146224|NCT02719691|530699229|FG000|Overall Study|Withdrawal by Subject|0|||
147238531|NCT01193530|531046080|FG001|Overall Study|Began Contraindicated Therapy|0|||
147238532|NCT01193530|531046079|FG000|Overall Study|Lost Light Box|0|||
147238533|NCT01193530|531046080|FG001|Overall Study|Lost Light Box|1|||
147238534|NCT01193530|531046079|FG000|Overall Study|Returned home - out of state|0|||
147238535|NCT01193530|531046080|FG001|Overall Study|Returned home - out of state|1|||
147238536|NCT01193530|531046079|FG000|Overall Study|Non-Compliance|0|||
147238537|NCT01193530|531046080|FG001|Overall Study|Non-Compliance|1|||
147238538|NCT04218695|531046081|FG000|Overall Study|Adverse Event|1|||
147238539|NCT04218695|531046082|FG001|Overall Study|Adverse Event|0|||
147238540|NCT01890473|531046083|FG000|Overall Study|Lost to Follow-up|1|||
147238541|NCT01890473|531046084|FG001|Overall Study|Lost to Follow-up|0|||
147238542|NCT01890473|531046083|FG000|Overall Study|Poor/non-compliance|1|||
147238543|NCT01890473|531046084|FG001|Overall Study|Poor/non-compliance|0|||
147238544|NCT03166735|531046085|FG000|Overall Study|Not Treated|1|||
147238545|NCT03166735|531046086|FG001|Overall Study|Not Treated|0|||
147238546|NCT03166735|531046087|FG002|Overall Study|Not Treated|0|||
147238547|NCT03166735|531046088|FG003|Overall Study|Not Treated|0|||
147238548|NCT03166735|531046089|FG004|Overall Study|Not Treated|0|||
147238549|NCT03166735|531046085|FG000|Overall Study|follow-up not completed as planned|0|||
147238550|NCT03166735|531046086|FG001|Overall Study|follow-up not completed as planned|1|||
147238551|NCT03166735|531046087|FG002|Overall Study|follow-up not completed as planned|1|||
147238552|NCT03166735|531046088|FG003|Overall Study|follow-up not completed as planned|0|||
147238553|NCT03166735|531046089|FG004|Overall Study|follow-up not completed as planned|1|||
147238554|NCT03166735|531046085|FG000|Overall Study|Withdrawal by Subject|0|||
147238555|NCT03166735|531046086|FG001|Overall Study|Withdrawal by Subject|0|||
147238556|NCT03166735|531046087|FG002|Overall Study|Withdrawal by Subject|1|||
147238557|NCT03166735|531046088|FG003|Overall Study|Withdrawal by Subject|1|||
147238558|NCT03166735|531046089|FG004|Overall Study|Withdrawal by Subject|2|||
147238559|NCT03166735|531046085|FG000|Overall Study|Lost to Follow-up|0|||
147238560|NCT03166735|531046086|FG001|Overall Study|Lost to Follow-up|2|||
147238561|NCT03166735|531046087|FG002|Overall Study|Lost to Follow-up|1|||
147238562|NCT03166735|531046088|FG003|Overall Study|Lost to Follow-up|0|||
147238563|NCT03166735|531046089|FG004|Overall Study|Lost to Follow-up|1|||
147238564|NCT01543958|531046090|FG000|Overall Study|Loss to follow-up|3|||
147238565|NCT01543958|531046090|FG000|Overall Study|ART initiation|1|||
147238566|NCT04019288|531046091|FG000|Overall Study|Death|1|||
147238567|NCT04019288|531046092|FG001|Overall Study|Death|0|||
147238568|NCT04019288|531046093|FG002|Overall Study|Death|0|||
147238569|NCT01945281|531046094|FG000|Overall Study|Adverse Event|1|||
147238570|NCT01945281|531046095|FG001|Overall Study|Adverse Event|0|||
147238571|NCT01945281|531046094|FG000|Overall Study|Death|3|||
147238572|NCT01945281|531046095|FG001|Overall Study|Death|3|||
147146225|NCT02719691|530699230|FG001|Overall Study|Withdrawal by Subject|0|||
147238573|NCT01945281|531046094|FG000|Overall Study|Physician Decision|1|||
147238574|NCT01945281|531046095|FG001|Overall Study|Physician Decision|1|||
147238575|NCT01945281|531046094|FG000|Overall Study|Technical Problems|1|||
147238576|NCT01945281|531046095|FG001|Overall Study|Technical Problems|0|||
147146226|NCT02719691|530699231|FG002|Overall Study|Withdrawal by Subject|0|||
147146227|NCT02719691|530699232|FG003|Overall Study|Withdrawal by Subject|0|||
147146228|NCT02719691|530699233|FG004|Overall Study|Withdrawal by Subject|0|||
147146229|NCT02719691|530699234|FG005|Overall Study|Withdrawal by Subject|1|||
147146230|NCT02719691|530699235|FG006|Overall Study|Withdrawal by Subject|0|||
147146231|NCT00336284|530699236|FG000|Overall Study|Death|52|||
147146232|NCT00336284|530699237|FG001|Overall Study|Death|26|||
147146233|NCT00336284|530699236|FG000|Overall Study|Lost to Follow-up|82|||
147146234|NCT00336284|530699237|FG001|Overall Study|Lost to Follow-up|61|||
147146235|NCT00336284|530699236|FG000|Overall Study|Withdrawal by Physician or Subject|102|||
147146236|NCT00336284|530699237|FG001|Overall Study|Withdrawal by Physician or Subject|64|||
147146237|NCT00861757|530699242|FG000|Overall Study|Adverse Event|1|||
147146238|NCT00861757|530699243|FG001|Overall Study|Adverse Event|5|||
147146239|NCT00861757|530699244|FG002|Overall Study|Adverse Event|7|||
147146240|NCT00861757|530699245|FG003|Overall Study|Adverse Event|2|||
147146241|NCT00861757|530699242|FG000|Overall Study|Entry Criteria Not Met|1|||
147146242|NCT00861757|530699243|FG001|Overall Study|Entry Criteria Not Met|2|||
147146243|NCT00861757|530699244|FG002|Overall Study|Entry Criteria Not Met|1|||
147146244|NCT00861757|530699245|FG003|Overall Study|Entry Criteria Not Met|1|||
147146245|NCT00861757|530699242|FG000|Overall Study|Lack of Efficacy|3|||
147146246|NCT00861757|530699243|FG001|Overall Study|Lack of Efficacy|1|||
147146247|NCT00861757|530699244|FG002|Overall Study|Lack of Efficacy|0|||
147146248|NCT00861757|530699245|FG003|Overall Study|Lack of Efficacy|1|||
147146249|NCT00861757|530699242|FG000|Overall Study|Lost to Follow-up|1|||
147146250|NCT00861757|530699243|FG001|Overall Study|Lost to Follow-up|0|||
147146251|NCT00861757|530699244|FG002|Overall Study|Lost to Follow-up|1|||
147146252|NCT00861757|530699245|FG003|Overall Study|Lost to Follow-up|1|||
147146253|NCT00861757|530699242|FG000|Overall Study|Physician Decision|0|||
147146254|NCT00861757|530699243|FG001|Overall Study|Physician Decision|0|||
147146255|NCT00861757|530699244|FG002|Overall Study|Physician Decision|0|||
147146256|NCT00861757|530699245|FG003|Overall Study|Physician Decision|1|||
147146257|NCT00861757|530699242|FG000|Overall Study|Protocol Violation|2|||
147146258|NCT00861757|530699243|FG001|Overall Study|Protocol Violation|2|||
147146259|NCT00861757|530699244|FG002|Overall Study|Protocol Violation|4|||
147146260|NCT00861757|530699245|FG003|Overall Study|Protocol Violation|1|||
147146261|NCT00861757|530699242|FG000|Overall Study|Withdrawal by Subject|1|||
147146262|NCT00861757|530699243|FG001|Overall Study|Withdrawal by Subject|5|||
147146263|NCT00861757|530699244|FG002|Overall Study|Withdrawal by Subject|5|||
147146264|NCT00861757|530699245|FG003|Overall Study|Withdrawal by Subject|2|||
147146265|NCT01521923|530699249|FG000|Overall Study|AE, serious fatal|1|||
147146266|NCT01521923|530699250|FG001|Overall Study|AE, serious fatal|0|||
147318745|NCT01349907|531333567|FG001|Overall Study|Withdrawal by Subject|8|||
147318746|NCT01349907|531333566|FG000|Overall Study|Protocol Violation|33|||
147318747|NCT01349907|531333567|FG001|Overall Study|Protocol Violation|13|||
147318748|NCT01349907|531333566|FG000|Overall Study|Administrative|1|||
147318749|NCT01349907|531333567|FG001|Overall Study|Administrative|1|||
147318750|NCT01477749|531333570|FG000|Overall Study|Physician Decision|4|||
147318751|NCT04004208|531333574|FG000|Overall Study|Withdrawal by parent/guardian|1|||
147318752|NCT04004208|531333575|FG001|Overall Study|Withdrawal by parent/guardian|1|||
147318753|NCT04004208|531333574|FG000|Overall Study|Death|3|||
147318754|NCT04004208|531333575|FG001|Overall Study|Death|0|||
147318755|NCT04004208|531333574|FG000|Overall Study|COVID-19 pandemic|1|||
147318756|NCT04004208|531333575|FG001|Overall Study|COVID-19 pandemic|0|||
147318757|NCT04004208|531333574|FG000|Overall Study|Physician Decision|1|||
147318758|NCT04004208|531333575|FG001|Overall Study|Physician Decision|0|||
147318759|NCT04004208|531333574|FG000|Overall Study|Adverse Event|1|||
147318760|NCT04004208|531333575|FG001|Overall Study|Adverse Event|1|||
147318761|NCT01310868|531333581|FG000|Overall Study|Do not have histologically confirmed GBM|13|||
147318762|NCT01628874|531333588|FG000|Overall Study|Physician Decision|1|||
147318763|NCT01628874|531333589|FG001|Overall Study|Physician Decision|1|||
147318764|NCT01628874|531333588|FG000|Overall Study|Age >4 months|4|||
147318765|NCT01628874|531333589|FG001|Overall Study|Age >4 months|2|||
147146267|NCT01521923|530699251|FG002|Overall Study|AE, serious fatal|0|||
147318766|NCT00873093|531333590|FG000|Overall Study|Adverse Event|0|||
147318767|NCT00873093|531333591|FG001|Overall Study|Adverse Event|2|||
147146268|NCT01521923|530699252|FG003|Overall Study|AE, serious fatal|0|||
147146269|NCT01521923|530699249|FG000|Overall Study|SAE, non-fatal|0|||
147146270|NCT01521923|530699250|FG001|Overall Study|SAE, non-fatal|2|||
147146271|NCT01521923|530699251|FG002|Overall Study|SAE, non-fatal|2|||
147146272|NCT01521923|530699252|FG003|Overall Study|SAE, non-fatal|0|||
147146273|NCT01521923|530699249|FG000|Overall Study|AE, non-serious, non-fatal|1|||
147146274|NCT01521923|530699250|FG001|Overall Study|AE, non-serious, non-fatal|3|||
147318768|NCT00873093|531333592|FG002|Overall Study|Adverse Event|0|||
147318769|NCT00873093|531333593|FG003|Overall Study|Adverse Event|0|||
147318770|NCT00873093|531333594|FG004|Overall Study|Adverse Event|0|||
147318771|NCT00873093|531333590|FG000|Overall Study|Death|0|||
147318772|NCT00873093|531333591|FG001|Overall Study|Death|3|||
147318773|NCT00873093|531333592|FG002|Overall Study|Death|2|||
147318774|NCT00873093|531333593|FG003|Overall Study|Death|0|||
147318775|NCT00873093|531333594|FG004|Overall Study|Death|0|||
147238577|NCT00934089|531046097|FG000|First Intervention Period (14 Days)|Withdrawal by Subject|1|||
147238578|NCT00934089|531046098|FG001|First Intervention Period (14 Days)|Withdrawal by Subject|0|||
147238579|NCT00934089|531046097|FG000|First Intervention Period (14 Days)|Randomized, but not treated|1|||
147238580|NCT00934089|531046098|FG001|First Intervention Period (14 Days)|Randomized, but not treated|0|||
147238581|NCT00799383|531046101|FG000|Overall Study|Protocol Violation|1|||
147238582|NCT00799383|531046102|FG001|Overall Study|Protocol Violation|1|||
147238583|NCT00799383|531046101|FG000|Overall Study|Adverse Event|0|||
147238584|NCT00799383|531046102|FG001|Overall Study|Adverse Event|1|||
147238585|NCT00799383|531046101|FG000|Overall Study|Lost to Follow-up|1|||
147238586|NCT00799383|531046102|FG001|Overall Study|Lost to Follow-up|2|||
147238587|NCT00799383|531046101|FG000|Overall Study|Urinary Calcium/Creatinine > 0.2|1|||
147238588|NCT00799383|531046102|FG001|Overall Study|Urinary Calcium/Creatinine > 0.2|1|||
147238589|NCT00799383|531046101|FG000|Overall Study|Withdrawal by Subject|0|||
147238590|NCT00799383|531046102|FG001|Overall Study|Withdrawal by Subject|1|||
147238591|NCT00926328|531046103|FG000|Overall Study|Lost to Follow-up|12|||
147238592|NCT00926328|531046104|FG001|Overall Study|Lost to Follow-up|14|||
147238593|NCT00726986|531046105|FG000|Induction Phase|Adverse Event|4|||
147238594|NCT00726986|531046105|FG000|Induction Phase|Withdrawal by Subject|2|||
147238595|NCT00726986|531046105|FG000|Induction Phase|Death|2|||
147238596|NCT00726986|531046105|FG000|Induction Phase|Lack of Efficacy|5|||
147238597|NCT00726986|531046105|FG000|Induction Phase|Secondary Disease|2|||
147238598|NCT00726986|531046105|FG000|Maintenance Phase|Adverse Event|1|||
147238599|NCT00726986|531046105|FG000|Maintenance Phase|Lack of Efficacy|2|||
147238600|NCT01434667|531046111|FG000|Overall Study|Lost to Follow-up|5|||
147318776|NCT00873093|531333590|FG000|Overall Study|Physician Decision|0|||
147318777|NCT00873093|531333591|FG001|Overall Study|Physician Decision|17|||
147318778|NCT00873093|531333592|FG002|Overall Study|Physician Decision|10|||
147318779|NCT00873093|531333593|FG003|Overall Study|Physician Decision|10|||
147318780|NCT00873093|531333594|FG004|Overall Study|Physician Decision|2|||
147318781|NCT00873093|531333590|FG000|Overall Study|Withdrawal by Subject|1|||
147318782|NCT00873093|531333591|FG001|Overall Study|Withdrawal by Subject|4|||
147318783|NCT00873093|531333592|FG002|Overall Study|Withdrawal by Subject|4|||
147318784|NCT00873093|531333593|FG003|Overall Study|Withdrawal by Subject|0|||
147318785|NCT00873093|531333594|FG004|Overall Study|Withdrawal by Subject|0|||
147318786|NCT00873093|531333590|FG000|Overall Study|Ineligible|0|||
147318787|NCT00873093|531333591|FG001|Overall Study|Ineligible|1|||
147318788|NCT00873093|531333592|FG002|Overall Study|Ineligible|0|||
147318789|NCT00873093|531333593|FG003|Overall Study|Ineligible|1|||
147318790|NCT00873093|531333594|FG004|Overall Study|Ineligible|0|||
147318791|NCT01848834|531333595|FG000|Overall Study|Adverse Event|3|||
147318792|NCT01848834|531333596|FG001|Overall Study|Adverse Event|11|||
147318793|NCT01848834|531333597|FG002|Overall Study|Adverse Event|3|||
147318794|NCT01848834|531333598|FG003|Overall Study|Adverse Event|5|||
147318795|NCT01848834|531333599|FG004|Overall Study|Adverse Event|9|||
147318796|NCT01848834|531333595|FG000|Overall Study|Death|2|||
147318797|NCT01848834|531333596|FG001|Overall Study|Death|11|||
147318798|NCT01848834|531333597|FG002|Overall Study|Death|1|||
147318799|NCT01848834|531333598|FG003|Overall Study|Death|8|||
147318800|NCT01848834|531333599|FG004|Overall Study|Death|27|||
147318801|NCT01848834|531333595|FG000|Overall Study|Excluded Medication|5|||
147318802|NCT01848834|531333596|FG001|Overall Study|Excluded Medication|4|||
147318803|NCT01848834|531333597|FG002|Overall Study|Excluded Medication|3|||
147318804|NCT01848834|531333598|FG003|Overall Study|Excluded Medication|6|||
147318805|NCT01848834|531333599|FG004|Overall Study|Excluded Medication|6|||
147318806|NCT01848834|531333595|FG000|Overall Study|Lost to Follow-up|5|||
147318807|NCT01848834|531333596|FG001|Overall Study|Lost to Follow-up|5|||
147318808|NCT01848834|531333597|FG002|Overall Study|Lost to Follow-up|3|||
147318809|NCT01848834|531333598|FG003|Overall Study|Lost to Follow-up|0|||
147318810|NCT01848834|531333599|FG004|Overall Study|Lost to Follow-up|3|||
147318811|NCT01848834|531333595|FG000|Overall Study|Physician Decision|1|||
147318812|NCT01848834|531333596|FG001|Overall Study|Physician Decision|3|||
147574537|NCT02488109|532261207|FG001|Treatment in Hospital|Withdrawal by Subject|5|||
147574538|NCT02488109|532261206|FG000|12-month Follow-Up|Lost to Follow-up|4|||
147238601|NCT01434667|531046112|FG001|Overall Study|Lost to Follow-up|10|||
147238602|NCT02165215|531046115|FG000|Induction Phase|Adverse Event|1|||
147238603|NCT02165215|531046116|FG001|Induction Phase|Adverse Event|0|||
147238604|NCT02165215|531046117|FG002|Induction Phase|Adverse Event|0|||
147238605|NCT02165215|531046115|FG000|Induction Phase|Withdrawal by Subject|10|||
147318813|NCT01848834|531333597|FG002|Overall Study|Physician Decision|4|||
147318814|NCT01848834|531333598|FG003|Overall Study|Physician Decision|0|||
147318815|NCT01848834|531333599|FG004|Overall Study|Physician Decision|11|||
147318816|NCT01848834|531333595|FG000|Overall Study|Protocol Violation|0|||
147318817|NCT01848834|531333596|FG001|Overall Study|Protocol Violation|0|||
147318818|NCT01848834|531333597|FG002|Overall Study|Protocol Violation|0|||
147318819|NCT01848834|531333598|FG003|Overall Study|Protocol Violation|0|||
147318820|NCT01848834|531333599|FG004|Overall Study|Protocol Violation|1|||
147318821|NCT01848834|531333595|FG000|Overall Study|Sponsor Decision|1|||
147318822|NCT01848834|531333596|FG001|Overall Study|Sponsor Decision|1|||
147318823|NCT01848834|531333597|FG002|Overall Study|Sponsor Decision|0|||
147318824|NCT01848834|531333598|FG003|Overall Study|Sponsor Decision|1|||
147318825|NCT01848834|531333599|FG004|Overall Study|Sponsor Decision|1|||
147318826|NCT01848834|531333595|FG000|Overall Study|Withdrawal by Subject|2|||
147318827|NCT01848834|531333596|FG001|Overall Study|Withdrawal by Subject|13|||
147318828|NCT01848834|531333597|FG002|Overall Study|Withdrawal by Subject|10|||
147445796|NCT01709435|531797449|FG003|Overall Study|Lack of Efficacy|2|||
147445797|NCT01709435|531797450|FG004|Overall Study|Lack of Efficacy|6|||
147445798|NCT01709435|531797451|FG005|Overall Study|Lack of Efficacy|3|||
147445799|NCT01709435|531797446|FG000|Overall Study|Physician Decision|0|||
147445800|NCT01709435|531797447|FG001|Overall Study|Physician Decision|1|||
147445801|NCT01709435|531797448|FG002|Overall Study|Physician Decision|0|||
147445802|NCT01709435|531797449|FG003|Overall Study|Physician Decision|1|||
147445803|NCT01709435|531797450|FG004|Overall Study|Physician Decision|2|||
147445804|NCT01709435|531797451|FG005|Overall Study|Physician Decision|0|||
147445805|NCT01709435|531797446|FG000|Overall Study|Withdrawal by Subject|0|||
147445806|NCT01709435|531797447|FG001|Overall Study|Withdrawal by Subject|0|||
147445807|NCT01709435|531797448|FG002|Overall Study|Withdrawal by Subject|3|||
147445808|NCT01709435|531797449|FG003|Overall Study|Withdrawal by Subject|0|||
147445809|NCT01709435|531797450|FG004|Overall Study|Withdrawal by Subject|2|||
147445810|NCT01709435|531797451|FG005|Overall Study|Withdrawal by Subject|2|||
147445811|NCT02409290|531797452|FG000|Overall Study|Protocol Violation|3|||
147445812|NCT02409290|531797453|FG001|Overall Study|Protocol Violation|6|||
147445813|NCT02409290|531797454|FG002|Overall Study|Protocol Violation|9|||
147445814|NCT02409290|531797455|FG003|Overall Study|Protocol Violation|4|||
147445815|NCT02409290|531797452|FG000|Overall Study|No positive culture/no baseline sample|3|||
147445816|NCT02409290|531797453|FG001|Overall Study|No positive culture/no baseline sample|9|||
147445817|NCT02409290|531797454|FG002|Overall Study|No positive culture/no baseline sample|6|||
147445818|NCT02409290|531797455|FG003|Overall Study|No positive culture/no baseline sample|5|||
147445819|NCT02409290|531797452|FG000|Overall Study|Completed but not analysed as recruitment stopped to this arm|26|||
147445820|NCT02409290|531797453|FG001|Overall Study|Completed but not analysed as recruitment stopped to this arm|0|||
147445821|NCT02409290|531797454|FG002|Overall Study|Completed but not analysed as recruitment stopped to this arm|0|||
147445822|NCT02409290|531797455|FG003|Overall Study|Completed but not analysed as recruitment stopped to this arm|0|||
147445823|NCT02121262|531797456|FG000|Overall Study|Adverse Event|6|||
147445824|NCT02121262|531797457|FG001|Overall Study|Adverse Event|3|||
147445825|NCT02121262|531797456|FG000|Overall Study|Lack of Efficacy|3|||
147445826|NCT02121262|531797457|FG001|Overall Study|Lack of Efficacy|0|||
147445827|NCT02121262|531797456|FG000|Overall Study|Personal Reasons|19|||
147445828|NCT02121262|531797457|FG001|Overall Study|Personal Reasons|5|||
147445829|NCT02121262|531797456|FG000|Overall Study|Protocol Violation|1|||
147146275|NCT01521923|530699251|FG002|Overall Study|AE, non-serious, non-fatal|6|||
147146276|NCT01521923|530699252|FG003|Overall Study|AE, non-serious, non-fatal|2|||
147146277|NCT01521923|530699249|FG000|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|0|||
147146278|NCT01521923|530699250|FG001|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|0|||
147318829|NCT01848834|531333598|FG003|Overall Study|Withdrawal by Subject|6|||
147318830|NCT01848834|531333599|FG004|Overall Study|Withdrawal by Subject|36|||
147318831|NCT03259373|531333604|FG000|Overall Study|Evidence of OAC treatment prior to start date based on more complete data|636|||
147318832|NCT03259373|531333605|FG001|Overall Study|Evidence of OAC treatment prior to start date based on more complete data|118|||
147318833|NCT03259373|531333604|FG000|Overall Study|Disenrolled earlier than originally captured in data (due to changing in data over time)|320|||
147318834|NCT03259373|531333605|FG001|Overall Study|Disenrolled earlier than originally captured in data (due to changing in data over time)|344|||
147318835|NCT03259373|531333604|FG000|Overall Study|Unable to be identified in dataset used for analysis|43|||
147318836|NCT03259373|531333605|FG001|Overall Study|Unable to be identified in dataset used for analysis|49|||
147318837|NCT03259373|531333604|FG000|Overall Study|Censored between old dataset and the follow-up start date (due to changing in data over time)|3446|||
147318838|NCT03259373|531333605|FG001|Overall Study|Censored between old dataset and the follow-up start date (due to changing in data over time)|3599|||
147318839|NCT03259373|531333604|FG000|Overall Study|Censored prior to old dataset, other reason (unable to specify reason from available data)|32|||
147318840|NCT03259373|531333605|FG001|Overall Study|Censored prior to old dataset, other reason (unable to specify reason from available data)|63|||
147318841|NCT03259373|531333604|FG000|Overall Study|On OAC treatment at follow up start (due to data lags)|4272|||
147318842|NCT03259373|531333605|FG001|Overall Study|On OAC treatment at follow up start (due to data lags)|4411|||
147445830|NCT02121262|531797457|FG001|Overall Study|Protocol Violation|1|||
147146279|NCT01521923|530699251|FG002|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|0|||
147146280|NCT01521923|530699252|FG003|Overall Study|SAE, nonfatal + AE, non-serious nonfatal|1|||
147445831|NCT02121262|531797456|FG000|Overall Study|Participant Dropped-out|0|||
147445832|NCT02121262|531797457|FG001|Overall Study|Participant Dropped-out|1|||
147445833|NCT02121262|531797456|FG000|Overall Study|Participant was Deemed Unsuitable|1|||
147445834|NCT02121262|531797457|FG001|Overall Study|Participant was Deemed Unsuitable|0|||
147445835|NCT02121262|531797456|FG000|Overall Study|Consent Withdrawn|1|||
147445836|NCT02121262|531797457|FG001|Overall Study|Consent Withdrawn|0|||
147146281|NCT01521923|530699249|FG000|Overall Study|Lack of Efficacy|1|||
147445837|NCT01553188|531797458|FG000|Overall Study|Patient choice|1|||
147445838|NCT01553188|531797459|FG001|Overall Study|Patient choice|0|||
147574539|NCT02488109|532261207|FG001|12-month Follow-Up|Lost to Follow-up|7|||
147574540|NCT02302716|532261208|FG000|Overall Study|Adverse Event|1|||
147574541|NCT02302716|532261209|FG001|Overall Study|Adverse Event|1|||
147574542|NCT02302716|532261208|FG000|Overall Study|Death|0|||
147574543|NCT02302716|532261209|FG001|Overall Study|Death|1|||
147574544|NCT02302716|532261208|FG000|Overall Study|Lack of Efficacy|0|||
147574545|NCT02302716|532261209|FG001|Overall Study|Lack of Efficacy|1|||
147574546|NCT02302716|532261208|FG000|Overall Study|Lost to Follow-up|2|||
147574547|NCT02302716|532261209|FG001|Overall Study|Lost to Follow-up|4|||
147146282|NCT01521923|530699250|FG001|Overall Study|Lack of Efficacy|1|||
147146283|NCT01521923|530699251|FG002|Overall Study|Lack of Efficacy|0|||
147146284|NCT01521923|530699252|FG003|Overall Study|Lack of Efficacy|0|||
147146285|NCT01521923|530699249|FG000|Overall Study|Protocol Violation|0|||
147146286|NCT01521923|530699250|FG001|Overall Study|Protocol Violation|0|||
147318843|NCT00885495|531333606|FG000|Overall Study|Adverse Event|1|||
147318844|NCT00885495|531333607|FG001|Overall Study|Adverse Event|2|||
147318845|NCT00885495|531333606|FG000|Overall Study|Protocol Violation|0|||
147318846|NCT00885495|531333607|FG001|Overall Study|Protocol Violation|1|||
147318847|NCT00885495|531333606|FG000|Overall Study|Withdrawal by Subject|1|||
147318848|NCT00885495|531333607|FG001|Overall Study|Withdrawal by Subject|0|||
147318849|NCT04504916|531333608|FG000|Overall Study|Study terminated|7|||
147318850|NCT04504916|531333609|FG001|Overall Study|Study terminated|8|||
147318851|NCT04504916|531333608|FG000|Overall Study|Death|54|||
147318852|NCT04504916|531333609|FG001|Overall Study|Death|18|||
147318853|NCT04504916|531333608|FG000|Overall Study|Lost to Follow-up|1|||
147318854|NCT04504916|531333609|FG001|Overall Study|Lost to Follow-up|1|||
147318855|NCT04504916|531333608|FG000|Overall Study|Withdrawal by Subject|8|||
147318856|NCT04504916|531333609|FG001|Overall Study|Withdrawal by Subject|4|||
147318857|NCT04504916|531333608|FG000|Overall Study|Did not agree to follow-up|0|||
147318858|NCT04504916|531333609|FG001|Overall Study|Did not agree to follow-up|1|||
147318859|NCT01368211|531333610|FG000|Second Platelets Transfusion|No need for additional transfusion|1|||
147318860|NCT01368211|531333611|FG001|Second Platelets Transfusion|No need for additional transfusion|2|||
147318861|NCT01513967|531333612|FG000|Overall Study|Pregnancy|0|||
147318862|NCT01513967|531333613|FG001|Overall Study|Pregnancy|0|||
147318863|NCT01513967|531333614|FG002|Overall Study|Pregnancy|0|||
147318864|NCT01513967|531333615|FG003|Overall Study|Pregnancy|0|||
147318865|NCT01513967|531333616|FG004|Overall Study|Pregnancy|0|||
147318866|NCT01513967|531333617|FG005|Overall Study|Pregnancy|0|||
147318867|NCT01513967|531333618|FG006|Overall Study|Pregnancy|1|||
147318868|NCT01513967|531333619|FG007|Overall Study|Pregnancy|0|||
147318869|NCT01513967|531333612|FG000|Overall Study|missed a study visit|0|||
147318870|NCT01513967|531333613|FG001|Overall Study|missed a study visit|0|||
147318871|NCT01513967|531333614|FG002|Overall Study|missed a study visit|0|||
147318872|NCT01513967|531333615|FG003|Overall Study|missed a study visit|0|||
147318873|NCT01513967|531333616|FG004|Overall Study|missed a study visit|0|||
147318874|NCT01513967|531333617|FG005|Overall Study|missed a study visit|0|||
147318875|NCT01513967|531333618|FG006|Overall Study|missed a study visit|1|||
147318876|NCT01513967|531333619|FG007|Overall Study|missed a study visit|0|||
147318877|NCT01513967|531333612|FG000|Overall Study|excluded due to positive drug screen|0|||
147318878|NCT01513967|531333613|FG001|Overall Study|excluded due to positive drug screen|0|||
147318879|NCT01513967|531333614|FG002|Overall Study|excluded due to positive drug screen|0|||
147574548|NCT02302716|532261208|FG000|Overall Study|Physician Decision|3|||
147574549|NCT02302716|532261209|FG001|Overall Study|Physician Decision|4|||
147146287|NCT01521923|530699251|FG002|Overall Study|Protocol Violation|1|||
147574550|NCT02302716|532261208|FG000|Overall Study|Withdrawal by Subject|13|||
147574551|NCT02302716|532261209|FG001|Overall Study|Withdrawal by Subject|7|||
147574552|NCT02302716|532261208|FG000|Overall Study|Protocol Violation|0|||
147574553|NCT02302716|532261209|FG001|Overall Study|Protocol Violation|1|||
147574554|NCT00557245|532261213|FG000|Overall Study|Lost to Follow-up|7|||
147574555|NCT00557245|532261214|FG001|Overall Study|Lost to Follow-up|8|||
147574556|NCT00557245|532261215|FG002|Overall Study|Lost to Follow-up|10|||
147574557|NCT00557245|532261213|FG000|Overall Study|Ineligible|5|||
147574558|NCT00557245|532261214|FG001|Overall Study|Ineligible|4|||
147574559|NCT00557245|532261215|FG002|Overall Study|Ineligible|2|||
147574560|NCT00521586|532261216|FG000|Initial Vaccination (Year 0)|Subject request|8|||
147574561|NCT00521586|532261217|FG001|Initial Vaccination (Year 0)|Subject request|11|||
147574562|NCT00521586|532261216|FG000|Initial Vaccination (Year 0)|Lost to Follow-up|5|||
147574563|NCT00521586|532261217|FG001|Initial Vaccination (Year 0)|Lost to Follow-up|10|||
147574564|NCT00521586|532261216|FG000|Initial Vaccination (Year 0)|Protocol Violation|2|||
147574565|NCT00521586|532261217|FG001|Initial Vaccination (Year 0)|Protocol Violation|5|||
147574566|NCT00521586|532261216|FG000|Initial Vaccination (Year 0)|Other, unspecified|3|||
147574567|NCT00521586|532261217|FG001|Initial Vaccination (Year 0)|Other, unspecified|1|||
147318880|NCT01513967|531333615|FG003|Overall Study|excluded due to positive drug screen|0|||
147318881|NCT01513967|531333616|FG004|Overall Study|excluded due to positive drug screen|0|||
147318882|NCT01513967|531333617|FG005|Overall Study|excluded due to positive drug screen|0|||
147318883|NCT01513967|531333618|FG006|Overall Study|excluded due to positive drug screen|0|||
147445839|NCT01553188|531797460|FG002|Overall Study|Patient choice|0|||
147238606|NCT02165215|531046116|FG001|Induction Phase|Withdrawal by Subject|0|||
147238607|NCT02165215|531046117|FG002|Induction Phase|Withdrawal by Subject|0|||
147238608|NCT02165215|531046115|FG000|Induction Phase|Protocol Violation|1|||
147238609|NCT02165215|531046116|FG001|Induction Phase|Protocol Violation|0|||
147238610|NCT02165215|531046117|FG002|Induction Phase|Protocol Violation|0|||
147238611|NCT02165215|531046115|FG000|Induction Phase|Physician Decision|1|||
147238612|NCT02165215|531046116|FG001|Induction Phase|Physician Decision|0|||
147238613|NCT02165215|531046117|FG002|Induction Phase|Physician Decision|0|||
147238614|NCT02165215|531046115|FG000|Induction Phase|Lack of Efficacy|2|||
147238615|NCT02165215|531046116|FG001|Induction Phase|Lack of Efficacy|0|||
147238616|NCT02165215|531046117|FG002|Induction Phase|Lack of Efficacy|0|||
147238617|NCT02165215|531046115|FG000|Induction Phase|Non-Compliance|2|||
147238618|NCT02165215|531046116|FG001|Induction Phase|Non-Compliance|0|||
147238619|NCT02165215|531046117|FG002|Induction Phase|Non-Compliance|0|||
147238620|NCT02165215|531046115|FG000|Induction Phase|Lost to Follow-up|6|||
147238621|NCT02165215|531046116|FG001|Induction Phase|Lost to Follow-up|0|||
147238622|NCT02165215|531046117|FG002|Induction Phase|Lost to Follow-up|0|||
147238623|NCT02165215|531046115|FG000|Maintenance Phase|Withdrawal by Subject|0|||
147238624|NCT02165215|531046116|FG001|Maintenance Phase|Withdrawal by Subject|7|||
147238625|NCT02165215|531046117|FG002|Maintenance Phase|Withdrawal by Subject|3|||
147238626|NCT02165215|531046115|FG000|Maintenance Phase|Multiple reasons|0|||
147238627|NCT02165215|531046116|FG001|Maintenance Phase|Multiple reasons|2|||
147238628|NCT02165215|531046117|FG002|Maintenance Phase|Multiple reasons|1|||
147238629|NCT02165215|531046115|FG000|Maintenance Phase|Lost to Follow-up|0|||
147238630|NCT02165215|531046116|FG001|Maintenance Phase|Lost to Follow-up|2|||
147238631|NCT02165215|531046117|FG002|Maintenance Phase|Lost to Follow-up|0|||
147238632|NCT02165215|531046115|FG000|Maintenance Phase|Adverse Event|0|||
147238633|NCT02165215|531046116|FG001|Maintenance Phase|Adverse Event|1|||
147238634|NCT02165215|531046117|FG002|Maintenance Phase|Adverse Event|1|||
147238635|NCT05074667|531046118|FG000|Overall Study|Death|1|||
147238636|NCT05074667|531046118|FG000|Overall Study|Withdrawal by Subject|4|||
147238637|NCT05074667|531046118|FG000|Overall Study|Lost to Follow-up|10|||
147238638|NCT01877265|531046119|FG000|Treatment Period 1|Sponsor Decision|0|||
147238639|NCT01877265|531046120|FG001|Treatment Period 1|Sponsor Decision|0|||
147238640|NCT01877265|531046121|FG002|Treatment Period 1|Sponsor Decision|1|||
147238641|NCT01877265|531046122|FG003|Treatment Period 1|Sponsor Decision|0|||
147238642|NCT01877265|531046123|FG004|Treatment Period 1|Sponsor Decision|0|||
147238643|NCT01877265|531046124|FG005|Treatment Period 1|Sponsor Decision|0|||
147238644|NCT01877265|531046119|FG000|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0|||
147238645|NCT01877265|531046120|FG001|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0|||
147238646|NCT01877265|531046121|FG002|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0|||
147238647|NCT01877265|531046122|FG003|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0|||
147238648|NCT01877265|531046123|FG004|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|0|||
147238649|NCT01877265|531046124|FG005|Washout Period 2 (at Least 14 Days)|Lost to Follow-up|1|||
147238650|NCT01877265|531046119|FG000|Treatment Period 3|Lost to Follow-up|1|||
147574568|NCT00521586|532261216|FG000|Initial Vaccination (Year 0)|Investigator request|2|||
147574569|NCT00521586|532261217|FG001|Initial Vaccination (Year 0)|Investigator request|0|||
147574570|NCT00521586|532261216|FG000|Initial Vaccination (Year 0)|Adverse Event|0|||
147574571|NCT00521586|532261217|FG001|Initial Vaccination (Year 0)|Adverse Event|1|||
147574572|NCT00521586|532261216|FG000|Initial Vaccination (Year 0)|Death|1|||
147574573|NCT00521586|532261217|FG001|Initial Vaccination (Year 0)|Death|0|||
147574574|NCT00521586|532261216|FG000|Initial Vaccination (Year 0)|Failed to return|0|||
147574575|NCT00521586|532261217|FG001|Initial Vaccination (Year 0)|Failed to return|1|||
147574576|NCT00521586|532261216|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Adverse Event|5|||
147574577|NCT00521586|532261217|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Adverse Event|1|||
147574578|NCT00521586|532261216|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Death|5|||
147574579|NCT00521586|532261217|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Death|2|||
147574580|NCT00521586|532261216|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Failed to return|7|||
147574581|NCT00521586|532261217|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Failed to return|3|||
147574582|NCT00521586|532261216|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Investigator request|3|||
147574583|NCT00521586|532261217|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Investigator request|3|||
147574584|NCT00521586|532261216|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Lost to Follow-up|55|||
147574585|NCT00521586|532261217|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Lost to Follow-up|56|||
147574586|NCT00521586|532261216|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Other|22|||
147238651|NCT01877265|531046120|FG001|Treatment Period 3|Lost to Follow-up|0|||
147238652|NCT01877265|531046121|FG002|Treatment Period 3|Lost to Follow-up|0|||
147238653|NCT01877265|531046122|FG003|Treatment Period 3|Lost to Follow-up|0|||
147238654|NCT01877265|531046123|FG004|Treatment Period 3|Lost to Follow-up|0|||
147238655|NCT01877265|531046124|FG005|Treatment Period 3|Lost to Follow-up|0|||
147238656|NCT02279420|531046125|FG000|Overall Study|Lost to Follow-up|23|||
147238657|NCT03535844|531046128|FG000|Overall Study|Withdrawal by Subject|0|||
147238658|NCT03535844|531046129|FG001|Overall Study|Withdrawal by Subject|1|||
147238659|NCT00297830|531046132|FG000|6 Month Visit|Death|1|||
147146288|NCT01521923|530699252|FG003|Overall Study|Protocol Violation|0|||
147146289|NCT01521923|530699249|FG000|Overall Study|Lost to Follow-up|1|||
147146290|NCT01521923|530699250|FG001|Overall Study|Lost to Follow-up|0|||
147146291|NCT01521923|530699251|FG002|Overall Study|Lost to Follow-up|2|||
147146292|NCT01521923|530699252|FG003|Overall Study|Lost to Follow-up|1|||
147146293|NCT01521923|530699249|FG000|Overall Study|Withdrawal by Subject|1|||
147146294|NCT01521923|530699250|FG001|Overall Study|Withdrawal by Subject|1|||
147146295|NCT01521923|530699251|FG002|Overall Study|Withdrawal by Subject|1|||
147146296|NCT01521923|530699252|FG003|Overall Study|Withdrawal by Subject|2|||
147146297|NCT01521923|530699249|FG000|Overall Study|Other|2|||
147146298|NCT01521923|530699250|FG001|Overall Study|Other|1|||
147146299|NCT01521923|530699251|FG002|Overall Study|Other|3|||
147146300|NCT01521923|530699252|FG003|Overall Study|Other|6|||
147146301|NCT01521923|530699249|FG000|Overall Study|AE, captured in Period 1|0|||
147146302|NCT01521923|530699250|FG001|Overall Study|AE, captured in Period 1|1|||
147146303|NCT01521923|530699251|FG002|Overall Study|AE, captured in Period 1|0|||
147146304|NCT01521923|530699252|FG003|Overall Study|AE, captured in Period 1|1|||
147146305|NCT02403817|530699255|FG000|Overall Study|Withdrawal by Subject|5|||
147146306|NCT02403817|530699256|FG001|Overall Study|Withdrawal by Subject|0|||
147146307|NCT00473889|530699259|FG000|Overall Study|Did not receive study medication|1|||
147146308|NCT00473889|530699260|FG001|Overall Study|Did not receive study medication|4|||
147146309|NCT00473889|530699259|FG000|Overall Study|Adverse Event|30|||
147146310|NCT00473889|530699260|FG001|Overall Study|Adverse Event|17|||
147146311|NCT00473889|530699259|FG000|Overall Study|Protocol Violation|4|||
147146312|NCT00473889|530699260|FG001|Overall Study|Protocol Violation|2|||
147146313|NCT00473889|530699259|FG000|Overall Study|Lack of Efficacy|28|||
147146314|NCT00473889|530699260|FG001|Overall Study|Lack of Efficacy|29|||
147146315|NCT00473889|530699259|FG000|Overall Study|Lost to Follow-up|2|||
147146316|NCT00473889|530699260|FG001|Overall Study|Lost to Follow-up|1|||
147146317|NCT00473889|530699259|FG000|Overall Study|Physician Decision|10|||
147146318|NCT00473889|530699260|FG001|Overall Study|Physician Decision|5|||
147146319|NCT00473889|530699259|FG000|Overall Study|Trial Terminated|3|||
147146320|NCT00473889|530699260|FG001|Overall Study|Trial Terminated|6|||
147146321|NCT00473889|530699259|FG000|Overall Study|Withdrawal by Subject|5|||
147146322|NCT00473889|530699260|FG001|Overall Study|Withdrawal by Subject|0|||
147146323|NCT04908384|530699264|FG000|Overall Study|Lost to Follow-up|4|||
147146324|NCT04908384|530699265|FG001|Overall Study|Lost to Follow-up|4|||
147146325|NCT04908384|530699266|FG002|Overall Study|Lost to Follow-up|0|||
147146326|NCT04908384|530699267|FG003|Overall Study|Lost to Follow-up|0|||
147146327|NCT01947283|530699268|FG000|Overall Study|Death|1|||
147146328|NCT01947283|530699269|FG001|Overall Study|Death|1|||
147146329|NCT01947283|530699270|FG002|Overall Study|Death|1|||
147146330|NCT01947283|530699271|FG003|Overall Study|Death|0|||
147146331|NCT01947283|530699272|FG004|Overall Study|Death|0|||
147146332|NCT01947283|530699273|FG005|Overall Study|Death|0|||
147146333|NCT01947283|530699274|FG006|Overall Study|Death|0|||
147146334|NCT01947283|530699268|FG000|Overall Study|Lost to Follow-up|4|||
147146335|NCT01947283|530699269|FG001|Overall Study|Lost to Follow-up|6|||
147146336|NCT01947283|530699270|FG002|Overall Study|Lost to Follow-up|5|||
147146337|NCT01947283|530699271|FG003|Overall Study|Lost to Follow-up|5|||
147146338|NCT01947283|530699272|FG004|Overall Study|Lost to Follow-up|0|||
147146339|NCT01947283|530699273|FG005|Overall Study|Lost to Follow-up|2|||
147146340|NCT01947283|530699274|FG006|Overall Study|Lost to Follow-up|5|||
147146341|NCT01947283|530699268|FG000|Overall Study|Withdrawal by Subject|10|||
147146342|NCT01947283|530699269|FG001|Overall Study|Withdrawal by Subject|8|||
147146343|NCT01947283|530699270|FG002|Overall Study|Withdrawal by Subject|4|||
147146344|NCT01947283|530699271|FG003|Overall Study|Withdrawal by Subject|1|||
147146345|NCT01947283|530699272|FG004|Overall Study|Withdrawal by Subject|0|||
147146346|NCT01947283|530699273|FG005|Overall Study|Withdrawal by Subject|0|||
147146347|NCT01947283|530699274|FG006|Overall Study|Withdrawal by Subject|2|||
147146348|NCT01947283|530699268|FG000|Overall Study|No Clinical Recording|12|||
147146349|NCT01947283|530699269|FG001|Overall Study|No Clinical Recording|6|||
147574587|NCT00521586|532261217|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Other|26|||
147146350|NCT01947283|530699270|FG002|Overall Study|No Clinical Recording|8|||
147146351|NCT01947283|530699271|FG003|Overall Study|No Clinical Recording|10|||
147146352|NCT01947283|530699272|FG004|Overall Study|No Clinical Recording|0|||
147146353|NCT01947283|530699273|FG005|Overall Study|No Clinical Recording|0|||
147146354|NCT01947283|530699274|FG006|Overall Study|No Clinical Recording|0|||
147146355|NCT01947283|530699268|FG000|Overall Study|Non-coding Clinical Recording language|0|||
147146356|NCT01947283|530699269|FG001|Overall Study|Non-coding Clinical Recording language|0|||
147146357|NCT01947283|530699270|FG002|Overall Study|Non-coding Clinical Recording language|0|||
147146358|NCT01947283|530699271|FG003|Overall Study|Non-coding Clinical Recording language|1|||
147146359|NCT01947283|530699272|FG004|Overall Study|Non-coding Clinical Recording language|0|||
147146360|NCT01947283|530699273|FG005|Overall Study|Non-coding Clinical Recording language|0|||
147146361|NCT01947283|530699274|FG006|Overall Study|Non-coding Clinical Recording language|0|||
147146362|NCT01947283|530699268|FG000|Overall Study|Missing Follow-up Assessment|2|||
147238660|NCT00297830|531046133|FG001|6 Month Visit|Death|0|||
147574588|NCT00521586|532261216|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Protocol Violation|18|||
147574589|NCT00521586|532261217|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Protocol Violation|22|||
147318884|NCT01513967|531333619|FG007|Overall Study|excluded due to positive drug screen|2|||
147318885|NCT01513967|531333612|FG000|Overall Study|Physician Decision|0|||
147318886|NCT01513967|531333613|FG001|Overall Study|Physician Decision|0|||
147318887|NCT01513967|531333614|FG002|Overall Study|Physician Decision|0|||
147318888|NCT01513967|531333615|FG003|Overall Study|Physician Decision|0|||
147318889|NCT01513967|531333616|FG004|Overall Study|Physician Decision|0|||
147318890|NCT01513967|531333617|FG005|Overall Study|Physician Decision|1|||
147318891|NCT01513967|531333618|FG006|Overall Study|Physician Decision|0|||
147318892|NCT01513967|531333619|FG007|Overall Study|Physician Decision|0|||
147318893|NCT01563978|531333621|FG000|Overall Study|Physician Decision|1|||
147318894|NCT01563978|531333622|FG001|Overall Study|Physician Decision|0|||
147318895|NCT01563978|531333621|FG000|Overall Study|Lost to Follow-up|1|||
147318896|NCT01563978|531333622|FG001|Overall Study|Lost to Follow-up|0|||
147318897|NCT01563978|531333621|FG000|Overall Study|Dev. of study specific discont. criteria|1|||
147318898|NCT01563978|531333622|FG001|Overall Study|Dev. of study specific discont. criteria|0|||
147318899|NCT01563978|531333621|FG000|Overall Study|Adverse Event|1|||
147318900|NCT01563978|531333622|FG001|Overall Study|Adverse Event|2|||
147318901|NCT05764239|531333623|FG000|DEP (Part 1)|Study terminated by Sponsor|28|||
147318902|NCT05764239|531333623|FG000|DEP (Part 1)|Withdrawal by Subject|3|||
147318903|NCT05764239|531333623|FG000|DEP (Part 1)|Non-compliance with study drug|2|||
147318904|NCT05764239|531333623|FG000|DEP (Part 1)|Adverse Event|1|||
147318905|NCT05764239|531333623|FG000|DEP (Part 1)|Lost to Follow-up|1|||
147318906|NCT05764239|531333623|FG000|RWP (Part 2, SYNB1934v1)|Study terminated by Sponsor|7|||
147318907|NCT05764239|531333623|FG000|RWP (Part 2, SYNB1934v1)|Non-compliance with study drug|2|||
147318908|NCT05764239|531333623|FG000|RWP (Part 2, Placebo)|Study terminated by Sponsor|8|||
147318909|NCT05764239|531333623|FG000|OLE (Part 3)|Study terminated by Sponsor|10|||
147318910|NCT04630756|531333624|FG000|Module 1 Part A: AZD4573 9 mg|Ongoing subjects in Post Trial Access Program|1|||
147318911|NCT04630756|531333625|FG001|Module 1 Part A: AZD4573 9 mg|Ongoing subjects in Post Trial Access Program|0|||
147318912|NCT04630756|531333626|FG002|Module 1 Part A: AZD4573 9 mg|Ongoing subjects in Post Trial Access Program|0|||
147318913|NCT05593211|531333628|FG000|Overall Study|Withdrawal by Subject|1|||
147318914|NCT03077620|531333632|FG000|Overall Study|Unable to place lumbar catheter|1|||
147318915|NCT03077620|531333633|FG001|Overall Study|Unable to place lumbar catheter|0|||
147318916|NCT03077620|531333634|FG002|Overall Study|Unable to place lumbar catheter|1|||
147318917|NCT03077620|531333635|FG003|Overall Study|Unable to place lumbar catheter|0|||
147318918|NCT03077620|531333632|FG000|Overall Study|Withdrawal by Subject|0|||
147318919|NCT03077620|531333633|FG001|Overall Study|Withdrawal by Subject|1|||
147318920|NCT03077620|531333634|FG002|Overall Study|Withdrawal by Subject|0|||
147318921|NCT03077620|531333635|FG003|Overall Study|Withdrawal by Subject|0|||
147318922|NCT03077620|531333632|FG000|Overall Study|Physician Decision|0|||
147318923|NCT03077620|531333633|FG001|Overall Study|Physician Decision|0|||
147318924|NCT03077620|531333634|FG002|Overall Study|Physician Decision|1|||
147318925|NCT03077620|531333635|FG003|Overall Study|Physician Decision|0|||
147318926|NCT03225846|531333636|FG000|Overall Study|Adverse Event|0|||
147318927|NCT03225846|531333637|FG001|Overall Study|Adverse Event|0|||
147318928|NCT03225846|531333638|FG002|Overall Study|Adverse Event|0|||
147318929|NCT03225846|531333639|FG003|Overall Study|Adverse Event|0|||
147318930|NCT03225846|531333640|FG004|Overall Study|Adverse Event|0|||
147318931|NCT03225846|531333641|FG005|Overall Study|Adverse Event|0|||
147318932|NCT03225846|531333642|FG006|Overall Study|Adverse Event|6|||
147318933|NCT03225846|531333636|FG000|Overall Study|Withdrawal by Subject|0|||
147318934|NCT03225846|531333637|FG001|Overall Study|Withdrawal by Subject|1|||
147318935|NCT03225846|531333638|FG002|Overall Study|Withdrawal by Subject|0|||
147318936|NCT03225846|531333639|FG003|Overall Study|Withdrawal by Subject|0|||
147318937|NCT03225846|531333640|FG004|Overall Study|Withdrawal by Subject|0|||
147318938|NCT03225846|531333641|FG005|Overall Study|Withdrawal by Subject|0|||
147318939|NCT03225846|531333642|FG006|Overall Study|Withdrawal by Subject|0|||
147318940|NCT03225846|531333636|FG000|Overall Study|Death|0|||
147574590|NCT00521586|532261216|FG000|Follow-up (From 6-month[Year 0]-Year 5)|Subject request|54|||
147574591|NCT00521586|532261217|FG001|Follow-up (From 6-month[Year 0]-Year 5)|Subject request|57|||
147574592|NCT00521586|532261216|FG000|Revaccination With 13vPnC (Year 5)|Subject request|0|||
147574593|NCT00521586|532261217|FG001|Revaccination With 13vPnC (Year 5)|Subject request|1|||
147318941|NCT03225846|531333637|FG001|Overall Study|Death|1|||
147318942|NCT03225846|531333638|FG002|Overall Study|Death|0|||
147318943|NCT03225846|531333639|FG003|Overall Study|Death|0|||
147318944|NCT03225846|531333640|FG004|Overall Study|Death|0|||
147318945|NCT03225846|531333641|FG005|Overall Study|Death|0|||
147318946|NCT03225846|531333642|FG006|Overall Study|Death|0|||
147318947|NCT03225846|531333636|FG000|Overall Study|Patient did not wish to comply with IC/EC|0|||
147318948|NCT03225846|531333637|FG001|Overall Study|Patient did not wish to comply with IC/EC|0|||
147318949|NCT03225846|531333638|FG002|Overall Study|Patient did not wish to comply with IC/EC|1|||
147318950|NCT03225846|531333639|FG003|Overall Study|Patient did not wish to comply with IC/EC|0|||
147318951|NCT03225846|531333640|FG004|Overall Study|Patient did not wish to comply with IC/EC|0|||
147574594|NCT00521586|532261216|FG000|Revaccination With 13vPnC (Year 5)|Failed to return|1|||
147574595|NCT00521586|532261217|FG001|Revaccination With 13vPnC (Year 5)|Failed to return|4|||
147574596|NCT00521586|532261216|FG000|Revaccination With 13vPnC (Year 5)|Lost to Follow-up|2|||
147574597|NCT00521586|532261217|FG001|Revaccination With 13vPnC (Year 5)|Lost to Follow-up|7|||
147574598|NCT02392195|532261227|FG000|Overall Study|Lost to Follow-up|4|||
147574599|NCT02392195|532261227|FG000|Overall Study|Withdrawal by Subject|4|||
147574600|NCT00545792|532261230|FG000|Overall Study|Withdrawal by Subject|1|||
147574601|NCT01642277|532261231|FG000|Overall Study|Adverse Event|10|||
147574602|NCT01642277|532261232|FG001|Overall Study|Adverse Event|0|||
147574603|NCT01642277|532261231|FG000|Overall Study|Physician Decision|2|||
147574604|NCT01642277|532261232|FG001|Overall Study|Physician Decision|0|||
147574605|NCT01642277|532261231|FG000|Overall Study|Protocol Violation|1|||
147574606|NCT01642277|532261232|FG001|Overall Study|Protocol Violation|0|||
147574607|NCT01642277|532261231|FG000|Overall Study|Withdrawal by Subject|11|||
147574608|NCT01642277|532261232|FG001|Overall Study|Withdrawal by Subject|0|||
147574609|NCT03679598|532261233|FG000|Overall Study|Adverse Event|2|||
147574610|NCT03679598|532261234|FG001|Overall Study|Adverse Event|0|||
147574611|NCT03605342|532261235|FG000|Overall Study|Withdrawal by Subject|9|||
147574612|NCT03605342|532261236|FG001|Overall Study|Withdrawal by Subject|7|||
147574613|NCT03605342|532261235|FG000|Overall Study|Lost to Follow-up|1|||
147574614|NCT03605342|532261236|FG001|Overall Study|Lost to Follow-up|1|||
147574615|NCT01403194|532261239|FG000|Overall Study|Screen Failure|2|||
147574616|NCT01403194|532261239|FG000|Overall Study|Lost to Follow-up|8|||
147574617|NCT03428750|532261242|FG000|Overall Study|Withdrawal by Subject|11|||
147574618|NCT03428750|532261243|FG001|Overall Study|Withdrawal by Subject|10|||
147574619|NCT03428750|532261242|FG000|Overall Study|Lost to Follow-up|3|||
147574620|NCT03428750|532261243|FG001|Overall Study|Lost to Follow-up|9|||
147574621|NCT03428750|532261242|FG000|Overall Study|Adverse Event|9|||
147574622|NCT03428750|532261243|FG001|Overall Study|Adverse Event|1|||
147574623|NCT03428750|532261242|FG000|Overall Study|Protocol Violation|1|||
147574624|NCT03428750|532261243|FG001|Overall Study|Protocol Violation|0|||
147574625|NCT03428750|532261242|FG000|Overall Study|Administrative|0|||
147574626|NCT03428750|532261243|FG001|Overall Study|Administrative|1|||
147574627|NCT04474405|532261244|FG000|Overall Study|Withdrawal by Subject|0|||
147574628|NCT04474405|532261245|FG001|Overall Study|Withdrawal by Subject|0|||
147574629|NCT04474405|532261246|FG002|Overall Study|Withdrawal by Subject|1|||
147574630|NCT04474405|532261247|FG003|Overall Study|Withdrawal by Subject|0|||
147574631|NCT04474405|532261248|FG004|Overall Study|Withdrawal by Subject|1|||
147574632|NCT04474405|532261249|FG005|Overall Study|Withdrawal by Subject|0|||
147574633|NCT04474405|532261244|FG000|Overall Study|Other|0|||
147574634|NCT04474405|532261245|FG001|Overall Study|Other|0|||
147574635|NCT04474405|532261246|FG002|Overall Study|Other|0|||
147574636|NCT04474405|532261247|FG003|Overall Study|Other|0|||
147574637|NCT04474405|532261248|FG004|Overall Study|Other|3|||
147574638|NCT04474405|532261249|FG005|Overall Study|Other|0|||
147574639|NCT00918645|532261250|FG000|Overall Study|Withdrawal by Subject|1|||
147574640|NCT05133180|532261251|FG000|Overall Study|Withdrawal of consent|1|||
147574641|NCT05133180|532261252|FG001|Overall Study|Withdrawal of consent|1|||
147146363|NCT01947283|530699269|FG001|Overall Study|Missing Follow-up Assessment|2|||
147146364|NCT01947283|530699270|FG002|Overall Study|Missing Follow-up Assessment|3|||
147146365|NCT01947283|530699271|FG003|Overall Study|Missing Follow-up Assessment|0|||
147146366|NCT01947283|530699272|FG004|Overall Study|Missing Follow-up Assessment|0|||
147146367|NCT01947283|530699273|FG005|Overall Study|Missing Follow-up Assessment|2|||
147146368|NCT01947283|530699274|FG006|Overall Study|Missing Follow-up Assessment|0|||
147146369|NCT01947283|530699268|FG000|Overall Study|No patients were enrolled in study|0|||
147146370|NCT01947283|530699269|FG001|Overall Study|No patients were enrolled in study|0|||
147146371|NCT01947283|530699270|FG002|Overall Study|No patients were enrolled in study|0|||
147146372|NCT01947283|530699271|FG003|Overall Study|No patients were enrolled in study|0|||
147146373|NCT01947283|530699272|FG004|Overall Study|No patients were enrolled in study|0|||
147146374|NCT01947283|530699273|FG005|Overall Study|No patients were enrolled in study|3|||
147146375|NCT01947283|530699274|FG006|Overall Study|No patients were enrolled in study|1|||
147146376|NCT00430989|530699275|FG000|Overall Study|Lost to Follow-up|2|||
147146377|NCT00430989|530699276|FG001|Overall Study|Lost to Follow-up|3|||
147146378|NCT00430989|530699275|FG000|Overall Study|Withdrawal by Subject|15|||
147574642|NCT05133180|532261251|FG000|Overall Study|Lost to Follow-up|1|||
147574643|NCT05133180|532261252|FG001|Overall Study|Lost to Follow-up|1|||
147574644|NCT05133180|532261251|FG000|Overall Study|Documented disease progression|0|||
147574645|NCT05133180|532261252|FG001|Overall Study|Documented disease progression|1|||
147146379|NCT00430989|530699276|FG001|Overall Study|Withdrawal by Subject|14|||
147146380|NCT00430989|530699275|FG000|Overall Study|Protocol Violation|30|||
147574646|NCT01604941|532261253|FG000|Overall Study|Adverse Event|1|||
147574647|NCT01604941|532261254|FG001|Overall Study|Adverse Event|2|||
147574648|NCT01604941|532261255|FG002|Overall Study|Adverse Event|0|||
147574649|NCT01604941|532261256|FG003|Overall Study|Adverse Event|0|||
147574650|NCT01604941|532261257|FG004|Overall Study|Adverse Event|1|||
147574651|NCT01604941|532261258|FG005|Overall Study|Adverse Event|5|||
147574652|NCT01604941|532261253|FG000|Overall Study|Non-compliance|1|||
147574653|NCT01604941|532261254|FG001|Overall Study|Non-compliance|0|||
147574654|NCT01604941|532261255|FG002|Overall Study|Non-compliance|0|||
147574655|NCT01604941|532261256|FG003|Overall Study|Non-compliance|0|||
147574656|NCT01604941|532261257|FG004|Overall Study|Non-compliance|0|||
147574657|NCT01604941|532261258|FG005|Overall Study|Non-compliance|0|||
147574658|NCT01604941|532261253|FG000|Overall Study|Participant Decision|0|||
147574659|NCT01604941|532261254|FG001|Overall Study|Participant Decision|0|||
147574660|NCT01604941|532261255|FG002|Overall Study|Participant Decision|0|||
147574661|NCT01604941|532261256|FG003|Overall Study|Participant Decision|0|||
147574662|NCT01604941|532261257|FG004|Overall Study|Participant Decision|0|||
147574663|NCT01604941|532261258|FG005|Overall Study|Participant Decision|2|||
147574664|NCT01604941|532261253|FG000|Overall Study|Early Study Termination|9|||
147574665|NCT01604941|532261254|FG001|Overall Study|Early Study Termination|2|||
147574666|NCT01604941|532261255|FG002|Overall Study|Early Study Termination|3|||
147574667|NCT01604941|532261256|FG003|Overall Study|Early Study Termination|3|||
147574668|NCT01604941|532261257|FG004|Overall Study|Early Study Termination|0|||
147574669|NCT01604941|532261258|FG005|Overall Study|Early Study Termination|0|||
147574670|NCT03366792|532261259|FG000|Overall Study|Withdrawal by Subject|7|||
147574671|NCT03366792|532261259|FG000|Overall Study|Lost to Follow-up|2|||
147574672|NCT03366792|532261259|FG000|Overall Study|Ineligible (could not reach perinium)|2|||
147574673|NCT03366792|532261259|FG000|Overall Study|Study Closure (interim analysis showed no significant results)|4|||
147574674|NCT03325881|532261263|FG000|Overall Study|Protocol Violation|0|||
147574675|NCT03325881|532261264|FG001|Overall Study|Protocol Violation|1|||
147574676|NCT03325881|532261263|FG000|Overall Study|Withdrawal by Subject|0|||
147574677|NCT03325881|532261264|FG001|Overall Study|Withdrawal by Subject|2|||
147574678|NCT03325881|532261263|FG000|Overall Study|Lack of Efficacy|2|||
147574679|NCT03325881|532261264|FG001|Overall Study|Lack of Efficacy|0|||
147574680|NCT03325881|532261263|FG000|Overall Study|Not treated|1|||
147574681|NCT03325881|532261264|FG001|Overall Study|Not treated|0|||
147574682|NCT03676634|532261266|FG000|Overall Study|Red blood cell loss|1|||
147574683|NCT03676634|532261266|FG000|Overall Study|Out-of-limit pulse|2|||
147574684|NCT02213263|532261269|FG000|Overall Study|Insufficient clinical response|4|||
147574685|NCT02213263|532261270|FG001|Overall Study|Insufficient clinical response|3|||
147574686|NCT02213263|532261269|FG000|Overall Study|Lost to Follow-up|0|||
147574687|NCT02213263|532261270|FG001|Overall Study|Lost to Follow-up|1|||
147574688|NCT02213263|532261269|FG000|Overall Study|No longer willing to participate|3|||
147574689|NCT02213263|532261270|FG001|Overall Study|No longer willing to participate|4|||
147574690|NCT02213263|532261269|FG000|Overall Study|Progressive disease|20|||
147574691|NCT02213263|532261270|FG001|Overall Study|Progressive disease|14|||
147574692|NCT02213263|532261269|FG000|Overall Study|Protocol Violation|0|||
147574693|NCT02213263|532261270|FG001|Overall Study|Protocol Violation|1|||
147574694|NCT02213263|532261269|FG000|Overall Study|Adverse Event|1|||
147574695|NCT02213263|532261270|FG001|Overall Study|Adverse Event|3|||
147574696|NCT01188681|532261271|FG000|Overall Study|bladder cancer|0|||
147574697|NCT01188681|532261272|FG001|Overall Study|bladder cancer|0|||
147574698|NCT01188681|532261273|FG002|Overall Study|bladder cancer|1|||
147574699|NCT01188681|532261274|FG003|Overall Study|bladder cancer|0|||
147574700|NCT01188681|532261271|FG000|Overall Study|Withdrawal by Subject|0|||
147574701|NCT01188681|532261272|FG001|Overall Study|Withdrawal by Subject|0|||
147574702|NCT01188681|532261273|FG002|Overall Study|Withdrawal by Subject|0|||
147574703|NCT01188681|532261274|FG003|Overall Study|Withdrawal by Subject|1|||
147574704|NCT00216736|532261278|FG000|Overall Study|Lost to Follow-up|1|||
147574705|NCT00216736|532261279|FG001|Overall Study|Lost to Follow-up|1|||
147574706|NCT02890992|532261280|FG000|130 Weeks Open-Label Extension Period|Adverse Event|0|||
147574707|NCT02890992|532261281|FG001|130 Weeks Open-Label Extension Period|Adverse Event|1|||
147574708|NCT02890992|532261282|FG002|130 Weeks Open-Label Extension Period|Adverse Event|0|||
147574709|NCT02890992|532261283|FG003|130 Weeks Open-Label Extension Period|Adverse Event|0|||
147574710|NCT02890992|532261284|FG004|130 Weeks Open-Label Extension Period|Adverse Event|0|||
147574711|NCT02890992|532261285|FG005|130 Weeks Open-Label Extension Period|Adverse Event|0|||
147574712|NCT02890992|532261286|FG006|130 Weeks Open-Label Extension Period|Adverse Event|0|||
147574713|NCT02890992|532261287|FG007|130 Weeks Open-Label Extension Period|Adverse Event|0|||
147574714|NCT02890992|532261280|FG000|130 Weeks Open-Label Extension Period|Included but not treated|0|||
147652380|NCT03026283|532550247|FG003|Optimal Care/Stress Test/ICA|Withdrawal by Subject|1|||
147574715|NCT02890992|532261281|FG001|130 Weeks Open-Label Extension Period|Included but not treated|0|||
147574716|NCT02890992|532261282|FG002|130 Weeks Open-Label Extension Period|Included but not treated|0|||
147574717|NCT02890992|532261283|FG003|130 Weeks Open-Label Extension Period|Included but not treated|0|||
147574718|NCT02890992|532261284|FG004|130 Weeks Open-Label Extension Period|Included but not treated|0|||
147574719|NCT02890992|532261285|FG005|130 Weeks Open-Label Extension Period|Included but not treated|0|||
147574720|NCT02890992|532261286|FG006|130 Weeks Open-Label Extension Period|Included but not treated|1|||
147574721|NCT02890992|532261287|FG007|130 Weeks Open-Label Extension Period|Included but not treated|1|||
147652381|NCT03026283|532550248|FG004|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
147574722|NCT02890992|532261280|FG000|130 Weeks Open-Label Extension Period|Other than specified|0|||
147574723|NCT02890992|532261281|FG001|130 Weeks Open-Label Extension Period|Other than specified|2|||
147318952|NCT03225846|531333641|FG005|Overall Study|Patient did not wish to comply with IC/EC|0|||
147318953|NCT03225846|531333642|FG006|Overall Study|Patient did not wish to comply with IC/EC|0|||
147318954|NCT03225846|531333636|FG000|Overall Study|Patient decision|0|||
147318955|NCT03225846|531333637|FG001|Overall Study|Patient decision|0|||
147318956|NCT03225846|531333638|FG002|Overall Study|Patient decision|0|||
147318957|NCT03225846|531333639|FG003|Overall Study|Patient decision|0|||
147318958|NCT03225846|531333640|FG004|Overall Study|Patient decision|0|||
147318959|NCT03225846|531333641|FG005|Overall Study|Patient decision|0|||
147318960|NCT03225846|531333642|FG006|Overall Study|Patient decision|1|||
147318961|NCT04248465|531333643|FG000|Randomized-Controlled Period|Death|12|||
147318962|NCT04248465|531333644|FG001|Randomized-Controlled Period|Death|5|||
147318963|NCT04248465|531333643|FG000|Randomized-Controlled Period|Adverse Event|2|||
147318964|NCT04248465|531333644|FG001|Randomized-Controlled Period|Adverse Event|0|||
147318965|NCT04248465|531333643|FG000|Randomized-Controlled Period|Study Terminated by Sponsor|194|||
147318966|NCT04248465|531333644|FG001|Randomized-Controlled Period|Study Terminated by Sponsor|99|||
147318967|NCT04248465|531333643|FG000|Randomized-Controlled Period|Withdrawal by Subject|30|||
147318968|NCT04248465|531333644|FG001|Randomized-Controlled Period|Withdrawal by Subject|17|||
147318969|NCT04248465|531333643|FG000|Randomized-Controlled Period|Physician Decision|1|||
147318970|NCT04248465|531333644|FG001|Randomized-Controlled Period|Physician Decision|1|||
147318971|NCT04248465|531333643|FG000|Randomized-Controlled Period|Lost to Follow-up|1|||
147318972|NCT04248465|531333644|FG001|Randomized-Controlled Period|Lost to Follow-up|0|||
147318973|NCT04248465|531333643|FG000|Open-label Extension Period|Study Terminated by Sponsor|14|||
147318974|NCT04248465|531333644|FG001|Open-label Extension Period|Study Terminated by Sponsor|4|||
147318975|NCT04248465|531333643|FG000|Open-label Extension Period|Withdrawal by Subject|0|||
147318976|NCT04248465|531333644|FG001|Open-label Extension Period|Withdrawal by Subject|1|||
147318977|NCT03621982|531333645|FG000|Overall Study|Withdrawal by Subject|1|||
147318978|NCT03621982|531333646|FG001|Overall Study|Withdrawal by Subject|0|||
147318979|NCT03621982|531333647|FG002|Overall Study|Withdrawal by Subject|0|||
147318980|NCT03621982|531333648|FG003|Overall Study|Withdrawal by Subject|1|||
147318981|NCT03621982|531333649|FG004|Overall Study|Withdrawal by Subject|0|||
147318982|NCT03621982|531333650|FG005|Overall Study|Withdrawal by Subject|1|||
147318983|NCT03621982|531333651|FG006|Overall Study|Withdrawal by Subject|1|||
147318984|NCT03621982|531333652|FG007|Overall Study|Withdrawal by Subject|0|||
147318985|NCT03621982|531333653|FG008|Overall Study|Withdrawal by Subject|1|||
147318986|NCT03621982|531333654|FG009|Overall Study|Withdrawal by Subject|0|||
147318987|NCT03621982|531333655|FG010|Overall Study|Withdrawal by Subject|2|||
147318988|NCT03621982|531333656|FG011|Overall Study|Withdrawal by Subject|1|||
147318989|NCT03621982|531333657|FG012|Overall Study|Withdrawal by Subject|2|||
147318990|NCT03621982|531333658|FG013|Overall Study|Withdrawal by Subject|2|||
147318991|NCT03621982|531333645|FG000|Overall Study|Investigator/Sponsor decision|0|||
147318992|NCT03621982|531333646|FG001|Overall Study|Investigator/Sponsor decision|0|||
147318993|NCT03621982|531333647|FG002|Overall Study|Investigator/Sponsor decision|0|||
147318994|NCT03621982|531333648|FG003|Overall Study|Investigator/Sponsor decision|0|||
147318995|NCT03621982|531333649|FG004|Overall Study|Investigator/Sponsor decision|0|||
147318996|NCT03621982|531333650|FG005|Overall Study|Investigator/Sponsor decision|0|||
147318997|NCT03621982|531333651|FG006|Overall Study|Investigator/Sponsor decision|0|||
147318998|NCT03621982|531333652|FG007|Overall Study|Investigator/Sponsor decision|0|||
147318999|NCT03621982|531333653|FG008|Overall Study|Investigator/Sponsor decision|0|||
147319000|NCT03621982|531333654|FG009|Overall Study|Investigator/Sponsor decision|0|||
147319001|NCT03621982|531333655|FG010|Overall Study|Investigator/Sponsor decision|0|||
147319002|NCT03621982|531333656|FG011|Overall Study|Investigator/Sponsor decision|4|||
147319003|NCT03621982|531333657|FG012|Overall Study|Investigator/Sponsor decision|0|||
147319004|NCT03621982|531333658|FG013|Overall Study|Investigator/Sponsor decision|2|||
147319005|NCT03621982|531333645|FG000|Overall Study|Death|2|||
147319006|NCT03621982|531333646|FG001|Overall Study|Death|4|||
147319007|NCT03621982|531333647|FG002|Overall Study|Death|4|||
147319008|NCT03621982|531333648|FG003|Overall Study|Death|3|||
147319009|NCT03621982|531333649|FG004|Overall Study|Death|8|||
147319010|NCT03621982|531333650|FG005|Overall Study|Death|4|||
147319011|NCT03621982|531333651|FG006|Overall Study|Death|6|||
147319012|NCT03621982|531333652|FG007|Overall Study|Death|3|||
147319013|NCT03621982|531333653|FG008|Overall Study|Death|0|||
147319014|NCT03621982|531333654|FG009|Overall Study|Death|3|||
147319015|NCT03621982|531333655|FG010|Overall Study|Death|8|||
147319016|NCT03621982|531333656|FG011|Overall Study|Death|4|||
147445840|NCT01553188|531797461|FG003|Overall Study|Patient choice|0|||
147319017|NCT03621982|531333657|FG012|Overall Study|Death|2|||
147319018|NCT03621982|531333658|FG013|Overall Study|Death|2|||
147319019|NCT03621982|531333645|FG000|Overall Study|Lost to Follow-up|0|||
147319020|NCT03621982|531333646|FG001|Overall Study|Lost to Follow-up|0|||
147319021|NCT03621982|531333647|FG002|Overall Study|Lost to Follow-up|1|||
147319022|NCT03621982|531333648|FG003|Overall Study|Lost to Follow-up|0|||
147319023|NCT03621982|531333649|FG004|Overall Study|Lost to Follow-up|0|||
147319024|NCT03621982|531333650|FG005|Overall Study|Lost to Follow-up|0|||
147319025|NCT03621982|531333651|FG006|Overall Study|Lost to Follow-up|1|||
147146381|NCT00430989|530699276|FG001|Overall Study|Protocol Violation|37|||
147146382|NCT00430989|530699275|FG000|Overall Study|Not eligible|13|||
147146383|NCT00430989|530699276|FG001|Overall Study|Not eligible|6|||
147146384|NCT05002985|530699277|FG000|Overall Study|Withdrawal by Subject|1|||
147146385|NCT03782259|530699278|FG000|Overall Study|Lost to Follow-up|1|||
147146386|NCT03782259|530699279|FG001|Overall Study|Lost to Follow-up|1|||
147574724|NCT02890992|532261282|FG002|130 Weeks Open-Label Extension Period|Other than specified|0|||
147146387|NCT03782259|530699278|FG000|Overall Study|Moved out of state|0|||
147146388|NCT03782259|530699279|FG001|Overall Study|Moved out of state|2|||
147146389|NCT03782259|530699278|FG000|Overall Study|MRI incompatibility: Pacemaker implanted prior to subject final MRI scan|0|||
147146390|NCT03782259|530699279|FG001|Overall Study|MRI incompatibility: Pacemaker implanted prior to subject final MRI scan|1|||
147146391|NCT03782259|530699278|FG000|Overall Study|Subject discontinued intervention|1|||
147146392|NCT03782259|530699279|FG001|Overall Study|Subject discontinued intervention|0|||
147146393|NCT00603941|530699283|FG000|Overall Study|Disease progression|6|||
147146394|NCT00603941|530699284|FG001|Overall Study|Disease progression|7|||
147146395|NCT00603941|530699285|FG002|Overall Study|Disease progression|1|||
147146396|NCT00603941|530699283|FG000|Overall Study|Adverse Event|1|||
147146397|NCT00603941|530699284|FG001|Overall Study|Adverse Event|0|||
147146398|NCT00603941|530699285|FG002|Overall Study|Adverse Event|1|||
147146399|NCT00603941|530699283|FG000|Overall Study|Physician Decision|0|||
147146400|NCT00603941|530699284|FG001|Overall Study|Physician Decision|1|||
147146401|NCT00603941|530699285|FG002|Overall Study|Physician Decision|0|||
147146402|NCT00603941|530699283|FG000|Overall Study|Withdrawal by Subject|0|||
147146403|NCT00603941|530699284|FG001|Overall Study|Withdrawal by Subject|2|||
147238661|NCT00297830|531046134|FG002|6 Month Visit|Death|2|||
147238662|NCT00297830|531046132|FG000|6 Month Visit|Withdrawal by Subject|2|||
147238663|NCT00297830|531046133|FG001|6 Month Visit|Withdrawal by Subject|1|||
147238664|NCT00297830|531046134|FG002|6 Month Visit|Withdrawal by Subject|1|||
147238665|NCT00297830|531046132|FG000|6 Month Visit|Adverse Event|0|||
147238666|NCT00297830|531046133|FG001|6 Month Visit|Adverse Event|1|||
147238667|NCT00297830|531046134|FG002|6 Month Visit|Adverse Event|0|||
147238668|NCT00297830|531046132|FG000|12 Month Visit|Lost to Follow-up|1|||
147238669|NCT00297830|531046133|FG001|12 Month Visit|Lost to Follow-up|0|||
147238670|NCT00297830|531046134|FG002|12 Month Visit|Lost to Follow-up|0|||
147238671|NCT00297830|531046132|FG000|12 Month Visit|Adverse Event|0|||
147238672|NCT00297830|531046133|FG001|12 Month Visit|Adverse Event|3|||
147238673|NCT00297830|531046134|FG002|12 Month Visit|Adverse Event|0|||
147238674|NCT00297830|531046132|FG000|12 Month Visit|Withdrawal by Subject|0|||
147238675|NCT00297830|531046133|FG001|12 Month Visit|Withdrawal by Subject|3|||
147238676|NCT00297830|531046134|FG002|12 Month Visit|Withdrawal by Subject|0|||
147238677|NCT02835820|531046135|FG000|Overall Study|Baseline Screen Failure|0|||
147238678|NCT02835820|531046136|FG001|Overall Study|Baseline Screen Failure|3|||
147238679|NCT00003473|531046139|FG000|Overall Study|Three patients were not evaluable.|3|||
147238680|NCT04613375|531046143|FG000|Overall Study|Death|198|||
147238681|NCT04613375|531046143|FG000|Overall Study|Withdrawal by Subject|3|||
147238682|NCT01847274|531046144|FG000|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|22|||
147238683|NCT01847274|531046145|FG001|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|8|||
147238684|NCT01847274|531046146|FG002|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|31|||
147238685|NCT01847274|531046147|FG003|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|13|||
147238686|NCT01847274|531046148|FG004|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
147238687|NCT01847274|531046149|FG005|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
147238688|NCT01847274|531046150|FG006|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
147238689|NCT01847274|531046151|FG007|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
147238690|NCT01847274|531046152|FG008|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
147238691|NCT01847274|531046153|FG009|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
147238692|NCT01847274|531046154|FG010|Main Study (Upto 7years 7months 6 Days)|Ongoing at the time of analysis|0|||
147238693|NCT01847274|531046144|FG000|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|20|||
147238694|NCT01847274|531046145|FG001|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|11|||
147238695|NCT01847274|531046146|FG002|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|29|||
147238696|NCT01847274|531046147|FG003|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|14|||
147238697|NCT01847274|531046148|FG004|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
147319026|NCT03621982|531333652|FG007|Overall Study|Lost to Follow-up|0|||
147146404|NCT00603941|530699285|FG002|Overall Study|Withdrawal by Subject|0|||
147146405|NCT00833469|530699286|FG000|Overall Study|Withdrawal by Subject|1|||
147146406|NCT00833469|530699286|FG000|Overall Study|Lost to Follow-up|1|||
147146407|NCT01642901|530699287|FG000|12-month Follow-up|Withdrawal by Subject|1|||
147146408|NCT01642901|530699288|FG001|12-month Follow-up|Withdrawal by Subject|0|||
147238698|NCT01847274|531046149|FG005|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
147238699|NCT01847274|531046150|FG006|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
147238700|NCT01847274|531046151|FG007|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
147319027|NCT03621982|531333653|FG008|Overall Study|Lost to Follow-up|0|||
147574725|NCT02890992|532261283|FG003|130 Weeks Open-Label Extension Period|Other than specified|0|||
147574726|NCT02890992|532261284|FG004|130 Weeks Open-Label Extension Period|Other than specified|0|||
147574727|NCT02890992|532261285|FG005|130 Weeks Open-Label Extension Period|Other than specified|0|||
147574728|NCT02890992|532261286|FG006|130 Weeks Open-Label Extension Period|Other than specified|0|||
147574729|NCT02890992|532261287|FG007|130 Weeks Open-Label Extension Period|Other than specified|0|||
147574730|NCT02622386|532261288|FG000|First Assignment|Withdrawal by Subject|3|||
147574731|NCT02622386|532261289|FG001|First Assignment|Withdrawal by Subject|2|||
147574732|NCT02622386|532261288|FG000|Washout|Withdrawal by Subject|4|||
147574733|NCT02622386|532261289|FG001|Washout|Withdrawal by Subject|4|||
147574734|NCT02622386|532261288|FG000|Second Assignment|Withdrawal by Subject|0|||
147574735|NCT02622386|532261289|FG001|Second Assignment|Withdrawal by Subject|2|||
147574736|NCT03236311|532261290|FG000|Overall Study|Study terminated by sponsor|0|||
147574737|NCT03236311|532261291|FG001|Overall Study|Study terminated by sponsor|2|||
147574738|NCT03236311|532261290|FG000|Overall Study|Adverse Event|0|||
147574739|NCT03236311|532261291|FG001|Overall Study|Adverse Event|1|||
147574740|NCT00918684|532261293|FG000|Two Week Drug Washout and Placebo Phase|Placebo Reponder|16|||
147574741|NCT00918684|532261293|FG000|Treatment Phase|Lack of Efficacy|6|||
147574742|NCT00918684|532261293|FG000|Treatment Phase|Lost to Follow-up|2|||
147574743|NCT00918684|532261293|FG000|Treatment Phase|Physician Decision|8|||
147574744|NCT00918684|532261293|FG000|Treatment Phase|Protocol Violation|1|||
147574745|NCT00918684|532261293|FG000|Treatment Phase|Withdrawal by Subject|8|||
147574746|NCT01051349|532261294|FG000|Overall Study|Adverse Event|88|||
147574747|NCT01051349|532261294|FG000|Overall Study|Consent Withdrawn|54|||
147574748|NCT01051349|532261294|FG000|Overall Study|Investigator Decision|6|||
147574749|NCT01051349|532261294|FG000|Overall Study|Lost to Follow-up|6|||
147574750|NCT01051349|532261294|FG000|Overall Study|Subject non-compliance|7|||
147574751|NCT01051349|532261294|FG000|Overall Study|Reason not Specified|12|||
147574752|NCT00402103|532261295|FG000|Overall Study|Adverse Event|60|||
147574753|NCT00402103|532261296|FG001|Overall Study|Adverse Event|7|||
147574754|NCT00402103|532261295|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
147574755|NCT00402103|532261296|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
147574756|NCT00402103|532261295|FG000|Overall Study|Condition no longer requires study drug|2|||
147574757|NCT00402103|532261296|FG001|Overall Study|Condition no longer requires study drug|0|||
147574758|NCT00402103|532261295|FG000|Overall Study|Protocol Deviation|8|||
147574759|NCT00402103|532261296|FG001|Overall Study|Protocol Deviation|0|||
147574760|NCT00402103|532261295|FG000|Overall Study|Patient withdrew consent|12|||
147574761|NCT00402103|532261296|FG001|Overall Study|Patient withdrew consent|1|||
147574762|NCT00402103|532261295|FG000|Overall Study|Lost to Follow-up|6|||
147574763|NCT00402103|532261296|FG001|Overall Study|Lost to Follow-up|3|||
147574764|NCT00402103|532261295|FG000|Overall Study|Administrative problems|2|||
147574765|NCT00402103|532261296|FG001|Overall Study|Administrative problems|0|||
147574766|NCT00484679|532261297|FG000|Overall Study|Withdrawal by Subject|3|||
147574767|NCT00841542|532261298|FG000|Period 1|Adverse Event|1|||
147574768|NCT00841542|532261299|FG001|Period 1|Adverse Event|0|||
147574769|NCT00418145|532261300|FG000|Overall Study|study terminated|6|||
147574770|NCT02462837|532261301|FG000|Overall Study|pt developed hives|1|||
147574771|NCT02462837|532261302|FG001|Overall Study|pt developed hives|0|||
147574772|NCT02462837|532261301|FG000|Overall Study|Withdrawal by Subject|1|||
147574773|NCT02462837|532261302|FG001|Overall Study|Withdrawal by Subject|0|||
147574774|NCT01075282|532261306|FG000|Overall Study|Withdrawal by Subject|11|||
147574775|NCT01075282|532261307|FG001|Overall Study|Withdrawal by Subject|7|||
147574776|NCT01075282|532261308|FG002|Overall Study|Withdrawal by Subject|11|||
147574777|NCT01075282|532261306|FG000|Overall Study|Adverse Event|9|||
147574778|NCT01075282|532261307|FG001|Overall Study|Adverse Event|8|||
147574779|NCT01075282|532261308|FG002|Overall Study|Adverse Event|5|||
147574780|NCT01075282|532261306|FG000|Overall Study|Entry Criteria Not Met|3|||
147574781|NCT01075282|532261307|FG001|Overall Study|Entry Criteria Not Met|2|||
147652382|NCT03026283|532550249|FG005|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
147238701|NCT01847274|531046152|FG008|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
147238702|NCT01847274|531046153|FG009|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
147238703|NCT01847274|531046154|FG010|Main Study (Upto 7years 7months 6 Days)|Withdrawal by Subject|0|||
147238704|NCT01847274|531046144|FG000|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|7|||
147238705|NCT01847274|531046145|FG001|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|2|||
147238706|NCT01847274|531046146|FG002|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|5|||
147238707|NCT01847274|531046147|FG003|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|1|||
147238708|NCT01847274|531046148|FG004|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
147238709|NCT01847274|531046149|FG005|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
147238710|NCT01847274|531046150|FG006|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
147238711|NCT01847274|531046151|FG007|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
147238712|NCT01847274|531046152|FG008|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
147319028|NCT03621982|531333654|FG009|Overall Study|Lost to Follow-up|1|||
147574782|NCT01075282|532261308|FG002|Overall Study|Entry Criteria Not Met|0|||
147574783|NCT01075282|532261306|FG000|Overall Study|Lost to Follow-up|3|||
147574784|NCT01075282|532261307|FG001|Overall Study|Lost to Follow-up|3|||
147574785|NCT01075282|532261308|FG002|Overall Study|Lost to Follow-up|3|||
147574786|NCT01075282|532261306|FG000|Overall Study|Physician Decision|3|||
147574787|NCT01075282|532261307|FG001|Overall Study|Physician Decision|3|||
147574788|NCT01075282|532261308|FG002|Overall Study|Physician Decision|3|||
147574789|NCT01075282|532261306|FG000|Overall Study|Lack of Efficacy|1|||
147574790|NCT01075282|532261307|FG001|Overall Study|Lack of Efficacy|1|||
147574791|NCT01075282|532261308|FG002|Overall Study|Lack of Efficacy|0|||
147574792|NCT01075282|532261306|FG000|Overall Study|Treatment Non-compliance|1|||
147574793|NCT01075282|532261307|FG001|Overall Study|Treatment Non-compliance|2|||
147574794|NCT01075282|532261308|FG002|Overall Study|Treatment Non-compliance|2|||
147652383|NCT03026283|532550250|FG006|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
147652384|NCT03026283|532550251|FG007|Optimal Care/Stress Test/ICA|Withdrawal by Subject|0|||
147146409|NCT02707965|530699289|FG000|Overall Study|Withdrawal by Subject|0|||
147146410|NCT02707965|530699290|FG001|Overall Study|Withdrawal by Subject|0|||
147146411|NCT02707965|530699291|FG002|Overall Study|Withdrawal by Subject|1|||
147146412|NCT02707965|530699292|FG003|Overall Study|Withdrawal by Subject|0|||
147146413|NCT02707965|530699293|FG004|Overall Study|Withdrawal by Subject|0|||
147146414|NCT02707965|530699294|FG005|Overall Study|Withdrawal by Subject|0|||
147146415|NCT02707965|530699295|FG006|Overall Study|Withdrawal by Subject|0|||
147146416|NCT02707965|530699296|FG007|Overall Study|Withdrawal by Subject|2|||
147146417|NCT02707965|530699297|FG008|Overall Study|Withdrawal by Subject|0|||
147146418|NCT02707965|530699298|FG009|Overall Study|Withdrawal by Subject|0|||
147146419|NCT02707965|530699299|FG010|Overall Study|Withdrawal by Subject|0|||
147146420|NCT02707965|530699300|FG011|Overall Study|Withdrawal by Subject|0|||
147146421|NCT02707965|530699301|FG012|Overall Study|Withdrawal by Subject|0|||
147146422|NCT02707965|530699302|FG013|Overall Study|Withdrawal by Subject|0|||
147146423|NCT02707965|530699303|FG014|Overall Study|Withdrawal by Subject|0|||
147146424|NCT02707965|530699304|FG015|Overall Study|Withdrawal by Subject|0|||
147146425|NCT02707965|530699289|FG000|Overall Study|PI decisions|0|||
147146426|NCT02707965|530699290|FG001|Overall Study|PI decisions|0|||
147146427|NCT02707965|530699291|FG002|Overall Study|PI decisions|0|||
147146428|NCT02707965|530699292|FG003|Overall Study|PI decisions|0|||
147146429|NCT02707965|530699293|FG004|Overall Study|PI decisions|0|||
147146430|NCT02707965|530699294|FG005|Overall Study|PI decisions|0|||
147146431|NCT02707965|530699295|FG006|Overall Study|PI decisions|0|||
147146432|NCT02707965|530699296|FG007|Overall Study|PI decisions|0|||
147146433|NCT02707965|530699297|FG008|Overall Study|PI decisions|0|||
147146434|NCT02707965|530699298|FG009|Overall Study|PI decisions|0|||
147146435|NCT02707965|530699299|FG010|Overall Study|PI decisions|0|||
147146436|NCT02707965|530699300|FG011|Overall Study|PI decisions|0|||
147146437|NCT02707965|530699301|FG012|Overall Study|PI decisions|0|||
147146438|NCT02707965|530699302|FG013|Overall Study|PI decisions|0|||
147146439|NCT02707965|530699303|FG014|Overall Study|PI decisions|2|||
147146440|NCT02707965|530699304|FG015|Overall Study|PI decisions|0|||
147146441|NCT02707965|530699289|FG000|Overall Study|Protocol deviation|1|||
147319029|NCT03621982|531333655|FG010|Overall Study|Lost to Follow-up|0|||
147319030|NCT03621982|531333656|FG011|Overall Study|Lost to Follow-up|0|||
147319031|NCT03621982|531333657|FG012|Overall Study|Lost to Follow-up|0|||
147319032|NCT03621982|531333658|FG013|Overall Study|Lost to Follow-up|0|||
147319033|NCT00238420|531333659|FG000|Overall Study|Protocol Violation|1|||
147319034|NCT00238420|531333660|FG001|Overall Study|Protocol Violation|1|||
147319035|NCT00442286|531333661|FG000|Overall Study|Death|2|||
147319036|NCT00442286|531333662|FG001|Overall Study|Death|2|||
147319037|NCT00442286|531333661|FG000|Overall Study|Lost to Follow-up|1|||
147319038|NCT00442286|531333662|FG001|Overall Study|Lost to Follow-up|0|||
147319039|NCT00442286|531333661|FG000|Overall Study|Withdrawal by Subject|2|||
147319040|NCT00442286|531333662|FG001|Overall Study|Withdrawal by Subject|0|||
147319041|NCT00442286|531333661|FG000|Overall Study|System explanted|1|||
147319042|NCT00442286|531333662|FG001|Overall Study|System explanted|0|||
147319043|NCT00442286|531333661|FG000|Overall Study|Patient Injury|1|||
147319044|NCT00442286|531333662|FG001|Overall Study|Patient Injury|0|||
147319045|NCT05221749|531333665|FG000|Overall Study|Lost to Follow-up|2|||
147319046|NCT05221749|531333666|FG001|Overall Study|Lost to Follow-up|3|||
147319047|NCT04140890|531333667|FG000|Overall Study|Withdrawal by Subject|0|||
147319048|NCT04140890|531333668|FG001|Overall Study|Withdrawal by Subject|1|||
147146442|NCT02707965|530699290|FG001|Overall Study|Protocol deviation|1|||
147319049|NCT02102464|531333671|FG000|Randomized Study|Withdrawal by Subject|0|||
147146443|NCT02707965|530699291|FG002|Overall Study|Protocol deviation|0|||
147146444|NCT02707965|530699292|FG003|Overall Study|Protocol deviation|0|||
147146445|NCT02707965|530699293|FG004|Overall Study|Protocol deviation|0|||
147146446|NCT02707965|530699294|FG005|Overall Study|Protocol deviation|0|||
147319050|NCT02102464|531333672|FG001|Randomized Study|Withdrawal by Subject|1|||
147319051|NCT02102464|531333673|FG002|Randomized Study|Withdrawal by Subject|0|||
147319052|NCT02388074|531333674|FG000|Overall Study|Lost in Transit|2|||
147319053|NCT02388074|531333674|FG000|Overall Study|Sample Not Returned|1|||
147574795|NCT01075282|532261306|FG000|Overall Study|Protocol Violation|0|||
147574796|NCT01075282|532261307|FG001|Overall Study|Protocol Violation|2|||
147574797|NCT01075282|532261308|FG002|Overall Study|Protocol Violation|1|||
147146447|NCT02707965|530699295|FG006|Overall Study|Protocol deviation|0|||
147146448|NCT02707965|530699296|FG007|Overall Study|Protocol deviation|1|||
147146449|NCT02707965|530699297|FG008|Overall Study|Protocol deviation|0|||
147146450|NCT02707965|530699298|FG009|Overall Study|Protocol deviation|0|||
147146451|NCT02707965|530699299|FG010|Overall Study|Protocol deviation|0|||
147146452|NCT02707965|530699300|FG011|Overall Study|Protocol deviation|0|||
147146453|NCT02707965|530699301|FG012|Overall Study|Protocol deviation|0|||
147146454|NCT02707965|530699302|FG013|Overall Study|Protocol deviation|0|||
147146455|NCT02707965|530699303|FG014|Overall Study|Protocol deviation|0|||
147146456|NCT02707965|530699304|FG015|Overall Study|Protocol deviation|0|||
147146457|NCT02943070|530699305|FG000|Overall Study|Physician Decision|1|||
147146458|NCT02943070|530699305|FG000|Overall Study|Adverse Event|2|||
147146459|NCT02943070|530699305|FG000|Overall Study|Death|2|||
147146460|NCT02943070|530699305|FG000|Overall Study|Withdrawal by Subject|3|||
147146461|NCT02943070|530699305|FG000|Overall Study|Lost to Follow-up|4|||
147146462|NCT02943070|530699305|FG000|Overall Study|Retreatment or TURP|13|||
147146463|NCT02943070|530699305|FG000|Overall Study|Subjects exited after their 48 month visit per the Sponsor's decision to close the study.|18|||
147146464|NCT00570778|530699306|FG000|Overall Study|Protocol deviation|2|||
147146465|NCT00570778|530699307|FG001|Overall Study|Protocol deviation|1|||
147146466|NCT00570778|530699308|FG002|Overall Study|Protocol deviation|2|||
147146467|NCT00570778|530699309|FG003|Overall Study|Protocol deviation|2|||
147146468|NCT00570778|530699306|FG000|Overall Study|Adverse Event|0|||
147146469|NCT00570778|530699307|FG001|Overall Study|Adverse Event|1|||
147146470|NCT00570778|530699308|FG002|Overall Study|Adverse Event|4|||
147146471|NCT00570778|530699309|FG003|Overall Study|Adverse Event|1|||
147146472|NCT00570778|530699306|FG000|Overall Study|Subject withdrew consent|0|||
147146473|NCT00570778|530699307|FG001|Overall Study|Subject withdrew consent|1|||
147146474|NCT00570778|530699308|FG002|Overall Study|Subject withdrew consent|0|||
147146475|NCT00570778|530699309|FG003|Overall Study|Subject withdrew consent|1|||
147146476|NCT00570778|530699306|FG000|Overall Study|Abnormal test procedure|1|||
147146477|NCT00570778|530699307|FG001|Overall Study|Abnormal test procedure|0|||
147146478|NCT00570778|530699308|FG002|Overall Study|Abnormal test procedure|0|||
147146479|NCT00570778|530699309|FG003|Overall Study|Abnormal test procedure|0|||
147146480|NCT00570778|530699306|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
147146481|NCT00570778|530699307|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
147146482|NCT00570778|530699308|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
147146483|NCT00570778|530699309|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
147146484|NCT00570778|530699306|FG000|Overall Study|Lost to Follow-up|0|||
147146485|NCT00570778|530699307|FG001|Overall Study|Lost to Follow-up|0|||
147238713|NCT01847274|531046153|FG009|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
147238714|NCT01847274|531046154|FG010|Main Study (Upto 7years 7months 6 Days)|Lost to Follow-up|0|||
147238715|NCT01847274|531046144|FG000|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
147238716|NCT01847274|531046145|FG001|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
147238717|NCT01847274|531046146|FG002|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
147238718|NCT01847274|531046147|FG003|Main Study (Upto 7years 7months 6 Days)|Disease progression|2|||
147238719|NCT01847274|531046148|FG004|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
147238720|NCT01847274|531046149|FG005|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
147238721|NCT01847274|531046150|FG006|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
147238722|NCT01847274|531046151|FG007|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
147238723|NCT01847274|531046152|FG008|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
147238724|NCT01847274|531046153|FG009|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
147238725|NCT01847274|531046154|FG010|Main Study (Upto 7years 7months 6 Days)|Disease progression|0|||
147238726|NCT01847274|531046144|FG000|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|12|||
147238727|NCT01847274|531046145|FG001|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|12|||
147238728|NCT01847274|531046146|FG002|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|15|||
147238729|NCT01847274|531046147|FG003|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|14|||
147238730|NCT01847274|531046148|FG004|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
147238731|NCT01847274|531046149|FG005|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
147238732|NCT01847274|531046150|FG006|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
147238733|NCT01847274|531046151|FG007|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
147238734|NCT01847274|531046152|FG008|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
147238735|NCT01847274|531046153|FG009|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
147146486|NCT00570778|530699308|FG002|Overall Study|Lost to Follow-up|1|||
147146487|NCT00570778|530699309|FG003|Overall Study|Lost to Follow-up|0|||
147146488|NCT00570778|530699306|FG000|Overall Study|Subject no longer requires study drug|0|||
147146489|NCT00570778|530699307|FG001|Overall Study|Subject no longer requires study drug|1|||
147146490|NCT00570778|530699308|FG002|Overall Study|Subject no longer requires study drug|0|||
147146491|NCT00570778|530699309|FG003|Overall Study|Subject no longer requires study drug|0|||
147146492|NCT00711594|530699310|FG000|Overall Study|Progressive disease|2|||
147146493|NCT00711594|530699311|FG001|Overall Study|Progressive disease|2|||
147445841|NCT01553188|531797458|FG000|Overall Study|Intercurrent illness and adverse event|0|||
147445842|NCT01553188|531797459|FG001|Overall Study|Intercurrent illness and adverse event|1|||
147445843|NCT01553188|531797460|FG002|Overall Study|Intercurrent illness and adverse event|2|||
147445844|NCT01553188|531797461|FG003|Overall Study|Intercurrent illness and adverse event|0|||
147445845|NCT01378104|531797467|FG000|Overall Study|Adverse Event|8|||
147445846|NCT01378104|531797468|FG001|Overall Study|Adverse Event|8|||
147445847|NCT01378104|531797467|FG000|Overall Study|Lack of Efficacy|7|||
147445848|NCT01378104|531797468|FG001|Overall Study|Lack of Efficacy|5|||
147445849|NCT01378104|531797467|FG000|Overall Study|Withdrawal by Subject|12|||
147445850|NCT01378104|531797468|FG001|Overall Study|Withdrawal by Subject|13|||
147445851|NCT00455013|531797469|FG000|Short Term Period|Adverse Event|2|||
147445852|NCT00455013|531797470|FG001|Short Term Period|Adverse Event|5|||
147445853|NCT00455013|531797471|FG002|Short Term Period|Adverse Event|0|||
147445854|NCT00455013|531797469|FG000|Short Term Period|Withdrawal by Subject|0|||
147445855|NCT00455013|531797470|FG001|Short Term Period|Withdrawal by Subject|0|||
147445856|NCT00455013|531797471|FG002|Short Term Period|Withdrawal by Subject|1|||
147445857|NCT00455013|531797469|FG000|Short Term Period|Lack of Efficacy|4|||
147445858|NCT00455013|531797470|FG001|Short Term Period|Lack of Efficacy|0|||
147445859|NCT00455013|531797471|FG002|Short Term Period|Lack of Efficacy|0|||
147445860|NCT00455013|531797469|FG000|Short Term Period|Other|0|||
147445861|NCT00455013|531797470|FG001|Short Term Period|Other|0|||
147445862|NCT00455013|531797471|FG002|Short Term Period|Other|1|||
147445863|NCT00455013|531797469|FG000|Long Term Extension (LTE)|Adverse Event|0|||
147445864|NCT00455013|531797470|FG001|Long Term Extension (LTE)|Adverse Event|1|||
147445865|NCT00455013|531797471|FG002|Long Term Extension (LTE)|Adverse Event|1|||
147574798|NCT01075282|532261306|FG000|Overall Study|Death|0|||
147574799|NCT01075282|532261307|FG001|Overall Study|Death|1|||
147146494|NCT00711594|530699312|FG002|Overall Study|Progressive disease|6|||
147146495|NCT00711594|530699313|FG003|Overall Study|Progressive disease|44|||
147146496|NCT00711594|530699310|FG000|Overall Study|Other Adverse Event|1|||
147146497|NCT00711594|530699311|FG001|Overall Study|Other Adverse Event|0|||
147146498|NCT00711594|530699312|FG002|Overall Study|Other Adverse Event|0|||
147146499|NCT00711594|530699313|FG003|Overall Study|Other Adverse Event|16|||
147146500|NCT00711594|530699310|FG000|Overall Study|Withdrawal by Subject|0|||
147146501|NCT00711594|530699311|FG001|Overall Study|Withdrawal by Subject|1|||
147574800|NCT01075282|532261308|FG002|Overall Study|Death|2|||
147146502|NCT00711594|530699312|FG002|Overall Study|Withdrawal by Subject|0|||
147146503|NCT00711594|530699313|FG003|Overall Study|Withdrawal by Subject|2|||
147146504|NCT01014767|530699314|FG000|Overall Study|PI left institution, data unavailable|12|||
147146505|NCT01014767|530699315|FG001|Overall Study|PI left institution, data unavailable|1|||
147146506|NCT01014767|530699316|FG002|Overall Study|PI left institution, data unavailable|4|||
147146507|NCT01014767|530699317|FG003|Overall Study|PI left institution, data unavailable|1|||
147146508|NCT00131352|530699321|FG000|Initial Treatment Period|Adverse Event|1|||
147146509|NCT00131352|530699322|FG001|Initial Treatment Period|Adverse Event|3|||
147146510|NCT00131352|530699321|FG000|Initial Treatment Period|Non-compliant|1|||
147146511|NCT00131352|530699322|FG001|Initial Treatment Period|Non-compliant|2|||
147146512|NCT00131352|530699321|FG000|Initial Treatment Period|Withdrawal by Subject|1|||
147146513|NCT00131352|530699322|FG001|Initial Treatment Period|Withdrawal by Subject|1|||
147146514|NCT00131352|530699321|FG000|Initial Treatment Period|Lack of Efficacy|6|||
147146515|NCT00131352|530699322|FG001|Initial Treatment Period|Lack of Efficacy|4|||
147146516|NCT00131352|530699321|FG000|Initial Treatment Period|Other|0|||
147146517|NCT00131352|530699322|FG001|Initial Treatment Period|Other|2|||
147146518|NCT00131352|530699321|FG000|Repeat Treatment Period|Adverse Event|1|||
147146519|NCT00131352|530699322|FG001|Repeat Treatment Period|Adverse Event|0|||
147146520|NCT00131352|530699321|FG000|Repeat Treatment Period|Other|1|||
147146521|NCT00131352|530699322|FG001|Repeat Treatment Period|Other|0|||
147146522|NCT02443337|530699325|FG000|Overall Study|Adverse Event|0|||
147146523|NCT02443337|530699326|FG001|Overall Study|Adverse Event|1|||
147146524|NCT02443337|530699325|FG000|Overall Study|Clinical Progressive Disease|3|||
147146525|NCT02443337|530699326|FG001|Overall Study|Clinical Progressive Disease|0|||
147146526|NCT02443337|530699325|FG000|Overall Study|Withdrawal by Subject|2|||
147146527|NCT02443337|530699326|FG001|Overall Study|Withdrawal by Subject|1|||
147146528|NCT02096952|530699327|FG000|Overall Study|Adverse Event|1|||
147146529|NCT00988052|530699329|FG000|Overall Study|Missing|1|||
147146530|NCT00988052|530699330|FG001|Overall Study|Missing|0|||
147146531|NCT00988052|530699329|FG000|Overall Study|Teva requested subject withdrawal|3|||
147146532|NCT00988052|530699330|FG001|Overall Study|Teva requested subject withdrawal|1|||
147146533|NCT00988052|530699329|FG000|Overall Study|Death|1|||
147146534|NCT00988052|530699330|FG001|Overall Study|Death|3|||
147146535|NCT00988052|530699329|FG000|Overall Study|Protocol Violation|6|||
147445866|NCT00455013|531797469|FG000|Long Term Extension (LTE)|Withdrawal by Subject|1|||
147445867|NCT00455013|531797470|FG001|Long Term Extension (LTE)|Withdrawal by Subject|0|||
147445868|NCT00455013|531797471|FG002|Long Term Extension (LTE)|Withdrawal by Subject|1|||
147445869|NCT00455013|531797469|FG000|Long Term Extension (LTE)|Death|1|||
147574801|NCT02679729|532261309|FG000|Overall Study|Lost to Follow-up|0|||
147574802|NCT02679729|532261310|FG001|Overall Study|Lost to Follow-up|1|||
147574803|NCT02679729|532261311|FG002|Overall Study|Lost to Follow-up|0|||
147238736|NCT01847274|531046154|FG010|Main Study (Upto 7years 7months 6 Days)|Subject unblinded by sponsor|0|||
147238737|NCT01847274|531046144|FG000|Main Study (Upto 7years 7months 6 Days)|Death|72|||
147238738|NCT01847274|531046145|FG001|Main Study (Upto 7years 7months 6 Days)|Death|29|||
147238739|NCT01847274|531046146|FG002|Main Study (Upto 7years 7months 6 Days)|Death|146|||
147238740|NCT01847274|531046147|FG003|Main Study (Upto 7years 7months 6 Days)|Death|68|||
147238741|NCT01847274|531046148|FG004|Main Study (Upto 7years 7months 6 Days)|Death|0|||
147238742|NCT01847274|531046149|FG005|Main Study (Upto 7years 7months 6 Days)|Death|0|||
147238743|NCT01847274|531046150|FG006|Main Study (Upto 7years 7months 6 Days)|Death|0|||
147238744|NCT01847274|531046151|FG007|Main Study (Upto 7years 7months 6 Days)|Death|0|||
147238745|NCT01847274|531046152|FG008|Main Study (Upto 7years 7months 6 Days)|Death|0|||
147238746|NCT01847274|531046153|FG009|Main Study (Upto 7years 7months 6 Days)|Death|0|||
147238747|NCT01847274|531046154|FG010|Main Study (Upto 7years 7months 6 Days)|Death|0|||
147238748|NCT01847274|531046144|FG000|Main Study (Upto 7years 7months 6 Days)|Other reasons|5|||
147238749|NCT01847274|531046145|FG001|Main Study (Upto 7years 7months 6 Days)|Other reasons|3|||
147238750|NCT01847274|531046146|FG002|Main Study (Upto 7years 7months 6 Days)|Other reasons|8|||
147238751|NCT01847274|531046147|FG003|Main Study (Upto 7years 7months 6 Days)|Other reasons|4|||
147238752|NCT01847274|531046148|FG004|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
147238753|NCT01847274|531046149|FG005|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
147238754|NCT01847274|531046150|FG006|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
147238755|NCT01847274|531046151|FG007|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
147238756|NCT01847274|531046152|FG008|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
147238757|NCT01847274|531046153|FG009|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
147238758|NCT01847274|531046154|FG010|Main Study (Upto 7years 7months 6 Days)|Other reasons|0|||
147238759|NCT01847274|531046144|FG000|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
147238760|NCT01847274|531046145|FG001|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
147238761|NCT01847274|531046146|FG002|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
147238762|NCT01847274|531046147|FG003|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
147238763|NCT01847274|531046148|FG004|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
147238764|NCT01847274|531046149|FG005|FE Sub-study, Period1 (Day1)|Adverse Event|1|||
147238765|NCT01847274|531046150|FG006|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
147238766|NCT01847274|531046151|FG007|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
147238767|NCT01847274|531046152|FG008|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
147238768|NCT01847274|531046153|FG009|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
147238769|NCT01847274|531046154|FG010|FE Sub-study, Period1 (Day1)|Adverse Event|0|||
147238770|NCT01847274|531046144|FG000|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
147238771|NCT01847274|531046145|FG001|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
147238772|NCT01847274|531046146|FG002|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
147238773|NCT01847274|531046147|FG003|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
147238774|NCT01847274|531046148|FG004|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|1|||
147238775|NCT01847274|531046149|FG005|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
147238776|NCT01847274|531046150|FG006|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
147238777|NCT01847274|531046151|FG007|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
147238778|NCT01847274|531046152|FG008|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
147238779|NCT01847274|531046153|FG009|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
147238780|NCT01847274|531046154|FG010|FE Sub-study, Washout 1 (Up to Day 7)|Transferred to Other Arm/Group|0|||
147238781|NCT01847274|531046144|FG000|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
147238782|NCT01847274|531046145|FG001|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
147238783|NCT01847274|531046146|FG002|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
147238784|NCT01847274|531046147|FG003|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
147238785|NCT01847274|531046148|FG004|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
147238786|NCT01847274|531046149|FG005|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
147238787|NCT01847274|531046150|FG006|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|4|||
147238788|NCT01847274|531046151|FG007|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
147238789|NCT01847274|531046152|FG008|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
147238790|NCT01847274|531046153|FG009|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
147238791|NCT01847274|531046154|FG010|QTcSub-study(Upto 5 Year,10 Month,22day)|Withdrawal by Subject|0|||
147238792|NCT01847274|531046144|FG000|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
147238793|NCT01847274|531046145|FG001|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
147238794|NCT01847274|531046146|FG002|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
147238795|NCT01847274|531046147|FG003|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
147238796|NCT01847274|531046148|FG004|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
147238797|NCT01847274|531046149|FG005|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
147238798|NCT01847274|531046150|FG006|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|5|||
147238799|NCT01847274|531046151|FG007|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
147238800|NCT01847274|531046152|FG008|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
147319054|NCT01778062|531333677|FG000|Overall Study|Adverse Event|1|||
147319055|NCT01778062|531333678|FG001|Overall Study|Adverse Event|3|||
147574804|NCT02679729|532261312|FG003|Overall Study|Lost to Follow-up|0|||
147146536|NCT00988052|530699330|FG001|Overall Study|Protocol Violation|5|||
147146537|NCT00988052|530699329|FG000|Overall Study|Pregnancy|6|||
147146538|NCT00988052|530699330|FG001|Overall Study|Pregnancy|6|||
147146539|NCT00988052|530699329|FG000|Overall Study|Lack of Efficacy|8|||
147146540|NCT00988052|530699330|FG001|Overall Study|Lack of Efficacy|7|||
147146541|NCT00988052|530699329|FG000|Overall Study|Lost to Follow-up|6|||
147146542|NCT00988052|530699330|FG001|Overall Study|Lost to Follow-up|11|||
147146543|NCT00988052|530699329|FG000|Overall Study|Physician Decision|27|||
147146544|NCT00988052|530699330|FG001|Overall Study|Physician Decision|28|||
147146545|NCT00988052|530699329|FG000|Overall Study|Adverse Event|35|||
147146546|NCT00988052|530699330|FG001|Overall Study|Adverse Event|28|||
147146547|NCT00988052|530699329|FG000|Overall Study|Withdrawal by Subject|90|||
147146548|NCT00988052|530699330|FG001|Overall Study|Withdrawal by Subject|91|||
147146549|NCT00988052|530699329|FG000|Overall Study|Study terminated by sponsor|240|||
147146550|NCT00988052|530699330|FG001|Overall Study|Study terminated by sponsor|236|||
147146551|NCT02446769|530699332|FG000|Screening Period|Screen Failure|11|||
147146552|NCT02446769|530699333|FG001|Screening Period|Screen Failure|0|||
147146553|NCT02446769|530699334|FG002|Screening Period|Screen Failure|0|||
147146554|NCT02446769|530699332|FG000|Study Period|Randomized in Error|0|||
147146555|NCT02446769|530699333|FG001|Study Period|Randomized in Error|2|||
147146556|NCT02446769|530699334|FG002|Study Period|Randomized in Error|0|||
147146557|NCT04482439|530699335|FG000|Overall Study|Lost to Follow-up|1|||
147146558|NCT04482439|530699335|FG000|Overall Study|Unrelated illness|1|||
147146559|NCT03072043|530699338|FG000|Overall Study|Death|0|||
147146560|NCT03072043|530699339|FG001|Overall Study|Death|0|||
147146561|NCT03072043|530699340|FG002|Overall Study|Death|3|||
147146562|NCT03072043|530699338|FG000|Overall Study|Adverse Event|0|||
147146563|NCT03072043|530699339|FG001|Overall Study|Adverse Event|0|||
147146564|NCT03072043|530699340|FG002|Overall Study|Adverse Event|2|||
147146565|NCT03072043|530699338|FG000|Overall Study|Withdrawal by Subject|0|||
147146566|NCT03072043|530699339|FG001|Overall Study|Withdrawal by Subject|0|||
147319056|NCT01778062|531333677|FG000|Overall Study|Consent Withdrawal|1|||
147574805|NCT02679729|532261313|FG004|Overall Study|Lost to Follow-up|1|||
147574806|NCT02679729|532261314|FG005|Overall Study|Lost to Follow-up|0|||
147574807|NCT02679729|532261315|FG006|Overall Study|Lost to Follow-up|0|||
147574808|NCT02679729|532261316|FG007|Overall Study|Lost to Follow-up|0|||
147574809|NCT02679729|532261317|FG008|Overall Study|Lost to Follow-up|0|||
147574810|NCT02679729|532261309|FG000|Overall Study|Participant decision|0|||
147574811|NCT02679729|532261310|FG001|Overall Study|Participant decision|1|||
147574812|NCT02679729|532261311|FG002|Overall Study|Participant decision|0|||
147574813|NCT02679729|532261312|FG003|Overall Study|Participant decision|0|||
147574814|NCT02679729|532261313|FG004|Overall Study|Participant decision|0|||
147574815|NCT02679729|532261314|FG005|Overall Study|Participant decision|0|||
147574816|NCT02679729|532261315|FG006|Overall Study|Participant decision|1|||
147574817|NCT02679729|532261316|FG007|Overall Study|Participant decision|0|||
147574818|NCT02679729|532261317|FG008|Overall Study|Participant decision|0|||
147574819|NCT00906399|532261335|FG000|Year 1|Randomized But Not Treated|0|||
147574820|NCT00906399|532261336|FG001|Year 1|Randomized But Not Treated|1|||
147574821|NCT00906399|532261337|FG002|Year 1|Randomized But Not Treated|3|||
147574822|NCT00906399|532261338|FG003|Year 1|Randomized But Not Treated|0|||
147574823|NCT00906399|532261339|FG004|Year 1|Randomized But Not Treated|0|||
147574824|NCT00906399|532261340|FG005|Year 1|Randomized But Not Treated|0|||
147574825|NCT00906399|532261341|FG006|Year 1|Randomized But Not Treated|0|||
147574826|NCT00906399|532261335|FG000|Year 1|Adverse Event|4|||
147574827|NCT00906399|532261336|FG001|Year 1|Adverse Event|22|||
147574828|NCT00906399|532261337|FG002|Year 1|Adverse Event|24|||
147574829|NCT00906399|532261338|FG003|Year 1|Adverse Event|0|||
147574830|NCT00906399|532261339|FG004|Year 1|Adverse Event|0|||
147574831|NCT00906399|532261340|FG005|Year 1|Adverse Event|0|||
147574832|NCT00906399|532261341|FG006|Year 1|Adverse Event|0|||
147574833|NCT00906399|532261335|FG000|Year 1|Lost to Follow-up|4|||
147574834|NCT00906399|532261336|FG001|Year 1|Lost to Follow-up|4|||
147574835|NCT00906399|532261337|FG002|Year 1|Lost to Follow-up|2|||
147146567|NCT03072043|530699340|FG002|Overall Study|Withdrawal by Subject|4|||
147146568|NCT01277822|530699341|FG000|Overall Study|Adverse Event|2|||
147146569|NCT01277822|530699342|FG001|Overall Study|Adverse Event|1|||
147146570|NCT01277822|530699341|FG000|Overall Study|Withdrawal by Subject|6|||
147146571|NCT01277822|530699342|FG001|Overall Study|Withdrawal by Subject|7|||
147574836|NCT00906399|532261338|FG003|Year 1|Lost to Follow-up|0|||
147574837|NCT00906399|532261339|FG004|Year 1|Lost to Follow-up|0|||
147574838|NCT00906399|532261340|FG005|Year 1|Lost to Follow-up|0|||
147574839|NCT00906399|532261341|FG006|Year 1|Lost to Follow-up|0|||
147574840|NCT00906399|532261335|FG000|Year 1|Withdrawal by Subject|30|||
147574841|NCT00906399|532261336|FG001|Year 1|Withdrawal by Subject|32|||
147574842|NCT00906399|532261337|FG002|Year 1|Withdrawal by Subject|36|||
147574843|NCT00906399|532261338|FG003|Year 1|Withdrawal by Subject|0|||
147574844|NCT00906399|532261339|FG004|Year 1|Withdrawal by Subject|0|||
147574845|NCT00906399|532261340|FG005|Year 1|Withdrawal by Subject|0|||
147574846|NCT00906399|532261341|FG006|Year 1|Withdrawal by Subject|0|||
147574847|NCT00906399|532261335|FG000|Year 1|Physician Decision|0|||
147574848|NCT00906399|532261336|FG001|Year 1|Physician Decision|1|||
147574849|NCT00906399|532261337|FG002|Year 1|Physician Decision|3|||
147146572|NCT01277822|530699341|FG000|Overall Study|Physician Decision|1|||
147146573|NCT01277822|530699342|FG001|Overall Study|Physician Decision|1|||
147146574|NCT01277822|530699341|FG000|Overall Study|Protocol Violation|1|||
147146575|NCT01277822|530699342|FG001|Overall Study|Protocol Violation|0|||
147146576|NCT01277822|530699341|FG000|Overall Study|Lost to Follow-up|2|||
147146577|NCT01277822|530699342|FG001|Overall Study|Lost to Follow-up|1|||
147146578|NCT01277822|530699341|FG000|Overall Study|Contraindicated medication used|2|||
147146579|NCT01277822|530699342|FG001|Overall Study|Contraindicated medication used|1|||
147146580|NCT01277822|530699341|FG000|Overall Study|Participant moved|1|||
147146581|NCT01277822|530699342|FG001|Overall Study|Participant moved|0|||
147146582|NCT02923531|530699343|FG000|Overall Study|Adverse Event|4|||
147146583|NCT02923531|530699343|FG000|Overall Study|Clinical Deterioration|1|||
147146584|NCT02923531|530699343|FG000|Overall Study|Disease Progression|3|||
147146585|NCT02923531|530699343|FG000|Overall Study|Study Termination|1|||
147146586|NCT00997984|530699344|FG000|Overall Study|Adverse Event|1|||
147146587|NCT00997984|530699345|FG001|Overall Study|Adverse Event|8|||
147146588|NCT00997984|530699346|FG002|Overall Study|Adverse Event|8|||
147146589|NCT00997984|530699344|FG000|Overall Study|Protocol Violation|1|||
147146590|NCT00997984|530699345|FG001|Overall Study|Protocol Violation|3|||
147146591|NCT00997984|530699346|FG002|Overall Study|Protocol Violation|0|||
147146592|NCT00997984|530699344|FG000|Overall Study|Withdrawal by Subject|6|||
147146593|NCT00997984|530699345|FG001|Overall Study|Withdrawal by Subject|9|||
147146594|NCT00997984|530699346|FG002|Overall Study|Withdrawal by Subject|5|||
147146595|NCT00997984|530699344|FG000|Overall Study|Lost to Follow-up|8|||
147146596|NCT00997984|530699345|FG001|Overall Study|Lost to Follow-up|5|||
147146597|NCT00997984|530699346|FG002|Overall Study|Lost to Follow-up|4|||
147146598|NCT00997984|530699344|FG000|Overall Study|Lack of Efficacy|20|||
147146599|NCT00997984|530699345|FG001|Overall Study|Lack of Efficacy|6|||
147146600|NCT00997984|530699346|FG002|Overall Study|Lack of Efficacy|3|||
147146601|NCT00997984|530699344|FG000|Overall Study|Met exclusion criteria|1|||
147146602|NCT00997984|530699345|FG001|Overall Study|Met exclusion criteria|0|||
147146603|NCT00997984|530699346|FG002|Overall Study|Met exclusion criteria|0|||
147146604|NCT00997984|530699344|FG000|Overall Study|non-compliance|0|||
147146605|NCT00997984|530699345|FG001|Overall Study|non-compliance|2|||
147146606|NCT00997984|530699346|FG002|Overall Study|non-compliance|3|||
147146607|NCT00997984|530699344|FG000|Overall Study|Wrong medication dispensed|0|||
147146608|NCT00997984|530699345|FG001|Overall Study|Wrong medication dispensed|1|||
147319057|NCT01778062|531333678|FG001|Overall Study|Consent Withdrawal|5|||
147319058|NCT01778062|531333677|FG000|Overall Study|major protocol deviation|4|||
147319059|NCT01778062|531333678|FG001|Overall Study|major protocol deviation|3|||
147319060|NCT04039503|531333679|FG000|Overall Study|Adverse Event|3|||
147319061|NCT04039503|531333680|FG001|Overall Study|Adverse Event|0|||
147319062|NCT04039503|531333681|FG002|Overall Study|Adverse Event|2|||
147319063|NCT04039503|531333682|FG003|Overall Study|Adverse Event|0|||
147319064|NCT04039503|531333679|FG000|Overall Study|Lost to Follow-up|0|||
147146609|NCT00997984|530699346|FG002|Overall Study|Wrong medication dispensed|0|||
147146610|NCT00997984|530699344|FG000|Overall Study|Suicidal ideation|0|||
147574850|NCT00906399|532261338|FG003|Year 1|Physician Decision|0|||
147574851|NCT00906399|532261339|FG004|Year 1|Physician Decision|0|||
147146611|NCT00997984|530699345|FG001|Overall Study|Suicidal ideation|0|||
147146612|NCT00997984|530699346|FG002|Overall Study|Suicidal ideation|1|||
147146613|NCT00997984|530699344|FG000|Overall Study|Work schedule|0|||
147146614|NCT00997984|530699345|FG001|Overall Study|Work schedule|0|||
147146615|NCT00997984|530699346|FG002|Overall Study|Work schedule|2|||
147146616|NCT02997865|530699348|FG000|Overall Study|Death|2|||
147319065|NCT04039503|531333680|FG001|Overall Study|Lost to Follow-up|0|||
147319066|NCT04039503|531333681|FG002|Overall Study|Lost to Follow-up|1|||
147146617|NCT02997865|530699349|FG001|Overall Study|Death|1|||
147146618|NCT02997865|530699348|FG000|Overall Study|Lost to Follow-up|6|||
147146619|NCT02997865|530699349|FG001|Overall Study|Lost to Follow-up|3|||
147146620|NCT02997865|530699348|FG000|Overall Study|Withdrawal by Subject|5|||
147146621|NCT02997865|530699349|FG001|Overall Study|Withdrawal by Subject|0|||
147146622|NCT00295646|530699356|FG000|Overall Study|Protocol Violation|18|||
147146623|NCT00295646|530699357|FG001|Overall Study|Protocol Violation|20|||
147319067|NCT04039503|531333682|FG003|Overall Study|Lost to Follow-up|0|||
147146624|NCT00295646|530699358|FG002|Overall Study|Protocol Violation|20|||
147146625|NCT00295646|530699359|FG003|Overall Study|Protocol Violation|18|||
147146626|NCT00295646|530699356|FG000|Overall Study|Withdrawal by Subject|8|||
147146627|NCT00295646|530699357|FG001|Overall Study|Withdrawal by Subject|9|||
147146628|NCT00295646|530699358|FG002|Overall Study|Withdrawal by Subject|11|||
147146629|NCT00295646|530699359|FG003|Overall Study|Withdrawal by Subject|14|||
147319068|NCT04039503|531333679|FG000|Overall Study|Protocol Violation|0|||
147146630|NCT00295646|530699356|FG000|Overall Study|Lost to Follow-up|0|||
147319069|NCT04039503|531333680|FG001|Overall Study|Protocol Violation|1|||
147574852|NCT00906399|532261340|FG005|Year 1|Physician Decision|0|||
147574853|NCT00906399|532261341|FG006|Year 1|Physician Decision|0|||
147146631|NCT00295646|530699357|FG001|Overall Study|Lost to Follow-up|5|||
147146632|NCT00295646|530699358|FG002|Overall Study|Lost to Follow-up|1|||
147146633|NCT00295646|530699359|FG003|Overall Study|Lost to Follow-up|5|||
147146634|NCT00295646|530699356|FG000|Overall Study|Death|9|||
147146635|NCT00295646|530699357|FG001|Overall Study|Death|7|||
147146636|NCT00295646|530699358|FG002|Overall Study|Death|18|||
147146637|NCT00295646|530699359|FG003|Overall Study|Death|8|||
147146638|NCT02243371|530699360|FG000|Overall Study|Progressive Disease (clinic & radio)|35|||
147146639|NCT02243371|530699361|FG001|Overall Study|Progressive Disease (clinic & radio)|24|||
147146640|NCT02243371|530699360|FG000|Overall Study|Death (unrelated)|2|||
147146641|NCT02243371|530699361|FG001|Overall Study|Death (unrelated)|4|||
147146642|NCT02243371|530699360|FG000|Overall Study|Adverse Event (unrelated)|0|||
147146643|NCT02243371|530699361|FG001|Overall Study|Adverse Event (unrelated)|1|||
147146644|NCT02243371|530699360|FG000|Overall Study|Lack of Clinical Benefit|0|||
147146645|NCT02243371|530699361|FG001|Overall Study|Lack of Clinical Benefit|1|||
147146646|NCT02243371|530699360|FG000|Overall Study|Withdrawal by Subject|0|||
147146647|NCT02243371|530699361|FG001|Overall Study|Withdrawal by Subject|2|||
147146648|NCT01945996|530699363|FG000|Overall Study|Lost to Follow-up|3|||
147146649|NCT01945996|530699364|FG001|Overall Study|Lost to Follow-up|5|||
147146650|NCT00271856|530699365|FG000|Overall Study|Withdrawal by Subject|1|||
147146651|NCT00271856|530699366|FG001|Overall Study|Withdrawal by Subject|7|||
147146652|NCT00271856|530699365|FG000|Overall Study|Lost to Follow-up|10|||
147146653|NCT00271856|530699366|FG001|Overall Study|Lost to Follow-up|11|||
147146654|NCT04677543|530699367|FG000|Overall Study|Withdrawal by Subject|4|||
147146655|NCT04677543|530699368|FG001|Overall Study|Withdrawal by Subject|1|||
147146656|NCT04677543|530699367|FG000|Overall Study|Physician Decision|0|||
147146657|NCT04677543|530699368|FG001|Overall Study|Physician Decision|1|||
147146658|NCT04677543|530699367|FG000|Overall Study|Adverse Event|0|||
147146659|NCT04677543|530699368|FG001|Overall Study|Adverse Event|1|||
147146660|NCT00854724|530700912|FG000|First Intervention|Withdrawal by Subject|1|||
147146661|NCT00854724|530700913|FG001|First Intervention|Withdrawal by Subject|1|||
147146662|NCT00854724|530700912|FG000|Washout|Protocol Violation|1|||
147146663|NCT00854724|530700913|FG001|Washout|Protocol Violation|0|||
147146664|NCT00854724|530700912|FG000|Washout|Withdrawal by Subject|0|||
147146665|NCT00854724|530700913|FG001|Washout|Withdrawal by Subject|1|||
147146666|NCT00854724|530700912|FG000|Second Intervention|Protocol Violation|1|||
147146667|NCT00854724|530700913|FG001|Second Intervention|Protocol Violation|0|||
147146668|NCT00854724|530700912|FG000|Second Intervention|Physician Decision|0|||
147146669|NCT00854724|530700913|FG001|Second Intervention|Physician Decision|1|||
147146670|NCT01498692|530700922|FG000|Overall Study|Death|4|||
147146671|NCT01498692|530700922|FG000|Overall Study|Withdrawal by Subject|1|||
147146672|NCT01498692|530700922|FG000|Overall Study|Missed 12-month visit|3|||
147146673|NCT04729972|530700923|FG000|Overall Study|Adverse Event|1|||
147146674|NCT00590122|530700924|FG000|Overall Study|swallowed oral dissolving dose|1|||
147146675|NCT00590122|530700925|FG001|Overall Study|swallowed oral dissolving dose|0|||
147146676|NCT01208324|530700926|FG000|Post-randomization of Patch|Withdrawal by Subject|1|||
147146677|NCT01208324|530700927|FG001|Post-randomization of Patch|Withdrawal by Subject|0|||
147146678|NCT01208324|530700928|FG002|Post-randomization of Patch|Withdrawal by Subject|0|||
147146679|NCT01208324|530700929|FG003|Post-randomization of Patch|Withdrawal by Subject|0|||
147146680|NCT01701362|530700930|FG000|Overall Study|Adverse events not related to study drug|1|||
147146681|NCT01701362|530700931|FG001|Overall Study|Adverse events not related to study drug|6|||
147146682|NCT01701362|530700930|FG000|Overall Study|Adverse events related to study drug|12|||
147146683|NCT01701362|530700931|FG001|Overall Study|Adverse events related to study drug|10|||
147146684|NCT01701362|530700930|FG000|Overall Study|Protocol Violation|5|||
147146685|NCT01701362|530700931|FG001|Overall Study|Protocol Violation|3|||
147146686|NCT01701362|530700930|FG000|Overall Study|No longer willing to participate|8|||
147146687|NCT01701362|530700931|FG001|Overall Study|No longer willing to participate|14|||
147146688|NCT01701362|530700930|FG000|Overall Study|Lost to Follow-up|6|||
147146689|NCT01701362|530700931|FG001|Overall Study|Lost to Follow-up|9|||
147146690|NCT01701362|530700930|FG000|Overall Study|Insufficient clinical response|6|||
147146691|NCT01701362|530700931|FG001|Overall Study|Insufficient clinical response|6|||
147146692|NCT01701362|530700930|FG000|Overall Study|Death|0|||
147146693|NCT01701362|530700931|FG001|Overall Study|Death|1|||
147319070|NCT04039503|531333681|FG002|Overall Study|Protocol Violation|2|||
147319071|NCT04039503|531333682|FG003|Overall Study|Protocol Violation|1|||
147319072|NCT04039503|531333679|FG000|Overall Study|Withdrawal by Subject|4|||
147146694|NCT01701362|530700930|FG000|Overall Study|Randomized but not treated|1|||
147146695|NCT01701362|530700931|FG001|Overall Study|Randomized but not treated|2|||
147146696|NCT01701362|530700930|FG000|Overall Study|Reasons other than those mentioned above|3|||
147146697|NCT01701362|530700931|FG001|Overall Study|Reasons other than those mentioned above|5|||
147146698|NCT00249808|530700932|FG000|Overall Study|Other|27|||
147146699|NCT00249808|530700932|FG000|Overall Study|Protocol Violation|3|||
147146700|NCT00249808|530700932|FG000|Overall Study|Lost to Follow-up|8|||
147146701|NCT00249808|530700932|FG000|Overall Study|Adverse Event|81|||
147146702|NCT00249808|530700932|FG000|Overall Study|Lack of Efficacy|52|||
147319073|NCT04039503|531333680|FG001|Overall Study|Withdrawal by Subject|3|||
147445870|NCT00455013|531797470|FG001|Long Term Extension (LTE)|Death|1|||
147146703|NCT00249808|530700932|FG000|Overall Study|Did Not Provide Post-Baseline Data|11|||
147146704|NCT03654040|530700933|FG000|Overall Study|Death|1|||
147146705|NCT03654040|530700934|FG001|Overall Study|Death|0|||
147146706|NCT03654040|530700933|FG000|Overall Study|Withdrawal by Subject|1|||
147146707|NCT03654040|530700934|FG001|Overall Study|Withdrawal by Subject|0|||
147146708|NCT03654040|530700933|FG000|Overall Study|Study terminated by sponsor|8|||
147146709|NCT03654040|530700934|FG001|Overall Study|Study terminated by sponsor|2|||
147146710|NCT03654040|530700933|FG000|Overall Study|Failure to initiate study therapy|2|||
147146711|NCT03654040|530700934|FG001|Overall Study|Failure to initiate study therapy|0|||
147146712|NCT03654040|530700933|FG000|Overall Study|Transplanted at another center|2|||
147319074|NCT04039503|531333681|FG002|Overall Study|Withdrawal by Subject|5|||
147319075|NCT04039503|531333682|FG003|Overall Study|Withdrawal by Subject|2|||
147319076|NCT03387514|531333684|FG000|Overall Study|Withdrawal by Subject|2|||
147319077|NCT03387514|531333684|FG000|Overall Study|Physician Decision|1|||
147319078|NCT03387514|531333684|FG000|Overall Study|Lost to Follow-up|2|||
147319079|NCT00245011|531333695|FG000|Overall Study|Lack of Efficacy|1|||
147319080|NCT03040687|531333700|FG000|Overall Study|Withdrawal by Subject|1|||
147319081|NCT03040687|531333701|FG001|Overall Study|Withdrawal by Subject|0|||
147319082|NCT03040687|531333702|FG002|Overall Study|Withdrawal by Subject|0|||
147319083|NCT03317379|531333703|FG000|Overall Study|Lost to Follow-up|0|||
147319084|NCT03317379|531333704|FG001|Overall Study|Lost to Follow-up|3|||
147319085|NCT03317379|531333705|FG002|Overall Study|Lost to Follow-up|2|||
147319086|NCT02846558|531333706|FG000|Overall Study|Adverse Event|1|||
147319087|NCT02846558|531333707|FG001|Overall Study|Adverse Event|0|||
147319088|NCT02846558|531333708|FG002|Overall Study|Adverse Event|0|||
147319089|NCT02846558|531333709|FG003|Overall Study|Adverse Event|0|||
147319090|NCT02846558|531333706|FG000|Overall Study|Withdrawal by Subject|5|||
147319091|NCT02846558|531333707|FG001|Overall Study|Withdrawal by Subject|4|||
147319092|NCT02846558|531333708|FG002|Overall Study|Withdrawal by Subject|2|||
147319093|NCT02846558|531333709|FG003|Overall Study|Withdrawal by Subject|2|||
147319094|NCT02846558|531333706|FG000|Overall Study|Lost to Follow-up|2|||
147319095|NCT02846558|531333707|FG001|Overall Study|Lost to Follow-up|0|||
147319096|NCT02846558|531333708|FG002|Overall Study|Lost to Follow-up|0|||
147319097|NCT02846558|531333709|FG003|Overall Study|Lost to Follow-up|0|||
147319098|NCT04445155|531333710|FG000|Overall Study|Lost to Follow-up|11|||
147319099|NCT04445155|531333711|FG001|Overall Study|Lost to Follow-up|2|||
147319100|NCT04445155|531333712|FG002|Overall Study|Lost to Follow-up|3|||
147319101|NCT04445155|531333713|FG003|Overall Study|Lost to Follow-up|0|||
147319102|NCT04445155|531333710|FG000|Overall Study|Withdrawal by Subject|8|||
147319103|NCT04445155|531333711|FG001|Overall Study|Withdrawal by Subject|0|||
147319104|NCT04445155|531333712|FG002|Overall Study|Withdrawal by Subject|0|||
147319105|NCT04445155|531333713|FG003|Overall Study|Withdrawal by Subject|0|||
147319106|NCT04445155|531333710|FG000|Overall Study|Unable to recruit parent participants so unable to begin study as initially designed|12|||
147146713|NCT03654040|530700934|FG001|Overall Study|Transplanted at another center|0|||
147146714|NCT03654040|530700933|FG000|Overall Study|Failure to meet eligibility criteria|14|||
147146715|NCT03654040|530700934|FG001|Overall Study|Failure to meet eligibility criteria|2|||
147146716|NCT03654040|530700933|FG000|Overall Study|No longer transplant candidate|1|||
147146717|NCT03654040|530700934|FG001|Overall Study|No longer transplant candidate|0|||
147146718|NCT03654040|530700933|FG000|Overall Study|Manufacturing unable to accept specimens|1|||
147146719|NCT03654040|530700934|FG001|Overall Study|Manufacturing unable to accept specimens|0|||
147146720|NCT03654040|530700933|FG000|Overall Study|Recipient ineligible|0|||
147146721|NCT03654040|530700934|FG001|Overall Study|Recipient ineligible|2|||
147146722|NCT03654040|530700933|FG000|Overall Study|Received deceased liver|0|||
147146723|NCT03654040|530700934|FG001|Overall Study|Received deceased liver|1|||
147146724|NCT01709110|530700935|FG000|Overall Study|Adverse Event|56|||
147146725|NCT01709110|530700936|FG001|Overall Study|Adverse Event|48|||
147146726|NCT01709110|530700935|FG000|Overall Study|Death|14|||
147146727|NCT01709110|530700936|FG001|Overall Study|Death|6|||
147146728|NCT01709110|530700935|FG000|Overall Study|Lost to Follow-up|7|||
147146729|NCT01709110|530700936|FG001|Overall Study|Lost to Follow-up|5|||
147146730|NCT01709110|530700935|FG000|Overall Study|Protocol Violation|4|||
147146731|NCT01709110|530700936|FG001|Overall Study|Protocol Violation|6|||
147146732|NCT01709110|530700935|FG000|Overall Study|Withdrawal by Subject|96|||
147146733|NCT01709110|530700936|FG001|Overall Study|Withdrawal by Subject|89|||
147146734|NCT01709110|530700935|FG000|Overall Study|Physician Decision|4|||
147146735|NCT01709110|530700936|FG001|Overall Study|Physician Decision|10|||
147146736|NCT01709110|530700935|FG000|Overall Study|Sponsor Decision|2|||
147146737|NCT01709110|530700936|FG001|Overall Study|Sponsor Decision|2|||
147319107|NCT04445155|531333711|FG001|Overall Study|Unable to recruit parent participants so unable to begin study as initially designed|0|||
147319108|NCT04445155|531333712|FG002|Overall Study|Unable to recruit parent participants so unable to begin study as initially designed|0|||
147319109|NCT04445155|531333713|FG003|Overall Study|Unable to recruit parent participants so unable to begin study as initially designed|0|||
147319110|NCT04445155|531333710|FG000|Overall Study|Only completed a portion of the final outcome measures (T2)|4|||
147319111|NCT04445155|531333711|FG001|Overall Study|Only completed a portion of the final outcome measures (T2)|0|||
147146738|NCT01709110|530700935|FG000|Overall Study|Lack of Efficacy|1|||
147146739|NCT01709110|530700936|FG001|Overall Study|Lack of Efficacy|1|||
147319112|NCT04445155|531333712|FG002|Overall Study|Only completed a portion of the final outcome measures (T2)|0|||
147319113|NCT04445155|531333713|FG003|Overall Study|Only completed a portion of the final outcome measures (T2)|0|||
147319114|NCT00904150|531333716|FG000|Saliva Samples (DNA)|saliva samples not suitable for assay|3|||
147319115|NCT00904150|531333717|FG001|Saliva Samples (DNA)|saliva samples not suitable for assay|0|||
147319116|NCT00904150|531333716|FG000|Saliva Samples (DNA)|Australian samples of different genotype|0|||
147319117|NCT00904150|531333717|FG001|Saliva Samples (DNA)|Australian samples of different genotype|145|||
147319118|NCT03280563|531334791|FG000|Stage 1|Death|2|||
147319119|NCT03280563|531334792|FG001|Stage 1|Death|1|||
147319120|NCT03280563|531334793|FG002|Stage 1|Death|0|||
147319121|NCT03280563|531334794|FG003|Stage 1|Death|0|||
147319122|NCT03280563|531334795|FG004|Stage 1|Death|0|||
147319123|NCT03280563|531334796|FG005|Stage 1|Death|3|||
147319124|NCT03280563|531334797|FG006|Stage 1|Death|0|||
147319125|NCT03280563|531334798|FG007|Stage 1|Death|0|||
147319126|NCT03280563|531334799|FG008|Stage 1|Death|0|||
147319127|NCT03280563|531334791|FG000|Stage 1|Study Ended by Sponsor|0|||
147319128|NCT03280563|531334792|FG001|Stage 1|Study Ended by Sponsor|0|||
147319129|NCT03280563|531334793|FG002|Stage 1|Study Ended by Sponsor|1|||
147319130|NCT03280563|531334794|FG003|Stage 1|Study Ended by Sponsor|0|||
147319131|NCT03280563|531334795|FG004|Stage 1|Study Ended by Sponsor|0|||
147319132|NCT03280563|531334796|FG005|Stage 1|Study Ended by Sponsor|1|||
147319133|NCT03280563|531334797|FG006|Stage 1|Study Ended by Sponsor|0|||
147319134|NCT03280563|531334798|FG007|Stage 1|Study Ended by Sponsor|0|||
147319135|NCT03280563|531334799|FG008|Stage 1|Study Ended by Sponsor|0|||
147319136|NCT03280563|531334791|FG000|Stage 1|Withdrawal by Subject|5|||
147319137|NCT03280563|531334792|FG001|Stage 1|Withdrawal by Subject|1|||
147319138|NCT03280563|531334793|FG002|Stage 1|Withdrawal by Subject|2|||
147319139|NCT03280563|531334794|FG003|Stage 1|Withdrawal by Subject|0|||
147319140|NCT03280563|531334795|FG004|Stage 1|Withdrawal by Subject|0|||
147319141|NCT03280563|531334796|FG005|Stage 1|Withdrawal by Subject|2|||
147574854|NCT00906399|532261335|FG000|Year 1|Death|2|||
147146740|NCT01709110|530700935|FG000|Overall Study|Caregiver Decision|1|||
147574855|NCT00906399|532261336|FG001|Year 1|Death|1|||
147574856|NCT00906399|532261337|FG002|Year 1|Death|1|||
147574857|NCT00906399|532261338|FG003|Year 1|Death|0|||
147574858|NCT00906399|532261339|FG004|Year 1|Death|0|||
147574859|NCT00906399|532261340|FG005|Year 1|Death|0|||
147574860|NCT00906399|532261341|FG006|Year 1|Death|0|||
147146741|NCT01709110|530700936|FG001|Overall Study|Caregiver Decision|1|||
147146742|NCT00485758|530700946|FG000|Overall Study|Adverse Event|102|||
147146743|NCT00485758|530700947|FG001|Overall Study|Adverse Event|31|||
147146744|NCT00485758|530700946|FG000|Overall Study|Death|0|||
147146745|NCT00485758|530700947|FG001|Overall Study|Death|1|||
147146746|NCT00485758|530700946|FG000|Overall Study|Lost to Follow-up|5|||
147146747|NCT00485758|530700947|FG001|Overall Study|Lost to Follow-up|1|||
147146748|NCT00485758|530700946|FG000|Overall Study|Physician Decision|3|||
147146749|NCT00485758|530700947|FG001|Overall Study|Physician Decision|3|||
147146750|NCT00485758|530700946|FG000|Overall Study|Protocol Violation|11|||
147146751|NCT00485758|530700947|FG001|Overall Study|Protocol Violation|2|||
147146752|NCT00485758|530700946|FG000|Overall Study|Withdrawal by Subject|32|||
147146753|NCT00485758|530700947|FG001|Overall Study|Withdrawal by Subject|27|||
147146754|NCT00485758|530700946|FG000|Overall Study|Study Terminated by Sponsor|3|||
147146755|NCT00485758|530700947|FG001|Overall Study|Study Terminated by Sponsor|0|||
147146756|NCT04123093|530700948|FG000|Phase 1|Subject did not show up for baseline visit and was replaced|1|||
147146757|NCT04123093|530700949|FG001|Phase 1|Subject did not show up for baseline visit and was replaced|0|||
147146758|NCT04123093|530700948|FG000|Phase 2|Physician Decision|0|||
147146759|NCT04123093|530700949|FG001|Phase 2|Physician Decision|1|||
147146760|NCT04123093|530700948|FG000|Phase 2|Withdrawal by Subject|0|||
147146761|NCT04123093|530700949|FG001|Phase 2|Withdrawal by Subject|1|||
147146762|NCT00984165|530700950|FG000|Overall Study|Death on study|2|||
147319142|NCT03280563|531334797|FG006|Stage 1|Withdrawal by Subject|0|||
147574861|NCT00906399|532261335|FG000|Year 1|Other|4|||
147574862|NCT00906399|532261336|FG001|Year 1|Other|2|||
147574863|NCT00906399|532261337|FG002|Year 1|Other|7|||
147146763|NCT00984165|530700951|FG001|Overall Study|Death on study|0|||
147146764|NCT00984165|530700952|FG002|Overall Study|Death on study|0|||
147146765|NCT00984165|530700953|FG003|Overall Study|Death on study|0|||
147146766|NCT00984165|530700950|FG000|Overall Study|Disease progression on study|5|||
147146767|NCT00984165|530700951|FG001|Overall Study|Disease progression on study|1|||
147319143|NCT03280563|531334798|FG007|Stage 1|Withdrawal by Subject|0|||
147319144|NCT03280563|531334799|FG008|Stage 1|Withdrawal by Subject|0|||
147319145|NCT03280563|531334791|FG000|Stage 1|Reason Not Specified|0|||
147319146|NCT03280563|531334792|FG001|Stage 1|Reason Not Specified|0|||
147319147|NCT03280563|531334793|FG002|Stage 1|Reason Not Specified|0|||
147574864|NCT00906399|532261338|FG003|Year 1|Other|0|||
147574865|NCT00906399|532261339|FG004|Year 1|Other|0|||
147574866|NCT00906399|532261340|FG005|Year 1|Other|0|||
147574867|NCT00906399|532261341|FG006|Year 1|Other|0|||
147574868|NCT00906399|532261335|FG000|Year 2|Adverse Event|0|||
147574869|NCT00906399|532261336|FG001|Year 2|Adverse Event|0|||
147146768|NCT00984165|530700952|FG002|Overall Study|Disease progression on study|0|||
147146769|NCT00984165|530700953|FG003|Overall Study|Disease progression on study|0|||
147146770|NCT00984165|530700950|FG000|Overall Study|Death of recipient|0|||
147146771|NCT00984165|530700951|FG001|Overall Study|Death of recipient|0|||
147146772|NCT00984165|530700952|FG002|Overall Study|Death of recipient|0|||
147146773|NCT00984165|530700953|FG003|Overall Study|Death of recipient|1|||
147146774|NCT00984165|530700950|FG000|Overall Study|New protocol|0|||
147319148|NCT03280563|531334794|FG003|Stage 1|Reason Not Specified|0|||
147319149|NCT03280563|531334795|FG004|Stage 1|Reason Not Specified|0|||
147319150|NCT03280563|531334796|FG005|Stage 1|Reason Not Specified|1|||
147319151|NCT03280563|531334797|FG006|Stage 1|Reason Not Specified|0|||
147319152|NCT03280563|531334798|FG007|Stage 1|Reason Not Specified|0|||
147319153|NCT03280563|531334799|FG008|Stage 1|Reason Not Specified|0|||
147319154|NCT03280563|531334791|FG000|Stage 1|Physician Decision|0|||
147319155|NCT03280563|531334792|FG001|Stage 1|Physician Decision|1|||
147319156|NCT03280563|531334793|FG002|Stage 1|Physician Decision|0|||
147319157|NCT03280563|531334794|FG003|Stage 1|Physician Decision|0|||
147319158|NCT03280563|531334795|FG004|Stage 1|Physician Decision|0|||
147319159|NCT03280563|531334796|FG005|Stage 1|Physician Decision|0|||
147319160|NCT03280563|531334797|FG006|Stage 1|Physician Decision|0|||
147319161|NCT03280563|531334798|FG007|Stage 1|Physician Decision|0|||
147319162|NCT03280563|531334799|FG008|Stage 1|Physician Decision|0|||
147319163|NCT03280563|531334791|FG000|Stage 2|Death|0|||
147319164|NCT03280563|531334792|FG001|Stage 2|Death|0|||
147319165|NCT03280563|531334793|FG002|Stage 2|Death|0|||
147319166|NCT03280563|531334794|FG003|Stage 2|Death|0|||
147319167|NCT03280563|531334795|FG004|Stage 2|Death|0|||
147319168|NCT03280563|531334796|FG005|Stage 2|Death|0|||
147319169|NCT03280563|531334797|FG006|Stage 2|Death|0|||
147319170|NCT03280563|531334798|FG007|Stage 2|Death|1|||
147319171|NCT03280563|531334799|FG008|Stage 2|Death|0|||
147319172|NCT03280563|531334791|FG000|Stage 2|Progressive Disease|0|||
147319173|NCT03280563|531334792|FG001|Stage 2|Progressive Disease|0|||
147319174|NCT03280563|531334793|FG002|Stage 2|Progressive Disease|0|||
147319175|NCT03280563|531334794|FG003|Stage 2|Progressive Disease|0|||
147319176|NCT03280563|531334795|FG004|Stage 2|Progressive Disease|0|||
147319177|NCT03280563|531334796|FG005|Stage 2|Progressive Disease|0|||
147319178|NCT03280563|531334797|FG006|Stage 2|Progressive Disease|2|||
147319179|NCT03280563|531334798|FG007|Stage 2|Progressive Disease|0|||
147319180|NCT03280563|531334799|FG008|Stage 2|Progressive Disease|0|||
147319181|NCT03280563|531334791|FG000|Long-term Survival Follow-up|Death|10|||
147319182|NCT03280563|531334792|FG001|Long-term Survival Follow-up|Death|14|||
147319183|NCT03280563|531334793|FG002|Long-term Survival Follow-up|Death|15|||
147319184|NCT03280563|531334794|FG003|Long-term Survival Follow-up|Death|3|||
147319185|NCT03280563|531334795|FG004|Long-term Survival Follow-up|Death|6|||
147319186|NCT03280563|531334796|FG005|Long-term Survival Follow-up|Death|18|||
147319187|NCT03280563|531334797|FG006|Long-term Survival Follow-up|Death|11|||
147319188|NCT03280563|531334798|FG007|Long-term Survival Follow-up|Death|1|||
147319189|NCT03280563|531334799|FG008|Long-term Survival Follow-up|Death|3|||
147319190|NCT03280563|531334791|FG000|Long-term Survival Follow-up|Study Ended by Sponsor|4|||
147319191|NCT03280563|531334792|FG001|Long-term Survival Follow-up|Study Ended by Sponsor|9|||
147319192|NCT03280563|531334793|FG002|Long-term Survival Follow-up|Study Ended by Sponsor|3|||
147319193|NCT03280563|531334794|FG003|Long-term Survival Follow-up|Study Ended by Sponsor|0|||
147319194|NCT03280563|531334795|FG004|Long-term Survival Follow-up|Study Ended by Sponsor|0|||
147319195|NCT03280563|531334796|FG005|Long-term Survival Follow-up|Study Ended by Sponsor|13|||
147319196|NCT03280563|531334797|FG006|Long-term Survival Follow-up|Study Ended by Sponsor|0|||
147319197|NCT03280563|531334798|FG007|Long-term Survival Follow-up|Study Ended by Sponsor|2|||
147319198|NCT03280563|531334799|FG008|Long-term Survival Follow-up|Study Ended by Sponsor|0|||
147319199|NCT03280563|531334791|FG000|Long-term Survival Follow-up|Withdrawal by Subject|1|||
147574870|NCT00906399|532261337|FG002|Year 2|Adverse Event|0|||
147574871|NCT00906399|532261338|FG003|Year 2|Adverse Event|9|||
147574872|NCT00906399|532261339|FG004|Year 2|Adverse Event|8|||
147574873|NCT00906399|532261340|FG005|Year 2|Adverse Event|11|||
147574874|NCT00906399|532261341|FG006|Year 2|Adverse Event|6|||
147574875|NCT00906399|532261335|FG000|Year 2|Lost to Follow-up|0|||
147574876|NCT00906399|532261336|FG001|Year 2|Lost to Follow-up|0|||
147146775|NCT00984165|530700951|FG001|Overall Study|New protocol|0|||
147319200|NCT03280563|531334792|FG001|Long-term Survival Follow-up|Withdrawal by Subject|1|||
147319201|NCT03280563|531334793|FG002|Long-term Survival Follow-up|Withdrawal by Subject|1|||
147319202|NCT03280563|531334794|FG003|Long-term Survival Follow-up|Withdrawal by Subject|0|||
147445871|NCT00455013|531797471|FG002|Long Term Extension (LTE)|Death|0|||
147146776|NCT00984165|530700952|FG002|Overall Study|New protocol|0|||
147146777|NCT00984165|530700953|FG003|Overall Study|New protocol|1|||
147319203|NCT03280563|531334795|FG004|Long-term Survival Follow-up|Withdrawal by Subject|1|||
147319204|NCT03280563|531334796|FG005|Long-term Survival Follow-up|Withdrawal by Subject|0|||
147445872|NCT00455013|531797469|FG000|Long Term Extension (LTE)|No longer met criteria|0|||
147574877|NCT00906399|532261337|FG002|Year 2|Lost to Follow-up|0|||
147574878|NCT00906399|532261338|FG003|Year 2|Lost to Follow-up|1|||
147574879|NCT00906399|532261339|FG004|Year 2|Lost to Follow-up|4|||
147319205|NCT03280563|531334797|FG006|Long-term Survival Follow-up|Withdrawal by Subject|0|||
147319206|NCT03280563|531334798|FG007|Long-term Survival Follow-up|Withdrawal by Subject|0|||
147319207|NCT03280563|531334799|FG008|Long-term Survival Follow-up|Withdrawal by Subject|0|||
147319208|NCT03280563|531334791|FG000|Long-term Survival Follow-up|Lost to Follow-up|0|||
147319209|NCT03280563|531334792|FG001|Long-term Survival Follow-up|Lost to Follow-up|1|||
147319210|NCT03280563|531334793|FG002|Long-term Survival Follow-up|Lost to Follow-up|1|||
147319211|NCT03280563|531334794|FG003|Long-term Survival Follow-up|Lost to Follow-up|0|||
147319212|NCT03280563|531334795|FG004|Long-term Survival Follow-up|Lost to Follow-up|2|||
147319213|NCT03280563|531334796|FG005|Long-term Survival Follow-up|Lost to Follow-up|1|||
147319214|NCT03280563|531334797|FG006|Long-term Survival Follow-up|Lost to Follow-up|0|||
147319215|NCT03280563|531334798|FG007|Long-term Survival Follow-up|Lost to Follow-up|0|||
147319216|NCT03280563|531334799|FG008|Long-term Survival Follow-up|Lost to Follow-up|0|||
147319217|NCT04213846|531334800|FG000|Overall Study|Withdrawal by Subject|7|||
147319218|NCT04213846|531334801|FG001|Overall Study|Withdrawal by Subject|6|||
147319219|NCT04213846|531334800|FG000|Overall Study|Lost to Follow-up|15|||
147319220|NCT04213846|531334801|FG001|Overall Study|Lost to Follow-up|21|||
147319221|NCT02107274|531334802|FG000|Treatment vs. Placebo|Adverse Event|3|||
147319222|NCT02107274|531334803|FG001|Treatment vs. Placebo|Adverse Event|0|||
147319223|NCT02107274|531334802|FG000|Treatment vs. Placebo|Lost to Follow-up|0|||
147319224|NCT02107274|531334803|FG001|Treatment vs. Placebo|Lost to Follow-up|2|||
147319225|NCT02107274|531334802|FG000|Control Phase|Lost to Follow-up|1|||
147319226|NCT02107274|531334803|FG001|Control Phase|Lost to Follow-up|1|||
147319227|NCT02107274|531334802|FG000|Control Phase|Death|2|||
147319228|NCT02107274|531334803|FG001|Control Phase|Death|0|||
147319229|NCT02107274|531334802|FG000|Control Phase|Adverse Event|0|||
147319230|NCT02107274|531334803|FG001|Control Phase|Adverse Event|1|||
147319231|NCT03158948|531334807|FG000|Overall Study|Death|1|||
147319232|NCT03158948|531334808|FG001|Overall Study|Death|1|||
147319233|NCT03158948|531334809|FG002|Overall Study|Death|3|||
147319234|NCT03158948|531334810|FG003|Overall Study|Death|2|||
147319235|NCT03158948|531334807|FG000|Overall Study|Physician Decision|0|||
147319236|NCT03158948|531334808|FG001|Overall Study|Physician Decision|0|||
147319237|NCT03158948|531334809|FG002|Overall Study|Physician Decision|0|||
147319238|NCT03158948|531334810|FG003|Overall Study|Physician Decision|1|||
147319239|NCT04730947|531334811|FG000|Overall Study|Withdrawal by Subject|0|||
147319240|NCT04730947|531334812|FG001|Overall Study|Withdrawal by Subject|1|||
147574880|NCT00906399|532261340|FG005|Year 2|Lost to Follow-up|2|||
147574881|NCT00906399|532261341|FG006|Year 2|Lost to Follow-up|4|||
147574882|NCT00906399|532261335|FG000|Year 2|Withdrawal by Subject|0|||
147574883|NCT00906399|532261336|FG001|Year 2|Withdrawal by Subject|0|||
147574884|NCT00906399|532261337|FG002|Year 2|Withdrawal by Subject|0|||
147574885|NCT00906399|532261338|FG003|Year 2|Withdrawal by Subject|17|||
147574886|NCT00906399|532261339|FG004|Year 2|Withdrawal by Subject|18|||
147574887|NCT00906399|532261340|FG005|Year 2|Withdrawal by Subject|27|||
147574888|NCT00906399|532261341|FG006|Year 2|Withdrawal by Subject|13|||
147574889|NCT00906399|532261335|FG000|Year 2|Physician Decision|0|||
147574890|NCT00906399|532261336|FG001|Year 2|Physician Decision|0|||
147574891|NCT00906399|532261337|FG002|Year 2|Physician Decision|0|||
147574892|NCT00906399|532261338|FG003|Year 2|Physician Decision|0|||
147574893|NCT00906399|532261339|FG004|Year 2|Physician Decision|2|||
147574894|NCT00906399|532261340|FG005|Year 2|Physician Decision|6|||
147574895|NCT00906399|532261341|FG006|Year 2|Physician Decision|3|||
147574896|NCT00906399|532261335|FG000|Year 2|Death|0|||
147574897|NCT00906399|532261336|FG001|Year 2|Death|0|||
147574898|NCT00906399|532261337|FG002|Year 2|Death|0|||
147574899|NCT00906399|532261338|FG003|Year 2|Death|1|||
147574900|NCT00906399|532261339|FG004|Year 2|Death|0|||
147574901|NCT00906399|532261340|FG005|Year 2|Death|0|||
147574902|NCT00906399|532261341|FG006|Year 2|Death|3|||
147574903|NCT00906399|532261335|FG000|Year 2|Other|0|||
147574904|NCT00906399|532261336|FG001|Year 2|Other|0|||
147574905|NCT00906399|532261337|FG002|Year 2|Other|0|||
147574906|NCT00906399|532261338|FG003|Year 2|Other|2|||
147574907|NCT00906399|532261339|FG004|Year 2|Other|3|||
147319241|NCT00354029|531334815|FG000|Overall Study|Protocol Violation|4|||
147319242|NCT00354029|531334816|FG001|Overall Study|Protocol Violation|2|||
147319243|NCT01021332|531334817|FG000|Overall Study|Not fulfilling incl./excl.criteria|5|||
147319244|NCT01021332|531334817|FG000|Overall Study|Adverse Event|43|||
147319245|NCT01021332|531334817|FG000|Overall Study|Lack of Efficacy|19|||
147319246|NCT01021332|531334817|FG000|Overall Study|Withdrawal of Consent|23|||
147574908|NCT00906399|532261340|FG005|Year 2|Other|1|||
147574909|NCT00906399|532261341|FG006|Year 2|Other|0|||
147574910|NCT00624286|532261342|FG000|Overall Study|Protocol Deviation|7|||
147574911|NCT00624286|532261343|FG001|Overall Study|Protocol Deviation|9|||
147574912|NCT00624286|532261342|FG000|Overall Study|Adverse Event|6|||
147574913|NCT00624286|532261343|FG001|Overall Study|Adverse Event|3|||
147574914|NCT00624286|532261342|FG000|Overall Study|Withdrawal by Subject|5|||
147574915|NCT00624286|532261343|FG001|Overall Study|Withdrawal by Subject|4|||
147574916|NCT00624286|532261342|FG000|Overall Study|Lost to Follow-up|3|||
147574917|NCT00624286|532261343|FG001|Overall Study|Lost to Follow-up|2|||
147574918|NCT00624286|532261342|FG000|Overall Study|Administrative problems|3|||
147652385|NCT03026283|532550244|FG000|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
147652386|NCT03026283|532550245|FG001|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
147652387|NCT03026283|532550246|FG002|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
147652388|NCT03026283|532550247|FG003|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
147652389|NCT03026283|532550248|FG004|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|25|||
147652390|NCT03026283|532550249|FG005|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|19|||
147652391|NCT03026283|532550250|FG006|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
147652392|NCT03026283|532550251|FG007|Optimal Care/Stress Test/ICA|Referring MD used only optimal med care|0|||
147652393|NCT03782571|532550256|FG000|Period 1|Withdrawal by Subject|1|||
147652394|NCT03782571|532550257|FG001|Period 1|Withdrawal by Subject|0|||
147652395|NCT03782571|532550258|FG002|Period 1|Withdrawal by Subject|0|||
147652396|NCT03782571|532550259|FG003|Period 1|Withdrawal by Subject|0|||
147652397|NCT03782571|532550256|FG000|Period 3|Subject Unable to Attend V5|1|||
147652398|NCT03782571|532550257|FG001|Period 3|Subject Unable to Attend V5|0|||
147146778|NCT00984165|530700950|FG000|Overall Study|P+/donor pair removed from protocol|0|||
147146779|NCT00984165|530700951|FG001|Overall Study|P+/donor pair removed from protocol|0|||
147146780|NCT00984165|530700952|FG002|Overall Study|P+/donor pair removed from protocol|0|||
147146781|NCT00984165|530700953|FG003|Overall Study|P+/donor pair removed from protocol|1|||
147146782|NCT00984165|530700950|FG000|Overall Study|removed with a pair recipient|0|||
147146783|NCT00984165|530700951|FG001|Overall Study|removed with a pair recipient|0|||
147652399|NCT03782571|532550258|FG002|Period 3|Subject Unable to Attend V5|0|||
147652400|NCT03782571|532550259|FG003|Period 3|Subject Unable to Attend V5|0|||
147652401|NCT03782571|532550256|FG000|Period 3|Adverse Event|1|||
147652402|NCT03782571|532550257|FG001|Period 3|Adverse Event|0|||
147652403|NCT03782571|532550258|FG002|Period 3|Adverse Event|0|||
147652404|NCT03782571|532550259|FG003|Period 3|Adverse Event|0|||
147652405|NCT01826981|532550267|FG000|Overall Study|Lack of Efficacy|0|||
147652406|NCT01826981|532550268|FG001|Overall Study|Lack of Efficacy|1|||
147652407|NCT01826981|532550269|FG002|Overall Study|Lack of Efficacy|0|||
147652408|NCT01826981|532550270|FG003|Overall Study|Lack of Efficacy|0|||
147652409|NCT01826981|532550271|FG004|Overall Study|Lack of Efficacy|5|||
147652410|NCT01826981|532550272|FG005|Overall Study|Lack of Efficacy|0|||
147652411|NCT01826981|532550273|FG006|Overall Study|Lack of Efficacy|0|||
147652412|NCT01826981|532550274|FG007|Overall Study|Lack of Efficacy|8|||
147652413|NCT01826981|532550275|FG008|Overall Study|Lack of Efficacy|7|||
147652414|NCT01826981|532550276|FG009|Overall Study|Lack of Efficacy|0|||
147652415|NCT01826981|532550277|FG010|Overall Study|Lack of Efficacy|1|||
147652416|NCT01826981|532550278|FG011|Overall Study|Lack of Efficacy|0|||
147652417|NCT01826981|532550279|FG012|Overall Study|Lack of Efficacy|0|||
147652418|NCT01826981|532550280|FG013|Overall Study|Lack of Efficacy|3|||
147652419|NCT01826981|532550281|FG014|Overall Study|Lack of Efficacy|0|||
147652420|NCT01826981|532550267|FG000|Overall Study|Lost to Follow-up|0|||
147652421|NCT01826981|532550268|FG001|Overall Study|Lost to Follow-up|0|||
147652422|NCT01826981|532550269|FG002|Overall Study|Lost to Follow-up|0|||
147652423|NCT01826981|532550270|FG003|Overall Study|Lost to Follow-up|0|||
147652424|NCT01826981|532550271|FG004|Overall Study|Lost to Follow-up|1|||
147652425|NCT01826981|532550272|FG005|Overall Study|Lost to Follow-up|1|||
147652426|NCT01826981|532550273|FG006|Overall Study|Lost to Follow-up|0|||
147652427|NCT01826981|532550274|FG007|Overall Study|Lost to Follow-up|1|||
147652428|NCT01826981|532550275|FG008|Overall Study|Lost to Follow-up|0|||
147652429|NCT01826981|532550276|FG009|Overall Study|Lost to Follow-up|1|||
147652430|NCT01826981|532550277|FG010|Overall Study|Lost to Follow-up|1|||
147652431|NCT01826981|532550278|FG011|Overall Study|Lost to Follow-up|1|||
147652432|NCT01826981|532550279|FG012|Overall Study|Lost to Follow-up|1|||
147652433|NCT01826981|532550280|FG013|Overall Study|Lost to Follow-up|0|||
147652434|NCT01826981|532550281|FG014|Overall Study|Lost to Follow-up|0|||
147652435|NCT01826981|532550267|FG000|Overall Study|Withdrew Consent|0|||
147652436|NCT01826981|532550268|FG001|Overall Study|Withdrew Consent|0|||
147652437|NCT01826981|532550269|FG002|Overall Study|Withdrew Consent|0|||
147652438|NCT01826981|532550270|FG003|Overall Study|Withdrew Consent|0|||
147652439|NCT01826981|532550271|FG004|Overall Study|Withdrew Consent|0|||
147652440|NCT01826981|532550272|FG005|Overall Study|Withdrew Consent|0|||
147652441|NCT01826981|532550273|FG006|Overall Study|Withdrew Consent|1|||
147652442|NCT01826981|532550274|FG007|Overall Study|Withdrew Consent|1|||
147652443|NCT01826981|532550275|FG008|Overall Study|Withdrew Consent|0|||
147652444|NCT01826981|532550276|FG009|Overall Study|Withdrew Consent|0|||
147146784|NCT00984165|530700952|FG002|Overall Study|removed with a pair recipient|0|||
147146785|NCT00984165|530700953|FG003|Overall Study|removed with a pair recipient|1|||
147146786|NCT00135330|530700954|FG000|Overall Study|Adverse Event|2|||
147652445|NCT01826981|532550277|FG010|Overall Study|Withdrew Consent|0|||
147652446|NCT01826981|532550278|FG011|Overall Study|Withdrew Consent|1|||
147652447|NCT01826981|532550279|FG012|Overall Study|Withdrew Consent|0|||
147652448|NCT01826981|532550280|FG013|Overall Study|Withdrew Consent|1|||
147652449|NCT01826981|532550281|FG014|Overall Study|Withdrew Consent|0|||
147652450|NCT01826981|532550267|FG000|Overall Study|Adverse Event|0|||
147652451|NCT01826981|532550268|FG001|Overall Study|Adverse Event|0|||
147652452|NCT01826981|532550269|FG002|Overall Study|Adverse Event|0|||
147319247|NCT01021332|531334817|FG000|Overall Study|Lost to Follow-up|4|||
147319248|NCT01021332|531334817|FG000|Overall Study|Protocol Violation|9|||
147574919|NCT00624286|532261343|FG001|Overall Study|Administrative problems|0|||
147574920|NCT00624286|532261342|FG000|Overall Study|Lack of Efficacy|1|||
147574921|NCT00624286|532261343|FG001|Overall Study|Lack of Efficacy|6|||
147574922|NCT00624286|532261342|FG000|Overall Study|Not stated|0|||
147574923|NCT00624286|532261343|FG001|Overall Study|Not stated|1|||
147574924|NCT00624286|532261342|FG000|Overall Study|Abnormal test procedure result(s)|0|||
147574925|NCT00624286|532261343|FG001|Overall Study|Abnormal test procedure result(s)|1|||
147574926|NCT00624286|532261342|FG000|Overall Study|Death|0|||
147574927|NCT00624286|532261343|FG001|Overall Study|Death|1|||
147574928|NCT03488108|532261347|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|0|||
147574929|NCT03488108|532261348|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
147574930|NCT03488108|532261347|FG000|Second Intervention (12 Weeks)|Withdrawal by Subject|1|||
147574931|NCT03488108|532261348|FG001|Second Intervention (12 Weeks)|Withdrawal by Subject|0|||
147574932|NCT00674128|532261355|FG000|Overall Study|Withdrawal by Subject|25|||
147574933|NCT00674128|532261356|FG001|Overall Study|Withdrawal by Subject|23|||
147574934|NCT04631562|532261363|FG000|Overall Study|Withdrawal by Subject|0|||
147574935|NCT04631562|532261364|FG001|Overall Study|Withdrawal by Subject|0|||
147574936|NCT04631562|532261365|FG002|Overall Study|Withdrawal by Subject|0|||
147574937|NCT04631562|532261366|FG003|Overall Study|Withdrawal by Subject|0|||
147574938|NCT04631562|532261367|FG004|Overall Study|Withdrawal by Subject|0|||
147574939|NCT04631562|532261368|FG005|Overall Study|Withdrawal by Subject|0|||
147574940|NCT04631562|532261369|FG006|Overall Study|Withdrawal by Subject|0|||
147574941|NCT04631562|532261370|FG007|Overall Study|Withdrawal by Subject|1|||
147574942|NCT04631562|532261371|FG008|Overall Study|Withdrawal by Subject|0|||
147574943|NCT04631562|532261363|FG000|Overall Study|Other|0|||
147574944|NCT04631562|532261364|FG001|Overall Study|Other|0|||
147574945|NCT04631562|532261365|FG002|Overall Study|Other|0|||
147574946|NCT04631562|532261366|FG003|Overall Study|Other|0|||
147574947|NCT04631562|532261367|FG004|Overall Study|Other|0|||
147574948|NCT04631562|532261368|FG005|Overall Study|Other|0|||
147574949|NCT04631562|532261369|FG006|Overall Study|Other|0|||
147574950|NCT04631562|532261370|FG007|Overall Study|Other|0|||
147574951|NCT04631562|532261371|FG008|Overall Study|Other|1|||
147574952|NCT04631562|532261363|FG000|Overall Study|Lost to Follow-up|0|||
147574953|NCT04631562|532261364|FG001|Overall Study|Lost to Follow-up|0|||
147574954|NCT04631562|532261365|FG002|Overall Study|Lost to Follow-up|0|||
147574955|NCT04631562|532261366|FG003|Overall Study|Lost to Follow-up|1|||
147574956|NCT04631562|532261367|FG004|Overall Study|Lost to Follow-up|0|||
147574957|NCT04631562|532261368|FG005|Overall Study|Lost to Follow-up|0|||
147574958|NCT04631562|532261369|FG006|Overall Study|Lost to Follow-up|0|||
147574959|NCT04631562|532261370|FG007|Overall Study|Lost to Follow-up|0|||
147574960|NCT04631562|532261371|FG008|Overall Study|Lost to Follow-up|0|||
147574961|NCT04631562|532261363|FG000|Overall Study|Adverse Event|0|||
147574962|NCT04631562|532261364|FG001|Overall Study|Adverse Event|0|||
147574963|NCT04631562|532261365|FG002|Overall Study|Adverse Event|0|||
147574964|NCT04631562|532261366|FG003|Overall Study|Adverse Event|0|||
147574965|NCT04631562|532261367|FG004|Overall Study|Adverse Event|0|||
147574966|NCT04631562|532261368|FG005|Overall Study|Adverse Event|0|||
147574967|NCT04631562|532261369|FG006|Overall Study|Adverse Event|1|||
147574968|NCT04631562|532261370|FG007|Overall Study|Adverse Event|0|||
147574969|NCT04631562|532261371|FG008|Overall Study|Adverse Event|0|||
147574970|NCT02615249|532261372|FG000|Overall Study|Withdrawal by Subject|1|||
147574971|NCT00849797|532261378|FG000|First Intervention|bad veins|1|||
147574972|NCT00849797|532261379|FG001|First Intervention|bad veins|0|||
147574973|NCT00849797|532261378|FG000|First Intervention|Adverse Event|0|||
147574974|NCT00849797|532261379|FG001|First Intervention|Adverse Event|1|||
147574975|NCT00849797|532261378|FG000|Washout: One Week|Withdrawal by Subject|0|||
147574976|NCT00849797|532261379|FG001|Washout: One Week|Withdrawal by Subject|2|||
147574977|NCT00679081|532261380|FG000|Overall Study|Lost to Follow-up|1|||
147574978|NCT00725322|532261381|FG000|Washout (28 Days)|Withdrawal by Subject|2|||
147574979|NCT00725322|532261382|FG001|Washout (28 Days)|Withdrawal by Subject|0|||
147652453|NCT01826981|532550270|FG003|Overall Study|Adverse Event|0|||
147146787|NCT00135330|530700955|FG001|Overall Study|Adverse Event|5|||
147146788|NCT00135330|530700956|FG002|Overall Study|Adverse Event|1|||
147146789|NCT00135330|530700954|FG000|Overall Study|Lost to Follow-up|0|||
147146790|NCT00135330|530700955|FG001|Overall Study|Lost to Follow-up|2|||
147146791|NCT00135330|530700956|FG002|Overall Study|Lost to Follow-up|3|||
147146792|NCT00135330|530700954|FG000|Overall Study|Physician Decision|1|||
147146793|NCT00135330|530700955|FG001|Overall Study|Physician Decision|1|||
147146794|NCT00135330|530700956|FG002|Overall Study|Physician Decision|0|||
147146795|NCT00135330|530700954|FG000|Overall Study|Protocol Violation|4|||
147146796|NCT00135330|530700955|FG001|Overall Study|Protocol Violation|3|||
147146797|NCT00135330|530700956|FG002|Overall Study|Protocol Violation|3|||
147146798|NCT00135330|530700954|FG000|Overall Study|Patient Decision|5|||
147146799|NCT00135330|530700955|FG001|Overall Study|Patient Decision|1|||
147574980|NCT00725322|532261381|FG000|Washout (28 Days)|Protocol Violation|0|||
147574981|NCT00725322|532261382|FG001|Washout (28 Days)|Protocol Violation|1|||
147652454|NCT01826981|532550271|FG004|Overall Study|Adverse Event|1|||
147652455|NCT01826981|532550272|FG005|Overall Study|Adverse Event|0|||
147652456|NCT01826981|532550273|FG006|Overall Study|Adverse Event|0|||
147652457|NCT01826981|532550274|FG007|Overall Study|Adverse Event|0|||
147652458|NCT01826981|532550275|FG008|Overall Study|Adverse Event|0|||
147652459|NCT01826981|532550276|FG009|Overall Study|Adverse Event|0|||
147652460|NCT01826981|532550277|FG010|Overall Study|Adverse Event|0|||
147652461|NCT01826981|532550278|FG011|Overall Study|Adverse Event|0|||
147652462|NCT01826981|532550279|FG012|Overall Study|Adverse Event|0|||
147652463|NCT01826981|532550280|FG013|Overall Study|Adverse Event|0|||
147146800|NCT00135330|530700956|FG002|Overall Study|Patient Decision|4|||
147146801|NCT00135330|530700954|FG000|Overall Study|Sponsor Decision|0|||
147146802|NCT00135330|530700955|FG001|Overall Study|Sponsor Decision|1|||
147146803|NCT00135330|530700956|FG002|Overall Study|Sponsor Decision|0|||
147146804|NCT02229825|530700963|FG000|Overall Study|Personal Reasons|0|||
147146805|NCT02229825|530700964|FG001|Overall Study|Personal Reasons|1|||
147146806|NCT02229825|530700963|FG000|Overall Study|Refused continuing medication|7|||
147319249|NCT01021332|531334817|FG000|Overall Study|Miscellaneous|3|||
147319250|NCT01923428|531334825|FG000|Overall Study|Adverse Event|8|||
147319251|NCT01923428|531334826|FG001|Overall Study|Adverse Event|6|||
147319252|NCT01923428|531334827|FG002|Overall Study|Adverse Event|3|||
147319253|NCT01923428|531334828|FG003|Overall Study|Adverse Event|3|||
147319254|NCT01923428|531334825|FG000|Overall Study|Withdrawal by Subject|5|||
147319255|NCT01923428|531334826|FG001|Overall Study|Withdrawal by Subject|3|||
147319256|NCT01923428|531334827|FG002|Overall Study|Withdrawal by Subject|0|||
147319257|NCT01923428|531334828|FG003|Overall Study|Withdrawal by Subject|4|||
147319258|NCT01923428|531334825|FG000|Overall Study|Lost to Follow-up|2|||
147319259|NCT01923428|531334826|FG001|Overall Study|Lost to Follow-up|1|||
147319260|NCT01923428|531334827|FG002|Overall Study|Lost to Follow-up|5|||
147652464|NCT01826981|532550281|FG014|Overall Study|Adverse Event|0|||
147652465|NCT01826981|532550267|FG000|Overall Study|Upper G-I Haemorrhage|0|||
147652466|NCT01826981|532550268|FG001|Overall Study|Upper G-I Haemorrhage|0|||
147652467|NCT01826981|532550269|FG002|Overall Study|Upper G-I Haemorrhage|0|||
147652468|NCT01826981|532550270|FG003|Overall Study|Upper G-I Haemorrhage|0|||
147652469|NCT01826981|532550271|FG004|Overall Study|Upper G-I Haemorrhage|0|||
147652470|NCT01826981|532550272|FG005|Overall Study|Upper G-I Haemorrhage|0|||
147652471|NCT01826981|532550273|FG006|Overall Study|Upper G-I Haemorrhage|0|||
147146807|NCT02229825|530700964|FG001|Overall Study|Refused continuing medication|6|||
147652472|NCT01826981|532550274|FG007|Overall Study|Upper G-I Haemorrhage|0|||
147652473|NCT01826981|532550275|FG008|Overall Study|Upper G-I Haemorrhage|0|||
147652474|NCT01826981|532550276|FG009|Overall Study|Upper G-I Haemorrhage|0|||
147652475|NCT01826981|532550277|FG010|Overall Study|Upper G-I Haemorrhage|0|||
147652476|NCT01826981|532550278|FG011|Overall Study|Upper G-I Haemorrhage|0|||
147652477|NCT01826981|532550279|FG012|Overall Study|Upper G-I Haemorrhage|0|||
147652478|NCT01826981|532550280|FG013|Overall Study|Upper G-I Haemorrhage|1|||
147652479|NCT01826981|532550281|FG014|Overall Study|Upper G-I Haemorrhage|0|||
147146808|NCT02229825|530700963|FG000|Overall Study|Lost to Follow-up|1|||
147146809|NCT02229825|530700964|FG001|Overall Study|Lost to Follow-up|2|||
147146810|NCT02229825|530700963|FG000|Overall Study|Protocol Violation|1|||
147652480|NCT01826981|532550267|FG000|Overall Study|Enrolled/Randomized but Not Treated|0|||
147652481|NCT01826981|532550268|FG001|Overall Study|Enrolled/Randomized but Not Treated|0|||
147652482|NCT01826981|532550269|FG002|Overall Study|Enrolled/Randomized but Not Treated|0|||
147652483|NCT01826981|532550270|FG003|Overall Study|Enrolled/Randomized but Not Treated|0|||
147652484|NCT01826981|532550271|FG004|Overall Study|Enrolled/Randomized but Not Treated|0|||
147652485|NCT01826981|532550272|FG005|Overall Study|Enrolled/Randomized but Not Treated|0|||
147652486|NCT01826981|532550273|FG006|Overall Study|Enrolled/Randomized but Not Treated|0|||
147652487|NCT01826981|532550274|FG007|Overall Study|Enrolled/Randomized but Not Treated|1|||
147652488|NCT01826981|532550275|FG008|Overall Study|Enrolled/Randomized but Not Treated|0|||
147652489|NCT01826981|532550276|FG009|Overall Study|Enrolled/Randomized but Not Treated|0|||
147652490|NCT01826981|532550277|FG010|Overall Study|Enrolled/Randomized but Not Treated|0|||
147652491|NCT01826981|532550278|FG011|Overall Study|Enrolled/Randomized but Not Treated|0|||
147652492|NCT01826981|532550279|FG012|Overall Study|Enrolled/Randomized but Not Treated|0|||
147652493|NCT01826981|532550280|FG013|Overall Study|Enrolled/Randomized but Not Treated|0|||
147652494|NCT01826981|532550281|FG014|Overall Study|Enrolled/Randomized but Not Treated|0|||
147652495|NCT01796301|532550286|FG000|Overall Study|Withdrawal by Subject|15|||
147652496|NCT01796301|532550287|FG001|Overall Study|Withdrawal by Subject|15|||
147652497|NCT01796301|532550286|FG000|Overall Study|Lost to Follow-up|3|||
147652498|NCT01796301|532550287|FG001|Overall Study|Lost to Follow-up|3|||
147652499|NCT01796301|532550286|FG000|Overall Study|Death|0|||
147146811|NCT02229825|530700964|FG001|Overall Study|Protocol Violation|1|||
147146812|NCT02229825|530700963|FG000|Overall Study|Lack of Efficacy|4|||
147146813|NCT02229825|530700964|FG001|Overall Study|Lack of Efficacy|10|||
147146814|NCT02229825|530700963|FG000|Overall Study|Adverse Event|11|||
147319261|NCT01923428|531334828|FG003|Overall Study|Lost to Follow-up|0|||
147319262|NCT01923428|531334825|FG000|Overall Study|Protocol Violation|3|||
147319263|NCT01923428|531334826|FG001|Overall Study|Protocol Violation|0|||
147319264|NCT01923428|531334827|FG002|Overall Study|Protocol Violation|2|||
147574982|NCT01279486|532261383|FG000|Overall Study|Lost to Follow-up|1|||
147574983|NCT03500094|532261387|FG000|Overall Study|Withdrawal by Subject|1|||
147652500|NCT01796301|532550287|FG001|Overall Study|Death|1|||
147652501|NCT01796301|532550286|FG000|Overall Study|Decision by Sponsor|0|||
147652502|NCT01796301|532550287|FG001|Overall Study|Decision by Sponsor|1|||
147652503|NCT00667563|532550288|FG000|Overall Study|Protocol Violation|24|||
147652504|NCT00264290|532550305|FG000|Intervention (8 Weeks)|Adverse Event|1|||
147652505|NCT00264290|532550306|FG001|Intervention (8 Weeks)|Adverse Event|0|||
147652506|NCT00707980|532550307|FG000|Overall Study|Adverse Event|49|||
147652507|NCT00707980|532550307|FG000|Overall Study|Lack of Efficacy|35|||
147652508|NCT00707980|532550307|FG000|Overall Study|Non-Compliance with Study Drug|28|||
147652509|NCT00707980|532550307|FG000|Overall Study|Protocol Deviations|19|||
147146815|NCT02229825|530700964|FG001|Overall Study|Adverse Event|9|||
147146816|NCT02229825|530700963|FG000|Overall Study|Not treated|0|||
147146817|NCT02229825|530700964|FG001|Overall Study|Not treated|1|||
147146818|NCT01390298|530700969|FG000|Overall Study|Death|1|||
147146819|NCT01390298|530700969|FG000|Overall Study|long term ICU admission|1|||
147146820|NCT01390298|530700969|FG000|Overall Study|Withdrawal by Subject|14|||
147146821|NCT01390298|530700969|FG000|Overall Study|Lost to Follow-up|7|||
147146822|NCT01390298|530700969|FG000|Overall Study|Surgery cancelled|1|||
147146823|NCT00803361|530700986|FG000|Overall Study|Adverse Event|13|||
147146824|NCT00803361|530700987|FG001|Overall Study|Adverse Event|3|||
147146825|NCT00803361|530700986|FG000|Overall Study|Lack of Efficacy|4|||
147146826|NCT00803361|530700987|FG001|Overall Study|Lack of Efficacy|13|||
147146827|NCT00803361|530700986|FG000|Overall Study|Lost to Follow-up|1|||
147146828|NCT00803361|530700987|FG001|Overall Study|Lost to Follow-up|2|||
147146829|NCT00803361|530700986|FG000|Overall Study|Physician Decision|1|||
147146830|NCT00803361|530700987|FG001|Overall Study|Physician Decision|0|||
147146831|NCT00803361|530700986|FG000|Overall Study|Protocol Violation|2|||
147146832|NCT00803361|530700987|FG001|Overall Study|Protocol Violation|4|||
147146833|NCT00803361|530700986|FG000|Overall Study|Withdrawal by Subject|5|||
147146834|NCT00803361|530700987|FG001|Overall Study|Withdrawal by Subject|6|||
147146835|NCT01437111|530700991|FG000|Overall Study|Adverse Event|2|||
147146836|NCT01437111|530700991|FG000|Overall Study|Withdrawal by Subject|4|||
147146837|NCT01437111|530700991|FG000|Overall Study|Not reported|5|||
147146838|NCT01437111|530700991|FG000|Overall Study|Physician Decision|1|||
147574984|NCT03500094|532261387|FG000|Overall Study|Withdrawal by Parent or Legally-authorized Representative|1|||
147574985|NCT03500094|532261387|FG000|Overall Study|Lost to Follow-up|1|||
147574986|NCT02727192|532263385|FG000|Overall Study|Lost to Follow-up|1|||
147574987|NCT02727192|532263386|FG001|Overall Study|Lost to Follow-up|0|||
147574988|NCT02727192|532263387|FG002|Overall Study|Lost to Follow-up|0|||
147574989|NCT01380782|532263389|FG000|Overall Study|Adverse Event|0|||
147574990|NCT01380782|532263390|FG001|Overall Study|Adverse Event|1|||
147574991|NCT01380782|532263391|FG002|Overall Study|Adverse Event|0|||
147574992|NCT01380782|532263392|FG003|Overall Study|Adverse Event|0|||
147574993|NCT01380782|532263389|FG000|Overall Study|Death|1|||
147574994|NCT01380782|532263390|FG001|Overall Study|Death|0|||
147574995|NCT01380782|532263391|FG002|Overall Study|Death|0|||
147574996|NCT01380782|532263392|FG003|Overall Study|Death|0|||
147574997|NCT01380782|532263389|FG000|Overall Study|Lack of Efficacy|10|||
147574998|NCT01380782|532263390|FG001|Overall Study|Lack of Efficacy|9|||
147574999|NCT01380782|532263391|FG002|Overall Study|Lack of Efficacy|10|||
147575000|NCT01380782|532263392|FG003|Overall Study|Lack of Efficacy|3|||
147575001|NCT01380782|532263389|FG000|Overall Study|Physician Decision|1|||
147575002|NCT01380782|532263390|FG001|Overall Study|Physician Decision|0|||
147575003|NCT01380782|532263391|FG002|Overall Study|Physician Decision|0|||
147575004|NCT01380782|532263392|FG003|Overall Study|Physician Decision|0|||
147575005|NCT01380782|532263389|FG000|Overall Study|Withdrawal by Subject|0|||
147652510|NCT00707980|532550307|FG000|Overall Study|Withdrawal of Consent|81|||
147652511|NCT00707980|532550307|FG000|Overall Study|Lost to Follow-up|59|||
147652512|NCT00707980|532550307|FG000|Overall Study|Other|39|||
147146839|NCT01437111|530700991|FG000|Overall Study|Lost to Follow-up|5|||
147146840|NCT01437111|530700991|FG000|Overall Study|Protocol Violation|1|||
147146841|NCT02131311|530700992|FG000|Overall Study|Adverse Event|2|||
147146842|NCT02131311|530700992|FG000|Overall Study|Protocol Violation|1|||
147146843|NCT02131311|530700992|FG000|Overall Study|Lost to Follow-up|1|||
147146844|NCT02623205|530700993|FG000|Overall Study|Lost to Follow-Up or Discontinued Intervention|4|||
147575006|NCT01380782|532263390|FG001|Overall Study|Withdrawal by Subject|0|||
147575007|NCT01380782|532263391|FG002|Overall Study|Withdrawal by Subject|1|||
147575008|NCT01380782|532263392|FG003|Overall Study|Withdrawal by Subject|1|||
147575009|NCT01701063|532263393|FG000|Overall Study|Lost to Follow-up|0|||
147575010|NCT01701063|532263394|FG001|Overall Study|Lost to Follow-up|1|||
147575011|NCT01701063|532263395|FG002|Overall Study|Lost to Follow-up|0|||
147575012|NCT01701063|532263393|FG000|Overall Study|Withdrawal by Subject|0|||
147575013|NCT01701063|532263394|FG001|Overall Study|Withdrawal by Subject|0|||
147575014|NCT01701063|532263395|FG002|Overall Study|Withdrawal by Subject|1|||
147575015|NCT01701063|532263393|FG000|Overall Study|Other|0|||
147575016|NCT01701063|532263394|FG001|Overall Study|Other|0|||
147575017|NCT01701063|532263395|FG002|Overall Study|Other|1|||
147575018|NCT02043132|532263396|FG000|Overall Study|Lost to Follow-up|1|||
147575019|NCT02043132|532263397|FG001|Overall Study|Lost to Follow-up|1|||
147575020|NCT02043132|532263396|FG000|Overall Study|screen failures|4|||
147575021|NCT02043132|532263397|FG001|Overall Study|screen failures|8|||
147575022|NCT04194801|532263398|FG000|Part Ib/II End Of Treatment-BLU554|Adverse Event|0|||
147575023|NCT04194801|532263399|FG001|Part Ib/II End Of Treatment-BLU554|Adverse Event|2|||
147575024|NCT04194801|532263400|FG002|Part Ib/II End Of Treatment-BLU554|Adverse Event|1|||
147575025|NCT04194801|532263398|FG000|Part Ib/II End Of Treatment-BLU554|Death|0|||
147575026|NCT04194801|532263399|FG001|Part Ib/II End Of Treatment-BLU554|Death|0|||
147575027|NCT04194801|532263400|FG002|Part Ib/II End Of Treatment-BLU554|Death|1|||
147575028|NCT04194801|532263398|FG000|Part Ib/II End Of Treatment-BLU554|Physician Decision|1|||
147575029|NCT04194801|532263399|FG001|Part Ib/II End Of Treatment-BLU554|Physician Decision|0|||
147575030|NCT04194801|532263400|FG002|Part Ib/II End Of Treatment-BLU554|Physician Decision|0|||
147575031|NCT04194801|532263398|FG000|Part Ib/II End Of Treatment-BLU554|Radiographic disease progression|3|||
147652513|NCT04217317|532550313|FG000|Overall Study|Lack of Efficacy|4|||
147652514|NCT04217317|532550313|FG000|Overall Study|Physician Decision|1|||
147652515|NCT02087943|532550314|FG000|Placebo-Controlled Phase Week 0-12|Adverse Event|1|||
147652516|NCT02087943|532550315|FG001|Placebo-Controlled Phase Week 0-12|Adverse Event|2|||
147652517|NCT02087943|532550316|FG002|Placebo-Controlled Phase Week 0-12|Adverse Event|6|||
147652518|NCT02087943|532550317|FG003|Placebo-Controlled Phase Week 0-12|Adverse Event|0|||
147652519|NCT02087943|532550318|FG004|Placebo-Controlled Phase Week 0-12|Adverse Event|0|||
147652520|NCT02087943|532550314|FG000|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|8|||
147652521|NCT02087943|532550315|FG001|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|7|||
147575032|NCT04194801|532263399|FG001|Part Ib/II End Of Treatment-BLU554|Radiographic disease progression|4|||
147575033|NCT04194801|532263400|FG002|Part Ib/II End Of Treatment-BLU554|Radiographic disease progression|9|||
147575034|NCT04194801|532263398|FG000|Part Ib/II End Of Treatment-BLU554|Symptomatic deterioration without radiographic evidence|0|||
147575035|NCT04194801|532263399|FG001|Part Ib/II End Of Treatment-BLU554|Symptomatic deterioration without radiographic evidence|1|||
147575036|NCT04194801|532263400|FG002|Part Ib/II End Of Treatment-BLU554|Symptomatic deterioration without radiographic evidence|0|||
147575037|NCT04194801|532263398|FG000|Part Ib/II End Of Treatment-BLU554|Other|0|||
147575038|NCT04194801|532263399|FG001|Part Ib/II End Of Treatment-BLU554|Other|0|||
147652522|NCT02087943|532550316|FG002|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|4|||
147652523|NCT02087943|532550317|FG003|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|0|||
147652524|NCT02087943|532550318|FG004|Placebo-Controlled Phase Week 0-12|Lack of Efficacy|0|||
147652525|NCT02087943|532550314|FG000|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|4|||
147652526|NCT02087943|532550315|FG001|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|2|||
147652527|NCT02087943|532550316|FG002|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|2|||
147652528|NCT02087943|532550317|FG003|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|0|||
147238801|NCT01847274|531046153|FG009|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
147238802|NCT01847274|531046154|FG010|QTcSub-study(Upto 5 Year,10 Month,22day)|Death|0|||
147238803|NCT01847274|531046144|FG000|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
147238804|NCT01847274|531046145|FG001|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
147238805|NCT01847274|531046146|FG002|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
147238806|NCT01847274|531046147|FG003|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
147238807|NCT01847274|531046148|FG004|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
147238808|NCT01847274|531046149|FG005|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
147238809|NCT01847274|531046150|FG006|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|17|||
147238810|NCT01847274|531046151|FG007|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
147238811|NCT01847274|531046152|FG008|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
147238812|NCT01847274|531046153|FG009|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
147238813|NCT01847274|531046154|FG010|QTcSub-study(Upto 5 Year,10 Month,22day)|Other Reasons|0|||
147238814|NCT01847274|531046144|FG000|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
147238815|NCT01847274|531046145|FG001|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
147238816|NCT01847274|531046146|FG002|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
147238817|NCT01847274|531046147|FG003|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
147238818|NCT01847274|531046148|FG004|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
147238819|NCT01847274|531046149|FG005|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
147238820|NCT01847274|531046150|FG006|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|0|||
147238821|NCT01847274|531046151|FG007|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|15|||
147238822|NCT01847274|531046152|FG008|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|8|||
147575039|NCT04194801|532263400|FG002|Part Ib/II End Of Treatment-BLU554|Other|2|||
147575040|NCT04194801|532263398|FG000|Part Ib/II End Of Treatment-BLU554|Ongoing treatment|0|||
147575041|NCT04194801|532263399|FG001|Part Ib/II End Of Treatment-BLU554|Ongoing treatment|0|||
147575042|NCT04194801|532263400|FG002|Part Ib/II End Of Treatment-BLU554|Ongoing treatment|2|||
147575043|NCT04194801|532263398|FG000|Part Ib/II End Of Treatment-CS1001|Adverse Event|1|||
147575044|NCT04194801|532263399|FG001|Part Ib/II End Of Treatment-CS1001|Adverse Event|0|||
147575045|NCT04194801|532263400|FG002|Part Ib/II End Of Treatment-CS1001|Adverse Event|2|||
147146845|NCT02623205|530700994|FG001|Overall Study|Lost to Follow-Up or Discontinued Intervention|3|||
147146846|NCT02473471|530700998|FG000|Overall Study|poor oral hygiene|2|||
147652529|NCT02087943|532550318|FG004|Placebo-Controlled Phase Week 0-12|Withdrawal by Subject|0|||
147652530|NCT02087943|532550314|FG000|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|1|||
147146847|NCT02473471|530700998|FG000|Overall Study|Lost to Follow-up|1|||
147146848|NCT03082677|530700999|FG000|Overall Study|Not Treated|2|||
147146849|NCT01667133|530701000|FG000|Phase 1: Dose-escalation|Adverse Event|0|||
147146850|NCT01667133|530701001|FG001|Phase 1: Dose-escalation|Adverse Event|0|||
147146851|NCT01667133|530701002|FG002|Phase 1: Dose-escalation|Adverse Event|1|||
147146852|NCT01667133|530701003|FG003|Phase 1: Dose-escalation|Adverse Event|0|||
147146853|NCT01667133|530701004|FG004|Phase 1: Dose-escalation|Adverse Event|0|||
147652531|NCT02087943|532550315|FG001|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|0|||
147652532|NCT02087943|532550316|FG002|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|1|||
147652533|NCT02087943|532550317|FG003|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|0|||
147652534|NCT02087943|532550318|FG004|Placebo-Controlled Phase Week 0-12|Lost to Follow-up|0|||
147146854|NCT01667133|530701005|FG005|Phase 1: Dose-escalation|Adverse Event|0|||
147146855|NCT01667133|530701006|FG006|Phase 1: Dose-escalation|Adverse Event|0|||
147146856|NCT01667133|530701007|FG007|Phase 1: Dose-escalation|Adverse Event|0|||
147146857|NCT01667133|530701008|FG008|Phase 1: Dose-escalation|Adverse Event|0|||
147146858|NCT01667133|530701009|FG009|Phase 1: Dose-escalation|Adverse Event|0|||
147575046|NCT04194801|532263398|FG000|Part Ib/II End Of Treatment-CS1001|Death|0|||
147575047|NCT04194801|532263399|FG001|Part Ib/II End Of Treatment-CS1001|Death|0|||
147575048|NCT04194801|532263400|FG002|Part Ib/II End Of Treatment-CS1001|Death|1|||
147575049|NCT04194801|532263398|FG000|Part Ib/II End Of Treatment-CS1001|Radiographic disease progression|3|||
147575050|NCT04194801|532263399|FG001|Part Ib/II End Of Treatment-CS1001|Radiographic disease progression|6|||
147575051|NCT04194801|532263400|FG002|Part Ib/II End Of Treatment-CS1001|Radiographic disease progression|9|||
147575052|NCT04194801|532263398|FG000|Part Ib/II End Of Treatment-CS1001|Symptomatic deterioration without radiographic evidence|0|||
147575053|NCT04194801|532263399|FG001|Part Ib/II End Of Treatment-CS1001|Symptomatic deterioration without radiographic evidence|1|||
147575054|NCT04194801|532263400|FG002|Part Ib/II End Of Treatment-CS1001|Symptomatic deterioration without radiographic evidence|0|||
147575055|NCT04194801|532263398|FG000|Part Ib/II End Of Treatment-CS1001|Other|0|||
147575056|NCT04194801|532263399|FG001|Part Ib/II End Of Treatment-CS1001|Other|0|||
147575057|NCT04194801|532263400|FG002|Part Ib/II End Of Treatment-CS1001|Other|1|||
147575058|NCT04194801|532263398|FG000|Part Ib/II End Of Treatment-CS1001|Ongoing treatment|0|||
147575059|NCT04194801|532263399|FG001|Part Ib/II End Of Treatment-CS1001|Ongoing treatment|0|||
147575060|NCT04194801|532263400|FG002|Part Ib/II End Of Treatment-CS1001|Ongoing treatment|2|||
147575061|NCT04194801|532263398|FG000|Part Ib/II End of Study|Death|2|||
147575062|NCT04194801|532263399|FG001|Part Ib/II End of Study|Death|3|||
147575063|NCT04194801|532263400|FG002|Part Ib/II End of Study|Death|3|||
147575064|NCT04194801|532263398|FG000|Part Ib/II End of Study|Lost to Follow-up|0|||
147575065|NCT04194801|532263399|FG001|Part Ib/II End of Study|Lost to Follow-up|1|||
147575066|NCT04194801|532263400|FG002|Part Ib/II End of Study|Lost to Follow-up|0|||
147575067|NCT04194801|532263398|FG000|Part Ib/II End of Study|Withdrawal by Subject|1|||
147575068|NCT04194801|532263399|FG001|Part Ib/II End of Study|Withdrawal by Subject|0|||
147575069|NCT04194801|532263400|FG002|Part Ib/II End of Study|Withdrawal by Subject|2|||
147575070|NCT04194801|532263398|FG000|Part Ib/II End of Study|Study ended by sponsor|1|||
147575071|NCT04194801|532263399|FG001|Part Ib/II End of Study|Study ended by sponsor|3|||
147575072|NCT04194801|532263400|FG002|Part Ib/II End of Study|Study ended by sponsor|8|||
147575073|NCT04194801|532263398|FG000|Part Ib/II End of Study|Ongoing treatment|0|||
147575074|NCT04194801|532263399|FG001|Part Ib/II End of Study|Ongoing treatment|0|||
147575075|NCT04194801|532263400|FG002|Part Ib/II End of Study|Ongoing treatment|2|||
147575076|NCT00506831|532263401|FG000|Overall Study|Death|1|||
147575077|NCT00506831|532263401|FG000|Overall Study|Withdrawal by Subject|1|||
147575078|NCT01410227|532263405|FG000|Overall Study|Adverse Event|1|||
147575079|NCT01410227|532263406|FG001|Overall Study|Adverse Event|0|||
147575080|NCT01410227|532263407|FG002|Overall Study|Adverse Event|0|||
147575081|NCT01410227|532263408|FG003|Overall Study|Adverse Event|0|||
147575082|NCT01410227|532263405|FG000|Overall Study|Withdrawal by Subject|3|||
147575083|NCT01410227|532263406|FG001|Overall Study|Withdrawal by Subject|0|||
147575084|NCT01410227|532263407|FG002|Overall Study|Withdrawal by Subject|1|||
147575085|NCT01410227|532263408|FG003|Overall Study|Withdrawal by Subject|0|||
147575086|NCT01410227|532263405|FG000|Overall Study|Pregnancy|0|||
147652535|NCT02087943|532550314|FG000|Placebo-Controlled Phase Week 0-12|Protocol Violation|0|||
147652536|NCT02087943|532550315|FG001|Placebo-Controlled Phase Week 0-12|Protocol Violation|1|||
147146859|NCT01667133|530701010|FG010|Phase 1: Dose-escalation|Adverse Event|0|||
147146860|NCT01667133|530701011|FG011|Phase 1: Dose-escalation|Adverse Event|0|||
147146861|NCT01667133|530701000|FG000|Phase 1: Dose-escalation|Lack of Efficacy|0|||
147575087|NCT01410227|532263406|FG001|Overall Study|Pregnancy|0|||
147575088|NCT01410227|532263407|FG002|Overall Study|Pregnancy|0|||
147575089|NCT01410227|532263408|FG003|Overall Study|Pregnancy|1|||
147575090|NCT01410227|532263405|FG000|Overall Study|Met Excl. Criteria After Starting Study|0|||
147575091|NCT01410227|532263406|FG001|Overall Study|Met Excl. Criteria After Starting Study|0|||
147575092|NCT01410227|532263407|FG002|Overall Study|Met Excl. Criteria After Starting Study|1|||
147575093|NCT01410227|532263408|FG003|Overall Study|Met Excl. Criteria After Starting Study|0|||
147575094|NCT01808651|532263409|FG000|Study Period 1|Lost to Follow-up|1|||
147575095|NCT01808651|532263410|FG001|Study Period 1|Lost to Follow-up|3|||
147575096|NCT01808651|532263411|FG002|Study Period 1|Lost to Follow-up|0|||
147575097|NCT01808651|532263409|FG000|Study Period 1|Protocol Violation|1|||
147575098|NCT01808651|532263410|FG001|Study Period 1|Protocol Violation|0|||
147575099|NCT01808651|532263411|FG002|Study Period 1|Protocol Violation|1|||
147575100|NCT01808651|532263409|FG000|Study Period 1|Physician Decision|3|||
147575101|NCT01808651|532263410|FG001|Study Period 1|Physician Decision|2|||
147575102|NCT01808651|532263411|FG002|Study Period 1|Physician Decision|0|||
147575103|NCT01808651|532263409|FG000|Study Period 1|Lack of Efficacy|2|||
147575104|NCT01808651|532263410|FG001|Study Period 1|Lack of Efficacy|1|||
147575105|NCT01808651|532263411|FG002|Study Period 1|Lack of Efficacy|0|||
147575106|NCT01808651|532263409|FG000|Study Period 1|Adverse Event|10|||
147575107|NCT01808651|532263410|FG001|Study Period 1|Adverse Event|4|||
147575108|NCT01808651|532263411|FG002|Study Period 1|Adverse Event|1|||
147575109|NCT01808651|532263409|FG000|Study Period 1|Participant Decision|9|||
147575110|NCT01808651|532263410|FG001|Study Period 1|Participant Decision|7|||
147575111|NCT01808651|532263411|FG002|Study Period 1|Participant Decision|3|||
147575112|NCT00585286|532263413|FG000|Overall Study|Lost to Follow-up|1|||
147575113|NCT00608322|532263416|FG000|Overall Study|Death|2|||
147575114|NCT00608322|532263417|FG001|Overall Study|Death|1|||
147575115|NCT03497130|532263418|FG000|Overall Study|Lost to Follow-up|1|||
147575116|NCT03497130|532263419|FG001|Overall Study|Lost to Follow-up|1|||
147575117|NCT04002648|532263420|FG000|Overall Study|Lost to Follow-up|2|||
147575118|NCT04002648|532263421|FG001|Overall Study|Lost to Follow-up|0|||
147575119|NCT00606281|532263427|FG000|Overall Study|Adverse Event|11|||
147575120|NCT00606281|532263428|FG001|Overall Study|Adverse Event|12|||
147575121|NCT00606281|532263427|FG000|Overall Study|Death|1|||
147575122|NCT00606281|532263428|FG001|Overall Study|Death|0|||
147575123|NCT00606281|532263427|FG000|Overall Study|Lack of Efficacy|28|||
147575124|NCT00606281|532263428|FG001|Overall Study|Lack of Efficacy|35|||
147575125|NCT00606281|532263427|FG000|Overall Study|Physician Decision|0|||
147575126|NCT00606281|532263428|FG001|Overall Study|Physician Decision|1|||
147575127|NCT00606281|532263427|FG000|Overall Study|Protocol Violation|3|||
147575128|NCT00606281|532263428|FG001|Overall Study|Protocol Violation|3|||
147575129|NCT00606281|532263427|FG000|Overall Study|Withdrawal by Subject|11|||
147575130|NCT00606281|532263428|FG001|Overall Study|Withdrawal by Subject|13|||
147575131|NCT00606281|532263427|FG000|Overall Study|Progression to depressive phase|1|||
147575132|NCT00606281|532263428|FG001|Overall Study|Progression to depressive phase|1|||
147575133|NCT00606281|532263427|FG000|Overall Study|Change of residence or other commitments|1|||
147575134|NCT00606281|532263428|FG001|Overall Study|Change of residence or other commitments|1|||
147575135|NCT00829712|532263429|FG000|Washout of 7 Days|Withdrawal by Subject|0|||
147575136|NCT00829712|532263430|FG001|Washout of 7 Days|Withdrawal by Subject|1|||
147575137|NCT03131895|532263432|FG000|Washout Period (at Least 5 Days)|Adverse Event|1|||
147575138|NCT03131895|532263433|FG001|Washout Period (at Least 5 Days)|Adverse Event|0|||
147575139|NCT03131895|532263434|FG002|Washout Period (at Least 5 Days)|Adverse Event|0|||
147575140|NCT03131895|532263435|FG003|Washout Period (at Least 5 Days)|Adverse Event|1|||
147575141|NCT03131895|532263432|FG000|Washout Period (at Least 5 Days)|Lost to Follow-up|0|||
147575142|NCT03131895|532263433|FG001|Washout Period (at Least 5 Days)|Lost to Follow-up|3|||
147575143|NCT03131895|532263434|FG002|Washout Period (at Least 5 Days)|Lost to Follow-up|2|||
147575144|NCT03131895|532263435|FG003|Washout Period (at Least 5 Days)|Lost to Follow-up|3|||
147249862|NCT01018186|531083794|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
147575145|NCT03131895|532263432|FG000|Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
147575146|NCT03131895|532263433|FG001|Washout Period (at Least 5 Days)|Withdrawal by Subject|2|||
147575147|NCT03131895|532263434|FG002|Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
147575148|NCT03131895|532263435|FG003|Washout Period (at Least 5 Days)|Withdrawal by Subject|1|||
147575149|NCT03131895|532263432|FG000|Washout Period (at Least 5 Days)|Other|0|||
147575150|NCT03131895|532263433|FG001|Washout Period (at Least 5 Days)|Other|0|||
147575151|NCT03131895|532263434|FG002|Washout Period (at Least 5 Days)|Other|2|||
147575152|NCT03131895|532263435|FG003|Washout Period (at Least 5 Days)|Other|0|||
147575153|NCT03131895|532263432|FG000|Intervention Period 2 (2 Days)|Lost to Follow-up|0|||
147652537|NCT02087943|532550316|FG002|Placebo-Controlled Phase Week 0-12|Protocol Violation|0|||
147652538|NCT02087943|532550317|FG003|Placebo-Controlled Phase Week 0-12|Protocol Violation|0|||
147575154|NCT03131895|532263433|FG001|Intervention Period 2 (2 Days)|Lost to Follow-up|1|||
147575155|NCT03131895|532263434|FG002|Intervention Period 2 (2 Days)|Lost to Follow-up|0|||
147575156|NCT03131895|532263435|FG003|Intervention Period 2 (2 Days)|Lost to Follow-up|0|||
147575157|NCT03131895|532263432|FG000|Intervention Period 2 (2 Days)|Withdrawal by Subject|1|||
147575158|NCT03131895|532263433|FG001|Intervention Period 2 (2 Days)|Withdrawal by Subject|0|||
147575159|NCT03131895|532263434|FG002|Intervention Period 2 (2 Days)|Withdrawal by Subject|0|||
147575160|NCT03131895|532263435|FG003|Intervention Period 2 (2 Days)|Withdrawal by Subject|0|||
147575161|NCT05752721|532263438|FG000|Overall Study|Lost to Follow-up|22|||
147575162|NCT05752721|532263439|FG001|Overall Study|Lost to Follow-up|20|||
147575163|NCT05752721|532263438|FG000|Overall Study|Withdrawal by Subject|15|||
147575164|NCT05752721|532263439|FG001|Overall Study|Withdrawal by Subject|12|||
147575165|NCT02280863|532263440|FG000|Integrated Platform|Met stopping criteria|0|||
147575166|NCT02280863|532263441|FG001|Integrated Platform|Met stopping criteria|1|||
147575167|NCT03158727|532263450|FG000|Overall Study|Withdrawal by Subject|2|||
147575168|NCT03158727|532263451|FG001|Overall Study|Withdrawal by Subject|6|||
147575169|NCT03158727|532263450|FG000|Overall Study|Death|11|||
147652539|NCT02087943|532550318|FG004|Placebo-Controlled Phase Week 0-12|Protocol Violation|0|||
147652540|NCT02087943|532550314|FG000|Active Treatment Phase Week 12-24|Adverse Event|0|||
147652541|NCT02087943|532550315|FG001|Active Treatment Phase Week 12-24|Adverse Event|1|||
147652542|NCT02087943|532550316|FG002|Active Treatment Phase Week 12-24|Adverse Event|2|||
147652543|NCT02087943|532550317|FG003|Active Treatment Phase Week 12-24|Adverse Event|0|||
147652544|NCT02087943|532550318|FG004|Active Treatment Phase Week 12-24|Adverse Event|1|||
147652545|NCT02087943|532550314|FG000|Active Treatment Phase Week 12-24|Lack of Efficacy|0|||
147652546|NCT02087943|532550315|FG001|Active Treatment Phase Week 12-24|Lack of Efficacy|3|||
147238823|NCT01847274|531046153|FG009|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|18|||
147238824|NCT01847274|531046154|FG010|Main Study PSU (Up to 8months, 26days)|Subject Unblinded by Sponsor|12|||
147238825|NCT01847274|531046144|FG000|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
147238826|NCT01847274|531046145|FG001|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
147238827|NCT01847274|531046146|FG002|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
147238828|NCT01847274|531046147|FG003|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
147238829|NCT01847274|531046148|FG004|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
147238830|NCT01847274|531046149|FG005|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
147238831|NCT01847274|531046150|FG006|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
147238832|NCT01847274|531046151|FG007|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|6|||
147238833|NCT01847274|531046152|FG008|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
147238834|NCT01847274|531046153|FG009|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|9|||
147238835|NCT01847274|531046154|FG010|Main Study PSU (Up to 8months, 26days)|Subject Moved to Rollover Study|0|||
147238836|NCT01847274|531046144|FG000|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
147238837|NCT01847274|531046145|FG001|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
147238838|NCT01847274|531046146|FG002|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
147238839|NCT01847274|531046147|FG003|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
147238840|NCT01847274|531046148|FG004|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
147238841|NCT01847274|531046149|FG005|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
147238842|NCT01847274|531046150|FG006|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
147238843|NCT01847274|531046151|FG007|Main Study PSU (Up to 8months, 26days)|Other reasons|1|||
147238844|NCT01847274|531046152|FG008|Main Study PSU (Up to 8months, 26days)|Other reasons|0|||
147238845|NCT01847274|531046153|FG009|Main Study PSU (Up to 8months, 26days)|Other reasons|3|||
147238846|NCT01847274|531046154|FG010|Main Study PSU (Up to 8months, 26days)|Other reasons|1|||
147238847|NCT01847274|531046144|FG000|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
147238848|NCT01847274|531046145|FG001|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
147238849|NCT01847274|531046146|FG002|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
147238850|NCT01847274|531046147|FG003|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
147238851|NCT01847274|531046148|FG004|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
147238852|NCT01847274|531046149|FG005|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
147238853|NCT01847274|531046150|FG006|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
147238854|NCT01847274|531046151|FG007|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
147238855|NCT01847274|531046152|FG008|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
147238856|NCT01847274|531046153|FG009|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|1|||
147238857|NCT01847274|531046154|FG010|Main Study PSU (Up to 8months, 26days)|Withdrawal by Subject|0|||
147238858|NCT01921387|531046155|FG000|Overall Study|Adverse Event|1|||
147238859|NCT01786668|531046163|FG000|Overall Study|Adverse Event|0|||
147238860|NCT01786668|531046164|FG001|Overall Study|Adverse Event|1|||
147238861|NCT01786668|531046165|FG002|Overall Study|Adverse Event|1|||
147238862|NCT01786668|531046166|FG003|Overall Study|Adverse Event|2|||
147238863|NCT01786668|531046163|FG000|Overall Study|Withdrawal by Subject|0|||
147238864|NCT01786668|531046164|FG001|Overall Study|Withdrawal by Subject|0|||
147238865|NCT01786668|531046165|FG002|Overall Study|Withdrawal by Subject|3|||
147238866|NCT01786668|531046166|FG003|Overall Study|Withdrawal by Subject|1|||
147238867|NCT01786668|531046163|FG000|Overall Study|Pregnancy|0|||
147238868|NCT01786668|531046164|FG001|Overall Study|Pregnancy|0|||
147238869|NCT01786668|531046165|FG002|Overall Study|Pregnancy|0|||
147238870|NCT01786668|531046166|FG003|Overall Study|Pregnancy|1|||
147238871|NCT01786668|531046163|FG000|Overall Study|Lost to Follow-up|1|||
147238872|NCT01786668|531046164|FG001|Overall Study|Lost to Follow-up|0|||
147238873|NCT01786668|531046165|FG002|Overall Study|Lost to Follow-up|1|||
147575170|NCT03158727|532263451|FG001|Overall Study|Death|12|||
147575171|NCT03158727|532263450|FG000|Overall Study|Lost to Follow-up|1|||
147575172|NCT03158727|532263451|FG001|Overall Study|Lost to Follow-up|0|||
147575173|NCT03158727|532263450|FG000|Overall Study|Participant doesn't want to come back to the hospital for the visit|2|||
147575174|NCT03158727|532263451|FG001|Overall Study|Participant doesn't want to come back to the hospital for the visit|0|||
147575175|NCT03158727|532263450|FG000|Overall Study|Visit 11 not done by mistake|0|||
147652547|NCT02087943|532550316|FG002|Active Treatment Phase Week 12-24|Lack of Efficacy|1|||
147652548|NCT02087943|532550317|FG003|Active Treatment Phase Week 12-24|Lack of Efficacy|1|||
147319265|NCT01923428|531334828|FG003|Overall Study|Protocol Violation|1|||
147319266|NCT01923428|531334825|FG000|Overall Study|Non Compliance to treatment|1|||
147319267|NCT01923428|531334826|FG001|Overall Study|Non Compliance to treatment|2|||
147319268|NCT01923428|531334827|FG002|Overall Study|Non Compliance to treatment|0|||
147319269|NCT01923428|531334828|FG003|Overall Study|Non Compliance to treatment|1|||
147319270|NCT01923428|531334825|FG000|Overall Study|Lack of Efficacy|0|||
147319271|NCT01923428|531334826|FG001|Overall Study|Lack of Efficacy|0|||
147319272|NCT01923428|531334827|FG002|Overall Study|Lack of Efficacy|1|||
147319273|NCT01923428|531334828|FG003|Overall Study|Lack of Efficacy|1|||
147319274|NCT04320615|531334829|FG000|Overall Study|Withdrawal by Subject|4|||
147319275|NCT04320615|531334830|FG001|Overall Study|Withdrawal by Subject|10|||
147319276|NCT04320615|531334829|FG000|Overall Study|Physician Decision|2|||
147319277|NCT04320615|531334830|FG001|Overall Study|Physician Decision|0|||
147319278|NCT04320615|531334829|FG000|Overall Study|Other|2|||
147319279|NCT04320615|531334830|FG001|Overall Study|Other|0|||
147319280|NCT04320615|531334829|FG000|Overall Study|Lost to Follow-up|5|||
147319281|NCT04320615|531334830|FG001|Overall Study|Lost to Follow-up|23|||
147319282|NCT04320615|531334829|FG000|Overall Study|Death|35|||
147319283|NCT04320615|531334830|FG001|Overall Study|Death|71|||
147319284|NCT02107443|531334831|FG000|Overall Study|Death|42|||
147319285|NCT02107443|531334832|FG001|Overall Study|Death|30|||
147319286|NCT02107443|531334831|FG000|Overall Study|Study Protocol Violation|3|||
147319287|NCT02107443|531334832|FG001|Overall Study|Study Protocol Violation|1|||
147319288|NCT02107443|531334831|FG000|Overall Study|Registered but Not Eligible|0|||
147319289|NCT02107443|531334832|FG001|Overall Study|Registered but Not Eligible|1|||
147319290|NCT02107443|531334831|FG000|Overall Study|Withdrawal: Hospitalization/Hospice|28|||
147319291|NCT02107443|531334832|FG001|Overall Study|Withdrawal: Hospitalization/Hospice|28|||
147319292|NCT02107443|531334831|FG000|Overall Study|Withdrawal: Disliked Study Procedures|1|||
147319293|NCT02107443|531334832|FG001|Overall Study|Withdrawal: Disliked Study Procedures|2|||
147319294|NCT02107443|531334831|FG000|Overall Study|Withdrawal: Changed Mind|2|||
147319295|NCT02107443|531334832|FG001|Overall Study|Withdrawal: Changed Mind|0|||
147319296|NCT02107443|531334831|FG000|Overall Study|Withdrawal: Changed MD/Facility|1|||
147319297|NCT02107443|531334832|FG001|Overall Study|Withdrawal: Changed MD/Facility|3|||
147319298|NCT02107443|531334831|FG000|Overall Study|Withdrawal: Too Many Forms|3|||
147319299|NCT02107443|531334832|FG001|Overall Study|Withdrawal: Too Many Forms|1|||
147319300|NCT02107443|531334831|FG000|Overall Study|Withdrawal: Too Time Consuming|3|||
147319301|NCT02107443|531334832|FG001|Overall Study|Withdrawal: Too Time Consuming|6|||
147319302|NCT02107443|531334831|FG000|Overall Study|Withdrawal: Feeling Overwhelmed|2|||
147319303|NCT02107443|531334832|FG001|Overall Study|Withdrawal: Feeling Overwhelmed|1|||
147319304|NCT02107443|531334831|FG000|Overall Study|Withdrawal: Other Medical|9|||
147319305|NCT02107443|531334832|FG001|Overall Study|Withdrawal: Other Medical|5|||
147319306|NCT02107443|531334831|FG000|Overall Study|Withdrawal: Disease Progression|4|||
147319307|NCT02107443|531334832|FG001|Overall Study|Withdrawal: Disease Progression|2|||
147319308|NCT02107443|531334831|FG000|Overall Study|Withdrawal: Personal Issues|0|||
147319309|NCT02107443|531334832|FG001|Overall Study|Withdrawal: Personal Issues|3|||
147319310|NCT01400893|531334833|FG000|Overall Study|Death|27|||
147319311|NCT01400893|531334834|FG001|Overall Study|Death|21|||
147319312|NCT01400893|531334833|FG000|Overall Study|Lost to Follow-up|0|||
147445873|NCT00455013|531797470|FG001|Long Term Extension (LTE)|No longer met criteria|0|||
147575176|NCT03158727|532263451|FG001|Overall Study|Visit 11 not done by mistake|1|||
147575177|NCT03158727|532263450|FG000|Overall Study|Enrolled, not treated|1|||
147575178|NCT03158727|532263451|FG001|Overall Study|Enrolled, not treated|0|||
147575179|NCT00669162|532263452|FG000|Overall Study|Withdrawal by Subject|1|||
147146862|NCT01667133|530701001|FG001|Phase 1: Dose-escalation|Lack of Efficacy|0|||
147319313|NCT01400893|531334834|FG001|Overall Study|Lost to Follow-up|6|||
147319314|NCT00946647|531334835|FG000|Phase 1 Part|Adverse Event|2|||
147319315|NCT00946647|531334836|FG001|Phase 1 Part|Adverse Event|5|||
147319316|NCT00946647|531334837|FG002|Phase 1 Part|Adverse Event|3|||
147319317|NCT00946647|531334838|FG003|Phase 1 Part|Adverse Event|0|||
147319318|NCT00946647|531334839|FG004|Phase 1 Part|Adverse Event|0|||
147319319|NCT00946647|531334835|FG000|Phase 1 Part|Disease progression|3|||
147319320|NCT00946647|531334836|FG001|Phase 1 Part|Disease progression|6|||
147319321|NCT00946647|531334837|FG002|Phase 1 Part|Disease progression|1|||
147319322|NCT00946647|531334838|FG003|Phase 1 Part|Disease progression|0|||
147319323|NCT00946647|531334839|FG004|Phase 1 Part|Disease progression|0|||
147319324|NCT00946647|531334835|FG000|Phase 1 Part|Withdrawal by Subject|1|||
147319325|NCT00946647|531334836|FG001|Phase 1 Part|Withdrawal by Subject|4|||
147319326|NCT00946647|531334837|FG002|Phase 1 Part|Withdrawal by Subject|3|||
147319327|NCT00946647|531334838|FG003|Phase 1 Part|Withdrawal by Subject|0|||
147319328|NCT00946647|531334839|FG004|Phase 1 Part|Withdrawal by Subject|0|||
147319329|NCT00946647|531334835|FG000|Phase 1 Part|Abnormal values|0|||
147319330|NCT00946647|531334836|FG001|Phase 1 Part|Abnormal values|2|||
147319331|NCT00946647|531334837|FG002|Phase 1 Part|Abnormal values|0|||
147319332|NCT00946647|531334838|FG003|Phase 1 Part|Abnormal values|0|||
147319333|NCT00946647|531334839|FG004|Phase 1 Part|Abnormal values|0|||
147319334|NCT00946647|531334835|FG000|Phase 1 Part|Reason missing|0|||
147445874|NCT00455013|531797471|FG002|Long Term Extension (LTE)|No longer met criteria|1|||
147445875|NCT00455013|531797469|FG000|Long Term Extension (LTE)|Subject Request or refused|0|||
147445876|NCT00455013|531797470|FG001|Long Term Extension (LTE)|Subject Request or refused|0|||
147445877|NCT00455013|531797471|FG002|Long Term Extension (LTE)|Subject Request or refused|3|||
147445878|NCT00455013|531797469|FG000|Long Term Extension (LTE)|Poor non-compliance|0|||
147445879|NCT00455013|531797470|FG001|Long Term Extension (LTE)|Poor non-compliance|1|||
147445880|NCT00455013|531797471|FG002|Long Term Extension (LTE)|Poor non-compliance|0|||
147445881|NCT00455013|531797469|FG000|Long Term Extension (LTE)|non-specified|0|||
147445882|NCT00455013|531797470|FG001|Long Term Extension (LTE)|non-specified|0|||
147445883|NCT00455013|531797471|FG002|Long Term Extension (LTE)|non-specified|1|||
147445884|NCT01445951|531797472|FG000|Overall Study|Adverse Event|16|||
147445885|NCT01445951|531797473|FG001|Overall Study|Adverse Event|9|||
147445886|NCT01445951|531797474|FG002|Overall Study|Adverse Event|0|||
147445887|NCT01445951|531797472|FG000|Overall Study|Protocol Violation|2|||
147445888|NCT01445951|531797473|FG001|Overall Study|Protocol Violation|2|||
147445889|NCT01445951|531797474|FG002|Overall Study|Protocol Violation|2|||
147575180|NCT00807495|532263453|FG000|Overall Study|Adverse Event|6|||
147575181|NCT00807495|532263454|FG001|Overall Study|Adverse Event|3|||
147575182|NCT00807495|532263455|FG002|Overall Study|Adverse Event|1|||
147575183|NCT00807495|532263456|FG003|Overall Study|Adverse Event|1|||
147575184|NCT00807495|532263457|FG004|Overall Study|Adverse Event|2|||
147575185|NCT00807495|532263453|FG000|Overall Study|Withdrawal by Patient|2|||
147575186|NCT00807495|532263454|FG001|Overall Study|Withdrawal by Patient|0|||
147575187|NCT00807495|532263455|FG002|Overall Study|Withdrawal by Patient|1|||
147575188|NCT00807495|532263456|FG003|Overall Study|Withdrawal by Patient|0|||
147575189|NCT00807495|532263457|FG004|Overall Study|Withdrawal by Patient|0|||
147575190|NCT00807495|532263453|FG000|Overall Study|Reason Not Specified|0|||
147575191|NCT00807495|532263454|FG001|Overall Study|Reason Not Specified|3|||
147575192|NCT00807495|532263455|FG002|Overall Study|Reason Not Specified|2|||
147575193|NCT00807495|532263456|FG003|Overall Study|Reason Not Specified|0|||
147575194|NCT00807495|532263457|FG004|Overall Study|Reason Not Specified|3|||
147575195|NCT00985439|532263458|FG000|Overall Study|Adverse Event|0|||
147575196|NCT00985439|532263459|FG001|Overall Study|Adverse Event|0|||
147575197|NCT00985439|532263460|FG002|Overall Study|Adverse Event|1|||
147575198|NCT00985439|532263461|FG003|Overall Study|Adverse Event|0|||
147575199|NCT01174186|532263462|FG000|Overall Study|Lost to Follow-up|0|||
147575200|NCT01174186|532263463|FG001|Overall Study|Lost to Follow-up|1|||
147575201|NCT01174186|532263462|FG000|Overall Study|Withdrawal by Subject|0|||
147575202|NCT01174186|532263463|FG001|Overall Study|Withdrawal by Subject|2|||
147575203|NCT00463684|532263468|FG000|Overall Study|Withdrawal by Subject|1|||
147575204|NCT00463684|532263468|FG000|Overall Study|Lost to Follow-up|3|||
147575205|NCT01906372|532263469|FG000|Overall Study|Withdrawal by Subject|2|||
147575206|NCT03629054|532263471|FG000|Period 2 (4 Days)|Not treated|0|||
147575207|NCT03629054|532263472|FG001|Period 2 (4 Days)|Not treated|1|||
147575208|NCT00924638|532263473|FG000|Overall Study|Death|3|||
147575209|NCT00924638|532263474|FG001|Overall Study|Death|2|||
147575210|NCT00924638|532263473|FG000|Overall Study|Lost to Follow-up|1|||
147575211|NCT00924638|532263474|FG001|Overall Study|Lost to Follow-up|1|||
147575212|NCT00924638|532263473|FG000|Overall Study|Withdrawal by Subject|5|||
147575213|NCT00924638|532263474|FG001|Overall Study|Withdrawal by Subject|7|||
147575214|NCT00924638|532263473|FG000|Overall Study|Physician Decision|3|||
147575215|NCT00924638|532263474|FG001|Overall Study|Physician Decision|3|||
147575216|NCT00367133|532263475|FG000|2 Years|Death|20|||
147575217|NCT00367133|532263476|FG001|2 Years|Death|12|||
147575218|NCT00367133|532263477|FG002|2 Years|Death|12|||
147575219|NCT00367133|532263475|FG000|2 Years|Dropped|34|||
147575220|NCT00367133|532263476|FG001|2 Years|Dropped|19|||
147575221|NCT00367133|532263477|FG002|2 Years|Dropped|33|||
147575222|NCT00367133|532263475|FG000|2 Years|Missed visit|4|||
147575223|NCT00367133|532263476|FG001|2 Years|Missed visit|5|||
147575224|NCT00367133|532263477|FG002|2 Years|Missed visit|4|||
147575225|NCT00847535|532263483|FG000|Overall Study|Withdrawal by Subject|2|||
147575226|NCT00847535|532263484|FG001|Overall Study|Withdrawal by Subject|1|||
147575227|NCT00847535|532263485|FG002|Overall Study|Withdrawal by Subject|1|||
147575228|NCT00847535|532263483|FG000|Overall Study|Lost to Follow-up|0|||
147319335|NCT00946647|531334836|FG001|Phase 1 Part|Reason missing|1|||
147319336|NCT00946647|531334837|FG002|Phase 1 Part|Reason missing|0|||
147319337|NCT00946647|531334838|FG003|Phase 1 Part|Reason missing|0|||
147319338|NCT00946647|531334839|FG004|Phase 1 Part|Reason missing|0|||
147319339|NCT00946647|531334835|FG000|Phase ll Part|Untreated|0|||
147319340|NCT00946647|531334836|FG001|Phase ll Part|Untreated|0|||
147445890|NCT01445951|531797472|FG000|Overall Study|Withdrawal by Subject|21|||
147575229|NCT00847535|532263484|FG001|Overall Study|Lost to Follow-up|1|||
147575230|NCT00847535|532263485|FG002|Overall Study|Lost to Follow-up|0|||
147575231|NCT01252953|532263486|FG000|Overall Study|Withdrawal by Subject|16|||
147575232|NCT01252953|532263487|FG001|Overall Study|Withdrawal by Subject|17|||
147575233|NCT01252953|532263486|FG000|Overall Study|Lost to Follow-up|22|||
147575234|NCT01252953|532263487|FG001|Overall Study|Lost to Follow-up|21|||
147575235|NCT02336074|532263488|FG000|Overall Study|Adverse Event|0|||
147575236|NCT02336074|532263489|FG001|Overall Study|Adverse Event|2|||
147575237|NCT02054715|532263492|FG000|Baseline/Follow-up 1|Refused|1|||
147575238|NCT02054715|532263493|FG001|Baseline/Follow-up 1|Refused|3|||
147575239|NCT02054715|532263492|FG000|Baseline/Follow-up 1|Medical|0|||
147652549|NCT02087943|532550318|FG004|Active Treatment Phase Week 12-24|Lack of Efficacy|0|||
147652550|NCT02087943|532550314|FG000|Active Treatment Phase Week 12-24|Withdrawal by Subject|0|||
147652551|NCT02087943|532550315|FG001|Active Treatment Phase Week 12-24|Withdrawal by Subject|0|||
147652552|NCT02087943|532550316|FG002|Active Treatment Phase Week 12-24|Withdrawal by Subject|1|||
147652553|NCT02087943|532550317|FG003|Active Treatment Phase Week 12-24|Withdrawal by Subject|0|||
147652554|NCT02087943|532550318|FG004|Active Treatment Phase Week 12-24|Withdrawal by Subject|0|||
147652555|NCT02087943|532550314|FG000|Active Treatment Phase Week 12-24|Lost to Follow-up|0|||
147652556|NCT02087943|532550315|FG001|Active Treatment Phase Week 12-24|Lost to Follow-up|0|||
147652557|NCT02087943|532550316|FG002|Active Treatment Phase Week 12-24|Lost to Follow-up|0|||
147652558|NCT02087943|532550317|FG003|Active Treatment Phase Week 12-24|Lost to Follow-up|0|||
147652559|NCT02087943|532550318|FG004|Active Treatment Phase Week 12-24|Lost to Follow-up|1|||
147652560|NCT02087943|532550314|FG000|Active Treatment Phase Week 12-24|Other-Unspecified|0|||
147652561|NCT02087943|532550315|FG001|Active Treatment Phase Week 12-24|Other-Unspecified|0|||
147652562|NCT02087943|532550316|FG002|Active Treatment Phase Week 12-24|Other-Unspecified|1|||
147652563|NCT02087943|532550317|FG003|Active Treatment Phase Week 12-24|Other-Unspecified|1|||
147652564|NCT02087943|532550318|FG004|Active Treatment Phase Week 12-24|Other-Unspecified|0|||
147652565|NCT03836209|532550320|FG000|Overall Study|Adverse Event|5|||
147652566|NCT03836209|532550321|FG001|Overall Study|Adverse Event|2|||
147652567|NCT03836209|532550320|FG000|Overall Study|Death|4|||
147652568|NCT03836209|532550321|FG001|Overall Study|Death|1|||
147652569|NCT03836209|532550320|FG000|Overall Study|Lack of Efficacy|7|||
147652570|NCT03836209|532550321|FG001|Overall Study|Lack of Efficacy|10|||
147652571|NCT03836209|532550320|FG000|Overall Study|Physician Decision|7|||
147652572|NCT03836209|532550321|FG001|Overall Study|Physician Decision|11|||
147652573|NCT03836209|532550320|FG000|Overall Study|Protocol Violation|0|||
147652574|NCT03836209|532550321|FG001|Overall Study|Protocol Violation|3|||
147652575|NCT03836209|532550320|FG000|Overall Study|Withdrawal by Subject|2|||
147652576|NCT03836209|532550321|FG001|Overall Study|Withdrawal by Subject|10|||
147652577|NCT03836209|532550320|FG000|Overall Study|Intercurrent illness, Recurrence of disease, Subject proceeded to transplant or non-protocol therapy|55|||
147652578|NCT03836209|532550321|FG001|Overall Study|Intercurrent illness, Recurrence of disease, Subject proceeded to transplant or non-protocol therapy|44|||
147652579|NCT03739710|532550322|FG000|Overall Study|Screen Failed|81|||
147652580|NCT01753115|532550323|FG000|Overall Study|Lost to Follow-up|3|||
147652581|NCT01753115|532550324|FG001|Overall Study|Lost to Follow-up|6|||
147652582|NCT01753115|532550325|FG002|Overall Study|Lost to Follow-up|8|||
147652583|NCT01753115|532550323|FG000|Overall Study|Withdrawal by Subject|6|||
147652584|NCT01753115|532550324|FG001|Overall Study|Withdrawal by Subject|5|||
147652585|NCT01753115|532550325|FG002|Overall Study|Withdrawal by Subject|6|||
147652586|NCT01753115|532550323|FG000|Overall Study|Subject non-compliant|3|||
147238874|NCT01786668|531046166|FG003|Overall Study|Lost to Follow-up|0|||
147238875|NCT03570697|531046167|FG000|Overall Study|Lost to Follow-up|0|||
147238876|NCT03570697|531046168|FG001|Overall Study|Lost to Follow-up|1|||
147238877|NCT03570697|531046167|FG000|Overall Study|Death|2|||
147238878|NCT03570697|531046168|FG001|Overall Study|Death|0|||
147238879|NCT03570697|531046167|FG000|Overall Study|Withdrawal by Subject|4|||
147238880|NCT03570697|531046168|FG001|Overall Study|Withdrawal by Subject|2|||
147238881|NCT01876420|531046170|FG000|Overall Study|Missed 30 day visit|1|||
147238882|NCT03173313|531046171|FG000|Overall Study|Lost to Follow-up|2|||
147238883|NCT03173313|531046172|FG001|Overall Study|Lost to Follow-up|3|||
147238884|NCT03173313|531046171|FG000|Overall Study|Withdrawal by Subject|0|||
147238885|NCT03173313|531046172|FG001|Overall Study|Withdrawal by Subject|1|||
147238886|NCT03173313|531046171|FG000|Overall Study|Death|5|||
147238887|NCT03173313|531046172|FG001|Overall Study|Death|0|||
147238888|NCT03173313|531046171|FG000|Overall Study|Physician Decision|1|||
147238889|NCT03173313|531046172|FG001|Overall Study|Physician Decision|0|||
147238890|NCT03173313|531046171|FG000|Overall Study|Diagnosis of Takotsubo Cardiomyopathy|0|||
147238891|NCT03173313|531046172|FG001|Overall Study|Diagnosis of Takotsubo Cardiomyopathy|1|||
147238892|NCT03173313|531046171|FG000|Overall Study|Bone Fracture|1|||
147238893|NCT03173313|531046172|FG001|Overall Study|Bone Fracture|0|||
147238894|NCT05338216|531046175|FG000|Overall Study|Withdrawal by Subject|1|||
147238895|NCT05338216|531046176|FG001|Overall Study|Withdrawal by Subject|1|||
147238896|NCT04457336|531046177|FG000|Period 2: Part A|Withdrawal by Subject|0|||
147652587|NCT01753115|532550324|FG001|Overall Study|Subject non-compliant|3|||
147575240|NCT02054715|532263493|FG001|Baseline/Follow-up 1|Medical|1|||
147319341|NCT00946647|531334837|FG002|Phase ll Part|Untreated|0|||
147319342|NCT00946647|531334838|FG003|Phase ll Part|Untreated|0|||
147319343|NCT00946647|531334839|FG004|Phase ll Part|Untreated|2|||
147319344|NCT00946647|531334835|FG000|Phase ll Part|Adverse Event|0|||
147319345|NCT00946647|531334836|FG001|Phase ll Part|Adverse Event|0|||
147319346|NCT00946647|531334837|FG002|Phase ll Part|Adverse Event|0|||
147319347|NCT00946647|531334838|FG003|Phase ll Part|Adverse Event|10|||
147319348|NCT00946647|531334839|FG004|Phase ll Part|Adverse Event|6|||
147319349|NCT00946647|531334835|FG000|Phase ll Part|Withdrawal by Subject|0|||
147319350|NCT00946647|531334836|FG001|Phase ll Part|Withdrawal by Subject|0|||
147319351|NCT00946647|531334837|FG002|Phase ll Part|Withdrawal by Subject|0|||
147319352|NCT00946647|531334838|FG003|Phase ll Part|Withdrawal by Subject|8|||
147319353|NCT00946647|531334839|FG004|Phase ll Part|Withdrawal by Subject|6|||
147319354|NCT00946647|531334835|FG000|Phase ll Part|Administrative problems|0|||
147319355|NCT00946647|531334836|FG001|Phase ll Part|Administrative problems|0|||
147319356|NCT00946647|531334837|FG002|Phase ll Part|Administrative problems|0|||
147319357|NCT00946647|531334838|FG003|Phase ll Part|Administrative problems|3|||
147319358|NCT00946647|531334839|FG004|Phase ll Part|Administrative problems|8|||
147319359|NCT00946647|531334835|FG000|Phase ll Part|Death|0|||
147319360|NCT00946647|531334836|FG001|Phase ll Part|Death|0|||
147319361|NCT00946647|531334837|FG002|Phase ll Part|Death|0|||
147319362|NCT00946647|531334838|FG003|Phase ll Part|Death|7|||
147319363|NCT00946647|531334839|FG004|Phase ll Part|Death|4|||
147319364|NCT00946647|531334835|FG000|Phase ll Part|Disease progression|0|||
147319365|NCT00946647|531334836|FG001|Phase ll Part|Disease progression|0|||
147319366|NCT00946647|531334837|FG002|Phase ll Part|Disease progression|0|||
147319367|NCT00946647|531334838|FG003|Phase ll Part|Disease progression|6|||
147319368|NCT00946647|531334839|FG004|Phase ll Part|Disease progression|14|||
147319369|NCT00946647|531334835|FG000|Phase ll Part|Protocol Violation|0|||
147319370|NCT00946647|531334836|FG001|Phase ll Part|Protocol Violation|0|||
147319371|NCT00946647|531334837|FG002|Phase ll Part|Protocol Violation|0|||
147319372|NCT00946647|531334838|FG003|Phase ll Part|Protocol Violation|4|||
147319373|NCT00946647|531334839|FG004|Phase ll Part|Protocol Violation|2|||
147319374|NCT00946647|531334835|FG000|Phase ll Part|Subj cond no longer required study drug|0|||
147319375|NCT00946647|531334836|FG001|Phase ll Part|Subj cond no longer required study drug|0|||
147319376|NCT00946647|531334837|FG002|Phase ll Part|Subj cond no longer required study drug|0|||
147319377|NCT00946647|531334838|FG003|Phase ll Part|Subj cond no longer required study drug|2|||
147319378|NCT00946647|531334839|FG004|Phase ll Part|Subj cond no longer required study drug|0|||
147319379|NCT03057834|531334840|FG000|Overall Study|Withdrawal by Subject|25|||
147319380|NCT03057834|531334841|FG001|Overall Study|Withdrawal by Subject|29|||
147319381|NCT03990363|531334844|FG000|Overall Study|Withdrawal by Subject|10|||
147319382|NCT03990363|531334845|FG001|Overall Study|Withdrawal by Subject|9|||
147319383|NCT03990363|531334846|FG002|Overall Study|Withdrawal by Subject|18|||
147319384|NCT03990363|531334847|FG003|Overall Study|Withdrawal by Subject|11|||
147319385|NCT03990363|531334848|FG004|Overall Study|Withdrawal by Subject|9|||
147319386|NCT03990363|531334844|FG000|Overall Study|Physician Decision|1|||
147319387|NCT03990363|531334845|FG001|Overall Study|Physician Decision|0|||
147319388|NCT03990363|531334846|FG002|Overall Study|Physician Decision|0|||
147319389|NCT03990363|531334847|FG003|Overall Study|Physician Decision|0|||
147319390|NCT03990363|531334848|FG004|Overall Study|Physician Decision|0|||
147319391|NCT03990363|531334844|FG000|Overall Study|Adverse Event|1|||
147319392|NCT03990363|531334845|FG001|Overall Study|Adverse Event|3|||
147319393|NCT03990363|531334846|FG002|Overall Study|Adverse Event|2|||
147319394|NCT03990363|531334847|FG003|Overall Study|Adverse Event|2|||
147319395|NCT03990363|531334848|FG004|Overall Study|Adverse Event|0|||
147319396|NCT03990363|531334844|FG000|Overall Study|Death|14|||
147319397|NCT03990363|531334845|FG001|Overall Study|Death|8|||
147319398|NCT03990363|531334846|FG002|Overall Study|Death|14|||
147319399|NCT03990363|531334847|FG003|Overall Study|Death|10|||
147575241|NCT02054715|532263492|FG000|Baseline/Follow-up 1|Changed MD/Facility|0|||
147575242|NCT02054715|532263493|FG001|Baseline/Follow-up 1|Changed MD/Facility|1|||
147575243|NCT02054715|532263492|FG000|Baseline/Follow-up 1|Disliked Procedure|0|||
147575244|NCT02054715|532263493|FG001|Baseline/Follow-up 1|Disliked Procedure|1|||
147575245|NCT02054715|532263492|FG000|Baseline/Follow-up 1|No Reason|0|||
147575246|NCT02054715|532263493|FG001|Baseline/Follow-up 1|No Reason|1|||
147575247|NCT02054715|532263492|FG000|Baseline/Follow-up 1|Overwhelmed|2|||
147319400|NCT03990363|531334848|FG004|Overall Study|Death|11|||
147319401|NCT03990363|531334844|FG000|Overall Study|Failure to meet randomization criteria|0|||
147319402|NCT03990363|531334845|FG001|Overall Study|Failure to meet randomization criteria|1|||
147319403|NCT03990363|531334846|FG002|Overall Study|Failure to meet randomization criteria|1|||
147319404|NCT03990363|531334847|FG003|Overall Study|Failure to meet randomization criteria|0|||
147319405|NCT03990363|531334848|FG004|Overall Study|Failure to meet randomization criteria|0|||
147319406|NCT03990363|531334844|FG000|Overall Study|Lost to Follow-up|0|||
147319407|NCT03990363|531334845|FG001|Overall Study|Lost to Follow-up|0|||
147319408|NCT03990363|531334846|FG002|Overall Study|Lost to Follow-up|0|||
147319409|NCT03990363|531334847|FG003|Overall Study|Lost to Follow-up|1|||
147319410|NCT03990363|531334848|FG004|Overall Study|Lost to Follow-up|2|||
147319411|NCT03990363|531334844|FG000|Overall Study|Non-compliance with study drug|2|||
147575248|NCT02054715|532263493|FG001|Baseline/Follow-up 1|Overwhelmed|0|||
147575249|NCT02054715|532263492|FG000|Baseline/Follow-up 1|Ineligible|3|||
147652588|NCT01753115|532550325|FG002|Overall Study|Subject non-compliant|0|||
147652589|NCT01753115|532550323|FG000|Overall Study|Used excluded drug|0|||
147652590|NCT01753115|532550324|FG001|Overall Study|Used excluded drug|1|||
147575250|NCT02054715|532263493|FG001|Baseline/Follow-up 1|Ineligible|0|||
147575251|NCT02054715|532263492|FG000|Baseline/Follow-up 1|Hospitalization|1|||
147575252|NCT02054715|532263493|FG001|Baseline/Follow-up 1|Hospitalization|0|||
147575253|NCT02054715|532263492|FG000|Baseline/Follow-up 1|Changed Mind|1|||
147575254|NCT02054715|532263493|FG001|Baseline/Follow-up 1|Changed Mind|0|||
147575255|NCT02054715|532263492|FG000|Follow-up 2|Lost to Followup|3|||
147575256|NCT02054715|532263493|FG001|Follow-up 2|Lost to Followup|1|||
147575257|NCT02054715|532263492|FG000|Follow-up 2|Refused|3|||
147575258|NCT02054715|532263493|FG001|Follow-up 2|Refused|2|||
147575259|NCT02054715|532263492|FG000|Follow-up 2|Followup Not Completed|3|||
147575260|NCT02054715|532263493|FG001|Follow-up 2|Followup Not Completed|4|||
147575261|NCT02054715|532263492|FG000|Follow-up 2|Ineligible|4|||
147575262|NCT02054715|532263493|FG001|Follow-up 2|Ineligible|5|||
147575263|NCT02054715|532263492|FG000|Follow-up 2|Death|3|||
147575264|NCT02054715|532263493|FG001|Follow-up 2|Death|3|||
147575265|NCT02054715|532263492|FG000|Follow-up 2|Hospitalization|0|||
147575266|NCT02054715|532263493|FG001|Follow-up 2|Hospitalization|2|||
147575267|NCT02054715|532263492|FG000|Follow-up 2|Changed MD/Facility|0|||
147575268|NCT02054715|532263493|FG001|Follow-up 2|Changed MD/Facility|1|||
147575269|NCT02054715|532263492|FG000|Follow-up 2|Changed Mind|0|||
147575270|NCT02054715|532263493|FG001|Follow-up 2|Changed Mind|1|||
147575271|NCT02054715|532263492|FG000|Follow-up 2|No Reason|2|||
147575272|NCT02054715|532263493|FG001|Follow-up 2|No Reason|0|||
147575273|NCT02054715|532263492|FG000|Follow-up 2|Treatment Change or Delay|1|||
147575274|NCT02054715|532263493|FG001|Follow-up 2|Treatment Change or Delay|0|||
147652591|NCT01753115|532550325|FG002|Overall Study|Used excluded drug|0|||
147652592|NCT04313400|532550331|FG000|Overall Study|Withdrawal by Subject|0|||
147652593|NCT04313400|532550332|FG001|Overall Study|Withdrawal by Subject|0|||
147652594|NCT04313400|532550333|FG002|Overall Study|Withdrawal by Subject|0|||
147238897|NCT04457336|531046178|FG001|Period 2: Part A|Withdrawal by Subject|1|||
147238898|NCT04457336|531046179|FG002|Period 2: Part A|Withdrawal by Subject|1|||
147238899|NCT04457336|531046180|FG003|Period 2: Part A|Withdrawal by Subject|1|||
147238900|NCT04457336|531046181|FG004|Period 2: Part A|Withdrawal by Subject|0|||
147238901|NCT04457336|531046182|FG005|Period 2: Part A|Withdrawal by Subject|0|||
147238902|NCT04457336|531046183|FG006|Period 2: Part A|Withdrawal by Subject|0|||
147238903|NCT04457336|531046184|FG007|Period 2: Part A|Withdrawal by Subject|0|||
147238904|NCT04457336|531046177|FG000|Period 2: Part A|Adverse Event|0|||
147238905|NCT04457336|531046178|FG001|Period 2: Part A|Adverse Event|0|||
147238906|NCT04457336|531046179|FG002|Period 2: Part A|Adverse Event|1|||
147238907|NCT04457336|531046180|FG003|Period 2: Part A|Adverse Event|1|||
147238908|NCT04457336|531046181|FG004|Period 2: Part A|Adverse Event|0|||
147238909|NCT04457336|531046182|FG005|Period 2: Part A|Adverse Event|0|||
147238910|NCT04457336|531046183|FG006|Period 2: Part A|Adverse Event|0|||
147238911|NCT04457336|531046184|FG007|Period 2: Part A|Adverse Event|0|||
147238912|NCT04457336|531046177|FG000|Period 2: Part A|Study Terminated|0|||
147238913|NCT04457336|531046178|FG001|Period 2: Part A|Study Terminated|0|||
147238914|NCT04457336|531046179|FG002|Period 2: Part A|Study Terminated|1|||
147238915|NCT04457336|531046180|FG003|Period 2: Part A|Study Terminated|0|||
147238916|NCT04457336|531046181|FG004|Period 2: Part A|Study Terminated|0|||
147238917|NCT04457336|531046182|FG005|Period 2: Part A|Study Terminated|0|||
147238918|NCT04457336|531046183|FG006|Period 2: Part A|Study Terminated|0|||
147238919|NCT04457336|531046184|FG007|Period 2: Part A|Study Terminated|0|||
147238920|NCT04457336|531046177|FG000|Period 2: Part A|Protocol Violation|0|||
147575275|NCT00858780|532263494|FG000|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|18|||
147575276|NCT00858780|532263495|FG001|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0|||
147575277|NCT00858780|532263496|FG002|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0|||
147652595|NCT04313400|532550334|FG003|Overall Study|Withdrawal by Subject|0|||
147652596|NCT04313400|532550335|FG004|Overall Study|Withdrawal by Subject|0|||
147238921|NCT04457336|531046178|FG001|Period 2: Part A|Protocol Violation|1|||
147238922|NCT04457336|531046179|FG002|Period 2: Part A|Protocol Violation|0|||
147238923|NCT04457336|531046180|FG003|Period 2: Part A|Protocol Violation|0|||
147238924|NCT04457336|531046181|FG004|Period 2: Part A|Protocol Violation|0|||
147238925|NCT04457336|531046182|FG005|Period 2: Part A|Protocol Violation|0|||
147575278|NCT00858780|532263497|FG003|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0|||
147575279|NCT00858780|532263498|FG004|Open-Label (OL) Run-In(Week-8 to Week 0)|Did not enter double-blind period|0|||
147575280|NCT00858780|532263494|FG000|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0|||
147575281|NCT00858780|532263495|FG001|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0|||
147575282|NCT00858780|532263496|FG002|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|1|||
147238926|NCT04457336|531046183|FG006|Period 2: Part A|Protocol Violation|0|||
147238927|NCT04457336|531046184|FG007|Period 2: Part A|Protocol Violation|0|||
147575283|NCT00858780|532263497|FG003|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0|||
147652597|NCT04313400|532550336|FG005|Overall Study|Withdrawal by Subject|4|||
147575284|NCT00858780|532263498|FG004|Double-Blind (Week 0 to Failure/Week 48)|Adverse Event|0|||
147238928|NCT04457336|531046177|FG000|Period 2: Part A|Lost to Follow-up|0|||
147238929|NCT04457336|531046178|FG001|Period 2: Part A|Lost to Follow-up|1|||
147238930|NCT04457336|531046179|FG002|Period 2: Part A|Lost to Follow-up|0|||
147238931|NCT04457336|531046180|FG003|Period 2: Part A|Lost to Follow-up|0|||
147238932|NCT04457336|531046181|FG004|Period 2: Part A|Lost to Follow-up|0|||
147575285|NCT00858780|532263494|FG000|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|0|||
147575286|NCT00858780|532263495|FG001|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|1|||
147575287|NCT00858780|532263496|FG002|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|1|||
147575288|NCT00858780|532263497|FG003|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|1|||
147575289|NCT00858780|532263498|FG004|Double-Blind (Week 0 to Failure/Week 48)|Withdrawal by Subject|0|||
147575290|NCT00858780|532263494|FG000|Double-Blind (Week 0 to Failure/Week 48)|Other|0|||
147575291|NCT00858780|532263495|FG001|Double-Blind (Week 0 to Failure/Week 48)|Other|1|||
147575292|NCT00858780|532263496|FG002|Double-Blind (Week 0 to Failure/Week 48)|Other|0|||
147575293|NCT00858780|532263497|FG003|Double-Blind (Week 0 to Failure/Week 48)|Other|0|||
147575294|NCT00858780|532263498|FG004|Double-Blind (Week 0 to Failure/Week 48)|Other|0|||
147575295|NCT00858780|532263494|FG000|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0|||
147575296|NCT00858780|532263495|FG001|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0|||
147575297|NCT00858780|532263496|FG002|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0|||
147575298|NCT00858780|532263497|FG003|OL Re-Treatment (Failure to Week 48)|Protocol Violation|0|||
147575299|NCT00858780|532263498|FG004|OL Re-Treatment (Failure to Week 48)|Protocol Violation|1|||
147575300|NCT00858780|532263494|FG000|OL Re-Treatment (Failure to Week 48)|Other|0|||
147575301|NCT00858780|532263495|FG001|OL Re-Treatment (Failure to Week 48)|Other|0|||
147575302|NCT00858780|532263496|FG002|OL Re-Treatment (Failure to Week 48)|Other|0|||
147575303|NCT00858780|532263497|FG003|OL Re-Treatment (Failure to Week 48)|Other|0|||
147575304|NCT00858780|532263498|FG004|OL Re-Treatment (Failure to Week 48)|Other|1|||
147575305|NCT05098743|532263502|FG000|Overall Study|One participant had no data because they were unable to download the app despite multiple attempts|1|||
147575306|NCT05098743|532263503|FG001|Overall Study|One participant had no data because they were unable to download the app despite multiple attempts|0|||
147575307|NCT05098743|532263502|FG000|Overall Study|Lost to Follow-up|1|||
147575308|NCT05098743|532263503|FG001|Overall Study|Lost to Follow-up|2|||
147575309|NCT01456221|532263504|FG000|Overall Study|Withdrawal by Subject|56|||
147575310|NCT01456221|532263505|FG001|Overall Study|Withdrawal by Subject|49|||
147575311|NCT01456221|532263504|FG000|Overall Study|Lost to Follow-up|1|||
147575312|NCT01456221|532263505|FG001|Overall Study|Lost to Follow-up|4|||
147575313|NCT01456221|532263504|FG000|Overall Study|Received medication|3|||
147575314|NCT01456221|532263505|FG001|Overall Study|Received medication|2|||
147575315|NCT01456221|532263504|FG000|Overall Study|Incomplete data|4|||
147575316|NCT01456221|532263505|FG001|Overall Study|Incomplete data|2|||
147575317|NCT04025021|532263506|FG000|Overall Study|Study discontinued with onset of COVID-19 pandemic|2|||
147575318|NCT04025021|532263507|FG001|Overall Study|Study discontinued with onset of COVID-19 pandemic|1|||
147575319|NCT03498560|532263508|FG000|Overall Study|Found Ineligible|2|||
147575320|NCT03498560|532263508|FG000|Overall Study|Withdrawal by Subject|14|||
147575321|NCT03498560|532263508|FG000|Overall Study|Lost to Follow-up|4|||
147575322|NCT03498560|532263508|FG000|Overall Study|Death|1|||
147575323|NCT00867360|532263513|FG000|Overall Study|Withdrawal by Subject|1|||
147575324|NCT00867360|532263514|FG001|Overall Study|Withdrawal by Subject|0|||
147575325|NCT00867360|532263513|FG000|Overall Study|Physician Decision|0|||
147575326|NCT00867360|532263514|FG001|Overall Study|Physician Decision|1|||
147575327|NCT01004510|532263515|FG000|Overall Study|Adverse Event|1|||
147575328|NCT00112437|532263518|FG000|Year 1 (12-Month Base Study)|Adverse Event|9|||
147575329|NCT00112437|532263519|FG001|Year 1 (12-Month Base Study)|Adverse Event|10|||
147575330|NCT00112437|532263520|FG002|Year 1 (12-Month Base Study)|Adverse Event|6|||
147575331|NCT00112437|532263521|FG003|Year 1 (12-Month Base Study)|Adverse Event|4|||
147575332|NCT00112437|532263522|FG004|Year 1 (12-Month Base Study)|Adverse Event|3|||
147575333|NCT00112437|532263523|FG005|Year 1 (12-Month Base Study)|Adverse Event|0|||
147575334|NCT00112437|532263524|FG006|Year 1 (12-Month Base Study)|Adverse Event|0|||
147575335|NCT00112437|532263525|FG007|Year 1 (12-Month Base Study)|Adverse Event|0|||
147575336|NCT00112437|532263526|FG008|Year 1 (12-Month Base Study)|Adverse Event|0|||
147575337|NCT00112437|532263527|FG009|Year 1 (12-Month Base Study)|Adverse Event|0|||
147575338|NCT00112437|532263528|FG010|Year 1 (12-Month Base Study)|Adverse Event|0|||
147575339|NCT00112437|532263529|FG011|Year 1 (12-Month Base Study)|Adverse Event|0|||
147575340|NCT00112437|532263530|FG012|Year 1 (12-Month Base Study)|Adverse Event|0|||
147575341|NCT00112437|532263531|FG013|Year 1 (12-Month Base Study)|Adverse Event|0|||
147575342|NCT00112437|532263532|FG014|Year 1 (12-Month Base Study)|Adverse Event|0|||
147575343|NCT00112437|532263533|FG015|Year 1 (12-Month Base Study)|Adverse Event|0|||
147575344|NCT00112437|532263534|FG016|Year 1 (12-Month Base Study)|Adverse Event|0|||
147575345|NCT00112437|532263535|FG017|Year 1 (12-Month Base Study)|Adverse Event|0|||
147238933|NCT04457336|531046182|FG005|Period 2: Part A|Lost to Follow-up|0|||
147238934|NCT04457336|531046183|FG006|Period 2: Part A|Lost to Follow-up|0|||
147238935|NCT04457336|531046184|FG007|Period 2: Part A|Lost to Follow-up|0|||
147445891|NCT01445951|531797473|FG001|Overall Study|Withdrawal by Subject|16|||
147445892|NCT01445951|531797474|FG002|Overall Study|Withdrawal by Subject|8|||
147575346|NCT00112437|532263536|FG018|Year 1 (12-Month Base Study)|Adverse Event|0|||
147575347|NCT00112437|532263537|FG019|Year 1 (12-Month Base Study)|Adverse Event|0|||
147146863|NCT01667133|530701002|FG002|Phase 1: Dose-escalation|Lack of Efficacy|1|||
147575348|NCT00112437|532263538|FG020|Year 1 (12-Month Base Study)|Adverse Event|0|||
147146864|NCT01667133|530701003|FG003|Phase 1: Dose-escalation|Lack of Efficacy|0|||
147146865|NCT01667133|530701004|FG004|Phase 1: Dose-escalation|Lack of Efficacy|0|||
147146866|NCT01667133|530701005|FG005|Phase 1: Dose-escalation|Lack of Efficacy|0|||
147146867|NCT01667133|530701006|FG006|Phase 1: Dose-escalation|Lack of Efficacy|0|||
147146868|NCT01667133|530701007|FG007|Phase 1: Dose-escalation|Lack of Efficacy|0|||
147146869|NCT01667133|530701008|FG008|Phase 1: Dose-escalation|Lack of Efficacy|0|||
147146870|NCT01667133|530701009|FG009|Phase 1: Dose-escalation|Lack of Efficacy|0|||
147146871|NCT01667133|530701010|FG010|Phase 1: Dose-escalation|Lack of Efficacy|0|||
147146872|NCT01667133|530701011|FG011|Phase 1: Dose-escalation|Lack of Efficacy|0|||
147146873|NCT01667133|530701000|FG000|Phase 1: Dose-escalation|Progressive Disease|0|||
147146874|NCT01667133|530701001|FG001|Phase 1: Dose-escalation|Progressive Disease|1|||
147146875|NCT01667133|530701002|FG002|Phase 1: Dose-escalation|Progressive Disease|2|||
147146876|NCT01667133|530701003|FG003|Phase 1: Dose-escalation|Progressive Disease|0|||
147146877|NCT01667133|530701004|FG004|Phase 1: Dose-escalation|Progressive Disease|1|||
147146878|NCT01667133|530701005|FG005|Phase 1: Dose-escalation|Progressive Disease|1|||
147146879|NCT01667133|530701006|FG006|Phase 1: Dose-escalation|Progressive Disease|1|||
147146880|NCT01667133|530701007|FG007|Phase 1: Dose-escalation|Progressive Disease|0|||
147146881|NCT01667133|530701008|FG008|Phase 1: Dose-escalation|Progressive Disease|0|||
147146882|NCT01667133|530701009|FG009|Phase 1: Dose-escalation|Progressive Disease|0|||
147146883|NCT01667133|530701010|FG010|Phase 1: Dose-escalation|Progressive Disease|0|||
147146884|NCT01667133|530701011|FG011|Phase 1: Dose-escalation|Progressive Disease|0|||
147319412|NCT03990363|531334845|FG001|Overall Study|Non-compliance with study drug|1|||
147575349|NCT00112437|532263539|FG021|Year 1 (12-Month Base Study)|Adverse Event|0|||
147319413|NCT03990363|531334846|FG002|Overall Study|Non-compliance with study drug|2|||
147319414|NCT03990363|531334847|FG003|Overall Study|Non-compliance with study drug|0|||
147319415|NCT03990363|531334848|FG004|Overall Study|Non-compliance with study drug|0|||
147319416|NCT03990363|531334844|FG000|Overall Study|Study terminated by sponsor|0|||
147319417|NCT03990363|531334845|FG001|Overall Study|Study terminated by sponsor|1|||
147319418|NCT03990363|531334846|FG002|Overall Study|Study terminated by sponsor|0|||
147319419|NCT03990363|531334847|FG003|Overall Study|Study terminated by sponsor|0|||
147319420|NCT03990363|531334848|FG004|Overall Study|Study terminated by sponsor|0|||
147319421|NCT03990363|531334844|FG000|Overall Study|Site terminated by sponsor|2|||
147319422|NCT03990363|531334845|FG001|Overall Study|Site terminated by sponsor|1|||
147319423|NCT03990363|531334846|FG002|Overall Study|Site terminated by sponsor|2|||
147575350|NCT00112437|532263540|FG022|Year 1 (12-Month Base Study)|Adverse Event|0|||
147575351|NCT00112437|532263541|FG023|Year 1 (12-Month Base Study)|Adverse Event|0|||
147575352|NCT00112437|532263542|FG024|Year 1 (12-Month Base Study)|Adverse Event|0|||
147575353|NCT00112437|532263543|FG025|Year 1 (12-Month Base Study)|Adverse Event|0|||
147575354|NCT00112437|532263518|FG000|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
147575355|NCT00112437|532263519|FG001|Year 1 (12-Month Base Study)|Lack of Efficacy|1|||
147575356|NCT00112437|532263520|FG002|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
147319424|NCT03990363|531334847|FG003|Overall Study|Site terminated by sponsor|0|||
147319425|NCT03990363|531334848|FG004|Overall Study|Site terminated by sponsor|2|||
147319426|NCT03990363|531334844|FG000|Overall Study|Not categorized|5|||
147319427|NCT03990363|531334845|FG001|Overall Study|Not categorized|5|||
147319428|NCT03990363|531334846|FG002|Overall Study|Not categorized|3|||
147319429|NCT03990363|531334847|FG003|Overall Study|Not categorized|2|||
147319430|NCT03990363|531334848|FG004|Overall Study|Not categorized|2|||
147319431|NCT01544582|531334849|FG000|Screening/Eligibility|Initiated Different CHC Treatment|1|||
147319432|NCT01544582|531334850|FG001|Screening/Eligibility|Initiated Different CHC Treatment|0|||
147575357|NCT00112437|532263521|FG003|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
147575358|NCT00112437|532263522|FG004|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
147575359|NCT00112437|532263523|FG005|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
147575360|NCT00112437|532263524|FG006|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
147575361|NCT00112437|532263525|FG007|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
147146885|NCT01667133|530701000|FG000|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
147146886|NCT01667133|530701001|FG001|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
147146887|NCT01667133|530701002|FG002|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
147319433|NCT01544582|531334851|FG002|Screening/Eligibility|Initiated Different CHC Treatment|0|||
147319434|NCT01544582|531334852|FG003|Screening/Eligibility|Initiated Different CHC Treatment|0|||
147146888|NCT01667133|530701003|FG003|Phase 1: Dose-escalation|Withdrawal by Subject|1|||
147146889|NCT01667133|530701004|FG004|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
147146890|NCT01667133|530701005|FG005|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
147319435|NCT01544582|531334849|FG000|Screening/Eligibility|Eligibility Criteria Not Met|33|||
147319436|NCT01544582|531334850|FG001|Screening/Eligibility|Eligibility Criteria Not Met|0|||
147575362|NCT00112437|532263526|FG008|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
147146891|NCT01667133|530701006|FG006|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
147575363|NCT00112437|532263527|FG009|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
147575364|NCT00112437|532263528|FG010|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
147575365|NCT00112437|532263529|FG011|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
147575366|NCT00112437|532263530|FG012|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
147146892|NCT01667133|530701007|FG007|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
147146893|NCT01667133|530701008|FG008|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
147146894|NCT01667133|530701009|FG009|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
147146895|NCT01667133|530701010|FG010|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
147146896|NCT01667133|530701011|FG011|Phase 1: Dose-escalation|Withdrawal by Subject|0|||
147146897|NCT01667133|530701000|FG000|Phase 2: Dose-expansion|Adverse Event|0|||
147146898|NCT01667133|530701001|FG001|Phase 2: Dose-expansion|Adverse Event|0|||
147146899|NCT01667133|530701002|FG002|Phase 2: Dose-expansion|Adverse Event|0|||
147575367|NCT00112437|532263531|FG013|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
147575368|NCT00112437|532263532|FG014|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
147575369|NCT00112437|532263533|FG015|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
147575370|NCT00112437|532263534|FG016|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
147575371|NCT00112437|532263535|FG017|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
147575372|NCT00112437|532263536|FG018|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
147575373|NCT00112437|532263537|FG019|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
147575374|NCT00112437|532263538|FG020|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
147575375|NCT00112437|532263539|FG021|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
147575376|NCT00112437|532263540|FG022|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
147575377|NCT00112437|532263541|FG023|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
147575378|NCT00112437|532263542|FG024|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
147575379|NCT00112437|532263543|FG025|Year 1 (12-Month Base Study)|Lack of Efficacy|0|||
147575380|NCT00112437|532263518|FG000|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
147575381|NCT00112437|532263519|FG001|Year 1 (12-Month Base Study)|Lost to Follow-up|1|||
147575382|NCT00112437|532263520|FG002|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
147575383|NCT00112437|532263521|FG003|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
147575384|NCT00112437|532263522|FG004|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
147575385|NCT00112437|532263523|FG005|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
147575386|NCT00112437|532263524|FG006|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
147575387|NCT00112437|532263525|FG007|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
147146900|NCT01667133|530701003|FG003|Phase 2: Dose-expansion|Adverse Event|0|||
147146901|NCT01667133|530701004|FG004|Phase 2: Dose-expansion|Adverse Event|0|||
147146902|NCT01667133|530701005|FG005|Phase 2: Dose-expansion|Adverse Event|0|||
147319437|NCT01544582|531334851|FG002|Screening/Eligibility|Eligibility Criteria Not Met|0|||
147319438|NCT01544582|531334852|FG003|Screening/Eligibility|Eligibility Criteria Not Met|0|||
147319439|NCT01544582|531334849|FG000|Analysis Population|Participant Refuses to Continue Study|0|||
147319440|NCT01544582|531334850|FG001|Analysis Population|Participant Refuses to Continue Study|15|||
147319441|NCT01544582|531334851|FG002|Analysis Population|Participant Refuses to Continue Study|17|||
147319442|NCT01544582|531334852|FG003|Analysis Population|Participant Refuses to Continue Study|4|||
147319443|NCT01544582|531334849|FG000|Analysis Population|Physician Decision|0|||
147319444|NCT01544582|531334850|FG001|Analysis Population|Physician Decision|13|||
147319445|NCT01544582|531334851|FG002|Analysis Population|Physician Decision|10|||
147319446|NCT01544582|531334852|FG003|Analysis Population|Physician Decision|9|||
147319447|NCT01544582|531334849|FG000|Analysis Population|Safety Reason|0|||
147319448|NCT01544582|531334850|FG001|Analysis Population|Safety Reason|33|||
147319449|NCT01544582|531334851|FG002|Analysis Population|Safety Reason|31|||
147319450|NCT01544582|531334852|FG003|Analysis Population|Safety Reason|8|||
147319451|NCT01544582|531334849|FG000|Analysis Population|Effectiveness Reason|0|||
147319452|NCT01544582|531334850|FG001|Analysis Population|Effectiveness Reason|48|||
147319453|NCT01544582|531334851|FG002|Analysis Population|Effectiveness Reason|29|||
147319454|NCT01544582|531334852|FG003|Analysis Population|Effectiveness Reason|12|||
147319455|NCT01544582|531334849|FG000|Analysis Population|New Contraindication-Alcohol Abuse|0|||
147319456|NCT01544582|531334850|FG001|Analysis Population|New Contraindication-Alcohol Abuse|0|||
147319457|NCT01544582|531334851|FG002|Analysis Population|New Contraindication-Alcohol Abuse|0|||
147319458|NCT01544582|531334852|FG003|Analysis Population|New Contraindication-Alcohol Abuse|1|||
147319459|NCT01544582|531334849|FG000|Analysis Population|Lost to Follow-up|0|||
147319460|NCT01544582|531334850|FG001|Analysis Population|Lost to Follow-up|6|||
147319461|NCT01544582|531334851|FG002|Analysis Population|Lost to Follow-up|6|||
147319462|NCT01544582|531334852|FG003|Analysis Population|Lost to Follow-up|5|||
147319463|NCT01544582|531334849|FG000|Analysis Population|Bad Tolerance to Treatment|0|||
147319464|NCT01544582|531334850|FG001|Analysis Population|Bad Tolerance to Treatment|0|||
147319465|NCT01544582|531334851|FG002|Analysis Population|Bad Tolerance to Treatment|2|||
147319466|NCT01544582|531334852|FG003|Analysis Population|Bad Tolerance to Treatment|0|||
147319467|NCT01544582|531334849|FG000|Analysis Population|Did Not Meet Inclusion Criteria|0|||
147319468|NCT01544582|531334850|FG001|Analysis Population|Did Not Meet Inclusion Criteria|0|||
147319469|NCT01544582|531334851|FG002|Analysis Population|Did Not Meet Inclusion Criteria|3|||
147575388|NCT00112437|532263526|FG008|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
147319470|NCT01544582|531334852|FG003|Analysis Population|Did Not Meet Inclusion Criteria|0|||
147319471|NCT01544582|531334849|FG000|Analysis Population|Intolerance|0|||
147319472|NCT01544582|531334850|FG001|Analysis Population|Intolerance|1|||
147319473|NCT01544582|531334851|FG002|Analysis Population|Intolerance|0|||
147319474|NCT01544582|531334852|FG003|Analysis Population|Intolerance|0|||
147319475|NCT01544582|531334849|FG000|Analysis Population|Liver Transplantation|0|||
147319476|NCT01544582|531334850|FG001|Analysis Population|Liver Transplantation|0|||
147319477|NCT01544582|531334851|FG002|Analysis Population|Liver Transplantation|1|||
147319478|NCT01544582|531334852|FG003|Analysis Population|Liver Transplantation|0|||
147319479|NCT01544582|531334849|FG000|Analysis Population|No Social Insurance|0|||
147319480|NCT01544582|531334850|FG001|Analysis Population|No Social Insurance|0|||
147319481|NCT01544582|531334851|FG002|Analysis Population|No Social Insurance|1|||
147319482|NCT01544582|531334852|FG003|Analysis Population|No Social Insurance|0|||
147319483|NCT01544582|531334849|FG000|Analysis Population|Poor Adherence|0|||
147319484|NCT01544582|531334850|FG001|Analysis Population|Poor Adherence|0|||
147319485|NCT01544582|531334851|FG002|Analysis Population|Poor Adherence|1|||
147319486|NCT01544582|531334852|FG003|Analysis Population|Poor Adherence|0|||
147319487|NCT01544582|531334849|FG000|Analysis Population|Poor Participant Compliance|0|||
147319488|NCT01544582|531334850|FG001|Analysis Population|Poor Participant Compliance|1|||
147319489|NCT01544582|531334851|FG002|Analysis Population|Poor Participant Compliance|0|||
147319490|NCT01544582|531334852|FG003|Analysis Population|Poor Participant Compliance|0|||
147319491|NCT01544582|531334849|FG000|Analysis Population|Programmed Surgery|0|||
147319492|NCT01544582|531334850|FG001|Analysis Population|Programmed Surgery|1|||
147319493|NCT01544582|531334851|FG002|Analysis Population|Programmed Surgery|0|||
147319494|NCT01544582|531334852|FG003|Analysis Population|Programmed Surgery|0|||
147319495|NCT01544582|531334849|FG000|Analysis Population|Participant in Jail|0|||
147319496|NCT01544582|531334850|FG001|Analysis Population|Participant in Jail|0|||
147319497|NCT01544582|531334851|FG002|Analysis Population|Participant in Jail|1|||
147319498|NCT01544582|531334852|FG003|Analysis Population|Participant in Jail|0|||
147319499|NCT00550173|531334853|FG000|Overall Study|Death|45|||
147319500|NCT00550173|531334854|FG001|Overall Study|Death|38|||
147319501|NCT00550173|531334855|FG002|Overall Study|Death|50|||
147319502|NCT00550173|531334853|FG000|Overall Study|Physician Decision|1|||
147319503|NCT00550173|531334854|FG001|Overall Study|Physician Decision|2|||
147319504|NCT00550173|531334855|FG002|Overall Study|Physician Decision|2|||
147319505|NCT00550173|531334853|FG000|Overall Study|Withdrawal by Subject|9|||
147319506|NCT00550173|531334854|FG001|Overall Study|Withdrawal by Subject|12|||
147319507|NCT00550173|531334855|FG002|Overall Study|Withdrawal by Subject|17|||
147319508|NCT00550173|531334853|FG000|Overall Study|Sponsor Decision|13|||
147319509|NCT00550173|531334854|FG001|Overall Study|Sponsor Decision|7|||
147319510|NCT00550173|531334855|FG002|Overall Study|Sponsor Decision|1|||
147319511|NCT00550173|531334853|FG000|Overall Study|Lost to Follow-up|4|||
147319512|NCT00550173|531334854|FG001|Overall Study|Lost to Follow-up|4|||
147319513|NCT00550173|531334855|FG002|Overall Study|Lost to Follow-up|3|||
147319514|NCT00810641|531334864|FG000|Overall Study|Withdrawal by Subject|0|||
147319515|NCT00810641|531334865|FG001|Overall Study|Withdrawal by Subject|1|||
147319516|NCT00810641|531334866|FG002|Overall Study|Withdrawal by Subject|2|||
147319517|NCT01556243|531334867|FG000|Overall Study|Ineligible|34|||
147319518|NCT01556243|531334867|FG000|Overall Study|Converted to mastectomy|14|||
147319519|NCT01556243|531334867|FG000|Overall Study|Unable to achieve negative margins|2|||
147319520|NCT01556243|531334867|FG000|Overall Study|Withdrawal by Subject|16|||
147319521|NCT01388543|531334868|FG000|Day 14|Adverse Event|1|||
147319522|NCT01388543|531334869|FG001|Day 14|Adverse Event|4|||
147319523|NCT02325713|531334872|FG000|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
147319524|NCT02325713|531334873|FG001|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
147319525|NCT02325713|531334874|FG002|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
147319526|NCT02325713|531334875|FG003|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
147319527|NCT02325713|531334876|FG004|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
147319528|NCT02325713|531334877|FG005|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
147319529|NCT02325713|531334878|FG006|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
147319530|NCT02325713|531334879|FG007|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
147319531|NCT02325713|531334880|FG008|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
147319532|NCT02325713|531334881|FG009|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
147319533|NCT02325713|531334882|FG010|Intervention Period 1 (2 Days)|Protocol Non-Compliance|1|||
147319534|NCT02325713|531334883|FG011|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
147319535|NCT02325713|531334884|FG012|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
147319536|NCT02325713|531334885|FG013|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
147319537|NCT02325713|531334886|FG014|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
147319538|NCT02325713|531334887|FG015|Intervention Period 1 (2 Days)|Protocol Non-Compliance|0|||
147319539|NCT02325713|531334872|FG000|Intervention Period 2 (2 Days)|Protocol Non-Compliance|1|||
147319540|NCT02325713|531334873|FG001|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
147319541|NCT02325713|531334874|FG002|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
147445893|NCT01445951|531797472|FG000|Overall Study|Physician Decision|3|||
147445894|NCT01445951|531797473|FG001|Overall Study|Physician Decision|1|||
147652598|NCT04313400|532550337|FG006|Overall Study|Withdrawal by Subject|1|||
147652599|NCT04313400|532550331|FG000|Overall Study|Adverse Event|0|||
147652600|NCT04313400|532550332|FG001|Overall Study|Adverse Event|0|||
147652601|NCT04313400|532550333|FG002|Overall Study|Adverse Event|0|||
147652602|NCT04313400|532550334|FG003|Overall Study|Adverse Event|0|||
147652603|NCT04313400|532550335|FG004|Overall Study|Adverse Event|0|||
147652604|NCT04313400|532550336|FG005|Overall Study|Adverse Event|1|||
147652605|NCT04313400|532550337|FG006|Overall Study|Adverse Event|0|||
147652606|NCT04313400|532550331|FG000|Overall Study|Lost to Follow-up|0|||
147652607|NCT04313400|532550332|FG001|Overall Study|Lost to Follow-up|0|||
147652608|NCT04313400|532550333|FG002|Overall Study|Lost to Follow-up|0|||
147652609|NCT04313400|532550334|FG003|Overall Study|Lost to Follow-up|0|||
147652610|NCT04313400|532550335|FG004|Overall Study|Lost to Follow-up|0|||
147652611|NCT04313400|532550336|FG005|Overall Study|Lost to Follow-up|1|||
147652612|NCT04313400|532550337|FG006|Overall Study|Lost to Follow-up|0|||
147652613|NCT00329745|532550346|FG000|Overall Study|Protocol Violation|1|||
147652614|NCT00329745|532550347|FG001|Overall Study|Protocol Violation|0|||
147652615|NCT00329745|532550346|FG000|Overall Study|Withdrawal by Subject|0|||
147652616|NCT00329745|532550347|FG001|Overall Study|Withdrawal by Subject|1|||
147652617|NCT00329745|532550346|FG000|Overall Study|Lost to Follow-up|86|||
147652618|NCT00329745|532550347|FG001|Overall Study|Lost to Follow-up|101|||
147652619|NCT03224624|532550350|FG000|Overall Study|Lost to Follow-up|9|||
147652620|NCT03224624|532550351|FG001|Overall Study|Lost to Follow-up|4|||
147652621|NCT03224624|532550350|FG000|Overall Study|Death|1|||
147319542|NCT02325713|531334875|FG003|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
147319543|NCT02325713|531334876|FG004|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
147319544|NCT02325713|531334877|FG005|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
147319545|NCT02325713|531334878|FG006|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
147319546|NCT02325713|531334879|FG007|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
147319547|NCT02325713|531334880|FG008|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
147319548|NCT02325713|531334881|FG009|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
147319549|NCT02325713|531334882|FG010|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
147319550|NCT02325713|531334883|FG011|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
147319551|NCT02325713|531334884|FG012|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
147319552|NCT02325713|531334885|FG013|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
147319553|NCT02325713|531334886|FG014|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
147319554|NCT02325713|531334887|FG015|Intervention Period 2 (2 Days)|Protocol Non-Compliance|0|||
147319555|NCT02325713|531334872|FG000|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
147319556|NCT02325713|531334873|FG001|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
147319557|NCT02325713|531334874|FG002|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
147319558|NCT02325713|531334875|FG003|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
147319559|NCT02325713|531334876|FG004|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
147319560|NCT02325713|531334877|FG005|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
147319561|NCT02325713|531334878|FG006|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
147319562|NCT02325713|531334879|FG007|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
147319563|NCT02325713|531334880|FG008|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
147319564|NCT02325713|531334881|FG009|Intervention Period 3 (2 Days)|Withdrawal by Subject|1|||
147319565|NCT02325713|531334882|FG010|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
147319566|NCT02325713|531334883|FG011|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
147319567|NCT02325713|531334884|FG012|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
147319568|NCT02325713|531334885|FG013|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
147319569|NCT02325713|531334886|FG014|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
147319570|NCT02325713|531334887|FG015|Intervention Period 3 (2 Days)|Withdrawal by Subject|0|||
147319571|NCT01213173|531334888|FG000|Overall Study|Protocol Violation|2|||
147319572|NCT01213173|531334889|FG001|Overall Study|Protocol Violation|0|||
147319573|NCT01213173|531334888|FG000|Overall Study|Adverse Event|4|||
147319574|NCT01213173|531334889|FG001|Overall Study|Adverse Event|8|||
147319575|NCT01213173|531334888|FG000|Overall Study|Withdrawal by Subject|5|||
147652622|NCT03224624|532550351|FG001|Overall Study|Death|0|||
147652623|NCT01884545|532550352|FG000|Overall Study|Lost to Follow-up|6|||
147652624|NCT01884545|532550353|FG001|Overall Study|Lost to Follow-up|4|||
147652625|NCT01884545|532550354|FG002|Overall Study|Lost to Follow-up|9|||
147652626|NCT01884545|532550355|FG003|Overall Study|Lost to Follow-up|4|||
147652627|NCT01884545|532550352|FG000|Overall Study|Patient withdrawn|7|||
147652628|NCT01884545|532550353|FG001|Overall Study|Patient withdrawn|12|||
147652629|NCT01884545|532550354|FG002|Overall Study|Patient withdrawn|5|||
147319576|NCT01213173|531334889|FG001|Overall Study|Withdrawal by Subject|5|||
147319577|NCT01213173|531334888|FG000|Overall Study|Incorrect Enrollment|1|||
147652630|NCT01884545|532550355|FG003|Overall Study|Patient withdrawn|5|||
147652631|NCT01884545|532550352|FG000|Overall Study|Non-adherence|0|||
147652632|NCT01884545|532550353|FG001|Overall Study|Non-adherence|2|||
147652633|NCT01884545|532550354|FG002|Overall Study|Non-adherence|0|||
147652634|NCT01884545|532550355|FG003|Overall Study|Non-adherence|0|||
147652635|NCT01424241|532550356|FG000|Overall Study|Withdrawal by Subject|1|||
147652636|NCT01424241|532550356|FG000|Overall Study|Time constraints|2|||
147652637|NCT02782377|532550357|FG000|Overall Study|Physician Decision|5|||
147652638|NCT00303472|532550359|FG000|Treatment Period|Adverse Event|0|||
147652639|NCT00303472|532550360|FG001|Treatment Period|Adverse Event|0|||
147652640|NCT00303472|532550361|FG002|Treatment Period|Adverse Event|0|||
147652641|NCT00303472|532550362|FG003|Treatment Period|Adverse Event|0|||
147652642|NCT00303472|532550363|FG004|Treatment Period|Adverse Event|1|||
147652643|NCT00303472|532550364|FG005|Treatment Period|Adverse Event|0|||
147652644|NCT00303472|532550365|FG006|Treatment Period|Adverse Event|0|||
147652645|NCT00303472|532550359|FG000|Treatment Period|Death|0|||
147652646|NCT00303472|532550360|FG001|Treatment Period|Death|0|||
147652647|NCT00303472|532550361|FG002|Treatment Period|Death|0|||
147652648|NCT00303472|532550362|FG003|Treatment Period|Death|1|||
147652649|NCT00303472|532550363|FG004|Treatment Period|Death|0|||
147652650|NCT00303472|532550364|FG005|Treatment Period|Death|0|||
147652651|NCT00303472|532550365|FG006|Treatment Period|Death|1|||
147652652|NCT00303472|532550359|FG000|Treatment Period|Withdrawal by Subject|0|||
147652653|NCT00303472|532550360|FG001|Treatment Period|Withdrawal by Subject|0|||
147652654|NCT00303472|532550361|FG002|Treatment Period|Withdrawal by Subject|0|||
147652655|NCT00303472|532550362|FG003|Treatment Period|Withdrawal by Subject|1|||
147652656|NCT00303472|532550363|FG004|Treatment Period|Withdrawal by Subject|0|||
147652657|NCT00303472|532550364|FG005|Treatment Period|Withdrawal by Subject|1|||
147652658|NCT00303472|532550365|FG006|Treatment Period|Withdrawal by Subject|0|||
147652659|NCT00303472|532550359|FG000|Treatment Period|Other|0|||
147652660|NCT00303472|532550360|FG001|Treatment Period|Other|0|||
147652661|NCT00303472|532550361|FG002|Treatment Period|Other|0|||
147652662|NCT00303472|532550362|FG003|Treatment Period|Other|0|||
147652663|NCT00303472|532550363|FG004|Treatment Period|Other|1|||
147652664|NCT00303472|532550364|FG005|Treatment Period|Other|0|||
147652665|NCT00303472|532550365|FG006|Treatment Period|Other|1|||
147652666|NCT00303472|532550359|FG000|Treatment Period|Disease Progression (to AML)|0|||
147652667|NCT00303472|532550360|FG001|Treatment Period|Disease Progression (to AML)|0|||
147652668|NCT00303472|532550361|FG002|Treatment Period|Disease Progression (to AML)|0|||
147652669|NCT00303472|532550362|FG003|Treatment Period|Disease Progression (to AML)|0|||
147652670|NCT00303472|532550363|FG004|Treatment Period|Disease Progression (to AML)|1|||
147652671|NCT00303472|532550364|FG005|Treatment Period|Disease Progression (to AML)|0|||
147652672|NCT00303472|532550365|FG006|Treatment Period|Disease Progression (to AML)|0|||
147652673|NCT00303472|532550359|FG000|Treatment Extension (Optional)|Adverse Event|1|||
147652674|NCT00303472|532550360|FG001|Treatment Extension (Optional)|Adverse Event|0|||
147652675|NCT00303472|532550361|FG002|Treatment Extension (Optional)|Adverse Event|1|||
147652676|NCT00303472|532550362|FG003|Treatment Extension (Optional)|Adverse Event|0|||
147652677|NCT00303472|532550363|FG004|Treatment Extension (Optional)|Adverse Event|0|||
147652678|NCT00303472|532550364|FG005|Treatment Extension (Optional)|Adverse Event|0|||
147652679|NCT00303472|532550365|FG006|Treatment Extension (Optional)|Adverse Event|0|||
147652680|NCT00303472|532550359|FG000|Treatment Extension (Optional)|Death|2|||
147652681|NCT00303472|532550360|FG001|Treatment Extension (Optional)|Death|0|||
147652682|NCT00303472|532550361|FG002|Treatment Extension (Optional)|Death|1|||
147652683|NCT00303472|532550362|FG003|Treatment Extension (Optional)|Death|0|||
147652684|NCT00303472|532550363|FG004|Treatment Extension (Optional)|Death|0|||
147652685|NCT00303472|532550364|FG005|Treatment Extension (Optional)|Death|0|||
147652686|NCT00303472|532550365|FG006|Treatment Extension (Optional)|Death|0|||
147652687|NCT00303472|532550359|FG000|Treatment Extension (Optional)|Lost to Follow-up|0|||
147652688|NCT00303472|532550360|FG001|Treatment Extension (Optional)|Lost to Follow-up|0|||
147652689|NCT00303472|532550361|FG002|Treatment Extension (Optional)|Lost to Follow-up|0|||
147652690|NCT00303472|532550362|FG003|Treatment Extension (Optional)|Lost to Follow-up|1|||
147652691|NCT00303472|532550363|FG004|Treatment Extension (Optional)|Lost to Follow-up|0|||
147652692|NCT00303472|532550364|FG005|Treatment Extension (Optional)|Lost to Follow-up|0|||
147652693|NCT00303472|532550365|FG006|Treatment Extension (Optional)|Lost to Follow-up|0|||
147652694|NCT00303472|532550359|FG000|Treatment Extension (Optional)|Physician Decision|0|||
147652695|NCT00303472|532550360|FG001|Treatment Extension (Optional)|Physician Decision|4|||
147652696|NCT00303472|532550361|FG002|Treatment Extension (Optional)|Physician Decision|2|||
147652697|NCT00303472|532550362|FG003|Treatment Extension (Optional)|Physician Decision|3|||
147652698|NCT00303472|532550363|FG004|Treatment Extension (Optional)|Physician Decision|2|||
147146903|NCT01667133|530701006|FG006|Phase 2: Dose-expansion|Adverse Event|0|||
147146904|NCT01667133|530701007|FG007|Phase 2: Dose-expansion|Adverse Event|2|||
147146905|NCT01667133|530701008|FG008|Phase 2: Dose-expansion|Adverse Event|1|||
147652699|NCT00303472|532550364|FG005|Treatment Extension (Optional)|Physician Decision|0|||
147652700|NCT00303472|532550365|FG006|Treatment Extension (Optional)|Physician Decision|0|||
147652701|NCT00303472|532550359|FG000|Treatment Extension (Optional)|Withdrawal by Subject|1|||
147652702|NCT00303472|532550360|FG001|Treatment Extension (Optional)|Withdrawal by Subject|0|||
147652703|NCT00303472|532550361|FG002|Treatment Extension (Optional)|Withdrawal by Subject|1|||
147146906|NCT01667133|530701009|FG009|Phase 2: Dose-expansion|Adverse Event|1|||
147652704|NCT00303472|532550362|FG003|Treatment Extension (Optional)|Withdrawal by Subject|2|||
147652705|NCT00303472|532550363|FG004|Treatment Extension (Optional)|Withdrawal by Subject|1|||
147652706|NCT00303472|532550364|FG005|Treatment Extension (Optional)|Withdrawal by Subject|0|||
147652707|NCT00303472|532550365|FG006|Treatment Extension (Optional)|Withdrawal by Subject|0|||
147652708|NCT00303472|532550359|FG000|Treatment Extension (Optional)|Other|0|||
147652709|NCT00303472|532550360|FG001|Treatment Extension (Optional)|Other|2|||
147652710|NCT00303472|532550361|FG002|Treatment Extension (Optional)|Other|4|||
147652711|NCT00303472|532550362|FG003|Treatment Extension (Optional)|Other|2|||
147652712|NCT00303472|532550363|FG004|Treatment Extension (Optional)|Other|1|||
147652713|NCT00303472|532550364|FG005|Treatment Extension (Optional)|Other|0|||
147652714|NCT00303472|532550365|FG006|Treatment Extension (Optional)|Other|0|||
147652715|NCT00303472|532550359|FG000|Treatment Extension (Optional)|Disease Progression (to AML)|1|||
147652716|NCT00303472|532550360|FG001|Treatment Extension (Optional)|Disease Progression (to AML)|0|||
147652717|NCT00303472|532550361|FG002|Treatment Extension (Optional)|Disease Progression (to AML)|0|||
147652718|NCT00303472|532550362|FG003|Treatment Extension (Optional)|Disease Progression (to AML)|0|||
147652719|NCT00303472|532550363|FG004|Treatment Extension (Optional)|Disease Progression (to AML)|0|||
147652720|NCT00303472|532550364|FG005|Treatment Extension (Optional)|Disease Progression (to AML)|1|||
147652721|NCT00303472|532550365|FG006|Treatment Extension (Optional)|Disease Progression (to AML)|0|||
147652722|NCT01249833|532550371|FG000|Overall Study|Lost to Follow-up|0|||
147652723|NCT01249833|532550372|FG001|Overall Study|Lost to Follow-up|1|||
147652724|NCT03796676|532550373|FG000|Overall Study|Adverse Event|2|||
147652725|NCT03796676|532550374|FG001|Overall Study|Adverse Event|1|||
147652726|NCT03796676|532550375|FG002|Overall Study|Adverse Event|2|||
147652727|NCT03796676|532550373|FG000|Overall Study|Lost to Follow-up|2|||
147652728|NCT03796676|532550374|FG001|Overall Study|Lost to Follow-up|1|||
147652729|NCT03796676|532550375|FG002|Overall Study|Lost to Follow-up|0|||
147652730|NCT03796676|532550373|FG000|Overall Study|Protocol Violation|0|||
147146907|NCT01667133|530701010|FG010|Phase 2: Dose-expansion|Adverse Event|0|||
147146908|NCT01667133|530701011|FG011|Phase 2: Dose-expansion|Adverse Event|0|||
147238936|NCT04457336|531046177|FG000|Period 2: Part A|Other|0|||
147238937|NCT04457336|531046178|FG001|Period 2: Part A|Other|1|||
147238938|NCT04457336|531046179|FG002|Period 2: Part A|Other|0|||
147238939|NCT04457336|531046180|FG003|Period 2: Part A|Other|0|||
147238940|NCT04457336|531046181|FG004|Period 2: Part A|Other|0|||
147238941|NCT04457336|531046182|FG005|Period 2: Part A|Other|0|||
147238942|NCT04457336|531046183|FG006|Period 2: Part A|Other|0|||
147238943|NCT04457336|531046184|FG007|Period 2: Part A|Other|0|||
147319578|NCT01213173|531334889|FG001|Overall Study|Incorrect Enrollment|3|||
147319579|NCT02253316|531334890|FG000|Consolidation|Progression|4|||
147319580|NCT02253316|531334891|FG001|Consolidation|Progression|0|||
147319581|NCT02253316|531334892|FG002|Consolidation|Progression|0|||
147319582|NCT02253316|531334890|FG000|Consolidation|Non-Compliance|1|||
147652731|NCT03796676|532550374|FG001|Overall Study|Protocol Violation|0|||
147652732|NCT03796676|532550375|FG002|Overall Study|Protocol Violation|1|||
147652733|NCT03796676|532550373|FG000|Overall Study|Withdrawal by Subject|1|||
147652734|NCT03796676|532550374|FG001|Overall Study|Withdrawal by Subject|1|||
147652735|NCT03796676|532550375|FG002|Overall Study|Withdrawal by Subject|0|||
147146909|NCT01667133|530701000|FG000|Phase 2: Dose-expansion|Lack of Efficacy|0|||
147146910|NCT01667133|530701001|FG001|Phase 2: Dose-expansion|Lack of Efficacy|0|||
147146911|NCT01667133|530701002|FG002|Phase 2: Dose-expansion|Lack of Efficacy|0|||
147146912|NCT01667133|530701003|FG003|Phase 2: Dose-expansion|Lack of Efficacy|0|||
147146913|NCT01667133|530701004|FG004|Phase 2: Dose-expansion|Lack of Efficacy|0|||
147146914|NCT01667133|530701005|FG005|Phase 2: Dose-expansion|Lack of Efficacy|0|||
147146915|NCT01667133|530701006|FG006|Phase 2: Dose-expansion|Lack of Efficacy|0|||
147146916|NCT01667133|530701007|FG007|Phase 2: Dose-expansion|Lack of Efficacy|0|||
147146917|NCT01667133|530701008|FG008|Phase 2: Dose-expansion|Lack of Efficacy|0|||
147146918|NCT01667133|530701009|FG009|Phase 2: Dose-expansion|Lack of Efficacy|2|||
147146919|NCT01667133|530701010|FG010|Phase 2: Dose-expansion|Lack of Efficacy|0|||
147146920|NCT01667133|530701011|FG011|Phase 2: Dose-expansion|Lack of Efficacy|0|||
147146921|NCT01667133|530701000|FG000|Phase 2: Dose-expansion|Progressive Disease|0|||
147146922|NCT01667133|530701001|FG001|Phase 2: Dose-expansion|Progressive Disease|0|||
147146923|NCT01667133|530701002|FG002|Phase 2: Dose-expansion|Progressive Disease|0|||
147146924|NCT01667133|530701003|FG003|Phase 2: Dose-expansion|Progressive Disease|0|||
147146925|NCT01667133|530701004|FG004|Phase 2: Dose-expansion|Progressive Disease|0|||
147146926|NCT01667133|530701005|FG005|Phase 2: Dose-expansion|Progressive Disease|0|||
147146927|NCT01667133|530701006|FG006|Phase 2: Dose-expansion|Progressive Disease|0|||
147238944|NCT04457336|531046177|FG000|Period 2: Part A|Physician Decision|0|||
147238945|NCT04457336|531046178|FG001|Period 2: Part A|Physician Decision|0|||
147319583|NCT02253316|531334891|FG001|Consolidation|Non-Compliance|0|||
147652736|NCT03796676|532550373|FG000|Overall Study|Participant did not complete Week 16 due to COVID-19 impact|1|||
147652737|NCT03796676|532550374|FG001|Overall Study|Participant did not complete Week 16 due to COVID-19 impact|0|||
147146928|NCT01667133|530701007|FG007|Phase 2: Dose-expansion|Progressive Disease|0|||
147238946|NCT04457336|531046179|FG002|Period 2: Part A|Physician Decision|0|||
147238947|NCT04457336|531046180|FG003|Period 2: Part A|Physician Decision|1|||
147319584|NCT02253316|531334892|FG002|Consolidation|Non-Compliance|0|||
147319585|NCT02253316|531334890|FG000|Consolidation|Patient Withdrew Logistical Concerns|2|||
147319586|NCT02253316|531334891|FG001|Consolidation|Patient Withdrew Logistical Concerns|0|||
147319587|NCT02253316|531334892|FG002|Consolidation|Patient Withdrew Logistical Concerns|0|||
147319588|NCT02253316|531334890|FG000|Consolidation|Secondary Malignancy|2|||
147319589|NCT02253316|531334891|FG001|Consolidation|Secondary Malignancy|0|||
147319590|NCT02253316|531334892|FG002|Consolidation|Secondary Malignancy|0|||
147319591|NCT02253316|531334890|FG000|Consolidation|Adverse Event|7|||
147319592|NCT02253316|531334891|FG001|Consolidation|Adverse Event|0|||
147319593|NCT02253316|531334892|FG002|Consolidation|Adverse Event|0|||
147319594|NCT02253316|531334890|FG000|Maintenance|Patient Withdrew Logistical Concerns|0|||
147319595|NCT02253316|531334891|FG001|Maintenance|Patient Withdrew Logistical Concerns|7|||
147319596|NCT02253316|531334892|FG002|Maintenance|Patient Withdrew Logistical Concerns|7|||
147319597|NCT02253316|531334890|FG000|Maintenance|Physician Decision|0|||
147319598|NCT02253316|531334891|FG001|Maintenance|Physician Decision|7|||
147319599|NCT02253316|531334892|FG002|Maintenance|Physician Decision|16|||
147319600|NCT02253316|531334890|FG000|Maintenance|Non-Compliance|0|||
147319601|NCT02253316|531334891|FG001|Maintenance|Non-Compliance|1|||
147319602|NCT02253316|531334892|FG002|Maintenance|Non-Compliance|1|||
147319603|NCT02253316|531334890|FG000|Maintenance|Secondary Malignancy|0|||
147319604|NCT02253316|531334891|FG001|Maintenance|Secondary Malignancy|2|||
147319605|NCT02253316|531334892|FG002|Maintenance|Secondary Malignancy|6|||
147319606|NCT02253316|531334890|FG000|Maintenance|Adverse Event|0|||
147319607|NCT02253316|531334891|FG001|Maintenance|Adverse Event|8|||
147319608|NCT02253316|531334892|FG002|Maintenance|Adverse Event|12|||
147319609|NCT02253316|531334890|FG000|Maintenance|Still receiving active treatment|0|||
147319610|NCT02253316|531334891|FG001|Maintenance|Still receiving active treatment|4|||
147319611|NCT02253316|531334892|FG002|Maintenance|Still receiving active treatment|0|||
147319612|NCT02353832|531334893|FG000|Overall Study|Ineligible after enrollment|1|||
147319613|NCT02353832|531334893|FG000|Overall Study|Lost to Follow-up|1|||
147319614|NCT02684903|531334894|FG000|Overall Study|COVID-19 shutdown of lab|4|||
147319615|NCT02684903|531334895|FG001|Overall Study|COVID-19 shutdown of lab|6|||
147319616|NCT02684903|531334894|FG000|Overall Study|Lost to Follow-up|31|||
147319617|NCT02684903|531334895|FG001|Overall Study|Lost to Follow-up|41|||
147319618|NCT01950390|531334900|FG000|Overall Study|Never started treatment|3|||
147319619|NCT01950390|531334901|FG001|Overall Study|Never started treatment|2|||
147319620|NCT01950390|531334900|FG000|Overall Study|Disease progression|45|||
147319621|NCT01950390|531334901|FG001|Overall Study|Disease progression|52|||
147319622|NCT01950390|531334900|FG000|Overall Study|Adverse Event|22|||
147319623|NCT01950390|531334901|FG001|Overall Study|Adverse Event|16|||
147319624|NCT01950390|531334900|FG000|Overall Study|Death|5|||
147319625|NCT01950390|531334901|FG001|Overall Study|Death|3|||
147319626|NCT01950390|531334900|FG000|Overall Study|Withdrawal by Subject|5|||
147319627|NCT01950390|531334901|FG001|Overall Study|Withdrawal by Subject|1|||
147319628|NCT01950390|531334900|FG000|Overall Study|Alternative therapy|0|||
147319629|NCT01950390|531334901|FG001|Overall Study|Alternative therapy|3|||
147319630|NCT01950390|531334900|FG000|Overall Study|Complicating disease|1|||
147319631|NCT01950390|531334901|FG001|Overall Study|Complicating disease|0|||
147319632|NCT01950390|531334900|FG000|Overall Study|On treatment|1|||
147319633|NCT01950390|531334901|FG001|Overall Study|On treatment|0|||
147319634|NCT01950390|531334900|FG000|Overall Study|Symptomatic deterioration|2|||
147319635|NCT01950390|531334901|FG001|Overall Study|Symptomatic deterioration|1|||
147319636|NCT01950390|531334900|FG000|Overall Study|Physician Decision|0|||
147319637|NCT01950390|531334901|FG001|Overall Study|Physician Decision|4|||
147319638|NCT01950390|531334900|FG000|Overall Study|Lack of clinical benefit|0|||
147319639|NCT01950390|531334901|FG001|Overall Study|Lack of clinical benefit|1|||
147319640|NCT01950390|531334900|FG000|Overall Study|Maintained PR and moved to observation only|0|||
147319641|NCT01950390|531334901|FG001|Overall Study|Maintained PR and moved to observation only|1|||
147319642|NCT00731042|531336123|FG000|Second Intervention|Did not meet inclusion criteria|0|||
147319643|NCT00731042|531336124|FG001|Second Intervention|Did not meet inclusion criteria|2|||
147319644|NCT00802841|531336133|FG000|Overall Study|Administrative problems|1|||
147319645|NCT00802841|531336134|FG001|Overall Study|Administrative problems|0|||
147319646|NCT00802841|531336133|FG000|Overall Study|Lost to Follow-up|2|||
147319647|NCT00802841|531336134|FG001|Overall Study|Lost to Follow-up|1|||
147319648|NCT00802841|531336133|FG000|Overall Study|Death|1|||
147146929|NCT01667133|530701008|FG008|Phase 2: Dose-expansion|Progressive Disease|0|||
147319649|NCT00802841|531336134|FG001|Overall Study|Death|2|||
147146930|NCT01667133|530701009|FG009|Phase 2: Dose-expansion|Progressive Disease|0|||
147146931|NCT01667133|530701010|FG010|Phase 2: Dose-expansion|Progressive Disease|3|||
147146932|NCT01667133|530701011|FG011|Phase 2: Dose-expansion|Progressive Disease|5|||
147146933|NCT01667133|530701000|FG000|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
147146934|NCT01667133|530701001|FG001|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
147146935|NCT01667133|530701002|FG002|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
147146936|NCT01667133|530701003|FG003|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
147319650|NCT00802841|531336133|FG000|Overall Study|Adverse Event|8|||
147319651|NCT00802841|531336134|FG001|Overall Study|Adverse Event|2|||
147319652|NCT00802841|531336133|FG000|Overall Study|Disease progression|7|||
147319653|NCT00802841|531336134|FG001|Overall Study|Disease progression|3|||
147319654|NCT00802841|531336133|FG000|Overall Study|Withdrawal by Subject|9|||
147319655|NCT00802841|531336134|FG001|Overall Study|Withdrawal by Subject|5|||
147238948|NCT04457336|531046181|FG004|Period 2: Part A|Physician Decision|0|||
147238949|NCT04457336|531046182|FG005|Period 2: Part A|Physician Decision|0|||
147238950|NCT04457336|531046183|FG006|Period 2: Part A|Physician Decision|0|||
147238951|NCT04457336|531046184|FG007|Period 2: Part A|Physician Decision|0|||
147238952|NCT04457336|531046177|FG000|Period 3: Part B|Study Terminated|0|||
147238953|NCT04457336|531046178|FG001|Period 3: Part B|Study Terminated|0|||
147238954|NCT04457336|531046179|FG002|Period 3: Part B|Study Terminated|0|||
147238955|NCT04457336|531046180|FG003|Period 3: Part B|Study Terminated|0|||
147238956|NCT04457336|531046181|FG004|Period 3: Part B|Study Terminated|1|||
147319656|NCT00802841|531336133|FG000|Overall Study|Protocol deviation|2|||
147319657|NCT00802841|531336134|FG001|Overall Study|Protocol deviation|6|||
147319658|NCT00802841|531336133|FG000|Overall Study|Treatment duration completed|66|||
147319659|NCT00802841|531336134|FG001|Overall Study|Treatment duration completed|76|||
147319660|NCT00432159|531336137|FG000|Overall Study|Death|0|||
147319661|NCT00432159|531336138|FG001|Overall Study|Death|1|||
147319662|NCT00432159|531336139|FG002|Overall Study|Death|0|||
147319663|NCT00432159|531336140|FG003|Overall Study|Death|0|||
147319664|NCT00432159|531336141|FG004|Overall Study|Death|0|||
147319665|NCT00432159|531336137|FG000|Overall Study|Failure|9|||
147319666|NCT00432159|531336138|FG001|Overall Study|Failure|5|||
147319667|NCT00432159|531336139|FG002|Overall Study|Failure|3|||
147319668|NCT00432159|531336140|FG003|Overall Study|Failure|2|||
147319669|NCT00432159|531336141|FG004|Overall Study|Failure|3|||
147319670|NCT00432159|531336137|FG000|Overall Study|Missing NDI and/or neuro. assessment|13|||
147319671|NCT00432159|531336138|FG001|Overall Study|Missing NDI and/or neuro. assessment|24|||
147319672|NCT00432159|531336139|FG002|Overall Study|Missing NDI and/or neuro. assessment|1|||
147319673|NCT00432159|531336140|FG003|Overall Study|Missing NDI and/or neuro. assessment|3|||
147319674|NCT00432159|531336141|FG004|Overall Study|Missing NDI and/or neuro. assessment|7|||
147319675|NCT04096365|531336143|FG000|Overall Study|Adverse Event|1|||
147319676|NCT01939158|531336146|FG000|Overall Study|Adverse Event|1|||
147319677|NCT01939158|531336147|FG001|Overall Study|Adverse Event|0|||
147319678|NCT01939158|531336148|FG002|Overall Study|Adverse Event|0|||
147319679|NCT01939158|531336149|FG003|Overall Study|Adverse Event|0|||
147319680|NCT01939158|531336146|FG000|Overall Study|Withdrawal by Subject|22|||
147319681|NCT01939158|531336147|FG001|Overall Study|Withdrawal by Subject|25|||
147319682|NCT01939158|531336148|FG002|Overall Study|Withdrawal by Subject|15|||
147319683|NCT01939158|531336149|FG003|Overall Study|Withdrawal by Subject|17|||
147319684|NCT01939158|531336146|FG000|Overall Study|Migrated/moved from study area|5|||
147319685|NCT01939158|531336147|FG001|Overall Study|Migrated/moved from study area|7|||
147319686|NCT01939158|531336148|FG002|Overall Study|Migrated/moved from study area|3|||
147575389|NCT00112437|532263527|FG009|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
147575390|NCT00112437|532263528|FG010|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
147575391|NCT00112437|532263529|FG011|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
147575392|NCT00112437|532263530|FG012|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
147575393|NCT00112437|532263531|FG013|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
147575394|NCT00112437|532263532|FG014|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
147575395|NCT00112437|532263533|FG015|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
147575396|NCT00112437|532263534|FG016|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
147575397|NCT00112437|532263535|FG017|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
147575398|NCT00112437|532263536|FG018|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
147575399|NCT00112437|532263537|FG019|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
147575400|NCT00112437|532263538|FG020|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
147575401|NCT00112437|532263539|FG021|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
147575402|NCT00112437|532263540|FG022|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
147575403|NCT00112437|532263541|FG023|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
147575404|NCT00112437|532263542|FG024|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
147575405|NCT00112437|532263543|FG025|Year 1 (12-Month Base Study)|Lost to Follow-up|0|||
147575406|NCT00112437|532263518|FG000|Year 1 (12-Month Base Study)|Protocol Violation|1|||
147575407|NCT00112437|532263519|FG001|Year 1 (12-Month Base Study)|Protocol Violation|0|||
147575408|NCT00112437|532263520|FG002|Year 1 (12-Month Base Study)|Protocol Violation|3|||
147575409|NCT00112437|532263521|FG003|Year 1 (12-Month Base Study)|Protocol Violation|1|||
147575410|NCT00112437|532263522|FG004|Year 1 (12-Month Base Study)|Protocol Violation|1|||
147575411|NCT00112437|532263523|FG005|Year 1 (12-Month Base Study)|Protocol Violation|0|||
147575412|NCT00112437|532263524|FG006|Year 1 (12-Month Base Study)|Protocol Violation|0|||
147238957|NCT04457336|531046182|FG005|Period 3: Part B|Study Terminated|10|||
147238958|NCT04457336|531046183|FG006|Period 3: Part B|Study Terminated|13|||
147238959|NCT04457336|531046184|FG007|Period 3: Part B|Study Terminated|0|||
147319687|NCT01939158|531336149|FG003|Overall Study|Migrated/moved from study area|6|||
147319688|NCT01939158|531336146|FG000|Overall Study|Lost to Follow-up|18|||
147319689|NCT01939158|531336147|FG001|Overall Study|Lost to Follow-up|17|||
147319690|NCT01939158|531336148|FG002|Overall Study|Lost to Follow-up|17|||
147319691|NCT01939158|531336149|FG003|Overall Study|Lost to Follow-up|17|||
147319692|NCT01939158|531336146|FG000|Overall Study|Death|0|||
147319693|NCT01939158|531336147|FG001|Overall Study|Death|0|||
147319694|NCT01939158|531336148|FG002|Overall Study|Death|1|||
147146937|NCT01667133|530701004|FG004|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
147146938|NCT01667133|530701005|FG005|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
147146939|NCT01667133|530701006|FG006|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
147146940|NCT01667133|530701007|FG007|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
147146941|NCT01667133|530701008|FG008|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
147146942|NCT01667133|530701009|FG009|Phase 2: Dose-expansion|Withdrawal by Subject|2|||
147146943|NCT01667133|530701010|FG010|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
147146944|NCT01667133|530701011|FG011|Phase 2: Dose-expansion|Withdrawal by Subject|0|||
147146945|NCT01667133|530701000|FG000|Phase 2: Dose-expansion|Death|0|||
147146946|NCT01667133|530701001|FG001|Phase 2: Dose-expansion|Death|0|||
147146947|NCT01667133|530701002|FG002|Phase 2: Dose-expansion|Death|0|||
147146948|NCT01667133|530701003|FG003|Phase 2: Dose-expansion|Death|0|||
147146949|NCT01667133|530701004|FG004|Phase 2: Dose-expansion|Death|0|||
147146950|NCT01667133|530701005|FG005|Phase 2: Dose-expansion|Death|0|||
147146951|NCT01667133|530701006|FG006|Phase 2: Dose-expansion|Death|0|||
147146952|NCT01667133|530701007|FG007|Phase 2: Dose-expansion|Death|0|||
147146953|NCT01667133|530701008|FG008|Phase 2: Dose-expansion|Death|0|||
147652738|NCT03796676|532550375|FG002|Overall Study|Participant did not complete Week 16 due to COVID-19 impact|0|||
147652739|NCT00262002|532550380|FG000|Overall Study|Adverse Event|2|||
147652740|NCT00262002|532550381|FG001|Overall Study|Adverse Event|1|||
147652741|NCT00262002|532550382|FG002|Overall Study|Adverse Event|0|||
147652742|NCT00262002|532550383|FG003|Overall Study|Adverse Event|0|||
147652743|NCT00262002|532550384|FG004|Overall Study|Adverse Event|0|||
147652744|NCT00262002|532550385|FG005|Overall Study|Adverse Event|1|||
147652745|NCT00262002|532550386|FG006|Overall Study|Adverse Event|0|||
147652746|NCT00262002|532550380|FG000|Overall Study|Withdrawal by Subject|4|||
147652747|NCT00262002|532550381|FG001|Overall Study|Withdrawal by Subject|2|||
147652748|NCT00262002|532550382|FG002|Overall Study|Withdrawal by Subject|0|||
147652749|NCT00262002|532550383|FG003|Overall Study|Withdrawal by Subject|1|||
147652750|NCT00262002|532550384|FG004|Overall Study|Withdrawal by Subject|2|||
147652751|NCT00262002|532550385|FG005|Overall Study|Withdrawal by Subject|2|||
147652752|NCT00262002|532550386|FG006|Overall Study|Withdrawal by Subject|2|||
147652753|NCT00262002|532550380|FG000|Overall Study|Lost to Follow-up|2|||
147652754|NCT00262002|532550381|FG001|Overall Study|Lost to Follow-up|0|||
147652755|NCT00262002|532550382|FG002|Overall Study|Lost to Follow-up|0|||
147652756|NCT00262002|532550383|FG003|Overall Study|Lost to Follow-up|2|||
147652757|NCT00262002|532550384|FG004|Overall Study|Lost to Follow-up|0|||
147652758|NCT00262002|532550385|FG005|Overall Study|Lost to Follow-up|1|||
147652759|NCT00262002|532550386|FG006|Overall Study|Lost to Follow-up|0|||
147652760|NCT00262002|532550380|FG000|Overall Study|Inapropriate enrollment|0|||
147652761|NCT00262002|532550381|FG001|Overall Study|Inapropriate enrollment|1|||
147652762|NCT00262002|532550382|FG002|Overall Study|Inapropriate enrollment|0|||
147652763|NCT00262002|532550383|FG003|Overall Study|Inapropriate enrollment|0|||
147652764|NCT00262002|532550384|FG004|Overall Study|Inapropriate enrollment|0|||
147652765|NCT00262002|532550385|FG005|Overall Study|Inapropriate enrollment|0|||
147652766|NCT00262002|532550386|FG006|Overall Study|Inapropriate enrollment|0|||
147652767|NCT00262002|532550380|FG000|Overall Study|Protocol Violation|3|||
147652768|NCT00262002|532550381|FG001|Overall Study|Protocol Violation|2|||
147652769|NCT00262002|532550382|FG002|Overall Study|Protocol Violation|0|||
147652770|NCT00262002|532550383|FG003|Overall Study|Protocol Violation|2|||
147652771|NCT00262002|532550384|FG004|Overall Study|Protocol Violation|5|||
147652772|NCT00262002|532550385|FG005|Overall Study|Protocol Violation|3|||
147652773|NCT00262002|532550386|FG006|Overall Study|Protocol Violation|2|||
147652774|NCT00262002|532550380|FG000|Overall Study|Unable to classify|0|||
147652775|NCT00262002|532550381|FG001|Overall Study|Unable to classify|0|||
147652776|NCT00262002|532550382|FG002|Overall Study|Unable to classify|0|||
147652777|NCT00262002|532550383|FG003|Overall Study|Unable to classify|0|||
147146954|NCT01667133|530701009|FG009|Phase 2: Dose-expansion|Death|1|||
147146955|NCT01667133|530701010|FG010|Phase 2: Dose-expansion|Death|0|||
147146956|NCT01667133|530701011|FG011|Phase 2: Dose-expansion|Death|0|||
147652778|NCT00262002|532550384|FG004|Overall Study|Unable to classify|0|||
147652779|NCT00262002|532550385|FG005|Overall Study|Unable to classify|0|||
147652780|NCT00262002|532550386|FG006|Overall Study|Unable to classify|2|||
147652781|NCT01085084|532550387|FG000|Overall Study|Withdrawal by Subject|1|||
147652782|NCT01085084|532550388|FG001|Overall Study|Withdrawal by Subject|0|||
147652783|NCT01085084|532550389|FG002|Overall Study|Withdrawal by Subject|0|||
147146957|NCT01667133|530701000|FG000|Phase 2: Dose-expansion|Other|0|||
147146958|NCT01667133|530701001|FG001|Phase 2: Dose-expansion|Other|0|||
147146959|NCT01667133|530701002|FG002|Phase 2: Dose-expansion|Other|0|||
147146960|NCT01667133|530701003|FG003|Phase 2: Dose-expansion|Other|0|||
147146961|NCT01667133|530701004|FG004|Phase 2: Dose-expansion|Other|0|||
147146962|NCT01667133|530701005|FG005|Phase 2: Dose-expansion|Other|0|||
147445895|NCT01445951|531797474|FG002|Overall Study|Physician Decision|0|||
147652784|NCT01085084|532550387|FG000|Overall Study|Lost to Follow-up|2|||
147652785|NCT01085084|532550388|FG001|Overall Study|Lost to Follow-up|1|||
147652786|NCT01085084|532550389|FG002|Overall Study|Lost to Follow-up|1|||
147652787|NCT01085084|532550387|FG000|Overall Study|Adverse Event|4|||
147652788|NCT01085084|532550388|FG001|Overall Study|Adverse Event|3|||
147146963|NCT01667133|530701006|FG006|Phase 2: Dose-expansion|Other|0|||
147146964|NCT01667133|530701007|FG007|Phase 2: Dose-expansion|Other|0|||
147146965|NCT01667133|530701008|FG008|Phase 2: Dose-expansion|Other|0|||
147146966|NCT01667133|530701009|FG009|Phase 2: Dose-expansion|Other|0|||
147146967|NCT01667133|530701010|FG010|Phase 2: Dose-expansion|Other|0|||
147146968|NCT01667133|530701011|FG011|Phase 2: Dose-expansion|Other|1|||
147146969|NCT00255723|530701018|FG000|Overall Study|Adverse Event|1|||
147146970|NCT00255723|530701019|FG001|Overall Study|Adverse Event|1|||
147146971|NCT00255723|530701018|FG000|Overall Study|Death|0|||
147146972|NCT00255723|530701019|FG001|Overall Study|Death|1|||
147146973|NCT00255723|530701018|FG000|Overall Study|Response Data Not Available|1|||
147146974|NCT00255723|530701019|FG001|Overall Study|Response Data Not Available|0|||
147146975|NCT03711370|530701021|FG000|Overall Study|Lost to Follow-up|16|||
147146976|NCT03711370|530701022|FG001|Overall Study|Lost to Follow-up|10|||
147575413|NCT00112437|532263525|FG007|Year 1 (12-Month Base Study)|Protocol Violation|0|||
147575414|NCT00112437|532263526|FG008|Year 1 (12-Month Base Study)|Protocol Violation|0|||
147575415|NCT00112437|532263527|FG009|Year 1 (12-Month Base Study)|Protocol Violation|0|||
147575416|NCT00112437|532263528|FG010|Year 1 (12-Month Base Study)|Protocol Violation|0|||
147575417|NCT00112437|532263529|FG011|Year 1 (12-Month Base Study)|Protocol Violation|0|||
147575418|NCT00112437|532263530|FG012|Year 1 (12-Month Base Study)|Protocol Violation|0|||
147575419|NCT00112437|532263531|FG013|Year 1 (12-Month Base Study)|Protocol Violation|0|||
147575420|NCT00112437|532263532|FG014|Year 1 (12-Month Base Study)|Protocol Violation|0|||
147575421|NCT00112437|532263533|FG015|Year 1 (12-Month Base Study)|Protocol Violation|0|||
147575422|NCT00112437|532263534|FG016|Year 1 (12-Month Base Study)|Protocol Violation|0|||
147575423|NCT00112437|532263535|FG017|Year 1 (12-Month Base Study)|Protocol Violation|0|||
147575424|NCT00112437|532263536|FG018|Year 1 (12-Month Base Study)|Protocol Violation|0|||
147575425|NCT00112437|532263537|FG019|Year 1 (12-Month Base Study)|Protocol Violation|0|||
147575426|NCT00112437|532263538|FG020|Year 1 (12-Month Base Study)|Protocol Violation|0|||
147575427|NCT00112437|532263539|FG021|Year 1 (12-Month Base Study)|Protocol Violation|0|||
147575428|NCT00112437|532263540|FG022|Year 1 (12-Month Base Study)|Protocol Violation|0|||
147575429|NCT00112437|532263541|FG023|Year 1 (12-Month Base Study)|Protocol Violation|0|||
147575430|NCT00112437|532263542|FG024|Year 1 (12-Month Base Study)|Protocol Violation|0|||
147575431|NCT00112437|532263543|FG025|Year 1 (12-Month Base Study)|Protocol Violation|0|||
147575432|NCT00112437|532263518|FG000|Year 1 (12-Month Base Study)|Withdrawal by Subject|5|||
147575433|NCT00112437|532263519|FG001|Year 1 (12-Month Base Study)|Withdrawal by Subject|5|||
147575434|NCT00112437|532263520|FG002|Year 1 (12-Month Base Study)|Withdrawal by Subject|2|||
147575435|NCT00112437|532263521|FG003|Year 1 (12-Month Base Study)|Withdrawal by Subject|1|||
147575436|NCT00112437|532263522|FG004|Year 1 (12-Month Base Study)|Withdrawal by Subject|7|||
147575437|NCT00112437|532263523|FG005|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
147575438|NCT00112437|532263524|FG006|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
147575439|NCT00112437|532263525|FG007|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
147575440|NCT00112437|532263526|FG008|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
147575441|NCT00112437|532263527|FG009|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
147575442|NCT00112437|532263528|FG010|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
147575443|NCT00112437|532263529|FG011|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
147146977|NCT03711370|530701021|FG000|Overall Study|Pre-test or Post-test visits were >2 weeks apart|0|||
147146978|NCT03711370|530701022|FG001|Overall Study|Pre-test or Post-test visits were >2 weeks apart|6|||
147146979|NCT01169701|530701025|FG000|Overall Study|Lost to Follow-up|1|||
147146980|NCT01169701|530701026|FG001|Overall Study|Lost to Follow-up|1|||
147146981|NCT01169701|530701025|FG000|Overall Study|Withdrawal by Subject|1|||
147238960|NCT04457336|531046177|FG000|Period 3: Part B|Withdrawal by Subject|0|||
147238961|NCT04457336|531046178|FG001|Period 3: Part B|Withdrawal by Subject|0|||
147238962|NCT04457336|531046179|FG002|Period 3: Part B|Withdrawal by Subject|0|||
147238963|NCT04457336|531046180|FG003|Period 3: Part B|Withdrawal by Subject|0|||
147238964|NCT04457336|531046181|FG004|Period 3: Part B|Withdrawal by Subject|0|||
147238965|NCT04457336|531046182|FG005|Period 3: Part B|Withdrawal by Subject|1|||
147238966|NCT04457336|531046183|FG006|Period 3: Part B|Withdrawal by Subject|2|||
147238967|NCT04457336|531046184|FG007|Period 3: Part B|Withdrawal by Subject|0|||
147238968|NCT04457336|531046177|FG000|Period 4: Part C|Study Terminated|0|||
147238969|NCT04457336|531046178|FG001|Period 4: Part C|Study Terminated|0|||
147238970|NCT04457336|531046179|FG002|Period 4: Part C|Study Terminated|0|||
147238971|NCT04457336|531046180|FG003|Period 4: Part C|Study Terminated|0|||
147238972|NCT04457336|531046181|FG004|Period 4: Part C|Study Terminated|0|||
147238973|NCT04457336|531046182|FG005|Period 4: Part C|Study Terminated|0|||
147238974|NCT04457336|531046183|FG006|Period 4: Part C|Study Terminated|0|||
147238975|NCT04457336|531046184|FG007|Period 4: Part C|Study Terminated|30|||
147238976|NCT04457336|531046177|FG000|Period 4: Part C|Adverse Event|0|||
147238977|NCT04457336|531046178|FG001|Period 4: Part C|Adverse Event|0|||
147238978|NCT04457336|531046179|FG002|Period 4: Part C|Adverse Event|0|||
147146982|NCT01169701|530701026|FG001|Overall Study|Withdrawal by Subject|3|||
147238979|NCT04457336|531046180|FG003|Period 4: Part C|Adverse Event|0|||
147238980|NCT04457336|531046181|FG004|Period 4: Part C|Adverse Event|0|||
147238981|NCT04457336|531046182|FG005|Period 4: Part C|Adverse Event|0|||
147238982|NCT04457336|531046183|FG006|Period 4: Part C|Adverse Event|0|||
147146983|NCT01169701|530701025|FG000|Overall Study|Adverse Event|1|||
147146984|NCT01169701|530701026|FG001|Overall Study|Adverse Event|2|||
147146985|NCT01169701|530701025|FG000|Overall Study|Exclusion criteria|2|||
147146986|NCT01169701|530701026|FG001|Overall Study|Exclusion criteria|0|||
147146987|NCT01169701|530701025|FG000|Overall Study|Death|0|||
147146988|NCT01169701|530701026|FG001|Overall Study|Death|1|||
147146989|NCT01169701|530701025|FG000|Overall Study|Administrative problems|0|||
147146990|NCT01169701|530701026|FG001|Overall Study|Administrative problems|1|||
147575444|NCT00112437|532263530|FG012|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
147575445|NCT00112437|532263531|FG013|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
147575446|NCT00112437|532263532|FG014|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
147575447|NCT00112437|532263533|FG015|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
147575448|NCT00112437|532263534|FG016|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
147575449|NCT00112437|532263535|FG017|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
147575450|NCT00112437|532263536|FG018|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
147575451|NCT00112437|532263537|FG019|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
147575452|NCT00112437|532263538|FG020|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
147575453|NCT00112437|532263539|FG021|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
147575454|NCT00112437|532263540|FG022|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
147575455|NCT00112437|532263541|FG023|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
147575456|NCT00112437|532263542|FG024|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
147575457|NCT00112437|532263543|FG025|Year 1 (12-Month Base Study)|Withdrawal by Subject|0|||
147575458|NCT00112437|532263518|FG000|Year 1 (12-Month Base Study)|moved|0|||
147575459|NCT00112437|532263519|FG001|Year 1 (12-Month Base Study)|moved|1|||
147575460|NCT00112437|532263520|FG002|Year 1 (12-Month Base Study)|moved|1|||
147575461|NCT00112437|532263521|FG003|Year 1 (12-Month Base Study)|moved|0|||
147575462|NCT00112437|532263522|FG004|Year 1 (12-Month Base Study)|moved|0|||
147575463|NCT00112437|532263523|FG005|Year 1 (12-Month Base Study)|moved|0|||
147575464|NCT00112437|532263524|FG006|Year 1 (12-Month Base Study)|moved|0|||
147575465|NCT00112437|532263525|FG007|Year 1 (12-Month Base Study)|moved|0|||
147575466|NCT00112437|532263526|FG008|Year 1 (12-Month Base Study)|moved|0|||
147575467|NCT00112437|532263527|FG009|Year 1 (12-Month Base Study)|moved|0|||
147575468|NCT00112437|532263528|FG010|Year 1 (12-Month Base Study)|moved|0|||
147575469|NCT00112437|532263529|FG011|Year 1 (12-Month Base Study)|moved|0|||
147575470|NCT00112437|532263530|FG012|Year 1 (12-Month Base Study)|moved|0|||
147575471|NCT00112437|532263531|FG013|Year 1 (12-Month Base Study)|moved|0|||
147575472|NCT00112437|532263532|FG014|Year 1 (12-Month Base Study)|moved|0|||
147575473|NCT00112437|532263533|FG015|Year 1 (12-Month Base Study)|moved|0|||
147575474|NCT00112437|532263534|FG016|Year 1 (12-Month Base Study)|moved|0|||
147575475|NCT00112437|532263535|FG017|Year 1 (12-Month Base Study)|moved|0|||
147575476|NCT00112437|532263536|FG018|Year 1 (12-Month Base Study)|moved|0|||
147575477|NCT00112437|532263537|FG019|Year 1 (12-Month Base Study)|moved|0|||
147575478|NCT00112437|532263538|FG020|Year 1 (12-Month Base Study)|moved|0|||
147575479|NCT00112437|532263539|FG021|Year 1 (12-Month Base Study)|moved|0|||
147319695|NCT01939158|531336149|FG003|Overall Study|Death|1|||
147319696|NCT01939158|531336146|FG000|Overall Study|No longer meets eligibility criteria|0|||
147319697|NCT01939158|531336147|FG001|Overall Study|No longer meets eligibility criteria|0|||
147319698|NCT01939158|531336148|FG002|Overall Study|No longer meets eligibility criteria|1|||
147319699|NCT01939158|531336149|FG003|Overall Study|No longer meets eligibility criteria|0|||
147319700|NCT01939158|531336146|FG000|Overall Study|Other|1|||
147319701|NCT01939158|531336147|FG001|Overall Study|Other|3|||
147319702|NCT01939158|531336148|FG002|Overall Study|Other|4|||
147319703|NCT01939158|531336149|FG003|Overall Study|Other|3|||
147319704|NCT05310084|531336150|FG000|Overall Study|Withdrawal by Subject|2|||
147319705|NCT05310084|531336151|FG001|Overall Study|Withdrawal by Subject|3|||
147319706|NCT05310084|531336150|FG000|Overall Study|Participant availability|0|||
147319707|NCT05310084|531336151|FG001|Overall Study|Participant availability|4|||
147319708|NCT05310084|531336150|FG000|Overall Study|Lost to Follow-up|1|||
147319709|NCT05310084|531336151|FG001|Overall Study|Lost to Follow-up|1|||
147575480|NCT00112437|532263540|FG022|Year 1 (12-Month Base Study)|moved|0|||
147146991|NCT01169701|530701025|FG000|Overall Study|Serious adverse event|0|||
147146992|NCT01169701|530701026|FG001|Overall Study|Serious adverse event|1|||
147146993|NCT01169701|530701025|FG000|Overall Study|Sponsor decision|0|||
147575481|NCT00112437|532263541|FG023|Year 1 (12-Month Base Study)|moved|0|||
147575482|NCT00112437|532263542|FG024|Year 1 (12-Month Base Study)|moved|0|||
147575483|NCT00112437|532263543|FG025|Year 1 (12-Month Base Study)|moved|0|||
147575484|NCT00112437|532263518|FG000|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
147575485|NCT00112437|532263519|FG001|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
147146994|NCT01169701|530701026|FG001|Overall Study|Sponsor decision|1|||
147146995|NCT01536561|530701027|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|40|||
147319710|NCT05310084|531336150|FG000|Overall Study|Adverse Event|1|||
147319711|NCT05310084|531336151|FG001|Overall Study|Adverse Event|1|||
147319712|NCT05310084|531336150|FG000|Overall Study|Randomized but not vaccinated|4|||
147319713|NCT05310084|531336151|FG001|Overall Study|Randomized but not vaccinated|2|||
147319714|NCT02065245|531336153|FG000|Infusion 1|Lost to Follow-up|0|||
147319715|NCT02065245|531336154|FG001|Infusion 1|Lost to Follow-up|0|||
147319716|NCT02065245|531336155|FG002|Infusion 1|Lost to Follow-up|0|||
147319717|NCT02065245|531336156|FG003|Infusion 1|Lost to Follow-up|0|||
147319718|NCT02065245|531336157|FG004|Infusion 1|Lost to Follow-up|0|||
147319719|NCT02065245|531336158|FG005|Infusion 1|Lost to Follow-up|0|||
147319720|NCT02065245|531336159|FG006|Infusion 1|Lost to Follow-up|1|||
147319721|NCT02065245|531336153|FG000|Infusion 1|Death|0|||
147319722|NCT02065245|531336154|FG001|Infusion 1|Death|0|||
147319723|NCT02065245|531336155|FG002|Infusion 1|Death|1|||
147319724|NCT02065245|531336156|FG003|Infusion 1|Death|0|||
147319725|NCT02065245|531336157|FG004|Infusion 1|Death|1|||
147319726|NCT02065245|531336158|FG005|Infusion 1|Death|0|||
147319727|NCT02065245|531336159|FG006|Infusion 1|Death|0|||
147319728|NCT02065245|531336153|FG000|Infusion 2|Death|0|||
147319729|NCT02065245|531336154|FG001|Infusion 2|Death|0|||
147319730|NCT02065245|531336155|FG002|Infusion 2|Death|0|||
147319731|NCT02065245|531336156|FG003|Infusion 2|Death|0|||
147319732|NCT02065245|531336157|FG004|Infusion 2|Death|0|||
147319733|NCT02065245|531336158|FG005|Infusion 2|Death|0|||
147319734|NCT02065245|531336159|FG006|Infusion 2|Death|1|||
147319735|NCT02065245|531336153|FG000|Infusion 3|Lost to Follow-up|1|||
147319736|NCT02065245|531336154|FG001|Infusion 3|Lost to Follow-up|1|||
147319737|NCT02065245|531336155|FG002|Infusion 3|Lost to Follow-up|0|||
147319738|NCT02065245|531336156|FG003|Infusion 3|Lost to Follow-up|0|||
147319739|NCT02065245|531336157|FG004|Infusion 3|Lost to Follow-up|0|||
147319740|NCT02065245|531336158|FG005|Infusion 3|Lost to Follow-up|0|||
147319741|NCT02065245|531336159|FG006|Infusion 3|Lost to Follow-up|0|||
147319742|NCT01518257|531336160|FG000|Overall Study|Lost to Follow-up|1|||
147319743|NCT01518257|531336161|FG001|Overall Study|Lost to Follow-up|0|||
147319744|NCT01518257|531336160|FG000|Overall Study|Other Miscellaneous Reason|1|||
147319745|NCT01518257|531336161|FG001|Overall Study|Other Miscellaneous Reason|0|||
147319746|NCT01460381|531336164|FG000|Period 2 (Days 8-15)|Lost to Follow-up|1|||
147319747|NCT01460381|531336165|FG001|Period 2 (Days 8-15)|Lost to Follow-up|0|||
147319748|NCT01033643|531336167|FG000|Overall Study|Withdrew Consent|0|||
147319749|NCT01033643|531336168|FG001|Overall Study|Withdrew Consent|3|||
147319750|NCT01033643|531336169|FG002|Overall Study|Withdrew Consent|0|||
147319751|NCT01033643|531336170|FG003|Overall Study|Withdrew Consent|0|||
147319752|NCT01033643|531336171|FG004|Overall Study|Withdrew Consent|0|||
147319753|NCT01033643|531336172|FG005|Overall Study|Withdrew Consent|1|||
147319754|NCT03527277|531336173|FG000|Overall Study|Withdrawal by Subject|5|||
147319755|NCT03527277|531336174|FG001|Overall Study|Withdrawal by Subject|0|||
147319756|NCT03527277|531336173|FG000|Overall Study|Withdrawn by PI due to veins not suitable for multiple blood draws|0|||
147319757|NCT03527277|531336174|FG001|Overall Study|Withdrawn by PI due to veins not suitable for multiple blood draws|1|||
147319758|NCT03527277|531336173|FG000|Overall Study|Withdrawn by PI due to dietary miscompliance|1|||
147319759|NCT03527277|531336174|FG001|Overall Study|Withdrawn by PI due to dietary miscompliance|0|||
147319760|NCT02652130|531336179|FG000|Overall Study|Death|1|||
147319761|NCT03930186|531336180|FG000|Weeks 0 to 16|Adverse Event|6|||
147319762|NCT03930186|531336180|FG000|Weeks 0 to 16|Withdrawal by Subject|6|||
147319763|NCT03930186|531336180|FG000|Weeks 16 to 32|Adverse Event|1|||
147319764|NCT03930186|531336180|FG000|Weeks 16 to 32|Withdrawal by Subject|3|||
147319765|NCT02013687|531336194|FG000|Overall Study|Lost to Follow-up|0|||
147319766|NCT02013687|531336195|FG001|Overall Study|Lost to Follow-up|0|||
147319767|NCT02013687|531336196|FG002|Overall Study|Lost to Follow-up|1|||
147319768|NCT02013687|531336197|FG003|Overall Study|Lost to Follow-up|0|||
147319769|NCT02013687|531336194|FG000|Overall Study|Protocol Violation|0|||
147319770|NCT02013687|531336195|FG001|Overall Study|Protocol Violation|0|||
147319771|NCT02013687|531336196|FG002|Overall Study|Protocol Violation|0|||
147319772|NCT02013687|531336197|FG003|Overall Study|Protocol Violation|1|||
147319773|NCT02013687|531336194|FG000|Overall Study|Withdrawal by Subject|0|||
147319774|NCT02013687|531336195|FG001|Overall Study|Withdrawal by Subject|0|||
147319775|NCT02013687|531336196|FG002|Overall Study|Withdrawal by Subject|0|||
147319776|NCT02013687|531336197|FG003|Overall Study|Withdrawal by Subject|1|||
147319777|NCT02013687|531336194|FG000|Overall Study|Missed visits due to patient travel|0|||
147319778|NCT02013687|531336195|FG001|Overall Study|Missed visits due to patient travel|0|||
147319779|NCT02013687|531336196|FG002|Overall Study|Missed visits due to patient travel|1|||
147319780|NCT02013687|531336197|FG003|Overall Study|Missed visits due to patient travel|0|||
147445896|NCT01445951|531797472|FG000|Overall Study|Lost to Follow-up|1|||
147319781|NCT01782326|531336198|FG000|Planned Treatment Epoch|Subject/guardian decision|149|||
147319782|NCT01782326|531336199|FG001|Planned Treatment Epoch|Subject/guardian decision|151|||
147319783|NCT01782326|531336198|FG000|Planned Treatment Epoch|Death|29|||
147319784|NCT01782326|531336199|FG001|Planned Treatment Epoch|Death|30|||
147319785|NCT01782326|531336198|FG000|Planned Treatment Epoch|Physician Decision|18|||
147319786|NCT01782326|531336199|FG001|Planned Treatment Epoch|Physician Decision|16|||
147319787|NCT01782326|531336198|FG000|Planned Treatment Epoch|Protocol deviation|2|||
147319788|NCT01782326|531336199|FG001|Planned Treatment Epoch|Protocol deviation|3|||
147319789|NCT01782326|531336198|FG000|Planned Treatment Epoch|Lost to Follow-up|4|||
147319790|NCT01782326|531336199|FG001|Planned Treatment Epoch|Lost to Follow-up|4|||
147319791|NCT01782326|531336198|FG000|Planned Treatment Epoch|Technical problems|0|||
147319792|NCT01782326|531336199|FG001|Planned Treatment Epoch|Technical problems|4|||
147319793|NCT01782326|531336198|FG000|Double-blind Treatment|Adverse Event|129|||
147319794|NCT01782326|531336199|FG001|Double-blind Treatment|Adverse Event|145|||
147319795|NCT01782326|531336198|FG000|Double-blind Treatment|Subject/guardian decision|111|||
147319796|NCT01782326|531336199|FG001|Double-blind Treatment|Subject/guardian decision|125|||
147319797|NCT01782326|531336198|FG000|Double-blind Treatment|Lack of Efficacy|17|||
147319798|NCT01782326|531336199|FG001|Double-blind Treatment|Lack of Efficacy|22|||
147575486|NCT00112437|532263520|FG002|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
147575487|NCT00112437|532263521|FG003|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|2|||
147575488|NCT00112437|532263522|FG004|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
147575489|NCT00112437|532263523|FG005|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
147319799|NCT01782326|531336198|FG000|Double-blind Treatment|Physician Decision|13|||
147319800|NCT01782326|531336199|FG001|Double-blind Treatment|Physician Decision|16|||
147319801|NCT01782326|531336198|FG000|Double-blind Treatment|Protocol deviation|8|||
147319802|NCT01782326|531336199|FG001|Double-blind Treatment|Protocol deviation|7|||
147319803|NCT01782326|531336198|FG000|Double-blind Treatment|Technical problems|0|||
147319804|NCT01782326|531336199|FG001|Double-blind Treatment|Technical problems|5|||
147319805|NCT02559817|531336200|FG000|Treatment Period|Adverse Event|1|||
147319806|NCT02559817|531336201|FG001|Treatment Period|Adverse Event|0|||
147319807|NCT02559817|531336202|FG002|Treatment Period|Adverse Event|1|||
147319808|NCT02559817|531336203|FG003|Treatment Period|Adverse Event|0|||
147319809|NCT02559817|531336204|FG004|Treatment Period|Adverse Event|0|||
147319810|NCT02559817|531336200|FG000|Treatment Period|Lack of Efficacy|0|||
147319811|NCT02559817|531336201|FG001|Treatment Period|Lack of Efficacy|1|||
147319812|NCT02559817|531336202|FG002|Treatment Period|Lack of Efficacy|0|||
147319813|NCT02559817|531336203|FG003|Treatment Period|Lack of Efficacy|0|||
147319814|NCT02559817|531336204|FG004|Treatment Period|Lack of Efficacy|0|||
147319815|NCT02559817|531336200|FG000|Treatment Period|Lost to Follow-up|0|||
147319816|NCT02559817|531336201|FG001|Treatment Period|Lost to Follow-up|1|||
147319817|NCT02559817|531336202|FG002|Treatment Period|Lost to Follow-up|0|||
147319818|NCT02559817|531336203|FG003|Treatment Period|Lost to Follow-up|1|||
147319819|NCT02559817|531336204|FG004|Treatment Period|Lost to Follow-up|0|||
147319820|NCT02559817|531336200|FG000|Treatment Period|Non-Compliance With Study Drug|0|||
147319821|NCT02559817|531336201|FG001|Treatment Period|Non-Compliance With Study Drug|0|||
147319822|NCT02559817|531336202|FG002|Treatment Period|Non-Compliance With Study Drug|1|||
147319823|NCT02559817|531336203|FG003|Treatment Period|Non-Compliance With Study Drug|0|||
147319824|NCT02559817|531336204|FG004|Treatment Period|Non-Compliance With Study Drug|0|||
147319825|NCT02559817|531336200|FG000|Treatment Period|Protocol Violation|0|||
147319826|NCT02559817|531336201|FG001|Treatment Period|Protocol Violation|0|||
147319827|NCT02559817|531336202|FG002|Treatment Period|Protocol Violation|0|||
147319828|NCT02559817|531336203|FG003|Treatment Period|Protocol Violation|1|||
147319829|NCT02559817|531336204|FG004|Treatment Period|Protocol Violation|0|||
147319830|NCT03389893|531336205|FG000|Randomized Double Blind Period|Withdrawal by Subject|1|||
147319831|NCT03389893|531336206|FG001|Randomized Double Blind Period|Withdrawal by Subject|0|||
147319832|NCT03389893|531336207|FG002|Randomized Double Blind Period|Withdrawal by Subject|0|||
147319833|NCT03389893|531336208|FG003|Randomized Double Blind Period|Withdrawal by Subject|0|||
147319834|NCT03389893|531336205|FG000|Open Label Extension and Follow-Up|Lost to Follow-up|0|||
147319835|NCT03389893|531336206|FG001|Open Label Extension and Follow-Up|Lost to Follow-up|0|||
147319836|NCT03389893|531336207|FG002|Open Label Extension and Follow-Up|Lost to Follow-up|2|||
147319837|NCT03389893|531336208|FG003|Open Label Extension and Follow-Up|Lost to Follow-up|1|||
147575490|NCT00112437|532263524|FG006|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
147319838|NCT03389893|531336205|FG000|Open Label Extension and Follow-Up|Physician Decision|0|||
147319839|NCT03389893|531336206|FG001|Open Label Extension and Follow-Up|Physician Decision|0|||
147319840|NCT03389893|531336207|FG002|Open Label Extension and Follow-Up|Physician Decision|1|||
147319841|NCT03389893|531336208|FG003|Open Label Extension and Follow-Up|Physician Decision|0|||
147319842|NCT03389893|531336205|FG000|Open Label Extension and Follow-Up|Participant Moved|0|||
147319843|NCT03389893|531336206|FG001|Open Label Extension and Follow-Up|Participant Moved|0|||
147319844|NCT03389893|531336207|FG002|Open Label Extension and Follow-Up|Participant Moved|1|||
147319845|NCT03389893|531336208|FG003|Open Label Extension and Follow-Up|Participant Moved|0|||
147319846|NCT00388362|531336211|FG000|Enrolled|Ineligible|1|||
147319847|NCT00388362|531336211|FG000|Enrolled|Adverse Event|9|||
147319848|NCT00388362|531336211|FG000|Enrolled|Death|1|||
147319849|NCT00388362|531336211|FG000|Enrolled|Loss insurance|1|||
147319850|NCT00388362|531336211|FG000|Enrolled|Withdrawal by Subject|1|||
147319851|NCT00388362|531336211|FG000|Remained on Study Median of 514 Days|Death|2|||
147319852|NCT02335268|531336212|FG000|Overall Study|Physician Decision|5|||
147575491|NCT00112437|532263525|FG007|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
147575492|NCT00112437|532263526|FG008|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
147652789|NCT01085084|532550389|FG002|Overall Study|Adverse Event|6|||
147319853|NCT02335268|531336213|FG001|Overall Study|Physician Decision|1|||
147319854|NCT02335268|531336212|FG000|Overall Study|Lack of Efficacy|2|||
147238983|NCT04457336|531046184|FG007|Period 4: Part C|Adverse Event|2|||
147319855|NCT02335268|531336213|FG001|Overall Study|Lack of Efficacy|1|||
147319856|NCT02335268|531336212|FG000|Overall Study|Adverse Event|5|||
147319857|NCT02335268|531336213|FG001|Overall Study|Adverse Event|2|||
147319858|NCT02335268|531336212|FG000|Overall Study|increase blasts|2|||
147319859|NCT02335268|531336213|FG001|Overall Study|increase blasts|0|||
147319860|NCT02335268|531336212|FG000|Overall Study|Withdrawal by Subject|3|||
147319861|NCT02335268|531336213|FG001|Overall Study|Withdrawal by Subject|2|||
147319862|NCT04894903|531336218|FG000|Overall Study|Death|1|||
147319863|NCT04894903|531336219|FG001|Overall Study|Death|0|||
147319864|NCT04894903|531336218|FG000|Overall Study|Pregnancy|1|||
147319865|NCT04894903|531336219|FG001|Overall Study|Pregnancy|0|||
147319866|NCT04894903|531336218|FG000|Overall Study|Withdrawal by Subject|1|||
147319867|NCT04894903|531336219|FG001|Overall Study|Withdrawal by Subject|1|||
147319868|NCT04894903|531336218|FG000|Overall Study|moved or exited health system|1|||
147319869|NCT04894903|531336219|FG001|Overall Study|moved or exited health system|3|||
147319870|NCT01670500|531336220|FG000|Overall Study|Withdrawal by Subject|1|||
147319871|NCT01670500|531336221|FG001|Overall Study|Withdrawal by Subject|0|||
147319872|NCT01822353|531336223|FG000|Overall Study|Adverse Event|1|||
147319873|NCT01822353|531336224|FG001|Overall Study|Adverse Event|3|||
147319874|NCT01822353|531336225|FG002|Overall Study|Adverse Event|1|||
147319875|NCT01822353|531336223|FG000|Overall Study|Pregnancy|0|||
147319876|NCT01822353|531336224|FG001|Overall Study|Pregnancy|1|||
147319877|NCT01822353|531336225|FG002|Overall Study|Pregnancy|0|||
147319878|NCT01822353|531336223|FG000|Overall Study|Withdrawal by Subject|3|||
147575493|NCT00112437|532263527|FG009|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
147575494|NCT00112437|532263528|FG010|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
147575495|NCT00112437|532263529|FG011|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
147575496|NCT00112437|532263530|FG012|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
147238984|NCT04457336|531046177|FG000|Period 4: Part C|Site Terminated|0|||
147319879|NCT01822353|531336224|FG001|Overall Study|Withdrawal by Subject|1|||
147319880|NCT01822353|531336225|FG002|Overall Study|Withdrawal by Subject|0|||
147319881|NCT02550873|531336226|FG000|Randomized Double Blind|Adverse Event|3|||
147319882|NCT02550873|531336227|FG001|Randomized Double Blind|Adverse Event|1|||
147319883|NCT02550873|531336228|FG002|Randomized Double Blind|Adverse Event|0|||
147319884|NCT02550873|531336226|FG000|Randomized Double Blind|Disease progression|1|||
147319885|NCT02550873|531336227|FG001|Randomized Double Blind|Disease progression|1|||
147319886|NCT02550873|531336228|FG002|Randomized Double Blind|Disease progression|0|||
147319887|NCT02550873|531336226|FG000|Open Label Extension|Study ongoing|0|||
147319888|NCT02550873|531336227|FG001|Open Label Extension|Study ongoing|0|||
147319889|NCT02550873|531336228|FG002|Open Label Extension|Study ongoing|111|||
147319890|NCT01857323|531336229|FG000|Overall Study|Adverse Event|1|||
147238985|NCT04457336|531046178|FG001|Period 4: Part C|Site Terminated|0|||
147238986|NCT04457336|531046179|FG002|Period 4: Part C|Site Terminated|0|||
147238987|NCT04457336|531046180|FG003|Period 4: Part C|Site Terminated|0|||
147238988|NCT04457336|531046181|FG004|Period 4: Part C|Site Terminated|0|||
147238989|NCT04457336|531046182|FG005|Period 4: Part C|Site Terminated|0|||
147238990|NCT04457336|531046183|FG006|Period 4: Part C|Site Terminated|0|||
147238991|NCT04457336|531046184|FG007|Period 4: Part C|Site Terminated|1|||
147238992|NCT04457336|531046177|FG000|Period 4: Part C|Other|0|||
147238993|NCT04457336|531046178|FG001|Period 4: Part C|Other|0|||
147238994|NCT04457336|531046179|FG002|Period 4: Part C|Other|0|||
147238995|NCT04457336|531046180|FG003|Period 4: Part C|Other|0|||
147238996|NCT04457336|531046181|FG004|Period 4: Part C|Other|0|||
147238997|NCT04457336|531046182|FG005|Period 4: Part C|Other|0|||
147238998|NCT04457336|531046183|FG006|Period 4: Part C|Other|0|||
147238999|NCT04457336|531046184|FG007|Period 4: Part C|Other|2|||
147239000|NCT04457336|531046177|FG000|Period 4: Part C|Withdrawal by Subject|0|||
147239001|NCT04457336|531046178|FG001|Period 4: Part C|Withdrawal by Subject|0|||
147239002|NCT04457336|531046179|FG002|Period 4: Part C|Withdrawal by Subject|0|||
147239003|NCT04457336|531046180|FG003|Period 4: Part C|Withdrawal by Subject|0|||
147239004|NCT04457336|531046181|FG004|Period 4: Part C|Withdrawal by Subject|0|||
147239005|NCT04457336|531046182|FG005|Period 4: Part C|Withdrawal by Subject|0|||
147239006|NCT04457336|531046183|FG006|Period 4: Part C|Withdrawal by Subject|0|||
147239007|NCT04457336|531046184|FG007|Period 4: Part C|Withdrawal by Subject|3|||
147239008|NCT03330288|531046191|FG000|Overall Study|Other reason|1|||
147239009|NCT03330288|531046192|FG001|Overall Study|Other reason|1|||
147239010|NCT03330288|531046191|FG000|Overall Study|Switching to a different disease-modifying delayed-release drug SYSADOA|1|||
147319891|NCT01857323|531336229|FG000|Overall Study|Withdrawal by Subject|3|||
147319892|NCT01857323|531336229|FG000|Overall Study|Non-compliance|1|||
147319893|NCT01857323|531336229|FG000|Overall Study|Protocol Violation|6|||
147445897|NCT01445951|531797473|FG001|Overall Study|Lost to Follow-up|2|||
147239011|NCT03330288|531046192|FG001|Overall Study|Switching to a different disease-modifying delayed-release drug SYSADOA|0|||
147239012|NCT03330288|531046191|FG000|Overall Study|Adverse Event|1|||
147239013|NCT03330288|531046192|FG001|Overall Study|Adverse Event|0|||
147239014|NCT03330288|531046191|FG000|Overall Study|Withdrawal by Subject|1|||
147239015|NCT03330288|531046192|FG001|Overall Study|Withdrawal by Subject|0|||
147319894|NCT01857323|531336229|FG000|Overall Study|Lost to Follow-up|1|||
147319895|NCT01857323|531336229|FG000|Overall Study|Other|4|||
147319896|NCT01857323|531336229|FG000|Overall Study|Did not complete 180 doses|48|||
147319897|NCT03873246|531336230|FG000|Overall Study|Adverse Event|1|||
147319898|NCT03873246|531336231|FG001|Overall Study|Adverse Event|3|||
147319899|NCT03873246|531336232|FG002|Overall Study|Adverse Event|3|||
147319900|NCT03873246|531336230|FG000|Overall Study|Lost to Follow-up|4|||
147319901|NCT03873246|531336231|FG001|Overall Study|Lost to Follow-up|4|||
147319902|NCT03873246|531336232|FG002|Overall Study|Lost to Follow-up|5|||
147319903|NCT03873246|531336230|FG000|Overall Study|Protocol Violation|0|||
147319904|NCT03873246|531336231|FG001|Overall Study|Protocol Violation|1|||
147319905|NCT03873246|531336232|FG002|Overall Study|Protocol Violation|0|||
147319906|NCT03873246|531336230|FG000|Overall Study|Withdrawal by Subject|0|||
147319907|NCT03873246|531336231|FG001|Overall Study|Withdrawal by Subject|4|||
147319908|NCT03873246|531336232|FG002|Overall Study|Withdrawal by Subject|1|||
147575497|NCT00112437|532263531|FG013|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
147319909|NCT04209790|531336233|FG000|Overall Study|Physician Decision|1|||
147319910|NCT05617040|531336234|FG000|Overall Study|Adverse Event|0|||
147146996|NCT01536561|530701027|FG000|Dosimetric and Therapeutic Treatment|Received Alternate Treatment|2|||
147146997|NCT01536561|530701027|FG000|Dosimetric and Therapeutic Treatment|Adverse Event|1|||
147146998|NCT01536561|530701027|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|1|||
147146999|NCT01536561|530701027|FG000|Dosimetric and Therapeutic Treatment|Death|2|||
147147000|NCT01536561|530701027|FG000|Dosimetric and Therapeutic Treatment|Enrolled in Study BEX104526|13|||
147147001|NCT00553436|530701028|FG000|Overall Study|Conversion to another procedure|1|||
147147002|NCT04188834|530701029|FG000|Overall Study|Participants did not complete enough proportion of experiment(s) to be included in analysis|4|||
147147003|NCT01030952|530701030|FG000|Overall Study|Protocol Violation|0|||
147147004|NCT01030952|530701031|FG001|Overall Study|Protocol Violation|1|||
147147005|NCT01030952|530701030|FG000|Overall Study|Informed consent withdrawal|1|||
147147006|NCT01030952|530701031|FG001|Overall Study|Informed consent withdrawal|0|||
147147007|NCT01030952|530701030|FG000|Overall Study|Lost to Follow-up|0|||
147319911|NCT05617040|531336235|FG001|Overall Study|Adverse Event|1|||
147319912|NCT05617040|531336236|FG002|Overall Study|Adverse Event|0|||
147319913|NCT05617040|531336234|FG000|Overall Study|Death|0|||
147319914|NCT05617040|531336235|FG001|Overall Study|Death|0|||
147319915|NCT05617040|531336236|FG002|Overall Study|Death|1|||
147575498|NCT00112437|532263532|FG014|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
147575499|NCT00112437|532263533|FG015|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
147575500|NCT00112437|532263534|FG016|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
147575501|NCT00112437|532263535|FG017|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
147575502|NCT00112437|532263536|FG018|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
147575503|NCT00112437|532263537|FG019|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
147575504|NCT00112437|532263538|FG020|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
147575505|NCT00112437|532263539|FG021|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
147575506|NCT00112437|532263540|FG022|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
147575507|NCT00112437|532263541|FG023|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
147575508|NCT00112437|532263542|FG024|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
147575509|NCT00112437|532263543|FG025|Year 1 (12-Month Base Study)|patient was unsure that they needed drug|0|||
147575510|NCT00112437|532263518|FG000|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
147575511|NCT00112437|532263519|FG001|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
147575512|NCT00112437|532263520|FG002|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
147575513|NCT00112437|532263521|FG003|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
147575514|NCT00112437|532263522|FG004|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|1|||
147575515|NCT00112437|532263523|FG005|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
147575516|NCT00112437|532263524|FG006|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
147575517|NCT00112437|532263525|FG007|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
147575518|NCT00112437|532263526|FG008|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
147575519|NCT00112437|532263527|FG009|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
147575520|NCT00112437|532263528|FG010|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
147575521|NCT00112437|532263529|FG011|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
147575522|NCT00112437|532263530|FG012|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
147575523|NCT00112437|532263531|FG013|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
147575524|NCT00112437|532263532|FG014|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
147575525|NCT00112437|532263533|FG015|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
147575526|NCT00112437|532263534|FG016|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
147319916|NCT04562779|531336237|FG000|Overall Study|Lost to Follow-up|7|||
147319917|NCT04562779|531336238|FG001|Overall Study|Lost to Follow-up|5|||
147319918|NCT04562779|531336239|FG002|Overall Study|Lost to Follow-up|10|||
147319919|NCT04562779|531336237|FG000|Overall Study|Protocol Violation|2|||
147319920|NCT04562779|531336238|FG001|Overall Study|Protocol Violation|2|||
147319921|NCT04562779|531336239|FG002|Overall Study|Protocol Violation|0|||
147319922|NCT03173248|531336240|FG000|Overall Study|Death|28|||
147319923|NCT03173248|531336241|FG001|Overall Study|Death|46|||
147319924|NCT03173248|531336240|FG000|Overall Study|Lost to Follow-up|0|||
147575527|NCT00112437|532263535|FG017|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
147575528|NCT00112437|532263536|FG018|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
147575529|NCT00112437|532263537|FG019|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
147575530|NCT00112437|532263538|FG020|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
147575531|NCT00112437|532263539|FG021|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
147575532|NCT00112437|532263540|FG022|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
147319925|NCT03173248|531336241|FG001|Overall Study|Lost to Follow-up|1|||
147319926|NCT03173248|531336240|FG000|Overall Study|Withdrawal by Subject|6|||
147319927|NCT03173248|531336241|FG001|Overall Study|Withdrawal by Subject|4|||
147319928|NCT03173248|531336240|FG000|Overall Study|Ongoing at Data Cut-off Date: 18 March 2021|38|||
147319929|NCT03173248|531336241|FG001|Overall Study|Ongoing at Data Cut-off Date: 18 March 2021|23|||
147319930|NCT05567952|531338309|FG000|Overall Study|Lost to Follow-up|3|||
147319931|NCT05567952|531338310|FG001|Overall Study|Lost to Follow-up|2|||
147319932|NCT05567952|531338309|FG000|Overall Study|Withdrawal by Subject|6|||
147319933|NCT05567952|531338310|FG001|Overall Study|Withdrawal by Subject|3|||
147575533|NCT00112437|532263541|FG023|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
147319934|NCT05567952|531338309|FG000|Overall Study|Other|3|||
147319935|NCT05567952|531338310|FG001|Overall Study|Other|1|||
147319936|NCT05194735|531338311|FG000|Overall Study|Apheresed but not administered TCR-T cells due to manufacturing failure|0|||
147319937|NCT05194735|531338312|FG001|Overall Study|Apheresed but not administered TCR-T cells due to manufacturing failure|1|||
147319938|NCT05194735|531338313|FG002|Overall Study|Apheresed but not administered TCR-T cells due to manufacturing failure|0|||
147319939|NCT05194735|531338311|FG000|Overall Study|Apheresed but not administered TCR-T cells due to participant developed brain metastases|0|||
147319940|NCT05194735|531338312|FG001|Overall Study|Apheresed but not administered TCR-T cells due to participant developed brain metastases|1|||
147319941|NCT05194735|531338313|FG002|Overall Study|Apheresed but not administered TCR-T cells due to participant developed brain metastases|0|||
147319942|NCT05194735|531338311|FG000|Overall Study|Apheresed but not administered TCR-T cells due to early termination of study|0|||
147147008|NCT01030952|530701031|FG001|Overall Study|Lost to Follow-up|1|||
147147009|NCT01030952|530701030|FG000|Overall Study|Unexplained|1|||
147147010|NCT01030952|530701031|FG001|Overall Study|Unexplained|1|||
147147011|NCT02455336|530701034|FG000|Overall Study|Withdrawal by Subject|0|||
147147012|NCT02455336|530701035|FG001|Overall Study|Withdrawal by Subject|2|||
147147013|NCT02455336|530701034|FG000|Overall Study|Adverse Event|3|||
147575534|NCT00112437|532263542|FG024|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
147575535|NCT00112437|532263543|FG025|Year 1 (12-Month Base Study)|DXA was lower by more than 8%|0|||
147575536|NCT00112437|532263518|FG000|Year 2 (12-Month Extension)|Adverse Event|0|||
147575537|NCT00112437|532263519|FG001|Year 2 (12-Month Extension)|Adverse Event|0|||
147575538|NCT00112437|532263520|FG002|Year 2 (12-Month Extension)|Adverse Event|0|||
147575539|NCT00112437|532263521|FG003|Year 2 (12-Month Extension)|Adverse Event|0|||
147575540|NCT00112437|532263522|FG004|Year 2 (12-Month Extension)|Adverse Event|0|||
147575541|NCT00112437|532263523|FG005|Year 2 (12-Month Extension)|Adverse Event|1|||
147575542|NCT00112437|532263524|FG006|Year 2 (12-Month Extension)|Adverse Event|2|||
147575543|NCT00112437|532263525|FG007|Year 2 (12-Month Extension)|Adverse Event|6|||
147575544|NCT00112437|532263526|FG008|Year 2 (12-Month Extension)|Adverse Event|1|||
147575545|NCT00112437|532263527|FG009|Year 2 (12-Month Extension)|Adverse Event|7|||
147575546|NCT00112437|532263528|FG010|Year 2 (12-Month Extension)|Adverse Event|0|||
147575547|NCT00112437|532263529|FG011|Year 2 (12-Month Extension)|Adverse Event|0|||
147575548|NCT00112437|532263530|FG012|Year 2 (12-Month Extension)|Adverse Event|0|||
147575549|NCT00112437|532263531|FG013|Year 2 (12-Month Extension)|Adverse Event|0|||
147319943|NCT05194735|531338312|FG001|Overall Study|Apheresed but not administered TCR-T cells due to early termination of study|3|||
147575550|NCT00112437|532263532|FG014|Year 2 (12-Month Extension)|Adverse Event|0|||
147575551|NCT00112437|532263533|FG015|Year 2 (12-Month Extension)|Adverse Event|0|||
147575552|NCT00112437|532263534|FG016|Year 2 (12-Month Extension)|Adverse Event|0|||
147319944|NCT05194735|531338313|FG002|Overall Study|Apheresed but not administered TCR-T cells due to early termination of study|0|||
147319945|NCT05194735|531338311|FG000|Overall Study|Cells manufactured but not infused due to participant cerebrovascular accident|0|||
147319946|NCT05194735|531338312|FG001|Overall Study|Cells manufactured but not infused due to participant cerebrovascular accident|1|||
147319947|NCT05194735|531338313|FG002|Overall Study|Cells manufactured but not infused due to participant cerebrovascular accident|0|||
147575553|NCT00112437|532263535|FG017|Year 2 (12-Month Extension)|Adverse Event|0|||
147575554|NCT00112437|532263536|FG018|Year 2 (12-Month Extension)|Adverse Event|0|||
147575555|NCT00112437|532263537|FG019|Year 2 (12-Month Extension)|Adverse Event|0|||
147575556|NCT00112437|532263538|FG020|Year 2 (12-Month Extension)|Adverse Event|0|||
147652790|NCT01085084|532550387|FG000|Overall Study|Treatment Failure|0|||
147147014|NCT02455336|530701035|FG001|Overall Study|Adverse Event|0|||
147147015|NCT02455336|530701034|FG000|Overall Study|Non-responder to treatment|2|||
147147016|NCT02455336|530701035|FG001|Overall Study|Non-responder to treatment|0|||
147319948|NCT01616563|531338315|FG000|Overall Study|Lost to Follow-up|40|||
147319949|NCT01106287|531338316|FG000|Overall Study|Adverse Event|1|||
147319950|NCT01106287|531338317|FG001|Overall Study|Adverse Event|0|||
147319951|NCT01106287|531338318|FG002|Overall Study|Adverse Event|0|||
147319952|NCT01106287|531338319|FG003|Overall Study|Adverse Event|0|||
147319953|NCT00072475|531338320|FG000|Overall Study|Adverse Event|44|||
147319954|NCT00072475|531338320|FG000|Overall Study|Death|3|||
147319955|NCT00072475|531338320|FG000|Overall Study|Withdrawal by Subject|46|||
147319956|NCT00072475|531338320|FG000|Overall Study|Patient/Investigator Decision|4|||
147319957|NCT02123966|531338321|FG000|Overall Study|Intercurrent Illness|1|||
147319958|NCT01097655|531338322|FG000|Overall Study|Withdrawal by Subject|1|||
147319959|NCT01097655|531338322|FG000|Overall Study|Subject Documented Twice|1|||
147319960|NCT01097655|531338322|FG000|Overall Study|Did Not Meet Inclusion Criteria|8|||
147319961|NCT02028884|531338325|FG000|Double-blind Period|Adverse Event|5|||
147319962|NCT02028884|531338326|FG001|Double-blind Period|Adverse Event|3|||
147319963|NCT02028884|531338327|FG002|Double-blind Period|Adverse Event|0|||
147319964|NCT02028884|531338325|FG000|Double-blind Period|Eligibility Violation|1|||
147319965|NCT02028884|531338326|FG001|Double-blind Period|Eligibility Violation|0|||
147319966|NCT02028884|531338327|FG002|Double-blind Period|Eligibility Violation|0|||
147319967|NCT02028884|531338325|FG000|Double-blind Period|Non-Compliance With Study Drug|2|||
147319968|NCT02028884|531338326|FG001|Double-blind Period|Non-Compliance With Study Drug|0|||
147319969|NCT02028884|531338327|FG002|Double-blind Period|Non-Compliance With Study Drug|0|||
147319970|NCT02028884|531338325|FG000|Double-blind Period|Withdrawal by Subject|2|||
147319971|NCT02028884|531338326|FG001|Double-blind Period|Withdrawal by Subject|0|||
147319972|NCT02028884|531338327|FG002|Double-blind Period|Withdrawal by Subject|0|||
147319973|NCT02028884|531338325|FG000|Open-label Extension Period|Adverse Event|3|||
147319974|NCT02028884|531338326|FG001|Open-label Extension Period|Adverse Event|1|||
147319975|NCT02028884|531338327|FG002|Open-label Extension Period|Adverse Event|0|||
147319976|NCT02028884|531338325|FG000|Open-label Extension Period|Lack of Efficacy|3|||
147319977|NCT02028884|531338326|FG001|Open-label Extension Period|Lack of Efficacy|0|||
147319978|NCT02028884|531338327|FG002|Open-label Extension Period|Lack of Efficacy|0|||
147319979|NCT02028884|531338325|FG000|Open-label Extension Period|Refused Treatment/Did Not Cooperate|0|||
147319980|NCT02028884|531338326|FG001|Open-label Extension Period|Refused Treatment/Did Not Cooperate|1|||
147319981|NCT02028884|531338327|FG002|Open-label Extension Period|Refused Treatment/Did Not Cooperate|0|||
147319982|NCT02028884|531338325|FG000|Open-label Extension Period|Withdrawal by Subject|0|||
147319983|NCT02028884|531338326|FG001|Open-label Extension Period|Withdrawal by Subject|6|||
147319984|NCT02028884|531338327|FG002|Open-label Extension Period|Withdrawal by Subject|0|||
147319985|NCT02028884|531338325|FG000|Open-label Extension Period|Switched to another treatment option|3|||
147319986|NCT02028884|531338326|FG001|Open-label Extension Period|Switched to another treatment option|0|||
147319987|NCT02028884|531338327|FG002|Open-label Extension Period|Switched to another treatment option|0|||
147319988|NCT02403674|531338328|FG000|Base Study|Death|1|||
147319989|NCT02403674|531338329|FG001|Base Study|Death|4|||
147319990|NCT02403674|531338328|FG000|Base Study|Adverse Event|11|||
147319991|NCT02403674|531338329|FG001|Base Study|Adverse Event|26|||
147319992|NCT02403674|531338328|FG000|Base Study|Lack of Efficacy|31|||
147319993|NCT02403674|531338329|FG001|Base Study|Lack of Efficacy|23|||
147319994|NCT02403674|531338328|FG000|Base Study|Lost to Follow-up|6|||
147319995|NCT02403674|531338329|FG001|Base Study|Lost to Follow-up|8|||
147319996|NCT02403674|531338328|FG000|Base Study|Withdrawal by Subject|10|||
147319997|NCT02403674|531338329|FG001|Base Study|Withdrawal by Subject|17|||
147319998|NCT02403674|531338328|FG000|Base Study|Physician Decision|2|||
147319999|NCT02403674|531338329|FG001|Base Study|Physician Decision|2|||
147320000|NCT02403674|531338328|FG000|Base Study|Pregnancy|2|||
147320001|NCT02403674|531338329|FG001|Base Study|Pregnancy|2|||
147320002|NCT02403674|531338328|FG000|Base Study|Protocol Violation|8|||
147320003|NCT02403674|531338329|FG001|Base Study|Protocol Violation|4|||
147320004|NCT02403674|531338328|FG000|Base Study|Non-Compliance with study drug|1|||
147320005|NCT02403674|531338329|FG001|Base Study|Non-Compliance with study drug|4|||
147320006|NCT02403674|531338328|FG000|Study Extension 1 (Open-Label)|Adverse Event|1|||
147320007|NCT02403674|531338329|FG001|Study Extension 1 (Open-Label)|Adverse Event|4|||
147320008|NCT02403674|531338328|FG000|Study Extension 1 (Open-Label)|Lack of Efficacy|10|||
147320009|NCT02403674|531338329|FG001|Study Extension 1 (Open-Label)|Lack of Efficacy|13|||
147320010|NCT02403674|531338328|FG000|Study Extension 1 (Open-Label)|Lost to Follow-up|8|||
147445898|NCT01445951|531797474|FG002|Overall Study|Lost to Follow-up|4|||
147320011|NCT02403674|531338329|FG001|Study Extension 1 (Open-Label)|Lost to Follow-up|5|||
147320012|NCT02403674|531338328|FG000|Study Extension 1 (Open-Label)|Withdrawal by Subject|11|||
147320013|NCT02403674|531338329|FG001|Study Extension 1 (Open-Label)|Withdrawal by Subject|13|||
147320014|NCT02403674|531338328|FG000|Study Extension 1 (Open-Label)|Physician Decision|2|||
147320015|NCT02403674|531338329|FG001|Study Extension 1 (Open-Label)|Physician Decision|5|||
147445899|NCT01445951|531797472|FG000|Overall Study|Pregnancy|0|||
147320016|NCT02403674|531338328|FG000|Study Extension 1 (Open-Label)|Pregnancy|4|||
147320017|NCT02403674|531338329|FG001|Study Extension 1 (Open-Label)|Pregnancy|2|||
147320018|NCT02403674|531338328|FG000|Study Extension 1 (Open-Label)|Death|1|||
147320019|NCT02403674|531338329|FG001|Study Extension 1 (Open-Label)|Death|0|||
147445900|NCT01445951|531797473|FG001|Overall Study|Pregnancy|1|||
147147017|NCT00391430|530701036|FG000|Overall Study|Withdrawal by Subject|3|||
147147018|NCT00391430|530701037|FG001|Overall Study|Withdrawal by Subject|0|||
147320020|NCT02403674|531338328|FG000|Study Extension 1 (Open-Label)|Availability of study drug locally|22|||
147320021|NCT02403674|531338329|FG001|Study Extension 1 (Open-Label)|Availability of study drug locally|19|||
147320022|NCT02403674|531338328|FG000|Study Extension 1 (Open-Label)|Non-Compliance|2|||
147320023|NCT02403674|531338329|FG001|Study Extension 1 (Open-Label)|Non-Compliance|3|||
147652791|NCT01085084|532550388|FG001|Overall Study|Treatment Failure|1|||
147652792|NCT01085084|532550389|FG002|Overall Study|Treatment Failure|2|||
147652793|NCT02749799|532550390|FG000|Overall Study|Adverse Event|2|||
147652794|NCT02749799|532550390|FG000|Overall Study|Lost to Follow-up|4|||
147652795|NCT02749799|532550390|FG000|Overall Study|Protocol Violation|1|||
147652796|NCT02749799|532550390|FG000|Overall Study|Withdrawal by Subject|1|||
147652797|NCT02070978|532550391|FG000|Overall Study|Adverse Event|6|||
147652798|NCT02070978|532550392|FG001|Overall Study|Adverse Event|2|||
147652799|NCT02070978|532550393|FG002|Overall Study|Adverse Event|0|||
147652800|NCT02070978|532550391|FG000|Overall Study|Lost to Follow-up|1|||
147652801|NCT02070978|532550392|FG001|Overall Study|Lost to Follow-up|3|||
147652802|NCT02070978|532550393|FG002|Overall Study|Lost to Follow-up|4|||
147147019|NCT00391430|530701038|FG002|Overall Study|Withdrawal by Subject|12|||
147320024|NCT02403674|531338328|FG000|Study Extension 2 (Open-Label)|Lack of Efficacy|1|||
147320025|NCT02403674|531338329|FG001|Study Extension 2 (Open-Label)|Lack of Efficacy|1|||
147320026|NCT02403674|531338328|FG000|Study Extension 2 (Open-Label)|Lost to Follow-up|1|||
147320027|NCT02403674|531338329|FG001|Study Extension 2 (Open-Label)|Lost to Follow-up|7|||
147320028|NCT02403674|531338328|FG000|Study Extension 2 (Open-Label)|Withdrawal by Subject|8|||
147320029|NCT02403674|531338329|FG001|Study Extension 2 (Open-Label)|Withdrawal by Subject|6|||
147320030|NCT02403674|531338328|FG000|Study Extension 2 (Open-Label)|Physician Decision|1|||
147320031|NCT02403674|531338329|FG001|Study Extension 2 (Open-Label)|Physician Decision|1|||
147320032|NCT02403674|531338328|FG000|Study Extension 2 (Open-Label)|Pregnancy|0|||
147320033|NCT02403674|531338329|FG001|Study Extension 2 (Open-Label)|Pregnancy|1|||
147320034|NCT02403674|531338328|FG000|Study Extension 2 (Open-Label)|Death|2|||
147320035|NCT02403674|531338329|FG001|Study Extension 2 (Open-Label)|Death|2|||
147320036|NCT02403674|531338328|FG000|Study Extension 2 (Open-Label)|Availability of study drug locally|27|||
147320037|NCT02403674|531338329|FG001|Study Extension 2 (Open-Label)|Availability of study drug locally|23|||
147320038|NCT02403674|531338328|FG000|Study Extension 2 (Open-Label)|Non-Compliance with study drug|2|||
147320039|NCT02403674|531338329|FG001|Study Extension 2 (Open-Label)|Non-Compliance with study drug|0|||
147320040|NCT02403674|531338328|FG000|Study Extension 3 (Open-Label)|Lost to Follow-up|5|||
147320041|NCT02403674|531338329|FG001|Study Extension 3 (Open-Label)|Lost to Follow-up|4|||
147320042|NCT02403674|531338328|FG000|Study Extension 3 (Open-Label)|Withdrawal by Subject|1|||
147320043|NCT02403674|531338329|FG001|Study Extension 3 (Open-Label)|Withdrawal by Subject|3|||
147320044|NCT02403674|531338328|FG000|Study Extension 3 (Open-Label)|Physician Decision|1|||
147320045|NCT02403674|531338329|FG001|Study Extension 3 (Open-Label)|Physician Decision|5|||
147320046|NCT02403674|531338328|FG000|Study Extension 3 (Open-Label)|Pregnancy|0|||
147320047|NCT02403674|531338329|FG001|Study Extension 3 (Open-Label)|Pregnancy|1|||
147320048|NCT02403674|531338328|FG000|Study Extension 3 (Open-Label)|Availability of study drug locally|14|||
147320049|NCT02403674|531338329|FG001|Study Extension 3 (Open-Label)|Availability of study drug locally|13|||
147320050|NCT00826280|531338330|FG000|Overall Study|Randomized but drug not received|1|||
147320051|NCT00826280|531338331|FG001|Overall Study|Randomized but drug not received|0|||
147320052|NCT00826280|531338332|FG002|Overall Study|Randomized but drug not received|1|||
147320053|NCT00826280|531338330|FG000|Overall Study|Adverse Event|1|||
147320054|NCT00826280|531338331|FG001|Overall Study|Adverse Event|3|||
147445901|NCT01445951|531797474|FG002|Overall Study|Pregnancy|4|||
147445902|NCT01445951|531797472|FG000|Overall Study|Death|0|||
147445903|NCT01445951|531797473|FG001|Overall Study|Death|0|||
147575557|NCT00112437|532263539|FG021|Year 2 (12-Month Extension)|Adverse Event|0|||
147575558|NCT00112437|532263540|FG022|Year 2 (12-Month Extension)|Adverse Event|0|||
147575559|NCT00112437|532263541|FG023|Year 2 (12-Month Extension)|Adverse Event|0|||
147575560|NCT00112437|532263542|FG024|Year 2 (12-Month Extension)|Adverse Event|0|||
147575561|NCT00112437|532263543|FG025|Year 2 (12-Month Extension)|Adverse Event|0|||
147575562|NCT00112437|532263518|FG000|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
147575563|NCT00112437|532263519|FG001|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
147575564|NCT00112437|532263520|FG002|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
147575565|NCT00112437|532263521|FG003|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
147575566|NCT00112437|532263522|FG004|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
147575567|NCT00112437|532263523|FG005|Year 2 (12-Month Extension)|Lack of Efficacy|1|||
147575568|NCT00112437|532263524|FG006|Year 2 (12-Month Extension)|Lack of Efficacy|6|||
147575569|NCT00112437|532263525|FG007|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
147575570|NCT00112437|532263526|FG008|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
147575571|NCT00112437|532263527|FG009|Year 2 (12-Month Extension)|Lack of Efficacy|2|||
147575572|NCT00112437|532263528|FG010|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
147575573|NCT00112437|532263529|FG011|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
147575574|NCT00112437|532263530|FG012|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
147652803|NCT02070978|532550391|FG000|Overall Study|Withdrawal by Subject|3|||
147147020|NCT02467192|530701039|FG000|Overall Study|Death|1|||
147147021|NCT02467192|530701039|FG000|Overall Study|revealed to have pneumonia before|2|||
147147022|NCT00809926|530701041|FG000|Overall Study|Adverse Event|18|||
147147023|NCT00809926|530701042|FG001|Overall Study|Adverse Event|10|||
147147024|NCT00809926|530701041|FG000|Overall Study|Unsatisfactory therapeutic effect|3|||
147147025|NCT00809926|530701042|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
147147026|NCT00809926|530701041|FG000|Overall Study|Patient withdrew consent|8|||
147239016|NCT03330288|531046191|FG000|Overall Study|Lost to Follow-up|26|||
147239017|NCT03330288|531046192|FG001|Overall Study|Lost to Follow-up|7|||
147320055|NCT00826280|531338332|FG002|Overall Study|Adverse Event|0|||
147320056|NCT00826280|531338330|FG000|Overall Study|Lost to Follow-up|0|||
147320057|NCT00826280|531338331|FG001|Overall Study|Lost to Follow-up|1|||
147320058|NCT00826280|531338332|FG002|Overall Study|Lost to Follow-up|0|||
147320059|NCT00826280|531338330|FG000|Overall Study|Sponsor discontinued subject or study|1|||
147320060|NCT00826280|531338331|FG001|Overall Study|Sponsor discontinued subject or study|0|||
147320061|NCT00826280|531338332|FG002|Overall Study|Sponsor discontinued subject or study|0|||
147320062|NCT00826280|531338330|FG000|Overall Study|Reversible ischemic defect not present|43|||
147320063|NCT00826280|531338331|FG001|Overall Study|Reversible ischemic defect not present|40|||
147320064|NCT00826280|531338332|FG002|Overall Study|Reversible ischemic defect not present|44|||
147239018|NCT01042678|531046193|FG000|Overall Study|Physician Decision|1|||
147239019|NCT01042678|531046194|FG001|Overall Study|Physician Decision|0|||
147239020|NCT01042678|531046195|FG002|Overall Study|Physician Decision|0|||
147239021|NCT01042678|531046196|FG003|Overall Study|Physician Decision|0|||
147239022|NCT01042678|531046197|FG004|Overall Study|Physician Decision|0|||
147239023|NCT01042678|531046198|FG005|Overall Study|Physician Decision|0|||
147239024|NCT01416272|531046199|FG000|Overall Study|Unacceptable distance visual acuity|2|||
147239025|NCT01416272|531046199|FG000|Overall Study|Lost to Follow-up|1|||
147239026|NCT01416272|531046199|FG000|Overall Study|Study related complaints|1|||
147239027|NCT01719783|531046202|FG000|Dose 2|Physician Decision|1|||
147239028|NCT01719783|531046203|FG001|Dose 2|Physician Decision|0|||
147320065|NCT00826280|531338330|FG000|Overall Study|Interpretation Failure|1|||
147320066|NCT00826280|531338331|FG001|Overall Study|Interpretation Failure|0|||
147320067|NCT00826280|531338332|FG002|Overall Study|Interpretation Failure|0|||
147320068|NCT00826280|531338330|FG000|Overall Study|Machine Failure|1|||
147320069|NCT00826280|531338331|FG001|Overall Study|Machine Failure|1|||
147320070|NCT00826280|531338332|FG002|Overall Study|Machine Failure|0|||
147239029|NCT01350492|531046204|FG000|Intervention|Lost to Follow-up|2|||
147320071|NCT00826280|531338330|FG000|Overall Study|One or more non-interpretable scan|0|||
147320072|NCT00826280|531338331|FG001|Overall Study|One or more non-interpretable scan|1|||
147320073|NCT00826280|531338332|FG002|Overall Study|One or more non-interpretable scan|1|||
147320074|NCT03487666|531338333|FG000|Overall Study|Disease progression|4|||
147320075|NCT03487666|531338334|FG001|Overall Study|Disease progression|2|||
147320076|NCT03487666|531338335|FG002|Overall Study|Disease progression|0|||
147320077|NCT03487666|531338333|FG000|Overall Study|Adverse Event|0|||
147320078|NCT03487666|531338334|FG001|Overall Study|Adverse Event|0|||
147320079|NCT03487666|531338335|FG002|Overall Study|Adverse Event|1|||
147320080|NCT03201757|531338336|FG000|Overall Study|Withdrawal by Subject|133|||
147320081|NCT03201757|531338336|FG000|Overall Study|Adverse Event|44|||
147320082|NCT03201757|531338336|FG000|Overall Study|Lost to Follow-up|37|||
147320083|NCT03201757|531338336|FG000|Overall Study|Pregnancy|2|||
147320084|NCT03201757|531338336|FG000|Overall Study|Lack of Efficacy|1|||
147320085|NCT03201757|531338336|FG000|Overall Study|Protocol Violation|20|||
147320086|NCT03201757|531338336|FG000|Overall Study|Study Terminated at Site by Sponsor Due to Regional War|1|||
147320087|NCT03201757|531338336|FG000|Overall Study|Not Yet Determined|5|||
147320088|NCT03201757|531338336|FG000|Overall Study|Logistical Difficulties Due to Regional Wars & COVID-19|72|||
147320089|NCT03201757|531338336|FG000|Overall Study|Other|20|||
147320090|NCT00765362|531338338|FG000|Overall Study|Death|9|||
147320091|NCT00765362|531338338|FG000|Overall Study|Adverse Event|2|||
147320092|NCT00765362|531338338|FG000|Overall Study|Protocol Violation|18|||
147320093|NCT00765362|531338338|FG000|Overall Study|Withdrawal by Subject|13|||
147320094|NCT00765362|531338338|FG000|Overall Study|Lost to Follow-up|95|||
147147027|NCT00809926|530701042|FG001|Overall Study|Patient withdrew consent|6|||
147147028|NCT00809926|530701041|FG000|Overall Study|Lost to Follow-up|2|||
147147029|NCT00809926|530701042|FG001|Overall Study|Lost to Follow-up|1|||
147320095|NCT00664521|531338340|FG000|Overall Study|Adverse Event|4|||
147320096|NCT00664521|531338341|FG001|Overall Study|Adverse Event|1|||
147320097|NCT00664521|531338340|FG000|Overall Study|Lost to Follow-up|1|||
147320098|NCT00664521|531338341|FG001|Overall Study|Lost to Follow-up|0|||
147320099|NCT00664521|531338340|FG000|Overall Study|Other|1|||
147320100|NCT00664521|531338341|FG001|Overall Study|Other|0|||
147320101|NCT02800928|531338342|FG000|Overall Study|Withdrawal by Subject|1|||
147320102|NCT02800928|531338343|FG001|Overall Study|Withdrawal by Subject|1|||
147320103|NCT02800928|531338342|FG000|Overall Study|Protocol Violation|1|||
147147030|NCT00809926|530701041|FG000|Overall Study|Administrative Problems|0|||
147239030|NCT01350492|531046205|FG001|Intervention|Lost to Follow-up|5|||
147239031|NCT01350492|531046204|FG000|Intervention|Withdrawal by Subject|3|||
147320104|NCT02800928|531338343|FG001|Overall Study|Protocol Violation|1|||
147320105|NCT02886728|531338350|FG000|Overall Study|Withdrew Consent|31|||
147320106|NCT02886728|531338351|FG001|Overall Study|Withdrew Consent|13|||
147320107|NCT02886728|531338352|FG002|Overall Study|Withdrew Consent|11|||
147320108|NCT02886728|531338353|FG003|Overall Study|Withdrew Consent|47|||
147320109|NCT02886728|531338350|FG000|Overall Study|Lost to Follow-up|12|||
147320110|NCT02886728|531338351|FG001|Overall Study|Lost to Follow-up|6|||
147320111|NCT02886728|531338352|FG002|Overall Study|Lost to Follow-up|13|||
147320112|NCT02886728|531338353|FG003|Overall Study|Lost to Follow-up|12|||
147320113|NCT02886728|531338350|FG000|Overall Study|Adverse Event|13|||
147320114|NCT02886728|531338351|FG001|Overall Study|Adverse Event|5|||
147320115|NCT02886728|531338352|FG002|Overall Study|Adverse Event|5|||
147320116|NCT02886728|531338353|FG003|Overall Study|Adverse Event|11|||
147320117|NCT02886728|531338350|FG000|Overall Study|Investigator's Discretion|11|||
147320118|NCT02886728|531338351|FG001|Overall Study|Investigator's Discretion|7|||
147320119|NCT02886728|531338352|FG002|Overall Study|Investigator's Discretion|5|||
147320120|NCT02886728|531338353|FG003|Overall Study|Investigator's Discretion|11|||
147320121|NCT02886728|531338350|FG000|Overall Study|Death|3|||
147320122|NCT02886728|531338351|FG001|Overall Study|Death|1|||
147320123|NCT02886728|531338352|FG002|Overall Study|Death|0|||
147320124|NCT02886728|531338353|FG003|Overall Study|Death|0|||
147320125|NCT02886728|531338350|FG000|Overall Study|Protocol Violation|0|||
147320126|NCT02886728|531338351|FG001|Overall Study|Protocol Violation|0|||
147320127|NCT02886728|531338352|FG002|Overall Study|Protocol Violation|0|||
147320128|NCT02886728|531338353|FG003|Overall Study|Protocol Violation|4|||
147320129|NCT02886728|531338350|FG000|Overall Study|Non-Compliance with Study Drug|1|||
147320130|NCT02886728|531338351|FG001|Overall Study|Non-Compliance with Study Drug|0|||
147320131|NCT02886728|531338352|FG002|Overall Study|Non-Compliance with Study Drug|1|||
147320132|NCT02886728|531338353|FG003|Overall Study|Non-Compliance with Study Drug|0|||
147320133|NCT02886728|531338350|FG000|Overall Study|Pregnancy|0|||
147320134|NCT02886728|531338351|FG001|Overall Study|Pregnancy|0|||
147320135|NCT02886728|531338352|FG002|Overall Study|Pregnancy|1|||
147320136|NCT02886728|531338353|FG003|Overall Study|Pregnancy|0|||
147320137|NCT02886728|531338350|FG000|Overall Study|Randomized but Not Dosed|1|||
147320138|NCT02886728|531338351|FG001|Overall Study|Randomized but Not Dosed|0|||
147320139|NCT02886728|531338352|FG002|Overall Study|Randomized but Not Dosed|0|||
147320140|NCT02886728|531338353|FG003|Overall Study|Randomized but Not Dosed|2|||
147320141|NCT04990440|531338362|FG000|Overall Study|Sponsor's Decision|0|||
147320142|NCT04990440|531338363|FG001|Overall Study|Sponsor's Decision|0|||
147320143|NCT04990440|531338364|FG002|Overall Study|Sponsor's Decision|1|||
147320144|NCT03712098|531338365|FG000|Overall Study|Lost to Follow-up|3|||
147320145|NCT03712098|531338366|FG001|Overall Study|Lost to Follow-up|7|||
147320146|NCT03712098|531338365|FG000|Overall Study|Withdrawal by Subject|9|||
147320147|NCT03712098|531338366|FG001|Overall Study|Withdrawal by Subject|4|||
147320148|NCT03712098|531338365|FG000|Overall Study|Protocol Violation|2|||
147320149|NCT03712098|531338366|FG001|Overall Study|Protocol Violation|1|||
147320150|NCT02954575|531338375|FG000|Overall Study|Withdrawal by Subject|2|||
147320151|NCT02954575|531338375|FG000|Overall Study|Adverse Event|1|||
147320152|NCT01066156|531338376|FG000|Overall Study|ineligible|2|||
147320153|NCT01066156|531338376|FG000|Overall Study|Lost to Follow-up|7|||
147320154|NCT01066156|531338376|FG000|Overall Study|Withdrawal by Subject|1|||
147320155|NCT00146640|531338381|FG000|Overall Study|Adverse Event|12|||
147320156|NCT00146640|531338382|FG001|Overall Study|Adverse Event|10|||
147320157|NCT00146640|531338381|FG000|Overall Study|Medical Reasons|3|||
147320158|NCT00146640|531338382|FG001|Overall Study|Medical Reasons|0|||
147147031|NCT00809926|530701042|FG001|Overall Study|Administrative Problems|1|||
147147032|NCT00809926|530701041|FG000|Overall Study|Protocol deviation|0|||
147147033|NCT00809926|530701042|FG001|Overall Study|Protocol deviation|2|||
147147034|NCT01963767|530701058|FG000|Overall Study|Withdrawal by Subject|4|||
147147035|NCT01963767|530701059|FG001|Overall Study|Withdrawal by Subject|2|||
147147036|NCT01963767|530701058|FG000|Overall Study|Adverse Event|2|||
147147037|NCT01963767|530701059|FG001|Overall Study|Adverse Event|0|||
147147038|NCT01082081|530701062|FG000|Overall Study|Lost to Follow-up|0|||
147147039|NCT01082081|530701063|FG001|Overall Study|Lost to Follow-up|0|||
147147040|NCT01082081|530701064|FG002|Overall Study|Lost to Follow-up|1|||
147320159|NCT00146640|531338381|FG000|Overall Study|Non-Medical Reasons|8|||
147320160|NCT00146640|531338382|FG001|Overall Study|Non-Medical Reasons|4|||
147320161|NCT02059161|531338383|FG000|Overall Study|Pregnancy|0|||
147320162|NCT02059161|531338384|FG001|Overall Study|Pregnancy|2|||
147147041|NCT01082081|530701062|FG000|Overall Study|Withdrawal by Subject|0|||
147320163|NCT02059161|531338383|FG000|Overall Study|Adverse Event|2|||
147320164|NCT02059161|531338384|FG001|Overall Study|Adverse Event|6|||
147320165|NCT02059161|531338383|FG000|Overall Study|Lost to Follow-up|20|||
147320166|NCT02059161|531338384|FG001|Overall Study|Lost to Follow-up|12|||
147320167|NCT02059161|531338383|FG000|Overall Study|Physician Decision|4|||
147147042|NCT01082081|530701063|FG001|Overall Study|Withdrawal by Subject|0|||
147320168|NCT02059161|531338384|FG001|Overall Study|Physician Decision|4|||
147320169|NCT02059161|531338383|FG000|Overall Study|Protocol Violation|1|||
147320170|NCT02059161|531338384|FG001|Overall Study|Protocol Violation|1|||
147320171|NCT02059161|531338383|FG000|Overall Study|Withdrawal by Subject|16|||
147320172|NCT02059161|531338384|FG001|Overall Study|Withdrawal by Subject|13|||
147320173|NCT02059161|531338383|FG000|Overall Study|Randomized in error, no study drug|0|||
147320174|NCT02059161|531338384|FG001|Overall Study|Randomized in error, no study drug|1|||
147147043|NCT01082081|530701064|FG002|Overall Study|Withdrawal by Subject|1|||
147147044|NCT01082081|530701062|FG000|Overall Study|Other Reason|0|||
147147045|NCT01082081|530701063|FG001|Overall Study|Other Reason|1|||
147147046|NCT01082081|530701064|FG002|Overall Study|Other Reason|0|||
147147047|NCT00670930|530701065|FG000|Overall Study|Adminstrative Problem|0|||
147147048|NCT00670930|530701066|FG001|Overall Study|Adminstrative Problem|1|||
147147049|NCT00670930|530701065|FG000|Overall Study|Lost to Follow-up|1|||
147147050|NCT00670930|530701066|FG001|Overall Study|Lost to Follow-up|0|||
147147051|NCT03159468|530701068|FG000|Overall Study|Withdrawal by Subject|0|||
147147052|NCT03159468|530701069|FG001|Overall Study|Withdrawal by Subject|0|||
147147053|NCT03159468|530701070|FG002|Overall Study|Withdrawal by Subject|3|||
147147054|NCT03159468|530701071|FG003|Overall Study|Withdrawal by Subject|0|||
147147055|NCT03159468|530701072|FG004|Overall Study|Withdrawal by Subject|0|||
147147056|NCT03159468|530701073|FG005|Overall Study|Withdrawal by Subject|0|||
147147057|NCT02712983|530703190|FG000|Treatment Phase|Adverse Event|3|||
147147058|NCT02712983|530703191|FG001|Treatment Phase|Adverse Event|1|||
147147059|NCT02712983|530703192|FG002|Treatment Phase|Adverse Event|1|||
147147060|NCT02712983|530703193|FG003|Treatment Phase|Adverse Event|4|||
147147061|NCT02712983|530703194|FG004|Treatment Phase|Adverse Event|3|||
147147062|NCT02712983|530703195|FG005|Treatment Phase|Adverse Event|0|||
147147063|NCT02712983|530703196|FG006|Treatment Phase|Adverse Event|6|||
147147064|NCT02712983|530703197|FG007|Treatment Phase|Adverse Event|6|||
147147065|NCT02712983|530703198|FG008|Treatment Phase|Adverse Event|1|||
147147066|NCT02712983|530703190|FG000|Treatment Phase|Protocol Deviation|0|||
147147067|NCT02712983|530703191|FG001|Treatment Phase|Protocol Deviation|0|||
147147068|NCT02712983|530703192|FG002|Treatment Phase|Protocol Deviation|0|||
147147069|NCT02712983|530703193|FG003|Treatment Phase|Protocol Deviation|2|||
147147070|NCT02712983|530703194|FG004|Treatment Phase|Protocol Deviation|0|||
147147071|NCT02712983|530703195|FG005|Treatment Phase|Protocol Deviation|0|||
147147072|NCT02712983|530703196|FG006|Treatment Phase|Protocol Deviation|1|||
147239032|NCT01350492|531046205|FG001|Intervention|Withdrawal by Subject|1|||
147239033|NCT01350492|531046204|FG000|Post Intervention Follow-Up|Lost to Follow-up|6|||
147239034|NCT01350492|531046205|FG001|Post Intervention Follow-Up|Lost to Follow-up|1|||
147239035|NCT01350492|531046204|FG000|Post Intervention Follow-Up|Withdrawal by Subject|0|||
147239036|NCT01350492|531046205|FG001|Post Intervention Follow-Up|Withdrawal by Subject|1|||
147239037|NCT00205881|531046206|FG000|Overall Study|Withdrawal by Subject|16|||
147239038|NCT01443078|531046208|FG000|Overall Study|Responded to neoadjuvant platinum txt|27|||
147239039|NCT01443078|531046208|FG000|Overall Study|Withdrawal by Subject|1|||
147239040|NCT01443078|531046208|FG000|Overall Study|Patient had brain mets|1|||
147239041|NCT02217878|531046209|FG000|Overall Study|required morphine due to chest pain|1|||
147239042|NCT02217878|531046210|FG001|Overall Study|required morphine due to chest pain|2|||
147239043|NCT02217878|531046209|FG000|Overall Study|initial diagnosis of STEMI not confirmed|1|||
147239044|NCT02217878|531046210|FG001|Overall Study|initial diagnosis of STEMI not confirmed|0|||
147239045|NCT00415168|531046211|FG000|Overall Study|Death|26|||
147239046|NCT00415168|531046211|FG000|Overall Study|Lost to Follow-up|3|||
147239047|NCT00415168|531046211|FG000|Overall Study|Physician Decision|13|||
147239048|NCT00415168|531046211|FG000|Overall Study|Sponsor Decision|4|||
147239049|NCT00415168|531046211|FG000|Overall Study|Withdrawal by Subject|6|||
147239050|NCT01201785|531046215|FG000|Overall Study|Lost to Follow-up|16|||
147239051|NCT02151110|531046216|FG000|Overall Study|Withdrawal by Subject|0|||
147239052|NCT02151110|531046217|FG001|Overall Study|Withdrawal by Subject|0|||
147239053|NCT02151110|531046218|FG002|Overall Study|Withdrawal by Subject|0|||
147239054|NCT02151110|531046219|FG003|Overall Study|Withdrawal by Subject|0|||
147239055|NCT02151110|531046220|FG004|Overall Study|Withdrawal by Subject|0|||
147320175|NCT02059161|531338383|FG000|Overall Study|Non-compliance with study drug|6|||
147320176|NCT02059161|531338384|FG001|Overall Study|Non-compliance with study drug|2|||
147320177|NCT01723826|531338388|FG000|Overall Study|Adverse Event|4|||
147320178|NCT01723826|531338389|FG001|Overall Study|Adverse Event|1|||
147320179|NCT01723826|531338390|FG002|Overall Study|Adverse Event|4|||
147320180|NCT01723826|531338391|FG003|Overall Study|Adverse Event|5|||
147320181|NCT01723826|531338388|FG000|Overall Study|Death according to AE eCRF|2|||
147320182|NCT01723826|531338389|FG001|Overall Study|Death according to AE eCRF|3|||
147320183|NCT01723826|531338390|FG002|Overall Study|Death according to AE eCRF|3|||
147320184|NCT01723826|531338391|FG003|Overall Study|Death according to AE eCRF|7|||
147320185|NCT01723826|531338388|FG000|Overall Study|Lost to Follow-up|1|||
147320186|NCT01723826|531338389|FG001|Overall Study|Lost to Follow-up|3|||
147320187|NCT01723826|531338390|FG002|Overall Study|Lost to Follow-up|1|||
147320188|NCT01723826|531338391|FG003|Overall Study|Lost to Follow-up|1|||
147320189|NCT01723826|531338388|FG000|Overall Study|Non-compliance|0|||
147147073|NCT02712983|530703197|FG007|Treatment Phase|Protocol Deviation|0|||
147147074|NCT02712983|530703198|FG008|Treatment Phase|Protocol Deviation|0|||
147147075|NCT02712983|530703190|FG000|Treatment Phase|Technical Problems|0|||
147147076|NCT02712983|530703191|FG001|Treatment Phase|Technical Problems|0|||
147147077|NCT02712983|530703192|FG002|Treatment Phase|Technical Problems|0|||
147147078|NCT02712983|530703193|FG003|Treatment Phase|Technical Problems|0|||
147320190|NCT01723826|531338389|FG001|Overall Study|Non-compliance|1|||
147320191|NCT01723826|531338390|FG002|Overall Study|Non-compliance|3|||
147320192|NCT01723826|531338391|FG003|Overall Study|Non-compliance|3|||
147320193|NCT01723826|531338388|FG000|Overall Study|Non-compliance With Study Drug|0|||
147320194|NCT01723826|531338389|FG001|Overall Study|Non-compliance With Study Drug|1|||
147320195|NCT01723826|531338390|FG002|Overall Study|Non-compliance With Study Drug|0|||
147320196|NCT01723826|531338391|FG003|Overall Study|Non-compliance With Study Drug|0|||
147320197|NCT01723826|531338388|FG000|Overall Study|Other Reason|8|||
147320198|NCT01723826|531338389|FG001|Overall Study|Other Reason|6|||
147320199|NCT01723826|531338390|FG002|Overall Study|Other Reason|12|||
147320200|NCT01723826|531338391|FG003|Overall Study|Other Reason|14|||
147320201|NCT01723826|531338388|FG000|Overall Study|Physician Decision|1|||
147320202|NCT01723826|531338389|FG001|Overall Study|Physician Decision|3|||
147320203|NCT01723826|531338390|FG002|Overall Study|Physician Decision|4|||
147320204|NCT01723826|531338391|FG003|Overall Study|Physician Decision|11|||
147320205|NCT01723826|531338388|FG000|Overall Study|Protocol Violation|1|||
147320206|NCT01723826|531338389|FG001|Overall Study|Protocol Violation|1|||
147320207|NCT01723826|531338390|FG002|Overall Study|Protocol Violation|3|||
147320208|NCT01723826|531338391|FG003|Overall Study|Protocol Violation|1|||
147320209|NCT01723826|531338388|FG000|Overall Study|Withdrawal by Subject|10|||
147320210|NCT01723826|531338389|FG001|Overall Study|Withdrawal by Subject|17|||
147320211|NCT01723826|531338390|FG002|Overall Study|Withdrawal by Subject|27|||
147320212|NCT01723826|531338391|FG003|Overall Study|Withdrawal by Subject|48|||
147320213|NCT01627340|531338392|FG000|Overall Study|Adverse Event|1|||
147320214|NCT01627340|531338393|FG001|Overall Study|Adverse Event|0|||
147320215|NCT01627340|531338392|FG000|Overall Study|Lost to Follow-up|8|||
147147079|NCT02712983|530703194|FG004|Treatment Phase|Technical Problems|0|||
147147080|NCT02712983|530703195|FG005|Treatment Phase|Technical Problems|0|||
147147081|NCT02712983|530703196|FG006|Treatment Phase|Technical Problems|1|||
147147082|NCT02712983|530703197|FG007|Treatment Phase|Technical Problems|0|||
147147083|NCT02712983|530703198|FG008|Treatment Phase|Technical Problems|0|||
147147084|NCT02712983|530703190|FG000|Treatment Phase|Physician Decision|0|||
147147085|NCT02712983|530703191|FG001|Treatment Phase|Physician Decision|0|||
147147086|NCT02712983|530703192|FG002|Treatment Phase|Physician Decision|0|||
147147087|NCT02712983|530703193|FG003|Treatment Phase|Physician Decision|0|||
147147088|NCT02712983|530703194|FG004|Treatment Phase|Physician Decision|0|||
147147089|NCT02712983|530703195|FG005|Treatment Phase|Physician Decision|0|||
147147090|NCT02712983|530703196|FG006|Treatment Phase|Physician Decision|0|||
147147091|NCT02712983|530703197|FG007|Treatment Phase|Physician Decision|1|||
147147092|NCT02712983|530703198|FG008|Treatment Phase|Physician Decision|1|||
147147093|NCT02712983|530703190|FG000|Treatment Phase|Subject Decision|2|||
147147094|NCT02712983|530703191|FG001|Treatment Phase|Subject Decision|0|||
147147095|NCT02712983|530703192|FG002|Treatment Phase|Subject Decision|0|||
147147096|NCT02712983|530703193|FG003|Treatment Phase|Subject Decision|2|||
147147097|NCT02712983|530703194|FG004|Treatment Phase|Subject Decision|1|||
147147098|NCT02712983|530703195|FG005|Treatment Phase|Subject Decision|0|||
147147099|NCT02712983|530703196|FG006|Treatment Phase|Subject Decision|1|||
147147100|NCT02712983|530703197|FG007|Treatment Phase|Subject Decision|2|||
147147101|NCT02712983|530703198|FG008|Treatment Phase|Subject Decision|0|||
147147102|NCT02712983|530703190|FG000|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
147147103|NCT02712983|530703191|FG001|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|1|||
147147104|NCT02712983|530703192|FG002|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
147147105|NCT02712983|530703193|FG003|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
147147106|NCT02712983|530703194|FG004|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
147147107|NCT02712983|530703195|FG005|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
147147108|NCT02712983|530703196|FG006|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|1|||
147147109|NCT02712983|530703197|FG007|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|1|||
147147110|NCT02712983|530703198|FG008|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
147147111|NCT02712983|530703190|FG000|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
147147112|NCT02712983|530703191|FG001|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
147147113|NCT02712983|530703192|FG002|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
147147114|NCT02712983|530703193|FG003|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|1|||
147147115|NCT02712983|530703194|FG004|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
147147116|NCT02712983|530703195|FG005|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
147320216|NCT01627340|531338393|FG001|Overall Study|Lost to Follow-up|4|||
147320217|NCT01627340|531338392|FG000|Overall Study|Pregnancy|1|||
147320218|NCT01627340|531338393|FG001|Overall Study|Pregnancy|0|||
147320219|NCT01627340|531338392|FG000|Overall Study|Withdrawal by Subject|2|||
147575575|NCT00112437|532263531|FG013|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
147320220|NCT01627340|531338393|FG001|Overall Study|Withdrawal by Subject|0|||
147320221|NCT03160079|531338412|FG000|Overall Study|Adverse Event|2|||
147147117|NCT02712983|530703196|FG006|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
147320222|NCT03160079|531338413|FG001|Overall Study|Adverse Event|0|||
147320223|NCT03160079|531338412|FG000|Overall Study|Disease Progression|1|||
147320224|NCT03160079|531338413|FG001|Overall Study|Disease Progression|0|||
147147118|NCT02712983|530703197|FG007|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
147147119|NCT02712983|530703198|FG008|Post-Treatment Efficacy Follow-Up Phase|Lost to Follow-up|0|||
147147120|NCT02712983|530703190|FG000|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0|||
147147121|NCT02712983|530703191|FG001|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0|||
147147122|NCT02712983|530703192|FG002|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0|||
147147123|NCT02712983|530703193|FG003|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0|||
147147124|NCT02712983|530703194|FG004|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|2|||
147147125|NCT02712983|530703195|FG005|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|1|||
147147126|NCT02712983|530703196|FG006|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|1|||
147147127|NCT02712983|530703197|FG007|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|2|||
147147128|NCT02712983|530703198|FG008|Post-Treatment Efficacy Follow-Up Phase|Subject Decision|0|||
147147129|NCT05360966|530703203|FG000|Overall Study|Adverse Event|5|||
147147130|NCT05360966|530703204|FG001|Overall Study|Adverse Event|5|||
147147131|NCT05360966|530703203|FG000|Overall Study|Withdrawal of Consent|5|||
147147132|NCT05360966|530703204|FG001|Overall Study|Withdrawal of Consent|3|||
147147133|NCT05360966|530703203|FG000|Overall Study|Noncompliance|2|||
147147134|NCT05360966|530703204|FG001|Overall Study|Noncompliance|1|||
147147135|NCT05360966|530703203|FG000|Overall Study|Lost to Follow-up|2|||
147147136|NCT05360966|530703204|FG001|Overall Study|Lost to Follow-up|3|||
147147137|NCT05360966|530703203|FG000|Overall Study|Protocol Deviation|2|||
147147138|NCT05360966|530703204|FG001|Overall Study|Protocol Deviation|1|||
147147139|NCT05360966|530703203|FG000|Overall Study|As specified in the Clinical Study Report|1|||
147147140|NCT05360966|530703204|FG001|Overall Study|As specified in the Clinical Study Report|3|||
147147141|NCT05258890|530703206|FG000|Overall Study|Patient withdrawal|6|||
147147142|NCT05258890|530703207|FG001|Overall Study|Patient withdrawal|7|||
147147143|NCT05258890|530703206|FG000|Overall Study|Patient lost to follow-up|10|||
147147144|NCT05258890|530703207|FG001|Overall Study|Patient lost to follow-up|3|||
147147145|NCT05258890|530703206|FG000|Overall Study|Social network member withdrawal|1|||
147147146|NCT05258890|530703207|FG001|Overall Study|Social network member withdrawal|0|||
147147147|NCT05258890|530703206|FG000|Overall Study|Social network member lost to follow-up|5|||
147147148|NCT05258890|530703207|FG001|Overall Study|Social network member lost to follow-up|0|||
147147149|NCT05959447|530703208|FG000|Part 1 (Up to Day 21)|Adverse Event|1|||
147147150|NCT05959447|530703209|FG001|Part 1 (Up to Day 21)|Adverse Event|0|||
147147151|NCT05959447|530703208|FG000|Part 1 (Up to Day 21)|Enrolled but did not receive study treatment|9|||
147147152|NCT05959447|530703209|FG001|Part 1 (Up to Day 21)|Enrolled but did not receive study treatment|0|||
147147153|NCT05959447|530703208|FG000|Part 2 (Up to Day 22)|Adverse Event|0|||
147147154|NCT05959447|530703209|FG001|Part 2 (Up to Day 22)|Adverse Event|2|||
147147155|NCT05959447|530703208|FG000|Part 2 (Up to Day 22)|Enrolled but did not receive study treatment|0|||
147147156|NCT05959447|530703209|FG001|Part 2 (Up to Day 22)|Enrolled but did not receive study treatment|4|||
147147157|NCT00566982|530703210|FG000|Overall Study|Adverse Event|6|||
147147158|NCT00566982|530703211|FG001|Overall Study|Adverse Event|48|||
147147159|NCT00566982|530703210|FG000|Overall Study|Withdrawal by Subject|1|||
147147160|NCT00566982|530703211|FG001|Overall Study|Withdrawal by Subject|14|||
147147161|NCT00566982|530703210|FG000|Overall Study|Protocol Violation|1|||
147147162|NCT00566982|530703211|FG001|Overall Study|Protocol Violation|4|||
147147163|NCT00566982|530703210|FG000|Overall Study|Lost to Follow-up|0|||
147147164|NCT00566982|530703211|FG001|Overall Study|Lost to Follow-up|1|||
147147165|NCT00566982|530703210|FG000|Overall Study|Other-family problems & doctor's request|0|||
147147166|NCT00566982|530703211|FG001|Overall Study|Other-family problems & doctor's request|2|||
147147167|NCT00443872|530703214|FG000|Overall Study|Protocol Violation|7|||
147147168|NCT00443872|530703214|FG000|Overall Study|Lost to Follow-up|2|||
147147169|NCT00443872|530703214|FG000|Overall Study|Adverse Event|8|||
147147170|NCT02789345|530703215|FG000|Overall Study|Adverse Event|0|||
147147171|NCT02789345|530703216|FG001|Overall Study|Adverse Event|0|||
147147172|NCT02789345|530703217|FG002|Overall Study|Adverse Event|1|||
147147173|NCT02789345|530703215|FG000|Overall Study|Death|0|||
147147174|NCT02789345|530703216|FG001|Overall Study|Death|0|||
147147175|NCT02789345|530703217|FG002|Overall Study|Death|1|||
147147176|NCT02789345|530703215|FG000|Overall Study|Physician Decision|2|||
147147177|NCT02789345|530703216|FG001|Overall Study|Physician Decision|0|||
147147178|NCT02789345|530703217|FG002|Overall Study|Physician Decision|1|||
147147179|NCT02789345|530703215|FG000|Overall Study|Progressive Disease|1|||
147147180|NCT02789345|530703216|FG001|Overall Study|Progressive Disease|3|||
147147181|NCT02789345|530703217|FG002|Overall Study|Progressive Disease|14|||
147239056|NCT02151110|531046221|FG005|Overall Study|Withdrawal by Subject|0|||
147147182|NCT00700622|530703224|FG000|Overall Study|Adverse Event|4|||
147147183|NCT00700622|530703225|FG001|Overall Study|Adverse Event|0|||
147239057|NCT02151110|531046222|FG006|Overall Study|Withdrawal by Subject|0|||
147239058|NCT02151110|531046223|FG007|Overall Study|Withdrawal by Subject|1|||
147575576|NCT00112437|532263532|FG014|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
147147184|NCT00700622|530703224|FG000|Overall Study|Lost to Follow-up|0|||
147147185|NCT00700622|530703225|FG001|Overall Study|Lost to Follow-up|1|||
147147186|NCT00700622|530703224|FG000|Overall Study|Physician Decision|2|||
147147187|NCT00700622|530703225|FG001|Overall Study|Physician Decision|1|||
147147188|NCT00700622|530703224|FG000|Overall Study|Protocol Violation|0|||
147147189|NCT00700622|530703225|FG001|Overall Study|Protocol Violation|1|||
147147190|NCT00700622|530703224|FG000|Overall Study|Withdrawal by Subject|4|||
147147191|NCT00700622|530703225|FG001|Overall Study|Withdrawal by Subject|1|||
147147192|NCT00700622|530703224|FG000|Overall Study|Other|3|||
147147193|NCT00700622|530703225|FG001|Overall Study|Other|1|||
147147194|NCT00383331|530703226|FG000|Overall Study|Protocol Violation|0|||
147147195|NCT00383331|530703227|FG001|Overall Study|Protocol Violation|1|||
147147196|NCT02253433|530703228|FG000|Overall Study|Unable to Contact|9|||
147147197|NCT02253433|530703229|FG001|Overall Study|Unable to Contact|16|||
147147198|NCT02253433|530703228|FG000|Overall Study|Death|1|||
147147199|NCT02253433|530703229|FG001|Overall Study|Death|1|||
147147200|NCT02253433|530703228|FG000|Overall Study|No Longer Interested|3|||
147147201|NCT02253433|530703229|FG001|Overall Study|No Longer Interested|15|||
147147202|NCT02253433|530703228|FG000|Overall Study|Out of Study Area|2|||
147147203|NCT02253433|530703229|FG001|Overall Study|Out of Study Area|7|||
147147204|NCT02253433|530703228|FG000|Overall Study|Uncomfortable with home visitors|0|||
147147205|NCT02253433|530703229|FG001|Overall Study|Uncomfortable with home visitors|3|||
147147206|NCT02253433|530703228|FG000|Overall Study|Unstable Housing/Homeless|0|||
147147207|NCT02253433|530703229|FG001|Overall Study|Unstable Housing/Homeless|7|||
147147208|NCT02253433|530703228|FG000|Overall Study|Too Busy|0|||
147147209|NCT02253433|530703229|FG001|Overall Study|Too Busy|4|||
147147210|NCT02253433|530703228|FG000|Overall Study|Medical or Other Concerns|1|||
147147211|NCT02253433|530703229|FG001|Overall Study|Medical or Other Concerns|2|||
147147212|NCT03520920|530703241|FG000|Overall Study|Death|13|||
147147213|NCT03520920|530703242|FG001|Overall Study|Death|1|||
147147214|NCT03520920|530703243|FG002|Overall Study|Death|0|||
147147215|NCT03520920|530703241|FG000|Overall Study|Withdrawal by Subject|2|||
147147216|NCT03520920|530703242|FG001|Overall Study|Withdrawal by Subject|1|||
147147217|NCT03520920|530703243|FG002|Overall Study|Withdrawal by Subject|0|||
147147218|NCT03520920|530703241|FG000|Overall Study|Study Terminated by the Sponsor|5|||
147147219|NCT03520920|530703242|FG001|Overall Study|Study Terminated by the Sponsor|14|||
147147220|NCT03520920|530703243|FG002|Overall Study|Study Terminated by the Sponsor|5|||
147147221|NCT00372619|530703244|FG000|Overall Study|Ineligible|0|||
147147222|NCT00372619|530703245|FG001|Overall Study|Ineligible|0|||
147147223|NCT00372619|530703246|FG002|Overall Study|Ineligible|0|||
147147224|NCT00372619|530703247|FG003|Overall Study|Ineligible|0|||
147147225|NCT00372619|530703248|FG004|Overall Study|Ineligible|0|||
147147226|NCT00372619|530703249|FG005|Overall Study|Ineligible|2|||
147147227|NCT00372619|530703250|FG006|Overall Study|Ineligible|0|||
147147228|NCT00372619|530703244|FG000|Overall Study|Inevaluable|0|||
147147229|NCT00372619|530703245|FG001|Overall Study|Inevaluable|0|||
147147230|NCT00372619|530703246|FG002|Overall Study|Inevaluable|0|||
147147231|NCT00372619|530703247|FG003|Overall Study|Inevaluable|0|||
147147232|NCT00372619|530703248|FG004|Overall Study|Inevaluable|0|||
147147233|NCT00372619|530703249|FG005|Overall Study|Inevaluable|1|||
147147234|NCT00372619|530703250|FG006|Overall Study|Inevaluable|0|||
147147235|NCT00066222|530703251|FG000|Overall Study|No protocol treatment received|1|||
147147236|NCT00405392|530703252|FG000|Overall Study|Adverse Event|15|||
147147237|NCT00405392|530703253|FG001|Overall Study|Adverse Event|14|||
147147238|NCT00405392|530703252|FG000|Overall Study|Did not meet Eligibility criteria|7|||
147147239|NCT00405392|530703253|FG001|Overall Study|Did not meet Eligibility criteria|2|||
147147240|NCT00405392|530703252|FG000|Overall Study|Withdrawal by Subject|4|||
147147241|NCT00405392|530703253|FG001|Overall Study|Withdrawal by Subject|3|||
147147242|NCT00405392|530703252|FG000|Overall Study|Lost to Follow-up|1|||
147147243|NCT00405392|530703253|FG001|Overall Study|Lost to Follow-up|2|||
147147244|NCT00405392|530703252|FG000|Overall Study|Data missing|2|||
147147245|NCT00405392|530703253|FG001|Overall Study|Data missing|0|||
147147246|NCT00405392|530703252|FG000|Overall Study|Non-compliance|0|||
147147247|NCT00405392|530703253|FG001|Overall Study|Non-compliance|1|||
147147248|NCT00405392|530703252|FG000|Overall Study|Other|1|||
147147249|NCT00405392|530703253|FG001|Overall Study|Other|5|||
147147250|NCT01703091|530703265|FG000|Overall Study|Adverse Event|5|||
147147251|NCT01703091|530703266|FG001|Overall Study|Adverse Event|3|||
147147252|NCT01703091|530703265|FG000|Overall Study|Physician Decision|2|||
147147253|NCT01703091|530703266|FG001|Overall Study|Physician Decision|1|||
147147254|NCT01703091|530703265|FG000|Overall Study|Withdrawal by Subject|1|||
147320225|NCT03160079|531338412|FG000|Overall Study|Physician Decision|1|||
147320226|NCT03160079|531338413|FG001|Overall Study|Physician Decision|0|||
147320227|NCT05893797|531338417|FG000|Study Period 1 (Weeks 1 to 6)|Adverse Event|1|||
147147255|NCT01703091|530703266|FG001|Overall Study|Withdrawal by Subject|0|||
147147256|NCT01703091|530703265|FG000|Overall Study|Sponsor Decision|1|||
147147257|NCT01703091|530703266|FG001|Overall Study|Sponsor Decision|0|||
147147258|NCT05420961|530703267|FG000|Overall Study|Withdrawal by Subject|2|||
147147259|NCT05420961|530703268|FG001|Overall Study|Withdrawal by Subject|1|||
147147260|NCT05420961|530703269|FG002|Overall Study|Withdrawal by Subject|1|||
147147261|NCT05420961|530703270|FG003|Overall Study|Withdrawal by Subject|0|||
147147262|NCT05420961|530703271|FG004|Overall Study|Withdrawal by Subject|0|||
147147263|NCT05420961|530703267|FG000|Overall Study|Lost to Follow-up|0|||
147147264|NCT05420961|530703268|FG001|Overall Study|Lost to Follow-up|0|||
147652804|NCT02070978|532550392|FG001|Overall Study|Withdrawal by Subject|5|||
147652805|NCT02070978|532550393|FG002|Overall Study|Withdrawal by Subject|3|||
147147265|NCT05420961|530703269|FG002|Overall Study|Lost to Follow-up|1|||
147147266|NCT05420961|530703270|FG003|Overall Study|Lost to Follow-up|0|||
147147267|NCT05420961|530703271|FG004|Overall Study|Lost to Follow-up|0|||
147147268|NCT05420961|530703267|FG000|Overall Study|Randomized by mistake without study treatment|0|||
147147269|NCT05420961|530703268|FG001|Overall Study|Randomized by mistake without study treatment|0|||
147147270|NCT05420961|530703269|FG002|Overall Study|Randomized by mistake without study treatment|1|||
147147271|NCT05420961|530703270|FG003|Overall Study|Randomized by mistake without study treatment|0|||
147147272|NCT05420961|530703271|FG004|Overall Study|Randomized by mistake without study treatment|1|||
147147273|NCT03902392|530703272|FG000|Overall Study|Lost to Follow-up|7|||
147147274|NCT03902392|530703273|FG001|Overall Study|Lost to Follow-up|7|||
147147275|NCT00244725|530703274|FG000|Overall Study|Lost to Follow-up|3|||
147147276|NCT00244725|530703275|FG001|Overall Study|Lost to Follow-up|4|||
147147277|NCT00244725|530703276|FG002|Overall Study|Lost to Follow-up|9|||
147147278|NCT00244725|530703277|FG003|Overall Study|Lost to Follow-up|2|||
147147279|NCT00244725|530703274|FG000|Overall Study|Withdrawal by Subject|9|||
147147280|NCT00244725|530703275|FG001|Overall Study|Withdrawal by Subject|7|||
147147281|NCT00244725|530703276|FG002|Overall Study|Withdrawal by Subject|7|||
147147282|NCT00244725|530703277|FG003|Overall Study|Withdrawal by Subject|8|||
147147283|NCT00244725|530703274|FG000|Overall Study|Not meet treatment eligibility criteria|1|||
147147284|NCT00244725|530703275|FG001|Overall Study|Not meet treatment eligibility criteria|2|||
147147285|NCT00244725|530703276|FG002|Overall Study|Not meet treatment eligibility criteria|0|||
147147286|NCT00244725|530703277|FG003|Overall Study|Not meet treatment eligibility criteria|0|||
147147287|NCT00244725|530703274|FG000|Overall Study|Physician Decision|3|||
147147288|NCT00244725|530703275|FG001|Overall Study|Physician Decision|0|||
147239059|NCT02151110|531046216|FG000|Overall Study|Lost to Follow-up|0|||
147239060|NCT02151110|531046217|FG001|Overall Study|Lost to Follow-up|0|||
147239061|NCT02151110|531046218|FG002|Overall Study|Lost to Follow-up|0|||
147239062|NCT02151110|531046219|FG003|Overall Study|Lost to Follow-up|0|||
147239063|NCT02151110|531046220|FG004|Overall Study|Lost to Follow-up|0|||
147239064|NCT02151110|531046221|FG005|Overall Study|Lost to Follow-up|0|||
147239065|NCT02151110|531046222|FG006|Overall Study|Lost to Follow-up|0|||
147239066|NCT02151110|531046223|FG007|Overall Study|Lost to Follow-up|2|||
147239067|NCT01064310|531046224|FG000|Period 1|Adverse Event|7|||
147239068|NCT01064310|531046225|FG001|Period 1|Adverse Event|10|||
147239069|NCT01064310|531046226|FG002|Period 1|Adverse Event|0|||
147239070|NCT01064310|531046224|FG000|Period 1|Physician Decision|1|||
147239071|NCT01064310|531046225|FG001|Period 1|Physician Decision|0|||
147239072|NCT01064310|531046226|FG002|Period 1|Physician Decision|0|||
147239073|NCT01064310|531046224|FG000|Period 1|Withdrawal by Subject|2|||
147239074|NCT01064310|531046225|FG001|Period 1|Withdrawal by Subject|2|||
147239075|NCT01064310|531046226|FG002|Period 1|Withdrawal by Subject|0|||
147239076|NCT01064310|531046224|FG000|Period 1|Lack of Efficacy|3|||
147239077|NCT01064310|531046225|FG001|Period 1|Lack of Efficacy|5|||
147239078|NCT01064310|531046226|FG002|Period 1|Lack of Efficacy|0|||
147239079|NCT01064310|531046224|FG000|Period 1|Entered Open-label Period|1|||
147239080|NCT01064310|531046225|FG001|Period 1|Entered Open-label Period|1|||
147239081|NCT01064310|531046226|FG002|Period 1|Entered Open-label Period|0|||
147239082|NCT01064310|531046224|FG000|Period 2|Adverse Event|2|||
147239083|NCT01064310|531046225|FG001|Period 2|Adverse Event|1|||
147239084|NCT01064310|531046226|FG002|Period 2|Adverse Event|0|||
147239085|NCT01064310|531046224|FG000|Period 2|Physician Decision|0|||
147239086|NCT01064310|531046225|FG001|Period 2|Physician Decision|1|||
147239087|NCT01064310|531046226|FG002|Period 2|Physician Decision|0|||
147239088|NCT01064310|531046224|FG000|Period 2|Entered Open-label Period|1|||
147239089|NCT01064310|531046225|FG001|Period 2|Entered Open-label Period|0|||
147239090|NCT01064310|531046226|FG002|Period 2|Entered Open-label Period|0|||
147239091|NCT01064310|531046224|FG000|Period 2|Lack of Efficacy|1|||
147239092|NCT01064310|531046225|FG001|Period 2|Lack of Efficacy|4|||
147239093|NCT01064310|531046226|FG002|Period 2|Lack of Efficacy|0|||
147239094|NCT01064310|531046224|FG000|Open Label Pazopinib|Withdrawal by Subject|0|||
147239095|NCT01064310|531046225|FG001|Open Label Pazopinib|Withdrawal by Subject|0|||
147239096|NCT01064310|531046226|FG002|Open Label Pazopinib|Withdrawal by Subject|1|||
147239097|NCT01064310|531046224|FG000|Open Label Pazopinib|Adverse Event|0|||
147239098|NCT01064310|531046225|FG001|Open Label Pazopinib|Adverse Event|0|||
147320228|NCT05893797|531338417|FG000|Study Period 1 (Weeks 1 to 6)|Lost to Follow-up|1|||
147239099|NCT01064310|531046226|FG002|Open Label Pazopinib|Adverse Event|12|||
147320229|NCT05893797|531338417|FG000|Study Period 1 (Weeks 1 to 6)|Withdrawal by Subject|2|||
147320230|NCT05893797|531338417|FG000|Study Period 2 (Weeks 7 to 18)|Physician Decision|2|||
147147289|NCT00244725|530703276|FG002|Overall Study|Physician Decision|1|||
147147290|NCT00244725|530703277|FG003|Overall Study|Physician Decision|2|||
147239100|NCT01064310|531046224|FG000|Open Label Pazopinib|Lack of Efficacy|0|||
147239101|NCT01064310|531046225|FG001|Open Label Pazopinib|Lack of Efficacy|0|||
147239102|NCT01064310|531046226|FG002|Open Label Pazopinib|Lack of Efficacy|51|||
147239103|NCT01064310|531046224|FG000|Open Label Pazopinib|Physician Decision|0|||
147239104|NCT01064310|531046225|FG001|Open Label Pazopinib|Physician Decision|0|||
147320231|NCT04770220|531338418|FG000|Overall Study|Adverse Event|2|||
147320232|NCT04770220|531338419|FG001|Overall Study|Adverse Event|11|||
147320233|NCT04770220|531338418|FG000|Overall Study|Withdrawal by Subject|5|||
147320234|NCT04770220|531338419|FG001|Overall Study|Withdrawal by Subject|11|||
147320235|NCT04770220|531338418|FG000|Overall Study|Lost to Follow-up|4|||
147320236|NCT04770220|531338419|FG001|Overall Study|Lost to Follow-up|3|||
147320237|NCT04770220|531338418|FG000|Overall Study|not otherwise specified|2|||
147320238|NCT04770220|531338419|FG001|Overall Study|not otherwise specified|3|||
147320239|NCT04770220|531338418|FG000|Overall Study|Physician Decision|1|||
147320240|NCT04770220|531338419|FG001|Overall Study|Physician Decision|3|||
147320241|NCT04955626|531338420|FG000|Blinded Period|Lost to Follow-up|28|||
147320242|NCT04955626|531338421|FG001|Blinded Period|Lost to Follow-up|28|||
147320243|NCT04955626|531338422|FG002|Blinded Period|Lost to Follow-up|7|||
147320244|NCT04955626|531338423|FG003|Blinded Period|Lost to Follow-up|14|||
147320245|NCT04955626|531338424|FG004|Blinded Period|Lost to Follow-up|3|||
147320246|NCT04955626|531338425|FG005|Blinded Period|Lost to Follow-up|2|||
147320247|NCT04955626|531338426|FG006|Blinded Period|Lost to Follow-up|6|||
147320248|NCT04955626|531338427|FG007|Blinded Period|Lost to Follow-up|4|||
147320249|NCT04955626|531338428|FG008|Blinded Period|Lost to Follow-up|5|||
147320250|NCT04955626|531338429|FG009|Blinded Period|Lost to Follow-up|8|||
147320251|NCT04955626|531338430|FG010|Blinded Period|Lost to Follow-up|10|||
147320252|NCT04955626|531338431|FG011|Blinded Period|Lost to Follow-up|32|||
147320253|NCT04955626|531338432|FG012|Blinded Period|Lost to Follow-up|0|||
147320254|NCT04955626|531338433|FG013|Blinded Period|Lost to Follow-up|0|||
147320255|NCT04955626|531338434|FG014|Blinded Period|Lost to Follow-up|0|||
147320256|NCT04955626|531338435|FG015|Blinded Period|Lost to Follow-up|12|||
147320257|NCT04955626|531338436|FG016|Blinded Period|Lost to Follow-up|2|||
147320258|NCT04955626|531338437|FG017|Blinded Period|Lost to Follow-up|5|||
147320259|NCT04955626|531338438|FG018|Blinded Period|Lost to Follow-up|0|||
147320260|NCT04955626|531338439|FG019|Blinded Period|Lost to Follow-up|0|||
147320261|NCT04955626|531338440|FG020|Blinded Period|Lost to Follow-up|0|||
147320262|NCT04955626|531338441|FG021|Blinded Period|Lost to Follow-up|0|||
147320263|NCT04955626|531338442|FG022|Blinded Period|Lost to Follow-up|0|||
147320264|NCT04955626|531338443|FG023|Blinded Period|Lost to Follow-up|0|||
147320265|NCT04955626|531338444|FG024|Blinded Period|Lost to Follow-up|3|||
147320266|NCT04955626|531338445|FG025|Blinded Period|Lost to Follow-up|1|||
147320267|NCT04955626|531338446|FG026|Blinded Period|Lost to Follow-up|2|||
147320268|NCT04955626|531338447|FG027|Blinded Period|Lost to Follow-up|2|||
147320269|NCT04955626|531338448|FG028|Blinded Period|Lost to Follow-up|2|||
147320270|NCT04955626|531338449|FG029|Blinded Period|Lost to Follow-up|0|||
147320271|NCT04955626|531338450|FG030|Blinded Period|Lost to Follow-up|0|||
147320272|NCT04955626|531338451|FG031|Blinded Period|Lost to Follow-up|0|||
147320273|NCT04955626|531338452|FG032|Blinded Period|Lost to Follow-up|0|||
147320274|NCT04955626|531338453|FG033|Blinded Period|Lost to Follow-up|0|||
147320275|NCT04955626|531338454|FG034|Blinded Period|Lost to Follow-up|0|||
147320276|NCT04955626|531338455|FG035|Blinded Period|Lost to Follow-up|0|||
147320277|NCT04955626|531338420|FG000|Blinded Period|Protocol Violation|5|||
147320278|NCT04955626|531338421|FG001|Blinded Period|Protocol Violation|14|||
147147291|NCT00244725|530703274|FG000|Overall Study|Adverse Events|3|||
147147292|NCT00244725|530703275|FG001|Overall Study|Adverse Events|1|||
147147293|NCT00244725|530703276|FG002|Overall Study|Adverse Events|4|||
147147294|NCT00244725|530703277|FG003|Overall Study|Adverse Events|4|||
147147295|NCT00244725|530703274|FG000|Overall Study|Withdrwal by participant|1|||
147147296|NCT00244725|530703275|FG001|Overall Study|Withdrwal by participant|0|||
147147297|NCT00244725|530703276|FG002|Overall Study|Withdrwal by participant|0|||
147147298|NCT00244725|530703277|FG003|Overall Study|Withdrwal by participant|1|||
147147299|NCT00244725|530703274|FG000|Overall Study|Liver function test abnormality|2|||
147147300|NCT00244725|530703275|FG001|Overall Study|Liver function test abnormality|0|||
147147301|NCT00244725|530703276|FG002|Overall Study|Liver function test abnormality|0|||
147147302|NCT00244725|530703277|FG003|Overall Study|Liver function test abnormality|1|||
147147303|NCT00244725|530703274|FG000|Overall Study|Sponsor withdrew the participant|1|||
147147304|NCT00244725|530703275|FG001|Overall Study|Sponsor withdrew the participant|0|||
147147305|NCT00244725|530703276|FG002|Overall Study|Sponsor withdrew the participant|0|||
147147306|NCT00244725|530703277|FG003|Overall Study|Sponsor withdrew the participant|1|||
147147307|NCT00244725|530703274|FG000|Overall Study|Mediciation Error|0|||
147147308|NCT00244725|530703275|FG001|Overall Study|Mediciation Error|1|||
147147309|NCT00244725|530703276|FG002|Overall Study|Mediciation Error|0|||
147147310|NCT00244725|530703277|FG003|Overall Study|Mediciation Error|0|||
147147311|NCT00244725|530703274|FG000|Overall Study|Rehab Refused to allow participantion|0|||
147320279|NCT04955626|531338422|FG002|Blinded Period|Protocol Violation|0|||
147320280|NCT04955626|531338423|FG003|Blinded Period|Protocol Violation|1|||
147320281|NCT04955626|531338424|FG004|Blinded Period|Protocol Violation|2|||
147320282|NCT04955626|531338425|FG005|Blinded Period|Protocol Violation|2|||
147320283|NCT04955626|531338426|FG006|Blinded Period|Protocol Violation|0|||
147147312|NCT00244725|530703275|FG001|Overall Study|Rehab Refused to allow participantion|1|||
147320284|NCT04955626|531338427|FG007|Blinded Period|Protocol Violation|0|||
147320285|NCT04955626|531338428|FG008|Blinded Period|Protocol Violation|0|||
147320286|NCT04955626|531338429|FG009|Blinded Period|Protocol Violation|4|||
147320287|NCT04955626|531338430|FG010|Blinded Period|Protocol Violation|6|||
147147313|NCT00244725|530703276|FG002|Overall Study|Rehab Refused to allow participantion|0|||
147147314|NCT00244725|530703277|FG003|Overall Study|Rehab Refused to allow participantion|0|||
147147315|NCT00244725|530703274|FG000|Overall Study|Headache|0|||
147147316|NCT00244725|530703275|FG001|Overall Study|Headache|1|||
147147317|NCT00244725|530703276|FG002|Overall Study|Headache|0|||
147147318|NCT00244725|530703277|FG003|Overall Study|Headache|0|||
147147319|NCT00244725|530703274|FG000|Overall Study|Received prohibited medication|0|||
147147320|NCT00244725|530703275|FG001|Overall Study|Received prohibited medication|1|||
147147321|NCT00244725|530703276|FG002|Overall Study|Received prohibited medication|0|||
147147322|NCT00244725|530703277|FG003|Overall Study|Received prohibited medication|1|||
147147323|NCT00244725|530703274|FG000|Overall Study|Confirmed venous thromboembolism (VTE)|0|||
147147324|NCT00244725|530703275|FG001|Overall Study|Confirmed venous thromboembolism (VTE)|1|||
147147325|NCT00244725|530703276|FG002|Overall Study|Confirmed venous thromboembolism (VTE)|0|||
147147326|NCT00244725|530703277|FG003|Overall Study|Confirmed venous thromboembolism (VTE)|0|||
147147327|NCT00244725|530703274|FG000|Overall Study|Administrative reason|0|||
147147328|NCT00244725|530703275|FG001|Overall Study|Administrative reason|0|||
147147329|NCT00244725|530703276|FG002|Overall Study|Administrative reason|1|||
147147330|NCT00244725|530703277|FG003|Overall Study|Administrative reason|0|||
147147331|NCT00244725|530703274|FG000|Overall Study|Vomit|0|||
147147332|NCT00244725|530703275|FG001|Overall Study|Vomit|0|||
147147333|NCT00244725|530703276|FG002|Overall Study|Vomit|1|||
147147334|NCT00244725|530703277|FG003|Overall Study|Vomit|0|||
147147335|NCT00244725|530703274|FG000|Overall Study|Failed to follow-up|0|||
147147336|NCT00244725|530703275|FG001|Overall Study|Failed to follow-up|0|||
147147337|NCT00244725|530703276|FG002|Overall Study|Failed to follow-up|1|||
147147338|NCT00244725|530703277|FG003|Overall Study|Failed to follow-up|1|||
147147339|NCT03799952|530703278|FG000|Overall Study|Program was too easy, discontinued|1|||
147147340|NCT03799952|530703279|FG001|Overall Study|Program was too easy, discontinued|0|||
147147341|NCT03799952|530703278|FG000|Overall Study|Lost to Follow-up|0|||
147147342|NCT03799952|530703279|FG001|Overall Study|Lost to Follow-up|2|||
147147343|NCT03248167|530703280|FG000|Overall Study|Withdrawal by Subject|2|||
147147344|NCT03248167|530703281|FG001|Overall Study|Withdrawal by Subject|2|||
147147345|NCT03248167|530703280|FG000|Overall Study|Physician Decision|0|||
147147346|NCT03248167|530703281|FG001|Overall Study|Physician Decision|1|||
147147347|NCT03248167|530703280|FG000|Overall Study|Institution Mandated COVID-19 Research Pause|2|||
147147348|NCT03248167|530703281|FG001|Overall Study|Institution Mandated COVID-19 Research Pause|1|||
147147349|NCT03248167|530703280|FG000|Overall Study|Lost to Follow-up|1|||
147147350|NCT03248167|530703281|FG001|Overall Study|Lost to Follow-up|0|||
147147351|NCT02122146|530703282|FG000|Part 1: Dose Escalation|Death|0|||
147147352|NCT02122146|530703283|FG001|Part 1: Dose Escalation|Death|1|||
147147353|NCT02122146|530703284|FG002|Part 1: Dose Escalation|Death|1|||
147147354|NCT02122146|530703285|FG003|Part 1: Dose Escalation|Death|0|||
147147355|NCT02122146|530703286|FG004|Part 1: Dose Escalation|Death|0|||
147147356|NCT02122146|530703287|FG005|Part 1: Dose Escalation|Death|0|||
147147357|NCT02122146|530703288|FG006|Part 1: Dose Escalation|Death|0|||
147147358|NCT02122146|530703289|FG007|Part 1: Dose Escalation|Death|0|||
147147359|NCT02122146|530703282|FG000|Part 1: Dose Escalation|Lost to Follow-up|0|||
147147360|NCT02122146|530703283|FG001|Part 1: Dose Escalation|Lost to Follow-up|0|||
147147361|NCT02122146|530703284|FG002|Part 1: Dose Escalation|Lost to Follow-up|1|||
147147362|NCT02122146|530703285|FG003|Part 1: Dose Escalation|Lost to Follow-up|0|||
147147363|NCT02122146|530703286|FG004|Part 1: Dose Escalation|Lost to Follow-up|1|||
147147364|NCT02122146|530703287|FG005|Part 1: Dose Escalation|Lost to Follow-up|0|||
147147365|NCT02122146|530703288|FG006|Part 1: Dose Escalation|Lost to Follow-up|0|||
147147366|NCT02122146|530703289|FG007|Part 1: Dose Escalation|Lost to Follow-up|0|||
147147367|NCT02122146|530703282|FG000|Part 1: Dose Escalation|Withdrawal by Subject|0|||
147147368|NCT02122146|530703283|FG001|Part 1: Dose Escalation|Withdrawal by Subject|0|||
147147369|NCT02122146|530703284|FG002|Part 1: Dose Escalation|Withdrawal by Subject|0|||
147147370|NCT02122146|530703285|FG003|Part 1: Dose Escalation|Withdrawal by Subject|1|||
147147371|NCT02122146|530703286|FG004|Part 1: Dose Escalation|Withdrawal by Subject|0|||
147445904|NCT01445951|531797474|FG002|Overall Study|Death|1|||
147445905|NCT01445951|531797472|FG000|Overall Study|Non-compliance with study drug|1|||
147147372|NCT02122146|530703287|FG005|Part 1: Dose Escalation|Withdrawal by Subject|0|||
147147373|NCT02122146|530703288|FG006|Part 1: Dose Escalation|Withdrawal by Subject|0|||
147147374|NCT02122146|530703289|FG007|Part 1: Dose Escalation|Withdrawal by Subject|0|||
147147375|NCT02122146|530703282|FG000|Part 1: Dose Escalation|Other|1|||
147147376|NCT02122146|530703283|FG001|Part 1: Dose Escalation|Other|0|||
147147377|NCT02122146|530703284|FG002|Part 1: Dose Escalation|Other|0|||
147147378|NCT02122146|530703285|FG003|Part 1: Dose Escalation|Other|0|||
147445906|NCT01445951|531797473|FG001|Overall Study|Non-compliance with study drug|2|||
147445907|NCT01445951|531797474|FG002|Overall Study|Non-compliance with study drug|0|||
147445908|NCT01445951|531797472|FG000|Overall Study|Non-compliance with protocol|0|||
147147379|NCT02122146|530703286|FG004|Part 1: Dose Escalation|Other|0|||
147147380|NCT02122146|530703287|FG005|Part 1: Dose Escalation|Other|1|||
147147381|NCT02122146|530703288|FG006|Part 1: Dose Escalation|Other|1|||
147445909|NCT01445951|531797473|FG001|Overall Study|Non-compliance with protocol|1|||
147445910|NCT01445951|531797474|FG002|Overall Study|Non-compliance with protocol|0|||
147147382|NCT02122146|530703289|FG007|Part 1: Dose Escalation|Other|2|||
147147383|NCT01107392|530703290|FG000|Overall Study|Adverse Event|2|||
147147384|NCT01107392|530703291|FG001|Overall Study|Adverse Event|0|||
147147385|NCT01107392|530703290|FG000|Overall Study|Personal Reasons|2|||
147147386|NCT01107392|530703291|FG001|Overall Study|Personal Reasons|3|||
147147387|NCT01107392|530703290|FG000|Overall Study|Administrative decision|1|||
147147388|NCT01107392|530703291|FG001|Overall Study|Administrative decision|0|||
147147389|NCT02584452|530703292|FG000|Overall Study|Physician Decision|1|||
147147390|NCT02584452|530703293|FG001|Overall Study|Physician Decision|1|||
147147391|NCT02584452|530703292|FG000|Overall Study|Lost to Follow-up|1|||
147147392|NCT02584452|530703293|FG001|Overall Study|Lost to Follow-up|1|||
147147393|NCT00177294|530703294|FG000|Overall Study|Withdrawal by Subject|7|||
147239105|NCT01064310|531046226|FG002|Open Label Pazopinib|Physician Decision|20|||
147239106|NCT02639065|531046227|FG000|Study Treatment|Disease Progression|13|||
147239107|NCT02639065|531046227|FG000|Study Treatment|Adverse Event|9|||
147239108|NCT02639065|531046227|FG000|Study Treatment|Withdrawal by Subject|1|||
147239109|NCT02639065|531046227|FG000|Follow up|Subject refused to follow up|1|||
147239110|NCT02639065|531046227|FG000|Follow up|Symptomatic Deterioration|2|||
147239111|NCT02639065|531046227|FG000|Follow up|Death|2|||
147239112|NCT02639065|531046227|FG000|Follow up|Study Terminated|1|||
147239113|NCT02639065|531046227|FG000|Follow up|Disease Progression|3|||
147239114|NCT00873015|531046231|FG000|Overall Study|Withdrawal by Subject|0|||
147239115|NCT00873015|531046232|FG001|Overall Study|Withdrawal by Subject|1|||
147239116|NCT00873015|531046233|FG002|Overall Study|Withdrawal by Subject|0|||
147239117|NCT00873015|531046234|FG003|Overall Study|Withdrawal by Subject|0|||
147239118|NCT03128411|531046235|FG000|Treatment Phase|Adverse Event|21|||
147239119|NCT03128411|531046235|FG000|Treatment Phase|Physician Decision|1|||
147239120|NCT03128411|531046235|FG000|Treatment Phase|Other|2|||
147239121|NCT03128411|531046235|FG000|Long Term Follow-up Phase|Death|2|||
147239122|NCT00345839|531046236|FG000|Overall Study|Withdrawal by Subject|91|||
147239123|NCT00345839|531046237|FG001|Overall Study|Withdrawal by Subject|98|||
147239124|NCT00345839|531046236|FG000|Overall Study|Lost to Follow-up|58|||
147239125|NCT00345839|531046237|FG001|Overall Study|Lost to Follow-up|61|||
147239126|NCT00967668|531047462|FG000|Overall Study|Withdrawal by Subject|13|||
147239127|NCT00967668|531047463|FG001|Overall Study|Withdrawal by Subject|8|||
147239128|NCT00967668|531047464|FG002|Overall Study|Withdrawal by Subject|8|||
147239129|NCT00967668|531047462|FG000|Overall Study|Death|0|||
147239130|NCT00967668|531047463|FG001|Overall Study|Death|2|||
147239131|NCT00967668|531047464|FG002|Overall Study|Death|4|||
147239132|NCT00967668|531047462|FG000|Overall Study|Removed due to behavior|1|||
147239133|NCT00967668|531047463|FG001|Overall Study|Removed due to behavior|1|||
147239134|NCT00967668|531047464|FG002|Overall Study|Removed due to behavior|2|||
147239135|NCT00967668|531047462|FG000|Overall Study|Refused Year 2|11|||
147239136|NCT00967668|531047463|FG001|Overall Study|Refused Year 2|6|||
147239137|NCT00967668|531047464|FG002|Overall Study|Refused Year 2|4|||
147239138|NCT00967668|531047462|FG000|Overall Study|Lost to follow-up at 12-mo|27|||
147239139|NCT00967668|531047463|FG001|Overall Study|Lost to follow-up at 12-mo|29|||
147239140|NCT00967668|531047464|FG002|Overall Study|Lost to follow-up at 12-mo|26|||
147239141|NCT00967668|531047462|FG000|Overall Study|Lost to Follow-up|15|||
147239142|NCT00967668|531047463|FG001|Overall Study|Lost to Follow-up|9|||
147239143|NCT00967668|531047464|FG002|Overall Study|Lost to Follow-up|16|||
147239144|NCT00967668|531047462|FG000|Overall Study|Refused 12-mo assessment|3|||
147239145|NCT00967668|531047463|FG001|Overall Study|Refused 12-mo assessment|1|||
147239146|NCT00967668|531047464|FG002|Overall Study|Refused 12-mo assessment|9|||
147239147|NCT00967668|531047462|FG000|Overall Study|Pregnancy|1|||
147239148|NCT00967668|531047463|FG001|Overall Study|Pregnancy|0|||
147239149|NCT00967668|531047464|FG002|Overall Study|Pregnancy|0|||
147239150|NCT01871532|531047468|FG000|Overall Study|Withdrawal by Subject|1|||
147239151|NCT01871532|531047469|FG001|Overall Study|Withdrawal by Subject|2|||
147575577|NCT00112437|532263533|FG015|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
147575578|NCT00112437|532263534|FG016|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
147575579|NCT00112437|532263535|FG017|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
147575580|NCT00112437|532263536|FG018|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
147239152|NCT01673867|531047470|FG000|Randomization|Adverse event unrelated to study drug|1|||
147239153|NCT01673867|531047471|FG001|Randomization|Adverse event unrelated to study drug|0|||
147239154|NCT01673867|531047470|FG000|Randomization|Participant request to discontinue study treatment|0|||
147239155|NCT01673867|531047471|FG001|Randomization|Participant request to discontinue study treatment|4|||
147147394|NCT00177294|530703295|FG001|Overall Study|Withdrawal by Subject|5|||
147239156|NCT01673867|531047470|FG000|Randomization|Withdrawal by participant|0|||
147239157|NCT01673867|531047471|FG001|Randomization|Withdrawal by participant|12|||
147239158|NCT01673867|531047470|FG000|Randomization|Lost to Follow-up|0|||
147239159|NCT01673867|531047471|FG001|Randomization|Lost to Follow-up|1|||
147239160|NCT01673867|531047470|FG000|Randomization|Participant no longer meets study criteria|4|||
147239161|NCT01673867|531047471|FG001|Randomization|Participant no longer meets study criteria|5|||
147147395|NCT02998671|530703296|FG000|Period 1|Study Terminated By Sponsor|2|||
147147396|NCT02998671|530703297|FG001|Period 1|Study Terminated By Sponsor|1|||
147147397|NCT02998671|530703298|FG002|Period 1|Study Terminated By Sponsor|0|||
147147398|NCT02998671|530703299|FG003|Period 1|Study Terminated By Sponsor|0|||
147147399|NCT02998671|530703300|FG004|Period 1|Study Terminated By Sponsor|1|||
147147400|NCT02998671|530703296|FG000|Period 1|Withdrawal by Subject|1|||
147147401|NCT02998671|530703297|FG001|Period 1|Withdrawal by Subject|2|||
147147402|NCT02998671|530703298|FG002|Period 1|Withdrawal by Subject|0|||
147147403|NCT02998671|530703299|FG003|Period 1|Withdrawal by Subject|0|||
147320288|NCT04955626|531338431|FG011|Blinded Period|Protocol Violation|1|||
147320289|NCT04955626|531338432|FG012|Blinded Period|Protocol Violation|0|||
147320290|NCT04955626|531338433|FG013|Blinded Period|Protocol Violation|0|||
147320291|NCT04955626|531338434|FG014|Blinded Period|Protocol Violation|2|||
147320292|NCT04955626|531338435|FG015|Blinded Period|Protocol Violation|6|||
147320293|NCT04955626|531338436|FG016|Blinded Period|Protocol Violation|4|||
147320294|NCT04955626|531338437|FG017|Blinded Period|Protocol Violation|6|||
147320295|NCT04955626|531338438|FG018|Blinded Period|Protocol Violation|0|||
147320296|NCT04955626|531338439|FG019|Blinded Period|Protocol Violation|1|||
147320297|NCT04955626|531338440|FG020|Blinded Period|Protocol Violation|0|||
147320298|NCT04955626|531338441|FG021|Blinded Period|Protocol Violation|1|||
147320299|NCT04955626|531338442|FG022|Blinded Period|Protocol Violation|0|||
147147404|NCT02998671|530703300|FG004|Period 1|Withdrawal by Subject|2|||
147147405|NCT02998671|530703296|FG000|Period 1|Pregnancy|1|||
147147406|NCT02998671|530703297|FG001|Period 1|Pregnancy|0|||
147147407|NCT02998671|530703298|FG002|Period 1|Pregnancy|0|||
147147408|NCT02998671|530703299|FG003|Period 1|Pregnancy|0|||
147147409|NCT02998671|530703300|FG004|Period 1|Pregnancy|0|||
147147410|NCT02998671|530703296|FG000|Period 1|Adverse Event|0|||
147147411|NCT02998671|530703297|FG001|Period 1|Adverse Event|0|||
147147412|NCT02998671|530703298|FG002|Period 1|Adverse Event|0|||
147147413|NCT02998671|530703299|FG003|Period 1|Adverse Event|0|||
147147414|NCT02998671|530703300|FG004|Period 1|Adverse Event|1|||
147147415|NCT02998671|530703296|FG000|Period 2|Adverse Event|0|||
147147416|NCT02998671|530703297|FG001|Period 2|Adverse Event|1|||
147147417|NCT02998671|530703298|FG002|Period 2|Adverse Event|0|||
147147418|NCT02998671|530703299|FG003|Period 2|Adverse Event|0|||
147147419|NCT02998671|530703300|FG004|Period 2|Adverse Event|0|||
147147420|NCT02998671|530703296|FG000|Period 2|Study Terminated By Sponsor|3|||
147147421|NCT02998671|530703297|FG001|Period 2|Study Terminated By Sponsor|5|||
147147422|NCT02998671|530703298|FG002|Period 2|Study Terminated By Sponsor|1|||
147147423|NCT02998671|530703299|FG003|Period 2|Study Terminated By Sponsor|3|||
147147424|NCT02998671|530703300|FG004|Period 2|Study Terminated By Sponsor|0|||
147147425|NCT02998671|530703296|FG000|Period 2|Withdrawal by Subject|0|||
147147426|NCT02998671|530703297|FG001|Period 2|Withdrawal by Subject|1|||
147147427|NCT02998671|530703298|FG002|Period 2|Withdrawal by Subject|0|||
147147428|NCT02998671|530703299|FG003|Period 2|Withdrawal by Subject|0|||
147147429|NCT02998671|530703300|FG004|Period 2|Withdrawal by Subject|0|||
147147430|NCT02998671|530703296|FG000|Period 2|Lost to Follow-up|0|||
147147431|NCT02998671|530703297|FG001|Period 2|Lost to Follow-up|0|||
147147432|NCT02998671|530703298|FG002|Period 2|Lost to Follow-up|0|||
147147433|NCT02998671|530703299|FG003|Period 2|Lost to Follow-up|1|||
147147434|NCT02998671|530703300|FG004|Period 2|Lost to Follow-up|0|||
147147435|NCT01603043|530703303|FG000|Overall Study|Study Futility|7|||
147147436|NCT01603043|530703304|FG001|Overall Study|Study Futility|3|||
147147437|NCT04532294|530703305|FG000|Overall Study|Withdrawal by Subject|0|||
147147438|NCT04532294|530703306|FG001|Overall Study|Withdrawal by Subject|0|||
147147439|NCT04532294|530703307|FG002|Overall Study|Withdrawal by Subject|1|||
147147440|NCT04532294|530703305|FG000|Overall Study|Participants Not Dosed|0|||
147147441|NCT04532294|530703306|FG001|Overall Study|Participants Not Dosed|0|||
147147442|NCT04532294|530703307|FG002|Overall Study|Participants Not Dosed|2|||
147147443|NCT03089047|530703308|FG000|Overall Study|Lost to Follow-up|1|||
147147444|NCT03089047|530703309|FG001|Overall Study|Lost to Follow-up|0|||
147147445|NCT03599518|530703310|FG000|Overall Study|Clinical progression|0|||
147147446|NCT03599518|530703311|FG001|Overall Study|Clinical progression|0|||
147147447|NCT03599518|530703312|FG002|Overall Study|Clinical progression|0|||
147147448|NCT03599518|530703313|FG003|Overall Study|Clinical progression|0|||
147147449|NCT03599518|530703314|FG004|Overall Study|Clinical progression|1|||
147147450|NCT03599518|530703310|FG000|Overall Study|Adverse Event|0|||
147147451|NCT03599518|530703311|FG001|Overall Study|Adverse Event|0|||
147147452|NCT03599518|530703312|FG002|Overall Study|Adverse Event|0|||
147147453|NCT03599518|530703313|FG003|Overall Study|Adverse Event|0|||
147147454|NCT03599518|530703314|FG004|Overall Study|Adverse Event|1|||
147147455|NCT03599518|530703310|FG000|Overall Study|Progressive disease as per RECIST v1.1|5|||
147147456|NCT03599518|530703311|FG001|Overall Study|Progressive disease as per RECIST v1.1|4|||
147147457|NCT03599518|530703312|FG002|Overall Study|Progressive disease as per RECIST v1.1|5|||
147147458|NCT03599518|530703313|FG003|Overall Study|Progressive disease as per RECIST v1.1|1|||
147147459|NCT03599518|530703314|FG004|Overall Study|Progressive disease as per RECIST v1.1|2|||
147147460|NCT03599518|530703310|FG000|Overall Study|Participant withdrawal from study treatment|0|||
147147461|NCT03599518|530703311|FG001|Overall Study|Participant withdrawal from study treatment|0|||
147320300|NCT04955626|531338443|FG023|Blinded Period|Protocol Violation|0|||
147320301|NCT04955626|531338444|FG024|Blinded Period|Protocol Violation|4|||
147320302|NCT04955626|531338445|FG025|Blinded Period|Protocol Violation|6|||
147147462|NCT03599518|530703312|FG002|Overall Study|Participant withdrawal from study treatment|1|||
147147463|NCT03599518|530703313|FG003|Overall Study|Participant withdrawal from study treatment|0|||
147147464|NCT03599518|530703314|FG004|Overall Study|Participant withdrawal from study treatment|0|||
147147465|NCT00375505|530703317|FG000|Overall Study|Adverse Event|1|||
147147466|NCT00375505|530703318|FG001|Overall Study|Adverse Event|2|||
147147467|NCT00429182|530703322|FG000|Overall Study|Not evaluable, Disease Progression|2|||
147147468|NCT00429182|530703322|FG000|Overall Study|Not eligible|5|||
147147469|NCT03497039|530703323|FG000|Overall Study|Withdrawal by Subject|1|||
147147470|NCT03497039|530703324|FG001|Overall Study|Withdrawal by Subject|0|||
147147471|NCT03497039|530703323|FG000|Overall Study|Protocol Violation|0|||
147147472|NCT03497039|530703324|FG001|Overall Study|Protocol Violation|1|||
147147473|NCT00861692|530703326|FG000|Overall Study|Death|6|||
147147474|NCT05111002|530703331|FG000|Primary Outcome|Negative Confirmatory Aptima MG Test|1|||
147147475|NCT05111002|530703332|FG001|Primary Outcome|Negative Confirmatory Aptima MG Test|0|||
147147476|NCT05111002|530703331|FG000|Secondary Outcome|Lost to Follow-up|1|||
147147477|NCT05111002|530703332|FG001|Secondary Outcome|Lost to Follow-up|0|||
147147478|NCT04776720|530703337|FG000|Overall Study|COVID Related|4|||
147147479|NCT04776720|530703338|FG001|Overall Study|COVID Related|2|||
147147480|NCT04776720|530703337|FG000|Overall Study|Adverse Event|2|||
147147481|NCT04776720|530703338|FG001|Overall Study|Adverse Event|0|||
147147482|NCT04776720|530703337|FG000|Overall Study|Serious Adverse Event|0|||
147147483|NCT04776720|530703338|FG001|Overall Study|Serious Adverse Event|1|||
147147484|NCT04776720|530703337|FG000|Overall Study|Too Busy|3|||
147147485|NCT04776720|530703338|FG001|Overall Study|Too Busy|1|||
147147486|NCT04776720|530703337|FG000|Overall Study|Lost to Follow-up|1|||
147147487|NCT04776720|530703338|FG001|Overall Study|Lost to Follow-up|2|||
147147488|NCT04776720|530703337|FG000|Overall Study|Family|2|||
147147489|NCT04776720|530703338|FG001|Overall Study|Family|2|||
147147490|NCT04776720|530703337|FG000|Overall Study|No remote technology access|0|||
147147491|NCT04776720|530703338|FG001|Overall Study|No remote technology access|1|||
147147492|NCT04776720|530703337|FG000|Overall Study|Withdrawal by Subject|1|||
147147493|NCT04776720|530703338|FG001|Overall Study|Withdrawal by Subject|0|||
147147494|NCT04776720|530703337|FG000|Overall Study|Cannot tolerate intervention|1|||
147147495|NCT04776720|530703338|FG001|Overall Study|Cannot tolerate intervention|0|||
147147496|NCT04776720|530703337|FG000|Overall Study|Incomplete outcome data|6|||
147147497|NCT04776720|530703338|FG001|Overall Study|Incomplete outcome data|1|||
147147498|NCT02712996|530703343|FG000|Second Intervention (Study Days 43-84)|Adverse Event|0|||
147147499|NCT02712996|530703344|FG001|Second Intervention (Study Days 43-84)|Adverse Event|1|||
147147500|NCT01451749|530703350|FG000|Overall Study|Protocol Violation|14|||
147147501|NCT01451749|530703351|FG001|Overall Study|Protocol Violation|7|||
147147502|NCT01451749|530703350|FG000|Overall Study|Lost to Follow-up|15|||
147147503|NCT01451749|530703351|FG001|Overall Study|Lost to Follow-up|5|||
147147504|NCT01451749|530703350|FG000|Overall Study|Meet the exclusion criteria,and|1|||
147147505|NCT01451749|530703351|FG001|Overall Study|Meet the exclusion criteria,and|1|||
147147506|NCT01451749|530703350|FG000|Overall Study|Adverse Event|2|||
147147507|NCT01451749|530703351|FG001|Overall Study|Adverse Event|0|||
147147508|NCT01451749|530703350|FG000|Overall Study|Withdrawal by Subject|0|||
147147509|NCT01451749|530703351|FG001|Overall Study|Withdrawal by Subject|1|||
147147510|NCT00972517|530703352|FG000|Overall Study|Adverse Event|0|||
147147511|NCT00972517|530703353|FG001|Overall Study|Adverse Event|0|||
147147512|NCT00972517|530703354|FG002|Overall Study|Adverse Event|0|||
147147513|NCT00972517|530703355|FG003|Overall Study|Adverse Event|1|||
147147514|NCT00972517|530703356|FG004|Overall Study|Adverse Event|0|||
147147515|NCT00972517|530703357|FG005|Overall Study|Adverse Event|0|||
147147516|NCT00972517|530703352|FG000|Overall Study|Withdrawal by Subject|0|||
147147517|NCT00972517|530703353|FG001|Overall Study|Withdrawal by Subject|1|||
147147518|NCT00972517|530703354|FG002|Overall Study|Withdrawal by Subject|0|||
147147519|NCT00972517|530703355|FG003|Overall Study|Withdrawal by Subject|2|||
147147520|NCT00972517|530703356|FG004|Overall Study|Withdrawal by Subject|1|||
147147521|NCT00972517|530703357|FG005|Overall Study|Withdrawal by Subject|0|||
147147522|NCT02311881|530703358|FG000|Overall Study|Did not meet the study criteria|2|||
147147523|NCT02311881|530703359|FG001|Overall Study|Did not meet the study criteria|2|||
147147524|NCT02311881|530703360|FG002|Overall Study|Did not meet the study criteria|0|||
147147525|NCT02311881|530703358|FG000|Overall Study|Adverse Event|7|||
147147526|NCT02311881|530703359|FG001|Overall Study|Adverse Event|15|||
147147527|NCT02311881|530703360|FG002|Overall Study|Adverse Event|8|||
147147528|NCT02311881|530703358|FG000|Overall Study|Lost to Follow-up|3|||
147147529|NCT02311881|530703359|FG001|Overall Study|Lost to Follow-up|3|||
147147530|NCT02311881|530703360|FG002|Overall Study|Lost to Follow-up|2|||
147147531|NCT02311881|530703358|FG000|Overall Study|Protocol Violation|1|||
147147532|NCT02311881|530703359|FG001|Overall Study|Protocol Violation|2|||
147239162|NCT01673867|531047470|FG000|Treatment|Disease Progression|208|||
147239163|NCT01673867|531047471|FG001|Treatment|Disease Progression|178|||
147239164|NCT01673867|531047470|FG000|Treatment|Study Drug Toxicity|23|||
147147533|NCT02311881|530703360|FG002|Overall Study|Protocol Violation|3|||
147147534|NCT02311881|530703358|FG000|Overall Study|Withdrawal of consent|14|||
147239165|NCT01673867|531047471|FG001|Treatment|Study Drug Toxicity|43|||
147147535|NCT02311881|530703359|FG001|Overall Study|Withdrawal of consent|16|||
147445911|NCT01445951|531797472|FG000|Overall Study|Sponsor decision - subject travel|0|||
147445912|NCT01445951|531797473|FG001|Overall Study|Sponsor decision - subject travel|1|||
147147536|NCT02311881|530703360|FG002|Overall Study|Withdrawal of consent|17|||
147147537|NCT02311881|530703358|FG000|Overall Study|Other|0|||
147147538|NCT02311881|530703359|FG001|Overall Study|Other|0|||
147147539|NCT02311881|530703360|FG002|Overall Study|Other|1|||
147147540|NCT02311881|530703358|FG000|Overall Study|Lack of Efficacy|1|||
147147541|NCT02311881|530703359|FG001|Overall Study|Lack of Efficacy|2|||
147147542|NCT02311881|530703360|FG002|Overall Study|Lack of Efficacy|0|||
147147543|NCT02311881|530703358|FG000|Overall Study|Subject has border line pregnancy test|1|||
147147544|NCT02311881|530703359|FG001|Overall Study|Subject has border line pregnancy test|0|||
147147545|NCT02311881|530703360|FG002|Overall Study|Subject has border line pregnancy test|0|||
147147546|NCT02311881|530703358|FG000|Overall Study|Withdrawal by Subject|3|||
147147547|NCT02311881|530703359|FG001|Overall Study|Withdrawal by Subject|1|||
147147548|NCT02311881|530703360|FG002|Overall Study|Withdrawal by Subject|4|||
147147549|NCT02311881|530703358|FG000|Overall Study|Sponsor Decision|1|||
147147550|NCT02311881|530703359|FG001|Overall Study|Sponsor Decision|1|||
147147551|NCT02311881|530703360|FG002|Overall Study|Sponsor Decision|1|||
147147552|NCT02311881|530703358|FG000|Overall Study|Protocol Deviation|1|||
147147553|NCT02311881|530703359|FG001|Overall Study|Protocol Deviation|0|||
147147554|NCT02311881|530703360|FG002|Overall Study|Protocol Deviation|0|||
147147555|NCT02311881|530703358|FG000|Overall Study|Non-Compliance|1|||
147147556|NCT02311881|530703359|FG001|Overall Study|Non-Compliance|0|||
147147557|NCT02311881|530703360|FG002|Overall Study|Non-Compliance|2|||
147147558|NCT02311881|530703358|FG000|Overall Study|Physician Decision|0|||
147147559|NCT02311881|530703359|FG001|Overall Study|Physician Decision|0|||
147147560|NCT02311881|530703360|FG002|Overall Study|Physician Decision|1|||
147147561|NCT02311881|530703358|FG000|Overall Study|Medical Monitor Discretion|0|||
147147562|NCT02311881|530703359|FG001|Overall Study|Medical Monitor Discretion|0|||
147147563|NCT02311881|530703360|FG002|Overall Study|Medical Monitor Discretion|1|||
147147564|NCT02311881|530703358|FG000|Overall Study|Participant taking another medication|0|||
147147565|NCT02311881|530703359|FG001|Overall Study|Participant taking another medication|0|||
147147566|NCT02311881|530703360|FG002|Overall Study|Participant taking another medication|1|||
147147567|NCT02311881|530703358|FG000|Overall Study|Serious Adverse Event|0|||
147147568|NCT02311881|530703359|FG001|Overall Study|Serious Adverse Event|1|||
147147569|NCT02311881|530703360|FG002|Overall Study|Serious Adverse Event|0|||
147147570|NCT00790582|530703365|FG000|Overall Study|Death|14|||
147147571|NCT00790582|530703366|FG001|Overall Study|Death|32|||
147147572|NCT00790582|530703365|FG000|Overall Study|Physician Decision|7|||
147147573|NCT00790582|530703366|FG001|Overall Study|Physician Decision|1|||
147147574|NCT00790582|530703365|FG000|Overall Study|Lost to Follow-up|3|||
147147575|NCT00790582|530703366|FG001|Overall Study|Lost to Follow-up|3|||
147147576|NCT00790582|530703365|FG000|Overall Study|Withdrawal by Subject|7|||
147147577|NCT00790582|530703366|FG001|Overall Study|Withdrawal by Subject|51|||
147147578|NCT02949024|530703367|FG000|Overall Study|Withdrawal by Subject|0|||
147147579|NCT02949024|530703368|FG001|Overall Study|Withdrawal by Subject|1|||
147147580|NCT01027650|530703369|FG000|Overall Study|Personal Reasons|0|||
147147581|NCT01027650|530703370|FG001|Overall Study|Personal Reasons|0|||
147147582|NCT01027650|530703371|FG002|Overall Study|Personal Reasons|0|||
147147583|NCT01027650|530703372|FG003|Overall Study|Personal Reasons|0|||
147147584|NCT01027650|530703373|FG004|Overall Study|Personal Reasons|2|||
147147585|NCT01027650|530703374|FG005|Overall Study|Personal Reasons|1|||
147147586|NCT01027650|530703375|FG006|Overall Study|Personal Reasons|0|||
147147587|NCT01027650|530703376|FG007|Overall Study|Personal Reasons|0|||
147147588|NCT01027650|530703369|FG000|Overall Study|Lost to Follow-up|0|||
147147589|NCT01027650|530703370|FG001|Overall Study|Lost to Follow-up|0|||
147147590|NCT01027650|530703371|FG002|Overall Study|Lost to Follow-up|0|||
147147591|NCT01027650|530703372|FG003|Overall Study|Lost to Follow-up|0|||
147147592|NCT01027650|530703373|FG004|Overall Study|Lost to Follow-up|0|||
147239166|NCT01673867|531047470|FG000|Treatment|Death|2|||
147239167|NCT01673867|531047471|FG001|Treatment|Death|3|||
147239168|NCT01673867|531047470|FG000|Treatment|Adverse event unrelated to study drug|23|||
147239169|NCT01673867|531047471|FG001|Treatment|Adverse event unrelated to study drug|10|||
147239170|NCT01673867|531047470|FG000|Treatment|Participant request to discontinue study treatment|7|||
147239171|NCT01673867|531047471|FG001|Treatment|Participant request to discontinue study treatment|17|||
147239172|NCT01673867|531047470|FG000|Treatment|Withdrawal by participant|5|||
147239173|NCT01673867|531047471|FG001|Treatment|Withdrawal by participant|5|||
147239174|NCT01673867|531047470|FG000|Treatment|Maximum clinical benefit|1|||
147239175|NCT01673867|531047471|FG001|Treatment|Maximum clinical benefit|10|||
147239176|NCT01673867|531047470|FG000|Treatment|Participant no longer meets study criteria|2|||
147239177|NCT01673867|531047471|FG001|Treatment|Participant no longer meets study criteria|0|||
147239178|NCT01673867|531047470|FG000|Treatment|Administrative reason by sponsor|3|||
147239179|NCT01673867|531047471|FG001|Treatment|Administrative reason by sponsor|0|||
147239180|NCT01673867|531047470|FG000|Treatment|Other reason|11|||
147239181|NCT01673867|531047471|FG001|Treatment|Other reason|2|||
147320303|NCT04955626|531338446|FG026|Blinded Period|Protocol Violation|5|||
147320304|NCT04955626|531338447|FG027|Blinded Period|Protocol Violation|3|||
147320305|NCT04955626|531338448|FG028|Blinded Period|Protocol Violation|4|||
147320306|NCT04955626|531338449|FG029|Blinded Period|Protocol Violation|3|||
147320307|NCT04955626|531338450|FG030|Blinded Period|Protocol Violation|0|||
147320308|NCT04955626|531338451|FG031|Blinded Period|Protocol Violation|0|||
147320309|NCT04955626|531338452|FG032|Blinded Period|Protocol Violation|0|||
147320310|NCT04955626|531338453|FG033|Blinded Period|Protocol Violation|0|||
147320311|NCT04955626|531338454|FG034|Blinded Period|Protocol Violation|0|||
147320312|NCT04955626|531338455|FG035|Blinded Period|Protocol Violation|0|||
147320313|NCT04955626|531338420|FG000|Blinded Period|Death|0|||
147320314|NCT04955626|531338421|FG001|Blinded Period|Death|2|||
147320315|NCT04955626|531338422|FG002|Blinded Period|Death|0|||
147320316|NCT04955626|531338423|FG003|Blinded Period|Death|0|||
147320317|NCT04955626|531338424|FG004|Blinded Period|Death|0|||
147320318|NCT04955626|531338425|FG005|Blinded Period|Death|0|||
147320319|NCT04955626|531338426|FG006|Blinded Period|Death|0|||
147320320|NCT04955626|531338427|FG007|Blinded Period|Death|2|||
147320321|NCT04955626|531338428|FG008|Blinded Period|Death|1|||
147575581|NCT00112437|532263537|FG019|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
147575582|NCT00112437|532263538|FG020|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
147575583|NCT00112437|532263539|FG021|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
147575584|NCT00112437|532263540|FG022|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
147575585|NCT00112437|532263541|FG023|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
147575586|NCT00112437|532263542|FG024|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
147147593|NCT01027650|530703374|FG005|Overall Study|Lost to Follow-up|0|||
147320322|NCT04955626|531338429|FG009|Blinded Period|Death|1|||
147320323|NCT04955626|531338430|FG010|Blinded Period|Death|0|||
147320324|NCT04955626|531338431|FG011|Blinded Period|Death|2|||
147320325|NCT04955626|531338432|FG012|Blinded Period|Death|0|||
147320326|NCT04955626|531338433|FG013|Blinded Period|Death|0|||
147320327|NCT04955626|531338434|FG014|Blinded Period|Death|0|||
147320328|NCT04955626|531338435|FG015|Blinded Period|Death|0|||
147320329|NCT04955626|531338436|FG016|Blinded Period|Death|0|||
147320330|NCT04955626|531338437|FG017|Blinded Period|Death|0|||
147320331|NCT04955626|531338438|FG018|Blinded Period|Death|0|||
147320332|NCT04955626|531338439|FG019|Blinded Period|Death|0|||
147320333|NCT04955626|531338440|FG020|Blinded Period|Death|0|||
147320334|NCT04955626|531338441|FG021|Blinded Period|Death|0|||
147320335|NCT04955626|531338442|FG022|Blinded Period|Death|0|||
147320336|NCT04955626|531338443|FG023|Blinded Period|Death|1|||
147320337|NCT04955626|531338444|FG024|Blinded Period|Death|0|||
147320338|NCT04955626|531338445|FG025|Blinded Period|Death|0|||
147320339|NCT04955626|531338446|FG026|Blinded Period|Death|1|||
147320340|NCT04955626|531338447|FG027|Blinded Period|Death|1|||
147320341|NCT04955626|531338448|FG028|Blinded Period|Death|0|||
147147594|NCT01027650|530703375|FG006|Overall Study|Lost to Follow-up|1|||
147147595|NCT01027650|530703376|FG007|Overall Study|Lost to Follow-up|0|||
147147596|NCT01027650|530703369|FG000|Overall Study|Lack of Efficacy|0|||
147147597|NCT01027650|530703370|FG001|Overall Study|Lack of Efficacy|0|||
147147598|NCT01027650|530703371|FG002|Overall Study|Lack of Efficacy|0|||
147147599|NCT01027650|530703372|FG003|Overall Study|Lack of Efficacy|0|||
147147600|NCT01027650|530703373|FG004|Overall Study|Lack of Efficacy|0|||
147147601|NCT01027650|530703374|FG005|Overall Study|Lack of Efficacy|1|||
147147602|NCT01027650|530703375|FG006|Overall Study|Lack of Efficacy|0|||
147147603|NCT01027650|530703376|FG007|Overall Study|Lack of Efficacy|0|||
147147604|NCT00912782|530703380|FG000|Overall Study|Death|2|||
147320342|NCT04955626|531338449|FG029|Blinded Period|Death|1|||
147320343|NCT04955626|531338450|FG030|Blinded Period|Death|0|||
147320344|NCT04955626|531338451|FG031|Blinded Period|Death|0|||
147575587|NCT00112437|532263543|FG025|Year 2 (12-Month Extension)|Lack of Efficacy|0|||
147320345|NCT04955626|531338452|FG032|Blinded Period|Death|0|||
147320346|NCT04955626|531338453|FG033|Blinded Period|Death|0|||
147320347|NCT04955626|531338454|FG034|Blinded Period|Death|0|||
147320348|NCT04955626|531338455|FG035|Blinded Period|Death|0|||
147320349|NCT04955626|531338420|FG000|Blinded Period|Adverse Event|0|||
147320350|NCT04955626|531338421|FG001|Blinded Period|Adverse Event|1|||
147320351|NCT04955626|531338422|FG002|Blinded Period|Adverse Event|1|||
147320352|NCT04955626|531338423|FG003|Blinded Period|Adverse Event|1|||
147320353|NCT04955626|531338424|FG004|Blinded Period|Adverse Event|0|||
147320354|NCT04955626|531338425|FG005|Blinded Period|Adverse Event|0|||
147320355|NCT04955626|531338426|FG006|Blinded Period|Adverse Event|0|||
147320356|NCT04955626|531338427|FG007|Blinded Period|Adverse Event|0|||
147320357|NCT04955626|531338428|FG008|Blinded Period|Adverse Event|0|||
147320358|NCT04955626|531338429|FG009|Blinded Period|Adverse Event|1|||
147147605|NCT00912782|530703381|FG001|Overall Study|Death|1|||
147147606|NCT00912782|530703380|FG000|Overall Study|Lost to Follow-up|0|||
147147607|NCT00912782|530703381|FG001|Overall Study|Lost to Follow-up|1|||
147320359|NCT04955626|531338430|FG010|Blinded Period|Adverse Event|1|||
147320360|NCT04955626|531338431|FG011|Blinded Period|Adverse Event|0|||
147320361|NCT04955626|531338432|FG012|Blinded Period|Adverse Event|0|||
147320362|NCT04955626|531338433|FG013|Blinded Period|Adverse Event|0|||
147320363|NCT04955626|531338434|FG014|Blinded Period|Adverse Event|0|||
147320364|NCT04955626|531338435|FG015|Blinded Period|Adverse Event|0|||
147147608|NCT00912782|530703380|FG000|Overall Study|Did not receive vascular access type|1|||
147147609|NCT00912782|530703381|FG001|Overall Study|Did not receive vascular access type|2|||
147147610|NCT00912782|530703380|FG000|Overall Study|Relocated before study completion|0|||
147147611|NCT00912782|530703381|FG001|Overall Study|Relocated before study completion|1|||
147147612|NCT00948857|530705286|FG000|Overall Study|Lost to Follow-up|1|||
147147613|NCT00948857|530705287|FG001|Overall Study|Lost to Follow-up|0|||
147147614|NCT03430843|530705288|FG000|Overall Study|Death|233|||
147147615|NCT03430843|530705289|FG001|Overall Study|Death|233|||
147147616|NCT03430843|530705288|FG000|Overall Study|Sponsor Decision|17|||
147147617|NCT03430843|530705289|FG001|Overall Study|Sponsor Decision|6|||
147147618|NCT03430843|530705288|FG000|Overall Study|Withdrawal by Subject|5|||
147147619|NCT03430843|530705289|FG001|Overall Study|Withdrawal by Subject|14|||
147147620|NCT03430843|530705288|FG000|Overall Study|Lost to Follow-up|1|||
147147621|NCT03430843|530705289|FG001|Overall Study|Lost to Follow-up|3|||
147147622|NCT05396014|530705294|FG000|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|18|||
147147623|NCT05396014|530705295|FG001|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
147147624|NCT05396014|530705296|FG002|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
147147625|NCT05396014|530705297|FG003|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
147147626|NCT05396014|530705298|FG004|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
147147627|NCT05396014|530705299|FG005|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
147147628|NCT05396014|530705300|FG006|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
147147629|NCT05396014|530705301|FG007|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
147147630|NCT05396014|530705302|FG008|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
147320365|NCT04955626|531338436|FG016|Blinded Period|Adverse Event|0|||
147320366|NCT04955626|531338437|FG017|Blinded Period|Adverse Event|0|||
147320367|NCT04955626|531338438|FG018|Blinded Period|Adverse Event|1|||
147320368|NCT04955626|531338439|FG019|Blinded Period|Adverse Event|0|||
147320369|NCT04955626|531338440|FG020|Blinded Period|Adverse Event|0|||
147320370|NCT04955626|531338441|FG021|Blinded Period|Adverse Event|0|||
147320371|NCT04955626|531338442|FG022|Blinded Period|Adverse Event|0|||
147320372|NCT04955626|531338443|FG023|Blinded Period|Adverse Event|0|||
147320373|NCT04955626|531338444|FG024|Blinded Period|Adverse Event|0|||
147320374|NCT04955626|531338445|FG025|Blinded Period|Adverse Event|0|||
147320375|NCT04955626|531338446|FG026|Blinded Period|Adverse Event|1|||
147320376|NCT04955626|531338447|FG027|Blinded Period|Adverse Event|0|||
147320377|NCT04955626|531338448|FG028|Blinded Period|Adverse Event|0|||
147575588|NCT00112437|532263518|FG000|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
147575589|NCT00112437|532263519|FG001|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
147575590|NCT00112437|532263520|FG002|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
147575591|NCT00112437|532263521|FG003|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
147575592|NCT00112437|532263522|FG004|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
147575593|NCT00112437|532263523|FG005|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
147575594|NCT00112437|532263524|FG006|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
147575595|NCT00112437|532263525|FG007|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
147575596|NCT00112437|532263526|FG008|Year 2 (12-Month Extension)|Lost to Follow-up|1|||
147575597|NCT00112437|532263527|FG009|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
147575598|NCT00112437|532263528|FG010|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
147575599|NCT00112437|532263529|FG011|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
147575600|NCT00112437|532263530|FG012|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
147575601|NCT00112437|532263531|FG013|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
147575602|NCT00112437|532263532|FG014|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
147575603|NCT00112437|532263533|FG015|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
147575604|NCT00112437|532263534|FG016|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
147575605|NCT00112437|532263535|FG017|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
147575606|NCT00112437|532263536|FG018|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
147575607|NCT00112437|532263537|FG019|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
147320378|NCT04955626|531338449|FG029|Blinded Period|Adverse Event|0|||
147320379|NCT04955626|531338450|FG030|Blinded Period|Adverse Event|0|||
147575608|NCT00112437|532263538|FG020|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
147575609|NCT00112437|532263539|FG021|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
147575610|NCT00112437|532263540|FG022|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
147147631|NCT05396014|530705303|FG009|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
147147632|NCT05396014|530705304|FG010|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
147575611|NCT00112437|532263541|FG023|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
147575612|NCT00112437|532263542|FG024|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
147575613|NCT00112437|532263543|FG025|Year 2 (12-Month Extension)|Lost to Follow-up|0|||
147147633|NCT05396014|530705305|FG011|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
147147634|NCT05396014|530705306|FG012|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
147147635|NCT05396014|530705307|FG013|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|13|||
147320380|NCT04955626|531338451|FG031|Blinded Period|Adverse Event|0|||
147320381|NCT04955626|531338452|FG032|Blinded Period|Adverse Event|0|||
147320382|NCT04955626|531338453|FG033|Blinded Period|Adverse Event|0|||
147320383|NCT04955626|531338454|FG034|Blinded Period|Adverse Event|0|||
147320384|NCT04955626|531338455|FG035|Blinded Period|Adverse Event|0|||
147575614|NCT00112437|532263518|FG000|Year 2 (12-Month Extension)|Protocol Violation|0|||
147575615|NCT00112437|532263519|FG001|Year 2 (12-Month Extension)|Protocol Violation|0|||
147575616|NCT00112437|532263520|FG002|Year 2 (12-Month Extension)|Protocol Violation|0|||
147575617|NCT00112437|532263521|FG003|Year 2 (12-Month Extension)|Protocol Violation|0|||
147575618|NCT00112437|532263522|FG004|Year 2 (12-Month Extension)|Protocol Violation|0|||
147575619|NCT00112437|532263523|FG005|Year 2 (12-Month Extension)|Protocol Violation|0|||
147575620|NCT00112437|532263524|FG006|Year 2 (12-Month Extension)|Protocol Violation|0|||
147147636|NCT05396014|530705308|FG014|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
147320385|NCT04955626|531338420|FG000|Blinded Period|No longer meets eligibility criteria|1|||
147320386|NCT04955626|531338421|FG001|Blinded Period|No longer meets eligibility criteria|2|||
147320387|NCT04955626|531338422|FG002|Blinded Period|No longer meets eligibility criteria|0|||
147320388|NCT04955626|531338423|FG003|Blinded Period|No longer meets eligibility criteria|1|||
147320389|NCT04955626|531338424|FG004|Blinded Period|No longer meets eligibility criteria|0|||
147320390|NCT04955626|531338425|FG005|Blinded Period|No longer meets eligibility criteria|0|||
147320391|NCT04955626|531338426|FG006|Blinded Period|No longer meets eligibility criteria|0|||
147320392|NCT04955626|531338427|FG007|Blinded Period|No longer meets eligibility criteria|0|||
147320393|NCT04955626|531338428|FG008|Blinded Period|No longer meets eligibility criteria|1|||
147320394|NCT04955626|531338429|FG009|Blinded Period|No longer meets eligibility criteria|0|||
147320395|NCT04955626|531338430|FG010|Blinded Period|No longer meets eligibility criteria|1|||
147320396|NCT04955626|531338431|FG011|Blinded Period|No longer meets eligibility criteria|1|||
147320397|NCT04955626|531338432|FG012|Blinded Period|No longer meets eligibility criteria|0|||
147320398|NCT04955626|531338433|FG013|Blinded Period|No longer meets eligibility criteria|0|||
147320399|NCT04955626|531338434|FG014|Blinded Period|No longer meets eligibility criteria|0|||
147320400|NCT04955626|531338435|FG015|Blinded Period|No longer meets eligibility criteria|3|||
147320401|NCT04955626|531338436|FG016|Blinded Period|No longer meets eligibility criteria|0|||
147320402|NCT04955626|531338437|FG017|Blinded Period|No longer meets eligibility criteria|2|||
147320403|NCT04955626|531338438|FG018|Blinded Period|No longer meets eligibility criteria|0|||
147320404|NCT04955626|531338439|FG019|Blinded Period|No longer meets eligibility criteria|0|||
147320405|NCT04955626|531338440|FG020|Blinded Period|No longer meets eligibility criteria|0|||
147320406|NCT04955626|531338441|FG021|Blinded Period|No longer meets eligibility criteria|0|||
147320407|NCT04955626|531338442|FG022|Blinded Period|No longer meets eligibility criteria|0|||
147320408|NCT04955626|531338443|FG023|Blinded Period|No longer meets eligibility criteria|0|||
147320409|NCT04955626|531338444|FG024|Blinded Period|No longer meets eligibility criteria|1|||
147320410|NCT04955626|531338445|FG025|Blinded Period|No longer meets eligibility criteria|0|||
147320411|NCT04955626|531338446|FG026|Blinded Period|No longer meets eligibility criteria|0|||
147320412|NCT04955626|531338447|FG027|Blinded Period|No longer meets eligibility criteria|1|||
147320413|NCT04955626|531338448|FG028|Blinded Period|No longer meets eligibility criteria|0|||
147320414|NCT04955626|531338449|FG029|Blinded Period|No longer meets eligibility criteria|0|||
147320415|NCT04955626|531338450|FG030|Blinded Period|No longer meets eligibility criteria|0|||
147320416|NCT04955626|531338451|FG031|Blinded Period|No longer meets eligibility criteria|0|||
147320417|NCT04955626|531338452|FG032|Blinded Period|No longer meets eligibility criteria|0|||
147320418|NCT04955626|531338453|FG033|Blinded Period|No longer meets eligibility criteria|0|||
147320419|NCT04955626|531338454|FG034|Blinded Period|No longer meets eligibility criteria|0|||
147320420|NCT04955626|531338455|FG035|Blinded Period|No longer meets eligibility criteria|0|||
147320421|NCT04955626|531338420|FG000|Blinded Period|Other|54|||
147320422|NCT04955626|531338421|FG001|Blinded Period|Other|3|||
147320423|NCT04955626|531338422|FG002|Blinded Period|Other|4|||
147320424|NCT04955626|531338423|FG003|Blinded Period|Other|2|||
147320425|NCT04955626|531338424|FG004|Blinded Period|Other|0|||
147320426|NCT04955626|531338425|FG005|Blinded Period|Other|0|||
147320427|NCT04955626|531338426|FG006|Blinded Period|Other|2|||
147320428|NCT04955626|531338427|FG007|Blinded Period|Other|2|||
147320429|NCT04955626|531338428|FG008|Blinded Period|Other|1|||
147320430|NCT04955626|531338429|FG009|Blinded Period|Other|0|||
147320431|NCT04955626|531338430|FG010|Blinded Period|Other|1|||
147320432|NCT04955626|531338431|FG011|Blinded Period|Other|1|||
147147637|NCT05396014|530705309|FG015|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
147147638|NCT05396014|530705310|FG016|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
147147639|NCT05396014|530705311|FG017|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
147147640|NCT05396014|530705312|FG018|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
147147641|NCT05396014|530705313|FG019|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
147575621|NCT00112437|532263525|FG007|Year 2 (12-Month Extension)|Protocol Violation|0|||
147575622|NCT00112437|532263526|FG008|Year 2 (12-Month Extension)|Protocol Violation|1|||
147147642|NCT05396014|530705314|FG020|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
147147643|NCT05396014|530705315|FG021|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
147320433|NCT04955626|531338432|FG012|Blinded Period|Other|0|||
147320434|NCT04955626|531338433|FG013|Blinded Period|Other|0|||
147320435|NCT04955626|531338434|FG014|Blinded Period|Other|0|||
147320436|NCT04955626|531338435|FG015|Blinded Period|Other|0|||
147320437|NCT04955626|531338436|FG016|Blinded Period|Other|0|||
147320438|NCT04955626|531338437|FG017|Blinded Period|Other|1|||
147320439|NCT04955626|531338438|FG018|Blinded Period|Other|0|||
147320440|NCT04955626|531338439|FG019|Blinded Period|Other|0|||
147320441|NCT04955626|531338440|FG020|Blinded Period|Other|0|||
147320442|NCT04955626|531338441|FG021|Blinded Period|Other|0|||
147320443|NCT04955626|531338442|FG022|Blinded Period|Other|0|||
147320444|NCT04955626|531338443|FG023|Blinded Period|Other|0|||
147320445|NCT04955626|531338444|FG024|Blinded Period|Other|0|||
147320446|NCT04955626|531338445|FG025|Blinded Period|Other|0|||
147320447|NCT04955626|531338446|FG026|Blinded Period|Other|2|||
147320448|NCT04955626|531338447|FG027|Blinded Period|Other|0|||
147575623|NCT00112437|532263527|FG009|Year 2 (12-Month Extension)|Protocol Violation|0|||
147575624|NCT00112437|532263528|FG010|Year 2 (12-Month Extension)|Protocol Violation|0|||
147575625|NCT00112437|532263529|FG011|Year 2 (12-Month Extension)|Protocol Violation|0|||
147575626|NCT00112437|532263530|FG012|Year 2 (12-Month Extension)|Protocol Violation|0|||
147575627|NCT00112437|532263531|FG013|Year 2 (12-Month Extension)|Protocol Violation|0|||
147575628|NCT00112437|532263532|FG014|Year 2 (12-Month Extension)|Protocol Violation|0|||
147575629|NCT00112437|532263533|FG015|Year 2 (12-Month Extension)|Protocol Violation|0|||
147575630|NCT00112437|532263534|FG016|Year 2 (12-Month Extension)|Protocol Violation|0|||
147320449|NCT04955626|531338448|FG028|Blinded Period|Other|0|||
147320450|NCT04955626|531338449|FG029|Blinded Period|Other|0|||
147320451|NCT04955626|531338450|FG030|Blinded Period|Other|0|||
147320452|NCT04955626|531338451|FG031|Blinded Period|Other|0|||
147575631|NCT00112437|532263535|FG017|Year 2 (12-Month Extension)|Protocol Violation|0|||
147575632|NCT00112437|532263536|FG018|Year 2 (12-Month Extension)|Protocol Violation|0|||
147575633|NCT00112437|532263537|FG019|Year 2 (12-Month Extension)|Protocol Violation|0|||
147575634|NCT00112437|532263538|FG020|Year 2 (12-Month Extension)|Protocol Violation|0|||
147147644|NCT05396014|530705316|FG022|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
147320453|NCT04955626|531338452|FG032|Blinded Period|Other|0|||
147320454|NCT04955626|531338453|FG033|Blinded Period|Other|0|||
147320455|NCT04955626|531338454|FG034|Blinded Period|Other|0|||
147320456|NCT04955626|531338455|FG035|Blinded Period|Other|0|||
147320457|NCT04955626|531338420|FG000|Blinded Period|Physician Decision|1|||
147320458|NCT04955626|531338421|FG001|Blinded Period|Physician Decision|1|||
147445913|NCT01445951|531797474|FG002|Overall Study|Sponsor decision - subject travel|0|||
147445914|NCT01445951|531797472|FG000|Overall Study|Cough|0|||
147147645|NCT05396014|530705317|FG023|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
147147646|NCT05396014|530705318|FG024|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
147445915|NCT01445951|531797473|FG001|Overall Study|Cough|1|||
147445916|NCT01445951|531797474|FG002|Overall Study|Cough|0|||
147147647|NCT05396014|530705319|FG025|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
147147648|NCT05396014|530705320|FG026|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|14|||
147147649|NCT05396014|530705321|FG027|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
147147650|NCT05396014|530705322|FG028|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
147147651|NCT05396014|530705323|FG029|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
147147652|NCT05396014|530705324|FG030|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
147147653|NCT05396014|530705325|FG031|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
147147654|NCT05396014|530705326|FG032|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
147147655|NCT05396014|530705327|FG033|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
147147656|NCT05396014|530705328|FG034|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
147147657|NCT05396014|530705329|FG035|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
147147658|NCT05396014|530705330|FG036|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
147147659|NCT05396014|530705331|FG037|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
147147660|NCT05396014|530705332|FG038|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
147147661|NCT05396014|530705333|FG039|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|14|||
147147662|NCT05396014|530705334|FG040|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
147147663|NCT05396014|530705335|FG041|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
147147664|NCT05396014|530705336|FG042|Stage 1 Intervention (Weeks 0-12)|Withdrawal by Subject|0|||
147147665|NCT05396014|530705294|FG000|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|15|||
147147666|NCT05396014|530705295|FG001|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
147147667|NCT05396014|530705296|FG002|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
147320459|NCT04955626|531338422|FG002|Blinded Period|Physician Decision|0|||
147320460|NCT04955626|531338423|FG003|Blinded Period|Physician Decision|3|||
147320461|NCT04955626|531338424|FG004|Blinded Period|Physician Decision|0|||
147320462|NCT04955626|531338425|FG005|Blinded Period|Physician Decision|0|||
147445917|NCT01519765|531797477|FG000|Overall Study|Adverse Event|0|||
147652806|NCT02070978|532550391|FG000|Overall Study|Protocol Violation|1|||
147320463|NCT04955626|531338426|FG006|Blinded Period|Physician Decision|1|||
147320464|NCT04955626|531338427|FG007|Blinded Period|Physician Decision|1|||
147320465|NCT04955626|531338428|FG008|Blinded Period|Physician Decision|0|||
147320466|NCT04955626|531338429|FG009|Blinded Period|Physician Decision|0|||
147320467|NCT04955626|531338430|FG010|Blinded Period|Physician Decision|0|||
147320468|NCT04955626|531338431|FG011|Blinded Period|Physician Decision|5|||
147320469|NCT04955626|531338432|FG012|Blinded Period|Physician Decision|0|||
147445918|NCT01519765|531797478|FG001|Overall Study|Adverse Event|1|||
147320470|NCT04955626|531338433|FG013|Blinded Period|Physician Decision|0|||
147320471|NCT04955626|531338434|FG014|Blinded Period|Physician Decision|0|||
147320472|NCT04955626|531338435|FG015|Blinded Period|Physician Decision|0|||
147320473|NCT04955626|531338436|FG016|Blinded Period|Physician Decision|0|||
147320474|NCT04955626|531338437|FG017|Blinded Period|Physician Decision|0|||
147320475|NCT04955626|531338438|FG018|Blinded Period|Physician Decision|0|||
147320476|NCT04955626|531338439|FG019|Blinded Period|Physician Decision|0|||
147320477|NCT04955626|531338440|FG020|Blinded Period|Physician Decision|0|||
147320478|NCT04955626|531338441|FG021|Blinded Period|Physician Decision|0|||
147320479|NCT04955626|531338442|FG022|Blinded Period|Physician Decision|0|||
147320480|NCT04955626|531338443|FG023|Blinded Period|Physician Decision|0|||
147320481|NCT04955626|531338444|FG024|Blinded Period|Physician Decision|0|||
147320482|NCT04955626|531338445|FG025|Blinded Period|Physician Decision|0|||
147320483|NCT04955626|531338446|FG026|Blinded Period|Physician Decision|0|||
147320484|NCT04955626|531338447|FG027|Blinded Period|Physician Decision|0|||
147320485|NCT04955626|531338448|FG028|Blinded Period|Physician Decision|0|||
147320486|NCT04955626|531338449|FG029|Blinded Period|Physician Decision|0|||
147320487|NCT04955626|531338450|FG030|Blinded Period|Physician Decision|0|||
147320488|NCT04955626|531338451|FG031|Blinded Period|Physician Decision|0|||
147320489|NCT04955626|531338452|FG032|Blinded Period|Physician Decision|0|||
147320490|NCT04955626|531338453|FG033|Blinded Period|Physician Decision|0|||
147320491|NCT04955626|531338454|FG034|Blinded Period|Physician Decision|0|||
147320492|NCT04955626|531338455|FG035|Blinded Period|Physician Decision|0|||
147320493|NCT04955626|531338420|FG000|Blinded Period|Withdrawal by Subject|26|||
147147668|NCT05396014|530705297|FG003|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
147147669|NCT05396014|530705298|FG004|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
147147670|NCT05396014|530705299|FG005|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
147320494|NCT04955626|531338421|FG001|Blinded Period|Withdrawal by Subject|62|||
147320495|NCT04955626|531338422|FG002|Blinded Period|Withdrawal by Subject|14|||
147320496|NCT04955626|531338423|FG003|Blinded Period|Withdrawal by Subject|16|||
147320497|NCT04955626|531338424|FG004|Blinded Period|Withdrawal by Subject|1|||
147320498|NCT04955626|531338425|FG005|Blinded Period|Withdrawal by Subject|2|||
147320499|NCT04955626|531338426|FG006|Blinded Period|Withdrawal by Subject|9|||
147147671|NCT05396014|530705300|FG006|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
147147672|NCT05396014|530705301|FG007|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
147147673|NCT05396014|530705302|FG008|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
147320500|NCT04955626|531338427|FG007|Blinded Period|Withdrawal by Subject|5|||
147320501|NCT04955626|531338428|FG008|Blinded Period|Withdrawal by Subject|3|||
147320502|NCT04955626|531338429|FG009|Blinded Period|Withdrawal by Subject|15|||
147320503|NCT04955626|531338430|FG010|Blinded Period|Withdrawal by Subject|11|||
147320504|NCT04955626|531338431|FG011|Blinded Period|Withdrawal by Subject|7|||
147320505|NCT04955626|531338432|FG012|Blinded Period|Withdrawal by Subject|2|||
147320506|NCT04955626|531338433|FG013|Blinded Period|Withdrawal by Subject|0|||
147320507|NCT04955626|531338434|FG014|Blinded Period|Withdrawal by Subject|1|||
147320508|NCT04955626|531338435|FG015|Blinded Period|Withdrawal by Subject|11|||
147320509|NCT04955626|531338436|FG016|Blinded Period|Withdrawal by Subject|2|||
147320510|NCT04955626|531338437|FG017|Blinded Period|Withdrawal by Subject|5|||
147320511|NCT04955626|531338438|FG018|Blinded Period|Withdrawal by Subject|0|||
147320512|NCT04955626|531338439|FG019|Blinded Period|Withdrawal by Subject|0|||
147320513|NCT04955626|531338440|FG020|Blinded Period|Withdrawal by Subject|1|||
147320514|NCT04955626|531338441|FG021|Blinded Period|Withdrawal by Subject|0|||
147445919|NCT01519765|531797477|FG000|Overall Study|Lack of Efficacy|2|||
147445920|NCT01519765|531797478|FG001|Overall Study|Lack of Efficacy|0|||
147147674|NCT05396014|530705303|FG009|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
147147675|NCT05396014|530705304|FG010|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
147147676|NCT05396014|530705305|FG011|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
147147677|NCT05396014|530705306|FG012|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
147147678|NCT05396014|530705307|FG013|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|8|||
147147679|NCT05396014|530705308|FG014|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
147147680|NCT05396014|530705309|FG015|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
147147681|NCT05396014|530705310|FG016|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
147147682|NCT05396014|530705311|FG017|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
147320515|NCT04955626|531338442|FG022|Blinded Period|Withdrawal by Subject|0|||
147320516|NCT04955626|531338443|FG023|Blinded Period|Withdrawal by Subject|0|||
147320517|NCT04955626|531338444|FG024|Blinded Period|Withdrawal by Subject|5|||
147320518|NCT04955626|531338445|FG025|Blinded Period|Withdrawal by Subject|1|||
147320519|NCT04955626|531338446|FG026|Blinded Period|Withdrawal by Subject|5|||
147320520|NCT04955626|531338447|FG027|Blinded Period|Withdrawal by Subject|1|||
147320521|NCT04955626|531338448|FG028|Blinded Period|Withdrawal by Subject|4|||
147320522|NCT04955626|531338449|FG029|Blinded Period|Withdrawal by Subject|2|||
147320523|NCT04955626|531338450|FG030|Blinded Period|Withdrawal by Subject|0|||
147320524|NCT04955626|531338451|FG031|Blinded Period|Withdrawal by Subject|0|||
147320525|NCT04955626|531338452|FG032|Blinded Period|Withdrawal by Subject|0|||
147320526|NCT04955626|531338453|FG033|Blinded Period|Withdrawal by Subject|0|||
147445921|NCT01519765|531797477|FG000|Overall Study|Protocol Violation|1|||
147445922|NCT01519765|531797478|FG001|Overall Study|Protocol Violation|0|||
147147683|NCT05396014|530705312|FG018|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
147147684|NCT05396014|530705313|FG019|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
147147685|NCT05396014|530705314|FG020|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
147147686|NCT05396014|530705315|FG021|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
147147687|NCT05396014|530705316|FG022|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
147147688|NCT05396014|530705317|FG023|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
147147689|NCT05396014|530705318|FG024|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
147147690|NCT05396014|530705319|FG025|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
147147691|NCT05396014|530705320|FG026|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|8|||
147147692|NCT05396014|530705321|FG027|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
147147693|NCT05396014|530705322|FG028|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
147147694|NCT05396014|530705323|FG029|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
147147695|NCT05396014|530705324|FG030|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
147147696|NCT05396014|530705325|FG031|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
147147697|NCT05396014|530705326|FG032|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
147147698|NCT05396014|530705327|FG033|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
147147699|NCT05396014|530705328|FG034|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
147147700|NCT05396014|530705329|FG035|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
147147701|NCT05396014|530705330|FG036|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
147147702|NCT05396014|530705331|FG037|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
147147703|NCT05396014|530705332|FG038|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
147147704|NCT05396014|530705333|FG039|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|14|||
147147705|NCT05396014|530705334|FG040|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
147147706|NCT05396014|530705335|FG041|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
147147707|NCT05396014|530705336|FG042|Stage 1 Intervention (Weeks 0-12)|Lost to Follow-up|0|||
147147708|NCT05396014|530705294|FG000|Stage 1 Intervention (Weeks 0-12)|Adverse Event|2|||
147147709|NCT05396014|530705295|FG001|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
147147710|NCT05396014|530705296|FG002|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
147147711|NCT05396014|530705297|FG003|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
147147712|NCT05396014|530705298|FG004|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
147147713|NCT05396014|530705299|FG005|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
147147714|NCT05396014|530705300|FG006|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
147147715|NCT05396014|530705301|FG007|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
147147716|NCT05396014|530705302|FG008|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
147147717|NCT05396014|530705303|FG009|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
147147718|NCT05396014|530705304|FG010|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
147147719|NCT05396014|530705305|FG011|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
147147720|NCT05396014|530705306|FG012|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
147147721|NCT05396014|530705307|FG013|Stage 1 Intervention (Weeks 0-12)|Adverse Event|2|||
147147722|NCT05396014|530705308|FG014|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
147147723|NCT05396014|530705309|FG015|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
147147724|NCT05396014|530705310|FG016|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
147147725|NCT05396014|530705311|FG017|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
147147726|NCT05396014|530705312|FG018|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
147147727|NCT05396014|530705313|FG019|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
147147728|NCT05396014|530705314|FG020|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
147147729|NCT05396014|530705315|FG021|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
147147730|NCT05396014|530705316|FG022|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
147147731|NCT05396014|530705317|FG023|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
147147732|NCT05396014|530705318|FG024|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
147147733|NCT05396014|530705319|FG025|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
147147734|NCT05396014|530705320|FG026|Stage 1 Intervention (Weeks 0-12)|Adverse Event|2|||
147147735|NCT05396014|530705321|FG027|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
147147736|NCT05396014|530705322|FG028|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
147147737|NCT05396014|530705323|FG029|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
147147738|NCT05396014|530705324|FG030|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
147147739|NCT05396014|530705325|FG031|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
147147740|NCT05396014|530705326|FG032|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
147147741|NCT05396014|530705327|FG033|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
147147742|NCT05396014|530705328|FG034|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
147147743|NCT05396014|530705329|FG035|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
147239182|NCT03486223|531047481|FG000|Intervention 1|received oral steroids for sinus infection; randomized but did not receive intervention|0|||
147575635|NCT00112437|532263539|FG021|Year 2 (12-Month Extension)|Protocol Violation|0|||
147147744|NCT05396014|530705330|FG036|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
147147745|NCT05396014|530705331|FG037|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
147147746|NCT05396014|530705332|FG038|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
147147747|NCT05396014|530705333|FG039|Stage 1 Intervention (Weeks 0-12)|Adverse Event|1|||
147320527|NCT04955626|531338454|FG034|Blinded Period|Withdrawal by Subject|0|||
147320528|NCT04955626|531338455|FG035|Blinded Period|Withdrawal by Subject|0|||
147320529|NCT04955626|531338420|FG000|Blinded Period|Refused further study procedures|0|||
147320530|NCT04955626|531338421|FG001|Blinded Period|Refused further study procedures|0|||
147320531|NCT04955626|531338422|FG002|Blinded Period|Refused further study procedures|0|||
147320532|NCT04955626|531338423|FG003|Blinded Period|Refused further study procedures|0|||
147320533|NCT04955626|531338424|FG004|Blinded Period|Refused further study procedures|0|||
147320534|NCT04955626|531338425|FG005|Blinded Period|Refused further study procedures|0|||
147320535|NCT04955626|531338426|FG006|Blinded Period|Refused further study procedures|1|||
147320536|NCT04955626|531338427|FG007|Blinded Period|Refused further study procedures|0|||
147320537|NCT04955626|531338428|FG008|Blinded Period|Refused further study procedures|0|||
147320538|NCT04955626|531338429|FG009|Blinded Period|Refused further study procedures|0|||
147320539|NCT04955626|531338430|FG010|Blinded Period|Refused further study procedures|0|||
147320540|NCT04955626|531338431|FG011|Blinded Period|Refused further study procedures|2|||
147320541|NCT04955626|531338432|FG012|Blinded Period|Refused further study procedures|0|||
147320542|NCT04955626|531338433|FG013|Blinded Period|Refused further study procedures|0|||
147320543|NCT04955626|531338434|FG014|Blinded Period|Refused further study procedures|0|||
147320544|NCT04955626|531338435|FG015|Blinded Period|Refused further study procedures|0|||
147320545|NCT04955626|531338436|FG016|Blinded Period|Refused further study procedures|0|||
147320546|NCT04955626|531338437|FG017|Blinded Period|Refused further study procedures|0|||
147320547|NCT04955626|531338438|FG018|Blinded Period|Refused further study procedures|0|||
147320548|NCT04955626|531338439|FG019|Blinded Period|Refused further study procedures|0|||
147320549|NCT04955626|531338440|FG020|Blinded Period|Refused further study procedures|0|||
147320550|NCT04955626|531338441|FG021|Blinded Period|Refused further study procedures|0|||
147320551|NCT04955626|531338442|FG022|Blinded Period|Refused further study procedures|0|||
147320552|NCT04955626|531338443|FG023|Blinded Period|Refused further study procedures|0|||
147320553|NCT04955626|531338444|FG024|Blinded Period|Refused further study procedures|0|||
147320554|NCT04955626|531338445|FG025|Blinded Period|Refused further study procedures|0|||
147320555|NCT04955626|531338446|FG026|Blinded Period|Refused further study procedures|0|||
147320556|NCT04955626|531338447|FG027|Blinded Period|Refused further study procedures|0|||
147320557|NCT04955626|531338448|FG028|Blinded Period|Refused further study procedures|0|||
147320558|NCT04955626|531338449|FG029|Blinded Period|Refused further study procedures|0|||
147320559|NCT04955626|531338450|FG030|Blinded Period|Refused further study procedures|0|||
147320560|NCT04955626|531338451|FG031|Blinded Period|Refused further study procedures|0|||
147320561|NCT04955626|531338452|FG032|Blinded Period|Refused further study procedures|0|||
147320562|NCT04955626|531338453|FG033|Blinded Period|Refused further study procedures|0|||
147320563|NCT04955626|531338454|FG034|Blinded Period|Refused further study procedures|0|||
147320564|NCT04955626|531338455|FG035|Blinded Period|Refused further study procedures|0|||
147320565|NCT04955626|531338420|FG000|Blinded Period|Participants entered open label period|4544|||
147320566|NCT04955626|531338421|FG001|Blinded Period|Participants entered open label period|4906|||
147320567|NCT04955626|531338422|FG002|Blinded Period|Participants entered open label period|0|||
147320568|NCT04955626|531338423|FG003|Blinded Period|Participants entered open label period|0|||
147147748|NCT05396014|530705334|FG040|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
147147749|NCT05396014|530705335|FG041|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
147147750|NCT05396014|530705336|FG042|Stage 1 Intervention (Weeks 0-12)|Adverse Event|0|||
147147751|NCT05396014|530705294|FG000|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
147445923|NCT01519765|531797477|FG000|Overall Study|Withdrawal by Subject|0|||
147445924|NCT01519765|531797478|FG001|Overall Study|Withdrawal by Subject|1|||
147445925|NCT00078325|531797479|FG000|Overall Study|Adverse Event|15|||
147445926|NCT00078325|531797480|FG001|Overall Study|Adverse Event|10|||
147445927|NCT00078325|531797481|FG002|Overall Study|Adverse Event|5|||
147147752|NCT05396014|530705295|FG001|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
147147753|NCT05396014|530705296|FG002|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
147147754|NCT05396014|530705297|FG003|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
147147755|NCT05396014|530705298|FG004|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
147147756|NCT05396014|530705299|FG005|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
147320569|NCT04955626|531338424|FG004|Blinded Period|Participants entered open label period|0|||
147320570|NCT04955626|531338425|FG005|Blinded Period|Participants entered open label period|0|||
147320571|NCT04955626|531338426|FG006|Blinded Period|Participants entered open label period|0|||
147445928|NCT00078325|531797479|FG000|Overall Study|Protocol Violation|2|||
147445929|NCT00078325|531797480|FG001|Overall Study|Protocol Violation|2|||
147445930|NCT00078325|531797481|FG002|Overall Study|Protocol Violation|0|||
147445931|NCT00078325|531797479|FG000|Overall Study|Withdrawal by Subject|1|||
147147757|NCT05396014|530705300|FG006|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
147320572|NCT04955626|531338427|FG007|Blinded Period|Participants entered open label period|0|||
147320573|NCT04955626|531338428|FG008|Blinded Period|Participants entered open label period|0|||
147320574|NCT04955626|531338429|FG009|Blinded Period|Participants entered open label period|0|||
147320575|NCT04955626|531338430|FG010|Blinded Period|Participants entered open label period|0|||
147445932|NCT00078325|531797480|FG001|Overall Study|Withdrawal by Subject|5|||
147445933|NCT00078325|531797481|FG002|Overall Study|Withdrawal by Subject|3|||
147320576|NCT04955626|531338431|FG011|Blinded Period|Participants entered open label period|0|||
147320577|NCT04955626|531338432|FG012|Blinded Period|Participants entered open label period|0|||
147320578|NCT04955626|531338433|FG013|Blinded Period|Participants entered open label period|0|||
147147758|NCT05396014|530705301|FG007|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
147147759|NCT05396014|530705302|FG008|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
147147760|NCT05396014|530705303|FG009|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
147147761|NCT05396014|530705304|FG010|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
147147762|NCT05396014|530705305|FG011|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
147147763|NCT05396014|530705306|FG012|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
147147764|NCT05396014|530705307|FG013|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
147147765|NCT05396014|530705308|FG014|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
147147766|NCT05396014|530705309|FG015|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
147147767|NCT05396014|530705310|FG016|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
147147768|NCT05396014|530705311|FG017|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
147147769|NCT05396014|530705312|FG018|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
147147770|NCT05396014|530705313|FG019|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
147147771|NCT05396014|530705314|FG020|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
147147772|NCT05396014|530705315|FG021|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
147147773|NCT05396014|530705316|FG022|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
147147774|NCT05396014|530705317|FG023|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
147147775|NCT05396014|530705318|FG024|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
147147776|NCT05396014|530705319|FG025|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
147147777|NCT05396014|530705320|FG026|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|1|||
147239183|NCT03486223|531047482|FG001|Intervention 1|received oral steroids for sinus infection; randomized but did not receive intervention|1|||
147239184|NCT01819831|531047483|FG000|Overall Study|Withdrawal by Subject|1|||
147239185|NCT01513343|531047486|FG000|Group Allocation|Dropped out after randomization, did not attend any lessons, included in analyses as intent-to-treat|8|||
147239186|NCT01513343|531047487|FG001|Group Allocation|Dropped out after randomization, did not attend any lessons, included in analyses as intent-to-treat|0|||
147239187|NCT01513343|531047486|FG000|Post Data Collection|Dropped/withdrew from study|7|||
147239188|NCT01513343|531047487|FG001|Post Data Collection|Dropped/withdrew from study|1|||
147239189|NCT01513343|531047486|FG000|Post Data Collection|Lost to Follow-up|10|||
147239190|NCT01513343|531047487|FG001|Post Data Collection|Lost to Follow-up|23|||
147239191|NCT01513343|531047486|FG000|6-month Follow-up|Lost to Follow-up|28|||
147239192|NCT01513343|531047487|FG001|6-month Follow-up|Lost to Follow-up|17|||
147239193|NCT01513343|531047486|FG000|12-month Follow-up|Lost to Follow-up|10|||
147239194|NCT01513343|531047487|FG001|12-month Follow-up|Lost to Follow-up|3|||
147239195|NCT04401423|531047503|FG000|Overall Study|Withdrawal by Subject|3|||
147239196|NCT04401423|531047504|FG001|Overall Study|Withdrawal by Subject|1|||
147239197|NCT04401423|531047503|FG000|Overall Study|Physician Decision|2|||
147239198|NCT04401423|531047504|FG001|Overall Study|Physician Decision|1|||
147239199|NCT02193867|531047505|FG000|Overall Study|Death|2|||
147239200|NCT02193867|531047505|FG000|Overall Study|Sponsor Study Termination|2|||
147239201|NCT01867424|531047506|FG000|Overall Study|Patient noncompliance|2|||
147239202|NCT01867424|531047507|FG001|Overall Study|Patient noncompliance|1|||
147239203|NCT02582983|531047508|FG000|Overall Study|Death|3|||
147239204|NCT02582983|531047508|FG000|Overall Study|Withdrawal by Subject|2|||
147239205|NCT02582983|531047508|FG000|Overall Study|Adverse Event|1|||
147239206|NCT05209360|531047509|FG000|Overall Study|Withdrawal by Subject|0|||
147239207|NCT05209360|531047510|FG001|Overall Study|Withdrawal by Subject|0|||
147239208|NCT05209360|531047511|FG002|Overall Study|Withdrawal by Subject|1|||
147239209|NCT05209360|531047512|FG003|Overall Study|Withdrawal by Subject|0|||
147239210|NCT05209360|531047513|FG004|Overall Study|Withdrawal by Subject|0|||
147239211|NCT05209360|531047514|FG005|Overall Study|Withdrawal by Subject|0|||
147239212|NCT00724932|531047519|FG000|Overall Study|Lost to Follow-up|1|||
147239213|NCT00724932|531047520|FG001|Overall Study|Lost to Follow-up|0|||
147239214|NCT00724932|531047519|FG000|Overall Study|Not treated|4|||
147320579|NCT04955626|531338434|FG014|Blinded Period|Participants entered open label period|0|||
147445934|NCT00078325|531797479|FG000|Overall Study|Lost to Follow-up|0|||
147445935|NCT00078325|531797480|FG001|Overall Study|Lost to Follow-up|1|||
147445936|NCT00078325|531797481|FG002|Overall Study|Lost to Follow-up|1|||
147147778|NCT05396014|530705321|FG027|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
147239215|NCT00724932|531047520|FG001|Overall Study|Not treated|3|||
147239216|NCT02021331|531047521|FG000|Overall Study|Adverse Event|0|||
147239217|NCT02021331|531047522|FG001|Overall Study|Adverse Event|2|||
147239218|NCT01081678|531047525|FG000|Overall Study|Ineligibility Determined|0|||
147239219|NCT01081678|531047526|FG001|Overall Study|Ineligibility Determined|0|||
147239220|NCT01081678|531047527|FG002|Overall Study|Ineligibility Determined|1|||
147239221|NCT01081678|531047528|FG003|Overall Study|Ineligibility Determined|1|||
147239222|NCT01081678|531047525|FG000|Overall Study|Noncompliance|3|||
147239223|NCT01081678|531047526|FG001|Overall Study|Noncompliance|4|||
147239224|NCT01081678|531047527|FG002|Overall Study|Noncompliance|5|||
147239225|NCT01081678|531047528|FG003|Overall Study|Noncompliance|2|||
147320580|NCT04955626|531338435|FG015|Blinded Period|Participants entered open label period|0|||
147320581|NCT04955626|531338436|FG016|Blinded Period|Participants entered open label period|0|||
147320582|NCT04955626|531338437|FG017|Blinded Period|Participants entered open label period|0|||
147320583|NCT04955626|531338438|FG018|Blinded Period|Participants entered open label period|0|||
147320584|NCT04955626|531338439|FG019|Blinded Period|Participants entered open label period|0|||
147320585|NCT04955626|531338440|FG020|Blinded Period|Participants entered open label period|0|||
147320586|NCT04955626|531338441|FG021|Blinded Period|Participants entered open label period|0|||
147320587|NCT04955626|531338442|FG022|Blinded Period|Participants entered open label period|0|||
147320588|NCT04955626|531338443|FG023|Blinded Period|Participants entered open label period|0|||
147320589|NCT04955626|531338444|FG024|Blinded Period|Participants entered open label period|0|||
147320590|NCT04955626|531338445|FG025|Blinded Period|Participants entered open label period|0|||
147320591|NCT04955626|531338446|FG026|Blinded Period|Participants entered open label period|0|||
147320592|NCT04955626|531338447|FG027|Blinded Period|Participants entered open label period|0|||
147320593|NCT04955626|531338448|FG028|Blinded Period|Participants entered open label period|0|||
147320594|NCT04955626|531338449|FG029|Blinded Period|Participants entered open label period|0|||
147320595|NCT04955626|531338450|FG030|Blinded Period|Participants entered open label period|0|||
147320596|NCT04955626|531338451|FG031|Blinded Period|Participants entered open label period|0|||
147320597|NCT04955626|531338452|FG032|Blinded Period|Participants entered open label period|0|||
147320598|NCT04955626|531338453|FG033|Blinded Period|Participants entered open label period|0|||
147320599|NCT04955626|531338454|FG034|Blinded Period|Participants entered open label period|0|||
147320600|NCT04955626|531338455|FG035|Blinded Period|Participants entered open label period|0|||
147320601|NCT04955626|531338420|FG000|Blinded Period|Withdrawal by parent/guardian|0|||
147320602|NCT04955626|531338421|FG001|Blinded Period|Withdrawal by parent/guardian|0|||
147320603|NCT04955626|531338422|FG002|Blinded Period|Withdrawal by parent/guardian|1|||
147320604|NCT04955626|531338423|FG003|Blinded Period|Withdrawal by parent/guardian|1|||
147320605|NCT04955626|531338424|FG004|Blinded Period|Withdrawal by parent/guardian|0|||
147320606|NCT04955626|531338425|FG005|Blinded Period|Withdrawal by parent/guardian|1|||
147320607|NCT04955626|531338426|FG006|Blinded Period|Withdrawal by parent/guardian|0|||
147320608|NCT04955626|531338427|FG007|Blinded Period|Withdrawal by parent/guardian|0|||
147320609|NCT04955626|531338428|FG008|Blinded Period|Withdrawal by parent/guardian|0|||
147320610|NCT04955626|531338429|FG009|Blinded Period|Withdrawal by parent/guardian|0|||
147320611|NCT04955626|531338430|FG010|Blinded Period|Withdrawal by parent/guardian|0|||
147320612|NCT04955626|531338431|FG011|Blinded Period|Withdrawal by parent/guardian|0|||
147575636|NCT00112437|532263540|FG022|Year 2 (12-Month Extension)|Protocol Violation|0|||
147575637|NCT00112437|532263541|FG023|Year 2 (12-Month Extension)|Protocol Violation|0|||
147575638|NCT00112437|532263542|FG024|Year 2 (12-Month Extension)|Protocol Violation|0|||
147575639|NCT00112437|532263543|FG025|Year 2 (12-Month Extension)|Protocol Violation|0|||
147575640|NCT00112437|532263518|FG000|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
147575641|NCT00112437|532263519|FG001|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
147575642|NCT00112437|532263520|FG002|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
147147779|NCT05396014|530705322|FG028|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
147147780|NCT05396014|530705323|FG029|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
147320613|NCT04955626|531338432|FG012|Blinded Period|Withdrawal by parent/guardian|0|||
147320614|NCT04955626|531338433|FG013|Blinded Period|Withdrawal by parent/guardian|0|||
147320615|NCT04955626|531338434|FG014|Blinded Period|Withdrawal by parent/guardian|0|||
147320616|NCT04955626|531338435|FG015|Blinded Period|Withdrawal by parent/guardian|0|||
147320617|NCT04955626|531338436|FG016|Blinded Period|Withdrawal by parent/guardian|0|||
147320618|NCT04955626|531338437|FG017|Blinded Period|Withdrawal by parent/guardian|0|||
147320619|NCT04955626|531338438|FG018|Blinded Period|Withdrawal by parent/guardian|0|||
147320620|NCT04955626|531338439|FG019|Blinded Period|Withdrawal by parent/guardian|0|||
147320621|NCT04955626|531338440|FG020|Blinded Period|Withdrawal by parent/guardian|0|||
147320622|NCT04955626|531338441|FG021|Blinded Period|Withdrawal by parent/guardian|0|||
147320623|NCT04955626|531338442|FG022|Blinded Period|Withdrawal by parent/guardian|0|||
147575643|NCT00112437|532263521|FG003|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
147147781|NCT05396014|530705324|FG030|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
147147782|NCT05396014|530705325|FG031|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
147239226|NCT01081678|531047525|FG000|Overall Study|Adverse Event|2|||
147239227|NCT01081678|531047526|FG001|Overall Study|Adverse Event|1|||
147239228|NCT01081678|531047527|FG002|Overall Study|Adverse Event|2|||
147239229|NCT01081678|531047528|FG003|Overall Study|Adverse Event|2|||
147239230|NCT01081678|531047525|FG000|Overall Study|Withdrawal by Subject|15|||
147239231|NCT01081678|531047526|FG001|Overall Study|Withdrawal by Subject|7|||
147239232|NCT01081678|531047527|FG002|Overall Study|Withdrawal by Subject|17|||
147239233|NCT01081678|531047528|FG003|Overall Study|Withdrawal by Subject|14|||
147239234|NCT01081678|531047525|FG000|Overall Study|Administrative Decision|1|||
147239235|NCT01081678|531047526|FG001|Overall Study|Administrative Decision|0|||
147239236|NCT01081678|531047527|FG002|Overall Study|Administrative Decision|0|||
147239237|NCT01081678|531047528|FG003|Overall Study|Administrative Decision|1|||
147239238|NCT01081678|531047525|FG000|Overall Study|Lost to Follow-up|4|||
147147783|NCT05396014|530705326|FG032|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
147147784|NCT05396014|530705327|FG033|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
147147785|NCT05396014|530705328|FG034|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
147147786|NCT05396014|530705329|FG035|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
147147787|NCT05396014|530705330|FG036|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
147147788|NCT05396014|530705331|FG037|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
147147789|NCT05396014|530705332|FG038|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
147147790|NCT05396014|530705333|FG039|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|1|||
147147791|NCT05396014|530705334|FG040|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
147147792|NCT05396014|530705335|FG041|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
147147793|NCT05396014|530705336|FG042|Stage 1 Intervention (Weeks 0-12)|Protocol Violation|0|||
147147794|NCT05396014|530705294|FG000|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
147147795|NCT05396014|530705295|FG001|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
147147796|NCT05396014|530705296|FG002|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
147147797|NCT05396014|530705297|FG003|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
147147798|NCT05396014|530705298|FG004|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
147147799|NCT05396014|530705299|FG005|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
147147800|NCT05396014|530705300|FG006|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
147147801|NCT05396014|530705301|FG007|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
147147802|NCT05396014|530705302|FG008|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
147147803|NCT05396014|530705303|FG009|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
147147804|NCT05396014|530705304|FG010|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
147147805|NCT05396014|530705305|FG011|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
147147806|NCT05396014|530705306|FG012|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
147147807|NCT05396014|530705307|FG013|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
147147808|NCT05396014|530705308|FG014|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
147147809|NCT05396014|530705309|FG015|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
147147810|NCT05396014|530705310|FG016|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
147147811|NCT05396014|530705311|FG017|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
147147812|NCT05396014|530705312|FG018|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
147147813|NCT05396014|530705313|FG019|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
147147814|NCT05396014|530705314|FG020|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
147147815|NCT05396014|530705315|FG021|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
147147816|NCT05396014|530705316|FG022|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
147147817|NCT05396014|530705317|FG023|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
147147818|NCT05396014|530705318|FG024|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
147147819|NCT05396014|530705319|FG025|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
147147820|NCT05396014|530705320|FG026|Stage 1 Intervention (Weeks 0-12)|Physician Decision|1|||
147147821|NCT05396014|530705321|FG027|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
147147822|NCT05396014|530705322|FG028|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
147147823|NCT05396014|530705323|FG029|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
147147824|NCT05396014|530705324|FG030|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
147147825|NCT05396014|530705325|FG031|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
147147826|NCT05396014|530705326|FG032|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
147147827|NCT05396014|530705327|FG033|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
147147828|NCT05396014|530705328|FG034|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
147147829|NCT05396014|530705329|FG035|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
147147830|NCT05396014|530705330|FG036|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
147147831|NCT05396014|530705331|FG037|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
147147832|NCT05396014|530705332|FG038|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
147147833|NCT05396014|530705333|FG039|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
147147834|NCT05396014|530705334|FG040|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
147147835|NCT05396014|530705335|FG041|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
147147836|NCT05396014|530705336|FG042|Stage 1 Intervention (Weeks 0-12)|Physician Decision|0|||
147147837|NCT05396014|530705294|FG000|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
147147838|NCT05396014|530705295|FG001|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
147147839|NCT05396014|530705296|FG002|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
147147840|NCT05396014|530705297|FG003|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
147147841|NCT05396014|530705298|FG004|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
147147842|NCT05396014|530705299|FG005|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
147147843|NCT05396014|530705300|FG006|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
147147844|NCT05396014|530705301|FG007|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
147445937|NCT00078325|531797479|FG000|Overall Study|Physician Decision|2|||
147445938|NCT00078325|531797480|FG001|Overall Study|Physician Decision|0|||
147147845|NCT05396014|530705302|FG008|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
147575644|NCT00112437|532263522|FG004|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
147575645|NCT00112437|532263523|FG005|Year 2 (12-Month Extension)|Withdrawal by Subject|1|||
147147846|NCT05396014|530705303|FG009|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
147147847|NCT05396014|530705304|FG010|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
147575646|NCT00112437|532263524|FG006|Year 2 (12-Month Extension)|Withdrawal by Subject|1|||
147575647|NCT00112437|532263525|FG007|Year 2 (12-Month Extension)|Withdrawal by Subject|2|||
147575648|NCT00112437|532263526|FG008|Year 2 (12-Month Extension)|Withdrawal by Subject|4|||
147575649|NCT00112437|532263527|FG009|Year 2 (12-Month Extension)|Withdrawal by Subject|1|||
147575650|NCT00112437|532263528|FG010|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
147575651|NCT00112437|532263529|FG011|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
147575652|NCT00112437|532263530|FG012|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
147575653|NCT00112437|532263531|FG013|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
147575654|NCT00112437|532263532|FG014|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
147575655|NCT00112437|532263533|FG015|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
147575656|NCT00112437|532263534|FG016|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
147652807|NCT02070978|532550392|FG001|Overall Study|Protocol Violation|0|||
147652808|NCT02070978|532550393|FG002|Overall Study|Protocol Violation|3|||
147147848|NCT05396014|530705305|FG011|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
147147849|NCT05396014|530705306|FG012|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
147147850|NCT05396014|530705307|FG013|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|1|||
147147851|NCT05396014|530705308|FG014|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
147147852|NCT05396014|530705309|FG015|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
147147853|NCT05396014|530705310|FG016|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
147147854|NCT05396014|530705311|FG017|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
147147855|NCT05396014|530705312|FG018|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
147147856|NCT05396014|530705313|FG019|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
147147857|NCT05396014|530705314|FG020|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
147147858|NCT05396014|530705315|FG021|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
147147859|NCT05396014|530705316|FG022|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
147147860|NCT05396014|530705317|FG023|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
147147861|NCT05396014|530705318|FG024|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
147147862|NCT05396014|530705319|FG025|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
147147863|NCT05396014|530705320|FG026|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
147147864|NCT05396014|530705321|FG027|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
147147865|NCT05396014|530705322|FG028|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
147147866|NCT05396014|530705323|FG029|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
147147867|NCT05396014|530705324|FG030|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
147147868|NCT05396014|530705325|FG031|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
147147869|NCT05396014|530705326|FG032|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
147147870|NCT05396014|530705327|FG033|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
147147871|NCT05396014|530705328|FG034|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
147147872|NCT05396014|530705329|FG035|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
147147873|NCT05396014|530705330|FG036|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
147147874|NCT05396014|530705331|FG037|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
147147875|NCT05396014|530705332|FG038|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
147147876|NCT05396014|530705333|FG039|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
147147877|NCT05396014|530705334|FG040|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
147239239|NCT01081678|531047526|FG001|Overall Study|Lost to Follow-up|1|||
147239240|NCT01081678|531047527|FG002|Overall Study|Lost to Follow-up|4|||
147239241|NCT01081678|531047528|FG003|Overall Study|Lost to Follow-up|3|||
147239242|NCT01081678|531047525|FG000|Overall Study|Death|2|||
147239243|NCT01081678|531047526|FG001|Overall Study|Death|2|||
147239244|NCT01081678|531047527|FG002|Overall Study|Death|2|||
147239245|NCT01081678|531047528|FG003|Overall Study|Death|6|||
147239246|NCT01081678|531047525|FG000|Overall Study|Other|0|||
147239247|NCT01081678|531047526|FG001|Overall Study|Other|1|||
147239248|NCT01081678|531047527|FG002|Overall Study|Other|0|||
147239249|NCT01081678|531047528|FG003|Overall Study|Other|0|||
147239250|NCT01619423|531047531|FG000|Part 1 (Dose Escalation)|High basal Mn|0|||
147239251|NCT01619423|531047532|FG001|Part 1 (Dose Escalation)|High basal Mn|2|||
147239252|NCT01619423|531047533|FG002|Part 1 (Dose Escalation)|High basal Mn|0|||
147239253|NCT01619423|531047534|FG003|Part 1 (Dose Escalation)|High basal Mn|0|||
147239254|NCT01281865|531047535|FG000|Overall Study|Adverse Event|1|||
147239255|NCT01281865|531047536|FG001|Overall Study|Adverse Event|1|||
147239256|NCT01281865|531047535|FG000|Overall Study|Withdrawal by Subject|1|||
147239257|NCT01281865|531047536|FG001|Overall Study|Withdrawal by Subject|0|||
147239258|NCT01281865|531047535|FG000|Overall Study|Lack of Efficacy|1|||
147239259|NCT01281865|531047536|FG001|Overall Study|Lack of Efficacy|0|||
147445939|NCT00078325|531797481|FG002|Overall Study|Physician Decision|1|||
147445940|NCT00078325|531797479|FG000|Overall Study|Miscellaneous|1|||
147445941|NCT00078325|531797480|FG001|Overall Study|Miscellaneous|1|||
147445942|NCT00078325|531797481|FG002|Overall Study|Miscellaneous|1|||
147445943|NCT04126083|531797485|FG000|Overall Study|Withdrawal by Subject|1|||
147445944|NCT02354222|531797486|FG000|Overall Study|Adverse Event|0|||
147445945|NCT02354222|531797487|FG001|Overall Study|Adverse Event|3|||
147445946|NCT02354222|531797486|FG000|Overall Study|Physician Decision|1|||
147445947|NCT02354222|531797487|FG001|Overall Study|Physician Decision|1|||
147445948|NCT02354222|531797486|FG000|Overall Study|Pregnancy|1|||
147445949|NCT02354222|531797487|FG001|Overall Study|Pregnancy|0|||
147445950|NCT02354222|531797486|FG000|Overall Study|Withdrawal by Subject|2|||
147445951|NCT02354222|531797487|FG001|Overall Study|Withdrawal by Subject|3|||
147445952|NCT02354222|531797486|FG000|Overall Study|Conflict with the stopping criteria|0|||
147445953|NCT02354222|531797487|FG001|Overall Study|Conflict with the stopping criteria|4|||
147445954|NCT02739620|531797488|FG000|Overall Study|Lost to Follow-up|3|||
147445955|NCT02739620|531797489|FG001|Overall Study|Lost to Follow-up|1|||
147445956|NCT02739620|531797488|FG000|Overall Study|Adverse Event|0|||
147445957|NCT02739620|531797489|FG001|Overall Study|Adverse Event|1|||
147445958|NCT00578136|531797490|FG000|Overall Study|Not given intervention|1|||
147445959|NCT00578136|531797491|FG001|Overall Study|Not given intervention|1|||
147445960|NCT00754793|531797493|FG000|Overall Study|voluntary withdrawn from study|0|||
147445961|NCT00754793|531797494|FG001|Overall Study|voluntary withdrawn from study|1|||
147575657|NCT00112437|532263535|FG017|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
147575658|NCT00112437|532263536|FG018|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
147575659|NCT00112437|532263537|FG019|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
147575660|NCT00112437|532263538|FG020|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
147575661|NCT00112437|532263539|FG021|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
147320624|NCT04955626|531338443|FG023|Blinded Period|Withdrawal by parent/guardian|0|||
147320625|NCT04955626|531338444|FG024|Blinded Period|Withdrawal by parent/guardian|0|||
147320626|NCT04955626|531338445|FG025|Blinded Period|Withdrawal by parent/guardian|0|||
147320627|NCT04955626|531338446|FG026|Blinded Period|Withdrawal by parent/guardian|0|||
147320628|NCT04955626|531338447|FG027|Blinded Period|Withdrawal by parent/guardian|0|||
147320629|NCT04955626|531338448|FG028|Blinded Period|Withdrawal by parent/guardian|0|||
147320630|NCT04955626|531338449|FG029|Blinded Period|Withdrawal by parent/guardian|0|||
147320631|NCT04955626|531338450|FG030|Blinded Period|Withdrawal by parent/guardian|0|||
147320632|NCT04955626|531338451|FG031|Blinded Period|Withdrawal by parent/guardian|0|||
147320633|NCT04955626|531338452|FG032|Blinded Period|Withdrawal by parent/guardian|0|||
147320634|NCT04955626|531338453|FG033|Blinded Period|Withdrawal by parent/guardian|0|||
147320635|NCT04955626|531338454|FG034|Blinded Period|Withdrawal by parent/guardian|0|||
147320636|NCT04955626|531338455|FG035|Blinded Period|Withdrawal by parent/guardian|0|||
147320637|NCT04955626|531338420|FG000|Blinded Period|Medication error|0|||
147320638|NCT04955626|531338421|FG001|Blinded Period|Medication error|0|||
147320639|NCT04955626|531338422|FG002|Blinded Period|Medication error|0|||
147320640|NCT04955626|531338423|FG003|Blinded Period|Medication error|0|||
147320641|NCT04955626|531338424|FG004|Blinded Period|Medication error|0|||
147320642|NCT04955626|531338425|FG005|Blinded Period|Medication error|0|||
147320643|NCT04955626|531338426|FG006|Blinded Period|Medication error|0|||
147320644|NCT04955626|531338427|FG007|Blinded Period|Medication error|0|||
147320645|NCT04955626|531338428|FG008|Blinded Period|Medication error|0|||
147320646|NCT04955626|531338429|FG009|Blinded Period|Medication error|0|||
147320647|NCT04955626|531338430|FG010|Blinded Period|Medication error|2|||
147320648|NCT04955626|531338431|FG011|Blinded Period|Medication error|0|||
147320649|NCT04955626|531338432|FG012|Blinded Period|Medication error|0|||
147320650|NCT04955626|531338433|FG013|Blinded Period|Medication error|0|||
147445962|NCT00932360|531797496|FG000|Washout (One Week)|Withdrawal by Subject|0|||
147445963|NCT00932360|531797497|FG001|Washout (One Week)|Withdrawal by Subject|0|||
147445964|NCT00932360|531797498|FG002|Washout (One Week)|Withdrawal by Subject|0|||
147445965|NCT00932360|531797499|FG003|Washout (One Week)|Withdrawal by Subject|0|||
147445966|NCT00932360|531797500|FG004|Washout (One Week)|Withdrawal by Subject|2|||
147445967|NCT00932360|531797501|FG005|Washout (One Week)|Withdrawal by Subject|0|||
147445968|NCT02536313|531797502|FG000|Overall Study|Lack of Efficacy|0|||
147445969|NCT02536313|531797503|FG001|Overall Study|Lack of Efficacy|1|||
147445970|NCT02437864|531797513|FG000|Overall Study|Protocol Violation|4|||
147445971|NCT02437864|531797514|FG001|Overall Study|Protocol Violation|0|||
147445972|NCT01892163|531797515|FG000|Overall Study|Death|1|||
147575662|NCT00112437|532263540|FG022|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
147320651|NCT04955626|531338434|FG014|Blinded Period|Medication error|0|||
147320652|NCT04955626|531338435|FG015|Blinded Period|Medication error|0|||
147320653|NCT04955626|531338436|FG016|Blinded Period|Medication error|0|||
147320654|NCT04955626|531338437|FG017|Blinded Period|Medication error|0|||
147445973|NCT01892163|531797516|FG001|Overall Study|Death|1|||
147445974|NCT01892163|531797515|FG000|Overall Study|Lost to Follow-up|1|||
147445975|NCT01892163|531797516|FG001|Overall Study|Lost to Follow-up|0|||
147445976|NCT01924182|531797517|FG000|Overall Study|Withdrawal by Subject|1|||
147445977|NCT01924182|531797518|FG001|Overall Study|Withdrawal by Subject|0|||
147445978|NCT00645593|531797521|FG000|Overall Study|Later found to be ineligible|1|||
147652809|NCT02070978|532550391|FG000|Overall Study|Lack of Efficacy|0|||
147652810|NCT02070978|532550392|FG001|Overall Study|Lack of Efficacy|1|||
147652811|NCT02070978|532550393|FG002|Overall Study|Lack of Efficacy|0|||
147652812|NCT02070978|532550391|FG000|Overall Study|Death|0|||
147652813|NCT02070978|532550392|FG001|Overall Study|Death|0|||
147652814|NCT02070978|532550393|FG002|Overall Study|Death|2|||
147445979|NCT00645593|531797522|FG001|Overall Study|Later found to be ineligible|0|||
147445980|NCT01585272|531797523|FG000|Overall Study|Adverse Event|22|||
147147878|NCT05396014|530705335|FG041|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
147147879|NCT05396014|530705336|FG042|Stage 2 Screening (Week 12 Pre-Rand.)|Withdrawal by Subject|0|||
147147880|NCT05396014|530705294|FG000|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|1|||
147147881|NCT05396014|530705295|FG001|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
147147882|NCT05396014|530705296|FG002|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
147147883|NCT05396014|530705297|FG003|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
147147884|NCT05396014|530705298|FG004|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
147147885|NCT05396014|530705299|FG005|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
147147886|NCT05396014|530705300|FG006|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
147147887|NCT05396014|530705301|FG007|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
147147888|NCT05396014|530705302|FG008|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
147147889|NCT05396014|530705303|FG009|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
147147890|NCT05396014|530705304|FG010|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
147147891|NCT05396014|530705305|FG011|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
147147892|NCT05396014|530705306|FG012|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
147147893|NCT05396014|530705307|FG013|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|1|||
147147894|NCT05396014|530705308|FG014|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
147147895|NCT05396014|530705309|FG015|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
147147896|NCT05396014|530705310|FG016|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
147147897|NCT05396014|530705311|FG017|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
147147898|NCT05396014|530705312|FG018|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
147147899|NCT05396014|530705313|FG019|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
147147900|NCT05396014|530705314|FG020|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
147147901|NCT05396014|530705315|FG021|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
147147902|NCT05396014|530705316|FG022|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
147147903|NCT05396014|530705317|FG023|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
147147904|NCT05396014|530705318|FG024|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
147147905|NCT05396014|530705319|FG025|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
147147906|NCT05396014|530705320|FG026|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
147147907|NCT05396014|530705321|FG027|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
147147908|NCT05396014|530705322|FG028|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
147147909|NCT05396014|530705323|FG029|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
147147910|NCT05396014|530705324|FG030|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
147147911|NCT05396014|530705325|FG031|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
147147912|NCT05396014|530705326|FG032|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
147147913|NCT05396014|530705327|FG033|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
147445981|NCT01585272|531797523|FG000|Overall Study|Protocol Violation|7|||
147652815|NCT02070978|532550391|FG000|Overall Study|Un-specified|3|||
147652816|NCT02070978|532550392|FG001|Overall Study|Un-specified|2|||
147652817|NCT02070978|532550393|FG002|Overall Study|Un-specified|2|||
147652818|NCT02070978|532550391|FG000|Overall Study|Terminated by Sponsor|33|||
147652819|NCT02070978|532550392|FG001|Overall Study|Terminated by Sponsor|40|||
147147914|NCT05396014|530705328|FG034|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
147147915|NCT05396014|530705329|FG035|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
147147916|NCT05396014|530705330|FG036|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
147239260|NCT03478657|531047537|FG000|Overall Study|Withdrawal by Subject|0|||
147239261|NCT03478657|531047538|FG001|Overall Study|Withdrawal by Subject|1|||
147239262|NCT03948581|531047539|FG000|Overall Study|Lost to Follow-up|0|||
147239263|NCT03948581|531047540|FG001|Overall Study|Lost to Follow-up|1|||
147239264|NCT03068455|531047541|FG000|Pre-treatment Period|Disease progression|0|||
147239265|NCT03068455|531047542|FG001|Pre-treatment Period|Disease progression|1|||
147239266|NCT03068455|531047541|FG000|Pre-treatment Period|Participant withdrew consent|1|||
147239267|NCT03068455|531047542|FG001|Pre-treatment Period|Participant withdrew consent|1|||
147445982|NCT01585272|531797523|FG000|Overall Study|Withdrawal by Subject|10|||
147147917|NCT05396014|530705331|FG037|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
147147918|NCT05396014|530705332|FG038|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
147239268|NCT03068455|531047541|FG000|Pre-treatment Period|Poor/non-compliance|0|||
147239269|NCT03068455|531047542|FG001|Pre-treatment Period|Poor/non-compliance|1|||
147239270|NCT03068455|531047541|FG000|Pre-treatment Period|Participant no longer meets study criteria|1|||
147239271|NCT03068455|531047542|FG001|Pre-treatment Period|Participant no longer meets study criteria|3|||
147239272|NCT03068455|531047541|FG000|Pre-treatment Period|Not reported|2|||
147652820|NCT02070978|532550393|FG002|Overall Study|Terminated by Sponsor|39|||
147147919|NCT05396014|530705333|FG039|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|2|||
147147920|NCT05396014|530705334|FG040|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
147147921|NCT05396014|530705335|FG041|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
147147922|NCT05396014|530705336|FG042|Stage 2 Screening (Week 12 Pre-Rand.)|Lost to Follow-up|0|||
147147923|NCT05396014|530705294|FG000|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|1|||
147147924|NCT05396014|530705295|FG001|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
147147925|NCT05396014|530705296|FG002|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
147147926|NCT05396014|530705297|FG003|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
147147927|NCT05396014|530705298|FG004|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
147147928|NCT05396014|530705299|FG005|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
147147929|NCT05396014|530705300|FG006|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
147147930|NCT05396014|530705301|FG007|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
147147931|NCT05396014|530705302|FG008|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
147147932|NCT05396014|530705303|FG009|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
147147933|NCT05396014|530705304|FG010|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
147147934|NCT05396014|530705305|FG011|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
147147935|NCT05396014|530705306|FG012|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
147147936|NCT05396014|530705307|FG013|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
147147937|NCT05396014|530705308|FG014|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
147147938|NCT05396014|530705309|FG015|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
147147939|NCT05396014|530705310|FG016|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
147147940|NCT05396014|530705311|FG017|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
147147941|NCT05396014|530705312|FG018|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
147239273|NCT03068455|531047542|FG001|Pre-treatment Period|Not reported|1|||
147239274|NCT03068455|531047541|FG000|Treatment Period|Disease progression|166|||
147239275|NCT03068455|531047542|FG001|Treatment Period|Disease progression|208|||
147239276|NCT03068455|531047541|FG000|Treatment Period|Study drug toxicity|317|||
147239277|NCT03068455|531047542|FG001|Treatment Period|Study drug toxicity|104|||
147239278|NCT03068455|531047541|FG000|Treatment Period|Adverse Event unrelated to study drug|15|||
147239279|NCT03068455|531047542|FG001|Treatment Period|Adverse Event unrelated to study drug|7|||
147239280|NCT03068455|531047541|FG000|Treatment Period|Participant request to stop therapy|33|||
147239281|NCT03068455|531047542|FG001|Treatment Period|Participant request to stop therapy|20|||
147239282|NCT03068455|531047541|FG000|Treatment Period|Participant withdrew consent|5|||
147239283|NCT03068455|531047542|FG001|Treatment Period|Participant withdrew consent|10|||
147239284|NCT03068455|531047541|FG000|Treatment Period|Poor/non-compliance|3|||
147239285|NCT03068455|531047542|FG001|Treatment Period|Poor/non-compliance|0|||
147239286|NCT03068455|531047541|FG000|Treatment Period|Participant no longer meets study criteria|1|||
147239287|NCT03068455|531047542|FG001|Treatment Period|Participant no longer meets study criteria|3|||
147239288|NCT03068455|531047541|FG000|Treatment Period|Other reasons|12|||
147239289|NCT03068455|531047542|FG001|Treatment Period|Other reasons|4|||
147239290|NCT00005044|531047552|FG000|Overall Study|Protocol Violation|37|||
147239291|NCT00005044|531047553|FG001|Overall Study|Protocol Violation|46|||
147239292|NCT00005044|531047552|FG000|Overall Study|Withdrawal by Subject|1|||
147239293|NCT00005044|531047553|FG001|Overall Study|Withdrawal by Subject|5|||
147239294|NCT00005044|531047552|FG000|Overall Study|No protocol treatment|0|||
147239295|NCT00005044|531047553|FG001|Overall Study|No protocol treatment|1|||
147239296|NCT00181155|531047554|FG000|Overall Study|Physician Decision|1|||
147239297|NCT00181155|531047555|FG001|Overall Study|Physician Decision|0|||
147239298|NCT00181155|531047554|FG000|Overall Study|Withdrawal by Subject|1|||
147239299|NCT00181155|531047555|FG001|Overall Study|Withdrawal by Subject|0|||
147239300|NCT02572401|531047556|FG000|Overall Study|Lost to Follow-up|5|||
147239301|NCT02572401|531047557|FG001|Overall Study|Lost to Follow-up|8|||
147239302|NCT02572401|531047558|FG002|Overall Study|Lost to Follow-up|9|||
147239303|NCT02572401|531047559|FG003|Overall Study|Lost to Follow-up|9|||
147239304|NCT02572401|531047556|FG000|Overall Study|Death|0|||
147239305|NCT02572401|531047557|FG001|Overall Study|Death|0|||
147239306|NCT02572401|531047558|FG002|Overall Study|Death|0|||
147239307|NCT02572401|531047559|FG003|Overall Study|Death|1|||
147239308|NCT01548287|531047560|FG000|Screening|No reason provided|0|||
147239309|NCT01548287|531047561|FG001|Screening|No reason provided|0|||
147239310|NCT01548287|531047562|FG002|Screening|No reason provided|0|||
147239311|NCT01548287|531047563|FG003|Screening|No reason provided|0|||
147239312|NCT01548287|531047564|FG004|Screening|No reason provided|9|||
147239313|NCT01548287|531047560|FG000|Screening|Did not meet eligibility criteria|0|||
147239314|NCT01548287|531047561|FG001|Screening|Did not meet eligibility criteria|0|||
147239315|NCT01548287|531047562|FG002|Screening|Did not meet eligibility criteria|0|||
147239316|NCT01548287|531047563|FG003|Screening|Did not meet eligibility criteria|0|||
147239317|NCT01548287|531047564|FG004|Screening|Did not meet eligibility criteria|74|||
147239318|NCT01548287|531047560|FG000|Randomized Period|Did not meet inclusion criteria|0|||
147239319|NCT01548287|531047561|FG001|Randomized Period|Did not meet inclusion criteria|0|||
147320655|NCT04955626|531338438|FG018|Blinded Period|Medication error|0|||
147320656|NCT04955626|531338439|FG019|Blinded Period|Medication error|0|||
147320657|NCT04955626|531338440|FG020|Blinded Period|Medication error|0|||
147320658|NCT04955626|531338441|FG021|Blinded Period|Medication error|0|||
147320659|NCT04955626|531338442|FG022|Blinded Period|Medication error|0|||
147320660|NCT04955626|531338443|FG023|Blinded Period|Medication error|0|||
147320661|NCT04955626|531338444|FG024|Blinded Period|Medication error|0|||
147320662|NCT04955626|531338445|FG025|Blinded Period|Medication error|0|||
147320663|NCT04955626|531338446|FG026|Blinded Period|Medication error|0|||
147320664|NCT04955626|531338447|FG027|Blinded Period|Medication error|0|||
147320665|NCT04955626|531338448|FG028|Blinded Period|Medication error|4|||
147320666|NCT04955626|531338449|FG029|Blinded Period|Medication error|0|||
147320667|NCT04955626|531338450|FG030|Blinded Period|Medication error|0|||
147320668|NCT04955626|531338451|FG031|Blinded Period|Medication error|0|||
147320669|NCT04955626|531338452|FG032|Blinded Period|Medication error|0|||
147320670|NCT04955626|531338453|FG033|Blinded Period|Medication error|0|||
147320671|NCT04955626|531338454|FG034|Blinded Period|Medication error|0|||
147320672|NCT04955626|531338455|FG035|Blinded Period|Medication error|0|||
147320673|NCT04955626|531338420|FG000|Open-Label Period|Lost to Follow-up|109|||
147147942|NCT05396014|530705313|FG019|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
147147943|NCT05396014|530705314|FG020|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
147147944|NCT05396014|530705315|FG021|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
147147945|NCT05396014|530705316|FG022|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
147147946|NCT05396014|530705317|FG023|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
147147947|NCT05396014|530705318|FG024|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
147147948|NCT05396014|530705319|FG025|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
147147949|NCT05396014|530705320|FG026|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|1|||
147147950|NCT05396014|530705321|FG027|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
147147951|NCT05396014|530705322|FG028|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
147147952|NCT05396014|530705323|FG029|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
147147953|NCT05396014|530705324|FG030|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
147147954|NCT05396014|530705325|FG031|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
147147955|NCT05396014|530705326|FG032|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
147147956|NCT05396014|530705327|FG033|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
147147957|NCT05396014|530705328|FG034|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
147147958|NCT05396014|530705329|FG035|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
147147959|NCT05396014|530705330|FG036|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
147147960|NCT05396014|530705331|FG037|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
147147961|NCT05396014|530705332|FG038|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
147147962|NCT05396014|530705333|FG039|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
147147963|NCT05396014|530705334|FG040|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
147147964|NCT05396014|530705335|FG041|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
147147965|NCT05396014|530705336|FG042|Stage 2 Screening (Week 12 Pre-Rand.)|Physician Decision|0|||
147147966|NCT05396014|530705294|FG000|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
147147967|NCT05396014|530705295|FG001|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
147147968|NCT05396014|530705296|FG002|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
147147969|NCT05396014|530705297|FG003|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
147147970|NCT05396014|530705298|FG004|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
147147971|NCT05396014|530705299|FG005|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
147147972|NCT05396014|530705300|FG006|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
147147973|NCT05396014|530705301|FG007|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
147147974|NCT05396014|530705302|FG008|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
147147975|NCT05396014|530705303|FG009|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
147147976|NCT05396014|530705304|FG010|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
147147977|NCT05396014|530705305|FG011|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
147147978|NCT05396014|530705306|FG012|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
147147979|NCT05396014|530705307|FG013|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|1|||
147320674|NCT04955626|531338421|FG001|Open-Label Period|Lost to Follow-up|41|||
147320675|NCT04955626|531338422|FG002|Open-Label Period|Lost to Follow-up|0|||
147320676|NCT04955626|531338423|FG003|Open-Label Period|Lost to Follow-up|0|||
147320677|NCT04955626|531338424|FG004|Open-Label Period|Lost to Follow-up|0|||
147320678|NCT04955626|531338425|FG005|Open-Label Period|Lost to Follow-up|0|||
147320679|NCT04955626|531338426|FG006|Open-Label Period|Lost to Follow-up|0|||
147320680|NCT04955626|531338427|FG007|Open-Label Period|Lost to Follow-up|0|||
147320681|NCT04955626|531338428|FG008|Open-Label Period|Lost to Follow-up|0|||
147320682|NCT04955626|531338429|FG009|Open-Label Period|Lost to Follow-up|0|||
147320683|NCT04955626|531338430|FG010|Open-Label Period|Lost to Follow-up|0|||
147320684|NCT04955626|531338431|FG011|Open-Label Period|Lost to Follow-up|0|||
147320685|NCT04955626|531338432|FG012|Open-Label Period|Lost to Follow-up|0|||
147320686|NCT04955626|531338433|FG013|Open-Label Period|Lost to Follow-up|0|||
147320687|NCT04955626|531338434|FG014|Open-Label Period|Lost to Follow-up|0|||
147320688|NCT04955626|531338435|FG015|Open-Label Period|Lost to Follow-up|0|||
147320689|NCT04955626|531338436|FG016|Open-Label Period|Lost to Follow-up|0|||
147320690|NCT04955626|531338437|FG017|Open-Label Period|Lost to Follow-up|0|||
147320691|NCT04955626|531338438|FG018|Open-Label Period|Lost to Follow-up|0|||
147320692|NCT04955626|531338439|FG019|Open-Label Period|Lost to Follow-up|0|||
147320693|NCT04955626|531338440|FG020|Open-Label Period|Lost to Follow-up|0|||
147320694|NCT04955626|531338441|FG021|Open-Label Period|Lost to Follow-up|0|||
147320695|NCT04955626|531338442|FG022|Open-Label Period|Lost to Follow-up|0|||
147320696|NCT04955626|531338443|FG023|Open-Label Period|Lost to Follow-up|0|||
147320697|NCT04955626|531338444|FG024|Open-Label Period|Lost to Follow-up|0|||
147320698|NCT04955626|531338445|FG025|Open-Label Period|Lost to Follow-up|0|||
147320699|NCT04955626|531338446|FG026|Open-Label Period|Lost to Follow-up|0|||
147320700|NCT04955626|531338447|FG027|Open-Label Period|Lost to Follow-up|0|||
147320701|NCT04955626|531338448|FG028|Open-Label Period|Lost to Follow-up|0|||
147320702|NCT04955626|531338449|FG029|Open-Label Period|Lost to Follow-up|0|||
147320703|NCT04955626|531338450|FG030|Open-Label Period|Lost to Follow-up|0|||
147320704|NCT04955626|531338451|FG031|Open-Label Period|Lost to Follow-up|0|||
147320705|NCT04955626|531338452|FG032|Open-Label Period|Lost to Follow-up|0|||
147320706|NCT04955626|531338453|FG033|Open-Label Period|Lost to Follow-up|0|||
147147980|NCT05396014|530705308|FG014|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
147147981|NCT05396014|530705309|FG015|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
147147982|NCT05396014|530705310|FG016|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
147147983|NCT05396014|530705311|FG017|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
147147984|NCT05396014|530705312|FG018|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
147147985|NCT05396014|530705313|FG019|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
147147986|NCT05396014|530705314|FG020|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
147147987|NCT05396014|530705315|FG021|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
147147988|NCT05396014|530705316|FG022|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
147320707|NCT04955626|531338454|FG034|Open-Label Period|Lost to Follow-up|0|||
147320708|NCT04955626|531338455|FG035|Open-Label Period|Lost to Follow-up|0|||
147320709|NCT04955626|531338420|FG000|Open-Label Period|Protocol Violation|377|||
147320710|NCT04955626|531338421|FG001|Open-Label Period|Protocol Violation|48|||
147320711|NCT04955626|531338422|FG002|Open-Label Period|Protocol Violation|0|||
147320712|NCT04955626|531338423|FG003|Open-Label Period|Protocol Violation|0|||
147320713|NCT04955626|531338424|FG004|Open-Label Period|Protocol Violation|0|||
147320714|NCT04955626|531338425|FG005|Open-Label Period|Protocol Violation|0|||
147320715|NCT04955626|531338426|FG006|Open-Label Period|Protocol Violation|0|||
147320716|NCT04955626|531338427|FG007|Open-Label Period|Protocol Violation|0|||
147320717|NCT04955626|531338428|FG008|Open-Label Period|Protocol Violation|0|||
147320718|NCT04955626|531338429|FG009|Open-Label Period|Protocol Violation|0|||
147320719|NCT04955626|531338430|FG010|Open-Label Period|Protocol Violation|0|||
147320720|NCT04955626|531338431|FG011|Open-Label Period|Protocol Violation|0|||
147320721|NCT04955626|531338432|FG012|Open-Label Period|Protocol Violation|0|||
147320722|NCT04955626|531338433|FG013|Open-Label Period|Protocol Violation|0|||
147320723|NCT04955626|531338434|FG014|Open-Label Period|Protocol Violation|0|||
147320724|NCT04955626|531338435|FG015|Open-Label Period|Protocol Violation|0|||
147320725|NCT04955626|531338436|FG016|Open-Label Period|Protocol Violation|0|||
147320726|NCT04955626|531338437|FG017|Open-Label Period|Protocol Violation|0|||
147320727|NCT04955626|531338438|FG018|Open-Label Period|Protocol Violation|0|||
147320728|NCT04955626|531338439|FG019|Open-Label Period|Protocol Violation|0|||
147147989|NCT05396014|530705317|FG023|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
147147990|NCT05396014|530705318|FG024|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
147147991|NCT05396014|530705319|FG025|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
147320729|NCT04955626|531338440|FG020|Open-Label Period|Protocol Violation|0|||
147147992|NCT05396014|530705320|FG026|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
147147993|NCT05396014|530705321|FG027|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
147147994|NCT05396014|530705322|FG028|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
147147995|NCT05396014|530705323|FG029|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
147147996|NCT05396014|530705324|FG030|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
147147997|NCT05396014|530705325|FG031|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
147147998|NCT05396014|530705326|FG032|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
147147999|NCT05396014|530705327|FG033|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
147320730|NCT04955626|531338441|FG021|Open-Label Period|Protocol Violation|0|||
147320731|NCT04955626|531338442|FG022|Open-Label Period|Protocol Violation|0|||
147320732|NCT04955626|531338443|FG023|Open-Label Period|Protocol Violation|0|||
147320733|NCT04955626|531338444|FG024|Open-Label Period|Protocol Violation|0|||
147320734|NCT04955626|531338445|FG025|Open-Label Period|Protocol Violation|0|||
147320735|NCT04955626|531338446|FG026|Open-Label Period|Protocol Violation|0|||
147320736|NCT04955626|531338447|FG027|Open-Label Period|Protocol Violation|0|||
147320737|NCT04955626|531338448|FG028|Open-Label Period|Protocol Violation|0|||
147320738|NCT04955626|531338449|FG029|Open-Label Period|Protocol Violation|0|||
147320739|NCT04955626|531338450|FG030|Open-Label Period|Protocol Violation|0|||
147320740|NCT04955626|531338451|FG031|Open-Label Period|Protocol Violation|0|||
147320741|NCT04955626|531338452|FG032|Open-Label Period|Protocol Violation|0|||
147320742|NCT04955626|531338453|FG033|Open-Label Period|Protocol Violation|0|||
147320743|NCT04955626|531338454|FG034|Open-Label Period|Protocol Violation|0|||
147320744|NCT04955626|531338455|FG035|Open-Label Period|Protocol Violation|0|||
147320745|NCT04955626|531338420|FG000|Open-Label Period|Death|5|||
147320746|NCT04955626|531338421|FG001|Open-Label Period|Death|5|||
147320747|NCT04955626|531338422|FG002|Open-Label Period|Death|0|||
147320748|NCT04955626|531338423|FG003|Open-Label Period|Death|0|||
147320749|NCT04955626|531338424|FG004|Open-Label Period|Death|0|||
147320750|NCT04955626|531338425|FG005|Open-Label Period|Death|0|||
147320751|NCT04955626|531338426|FG006|Open-Label Period|Death|0|||
147320752|NCT04955626|531338427|FG007|Open-Label Period|Death|0|||
147320753|NCT04955626|531338428|FG008|Open-Label Period|Death|0|||
147320754|NCT04955626|531338429|FG009|Open-Label Period|Death|0|||
147320755|NCT04955626|531338430|FG010|Open-Label Period|Death|0|||
147320756|NCT04955626|531338431|FG011|Open-Label Period|Death|0|||
147320757|NCT04955626|531338432|FG012|Open-Label Period|Death|0|||
147320758|NCT04955626|531338433|FG013|Open-Label Period|Death|0|||
147320759|NCT04955626|531338434|FG014|Open-Label Period|Death|0|||
147320760|NCT04955626|531338435|FG015|Open-Label Period|Death|0|||
147320761|NCT04955626|531338436|FG016|Open-Label Period|Death|0|||
147320762|NCT04955626|531338437|FG017|Open-Label Period|Death|0|||
147320763|NCT04955626|531338438|FG018|Open-Label Period|Death|0|||
147320764|NCT04955626|531338439|FG019|Open-Label Period|Death|0|||
147320765|NCT04955626|531338440|FG020|Open-Label Period|Death|0|||
147320766|NCT04955626|531338441|FG021|Open-Label Period|Death|0|||
147320767|NCT04955626|531338442|FG022|Open-Label Period|Death|0|||
147320768|NCT04955626|531338443|FG023|Open-Label Period|Death|0|||
147320769|NCT04955626|531338444|FG024|Open-Label Period|Death|0|||
147320770|NCT04955626|531338445|FG025|Open-Label Period|Death|0|||
147320771|NCT04955626|531338446|FG026|Open-Label Period|Death|0|||
147320772|NCT04955626|531338447|FG027|Open-Label Period|Death|0|||
147320773|NCT04955626|531338448|FG028|Open-Label Period|Death|0|||
147320774|NCT04955626|531338449|FG029|Open-Label Period|Death|0|||
147320775|NCT04955626|531338450|FG030|Open-Label Period|Death|0|||
147320776|NCT04955626|531338451|FG031|Open-Label Period|Death|0|||
147320777|NCT04955626|531338452|FG032|Open-Label Period|Death|0|||
147320778|NCT04955626|531338453|FG033|Open-Label Period|Death|0|||
147320779|NCT04955626|531338454|FG034|Open-Label Period|Death|0|||
147320780|NCT04955626|531338455|FG035|Open-Label Period|Death|0|||
147320781|NCT04955626|531338420|FG000|Open-Label Period|No longer meets eligibility criteria|20|||
147320782|NCT04955626|531338421|FG001|Open-Label Period|No longer meets eligibility criteria|4|||
147320783|NCT04955626|531338422|FG002|Open-Label Period|No longer meets eligibility criteria|0|||
147320784|NCT04955626|531338423|FG003|Open-Label Period|No longer meets eligibility criteria|0|||
147320785|NCT04955626|531338424|FG004|Open-Label Period|No longer meets eligibility criteria|0|||
147320786|NCT04955626|531338425|FG005|Open-Label Period|No longer meets eligibility criteria|0|||
147320787|NCT04955626|531338426|FG006|Open-Label Period|No longer meets eligibility criteria|0|||
147320788|NCT04955626|531338427|FG007|Open-Label Period|No longer meets eligibility criteria|0|||
147320789|NCT04955626|531338428|FG008|Open-Label Period|No longer meets eligibility criteria|0|||
147320790|NCT04955626|531338429|FG009|Open-Label Period|No longer meets eligibility criteria|0|||
147148000|NCT05396014|530705328|FG034|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
147148001|NCT05396014|530705329|FG035|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
147148002|NCT05396014|530705330|FG036|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
147148003|NCT05396014|530705331|FG037|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
147148004|NCT05396014|530705332|FG038|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
147148005|NCT05396014|530705333|FG039|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
147148006|NCT05396014|530705334|FG040|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
147148007|NCT05396014|530705335|FG041|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
147148008|NCT05396014|530705336|FG042|Stage 2 Screening (Week 12 Pre-Rand.)|Adverse Event|0|||
147148009|NCT05396014|530705294|FG000|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
147148010|NCT05396014|530705295|FG001|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
147320791|NCT04955626|531338430|FG010|Open-Label Period|No longer meets eligibility criteria|0|||
147320792|NCT04955626|531338431|FG011|Open-Label Period|No longer meets eligibility criteria|0|||
147320793|NCT04955626|531338432|FG012|Open-Label Period|No longer meets eligibility criteria|0|||
147320794|NCT04955626|531338433|FG013|Open-Label Period|No longer meets eligibility criteria|0|||
147320795|NCT04955626|531338434|FG014|Open-Label Period|No longer meets eligibility criteria|0|||
147320796|NCT04955626|531338435|FG015|Open-Label Period|No longer meets eligibility criteria|0|||
147320797|NCT04955626|531338436|FG016|Open-Label Period|No longer meets eligibility criteria|0|||
147320798|NCT04955626|531338437|FG017|Open-Label Period|No longer meets eligibility criteria|0|||
147445983|NCT00993265|531797528|FG000|Overall Study|Adverse Event|1|||
147320799|NCT04955626|531338438|FG018|Open-Label Period|No longer meets eligibility criteria|0|||
147320800|NCT04955626|531338439|FG019|Open-Label Period|No longer meets eligibility criteria|0|||
147320801|NCT04955626|531338440|FG020|Open-Label Period|No longer meets eligibility criteria|0|||
147320802|NCT04955626|531338441|FG021|Open-Label Period|No longer meets eligibility criteria|0|||
147445984|NCT00993265|531797529|FG001|Overall Study|Adverse Event|0|||
147148011|NCT05396014|530705296|FG002|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
147148012|NCT05396014|530705297|FG003|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|2|||
147148013|NCT05396014|530705298|FG004|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
147148014|NCT05396014|530705299|FG005|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
147148015|NCT05396014|530705300|FG006|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
147148016|NCT05396014|530705301|FG007|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
147148017|NCT05396014|530705302|FG008|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|2|||
147148018|NCT05396014|530705303|FG009|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
147148019|NCT05396014|530705304|FG010|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
147148020|NCT05396014|530705305|FG011|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
147148021|NCT05396014|530705306|FG012|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
147148022|NCT05396014|530705307|FG013|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
147148023|NCT05396014|530705308|FG014|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
147148024|NCT05396014|530705309|FG015|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
147148025|NCT05396014|530705310|FG016|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
147148026|NCT05396014|530705311|FG017|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
147148027|NCT05396014|530705312|FG018|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
147148028|NCT05396014|530705313|FG019|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
147148029|NCT05396014|530705314|FG020|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
147148030|NCT05396014|530705315|FG021|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
147148031|NCT05396014|530705316|FG022|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
147148032|NCT05396014|530705317|FG023|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
147148033|NCT05396014|530705318|FG024|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
147148034|NCT05396014|530705319|FG025|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|2|||
147148035|NCT05396014|530705320|FG026|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
147148036|NCT05396014|530705321|FG027|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
147148037|NCT05396014|530705322|FG028|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
147148038|NCT05396014|530705323|FG029|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
147148039|NCT05396014|530705324|FG030|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
147148040|NCT05396014|530705325|FG031|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
147148041|NCT05396014|530705326|FG032|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
147148042|NCT05396014|530705327|FG033|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
147148043|NCT05396014|530705328|FG034|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
147148044|NCT05396014|530705329|FG035|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
147148045|NCT05396014|530705330|FG036|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
147148046|NCT05396014|530705331|FG037|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
147148047|NCT05396014|530705332|FG038|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
147148048|NCT05396014|530705333|FG039|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|0|||
147148049|NCT05396014|530705334|FG040|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|3|||
147148050|NCT05396014|530705335|FG041|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|2|||
147148051|NCT05396014|530705336|FG042|Stage 2 Intervention (Weeks 12-24)|Lost to Follow-up|1|||
147148052|NCT05396014|530705294|FG000|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
147148053|NCT05396014|530705295|FG001|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
147148054|NCT05396014|530705296|FG002|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
147148055|NCT05396014|530705297|FG003|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
147148056|NCT05396014|530705298|FG004|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
147148057|NCT05396014|530705299|FG005|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
147148058|NCT05396014|530705300|FG006|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
147148059|NCT05396014|530705301|FG007|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
147148060|NCT05396014|530705302|FG008|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|2|||
147148061|NCT05396014|530705303|FG009|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
147148062|NCT05396014|530705304|FG010|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
147148063|NCT05396014|530705305|FG011|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
147320803|NCT04955626|531338442|FG022|Open-Label Period|No longer meets eligibility criteria|0|||
147320804|NCT04955626|531338443|FG023|Open-Label Period|No longer meets eligibility criteria|0|||
147320805|NCT04955626|531338444|FG024|Open-Label Period|No longer meets eligibility criteria|0|||
147148064|NCT05396014|530705306|FG012|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
147148065|NCT05396014|530705307|FG013|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
147148066|NCT05396014|530705308|FG014|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
147320806|NCT04955626|531338445|FG025|Open-Label Period|No longer meets eligibility criteria|0|||
147320807|NCT04955626|531338446|FG026|Open-Label Period|No longer meets eligibility criteria|0|||
147148067|NCT05396014|530705309|FG015|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
147148068|NCT05396014|530705310|FG016|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
147148069|NCT05396014|530705311|FG017|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
147652821|NCT03951753|532550394|FG000|Overall Study|Adverse Event|1|||
147652822|NCT03951753|532550395|FG001|Overall Study|Adverse Event|0|||
147320808|NCT04955626|531338447|FG027|Open-Label Period|No longer meets eligibility criteria|0|||
147320809|NCT04955626|531338448|FG028|Open-Label Period|No longer meets eligibility criteria|0|||
147320810|NCT04955626|531338449|FG029|Open-Label Period|No longer meets eligibility criteria|0|||
147320811|NCT04955626|531338450|FG030|Open-Label Period|No longer meets eligibility criteria|0|||
147148070|NCT05396014|530705312|FG018|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
147148071|NCT05396014|530705313|FG019|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
147148072|NCT05396014|530705314|FG020|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
147148073|NCT05396014|530705315|FG021|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
147148074|NCT05396014|530705316|FG022|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|2|||
147148075|NCT05396014|530705317|FG023|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
147148076|NCT05396014|530705318|FG024|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
147148077|NCT05396014|530705319|FG025|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
147148078|NCT05396014|530705320|FG026|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
147148079|NCT05396014|530705321|FG027|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
147148080|NCT05396014|530705322|FG028|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
147148081|NCT05396014|530705323|FG029|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
147148082|NCT05396014|530705324|FG030|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
147148083|NCT05396014|530705325|FG031|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
147148084|NCT05396014|530705326|FG032|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
147148085|NCT05396014|530705327|FG033|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
147148086|NCT05396014|530705328|FG034|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
147148087|NCT05396014|530705329|FG035|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|2|||
147148088|NCT05396014|530705330|FG036|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
147148089|NCT05396014|530705331|FG037|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
147148090|NCT05396014|530705332|FG038|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
147148091|NCT05396014|530705333|FG039|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|0|||
147148092|NCT05396014|530705334|FG040|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
147148093|NCT05396014|530705335|FG041|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|3|||
147148094|NCT05396014|530705336|FG042|Stage 2 Intervention (Weeks 12-24)|Withdrawal by Subject|1|||
147148095|NCT05396014|530705294|FG000|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
147148096|NCT05396014|530705295|FG001|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
147148097|NCT05396014|530705296|FG002|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
147148098|NCT05396014|530705297|FG003|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
147148099|NCT05396014|530705298|FG004|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
147148100|NCT05396014|530705299|FG005|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
147148101|NCT05396014|530705300|FG006|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
147148102|NCT05396014|530705301|FG007|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
147148103|NCT05396014|530705302|FG008|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
147148104|NCT05396014|530705303|FG009|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
147148105|NCT05396014|530705304|FG010|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
147148106|NCT05396014|530705305|FG011|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
147148107|NCT05396014|530705306|FG012|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
147148108|NCT05396014|530705307|FG013|Stage 2 Intervention (Weeks 12-24)|Adverse Event|1|||
147148109|NCT05396014|530705308|FG014|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
147148110|NCT05396014|530705309|FG015|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
147445985|NCT00993265|531797528|FG000|Overall Study|Changed dose of concomitant drug|2|||
147445986|NCT00993265|531797529|FG001|Overall Study|Changed dose of concomitant drug|0|||
147445987|NCT00993265|531797528|FG000|Overall Study|Non-compliant with study medication|1|||
147445988|NCT00993265|531797529|FG001|Overall Study|Non-compliant with study medication|0|||
147445989|NCT02577146|531797530|FG000|Overall Study|Lost to Follow-up|8|||
147445990|NCT02577146|531797530|FG000|Overall Study|Physician Decision|3|||
147445991|NCT02577146|531797530|FG000|Overall Study|Screen Failure|17|||
147445992|NCT00219284|531797531|FG000|Treatment Phase - 16 Weeks|Adverse Event|26|||
147445993|NCT00219284|531797532|FG001|Treatment Phase - 16 Weeks|Adverse Event|24|||
147320812|NCT04955626|531338451|FG031|Open-Label Period|No longer meets eligibility criteria|0|||
147148111|NCT05396014|530705310|FG016|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
147148112|NCT05396014|530705311|FG017|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
147148113|NCT05396014|530705312|FG018|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
147148114|NCT05396014|530705313|FG019|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
147148115|NCT05396014|530705314|FG020|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
147148116|NCT05396014|530705315|FG021|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
147320813|NCT04955626|531338452|FG032|Open-Label Period|No longer meets eligibility criteria|0|||
147445994|NCT00219284|531797531|FG000|Treatment Phase - 16 Weeks|Abnormal laboratory value(s)|0|||
147148117|NCT05396014|530705316|FG022|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
147148118|NCT05396014|530705317|FG023|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
147320814|NCT04955626|531338453|FG033|Open-Label Period|No longer meets eligibility criteria|0|||
147320815|NCT04955626|531338454|FG034|Open-Label Period|No longer meets eligibility criteria|0|||
147445995|NCT00219284|531797532|FG001|Treatment Phase - 16 Weeks|Abnormal laboratory value(s)|1|||
147320816|NCT04955626|531338455|FG035|Open-Label Period|No longer meets eligibility criteria|0|||
147148119|NCT05396014|530705318|FG024|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
147148120|NCT05396014|530705319|FG025|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
147148121|NCT05396014|530705320|FG026|Stage 2 Intervention (Weeks 12-24)|Adverse Event|1|||
147148122|NCT05396014|530705321|FG027|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
147148123|NCT05396014|530705322|FG028|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
147148124|NCT05396014|530705323|FG029|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
147148125|NCT05396014|530705324|FG030|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
147148126|NCT05396014|530705325|FG031|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
147148127|NCT05396014|530705326|FG032|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
147148128|NCT05396014|530705327|FG033|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
147148129|NCT05396014|530705328|FG034|Stage 2 Intervention (Weeks 12-24)|Adverse Event|1|||
147148130|NCT05396014|530705329|FG035|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
147148131|NCT05396014|530705330|FG036|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
147148132|NCT05396014|530705331|FG037|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
147148133|NCT05396014|530705332|FG038|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
147148134|NCT05396014|530705333|FG039|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
147148135|NCT05396014|530705334|FG040|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
147148136|NCT05396014|530705335|FG041|Stage 2 Intervention (Weeks 12-24)|Adverse Event|0|||
147148137|NCT05396014|530705336|FG042|Stage 2 Intervention (Weeks 12-24)|Adverse Event|1|||
147148138|NCT05396014|530705294|FG000|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
147148139|NCT05396014|530705295|FG001|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
147148140|NCT05396014|530705296|FG002|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
147148141|NCT05396014|530705297|FG003|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
147148142|NCT05396014|530705298|FG004|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
147148143|NCT05396014|530705299|FG005|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
147148144|NCT05396014|530705300|FG006|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
147148145|NCT05396014|530705301|FG007|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
147148146|NCT05396014|530705302|FG008|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
147148147|NCT05396014|530705303|FG009|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
147148148|NCT05396014|530705304|FG010|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
147148149|NCT05396014|530705305|FG011|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
147148150|NCT05396014|530705306|FG012|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
147148151|NCT05396014|530705307|FG013|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
147148152|NCT05396014|530705308|FG014|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
147148153|NCT05396014|530705309|FG015|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
147148154|NCT05396014|530705310|FG016|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
147148155|NCT05396014|530705311|FG017|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
147148156|NCT05396014|530705312|FG018|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
147148157|NCT05396014|530705313|FG019|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
147148158|NCT05396014|530705314|FG020|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
147148159|NCT05396014|530705315|FG021|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
147148160|NCT05396014|530705316|FG022|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
147148161|NCT05396014|530705317|FG023|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
147148162|NCT05396014|530705318|FG024|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
147148163|NCT05396014|530705319|FG025|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
147148164|NCT05396014|530705320|FG026|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|1|||
147148165|NCT05396014|530705321|FG027|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
147148166|NCT05396014|530705322|FG028|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
147148167|NCT05396014|530705323|FG029|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
147148168|NCT05396014|530705324|FG030|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
147148169|NCT05396014|530705325|FG031|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
147148170|NCT05396014|530705326|FG032|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
147148171|NCT05396014|530705327|FG033|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
147148172|NCT05396014|530705328|FG034|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
147148173|NCT05396014|530705329|FG035|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
147148174|NCT05396014|530705330|FG036|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
147148175|NCT05396014|530705331|FG037|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
147148176|NCT05396014|530705332|FG038|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
147320817|NCT04955626|531338420|FG000|Open-Label Period|Other|621|||
147320818|NCT04955626|531338421|FG001|Open-Label Period|Other|429|||
147320819|NCT04955626|531338422|FG002|Open-Label Period|Other|0|||
147320820|NCT04955626|531338423|FG003|Open-Label Period|Other|0|||
147320821|NCT04955626|531338424|FG004|Open-Label Period|Other|0|||
147320822|NCT04955626|531338425|FG005|Open-Label Period|Other|0|||
147320823|NCT04955626|531338426|FG006|Open-Label Period|Other|0|||
147320824|NCT04955626|531338427|FG007|Open-Label Period|Other|0|||
147320825|NCT04955626|531338428|FG008|Open-Label Period|Other|0|||
147652823|NCT03951753|532550396|FG002|Overall Study|Adverse Event|3|||
147320826|NCT04955626|531338429|FG009|Open-Label Period|Other|0|||
147320827|NCT04955626|531338430|FG010|Open-Label Period|Other|0|||
147320828|NCT04955626|531338431|FG011|Open-Label Period|Other|0|||
147320829|NCT04955626|531338432|FG012|Open-Label Period|Other|0|||
147320830|NCT04955626|531338433|FG013|Open-Label Period|Other|0|||
147320831|NCT04955626|531338434|FG014|Open-Label Period|Other|0|||
147320832|NCT04955626|531338435|FG015|Open-Label Period|Other|0|||
147320833|NCT04955626|531338436|FG016|Open-Label Period|Other|0|||
147320834|NCT04955626|531338437|FG017|Open-Label Period|Other|0|||
147320835|NCT04955626|531338438|FG018|Open-Label Period|Other|0|||
147320836|NCT04955626|531338439|FG019|Open-Label Period|Other|0|||
147320837|NCT04955626|531338440|FG020|Open-Label Period|Other|0|||
147320838|NCT04955626|531338441|FG021|Open-Label Period|Other|0|||
147320839|NCT04955626|531338442|FG022|Open-Label Period|Other|0|||
147320840|NCT04955626|531338443|FG023|Open-Label Period|Other|0|||
147320841|NCT04955626|531338444|FG024|Open-Label Period|Other|0|||
147320842|NCT04955626|531338445|FG025|Open-Label Period|Other|0|||
147320843|NCT04955626|531338446|FG026|Open-Label Period|Other|0|||
147320844|NCT04955626|531338447|FG027|Open-Label Period|Other|0|||
147320845|NCT04955626|531338448|FG028|Open-Label Period|Other|0|||
147320846|NCT04955626|531338449|FG029|Open-Label Period|Other|0|||
147320847|NCT04955626|531338450|FG030|Open-Label Period|Other|0|||
147320848|NCT04955626|531338451|FG031|Open-Label Period|Other|0|||
147320849|NCT04955626|531338452|FG032|Open-Label Period|Other|0|||
147320850|NCT04955626|531338453|FG033|Open-Label Period|Other|0|||
147320851|NCT04955626|531338454|FG034|Open-Label Period|Other|0|||
147320852|NCT04955626|531338455|FG035|Open-Label Period|Other|0|||
147320853|NCT04955626|531338420|FG000|Open-Label Period|Physician Decision|2|||
147320854|NCT04955626|531338421|FG001|Open-Label Period|Physician Decision|0|||
147320855|NCT04955626|531338422|FG002|Open-Label Period|Physician Decision|0|||
147320856|NCT04955626|531338423|FG003|Open-Label Period|Physician Decision|0|||
147148177|NCT05396014|530705333|FG039|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
147148178|NCT05396014|530705334|FG040|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
147148179|NCT05396014|530705335|FG041|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
147148180|NCT05396014|530705336|FG042|Stage 2 Intervention (Weeks 12-24)|Protocol Violation|0|||
147148181|NCT03062280|530705337|FG000|Overall Study|Adverse Event|1|||
147148182|NCT03062280|530705337|FG000|Overall Study|Death|1|||
147148183|NCT03062280|530705337|FG000|Overall Study|Fertility Treatment|2|||
147148184|NCT03062280|530705337|FG000|Overall Study|Physician Decision|2|||
147148185|NCT03062280|530705337|FG000|Overall Study|Pregnancy|5|||
147148186|NCT03062280|530705337|FG000|Overall Study|Withdrawal by Subject|11|||
147148187|NCT04439539|530705338|FG000|IP:Day 1-Week 36(Post-PA5)/52(Prior-PA5)|Withdrawal by Subject|1|||
147148188|NCT04439539|530705339|FG001|IP:Day 1-Week 36(Post-PA5)/52(Prior-PA5)|Withdrawal by Subject|0|||
147148189|NCT04439539|530705340|FG002|IP:Day 1-Week 36(Post-PA5)/52(Prior-PA5)|Withdrawal by Subject|2|||
147148190|NCT04439539|530705338|FG000|Follow-up (FU) Phase: FU Week 1 to 48|Other|0|||
147148191|NCT04439539|530705339|FG001|Follow-up (FU) Phase: FU Week 1 to 48|Other|1|||
147148192|NCT04439539|530705340|FG002|Follow-up (FU) Phase: FU Week 1 to 48|Other|0|||
147148193|NCT04439539|530705338|FG000|Follow-up (FU) Phase: FU Week 1 to 48|Withdrawal by Subject|0|||
147148194|NCT04439539|530705339|FG001|Follow-up (FU) Phase: FU Week 1 to 48|Withdrawal by Subject|1|||
147148195|NCT04439539|530705340|FG002|Follow-up (FU) Phase: FU Week 1 to 48|Withdrawal by Subject|0|||
147148196|NCT04551963|530705350|FG000|Overall Study|Physician Decision|1|||
147148197|NCT04551963|530705351|FG001|Overall Study|Physician Decision|1|||
147148198|NCT04551963|530705350|FG000|Overall Study|Death|1|||
147148199|NCT04551963|530705351|FG001|Overall Study|Death|0|||
147148200|NCT03379259|530705352|FG000|Overall Study|Commenced new anti-cancer therapy|1|||
147320857|NCT04955626|531338424|FG004|Open-Label Period|Physician Decision|0|||
147320858|NCT04955626|531338425|FG005|Open-Label Period|Physician Decision|0|||
147320859|NCT04955626|531338426|FG006|Open-Label Period|Physician Decision|0|||
147320860|NCT04955626|531338427|FG007|Open-Label Period|Physician Decision|0|||
147320861|NCT04955626|531338428|FG008|Open-Label Period|Physician Decision|0|||
147320862|NCT04955626|531338429|FG009|Open-Label Period|Physician Decision|0|||
147320863|NCT04955626|531338430|FG010|Open-Label Period|Physician Decision|0|||
147575663|NCT00112437|532263541|FG023|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
147148201|NCT03379259|530705353|FG001|Overall Study|Commenced new anti-cancer therapy|0|||
147148202|NCT03379259|530705354|FG002|Overall Study|Commenced new anti-cancer therapy|0|||
147148203|NCT03379259|530705355|FG003|Overall Study|Commenced new anti-cancer therapy|0|||
147320864|NCT04955626|531338431|FG011|Open-Label Period|Physician Decision|0|||
147320865|NCT04955626|531338432|FG012|Open-Label Period|Physician Decision|0|||
147320866|NCT04955626|531338433|FG013|Open-Label Period|Physician Decision|0|||
147320867|NCT04955626|531338434|FG014|Open-Label Period|Physician Decision|0|||
147320868|NCT04955626|531338435|FG015|Open-Label Period|Physician Decision|0|||
147320869|NCT04955626|531338436|FG016|Open-Label Period|Physician Decision|0|||
147320870|NCT04955626|531338437|FG017|Open-Label Period|Physician Decision|0|||
147320871|NCT04955626|531338438|FG018|Open-Label Period|Physician Decision|0|||
147320872|NCT04955626|531338439|FG019|Open-Label Period|Physician Decision|0|||
147320873|NCT04955626|531338440|FG020|Open-Label Period|Physician Decision|0|||
147320874|NCT04955626|531338441|FG021|Open-Label Period|Physician Decision|0|||
147148204|NCT03379259|530705356|FG004|Overall Study|Commenced new anti-cancer therapy|0|||
147148205|NCT03379259|530705357|FG005|Overall Study|Commenced new anti-cancer therapy|0|||
147148206|NCT03379259|530705352|FG000|Overall Study|Death|0|||
147320875|NCT04955626|531338442|FG022|Open-Label Period|Physician Decision|0|||
147320876|NCT04955626|531338443|FG023|Open-Label Period|Physician Decision|0|||
147320877|NCT04955626|531338444|FG024|Open-Label Period|Physician Decision|0|||
147148207|NCT03379259|530705353|FG001|Overall Study|Death|1|||
147148208|NCT03379259|530705354|FG002|Overall Study|Death|2|||
147148209|NCT03379259|530705355|FG003|Overall Study|Death|1|||
147148210|NCT03379259|530705356|FG004|Overall Study|Death|4|||
147148211|NCT03379259|530705357|FG005|Overall Study|Death|2|||
147148212|NCT03379259|530705352|FG000|Overall Study|Withdrawal by Subject|0|||
147148213|NCT03379259|530705353|FG001|Overall Study|Withdrawal by Subject|0|||
147148214|NCT03379259|530705354|FG002|Overall Study|Withdrawal by Subject|1|||
147148215|NCT03379259|530705355|FG003|Overall Study|Withdrawal by Subject|0|||
147148216|NCT03379259|530705356|FG004|Overall Study|Withdrawal by Subject|2|||
147148217|NCT03379259|530705357|FG005|Overall Study|Withdrawal by Subject|0|||
147148218|NCT03379259|530705352|FG000|Overall Study|Study terminated by sponsor|0|||
147148219|NCT03379259|530705353|FG001|Overall Study|Study terminated by sponsor|0|||
147148220|NCT03379259|530705354|FG002|Overall Study|Study terminated by sponsor|0|||
147148221|NCT03379259|530705355|FG003|Overall Study|Study terminated by sponsor|1|||
147148222|NCT03379259|530705356|FG004|Overall Study|Study terminated by sponsor|1|||
147148223|NCT03379259|530705357|FG005|Overall Study|Study terminated by sponsor|4|||
147148224|NCT03379259|530705352|FG000|Overall Study|Disease progression|0|||
147148225|NCT03379259|530705353|FG001|Overall Study|Disease progression|0|||
147320878|NCT04955626|531338445|FG025|Open-Label Period|Physician Decision|0|||
147320879|NCT04955626|531338446|FG026|Open-Label Period|Physician Decision|0|||
147320880|NCT04955626|531338447|FG027|Open-Label Period|Physician Decision|0|||
147320881|NCT04955626|531338448|FG028|Open-Label Period|Physician Decision|0|||
147320882|NCT04955626|531338449|FG029|Open-Label Period|Physician Decision|0|||
147320883|NCT04955626|531338450|FG030|Open-Label Period|Physician Decision|0|||
147320884|NCT04955626|531338451|FG031|Open-Label Period|Physician Decision|0|||
147320885|NCT04955626|531338452|FG032|Open-Label Period|Physician Decision|0|||
147320886|NCT04955626|531338453|FG033|Open-Label Period|Physician Decision|0|||
147320887|NCT04955626|531338454|FG034|Open-Label Period|Physician Decision|0|||
147320888|NCT04955626|531338455|FG035|Open-Label Period|Physician Decision|0|||
147320889|NCT04955626|531338420|FG000|Open-Label Period|Withdrawal by Subject|135|||
147320890|NCT04955626|531338421|FG001|Open-Label Period|Withdrawal by Subject|25|||
147148226|NCT03379259|530705354|FG002|Overall Study|Disease progression|0|||
147148227|NCT03379259|530705355|FG003|Overall Study|Disease progression|1|||
147148228|NCT03379259|530705356|FG004|Overall Study|Disease progression|0|||
147148229|NCT03379259|530705357|FG005|Overall Study|Disease progression|1|||
147148230|NCT03379259|530705352|FG000|Overall Study|Lost to Follow-up|0|||
147148231|NCT03379259|530705353|FG001|Overall Study|Lost to Follow-up|0|||
147148232|NCT03379259|530705354|FG002|Overall Study|Lost to Follow-up|0|||
147148233|NCT03379259|530705355|FG003|Overall Study|Lost to Follow-up|0|||
147148234|NCT03379259|530705356|FG004|Overall Study|Lost to Follow-up|1|||
147148235|NCT03379259|530705357|FG005|Overall Study|Lost to Follow-up|0|||
147148236|NCT03379259|530705352|FG000|Overall Study|Deteriorating condition|0|||
147148237|NCT03379259|530705353|FG001|Overall Study|Deteriorating condition|0|||
147148238|NCT03379259|530705354|FG002|Overall Study|Deteriorating condition|0|||
147148239|NCT03379259|530705355|FG003|Overall Study|Deteriorating condition|0|||
147148240|NCT03379259|530705356|FG004|Overall Study|Deteriorating condition|1|||
147148241|NCT03379259|530705357|FG005|Overall Study|Deteriorating condition|0|||
147148242|NCT03850093|530705358|FG000|Overall Study|Withdrawal by Subject|1|||
147148243|NCT03850093|530705359|FG001|Overall Study|Withdrawal by Subject|0|||
147148244|NCT03850093|530705360|FG002|Overall Study|Withdrawal by Subject|2|||
147320891|NCT04955626|531338422|FG002|Open-Label Period|Withdrawal by Subject|0|||
147320892|NCT04955626|531338423|FG003|Open-Label Period|Withdrawal by Subject|0|||
147320893|NCT04955626|531338424|FG004|Open-Label Period|Withdrawal by Subject|0|||
147320894|NCT04955626|531338425|FG005|Open-Label Period|Withdrawal by Subject|0|||
147320895|NCT04955626|531338426|FG006|Open-Label Period|Withdrawal by Subject|0|||
147320896|NCT04955626|531338427|FG007|Open-Label Period|Withdrawal by Subject|0|||
147320897|NCT04955626|531338428|FG008|Open-Label Period|Withdrawal by Subject|0|||
147320898|NCT04955626|531338429|FG009|Open-Label Period|Withdrawal by Subject|0|||
147148245|NCT02836717|530705361|FG000|Test Phase|Lack of Efficacy|14|||
147148246|NCT02836717|530705362|FG001|Test Phase|Lack of Efficacy|8|||
147148247|NCT02836717|530705363|FG002|Test Phase|Lack of Efficacy|0|||
147148248|NCT02836717|530705361|FG000|Study Phase|Adverse Event|2|||
147148249|NCT02836717|530705362|FG001|Study Phase|Adverse Event|0|||
147148250|NCT02836717|530705363|FG002|Study Phase|Adverse Event|0|||
147148251|NCT02836717|530705361|FG000|Study Phase|Lack of Efficacy|8|||
147148252|NCT02836717|530705362|FG001|Study Phase|Lack of Efficacy|6|||
147148253|NCT02836717|530705363|FG002|Study Phase|Lack of Efficacy|1|||
147148254|NCT02836717|530705361|FG000|Study Phase|Withdrawal by Subject|1|||
147148255|NCT02836717|530705362|FG001|Study Phase|Withdrawal by Subject|0|||
147148256|NCT02836717|530705363|FG002|Study Phase|Withdrawal by Subject|0|||
147148257|NCT02836717|530705361|FG000|Study Phase|Death|1|||
147320899|NCT04955626|531338430|FG010|Open-Label Period|Withdrawal by Subject|0|||
147320900|NCT04955626|531338431|FG011|Open-Label Period|Withdrawal by Subject|0|||
147148258|NCT02836717|530705362|FG001|Study Phase|Death|0|||
147148259|NCT02836717|530705363|FG002|Study Phase|Death|0|||
147148260|NCT02836717|530705361|FG000|Study Phase|abdominal surgeries|2|||
147148261|NCT02836717|530705362|FG001|Study Phase|abdominal surgeries|1|||
147148262|NCT02836717|530705363|FG002|Study Phase|abdominal surgeries|0|||
147148263|NCT01309997|530705366|FG000|Overall Study|Adverse Event|1|||
147148264|NCT01309997|530705367|FG001|Overall Study|Adverse Event|0|||
147148265|NCT01309997|530705366|FG000|Overall Study|Death|1|||
147148266|NCT01309997|530705367|FG001|Overall Study|Death|3|||
147148267|NCT01309997|530705366|FG000|Overall Study|Lack of Efficacy|2|||
147320901|NCT04955626|531338432|FG012|Open-Label Period|Withdrawal by Subject|0|||
147320902|NCT04955626|531338433|FG013|Open-Label Period|Withdrawal by Subject|0|||
147320903|NCT04955626|531338434|FG014|Open-Label Period|Withdrawal by Subject|0|||
147320904|NCT04955626|531338435|FG015|Open-Label Period|Withdrawal by Subject|0|||
147320905|NCT04955626|531338436|FG016|Open-Label Period|Withdrawal by Subject|0|||
147320906|NCT04955626|531338437|FG017|Open-Label Period|Withdrawal by Subject|0|||
147320907|NCT04955626|531338438|FG018|Open-Label Period|Withdrawal by Subject|0|||
147320908|NCT04955626|531338439|FG019|Open-Label Period|Withdrawal by Subject|0|||
147320909|NCT04955626|531338440|FG020|Open-Label Period|Withdrawal by Subject|0|||
147320910|NCT04955626|531338441|FG021|Open-Label Period|Withdrawal by Subject|0|||
147148268|NCT01309997|530705367|FG001|Overall Study|Lack of Efficacy|2|||
147148269|NCT01309997|530705366|FG000|Overall Study|Withdrawal by Subject|1|||
147148270|NCT01309997|530705367|FG001|Overall Study|Withdrawal by Subject|1|||
147148271|NCT00282087|530705368|FG000|Overall Study|Death|1|||
147148272|NCT03226249|530705369|FG000|2-4 Cycles of AVD +/- Chemo & RT, PET#4|Transferred to another state|1|||
147148273|NCT03226249|530705369|FG000|PEM Consolidation (1-2 Years)|Per Protocol not eligible|29|||
147148274|NCT03226249|530705369|FG000|Survival Follow-up|Patients still in follow-up.|30|||
147148275|NCT01532921|530705372|FG000|Overall Study|Death|3|||
147148276|NCT01532921|530705372|FG000|Overall Study|Withdrawal by Subject|2|||
147148277|NCT01532921|530705372|FG000|Overall Study|Lost to Follow-up|3|||
147148278|NCT01532921|530705372|FG000|Overall Study|Physician Decision|7|||
147148279|NCT01532921|530705372|FG000|Overall Study|Device was explanted during procedure|1|||
147148280|NCT03462641|530705373|FG000|Visit 1|Failed to complete dopaminergic PET scan|1|||
147148281|NCT03462641|530705374|FG001|Visit 1|Failed to complete dopaminergic PET scan|0|||
147148282|NCT03462641|530705373|FG000|Visit 2|Withdrawal by Subject|0|||
147148283|NCT03462641|530705374|FG001|Visit 2|Withdrawal by Subject|1|||
147148284|NCT01804049|530705375|FG000|Overall Study|Adverse Event|2|||
147148285|NCT01804049|530705376|FG001|Overall Study|Adverse Event|10|||
147148286|NCT01804049|530705375|FG000|Overall Study|Lost to Follow-up|2|||
147148287|NCT01804049|530705376|FG001|Overall Study|Lost to Follow-up|1|||
147148288|NCT01804049|530705375|FG000|Overall Study|Decreased interest/personal|4|||
147148289|NCT01804049|530705376|FG001|Overall Study|Decreased interest/personal|5|||
147148290|NCT01804049|530705375|FG000|Overall Study|Other health concerns|2|||
147320911|NCT04955626|531338442|FG022|Open-Label Period|Withdrawal by Subject|0|||
147320912|NCT04955626|531338443|FG023|Open-Label Period|Withdrawal by Subject|0|||
147320913|NCT04955626|531338444|FG024|Open-Label Period|Withdrawal by Subject|0|||
147320914|NCT04955626|531338445|FG025|Open-Label Period|Withdrawal by Subject|0|||
147320915|NCT04955626|531338446|FG026|Open-Label Period|Withdrawal by Subject|0|||
147320916|NCT04955626|531338447|FG027|Open-Label Period|Withdrawal by Subject|0|||
147320917|NCT04955626|531338448|FG028|Open-Label Period|Withdrawal by Subject|0|||
147320918|NCT04955626|531338449|FG029|Open-Label Period|Withdrawal by Subject|0|||
147320919|NCT04955626|531338450|FG030|Open-Label Period|Withdrawal by Subject|0|||
147320920|NCT04955626|531338451|FG031|Open-Label Period|Withdrawal by Subject|0|||
147320921|NCT04955626|531338452|FG032|Open-Label Period|Withdrawal by Subject|0|||
147320922|NCT04955626|531338453|FG033|Open-Label Period|Withdrawal by Subject|0|||
147320923|NCT04955626|531338454|FG034|Open-Label Period|Withdrawal by Subject|0|||
147320924|NCT04955626|531338455|FG035|Open-Label Period|Withdrawal by Subject|0|||
147320925|NCT04955626|531338420|FG000|Open-Label Period|Refused further study procedures|1|||
147320926|NCT04955626|531338421|FG001|Open-Label Period|Refused further study procedures|0|||
147148291|NCT01804049|530705376|FG001|Overall Study|Other health concerns|7|||
147320927|NCT04955626|531338422|FG002|Open-Label Period|Refused further study procedures|0|||
147320928|NCT04955626|531338423|FG003|Open-Label Period|Refused further study procedures|0|||
147320929|NCT04955626|531338424|FG004|Open-Label Period|Refused further study procedures|0|||
147320930|NCT04955626|531338425|FG005|Open-Label Period|Refused further study procedures|0|||
147320931|NCT04955626|531338426|FG006|Open-Label Period|Refused further study procedures|0|||
147148292|NCT01804049|530705375|FG000|Overall Study|Moved out of area|0|||
147148293|NCT01804049|530705376|FG001|Overall Study|Moved out of area|7|||
147148294|NCT01804049|530705375|FG000|Overall Study|other MD recommended|1|||
147148295|NCT01804049|530705376|FG001|Overall Study|other MD recommended|1|||
147148296|NCT01804049|530705375|FG000|Overall Study|Enrollment in dual studies|0|||
147148297|NCT01804049|530705376|FG001|Overall Study|Enrollment in dual studies|1|||
147148298|NCT00588237|530705381|FG000|Overall Study|Evaluable for toxicity only|3|||
147148299|NCT00588237|530705381|FG000|Overall Study|Patien not treated|1|||
147148300|NCT02201329|530705384|FG000|Overall Study|Progressive Dis./Relapse/Clinical Prog.|3|||
147148301|NCT02201329|530705384|FG000|Overall Study|Withdrawal by Subject|2|||
147148302|NCT01262638|530705385|FG000|Overall Study|Adverse Event|3|||
147148303|NCT01262638|530705386|FG001|Overall Study|Adverse Event|4|||
147148304|NCT01262638|530705387|FG002|Overall Study|Adverse Event|3|||
147148305|NCT01262638|530705388|FG003|Overall Study|Adverse Event|4|||
147148306|NCT01262638|530705385|FG000|Overall Study|Protocol Violation|1|||
147148307|NCT01262638|530705386|FG001|Overall Study|Protocol Violation|0|||
147148308|NCT01262638|530705387|FG002|Overall Study|Protocol Violation|0|||
147148309|NCT01262638|530705388|FG003|Overall Study|Protocol Violation|1|||
147148310|NCT01262638|530705385|FG000|Overall Study|Withdrawal by Subject|2|||
147148311|NCT01262638|530705386|FG001|Overall Study|Withdrawal by Subject|1|||
147148312|NCT01262638|530705387|FG002|Overall Study|Withdrawal by Subject|0|||
147148313|NCT01262638|530705388|FG003|Overall Study|Withdrawal by Subject|1|||
147148314|NCT01262638|530705385|FG000|Overall Study|Per Investigator/Sponsor/Regulatory Body|0|||
147148315|NCT01262638|530705386|FG001|Overall Study|Per Investigator/Sponsor/Regulatory Body|0|||
147148316|NCT01262638|530705387|FG002|Overall Study|Per Investigator/Sponsor/Regulatory Body|1|||
147148317|NCT01262638|530705388|FG003|Overall Study|Per Investigator/Sponsor/Regulatory Body|0|||
147148318|NCT01262638|530705385|FG000|Overall Study|Lost to Follow-up|1|||
147148319|NCT01262638|530705386|FG001|Overall Study|Lost to Follow-up|1|||
147148320|NCT01262638|530705387|FG002|Overall Study|Lost to Follow-up|1|||
147148321|NCT01262638|530705388|FG003|Overall Study|Lost to Follow-up|1|||
147148322|NCT01262638|530705385|FG000|Overall Study|Participant Went Out of Town|0|||
147148323|NCT01262638|530705386|FG001|Overall Study|Participant Went Out of Town|0|||
147148324|NCT01262638|530705387|FG002|Overall Study|Participant Went Out of Town|1|||
147148325|NCT01262638|530705388|FG003|Overall Study|Participant Went Out of Town|0|||
147148326|NCT03472495|530705394|FG000|Overall Study|Treatment no longer indicated|1|||
147148327|NCT03472495|530705395|FG001|Overall Study|Treatment no longer indicated|2|||
147148328|NCT03472495|530705394|FG000|Overall Study|Physician Decision|0|||
147148329|NCT03472495|530705395|FG001|Overall Study|Physician Decision|2|||
147148330|NCT01001767|530705398|FG000|Overall Study|no baseline study performed|1|||
147148331|NCT01001767|530705399|FG001|Overall Study|no baseline study performed|0|||
147148332|NCT01001767|530705398|FG000|Overall Study|Protocol Violation|1|||
147148333|NCT01001767|530705399|FG001|Overall Study|Protocol Violation|0|||
147148334|NCT01001767|530705398|FG000|Overall Study|Lost to Follow-up|1|||
147148335|NCT01001767|530705399|FG001|Overall Study|Lost to Follow-up|0|||
147148336|NCT01001767|530705398|FG000|Overall Study|Physician Decision|1|||
147148337|NCT01001767|530705399|FG001|Overall Study|Physician Decision|0|||
147148338|NCT00851552|530705401|FG000|Overall Study|Death|2|||
147148339|NCT00851552|530705401|FG000|Overall Study|Adverse Event|1|||
147148340|NCT00851552|530705401|FG000|Overall Study|Disease Progression|4|||
147148341|NCT02689206|530705402|FG000|Overall Study|Adverse Event|0|||
147148342|NCT02689206|530705403|FG001|Overall Study|Adverse Event|0|||
147148343|NCT02689206|530705404|FG002|Overall Study|Adverse Event|1|||
147148344|NCT02689206|530705405|FG003|Overall Study|Adverse Event|0|||
147148345|NCT02689206|530705406|FG004|Overall Study|Adverse Event|2|||
147148346|NCT02689206|530705402|FG000|Overall Study|Protocol Violation|1|||
147148347|NCT02689206|530705403|FG001|Overall Study|Protocol Violation|0|||
147148348|NCT02689206|530705404|FG002|Overall Study|Protocol Violation|0|||
147148349|NCT02689206|530705405|FG003|Overall Study|Protocol Violation|1|||
147148350|NCT02689206|530705406|FG004|Overall Study|Protocol Violation|2|||
147148351|NCT02689206|530705402|FG000|Overall Study|Other: Reached stopping criteria|0|||
147148352|NCT02689206|530705403|FG001|Overall Study|Other: Reached stopping criteria|1|||
147148353|NCT02689206|530705404|FG002|Overall Study|Other: Reached stopping criteria|2|||
147148354|NCT02689206|530705405|FG003|Overall Study|Other: Reached stopping criteria|3|||
147148355|NCT02689206|530705406|FG004|Overall Study|Other: Reached stopping criteria|4|||
147148356|NCT02689206|530705402|FG000|Overall Study|Physician Decision|1|||
147148357|NCT02689206|530705403|FG001|Overall Study|Physician Decision|0|||
147148358|NCT02689206|530705404|FG002|Overall Study|Physician Decision|0|||
147320932|NCT04955626|531338427|FG007|Open-Label Period|Refused further study procedures|0|||
147320933|NCT04955626|531338428|FG008|Open-Label Period|Refused further study procedures|0|||
147320934|NCT04955626|531338429|FG009|Open-Label Period|Refused further study procedures|0|||
147148359|NCT02689206|530705405|FG003|Overall Study|Physician Decision|0|||
147148360|NCT02689206|530705406|FG004|Overall Study|Physician Decision|0|||
147148361|NCT02689206|530705402|FG000|Overall Study|Withdrawal by Subject|1|||
147148362|NCT02689206|530705403|FG001|Overall Study|Withdrawal by Subject|0|||
147148363|NCT02689206|530705404|FG002|Overall Study|Withdrawal by Subject|1|||
147320935|NCT04955626|531338430|FG010|Open-Label Period|Refused further study procedures|0|||
147148364|NCT02689206|530705405|FG003|Overall Study|Withdrawal by Subject|0|||
147148365|NCT02689206|530705406|FG004|Overall Study|Withdrawal by Subject|0|||
147148366|NCT01479764|530705408|FG000|Randomized|Adverse Event|1|||
147148367|NCT01479764|530705409|FG001|Randomized|Adverse Event|1|||
147148368|NCT01479764|530705408|FG000|Randomized|Withdrawal by Subject|1|||
147148369|NCT01479764|530705409|FG001|Randomized|Withdrawal by Subject|0|||
147148370|NCT01479764|530705408|FG000|Treated|Lost to Follow-up|0|||
147148371|NCT01479764|530705409|FG001|Treated|Lost to Follow-up|2|||
147148372|NCT01916824|530705410|FG000|Overall Study|Lost to Follow-up|3|||
147320936|NCT04955626|531338431|FG011|Open-Label Period|Refused further study procedures|0|||
147320937|NCT04955626|531338432|FG012|Open-Label Period|Refused further study procedures|0|||
147652824|NCT03951753|532550394|FG000|Overall Study|Withdrawal by Subject|3|||
147652825|NCT03951753|532550395|FG001|Overall Study|Withdrawal by Subject|1|||
147652826|NCT03951753|532550396|FG002|Overall Study|Withdrawal by Subject|0|||
147652827|NCT03951753|532550394|FG000|Overall Study|Lost to Follow-up|0|||
147652828|NCT03951753|532550395|FG001|Overall Study|Lost to Follow-up|0|||
147652829|NCT03951753|532550396|FG002|Overall Study|Lost to Follow-up|1|||
147652830|NCT01905592|532550399|FG000|Overall Study|Disease Progression|51|||
147652831|NCT01905592|532550400|FG001|Overall Study|Disease Progression|110|||
147652832|NCT01905592|532550399|FG000|Overall Study|Toxicity|1|||
147652833|NCT01905592|532550400|FG001|Overall Study|Toxicity|16|||
147652834|NCT01905592|532550399|FG000|Overall Study|Physician Decision|0|||
147652835|NCT01905592|532550400|FG001|Overall Study|Physician Decision|2|||
147320938|NCT04955626|531338433|FG013|Open-Label Period|Refused further study procedures|0|||
147320939|NCT04955626|531338434|FG014|Open-Label Period|Refused further study procedures|0|||
147320940|NCT04955626|531338435|FG015|Open-Label Period|Refused further study procedures|0|||
147652836|NCT01905592|532550399|FG000|Overall Study|Start of New anti-cancer Treatment|1|||
147652837|NCT01905592|532550400|FG001|Overall Study|Start of New anti-cancer Treatment|0|||
147652838|NCT01905592|532550399|FG000|Overall Study|Protocol Violation|0|||
147652839|NCT01905592|532550400|FG001|Overall Study|Protocol Violation|1|||
147652840|NCT01905592|532550399|FG000|Overall Study|Sponsor's decision|1|||
147652841|NCT01905592|532550400|FG001|Overall Study|Sponsor's decision|1|||
147652842|NCT01905592|532550399|FG000|Overall Study|Not treated|7|||
147148373|NCT01916824|530705411|FG001|Overall Study|Lost to Follow-up|6|||
147320941|NCT04955626|531338436|FG016|Open-Label Period|Refused further study procedures|0|||
147320942|NCT04955626|531338437|FG017|Open-Label Period|Refused further study procedures|0|||
147320943|NCT04955626|531338438|FG018|Open-Label Period|Refused further study procedures|0|||
147320944|NCT04955626|531338439|FG019|Open-Label Period|Refused further study procedures|0|||
147320945|NCT04955626|531338440|FG020|Open-Label Period|Refused further study procedures|0|||
147320946|NCT04955626|531338441|FG021|Open-Label Period|Refused further study procedures|0|||
147320947|NCT04955626|531338442|FG022|Open-Label Period|Refused further study procedures|0|||
147575664|NCT00112437|532263542|FG024|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
147575665|NCT00112437|532263543|FG025|Year 2 (12-Month Extension)|Withdrawal by Subject|0|||
147575666|NCT00112437|532263518|FG000|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
147575667|NCT00112437|532263519|FG001|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
147575668|NCT00112437|532263520|FG002|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
147575669|NCT00112437|532263521|FG003|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
147575670|NCT00112437|532263522|FG004|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
147575671|NCT00112437|532263523|FG005|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
147575672|NCT00112437|532263524|FG006|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
147575673|NCT00112437|532263525|FG007|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
147575674|NCT00112437|532263526|FG008|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
147575675|NCT00112437|532263527|FG009|Year 2 (12-Month Extension)|Patient stopped taking medication|1|||
147575676|NCT00112437|532263528|FG010|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
147575677|NCT00112437|532263529|FG011|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
147575678|NCT00112437|532263530|FG012|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
147575679|NCT00112437|532263531|FG013|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
147575680|NCT00112437|532263532|FG014|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
147575681|NCT00112437|532263533|FG015|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
147575682|NCT00112437|532263534|FG016|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
147575683|NCT00112437|532263535|FG017|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
147575684|NCT00112437|532263536|FG018|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
147575685|NCT00112437|532263537|FG019|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
147575686|NCT00112437|532263538|FG020|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
147148374|NCT01916824|530705410|FG000|Overall Study|Physician Decision|2|||
147148375|NCT01916824|530705411|FG001|Overall Study|Physician Decision|0|||
147148376|NCT01916824|530705410|FG000|Overall Study|Withdrawal by Subject|2|||
147148377|NCT01916824|530705411|FG001|Overall Study|Withdrawal by Subject|3|||
147148378|NCT00771927|530705412|FG000|Overall Study|Adverse Event|100|||
147148379|NCT00771927|530705413|FG001|Overall Study|Adverse Event|105|||
147575687|NCT00112437|532263539|FG021|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
147652843|NCT01905592|532550400|FG001|Overall Study|Not treated|3|||
147652844|NCT01905592|532550399|FG000|Overall Study|Withdrawal by Subject|10|||
147652845|NCT01905592|532550400|FG001|Overall Study|Withdrawal by Subject|2|||
147652846|NCT00314808|532551839|FG000|Overall Study|Disease Progression without AE|4|||
147652847|NCT00314808|532551839|FG000|Overall Study|Withdrawal by Subject/PI without AE|4|||
147148380|NCT00771927|530705412|FG000|Overall Study|Lack of Efficacy|70|||
147148381|NCT00771927|530705413|FG001|Overall Study|Lack of Efficacy|42|||
147652848|NCT04304508|532551840|FG000|Overall Study|Subject Decision|29|||
147148382|NCT00771927|530705412|FG000|Overall Study|Lost to Follow-up|46|||
147148383|NCT00771927|530705413|FG001|Overall Study|Lost to Follow-up|46|||
147148384|NCT00771927|530705412|FG000|Overall Study|Withdrawal by Subject|16|||
147148385|NCT00771927|530705413|FG001|Overall Study|Withdrawal by Subject|17|||
147148386|NCT00771927|530705412|FG000|Overall Study|Other reason|23|||
147148387|NCT00771927|530705413|FG001|Overall Study|Other reason|27|||
147148388|NCT03835481|530705414|FG000|Double-blind Period|Other not stated below|0|||
147148389|NCT03835481|530705415|FG001|Double-blind Period|Other not stated below|0|||
147148390|NCT03835481|530705416|FG002|Double-blind Period|Other not stated below|0|||
147148391|NCT03835481|530705417|FG003|Double-blind Period|Other not stated below|1|||
147148392|NCT03835481|530705418|FG004|Double-blind Period|Other not stated below|1|||
147148393|NCT03835481|530705414|FG000|Double-blind Period|Termination of treatment by sponsor|0|||
147148394|NCT03835481|530705415|FG001|Double-blind Period|Termination of treatment by sponsor|0|||
147148395|NCT03835481|530705416|FG002|Double-blind Period|Termination of treatment by sponsor|0|||
147148396|NCT03835481|530705417|FG003|Double-blind Period|Termination of treatment by sponsor|0|||
147148397|NCT03835481|530705418|FG004|Double-blind Period|Termination of treatment by sponsor|35|||
147148398|NCT03835481|530705414|FG000|Double-blind Period|Withdrawal by Subject|0|||
147148399|NCT03835481|530705415|FG001|Double-blind Period|Withdrawal by Subject|0|||
147148400|NCT03835481|530705416|FG002|Double-blind Period|Withdrawal by Subject|1|||
147148401|NCT03835481|530705417|FG003|Double-blind Period|Withdrawal by Subject|0|||
147148402|NCT03835481|530705418|FG004|Double-blind Period|Withdrawal by Subject|5|||
147148403|NCT03835481|530705414|FG000|Double-blind Period|Lost to Follow-up|0|||
147148404|NCT03835481|530705415|FG001|Double-blind Period|Lost to Follow-up|0|||
147148405|NCT03835481|530705416|FG002|Double-blind Period|Lost to Follow-up|0|||
147148406|NCT03835481|530705417|FG003|Double-blind Period|Lost to Follow-up|1|||
147148407|NCT03835481|530705418|FG004|Double-blind Period|Lost to Follow-up|0|||
147148408|NCT03835481|530705414|FG000|Double-blind Period|Protocol Violation|0|||
147148409|NCT03835481|530705415|FG001|Double-blind Period|Protocol Violation|2|||
147148410|NCT03835481|530705416|FG002|Double-blind Period|Protocol Violation|0|||
147148411|NCT03835481|530705417|FG003|Double-blind Period|Protocol Violation|1|||
147148412|NCT03835481|530705418|FG004|Double-blind Period|Protocol Violation|0|||
147148413|NCT03835481|530705414|FG000|Open Label Period (After Week 12)|Termination of treatment by Sponsor|0|||
147148414|NCT03835481|530705415|FG001|Open Label Period (After Week 12)|Termination of treatment by Sponsor|0|||
147148415|NCT03835481|530705416|FG002|Open Label Period (After Week 12)|Termination of treatment by Sponsor|23|||
147148416|NCT03835481|530705417|FG003|Open Label Period (After Week 12)|Termination of treatment by Sponsor|31|||
147148417|NCT03835481|530705418|FG004|Open Label Period (After Week 12)|Termination of treatment by Sponsor|35|||
147148418|NCT03835481|530705414|FG000|Open Label Period (After Week 12)|Withdrawal by Subject|0|||
147148419|NCT03835481|530705415|FG001|Open Label Period (After Week 12)|Withdrawal by Subject|0|||
147148420|NCT03835481|530705416|FG002|Open Label Period (After Week 12)|Withdrawal by Subject|7|||
147148421|NCT03835481|530705417|FG003|Open Label Period (After Week 12)|Withdrawal by Subject|9|||
147148422|NCT03835481|530705418|FG004|Open Label Period (After Week 12)|Withdrawal by Subject|1|||
147148423|NCT03835481|530705414|FG000|Open Label Period (After Week 12)|Lost to Follow-up|0|||
147148424|NCT03835481|530705415|FG001|Open Label Period (After Week 12)|Lost to Follow-up|0|||
147148425|NCT03835481|530705416|FG002|Open Label Period (After Week 12)|Lost to Follow-up|4|||
147148426|NCT03835481|530705417|FG003|Open Label Period (After Week 12)|Lost to Follow-up|3|||
147148427|NCT03835481|530705418|FG004|Open Label Period (After Week 12)|Lost to Follow-up|0|||
147148428|NCT03835481|530705414|FG000|Open Label Period (After Week 12)|Adverse Event|0|||
147148429|NCT03835481|530705415|FG001|Open Label Period (After Week 12)|Adverse Event|0|||
147148430|NCT03835481|530705416|FG002|Open Label Period (After Week 12)|Adverse Event|1|||
147148431|NCT03835481|530705417|FG003|Open Label Period (After Week 12)|Adverse Event|1|||
147148432|NCT03835481|530705418|FG004|Open Label Period (After Week 12)|Adverse Event|0|||
147148433|NCT03835481|530705414|FG000|Open Label Period (After Week 12)|Covid-19 related, not due to Adverse event|0|||
147148434|NCT03835481|530705415|FG001|Open Label Period (After Week 12)|Covid-19 related, not due to Adverse event|0|||
147148435|NCT03835481|530705416|FG002|Open Label Period (After Week 12)|Covid-19 related, not due to Adverse event|0|||
147148436|NCT03835481|530705417|FG003|Open Label Period (After Week 12)|Covid-19 related, not due to Adverse event|1|||
147148437|NCT03835481|530705418|FG004|Open Label Period (After Week 12)|Covid-19 related, not due to Adverse event|0|||
147575688|NCT00112437|532263540|FG022|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
147575689|NCT00112437|532263541|FG023|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
147575690|NCT00112437|532263542|FG024|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
147148438|NCT03835481|530705414|FG000|Open Label Period (After Week 12)|Other not stated above|0|||
147148439|NCT03835481|530705415|FG001|Open Label Period (After Week 12)|Other not stated above|0|||
147148440|NCT03835481|530705416|FG002|Open Label Period (After Week 12)|Other not stated above|0|||
147148441|NCT03835481|530705417|FG003|Open Label Period (After Week 12)|Other not stated above|1|||
147148442|NCT03835481|530705418|FG004|Open Label Period (After Week 12)|Other not stated above|1|||
147148443|NCT00191945|530705420|FG000|Double-Blind Acute Treatment|Parent's Decision|3|||
147575691|NCT00112437|532263543|FG025|Year 2 (12-Month Extension)|Patient stopped taking medication|0|||
147575692|NCT00112437|532263518|FG000|Year 2 (12-Month Extension)|patient was out of windows|0|||
147148444|NCT00191945|530705421|FG001|Double-Blind Acute Treatment|Parent's Decision|0|||
147148445|NCT00191945|530705420|FG000|Double-Blind Acute Treatment|Lost to Follow-up|0|||
147148446|NCT00191945|530705421|FG001|Double-Blind Acute Treatment|Lost to Follow-up|1|||
147148447|NCT00191945|530705420|FG000|Double-Blind Acute Treatment|Non Protocol Compliance|3|||
147148448|NCT00191945|530705421|FG001|Double-Blind Acute Treatment|Non Protocol Compliance|0|||
147148449|NCT00191945|530705420|FG000|Double-Blind Acute Treatment|Physician Decision|0|||
147575693|NCT00112437|532263519|FG001|Year 2 (12-Month Extension)|patient was out of windows|0|||
147575694|NCT00112437|532263520|FG002|Year 2 (12-Month Extension)|patient was out of windows|0|||
147575695|NCT00112437|532263521|FG003|Year 2 (12-Month Extension)|patient was out of windows|0|||
147575696|NCT00112437|532263522|FG004|Year 2 (12-Month Extension)|patient was out of windows|0|||
147148450|NCT00191945|530705421|FG001|Double-Blind Acute Treatment|Physician Decision|2|||
147148451|NCT02063984|530705422|FG000|Overall Study|Lost to Follow-up|6|||
147148452|NCT02063984|530705423|FG001|Overall Study|Lost to Follow-up|5|||
147148453|NCT00958347|530705426|FG000|Overall Study|Death|43|||
147148454|NCT00958347|530705426|FG000|Overall Study|Withdrawal by Subject|23|||
147148455|NCT00958347|530705426|FG000|Overall Study|Lost to Follow-up|15|||
147575697|NCT00112437|532263523|FG005|Year 2 (12-Month Extension)|patient was out of windows|0|||
147575698|NCT00112437|532263524|FG006|Year 2 (12-Month Extension)|patient was out of windows|0|||
147575699|NCT00112437|532263525|FG007|Year 2 (12-Month Extension)|patient was out of windows|0|||
147575700|NCT00112437|532263526|FG008|Year 2 (12-Month Extension)|patient was out of windows|0|||
147575701|NCT00112437|532263527|FG009|Year 2 (12-Month Extension)|patient was out of windows|1|||
147575702|NCT00112437|532263528|FG010|Year 2 (12-Month Extension)|patient was out of windows|0|||
147575703|NCT00112437|532263529|FG011|Year 2 (12-Month Extension)|patient was out of windows|0|||
147575704|NCT00112437|532263530|FG012|Year 2 (12-Month Extension)|patient was out of windows|0|||
147575705|NCT00112437|532263531|FG013|Year 2 (12-Month Extension)|patient was out of windows|0|||
147575706|NCT00112437|532263532|FG014|Year 2 (12-Month Extension)|patient was out of windows|0|||
147575707|NCT00112437|532263533|FG015|Year 2 (12-Month Extension)|patient was out of windows|0|||
147148456|NCT00958347|530705426|FG000|Overall Study|revision/removal|10|||
147148457|NCT00958347|530705426|FG000|Overall Study|study termination|135|||
147148458|NCT02146131|530705427|FG000|Overall Study|Physician Decision|61|||
147148459|NCT02146131|530705428|FG001|Overall Study|Physician Decision|56|||
147148460|NCT02567799|530705429|FG000|Concurrent Chemoradiotherapy|Death|1|||
147148461|NCT02567799|530705430|FG001|Concurrent Chemoradiotherapy|Death|0|||
147148462|NCT02567799|530705431|FG002|Concurrent Chemoradiotherapy|Death|0|||
147148463|NCT02567799|530705429|FG000|Concurrent Chemoradiotherapy|Adverse Event|0|||
147148464|NCT02567799|530705430|FG001|Concurrent Chemoradiotherapy|Adverse Event|1|||
147148465|NCT02567799|530705431|FG002|Concurrent Chemoradiotherapy|Adverse Event|0|||
147148466|NCT02567799|530705429|FG000|Concurrent Chemoradiotherapy|Progressive Disease|0|||
147148467|NCT02567799|530705430|FG001|Concurrent Chemoradiotherapy|Progressive Disease|2|||
147148468|NCT02567799|530705431|FG002|Concurrent Chemoradiotherapy|Progressive Disease|1|||
147148469|NCT02567799|530705429|FG000|Follow-up|Death|1|||
147148470|NCT02567799|530705430|FG001|Follow-up|Death|0|||
147148471|NCT02567799|530705431|FG002|Follow-up|Death|1|||
147148472|NCT02567799|530705429|FG000|Follow-up|Progressive Disease|1|||
147148473|NCT02567799|530705430|FG001|Follow-up|Progressive Disease|1|||
147575708|NCT00112437|532263534|FG016|Year 2 (12-Month Extension)|patient was out of windows|0|||
147575709|NCT00112437|532263535|FG017|Year 2 (12-Month Extension)|patient was out of windows|0|||
147320948|NCT04955626|531338443|FG023|Open-Label Period|Refused further study procedures|0|||
147320949|NCT04955626|531338444|FG024|Open-Label Period|Refused further study procedures|0|||
147575710|NCT00112437|532263536|FG018|Year 2 (12-Month Extension)|patient was out of windows|0|||
147575711|NCT00112437|532263537|FG019|Year 2 (12-Month Extension)|patient was out of windows|0|||
147575712|NCT00112437|532263538|FG020|Year 2 (12-Month Extension)|patient was out of windows|0|||
147575713|NCT00112437|532263539|FG021|Year 2 (12-Month Extension)|patient was out of windows|0|||
147575714|NCT00112437|532263540|FG022|Year 2 (12-Month Extension)|patient was out of windows|0|||
147575715|NCT00112437|532263541|FG023|Year 2 (12-Month Extension)|patient was out of windows|0|||
147575716|NCT00112437|532263542|FG024|Year 2 (12-Month Extension)|patient was out of windows|0|||
147148474|NCT02567799|530705431|FG002|Follow-up|Progressive Disease|3|||
147148475|NCT03292640|530705432|FG000|Overall Study|Withdrawal by Subject|17|||
147148476|NCT03292640|530705433|FG001|Overall Study|Withdrawal by Subject|16|||
147148477|NCT03292640|530705432|FG000|Overall Study|Adverse Event|20|||
147148478|NCT03292640|530705433|FG001|Overall Study|Adverse Event|2|||
147320950|NCT04955626|531338445|FG025|Open-Label Period|Refused further study procedures|0|||
147320951|NCT04955626|531338446|FG026|Open-Label Period|Refused further study procedures|0|||
147320952|NCT04955626|531338447|FG027|Open-Label Period|Refused further study procedures|0|||
147148479|NCT03292640|530705432|FG000|Overall Study|Lost to Follow-up|24|||
147575717|NCT00112437|532263543|FG025|Year 2 (12-Month Extension)|patient was out of windows|0|||
147575718|NCT00112437|532263518|FG000|Year 2 (12-Month Extension)|Moved|0|||
147575719|NCT00112437|532263519|FG001|Year 2 (12-Month Extension)|Moved|0|||
147575720|NCT00112437|532263520|FG002|Year 2 (12-Month Extension)|Moved|0|||
147575721|NCT00112437|532263521|FG003|Year 2 (12-Month Extension)|Moved|0|||
147575722|NCT00112437|532263522|FG004|Year 2 (12-Month Extension)|Moved|0|||
147148480|NCT03292640|530705433|FG001|Overall Study|Lost to Follow-up|24|||
147320953|NCT04955626|531338448|FG028|Open-Label Period|Refused further study procedures|0|||
147320954|NCT04955626|531338449|FG029|Open-Label Period|Refused further study procedures|0|||
147320955|NCT04955626|531338450|FG030|Open-Label Period|Refused further study procedures|0|||
147148481|NCT04380753|530705436|FG000|Overall Study|Participants continuing study|4|||
147148482|NCT04380753|530705436|FG000|Overall Study|Death|2|||
147148483|NCT05356910|530705437|FG000|Overall Study|Lost to Follow-up|10|||
147148484|NCT05356910|530705438|FG001|Overall Study|Lost to Follow-up|19|||
147148485|NCT05356910|530705439|FG002|Overall Study|Lost to Follow-up|0|||
147148486|NCT05356910|530705440|FG003|Overall Study|Lost to Follow-up|0|||
147148487|NCT05356910|530705437|FG000|Overall Study|Withdrawal by Subject|4|||
147148488|NCT05356910|530705438|FG001|Overall Study|Withdrawal by Subject|2|||
147148489|NCT05356910|530705439|FG002|Overall Study|Withdrawal by Subject|0|||
147148490|NCT05356910|530705440|FG003|Overall Study|Withdrawal by Subject|0|||
147148491|NCT03306433|530705443|FG000|Overall Study|Lost to Follow-up|3|||
147148492|NCT03306433|530705443|FG000|Overall Study|Patient did not have teeth extracted|1|||
147148493|NCT03306433|530705443|FG000|Overall Study|Teeth not sent to the lab or participant only had two teeth for extraction|3|||
147148494|NCT00819156|530705444|FG000|Overall Study|Adverse Event|1|||
147148495|NCT00819156|530705445|FG001|Overall Study|Adverse Event|4|||
147148496|NCT00819156|530705446|FG002|Overall Study|Adverse Event|2|||
147148497|NCT00819156|530705447|FG003|Overall Study|Adverse Event|1|||
147148498|NCT00819156|530705448|FG004|Overall Study|Adverse Event|2|||
147148499|NCT00819156|530705449|FG005|Overall Study|Adverse Event|3|||
147148500|NCT00819156|530705444|FG000|Overall Study|Withdrawal by Subject|0|||
147148501|NCT00819156|530705445|FG001|Overall Study|Withdrawal by Subject|3|||
147148502|NCT00819156|530705446|FG002|Overall Study|Withdrawal by Subject|2|||
147148503|NCT00819156|530705447|FG003|Overall Study|Withdrawal by Subject|0|||
147148504|NCT00819156|530705448|FG004|Overall Study|Withdrawal by Subject|1|||
147148505|NCT00819156|530705449|FG005|Overall Study|Withdrawal by Subject|0|||
147148506|NCT00819156|530705444|FG000|Overall Study|Protocol Violation|1|||
147148507|NCT00819156|530705445|FG001|Overall Study|Protocol Violation|0|||
147148508|NCT00819156|530705446|FG002|Overall Study|Protocol Violation|1|||
147148509|NCT00819156|530705447|FG003|Overall Study|Protocol Violation|0|||
147148510|NCT00819156|530705448|FG004|Overall Study|Protocol Violation|0|||
147148511|NCT00819156|530705449|FG005|Overall Study|Protocol Violation|1|||
147148512|NCT00819156|530705444|FG000|Overall Study|Lost to Follow-up|0|||
147148513|NCT00819156|530705445|FG001|Overall Study|Lost to Follow-up|1|||
147148514|NCT00819156|530705446|FG002|Overall Study|Lost to Follow-up|0|||
147148515|NCT00819156|530705447|FG003|Overall Study|Lost to Follow-up|0|||
147148516|NCT00819156|530705448|FG004|Overall Study|Lost to Follow-up|0|||
147148517|NCT00819156|530705449|FG005|Overall Study|Lost to Follow-up|2|||
147148518|NCT00819156|530705444|FG000|Overall Study|Testosterone >1ng/ml from Day 28+|5|||
147148519|NCT00819156|530705445|FG001|Overall Study|Testosterone >1ng/ml from Day 28+|2|||
147320956|NCT04955626|531338451|FG031|Open-Label Period|Refused further study procedures|0|||
147320957|NCT04955626|531338452|FG032|Open-Label Period|Refused further study procedures|0|||
147320958|NCT04955626|531338453|FG033|Open-Label Period|Refused further study procedures|0|||
147320959|NCT04955626|531338454|FG034|Open-Label Period|Refused further study procedures|0|||
147320960|NCT04955626|531338455|FG035|Open-Label Period|Refused further study procedures|0|||
147320961|NCT04955626|531338420|FG000|Open-Label Period|Adverse Event|1|||
147320962|NCT04955626|531338421|FG001|Open-Label Period|Adverse Event|0|||
147320963|NCT04955626|531338422|FG002|Open-Label Period|Adverse Event|0|||
147320964|NCT04955626|531338423|FG003|Open-Label Period|Adverse Event|0|||
147320965|NCT04955626|531338424|FG004|Open-Label Period|Adverse Event|0|||
147320966|NCT04955626|531338425|FG005|Open-Label Period|Adverse Event|0|||
147320967|NCT04955626|531338426|FG006|Open-Label Period|Adverse Event|0|||
147320968|NCT04955626|531338427|FG007|Open-Label Period|Adverse Event|0|||
147320969|NCT04955626|531338428|FG008|Open-Label Period|Adverse Event|0|||
147320970|NCT04955626|531338429|FG009|Open-Label Period|Adverse Event|0|||
147320971|NCT04955626|531338430|FG010|Open-Label Period|Adverse Event|0|||
147320972|NCT04955626|531338431|FG011|Open-Label Period|Adverse Event|0|||
147320973|NCT04955626|531338432|FG012|Open-Label Period|Adverse Event|0|||
147320974|NCT04955626|531338433|FG013|Open-Label Period|Adverse Event|0|||
147320975|NCT04955626|531338434|FG014|Open-Label Period|Adverse Event|0|||
147320976|NCT04955626|531338435|FG015|Open-Label Period|Adverse Event|0|||
147148520|NCT00819156|530705446|FG002|Overall Study|Testosterone >1ng/ml from Day 28+|1|||
147148521|NCT00819156|530705447|FG003|Overall Study|Testosterone >1ng/ml from Day 28+|1|||
147148522|NCT00819156|530705448|FG004|Overall Study|Testosterone >1ng/ml from Day 28+|1|||
147148523|NCT00819156|530705449|FG005|Overall Study|Testosterone >1ng/ml from Day 28+|2|||
147148524|NCT00819156|530705444|FG000|Overall Study|Testosterone >=.5ng/ml 2 visits|3|||
147148525|NCT00819156|530705445|FG001|Overall Study|Testosterone >=.5ng/ml 2 visits|0|||
147148526|NCT00819156|530705446|FG002|Overall Study|Testosterone >=.5ng/ml 2 visits|0|||
147148527|NCT00819156|530705447|FG003|Overall Study|Testosterone >=.5ng/ml 2 visits|0|||
147320977|NCT04955626|531338436|FG016|Open-Label Period|Adverse Event|0|||
147320978|NCT04955626|531338437|FG017|Open-Label Period|Adverse Event|0|||
147320979|NCT04955626|531338438|FG018|Open-Label Period|Adverse Event|0|||
147148528|NCT00819156|530705448|FG004|Overall Study|Testosterone >=.5ng/ml 2 visits|1|||
147148529|NCT00819156|530705449|FG005|Overall Study|Testosterone >=.5ng/ml 2 visits|0|||
147148530|NCT00819156|530705444|FG000|Overall Study|Prostate-specific antigen progression|0|||
147148531|NCT00819156|530705445|FG001|Overall Study|Prostate-specific antigen progression|0|||
147575723|NCT00112437|532263523|FG005|Year 2 (12-Month Extension)|Moved|0|||
147575724|NCT00112437|532263524|FG006|Year 2 (12-Month Extension)|Moved|0|||
147575725|NCT00112437|532263525|FG007|Year 2 (12-Month Extension)|Moved|0|||
147575726|NCT00112437|532263526|FG008|Year 2 (12-Month Extension)|Moved|0|||
147148532|NCT00819156|530705446|FG002|Overall Study|Prostate-specific antigen progression|0|||
147148533|NCT00819156|530705447|FG003|Overall Study|Prostate-specific antigen progression|0|||
147148534|NCT00819156|530705448|FG004|Overall Study|Prostate-specific antigen progression|1|||
147148535|NCT00819156|530705449|FG005|Overall Study|Prostate-specific antigen progression|0|||
147148536|NCT00803595|530705450|FG000|Overall Study|Adverse Event|3|||
147148537|NCT00803595|530705451|FG001|Overall Study|Adverse Event|4|||
147148538|NCT00803595|530705452|FG002|Overall Study|Adverse Event|1|||
147148539|NCT00803595|530705450|FG000|Overall Study|Protocol Violation|7|||
147148540|NCT00803595|530705451|FG001|Overall Study|Protocol Violation|2|||
147148541|NCT00803595|530705452|FG002|Overall Study|Protocol Violation|12|||
147148542|NCT00803595|530705450|FG000|Overall Study|Withdrawal by Subject|5|||
147148543|NCT00803595|530705451|FG001|Overall Study|Withdrawal by Subject|2|||
147148544|NCT00803595|530705452|FG002|Overall Study|Withdrawal by Subject|3|||
147148545|NCT02195700|530705456|FG000|Overall Study|Protocol Violation|0|||
147148546|NCT02195700|530705457|FG001|Overall Study|Protocol Violation|2|||
147148547|NCT02195700|530705456|FG000|Overall Study|Noncompliance|1|||
147148548|NCT02195700|530705457|FG001|Overall Study|Noncompliance|0|||
147148549|NCT02195700|530705456|FG000|Overall Study|Adverse Event|1|||
147148550|NCT02195700|530705457|FG001|Overall Study|Adverse Event|2|||
147148551|NCT02195700|530705456|FG000|Overall Study|Withdrawal by Subject|3|||
147148552|NCT02195700|530705457|FG001|Overall Study|Withdrawal by Subject|2|||
147148553|NCT02195700|530705456|FG000|Overall Study|Lost to Follow-up|1|||
147148554|NCT02195700|530705457|FG001|Overall Study|Lost to Follow-up|1|||
147148555|NCT01597908|530705458|FG000|Randomized Phase|Death|217|||
147148556|NCT01597908|530705459|FG001|Randomized Phase|Death|238|||
147148557|NCT01597908|530705460|FG002|Randomized Phase|Death|0|||
147148558|NCT01597908|530705458|FG000|Randomized Phase|Sponsor Decision|93|||
147148559|NCT01597908|530705459|FG001|Randomized Phase|Sponsor Decision|39|||
147148560|NCT01597908|530705460|FG002|Randomized Phase|Sponsor Decision|0|||
147148561|NCT01597908|530705458|FG000|Randomized Phase|Lost to Follow-up|9|||
147239320|NCT01548287|531047562|FG002|Randomized Period|Did not meet inclusion criteria|2|||
147239321|NCT01548287|531047563|FG003|Randomized Period|Did not meet inclusion criteria|0|||
147239322|NCT01548287|531047564|FG004|Randomized Period|Did not meet inclusion criteria|0|||
147239323|NCT01548287|531047560|FG000|Randomized Period|Adverse Event|0|||
147239324|NCT01548287|531047561|FG001|Randomized Period|Adverse Event|2|||
147239325|NCT01548287|531047562|FG002|Randomized Period|Adverse Event|5|||
147239326|NCT01548287|531047563|FG003|Randomized Period|Adverse Event|0|||
147239327|NCT01548287|531047564|FG004|Randomized Period|Adverse Event|0|||
147239328|NCT02762578|531047569|FG000|Overall Study|Adverse Event|1|||
147239329|NCT02762578|531047570|FG001|Overall Study|Adverse Event|6|||
147239330|NCT02762578|531047569|FG000|Overall Study|Protocol Violation|4|||
147239331|NCT02762578|531047570|FG001|Overall Study|Protocol Violation|2|||
147239332|NCT02762578|531047569|FG000|Overall Study|Withdrawal by Subject|4|||
147239333|NCT02762578|531047570|FG001|Overall Study|Withdrawal by Subject|2|||
147239334|NCT02762578|531047569|FG000|Overall Study|Unclassified|6|||
147239335|NCT02762578|531047570|FG001|Overall Study|Unclassified|0|||
147239336|NCT00259610|531047571|FG000|Overall Study|Withdrawal by Subject|33|||
147239337|NCT00259610|531047572|FG001|Overall Study|Withdrawal by Subject|25|||
147239338|NCT00259610|531047573|FG002|Overall Study|Withdrawal by Subject|29|||
147239339|NCT00259610|531047574|FG003|Overall Study|Withdrawal by Subject|19|||
147239340|NCT00259610|531047571|FG000|Overall Study|Lost to Follow-up|19|||
147239341|NCT00259610|531047572|FG001|Overall Study|Lost to Follow-up|8|||
147239342|NCT00259610|531047573|FG002|Overall Study|Lost to Follow-up|18|||
147239343|NCT00259610|531047574|FG003|Overall Study|Lost to Follow-up|15|||
147575727|NCT00112437|532263527|FG009|Year 2 (12-Month Extension)|Moved|1|||
147575728|NCT00112437|532263528|FG010|Year 2 (12-Month Extension)|Moved|0|||
147575729|NCT00112437|532263529|FG011|Year 2 (12-Month Extension)|Moved|0|||
147148562|NCT01597908|530705459|FG001|Randomized Phase|Lost to Follow-up|16|||
147148563|NCT01597908|530705460|FG002|Randomized Phase|Lost to Follow-up|0|||
147148564|NCT01597908|530705458|FG000|Randomized Phase|Physician Decision|6|||
147148565|NCT01597908|530705459|FG001|Randomized Phase|Physician Decision|3|||
147148566|NCT01597908|530705460|FG002|Randomized Phase|Physician Decision|0|||
147148567|NCT01597908|530705458|FG000|Randomized Phase|Withdrawal by Subject|26|||
147239344|NCT00259610|531047571|FG000|Overall Study|Physician Decision|6|||
147148568|NCT01597908|530705459|FG001|Randomized Phase|Withdrawal by Subject|22|||
147148569|NCT01597908|530705460|FG002|Randomized Phase|Withdrawal by Subject|0|||
147239345|NCT00259610|531047572|FG001|Overall Study|Physician Decision|4|||
147239346|NCT00259610|531047573|FG002|Overall Study|Physician Decision|7|||
147239347|NCT00259610|531047574|FG003|Overall Study|Physician Decision|2|||
147239348|NCT00259610|531047571|FG000|Overall Study|Death|1|||
147575730|NCT00112437|532263530|FG012|Year 2 (12-Month Extension)|Moved|0|||
147239349|NCT00259610|531047572|FG001|Overall Study|Death|1|||
147652849|NCT04304508|532551841|FG001|Overall Study|Subject Decision|39|||
147652850|NCT04304508|532551842|FG002|Overall Study|Subject Decision|37|||
147652851|NCT04304508|532551843|FG003|Overall Study|Subject Decision|48|||
147652852|NCT04304508|532551840|FG000|Overall Study|Death|6|||
147652853|NCT04304508|532551841|FG001|Overall Study|Death|1|||
147652854|NCT04304508|532551842|FG002|Overall Study|Death|8|||
147652855|NCT04304508|532551843|FG003|Overall Study|Death|5|||
147652856|NCT04304508|532551840|FG000|Overall Study|Non-compliance With Study Drug|3|||
147652857|NCT04304508|532551841|FG001|Overall Study|Non-compliance With Study Drug|1|||
147652858|NCT04304508|532551842|FG002|Overall Study|Non-compliance With Study Drug|2|||
147652859|NCT04304508|532551843|FG003|Overall Study|Non-compliance With Study Drug|0|||
147652860|NCT04304508|532551840|FG000|Overall Study|Switching To Other Therapy|1|||
147148570|NCT01597908|530705458|FG000|Randomized Phase|Crossover to Dabrafenib&Trametinib|0|||
147148571|NCT01597908|530705459|FG001|Randomized Phase|Crossover to Dabrafenib&Trametinib|34|||
147148572|NCT01597908|530705460|FG002|Randomized Phase|Crossover to Dabrafenib&Trametinib|0|||
147148573|NCT01597908|530705458|FG000|Crossover Phase|Death|0|||
147148574|NCT01597908|530705459|FG001|Crossover Phase|Death|0|||
147575731|NCT00112437|532263531|FG013|Year 2 (12-Month Extension)|Moved|0|||
147575732|NCT00112437|532263532|FG014|Year 2 (12-Month Extension)|Moved|0|||
147575733|NCT00112437|532263533|FG015|Year 2 (12-Month Extension)|Moved|0|||
147575734|NCT00112437|532263534|FG016|Year 2 (12-Month Extension)|Moved|0|||
147575735|NCT00112437|532263535|FG017|Year 2 (12-Month Extension)|Moved|0|||
147575736|NCT00112437|532263536|FG018|Year 2 (12-Month Extension)|Moved|0|||
147575737|NCT00112437|532263537|FG019|Year 2 (12-Month Extension)|Moved|0|||
147575738|NCT00112437|532263538|FG020|Year 2 (12-Month Extension)|Moved|0|||
147575739|NCT00112437|532263539|FG021|Year 2 (12-Month Extension)|Moved|0|||
147575740|NCT00112437|532263540|FG022|Year 2 (12-Month Extension)|Moved|0|||
147575741|NCT00112437|532263541|FG023|Year 2 (12-Month Extension)|Moved|0|||
147575742|NCT00112437|532263542|FG024|Year 2 (12-Month Extension)|Moved|0|||
147575743|NCT00112437|532263543|FG025|Year 2 (12-Month Extension)|Moved|0|||
147575744|NCT00112437|532263518|FG000|Year 3 (12-Month Extension)|Adverse Event|0|||
147575745|NCT00112437|532263519|FG001|Year 3 (12-Month Extension)|Adverse Event|0|||
147148575|NCT01597908|530705460|FG002|Crossover Phase|Death|11|||
147148576|NCT01597908|530705458|FG000|Crossover Phase|Withdrawal by Subject|0|||
147148577|NCT01597908|530705459|FG001|Crossover Phase|Withdrawal by Subject|0|||
147148578|NCT01597908|530705460|FG002|Crossover Phase|Withdrawal by Subject|3|||
147148579|NCT01597908|530705458|FG000|Crossover Phase|Sponsor Decision|0|||
147148580|NCT01597908|530705459|FG001|Crossover Phase|Sponsor Decision|0|||
147148581|NCT01597908|530705460|FG002|Crossover Phase|Sponsor Decision|20|||
147148582|NCT02931838|530705461|FG000|Overall Study|Reason not provided by investigator|1|||
147148583|NCT02931838|530705462|FG001|Overall Study|Reason not provided by investigator|0|||
147148584|NCT02931838|530705463|FG002|Overall Study|Reason not provided by investigator|1|||
147148585|NCT02931838|530705464|FG003|Overall Study|Reason not provided by investigator|0|||
147148586|NCT02931838|530705465|FG004|Overall Study|Reason not provided by investigator|0|||
147148587|NCT02931838|530705466|FG005|Overall Study|Reason not provided by investigator|0|||
147148588|NCT02931838|530705461|FG000|Overall Study|Poor/non-compliance|0|||
147148589|NCT02931838|530705462|FG001|Overall Study|Poor/non-compliance|0|||
147148590|NCT02931838|530705463|FG002|Overall Study|Poor/non-compliance|1|||
147148591|NCT02931838|530705464|FG003|Overall Study|Poor/non-compliance|0|||
147148592|NCT02931838|530705465|FG004|Overall Study|Poor/non-compliance|0|||
147148593|NCT02931838|530705466|FG005|Overall Study|Poor/non-compliance|0|||
147148594|NCT02931838|530705461|FG000|Overall Study|Lack of Efficacy|5|||
147148595|NCT02931838|530705462|FG001|Overall Study|Lack of Efficacy|4|||
147148596|NCT02931838|530705463|FG002|Overall Study|Lack of Efficacy|0|||
147148597|NCT02931838|530705464|FG003|Overall Study|Lack of Efficacy|0|||
147148598|NCT02931838|530705465|FG004|Overall Study|Lack of Efficacy|0|||
147148599|NCT02931838|530705466|FG005|Overall Study|Lack of Efficacy|1|||
147148600|NCT02931838|530705461|FG000|Overall Study|Lost to Follow-up|1|||
147148601|NCT02931838|530705462|FG001|Overall Study|Lost to Follow-up|0|||
147148602|NCT02931838|530705463|FG002|Overall Study|Lost to Follow-up|1|||
147148603|NCT02931838|530705464|FG003|Overall Study|Lost to Follow-up|1|||
147148604|NCT02931838|530705465|FG004|Overall Study|Lost to Follow-up|2|||
147148605|NCT02931838|530705466|FG005|Overall Study|Lost to Follow-up|0|||
147148606|NCT02931838|530705461|FG000|Overall Study|Subject request to discontinue treatment|4|||
147148607|NCT02931838|530705462|FG001|Overall Study|Subject request to discontinue treatment|3|||
147575746|NCT00112437|532263520|FG002|Year 3 (12-Month Extension)|Adverse Event|0|||
147652861|NCT04304508|532551841|FG001|Overall Study|Switching To Other Therapy|1|||
147652862|NCT04304508|532551842|FG002|Overall Study|Switching To Other Therapy|1|||
147652863|NCT04304508|532551843|FG003|Overall Study|Switching To Other Therapy|2|||
147652864|NCT04304508|532551840|FG000|Overall Study|Subject Decision: COVID-19 Pandemic Related|0|||
147652865|NCT04304508|532551841|FG001|Overall Study|Subject Decision: COVID-19 Pandemic Related|1|||
147148608|NCT02931838|530705463|FG002|Overall Study|Subject request to discontinue treatment|3|||
147148609|NCT02931838|530705464|FG003|Overall Study|Subject request to discontinue treatment|0|||
147148610|NCT02931838|530705465|FG004|Overall Study|Subject request to discontinue treatment|1|||
147239350|NCT00259610|531047573|FG002|Overall Study|Death|2|||
147239351|NCT00259610|531047574|FG003|Overall Study|Death|0|||
147239352|NCT00259610|531047571|FG000|Overall Study|non medical reason|6|||
147320980|NCT04955626|531338439|FG019|Open-Label Period|Adverse Event|0|||
147320981|NCT04955626|531338440|FG020|Open-Label Period|Adverse Event|0|||
147320982|NCT04955626|531338441|FG021|Open-Label Period|Adverse Event|0|||
147320983|NCT04955626|531338442|FG022|Open-Label Period|Adverse Event|0|||
147320984|NCT04955626|531338443|FG023|Open-Label Period|Adverse Event|0|||
147320985|NCT04955626|531338444|FG024|Open-Label Period|Adverse Event|0|||
147320986|NCT04955626|531338445|FG025|Open-Label Period|Adverse Event|0|||
147320987|NCT04955626|531338446|FG026|Open-Label Period|Adverse Event|0|||
147320988|NCT04955626|531338447|FG027|Open-Label Period|Adverse Event|0|||
147320989|NCT04955626|531338448|FG028|Open-Label Period|Adverse Event|0|||
147320990|NCT04955626|531338449|FG029|Open-Label Period|Adverse Event|0|||
147320991|NCT04955626|531338450|FG030|Open-Label Period|Adverse Event|0|||
147320992|NCT04955626|531338451|FG031|Open-Label Period|Adverse Event|0|||
147320993|NCT04955626|531338452|FG032|Open-Label Period|Adverse Event|0|||
147320994|NCT04955626|531338453|FG033|Open-Label Period|Adverse Event|0|||
147320995|NCT04955626|531338454|FG034|Open-Label Period|Adverse Event|0|||
147320996|NCT04955626|531338455|FG035|Open-Label Period|Adverse Event|0|||
147320997|NCT04955626|531338420|FG000|Open-Label Period|Withdrawal by parent/guardian|1|||
147320998|NCT04955626|531338421|FG001|Open-Label Period|Withdrawal by parent/guardian|0|||
147320999|NCT04955626|531338422|FG002|Open-Label Period|Withdrawal by parent/guardian|0|||
147321000|NCT04955626|531338423|FG003|Open-Label Period|Withdrawal by parent/guardian|0|||
147321001|NCT04955626|531338424|FG004|Open-Label Period|Withdrawal by parent/guardian|0|||
147321002|NCT04955626|531338425|FG005|Open-Label Period|Withdrawal by parent/guardian|0|||
147321003|NCT04955626|531338426|FG006|Open-Label Period|Withdrawal by parent/guardian|0|||
147321004|NCT04955626|531338427|FG007|Open-Label Period|Withdrawal by parent/guardian|0|||
147321005|NCT04955626|531338428|FG008|Open-Label Period|Withdrawal by parent/guardian|0|||
147321006|NCT04955626|531338429|FG009|Open-Label Period|Withdrawal by parent/guardian|0|||
147652866|NCT04304508|532551842|FG002|Overall Study|Subject Decision: COVID-19 Pandemic Related|0|||
147652867|NCT04304508|532551843|FG003|Overall Study|Subject Decision: COVID-19 Pandemic Related|2|||
147652868|NCT04304508|532551840|FG000|Overall Study|Withdrawal by Subject|7|||
147148611|NCT02931838|530705466|FG005|Overall Study|Subject request to discontinue treatment|0|||
147148612|NCT02931838|530705461|FG000|Overall Study|Withdrawal by Subject|1|||
147148613|NCT02931838|530705462|FG001|Overall Study|Withdrawal by Subject|2|||
147148614|NCT02931838|530705463|FG002|Overall Study|Withdrawal by Subject|0|||
147148615|NCT02931838|530705464|FG003|Overall Study|Withdrawal by Subject|1|||
147148616|NCT02931838|530705465|FG004|Overall Study|Withdrawal by Subject|0|||
147148617|NCT02931838|530705466|FG005|Overall Study|Withdrawal by Subject|0|||
147148618|NCT02931838|530705461|FG000|Overall Study|Adverse Event|2|||
147148619|NCT02931838|530705462|FG001|Overall Study|Adverse Event|1|||
147148620|NCT02931838|530705463|FG002|Overall Study|Adverse Event|2|||
147148621|NCT02931838|530705464|FG003|Overall Study|Adverse Event|1|||
147148622|NCT02931838|530705465|FG004|Overall Study|Adverse Event|3|||
147148623|NCT02931838|530705466|FG005|Overall Study|Adverse Event|1|||
147148624|NCT00104728|530705467|FG000|Overall Study|screen failures|19|||
147148625|NCT02709577|530705468|FG000|Overall Study|non-accommodating anatomy|0|||
147148626|NCT02709577|530705469|FG001|Overall Study|non-accommodating anatomy|1|||
147148627|NCT02709577|530705470|FG002|Overall Study|non-accommodating anatomy|0|||
147148628|NCT02709577|530705471|FG003|Overall Study|non-accommodating anatomy|0|||
147148629|NCT02709577|530705468|FG000|Overall Study|procedural complication|0|||
147148630|NCT02709577|530705469|FG001|Overall Study|procedural complication|1|||
147148631|NCT02709577|530705470|FG002|Overall Study|procedural complication|0|||
147148632|NCT02709577|530705471|FG003|Overall Study|procedural complication|0|||
147148633|NCT02709577|530705468|FG000|Overall Study|Withdrawal by Subject|2|||
147148634|NCT02709577|530705469|FG001|Overall Study|Withdrawal by Subject|3|||
147148635|NCT02709577|530705470|FG002|Overall Study|Withdrawal by Subject|2|||
147148636|NCT02709577|530705471|FG003|Overall Study|Withdrawal by Subject|0|||
147148637|NCT01042158|530705472|FG000|Overall Study|Physician Decision|1|||
147148638|NCT01575808|530705473|FG000|Overall Study|Death|2|||
147148639|NCT01575808|530705474|FG001|Overall Study|Death|0|||
147148640|NCT01575808|530705473|FG000|Overall Study|Withdrawal by Subject|1|||
147148641|NCT01575808|530705474|FG001|Overall Study|Withdrawal by Subject|0|||
147148642|NCT00064259|530706790|FG000|Overall Study|Adverse Event|1|||
147148643|NCT00064259|530706791|FG001|Overall Study|Adverse Event|0|||
147148644|NCT00064259|530706792|FG002|Overall Study|Adverse Event|0|||
147148645|NCT00064259|530706793|FG003|Overall Study|Adverse Event|1|||
147148646|NCT01132651|530706796|FG000|Overall Study|Lost to Follow-up|1|||
147148647|NCT01132651|530706797|FG001|Overall Study|Lost to Follow-up|1|||
147148648|NCT01519791|530706803|FG000|Overall Study|SAE,non-fatal + AE,non-serious non-fatal|2|||
147148649|NCT01519791|530706804|FG001|Overall Study|SAE,non-fatal + AE,non-serious non-fatal|1|||
147148650|NCT01519791|530706803|FG000|Overall Study|Protocol Violation|6|||
147148651|NCT01519791|530706804|FG001|Overall Study|Protocol Violation|19|||
147148652|NCT01519791|530706803|FG000|Overall Study|Other Reason|87|||
147148653|NCT01519791|530706804|FG001|Overall Study|Other Reason|222|||
147321007|NCT04955626|531338430|FG010|Open-Label Period|Withdrawal by parent/guardian|0|||
147321008|NCT04955626|531338431|FG011|Open-Label Period|Withdrawal by parent/guardian|0|||
147148654|NCT01519791|530706803|FG000|Overall Study|subjects randomized in error|2|||
147148655|NCT01519791|530706804|FG001|Overall Study|subjects randomized in error|0|||
147148656|NCT01519791|530706803|FG000|Overall Study|Lack of Efficacy|16|||
147148657|NCT01519791|530706804|FG001|Overall Study|Lack of Efficacy|20|||
147148658|NCT01519791|530706803|FG000|Overall Study|SAE, non-fatal|6|||
147148659|NCT01519791|530706804|FG001|Overall Study|SAE, non-fatal|22|||
147148660|NCT01519791|530706803|FG000|Overall Study|AE, serious fatal|0|||
147148661|NCT01519791|530706804|FG001|Overall Study|AE, serious fatal|1|||
147445996|NCT00219284|531797531|FG000|Treatment Phase - 16 Weeks|Lack of Efficacy|3|||
147445997|NCT00219284|531797532|FG001|Treatment Phase - 16 Weeks|Lack of Efficacy|10|||
147148662|NCT01519791|530706803|FG000|Overall Study|SAE, fatal + SAE, non-fatal|0|||
147148663|NCT01519791|530706804|FG001|Overall Study|SAE, fatal + SAE, non-fatal|1|||
147148664|NCT01519791|530706803|FG000|Overall Study|AE, non-serious non-fatal|12|||
147148665|NCT01519791|530706804|FG001|Overall Study|AE, non-serious non-fatal|31|||
147148666|NCT01519791|530706803|FG000|Overall Study|Withdrawal by Subject|15|||
147148667|NCT01519791|530706804|FG001|Overall Study|Withdrawal by Subject|37|||
147148668|NCT01519791|530706803|FG000|Overall Study|Lost to Follow-up|6|||
147148669|NCT01519791|530706804|FG001|Overall Study|Lost to Follow-up|14|||
147148670|NCT03206970|530706807|FG000|Overall Study|Death|21|||
147148671|NCT03206970|530706807|FG000|Overall Study|Withdrawal by Subject|13|||
147148672|NCT03206970|530706807|FG000|Overall Study|Lost to Follow-up|3|||
147148673|NCT03206970|530706807|FG000|Overall Study|Primary and secondary objectives were met and remaining participants transferred to LTE by sponsor|49|||
147148674|NCT00375427|530706808|FG000|Overall Study|Adverse Event|21|||
147148675|NCT00375427|530706809|FG001|Overall Study|Adverse Event|27|||
147148676|NCT00375427|530706808|FG000|Overall Study|Abnormal test procedure result(s)|0|||
147148677|NCT00375427|530706809|FG001|Overall Study|Abnormal test procedure result(s)|1|||
147148678|NCT00375427|530706808|FG000|Overall Study|Abnormal laboratory value(s)|1|||
147148679|NCT00375427|530706809|FG001|Overall Study|Abnormal laboratory value(s)|2|||
147148680|NCT00375427|530706808|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
147148681|NCT00375427|530706809|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
147148682|NCT00375427|530706808|FG000|Overall Study|Patient no longer requires study drug|3|||
147148683|NCT00375427|530706809|FG001|Overall Study|Patient no longer requires study drug|7|||
147148684|NCT00375427|530706808|FG000|Overall Study|Protocol Violation|10|||
147148685|NCT00375427|530706809|FG001|Overall Study|Protocol Violation|8|||
147148686|NCT00375427|530706808|FG000|Overall Study|Withdrawal by Subject|9|||
147148687|NCT00375427|530706809|FG001|Overall Study|Withdrawal by Subject|13|||
147148688|NCT00375427|530706808|FG000|Overall Study|Lost to Follow-up|1|||
147148689|NCT00375427|530706809|FG001|Overall Study|Lost to Follow-up|1|||
147148690|NCT00375427|530706808|FG000|Overall Study|Administrative reasons|0|||
147148691|NCT00375427|530706809|FG001|Overall Study|Administrative reasons|1|||
147148692|NCT00375427|530706808|FG000|Overall Study|Death|11|||
147148693|NCT00375427|530706809|FG001|Overall Study|Death|10|||
147148694|NCT00070109|530706811|FG000|Overall Study|Death|1|||
147148695|NCT00070109|530706812|FG001|Overall Study|Death|1|||
147148696|NCT00070109|530706813|FG002|Overall Study|Death|0|||
147148697|NCT00070109|530706814|FG003|Overall Study|Death|0|||
147148698|NCT00070109|530706815|FG004|Overall Study|Death|1|||
147148699|NCT00070109|530706811|FG000|Overall Study|Lack of Efficacy|6|||
147148700|NCT00070109|530706812|FG001|Overall Study|Lack of Efficacy|4|||
147148701|NCT00070109|530706813|FG002|Overall Study|Lack of Efficacy|5|||
147148702|NCT00070109|530706814|FG003|Overall Study|Lack of Efficacy|15|||
147148703|NCT00070109|530706815|FG004|Overall Study|Lack of Efficacy|5|||
147148704|NCT00070109|530706811|FG000|Overall Study|Physician Decision|1|||
147148705|NCT00070109|530706812|FG001|Overall Study|Physician Decision|0|||
147148706|NCT00070109|530706813|FG002|Overall Study|Physician Decision|0|||
147148707|NCT00070109|530706814|FG003|Overall Study|Physician Decision|0|||
147148708|NCT00070109|530706815|FG004|Overall Study|Physician Decision|0|||
147148709|NCT00070109|530706811|FG000|Overall Study|Withdrawal by Subject|0|||
147148710|NCT00070109|530706812|FG001|Overall Study|Withdrawal by Subject|1|||
147148711|NCT00070109|530706813|FG002|Overall Study|Withdrawal by Subject|1|||
147148712|NCT00070109|530706814|FG003|Overall Study|Withdrawal by Subject|0|||
147148713|NCT00070109|530706815|FG004|Overall Study|Withdrawal by Subject|0|||
147148714|NCT00070109|530706811|FG000|Overall Study|Adverse Event|0|||
147148715|NCT00070109|530706812|FG001|Overall Study|Adverse Event|0|||
147148716|NCT00070109|530706813|FG002|Overall Study|Adverse Event|2|||
147148717|NCT00070109|530706814|FG003|Overall Study|Adverse Event|4|||
147148718|NCT00070109|530706815|FG004|Overall Study|Adverse Event|2|||
147148719|NCT00070109|530706811|FG000|Overall Study|removed from prot thpy prior to chemo|0|||
147148720|NCT00070109|530706812|FG001|Overall Study|removed from prot thpy prior to chemo|0|||
147148721|NCT00070109|530706813|FG002|Overall Study|removed from prot thpy prior to chemo|0|||
147148722|NCT00070109|530706814|FG003|Overall Study|removed from prot thpy prior to chemo|1|||
147445998|NCT00219284|531797531|FG000|Treatment Phase - 16 Weeks|Protocol Violation|9|||
147652869|NCT04304508|532551841|FG001|Overall Study|Withdrawal by Subject|5|||
147148723|NCT00070109|530706815|FG004|Overall Study|removed from prot thpy prior to chemo|0|||
147148724|NCT00716482|530706824|FG000|Overall Study|Lost to Follow-up|6|||
147148725|NCT00716482|530706824|FG000|Overall Study|Inadequate acquisition or analysis|50|||
147148726|NCT00716482|530706824|FG000|Overall Study|no pathology obtained|10|||
147148727|NCT00716482|530706824|FG000|Overall Study|technical/machine error|28|||
147148728|NCT00716482|530706824|FG000|Overall Study|inclusion/exclusion criteria not met|25|||
147148729|NCT02550288|530706825|FG000|Overall Study|Adverse Event|0|||
147148730|NCT02550288|530706826|FG001|Overall Study|Adverse Event|1|||
147148731|NCT02550288|530706827|FG002|Overall Study|Adverse Event|0|||
147148732|NCT02550288|530706828|FG003|Overall Study|Adverse Event|0|||
147148733|NCT02550288|530706829|FG004|Overall Study|Adverse Event|0|||
147148734|NCT02550288|530706825|FG000|Overall Study|Physician Decision|0|||
147148735|NCT02550288|530706826|FG001|Overall Study|Physician Decision|0|||
147148736|NCT02550288|530706827|FG002|Overall Study|Physician Decision|0|||
147148737|NCT02550288|530706828|FG003|Overall Study|Physician Decision|1|||
147148738|NCT02550288|530706829|FG004|Overall Study|Physician Decision|0|||
147148739|NCT02550288|530706825|FG000|Overall Study|Protocol Violation|2|||
147148740|NCT02550288|530706826|FG001|Overall Study|Protocol Violation|2|||
147148741|NCT02550288|530706827|FG002|Overall Study|Protocol Violation|1|||
147148742|NCT02550288|530706828|FG003|Overall Study|Protocol Violation|0|||
147148743|NCT02550288|530706829|FG004|Overall Study|Protocol Violation|3|||
147148744|NCT02550288|530706825|FG000|Overall Study|Participant moved|0|||
147148745|NCT02550288|530706826|FG001|Overall Study|Participant moved|0|||
147148746|NCT02550288|530706827|FG002|Overall Study|Participant moved|0|||
147148747|NCT02550288|530706828|FG003|Overall Study|Participant moved|1|||
147148748|NCT02550288|530706829|FG004|Overall Study|Participant moved|0|||
147148749|NCT02550288|530706825|FG000|Overall Study|Withdrawal by Subject|0|||
147148750|NCT02550288|530706826|FG001|Overall Study|Withdrawal by Subject|0|||
147148751|NCT02550288|530706827|FG002|Overall Study|Withdrawal by Subject|0|||
147148752|NCT02550288|530706828|FG003|Overall Study|Withdrawal by Subject|1|||
147148753|NCT02550288|530706829|FG004|Overall Study|Withdrawal by Subject|0|||
147148754|NCT01524224|530706830|FG000|Overall Study|Progressive Disease|1|||
147148755|NCT01524224|530706831|FG001|Overall Study|Progressive Disease|0|||
147148756|NCT01524224|530706832|FG002|Overall Study|Progressive Disease|2|||
147148757|NCT01524224|530706833|FG003|Overall Study|Progressive Disease|1|||
147148758|NCT01524224|530706834|FG004|Overall Study|Progressive Disease|2|||
147148759|NCT01524224|530706835|FG005|Overall Study|Progressive Disease|1|||
147148760|NCT01524224|530706836|FG006|Overall Study|Progressive Disease|1|||
147148761|NCT01524224|530706837|FG007|Overall Study|Progressive Disease|5|||
147148762|NCT01524224|530706830|FG000|Overall Study|Withdrawal by Subject|2|||
147148763|NCT01524224|530706831|FG001|Overall Study|Withdrawal by Subject|0|||
147148764|NCT01524224|530706832|FG002|Overall Study|Withdrawal by Subject|0|||
147148765|NCT01524224|530706833|FG003|Overall Study|Withdrawal by Subject|0|||
147148766|NCT01524224|530706834|FG004|Overall Study|Withdrawal by Subject|0|||
147148767|NCT01524224|530706835|FG005|Overall Study|Withdrawal by Subject|0|||
147148768|NCT01524224|530706836|FG006|Overall Study|Withdrawal by Subject|2|||
147148769|NCT01524224|530706837|FG007|Overall Study|Withdrawal by Subject|0|||
147148770|NCT01524224|530706830|FG000|Overall Study|Adverse Event|0|||
147148771|NCT01524224|530706831|FG001|Overall Study|Adverse Event|1|||
147148772|NCT01524224|530706832|FG002|Overall Study|Adverse Event|0|||
147148773|NCT01524224|530706833|FG003|Overall Study|Adverse Event|0|||
147148774|NCT01524224|530706834|FG004|Overall Study|Adverse Event|0|||
147148775|NCT01524224|530706835|FG005|Overall Study|Adverse Event|1|||
147148776|NCT01524224|530706836|FG006|Overall Study|Adverse Event|0|||
147148777|NCT01524224|530706837|FG007|Overall Study|Adverse Event|0|||
147148778|NCT01524224|530706830|FG000|Overall Study|Physician Decision|0|||
147148779|NCT01524224|530706831|FG001|Overall Study|Physician Decision|0|||
147148780|NCT01524224|530706832|FG002|Overall Study|Physician Decision|0|||
147148781|NCT01524224|530706833|FG003|Overall Study|Physician Decision|1|||
147148782|NCT01524224|530706834|FG004|Overall Study|Physician Decision|1|||
147148783|NCT01524224|530706835|FG005|Overall Study|Physician Decision|0|||
147148784|NCT01524224|530706836|FG006|Overall Study|Physician Decision|0|||
147148785|NCT01524224|530706837|FG007|Overall Study|Physician Decision|1|||
147148786|NCT01524224|530706830|FG000|Overall Study|Sponsor Decision|0|||
147148787|NCT01524224|530706831|FG001|Overall Study|Sponsor Decision|0|||
147148788|NCT01524224|530706832|FG002|Overall Study|Sponsor Decision|0|||
147148789|NCT01524224|530706833|FG003|Overall Study|Sponsor Decision|0|||
147148790|NCT01524224|530706834|FG004|Overall Study|Sponsor Decision|1|||
147148791|NCT01524224|530706835|FG005|Overall Study|Sponsor Decision|0|||
147148792|NCT01524224|530706836|FG006|Overall Study|Sponsor Decision|0|||
147148793|NCT01524224|530706837|FG007|Overall Study|Sponsor Decision|0|||
147148794|NCT03517371|530706839|FG000|Overall Study|Adverse Event|8|||
147148795|NCT03517371|530706840|FG001|Overall Study|Adverse Event|9|||
147148796|NCT03517371|530706839|FG000|Overall Study|Lost to Follow-up|1|||
147148797|NCT03517371|530706840|FG001|Overall Study|Lost to Follow-up|2|||
147148798|NCT03517371|530706839|FG000|Overall Study|Withdrawal by Subject|4|||
147148799|NCT03517371|530706840|FG001|Overall Study|Withdrawal by Subject|4|||
147148800|NCT03517371|530706839|FG000|Overall Study|Not idiopathic Parkinson's disease|0|||
147575747|NCT00112437|532263521|FG003|Year 3 (12-Month Extension)|Adverse Event|0|||
147148801|NCT03517371|530706840|FG001|Overall Study|Not idiopathic Parkinson's disease|3|||
147148802|NCT03517371|530706839|FG000|Overall Study|COVID restrictions|2|||
147148803|NCT03517371|530706840|FG001|Overall Study|COVID restrictions|0|||
147148804|NCT03517371|530706839|FG000|Overall Study|Receiving DBS Surgery|0|||
147575748|NCT00112437|532263522|FG004|Year 3 (12-Month Extension)|Adverse Event|0|||
147575749|NCT00112437|532263523|FG005|Year 3 (12-Month Extension)|Adverse Event|0|||
147575750|NCT00112437|532263524|FG006|Year 3 (12-Month Extension)|Adverse Event|0|||
147575751|NCT00112437|532263525|FG007|Year 3 (12-Month Extension)|Adverse Event|0|||
147575752|NCT00112437|532263526|FG008|Year 3 (12-Month Extension)|Adverse Event|0|||
147575753|NCT00112437|532263527|FG009|Year 3 (12-Month Extension)|Adverse Event|0|||
147575754|NCT00112437|532263528|FG010|Year 3 (12-Month Extension)|Adverse Event|1|||
147575755|NCT00112437|532263529|FG011|Year 3 (12-Month Extension)|Adverse Event|0|||
147575756|NCT00112437|532263530|FG012|Year 3 (12-Month Extension)|Adverse Event|0|||
147575757|NCT00112437|532263531|FG013|Year 3 (12-Month Extension)|Adverse Event|0|||
147575758|NCT00112437|532263532|FG014|Year 3 (12-Month Extension)|Adverse Event|0|||
147575759|NCT00112437|532263533|FG015|Year 3 (12-Month Extension)|Adverse Event|1|||
147575760|NCT00112437|532263534|FG016|Year 3 (12-Month Extension)|Adverse Event|3|||
147575761|NCT00112437|532263535|FG017|Year 3 (12-Month Extension)|Adverse Event|1|||
147575762|NCT00112437|532263536|FG018|Year 3 (12-Month Extension)|Adverse Event|0|||
147148805|NCT03517371|530706840|FG001|Overall Study|Receiving DBS Surgery|1|||
147148806|NCT02318368|530706841|FG000|Overall Study|Withdrawal by Subject|2|||
147148807|NCT02318368|530706842|FG001|Overall Study|Withdrawal by Subject|0|||
147148808|NCT02318368|530706841|FG000|Overall Study|Study terminated by the sponsor|5|||
147148809|NCT02318368|530706842|FG001|Overall Study|Study terminated by the sponsor|2|||
147148810|NCT02318368|530706841|FG000|Overall Study|Death|0|||
147575763|NCT00112437|532263537|FG019|Year 3 (12-Month Extension)|Adverse Event|1|||
147575764|NCT00112437|532263538|FG020|Year 3 (12-Month Extension)|Adverse Event|0|||
147575765|NCT00112437|532263539|FG021|Year 3 (12-Month Extension)|Adverse Event|0|||
147575766|NCT00112437|532263540|FG022|Year 3 (12-Month Extension)|Adverse Event|0|||
147575767|NCT00112437|532263541|FG023|Year 3 (12-Month Extension)|Adverse Event|0|||
147575768|NCT00112437|532263542|FG024|Year 3 (12-Month Extension)|Adverse Event|0|||
147148811|NCT02318368|530706842|FG001|Overall Study|Death|1|||
147148812|NCT01901614|530706843|FG000|Overall Study|Adverse Event|0|||
147148813|NCT01901614|530706844|FG001|Overall Study|Adverse Event|1|||
147148814|NCT01901614|530706843|FG000|Overall Study|Lost to Follow-up|1|||
147148815|NCT01901614|530706844|FG001|Overall Study|Lost to Follow-up|0|||
147148816|NCT01901614|530706843|FG000|Overall Study|Screen Fail|1|||
147148817|NCT01901614|530706844|FG001|Overall Study|Screen Fail|0|||
147148818|NCT03629223|530706845|FG000|Treatment Period 1 (21 Days)|Adverse Event|0|||
147148819|NCT03629223|530706846|FG001|Treatment Period 1 (21 Days)|Adverse Event|0|||
147148820|NCT03629223|530706847|FG002|Treatment Period 1 (21 Days)|Adverse Event|0|||
147148821|NCT03629223|530706848|FG003|Treatment Period 1 (21 Days)|Adverse Event|1|||
147148822|NCT03629223|530706849|FG004|Treatment Period 1 (21 Days)|Adverse Event|0|||
147148823|NCT03629223|530706850|FG005|Treatment Period 1 (21 Days)|Adverse Event|0|||
147148824|NCT03629223|530706845|FG000|Treatment Period 1 (21 Days)|Lost to Follow-up|0|||
147148825|NCT03629223|530706846|FG001|Treatment Period 1 (21 Days)|Lost to Follow-up|0|||
147148826|NCT03629223|530706847|FG002|Treatment Period 1 (21 Days)|Lost to Follow-up|0|||
147148827|NCT03629223|530706848|FG003|Treatment Period 1 (21 Days)|Lost to Follow-up|1|||
147148828|NCT03629223|530706849|FG004|Treatment Period 1 (21 Days)|Lost to Follow-up|0|||
147148829|NCT03629223|530706850|FG005|Treatment Period 1 (21 Days)|Lost to Follow-up|0|||
147148830|NCT03629223|530706845|FG000|Treatment Period 1 (21 Days)|Benzodiazepines positive|0|||
147148831|NCT03629223|530706846|FG001|Treatment Period 1 (21 Days)|Benzodiazepines positive|1|||
147148832|NCT03629223|530706847|FG002|Treatment Period 1 (21 Days)|Benzodiazepines positive|0|||
147148833|NCT03629223|530706848|FG003|Treatment Period 1 (21 Days)|Benzodiazepines positive|0|||
147148834|NCT03629223|530706849|FG004|Treatment Period 1 (21 Days)|Benzodiazepines positive|0|||
147148835|NCT03629223|530706850|FG005|Treatment Period 1 (21 Days)|Benzodiazepines positive|0|||
147148836|NCT03629223|530706845|FG000|Treatment Period 1 (21 Days)|Toothache treatment|0|||
147148837|NCT03629223|530706846|FG001|Treatment Period 1 (21 Days)|Toothache treatment|1|||
147148838|NCT03629223|530706847|FG002|Treatment Period 1 (21 Days)|Toothache treatment|0|||
147148839|NCT03629223|530706848|FG003|Treatment Period 1 (21 Days)|Toothache treatment|0|||
147148840|NCT03629223|530706849|FG004|Treatment Period 1 (21 Days)|Toothache treatment|0|||
147148841|NCT03629223|530706850|FG005|Treatment Period 1 (21 Days)|Toothache treatment|0|||
147148842|NCT03629223|530706845|FG000|Treatment Period 2 (21 Days)|Did not attend the ambulatory visits|1|||
147148843|NCT03629223|530706846|FG001|Treatment Period 2 (21 Days)|Did not attend the ambulatory visits|0|||
147148844|NCT03629223|530706847|FG002|Treatment Period 2 (21 Days)|Did not attend the ambulatory visits|0|||
147148845|NCT03629223|530706848|FG003|Treatment Period 2 (21 Days)|Did not attend the ambulatory visits|0|||
147148846|NCT03629223|530706849|FG004|Treatment Period 2 (21 Days)|Did not attend the ambulatory visits|0|||
147148847|NCT03629223|530706850|FG005|Treatment Period 2 (21 Days)|Did not attend the ambulatory visits|0|||
147148848|NCT02674464|530706851|FG000|Overall Study|Death|10|||
147148849|NCT02674464|530706852|FG001|Overall Study|Death|21|||
147148850|NCT02674464|530706851|FG000|Overall Study|Withdrawal by Subject|24|||
147148851|NCT02674464|530706852|FG001|Overall Study|Withdrawal by Subject|44|||
147148852|NCT02674464|530706851|FG000|Overall Study|Lost to Follow-up|97|||
147148853|NCT02674464|530706852|FG001|Overall Study|Lost to Follow-up|92|||
147575769|NCT00112437|532263543|FG025|Year 3 (12-Month Extension)|Adverse Event|0|||
147575770|NCT00112437|532263518|FG000|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
147575771|NCT00112437|532263519|FG001|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
147148854|NCT02674464|530706851|FG000|Overall Study|Outside survey window|6|||
147148855|NCT02674464|530706852|FG001|Overall Study|Outside survey window|3|||
147148856|NCT00783835|530706853|FG000|Overall Study|Adverse Event|3|||
147148857|NCT00783835|530706853|FG000|Overall Study|Medical Criteria|1|||
147148858|NCT00783835|530706853|FG000|Overall Study|Withdrawal by Subject|2|||
147148859|NCT00783835|530706853|FG000|Overall Study|Lost to Follow-up|1|||
147148860|NCT00783835|530706853|FG000|Overall Study|Participant not Adherent|3|||
147148861|NCT01555073|530706854|FG000|Overall Study|Lost to Follow-up|1|||
147148862|NCT01555073|530706855|FG001|Overall Study|Lost to Follow-up|2|||
147148863|NCT01555073|530706856|FG002|Overall Study|Lost to Follow-up|0|||
147148864|NCT01555073|530706857|FG003|Overall Study|Lost to Follow-up|5|||
147148865|NCT01369199|530706860|FG000|Overall Study|Withdrawal by Subject|1|||
147148866|NCT01369199|530706860|FG000|Overall Study|Lost to Follow-up|2|||
147148867|NCT01071252|530706861|FG000|Overall Study|unsatisfactory therapeutic effect|4|||
147148868|NCT01071252|530706862|FG001|Overall Study|unsatisfactory therapeutic effect|6|||
147148869|NCT01071252|530706863|FG002|Overall Study|unsatisfactory therapeutic effect|2|||
147148870|NCT01071252|530706864|FG003|Overall Study|unsatisfactory therapeutic effect|0|||
147148871|NCT01071252|530706865|FG004|Overall Study|unsatisfactory therapeutic effect|6|||
147148872|NCT01071252|530706861|FG000|Overall Study|Withdrawal by Subject|8|||
147148873|NCT01071252|530706862|FG001|Overall Study|Withdrawal by Subject|2|||
147148874|NCT01071252|530706863|FG002|Overall Study|Withdrawal by Subject|1|||
147148875|NCT01071252|530706864|FG003|Overall Study|Withdrawal by Subject|2|||
147148876|NCT01071252|530706865|FG004|Overall Study|Withdrawal by Subject|3|||
147148877|NCT01071252|530706861|FG000|Overall Study|administrative problems|1|||
147148878|NCT01071252|530706862|FG001|Overall Study|administrative problems|1|||
147148879|NCT01071252|530706863|FG002|Overall Study|administrative problems|0|||
147148880|NCT01071252|530706864|FG003|Overall Study|administrative problems|2|||
147148881|NCT01071252|530706865|FG004|Overall Study|administrative problems|1|||
147148882|NCT01071252|530706861|FG000|Overall Study|Lost to Follow-up|1|||
147148883|NCT01071252|530706862|FG001|Overall Study|Lost to Follow-up|0|||
147148884|NCT01071252|530706863|FG002|Overall Study|Lost to Follow-up|1|||
147148885|NCT01071252|530706864|FG003|Overall Study|Lost to Follow-up|2|||
147148886|NCT01071252|530706865|FG004|Overall Study|Lost to Follow-up|0|||
147148887|NCT01071252|530706861|FG000|Overall Study|Adverse Event|1|||
147148888|NCT01071252|530706862|FG001|Overall Study|Adverse Event|1|||
147148889|NCT01071252|530706863|FG002|Overall Study|Adverse Event|0|||
147148890|NCT01071252|530706864|FG003|Overall Study|Adverse Event|1|||
147148891|NCT01071252|530706865|FG004|Overall Study|Adverse Event|0|||
147148892|NCT01071252|530706861|FG000|Overall Study|Death|0|||
147148893|NCT01071252|530706862|FG001|Overall Study|Death|0|||
147148894|NCT01071252|530706863|FG002|Overall Study|Death|0|||
147148895|NCT01071252|530706864|FG003|Overall Study|Death|0|||
147148896|NCT01071252|530706865|FG004|Overall Study|Death|1|||
147148897|NCT01066104|530706866|FG000|Overall Study|Adverse Event|1|||
147148898|NCT01066104|530706867|FG001|Overall Study|Adverse Event|1|||
147148899|NCT01066104|530706866|FG000|Overall Study|Protocol Violation|1|||
147575772|NCT00112437|532263520|FG002|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
147575773|NCT00112437|532263521|FG003|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
147575774|NCT00112437|532263522|FG004|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
147575775|NCT00112437|532263523|FG005|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
147575776|NCT00112437|532263524|FG006|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
147575777|NCT00112437|532263525|FG007|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
147575778|NCT00112437|532263526|FG008|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
147575779|NCT00112437|532263527|FG009|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
147575780|NCT00112437|532263528|FG010|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
147575781|NCT00112437|532263529|FG011|Year 3 (12-Month Extension)|Lack of Efficacy|1|||
147575782|NCT00112437|532263530|FG012|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
147575783|NCT00112437|532263531|FG013|Year 3 (12-Month Extension)|Lack of Efficacy|1|||
147575784|NCT00112437|532263532|FG014|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
147148900|NCT01066104|530706867|FG001|Overall Study|Protocol Violation|0|||
147148901|NCT04660552|530706868|FG000|Overall Study|Withdrawal by Subject|3|||
147148902|NCT04660552|530706869|FG001|Overall Study|Withdrawal by Subject|1|||
147239353|NCT00259610|531047572|FG001|Overall Study|non medical reason|2|||
147239354|NCT00259610|531047573|FG002|Overall Study|non medical reason|10|||
147239355|NCT00259610|531047574|FG003|Overall Study|non medical reason|3|||
147239356|NCT00259610|531047571|FG000|Overall Study|Adverse Event|3|||
147575785|NCT00112437|532263533|FG015|Year 3 (12-Month Extension)|Lack of Efficacy|1|||
147575786|NCT00112437|532263534|FG016|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
147148903|NCT00470262|530706870|FG000|Overall Study|Withdrawal by Subject|2|||
147148904|NCT00470262|530706871|FG001|Overall Study|Withdrawal by Subject|0|||
147148905|NCT04004221|530706874|FG000|Overall Study|Death|89|||
147148906|NCT04004221|530706874|FG000|Overall Study|Withdrawal by Subject|5|||
147148907|NCT04004221|530706874|FG000|Overall Study|Participants transferred to Long-Term Extension (LTE) study|9|||
147148908|NCT04004221|530706874|FG000|Overall Study|Sponsor Decision|9|||
147148909|NCT04004221|530706874|FG000|Overall Study|Participant refused to enter LTE|1|||
147239357|NCT00259610|531047572|FG001|Overall Study|Adverse Event|4|||
147575787|NCT00112437|532263535|FG017|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
147575788|NCT00112437|532263536|FG018|Year 3 (12-Month Extension)|Lack of Efficacy|2|||
147575789|NCT00112437|532263537|FG019|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
147575790|NCT00112437|532263538|FG020|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
147575791|NCT00112437|532263539|FG021|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
147575792|NCT00112437|532263540|FG022|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
147575793|NCT00112437|532263541|FG023|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
147575794|NCT00112437|532263542|FG024|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
147575795|NCT00112437|532263543|FG025|Year 3 (12-Month Extension)|Lack of Efficacy|0|||
147575796|NCT00112437|532263518|FG000|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
147575797|NCT00112437|532263519|FG001|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
147575798|NCT00112437|532263520|FG002|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
147575799|NCT00112437|532263521|FG003|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
147575800|NCT00112437|532263522|FG004|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
147575801|NCT00112437|532263523|FG005|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
147575802|NCT00112437|532263524|FG006|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
147575803|NCT00112437|532263525|FG007|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
147575804|NCT00112437|532263526|FG008|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
147575805|NCT00112437|532263527|FG009|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
147575806|NCT00112437|532263528|FG010|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
147575807|NCT00112437|532263529|FG011|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
147575808|NCT00112437|532263530|FG012|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
147575809|NCT00112437|532263531|FG013|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
147575810|NCT00112437|532263532|FG014|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
147575811|NCT00112437|532263533|FG015|Year 3 (12-Month Extension)|Lost to Follow-up|1|||
147575812|NCT00112437|532263534|FG016|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
147575813|NCT00112437|532263535|FG017|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
147575814|NCT00112437|532263536|FG018|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
147575815|NCT00112437|532263537|FG019|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
147575816|NCT00112437|532263538|FG020|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
147575817|NCT00112437|532263539|FG021|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
147575818|NCT00112437|532263540|FG022|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
147575819|NCT00112437|532263541|FG023|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
147575820|NCT00112437|532263542|FG024|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
147575821|NCT00112437|532263543|FG025|Year 3 (12-Month Extension)|Lost to Follow-up|0|||
147575822|NCT00112437|532263518|FG000|Year 3 (12-Month Extension)|Protocol Violation|0|||
147575823|NCT00112437|532263519|FG001|Year 3 (12-Month Extension)|Protocol Violation|0|||
147575824|NCT00112437|532263520|FG002|Year 3 (12-Month Extension)|Protocol Violation|0|||
147575825|NCT00112437|532263521|FG003|Year 3 (12-Month Extension)|Protocol Violation|0|||
147575826|NCT00112437|532263522|FG004|Year 3 (12-Month Extension)|Protocol Violation|0|||
147575827|NCT00112437|532263523|FG005|Year 3 (12-Month Extension)|Protocol Violation|0|||
147575828|NCT00112437|532263524|FG006|Year 3 (12-Month Extension)|Protocol Violation|0|||
147575829|NCT00112437|532263525|FG007|Year 3 (12-Month Extension)|Protocol Violation|0|||
147575830|NCT00112437|532263526|FG008|Year 3 (12-Month Extension)|Protocol Violation|0|||
147575831|NCT00112437|532263527|FG009|Year 3 (12-Month Extension)|Protocol Violation|0|||
147575832|NCT00112437|532263528|FG010|Year 3 (12-Month Extension)|Protocol Violation|0|||
147575833|NCT00112437|532263529|FG011|Year 3 (12-Month Extension)|Protocol Violation|0|||
147575834|NCT00112437|532263530|FG012|Year 3 (12-Month Extension)|Protocol Violation|0|||
147575835|NCT00112437|532263531|FG013|Year 3 (12-Month Extension)|Protocol Violation|0|||
147575836|NCT00112437|532263532|FG014|Year 3 (12-Month Extension)|Protocol Violation|0|||
147575837|NCT00112437|532263533|FG015|Year 3 (12-Month Extension)|Protocol Violation|1|||
147148910|NCT01970241|530706875|FG000|Overall Study|Withdrawal by Subject|2|||
147148911|NCT01970241|530706876|FG001|Overall Study|Withdrawal by Subject|0|||
147148912|NCT01970241|530706875|FG000|Overall Study|Steroid d/c;discharge<48 hrs.|15|||
147148913|NCT01970241|530706876|FG001|Overall Study|Steroid d/c;discharge<48 hrs.|8|||
147575838|NCT00112437|532263534|FG016|Year 3 (12-Month Extension)|Protocol Violation|0|||
147575839|NCT00112437|532263535|FG017|Year 3 (12-Month Extension)|Protocol Violation|0|||
147575840|NCT00112437|532263536|FG018|Year 3 (12-Month Extension)|Protocol Violation|0|||
147148914|NCT00992056|530706879|FG000|Treatment Period 1 (6 Weeks)|Withdrawal by Subject|1|||
147148915|NCT00992056|530706880|FG001|Treatment Period 1 (6 Weeks)|Withdrawal by Subject|2|||
147148916|NCT00992056|530706879|FG000|Washout Period (2 Weeks)|Physician Decision|1|||
147575841|NCT00112437|532263537|FG019|Year 3 (12-Month Extension)|Protocol Violation|0|||
147148917|NCT00992056|530706880|FG001|Washout Period (2 Weeks)|Physician Decision|0|||
147148918|NCT02038946|530706883|FG000|Overall Study|Death|5|||
147148919|NCT02038946|530706883|FG000|Overall Study|Withdrawal by Subject|3|||
147148920|NCT02038946|530706883|FG000|Overall Study|Lost to Follow-up|2|||
147575842|NCT00112437|532263538|FG020|Year 3 (12-Month Extension)|Protocol Violation|0|||
147239358|NCT00259610|531047573|FG002|Overall Study|Adverse Event|5|||
147575843|NCT00112437|532263539|FG021|Year 3 (12-Month Extension)|Protocol Violation|0|||
147148921|NCT02038946|530706883|FG000|Overall Study|Other reasons|2|||
147148922|NCT01558596|530706884|FG000|Overall Study|Withdrawal by Subject|1|||
147148923|NCT01558596|530706885|FG001|Overall Study|Withdrawal by Subject|0|||
147148924|NCT01558596|530706884|FG000|Overall Study|surgery elsewhere or cancelled|1|||
147148925|NCT01558596|530706885|FG001|Overall Study|surgery elsewhere or cancelled|1|||
147148926|NCT01558596|530706884|FG000|Overall Study|Protocol Violation|1|||
147148927|NCT01558596|530706885|FG001|Overall Study|Protocol Violation|0|||
147148928|NCT01270880|530706899|FG000|Overall Study|Never rec'd treatment, but registered.|1|||
147148929|NCT01221753|530706906|FG000|Overall Study|Adverse Event|1|||
147148930|NCT04552288|530706908|FG000|Overall Study|Death|3|||
147148931|NCT04552288|530706908|FG000|Overall Study|Lost to Follow-up|6|||
147148932|NCT04552288|530706908|FG000|Overall Study|Physician Decision|3|||
147148933|NCT04552288|530706908|FG000|Overall Study|Protocol Violation|9|||
147148934|NCT04552288|530706908|FG000|Overall Study|Withdrawal by Subject|6|||
147148935|NCT04552288|530706908|FG000|Overall Study|Disease progression, Complicated disease, Ineligible|10|||
147148936|NCT01831466|530706909|FG000|Overall Study|Protocol Violation|1|||
147148937|NCT01831466|530706910|FG001|Overall Study|Protocol Violation|1|||
147148938|NCT01831466|530706911|FG002|Overall Study|Protocol Violation|2|||
147148939|NCT01831466|530706912|FG003|Overall Study|Protocol Violation|0|||
147148940|NCT01831466|530706913|FG004|Overall Study|Protocol Violation|0|||
147148941|NCT01831466|530706914|FG005|Overall Study|Protocol Violation|1|||
147148942|NCT01831466|530706915|FG006|Overall Study|Protocol Violation|0|||
147148943|NCT01831466|530706916|FG007|Overall Study|Protocol Violation|0|||
147148944|NCT01831466|530706917|FG008|Overall Study|Protocol Violation|0|||
147148945|NCT01831466|530706918|FG009|Overall Study|Protocol Violation|0|||
147148946|NCT01831466|530706919|FG010|Overall Study|Protocol Violation|0|||
147148947|NCT01831466|530706920|FG011|Overall Study|Protocol Violation|0|||
147148948|NCT01831466|530706909|FG000|Overall Study|Other|2|||
147148949|NCT01831466|530706910|FG001|Overall Study|Other|3|||
147148950|NCT01831466|530706911|FG002|Overall Study|Other|2|||
147148951|NCT01831466|530706912|FG003|Overall Study|Other|2|||
147148952|NCT01831466|530706913|FG004|Overall Study|Other|2|||
147148953|NCT01831466|530706914|FG005|Overall Study|Other|1|||
147148954|NCT01831466|530706915|FG006|Overall Study|Other|0|||
147148955|NCT01831466|530706916|FG007|Overall Study|Other|0|||
147148956|NCT01831466|530706917|FG008|Overall Study|Other|0|||
147148957|NCT01831466|530706918|FG009|Overall Study|Other|0|||
147148958|NCT01831466|530706919|FG010|Overall Study|Other|0|||
147148959|NCT01831466|530706920|FG011|Overall Study|Other|0|||
147148960|NCT01831466|530706909|FG000|Overall Study|Non-compliance with study treatment|2|||
147148961|NCT01831466|530706910|FG001|Overall Study|Non-compliance with study treatment|1|||
147148962|NCT01831466|530706911|FG002|Overall Study|Non-compliance with study treatment|1|||
147148963|NCT01831466|530706912|FG003|Overall Study|Non-compliance with study treatment|0|||
147148964|NCT01831466|530706913|FG004|Overall Study|Non-compliance with study treatment|0|||
147148965|NCT01831466|530706914|FG005|Overall Study|Non-compliance with study treatment|1|||
147148966|NCT01831466|530706915|FG006|Overall Study|Non-compliance with study treatment|0|||
147148967|NCT01831466|530706916|FG007|Overall Study|Non-compliance with study treatment|0|||
147575844|NCT00112437|532263540|FG022|Year 3 (12-Month Extension)|Protocol Violation|0|||
147575845|NCT00112437|532263541|FG023|Year 3 (12-Month Extension)|Protocol Violation|0|||
147575846|NCT00112437|532263542|FG024|Year 3 (12-Month Extension)|Protocol Violation|0|||
147575847|NCT00112437|532263543|FG025|Year 3 (12-Month Extension)|Protocol Violation|0|||
147575848|NCT00112437|532263518|FG000|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
147148968|NCT01831466|530706917|FG008|Overall Study|Non-compliance with study treatment|0|||
147148969|NCT01831466|530706918|FG009|Overall Study|Non-compliance with study treatment|0|||
147148970|NCT01831466|530706919|FG010|Overall Study|Non-compliance with study treatment|0|||
147148971|NCT01831466|530706920|FG011|Overall Study|Non-compliance with study treatment|0|||
147148972|NCT01831466|530706909|FG000|Overall Study|Death|0|||
147148973|NCT01831466|530706910|FG001|Overall Study|Death|1|||
147148974|NCT01831466|530706911|FG002|Overall Study|Death|0|||
147148975|NCT01831466|530706912|FG003|Overall Study|Death|0|||
147575849|NCT00112437|532263519|FG001|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
147148976|NCT01831466|530706913|FG004|Overall Study|Death|0|||
147148977|NCT01831466|530706914|FG005|Overall Study|Death|0|||
147148978|NCT01831466|530706915|FG006|Overall Study|Death|0|||
147148979|NCT01831466|530706916|FG007|Overall Study|Death|0|||
147148980|NCT01831466|530706917|FG008|Overall Study|Death|0|||
147148981|NCT01831466|530706918|FG009|Overall Study|Death|0|||
147148982|NCT01831466|530706919|FG010|Overall Study|Death|0|||
147148983|NCT01831466|530706920|FG011|Overall Study|Death|0|||
147148984|NCT01831466|530706909|FG000|Overall Study|Withdrawal by Subject|6|||
147148985|NCT01831466|530706910|FG001|Overall Study|Withdrawal by Subject|3|||
147148986|NCT01831466|530706911|FG002|Overall Study|Withdrawal by Subject|3|||
147148987|NCT01831466|530706912|FG003|Overall Study|Withdrawal by Subject|3|||
147575850|NCT00112437|532263520|FG002|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
147575851|NCT00112437|532263521|FG003|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
147575852|NCT00112437|532263522|FG004|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
147148988|NCT01831466|530706913|FG004|Overall Study|Withdrawal by Subject|3|||
147148989|NCT01831466|530706914|FG005|Overall Study|Withdrawal by Subject|5|||
147148990|NCT01831466|530706915|FG006|Overall Study|Withdrawal by Subject|0|||
147148991|NCT01831466|530706916|FG007|Overall Study|Withdrawal by Subject|0|||
147148992|NCT01831466|530706917|FG008|Overall Study|Withdrawal by Subject|0|||
147148993|NCT01831466|530706918|FG009|Overall Study|Withdrawal by Subject|1|||
147148994|NCT01831466|530706919|FG010|Overall Study|Withdrawal by Subject|0|||
147148995|NCT01831466|530706920|FG011|Overall Study|Withdrawal by Subject|1|||
147148996|NCT01831466|530706909|FG000|Overall Study|Lost to Follow-up|0|||
147148997|NCT01831466|530706910|FG001|Overall Study|Lost to Follow-up|1|||
147148998|NCT01831466|530706911|FG002|Overall Study|Lost to Follow-up|4|||
147148999|NCT01831466|530706912|FG003|Overall Study|Lost to Follow-up|2|||
147149000|NCT01831466|530706913|FG004|Overall Study|Lost to Follow-up|0|||
147149001|NCT01831466|530706914|FG005|Overall Study|Lost to Follow-up|3|||
147149002|NCT01831466|530706915|FG006|Overall Study|Lost to Follow-up|0|||
147149003|NCT01831466|530706916|FG007|Overall Study|Lost to Follow-up|0|||
147149004|NCT01831466|530706917|FG008|Overall Study|Lost to Follow-up|0|||
147149005|NCT01831466|530706918|FG009|Overall Study|Lost to Follow-up|1|||
147149006|NCT01831466|530706919|FG010|Overall Study|Lost to Follow-up|0|||
147149007|NCT01831466|530706920|FG011|Overall Study|Lost to Follow-up|1|||
147149008|NCT01831466|530706909|FG000|Overall Study|Lack of Efficacy|5|||
147149009|NCT01831466|530706910|FG001|Overall Study|Lack of Efficacy|8|||
147149010|NCT01831466|530706911|FG002|Overall Study|Lack of Efficacy|7|||
147149011|NCT01831466|530706912|FG003|Overall Study|Lack of Efficacy|6|||
147149012|NCT01831466|530706913|FG004|Overall Study|Lack of Efficacy|9|||
147149013|NCT01831466|530706914|FG005|Overall Study|Lack of Efficacy|8|||
147149014|NCT01831466|530706915|FG006|Overall Study|Lack of Efficacy|1|||
147149015|NCT01831466|530706916|FG007|Overall Study|Lack of Efficacy|1|||
147149016|NCT01831466|530706917|FG008|Overall Study|Lack of Efficacy|2|||
147149017|NCT01831466|530706918|FG009|Overall Study|Lack of Efficacy|2|||
147149018|NCT01831466|530706919|FG010|Overall Study|Lack of Efficacy|2|||
147149019|NCT01831466|530706920|FG011|Overall Study|Lack of Efficacy|0|||
147149020|NCT01831466|530706909|FG000|Overall Study|Adverse Event|0|||
147149021|NCT01831466|530706910|FG001|Overall Study|Adverse Event|0|||
147149022|NCT01831466|530706911|FG002|Overall Study|Adverse Event|4|||
147149023|NCT01831466|530706912|FG003|Overall Study|Adverse Event|6|||
147149024|NCT01831466|530706913|FG004|Overall Study|Adverse Event|3|||
147149025|NCT01831466|530706914|FG005|Overall Study|Adverse Event|7|||
147149026|NCT01831466|530706915|FG006|Overall Study|Adverse Event|0|||
147149027|NCT01831466|530706916|FG007|Overall Study|Adverse Event|1|||
147149028|NCT01831466|530706917|FG008|Overall Study|Adverse Event|1|||
147149029|NCT01831466|530706918|FG009|Overall Study|Adverse Event|1|||
147149030|NCT01831466|530706919|FG010|Overall Study|Adverse Event|0|||
147149031|NCT01831466|530706920|FG011|Overall Study|Adverse Event|2|||
147149032|NCT02798315|530706921|FG000|Overall Study|Failure to return|1|||
147149033|NCT00005947|530706922|FG000|Overall Study|Death|54|||
147445999|NCT00219284|531797532|FG001|Treatment Phase - 16 Weeks|Protocol Violation|5|||
147575853|NCT00112437|532263523|FG005|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
147575854|NCT00112437|532263524|FG006|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
147149034|NCT00005947|530706923|FG001|Overall Study|Death|40|||
147149035|NCT00005947|530706922|FG000|Overall Study|Patient Refused to Continue|2|||
147149036|NCT00005947|530706923|FG001|Overall Study|Patient Refused to Continue|1|||
147149037|NCT00005947|530706922|FG000|Overall Study|Site Closure|1|||
147149038|NCT00005947|530706923|FG001|Overall Study|Site Closure|0|||
147149039|NCT03335150|530706927|FG000|Overall Study|Withdrawal by Subject|10|||
147149040|NCT03335150|530706928|FG001|Overall Study|Withdrawal by Subject|4|||
147149041|NCT03335150|530706927|FG000|Overall Study|Adverse Event|0|||
147239359|NCT00259610|531047574|FG003|Overall Study|Adverse Event|2|||
147239360|NCT00259610|531047571|FG000|Overall Study|Serious Adverse Event|8|||
147239361|NCT00259610|531047572|FG001|Overall Study|Serious Adverse Event|2|||
147239362|NCT00259610|531047573|FG002|Overall Study|Serious Adverse Event|2|||
147239363|NCT00259610|531047574|FG003|Overall Study|Serious Adverse Event|2|||
147239364|NCT01768286|531047577|FG000|Overall Study|Randomized But Not Treated|0|||
147239365|NCT01768286|531047578|FG001|Overall Study|Randomized But Not Treated|0|||
147239366|NCT01768286|531047579|FG002|Overall Study|Randomized But Not Treated|1|||
147239367|NCT01768286|531047580|FG003|Overall Study|Randomized But Not Treated|0|||
147239368|NCT01768286|531047577|FG000|Overall Study|Lack of Efficacy|7|||
147239369|NCT01768286|531047578|FG001|Overall Study|Lack of Efficacy|4|||
147446000|NCT00219284|531797531|FG000|Treatment Phase - 16 Weeks|Withdrawal by Subject|5|||
147446001|NCT00219284|531797532|FG001|Treatment Phase - 16 Weeks|Withdrawal by Subject|9|||
147149042|NCT03335150|530706928|FG001|Overall Study|Adverse Event|1|||
147149043|NCT02218697|530706933|FG000|Overall Study|Adverse Event|0|||
147149044|NCT02218697|530706934|FG001|Overall Study|Adverse Event|2|||
147149045|NCT02218697|530706933|FG000|Overall Study|Unwilling to be vaccinated in left arm|0|||
147149046|NCT02218697|530706934|FG001|Overall Study|Unwilling to be vaccinated in left arm|1|||
147149047|NCT02218697|530706933|FG000|Overall Study|Withdrawal by Subject|2|||
147149048|NCT02218697|530706934|FG001|Overall Study|Withdrawal by Subject|3|||
147239370|NCT01768286|531047579|FG002|Overall Study|Lack of Efficacy|0|||
147446002|NCT00219284|531797531|FG000|Treatment Phase - 16 Weeks|Lost to Follow-up|1|||
147149049|NCT01059864|530706935|FG000|Open-Label Run-In Phase|Adverse Event|7|||
147149050|NCT01059864|530706936|FG001|Open-Label Run-In Phase|Adverse Event|0|||
147652870|NCT04304508|532551842|FG002|Overall Study|Withdrawal by Subject|11|||
147652871|NCT04304508|532551843|FG003|Overall Study|Withdrawal by Subject|6|||
147652872|NCT04304508|532551840|FG000|Overall Study|Logistical Difficulties|2|||
147652873|NCT04304508|532551841|FG001|Overall Study|Logistical Difficulties|2|||
147652874|NCT04304508|532551842|FG002|Overall Study|Logistical Difficulties|3|||
147652875|NCT04304508|532551843|FG003|Overall Study|Logistical Difficulties|2|||
147652876|NCT04304508|532551840|FG000|Overall Study|Missing Information|1|||
147652877|NCT04304508|532551841|FG001|Overall Study|Missing Information|2|||
147652878|NCT04304508|532551842|FG002|Overall Study|Missing Information|1|||
147652879|NCT04304508|532551843|FG003|Overall Study|Missing Information|3|||
147652880|NCT04304508|532551840|FG000|Overall Study|Other|7|||
147652881|NCT04304508|532551841|FG001|Overall Study|Other|6|||
147652882|NCT04304508|532551842|FG002|Overall Study|Other|5|||
147652883|NCT04304508|532551843|FG003|Overall Study|Other|4|||
147652884|NCT04304508|532551840|FG000|Overall Study|Physician Decision: COVID-19 Pandemic Related|1|||
147652885|NCT04304508|532551841|FG001|Overall Study|Physician Decision: COVID-19 Pandemic Related|0|||
147652886|NCT04304508|532551842|FG002|Overall Study|Physician Decision: COVID-19 Pandemic Related|0|||
147652887|NCT04304508|532551843|FG003|Overall Study|Physician Decision: COVID-19 Pandemic Related|0|||
147652888|NCT04304508|532551840|FG000|Overall Study|Physician Decision|3|||
147149051|NCT01059864|530706937|FG002|Open-Label Run-In Phase|Adverse Event|0|||
147149052|NCT01059864|530706935|FG000|Open-Label Run-In Phase|Lack of Efficacy|1|||
147149053|NCT01059864|530706936|FG001|Open-Label Run-In Phase|Lack of Efficacy|0|||
147149054|NCT01059864|530706937|FG002|Open-Label Run-In Phase|Lack of Efficacy|0|||
147149055|NCT01059864|530706935|FG000|Open-Label Run-In Phase|Lost to Follow-up|2|||
147149056|NCT01059864|530706936|FG001|Open-Label Run-In Phase|Lost to Follow-up|0|||
147149057|NCT01059864|530706937|FG002|Open-Label Run-In Phase|Lost to Follow-up|0|||
147149058|NCT01059864|530706935|FG000|Open-Label Run-In Phase|Withdrawal by Subject|1|||
147149059|NCT01059864|530706936|FG001|Open-Label Run-In Phase|Withdrawal by Subject|0|||
147149060|NCT01059864|530706937|FG002|Open-Label Run-In Phase|Withdrawal by Subject|0|||
147149061|NCT01059864|530706935|FG000|Open-Label Run-In Phase|Protocol Violation|2|||
147149062|NCT01059864|530706936|FG001|Open-Label Run-In Phase|Protocol Violation|0|||
147149063|NCT01059864|530706937|FG002|Open-Label Run-In Phase|Protocol Violation|0|||
147149064|NCT01059864|530706935|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
147149065|NCT01059864|530706936|FG001|Double-Blind Treatment Phase|Adverse Event|3|||
147149066|NCT01059864|530706937|FG002|Double-Blind Treatment Phase|Adverse Event|3|||
147149067|NCT00451958|530706938|FG000|CS21A (NCT00451958)|Adverse Event|21|||
147149068|NCT00451958|530706939|FG001|CS21A (NCT00451958)|Adverse Event|34|||
147149069|NCT00451958|530706940|FG002|CS21A (NCT00451958)|Adverse Event|14|||
147149070|NCT00451958|530706941|FG003|CS21A (NCT00451958)|Adverse Event|17|||
147149071|NCT00451958|530706942|FG004|CS21A (NCT00451958)|Adverse Event|0|||
147149072|NCT00451958|530706938|FG000|CS21A (NCT00451958)|Lost to Follow-up|6|||
147149073|NCT00451958|530706939|FG001|CS21A (NCT00451958)|Lost to Follow-up|5|||
147149074|NCT00451958|530706940|FG002|CS21A (NCT00451958)|Lost to Follow-up|1|||
147149075|NCT00451958|530706941|FG003|CS21A (NCT00451958)|Lost to Follow-up|1|||
147149076|NCT00451958|530706942|FG004|CS21A (NCT00451958)|Lost to Follow-up|0|||
147149077|NCT00451958|530706938|FG000|CS21A (NCT00451958)|Protocol Violation|1|||
147149078|NCT00451958|530706939|FG001|CS21A (NCT00451958)|Protocol Violation|3|||
147149079|NCT00451958|530706940|FG002|CS21A (NCT00451958)|Protocol Violation|2|||
147149080|NCT00451958|530706941|FG003|CS21A (NCT00451958)|Protocol Violation|0|||
147149081|NCT00451958|530706942|FG004|CS21A (NCT00451958)|Protocol Violation|0|||
147149082|NCT00451958|530706938|FG000|CS21A (NCT00451958)|Physician Decision|2|||
147149083|NCT00451958|530706939|FG001|CS21A (NCT00451958)|Physician Decision|4|||
147149084|NCT00451958|530706940|FG002|CS21A (NCT00451958)|Physician Decision|4|||
147239371|NCT01768286|531047580|FG003|Overall Study|Lack of Efficacy|1|||
147239372|NCT01768286|531047577|FG000|Overall Study|Withdrew Consent|0|||
147239373|NCT01768286|531047578|FG001|Overall Study|Withdrew Consent|0|||
147239374|NCT01768286|531047579|FG002|Overall Study|Withdrew Consent|1|||
147239375|NCT01768286|531047580|FG003|Overall Study|Withdrew Consent|0|||
147239376|NCT02083965|531047581|FG000|Treatment Period|Other|1|||
147239377|NCT02083965|531047582|FG001|Treatment Period|Other|0|||
147239378|NCT03344796|531047584|FG000|Overall Study|Lost to Follow-up|0|||
147239379|NCT03344796|531047585|FG001|Overall Study|Lost to Follow-up|0|||
147652889|NCT04304508|532551841|FG001|Overall Study|Physician Decision|4|||
147149085|NCT00451958|530706941|FG003|CS21A (NCT00451958)|Physician Decision|4|||
147149086|NCT00451958|530706942|FG004|CS21A (NCT00451958)|Physician Decision|0|||
147149087|NCT00451958|530706938|FG000|CS21A (NCT00451958)|Withdrawal by Subject|7|||
147149088|NCT00451958|530706939|FG001|CS21A (NCT00451958)|Withdrawal by Subject|4|||
147239380|NCT03344796|531047586|FG002|Overall Study|Lost to Follow-up|0|||
147652890|NCT04304508|532551842|FG002|Overall Study|Physician Decision|9|||
147239381|NCT03344796|531047587|FG003|Overall Study|Lost to Follow-up|0|||
147239382|NCT03344796|531047588|FG004|Overall Study|Lost to Follow-up|0|||
147239383|NCT03344796|531047589|FG005|Overall Study|Lost to Follow-up|2|||
147652891|NCT04304508|532551843|FG003|Overall Study|Physician Decision|7|||
147652892|NCT04304508|532551840|FG000|Overall Study|Study drug never administered|10|||
147149089|NCT00451958|530706940|FG002|CS21A (NCT00451958)|Withdrawal by Subject|4|||
147239384|NCT00939770|531047590|FG000|Overall Study|Adverse Event|1|||
147575855|NCT00112437|532263525|FG007|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
147575856|NCT00112437|532263526|FG008|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
147575857|NCT00112437|532263527|FG009|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
147575858|NCT00112437|532263528|FG010|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
147575859|NCT00112437|532263529|FG011|Year 3 (12-Month Extension)|Withdrawal by Subject|3|||
147575860|NCT00112437|532263530|FG012|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
147575861|NCT00112437|532263531|FG013|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
147575862|NCT00112437|532263532|FG014|Year 3 (12-Month Extension)|Withdrawal by Subject|1|||
147575863|NCT00112437|532263533|FG015|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
147575864|NCT00112437|532263534|FG016|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
147575865|NCT00112437|532263535|FG017|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
147575866|NCT00112437|532263536|FG018|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
147575867|NCT00112437|532263537|FG019|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
147575868|NCT00112437|532263538|FG020|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
147575869|NCT00112437|532263539|FG021|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
147575870|NCT00112437|532263540|FG022|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
147575871|NCT00112437|532263541|FG023|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
147575872|NCT00112437|532263542|FG024|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
147575873|NCT00112437|532263543|FG025|Year 3 (12-Month Extension)|Withdrawal by Subject|0|||
147575874|NCT00112437|532263518|FG000|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
147575875|NCT00112437|532263519|FG001|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
147575876|NCT00112437|532263520|FG002|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
147575877|NCT00112437|532263521|FG003|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
147575878|NCT00112437|532263522|FG004|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
147575879|NCT00112437|532263523|FG005|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
147575880|NCT00112437|532263524|FG006|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
147575881|NCT00112437|532263525|FG007|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
147575882|NCT00112437|532263526|FG008|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
147575883|NCT00112437|532263527|FG009|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
147575884|NCT00112437|532263528|FG010|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|1|||
147575885|NCT00112437|532263529|FG011|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|1|||
147575886|NCT00112437|532263530|FG012|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
147575887|NCT00112437|532263531|FG013|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
147575888|NCT00112437|532263532|FG014|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
147575889|NCT00112437|532263533|FG015|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
147575890|NCT00112437|532263534|FG016|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
147575891|NCT00112437|532263535|FG017|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
147575892|NCT00112437|532263536|FG018|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
147575893|NCT00112437|532263537|FG019|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
147575894|NCT00112437|532263538|FG020|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
147575895|NCT00112437|532263539|FG021|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
147575896|NCT00112437|532263540|FG022|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
147575897|NCT00112437|532263541|FG023|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
147575898|NCT00112437|532263542|FG024|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
147575899|NCT00112437|532263543|FG025|Year 3 (12-Month Extension)|cortisone therapy, upcoming surgery|0|||
147575900|NCT00112437|532263518|FG000|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
147575901|NCT00112437|532263519|FG001|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
147575902|NCT00112437|532263520|FG002|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
147575903|NCT00112437|532263521|FG003|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
147575904|NCT00112437|532263522|FG004|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
147575905|NCT00112437|532263523|FG005|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
147575906|NCT00112437|532263524|FG006|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
147575907|NCT00112437|532263525|FG007|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
147575908|NCT00112437|532263526|FG008|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
147575909|NCT00112437|532263527|FG009|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
147575910|NCT00112437|532263528|FG010|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
147575911|NCT00112437|532263529|FG011|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
147575912|NCT00112437|532263530|FG012|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
147575913|NCT00112437|532263531|FG013|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
147652893|NCT04304508|532551841|FG001|Overall Study|Study drug never administered|4|||
147652894|NCT04304508|532551842|FG002|Overall Study|Study drug never administered|4|||
147652895|NCT04304508|532551843|FG003|Overall Study|Study drug never administered|4|||
147239385|NCT00939770|531047591|FG001|Overall Study|Adverse Event|1|||
147652896|NCT04304508|532551840|FG000|Overall Study|Adverse Event|49|||
147652897|NCT04304508|532551841|FG001|Overall Study|Adverse Event|50|||
147239386|NCT00939770|531047592|FG002|Overall Study|Adverse Event|0|||
147239387|NCT00939770|531047593|FG003|Overall Study|Adverse Event|0|||
147575914|NCT00112437|532263532|FG014|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
147575915|NCT00112437|532263533|FG015|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
147575916|NCT00112437|532263534|FG016|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
147575917|NCT00112437|532263535|FG017|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
147575918|NCT00112437|532263536|FG018|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
147575919|NCT00112437|532263537|FG019|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
147575920|NCT00112437|532263538|FG020|Years 4-5 (24-Month Extension)|Lack of Efficacy|2|||
147575921|NCT00112437|532263539|FG021|Years 4-5 (24-Month Extension)|Lack of Efficacy|1|||
147575922|NCT00112437|532263540|FG022|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
147575923|NCT00112437|532263541|FG023|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
147575924|NCT00112437|532263542|FG024|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
147575925|NCT00112437|532263543|FG025|Years 4-5 (24-Month Extension)|Lack of Efficacy|0|||
147575926|NCT00112437|532263518|FG000|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
147575927|NCT00112437|532263519|FG001|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
147575928|NCT00112437|532263520|FG002|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
147575929|NCT00112437|532263521|FG003|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
147575930|NCT00112437|532263522|FG004|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
147575931|NCT00112437|532263523|FG005|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
147575932|NCT00112437|532263524|FG006|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
147575933|NCT00112437|532263525|FG007|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
147575934|NCT00112437|532263526|FG008|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
147575935|NCT00112437|532263527|FG009|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
147575936|NCT00112437|532263528|FG010|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
147575937|NCT00112437|532263529|FG011|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
147575938|NCT00112437|532263530|FG012|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
147575939|NCT00112437|532263531|FG013|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
147575940|NCT00112437|532263532|FG014|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
147575941|NCT00112437|532263533|FG015|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
147575942|NCT00112437|532263534|FG016|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
147575943|NCT00112437|532263535|FG017|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
147575944|NCT00112437|532263536|FG018|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
147575945|NCT00112437|532263537|FG019|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
147575946|NCT00112437|532263538|FG020|Years 4-5 (24-Month Extension)|Discontinued for other reasons|1|||
147575947|NCT00112437|532263539|FG021|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
147575948|NCT00112437|532263540|FG022|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
147575949|NCT00112437|532263541|FG023|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
147575950|NCT00112437|532263542|FG024|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
147575951|NCT00112437|532263543|FG025|Years 4-5 (24-Month Extension)|Discontinued for other reasons|0|||
147575952|NCT00112437|532263518|FG000|Years 4-5 (24-Month Extension)|Adverse Event|0|||
147575953|NCT00112437|532263519|FG001|Years 4-5 (24-Month Extension)|Adverse Event|0|||
147575954|NCT00112437|532263520|FG002|Years 4-5 (24-Month Extension)|Adverse Event|0|||
147575955|NCT00112437|532263521|FG003|Years 4-5 (24-Month Extension)|Adverse Event|0|||
147575956|NCT00112437|532263522|FG004|Years 4-5 (24-Month Extension)|Adverse Event|0|||
147575957|NCT00112437|532263523|FG005|Years 4-5 (24-Month Extension)|Adverse Event|0|||
147575958|NCT00112437|532263524|FG006|Years 4-5 (24-Month Extension)|Adverse Event|0|||
147575959|NCT00112437|532263525|FG007|Years 4-5 (24-Month Extension)|Adverse Event|0|||
147575960|NCT00112437|532263526|FG008|Years 4-5 (24-Month Extension)|Adverse Event|0|||
147575961|NCT00112437|532263527|FG009|Years 4-5 (24-Month Extension)|Adverse Event|0|||
147575962|NCT00112437|532263528|FG010|Years 4-5 (24-Month Extension)|Adverse Event|0|||
147575963|NCT00112437|532263529|FG011|Years 4-5 (24-Month Extension)|Adverse Event|0|||
147575964|NCT00112437|532263530|FG012|Years 4-5 (24-Month Extension)|Adverse Event|0|||
147575965|NCT00112437|532263531|FG013|Years 4-5 (24-Month Extension)|Adverse Event|0|||
147575966|NCT00112437|532263532|FG014|Years 4-5 (24-Month Extension)|Adverse Event|0|||
147575967|NCT00112437|532263533|FG015|Years 4-5 (24-Month Extension)|Adverse Event|0|||
147575968|NCT00112437|532263534|FG016|Years 4-5 (24-Month Extension)|Adverse Event|0|||
147575969|NCT00112437|532263535|FG017|Years 4-5 (24-Month Extension)|Adverse Event|0|||
147575970|NCT00112437|532263536|FG018|Years 4-5 (24-Month Extension)|Adverse Event|0|||
147149090|NCT00451958|530706941|FG003|CS21A (NCT00451958)|Withdrawal by Subject|3|||
147149091|NCT00451958|530706942|FG004|CS21A (NCT00451958)|Withdrawal by Subject|0|||
147575971|NCT00112437|532263537|FG019|Years 4-5 (24-Month Extension)|Adverse Event|0|||
147575972|NCT00112437|532263538|FG020|Years 4-5 (24-Month Extension)|Adverse Event|0|||
147575973|NCT00112437|532263539|FG021|Years 4-5 (24-Month Extension)|Adverse Event|4|||
147575974|NCT00112437|532263540|FG022|Years 4-5 (24-Month Extension)|Adverse Event|0|||
147575975|NCT00112437|532263541|FG023|Years 4-5 (24-Month Extension)|Adverse Event|0|||
147149092|NCT00451958|530706938|FG000|CS21A (NCT00451958)|Miscellaneous reasons|28|||
147652898|NCT04304508|532551842|FG002|Overall Study|Adverse Event|51|||
147149093|NCT00451958|530706939|FG001|CS21A (NCT00451958)|Miscellaneous reasons|27|||
147575976|NCT00112437|532263542|FG024|Years 4-5 (24-Month Extension)|Adverse Event|0|||
147149094|NCT00451958|530706940|FG002|CS21A (NCT00451958)|Miscellaneous reasons|17|||
147149095|NCT00451958|530706941|FG003|CS21A (NCT00451958)|Miscellaneous reasons|14|||
147149096|NCT00451958|530706942|FG004|CS21A (NCT00451958)|Miscellaneous reasons|0|||
147149097|NCT02175277|530706943|FG000|Overall Study|Protocol-specified Criteria|1|||
147149098|NCT02482428|530708369|FG000|Overall Study|Lost to Follow-up|4|||
147149099|NCT02482428|530708370|FG001|Overall Study|Lost to Follow-up|9|||
147149100|NCT02482428|530708371|FG002|Overall Study|Lost to Follow-up|1|||
147149101|NCT02482428|530708372|FG003|Overall Study|Lost to Follow-up|2|||
147149102|NCT02482428|530708373|FG004|Overall Study|Lost to Follow-up|4|||
147149103|NCT02482428|530708369|FG000|Overall Study|Physician Decision|0|||
147149104|NCT02482428|530708370|FG001|Overall Study|Physician Decision|0|||
147149105|NCT02482428|530708371|FG002|Overall Study|Physician Decision|0|||
147149106|NCT02482428|530708372|FG003|Overall Study|Physician Decision|0|||
147149107|NCT02482428|530708373|FG004|Overall Study|Physician Decision|1|||
147149108|NCT02482428|530708369|FG000|Overall Study|protocol deviation|1|||
147149109|NCT02482428|530708370|FG001|Overall Study|protocol deviation|1|||
147149110|NCT02482428|530708371|FG002|Overall Study|protocol deviation|0|||
147149111|NCT02482428|530708372|FG003|Overall Study|protocol deviation|0|||
147149112|NCT02482428|530708373|FG004|Overall Study|protocol deviation|0|||
147149113|NCT02482428|530708369|FG000|Overall Study|subject/guardian decision|4|||
147149114|NCT02482428|530708370|FG001|Overall Study|subject/guardian decision|2|||
147149115|NCT02482428|530708371|FG002|Overall Study|subject/guardian decision|0|||
147149116|NCT02482428|530708372|FG003|Overall Study|subject/guardian decision|0|||
147149117|NCT02482428|530708373|FG004|Overall Study|subject/guardian decision|2|||
147149118|NCT02547038|530708374|FG000|Overall Study|Lost to Follow-up|3|||
147149119|NCT02547038|530708375|FG001|Overall Study|Lost to Follow-up|2|||
147149120|NCT00516893|530708376|FG000|Overall Study|Lost to Follow-up|4|||
147149121|NCT00516893|530708376|FG000|Overall Study|Adverse Event|3|||
147149122|NCT00516893|530708376|FG000|Overall Study|Withdrawal by Subject|2|||
147149123|NCT00516893|530708376|FG000|Overall Study|Noncompliance|2|||
147149124|NCT00516893|530708376|FG000|Overall Study|Death|1|||
147149125|NCT00516893|530708376|FG000|Overall Study|Persistent Antibodies per Protocol|6|||
147149126|NCT00516893|530708376|FG000|Overall Study|Relocated|1|||
147149127|NCT00516893|530708376|FG000|Overall Study|Pregnancy|1|||
147149128|NCT00516893|530708376|FG000|Overall Study|Received Medication From Another Study|1|||
147149129|NCT00301262|530708379|FG000|Double Blind Phase (DB)|Adverse Event|1|||
147149130|NCT00301262|530708380|FG001|Double Blind Phase (DB)|Adverse Event|0|||
147149131|NCT00301262|530708379|FG000|Double Blind Phase (DB)|Lack of Efficacy|0|||
147149132|NCT00301262|530708380|FG001|Double Blind Phase (DB)|Lack of Efficacy|1|||
147149133|NCT00301262|530708379|FG000|Double Blind Phase (DB)|Lost to Follow-up|3|||
147149134|NCT00301262|530708380|FG001|Double Blind Phase (DB)|Lost to Follow-up|3|||
147149135|NCT00301262|530708379|FG000|Double Blind Phase (DB)|Withdrawal by Subject|5|||
147149136|NCT00301262|530708380|FG001|Double Blind Phase (DB)|Withdrawal by Subject|5|||
147149137|NCT00301262|530708379|FG000|Double Blind Phase (DB)|Other|1|||
147149138|NCT00301262|530708380|FG001|Double Blind Phase (DB)|Other|4|||
147149139|NCT00301262|530708379|FG000|Open Label Phase (OL)|Adverse Event|1|||
147149140|NCT00301262|530708380|FG001|Open Label Phase (OL)|Adverse Event|0|||
147149141|NCT00301262|530708379|FG000|Open Label Phase (OL)|Lost to Follow-up|1|||
147149142|NCT00301262|530708380|FG001|Open Label Phase (OL)|Lost to Follow-up|2|||
147149143|NCT00301262|530708379|FG000|Open Label Phase (OL)|Other|2|||
147149144|NCT00301262|530708380|FG001|Open Label Phase (OL)|Other|0|||
147149145|NCT01443364|530708381|FG000|Overall Study|Lack of Efficacy|14|||
147149146|NCT01443364|530708381|FG000|Overall Study|Lost to Follow-up|3|||
147149147|NCT01443364|530708381|FG000|Overall Study|Withdrawal by Subject|5|||
147149148|NCT01443364|530708381|FG000|Overall Study|Other Reason|4|||
147149149|NCT01443364|530708381|FG000|Overall Study|SAE, non-fatal|6|||
147149150|NCT01443364|530708381|FG000|Overall Study|AE, non-serious non-fatal|8|||
147149151|NCT01443364|530708381|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
147149152|NCT00623233|530708382|FG000|Overall Study|Adverse Event|10|||
147149153|NCT00623233|530708382|FG000|Overall Study|Physician Decision|10|||
147149154|NCT00623233|530708382|FG000|Overall Study|Lost to Follow-up|1|||
147149155|NCT00623233|530708382|FG000|Overall Study|Withdrawal by Subject|3|||
147149156|NCT00559845|530708383|FG000|Overall Study|Withdrew Consent|1|||
147149157|NCT00559845|530708383|FG000|Overall Study|Disease Progression|1|||
147149158|NCT00559845|530708383|FG000|Overall Study|Adverse Event|3|||
147149159|NCT00559845|530708383|FG000|Overall Study|Did Not Attend Cycle 6 Hospital Visit|1|||
147149160|NCT00559845|530708383|FG000|Overall Study|Premature Surgery-Investigator Decision|1|||
147149161|NCT00459875|530708384|FG000|Overall Study|Ineligible participant|1|||
147149162|NCT00459875|530708384|FG000|Overall Study|Adverse Event|2|||
147149163|NCT02150057|530708385|FG000|Overall Study|Lost to Follow-up|6|||
147149164|NCT02150057|530708386|FG001|Overall Study|Lost to Follow-up|4|||
147149165|NCT01696994|530708387|FG000|Overall Study|Cancer Before Rand. (Ovarian Screening)|0|||
147446003|NCT00219284|531797532|FG001|Treatment Phase - 16 Weeks|Lost to Follow-up|2|||
147149166|NCT01696994|530708388|FG001|Overall Study|Cancer Before Rand. (Ovarian Screening)|2|||
147149167|NCT01696994|530708387|FG000|Overall Study|Died Before Randomization|1|||
147149168|NCT01696994|530708388|FG001|Overall Study|Died Before Randomization|2|||
147149169|NCT01696994|530708387|FG000|Overall Study|Died Before ASU (Control)|73|||
147149170|NCT01696994|530708388|FG001|Overall Study|Died Before ASU (Control)|0|||
147149171|NCT01696994|530708387|FG000|Overall Study|No Ovaries at Baseline|4807|||
147149172|NCT01696994|530708388|FG001|Overall Study|No Ovaries at Baseline|4851|||
147149173|NCT01696994|530708387|FG000|Overall Study|Refused ASU (Control)|311|||
147149174|NCT01696994|530708388|FG001|Overall Study|Refused ASU (Control)|0|||
147149175|NCT01696994|530708387|FG000|Overall Study|Refused Screen (Ovarian Screening)|0|||
147149176|NCT01696994|530708388|FG001|Overall Study|Refused Screen (Ovarian Screening)|3582|||
147149177|NCT00576628|530708391|FG000|Overall Study|Adverse Event|11|||
147149178|NCT00576628|530708391|FG000|Overall Study|Death|2|||
147149179|NCT00576628|530708391|FG000|Overall Study|Failure to return|1|||
147149180|NCT00576628|530708391|FG000|Overall Study|Refused Treatment|8|||
147149181|NCT00576628|530708391|FG000|Overall Study|Pregnancy|1|||
147149182|NCT00576628|530708391|FG000|Overall Study|RBC transfusion|1|||
147149183|NCT00576628|530708391|FG000|Overall Study|Progression of Kidney Disease|1|||
147149184|NCT00576628|530708391|FG000|Overall Study|Progression of Renal Failure|1|||
147149185|NCT00576628|530708391|FG000|Overall Study|The patient move into other town|1|||
147149186|NCT00576628|530708391|FG000|Overall Study|Transplantation|1|||
147149187|NCT00576628|530708391|FG000|Overall Study|Dialysis|15|||
147149188|NCT03645421|530708394|FG000|Overall Study|Adverse Event|0|||
147149189|NCT03645421|530708395|FG001|Overall Study|Adverse Event|0|||
147149190|NCT03645421|530708396|FG002|Overall Study|Adverse Event|4|||
147149191|NCT03645421|530708397|FG003|Overall Study|Adverse Event|1|||
147149192|NCT03645421|530708394|FG000|Overall Study|Withdrawal by patient|0|||
147149193|NCT03645421|530708395|FG001|Overall Study|Withdrawal by patient|0|||
147149194|NCT03645421|530708396|FG002|Overall Study|Withdrawal by patient|0|||
147149195|NCT03645421|530708397|FG003|Overall Study|Withdrawal by patient|3|||
147149196|NCT03645421|530708394|FG000|Overall Study|Study specific withdrawal criteria|0|||
147149197|NCT03645421|530708395|FG001|Overall Study|Study specific withdrawal criteria|0|||
147149198|NCT03645421|530708396|FG002|Overall Study|Study specific withdrawal criteria|1|||
147149199|NCT03645421|530708397|FG003|Overall Study|Study specific withdrawal criteria|0|||
147149200|NCT00224120|530708402|FG000|Overall Study|Adverse Event|10|||
147149201|NCT00224120|530708403|FG001|Overall Study|Adverse Event|4|||
147149202|NCT00224120|530708402|FG000|Overall Study|Protocol Violation|1|||
147149203|NCT00224120|530708403|FG001|Overall Study|Protocol Violation|0|||
147149204|NCT00224120|530708402|FG000|Overall Study|Withdrawal by Subject|5|||
147149205|NCT00224120|530708403|FG001|Overall Study|Withdrawal by Subject|10|||
147149206|NCT00224120|530708402|FG000|Overall Study|Lack of Efficacy|0|||
147149207|NCT00224120|530708403|FG001|Overall Study|Lack of Efficacy|2|||
147149208|NCT00224120|530708402|FG000|Overall Study|Lost to Follow-up|2|||
147149209|NCT00224120|530708403|FG001|Overall Study|Lost to Follow-up|3|||
147149210|NCT00224120|530708402|FG000|Overall Study|Other|4|||
147149211|NCT00224120|530708403|FG001|Overall Study|Other|5|||
147149212|NCT00104416|530708404|FG000|Double-Blind Phase|Adverse Event|2|||
147149213|NCT00104416|530708405|FG001|Double-Blind Phase|Adverse Event|1|||
147149214|NCT00104416|530708406|FG002|Double-Blind Phase|Adverse Event|0|||
147149215|NCT00104416|530708407|FG003|Double-Blind Phase|Adverse Event|0|||
147149216|NCT00104416|530708408|FG004|Double-Blind Phase|Adverse Event|0|||
147149217|NCT00104416|530708404|FG000|Double-Blind Phase|Lost to Follow-up|0|||
147149218|NCT00104416|530708405|FG001|Double-Blind Phase|Lost to Follow-up|1|||
147149219|NCT00104416|530708406|FG002|Double-Blind Phase|Lost to Follow-up|0|||
147149220|NCT00104416|530708407|FG003|Double-Blind Phase|Lost to Follow-up|0|||
147149221|NCT00104416|530708408|FG004|Double-Blind Phase|Lost to Follow-up|0|||
147149222|NCT00104416|530708404|FG000|Double-Blind Phase|Protocol Violation|0|||
147149223|NCT00104416|530708405|FG001|Double-Blind Phase|Protocol Violation|1|||
147149224|NCT00104416|530708406|FG002|Double-Blind Phase|Protocol Violation|0|||
147149225|NCT00104416|530708407|FG003|Double-Blind Phase|Protocol Violation|0|||
147149226|NCT00104416|530708408|FG004|Double-Blind Phase|Protocol Violation|0|||
147149227|NCT00104416|530708404|FG000|Double-Blind Phase|Withdrawal by Subject|2|||
147239388|NCT00939770|531047594|FG004|Overall Study|Adverse Event|6|||
147149228|NCT00104416|530708405|FG001|Double-Blind Phase|Withdrawal by Subject|3|||
147149229|NCT00104416|530708406|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
147149230|NCT00104416|530708407|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
147149231|NCT00104416|530708408|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
147149232|NCT00104416|530708404|FG000|Double-Blind Phase|Pregnancy|1|||
147149233|NCT00104416|530708405|FG001|Double-Blind Phase|Pregnancy|0|||
147149234|NCT00104416|530708406|FG002|Double-Blind Phase|Pregnancy|0|||
147149235|NCT00104416|530708407|FG003|Double-Blind Phase|Pregnancy|0|||
147149236|NCT00104416|530708408|FG004|Double-Blind Phase|Pregnancy|0|||
147575977|NCT00112437|532263543|FG025|Years 4-5 (24-Month Extension)|Adverse Event|0|||
147149237|NCT00104416|530708404|FG000|Double-Blind Phase|Participant Did Not Take Drug|3|||
147149238|NCT00104416|530708405|FG001|Double-Blind Phase|Participant Did Not Take Drug|4|||
147149239|NCT00104416|530708406|FG002|Double-Blind Phase|Participant Did Not Take Drug|0|||
147149240|NCT00104416|530708407|FG003|Double-Blind Phase|Participant Did Not Take Drug|0|||
147149241|NCT00104416|530708408|FG004|Double-Blind Phase|Participant Did Not Take Drug|0|||
147149242|NCT00104416|530708404|FG000|Continuation Phase|Adverse Event|0|||
147149243|NCT00104416|530708405|FG001|Continuation Phase|Adverse Event|0|||
147149244|NCT00104416|530708406|FG002|Continuation Phase|Adverse Event|2|||
147149245|NCT00104416|530708407|FG003|Continuation Phase|Adverse Event|0|||
147149246|NCT00104416|530708408|FG004|Continuation Phase|Adverse Event|2|||
147149247|NCT00104416|530708404|FG000|Continuation Phase|Lost to Follow-up|0|||
147149248|NCT00104416|530708405|FG001|Continuation Phase|Lost to Follow-up|0|||
147149249|NCT00104416|530708406|FG002|Continuation Phase|Lost to Follow-up|1|||
147149250|NCT00104416|530708407|FG003|Continuation Phase|Lost to Follow-up|0|||
147149251|NCT00104416|530708408|FG004|Continuation Phase|Lost to Follow-up|1|||
147149252|NCT00104416|530708404|FG000|Continuation Phase|Withdrawal by Subject|0|||
147149253|NCT00104416|530708405|FG001|Continuation Phase|Withdrawal by Subject|0|||
147149254|NCT00104416|530708406|FG002|Continuation Phase|Withdrawal by Subject|2|||
147149255|NCT00104416|530708407|FG003|Continuation Phase|Withdrawal by Subject|1|||
147149256|NCT00104416|530708408|FG004|Continuation Phase|Withdrawal by Subject|1|||
147149257|NCT00104416|530708404|FG000|Continuation Phase|Pregnancy|0|||
147149258|NCT00104416|530708405|FG001|Continuation Phase|Pregnancy|0|||
147149259|NCT00104416|530708406|FG002|Continuation Phase|Pregnancy|1|||
147149260|NCT00104416|530708407|FG003|Continuation Phase|Pregnancy|1|||
147149261|NCT00104416|530708408|FG004|Continuation Phase|Pregnancy|0|||
147149262|NCT00104416|530708404|FG000|Continuation Phase|Non-compliance|0|||
147149263|NCT00104416|530708405|FG001|Continuation Phase|Non-compliance|0|||
147149264|NCT00104416|530708406|FG002|Continuation Phase|Non-compliance|0|||
147149265|NCT00104416|530708407|FG003|Continuation Phase|Non-compliance|0|||
147149266|NCT00104416|530708408|FG004|Continuation Phase|Non-compliance|1|||
147149267|NCT01164891|530708415|FG000|Overall Study|Disease Progression|5|||
147149268|NCT01164891|530708415|FG000|Overall Study|Adverse Event|1|||
147149269|NCT03985943|530708416|FG000|Initial Treatment(Day 1-Week 16 Predose)|Pregnancy|0|||
147149270|NCT03985943|530708417|FG001|Initial Treatment(Day 1-Week 16 Predose)|Pregnancy|2|||
147149271|NCT03985943|530708418|FG002|Initial Treatment(Day 1-Week 16 Predose)|Pregnancy|0|||
147149272|NCT03985943|530708419|FG003|Initial Treatment(Day 1-Week 16 Predose)|Pregnancy|0|||
147149273|NCT03985943|530708420|FG004|Initial Treatment(Day 1-Week 16 Predose)|Pregnancy|0|||
147149274|NCT03985943|530708421|FG005|Initial Treatment(Day 1-Week 16 Predose)|Pregnancy|0|||
147149275|NCT03985943|530708416|FG000|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|2|||
147149276|NCT03985943|530708417|FG001|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|5|||
147149277|NCT03985943|530708418|FG002|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
147149278|NCT03985943|530708419|FG003|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
147149279|NCT03985943|530708420|FG004|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
147149280|NCT03985943|530708421|FG005|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
147149281|NCT03985943|530708416|FG000|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|9|||
147149282|NCT03985943|530708417|FG001|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|9|||
147149283|NCT03985943|530708418|FG002|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
147149284|NCT03985943|530708419|FG003|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
147149285|NCT03985943|530708420|FG004|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
147149286|NCT03985943|530708421|FG005|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
147149287|NCT03985943|530708416|FG000|Initial Treatment(Day 1-Week 16 Predose)|Subjects request|11|||
147149288|NCT03985943|530708417|FG001|Initial Treatment(Day 1-Week 16 Predose)|Subjects request|25|||
147149289|NCT03985943|530708418|FG002|Initial Treatment(Day 1-Week 16 Predose)|Subjects request|0|||
147149290|NCT03985943|530708419|FG003|Initial Treatment(Day 1-Week 16 Predose)|Subjects request|0|||
147149291|NCT03985943|530708420|FG004|Initial Treatment(Day 1-Week 16 Predose)|Subjects request|0|||
147149292|NCT03985943|530708421|FG005|Initial Treatment(Day 1-Week 16 Predose)|Subjects request|0|||
147149293|NCT03985943|530708416|FG000|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
147149294|NCT03985943|530708417|FG001|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|10|||
147149295|NCT03985943|530708418|FG002|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
147149296|NCT03985943|530708419|FG003|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
147149297|NCT03985943|530708420|FG004|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
147149298|NCT03985943|530708421|FG005|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
147149299|NCT03985943|530708416|FG000|Initial Treatment(Day 1-Week 16 Predose)|Protocol deviation|3|||
147149300|NCT03985943|530708417|FG001|Initial Treatment(Day 1-Week 16 Predose)|Protocol deviation|4|||
147149301|NCT03985943|530708418|FG002|Initial Treatment(Day 1-Week 16 Predose)|Protocol deviation|0|||
147149302|NCT03985943|530708419|FG003|Initial Treatment(Day 1-Week 16 Predose)|Protocol deviation|0|||
147149303|NCT03985943|530708420|FG004|Initial Treatment(Day 1-Week 16 Predose)|Protocol deviation|0|||
147149304|NCT03985943|530708421|FG005|Initial Treatment(Day 1-Week 16 Predose)|Protocol deviation|0|||
147149305|NCT03985943|530708416|FG000|Initial Treatment(Day 1-Week 16 Predose)|Physician/Principal Investigators Decision|0|||
147149306|NCT03985943|530708417|FG001|Initial Treatment(Day 1-Week 16 Predose)|Physician/Principal Investigators Decision|1|||
147239389|NCT00939770|531047595|FG005|Overall Study|Adverse Event|2|||
147239390|NCT00939770|531047596|FG006|Overall Study|Adverse Event|1|||
147575978|NCT00112437|532263518|FG000|Years 4-5 (24-Month Extension)|Participant moved|0|||
147575979|NCT00112437|532263519|FG001|Years 4-5 (24-Month Extension)|Participant moved|0|||
147575980|NCT00112437|532263520|FG002|Years 4-5 (24-Month Extension)|Participant moved|0|||
147239391|NCT00939770|531047597|FG007|Overall Study|Adverse Event|1|||
147149307|NCT03985943|530708418|FG002|Initial Treatment(Day 1-Week 16 Predose)|Physician/Principal Investigators Decision|0|||
147149308|NCT03985943|530708419|FG003|Initial Treatment(Day 1-Week 16 Predose)|Physician/Principal Investigators Decision|0|||
147149309|NCT03985943|530708420|FG004|Initial Treatment(Day 1-Week 16 Predose)|Physician/Principal Investigators Decision|0|||
147149310|NCT03985943|530708421|FG005|Initial Treatment(Day 1-Week 16 Predose)|Physician/Principal Investigators Decision|0|||
147149311|NCT03985943|530708416|FG000|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not treated|0|||
147149312|NCT03985943|530708417|FG001|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not treated|4|||
147149313|NCT03985943|530708418|FG002|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not treated|0|||
147149314|NCT03985943|530708419|FG003|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not treated|0|||
147149315|NCT03985943|530708420|FG004|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not treated|0|||
147149316|NCT03985943|530708421|FG005|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not treated|0|||
147149317|NCT03985943|530708416|FG000|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
147149318|NCT03985943|530708417|FG001|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
147149319|NCT03985943|530708418|FG002|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|4|||
147149320|NCT03985943|530708419|FG003|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|3|||
147149321|NCT03985943|530708420|FG004|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|12|||
147149322|NCT03985943|530708421|FG005|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|4|||
147149323|NCT03985943|530708416|FG000|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
147149324|NCT03985943|530708417|FG001|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
147149325|NCT03985943|530708418|FG002|Maintenance Period (Week 16-Week 48)|Adverse Event|1|||
147149326|NCT03985943|530708419|FG003|Maintenance Period (Week 16-Week 48)|Adverse Event|3|||
147149327|NCT03985943|530708420|FG004|Maintenance Period (Week 16-Week 48)|Adverse Event|1|||
147149328|NCT03985943|530708421|FG005|Maintenance Period (Week 16-Week 48)|Adverse Event|1|||
147149329|NCT03985943|530708416|FG000|Maintenance Period (Week 16-Week 48)|Subjects request|0|||
147149330|NCT03985943|530708417|FG001|Maintenance Period (Week 16-Week 48)|Subjects request|0|||
147149331|NCT03985943|530708418|FG002|Maintenance Period (Week 16-Week 48)|Subjects request|6|||
147149332|NCT03985943|530708419|FG003|Maintenance Period (Week 16-Week 48)|Subjects request|4|||
147149333|NCT03985943|530708420|FG004|Maintenance Period (Week 16-Week 48)|Subjects request|5|||
147149334|NCT03985943|530708421|FG005|Maintenance Period (Week 16-Week 48)|Subjects request|9|||
147149335|NCT03985943|530708416|FG000|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
147149336|NCT03985943|530708417|FG001|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
147149337|NCT03985943|530708418|FG002|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
147149338|NCT03985943|530708419|FG003|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|1|||
147149339|NCT03985943|530708420|FG004|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|1|||
147149340|NCT03985943|530708421|FG005|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|1|||
147149341|NCT03985943|530708416|FG000|Maintenance Period (Week 16-Week 48)|Protocol Deviation|0|||
147149342|NCT03985943|530708417|FG001|Maintenance Period (Week 16-Week 48)|Protocol Deviation|0|||
147149343|NCT03985943|530708418|FG002|Maintenance Period (Week 16-Week 48)|Protocol Deviation|1|||
147149344|NCT03985943|530708419|FG003|Maintenance Period (Week 16-Week 48)|Protocol Deviation|0|||
147149345|NCT03985943|530708420|FG004|Maintenance Period (Week 16-Week 48)|Protocol Deviation|1|||
147149346|NCT03985943|530708421|FG005|Maintenance Period (Week 16-Week 48)|Protocol Deviation|0|||
147149347|NCT03985943|530708416|FG000|Maintenance Period (Week 16-Week 48)|Physician/PI Decision|0|||
147149348|NCT03985943|530708417|FG001|Maintenance Period (Week 16-Week 48)|Physician/PI Decision|0|||
147149349|NCT03985943|530708418|FG002|Maintenance Period (Week 16-Week 48)|Physician/PI Decision|2|||
147149350|NCT03985943|530708419|FG003|Maintenance Period (Week 16-Week 48)|Physician/PI Decision|1|||
147149351|NCT03985943|530708420|FG004|Maintenance Period (Week 16-Week 48)|Physician/PI Decision|1|||
147149352|NCT03985943|530708421|FG005|Maintenance Period (Week 16-Week 48)|Physician/PI Decision|2|||
147149353|NCT03985943|530708416|FG000|Maintenance Period (Week 16-Week 48)|Other|0|||
147149354|NCT03985943|530708417|FG001|Maintenance Period (Week 16-Week 48)|Other|0|||
147149355|NCT03985943|530708418|FG002|Maintenance Period (Week 16-Week 48)|Other|0|||
147149356|NCT03985943|530708419|FG003|Maintenance Period (Week 16-Week 48)|Other|0|||
147149357|NCT03985943|530708420|FG004|Maintenance Period (Week 16-Week 48)|Other|1|||
147149358|NCT03985943|530708421|FG005|Maintenance Period (Week 16-Week 48)|Other|1|||
147149359|NCT00441142|530708422|FG000|Overall Study|Adverse Event|2|||
147149360|NCT00441142|530708423|FG001|Overall Study|Adverse Event|3|||
147149361|NCT00441142|530708424|FG002|Overall Study|Adverse Event|3|||
147149362|NCT00441142|530708425|FG003|Overall Study|Adverse Event|22|||
147149363|NCT00441142|530708422|FG000|Overall Study|Lack of Efficacy|3|||
147149364|NCT00441142|530708423|FG001|Overall Study|Lack of Efficacy|3|||
147149365|NCT00441142|530708424|FG002|Overall Study|Lack of Efficacy|17|||
147149366|NCT00441142|530708425|FG003|Overall Study|Lack of Efficacy|32|||
147239392|NCT00939770|531047590|FG000|Overall Study|Lack of Efficacy|4|||
147239393|NCT00939770|531047591|FG001|Overall Study|Lack of Efficacy|6|||
147239394|NCT00939770|531047592|FG002|Overall Study|Lack of Efficacy|13|||
147239395|NCT00939770|531047593|FG003|Overall Study|Lack of Efficacy|9|||
147239396|NCT00939770|531047594|FG004|Overall Study|Lack of Efficacy|16|||
147575981|NCT00112437|532263521|FG003|Years 4-5 (24-Month Extension)|Participant moved|0|||
147149367|NCT00441142|530708422|FG000|Overall Study|Withdrawal by Subject|0|||
147149368|NCT00441142|530708423|FG001|Overall Study|Withdrawal by Subject|0|||
147575982|NCT00112437|532263522|FG004|Years 4-5 (24-Month Extension)|Participant moved|0|||
147575983|NCT00112437|532263523|FG005|Years 4-5 (24-Month Extension)|Participant moved|0|||
147575984|NCT00112437|532263524|FG006|Years 4-5 (24-Month Extension)|Participant moved|0|||
147575985|NCT00112437|532263525|FG007|Years 4-5 (24-Month Extension)|Participant moved|0|||
147575986|NCT00112437|532263526|FG008|Years 4-5 (24-Month Extension)|Participant moved|0|||
147575987|NCT00112437|532263527|FG009|Years 4-5 (24-Month Extension)|Participant moved|0|||
147575988|NCT00112437|532263528|FG010|Years 4-5 (24-Month Extension)|Participant moved|0|||
147575989|NCT00112437|532263529|FG011|Years 4-5 (24-Month Extension)|Participant moved|0|||
147575990|NCT00112437|532263530|FG012|Years 4-5 (24-Month Extension)|Participant moved|0|||
147575991|NCT00112437|532263531|FG013|Years 4-5 (24-Month Extension)|Participant moved|0|||
147575992|NCT00112437|532263532|FG014|Years 4-5 (24-Month Extension)|Participant moved|0|||
147575993|NCT00112437|532263533|FG015|Years 4-5 (24-Month Extension)|Participant moved|0|||
147575994|NCT00112437|532263534|FG016|Years 4-5 (24-Month Extension)|Participant moved|0|||
147575995|NCT00112437|532263535|FG017|Years 4-5 (24-Month Extension)|Participant moved|0|||
147575996|NCT00112437|532263536|FG018|Years 4-5 (24-Month Extension)|Participant moved|0|||
147575997|NCT00112437|532263537|FG019|Years 4-5 (24-Month Extension)|Participant moved|0|||
147575998|NCT00112437|532263538|FG020|Years 4-5 (24-Month Extension)|Participant moved|0|||
147575999|NCT00112437|532263539|FG021|Years 4-5 (24-Month Extension)|Participant moved|1|||
147576000|NCT00112437|532263540|FG022|Years 4-5 (24-Month Extension)|Participant moved|0|||
147576001|NCT00112437|532263541|FG023|Years 4-5 (24-Month Extension)|Participant moved|0|||
147576002|NCT00112437|532263542|FG024|Years 4-5 (24-Month Extension)|Participant moved|0|||
147576003|NCT00112437|532263543|FG025|Years 4-5 (24-Month Extension)|Participant moved|0|||
147576004|NCT00112437|532263518|FG000|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
147576005|NCT00112437|532263519|FG001|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
147576006|NCT00112437|532263520|FG002|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
147576007|NCT00112437|532263521|FG003|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
147576008|NCT00112437|532263522|FG004|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
147576009|NCT00112437|532263523|FG005|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
147576010|NCT00112437|532263524|FG006|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
147576011|NCT00112437|532263525|FG007|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
147576012|NCT00112437|532263526|FG008|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
147576013|NCT00112437|532263527|FG009|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
147576014|NCT00112437|532263528|FG010|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
147576015|NCT00112437|532263529|FG011|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
147576016|NCT00112437|532263530|FG012|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
147576017|NCT00112437|532263531|FG013|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
147576018|NCT00112437|532263532|FG014|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
147576019|NCT00112437|532263533|FG015|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
147576020|NCT00112437|532263534|FG016|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
147576021|NCT00112437|532263535|FG017|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
147576022|NCT00112437|532263536|FG018|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
147576023|NCT00112437|532263537|FG019|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
147576024|NCT00112437|532263538|FG020|Years 4-5 (24-Month Extension)|Withdrawal by Subject|1|||
147576025|NCT00112437|532263539|FG021|Years 4-5 (24-Month Extension)|Withdrawal by Subject|2|||
147576026|NCT00112437|532263540|FG022|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
147576027|NCT00112437|532263541|FG023|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
147576028|NCT00112437|532263542|FG024|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
147576029|NCT00112437|532263543|FG025|Years 4-5 (24-Month Extension)|Withdrawal by Subject|0|||
147576030|NCT00112437|532263518|FG000|Years 6-10 (60-Month Extension)|Adverse Event|0|||
147576031|NCT00112437|532263519|FG001|Years 6-10 (60-Month Extension)|Adverse Event|0|||
147576032|NCT00112437|532263520|FG002|Years 6-10 (60-Month Extension)|Adverse Event|0|||
147576033|NCT00112437|532263521|FG003|Years 6-10 (60-Month Extension)|Adverse Event|0|||
147576034|NCT00112437|532263522|FG004|Years 6-10 (60-Month Extension)|Adverse Event|0|||
147576035|NCT00112437|532263523|FG005|Years 6-10 (60-Month Extension)|Adverse Event|0|||
147576036|NCT00112437|532263524|FG006|Years 6-10 (60-Month Extension)|Adverse Event|0|||
147576037|NCT00112437|532263525|FG007|Years 6-10 (60-Month Extension)|Adverse Event|0|||
147576038|NCT00112437|532263526|FG008|Years 6-10 (60-Month Extension)|Adverse Event|0|||
147576039|NCT00112437|532263527|FG009|Years 6-10 (60-Month Extension)|Adverse Event|0|||
147576040|NCT00112437|532263528|FG010|Years 6-10 (60-Month Extension)|Adverse Event|0|||
147149369|NCT00441142|530708424|FG002|Overall Study|Withdrawal by Subject|2|||
147149370|NCT00441142|530708425|FG003|Overall Study|Withdrawal by Subject|10|||
147576041|NCT00112437|532263529|FG011|Years 6-10 (60-Month Extension)|Adverse Event|0|||
147576042|NCT00112437|532263530|FG012|Years 6-10 (60-Month Extension)|Adverse Event|0|||
147576043|NCT00112437|532263531|FG013|Years 6-10 (60-Month Extension)|Adverse Event|0|||
147576044|NCT00112437|532263532|FG014|Years 6-10 (60-Month Extension)|Adverse Event|0|||
147576045|NCT00112437|532263533|FG015|Years 6-10 (60-Month Extension)|Adverse Event|0|||
147652899|NCT04304508|532551843|FG003|Overall Study|Adverse Event|56|||
147652900|NCT04304508|532551840|FG000|Overall Study|Lost to Follow-up|1|||
147652901|NCT04304508|532551841|FG001|Overall Study|Lost to Follow-up|5|||
147652902|NCT04304508|532551842|FG002|Overall Study|Lost to Follow-up|2|||
147652903|NCT04304508|532551843|FG003|Overall Study|Lost to Follow-up|3|||
147652904|NCT01775787|532551850|FG000|First 7-10 Days|Adverse Event|0|||
147652905|NCT01775787|532551851|FG001|First 7-10 Days|Adverse Event|1|||
147652906|NCT01775787|532551850|FG000|First 7-10 Days|family emergency|0|||
147652907|NCT01775787|532551851|FG001|First 7-10 Days|family emergency|1|||
147652908|NCT01775787|532551850|FG000|First 7-10 Days|time commitment|0|||
147652909|NCT01775787|532551851|FG001|First 7-10 Days|time commitment|2|||
147652910|NCT01775787|532551850|FG000|First 7-10 Days|concerns with using IV|1|||
147652911|NCT01775787|532551851|FG001|First 7-10 Days|concerns with using IV|2|||
147149371|NCT00441142|530708422|FG000|Overall Study|Patient still receiving active study tx|1|||
147149372|NCT00441142|530708423|FG001|Overall Study|Patient still receiving active study tx|0|||
147149373|NCT00441142|530708424|FG002|Overall Study|Patient still receiving active study tx|0|||
147149374|NCT00441142|530708425|FG003|Overall Study|Patient still receiving active study tx|2|||
147149375|NCT00441142|530708422|FG000|Overall Study|Physician Decision|0|||
147149376|NCT00441142|530708423|FG001|Overall Study|Physician Decision|1|||
147149377|NCT00441142|530708424|FG002|Overall Study|Physician Decision|0|||
147149378|NCT00441142|530708425|FG003|Overall Study|Physician Decision|1|||
147149379|NCT00441142|530708422|FG000|Overall Study|Death|0|||
147149380|NCT00441142|530708423|FG001|Overall Study|Death|0|||
147149381|NCT00441142|530708424|FG002|Overall Study|Death|0|||
147149382|NCT00441142|530708425|FG003|Overall Study|Death|1|||
147149383|NCT00338286|530708426|FG000|Overall Study|Withdrawal by Subject|50|||
147149384|NCT00338286|530708427|FG001|Overall Study|Withdrawal by Subject|54|||
147149385|NCT00338286|530708426|FG000|Overall Study|Lost to Follow-up|80|||
147149386|NCT00338286|530708427|FG001|Overall Study|Lost to Follow-up|66|||
147149387|NCT00338286|530708426|FG000|Overall Study|Other|103|||
147149388|NCT00338286|530708427|FG001|Overall Study|Other|93|||
147149389|NCT01265563|530708428|FG000|Overall Study|Withdrawal by Subject|0|||
147321009|NCT04955626|531338432|FG012|Open-Label Period|Withdrawal by parent/guardian|0|||
147321010|NCT04955626|531338433|FG013|Open-Label Period|Withdrawal by parent/guardian|0|||
147576046|NCT00112437|532263534|FG016|Years 6-10 (60-Month Extension)|Adverse Event|0|||
147576047|NCT00112437|532263535|FG017|Years 6-10 (60-Month Extension)|Adverse Event|0|||
147576048|NCT00112437|532263536|FG018|Years 6-10 (60-Month Extension)|Adverse Event|0|||
147576049|NCT00112437|532263537|FG019|Years 6-10 (60-Month Extension)|Adverse Event|0|||
147576050|NCT00112437|532263538|FG020|Years 6-10 (60-Month Extension)|Adverse Event|0|||
147576051|NCT00112437|532263539|FG021|Years 6-10 (60-Month Extension)|Adverse Event|0|||
147576052|NCT00112437|532263540|FG022|Years 6-10 (60-Month Extension)|Adverse Event|1|||
147576053|NCT00112437|532263541|FG023|Years 6-10 (60-Month Extension)|Adverse Event|2|||
147576054|NCT00112437|532263542|FG024|Years 6-10 (60-Month Extension)|Adverse Event|0|||
147576055|NCT00112437|532263543|FG025|Years 6-10 (60-Month Extension)|Adverse Event|1|||
147576056|NCT00112437|532263518|FG000|Years 6-10 (60-Month Extension)|Death|0|||
147576057|NCT00112437|532263519|FG001|Years 6-10 (60-Month Extension)|Death|0|||
147576058|NCT00112437|532263520|FG002|Years 6-10 (60-Month Extension)|Death|0|||
147576059|NCT00112437|532263521|FG003|Years 6-10 (60-Month Extension)|Death|0|||
147576060|NCT00112437|532263522|FG004|Years 6-10 (60-Month Extension)|Death|0|||
147149390|NCT01265563|530708429|FG001|Overall Study|Withdrawal by Subject|1|||
147149391|NCT01265563|530708430|FG002|Overall Study|Withdrawal by Subject|1|||
147149392|NCT01265563|530708431|FG003|Overall Study|Withdrawal by Subject|0|||
147149393|NCT01265563|530708432|FG004|Overall Study|Withdrawal by Subject|2|||
147149394|NCT03248531|530708433|FG000|Overall Study|Adverse Event|0|||
147149395|NCT03248531|530708434|FG001|Overall Study|Adverse Event|0|||
147149396|NCT03248531|530708435|FG002|Overall Study|Adverse Event|1|||
147149397|NCT03248531|530708433|FG000|Overall Study|Lost to Follow-up|1|||
147149398|NCT03248531|530708434|FG001|Overall Study|Lost to Follow-up|0|||
147149399|NCT03248531|530708435|FG002|Overall Study|Lost to Follow-up|5|||
147149400|NCT03248531|530708433|FG000|Overall Study|Withdrawal by Subject|3|||
147149401|NCT03248531|530708434|FG001|Overall Study|Withdrawal by Subject|3|||
147149402|NCT03248531|530708435|FG002|Overall Study|Withdrawal by Subject|2|||
147576061|NCT00112437|532263523|FG005|Years 6-10 (60-Month Extension)|Death|0|||
147652912|NCT01775787|532551850|FG000|Second 7-10 Days|time commitment|0|||
147652913|NCT01775787|532551851|FG001|Second 7-10 Days|time commitment|1|||
147652914|NCT01775787|532551850|FG000|Second 7-10 Days|concerns with using IV|0|||
147149403|NCT03248531|530708433|FG000|Overall Study|Sponsor Request|0|||
147149404|NCT03248531|530708434|FG001|Overall Study|Sponsor Request|2|||
147149405|NCT03248531|530708435|FG002|Overall Study|Sponsor Request|0|||
147149406|NCT04075513|530708438|FG000|Overall Study|Withdrawal by Subject|2|||
147149407|NCT04075513|530708439|FG001|Overall Study|Withdrawal by Subject|2|||
147149408|NCT04075513|530708438|FG000|Overall Study|Lack of Efficacy|1|||
147149409|NCT04075513|530708439|FG001|Overall Study|Lack of Efficacy|0|||
147149410|NCT04075513|530708438|FG000|Overall Study|Lost to Follow-up|4|||
147149411|NCT04075513|530708439|FG001|Overall Study|Lost to Follow-up|2|||
147576062|NCT00112437|532263524|FG006|Years 6-10 (60-Month Extension)|Death|0|||
147576063|NCT00112437|532263525|FG007|Years 6-10 (60-Month Extension)|Death|0|||
147576064|NCT00112437|532263526|FG008|Years 6-10 (60-Month Extension)|Death|0|||
147149412|NCT04075513|530708438|FG000|Overall Study|Switch to insulin pump|1|||
147149413|NCT04075513|530708439|FG001|Overall Study|Switch to insulin pump|0|||
147149414|NCT05411822|530708441|FG000|Overall Study|Withdrawal by Subject|2|||
147149415|NCT05411822|530708442|FG001|Overall Study|Withdrawal by Subject|1|||
147149416|NCT05312697|530708443|FG000|Overall Study|Sponsor Terminated Trial|2|||
147149417|NCT04283656|530708444|FG000|Overall Study|Adverse Event|1|||
147149418|NCT04283656|530708445|FG001|Overall Study|Adverse Event|0|||
147149419|NCT04283656|530708444|FG000|Overall Study|Lost to Follow-up|0|||
147149420|NCT04283656|530708445|FG001|Overall Study|Lost to Follow-up|1|||
147149421|NCT00964002|530708448|FG000|Overall Study|Protocol Violation|8|||
147149422|NCT02036580|530708451|FG000|Overall Study|Withdrawal by Subject|0|||
147149423|NCT02036580|530708452|FG001|Overall Study|Withdrawal by Subject|1|||
147149424|NCT02036580|530708453|FG002|Overall Study|Withdrawal by Subject|0|||
147149425|NCT02036580|530708451|FG000|Overall Study|Adverse Event|1|||
147149426|NCT02036580|530708452|FG001|Overall Study|Adverse Event|0|||
147149427|NCT02036580|530708453|FG002|Overall Study|Adverse Event|0|||
147149428|NCT00976716|530708457|FG000|Overall Study|Adverse Event|1|||
147149429|NCT04222699|530708458|FG000|Overall Study|Lost to Follow-up|2|||
147149430|NCT03583359|530708464|FG000|Overall Study|Withdrawal by Subject|15|||
147149431|NCT03583359|530708465|FG001|Overall Study|Withdrawal by Subject|6|||
147149432|NCT03583359|530708464|FG000|Overall Study|Lost to Follow-up|12|||
147149433|NCT03583359|530708465|FG001|Overall Study|Lost to Follow-up|3|||
147149434|NCT03583359|530708464|FG000|Overall Study|Adverse Event|0|||
147149435|NCT03583359|530708465|FG001|Overall Study|Adverse Event|1|||
147149436|NCT03583359|530708464|FG000|Overall Study|Protocol Violation|0|||
147149437|NCT03583359|530708465|FG001|Overall Study|Protocol Violation|1|||
147149438|NCT03583359|530708464|FG000|Overall Study|Other|2|||
147149439|NCT03583359|530708465|FG001|Overall Study|Other|1|||
147149440|NCT00703846|530708471|FG000|Overall Study|Adverse Event|8|||
147149441|NCT00703846|530708471|FG000|Overall Study|Lost to Follow-up|55|||
147149442|NCT00703846|530708471|FG000|Overall Study|Lack of Efficacy|15|||
147149443|NCT00703846|530708471|FG000|Overall Study|Noncompliance with Study Treatment|2|||
147149444|NCT00703846|530708471|FG000|Overall Study|Withdrawal by Subject|40|||
147149445|NCT00703846|530708471|FG000|Overall Study|Death|1|||
147149446|NCT00703846|530708471|FG000|Overall Study|Other|14|||
147149447|NCT00703846|530708471|FG000|Overall Study|Did Not Receive Study Drug|2|||
147239397|NCT00939770|531047595|FG005|Overall Study|Lack of Efficacy|8|||
147239398|NCT00939770|531047596|FG006|Overall Study|Lack of Efficacy|11|||
147239399|NCT00939770|531047597|FG007|Overall Study|Lack of Efficacy|1|||
147239400|NCT00939770|531047590|FG000|Overall Study|Lost to Follow-up|0|||
147239401|NCT00939770|531047591|FG001|Overall Study|Lost to Follow-up|0|||
147239402|NCT00939770|531047592|FG002|Overall Study|Lost to Follow-up|0|||
147576065|NCT00112437|532263527|FG009|Years 6-10 (60-Month Extension)|Death|0|||
147576066|NCT00112437|532263528|FG010|Years 6-10 (60-Month Extension)|Death|0|||
147576067|NCT00112437|532263529|FG011|Years 6-10 (60-Month Extension)|Death|0|||
147576068|NCT00112437|532263530|FG012|Years 6-10 (60-Month Extension)|Death|0|||
147576069|NCT00112437|532263531|FG013|Years 6-10 (60-Month Extension)|Death|0|||
147576070|NCT00112437|532263532|FG014|Years 6-10 (60-Month Extension)|Death|0|||
147576071|NCT00112437|532263533|FG015|Years 6-10 (60-Month Extension)|Death|0|||
147576072|NCT00112437|532263534|FG016|Years 6-10 (60-Month Extension)|Death|0|||
147576073|NCT00112437|532263535|FG017|Years 6-10 (60-Month Extension)|Death|0|||
147576074|NCT00112437|532263536|FG018|Years 6-10 (60-Month Extension)|Death|0|||
147576075|NCT00112437|532263537|FG019|Years 6-10 (60-Month Extension)|Death|0|||
147576076|NCT00112437|532263538|FG020|Years 6-10 (60-Month Extension)|Death|0|||
147576077|NCT00112437|532263539|FG021|Years 6-10 (60-Month Extension)|Death|0|||
147576078|NCT00112437|532263540|FG022|Years 6-10 (60-Month Extension)|Death|0|||
147576079|NCT00112437|532263541|FG023|Years 6-10 (60-Month Extension)|Death|2|||
147576080|NCT00112437|532263542|FG024|Years 6-10 (60-Month Extension)|Death|0|||
147576081|NCT00112437|532263543|FG025|Years 6-10 (60-Month Extension)|Death|0|||
147576082|NCT00112437|532263518|FG000|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
147576083|NCT00112437|532263519|FG001|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
147576084|NCT00112437|532263520|FG002|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
147576085|NCT00112437|532263521|FG003|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
147576086|NCT00112437|532263522|FG004|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
147576087|NCT00112437|532263523|FG005|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
147576088|NCT00112437|532263524|FG006|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
147149448|NCT04601532|530708472|FG000|Overall Study|Lost to Follow-up|1|||
147149449|NCT04601532|530708473|FG001|Overall Study|Lost to Follow-up|2|||
147149450|NCT04601532|530708472|FG000|Overall Study|Withdrawn due to allergic reaction to Silver sulfadiazine.|1|||
147149451|NCT04601532|530708473|FG001|Overall Study|Withdrawn due to allergic reaction to Silver sulfadiazine.|0|||
147149452|NCT02566785|530708474|FG000|Overall Study|Lost to Follow-up|0|||
147239403|NCT00939770|531047593|FG003|Overall Study|Lost to Follow-up|0|||
147576089|NCT00112437|532263525|FG007|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
147576090|NCT00112437|532263526|FG008|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
147576091|NCT00112437|532263527|FG009|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
147576092|NCT00112437|532263528|FG010|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
147149453|NCT02566785|530708475|FG001|Overall Study|Lost to Follow-up|2|||
147149454|NCT02566785|530708474|FG000|Overall Study|Worsening condition|1|||
147149455|NCT02566785|530708475|FG001|Overall Study|Worsening condition|1|||
147149456|NCT00837161|530708478|FG000|Overall Study|refused hysterectomy|2|||
147149457|NCT01659996|530708479|FG000|Overall Study|Protocol Violation|3|||
147149458|NCT01659996|530708480|FG001|Overall Study|Protocol Violation|3|||
147149459|NCT01659996|530708481|FG002|Overall Study|Protocol Violation|3|||
147149460|NCT01659996|530708479|FG000|Overall Study|Lost to Follow-up|1|||
147149461|NCT01659996|530708480|FG001|Overall Study|Lost to Follow-up|3|||
147149462|NCT01659996|530708481|FG002|Overall Study|Lost to Follow-up|2|||
147149463|NCT01659996|530708479|FG000|Overall Study|Adverse Event|0|||
147149464|NCT01659996|530708480|FG001|Overall Study|Adverse Event|0|||
147149465|NCT01659996|530708481|FG002|Overall Study|Adverse Event|1|||
147149466|NCT01659996|530708479|FG000|Overall Study|Withdrawal by Subject|4|||
147149467|NCT01659996|530708480|FG001|Overall Study|Withdrawal by Subject|1|||
147149468|NCT01659996|530708481|FG002|Overall Study|Withdrawal by Subject|5|||
147149469|NCT03206918|530708482|FG000|Overall Study|Death|11|||
147149470|NCT03206918|530708482|FG000|Overall Study|Withdrawal by Subject|5|||
147149471|NCT03206918|530708482|FG000|Overall Study|Study terminated by sponsor|12|||
147149472|NCT03206918|530708482|FG000|Overall Study|Lost to Follow-up|3|||
147149473|NCT03206918|530708482|FG000|Overall Study|Transferred to extension study BGB-3111-LTE1 (NCT04170283)|60|||
147149474|NCT02701764|530708483|FG000|Overall Study|Lost to Follow-up|0|||
147149475|NCT02701764|530708484|FG001|Overall Study|Lost to Follow-up|1|||
147149476|NCT03823287|530708485|FG000|Overall Study|Withdrawal by Subject|25|||
147149477|NCT03823287|530708486|FG001|Overall Study|Withdrawal by Subject|17|||
147149478|NCT03823287|530708485|FG000|Overall Study|Death|13|||
147149479|NCT03823287|530708486|FG001|Overall Study|Death|7|||
147149480|NCT03823287|530708485|FG000|Overall Study|Lost to Follow-up|7|||
147149481|NCT03823287|530708486|FG001|Overall Study|Lost to Follow-up|8|||
147149482|NCT03823287|530708485|FG000|Overall Study|Adverse Event|6|||
147149483|NCT03823287|530708486|FG001|Overall Study|Adverse Event|8|||
147149484|NCT03823287|530708485|FG000|Overall Study|Physician Decision|5|||
147149485|NCT03823287|530708486|FG001|Overall Study|Physician Decision|2|||
147149486|NCT03823287|530708485|FG000|Overall Study|Lack of Efficacy|2|||
147149487|NCT03823287|530708486|FG001|Overall Study|Lack of Efficacy|0|||
147149488|NCT03823287|530708485|FG000|Overall Study|Other|2|||
147149489|NCT03823287|530708486|FG001|Overall Study|Other|4|||
147149490|NCT03110029|530708493|FG000|Overall Study|Withdrawal by Subject|1|||
147149491|NCT03110029|530708494|FG001|Overall Study|Withdrawal by Subject|1|||
147149492|NCT03281629|530708495|FG000|Overall Study|The two participants dropped out due to COVID-19 lockdown.|2|||
147149493|NCT03281629|530708496|FG001|Overall Study|The two participants dropped out due to COVID-19 lockdown.|0|||
147149494|NCT03281629|530708495|FG000|Overall Study|Death|0|||
147149495|NCT03281629|530708496|FG001|Overall Study|Death|1|||
147149496|NCT03281629|530708495|FG000|Overall Study|Participant's schedule change and cannot participate in the study|0|||
147149497|NCT03281629|530708496|FG001|Overall Study|Participant's schedule change and cannot participate in the study|1|||
147149498|NCT00782171|530710489|FG000|Overall Study|Lost to Follow-up|2|||
147149499|NCT00782171|530710490|FG001|Overall Study|Lost to Follow-up|2|||
147149500|NCT00782171|530710489|FG000|Overall Study|Withdrawal by Subject|2|||
147149501|NCT00782171|530710490|FG001|Overall Study|Withdrawal by Subject|1|||
147149502|NCT00782171|530710489|FG000|Overall Study|complications|3|||
147149503|NCT00782171|530710490|FG001|Overall Study|complications|1|||
147149504|NCT00782171|530710489|FG000|Overall Study|others|7|||
147149505|NCT00782171|530710490|FG001|Overall Study|others|9|||
147149506|NCT00782171|530710489|FG000|Overall Study|not eligible|8|||
147149507|NCT00782171|530710490|FG001|Overall Study|not eligible|6|||
147149508|NCT03522246|530710493|FG000|Overall Study|Ongoing in Long-Term Follow-up (Alive)|184|||
147149509|NCT03522246|530710494|FG001|Overall Study|Ongoing in Long-Term Follow-up (Alive)|194|||
147149510|NCT03522246|530710495|FG002|Overall Study|Ongoing in Long-Term Follow-up (Alive)|46|||
147149511|NCT03522246|530710496|FG003|Overall Study|Ongoing in Long-Term Follow-up (Alive)|45|||
147149512|NCT03522246|530710497|FG004|Overall Study|Ongoing in Long-Term Follow-up (Alive)|0|||
147149513|NCT00489424|530710500|FG000|Overall Study|Adverse Event|3|||
147149514|NCT00489424|530710501|FG001|Overall Study|Adverse Event|3|||
147149515|NCT00489424|530710502|FG002|Overall Study|Adverse Event|4|||
147149516|NCT00489424|530710500|FG000|Overall Study|Lack of Efficacy|1|||
147149517|NCT00489424|530710501|FG001|Overall Study|Lack of Efficacy|0|||
147149518|NCT00489424|530710502|FG002|Overall Study|Lack of Efficacy|0|||
147149519|NCT00489424|530710500|FG000|Overall Study|Administrative problems|0|||
147239404|NCT00939770|531047594|FG004|Overall Study|Lost to Follow-up|1|||
147239405|NCT00939770|531047595|FG005|Overall Study|Lost to Follow-up|0|||
147149520|NCT00489424|530710501|FG001|Overall Study|Administrative problems|2|||
147149521|NCT00489424|530710502|FG002|Overall Study|Administrative problems|1|||
147149522|NCT01558115|530710503|FG000|Overall Study|Withdrawal by Subject|3|||
147149523|NCT01558115|530710503|FG000|Overall Study|Study closed due to poor enrollment|4|||
147149524|NCT01436656|530710504|FG000|Dose Escalation|Death|1|||
147239406|NCT00939770|531047596|FG006|Overall Study|Lost to Follow-up|0|||
147239407|NCT00939770|531047597|FG007|Overall Study|Lost to Follow-up|0|||
147149525|NCT01436656|530710505|FG001|Dose Escalation|Death|3|||
147149526|NCT01436656|530710506|FG002|Dose Escalation|Death|1|||
147149527|NCT01436656|530710507|FG003|Dose Escalation|Death|0|||
147149528|NCT01436656|530710508|FG004|Dose Escalation|Death|2|||
147149529|NCT01436656|530710509|FG005|Dose Escalation|Death|1|||
147149530|NCT01436656|530710510|FG006|Dose Escalation|Death|1|||
147149531|NCT01436656|530710511|FG007|Dose Escalation|Death|1|||
147149532|NCT01436656|530710512|FG008|Dose Escalation|Death|1|||
147149533|NCT01436656|530710513|FG009|Dose Escalation|Death|0|||
147149534|NCT01436656|530710514|FG010|Dose Escalation|Death|0|||
147149535|NCT01436656|530710515|FG011|Dose Escalation|Death|0|||
147149536|NCT01436656|530710516|FG012|Dose Escalation|Death|0|||
147149537|NCT01436656|530710517|FG013|Dose Escalation|Death|0|||
147149538|NCT01436656|530710518|FG014|Dose Escalation|Death|0|||
147149539|NCT01436656|530710519|FG015|Dose Escalation|Death|0|||
147149540|NCT01436656|530710520|FG016|Dose Escalation|Death|0|||
147149541|NCT01436656|530710521|FG017|Dose Escalation|Death|0|||
147149542|NCT01436656|530710504|FG000|Dose Escalation|Protocol Violation|0|||
147149543|NCT01436656|530710505|FG001|Dose Escalation|Protocol Violation|0|||
147149544|NCT01436656|530710506|FG002|Dose Escalation|Protocol Violation|0|||
147149545|NCT01436656|530710507|FG003|Dose Escalation|Protocol Violation|0|||
147149546|NCT01436656|530710508|FG004|Dose Escalation|Protocol Violation|0|||
147149547|NCT01436656|530710509|FG005|Dose Escalation|Protocol Violation|1|||
147149548|NCT01436656|530710510|FG006|Dose Escalation|Protocol Violation|0|||
147149549|NCT01436656|530710511|FG007|Dose Escalation|Protocol Violation|0|||
147149550|NCT01436656|530710512|FG008|Dose Escalation|Protocol Violation|0|||
147149551|NCT01436656|530710513|FG009|Dose Escalation|Protocol Violation|0|||
147149552|NCT01436656|530710514|FG010|Dose Escalation|Protocol Violation|0|||
147149553|NCT01436656|530710515|FG011|Dose Escalation|Protocol Violation|0|||
147149554|NCT01436656|530710516|FG012|Dose Escalation|Protocol Violation|0|||
147149555|NCT01436656|530710517|FG013|Dose Escalation|Protocol Violation|0|||
147149556|NCT01436656|530710518|FG014|Dose Escalation|Protocol Violation|0|||
147149557|NCT01436656|530710519|FG015|Dose Escalation|Protocol Violation|0|||
147149558|NCT01436656|530710520|FG016|Dose Escalation|Protocol Violation|0|||
147149559|NCT01436656|530710521|FG017|Dose Escalation|Protocol Violation|0|||
147149560|NCT01436656|530710504|FG000|Dose Escalation|Withdrawal by Subject|0|||
147149561|NCT01436656|530710505|FG001|Dose Escalation|Withdrawal by Subject|0|||
147149562|NCT01436656|530710506|FG002|Dose Escalation|Withdrawal by Subject|0|||
147149563|NCT01436656|530710507|FG003|Dose Escalation|Withdrawal by Subject|0|||
147149564|NCT01436656|530710508|FG004|Dose Escalation|Withdrawal by Subject|1|||
147149565|NCT01436656|530710509|FG005|Dose Escalation|Withdrawal by Subject|0|||
147149566|NCT01436656|530710510|FG006|Dose Escalation|Withdrawal by Subject|0|||
147149567|NCT01436656|530710511|FG007|Dose Escalation|Withdrawal by Subject|2|||
147149568|NCT01436656|530710512|FG008|Dose Escalation|Withdrawal by Subject|0|||
147149569|NCT01436656|530710513|FG009|Dose Escalation|Withdrawal by Subject|1|||
147149570|NCT01436656|530710514|FG010|Dose Escalation|Withdrawal by Subject|1|||
147149571|NCT01436656|530710515|FG011|Dose Escalation|Withdrawal by Subject|0|||
147149572|NCT01436656|530710516|FG012|Dose Escalation|Withdrawal by Subject|0|||
147149573|NCT01436656|530710517|FG013|Dose Escalation|Withdrawal by Subject|0|||
147149574|NCT01436656|530710518|FG014|Dose Escalation|Withdrawal by Subject|0|||
147149575|NCT01436656|530710519|FG015|Dose Escalation|Withdrawal by Subject|0|||
147149576|NCT01436656|530710520|FG016|Dose Escalation|Withdrawal by Subject|0|||
147149577|NCT01436656|530710521|FG017|Dose Escalation|Withdrawal by Subject|0|||
147239408|NCT00939770|531047590|FG000|Overall Study|Physician Decision|0|||
147239409|NCT00939770|531047591|FG001|Overall Study|Physician Decision|0|||
147239410|NCT00939770|531047592|FG002|Overall Study|Physician Decision|2|||
147239411|NCT00939770|531047593|FG003|Overall Study|Physician Decision|0|||
147239412|NCT00939770|531047594|FG004|Overall Study|Physician Decision|7|||
147239413|NCT00939770|531047595|FG005|Overall Study|Physician Decision|1|||
147576093|NCT00112437|532263529|FG011|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
147239414|NCT00939770|531047596|FG006|Overall Study|Physician Decision|0|||
147576094|NCT00112437|532263530|FG012|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
147149578|NCT01436656|530710504|FG000|Dose Escalation|Administrative problems|0|||
147149579|NCT01436656|530710505|FG001|Dose Escalation|Administrative problems|1|||
147149580|NCT01436656|530710506|FG002|Dose Escalation|Administrative problems|0|||
147149581|NCT01436656|530710507|FG003|Dose Escalation|Administrative problems|0|||
147149582|NCT01436656|530710508|FG004|Dose Escalation|Administrative problems|0|||
147149583|NCT01436656|530710509|FG005|Dose Escalation|Administrative problems|0|||
147149584|NCT01436656|530710510|FG006|Dose Escalation|Administrative problems|0|||
147149585|NCT01436656|530710511|FG007|Dose Escalation|Administrative problems|0|||
147149586|NCT01436656|530710512|FG008|Dose Escalation|Administrative problems|0|||
147149587|NCT01436656|530710513|FG009|Dose Escalation|Administrative problems|0|||
147149588|NCT01436656|530710514|FG010|Dose Escalation|Administrative problems|0|||
147149589|NCT01436656|530710515|FG011|Dose Escalation|Administrative problems|0|||
147149590|NCT01436656|530710516|FG012|Dose Escalation|Administrative problems|0|||
147576095|NCT00112437|532263531|FG013|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
147149591|NCT01436656|530710517|FG013|Dose Escalation|Administrative problems|0|||
147239415|NCT00939770|531047597|FG007|Overall Study|Physician Decision|6|||
147576096|NCT00112437|532263532|FG014|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
147652915|NCT01775787|532551851|FG001|Second 7-10 Days|concerns with using IV|1|||
147652916|NCT01299896|532551852|FG000|Overall Study|Withdrawal by Subject|1|||
147652917|NCT01299896|532551853|FG001|Overall Study|Withdrawal by Subject|7|||
147652918|NCT01299896|532551852|FG000|Overall Study|Lost to Follow-up|0|||
147652919|NCT01299896|532551853|FG001|Overall Study|Lost to Follow-up|11|||
147652920|NCT01502956|532551858|FG000|Overall Study|Death|0|||
147652921|NCT01502956|532551859|FG001|Overall Study|Death|2|||
147652922|NCT01502956|532551858|FG000|Overall Study|Lost to Follow-up|14|||
147652923|NCT01502956|532551859|FG001|Overall Study|Lost to Follow-up|11|||
147652924|NCT01502956|532551858|FG000|Overall Study|Physician Decision|2|||
147652925|NCT01502956|532551859|FG001|Overall Study|Physician Decision|3|||
147652926|NCT01502956|532551858|FG000|Overall Study|Withdrawal by Subject|8|||
147652927|NCT01502956|532551859|FG001|Overall Study|Withdrawal by Subject|10|||
147652928|NCT01616758|532551860|FG000|Overall Study|Adverse Event|1|||
147652929|NCT01616758|532551860|FG000|Overall Study|Withdrawal by Subject|2|||
147652930|NCT01616758|532551860|FG000|Overall Study|Disease progression|18|||
147652931|NCT01616758|532551860|FG000|Overall Study|Study termination by Sponsor|1|||
147652932|NCT00199849|532551862|FG000|Overall Study|Unrelated illness or complication|0|||
147652933|NCT00199849|532551863|FG001|Overall Study|Unrelated illness or complication|1|||
147652934|NCT00199849|532551864|FG002|Overall Study|Unrelated illness or complication|0|||
147652935|NCT00199849|532551862|FG000|Overall Study|Progressive disease requiring intervention|0|||
147652936|NCT00199849|532551863|FG001|Overall Study|Progressive disease requiring intervention|0|||
147652937|NCT00199849|532551864|FG002|Overall Study|Progressive disease requiring intervention|1|||
147652938|NCT00199849|532551862|FG000|Overall Study|Did not meet eligibility criteria - not dosed|0|||
147652939|NCT00199849|532551863|FG001|Overall Study|Did not meet eligibility criteria - not dosed|0|||
147652940|NCT00199849|532551864|FG002|Overall Study|Did not meet eligibility criteria - not dosed|1|||
147652941|NCT04727528|532551865|FG000|Open-label Period|Did not meet randomization criteria for double-blind treatment phase|1|||
147652942|NCT04727528|532551866|FG001|Open-label Period|Did not meet randomization criteria for double-blind treatment phase|0|||
147652943|NCT04727528|532551865|FG000|Open-label Period|Randomized who did not receive treatment|1|||
147652944|NCT04727528|532551866|FG001|Open-label Period|Randomized who did not receive treatment|0|||
147652945|NCT04727528|532551865|FG000|Double-blind Treatment Phase|Adverse Event|0|||
147652946|NCT04727528|532551866|FG001|Double-blind Treatment Phase|Adverse Event|1|||
147652947|NCT04727528|532551865|FG000|Double-blind Treatment Phase|Death|0|||
147652948|NCT04727528|532551866|FG001|Double-blind Treatment Phase|Death|1|||
147652949|NCT04727528|532551865|FG000|Double-blind Treatment Phase|Missed doses whilst in hospital|0|||
147652950|NCT04727528|532551866|FG001|Double-blind Treatment Phase|Missed doses whilst in hospital|1|||
147652951|NCT04727528|532551865|FG000|Double-blind Treatment Phase|Investigator decision to start rescue therapy for hyperkalemia|0|||
147652952|NCT04727528|532551866|FG001|Double-blind Treatment Phase|Investigator decision to start rescue therapy for hyperkalemia|1|||
147652953|NCT04727528|532551865|FG000|Double-blind Treatment Phase|Physician Decision|0|||
147652954|NCT04727528|532551866|FG001|Double-blind Treatment Phase|Physician Decision|1|||
147652955|NCT04727528|532551865|FG000|Double-blind Treatment Phase|Withdrawal by Subject|1|||
147652956|NCT04727528|532551866|FG001|Double-blind Treatment Phase|Withdrawal by Subject|0|||
147652957|NCT03479008|532551872|FG000|Overall Study|Withdrawal by Subject|3|||
147149592|NCT01436656|530710518|FG014|Dose Escalation|Administrative problems|0|||
147149593|NCT01436656|530710519|FG015|Dose Escalation|Administrative problems|0|||
147149594|NCT01436656|530710520|FG016|Dose Escalation|Administrative problems|0|||
147149595|NCT01436656|530710521|FG017|Dose Escalation|Administrative problems|0|||
147149596|NCT01436656|530710504|FG000|Dose Escalation|Lost to Follow-up|1|||
147149597|NCT01436656|530710505|FG001|Dose Escalation|Lost to Follow-up|0|||
147149598|NCT01436656|530710506|FG002|Dose Escalation|Lost to Follow-up|0|||
147149599|NCT01436656|530710507|FG003|Dose Escalation|Lost to Follow-up|0|||
147149600|NCT01436656|530710508|FG004|Dose Escalation|Lost to Follow-up|1|||
147149601|NCT01436656|530710509|FG005|Dose Escalation|Lost to Follow-up|0|||
147149602|NCT01436656|530710510|FG006|Dose Escalation|Lost to Follow-up|0|||
147149603|NCT01436656|530710511|FG007|Dose Escalation|Lost to Follow-up|0|||
147149604|NCT01436656|530710512|FG008|Dose Escalation|Lost to Follow-up|0|||
147149605|NCT01436656|530710513|FG009|Dose Escalation|Lost to Follow-up|0|||
147149606|NCT01436656|530710514|FG010|Dose Escalation|Lost to Follow-up|0|||
147149607|NCT01436656|530710515|FG011|Dose Escalation|Lost to Follow-up|0|||
147149608|NCT01436656|530710516|FG012|Dose Escalation|Lost to Follow-up|0|||
147149609|NCT01436656|530710517|FG013|Dose Escalation|Lost to Follow-up|0|||
147149610|NCT01436656|530710518|FG014|Dose Escalation|Lost to Follow-up|0|||
147149611|NCT01436656|530710519|FG015|Dose Escalation|Lost to Follow-up|0|||
147149612|NCT01436656|530710520|FG016|Dose Escalation|Lost to Follow-up|0|||
147149613|NCT01436656|530710521|FG017|Dose Escalation|Lost to Follow-up|0|||
147149614|NCT01436656|530710504|FG000|Dose Escalation|New anti-cancer therapy|1|||
147652958|NCT01704755|532551873|FG000|Overall Study|Adverse Event|4|||
147149615|NCT01436656|530710505|FG001|Dose Escalation|New anti-cancer therapy|0|||
147149616|NCT01436656|530710506|FG002|Dose Escalation|New anti-cancer therapy|0|||
147149617|NCT01436656|530710507|FG003|Dose Escalation|New anti-cancer therapy|0|||
147149618|NCT01436656|530710508|FG004|Dose Escalation|New anti-cancer therapy|0|||
147149619|NCT01436656|530710509|FG005|Dose Escalation|New anti-cancer therapy|0|||
147576097|NCT00112437|532263533|FG015|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
147149620|NCT01436656|530710510|FG006|Dose Escalation|New anti-cancer therapy|0|||
147149621|NCT01436656|530710511|FG007|Dose Escalation|New anti-cancer therapy|0|||
147149622|NCT01436656|530710512|FG008|Dose Escalation|New anti-cancer therapy|1|||
147149623|NCT01436656|530710513|FG009|Dose Escalation|New anti-cancer therapy|1|||
147149624|NCT01436656|530710514|FG010|Dose Escalation|New anti-cancer therapy|0|||
147149625|NCT01436656|530710515|FG011|Dose Escalation|New anti-cancer therapy|0|||
147149626|NCT01436656|530710516|FG012|Dose Escalation|New anti-cancer therapy|0|||
147149627|NCT01436656|530710517|FG013|Dose Escalation|New anti-cancer therapy|0|||
147149628|NCT01436656|530710518|FG014|Dose Escalation|New anti-cancer therapy|0|||
147149629|NCT01436656|530710519|FG015|Dose Escalation|New anti-cancer therapy|0|||
147149630|NCT01436656|530710520|FG016|Dose Escalation|New anti-cancer therapy|0|||
147149631|NCT01436656|530710521|FG017|Dose Escalation|New anti-cancer therapy|0|||
147149632|NCT01436656|530710504|FG000|Dose Expansion|Adverse Event|0|||
147149633|NCT01436656|530710505|FG001|Dose Expansion|Adverse Event|0|||
147149634|NCT01436656|530710506|FG002|Dose Expansion|Adverse Event|0|||
147149635|NCT01436656|530710507|FG003|Dose Expansion|Adverse Event|0|||
147149636|NCT01436656|530710508|FG004|Dose Expansion|Adverse Event|0|||
147149637|NCT01436656|530710509|FG005|Dose Expansion|Adverse Event|0|||
147149638|NCT01436656|530710510|FG006|Dose Expansion|Adverse Event|0|||
147149639|NCT01436656|530710511|FG007|Dose Expansion|Adverse Event|0|||
147149640|NCT01436656|530710512|FG008|Dose Expansion|Adverse Event|0|||
147149641|NCT01436656|530710513|FG009|Dose Expansion|Adverse Event|0|||
147149642|NCT01436656|530710514|FG010|Dose Expansion|Adverse Event|0|||
147149643|NCT01436656|530710515|FG011|Dose Expansion|Adverse Event|1|||
147149644|NCT01436656|530710516|FG012|Dose Expansion|Adverse Event|0|||
147149645|NCT01436656|530710517|FG013|Dose Expansion|Adverse Event|0|||
147149646|NCT01436656|530710518|FG014|Dose Expansion|Adverse Event|0|||
147149647|NCT01436656|530710519|FG015|Dose Expansion|Adverse Event|0|||
147149648|NCT01436656|530710520|FG016|Dose Expansion|Adverse Event|0|||
147149649|NCT01436656|530710521|FG017|Dose Expansion|Adverse Event|0|||
147149650|NCT01436656|530710504|FG000|Dose Expansion|Withdrawal by Subject|0|||
147149651|NCT01436656|530710505|FG001|Dose Expansion|Withdrawal by Subject|0|||
147149652|NCT01436656|530710506|FG002|Dose Expansion|Withdrawal by Subject|0|||
147149653|NCT01436656|530710507|FG003|Dose Expansion|Withdrawal by Subject|0|||
147149654|NCT01436656|530710508|FG004|Dose Expansion|Withdrawal by Subject|0|||
147149655|NCT01436656|530710509|FG005|Dose Expansion|Withdrawal by Subject|0|||
147149656|NCT01436656|530710510|FG006|Dose Expansion|Withdrawal by Subject|0|||
147149657|NCT01436656|530710511|FG007|Dose Expansion|Withdrawal by Subject|0|||
147149658|NCT01436656|530710512|FG008|Dose Expansion|Withdrawal by Subject|0|||
147149659|NCT01436656|530710513|FG009|Dose Expansion|Withdrawal by Subject|0|||
147149660|NCT01436656|530710514|FG010|Dose Expansion|Withdrawal by Subject|0|||
147149661|NCT01436656|530710515|FG011|Dose Expansion|Withdrawal by Subject|1|||
147149662|NCT01436656|530710516|FG012|Dose Expansion|Withdrawal by Subject|3|||
147149663|NCT01436656|530710517|FG013|Dose Expansion|Withdrawal by Subject|1|||
147149664|NCT01436656|530710518|FG014|Dose Expansion|Withdrawal by Subject|2|||
147149665|NCT01436656|530710519|FG015|Dose Expansion|Withdrawal by Subject|0|||
147149666|NCT01436656|530710520|FG016|Dose Expansion|Withdrawal by Subject|1|||
147149667|NCT01436656|530710521|FG017|Dose Expansion|Withdrawal by Subject|1|||
147149668|NCT01436656|530710504|FG000|Dose Expansion|Death|0|||
147149669|NCT01436656|530710505|FG001|Dose Expansion|Death|0|||
147149670|NCT01436656|530710506|FG002|Dose Expansion|Death|0|||
147149671|NCT01436656|530710507|FG003|Dose Expansion|Death|0|||
147576098|NCT00112437|532263534|FG016|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
147149672|NCT01436656|530710508|FG004|Dose Expansion|Death|0|||
147149673|NCT01436656|530710509|FG005|Dose Expansion|Death|0|||
147576099|NCT00112437|532263535|FG017|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
147576100|NCT00112437|532263536|FG018|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
147576101|NCT00112437|532263537|FG019|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
147149674|NCT01436656|530710510|FG006|Dose Expansion|Death|0|||
147149675|NCT01436656|530710511|FG007|Dose Expansion|Death|0|||
147149676|NCT01436656|530710512|FG008|Dose Expansion|Death|0|||
147149677|NCT01436656|530710513|FG009|Dose Expansion|Death|0|||
147149678|NCT01436656|530710514|FG010|Dose Expansion|Death|0|||
147149679|NCT01436656|530710515|FG011|Dose Expansion|Death|0|||
147149680|NCT01436656|530710516|FG012|Dose Expansion|Death|1|||
147576102|NCT00112437|532263538|FG020|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
147149681|NCT01436656|530710517|FG013|Dose Expansion|Death|0|||
147149682|NCT01436656|530710518|FG014|Dose Expansion|Death|3|||
147149683|NCT01436656|530710519|FG015|Dose Expansion|Death|0|||
147149684|NCT01436656|530710520|FG016|Dose Expansion|Death|3|||
147149685|NCT01436656|530710521|FG017|Dose Expansion|Death|3|||
147149686|NCT01436656|530710504|FG000|Dose Expansion|Lost to Follow-up|0|||
147149687|NCT01436656|530710505|FG001|Dose Expansion|Lost to Follow-up|0|||
147149688|NCT01436656|530710506|FG002|Dose Expansion|Lost to Follow-up|0|||
147149689|NCT01436656|530710507|FG003|Dose Expansion|Lost to Follow-up|0|||
147149690|NCT01436656|530710508|FG004|Dose Expansion|Lost to Follow-up|0|||
147149691|NCT01436656|530710509|FG005|Dose Expansion|Lost to Follow-up|0|||
147576103|NCT00112437|532263539|FG021|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
147239416|NCT00939770|531047590|FG000|Overall Study|Protocol Violation|0|||
147576104|NCT00112437|532263540|FG022|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
147576105|NCT00112437|532263541|FG023|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
147576106|NCT00112437|532263542|FG024|Years 6-10 (60-Month Extension)|Lost to Follow-up|0|||
147576107|NCT00112437|532263543|FG025|Years 6-10 (60-Month Extension)|Lost to Follow-up|1|||
147576108|NCT00112437|532263518|FG000|Years 6-10 (60-Month Extension)|Other|0|||
147576109|NCT00112437|532263519|FG001|Years 6-10 (60-Month Extension)|Other|0|||
147576110|NCT00112437|532263520|FG002|Years 6-10 (60-Month Extension)|Other|0|||
147576111|NCT00112437|532263521|FG003|Years 6-10 (60-Month Extension)|Other|0|||
147576112|NCT00112437|532263522|FG004|Years 6-10 (60-Month Extension)|Other|0|||
147576113|NCT00112437|532263523|FG005|Years 6-10 (60-Month Extension)|Other|0|||
147576114|NCT00112437|532263524|FG006|Years 6-10 (60-Month Extension)|Other|0|||
147576115|NCT00112437|532263525|FG007|Years 6-10 (60-Month Extension)|Other|0|||
147576116|NCT00112437|532263526|FG008|Years 6-10 (60-Month Extension)|Other|0|||
147576117|NCT00112437|532263527|FG009|Years 6-10 (60-Month Extension)|Other|0|||
147576118|NCT00112437|532263528|FG010|Years 6-10 (60-Month Extension)|Other|0|||
147576119|NCT00112437|532263529|FG011|Years 6-10 (60-Month Extension)|Other|0|||
147576120|NCT00112437|532263530|FG012|Years 6-10 (60-Month Extension)|Other|0|||
147576121|NCT00112437|532263531|FG013|Years 6-10 (60-Month Extension)|Other|0|||
147576122|NCT00112437|532263532|FG014|Years 6-10 (60-Month Extension)|Other|0|||
147576123|NCT00112437|532263533|FG015|Years 6-10 (60-Month Extension)|Other|0|||
147576124|NCT00112437|532263534|FG016|Years 6-10 (60-Month Extension)|Other|0|||
147576125|NCT00112437|532263535|FG017|Years 6-10 (60-Month Extension)|Other|0|||
147576126|NCT00112437|532263536|FG018|Years 6-10 (60-Month Extension)|Other|0|||
147576127|NCT00112437|532263537|FG019|Years 6-10 (60-Month Extension)|Other|0|||
147576128|NCT00112437|532263538|FG020|Years 6-10 (60-Month Extension)|Other|0|||
147576129|NCT00112437|532263539|FG021|Years 6-10 (60-Month Extension)|Other|0|||
147576130|NCT00112437|532263540|FG022|Years 6-10 (60-Month Extension)|Other|0|||
147576131|NCT00112437|532263541|FG023|Years 6-10 (60-Month Extension)|Other|0|||
147576132|NCT00112437|532263542|FG024|Years 6-10 (60-Month Extension)|Other|1|||
147576133|NCT00112437|532263543|FG025|Years 6-10 (60-Month Extension)|Other|0|||
147576134|NCT00112437|532263518|FG000|Years 6-10 (60-Month Extension)|Physician Decision|0|||
147576135|NCT00112437|532263519|FG001|Years 6-10 (60-Month Extension)|Physician Decision|0|||
147576136|NCT00112437|532263520|FG002|Years 6-10 (60-Month Extension)|Physician Decision|0|||
147576137|NCT00112437|532263521|FG003|Years 6-10 (60-Month Extension)|Physician Decision|0|||
147576138|NCT00112437|532263522|FG004|Years 6-10 (60-Month Extension)|Physician Decision|0|||
147576139|NCT00112437|532263523|FG005|Years 6-10 (60-Month Extension)|Physician Decision|0|||
147576140|NCT00112437|532263524|FG006|Years 6-10 (60-Month Extension)|Physician Decision|0|||
147576141|NCT00112437|532263525|FG007|Years 6-10 (60-Month Extension)|Physician Decision|0|||
147576142|NCT00112437|532263526|FG008|Years 6-10 (60-Month Extension)|Physician Decision|0|||
147576143|NCT00112437|532263527|FG009|Years 6-10 (60-Month Extension)|Physician Decision|0|||
147576144|NCT00112437|532263528|FG010|Years 6-10 (60-Month Extension)|Physician Decision|0|||
147576145|NCT00112437|532263529|FG011|Years 6-10 (60-Month Extension)|Physician Decision|0|||
147576146|NCT00112437|532263530|FG012|Years 6-10 (60-Month Extension)|Physician Decision|0|||
147576147|NCT00112437|532263531|FG013|Years 6-10 (60-Month Extension)|Physician Decision|0|||
147576148|NCT00112437|532263532|FG014|Years 6-10 (60-Month Extension)|Physician Decision|0|||
147576149|NCT00112437|532263533|FG015|Years 6-10 (60-Month Extension)|Physician Decision|0|||
147576150|NCT00112437|532263534|FG016|Years 6-10 (60-Month Extension)|Physician Decision|0|||
147576151|NCT00112437|532263535|FG017|Years 6-10 (60-Month Extension)|Physician Decision|0|||
147576152|NCT00112437|532263536|FG018|Years 6-10 (60-Month Extension)|Physician Decision|0|||
147576153|NCT00112437|532263537|FG019|Years 6-10 (60-Month Extension)|Physician Decision|0|||
147576154|NCT00112437|532263538|FG020|Years 6-10 (60-Month Extension)|Physician Decision|0|||
147576155|NCT00112437|532263539|FG021|Years 6-10 (60-Month Extension)|Physician Decision|0|||
147576156|NCT00112437|532263540|FG022|Years 6-10 (60-Month Extension)|Physician Decision|0|||
147576157|NCT00112437|532263541|FG023|Years 6-10 (60-Month Extension)|Physician Decision|2|||
147576158|NCT00112437|532263542|FG024|Years 6-10 (60-Month Extension)|Physician Decision|0|||
147576159|NCT00112437|532263543|FG025|Years 6-10 (60-Month Extension)|Physician Decision|0|||
147576160|NCT00112437|532263518|FG000|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
147239417|NCT00939770|531047591|FG001|Overall Study|Protocol Violation|0|||
147239418|NCT00939770|531047592|FG002|Overall Study|Protocol Violation|0|||
147239419|NCT00939770|531047593|FG003|Overall Study|Protocol Violation|0|||
147239420|NCT00939770|531047594|FG004|Overall Study|Protocol Violation|1|||
147239421|NCT00939770|531047595|FG005|Overall Study|Protocol Violation|0|||
147239422|NCT00939770|531047596|FG006|Overall Study|Protocol Violation|0|||
147239423|NCT00939770|531047597|FG007|Overall Study|Protocol Violation|0|||
147239424|NCT00939770|531047590|FG000|Overall Study|Withdrawal by Subject|0|||
147239425|NCT00939770|531047591|FG001|Overall Study|Withdrawal by Subject|1|||
147576161|NCT00112437|532263519|FG001|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
147576162|NCT00112437|532263520|FG002|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
147576163|NCT00112437|532263521|FG003|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
147576164|NCT00112437|532263522|FG004|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
147239426|NCT00939770|531047592|FG002|Overall Study|Withdrawal by Subject|5|||
147239427|NCT00939770|531047593|FG003|Overall Study|Withdrawal by Subject|2|||
147239428|NCT00939770|531047594|FG004|Overall Study|Withdrawal by Subject|6|||
147239429|NCT00939770|531047595|FG005|Overall Study|Withdrawal by Subject|0|||
147239430|NCT00939770|531047596|FG006|Overall Study|Withdrawal by Subject|2|||
147239431|NCT00939770|531047597|FG007|Overall Study|Withdrawal by Subject|2|||
147239432|NCT01146665|531047598|FG000|Overall Study|Withdrawal by Subject|10|||
147576165|NCT00112437|532263523|FG005|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
147576166|NCT00112437|532263524|FG006|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
147576167|NCT00112437|532263525|FG007|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
147149692|NCT01436656|530710510|FG006|Dose Expansion|Lost to Follow-up|0|||
147149693|NCT01436656|530710511|FG007|Dose Expansion|Lost to Follow-up|0|||
147149694|NCT01436656|530710512|FG008|Dose Expansion|Lost to Follow-up|0|||
147149695|NCT01436656|530710513|FG009|Dose Expansion|Lost to Follow-up|0|||
147149696|NCT01436656|530710514|FG010|Dose Expansion|Lost to Follow-up|0|||
147149697|NCT01436656|530710515|FG011|Dose Expansion|Lost to Follow-up|0|||
147149698|NCT01436656|530710516|FG012|Dose Expansion|Lost to Follow-up|0|||
147149699|NCT01436656|530710517|FG013|Dose Expansion|Lost to Follow-up|0|||
147149700|NCT01436656|530710518|FG014|Dose Expansion|Lost to Follow-up|0|||
147149701|NCT01436656|530710519|FG015|Dose Expansion|Lost to Follow-up|0|||
147149702|NCT01436656|530710520|FG016|Dose Expansion|Lost to Follow-up|0|||
147149703|NCT01436656|530710521|FG017|Dose Expansion|Lost to Follow-up|3|||
147149704|NCT01436656|530710504|FG000|Dose Expansion|Disease progression|0|||
147149705|NCT01436656|530710505|FG001|Dose Expansion|Disease progression|0|||
147149706|NCT01436656|530710506|FG002|Dose Expansion|Disease progression|0|||
147149707|NCT01436656|530710507|FG003|Dose Expansion|Disease progression|0|||
147149708|NCT01436656|530710508|FG004|Dose Expansion|Disease progression|0|||
147149709|NCT01436656|530710509|FG005|Dose Expansion|Disease progression|0|||
147149710|NCT01436656|530710510|FG006|Dose Expansion|Disease progression|0|||
147149711|NCT01436656|530710511|FG007|Dose Expansion|Disease progression|0|||
147149712|NCT01436656|530710512|FG008|Dose Expansion|Disease progression|0|||
147149713|NCT01436656|530710513|FG009|Dose Expansion|Disease progression|0|||
147149714|NCT01436656|530710514|FG010|Dose Expansion|Disease progression|0|||
147149715|NCT01436656|530710515|FG011|Dose Expansion|Disease progression|3|||
147149716|NCT01436656|530710516|FG012|Dose Expansion|Disease progression|1|||
147149717|NCT01436656|530710517|FG013|Dose Expansion|Disease progression|0|||
147149718|NCT01436656|530710518|FG014|Dose Expansion|Disease progression|1|||
147149719|NCT01436656|530710519|FG015|Dose Expansion|Disease progression|0|||
147149720|NCT01436656|530710520|FG016|Dose Expansion|Disease progression|0|||
147149721|NCT01436656|530710521|FG017|Dose Expansion|Disease progression|1|||
147149722|NCT01436656|530710504|FG000|Dose Expansion|New cancer therapy|0|||
147149723|NCT01436656|530710505|FG001|Dose Expansion|New cancer therapy|0|||
147149724|NCT01436656|530710506|FG002|Dose Expansion|New cancer therapy|0|||
147149725|NCT01436656|530710507|FG003|Dose Expansion|New cancer therapy|0|||
147149726|NCT01436656|530710508|FG004|Dose Expansion|New cancer therapy|0|||
147149727|NCT01436656|530710509|FG005|Dose Expansion|New cancer therapy|0|||
147149728|NCT01436656|530710510|FG006|Dose Expansion|New cancer therapy|0|||
147149729|NCT01436656|530710511|FG007|Dose Expansion|New cancer therapy|0|||
147149730|NCT01436656|530710512|FG008|Dose Expansion|New cancer therapy|0|||
147149731|NCT01436656|530710513|FG009|Dose Expansion|New cancer therapy|0|||
147149732|NCT01436656|530710514|FG010|Dose Expansion|New cancer therapy|0|||
147149733|NCT01436656|530710515|FG011|Dose Expansion|New cancer therapy|1|||
147149734|NCT01436656|530710516|FG012|Dose Expansion|New cancer therapy|1|||
147149735|NCT01436656|530710517|FG013|Dose Expansion|New cancer therapy|0|||
147149736|NCT01436656|530710518|FG014|Dose Expansion|New cancer therapy|2|||
147149737|NCT01436656|530710519|FG015|Dose Expansion|New cancer therapy|0|||
147576168|NCT00112437|532263526|FG008|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
147239433|NCT01146665|531047599|FG001|Overall Study|Withdrawal by Subject|16|||
147239434|NCT04560998|531047600|FG000|Overall Study|Withdrawal by Subject|18|||
147321011|NCT04955626|531338434|FG014|Open-Label Period|Withdrawal by parent/guardian|0|||
147321012|NCT04955626|531338435|FG015|Open-Label Period|Withdrawal by parent/guardian|0|||
147321013|NCT04955626|531338436|FG016|Open-Label Period|Withdrawal by parent/guardian|0|||
147576169|NCT00112437|532263527|FG009|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
147576170|NCT00112437|532263528|FG010|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
147576171|NCT00112437|532263529|FG011|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
147652959|NCT01704755|532551874|FG001|Overall Study|Adverse Event|1|||
147652960|NCT01704755|532551873|FG000|Overall Study|Lost to Follow-up|3|||
147149738|NCT01436656|530710520|FG016|Dose Expansion|New cancer therapy|0|||
147149739|NCT01436656|530710521|FG017|Dose Expansion|New cancer therapy|0|||
147149740|NCT00880269|530710522|FG000|Overall Study|Protocol Violation|1|||
147149741|NCT00880269|530710523|FG001|Overall Study|Protocol Violation|0|||
147149742|NCT00880269|530710522|FG000|Overall Study|Disease Progression|13|||
147149743|NCT00880269|530710523|FG001|Overall Study|Disease Progression|11|||
147149744|NCT00880269|530710522|FG000|Overall Study|New Cancer Therapy|1|||
147149745|NCT00880269|530710523|FG001|Overall Study|New Cancer Therapy|0|||
147239435|NCT04560998|531047601|FG001|Overall Study|Withdrawal by Subject|12|||
147239436|NCT04560998|531047600|FG000|Overall Study|Lost to Follow-up|8|||
147149746|NCT00880269|530710522|FG000|Overall Study|Death|4|||
147149747|NCT00880269|530710523|FG001|Overall Study|Death|2|||
147149748|NCT00880269|530710522|FG000|Overall Study|Lost to Follow-up|0|||
147149749|NCT00880269|530710523|FG001|Overall Study|Lost to Follow-up|1|||
147149750|NCT00880269|530710522|FG000|Overall Study|Withdrawal by Subject|3|||
147149751|NCT00880269|530710523|FG001|Overall Study|Withdrawal by Subject|4|||
147321014|NCT04955626|531338437|FG017|Open-Label Period|Withdrawal by parent/guardian|0|||
147321015|NCT04955626|531338438|FG018|Open-Label Period|Withdrawal by parent/guardian|0|||
147321016|NCT04955626|531338439|FG019|Open-Label Period|Withdrawal by parent/guardian|0|||
147321017|NCT04955626|531338440|FG020|Open-Label Period|Withdrawal by parent/guardian|0|||
147321018|NCT04955626|531338441|FG021|Open-Label Period|Withdrawal by parent/guardian|0|||
147321019|NCT04955626|531338442|FG022|Open-Label Period|Withdrawal by parent/guardian|0|||
147321020|NCT04955626|531338443|FG023|Open-Label Period|Withdrawal by parent/guardian|0|||
147576172|NCT00112437|532263530|FG012|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
147576173|NCT00112437|532263531|FG013|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
147149752|NCT00880269|530710522|FG000|Overall Study|Adverse Event|10|||
147149753|NCT00880269|530710523|FG001|Overall Study|Adverse Event|9|||
147149754|NCT02516982|530710527|FG000|Overall Study|Called in to antenatal appointment|32|||
147149755|NCT02516982|530710528|FG001|Overall Study|Called in to antenatal appointment|35|||
147149756|NCT02516982|530710529|FG002|Overall Study|Called in to antenatal appointment|0|||
147149757|NCT02516982|530710530|FG003|Overall Study|Called in to antenatal appointment|0|||
147149758|NCT02516982|530710527|FG000|Overall Study|Withdrawal by Subject|0|||
147149759|NCT02516982|530710528|FG001|Overall Study|Withdrawal by Subject|0|||
147149760|NCT02516982|530710529|FG002|Overall Study|Withdrawal by Subject|1|||
147149761|NCT02516982|530710530|FG003|Overall Study|Withdrawal by Subject|2|||
147149762|NCT02516982|530710527|FG000|Overall Study|Protocol Violation|0|||
147149763|NCT02516982|530710528|FG001|Overall Study|Protocol Violation|0|||
147149764|NCT02516982|530710529|FG002|Overall Study|Protocol Violation|1|||
147149765|NCT02516982|530710530|FG003|Overall Study|Protocol Violation|1|||
147149766|NCT02516982|530710527|FG000|Overall Study|Did not install the app|0|||
147239437|NCT04560998|531047601|FG001|Overall Study|Lost to Follow-up|5|||
147576174|NCT00112437|532263532|FG014|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
147576175|NCT00112437|532263533|FG015|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
147239438|NCT04560998|531047600|FG000|Overall Study|Physician Decision|4|||
147239439|NCT04560998|531047601|FG001|Overall Study|Physician Decision|0|||
147239440|NCT03749447|531049171|FG000|Overall Study|Adverse Event|11|||
147239441|NCT03749447|531049172|FG001|Overall Study|Adverse Event|3|||
147239442|NCT03749447|531049171|FG000|Overall Study|Death|1|||
147239443|NCT03749447|531049172|FG001|Overall Study|Death|1|||
147239444|NCT03749447|531049171|FG000|Overall Study|Lost to Follow-up|2|||
147239445|NCT03749447|531049172|FG001|Overall Study|Lost to Follow-up|2|||
147239446|NCT03749447|531049171|FG000|Overall Study|Reason Not Specified|0|||
147239447|NCT03749447|531049172|FG001|Overall Study|Reason Not Specified|3|||
147239448|NCT03749447|531049171|FG000|Overall Study|Physician Decision|4|||
147239449|NCT03749447|531049172|FG001|Overall Study|Physician Decision|3|||
147239450|NCT03749447|531049171|FG000|Overall Study|Protocol-Specified Withdrawal Criteria Met|1|||
147239451|NCT03749447|531049172|FG001|Overall Study|Protocol-Specified Withdrawal Criteria Met|3|||
147239452|NCT03749447|531049171|FG000|Overall Study|Study Terminated By Sponsor|112|||
147239453|NCT03749447|531049172|FG001|Overall Study|Study Terminated By Sponsor|105|||
147239454|NCT03749447|531049171|FG000|Overall Study|Withdrawal by Subject|12|||
147239455|NCT03749447|531049172|FG001|Overall Study|Withdrawal by Subject|6|||
147239456|NCT03749447|531049171|FG000|Overall Study|Non-compliance With Study Drug|0|||
147239457|NCT03749447|531049172|FG001|Overall Study|Non-compliance With Study Drug|1|||
147239458|NCT01218113|531049173|FG000|Overall Study|Withdrawal by Subject|1|||
147239459|NCT01218113|531049174|FG001|Overall Study|Withdrawal by Subject|0|||
147239460|NCT01218113|531049175|FG002|Overall Study|Withdrawal by Subject|1|||
147239461|NCT01218113|531049173|FG000|Overall Study|Lost to Follow-up|4|||
147321021|NCT04955626|531338444|FG024|Open-Label Period|Withdrawal by parent/guardian|0|||
147321022|NCT04955626|531338445|FG025|Open-Label Period|Withdrawal by parent/guardian|0|||
147321023|NCT04955626|531338446|FG026|Open-Label Period|Withdrawal by parent/guardian|0|||
147321024|NCT04955626|531338447|FG027|Open-Label Period|Withdrawal by parent/guardian|0|||
147576176|NCT00112437|532263534|FG016|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
147576177|NCT00112437|532263535|FG017|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
147576178|NCT00112437|532263536|FG018|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
147149767|NCT02516982|530710528|FG001|Overall Study|Did not install the app|0|||
147149768|NCT02516982|530710529|FG002|Overall Study|Did not install the app|46|||
147149769|NCT02516982|530710530|FG003|Overall Study|Did not install the app|47|||
147149770|NCT01951586|530710531|FG000|Overall Study|Death|61|||
147149771|NCT01951586|530710532|FG001|Overall Study|Death|120|||
147149772|NCT01951586|530710531|FG000|Overall Study|Withdrawal by Subject|8|||
147149773|NCT01951586|530710532|FG001|Overall Study|Withdrawal by Subject|17|||
147239462|NCT01218113|531049174|FG001|Overall Study|Lost to Follow-up|1|||
147239463|NCT01218113|531049175|FG002|Overall Study|Lost to Follow-up|4|||
147239464|NCT01218113|531049173|FG000|Overall Study|Protocol Deviation Eligibility Criteria|0|||
147239465|NCT01218113|531049174|FG001|Overall Study|Protocol Deviation Eligibility Criteria|0|||
147576179|NCT00112437|532263537|FG019|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
147576180|NCT00112437|532263538|FG020|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
147576181|NCT00112437|532263539|FG021|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
147576182|NCT00112437|532263540|FG022|Years 6-10 (60-Month Extension)|Withdrawal by Subject|4|||
147576183|NCT00112437|532263541|FG023|Years 6-10 (60-Month Extension)|Withdrawal by Subject|6|||
147576184|NCT00112437|532263542|FG024|Years 6-10 (60-Month Extension)|Withdrawal by Subject|0|||
147576185|NCT00112437|532263543|FG025|Years 6-10 (60-Month Extension)|Withdrawal by Subject|3|||
147149774|NCT01951586|530710531|FG000|Overall Study|Lost to Follow-up|0|||
147149775|NCT01951586|530710532|FG001|Overall Study|Lost to Follow-up|1|||
147149776|NCT01951586|530710531|FG000|Overall Study|Sponsor Decision|9|||
147149777|NCT01951586|530710532|FG001|Overall Study|Sponsor Decision|10|||
147149778|NCT02120781|530710533|FG000|Overall Study|Physician Decision|2|||
147149779|NCT02120781|530710534|FG001|Overall Study|Physician Decision|0|||
147149780|NCT02120781|530710533|FG000|Overall Study|Completion not documented|2|||
147149781|NCT02120781|530710534|FG001|Overall Study|Completion not documented|1|||
147149782|NCT00748618|530710539|FG000|Overall Study|Adverse Event|1|||
147149783|NCT00748618|530710540|FG001|Overall Study|Adverse Event|0|||
147149784|NCT00466947|530710541|FG000|Primary Outcome Analysis Period|Other: study still ongoing|11875|||
147149785|NCT00466947|530710542|FG001|Primary Outcome Analysis Period|Other: study still ongoing|11863|||
147149786|NCT00466947|530710541|FG000|Study End Analysis Period|Adverse Event|35|||
147149787|NCT00466947|530710542|FG001|Study End Analysis Period|Adverse Event|43|||
147149788|NCT00466947|530710541|FG000|Study End Analysis Period|Lost to Follow-up|1137|||
147149789|NCT00466947|530710542|FG001|Study End Analysis Period|Lost to Follow-up|1167|||
147149790|NCT00466947|530710541|FG000|Study End Analysis Period|Physician Decision|29|||
147149791|NCT00466947|530710542|FG001|Study End Analysis Period|Physician Decision|29|||
147149792|NCT00466947|530710541|FG000|Study End Analysis Period|Protocol Violation|9|||
147149793|NCT00466947|530710542|FG001|Study End Analysis Period|Protocol Violation|17|||
147149794|NCT00466947|530710541|FG000|Study End Analysis Period|Withdrawal by Subject|1264|||
147149795|NCT00466947|530710542|FG001|Study End Analysis Period|Withdrawal by Subject|1267|||
147149796|NCT00466947|530710541|FG000|Study End Analysis Period|Other - Forbidden vaccination|21|||
147149797|NCT00466947|530710542|FG001|Study End Analysis Period|Other - Forbidden vaccination|10|||
147149798|NCT00466947|530710541|FG000|Study End Analysis Period|Other - Subject without a legal guardian|1|||
147149799|NCT00466947|530710542|FG001|Study End Analysis Period|Other - Subject without a legal guardian|0|||
147149800|NCT00466947|530710541|FG000|Study End Analysis Period|Other - Unconformity in team's treatment|0|||
147149801|NCT00466947|530710542|FG001|Study End Analysis Period|Other - Unconformity in team's treatment|1|||
147149802|NCT01995526|530710543|FG000|Overall Study|Physician Decision|1|||
147149803|NCT01977729|530710547|FG000|Overall Study|Study terminated|1|||
147149804|NCT03286543|530710548|FG000|Consented|Screen failure before randomization|2|||
147149805|NCT03286543|530710549|FG001|Consented|Screen failure before randomization|0|||
147149806|NCT03286543|530710550|FG002|Consented|Screen failure before randomization|0|||
147149807|NCT03286543|530710548|FG000|Consented|Screen failure before enrollment|4|||
147576186|NCT01824576|532263545|FG000|Overall Study|Device deficiency|2|||
147576187|NCT03218787|532263546|FG000|Overall Study|Lost to Follow-up|12|||
147576188|NCT03218787|532263546|FG000|Overall Study|Withdrawal by Subject|72|||
147576189|NCT03218787|532263546|FG000|Overall Study|Physician Decision|11|||
147576190|NCT03218787|532263546|FG000|Overall Study|Death|111|||
147576191|NCT00147498|532263547|FG000|Overall Study|Adverse Event|1|||
147576192|NCT00147498|532263548|FG001|Overall Study|Adverse Event|6|||
147576193|NCT00147498|532263549|FG002|Overall Study|Adverse Event|7|||
147576194|NCT00147498|532263550|FG003|Overall Study|Adverse Event|3|||
147576195|NCT00147498|532263547|FG000|Overall Study|Lack of Efficacy|1|||
147576196|NCT00147498|532263548|FG001|Overall Study|Lack of Efficacy|1|||
147576197|NCT00147498|532263549|FG002|Overall Study|Lack of Efficacy|1|||
147576198|NCT00147498|532263550|FG003|Overall Study|Lack of Efficacy|8|||
147576199|NCT00147498|532263547|FG000|Overall Study|Laboratory abnormality|0|||
147576200|NCT00147498|532263548|FG001|Overall Study|Laboratory abnormality|0|||
147576201|NCT00147498|532263549|FG002|Overall Study|Laboratory abnormality|2|||
147576202|NCT00147498|532263550|FG003|Overall Study|Laboratory abnormality|0|||
147576203|NCT00147498|532263547|FG000|Overall Study|Participant defaulted|0|||
147149808|NCT03286543|530710549|FG001|Consented|Screen failure before enrollment|0|||
147149809|NCT03286543|530710550|FG002|Consented|Screen failure before enrollment|0|||
147149810|NCT03286543|530710548|FG000|Consented|TKA cancelled after enrollment|1|||
147149811|NCT03286543|530710549|FG001|Consented|TKA cancelled after enrollment|0|||
147149812|NCT03286543|530710550|FG002|Consented|TKA cancelled after enrollment|0|||
147149813|NCT03286543|530710548|FG000|Consented|Withdrawn from study|12|||
147149814|NCT03286543|530710549|FG001|Consented|Withdrawn from study|0|||
147576204|NCT00147498|532263548|FG001|Overall Study|Participant defaulted|1|||
147576205|NCT00147498|532263549|FG002|Overall Study|Participant defaulted|4|||
147576206|NCT00147498|532263550|FG003|Overall Study|Participant defaulted|3|||
147576207|NCT00147498|532263547|FG000|Overall Study|Other|1|||
147576208|NCT00147498|532263548|FG001|Overall Study|Other|1|||
147576209|NCT00147498|532263549|FG002|Overall Study|Other|3|||
147576210|NCT00147498|532263550|FG003|Overall Study|Other|3|||
147576211|NCT01229150|532263551|FG000|Overall Study|Toxicity|2|||
147149815|NCT03286543|530710550|FG002|Consented|Withdrawn from study|0|||
147321025|NCT04955626|531338448|FG028|Open-Label Period|Withdrawal by parent/guardian|0|||
147321026|NCT04955626|531338449|FG029|Open-Label Period|Withdrawal by parent/guardian|0|||
147321027|NCT04955626|531338450|FG030|Open-Label Period|Withdrawal by parent/guardian|0|||
147321028|NCT04955626|531338451|FG031|Open-Label Period|Withdrawal by parent/guardian|0|||
147321029|NCT04955626|531338452|FG032|Open-Label Period|Withdrawal by parent/guardian|0|||
147321030|NCT04955626|531338453|FG033|Open-Label Period|Withdrawal by parent/guardian|0|||
147321031|NCT04955626|531338454|FG034|Open-Label Period|Withdrawal by parent/guardian|0|||
147321032|NCT04955626|531338455|FG035|Open-Label Period|Withdrawal by parent/guardian|0|||
147321033|NCT04955626|531338420|FG000|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
147321034|NCT04955626|531338421|FG001|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|476|||
147321035|NCT04955626|531338422|FG002|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
147149816|NCT03286543|530710548|FG000|Study Enrollment|TKA cancelled after enrollment|0|||
147149817|NCT03286543|530710549|FG001|Study Enrollment|TKA cancelled after enrollment|0|||
147149818|NCT03286543|530710550|FG002|Study Enrollment|TKA cancelled after enrollment|1|||
147149819|NCT03286543|530710548|FG000|Study Enrollment|Withdrawn from study|0|||
147149820|NCT03286543|530710549|FG001|Study Enrollment|Withdrawn from study|6|||
147149821|NCT03286543|530710550|FG002|Study Enrollment|Withdrawn from study|6|||
147149822|NCT03636893|530710551|FG000|Overall Study|Death|0|||
147149823|NCT03636893|530710552|FG001|Overall Study|Death|1|||
147149824|NCT03636893|530710551|FG000|Overall Study|Protocol Violation|0|||
147149825|NCT03636893|530710552|FG001|Overall Study|Protocol Violation|3|||
147149826|NCT03636893|530710551|FG000|Overall Study|Withdrawal by Subject|1|||
147149827|NCT03636893|530710552|FG001|Overall Study|Withdrawal by Subject|2|||
147149828|NCT03636893|530710551|FG000|Overall Study|Refusal to surgery|4|||
147149829|NCT03636893|530710552|FG001|Overall Study|Refusal to surgery|3|||
147149830|NCT03636893|530710551|FG000|Overall Study|Early surgery (for acute bleeding)|3|||
147149831|NCT03636893|530710552|FG001|Overall Study|Early surgery (for acute bleeding)|0|||
147149832|NCT03636893|530710551|FG000|Overall Study|Adverse Event|1|||
147149833|NCT03636893|530710552|FG001|Overall Study|Adverse Event|1|||
147149834|NCT00438360|530710553|FG000|Overall Study|Adverse Event|6|||
147149835|NCT00438360|530710554|FG001|Overall Study|Adverse Event|1|||
147149836|NCT00438360|530710553|FG000|Overall Study|Lack of Efficacy|42|||
147149837|NCT00438360|530710554|FG001|Overall Study|Lack of Efficacy|27|||
147149838|NCT00438360|530710553|FG000|Overall Study|Other|24|||
147149839|NCT00438360|530710554|FG001|Overall Study|Other|15|||
147149840|NCT00758069|530710555|FG000|Overall Study|Lack of Efficacy|0|||
147149841|NCT00758069|530710556|FG001|Overall Study|Lack of Efficacy|0|||
147149842|NCT00758069|530710557|FG002|Overall Study|Lack of Efficacy|1|||
147149843|NCT00758069|530710555|FG000|Overall Study|Incorrect Study Drug|1|||
147149844|NCT00758069|530710556|FG001|Overall Study|Incorrect Study Drug|0|||
147149845|NCT00758069|530710557|FG002|Overall Study|Incorrect Study Drug|0|||
147149846|NCT04560816|530710558|FG000|Overall Study|Withdrawal by Subject|1|||
147149847|NCT04560816|530710559|FG001|Overall Study|Withdrawal by Subject|1|||
147149848|NCT04560816|530710560|FG002|Overall Study|Withdrawal by Subject|1|||
147149849|NCT04560816|530710561|FG003|Overall Study|Withdrawal by Subject|0|||
147149850|NCT04560816|530710562|FG004|Overall Study|Withdrawal by Subject|3|||
147149851|NCT04560816|530710563|FG005|Overall Study|Withdrawal by Subject|0|||
147149852|NCT04560816|530710558|FG000|Overall Study|Lost to Follow-up|1|||
147149853|NCT04560816|530710559|FG001|Overall Study|Lost to Follow-up|0|||
147149854|NCT04560816|530710560|FG002|Overall Study|Lost to Follow-up|0|||
147149855|NCT04560816|530710561|FG003|Overall Study|Lost to Follow-up|0|||
147149856|NCT04560816|530710562|FG004|Overall Study|Lost to Follow-up|0|||
147149857|NCT04560816|530710563|FG005|Overall Study|Lost to Follow-up|0|||
147149858|NCT04560816|530710558|FG000|Overall Study|Protocol Violation|1|||
147149859|NCT04560816|530710559|FG001|Overall Study|Protocol Violation|0|||
147321036|NCT04955626|531338423|FG003|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
147321037|NCT04955626|531338424|FG004|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
147321038|NCT04955626|531338425|FG005|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
147321039|NCT04955626|531338426|FG006|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
147321040|NCT04955626|531338427|FG007|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
147321041|NCT04955626|531338428|FG008|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
147321042|NCT04955626|531338429|FG009|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
147321043|NCT04955626|531338430|FG010|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
147149860|NCT04560816|530710560|FG002|Overall Study|Protocol Violation|0|||
147149861|NCT04560816|530710561|FG003|Overall Study|Protocol Violation|0|||
147149862|NCT04560816|530710562|FG004|Overall Study|Protocol Violation|0|||
147149863|NCT04560816|530710563|FG005|Overall Study|Protocol Violation|0|||
147149864|NCT02277691|530710564|FG000|Overall Study|Pretreatment Event/Adverse Event|33|||
147149865|NCT02277691|530710564|FG000|Overall Study|Voluntary Withdrawal|7|||
147149866|NCT02277691|530710564|FG000|Overall Study|Lack of Efficacy|5|||
147149867|NCT02277691|530710564|FG000|Overall Study|Used Other Antihypertensive Drug|1|||
147149868|NCT01147250|530710565|FG000|Overall Study|Lost to Follow-up|14|||
147149869|NCT01147250|530710566|FG001|Overall Study|Lost to Follow-up|11|||
147576212|NCT01229150|532263552|FG001|Overall Study|Toxicity|2|||
147576213|NCT01229150|532263553|FG002|Overall Study|Toxicity|0|||
147576214|NCT01229150|532263554|FG003|Overall Study|Toxicity|0|||
147576215|NCT03531827|532263555|FG000|Overall Study|Adverse Event|2|||
147576216|NCT03531827|532263556|FG001|Overall Study|Adverse Event|0|||
147576217|NCT03531827|532263555|FG000|Overall Study|Progressive disease|1|||
147576218|NCT03531827|532263556|FG001|Overall Study|Progressive disease|0|||
147576219|NCT01494532|532263559|FG000|Overall Study|Adverse Event|4|||
147576220|NCT01494532|532263560|FG001|Overall Study|Adverse Event|1|||
147576221|NCT01494532|532263561|FG002|Overall Study|Adverse Event|8|||
147576222|NCT01494532|532263562|FG003|Overall Study|Adverse Event|6|||
147576223|NCT01494532|532263563|FG004|Overall Study|Adverse Event|5|||
147576224|NCT01494532|532263564|FG005|Overall Study|Adverse Event|0|||
147576225|NCT01494532|532263559|FG000|Overall Study|Lack of Efficacy|0|||
147576226|NCT01494532|532263560|FG001|Overall Study|Lack of Efficacy|0|||
147576227|NCT01494532|532263561|FG002|Overall Study|Lack of Efficacy|0|||
147576228|NCT01494532|532263562|FG003|Overall Study|Lack of Efficacy|0|||
147576229|NCT01494532|532263563|FG004|Overall Study|Lack of Efficacy|2|||
147576230|NCT01494532|532263564|FG005|Overall Study|Lack of Efficacy|0|||
147576231|NCT01494532|532263559|FG000|Overall Study|Protocol deviation|2|||
147576232|NCT01494532|532263560|FG001|Overall Study|Protocol deviation|1|||
147576233|NCT01494532|532263561|FG002|Overall Study|Protocol deviation|3|||
147576234|NCT01494532|532263562|FG003|Overall Study|Protocol deviation|2|||
147576235|NCT01494532|532263563|FG004|Overall Study|Protocol deviation|3|||
147576236|NCT01494532|532263564|FG005|Overall Study|Protocol deviation|0|||
147576237|NCT01494532|532263559|FG000|Overall Study|Protocol-defined stopping criteria|0|||
147576238|NCT01494532|532263560|FG001|Overall Study|Protocol-defined stopping criteria|0|||
147576239|NCT01494532|532263561|FG002|Overall Study|Protocol-defined stopping criteria|1|||
147576240|NCT01494532|532263562|FG003|Overall Study|Protocol-defined stopping criteria|0|||
147576241|NCT01494532|532263563|FG004|Overall Study|Protocol-defined stopping criteria|0|||
147576242|NCT01494532|532263564|FG005|Overall Study|Protocol-defined stopping criteria|0|||
147576243|NCT01494532|532263559|FG000|Overall Study|Lost to Follow-up|1|||
147576244|NCT01494532|532263560|FG001|Overall Study|Lost to Follow-up|0|||
147576245|NCT01494532|532263561|FG002|Overall Study|Lost to Follow-up|0|||
147576246|NCT01494532|532263562|FG003|Overall Study|Lost to Follow-up|2|||
147576247|NCT01494532|532263563|FG004|Overall Study|Lost to Follow-up|0|||
147576248|NCT01494532|532263564|FG005|Overall Study|Lost to Follow-up|0|||
147576249|NCT01494532|532263559|FG000|Overall Study|Physician Decision|0|||
147576250|NCT01494532|532263560|FG001|Overall Study|Physician Decision|1|||
147576251|NCT01494532|532263561|FG002|Overall Study|Physician Decision|1|||
147576252|NCT01494532|532263562|FG003|Overall Study|Physician Decision|2|||
147576253|NCT01494532|532263563|FG004|Overall Study|Physician Decision|0|||
147576254|NCT01494532|532263564|FG005|Overall Study|Physician Decision|0|||
147576255|NCT01494532|532263559|FG000|Overall Study|Withdrawal by Subject|3|||
147576256|NCT01494532|532263560|FG001|Overall Study|Withdrawal by Subject|1|||
147576257|NCT01494532|532263561|FG002|Overall Study|Withdrawal by Subject|4|||
147576258|NCT01494532|532263562|FG003|Overall Study|Withdrawal by Subject|3|||
147576259|NCT01494532|532263563|FG004|Overall Study|Withdrawal by Subject|2|||
147576260|NCT01494532|532263564|FG005|Overall Study|Withdrawal by Subject|0|||
147576261|NCT03506633|532265416|FG000|Washout (14 Days)|Withdrawal by Subject|1|||
147576262|NCT03506633|532265417|FG001|Washout (14 Days)|Withdrawal by Subject|0|||
147576263|NCT00258856|532265421|FG000|Overall Study|Lost to Follow-up|1|||
147576264|NCT00258856|532265422|FG001|Overall Study|Lost to Follow-up|0|||
147576265|NCT00258856|532265423|FG002|Overall Study|Lost to Follow-up|2|||
147576266|NCT00258856|532265424|FG003|Overall Study|Lost to Follow-up|0|||
147576267|NCT00258856|532265421|FG000|Overall Study|Non-compliance|2|||
147576268|NCT00258856|532265422|FG001|Overall Study|Non-compliance|0|||
147576269|NCT00258856|532265423|FG002|Overall Study|Non-compliance|0|||
147576270|NCT00258856|532265424|FG003|Overall Study|Non-compliance|1|||
147576271|NCT03247686|532265425|FG000|Overall Study|Withdrawal by Subject|1|||
147576272|NCT03247686|532265426|FG001|Overall Study|Withdrawal by Subject|2|||
147576273|NCT01109849|532265429|FG000|Initial Randomization: ADHD Treatment|Lost to Follow-up|9|||
147149870|NCT01147250|530710565|FG000|Overall Study|Withdrawal by Subject|83|||
147149871|NCT01147250|530710566|FG001|Overall Study|Withdrawal by Subject|88|||
147149872|NCT01147250|530710565|FG000|Overall Study|Site termination by sponsor|13|||
147149873|NCT01147250|530710566|FG001|Overall Study|Site termination by sponsor|5|||
147576274|NCT01109849|532265430|FG001|Initial Randomization: ADHD Treatment|Lost to Follow-up|35|||
147576275|NCT01109849|532265431|FG002|Initial Randomization: ADHD Treatment|Lost to Follow-up|0|||
147576276|NCT01109849|532265432|FG003|Initial Randomization: ADHD Treatment|Lost to Follow-up|0|||
147576277|NCT01109849|532265433|FG004|Initial Randomization: ADHD Treatment|Lost to Follow-up|0|||
147576278|NCT01109849|532265429|FG000|Initial Randomization: ADHD Treatment|Protocol Violation|1|||
147576279|NCT01109849|532265430|FG001|Initial Randomization: ADHD Treatment|Protocol Violation|0|||
147576280|NCT01109849|532265431|FG002|Initial Randomization: ADHD Treatment|Protocol Violation|0|||
147576281|NCT01109849|532265432|FG003|Initial Randomization: ADHD Treatment|Protocol Violation|0|||
147576282|NCT01109849|532265433|FG004|Initial Randomization: ADHD Treatment|Protocol Violation|0|||
147576283|NCT01109849|532265429|FG000|Initial Randomization: ADHD Treatment|Withdrawal by Subject|6|||
147652961|NCT01704755|532551874|FG001|Overall Study|Lost to Follow-up|4|||
147149874|NCT01147250|530710565|FG000|Overall Study|Other than specified|0|||
147149875|NCT01147250|530710566|FG001|Overall Study|Other than specified|1|||
147149876|NCT02684617|530710567|FG000|Overall Study|Adverse Event|1|||
147149877|NCT02684617|530710568|FG001|Overall Study|Adverse Event|0|||
147149878|NCT02684617|530710569|FG002|Overall Study|Adverse Event|1|||
147149879|NCT02684617|530710567|FG000|Overall Study|Death|8|||
147149880|NCT02684617|530710568|FG001|Overall Study|Death|16|||
147149881|NCT02684617|530710569|FG002|Overall Study|Death|28|||
147149882|NCT02684617|530710567|FG000|Overall Study|Withdrawal by Subject|2|||
147149883|NCT02684617|530710568|FG001|Overall Study|Withdrawal by Subject|0|||
147149884|NCT02684617|530710569|FG002|Overall Study|Withdrawal by Subject|4|||
147149885|NCT02684617|530710567|FG000|Overall Study|Screen Failure|1|||
147149886|NCT02684617|530710568|FG001|Overall Study|Screen Failure|0|||
147149887|NCT02684617|530710569|FG002|Overall Study|Screen Failure|2|||
147149888|NCT02684617|530710567|FG000|Overall Study|Study Terminated by Sponsor|6|||
147149889|NCT02684617|530710568|FG001|Overall Study|Study Terminated by Sponsor|1|||
147149890|NCT02684617|530710569|FG002|Overall Study|Study Terminated by Sponsor|5|||
147149891|NCT04952597|530710570|FG000|Overall Study|Death|12|||
147149892|NCT04952597|530710571|FG001|Overall Study|Death|13|||
147149893|NCT04952597|530710572|FG002|Overall Study|Death|14|||
147149894|NCT04952597|530710570|FG000|Overall Study|Withdrawal by Subject|1|||
147149895|NCT04952597|530710571|FG001|Overall Study|Withdrawal by Subject|0|||
147149896|NCT04952597|530710572|FG002|Overall Study|Withdrawal by Subject|3|||
147149897|NCT04952597|530710570|FG000|Overall Study|Lost to Follow-up|0|||
147149898|NCT04952597|530710571|FG001|Overall Study|Lost to Follow-up|1|||
147149899|NCT04952597|530710572|FG002|Overall Study|Lost to Follow-up|1|||
147149900|NCT00022763|530710580|FG000|Overall Study|Adverse Event|1|||
147149901|NCT00022763|530710581|FG001|Overall Study|Adverse Event|2|||
147149902|NCT00022763|530710580|FG000|Overall Study|Injection Site Reactions|0|||
147149903|NCT00022763|530710581|FG001|Overall Study|Injection Site Reactions|2|||
147149904|NCT00022763|530710580|FG000|Overall Study|Death|0|||
147149905|NCT00022763|530710581|FG001|Overall Study|Death|1|||
147149906|NCT00022763|530710580|FG000|Overall Study|Lost to Follow-up|0|||
147149907|NCT00022763|530710581|FG001|Overall Study|Lost to Follow-up|3|||
147149908|NCT00022763|530710580|FG000|Overall Study|Withdrawal by Subject|4|||
147149909|NCT00022763|530710581|FG001|Overall Study|Withdrawal by Subject|7|||
147149910|NCT00022763|530710580|FG000|Overall Study|Insufficient Therapy|1|||
147149911|NCT00022763|530710581|FG001|Overall Study|Insufficient Therapy|0|||
147149912|NCT00022763|530710580|FG000|Overall Study|Admin|3|||
147149913|NCT00022763|530710581|FG001|Overall Study|Admin|2|||
147149914|NCT04908865|530710582|FG000|Overall Study|Adverse Event|2|||
147149915|NCT04908865|530710582|FG000|Overall Study|Lack of Efficacy|5|||
147149916|NCT04908865|530710582|FG000|Overall Study|Lost to Follow-up|1|||
147149917|NCT02141399|530710583|FG000|Overall Study|Adverse Event|158|||
147149918|NCT02141399|530710583|FG000|Overall Study|Lack of Efficacy|62|||
147149919|NCT02141399|530710583|FG000|Overall Study|Lost to Follow-up|151|||
147149920|NCT02141399|530710583|FG000|Overall Study|Non-compliance with study drug|18|||
147239466|NCT01218113|531049175|FG002|Overall Study|Protocol Deviation Eligibility Criteria|1|||
147239467|NCT00115739|531049176|FG000|Overall Study|Lost to Follow-up|3|||
147239468|NCT00259649|531049177|FG000|Overall Study|Lost to Follow-up|7|||
147239469|NCT00259649|531049177|FG000|Overall Study|irregular menses|3|||
147239470|NCT00745823|531049180|FG000|Overall Study|Adverse Event|5|||
147239471|NCT00745823|531049181|FG001|Overall Study|Adverse Event|3|||
147239472|NCT00745823|531049180|FG000|Overall Study|Lack of Efficacy|20|||
147239473|NCT00745823|531049181|FG001|Overall Study|Lack of Efficacy|6|||
147239474|NCT00745823|531049180|FG000|Overall Study|Lost to Follow-up|10|||
147239475|NCT00745823|531049181|FG001|Overall Study|Lost to Follow-up|11|||
147239476|NCT00745823|531049180|FG000|Overall Study|Physician Decision|10|||
147239477|NCT00745823|531049181|FG001|Overall Study|Physician Decision|5|||
147239478|NCT00745823|531049180|FG000|Overall Study|Pregnancy|0|||
147239479|NCT00745823|531049181|FG001|Overall Study|Pregnancy|4|||
147239480|NCT00745823|531049180|FG000|Overall Study|Withdrawal by Subject|14|||
147239481|NCT00745823|531049181|FG001|Overall Study|Withdrawal by Subject|8|||
147239482|NCT00745823|531049180|FG000|Overall Study|Study Terminated by Sponsor|326|||
147321044|NCT04955626|531338431|FG011|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
147149921|NCT02141399|530710583|FG000|Overall Study|Other|45|||
147149922|NCT02141399|530710583|FG000|Overall Study|Physician Decision|17|||
147149923|NCT02141399|530710583|FG000|Overall Study|Pregnancy|3|||
147149924|NCT02141399|530710583|FG000|Overall Study|Protocol Violation|38|||
147149925|NCT02141399|530710583|FG000|Overall Study|Withdrawal by Subject|238|||
147149926|NCT02141399|530710583|FG000|Overall Study|Failure to meet eligibility criteria|14|||
147149927|NCT04445519|530710584|FG000|Overall Study|Due to adaptive design|3|||
147149928|NCT04445519|530710585|FG001|Overall Study|Due to adaptive design|0|||
147149929|NCT04445519|530710586|FG002|Overall Study|Due to adaptive design|0|||
147239483|NCT00745823|531049181|FG001|Overall Study|Study Terminated by Sponsor|349|||
147239484|NCT01433991|531049191|FG000|Pretreatment Phase (Single Agent Run-in)|Did not enter into treatment phase|2|||
147239485|NCT01433991|531049192|FG001|Pretreatment Phase (Single Agent Run-in)|Did not enter into treatment phase|0|||
147239486|NCT01433991|531049193|FG002|Pretreatment Phase (Single Agent Run-in)|Did not enter into treatment phase|0|||
147149930|NCT04445519|530710584|FG000|Overall Study|Lost to Follow-up|0|||
147149931|NCT04445519|530710585|FG001|Overall Study|Lost to Follow-up|1|||
147149932|NCT04445519|530710586|FG002|Overall Study|Lost to Follow-up|4|||
147149933|NCT04445519|530710584|FG000|Overall Study|Sponsor or IRB Decision|0|||
147149934|NCT04445519|530710585|FG001|Overall Study|Sponsor or IRB Decision|1|||
147149935|NCT04445519|530710586|FG002|Overall Study|Sponsor or IRB Decision|2|||
147149936|NCT04445519|530710584|FG000|Overall Study|Withdrawal by Subject|0|||
147149937|NCT04445519|530710585|FG001|Overall Study|Withdrawal by Subject|3|||
147149938|NCT04445519|530710586|FG002|Overall Study|Withdrawal by Subject|3|||
147149939|NCT04445519|530710584|FG000|Overall Study|Adverse Event|0|||
147149940|NCT04445519|530710585|FG001|Overall Study|Adverse Event|8|||
147149941|NCT04445519|530710586|FG002|Overall Study|Adverse Event|6|||
147149942|NCT04445519|530710584|FG000|Overall Study|Other Reason|0|||
147149943|NCT04445519|530710585|FG001|Overall Study|Other Reason|1|||
147149944|NCT04445519|530710586|FG002|Overall Study|Other Reason|1|||
147149945|NCT04445519|530710584|FG000|Overall Study|Protocol Violation|0|||
147149946|NCT04445519|530710585|FG001|Overall Study|Protocol Violation|0|||
147149947|NCT04445519|530710586|FG002|Overall Study|Protocol Violation|1|||
147149948|NCT01345929|530710587|FG000|Overall Study|Withdrawal by Subject|9|||
147149949|NCT01345929|530710588|FG001|Overall Study|Withdrawal by Subject|8|||
147149950|NCT01345929|530710587|FG000|Overall Study|Lost to Follow-up|9|||
147149951|NCT01345929|530710588|FG001|Overall Study|Lost to Follow-up|9|||
147149952|NCT01345929|530710587|FG000|Overall Study|Adverse Event|0|||
147149953|NCT01345929|530710588|FG001|Overall Study|Adverse Event|1|||
147149954|NCT01345929|530710587|FG000|Overall Study|Didn't meet eligibility criteria|2|||
147149955|NCT01345929|530710588|FG001|Overall Study|Didn't meet eligibility criteria|0|||
147149956|NCT01345929|530710587|FG000|Overall Study|40,000 CFU/ML|1|||
147149957|NCT01345929|530710588|FG001|Overall Study|40,000 CFU/ML|0|||
147149958|NCT01345929|530710587|FG000|Overall Study|Patient withdrawal|0|||
147149959|NCT01345929|530710588|FG001|Overall Study|Patient withdrawal|1|||
147149960|NCT02819297|530710593|FG000|Overall Study|Withdrawal by Subject|25|||
147149961|NCT02819297|530710594|FG001|Overall Study|Withdrawal by Subject|13|||
147149962|NCT02819297|530710593|FG000|Overall Study|Lost to Follow-up|12|||
147149963|NCT02819297|530710594|FG001|Overall Study|Lost to Follow-up|14|||
147149964|NCT02819297|530710593|FG000|Overall Study|Adverse Event|12|||
147149965|NCT02819297|530710594|FG001|Overall Study|Adverse Event|10|||
147149966|NCT02819297|530710593|FG000|Overall Study|Physician Decision|5|||
147149967|NCT02819297|530710594|FG001|Overall Study|Physician Decision|5|||
147149968|NCT02819297|530710593|FG000|Overall Study|Lack of Efficacy|5|||
147149969|NCT02819297|530710594|FG001|Overall Study|Lack of Efficacy|8|||
147149970|NCT02819297|530710593|FG000|Overall Study|Protocol Violation|1|||
147149971|NCT02819297|530710594|FG001|Overall Study|Protocol Violation|2|||
147149972|NCT02858440|530710595|FG000|Overall Study|Lost to Follow-up|3|||
147149973|NCT02858440|530710595|FG000|Overall Study|Protocol Violation|2|||
147149974|NCT02858440|530710595|FG000|Overall Study|Consent withdrawal|3|||
147149975|NCT02858440|530710595|FG000|Overall Study|Migrated/moved from study area|4|||
147149976|NCT01670279|530710596|FG000|Overall Study|Adverse Event|0|||
147149977|NCT01670279|530710597|FG001|Overall Study|Adverse Event|1|||
147149978|NCT01670279|530710598|FG002|Overall Study|Adverse Event|0|||
147149979|NCT01670279|530710599|FG003|Overall Study|Adverse Event|0|||
147149980|NCT01670279|530710596|FG000|Overall Study|Physician Decision|0|||
147149981|NCT01670279|530710597|FG001|Overall Study|Physician Decision|1|||
147149982|NCT01670279|530710598|FG002|Overall Study|Physician Decision|0|||
147149983|NCT01670279|530710599|FG003|Overall Study|Physician Decision|0|||
147149984|NCT01670279|530710596|FG000|Overall Study|Participant met withdrawal criteria|0|||
147149985|NCT01670279|530710597|FG001|Overall Study|Participant met withdrawal criteria|0|||
147149986|NCT01670279|530710598|FG002|Overall Study|Participant met withdrawal criteria|0|||
147149987|NCT01670279|530710599|FG003|Overall Study|Participant met withdrawal criteria|1|||
147149988|NCT01534351|530710602|FG000|Overall Study|Study Terminated Early|1|||
147149989|NCT01534351|530710603|FG001|Overall Study|Study Terminated Early|0|||
147149990|NCT01534351|530710604|FG002|Overall Study|Study Terminated Early|0|||
147149991|NCT02702609|530710605|FG000|Overall Study|Lost to Follow-up|8|||
147149992|NCT02702609|530710606|FG001|Overall Study|Lost to Follow-up|4|||
147149993|NCT02702609|530710605|FG000|Overall Study|Physician Decision|1|||
147239487|NCT01433991|531049194|FG003|Pretreatment Phase (Single Agent Run-in)|Did not enter into treatment phase|0|||
147652962|NCT01704755|532551873|FG000|Overall Study|Withdrew consent|1|||
147149994|NCT02702609|530710606|FG001|Overall Study|Physician Decision|0|||
147149995|NCT04153981|530710607|FG000|Overall Study|Death|1|||
147149996|NCT04153981|530710607|FG000|Overall Study|Withdrawal by Subject|24|||
147149997|NCT04153981|530710607|FG000|Overall Study|Lost to Follow-up|1|||
147149998|NCT04153981|530710607|FG000|Overall Study|Physician Decision|1|||
147149999|NCT04153981|530710607|FG000|Overall Study|Due to Unavailable Glucometer|1|||
147150000|NCT04153981|530710607|FG000|Overall Study|Covid 19|52|||
147150001|NCT04153981|530710607|FG000|Overall Study|Participant Dropped Out as Required Laboratory Test was Not Performed|5|||
147150002|NCT04153981|530710607|FG000|Overall Study|Due to Low Fasting Blood Sugar Levels|1|||
147150003|NCT02091362|530710617|FG000|Period 1|Protocol Violation|1|||
147150004|NCT02091362|530710618|FG001|Period 1|Protocol Violation|0|||
147150005|NCT02091362|530710617|FG000|Period 1|Withdrawal by Subject|2|||
147150006|NCT02091362|530710618|FG001|Period 1|Withdrawal by Subject|3|||
147150007|NCT02091362|530710617|FG000|Period 1|Lost to Follow-up|0|||
147150008|NCT02091362|530710618|FG001|Period 1|Lost to Follow-up|1|||
147150009|NCT02091362|530710617|FG000|Period 1|Adverse Event|2|||
147150010|NCT02091362|530710618|FG001|Period 1|Adverse Event|0|||
147150011|NCT02091362|530710617|FG000|Wash-out|Lost to Follow-up|1|||
147150012|NCT02091362|530710618|FG001|Wash-out|Lost to Follow-up|1|||
147150013|NCT02091362|530710617|FG000|Wash-out|Withdrawal by Subject|0|||
147150014|NCT02091362|530710618|FG001|Wash-out|Withdrawal by Subject|2|||
147150015|NCT02091362|530710617|FG000|Period 2|Adverse Event|1|||
147150016|NCT02091362|530710618|FG001|Period 2|Adverse Event|0|||
147150017|NCT02091362|530710617|FG000|Period 2|Lost to Follow-up|0|||
147150018|NCT02091362|530710618|FG001|Period 2|Lost to Follow-up|1|||
147150019|NCT02091362|530710617|FG000|Period 2|Withdrawal by Subject|1|||
147150020|NCT02091362|530710618|FG001|Period 2|Withdrawal by Subject|1|||
147150021|NCT00690430|530710619|FG000|Core Phase|Abnormal Laboratory value|0|||
147150022|NCT00690430|530710620|FG001|Core Phase|Abnormal Laboratory value|1|||
147150023|NCT00690430|530710621|FG002|Core Phase|Abnormal Laboratory value|0|||
147150024|NCT00690430|530710619|FG000|Core Phase|Adverse Event|5|||
147150025|NCT00690430|530710620|FG001|Core Phase|Adverse Event|1|||
147150026|NCT00690430|530710621|FG002|Core Phase|Adverse Event|0|||
147150027|NCT00690430|530710619|FG000|Core Phase|Death|0|||
147150028|NCT00690430|530710620|FG001|Core Phase|Death|2|||
147150029|NCT00690430|530710621|FG002|Core Phase|Death|0|||
147150030|NCT00690430|530710619|FG000|Core Phase|Protocol Violation|1|||
147321045|NCT04955626|531338432|FG012|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
147321046|NCT04955626|531338433|FG013|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
147321047|NCT04955626|531338434|FG014|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
147321048|NCT04955626|531338435|FG015|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
147321049|NCT04955626|531338436|FG016|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
147150031|NCT00690430|530710620|FG001|Core Phase|Protocol Violation|0|||
147150032|NCT00690430|530710621|FG002|Core Phase|Protocol Violation|0|||
147150033|NCT00690430|530710619|FG000|Core Phase|Withdrawal by Subject|3|||
147150034|NCT00690430|530710620|FG001|Core Phase|Withdrawal by Subject|3|||
147150035|NCT00690430|530710621|FG002|Core Phase|Withdrawal by Subject|0|||
147150036|NCT00690430|530710619|FG000|Core Phase|Subject no longer requires study drug|1|||
147150037|NCT00690430|530710620|FG001|Core Phase|Subject no longer requires study drug|0|||
147150038|NCT00690430|530710621|FG002|Core Phase|Subject no longer requires study drug|0|||
147150039|NCT00690430|530710619|FG000|Core Phase|Lack of Efficacy|8|||
147150040|NCT00690430|530710620|FG001|Core Phase|Lack of Efficacy|10|||
147150041|NCT00690430|530710621|FG002|Core Phase|Lack of Efficacy|0|||
147150042|NCT00690430|530710619|FG000|Core Phase|Administrative Problems|0|||
147150043|NCT00690430|530710620|FG001|Core Phase|Administrative Problems|1|||
147150044|NCT00690430|530710621|FG002|Core Phase|Administrative Problems|0|||
147150045|NCT00690430|530710619|FG000|Core Phase|Early Termination|0|||
147150046|NCT00690430|530710620|FG001|Core Phase|Early Termination|5|||
147150047|NCT00690430|530710621|FG002|Core Phase|Early Termination|0|||
147150048|NCT00690430|530710619|FG000|Extension Phase|Lack of Efficacy|3|||
147150049|NCT00690430|530710620|FG001|Extension Phase|Lack of Efficacy|1|||
147150050|NCT00690430|530710621|FG002|Extension Phase|Lack of Efficacy|4|||
147150051|NCT00690430|530710619|FG000|Extension Phase|Abnormal Lab Values|1|||
147150052|NCT00690430|530710620|FG001|Extension Phase|Abnormal Lab Values|0|||
147150053|NCT00690430|530710621|FG002|Extension Phase|Abnormal Lab Values|0|||
147150054|NCT00690430|530710619|FG000|Extension Phase|Abnormal test procedure results|1|||
147150055|NCT00690430|530710620|FG001|Extension Phase|Abnormal test procedure results|0|||
147150056|NCT00690430|530710621|FG002|Extension Phase|Abnormal test procedure results|0|||
147150057|NCT00690430|530710619|FG000|Extension Phase|Administrative Problems|0|||
147150058|NCT00690430|530710620|FG001|Extension Phase|Administrative Problems|1|||
147150059|NCT00690430|530710621|FG002|Extension Phase|Administrative Problems|1|||
147150060|NCT00690430|530710619|FG000|Extension Phase|Adverse Event|2|||
147321050|NCT04955626|531338437|FG017|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
147321051|NCT04955626|531338438|FG018|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
147150061|NCT00690430|530710620|FG001|Extension Phase|Adverse Event|1|||
147150062|NCT00690430|530710621|FG002|Extension Phase|Adverse Event|2|||
147150063|NCT00690430|530710619|FG000|Extension Phase|Death|1|||
147150064|NCT00690430|530710620|FG001|Extension Phase|Death|1|||
147150065|NCT00690430|530710621|FG002|Extension Phase|Death|1|||
147150066|NCT00690430|530710619|FG000|Extension Phase|Withdrawal by Subject|0|||
147150067|NCT00690430|530710620|FG001|Extension Phase|Withdrawal by Subject|0|||
147150068|NCT00690430|530710621|FG002|Extension Phase|Withdrawal by Subject|2|||
147150069|NCT00690430|530710619|FG000|Extension Phase|Early Termination|10|||
147150070|NCT00690430|530710620|FG001|Extension Phase|Early Termination|1|||
147150071|NCT00690430|530710621|FG002|Extension Phase|Early Termination|3|||
147150072|NCT02125838|530710624|FG000|Overall Study|Lost to Follow-up|4|||
147150073|NCT02125838|530710625|FG001|Overall Study|Lost to Follow-up|4|||
147150074|NCT02565147|530710626|FG000|Overall Study|Withdrawal by Subject|5|||
147150075|NCT02565147|530710627|FG001|Overall Study|Withdrawal by Subject|1|||
147150076|NCT02565147|530710626|FG000|Overall Study|Lost to Follow-up|0|||
147150077|NCT02565147|530710627|FG001|Overall Study|Lost to Follow-up|1|||
147150078|NCT02565147|530710626|FG000|Overall Study|Death|1|||
147150079|NCT02565147|530710627|FG001|Overall Study|Death|1|||
147150080|NCT00787839|530710628|FG000|Overall Study|Failure to have the OGTT was most common|404|||
147150081|NCT00286091|530710635|FG000|Double-blind Treatment Phase|Withdrawal by Subject|103|||
147150082|NCT00286091|530710636|FG001|Double-blind Treatment Phase|Withdrawal by Subject|113|||
147150083|NCT00286091|530710635|FG000|Double-blind Treatment Phase|Protocol-Specified Criteria|307|||
147150084|NCT00286091|530710636|FG001|Double-blind Treatment Phase|Protocol-Specified Criteria|269|||
147150085|NCT00286091|530710635|FG000|Double-blind Treatment Phase|Death|58|||
147150086|NCT00286091|530710636|FG001|Double-blind Treatment Phase|Death|65|||
147150087|NCT00286091|530710635|FG000|Double-blind Treatment Phase|Adverse Event|28|||
147150088|NCT00286091|530710636|FG001|Double-blind Treatment Phase|Adverse Event|40|||
147150089|NCT00286091|530710635|FG000|Double-blind Treatment Phase|Disease Progression|22|||
147150090|NCT00286091|530710636|FG001|Double-blind Treatment Phase|Disease Progression|35|||
147150091|NCT00286091|530710635|FG000|Double-blind Treatment Phase|Other|25|||
147150092|NCT00286091|530710636|FG001|Double-blind Treatment Phase|Other|33|||
147150093|NCT00286091|530710635|FG000|Double-blind Treatment Phase|Administrative Decision|20|||
147150094|NCT00286091|530710636|FG001|Double-blind Treatment Phase|Administrative Decision|21|||
147150095|NCT00286091|530710635|FG000|Double-blind Treatment Phase|Noncompliance|8|||
147150096|NCT00286091|530710636|FG001|Double-blind Treatment Phase|Noncompliance|8|||
147150097|NCT00286091|530710635|FG000|Double-blind Treatment Phase|Lost to Follow-up|11|||
147150098|NCT00286091|530710636|FG001|Double-blind Treatment Phase|Lost to Follow-up|4|||
147150099|NCT00286091|530710635|FG000|Double-blind Treatment Phase|Protocol Deviation|1|||
147150100|NCT00286091|530710636|FG001|Double-blind Treatment Phase|Protocol Deviation|3|||
147150101|NCT00286091|530710635|FG000|Double-blind Treatment Phase|Ineligibility Determined|1|||
147150102|NCT00286091|530710636|FG001|Double-blind Treatment Phase|Ineligibility Determined|2|||
147150103|NCT00286091|530710635|FG000|Open-label Treatment Phase|Physician Decision|24|||
147150104|NCT00286091|530710636|FG001|Open-label Treatment Phase|Physician Decision|21|||
147150105|NCT00286091|530710635|FG000|Open-label Treatment Phase|Adverse Event|5|||
147150106|NCT00286091|530710636|FG001|Open-label Treatment Phase|Adverse Event|16|||
147150107|NCT00286091|530710635|FG000|Open-label Treatment Phase|Other|11|||
147150108|NCT00286091|530710636|FG001|Open-label Treatment Phase|Other|11|||
147150109|NCT00286091|530710635|FG000|Open-label Treatment Phase|Withdrawal by Subject|14|||
147150110|NCT00286091|530710636|FG001|Open-label Treatment Phase|Withdrawal by Subject|10|||
147150111|NCT00286091|530710635|FG000|Open-label Treatment Phase|Death|10|||
147150112|NCT00286091|530710636|FG001|Open-label Treatment Phase|Death|7|||
147150113|NCT00286091|530710635|FG000|Open-label Treatment Phase|Disease Progression|9|||
147150114|NCT00286091|530710636|FG001|Open-label Treatment Phase|Disease Progression|3|||
147150115|NCT00286091|530710635|FG000|Open-label Treatment Phase|Noncompliance|3|||
147150116|NCT00286091|530710636|FG001|Open-label Treatment Phase|Noncompliance|1|||
147150117|NCT00286091|530710635|FG000|Open-label Treatment Phase|Lost to Follow-up|0|||
147150118|NCT00286091|530710636|FG001|Open-label Treatment Phase|Lost to Follow-up|1|||
147150119|NCT00286091|530710635|FG000|Open-label Treatment Phase|Protocol-specified Criteria|1|||
147150120|NCT00286091|530710636|FG001|Open-label Treatment Phase|Protocol-specified Criteria|0|||
147150121|NCT00286091|530710635|FG000|Open-label Treatment Phase|Missing End of Study Information|0|||
147150122|NCT00286091|530710636|FG001|Open-label Treatment Phase|Missing End of Study Information|1|||
147150123|NCT02936869|530710639|FG000|Overall Study|Lost to Follow-up|1|||
147150124|NCT02936869|530710640|FG001|Overall Study|Lost to Follow-up|3|||
147150125|NCT02936869|530710639|FG000|Overall Study|Death|0|||
147150126|NCT02936869|530710640|FG001|Overall Study|Death|1|||
147150127|NCT02936869|530710639|FG000|Overall Study|Legal Case|0|||
147150128|NCT02936869|530710640|FG001|Overall Study|Legal Case|1|||
147150129|NCT02936869|530710639|FG000|Overall Study|Protocol Violation|1|||
147150130|NCT02936869|530710640|FG001|Overall Study|Protocol Violation|0|||
147150131|NCT00335738|530710641|FG000|Overall Study|Physician Decision|6|||
147150132|NCT00335738|530710642|FG001|Overall Study|Physician Decision|0|||
147150133|NCT00335738|530710641|FG000|Overall Study|Withdrawal by Subject|2|||
147150134|NCT00335738|530710642|FG001|Overall Study|Withdrawal by Subject|0|||
147150135|NCT00335738|530710641|FG000|Overall Study|Ineligible|3|||
147576284|NCT01109849|532265430|FG001|Initial Randomization: ADHD Treatment|Withdrawal by Subject|7|||
147576285|NCT01109849|532265431|FG002|Initial Randomization: ADHD Treatment|Withdrawal by Subject|0|||
147576286|NCT01109849|532265432|FG003|Initial Randomization: ADHD Treatment|Withdrawal by Subject|0|||
147150136|NCT00335738|530710642|FG001|Overall Study|Ineligible|4|||
147150137|NCT00506454|530710649|FG000|Overall Study|Withdrawal by Subject|1|||
147150138|NCT00506454|530710650|FG001|Overall Study|Withdrawal by Subject|1|||
147150139|NCT00902850|530710652|FG000|Overall Study|Physician Decision|2|||
147150140|NCT00902850|530710653|FG001|Overall Study|Physician Decision|2|||
147150141|NCT00260832|530710654|FG000|Overall Study|Adverse Event|26|||
147150142|NCT00260832|530710655|FG001|Overall Study|Adverse Event|19|||
147150143|NCT00260832|530710654|FG000|Overall Study|Progression|116|||
147150144|NCT00260832|530710655|FG001|Overall Study|Progression|96|||
147150145|NCT00260832|530710654|FG000|Overall Study|Withdrawal by Subject|15|||
147150146|NCT00260832|530710655|FG001|Overall Study|Withdrawal by Subject|17|||
147150147|NCT00260832|530710654|FG000|Overall Study|Physician Decision|15|||
147446004|NCT00219284|531797531|FG000|Extension Phase - 8 Weeks|Adverse Event|2|||
147446005|NCT00219284|531797532|FG001|Extension Phase - 8 Weeks|Adverse Event|3|||
147652963|NCT01704755|532551874|FG001|Overall Study|Withdrew consent|1|||
147652964|NCT01704755|532551873|FG000|Overall Study|Other (not specified)|3|||
147652965|NCT01704755|532551874|FG001|Overall Study|Other (not specified)|1|||
147652966|NCT01704755|532551873|FG000|Overall Study|Withdrew consent and personal issues|1|||
147652967|NCT01704755|532551874|FG001|Overall Study|Withdrew consent and personal issues|0|||
147652968|NCT02187029|532551877|FG000|Overall Study|Adverse Event|0|||
147652969|NCT02187029|532551878|FG001|Overall Study|Adverse Event|1|||
147652970|NCT02187029|532551879|FG002|Overall Study|Adverse Event|1|||
147652971|NCT02187029|532551880|FG003|Overall Study|Adverse Event|0|||
147652972|NCT02187029|532551877|FG000|Overall Study|Study Terminated by Sponsor|0|||
147652973|NCT02187029|532551878|FG001|Overall Study|Study Terminated by Sponsor|0|||
147652974|NCT02187029|532551879|FG002|Overall Study|Study Terminated by Sponsor|10|||
147652975|NCT02187029|532551880|FG003|Overall Study|Study Terminated by Sponsor|3|||
147652976|NCT02187029|532551877|FG000|Overall Study|Withdrawal by Subject|1|||
147652977|NCT02187029|532551878|FG001|Overall Study|Withdrawal by Subject|0|||
147652978|NCT02187029|532551879|FG002|Overall Study|Withdrawal by Subject|0|||
147652979|NCT02187029|532551880|FG003|Overall Study|Withdrawal by Subject|0|||
147652980|NCT01188668|532551881|FG000|Period 1: ARIP Alone|Protocol Violation|2|||
147652981|NCT01188668|532551881|FG000|Period 2: Coadministration ARIP + DVS SR|Lost to Follow-up|2|||
147652982|NCT01188668|532551881|FG000|Period 2: Coadministration ARIP + DVS SR|Withdrawal by Subject|1|||
147652983|NCT02937636|532551884|FG000|Overall Study|Other (Not specified)|3|||
147652984|NCT02937636|532551885|FG001|Overall Study|Other (Not specified)|2|||
147652985|NCT00770913|532551886|FG000|Overall Study|Adverse Event|1|||
147652986|NCT00770913|532551887|FG001|Overall Study|Adverse Event|3|||
147652987|NCT00770913|532551888|FG002|Overall Study|Adverse Event|6|||
147652988|NCT00770913|532551886|FG000|Overall Study|Refusal to continue participation|6|||
147321052|NCT04955626|531338439|FG019|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
147321053|NCT04955626|531338440|FG020|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
147652989|NCT00770913|532551887|FG001|Overall Study|Refusal to continue participation|4|||
147652990|NCT00770913|532551888|FG002|Overall Study|Refusal to continue participation|5|||
147652991|NCT00770913|532551886|FG000|Overall Study|Physician Decision|0|||
147321054|NCT04955626|531338441|FG021|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
147321055|NCT04955626|531338442|FG022|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
147321056|NCT04955626|531338443|FG023|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
147321057|NCT04955626|531338444|FG024|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
147321058|NCT04955626|531338445|FG025|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
147321059|NCT04955626|531338446|FG026|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
147321060|NCT04955626|531338447|FG027|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
147321061|NCT04955626|531338448|FG028|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
147446006|NCT00219284|531797531|FG000|Extension Phase - 8 Weeks|Withdrawal by Subject|0|||
147446007|NCT00219284|531797532|FG001|Extension Phase - 8 Weeks|Withdrawal by Subject|2|||
147446008|NCT00219284|531797531|FG000|Extension Phase - 8 Weeks|Lost to Follow-up|0|||
147446009|NCT00219284|531797532|FG001|Extension Phase - 8 Weeks|Lost to Follow-up|2|||
147446010|NCT00361270|531797534|FG000|Overall Study|Death|0|||
147652992|NCT00770913|532551887|FG001|Overall Study|Physician Decision|1|||
147652993|NCT00770913|532551888|FG002|Overall Study|Physician Decision|1|||
147652994|NCT00770913|532551886|FG000|Overall Study|Protocol Violation|3|||
147652995|NCT00770913|532551887|FG001|Overall Study|Protocol Violation|0|||
147652996|NCT00770913|532551888|FG002|Overall Study|Protocol Violation|1|||
147652997|NCT00770913|532551886|FG000|Overall Study|Incorrect drug was allocated|1|||
147652998|NCT00770913|532551887|FG001|Overall Study|Incorrect drug was allocated|0|||
147652999|NCT00770913|532551888|FG002|Overall Study|Incorrect drug was allocated|0|||
147653000|NCT00359294|532551892|FG000|Overall Study|Progressive disease|1|||
147150148|NCT00260832|530710655|FG001|Overall Study|Physician Decision|9|||
147150149|NCT00260832|530710654|FG000|Overall Study|Death|43|||
147150150|NCT00260832|530710655|FG001|Overall Study|Death|62|||
147150151|NCT00260832|530710654|FG000|Overall Study|Other|10|||
147150152|NCT00260832|530710655|FG001|Overall Study|Other|7|||
147150153|NCT00260832|530710654|FG000|Overall Study|Protocol Violation|3|||
147150154|NCT00260832|530710655|FG001|Overall Study|Protocol Violation|1|||
147150155|NCT03745638|530710656|FG000|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|4|||
147150156|NCT03745638|530710657|FG001|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|2|||
147150157|NCT03745638|530710658|FG002|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|1|||
147150158|NCT03745638|530710659|FG003|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
147150159|NCT03745638|530710660|FG004|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
147150160|NCT03745638|530710661|FG005|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
147150161|NCT03745638|530710662|FG006|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
147150162|NCT03745638|530710656|FG000|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|1|||
147150163|NCT03745638|530710657|FG001|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
147150164|NCT03745638|530710658|FG002|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
147150165|NCT03745638|530710659|FG003|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
147150166|NCT03745638|530710660|FG004|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
147150167|NCT03745638|530710661|FG005|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
147150168|NCT03745638|530710662|FG006|Vehicle Control Period (Day 1 to Week 8)|Lack of Efficacy|0|||
147150169|NCT03745638|530710656|FG000|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|5|||
147150170|NCT03745638|530710657|FG001|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|12|||
147150171|NCT03745638|530710658|FG002|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|8|||
147150172|NCT03745638|530710659|FG003|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
147150173|NCT03745638|530710660|FG004|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
147150174|NCT03745638|530710661|FG005|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
147150175|NCT03745638|530710662|FG006|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
147150176|NCT03745638|530710656|FG000|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|1|||
147150177|NCT03745638|530710657|FG001|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|1|||
147150178|NCT03745638|530710658|FG002|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
147150179|NCT03745638|530710659|FG003|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
147150180|NCT03745638|530710660|FG004|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
147150181|NCT03745638|530710661|FG005|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
147150182|NCT03745638|530710662|FG006|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
147150183|NCT03745638|530710656|FG000|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|1|||
147150184|NCT03745638|530710657|FG001|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
147150185|NCT03745638|530710658|FG002|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
147150186|NCT03745638|530710659|FG003|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
147150187|NCT03745638|530710660|FG004|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
147150188|NCT03745638|530710661|FG005|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
147150189|NCT03745638|530710662|FG006|Vehicle Control Period (Day 1 to Week 8)|Pregnancy|0|||
147150190|NCT03745638|530710656|FG000|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
147150191|NCT03745638|530710657|FG001|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|3|||
147150192|NCT03745638|530710658|FG002|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
147150193|NCT03745638|530710659|FG003|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
147150194|NCT03745638|530710660|FG004|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
147150195|NCT03745638|530710661|FG005|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
147150196|NCT03745638|530710662|FG006|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
147150197|NCT03745638|530710656|FG000|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|17|||
147150198|NCT03745638|530710657|FG001|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|11|||
147150199|NCT03745638|530710658|FG002|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|19|||
147150200|NCT03745638|530710659|FG003|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
147150201|NCT03745638|530710660|FG004|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
147150202|NCT03745638|530710661|FG005|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
147150203|NCT03745638|530710662|FG006|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
147150204|NCT03745638|530710656|FG000|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|2|||
147150205|NCT03745638|530710657|FG001|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|1|||
147150206|NCT03745638|530710658|FG002|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0|||
147150207|NCT03745638|530710659|FG003|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0|||
147150208|NCT03745638|530710660|FG004|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0|||
147150209|NCT03745638|530710661|FG005|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0|||
147576287|NCT01109849|532265433|FG004|Initial Randomization: ADHD Treatment|Withdrawal by Subject|0|||
147576288|NCT01109849|532265429|FG000|Initial Randomization: ADHD Treatment|move away|2|||
147576289|NCT01109849|532265430|FG001|Initial Randomization: ADHD Treatment|move away|7|||
147576290|NCT01109849|532265431|FG002|Initial Randomization: ADHD Treatment|move away|0|||
147576291|NCT01109849|532265432|FG003|Initial Randomization: ADHD Treatment|move away|0|||
147576292|NCT01109849|532265433|FG004|Initial Randomization: ADHD Treatment|move away|0|||
147150210|NCT03745638|530710662|FG006|Vehicle Control Period (Day 1 to Week 8)|Reason Not Specified|0|||
147321062|NCT04955626|531338449|FG029|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
147576293|NCT01109849|532265429|FG000|Adaptive Randomization: Weight Recovery|Lost to Follow-up|0|||
147576294|NCT01109849|532265430|FG001|Adaptive Randomization: Weight Recovery|Lost to Follow-up|0|||
147576295|NCT01109849|532265431|FG002|Adaptive Randomization: Weight Recovery|Lost to Follow-up|1|||
147576296|NCT01109849|532265432|FG003|Adaptive Randomization: Weight Recovery|Lost to Follow-up|1|||
147653001|NCT00359294|532551893|FG001|Overall Study|Progressive disease|1|||
147653002|NCT00359294|532551894|FG002|Overall Study|Progressive disease|2|||
147150211|NCT03745638|530710656|FG000|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
147150212|NCT03745638|530710657|FG001|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
147150213|NCT03745638|530710658|FG002|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
147150214|NCT03745638|530710659|FG003|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
147446011|NCT00361270|531797535|FG001|Overall Study|Death|0|||
147576297|NCT01109849|532265433|FG004|Adaptive Randomization: Weight Recovery|Lost to Follow-up|1|||
147576298|NCT01109849|532265429|FG000|Adaptive Randomization: Weight Recovery|moved away|0|||
147150215|NCT03745638|530710660|FG004|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
147150216|NCT03745638|530710661|FG005|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|6|||
147150217|NCT03745638|530710662|FG006|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|1|||
147150218|NCT03745638|530710656|FG000|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
147150219|NCT03745638|530710657|FG001|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
147150220|NCT03745638|530710658|FG002|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
147150221|NCT03745638|530710659|FG003|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|1|||
147150222|NCT03745638|530710660|FG004|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
147150223|NCT03745638|530710661|FG005|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|2|||
147150224|NCT03745638|530710662|FG006|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|2|||
147150225|NCT03745638|530710656|FG000|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
147150226|NCT03745638|530710657|FG001|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
147576299|NCT01109849|532265430|FG001|Adaptive Randomization: Weight Recovery|moved away|0|||
147576300|NCT01109849|532265431|FG002|Adaptive Randomization: Weight Recovery|moved away|0|||
147576301|NCT01109849|532265432|FG003|Adaptive Randomization: Weight Recovery|moved away|2|||
147576302|NCT01109849|532265433|FG004|Adaptive Randomization: Weight Recovery|moved away|0|||
147576303|NCT01541215|532265441|FG000|Treatment Period (52 Weeks)|Withdrawal criteria|6|||
147576304|NCT01541215|532265442|FG001|Treatment Period (52 Weeks)|Withdrawal criteria|8|||
147576305|NCT01541215|532265441|FG000|Treatment Period (52 Weeks)|Non-compliance|4|||
147576306|NCT01541215|532265442|FG001|Treatment Period (52 Weeks)|Non-compliance|4|||
147576307|NCT01541215|532265441|FG000|Treatment Period (52 Weeks)|Adverse Event|0|||
147576308|NCT01541215|532265442|FG001|Treatment Period (52 Weeks)|Adverse Event|1|||
147576309|NCT01541215|532265441|FG000|Treatment Period (52 Weeks)|Unclassified|0|||
147576310|NCT01541215|532265442|FG001|Treatment Period (52 Weeks)|Unclassified|3|||
147576311|NCT01541215|532265441|FG000|Follow up 1 (Weeks 53-104)|Lost to Follow-up|1|||
147576312|NCT01541215|532265442|FG001|Follow up 1 (Weeks 53-104)|Lost to Follow-up|0|||
147150227|NCT03745638|530710658|FG002|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
147150228|NCT03745638|530710659|FG003|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|3|||
147150229|NCT03745638|530710660|FG004|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|5|||
147150230|NCT03745638|530710661|FG005|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|13|||
147150231|NCT03745638|530710662|FG006|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|24|||
147576313|NCT01541215|532265441|FG000|Follow up 1 (Weeks 53-104)|Withdrawal by Subject|1|||
147576314|NCT01541215|532265442|FG001|Follow up 1 (Weeks 53-104)|Withdrawal by Subject|0|||
147576315|NCT02316223|532265453|FG000|Overall Study|Lack of Efficacy|0|||
147576316|NCT02316223|532265454|FG001|Overall Study|Lack of Efficacy|1|||
147576317|NCT02316223|532265455|FG002|Overall Study|Lack of Efficacy|1|||
147576318|NCT02316223|532265453|FG000|Overall Study|Lost to Follow-up|27|||
147576319|NCT02316223|532265454|FG001|Overall Study|Lost to Follow-up|34|||
147576320|NCT02316223|532265455|FG002|Overall Study|Lost to Follow-up|36|||
147576321|NCT02316223|532265453|FG000|Overall Study|COPD Diagnosis|3|||
147576322|NCT02316223|532265454|FG001|Overall Study|COPD Diagnosis|2|||
147576323|NCT02316223|532265455|FG002|Overall Study|COPD Diagnosis|3|||
147576324|NCT02316223|532265453|FG000|Overall Study|Reside outside study area|1|||
147576325|NCT02316223|532265454|FG001|Overall Study|Reside outside study area|1|||
147576326|NCT02316223|532265455|FG002|Overall Study|Reside outside study area|1|||
147576327|NCT02316223|532265453|FG000|Overall Study|No asthma|2|||
147576328|NCT02316223|532265454|FG001|Overall Study|No asthma|0|||
147576329|NCT02316223|532265455|FG002|Overall Study|No asthma|0|||
147576330|NCT02316223|532265453|FG000|Overall Study|Discontinued by PI|11|||
147576331|NCT02316223|532265454|FG001|Overall Study|Discontinued by PI|19|||
147576332|NCT02316223|532265455|FG002|Overall Study|Discontinued by PI|3|||
147576333|NCT00529763|532265457|FG000|Overall Study|Adverse Event Unrelated to Study Drug|1|||
147576334|NCT00529763|532265458|FG001|Overall Study|Adverse Event Unrelated to Study Drug|5|||
147576335|NCT00529763|532265459|FG002|Overall Study|Adverse Event Unrelated to Study Drug|3|||
147576336|NCT00529763|532265457|FG000|Overall Study|Death|1|||
147576337|NCT00529763|532265458|FG001|Overall Study|Death|1|||
147150232|NCT03745638|530710656|FG000|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
147150233|NCT03745638|530710657|FG001|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
147150234|NCT03745638|530710658|FG002|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
147576338|NCT00529763|532265459|FG002|Overall Study|Death|1|||
147653003|NCT00359294|532551895|FG003|Overall Study|Progressive disease|3|||
147150235|NCT03745638|530710659|FG003|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
147576339|NCT00529763|532265457|FG000|Overall Study|Disease Progression|10|||
147576340|NCT00529763|532265458|FG001|Overall Study|Disease Progression|16|||
147576341|NCT00529763|532265459|FG002|Overall Study|Disease Progression|11|||
147576342|NCT00529763|532265457|FG000|Overall Study|Lost to Follow-up|1|||
147576343|NCT00529763|532265458|FG001|Overall Study|Lost to Follow-up|2|||
147576344|NCT00529763|532265459|FG002|Overall Study|Lost to Follow-up|3|||
147576345|NCT00529763|532265457|FG000|Overall Study|Stem Cell Transplant|0|||
147576346|NCT00529763|532265458|FG001|Overall Study|Stem Cell Transplant|3|||
147653004|NCT00359294|532551896|FG004|Overall Study|Progressive disease|2|||
147653005|NCT00359294|532551892|FG000|Overall Study|Withdrawal by Subject|0|||
147150236|NCT03745638|530710660|FG004|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|1|||
147150237|NCT03745638|530710661|FG005|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|3|||
147150238|NCT03745638|530710662|FG006|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
147150239|NCT03745638|530710656|FG000|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
147150240|NCT03745638|530710657|FG001|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
147150241|NCT03745638|530710658|FG002|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
147150242|NCT03745638|530710659|FG003|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
147150243|NCT03745638|530710660|FG004|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
147150244|NCT03745638|530710661|FG005|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|1|||
147150245|NCT03745638|530710662|FG006|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
147150246|NCT03745638|530710656|FG000|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
147150247|NCT03745638|530710657|FG001|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
147150248|NCT03745638|530710658|FG002|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
147150249|NCT03745638|530710659|FG003|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|7|||
147150250|NCT03745638|530710660|FG004|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|3|||
147150251|NCT03745638|530710661|FG005|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|17|||
147150252|NCT03745638|530710662|FG006|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|21|||
147150253|NCT03745638|530710656|FG000|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0|||
147150254|NCT03745638|530710657|FG001|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0|||
147150255|NCT03745638|530710658|FG002|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0|||
147150256|NCT03745638|530710659|FG003|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0|||
147150257|NCT03745638|530710660|FG004|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|0|||
147150258|NCT03745638|530710661|FG005|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|4|||
147150259|NCT03745638|530710662|FG006|Long-Term Safety Period (Weeks 8 to 52)|Reason Not Specified|3|||
147150260|NCT03098433|530710663|FG000|Overall Study|Withdrawal by Subject|10|||
147150261|NCT03604172|530710665|FG000|Overall Study|Lost to Follow-up|1|||
147150262|NCT03604172|530710666|FG001|Overall Study|Lost to Follow-up|2|||
147150263|NCT02676895|530710667|FG000|Overall Study|Administrative reason|1|||
147150264|NCT02676895|530710668|FG001|Overall Study|Administrative reason|0|||
147150265|NCT02676895|530710669|FG002|Overall Study|Administrative reason|0|||
147150266|NCT02676895|530710667|FG000|Overall Study|Protocol Violation|1|||
147150267|NCT02676895|530710668|FG001|Overall Study|Protocol Violation|0|||
147150268|NCT02676895|530710669|FG002|Overall Study|Protocol Violation|0|||
147150269|NCT02676895|530710667|FG000|Overall Study|Adverse Event|0|||
147150270|NCT02676895|530710668|FG001|Overall Study|Adverse Event|3|||
147150271|NCT02676895|530710669|FG002|Overall Study|Adverse Event|1|||
147150272|NCT02676895|530710667|FG000|Overall Study|Lost to Follow-up|0|||
147150273|NCT02676895|530710668|FG001|Overall Study|Lost to Follow-up|0|||
147150274|NCT02676895|530710669|FG002|Overall Study|Lost to Follow-up|1|||
147150275|NCT02676895|530710667|FG000|Overall Study|Withdrawal by Subject|0|||
147150276|NCT02676895|530710668|FG001|Overall Study|Withdrawal by Subject|0|||
147653006|NCT00359294|532551893|FG001|Overall Study|Withdrawal by Subject|0|||
147653007|NCT00359294|532551894|FG002|Overall Study|Withdrawal by Subject|0|||
147653008|NCT00359294|532551895|FG003|Overall Study|Withdrawal by Subject|0|||
147653009|NCT00359294|532551896|FG004|Overall Study|Withdrawal by Subject|1|||
147150277|NCT02676895|530710669|FG002|Overall Study|Withdrawal by Subject|1|||
147150278|NCT00182078|530710673|FG000|Overall Study|Withdrawal by Subject|1|||
147150279|NCT00182078|530710674|FG001|Overall Study|Withdrawal by Subject|0|||
147150280|NCT00395486|530710675|FG000|Overall Study|Adverse Event|1|||
147150281|NCT00395486|530710676|FG001|Overall Study|Adverse Event|2|||
147150282|NCT00395486|530710675|FG000|Overall Study|Withdrawal by Subject|5|||
147150283|NCT00395486|530710676|FG001|Overall Study|Withdrawal by Subject|2|||
147150284|NCT00395486|530710675|FG000|Overall Study|Lost to Follow-up|0|||
147150285|NCT00395486|530710676|FG001|Overall Study|Lost to Follow-up|1|||
147150286|NCT01814046|530710680|FG000|Drug Administration|Death due to complications of RSV|1|||
147150287|NCT01814046|530710681|FG001|Drug Administration|Death due to complications of RSV|0|||
147150288|NCT01814046|530710682|FG002|Drug Administration|Death due to complications of RSV|0|||
147150289|NCT00564902|530710683|FG000|Overall Study|Withdrawal by Subject|0|||
147150290|NCT00564902|530710684|FG001|Overall Study|Withdrawal by Subject|3|||
147653010|NCT00359294|532551892|FG000|Overall Study|Not treated|0|||
147150291|NCT00564902|530710685|FG002|Overall Study|Withdrawal by Subject|4|||
147150292|NCT00564902|530710683|FG000|Overall Study|Death|1|||
147150293|NCT00564902|530710684|FG001|Overall Study|Death|1|||
147150294|NCT00564902|530710685|FG002|Overall Study|Death|0|||
147239488|NCT01433991|531049191|FG000|Treatment Phase (Combination Agent)|Adverse Event|1|||
147239489|NCT01433991|531049192|FG001|Treatment Phase (Combination Agent)|Adverse Event|0|||
147239490|NCT01433991|531049193|FG002|Treatment Phase (Combination Agent)|Adverse Event|3|||
147239491|NCT01433991|531049194|FG003|Treatment Phase (Combination Agent)|Adverse Event|1|||
147653011|NCT00359294|532551893|FG001|Overall Study|Not treated|0|||
147576347|NCT00529763|532265459|FG002|Overall Study|Stem Cell Transplant|1|||
147576348|NCT00529763|532265457|FG000|Overall Study|Study Drug Toxicity|3|||
147576349|NCT00529763|532265458|FG001|Overall Study|Study Drug Toxicity|6|||
147576350|NCT00529763|532265459|FG002|Overall Study|Study Drug Toxicity|4|||
147576351|NCT00529763|532265457|FG000|Overall Study|Participant Withdrew Consent|2|||
147576352|NCT00529763|532265458|FG001|Overall Study|Participant Withdrew Consent|3|||
147576353|NCT00529763|532265459|FG002|Overall Study|Participant Withdrew Consent|4|||
147576354|NCT00529763|532265457|FG000|Overall Study|Other reasons|2|||
147576355|NCT00529763|532265458|FG001|Overall Study|Other reasons|0|||
147576356|NCT00529763|532265459|FG002|Overall Study|Other reasons|2|||
147576357|NCT00529763|532265457|FG000|Overall Study|Participant request to discontinue treatment|1|||
147576358|NCT00529763|532265458|FG001|Overall Study|Participant request to discontinue treatment|1|||
147576359|NCT00529763|532265459|FG002|Overall Study|Participant request to discontinue treatment|3|||
147576360|NCT03669250|532265460|FG000|Overall Study|Adverse Event|0|||
147576361|NCT03669250|532265461|FG001|Overall Study|Adverse Event|0|||
147576362|NCT03669250|532265462|FG002|Overall Study|Adverse Event|0|||
147576363|NCT03669250|532265463|FG003|Overall Study|Adverse Event|0|||
147576364|NCT03669250|532265464|FG004|Overall Study|Adverse Event|1|||
147576365|NCT03669250|532265465|FG005|Overall Study|Adverse Event|0|||
147576366|NCT03669250|532265460|FG000|Overall Study|Withdrawal by Subject|0|||
147576367|NCT03669250|532265461|FG001|Overall Study|Withdrawal by Subject|1|||
147576368|NCT03669250|532265462|FG002|Overall Study|Withdrawal by Subject|0|||
147576369|NCT03669250|532265463|FG003|Overall Study|Withdrawal by Subject|1|||
147576370|NCT03669250|532265464|FG004|Overall Study|Withdrawal by Subject|0|||
147576371|NCT03669250|532265465|FG005|Overall Study|Withdrawal by Subject|0|||
147576372|NCT00828321|532265466|FG000|Washout of 42 Days|Withdrawal by Subject|2|||
147576373|NCT00828321|532265467|FG001|Washout of 42 Days|Withdrawal by Subject|0|||
147576374|NCT00828321|532265466|FG000|Second Intervention|Protocol Violation|0|||
147576375|NCT00828321|532265467|FG001|Second Intervention|Protocol Violation|1|||
147576376|NCT02997176|532265468|FG000|Overall Study|Adverse Event|0|||
147576377|NCT02997176|532265469|FG001|Overall Study|Adverse Event|0|||
147576378|NCT02997176|532265470|FG002|Overall Study|Adverse Event|0|||
147576379|NCT02997176|532265471|FG003|Overall Study|Adverse Event|8|||
147239492|NCT01433991|531049191|FG000|Treatment Phase (Combination Agent)|Lost to Follow-up|0|||
147239493|NCT01433991|531049192|FG001|Treatment Phase (Combination Agent)|Lost to Follow-up|0|||
147239494|NCT01433991|531049193|FG002|Treatment Phase (Combination Agent)|Lost to Follow-up|0|||
147239495|NCT01433991|531049194|FG003|Treatment Phase (Combination Agent)|Lost to Follow-up|1|||
147239496|NCT01433991|531049191|FG000|Treatment Phase (Combination Agent)|Participant Choice|0|||
147239497|NCT01433991|531049192|FG001|Treatment Phase (Combination Agent)|Participant Choice|0|||
147239498|NCT01433991|531049193|FG002|Treatment Phase (Combination Agent)|Participant Choice|0|||
147239499|NCT01433991|531049194|FG003|Treatment Phase (Combination Agent)|Participant Choice|1|||
147239500|NCT01433991|531049191|FG000|Treatment Phase (Combination Agent)|Clinical progression|0|||
147239501|NCT01433991|531049192|FG001|Treatment Phase (Combination Agent)|Clinical progression|1|||
147239502|NCT01433991|531049193|FG002|Treatment Phase (Combination Agent)|Clinical progression|2|||
147239503|NCT01433991|531049194|FG003|Treatment Phase (Combination Agent)|Clinical progression|3|||
147239504|NCT01433991|531049191|FG000|Treatment Phase (Combination Agent)|Progressive disease|1|||
147239505|NCT01433991|531049192|FG001|Treatment Phase (Combination Agent)|Progressive disease|0|||
147239506|NCT01433991|531049193|FG002|Treatment Phase (Combination Agent)|Progressive disease|0|||
147239507|NCT01433991|531049194|FG003|Treatment Phase (Combination Agent)|Progressive disease|0|||
147239508|NCT01433991|531049191|FG000|Treatment Phase (Combination Agent)|Terminated by sponsor|0|||
147239509|NCT01433991|531049192|FG001|Treatment Phase (Combination Agent)|Terminated by sponsor|0|||
147239510|NCT01433991|531049193|FG002|Treatment Phase (Combination Agent)|Terminated by sponsor|1|||
147239511|NCT01433991|531049194|FG003|Treatment Phase (Combination Agent)|Terminated by sponsor|0|||
147239512|NCT00787891|531049197|FG000|Short-term Double-blind Phase (Part 1)|Adverse Event|1|||
147239513|NCT00787891|531049198|FG001|Short-term Double-blind Phase (Part 1)|Adverse Event|2|||
147239514|NCT00787891|531049197|FG000|Short-term Double-blind Phase (Part 1)|Lost to Follow-up|2|||
147239515|NCT00787891|531049198|FG001|Short-term Double-blind Phase (Part 1)|Lost to Follow-up|2|||
147239516|NCT00787891|531049197|FG000|Short-term Double-blind Phase (Part 1)|Protocol Violation|0|||
147239517|NCT00787891|531049198|FG001|Short-term Double-blind Phase (Part 1)|Protocol Violation|1|||
147239518|NCT00787891|531049197|FG000|Short-term Double-blind Phase (Part 1)|Physician Decision|1|||
147321063|NCT04955626|531338450|FG030|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
147576380|NCT02997176|532265468|FG000|Overall Study|Progressive Disease|1|||
147576381|NCT02997176|532265469|FG001|Overall Study|Progressive Disease|0|||
147576382|NCT02997176|532265470|FG002|Overall Study|Progressive Disease|1|||
147576383|NCT02997176|532265471|FG003|Overall Study|Progressive Disease|1|||
147576384|NCT02997176|532265468|FG000|Overall Study|Death|0|||
147239519|NCT00787891|531049198|FG001|Short-term Double-blind Phase (Part 1)|Physician Decision|0|||
147576385|NCT02997176|532265469|FG001|Overall Study|Death|0|||
147576386|NCT02997176|532265470|FG002|Overall Study|Death|1|||
147576387|NCT02997176|532265471|FG003|Overall Study|Death|1|||
147576388|NCT02997176|532265468|FG000|Overall Study|Withdrawal by Subject|0|||
147576389|NCT02997176|532265469|FG001|Overall Study|Withdrawal by Subject|2|||
147446012|NCT00361270|531797536|FG002|Overall Study|Death|0|||
147446013|NCT00361270|531797537|FG003|Overall Study|Death|2|||
147446014|NCT00361270|531797534|FG000|Overall Study|Lost to Follow-up|4|||
147446015|NCT00361270|531797535|FG001|Overall Study|Lost to Follow-up|1|||
147446016|NCT00361270|531797536|FG002|Overall Study|Lost to Follow-up|0|||
147446017|NCT00361270|531797537|FG003|Overall Study|Lost to Follow-up|0|||
147446018|NCT00361270|531797534|FG000|Overall Study|Physician Decision|0|||
147446019|NCT00361270|531797535|FG001|Overall Study|Physician Decision|0|||
147446020|NCT00361270|531797536|FG002|Overall Study|Physician Decision|1|||
147446021|NCT00361270|531797537|FG003|Overall Study|Physician Decision|0|||
147446022|NCT00361270|531797534|FG000|Overall Study|Protocol Violation|9|||
147446023|NCT00361270|531797535|FG001|Overall Study|Protocol Violation|4|||
147446024|NCT00361270|531797536|FG002|Overall Study|Protocol Violation|5|||
147446025|NCT00361270|531797537|FG003|Overall Study|Protocol Violation|4|||
147446026|NCT00361270|531797534|FG000|Overall Study|Withdrawal by Subject|6|||
147446027|NCT00361270|531797535|FG001|Overall Study|Withdrawal by Subject|6|||
147446028|NCT00361270|531797536|FG002|Overall Study|Withdrawal by Subject|3|||
147446029|NCT00361270|531797537|FG003|Overall Study|Withdrawal by Subject|7|||
147446030|NCT00361270|531797534|FG000|Overall Study|Afraid of Hypnosis|1|||
147446031|NCT00361270|531797535|FG001|Overall Study|Afraid of Hypnosis|2|||
147446032|NCT00361270|531797536|FG002|Overall Study|Afraid of Hypnosis|0|||
147446033|NCT00361270|531797537|FG003|Overall Study|Afraid of Hypnosis|0|||
147446034|NCT00361270|531797534|FG000|Overall Study|Problems with Transportation|4|||
147446035|NCT00361270|531797535|FG001|Overall Study|Problems with Transportation|0|||
147446036|NCT00361270|531797536|FG002|Overall Study|Problems with Transportation|0|||
147446037|NCT00361270|531797537|FG003|Overall Study|Problems with Transportation|0|||
147446038|NCT00361270|531797534|FG000|Overall Study|Adverse Event|0|||
147446039|NCT00361270|531797535|FG001|Overall Study|Adverse Event|1|||
147446040|NCT00361270|531797536|FG002|Overall Study|Adverse Event|1|||
147446041|NCT00361270|531797537|FG003|Overall Study|Adverse Event|0|||
147446042|NCT02258451|531797540|FG000|Overall Study|Discontinuation all treatment due to progressive disease - radiological progression|90|||
147446043|NCT02258451|531797541|FG001|Overall Study|Discontinuation all treatment due to progressive disease - radiological progression|101|||
147446044|NCT02258451|531797540|FG000|Overall Study|Discontinuation all treatment due to progressive disease - clinical progression|7|||
147446045|NCT02258451|531797541|FG001|Overall Study|Discontinuation all treatment due to progressive disease - clinical progression|7|||
147446046|NCT02258451|531797540|FG000|Overall Study|Discontinuation all treatment due to adverse event not associated with clinical disease progression|8|||
147576390|NCT02997176|532265470|FG002|Overall Study|Withdrawal by Subject|0|||
147576391|NCT02997176|532265471|FG003|Overall Study|Withdrawal by Subject|1|||
147446047|NCT02258451|531797541|FG001|Overall Study|Discontinuation all treatment due to adverse event not associated with clinical disease progression|1|||
147446048|NCT02258451|531797540|FG000|Overall Study|Discontinuation all treatment due to adverse event associated with clinical disease progression|8|||
147446049|NCT02258451|531797541|FG001|Overall Study|Discontinuation all treatment due to adverse event associated with clinical disease progression|6|||
147150295|NCT02097719|530710689|FG000|Overall Study|Subject Withdrew Consent|1|||
147150296|NCT02097719|530710690|FG001|Overall Study|Subject Withdrew Consent|0|||
147150297|NCT02097719|530710689|FG000|Overall Study|Lost to Follow-up|0|||
147150298|NCT02097719|530710690|FG001|Overall Study|Lost to Follow-up|1|||
147150299|NCT02097719|530710689|FG000|Overall Study|Adverse Event|2|||
147150300|NCT02097719|530710690|FG001|Overall Study|Adverse Event|0|||
147150301|NCT01854775|530710693|FG000|Treatment Phase (48 Weeks)|Withdrawal by Subject|1|||
147150302|NCT01854775|530710694|FG001|Treatment Phase (48 Weeks)|Withdrawal by Subject|1|||
147150303|NCT01854775|530710695|FG002|Treatment Phase (48 Weeks)|Withdrawal by Subject|0|||
147150304|NCT01854775|530710693|FG000|Treatment Phase (48 Weeks)|Lost to Follow-up|1|||
147150305|NCT01854775|530710694|FG001|Treatment Phase (48 Weeks)|Lost to Follow-up|0|||
147150306|NCT01854775|530710695|FG002|Treatment Phase (48 Weeks)|Lost to Follow-up|0|||
147150307|NCT01854775|530710693|FG000|Treatment Phase (48 Weeks)|Still on Study up to the Data-Cut-Date|0|||
147150308|NCT01854775|530710694|FG001|Treatment Phase (48 Weeks)|Still on Study up to the Data-Cut-Date|0|||
147150309|NCT01854775|530710695|FG002|Treatment Phase (48 Weeks)|Still on Study up to the Data-Cut-Date|9|||
147150310|NCT01854775|530710693|FG000|Extension Phase|Pregnancy|3|||
147446050|NCT02258451|531797540|FG000|Overall Study|Discontinuation all treatment due to death|4|||
147446051|NCT02258451|531797541|FG001|Overall Study|Discontinuation all treatment due to death|3|||
147446052|NCT02258451|531797540|FG000|Overall Study|Discontinuation all treatment due to withdrawal by participant|21|||
147576392|NCT01630616|532265476|FG000|Overall Study|Adverse Event|0|||
147576393|NCT01630616|532265477|FG001|Overall Study|Adverse Event|0|||
147576394|NCT01630616|532265478|FG002|Overall Study|Adverse Event|0|||
147576395|NCT01630616|532265479|FG003|Overall Study|Adverse Event|1|||
147576396|NCT01630616|532265480|FG004|Overall Study|Adverse Event|0|||
147576397|NCT01630616|532265481|FG005|Overall Study|Adverse Event|0|||
147150311|NCT01854775|530710694|FG001|Extension Phase|Pregnancy|0|||
147576398|NCT01630616|532265476|FG000|Overall Study|Withdrawal by Subject|0|||
147576399|NCT01630616|532265477|FG001|Overall Study|Withdrawal by Subject|0|||
147576400|NCT01630616|532265478|FG002|Overall Study|Withdrawal by Subject|0|||
147576401|NCT01630616|532265479|FG003|Overall Study|Withdrawal by Subject|2|||
147150312|NCT01854775|530710695|FG002|Extension Phase|Pregnancy|0|||
147576402|NCT01630616|532265480|FG004|Overall Study|Withdrawal by Subject|0|||
147150313|NCT01854775|530710693|FG000|Extension Phase|Investigator's Discretion|1|||
147150314|NCT01854775|530710694|FG001|Extension Phase|Investigator's Discretion|0|||
147150315|NCT01854775|530710695|FG002|Extension Phase|Investigator's Discretion|0|||
147150316|NCT01854775|530710693|FG000|Extension Phase|Non-Compliance with Study Drug|1|||
147150317|NCT01854775|530710694|FG001|Extension Phase|Non-Compliance with Study Drug|0|||
147150318|NCT01854775|530710695|FG002|Extension Phase|Non-Compliance with Study Drug|0|||
147150319|NCT01854775|530710693|FG000|Extension Phase|Lost to Follow-up|2|||
147150320|NCT01854775|530710694|FG001|Extension Phase|Lost to Follow-up|0|||
147150321|NCT01854775|530710695|FG002|Extension Phase|Lost to Follow-up|0|||
147150322|NCT01854775|530710693|FG000|Extension Phase|Still on Study|32|||
147150323|NCT01854775|530710694|FG001|Extension Phase|Still on Study|47|||
147150324|NCT01854775|530710695|FG002|Extension Phase|Still on Study|18|||
147150325|NCT00984594|530710697|FG000|Overall Study|Lost to Follow-up|1|||
147150326|NCT00984594|530710698|FG001|Overall Study|Lost to Follow-up|0|||
147150327|NCT00984594|530710697|FG000|Overall Study|Withdrawal by Subject|0|||
147150328|NCT00984594|530710698|FG001|Overall Study|Withdrawal by Subject|1|||
147150329|NCT00875485|530712513|FG000|Challenge Dose Epoch|Pregnancy|1|||
147150330|NCT00875485|530712514|FG001|Challenge Dose Epoch|Pregnancy|0|||
147150331|NCT01271010|530712515|FG000|Overall Study|Reason not specified|11|||
147150332|NCT01271010|530712515|FG000|Overall Study|Start of new CLL therapy|1|||
147150333|NCT01271010|530712515|FG000|Overall Study|Protocol Violation|1|||
147150334|NCT01271010|530712515|FG000|Overall Study|Death|2|||
147150335|NCT01271010|530712515|FG000|Overall Study|Progression and relapse of disease|1|||
147150336|NCT01271010|530712515|FG000|Overall Study|Withdrawal by Subject|18|||
147150337|NCT01271010|530712515|FG000|Overall Study|Disease progression|27|||
147150338|NCT01631747|530712516|FG000|Randomization Through End of Pregnancy|Lost to Follow-up|1|||
147150339|NCT01631747|530712517|FG001|Randomization Through End of Pregnancy|Lost to Follow-up|0|||
147150340|NCT01631747|530712516|FG000|Live Birth|Pregnancy Termination|1|||
147150341|NCT01631747|530712517|FG001|Live Birth|Pregnancy Termination|0|||
147150342|NCT01631747|530712516|FG000|Live Birth|MIscarriage|2|||
147150343|NCT01631747|530712517|FG001|Live Birth|MIscarriage|0|||
147150344|NCT01631747|530712516|FG000|Live Birth|Stillbirth|1|||
147239520|NCT00787891|531049197|FG000|Short-term Double-blind Phase (Part 1)|Withdrawal by Subject|6|||
147239521|NCT00787891|531049198|FG001|Short-term Double-blind Phase (Part 1)|Withdrawal by Subject|2|||
147239522|NCT00787891|531049197|FG000|Short-term Double-blind Phase (Part 1)|Other|0|||
147239523|NCT00787891|531049198|FG001|Short-term Double-blind Phase (Part 1)|Other|2|||
147239524|NCT00787891|531049197|FG000|Maintenance Double-blind Phase (Part 2)|Adverse Event|0|||
147239525|NCT00787891|531049198|FG001|Maintenance Double-blind Phase (Part 2)|Adverse Event|1|||
147239526|NCT00787891|531049197|FG000|Maintenance Double-blind Phase (Part 2)|Non-Compliance With Study Drug|1|||
147239527|NCT00787891|531049198|FG001|Maintenance Double-blind Phase (Part 2)|Non-Compliance With Study Drug|1|||
147239528|NCT00787891|531049197|FG000|Maintenance Double-blind Phase (Part 2)|Withdrawal by Subject|1|||
147239529|NCT00787891|531049198|FG001|Maintenance Double-blind Phase (Part 2)|Withdrawal by Subject|3|||
147239530|NCT00787891|531049197|FG000|Maintenance Double-blind Phase (Part 2)|Other|5|||
147239531|NCT00787891|531049198|FG001|Maintenance Double-blind Phase (Part 2)|Other|2|||
147576403|NCT01630616|532265481|FG005|Overall Study|Withdrawal by Subject|0|||
147576404|NCT00691704|532265483|FG000|Induction Therapy|Disease Progression|1|||
147576405|NCT00691704|532265483|FG000|Induction Therapy|Active Hepatitis|1|||
147150345|NCT01631747|530712517|FG001|Live Birth|Stillbirth|1|||
147150346|NCT01631747|530712516|FG000|One Year Infant Outcomes|Patient Refused|13|||
147150347|NCT01631747|530712517|FG001|One Year Infant Outcomes|Patient Refused|9|||
147150348|NCT01456195|530712518|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
147150349|NCT01456195|530712519|FG001|Overall Study|Pretreatment Event/Adverse Event|4|||
147150350|NCT01456195|530712520|FG002|Overall Study|Pretreatment Event/Adverse Event|1|||
147150351|NCT01456195|530712518|FG000|Overall Study|Lost to Follow-up|3|||
147150352|NCT01456195|530712519|FG001|Overall Study|Lost to Follow-up|1|||
147150353|NCT01456195|530712520|FG002|Overall Study|Lost to Follow-up|3|||
147150354|NCT01456195|530712518|FG000|Overall Study|Voluntary Withdrawal|5|||
147150355|NCT01456195|530712519|FG001|Overall Study|Voluntary Withdrawal|3|||
147150356|NCT01456195|530712520|FG002|Overall Study|Voluntary Withdrawal|7|||
147150357|NCT01456195|530712518|FG000|Overall Study|Lack of Efficacy|0|||
147150358|NCT01456195|530712519|FG001|Overall Study|Lack of Efficacy|1|||
147150359|NCT01456195|530712520|FG002|Overall Study|Lack of Efficacy|0|||
147150360|NCT01456195|530712518|FG000|Overall Study|Other Reasons|2|||
147150361|NCT01456195|530712519|FG001|Overall Study|Other Reasons|1|||
147150362|NCT01456195|530712520|FG002|Overall Study|Other Reasons|3|||
147150363|NCT02109432|530712521|FG000|Overall Study|Withdrawal by Subject|1|||
147150364|NCT02908685|530712528|FG000|Part 1 OLE|Withdrawal by Subject|0|||
147150365|NCT02908685|530712529|FG001|Part 1 OLE|Withdrawal by Subject|0|||
147150366|NCT02908685|530712530|FG002|Part 1 OLE|Withdrawal by Subject|0|||
147150367|NCT02908685|530712531|FG003|Part 1 OLE|Withdrawal by Subject|0|||
147150368|NCT02908685|530712532|FG004|Part 1 OLE|Withdrawal by Subject|0|||
147239532|NCT00290888|531049201|FG000|Overall Study|Physician Decision|3|||
147239533|NCT00290888|531049202|FG001|Overall Study|Physician Decision|1|||
147576406|NCT00691704|532265483|FG000|Two Years of Maintenance Therapy|Disease Progression|8|||
147150369|NCT02908685|530712533|FG005|Part 1 OLE|Withdrawal by Subject|0|||
147150370|NCT02908685|530712534|FG006|Part 1 OLE|Withdrawal by Subject|0|||
147150371|NCT02908685|530712535|FG007|Part 1 OLE|Withdrawal by Subject|0|||
147150372|NCT02908685|530712536|FG008|Part 1 OLE|Withdrawal by Subject|0|||
147150373|NCT02908685|530712537|FG009|Part 1 OLE|Withdrawal by Subject|0|||
147150374|NCT02908685|530712538|FG010|Part 1 OLE|Withdrawal by Subject|2|||
147150375|NCT02908685|530712539|FG011|Part 1 OLE|Withdrawal by Subject|1|||
147576407|NCT00691704|532265483|FG000|Two Years of Maintenance Therapy|Physician Decision|4|||
147576408|NCT00691704|532265483|FG000|Two Years of Maintenance Therapy|Withdrawal by Subject|1|||
147576409|NCT04406194|532265484|FG000|Period 1|Withdrawal by Subject|0|||
147576410|NCT04406194|532265485|FG001|Period 1|Withdrawal by Subject|1|||
147576411|NCT04102345|532265487|FG000|Overall Study|Withdrawal by Subject|1|||
147576412|NCT04102345|532265488|FG001|Overall Study|Withdrawal by Subject|0|||
147576413|NCT00385736|532265493|FG000|Efficacy Analysis Set - Induction|Adverse Event|5|||
147576414|NCT00385736|532265494|FG001|Efficacy Analysis Set - Induction|Adverse Event|6|||
147576415|NCT00385736|532265495|FG002|Efficacy Analysis Set - Induction|Adverse Event|4|||
147576416|NCT00385736|532265493|FG000|Efficacy Analysis Set - Induction|Withdrawal by Subject|0|||
147576417|NCT00385736|532265494|FG001|Efficacy Analysis Set - Induction|Withdrawal by Subject|2|||
147576418|NCT00385736|532265495|FG002|Efficacy Analysis Set - Induction|Withdrawal by Subject|1|||
147576419|NCT00385736|532265493|FG000|Efficacy Analysis Set - Induction|Lost to Follow-up|0|||
147576420|NCT00385736|532265494|FG001|Efficacy Analysis Set - Induction|Lost to Follow-up|2|||
147576421|NCT00385736|532265495|FG002|Efficacy Analysis Set - Induction|Lost to Follow-up|0|||
147576422|NCT00385736|532265493|FG000|Efficacy Analysis Set - Induction|Lack of Efficacy|4|||
147576423|NCT00385736|532265494|FG001|Efficacy Analysis Set - Induction|Lack of Efficacy|2|||
147576424|NCT00385736|532265495|FG002|Efficacy Analysis Set - Induction|Lack of Efficacy|1|||
147576425|NCT00385736|532265493|FG000|Efficacy Analysis Set - Induction|Protocol Violation|0|||
147576426|NCT00385736|532265494|FG001|Efficacy Analysis Set - Induction|Protocol Violation|0|||
147576427|NCT00385736|532265495|FG002|Efficacy Analysis Set - Induction|Protocol Violation|2|||
147576428|NCT00385736|532265493|FG000|Efficacy Analysis Set - Induction|Other|0|||
147576429|NCT00385736|532265494|FG001|Efficacy Analysis Set - Induction|Other|0|||
147576430|NCT00385736|532265495|FG002|Efficacy Analysis Set - Induction|Other|1|||
147576431|NCT00385736|532265493|FG000|Efficacy Analysis Set - Maintenance|Adverse Event|23|||
147576432|NCT00385736|532265494|FG001|Efficacy Analysis Set - Maintenance|Adverse Event|15|||
147576433|NCT00385736|532265495|FG002|Efficacy Analysis Set - Maintenance|Adverse Event|23|||
147576434|NCT00385736|532265493|FG000|Efficacy Analysis Set - Maintenance|Withdrawal by Subject|6|||
147576435|NCT00385736|532265494|FG001|Efficacy Analysis Set - Maintenance|Withdrawal by Subject|6|||
147576436|NCT00385736|532265495|FG002|Efficacy Analysis Set - Maintenance|Withdrawal by Subject|14|||
147576437|NCT00385736|532265493|FG000|Efficacy Analysis Set - Maintenance|Lost to Follow-up|0|||
147576438|NCT00385736|532265494|FG001|Efficacy Analysis Set - Maintenance|Lost to Follow-up|2|||
147576439|NCT00385736|532265495|FG002|Efficacy Analysis Set - Maintenance|Lost to Follow-up|2|||
147576440|NCT00385736|532265493|FG000|Efficacy Analysis Set - Maintenance|Lack of Efficacy|38|||
147576441|NCT00385736|532265494|FG001|Efficacy Analysis Set - Maintenance|Lack of Efficacy|16|||
147576442|NCT00385736|532265495|FG002|Efficacy Analysis Set - Maintenance|Lack of Efficacy|31|||
147576443|NCT00385736|532265493|FG000|Efficacy Analysis Set - Maintenance|Protocol Violation|2|||
147576444|NCT00385736|532265494|FG001|Efficacy Analysis Set - Maintenance|Protocol Violation|1|||
147576445|NCT00385736|532265495|FG002|Efficacy Analysis Set - Maintenance|Protocol Violation|6|||
147576446|NCT00385736|532265493|FG000|Efficacy Analysis Set - Maintenance|Other|0|||
147576447|NCT00385736|532265494|FG001|Efficacy Analysis Set - Maintenance|Other|4|||
147150376|NCT02908685|530712540|FG012|Part 1 OLE|Withdrawal by Subject|0|||
147150377|NCT02908685|530712541|FG013|Part 1 OLE|Withdrawal by Subject|0|||
147150378|NCT02908685|530712528|FG000|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
147150379|NCT02908685|530712529|FG001|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
147150380|NCT02908685|530712530|FG002|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
147150381|NCT02908685|530712531|FG003|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
147150382|NCT02908685|530712532|FG004|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
147239534|NCT00134082|531049203|FG000|Overall Study|Adverse Event|2|||
147239535|NCT00134082|531049203|FG000|Overall Study|Death|1|||
147239536|NCT01606007|531049205|FG000|Overall Study|Reason 'Other' in the protocol|0|||
147239537|NCT01606007|531049206|FG001|Overall Study|Reason 'Other' in the protocol|1|||
147239538|NCT01606007|531049207|FG002|Overall Study|Reason 'Other' in the protocol|1|||
147239539|NCT01606007|531049205|FG000|Overall Study|Pregnancy|0|||
147150383|NCT02908685|530712533|FG005|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
147239540|NCT01606007|531049206|FG001|Overall Study|Pregnancy|1|||
147239541|NCT01606007|531049207|FG002|Overall Study|Pregnancy|1|||
147239542|NCT01606007|531049205|FG000|Overall Study|Withdrawal by Subject|8|||
147239543|NCT01606007|531049206|FG001|Overall Study|Withdrawal by Subject|6|||
147576448|NCT00385736|532265495|FG002|Efficacy Analysis Set - Maintenance|Other|4|||
147576449|NCT00385736|532265493|FG000|Safety Analysis Set|Adverse Event|23|||
147576450|NCT00385736|532265494|FG001|Safety Analysis Set|Adverse Event|15|||
147576451|NCT00385736|532265495|FG002|Safety Analysis Set|Adverse Event|23|||
147576452|NCT00385736|532265493|FG000|Safety Analysis Set|Withdrawal by Subject|6|||
147653012|NCT00359294|532551894|FG002|Overall Study|Not treated|0|||
147576453|NCT00385736|532265494|FG001|Safety Analysis Set|Withdrawal by Subject|6|||
147576454|NCT00385736|532265495|FG002|Safety Analysis Set|Withdrawal by Subject|14|||
147576455|NCT00385736|532265493|FG000|Safety Analysis Set|Lost to Follow-up|0|||
147576456|NCT00385736|532265494|FG001|Safety Analysis Set|Lost to Follow-up|2|||
147576457|NCT00385736|532265495|FG002|Safety Analysis Set|Lost to Follow-up|2|||
147150384|NCT02908685|530712534|FG006|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
147150385|NCT02908685|530712535|FG007|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
147150386|NCT02908685|530712536|FG008|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
147150387|NCT02908685|530712537|FG009|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
147150388|NCT02908685|530712538|FG010|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
147150389|NCT02908685|530712539|FG011|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|0|||
147150390|NCT02908685|530712540|FG012|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|2|||
147150391|NCT02908685|530712541|FG013|Part 2 Placebo-Controlled: Month 1-12|Changed to Spinraza|1|||
147150392|NCT02908685|530712528|FG000|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
147150393|NCT02908685|530712529|FG001|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
147150394|NCT02908685|530712530|FG002|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
147150395|NCT02908685|530712531|FG003|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
147150396|NCT02908685|530712532|FG004|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
147150397|NCT02908685|530712533|FG005|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
147150398|NCT02908685|530712534|FG006|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
147150399|NCT02908685|530712535|FG007|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
147150400|NCT02908685|530712536|FG008|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
147150401|NCT02908685|530712537|FG009|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
147150402|NCT02908685|530712538|FG010|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
147150403|NCT02908685|530712539|FG011|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
147150404|NCT02908685|530712540|FG012|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|1|||
147150405|NCT02908685|530712541|FG013|Part 2 Placebo-Controlled: Month 1-12|Changed to other treatment|0|||
147150406|NCT02908685|530712528|FG000|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
147150407|NCT02908685|530712529|FG001|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
147150408|NCT02908685|530712530|FG002|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
147150409|NCT02908685|530712531|FG003|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
147150410|NCT02908685|530712532|FG004|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
147150411|NCT02908685|530712533|FG005|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
147150412|NCT02908685|530712534|FG006|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
147150413|NCT02908685|530712535|FG007|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
147150414|NCT02908685|530712536|FG008|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
147150415|NCT02908685|530712537|FG009|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
147150416|NCT02908685|530712538|FG010|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
147150417|NCT02908685|530712539|FG011|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
147150418|NCT02908685|530712540|FG012|Part 2 OLT: Month 12-24|Withdrawal by Subject|1|||
147150419|NCT02908685|530712541|FG013|Part 2 OLT: Month 12-24|Withdrawal by Subject|0|||
147150420|NCT02908685|530712528|FG000|Part 2 OLE: > Month 24|Death|0|||
147150421|NCT02908685|530712529|FG001|Part 2 OLE: > Month 24|Death|0|||
147150422|NCT02908685|530712530|FG002|Part 2 OLE: > Month 24|Death|0|||
147150423|NCT02908685|530712531|FG003|Part 2 OLE: > Month 24|Death|0|||
147150424|NCT02908685|530712532|FG004|Part 2 OLE: > Month 24|Death|0|||
147150425|NCT02908685|530712533|FG005|Part 2 OLE: > Month 24|Death|0|||
147150426|NCT02908685|530712534|FG006|Part 2 OLE: > Month 24|Death|0|||
147150427|NCT02908685|530712535|FG007|Part 2 OLE: > Month 24|Death|0|||
147150428|NCT02908685|530712536|FG008|Part 2 OLE: > Month 24|Death|0|||
147150429|NCT02908685|530712537|FG009|Part 2 OLE: > Month 24|Death|0|||
147150430|NCT02908685|530712538|FG010|Part 2 OLE: > Month 24|Death|0|||
147150431|NCT02908685|530712539|FG011|Part 2 OLE: > Month 24|Death|0|||
147150432|NCT02908685|530712540|FG012|Part 2 OLE: > Month 24|Death|1|||
147150433|NCT02908685|530712541|FG013|Part 2 OLE: > Month 24|Death|0|||
147150434|NCT02908685|530712528|FG000|Part 2 OLE: > Month 24|Reason not specified|0|||
147150435|NCT02908685|530712529|FG001|Part 2 OLE: > Month 24|Reason not specified|0|||
147576458|NCT00385736|532265493|FG000|Safety Analysis Set|Lack of Efficacy|38|||
147576459|NCT00385736|532265494|FG001|Safety Analysis Set|Lack of Efficacy|16|||
147576460|NCT00385736|532265495|FG002|Safety Analysis Set|Lack of Efficacy|31|||
147653013|NCT00359294|532551895|FG003|Overall Study|Not treated|1|||
147150436|NCT02908685|530712530|FG002|Part 2 OLE: > Month 24|Reason not specified|0|||
147150437|NCT02908685|530712531|FG003|Part 2 OLE: > Month 24|Reason not specified|0|||
147150438|NCT02908685|530712532|FG004|Part 2 OLE: > Month 24|Reason not specified|0|||
147150439|NCT02908685|530712533|FG005|Part 2 OLE: > Month 24|Reason not specified|0|||
147576461|NCT00385736|532265493|FG000|Safety Analysis Set|Protocol Violation|2|||
147150440|NCT02908685|530712534|FG006|Part 2 OLE: > Month 24|Reason not specified|0|||
147150441|NCT02908685|530712535|FG007|Part 2 OLE: > Month 24|Reason not specified|0|||
147150442|NCT02908685|530712536|FG008|Part 2 OLE: > Month 24|Reason not specified|0|||
147653014|NCT00359294|532551896|FG004|Overall Study|Not treated|0|||
147653015|NCT00359294|532551892|FG000|Overall Study|Physician Decision|0|||
147576462|NCT00385736|532265494|FG001|Safety Analysis Set|Protocol Violation|1|||
147576463|NCT00385736|532265495|FG002|Safety Analysis Set|Protocol Violation|6|||
147576464|NCT00385736|532265493|FG000|Safety Analysis Set|Other|1|||
147576465|NCT00385736|532265494|FG001|Safety Analysis Set|Other|4|||
147576466|NCT00385736|532265495|FG002|Safety Analysis Set|Other|4|||
147576467|NCT05497557|532265496|FG000|Period 2: Omeprazole Alone|Withdrawal by Subject|0|||
147576468|NCT05497557|532265497|FG001|Period 2: Omeprazole Alone|Withdrawal by Subject|2|||
147576469|NCT05497557|532265498|FG002|Period 2: Omeprazole Alone|Withdrawal by Subject|0|||
147576470|NCT03827395|532265499|FG000|Overall Study|Lost to Follow-up|1|||
147576471|NCT03827395|532265500|FG001|Overall Study|Lost to Follow-up|0|||
147576472|NCT03827395|532265499|FG000|Overall Study|Protocol Violation|1|||
147576473|NCT03827395|532265500|FG001|Overall Study|Protocol Violation|0|||
147576474|NCT03827395|532265499|FG000|Overall Study|Became ineligible after enrollment|1|||
147576475|NCT03827395|532265500|FG001|Overall Study|Became ineligible after enrollment|2|||
147576476|NCT01923740|532265501|FG000|Overall Study|Lost to Follow-up|4|||
147576477|NCT01923740|532265502|FG001|Overall Study|Lost to Follow-up|9|||
147576478|NCT01923740|532265501|FG000|Overall Study|Withdrawal by Subject|2|||
147150443|NCT02908685|530712537|FG009|Part 2 OLE: > Month 24|Reason not specified|0|||
147150444|NCT02908685|530712538|FG010|Part 2 OLE: > Month 24|Reason not specified|0|||
147150445|NCT02908685|530712539|FG011|Part 2 OLE: > Month 24|Reason not specified|0|||
147150446|NCT02908685|530712540|FG012|Part 2 OLE: > Month 24|Reason not specified|2|||
147150447|NCT02908685|530712541|FG013|Part 2 OLE: > Month 24|Reason not specified|1|||
147150448|NCT02908685|530712528|FG000|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
147150449|NCT02908685|530712529|FG001|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
147150450|NCT02908685|530712530|FG002|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
147150451|NCT02908685|530712531|FG003|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
147150452|NCT02908685|530712532|FG004|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
147150453|NCT02908685|530712533|FG005|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
147150454|NCT02908685|530712534|FG006|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
147150455|NCT02908685|530712535|FG007|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
147150456|NCT02908685|530712536|FG008|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
147150457|NCT02908685|530712537|FG009|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
147150458|NCT02908685|530712538|FG010|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
147150459|NCT02908685|530712539|FG011|Part 2 OLE: > Month 24|Withdrawal by Subject|0|||
147150460|NCT02908685|530712540|FG012|Part 2 OLE: > Month 24|Withdrawal by Subject|10|||
147150461|NCT02908685|530712541|FG013|Part 2 OLE: > Month 24|Withdrawal by Subject|5|||
147150462|NCT02954406|530712542|FG000|Overall Study|Adverse Event|0|||
147150463|NCT02954406|530712543|FG001|Overall Study|Adverse Event|1|||
147150464|NCT02954406|530712544|FG002|Overall Study|Adverse Event|0|||
147150465|NCT02954406|530712545|FG003|Overall Study|Adverse Event|0|||
147150466|NCT02954406|530712546|FG004|Overall Study|Adverse Event|1|||
147150467|NCT02954406|530712547|FG005|Overall Study|Adverse Event|0|||
147150468|NCT02954406|530712548|FG006|Overall Study|Adverse Event|0|||
147150469|NCT02954406|530712549|FG007|Overall Study|Adverse Event|0|||
147150470|NCT02954406|530712550|FG008|Overall Study|Adverse Event|1|||
147150471|NCT02954406|530712551|FG009|Overall Study|Adverse Event|1|||
147150472|NCT02954406|530712552|FG010|Overall Study|Adverse Event|0|||
147239544|NCT01606007|531049207|FG002|Overall Study|Withdrawal by Subject|1|||
147239545|NCT01606007|531049205|FG000|Overall Study|Adverse Event|0|||
147239546|NCT01606007|531049206|FG001|Overall Study|Adverse Event|1|||
147239547|NCT01606007|531049207|FG002|Overall Study|Adverse Event|1|||
147239548|NCT01606007|531049205|FG000|Overall Study|discontinue study treatment|0|||
147239549|NCT01606007|531049206|FG001|Overall Study|discontinue study treatment|2|||
147239550|NCT01606007|531049207|FG002|Overall Study|discontinue study treatment|1|||
147239551|NCT01606007|531049205|FG000|Overall Study|Lost to Follow-up|6|||
147239552|NCT01606007|531049206|FG001|Overall Study|Lost to Follow-up|8|||
147239553|NCT01606007|531049207|FG002|Overall Study|Lost to Follow-up|5|||
147239554|NCT01606007|531049205|FG000|Overall Study|Poor/Non-compliance|1|||
147239555|NCT01606007|531049206|FG001|Overall Study|Poor/Non-compliance|0|||
147239556|NCT01606007|531049207|FG002|Overall Study|Poor/Non-compliance|0|||
147239557|NCT03758066|531049208|FG000|Overall Study|Lost to Follow-up|14|||
147239558|NCT02590003|531049210|FG000|Overall Study|Death|1|||
147239559|NCT02590003|531049211|FG001|Overall Study|Death|2|||
147239560|NCT03733470|531049212|FG000|Overall Study|PI Decision|1|||
147239561|NCT03733470|531049213|FG001|Overall Study|PI Decision|1|||
147239562|NCT01849783|531049220|FG000|Overall Study|Adverse Event|5|||
147150473|NCT02954406|530712542|FG000|Overall Study|Progressive Disease|3|||
147150474|NCT02954406|530712543|FG001|Overall Study|Progressive Disease|4|||
147239563|NCT01849783|531049220|FG000|Overall Study|Death|2|||
147239564|NCT01849783|531049220|FG000|Overall Study|Physician Decision|1|||
147150475|NCT02954406|530712544|FG002|Overall Study|Progressive Disease|3|||
147239565|NCT01849783|531049220|FG000|Overall Study|Withdrawal by Subject|1|||
147239566|NCT01849783|531049220|FG000|Overall Study|Unable to comply|2|||
147239567|NCT01849783|531049220|FG000|Overall Study|Disease progression|11|||
147576479|NCT01923740|532265502|FG001|Overall Study|Withdrawal by Subject|0|||
147576480|NCT01537887|532265503|FG000|Period 1|Physician Decision|0|||
147576481|NCT01537887|532265504|FG001|Period 1|Physician Decision|0|||
147150476|NCT02954406|530712545|FG003|Overall Study|Progressive Disease|4|||
147150477|NCT02954406|530712546|FG004|Overall Study|Progressive Disease|3|||
147150478|NCT02954406|530712547|FG005|Overall Study|Progressive Disease|3|||
147150479|NCT02954406|530712548|FG006|Overall Study|Progressive Disease|2|||
147150480|NCT02954406|530712549|FG007|Overall Study|Progressive Disease|2|||
147150481|NCT02954406|530712550|FG008|Overall Study|Progressive Disease|1|||
147150482|NCT02954406|530712551|FG009|Overall Study|Progressive Disease|1|||
147150483|NCT02954406|530712552|FG010|Overall Study|Progressive Disease|0|||
147150484|NCT02954406|530712542|FG000|Overall Study|Symptomatic Deterioration|0|||
147150485|NCT02954406|530712543|FG001|Overall Study|Symptomatic Deterioration|1|||
147150486|NCT02954406|530712544|FG002|Overall Study|Symptomatic Deterioration|0|||
147150487|NCT02954406|530712545|FG003|Overall Study|Symptomatic Deterioration|0|||
147150488|NCT02954406|530712546|FG004|Overall Study|Symptomatic Deterioration|0|||
147150489|NCT02954406|530712547|FG005|Overall Study|Symptomatic Deterioration|0|||
147150490|NCT02954406|530712548|FG006|Overall Study|Symptomatic Deterioration|0|||
147150491|NCT02954406|530712549|FG007|Overall Study|Symptomatic Deterioration|0|||
147150492|NCT02954406|530712550|FG008|Overall Study|Symptomatic Deterioration|0|||
147150493|NCT02954406|530712551|FG009|Overall Study|Symptomatic Deterioration|0|||
147150494|NCT02954406|530712552|FG010|Overall Study|Symptomatic Deterioration|0|||
147150495|NCT02954406|530712542|FG000|Overall Study|Death|0|||
147150496|NCT02954406|530712543|FG001|Overall Study|Death|0|||
147150497|NCT02954406|530712544|FG002|Overall Study|Death|0|||
147150498|NCT02954406|530712545|FG003|Overall Study|Death|0|||
147150499|NCT02954406|530712546|FG004|Overall Study|Death|1|||
147150500|NCT02954406|530712547|FG005|Overall Study|Death|0|||
147150501|NCT02954406|530712548|FG006|Overall Study|Death|0|||
147150502|NCT02954406|530712549|FG007|Overall Study|Death|0|||
147150503|NCT02954406|530712550|FG008|Overall Study|Death|1|||
147150504|NCT02954406|530712551|FG009|Overall Study|Death|1|||
147150505|NCT02954406|530712552|FG010|Overall Study|Death|0|||
147150506|NCT02954406|530712542|FG000|Overall Study|Reason Not Specified|0|||
147150507|NCT02954406|530712543|FG001|Overall Study|Reason Not Specified|0|||
147150508|NCT02954406|530712544|FG002|Overall Study|Reason Not Specified|3|||
147150509|NCT02954406|530712545|FG003|Overall Study|Reason Not Specified|2|||
147150510|NCT02954406|530712546|FG004|Overall Study|Reason Not Specified|2|||
147150511|NCT02954406|530712547|FG005|Overall Study|Reason Not Specified|0|||
147150512|NCT02954406|530712548|FG006|Overall Study|Reason Not Specified|1|||
147150513|NCT02954406|530712549|FG007|Overall Study|Reason Not Specified|0|||
147150514|NCT02954406|530712550|FG008|Overall Study|Reason Not Specified|1|||
147150515|NCT02954406|530712551|FG009|Overall Study|Reason Not Specified|0|||
147150516|NCT02954406|530712552|FG010|Overall Study|Reason Not Specified|0|||
147150517|NCT04683029|530712559|FG000|Main Study: Week 0-Week 60|Withdrawal by Subject|1|||
147150518|NCT04683029|530712560|FG001|Main Study: Week 0-Week 60|Withdrawal by Subject|0|||
147150519|NCT04683029|530712561|FG002|Main Study: Week 0-Week 60|Withdrawal by Subject|0|||
147150520|NCT04683029|530712562|FG003|Main Study: Week 0-Week 60|Withdrawal by Subject|0|||
147150521|NCT04683029|530712559|FG000|Long-term Extension(LTE):Week52-Week 112|Withdrawal by Subject|0|||
147150522|NCT04683029|530712560|FG001|Long-term Extension(LTE):Week52-Week 112|Withdrawal by Subject|0|||
147150523|NCT04683029|530712561|FG002|Long-term Extension(LTE):Week52-Week 112|Withdrawal by Subject|0|||
147150524|NCT04683029|530712562|FG003|Long-term Extension(LTE):Week52-Week 112|Withdrawal by Subject|2|||
147150525|NCT04683029|530712559|FG000|Long-term Extension(LTE):Week52-Week 112|Death|0|||
147150526|NCT04683029|530712560|FG001|Long-term Extension(LTE):Week52-Week 112|Death|0|||
147150527|NCT04683029|530712561|FG002|Long-term Extension(LTE):Week52-Week 112|Death|1|||
147150528|NCT04683029|530712562|FG003|Long-term Extension(LTE):Week52-Week 112|Death|0|||
147150529|NCT04299308|530712563|FG000|Overall Study|Withdrawal by Subject|1|||
147150530|NCT04299308|530712564|FG001|Overall Study|Withdrawal by Subject|0|||
147150531|NCT04299308|530712563|FG000|Overall Study|issue with PET image (1)|1|||
147150532|NCT04299308|530712564|FG001|Overall Study|issue with PET image (1)|0|||
147150533|NCT00814580|530712565|FG000|Overall Study|Adverse Event|6|||
147150534|NCT00814580|530712566|FG001|Overall Study|Adverse Event|15|||
147150535|NCT00814580|530712565|FG000|Overall Study|Lack of Efficacy|18|||
147150536|NCT00814580|530712566|FG001|Overall Study|Lack of Efficacy|25|||
147150537|NCT00814580|530712565|FG000|Overall Study|Protocol Violation|2|||
147150538|NCT00814580|530712566|FG001|Overall Study|Protocol Violation|0|||
147150539|NCT00814580|530712565|FG000|Overall Study|Withdrawal by Subject|2|||
147150540|NCT00814580|530712566|FG001|Overall Study|Withdrawal by Subject|2|||
147150541|NCT00814580|530712565|FG000|Overall Study|Other|1|||
147150542|NCT00814580|530712566|FG001|Overall Study|Other|3|||
147150543|NCT00814580|530712565|FG000|Overall Study|Did Not Take Drug|2|||
147150544|NCT00814580|530712566|FG001|Overall Study|Did Not Take Drug|2|||
147150545|NCT02920528|530712571|FG000|Overall Study|Incomplete Data|1|||
147150546|NCT02920528|530712572|FG001|Overall Study|Incomplete Data|1|||
147150547|NCT02920528|530712573|FG002|Overall Study|Incomplete Data|1|||
147150548|NCT02920528|530712571|FG000|Overall Study|Adverse Event|0|||
147150549|NCT02920528|530712572|FG001|Overall Study|Adverse Event|0|||
147150550|NCT02920528|530712573|FG002|Overall Study|Adverse Event|3|||
147150551|NCT02920528|530712571|FG000|Overall Study|Did not meet inclusion criteria|2|||
147150552|NCT02920528|530712572|FG001|Overall Study|Did not meet inclusion criteria|0|||
147653016|NCT00359294|532551893|FG001|Overall Study|Physician Decision|0|||
147653017|NCT00359294|532551894|FG002|Overall Study|Physician Decision|1|||
147653018|NCT00359294|532551895|FG003|Overall Study|Physician Decision|0|||
147653019|NCT00359294|532551896|FG004|Overall Study|Physician Decision|0|||
147653020|NCT04208412|532551899|FG000|Overall Study|Early discontinuation per protocol; sufficient number of subjects completed the study|8|||
147653021|NCT04208412|532551900|FG001|Overall Study|Early discontinuation per protocol; sufficient number of subjects completed the study|5|||
147653022|NCT04208412|532551899|FG000|Overall Study|Withdrawal by Subject|1|||
147653023|NCT04208412|532551900|FG001|Overall Study|Withdrawal by Subject|0|||
147576482|NCT01537887|532265505|FG002|Period 1|Physician Decision|0|||
147576483|NCT01537887|532265506|FG003|Period 1|Physician Decision|0|||
147576484|NCT01537887|532265507|FG004|Period 1|Physician Decision|1|||
147576485|NCT01537887|532265508|FG005|Period 1|Physician Decision|1|||
147576486|NCT01537887|532265503|FG000|Period 1|Did not receive treatment|0|||
147576487|NCT01537887|532265504|FG001|Period 1|Did not receive treatment|0|||
147653024|NCT04208412|532551899|FG000|Overall Study|Lost to Follow-up|0|||
147653025|NCT04208412|532551900|FG001|Overall Study|Lost to Follow-up|1|||
147653026|NCT01348100|532551905|FG000|Overall Study|Subject Withdrew Consent|0|||
147653027|NCT01348100|532551906|FG001|Overall Study|Subject Withdrew Consent|0|||
147653028|NCT01348100|532551907|FG002|Overall Study|Subject Withdrew Consent|2|||
147653029|NCT01348100|532551908|FG003|Overall Study|Subject Withdrew Consent|0|||
147653030|NCT01348100|532551909|FG004|Overall Study|Subject Withdrew Consent|1|||
147653031|NCT01348100|532551910|FG005|Overall Study|Subject Withdrew Consent|0|||
147653032|NCT01348100|532551911|FG006|Overall Study|Subject Withdrew Consent|1|||
147653033|NCT01348100|532551905|FG000|Overall Study|Protocol Deviation|0|||
147653034|NCT01348100|532551906|FG001|Overall Study|Protocol Deviation|0|||
147653035|NCT01348100|532551907|FG002|Overall Study|Protocol Deviation|0|||
147653036|NCT01348100|532551908|FG003|Overall Study|Protocol Deviation|1|||
147653037|NCT01348100|532551909|FG004|Overall Study|Protocol Deviation|0|||
147653038|NCT01348100|532551910|FG005|Overall Study|Protocol Deviation|0|||
147653039|NCT01348100|532551911|FG006|Overall Study|Protocol Deviation|0|||
147653040|NCT01348100|532551905|FG000|Overall Study|Unsatisfactory Therapeutic Effect|0|||
147653041|NCT01348100|532551906|FG001|Overall Study|Unsatisfactory Therapeutic Effect|0|||
147653042|NCT01348100|532551907|FG002|Overall Study|Unsatisfactory Therapeutic Effect|0|||
147653043|NCT01348100|532551908|FG003|Overall Study|Unsatisfactory Therapeutic Effect|0|||
147321064|NCT04955626|531338451|FG031|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
147321065|NCT04955626|531338452|FG032|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
147321066|NCT04955626|531338453|FG033|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
147321067|NCT04955626|531338454|FG034|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
147576488|NCT01537887|532265505|FG002|Period 1|Did not receive treatment|1|||
147576489|NCT01537887|532265506|FG003|Period 1|Did not receive treatment|0|||
147576490|NCT01537887|532265507|FG004|Period 1|Did not receive treatment|0|||
147576491|NCT01537887|532265508|FG005|Period 1|Did not receive treatment|0|||
147576492|NCT01537887|532265503|FG000|Period 2|Withdrawal by Subject|0|||
147576493|NCT01537887|532265504|FG001|Period 2|Withdrawal by Subject|1|||
147576494|NCT01537887|532265505|FG002|Period 2|Withdrawal by Subject|0|||
147576495|NCT01537887|532265506|FG003|Period 2|Withdrawal by Subject|0|||
147576496|NCT01537887|532265507|FG004|Period 2|Withdrawal by Subject|0|||
147576497|NCT01537887|532265508|FG005|Period 2|Withdrawal by Subject|0|||
147576498|NCT01537887|532265503|FG000|Period 3|Adverse Event|0|||
147576499|NCT01537887|532265504|FG001|Period 3|Adverse Event|0|||
147576500|NCT01537887|532265505|FG002|Period 3|Adverse Event|1|||
147576501|NCT01537887|532265506|FG003|Period 3|Adverse Event|0|||
147576502|NCT01537887|532265507|FG004|Period 3|Adverse Event|0|||
147653044|NCT01348100|532551909|FG004|Overall Study|Unsatisfactory Therapeutic Effect|0|||
147653045|NCT01348100|532551910|FG005|Overall Study|Unsatisfactory Therapeutic Effect|1|||
147321068|NCT04955626|531338455|FG035|Open-Label Period|Did not receive Open-label BNT162b2 30 mcg|0|||
147321069|NCT00003509|531338457|FG000|Overall Study|Not evaluable|5|||
147321070|NCT03658811|531338458|FG000|Overall Study|Lost to Follow-up|3|||
147321071|NCT04951479|531338459|FG000|Overall Study|Pre-existing Acute Knee Injury|1|||
147321072|NCT04060680|531338461|FG000|Overall Study|Unsuccessful implant|17|||
147321073|NCT04060680|531338462|FG001|Overall Study|Unsuccessful implant|2|||
147321074|NCT04060680|531338461|FG000|Overall Study|Adverse Event|3|||
147653046|NCT01348100|532551911|FG006|Overall Study|Unsatisfactory Therapeutic Effect|0|||
147653047|NCT01348100|532551905|FG000|Overall Study|Lost to Follow-up|0|||
147150553|NCT02920528|530712573|FG002|Overall Study|Did not meet inclusion criteria|1|||
147321075|NCT04060680|531338462|FG001|Overall Study|Adverse Event|0|||
147321076|NCT04060680|531338461|FG000|Overall Study|Death|2|||
147321077|NCT04060680|531338462|FG001|Overall Study|Death|0|||
147653048|NCT01348100|532551906|FG001|Overall Study|Lost to Follow-up|0|||
147576503|NCT01537887|532265508|FG005|Period 3|Adverse Event|0|||
147576504|NCT01537887|532265503|FG000|Period 3|Withdrawal by Subject|0|||
147576505|NCT01537887|532265504|FG001|Period 3|Withdrawal by Subject|1|||
147576506|NCT01537887|532265505|FG002|Period 3|Withdrawal by Subject|0|||
147576507|NCT01537887|532265506|FG003|Period 3|Withdrawal by Subject|0|||
147576508|NCT01537887|532265507|FG004|Period 3|Withdrawal by Subject|0|||
147576509|NCT01537887|532265508|FG005|Period 3|Withdrawal by Subject|0|||
147150554|NCT01340625|530712574|FG000|First Intervention|Adverse Event|1|||
147150555|NCT01340625|530712575|FG001|First Intervention|Adverse Event|0|||
147150556|NCT01340625|530712574|FG000|Washout Period of 28 Days|Withdrawal by Subject|1|||
147150557|NCT01340625|530712575|FG001|Washout Period of 28 Days|Withdrawal by Subject|0|||
147150558|NCT01986231|530712576|FG000|Overall Study|Adverse Event|1|||
147150559|NCT00962741|530712581|FG000|Overall Study|Failed to return|3|||
147150560|NCT00962741|530712581|FG000|Overall Study|Lost to Follow-up|2|||
147150561|NCT00962741|530712581|FG000|Overall Study|Withdrawal by Subject|1|||
147150562|NCT00962741|530712581|FG000|Overall Study|Lack of Efficacy|1|||
147150563|NCT00962741|530712581|FG000|Overall Study|drug ineffective+prohibited drug taken|1|||
147150564|NCT02003638|530712582|FG000|Overall Study|Withdrawal by Subject|1|||
147150565|NCT02003638|530712583|FG001|Overall Study|Withdrawal by Subject|0|||
147150566|NCT00654745|530712584|FG000|Overall Study|Adverse Event|12|||
147150567|NCT00654745|530712584|FG000|Overall Study|Lost to Follow-up|7|||
147150568|NCT00654745|530712584|FG000|Overall Study|Protocol Violation|11|||
147150569|NCT00654745|530712584|FG000|Overall Study|Withdrawal by Subject|10|||
147150570|NCT00654745|530712584|FG000|Overall Study|poor ABPM, noncompliance, lab MAs|3|||
147150571|NCT03249909|530712585|FG000|Overall Study|Withdrawal by Subject|3|||
147150572|NCT03249909|530712586|FG001|Overall Study|Withdrawal by Subject|0|||
147150573|NCT03249909|530712587|FG002|Overall Study|Withdrawal by Subject|0|||
147150574|NCT03249909|530712585|FG000|Overall Study|Adverse Event|3|||
147150575|NCT03249909|530712586|FG001|Overall Study|Adverse Event|0|||
147150576|NCT03249909|530712587|FG002|Overall Study|Adverse Event|0|||
147150577|NCT03249909|530712585|FG000|Overall Study|Lost to Follow-up|0|||
147150578|NCT03249909|530712586|FG001|Overall Study|Lost to Follow-up|1|||
147150579|NCT03249909|530712587|FG002|Overall Study|Lost to Follow-up|0|||
147150580|NCT00606034|530712588|FG000|Overall Study|incarceration|1|||
147150581|NCT05286658|530712590|FG000|Overall Study|Head circumference too large for MEG scanner (exclusion criterion for the study).|1|||
147150582|NCT05286658|530712590|FG000|Overall Study|Participant did not show SIS (the dependent measure), thus the hypothesis could not be assessed|1|||
147150583|NCT00935493|530712593|FG000|Overall Study|Lost to Follow-up|1|||
147150584|NCT00935493|530712594|FG001|Overall Study|Lost to Follow-up|1|||
147150585|NCT00935493|530712595|FG002|Overall Study|Lost to Follow-up|1|||
147150586|NCT00935493|530712593|FG000|Overall Study|Treatment Discontinued|0|||
147150587|NCT00935493|530712594|FG001|Overall Study|Treatment Discontinued|1|||
147150588|NCT00935493|530712595|FG002|Overall Study|Treatment Discontinued|0|||
147150589|NCT02027311|530712598|FG000|Overall Study|Protocol Violation|3|||
147150590|NCT02027311|530712599|FG001|Overall Study|Protocol Violation|2|||
147150591|NCT03928418|530712600|FG000|Overall Study|Lost to Follow-up|5|||
147150592|NCT03928418|530712601|FG001|Overall Study|Lost to Follow-up|3|||
147150593|NCT03928418|530712602|FG002|Overall Study|Lost to Follow-up|5|||
147150594|NCT03928418|530712600|FG000|Overall Study|Pilot participant - excluded from analyses|1|||
147150595|NCT03928418|530712601|FG001|Overall Study|Pilot participant - excluded from analyses|1|||
147150596|NCT03928418|530712602|FG002|Overall Study|Pilot participant - excluded from analyses|1|||
147150597|NCT03423238|530712605|FG000|Overall Study|Lost to Follow-up|1|||
147150598|NCT03423238|530712606|FG001|Overall Study|Lost to Follow-up|0|||
147150599|NCT03423238|530712605|FG000|Overall Study|Withdrawal by Subject|1|||
147150600|NCT03423238|530712606|FG001|Overall Study|Withdrawal by Subject|0|||
147150601|NCT04470050|530712608|FG000|Double-blind Treatment Phase|Adverse Event|0|||
147150602|NCT04470050|530712609|FG001|Double-blind Treatment Phase|Adverse Event|0|||
147150603|NCT04470050|530712610|FG002|Double-blind Treatment Phase|Adverse Event|0|||
147150604|NCT04470050|530712611|FG003|Double-blind Treatment Phase|Adverse Event|1|||
147150605|NCT04470050|530712612|FG004|Double-blind Treatment Phase|Adverse Event|0|||
147150606|NCT04470050|530712613|FG005|Double-blind Treatment Phase|Adverse Event|0|||
147150607|NCT04470050|530712614|FG006|Double-blind Treatment Phase|Adverse Event|0|||
147150608|NCT04470050|530712608|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
147150609|NCT04470050|530712609|FG001|Double-blind Treatment Phase|Lost to Follow-up|0|||
147150610|NCT04470050|530712610|FG002|Double-blind Treatment Phase|Lost to Follow-up|0|||
147239568|NCT03095612|531049224|FG000|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|0|||
147239569|NCT03095612|531049225|FG001|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|4|||
147239570|NCT03095612|531049226|FG002|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|0|||
147239571|NCT03095612|531049227|FG003|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|0|||
147239572|NCT03095612|531049228|FG004|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|0|||
147239573|NCT03095612|531049229|FG005|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|0|||
147239574|NCT03095612|531049230|FG006|Dose Escalation:Selinexor 80mg+Docetaxel|Dose not tolerated by the subject|0|||
147150611|NCT04470050|530712611|FG003|Double-blind Treatment Phase|Lost to Follow-up|0|||
147150612|NCT04470050|530712612|FG004|Double-blind Treatment Phase|Lost to Follow-up|1|||
147150613|NCT04470050|530712613|FG005|Double-blind Treatment Phase|Lost to Follow-up|0|||
147150614|NCT04470050|530712614|FG006|Double-blind Treatment Phase|Lost to Follow-up|0|||
147150615|NCT04470050|530712608|FG000|Double-blind Treatment Phase|Withdrawal by Subject|10|||
147150616|NCT04470050|530712609|FG001|Double-blind Treatment Phase|Withdrawal by Subject|12|||
147150617|NCT04470050|530712610|FG002|Double-blind Treatment Phase|Withdrawal by Subject|15|||
147150618|NCT04470050|530712611|FG003|Double-blind Treatment Phase|Withdrawal by Subject|11|||
147150619|NCT04470050|530712612|FG004|Double-blind Treatment Phase|Withdrawal by Subject|15|||
147150620|NCT04470050|530712613|FG005|Double-blind Treatment Phase|Withdrawal by Subject|9|||
147150621|NCT04470050|530712614|FG006|Double-blind Treatment Phase|Withdrawal by Subject|19|||
147150622|NCT03640507|530712615|FG000|Overall Study|Withdrawal by Subject|0|||
147150623|NCT03640507|530712616|FG001|Overall Study|Withdrawal by Subject|0|||
147150624|NCT03640507|530712617|FG002|Overall Study|Withdrawal by Subject|1|||
147150625|NCT03028129|530712620|FG000|Overall Study|Adverse Event|13|||
147150626|NCT03028129|530712621|FG001|Overall Study|Adverse Event|2|||
147150627|NCT03028129|530712620|FG000|Overall Study|Lost to Follow-up|50|||
147150628|NCT03028129|530712621|FG001|Overall Study|Lost to Follow-up|38|||
147576510|NCT04723693|532265509|FG000|Overall Study|Withdrawal by Subject|2|||
147576511|NCT00294047|532265510|FG000|Month 48|Adverse Event|28|||
147576512|NCT00294047|532265511|FG001|Month 48|Adverse Event|13|||
147576513|NCT00294047|532265510|FG000|Month 48|Protocol Violation|4|||
147576514|NCT00294047|532265511|FG001|Month 48|Protocol Violation|4|||
147576515|NCT00294047|532265510|FG000|Month 48|Withdrawal by Subject|111|||
147576516|NCT00294047|532265511|FG001|Month 48|Withdrawal by Subject|115|||
147576517|NCT00294047|532265510|FG000|Month 48|Lost to Follow-up|272|||
147576518|NCT00294047|532265511|FG001|Month 48|Lost to Follow-up|287|||
147576519|NCT00294047|532265510|FG000|Month 48|Other|10|||
147576520|NCT00294047|532265511|FG001|Month 48|Other|14|||
147576521|NCT00294047|532265510|FG000|Month 84|Adverse Event|4|||
147576522|NCT00294047|532265511|FG001|Month 84|Adverse Event|2|||
147576523|NCT00294047|532265510|FG000|Month 84|Protocol Violation|1|||
147576524|NCT00294047|532265511|FG001|Month 84|Protocol Violation|1|||
147576525|NCT00294047|532265510|FG000|Month 84|Withdrawal by Subject|33|||
147576526|NCT00294047|532265511|FG001|Month 84|Withdrawal by Subject|31|||
147576527|NCT00294047|532265510|FG000|Month 84|Lost to Follow-up|187|||
147576528|NCT00294047|532265511|FG001|Month 84|Lost to Follow-up|190|||
147150629|NCT03028129|530712620|FG000|Overall Study|Physician Decision|0|||
147150630|NCT03028129|530712621|FG001|Overall Study|Physician Decision|1|||
147150631|NCT03028129|530712620|FG000|Overall Study|Protocol Violation|1|||
147150632|NCT03028129|530712621|FG001|Overall Study|Protocol Violation|1|||
147150633|NCT03028129|530712620|FG000|Overall Study|Withdrawal by Subject|62|||
147150634|NCT03028129|530712621|FG001|Overall Study|Withdrawal by Subject|45|||
147150635|NCT01076205|530712622|FG000|Overall Study|Adverse Drug Reaction|299|||
147150636|NCT01076205|530712622|FG000|Overall Study|Lack of Effectiveness|1423|||
147150637|NCT01076205|530712622|FG000|Overall Study|Other Reason|1075|||
147150638|NCT01076205|530712622|FG000|Overall Study|Unknown Reason|71|||
147150639|NCT01076205|530712622|FG000|Overall Study|Lost to Follow-up|3151|||
147150640|NCT02993822|530712628|FG000|Overall Study|Lack of Efficacy|1|||
147150641|NCT02993822|530712629|FG001|Overall Study|Lack of Efficacy|1|||
147150642|NCT02993822|530712630|FG002|Overall Study|Lack of Efficacy|0|||
147150643|NCT02993822|530712631|FG003|Overall Study|Lack of Efficacy|0|||
147150644|NCT02993822|530712628|FG000|Overall Study|Protocol Violation|1|||
147150645|NCT02993822|530712629|FG001|Overall Study|Protocol Violation|0|||
147150646|NCT02993822|530712630|FG002|Overall Study|Protocol Violation|0|||
147150647|NCT02993822|530712631|FG003|Overall Study|Protocol Violation|0|||
147150648|NCT02993822|530712628|FG000|Overall Study|Unable to attend follow-up due to illness|0|||
147150649|NCT02993822|530712629|FG001|Overall Study|Unable to attend follow-up due to illness|0|||
147150650|NCT02993822|530712630|FG002|Overall Study|Unable to attend follow-up due to illness|0|||
147150651|NCT02993822|530712631|FG003|Overall Study|Unable to attend follow-up due to illness|1|||
147150652|NCT02993822|530712628|FG000|Overall Study|Adverse Event|3|||
147150653|NCT02993822|530712629|FG001|Overall Study|Adverse Event|1|||
147576529|NCT00294047|532265510|FG000|Month 84|Absent Cervix|2|||
147576530|NCT00294047|532265511|FG001|Month 84|Absent Cervix|0|||
147576531|NCT00294047|532265510|FG000|Month 84|Work related reasons|4|||
147576532|NCT00294047|532265511|FG001|Month 84|Work related reasons|2|||
147576533|NCT00294047|532265510|FG000|Month 84|Center closed, subject did not transfer|1|||
147576534|NCT00294047|532265511|FG001|Month 84|Center closed, subject did not transfer|0|||
147576535|NCT00294047|532265510|FG000|Month 84|Family problems|2|||
147576536|NCT00294047|532265511|FG001|Month 84|Family problems|2|||
147576537|NCT00294047|532265510|FG000|Month 84|Lack of time|3|||
147150654|NCT02993822|530712630|FG002|Overall Study|Adverse Event|7|||
147150655|NCT02993822|530712631|FG003|Overall Study|Adverse Event|0|||
147150656|NCT02993822|530712628|FG000|Overall Study|Withdrawal by Subject|4|||
147150657|NCT02993822|530712629|FG001|Overall Study|Withdrawal by Subject|2|||
147150658|NCT02993822|530712630|FG002|Overall Study|Withdrawal by Subject|2|||
147150659|NCT02993822|530712631|FG003|Overall Study|Withdrawal by Subject|3|||
147576538|NCT00294047|532265511|FG001|Month 84|Lack of time|1|||
147576539|NCT00294047|532265510|FG000|Month 84|Personal reason|2|||
147150660|NCT02993822|530712628|FG000|Overall Study|Lost to Follow-up|1|||
147150661|NCT02993822|530712629|FG001|Overall Study|Lost to Follow-up|0|||
147576540|NCT00294047|532265511|FG001|Month 84|Personal reason|4|||
147576541|NCT00294047|532265510|FG000|Month 84|Subject does not want male physician|1|||
147576542|NCT00294047|532265511|FG001|Month 84|Subject does not want male physician|0|||
147576543|NCT00294047|532265510|FG000|Month 84|Transport reimbursement delayed|0|||
147576544|NCT00294047|532265511|FG001|Month 84|Transport reimbursement delayed|1|||
147150662|NCT02993822|530712630|FG002|Overall Study|Lost to Follow-up|1|||
147150663|NCT02993822|530712631|FG003|Overall Study|Lost to Follow-up|0|||
147150664|NCT01939977|530712632|FG000|Overall Study|Adverse Event|4|||
147150665|NCT01939977|530712633|FG001|Overall Study|Adverse Event|3|||
147150666|NCT01939977|530712632|FG000|Overall Study|Lack of Efficacy|3|||
147150667|NCT01939977|530712633|FG001|Overall Study|Lack of Efficacy|0|||
147150668|NCT01939977|530712632|FG000|Overall Study|Physician Decision|1|||
147150669|NCT01939977|530712633|FG001|Overall Study|Physician Decision|1|||
147150670|NCT01939977|530712632|FG000|Overall Study|Withdrawal by Subject|0|||
147150671|NCT01939977|530712633|FG001|Overall Study|Withdrawal by Subject|2|||
147150672|NCT01939977|530712632|FG000|Overall Study|Did not meet inclusion criteria|1|||
147150673|NCT01939977|530712633|FG001|Overall Study|Did not meet inclusion criteria|0|||
147150674|NCT01939977|530712632|FG000|Overall Study|Did not receive study medication|0|||
147150675|NCT01939977|530712633|FG001|Overall Study|Did not receive study medication|1|||
147150676|NCT01696981|530712644|FG000|Overall Study|Cancer Before Rand. (Colo. Screening)|0|||
147150677|NCT01696981|530712645|FG001|Overall Study|Cancer Before Rand. (Colo. Screening)|20|||
147150678|NCT01696981|530712644|FG000|Overall Study|Died Before Randomization|3|||
147150679|NCT01696981|530712645|FG001|Overall Study|Died Before Randomization|8|||
147150680|NCT01696981|530712644|FG000|Overall Study|Died Before ASU (Control)|278|||
147576545|NCT00294047|532265510|FG000|Month 84|Unable to reach study site|1|||
147576546|NCT00294047|532265511|FG001|Month 84|Unable to reach study site|0|||
147576547|NCT00294047|532265510|FG000|Month 84|Under investigation locally|1|||
147576548|NCT00294047|532265511|FG001|Month 84|Under investigation locally|0|||
147576549|NCT00294047|532265510|FG000|Month 84|Visit missed|0|||
147576550|NCT00294047|532265511|FG001|Month 84|Visit missed|1|||
147576551|NCT00294047|532265510|FG000|Month 84|No consent for Month 84 Follow-up|731|||
147576552|NCT00294047|532265511|FG001|Month 84|No consent for Month 84 Follow-up|754|||
147576553|NCT02157974|532265512|FG000|Overall Study|Withdrawal by Subject|0|||
147576554|NCT02157974|532265513|FG001|Overall Study|Withdrawal by Subject|1|||
147576555|NCT02157974|532265514|FG002|Overall Study|Withdrawal by Subject|0|||
147576556|NCT02157974|532265515|FG003|Overall Study|Withdrawal by Subject|0|||
147576557|NCT02157974|532265516|FG004|Overall Study|Withdrawal by Subject|0|||
147576558|NCT02157974|532265512|FG000|Overall Study|Screen Failure|0|||
147576559|NCT02157974|532265513|FG001|Overall Study|Screen Failure|1|||
147576560|NCT02157974|532265514|FG002|Overall Study|Screen Failure|0|||
147576561|NCT02157974|532265515|FG003|Overall Study|Screen Failure|0|||
147576562|NCT02157974|532265516|FG004|Overall Study|Screen Failure|0|||
147576563|NCT02157974|532265512|FG000|Overall Study|Nurse not able to place IV so unable to complete visit|0|||
147576564|NCT02157974|532265513|FG001|Overall Study|Nurse not able to place IV so unable to complete visit|1|||
147150681|NCT01696981|530712645|FG001|Overall Study|Died Before ASU (Control)|0|||
147150682|NCT01696981|530712644|FG000|Overall Study|Refused ASU (Control)|920|||
147150683|NCT01696981|530712645|FG001|Overall Study|Refused ASU (Control)|0|||
147150684|NCT01696981|530712644|FG000|Overall Study|Refused Screen (Colorectal Screening)|0|||
147239575|NCT04447794|531049233|FG000|Overall Study|Lost to Follow-up|2|||
147239576|NCT04447794|531049234|FG001|Overall Study|Lost to Follow-up|3|||
147239577|NCT04447794|531049235|FG002|Overall Study|Lost to Follow-up|8|||
147239578|NCT04447794|531049233|FG000|Overall Study|Withdrawal by Subject|1|||
147239579|NCT04447794|531049234|FG001|Overall Study|Withdrawal by Subject|1|||
147239580|NCT04447794|531049235|FG002|Overall Study|Withdrawal by Subject|0|||
147239581|NCT04203498|531049238|FG000|Overall Study|Decision by the investigator, GW, or authority|0|||
147239582|NCT04203498|531049239|FG001|Overall Study|Decision by the investigator, GW, or authority|1|||
147239583|NCT04203498|531049238|FG000|Overall Study|Withdrawal of patient consent|7|||
147239584|NCT04203498|531049239|FG001|Overall Study|Withdrawal of patient consent|2|||
147239585|NCT04203498|531049238|FG000|Overall Study|Adverse Event|4|||
147239586|NCT04203498|531049239|FG001|Overall Study|Adverse Event|1|||
147239587|NCT04203498|531049238|FG000|Overall Study|Drug not dispensed due to endpoint error|1|||
147239588|NCT04203498|531049239|FG001|Overall Study|Drug not dispensed due to endpoint error|0|||
147239589|NCT04203498|531049238|FG000|Overall Study|Did not receive IMP|2|||
147239590|NCT04203498|531049239|FG001|Overall Study|Did not receive IMP|0|||
147239591|NCT01235689|531049241|FG000|Overall Study|Adverse Event|12|||
147239592|NCT01235689|531049242|FG001|Overall Study|Adverse Event|16|||
147239593|NCT01235689|531049241|FG000|Overall Study|Lack of Efficacy|12|||
147239594|NCT01235689|531049242|FG001|Overall Study|Lack of Efficacy|5|||
147239595|NCT01235689|531049241|FG000|Overall Study|Withdrawal by Subject|3|||
147239596|NCT01235689|531049242|FG001|Overall Study|Withdrawal by Subject|4|||
147239597|NCT01235689|531049241|FG000|Overall Study|Lost to Follow-up|1|||
147239598|NCT01235689|531049242|FG001|Overall Study|Lost to Follow-up|2|||
147239599|NCT01235689|531049241|FG000|Overall Study|Miscellaneous|1|||
147239600|NCT01235689|531049242|FG001|Overall Study|Miscellaneous|5|||
147239601|NCT03988088|531049247|FG000|Single-Dose Pharmacokinetic Study|Adverse Event|0|||
147239602|NCT03988088|531049248|FG001|Single-Dose Pharmacokinetic Study|Adverse Event|1|||
147239603|NCT03988088|531049249|FG002|Single-Dose Pharmacokinetic Study|Adverse Event|0|||
147239604|NCT03988088|531049250|FG003|Single-Dose Pharmacokinetic Study|Adverse Event|0|||
147239605|NCT03988088|531049247|FG000|Open-Label Addendum|Lost to Follow-up|0|||
147150685|NCT01696981|530712645|FG001|Overall Study|Refused Screen (Colorectal Screening)|10346|||
147150686|NCT00851890|530712648|FG000|Overall Study|Lost to Follow-up|0|||
147150687|NCT00851890|530712649|FG001|Overall Study|Lost to Follow-up|1|||
147150688|NCT00851890|530712650|FG002|Overall Study|Lost to Follow-up|0|||
147150689|NCT00851890|530712651|FG003|Overall Study|Lost to Follow-up|1|||
147150690|NCT03135431|530712652|FG000|Overall Study|Study Surgeon not available|2|||
147150691|NCT03135431|530712653|FG001|Overall Study|Study Surgeon not available|0|||
147150692|NCT02597452|530712655|FG000|Overall Study|testing incomplete|30|||
147150693|NCT03122145|530712656|FG000|Overall Study|Concurrent respiratory disease|3|||
147150694|NCT03122145|530712657|FG001|Overall Study|Concurrent respiratory disease|0|||
147150695|NCT00281099|530712658|FG000|Overall Study|Death|46|||
147150696|NCT00281099|530712659|FG001|Overall Study|Death|57|||
147150697|NCT00281099|530712658|FG000|Overall Study|Lost to Follow-up|10|||
147150698|NCT00281099|530712659|FG001|Overall Study|Lost to Follow-up|19|||
147150699|NCT00281099|530712658|FG000|Overall Study|Withdrawal by Subject|65|||
147150700|NCT00281099|530712659|FG001|Overall Study|Withdrawal by Subject|70|||
147150701|NCT00281099|530712658|FG000|Overall Study|Physician Decision|79|||
147150702|NCT00281099|530712659|FG001|Overall Study|Physician Decision|72|||
147150703|NCT00281099|530712658|FG000|Overall Study|Heart Transplant/Device Exit/Changeout|5|||
147150704|NCT00281099|530712659|FG001|Overall Study|Heart Transplant/Device Exit/Changeout|4|||
147150705|NCT03108521|530712663|FG000|Overall Study|Lost to Follow-up|3|||
147150706|NCT03108521|530712664|FG001|Overall Study|Lost to Follow-up|0|||
147150707|NCT03108521|530712663|FG000|Overall Study|Lack of Efficacy|2|||
147150708|NCT03108521|530712664|FG001|Overall Study|Lack of Efficacy|0|||
147150709|NCT03108521|530712663|FG000|Overall Study|Physician Decision|4|||
147150710|NCT03108521|530712664|FG001|Overall Study|Physician Decision|0|||
147150711|NCT03108521|530712663|FG000|Overall Study|Adverse Event|3|||
147150712|NCT03108521|530712664|FG001|Overall Study|Adverse Event|0|||
147150713|NCT06899737|530712670|FG000|Overall Study|Lost to Follow-up|19|||
147150714|NCT06899737|530712671|FG001|Overall Study|Lost to Follow-up|7|||
147150715|NCT00334737|530712673|FG000|Hospital Phase|Death|1|||
147150716|NCT00334737|530712674|FG001|Hospital Phase|Death|2|||
147150717|NCT00334737|530712675|FG002|Hospital Phase|Death|3|||
147150718|NCT00334737|530712673|FG000|Hospital Phase|Withdrawal by Subject|0|||
147150719|NCT00334737|530712674|FG001|Hospital Phase|Withdrawal by Subject|0|||
147150720|NCT00334737|530712675|FG002|Hospital Phase|Withdrawal by Subject|1|||
147150721|NCT00334737|530712673|FG000|Hospital Phase|Did not receive study drug|1|||
147150722|NCT00334737|530712674|FG001|Hospital Phase|Did not receive study drug|0|||
147150723|NCT00334737|530712675|FG002|Hospital Phase|Did not receive study drug|0|||
147150724|NCT00334737|530712673|FG000|Follow up Phase|Lost to Follow-up|5|||
147150725|NCT00334737|530712674|FG001|Follow up Phase|Lost to Follow-up|3|||
147150726|NCT00334737|530712675|FG002|Follow up Phase|Lost to Follow-up|6|||
147150727|NCT01691014|530714397|FG000|Overall Study|Premature Termination|1|||
147150728|NCT01691014|530714398|FG001|Overall Study|Premature Termination|6|||
147150729|NCT01691014|530714399|FG002|Overall Study|Premature Termination|0|||
147150730|NCT01691014|530714400|FG003|Overall Study|Premature Termination|3|||
147150731|NCT01691014|530714397|FG000|Overall Study|Other|0|||
147150732|NCT01691014|530714398|FG001|Overall Study|Other|0|||
147150733|NCT01691014|530714399|FG002|Overall Study|Other|2|||
147150734|NCT01691014|530714400|FG003|Overall Study|Other|0|||
147150735|NCT01691014|530714397|FG000|Overall Study|Withdrawal by Subject|0|||
147150736|NCT01691014|530714398|FG001|Overall Study|Withdrawal by Subject|1|||
147150737|NCT01691014|530714399|FG002|Overall Study|Withdrawal by Subject|1|||
147150738|NCT01691014|530714400|FG003|Overall Study|Withdrawal by Subject|1|||
147239606|NCT03988088|531049248|FG001|Open-Label Addendum|Lost to Follow-up|0|||
147239607|NCT03988088|531049249|FG002|Open-Label Addendum|Lost to Follow-up|1|||
147239608|NCT03988088|531049250|FG003|Open-Label Addendum|Lost to Follow-up|0|||
147239609|NCT03546062|531049251|FG000|Overall Study|Adverse Event|6|||
147239610|NCT03546062|531049252|FG001|Overall Study|Adverse Event|5|||
147239611|NCT03546062|531049253|FG002|Overall Study|Adverse Event|8|||
147239612|NCT00781274|531049254|FG000|Overall Study|Withdrawal by Subject|2|||
147576565|NCT02157974|532265514|FG002|Overall Study|Nurse not able to place IV so unable to complete visit|0|||
147576566|NCT02157974|532265515|FG003|Overall Study|Nurse not able to place IV so unable to complete visit|0|||
147576567|NCT02157974|532265516|FG004|Overall Study|Nurse not able to place IV so unable to complete visit|0|||
147150739|NCT01691014|530714397|FG000|Overall Study|Adverse Event|0|||
147150740|NCT01691014|530714398|FG001|Overall Study|Adverse Event|5|||
147150741|NCT01691014|530714399|FG002|Overall Study|Adverse Event|1|||
147239613|NCT01090492|531049255|FG000|First Intervention Period (4 Weeks)|Protocol Violation|1|||
147239614|NCT01090492|531049256|FG001|First Intervention Period (4 Weeks)|Protocol Violation|1|||
147150742|NCT01691014|530714400|FG003|Overall Study|Adverse Event|1|||
147150743|NCT01691014|530714397|FG000|Overall Study|Lack of Efficacy|2|||
147150744|NCT01691014|530714398|FG001|Overall Study|Lack of Efficacy|3|||
147150745|NCT01691014|530714399|FG002|Overall Study|Lack of Efficacy|7|||
147150746|NCT01691014|530714400|FG003|Overall Study|Lack of Efficacy|0|||
147150747|NCT03372551|530714401|FG000|First Intervention (1 Week)|Withdrawal by Subject|1|||
147150748|NCT03372551|530714402|FG001|First Intervention (1 Week)|Withdrawal by Subject|0|||
147150749|NCT00066703|530714403|FG000|Overall Study|Adverse Event|80|||
147446053|NCT02258451|531797541|FG001|Overall Study|Discontinuation all treatment due to withdrawal by participant|13|||
147150750|NCT00066703|530714404|FG001|Overall Study|Adverse Event|111|||
147150751|NCT00066703|530714403|FG000|Overall Study|Death|3|||
147150752|NCT00066703|530714404|FG001|Overall Study|Death|0|||
147150753|NCT00066703|530714403|FG000|Overall Study|Lack of Efficacy|114|||
147150754|NCT00066703|530714404|FG001|Overall Study|Lack of Efficacy|69|||
147150755|NCT00066703|530714403|FG000|Overall Study|Lost to Follow-up|31|||
147576568|NCT00540423|532265519|FG000|Double-Blind Treatment Period|Adverse Event|0|||
147576569|NCT00540423|532265520|FG001|Double-Blind Treatment Period|Adverse Event|1|||
147576570|NCT00540423|532265521|FG002|Double-Blind Treatment Period|Adverse Event|0|||
147576571|NCT00540423|532265519|FG000|Open-Label Treatment Period|Lack of Efficacy|0|||
147576572|NCT00540423|532265520|FG001|Open-Label Treatment Period|Lack of Efficacy|0|||
147576573|NCT00540423|532265521|FG002|Open-Label Treatment Period|Lack of Efficacy|2|||
147576574|NCT00263588|532265525|FG000|Overall Study|Death|54|||
147576575|NCT00263588|532265526|FG001|Overall Study|Death|90|||
147150756|NCT00066703|530714404|FG001|Overall Study|Lost to Follow-up|28|||
147150757|NCT00066703|530714403|FG000|Overall Study|Withdrawal by Subject|38|||
147150758|NCT00066703|530714404|FG001|Overall Study|Withdrawal by Subject|63|||
147150759|NCT00066703|530714403|FG000|Overall Study|Treatment ongoing|346|||
147150760|NCT00066703|530714404|FG001|Overall Study|Treatment ongoing|311|||
147150761|NCT01696968|530714405|FG000|Overall Study|Cancer Before Rand. (Lung Screening)|0|||
147150762|NCT01696968|530714406|FG001|Overall Study|Cancer Before Rand. (Lung Screening)|8|||
147150763|NCT01696968|530714405|FG000|Overall Study|Died Before Randomization|3|||
147150764|NCT01696968|530714406|FG001|Overall Study|Died Before Randomization|8|||
147150765|NCT01696968|530714405|FG000|Overall Study|Died Before ASU (Control)|278|||
147150766|NCT01696968|530714406|FG001|Overall Study|Died Before ASU (Control)|0|||
147150767|NCT01696968|530714405|FG000|Overall Study|Refused ASU (Control)|920|||
147150768|NCT01696968|530714406|FG001|Overall Study|Refused ASU (Control)|0|||
147150769|NCT01696968|530714405|FG000|Overall Study|Refused Screen (Lung Screening)|0|||
147150770|NCT01696968|530714406|FG001|Overall Study|Refused Screen (Lung Screening)|6796|||
147150771|NCT03727646|530714407|FG000|Overall Study|Adverse Event|1|||
147150772|NCT03727646|530714408|FG001|Overall Study|Adverse Event|0|||
147150773|NCT04753658|530714411|FG000|Overall Study|Progressive disease|7|||
147150774|NCT04753658|530714411|FG000|Overall Study|Other|7|||
147150775|NCT04753658|530714411|FG000|Overall Study|Adverse Event|1|||
147150776|NCT05659719|530714412|FG000|Overall Study|At sponsor's request|0|||
147150777|NCT05659719|530714413|FG001|Overall Study|At sponsor's request|0|||
147150778|NCT05659719|530714414|FG002|Overall Study|At sponsor's request|0|||
147150779|NCT05659719|530714415|FG003|Overall Study|At sponsor's request|95|||
147150780|NCT05659719|530714412|FG000|Overall Study|Increased age moving to different baseline study with prospects of moving to intervention in future|0|||
147150781|NCT05659719|530714413|FG001|Overall Study|Increased age moving to different baseline study with prospects of moving to intervention in future|0|||
147150782|NCT05659719|530714414|FG002|Overall Study|Increased age moving to different baseline study with prospects of moving to intervention in future|0|||
147150783|NCT05659719|530714415|FG003|Overall Study|Increased age moving to different baseline study with prospects of moving to intervention in future|1|||
147150784|NCT05659719|530714412|FG000|Overall Study|Inclusion/Exclusion criteria|0|||
147150785|NCT05659719|530714413|FG001|Overall Study|Inclusion/Exclusion criteria|0|||
147150786|NCT05659719|530714414|FG002|Overall Study|Inclusion/Exclusion criteria|0|||
147150787|NCT05659719|530714415|FG003|Overall Study|Inclusion/Exclusion criteria|5|||
147150788|NCT05659719|530714412|FG000|Overall Study|Wish of the child, or of the child's parent(S)/legal guardian(S), to withdrew from the study|0|||
147150789|NCT05659719|530714413|FG001|Overall Study|Wish of the child, or of the child's parent(S)/legal guardian(S), to withdrew from the study|0|||
147239615|NCT01090492|531049257|FG002|First Intervention Period (4 Weeks)|Protocol Violation|1|||
147239616|NCT01090492|531049258|FG003|First Intervention Period (4 Weeks)|Protocol Violation|2|||
147239617|NCT01090492|531049259|FG004|First Intervention Period (4 Weeks)|Protocol Violation|0|||
147239618|NCT01090492|531049260|FG005|First Intervention Period (4 Weeks)|Protocol Violation|0|||
147239619|NCT01090492|531049261|FG006|First Intervention Period (4 Weeks)|Protocol Violation|1|||
147239620|NCT01090492|531049262|FG007|First Intervention Period (4 Weeks)|Protocol Violation|0|||
147239621|NCT01090492|531049255|FG000|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
147239622|NCT01090492|531049256|FG001|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|2|||
147239623|NCT01090492|531049257|FG002|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
147239624|NCT01090492|531049258|FG003|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
147239625|NCT01090492|531049259|FG004|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
147239626|NCT01090492|531049260|FG005|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
147446054|NCT02258451|531797540|FG000|Overall Study|Discontinuation all treatment due to end point reached|1|||
147653049|NCT01348100|532551907|FG002|Overall Study|Lost to Follow-up|0|||
147653050|NCT01348100|532551908|FG003|Overall Study|Lost to Follow-up|0|||
147653051|NCT01348100|532551909|FG004|Overall Study|Lost to Follow-up|0|||
147239627|NCT01090492|531049261|FG006|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|0|||
147576576|NCT00263588|532265525|FG000|Overall Study|disease progression, coma, 1 unknown|10|||
147576577|NCT00263588|532265526|FG001|Overall Study|disease progression, coma, 1 unknown|11|||
147150790|NCT05659719|530714414|FG002|Overall Study|Wish of the child, or of the child's parent(S)/legal guardian(S), to withdrew from the study|0|||
147150791|NCT05659719|530714415|FG003|Overall Study|Wish of the child, or of the child's parent(S)/legal guardian(S), to withdrew from the study|27|||
147150792|NCT05659719|530714412|FG000|Overall Study|Lost to Follow-up|0|||
147150793|NCT05659719|530714413|FG001|Overall Study|Lost to Follow-up|0|||
147150794|NCT05659719|530714414|FG002|Overall Study|Lost to Follow-up|0|||
147150795|NCT05659719|530714415|FG003|Overall Study|Lost to Follow-up|2|||
147150796|NCT05659719|530714412|FG000|Overall Study|Moved to another observational study|0|||
147150797|NCT05659719|530714413|FG001|Overall Study|Moved to another observational study|0|||
147150798|NCT05659719|530714414|FG002|Overall Study|Moved to another observational study|0|||
147150799|NCT05659719|530714415|FG003|Overall Study|Moved to another observational study|1|||
147150800|NCT05659719|530714412|FG000|Overall Study|The child was enrolled in an interventional study|0|||
147150801|NCT05659719|530714413|FG001|Overall Study|The child was enrolled in an interventional study|0|||
147150802|NCT05659719|530714414|FG002|Overall Study|The child was enrolled in an interventional study|0|||
147150803|NCT05659719|530714415|FG003|Overall Study|The child was enrolled in an interventional study|55|||
147150804|NCT05659719|530714412|FG000|Overall Study|The child went to lower limbs elongation surgery in few weeks' time|0|||
147150805|NCT05659719|530714413|FG001|Overall Study|The child went to lower limbs elongation surgery in few weeks' time|0|||
147150806|NCT05659719|530714414|FG002|Overall Study|The child went to lower limbs elongation surgery in few weeks' time|0|||
147150807|NCT05659719|530714415|FG003|Overall Study|The child went to lower limbs elongation surgery in few weeks' time|1|||
147150808|NCT05659719|530714412|FG000|Overall Study|The family wished to pursue a prescription a voxzogo instead of waiting for phase 3|0|||
147150809|NCT05659719|530714413|FG001|Overall Study|The family wished to pursue a prescription a voxzogo instead of waiting for phase 3|0|||
147150810|NCT05659719|530714414|FG002|Overall Study|The family wished to pursue a prescription a voxzogo instead of waiting for phase 3|0|||
147150811|NCT05659719|530714415|FG003|Overall Study|The family wished to pursue a prescription a voxzogo instead of waiting for phase 3|2|||
147150812|NCT05924165|530714422|FG000|Overall Study|Physician Decision|2|||
147150813|NCT05924165|530714423|FG001|Overall Study|Physician Decision|3|||
147150814|NCT01681186|530714424|FG000|Washout Period From Second Intervention|Adverse Event|0|||
147150815|NCT01681186|530714425|FG001|Washout Period From Second Intervention|Adverse Event|0|||
147150816|NCT01681186|530714426|FG002|Washout Period From Second Intervention|Adverse Event|0|||
147150817|NCT01681186|530714427|FG003|Washout Period From Second Intervention|Adverse Event|0|||
147150818|NCT01681186|530714428|FG004|Washout Period From Second Intervention|Adverse Event|0|||
147150819|NCT01681186|530714429|FG005|Washout Period From Second Intervention|Adverse Event|0|||
147150820|NCT01681186|530714430|FG006|Washout Period From Second Intervention|Adverse Event|1|||
147150821|NCT01681186|530714431|FG007|Washout Period From Second Intervention|Adverse Event|0|||
147150822|NCT01681186|530714424|FG000|Washout Period From Second Intervention|Protocol Violation|0|||
147150823|NCT01681186|530714425|FG001|Washout Period From Second Intervention|Protocol Violation|0|||
147150824|NCT01681186|530714426|FG002|Washout Period From Second Intervention|Protocol Violation|0|||
147150825|NCT01681186|530714427|FG003|Washout Period From Second Intervention|Protocol Violation|0|||
147150826|NCT01681186|530714428|FG004|Washout Period From Second Intervention|Protocol Violation|0|||
147150827|NCT01681186|530714429|FG005|Washout Period From Second Intervention|Protocol Violation|0|||
147150828|NCT01681186|530714430|FG006|Washout Period From Second Intervention|Protocol Violation|0|||
147150829|NCT01681186|530714431|FG007|Washout Period From Second Intervention|Protocol Violation|1|||
147150830|NCT01681186|530714424|FG000|Washout Period From Third Intervention|Lost to Follow-up|0|||
147150831|NCT01681186|530714425|FG001|Washout Period From Third Intervention|Lost to Follow-up|0|||
147150832|NCT01681186|530714426|FG002|Washout Period From Third Intervention|Lost to Follow-up|0|||
147150833|NCT01681186|530714427|FG003|Washout Period From Third Intervention|Lost to Follow-up|0|||
147150834|NCT01681186|530714428|FG004|Washout Period From Third Intervention|Lost to Follow-up|0|||
147150835|NCT01681186|530714429|FG005|Washout Period From Third Intervention|Lost to Follow-up|0|||
147150836|NCT01681186|530714430|FG006|Washout Period From Third Intervention|Lost to Follow-up|1|||
147150837|NCT01681186|530714431|FG007|Washout Period From Third Intervention|Lost to Follow-up|0|||
147150838|NCT01681186|530714424|FG000|Fourth Intervention|Protocol Violation|0|||
147150839|NCT01681186|530714425|FG001|Fourth Intervention|Protocol Violation|0|||
147150840|NCT01681186|530714426|FG002|Fourth Intervention|Protocol Violation|0|||
147150841|NCT01681186|530714427|FG003|Fourth Intervention|Protocol Violation|0|||
147150842|NCT01681186|530714428|FG004|Fourth Intervention|Protocol Violation|0|||
147150843|NCT01681186|530714429|FG005|Fourth Intervention|Protocol Violation|0|||
147150844|NCT01681186|530714430|FG006|Fourth Intervention|Protocol Violation|0|||
147150845|NCT01681186|530714431|FG007|Fourth Intervention|Protocol Violation|1|||
147150846|NCT05160415|530714432|FG000|Overall Study|Withdrawal by Subject|3|||
147150847|NCT04308239|530714439|FG000|Pre-intervention Evaluation (1 Week)|Did not attend due to schedule conflict|2|||
147150848|NCT04308239|530714440|FG001|Pre-intervention Evaluation (1 Week)|Did not attend due to schedule conflict|1|||
147150849|NCT04308239|530714439|FG000|Pre-intervention Evaluation (1 Week)|testing error during evaluation|1|||
147150850|NCT04308239|530714440|FG001|Pre-intervention Evaluation (1 Week)|testing error during evaluation|2|||
147150851|NCT04308239|530714439|FG000|Post-intervention Evaluation (1 Week)|Withdrawal by Subject|1|||
147150852|NCT04308239|530714440|FG001|Post-intervention Evaluation (1 Week)|Withdrawal by Subject|2|||
147150853|NCT04308239|530714439|FG000|Post-intervention Evaluation (1 Week)|testing error during evaluation|0|||
147150854|NCT04308239|530714440|FG001|Post-intervention Evaluation (1 Week)|testing error during evaluation|2|||
147150855|NCT00316225|530714441|FG000|Overall Study|Adverse Event|2|||
147150856|NCT00316225|530714441|FG000|Overall Study|Physician Decision|3|||
147150857|NCT00316225|530714441|FG000|Overall Study|Progressive Disease|15|||
147150858|NCT00316225|530714441|FG000|Overall Study|Withdrawal by Subject|3|||
147150859|NCT00316225|530714441|FG000|Overall Study|Death|2|||
147150860|NCT01814878|530714442|FG000|Overall Study|Adverse Event|16|||
147150861|NCT01814878|530714443|FG001|Overall Study|Adverse Event|5|||
147150862|NCT01814878|530714442|FG000|Overall Study|Withdrawal by Subject|20|||
147150863|NCT01814878|530714443|FG001|Overall Study|Withdrawal by Subject|16|||
147150864|NCT01814878|530714442|FG000|Overall Study|Protocol Violation|5|||
147150865|NCT01814878|530714443|FG001|Overall Study|Protocol Violation|5|||
147150866|NCT01814878|530714442|FG000|Overall Study|Physician Decision|3|||
147150867|NCT01814878|530714443|FG001|Overall Study|Physician Decision|1|||
147150868|NCT01814878|530714442|FG000|Overall Study|Screening failure (drop-out)|0|||
147150869|NCT01814878|530714443|FG001|Overall Study|Screening failure (drop-out)|3|||
147150870|NCT01814878|530714442|FG000|Overall Study|Other|2|||
147150871|NCT01814878|530714443|FG001|Overall Study|Other|0|||
147150872|NCT00878254|530714448|FG000|Overall Study|Physician Decision|1|||
147150873|NCT00878254|530714448|FG000|Overall Study|Death|1|||
147150874|NCT00878254|530714448|FG000|Overall Study|Withdrawal by Subject|1|||
147150875|NCT00194077|530714452|FG000|Overall Study|Lack of Efficacy|22|||
147150876|NCT00194077|530714453|FG001|Overall Study|Lack of Efficacy|29|||
147150877|NCT00194077|530714452|FG000|Overall Study|Study nonadherence|1|||
147150878|NCT00194077|530714453|FG001|Overall Study|Study nonadherence|0|||
147150879|NCT00194077|530714452|FG000|Overall Study|Withdrawal by Subject|1|||
147150880|NCT00194077|530714453|FG001|Overall Study|Withdrawal by Subject|1|||
147150881|NCT03470194|530714456|FG000|Overall Study|Lost to Follow-up|11|||
147150882|NCT03470194|530714457|FG001|Overall Study|Lost to Follow-up|17|||
147150883|NCT05332392|530714458|FG000|Overall Study|Did not meet inclusion criteria|25|||
147150884|NCT05332392|530714458|FG000|Overall Study|Principal Investigator's decision|17|||
147150885|NCT05332392|530714458|FG000|Overall Study|Adverse Event|1|||
147150886|NCT05332392|530714458|FG000|Overall Study|Subject's decision|1|||
147150887|NCT01268046|530714459|FG000|Overall Study|Withdrawal by Subject|1|||
147150888|NCT01268046|530714460|FG001|Overall Study|Withdrawal by Subject|0|||
147150889|NCT01268046|530714461|FG002|Overall Study|Withdrawal by Subject|0|||
147150890|NCT01268046|530714462|FG003|Overall Study|Withdrawal by Subject|1|||
147150891|NCT01268046|530714459|FG000|Overall Study|Lost to Follow-up|0|||
147150892|NCT01268046|530714460|FG001|Overall Study|Lost to Follow-up|0|||
147150893|NCT01268046|530714461|FG002|Overall Study|Lost to Follow-up|1|||
147150894|NCT01268046|530714462|FG003|Overall Study|Lost to Follow-up|0|||
147150895|NCT01450696|530714464|FG000|Overall Study|Never Treated|1|||
147150896|NCT01450696|530714465|FG001|Overall Study|Never Treated|1|||
147150897|NCT01450696|530714464|FG000|Overall Study|Death|77|||
147150898|NCT01450696|530714465|FG001|Overall Study|Death|84|||
147150899|NCT01450696|530714464|FG000|Overall Study|Lost to Follow-up|3|||
147150900|NCT01450696|530714465|FG001|Overall Study|Lost to Follow-up|3|||
147150901|NCT01450696|530714464|FG000|Overall Study|Non-Compliance|1|||
147150902|NCT01450696|530714465|FG001|Overall Study|Non-Compliance|0|||
147150903|NCT01450696|530714464|FG000|Overall Study|Withdrawal by Subject|13|||
147150904|NCT01450696|530714465|FG001|Overall Study|Withdrawal by Subject|2|||
147150905|NCT01450696|530714464|FG000|Overall Study|Study Terminated by Sponsor|53|||
147150906|NCT01450696|530714465|FG001|Overall Study|Study Terminated by Sponsor|58|||
147150907|NCT03818607|530714466|FG000|Period 1 (Week 1 to Week 52)|Adverse Event|0|||
147150908|NCT03818607|530714467|FG001|Period 1 (Week 1 to Week 52)|Adverse Event|1|||
147150909|NCT03818607|530714466|FG000|Period 2 (Week 53 to Week 79)|Participant's personal needs|0|||
147150910|NCT03818607|530714467|FG001|Period 2 (Week 53 to Week 79)|Participant's personal needs|1|||
147150911|NCT03818607|530714466|FG000|Period 2 (Week 53 to Week 79)|Withdrawal by Subject|1|||
147150912|NCT03818607|530714467|FG001|Period 2 (Week 53 to Week 79)|Withdrawal by Subject|0|||
147150913|NCT05730335|530714472|FG000|Overall Study|Lost to Follow-up|8|||
147150914|NCT05730335|530714472|FG000|Overall Study|Withdrawal by Subject|6|||
147321078|NCT04060680|531338461|FG000|Overall Study|Study product no longer in use|1|||
147321079|NCT04060680|531338462|FG001|Overall Study|Study product no longer in use|0|||
147321080|NCT04060680|531338461|FG000|Overall Study|Withdrawal by Subject|1|||
147321081|NCT04060680|531338462|FG001|Overall Study|Withdrawal by Subject|0|||
147321082|NCT03706690|531338463|FG000|Overall Study|Withdrawal by Subject|8|||
147321083|NCT03706690|531338464|FG001|Overall Study|Withdrawal by Subject|8|||
147321084|NCT03706690|531338463|FG000|Overall Study|Death|143|||
147150915|NCT00615719|530714481|FG000|Overall Study|Physician Decision|5|||
147150916|NCT03748706|530714482|FG000|Overall Study|Lost to Follow-up|1|||
147150917|NCT00842153|530714483|FG000|Overall Study|Adverse Event|0|||
147150918|NCT00842153|530714484|FG001|Overall Study|Adverse Event|1|||
147150919|NCT00842153|530714483|FG000|Overall Study|Lost to Follow-up|1|||
147150920|NCT00842153|530714484|FG001|Overall Study|Lost to Follow-up|2|||
147150921|NCT01355679|530714486|FG000|Overall Study|benign tumor types found at biopsy|2|||
147150922|NCT05319600|530714488|FG000|Overall Study|Withdrawal by Subject|1|||
147150923|NCT05319600|530714489|FG001|Overall Study|Withdrawal by Subject|0|||
147150924|NCT05319600|530714488|FG000|Overall Study|Lost to Follow-up|0|||
147150925|NCT05319600|530714489|FG001|Overall Study|Lost to Follow-up|4|||
147150926|NCT05141175|530714496|FG000|Overall Study|Withdrawal by Subject|1|||
147150927|NCT01104545|530714502|FG000|Overall Study|Adverse Event|0|||
147150928|NCT01104545|530714503|FG001|Overall Study|Adverse Event|1|||
147150929|NCT01104545|530714504|FG002|Overall Study|Adverse Event|2|||
147150930|NCT00923351|530714505|FG000|Overall Study|no apheresis/adequate tumor sample|0|||
147150931|NCT00923351|530714506|FG001|Overall Study|no apheresis/adequate tumor sample|0|||
147150932|NCT00923351|530714507|FG002|Overall Study|no apheresis/adequate tumor sample|12|||
147150933|NCT01262560|530714514|FG000|Overall Study|Protocol Violation|0|||
147150934|NCT01262560|530714515|FG001|Overall Study|Protocol Violation|1|||
147150935|NCT01262560|530714516|FG002|Overall Study|Protocol Violation|2|||
147150936|NCT02443116|530714521|FG000|Part 1|Adverse Event|2|||
147150937|NCT02443116|530714522|FG001|Part 1|Adverse Event|3|||
147150938|NCT02443116|530714523|FG002|Part 1|Adverse Event|0|||
147150939|NCT02443116|530714524|FG003|Part 1|Adverse Event|0|||
147150940|NCT02443116|530714525|FG004|Part 1|Adverse Event|0|||
147150941|NCT02443116|530714526|FG005|Part 1|Adverse Event|0|||
147150942|NCT02443116|530714527|FG006|Part 1|Adverse Event|0|||
147150943|NCT02443116|530714528|FG007|Part 1|Adverse Event|0|||
147150944|NCT02443116|530714529|FG008|Part 1|Adverse Event|0|||
147150945|NCT02443116|530714521|FG000|Part 1|Withdrew informed consent|0|||
147150946|NCT02443116|530714522|FG001|Part 1|Withdrew informed consent|1|||
147150947|NCT02443116|530714523|FG002|Part 1|Withdrew informed consent|0|||
147150948|NCT02443116|530714524|FG003|Part 1|Withdrew informed consent|0|||
147150949|NCT02443116|530714525|FG004|Part 1|Withdrew informed consent|0|||
147150950|NCT02443116|530714526|FG005|Part 1|Withdrew informed consent|0|||
147150951|NCT02443116|530714527|FG006|Part 1|Withdrew informed consent|0|||
147150952|NCT02443116|530714528|FG007|Part 1|Withdrew informed consent|0|||
147150953|NCT02443116|530714529|FG008|Part 1|Withdrew informed consent|0|||
147150954|NCT02443116|530714521|FG000|Part 1|Lost to Follow-up|0|||
147150955|NCT02443116|530714522|FG001|Part 1|Lost to Follow-up|0|||
147150956|NCT02443116|530714523|FG002|Part 1|Lost to Follow-up|2|||
147150957|NCT02443116|530714524|FG003|Part 1|Lost to Follow-up|0|||
147150958|NCT02443116|530714525|FG004|Part 1|Lost to Follow-up|0|||
147150959|NCT02443116|530714526|FG005|Part 1|Lost to Follow-up|0|||
147150960|NCT02443116|530714527|FG006|Part 1|Lost to Follow-up|0|||
147150961|NCT02443116|530714528|FG007|Part 1|Lost to Follow-up|0|||
147150962|NCT02443116|530714529|FG008|Part 1|Lost to Follow-up|0|||
147150963|NCT02443116|530714521|FG000|Part 1|Participant moved out of state|0|||
147150964|NCT02443116|530714522|FG001|Part 1|Participant moved out of state|0|||
147150965|NCT02443116|530714523|FG002|Part 1|Participant moved out of state|1|||
147150966|NCT02443116|530714524|FG003|Part 1|Participant moved out of state|0|||
147150967|NCT02443116|530714525|FG004|Part 1|Participant moved out of state|0|||
147150968|NCT02443116|530714526|FG005|Part 1|Participant moved out of state|0|||
147150969|NCT02443116|530714527|FG006|Part 1|Participant moved out of state|0|||
147150970|NCT02443116|530714528|FG007|Part 1|Participant moved out of state|0|||
147150971|NCT02443116|530714529|FG008|Part 1|Participant moved out of state|0|||
147150972|NCT02443116|530714521|FG000|Part 1|Participant enrolled in another clinical trial|0|||
147150973|NCT02443116|530714522|FG001|Part 1|Participant enrolled in another clinical trial|0|||
147150974|NCT02443116|530714523|FG002|Part 1|Participant enrolled in another clinical trial|1|||
147150975|NCT02443116|530714524|FG003|Part 1|Participant enrolled in another clinical trial|0|||
147321085|NCT03706690|531338464|FG001|Overall Study|Death|75|||
147321086|NCT03706690|531338463|FG000|Overall Study|Ongoing at DCO|121|||
147321087|NCT03706690|531338464|FG001|Overall Study|Ongoing at DCO|52|||
147321088|NCT02711826|531338465|FG000|Overall Study|Physician Decision|0|||
147321089|NCT02711826|531338466|FG001|Overall Study|Physician Decision|0|||
147321090|NCT02711826|531338467|FG002|Overall Study|Physician Decision|0|||
147150976|NCT02443116|530714525|FG004|Part 1|Participant enrolled in another clinical trial|0|||
147150977|NCT02443116|530714526|FG005|Part 1|Participant enrolled in another clinical trial|0|||
147150978|NCT02443116|530714527|FG006|Part 1|Participant enrolled in another clinical trial|0|||
147150979|NCT02443116|530714528|FG007|Part 1|Participant enrolled in another clinical trial|0|||
147150980|NCT02443116|530714529|FG008|Part 1|Participant enrolled in another clinical trial|0|||
147150981|NCT02443116|530714521|FG000|Part 2|Adverse Event|0|||
147150982|NCT02443116|530714522|FG001|Part 2|Adverse Event|0|||
147150983|NCT02443116|530714523|FG002|Part 2|Adverse Event|0|||
147150984|NCT02443116|530714524|FG003|Part 2|Adverse Event|0|||
147150985|NCT02443116|530714525|FG004|Part 2|Adverse Event|1|||
147150986|NCT02443116|530714526|FG005|Part 2|Adverse Event|1|||
147150987|NCT02443116|530714527|FG006|Part 2|Adverse Event|2|||
147150988|NCT02443116|530714528|FG007|Part 2|Adverse Event|0|||
147150989|NCT02443116|530714529|FG008|Part 2|Adverse Event|0|||
147150990|NCT02443116|530714521|FG000|Part 2|Withdrew informed consent|0|||
147150991|NCT02443116|530714522|FG001|Part 2|Withdrew informed consent|0|||
147150992|NCT02443116|530714523|FG002|Part 2|Withdrew informed consent|0|||
147150993|NCT02443116|530714524|FG003|Part 2|Withdrew informed consent|0|||
147150994|NCT02443116|530714525|FG004|Part 2|Withdrew informed consent|0|||
147321091|NCT02711826|531338468|FG003|Overall Study|Physician Decision|1|||
147150995|NCT02443116|530714526|FG005|Part 2|Withdrew informed consent|1|||
147576578|NCT00263588|532265525|FG000|Overall Study|Lost to Follow-up|7|||
147576579|NCT00263588|532265526|FG001|Overall Study|Lost to Follow-up|10|||
147150996|NCT02443116|530714527|FG006|Part 2|Withdrew informed consent|1|||
147150997|NCT02443116|530714528|FG007|Part 2|Withdrew informed consent|0|||
147150998|NCT02443116|530714529|FG008|Part 2|Withdrew informed consent|0|||
147150999|NCT02443116|530714521|FG000|Part 2|Inability to comply with protocol|0|||
147151000|NCT02443116|530714522|FG001|Part 2|Inability to comply with protocol|0|||
147151001|NCT02443116|530714523|FG002|Part 2|Inability to comply with protocol|0|||
147151002|NCT02443116|530714524|FG003|Part 2|Inability to comply with protocol|1|||
147151003|NCT02443116|530714525|FG004|Part 2|Inability to comply with protocol|0|||
147151004|NCT02443116|530714526|FG005|Part 2|Inability to comply with protocol|0|||
147151005|NCT02443116|530714527|FG006|Part 2|Inability to comply with protocol|0|||
147151006|NCT02443116|530714528|FG007|Part 2|Inability to comply with protocol|0|||
147151007|NCT02443116|530714529|FG008|Part 2|Inability to comply with protocol|0|||
147151008|NCT02443116|530714521|FG000|Part 2|Lost to Follow-up|0|||
147151009|NCT02443116|530714522|FG001|Part 2|Lost to Follow-up|0|||
147151010|NCT02443116|530714523|FG002|Part 2|Lost to Follow-up|0|||
147151011|NCT02443116|530714524|FG003|Part 2|Lost to Follow-up|1|||
147151012|NCT02443116|530714525|FG004|Part 2|Lost to Follow-up|0|||
147151013|NCT02443116|530714526|FG005|Part 2|Lost to Follow-up|0|||
147151014|NCT02443116|530714527|FG006|Part 2|Lost to Follow-up|0|||
147151015|NCT02443116|530714528|FG007|Part 2|Lost to Follow-up|0|||
147151016|NCT02443116|530714529|FG008|Part 2|Lost to Follow-up|0|||
147151017|NCT02443116|530714521|FG000|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
147151018|NCT02443116|530714522|FG001|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
147151019|NCT02443116|530714523|FG002|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
147151020|NCT02443116|530714524|FG003|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
147151021|NCT02443116|530714525|FG004|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
147151022|NCT02443116|530714526|FG005|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|1|||
147151023|NCT02443116|530714527|FG006|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
147151024|NCT02443116|530714528|FG007|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
147151025|NCT02443116|530714529|FG008|Part 2|Early end of treatment secondary to cardiac arrest and subsequently lost to follow up|0|||
147151026|NCT02443116|530714521|FG000|Part 3|Adverse Event|0|||
147151027|NCT02443116|530714522|FG001|Part 3|Adverse Event|0|||
147151028|NCT02443116|530714523|FG002|Part 3|Adverse Event|0|||
147151029|NCT02443116|530714524|FG003|Part 3|Adverse Event|0|||
147151030|NCT02443116|530714525|FG004|Part 3|Adverse Event|0|||
147151031|NCT02443116|530714526|FG005|Part 3|Adverse Event|0|||
147151032|NCT02443116|530714527|FG006|Part 3|Adverse Event|0|||
147151033|NCT02443116|530714528|FG007|Part 3|Adverse Event|0|||
147151034|NCT02443116|530714529|FG008|Part 3|Adverse Event|1|||
147151035|NCT02443116|530714521|FG000|Part 3|Withdrew informed consent|0|||
147151036|NCT02443116|530714522|FG001|Part 3|Withdrew informed consent|0|||
147151037|NCT02443116|530714523|FG002|Part 3|Withdrew informed consent|0|||
147151038|NCT02443116|530714524|FG003|Part 3|Withdrew informed consent|0|||
147151039|NCT02443116|530714525|FG004|Part 3|Withdrew informed consent|0|||
147151040|NCT02443116|530714526|FG005|Part 3|Withdrew informed consent|0|||
147151041|NCT02443116|530714527|FG006|Part 3|Withdrew informed consent|0|||
147151042|NCT02443116|530714528|FG007|Part 3|Withdrew informed consent|3|||
147151043|NCT02443116|530714529|FG008|Part 3|Withdrew informed consent|2|||
147151044|NCT02443116|530714521|FG000|Part 3|Lost to Follow-up|0|||
147151045|NCT02443116|530714522|FG001|Part 3|Lost to Follow-up|0|||
147151046|NCT02443116|530714523|FG002|Part 3|Lost to Follow-up|0|||
147151047|NCT02443116|530714524|FG003|Part 3|Lost to Follow-up|0|||
147151048|NCT02443116|530714525|FG004|Part 3|Lost to Follow-up|0|||
147151049|NCT02443116|530714526|FG005|Part 3|Lost to Follow-up|0|||
147151050|NCT02443116|530714527|FG006|Part 3|Lost to Follow-up|0|||
147239628|NCT01090492|531049262|FG007|First Intervention Period (4 Weeks)|Did not meet inclusion criteria|1|||
147239629|NCT01090492|531049255|FG000|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
147239630|NCT01090492|531049256|FG001|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
147446055|NCT02258451|531797541|FG001|Overall Study|Discontinuation all treatment due to end point reached|1|||
147446056|NCT02258451|531797540|FG000|Overall Study|Discontinuation all treatment due to physician decision|0|||
147151051|NCT02443116|530714528|FG007|Part 3|Lost to Follow-up|1|||
147151052|NCT02443116|530714529|FG008|Part 3|Lost to Follow-up|2|||
147239631|NCT01090492|531049257|FG002|First Intervention Period (4 Weeks)|Lost to Follow-up|1|||
147446057|NCT02258451|531797541|FG001|Overall Study|Discontinuation all treatment due to physician decision|2|||
147151053|NCT04295759|530714530|FG000|Overall Study|Lack of Efficacy|9|||
147151054|NCT04295759|530714530|FG000|Overall Study|Death|1|||
147151055|NCT04295759|530714530|FG000|Overall Study|Withdrawal by Subject|2|||
147151056|NCT04295759|530714530|FG000|Overall Study|Deemed ineligible|1|||
147151057|NCT00465972|530714531|FG000|Overall Study|Withdrawal by Subject|2|||
147151058|NCT00465972|530714532|FG001|Overall Study|Withdrawal by Subject|1|||
147151059|NCT00349349|530714533|FG000|Overall Study|Adverse Event|5|||
147151060|NCT00349349|530714534|FG001|Overall Study|Adverse Event|6|||
147151061|NCT00349349|530714535|FG002|Overall Study|Adverse Event|2|||
147151062|NCT00349349|530714533|FG000|Overall Study|Withdrawal by Subject|5|||
147151063|NCT00349349|530714534|FG001|Overall Study|Withdrawal by Subject|2|||
147151064|NCT00349349|530714535|FG002|Overall Study|Withdrawal by Subject|1|||
147151065|NCT00349349|530714533|FG000|Overall Study|Withdrawn due to Disease Progression|27|||
147151066|NCT00349349|530714534|FG001|Overall Study|Withdrawn due to Disease Progression|37|||
147151067|NCT00349349|530714535|FG002|Overall Study|Withdrawn due to Disease Progression|1|||
147151068|NCT00349349|530714533|FG000|Overall Study|Death|13|||
147151069|NCT00349349|530714534|FG001|Overall Study|Death|10|||
147151070|NCT00349349|530714535|FG002|Overall Study|Death|1|||
147151071|NCT00349349|530714533|FG000|Overall Study|Other Treatment Selected|2|||
147151072|NCT00349349|530714534|FG001|Overall Study|Other Treatment Selected|0|||
147151073|NCT00349349|530714535|FG002|Overall Study|Other Treatment Selected|0|||
147151074|NCT00349349|530714533|FG000|Overall Study|Participant Reduced General Condition|0|||
147151075|NCT00349349|530714534|FG001|Overall Study|Participant Reduced General Condition|1|||
147151076|NCT00349349|530714535|FG002|Overall Study|Participant Reduced General Condition|0|||
147151077|NCT00349349|530714533|FG000|Overall Study|Physician Decision|1|||
147151078|NCT00349349|530714534|FG001|Overall Study|Physician Decision|2|||
147151079|NCT00349349|530714535|FG002|Overall Study|Physician Decision|1|||
147151080|NCT00349349|530714533|FG000|Overall Study|No Response|0|||
147151081|NCT00349349|530714534|FG001|Overall Study|No Response|3|||
147151082|NCT00349349|530714535|FG002|Overall Study|No Response|0|||
147151083|NCT00349349|530714533|FG000|Overall Study|New Malignancy (Bladder Cancer)|0|||
147151084|NCT00349349|530714534|FG001|Overall Study|New Malignancy (Bladder Cancer)|1|||
147151085|NCT00349349|530714535|FG002|Overall Study|New Malignancy (Bladder Cancer)|0|||
147151086|NCT03028415|530714536|FG000|Overall Study|Lost to Follow-up|6|||
147151087|NCT03028415|530714537|FG001|Overall Study|Lost to Follow-up|3|||
147151088|NCT03028415|530714536|FG000|Overall Study|Withdrawal by Subject|1|||
147151089|NCT03028415|530714537|FG001|Overall Study|Withdrawal by Subject|0|||
147151090|NCT03028415|530714536|FG000|Overall Study|Discontinued due to COVID-19|1|||
147151091|NCT03028415|530714537|FG001|Overall Study|Discontinued due to COVID-19|0|||
147151092|NCT01108731|530714545|FG000|Overall Study|Withdrawal by Subject|1|||
147151093|NCT01108731|530714546|FG001|Overall Study|Withdrawal by Subject|1|||
147151094|NCT01108731|530714545|FG000|Overall Study|Adverse Event|3|||
147151095|NCT01108731|530714546|FG001|Overall Study|Adverse Event|3|||
147151096|NCT01063062|530714547|FG000|Overall Study|Patient withdrew consent|0|||
147151097|NCT01063062|530714548|FG001|Overall Study|Patient withdrew consent|1|||
147151098|NCT01063062|530714547|FG000|Overall Study|Adverse Event|2|||
147151099|NCT01063062|530714548|FG001|Overall Study|Adverse Event|4|||
147151100|NCT01063062|530714547|FG000|Overall Study|Protocol Violation|5|||
147151101|NCT01063062|530714548|FG001|Overall Study|Protocol Violation|4|||
147151102|NCT01063062|530714547|FG000|Overall Study|Investigator's request|1|||
147151103|NCT01063062|530714548|FG001|Overall Study|Investigator's request|0|||
147151104|NCT01063062|530714547|FG000|Overall Study|Lost to Follow-up|0|||
147151105|NCT01063062|530714548|FG001|Overall Study|Lost to Follow-up|2|||
147151106|NCT01063062|530714547|FG000|Overall Study|Miscellaneous reason|0|||
147151107|NCT01063062|530714548|FG001|Overall Study|Miscellaneous reason|1|||
147151108|NCT02015481|530714549|FG000|Overall Study|Death|1|||
147151109|NCT01352221|530714556|FG000|Double-blind Phase|Adverse Event|6|||
147151110|NCT01352221|530714557|FG001|Double-blind Phase|Adverse Event|4|||
147151111|NCT01352221|530714558|FG002|Double-blind Phase|Adverse Event|0|||
147151112|NCT01352221|530714559|FG003|Double-blind Phase|Adverse Event|0|||
147151113|NCT01352221|530714556|FG000|Double-blind Phase|Withdrawal by Subject|3|||
147151114|NCT01352221|530714557|FG001|Double-blind Phase|Withdrawal by Subject|5|||
147151115|NCT01352221|530714558|FG002|Double-blind Phase|Withdrawal by Subject|0|||
147151116|NCT01352221|530714559|FG003|Double-blind Phase|Withdrawal by Subject|0|||
147151117|NCT01352221|530714556|FG000|Double-blind Phase|Lost to Follow-up|0|||
147151118|NCT01352221|530714557|FG001|Double-blind Phase|Lost to Follow-up|1|||
147151119|NCT01352221|530714558|FG002|Double-blind Phase|Lost to Follow-up|0|||
147151120|NCT01352221|530714559|FG003|Double-blind Phase|Lost to Follow-up|0|||
147151121|NCT01352221|530714556|FG000|Double-blind Phase|Protocol Violation|0|||
147151122|NCT01352221|530714557|FG001|Double-blind Phase|Protocol Violation|1|||
147151123|NCT01352221|530714558|FG002|Double-blind Phase|Protocol Violation|0|||
147151124|NCT01352221|530714559|FG003|Double-blind Phase|Protocol Violation|0|||
147151125|NCT01352221|530714556|FG000|Open-label Phase|Physician Decision|0|||
147151126|NCT01352221|530714557|FG001|Open-label Phase|Physician Decision|0|||
147151127|NCT01352221|530714558|FG002|Open-label Phase|Physician Decision|2|||
147151128|NCT01352221|530714559|FG003|Open-label Phase|Physician Decision|1|||
147151129|NCT01352221|530714556|FG000|Open-label Phase|Pregnancy|0|||
147151130|NCT01352221|530714557|FG001|Open-label Phase|Pregnancy|0|||
147151131|NCT01352221|530714558|FG002|Open-label Phase|Pregnancy|1|||
147151132|NCT01352221|530714559|FG003|Open-label Phase|Pregnancy|0|||
147151133|NCT01352221|530714556|FG000|Open-label Phase|Adverse Event|0|||
147151134|NCT01352221|530714557|FG001|Open-label Phase|Adverse Event|0|||
147151135|NCT01352221|530714558|FG002|Open-label Phase|Adverse Event|8|||
147151136|NCT01352221|530714559|FG003|Open-label Phase|Adverse Event|4|||
147151137|NCT01352221|530714556|FG000|Open-label Phase|Withdrawal by Subject|0|||
147151138|NCT01352221|530714557|FG001|Open-label Phase|Withdrawal by Subject|0|||
147151139|NCT01352221|530714558|FG002|Open-label Phase|Withdrawal by Subject|1|||
147151140|NCT01352221|530714559|FG003|Open-label Phase|Withdrawal by Subject|6|||
147151141|NCT01352221|530714556|FG000|Open-label Phase|Worsening of IBD|0|||
147151142|NCT01352221|530714557|FG001|Open-label Phase|Worsening of IBD|0|||
147151143|NCT01352221|530714558|FG002|Open-label Phase|Worsening of IBD|1|||
147151144|NCT01352221|530714559|FG003|Open-label Phase|Worsening of IBD|0|||
147151145|NCT01170273|530714565|FG000|Overall Study|Lost to Follow-up|6|||
147151146|NCT01170273|530714566|FG001|Overall Study|Lost to Follow-up|8|||
147151147|NCT01170273|530714565|FG000|Overall Study|Protocol Violation|1|||
147151148|NCT01170273|530714566|FG001|Overall Study|Protocol Violation|0|||
147151149|NCT01170273|530714565|FG000|Overall Study|Death|1|||
147151150|NCT01170273|530714566|FG001|Overall Study|Death|0|||
147151151|NCT01170273|530714565|FG000|Overall Study|Adverse Event|0|||
147151152|NCT01170273|530714566|FG001|Overall Study|Adverse Event|1|||
147151153|NCT01673854|530714567|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Disease progression|7|||
147151154|NCT01673854|530714567|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Study drug toxicity|6|||
147151155|NCT01673854|530714567|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Administrative Reason by Sponsor|2|||
147151156|NCT01673854|530714567|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Adverse event unrelated to study drug|1|||
147151157|NCT01673854|530714567|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Maximum clinical benefit|1|||
147151158|NCT01673854|530714567|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Death|1|||
147151159|NCT01673854|530714567|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Not identified|2|||
147151160|NCT01673854|530714567|FG000|Ipilimumab Phase (Ipilimumab, 10 mg/kg)|Not reported|7|||
147151161|NCT01673854|530714567|FG000|Vem 2 Phase (Vemurafenib Retreatment)|Disease progression|12|||
147151162|NCT01673854|530714567|FG000|Vem 2 Phase (Vemurafenib Retreatment)|Study drug toxicity|5|||
147151163|NCT01673854|530714567|FG000|Vem 2 Phase (Vemurafenib Retreatment)|Adverse event unrelated to study drug|1|||
147151164|NCT01673854|530714567|FG000|Vem 2 Phase (Vemurafenib Retreatment)|Death|1|||
147151165|NCT02316353|530714568|FG000|Overall Study|Pregnancy|1|||
147151166|NCT02316353|530714569|FG001|Overall Study|Pregnancy|3|||
147151167|NCT02316353|530714568|FG000|Overall Study|Adverse Event|1|||
147151168|NCT02316353|530714569|FG001|Overall Study|Adverse Event|3|||
147151169|NCT02316353|530714568|FG000|Overall Study|Withdrawal by Subject|6|||
147151170|NCT02316353|530714569|FG001|Overall Study|Withdrawal by Subject|2|||
147151171|NCT00375674|530714570|FG000|Overall Study|Other|26|||
147151172|NCT00375674|530714571|FG001|Overall Study|Other|18|||
147151173|NCT00375674|530714570|FG000|Overall Study|Death|67|||
147151174|NCT00375674|530714571|FG001|Overall Study|Death|76|||
147151175|NCT00375674|530714570|FG000|Overall Study|Participants refused further follow-up|31|||
147151176|NCT00375674|530714571|FG001|Overall Study|Participants refused further follow-up|30|||
147151177|NCT00375674|530714570|FG000|Overall Study|Lost to Follow-up|17|||
147151178|NCT00375674|530714571|FG001|Overall Study|Lost to Follow-up|15|||
147151179|NCT00375674|530714570|FG000|Overall Study|Enrolled but not treated|3|||
147151180|NCT00375674|530714571|FG001|Overall Study|Enrolled but not treated|2|||
147151181|NCT05897242|530716454|FG000|Overall Study|Lost to Follow-up|6|||
147151182|NCT05897242|530716455|FG001|Overall Study|Lost to Follow-up|1|||
147151183|NCT05897242|530716454|FG000|Overall Study|Incomplete|1|||
147151184|NCT05897242|530716455|FG001|Overall Study|Incomplete|0|||
147151185|NCT05897242|530716454|FG000|Overall Study|Withdrawal by Subject|1|||
147151186|NCT05897242|530716455|FG001|Overall Study|Withdrawal by Subject|0|||
147151187|NCT00809835|530716456|FG000|Overall Study|Lost to Follow-up|7|||
147151188|NCT00809835|530716457|FG001|Overall Study|Lost to Follow-up|6|||
147151189|NCT00809835|530716458|FG002|Overall Study|Lost to Follow-up|10|||
147151190|NCT00809835|530716459|FG003|Overall Study|Lost to Follow-up|2|||
147151191|NCT00809835|530716456|FG000|Overall Study|Withdrawal by Subject|1|||
147151192|NCT00809835|530716457|FG001|Overall Study|Withdrawal by Subject|1|||
147151193|NCT00809835|530716458|FG002|Overall Study|Withdrawal by Subject|1|||
147151194|NCT00809835|530716459|FG003|Overall Study|Withdrawal by Subject|0|||
147151195|NCT02582814|530716460|FG000|Overall Study|Study-specific withdrawal criteria|1|||
147151196|NCT02582814|530716461|FG001|Overall Study|Study-specific withdrawal criteria|0|||
147151197|NCT02582814|530716460|FG000|Overall Study|Withdrawal by Subject|4|||
147151198|NCT02582814|530716461|FG001|Overall Study|Withdrawal by Subject|3|||
147151199|NCT02582814|530716460|FG000|Overall Study|Adverse Event|4|||
147151200|NCT02582814|530716461|FG001|Overall Study|Adverse Event|4|||
147151201|NCT03530995|530716462|FG000|Part 1 Period 3|Withdrawal by Subject|2|||
147151202|NCT03530995|530716463|FG001|Part 1 Period 3|Withdrawal by Subject|0|||
147151203|NCT03530995|530716462|FG000|Part 1 Period 3|Protocol Violation|1|||
147151204|NCT03530995|530716463|FG001|Part 1 Period 3|Protocol Violation|0|||
147151205|NCT03530995|530716462|FG000|Part 1 Period 4|Physician Decision|1|||
147151206|NCT03530995|530716463|FG001|Part 1 Period 4|Physician Decision|0|||
147151207|NCT03530995|530716462|FG000|Part 1 Period 4|Withdrawal by Subject|1|||
147151208|NCT03530995|530716463|FG001|Part 1 Period 4|Withdrawal by Subject|0|||
147151209|NCT04848220|530716475|FG000|Overall Study|Unable to proceed to study procedure|0|||
147151210|NCT04848220|530716476|FG001|Overall Study|Unable to proceed to study procedure|1|||
147151211|NCT04848220|530716477|FG002|Overall Study|Unable to proceed to study procedure|0|||
147151212|NCT04848220|530716475|FG000|Overall Study|Fractional flow not significant|0|||
147151213|NCT04848220|530716476|FG001|Overall Study|Fractional flow not significant|1|||
147151214|NCT04848220|530716477|FG002|Overall Study|Fractional flow not significant|0|||
147151215|NCT02557100|530716488|FG000|Single Blind Treatment Period|Lost to Follow-up|0|||
147151216|NCT02557100|530716489|FG001|Single Blind Treatment Period|Lost to Follow-up|1|||
147151217|NCT02557100|530716490|FG002|Single Blind Treatment Period|Lost to Follow-up|0|||
147151218|NCT02557100|530716488|FG000|Single Blind Treatment Period|Death|0|||
147151219|NCT02557100|530716489|FG001|Single Blind Treatment Period|Death|1|||
147151220|NCT02557100|530716490|FG002|Single Blind Treatment Period|Death|0|||
147151221|NCT02557100|530716488|FG000|Single Blind Treatment Period|Request to Discontinue|0|||
147151222|NCT02557100|530716489|FG001|Single Blind Treatment Period|Request to Discontinue|1|||
147151223|NCT02557100|530716490|FG002|Single Blind Treatment Period|Request to Discontinue|0|||
147151224|NCT02557100|530716488|FG000|Single Blind Treatment Period|Adverse Event|0|||
147151225|NCT02557100|530716489|FG001|Single Blind Treatment Period|Adverse Event|1|||
147151226|NCT02557100|530716490|FG002|Single Blind Treatment Period|Adverse Event|0|||
147151227|NCT02557100|530716488|FG000|Transition to Open Label|Entered Cumulative Abatacept Period|40|||
147151228|NCT02557100|530716489|FG001|Transition to Open Label|Entered Cumulative Abatacept Period|36|||
147151229|NCT02557100|530716490|FG002|Transition to Open Label|Entered Cumulative Abatacept Period|0|||
147151230|NCT02557100|530716488|FG000|Cumulative Abatacept Period|Other Reasons|0|||
147151231|NCT02557100|530716489|FG001|Cumulative Abatacept Period|Other Reasons|0|||
147151232|NCT02557100|530716490|FG002|Cumulative Abatacept Period|Other Reasons|1|||
147151233|NCT02557100|530716488|FG000|Cumulative Abatacept Period|Lost to Follow-up|0|||
147151234|NCT02557100|530716489|FG001|Cumulative Abatacept Period|Lost to Follow-up|0|||
147151235|NCT02557100|530716490|FG002|Cumulative Abatacept Period|Lost to Follow-up|2|||
147151236|NCT02557100|530716488|FG000|Cumulative Abatacept Period|Request to Discontinue|0|||
147151237|NCT02557100|530716489|FG001|Cumulative Abatacept Period|Request to Discontinue|0|||
147151238|NCT02557100|530716490|FG002|Cumulative Abatacept Period|Request to Discontinue|1|||
147151239|NCT00510718|530716491|FG000|Multiple Dose Period: 12 Weeks|Adverse Event|1|||
147151240|NCT00510718|530716492|FG001|Multiple Dose Period: 12 Weeks|Adverse Event|8|||
147151241|NCT00510718|530716491|FG000|Multiple Dose Period: 12 Weeks|PSA Disease Progression|3|||
147151242|NCT00510718|530716492|FG001|Multiple Dose Period: 12 Weeks|PSA Disease Progression|6|||
147151243|NCT00510718|530716491|FG000|Multiple Dose Period: 12 Weeks|Radiologic Disease Progression|8|||
147151244|NCT00510718|530716492|FG001|Multiple Dose Period: 12 Weeks|Radiologic Disease Progression|11|||
147151245|NCT00510718|530716491|FG000|Multiple Dose Period: 12 Weeks|Clinical Disease Progression|1|||
147151246|NCT00510718|530716492|FG001|Multiple Dose Period: 12 Weeks|Clinical Disease Progression|3|||
147151247|NCT00510718|530716491|FG000|Multiple Dose Period: 12 Weeks|Withdrawal by Subject|1|||
147151248|NCT00510718|530716492|FG001|Multiple Dose Period: 12 Weeks|Withdrawal by Subject|3|||
147151249|NCT00510718|530716491|FG000|Multiple Dose Period: 12 Weeks|Other|1|||
147151250|NCT00510718|530716492|FG001|Multiple Dose Period: 12 Weeks|Other|1|||
147151251|NCT05791565|530716500|FG000|Washout Period (Minimum 72 Hours)|Adverse Event|1|||
147151252|NCT05791565|530716501|FG001|Washout Period (Minimum 72 Hours)|Adverse Event|0|||
147151253|NCT02388165|530716502|FG000|Overall Study|Study terminated by sponsor|5|||
147151254|NCT02388165|530716503|FG001|Overall Study|Study terminated by sponsor|5|||
147151255|NCT02388165|530716502|FG000|Overall Study|Other|11|||
147151256|NCT02388165|530716503|FG001|Overall Study|Other|13|||
147151257|NCT02388165|530716502|FG000|Overall Study|No longer meet eligibility criteria|40|||
147151258|NCT02388165|530716503|FG001|Overall Study|No longer meet eligibility criteria|43|||
147151259|NCT02388165|530716502|FG000|Overall Study|Withdrawal of consent|31|||
147151260|NCT02388165|530716503|FG001|Overall Study|Withdrawal of consent|32|||
147151261|NCT02388165|530716502|FG000|Overall Study|Lost to Follow-up|19|||
147151262|NCT02388165|530716503|FG001|Overall Study|Lost to Follow-up|20|||
147151263|NCT02388165|530716502|FG000|Overall Study|Death|13|||
147151264|NCT02388165|530716503|FG001|Overall Study|Death|10|||
147151265|NCT02388165|530716502|FG000|Overall Study|Adverse Event|3|||
147151266|NCT02388165|530716503|FG001|Overall Study|Adverse Event|5|||
147151267|NCT02388165|530716502|FG000|Overall Study|Did not meet entrance criteria|5|||
147151268|NCT02388165|530716503|FG001|Overall Study|Did not meet entrance criteria|2|||
147151269|NCT00705250|530716504|FG000|Overall Study|Withdrawal by Subject|1|||
147151270|NCT00705250|530716504|FG000|Overall Study|Patient died in car accident|1|||
147239632|NCT01090492|531049258|FG003|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
147239633|NCT01090492|531049259|FG004|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
147151271|NCT01406938|530716505|FG000|Induction Period|Subject/guardian decision|6|||
147151272|NCT01406938|530716506|FG001|Induction Period|Subject/guardian decision|8|||
147151273|NCT01406938|530716507|FG002|Induction Period|Subject/guardian decision|0|||
147151274|NCT01406938|530716508|FG003|Induction Period|Subject/guardian decision|0|||
147151275|NCT01406938|530716509|FG004|Induction Period|Subject/guardian decision|0|||
147151276|NCT01406938|530716510|FG005|Induction Period|Subject/guardian decision|0|||
147151277|NCT01406938|530716505|FG000|Induction Period|Protocol deviation|1|||
147151278|NCT01406938|530716506|FG001|Induction Period|Protocol deviation|0|||
147151279|NCT01406938|530716507|FG002|Induction Period|Protocol deviation|0|||
147151280|NCT01406938|530716508|FG003|Induction Period|Protocol deviation|0|||
147151281|NCT01406938|530716509|FG004|Induction Period|Protocol deviation|0|||
147151282|NCT01406938|530716510|FG005|Induction Period|Protocol deviation|0|||
147151283|NCT01406938|530716505|FG000|Induction Period|Adverse Event|8|||
147151284|NCT01406938|530716506|FG001|Induction Period|Adverse Event|9|||
147151285|NCT01406938|530716507|FG002|Induction Period|Adverse Event|0|||
147151286|NCT01406938|530716508|FG003|Induction Period|Adverse Event|0|||
147151287|NCT01406938|530716509|FG004|Induction Period|Adverse Event|0|||
147151288|NCT01406938|530716510|FG005|Induction Period|Adverse Event|0|||
147151289|NCT01406938|530716505|FG000|Induction Period|Lack of Efficacy|1|||
147151290|NCT01406938|530716506|FG001|Induction Period|Lack of Efficacy|0|||
147151291|NCT01406938|530716507|FG002|Induction Period|Lack of Efficacy|0|||
147151292|NCT01406938|530716508|FG003|Induction Period|Lack of Efficacy|0|||
147151293|NCT01406938|530716509|FG004|Induction Period|Lack of Efficacy|0|||
147151294|NCT01406938|530716510|FG005|Induction Period|Lack of Efficacy|0|||
147151295|NCT01406938|530716505|FG000|Induction Period|Lost to Follow-up|2|||
147151296|NCT01406938|530716506|FG001|Induction Period|Lost to Follow-up|3|||
147151297|NCT01406938|530716507|FG002|Induction Period|Lost to Follow-up|0|||
147151298|NCT01406938|530716508|FG003|Induction Period|Lost to Follow-up|0|||
147151299|NCT01406938|530716509|FG004|Induction Period|Lost to Follow-up|0|||
147151300|NCT01406938|530716510|FG005|Induction Period|Lost to Follow-up|0|||
147151301|NCT01406938|530716505|FG000|Maintenance Period|Adverse Event|0|||
147151302|NCT01406938|530716506|FG001|Maintenance Period|Adverse Event|0|||
147151303|NCT01406938|530716507|FG002|Maintenance Period|Adverse Event|2|||
147151304|NCT01406938|530716508|FG003|Maintenance Period|Adverse Event|8|||
147151305|NCT01406938|530716509|FG004|Maintenance Period|Adverse Event|4|||
147151306|NCT01406938|530716510|FG005|Maintenance Period|Adverse Event|2|||
147151307|NCT01406938|530716505|FG000|Maintenance Period|Death|0|||
147151308|NCT01406938|530716506|FG001|Maintenance Period|Death|0|||
147151309|NCT01406938|530716507|FG002|Maintenance Period|Death|0|||
147151310|NCT01406938|530716508|FG003|Maintenance Period|Death|0|||
147151311|NCT01406938|530716509|FG004|Maintenance Period|Death|1|||
147151312|NCT01406938|530716510|FG005|Maintenance Period|Death|0|||
147151313|NCT01406938|530716505|FG000|Maintenance Period|Subject/guardian decision|0|||
147151314|NCT01406938|530716506|FG001|Maintenance Period|Subject/guardian decision|0|||
147151315|NCT01406938|530716507|FG002|Maintenance Period|Subject/guardian decision|11|||
147151316|NCT01406938|530716508|FG003|Maintenance Period|Subject/guardian decision|7|||
147151317|NCT01406938|530716509|FG004|Maintenance Period|Subject/guardian decision|10|||
147151318|NCT01406938|530716510|FG005|Maintenance Period|Subject/guardian decision|7|||
147576580|NCT00263588|532265525|FG000|Overall Study|Withdrawal by Subject|3|||
147576581|NCT00263588|532265526|FG001|Overall Study|Withdrawal by Subject|4|||
147576582|NCT00263588|532265525|FG000|Overall Study|Protocol Violation|0|||
147151319|NCT01406938|530716505|FG000|Maintenance Period|Protocol Violation|0|||
147151320|NCT01406938|530716506|FG001|Maintenance Period|Protocol Violation|0|||
147151321|NCT01406938|530716507|FG002|Maintenance Period|Protocol Violation|2|||
147576583|NCT00263588|532265526|FG001|Overall Study|Protocol Violation|1|||
147576584|NCT00263588|532265525|FG000|Overall Study|Investigator decision|7|||
147576585|NCT00263588|532265526|FG001|Overall Study|Investigator decision|15|||
147576586|NCT00263588|532265525|FG000|Overall Study|Sponsor terminated study|0|||
147576587|NCT00263588|532265526|FG001|Overall Study|Sponsor terminated study|1|||
147576588|NCT02412852|532265527|FG000|Overall Study|Withdrawal by Subject|0|||
147576589|NCT02412852|532265528|FG001|Overall Study|Withdrawal by Subject|1|||
147576590|NCT02412852|532265529|FG002|Overall Study|Withdrawal by Subject|0|||
147576591|NCT02412852|532265530|FG003|Overall Study|Withdrawal by Subject|0|||
147576592|NCT02412852|532265527|FG000|Overall Study|Physician Decision|0|||
147576593|NCT02412852|532265528|FG001|Overall Study|Physician Decision|0|||
147576594|NCT02412852|532265529|FG002|Overall Study|Physician Decision|0|||
147576595|NCT02412852|532265530|FG003|Overall Study|Physician Decision|1|||
147576596|NCT05274763|532265531|FG000|Overall Study|Lost to Follow-up|1|||
147576597|NCT02121184|532265532|FG000|Overall Study|No oxytoxin administered prior to combined spinal epidural catheter placement|1|||
147576598|NCT02121184|532265533|FG001|Overall Study|No oxytoxin administered prior to combined spinal epidural catheter placement|0|||
147576599|NCT02121184|532265532|FG000|Overall Study|Multiple parasthesias at time after combined spinal epidural catheter placement|0|||
147576600|NCT02121184|532265533|FG001|Overall Study|Multiple parasthesias at time after combined spinal epidural catheter placement|1|||
147576601|NCT02121184|532265532|FG000|Overall Study|Emergency cesarean section required|0|||
147576602|NCT02121184|532265533|FG001|Overall Study|Emergency cesarean section required|2|||
147576603|NCT02121184|532265532|FG000|Overall Study|Combined spinal epidural completed without notifying study team|1|||
147576604|NCT02121184|532265533|FG001|Overall Study|Combined spinal epidural completed without notifying study team|0|||
147576605|NCT00101439|532265538|FG000|Period 2|Withdrawal by Subject|0|||
147576606|NCT00101439|532265539|FG001|Period 2|Withdrawal by Subject|2|||
147576607|NCT01867658|532265540|FG000|Overall Study|Withdrawal by Subject|6|||
147151322|NCT01406938|530716508|FG003|Maintenance Period|Protocol Violation|2|||
147151323|NCT01406938|530716509|FG004|Maintenance Period|Protocol Violation|2|||
147151324|NCT01406938|530716510|FG005|Maintenance Period|Protocol Violation|2|||
147151325|NCT01406938|530716505|FG000|Maintenance Period|Pregnancy|0|||
147151326|NCT01406938|530716506|FG001|Maintenance Period|Pregnancy|0|||
147151327|NCT01406938|530716507|FG002|Maintenance Period|Pregnancy|0|||
147151328|NCT01406938|530716508|FG003|Maintenance Period|Pregnancy|0|||
147321092|NCT02711826|531338469|FG004|Overall Study|Physician Decision|0|||
147321093|NCT02711826|531338465|FG000|Overall Study|Withdrawal by Subject|0|||
147321094|NCT02711826|531338466|FG001|Overall Study|Withdrawal by Subject|1|||
147321095|NCT02711826|531338467|FG002|Overall Study|Withdrawal by Subject|0|||
147321096|NCT02711826|531338468|FG003|Overall Study|Withdrawal by Subject|4|||
147321097|NCT02711826|531338469|FG004|Overall Study|Withdrawal by Subject|0|||
147321098|NCT02711826|531338465|FG000|Overall Study|Failure to manufacture cellular product|0|||
147321099|NCT02711826|531338466|FG001|Overall Study|Failure to manufacture cellular product|0|||
147321100|NCT02711826|531338467|FG002|Overall Study|Failure to manufacture cellular product|5|||
147321101|NCT02711826|531338468|FG003|Overall Study|Failure to manufacture cellular product|0|||
147321102|NCT02711826|531338469|FG004|Overall Study|Failure to manufacture cellular product|0|||
147321103|NCT02711826|531338465|FG000|Overall Study|Infusion canceled for active infection|0|||
147321104|NCT02711826|531338466|FG001|Overall Study|Infusion canceled for active infection|1|||
147321105|NCT02711826|531338467|FG002|Overall Study|Infusion canceled for active infection|0|||
147321106|NCT02711826|531338468|FG003|Overall Study|Infusion canceled for active infection|0|||
147321107|NCT02711826|531338469|FG004|Overall Study|Infusion canceled for active infection|0|||
147321108|NCT02711826|531338465|FG000|Overall Study|Screen failures|0|||
147321109|NCT02711826|531338466|FG001|Overall Study|Screen failures|0|||
147321110|NCT02711826|531338467|FG002|Overall Study|Screen failures|0|||
147321111|NCT02711826|531338468|FG003|Overall Study|Screen failures|4|||
147321112|NCT02711826|531338469|FG004|Overall Study|Screen failures|0|||
147576608|NCT01867658|532265540|FG000|Overall Study|Death|2|||
147576609|NCT01867658|532265540|FG000|Overall Study|Subject could not be contacted|1|||
147576610|NCT02845336|532265541|FG000|Overall Study|Lost to Follow-up|3|||
147321113|NCT00729690|531338471|FG000|Overall Study|IT Catheter Malfunction|0|||
147321114|NCT00729690|531338472|FG001|Overall Study|IT Catheter Malfunction|2|||
147321115|NCT00729690|531338473|FG002|Overall Study|IT Catheter Malfunction|2|||
147321116|NCT02169219|531338474|FG000|Overall Study|Lack of Efficacy|6|||
147321117|NCT02886936|531338475|FG000|Overall Study|Lost to Follow-up|4|||
147321118|NCT02886936|531338476|FG001|Overall Study|Lost to Follow-up|3|||
147321119|NCT02886936|531338477|FG002|Overall Study|Lost to Follow-up|0|||
147321120|NCT02507219|531338478|FG000|Overall Study|Physician Decision|1|||
147321121|NCT02507219|531338479|FG001|Overall Study|Physician Decision|0|||
147321122|NCT02507219|531338480|FG002|Overall Study|Physician Decision|0|||
147321123|NCT02507219|531338481|FG003|Overall Study|Physician Decision|0|||
147321124|NCT02507219|531338482|FG004|Overall Study|Physician Decision|0|||
147321125|NCT02507219|531338483|FG005|Overall Study|Physician Decision|0|||
147321126|NCT02507219|531338478|FG000|Overall Study|Withdrawal by Subject|0|||
147321127|NCT02507219|531338479|FG001|Overall Study|Withdrawal by Subject|0|||
147321128|NCT02507219|531338480|FG002|Overall Study|Withdrawal by Subject|0|||
147321129|NCT02507219|531338481|FG003|Overall Study|Withdrawal by Subject|0|||
147321130|NCT02507219|531338482|FG004|Overall Study|Withdrawal by Subject|1|||
147321131|NCT02507219|531338483|FG005|Overall Study|Withdrawal by Subject|0|||
147321132|NCT02320721|531338484|FG000|Overall Study|Adverse Event|6|||
147321133|NCT02320721|531338485|FG001|Overall Study|Adverse Event|6|||
147321134|NCT02320721|531338484|FG000|Overall Study|Lack of Efficacy|2|||
147321135|NCT02320721|531338485|FG001|Overall Study|Lack of Efficacy|0|||
147321136|NCT02320721|531338484|FG000|Overall Study|Poor compliance to protocol|3|||
147321137|NCT02320721|531338485|FG001|Overall Study|Poor compliance to protocol|7|||
147321138|NCT02320721|531338484|FG000|Overall Study|Randomized but not treated|0|||
147321139|NCT02320721|531338485|FG001|Overall Study|Randomized but not treated|1|||
147321140|NCT02320721|531338484|FG000|Overall Study|Hypoglycemia|1|||
147321141|NCT02320721|531338485|FG001|Overall Study|Hypoglycemia|0|||
147576611|NCT02845336|532265542|FG001|Overall Study|Lost to Follow-up|1|||
147576612|NCT02845336|532265541|FG000|Overall Study|Inability to get medication|2|||
147576613|NCT02845336|532265542|FG001|Overall Study|Inability to get medication|0|||
147576614|NCT01496118|532265543|FG000|Overall Study|Disease progression|3|||
147576615|NCT01496118|532265544|FG001|Overall Study|Disease progression|2|||
147576616|NCT01496118|532265545|FG002|Overall Study|Disease progression|3|||
147576617|NCT01496118|532265546|FG003|Overall Study|Disease progression|1|||
147576618|NCT01496118|532265547|FG004|Overall Study|Disease progression|2|||
147576619|NCT01496118|532265548|FG005|Overall Study|Disease progression|2|||
147576620|NCT01496118|532265549|FG006|Overall Study|Disease progression|14|||
147576621|NCT01496118|532265550|FG007|Overall Study|Disease progression|10|||
147576622|NCT01496118|532265543|FG000|Overall Study|Physician Decision|0|||
147576623|NCT01496118|532265544|FG001|Overall Study|Physician Decision|0|||
147576624|NCT01496118|532265545|FG002|Overall Study|Physician Decision|0|||
147321142|NCT02320721|531338484|FG000|Overall Study|Other than specified above|15|||
147321143|NCT02320721|531338485|FG001|Overall Study|Other than specified above|20|||
147321144|NCT02419755|531338486|FG000|Overall Study|Death|1|||
147321145|NCT02419755|531338487|FG001|Overall Study|Death|3|||
147576625|NCT01496118|532265546|FG003|Overall Study|Physician Decision|0|||
147576626|NCT01496118|532265547|FG004|Overall Study|Physician Decision|1|||
147576627|NCT01496118|532265548|FG005|Overall Study|Physician Decision|0|||
147321146|NCT02419755|531338486|FG000|Overall Study|Relapse|0|||
147576628|NCT01496118|532265549|FG006|Overall Study|Physician Decision|3|||
147576629|NCT01496118|532265550|FG007|Overall Study|Physician Decision|6|||
147321147|NCT02419755|531338487|FG001|Overall Study|Relapse|1|||
147321148|NCT02419755|531338486|FG000|Overall Study|Ineligible|1|||
147321149|NCT02419755|531338487|FG001|Overall Study|Ineligible|0|||
147321150|NCT02419755|531338486|FG000|Overall Study|Withdrawal by Subject|1|||
147321151|NCT02419755|531338487|FG001|Overall Study|Withdrawal by Subject|0|||
147321152|NCT05397470|531338490|FG000|Part A: PCT Period (Up to 48 Weeks)|Adverse Event|0|||
147321153|NCT05397470|531338491|FG001|Part A: PCT Period (Up to 48 Weeks)|Adverse Event|1|||
147653052|NCT01348100|532551910|FG005|Overall Study|Lost to Follow-up|0|||
147653053|NCT01348100|532551911|FG006|Overall Study|Lost to Follow-up|1|||
147653054|NCT01348100|532551905|FG000|Overall Study|Administrative Problems|0|||
147653055|NCT01348100|532551906|FG001|Overall Study|Administrative Problems|0|||
147653056|NCT01348100|532551907|FG002|Overall Study|Administrative Problems|0|||
147653057|NCT01348100|532551908|FG003|Overall Study|Administrative Problems|0|||
147653058|NCT01348100|532551909|FG004|Overall Study|Administrative Problems|0|||
147653059|NCT01348100|532551910|FG005|Overall Study|Administrative Problems|1|||
147653060|NCT01348100|532551911|FG006|Overall Study|Administrative Problems|1|||
147653061|NCT02347072|532551914|FG000|Overall Study|Adverse Event|2|||
147653062|NCT02347072|532551914|FG000|Overall Study|Withdrawal by Subject|6|||
147653063|NCT02347072|532551914|FG000|Overall Study|Physician Decision|1|||
147653064|NCT02347072|532551914|FG000|Overall Study|Lost to Follow-up|2|||
147653065|NCT02347072|532551914|FG000|Overall Study|Protocol Violation|1|||
147653066|NCT02347072|532551914|FG000|Overall Study|Disc due to Protocol-specified Criteria|6|||
147653067|NCT01134393|532551920|FG000|Overall Study|Adverse Event|18|||
147653068|NCT01134393|532551920|FG000|Overall Study|Lack of Efficacy|2|||
147653069|NCT01134393|532551920|FG000|Overall Study|Protocol Violation|12|||
147653070|NCT01134393|532551920|FG000|Overall Study|Lost to Follow-up|3|||
147653071|NCT01134393|532551920|FG000|Overall Study|Withdrawal by Subject|11|||
147653072|NCT01134393|532551920|FG000|Overall Study|Other|6|||
147653073|NCT01808222|532551924|FG000|Overall Study|mpMR scan was not performed|1|||
147653074|NCT03762681|532551927|FG000|Part 1|Withdrawal by Subject|0|||
147653075|NCT03762681|532551928|FG001|Part 1|Withdrawal by Subject|0|||
147653076|NCT03762681|532551929|FG002|Part 1|Withdrawal by Subject|0|||
147653077|NCT03762681|532551930|FG003|Part 1|Withdrawal by Subject|1|||
147653078|NCT03762681|532551931|FG004|Part 1|Withdrawal by Subject|0|||
147653079|NCT03762681|532551932|FG005|Part 1|Withdrawal by Subject|0|||
147653080|NCT03762681|532551933|FG006|Part 1|Withdrawal by Subject|0|||
147653081|NCT03762681|532551934|FG007|Part 1|Withdrawal by Subject|0|||
147653082|NCT03762681|532551927|FG000|Part 2a|Pandemic Travel Restrictions|0|||
147653083|NCT03762681|532551928|FG001|Part 2a|Pandemic Travel Restrictions|0|||
147653084|NCT03762681|532551929|FG002|Part 2a|Pandemic Travel Restrictions|0|||
147653085|NCT03762681|532551930|FG003|Part 2a|Pandemic Travel Restrictions|0|||
147653086|NCT03762681|532551931|FG004|Part 2a|Pandemic Travel Restrictions|0|||
147653087|NCT03762681|532551932|FG005|Part 2a|Pandemic Travel Restrictions|0|||
147653088|NCT03762681|532551933|FG006|Part 2a|Pandemic Travel Restrictions|0|||
147653089|NCT03762681|532551934|FG007|Part 2a|Pandemic Travel Restrictions|1|||
147653090|NCT00524680|532551937|FG000|Overall Study|progression|0|||
147653091|NCT00524680|532551938|FG001|Overall Study|progression|0|||
147653092|NCT00524680|532551939|FG002|Overall Study|progression|0|||
147653093|NCT00524680|532551940|FG003|Overall Study|progression|1|||
147653094|NCT00524680|532551937|FG000|Overall Study|Adverse Event|2|||
147653095|NCT00524680|532551938|FG001|Overall Study|Adverse Event|0|||
147653096|NCT00524680|532551939|FG002|Overall Study|Adverse Event|0|||
147653097|NCT00524680|532551940|FG003|Overall Study|Adverse Event|1|||
147653098|NCT00524680|532551937|FG000|Overall Study|Other|0|||
147653099|NCT00524680|532551938|FG001|Overall Study|Other|1|||
147653100|NCT00524680|532551939|FG002|Overall Study|Other|2|||
147653101|NCT00524680|532551940|FG003|Overall Study|Other|3|||
147653102|NCT00524680|532551937|FG000|Overall Study|Withdrawal by Subject|1|||
147653103|NCT00524680|532551938|FG001|Overall Study|Withdrawal by Subject|0|||
147653104|NCT00524680|532551939|FG002|Overall Study|Withdrawal by Subject|1|||
147321154|NCT05397470|531338492|FG002|Part A: PCT Period (Up to 48 Weeks)|Adverse Event|0|||
147446058|NCT02258451|531797540|FG000|Overall Study|Discontinuation all treatment due to study terminated by sponsor|0|||
147653105|NCT00524680|532551940|FG003|Overall Study|Withdrawal by Subject|1|||
147653106|NCT01146561|532551941|FG000|Overall Study|Withdrawal by Subject|1|||
147321155|NCT05397470|531338490|FG000|Part A: PCT Period (Up to 48 Weeks)|Protocol Violation|1|||
147321156|NCT05397470|531338491|FG001|Part A: PCT Period (Up to 48 Weeks)|Protocol Violation|1|||
147321157|NCT05397470|531338492|FG002|Part A: PCT Period (Up to 48 Weeks)|Protocol Violation|0|||
147653107|NCT01146561|532551941|FG000|Overall Study|Lost to Follow-up|1|||
147653108|NCT04318132|532551944|FG000|Overall Study|Protocol Violation|0|||
147653109|NCT04318132|532551945|FG001|Overall Study|Protocol Violation|0|||
147653110|NCT04318132|532551946|FG002|Overall Study|Protocol Violation|3|||
147653111|NCT04318132|532551947|FG003|Overall Study|Protocol Violation|0|||
147653112|NCT00073008|532551949|FG000|Overall Study|Missing|6|||
147653113|NCT00073008|532551950|FG001|Overall Study|Missing|6|||
147653114|NCT00073008|532551949|FG000|Overall Study|Withdrawal by Subject|2|||
147653115|NCT00073008|532551950|FG001|Overall Study|Withdrawal by Subject|2|||
147653116|NCT00073008|532551949|FG000|Overall Study|Lost to Follow-up|1|||
147653117|NCT00073008|532551950|FG001|Overall Study|Lost to Follow-up|3|||
147653118|NCT00073008|532551949|FG000|Overall Study|Death|46|||
147653119|NCT00073008|532551950|FG001|Overall Study|Death|47|||
147653120|NCT00073008|532551949|FG000|Overall Study|"Other selected on Case Report Form"|7|||
147653121|NCT00073008|532551950|FG001|Overall Study|"Other selected on Case Report Form"|5|||
147653122|NCT01926197|532551951|FG000|Overall Study|Withdrawn to receive chemotherapy|1|||
147653123|NCT01926197|532551952|FG001|Overall Study|Withdrawn to receive chemotherapy|0|||
147653124|NCT01926197|532551951|FG000|Overall Study|Withdrawn due to non-coverage by insurance|0|||
147653125|NCT01926197|532551952|FG001|Overall Study|Withdrawn due to non-coverage by insurance|1|||
147653126|NCT03628716|532551953|FG000|Overall Study|Adverse Event|1|||
147653127|NCT03628716|532551954|FG001|Overall Study|Adverse Event|1|||
147653128|NCT03628716|532551953|FG000|Overall Study|Death|1|||
147653129|NCT03628716|532551954|FG001|Overall Study|Death|0|||
147653130|NCT03628716|532551953|FG000|Overall Study|Lack of Efficacy|15|||
147653131|NCT03628716|532551954|FG001|Overall Study|Lack of Efficacy|20|||
147653132|NCT03628716|532551953|FG000|Overall Study|Withdrawal by Subject|1|||
147653133|NCT03628716|532551954|FG001|Overall Study|Withdrawal by Subject|2|||
147653134|NCT03628716|532551953|FG000|Overall Study|Study Terminated by Sponsor|1|||
147653135|NCT03628716|532551954|FG001|Overall Study|Study Terminated by Sponsor|0|||
147653136|NCT00856843|532551955|FG000|Overall Study|Withdrawal by Subject|1|||
147653137|NCT00856843|532551956|FG001|Overall Study|Withdrawal by Subject|5|||
147653138|NCT00856843|532551955|FG000|Overall Study|Lack of Efficacy|1|||
147653139|NCT00856843|532551956|FG001|Overall Study|Lack of Efficacy|0|||
147653140|NCT00829829|532551957|FG000|Overall Study|Protocol Violation|0|||
147653141|NCT00829829|532551958|FG001|Overall Study|Protocol Violation|3|||
147653142|NCT00829829|532551959|FG002|Overall Study|Protocol Violation|0|||
147653143|NCT00829829|532551957|FG000|Overall Study|Adverse Event|4|||
147653144|NCT00829829|532551958|FG001|Overall Study|Adverse Event|4|||
147653145|NCT00829829|532551959|FG002|Overall Study|Adverse Event|3|||
147653146|NCT00829829|532551957|FG000|Overall Study|Withdrawal by Subject|8|||
147653147|NCT00829829|532551958|FG001|Overall Study|Withdrawal by Subject|4|||
147151329|NCT01406938|530716509|FG004|Maintenance Period|Pregnancy|1|||
147151330|NCT01406938|530716510|FG005|Maintenance Period|Pregnancy|0|||
147151331|NCT01406938|530716505|FG000|Maintenance Period|Lost to Follow-up|0|||
147151332|NCT01406938|530716506|FG001|Maintenance Period|Lost to Follow-up|0|||
147151333|NCT01406938|530716507|FG002|Maintenance Period|Lost to Follow-up|0|||
147151334|NCT01406938|530716508|FG003|Maintenance Period|Lost to Follow-up|0|||
147151335|NCT01406938|530716509|FG004|Maintenance Period|Lost to Follow-up|4|||
147151336|NCT01406938|530716510|FG005|Maintenance Period|Lost to Follow-up|0|||
147151337|NCT01406938|530716505|FG000|Maintenance Period|Lack of Efficacy|0|||
147151338|NCT01406938|530716506|FG001|Maintenance Period|Lack of Efficacy|0|||
147151339|NCT01406938|530716507|FG002|Maintenance Period|Lack of Efficacy|2|||
147151340|NCT01406938|530716508|FG003|Maintenance Period|Lack of Efficacy|1|||
147151341|NCT01406938|530716509|FG004|Maintenance Period|Lack of Efficacy|3|||
147151342|NCT01406938|530716510|FG005|Maintenance Period|Lack of Efficacy|5|||
147151343|NCT01406938|530716505|FG000|Follow up|Lack of Efficacy|3|||
147151344|NCT01406938|530716506|FG001|Follow up|Lack of Efficacy|2|||
147151345|NCT01406938|530716507|FG002|Follow up|Lack of Efficacy|1|||
147151346|NCT01406938|530716508|FG003|Follow up|Lack of Efficacy|0|||
147151347|NCT01406938|530716509|FG004|Follow up|Lack of Efficacy|0|||
147151348|NCT01406938|530716510|FG005|Follow up|Lack of Efficacy|0|||
147151349|NCT01406938|530716505|FG000|Follow up|Patient/guardian decision|4|||
147151350|NCT01406938|530716506|FG001|Follow up|Patient/guardian decision|2|||
147151351|NCT01406938|530716507|FG002|Follow up|Patient/guardian decision|4|||
147151352|NCT01406938|530716508|FG003|Follow up|Patient/guardian decision|2|||
147151353|NCT01406938|530716509|FG004|Follow up|Patient/guardian decision|4|||
147151354|NCT01406938|530716510|FG005|Follow up|Patient/guardian decision|1|||
147151355|NCT01406938|530716505|FG000|Follow up|Protocol Violation|0|||
147151356|NCT01406938|530716506|FG001|Follow up|Protocol Violation|0|||
147151357|NCT01406938|530716507|FG002|Follow up|Protocol Violation|1|||
147151358|NCT01406938|530716508|FG003|Follow up|Protocol Violation|0|||
147151359|NCT01406938|530716509|FG004|Follow up|Protocol Violation|0|||
147151360|NCT01406938|530716510|FG005|Follow up|Protocol Violation|0|||
147151361|NCT01406938|530716505|FG000|Follow up|Physician Decision|0|||
147151362|NCT01406938|530716506|FG001|Follow up|Physician Decision|0|||
147653148|NCT00829829|532551959|FG002|Overall Study|Withdrawal by Subject|2|||
147653149|NCT00829829|532551957|FG000|Overall Study|Decision by the Sponsor|1|||
147653150|NCT00829829|532551958|FG001|Overall Study|Decision by the Sponsor|0|||
147653151|NCT00829829|532551959|FG002|Overall Study|Decision by the Sponsor|2|||
147653152|NCT00829829|532551957|FG000|Overall Study|Lost to Follow-up|7|||
147151363|NCT01406938|530716507|FG002|Follow up|Physician Decision|2|||
147151364|NCT01406938|530716508|FG003|Follow up|Physician Decision|0|||
147151365|NCT01406938|530716509|FG004|Follow up|Physician Decision|3|||
147151366|NCT01406938|530716510|FG005|Follow up|Physician Decision|1|||
147151367|NCT01406938|530716505|FG000|Follow up|Lost to Follow-up|1|||
147151368|NCT01406938|530716506|FG001|Follow up|Lost to Follow-up|1|||
147653153|NCT00829829|532551958|FG001|Overall Study|Lost to Follow-up|3|||
147653154|NCT00829829|532551959|FG002|Overall Study|Lost to Follow-up|3|||
147653155|NCT00829829|532551957|FG000|Overall Study|Other than specified above|2|||
147151369|NCT01406938|530716507|FG002|Follow up|Lost to Follow-up|0|||
147151370|NCT01406938|530716508|FG003|Follow up|Lost to Follow-up|1|||
147151371|NCT01406938|530716509|FG004|Follow up|Lost to Follow-up|2|||
147151372|NCT01406938|530716510|FG005|Follow up|Lost to Follow-up|1|||
147151373|NCT01576146|530716515|FG000|Extension Period 1|Adverse Event|2|||
147151374|NCT01576146|530716515|FG000|Extension Period 1|Death|2|||
147151375|NCT01576146|530716515|FG000|Extension Period 1|Physician Decision|2|||
147151376|NCT01576146|530716515|FG000|Extension Period 1|Withdrawal by Subject|1|||
147151377|NCT01576146|530716515|FG000|Extension Period 1|Lost to Follow-up|1|||
147151378|NCT01576146|530716515|FG000|Extension Period 1|Parathyroidectomy|1|||
147151379|NCT01576146|530716515|FG000|Extension Period 1|Renal Transplant|1|||
147151380|NCT01576146|530716515|FG000|Extension Period 2|Sponsor Decision|13|||
147151381|NCT01576146|530716515|FG000|Extension Period 2|Death|1|||
147151382|NCT01576146|530716515|FG000|Extension Period 2|Adverse Event|1|||
147151383|NCT01576146|530716515|FG000|Extension Period 2|Renal Transplant|1|||
147151384|NCT01576146|530716515|FG000|Extension Period 2|Treatment Not Resumed Within 8 Weeks|1|||
147151385|NCT01667224|530716520|FG000|Overall Study|Withdrawal by Subject|3|||
147151386|NCT01667224|530716521|FG001|Overall Study|Withdrawal by Subject|1|||
147151387|NCT01667224|530716520|FG000|Overall Study|Protocol Violation|1|||
147151388|NCT01667224|530716521|FG001|Overall Study|Protocol Violation|1|||
147151389|NCT01811485|530716522|FG000|Overall Study|Adverse Event|1|||
147151390|NCT01811485|530716523|FG001|Overall Study|Adverse Event|3|||
147151391|NCT01811485|530716524|FG002|Overall Study|Adverse Event|2|||
147151392|NCT01811485|530716522|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
147151393|NCT01811485|530716523|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
147151394|NCT01811485|530716524|FG002|Overall Study|Unsatisfactory therapeutic effect|3|||
147151395|NCT01811485|530716522|FG000|Overall Study|Administrative problems|1|||
147151396|NCT01811485|530716523|FG001|Overall Study|Administrative problems|0|||
147151397|NCT01811485|530716524|FG002|Overall Study|Administrative problems|0|||
147151398|NCT01811485|530716522|FG000|Overall Study|Protocol Deviation|0|||
147151399|NCT01811485|530716523|FG001|Overall Study|Protocol Deviation|1|||
147151400|NCT01811485|530716524|FG002|Overall Study|Protocol Deviation|0|||
147151401|NCT01545934|530716525|FG000|Overall Study|Withdrawal by Subject|4|||
147151402|NCT01545934|530716526|FG001|Overall Study|Withdrawal by Subject|3|||
147151403|NCT01545934|530716525|FG000|Overall Study|Lost to Follow-up|1|||
147151404|NCT01545934|530716526|FG001|Overall Study|Lost to Follow-up|0|||
147151405|NCT03654404|530716527|FG000|Overall Study|Death|1|||
147151406|NCT03654404|530716527|FG000|Overall Study|Lost to Follow-up|2|||
147151407|NCT03654404|530716527|FG000|Overall Study|Withdrawal by Subject|5|||
147151408|NCT03299881|530716528|FG000|Overall Study|Study Termination|17|||
147151409|NCT03299881|530716529|FG001|Overall Study|Study Termination|13|||
147151410|NCT01474772|530716530|FG000|Period 1|Adverse Event (AE) Related to Study Drug|6|||
147151411|NCT01474772|530716531|FG001|Period 1|Adverse Event (AE) Related to Study Drug|1|||
147151412|NCT01474772|530716530|FG000|Period 1|AE not Related to Study Drug|1|||
147151413|NCT01474772|530716531|FG001|Period 1|AE not Related to Study Drug|0|||
147151414|NCT01474772|530716530|FG000|Period 1|Withdrawal by Subject|3|||
147151415|NCT01474772|530716531|FG001|Period 1|Withdrawal by Subject|1|||
147151416|NCT01474772|530716530|FG000|Period 1|Lost to Follow-up|1|||
147151417|NCT01474772|530716531|FG001|Period 1|Lost to Follow-up|0|||
147151418|NCT01474772|530716530|FG000|Period 1|Reason not Specified|1|||
147151419|NCT01474772|530716531|FG001|Period 1|Reason not Specified|1|||
147151420|NCT01474772|530716530|FG000|Washout|AE not Related to Study Drug|2|||
147151421|NCT01474772|530716531|FG001|Washout|AE not Related to Study Drug|0|||
147151422|NCT01474772|530716530|FG000|Washout|Withdrawal by Subject|1|||
147151423|NCT01474772|530716531|FG001|Washout|Withdrawal by Subject|0|||
147151424|NCT01474772|530716530|FG000|Washout|Lost to Follow-up|0|||
147151425|NCT01474772|530716531|FG001|Washout|Lost to Follow-up|1|||
147151426|NCT01474772|530716530|FG000|Washout|Reason not Specified|0|||
147151427|NCT01474772|530716531|FG001|Washout|Reason not Specified|1|||
147151428|NCT01474772|530716530|FG000|Period 2|Death|0|||
147151429|NCT01474772|530716531|FG001|Period 2|Death|1|||
147151430|NCT01474772|530716530|FG000|Period 2|AE Related to Study Drug|0|||
147151431|NCT01474772|530716531|FG001|Period 2|AE Related to Study Drug|1|||
147151432|NCT01474772|530716530|FG000|Period 2|AE not Related to Study Drug|4|||
147151433|NCT01474772|530716531|FG001|Period 2|AE not Related to Study Drug|1|||
147151434|NCT01474772|530716530|FG000|Period 2|Lack of Efficacy|1|||
147239634|NCT01090492|531049260|FG005|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
147239635|NCT01090492|531049261|FG006|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
147239636|NCT01090492|531049262|FG007|First Intervention Period (4 Weeks)|Lost to Follow-up|0|||
147239637|NCT01090492|531049255|FG000|First Intervention Period (4 Weeks)|Other|0|||
147239638|NCT01090492|531049256|FG001|First Intervention Period (4 Weeks)|Other|0|||
147239639|NCT01090492|531049257|FG002|First Intervention Period (4 Weeks)|Other|1|||
147151435|NCT01474772|530716531|FG001|Period 2|Lack of Efficacy|0|||
147239640|NCT01090492|531049258|FG003|First Intervention Period (4 Weeks)|Other|1|||
147151436|NCT01474772|530716530|FG000|Period 2|Withdrawal by Subject|3|||
147151437|NCT01474772|530716531|FG001|Period 2|Withdrawal by Subject|4|||
147151438|NCT01474772|530716530|FG000|Period 2|Lost to Follow-up|1|||
147151439|NCT01474772|530716531|FG001|Period 2|Lost to Follow-up|1|||
147151440|NCT01474772|530716530|FG000|Period 2|Reason not Specified|0|||
147151441|NCT01474772|530716531|FG001|Period 2|Reason not Specified|2|||
147151442|NCT01474772|530716530|FG000|Follow-up|AE not Related to Study Drug|0|||
147151443|NCT01474772|530716531|FG001|Follow-up|AE not Related to Study Drug|1|||
147151444|NCT01822899|530716532|FG000|Overall Study|Adverse Event|6|||
147151445|NCT01822899|530716533|FG001|Overall Study|Adverse Event|5|||
147151446|NCT01822899|530716532|FG000|Overall Study|Lack of Efficacy|6|||
147151447|NCT01822899|530716533|FG001|Overall Study|Lack of Efficacy|3|||
147151448|NCT01822899|530716532|FG000|Overall Study|Protocol Violation|6|||
147151449|NCT01822899|530716533|FG001|Overall Study|Protocol Violation|3|||
147151450|NCT01822899|530716532|FG000|Overall Study|Lost to Follow-up|1|||
147151451|NCT01822899|530716533|FG001|Overall Study|Lost to Follow-up|0|||
147151452|NCT01822899|530716532|FG000|Overall Study|Withdrawal by Subject|5|||
147151453|NCT01822899|530716533|FG001|Overall Study|Withdrawal by Subject|7|||
147151454|NCT02314156|530716534|FG000|Overall Study|Adverse Event|1|||
147151455|NCT02314156|530716535|FG001|Overall Study|Adverse Event|0|||
147151456|NCT02314156|530716534|FG000|Overall Study|Withdrawal by Subject|1|||
147151457|NCT02314156|530716535|FG001|Overall Study|Withdrawal by Subject|0|||
147151458|NCT02846389|530716536|FG000|Overall Study|Withdrawal by Subject|1|||
147151459|NCT02846389|530716537|FG001|Overall Study|Withdrawal by Subject|1|||
147151460|NCT02321319|530716538|FG000|Overall Study|Product discontinued|5|||
147151461|NCT02249091|530716539|FG000|Overall Study|Lack of Efficacy|8|||
147151462|NCT02249091|530716540|FG001|Overall Study|Lack of Efficacy|3|||
147151463|NCT02249091|530716539|FG000|Overall Study|Physician Decision|4|||
147151464|NCT02249091|530716540|FG001|Overall Study|Physician Decision|1|||
147151465|NCT02249091|530716539|FG000|Overall Study|Withdrawal by Subject|2|||
147151466|NCT02249091|530716540|FG001|Overall Study|Withdrawal by Subject|2|||
147151467|NCT02249091|530716539|FG000|Overall Study|Death|3|||
147151468|NCT02249091|530716540|FG001|Overall Study|Death|4|||
147151469|NCT02249091|530716539|FG000|Overall Study|Adverse Event|1|||
147151470|NCT02249091|530716540|FG001|Overall Study|Adverse Event|0|||
147151471|NCT02249091|530716539|FG000|Overall Study|Stable disease with following SCT|0|||
147151472|NCT02249091|530716540|FG001|Overall Study|Stable disease with following SCT|1|||
147151473|NCT02249091|530716539|FG000|Overall Study|Ongoing bone marrow aplasia, periph. pancytopenia|0|||
147151474|NCT02249091|530716540|FG001|Overall Study|Ongoing bone marrow aplasia, periph. pancytopenia|1|||
147151475|NCT02249091|530716539|FG000|Overall Study|CR with subsequent donor lymphocyte infusion|1|||
147151476|NCT02249091|530716540|FG001|Overall Study|CR with subsequent donor lymphocyte infusion|0|||
147151477|NCT02249091|530716539|FG000|Overall Study|Refractory AML|1|||
147151478|NCT02249091|530716540|FG001|Overall Study|Refractory AML|1|||
147151479|NCT05059301|530716541|FG000|Overall Study|Adverse Event|0|||
147151480|NCT05059301|530716542|FG001|Overall Study|Adverse Event|2|||
147151481|NCT05059301|530716543|FG002|Overall Study|Adverse Event|2|||
147151482|NCT05059301|530716541|FG000|Overall Study|Lost to Follow-up|2|||
147151483|NCT05059301|530716542|FG001|Overall Study|Lost to Follow-up|3|||
147151484|NCT05059301|530716543|FG002|Overall Study|Lost to Follow-up|3|||
147151485|NCT00853242|530716544|FG000|Overall Study|Adverse Event|0|||
147151486|NCT00853242|530716545|FG001|Overall Study|Adverse Event|1|||
147151487|NCT00853242|530716546|FG002|Overall Study|Adverse Event|1|||
147151488|NCT00853242|530716547|FG003|Overall Study|Adverse Event|0|||
147151489|NCT00853242|530716548|FG004|Overall Study|Adverse Event|3|||
147151490|NCT00853242|530716549|FG005|Overall Study|Adverse Event|1|||
147151491|NCT00853242|530716550|FG006|Overall Study|Adverse Event|1|||
147576630|NCT01496118|532265543|FG000|Overall Study|Adverse Event|1|||
147151492|NCT00853242|530716544|FG000|Overall Study|Noncompliant|0|||
147239641|NCT01090492|531049259|FG004|First Intervention Period (4 Weeks)|Other|2|||
147239642|NCT01090492|531049260|FG005|First Intervention Period (4 Weeks)|Other|0|||
147239643|NCT01090492|531049261|FG006|First Intervention Period (4 Weeks)|Other|0|||
147239644|NCT01090492|531049262|FG007|First Intervention Period (4 Weeks)|Other|0|||
147239645|NCT01090492|531049255|FG000|First Intervention Period (4 Weeks)|Pregnancy|0|||
147239646|NCT01090492|531049256|FG001|First Intervention Period (4 Weeks)|Pregnancy|0|||
147239647|NCT01090492|531049257|FG002|First Intervention Period (4 Weeks)|Pregnancy|0|||
147576631|NCT01496118|532265544|FG001|Overall Study|Adverse Event|1|||
147576632|NCT01496118|532265545|FG002|Overall Study|Adverse Event|0|||
147576633|NCT01496118|532265546|FG003|Overall Study|Adverse Event|0|||
147151493|NCT00853242|530716545|FG001|Overall Study|Noncompliant|0|||
147239648|NCT01090492|531049258|FG003|First Intervention Period (4 Weeks)|Pregnancy|0|||
147239649|NCT01090492|531049259|FG004|First Intervention Period (4 Weeks)|Pregnancy|1|||
147239650|NCT01090492|531049260|FG005|First Intervention Period (4 Weeks)|Pregnancy|0|||
147576634|NCT01496118|532265547|FG004|Overall Study|Adverse Event|0|||
147151494|NCT00853242|530716546|FG002|Overall Study|Noncompliant|0|||
147151495|NCT00853242|530716547|FG003|Overall Study|Noncompliant|0|||
147151496|NCT00853242|530716548|FG004|Overall Study|Noncompliant|1|||
147151497|NCT00853242|530716549|FG005|Overall Study|Noncompliant|0|||
147151498|NCT00853242|530716550|FG006|Overall Study|Noncompliant|0|||
147151499|NCT00853242|530716544|FG000|Overall Study|Withdrawal by Subject|1|||
147151500|NCT00853242|530716545|FG001|Overall Study|Withdrawal by Subject|2|||
147151501|NCT00853242|530716546|FG002|Overall Study|Withdrawal by Subject|0|||
147151502|NCT00853242|530716547|FG003|Overall Study|Withdrawal by Subject|4|||
147151503|NCT00853242|530716548|FG004|Overall Study|Withdrawal by Subject|0|||
147151504|NCT00853242|530716549|FG005|Overall Study|Withdrawal by Subject|0|||
147151505|NCT00853242|530716550|FG006|Overall Study|Withdrawal by Subject|2|||
147151506|NCT00853242|530716544|FG000|Overall Study|Other|2|||
147151507|NCT00853242|530716545|FG001|Overall Study|Other|0|||
147151508|NCT00853242|530716546|FG002|Overall Study|Other|2|||
147151509|NCT00853242|530716547|FG003|Overall Study|Other|0|||
147151510|NCT00853242|530716548|FG004|Overall Study|Other|0|||
147151511|NCT00853242|530716549|FG005|Overall Study|Other|1|||
147151512|NCT00853242|530716550|FG006|Overall Study|Other|2|||
147151513|NCT01035463|530716551|FG000|Overall Study|Adverse Event|0|||
147151514|NCT01035463|530716552|FG001|Overall Study|Adverse Event|0|||
147151515|NCT01035463|530716553|FG002|Overall Study|Adverse Event|4|||
147151516|NCT01035463|530716554|FG003|Overall Study|Adverse Event|1|||
147151517|NCT01035463|530716555|FG004|Overall Study|Adverse Event|5|||
147151518|NCT01035463|530716556|FG005|Overall Study|Adverse Event|7|||
147151519|NCT01035463|530716551|FG000|Overall Study|Withdrawal by Subject|0|||
147151520|NCT01035463|530716552|FG001|Overall Study|Withdrawal by Subject|2|||
147151521|NCT01035463|530716553|FG002|Overall Study|Withdrawal by Subject|1|||
147151522|NCT01035463|530716554|FG003|Overall Study|Withdrawal by Subject|0|||
147151523|NCT01035463|530716555|FG004|Overall Study|Withdrawal by Subject|1|||
147151524|NCT01035463|530716556|FG005|Overall Study|Withdrawal by Subject|4|||
147151525|NCT01035463|530716551|FG000|Overall Study|Disease progression|0|||
147151526|NCT01035463|530716552|FG001|Overall Study|Disease progression|0|||
147151527|NCT01035463|530716553|FG002|Overall Study|Disease progression|0|||
147151528|NCT01035463|530716554|FG003|Overall Study|Disease progression|0|||
147151529|NCT01035463|530716555|FG004|Overall Study|Disease progression|0|||
147151530|NCT01035463|530716556|FG005|Overall Study|Disease progression|3|||
147151531|NCT01035463|530716551|FG000|Overall Study|Other Malignancy|0|||
147151532|NCT01035463|530716552|FG001|Overall Study|Other Malignancy|0|||
147151533|NCT01035463|530716553|FG002|Overall Study|Other Malignancy|0|||
147151534|NCT01035463|530716554|FG003|Overall Study|Other Malignancy|0|||
147151535|NCT01035463|530716555|FG004|Overall Study|Other Malignancy|0|||
147151536|NCT01035463|530716556|FG005|Overall Study|Other Malignancy|2|||
147151537|NCT01035463|530716551|FG000|Overall Study|Other|0|||
147151538|NCT01035463|530716552|FG001|Overall Study|Other|0|||
147151539|NCT01035463|530716553|FG002|Overall Study|Other|0|||
147151540|NCT01035463|530716554|FG003|Overall Study|Other|1|||
147151541|NCT01035463|530716555|FG004|Overall Study|Other|0|||
147151542|NCT01035463|530716556|FG005|Overall Study|Other|2|||
147151543|NCT02516098|530716557|FG000|Period 1|Protocol Violation|1|||
147151544|NCT02516098|530716558|FG001|Period 1|Protocol Violation|0|||
147151545|NCT02516098|530716557|FG000|Washout After Period 1|Adverse Event|0|||
147151546|NCT02516098|530716558|FG001|Washout After Period 1|Adverse Event|1|||
147151547|NCT02516098|530716557|FG000|Period 2|Withdrawal by Subject|0|||
147151548|NCT02516098|530716558|FG001|Period 2|Withdrawal by Subject|1|||
147151549|NCT01734395|530716559|FG000|Overall Study|Other|65|||
147151550|NCT01734395|530716559|FG000|Overall Study|Lost to Follow-up|287|||
147151551|NCT01734395|530716559|FG000|Overall Study|Lack of Efficacy|5|||
147151552|NCT01734395|530716559|FG000|Overall Study|Adverse Event|40|||
147151553|NCT01734395|530716559|FG000|Overall Study|Withdrawal by Subject|10|||
147151554|NCT01734395|530716559|FG000|Overall Study|Missing the reasons for not completed|3|||
147151555|NCT01092780|530716560|FG000|Washout Period 1|Adverse Event|0|||
147151556|NCT01092780|530716561|FG001|Washout Period 1|Adverse Event|1|||
147151557|NCT01092780|530716562|FG002|Washout Period 1|Adverse Event|0|||
147151558|NCT01092780|530716563|FG003|Washout Period 1|Adverse Event|0|||
147151559|NCT01092780|530716560|FG000|Washout Period 1|Noncompliance with nCPAP|1|||
147576635|NCT01496118|532265548|FG005|Overall Study|Adverse Event|0|||
147151560|NCT01092780|530716561|FG001|Washout Period 1|Noncompliance with nCPAP|0|||
147151561|NCT01092780|530716562|FG002|Washout Period 1|Noncompliance with nCPAP|0|||
147151562|NCT01092780|530716563|FG003|Washout Period 1|Noncompliance with nCPAP|0|||
147151563|NCT01092780|530716560|FG000|Washout Period 2|Adverse Event|0|||
147151564|NCT01092780|530716561|FG001|Washout Period 2|Adverse Event|1|||
147151565|NCT01092780|530716562|FG002|Washout Period 2|Adverse Event|1|||
147151566|NCT01092780|530716563|FG003|Washout Period 2|Adverse Event|0|||
147151567|NCT01257230|530716564|FG000|Overall Study|Not Treated|0|||
147151568|NCT01257230|530716565|FG001|Overall Study|Not Treated|0|||
147151569|NCT01257230|530716566|FG002|Overall Study|Not Treated|1|||
147151570|NCT01257230|530716564|FG000|Overall Study|Adverse Event|2|||
147151571|NCT01257230|530716565|FG001|Overall Study|Adverse Event|0|||
147151572|NCT01257230|530716566|FG002|Overall Study|Adverse Event|0|||
147151573|NCT01257230|530716564|FG000|Overall Study|Lack of Efficacy|0|||
147151574|NCT01257230|530716565|FG001|Overall Study|Lack of Efficacy|1|||
147151575|NCT01257230|530716566|FG002|Overall Study|Lack of Efficacy|0|||
147151576|NCT01257230|530716564|FG000|Overall Study|Protocol Violation|3|||
147151577|NCT01257230|530716565|FG001|Overall Study|Protocol Violation|0|||
147151578|NCT01257230|530716566|FG002|Overall Study|Protocol Violation|1|||
147151579|NCT01257230|530716564|FG000|Overall Study|Withdrawal by Subject|0|||
147151580|NCT01257230|530716565|FG001|Overall Study|Withdrawal by Subject|4|||
147576636|NCT01496118|532265549|FG006|Overall Study|Adverse Event|6|||
147151581|NCT01257230|530716566|FG002|Overall Study|Withdrawal by Subject|1|||
147151582|NCT01257230|530716564|FG000|Overall Study|Other reason not defined above|1|||
147151583|NCT01257230|530716565|FG001|Overall Study|Other reason not defined above|5|||
147151584|NCT01257230|530716566|FG002|Overall Study|Other reason not defined above|3|||
147151585|NCT04026009|530716569|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
147151586|NCT04026009|530716570|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
147151587|NCT04026009|530716571|FG002|Overall Study|Eligibility criteria not fulfilled|0|||
147151588|NCT04026009|530716572|FG003|Overall Study|Eligibility criteria not fulfilled|1|||
147151589|NCT04026009|530716573|FG004|Overall Study|Eligibility criteria not fulfilled|0|||
147151590|NCT04026009|530716569|FG000|Overall Study|Consent withdrawal, not due to adverse event|0|||
147151591|NCT04026009|530716570|FG001|Overall Study|Consent withdrawal, not due to adverse event|0|||
147151592|NCT04026009|530716571|FG002|Overall Study|Consent withdrawal, not due to adverse event|0|||
147151593|NCT04026009|530716572|FG003|Overall Study|Consent withdrawal, not due to adverse event|0|||
147151594|NCT04026009|530716573|FG004|Overall Study|Consent withdrawal, not due to adverse event|1|||
147151595|NCT02957747|530716574|FG000|Overall Study|Withdrawal by Subject|0|||
147151596|NCT02957747|530716575|FG001|Overall Study|Withdrawal by Subject|3|||
147151597|NCT02957747|530716574|FG000|Overall Study|Lost to Follow-up|10|||
147151598|NCT02957747|530716575|FG001|Overall Study|Lost to Follow-up|5|||
147151599|NCT02466425|530716578|FG000|Overall Study|Adverse Event|3|||
147151600|NCT02466425|530716579|FG001|Overall Study|Adverse Event|11|||
147151601|NCT02466425|530716578|FG000|Overall Study|Lack of Efficacy|4|||
147151602|NCT02466425|530716579|FG001|Overall Study|Lack of Efficacy|1|||
147151603|NCT02466425|530716578|FG000|Overall Study|Lost to Follow-up|3|||
147151604|NCT02466425|530716579|FG001|Overall Study|Lost to Follow-up|0|||
147151605|NCT02466425|530716578|FG000|Overall Study|Protocol Violation|1|||
147151606|NCT02466425|530716579|FG001|Overall Study|Protocol Violation|0|||
147151607|NCT02466425|530716578|FG000|Overall Study|Withdrawal by Subject|0|||
147151608|NCT02466425|530716579|FG001|Overall Study|Withdrawal by Subject|1|||
147151609|NCT02466425|530716578|FG000|Overall Study|Other|1|||
147151610|NCT02466425|530716579|FG001|Overall Study|Other|3|||
147151611|NCT02466425|530716578|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
147151612|NCT02466425|530716579|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
147151613|NCT01721486|530716584|FG000|Overall Study|Protocol Violation|1|||
147151614|NCT01721486|530716585|FG001|Overall Study|Protocol Violation|0|||
147151615|NCT01721486|530716584|FG000|Overall Study|Physician Decision|0|||
147151616|NCT01721486|530716585|FG001|Overall Study|Physician Decision|1|||
147151617|NCT00582712|530716586|FG000|Overall Study|Adverse Event|1|||
147151618|NCT00582712|530716586|FG000|Overall Study|Lack of Efficacy|1|||
147151619|NCT00582712|530716586|FG000|Overall Study|Withdrawal by Subject|1|||
147151620|NCT00582712|530716586|FG000|Overall Study|Complicating disease requiring treatment|1|||
147151621|NCT01901289|530716587|FG000|Overall Study|Death|32|||
147151622|NCT01901289|530716587|FG000|Overall Study|Lost to Follow-up|16|||
147151623|NCT01901289|530716587|FG000|Overall Study|Withdrawal by Subject|35|||
147151624|NCT01901289|530716587|FG000|Overall Study|Other type of endpoint met|2|||
147151625|NCT01813058|530716589|FG000|Overall Study|Withdrawal by Subject|5|||
147151626|NCT01813058|530716590|FG001|Overall Study|Withdrawal by Subject|4|||
147151627|NCT03585764|530716591|FG000|Overall Study|Death|3|||
147151628|NCT03585764|530716592|FG001|Overall Study|Death|2|||
147151629|NCT03585764|530716593|FG002|Overall Study|Death|3|||
147151630|NCT03585764|530716594|FG003|Overall Study|Death|0|||
147151631|NCT03585764|530716591|FG000|Overall Study|Lost to Follow-up|0|||
147239651|NCT01090492|531049261|FG006|First Intervention Period (4 Weeks)|Pregnancy|0|||
147239652|NCT01090492|531049262|FG007|First Intervention Period (4 Weeks)|Pregnancy|0|||
147239653|NCT01090492|531049255|FG000|First Intervention Period (4 Weeks)|Adverse Event|0|||
147239654|NCT01090492|531049256|FG001|First Intervention Period (4 Weeks)|Adverse Event|2|||
147239655|NCT01090492|531049257|FG002|First Intervention Period (4 Weeks)|Adverse Event|0|||
147239656|NCT01090492|531049258|FG003|First Intervention Period (4 Weeks)|Adverse Event|3|||
147239657|NCT01090492|531049259|FG004|First Intervention Period (4 Weeks)|Adverse Event|1|||
147239658|NCT01090492|531049260|FG005|First Intervention Period (4 Weeks)|Adverse Event|2|||
147239659|NCT01090492|531049261|FG006|First Intervention Period (4 Weeks)|Adverse Event|0|||
147239660|NCT01090492|531049262|FG007|First Intervention Period (4 Weeks)|Adverse Event|5|||
147239661|NCT01090492|531049255|FG000|Second Intervention Period (4 Weeks)|Protocol Violation|1|||
147239662|NCT01090492|531049256|FG001|Second Intervention Period (4 Weeks)|Protocol Violation|0|||
147151632|NCT03585764|530716592|FG001|Overall Study|Lost to Follow-up|1|||
147151633|NCT03585764|530716593|FG002|Overall Study|Lost to Follow-up|0|||
147151634|NCT03585764|530716594|FG003|Overall Study|Lost to Follow-up|0|||
147151635|NCT03585764|530716591|FG000|Overall Study|Physician Decision|0|||
147151636|NCT03585764|530716592|FG001|Overall Study|Physician Decision|0|||
147151637|NCT03585764|530716593|FG002|Overall Study|Physician Decision|2|||
147151638|NCT03585764|530716594|FG003|Overall Study|Physician Decision|0|||
147151639|NCT01581021|530716595|FG000|Overall Study|Lost to Follow-up|4|||
147151640|NCT01581021|530716596|FG001|Overall Study|Lost to Follow-up|6|||
147151641|NCT01581021|530716595|FG000|Overall Study|More than 2 hooks in thoracic|3|||
147151642|NCT01581021|530716596|FG001|Overall Study|More than 2 hooks in thoracic|0|||
147151643|NCT01581021|530716595|FG000|Overall Study|Neuromuscular|2|||
147151644|NCT01581021|530716596|FG001|Overall Study|Neuromuscular|1|||
147151645|NCT01581021|530716595|FG000|Overall Study|Not Randomized|1|||
147151646|NCT01581021|530716596|FG001|Overall Study|Not Randomized|2|||
147151647|NCT01581021|530716595|FG000|Overall Study|Lenke 6 Classification|0|||
147151648|NCT01581021|530716596|FG001|Overall Study|Lenke 6 Classification|1|||
147151649|NCT01581021|530716595|FG000|Overall Study|Lack of Efficacy|0|||
147151650|NCT01581021|530716596|FG001|Overall Study|Lack of Efficacy|1|||
147151651|NCT03403361|530716597|FG000|Overall Study|Not imaged due to issues during the pandemic|16|||
147151652|NCT01932372|530716598|FG000|Overall Study|Not meeting eligibility criteria|33|||
147151653|NCT01932372|530716599|FG001|Overall Study|Not meeting eligibility criteria|179|||
147151654|NCT01917929|530716604|FG000|Overall Study|Death|8|||
147151655|NCT01917929|530716604|FG000|Overall Study|Lost to Follow-up|19|||
147151656|NCT01917929|530716604|FG000|Overall Study|Withdrawal by Subject|33|||
147151657|NCT01917929|530716604|FG000|Overall Study|Adverse Event|6|||
147151658|NCT01917929|530716604|FG000|Overall Study|Investigative Site Terminated|35|||
147151659|NCT01917929|530716604|FG000|Overall Study|Censored because study device not implanted|6|||
147151660|NCT01917929|530716604|FG000|Overall Study|Censored because surgery not performed|3|||
147151661|NCT01917929|530716604|FG000|Overall Study|Censored because of inclusion exclusion violation|3|||
147151662|NCT01917929|530716604|FG000|Overall Study|Sponsor terminated study|175|||
147151663|NCT00673231|530716605|FG000|Overall Study|Withdrawal by Subject|14|||
147151664|NCT00673231|530716606|FG001|Overall Study|Withdrawal by Subject|10|||
147151665|NCT00673231|530716607|FG002|Overall Study|Withdrawal by Subject|8|||
147151666|NCT00673231|530716608|FG003|Overall Study|Withdrawal by Subject|6|||
147151667|NCT00673231|530716605|FG000|Overall Study|Adverse Event|6|||
147151668|NCT00673231|530716606|FG001|Overall Study|Adverse Event|5|||
147151669|NCT00673231|530716607|FG002|Overall Study|Adverse Event|9|||
147151670|NCT00673231|530716608|FG003|Overall Study|Adverse Event|6|||
147151671|NCT00673231|530716605|FG000|Overall Study|Lost to Follow-up|1|||
147151672|NCT00673231|530716606|FG001|Overall Study|Lost to Follow-up|2|||
147151673|NCT00673231|530716607|FG002|Overall Study|Lost to Follow-up|1|||
147151674|NCT00673231|530716608|FG003|Overall Study|Lost to Follow-up|2|||
147151675|NCT00673231|530716605|FG000|Overall Study|Death|0|||
147151676|NCT00673231|530716606|FG001|Overall Study|Death|0|||
147151677|NCT00673231|530716607|FG002|Overall Study|Death|1|||
147151678|NCT00673231|530716608|FG003|Overall Study|Death|0|||
147151679|NCT00673231|530716605|FG000|Overall Study|Study criteria,compliance,safety, other|8|||
147151680|NCT00673231|530716606|FG001|Overall Study|Study criteria,compliance,safety, other|5|||
147151681|NCT00673231|530716607|FG002|Overall Study|Study criteria,compliance,safety, other|7|||
147151682|NCT00673231|530716608|FG003|Overall Study|Study criteria,compliance,safety, other|4|||
147151683|NCT03594747|530716612|FG000|Overall Study|Death|78|||
147151684|NCT03594747|530716613|FG001|Overall Study|Death|86|||
147151685|NCT03594747|530716614|FG002|Overall Study|Death|87|||
147151686|NCT03594747|530716612|FG000|Overall Study|Withdrawal by Subject|5|||
147151687|NCT03594747|530716613|FG001|Overall Study|Withdrawal by Subject|2|||
147151688|NCT03594747|530716614|FG002|Overall Study|Withdrawal by Subject|11|||
147151689|NCT03594747|530716612|FG000|Overall Study|Lost to Follow-up|4|||
147151690|NCT03594747|530716613|FG001|Overall Study|Lost to Follow-up|1|||
147151691|NCT03594747|530716614|FG002|Overall Study|Lost to Follow-up|1|||
147151692|NCT03594747|530716612|FG000|Overall Study|Physician Decision|0|||
147151693|NCT03594747|530716613|FG001|Overall Study|Physician Decision|1|||
147151694|NCT03594747|530716614|FG002|Overall Study|Physician Decision|0|||
147151695|NCT03594747|530716612|FG000|Overall Study|Sponsor decision|23|||
147151696|NCT03594747|530716613|FG001|Overall Study|Sponsor decision|17|||
147151697|NCT03594747|530716614|FG002|Overall Study|Sponsor decision|16|||
147576637|NCT01496118|532265550|FG007|Overall Study|Adverse Event|10|||
147151698|NCT03594747|530716612|FG000|Overall Study|Did not meet inclusion criteria|0|||
147151699|NCT03594747|530716613|FG001|Overall Study|Did not meet inclusion criteria|0|||
147151700|NCT03594747|530716614|FG002|Overall Study|Did not meet inclusion criteria|1|||
147151701|NCT03594747|530716612|FG000|Overall Study|Transfer to long term extension study|10|||
147151702|NCT03594747|530716613|FG001|Overall Study|Transfer to long term extension study|12|||
147151703|NCT03594747|530716614|FG002|Overall Study|Transfer to long term extension study|5|||
147151704|NCT02470585|530716615|FG000|Overall Study|Death|224|||
147151705|NCT02470585|530716616|FG001|Overall Study|Death|227|||
147151706|NCT02470585|530716617|FG002|Overall Study|Death|199|||
147151707|NCT02470585|530716615|FG000|Overall Study|Withdrew consent|21|||
147151708|NCT02470585|530716616|FG001|Overall Study|Withdrew consent|22|||
147151709|NCT02470585|530716617|FG002|Overall Study|Withdrew consent|31|||
147151710|NCT02470585|530716615|FG000|Overall Study|Lost to Follow-up|8|||
147576638|NCT01496118|532265543|FG000|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
147576639|NCT01496118|532265544|FG001|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
147151711|NCT02470585|530716616|FG001|Overall Study|Lost to Follow-up|15|||
147151712|NCT02470585|530716617|FG002|Overall Study|Lost to Follow-up|13|||
147151713|NCT02470585|530716615|FG000|Overall Study|Sponsor discontinued study|117|||
147151714|NCT02470585|530716616|FG001|Overall Study|Sponsor discontinued study|110|||
147151715|NCT02470585|530716617|FG002|Overall Study|Sponsor discontinued study|122|||
147151716|NCT02470585|530716615|FG000|Overall Study|Other, not specified|5|||
147151717|NCT02470585|530716616|FG001|Overall Study|Other, not specified|7|||
147151718|NCT02470585|530716617|FG002|Overall Study|Other, not specified|14|||
147151719|NCT02470585|530716615|FG000|Overall Study|Missing due to site non-compliance|0|||
147151720|NCT02470585|530716616|FG001|Overall Study|Missing due to site non-compliance|2|||
147151721|NCT02470585|530716617|FG002|Overall Study|Missing due to site non-compliance|3|||
147151722|NCT02907216|530716618|FG000|Overall Study|No benefit to be obtained by continuing|0|||
147151723|NCT02907216|530716619|FG001|Overall Study|No benefit to be obtained by continuing|1|||
147151724|NCT02907216|530716618|FG000|Overall Study|Withdrawal by Subject|1|||
147151725|NCT02907216|530716619|FG001|Overall Study|Withdrawal by Subject|0|||
147151726|NCT02095873|530716621|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|1|||
147151727|NCT02095873|530716622|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|0|||
147151728|NCT02095873|530716621|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|1|||
147151729|NCT02095873|530716622|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|0|||
147151730|NCT02095873|530716621|FG000|Second Intervention (8 Weeks)|Protocol Violation|1|||
147151731|NCT02095873|530716622|FG001|Second Intervention (8 Weeks)|Protocol Violation|0|||
147151732|NCT00792740|530716623|FG000|Overall Study|Disease Worsening|3|||
147151733|NCT00792740|530716624|FG001|Overall Study|Disease Worsening|2|||
147151734|NCT00792740|530716623|FG000|Overall Study|Personal Reason|1|||
147151735|NCT00792740|530716624|FG001|Overall Study|Personal Reason|0|||
147151736|NCT00792740|530716623|FG000|Overall Study|Adverse Event|1|||
147151737|NCT00792740|530716624|FG001|Overall Study|Adverse Event|3|||
147151738|NCT00792740|530716623|FG000|Overall Study|Patient's withdrawal of consent|0|||
147151739|NCT00792740|530716624|FG001|Overall Study|Patient's withdrawal of consent|1|||
147151740|NCT00792740|530716623|FG000|Overall Study|Termination of the trial by the Sponsor|2|||
147151741|NCT00792740|530716624|FG001|Overall Study|Termination of the trial by the Sponsor|0|||
147151742|NCT00792740|530716623|FG000|Overall Study|Other reasons|0|||
147151743|NCT00792740|530716624|FG001|Overall Study|Other reasons|1|||
147151744|NCT02485639|530716629|FG000|Overall Study|8 participants did not complete study. Study halted due to CoronaVIrus Disease COVID-19 pandemic.|8|||
147151745|NCT02485639|530716629|FG000|Overall Study|Early termination|4|||
147151746|NCT02485639|530716629|FG000|Overall Study|Withdrawal by Subject|4|||
147151747|NCT02016716|530716630|FG000|Overall Study|Withdrawal by Subject|5|||
147151748|NCT02016716|530716631|FG001|Overall Study|Withdrawal by Subject|5|||
147151749|NCT02016716|530716632|FG002|Overall Study|Withdrawal by Subject|5|||
147151750|NCT02016716|530716630|FG000|Overall Study|Protocol-specified Criteria|0|||
147151751|NCT02016716|530716631|FG001|Overall Study|Protocol-specified Criteria|1|||
147151752|NCT02016716|530716632|FG002|Overall Study|Protocol-specified Criteria|0|||
147151753|NCT02016716|530716630|FG000|Overall Study|Lost to Follow-up|1|||
147151754|NCT02016716|530716631|FG001|Overall Study|Lost to Follow-up|2|||
147151755|NCT02016716|530716632|FG002|Overall Study|Lost to Follow-up|1|||
147151756|NCT03479541|530716637|FG000|Early and Late Physical Therapy|Lost to Follow-up|2|||
147151757|NCT03479541|530716638|FG001|Early and Late Physical Therapy|Lost to Follow-up|18|||
147151758|NCT03479541|530716639|FG002|Early and Late Physical Therapy|Lost to Follow-up|0|||
147151759|NCT03479541|530716640|FG003|Early and Late Physical Therapy|Lost to Follow-up|0|||
147151760|NCT03479541|530716637|FG000|Early and Late Physical Therapy|Withdrawal by Subject|15|||
147151761|NCT03479541|530716638|FG001|Early and Late Physical Therapy|Withdrawal by Subject|32|||
147151762|NCT03479541|530716639|FG002|Early and Late Physical Therapy|Withdrawal by Subject|0|||
147151763|NCT03479541|530716640|FG003|Early and Late Physical Therapy|Withdrawal by Subject|0|||
147151764|NCT03479541|530716637|FG000|Early and Late Physical Therapy|Early Termination - PI Decision|2|||
147151765|NCT03479541|530716638|FG001|Early and Late Physical Therapy|Early Termination - PI Decision|8|||
147151766|NCT03479541|530716639|FG002|Early and Late Physical Therapy|Early Termination - PI Decision|0|||
147151767|NCT03479541|530716640|FG003|Early and Late Physical Therapy|Early Termination - PI Decision|0|||
147151768|NCT03479541|530716637|FG000|Home Monitoring|Lost to Follow-up|0|||
147151769|NCT03479541|530716638|FG001|Home Monitoring|Lost to Follow-up|0|||
147151770|NCT03479541|530716639|FG002|Home Monitoring|Lost to Follow-up|8|||
147151771|NCT03479541|530716640|FG003|Home Monitoring|Lost to Follow-up|12|||
147151772|NCT03479541|530716637|FG000|Home Monitoring|Withdrawal by Subject|0|||
147151773|NCT03479541|530716638|FG001|Home Monitoring|Withdrawal by Subject|0|||
147151774|NCT03479541|530716639|FG002|Home Monitoring|Withdrawal by Subject|17|||
147151775|NCT03479541|530716640|FG003|Home Monitoring|Withdrawal by Subject|30|||
147151776|NCT03479541|530716637|FG000|Home Monitoring|Early Termination - PI Decision|0|||
147151777|NCT03479541|530716638|FG001|Home Monitoring|Early Termination - PI Decision|0|||
147576640|NCT01496118|532265545|FG002|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
147151778|NCT03479541|530716639|FG002|Home Monitoring|Early Termination - PI Decision|4|||
147151779|NCT03479541|530716640|FG003|Home Monitoring|Early Termination - PI Decision|6|||
147151780|NCT02147197|530716642|FG000|Overall Study|Adverse Event|1|||
147576641|NCT01496118|532265546|FG003|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
147576642|NCT01496118|532265547|FG004|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
147151781|NCT02147197|530716643|FG001|Overall Study|Adverse Event|0|||
147151782|NCT02147197|530716644|FG002|Overall Study|Adverse Event|0|||
147151783|NCT02147197|530716642|FG000|Overall Study|Withdrawal of Consent|4|||
147151784|NCT02147197|530716643|FG001|Overall Study|Withdrawal of Consent|3|||
147151785|NCT02147197|530716644|FG002|Overall Study|Withdrawal of Consent|2|||
147151786|NCT02147197|530716642|FG000|Overall Study|Lost to Follow-up|2|||
147151787|NCT02147197|530716643|FG001|Overall Study|Lost to Follow-up|3|||
147151788|NCT02147197|530716644|FG002|Overall Study|Lost to Follow-up|1|||
147151789|NCT02147197|530716642|FG000|Overall Study|Protocol Violation|1|||
147151790|NCT02147197|530716643|FG001|Overall Study|Protocol Violation|0|||
147151791|NCT02147197|530716644|FG002|Overall Study|Protocol Violation|3|||
147151792|NCT02147197|530716642|FG000|Overall Study|Other Miscellaneous Reasons|1|||
147151793|NCT02147197|530716643|FG001|Overall Study|Other Miscellaneous Reasons|0|||
147151794|NCT02147197|530716644|FG002|Overall Study|Other Miscellaneous Reasons|3|||
147151795|NCT00394251|530718957|FG000|Overall Study|Adverse Event|7|||
147151796|NCT00394251|530718958|FG001|Overall Study|Adverse Event|5|||
147151797|NCT00394251|530718957|FG000|Overall Study|Unacceptable Toxicity|20|||
147151798|NCT00394251|530718958|FG001|Overall Study|Unacceptable Toxicity|18|||
147151799|NCT00394251|530718957|FG000|Overall Study|Physician Decision|1|||
147151800|NCT00394251|530718958|FG001|Overall Study|Physician Decision|1|||
147151801|NCT00394251|530718957|FG000|Overall Study|Protocol Violation|0|||
147151802|NCT00394251|530718958|FG001|Overall Study|Protocol Violation|1|||
147151803|NCT00394251|530718957|FG000|Overall Study|Withdrawal by Subject|7|||
147151804|NCT00394251|530718958|FG001|Overall Study|Withdrawal by Subject|11|||
147151805|NCT00394251|530718957|FG000|Overall Study|Non-compliance, pt moved, pt/inv agree|2|||
147151806|NCT00394251|530718958|FG001|Overall Study|Non-compliance, pt moved, pt/inv agree|2|||
147151807|NCT04644276|530718959|FG000|Overall Study|Did not complete overall impressions as study was put on hold and then terminated|0|||
147151808|NCT04644276|530718960|FG001|Overall Study|Did not complete overall impressions as study was put on hold and then terminated|0|||
147151809|NCT04644276|530718961|FG002|Overall Study|Did not complete overall impressions as study was put on hold and then terminated|1|||
147151810|NCT03195660|530718962|FG000|Overall Study|The study was terminated|2|||
147151811|NCT03367403|530718963|FG000|Overall Study|Adverse Event|20|||
147151812|NCT03367403|530718964|FG001|Overall Study|Adverse Event|6|||
147151813|NCT03367403|530718965|FG002|Overall Study|Adverse Event|2|||
147151814|NCT03367403|530718963|FG000|Overall Study|Withdrawal by Subject|12|||
147151815|NCT03367403|530718964|FG001|Overall Study|Withdrawal by Subject|13|||
147151816|NCT03367403|530718965|FG002|Overall Study|Withdrawal by Subject|1|||
147151817|NCT03367403|530718963|FG000|Overall Study|Death|1|||
147151818|NCT03367403|530718964|FG001|Overall Study|Death|2|||
147151819|NCT03367403|530718965|FG002|Overall Study|Death|0|||
147151820|NCT03367403|530718963|FG000|Overall Study|Physician Decision|0|||
147151821|NCT03367403|530718964|FG001|Overall Study|Physician Decision|1|||
147151822|NCT03367403|530718965|FG002|Overall Study|Physician Decision|0|||
147151823|NCT03367403|530718963|FG000|Overall Study|Protocol Violation|1|||
147151824|NCT03367403|530718964|FG001|Overall Study|Protocol Violation|1|||
147151825|NCT03367403|530718965|FG002|Overall Study|Protocol Violation|0|||
147151826|NCT03367403|530718963|FG000|Overall Study|Withdrawal Due to Caregiver Circumstances|0|||
147151827|NCT03367403|530718964|FG001|Overall Study|Withdrawal Due to Caregiver Circumstances|2|||
147151828|NCT03367403|530718965|FG002|Overall Study|Withdrawal Due to Caregiver Circumstances|0|||
147151829|NCT03367403|530718963|FG000|Overall Study|COVID-19|3|||
147151830|NCT03367403|530718964|FG001|Overall Study|COVID-19|6|||
147151831|NCT03367403|530718965|FG002|Overall Study|COVID-19|0|||
147151832|NCT03367403|530718963|FG000|Overall Study|Abuse of Alcohol Intake|0|||
147151833|NCT03367403|530718964|FG001|Overall Study|Abuse of Alcohol Intake|1|||
147151834|NCT03367403|530718965|FG002|Overall Study|Abuse of Alcohol Intake|0|||
147151835|NCT03367403|530718963|FG000|Overall Study|Subject and Study Partner do not believe study has been Beneficial and Cognition has Declined|0|||
147151836|NCT03367403|530718964|FG001|Overall Study|Subject and Study Partner do not believe study has been Beneficial and Cognition has Declined|1|||
147151837|NCT03367403|530718965|FG002|Overall Study|Subject and Study Partner do not believe study has been Beneficial and Cognition has Declined|0|||
147151838|NCT00759876|530718966|FG000|Overall Study|Sponsor terminated study early|36|||
147151839|NCT00923975|530718971|FG000|Overall Study|Did not meet inclusion criteria|1|||
147151840|NCT01005316|530718974|FG000|Overall Study|Adverse Event|0|||
147151841|NCT01005316|530718975|FG001|Overall Study|Adverse Event|0|||
147151842|NCT01005316|530718976|FG002|Overall Study|Adverse Event|0|||
147151843|NCT01005316|530718977|FG003|Overall Study|Adverse Event|1|||
147151844|NCT01005316|530718974|FG000|Overall Study|Death|20|||
147151845|NCT01005316|530718975|FG001|Overall Study|Death|5|||
147151846|NCT01005316|530718976|FG002|Overall Study|Death|1|||
147151847|NCT01005316|530718977|FG003|Overall Study|Death|15|||
147151848|NCT01005316|530718974|FG000|Overall Study|Study Termination|5|||
147151849|NCT01005316|530718975|FG001|Overall Study|Study Termination|63|||
147151850|NCT01005316|530718976|FG002|Overall Study|Study Termination|9|||
147151851|NCT01005316|530718977|FG003|Overall Study|Study Termination|85|||
147151852|NCT01005316|530718974|FG000|Overall Study|Lost to Follow-up|1|||
147151853|NCT01005316|530718975|FG001|Overall Study|Lost to Follow-up|3|||
147151854|NCT01005316|530718976|FG002|Overall Study|Lost to Follow-up|0|||
147151855|NCT01005316|530718977|FG003|Overall Study|Lost to Follow-up|2|||
147151856|NCT01005316|530718974|FG000|Overall Study|Physician Decision|6|||
147151857|NCT01005316|530718975|FG001|Overall Study|Physician Decision|0|||
147151858|NCT01005316|530718976|FG002|Overall Study|Physician Decision|0|||
147151859|NCT01005316|530718977|FG003|Overall Study|Physician Decision|0|||
147151860|NCT01005316|530718974|FG000|Overall Study|Sponsor Decision|6|||
147151861|NCT01005316|530718975|FG001|Overall Study|Sponsor Decision|3|||
147151862|NCT01005316|530718976|FG002|Overall Study|Sponsor Decision|0|||
147151863|NCT01005316|530718977|FG003|Overall Study|Sponsor Decision|0|||
147151864|NCT01005316|530718974|FG000|Overall Study|Withdrawal by Subject|1|||
147151865|NCT01005316|530718975|FG001|Overall Study|Withdrawal by Subject|1|||
147151866|NCT01005316|530718976|FG002|Overall Study|Withdrawal by Subject|0|||
147151867|NCT01005316|530718977|FG003|Overall Study|Withdrawal by Subject|2|||
147151868|NCT01005316|530718974|FG000|Overall Study|Consented to Another Study|2|||
147151869|NCT01005316|530718975|FG001|Overall Study|Consented to Another Study|0|||
147151870|NCT01005316|530718976|FG002|Overall Study|Consented to Another Study|0|||
147151871|NCT01005316|530718977|FG003|Overall Study|Consented to Another Study|0|||
147151872|NCT01005316|530718974|FG000|Overall Study|Delisted|8|||
147151873|NCT01005316|530718975|FG001|Overall Study|Delisted|0|||
147151874|NCT01005316|530718976|FG002|Overall Study|Delisted|0|||
147151875|NCT01005316|530718977|FG003|Overall Study|Delisted|0|||
147151876|NCT01005316|530718974|FG000|Overall Study|Transferred Care|1|||
147151877|NCT01005316|530718975|FG001|Overall Study|Transferred Care|0|||
147151878|NCT01005316|530718976|FG002|Overall Study|Transferred Care|1|||
147151879|NCT01005316|530718977|FG003|Overall Study|Transferred Care|3|||
147151880|NCT01005316|530718974|FG000|Overall Study|Retransplanted|0|||
147151881|NCT01005316|530718975|FG001|Overall Study|Retransplanted|1|||
147151882|NCT01005316|530718976|FG002|Overall Study|Retransplanted|0|||
147151883|NCT01005316|530718977|FG003|Overall Study|Retransplanted|0|||
147151884|NCT00632827|530718978|FG000|Overall Study|Excluded after GVD (Not evaluable)|2|||
147151885|NCT00632827|530718978|FG000|Overall Study|Death|2|||
147151886|NCT00632827|530718978|FG000|Overall Study|Adverse Event|5|||
147151887|NCT00632827|530718978|FG000|Overall Study|Lost to Follow-up|1|||
147151888|NCT01126268|530718986|FG000|Overall Study|Adverse Event|1|||
147151889|NCT01205061|530718987|FG000|Overall Study|Adverse Event|4|||
147151890|NCT01205061|530718987|FG000|Overall Study|Withdrawal by Subject|11|||
147151891|NCT01205061|530718987|FG000|Overall Study|Clinical Investigational Plan Violation|1|||
147151892|NCT01205061|530718987|FG000|Overall Study|Lost to Follow-up|9|||
147151893|NCT01205061|530718987|FG000|Overall Study|Other|1|||
147151894|NCT00765037|530718988|FG000|Overall Study|Lost to Follow-up|5|||
147151895|NCT00765037|530718988|FG000|Overall Study|Adverse Event|1|||
147151896|NCT01988662|530718993|FG000|Overall Study|Subject/guardian decision|1|||
147151897|NCT01988662|530718994|FG001|Overall Study|Subject/guardian decision|1|||
147151898|NCT01988662|530718993|FG000|Overall Study|Adverse Event|3|||
147151899|NCT01988662|530718994|FG001|Overall Study|Adverse Event|1|||
147151900|NCT03425006|530718995|FG000|Overall Study|Withdrawal by Subject|1|||
147151901|NCT03425006|530718995|FG000|Overall Study|Physician Decision|1|||
147151902|NCT03425006|530718995|FG000|Overall Study|Death|1|||
147151903|NCT03831191|530719006|FG000|Induction Period (16 Weeks)|Adverse Event|2|||
147151904|NCT03831191|530719007|FG001|Induction Period (16 Weeks)|Adverse Event|1|||
147151905|NCT03831191|530719008|FG002|Induction Period (16 Weeks)|Adverse Event|3|||
147151906|NCT03831191|530719009|FG003|Induction Period (16 Weeks)|Adverse Event|4|||
147151907|NCT03831191|530719010|FG004|Induction Period (16 Weeks)|Adverse Event|0|||
147151908|NCT03831191|530719011|FG005|Induction Period (16 Weeks)|Adverse Event|0|||
147151909|NCT03831191|530719012|FG006|Induction Period (16 Weeks)|Adverse Event|0|||
147151910|NCT03831191|530719013|FG007|Induction Period (16 Weeks)|Adverse Event|0|||
147151911|NCT03831191|530719014|FG008|Induction Period (16 Weeks)|Adverse Event|0|||
147151912|NCT03831191|530719015|FG009|Induction Period (16 Weeks)|Adverse Event|0|||
147151913|NCT03831191|530719016|FG010|Induction Period (16 Weeks)|Adverse Event|0|||
147151914|NCT03831191|530719017|FG011|Induction Period (16 Weeks)|Adverse Event|0|||
147151915|NCT03831191|530719018|FG012|Induction Period (16 Weeks)|Adverse Event|0|||
147151916|NCT03831191|530719019|FG013|Induction Period (16 Weeks)|Adverse Event|0|||
147151917|NCT03831191|530719020|FG014|Induction Period (16 Weeks)|Adverse Event|0|||
147321158|NCT05397470|531338490|FG000|Part A: PCT Period (Up to 48 Weeks)|Withdrawal by Subject|2|||
147321159|NCT05397470|531338491|FG001|Part A: PCT Period (Up to 48 Weeks)|Withdrawal by Subject|1|||
147321160|NCT05397470|531338492|FG002|Part A: PCT Period (Up to 48 Weeks)|Withdrawal by Subject|0|||
147321161|NCT05397470|531338490|FG000|Part A: PCT Period (Up to 48 Weeks)|Other|0|||
147321162|NCT05397470|531338491|FG001|Part A: PCT Period (Up to 48 Weeks)|Other|1|||
147321163|NCT05397470|531338492|FG002|Part A: PCT Period (Up to 48 Weeks)|Other|0|||
147321164|NCT05397470|531338490|FG000|Part B: OLE Period (Up to Week 127)|Withdrawal by Subject|0|||
147151918|NCT03831191|530719006|FG000|Induction Period (16 Weeks)|Lack of Efficacy|2|||
147151919|NCT03831191|530719007|FG001|Induction Period (16 Weeks)|Lack of Efficacy|3|||
147151920|NCT03831191|530719008|FG002|Induction Period (16 Weeks)|Lack of Efficacy|0|||
147151921|NCT03831191|530719009|FG003|Induction Period (16 Weeks)|Lack of Efficacy|0|||
147151922|NCT03831191|530719010|FG004|Induction Period (16 Weeks)|Lack of Efficacy|0|||
147151923|NCT03831191|530719011|FG005|Induction Period (16 Weeks)|Lack of Efficacy|0|||
147151924|NCT03831191|530719012|FG006|Induction Period (16 Weeks)|Lack of Efficacy|0|||
147151925|NCT03831191|530719013|FG007|Induction Period (16 Weeks)|Lack of Efficacy|0|||
147151926|NCT03831191|530719014|FG008|Induction Period (16 Weeks)|Lack of Efficacy|0|||
147151927|NCT03831191|530719015|FG009|Induction Period (16 Weeks)|Lack of Efficacy|0|||
147151928|NCT03831191|530719016|FG010|Induction Period (16 Weeks)|Lack of Efficacy|0|||
147653156|NCT00829829|532551958|FG001|Overall Study|Other than specified above|2|||
147653157|NCT00829829|532551959|FG002|Overall Study|Other than specified above|1|||
147151929|NCT03831191|530719017|FG011|Induction Period (16 Weeks)|Lack of Efficacy|0|||
147151930|NCT03831191|530719018|FG012|Induction Period (16 Weeks)|Lack of Efficacy|0|||
147151931|NCT03831191|530719019|FG013|Induction Period (16 Weeks)|Lack of Efficacy|0|||
147151932|NCT03831191|530719020|FG014|Induction Period (16 Weeks)|Lack of Efficacy|0|||
147151933|NCT03831191|530719006|FG000|Induction Period (16 Weeks)|Pregnancy|0|||
147151934|NCT03831191|530719007|FG001|Induction Period (16 Weeks)|Pregnancy|0|||
147151935|NCT03831191|530719008|FG002|Induction Period (16 Weeks)|Pregnancy|1|||
147151936|NCT03831191|530719009|FG003|Induction Period (16 Weeks)|Pregnancy|0|||
147151937|NCT03831191|530719010|FG004|Induction Period (16 Weeks)|Pregnancy|0|||
147151938|NCT03831191|530719011|FG005|Induction Period (16 Weeks)|Pregnancy|0|||
147151939|NCT03831191|530719012|FG006|Induction Period (16 Weeks)|Pregnancy|0|||
147151940|NCT03831191|530719013|FG007|Induction Period (16 Weeks)|Pregnancy|0|||
147151941|NCT03831191|530719014|FG008|Induction Period (16 Weeks)|Pregnancy|0|||
147151942|NCT03831191|530719015|FG009|Induction Period (16 Weeks)|Pregnancy|0|||
147151943|NCT03831191|530719016|FG010|Induction Period (16 Weeks)|Pregnancy|0|||
147151944|NCT03831191|530719017|FG011|Induction Period (16 Weeks)|Pregnancy|0|||
147151945|NCT03831191|530719018|FG012|Induction Period (16 Weeks)|Pregnancy|0|||
147151946|NCT03831191|530719019|FG013|Induction Period (16 Weeks)|Pregnancy|0|||
147151947|NCT03831191|530719020|FG014|Induction Period (16 Weeks)|Pregnancy|0|||
147151948|NCT03831191|530719006|FG000|Induction Period (16 Weeks)|Protocol Violation|0|||
147151949|NCT03831191|530719007|FG001|Induction Period (16 Weeks)|Protocol Violation|0|||
147151950|NCT03831191|530719008|FG002|Induction Period (16 Weeks)|Protocol Violation|0|||
147151951|NCT03831191|530719009|FG003|Induction Period (16 Weeks)|Protocol Violation|2|||
147151952|NCT03831191|530719010|FG004|Induction Period (16 Weeks)|Protocol Violation|0|||
147151953|NCT03831191|530719011|FG005|Induction Period (16 Weeks)|Protocol Violation|0|||
147151954|NCT03831191|530719012|FG006|Induction Period (16 Weeks)|Protocol Violation|0|||
147151955|NCT03831191|530719013|FG007|Induction Period (16 Weeks)|Protocol Violation|0|||
147151956|NCT03831191|530719014|FG008|Induction Period (16 Weeks)|Protocol Violation|0|||
147151957|NCT03831191|530719015|FG009|Induction Period (16 Weeks)|Protocol Violation|0|||
147151958|NCT03831191|530719016|FG010|Induction Period (16 Weeks)|Protocol Violation|0|||
147151959|NCT03831191|530719017|FG011|Induction Period (16 Weeks)|Protocol Violation|0|||
147151960|NCT03831191|530719018|FG012|Induction Period (16 Weeks)|Protocol Violation|0|||
147151961|NCT03831191|530719019|FG013|Induction Period (16 Weeks)|Protocol Violation|0|||
147151962|NCT03831191|530719020|FG014|Induction Period (16 Weeks)|Protocol Violation|0|||
147151963|NCT03831191|530719006|FG000|Induction Period (16 Weeks)|Withdrawal by Subject|7|||
147151964|NCT03831191|530719007|FG001|Induction Period (16 Weeks)|Withdrawal by Subject|2|||
147151965|NCT03831191|530719008|FG002|Induction Period (16 Weeks)|Withdrawal by Subject|1|||
147151966|NCT03831191|530719009|FG003|Induction Period (16 Weeks)|Withdrawal by Subject|3|||
147151967|NCT03831191|530719010|FG004|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
147151968|NCT03831191|530719011|FG005|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
147151969|NCT03831191|530719012|FG006|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
147151970|NCT03831191|530719013|FG007|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
147151971|NCT03831191|530719014|FG008|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
147151972|NCT03831191|530719015|FG009|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
147151973|NCT03831191|530719016|FG010|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
147151974|NCT03831191|530719017|FG011|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
147151975|NCT03831191|530719018|FG012|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
147151976|NCT03831191|530719019|FG013|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
147151977|NCT03831191|530719020|FG014|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
147151978|NCT03831191|530719006|FG000|Induction Period (16 Weeks)|Study Terminated by Sponsor|12|||
147151979|NCT03831191|530719007|FG001|Induction Period (16 Weeks)|Study Terminated by Sponsor|15|||
147151980|NCT03831191|530719008|FG002|Induction Period (16 Weeks)|Study Terminated by Sponsor|16|||
147151981|NCT03831191|530719009|FG003|Induction Period (16 Weeks)|Study Terminated by Sponsor|13|||
147151982|NCT03831191|530719010|FG004|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
147151983|NCT03831191|530719011|FG005|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
147151984|NCT03831191|530719012|FG006|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
147151985|NCT03831191|530719013|FG007|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
147151986|NCT03831191|530719014|FG008|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
147321165|NCT05397470|531338491|FG001|Part B: OLE Period (Up to Week 127)|Withdrawal by Subject|0|||
147151987|NCT03831191|530719015|FG009|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
147151988|NCT03831191|530719016|FG010|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
147151989|NCT03831191|530719017|FG011|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
147151990|NCT03831191|530719018|FG012|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
147151991|NCT03831191|530719019|FG013|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
147151992|NCT03831191|530719020|FG014|Induction Period (16 Weeks)|Study Terminated by Sponsor|0|||
147151993|NCT03831191|530719006|FG000|Induction Period (16 Weeks)|Sponsor Decision|0|||
147151994|NCT03831191|530719007|FG001|Induction Period (16 Weeks)|Sponsor Decision|0|||
147151995|NCT03831191|530719008|FG002|Induction Period (16 Weeks)|Sponsor Decision|0|||
147151996|NCT03831191|530719009|FG003|Induction Period (16 Weeks)|Sponsor Decision|1|||
147151997|NCT03831191|530719010|FG004|Induction Period (16 Weeks)|Sponsor Decision|0|||
147151998|NCT03831191|530719011|FG005|Induction Period (16 Weeks)|Sponsor Decision|0|||
147151999|NCT03831191|530719012|FG006|Induction Period (16 Weeks)|Sponsor Decision|0|||
147152000|NCT03831191|530719013|FG007|Induction Period (16 Weeks)|Sponsor Decision|0|||
147152001|NCT03831191|530719014|FG008|Induction Period (16 Weeks)|Sponsor Decision|0|||
147152002|NCT03831191|530719015|FG009|Induction Period (16 Weeks)|Sponsor Decision|0|||
147152003|NCT03831191|530719016|FG010|Induction Period (16 Weeks)|Sponsor Decision|0|||
147152004|NCT03831191|530719017|FG011|Induction Period (16 Weeks)|Sponsor Decision|0|||
147152005|NCT03831191|530719018|FG012|Induction Period (16 Weeks)|Sponsor Decision|0|||
147152006|NCT03831191|530719019|FG013|Induction Period (16 Weeks)|Sponsor Decision|0|||
147152007|NCT03831191|530719020|FG014|Induction Period (16 Weeks)|Sponsor Decision|0|||
147152008|NCT03831191|530719006|FG000|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|0|||
147152009|NCT03831191|530719007|FG001|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|0|||
147152010|NCT03831191|530719008|FG002|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|0|||
147152011|NCT03831191|530719009|FG003|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|0|||
147152012|NCT03831191|530719010|FG004|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|4|||
147152013|NCT03831191|530719011|FG005|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|5|||
147152014|NCT03831191|530719012|FG006|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|2|||
147152015|NCT03831191|530719013|FG007|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|4|||
147239663|NCT01090492|531049257|FG002|Second Intervention Period (4 Weeks)|Protocol Violation|0|||
147239664|NCT01090492|531049258|FG003|Second Intervention Period (4 Weeks)|Protocol Violation|0|||
147239665|NCT01090492|531049259|FG004|Second Intervention Period (4 Weeks)|Protocol Violation|1|||
147239666|NCT01090492|531049260|FG005|Second Intervention Period (4 Weeks)|Protocol Violation|0|||
147239667|NCT01090492|531049261|FG006|Second Intervention Period (4 Weeks)|Protocol Violation|1|||
147239668|NCT01090492|531049262|FG007|Second Intervention Period (4 Weeks)|Protocol Violation|1|||
147239669|NCT01090492|531049255|FG000|Second Intervention Period (4 Weeks)|Non-compliance|0|||
147576643|NCT01496118|532265548|FG005|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
147576644|NCT01496118|532265549|FG006|Overall Study|Conditions requiring other treatment not permitted by protocol|1|||
147576645|NCT01496118|532265550|FG007|Overall Study|Conditions requiring other treatment not permitted by protocol|0|||
147576646|NCT01496118|532265543|FG000|Overall Study|Death|0|||
147576647|NCT01496118|532265544|FG001|Overall Study|Death|0|||
147576648|NCT01496118|532265545|FG002|Overall Study|Death|0|||
147576649|NCT01496118|532265546|FG003|Overall Study|Death|0|||
147576650|NCT01496118|532265547|FG004|Overall Study|Death|0|||
147576651|NCT01496118|532265548|FG005|Overall Study|Death|0|||
147576652|NCT01496118|532265549|FG006|Overall Study|Death|1|||
147576653|NCT01496118|532265550|FG007|Overall Study|Death|1|||
147576654|NCT01496118|532265543|FG000|Overall Study|Withdrawal by Subject|0|||
147576655|NCT01496118|532265544|FG001|Overall Study|Withdrawal by Subject|0|||
147576656|NCT01496118|532265545|FG002|Overall Study|Withdrawal by Subject|0|||
147576657|NCT01496118|532265546|FG003|Overall Study|Withdrawal by Subject|2|||
147576658|NCT01496118|532265547|FG004|Overall Study|Withdrawal by Subject|0|||
147576659|NCT01496118|532265548|FG005|Overall Study|Withdrawal by Subject|1|||
147576660|NCT01496118|532265549|FG006|Overall Study|Withdrawal by Subject|6|||
147576661|NCT01496118|532265550|FG007|Overall Study|Withdrawal by Subject|3|||
147576662|NCT01151618|532265559|FG000|Overall Study|Adverse Event|2|||
147576663|NCT01151618|532265559|FG000|Overall Study|Withdrawal by Subject|7|||
147576664|NCT00562718|532265560|FG000|Overall Study|Death|1|||
147576665|NCT00562718|532265560|FG000|Overall Study|Withdrawal by Subject|3|||
147576666|NCT00562718|532265560|FG000|Overall Study|Adverse Event|4|||
147576667|NCT00562718|532265560|FG000|Overall Study|Lack of Efficacy|2|||
147576668|NCT00562718|532265560|FG000|Overall Study|not stated|1|||
147576669|NCT02227238|532265561|FG000|Randomized Phase (Up to Week 52)|Reached stopping criteria|0|||
147576670|NCT02227238|532265562|FG001|Randomized Phase (Up to Week 52)|Reached stopping criteria|1|||
147576671|NCT02227238|532265563|FG002|Randomized Phase (Up to Week 52)|Reached stopping criteria|0|||
147576672|NCT02227238|532265561|FG000|Randomized Phase (Up to Week 52)|Adverse Event|8|||
147576673|NCT02227238|532265562|FG001|Randomized Phase (Up to Week 52)|Adverse Event|18|||
147576674|NCT02227238|532265563|FG002|Randomized Phase (Up to Week 52)|Adverse Event|0|||
147576675|NCT02227238|532265561|FG000|Randomized Phase (Up to Week 52)|Lack of Efficacy|10|||
147576676|NCT02227238|532265562|FG001|Randomized Phase (Up to Week 52)|Lack of Efficacy|22|||
147576677|NCT02227238|532265563|FG002|Randomized Phase (Up to Week 52)|Lack of Efficacy|0|||
147576678|NCT02227238|532265561|FG000|Randomized Phase (Up to Week 52)|Protocol Violation|7|||
147576679|NCT02227238|532265562|FG001|Randomized Phase (Up to Week 52)|Protocol Violation|8|||
147576680|NCT02227238|532265563|FG002|Randomized Phase (Up to Week 52)|Protocol Violation|0|||
147576681|NCT02227238|532265561|FG000|Randomized Phase (Up to Week 52)|Withdrawal by Subject|5|||
147576682|NCT02227238|532265562|FG001|Randomized Phase (Up to Week 52)|Withdrawal by Subject|4|||
147653158|NCT02984267|532551960|FG000|Overall Study|Protocol Violation|1|||
147152016|NCT03831191|530719014|FG008|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|8|||
147152017|NCT03831191|530719015|FG009|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|1|||
147653159|NCT02984267|532551961|FG001|Overall Study|Protocol Violation|0|||
147576683|NCT02227238|532265563|FG002|Randomized Phase (Up to Week 52)|Withdrawal by Subject|0|||
147576684|NCT02227238|532265561|FG000|Randomized Phase (Up to Week 52)|Physician Decision|0|||
147576685|NCT02227238|532265562|FG001|Randomized Phase (Up to Week 52)|Physician Decision|9|||
147576686|NCT02227238|532265563|FG002|Randomized Phase (Up to Week 52)|Physician Decision|0|||
147576687|NCT02227238|532265561|FG000|Randomized Phase (Up to Week 52)|Lost to Follow-up|7|||
147576688|NCT02227238|532265562|FG001|Randomized Phase (Up to Week 52)|Lost to Follow-up|5|||
147576689|NCT02227238|532265563|FG002|Randomized Phase (Up to Week 52)|Lost to Follow-up|0|||
147576690|NCT02227238|532265561|FG000|Randomized Phase (Up to Week 52)|Randomized, but did not receive treatment|0|||
147576691|NCT02227238|532265562|FG001|Randomized Phase (Up to Week 52)|Randomized, but did not receive treatment|3|||
147576692|NCT02227238|532265563|FG002|Randomized Phase (Up to Week 52)|Randomized, but did not receive treatment|0|||
147576693|NCT02227238|532265561|FG000|Continuation Phase(From Weeks 52 to 295)|Adverse Event|0|||
147576694|NCT02227238|532265562|FG001|Continuation Phase(From Weeks 52 to 295)|Adverse Event|0|||
147576695|NCT02227238|532265563|FG002|Continuation Phase(From Weeks 52 to 295)|Adverse Event|8|||
147576696|NCT02227238|532265561|FG000|Continuation Phase(From Weeks 52 to 295)|Lack of Efficacy|0|||
147576697|NCT02227238|532265562|FG001|Continuation Phase(From Weeks 52 to 295)|Lack of Efficacy|0|||
147576698|NCT02227238|532265563|FG002|Continuation Phase(From Weeks 52 to 295)|Lack of Efficacy|16|||
147576699|NCT02227238|532265561|FG000|Continuation Phase(From Weeks 52 to 295)|Protocol Violation|0|||
147576700|NCT02227238|532265562|FG001|Continuation Phase(From Weeks 52 to 295)|Protocol Violation|0|||
147576701|NCT02227238|532265563|FG002|Continuation Phase(From Weeks 52 to 295)|Protocol Violation|8|||
147576702|NCT02227238|532265561|FG000|Continuation Phase(From Weeks 52 to 295)|Withdrawal by Subject|0|||
147576703|NCT02227238|532265562|FG001|Continuation Phase(From Weeks 52 to 295)|Withdrawal by Subject|0|||
147576704|NCT02227238|532265563|FG002|Continuation Phase(From Weeks 52 to 295)|Withdrawal by Subject|6|||
147576705|NCT02227238|532265561|FG000|Continuation Phase(From Weeks 52 to 295)|Physician Decision|0|||
147576706|NCT02227238|532265562|FG001|Continuation Phase(From Weeks 52 to 295)|Physician Decision|0|||
147576707|NCT02227238|532265563|FG002|Continuation Phase(From Weeks 52 to 295)|Physician Decision|4|||
147576708|NCT02227238|532265561|FG000|Continuation Phase(From Weeks 52 to 295)|Lost to Follow-up|0|||
147576709|NCT02227238|532265562|FG001|Continuation Phase(From Weeks 52 to 295)|Lost to Follow-up|0|||
147576710|NCT02227238|532265563|FG002|Continuation Phase(From Weeks 52 to 295)|Lost to Follow-up|7|||
147576711|NCT01507662|532265564|FG000|Overall Study|Death|26|||
147576712|NCT01507662|532265565|FG001|Overall Study|Death|18|||
147576713|NCT01507662|532265564|FG000|Overall Study|Withdrawal by Subject|290|||
147576714|NCT01507662|532265565|FG001|Overall Study|Withdrawal by Subject|287|||
147576715|NCT01507662|532265564|FG000|Overall Study|Lost to Follow-up|498|||
147576716|NCT01507662|532265565|FG001|Overall Study|Lost to Follow-up|523|||
147576717|NCT01507662|532265564|FG000|Overall Study|Proxy interview done|2|||
147576718|NCT01507662|532265565|FG001|Overall Study|Proxy interview done|3|||
147576719|NCT02896296|532265569|FG000|Overall Study|Adverse Event|1|||
147576720|NCT02896296|532265569|FG000|Overall Study|Lost to Follow-up|19|||
147576721|NCT02896296|532265569|FG000|Overall Study|Pregnancy|1|||
147576722|NCT02896296|532265569|FG000|Overall Study|Physician Decision|2|||
147576723|NCT02896296|532265569|FG000|Overall Study|Withdrawal by Subject|10|||
147576724|NCT02896296|532265569|FG000|Overall Study|Site closing|7|||
147576725|NCT02896296|532265569|FG000|Overall Study|Incarceration|1|||
147576726|NCT02896296|532265569|FG000|Overall Study|Relocation|1|||
147576727|NCT02264977|532265571|FG000|Overall Study|Death|3|||
147576728|NCT02264977|532265571|FG000|Overall Study|Physician Decision|1|||
147576729|NCT02264977|532265571|FG000|Overall Study|Refuse to return|1|||
147576730|NCT00243347|532265572|FG000|Overall Study|Lack of Efficacy|4|||
147576731|NCT00243347|532265572|FG000|Overall Study|Adverse Event|2|||
147576732|NCT00243347|532265572|FG000|Overall Study|Death|1|||
147576733|NCT00243347|532265572|FG000|Overall Study|Withdrawal by Subject|5|||
147576734|NCT00243347|532265572|FG000|Overall Study|Condition worsened|7|||
147576735|NCT03961204|532265576|FG000|Overall Study|Withdrawal by Subject|2|||
147576736|NCT03961204|532265576|FG000|Overall Study|Lost to Follow-up|3|||
147576737|NCT03961204|532265576|FG000|Overall Study|Other|1|||
147576738|NCT03961204|532265576|FG000|Overall Study|Missing|1|||
147576739|NCT02452463|532265579|FG000|Overall Study|Death|1|||
147576740|NCT02452463|532265580|FG001|Overall Study|Death|0|||
147576741|NCT02452463|532265581|FG002|Overall Study|Death|0|||
147576742|NCT02452463|532265579|FG000|Overall Study|Study Suspended|1|||
147576743|NCT02452463|532265580|FG001|Overall Study|Study Suspended|0|||
147321166|NCT05397470|531338492|FG002|Part B: OLE Period (Up to Week 127)|Withdrawal by Subject|4|||
147576744|NCT02452463|532265581|FG002|Overall Study|Study Suspended|0|||
147576745|NCT02452463|532265579|FG000|Overall Study|Recommended by DSMB|0|||
147576746|NCT02452463|532265580|FG001|Overall Study|Recommended by DSMB|1|||
147576747|NCT02452463|532265581|FG002|Overall Study|Recommended by DSMB|0|||
147321167|NCT05397470|531338490|FG000|Part B: OLE Period (Up to Week 127)|Lost to Follow-up|0|||
147576748|NCT02452463|532265579|FG000|Overall Study|Withdrawal by Subject|0|||
147576749|NCT02452463|532265580|FG001|Overall Study|Withdrawal by Subject|1|||
147576750|NCT02452463|532265581|FG002|Overall Study|Withdrawal by Subject|0|||
147576751|NCT03969641|532266735|FG000|Overall Study|Lost to Follow-up|5|||
147576752|NCT03969641|532266736|FG001|Overall Study|Lost to Follow-up|3|||
147576753|NCT03969641|532266735|FG000|Overall Study|Withdrawal by Subject|1|||
147576754|NCT03969641|532266736|FG001|Overall Study|Withdrawal by Subject|2|||
147576755|NCT03969641|532266735|FG000|Overall Study|Found to be ineligible|1|||
147576756|NCT03969641|532266736|FG001|Overall Study|Found to be ineligible|1|||
147576757|NCT03969641|532266735|FG000|Overall Study|Intrauterine fetal demise (IUFD)|0|||
147576758|NCT03969641|532266736|FG001|Overall Study|Intrauterine fetal demise (IUFD)|2|||
147576759|NCT03969641|532266735|FG000|Overall Study|Spontaneous abortion (SAB)|2|||
147576760|NCT03969641|532266736|FG001|Overall Study|Spontaneous abortion (SAB)|1|||
147576761|NCT03969641|532266735|FG000|Overall Study|Elective termination|0|||
147576762|NCT03969641|532266736|FG001|Overall Study|Elective termination|1|||
147576763|NCT00754052|532266742|FG000|Overall Study|Study terminated by Sponsor|5|||
147576764|NCT00754052|532266743|FG001|Overall Study|Study terminated by Sponsor|3|||
147576765|NCT02658019|532266747|FG000|Overall Study|Adverse Event|1|||
147576766|NCT03234907|532266748|FG000|Induction Phase (Week 0 to Week 10)|Protocol Deviation|1|||
147576767|NCT03234907|532266749|FG001|Induction Phase (Week 0 to Week 10)|Protocol Deviation|1|||
147576768|NCT03234907|532266750|FG002|Induction Phase (Week 0 to Week 10)|Protocol Deviation|0|||
147576769|NCT03234907|532266751|FG003|Induction Phase (Week 0 to Week 10)|Protocol Deviation|0|||
147576770|NCT03234907|532266752|FG004|Induction Phase (Week 0 to Week 10)|Protocol Deviation|0|||
147576771|NCT03234907|532266753|FG005|Induction Phase (Week 0 to Week 10)|Protocol Deviation|0|||
147576772|NCT03234907|532266748|FG000|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|6|||
147576773|NCT03234907|532266749|FG001|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|4|||
147576774|NCT03234907|532266750|FG002|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|0|||
147576775|NCT03234907|532266751|FG003|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|0|||
147576776|NCT03234907|532266752|FG004|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|0|||
147576777|NCT03234907|532266753|FG005|Induction Phase (Week 0 to Week 10)|Withdrawal by Subject|0|||
147576778|NCT03234907|532266748|FG000|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|2|||
147576779|NCT03234907|532266749|FG001|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|0|||
147576780|NCT03234907|532266750|FG002|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|0|||
147576781|NCT03234907|532266751|FG003|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|0|||
147576782|NCT03234907|532266752|FG004|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|0|||
147576783|NCT03234907|532266753|FG005|Induction Phase (Week 0 to Week 10)|Lack of Efficacy|0|||
147576784|NCT03234907|532266748|FG000|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|1|||
147576785|NCT03234907|532266749|FG001|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|1|||
147576786|NCT03234907|532266750|FG002|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|0|||
147576787|NCT03234907|532266751|FG003|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|0|||
147576788|NCT03234907|532266752|FG004|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|0|||
147576789|NCT03234907|532266753|FG005|Induction Phase (Week 0 to Week 10)|Enrolled but not Treated|0|||
147576790|NCT03234907|532266748|FG000|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|0|||
147576791|NCT03234907|532266749|FG001|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|0|||
147576792|NCT03234907|532266750|FG002|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|0|||
147576793|NCT03234907|532266751|FG003|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|4|||
147576794|NCT03234907|532266752|FG004|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|3|||
147576795|NCT03234907|532266753|FG005|Maintenance Phase (Week 10 to Week 60)|Withdrawal by Subject|7|||
147576796|NCT03234907|532266748|FG000|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|0|||
147576797|NCT03234907|532266749|FG001|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|0|||
147576798|NCT03234907|532266750|FG002|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|1|||
147576799|NCT03234907|532266751|FG003|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|3|||
147576800|NCT03234907|532266752|FG004|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|3|||
147576801|NCT03234907|532266753|FG005|Maintenance Phase (Week 10 to Week 60)|Lack of Efficacy|4|||
147576802|NCT03234907|532266748|FG000|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|0|||
147576803|NCT03234907|532266749|FG001|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|0|||
147576804|NCT03234907|532266750|FG002|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|0|||
147576805|NCT03234907|532266751|FG003|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|4|||
147576806|NCT03234907|532266752|FG004|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|4|||
147576807|NCT03234907|532266753|FG005|Maintenance Phase (Week 10 to Week 60)|Reason not Specified|10|||
147576808|NCT02986139|532266754|FG000|Overall Study|Sponsor Decision|1|||
147576809|NCT02986139|532266755|FG001|Overall Study|Sponsor Decision|2|||
147576810|NCT02986139|532266754|FG000|Overall Study|Withdrawal by Subject|0|||
147152018|NCT03831191|530719016|FG010|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|4|||
147152019|NCT03831191|530719017|FG011|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|7|||
147152020|NCT03831191|530719018|FG012|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|1|||
147152021|NCT03831191|530719019|FG013|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|1|||
147152022|NCT03831191|530719020|FG014|Maintenance Period (36 Weeks)|Study Terminated by Sponsor|6|||
147152023|NCT03831191|530719006|FG000|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
147576811|NCT02986139|532266755|FG001|Overall Study|Withdrawal by Subject|1|||
147576812|NCT02986139|532266754|FG000|Overall Study|Lost to Follow-up|0|||
147576813|NCT02986139|532266755|FG001|Overall Study|Lost to Follow-up|1|||
147576814|NCT00414726|532266756|FG000|Overall Study|Withdrawal by Subject|0|||
147576815|NCT00414726|532266757|FG001|Overall Study|Withdrawal by Subject|1|||
147576816|NCT02107196|532266758|FG000|12-week Treatment Period|Adverse Event|6|||
147576817|NCT02107196|532266759|FG001|12-week Treatment Period|Adverse Event|3|||
147576818|NCT02107196|532266758|FG000|12-week Treatment Period|Lack of Efficacy|2|||
147576819|NCT02107196|532266759|FG001|12-week Treatment Period|Lack of Efficacy|1|||
147576820|NCT02107196|532266758|FG000|12-week Treatment Period|Lost to Follow-up|3|||
147576821|NCT02107196|532266759|FG001|12-week Treatment Period|Lost to Follow-up|6|||
147576822|NCT02107196|532266758|FG000|12-week Treatment Period|Physician Decision|0|||
147576823|NCT02107196|532266759|FG001|12-week Treatment Period|Physician Decision|1|||
147576824|NCT02107196|532266758|FG000|12-week Treatment Period|Withdrawal by Subject|15|||
147576825|NCT02107196|532266759|FG001|12-week Treatment Period|Withdrawal by Subject|12|||
147576826|NCT02107196|532266758|FG000|12-week Treatment Period|Protocol Violation|7|||
147576827|NCT02107196|532266759|FG001|12-week Treatment Period|Protocol Violation|8|||
147576828|NCT02107196|532266758|FG000|12-week Treatment Period|Reason Missing|11|||
147576829|NCT02107196|532266759|FG001|12-week Treatment Period|Reason Missing|8|||
147576830|NCT02107196|532266758|FG000|4-week Randomized Withdrawal (RW) Period|Adverse Event|2|||
147576831|NCT02107196|532266759|FG001|4-week Randomized Withdrawal (RW) Period|Adverse Event|0|||
147576832|NCT02107196|532266758|FG000|4-week Randomized Withdrawal (RW) Period|Withdrawal by Subject|1|||
147576833|NCT02107196|532266759|FG001|4-week Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
147576834|NCT02107196|532266758|FG000|4-week Randomized Withdrawal (RW) Period|Protocol Violation|2|||
147576835|NCT02107196|532266759|FG001|4-week Randomized Withdrawal (RW) Period|Protocol Violation|0|||
147576836|NCT02107196|532266758|FG000|4-week Randomized Withdrawal (RW) Period|Reason Missing|18|||
147576837|NCT02107196|532266759|FG001|4-week Randomized Withdrawal (RW) Period|Reason Missing|5|||
147576838|NCT01993186|532266760|FG000|Double-Blind Placebo-Controlled Period|Protocol Violation|1|||
147576839|NCT01993186|532266761|FG001|Double-Blind Placebo-Controlled Period|Protocol Violation|0|||
147576840|NCT01993186|532266760|FG000|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|1|||
147576841|NCT01993186|532266761|FG001|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|0|||
147576842|NCT01993186|532266760|FG000|Open-Label Extension Period|Other, Not Specified|0|||
147576843|NCT01993186|532266761|FG001|Open-Label Extension Period|Other, Not Specified|1|||
147576844|NCT01993186|532266760|FG000|Open-Label Extension Period|Adverse Event|1|||
147576845|NCT01993186|532266761|FG001|Open-Label Extension Period|Adverse Event|0|||
147576846|NCT01993186|532266760|FG000|Open-Label Extension Period|Principal Investigator Decision|1|||
147576847|NCT01993186|532266761|FG001|Open-Label Extension Period|Principal Investigator Decision|0|||
147576848|NCT01993186|532266760|FG000|Open-Label Extension Period|Withdrawal by Subject|4|||
147576849|NCT01993186|532266761|FG001|Open-Label Extension Period|Withdrawal by Subject|5|||
147576850|NCT01993186|532266760|FG000|Open-Label Extension Period|Subject Non-Compliance|1|||
147576851|NCT01993186|532266761|FG001|Open-Label Extension Period|Subject Non-Compliance|0|||
147446059|NCT02258451|531797541|FG001|Overall Study|Discontinuation all treatment due to study terminated by sponsor|3|||
147446060|NCT02258451|531797540|FG000|Overall Study|Other reason|1|||
147446061|NCT02258451|531797541|FG001|Overall Study|Other reason|1|||
147446062|NCT02258451|531797540|FG000|Overall Study|Never treated|2|||
147446063|NCT02258451|531797541|FG001|Overall Study|Never treated|3|||
147446064|NCT00517751|531797551|FG000|Overall Study|Death|3|||
147446065|NCT00517751|531797551|FG000|Overall Study|Withdrawal by Subject|37|||
147446066|NCT00517751|531797551|FG000|Overall Study|Lost to Follow-up|4|||
147446067|NCT00517751|531797551|FG000|Overall Study|patient not over due|6|||
147446068|NCT00517751|531797551|FG000|Overall Study|Patient not due for visit|76|||
147446069|NCT00517751|531797551|FG000|Overall Study|Missing|3|||
147446070|NCT03021499|531797552|FG000|Overall Study|Adverse Event|1|||
147446071|NCT03021499|531797553|FG001|Overall Study|Adverse Event|0|||
147446072|NCT03021499|531797552|FG000|Overall Study|Death|1|||
147446073|NCT03021499|531797553|FG001|Overall Study|Death|5|||
147576852|NCT04158687|532266762|FG000|Overall Study|Adverse Event|2|||
147152024|NCT03831191|530719007|FG001|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
147152025|NCT03831191|530719008|FG002|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
147152026|NCT03831191|530719009|FG003|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
147152027|NCT03831191|530719010|FG004|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
147152028|NCT03831191|530719011|FG005|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
147152029|NCT03831191|530719012|FG006|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
147152030|NCT03831191|530719013|FG007|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
147446074|NCT03021499|531797552|FG000|Overall Study|Lack of Efficacy|0|||
147446075|NCT03021499|531797553|FG001|Overall Study|Lack of Efficacy|1|||
147446076|NCT03021499|531797552|FG000|Overall Study|Lost to Follow-up|1|||
147576853|NCT04158687|532266763|FG001|Overall Study|Adverse Event|3|||
147576854|NCT04158687|532266764|FG002|Overall Study|Adverse Event|0|||
147576855|NCT04158687|532266765|FG003|Overall Study|Adverse Event|3|||
147576856|NCT04158687|532266762|FG000|Overall Study|Lost to Follow-up|5|||
147576857|NCT04158687|532266763|FG001|Overall Study|Lost to Follow-up|12|||
147576858|NCT04158687|532266764|FG002|Overall Study|Lost to Follow-up|4|||
147576859|NCT04158687|532266765|FG003|Overall Study|Lost to Follow-up|5|||
147653160|NCT02984267|532551960|FG000|Overall Study|Withdrawal by Subject|0|||
147576860|NCT04158687|532266762|FG000|Overall Study|Coronavirus Disease 2019 (COVID-19) Related Reasons|2|||
147576861|NCT04158687|532266763|FG001|Overall Study|Coronavirus Disease 2019 (COVID-19) Related Reasons|3|||
147576862|NCT04158687|532266764|FG002|Overall Study|Coronavirus Disease 2019 (COVID-19) Related Reasons|2|||
147576863|NCT04158687|532266765|FG003|Overall Study|Coronavirus Disease 2019 (COVID-19) Related Reasons|0|||
147321168|NCT05397470|531338491|FG001|Part B: OLE Period (Up to Week 127)|Lost to Follow-up|0|||
147321169|NCT05397470|531338492|FG002|Part B: OLE Period (Up to Week 127)|Lost to Follow-up|1|||
147321170|NCT05397470|531338490|FG000|Part B: OLE Period (Up to Week 127)|Study closed/terminated|0|||
147321171|NCT05397470|531338491|FG001|Part B: OLE Period (Up to Week 127)|Study closed/terminated|0|||
147321172|NCT05397470|531338492|FG002|Part B: OLE Period (Up to Week 127)|Study closed/terminated|244|||
147321173|NCT06403605|531338493|FG000|Follow-up|Withdrawn per protocol with PAR <50% at week 6|17|||
147321174|NCT06403605|531338494|FG001|Follow-up|Withdrawn per protocol with PAR <50% at week 6|19|||
147321175|NCT06403605|531338493|FG000|Follow-up|Adverse Event|4|||
147321176|NCT06403605|531338494|FG001|Follow-up|Adverse Event|2|||
147321177|NCT06403605|531338493|FG000|Follow-up|Withdrawal by Subject|2|||
147321178|NCT06403605|531338494|FG001|Follow-up|Withdrawal by Subject|3|||
147321179|NCT06403605|531338493|FG000|Follow-up|Lost to Follow-up|1|||
147321180|NCT06403605|531338494|FG001|Follow-up|Lost to Follow-up|0|||
147321181|NCT06403605|531338493|FG000|Follow-up|Death|1|||
147321182|NCT06403605|531338494|FG001|Follow-up|Death|0|||
147321183|NCT06403605|531338493|FG000|Follow-up|Other reasons|0|||
147321184|NCT06403605|531338494|FG001|Follow-up|Other reasons|4|||
147321185|NCT00394095|531339965|FG000|Screening|Withdrawal by Subject|1|||
147321186|NCT00394095|531339966|FG001|Screening|Withdrawal by Subject|0|||
147321187|NCT00394095|531339965|FG000|Randomized|Withdrawal by Subject|5|||
147321188|NCT00394095|531339966|FG001|Randomized|Withdrawal by Subject|1|||
147321189|NCT00394095|531339965|FG000|Randomized|Adverse Event|1|||
147321190|NCT00394095|531339966|FG001|Randomized|Adverse Event|1|||
147321191|NCT00394095|531339965|FG000|Randomized|Overdose|1|||
147321192|NCT00394095|531339966|FG001|Randomized|Overdose|0|||
147321193|NCT00394095|531339965|FG000|Randomized|Lost to Follow-up|1|||
147321194|NCT00394095|531339966|FG001|Randomized|Lost to Follow-up|2|||
147321195|NCT01256476|531339968|FG000|Overall Study|Adverse Event|2|||
147321196|NCT01256476|531339969|FG001|Overall Study|Adverse Event|1|||
147321197|NCT01256476|531339968|FG000|Overall Study|Withdrawal by Subject|2|||
147321198|NCT01256476|531339969|FG001|Overall Study|Withdrawal by Subject|1|||
147321199|NCT01256476|531339968|FG000|Overall Study|Lost to Follow-up|1|||
147321200|NCT01256476|531339969|FG001|Overall Study|Lost to Follow-up|2|||
147321201|NCT01256476|531339968|FG000|Overall Study|Persistent ALT or AST elevation|1|||
147321202|NCT01256476|531339969|FG001|Overall Study|Persistent ALT or AST elevation|0|||
147321203|NCT01256476|531339968|FG000|Overall Study|Physician Decision|0|||
147321204|NCT01256476|531339969|FG001|Overall Study|Physician Decision|1|||
147321205|NCT01256476|531339968|FG000|Overall Study|Subject non-compliance|0|||
147321206|NCT01256476|531339969|FG001|Overall Study|Subject non-compliance|1|||
147321207|NCT01256476|531339968|FG000|Overall Study|LDL-C elevation exceeding 250 mg/dL|0|||
147321208|NCT01256476|531339969|FG001|Overall Study|LDL-C elevation exceeding 250 mg/dL|1|||
147321209|NCT02401529|531339972|FG000|Overall Study|Lost to Follow-up|2|||
147321210|NCT02401529|531339973|FG001|Overall Study|Lost to Follow-up|1|||
147321211|NCT02401529|531339972|FG000|Overall Study|Physician Decision|2|||
147321212|NCT02401529|531339973|FG001|Overall Study|Physician Decision|6|||
147321213|NCT02401529|531339972|FG000|Overall Study|Protocol Violation|5|||
147321214|NCT02401529|531339973|FG001|Overall Study|Protocol Violation|0|||
147321215|NCT01598987|531339976|FG000|Baseline to Month 12|Administrative problems|2|||
147321216|NCT01598987|531339976|FG000|Baseline to Month 12|Withdrawal by Subject|4|||
147576864|NCT04158687|532266762|FG000|Overall Study|Non-Compliance with Study Medication|2|||
147576865|NCT04158687|532266763|FG001|Overall Study|Non-Compliance with Study Medication|2|||
147576866|NCT04158687|532266764|FG002|Overall Study|Non-Compliance with Study Medication|3|||
147576867|NCT04158687|532266765|FG003|Overall Study|Non-Compliance with Study Medication|0|||
147576868|NCT04158687|532266762|FG000|Overall Study|Investigator Decision|0|||
147576869|NCT04158687|532266763|FG001|Overall Study|Investigator Decision|0|||
147576870|NCT04158687|532266764|FG002|Overall Study|Investigator Decision|2|||
147152031|NCT03831191|530719014|FG008|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
147152032|NCT03831191|530719015|FG009|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
147152033|NCT03831191|530719016|FG010|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
147321217|NCT01598987|531339976|FG000|Baseline to 24 Month|Withdrawal by Subject|5|||
147321218|NCT01598987|531339976|FG000|Baseline to 24 Month|Administrative problems|2|||
147576871|NCT04158687|532266765|FG003|Overall Study|Investigator Decision|0|||
147152034|NCT03831191|530719017|FG011|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
147321219|NCT01598987|531339976|FG000|Baseline to 24 Month|Lost to Follow-up|1|||
147321220|NCT00924664|531339977|FG000|Overall Study|Adverse Event|23|||
147321221|NCT00924664|531339978|FG001|Overall Study|Adverse Event|39|||
147321222|NCT00924664|531339977|FG000|Overall Study|Lack of Efficacy|10|||
147321223|NCT00924664|531339978|FG001|Overall Study|Lack of Efficacy|15|||
147321224|NCT00924664|531339977|FG000|Overall Study|Lost to Follow-up|10|||
147321225|NCT00924664|531339978|FG001|Overall Study|Lost to Follow-up|12|||
147321226|NCT00924664|531339977|FG000|Overall Study|Withdrawal by Subject|47|||
147576872|NCT04158687|532266762|FG000|Overall Study|Protocol Violation|0|||
147576873|NCT04158687|532266763|FG001|Overall Study|Protocol Violation|2|||
147576874|NCT04158687|532266764|FG002|Overall Study|Protocol Violation|1|||
147576875|NCT04158687|532266765|FG003|Overall Study|Protocol Violation|0|||
147576876|NCT04158687|532266762|FG000|Overall Study|Withdrawal of Consent by Subject|3|||
147576877|NCT04158687|532266763|FG001|Overall Study|Withdrawal of Consent by Subject|3|||
147576878|NCT04158687|532266764|FG002|Overall Study|Withdrawal of Consent by Subject|4|||
147576879|NCT04158687|532266765|FG003|Overall Study|Withdrawal of Consent by Subject|1|||
147576880|NCT04158687|532266762|FG000|Overall Study|Reason not Specified|3|||
147576881|NCT04158687|532266763|FG001|Overall Study|Reason not Specified|2|||
147576882|NCT04158687|532266764|FG002|Overall Study|Reason not Specified|4|||
147576883|NCT04158687|532266765|FG003|Overall Study|Reason not Specified|4|||
147576884|NCT04523480|532266766|FG000|Overall Study|Lost to Follow-up|30|||
147576885|NCT04523480|532266767|FG001|Overall Study|Lost to Follow-up|35|||
147576886|NCT04523480|532266768|FG002|Overall Study|Lost to Follow-up|0|||
147576887|NCT00640393|532266769|FG000|Part 1|Lost to Follow-up|2|||
147576888|NCT00640393|532266770|FG001|Part 1|Lost to Follow-up|0|||
147576889|NCT00640393|532266771|FG002|Part 1|Lost to Follow-up|0|||
147576890|NCT00640393|532266769|FG000|Part 1|Withdrawal by Subject|3|||
147576891|NCT00640393|532266770|FG001|Part 1|Withdrawal by Subject|0|||
147576892|NCT00640393|532266771|FG002|Part 1|Withdrawal by Subject|0|||
147576893|NCT00640393|532266769|FG000|Randomization|Withdrawn per protocol|17|||
147576894|NCT00640393|532266770|FG001|Randomization|Withdrawn per protocol|0|||
147576895|NCT00640393|532266771|FG002|Randomization|Withdrawn per protocol|0|||
147576896|NCT00640393|532266769|FG000|Randomization|Never randomized by site|2|||
147576897|NCT00640393|532266770|FG001|Randomization|Never randomized by site|0|||
147576898|NCT00640393|532266771|FG002|Randomization|Never randomized by site|0|||
147576899|NCT00640393|532266769|FG000|Part 2|Lost to Follow-up|0|||
147576900|NCT00640393|532266770|FG001|Part 2|Lost to Follow-up|2|||
147576901|NCT00640393|532266771|FG002|Part 2|Lost to Follow-up|2|||
147576902|NCT00640393|532266769|FG000|Part 2|Withdrawal by Subject|0|||
147576903|NCT00640393|532266770|FG001|Part 2|Withdrawal by Subject|6|||
147321227|NCT00924664|531339978|FG001|Overall Study|Withdrawal by Subject|71|||
147321228|NCT00924664|531339977|FG000|Overall Study|Protocol Violation|2|||
147321229|NCT00924664|531339978|FG001|Overall Study|Protocol Violation|5|||
147321230|NCT00924664|531339977|FG000|Overall Study|Pregnancy|1|||
147321231|NCT00924664|531339978|FG001|Overall Study|Pregnancy|1|||
147321232|NCT00924664|531339977|FG000|Overall Study|Death|0|||
147321233|NCT00924664|531339978|FG001|Overall Study|Death|2|||
147576904|NCT00640393|532266771|FG002|Part 2|Withdrawal by Subject|1|||
147576905|NCT00640393|532266769|FG000|Part 2|Non-adherence|0|||
147576906|NCT00640393|532266770|FG001|Part 2|Non-adherence|1|||
147576907|NCT00640393|532266771|FG002|Part 2|Non-adherence|0|||
147576908|NCT00640393|532266769|FG000|Part 2|Adverse Event|0|||
147576909|NCT00640393|532266770|FG001|Part 2|Adverse Event|1|||
147576910|NCT00640393|532266771|FG002|Part 2|Adverse Event|0|||
147576911|NCT03540160|532266776|FG000|Overall Study|Protocol Violation|1|||
147576912|NCT03540160|532266776|FG000|Overall Study|Physician Decision|8|||
147576913|NCT03540160|532266776|FG000|Overall Study|Lack of Efficacy|60|||
147576914|NCT03540160|532266776|FG000|Overall Study|Pregnancy|1|||
147576915|NCT03540160|532266776|FG000|Overall Study|Adverse Event|20|||
147576916|NCT03540160|532266776|FG000|Overall Study|Withdrawal by Subject|68|||
147576917|NCT03540160|532266776|FG000|Overall Study|COVID-19|2|||
147576918|NCT03540160|532266776|FG000|Overall Study|Study Closure|10|||
147576919|NCT03540160|532266776|FG000|Overall Study|Lost to Follow-up|18|||
147576920|NCT03540160|532266776|FG000|Overall Study|Sponsor decision|191|||
147576921|NCT00198133|532266777|FG000|Overall Study|Disease progression|2|||
147576922|NCT00198133|532266778|FG001|Overall Study|Disease progression|5|||
147576923|NCT00198133|532266777|FG000|Overall Study|Adverse Event|1|||
147576924|NCT00198133|532266778|FG001|Overall Study|Adverse Event|3|||
147576925|NCT00198133|532266777|FG000|Overall Study|Withdrawal by Subject|1|||
147576926|NCT00198133|532266778|FG001|Overall Study|Withdrawal by Subject|0|||
147576927|NCT00198133|532266777|FG000|Overall Study|Physician Decision|1|||
147321234|NCT00924664|531339977|FG000|Overall Study|Study terminated by sponsor|199|||
147576928|NCT00198133|532266778|FG001|Overall Study|Physician Decision|0|||
147576929|NCT00835666|532266781|FG000|Washout|Protocol Violation|1|||
147576930|NCT00835666|532266782|FG001|Washout|Protocol Violation|0|||
147576931|NCT00835666|532266781|FG000|Washout|Withdrawal by Subject|1|||
147576932|NCT00835666|532266782|FG001|Washout|Withdrawal by Subject|0|||
147576933|NCT00635648|532266783|FG000|Overall Study|Adverse Event|12|||
147576934|NCT00635648|532266783|FG000|Overall Study|Withdrawal by Subject|9|||
147576935|NCT00635648|532266783|FG000|Overall Study|Physician Decision|4|||
147576936|NCT00635648|532266783|FG000|Overall Study|Rapid progression of baseline disease|4|||
147576937|NCT00635648|532266783|FG000|Overall Study|Use of other antifungal agent needed|1|||
147576938|NCT00635648|532266783|FG000|Overall Study|No improvement after 7-10 days treatment|4|||
147576939|NCT00635648|532266783|FG000|Overall Study|Noncompliance with protocol|1|||
147576940|NCT00635648|532266783|FG000|Overall Study|Other reason|2|||
147576941|NCT02450539|532266787|FG000|Overall Study|Withdrawal by Subject|12|||
147446077|NCT03021499|531797553|FG001|Overall Study|Lost to Follow-up|3|||
147576942|NCT02450539|532266788|FG001|Overall Study|Withdrawal by Subject|6|||
147576943|NCT02450539|532266787|FG000|Overall Study|Lost to Follow-up|4|||
147576944|NCT02450539|532266788|FG001|Overall Study|Lost to Follow-up|1|||
147576945|NCT01484912|532266791|FG000|Overall Study|Withdrawal by Subject|1|||
147576946|NCT01484912|532266792|FG001|Overall Study|Withdrawal by Subject|0|||
147576947|NCT01484912|532266791|FG000|Overall Study|Physician Decision|0|||
147576948|NCT01484912|532266792|FG001|Overall Study|Physician Decision|1|||
147576949|NCT00472212|532266795|FG000|Overall Study|Lost to Follow-up|6|||
147576950|NCT00472212|532266796|FG001|Overall Study|Lost to Follow-up|4|||
147576951|NCT00958724|532266805|FG000|Overall Study|Disease Progression|6|||
147576952|NCT05604014|532266806|FG000|Overall Study|Lost to Follow-up|13|||
147576953|NCT00840203|532266807|FG000|First Intervention|Protocol Violation|1|||
147576954|NCT00840203|532266808|FG001|First Intervention|Protocol Violation|1|||
147576955|NCT00840203|532266807|FG000|Washout|Protocol Violation|1|||
147576956|NCT00840203|532266808|FG001|Washout|Protocol Violation|0|||
147576957|NCT00989950|532266820|FG000|Randomized Phase|Protocol Violation|1|||
147576958|NCT00989950|532266821|FG001|Randomized Phase|Protocol Violation|0|||
147576959|NCT00989950|532266822|FG002|Randomized Phase|Protocol Violation|0|||
147576960|NCT00989950|532266823|FG003|Randomized Phase|Protocol Violation|0|||
147576961|NCT00989950|532266820|FG000|Randomized Phase|Adverse Event|0|||
147653161|NCT02984267|532551961|FG001|Overall Study|Withdrawal by Subject|1|||
147653162|NCT02685072|532551962|FG000|Treatment Period|Lost to Follow-up|12|||
147653163|NCT02685072|532551963|FG001|Treatment Period|Lost to Follow-up|6|||
147653164|NCT02685072|532551962|FG000|Treatment Period|Withdrawal by Subject|1|||
147653165|NCT02685072|532551963|FG001|Treatment Period|Withdrawal by Subject|3|||
147653166|NCT02685072|532551962|FG000|1-Month Follow-Up|Withdrawal by Subject|1|||
147653167|NCT02685072|532551963|FG001|1-Month Follow-Up|Withdrawal by Subject|0|||
147653168|NCT01289574|532551965|FG000|Overall Study|Lack of Efficacy|4|||
147653169|NCT01289574|532551966|FG001|Overall Study|Lack of Efficacy|0|||
147653170|NCT01289574|532551967|FG002|Overall Study|Lack of Efficacy|1|||
147653171|NCT01289574|532551965|FG000|Overall Study|Lost to Follow-up|2|||
147653172|NCT01289574|532551966|FG001|Overall Study|Lost to Follow-up|0|||
147653173|NCT01289574|532551967|FG002|Overall Study|Lost to Follow-up|1|||
147653174|NCT01289574|532551965|FG000|Overall Study|Withdrawal by Subject|1|||
147152035|NCT03831191|530719018|FG012|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
147152036|NCT03831191|530719019|FG013|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
147152037|NCT03831191|530719020|FG014|Maintenance Period (36 Weeks)|Withdrawal by Subject|2|||
147152038|NCT03831191|530719006|FG000|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
147152039|NCT03831191|530719007|FG001|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
147152040|NCT03831191|530719008|FG002|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
147152041|NCT03831191|530719009|FG003|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
147152042|NCT03831191|530719010|FG004|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
147152043|NCT03831191|530719011|FG005|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
147152044|NCT03831191|530719012|FG006|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
147152045|NCT03831191|530719013|FG007|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
147152046|NCT03831191|530719014|FG008|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
147152047|NCT03831191|530719015|FG009|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
147152048|NCT03831191|530719016|FG010|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
147152049|NCT03831191|530719017|FG011|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
147152050|NCT03831191|530719018|FG012|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
147152051|NCT03831191|530719019|FG013|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
147152052|NCT03831191|530719020|FG014|Maintenance Period (36 Weeks)|Lost to Follow-up|1|||
147152053|NCT03070171|530719023|FG000|Treatment Period 2 + Washout|Other Adverse Event|0|||
147152054|NCT03070171|530719024|FG001|Treatment Period 2 + Washout|Other Adverse Event|1|||
147152055|NCT03070171|530719023|FG000|Treatment Period 4 + Washout|Withdrawal by Subject|0|||
147152056|NCT03070171|530719024|FG001|Treatment Period 4 + Washout|Withdrawal by Subject|1|||
147152057|NCT02300558|530719028|FG000|Single Blind Phase (24 Weeks)|Study Terminated by Sponsor|6|||
147152058|NCT02300558|530719028|FG000|Open-Label (OL) Extension Phase|Lack of Efficacy|2|||
147152059|NCT02300558|530719028|FG000|Open-Label (OL) Extension Phase|Withdrew Consent|1|||
147152060|NCT02300558|530719028|FG000|Open-Label (OL) Extension Phase|Study Terminated by Sponsor|29|||
147152061|NCT01471028|530719029|FG000|VTI-208|Adverse Event|39|||
147152062|NCT01471028|530719030|FG001|VTI-208|Adverse Event|41|||
147152063|NCT01471028|530719029|FG000|VTI-208|Withdrawal by Subject|0|||
147152064|NCT01471028|530719030|FG001|VTI-208|Withdrawal by Subject|2|||
147152065|NCT01471028|530719029|FG000|VTI-208|Lost to Follow-up|1|||
147152066|NCT01471028|530719030|FG001|VTI-208|Lost to Follow-up|1|||
147152067|NCT01471028|530719029|FG000|VTI-208E|Death|7|||
147152068|NCT01471028|530719030|FG001|VTI-208E|Death|10|||
147152069|NCT01471028|530719029|FG000|VTI-208E|Withdrawal by Subject|1|||
147576962|NCT00989950|532266821|FG001|Randomized Phase|Adverse Event|1|||
147576963|NCT00989950|532266822|FG002|Randomized Phase|Adverse Event|0|||
147576964|NCT00989950|532266823|FG003|Randomized Phase|Adverse Event|0|||
147576965|NCT03101358|532266825|FG000|Overall Study|Non-compliance with study schedule|1|||
147576966|NCT03101358|532266826|FG001|Overall Study|Non-compliance with study schedule|0|||
147653175|NCT01289574|532551966|FG001|Overall Study|Withdrawal by Subject|1|||
147152070|NCT01471028|530719030|FG001|VTI-208E|Withdrawal by Subject|0|||
147321235|NCT00924664|531339978|FG001|Overall Study|Study terminated by sponsor|330|||
147321236|NCT00924664|531339977|FG000|Overall Study|Other|29|||
147321237|NCT00924664|531339978|FG001|Overall Study|Other|52|||
147321238|NCT00924664|531339977|FG000|Overall Study|Randomized but not Treated|1|||
147321239|NCT00924664|531339978|FG001|Overall Study|Randomized but not Treated|0|||
147321240|NCT01450943|531339980|FG000|Overall Study|Screen failure, loss to follow-up|2|||
147321241|NCT01450943|531339981|FG001|Overall Study|Screen failure, loss to follow-up|7|||
147321242|NCT01450943|531339982|FG002|Overall Study|Screen failure, loss to follow-up|6|||
147321243|NCT03303105|531339985|FG000|Overall Study|Adverse Event|0|||
147321244|NCT03303105|531339986|FG001|Overall Study|Adverse Event|2|||
147321245|NCT03303105|531339985|FG000|Overall Study|Lack of Efficacy|1|||
147576967|NCT03101358|532266827|FG002|Overall Study|Non-compliance with study schedule|0|||
147576968|NCT03101358|532266828|FG003|Overall Study|Non-compliance with study schedule|1|||
147576969|NCT03101358|532266825|FG000|Overall Study|Decision to start another clinical trial. Not related to AE.|0|||
147576970|NCT03101358|532266826|FG001|Overall Study|Decision to start another clinical trial. Not related to AE.|0|||
147576971|NCT03101358|532266827|FG002|Overall Study|Decision to start another clinical trial. Not related to AE.|1|||
147576972|NCT03101358|532266828|FG003|Overall Study|Decision to start another clinical trial. Not related to AE.|0|||
147576973|NCT03101358|532266825|FG000|Overall Study|Physician Decision|1|||
147576974|NCT03101358|532266826|FG001|Overall Study|Physician Decision|0|||
147576975|NCT03101358|532266827|FG002|Overall Study|Physician Decision|0|||
147576976|NCT03101358|532266828|FG003|Overall Study|Physician Decision|3|||
147576977|NCT03101358|532266825|FG000|Overall Study|Adverse Event|0|||
147576978|NCT03101358|532266826|FG001|Overall Study|Adverse Event|0|||
147576979|NCT03101358|532266827|FG002|Overall Study|Adverse Event|1|||
147576980|NCT03101358|532266828|FG003|Overall Study|Adverse Event|0|||
147576981|NCT03101358|532266825|FG000|Overall Study|Oncologist decision to start subject on IV chemotherapy prohibited under protocol.|0|||
147576982|NCT03101358|532266826|FG001|Overall Study|Oncologist decision to start subject on IV chemotherapy prohibited under protocol.|0|||
147576983|NCT03101358|532266827|FG002|Overall Study|Oncologist decision to start subject on IV chemotherapy prohibited under protocol.|0|||
147576984|NCT03101358|532266828|FG003|Overall Study|Oncologist decision to start subject on IV chemotherapy prohibited under protocol.|1|||
147576985|NCT03101358|532266825|FG000|Overall Study|Lost to Follow-up|1|||
147576986|NCT03101358|532266826|FG001|Overall Study|Lost to Follow-up|0|||
147576987|NCT03101358|532266827|FG002|Overall Study|Lost to Follow-up|0|||
147576988|NCT03101358|532266828|FG003|Overall Study|Lost to Follow-up|1|||
147576989|NCT02426918|532266831|FG000|Overall Study|Adverse Event|2|||
147576990|NCT02426918|532266832|FG001|Overall Study|Adverse Event|2|||
147576991|NCT02426918|532266833|FG002|Overall Study|Adverse Event|0|||
147576992|NCT02426918|532266831|FG000|Overall Study|Physician Decision|1|||
147576993|NCT02426918|532266832|FG001|Overall Study|Physician Decision|1|||
147576994|NCT02426918|532266833|FG002|Overall Study|Physician Decision|1|||
147576995|NCT02426918|532266831|FG000|Overall Study|Withdrawal by Subject|5|||
147576996|NCT02426918|532266832|FG001|Overall Study|Withdrawal by Subject|5|||
147576997|NCT02426918|532266833|FG002|Overall Study|Withdrawal by Subject|4|||
147576998|NCT02426918|532266831|FG000|Overall Study|Other|9|||
147576999|NCT02426918|532266832|FG001|Overall Study|Other|11|||
147577000|NCT02426918|532266833|FG002|Overall Study|Other|9|||
147577001|NCT01190865|532266839|FG000|Overall Study|Withdrawal by Subject|1|||
147577002|NCT01190865|532266839|FG000|Overall Study|Non-compliance|2|||
147577003|NCT00829452|532266840|FG000|First Intervention|Withdrawal by Subject|0|||
147577004|NCT00829452|532266841|FG001|First Intervention|Withdrawal by Subject|1|||
147577005|NCT00829452|532266840|FG000|Washout of 42 Days|Withdrawal by Subject|0|||
147577006|NCT00829452|532266841|FG001|Washout of 42 Days|Withdrawal by Subject|1|||
147577007|NCT00829452|532266840|FG000|Second Intervention|Physician Decision|0|||
147577008|NCT00829452|532266841|FG001|Second Intervention|Physician Decision|1|||
147577009|NCT00574847|532266844|FG000|Overall Study|Adverse Event|2|||
147577010|NCT00574847|532266845|FG001|Overall Study|Adverse Event|0|||
147577011|NCT00574847|532266844|FG000|Overall Study|Death|1|||
147577012|NCT00574847|532266845|FG001|Overall Study|Death|0|||
147577013|NCT00574847|532266844|FG000|Overall Study|Withdrawal by Subject|2|||
147653176|NCT01289574|532551967|FG002|Overall Study|Withdrawal by Subject|1|||
147321246|NCT03303105|531339986|FG001|Overall Study|Lack of Efficacy|0|||
147321247|NCT03303105|531339985|FG000|Overall Study|Protocol Violation|1|||
147321248|NCT03303105|531339986|FG001|Overall Study|Protocol Violation|0|||
147321249|NCT03303105|531339985|FG000|Overall Study|Withdrawal by Subject|0|||
147321250|NCT03303105|531339986|FG001|Overall Study|Withdrawal by Subject|2|||
147321251|NCT04822298|531339989|FG000|Overall Study|Death|3|||
147321252|NCT01333943|531339993|FG000|Overall Study|Known neuropathy|1|||
147321253|NCT01333943|531339994|FG001|Overall Study|Known neuropathy|0|||
147446078|NCT03021499|531797552|FG000|Overall Study|Physician Decision|2|||
147577014|NCT00574847|532266845|FG001|Overall Study|Withdrawal by Subject|2|||
147577015|NCT00574847|532266844|FG000|Overall Study|Physician Decision|1|||
147577016|NCT00574847|532266845|FG001|Overall Study|Physician Decision|0|||
147577017|NCT00574847|532266844|FG000|Overall Study|Did not receive medication (declined)|2|||
147577018|NCT00574847|532266845|FG001|Overall Study|Did not receive medication (declined)|5|||
147577019|NCT02471807|532266850|FG000|Overall Study|Death|14|||
147653177|NCT01289574|532551965|FG000|Overall Study|Adverse Event|0|||
147577020|NCT02471807|532266850|FG000|Overall Study|Withdrawal by Subject|2|||
147577021|NCT02471807|532266850|FG000|Overall Study|Explant|5|||
147577022|NCT02471807|532266850|FG000|Overall Study|Lost to Follow-up|1|||
147577023|NCT01559363|532266853|FG000|Phase 1b: Up to 36 Months|Withdrawal by Subject|2|||
147577024|NCT01559363|532266854|FG001|Phase 1b: Up to 36 Months|Withdrawal by Subject|1|||
147577025|NCT01559363|532266855|FG002|Phase 1b: Up to 36 Months|Withdrawal by Subject|1|||
147577026|NCT01559363|532266856|FG003|Phase 1b: Up to 36 Months|Withdrawal by Subject|0|||
147577027|NCT01559363|532266857|FG004|Phase 1b: Up to 36 Months|Withdrawal by Subject|0|||
147577028|NCT01559363|532266858|FG005|Phase 1b: Up to 36 Months|Withdrawal by Subject|0|||
147577029|NCT01559363|532266853|FG000|Phase 1b: Up to 36 Months|Investigator decision|1|||
147577030|NCT01559363|532266854|FG001|Phase 1b: Up to 36 Months|Investigator decision|0|||
147577031|NCT01559363|532266855|FG002|Phase 1b: Up to 36 Months|Investigator decision|0|||
147577032|NCT01559363|532266856|FG003|Phase 1b: Up to 36 Months|Investigator decision|0|||
147577033|NCT01559363|532266857|FG004|Phase 1b: Up to 36 Months|Investigator decision|0|||
147577034|NCT01559363|532266858|FG005|Phase 1b: Up to 36 Months|Investigator decision|0|||
147577035|NCT01559363|532266853|FG000|Phase 1b: Up to 36 Months|Lost to Follow-up|1|||
147577036|NCT01559363|532266854|FG001|Phase 1b: Up to 36 Months|Lost to Follow-up|1|||
147577037|NCT01559363|532266855|FG002|Phase 1b: Up to 36 Months|Lost to Follow-up|0|||
147577038|NCT01559363|532266856|FG003|Phase 1b: Up to 36 Months|Lost to Follow-up|0|||
147577039|NCT01559363|532266857|FG004|Phase 1b: Up to 36 Months|Lost to Follow-up|0|||
147577040|NCT01559363|532266858|FG005|Phase 1b: Up to 36 Months|Lost to Follow-up|0|||
147577041|NCT01559363|532266853|FG000|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|2|||
147577042|NCT01559363|532266854|FG001|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|0|||
147577043|NCT01559363|532266855|FG002|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|1|||
147577044|NCT01559363|532266856|FG003|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|0|||
147577045|NCT01559363|532266857|FG004|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|0|||
147577046|NCT01559363|532266858|FG005|Phase 1b: Up to 36 Months|Adverse event or Serious adverse event|0|||
147577047|NCT01559363|532266853|FG000|Phase 1b: Up to 36 Months|Unspecified reason|0|||
147577048|NCT01559363|532266854|FG001|Phase 1b: Up to 36 Months|Unspecified reason|1|||
147577049|NCT01559363|532266855|FG002|Phase 1b: Up to 36 Months|Unspecified reason|0|||
147577050|NCT01559363|532266856|FG003|Phase 1b: Up to 36 Months|Unspecified reason|0|||
147577051|NCT01559363|532266857|FG004|Phase 1b: Up to 36 Months|Unspecified reason|0|||
147577052|NCT01559363|532266858|FG005|Phase 1b: Up to 36 Months|Unspecified reason|0|||
147577053|NCT01559363|532266853|FG000|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|0|||
147577054|NCT01559363|532266854|FG001|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|0|||
147577055|NCT01559363|532266855|FG002|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|0|||
147577056|NCT01559363|532266856|FG003|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|1|||
147577057|NCT01559363|532266857|FG004|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|1|||
147577058|NCT01559363|532266858|FG005|Phase 2a: Up to 28 Months|Adverse event or Serious adverse event|0|||
147577059|NCT01559363|532266853|FG000|Phase 2a: Up to 28 Months|Unspecified reason|0|||
147577060|NCT01559363|532266854|FG001|Phase 2a: Up to 28 Months|Unspecified reason|0|||
147577061|NCT01559363|532266855|FG002|Phase 2a: Up to 28 Months|Unspecified reason|0|||
147577062|NCT01559363|532266856|FG003|Phase 2a: Up to 28 Months|Unspecified reason|1|||
147577063|NCT01559363|532266857|FG004|Phase 2a: Up to 28 Months|Unspecified reason|0|||
147577064|NCT01559363|532266858|FG005|Phase 2a: Up to 28 Months|Unspecified reason|0|||
147577065|NCT00957021|532266861|FG000|Overall Study|Death|5|||
147577066|NCT00957021|532266861|FG000|Overall Study|Lost to Follow-up|8|||
147577067|NCT00957021|532266861|FG000|Overall Study|Withdrawal by Subject|34|||
147577068|NCT00957021|532266861|FG000|Overall Study|No 2 yr ROM data|35|||
147577069|NCT00957021|532266861|FG000|Overall Study|Revised study component by 2 yr visit|8|||
147577070|NCT00957021|532266861|FG000|Overall Study|Site Termination by the 2 yr visit|16|||
147577071|NCT00957021|532266861|FG000|Overall Study|Surgery Cancelled|9|||
147577072|NCT00957021|532266861|FG000|Overall Study|Termination due to language issue|2|||
147577073|NCT00487435|532266866|FG000|Overall Study|Adverse Event|146|||
147577074|NCT00487435|532266866|FG000|Overall Study|Death|2|||
147577075|NCT00487435|532266866|FG000|Overall Study|Lack of Efficacy|33|||
147577076|NCT00487435|532266866|FG000|Overall Study|Lost to Follow-up|54|||
147577077|NCT00487435|532266866|FG000|Overall Study|Pregnancy|2|||
147577078|NCT00487435|532266866|FG000|Overall Study|Withdrawal by Subject|132|||
147577079|NCT00487435|532266866|FG000|Overall Study|Resolution Of Pain|1|||
147577080|NCT00487435|532266866|FG000|Overall Study|Study Medication Non-Compliant|32|||
147577081|NCT00487435|532266866|FG000|Overall Study|Other|83|||
147239670|NCT01090492|531049256|FG001|Second Intervention Period (4 Weeks)|Non-compliance|1|||
147239671|NCT01090492|531049257|FG002|Second Intervention Period (4 Weeks)|Non-compliance|0|||
147239672|NCT01090492|531049258|FG003|Second Intervention Period (4 Weeks)|Non-compliance|0|||
147577082|NCT00868998|532266874|FG000|Overall Study|Screen Failure|1|||
147577083|NCT00868998|532266874|FG000|Overall Study|Withdrawal by Subject|1|||
147577084|NCT00868998|532266874|FG000|Overall Study|Progression of disease|2|||
147577085|NCT00868998|532266874|FG000|Overall Study|Death|1|||
147577086|NCT01483820|532266876|FG000|Overall Study|Lack of Efficacy|6|||
147577087|NCT01483820|532266876|FG000|Overall Study|Adverse Event|1|||
147577088|NCT01483820|532266876|FG000|Overall Study|Death|1|||
147577089|NCT01395017|532266879|FG000|Overall Study|Lost to Follow-up|1|||
147577090|NCT01395017|532266880|FG001|Overall Study|Lost to Follow-up|0|||
147577091|NCT01395017|532266879|FG000|Overall Study|Adverse Event|26|||
147577092|NCT01395017|532266880|FG001|Overall Study|Adverse Event|12|||
147577093|NCT01395017|532266879|FG000|Overall Study|Physician Decision|11|||
147577094|NCT01395017|532266880|FG001|Overall Study|Physician Decision|15|||
147577095|NCT01395017|532266879|FG000|Overall Study|Withdrawal by Subject|14|||
147577096|NCT01395017|532266880|FG001|Overall Study|Withdrawal by Subject|8|||
147577097|NCT01395017|532266879|FG000|Overall Study|Protocol deviation|1|||
147577098|NCT01395017|532266880|FG001|Overall Study|Protocol deviation|2|||
147577099|NCT01395017|532266879|FG000|Overall Study|Death|4|||
147577100|NCT01395017|532266880|FG001|Overall Study|Death|3|||
147577101|NCT01395017|532266879|FG000|Overall Study|Disease progression|42|||
147577102|NCT01395017|532266880|FG001|Overall Study|Disease progression|58|||
147577103|NCT01395017|532266879|FG000|Overall Study|Sponsor discontinued study|1|||
147577104|NCT01395017|532266880|FG001|Overall Study|Sponsor discontinued study|4|||
147577105|NCT00858403|532266882|FG000|Overall Study|Withdrawal by Subject|1|||
147577106|NCT00858403|532266882|FG000|Overall Study|Death|3|||
147577107|NCT00858403|532266882|FG000|Overall Study|Disease Progression|1|||
147577108|NCT01018862|532266889|FG000|Overall Study|Adverse Event|2|||
147577109|NCT01018862|532266890|FG001|Overall Study|Adverse Event|0|||
147577110|NCT01018862|532266891|FG002|Overall Study|Adverse Event|6|||
147577111|NCT01018862|532266889|FG000|Overall Study|Lack of Efficacy|1|||
147577112|NCT01018862|532266890|FG001|Overall Study|Lack of Efficacy|0|||
147577113|NCT01018862|532266891|FG002|Overall Study|Lack of Efficacy|2|||
147577114|NCT01018862|532266889|FG000|Overall Study|Lost to Follow-up|3|||
147577115|NCT01018862|532266890|FG001|Overall Study|Lost to Follow-up|1|||
147577116|NCT01018862|532266891|FG002|Overall Study|Lost to Follow-up|0|||
147577117|NCT01018862|532266889|FG000|Overall Study|Protocol Violation|1|||
147577118|NCT01018862|532266890|FG001|Overall Study|Protocol Violation|3|||
147577119|NCT01018862|532266891|FG002|Overall Study|Protocol Violation|3|||
147577120|NCT01018862|532266889|FG000|Overall Study|Withdrawal by Subject|1|||
147577121|NCT01018862|532266890|FG001|Overall Study|Withdrawal by Subject|2|||
147577122|NCT01018862|532266891|FG002|Overall Study|Withdrawal by Subject|1|||
147577123|NCT01018862|532266889|FG000|Overall Study|administrative problems|5|||
147577124|NCT01018862|532266890|FG001|Overall Study|administrative problems|4|||
147577125|NCT01018862|532266891|FG002|Overall Study|administrative problems|4|||
147577126|NCT01968031|532266895|FG000|Overall Study|Adverse Event|13|||
147577127|NCT01968031|532266896|FG001|Overall Study|Adverse Event|10|||
147577128|NCT01968031|532266897|FG002|Overall Study|Adverse Event|22|||
147577129|NCT01968031|532266895|FG000|Overall Study|Withdrawal by Subject|3|||
147577130|NCT01968031|532266896|FG001|Overall Study|Withdrawal by Subject|7|||
147577131|NCT01968031|532266897|FG002|Overall Study|Withdrawal by Subject|3|||
147577132|NCT01968031|532266895|FG000|Overall Study|Did not meet entry criteria|1|||
147577133|NCT01968031|532266896|FG001|Overall Study|Did not meet entry criteria|1|||
147577134|NCT01968031|532266897|FG002|Overall Study|Did not meet entry criteria|1|||
147577135|NCT01968031|532266895|FG000|Overall Study|Noncompliance|0|||
147577136|NCT01968031|532266896|FG001|Overall Study|Noncompliance|0|||
147577137|NCT01968031|532266897|FG002|Overall Study|Noncompliance|2|||
147577138|NCT01968031|532266895|FG000|Overall Study|Failed inclusion criteria|0|||
147577139|NCT01968031|532266896|FG001|Overall Study|Failed inclusion criteria|2|||
147577140|NCT01968031|532266897|FG002|Overall Study|Failed inclusion criteria|0|||
147577141|NCT01968031|532266895|FG000|Overall Study|Death|0|||
147577142|NCT01968031|532266896|FG001|Overall Study|Death|0|||
147577143|NCT01968031|532266897|FG002|Overall Study|Death|1|||
147577144|NCT01968031|532266895|FG000|Overall Study|Prohibited concomitant medication|1|||
147577145|NCT01968031|532266896|FG001|Overall Study|Prohibited concomitant medication|0|||
147577146|NCT01968031|532266897|FG002|Overall Study|Prohibited concomitant medication|0|||
147577147|NCT00874276|532266898|FG000|Overall Study|Withdrawal by Subject|1|||
147577148|NCT00874276|532266899|FG001|Overall Study|Withdrawal by Subject|1|||
147577149|NCT02485158|532268807|FG000|Overall Study|Withdrawal by Subject|3|||
147577150|NCT02485158|532268807|FG000|Overall Study|expected drug side effect|1|||
147577151|NCT01098851|532268808|FG000|Overall Study|Equipment failure|1|||
147653178|NCT01289574|532551966|FG001|Overall Study|Adverse Event|1|||
147653179|NCT01289574|532551967|FG002|Overall Study|Adverse Event|0|||
147239673|NCT01090492|531049259|FG004|Second Intervention Period (4 Weeks)|Non-compliance|0|||
147577152|NCT01098851|532268809|FG001|Overall Study|Equipment failure|0|||
147239674|NCT01090492|531049260|FG005|Second Intervention Period (4 Weeks)|Non-compliance|0|||
147239675|NCT01090492|531049261|FG006|Second Intervention Period (4 Weeks)|Non-compliance|0|||
147239676|NCT01090492|531049262|FG007|Second Intervention Period (4 Weeks)|Non-compliance|0|||
147577153|NCT03087786|532268810|FG000|Overall Study|Withdrawal by Subject|2|||
147577154|NCT03087786|532268811|FG001|Overall Study|Withdrawal by Subject|0|||
147577155|NCT00516295|532268817|FG000|Overall Study|Lack of Efficacy|2|||
147577156|NCT00516295|532268818|FG001|Overall Study|Lack of Efficacy|0|||
147577157|NCT00516295|532268819|FG002|Overall Study|Lack of Efficacy|0|||
147577158|NCT00516295|532268817|FG000|Overall Study|Ineligible|1|||
147577159|NCT00516295|532268818|FG001|Overall Study|Ineligible|0|||
147577160|NCT00516295|532268819|FG002|Overall Study|Ineligible|0|||
147577161|NCT00834444|532268820|FG000|First Intervention|Adverse Event|1|||
147577162|NCT00834444|532268821|FG001|First Intervention|Adverse Event|0|||
147577163|NCT00834444|532268820|FG000|First Intervention|Intolerance to Venopuncture|0|||
147577164|NCT00834444|532268821|FG001|First Intervention|Intolerance to Venopuncture|1|||
147577165|NCT00834444|532268820|FG000|Washout of 7 Days|Withdrawal by Subject|0|||
147577166|NCT00834444|532268821|FG001|Washout of 7 Days|Withdrawal by Subject|1|||
147577167|NCT00834444|532268820|FG000|Second Intervention|Adverse Event|1|||
147577168|NCT00834444|532268821|FG001|Second Intervention|Adverse Event|0|||
147577169|NCT00731939|532268825|FG000|Overall Study|Adverse Event|6|||
147577170|NCT00731939|532268825|FG000|Overall Study|Lost to Follow-up|15|||
147577171|NCT00731939|532268825|FG000|Overall Study|Not implanted with study device|9|||
147577172|NCT00731939|532268825|FG000|Overall Study|Withdrawal by Subject|2|||
147577173|NCT00731939|532268825|FG000|Overall Study|Did not meet enrollment criteria|2|||
147577174|NCT02704091|532268826|FG000|Overall Study|Adverse Event|4|||
147577175|NCT02704091|532268827|FG001|Overall Study|Adverse Event|3|||
147577176|NCT02704091|532268826|FG000|Overall Study|Protocol Violation|5|||
147577177|NCT02704091|532268827|FG001|Overall Study|Protocol Violation|3|||
147577178|NCT02704091|532268826|FG000|Overall Study|Consent withdrawn|4|||
147577179|NCT02704091|532268827|FG001|Overall Study|Consent withdrawn|4|||
147577180|NCT02704091|532268826|FG000|Overall Study|Lost to Follow-up|13|||
147577181|NCT02704091|532268827|FG001|Overall Study|Lost to Follow-up|5|||
147577182|NCT02704091|532268826|FG000|Overall Study|Other|2|||
147577183|NCT02704091|532268827|FG001|Overall Study|Other|8|||
147577184|NCT01634139|532268828|FG000|Overall Study|Non compliant with protocol|1|||
147577185|NCT01634139|532268829|FG001|Overall Study|Non compliant with protocol|0|||
147577186|NCT01634139|532268830|FG002|Overall Study|Non compliant with protocol|0|||
147577187|NCT01634139|532268828|FG000|Overall Study|Consent withdrawn not due to AE|4|||
147577188|NCT01634139|532268829|FG001|Overall Study|Consent withdrawn not due to AE|3|||
147577189|NCT01634139|532268830|FG002|Overall Study|Consent withdrawn not due to AE|2|||
147577190|NCT01634139|532268828|FG000|Overall Study|Other|4|||
147577191|NCT01634139|532268829|FG001|Overall Study|Other|0|||
147577192|NCT01634139|532268830|FG002|Overall Study|Other|3|||
147577193|NCT01634139|532268828|FG000|Overall Study|Lost to Follow-up|0|||
147577194|NCT01634139|532268829|FG001|Overall Study|Lost to Follow-up|2|||
147577195|NCT01634139|532268830|FG002|Overall Study|Lost to Follow-up|0|||
147577196|NCT01634139|532268828|FG000|Overall Study|Not treated|1|||
147577197|NCT01634139|532268829|FG001|Overall Study|Not treated|1|||
147577198|NCT01634139|532268830|FG002|Overall Study|Not treated|0|||
147577199|NCT00425308|532268831|FG000|Overall Study|Adverse Event|2|||
147577200|NCT00425308|532268832|FG001|Overall Study|Adverse Event|1|||
147577201|NCT00425308|532268831|FG000|Overall Study|Withdrawal by Subject|1|||
147577202|NCT00425308|532268832|FG001|Overall Study|Withdrawal by Subject|0|||
147577203|NCT00425308|532268831|FG000|Overall Study|Death|1|||
147577204|NCT00425308|532268832|FG001|Overall Study|Death|0|||
147577205|NCT04411680|532268833|FG000|Treatment Period|Adverse Event|3|||
147577206|NCT04411680|532268834|FG001|Treatment Period|Adverse Event|0|||
147577207|NCT04411680|532268833|FG000|Treatment Period|Discharged from hospital|18|||
147577208|NCT04411680|532268834|FG001|Treatment Period|Discharged from hospital|7|||
147577209|NCT04411680|532268833|FG000|Treatment Period|Missed 1 or more doses|8|||
147577210|NCT04411680|532268834|FG001|Treatment Period|Missed 1 or more doses|0|||
147577211|NCT04411680|532268833|FG000|Treatment Period|Transferred to another hospital|0|||
147577212|NCT04411680|532268834|FG001|Treatment Period|Transferred to another hospital|1|||
147577213|NCT04411680|532268833|FG000|Follow up Period|Withdrawal by Subject|2|||
147577214|NCT04411680|532268834|FG001|Follow up Period|Withdrawal by Subject|0|||
147577215|NCT04411680|532268833|FG000|Follow up Period|Lost to Follow-up|5|||
147577216|NCT04411680|532268834|FG001|Follow up Period|Lost to Follow-up|6|||
147577217|NCT04411680|532268833|FG000|Follow up Period|Death|11|||
147577218|NCT04411680|532268834|FG001|Follow up Period|Death|8|||
147239677|NCT01090492|531049255|FG000|Second Intervention Period (4 Weeks)|Other|0|||
147239678|NCT01090492|531049256|FG001|Second Intervention Period (4 Weeks)|Other|1|||
147239679|NCT01090492|531049257|FG002|Second Intervention Period (4 Weeks)|Other|1|||
147239680|NCT01090492|531049258|FG003|Second Intervention Period (4 Weeks)|Other|0|||
147239681|NCT01090492|531049259|FG004|Second Intervention Period (4 Weeks)|Other|0|||
147239682|NCT01090492|531049260|FG005|Second Intervention Period (4 Weeks)|Other|0|||
147577219|NCT00841659|532268835|FG000|Washout: 2 Weeks|Protocol Violation|1|||
147577220|NCT00841659|532268836|FG001|Washout: 2 Weeks|Protocol Violation|0|||
147577221|NCT02420353|532268837|FG000|Overall Study|Withdrawal by Subject|0|||
147577222|NCT02420353|532268838|FG001|Overall Study|Withdrawal by Subject|1|||
147577223|NCT00073307|532268844|FG000|Double-Blind (DB, as of ~31May2005)|Adverse Event|22|||
147577224|NCT00073307|532268845|FG001|Double-Blind (DB, as of ~31May2005)|Adverse Event|17|||
147577225|NCT00073307|532268846|FG002|Double-Blind (DB, as of ~31May2005)|Adverse Event|0|||
147577226|NCT00073307|532268844|FG000|Double-Blind (DB, as of ~31May2005)|Lost to Follow-up|1|||
147577227|NCT00073307|532268845|FG001|Double-Blind (DB, as of ~31May2005)|Lost to Follow-up|6|||
147577228|NCT00073307|532268846|FG002|Double-Blind (DB, as of ~31May2005)|Lost to Follow-up|0|||
147577229|NCT00073307|532268844|FG000|Double-Blind (DB, as of ~31May2005)|Withdrawal by Subject|6|||
147577230|NCT00073307|532268845|FG001|Double-Blind (DB, as of ~31May2005)|Withdrawal by Subject|11|||
147577231|NCT00073307|532268846|FG002|Double-Blind (DB, as of ~31May2005)|Withdrawal by Subject|0|||
147577232|NCT00073307|532268844|FG000|Double-Blind (DB, as of ~31May2005)|Protocol Violation|1|||
147577233|NCT00073307|532268845|FG001|Double-Blind (DB, as of ~31May2005)|Protocol Violation|1|||
147577234|NCT00073307|532268846|FG002|Double-Blind (DB, as of ~31May2005)|Protocol Violation|0|||
147577235|NCT00073307|532268844|FG000|Double-Blind (DB, as of ~31May2005)|Non-compliant with Study medication|1|||
147577236|NCT00073307|532268845|FG001|Double-Blind (DB, as of ~31May2005)|Non-compliant with Study medication|2|||
147577237|NCT00073307|532268846|FG002|Double-Blind (DB, as of ~31May2005)|Non-compliant with Study medication|0|||
147577238|NCT00073307|532268844|FG000|Double-Blind (DB, as of ~31May2005)|Unknown reason.|1|||
147577239|NCT00073307|532268845|FG001|Double-Blind (DB, as of ~31May2005)|Unknown reason.|0|||
147577240|NCT00073307|532268846|FG002|Double-Blind (DB, as of ~31May2005)|Unknown reason.|0|||
147577241|NCT00073307|532268844|FG000|Double-Blind (DB, as of ~31May2005)|Protocol driven decision point|0|||
147239683|NCT01090492|531049261|FG006|Second Intervention Period (4 Weeks)|Other|0|||
147239684|NCT01090492|531049262|FG007|Second Intervention Period (4 Weeks)|Other|0|||
147239685|NCT01090492|531049255|FG000|Second Intervention Period (4 Weeks)|Adverse Event|0|||
147239686|NCT01090492|531049256|FG001|Second Intervention Period (4 Weeks)|Adverse Event|0|||
147239687|NCT01090492|531049257|FG002|Second Intervention Period (4 Weeks)|Adverse Event|1|||
147239688|NCT01090492|531049258|FG003|Second Intervention Period (4 Weeks)|Adverse Event|0|||
147239689|NCT01090492|531049259|FG004|Second Intervention Period (4 Weeks)|Adverse Event|1|||
147577242|NCT00073307|532268845|FG001|Double-Blind (DB, as of ~31May2005)|Protocol driven decision point|1|||
147577243|NCT00073307|532268846|FG002|Double-Blind (DB, as of ~31May2005)|Protocol driven decision point|0|||
147577244|NCT00073307|532268844|FG000|Double-Blind (DB, as of ~31May2005)|entered Open Label (OL); Sorafenib only|165|||
147577245|NCT00073307|532268845|FG001|Double-Blind (DB, as of ~31May2005)|entered Open Label (OL); Sorafenib only|114|||
147577246|NCT00073307|532268846|FG002|Double-Blind (DB, as of ~31May2005)|entered Open Label (OL); Sorafenib only|0|||
147577247|NCT00073307|532268844|FG000|Double-Blind (DB, as of ~31May2005)|Subject did not receive treatment|0|||
147577248|NCT00073307|532268845|FG001|Double-Blind (DB, as of ~31May2005)|Subject did not receive treatment|1|||
147577249|NCT00073307|532268846|FG002|Double-Blind (DB, as of ~31May2005)|Subject did not receive treatment|0|||
147577250|NCT00073307|532268844|FG000|Open Label-Sorafenib Only [30Jun2008]|Adverse Event|17|||
147577251|NCT00073307|532268845|FG001|Open Label-Sorafenib Only [30Jun2008]|Adverse Event|0|||
147577252|NCT00073307|532268846|FG002|Open Label-Sorafenib Only [30Jun2008]|Adverse Event|19|||
147577253|NCT00073307|532268844|FG000|Open Label-Sorafenib Only [30Jun2008]|Lost to Follow-up|2|||
147577254|NCT00073307|532268845|FG001|Open Label-Sorafenib Only [30Jun2008]|Lost to Follow-up|0|||
147577255|NCT00073307|532268846|FG002|Open Label-Sorafenib Only [30Jun2008]|Lost to Follow-up|2|||
147577256|NCT00073307|532268844|FG000|Open Label-Sorafenib Only [30Jun2008]|Withdrawal by Subject|19|||
147577257|NCT00073307|532268845|FG001|Open Label-Sorafenib Only [30Jun2008]|Withdrawal by Subject|0|||
147577258|NCT00073307|532268846|FG002|Open Label-Sorafenib Only [30Jun2008]|Withdrawal by Subject|9|||
147577259|NCT00073307|532268844|FG000|Open Label-Sorafenib Only [30Jun2008]|Study terminated by Sponsor|37|||
147577260|NCT00073307|532268845|FG001|Open Label-Sorafenib Only [30Jun2008]|Study terminated by Sponsor|0|||
147577261|NCT00073307|532268846|FG002|Open Label-Sorafenib Only [30Jun2008]|Study terminated by Sponsor|28|||
147577262|NCT00073307|532268844|FG000|Open Label-Sorafenib Only [30Jun2008]|Per Investigator, not protocol driven|1|||
147577263|NCT00073307|532268845|FG001|Open Label-Sorafenib Only [30Jun2008]|Per Investigator, not protocol driven|0|||
147577264|NCT00073307|532268846|FG002|Open Label-Sorafenib Only [30Jun2008]|Per Investigator, not protocol driven|1|||
147577265|NCT00073307|532268844|FG000|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug|1|||
147577266|NCT00073307|532268845|FG001|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug|0|||
147577267|NCT00073307|532268846|FG002|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug|1|||
147577268|NCT00073307|532268844|FG000|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug (code error)|0|||
147577269|NCT00073307|532268845|FG001|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug (code error)|0|||
147577270|NCT00073307|532268846|FG002|Open Label-Sorafenib Only [30Jun2008]|Switched to commercial drug (code error)|3|||
147577271|NCT00073307|532268844|FG000|Open Label-Sorafenib Only [30Jun2008]|Missing|3|||
147577272|NCT00073307|532268845|FG001|Open Label-Sorafenib Only [30Jun2008]|Missing|0|||
147577273|NCT00073307|532268846|FG002|Open Label-Sorafenib Only [30Jun2008]|Missing|1|||
147577274|NCT00073307|532268844|FG000|Open Label-Sorafenib Only [30Jun2008]|No record of treatment discontinuation|19|||
147577275|NCT00073307|532268845|FG001|Open Label-Sorafenib Only [30Jun2008]|No record of treatment discontinuation|0|||
147577276|NCT00073307|532268846|FG002|Open Label-Sorafenib Only [30Jun2008]|No record of treatment discontinuation|9|||
147577277|NCT00073307|532268844|FG000|Open Label-Sorafenib Only [30Jun2008]|Did not enter OL/ Sorafenib only phase|35|||
147577278|NCT00073307|532268845|FG001|Open Label-Sorafenib Only [30Jun2008]|Did not enter OL/ Sorafenib only phase|0|||
147577279|NCT00073307|532268846|FG002|Open Label-Sorafenib Only [30Jun2008]|Did not enter OL/ Sorafenib only phase|83|||
147577280|NCT01438060|532268847|FG000|Acute Phase: Double-blind, 10 Weeks|Adverse Event|7|||
147577281|NCT01438060|532268848|FG001|Acute Phase: Double-blind, 10 Weeks|Adverse Event|9|||
147577282|NCT01438060|532268847|FG000|Acute Phase: Double-blind, 10 Weeks|Lack of Efficacy|6|||
147577283|NCT01438060|532268848|FG001|Acute Phase: Double-blind, 10 Weeks|Lack of Efficacy|3|||
147239690|NCT01090492|531049260|FG005|Second Intervention Period (4 Weeks)|Adverse Event|1|||
147577284|NCT01438060|532268847|FG000|Acute Phase: Double-blind, 10 Weeks|Withdrawal by Subject|3|||
147577285|NCT01438060|532268848|FG001|Acute Phase: Double-blind, 10 Weeks|Withdrawal by Subject|4|||
147577286|NCT01438060|532268847|FG000|Acute Phase: Double-blind, 10 Weeks|Lost to Follow-up|1|||
147577287|NCT01438060|532268848|FG001|Acute Phase: Double-blind, 10 Weeks|Lost to Follow-up|0|||
147577288|NCT01438060|532268847|FG000|Acute Phase: Double-blind, 10 Weeks|Death|0|||
147577289|NCT01438060|532268848|FG001|Acute Phase: Double-blind, 10 Weeks|Death|2|||
147577290|NCT01438060|532268847|FG000|Acute Phase: Double-blind, 10 Weeks|Other Reason|1|||
147577291|NCT01438060|532268848|FG001|Acute Phase: Double-blind, 10 Weeks|Other Reason|0|||
147577292|NCT01438060|532268847|FG000|Extension Phase: Week 10 to Week 130|Adverse Event|15|||
147577293|NCT01438060|532268848|FG001|Extension Phase: Week 10 to Week 130|Adverse Event|16|||
147577294|NCT01438060|532268847|FG000|Extension Phase: Week 10 to Week 130|Lack of Efficacy|8|||
147577295|NCT01438060|532268848|FG001|Extension Phase: Week 10 to Week 130|Lack of Efficacy|8|||
147577296|NCT01438060|532268847|FG000|Extension Phase: Week 10 to Week 130|Withdrawal by Subject|3|||
147577297|NCT01438060|532268848|FG001|Extension Phase: Week 10 to Week 130|Withdrawal by Subject|5|||
147577298|NCT01438060|532268847|FG000|Extension Phase: Week 10 to Week 130|Participant Unreliability|1|||
147577299|NCT01438060|532268848|FG001|Extension Phase: Week 10 to Week 130|Participant Unreliability|0|||
147577300|NCT01438060|532268847|FG000|Extension Phase: Week 10 to Week 130|Lost to Follow-up|2|||
147577301|NCT01438060|532268848|FG001|Extension Phase: Week 10 to Week 130|Lost to Follow-up|0|||
147577302|NCT01438060|532268847|FG000|Extension Phase: Week 10 to Week 130|Death|22|||
147577303|NCT01438060|532268848|FG001|Extension Phase: Week 10 to Week 130|Death|12|||
147577304|NCT01438060|532268847|FG000|Extension Phase: Week 10 to Week 130|Other Reason|7|||
147577305|NCT01438060|532268848|FG001|Extension Phase: Week 10 to Week 130|Other Reason|15|||
147577306|NCT01438060|532268847|FG000|On Study Beyond Week 140|Adverse Event|0|||
147577307|NCT01438060|532268848|FG001|On Study Beyond Week 140|Adverse Event|2|||
147577308|NCT01438060|532268847|FG000|On Study Beyond Week 140|Lack of Efficacy|0|||
147577309|NCT01438060|532268848|FG001|On Study Beyond Week 140|Lack of Efficacy|1|||
147577310|NCT01438060|532268847|FG000|On Study Beyond Week 140|Withdrawal by Subject|0|||
147577311|NCT01438060|532268848|FG001|On Study Beyond Week 140|Withdrawal by Subject|1|||
147577312|NCT01438060|532268847|FG000|On Study Beyond Week 140|Death|0|||
147577313|NCT01438060|532268848|FG001|On Study Beyond Week 140|Death|1|||
147577314|NCT01438060|532268847|FG000|On Study Beyond Week 140|Other Reason|0|||
147577315|NCT01438060|532268848|FG001|On Study Beyond Week 140|Other Reason|3|||
147577316|NCT01149057|532268849|FG000|Overall Study|Lack of Efficacy|16|||
147577317|NCT01149057|532268849|FG000|Overall Study|Adverse Event|13|||
147577318|NCT01149057|532268849|FG000|Overall Study|Withdrawal by Subject|9|||
147577319|NCT01149057|532268849|FG000|Overall Study|Positive Hepatitis B Core Antibody|5|||
147577320|NCT01149057|532268849|FG000|Overall Study|B Cell Depletion|4|||
147577321|NCT01149057|532268849|FG000|Overall Study|Participant Non-Compliance|2|||
147577322|NCT01149057|532268849|FG000|Overall Study|Lost to Follow-up|1|||
147577323|NCT01149057|532268849|FG000|Overall Study|High Parathyroid Hormone Value|1|||
147577324|NCT01149057|532268849|FG000|Overall Study|Other|6|||
147577325|NCT01964950|532268850|FG000|Overall Study|Protocol Violation|25|||
147577326|NCT04608448|532268851|FG000|Overall Study|Withdrawal by Subject|1|||
147577327|NCT04608448|532268851|FG000|Overall Study|Adverse Event|1|||
147577328|NCT03499873|532268852|FG000|Overall Study|Withdrawal by Subject|4|||
147577329|NCT03499873|532268853|FG001|Overall Study|Withdrawal by Subject|6|||
147577330|NCT03499873|532268854|FG002|Overall Study|Withdrawal by Subject|1|||
147577331|NCT03499873|532268852|FG000|Overall Study|Subjects condition worsened|0|||
147577332|NCT03499873|532268853|FG001|Overall Study|Subjects condition worsened|3|||
147577333|NCT03499873|532268854|FG002|Overall Study|Subjects condition worsened|11|||
147577334|NCT03499873|532268852|FG000|Overall Study|Adverse Event|8|||
147577335|NCT03499873|532268853|FG001|Overall Study|Adverse Event|3|||
147577336|NCT03499873|532268854|FG002|Overall Study|Adverse Event|6|||
147577337|NCT03499873|532268852|FG000|Overall Study|Physician Decision|1|||
147577338|NCT03499873|532268853|FG001|Overall Study|Physician Decision|0|||
147577339|NCT03499873|532268854|FG002|Overall Study|Physician Decision|0|||
147577340|NCT03499873|532268852|FG000|Overall Study|Administrative reasons|0|||
147577341|NCT03499873|532268853|FG001|Overall Study|Administrative reasons|1|||
147577342|NCT03499873|532268854|FG002|Overall Study|Administrative reasons|0|||
147577343|NCT03499873|532268852|FG000|Overall Study|Concomitant therapy|5|||
147577344|NCT03499873|532268853|FG001|Overall Study|Concomitant therapy|4|||
147577345|NCT03499873|532268854|FG002|Overall Study|Concomitant therapy|7|||
147239691|NCT01090492|531049261|FG006|Second Intervention Period (4 Weeks)|Adverse Event|7|||
147239692|NCT01090492|531049262|FG007|Second Intervention Period (4 Weeks)|Adverse Event|1|||
147577346|NCT03499873|532268852|FG000|Overall Study|Miscellaneous|1|||
147577347|NCT03499873|532268853|FG001|Overall Study|Miscellaneous|2|||
147577348|NCT03499873|532268854|FG002|Overall Study|Miscellaneous|2|||
147577349|NCT03499873|532268852|FG000|Overall Study|Investigational Product (IP) Missed dose compliance|1|||
147577350|NCT03499873|532268853|FG001|Overall Study|Investigational Product (IP) Missed dose compliance|1|||
147577351|NCT03499873|532268854|FG002|Overall Study|Investigational Product (IP) Missed dose compliance|0|||
147577352|NCT03602339|532268855|FG000|Overall Study|Withdrawal by Subject|9|||
147577353|NCT03602339|532268855|FG000|Overall Study|Physician Decision|2|||
147577354|NCT03602339|532268855|FG000|Overall Study|Other reason|4|||
147577355|NCT01297504|532268856|FG000|Overall Study|Invalid Consent|1|||
147577356|NCT01297504|532268856|FG000|Overall Study|Received Palivizumab in Previous Season|1|||
147577357|NCT01297504|532268856|FG000|Overall Study|No Study Visits|4|||
147577358|NCT01297504|532268856|FG000|Overall Study|Death|3|||
147577359|NCT01297504|532268856|FG000|Overall Study|Lost to Follow-up|43|||
147577360|NCT01297504|532268856|FG000|Overall Study|Withdrawal by Subject|9|||
147577361|NCT01297504|532268856|FG000|Overall Study|Site Closure|3|||
147577362|NCT01297504|532268856|FG000|Overall Study|Protocol Violation|3|||
147577363|NCT00654186|532268857|FG000|Overall Study|Withdrawal by Subject|5|||
147577364|NCT01024855|532268862|FG000|Overall Study|Inclusion/exclusion criteria|1|||
147577365|NCT03306277|532268864|FG000|Overall Study|Death|1|||
147577366|NCT03306277|532268864|FG000|Overall Study|Adverse Event|1|||
147577367|NCT03306277|532268864|FG000|Overall Study|Withdrawal by Subject|1|||
147577368|NCT01968551|532268866|FG000|Open Label Phase (48 Weeks)|Randomized but Never Treated|1|||
147577369|NCT01968551|532268867|FG001|Open Label Phase (48 Weeks)|Randomized but Never Treated|1|||
147577370|NCT01968551|532268868|FG002|Open Label Phase (48 Weeks)|Randomized but Never Treated|0|||
147577371|NCT01968551|532268866|FG000|Open Label Phase (48 Weeks)|Investigator's Discretion|0|||
147577372|NCT01968551|532268867|FG001|Open Label Phase (48 Weeks)|Investigator's Discretion|1|||
147577373|NCT01968551|532268868|FG002|Open Label Phase (48 Weeks)|Investigator's Discretion|0|||
147577374|NCT01968551|532268866|FG000|Open Label Phase (48 Weeks)|Withdrew Consent|1|||
147577375|NCT01968551|532268867|FG001|Open Label Phase (48 Weeks)|Withdrew Consent|1|||
147577376|NCT01968551|532268868|FG002|Open Label Phase (48 Weeks)|Withdrew Consent|3|||
147577377|NCT01968551|532268866|FG000|Open Label Phase (48 Weeks)|Lost to Follow-up|0|||
147577378|NCT01968551|532268867|FG001|Open Label Phase (48 Weeks)|Lost to Follow-up|0|||
147577379|NCT01968551|532268868|FG002|Open Label Phase (48 Weeks)|Lost to Follow-up|2|||
147577380|NCT01968551|532268866|FG000|Extension Phase|Adverse Event|0|||
147577381|NCT01968551|532268867|FG001|Extension Phase|Adverse Event|0|||
147577382|NCT01968551|532268868|FG002|Extension Phase|Adverse Event|2|||
147577383|NCT01968551|532268866|FG000|Extension Phase|Death|0|||
147577384|NCT01968551|532268867|FG001|Extension Phase|Death|1|||
147577385|NCT01968551|532268868|FG002|Extension Phase|Death|0|||
147577386|NCT01968551|532268866|FG000|Extension Phase|Withdrew Consent|0|||
147577387|NCT01968551|532268867|FG001|Extension Phase|Withdrew Consent|0|||
147577388|NCT01968551|532268868|FG002|Extension Phase|Withdrew Consent|1|||
147577389|NCT01968551|532268866|FG000|Extension Phase|Lost to Follow-up|1|||
147577390|NCT01968551|532268867|FG001|Extension Phase|Lost to Follow-up|0|||
147577391|NCT01968551|532268868|FG002|Extension Phase|Lost to Follow-up|1|||
147577392|NCT04060251|532268869|FG000|Overall Study|Study terminated due to low enrollment.|7|||
147577393|NCT04060251|532268870|FG001|Overall Study|Study terminated due to low enrollment.|5|||
147577394|NCT04060251|532268871|FG002|Overall Study|Study terminated due to low enrollment.|7|||
147577395|NCT04060251|532268869|FG000|Overall Study|Adverse Event|1|||
147577396|NCT04060251|532268870|FG001|Overall Study|Adverse Event|1|||
147577397|NCT04060251|532268871|FG002|Overall Study|Adverse Event|0|||
147577398|NCT01155531|532268872|FG000|Overall Study|Adverse Event|0|||
147577399|NCT01155531|532268873|FG001|Overall Study|Adverse Event|0|||
147577400|NCT01155531|532268874|FG002|Overall Study|Adverse Event|1|||
147577401|NCT01155531|532268875|FG003|Overall Study|Adverse Event|0|||
147577402|NCT01155531|532268872|FG000|Overall Study|Lost to Follow-up|0|||
147577403|NCT01155531|532268873|FG001|Overall Study|Lost to Follow-up|0|||
147577404|NCT01155531|532268874|FG002|Overall Study|Lost to Follow-up|0|||
147577405|NCT01155531|532268875|FG003|Overall Study|Lost to Follow-up|1|||
147577406|NCT01155531|532268872|FG000|Overall Study|Withdrawal by Subject|1|||
147577407|NCT01155531|532268873|FG001|Overall Study|Withdrawal by Subject|0|||
147577408|NCT01155531|532268874|FG002|Overall Study|Withdrawal by Subject|1|||
147577409|NCT01155531|532268875|FG003|Overall Study|Withdrawal by Subject|0|||
147577410|NCT01087502|532268876|FG000|Up to Interim Analysis (Week 12)|Adverse Event|5|||
147577411|NCT01087502|532268877|FG001|Up to Interim Analysis (Week 12)|Adverse Event|4|||
147577412|NCT01087502|532268876|FG000|Up to Interim Analysis (Week 12)|Protocol Violation|1|||
147577413|NCT01087502|532268877|FG001|Up to Interim Analysis (Week 12)|Protocol Violation|1|||
147577414|NCT01087502|532268876|FG000|Up to Interim Analysis (Week 12)|Withdrawal by Subject|1|||
147577415|NCT01087502|532268877|FG001|Up to Interim Analysis (Week 12)|Withdrawal by Subject|1|||
147577416|NCT01087502|532268876|FG000|Up to Interim Analysis (Week 12)|Lack of Efficacy|1|||
147577417|NCT01087502|532268877|FG001|Up to Interim Analysis (Week 12)|Lack of Efficacy|0|||
147577418|NCT01087502|532268876|FG000|Up to Interim Analysis (Week 12)|Other reason not described above|1|||
147577419|NCT01087502|532268877|FG001|Up to Interim Analysis (Week 12)|Other reason not described above|2|||
147577420|NCT01087502|532268876|FG000|Up to Final Analysis (Week 52)|Adverse Event|17|||
147577421|NCT01087502|532268877|FG001|Up to Final Analysis (Week 52)|Adverse Event|10|||
147577422|NCT01087502|532268876|FG000|Up to Final Analysis (Week 52)|Lack of Efficacy|1|||
147577423|NCT01087502|532268877|FG001|Up to Final Analysis (Week 52)|Lack of Efficacy|2|||
147577424|NCT01087502|532268876|FG000|Up to Final Analysis (Week 52)|Protocol Violation|4|||
147577425|NCT01087502|532268877|FG001|Up to Final Analysis (Week 52)|Protocol Violation|0|||
147577426|NCT01087502|532268876|FG000|Up to Final Analysis (Week 52)|Lost to Follow-up|2|||
147577427|NCT01087502|532268877|FG001|Up to Final Analysis (Week 52)|Lost to Follow-up|0|||
147577428|NCT01087502|532268876|FG000|Up to Final Analysis (Week 52)|Withdrawal by Subject|3|||
147577429|NCT01087502|532268877|FG001|Up to Final Analysis (Week 52)|Withdrawal by Subject|2|||
147577430|NCT01087502|532268876|FG000|Up to Final Analysis (Week 52)|Study site excluded from analysis|1|||
147577431|NCT01087502|532268877|FG001|Up to Final Analysis (Week 52)|Study site excluded from analysis|5|||
147577432|NCT01087502|532268876|FG000|Up to Final Analysis (Week 52)|Other reason not described above|5|||
147577433|NCT01087502|532268877|FG001|Up to Final Analysis (Week 52)|Other reason not described above|4|||
147577434|NCT01653704|532268878|FG000|Overall Study|Technical failure during recording|1|||
147577435|NCT01653704|532268879|FG001|Overall Study|Technical failure during recording|1|||
147577436|NCT01653704|532268878|FG000|Overall Study|Performance not reflective of training|1|||
147577437|NCT01653704|532268879|FG001|Overall Study|Performance not reflective of training|0|||
147577438|NCT02705716|532268880|FG000|Overall Study|Adverse Event|0|||
147446079|NCT03021499|531797553|FG001|Overall Study|Physician Decision|3|||
147577439|NCT02705716|532268881|FG001|Overall Study|Adverse Event|1|||
147577440|NCT02705716|532268880|FG000|Overall Study|Protocol Violation|3|||
147577441|NCT02705716|532268881|FG001|Overall Study|Protocol Violation|0|||
147577442|NCT02705716|532268880|FG000|Overall Study|Withdrawal of Consent|1|||
147577443|NCT02705716|532268881|FG001|Overall Study|Withdrawal of Consent|1|||
147446080|NCT03021499|531797552|FG000|Overall Study|Pregnancy|1|||
147446081|NCT03021499|531797553|FG001|Overall Study|Pregnancy|0|||
147446082|NCT03021499|531797552|FG000|Overall Study|Withdrawal by Subject|7|||
147446083|NCT03021499|531797553|FG001|Overall Study|Withdrawal by Subject|14|||
147446084|NCT03021499|531797552|FG000|Overall Study|Prohibited medication required|1|||
147446085|NCT03021499|531797553|FG001|Overall Study|Prohibited medication required|0|||
147446086|NCT03021499|531797552|FG000|Overall Study|Protocol non-compliance|1|||
147446087|NCT03021499|531797553|FG001|Overall Study|Protocol non-compliance|1|||
147446088|NCT03021499|531797552|FG000|Overall Study|None of the above|0|||
147446089|NCT03021499|531797553|FG001|Overall Study|None of the above|4|||
147446090|NCT03021499|531797552|FG000|Overall Study|Adverse Event (AE) Prior to First Dose|1|||
147446091|NCT03021499|531797553|FG001|Overall Study|Adverse Event (AE) Prior to First Dose|0|||
147446092|NCT01210690|531797554|FG000|Overall Study|Adverse Event|7|||
147446093|NCT01210690|531797554|FG000|Overall Study|Lack of Efficacy|12|||
147446094|NCT01210690|531797554|FG000|Overall Study|Lost to Follow-up|3|||
147446095|NCT01210690|531797554|FG000|Overall Study|Disease Remission|1|||
147446096|NCT01210690|531797554|FG000|Overall Study|Withdrawal by Subject|1|||
147446097|NCT01210690|531797554|FG000|Overall Study|Patient refused to swallow|1|||
147446098|NCT01210690|531797554|FG000|Overall Study|Patient could not take glucose|1|||
147446099|NCT00495820|531797555|FG000|Overall Study|Adverse Event|1|||
147446100|NCT00495820|531797556|FG001|Overall Study|Adverse Event|1|||
147446101|NCT00470054|531797557|FG000|Overall Study|Ineligible|1|||
147446102|NCT00820950|531797558|FG000|Overall Study|Scheduling Conflict|0|||
147446103|NCT00820950|531797559|FG001|Overall Study|Scheduling Conflict|0|||
147446104|NCT00820950|531797560|FG002|Overall Study|Scheduling Conflict|0|||
147446105|NCT00820950|531797561|FG003|Overall Study|Scheduling Conflict|0|||
147446106|NCT00820950|531797562|FG004|Overall Study|Scheduling Conflict|0|||
147446107|NCT00820950|531797563|FG005|Overall Study|Scheduling Conflict|0|||
147446108|NCT00820950|531797564|FG006|Overall Study|Scheduling Conflict|1|||
147577444|NCT01986647|532268882|FG000|Overall Study|Lost to Follow-up|4|||
147577445|NCT01986647|532268883|FG001|Overall Study|Lost to Follow-up|1|||
147577446|NCT01986647|532268884|FG002|Overall Study|Lost to Follow-up|4|||
147577447|NCT01986647|532268885|FG003|Overall Study|Lost to Follow-up|4|||
147577448|NCT01986647|532268882|FG000|Overall Study|Withdrawal by Subject|1|||
147577449|NCT01986647|532268883|FG001|Overall Study|Withdrawal by Subject|3|||
147577450|NCT01986647|532268884|FG002|Overall Study|Withdrawal by Subject|2|||
147577451|NCT01986647|532268885|FG003|Overall Study|Withdrawal by Subject|3|||
147577452|NCT01986647|532268882|FG000|Overall Study|Health|5|||
147577453|NCT01986647|532268883|FG001|Overall Study|Health|3|||
147577454|NCT01986647|532268884|FG002|Overall Study|Health|6|||
147577455|NCT01986647|532268885|FG003|Overall Study|Health|4|||
147577456|NCT01663896|532268888|FG000|Overall Study|Various reasons|43|||
147577457|NCT00999687|532268889|FG000|First Intervention|Withdrawal by Subject|1|||
147577458|NCT00999687|532268889|FG000|Second Intervention|Withdrawal by Subject|2|||
147446109|NCT00820950|531797565|FG007|Overall Study|Scheduling Conflict|1|||
147446110|NCT00820950|531797566|FG008|Overall Study|Scheduling Conflict|0|||
147446111|NCT00820950|531797567|FG009|Overall Study|Scheduling Conflict|0|||
147446112|NCT00820950|531797558|FG000|Overall Study|Protocol Violation|1|||
147446113|NCT00820950|531797559|FG001|Overall Study|Protocol Violation|1|||
147577459|NCT00999687|532268889|FG000|Second Intervention|Lack of Efficacy|1|||
147577460|NCT03541252|532268892|FG000|Overall Study|Withdrawal by Subject|1|||
147577461|NCT01960296|532268899|FG000|Overall Study|Postponed surgery|1|||
147446114|NCT00820950|531797560|FG002|Overall Study|Protocol Violation|0|||
147446115|NCT00820950|531797561|FG003|Overall Study|Protocol Violation|0|||
147446116|NCT00820950|531797562|FG004|Overall Study|Protocol Violation|0|||
147577462|NCT01960296|532268900|FG001|Overall Study|Postponed surgery|0|||
147446117|NCT00820950|531797563|FG005|Overall Study|Protocol Violation|0|||
147446118|NCT00820950|531797564|FG006|Overall Study|Protocol Violation|0|||
147446119|NCT00820950|531797565|FG007|Overall Study|Protocol Violation|0|||
147577463|NCT01960296|532268899|FG000|Overall Study|Received different procedure|1|||
147577464|NCT01960296|532268900|FG001|Overall Study|Received different procedure|3|||
147577465|NCT02003391|532268901|FG000|Overall Study|Withdrawal by Subject|2|||
147577466|NCT02003391|532268902|FG001|Overall Study|Withdrawal by Subject|1|||
147577467|NCT02003391|532268901|FG000|Overall Study|Protocol Violation|0|||
147577468|NCT02003391|532268902|FG001|Overall Study|Protocol Violation|1|||
147577469|NCT02003391|532268901|FG000|Overall Study|Adverse Event|1|||
147577470|NCT02003391|532268902|FG001|Overall Study|Adverse Event|0|||
147577471|NCT02272803|532268903|FG000|Overall Study|Disease progression|16|||
147577472|NCT02272803|532268904|FG001|Overall Study|Disease progression|8|||
147577473|NCT02272803|532268903|FG000|Overall Study|Adverse Event unrelated to study drug|3|||
147577474|NCT02272803|532268904|FG001|Overall Study|Adverse Event unrelated to study drug|5|||
147577475|NCT02272803|532268903|FG000|Overall Study|Study drug toxicity|4|||
147577476|NCT02272803|532268904|FG001|Overall Study|Study drug toxicity|9|||
147577477|NCT02272803|532268903|FG000|Overall Study|Participant request to discontinue study treatment|3|||
147577478|NCT02272803|532268904|FG001|Overall Study|Participant request to discontinue study treatment|7|||
147577479|NCT02272803|532268903|FG000|Overall Study|Maximum clinical benefit|4|||
147577480|NCT02272803|532268904|FG001|Overall Study|Maximum clinical benefit|2|||
147577481|NCT02272803|532268903|FG000|Overall Study|Poor/non-compliance|2|||
147577482|NCT02272803|532268904|FG001|Overall Study|Poor/non-compliance|2|||
147577483|NCT02272803|532268903|FG000|Overall Study|Withdrawal by Subject|2|||
147577484|NCT02272803|532268904|FG001|Overall Study|Withdrawal by Subject|1|||
147577485|NCT02272803|532268903|FG000|Overall Study|Death|0|||
147577486|NCT02272803|532268904|FG001|Overall Study|Death|1|||
147577487|NCT02272803|532268903|FG000|Overall Study|Other reasons|1|||
147577488|NCT02272803|532268904|FG001|Overall Study|Other reasons|3|||
147577489|NCT02272803|532268903|FG000|Overall Study|Administrative reason by sponsor|5|||
147577490|NCT02272803|532268904|FG001|Overall Study|Administrative reason by sponsor|4|||
147577491|NCT02611323|532268905|FG000|Overall Study|Death|3|||
147577492|NCT02611323|532268906|FG001|Overall Study|Death|1|||
147577493|NCT02611323|532268907|FG002|Overall Study|Death|0|||
147577494|NCT02611323|532268908|FG003|Overall Study|Death|0|||
147577495|NCT02611323|532268909|FG004|Overall Study|Death|1|||
147577496|NCT02611323|532268910|FG005|Overall Study|Death|1|||
147577497|NCT02611323|532268911|FG006|Overall Study|Death|8|||
147577498|NCT02611323|532268912|FG007|Overall Study|Death|0|||
147577499|NCT02611323|532268913|FG008|Overall Study|Death|4|||
147577500|NCT02611323|532268914|FG009|Overall Study|Death|6|||
147577501|NCT02611323|532268915|FG010|Overall Study|Death|26|||
147577502|NCT02611323|532268905|FG000|Overall Study|Lost to Follow-up|1|||
147577503|NCT02611323|532268906|FG001|Overall Study|Lost to Follow-up|0|||
147577504|NCT02611323|532268907|FG002|Overall Study|Lost to Follow-up|0|||
147577505|NCT02611323|532268908|FG003|Overall Study|Lost to Follow-up|0|||
147577506|NCT02611323|532268909|FG004|Overall Study|Lost to Follow-up|0|||
147577507|NCT02611323|532268910|FG005|Overall Study|Lost to Follow-up|0|||
147577508|NCT02611323|532268911|FG006|Overall Study|Lost to Follow-up|3|||
147577509|NCT02611323|532268912|FG007|Overall Study|Lost to Follow-up|0|||
147577510|NCT02611323|532268913|FG008|Overall Study|Lost to Follow-up|0|||
147577511|NCT02611323|532268914|FG009|Overall Study|Lost to Follow-up|0|||
147577512|NCT02611323|532268915|FG010|Overall Study|Lost to Follow-up|2|||
147577513|NCT02611323|532268905|FG000|Overall Study|Found Another Malignancy After Starting Trial|0|||
147577514|NCT02611323|532268906|FG001|Overall Study|Found Another Malignancy After Starting Trial|0|||
147577515|NCT02611323|532268907|FG002|Overall Study|Found Another Malignancy After Starting Trial|0|||
147577516|NCT02611323|532268908|FG003|Overall Study|Found Another Malignancy After Starting Trial|0|||
147577517|NCT02611323|532268909|FG004|Overall Study|Found Another Malignancy After Starting Trial|0|||
147577518|NCT02611323|532268910|FG005|Overall Study|Found Another Malignancy After Starting Trial|0|||
147577519|NCT02611323|532268911|FG006|Overall Study|Found Another Malignancy After Starting Trial|0|||
147577520|NCT02611323|532268912|FG007|Overall Study|Found Another Malignancy After Starting Trial|0|||
147577521|NCT02611323|532268913|FG008|Overall Study|Found Another Malignancy After Starting Trial|0|||
147577522|NCT02611323|532268914|FG009|Overall Study|Found Another Malignancy After Starting Trial|1|||
147577523|NCT02611323|532268915|FG010|Overall Study|Found Another Malignancy After Starting Trial|0|||
147577524|NCT02611323|532268905|FG000|Overall Study|Progressive Disease|0|||
147577525|NCT02611323|532268906|FG001|Overall Study|Progressive Disease|0|||
147577526|NCT02611323|532268907|FG002|Overall Study|Progressive Disease|0|||
147577527|NCT02611323|532268908|FG003|Overall Study|Progressive Disease|0|||
147577528|NCT02611323|532268909|FG004|Overall Study|Progressive Disease|0|||
147577529|NCT02611323|532268910|FG005|Overall Study|Progressive Disease|0|||
147577530|NCT02611323|532268911|FG006|Overall Study|Progressive Disease|0|||
147577531|NCT02611323|532268912|FG007|Overall Study|Progressive Disease|0|||
147577532|NCT02611323|532268913|FG008|Overall Study|Progressive Disease|0|||
147577533|NCT02611323|532268914|FG009|Overall Study|Progressive Disease|0|||
147577534|NCT02611323|532268915|FG010|Overall Study|Progressive Disease|1|||
147577535|NCT02611323|532268905|FG000|Overall Study|Withdrawal by Subject|1|||
147577536|NCT02611323|532268906|FG001|Overall Study|Withdrawal by Subject|0|||
147577537|NCT02611323|532268907|FG002|Overall Study|Withdrawal by Subject|0|||
147577538|NCT02611323|532268908|FG003|Overall Study|Withdrawal by Subject|0|||
147577539|NCT02611323|532268909|FG004|Overall Study|Withdrawal by Subject|0|||
147577540|NCT02611323|532268910|FG005|Overall Study|Withdrawal by Subject|0|||
147577541|NCT02611323|532268911|FG006|Overall Study|Withdrawal by Subject|0|||
147577542|NCT02611323|532268912|FG007|Overall Study|Withdrawal by Subject|1|||
147577543|NCT02611323|532268913|FG008|Overall Study|Withdrawal by Subject|0|||
147577544|NCT02611323|532268914|FG009|Overall Study|Withdrawal by Subject|1|||
147577545|NCT02611323|532268915|FG010|Overall Study|Withdrawal by Subject|0|||
147577546|NCT02597049|532268916|FG000|Overall Study|Lost to Follow-up|0|||
147577547|NCT02597049|532268917|FG001|Overall Study|Lost to Follow-up|3|||
147577548|NCT02597049|532268918|FG002|Overall Study|Lost to Follow-up|2|||
147577549|NCT02597049|532268916|FG000|Overall Study|Withdrawal by Subject|2|||
147577550|NCT02597049|532268917|FG001|Overall Study|Withdrawal by Subject|2|||
147577551|NCT02597049|532268918|FG002|Overall Study|Withdrawal by Subject|1|||
147577552|NCT02597049|532268916|FG000|Overall Study|Adverse Event|2|||
147577553|NCT02597049|532268917|FG001|Overall Study|Adverse Event|0|||
147577554|NCT02597049|532268918|FG002|Overall Study|Adverse Event|0|||
147577555|NCT02597049|532268916|FG000|Overall Study|Death|2|||
147577556|NCT02597049|532268917|FG001|Overall Study|Death|0|||
147577557|NCT02597049|532268918|FG002|Overall Study|Death|0|||
147577558|NCT02597049|532268916|FG000|Overall Study|Noncompliant with Study Visits|1|||
147577559|NCT02597049|532268917|FG001|Overall Study|Noncompliant with Study Visits|0|||
147577560|NCT02597049|532268918|FG002|Overall Study|Noncompliant with Study Visits|0|||
147577561|NCT03573544|532268921|FG000|Overall Study|Adverse Event|0|||
147577562|NCT03573544|532268922|FG001|Overall Study|Adverse Event|0|||
147577563|NCT03573544|532268923|FG002|Overall Study|Adverse Event|0|||
147577564|NCT03573544|532268924|FG003|Overall Study|Adverse Event|3|||
147577565|NCT03573544|532268925|FG004|Overall Study|Adverse Event|1|||
147577566|NCT03573544|532268926|FG005|Overall Study|Adverse Event|0|||
147577567|NCT03573544|532268927|FG006|Overall Study|Adverse Event|2|||
147577568|NCT03573544|532268928|FG007|Overall Study|Adverse Event|0|||
147577569|NCT03573544|532268921|FG000|Overall Study|Physician Decision|0|||
147577570|NCT03573544|532268922|FG001|Overall Study|Physician Decision|0|||
147577571|NCT03573544|532268923|FG002|Overall Study|Physician Decision|0|||
147577572|NCT03573544|532268924|FG003|Overall Study|Physician Decision|0|||
147577573|NCT03573544|532268925|FG004|Overall Study|Physician Decision|0|||
147577574|NCT03573544|532268926|FG005|Overall Study|Physician Decision|0|||
147577575|NCT03573544|532268927|FG006|Overall Study|Physician Decision|1|||
147577576|NCT03573544|532268928|FG007|Overall Study|Physician Decision|0|||
147577577|NCT03573544|532268921|FG000|Overall Study|Withdrawal by Subject|2|||
147577578|NCT03573544|532268922|FG001|Overall Study|Withdrawal by Subject|0|||
147577579|NCT03573544|532268923|FG002|Overall Study|Withdrawal by Subject|0|||
147577580|NCT03573544|532268924|FG003|Overall Study|Withdrawal by Subject|1|||
147577581|NCT03573544|532268925|FG004|Overall Study|Withdrawal by Subject|1|||
147577582|NCT03573544|532268926|FG005|Overall Study|Withdrawal by Subject|1|||
147577583|NCT03573544|532268927|FG006|Overall Study|Withdrawal by Subject|0|||
147577584|NCT03573544|532268928|FG007|Overall Study|Withdrawal by Subject|1|||
147577585|NCT03573544|532268921|FG000|Overall Study|Disease progression|3|||
147577586|NCT03573544|532268922|FG001|Overall Study|Disease progression|3|||
147577587|NCT03573544|532268923|FG002|Overall Study|Disease progression|6|||
147577588|NCT03573544|532268924|FG003|Overall Study|Disease progression|4|||
147577589|NCT03573544|532268925|FG004|Overall Study|Disease progression|5|||
147577590|NCT03573544|532268926|FG005|Overall Study|Disease progression|7|||
147577591|NCT03573544|532268927|FG006|Overall Study|Disease progression|6|||
147577592|NCT03573544|532268928|FG007|Overall Study|Disease progression|7|||
147577593|NCT01899053|532268929|FG000|Overall Study|Progressive Disease|4|||
147577594|NCT01899053|532268930|FG001|Overall Study|Progressive Disease|0|||
147577595|NCT01899053|532268931|FG002|Overall Study|Progressive Disease|3|||
147577596|NCT01899053|532268932|FG003|Overall Study|Progressive Disease|0|||
147577597|NCT01899053|532268933|FG004|Overall Study|Progressive Disease|3|||
147577598|NCT01899053|532268934|FG005|Overall Study|Progressive Disease|1|||
147577599|NCT01899053|532268935|FG006|Overall Study|Progressive Disease|1|||
147577600|NCT01899053|532268936|FG007|Overall Study|Progressive Disease|1|||
147577601|NCT01899053|532268937|FG008|Overall Study|Progressive Disease|4|||
147577602|NCT01899053|532268938|FG009|Overall Study|Progressive Disease|3|||
147577603|NCT01899053|532268939|FG010|Overall Study|Progressive Disease|12|||
147577604|NCT01899053|532268940|FG011|Overall Study|Progressive Disease|5|||
147577605|NCT01899053|532268941|FG012|Overall Study|Progressive Disease|8|||
147577606|NCT01899053|532268942|FG013|Overall Study|Progressive Disease|17|||
147577607|NCT01899053|532268929|FG000|Overall Study|Adverse Event|1|||
147577608|NCT01899053|532268930|FG001|Overall Study|Adverse Event|1|||
147577609|NCT01899053|532268931|FG002|Overall Study|Adverse Event|1|||
147577610|NCT01899053|532268932|FG003|Overall Study|Adverse Event|3|||
147577611|NCT01899053|532268933|FG004|Overall Study|Adverse Event|1|||
147577612|NCT01899053|532268934|FG005|Overall Study|Adverse Event|1|||
147577613|NCT01899053|532268935|FG006|Overall Study|Adverse Event|1|||
147577614|NCT01899053|532268936|FG007|Overall Study|Adverse Event|0|||
147577615|NCT01899053|532268937|FG008|Overall Study|Adverse Event|2|||
147577616|NCT01899053|532268938|FG009|Overall Study|Adverse Event|0|||
147577617|NCT01899053|532268939|FG010|Overall Study|Adverse Event|3|||
147577618|NCT01899053|532268940|FG011|Overall Study|Adverse Event|1|||
147577619|NCT01899053|532268941|FG012|Overall Study|Adverse Event|2|||
147577620|NCT01899053|532268942|FG013|Overall Study|Adverse Event|2|||
147152071|NCT01471028|530719029|FG000|VTI-208E|Lost to Follow-up|0|||
147321254|NCT01789203|531339995|FG000|Overall Study|Adverse Event|2|||
147577621|NCT01899053|532268929|FG000|Overall Study|Reason Not Specified|0|||
147577622|NCT01899053|532268930|FG001|Overall Study|Reason Not Specified|0|||
147577623|NCT01899053|532268931|FG002|Overall Study|Reason Not Specified|0|||
147577624|NCT01899053|532268932|FG003|Overall Study|Reason Not Specified|0|||
147577625|NCT01899053|532268933|FG004|Overall Study|Reason Not Specified|0|||
147577626|NCT01899053|532268934|FG005|Overall Study|Reason Not Specified|0|||
147577627|NCT01899053|532268935|FG006|Overall Study|Reason Not Specified|1|||
147577628|NCT01899053|532268936|FG007|Overall Study|Reason Not Specified|0|||
147577629|NCT01899053|532268937|FG008|Overall Study|Reason Not Specified|0|||
147577630|NCT01899053|532268938|FG009|Overall Study|Reason Not Specified|0|||
147577631|NCT01899053|532268939|FG010|Overall Study|Reason Not Specified|0|||
147577632|NCT01899053|532268940|FG011|Overall Study|Reason Not Specified|0|||
147577633|NCT01899053|532268941|FG012|Overall Study|Reason Not Specified|1|||
147577634|NCT01899053|532268942|FG013|Overall Study|Reason Not Specified|0|||
147577635|NCT01899053|532268929|FG000|Overall Study|Withdrawal by Subject|1|||
147577636|NCT01899053|532268930|FG001|Overall Study|Withdrawal by Subject|1|||
147577637|NCT01899053|532268931|FG002|Overall Study|Withdrawal by Subject|2|||
147577638|NCT01899053|532268932|FG003|Overall Study|Withdrawal by Subject|0|||
147577639|NCT01899053|532268933|FG004|Overall Study|Withdrawal by Subject|2|||
147577640|NCT01899053|532268934|FG005|Overall Study|Withdrawal by Subject|0|||
147577641|NCT01899053|532268935|FG006|Overall Study|Withdrawal by Subject|0|||
147577642|NCT01899053|532268936|FG007|Overall Study|Withdrawal by Subject|1|||
147577643|NCT01899053|532268937|FG008|Overall Study|Withdrawal by Subject|0|||
147577644|NCT01899053|532268938|FG009|Overall Study|Withdrawal by Subject|0|||
147577645|NCT01899053|532268939|FG010|Overall Study|Withdrawal by Subject|0|||
147577646|NCT01899053|532268940|FG011|Overall Study|Withdrawal by Subject|0|||
147577647|NCT01899053|532268941|FG012|Overall Study|Withdrawal by Subject|1|||
147577648|NCT01899053|532268942|FG013|Overall Study|Withdrawal by Subject|1|||
147577649|NCT01899053|532268929|FG000|Overall Study|Protocol Violation|0|||
147577650|NCT01899053|532268930|FG001|Overall Study|Protocol Violation|0|||
147577651|NCT01899053|532268931|FG002|Overall Study|Protocol Violation|1|||
147577652|NCT01899053|532268932|FG003|Overall Study|Protocol Violation|0|||
147577653|NCT01899053|532268933|FG004|Overall Study|Protocol Violation|0|||
147577654|NCT01899053|532268934|FG005|Overall Study|Protocol Violation|0|||
147577655|NCT01899053|532268935|FG006|Overall Study|Protocol Violation|0|||
147577656|NCT01899053|532268936|FG007|Overall Study|Protocol Violation|0|||
147577657|NCT01899053|532268937|FG008|Overall Study|Protocol Violation|0|||
147577658|NCT01899053|532268938|FG009|Overall Study|Protocol Violation|0|||
147577659|NCT01899053|532268939|FG010|Overall Study|Protocol Violation|0|||
147577660|NCT01899053|532268940|FG011|Overall Study|Protocol Violation|0|||
147577661|NCT01899053|532268941|FG012|Overall Study|Protocol Violation|0|||
147577662|NCT01899053|532268942|FG013|Overall Study|Protocol Violation|0|||
147577663|NCT01899053|532268929|FG000|Overall Study|Unsatisfactory Therapeutic Response|1|||
147577664|NCT01899053|532268930|FG001|Overall Study|Unsatisfactory Therapeutic Response|1|||
147577665|NCT01899053|532268931|FG002|Overall Study|Unsatisfactory Therapeutic Response|0|||
147577666|NCT01899053|532268932|FG003|Overall Study|Unsatisfactory Therapeutic Response|0|||
147577667|NCT01899053|532268933|FG004|Overall Study|Unsatisfactory Therapeutic Response|0|||
147577668|NCT01899053|532268934|FG005|Overall Study|Unsatisfactory Therapeutic Response|0|||
147577669|NCT01899053|532268935|FG006|Overall Study|Unsatisfactory Therapeutic Response|0|||
147577670|NCT01899053|532268936|FG007|Overall Study|Unsatisfactory Therapeutic Response|0|||
147577671|NCT01899053|532268937|FG008|Overall Study|Unsatisfactory Therapeutic Response|0|||
147577672|NCT01899053|532268938|FG009|Overall Study|Unsatisfactory Therapeutic Response|0|||
147577673|NCT01899053|532268939|FG010|Overall Study|Unsatisfactory Therapeutic Response|1|||
147577674|NCT01899053|532268940|FG011|Overall Study|Unsatisfactory Therapeutic Response|0|||
147577675|NCT01899053|532268941|FG012|Overall Study|Unsatisfactory Therapeutic Response|0|||
147577676|NCT01899053|532268942|FG013|Overall Study|Unsatisfactory Therapeutic Response|0|||
147577677|NCT01899053|532268929|FG000|Overall Study|Symptomatic Deterioration|0|||
147577678|NCT01899053|532268930|FG001|Overall Study|Symptomatic Deterioration|0|||
147577679|NCT01899053|532268931|FG002|Overall Study|Symptomatic Deterioration|0|||
147577680|NCT01899053|532268932|FG003|Overall Study|Symptomatic Deterioration|0|||
147577681|NCT01899053|532268933|FG004|Overall Study|Symptomatic Deterioration|0|||
147577682|NCT01899053|532268934|FG005|Overall Study|Symptomatic Deterioration|1|||
147577683|NCT01899053|532268935|FG006|Overall Study|Symptomatic Deterioration|0|||
147577684|NCT01899053|532268936|FG007|Overall Study|Symptomatic Deterioration|1|||
147577685|NCT01899053|532268937|FG008|Overall Study|Symptomatic Deterioration|0|||
147577686|NCT01899053|532268938|FG009|Overall Study|Symptomatic Deterioration|0|||
147577687|NCT01899053|532268939|FG010|Overall Study|Symptomatic Deterioration|0|||
147577688|NCT01899053|532268940|FG011|Overall Study|Symptomatic Deterioration|1|||
147577689|NCT01899053|532268941|FG012|Overall Study|Symptomatic Deterioration|2|||
147577690|NCT01899053|532268942|FG013|Overall Study|Symptomatic Deterioration|0|||
147577691|NCT03105297|532268943|FG000|Baseline Phase (Day 1)|Other|21|||
147577692|NCT03105297|532268943|FG000|Nasal Resistance Phase (Day 30, 31)|Adverse Event|1|||
147577693|NCT03105297|532268943|FG000|Nasal Resistance Phase (Day 30, 31)|Withdrawal by Subject|7|||
147577694|NCT00227370|532268945|FG000|Overall Study|Withdrawal by Subject|1|||
147577695|NCT00227370|532268946|FG001|Overall Study|Withdrawal by Subject|2|||
147577696|NCT00227370|532268945|FG000|Overall Study|Death|3|||
147577697|NCT00227370|532268946|FG001|Overall Study|Death|4|||
147577698|NCT00227370|532268945|FG000|Overall Study|Adverse Event|6|||
147577699|NCT00227370|532268946|FG001|Overall Study|Adverse Event|11|||
147577700|NCT00227370|532268945|FG000|Overall Study|Physician Decision|9|||
147577701|NCT00227370|532268946|FG001|Overall Study|Physician Decision|6|||
147577702|NCT00227370|532268945|FG000|Overall Study|Other reasons|2|||
147577703|NCT00227370|532268946|FG001|Overall Study|Other reasons|1|||
147577704|NCT03846193|532268947|FG000|Overall Study|Physician Decision|0|||
147577705|NCT03846193|532268948|FG001|Overall Study|Physician Decision|0|||
147577706|NCT03846193|532268949|FG002|Overall Study|Physician Decision|1|||
147577707|NCT03846193|532268950|FG003|Overall Study|Physician Decision|0|||
147577708|NCT03846193|532268951|FG004|Overall Study|Physician Decision|0|||
147577709|NCT03846193|532268947|FG000|Overall Study|Lost to Follow-up|0|||
147577710|NCT03846193|532268948|FG001|Overall Study|Lost to Follow-up|0|||
147577711|NCT03846193|532268949|FG002|Overall Study|Lost to Follow-up|0|||
147577712|NCT03846193|532268950|FG003|Overall Study|Lost to Follow-up|0|||
147577713|NCT03846193|532268951|FG004|Overall Study|Lost to Follow-up|1|||
147152072|NCT01471028|530719030|FG001|VTI-208E|Lost to Follow-up|2|||
147152073|NCT00695955|530719031|FG000|Cohort 1|Adverse Event|26|||
147577714|NCT03846193|532268947|FG000|Overall Study|switched to the GT005 2E10 vg via Transvitreal Procedure|0|||
147152074|NCT00695955|530719031|FG000|Cohort 1|Protocol Violation|2|||
147577715|NCT03846193|532268948|FG001|Overall Study|switched to the GT005 2E10 vg via Transvitreal Procedure|0|||
147152075|NCT00695955|530719031|FG000|Cohort 1|Lost to Follow-up|30|||
147152076|NCT00695955|530719031|FG000|Cohort 1|Withdrawal by Subject|25|||
147152077|NCT00695955|530719031|FG000|Cohort 1|Lack of Efficacy|3|||
147152078|NCT00695955|530719031|FG000|Cohort 1|Other|16|||
147152079|NCT00695955|530719031|FG000|Cohort 2|Adverse Event|24|||
147152080|NCT00695955|530719031|FG000|Cohort 2|Protocol Violation|5|||
147152081|NCT00695955|530719031|FG000|Cohort 2|Lost to Follow-up|38|||
147152082|NCT00695955|530719031|FG000|Cohort 2|Withdrawal by Subject|28|||
147152083|NCT00695955|530719031|FG000|Cohort 2|Lack of Efficacy|4|||
147152084|NCT00695955|530719031|FG000|Cohort 2|Other|5|||
147152085|NCT01177553|530719034|FG000|Overall Study|babies not yet 6 months of age|1|||
147152086|NCT01177553|530719035|FG001|Overall Study|babies not yet 6 months of age|0|||
147152087|NCT00610857|530719037|FG000|Overall Study|Not evaluable for response|2|||
147152088|NCT01626118|530719040|FG000|Overall Study|Lack of Efficacy|1|||
147152089|NCT01626118|530719041|FG001|Overall Study|Lack of Efficacy|0|||
147152090|NCT01626118|530719042|FG002|Overall Study|Lack of Efficacy|1|||
147152091|NCT01626118|530719043|FG003|Overall Study|Lack of Efficacy|3|||
147152092|NCT01626118|530719040|FG000|Overall Study|Lost to Follow-up|1|||
147152093|NCT01626118|530719041|FG001|Overall Study|Lost to Follow-up|0|||
147152094|NCT01626118|530719042|FG002|Overall Study|Lost to Follow-up|0|||
147152095|NCT01626118|530719043|FG003|Overall Study|Lost to Follow-up|0|||
147152096|NCT01626118|530719040|FG000|Overall Study|Adverse Event|0|||
147152097|NCT01626118|530719041|FG001|Overall Study|Adverse Event|1|||
147152098|NCT01626118|530719042|FG002|Overall Study|Adverse Event|1|||
147152099|NCT01626118|530719043|FG003|Overall Study|Adverse Event|0|||
147152100|NCT01626118|530719040|FG000|Overall Study|Investigator Decision|0|||
147152101|NCT01626118|530719041|FG001|Overall Study|Investigator Decision|1|||
147152102|NCT01626118|530719042|FG002|Overall Study|Investigator Decision|0|||
147152103|NCT01626118|530719043|FG003|Overall Study|Investigator Decision|0|||
147152104|NCT00888329|530719044|FG000|Overall Study|Physician Decision|6|||
147152105|NCT00888329|530719045|FG001|Overall Study|Physician Decision|9|||
147152106|NCT00002540|530719046|FG000|Overall Study|Cancer Before Rand. (Prostate Screening)|0|||
147152107|NCT00002540|530719047|FG001|Overall Study|Cancer Before Rand. (Prostate Screening)|25|||
147152108|NCT00002540|530719046|FG000|Overall Study|Died Before Randomization|2|||
147152109|NCT00002540|530719047|FG001|Overall Study|Died Before Randomization|6|||
147152110|NCT00002540|530719046|FG000|Overall Study|Died Before ASU (Control)|202|||
147152111|NCT00002540|530719047|FG001|Overall Study|Died Before ASU (Control)|0|||
147577716|NCT03846193|532268949|FG002|Overall Study|switched to the GT005 2E10 vg via Transvitreal Procedure|0|||
147577717|NCT03846193|532268950|FG003|Overall Study|switched to the GT005 2E10 vg via Transvitreal Procedure|2|||
147577718|NCT03846193|532268951|FG004|Overall Study|switched to the GT005 2E10 vg via Transvitreal Procedure|0|||
147577719|NCT01401062|532268955|FG000|Overall Study|Death|9|||
147152112|NCT00002540|530719046|FG000|Overall Study|Refused ASU (Control)|597|||
147152113|NCT00002540|530719047|FG001|Overall Study|Refused ASU (Control)|0|||
147152114|NCT00002540|530719046|FG000|Overall Study|Refused Screen (Prostate Screening)|0|||
147152115|NCT00002540|530719047|FG001|Overall Study|Refused Screen (Prostate Screening)|2433|||
147152116|NCT04826094|530719048|FG000|Overall Study|Lost to Follow-up|2|||
147152117|NCT04826094|530719049|FG001|Overall Study|Lost to Follow-up|1|||
147152118|NCT04826094|530719050|FG002|Overall Study|Lost to Follow-up|0|||
147152119|NCT04826094|530719051|FG003|Overall Study|Lost to Follow-up|0|||
147152120|NCT04826094|530719052|FG004|Overall Study|Lost to Follow-up|1|||
147152121|NCT04826094|530719053|FG005|Overall Study|Lost to Follow-up|3|||
147152122|NCT04826094|530719054|FG006|Overall Study|Lost to Follow-up|1|||
147152123|NCT04826094|530719055|FG007|Overall Study|Lost to Follow-up|1|||
147577720|NCT01401062|532268956|FG001|Overall Study|Death|7|||
147577721|NCT01401062|532268955|FG000|Overall Study|Physician Decision|1|||
147577722|NCT01401062|532268956|FG001|Overall Study|Physician Decision|0|||
147577723|NCT01401062|532268955|FG000|Overall Study|Withdrawal by Subject|1|||
147577724|NCT01401062|532268956|FG001|Overall Study|Withdrawal by Subject|1|||
147577725|NCT01131260|532268957|FG000|Overall Study|Randomization error|5|||
147577726|NCT01131260|532268958|FG001|Overall Study|Randomization error|1|||
147577727|NCT01131260|532268957|FG000|Overall Study|Declined to continue participation|8|||
147577728|NCT01131260|532268958|FG001|Overall Study|Declined to continue participation|13|||
147577729|NCT01131260|532268957|FG000|Overall Study|Physician Decision|22|||
147577730|NCT01131260|532268958|FG001|Overall Study|Physician Decision|24|||
147577731|NCT01131260|532268957|FG000|Overall Study|Technical problems|7|||
147577732|NCT01131260|532268958|FG001|Overall Study|Technical problems|6|||
147577733|NCT01131260|532268957|FG000|Overall Study|Staff error|2|||
147577734|NCT01131260|532268958|FG001|Overall Study|Staff error|1|||
147577735|NCT01131260|532268957|FG000|Overall Study|Ineligible|0|||
147577736|NCT01131260|532268958|FG001|Overall Study|Ineligible|2|||
147577737|NCT03684928|532268962|FG000|First Intervention|Lost to Follow-up|0|||
147577738|NCT03684928|532268963|FG001|First Intervention|Lost to Follow-up|1|||
147577739|NCT03684928|532268962|FG000|First Intervention|Withdrawal by Subject|0|||
147577740|NCT03684928|532268963|FG001|First Intervention|Withdrawal by Subject|2|||
147577741|NCT03684928|532268962|FG000|Second Intervention|Soft Tissue Injury|1|||
147577742|NCT03684928|532268963|FG001|Second Intervention|Soft Tissue Injury|0|||
147577743|NCT01891357|532268964|FG000|Overall Study|Protocol Violation|3|||
147577744|NCT00840879|532268965|FG000|Second Intervention|Withdrawal by Subject|1|||
147577745|NCT00840879|532268966|FG001|Second Intervention|Withdrawal by Subject|0|||
147577746|NCT03733145|532268967|FG000|Overall Study|screenfail|3|||
147577747|NCT03733145|532268968|FG001|Overall Study|screenfail|3|||
147577748|NCT03733145|532268969|FG002|Overall Study|screenfail|2|||
147577749|NCT02259348|532270455|FG000|Overall Study|Donors|6|||
147577750|NCT02259348|532270455|FG000|Overall Study|Death|4|||
147577751|NCT01622660|532270456|FG000|Overall Study|Adverse Event|1|||
147577752|NCT02583048|532270457|FG000|Overall Study|Withdrawal by Subject|0|||
147577753|NCT02583048|532270458|FG001|Overall Study|Withdrawal by Subject|1|||
147577754|NCT02583048|532270459|FG002|Overall Study|Withdrawal by Subject|0|||
147577755|NCT02583048|532270457|FG000|Overall Study|Failed to meet eligibility criterion|0|||
147577756|NCT02583048|532270458|FG001|Overall Study|Failed to meet eligibility criterion|0|||
147577757|NCT02583048|532270459|FG002|Overall Study|Failed to meet eligibility criterion|1|||
147577758|NCT02034513|532270462|FG000|Overall Study|Adverse Event|11|||
147577759|NCT02034513|532270463|FG001|Overall Study|Adverse Event|10|||
147577760|NCT02034513|532270462|FG000|Overall Study|Lack of Efficacy|0|||
147577761|NCT02034513|532270463|FG001|Overall Study|Lack of Efficacy|1|||
147577762|NCT02034513|532270462|FG000|Overall Study|Lost to Follow-up|6|||
147577763|NCT02034513|532270463|FG001|Overall Study|Lost to Follow-up|7|||
147577764|NCT02034513|532270462|FG000|Overall Study|Pregnancy|0|||
147577765|NCT02034513|532270463|FG001|Overall Study|Pregnancy|3|||
147577766|NCT02034513|532270462|FG000|Overall Study|Protocol Violation|7|||
147577767|NCT02034513|532270463|FG001|Overall Study|Protocol Violation|10|||
147577768|NCT02034513|532270462|FG000|Overall Study|Withdrawal by Subject|25|||
147577769|NCT02034513|532270463|FG001|Overall Study|Withdrawal by Subject|25|||
147577770|NCT02034513|532270462|FG000|Overall Study|Unclassified|0|||
147577771|NCT02034513|532270463|FG001|Overall Study|Unclassified|1|||
147577772|NCT00960154|532270464|FG000|Overall Study|Study termination|25|||
147577773|NCT00960154|532270465|FG001|Overall Study|Study termination|25|||
147577774|NCT04661202|532270466|FG000|Overall Study|Withdrawal by Subject|1|||
147577775|NCT04661202|532270467|FG001|Overall Study|Withdrawal by Subject|1|||
147577776|NCT04661202|532270466|FG000|Overall Study|Lack of Efficacy|2|||
147577777|NCT04661202|532270467|FG001|Overall Study|Lack of Efficacy|0|||
147577778|NCT02578641|532270468|FG000|Overall Study|Adverse Event|5|||
147577779|NCT02578641|532270469|FG001|Overall Study|Adverse Event|15|||
147577780|NCT02578641|532270468|FG000|Overall Study|Death|16|||
147577781|NCT02578641|532270469|FG001|Overall Study|Death|8|||
147577782|NCT02578641|532270468|FG000|Overall Study|Lost to Follow-up|0|||
147577783|NCT02578641|532270469|FG001|Overall Study|Lost to Follow-up|1|||
147152124|NCT04826094|530719048|FG000|Overall Study|Participant withdrew consent|1|||
147321255|NCT01789203|531339996|FG001|Overall Study|Adverse Event|2|||
147577784|NCT02578641|532270468|FG000|Overall Study|Withdrawal by Subject|14|||
147577785|NCT02578641|532270469|FG001|Overall Study|Withdrawal by Subject|7|||
147577786|NCT02578641|532270468|FG000|Overall Study|Progressive Disease|69|||
147577787|NCT02578641|532270469|FG001|Overall Study|Progressive Disease|21|||
147577788|NCT02578641|532270468|FG000|Overall Study|No Study Drug|2|||
147577789|NCT02578641|532270469|FG001|Overall Study|No Study Drug|0|||
147577790|NCT02578641|532270468|FG000|Overall Study|Randomized by Mistake with Study Treatment|0|||
147577791|NCT02578641|532270469|FG001|Overall Study|Randomized by Mistake with Study Treatment|1|||
147577792|NCT02578641|532270468|FG000|Overall Study|Non-compliance with Study Schedule|1|||
147577793|NCT02578641|532270469|FG001|Overall Study|Non-compliance with Study Schedule|0|||
147577794|NCT02578641|532270468|FG000|Overall Study|Other|1|||
147577795|NCT02578641|532270469|FG001|Overall Study|Other|10|||
147577796|NCT02578641|532270468|FG000|Overall Study|Not treated|1|||
147577797|NCT02578641|532270469|FG001|Overall Study|Not treated|4|||
147577798|NCT02313558|532270472|FG000|Overall Study|Withdrawal by Subject|2|||
147577799|NCT02313558|532270473|FG001|Overall Study|Withdrawal by Subject|0|||
147577800|NCT02313558|532270472|FG000|Overall Study|Lost to Follow-up|4|||
147577801|NCT02313558|532270473|FG001|Overall Study|Lost to Follow-up|4|||
147577802|NCT02694536|532270480|FG000|Overall Study|Progressive Disease|40|||
147577803|NCT02694536|532270480|FG000|Overall Study|Lost to Follow-up|1|||
147577804|NCT02694536|532270480|FG000|Overall Study|Study Drug-Related Adverse Event|1|||
147577805|NCT02694536|532270480|FG000|Overall Study|Withdrawal by Subject|8|||
147577806|NCT02694536|532270480|FG000|Overall Study|Death|8|||
147577807|NCT02694536|532270480|FG000|Overall Study|Other|22|||
147577808|NCT01911429|532270481|FG000|Overall Study|Adverse Event|5|||
147577809|NCT01911429|532270482|FG001|Overall Study|Adverse Event|3|||
147577810|NCT01911429|532270483|FG002|Overall Study|Adverse Event|9|||
147577811|NCT01911429|532270481|FG000|Overall Study|Lack of Efficacy|1|||
147577812|NCT01911429|532270482|FG001|Overall Study|Lack of Efficacy|2|||
147577813|NCT01911429|532270483|FG002|Overall Study|Lack of Efficacy|4|||
147577814|NCT01911429|532270481|FG000|Overall Study|Lost to Follow-up|0|||
147577815|NCT01911429|532270482|FG001|Overall Study|Lost to Follow-up|0|||
147577816|NCT01911429|532270483|FG002|Overall Study|Lost to Follow-up|1|||
147577817|NCT01911429|532270481|FG000|Overall Study|Protocol Violation|0|||
147577818|NCT01911429|532270482|FG001|Overall Study|Protocol Violation|0|||
147577819|NCT01911429|532270483|FG002|Overall Study|Protocol Violation|1|||
147577820|NCT01911429|532270481|FG000|Overall Study|Withdrawal by Subject|5|||
147577821|NCT01911429|532270482|FG001|Overall Study|Withdrawal by Subject|5|||
147577822|NCT01911429|532270483|FG002|Overall Study|Withdrawal by Subject|4|||
147577823|NCT01911429|532270481|FG000|Overall Study|Accidental randomization|0|||
147577824|NCT01911429|532270482|FG001|Overall Study|Accidental randomization|0|||
147577825|NCT01911429|532270483|FG002|Overall Study|Accidental randomization|1|||
147577826|NCT01911429|532270481|FG000|Overall Study|subject left study|1|||
147577827|NCT01911429|532270482|FG001|Overall Study|subject left study|0|||
147577828|NCT01911429|532270483|FG002|Overall Study|subject left study|0|||
147577829|NCT03707587|532270486|FG000|Overall Study|Death|0|||
147577830|NCT03707587|532270487|FG001|Overall Study|Death|1|||
147577831|NCT01266902|532270491|FG000|Period 1 (Main Study)|Investigator's decision/Participant's decision|2|||
147577832|NCT01266902|532270492|FG001|Period 1 (Main Study)|Investigator's decision/Participant's decision|3|||
147577833|NCT01266902|532270493|FG002|Period 1 (Main Study)|Investigator's decision/Participant's decision|0|||
147577834|NCT01266902|532270491|FG000|Period 1 (Main Study)|Lost to Follow-up|5|||
147577835|NCT01266902|532270492|FG001|Period 1 (Main Study)|Lost to Follow-up|12|||
147577836|NCT01266902|532270493|FG002|Period 1 (Main Study)|Lost to Follow-up|0|||
147577837|NCT01266902|532270491|FG000|Period 1 (Main Study)|Lack of Efficacy|4|||
147577838|NCT01266902|532270492|FG001|Period 1 (Main Study)|Lack of Efficacy|2|||
147577839|NCT01266902|532270493|FG002|Period 1 (Main Study)|Lack of Efficacy|0|||
147577840|NCT01266902|532270491|FG000|Period 1 (Main Study)|Adverse Event|3|||
147577841|NCT01266902|532270492|FG001|Period 1 (Main Study)|Adverse Event|11|||
147577842|NCT01266902|532270493|FG002|Period 1 (Main Study)|Adverse Event|0|||
147577843|NCT01266902|532270491|FG000|Period 1 (Main Study)|Withdrawal by Subject|2|||
147577844|NCT01266902|532270492|FG001|Period 1 (Main Study)|Withdrawal by Subject|12|||
147577845|NCT01266902|532270493|FG002|Period 1 (Main Study)|Withdrawal by Subject|0|||
147577846|NCT01266902|532270491|FG000|Period 1 (Main Study)|Subject non-compliant|3|||
147577847|NCT01266902|532270492|FG001|Period 1 (Main Study)|Subject non-compliant|7|||
147577848|NCT01266902|532270493|FG002|Period 1 (Main Study)|Subject non-compliant|0|||
147577849|NCT01266902|532270491|FG000|Period 1 (Main Study)|Continued RPV treatment|11|||
147577850|NCT01266902|532270492|FG001|Period 1 (Main Study)|Continued RPV treatment|34|||
147577851|NCT01266902|532270493|FG002|Period 1 (Main Study)|Continued RPV treatment|0|||
147577852|NCT01266902|532270491|FG000|Period 2 (After Protocol Amendment 3)|Withdrawal by Subject|0|||
147577853|NCT01266902|532270492|FG001|Period 2 (After Protocol Amendment 3)|Withdrawal by Subject|0|||
147577854|NCT01266902|532270493|FG002|Period 2 (After Protocol Amendment 3)|Withdrawal by Subject|1|||
147577855|NCT01266902|532270491|FG000|Period 2 (After Protocol Amendment 3)|Adverse Event|0|||
147577856|NCT01266902|532270492|FG001|Period 2 (After Protocol Amendment 3)|Adverse Event|0|||
147577857|NCT01266902|532270493|FG002|Period 2 (After Protocol Amendment 3)|Adverse Event|1|||
147577858|NCT01266902|532270491|FG000|Period 2 (After Protocol Amendment 3)|Lost to Follow-up|0|||
147321256|NCT01789203|531339995|FG000|Overall Study|Withdrawal by Subject|1|||
147577859|NCT01266902|532270492|FG001|Period 2 (After Protocol Amendment 3)|Lost to Follow-up|0|||
147577860|NCT01266902|532270493|FG002|Period 2 (After Protocol Amendment 3)|Lost to Follow-up|6|||
147577861|NCT05562011|532270496|FG000|Overall Study|Withdrawal by Subject|3|||
147321257|NCT01789203|531339996|FG001|Overall Study|Withdrawal by Subject|0|||
147577862|NCT05562011|532270496|FG000|Overall Study|Lost to Follow-up|1|||
147577863|NCT05562011|532270496|FG000|Overall Study|Could not co-enroll with other research study--device could not be placed postop|1|||
147577864|NCT05562011|532270496|FG000|Overall Study|Device not placed postop due to patient being discharged home after surgery (not staying overnight)|4|||
147577865|NCT05562011|532270496|FG000|Overall Study|Device malfunction|13|||
147577866|NCT04567329|532270497|FG000|Overall Study|Withdrawal by Subject|5|||
147577867|NCT04567329|532270498|FG001|Overall Study|Withdrawal by Subject|6|||
147577868|NCT04567329|532270497|FG000|Overall Study|Protocol Violation|2|||
147577869|NCT04567329|532270498|FG001|Overall Study|Protocol Violation|3|||
147577870|NCT04567329|532270497|FG000|Overall Study|Discontinued|2|||
147577871|NCT04567329|532270498|FG001|Overall Study|Discontinued|2|||
147577872|NCT04567329|532270497|FG000|Overall Study|Lost to Follow-up|0|||
147577873|NCT04567329|532270498|FG001|Overall Study|Lost to Follow-up|1|||
147577874|NCT04567329|532270497|FG000|Overall Study|Lack of Efficacy|0|||
147577875|NCT04567329|532270498|FG001|Overall Study|Lack of Efficacy|1|||
147577876|NCT00881751|532270524|FG000|Overall Study|Physician Decision|0|||
147577877|NCT00881751|532270525|FG001|Overall Study|Physician Decision|1|||
147577878|NCT00881751|532270524|FG000|Overall Study|Adverse Event|0|||
147577879|NCT00881751|532270525|FG001|Overall Study|Adverse Event|2|||
147577880|NCT00881751|532270524|FG000|Overall Study|Withdrawal by Subject|0|||
147577881|NCT00881751|532270525|FG001|Overall Study|Withdrawal by Subject|2|||
147577882|NCT02436200|532270528|FG000|Overall Study|Significant outlier|1|||
147577883|NCT00672984|532270529|FG000|First Intervention|Adverse Event|5|||
147577884|NCT00672984|532270530|FG001|First Intervention|Adverse Event|0|||
147577885|NCT00672984|532270531|FG002|First Intervention|Adverse Event|0|||
147577886|NCT00672984|532270529|FG000|First Intervention|Withdrawal by Subject|1|||
147577887|NCT00672984|532270530|FG001|First Intervention|Withdrawal by Subject|2|||
147577888|NCT00672984|532270531|FG002|First Intervention|Withdrawal by Subject|2|||
147577889|NCT00672984|532270529|FG000|First Intervention|Sponsor decision|3|||
147577890|NCT00672984|532270530|FG001|First Intervention|Sponsor decision|0|||
147577891|NCT00672984|532270531|FG002|First Intervention|Sponsor decision|0|||
147577892|NCT00672984|532270529|FG000|Second Intervention|Non-compliance with facility policies|0|||
147577893|NCT00672984|532270530|FG001|Second Intervention|Non-compliance with facility policies|2|||
147577894|NCT00672984|532270531|FG002|Second Intervention|Non-compliance with facility policies|0|||
147577895|NCT00672984|532270529|FG000|Second Intervention|Withdrawal by Subject|0|||
147577896|NCT00672984|532270530|FG001|Second Intervention|Withdrawal by Subject|3|||
147577897|NCT00672984|532270531|FG002|Second Intervention|Withdrawal by Subject|0|||
147577898|NCT00672984|532270529|FG000|Second Intervention|Protocol Violation|0|||
147577899|NCT00672984|532270530|FG001|Second Intervention|Protocol Violation|1|||
147577900|NCT00672984|532270531|FG002|Second Intervention|Protocol Violation|1|||
147577901|NCT00672984|532270529|FG000|Third Intervention|Adverse Event|1|||
147577902|NCT00672984|532270530|FG001|Third Intervention|Adverse Event|0|||
147577903|NCT00672984|532270531|FG002|Third Intervention|Adverse Event|1|||
147577904|NCT00009945|532270532|FG000|Overall Study|no follow up data|7|||
147577905|NCT00009945|532270533|FG001|Overall Study|no follow up data|5|||
147577906|NCT00819169|532270536|FG000|Overall Study|Withdrawal by Subject|2|||
147577907|NCT00819169|532270537|FG001|Overall Study|Withdrawal by Subject|0|||
147577908|NCT00819169|532270538|FG002|Overall Study|Withdrawal by Subject|0|||
147577909|NCT00819169|532270539|FG003|Overall Study|Withdrawal by Subject|1|||
147577910|NCT00819169|532270540|FG004|Overall Study|Withdrawal by Subject|1|||
147577911|NCT00819169|532270541|FG005|Overall Study|Withdrawal by Subject|1|||
147577912|NCT00819169|532270542|FG006|Overall Study|Withdrawal by Subject|5|||
147577913|NCT00819169|532270543|FG007|Overall Study|Withdrawal by Subject|1|||
147577914|NCT00819169|532270544|FG008|Overall Study|Withdrawal by Subject|4|||
147577915|NCT00819169|532270536|FG000|Overall Study|Lost to Follow-up|0|||
147577916|NCT00819169|532270537|FG001|Overall Study|Lost to Follow-up|2|||
147577917|NCT00819169|532270538|FG002|Overall Study|Lost to Follow-up|0|||
147577918|NCT00819169|532270539|FG003|Overall Study|Lost to Follow-up|1|||
147577919|NCT00819169|532270540|FG004|Overall Study|Lost to Follow-up|0|||
147577920|NCT00819169|532270541|FG005|Overall Study|Lost to Follow-up|6|||
147577921|NCT00819169|532270542|FG006|Overall Study|Lost to Follow-up|2|||
147577922|NCT00819169|532270543|FG007|Overall Study|Lost to Follow-up|2|||
147577923|NCT00819169|532270544|FG008|Overall Study|Lost to Follow-up|1|||
147577924|NCT00819169|532270536|FG000|Overall Study|Death|1|||
147577925|NCT00819169|532270537|FG001|Overall Study|Death|1|||
147577926|NCT00819169|532270538|FG002|Overall Study|Death|3|||
147577927|NCT00819169|532270539|FG003|Overall Study|Death|8|||
147577928|NCT00819169|532270540|FG004|Overall Study|Death|5|||
147577929|NCT00819169|532270541|FG005|Overall Study|Death|7|||
147577930|NCT00819169|532270542|FG006|Overall Study|Death|9|||
147152125|NCT04826094|530719049|FG001|Overall Study|Participant withdrew consent|0|||
147152126|NCT04826094|530719050|FG002|Overall Study|Participant withdrew consent|0|||
147152127|NCT04826094|530719051|FG003|Overall Study|Participant withdrew consent|1|||
147577931|NCT00819169|532270543|FG007|Overall Study|Death|4|||
147577932|NCT00819169|532270544|FG008|Overall Study|Death|7|||
147577933|NCT00819169|532270536|FG000|Overall Study|Ineligibility determined|0|||
147577934|NCT00819169|532270537|FG001|Overall Study|Ineligibility determined|0|||
147577935|NCT00819169|532270538|FG002|Overall Study|Ineligibility determined|0|||
147577936|NCT00819169|532270539|FG003|Overall Study|Ineligibility determined|2|||
147577937|NCT00819169|532270540|FG004|Overall Study|Ineligibility determined|0|||
147577938|NCT00819169|532270541|FG005|Overall Study|Ineligibility determined|0|||
147577939|NCT00819169|532270542|FG006|Overall Study|Ineligibility determined|0|||
147577940|NCT00819169|532270543|FG007|Overall Study|Ineligibility determined|0|||
147577941|NCT00819169|532270544|FG008|Overall Study|Ineligibility determined|1|||
147577942|NCT00819169|532270536|FG000|Overall Study|Adverse Event|0|||
147577943|NCT00819169|532270537|FG001|Overall Study|Adverse Event|0|||
147577944|NCT00819169|532270538|FG002|Overall Study|Adverse Event|0|||
147577945|NCT00819169|532270539|FG003|Overall Study|Adverse Event|0|||
147577946|NCT00819169|532270540|FG004|Overall Study|Adverse Event|1|||
147577947|NCT00819169|532270541|FG005|Overall Study|Adverse Event|0|||
147577948|NCT00819169|532270542|FG006|Overall Study|Adverse Event|0|||
147577949|NCT00819169|532270543|FG007|Overall Study|Adverse Event|0|||
147577950|NCT00819169|532270544|FG008|Overall Study|Adverse Event|0|||
147577951|NCT00819169|532270536|FG000|Overall Study|Administrative Decision|0|||
147577952|NCT00819169|532270537|FG001|Overall Study|Administrative Decision|0|||
147577953|NCT00819169|532270538|FG002|Overall Study|Administrative Decision|0|||
147577954|NCT00819169|532270539|FG003|Overall Study|Administrative Decision|0|||
147577955|NCT00819169|532270540|FG004|Overall Study|Administrative Decision|1|||
147577956|NCT00819169|532270541|FG005|Overall Study|Administrative Decision|2|||
147577957|NCT00819169|532270542|FG006|Overall Study|Administrative Decision|0|||
147577958|NCT00819169|532270543|FG007|Overall Study|Administrative Decision|2|||
147577959|NCT00819169|532270544|FG008|Overall Study|Administrative Decision|0|||
147577960|NCT00406393|532270545|FG000|Overall Study|Did not undergo transplantation|2|||
147577961|NCT00406393|532270546|FG001|Overall Study|Did not undergo transplantation|1|||
147577962|NCT01632306|532270547|FG000|Overall Study|Protocol Violation|1|||
147577963|NCT01632306|532270548|FG001|Overall Study|Protocol Violation|0|||
147577964|NCT01632306|532270549|FG002|Overall Study|Protocol Violation|0|||
147577965|NCT03966911|532270552|FG000|Overall Study|Adverse Event|1|||
147577966|NCT03966911|532270553|FG001|Overall Study|Adverse Event|1|||
147577967|NCT03966911|532270552|FG000|Overall Study|Withdrawal by Subject|8|||
147577968|NCT03966911|532270553|FG001|Overall Study|Withdrawal by Subject|2|||
147577969|NCT03966911|532270552|FG000|Overall Study|Unable to complete study visits due to COVID-19|0|||
147577970|NCT03966911|532270553|FG001|Overall Study|Unable to complete study visits due to COVID-19|13|||
147577971|NCT00985751|532270554|FG000|Overall Study|Adverse Event|0|||
147577972|NCT00985751|532270555|FG001|Overall Study|Adverse Event|0|||
147577973|NCT00985751|532270556|FG002|Overall Study|Adverse Event|0|||
147577974|NCT00985751|532270557|FG003|Overall Study|Adverse Event|0|||
147577975|NCT00985751|532270558|FG004|Overall Study|Adverse Event|1|||
147577976|NCT00380588|532270559|FG000|Overall Study|Unequivocal Disease Progression|25|||
147577977|NCT00380588|532270560|FG001|Overall Study|Unequivocal Disease Progression|34|||
147577978|NCT00380588|532270559|FG000|Overall Study|Next Cycle Not Started|4|||
147577979|NCT00380588|532270560|FG001|Overall Study|Next Cycle Not Started|0|||
147577980|NCT00380588|532270559|FG000|Overall Study|Adverse Event|7|||
147577981|NCT00380588|532270560|FG001|Overall Study|Adverse Event|3|||
147577982|NCT00380588|532270559|FG000|Overall Study|Withdrawal by Subject|1|||
147577983|NCT00380588|532270560|FG001|Overall Study|Withdrawal by Subject|3|||
147577984|NCT00380588|532270559|FG000|Overall Study|Physician Decision|2|||
147577985|NCT00380588|532270560|FG001|Overall Study|Physician Decision|0|||
147577986|NCT02905435|532270561|FG000|Overall Study|Death|2|||
147577987|NCT02905435|532270561|FG000|Overall Study|Physician Decision|1|||
147577988|NCT02905435|532270561|FG000|Overall Study|Lost to Follow-up|4|||
147577989|NCT01046084|532270569|FG000|Third Washout of 7 Days|Withdrawal by Subject|2|||
147577990|NCT01046084|532270570|FG001|Third Washout of 7 Days|Withdrawal by Subject|0|||
147577991|NCT00474188|532270571|FG000|Overall Study|Withdrawal by Subject|1|||
147577992|NCT00474188|532270571|FG000|Overall Study|Study discontinued by sponsor|5|||
147577993|NCT03614728|532270572|FG000|Part 1 (Up to 30.8 Months)|Study Terminated By Sponsor|1|||
147577994|NCT03614728|532270573|FG001|Part 1 (Up to 30.8 Months)|Study Terminated By Sponsor|0|||
147446120|NCT00820950|531797566|FG008|Overall Study|Protocol Violation|0|||
147577995|NCT03614728|532270574|FG002|Part 1 (Up to 30.8 Months)|Study Terminated By Sponsor|0|||
147577996|NCT03614728|532270575|FG003|Part 1 (Up to 30.8 Months)|Study Terminated By Sponsor|0|||
147577997|NCT03614728|532270572|FG000|Part 1 (Up to 30.8 Months)|Physician Decision|0|||
147577998|NCT03614728|532270573|FG001|Part 1 (Up to 30.8 Months)|Physician Decision|1|||
147577999|NCT03614728|532270574|FG002|Part 1 (Up to 30.8 Months)|Physician Decision|0|||
147578000|NCT03614728|532270575|FG003|Part 1 (Up to 30.8 Months)|Physician Decision|0|||
147578001|NCT00842309|532270580|FG000|Overall Study|Withdrawal by Subject|3|||
147578002|NCT00842309|532270581|FG001|Overall Study|Withdrawal by Subject|1|||
147578003|NCT01962298|532270582|FG000|Overall Study|Protocol Violation|1|||
147578004|NCT01962298|532270583|FG001|Overall Study|Protocol Violation|0|||
147578005|NCT01962298|532270584|FG002|Overall Study|Protocol Violation|1|||
147578006|NCT01962298|532270585|FG003|Overall Study|Protocol Violation|1|||
147578007|NCT01962298|532270586|FG004|Overall Study|Protocol Violation|0|||
147578008|NCT01962298|532270582|FG000|Overall Study|Data quality insufficient|2|||
147578009|NCT01962298|532270583|FG001|Overall Study|Data quality insufficient|0|||
147578010|NCT01962298|532270584|FG002|Overall Study|Data quality insufficient|3|||
147152128|NCT04826094|530719052|FG004|Overall Study|Participant withdrew consent|1|||
147152129|NCT04826094|530719053|FG005|Overall Study|Participant withdrew consent|1|||
147446121|NCT00820950|531797567|FG009|Overall Study|Protocol Violation|0|||
147578011|NCT01962298|532270585|FG003|Overall Study|Data quality insufficient|1|||
147578012|NCT01962298|532270586|FG004|Overall Study|Data quality insufficient|4|||
147578013|NCT01962298|532270582|FG000|Overall Study|Insufficient data|0|||
147446122|NCT00528021|531797570|FG000|Overall Study|Lack of Efficacy|17|||
147578014|NCT01962298|532270583|FG001|Overall Study|Insufficient data|2|||
147578015|NCT01962298|532270584|FG002|Overall Study|Insufficient data|1|||
147578016|NCT01962298|532270585|FG003|Overall Study|Insufficient data|0|||
147578017|NCT01962298|532270586|FG004|Overall Study|Insufficient data|1|||
147578018|NCT01962298|532270582|FG000|Overall Study|Incorrect data recorded|0|||
147578019|NCT01962298|532270583|FG001|Overall Study|Incorrect data recorded|1|||
147578020|NCT01962298|532270584|FG002|Overall Study|Incorrect data recorded|0|||
147578021|NCT01962298|532270585|FG003|Overall Study|Incorrect data recorded|0|||
147578022|NCT01962298|532270586|FG004|Overall Study|Incorrect data recorded|0|||
147578023|NCT01962298|532270582|FG000|Overall Study|Physician Decision|0|||
147578024|NCT01962298|532270583|FG001|Overall Study|Physician Decision|1|||
147578025|NCT01962298|532270584|FG002|Overall Study|Physician Decision|0|||
147578026|NCT01962298|532270585|FG003|Overall Study|Physician Decision|0|||
147578027|NCT01962298|532270586|FG004|Overall Study|Physician Decision|1|||
147578028|NCT04476277|532270587|FG000|Overall Study|Withdrawal by Subject|0|||
147578029|NCT04476277|532270588|FG001|Overall Study|Withdrawal by Subject|0|||
147578030|NCT04476277|532270589|FG002|Overall Study|Withdrawal by Subject|1|||
147578031|NCT04476277|532270590|FG003|Overall Study|Withdrawal by Subject|0|||
147578032|NCT01576705|532270591|FG000|Overall Study|TSH > 7 mIU/L at baseline|3|||
147578033|NCT01576705|532270592|FG001|Overall Study|TSH > 7 mIU/L at baseline|7|||
147578034|NCT01576705|532270593|FG002|Overall Study|TSH > 7 mIU/L at baseline|5|||
147578035|NCT01576705|532270594|FG003|Overall Study|TSH > 7 mIU/L at baseline|3|||
147578036|NCT01576705|532270591|FG000|Overall Study|invalid ICF|0|||
147578037|NCT01576705|532270592|FG001|Overall Study|invalid ICF|1|||
147578038|NCT01576705|532270593|FG002|Overall Study|invalid ICF|0|||
147578039|NCT01576705|532270594|FG003|Overall Study|invalid ICF|0|||
147578040|NCT03727139|532270595|FG000|Overall Study|Protocol Violation|60|||
147578041|NCT00566722|532270596|FG000|Overall Study|Adverse Event|0|||
147578042|NCT00566722|532270597|FG001|Overall Study|Adverse Event|1|||
147578043|NCT00566722|532270598|FG002|Overall Study|Adverse Event|0|||
147578044|NCT00566722|532270596|FG000|Overall Study|Withdrawal by Subject|0|||
147578045|NCT00566722|532270597|FG001|Overall Study|Withdrawal by Subject|0|||
147578046|NCT00566722|532270598|FG002|Overall Study|Withdrawal by Subject|1|||
147578047|NCT00566722|532270596|FG000|Overall Study|Lost to Follow-up|1|||
147578048|NCT00566722|532270597|FG001|Overall Study|Lost to Follow-up|1|||
147578049|NCT00566722|532270598|FG002|Overall Study|Lost to Follow-up|1|||
147578050|NCT00566722|532270596|FG000|Overall Study|Lack of Efficacy|1|||
147578051|NCT00566722|532270597|FG001|Overall Study|Lack of Efficacy|2|||
147578052|NCT00566722|532270598|FG002|Overall Study|Lack of Efficacy|4|||
147578053|NCT00566722|532270596|FG000|Overall Study|Did not meet exclusion criteria|0|||
147578054|NCT00566722|532270597|FG001|Overall Study|Did not meet exclusion criteria|0|||
147578055|NCT00566722|532270598|FG002|Overall Study|Did not meet exclusion criteria|2|||
147578056|NCT00566722|532270596|FG000|Overall Study|Serious adverse event|0|||
147578057|NCT00566722|532270597|FG001|Overall Study|Serious adverse event|1|||
147578058|NCT00566722|532270598|FG002|Overall Study|Serious adverse event|0|||
147578059|NCT00566722|532270596|FG000|Overall Study|Noncompliant with drug administration|0|||
147578060|NCT00566722|532270597|FG001|Overall Study|Noncompliant with drug administration|0|||
147578061|NCT00566722|532270598|FG002|Overall Study|Noncompliant with drug administration|1|||
147578062|NCT01390948|532270599|FG000|Overall Study|End of Study|1|||
147578063|NCT01390948|532270600|FG001|Overall Study|End of Study|0|||
147152130|NCT04826094|530719054|FG006|Overall Study|Participant withdrew consent|0|||
147152131|NCT04826094|530719055|FG007|Overall Study|Participant withdrew consent|1|||
147152132|NCT04826094|530719048|FG000|Overall Study|Non-adherence (protocol deviation)|0|||
147152133|NCT04826094|530719049|FG001|Overall Study|Non-adherence (protocol deviation)|0|||
147152134|NCT04826094|530719050|FG002|Overall Study|Non-adherence (protocol deviation)|0|||
147152135|NCT04826094|530719051|FG003|Overall Study|Non-adherence (protocol deviation)|0|||
147152136|NCT04826094|530719052|FG004|Overall Study|Non-adherence (protocol deviation)|0|||
147152137|NCT04826094|530719053|FG005|Overall Study|Non-adherence (protocol deviation)|0|||
147152138|NCT04826094|530719054|FG006|Overall Study|Non-adherence (protocol deviation)|1|||
147152139|NCT04826094|530719055|FG007|Overall Study|Non-adherence (protocol deviation)|0|||
147152140|NCT04826094|530719048|FG000|Overall Study|Withdrawn by Investigator|0|||
147152141|NCT04826094|530719049|FG001|Overall Study|Withdrawn by Investigator|0|||
147152142|NCT04826094|530719050|FG002|Overall Study|Withdrawn by Investigator|0|||
147578064|NCT01390948|532270601|FG002|Overall Study|End of Study|0|||
147578065|NCT01390948|532270599|FG000|Overall Study|Withdrew consent|2|||
147578066|NCT01390948|532270600|FG001|Overall Study|Withdrew consent|2|||
147578067|NCT01390948|532270601|FG002|Overall Study|Withdrew consent|0|||
147578068|NCT01390948|532270599|FG000|Overall Study|Progressive Disease|2|||
147578069|NCT01390948|532270600|FG001|Overall Study|Progressive Disease|5|||
147578070|NCT01390948|532270601|FG002|Overall Study|Progressive Disease|0|||
147578071|NCT01390948|532270599|FG000|Overall Study|Death during follow-up|10|||
147578072|NCT01390948|532270600|FG001|Overall Study|Death during follow-up|11|||
147578073|NCT01390948|532270601|FG002|Overall Study|Death during follow-up|1|||
147578074|NCT02218216|532270604|FG000|Overall Study|Study terminated before completed|6|||
147578075|NCT02218216|532270605|FG001|Overall Study|Study terminated before completed|0|||
147578076|NCT02218216|532270606|FG002|Overall Study|Study terminated before completed|0|||
147321258|NCT01789203|531339995|FG000|Overall Study|Death|1|||
147321259|NCT01789203|531339996|FG001|Overall Study|Death|0|||
147578077|NCT05740098|532270611|FG000|Overall Study|Lost to Follow-up|26|||
147578078|NCT05740098|532270612|FG001|Overall Study|Lost to Follow-up|17|||
147578079|NCT05740098|532270613|FG002|Overall Study|Lost to Follow-up|21|||
147578080|NCT03867760|532270614|FG000|Overall Study|Lost to Follow-up|2|||
147578081|NCT03867760|532270615|FG001|Overall Study|Lost to Follow-up|3|||
147578082|NCT03867760|532270614|FG000|Overall Study|Withdrawal by Subject|1|||
147578083|NCT03867760|532270615|FG001|Overall Study|Withdrawal by Subject|2|||
147578084|NCT03867760|532270614|FG000|Overall Study|subject could not meet study logistics|3|||
147578085|NCT03867760|532270615|FG001|Overall Study|subject could not meet study logistics|3|||
147578086|NCT01073631|532270616|FG000|Overall Study|Death|82|||
147578087|NCT01073631|532270616|FG000|Overall Study|Adverse Event|24|||
147578088|NCT01073631|532270616|FG000|Overall Study|Other|63|||
147578089|NCT04573309|532271896|FG000|Overall Study|Protocol Violation|1|||
147578090|NCT04573309|532271897|FG001|Overall Study|Protocol Violation|0|||
147578091|NCT01691430|532271900|FG000|Overall Study|Death|17|||
147578092|NCT01691430|532271901|FG001|Overall Study|Death|16|||
147578093|NCT01691430|532271900|FG000|Overall Study|Withdrawal by Subject|5|||
147578094|NCT01691430|532271901|FG001|Overall Study|Withdrawal by Subject|1|||
147578095|NCT01691430|532271900|FG000|Overall Study|Lost to Follow-up|0|||
147578096|NCT01691430|532271901|FG001|Overall Study|Lost to Follow-up|3|||
147578097|NCT01894230|532271902|FG000|Overall Study|Lost to Follow-up|2|||
147578098|NCT01894230|532271903|FG001|Overall Study|Lost to Follow-up|2|||
147578099|NCT01894230|532271902|FG000|Overall Study|Withdrawal by Subject|4|||
147578100|NCT01894230|532271903|FG001|Overall Study|Withdrawal by Subject|4|||
147578101|NCT01894230|532271902|FG000|Overall Study|Non-adherent|0|||
147578102|NCT01894230|532271903|FG001|Overall Study|Non-adherent|1|||
147578103|NCT01894230|532271902|FG000|Overall Study|Death|1|||
147578104|NCT01894230|532271903|FG001|Overall Study|Death|0|||
147578105|NCT02219009|532271906|FG000|Overall Study|Withdrawal by Subject|5|||
147578106|NCT02219009|532271907|FG001|Overall Study|Withdrawal by Subject|1|||
147578107|NCT02219009|532271906|FG000|Overall Study|Adverse Event|2|||
147578108|NCT02219009|532271907|FG001|Overall Study|Adverse Event|4|||
147578109|NCT02219009|532271906|FG000|Overall Study|Lost to Follow-up|2|||
147578110|NCT02219009|532271907|FG001|Overall Study|Lost to Follow-up|2|||
147578111|NCT02219009|532271906|FG000|Overall Study|Protocol deviation|1|||
147578112|NCT02219009|532271907|FG001|Overall Study|Protocol deviation|0|||
147578113|NCT02219009|532271906|FG000|Overall Study|Physician Decision|0|||
147578114|NCT02219009|532271907|FG001|Overall Study|Physician Decision|1|||
147578115|NCT00660387|532271908|FG000|Overall Study|Adverse Event|1|||
147578116|NCT00660387|532271909|FG001|Overall Study|Adverse Event|2|||
147578117|NCT00660387|532271908|FG000|Overall Study|Lack of Efficacy|0|||
147578118|NCT00660387|532271909|FG001|Overall Study|Lack of Efficacy|1|||
147578119|NCT00660387|532271908|FG000|Overall Study|Protocol Violation|1|||
147578120|NCT00660387|532271909|FG001|Overall Study|Protocol Violation|0|||
147578121|NCT02966340|532271910|FG000|Overall Study|Adverse Event|0|||
147578122|NCT02966340|532271911|FG001|Overall Study|Adverse Event|1|||
147578123|NCT02966340|532271910|FG000|Overall Study|Lost to Follow-up|0|||
147578124|NCT02966340|532271911|FG001|Overall Study|Lost to Follow-up|1|||
147578125|NCT02966340|532271910|FG000|Overall Study|Withdrawal by Subject|1|||
147578126|NCT02966340|532271911|FG001|Overall Study|Withdrawal by Subject|0|||
147321260|NCT01789203|531339995|FG000|Overall Study|Protocol Violation|2|||
147321261|NCT01789203|531339996|FG001|Overall Study|Protocol Violation|1|||
147321262|NCT01789203|531339995|FG000|Overall Study|Other|1|||
147321263|NCT01789203|531339996|FG001|Overall Study|Other|1|||
147321264|NCT01789203|531339995|FG000|Overall Study|patient non-adherent|2|||
147321265|NCT01789203|531339996|FG001|Overall Study|patient non-adherent|0|||
147321266|NCT01254305|531340003|FG000|Overall Study|Adverse Event|6|||
147321267|NCT01254305|531340004|FG001|Overall Study|Adverse Event|3|||
147321268|NCT01254305|531340005|FG002|Overall Study|Adverse Event|2|||
147578127|NCT02966340|532271910|FG000|Overall Study|data acquisition error|1|||
147578128|NCT02966340|532271911|FG001|Overall Study|data acquisition error|0|||
147578129|NCT02966340|532271910|FG000|Overall Study|startle non-responder|1|||
147578130|NCT02966340|532271911|FG001|Overall Study|startle non-responder|1|||
147321269|NCT01254305|531340003|FG000|Overall Study|Lack of Efficacy|1|||
147321270|NCT01254305|531340004|FG001|Overall Study|Lack of Efficacy|0|||
147321271|NCT01254305|531340005|FG002|Overall Study|Lack of Efficacy|1|||
147321272|NCT01254305|531340003|FG000|Overall Study|Protocol Violation|1|||
147578131|NCT04211766|532271912|FG000|Overall Study|Withdrawal by Subject|5|||
147321273|NCT01254305|531340004|FG001|Overall Study|Protocol Violation|7|||
147321274|NCT01254305|531340005|FG002|Overall Study|Protocol Violation|3|||
147578132|NCT04211766|532271913|FG001|Overall Study|Withdrawal by Subject|1|||
147578133|NCT00202839|532271914|FG000|Overall Study|Adverse Event|1|||
147578134|NCT00202839|532271915|FG001|Overall Study|Adverse Event|5|||
147578135|NCT00202839|532271914|FG000|Overall Study|Physician Decision|12|||
147578136|NCT00202839|532271915|FG001|Overall Study|Physician Decision|0|||
147578137|NCT00202839|532271914|FG000|Overall Study|Withdrawal by Subject|6|||
147578138|NCT00202839|532271915|FG001|Overall Study|Withdrawal by Subject|2|||
147578139|NCT00202839|532271914|FG000|Overall Study|Protocol Violation|2|||
147446123|NCT00528021|531797571|FG001|Overall Study|Lack of Efficacy|13|||
147446124|NCT00528021|531797572|FG002|Overall Study|Lack of Efficacy|7|||
147446125|NCT00528021|531797573|FG003|Overall Study|Lack of Efficacy|9|||
147446126|NCT02581202|531797576|FG000|Overall Study|Lack of Efficacy|2|||
147446127|NCT02581202|531797576|FG000|Overall Study|Withdrawal by Subject|4|||
147446128|NCT02581202|531797576|FG000|Overall Study|Lost to Follow-up|5|||
147446129|NCT02581202|531797576|FG000|Overall Study|Pregnancy|3|||
147446130|NCT04050982|531797577|FG000|Overall Study|Did not meet eligibility criteria|0|||
147446131|NCT04050982|531797578|FG001|Overall Study|Did not meet eligibility criteria|1|||
147446132|NCT04050982|531797579|FG002|Overall Study|Did not meet eligibility criteria|0|||
147446133|NCT04050982|531797577|FG000|Overall Study|Withdrawal by Subject|1|||
147446134|NCT04050982|531797578|FG001|Overall Study|Withdrawal by Subject|0|||
147446135|NCT04050982|531797579|FG002|Overall Study|Withdrawal by Subject|0|||
147446136|NCT04050982|531797577|FG000|Overall Study|Unable to enroll on platform|1|||
147446137|NCT04050982|531797578|FG001|Overall Study|Unable to enroll on platform|0|||
147446138|NCT04050982|531797579|FG002|Overall Study|Unable to enroll on platform|0|||
147446139|NCT01246583|531797580|FG000|Overall Study|Lost to Follow-up|0|||
147446140|NCT01246583|531797581|FG001|Overall Study|Lost to Follow-up|0|||
147446141|NCT01246583|531797582|FG002|Overall Study|Lost to Follow-up|0|||
147446142|NCT01246583|531797583|FG003|Overall Study|Lost to Follow-up|1|||
147446143|NCT01246583|531797580|FG000|Overall Study|Protocol Violation|0|||
147446144|NCT01246583|531797581|FG001|Overall Study|Protocol Violation|0|||
147446145|NCT01246583|531797582|FG002|Overall Study|Protocol Violation|1|||
147446146|NCT01246583|531797583|FG003|Overall Study|Protocol Violation|0|||
147446147|NCT01246583|531797580|FG000|Overall Study|Withdrawal by Subject|1|||
147446148|NCT01246583|531797581|FG001|Overall Study|Withdrawal by Subject|0|||
147446149|NCT01246583|531797582|FG002|Overall Study|Withdrawal by Subject|0|||
147446150|NCT01246583|531797583|FG003|Overall Study|Withdrawal by Subject|0|||
147446151|NCT05264740|531797584|FG000|Baseline|Withdrawal by Subject|0|||
147446152|NCT05264740|531797585|FG001|Baseline|Withdrawal by Subject|1|||
147446153|NCT05264740|531797584|FG000|Follow Up 1|Lost to Follow-up|1|||
147446154|NCT05264740|531797585|FG001|Follow Up 1|Lost to Follow-up|1|||
147446155|NCT05264740|531797584|FG000|Follow Up 1|Withdrawal by Subject|0|||
147446156|NCT05264740|531797585|FG001|Follow Up 1|Withdrawal by Subject|1|||
147446157|NCT05264740|531797584|FG000|Follow Up 2|Lost to Follow-up|1|||
147446158|NCT05264740|531797585|FG001|Follow Up 2|Lost to Follow-up|4|||
147446159|NCT05264740|531797584|FG000|Follow Up 3|Lost to Follow-up|7|||
147446160|NCT05264740|531797585|FG001|Follow Up 3|Lost to Follow-up|4|||
147446161|NCT00609791|531798854|FG000|Overall Study|Subject was deemed ineligible after starting study procedures|1|||
147446162|NCT04218201|531798855|FG000|Overall Study|Death|0|||
147446163|NCT04218201|531798856|FG001|Overall Study|Death|0|||
147446164|NCT04218201|531798857|FG002|Overall Study|Death|2|||
147446165|NCT04218201|531798858|FG003|Overall Study|Death|0|||
147446166|NCT04218201|531798855|FG000|Overall Study|Unable to contact participant|4|||
147446167|NCT04218201|531798856|FG001|Overall Study|Unable to contact participant|0|||
147446168|NCT04218201|531798857|FG002|Overall Study|Unable to contact participant|3|||
147446169|NCT04218201|531798858|FG003|Overall Study|Unable to contact participant|0|||
147446170|NCT04218201|531798855|FG000|Overall Study|Practical problems (e.g., no childcare or transportation)|3|||
147446171|NCT04218201|531798856|FG001|Overall Study|Practical problems (e.g., no childcare or transportation)|0|||
147446172|NCT04218201|531798857|FG002|Overall Study|Practical problems (e.g., no childcare or transportation)|0|||
147446173|NCT04218201|531798858|FG003|Overall Study|Practical problems (e.g., no childcare or transportation)|0|||
147446174|NCT04218201|531798855|FG000|Overall Study|Withdrawal by Subject|2|||
147446175|NCT04218201|531798856|FG001|Overall Study|Withdrawal by Subject|0|||
147446176|NCT04218201|531798857|FG002|Overall Study|Withdrawal by Subject|0|||
147446177|NCT04218201|531798858|FG003|Overall Study|Withdrawal by Subject|0|||
147446178|NCT04218201|531798855|FG000|Overall Study|PCP plans to leave practice|0|||
147446179|NCT04218201|531798856|FG001|Overall Study|PCP plans to leave practice|8|||
147446180|NCT04218201|531798857|FG002|Overall Study|PCP plans to leave practice|0|||
147446181|NCT04218201|531798858|FG003|Overall Study|PCP plans to leave practice|5|||
147446182|NCT04218201|531798855|FG000|Overall Study|Reduced panel|0|||
147446183|NCT04218201|531798856|FG001|Overall Study|Reduced panel|0|||
147446184|NCT04218201|531798857|FG002|Overall Study|Reduced panel|0|||
147446185|NCT04218201|531798858|FG003|Overall Study|Reduced panel|1|||
147446186|NCT04218201|531798855|FG000|Overall Study|No longer interested in participating|0|||
147446187|NCT04218201|531798856|FG001|Overall Study|No longer interested in participating|1|||
147446188|NCT04218201|531798857|FG002|Overall Study|No longer interested in participating|0|||
147446189|NCT04218201|531798858|FG003|Overall Study|No longer interested in participating|0|||
147446190|NCT02716987|531798861|FG000|Overall Study|Ligand synthesis failure|0|||
147446191|NCT02716987|531798862|FG001|Overall Study|Ligand synthesis failure|0|||
147446192|NCT02716987|531798863|FG002|Overall Study|Ligand synthesis failure|1|||
147446193|NCT02716987|531798864|FG003|Overall Study|Ligand synthesis failure|0|||
147446194|NCT02716987|531798865|FG004|Overall Study|Ligand synthesis failure|0|||
147446195|NCT02716987|531798866|FG005|Overall Study|Ligand synthesis failure|0|||
147446196|NCT02716987|531798861|FG000|Overall Study|Withdrawal by Subject|0|||
147446197|NCT02716987|531798862|FG001|Overall Study|Withdrawal by Subject|0|||
147578140|NCT00202839|532271915|FG001|Overall Study|Protocol Violation|1|||
147578141|NCT00202839|532271914|FG000|Overall Study|Lost to Follow-up|3|||
147578142|NCT00202839|532271915|FG001|Overall Study|Lost to Follow-up|2|||
147578143|NCT00642993|532271916|FG000|Overall Study|Adverse Event|85|||
147578144|NCT00642993|532271917|FG001|Overall Study|Adverse Event|4|||
147578145|NCT00642993|532271916|FG000|Overall Study|Lost to Follow-up|8|||
147578146|NCT00642993|532271917|FG001|Overall Study|Lost to Follow-up|4|||
147578147|NCT00642993|532271916|FG000|Overall Study|Withdrew - reason unrelated to treatment|11|||
147578148|NCT00642993|532271917|FG001|Overall Study|Withdrew - reason unrelated to treatment|3|||
147578149|NCT00642993|532271916|FG000|Overall Study|Protocol Violation|1|||
147578150|NCT00642993|532271917|FG001|Overall Study|Protocol Violation|4|||
147578151|NCT00642993|532271916|FG000|Overall Study|Did not meet protocol eligibility|0|||
147578152|NCT00642993|532271917|FG001|Overall Study|Did not meet protocol eligibility|1|||
147578153|NCT00642993|532271916|FG000|Overall Study|Administrative|1|||
147578154|NCT00642993|532271917|FG001|Overall Study|Administrative|0|||
147578155|NCT03119662|532271918|FG000|Overall Study|Withdrawal by Subject|0|||
147578156|NCT03119662|532271919|FG001|Overall Study|Withdrawal by Subject|1|||
147578157|NCT00757705|532271920|FG000|Overall Study|Adverse Event|19|||
147578158|NCT00757705|532271920|FG000|Overall Study|Lost to Follow-up|16|||
147578159|NCT00757705|532271920|FG000|Overall Study|Withdrawal by Subject|25|||
147578160|NCT00757705|532271920|FG000|Overall Study|Insufficient Response|26|||
147578161|NCT00757705|532271920|FG000|Overall Study|Ineligible to continue|8|||
147578162|NCT00757705|532271920|FG000|Overall Study|Non-compliant|9|||
147578163|NCT00757705|532271920|FG000|Overall Study|Other|18|||
147578164|NCT02817828|532271921|FG000|Overall Study|Lost to Follow-up|41|||
147578165|NCT02817828|532271921|FG000|Overall Study|Adverse event not related to bleeding|104|||
147578166|NCT02817828|532271921|FG000|Overall Study|Adverse event related to bleeding|53|||
147578167|NCT02817828|532271921|FG000|Overall Study|Protocol Violation|11|||
147578168|NCT02817828|532271921|FG000|Overall Study|Pregnancy|7|||
147578169|NCT02817828|532271921|FG000|Overall Study|Pregnancy wish|15|||
147578170|NCT02817828|532271921|FG000|Overall Study|Withdrawal by Subject|78|||
147578171|NCT02817828|532271921|FG000|Overall Study|Other|26|||
147578172|NCT00659815|532271928|FG000|Overall Study|Study related symptoms and complaints|2|||
147578173|NCT00659815|532271929|FG001|Overall Study|Study related symptoms and complaints|1|||
147578174|NCT00659815|532271928|FG000|Overall Study|Inability to maintain wearing schedule|1|||
147578175|NCT00659815|532271929|FG001|Overall Study|Inability to maintain wearing schedule|2|||
147578176|NCT00659815|532271928|FG000|Overall Study|Withdrawal by Subject|1|||
147578177|NCT00659815|532271929|FG001|Overall Study|Withdrawal by Subject|1|||
147578178|NCT02651987|532271930|FG000|Overall Study|Adverse Event|2|||
147578179|NCT02651987|532271931|FG001|Overall Study|Adverse Event|2|||
147578180|NCT02651987|532271930|FG000|Overall Study|Consent Withdrawn|2|||
147578181|NCT02651987|532271931|FG001|Overall Study|Consent Withdrawn|0|||
147578182|NCT02651987|532271930|FG000|Overall Study|Local PD|0|||
147578183|NCT02651987|532271931|FG001|Overall Study|Local PD|2|||
147578184|NCT02651987|532271930|FG000|Overall Study|Investigator Decision|1|||
147578185|NCT02651987|532271931|FG001|Overall Study|Investigator Decision|1|||
147578186|NCT04408924|532271932|FG000|Overall Study|Off Treatment on Post-Treatment-Discontinuation Follow-up|3|||
147578187|NCT04408924|532271932|FG000|Overall Study|Lost to Follow-up|3|||
147578188|NCT04408924|532271932|FG000|Overall Study|Withdrawal by Subject|5|||
147578189|NCT04408924|532271932|FG000|Overall Study|Sponsor Decision|2|||
147321275|NCT01254305|531340003|FG000|Overall Study|Withdrawal by Subject|4|||
147321276|NCT01254305|531340004|FG001|Overall Study|Withdrawal by Subject|2|||
147321277|NCT01254305|531340005|FG002|Overall Study|Withdrawal by Subject|4|||
147321278|NCT01254305|531340003|FG000|Overall Study|Lost to Follow-up|10|||
147321279|NCT01254305|531340004|FG001|Overall Study|Lost to Follow-up|6|||
147321280|NCT01254305|531340005|FG002|Overall Study|Lost to Follow-up|5|||
147321281|NCT01254305|531340003|FG000|Overall Study|Other Reasons|0|||
147321282|NCT01254305|531340004|FG001|Overall Study|Other Reasons|0|||
147321283|NCT01254305|531340005|FG002|Overall Study|Other Reasons|2|||
147321284|NCT03019458|531340009|FG000|Overall Study|Death|0|||
147321285|NCT03019458|531340010|FG001|Overall Study|Death|1|||
147321286|NCT00557505|531340011|FG000|Overall Study|Death|0|||
147321287|NCT00557505|531340012|FG001|Overall Study|Death|0|||
147321288|NCT00557505|531340013|FG002|Overall Study|Death|0|||
147321289|NCT00557505|531340014|FG003|Overall Study|Death|0|||
147321290|NCT00557505|531340015|FG004|Overall Study|Death|0|||
147321291|NCT00557505|531340016|FG005|Overall Study|Death|0|||
147321292|NCT00557505|531340017|FG006|Overall Study|Death|0|||
147578190|NCT02998541|532271934|FG000|Overall Study|Adverse Event|4|||
147578191|NCT02998541|532271935|FG001|Overall Study|Adverse Event|5|||
147578192|NCT02998541|532271936|FG002|Overall Study|Adverse Event|1|||
147578193|NCT02998541|532271934|FG000|Overall Study|Protocol Violation|1|||
147578194|NCT02998541|532271935|FG001|Overall Study|Protocol Violation|0|||
147578195|NCT02998541|532271936|FG002|Overall Study|Protocol Violation|0|||
147578196|NCT02998541|532271934|FG000|Overall Study|Withdrawal by Subject|3|||
147578197|NCT02998541|532271935|FG001|Overall Study|Withdrawal by Subject|1|||
147578198|NCT02998541|532271936|FG002|Overall Study|Withdrawal by Subject|0|||
147578199|NCT02998541|532271934|FG000|Overall Study|Lost to Follow-up|0|||
147578200|NCT02998541|532271935|FG001|Overall Study|Lost to Follow-up|3|||
147578201|NCT02998541|532271936|FG002|Overall Study|Lost to Follow-up|1|||
147578202|NCT02998541|532271934|FG000|Overall Study|Physician Decision|0|||
147578203|NCT02998541|532271935|FG001|Overall Study|Physician Decision|0|||
147578204|NCT02998541|532271936|FG002|Overall Study|Physician Decision|3|||
147578205|NCT02998541|532271934|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
147578206|NCT02998541|532271935|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
147578207|NCT02998541|532271936|FG002|Overall Study|Withdrawal by Parent/Guardian|1|||
147578208|NCT01513239|532271942|FG000|Period 1: Main Phase|Adverse Event|1|||
147578209|NCT01513239|532271943|FG001|Period 1: Main Phase|Adverse Event|1|||
147578210|NCT01513239|532271944|FG002|Period 1: Main Phase|Adverse Event|2|||
147578211|NCT01513239|532271945|FG003|Period 1: Main Phase|Adverse Event|0|||
147578212|NCT01513239|532271946|FG004|Period 1: Main Phase|Adverse Event|0|||
147578213|NCT01513239|532271947|FG005|Period 1: Main Phase|Adverse Event|0|||
147578214|NCT01513239|532271942|FG000|Period 1: Main Phase|Death|29|||
147578215|NCT01513239|532271943|FG001|Period 1: Main Phase|Death|22|||
147578216|NCT01513239|532271944|FG002|Period 1: Main Phase|Death|32|||
147578217|NCT01513239|532271945|FG003|Period 1: Main Phase|Death|0|||
147578218|NCT01513239|532271946|FG004|Period 1: Main Phase|Death|0|||
147578219|NCT01513239|532271947|FG005|Period 1: Main Phase|Death|0|||
147578220|NCT01513239|532271942|FG000|Period 1: Main Phase|Lost to Follow-up|11|||
147578221|NCT01513239|532271943|FG001|Period 1: Main Phase|Lost to Follow-up|10|||
147578222|NCT01513239|532271944|FG002|Period 1: Main Phase|Lost to Follow-up|6|||
147578223|NCT01513239|532271945|FG003|Period 1: Main Phase|Lost to Follow-up|0|||
147578224|NCT01513239|532271946|FG004|Period 1: Main Phase|Lost to Follow-up|0|||
147578225|NCT01513239|532271947|FG005|Period 1: Main Phase|Lost to Follow-up|0|||
147578226|NCT01513239|532271942|FG000|Period 1: Main Phase|Physician Decision|4|||
147578227|NCT01513239|532271943|FG001|Period 1: Main Phase|Physician Decision|4|||
147578228|NCT01513239|532271944|FG002|Period 1: Main Phase|Physician Decision|4|||
147578229|NCT01513239|532271945|FG003|Period 1: Main Phase|Physician Decision|0|||
147578230|NCT01513239|532271946|FG004|Period 1: Main Phase|Physician Decision|0|||
147578231|NCT01513239|532271947|FG005|Period 1: Main Phase|Physician Decision|0|||
147578232|NCT01513239|532271942|FG000|Period 1: Main Phase|Protocol Violation|2|||
147578233|NCT01513239|532271943|FG001|Period 1: Main Phase|Protocol Violation|2|||
147578234|NCT01513239|532271944|FG002|Period 1: Main Phase|Protocol Violation|2|||
147578235|NCT01513239|532271945|FG003|Period 1: Main Phase|Protocol Violation|0|||
147578236|NCT01513239|532271946|FG004|Period 1: Main Phase|Protocol Violation|0|||
147578237|NCT01513239|532271947|FG005|Period 1: Main Phase|Protocol Violation|0|||
147578238|NCT01513239|532271942|FG000|Period 1: Main Phase|Technical Problems|1|||
147578239|NCT01513239|532271943|FG001|Period 1: Main Phase|Technical Problems|2|||
147578240|NCT01513239|532271944|FG002|Period 1: Main Phase|Technical Problems|0|||
147578241|NCT01513239|532271945|FG003|Period 1: Main Phase|Technical Problems|0|||
147578242|NCT01513239|532271946|FG004|Period 1: Main Phase|Technical Problems|0|||
147578243|NCT01513239|532271947|FG005|Period 1: Main Phase|Technical Problems|0|||
147578244|NCT01513239|532271942|FG000|Period 1: Main Phase|Withdrawal by Subject|27|||
147578245|NCT01513239|532271943|FG001|Period 1: Main Phase|Withdrawal by Subject|29|||
147578246|NCT01513239|532271944|FG002|Period 1: Main Phase|Withdrawal by Subject|42|||
147578247|NCT01513239|532271945|FG003|Period 1: Main Phase|Withdrawal by Subject|0|||
147578248|NCT01513239|532271946|FG004|Period 1: Main Phase|Withdrawal by Subject|0|||
147578249|NCT01513239|532271947|FG005|Period 1: Main Phase|Withdrawal by Subject|0|||
147578250|NCT01513239|532271942|FG000|Period 2: 9 Month Extension Phase|Withdrawal by Subject|0|||
147578251|NCT01513239|532271943|FG001|Period 2: 9 Month Extension Phase|Withdrawal by Subject|0|||
147578252|NCT01513239|532271944|FG002|Period 2: 9 Month Extension Phase|Withdrawal by Subject|0|||
147578253|NCT01513239|532271945|FG003|Period 2: 9 Month Extension Phase|Withdrawal by Subject|5|||
147578254|NCT01513239|532271946|FG004|Period 2: 9 Month Extension Phase|Withdrawal by Subject|3|||
147578255|NCT01513239|532271947|FG005|Period 2: 9 Month Extension Phase|Withdrawal by Subject|2|||
147578256|NCT01513239|532271942|FG000|Period 2: 9 Month Extension Phase|Death|0|||
147578257|NCT01513239|532271943|FG001|Period 2: 9 Month Extension Phase|Death|0|||
147578258|NCT01513239|532271944|FG002|Period 2: 9 Month Extension Phase|Death|0|||
147578259|NCT01513239|532271945|FG003|Period 2: 9 Month Extension Phase|Death|2|||
147578260|NCT01513239|532271946|FG004|Period 2: 9 Month Extension Phase|Death|5|||
147578261|NCT01513239|532271947|FG005|Period 2: 9 Month Extension Phase|Death|2|||
147578262|NCT01513239|532271942|FG000|Period 2: 9 Month Extension Phase|Lost to Follow-up|0|||
147446198|NCT02716987|531798863|FG002|Overall Study|Withdrawal by Subject|0|||
147446199|NCT02716987|531798864|FG003|Overall Study|Withdrawal by Subject|0|||
147446200|NCT02716987|531798865|FG004|Overall Study|Withdrawal by Subject|1|||
147446201|NCT02716987|531798866|FG005|Overall Study|Withdrawal by Subject|1|||
147578263|NCT01513239|532271943|FG001|Period 2: 9 Month Extension Phase|Lost to Follow-up|0|||
147578264|NCT01513239|532271944|FG002|Period 2: 9 Month Extension Phase|Lost to Follow-up|0|||
147578265|NCT01513239|532271945|FG003|Period 2: 9 Month Extension Phase|Lost to Follow-up|2|||
147578266|NCT01513239|532271946|FG004|Period 2: 9 Month Extension Phase|Lost to Follow-up|1|||
147578267|NCT01513239|532271947|FG005|Period 2: 9 Month Extension Phase|Lost to Follow-up|0|||
147446202|NCT02829138|531798867|FG000|Overall Study|Withdrawal by Subject|1|||
147578268|NCT01513239|532271942|FG000|Period 2: 9 Month Extension Phase|Physician Decision|0|||
147578269|NCT01513239|532271943|FG001|Period 2: 9 Month Extension Phase|Physician Decision|0|||
147578270|NCT01513239|532271944|FG002|Period 2: 9 Month Extension Phase|Physician Decision|0|||
147578271|NCT01513239|532271945|FG003|Period 2: 9 Month Extension Phase|Physician Decision|1|||
147578272|NCT01513239|532271946|FG004|Period 2: 9 Month Extension Phase|Physician Decision|0|||
147578273|NCT01513239|532271947|FG005|Period 2: 9 Month Extension Phase|Physician Decision|0|||
147578274|NCT01513239|532271942|FG000|Period 2: 9 Month Extension Phase|Technical Problems|0|||
147578275|NCT01513239|532271943|FG001|Period 2: 9 Month Extension Phase|Technical Problems|0|||
147578276|NCT01513239|532271944|FG002|Period 2: 9 Month Extension Phase|Technical Problems|0|||
147578277|NCT01513239|532271945|FG003|Period 2: 9 Month Extension Phase|Technical Problems|0|||
147578278|NCT01513239|532271946|FG004|Period 2: 9 Month Extension Phase|Technical Problems|1|||
147578279|NCT01513239|532271947|FG005|Period 2: 9 Month Extension Phase|Technical Problems|1|||
147578280|NCT00396162|532271948|FG000|Overall Study|Withdrawal by Subject|2|||
147578281|NCT00396162|532271949|FG001|Overall Study|Withdrawal by Subject|3|||
147578282|NCT01741545|532271950|FG000|Treatment Period|Lack of Efficacy|0|||
147578283|NCT01741545|532271951|FG001|Treatment Period|Lack of Efficacy|1|||
147578284|NCT01741545|532271950|FG000|Treatment Period|Adverse event, non-fatal|1|||
147578285|NCT01741545|532271951|FG001|Treatment Period|Adverse event, non-fatal|3|||
147578286|NCT01741545|532271950|FG000|Follow-up Period (24 Weeks)|Other than specified|0|||
147578287|NCT01741545|532271951|FG001|Follow-up Period (24 Weeks)|Other than specified|1|||
147578288|NCT01741545|532271950|FG000|Follow-up Period (24 Weeks)|Withdrawal by Subject|1|||
147578289|NCT01741545|532271951|FG001|Follow-up Period (24 Weeks)|Withdrawal by Subject|1|||
147578290|NCT01456962|532271952|FG000|Overall Study|Lost to Follow-up|2|||
147578291|NCT01456962|532271953|FG001|Overall Study|Lost to Follow-up|1|||
147578292|NCT03358147|532271956|FG000|Overall Study|Withdrawal by Subject|13|||
147578293|NCT03358147|532271957|FG001|Overall Study|Withdrawal by Subject|19|||
147578294|NCT03358147|532271958|FG002|Overall Study|Withdrawal by Subject|16|||
147578295|NCT03358147|532271959|FG003|Overall Study|Withdrawal by Subject|10|||
147578296|NCT03358147|532271960|FG004|Overall Study|Withdrawal by Subject|5|||
147578297|NCT03358147|532271956|FG000|Overall Study|Adverse Event|3|||
147578298|NCT03358147|532271957|FG001|Overall Study|Adverse Event|9|||
147578299|NCT03358147|532271958|FG002|Overall Study|Adverse Event|7|||
147578300|NCT03358147|532271959|FG003|Overall Study|Adverse Event|5|||
147578301|NCT03358147|532271960|FG004|Overall Study|Adverse Event|2|||
147578302|NCT03358147|532271956|FG000|Overall Study|Lost to Follow-up|4|||
147578303|NCT03358147|532271957|FG001|Overall Study|Lost to Follow-up|3|||
147578304|NCT03358147|532271958|FG002|Overall Study|Lost to Follow-up|7|||
147578305|NCT03358147|532271959|FG003|Overall Study|Lost to Follow-up|6|||
147578306|NCT03358147|532271960|FG004|Overall Study|Lost to Follow-up|4|||
147578307|NCT03358147|532271956|FG000|Overall Study|Major Protocol Deviation|11|||
147578308|NCT03358147|532271957|FG001|Overall Study|Major Protocol Deviation|3|||
147578309|NCT03358147|532271958|FG002|Overall Study|Major Protocol Deviation|2|||
147578310|NCT03358147|532271959|FG003|Overall Study|Major Protocol Deviation|3|||
147578311|NCT03358147|532271960|FG004|Overall Study|Major Protocol Deviation|1|||
147578312|NCT03358147|532271956|FG000|Overall Study|Protocol specified criteria|2|||
147578313|NCT03358147|532271957|FG001|Overall Study|Protocol specified criteria|3|||
147578314|NCT03358147|532271958|FG002|Overall Study|Protocol specified criteria|0|||
147578315|NCT03358147|532271959|FG003|Overall Study|Protocol specified criteria|3|||
147578316|NCT03358147|532271960|FG004|Overall Study|Protocol specified criteria|1|||
147578317|NCT03358147|532271956|FG000|Overall Study|Physician Decision|1|||
147578318|NCT03358147|532271957|FG001|Overall Study|Physician Decision|0|||
147578319|NCT03358147|532271958|FG002|Overall Study|Physician Decision|1|||
147578320|NCT03358147|532271959|FG003|Overall Study|Physician Decision|6|||
147578321|NCT03358147|532271960|FG004|Overall Study|Physician Decision|1|||
147578322|NCT03358147|532271956|FG000|Overall Study|Administrative reasons|0|||
147578323|NCT03358147|532271957|FG001|Overall Study|Administrative reasons|1|||
147578324|NCT03358147|532271958|FG002|Overall Study|Administrative reasons|0|||
147578325|NCT03358147|532271959|FG003|Overall Study|Administrative reasons|3|||
147578326|NCT03358147|532271960|FG004|Overall Study|Administrative reasons|0|||
147578327|NCT03358147|532271956|FG000|Overall Study|Lack of Efficacy|0|||
147578328|NCT03358147|532271957|FG001|Overall Study|Lack of Efficacy|1|||
147321293|NCT00557505|531340018|FG007|Overall Study|Death|0|||
147321294|NCT00557505|531340019|FG008|Overall Study|Death|1|||
147321295|NCT00557505|531340011|FG000|Overall Study|Adverse Event|0|||
147152143|NCT04826094|530719051|FG003|Overall Study|Withdrawn by Investigator|0|||
147152144|NCT04826094|530719052|FG004|Overall Study|Withdrawn by Investigator|0|||
147152145|NCT04826094|530719053|FG005|Overall Study|Withdrawn by Investigator|1|||
147321296|NCT00557505|531340012|FG001|Overall Study|Adverse Event|0|||
147578329|NCT03358147|532271958|FG002|Overall Study|Lack of Efficacy|1|||
147578330|NCT03358147|532271959|FG003|Overall Study|Lack of Efficacy|0|||
147578331|NCT03358147|532271960|FG004|Overall Study|Lack of Efficacy|0|||
147578332|NCT02933060|532271961|FG000|Overall Study|Withdrawal by Subject|0|||
147578333|NCT02933060|532271962|FG001|Overall Study|Withdrawal by Subject|1|||
147578334|NCT01945580|532271963|FG000|Overall Study|Withdrawal by Subject|13|||
147152146|NCT04826094|530719054|FG006|Overall Study|Withdrawn by Investigator|0|||
147578335|NCT01945580|532271964|FG001|Overall Study|Withdrawal by Subject|35|||
147578336|NCT01945580|532271963|FG000|Overall Study|Physician Decision|3|||
147578337|NCT01945580|532271964|FG001|Overall Study|Physician Decision|2|||
147578338|NCT01945580|532271963|FG000|Overall Study|Lost to Follow-up|26|||
147578339|NCT01945580|532271964|FG001|Overall Study|Lost to Follow-up|39|||
147578340|NCT01945580|532271963|FG000|Overall Study|Death|7|||
147578341|NCT01945580|532271964|FG001|Overall Study|Death|2|||
147578342|NCT01945580|532271963|FG000|Overall Study|Patient moved out of state|0|||
147578343|NCT01945580|532271964|FG001|Overall Study|Patient moved out of state|1|||
147578344|NCT01945580|532271963|FG000|Overall Study|Moved out of state and firmly desired to withdraw. AE still not recovered and not resolved.|1|||
147578345|NCT01945580|532271964|FG001|Overall Study|Moved out of state and firmly desired to withdraw. AE still not recovered and not resolved.|0|||
147578346|NCT01945580|532271963|FG000|Overall Study|Family illness - unable to return|0|||
147578347|NCT01945580|532271964|FG001|Overall Study|Family illness - unable to return|1|||
147578348|NCT01945580|532271963|FG000|Overall Study|Weather emergency at time visit due; per sponsor completed study due to being too far out of window|0|||
147578349|NCT01945580|532271964|FG001|Overall Study|Weather emergency at time visit due; per sponsor completed study due to being too far out of window|1|||
147578350|NCT01945580|532271963|FG000|Overall Study|Death in family, then rescheduled but considered too far out of window to bring back|0|||
147578351|NCT01945580|532271964|FG001|Overall Study|Death in family, then rescheduled but considered too far out of window to bring back|1|||
147578352|NCT01945580|532271963|FG000|Overall Study|Noncompliance with 36 month visit|1|||
147578353|NCT01945580|532271964|FG001|Overall Study|Noncompliance with 36 month visit|0|||
147578354|NCT01945580|532271963|FG000|Overall Study|The patient moved.|1|||
147578355|NCT01945580|532271964|FG001|Overall Study|The patient moved.|0|||
147578356|NCT01945580|532271963|FG000|Overall Study|No data available|0|||
147578357|NCT01945580|532271964|FG001|Overall Study|No data available|2|||
147578358|NCT05034874|532271967|FG000|Overall Study|Withdrawal by Subject|6|||
147578359|NCT05034874|532271968|FG001|Overall Study|Withdrawal by Subject|6|||
147578360|NCT05034874|532271967|FG000|Overall Study|Lost to Follow-up|18|||
147578361|NCT05034874|532271968|FG001|Overall Study|Lost to Follow-up|8|||
147578362|NCT05034874|532271967|FG000|Overall Study|Physician Decision|0|||
147578363|NCT05034874|532271968|FG001|Overall Study|Physician Decision|1|||
147578364|NCT05034874|532271967|FG000|Overall Study|Skipped final visits, checked into rehab|2|||
147578365|NCT05034874|532271968|FG001|Overall Study|Skipped final visits, checked into rehab|1|||
147578366|NCT00474058|532271969|FG000|Overall Study|Adverse Event|11|||
147578367|NCT00474058|532271970|FG001|Overall Study|Adverse Event|6|||
147578368|NCT00474058|532271969|FG000|Overall Study|Lack of Efficacy|0|||
147578369|NCT00474058|532271970|FG001|Overall Study|Lack of Efficacy|4|||
147578370|NCT00474058|532271969|FG000|Overall Study|Withdrawal by Subject|11|||
147578371|NCT00474058|532271970|FG001|Overall Study|Withdrawal by Subject|7|||
147578372|NCT00474058|532271969|FG000|Overall Study|Other|2|||
147578373|NCT00474058|532271970|FG001|Overall Study|Other|0|||
147578374|NCT02640235|532271971|FG000|Overall Study|Withdrawal by Subject|7|||
147578375|NCT02640235|532271972|FG001|Overall Study|Withdrawal by Subject|6|||
147578376|NCT02640235|532271971|FG000|Overall Study|Lost to Follow-up|4|||
147578377|NCT02640235|532271972|FG001|Overall Study|Lost to Follow-up|3|||
147578378|NCT02640235|532271971|FG000|Overall Study|Death|2|||
147578379|NCT02640235|532271972|FG001|Overall Study|Death|3|||
147578380|NCT02640235|532271971|FG000|Overall Study|Other|1|||
147578381|NCT02640235|532271972|FG001|Overall Study|Other|2|||
147578382|NCT00503867|532271975|FG000|Overall Study|Lost to Follow-up|1|||
147578383|NCT00503867|532271975|FG000|Overall Study|Adverse Event|1|||
147578384|NCT05616728|532271976|FG000|Overall Study|Lost to Follow-up|0|||
147578385|NCT05616728|532271977|FG001|Overall Study|Lost to Follow-up|0|||
147578386|NCT05616728|532271978|FG002|Overall Study|Lost to Follow-up|1|||
147578387|NCT05616728|532271976|FG000|Overall Study|Withdrawal by Subject|1|||
147578388|NCT05616728|532271977|FG001|Overall Study|Withdrawal by Subject|1|||
147578389|NCT05616728|532271978|FG002|Overall Study|Withdrawal by Subject|0|||
147578390|NCT05616728|532271976|FG000|Overall Study|Physician Decision|1|||
147578391|NCT05616728|532271977|FG001|Overall Study|Physician Decision|1|||
147152147|NCT04826094|530719055|FG007|Overall Study|Withdrawn by Investigator|1|||
147152148|NCT04826094|530719048|FG000|Overall Study|Other: Moved from area|1|||
147578392|NCT05616728|532271978|FG002|Overall Study|Physician Decision|1|||
147578393|NCT05616728|532271976|FG000|Overall Study|Other|0|||
147578394|NCT05616728|532271977|FG001|Overall Study|Other|2|||
147578395|NCT05616728|532271978|FG002|Overall Study|Other|0|||
147578396|NCT00577655|532271979|FG000|Overall Study|Patient Request|0|||
147578397|NCT00577655|532271980|FG001|Overall Study|Patient Request|2|||
147578398|NCT00577655|532271979|FG000|Overall Study|Protocol Violation|0|||
147578399|NCT00577655|532271980|FG001|Overall Study|Protocol Violation|1|||
147578400|NCT00577655|532271979|FG000|Overall Study|Lost to Follow-up|1|||
147578401|NCT00577655|532271980|FG001|Overall Study|Lost to Follow-up|1|||
147578402|NCT00875524|532271982|FG000|Overall Study|Serious adverse event|0|||
147578403|NCT00875524|532271983|FG001|Overall Study|Serious adverse event|1|||
147578404|NCT00875524|532271982|FG000|Overall Study|Protocol Violation|4|||
147578405|NCT00875524|532271983|FG001|Overall Study|Protocol Violation|0|||
147578406|NCT00875524|532271982|FG000|Overall Study|Lost to Follow-up|1|||
147321297|NCT00557505|531340013|FG002|Overall Study|Adverse Event|1|||
147578407|NCT00875524|532271983|FG001|Overall Study|Lost to Follow-up|0|||
147578408|NCT00875524|532271982|FG000|Overall Study|Withdrawal by Subject|3|||
147578409|NCT00875524|532271983|FG001|Overall Study|Withdrawal by Subject|5|||
147578410|NCT01370863|532271987|FG000|Overall Study|Adverse Event|1|||
147578411|NCT01370863|532271988|FG001|Overall Study|Adverse Event|1|||
147578412|NCT01370863|532271987|FG000|Overall Study|Did not want second pH/MII monitoring|1|||
147578413|NCT01370863|532271988|FG001|Overall Study|Did not want second pH/MII monitoring|1|||
147578414|NCT01370863|532271987|FG000|Overall Study|Not meeting inclusion/exclusion criteria|0|||
147578415|NCT01370863|532271988|FG001|Overall Study|Not meeting inclusion/exclusion criteria|1|||
147578416|NCT02096705|532271991|FG000|Treatment|Adverse Event|6|||
147578417|NCT02096705|532271992|FG001|Treatment|Adverse Event|3|||
147578418|NCT02096705|532271991|FG000|Treatment|Subject request to discontinue treatment|1|||
147578419|NCT02096705|532271992|FG001|Treatment|Subject request to discontinue treatment|1|||
147578420|NCT02096705|532271991|FG000|Treatment|Withdrawal by Subject|1|||
147578421|NCT02096705|532271992|FG001|Treatment|Withdrawal by Subject|0|||
147578422|NCT02096705|532271991|FG000|Treatment|Other|1|||
147578423|NCT02096705|532271992|FG001|Treatment|Other|1|||
147578424|NCT02096705|532271991|FG000|Follow-up|Withdrawal by Subject|1|||
147578425|NCT02096705|532271992|FG001|Follow-up|Withdrawal by Subject|0|||
147578426|NCT02096705|532271991|FG000|Follow-up|Adverse Event|2|||
147578427|NCT02096705|532271992|FG001|Follow-up|Adverse Event|2|||
147578428|NCT02096705|532271991|FG000|Follow-up|Subjects not reporting status|1|||
147578429|NCT02096705|532271992|FG001|Follow-up|Subjects not reporting status|2|||
147578430|NCT02377349|532271993|FG000|Overall Study|Serious Adverse Event|1|||
147578431|NCT02377349|532271994|FG001|Overall Study|Serious Adverse Event|0|||
147578432|NCT02377349|532271993|FG000|Overall Study|Protocol Violation|3|||
147578433|NCT02377349|532271994|FG001|Overall Study|Protocol Violation|2|||
147578434|NCT02377349|532271993|FG000|Overall Study|Withdrawal by Subject|5|||
147578435|NCT02377349|532271994|FG001|Overall Study|Withdrawal by Subject|3|||
147578436|NCT02377349|532271993|FG000|Overall Study|Lost to follow-up (partial vaccination)|1|||
147578437|NCT02377349|532271994|FG001|Overall Study|Lost to follow-up (partial vaccination)|0|||
147578438|NCT02377349|532271993|FG000|Overall Study|Lost to follow-up (complete vaccination)|6|||
147578439|NCT02377349|532271994|FG001|Overall Study|Lost to follow-up (complete vaccination)|5|||
147578440|NCT02377349|532271993|FG000|Overall Study|Other|0|||
147578441|NCT02377349|532271994|FG001|Overall Study|Other|1|||
147578442|NCT03277248|532271997|FG000|Overall Study|Adverse Event|3|||
147578443|NCT03277248|532271998|FG001|Overall Study|Adverse Event|1|||
147578444|NCT03277248|532271997|FG000|Overall Study|Subject Withdrawal of Consent|6|||
147578445|NCT03277248|532271998|FG001|Overall Study|Subject Withdrawal of Consent|23|||
147578446|NCT03277248|532271997|FG000|Overall Study|Investigator/Sponsor Decision|2|||
147578447|NCT03277248|532271998|FG001|Overall Study|Investigator/Sponsor Decision|2|||
147578448|NCT03277248|532271997|FG000|Overall Study|Pregnancy|4|||
147578449|NCT03277248|532271998|FG001|Overall Study|Pregnancy|1|||
147578450|NCT03277248|532271997|FG000|Overall Study|Lost to Follow-up|0|||
147578451|NCT03277248|532271998|FG001|Overall Study|Lost to Follow-up|2|||
147321298|NCT00557505|531340014|FG003|Overall Study|Adverse Event|0|||
147321299|NCT00557505|531340015|FG004|Overall Study|Adverse Event|0|||
147321300|NCT00557505|531340016|FG005|Overall Study|Adverse Event|0|||
147321301|NCT00557505|531340017|FG006|Overall Study|Adverse Event|1|||
147321302|NCT00557505|531340018|FG007|Overall Study|Adverse Event|0|||
147321303|NCT00557505|531340019|FG008|Overall Study|Adverse Event|0|||
147321304|NCT00557505|531340011|FG000|Overall Study|Global deterioration of health|1|||
147321305|NCT00557505|531340012|FG001|Overall Study|Global deterioration of health|0|||
147321306|NCT00557505|531340013|FG002|Overall Study|Global deterioration of health|0|||
147321307|NCT00557505|531340014|FG003|Overall Study|Global deterioration of health|0|||
147321308|NCT00557505|531340015|FG004|Overall Study|Global deterioration of health|0|||
147321309|NCT00557505|531340016|FG005|Overall Study|Global deterioration of health|0|||
147321310|NCT00557505|531340017|FG006|Overall Study|Global deterioration of health|0|||
147321311|NCT00557505|531340018|FG007|Overall Study|Global deterioration of health|0|||
147321312|NCT00557505|531340019|FG008|Overall Study|Global deterioration of health|0|||
147321313|NCT00557505|531340011|FG000|Overall Study|Objective progression or relapse|2|||
147321314|NCT00557505|531340012|FG001|Overall Study|Objective progression or relapse|3|||
147578452|NCT03277248|532271997|FG000|Overall Study|Lack of Efficacy|0|||
147578453|NCT03277248|532271998|FG001|Overall Study|Lack of Efficacy|2|||
147321315|NCT00557505|531340013|FG002|Overall Study|Objective progression or relapse|3|||
147321316|NCT00557505|531340014|FG003|Overall Study|Objective progression or relapse|2|||
147578454|NCT03277248|532271997|FG000|Overall Study|Other-Alternative Treatment//COVID-19 related/Unspecified Reasons|3|||
147578455|NCT03277248|532271998|FG001|Overall Study|Other-Alternative Treatment//COVID-19 related/Unspecified Reasons|3|||
147578456|NCT05412121|532272007|FG000|Overall Study|Withdrawal by Subject|4|||
147578457|NCT05412121|532272007|FG000|Overall Study|Physician Decision|1|||
147578458|NCT05412121|532272007|FG000|Overall Study|Lost to Follow-up|5|||
147578459|NCT01971645|532272008|FG000|Overall Study|Adverse Event|1|||
147578460|NCT01971645|532272009|FG001|Overall Study|Adverse Event|0|||
147578461|NCT01971645|532272010|FG002|Overall Study|Adverse Event|0|||
147578462|NCT01971645|532272008|FG000|Overall Study|Lost to Follow-up|1|||
147446203|NCT02829138|531798868|FG001|Overall Study|Withdrawal by Subject|0|||
147446204|NCT01765920|531798869|FG000|Overall Study|Incorrect inclusion ineligible patient|2|||
147446205|NCT01765920|531798870|FG001|Overall Study|Incorrect inclusion ineligible patient|5|||
147446206|NCT01765920|531798869|FG000|Overall Study|Patient code disclosure|0|||
147446207|NCT01765920|531798870|FG001|Overall Study|Patient code disclosure|1|||
147446208|NCT01081249|531798871|FG000|Overall Study|Diagnosed with Bipolar Disorder|0|||
147446209|NCT01081249|531798872|FG001|Overall Study|Diagnosed with Bipolar Disorder|1|||
147446210|NCT02025907|531798873|FG000|Overall Study|Lack of Efficacy|1|||
147578463|NCT01971645|532272009|FG001|Overall Study|Lost to Follow-up|0|||
147578464|NCT01971645|532272010|FG002|Overall Study|Lost to Follow-up|1|||
147578465|NCT01971645|532272008|FG000|Overall Study|Protocol Violation|0|||
147578466|NCT01971645|532272009|FG001|Overall Study|Protocol Violation|0|||
147578467|NCT01971645|532272010|FG002|Overall Study|Protocol Violation|1|||
147578468|NCT02119936|532272011|FG000|Overall Study|Lost to Follow-up|10|||
147578469|NCT01566435|532272014|FG000|ACF Definitive Chemoradiation-cisplatin|Withdrawal by Subject|1|||
147578470|NCT04236596|532272015|FG000|Overall Study|Withdrawal by Subject|1|||
147578471|NCT04236596|532272015|FG000|Overall Study|Participants did not retain implant for entire trial|3|||
147578472|NCT04236596|532272015|FG000|Overall Study|Participants did not receive implant at all|4|||
147578473|NCT02957331|532272016|FG000|Overall Study|Protocol Violation|1|||
147578474|NCT02957331|532272017|FG001|Overall Study|Protocol Violation|0|||
147578475|NCT02588339|532272018|FG000|Overall Study|Withdrawal by Subject|1|||
147578476|NCT02588339|532272018|FG000|Overall Study|GVHD Progression prior to treatment|2|||
147578477|NCT01120899|532273521|FG000|Overall Study|Withdrawal by Subject|3|||
147578478|NCT02664415|532273522|FG000|Overall Study|Adverse Event|1|||
147578479|NCT02664415|532273523|FG001|Overall Study|Adverse Event|0|||
147578480|NCT01151280|532273524|FG000|Overall Study|Adverse Event|1|||
147578481|NCT01151280|532273524|FG000|Overall Study|Lack of Efficacy|3|||
147578482|NCT00660660|532273525|FG000|Overall Study|Adverse Event|1|||
147578483|NCT00660660|532273526|FG001|Overall Study|Adverse Event|0|||
147578484|NCT00660660|532273525|FG000|Overall Study|Lost to Follow-up|0|||
147578485|NCT00660660|532273526|FG001|Overall Study|Lost to Follow-up|6|||
147578486|NCT00660660|532273525|FG000|Overall Study|Lack of Efficacy|0|||
147578487|NCT00660660|532273526|FG001|Overall Study|Lack of Efficacy|2|||
147578488|NCT00660660|532273525|FG000|Overall Study|Withdrawal by Subject|3|||
147578489|NCT00660660|532273526|FG001|Overall Study|Withdrawal by Subject|0|||
147578490|NCT00660660|532273525|FG000|Overall Study|Incorrect enrollment and other|0|||
147578491|NCT00660660|532273526|FG001|Overall Study|Incorrect enrollment and other|1|||
147578492|NCT00660660|532273525|FG000|Overall Study|New medication after randomization|1|||
147578493|NCT00660660|532273526|FG001|Overall Study|New medication after randomization|0|||
147578494|NCT02308241|532273527|FG000|Overall Study|Withdrawal by Subject|3|||
147578495|NCT00486434|532273528|FG000|Overall Study|Withdrawal by Subject|34|||
147578496|NCT00486434|532273529|FG001|Overall Study|Withdrawal by Subject|39|||
147578497|NCT00486434|532273528|FG000|Overall Study|Adverse Event|118|||
147578498|NCT00486434|532273529|FG001|Overall Study|Adverse Event|44|||
147578499|NCT00486434|532273528|FG000|Overall Study|Protocol Violation|22|||
147578500|NCT00486434|532273529|FG001|Overall Study|Protocol Violation|21|||
147578501|NCT00486434|532273528|FG000|Overall Study|Lack of Efficacy|12|||
147578502|NCT00486434|532273529|FG001|Overall Study|Lack of Efficacy|19|||
147578503|NCT00486434|532273528|FG000|Overall Study|Lost to Follow-up|2|||
147578504|NCT00486434|532273529|FG001|Overall Study|Lost to Follow-up|3|||
147578505|NCT00486434|532273528|FG000|Overall Study|Death|1|||
147653180|NCT01289574|532551965|FG000|Overall Study|Subject wanted alternate treatment|0|||
147653181|NCT01289574|532551966|FG001|Overall Study|Subject wanted alternate treatment|1|||
147653182|NCT01289574|532551967|FG002|Overall Study|Subject wanted alternate treatment|0|||
147653183|NCT03885999|532551970|FG000|Overall Study|Adverse Event|1|||
147321317|NCT00557505|531340015|FG004|Overall Study|Objective progression or relapse|2|||
147321318|NCT00557505|531340016|FG005|Overall Study|Objective progression or relapse|3|||
147321319|NCT00557505|531340017|FG006|Overall Study|Objective progression or relapse|2|||
147321320|NCT00557505|531340018|FG007|Overall Study|Objective progression or relapse|5|||
147321321|NCT00557505|531340019|FG008|Overall Study|Objective progression or relapse|15|||
147321322|NCT00557505|531340011|FG000|Overall Study|Withdrawal by Subject|0|||
147321323|NCT00557505|531340012|FG001|Overall Study|Withdrawal by Subject|0|||
147321324|NCT00557505|531340013|FG002|Overall Study|Withdrawal by Subject|0|||
147321325|NCT00557505|531340014|FG003|Overall Study|Withdrawal by Subject|1|||
147578506|NCT00486434|532273529|FG001|Overall Study|Death|2|||
147578507|NCT00486434|532273528|FG000|Overall Study|Personal reasons|5|||
147578508|NCT00486434|532273529|FG001|Overall Study|Personal reasons|6|||
147578509|NCT02218541|532273530|FG000|Overall Study|Lost to Follow-up|2|||
147578510|NCT02218541|532273531|FG001|Overall Study|Lost to Follow-up|1|||
147578511|NCT02218541|532273530|FG000|Overall Study|Implant Failure|4|||
147578512|NCT02218541|532273531|FG001|Overall Study|Implant Failure|1|||
147578513|NCT00856349|532273532|FG000|Overall Study|Death|418|||
147578514|NCT00856349|532273532|FG000|Overall Study|Withdrawal by Subject|116|||
147653184|NCT02452554|532551971|FG000|Overall Study|Death|2|||
147321326|NCT00557505|531340015|FG004|Overall Study|Withdrawal by Subject|0|||
147321327|NCT00557505|531340016|FG005|Overall Study|Withdrawal by Subject|0|||
147578515|NCT00856349|532273532|FG000|Overall Study|Lost to Follow-up|91|||
147578516|NCT00856349|532273532|FG000|Overall Study|Protocol Violation|38|||
147578517|NCT00856349|532273532|FG000|Overall Study|Physician Decision|13|||
147578518|NCT00856349|532273532|FG000|Overall Study|Subject relocation|104|||
147578519|NCT00856349|532273532|FG000|Overall Study|Device explant|33|||
147578520|NCT00856349|532273532|FG000|Overall Study|Site closure|78|||
147578521|NCT00856349|532273532|FG000|Overall Study|Subject changed Dr, insurance issue, etc|130|||
147578522|NCT02725515|532273533|FG000|Overall Study|Refused infusion (no study treatment)|1|||
147578523|NCT02725515|532273534|FG001|Overall Study|Refused infusion (no study treatment)|0|||
147578524|NCT02725515|532273533|FG000|Overall Study|Loss of Improvement per Protocol|14|||
147578525|NCT02725515|532273534|FG001|Overall Study|Loss of Improvement per Protocol|25|||
147578526|NCT02725515|532273533|FG000|Overall Study|Withdrawal by Subject|2|||
147578527|NCT02725515|532273534|FG001|Overall Study|Withdrawal by Subject|1|||
147578528|NCT02725515|532273533|FG000|Overall Study|Non-Compliance With Study Drug|0|||
147578529|NCT02725515|532273534|FG001|Overall Study|Non-Compliance With Study Drug|3|||
147578530|NCT02725515|532273533|FG000|Overall Study|Lost to Follow-up|1|||
147578531|NCT02725515|532273534|FG001|Overall Study|Lost to Follow-up|1|||
147578532|NCT02725515|532273533|FG000|Overall Study|Adverse Event|7|||
147578533|NCT02725515|532273534|FG001|Overall Study|Adverse Event|2|||
147578534|NCT02725515|532273533|FG000|Overall Study|No Documented Disease Improvement|0|||
147578535|NCT02725515|532273534|FG001|Overall Study|No Documented Disease Improvement|1|||
147578536|NCT02725515|532273533|FG000|Overall Study|Completed Study Under Original Protocol|0|||
147578537|NCT02725515|532273534|FG001|Overall Study|Completed Study Under Original Protocol|1|||
147578538|NCT02725515|532273533|FG000|Overall Study|Lack of Response|0|||
147578539|NCT02725515|532273534|FG001|Overall Study|Lack of Response|1|||
147578540|NCT00183196|532273544|FG000|Overall Study|Withdrawal by Subject|18|||
147578541|NCT00183196|532273545|FG001|Overall Study|Withdrawal by Subject|11|||
147578542|NCT00183196|532273546|FG002|Overall Study|Withdrawal by Subject|13|||
147578543|NCT00183196|532273544|FG000|Overall Study|Adverse Event|1|||
147578544|NCT00183196|532273545|FG001|Overall Study|Adverse Event|2|||
147578545|NCT00183196|532273546|FG002|Overall Study|Adverse Event|2|||
147578546|NCT00183196|532273544|FG000|Overall Study|Legal event|1|||
147578547|NCT00183196|532273545|FG001|Overall Study|Legal event|1|||
147578548|NCT00183196|532273546|FG002|Overall Study|Legal event|1|||
147578549|NCT00183196|532273544|FG000|Overall Study|Required more intensive care|0|||
147578550|NCT00183196|532273545|FG001|Overall Study|Required more intensive care|1|||
147578551|NCT00183196|532273546|FG002|Overall Study|Required more intensive care|2|||
147578552|NCT03387462|532273547|FG000|Overall Study|Lost to Follow-up|1|||
147578553|NCT01460628|532273548|FG000|Overall Study|Adverse Event|3|||
147578554|NCT01460628|532273548|FG000|Overall Study|Withdrawal by Subject|2|||
147578555|NCT01664039|532273552|FG000|Overall Study|Adverse Event|3|||
147578556|NCT01664039|532273553|FG001|Overall Study|Adverse Event|4|||
147578557|NCT01664039|532273552|FG000|Overall Study|Lost to Follow-up|1|||
147578558|NCT01664039|532273553|FG001|Overall Study|Lost to Follow-up|1|||
147578559|NCT01664039|532273552|FG000|Overall Study|Withdrawal by Subject|1|||
147578560|NCT01664039|532273553|FG001|Overall Study|Withdrawal by Subject|3|||
147578561|NCT01664039|532273552|FG000|Overall Study|Noncompliance|1|||
147578562|NCT01664039|532273553|FG001|Overall Study|Noncompliance|1|||
147578563|NCT01853176|532273556|FG000|Overall Study|Study terminated|4|||
147578564|NCT01853176|532273557|FG001|Overall Study|Study terminated|0|||
147578565|NCT01944722|532273558|FG000|Overall Study|Didn't meet Inclusion/Exclusion Criteria|171|||
147578566|NCT01944722|532273558|FG000|Overall Study|Specimen Shipping Issues|34|||
147239693|NCT01090492|531049255|FG000|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
147239694|NCT01090492|531049256|FG001|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
147239695|NCT01090492|531049257|FG002|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
147239696|NCT01090492|531049258|FG003|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
147578567|NCT01944722|532273558|FG000|Overall Study|Improper Storage/Transport|5|||
147578568|NCT01944722|532273558|FG000|Overall Study|Insufficient Volume for Test|1|||
147578569|NCT01944722|532273558|FG000|Overall Study|Missing Specimens|3|||
147578570|NCT01944722|532273558|FG000|Overall Study|Specimens Mislabeled|2|||
147578571|NCT01944722|532273558|FG000|Overall Study|Withdrawal by Subject|8|||
147578572|NCT01944722|532273558|FG000|Overall Study|NILM Subjects <30 years old|8106|||
147578573|NCT01944722|532273558|FG000|Overall Study|Unsatisfactory Cytology Result|63|||
147578574|NCT01944722|532273558|FG000|Overall Study|>ASCUS Cytology|1122|||
147578575|NCT02906917|532273562|FG000|Initiation Period (Week 0-26)|Unclassified|1|||
147578576|NCT02906917|532273563|FG001|Initiation Period (Week 0-26)|Unclassified|3|||
147578577|NCT02906917|532273562|FG000|Initiation Period (Week 0-26)|Adverse Event|1|||
147578578|NCT02906917|532273563|FG001|Initiation Period (Week 0-26)|Adverse Event|0|||
147578579|NCT02906917|532273562|FG000|Initiation Period (Week 0-26)|Lost to Follow-up|1|||
147578580|NCT02906917|532273563|FG001|Initiation Period (Week 0-26)|Lost to Follow-up|4|||
147578581|NCT02906917|532273562|FG000|Initiation Period (Week 0-26)|Withdrawal by Subject|3|||
147578582|NCT02906917|532273563|FG001|Initiation Period (Week 0-26)|Withdrawal by Subject|4|||
147578583|NCT02906917|532273562|FG000|Intensification Period (Week 26-38)|Unclassified|3|||
147239697|NCT01090492|531049259|FG004|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
147446211|NCT02025907|531798874|FG001|Overall Study|Lack of Efficacy|0|||
147446212|NCT02025907|531798873|FG000|Overall Study|Withdrawal by Subject|15|||
147446213|NCT02025907|531798874|FG001|Overall Study|Withdrawal by Subject|8|||
147446214|NCT02025907|531798873|FG000|Overall Study|Protocol Violation|2|||
147446215|NCT02025907|531798874|FG001|Overall Study|Protocol Violation|0|||
147446216|NCT02025907|531798873|FG000|Overall Study|Physician Decision|2|||
147446217|NCT02025907|531798874|FG001|Overall Study|Physician Decision|0|||
147446218|NCT02025907|531798873|FG000|Overall Study|Lost to Follow-up|2|||
147446219|NCT02025907|531798874|FG001|Overall Study|Lost to Follow-up|2|||
147446220|NCT02025907|531798873|FG000|Overall Study|Adverse Event|3|||
147446221|NCT02025907|531798874|FG001|Overall Study|Adverse Event|1|||
147446222|NCT02025907|531798873|FG000|Overall Study|Potential misconduct,GCPcompliance issue|2|||
147446223|NCT02025907|531798874|FG001|Overall Study|Potential misconduct,GCPcompliance issue|1|||
147446224|NCT02411539|531798878|FG000|Overall Study|Lost to Follow-up|2|||
147446225|NCT02411539|531798879|FG001|Overall Study|Lost to Follow-up|0|||
147446226|NCT02411539|531798878|FG000|Overall Study|Confounding medical condition|0|||
147446227|NCT02411539|531798879|FG001|Overall Study|Confounding medical condition|1|||
147446228|NCT03631732|531798889|FG000|Randomized Phase Up to Week 24|Lost to Follow-up|3|||
147446229|NCT03631732|531798890|FG001|Randomized Phase Up to Week 24|Lost to Follow-up|0|||
147446230|NCT03631732|531798889|FG000|Randomized Phase Up to Week 24|Withdrew Consent|1|||
147446231|NCT03631732|531798890|FG001|Randomized Phase Up to Week 24|Withdrew Consent|2|||
147446232|NCT03631732|531798889|FG000|Randomized Phase Up to Week 24|Adverse Event|2|||
147446233|NCT03631732|531798890|FG001|Randomized Phase Up to Week 24|Adverse Event|0|||
147446234|NCT03631732|531798889|FG000|Randomized Phase Up to Week 24|Randomized but not treated|1|||
147446235|NCT03631732|531798890|FG001|Randomized Phase Up to Week 24|Randomized but not treated|0|||
147446236|NCT03631732|531798889|FG000|B/F/TAF Treatment Phase (After Week 24)|Lost to Follow-up|6|||
147446237|NCT03631732|531798890|FG001|B/F/TAF Treatment Phase (After Week 24)|Lost to Follow-up|1|||
147446238|NCT03631732|531798889|FG000|B/F/TAF Treatment Phase (After Week 24)|Withdrew Consent|3|||
147446239|NCT03631732|531798890|FG001|B/F/TAF Treatment Phase (After Week 24)|Withdrew Consent|3|||
147446240|NCT03631732|531798889|FG000|B/F/TAF Treatment Phase (After Week 24)|Adverse Event|4|||
147446241|NCT03631732|531798890|FG001|B/F/TAF Treatment Phase (After Week 24)|Adverse Event|1|||
147446242|NCT03631732|531798889|FG000|B/F/TAF Treatment Phase (After Week 24)|Death|1|||
147446243|NCT03631732|531798890|FG001|B/F/TAF Treatment Phase (After Week 24)|Death|0|||
147446244|NCT03631732|531798889|FG000|B/F/TAF Treatment Phase (After Week 24)|Investigator's discretion|1|||
147446245|NCT03631732|531798890|FG001|B/F/TAF Treatment Phase (After Week 24)|Investigator's discretion|0|||
147446246|NCT03631732|531798889|FG000|B/F/TAF Treatment Phase (After Week 24)|Lack of Efficacy|1|||
147321328|NCT00557505|531340017|FG006|Overall Study|Withdrawal by Subject|0|||
147321329|NCT00557505|531340018|FG007|Overall Study|Withdrawal by Subject|0|||
147321330|NCT00557505|531340019|FG008|Overall Study|Withdrawal by Subject|1|||
147321331|NCT00031447|531340020|FG000|Overall Study|Lost to Follow-up|0|||
147321332|NCT00031447|531340021|FG001|Overall Study|Lost to Follow-up|1|||
147321333|NCT00031447|531340020|FG000|Overall Study|Non-compliant|1|||
147321334|NCT00031447|531340021|FG001|Overall Study|Non-compliant|1|||
147321335|NCT00031447|531340020|FG000|Overall Study|Re-activation of Disease|2|||
147321336|NCT00031447|531340021|FG001|Overall Study|Re-activation of Disease|1|||
147321337|NCT00031447|531340020|FG000|Overall Study|Disruption of blinded study drug supply|7|||
147321338|NCT00031447|531340021|FG001|Overall Study|Disruption of blinded study drug supply|4|||
147321339|NCT01636362|531340022|FG000|Overall Study|Physician Decision|6|||
147321340|NCT01636362|531340022|FG000|Overall Study|Subject healed, not returning|1|||
147321341|NCT01636362|531340022|FG000|Overall Study|Withdrawal by Subject|1|||
147321342|NCT00519779|531340025|FG000|Overall Study|Withdrawal by Subject|0|||
147321343|NCT00519779|531340026|FG001|Overall Study|Withdrawal by Subject|1|||
147321344|NCT03330119|531340027|FG000|Overall Study|Received general anesthesia, Explarel or Naloxone; Return to OR; switched groups|166|||
147321345|NCT03330119|531340028|FG001|Overall Study|Received general anesthesia, Explarel or Naloxone; Return to OR; switched groups|282|||
147321346|NCT01561079|531340029|FG000|Overall Study|Physician Decision|17|||
147446247|NCT03631732|531798890|FG001|B/F/TAF Treatment Phase (After Week 24)|Lack of Efficacy|0|||
147578584|NCT02906917|532273563|FG001|Intensification Period (Week 26-38)|Unclassified|2|||
147578585|NCT02906917|532273562|FG000|Intensification Period (Week 26-38)|Adverse Event|0|||
147578586|NCT02906917|532273563|FG001|Intensification Period (Week 26-38)|Adverse Event|2|||
147578587|NCT02906917|532273562|FG000|Intensification Period (Week 26-38)|Lost to Follow-up|3|||
147578588|NCT02906917|532273563|FG001|Intensification Period (Week 26-38)|Lost to Follow-up|1|||
147578589|NCT02906917|532273562|FG000|Intensification Period (Week 26-38)|Withdrawal by Subject|3|||
147321347|NCT01561079|531340029|FG000|Overall Study|Withdrawal by Subject|59|||
147321348|NCT01561079|531340029|FG000|Overall Study|Protocol Violation|2|||
147446248|NCT00886600|531798891|FG000|Double-blind Monotherapy|Adverse Event|1|||
147321349|NCT01323660|531340030|FG000|Treatment Period 1 (12 Weeks)|Adverse Event|6|||
147578590|NCT02906917|532273563|FG001|Intensification Period (Week 26-38)|Withdrawal by Subject|2|||
147578591|NCT00687739|532273565|FG000|Overall Study|Lost to Follow-up|2|||
147321350|NCT01323660|531340031|FG001|Treatment Period 1 (12 Weeks)|Adverse Event|1|||
147578592|NCT00687739|532273566|FG001|Overall Study|Lost to Follow-up|2|||
147578593|NCT00687739|532273567|FG002|Overall Study|Lost to Follow-up|1|||
147578594|NCT00687739|532273568|FG003|Overall Study|Lost to Follow-up|2|||
147578595|NCT00687739|532273565|FG000|Overall Study|Adverse Event|0|||
147578596|NCT00687739|532273566|FG001|Overall Study|Adverse Event|1|||
147578597|NCT00687739|532273567|FG002|Overall Study|Adverse Event|1|||
147578598|NCT00687739|532273568|FG003|Overall Study|Adverse Event|0|||
147578599|NCT05387408|532273573|FG000|Overall Study|Lack of time and access to participants to complete the survey by the health fund administrators|4939|||
147578600|NCT03599362|532273577|FG000|Overall Study|Screen Failure|3|||
147578601|NCT01370083|532273579|FG000|Overall Study|Lost to Follow-up|2|||
147578602|NCT01370083|532273580|FG001|Overall Study|Lost to Follow-up|0|||
147578603|NCT01370083|532273579|FG000|Overall Study|Adverse Event|0|||
147578604|NCT01370083|532273580|FG001|Overall Study|Adverse Event|1|||
147578605|NCT02072096|532273582|FG000|Overall Study|Lack of Efficacy|18|||
147578606|NCT02072096|532273583|FG001|Overall Study|Lack of Efficacy|29|||
147578607|NCT02072096|532273582|FG000|Overall Study|Protocol Violation|7|||
147578608|NCT02072096|532273583|FG001|Overall Study|Protocol Violation|7|||
147578609|NCT02072096|532273582|FG000|Overall Study|Withdrawal by Subject|5|||
147578610|NCT02072096|532273583|FG001|Overall Study|Withdrawal by Subject|7|||
147578611|NCT02072096|532273582|FG000|Overall Study|Adverse Event|5|||
147578612|NCT02072096|532273583|FG001|Overall Study|Adverse Event|2|||
147578613|NCT02072096|532273582|FG000|Overall Study|No Reason Provided|4|||
147578614|NCT02072096|532273583|FG001|Overall Study|No Reason Provided|2|||
147578615|NCT02072096|532273582|FG000|Overall Study|Death|2|||
147578616|NCT02072096|532273583|FG001|Overall Study|Death|0|||
147578617|NCT02072096|532273582|FG000|Overall Study|Physician Decision|0|||
147578618|NCT02072096|532273583|FG001|Overall Study|Physician Decision|1|||
147578619|NCT02072096|532273582|FG000|Overall Study|Study Terminated by Sponsor|43|||
147578620|NCT02072096|532273583|FG001|Overall Study|Study Terminated by Sponsor|30|||
147578621|NCT02072096|532273582|FG000|Overall Study|Lost to Follow-up|1|||
147578622|NCT02072096|532273583|FG001|Overall Study|Lost to Follow-up|0|||
147578623|NCT01168856|532273593|FG000|Overall Study|Lost to Follow-up|4|||
147578624|NCT01168856|532273594|FG001|Overall Study|Lost to Follow-up|34|||
147578625|NCT01168856|532273593|FG000|Overall Study|Withdrawal by Subject|6|||
147578626|NCT01168856|532273594|FG001|Overall Study|Withdrawal by Subject|8|||
147578627|NCT01168856|532273593|FG000|Overall Study|Physician Decision|2|||
147578628|NCT01168856|532273594|FG001|Overall Study|Physician Decision|1|||
147578629|NCT01168856|532273593|FG000|Overall Study|Confirmed Quantifiable HCV RNA|0|||
147578630|NCT01168856|532273594|FG001|Overall Study|Confirmed Quantifiable HCV RNA|1|||
147578631|NCT01168856|532273593|FG000|Overall Study|Participant received anti-HCV treatment|1|||
147578632|NCT01168856|532273594|FG001|Overall Study|Participant received anti-HCV treatment|0|||
147578633|NCT01168856|532273593|FG000|Overall Study|Death|0|||
147321351|NCT01323660|531340032|FG002|Treatment Period 1 (12 Weeks)|Adverse Event|1|||
147321352|NCT01323660|531340033|FG003|Treatment Period 1 (12 Weeks)|Adverse Event|3|||
147321353|NCT01323660|531340034|FG004|Treatment Period 1 (12 Weeks)|Adverse Event|3|||
147321354|NCT01323660|531340035|FG005|Treatment Period 1 (12 Weeks)|Adverse Event|4|||
147321355|NCT01323660|531340030|FG000|Treatment Period 1 (12 Weeks)|Lack of Efficacy|6|||
147321356|NCT01323660|531340031|FG001|Treatment Period 1 (12 Weeks)|Lack of Efficacy|0|||
147321357|NCT01323660|531340032|FG002|Treatment Period 1 (12 Weeks)|Lack of Efficacy|2|||
147321358|NCT01323660|531340033|FG003|Treatment Period 1 (12 Weeks)|Lack of Efficacy|0|||
147321359|NCT01323660|531340034|FG004|Treatment Period 1 (12 Weeks)|Lack of Efficacy|1|||
147321360|NCT01323660|531340035|FG005|Treatment Period 1 (12 Weeks)|Lack of Efficacy|3|||
147321361|NCT01323660|531340030|FG000|Treatment Period 1 (12 Weeks)|Protocol Violation|2|||
147321362|NCT01323660|531340031|FG001|Treatment Period 1 (12 Weeks)|Protocol Violation|0|||
147321363|NCT01323660|531340032|FG002|Treatment Period 1 (12 Weeks)|Protocol Violation|1|||
147321364|NCT01323660|531340033|FG003|Treatment Period 1 (12 Weeks)|Protocol Violation|1|||
147321365|NCT01323660|531340034|FG004|Treatment Period 1 (12 Weeks)|Protocol Violation|1|||
147321366|NCT01323660|531340035|FG005|Treatment Period 1 (12 Weeks)|Protocol Violation|2|||
147321367|NCT01323660|531340030|FG000|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
147321368|NCT01323660|531340031|FG001|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
147321369|NCT01323660|531340032|FG002|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
147578634|NCT01168856|532273594|FG001|Overall Study|Death|2|||
147321370|NCT01323660|531340033|FG003|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
147578635|NCT01168856|532273593|FG000|Overall Study|Other|1|||
147321371|NCT01323660|531340034|FG004|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|1|||
147321372|NCT01323660|531340035|FG005|Treatment Period 1 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
147446249|NCT00886600|531798892|FG001|Double-blind Monotherapy|Adverse Event|1|||
147578636|NCT01168856|532273594|FG001|Overall Study|Other|291|||
147578637|NCT01168856|532273593|FG000|Overall Study|Protocol Violation|4|||
147578638|NCT01168856|532273594|FG001|Overall Study|Protocol Violation|6|||
147578639|NCT04442503|532273595|FG000|Overall Study|Adverse Event|1|||
147578640|NCT04442503|532273596|FG001|Overall Study|Adverse Event|1|||
147578641|NCT04442503|532273595|FG000|Overall Study|Lost to Follow-up|8|||
147578642|NCT04442503|532273596|FG001|Overall Study|Lost to Follow-up|6|||
147578643|NCT04442503|532273595|FG000|Overall Study|Physician Decision|0|||
147578644|NCT04442503|532273596|FG001|Overall Study|Physician Decision|2|||
147653185|NCT02452554|532551972|FG001|Overall Study|Death|1|||
147321373|NCT01323660|531340030|FG000|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
147321374|NCT01323660|531340031|FG001|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
147321375|NCT01323660|531340032|FG002|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
147321376|NCT01323660|531340033|FG003|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
147321377|NCT01323660|531340034|FG004|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
147321378|NCT01323660|531340035|FG005|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
147321379|NCT01323660|531340030|FG000|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|5|||
147321380|NCT01323660|531340031|FG001|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
147321381|NCT01323660|531340032|FG002|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1|||
147321382|NCT01323660|531340033|FG003|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1|||
147321383|NCT01323660|531340034|FG004|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|3|||
147321384|NCT01323660|531340035|FG005|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
147321385|NCT01323660|531340030|FG000|Washout Period (14 Days)|Adverse Event|0|||
147321386|NCT01323660|531340031|FG001|Washout Period (14 Days)|Adverse Event|0|||
147321387|NCT01323660|531340032|FG002|Washout Period (14 Days)|Adverse Event|0|||
147321388|NCT01323660|531340033|FG003|Washout Period (14 Days)|Adverse Event|0|||
147321389|NCT01323660|531340034|FG004|Washout Period (14 Days)|Adverse Event|1|||
147321390|NCT01323660|531340035|FG005|Washout Period (14 Days)|Adverse Event|0|||
147321391|NCT01323660|531340030|FG000|Washout Period (14 Days)|Lack of Efficacy|0|||
147321392|NCT01323660|531340031|FG001|Washout Period (14 Days)|Lack of Efficacy|0|||
147321393|NCT01323660|531340032|FG002|Washout Period (14 Days)|Lack of Efficacy|1|||
147321394|NCT01323660|531340033|FG003|Washout Period (14 Days)|Lack of Efficacy|3|||
147321395|NCT01323660|531340034|FG004|Washout Period (14 Days)|Lack of Efficacy|2|||
147321396|NCT01323660|531340035|FG005|Washout Period (14 Days)|Lack of Efficacy|2|||
147321397|NCT01323660|531340030|FG000|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
147321398|NCT01323660|531340031|FG001|Treatment Period 2 (12 Weeks)|Adverse Event|0|||
147321399|NCT01323660|531340032|FG002|Treatment Period 2 (12 Weeks)|Adverse Event|0|||
147321400|NCT01323660|531340033|FG003|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
147321401|NCT01323660|531340034|FG004|Treatment Period 2 (12 Weeks)|Adverse Event|1|||
147321402|NCT01323660|531340035|FG005|Treatment Period 2 (12 Weeks)|Adverse Event|2|||
147321403|NCT01323660|531340030|FG000|Treatment Period 2 (12 Weeks)|Lack of Efficacy|9|||
147321404|NCT01323660|531340031|FG001|Treatment Period 2 (12 Weeks)|Lack of Efficacy|0|||
147321405|NCT01323660|531340032|FG002|Treatment Period 2 (12 Weeks)|Lack of Efficacy|2|||
147321406|NCT01323660|531340033|FG003|Treatment Period 2 (12 Weeks)|Lack of Efficacy|2|||
147321407|NCT01323660|531340034|FG004|Treatment Period 2 (12 Weeks)|Lack of Efficacy|1|||
147321408|NCT01323660|531340035|FG005|Treatment Period 2 (12 Weeks)|Lack of Efficacy|3|||
147321409|NCT01323660|531340030|FG000|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0|||
147321410|NCT01323660|531340031|FG001|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0|||
147321411|NCT01323660|531340032|FG002|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0|||
147321412|NCT01323660|531340033|FG003|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0|||
147321413|NCT01323660|531340034|FG004|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|0|||
147321414|NCT01323660|531340035|FG005|Treatment Period 2 (12 Weeks)|Study Closed/Terminated|1|||
147321415|NCT01323660|531340030|FG000|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1|||
147321416|NCT01323660|531340031|FG001|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
147321417|NCT01323660|531340032|FG002|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
147321418|NCT01323660|531340033|FG003|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
147321419|NCT01323660|531340034|FG004|Treatment Period 2 (12 Weeks)|Lost to Follow-up|0|||
147321420|NCT01323660|531340035|FG005|Treatment Period 2 (12 Weeks)|Lost to Follow-up|1|||
147321421|NCT01323660|531340030|FG000|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
147321422|NCT01323660|531340031|FG001|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
147321423|NCT01323660|531340032|FG002|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
147321424|NCT01323660|531340033|FG003|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
147321425|NCT01323660|531340034|FG004|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|2|||
147321426|NCT01323660|531340035|FG005|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
147321427|NCT02118714|531340036|FG000|Overall Study|Lost to Follow-up|2|||
147321428|NCT02118714|531340036|FG000|Overall Study|Protocol Violation|1|||
147321429|NCT00570661|531340038|FG000|Overall Study|Disease worsening|5|||
147321430|NCT00570661|531340038|FG000|Overall Study|Unmet criterion of sufficient therapeutic response|1|||
147321431|NCT00570661|531340038|FG000|Overall Study|Adverse Event|1|||
147321432|NCT01734382|531340042|FG000|Part 1|Adverse Event|2|||
147578645|NCT04442503|532273595|FG000|Overall Study|Withdrawal by Subject|3|||
147321433|NCT01734382|531340043|FG001|Part 1|Adverse Event|0|||
147321434|NCT01734382|531340044|FG002|Part 1|Adverse Event|0|||
147321435|NCT01734382|531340042|FG000|Part 2|Adverse Event|0|||
147321436|NCT01734382|531340043|FG001|Part 2|Adverse Event|0|||
147321437|NCT01734382|531340044|FG002|Part 2|Adverse Event|1|||
147321438|NCT01734382|531340042|FG000|Part 2|Lack of Efficacy|0|||
147578646|NCT04442503|532273596|FG001|Overall Study|Withdrawal by Subject|4|||
147321439|NCT01734382|531340043|FG001|Part 2|Lack of Efficacy|1|||
147321440|NCT01734382|531340044|FG002|Part 2|Lack of Efficacy|1|||
147321441|NCT01734382|531340042|FG000|Part 2|Other|0|||
147321442|NCT01734382|531340043|FG001|Part 2|Other|0|||
147321443|NCT01734382|531340044|FG002|Part 2|Other|1|||
147578647|NCT04442503|532273595|FG000|Overall Study|Reason not Specified|0|||
147321444|NCT01734382|531340042|FG000|Part 2|Physician Decision|0|||
147321445|NCT01734382|531340043|FG001|Part 2|Physician Decision|0|||
147321446|NCT01734382|531340044|FG002|Part 2|Physician Decision|3|||
147321447|NCT01734382|531340042|FG000|Part 2|Protocol Violation|0|||
147321448|NCT01734382|531340043|FG001|Part 2|Protocol Violation|1|||
147321449|NCT01734382|531340044|FG002|Part 2|Protocol Violation|0|||
147321450|NCT01734382|531340042|FG000|Part 2|Withdrawal by Subject|0|||
147321451|NCT01734382|531340043|FG001|Part 2|Withdrawal by Subject|0|||
147321452|NCT01734382|531340044|FG002|Part 2|Withdrawal by Subject|1|||
147321453|NCT01052662|531340045|FG000|Overall Study|Lost to Follow-up|15|||
147321454|NCT01052662|531340046|FG001|Overall Study|Lost to Follow-up|13|||
147321455|NCT01052662|531340047|FG002|Overall Study|Lost to Follow-up|18|||
147321456|NCT01052662|531340045|FG000|Overall Study|Withdrawal by Subject|3|||
147321457|NCT01052662|531340046|FG001|Overall Study|Withdrawal by Subject|2|||
147321458|NCT01052662|531340047|FG002|Overall Study|Withdrawal by Subject|1|||
147321459|NCT01052662|531340045|FG000|Overall Study|Pharmacy issue|1|||
147321460|NCT01052662|531340046|FG001|Overall Study|Pharmacy issue|3|||
147321461|NCT01052662|531340047|FG002|Overall Study|Pharmacy issue|3|||
147321462|NCT01052662|531340045|FG000|Overall Study|Adverse Event|1|||
147321463|NCT01052662|531340046|FG001|Overall Study|Adverse Event|1|||
147321464|NCT01052662|531340047|FG002|Overall Study|Adverse Event|0|||
147578648|NCT04442503|532273596|FG001|Overall Study|Reason not Specified|1|||
147578649|NCT04442503|532273595|FG000|Overall Study|Randomized but not Treated|3|||
147321465|NCT01052662|531340045|FG000|Overall Study|Legal Problem|2|||
147321466|NCT01052662|531340046|FG001|Overall Study|Legal Problem|0|||
147321467|NCT01052662|531340047|FG002|Overall Study|Legal Problem|0|||
147321468|NCT01052662|531340045|FG000|Overall Study|Administrative|0|||
147321469|NCT01052662|531340046|FG001|Overall Study|Administrative|3|||
147321470|NCT01052662|531340047|FG002|Overall Study|Administrative|0|||
147321471|NCT02015663|531340049|FG000|Overall Study|unsatisfactory therapeutic effect|1|||
147321472|NCT02015663|531340050|FG001|Overall Study|unsatisfactory therapeutic effect|0|||
147321473|NCT02015663|531340049|FG000|Overall Study|Withdrawal by Subject|1|||
147321474|NCT02015663|531340050|FG001|Overall Study|Withdrawal by Subject|0|||
147321475|NCT02015663|531340049|FG000|Overall Study|Protocol Violation|0|||
147321476|NCT02015663|531340050|FG001|Overall Study|Protocol Violation|1|||
147321477|NCT02015663|531340049|FG000|Overall Study|Adverse Event|3|||
147321478|NCT02015663|531340050|FG001|Overall Study|Adverse Event|0|||
147321479|NCT02015663|531340049|FG000|Overall Study|Administrative problems|10|||
147321480|NCT02015663|531340050|FG001|Overall Study|Administrative problems|11|||
147321481|NCT00479674|531340051|FG000|Overall Study|Adverse Event|18|||
147321482|NCT00479674|531340051|FG000|Overall Study|Withdrawal by Subject|6|||
147321483|NCT00479674|531340051|FG000|Overall Study|Physician Decision|14|||
147321484|NCT00479674|531340051|FG000|Overall Study|none provided|3|||
147321485|NCT03293485|531340054|FG000|Overall Study|Death|1|||
147321486|NCT03293485|531340054|FG000|Overall Study|Screen Failure|2|||
147321487|NCT03293485|531340054|FG000|Overall Study|Withdrawal by Subject|2|||
147321488|NCT01272011|531340057|FG000|Overall Study|Withdrawal By Subject or Failed Screen|0|||
147321489|NCT01272011|531340058|FG001|Overall Study|Withdrawal By Subject or Failed Screen|2|||
147321490|NCT01272011|531340059|FG002|Overall Study|Withdrawal By Subject or Failed Screen|0|||
147321491|NCT02240680|531340062|FG000|Overall Study (Up to 24 Weeks)|Adverse Event|6|||
147321492|NCT02240680|531340063|FG001|Overall Study (Up to 24 Weeks)|Adverse Event|6|||
147321493|NCT02240680|531340064|FG002|Overall Study (Up to 24 Weeks)|Adverse Event|0|||
147321494|NCT02240680|531340065|FG003|Overall Study (Up to 24 Weeks)|Adverse Event|0|||
147321495|NCT02240680|531340062|FG000|Overall Study (Up to 24 Weeks)|Protocol Violation|4|||
147321496|NCT02240680|531340063|FG001|Overall Study (Up to 24 Weeks)|Protocol Violation|1|||
147321497|NCT02240680|531340064|FG002|Overall Study (Up to 24 Weeks)|Protocol Violation|0|||
147321498|NCT02240680|531340065|FG003|Overall Study (Up to 24 Weeks)|Protocol Violation|0|||
147446250|NCT00886600|531798893|FG002|Double-blind Monotherapy|Adverse Event|1|||
147578650|NCT04442503|532273596|FG001|Overall Study|Randomized but not Treated|1|||
147578651|NCT00387153|532273597|FG000|Overall Study|Adverse Event|1|||
147578652|NCT00387153|532273597|FG000|Overall Study|Disease Progression|3|||
147321499|NCT02240680|531340062|FG000|Overall Study (Up to 24 Weeks)|Lost to Follow-up|1|||
147321500|NCT02240680|531340063|FG001|Overall Study (Up to 24 Weeks)|Lost to Follow-up|0|||
147446251|NCT00886600|531798894|FG003|Double-blind Monotherapy|Adverse Event|1|||
147321501|NCT02240680|531340064|FG002|Overall Study (Up to 24 Weeks)|Lost to Follow-up|0|||
147321502|NCT02240680|531340065|FG003|Overall Study (Up to 24 Weeks)|Lost to Follow-up|0|||
147321503|NCT02240680|531340062|FG000|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|3|||
147321504|NCT02240680|531340063|FG001|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|1|||
147321505|NCT02240680|531340064|FG002|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|0|||
147321506|NCT02240680|531340065|FG003|Overall Study (Up to 24 Weeks)|Withdrawal by Subject|0|||
147321507|NCT02240680|531340062|FG000|Overall Study (Up to 24 Weeks)|Other than specified|1|||
147321508|NCT02240680|531340063|FG001|Overall Study (Up to 24 Weeks)|Other than specified|0|||
147321509|NCT02240680|531340064|FG002|Overall Study (Up to 24 Weeks)|Other than specified|0|||
147321510|NCT02240680|531340065|FG003|Overall Study (Up to 24 Weeks)|Other than specified|0|||
147578653|NCT00387153|532273597|FG000|Overall Study|Lack of Response|4|||
147578654|NCT00301964|532273602|FG000|Overall Study|Second primary|2|||
147578655|NCT00301964|532273602|FG000|Overall Study|Wrong primary|1|||
147578656|NCT00301964|532273602|FG000|Overall Study|Inadequate pathology|1|||
147578657|NCT02385708|532273603|FG000|Overall Study|Withdrawal by Subject|0|||
147578658|NCT02385708|532273604|FG001|Overall Study|Withdrawal by Subject|2|||
147578659|NCT02385708|532273603|FG000|Overall Study|Withdrawn - surgery canceled|2|||
147578660|NCT02385708|532273604|FG001|Overall Study|Withdrawn - surgery canceled|5|||
147578661|NCT02385708|532273603|FG000|Overall Study|Investigator decision|5|||
147578662|NCT02385708|532273604|FG001|Overall Study|Investigator decision|7|||
147578663|NCT02385708|532273603|FG000|Overall Study|Protocol Violation|1|||
147578664|NCT02385708|532273604|FG001|Overall Study|Protocol Violation|1|||
147578665|NCT03504085|532273606|FG000|End of Intervention - 12 Weeks|Lost to Follow-up|3|||
147578666|NCT03504085|532273607|FG001|End of Intervention - 12 Weeks|Lost to Follow-up|4|||
147578667|NCT03504085|532273606|FG000|Final Assessment - 6 Months|Lost to Follow-up|5|||
147578668|NCT03504085|532273607|FG001|Final Assessment - 6 Months|Lost to Follow-up|5|||
147578669|NCT02761915|532273608|FG000|Overall Study|Death|3|||
147578670|NCT02761915|532273609|FG001|Overall Study|Death|1|||
147578671|NCT02761915|532273610|FG002|Overall Study|Death|1|||
147578672|NCT02761915|532273611|FG003|Overall Study|Death|1|||
147578673|NCT02761915|532273612|FG004|Overall Study|Death|0|||
147578674|NCT02761915|532273613|FG005|Overall Study|Death|1|||
147578675|NCT02761915|532273608|FG000|Overall Study|Withdrawal by Subject|1|||
147578676|NCT02761915|532273609|FG001|Overall Study|Withdrawal by Subject|0|||
147578677|NCT02761915|532273610|FG002|Overall Study|Withdrawal by Subject|0|||
147578678|NCT02761915|532273611|FG003|Overall Study|Withdrawal by Subject|0|||
147578679|NCT02761915|532273612|FG004|Overall Study|Withdrawal by Subject|1|||
147578680|NCT02761915|532273613|FG005|Overall Study|Withdrawal by Subject|2|||
147578681|NCT02761915|532273608|FG000|Overall Study|Disease Progression|0|||
147578682|NCT02761915|532273609|FG001|Overall Study|Disease Progression|0|||
147578683|NCT02761915|532273610|FG002|Overall Study|Disease Progression|0|||
147578684|NCT02761915|532273611|FG003|Overall Study|Disease Progression|2|||
147578685|NCT02761915|532273612|FG004|Overall Study|Disease Progression|2|||
147578686|NCT02761915|532273613|FG005|Overall Study|Disease Progression|2|||
147578687|NCT01143337|532273614|FG000|Overall Study|Adverse Event|3|||
147578688|NCT01143337|532273615|FG001|Overall Study|Adverse Event|9|||
147578689|NCT01143337|532273616|FG002|Overall Study|Adverse Event|5|||
147578690|NCT01143337|532273614|FG000|Overall Study|Lack of Efficacy|6|||
147578691|NCT01143337|532273615|FG001|Overall Study|Lack of Efficacy|2|||
147578692|NCT01143337|532273616|FG002|Overall Study|Lack of Efficacy|1|||
147578693|NCT01143337|532273614|FG000|Overall Study|Protocol Violation|1|||
147578694|NCT01143337|532273615|FG001|Overall Study|Protocol Violation|0|||
147578695|NCT01143337|532273616|FG002|Overall Study|Protocol Violation|0|||
147578696|NCT01143337|532273614|FG000|Overall Study|Withdrawal by Subject|0|||
147578697|NCT01143337|532273615|FG001|Overall Study|Withdrawal by Subject|0|||
147578698|NCT01143337|532273616|FG002|Overall Study|Withdrawal by Subject|1|||
147578699|NCT01143337|532273614|FG000|Overall Study|Other reason|0|||
147578700|NCT01143337|532273615|FG001|Overall Study|Other reason|0|||
147578701|NCT01143337|532273616|FG002|Overall Study|Other reason|5|||
147578702|NCT01926119|532273627|FG000|Overall Study|Withdrawal by Subject|1|||
147578703|NCT02654145|532273631|FG000|Overall Study|Lack of Efficacy|1|||
147578704|NCT02654145|532273631|FG000|Overall Study|Protocol Violation|1|||
147578705|NCT02654145|532273631|FG000|Overall Study|Withdrawal by Subject|5|||
147578706|NCT00354835|532273632|FG000|Overall Study|Death|1|||
147578707|NCT00354835|532273633|FG001|Overall Study|Death|1|||
147578708|NCT00354835|532273632|FG000|Overall Study|Physician Decision|8|||
147578709|NCT00354835|532273633|FG001|Overall Study|Physician Decision|13|||
147578710|NCT00354835|532273632|FG000|Overall Study|Withdrawal by Subject|2|||
147578711|NCT00354835|532273633|FG001|Overall Study|Withdrawal by Subject|1|||
147578712|NCT00354835|532273632|FG000|Overall Study|Ineligible|17|||
147578713|NCT00354835|532273633|FG001|Overall Study|Ineligible|16|||
147653186|NCT02452554|532551973|FG002|Overall Study|Death|0|||
147152149|NCT04826094|530719049|FG001|Overall Study|Other: Moved from area|1|||
147152150|NCT04826094|530719050|FG002|Overall Study|Other: Moved from area|1|||
147152151|NCT04826094|530719051|FG003|Overall Study|Other: Moved from area|0|||
147578714|NCT00354835|532273632|FG000|Overall Study|Disease progression or relapse|15|||
147578715|NCT00354835|532273633|FG001|Overall Study|Disease progression or relapse|22|||
147578716|NCT00354835|532273632|FG000|Overall Study|Adverse Event|6|||
147578717|NCT00354835|532273633|FG001|Overall Study|Adverse Event|0|||
147578718|NCT00354835|532273632|FG000|Overall Study|Refusal of further therapy|3|||
147578719|NCT00354835|532273633|FG001|Overall Study|Refusal of further therapy|8|||
147578720|NCT00645853|532273634|FG000|Overall Study|Adverse Event|18|||
147578721|NCT00645853|532273635|FG001|Overall Study|Adverse Event|7|||
147578722|NCT00645853|532273634|FG000|Overall Study|AZ study closure in Hungary|60|||
147578723|NCT00645853|532273635|FG001|Overall Study|AZ study closure in Hungary|40|||
147578724|NCT00645853|532273634|FG000|Overall Study|Withdrawal by Subject|5|||
147578725|NCT00645853|532273635|FG001|Overall Study|Withdrawal by Subject|2|||
147578726|NCT00645853|532273634|FG000|Overall Study|Protocol Violation|0|||
147578727|NCT00645853|532273635|FG001|Overall Study|Protocol Violation|2|||
147653187|NCT02452554|532551974|FG003|Overall Study|Death|0|||
147152152|NCT04826094|530719052|FG004|Overall Study|Other: Moved from area|0|||
147152153|NCT04826094|530719053|FG005|Overall Study|Other: Moved from area|0|||
147152154|NCT04826094|530719054|FG006|Overall Study|Other: Moved from area|0|||
147152155|NCT04826094|530719055|FG007|Overall Study|Other: Moved from area|0|||
147152156|NCT04826094|530719048|FG000|Overall Study|Other: Declined|0|||
147152157|NCT04826094|530719049|FG001|Overall Study|Other: Declined|0|||
147578728|NCT00645853|532273634|FG000|Overall Study|Discontinuation criteria|2|||
147578729|NCT00645853|532273635|FG001|Overall Study|Discontinuation criteria|2|||
147578730|NCT00645853|532273634|FG000|Overall Study|recall of ICF, planned operation, death|7|||
147578731|NCT00645853|532273635|FG001|Overall Study|recall of ICF, planned operation, death|4|||
147578732|NCT02637141|532273638|FG000|Overall Study|Adverse Event|1|||
147578733|NCT02637141|532273639|FG001|Overall Study|Adverse Event|1|||
147578734|NCT02637141|532273640|FG002|Overall Study|Adverse Event|0|||
147578735|NCT02637141|532273638|FG000|Overall Study|Withdrawal by Subject|1|||
147578736|NCT02637141|532273639|FG001|Overall Study|Withdrawal by Subject|1|||
147578737|NCT02637141|532273640|FG002|Overall Study|Withdrawal by Subject|1|||
147578738|NCT01597791|532273641|FG000|Overall Study|Physician Decision|2|||
147578739|NCT01597791|532273642|FG001|Overall Study|Physician Decision|1|||
147578740|NCT01597791|532273641|FG000|Overall Study|Cesarean Section|6|||
147578741|NCT01597791|532273642|FG001|Overall Study|Cesarean Section|7|||
147578742|NCT01597791|532273641|FG000|Overall Study|Subject withdrawal|0|||
147578743|NCT01597791|532273642|FG001|Overall Study|Subject withdrawal|1|||
147578744|NCT01597791|532273641|FG000|Overall Study|Protocol Violation|0|||
147578745|NCT01597791|532273642|FG001|Overall Study|Protocol Violation|1|||
147578746|NCT01728116|532273643|FG000|Overall Study|Sponsor Terminated Study|106|||
147578747|NCT01728116|532273644|FG001|Overall Study|Sponsor Terminated Study|35|||
147578748|NCT01728116|532273643|FG000|Overall Study|Withdrawal by Subject|16|||
147578749|NCT01728116|532273644|FG001|Overall Study|Withdrawal by Subject|9|||
147578750|NCT01728116|532273643|FG000|Overall Study|Adverse Event|13|||
147578751|NCT01728116|532273644|FG001|Overall Study|Adverse Event|0|||
147578752|NCT01728116|532273643|FG000|Overall Study|Procedure/device failure|7|||
147578753|NCT01728116|532273644|FG001|Overall Study|Procedure/device failure|0|||
147578754|NCT01728116|532273643|FG000|Overall Study|Lost to Follow-up|9|||
147578755|NCT01728116|532273644|FG001|Overall Study|Lost to Follow-up|2|||
147578756|NCT01728116|532273643|FG000|Overall Study|Physician Decision|2|||
147578757|NCT01728116|532273644|FG001|Overall Study|Physician Decision|0|||
147578758|NCT01728116|532273643|FG000|Overall Study|Subject Non-Compliance|2|||
147578759|NCT01728116|532273644|FG001|Overall Study|Subject Non-Compliance|0|||
147578760|NCT01728116|532273643|FG000|Overall Study|Inter-current finding at procedure|1|||
147578761|NCT01728116|532273644|FG001|Overall Study|Inter-current finding at procedure|0|||
147578762|NCT01728116|532273643|FG000|Overall Study|Incorrectly enrolled in Study|0|||
147578763|NCT01728116|532273644|FG001|Overall Study|Incorrectly enrolled in Study|1|||
147578764|NCT01728116|532273643|FG000|Overall Study|various not noted previously|5|||
147578765|NCT01728116|532273644|FG001|Overall Study|various not noted previously|0|||
147578766|NCT01868243|532273645|FG000|Overall Study|Death|0|||
147578767|NCT01868243|532273646|FG001|Overall Study|Death|1|||
147578768|NCT00467597|532273647|FG000|Overall Study|Withdrawal by Subject|2|||
147578769|NCT00467597|532273648|FG001|Overall Study|Withdrawal by Subject|0|||
147578770|NCT03366428|532273649|FG000|Overall Study|Progressive disease per RECIST v1.1|33|||
147578771|NCT03366428|532273649|FG000|Overall Study|Adverse Event|12|||
147578772|NCT03366428|532273649|FG000|Overall Study|Clinical progression|2|||
147578773|NCT03366428|532273649|FG000|Overall Study|Withdrawal by Subject|4|||
147578774|NCT02166606|532273650|FG000|Overall Study|Adverse Event|3|||
147578775|NCT02166606|532273650|FG000|Overall Study|Death|31|||
147578776|NCT02166606|532273650|FG000|Overall Study|Protocol Violation|7|||
147578777|NCT02166606|532273650|FG000|Overall Study|Lost to Follow-up|30|||
147578778|NCT02166606|532273650|FG000|Overall Study|Withdrawal by Subject|1|||
147578779|NCT02166606|532273650|FG000|Overall Study|Physician Decision|1|||
147578780|NCT02166606|532273650|FG000|Overall Study|Device upgrade|1|||
147578781|NCT02166606|532273650|FG000|Overall Study|Enrolled after End of Enrollment|4|||
147578782|NCT00379353|532273653|FG000|Overall Study|Hospitalization|3|||
147578783|NCT00379353|532273654|FG001|Overall Study|Hospitalization|3|||
147578784|NCT00379353|532273653|FG000|Overall Study|Withdrawal by Subject|5|||
147578785|NCT00379353|532273654|FG001|Overall Study|Withdrawal by Subject|2|||
147578786|NCT00379353|532273653|FG000|Overall Study|Death|1|||
147653188|NCT02452554|532551975|FG004|Overall Study|Death|0|||
147578787|NCT00379353|532273654|FG001|Overall Study|Death|0|||
147578788|NCT00379353|532273653|FG000|Overall Study|Cardiac Tamponade|1|||
147152158|NCT04826094|530719050|FG002|Overall Study|Other: Declined|0|||
147152159|NCT04826094|530719051|FG003|Overall Study|Other: Declined|0|||
147578789|NCT00379353|532273654|FG001|Overall Study|Cardiac Tamponade|0|||
147578790|NCT00379353|532273653|FG000|Overall Study|Non-compliance|1|||
147578791|NCT00379353|532273654|FG001|Overall Study|Non-compliance|0|||
147578792|NCT00379353|532273653|FG000|Overall Study|Conflicting drug treatment|0|||
147578793|NCT00379353|532273654|FG001|Overall Study|Conflicting drug treatment|1|||
147578794|NCT01958476|532273655|FG000|Overall Study|Parent requested exclusion from analysis|1|||
147578795|NCT01958476|532273656|FG001|Overall Study|Parent requested exclusion from analysis|0|||
147446252|NCT00886600|531798891|FG000|Double-blind Monotherapy|Protocol Violation|0|||
147446253|NCT00886600|531798892|FG001|Double-blind Monotherapy|Protocol Violation|0|||
147446254|NCT00886600|531798893|FG002|Double-blind Monotherapy|Protocol Violation|0|||
147446255|NCT00886600|531798894|FG003|Double-blind Monotherapy|Protocol Violation|1|||
147446256|NCT00886600|531798891|FG000|Double-blind Monotherapy|Withdrawal by Subject|1|||
147446257|NCT00886600|531798892|FG001|Double-blind Monotherapy|Withdrawal by Subject|0|||
147446258|NCT00886600|531798893|FG002|Double-blind Monotherapy|Withdrawal by Subject|0|||
147446259|NCT00886600|531798894|FG003|Double-blind Monotherapy|Withdrawal by Subject|0|||
147578796|NCT02670551|532273659|FG000|Overall Study|Adverse Event|4|||
147578797|NCT02670551|532273660|FG001|Overall Study|Adverse Event|7|||
147578798|NCT02670551|532273661|FG002|Overall Study|Adverse Event|9|||
147578799|NCT02670551|532273659|FG000|Overall Study|Lack of Efficacy|2|||
147578800|NCT02670551|532273660|FG001|Overall Study|Lack of Efficacy|0|||
147578801|NCT02670551|532273661|FG002|Overall Study|Lack of Efficacy|3|||
147578802|NCT02670551|532273659|FG000|Overall Study|Withdrawal of Consent|6|||
147578803|NCT02670551|532273660|FG001|Overall Study|Withdrawal of Consent|3|||
147578804|NCT02670551|532273661|FG002|Overall Study|Withdrawal of Consent|8|||
147578805|NCT02670551|532273659|FG000|Overall Study|Lost to Follow-up|5|||
147578806|NCT02670551|532273660|FG001|Overall Study|Lost to Follow-up|7|||
147578807|NCT02670551|532273661|FG002|Overall Study|Lost to Follow-up|6|||
147578808|NCT02670551|532273659|FG000|Overall Study|Protocol Violation|1|||
147578809|NCT02670551|532273660|FG001|Overall Study|Protocol Violation|0|||
147578810|NCT02670551|532273661|FG002|Overall Study|Protocol Violation|0|||
147578811|NCT02670551|532273659|FG000|Overall Study|Noncompliance with study drug|3|||
147578812|NCT02670551|532273660|FG001|Overall Study|Noncompliance with study drug|3|||
147578813|NCT02670551|532273661|FG002|Overall Study|Noncompliance with study drug|2|||
147578814|NCT02670551|532273659|FG000|Overall Study|Other Miscellaneous Reasons|2|||
147578815|NCT02670551|532273660|FG001|Overall Study|Other Miscellaneous Reasons|3|||
147578816|NCT02670551|532273661|FG002|Overall Study|Other Miscellaneous Reasons|3|||
147578817|NCT02670551|532273659|FG000|Overall Study|Did Not Receive Treatment|5|||
147578818|NCT02670551|532273660|FG001|Overall Study|Did Not Receive Treatment|3|||
147578819|NCT02670551|532273661|FG002|Overall Study|Did Not Receive Treatment|0|||
147578820|NCT00714051|532273662|FG000|Overall Study|Withdrawal by Subject|1|||
147578821|NCT00714051|532273663|FG001|Overall Study|Withdrawal by Subject|0|||
147578822|NCT00714051|532273662|FG000|Overall Study|Death|0|||
147578823|NCT00714051|532273663|FG001|Overall Study|Death|1|||
147578824|NCT05315713|532273664|FG000|Overall Study|Death|5|||
147578825|NCT05315713|532273664|FG000|Overall Study|Progressive disease|1|||
147578826|NCT05315713|532273664|FG000|Overall Study|Withdrawal by Subject|1|||
147578827|NCT05315713|532273664|FG000|Overall Study|Study terminated by sponsor|1|||
147578828|NCT02535923|532273665|FG000|Overall Study|Lost to Follow-up|5|||
147578829|NCT02535923|532273666|FG001|Overall Study|Lost to Follow-up|5|||
147578830|NCT02535923|532273665|FG000|Overall Study|Withdrawal by Subject|4|||
147578831|NCT02535923|532273666|FG001|Overall Study|Withdrawal by Subject|3|||
147578832|NCT00685334|532273672|FG000|Overall Study|Withdrawal by Subject|5|||
147578833|NCT00685334|532273673|FG001|Overall Study|Withdrawal by Subject|6|||
147578834|NCT00685334|532273672|FG000|Overall Study|Lost to Follow-up|4|||
147578835|NCT00685334|532273673|FG001|Overall Study|Lost to Follow-up|0|||
147578836|NCT00685334|532273672|FG000|Overall Study|Chose to enter hospital|1|||
147578837|NCT00685334|532273673|FG001|Overall Study|Chose to enter hospital|1|||
147578838|NCT03694197|532273674|FG000|Overall Study|Adverse Event|9|||
147578839|NCT03694197|532273674|FG000|Overall Study|Protocol became inconvenient to participate|1|||
147578840|NCT03694197|532273674|FG000|Overall Study|Physician Decision|4|||
147578841|NCT03694197|532273674|FG000|Overall Study|Study terminated by sponsor|1350|||
147578842|NCT03694197|532273674|FG000|Overall Study|Participant moved|5|||
147578843|NCT03694197|532273674|FG000|Overall Study|Participant withdrew consent|10|||
147152160|NCT04826094|530719052|FG004|Overall Study|Other: Declined|1|||
147152161|NCT04826094|530719053|FG005|Overall Study|Other: Declined|0|||
147446260|NCT00886600|531798891|FG000|Combination Therapy Period|Adverse Event|0|||
147446261|NCT00886600|531798892|FG001|Combination Therapy Period|Adverse Event|0|||
147446262|NCT00886600|531798893|FG002|Combination Therapy Period|Adverse Event|1|||
147578844|NCT03694197|532273674|FG000|Overall Study|Related to IMP administration|1|||
147578845|NCT03694197|532273674|FG000|Overall Study|Not disclosed|5|||
147578846|NCT02300987|532274976|FG000|Primary Phase : Prior to Cross-over|Withdrawal by Subject|1|||
147578847|NCT02300987|532274977|FG001|Primary Phase : Prior to Cross-over|Withdrawal by Subject|0|||
147578848|NCT02300987|532274976|FG000|Primary Phase : Prior to Cross-over|Physician Decision|2|||
147578849|NCT02300987|532274977|FG001|Primary Phase : Prior to Cross-over|Physician Decision|0|||
147578850|NCT02300987|532274976|FG000|Primary Phase : Prior to Cross-over|progressive disease|3|||
147578851|NCT02300987|532274977|FG001|Primary Phase : Prior to Cross-over|progressive disease|2|||
147578852|NCT02300987|532274976|FG000|Secondary Phase : Cross-over to LEE011|Lack of Efficacy|1|||
147578853|NCT02300987|532274977|FG001|Secondary Phase : Cross-over to LEE011|Lack of Efficacy|0|||
147578854|NCT02300987|532274976|FG000|Secondary Phase : Cross-over to LEE011|Adverse Event|0|||
147578855|NCT02300987|532274977|FG001|Secondary Phase : Cross-over to LEE011|Adverse Event|1|||
147578856|NCT03086135|532274978|FG000|Overall Study|Adverse Event|1|||
147578857|NCT03086135|532274978|FG000|Overall Study|Lost to Follow-up|2|||
147446263|NCT00886600|531798894|FG003|Combination Therapy Period|Adverse Event|0|||
147446264|NCT00886600|531798891|FG000|Combination Therapy Period|Protocol Violation|0|||
147446265|NCT00886600|531798892|FG001|Combination Therapy Period|Protocol Violation|0|||
147446266|NCT00886600|531798893|FG002|Combination Therapy Period|Protocol Violation|1|||
147446267|NCT00886600|531798894|FG003|Combination Therapy Period|Protocol Violation|0|||
147446268|NCT01251367|531798895|FG000|Overall Study|Protocol Violation|1|||
147446269|NCT01251367|531798895|FG000|Overall Study|Lack of Efficacy|2|||
147446270|NCT01251367|531798895|FG000|Overall Study|Adverse Event|19|||
147446271|NCT01251367|531798895|FG000|Overall Study|Withdrawal by Subject|36|||
147446272|NCT01251367|531798895|FG000|Overall Study|Lost to Follow-up|5|||
147446273|NCT01251367|531798895|FG000|Overall Study|Subject Required Alternative Treatment|7|||
147446274|NCT01251367|531798895|FG000|Overall Study|No Study Drug Available|1|||
147446275|NCT01251367|531798895|FG000|Overall Study|Subject had Personal or Medical Issues|4|||
147446276|NCT01251367|531798895|FG000|Overall Study|End of Study Visit Performed in Error|1|||
147446277|NCT02255409|531798896|FG000|Overall Study|Administrative Reason|3|||
147446278|NCT02255409|531798897|FG001|Overall Study|Administrative Reason|7|||
147446279|NCT02255409|531798896|FG000|Overall Study|Withdrawal by Subject|1|||
147578858|NCT01023061|532274979|FG000|Overall Study|Withdrawal prior to treatment|2|||
147578859|NCT04590781|532274981|FG000|Overall Study|Death|0|||
147578860|NCT04590781|532274982|FG001|Overall Study|Death|2|||
147578861|NCT04590781|532274981|FG000|Overall Study|Withdrawal by Subject|2|||
147578862|NCT04590781|532274982|FG001|Overall Study|Withdrawal by Subject|0|||
147578863|NCT00820599|532274985|FG000|Overall Study|Death|129|||
147578864|NCT00820599|532274985|FG000|Overall Study|Withdrawal by Subject|2|||
147578865|NCT03686215|532274986|FG000|Overall Study|Adverse Event|0|||
147578866|NCT03686215|532274987|FG001|Overall Study|Adverse Event|0|||
147578867|NCT03686215|532274988|FG002|Overall Study|Adverse Event|7|||
147578868|NCT03686215|532274986|FG000|Overall Study|Physician Decision|0|||
147578869|NCT03686215|532274987|FG001|Overall Study|Physician Decision|0|||
147578870|NCT03686215|532274988|FG002|Overall Study|Physician Decision|1|||
147578871|NCT03686215|532274986|FG000|Overall Study|Protocol Violation|0|||
147578872|NCT03686215|532274987|FG001|Overall Study|Protocol Violation|0|||
147578873|NCT03686215|532274988|FG002|Overall Study|Protocol Violation|4|||
147578874|NCT03686215|532274986|FG000|Overall Study|Device issue|1|||
147578875|NCT03686215|532274987|FG001|Overall Study|Device issue|0|||
147578876|NCT03686215|532274988|FG002|Overall Study|Device issue|2|||
147578877|NCT00522041|532274989|FG000|Overall Study|Adverse Event|9|||
147578878|NCT00522041|532274990|FG001|Overall Study|Adverse Event|3|||
147578879|NCT00522041|532274989|FG000|Overall Study|Protocol Violation|2|||
147578880|NCT00522041|532274990|FG001|Overall Study|Protocol Violation|0|||
147578881|NCT00522041|532274989|FG000|Overall Study|Lost to Follow-up|1|||
147578882|NCT00522041|532274990|FG001|Overall Study|Lost to Follow-up|4|||
147578883|NCT00522041|532274989|FG000|Overall Study|Voluntary withdrawal|5|||
147578884|NCT00522041|532274990|FG001|Overall Study|Voluntary withdrawal|4|||
147578885|NCT00522041|532274989|FG000|Overall Study|Did not receive treatment|0|||
147578886|NCT00522041|532274990|FG001|Overall Study|Did not receive treatment|1|||
147578887|NCT00874549|532274991|FG000|Overall Study|Adverse Event|0|||
147578888|NCT00874549|532274992|FG001|Overall Study|Adverse Event|0|||
147578889|NCT00874549|532274993|FG002|Overall Study|Adverse Event|1|||
147578890|NCT00874549|532274994|FG003|Overall Study|Adverse Event|0|||
147578891|NCT00874549|532274991|FG000|Overall Study|Protocol Violation|1|||
147578892|NCT00874549|532274992|FG001|Overall Study|Protocol Violation|0|||
147578893|NCT00874549|532274993|FG002|Overall Study|Protocol Violation|2|||
147578894|NCT00874549|532274994|FG003|Overall Study|Protocol Violation|1|||
147578895|NCT00874549|532274991|FG000|Overall Study|Lost to Follow-up|0|||
147578896|NCT00874549|532274992|FG001|Overall Study|Lost to Follow-up|0|||
147578897|NCT00874549|532274993|FG002|Overall Study|Lost to Follow-up|1|||
147578898|NCT00874549|532274994|FG003|Overall Study|Lost to Follow-up|0|||
147578899|NCT00874549|532274991|FG000|Overall Study|Withdrawal by Subject|0|||
147578900|NCT00874549|532274992|FG001|Overall Study|Withdrawal by Subject|1|||
147578901|NCT00874549|532274993|FG002|Overall Study|Withdrawal by Subject|0|||
147578902|NCT00874549|532274994|FG003|Overall Study|Withdrawal by Subject|1|||
147152162|NCT04826094|530719054|FG006|Overall Study|Other: Declined|0|||
147152163|NCT04826094|530719055|FG007|Overall Study|Other: Declined|0|||
147152164|NCT04826094|530719048|FG000|Overall Study|Other: Vaccine not administered|0|||
147152165|NCT04826094|530719049|FG001|Overall Study|Other: Vaccine not administered|0|||
147446280|NCT02255409|531798897|FG001|Overall Study|Withdrawal by Subject|5|||
147446281|NCT02255409|531798896|FG000|Overall Study|Lost to Follow-up|10|||
147578903|NCT01710358|532274995|FG000|Treatment Period Part A (Weeks 0 to 24)|Adverse Event|15|||
147578904|NCT01710358|532274996|FG001|Treatment Period Part A (Weeks 0 to 24)|Adverse Event|18|||
147578905|NCT01710358|532274997|FG002|Treatment Period Part A (Weeks 0 to 24)|Adverse Event|7|||
147578906|NCT01710358|532274995|FG000|Treatment Period Part A (Weeks 0 to 24)|Death|0|||
147578907|NCT01710358|532274996|FG001|Treatment Period Part A (Weeks 0 to 24)|Death|2|||
147578908|NCT01710358|532274997|FG002|Treatment Period Part A (Weeks 0 to 24)|Death|0|||
147578909|NCT01710358|532274995|FG000|Treatment Period Part A (Weeks 0 to 24)|Entry Criteria Not Met|0|||
147578910|NCT01710358|532274996|FG001|Treatment Period Part A (Weeks 0 to 24)|Entry Criteria Not Met|1|||
147578911|NCT01710358|532274997|FG002|Treatment Period Part A (Weeks 0 to 24)|Entry Criteria Not Met|1|||
147578912|NCT01710358|532274995|FG000|Treatment Period Part A (Weeks 0 to 24)|Lack of Efficacy|15|||
147578913|NCT01710358|532274996|FG001|Treatment Period Part A (Weeks 0 to 24)|Lack of Efficacy|1|||
147578914|NCT01710358|532274997|FG002|Treatment Period Part A (Weeks 0 to 24)|Lack of Efficacy|3|||
147578915|NCT01710358|532274995|FG000|Treatment Period Part A (Weeks 0 to 24)|Lost to Follow-up|0|||
147578916|NCT01710358|532274996|FG001|Treatment Period Part A (Weeks 0 to 24)|Lost to Follow-up|1|||
147578917|NCT01710358|532274997|FG002|Treatment Period Part A (Weeks 0 to 24)|Lost to Follow-up|0|||
147578918|NCT01710358|532274995|FG000|Treatment Period Part A (Weeks 0 to 24)|Physician Decision|1|||
147578919|NCT01710358|532274996|FG001|Treatment Period Part A (Weeks 0 to 24)|Physician Decision|0|||
147578920|NCT01710358|532274997|FG002|Treatment Period Part A (Weeks 0 to 24)|Physician Decision|0|||
147578921|NCT01710358|532274995|FG000|Treatment Period Part A (Weeks 0 to 24)|Sponsor Decision|4|||
147578922|NCT01710358|532274996|FG001|Treatment Period Part A (Weeks 0 to 24)|Sponsor Decision|0|||
147578923|NCT01710358|532274997|FG002|Treatment Period Part A (Weeks 0 to 24)|Sponsor Decision|0|||
147578924|NCT01710358|532274995|FG000|Treatment Period Part A (Weeks 0 to 24)|Withdrawal by Subject|15|||
147578925|NCT01710358|532274996|FG001|Treatment Period Part A (Weeks 0 to 24)|Withdrawal by Subject|5|||
147578926|NCT01710358|532274997|FG002|Treatment Period Part A (Weeks 0 to 24)|Withdrawal by Subject|12|||
147578927|NCT01710358|532274995|FG000|Treatment Period Part A (Weeks 0 to 24)|Randomized But Not Treated|1|||
147578928|NCT01710358|532274996|FG001|Treatment Period Part A (Weeks 0 to 24)|Randomized But Not Treated|1|||
147578929|NCT01710358|532274997|FG002|Treatment Period Part A (Weeks 0 to 24)|Randomized But Not Treated|0|||
147578930|NCT01710358|532274995|FG000|Treatment Period Part B (Weeks 24 to 52)|Adverse Event|10|||
147578931|NCT01710358|532274996|FG001|Treatment Period Part B (Weeks 24 to 52)|Adverse Event|16|||
147578932|NCT01710358|532274997|FG002|Treatment Period Part B (Weeks 24 to 52)|Adverse Event|5|||
147578933|NCT01710358|532274995|FG000|Treatment Period Part B (Weeks 24 to 52)|Death|1|||
147578934|NCT01710358|532274996|FG001|Treatment Period Part B (Weeks 24 to 52)|Death|0|||
147578935|NCT01710358|532274997|FG002|Treatment Period Part B (Weeks 24 to 52)|Death|1|||
147578936|NCT01710358|532274995|FG000|Treatment Period Part B (Weeks 24 to 52)|Lack of Efficacy|0|||
147578937|NCT01710358|532274996|FG001|Treatment Period Part B (Weeks 24 to 52)|Lack of Efficacy|0|||
147578938|NCT01710358|532274997|FG002|Treatment Period Part B (Weeks 24 to 52)|Lack of Efficacy|1|||
147152166|NCT04826094|530719050|FG002|Overall Study|Other: Vaccine not administered|1|||
147152167|NCT04826094|530719051|FG003|Overall Study|Other: Vaccine not administered|0|||
147152168|NCT04826094|530719052|FG004|Overall Study|Other: Vaccine not administered|0|||
147152169|NCT04826094|530719053|FG005|Overall Study|Other: Vaccine not administered|1|||
147152170|NCT04826094|530719054|FG006|Overall Study|Other: Vaccine not administered|1|||
147152171|NCT04826094|530719055|FG007|Overall Study|Other: Vaccine not administered|3|||
147152172|NCT02151903|530719056|FG000|Overall Study|Withdrawal by Subject|1|||
147152173|NCT02151903|530719057|FG001|Overall Study|Withdrawal by Subject|0|||
147152174|NCT02151903|530719056|FG000|Overall Study|Progressive disease|2|||
147152175|NCT02151903|530719057|FG001|Overall Study|Progressive disease|1|||
147152176|NCT01864148|530719058|FG000|Overall Study|Other|2|||
147152177|NCT01864148|530719059|FG001|Overall Study|Other|1|||
147152178|NCT01864148|530719060|FG002|Overall Study|Other|1|||
147152179|NCT01864148|530719061|FG003|Overall Study|Other|3|||
147152180|NCT01864148|530719062|FG004|Overall Study|Other|1|||
147152181|NCT01864148|530719058|FG000|Overall Study|Death|0|||
147152182|NCT01864148|530719059|FG001|Overall Study|Death|0|||
147152183|NCT01864148|530719060|FG002|Overall Study|Death|0|||
147152184|NCT01864148|530719061|FG003|Overall Study|Death|1|||
147239698|NCT01090492|531049260|FG005|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
147152185|NCT01864148|530719062|FG004|Overall Study|Death|0|||
147152186|NCT01864148|530719058|FG000|Overall Study|Investigator Decision|5|||
147152187|NCT01864148|530719059|FG001|Overall Study|Investigator Decision|0|||
147239699|NCT01090492|531049261|FG006|Second Intervention Period (4 Weeks)|Lost to Follow-up|1|||
147239700|NCT01090492|531049262|FG007|Second Intervention Period (4 Weeks)|Lost to Follow-up|0|||
147239701|NCT00868608|531049263|FG000|Overall Study|Withdrawal by Subject|3|||
147239702|NCT00868608|531049264|FG001|Overall Study|Withdrawal by Subject|1|||
147239703|NCT00868608|531049265|FG002|Overall Study|Withdrawal by Subject|0|||
147578939|NCT01710358|532274995|FG000|Treatment Period Part B (Weeks 24 to 52)|Lost to Follow-up|0|||
147578940|NCT01710358|532274996|FG001|Treatment Period Part B (Weeks 24 to 52)|Lost to Follow-up|0|||
147578941|NCT01710358|532274997|FG002|Treatment Period Part B (Weeks 24 to 52)|Lost to Follow-up|1|||
147578942|NCT01710358|532274995|FG000|Treatment Period Part B (Weeks 24 to 52)|Physician Decision|0|||
147578943|NCT01710358|532274996|FG001|Treatment Period Part B (Weeks 24 to 52)|Physician Decision|1|||
147578944|NCT01710358|532274997|FG002|Treatment Period Part B (Weeks 24 to 52)|Physician Decision|0|||
147578945|NCT01710358|532274995|FG000|Treatment Period Part B (Weeks 24 to 52)|Sponsor Decision|1|||
147152188|NCT01864148|530719060|FG002|Overall Study|Investigator Decision|0|||
147152189|NCT01864148|530719061|FG003|Overall Study|Investigator Decision|4|||
147239704|NCT00868608|531049263|FG000|Overall Study|Lost to Follow-up|3|||
147152190|NCT01864148|530719062|FG004|Overall Study|Investigator Decision|6|||
147152191|NCT01864148|530719058|FG000|Overall Study|Withdrawal by Subject|9|||
147152192|NCT01864148|530719059|FG001|Overall Study|Withdrawal by Subject|2|||
147152193|NCT01864148|530719060|FG002|Overall Study|Withdrawal by Subject|6|||
147321511|NCT02240680|531340062|FG000|Japanese Patients (Up to 52 Weeks)|Adverse Event|0|||
147321512|NCT02240680|531340063|FG001|Japanese Patients (Up to 52 Weeks)|Adverse Event|0|||
147321513|NCT02240680|531340064|FG002|Japanese Patients (Up to 52 Weeks)|Adverse Event|6|||
147321514|NCT02240680|531340065|FG003|Japanese Patients (Up to 52 Weeks)|Adverse Event|7|||
147578946|NCT01710358|532274996|FG001|Treatment Period Part B (Weeks 24 to 52)|Sponsor Decision|2|||
147578947|NCT01710358|532274997|FG002|Treatment Period Part B (Weeks 24 to 52)|Sponsor Decision|0|||
147578948|NCT01710358|532274995|FG000|Treatment Period Part B (Weeks 24 to 52)|Withdrawal by Subject|4|||
147578949|NCT01710358|532274996|FG001|Treatment Period Part B (Weeks 24 to 52)|Withdrawal by Subject|3|||
147578950|NCT01710358|532274997|FG002|Treatment Period Part B (Weeks 24 to 52)|Withdrawal by Subject|7|||
147578951|NCT01710358|532274995|FG000|Rescue Period|Adverse Event|0|||
147578952|NCT01710358|532274996|FG001|Rescue Period|Adverse Event|15|||
147578953|NCT01710358|532274997|FG002|Rescue Period|Adverse Event|0|||
147578954|NCT01710358|532274995|FG000|Rescue Period|Death|0|||
147578955|NCT01710358|532274996|FG001|Rescue Period|Death|1|||
147578956|NCT01710358|532274997|FG002|Rescue Period|Death|0|||
147578957|NCT01710358|532274995|FG000|Rescue Period|Lack of Efficacy|0|||
147578958|NCT01710358|532274996|FG001|Rescue Period|Lack of Efficacy|7|||
147578959|NCT01710358|532274997|FG002|Rescue Period|Lack of Efficacy|0|||
147578960|NCT01710358|532274995|FG000|Rescue Period|Withdrawal by Subject|0|||
147578961|NCT01710358|532274996|FG001|Rescue Period|Withdrawal by Subject|8|||
147578962|NCT01710358|532274997|FG002|Rescue Period|Withdrawal by Subject|0|||
147578963|NCT00084864|532274998|FG000|Overall Study|Adverse Event|1|||
147578964|NCT00084864|532274999|FG001|Overall Study|Adverse Event|0|||
147578965|NCT00084864|532275000|FG002|Overall Study|Adverse Event|0|||
147578966|NCT00084864|532275001|FG003|Overall Study|Adverse Event|0|||
147578967|NCT01721772|532275006|FG000|Pre-Treatment|Participant no longer meets study criteria|3|||
147578968|NCT01721772|532275007|FG001|Pre-Treatment|Participant no longer meets study criteria|1|||
147578969|NCT01721772|532275006|FG000|Pre-Treatment|Poor/non-compliance|0|||
147578970|NCT01721772|532275007|FG001|Pre-Treatment|Poor/non-compliance|1|||
147578971|NCT01721772|532275006|FG000|Pre-Treatment|Participant withdrew consent|0|||
147578972|NCT01721772|532275007|FG001|Pre-Treatment|Participant withdrew consent|1|||
147578973|NCT01721772|532275006|FG000|Pre-Treatment|Adverse event unrelated to study drug|1|||
147578974|NCT01721772|532275007|FG001|Pre-Treatment|Adverse event unrelated to study drug|0|||
147578975|NCT01721772|532275006|FG000|Treatment|Disease progression|119|||
147578976|NCT01721772|532275007|FG001|Treatment|Disease progression|168|||
147578977|NCT01721772|532275006|FG000|Treatment|Study drug toxicity|19|||
147578978|NCT01721772|532275007|FG001|Treatment|Study drug toxicity|10|||
147578979|NCT01721772|532275006|FG000|Treatment|Adverse event unrelated to study drug|7|||
147578980|NCT01721772|532275007|FG001|Treatment|Adverse event unrelated to study drug|7|||
147578981|NCT01721772|532275006|FG000|Treatment|Maximum clinical benefit|16|||
147578982|NCT01721772|532275007|FG001|Treatment|Maximum clinical benefit|4|||
147578983|NCT01721772|532275006|FG000|Treatment|Other|19|||
147578984|NCT01721772|532275007|FG001|Treatment|Other|2|||
147578985|NCT01721772|532275006|FG000|Treatment|Participant withdrew consent|2|||
147578986|NCT01721772|532275007|FG001|Treatment|Participant withdrew consent|5|||
147578987|NCT01721772|532275006|FG000|Treatment|Participant request to discontinue study treatment|21|||
147578988|NCT01721772|532275007|FG001|Treatment|Participant request to discontinue study treatment|8|||
147578989|NCT01721772|532275006|FG000|Treatment|Death|1|||
147578990|NCT01721772|532275007|FG001|Treatment|Death|0|||
147578991|NCT01721772|532275006|FG000|Treatment|Not reported|1|||
147578992|NCT01721772|532275007|FG001|Treatment|Not reported|0|||
147578993|NCT01721772|532275006|FG000|Treatment|Poor/non-compliance|1|||
147578994|NCT01721772|532275007|FG001|Treatment|Poor/non-compliance|0|||
147578995|NCT01721772|532275006|FG000|Treatment|Lost to Follow-up|0|||
147578996|NCT01721772|532275007|FG001|Treatment|Lost to Follow-up|1|||
147578997|NCT04542694|532275008|FG000|Overall Study|The need for prohibited therapy|2|||
147578998|NCT04542694|532275009|FG001|Overall Study|The need for prohibited therapy|0|||
147578999|NCT04542694|532275008|FG000|Overall Study|Adverse Event|1|||
147579000|NCT04542694|532275009|FG001|Overall Study|Adverse Event|0|||
147579001|NCT04542694|532275008|FG000|Overall Study|Protocol Violation|1|||
147579002|NCT04542694|532275009|FG001|Overall Study|Protocol Violation|0|||
147579003|NCT00969124|532275010|FG000|Overall Study|Protocol Violation|2|||
147579004|NCT00969124|532275010|FG000|Overall Study|Inadequate bowel preparation|15|||
147579005|NCT00969124|532275010|FG000|Overall Study|Inability to reach cecum|9|||
147579006|NCT00969124|532275010|FG000|Overall Study|Previously unrecognized disease|3|||
147579007|NCT00969124|532275010|FG000|Overall Study|Technical error|1|||
147579008|NCT00874822|532275016|FG000|Overall Study|excluded by criteria|8|||
147579009|NCT02854800|532275017|FG000|Overall Study|Protocol Violation|16|||
147579010|NCT02854800|532275018|FG001|Overall Study|Protocol Violation|11|||
147579011|NCT02854800|532275019|FG002|Overall Study|Protocol Violation|3|||
147579012|NCT02854800|532275017|FG000|Overall Study|Withdrawal by Subject|4|||
147152194|NCT01864148|530719061|FG003|Overall Study|Withdrawal by Subject|8|||
147152195|NCT01864148|530719062|FG004|Overall Study|Withdrawal by Subject|8|||
147579013|NCT02854800|532275018|FG001|Overall Study|Withdrawal by Subject|2|||
147321515|NCT02240680|531340062|FG000|Japanese Patients (Up to 52 Weeks)|Protocol Violation|0|||
147653189|NCT02452554|532551976|FG005|Overall Study|Death|0|||
147653190|NCT02452554|532551971|FG000|Overall Study|Lack of Efficacy|13|||
147653191|NCT02452554|532551972|FG001|Overall Study|Lack of Efficacy|14|||
147653192|NCT02452554|532551973|FG002|Overall Study|Lack of Efficacy|9|||
147653193|NCT02452554|532551974|FG003|Overall Study|Lack of Efficacy|1|||
147653194|NCT02452554|532551975|FG004|Overall Study|Lack of Efficacy|5|||
147653195|NCT02452554|532551976|FG005|Overall Study|Lack of Efficacy|8|||
147653196|NCT02452554|532551971|FG000|Overall Study|Physician Decision|0|||
147653197|NCT02452554|532551972|FG001|Overall Study|Physician Decision|1|||
147653198|NCT02452554|532551973|FG002|Overall Study|Physician Decision|0|||
147653199|NCT02452554|532551974|FG003|Overall Study|Physician Decision|0|||
147653200|NCT02452554|532551975|FG004|Overall Study|Physician Decision|0|||
147653201|NCT02452554|532551976|FG005|Overall Study|Physician Decision|0|||
147152196|NCT01864148|530719058|FG000|Overall Study|Lost to Follow-up|0|||
147152197|NCT01864148|530719059|FG001|Overall Study|Lost to Follow-up|0|||
147152198|NCT01864148|530719060|FG002|Overall Study|Lost to Follow-up|0|||
147152199|NCT01864148|530719061|FG003|Overall Study|Lost to Follow-up|2|||
147152200|NCT01864148|530719062|FG004|Overall Study|Lost to Follow-up|1|||
147152201|NCT01864148|530719058|FG000|Overall Study|Adverse Event|4|||
147152202|NCT01864148|530719059|FG001|Overall Study|Adverse Event|2|||
147152203|NCT01864148|530719060|FG002|Overall Study|Adverse Event|4|||
147152204|NCT01864148|530719061|FG003|Overall Study|Adverse Event|7|||
147152205|NCT01864148|530719062|FG004|Overall Study|Adverse Event|7|||
147152206|NCT01864148|530719058|FG000|Overall Study|Not Dosed|0|||
147152207|NCT01864148|530719059|FG001|Overall Study|Not Dosed|0|||
147152208|NCT01864148|530719060|FG002|Overall Study|Not Dosed|0|||
147152209|NCT01864148|530719061|FG003|Overall Study|Not Dosed|1|||
147152210|NCT01864148|530719062|FG004|Overall Study|Not Dosed|0|||
147152211|NCT01500252|530719063|FG000|Overall Study|Death|4|||
147152212|NCT01500252|530719064|FG001|Overall Study|Death|2|||
147152213|NCT01500252|530719063|FG000|Overall Study|Lost to Follow-up|5|||
147152214|NCT01500252|530719064|FG001|Overall Study|Lost to Follow-up|4|||
147152215|NCT00778375|530719066|FG000|Overall Study|Ineligible|3|||
147152216|NCT03490292|530719067|FG000|Treatment: Expansion (Feb 2019-Dec 2021)|Death|0|||
147152217|NCT03490292|530719068|FG001|Treatment: Expansion (Feb 2019-Dec 2021)|Death|1|||
147152218|NCT03490292|530719067|FG000|Treatment: Expansion (Feb 2019-Dec 2021)|Off Treatment Pre-Surgery|0|||
147152219|NCT03490292|530719068|FG001|Treatment: Expansion (Feb 2019-Dec 2021)|Off Treatment Pre-Surgery|2|||
147152220|NCT03490292|530719067|FG000|Treatment: Expansion (Feb 2019-Dec 2021)|Off Treatment Post-Surgery|0|||
147152221|NCT03490292|530719068|FG001|Treatment: Expansion (Feb 2019-Dec 2021)|Off Treatment Post-Surgery|2|||
147152222|NCT03490292|530719067|FG000|Treatment: Expansion (Feb 2019-Dec 2021)|Adverse Event|0|||
147152223|NCT03490292|530719068|FG001|Treatment: Expansion (Feb 2019-Dec 2021)|Adverse Event|2|||
147152224|NCT03490292|530719067|FG000|1 Year Follow Up Post Last Dose|Death|1|||
147152225|NCT03490292|530719068|FG001|1 Year Follow Up Post Last Dose|Death|1|||
147152226|NCT01421303|530719069|FG000|Overall Study|Lost to Follow-up|13|||
147152227|NCT01421303|530719069|FG000|Overall Study|Non compliance with study procedure|1|||
147152228|NCT01421303|530719069|FG000|Overall Study|Other|7|||
147152229|NCT01421303|530719069|FG000|Overall Study|Withdrawal by Subject|1|||
147152230|NCT06003777|530719070|FG000|Period 1|Adverse Event|0|||
147152231|NCT06003777|530719071|FG001|Period 1|Adverse Event|0|||
147152232|NCT06003777|530719072|FG002|Period 1|Adverse Event|1|||
147152233|NCT06003777|530719073|FG003|Period 1|Adverse Event|0|||
147152234|NCT06003777|530719074|FG004|Period 1|Adverse Event|0|||
147152235|NCT06003777|530719075|FG005|Period 1|Adverse Event|0|||
147152236|NCT06003777|530719076|FG006|Period 1|Adverse Event|0|||
147152237|NCT06003777|530719077|FG007|Period 1|Adverse Event|0|||
147152238|NCT06003777|530719078|FG008|Period 1|Adverse Event|0|||
147152239|NCT06003777|530719079|FG009|Period 1|Adverse Event|0|||
147152240|NCT06003777|530719080|FG010|Period 1|Adverse Event|0|||
147152241|NCT06003777|530719081|FG011|Period 1|Adverse Event|0|||
147321516|NCT02240680|531340063|FG001|Japanese Patients (Up to 52 Weeks)|Protocol Violation|0|||
147321517|NCT02240680|531340064|FG002|Japanese Patients (Up to 52 Weeks)|Protocol Violation|1|||
147321518|NCT02240680|531340065|FG003|Japanese Patients (Up to 52 Weeks)|Protocol Violation|0|||
147653202|NCT02452554|532551971|FG000|Overall Study|Withdrawal by Subject|1|||
147653203|NCT02452554|532551972|FG001|Overall Study|Withdrawal by Subject|0|||
147653204|NCT02452554|532551973|FG002|Overall Study|Withdrawal by Subject|2|||
147152242|NCT06003777|530719070|FG000|Period 1|Withdrawal by Subject|0|||
147152243|NCT06003777|530719071|FG001|Period 1|Withdrawal by Subject|0|||
147152244|NCT06003777|530719072|FG002|Period 1|Withdrawal by Subject|0|||
147152245|NCT06003777|530719073|FG003|Period 1|Withdrawal by Subject|0|||
147152246|NCT06003777|530719074|FG004|Period 1|Withdrawal by Subject|1|||
147152247|NCT06003777|530719075|FG005|Period 1|Withdrawal by Subject|0|||
147152248|NCT06003777|530719076|FG006|Period 1|Withdrawal by Subject|0|||
147152249|NCT06003777|530719077|FG007|Period 1|Withdrawal by Subject|0|||
147152250|NCT06003777|530719078|FG008|Period 1|Withdrawal by Subject|0|||
147152251|NCT06003777|530719079|FG009|Period 1|Withdrawal by Subject|0|||
147152252|NCT06003777|530719080|FG010|Period 1|Withdrawal by Subject|0|||
147152253|NCT06003777|530719081|FG011|Period 1|Withdrawal by Subject|0|||
147653205|NCT02452554|532551974|FG003|Overall Study|Withdrawal by Subject|0|||
147653206|NCT02452554|532551975|FG004|Overall Study|Withdrawal by Subject|0|||
147152254|NCT06003777|530719070|FG000|Period 2|Withdrawal by Subject|0|||
147152255|NCT06003777|530719071|FG001|Period 2|Withdrawal by Subject|0|||
147152256|NCT06003777|530719072|FG002|Period 2|Withdrawal by Subject|0|||
147152257|NCT06003777|530719073|FG003|Period 2|Withdrawal by Subject|0|||
147152258|NCT06003777|530719074|FG004|Period 2|Withdrawal by Subject|0|||
147152259|NCT06003777|530719075|FG005|Period 2|Withdrawal by Subject|0|||
147152260|NCT06003777|530719076|FG006|Period 2|Withdrawal by Subject|0|||
147152261|NCT06003777|530719077|FG007|Period 2|Withdrawal by Subject|0|||
147152262|NCT06003777|530719078|FG008|Period 2|Withdrawal by Subject|1|||
147152263|NCT06003777|530719079|FG009|Period 2|Withdrawal by Subject|0|||
147152264|NCT06003777|530719080|FG010|Period 2|Withdrawal by Subject|0|||
147152265|NCT06003777|530719081|FG011|Period 2|Withdrawal by Subject|0|||
147152266|NCT06003777|530719070|FG000|Period 3|Adverse Event|0|||
147152267|NCT06003777|530719071|FG001|Period 3|Adverse Event|0|||
147152268|NCT06003777|530719072|FG002|Period 3|Adverse Event|0|||
147152269|NCT06003777|530719073|FG003|Period 3|Adverse Event|0|||
147152270|NCT06003777|530719074|FG004|Period 3|Adverse Event|0|||
147152271|NCT06003777|530719075|FG005|Period 3|Adverse Event|0|||
147152272|NCT06003777|530719076|FG006|Period 3|Adverse Event|1|||
147152273|NCT06003777|530719077|FG007|Period 3|Adverse Event|0|||
147152274|NCT06003777|530719078|FG008|Period 3|Adverse Event|0|||
147152275|NCT06003777|530719079|FG009|Period 3|Adverse Event|0|||
147152276|NCT06003777|530719080|FG010|Period 3|Adverse Event|0|||
147152277|NCT06003777|530719081|FG011|Period 3|Adverse Event|0|||
147152278|NCT06003777|530719070|FG000|Period 4|No longer met eligibility criteria|0|||
147152279|NCT06003777|530719071|FG001|Period 4|No longer met eligibility criteria|0|||
147152280|NCT06003777|530719072|FG002|Period 4|No longer met eligibility criteria|1|||
147152281|NCT06003777|530719073|FG003|Period 4|No longer met eligibility criteria|0|||
147152282|NCT06003777|530719074|FG004|Period 4|No longer met eligibility criteria|0|||
147152283|NCT06003777|530719075|FG005|Period 4|No longer met eligibility criteria|0|||
147152284|NCT06003777|530719076|FG006|Period 4|No longer met eligibility criteria|0|||
147152285|NCT06003777|530719077|FG007|Period 4|No longer met eligibility criteria|0|||
147152286|NCT06003777|530719078|FG008|Period 4|No longer met eligibility criteria|0|||
147152287|NCT06003777|530719079|FG009|Period 4|No longer met eligibility criteria|0|||
147152288|NCT06003777|530719080|FG010|Period 4|No longer met eligibility criteria|0|||
147152289|NCT06003777|530719081|FG011|Period 4|No longer met eligibility criteria|0|||
147152290|NCT06003777|530719070|FG000|Period 4|Withdrawal by Subject|0|||
147152291|NCT06003777|530719071|FG001|Period 4|Withdrawal by Subject|1|||
147152292|NCT06003777|530719072|FG002|Period 4|Withdrawal by Subject|0|||
147152293|NCT06003777|530719073|FG003|Period 4|Withdrawal by Subject|0|||
147152294|NCT06003777|530719074|FG004|Period 4|Withdrawal by Subject|0|||
147152295|NCT06003777|530719075|FG005|Period 4|Withdrawal by Subject|0|||
147152296|NCT06003777|530719076|FG006|Period 4|Withdrawal by Subject|0|||
147152297|NCT06003777|530719077|FG007|Period 4|Withdrawal by Subject|0|||
147152298|NCT06003777|530719078|FG008|Period 4|Withdrawal by Subject|0|||
147152299|NCT06003777|530719079|FG009|Period 4|Withdrawal by Subject|0|||
147152300|NCT06003777|530719080|FG010|Period 4|Withdrawal by Subject|0|||
147152301|NCT06003777|530719081|FG011|Period 4|Withdrawal by Subject|0|||
147152302|NCT00904670|530719082|FG000|Open Label Phase|Withdrawal by Subject|2|||
147152303|NCT00904670|530719083|FG001|Open Label Phase|Withdrawal by Subject|0|||
147152304|NCT00904670|530719082|FG000|Open Label Phase|Adverse Event|2|||
147152305|NCT00904670|530719083|FG001|Open Label Phase|Adverse Event|0|||
147152306|NCT00904670|530719082|FG000|Open Label Phase|Lack of Efficacy|1|||
147152307|NCT00904670|530719083|FG001|Open Label Phase|Lack of Efficacy|0|||
147152308|NCT00904670|530719082|FG000|Open Label Phase|Lost to Follow-up|1|||
147152309|NCT00904670|530719083|FG001|Open Label Phase|Lost to Follow-up|0|||
147152310|NCT00054327|530719086|FG000|Overall Study|Engraftment failure|1|||
147239705|NCT00868608|531049264|FG001|Overall Study|Lost to Follow-up|0|||
147239706|NCT00868608|531049265|FG002|Overall Study|Lost to Follow-up|1|||
147239707|NCT00868608|531049263|FG000|Overall Study|Death|16|||
147239708|NCT00868608|531049264|FG001|Overall Study|Death|2|||
147239709|NCT00868608|531049265|FG002|Overall Study|Death|4|||
147239710|NCT00868608|531049263|FG000|Overall Study|Other - Unspecified|1|||
147239711|NCT00868608|531049264|FG001|Overall Study|Other - Unspecified|0|||
147239712|NCT00868608|531049265|FG002|Overall Study|Other - Unspecified|0|||
147239713|NCT02935842|531049266|FG000|Testing and Therapy Period 2|Withdrawal by Subject|2|||
147239714|NCT02935842|531049267|FG001|Testing and Therapy Period 2|Withdrawal by Subject|0|||
147152311|NCT00054327|530719087|FG001|Overall Study|Engraftment failure|0|||
147152312|NCT00054327|530719088|FG002|Overall Study|Engraftment failure|0|||
147152313|NCT00054327|530719089|FG003|Overall Study|Engraftment failure|0|||
147152314|NCT00054327|530719090|FG004|Overall Study|Engraftment failure|0|||
147152315|NCT00054327|530719091|FG005|Overall Study|Engraftment failure|0|||
147152316|NCT00613327|530719095|FG000|Overall Study|Adverse Event|38|||
147152317|NCT00613327|530719095|FG000|Overall Study|Lost to Follow-up|8|||
147152318|NCT00613327|530719095|FG000|Overall Study|Withdrawal by Subject|6|||
147152319|NCT00613327|530719095|FG000|Overall Study|Protocol Violation|2|||
147152320|NCT00613327|530719095|FG000|Overall Study|Other|47|||
147152321|NCT00344318|530719096|FG000|Overall Study|Adverse Event|0|||
147239715|NCT02935842|531049268|FG002|Testing and Therapy Period 2|Withdrawal by Subject|0|||
147152322|NCT00344318|530719097|FG001|Overall Study|Adverse Event|3|||
147152323|NCT00344318|530719098|FG002|Overall Study|Adverse Event|0|||
147152324|NCT00344318|530719099|FG003|Overall Study|Adverse Event|1|||
147152325|NCT00344318|530719096|FG000|Overall Study|Withdrawal by Subject|2|||
147152326|NCT00344318|530719097|FG001|Overall Study|Withdrawal by Subject|2|||
147152327|NCT00344318|530719098|FG002|Overall Study|Withdrawal by Subject|0|||
147152328|NCT00344318|530719099|FG003|Overall Study|Withdrawal by Subject|2|||
147152329|NCT00344318|530719096|FG000|Overall Study|Lost to Follow-up|2|||
147152330|NCT00344318|530719097|FG001|Overall Study|Lost to Follow-up|0|||
147152331|NCT00344318|530719098|FG002|Overall Study|Lost to Follow-up|1|||
147152332|NCT00344318|530719099|FG003|Overall Study|Lost to Follow-up|0|||
147152333|NCT01606176|530719104|FG000|Overall Study|Adverse Event|2|||
147152334|NCT01606176|530719105|FG001|Overall Study|Adverse Event|3|||
147152335|NCT01606176|530719104|FG000|Overall Study|Disease progression|1|||
147152336|NCT01606176|530719105|FG001|Overall Study|Disease progression|0|||
147152337|NCT01606176|530719104|FG000|Overall Study|Withdrawal by Subject|1|||
147152338|NCT01606176|530719105|FG001|Overall Study|Withdrawal by Subject|0|||
147152339|NCT00361231|530719106|FG000|Overall Study|Physician Decision|3|||
147152340|NCT00361231|530719106|FG000|Overall Study|Symptomatic deterioration|5|||
147152341|NCT00361231|530719106|FG000|Overall Study|Radiographic disease progression|16|||
147152342|NCT00361231|530719106|FG000|Overall Study|Withdrawal by Subject|4|||
147152343|NCT00361231|530719106|FG000|Overall Study|Adverse Event|6|||
147152344|NCT01814397|530719109|FG000|Overall Study|Adverse Event|7|||
147152345|NCT01814397|530719109|FG000|Overall Study|Withdrawal by Subject|7|||
147152346|NCT00244933|530719110|FG000|Overall Study|Not response evaluable|2|||
147152347|NCT04731298|530719111|FG000|Follow-up (3 Years From HSCT)|Early termination of study.|0|||
147152348|NCT04731298|530719112|FG001|Follow-up (3 Years From HSCT)|Early termination of study.|2|||
147152349|NCT01208961|530719113|FG000|High-Fat Period III|Protocol Violation|1|||
147152350|NCT01208961|530719114|FG001|High-Fat Period III|Protocol Violation|0|||
147152351|NCT03213938|530719115|FG000|Overall Study|Lost to Follow-up|4|||
147152352|NCT03213938|530719116|FG001|Overall Study|Lost to Follow-up|3|||
147152353|NCT03213938|530719115|FG000|Overall Study|Lack of Efficacy|1|||
147152354|NCT03213938|530719116|FG001|Overall Study|Lack of Efficacy|0|||
147152355|NCT03213938|530719115|FG000|Overall Study|Decline to participate|5|||
147152356|NCT03213938|530719116|FG001|Overall Study|Decline to participate|4|||
147152357|NCT03213938|530719115|FG000|Overall Study|Without reason|4|||
147152358|NCT03213938|530719116|FG001|Overall Study|Without reason|5|||
147152359|NCT02487654|530719118|FG000|Overall Study|4 withdrawndue to non-identifiable GPs during HFS mapping in the GPA group.|0|||
147152360|NCT02487654|530719119|FG001|Overall Study|4 withdrawndue to non-identifiable GPs during HFS mapping in the GPA group.|4|||
147152361|NCT02487654|530719118|FG000|Overall Study|Withdrawal by Subject|3|||
147152362|NCT02487654|530719119|FG001|Overall Study|Withdrawal by Subject|7|||
147152363|NCT04238481|530719120|FG000|Overall Study|Miscellaneous|0|||
147152364|NCT04238481|530719121|FG001|Overall Study|Miscellaneous|1|||
147152365|NCT04238481|530719122|FG002|Overall Study|Miscellaneous|0|||
147152366|NCT04238481|530719123|FG003|Overall Study|Miscellaneous|0|||
147152367|NCT02152371|530719124|FG000|Overall Study|Adverse Event|6|||
147152368|NCT02152371|530719125|FG001|Overall Study|Adverse Event|2|||
147152369|NCT02152371|530719124|FG000|Overall Study|Withdrawal by Subject|3|||
147152370|NCT02152371|530719125|FG001|Overall Study|Withdrawal by Subject|7|||
147152371|NCT02152371|530719124|FG000|Overall Study|Protocol Violation|2|||
147152372|NCT02152371|530719125|FG001|Overall Study|Protocol Violation|3|||
147152373|NCT02152371|530719124|FG000|Overall Study|Lost to Follow-up|1|||
147152374|NCT02152371|530719125|FG001|Overall Study|Lost to Follow-up|0|||
147152375|NCT02152371|530719124|FG000|Overall Study|Lack of Efficacy|0|||
147152376|NCT02152371|530719125|FG001|Overall Study|Lack of Efficacy|1|||
147152377|NCT02152371|530719124|FG000|Overall Study|Physician Decision|0|||
147152378|NCT02152371|530719125|FG001|Overall Study|Physician Decision|2|||
147152379|NCT02152371|530719124|FG000|Overall Study|Reason Not Given|0|||
147152380|NCT02152371|530719125|FG001|Overall Study|Reason Not Given|1|||
147152381|NCT00350870|530719126|FG000|Overall Study|Withdrawal by Subject|21|||
147152382|NCT00350870|530719127|FG001|Overall Study|Withdrawal by Subject|17|||
147152383|NCT00350870|530719128|FG002|Overall Study|Withdrawal by Subject|15|||
147152384|NCT00350870|530719129|FG003|Overall Study|Withdrawal by Subject|14|||
147152385|NCT00350870|530719126|FG000|Overall Study|Physician Decision|1|||
147152386|NCT00350870|530719127|FG001|Overall Study|Physician Decision|0|||
147152387|NCT00350870|530719128|FG002|Overall Study|Physician Decision|1|||
147152388|NCT00350870|530719129|FG003|Overall Study|Physician Decision|1|||
147152389|NCT00349921|530719130|FG000|First Spinal Injection|Physician Decision|1|||
147152390|NCT00349921|530719131|FG001|First Spinal Injection|Physician Decision|0|||
147152391|NCT00349921|530719132|FG002|First Spinal Injection|Physician Decision|0|||
147152392|NCT00349921|530719133|FG003|First Spinal Injection|Physician Decision|0|||
147152393|NCT00349921|530719130|FG000|First Spinal Injection|Adverse Event|0|||
147152394|NCT00349921|530719131|FG001|First Spinal Injection|Adverse Event|0|||
147152395|NCT00349921|530719132|FG002|First Spinal Injection|Adverse Event|1|||
147152396|NCT00349921|530719133|FG003|First Spinal Injection|Adverse Event|0|||
147152397|NCT05285644|530719134|FG000|Overall Study|Adverse Event|3|||
147152398|NCT05285644|530719135|FG001|Overall Study|Adverse Event|3|||
147152399|NCT05285644|530719134|FG000|Overall Study|Withdrawal of Consent|2|||
147152400|NCT05285644|530719135|FG001|Overall Study|Withdrawal of Consent|5|||
147152401|NCT05285644|530719134|FG000|Overall Study|Noncompliance|0|||
147152402|NCT05285644|530719135|FG001|Overall Study|Noncompliance|4|||
147152403|NCT05285644|530719134|FG000|Overall Study|Lost to Follow-up|4|||
147152404|NCT05285644|530719135|FG001|Overall Study|Lost to Follow-up|6|||
147152405|NCT05285644|530719134|FG000|Overall Study|Disallowed Concurrent Medication|1|||
147152406|NCT05285644|530719135|FG001|Overall Study|Disallowed Concurrent Medication|1|||
147152407|NCT05285644|530719134|FG000|Overall Study|Investigator Decision|2|||
147152408|NCT05285644|530719135|FG001|Overall Study|Investigator Decision|0|||
147152409|NCT05285644|530719134|FG000|Overall Study|Protocol Deviation|1|||
147152410|NCT05285644|530719135|FG001|Overall Study|Protocol Deviation|0|||
147152411|NCT05285644|530719134|FG000|Overall Study|As specified in the Clinical Study Report|7|||
147152412|NCT05285644|530719135|FG001|Overall Study|As specified in the Clinical Study Report|3|||
147152413|NCT00107900|530719138|FG000|Overall Study|Adverse Event|3|||
147152414|NCT00107900|530719139|FG001|Overall Study|Adverse Event|2|||
147152415|NCT00107900|530719140|FG002|Overall Study|Adverse Event|10|||
147653207|NCT02452554|532551976|FG005|Overall Study|Withdrawal by Subject|1|||
147653208|NCT02452554|532551971|FG000|Overall Study|Ineligible|0|||
147653209|NCT02452554|532551972|FG001|Overall Study|Ineligible|1|||
147653210|NCT02452554|532551973|FG002|Overall Study|Ineligible|0|||
147653211|NCT02452554|532551974|FG003|Overall Study|Ineligible|0|||
147653212|NCT02452554|532551975|FG004|Overall Study|Ineligible|0|||
147653213|NCT02452554|532551976|FG005|Overall Study|Ineligible|0|||
147653214|NCT02452554|532551971|FG000|Overall Study|Never Received Treatment|1|||
147653215|NCT02452554|532551972|FG001|Overall Study|Never Received Treatment|0|||
147653216|NCT02452554|532551973|FG002|Overall Study|Never Received Treatment|0|||
147653217|NCT02452554|532551974|FG003|Overall Study|Never Received Treatment|0|||
147653218|NCT02452554|532551975|FG004|Overall Study|Never Received Treatment|0|||
147653219|NCT02452554|532551976|FG005|Overall Study|Never Received Treatment|0|||
147653220|NCT02669043|532551979|FG000|Overall Study|Didn't meet I/E criteria|4|||
147653221|NCT00467558|532551982|FG000|Overall Study|Lost to Follow-up|2|||
147653222|NCT00467558|532551983|FG001|Overall Study|Lost to Follow-up|0|||
147653223|NCT02636439|532551985|FG000|Overall Study|Adverse Event|2|||
147653224|NCT02636439|532551986|FG001|Overall Study|Adverse Event|2|||
147653225|NCT02636439|532551985|FG000|Overall Study|Lost to Follow-up|1|||
147653226|NCT02636439|532551986|FG001|Overall Study|Lost to Follow-up|0|||
147653227|NCT02636439|532551985|FG000|Overall Study|Non-compliance|1|||
147653228|NCT02636439|532551986|FG001|Overall Study|Non-compliance|1|||
147653229|NCT02636439|532551985|FG000|Overall Study|Personal reasons|2|||
147653230|NCT02636439|532551986|FG001|Overall Study|Personal reasons|0|||
147653231|NCT02494401|532551987|FG000|Overall Study|Lost to Follow-up|22|||
147653232|NCT02494401|532551988|FG001|Overall Study|Lost to Follow-up|25|||
147653233|NCT02494401|532551987|FG000|Overall Study|Withdrawal by Subject|3|||
147653234|NCT02494401|532551988|FG001|Overall Study|Withdrawal by Subject|2|||
147653235|NCT05188729|532551989|FG000|Overall Study|Withdrawal by Subject|0|||
147653236|NCT05188729|532551990|FG001|Overall Study|Withdrawal by Subject|0|||
147653237|NCT05188729|532551991|FG002|Overall Study|Withdrawal by Subject|0|||
147653238|NCT05188729|532551992|FG003|Overall Study|Withdrawal by Subject|0|||
147152416|NCT00107900|530719141|FG003|Overall Study|Adverse Event|3|||
147152417|NCT00107900|530719142|FG004|Overall Study|Adverse Event|5|||
147152418|NCT00107900|530719143|FG005|Overall Study|Adverse Event|3|||
147152419|NCT00107900|530719138|FG000|Overall Study|Death|0|||
147152420|NCT00107900|530719139|FG001|Overall Study|Death|0|||
147152421|NCT00107900|530719140|FG002|Overall Study|Death|0|||
147152422|NCT00107900|530719141|FG003|Overall Study|Death|0|||
147152423|NCT00107900|530719142|FG004|Overall Study|Death|1|||
147152424|NCT00107900|530719143|FG005|Overall Study|Death|0|||
147653239|NCT05188729|532551993|FG004|Overall Study|Withdrawal by Subject|0|||
147653240|NCT05188729|532551994|FG005|Overall Study|Withdrawal by Subject|0|||
147152425|NCT00107900|530719138|FG000|Overall Study|Lost to Follow-up|4|||
147152426|NCT00107900|530719139|FG001|Overall Study|Lost to Follow-up|1|||
147152427|NCT00107900|530719140|FG002|Overall Study|Lost to Follow-up|3|||
147152428|NCT00107900|530719141|FG003|Overall Study|Lost to Follow-up|2|||
147152429|NCT00107900|530719142|FG004|Overall Study|Lost to Follow-up|5|||
147152430|NCT00107900|530719143|FG005|Overall Study|Lost to Follow-up|5|||
147152431|NCT00107900|530719138|FG000|Overall Study|Protocol Violation|1|||
147152432|NCT00107900|530719139|FG001|Overall Study|Protocol Violation|0|||
147152433|NCT00107900|530719140|FG002|Overall Study|Protocol Violation|5|||
147152434|NCT00107900|530719141|FG003|Overall Study|Protocol Violation|5|||
147321519|NCT02240680|531340062|FG000|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|0|||
147152435|NCT00107900|530719142|FG004|Overall Study|Protocol Violation|7|||
147152436|NCT00107900|530719143|FG005|Overall Study|Protocol Violation|0|||
147653241|NCT05188729|532551995|FG006|Overall Study|Withdrawal by Subject|0|||
147653242|NCT05188729|532551996|FG007|Overall Study|Withdrawal by Subject|0|||
147653243|NCT05188729|532551997|FG008|Overall Study|Withdrawal by Subject|0|||
147653244|NCT05188729|532551998|FG009|Overall Study|Withdrawal by Subject|1|||
147653245|NCT05188729|532551999|FG010|Overall Study|Withdrawal by Subject|0|||
147653246|NCT05188729|532552000|FG011|Overall Study|Withdrawal by Subject|0|||
147152437|NCT00107900|530719138|FG000|Overall Study|Withdrawal by Subject|1|||
147152438|NCT00107900|530719139|FG001|Overall Study|Withdrawal by Subject|0|||
147152439|NCT00107900|530719140|FG002|Overall Study|Withdrawal by Subject|5|||
147152440|NCT00107900|530719141|FG003|Overall Study|Withdrawal by Subject|0|||
147152441|NCT00107900|530719142|FG004|Overall Study|Withdrawal by Subject|1|||
147152442|NCT00107900|530719143|FG005|Overall Study|Withdrawal by Subject|1|||
147152443|NCT00107900|530719138|FG000|Overall Study|Administrative Reasons|1|||
147152444|NCT00107900|530719139|FG001|Overall Study|Administrative Reasons|0|||
147152445|NCT00107900|530719140|FG002|Overall Study|Administrative Reasons|2|||
147152446|NCT00107900|530719141|FG003|Overall Study|Administrative Reasons|2|||
147152447|NCT00107900|530719142|FG004|Overall Study|Administrative Reasons|2|||
147152448|NCT00107900|530719143|FG005|Overall Study|Administrative Reasons|0|||
147152449|NCT00511433|530721190|FG000|Overall Study|Adverse Event|5|||
147152450|NCT00511433|530721191|FG001|Overall Study|Adverse Event|0|||
147152451|NCT00511433|530721190|FG000|Overall Study|Other Reason|1|||
147152452|NCT00511433|530721191|FG001|Overall Study|Other Reason|1|||
147152453|NCT01380535|530721192|FG000|Overall Study|Adverse Event|3|||
147152454|NCT01380535|530721193|FG001|Overall Study|Adverse Event|3|||
147152455|NCT01380535|530721192|FG000|Overall Study|Death|3|||
147152456|NCT01380535|530721193|FG001|Overall Study|Death|0|||
147152457|NCT01380535|530721192|FG000|Overall Study|Study site closed|0|||
147152458|NCT01380535|530721193|FG001|Overall Study|Study site closed|5|||
147152459|NCT01380535|530721192|FG000|Overall Study|Withdrawal by Subject|1|||
147152460|NCT01380535|530721193|FG001|Overall Study|Withdrawal by Subject|2|||
147152461|NCT01380535|530721192|FG000|Overall Study|Protocol Violation|0|||
147152462|NCT01380535|530721193|FG001|Overall Study|Protocol Violation|2|||
147579014|NCT02854800|532275019|FG002|Overall Study|Withdrawal by Subject|3|||
147152463|NCT01380535|530721192|FG000|Overall Study|Lack of Efficacy|0|||
147152464|NCT01380535|530721193|FG001|Overall Study|Lack of Efficacy|3|||
147152465|NCT03100539|530721194|FG000|Overall Study|Lost to Follow-up|60|||
147152466|NCT03100539|530721195|FG001|Overall Study|Lost to Follow-up|54|||
147152467|NCT03100539|530721196|FG002|Overall Study|Lost to Follow-up|17|||
147152468|NCT03100539|530721194|FG000|Overall Study|Uncollected|8|||
147152469|NCT03100539|530721195|FG001|Overall Study|Uncollected|8|||
147152470|NCT03100539|530721196|FG002|Overall Study|Uncollected|0|||
147152471|NCT03100539|530721194|FG000|Overall Study|Ally Health|0|||
147152472|NCT03100539|530721195|FG001|Overall Study|Ally Health|0|||
147152473|NCT03100539|530721196|FG002|Overall Study|Ally Health|3|||
147152474|NCT03100539|530721194|FG000|Overall Study|Disinterest|0|||
147152475|NCT03100539|530721195|FG001|Overall Study|Disinterest|0|||
147152476|NCT03100539|530721196|FG002|Overall Study|Disinterest|22|||
147152477|NCT03100539|530721194|FG000|Overall Study|Veteran Health|0|||
147152478|NCT03100539|530721195|FG001|Overall Study|Veteran Health|0|||
147152479|NCT03100539|530721196|FG002|Overall Study|Veteran Health|8|||
147239716|NCT02935842|531049269|FG003|Testing and Therapy Period 2|Withdrawal by Subject|0|||
147239717|NCT02935842|531049266|FG000|Testing and Therapy Period 3|Required other therapy (dysphagia)|1|||
147239718|NCT02935842|531049267|FG001|Testing and Therapy Period 3|Required other therapy (dysphagia)|2|||
147239719|NCT02935842|531049268|FG002|Testing and Therapy Period 3|Required other therapy (dysphagia)|2|||
147239720|NCT02935842|531049269|FG003|Testing and Therapy Period 3|Required other therapy (dysphagia)|0|||
147152480|NCT03100539|530721194|FG000|Overall Study|Moved|0|||
147152481|NCT03100539|530721195|FG001|Overall Study|Moved|0|||
147152482|NCT03100539|530721196|FG002|Overall Study|Moved|1|||
147152483|NCT03100539|530721194|FG000|Overall Study|Scheduling Conflicts|0|||
147239721|NCT02935842|531049266|FG000|Testing and Therapy Period 3|Accident prior to treatment|2|||
147239722|NCT02935842|531049267|FG001|Testing and Therapy Period 3|Accident prior to treatment|2|||
147239723|NCT02935842|531049268|FG002|Testing and Therapy Period 3|Accident prior to treatment|0|||
147239724|NCT02935842|531049269|FG003|Testing and Therapy Period 3|Accident prior to treatment|0|||
147239725|NCT02935842|531049266|FG000|Testing and Therapy Period 3|Lost to Follow-up|0|||
147239726|NCT02935842|531049267|FG001|Testing and Therapy Period 3|Lost to Follow-up|0|||
147239727|NCT02935842|531049268|FG002|Testing and Therapy Period 3|Lost to Follow-up|0|||
147239728|NCT02935842|531049269|FG003|Testing and Therapy Period 3|Lost to Follow-up|1|||
147239729|NCT02935842|531049266|FG000|Testing and Therapy Period 3|Withdrawal by Subject|0|||
147239730|NCT02935842|531049267|FG001|Testing and Therapy Period 3|Withdrawal by Subject|0|||
147239731|NCT02935842|531049268|FG002|Testing and Therapy Period 3|Withdrawal by Subject|3|||
147239732|NCT02935842|531049269|FG003|Testing and Therapy Period 3|Withdrawal by Subject|0|||
147239733|NCT00911547|531049270|FG000|Overall Study|Adverse Event|8|||
147239734|NCT00911547|531049271|FG001|Overall Study|Adverse Event|27|||
147239735|NCT00911547|531049272|FG002|Overall Study|Adverse Event|11|||
147152484|NCT03100539|530721195|FG001|Overall Study|Scheduling Conflicts|0|||
147239736|NCT00911547|531049273|FG003|Overall Study|Adverse Event|6|||
147239737|NCT00911547|531049270|FG000|Overall Study|Lost to Follow-up|0|||
147239738|NCT00911547|531049271|FG001|Overall Study|Lost to Follow-up|0|||
147239739|NCT00911547|531049272|FG002|Overall Study|Lost to Follow-up|2|||
147239740|NCT00911547|531049273|FG003|Overall Study|Lost to Follow-up|1|||
147152485|NCT03100539|530721196|FG002|Overall Study|Scheduling Conflicts|12|||
147152486|NCT02596958|530721197|FG000|Overall Study|Serious Adverse Drug Reactions|44|||
147152487|NCT02596958|530721197|FG000|Overall Study|Cancer Progression|441|||
147152488|NCT02596958|530721197|FG000|Overall Study|Death From Cancer|112|||
147152489|NCT02596958|530721197|FG000|Overall Study|Death From Other Cause|33|||
147152490|NCT02596958|530721197|FG000|Overall Study|Refusal of Treatment/Poor Cooperation|61|||
147152491|NCT02596958|530721197|FG000|Overall Study|Administrative Reasons/Other|231|||
147152492|NCT02596958|530721197|FG000|Overall Study|Lost to Follow-up|33|||
147152493|NCT02596958|530721197|FG000|Overall Study|Missing|32|||
147152494|NCT02596958|530721197|FG000|Overall Study|Excluded Due to Second Line Treatment|9|||
147152495|NCT02923830|530721198|FG000|Overall Study|Physician Decision|13|||
147152496|NCT02923830|530721199|FG001|Overall Study|Physician Decision|15|||
147152497|NCT01751906|530721206|FG000|Overall Study|Lost to Follow-up|151|||
147152498|NCT01751906|530721207|FG001|Overall Study|Lost to Follow-up|68|||
147152499|NCT01751906|530721206|FG000|Overall Study|Withdrawal by Subject|22|||
147152500|NCT01751906|530721207|FG001|Overall Study|Withdrawal by Subject|18|||
147152501|NCT01751906|530721206|FG000|Overall Study|Physician Decision|5|||
147152502|NCT01751906|530721207|FG001|Overall Study|Physician Decision|2|||
147152503|NCT01751906|530721206|FG000|Overall Study|Death|84|||
147152504|NCT01751906|530721207|FG001|Overall Study|Death|43|||
147152505|NCT01751906|530721206|FG000|Overall Study|Denied on premises for follow-up by law|1|||
147152506|NCT01751906|530721207|FG001|Overall Study|Denied on premises for follow-up by law|0|||
147152507|NCT02242435|530721210|FG000|Overall Study|Lost to Follow-up|3|||
147152508|NCT02242435|530721211|FG001|Overall Study|Lost to Follow-up|4|||
147152509|NCT02242435|530721210|FG000|Overall Study|Adverse Event|3|||
147152510|NCT02242435|530721211|FG001|Overall Study|Adverse Event|2|||
147152511|NCT02242435|530721210|FG000|Overall Study|Withdrawal by Subject|13|||
147152512|NCT02242435|530721211|FG001|Overall Study|Withdrawal by Subject|8|||
147152513|NCT02242435|530721210|FG000|Overall Study|Death|0|||
147152514|NCT02242435|530721211|FG001|Overall Study|Death|1|||
147152515|NCT02242435|530721210|FG000|Overall Study|Protocol Violation|1|||
147152516|NCT02242435|530721211|FG001|Overall Study|Protocol Violation|0|||
147152517|NCT02242435|530721210|FG000|Overall Study|Physician Decision|0|||
147152518|NCT02242435|530721211|FG001|Overall Study|Physician Decision|1|||
147152519|NCT01110330|530721212|FG000|Overall Study|Adverse Event|0|||
147239741|NCT00911547|531049270|FG000|Overall Study|Protocol Violation|0|||
147239742|NCT00911547|531049271|FG001|Overall Study|Protocol Violation|5|||
147239743|NCT00911547|531049272|FG002|Overall Study|Protocol Violation|5|||
147239744|NCT00911547|531049273|FG003|Overall Study|Protocol Violation|1|||
147239745|NCT00911547|531049270|FG000|Overall Study|Withdrawal by Subject|3|||
147239746|NCT00911547|531049271|FG001|Overall Study|Withdrawal by Subject|10|||
147239747|NCT00911547|531049272|FG002|Overall Study|Withdrawal by Subject|4|||
147239748|NCT00911547|531049273|FG003|Overall Study|Withdrawal by Subject|8|||
147239749|NCT00365508|531049280|FG000|Overall Study|Lost to Follow-up|139|||
147239750|NCT00365508|531049281|FG001|Overall Study|Lost to Follow-up|154|||
147239751|NCT02538029|531049283|FG000|Overall Study|unable to complete cognitive assessments|1|||
147239752|NCT02538029|531049284|FG001|Overall Study|unable to complete cognitive assessments|0|||
147239753|NCT02538029|531049285|FG002|Overall Study|unable to complete cognitive assessments|1|||
147239754|NCT00566995|531049288|FG000|Overall Study|Toxicity|4|||
147239755|NCT00566995|531049288|FG000|Overall Study|Withdrew consent|3|||
147239756|NCT00404235|531049289|FG000|Overall Study|Withdrawal by Subject|1|||
147239757|NCT00404235|531049290|FG001|Overall Study|Withdrawal by Subject|2|||
147239758|NCT00001880|531049291|FG000|Overall Study|Death|14|||
147239759|NCT00481078|531049292|FG000|Overall Study|Progression of disease|11|||
147239760|NCT00481078|531049293|FG001|Overall Study|Progression of disease|11|||
147239761|NCT00481078|531049292|FG000|Overall Study|Adverse Event|15|||
147239762|NCT00481078|531049293|FG001|Overall Study|Adverse Event|3|||
147239763|NCT00481078|531049292|FG000|Overall Study|Death|5|||
147239764|NCT00481078|531049293|FG001|Overall Study|Death|3|||
147239765|NCT00481078|531049292|FG000|Overall Study|Intercurrent illness|1|||
147239766|NCT00481078|531049293|FG001|Overall Study|Intercurrent illness|0|||
147239767|NCT00481078|531049292|FG000|Overall Study|Withdrawal by Subject|7|||
147239768|NCT00481078|531049293|FG001|Overall Study|Withdrawal by Subject|1|||
147239769|NCT00481078|531049292|FG000|Overall Study|Information not available|1|||
147239770|NCT00481078|531049293|FG001|Overall Study|Information not available|0|||
147239771|NCT00481078|531049292|FG000|Overall Study|Received other treatment|2|||
147239772|NCT00481078|531049293|FG001|Overall Study|Received other treatment|1|||
147239773|NCT00481078|531049292|FG000|Overall Study|Brain metastasis|0|||
147239774|NCT00481078|531049293|FG001|Overall Study|Brain metastasis|1|||
147239775|NCT00228384|531049296|FG000|Overall Study|Death|9|||
147239776|NCT00228384|531049297|FG001|Overall Study|Death|3|||
147239777|NCT00228384|531049296|FG000|Overall Study|Lost to Follow-up|6|||
147239778|NCT00228384|531049297|FG001|Overall Study|Lost to Follow-up|10|||
147239779|NCT00228384|531049296|FG000|Overall Study|Surgical Intervention (bypass)|5|||
147239780|NCT00228384|531049297|FG001|Overall Study|Surgical Intervention (bypass)|5|||
147579015|NCT05278858|532275021|FG000|Overall Study|Withdrawal by Subject|1|||
147321520|NCT02240680|531340063|FG001|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|0|||
147152520|NCT01110330|530721213|FG001|Overall Study|Adverse Event|4|||
147152521|NCT01110330|530721214|FG002|Overall Study|Adverse Event|3|||
147239781|NCT00228384|531049296|FG000|Overall Study|Withdrawal by Subject|9|||
147579016|NCT00840658|532275022|FG000|Overall Study|Death|2|||
147579017|NCT00840658|532275023|FG001|Overall Study|Death|2|||
147579018|NCT00840658|532275024|FG002|Overall Study|Death|3|||
147579019|NCT00840658|532275025|FG003|Overall Study|Death|3|||
147152522|NCT01110330|530721212|FG000|Overall Study|Lack of Efficacy|3|||
147152523|NCT01110330|530721213|FG001|Overall Study|Lack of Efficacy|1|||
147152524|NCT01110330|530721214|FG002|Overall Study|Lack of Efficacy|1|||
147152525|NCT01110330|530721212|FG000|Overall Study|Lost to Follow-up|9|||
147152526|NCT01110330|530721213|FG001|Overall Study|Lost to Follow-up|10|||
147152527|NCT01110330|530721214|FG002|Overall Study|Lost to Follow-up|15|||
147152528|NCT01110330|530721212|FG000|Overall Study|Physician Decision|0|||
147152529|NCT01110330|530721213|FG001|Overall Study|Physician Decision|1|||
147152530|NCT01110330|530721214|FG002|Overall Study|Physician Decision|0|||
147152531|NCT01110330|530721212|FG000|Overall Study|Protocol Violation|2|||
147152532|NCT01110330|530721213|FG001|Overall Study|Protocol Violation|0|||
147152533|NCT01110330|530721214|FG002|Overall Study|Protocol Violation|4|||
147152534|NCT01110330|530721212|FG000|Overall Study|Withdrawal by Subject|0|||
147152535|NCT01110330|530721213|FG001|Overall Study|Withdrawal by Subject|6|||
147152536|NCT01110330|530721214|FG002|Overall Study|Withdrawal by Subject|2|||
147152537|NCT01110330|530721212|FG000|Overall Study|Other|1|||
147152538|NCT01110330|530721213|FG001|Overall Study|Other|1|||
147152539|NCT01110330|530721214|FG002|Overall Study|Other|1|||
147152540|NCT03350035|530721235|FG000|Overall Study|Lack of Efficacy|2|||
147152541|NCT03350035|530721236|FG001|Overall Study|Lack of Efficacy|0|||
147152542|NCT03350035|530721237|FG002|Overall Study|Lack of Efficacy|0|||
147152543|NCT03350035|530721235|FG000|Overall Study|Subject discharged to hospice|0|||
147152544|NCT03350035|530721236|FG001|Overall Study|Subject discharged to hospice|0|||
147152545|NCT03350035|530721237|FG002|Overall Study|Subject discharged to hospice|1|||
147152546|NCT04115748|530721238|FG000|Main Study (Up to 16 Weeks)|Study terminated by sponsor|15|||
147152547|NCT04115748|530721239|FG001|Main Study (Up to 16 Weeks)|Study terminated by sponsor|16|||
147152548|NCT04115748|530721240|FG002|Main Study (Up to 16 Weeks)|Study terminated by sponsor|7|||
147152549|NCT04115748|530721241|FG003|Main Study (Up to 16 Weeks)|Study terminated by sponsor|15|||
147152550|NCT04115748|530721242|FG004|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
147152551|NCT04115748|530721243|FG005|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
147152552|NCT04115748|530721244|FG006|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
147152553|NCT04115748|530721245|FG007|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
147152554|NCT04115748|530721246|FG008|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
147152555|NCT04115748|530721247|FG009|Main Study (Up to 16 Weeks)|Study terminated by sponsor|0|||
147152556|NCT04115748|530721238|FG000|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
147152557|NCT04115748|530721239|FG001|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
147152558|NCT04115748|530721240|FG002|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
147152559|NCT04115748|530721241|FG003|Main Study (Up to 16 Weeks)|Withdrew consent|1|||
147152560|NCT04115748|530721242|FG004|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
147152561|NCT04115748|530721243|FG005|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
147152562|NCT04115748|530721244|FG006|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
147152563|NCT04115748|530721245|FG007|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
147152564|NCT04115748|530721246|FG008|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
147152565|NCT04115748|530721247|FG009|Main Study (Up to 16 Weeks)|Withdrew consent|0|||
147152566|NCT04115748|530721238|FG000|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|0|||
147152567|NCT04115748|530721239|FG001|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|0|||
147152568|NCT04115748|530721240|FG002|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|0|||
147152569|NCT04115748|530721241|FG003|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|0|||
147152570|NCT04115748|530721242|FG004|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|4|||
147152571|NCT04115748|530721243|FG005|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|3|||
147152572|NCT04115748|530721244|FG006|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|1|||
147152573|NCT04115748|530721245|FG007|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|1|||
147152574|NCT04115748|530721246|FG008|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|1|||
147152575|NCT04115748|530721247|FG009|LTE (After 16 Weeks to Week 50)|Study terminated by sponsor|2|||
147152576|NCT04115748|530721238|FG000|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
147152577|NCT04115748|530721239|FG001|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
147152578|NCT04115748|530721240|FG002|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
147152579|NCT04115748|530721241|FG003|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
147152580|NCT04115748|530721242|FG004|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
147152581|NCT04115748|530721243|FG005|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
147152582|NCT04115748|530721244|FG006|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
147152583|NCT04115748|530721245|FG007|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
147446282|NCT02255409|531798897|FG001|Overall Study|Lost to Follow-up|19|||
147579020|NCT00840658|532275022|FG000|Overall Study|Lost to Follow-up|3|||
147579021|NCT00840658|532275023|FG001|Overall Study|Lost to Follow-up|1|||
147152584|NCT04115748|530721246|FG008|LTE (After 16 Weeks to Week 50)|Adverse Event|1|||
147152585|NCT04115748|530721247|FG009|LTE (After 16 Weeks to Week 50)|Adverse Event|0|||
147152586|NCT00713349|530721248|FG000|Overall Study|Protocol Violation|1|||
147152587|NCT03764631|530721249|FG000|Overall Study|Personal Reasons|3|||
147152588|NCT03764631|530721250|FG001|Overall Study|Personal Reasons|2|||
147152589|NCT03764631|530721249|FG000|Overall Study|Switching Therapy|3|||
147152590|NCT03764631|530721250|FG001|Overall Study|Switching Therapy|3|||
147152591|NCT03764631|530721249|FG000|Overall Study|Adverse Event|0|||
147152592|NCT03764631|530721250|FG001|Overall Study|Adverse Event|1|||
147152593|NCT03764631|530721249|FG000|Overall Study|Lost to Follow-up|33|||
147152594|NCT03764631|530721250|FG001|Overall Study|Lost to Follow-up|41|||
147152595|NCT03764631|530721249|FG000|Overall Study|No data as study site was closed|2|||
147152596|NCT03764631|530721250|FG001|Overall Study|No data as study site was closed|6|||
147152597|NCT01200407|530721251|FG000|Overall Study|Lost to Follow-up|56|||
147152598|NCT01200407|530721251|FG000|Overall Study|Adverse Event|3|||
147152599|NCT01200407|530721251|FG000|Overall Study|Withdrawal by Subject|4|||
147152600|NCT01200407|530721251|FG000|Overall Study|Other|19|||
147152601|NCT02974855|530721254|FG000|Overall Study|Adverse Event|0|||
147152602|NCT02974855|530721255|FG001|Overall Study|Adverse Event|1|||
147152603|NCT02974855|530721256|FG002|Overall Study|Adverse Event|0|||
147152604|NCT02974855|530721257|FG003|Overall Study|Adverse Event|1|||
147152605|NCT00633074|530721258|FG000|Overall Study|Adverse Event|1|||
147152606|NCT00633074|530721259|FG001|Overall Study|Adverse Event|0|||
147152607|NCT02752633|530721261|FG000|Overall Study|Withdrawal by Subject|1|||
147152608|NCT01843673|530721262|FG000|Overall Study|Lack of Efficacy|2|||
147152609|NCT01843673|530721262|FG000|Overall Study|Withdrawal by Subject|4|||
147152610|NCT03275246|530721263|FG000|Overall Study|Protocol Violation|5|||
147152611|NCT03275246|530721263|FG000|Overall Study|The study was stopped before the patient reached the final 1 year follow-up|1|||
147152612|NCT00433966|530721266|FG000|Pharmacology Intervention/Randomization|Withdrawal by Subject|40|||
147152613|NCT00433966|530721267|FG001|Pharmacology Intervention/Randomization|Withdrawal by Subject|43|||
147152614|NCT00433966|530721268|FG002|Pharmacology Intervention/Randomization|Withdrawal by Subject|0|||
147152615|NCT00433966|530721269|FG003|Pharmacology Intervention/Randomization|Withdrawal by Subject|0|||
147152616|NCT00433966|530721266|FG000|Pharmacology Intervention/Randomization|Lost to Follow-up|97|||
147152617|NCT00433966|530721267|FG001|Pharmacology Intervention/Randomization|Lost to Follow-up|103|||
147152618|NCT00433966|530721268|FG002|Pharmacology Intervention/Randomization|Lost to Follow-up|0|||
147152619|NCT00433966|530721269|FG003|Pharmacology Intervention/Randomization|Lost to Follow-up|0|||
147152620|NCT00433966|530721266|FG000|Pharmacology Intervention/Randomization|Not true myocardial infarction|29|||
147152621|NCT00433966|530721267|FG001|Pharmacology Intervention/Randomization|Not true myocardial infarction|28|||
147152622|NCT00433966|530721268|FG002|Pharmacology Intervention/Randomization|Not true myocardial infarction|0|||
147152623|NCT00433966|530721269|FG003|Pharmacology Intervention/Randomization|Not true myocardial infarction|0|||
147152624|NCT00433966|530721266|FG000|Stent Intervention/Randomization|Withdrawal by Subject|0|||
147152625|NCT00433966|530721267|FG001|Stent Intervention/Randomization|Withdrawal by Subject|0|||
147152626|NCT00433966|530721268|FG002|Stent Intervention/Randomization|Withdrawal by Subject|41|||
147152627|NCT00433966|530721269|FG003|Stent Intervention/Randomization|Withdrawal by Subject|15|||
147152628|NCT00433966|530721266|FG000|Stent Intervention/Randomization|Lost to Follow-up|0|||
147152629|NCT00433966|530721267|FG001|Stent Intervention/Randomization|Lost to Follow-up|0|||
147321521|NCT02240680|531340064|FG002|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|1|||
147321522|NCT02240680|531340065|FG003|Japanese Patients (Up to 52 Weeks)|Withdrawal by Subject|0|||
147321523|NCT01657032|531340066|FG000|Overall Study|Lost to Follow-up|0|||
147321524|NCT01657032|531340067|FG001|Overall Study|Lost to Follow-up|7|||
147321525|NCT03633903|531340068|FG000|Overall Study|Withdrawal by Subject|1|||
147321526|NCT03633903|531340069|FG001|Overall Study|Withdrawal by Subject|2|||
147321527|NCT03633903|531340068|FG000|Overall Study|Lost to Follow-up|5|||
147321528|NCT03633903|531340069|FG001|Overall Study|Lost to Follow-up|5|||
147321529|NCT05968482|531340070|FG000|First Crossover Period|Withdrawal by Subject|0|||
147321530|NCT05968482|531340071|FG001|First Crossover Period|Withdrawal by Subject|0|||
147321531|NCT05968482|531340072|FG002|First Crossover Period|Withdrawal by Subject|1|||
147321532|NCT05968482|531340073|FG003|First Crossover Period|Withdrawal by Subject|0|||
147321533|NCT05968482|531340074|FG004|First Crossover Period|Withdrawal by Subject|0|||
147321534|NCT05968482|531340075|FG005|First Crossover Period|Withdrawal by Subject|0|||
147579022|NCT00840658|532275024|FG002|Overall Study|Lost to Follow-up|2|||
147579023|NCT00840658|532275025|FG003|Overall Study|Lost to Follow-up|1|||
147579024|NCT01859598|532275027|FG000|Visit 2 at 3 Months|Lost to Follow-up|1742|||
147579025|NCT00573313|532275028|FG000|Overall Study|Protocol Violation|5|||
147152630|NCT00433966|530721268|FG002|Stent Intervention/Randomization|Lost to Follow-up|113|||
147152631|NCT00433966|530721269|FG003|Stent Intervention/Randomization|Lost to Follow-up|47|||
147152632|NCT02570152|530721270|FG000|Overall Study|Protocol Violation|2|||
147152633|NCT02570152|530721270|FG000|Overall Study|Migrated/moved from study area|13|||
147152634|NCT03497975|530721272|FG000|Overall Study|Withdrew Consent|34|||
147152635|NCT03497975|530721273|FG001|Overall Study|Withdrew Consent|35|||
147152636|NCT03497975|530721272|FG000|Overall Study|Lost to Follow-up|7|||
147321535|NCT05968482|531340070|FG000|First Crossover Period|Adverse Event|0|||
147321536|NCT05968482|531340071|FG001|First Crossover Period|Adverse Event|0|||
147321537|NCT05968482|531340072|FG002|First Crossover Period|Adverse Event|0|||
147321538|NCT05968482|531340073|FG003|First Crossover Period|Adverse Event|0|||
147152637|NCT03497975|530721273|FG001|Overall Study|Lost to Follow-up|7|||
147152638|NCT03497975|530721272|FG000|Overall Study|Physician Decision|4|||
147152639|NCT03497975|530721273|FG001|Overall Study|Physician Decision|5|||
147152640|NCT03497975|530721272|FG000|Overall Study|Discontinued|42|||
147152641|NCT03497975|530721273|FG001|Overall Study|Discontinued|39|||
147152642|NCT03497975|530721272|FG000|Overall Study|Reason Not Specified|15|||
147152643|NCT03497975|530721273|FG001|Overall Study|Reason Not Specified|14|||
147152644|NCT01296711|530721274|FG000|Overall Study|Adverse Event|3|||
147152645|NCT01296711|530721275|FG001|Overall Study|Adverse Event|1|||
147152646|NCT01296711|530721276|FG002|Overall Study|Adverse Event|4|||
147152647|NCT01296711|530721277|FG003|Overall Study|Adverse Event|3|||
147152648|NCT01296711|530721278|FG004|Overall Study|Adverse Event|1|||
147152649|NCT01296711|530721279|FG005|Overall Study|Adverse Event|6|||
147152650|NCT01296711|530721280|FG006|Overall Study|Adverse Event|11|||
147152651|NCT01296711|530721281|FG007|Overall Study|Adverse Event|3|||
147152652|NCT01296711|530721274|FG000|Overall Study|Lack of Efficacy|1|||
147152653|NCT01296711|530721275|FG001|Overall Study|Lack of Efficacy|4|||
147152654|NCT01296711|530721276|FG002|Overall Study|Lack of Efficacy|1|||
147152655|NCT01296711|530721277|FG003|Overall Study|Lack of Efficacy|1|||
147152656|NCT01296711|530721278|FG004|Overall Study|Lack of Efficacy|1|||
147152657|NCT01296711|530721279|FG005|Overall Study|Lack of Efficacy|0|||
147152658|NCT01296711|530721280|FG006|Overall Study|Lack of Efficacy|2|||
147152659|NCT01296711|530721281|FG007|Overall Study|Lack of Efficacy|3|||
147152660|NCT01296711|530721274|FG000|Overall Study|Lost to Follow-up|0|||
147152661|NCT01296711|530721275|FG001|Overall Study|Lost to Follow-up|0|||
147152662|NCT01296711|530721276|FG002|Overall Study|Lost to Follow-up|1|||
147152663|NCT01296711|530721277|FG003|Overall Study|Lost to Follow-up|1|||
147152664|NCT01296711|530721278|FG004|Overall Study|Lost to Follow-up|2|||
147152665|NCT01296711|530721279|FG005|Overall Study|Lost to Follow-up|0|||
147152666|NCT01296711|530721280|FG006|Overall Study|Lost to Follow-up|4|||
147152667|NCT01296711|530721281|FG007|Overall Study|Lost to Follow-up|2|||
147152668|NCT01296711|530721274|FG000|Overall Study|Protocol Violation|0|||
147152669|NCT01296711|530721275|FG001|Overall Study|Protocol Violation|0|||
147152670|NCT01296711|530721276|FG002|Overall Study|Protocol Violation|0|||
147152671|NCT01296711|530721277|FG003|Overall Study|Protocol Violation|1|||
147152672|NCT01296711|530721278|FG004|Overall Study|Protocol Violation|1|||
147152673|NCT01296711|530721279|FG005|Overall Study|Protocol Violation|0|||
147152674|NCT01296711|530721280|FG006|Overall Study|Protocol Violation|0|||
147152675|NCT01296711|530721281|FG007|Overall Study|Protocol Violation|0|||
147152676|NCT01296711|530721274|FG000|Overall Study|Withdrawal by Subject|4|||
147152677|NCT01296711|530721275|FG001|Overall Study|Withdrawal by Subject|2|||
147152678|NCT01296711|530721276|FG002|Overall Study|Withdrawal by Subject|2|||
147152679|NCT01296711|530721277|FG003|Overall Study|Withdrawal by Subject|1|||
147152680|NCT01296711|530721278|FG004|Overall Study|Withdrawal by Subject|1|||
147152681|NCT01296711|530721279|FG005|Overall Study|Withdrawal by Subject|1|||
147152682|NCT01296711|530721280|FG006|Overall Study|Withdrawal by Subject|2|||
147152683|NCT01296711|530721281|FG007|Overall Study|Withdrawal by Subject|1|||
147152684|NCT01296711|530721274|FG000|Overall Study|Study termination|8|||
147152685|NCT01296711|530721275|FG001|Overall Study|Study termination|1|||
147152686|NCT01296711|530721276|FG002|Overall Study|Study termination|5|||
147152687|NCT01296711|530721277|FG003|Overall Study|Study termination|4|||
147152688|NCT01296711|530721278|FG004|Overall Study|Study termination|4|||
147152689|NCT01296711|530721279|FG005|Overall Study|Study termination|4|||
147152690|NCT01296711|530721280|FG006|Overall Study|Study termination|8|||
147152691|NCT01296711|530721281|FG007|Overall Study|Study termination|10|||
147152692|NCT01296711|530721274|FG000|Overall Study|Continued elevated liver enzymes|0|||
147239782|NCT00228384|531049297|FG001|Overall Study|Withdrawal by Subject|10|||
147239783|NCT00228384|531049296|FG000|Overall Study|Physician Decision|0|||
147239784|NCT00228384|531049297|FG001|Overall Study|Physician Decision|1|||
147239785|NCT01980940|531049299|FG000|Overall Study|Protocol Violation|0|||
147239786|NCT01980940|531049300|FG001|Overall Study|Protocol Violation|0|||
147239787|NCT01980940|531049301|FG002|Overall Study|Protocol Violation|0|||
147239788|NCT01980940|531049302|FG003|Overall Study|Protocol Violation|0|||
147152693|NCT01296711|530721275|FG001|Overall Study|Continued elevated liver enzymes|0|||
147152694|NCT01296711|530721276|FG002|Overall Study|Continued elevated liver enzymes|0|||
147152695|NCT01296711|530721277|FG003|Overall Study|Continued elevated liver enzymes|1|||
147152696|NCT01296711|530721278|FG004|Overall Study|Continued elevated liver enzymes|0|||
147152697|NCT01296711|530721279|FG005|Overall Study|Continued elevated liver enzymes|0|||
147152698|NCT01296711|530721280|FG006|Overall Study|Continued elevated liver enzymes|0|||
147152699|NCT01296711|530721281|FG007|Overall Study|Continued elevated liver enzymes|0|||
147152700|NCT01296711|530721274|FG000|Overall Study|Methotrexate discontinued|0|||
147152701|NCT01296711|530721275|FG001|Overall Study|Methotrexate discontinued|0|||
147152702|NCT01296711|530721276|FG002|Overall Study|Methotrexate discontinued|0|||
147152703|NCT01296711|530721277|FG003|Overall Study|Methotrexate discontinued|1|||
147152704|NCT01296711|530721278|FG004|Overall Study|Methotrexate discontinued|0|||
147152705|NCT01296711|530721279|FG005|Overall Study|Methotrexate discontinued|0|||
147239789|NCT01980940|531049303|FG004|Overall Study|Protocol Violation|0|||
147152706|NCT01296711|530721280|FG006|Overall Study|Methotrexate discontinued|0|||
147152707|NCT01296711|530721281|FG007|Overall Study|Methotrexate discontinued|0|||
147152708|NCT01296711|530721274|FG000|Overall Study|Investigator discretion|0|||
147152709|NCT01296711|530721275|FG001|Overall Study|Investigator discretion|0|||
147152710|NCT01296711|530721276|FG002|Overall Study|Investigator discretion|0|||
147152711|NCT01296711|530721277|FG003|Overall Study|Investigator discretion|0|||
147152712|NCT01296711|530721278|FG004|Overall Study|Investigator discretion|0|||
147152713|NCT01296711|530721279|FG005|Overall Study|Investigator discretion|0|||
147152714|NCT01296711|530721280|FG006|Overall Study|Investigator discretion|1|||
147152715|NCT01296711|530721281|FG007|Overall Study|Investigator discretion|0|||
147152716|NCT01296711|530721274|FG000|Overall Study|Other|0|||
147152717|NCT01296711|530721275|FG001|Overall Study|Other|0|||
147152718|NCT01296711|530721276|FG002|Overall Study|Other|0|||
147152719|NCT01296711|530721277|FG003|Overall Study|Other|0|||
147152720|NCT01296711|530721278|FG004|Overall Study|Other|0|||
147152721|NCT01296711|530721279|FG005|Overall Study|Other|0|||
147152722|NCT01296711|530721280|FG006|Overall Study|Other|1|||
147152723|NCT01296711|530721281|FG007|Overall Study|Other|0|||
147152724|NCT01296711|530721274|FG000|Overall Study|Required restricted steroid injections|0|||
147152725|NCT01296711|530721275|FG001|Overall Study|Required restricted steroid injections|0|||
147152726|NCT01296711|530721276|FG002|Overall Study|Required restricted steroid injections|0|||
147152727|NCT01296711|530721277|FG003|Overall Study|Required restricted steroid injections|0|||
147152728|NCT01296711|530721278|FG004|Overall Study|Required restricted steroid injections|0|||
147152729|NCT01296711|530721279|FG005|Overall Study|Required restricted steroid injections|0|||
147152730|NCT01296711|530721280|FG006|Overall Study|Required restricted steroid injections|1|||
147152731|NCT01296711|530721281|FG007|Overall Study|Required restricted steroid injections|0|||
147152732|NCT01296711|530721274|FG000|Overall Study|Ongoing missed appointments|0|||
147152733|NCT01296711|530721275|FG001|Overall Study|Ongoing missed appointments|0|||
147152734|NCT01296711|530721276|FG002|Overall Study|Ongoing missed appointments|0|||
147152735|NCT01296711|530721277|FG003|Overall Study|Ongoing missed appointments|0|||
147152736|NCT01296711|530721278|FG004|Overall Study|Ongoing missed appointments|0|||
147152737|NCT01296711|530721279|FG005|Overall Study|Ongoing missed appointments|0|||
147152738|NCT01296711|530721280|FG006|Overall Study|Ongoing missed appointments|1|||
147152739|NCT01296711|530721281|FG007|Overall Study|Ongoing missed appointments|0|||
147152740|NCT01296711|530721274|FG000|Overall Study|Failure to comply with visits|0|||
147152741|NCT01296711|530721275|FG001|Overall Study|Failure to comply with visits|0|||
147152742|NCT01296711|530721276|FG002|Overall Study|Failure to comply with visits|0|||
147152743|NCT01296711|530721277|FG003|Overall Study|Failure to comply with visits|0|||
147152744|NCT01296711|530721278|FG004|Overall Study|Failure to comply with visits|0|||
147152745|NCT01296711|530721279|FG005|Overall Study|Failure to comply with visits|0|||
147152746|NCT01296711|530721280|FG006|Overall Study|Failure to comply with visits|0|||
147152747|NCT01296711|530721281|FG007|Overall Study|Failure to comply with visits|1|||
147152748|NCT01296711|530721274|FG000|Overall Study|Patient decision due to transport|0|||
147152749|NCT01296711|530721275|FG001|Overall Study|Patient decision due to transport|0|||
147152750|NCT01296711|530721276|FG002|Overall Study|Patient decision due to transport|0|||
147152751|NCT01296711|530721277|FG003|Overall Study|Patient decision due to transport|0|||
147152752|NCT01296711|530721278|FG004|Overall Study|Patient decision due to transport|0|||
147152753|NCT01296711|530721279|FG005|Overall Study|Patient decision due to transport|0|||
147152754|NCT01296711|530721280|FG006|Overall Study|Patient decision due to transport|0|||
147152755|NCT01296711|530721281|FG007|Overall Study|Patient decision due to transport|1|||
147152756|NCT02120300|530721284|FG000|Overall Study|Enrolled but Never Treated|2|||
147152757|NCT02120300|530721285|FG001|Overall Study|Enrolled but Never Treated|0|||
147152758|NCT02120300|530721286|FG002|Overall Study|Enrolled but Never Treated|0|||
147152759|NCT02120300|530721287|FG003|Overall Study|Enrolled but Never Treated|0|||
147152760|NCT02120300|530721284|FG000|Overall Study|Lack of Efficacy|0|||
147152761|NCT02120300|530721285|FG001|Overall Study|Lack of Efficacy|0|||
147152762|NCT02120300|530721286|FG002|Overall Study|Lack of Efficacy|0|||
147152763|NCT02120300|530721287|FG003|Overall Study|Lack of Efficacy|1|||
147152764|NCT02120300|530721284|FG000|Overall Study|Lost to Follow-up|1|||
147152765|NCT02120300|530721285|FG001|Overall Study|Lost to Follow-up|0|||
147239790|NCT01980940|531049304|FG005|Overall Study|Protocol Violation|2|||
147239791|NCT01980940|531049305|FG006|Overall Study|Protocol Violation|0|||
147239792|NCT01980940|531049306|FG007|Overall Study|Protocol Violation|0|||
147579026|NCT00573313|532275029|FG001|Overall Study|Protocol Violation|0|||
147579027|NCT00573313|532275030|FG002|Overall Study|Protocol Violation|6|||
147579028|NCT00573313|532275031|FG003|Overall Study|Protocol Violation|0|||
147579029|NCT00295490|532275034|FG000|Overall Study|Protocol Violation|0|||
147579030|NCT00295490|532275035|FG001|Overall Study|Protocol Violation|0|||
147579031|NCT00295490|532275036|FG002|Overall Study|Protocol Violation|3|||
147579032|NCT00295490|532275037|FG003|Overall Study|Protocol Violation|3|||
147579033|NCT00295490|532275034|FG000|Overall Study|Withdrawal by Subject|0|||
147152766|NCT02120300|530721286|FG002|Overall Study|Lost to Follow-up|0|||
147152767|NCT02120300|530721287|FG003|Overall Study|Lost to Follow-up|0|||
147152768|NCT00700882|530721290|FG000|Overall Study|Never received treatment|6|||
147152769|NCT00700882|530721290|FG000|Overall Study|Ineligible|2|||
147152770|NCT00700882|530721290|FG000|Overall Study|No KIT mutation|51|||
147579034|NCT00295490|532275035|FG001|Overall Study|Withdrawal by Subject|2|||
147152771|NCT01832493|530721294|FG000|Overall Study|Physician Decision|2|||
147152772|NCT01832493|530721294|FG000|Overall Study|Protocol Violation|4|||
147152773|NCT01832493|530721294|FG000|Overall Study|Unable to place LV lead|2|||
147152774|NCT01732510|530721295|FG000|Overall Study|Adverse Event|0|||
147152775|NCT01732510|530721296|FG001|Overall Study|Adverse Event|1|||
147152776|NCT01732510|530721297|FG002|Overall Study|Adverse Event|1|||
147152777|NCT01732510|530721298|FG003|Overall Study|Adverse Event|0|||
147152778|NCT01732510|530721299|FG004|Overall Study|Adverse Event|0|||
147152779|NCT01732510|530721300|FG005|Overall Study|Adverse Event|0|||
147152780|NCT01732510|530721301|FG006|Overall Study|Adverse Event|1|||
147152781|NCT01732510|530721295|FG000|Overall Study|Protocol Violation|0|||
147152782|NCT01732510|530721296|FG001|Overall Study|Protocol Violation|0|||
147152783|NCT01732510|530721297|FG002|Overall Study|Protocol Violation|0|||
147152784|NCT01732510|530721298|FG003|Overall Study|Protocol Violation|1|||
147152785|NCT01732510|530721299|FG004|Overall Study|Protocol Violation|0|||
147152786|NCT01732510|530721300|FG005|Overall Study|Protocol Violation|0|||
147152787|NCT01732510|530721301|FG006|Overall Study|Protocol Violation|0|||
147152788|NCT01732510|530721295|FG000|Overall Study|Withdrawal by Subject|1|||
147152789|NCT01732510|530721296|FG001|Overall Study|Withdrawal by Subject|3|||
147152790|NCT01732510|530721297|FG002|Overall Study|Withdrawal by Subject|2|||
147152791|NCT01732510|530721298|FG003|Overall Study|Withdrawal by Subject|1|||
147152792|NCT01732510|530721299|FG004|Overall Study|Withdrawal by Subject|5|||
147152793|NCT01732510|530721300|FG005|Overall Study|Withdrawal by Subject|0|||
147152794|NCT01732510|530721301|FG006|Overall Study|Withdrawal by Subject|1|||
147152795|NCT01732510|530721295|FG000|Overall Study|Lost to Follow-up|0|||
147152796|NCT01732510|530721296|FG001|Overall Study|Lost to Follow-up|0|||
147152797|NCT01732510|530721297|FG002|Overall Study|Lost to Follow-up|1|||
147152798|NCT01732510|530721298|FG003|Overall Study|Lost to Follow-up|1|||
147152799|NCT01732510|530721299|FG004|Overall Study|Lost to Follow-up|0|||
147152800|NCT01732510|530721300|FG005|Overall Study|Lost to Follow-up|1|||
147152801|NCT01732510|530721301|FG006|Overall Study|Lost to Follow-up|0|||
147152802|NCT01732510|530721295|FG000|Overall Study|Physician Decision|0|||
147152803|NCT01732510|530721296|FG001|Overall Study|Physician Decision|1|||
147152804|NCT01732510|530721297|FG002|Overall Study|Physician Decision|0|||
147152805|NCT01732510|530721298|FG003|Overall Study|Physician Decision|0|||
147152806|NCT01732510|530721299|FG004|Overall Study|Physician Decision|0|||
147152807|NCT01732510|530721300|FG005|Overall Study|Physician Decision|0|||
147152808|NCT01732510|530721301|FG006|Overall Study|Physician Decision|0|||
147152809|NCT01732510|530721295|FG000|Overall Study|Pregnancy|0|||
147152810|NCT01732510|530721296|FG001|Overall Study|Pregnancy|0|||
147152811|NCT01732510|530721297|FG002|Overall Study|Pregnancy|0|||
147152812|NCT01732510|530721298|FG003|Overall Study|Pregnancy|1|||
147152813|NCT01732510|530721299|FG004|Overall Study|Pregnancy|0|||
147152814|NCT01732510|530721300|FG005|Overall Study|Pregnancy|0|||
147152815|NCT01732510|530721301|FG006|Overall Study|Pregnancy|0|||
147152816|NCT01732510|530721295|FG000|Overall Study|Study Terminated By Sponsor|0|||
147152817|NCT01732510|530721296|FG001|Overall Study|Study Terminated By Sponsor|0|||
147152818|NCT01732510|530721297|FG002|Overall Study|Study Terminated By Sponsor|0|||
147152819|NCT01732510|530721298|FG003|Overall Study|Study Terminated By Sponsor|1|||
147152820|NCT01732510|530721299|FG004|Overall Study|Study Terminated By Sponsor|0|||
147152821|NCT01732510|530721300|FG005|Overall Study|Study Terminated By Sponsor|12|||
147152822|NCT01732510|530721301|FG006|Overall Study|Study Terminated By Sponsor|6|||
147152823|NCT00313144|530721302|FG000|Overall Study|Discontinue Aralast ≥4 consecutive doses|12|||
147579035|NCT00295490|532275036|FG002|Overall Study|Withdrawal by Subject|0|||
147579036|NCT00295490|532275037|FG003|Overall Study|Withdrawal by Subject|1|||
147579037|NCT00295490|532275034|FG000|Overall Study|Lost to Follow-up|0|||
147579038|NCT00295490|532275035|FG001|Overall Study|Lost to Follow-up|0|||
147579039|NCT00295490|532275036|FG002|Overall Study|Lost to Follow-up|1|||
147579040|NCT00295490|532275037|FG003|Overall Study|Lost to Follow-up|0|||
147579041|NCT00295490|532275034|FG000|Overall Study|Adverse Event|1|||
147579042|NCT00295490|532275035|FG001|Overall Study|Adverse Event|0|||
147579043|NCT00295490|532275036|FG002|Overall Study|Adverse Event|0|||
147579044|NCT00295490|532275037|FG003|Overall Study|Adverse Event|0|||
147579045|NCT00295490|532275034|FG000|Overall Study|Other|0|||
147152824|NCT00313144|530721302|FG000|Overall Study|Death|7|||
147239793|NCT05695209|531049311|FG000|3-months|Withdrawal by Subject|2|||
147579046|NCT00295490|532275035|FG001|Overall Study|Other|2|||
147579047|NCT00295490|532275036|FG002|Overall Study|Other|0|||
147152825|NCT00313144|530721302|FG000|Overall Study|Lost to Follow-up|5|||
147152826|NCT00313144|530721302|FG000|Overall Study|Withdrawal by Subject|4|||
147152827|NCT00313144|530721302|FG000|Overall Study|Terminated by sponsor/ homecare provider|4|||
147152828|NCT00313144|530721302|FG000|Overall Study|Physician Decision|4|||
147152829|NCT00313144|530721302|FG000|Overall Study|Adverse event - transient|5|||
147152830|NCT00313144|530721302|FG000|Overall Study|Liver transplant|1|||
147579048|NCT00295490|532275037|FG003|Overall Study|Other|1|||
147579049|NCT03885934|532275038|FG000|Overall Study|Withdrawn by Parent/Guardian|1|||
147152831|NCT00313144|530721302|FG000|Overall Study|Insurance (homecare provider) change|1|||
147152832|NCT00313144|530721302|FG000|Overall Study|Change to different product|1|||
147152833|NCT00313144|530721302|FG000|Overall Study|Due to termination of the study|66|||
147152834|NCT00656058|530721307|FG000|Overall Study|Withdrawal by Subject|2|||
147152835|NCT00656058|530721307|FG000|Overall Study|Withdrawal by Subject|4|||
147152836|NCT00404755|530721308|FG000|Phase I (Bupropion)|Adverse Event|3|||
147152837|NCT00404755|530721308|FG000|Phase I (Bupropion)|Other|1|||
147152838|NCT00404755|530721308|FG000|Phase II (Escitalopram)|Lost to Follow-up|2|||
147152839|NCT05145322|530721309|FG000|Overall Study|Lost to Follow-up|4|||
147152840|NCT05145322|530721310|FG001|Overall Study|Lost to Follow-up|5|||
147152841|NCT06359028|530721311|FG000|Overall Study|Adverse Event|1|||
147152842|NCT06359028|530721312|FG001|Overall Study|Adverse Event|0|||
147152843|NCT06359028|530721311|FG000|Overall Study|Withdrawal by Subject|1|||
147152844|NCT06359028|530721312|FG001|Overall Study|Withdrawal by Subject|0|||
147152845|NCT04700540|530721313|FG000|Overall Study|Withdrawal by Subject|12|||
147152846|NCT04700540|530721314|FG001|Overall Study|Withdrawal by Subject|8|||
147152847|NCT04700540|530721313|FG000|Overall Study|Participant wished to discontinue intervention use, but remained in study to complete surveys only.|28|||
147152848|NCT04700540|530721314|FG001|Overall Study|Participant wished to discontinue intervention use, but remained in study to complete surveys only.|0|||
147152849|NCT02952313|530721315|FG000|Primary Endpoint|Lost to Follow-up|4|||
147152850|NCT02952313|530721315|FG000|Primary Endpoint|Withdrawal by Subject|1|||
147152851|NCT02952313|530721315|FG000|Primary Endpoint|Lack of Efficacy|1|||
147152852|NCT02952313|530721315|FG000|Primary Endpoint|Missed visit|1|||
147152853|NCT02952313|530721315|FG000|Long-term Follow-up|Lost to Follow-up|12|||
147152854|NCT02952313|530721315|FG000|Long-term Follow-up|Did not reconsent for long-term FU|7|||
147152855|NCT02952313|530721315|FG000|Long-term Follow-up|Lack of Efficacy|6|||
147152856|NCT02952313|530721315|FG000|Long-term Follow-up|Withdrawal by Subject|5|||
147152857|NCT02952313|530721315|FG000|Long-term Follow-up|Physician Decision|1|||
147152858|NCT02952313|530721315|FG000|Long-term Follow-up|Death|1|||
147152859|NCT04382586|530721316|FG000|Overall Study|Death|3|||
147152860|NCT04382586|530721317|FG001|Overall Study|Death|4|||
147152861|NCT04382586|530721316|FG000|Overall Study|Lost to Follow-up|11|||
147152862|NCT04382586|530721317|FG001|Overall Study|Lost to Follow-up|8|||
147152863|NCT04382586|530721316|FG000|Overall Study|Withdrawal by Subject|3|||
147152864|NCT04382586|530721317|FG001|Overall Study|Withdrawal by Subject|1|||
147152865|NCT04382586|530721316|FG000|Overall Study|Physician Decision|0|||
147152866|NCT04382586|530721317|FG001|Overall Study|Physician Decision|3|||
147152867|NCT02265536|530721319|FG000|Overall Study|Adverse Event|1|||
147152868|NCT02265536|530721320|FG001|Overall Study|Adverse Event|0|||
147152869|NCT02265536|530721321|FG002|Overall Study|Adverse Event|0|||
147152870|NCT02265536|530721322|FG003|Overall Study|Adverse Event|0|||
147152871|NCT02265536|530721323|FG004|Overall Study|Adverse Event|1|||
147152872|NCT02265536|530721324|FG005|Overall Study|Adverse Event|0|||
147152873|NCT02265536|530721319|FG000|Overall Study|Physician Decision|0|||
147152874|NCT02265536|530721320|FG001|Overall Study|Physician Decision|0|||
147152875|NCT02265536|530721321|FG002|Overall Study|Physician Decision|0|||
147152876|NCT02265536|530721322|FG003|Overall Study|Physician Decision|0|||
147152877|NCT02265536|530721323|FG004|Overall Study|Physician Decision|2|||
147152878|NCT02265536|530721324|FG005|Overall Study|Physician Decision|0|||
147152879|NCT02265536|530721319|FG000|Overall Study|Withdrawal by Subject|0|||
147152880|NCT02265536|530721320|FG001|Overall Study|Withdrawal by Subject|3|||
147152881|NCT02265536|530721321|FG002|Overall Study|Withdrawal by Subject|0|||
147152882|NCT02265536|530721322|FG003|Overall Study|Withdrawal by Subject|0|||
147152883|NCT02265536|530721323|FG004|Overall Study|Withdrawal by Subject|0|||
147152884|NCT02265536|530721324|FG005|Overall Study|Withdrawal by Subject|0|||
147152885|NCT00079391|530721329|FG000|Overall Study|Withdrawal by Subject|1|||
147152886|NCT02524275|530721330|FG000|Overall Study|not evaluable, completed less than 2 courses of chemotherapy.|5|||
147152887|NCT03763656|530721331|FG000|Overall Study|Physician Decision|1|||
147152888|NCT03763656|530721331|FG000|Overall Study|Protocol Violation|1|||
147152889|NCT03763656|530721331|FG000|Overall Study|Withdrawal by Subject|7|||
147239794|NCT05695209|531049312|FG001|3-months|Withdrawal by Subject|0|||
147239795|NCT05695209|531049311|FG000|3-months|Unable to contact for 3-month data collection|0|||
147239796|NCT05695209|531049312|FG001|3-months|Unable to contact for 3-month data collection|1|||
147239797|NCT05695209|531049311|FG000|6-months|Lost to Follow-up|1|||
147239798|NCT05695209|531049312|FG001|6-months|Lost to Follow-up|1|||
147239799|NCT05358444|531049313|FG000|Overall Study|Withdrawal by Subject|0|||
147152890|NCT00583752|530721332|FG000|Overall Study|Lost to Follow-up|5|||
147152891|NCT00583752|530721333|FG001|Overall Study|Lost to Follow-up|5|||
147152892|NCT01700959|530721334|FG000|Overall Study|Adverse Event|0|||
147152893|NCT01700959|530721335|FG001|Overall Study|Adverse Event|1|||
147152894|NCT01700959|530721336|FG002|Overall Study|Adverse Event|1|||
147152895|NCT01700959|530721337|FG003|Overall Study|Adverse Event|2|||
147152896|NCT01700959|530721338|FG004|Overall Study|Adverse Event|0|||
147152897|NCT01700959|530721339|FG005|Overall Study|Adverse Event|2|||
147152898|NCT01700959|530721334|FG000|Overall Study|Withdrawal by Subject|15|||
147152899|NCT01700959|530721335|FG001|Overall Study|Withdrawal by Subject|9|||
147152900|NCT01700959|530721336|FG002|Overall Study|Withdrawal by Subject|12|||
147152901|NCT01700959|530721337|FG003|Overall Study|Withdrawal by Subject|11|||
147239800|NCT05358444|531049314|FG001|Overall Study|Withdrawal by Subject|1|||
147239801|NCT05358444|531049313|FG000|Overall Study|Lost to Follow-up|0|||
147653247|NCT05188729|532552001|FG012|Overall Study|Withdrawal by Subject|0|||
147653248|NCT05188729|532551989|FG000|Overall Study|Lost to Follow-up|0|||
147653249|NCT05188729|532551990|FG001|Overall Study|Lost to Follow-up|0|||
147653250|NCT05188729|532551991|FG002|Overall Study|Lost to Follow-up|0|||
147653251|NCT05188729|532551992|FG003|Overall Study|Lost to Follow-up|0|||
147653252|NCT05188729|532551993|FG004|Overall Study|Lost to Follow-up|0|||
147653253|NCT05188729|532551994|FG005|Overall Study|Lost to Follow-up|0|||
147653254|NCT05188729|532551995|FG006|Overall Study|Lost to Follow-up|0|||
147653255|NCT05188729|532551996|FG007|Overall Study|Lost to Follow-up|0|||
147653256|NCT05188729|532551997|FG008|Overall Study|Lost to Follow-up|0|||
147653257|NCT05188729|532551998|FG009|Overall Study|Lost to Follow-up|0|||
147653258|NCT05188729|532551999|FG010|Overall Study|Lost to Follow-up|1|||
147653259|NCT05188729|532552000|FG011|Overall Study|Lost to Follow-up|1|||
147653260|NCT05188729|532552001|FG012|Overall Study|Lost to Follow-up|0|||
147653261|NCT00520767|532552005|FG000|Overall Study|Death|2|||
147653262|NCT00376532|532554481|FG000|Overall Study|Lack sufficient blood sample|6|||
147653263|NCT00376532|532554482|FG001|Overall Study|Lack sufficient blood sample|6|||
147653264|NCT01133704|532554483|FG000|Overall Study|Death|44|||
147653265|NCT01133704|532554484|FG001|Overall Study|Death|26|||
147653266|NCT01133704|532554483|FG000|Overall Study|Patient refused to continue|4|||
147653267|NCT01133704|532554484|FG001|Overall Study|Patient refused to continue|0|||
147653268|NCT01133704|532554483|FG000|Overall Study|Study Closure|1|||
147653269|NCT01133704|532554484|FG001|Overall Study|Study Closure|0|||
147653270|NCT02207400|532554485|FG000|Overall Study|Adverse Event|1|||
147653271|NCT02207400|532554486|FG001|Overall Study|Adverse Event|1|||
147653272|NCT02207400|532554485|FG000|Overall Study|Lost to Follow-up|6|||
147653273|NCT02207400|532554486|FG001|Overall Study|Lost to Follow-up|7|||
147653274|NCT02207400|532554485|FG000|Overall Study|Protocol Violation|1|||
147653275|NCT02207400|532554486|FG001|Overall Study|Protocol Violation|1|||
147653276|NCT02207400|532554485|FG000|Overall Study|Withdrawal by Subject|8|||
147653277|NCT02207400|532554486|FG001|Overall Study|Withdrawal by Subject|4|||
147653278|NCT02207400|532554485|FG000|Overall Study|Positive Urine Pregnancy Test|0|||
147653279|NCT02207400|532554486|FG001|Overall Study|Positive Urine Pregnancy Test|1|||
147653280|NCT03638466|532554487|FG000|Overall Study|Early Termination|0|||
147653281|NCT03638466|532554488|FG001|Overall Study|Early Termination|1|||
147653282|NCT03251482|532554489|FG000|Overall Study|Withdrawal by Subject|0|||
147653283|NCT03251482|532554490|FG001|Overall Study|Withdrawal by Subject|1|||
147653284|NCT03251482|532554491|FG002|Overall Study|Withdrawal by Subject|0|||
147653285|NCT03251482|532554492|FG003|Overall Study|Withdrawal by Subject|0|||
147653286|NCT03251482|532554493|FG004|Overall Study|Withdrawal by Subject|0|||
147653287|NCT02447328|532554496|FG000|Overall Study|Withdrawal by Subject|1|||
147653288|NCT02155309|532554500|FG000|Overall Study|Protocol Violation|0|||
147653289|NCT02155309|532554501|FG001|Overall Study|Protocol Violation|0|||
147653290|NCT02155309|532554502|FG002|Overall Study|Protocol Violation|1|||
147653291|NCT02030119|532554511|FG000|Overall Study|Withdrawal by Subject|3|||
147152902|NCT01700959|530721338|FG004|Overall Study|Withdrawal by Subject|8|||
147152903|NCT01700959|530721339|FG005|Overall Study|Withdrawal by Subject|12|||
147152904|NCT01700959|530721334|FG000|Overall Study|Ineligible|2|||
147152905|NCT01700959|530721335|FG001|Overall Study|Ineligible|1|||
147152906|NCT01700959|530721336|FG002|Overall Study|Ineligible|2|||
147152907|NCT01700959|530721337|FG003|Overall Study|Ineligible|0|||
147152908|NCT01700959|530721338|FG004|Overall Study|Ineligible|0|||
147152909|NCT01700959|530721339|FG005|Overall Study|Ineligible|1|||
147152910|NCT01700959|530721334|FG000|Overall Study|Noncompliant|9|||
147152911|NCT01700959|530721335|FG001|Overall Study|Noncompliant|9|||
147152912|NCT01700959|530721336|FG002|Overall Study|Noncompliant|17|||
147152913|NCT01700959|530721337|FG003|Overall Study|Noncompliant|18|||
147152914|NCT01700959|530721338|FG004|Overall Study|Noncompliant|15|||
147152915|NCT01700959|530721339|FG005|Overall Study|Noncompliant|9|||
147152916|NCT01700959|530721334|FG000|Overall Study|Side effects|1|||
147239802|NCT05358444|531049314|FG001|Overall Study|Lost to Follow-up|3|||
147239803|NCT05372419|531049315|FG000|Overall Study|Protocol Deviation|1|||
147239804|NCT05372419|531049315|FG000|Overall Study|Withdrawal by Subject|5|||
147239805|NCT05372419|531049315|FG000|Overall Study|Lost to Follow-up|7|||
147239806|NCT04362072|531049318|FG000|Treatment|Adverse Event|1|||
147653292|NCT02030119|532554512|FG001|Overall Study|Withdrawal by Subject|1|||
147653293|NCT02030119|532554513|FG002|Overall Study|Withdrawal by Subject|5|||
147653294|NCT02030119|532554514|FG003|Overall Study|Withdrawal by Subject|3|||
147653295|NCT02030119|532554511|FG000|Overall Study|Ineligible (see Pre-assignment Details)|0|||
147653296|NCT02030119|532554512|FG001|Overall Study|Ineligible (see Pre-assignment Details)|1|||
147152917|NCT01700959|530721335|FG001|Overall Study|Side effects|4|||
147239807|NCT04362072|531049318|FG000|Treatment|Death|9|||
147653297|NCT02030119|532554513|FG002|Overall Study|Ineligible (see Pre-assignment Details)|1|||
147653298|NCT02030119|532554514|FG003|Overall Study|Ineligible (see Pre-assignment Details)|0|||
147152918|NCT01700959|530721336|FG002|Overall Study|Side effects|8|||
147152919|NCT01700959|530721337|FG003|Overall Study|Side effects|4|||
147239808|NCT04362072|531049318|FG000|Treatment|Physician Decision|2|||
147653299|NCT03746405|532554515|FG000|Overall Study|Withdrawal by Subject|3|||
147653300|NCT03746405|532554516|FG001|Overall Study|Withdrawal by Subject|0|||
147579050|NCT03885934|532275039|FG001|Overall Study|Withdrawn by Parent/Guardian|0|||
147579051|NCT03885934|532275040|FG002|Overall Study|Withdrawn by Parent/Guardian|0|||
147579052|NCT03885934|532275041|FG003|Overall Study|Withdrawn by Parent/Guardian|0|||
147579053|NCT03885934|532275042|FG004|Overall Study|Withdrawn by Parent/Guardian|0|||
147579054|NCT03885934|532275043|FG005|Overall Study|Withdrawn by Parent/Guardian|0|||
147579055|NCT03255980|532275044|FG000|Overall Study|Grade =>3 Skin Toxicity|1|||
147579056|NCT03255980|532275045|FG001|Overall Study|Grade =>3 Skin Toxicity|4|||
147579057|NCT03255980|532275046|FG002|Overall Study|Grade =>3 Skin Toxicity|6|||
147579058|NCT03255980|532275047|FG003|Overall Study|Grade =>3 Skin Toxicity|5|||
147579059|NCT03255980|532275044|FG000|Overall Study|Adverse Event|1|||
147579060|NCT03255980|532275045|FG001|Overall Study|Adverse Event|1|||
147579061|NCT03255980|532275046|FG002|Overall Study|Adverse Event|0|||
147579062|NCT03255980|532275047|FG003|Overall Study|Adverse Event|1|||
147579063|NCT03255980|532275044|FG000|Overall Study|Lack of compliance to study or assessmen|0|||
147579064|NCT03255980|532275045|FG001|Overall Study|Lack of compliance to study or assessmen|1|||
147579065|NCT03255980|532275046|FG002|Overall Study|Lack of compliance to study or assessmen|0|||
147579066|NCT03255980|532275047|FG003|Overall Study|Lack of compliance to study or assessmen|0|||
147579067|NCT03255980|532275044|FG000|Overall Study|Lost to Follow-up|1|||
147579068|NCT03255980|532275045|FG001|Overall Study|Lost to Follow-up|1|||
147579069|NCT03255980|532275046|FG002|Overall Study|Lost to Follow-up|0|||
147579070|NCT03255980|532275047|FG003|Overall Study|Lost to Follow-up|3|||
147579071|NCT03255980|532275044|FG000|Overall Study|Withdrawal by Subject|0|||
147579072|NCT03255980|532275045|FG001|Overall Study|Withdrawal by Subject|1|||
147579073|NCT03255980|532275046|FG002|Overall Study|Withdrawal by Subject|0|||
147579074|NCT03255980|532275047|FG003|Overall Study|Withdrawal by Subject|3|||
147579075|NCT04473326|532275048|FG000|Overall Study|Death|0|||
147579076|NCT04473326|532275049|FG001|Overall Study|Death|1|||
147579077|NCT04473326|532275048|FG000|Overall Study|Withdrawal by Subject|1|||
147579078|NCT04473326|532275049|FG001|Overall Study|Withdrawal by Subject|2|||
147579079|NCT01451541|532275052|FG000|Overall Study|Adverse Event|4|||
147579080|NCT01451541|532275053|FG001|Overall Study|Adverse Event|3|||
147579081|NCT01451541|532275054|FG002|Overall Study|Adverse Event|6|||
147152920|NCT01700959|530721338|FG004|Overall Study|Side effects|4|||
147152921|NCT01700959|530721339|FG005|Overall Study|Side effects|1|||
147152922|NCT00830375|530721340|FG000|Overall Study|Lost to Follow-up|1|||
147152923|NCT01331837|530721341|FG000|Overall Study|Death|30|||
147152924|NCT01331837|530721342|FG001|Overall Study|Death|34|||
147152925|NCT01331837|530721341|FG000|Overall Study|Lost to Follow-up|3|||
147152926|NCT01331837|530721342|FG001|Overall Study|Lost to Follow-up|1|||
147152927|NCT01331837|530721341|FG000|Overall Study|Info not recorded|10|||
147152928|NCT01331837|530721342|FG001|Overall Study|Info not recorded|16|||
147152929|NCT01331837|530721341|FG000|Overall Study|Withdrawal by Subject|13|||
147152930|NCT01331837|530721342|FG001|Overall Study|Withdrawal by Subject|16|||
147152931|NCT03724981|530724128|FG000|First Device|Protocol Violation|1|||
147152932|NCT03724981|530724129|FG001|First Device|Protocol Violation|1|||
147152933|NCT02640625|530724130|FG000|Overall Study|Adverse Event|1|||
147152934|NCT00197145|530724132|FG000|Period 1: Randomized Treatment Phase|Withdrawal by Subject|1|||
147152935|NCT00197145|530724133|FG001|Period 1: Randomized Treatment Phase|Withdrawal by Subject|1|||
147152936|NCT00197145|530724132|FG000|Period 1: Randomized Treatment Phase|Sponsor terminated study|10|||
147152937|NCT00197145|530724133|FG001|Period 1: Randomized Treatment Phase|Sponsor terminated study|8|||
147152938|NCT00197145|530724132|FG000|Period 1: Randomized Treatment Phase|Other|2|||
147152939|NCT00197145|530724133|FG001|Period 1: Randomized Treatment Phase|Other|2|||
147152940|NCT00197145|530724132|FG000|Period 2 : Open Label Phase|Insufficient viral load response|1|||
147152941|NCT00197145|530724133|FG001|Period 2 : Open Label Phase|Insufficient viral load response|0|||
147152942|NCT00197145|530724132|FG000|Period 2 : Open Label Phase|Protocol defined virological failure|3|||
147152943|NCT00197145|530724133|FG001|Period 2 : Open Label Phase|Protocol defined virological failure|0|||
147152944|NCT00197145|530724132|FG000|Period 2 : Open Label Phase|Availability of alternative ART|2|||
147152945|NCT00197145|530724133|FG001|Period 2 : Open Label Phase|Availability of alternative ART|0|||
147152946|NCT00197145|530724132|FG000|Period 2 : Open Label Phase|Were ongoing till data freeze|3|||
147152947|NCT00197145|530724133|FG001|Period 2 : Open Label Phase|Were ongoing till data freeze|0|||
147152948|NCT00197145|530724132|FG000|Period 2 : Open Label Phase|Other|1|||
147152949|NCT00197145|530724133|FG001|Period 2 : Open Label Phase|Other|0|||
147152950|NCT02370537|530724134|FG000|Part A (Open-label Recruitment)|Withdrawal by Subject|0|||
147152951|NCT02370537|530724135|FG001|Part A (Open-label Recruitment)|Withdrawal by Subject|1|||
147152952|NCT02370537|530724136|FG002|Part A (Open-label Recruitment)|Withdrawal by Subject|0|||
147152953|NCT02370537|530724134|FG000|Part A (Open-label Recruitment)|Adverse Event|0|||
147152954|NCT02370537|530724135|FG001|Part A (Open-label Recruitment)|Adverse Event|0|||
147152955|NCT02370537|530724136|FG002|Part A (Open-label Recruitment)|Adverse Event|1|||
147152956|NCT02370537|530724134|FG000|Part B|Not randomised to receive treatment|1|||
147152957|NCT02370537|530724135|FG001|Part B|Not randomised to receive treatment|2|||
147152958|NCT02370537|530724136|FG002|Part B|Not randomised to receive treatment|259|||
147152959|NCT02370537|530724134|FG000|Part B|Withdrawal by Subject|0|||
147579082|NCT01451541|532275052|FG000|Overall Study|Lack of Efficacy|2|||
147579083|NCT01451541|532275053|FG001|Overall Study|Lack of Efficacy|0|||
147152960|NCT02370537|530724135|FG001|Part B|Withdrawal by Subject|1|||
147152961|NCT02370537|530724136|FG002|Part B|Withdrawal by Subject|0|||
147152962|NCT00882583|530724145|FG000|Overall Study|Physician Decision|1|||
147152963|NCT00882583|530724146|FG001|Overall Study|Physician Decision|0|||
147152964|NCT00882583|530724145|FG000|Overall Study|Adverse Event|0|||
147152965|NCT00882583|530724146|FG001|Overall Study|Adverse Event|1|||
147152966|NCT03596047|530724147|FG000|Overall Study|Withdrawal by Subject|7|||
147152967|NCT03596047|530724148|FG001|Overall Study|Withdrawal by Subject|4|||
147152968|NCT03596047|530724147|FG000|Overall Study|Lost to Follow-up|0|||
147152969|NCT03596047|530724148|FG001|Overall Study|Lost to Follow-up|2|||
147152970|NCT02589665|530724149|FG000|Induction Period|Did not receive drug|0|||
147152971|NCT02589665|530724150|FG001|Induction Period|Did not receive drug|0|||
147152972|NCT02589665|530724151|FG002|Induction Period|Did not receive drug|0|||
147152973|NCT02589665|530724152|FG003|Induction Period|Did not receive drug|1|||
147152974|NCT02589665|530724153|FG004|Induction Period|Did not receive drug|0|||
147152975|NCT02589665|530724154|FG005|Induction Period|Did not receive drug|0|||
147152976|NCT02589665|530724155|FG006|Induction Period|Did not receive drug|0|||
147152977|NCT02589665|530724156|FG007|Induction Period|Did not receive drug|0|||
147152978|NCT02589665|530724157|FG008|Induction Period|Did not receive drug|0|||
147152979|NCT02589665|530724158|FG009|Induction Period|Did not receive drug|0|||
147152980|NCT02589665|530724149|FG000|Induction Period|Adverse Event|3|||
147152981|NCT02589665|530724150|FG001|Induction Period|Adverse Event|0|||
147152982|NCT02589665|530724151|FG002|Induction Period|Adverse Event|2|||
147152983|NCT02589665|530724152|FG003|Induction Period|Adverse Event|2|||
147152984|NCT02589665|530724153|FG004|Induction Period|Adverse Event|0|||
147152985|NCT02589665|530724154|FG005|Induction Period|Adverse Event|0|||
147152986|NCT02589665|530724155|FG006|Induction Period|Adverse Event|0|||
147152987|NCT02589665|530724156|FG007|Induction Period|Adverse Event|0|||
147579084|NCT01451541|532275054|FG002|Overall Study|Lack of Efficacy|0|||
147579085|NCT01451541|532275052|FG000|Overall Study|Lost to Follow-up|4|||
147152988|NCT02589665|530724157|FG008|Induction Period|Adverse Event|0|||
147152989|NCT02589665|530724158|FG009|Induction Period|Adverse Event|0|||
147152990|NCT02589665|530724149|FG000|Induction Period|Withdrawal by Subject|0|||
147152991|NCT02589665|530724150|FG001|Induction Period|Withdrawal by Subject|1|||
147152992|NCT02589665|530724151|FG002|Induction Period|Withdrawal by Subject|0|||
147152993|NCT02589665|530724152|FG003|Induction Period|Withdrawal by Subject|1|||
147152994|NCT02589665|530724153|FG004|Induction Period|Withdrawal by Subject|0|||
147152995|NCT02589665|530724154|FG005|Induction Period|Withdrawal by Subject|0|||
147152996|NCT02589665|530724155|FG006|Induction Period|Withdrawal by Subject|0|||
147152997|NCT02589665|530724156|FG007|Induction Period|Withdrawal by Subject|0|||
147152998|NCT02589665|530724157|FG008|Induction Period|Withdrawal by Subject|0|||
147152999|NCT02589665|530724158|FG009|Induction Period|Withdrawal by Subject|0|||
147153000|NCT02589665|530724149|FG000|Induction Period|Protocol Violation|0|||
147153001|NCT02589665|530724150|FG001|Induction Period|Protocol Violation|1|||
147153002|NCT02589665|530724151|FG002|Induction Period|Protocol Violation|0|||
147153003|NCT02589665|530724152|FG003|Induction Period|Protocol Violation|0|||
147153004|NCT02589665|530724153|FG004|Induction Period|Protocol Violation|0|||
147153005|NCT02589665|530724154|FG005|Induction Period|Protocol Violation|0|||
147153006|NCT02589665|530724155|FG006|Induction Period|Protocol Violation|0|||
147153007|NCT02589665|530724156|FG007|Induction Period|Protocol Violation|0|||
147239809|NCT04362072|531049318|FG000|Treatment|Progressive disease|27|||
147153008|NCT02589665|530724157|FG008|Induction Period|Protocol Violation|0|||
147239810|NCT04362072|531049318|FG000|Treatment|Withdrawal by Subject|4|||
147239811|NCT04362072|531049318|FG000|Treatment|Global deterioration of health status|1|||
147239812|NCT04362072|531049318|FG000|Treatment|Switched to commercial Lorlatinib|13|||
147239813|NCT04362072|531049318|FG000|Treatment|Entered Lorlatinib continuation Study|11|||
147579086|NCT01451541|532275053|FG001|Overall Study|Lost to Follow-up|4|||
147579087|NCT01451541|532275054|FG002|Overall Study|Lost to Follow-up|7|||
147239814|NCT04362072|531049318|FG000|Treatment|Other|3|||
147239815|NCT04362072|531049318|FG000|Follow up|Death|2|||
147239816|NCT04362072|531049318|FG000|Follow up|Other|2|||
147579088|NCT01451541|532275052|FG000|Overall Study|Withdrawal by Subject|15|||
147153009|NCT02589665|530724158|FG009|Induction Period|Protocol Violation|0|||
147239817|NCT04731363|531049319|FG000|Overall Study|Could not obtain samples|0|||
147446283|NCT03775421|531798901|FG000|Overall Study|Lost to Follow-up|2|||
147579089|NCT01451541|532275053|FG001|Overall Study|Withdrawal by Subject|8|||
147153010|NCT02589665|530724149|FG000|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
147153011|NCT02589665|530724150|FG001|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
147153012|NCT02589665|530724151|FG002|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
147153013|NCT02589665|530724152|FG003|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
147153014|NCT02589665|530724153|FG004|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|7|||
147153015|NCT02589665|530724154|FG005|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|41|||
147239818|NCT04731363|531049320|FG001|Overall Study|Could not obtain samples|1|||
147239819|NCT04731363|531049321|FG002|Overall Study|Could not obtain samples|0|||
147579090|NCT01451541|532275054|FG002|Overall Study|Withdrawal by Subject|6|||
147579091|NCT01451541|532275052|FG000|Overall Study|randomization error, noncompliance|11|||
147579092|NCT01451541|532275053|FG001|Overall Study|randomization error, noncompliance|10|||
147579093|NCT01451541|532275054|FG002|Overall Study|randomization error, noncompliance|8|||
147579094|NCT04164758|532275059|FG000|Overall Study|COVID-19 withdrawal of consent|1|||
147579095|NCT04164758|532275060|FG001|Overall Study|COVID-19 withdrawal of consent|0|||
147579096|NCT04164758|532275061|FG002|Overall Study|COVID-19 withdrawal of consent|0|||
147579097|NCT04164758|532275059|FG000|Overall Study|Adverse Event|0|||
147579098|NCT04164758|532275060|FG001|Overall Study|Adverse Event|1|||
147579099|NCT04164758|532275061|FG002|Overall Study|Adverse Event|0|||
147579100|NCT00537095|532275065|FG000|Randomized Treatment Period (433 Days)|Adverse Event|24|||
147579101|NCT00537095|532275066|FG001|Randomized Treatment Period (433 Days)|Adverse Event|4|||
147579102|NCT00537095|532275065|FG000|Randomized Treatment Period (433 Days)|Objective Disease Progression|21|||
147579103|NCT00537095|532275066|FG001|Randomized Treatment Period (433 Days)|Objective Disease Progression|48|||
147579104|NCT00537095|532275065|FG000|Randomized Treatment Period (433 Days)|Death|3|||
147579105|NCT00537095|532275066|FG001|Randomized Treatment Period (433 Days)|Death|1|||
147579106|NCT00537095|532275065|FG000|Randomized Treatment Period (433 Days)|Withdrawal by Subject|2|||
147579107|NCT00537095|532275066|FG001|Randomized Treatment Period (433 Days)|Withdrawal by Subject|2|||
147579108|NCT00537095|532275065|FG000|Randomized Treatment Period (433 Days)|Subjective/ Clinic Progression or Lack of Efficacy|1|||
147579109|NCT00537095|532275066|FG001|Randomized Treatment Period (433 Days)|Subjective/ Clinic Progression or Lack of Efficacy|2|||
147579110|NCT00537095|532275065|FG000|Randomized Treatment Period (433 Days)|As per protocol (after 12 months of blinded treatment)|21|||
147579111|NCT00537095|532275066|FG001|Randomized Treatment Period (433 Days)|As per protocol (after 12 months of blinded treatment)|16|||
147579112|NCT00537095|532275065|FG000|Open-label Period (590 Days)|Adverse Event|2|||
147579113|NCT00537095|532275066|FG001|Open-label Period (590 Days)|Adverse Event|11|||
147579114|NCT00537095|532275065|FG000|Open-label Period (590 Days)|Objective Disease Progression|2|||
147579115|NCT00537095|532275066|FG001|Open-label Period (590 Days)|Objective Disease Progression|21|||
147579116|NCT00537095|532275065|FG000|Open-label Period (590 Days)|Death|2|||
147579117|NCT00537095|532275066|FG001|Open-label Period (590 Days)|Death|2|||
147579118|NCT00537095|532275065|FG000|Open-label Period (590 Days)|Withdrawal by Subject|1|||
147153016|NCT02589665|530724155|FG006|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|39|||
147153017|NCT02589665|530724156|FG007|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
147153018|NCT02589665|530724157|FG008|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
147153019|NCT02589665|530724158|FG009|Maintenance Period|Rolled Over to Study AMAP (NCT03519945)|0|||
147153020|NCT02589665|530724149|FG000|Maintenance Period|Withdrawal by Subject|0|||
147153021|NCT02589665|530724150|FG001|Maintenance Period|Withdrawal by Subject|0|||
147153022|NCT02589665|530724151|FG002|Maintenance Period|Withdrawal by Subject|0|||
147153023|NCT02589665|530724152|FG003|Maintenance Period|Withdrawal by Subject|0|||
147153024|NCT02589665|530724153|FG004|Maintenance Period|Withdrawal by Subject|4|||
147153025|NCT02589665|530724154|FG005|Maintenance Period|Withdrawal by Subject|2|||
147153026|NCT02589665|530724155|FG006|Maintenance Period|Withdrawal by Subject|4|||
147153027|NCT02589665|530724156|FG007|Maintenance Period|Withdrawal by Subject|0|||
147153028|NCT02589665|530724157|FG008|Maintenance Period|Withdrawal by Subject|0|||
147153029|NCT02589665|530724158|FG009|Maintenance Period|Withdrawal by Subject|0|||
147153030|NCT02589665|530724149|FG000|Maintenance Period|Lack of Efficacy|0|||
147153031|NCT02589665|530724150|FG001|Maintenance Period|Lack of Efficacy|0|||
147153032|NCT02589665|530724151|FG002|Maintenance Period|Lack of Efficacy|0|||
147153033|NCT02589665|530724152|FG003|Maintenance Period|Lack of Efficacy|0|||
147153034|NCT02589665|530724153|FG004|Maintenance Period|Lack of Efficacy|2|||
147153035|NCT02589665|530724154|FG005|Maintenance Period|Lack of Efficacy|1|||
147153036|NCT02589665|530724155|FG006|Maintenance Period|Lack of Efficacy|0|||
147153037|NCT02589665|530724156|FG007|Maintenance Period|Lack of Efficacy|0|||
147153038|NCT02589665|530724157|FG008|Maintenance Period|Lack of Efficacy|0|||
147153039|NCT02589665|530724158|FG009|Maintenance Period|Lack of Efficacy|0|||
147153040|NCT02589665|530724149|FG000|Maintenance Period|Adverse Event|0|||
147153041|NCT02589665|530724150|FG001|Maintenance Period|Adverse Event|0|||
147153042|NCT02589665|530724151|FG002|Maintenance Period|Adverse Event|0|||
147153043|NCT02589665|530724152|FG003|Maintenance Period|Adverse Event|0|||
147579119|NCT00537095|532275066|FG001|Open-label Period (590 Days)|Withdrawal by Subject|2|||
147653301|NCT03746405|532554515|FG000|Overall Study|technical difficulties|0|||
147653302|NCT03746405|532554516|FG001|Overall Study|technical difficulties|2|||
147653303|NCT02753816|532554517|FG000|Overall Study|Protocol Violation|0|||
147653304|NCT02753816|532554518|FG001|Overall Study|Protocol Violation|1|||
147153044|NCT02589665|530724153|FG004|Maintenance Period|Adverse Event|0|||
147153045|NCT02589665|530724154|FG005|Maintenance Period|Adverse Event|0|||
147153046|NCT02589665|530724155|FG006|Maintenance Period|Adverse Event|2|||
147579120|NCT00537095|532275065|FG000|Open-label Period (590 Days)|Subjective/ Clinic Progression or Lack of Efficacy|5|||
147653305|NCT02753816|532554519|FG002|Overall Study|Protocol Violation|0|||
147153047|NCT02589665|530724156|FG007|Maintenance Period|Adverse Event|0|||
147153048|NCT02589665|530724157|FG008|Maintenance Period|Adverse Event|0|||
147153049|NCT02589665|530724158|FG009|Maintenance Period|Adverse Event|0|||
147579121|NCT00537095|532275066|FG001|Open-label Period (590 Days)|Subjective/ Clinic Progression or Lack of Efficacy|3|||
147153050|NCT02589665|530724149|FG000|Maintenance Period|Lost to Follow-up|0|||
147153051|NCT02589665|530724150|FG001|Maintenance Period|Lost to Follow-up|0|||
147153052|NCT02589665|530724151|FG002|Maintenance Period|Lost to Follow-up|0|||
147153053|NCT02589665|530724152|FG003|Maintenance Period|Lost to Follow-up|0|||
147153054|NCT02589665|530724153|FG004|Maintenance Period|Lost to Follow-up|0|||
147153055|NCT02589665|530724154|FG005|Maintenance Period|Lost to Follow-up|1|||
147153056|NCT02589665|530724155|FG006|Maintenance Period|Lost to Follow-up|0|||
147153057|NCT02589665|530724156|FG007|Maintenance Period|Lost to Follow-up|0|||
147153058|NCT02589665|530724157|FG008|Maintenance Period|Lost to Follow-up|0|||
147153059|NCT02589665|530724158|FG009|Maintenance Period|Lost to Follow-up|0|||
147153060|NCT02589665|530724149|FG000|Maintenance Period|Physician Decision|0|||
147153061|NCT02589665|530724150|FG001|Maintenance Period|Physician Decision|0|||
147153062|NCT02589665|530724151|FG002|Maintenance Period|Physician Decision|0|||
147153063|NCT02589665|530724152|FG003|Maintenance Period|Physician Decision|0|||
147153064|NCT02589665|530724153|FG004|Maintenance Period|Physician Decision|0|||
147153065|NCT02589665|530724154|FG005|Maintenance Period|Physician Decision|1|||
147153066|NCT02589665|530724155|FG006|Maintenance Period|Physician Decision|0|||
147153067|NCT02589665|530724156|FG007|Maintenance Period|Physician Decision|0|||
147153068|NCT02589665|530724157|FG008|Maintenance Period|Physician Decision|0|||
147153069|NCT02589665|530724158|FG009|Maintenance Period|Physician Decision|0|||
147153070|NCT02589665|530724149|FG000|Maintenance Period|Reason Not Collected|0|||
147153071|NCT02589665|530724150|FG001|Maintenance Period|Reason Not Collected|0|||
147153072|NCT02589665|530724151|FG002|Maintenance Period|Reason Not Collected|0|||
147153073|NCT02589665|530724152|FG003|Maintenance Period|Reason Not Collected|0|||
147153074|NCT02589665|530724153|FG004|Maintenance Period|Reason Not Collected|0|||
147153075|NCT02589665|530724154|FG005|Maintenance Period|Reason Not Collected|1|||
147153076|NCT02589665|530724155|FG006|Maintenance Period|Reason Not Collected|1|||
147153077|NCT02589665|530724156|FG007|Maintenance Period|Reason Not Collected|0|||
147153078|NCT02589665|530724157|FG008|Maintenance Period|Reason Not Collected|0|||
147579122|NCT00533507|532275067|FG000|Overall Study|Withdrawal by Subject|1|||
147579123|NCT02943096|532275068|FG000|Overall Study|Lack of Efficacy|0|||
147579124|NCT02943096|532275069|FG001|Overall Study|Lack of Efficacy|1|||
147579125|NCT05065619|532275070|FG000|Up to Day 42|Lost to Follow-up|1|||
147579126|NCT05065619|532275071|FG001|Up to Day 42|Lost to Follow-up|0|||
147579127|NCT05065619|532275070|FG000|Up to Day 42|Withdrawal by Subject|1|||
147579128|NCT05065619|532275071|FG001|Up to Day 42|Withdrawal by Subject|0|||
147579129|NCT05065619|532275070|FG000|After Day 43|Lost to Follow-up|1|||
147579130|NCT05065619|532275071|FG001|After Day 43|Lost to Follow-up|0|||
147579131|NCT05065619|532275070|FG000|After Day 43|Physician Decision|3|||
147579132|NCT05065619|532275071|FG001|After Day 43|Physician Decision|0|||
147653306|NCT02372383|532554523|FG000|First Intervention (1 Day)|Unable to collect blood|0|||
147653307|NCT02372383|532554524|FG001|First Intervention (1 Day)|Unable to collect blood|1|||
147153079|NCT02589665|530724158|FG009|Maintenance Period|Reason Not Collected|0|||
147153080|NCT02589665|530724149|FG000|Induction Extension Period|Adverse Event|0|||
147153081|NCT02589665|530724150|FG001|Induction Extension Period|Adverse Event|0|||
147153082|NCT02589665|530724151|FG002|Induction Extension Period|Adverse Event|0|||
147153083|NCT02589665|530724152|FG003|Induction Extension Period|Adverse Event|0|||
147153084|NCT02589665|530724153|FG004|Induction Extension Period|Adverse Event|0|||
147153085|NCT02589665|530724154|FG005|Induction Extension Period|Adverse Event|0|||
147153086|NCT02589665|530724155|FG006|Induction Extension Period|Adverse Event|0|||
147153087|NCT02589665|530724156|FG007|Induction Extension Period|Adverse Event|0|||
147153088|NCT02589665|530724157|FG008|Induction Extension Period|Adverse Event|4|||
147153089|NCT02589665|530724158|FG009|Induction Extension Period|Adverse Event|0|||
147153090|NCT02589665|530724149|FG000|Induction Extension Period|Lack of Efficacy|0|||
147153091|NCT02589665|530724150|FG001|Induction Extension Period|Lack of Efficacy|0|||
147153092|NCT02589665|530724151|FG002|Induction Extension Period|Lack of Efficacy|0|||
147153093|NCT02589665|530724152|FG003|Induction Extension Period|Lack of Efficacy|0|||
147153094|NCT02589665|530724153|FG004|Induction Extension Period|Lack of Efficacy|0|||
147153095|NCT02589665|530724154|FG005|Induction Extension Period|Lack of Efficacy|0|||
147153096|NCT02589665|530724155|FG006|Induction Extension Period|Lack of Efficacy|0|||
147153097|NCT02589665|530724156|FG007|Induction Extension Period|Lack of Efficacy|0|||
147153098|NCT02589665|530724157|FG008|Induction Extension Period|Lack of Efficacy|3|||
147579133|NCT05065619|532275070|FG000|After Day 43|Withdrawal by Subject|1|||
147579134|NCT05065619|532275071|FG001|After Day 43|Withdrawal by Subject|2|||
147579135|NCT05065619|532275070|FG000|After Day 43|Public vaccination|6|||
147579136|NCT05065619|532275071|FG001|After Day 43|Public vaccination|8|||
147579137|NCT05065619|532275070|FG000|After Day 43|Difficult to go to the hospital due to moving|1|||
147153099|NCT02589665|530724158|FG009|Induction Extension Period|Lack of Efficacy|0|||
147153100|NCT02589665|530724149|FG000|Induction Extension Period|Withdrawal by Subject|0|||
147153101|NCT02589665|530724150|FG001|Induction Extension Period|Withdrawal by Subject|0|||
147153102|NCT02589665|530724151|FG002|Induction Extension Period|Withdrawal by Subject|0|||
147153103|NCT02589665|530724152|FG003|Induction Extension Period|Withdrawal by Subject|0|||
147153104|NCT02589665|530724153|FG004|Induction Extension Period|Withdrawal by Subject|0|||
147579138|NCT05065619|532275071|FG001|After Day 43|Difficult to go to the hospital due to moving|0|||
147579139|NCT05065619|532275070|FG000|After Day 43|Study Terminated by Sponsor|88|||
147579140|NCT05065619|532275071|FG001|After Day 43|Study Terminated by Sponsor|16|||
147579141|NCT00570128|532275081|FG000|Overall Study|Adverse Event|1|||
147579142|NCT00570128|532275082|FG001|Overall Study|Adverse Event|0|||
147579143|NCT00570128|532275081|FG000|Overall Study|Lost to Follow-up|1|||
147239820|NCT04731363|531049322|FG003|Overall Study|Could not obtain samples|0|||
147239821|NCT04731363|531049319|FG000|Overall Study|Physician Decision|0|||
147239822|NCT04731363|531049320|FG001|Overall Study|Physician Decision|1|||
147239823|NCT04731363|531049321|FG002|Overall Study|Physician Decision|0|||
147239824|NCT04731363|531049322|FG003|Overall Study|Physician Decision|0|||
147239825|NCT02034110|531051470|FG000|Overall Study|Physician Decision|0|||
147239826|NCT02034110|531051471|FG001|Overall Study|Physician Decision|0|||
147239827|NCT02034110|531051472|FG002|Overall Study|Physician Decision|0|||
147239828|NCT02034110|531051473|FG003|Overall Study|Physician Decision|0|||
147239829|NCT02034110|531051474|FG004|Overall Study|Physician Decision|2|||
147239830|NCT02034110|531051475|FG005|Overall Study|Physician Decision|0|||
147239831|NCT02034110|531051476|FG006|Overall Study|Physician Decision|1|||
147579144|NCT00570128|532275082|FG001|Overall Study|Lost to Follow-up|0|||
147579145|NCT00570128|532275081|FG000|Overall Study|Withdrawal by Subject|2|||
147579146|NCT00570128|532275082|FG001|Overall Study|Withdrawal by Subject|0|||
147579147|NCT03868631|532275083|FG000|Baseline to Week 6|Adverse Event|0|||
147579148|NCT03868631|532275084|FG001|Baseline to Week 6|Adverse Event|3|||
147579149|NCT03868631|532275083|FG000|Baseline to Week 6|Protocol Violation|1|||
147579150|NCT03868631|532275084|FG001|Baseline to Week 6|Protocol Violation|1|||
147153105|NCT02589665|530724154|FG005|Induction Extension Period|Withdrawal by Subject|0|||
147153106|NCT02589665|530724155|FG006|Induction Extension Period|Withdrawal by Subject|0|||
147579151|NCT03868631|532275083|FG000|Baseline to Week 6|Withdrawal by Subject|3|||
147579152|NCT03868631|532275084|FG001|Baseline to Week 6|Withdrawal by Subject|0|||
147579153|NCT03868631|532275083|FG000|Week 6 to Week 12 (Study Completion)|Adverse Event|2|||
147579154|NCT03868631|532275084|FG001|Week 6 to Week 12 (Study Completion)|Adverse Event|0|||
147579155|NCT03868631|532275083|FG000|Week 6 to Week 12 (Study Completion)|Protocol Violation|1|||
147579156|NCT03868631|532275084|FG001|Week 6 to Week 12 (Study Completion)|Protocol Violation|0|||
147579157|NCT03868631|532275083|FG000|Week 6 to Week 12 (Study Completion)|Withdrawal by Subject|1|||
147153107|NCT02589665|530724156|FG007|Induction Extension Period|Withdrawal by Subject|2|||
147153108|NCT02589665|530724157|FG008|Induction Extension Period|Withdrawal by Subject|3|||
147153109|NCT02589665|530724158|FG009|Induction Extension Period|Withdrawal by Subject|0|||
147153110|NCT02589665|530724149|FG000|Induction Extension Period|Physician Decision|0|||
147153111|NCT02589665|530724150|FG001|Induction Extension Period|Physician Decision|0|||
147153112|NCT02589665|530724151|FG002|Induction Extension Period|Physician Decision|0|||
147153113|NCT02589665|530724152|FG003|Induction Extension Period|Physician Decision|0|||
147153114|NCT02589665|530724153|FG004|Induction Extension Period|Physician Decision|0|||
147579158|NCT03868631|532275084|FG001|Week 6 to Week 12 (Study Completion)|Withdrawal by Subject|1|||
147579159|NCT01929681|532275085|FG000|Overall Study|Withdrawal by Subject|1|||
147579160|NCT01929681|532275086|FG001|Overall Study|Withdrawal by Subject|0|||
147579161|NCT01929681|532275085|FG000|Overall Study|Physician Decision|1|||
147579162|NCT01929681|532275086|FG001|Overall Study|Physician Decision|1|||
147579163|NCT01426854|532275087|FG000|Overall Study|Adverse Event|1|||
147579164|NCT01426854|532275088|FG001|Overall Study|Adverse Event|5|||
147579165|NCT01426854|532275087|FG000|Overall Study|Subject Decision Unrelated to AE|5|||
147579166|NCT01426854|532275088|FG001|Overall Study|Subject Decision Unrelated to AE|6|||
147579167|NCT01426854|532275087|FG000|Overall Study|Lost to Follow-up|3|||
147579168|NCT01426854|532275088|FG001|Overall Study|Lost to Follow-up|0|||
147579169|NCT01426854|532275087|FG000|Overall Study|Noncompliance|0|||
147579170|NCT01426854|532275088|FG001|Overall Study|Noncompliance|1|||
147579171|NCT01426854|532275087|FG000|Overall Study|Treatment Failure|0|||
147153115|NCT02589665|530724154|FG005|Induction Extension Period|Physician Decision|0|||
147239832|NCT02034110|531051477|FG007|Overall Study|Physician Decision|0|||
147239833|NCT02034110|531051470|FG000|Overall Study|Lost to Follow-up|1|||
147239834|NCT02034110|531051471|FG001|Overall Study|Lost to Follow-up|0|||
147579172|NCT01426854|532275088|FG001|Overall Study|Treatment Failure|16|||
147579173|NCT01426854|532275087|FG000|Overall Study|Protocol Deviation|0|||
147579174|NCT01426854|532275088|FG001|Overall Study|Protocol Deviation|1|||
147579175|NCT01426854|532275087|FG000|Overall Study|Other|3|||
147579176|NCT01426854|532275088|FG001|Overall Study|Other|2|||
147579177|NCT01971554|532275089|FG000|Overall Study|Lost to Follow-up|1|||
147579178|NCT01971554|532275090|FG001|Overall Study|Lost to Follow-up|0|||
147579179|NCT01971554|532275091|FG002|Overall Study|Lost to Follow-up|0|||
147579180|NCT01971554|532275092|FG003|Overall Study|Lost to Follow-up|0|||
147579181|NCT03555695|532275095|FG000|Overall Study|Withdrawal by Subject|1|||
147653308|NCT02372383|532554525|FG002|First Intervention (1 Day)|Unable to collect blood|0|||
147653309|NCT03130959|532554529|FG000|Overall Study|Disease progression|19|||
147579182|NCT03555695|532275095|FG000|Overall Study|Lost to Follow-up|1|||
147153116|NCT02589665|530724155|FG006|Induction Extension Period|Physician Decision|0|||
147153117|NCT02589665|530724156|FG007|Induction Extension Period|Physician Decision|0|||
147239835|NCT02034110|531051472|FG002|Overall Study|Lost to Follow-up|0|||
147153118|NCT02589665|530724157|FG008|Induction Extension Period|Physician Decision|1|||
147153119|NCT02589665|530724158|FG009|Induction Extension Period|Physician Decision|0|||
147153120|NCT02589665|530724149|FG000|Induction Extension Period|Reason Not Collected|0|||
147239836|NCT02034110|531051473|FG003|Overall Study|Lost to Follow-up|0|||
147153121|NCT02589665|530724150|FG001|Induction Extension Period|Reason Not Collected|0|||
147153122|NCT02589665|530724151|FG002|Induction Extension Period|Reason Not Collected|0|||
147153123|NCT02589665|530724152|FG003|Induction Extension Period|Reason Not Collected|0|||
147153124|NCT02589665|530724153|FG004|Induction Extension Period|Reason Not Collected|0|||
147153125|NCT02589665|530724154|FG005|Induction Extension Period|Reason Not Collected|0|||
147153126|NCT02589665|530724155|FG006|Induction Extension Period|Reason Not Collected|0|||
147153127|NCT02589665|530724156|FG007|Induction Extension Period|Reason Not Collected|0|||
147153128|NCT02589665|530724157|FG008|Induction Extension Period|Reason Not Collected|1|||
147153129|NCT02589665|530724158|FG009|Induction Extension Period|Reason Not Collected|0|||
147153130|NCT02589665|530724149|FG000|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
147153131|NCT02589665|530724150|FG001|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
147153132|NCT02589665|530724151|FG002|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
147153133|NCT02589665|530724152|FG003|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
147153134|NCT02589665|530724153|FG004|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
147153135|NCT02589665|530724154|FG005|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
147153136|NCT02589665|530724155|FG006|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
147153137|NCT02589665|530724156|FG007|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
147153138|NCT02589665|530724157|FG008|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|0|||
147153139|NCT02589665|530724158|FG009|Maintenance Extension Period|Rolled Over to Study AMAP (NCT03519945)|57|||
147153140|NCT02589665|530724149|FG000|Maintenance Extension Period|Withdrawal by Subject|0|||
147153141|NCT02589665|530724150|FG001|Maintenance Extension Period|Withdrawal by Subject|0|||
147153142|NCT02589665|530724151|FG002|Maintenance Extension Period|Withdrawal by Subject|0|||
147153143|NCT02589665|530724152|FG003|Maintenance Extension Period|Withdrawal by Subject|0|||
147153144|NCT02589665|530724153|FG004|Maintenance Extension Period|Withdrawal by Subject|0|||
147153145|NCT02589665|530724154|FG005|Maintenance Extension Period|Withdrawal by Subject|0|||
147153146|NCT02589665|530724155|FG006|Maintenance Extension Period|Withdrawal by Subject|0|||
147239837|NCT02034110|531051474|FG004|Overall Study|Lost to Follow-up|1|||
147239838|NCT02034110|531051475|FG005|Overall Study|Lost to Follow-up|0|||
147239839|NCT02034110|531051476|FG006|Overall Study|Lost to Follow-up|1|||
147239840|NCT02034110|531051477|FG007|Overall Study|Lost to Follow-up|0|||
147239841|NCT02034110|531051470|FG000|Overall Study|Withdrawal by Subject|5|||
147239842|NCT02034110|531051471|FG001|Overall Study|Withdrawal by Subject|7|||
147239843|NCT02034110|531051472|FG002|Overall Study|Withdrawal by Subject|0|||
147239844|NCT02034110|531051473|FG003|Overall Study|Withdrawal by Subject|3|||
147239845|NCT02034110|531051474|FG004|Overall Study|Withdrawal by Subject|7|||
147239846|NCT02034110|531051475|FG005|Overall Study|Withdrawal by Subject|0|||
147239847|NCT02034110|531051476|FG006|Overall Study|Withdrawal by Subject|3|||
147239848|NCT02034110|531051477|FG007|Overall Study|Withdrawal by Subject|1|||
147239849|NCT02034110|531051470|FG000|Overall Study|Study closed by sponsor|6|||
147239850|NCT02034110|531051471|FG001|Overall Study|Study closed by sponsor|2|||
147239851|NCT02034110|531051472|FG002|Overall Study|Study closed by sponsor|0|||
147239852|NCT02034110|531051473|FG003|Overall Study|Study closed by sponsor|6|||
147239853|NCT02034110|531051474|FG004|Overall Study|Study closed by sponsor|7|||
147239854|NCT02034110|531051475|FG005|Overall Study|Study closed by sponsor|0|||
147239855|NCT02034110|531051476|FG006|Overall Study|Study closed by sponsor|42|||
147239856|NCT02034110|531051477|FG007|Overall Study|Study closed by sponsor|0|||
147239857|NCT02587234|531051478|FG000|Overall Study|Withdrawal by Subject|1|||
147239858|NCT02587234|531051479|FG001|Overall Study|Withdrawal by Subject|1|||
147239859|NCT02587234|531051478|FG000|Overall Study|Lost to Follow-up|0|||
147239860|NCT02587234|531051479|FG001|Overall Study|Lost to Follow-up|2|||
147239861|NCT00590720|531051480|FG000|Overall Study|Lost to Follow-up|1|||
147239862|NCT00590720|531051481|FG001|Overall Study|Lost to Follow-up|0|||
147239863|NCT00590720|531051480|FG000|Overall Study|Withdrawal by Subject|0|||
147239864|NCT00590720|531051481|FG001|Overall Study|Withdrawal by Subject|1|||
147239865|NCT01001377|531051483|FG000|Overall Study|Ineligibility determined|2|||
147239866|NCT01001377|531051484|FG001|Overall Study|Ineligibility determined|0|||
147579183|NCT03555695|532275095|FG000|Overall Study|appendicitis (unrelated)|1|||
147579184|NCT03555695|532275095|FG000|Overall Study|pre-existing sciatica|1|||
147579185|NCT01942135|532275097|FG000|Overall Study|Adverse Event|21|||
147579186|NCT01942135|532275098|FG001|Overall Study|Adverse Event|7|||
147579187|NCT01942135|532275097|FG000|Overall Study|Global Deterioration of Health Status|9|||
147579188|NCT01942135|532275098|FG001|Overall Study|Global Deterioration of Health Status|6|||
147579189|NCT01942135|532275097|FG000|Overall Study|Randomized Not Treated|2|||
147579190|NCT01942135|532275098|FG001|Overall Study|Randomized Not Treated|2|||
147579191|NCT01942135|532275097|FG000|Overall Study|Death|2|||
147579192|NCT01942135|532275098|FG001|Overall Study|Death|1|||
147579193|NCT01942135|532275097|FG000|Overall Study|Objective Progression or Relapse + Progressive Disease|279|||
147579194|NCT01942135|532275098|FG001|Overall Study|Objective Progression or Relapse + Progressive Disease|148|||
147579195|NCT01942135|532275097|FG000|Overall Study|Participant Refused to Continue Treatment for Reason Other than Adverse Event|10|||
147579196|NCT01942135|532275098|FG001|Overall Study|Participant Refused to Continue Treatment for Reason Other than Adverse Event|3|||
147579197|NCT01942135|532275097|FG000|Overall Study|Withdrawal by Subject|4|||
147579198|NCT01942135|532275098|FG001|Overall Study|Withdrawal by Subject|3|||
147579199|NCT01942135|532275097|FG000|Overall Study|Protocol Violation|1|||
147579200|NCT01942135|532275098|FG001|Overall Study|Protocol Violation|0|||
147579201|NCT01942135|532275097|FG000|Overall Study|Other|19|||
147579202|NCT01942135|532275098|FG001|Overall Study|Other|4|||
147579203|NCT01717040|532275099|FG000|Overall Study|Lost to Follow-up|2|||
147579204|NCT01717040|532275100|FG001|Overall Study|Lost to Follow-up|3|||
147579205|NCT01717040|532275099|FG000|Overall Study|Lack of Efficacy|1|||
147579206|NCT01717040|532275100|FG001|Overall Study|Lack of Efficacy|1|||
147579207|NCT01717040|532275099|FG000|Overall Study|Adverse Event|1|||
147579208|NCT01717040|532275100|FG001|Overall Study|Adverse Event|0|||
147579209|NCT01717040|532275099|FG000|Overall Study|Required Medication Change|0|||
147579210|NCT01717040|532275100|FG001|Overall Study|Required Medication Change|1|||
147579211|NCT01717040|532275099|FG000|Overall Study|New Substance Use Disorder|1|||
147579212|NCT01717040|532275100|FG001|Overall Study|New Substance Use Disorder|0|||
147579213|NCT03196284|532275101|FG000|Main Part|Withdrawal by Subject|0|||
147579214|NCT03196284|532275102|FG001|Main Part|Withdrawal by Subject|1|||
147579215|NCT03196284|532275103|FG002|Main Part|Withdrawal by Subject|0|||
147579216|NCT03196284|532275101|FG000|Extension Part|Lack of Efficacy|0|||
147579217|NCT03196284|532275102|FG001|Extension Part|Lack of Efficacy|0|||
147579218|NCT03196284|532275103|FG002|Extension Part|Lack of Efficacy|1|||
147579219|NCT03196284|532275101|FG000|Extension Part|Withdrawal by Subject|0|||
147579220|NCT03196284|532275102|FG001|Extension Part|Withdrawal by Subject|0|||
147579221|NCT03196284|532275103|FG002|Extension Part|Withdrawal by Subject|1|||
147579222|NCT03196284|532275101|FG000|Extension Part|Physician Decision|0|||
147579223|NCT03196284|532275102|FG001|Extension Part|Physician Decision|0|||
147579224|NCT03196284|532275103|FG002|Extension Part|Physician Decision|1|||
147579225|NCT01139762|532275104|FG000|Washout and Placebo Lead-In Period|Entry Criteria Not Met|258|||
147653310|NCT03130959|532554530|FG001|Overall Study|Disease progression|7|||
147153147|NCT02589665|530724156|FG007|Maintenance Extension Period|Withdrawal by Subject|0|||
147153148|NCT02589665|530724157|FG008|Maintenance Extension Period|Withdrawal by Subject|0|||
147153149|NCT02589665|530724158|FG009|Maintenance Extension Period|Withdrawal by Subject|4|||
147153150|NCT02589665|530724149|FG000|Maintenance Extension Period|Lack of Efficacy|0|||
147153151|NCT02589665|530724150|FG001|Maintenance Extension Period|Lack of Efficacy|0|||
147153152|NCT02589665|530724151|FG002|Maintenance Extension Period|Lack of Efficacy|0|||
147153153|NCT02589665|530724152|FG003|Maintenance Extension Period|Lack of Efficacy|0|||
147153154|NCT02589665|530724153|FG004|Maintenance Extension Period|Lack of Efficacy|0|||
147153155|NCT02589665|530724154|FG005|Maintenance Extension Period|Lack of Efficacy|0|||
147153156|NCT02589665|530724155|FG006|Maintenance Extension Period|Lack of Efficacy|0|||
147153157|NCT02589665|530724156|FG007|Maintenance Extension Period|Lack of Efficacy|0|||
147321539|NCT05968482|531340074|FG004|First Crossover Period|Adverse Event|0|||
147321540|NCT05968482|531340075|FG005|First Crossover Period|Adverse Event|1|||
147153158|NCT02589665|530724157|FG008|Maintenance Extension Period|Lack of Efficacy|0|||
147153159|NCT02589665|530724158|FG009|Maintenance Extension Period|Lack of Efficacy|4|||
147153160|NCT02589665|530724149|FG000|Maintenance Extension Period|Adverse Event|0|||
147153161|NCT02589665|530724150|FG001|Maintenance Extension Period|Adverse Event|0|||
147153162|NCT02589665|530724151|FG002|Maintenance Extension Period|Adverse Event|0|||
147153163|NCT02589665|530724152|FG003|Maintenance Extension Period|Adverse Event|0|||
147321541|NCT05968482|531340070|FG000|Second Crossover Period|Withdrawal by Subject|0|||
147579226|NCT01139762|532275105|FG001|Washout and Placebo Lead-In Period|Entry Criteria Not Met|0|||
147153164|NCT02589665|530724153|FG004|Maintenance Extension Period|Adverse Event|0|||
147153165|NCT02589665|530724154|FG005|Maintenance Extension Period|Adverse Event|0|||
147153166|NCT02589665|530724155|FG006|Maintenance Extension Period|Adverse Event|0|||
147153167|NCT02589665|530724156|FG007|Maintenance Extension Period|Adverse Event|0|||
147153168|NCT02589665|530724157|FG008|Maintenance Extension Period|Adverse Event|0|||
147153169|NCT02589665|530724158|FG009|Maintenance Extension Period|Adverse Event|2|||
147153170|NCT02589665|530724149|FG000|Maintenance Extension Period|Non-responder|0|||
147153171|NCT02589665|530724150|FG001|Maintenance Extension Period|Non-responder|0|||
147153172|NCT02589665|530724151|FG002|Maintenance Extension Period|Non-responder|0|||
147153173|NCT02589665|530724152|FG003|Maintenance Extension Period|Non-responder|0|||
147321542|NCT05968482|531340071|FG001|Second Crossover Period|Withdrawal by Subject|0|||
147321543|NCT05968482|531340072|FG002|Second Crossover Period|Withdrawal by Subject|0|||
147579227|NCT01139762|532275106|FG002|Washout and Placebo Lead-In Period|Entry Criteria Not Met|0|||
147579228|NCT01139762|532275104|FG000|Washout and Placebo Lead-In Period|Adverse Event|1|||
147579229|NCT01139762|532275105|FG001|Washout and Placebo Lead-In Period|Adverse Event|0|||
147653311|NCT03130959|532554531|FG002|Overall Study|Disease progression|12|||
147153174|NCT02589665|530724153|FG004|Maintenance Extension Period|Non-responder|0|||
147153175|NCT02589665|530724154|FG005|Maintenance Extension Period|Non-responder|0|||
147579230|NCT01139762|532275106|FG002|Washout and Placebo Lead-In Period|Adverse Event|0|||
147579231|NCT01139762|532275104|FG000|Washout and Placebo Lead-In Period|Withdrawal by Subject|83|||
147579232|NCT01139762|532275105|FG001|Washout and Placebo Lead-In Period|Withdrawal by Subject|0|||
147579233|NCT01139762|532275106|FG002|Washout and Placebo Lead-In Period|Withdrawal by Subject|0|||
147579234|NCT01139762|532275104|FG000|Washout and Placebo Lead-In Period|Physician Decision|12|||
147579235|NCT01139762|532275105|FG001|Washout and Placebo Lead-In Period|Physician Decision|0|||
147579236|NCT01139762|532275106|FG002|Washout and Placebo Lead-In Period|Physician Decision|0|||
147579237|NCT01139762|532275104|FG000|Washout and Placebo Lead-In Period|Sponsor Decision|10|||
147579238|NCT01139762|532275105|FG001|Washout and Placebo Lead-In Period|Sponsor Decision|0|||
147579239|NCT01139762|532275106|FG002|Washout and Placebo Lead-In Period|Sponsor Decision|0|||
147579240|NCT01139762|532275104|FG000|Washout and Placebo Lead-In Period|Lost to Follow-up|10|||
147579241|NCT01139762|532275105|FG001|Washout and Placebo Lead-In Period|Lost to Follow-up|0|||
147579242|NCT01139762|532275106|FG002|Washout and Placebo Lead-In Period|Lost to Follow-up|0|||
147579243|NCT01139762|532275104|FG000|Double-Blind Randomized Active Treatment|Adverse Event|0|||
147579244|NCT01139762|532275105|FG001|Double-Blind Randomized Active Treatment|Adverse Event|4|||
147579245|NCT01139762|532275106|FG002|Double-Blind Randomized Active Treatment|Adverse Event|10|||
147579246|NCT01139762|532275104|FG000|Double-Blind Randomized Active Treatment|Death|0|||
147579247|NCT01139762|532275105|FG001|Double-Blind Randomized Active Treatment|Death|1|||
147579248|NCT01139762|532275106|FG002|Double-Blind Randomized Active Treatment|Death|1|||
147579249|NCT01139762|532275104|FG000|Double-Blind Randomized Active Treatment|Entry Criteria Not Met|0|||
147579250|NCT01139762|532275105|FG001|Double-Blind Randomized Active Treatment|Entry Criteria Not Met|14|||
147579251|NCT01139762|532275106|FG002|Double-Blind Randomized Active Treatment|Entry Criteria Not Met|17|||
147579252|NCT01139762|532275104|FG000|Double-Blind Randomized Active Treatment|Protocol Violation|0|||
147579253|NCT01139762|532275105|FG001|Double-Blind Randomized Active Treatment|Protocol Violation|2|||
147579254|NCT01139762|532275106|FG002|Double-Blind Randomized Active Treatment|Protocol Violation|8|||
147579255|NCT01139762|532275104|FG000|Double-Blind Randomized Active Treatment|Withdrawal by Subject|0|||
147579256|NCT01139762|532275105|FG001|Double-Blind Randomized Active Treatment|Withdrawal by Subject|6|||
147579257|NCT01139762|532275106|FG002|Double-Blind Randomized Active Treatment|Withdrawal by Subject|13|||
147579258|NCT01139762|532275104|FG000|Double-Blind Randomized Active Treatment|Physician Decision|0|||
147579259|NCT01139762|532275105|FG001|Double-Blind Randomized Active Treatment|Physician Decision|2|||
147579260|NCT01139762|532275106|FG002|Double-Blind Randomized Active Treatment|Physician Decision|0|||
147579261|NCT01139762|532275104|FG000|Double-Blind Randomized Active Treatment|Sponsor Decision|0|||
147579262|NCT01139762|532275105|FG001|Double-Blind Randomized Active Treatment|Sponsor Decision|5|||
147579263|NCT01139762|532275106|FG002|Double-Blind Randomized Active Treatment|Sponsor Decision|6|||
147579264|NCT01139762|532275104|FG000|Double-Blind Randomized Active Treatment|Lack of Efficacy|0|||
147579265|NCT01139762|532275105|FG001|Double-Blind Randomized Active Treatment|Lack of Efficacy|3|||
147579266|NCT01139762|532275106|FG002|Double-Blind Randomized Active Treatment|Lack of Efficacy|5|||
147579267|NCT01139762|532275104|FG000|Double-Blind Randomized Active Treatment|Lost to Follow-up|0|||
147579268|NCT01139762|532275105|FG001|Double-Blind Randomized Active Treatment|Lost to Follow-up|3|||
147579269|NCT01139762|532275106|FG002|Double-Blind Randomized Active Treatment|Lost to Follow-up|4|||
147579270|NCT01675596|532275107|FG000|Overall Study|Death|6|||
147579271|NCT01675596|532275107|FG000|Overall Study|Exit with other reason|1|||
147579272|NCT01675596|532275107|FG000|Overall Study|Missed Visit|1|||
147579273|NCT00087529|532275109|FG000|Overall Study|Death|1|||
147579274|NCT00087529|532275110|FG001|Overall Study|Death|0|||
147579275|NCT00087529|532275109|FG000|Overall Study|Adverse Event|0|||
147579276|NCT00087529|532275110|FG001|Overall Study|Adverse Event|8|||
147579277|NCT00087529|532275109|FG000|Overall Study|Pregnancy|0|||
147579278|NCT00087529|532275110|FG001|Overall Study|Pregnancy|1|||
147579279|NCT00087529|532275109|FG000|Overall Study|Lost to Follow-up|2|||
147579280|NCT00087529|532275110|FG001|Overall Study|Lost to Follow-up|3|||
147579281|NCT00087529|532275109|FG000|Overall Study|Participant Decision|14|||
147579282|NCT00087529|532275110|FG001|Overall Study|Participant Decision|37|||
147579283|NCT00087529|532275109|FG000|Overall Study|Physician Decision|4|||
147579284|NCT00087529|532275110|FG001|Overall Study|Physician Decision|8|||
147579285|NCT00087529|532275109|FG000|Overall Study|Initiation of Excluded Therapy|0|||
147579286|NCT00087529|532275110|FG001|Overall Study|Initiation of Excluded Therapy|1|||
147579287|NCT00087529|532275109|FG000|Overall Study|Participant Noncompliance|0|||
147153176|NCT02589665|530724155|FG006|Maintenance Extension Period|Non-responder|0|||
147321544|NCT05968482|531340073|FG003|Second Crossover Period|Withdrawal by Subject|0|||
147321545|NCT05968482|531340074|FG004|Second Crossover Period|Withdrawal by Subject|1|||
147321546|NCT05968482|531340075|FG005|Second Crossover Period|Withdrawal by Subject|0|||
147153177|NCT02589665|530724156|FG007|Maintenance Extension Period|Non-responder|0|||
147321547|NCT05968482|531340070|FG000|Third Crossover Period|Adverse Event|0|||
147579288|NCT00087529|532275110|FG001|Overall Study|Participant Noncompliance|1|||
147579289|NCT00087529|532275109|FG000|Overall Study|Disease Progression|5|||
147579290|NCT00087529|532275110|FG001|Overall Study|Disease Progression|4|||
147579291|NCT00087529|532275109|FG000|Overall Study|Did Not Continue to Safety Follow-Up|5|||
147579292|NCT00087529|532275110|FG001|Overall Study|Did Not Continue to Safety Follow-Up|5|||
147446284|NCT03775421|531798901|FG000|Overall Study|Withdrawal by Subject|10|||
147446285|NCT03775421|531798901|FG000|Overall Study|Physician Decision|3|||
147446286|NCT03775421|531798901|FG000|Overall Study|Death|1|||
147446287|NCT03775421|531798901|FG000|Overall Study|Study Terminated by Sponsor|94|||
147446288|NCT02016820|531798902|FG000|Overall Study|Lost to Follow-up|2|||
147446289|NCT02016820|531798903|FG001|Overall Study|Lost to Follow-up|4|||
147446290|NCT00473343|531798904|FG000|Overall Study|Adverse Event|9|||
147446291|NCT00473343|531798904|FG000|Overall Study|Lost to Follow-up|8|||
147446292|NCT00473343|531798904|FG000|Overall Study|Treatment failure|27|||
147446293|NCT00473343|531798904|FG000|Overall Study|Withdrew consent|3|||
147446294|NCT00473343|531798904|FG000|Overall Study|Other un-specified reason|3|||
147153178|NCT02589665|530724157|FG008|Maintenance Extension Period|Non-responder|0|||
147153179|NCT02589665|530724158|FG009|Maintenance Extension Period|Non-responder|1|||
147153180|NCT00176488|530724161|FG000|Overall Study|Initiated Cycle 1 Day 1 only|1|||
147153181|NCT00327015|530724162|FG000|Overall Study|Lack of Efficacy|18|||
147153182|NCT00327015|530724163|FG001|Overall Study|Lack of Efficacy|18|||
147153183|NCT00327015|530724164|FG002|Overall Study|Lack of Efficacy|35|||
147153184|NCT00327015|530724165|FG003|Overall Study|Lack of Efficacy|29|||
147153185|NCT00327015|530724162|FG000|Overall Study|Withdrawal of Consent by Subject|20|||
147153186|NCT00327015|530724163|FG001|Overall Study|Withdrawal of Consent by Subject|24|||
147153187|NCT00327015|530724164|FG002|Overall Study|Withdrawal of Consent by Subject|28|||
147153188|NCT00327015|530724165|FG003|Overall Study|Withdrawal of Consent by Subject|25|||
147153189|NCT00327015|530724162|FG000|Overall Study|Lost to Follow-up|22|||
147239867|NCT01001377|531051483|FG000|Overall Study|Withdrawal by Subject|19|||
147239868|NCT01001377|531051484|FG001|Overall Study|Withdrawal by Subject|20|||
147446295|NCT02290873|531798907|FG000|Overall Study|Withdrawal by Subject|0|||
147446296|NCT02290873|531798908|FG001|Overall Study|Withdrawal by Subject|1|||
147446297|NCT02290873|531798909|FG002|Overall Study|Withdrawal by Subject|1|||
147239869|NCT01001377|531051483|FG000|Overall Study|Lost to Follow-up|14|||
147239870|NCT01001377|531051484|FG001|Overall Study|Lost to Follow-up|17|||
147239871|NCT01001377|531051483|FG000|Overall Study|Death|391|||
147446298|NCT02290873|531798907|FG000|Overall Study|Nellcor device error|1|||
147446299|NCT02290873|531798908|FG001|Overall Study|Nellcor device error|0|||
147446300|NCT02290873|531798909|FG002|Overall Study|Nellcor device error|0|||
147446301|NCT02290873|531798907|FG000|Overall Study|Esophagogastroduodenoscopy was added|1|||
147446302|NCT02290873|531798908|FG001|Overall Study|Esophagogastroduodenoscopy was added|0|||
147579293|NCT01662024|532276869|FG000|Overall Study|Pregnancy|2|||
147579294|NCT01662024|532276869|FG000|Overall Study|Withdrawal by Subject|3|||
147579295|NCT00927251|532276870|FG000|Overall Study|Patients not implanted with 4296 lead|8|||
147579296|NCT01813435|532276871|FG000|Overall Study|did not finish experimental regimen|1902|||
147579297|NCT01813435|532276872|FG001|Overall Study|did not finish experimental regimen|770|||
147579298|NCT01813435|532276871|FG000|Overall Study|Lost to Follow-up|268|||
147579299|NCT01813435|532276872|FG001|Overall Study|Lost to Follow-up|237|||
147579300|NCT01490190|532276873|FG000|Overall Study|Withdrawal by Subject|9|||
147579301|NCT01490190|532276873|FG000|Overall Study|Adverse Event|17|||
147579302|NCT01490190|532276873|FG000|Overall Study|Protocol Violation|5|||
147579303|NCT01490190|532276873|FG000|Overall Study|Lost to Follow-up|13|||
147579304|NCT01490190|532276873|FG000|Overall Study|Relocation|1|||
147579305|NCT01490190|532276873|FG000|Overall Study|Inconvenience|1|||
147579306|NCT01490190|532276873|FG000|Overall Study|Ring expulsion|2|||
147579307|NCT02435433|532276876|FG000|Overall Study|Withdrawal by Subject|2|||
147579308|NCT02435433|532276877|FG001|Overall Study|Withdrawal by Subject|3|||
147579309|NCT02435433|532276878|FG002|Overall Study|Withdrawal by Subject|1|||
147579310|NCT02435433|532276879|FG003|Overall Study|Withdrawal by Subject|0|||
147579311|NCT02435433|532276880|FG004|Overall Study|Withdrawal by Subject|0|||
147579312|NCT02435433|532276876|FG000|Overall Study|Lost to Follow-up|2|||
147579313|NCT02435433|532276877|FG001|Overall Study|Lost to Follow-up|2|||
147579314|NCT02435433|532276878|FG002|Overall Study|Lost to Follow-up|4|||
147579315|NCT02435433|532276879|FG003|Overall Study|Lost to Follow-up|1|||
147579316|NCT02435433|532276880|FG004|Overall Study|Lost to Follow-up|0|||
147239872|NCT01001377|531051484|FG001|Overall Study|Death|384|||
147446303|NCT02290873|531798909|FG002|Overall Study|Esophagogastroduodenoscopy was added|0|||
147446304|NCT02290873|531798907|FG000|Overall Study|Protocol Violation|0|||
147446305|NCT02290873|531798908|FG001|Overall Study|Protocol Violation|0|||
147446306|NCT02290873|531798909|FG002|Overall Study|Protocol Violation|1|||
147446307|NCT02370615|531798910|FG000|Overall Study|Adverse Event|1|||
147579317|NCT01243151|532276881|FG000|Overall Study|Adverse Event|0|||
147579318|NCT01243151|532276882|FG001|Overall Study|Adverse Event|1|||
147579319|NCT01243151|532276883|FG002|Overall Study|Adverse Event|0|||
147579320|NCT01243151|532276884|FG003|Overall Study|Adverse Event|0|||
147153190|NCT00327015|530724163|FG001|Overall Study|Lost to Follow-up|23|||
147153191|NCT00327015|530724164|FG002|Overall Study|Lost to Follow-up|29|||
147239873|NCT03039283|531051488|FG000|Overall Study|Protocol Violation|2|||
147239874|NCT02732119|531051489|FG000|Phase I|Adverse Event|1|||
147446308|NCT02370615|531798911|FG001|Overall Study|Adverse Event|0|||
147579321|NCT01243151|532276885|FG004|Overall Study|Adverse Event|0|||
147579322|NCT01243151|532276881|FG000|Overall Study|Protocol Violation|0|||
147579323|NCT01243151|532276882|FG001|Overall Study|Protocol Violation|0|||
147153192|NCT00327015|530724165|FG003|Overall Study|Lost to Follow-up|22|||
147153193|NCT00327015|530724162|FG000|Overall Study|Adverse Event|14|||
147153194|NCT00327015|530724163|FG001|Overall Study|Adverse Event|10|||
147153195|NCT00327015|530724164|FG002|Overall Study|Adverse Event|14|||
147153196|NCT00327015|530724165|FG003|Overall Study|Adverse Event|14|||
147153197|NCT00327015|530724162|FG000|Overall Study|Subject no longer meets study criteria|4|||
147153198|NCT00327015|530724163|FG001|Overall Study|Subject no longer meets study criteria|2|||
147153199|NCT00327015|530724164|FG002|Overall Study|Subject no longer meets study criteria|8|||
147153200|NCT00327015|530724165|FG003|Overall Study|Subject no longer meets study criteria|7|||
147153201|NCT00327015|530724162|FG000|Overall Study|Poor/Noncompliance|11|||
147153202|NCT00327015|530724163|FG001|Overall Study|Poor/Noncompliance|8|||
147153203|NCT00327015|530724164|FG002|Overall Study|Poor/Noncompliance|4|||
147153204|NCT00327015|530724165|FG003|Overall Study|Poor/Noncompliance|5|||
147153205|NCT00327015|530724162|FG000|Overall Study|Physician Decision|0|||
147153206|NCT00327015|530724163|FG001|Overall Study|Physician Decision|1|||
147153207|NCT00327015|530724164|FG002|Overall Study|Physician Decision|3|||
147153208|NCT00327015|530724165|FG003|Overall Study|Physician Decision|2|||
147153209|NCT00327015|530724162|FG000|Overall Study|Death|1|||
147153210|NCT00327015|530724163|FG001|Overall Study|Death|2|||
147153211|NCT00327015|530724164|FG002|Overall Study|Death|2|||
147153212|NCT00327015|530724165|FG003|Overall Study|Death|3|||
147153213|NCT00327015|530724162|FG000|Overall Study|Pregnancy|0|||
147153214|NCT00327015|530724163|FG001|Overall Study|Pregnancy|2|||
147153215|NCT00327015|530724164|FG002|Overall Study|Pregnancy|1|||
147153216|NCT00327015|530724165|FG003|Overall Study|Pregnancy|1|||
147153217|NCT00327015|530724162|FG000|Overall Study|Administrative Reason by Sponsor|1|||
147153218|NCT00327015|530724163|FG001|Overall Study|Administrative Reason by Sponsor|2|||
147153219|NCT00327015|530724164|FG002|Overall Study|Administrative Reason by Sponsor|2|||
147153220|NCT00327015|530724165|FG003|Overall Study|Administrative Reason by Sponsor|1|||
147153221|NCT02650804|530724166|FG000|Overall Study|Adverse Event|3|||
147153222|NCT02650804|530724167|FG001|Overall Study|Adverse Event|2|||
147153223|NCT02650804|530724166|FG000|Overall Study|Death|1|||
147153224|NCT02650804|530724167|FG001|Overall Study|Death|2|||
147153225|NCT02650804|530724166|FG000|Overall Study|Progressive Disease|7|||
147153226|NCT02650804|530724167|FG001|Overall Study|Progressive Disease|10|||
147153227|NCT02650804|530724166|FG000|Overall Study|Physician Decision|0|||
147153228|NCT02650804|530724167|FG001|Overall Study|Physician Decision|2|||
147321548|NCT05968482|531340071|FG001|Third Crossover Period|Adverse Event|0|||
147321549|NCT05968482|531340072|FG002|Third Crossover Period|Adverse Event|0|||
147321550|NCT05968482|531340073|FG003|Third Crossover Period|Adverse Event|0|||
147321551|NCT05968482|531340074|FG004|Third Crossover Period|Adverse Event|1|||
147321552|NCT05968482|531340075|FG005|Third Crossover Period|Adverse Event|0|||
147321553|NCT05968482|531340070|FG000|Third Crossover Period|failure to meet continuation criteria|0|||
147579324|NCT01243151|532276883|FG002|Overall Study|Protocol Violation|1|||
147579325|NCT01243151|532276884|FG003|Overall Study|Protocol Violation|0|||
147579326|NCT01243151|532276885|FG004|Overall Study|Protocol Violation|0|||
147579327|NCT01243151|532276881|FG000|Overall Study|Other|0|||
147579328|NCT01243151|532276882|FG001|Overall Study|Other|0|||
147579329|NCT01243151|532276883|FG002|Overall Study|Other|0|||
147579330|NCT01243151|532276884|FG003|Overall Study|Other|1|||
147579331|NCT01243151|532276885|FG004|Overall Study|Other|0|||
147579332|NCT01243151|532276881|FG000|Overall Study|Randomized but not treated|0|||
147579333|NCT01243151|532276882|FG001|Overall Study|Randomized but not treated|0|||
147579334|NCT01243151|532276883|FG002|Overall Study|Randomized but not treated|0|||
147579335|NCT01243151|532276884|FG003|Overall Study|Randomized but not treated|1|||
147579336|NCT01243151|532276885|FG004|Overall Study|Randomized but not treated|0|||
147579337|NCT00397254|532276891|FG000|Overall Study|Lost to Follow-up|2|||
147579338|NCT00397254|532276892|FG001|Overall Study|Lost to Follow-up|2|||
147579339|NCT00210639|532276893|FG000|Overall Study|Lost to Follow-up|37|||
147153229|NCT02650804|530724166|FG000|Overall Study|Withdrawal by Subject|1|||
147153230|NCT02650804|530724167|FG001|Overall Study|Withdrawal by Subject|4|||
147153231|NCT02650804|530724166|FG000|Overall Study|Symptomatic deterioration|5|||
147153232|NCT02650804|530724167|FG001|Overall Study|Symptomatic deterioration|7|||
147153233|NCT02650804|530724166|FG000|Overall Study|Protocol Violation|0|||
147153234|NCT02650804|530724167|FG001|Overall Study|Protocol Violation|1|||
147153235|NCT01159171|530724168|FG000|Overall Study|Adverse Event|11|||
147153236|NCT01159171|530724168|FG000|Overall Study|Progression of Disease|28|||
147153237|NCT01159171|530724168|FG000|Overall Study|Protocol Violation|1|||
147153238|NCT01159171|530724168|FG000|Overall Study|Need for Surgery|5|||
147153239|NCT01159171|530724168|FG000|Overall Study|Medical Decision|4|||
147153240|NCT01159171|530724168|FG000|Overall Study|Death|1|||
147153241|NCT01892436|530724171|FG000|Overall Study|Withdrawal by Subject|8|||
147579340|NCT00210639|532276894|FG001|Overall Study|Lost to Follow-up|29|||
147579341|NCT00210639|532276893|FG000|Overall Study|Withdrawal by Subject|8|||
147579342|NCT00210639|532276894|FG001|Overall Study|Withdrawal by Subject|1|||
147579343|NCT00210639|532276893|FG000|Overall Study|Other|18|||
147579344|NCT00210639|532276894|FG001|Overall Study|Other|12|||
147579345|NCT02786953|532276895|FG000|Overall Study|Withdrawal by Subject|3|||
147579346|NCT02786953|532276896|FG001|Overall Study|Withdrawal by Subject|0|||
147239875|NCT02732119|531051490|FG001|Phase I|Adverse Event|3|||
147239876|NCT02732119|531051491|FG002|Phase I|Adverse Event|1|||
147239877|NCT02732119|531051492|FG003|Phase I|Adverse Event|0|||
147239878|NCT02732119|531051493|FG004|Phase I|Adverse Event|0|||
147239879|NCT02732119|531051489|FG000|Phase I|Progressive disease|7|||
147239880|NCT02732119|531051490|FG001|Phase I|Progressive disease|3|||
147239881|NCT02732119|531051491|FG002|Phase I|Progressive disease|2|||
147239882|NCT02732119|531051492|FG003|Phase I|Progressive disease|0|||
147239883|NCT02732119|531051493|FG004|Phase I|Progressive disease|0|||
147321554|NCT05968482|531340071|FG001|Third Crossover Period|failure to meet continuation criteria|1|||
147321555|NCT05968482|531340072|FG002|Third Crossover Period|failure to meet continuation criteria|0|||
147321556|NCT05968482|531340073|FG003|Third Crossover Period|failure to meet continuation criteria|0|||
147653312|NCT03130959|532554532|FG003|Overall Study|Disease progression|7|||
147653313|NCT03130959|532554533|FG004|Overall Study|Disease progression|12|||
147653314|NCT03130959|532554534|FG005|Overall Study|Disease progression|3|||
147653315|NCT03130959|532554535|FG006|Overall Study|Disease progression|6|||
147653316|NCT03130959|532554536|FG007|Overall Study|Disease progression|3|||
147653317|NCT03130959|532554537|FG008|Overall Study|Disease progression|15|||
147653318|NCT03130959|532554538|FG009|Overall Study|Disease progression|8|||
147653319|NCT03130959|532554529|FG000|Overall Study|Study drug toxicity|2|||
147653320|NCT03130959|532554530|FG001|Overall Study|Study drug toxicity|2|||
147653321|NCT03130959|532554531|FG002|Overall Study|Study drug toxicity|1|||
147653322|NCT03130959|532554532|FG003|Overall Study|Study drug toxicity|2|||
147653323|NCT03130959|532554533|FG004|Overall Study|Study drug toxicity|1|||
147653324|NCT03130959|532554534|FG005|Overall Study|Study drug toxicity|1|||
147653325|NCT03130959|532554535|FG006|Overall Study|Study drug toxicity|3|||
147653326|NCT03130959|532554536|FG007|Overall Study|Study drug toxicity|0|||
147653327|NCT03130959|532554537|FG008|Overall Study|Study drug toxicity|3|||
147653328|NCT03130959|532554538|FG009|Overall Study|Study drug toxicity|3|||
147653329|NCT03130959|532554529|FG000|Overall Study|Other reasons|0|||
147653330|NCT03130959|532554530|FG001|Overall Study|Other reasons|0|||
147653331|NCT03130959|532554531|FG002|Overall Study|Other reasons|0|||
147653332|NCT03130959|532554532|FG003|Overall Study|Other reasons|0|||
147653333|NCT03130959|532554533|FG004|Overall Study|Other reasons|0|||
147653334|NCT03130959|532554534|FG005|Overall Study|Other reasons|1|||
147653335|NCT03130959|532554535|FG006|Overall Study|Other reasons|1|||
147653336|NCT03130959|532554536|FG007|Overall Study|Other reasons|0|||
147653337|NCT03130959|532554537|FG008|Overall Study|Other reasons|0|||
147653338|NCT03130959|532554538|FG009|Overall Study|Other reasons|0|||
147653339|NCT03130959|532554529|FG000|Overall Study|Subject request to discontinue therapy|0|||
147653340|NCT03130959|532554530|FG001|Overall Study|Subject request to discontinue therapy|0|||
147653341|NCT03130959|532554531|FG002|Overall Study|Subject request to discontinue therapy|1|||
147653342|NCT03130959|532554532|FG003|Overall Study|Subject request to discontinue therapy|1|||
147653343|NCT03130959|532554533|FG004|Overall Study|Subject request to discontinue therapy|0|||
147653344|NCT03130959|532554534|FG005|Overall Study|Subject request to discontinue therapy|0|||
147653345|NCT03130959|532554535|FG006|Overall Study|Subject request to discontinue therapy|1|||
147653346|NCT03130959|532554536|FG007|Overall Study|Subject request to discontinue therapy|1|||
147653347|NCT03130959|532554537|FG008|Overall Study|Subject request to discontinue therapy|0|||
147653348|NCT03130959|532554538|FG009|Overall Study|Subject request to discontinue therapy|0|||
147653349|NCT03130959|532554529|FG000|Overall Study|Not reported|0|||
147653350|NCT03130959|532554530|FG001|Overall Study|Not reported|0|||
147653351|NCT03130959|532554531|FG002|Overall Study|Not reported|0|||
147653352|NCT03130959|532554532|FG003|Overall Study|Not reported|1|||
147653353|NCT03130959|532554533|FG004|Overall Study|Not reported|0|||
147653354|NCT03130959|532554534|FG005|Overall Study|Not reported|1|||
147321557|NCT05968482|531340074|FG004|Third Crossover Period|failure to meet continuation criteria|0|||
147321558|NCT05968482|531340075|FG005|Third Crossover Period|failure to meet continuation criteria|0|||
147321559|NCT01925170|531340078|FG000|Overall Study|Unverified cancer status|53|||
147321560|NCT01077024|531340079|FG000|Overall Study|Lost to Follow-up|20|||
147653355|NCT03130959|532554535|FG006|Overall Study|Not reported|0|||
147239884|NCT02732119|531051489|FG000|Phase I|Protocol deviation|0|||
147321561|NCT01077024|531340080|FG001|Overall Study|Lost to Follow-up|14|||
147321562|NCT01077024|531340079|FG000|Overall Study|Withdrawal by Subject|0|||
147321563|NCT01077024|531340080|FG001|Overall Study|Withdrawal by Subject|2|||
147321564|NCT01077024|531340079|FG000|Overall Study|Incarcerated|7|||
147321565|NCT01077024|531340080|FG001|Overall Study|Incarcerated|8|||
147653356|NCT03130959|532554536|FG007|Overall Study|Not reported|0|||
147653357|NCT03130959|532554537|FG008|Overall Study|Not reported|0|||
147653358|NCT03130959|532554538|FG009|Overall Study|Not reported|1|||
147653359|NCT03130959|532554529|FG000|Overall Study|Adverse Event unrelated to drug|0|||
147653360|NCT03130959|532554530|FG001|Overall Study|Adverse Event unrelated to drug|0|||
147653361|NCT03130959|532554531|FG002|Overall Study|Adverse Event unrelated to drug|1|||
147239885|NCT02732119|531051490|FG001|Phase I|Protocol deviation|1|||
147653362|NCT03130959|532554532|FG003|Overall Study|Adverse Event unrelated to drug|1|||
147239886|NCT02732119|531051491|FG002|Phase I|Protocol deviation|0|||
147653363|NCT03130959|532554533|FG004|Overall Study|Adverse Event unrelated to drug|1|||
147153242|NCT01892436|530724172|FG001|Overall Study|Withdrawal by Subject|15|||
147153243|NCT01892436|530724173|FG002|Overall Study|Withdrawal by Subject|4|||
147153244|NCT01892436|530724174|FG003|Overall Study|Withdrawal by Subject|4|||
147153245|NCT01892436|530724171|FG000|Overall Study|Death|1|||
147153246|NCT01892436|530724172|FG001|Overall Study|Death|1|||
147153247|NCT01892436|530724173|FG002|Overall Study|Death|0|||
147153248|NCT01892436|530724174|FG003|Overall Study|Death|0|||
147153249|NCT01892436|530724171|FG000|Overall Study|Physician Decision|2|||
147153250|NCT01892436|530724172|FG001|Overall Study|Physician Decision|1|||
147153251|NCT01892436|530724173|FG002|Overall Study|Physician Decision|0|||
147153252|NCT01892436|530724174|FG003|Overall Study|Physician Decision|1|||
147153253|NCT01892436|530724171|FG000|Overall Study|Pregnancy|0|||
147153254|NCT01892436|530724172|FG001|Overall Study|Pregnancy|2|||
147153255|NCT01892436|530724173|FG002|Overall Study|Pregnancy|1|||
147153256|NCT01892436|530724174|FG003|Overall Study|Pregnancy|0|||
147153257|NCT01892436|530724171|FG000|Overall Study|Technical problems|2|||
147153258|NCT01892436|530724172|FG001|Overall Study|Technical problems|1|||
147153259|NCT01892436|530724173|FG002|Overall Study|Technical problems|1|||
147153260|NCT01892436|530724174|FG003|Overall Study|Technical problems|1|||
147153261|NCT01892436|530724171|FG000|Overall Study|Lack of Efficacy|1|||
147153262|NCT01892436|530724172|FG001|Overall Study|Lack of Efficacy|2|||
147153263|NCT01892436|530724173|FG002|Overall Study|Lack of Efficacy|2|||
147153264|NCT01892436|530724174|FG003|Overall Study|Lack of Efficacy|2|||
147153265|NCT01892436|530724171|FG000|Overall Study|Lost to Follow-up|1|||
147153266|NCT01892436|530724172|FG001|Overall Study|Lost to Follow-up|1|||
147153267|NCT01892436|530724173|FG002|Overall Study|Lost to Follow-up|1|||
147153268|NCT01892436|530724174|FG003|Overall Study|Lost to Follow-up|3|||
147153269|NCT01892436|530724171|FG000|Overall Study|non-compliance with treatment|1|||
147153270|NCT01892436|530724172|FG001|Overall Study|non-compliance with treatment|0|||
147153271|NCT01892436|530724173|FG002|Overall Study|non-compliance with treatment|0|||
147153272|NCT01892436|530724174|FG003|Overall Study|non-compliance with treatment|0|||
147153273|NCT01892436|530724171|FG000|Overall Study|Adverse Event|7|||
147153274|NCT01892436|530724172|FG001|Overall Study|Adverse Event|6|||
147153275|NCT01892436|530724173|FG002|Overall Study|Adverse Event|2|||
147153276|NCT01892436|530724174|FG003|Overall Study|Adverse Event|3|||
147153277|NCT00837265|530724178|FG000|Pilot Phase|Withdrawal by Subject|0|||
147153278|NCT00837265|530724179|FG001|Pilot Phase|Withdrawal by Subject|2|||
147153279|NCT00837265|530724180|FG002|Pilot Phase|Withdrawal by Subject|3|||
147153280|NCT00837265|530724181|FG003|Pilot Phase|Withdrawal by Subject|2|||
147153281|NCT00837265|530724182|FG004|Pilot Phase|Withdrawal by Subject|0|||
147239887|NCT02732119|531051492|FG003|Phase I|Protocol deviation|0|||
147239888|NCT02732119|531051493|FG004|Phase I|Protocol deviation|0|||
147239889|NCT02732119|531051489|FG000|Phase I|Physician Decision|0|||
147239890|NCT02732119|531051490|FG001|Phase I|Physician Decision|3|||
147239891|NCT02732119|531051491|FG002|Phase I|Physician Decision|4|||
147239892|NCT02732119|531051492|FG003|Phase I|Physician Decision|0|||
147239893|NCT02732119|531051493|FG004|Phase I|Physician Decision|0|||
147239894|NCT02732119|531051489|FG000|Phase II|Adverse Event|0|||
147239895|NCT02732119|531051490|FG001|Phase II|Adverse Event|0|||
147239896|NCT02732119|531051491|FG002|Phase II|Adverse Event|0|||
147239897|NCT02732119|531051492|FG003|Phase II|Adverse Event|3|||
147239898|NCT02732119|531051493|FG004|Phase II|Adverse Event|3|||
147239899|NCT02732119|531051489|FG000|Phase II|Death|0|||
147239900|NCT02732119|531051490|FG001|Phase II|Death|0|||
147239901|NCT02732119|531051491|FG002|Phase II|Death|0|||
147239902|NCT02732119|531051492|FG003|Phase II|Death|1|||
147239903|NCT02732119|531051493|FG004|Phase II|Death|0|||
147239904|NCT02732119|531051489|FG000|Phase II|Progressive dissease|0|||
147239905|NCT02732119|531051490|FG001|Phase II|Progressive dissease|0|||
147239906|NCT02732119|531051491|FG002|Phase II|Progressive dissease|0|||
147239907|NCT02732119|531051492|FG003|Phase II|Progressive dissease|30|||
147239908|NCT02732119|531051493|FG004|Phase II|Progressive dissease|23|||
147239909|NCT02732119|531051489|FG000|Phase II|Study terminated by sponsor|0|||
147239910|NCT02732119|531051490|FG001|Phase II|Study terminated by sponsor|0|||
147239911|NCT02732119|531051491|FG002|Phase II|Study terminated by sponsor|0|||
147239912|NCT02732119|531051492|FG003|Phase II|Study terminated by sponsor|2|||
147239913|NCT02732119|531051493|FG004|Phase II|Study terminated by sponsor|2|||
147153282|NCT00837265|530724183|FG005|Pilot Phase|Withdrawal by Subject|0|||
147153283|NCT00837265|530724184|FG006|Pilot Phase|Withdrawal by Subject|0|||
147153284|NCT00837265|530724178|FG000|Pilot Phase|Decision of the investigator|2|||
147153285|NCT00837265|530724179|FG001|Pilot Phase|Decision of the investigator|1|||
147153286|NCT00837265|530724180|FG002|Pilot Phase|Decision of the investigator|0|||
147153287|NCT00837265|530724181|FG003|Pilot Phase|Decision of the investigator|0|||
147153288|NCT00837265|530724182|FG004|Pilot Phase|Decision of the investigator|0|||
147153289|NCT00837265|530724183|FG005|Pilot Phase|Decision of the investigator|0|||
147153290|NCT00837265|530724184|FG006|Pilot Phase|Decision of the investigator|0|||
147153291|NCT00837265|530724178|FG000|Pilot Phase|Adverse Event|1|||
147153292|NCT00837265|530724179|FG001|Pilot Phase|Adverse Event|0|||
147153293|NCT00837265|530724180|FG002|Pilot Phase|Adverse Event|0|||
147239914|NCT02732119|531051489|FG000|Phase II|Other|0|||
147239915|NCT02732119|531051490|FG001|Phase II|Other|0|||
147239916|NCT02732119|531051491|FG002|Phase II|Other|0|||
147153294|NCT00837265|530724181|FG003|Pilot Phase|Adverse Event|0|||
147153295|NCT00837265|530724182|FG004|Pilot Phase|Adverse Event|0|||
147153296|NCT00837265|530724183|FG005|Pilot Phase|Adverse Event|0|||
147153297|NCT00837265|530724184|FG006|Pilot Phase|Adverse Event|0|||
147153298|NCT00837265|530724178|FG000|Pilot Phase|Disease progression|0|||
147153299|NCT00837265|530724179|FG001|Pilot Phase|Disease progression|0|||
147153300|NCT00837265|530724180|FG002|Pilot Phase|Disease progression|0|||
147153301|NCT00837265|530724181|FG003|Pilot Phase|Disease progression|1|||
147153302|NCT00837265|530724182|FG004|Pilot Phase|Disease progression|0|||
147153303|NCT00837265|530724183|FG005|Pilot Phase|Disease progression|0|||
147153304|NCT00837265|530724184|FG006|Pilot Phase|Disease progression|0|||
147153305|NCT00837265|530724178|FG000|Pilot Phase|Participant left the city|0|||
147153306|NCT00837265|530724179|FG001|Pilot Phase|Participant left the city|0|||
147153307|NCT00837265|530724180|FG002|Pilot Phase|Participant left the city|0|||
147153308|NCT00837265|530724181|FG003|Pilot Phase|Participant left the city|1|||
147153309|NCT00837265|530724182|FG004|Pilot Phase|Participant left the city|0|||
147153310|NCT00837265|530724183|FG005|Pilot Phase|Participant left the city|0|||
147153311|NCT00837265|530724184|FG006|Pilot Phase|Participant left the city|0|||
147153312|NCT00837265|530724178|FG000|Main Phase|Withdrawal by Subject|0|||
147153313|NCT00837265|530724179|FG001|Main Phase|Withdrawal by Subject|0|||
147153314|NCT00837265|530724180|FG002|Main Phase|Withdrawal by Subject|0|||
147579347|NCT02786953|532276895|FG000|Overall Study|Physician Decision|0|||
147579348|NCT02786953|532276896|FG001|Overall Study|Physician Decision|1|||
147579349|NCT02627963|532276904|FG000|Overall Study|Randomized but not treated|2|||
147579350|NCT02627963|532276905|FG001|Overall Study|Randomized but not treated|6|||
147579351|NCT04697173|532276908|FG000|Overall Study|Withdrawal by Subject|34|||
147579352|NCT04697173|532276909|FG001|Overall Study|Withdrawal by Subject|38|||
147579353|NCT05004649|532276910|FG000|Overall Study|Eligibility Criteria - Threshold|4|||
147579354|NCT05004649|532276910|FG000|Overall Study|Lost to Follow-up|1|||
147579355|NCT05004649|532276910|FG000|Overall Study|Withdrawal by Subject|2|||
147579356|NCT05004649|532276910|FG000|Overall Study|COVID-19|1|||
147579357|NCT04133311|532276912|FG000|Period 1 Double Masked Treatment Period|Death|1|||
147579358|NCT04133311|532276913|FG001|Period 1 Double Masked Treatment Period|Death|0|||
147579359|NCT04133311|532276914|FG002|Period 1 Double Masked Treatment Period|Death|0|||
147579360|NCT04133311|532276915|FG003|Period 1 Double Masked Treatment Period|Death|0|||
147579361|NCT04133311|532276912|FG000|Period 1 Double Masked Treatment Period|Adverse Event|1|||
147579362|NCT04133311|532276913|FG001|Period 1 Double Masked Treatment Period|Adverse Event|1|||
147579363|NCT04133311|532276914|FG002|Period 1 Double Masked Treatment Period|Adverse Event|0|||
147579364|NCT04133311|532276915|FG003|Period 1 Double Masked Treatment Period|Adverse Event|0|||
147579365|NCT04133311|532276912|FG000|Period 1 Double Masked Treatment Period|Withdrawal by Subject|1|||
147579366|NCT04133311|532276913|FG001|Period 1 Double Masked Treatment Period|Withdrawal by Subject|1|||
147579367|NCT04133311|532276914|FG002|Period 1 Double Masked Treatment Period|Withdrawal by Subject|0|||
147579368|NCT04133311|532276915|FG003|Period 1 Double Masked Treatment Period|Withdrawal by Subject|0|||
147579369|NCT04133311|532276912|FG000|Period 1 Double Masked Treatment Period|Sponsor Temporarily Discontinued Study|0|||
147579370|NCT04133311|532276913|FG001|Period 1 Double Masked Treatment Period|Sponsor Temporarily Discontinued Study|1|||
147579371|NCT04133311|532276914|FG002|Period 1 Double Masked Treatment Period|Sponsor Temporarily Discontinued Study|0|||
147579372|NCT04133311|532276915|FG003|Period 1 Double Masked Treatment Period|Sponsor Temporarily Discontinued Study|0|||
147579373|NCT04133311|532276912|FG000|Period 2 Open Label Treatment Period|Adverse Event|0|||
147579374|NCT04133311|532276913|FG001|Period 2 Open Label Treatment Period|Adverse Event|0|||
147579375|NCT04133311|532276914|FG002|Period 2 Open Label Treatment Period|Adverse Event|0|||
147579376|NCT04133311|532276915|FG003|Period 2 Open Label Treatment Period|Adverse Event|2|||
147579377|NCT04133311|532276912|FG000|Period 2 Open Label Treatment Period|Withdrawal by Subject|0|||
147579378|NCT04133311|532276913|FG001|Period 2 Open Label Treatment Period|Withdrawal by Subject|0|||
147579379|NCT04133311|532276914|FG002|Period 2 Open Label Treatment Period|Withdrawal by Subject|2|||
147579380|NCT04133311|532276915|FG003|Period 2 Open Label Treatment Period|Withdrawal by Subject|2|||
147579381|NCT04133311|532276912|FG000|Period 2 Open Label Treatment Period|Pregnancy|0|||
147579382|NCT04133311|532276913|FG001|Period 2 Open Label Treatment Period|Pregnancy|0|||
147579383|NCT04133311|532276914|FG002|Period 2 Open Label Treatment Period|Pregnancy|1|||
147579384|NCT04133311|532276915|FG003|Period 2 Open Label Treatment Period|Pregnancy|0|||
147579385|NCT04133311|532276912|FG000|Period 2 Open Label Treatment Period|Early Termination|0|||
147153315|NCT00837265|530724181|FG003|Main Phase|Withdrawal by Subject|0|||
147239917|NCT02732119|531051492|FG003|Phase II|Other|2|||
147239918|NCT02732119|531051493|FG004|Phase II|Other|0|||
147239919|NCT02732119|531051489|FG000|Phase II|Physician Decision|0|||
147239920|NCT02732119|531051490|FG001|Phase II|Physician Decision|0|||
147239921|NCT02732119|531051491|FG002|Phase II|Physician Decision|0|||
147153316|NCT00837265|530724182|FG004|Main Phase|Withdrawal by Subject|4|||
147153317|NCT00837265|530724183|FG005|Main Phase|Withdrawal by Subject|2|||
147153318|NCT00837265|530724184|FG006|Main Phase|Withdrawal by Subject|1|||
147153319|NCT00837265|530724178|FG000|Main Phase|Decision of the investigator|0|||
147153320|NCT00837265|530724179|FG001|Main Phase|Decision of the investigator|0|||
147239922|NCT02732119|531051492|FG003|Phase II|Physician Decision|8|||
147579386|NCT04133311|532276913|FG001|Period 2 Open Label Treatment Period|Early Termination|0|||
147579387|NCT04133311|532276914|FG002|Period 2 Open Label Treatment Period|Early Termination|1|||
147579388|NCT04133311|532276915|FG003|Period 2 Open Label Treatment Period|Early Termination|0|||
147579389|NCT00728754|532276918|FG000|Permanent Prosthesis Placement|Adverse Event|1|||
147579390|NCT00728754|532276919|FG001|Permanent Prosthesis Placement|Adverse Event|1|||
147579391|NCT00728754|532276918|FG000|Permanent Prosthesis Placement|Lost to Follow-up|3|||
147579392|NCT00728754|532276919|FG001|Permanent Prosthesis Placement|Lost to Follow-up|3|||
147579393|NCT00728754|532276918|FG000|One Year Post Placement Follow-up|Adverse Event|1|||
147579394|NCT00728754|532276919|FG001|One Year Post Placement Follow-up|Adverse Event|0|||
147579395|NCT00354159|532276924|FG000|Randomized Study Period|Withdrawal by Subject|5|||
147579396|NCT00354159|532276925|FG001|Randomized Study Period|Withdrawal by Subject|3|||
147579397|NCT00354159|532276924|FG000|Randomized Study Period|Physician Decision|6|||
147579398|NCT00354159|532276925|FG001|Randomized Study Period|Physician Decision|10|||
147579399|NCT00354159|532276924|FG000|Randomized Study Period|Lost to Follow-up|4|||
147579400|NCT00354159|532276925|FG001|Randomized Study Period|Lost to Follow-up|0|||
147579401|NCT00354159|532276924|FG000|Randomized Study Period|Death|7|||
147579402|NCT00354159|532276925|FG001|Randomized Study Period|Death|9|||
147579403|NCT00354159|532276924|FG000|Long-term Follow-up|Withdrawal by Subject|9|||
147579404|NCT00354159|532276925|FG001|Long-term Follow-up|Withdrawal by Subject|9|||
147579405|NCT00354159|532276924|FG000|Long-term Follow-up|Physician Decision|127|||
147579406|NCT00354159|532276925|FG001|Long-term Follow-up|Physician Decision|122|||
147579407|NCT00354159|532276924|FG000|Long-term Follow-up|Lost to Follow-up|1|||
147579408|NCT00354159|532276925|FG001|Long-term Follow-up|Lost to Follow-up|0|||
147579409|NCT00354159|532276924|FG000|Long-term Follow-up|Death|14|||
147579410|NCT00354159|532276925|FG001|Long-term Follow-up|Death|11|||
147579411|NCT00354159|532276924|FG000|Long-term Follow-up|Study Closed|29|||
147579412|NCT00354159|532276925|FG001|Long-term Follow-up|Study Closed|34|||
147579413|NCT01532908|532276931|FG000|Overall Study|Not Transplanted|1|||
147579414|NCT01532908|532276932|FG001|Overall Study|Not Transplanted|0|||
147579415|NCT01993940|532276933|FG000|Overall Study|Adverse Event|16|||
147579416|NCT01993940|532276934|FG001|Overall Study|Adverse Event|11|||
147579417|NCT01993940|532276933|FG000|Overall Study|Withdrawal by Subject|15|||
147579418|NCT01993940|532276934|FG001|Overall Study|Withdrawal by Subject|19|||
147579419|NCT01993940|532276933|FG000|Overall Study|Lost to Follow-up|2|||
147579420|NCT01993940|532276934|FG001|Overall Study|Lost to Follow-up|5|||
147579421|NCT01993940|532276933|FG000|Overall Study|Protocol Violation|5|||
147579422|NCT01993940|532276934|FG001|Overall Study|Protocol Violation|8|||
147579423|NCT01993940|532276933|FG000|Overall Study|Death|1|||
147579424|NCT01993940|532276934|FG001|Overall Study|Death|0|||
147579425|NCT01993940|532276933|FG000|Overall Study|Other - Miscellaneous|1|||
147579426|NCT01993940|532276934|FG001|Overall Study|Other - Miscellaneous|1|||
147579427|NCT01824498|532276935|FG000|Washout (8 Weeks)|Withdrawal by Subject|2|||
147579428|NCT01824498|532276936|FG001|Washout (8 Weeks)|Withdrawal by Subject|0|||
147579429|NCT01824498|532276937|FG002|Washout (8 Weeks)|Withdrawal by Subject|2|||
147579430|NCT01824498|532276938|FG003|Washout (8 Weeks)|Withdrawal by Subject|1|||
147579431|NCT01824498|532276939|FG004|Washout (8 Weeks)|Withdrawal by Subject|1|||
147579432|NCT01824498|532276940|FG005|Washout (8 Weeks)|Withdrawal by Subject|0|||
147579433|NCT01567527|532276941|FG000|Conversion Phase.|Protocol deviation|3|||
147579434|NCT01567527|532276942|FG001|Conversion Phase.|Protocol deviation|0|||
147579435|NCT01567527|532276943|FG002|Conversion Phase.|Protocol deviation|0|||
147579436|NCT01567527|532276944|FG003|Conversion Phase.|Protocol deviation|0|||
147579437|NCT01567527|532276945|FG004|Conversion Phase.|Protocol deviation|0|||
147579438|NCT01567527|532276941|FG000|Conversion Phase.|Met withdrawal criteria|10|||
147579439|NCT01567527|532276942|FG001|Conversion Phase.|Met withdrawal criteria|0|||
147239923|NCT02732119|531051493|FG004|Phase II|Physician Decision|5|||
147239924|NCT00964860|531051494|FG000|Overall Study|Withdrawal by Subject|0|||
147239925|NCT00964860|531051495|FG001|Overall Study|Withdrawal by Subject|1|||
147239926|NCT00867568|531051496|FG000|Overall Study|Lack of Efficacy|10|||
147239927|NCT00867568|531051496|FG000|Overall Study|Adverse Event|4|||
147239928|NCT00867568|531051496|FG000|Overall Study|Withdrawal by Subject|1|||
147239929|NCT01056653|531051497|FG000|Overall Study|Lost to Follow-up|0|||
147239930|NCT01056653|531051498|FG001|Overall Study|Lost to Follow-up|0|||
147239931|NCT01056653|531051499|FG002|Overall Study|Lost to Follow-up|2|||
147579440|NCT01567527|532276943|FG002|Conversion Phase.|Met withdrawal criteria|0|||
147579441|NCT01567527|532276944|FG003|Conversion Phase.|Met withdrawal criteria|0|||
147579442|NCT01567527|532276945|FG004|Conversion Phase.|Met withdrawal criteria|0|||
147579443|NCT01567527|532276941|FG000|Conversion Phase.|Withdrawal by Subject|32|||
147239932|NCT03639935|531051500|FG000|Overall Study|Death|3|||
147239933|NCT03639935|531051500|FG000|Overall Study|Adverse Event|1|||
147579444|NCT01567527|532276942|FG001|Conversion Phase.|Withdrawal by Subject|0|||
147579445|NCT01567527|532276943|FG002|Conversion Phase.|Withdrawal by Subject|0|||
147579446|NCT01567527|532276944|FG003|Conversion Phase.|Withdrawal by Subject|0|||
147579447|NCT01567527|532276945|FG004|Conversion Phase.|Withdrawal by Subject|0|||
147239934|NCT03727230|531051502|FG000|Overall Study|Lost to Follow-up|12|||
147239935|NCT04377620|531051504|FG000|Overall Study|Death|42|||
147239936|NCT04377620|531051505|FG001|Overall Study|Death|48|||
147239937|NCT04377620|531051506|FG002|Overall Study|Death|36|||
147239938|NCT04377620|531051504|FG000|Overall Study|Withdrawal by Subject|0|||
147579448|NCT01567527|532276941|FG000|Conversion Phase.|Lost to Follow-up|16|||
147579449|NCT01567527|532276942|FG001|Conversion Phase.|Lost to Follow-up|0|||
147579450|NCT01567527|532276943|FG002|Conversion Phase.|Lost to Follow-up|0|||
147579451|NCT01567527|532276944|FG003|Conversion Phase.|Lost to Follow-up|0|||
147579452|NCT01567527|532276945|FG004|Conversion Phase.|Lost to Follow-up|0|||
147579453|NCT01567527|532276941|FG000|Conversion Phase.|Lack of Efficacy|2|||
147579454|NCT01567527|532276942|FG001|Conversion Phase.|Lack of Efficacy|0|||
147579455|NCT01567527|532276943|FG002|Conversion Phase.|Lack of Efficacy|0|||
147579456|NCT01567527|532276944|FG003|Conversion Phase.|Lack of Efficacy|0|||
147579457|NCT01567527|532276945|FG004|Conversion Phase.|Lack of Efficacy|0|||
147579458|NCT01567527|532276941|FG000|Conversion Phase.|Adverse Event|33|||
147579459|NCT01567527|532276942|FG001|Conversion Phase.|Adverse Event|0|||
147579460|NCT01567527|532276943|FG002|Conversion Phase.|Adverse Event|0|||
147579461|NCT01567527|532276944|FG003|Conversion Phase.|Adverse Event|0|||
147579462|NCT01567527|532276945|FG004|Conversion Phase.|Adverse Event|0|||
147579463|NCT01567527|532276941|FG000|Conversion Phase.|Withdrawn by the investigator|3|||
147579464|NCT01567527|532276942|FG001|Conversion Phase.|Withdrawn by the investigator|0|||
147579465|NCT01567527|532276943|FG002|Conversion Phase.|Withdrawn by the investigator|0|||
147579466|NCT01567527|532276944|FG003|Conversion Phase.|Withdrawn by the investigator|0|||
147579467|NCT01567527|532276945|FG004|Conversion Phase.|Withdrawn by the investigator|0|||
147579468|NCT01567527|532276941|FG000|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0|||
147579469|NCT01567527|532276942|FG001|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|41|||
147579470|NCT01567527|532276943|FG002|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0|||
147579471|NCT01567527|532276944|FG003|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0|||
147579472|NCT01567527|532276945|FG004|Oral Aripiprazole Stabilization Phase.|Met withdrawal criteria|0|||
147579473|NCT01567527|532276941|FG000|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0|||
147579474|NCT01567527|532276942|FG001|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|45|||
147579475|NCT01567527|532276943|FG002|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0|||
147579476|NCT01567527|532276944|FG003|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0|||
147579477|NCT01567527|532276945|FG004|Oral Aripiprazole Stabilization Phase.|Withdrawal by Subject|0|||
147579478|NCT01567527|532276941|FG000|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0|||
147579479|NCT01567527|532276942|FG001|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|44|||
147579480|NCT01567527|532276943|FG002|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0|||
147579481|NCT01567527|532276944|FG003|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0|||
147579482|NCT01567527|532276945|FG004|Oral Aripiprazole Stabilization Phase.|Lost to Follow-up|0|||
147579483|NCT01567527|532276941|FG000|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0|||
147579484|NCT01567527|532276942|FG001|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|12|||
147579485|NCT01567527|532276943|FG002|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0|||
147579486|NCT01567527|532276944|FG003|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0|||
147579487|NCT01567527|532276945|FG004|Oral Aripiprazole Stabilization Phase.|Lack of Efficacy|0|||
147579488|NCT01567527|532276941|FG000|Oral Aripiprazole Stabilization Phase.|Adverse Event|0|||
147579489|NCT01567527|532276942|FG001|Oral Aripiprazole Stabilization Phase.|Adverse Event|63|||
147579490|NCT01567527|532276943|FG002|Oral Aripiprazole Stabilization Phase.|Adverse Event|0|||
147579491|NCT01567527|532276944|FG003|Oral Aripiprazole Stabilization Phase.|Adverse Event|0|||
147579492|NCT01567527|532276945|FG004|Oral Aripiprazole Stabilization Phase.|Adverse Event|0|||
147579493|NCT01567527|532276941|FG000|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0|||
147579494|NCT01567527|532276942|FG001|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|2|||
147579495|NCT01567527|532276943|FG002|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0|||
147579496|NCT01567527|532276944|FG003|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0|||
147579497|NCT01567527|532276945|FG004|Oral Aripiprazole Stabilization Phase.|Withdrawn by the investigator|0|||
147579498|NCT01567527|532276941|FG000|IM Depot Stabilization.|Protocol deviation|0|||
147579499|NCT01567527|532276942|FG001|IM Depot Stabilization.|Protocol deviation|0|||
147579500|NCT01567527|532276943|FG002|IM Depot Stabilization.|Protocol deviation|5|||
147579501|NCT01567527|532276944|FG003|IM Depot Stabilization.|Protocol deviation|0|||
147579502|NCT01567527|532276945|FG004|IM Depot Stabilization.|Protocol deviation|0|||
147579503|NCT01567527|532276941|FG000|IM Depot Stabilization.|Met withdrawal criteria|0|||
147579504|NCT01567527|532276942|FG001|IM Depot Stabilization.|Met withdrawal criteria|0|||
147579505|NCT01567527|532276943|FG002|IM Depot Stabilization.|Met withdrawal criteria|26|||
147579506|NCT01567527|532276944|FG003|IM Depot Stabilization.|Met withdrawal criteria|0|||
147579507|NCT01567527|532276945|FG004|IM Depot Stabilization.|Met withdrawal criteria|0|||
147579508|NCT01567527|532276941|FG000|IM Depot Stabilization.|Withdrawal by Subject|0|||
147579509|NCT01567527|532276942|FG001|IM Depot Stabilization.|Withdrawal by Subject|0|||
147579510|NCT01567527|532276943|FG002|IM Depot Stabilization.|Withdrawal by Subject|56|||
147579511|NCT01567527|532276944|FG003|IM Depot Stabilization.|Withdrawal by Subject|0|||
147579512|NCT01567527|532276945|FG004|IM Depot Stabilization.|Withdrawal by Subject|0|||
147239939|NCT04377620|531051505|FG001|Overall Study|Withdrawal by Subject|2|||
147653364|NCT03130959|532554534|FG005|Overall Study|Adverse Event unrelated to drug|0|||
147653365|NCT03130959|532554535|FG006|Overall Study|Adverse Event unrelated to drug|1|||
147653366|NCT03130959|532554536|FG007|Overall Study|Adverse Event unrelated to drug|0|||
147653367|NCT03130959|532554537|FG008|Overall Study|Adverse Event unrelated to drug|1|||
147153321|NCT00837265|530724180|FG002|Main Phase|Decision of the investigator|0|||
147153322|NCT00837265|530724181|FG003|Main Phase|Decision of the investigator|0|||
147153323|NCT00837265|530724182|FG004|Main Phase|Decision of the investigator|0|||
147153324|NCT00837265|530724183|FG005|Main Phase|Decision of the investigator|2|||
147153325|NCT00837265|530724184|FG006|Main Phase|Decision of the investigator|1|||
147153326|NCT00837265|530724178|FG000|Main Phase|Adverse Event|0|||
147153327|NCT00837265|530724179|FG001|Main Phase|Adverse Event|0|||
147153328|NCT00837265|530724180|FG002|Main Phase|Adverse Event|0|||
147153329|NCT00837265|530724181|FG003|Main Phase|Adverse Event|0|||
147153330|NCT00837265|530724182|FG004|Main Phase|Adverse Event|0|||
147153331|NCT00837265|530724183|FG005|Main Phase|Adverse Event|1|||
147153332|NCT00837265|530724184|FG006|Main Phase|Adverse Event|0|||
147153333|NCT00837265|530724178|FG000|Main Phase|Death|0|||
147153334|NCT00837265|530724179|FG001|Main Phase|Death|0|||
147153335|NCT00837265|530724180|FG002|Main Phase|Death|0|||
147153336|NCT00837265|530724181|FG003|Main Phase|Death|0|||
147153337|NCT00837265|530724182|FG004|Main Phase|Death|2|||
147153338|NCT00837265|530724183|FG005|Main Phase|Death|0|||
147153339|NCT00837265|530724184|FG006|Main Phase|Death|1|||
147153340|NCT00837265|530724178|FG000|Main Phase|Lost to Follow-up|0|||
147153341|NCT00837265|530724179|FG001|Main Phase|Lost to Follow-up|0|||
147153342|NCT00837265|530724180|FG002|Main Phase|Lost to Follow-up|0|||
147153343|NCT00837265|530724181|FG003|Main Phase|Lost to Follow-up|0|||
147153344|NCT00837265|530724182|FG004|Main Phase|Lost to Follow-up|1|||
147153345|NCT00837265|530724183|FG005|Main Phase|Lost to Follow-up|0|||
147153346|NCT00837265|530724184|FG006|Main Phase|Lost to Follow-up|0|||
147153347|NCT00837265|530724178|FG000|Main Phase|Principal investigator resignation|0|||
147153348|NCT00837265|530724179|FG001|Main Phase|Principal investigator resignation|0|||
147153349|NCT00837265|530724180|FG002|Main Phase|Principal investigator resignation|0|||
147153350|NCT00837265|530724181|FG003|Main Phase|Principal investigator resignation|0|||
147153351|NCT00837265|530724182|FG004|Main Phase|Principal investigator resignation|2|||
147153352|NCT00837265|530724183|FG005|Main Phase|Principal investigator resignation|0|||
147153353|NCT00837265|530724184|FG006|Main Phase|Principal investigator resignation|0|||
147153354|NCT00837265|530724178|FG000|Main Phase|Participant's personal reason|0|||
147153355|NCT00837265|530724179|FG001|Main Phase|Participant's personal reason|0|||
147153356|NCT00837265|530724180|FG002|Main Phase|Participant's personal reason|0|||
147153357|NCT00837265|530724181|FG003|Main Phase|Participant's personal reason|0|||
147153358|NCT00837265|530724182|FG004|Main Phase|Participant's personal reason|1|||
147153359|NCT00837265|530724183|FG005|Main Phase|Participant's personal reason|0|||
147153360|NCT00837265|530724184|FG006|Main Phase|Participant's personal reason|0|||
147153361|NCT02759107|530724190|FG000|Overall Study|Adverse Event|0|||
147153362|NCT02759107|530724191|FG001|Overall Study|Adverse Event|0|||
147153363|NCT02759107|530724192|FG002|Overall Study|Adverse Event|0|||
147153364|NCT02759107|530724193|FG003|Overall Study|Adverse Event|0|||
147153365|NCT02759107|530724194|FG004|Overall Study|Adverse Event|0|||
147153366|NCT02759107|530724195|FG005|Overall Study|Adverse Event|0|||
147153367|NCT02759107|530724196|FG006|Overall Study|Adverse Event|0|||
147153368|NCT02759107|530724197|FG007|Overall Study|Adverse Event|0|||
147153369|NCT02759107|530724198|FG008|Overall Study|Adverse Event|0|||
147153370|NCT02759107|530724199|FG009|Overall Study|Adverse Event|0|||
147153371|NCT02759107|530724200|FG010|Overall Study|Adverse Event|0|||
147153372|NCT02759107|530724201|FG011|Overall Study|Adverse Event|0|||
147153373|NCT02759107|530724202|FG012|Overall Study|Adverse Event|2|||
147153374|NCT02759107|530724203|FG013|Overall Study|Adverse Event|0|||
147321566|NCT01077024|531340079|FG000|Overall Study|Other|4|||
147321567|NCT01077024|531340080|FG001|Overall Study|Other|4|||
147321568|NCT02034435|531340081|FG000|Overall Study|Withdrawal by Subject|1|||
147321569|NCT02034435|531340082|FG001|Overall Study|Withdrawal by Subject|0|||
147153375|NCT02759107|530724204|FG014|Overall Study|Adverse Event|0|||
147153376|NCT02759107|530724205|FG015|Overall Study|Adverse Event|1|||
147153377|NCT02759107|530724206|FG016|Overall Study|Adverse Event|0|||
147153378|NCT02759107|530724207|FG017|Overall Study|Adverse Event|2|||
147153379|NCT02759107|530724190|FG000|Overall Study|Scheduling Conflict|0|||
147153380|NCT02759107|530724191|FG001|Overall Study|Scheduling Conflict|0|||
147153381|NCT02759107|530724192|FG002|Overall Study|Scheduling Conflict|0|||
147153382|NCT02759107|530724193|FG003|Overall Study|Scheduling Conflict|0|||
147153383|NCT02759107|530724194|FG004|Overall Study|Scheduling Conflict|0|||
147153384|NCT02759107|530724195|FG005|Overall Study|Scheduling Conflict|0|||
147153385|NCT02759107|530724196|FG006|Overall Study|Scheduling Conflict|0|||
147153386|NCT02759107|530724197|FG007|Overall Study|Scheduling Conflict|0|||
147153387|NCT02759107|530724198|FG008|Overall Study|Scheduling Conflict|0|||
147153388|NCT02759107|530724199|FG009|Overall Study|Scheduling Conflict|1|||
147153389|NCT02759107|530724200|FG010|Overall Study|Scheduling Conflict|0|||
147153390|NCT02759107|530724201|FG011|Overall Study|Scheduling Conflict|0|||
147153391|NCT02759107|530724202|FG012|Overall Study|Scheduling Conflict|0|||
147153392|NCT02759107|530724203|FG013|Overall Study|Scheduling Conflict|0|||
147579513|NCT01567527|532276941|FG000|IM Depot Stabilization.|Sponsor discontinued study|0|||
147579514|NCT01567527|532276942|FG001|IM Depot Stabilization.|Sponsor discontinued study|0|||
147579515|NCT01567527|532276943|FG002|IM Depot Stabilization.|Sponsor discontinued study|1|||
147579516|NCT01567527|532276944|FG003|IM Depot Stabilization.|Sponsor discontinued study|0|||
147579517|NCT01567527|532276945|FG004|IM Depot Stabilization.|Sponsor discontinued study|0|||
147579518|NCT01567527|532276941|FG000|IM Depot Stabilization.|Lost to Follow-up|0|||
147579519|NCT01567527|532276942|FG001|IM Depot Stabilization.|Lost to Follow-up|0|||
147579520|NCT01567527|532276943|FG002|IM Depot Stabilization.|Lost to Follow-up|21|||
147239940|NCT04377620|531051506|FG002|Overall Study|Withdrawal by Subject|0|||
147579521|NCT01567527|532276944|FG003|IM Depot Stabilization.|Lost to Follow-up|0|||
147579522|NCT01567527|532276945|FG004|IM Depot Stabilization.|Lost to Follow-up|0|||
147579523|NCT01567527|532276941|FG000|IM Depot Stabilization.|Lack of Efficacy|0|||
147579524|NCT01567527|532276942|FG001|IM Depot Stabilization.|Lack of Efficacy|0|||
147579525|NCT01567527|532276943|FG002|IM Depot Stabilization.|Lack of Efficacy|7|||
147579526|NCT01567527|532276944|FG003|IM Depot Stabilization.|Lack of Efficacy|0|||
147579527|NCT01567527|532276945|FG004|IM Depot Stabilization.|Lack of Efficacy|0|||
147579528|NCT01567527|532276941|FG000|IM Depot Stabilization.|Adverse Event|0|||
147579529|NCT01567527|532276942|FG001|IM Depot Stabilization.|Adverse Event|0|||
147579530|NCT01567527|532276943|FG002|IM Depot Stabilization.|Adverse Event|37|||
147579531|NCT01567527|532276944|FG003|IM Depot Stabilization.|Adverse Event|0|||
147579532|NCT01567527|532276945|FG004|IM Depot Stabilization.|Adverse Event|0|||
147579533|NCT01567527|532276941|FG000|IM Depot Stabilization.|Withdrawn by the investigator|0|||
147579534|NCT01567527|532276942|FG001|IM Depot Stabilization.|Withdrawn by the investigator|0|||
147579535|NCT01567527|532276943|FG002|IM Depot Stabilization.|Withdrawn by the investigator|6|||
147579536|NCT01567527|532276944|FG003|IM Depot Stabilization.|Withdrawn by the investigator|0|||
147579537|NCT01567527|532276945|FG004|IM Depot Stabilization.|Withdrawn by the investigator|0|||
147579538|NCT01567527|532276941|FG000|Double-blind, Placebo-controlled Phase|Protocol deviation|0|||
147579539|NCT01567527|532276942|FG001|Double-blind, Placebo-controlled Phase|Protocol deviation|0|||
147579540|NCT01567527|532276943|FG002|Double-blind, Placebo-controlled Phase|Protocol deviation|0|||
147239941|NCT02059395|531051507|FG000|Overall Study|Lost to Follow-up|2|||
147239942|NCT02059395|531051508|FG001|Overall Study|Lost to Follow-up|4|||
147239943|NCT05379231|531051509|FG000|Home Visit|Withdrawal by Subject|2|||
147239944|NCT05379231|531051509|FG000|In-lab Visit|Withdrawal by Subject|2|||
147239945|NCT00730405|531051514|FG000|Overall Study-Treatment Phase|Adverse Event|5|||
147239946|NCT00730405|531051515|FG001|Overall Study-Treatment Phase|Adverse Event|10|||
147239947|NCT00730405|531051516|FG002|Overall Study-Treatment Phase|Adverse Event|4|||
147239948|NCT00730405|531051517|FG003|Overall Study-Treatment Phase|Adverse Event|8|||
147239949|NCT00730405|531051518|FG004|Overall Study-Treatment Phase|Adverse Event|4|||
147239950|NCT00730405|531051514|FG000|Overall Study-Treatment Phase|Lost to Follow-up|4|||
147239951|NCT00730405|531051515|FG001|Overall Study-Treatment Phase|Lost to Follow-up|5|||
147239952|NCT00730405|531051516|FG002|Overall Study-Treatment Phase|Lost to Follow-up|6|||
147239953|NCT00730405|531051517|FG003|Overall Study-Treatment Phase|Lost to Follow-up|4|||
147239954|NCT00730405|531051518|FG004|Overall Study-Treatment Phase|Lost to Follow-up|4|||
147239955|NCT00730405|531051514|FG000|Overall Study-Treatment Phase|Non-compliance with Study Treatment|1|||
147239956|NCT00730405|531051515|FG001|Overall Study-Treatment Phase|Non-compliance with Study Treatment|0|||
147239957|NCT00730405|531051516|FG002|Overall Study-Treatment Phase|Non-compliance with Study Treatment|5|||
147239958|NCT00730405|531051517|FG003|Overall Study-Treatment Phase|Non-compliance with Study Treatment|0|||
147239959|NCT00730405|531051518|FG004|Overall Study-Treatment Phase|Non-compliance with Study Treatment|1|||
147239960|NCT00730405|531051514|FG000|Overall Study-Treatment Phase|Withdrawal by Subject|7|||
147239961|NCT00730405|531051515|FG001|Overall Study-Treatment Phase|Withdrawal by Subject|1|||
147239962|NCT00730405|531051516|FG002|Overall Study-Treatment Phase|Withdrawal by Subject|2|||
147239963|NCT00730405|531051517|FG003|Overall Study-Treatment Phase|Withdrawal by Subject|5|||
147239964|NCT00730405|531051518|FG004|Overall Study-Treatment Phase|Withdrawal by Subject|8|||
147239965|NCT00730405|531051514|FG000|Overall Study-Treatment Phase|Did not met eligibility|0|||
147239966|NCT00730405|531051515|FG001|Overall Study-Treatment Phase|Did not met eligibility|0|||
147239967|NCT00730405|531051516|FG002|Overall Study-Treatment Phase|Did not met eligibility|1|||
147239968|NCT00730405|531051517|FG003|Overall Study-Treatment Phase|Did not met eligibility|0|||
147239969|NCT00730405|531051518|FG004|Overall Study-Treatment Phase|Did not met eligibility|0|||
147239970|NCT00730405|531051514|FG000|Overall Study-Treatment Phase|Participant meets exclusion|0|||
147239971|NCT00730405|531051515|FG001|Overall Study-Treatment Phase|Participant meets exclusion|0|||
147239972|NCT00730405|531051516|FG002|Overall Study-Treatment Phase|Participant meets exclusion|1|||
147579541|NCT01567527|532276944|FG003|Double-blind, Placebo-controlled Phase|Protocol deviation|1|||
147653368|NCT03130959|532554538|FG009|Overall Study|Adverse Event unrelated to drug|1|||
147239973|NCT00730405|531051517|FG003|Overall Study-Treatment Phase|Participant meets exclusion|0|||
147239974|NCT00730405|531051518|FG004|Overall Study-Treatment Phase|Participant meets exclusion|0|||
147239975|NCT00730405|531051514|FG000|Overall Study-Treatment Phase|Prohibited concomitant medication|1|||
147653369|NCT03130959|532554529|FG000|Overall Study|Participant withdrew consent|0|||
147653370|NCT03130959|532554530|FG001|Overall Study|Participant withdrew consent|1|||
147653371|NCT03130959|532554531|FG002|Overall Study|Participant withdrew consent|0|||
147653372|NCT03130959|532554532|FG003|Overall Study|Participant withdrew consent|2|||
147653373|NCT03130959|532554533|FG004|Overall Study|Participant withdrew consent|1|||
147653374|NCT03130959|532554534|FG005|Overall Study|Participant withdrew consent|0|||
147653375|NCT03130959|532554535|FG006|Overall Study|Participant withdrew consent|0|||
147653376|NCT03130959|532554536|FG007|Overall Study|Participant withdrew consent|0|||
147653377|NCT03130959|532554537|FG008|Overall Study|Participant withdrew consent|0|||
147653378|NCT03130959|532554538|FG009|Overall Study|Participant withdrew consent|2|||
147653379|NCT03130959|532554529|FG000|Overall Study|Administrative reason by sponsor|1|||
147653380|NCT03130959|532554530|FG001|Overall Study|Administrative reason by sponsor|0|||
147653381|NCT03130959|532554531|FG002|Overall Study|Administrative reason by sponsor|1|||
147653382|NCT03130959|532554532|FG003|Overall Study|Administrative reason by sponsor|0|||
147653383|NCT03130959|532554533|FG004|Overall Study|Administrative reason by sponsor|0|||
147653384|NCT03130959|532554534|FG005|Overall Study|Administrative reason by sponsor|0|||
147653385|NCT03130959|532554535|FG006|Overall Study|Administrative reason by sponsor|0|||
147653386|NCT03130959|532554536|FG007|Overall Study|Administrative reason by sponsor|0|||
147653387|NCT03130959|532554537|FG008|Overall Study|Administrative reason by sponsor|0|||
147653388|NCT03130959|532554538|FG009|Overall Study|Administrative reason by sponsor|0|||
147653389|NCT03130959|532554529|FG000|Overall Study|Lost to Follow-up|1|||
147653390|NCT03130959|532554530|FG001|Overall Study|Lost to Follow-up|0|||
147653391|NCT03130959|532554531|FG002|Overall Study|Lost to Follow-up|0|||
147653392|NCT03130959|532554532|FG003|Overall Study|Lost to Follow-up|0|||
147653393|NCT03130959|532554533|FG004|Overall Study|Lost to Follow-up|0|||
147653394|NCT03130959|532554534|FG005|Overall Study|Lost to Follow-up|0|||
147653395|NCT03130959|532554535|FG006|Overall Study|Lost to Follow-up|0|||
147653396|NCT03130959|532554536|FG007|Overall Study|Lost to Follow-up|0|||
147653397|NCT03130959|532554537|FG008|Overall Study|Lost to Follow-up|0|||
147653398|NCT03130959|532554538|FG009|Overall Study|Lost to Follow-up|0|||
147653399|NCT02384538|532554539|FG000|Overall Study|Adverse Event|1|||
147653400|NCT02384538|532554540|FG001|Overall Study|Adverse Event|4|||
147653401|NCT02384538|532554539|FG000|Overall Study|Lack of Efficacy|4|||
147653402|NCT02384538|532554540|FG001|Overall Study|Lack of Efficacy|4|||
147653403|NCT02384538|532554539|FG000|Overall Study|Withdrew Consent|0|||
147653404|NCT02384538|532554540|FG001|Overall Study|Withdrew Consent|4|||
147653405|NCT02384538|532554539|FG000|Overall Study|Other|1|||
147653406|NCT02384538|532554540|FG001|Overall Study|Other|3|||
147653407|NCT03042910|532554541|FG000|Overall Study|Adverse Event|1|||
147653408|NCT03042910|532554541|FG000|Overall Study|Disease Progression|2|||
147653409|NCT03042910|532554541|FG000|Overall Study|Withdrawal by Subject|3|||
147653410|NCT03042910|532554541|FG000|Overall Study|Enrolled but not treated|1|||
147653411|NCT00313586|532554542|FG000|Overall Study|Disease progression|14|||
147653412|NCT00313586|532554543|FG001|Overall Study|Disease progression|19|||
147653413|NCT00313586|532554544|FG002|Overall Study|Disease progression|10|||
147653414|NCT00313586|532554545|FG003|Overall Study|Disease progression|3|||
147653415|NCT00313586|532554542|FG000|Overall Study|Adverse Event|12|||
147653416|NCT00313586|532554543|FG001|Overall Study|Adverse Event|18|||
147653417|NCT00313586|532554544|FG002|Overall Study|Adverse Event|3|||
147653418|NCT00313586|532554545|FG003|Overall Study|Adverse Event|10|||
147653419|NCT00313586|532554542|FG000|Overall Study|Death|11|||
147653420|NCT00313586|532554543|FG001|Overall Study|Death|8|||
147653421|NCT00313586|532554544|FG002|Overall Study|Death|1|||
147653422|NCT00313586|532554545|FG003|Overall Study|Death|7|||
147653423|NCT00313586|532554542|FG000|Overall Study|Withdrawal by Subject|13|||
147653424|NCT00313586|532554543|FG001|Overall Study|Withdrawal by Subject|6|||
147153393|NCT02759107|530724204|FG014|Overall Study|Scheduling Conflict|0|||
147153394|NCT02759107|530724205|FG015|Overall Study|Scheduling Conflict|0|||
147153395|NCT02759107|530724206|FG016|Overall Study|Scheduling Conflict|0|||
147153396|NCT02759107|530724207|FG017|Overall Study|Scheduling Conflict|0|||
147153397|NCT02513485|530724208|FG000|Overall Study|Adverse Event|1|||
147153398|NCT02513485|530724209|FG001|Overall Study|Adverse Event|0|||
147153399|NCT00420004|530724211|FG000|Overall Study|Adverse Event|4|||
147321570|NCT02034435|531340083|FG002|Overall Study|Withdrawal by Subject|0|||
147321571|NCT02034435|531340084|FG003|Overall Study|Withdrawal by Subject|0|||
147653425|NCT00313586|532554544|FG002|Overall Study|Withdrawal by Subject|6|||
147653426|NCT00313586|532554545|FG003|Overall Study|Withdrawal by Subject|2|||
147653427|NCT00313586|532554542|FG000|Overall Study|Alternative therapy|3|||
147653428|NCT00313586|532554543|FG001|Overall Study|Alternative therapy|6|||
147653429|NCT00313586|532554544|FG002|Overall Study|Alternative therapy|2|||
147153400|NCT00420004|530724212|FG001|Overall Study|Adverse Event|1|||
147153401|NCT00420004|530724213|FG002|Overall Study|Adverse Event|1|||
147321572|NCT02034435|531340081|FG000|Overall Study|Illness|0|||
147321573|NCT02034435|531340082|FG001|Overall Study|Illness|2|||
147653430|NCT00313586|532554545|FG003|Overall Study|Alternative therapy|0|||
147653431|NCT00313586|532554542|FG000|Overall Study|Other complicating disease|2|||
147153402|NCT00420004|530724211|FG000|Overall Study|Lack of Efficacy|5|||
147153403|NCT00420004|530724212|FG001|Overall Study|Lack of Efficacy|4|||
147153404|NCT00420004|530724213|FG002|Overall Study|Lack of Efficacy|1|||
147153405|NCT00420004|530724211|FG000|Overall Study|Lost to Follow-up|31|||
147653432|NCT00313586|532554543|FG001|Overall Study|Other complicating disease|2|||
147579542|NCT01567527|532276945|FG004|Double-blind, Placebo-controlled Phase|Protocol deviation|1|||
147579543|NCT01567527|532276941|FG000|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|0|||
147579544|NCT01567527|532276942|FG001|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|0|||
147579545|NCT01567527|532276943|FG002|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|0|||
147579546|NCT01567527|532276944|FG003|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|16|||
147579547|NCT01567527|532276945|FG004|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode with AE|33|||
147579548|NCT01567527|532276941|FG000|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|0|||
147579549|NCT01567527|532276942|FG001|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|0|||
147579550|NCT01567527|532276943|FG002|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|0|||
147579551|NCT01567527|532276944|FG003|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|4|||
147579552|NCT01567527|532276945|FG004|Double-blind, Placebo-controlled Phase|Met withdrawal criteria|7|||
147579553|NCT01567527|532276941|FG000|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|0|||
147579554|NCT01567527|532276942|FG001|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|0|||
147579555|NCT01567527|532276943|FG002|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|0|||
147579556|NCT01567527|532276944|FG003|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|7|||
147579557|NCT01567527|532276945|FG004|Double-blind, Placebo-controlled Phase|AE without recurrence of any moodepisode|1|||
147579558|NCT01567527|532276941|FG000|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
147579559|NCT01567527|532276942|FG001|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
147579560|NCT01567527|532276943|FG002|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
147579561|NCT01567527|532276944|FG003|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|13|||
147579562|NCT01567527|532276945|FG004|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|10|||
147579563|NCT01567527|532276941|FG000|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|0|||
147579564|NCT01567527|532276942|FG001|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|0|||
147579565|NCT01567527|532276943|FG002|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|0|||
147579566|NCT01567527|532276944|FG003|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|1|||
147579567|NCT01567527|532276945|FG004|Double-blind, Placebo-controlled Phase|Sponsor discontinued study|3|||
147579568|NCT01567527|532276941|FG000|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|0|||
147579569|NCT01567527|532276942|FG001|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|0|||
147579570|NCT01567527|532276943|FG002|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|0|||
147579571|NCT01567527|532276944|FG003|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|19|||
147579572|NCT01567527|532276945|FG004|Double-blind, Placebo-controlled Phase|Recurrence of any mood episode withoutAE|35|||
147579573|NCT01567527|532276941|FG000|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
147579574|NCT01567527|532276942|FG001|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
147579575|NCT01567527|532276943|FG002|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
147579576|NCT01567527|532276944|FG003|Double-blind, Placebo-controlled Phase|Lost to Follow-up|8|||
147579577|NCT01567527|532276945|FG004|Double-blind, Placebo-controlled Phase|Lost to Follow-up|5|||
147579578|NCT02311894|532276947|FG000|Overall Study|Discontinued in error|1|||
147579579|NCT02311894|532276947|FG000|Overall Study|Lost to Follow-up|1|||
147579580|NCT02311894|532276947|FG000|Overall Study|Adverse Event|1|||
147579581|NCT02311894|532276947|FG000|Overall Study|Withdrawal by Subject|1|||
147579582|NCT01050764|532276950|FG000|Overall Study|Death, before HSCT|1|||
147579583|NCT01050764|532276950|FG000|Overall Study|Donor mobilization failure, death|1|||
147579584|NCT01050764|532276950|FG000|Overall Study|Death after HSCT, before T-cell infusion|1|||
147579585|NCT00556673|532276960|FG000|Overall Study|Protocol deviation|3|||
147579586|NCT00556673|532276961|FG001|Overall Study|Protocol deviation|2|||
147579587|NCT01528735|532276962|FG000|Treatment Period 1: Faldap/Del/RBV|Adverse Event|1|||
147579588|NCT01528735|532276963|FG001|Treatment Period 1: Faldap/Del/RBV|Adverse Event|1|||
147579589|NCT01528735|532276962|FG000|Treatment Period 2: Faldap/PegIFN/RBV|Withdrawal by Subject|1|||
147579590|NCT01528735|532276963|FG001|Treatment Period 2: Faldap/PegIFN/RBV|Withdrawal by Subject|0|||
147579591|NCT00757172|532276964|FG000|Overall Study|Withdrawal by Subject|4|||
147579592|NCT00757172|532276964|FG000|Overall Study|Physician Decision|3|||
147579593|NCT00757172|532276964|FG000|Overall Study|Progression|4|||
147579594|NCT00494013|532276965|FG000|Overall Study|Adverse Event|0|||
147579595|NCT00494013|532276966|FG001|Overall Study|Adverse Event|1|||
147579596|NCT00494013|532276965|FG000|Overall Study|Entry Criteria Not Met|1|||
147579597|NCT00494013|532276966|FG001|Overall Study|Entry Criteria Not Met|4|||
147579598|NCT00494013|532276965|FG000|Overall Study|Lost to Follow-up|5|||
147579599|NCT00494013|532276966|FG001|Overall Study|Lost to Follow-up|6|||
147579600|NCT00494013|532276965|FG000|Overall Study|Physician Decision|3|||
147579601|NCT00494013|532276966|FG001|Overall Study|Physician Decision|5|||
147579602|NCT00494013|532276965|FG000|Overall Study|Protocol Violation|8|||
147579603|NCT00494013|532276966|FG001|Overall Study|Protocol Violation|5|||
147579604|NCT00494013|532276965|FG000|Overall Study|Withdrawal by Subject|13|||
147579605|NCT00494013|532276966|FG001|Overall Study|Withdrawal by Subject|14|||
147321574|NCT02034435|531340083|FG002|Overall Study|Illness|0|||
147321575|NCT02034435|531340084|FG003|Overall Study|Illness|0|||
147579606|NCT00494013|532276965|FG000|Overall Study|Sponsor Decision|0|||
147579607|NCT00494013|532276966|FG001|Overall Study|Sponsor Decision|1|||
147579608|NCT04194151|532276967|FG000|Overall Study|Physician Decision|1|||
147579609|NCT04194151|532276968|FG001|Overall Study|Physician Decision|1|||
147579610|NCT04194151|532276969|FG002|Overall Study|Physician Decision|1|||
147579611|NCT04194151|532276970|FG003|Overall Study|Physician Decision|1|||
147579612|NCT04194151|532276971|FG004|Overall Study|Physician Decision|0|||
147579613|NCT04194151|532276972|FG005|Overall Study|Physician Decision|1|||
147579614|NCT04194151|532276967|FG000|Overall Study|Monitorization problem|0|||
147579615|NCT04194151|532276968|FG001|Overall Study|Monitorization problem|1|||
147579616|NCT04194151|532276969|FG002|Overall Study|Monitorization problem|0|||
147579617|NCT04194151|532276970|FG003|Overall Study|Monitorization problem|0|||
147239976|NCT00730405|531051515|FG001|Overall Study-Treatment Phase|Prohibited concomitant medication|0|||
147239977|NCT00730405|531051516|FG002|Overall Study-Treatment Phase|Prohibited concomitant medication|0|||
147239978|NCT00730405|531051517|FG003|Overall Study-Treatment Phase|Prohibited concomitant medication|0|||
147239979|NCT00730405|531051518|FG004|Overall Study-Treatment Phase|Prohibited concomitant medication|0|||
147239980|NCT00730405|531051514|FG000|Overall Study-Treatment Phase|Withdrew from study treatment|0|||
147239981|NCT00730405|531051515|FG001|Overall Study-Treatment Phase|Withdrew from study treatment|1|||
147239982|NCT00730405|531051516|FG002|Overall Study-Treatment Phase|Withdrew from study treatment|0|||
147239983|NCT00730405|531051517|FG003|Overall Study-Treatment Phase|Withdrew from study treatment|0|||
147239984|NCT00730405|531051518|FG004|Overall Study-Treatment Phase|Withdrew from study treatment|0|||
147239985|NCT00730405|531051514|FG000|Overall Study-Treatment Phase|Use of prohibited medication|0|||
147239986|NCT00730405|531051515|FG001|Overall Study-Treatment Phase|Use of prohibited medication|1|||
147239987|NCT00730405|531051516|FG002|Overall Study-Treatment Phase|Use of prohibited medication|0|||
147239988|NCT00730405|531051517|FG003|Overall Study-Treatment Phase|Use of prohibited medication|0|||
147239989|NCT00730405|531051518|FG004|Overall Study-Treatment Phase|Use of prohibited medication|2|||
147446309|NCT02287623|531798915|FG000|Overall Study|Protocol Violation|0|||
147579618|NCT04194151|532276971|FG004|Overall Study|Monitorization problem|0|||
147579619|NCT04194151|532276972|FG005|Overall Study|Monitorization problem|0|||
147579620|NCT01499043|532276973|FG000|Overall Study|Progressive disease (radiographic)|2|||
147579621|NCT01499043|532276973|FG000|Overall Study|Progressive disease (clinical)|1|||
147579622|NCT01499043|532276973|FG000|Overall Study|Withdrawal by Subject|2|||
147579623|NCT01499043|532276973|FG000|Overall Study|Adverse Event|1|||
147579624|NCT04203823|532276974|FG000|Overall Study|Withdrawal by Subject|2|||
147579625|NCT04203823|532276975|FG001|Overall Study|Withdrawal by Subject|2|||
147579626|NCT04203823|532276974|FG000|Overall Study|Adverse Event|1|||
147579627|NCT04203823|532276975|FG001|Overall Study|Adverse Event|1|||
147579628|NCT04203823|532276974|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
147579629|NCT04203823|532276975|FG001|Overall Study|Withdrawal by Parent/Guardian|4|||
147579630|NCT03193021|532276976|FG000|Overall Study|Lost to Follow-up|1|||
147579631|NCT03193021|532276977|FG001|Overall Study|Lost to Follow-up|1|||
147579632|NCT02286466|532276978|FG000|Overall Study|Death|1|||
147579633|NCT02286466|532276979|FG001|Overall Study|Death|3|||
147579634|NCT02286466|532276978|FG000|Overall Study|Withdrawal by Subject|5|||
147579635|NCT02286466|532276979|FG001|Overall Study|Withdrawal by Subject|2|||
147579636|NCT02286466|532276978|FG000|Overall Study|Lost to Follow-up|1|||
147579637|NCT02286466|532276979|FG001|Overall Study|Lost to Follow-up|4|||
147579638|NCT02286466|532276978|FG000|Overall Study|Declined Clinician Assessment|0|||
147579639|NCT02286466|532276979|FG001|Overall Study|Declined Clinician Assessment|1|||
147579640|NCT00835081|532276980|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
147579641|NCT00835081|532276981|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
147579642|NCT00421304|532276982|FG000|Overall Study|Lost to Follow-up|5|||
147579643|NCT00421304|532276983|FG001|Overall Study|Lost to Follow-up|2|||
147579644|NCT00421304|532276984|FG002|Overall Study|Lost to Follow-up|5|||
147579645|NCT00421304|532276982|FG000|Overall Study|Withdrawal by Subject|2|||
147579646|NCT00421304|532276983|FG001|Overall Study|Withdrawal by Subject|2|||
147579647|NCT00421304|532276984|FG002|Overall Study|Withdrawal by Subject|2|||
147579648|NCT00421304|532276982|FG000|Overall Study|Mistakenly randomized, chose not to participate in study|1|||
147579649|NCT00421304|532276983|FG001|Overall Study|Mistakenly randomized, chose not to participate in study|0|||
147579650|NCT00421304|532276984|FG002|Overall Study|Mistakenly randomized, chose not to participate in study|0|||
147579651|NCT00421304|532276982|FG000|Overall Study|Did not attend Day 360 visit|0|||
147579652|NCT00421304|532276983|FG001|Overall Study|Did not attend Day 360 visit|0|||
147579653|NCT00421304|532276984|FG002|Overall Study|Did not attend Day 360 visit|1|||
147579654|NCT04750239|532276985|FG000|Overall Study|Withdrawal by Subject|2|||
147579655|NCT04750239|532276985|FG000|Overall Study|Trial terminated by sponsor|1|||
147579656|NCT01912807|532276986|FG000|Overall Study|Did not meet elegibility criteria|6|||
147579657|NCT01912807|532276987|FG001|Overall Study|Did not meet elegibility criteria|4|||
147579658|NCT01912807|532276986|FG000|Overall Study|Lost to Follow-up|36|||
147579659|NCT01912807|532276987|FG001|Overall Study|Lost to Follow-up|37|||
147579660|NCT00919711|532276988|FG000|Overall Study|Withdrawal by Subject|15|||
147579661|NCT00919711|532276989|FG001|Overall Study|Withdrawal by Subject|7|||
147579662|NCT00919711|532276988|FG000|Overall Study|Adverse Event|13|||
147321576|NCT02034435|531340081|FG000|Overall Study|Inadequate IV access|1|||
147579663|NCT00919711|532276989|FG001|Overall Study|Adverse Event|3|||
147579664|NCT00919711|532276988|FG000|Overall Study|Other|1|||
147579665|NCT00919711|532276989|FG001|Overall Study|Other|2|||
147579666|NCT00919711|532276988|FG000|Overall Study|Administrative Decision|0|||
147579667|NCT00919711|532276989|FG001|Overall Study|Administrative Decision|1|||
147579668|NCT00919711|532276988|FG000|Overall Study|Lost to Follow-up|2|||
147579669|NCT00919711|532276989|FG001|Overall Study|Lost to Follow-up|0|||
147321577|NCT02034435|531340082|FG001|Overall Study|Inadequate IV access|0|||
147321578|NCT02034435|531340083|FG002|Overall Study|Inadequate IV access|0|||
147321579|NCT02034435|531340084|FG003|Overall Study|Inadequate IV access|1|||
147321580|NCT02839681|531340087|FG000|Overall Study|Death|2|||
147321581|NCT02300311|531340088|FG000|Overall Study|Other than the reason specified|1|||
147321582|NCT02300311|531340089|FG001|Overall Study|Other than the reason specified|0|||
147321583|NCT02300311|531340088|FG000|Overall Study|Refused to continue taking medication|18|||
147321584|NCT02300311|531340089|FG001|Overall Study|Refused to continue taking medication|0|||
147321585|NCT02687919|531340090|FG000|Overall Study|Withdrawal by Subject|6|||
147321586|NCT02687919|531340091|FG001|Overall Study|Withdrawal by Subject|6|||
147321587|NCT02687919|531340090|FG000|Overall Study|Protocol Violation|2|||
147321588|NCT02687919|531340091|FG001|Overall Study|Protocol Violation|0|||
147321589|NCT00419003|531340092|FG000|Phase I, Ketamine Infusion|Lack of Efficacy|6|||
147321590|NCT00419003|531340093|FG001|Phase I, Ketamine Infusion|Lack of Efficacy|6|||
147321591|NCT00419003|531340092|FG000|Phase 2, Riluzole/Placebo Follow-Up|Withdrawal by Subject|1|||
147321592|NCT00419003|531340093|FG001|Phase 2, Riluzole/Placebo Follow-Up|Withdrawal by Subject|0|||
147579670|NCT00919711|532276988|FG000|Overall Study|Death|1|||
147579671|NCT00919711|532276989|FG001|Overall Study|Death|0|||
147579672|NCT00919711|532276988|FG000|Overall Study|Noncompliance|1|||
147579673|NCT00919711|532276989|FG001|Overall Study|Noncompliance|0|||
147579674|NCT02614196|532276990|FG000|Double Blind Treatment Phase|Adverse Event|8|||
147579675|NCT02614196|532276991|FG001|Double Blind Treatment Phase|Adverse Event|5|||
147579676|NCT02614196|532276992|FG002|Double Blind Treatment Phase|Adverse Event|9|||
147579677|NCT02614196|532276993|FG003|Double Blind Treatment Phase|Adverse Event|0|||
147579678|NCT02614196|532276994|FG004|Double Blind Treatment Phase|Adverse Event|0|||
147579679|NCT02614196|532276995|FG005|Double Blind Treatment Phase|Adverse Event|0|||
147579680|NCT02614196|532276990|FG000|Double Blind Treatment Phase|Lack of Efficacy|6|||
147579681|NCT02614196|532276991|FG001|Double Blind Treatment Phase|Lack of Efficacy|1|||
147579682|NCT02614196|532276992|FG002|Double Blind Treatment Phase|Lack of Efficacy|1|||
147579683|NCT02614196|532276993|FG003|Double Blind Treatment Phase|Lack of Efficacy|0|||
147579684|NCT02614196|532276994|FG004|Double Blind Treatment Phase|Lack of Efficacy|0|||
147579685|NCT02614196|532276995|FG005|Double Blind Treatment Phase|Lack of Efficacy|0|||
147579686|NCT02614196|532276990|FG000|Double Blind Treatment Phase|Lost to Follow-up|10|||
147579687|NCT02614196|532276991|FG001|Double Blind Treatment Phase|Lost to Follow-up|7|||
147579688|NCT02614196|532276992|FG002|Double Blind Treatment Phase|Lost to Follow-up|1|||
147579689|NCT02614196|532276993|FG003|Double Blind Treatment Phase|Lost to Follow-up|0|||
147579690|NCT02614196|532276994|FG004|Double Blind Treatment Phase|Lost to Follow-up|0|||
147579691|NCT02614196|532276995|FG005|Double Blind Treatment Phase|Lost to Follow-up|0|||
147579692|NCT02614196|532276990|FG000|Double Blind Treatment Phase|Physician Decision|4|||
147579693|NCT02614196|532276991|FG001|Double Blind Treatment Phase|Physician Decision|0|||
147579694|NCT02614196|532276992|FG002|Double Blind Treatment Phase|Physician Decision|2|||
147579695|NCT02614196|532276993|FG003|Double Blind Treatment Phase|Physician Decision|0|||
147579696|NCT02614196|532276994|FG004|Double Blind Treatment Phase|Physician Decision|0|||
147579697|NCT02614196|532276995|FG005|Double Blind Treatment Phase|Physician Decision|0|||
147579698|NCT02614196|532276990|FG000|Double Blind Treatment Phase|Pregnancy|1|||
147579699|NCT02614196|532276991|FG001|Double Blind Treatment Phase|Pregnancy|2|||
147579700|NCT02614196|532276992|FG002|Double Blind Treatment Phase|Pregnancy|0|||
147579701|NCT02614196|532276993|FG003|Double Blind Treatment Phase|Pregnancy|0|||
147579702|NCT02614196|532276994|FG004|Double Blind Treatment Phase|Pregnancy|0|||
147579703|NCT02614196|532276995|FG005|Double Blind Treatment Phase|Pregnancy|0|||
147579704|NCT02614196|532276990|FG000|Double Blind Treatment Phase|Protocol Violation|5|||
147579705|NCT02614196|532276991|FG001|Double Blind Treatment Phase|Protocol Violation|2|||
147579706|NCT02614196|532276992|FG002|Double Blind Treatment Phase|Protocol Violation|1|||
147579707|NCT02614196|532276993|FG003|Double Blind Treatment Phase|Protocol Violation|0|||
147321593|NCT00772928|531340094|FG000|Overall Study|Lost to Follow-up|9|||
147321594|NCT00772928|531340095|FG001|Overall Study|Lost to Follow-up|6|||
147321595|NCT00772928|531340094|FG000|Overall Study|Protocol Violation|10|||
147579708|NCT02614196|532276994|FG004|Double Blind Treatment Phase|Protocol Violation|1|||
147579709|NCT02614196|532276995|FG005|Double Blind Treatment Phase|Protocol Violation|0|||
147579710|NCT02614196|532276990|FG000|Double Blind Treatment Phase|Terminated by sponsor|1|||
147579711|NCT02614196|532276991|FG001|Double Blind Treatment Phase|Terminated by sponsor|0|||
147579712|NCT02614196|532276992|FG002|Double Blind Treatment Phase|Terminated by sponsor|0|||
147579713|NCT02614196|532276993|FG003|Double Blind Treatment Phase|Terminated by sponsor|0|||
147579714|NCT02614196|532276994|FG004|Double Blind Treatment Phase|Terminated by sponsor|0|||
147321596|NCT00772928|531340095|FG001|Overall Study|Protocol Violation|12|||
147579715|NCT02614196|532276995|FG005|Double Blind Treatment Phase|Terminated by sponsor|0|||
147579716|NCT02614196|532276990|FG000|Double Blind Treatment Phase|Withdrawal by Subject|39|||
147579717|NCT02614196|532276991|FG001|Double Blind Treatment Phase|Withdrawal by Subject|11|||
147579718|NCT02614196|532276992|FG002|Double Blind Treatment Phase|Withdrawal by Subject|14|||
147579719|NCT02614196|532276993|FG003|Double Blind Treatment Phase|Withdrawal by Subject|4|||
147579720|NCT02614196|532276994|FG004|Double Blind Treatment Phase|Withdrawal by Subject|0|||
147579721|NCT02614196|532276995|FG005|Double Blind Treatment Phase|Withdrawal by Subject|0|||
147579722|NCT02614196|532276990|FG000|Double Blind Treatment Phase|Did not receive study drug|2|||
147579723|NCT02614196|532276991|FG001|Double Blind Treatment Phase|Did not receive study drug|2|||
147579724|NCT02614196|532276992|FG002|Double Blind Treatment Phase|Did not receive study drug|3|||
147579725|NCT02614196|532276993|FG003|Double Blind Treatment Phase|Did not receive study drug|0|||
147579726|NCT02614196|532276994|FG004|Double Blind Treatment Phase|Did not receive study drug|0|||
147579727|NCT02614196|532276995|FG005|Double Blind Treatment Phase|Did not receive study drug|0|||
147579728|NCT02614196|532276990|FG000|Post Treatment Follow-up Phase|Lost to Follow-up|8|||
147579729|NCT02614196|532276991|FG001|Post Treatment Follow-up Phase|Lost to Follow-up|3|||
147579730|NCT02614196|532276992|FG002|Post Treatment Follow-up Phase|Lost to Follow-up|3|||
147579731|NCT02614196|532276993|FG003|Post Treatment Follow-up Phase|Lost to Follow-up|0|||
147579732|NCT02614196|532276994|FG004|Post Treatment Follow-up Phase|Lost to Follow-up|1|||
147579733|NCT02614196|532276995|FG005|Post Treatment Follow-up Phase|Lost to Follow-up|0|||
147579734|NCT02614196|532276990|FG000|Post Treatment Follow-up Phase|Pregnancy|2|||
147579735|NCT02614196|532276991|FG001|Post Treatment Follow-up Phase|Pregnancy|0|||
147579736|NCT02614196|532276992|FG002|Post Treatment Follow-up Phase|Pregnancy|0|||
147579737|NCT02614196|532276993|FG003|Post Treatment Follow-up Phase|Pregnancy|0|||
147579738|NCT02614196|532276994|FG004|Post Treatment Follow-up Phase|Pregnancy|0|||
147579739|NCT02614196|532276995|FG005|Post Treatment Follow-up Phase|Pregnancy|0|||
147579740|NCT02614196|532276990|FG000|Post Treatment Follow-up Phase|Protocol Violation|0|||
147579741|NCT02614196|532276991|FG001|Post Treatment Follow-up Phase|Protocol Violation|1|||
147579742|NCT02614196|532276992|FG002|Post Treatment Follow-up Phase|Protocol Violation|0|||
147579743|NCT02614196|532276993|FG003|Post Treatment Follow-up Phase|Protocol Violation|0|||
147579744|NCT02614196|532276994|FG004|Post Treatment Follow-up Phase|Protocol Violation|1|||
147579745|NCT02614196|532276995|FG005|Post Treatment Follow-up Phase|Protocol Violation|0|||
147579746|NCT02614196|532276990|FG000|Post Treatment Follow-up Phase|Withdrawal by Subject|10|||
147579747|NCT02614196|532276991|FG001|Post Treatment Follow-up Phase|Withdrawal by Subject|1|||
147579748|NCT02614196|532276992|FG002|Post Treatment Follow-up Phase|Withdrawal by Subject|5|||
147239990|NCT00730405|531051514|FG000|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0|||
147239991|NCT00730405|531051515|FG001|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0|||
147239992|NCT00730405|531051516|FG002|Overall Study-Treatment Phase|Human immunodeficiency virus positive|1|||
147239993|NCT00730405|531051517|FG003|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0|||
147239994|NCT00730405|531051518|FG004|Overall Study-Treatment Phase|Human immunodeficiency virus positive|0|||
147239995|NCT00730405|531051514|FG000|Overall Study-Treatment Phase|Misrandomized|0|||
147239996|NCT00730405|531051515|FG001|Overall Study-Treatment Phase|Misrandomized|1|||
147239997|NCT00730405|531051516|FG002|Overall Study-Treatment Phase|Misrandomized|0|||
147239998|NCT00730405|531051517|FG003|Overall Study-Treatment Phase|Misrandomized|0|||
147239999|NCT00730405|531051518|FG004|Overall Study-Treatment Phase|Misrandomized|0|||
147240000|NCT00730405|531051514|FG000|Overall Study-Treatment Phase|Study drug interrupted|0|||
147240001|NCT00730405|531051515|FG001|Overall Study-Treatment Phase|Study drug interrupted|1|||
147240002|NCT00730405|531051516|FG002|Overall Study-Treatment Phase|Study drug interrupted|0|||
147240003|NCT00730405|531051517|FG003|Overall Study-Treatment Phase|Study drug interrupted|0|||
147240004|NCT00730405|531051518|FG004|Overall Study-Treatment Phase|Study drug interrupted|0|||
147240005|NCT00730405|531051514|FG000|Overall Study-Treatment Phase|Due to in-vitro fertilization|0|||
147240006|NCT00730405|531051515|FG001|Overall Study-Treatment Phase|Due to in-vitro fertilization|0|||
147240007|NCT00730405|531051516|FG002|Overall Study-Treatment Phase|Due to in-vitro fertilization|0|||
147240008|NCT00730405|531051517|FG003|Overall Study-Treatment Phase|Due to in-vitro fertilization|1|||
147240009|NCT00730405|531051518|FG004|Overall Study-Treatment Phase|Due to in-vitro fertilization|0|||
147240010|NCT00730405|531051514|FG000|Overall Study-Treatment Phase|Protocol violation due to eligibility|0|||
147240011|NCT00730405|531051515|FG001|Overall Study-Treatment Phase|Protocol violation due to eligibility|0|||
147240012|NCT00730405|531051516|FG002|Overall Study-Treatment Phase|Protocol violation due to eligibility|1|||
147240013|NCT00730405|531051517|FG003|Overall Study-Treatment Phase|Protocol violation due to eligibility|0|||
147240014|NCT00730405|531051518|FG004|Overall Study-Treatment Phase|Protocol violation due to eligibility|0|||
147579749|NCT02614196|532276993|FG003|Post Treatment Follow-up Phase|Withdrawal by Subject|1|||
147579750|NCT02614196|532276994|FG004|Post Treatment Follow-up Phase|Withdrawal by Subject|0|||
147579751|NCT02614196|532276995|FG005|Post Treatment Follow-up Phase|Withdrawal by Subject|0|||
147579752|NCT00903877|532276996|FG000|Overall Study|Did not meet study criteria|33|||
147579753|NCT00903877|532276996|FG000|Overall Study|Withdrawal by Subject|3|||
147579754|NCT00903877|532276996|FG000|Overall Study|Adverse Event|2|||
147240015|NCT00730405|531051514|FG000|Overall Study-Treatment Phase|Change of location|0|||
147579755|NCT00903877|532276996|FG000|Overall Study|Lost to Follow-up|1|||
147579756|NCT00903877|532276996|FG000|Overall Study|Participation put on hold|4|||
147579757|NCT01562613|532276997|FG000|Overall Study|Lost to Follow-up|2|||
147579758|NCT01562613|532276997|FG000|Overall Study|Withdrawal by Subject|2|||
147579759|NCT04388787|532276998|FG000|Blinded Period|Patient could not follow instructions|1|||
147579760|NCT04388787|532276998|FG000|Unblinded Period|Patients became fatiged after a single round of testing with sham vs subthreshold|9|||
147579761|NCT00663234|532276999|FG000|Overall Study|Not willing to adhere to requirements|1|||
147579762|NCT01253564|532277002|FG000|Overall Study|Disease Progression|22|||
147579763|NCT01253564|532277002|FG000|Overall Study|Withdrawal by Subject|1|||
147579764|NCT01253564|532277002|FG000|Overall Study|Serious Adverse Event|1|||
147579765|NCT01751087|532277005|FG000|Overall Study|Withdrawal by Subject|1|||
147579766|NCT01751087|532277006|FG001|Overall Study|Withdrawal by Subject|0|||
147579767|NCT01751087|532277007|FG002|Overall Study|Withdrawal by Subject|0|||
147579768|NCT01751087|532277005|FG000|Overall Study|Physician Decision|0|||
147579769|NCT01751087|532277006|FG001|Overall Study|Physician Decision|0|||
147579770|NCT01751087|532277007|FG002|Overall Study|Physician Decision|1|||
147579771|NCT01520987|532278617|FG000|Overall Study|Withdrawal by Subject|1|||
147579772|NCT01520987|532278618|FG001|Overall Study|Withdrawal by Subject|0|||
147579773|NCT01520987|532278619|FG002|Overall Study|Withdrawal by Subject|0|||
147579774|NCT01520987|532278620|FG003|Overall Study|Withdrawal by Subject|0|||
147579775|NCT01520987|532278621|FG004|Overall Study|Withdrawal by Subject|0|||
147579776|NCT01520987|532278622|FG005|Overall Study|Withdrawal by Subject|1|||
147579777|NCT01520987|532278623|FG006|Overall Study|Withdrawal by Subject|0|||
147579778|NCT01520987|532278624|FG007|Overall Study|Withdrawal by Subject|0|||
147579779|NCT02005562|532278625|FG000|Overall Study|Death|2|||
147579780|NCT02005562|532278626|FG001|Overall Study|Death|2|||
147579781|NCT02005562|532278625|FG000|Overall Study|Graft loss|7|||
147579782|NCT02005562|532278626|FG001|Overall Study|Graft loss|6|||
147579783|NCT02005562|532278625|FG000|Overall Study|Withdrawal by Subject|2|||
147579784|NCT02005562|532278626|FG001|Overall Study|Withdrawal by Subject|2|||
147579785|NCT02005562|532278625|FG000|Overall Study|No transplant|1|||
147579786|NCT02005562|532278626|FG001|Overall Study|No transplant|4|||
147579787|NCT02005562|532278625|FG000|Overall Study|Physician Decision|0|||
147579788|NCT02005562|532278626|FG001|Overall Study|Physician Decision|1|||
147579789|NCT04729101|532278627|FG000|Overall Study|Adverse Event|1|||
147579790|NCT04729101|532278628|FG001|Overall Study|Adverse Event|0|||
147153406|NCT00420004|530724212|FG001|Overall Study|Lost to Follow-up|12|||
147153407|NCT00420004|530724213|FG002|Overall Study|Lost to Follow-up|10|||
147153408|NCT00420004|530724211|FG000|Overall Study|Entry Criteria Not Met|0|||
147153409|NCT00420004|530724212|FG001|Overall Study|Entry Criteria Not Met|1|||
147153410|NCT00420004|530724213|FG002|Overall Study|Entry Criteria Not Met|0|||
147153411|NCT00420004|530724211|FG000|Overall Study|Physician Decision|14|||
147153412|NCT00420004|530724212|FG001|Overall Study|Physician Decision|4|||
147153413|NCT00420004|530724213|FG002|Overall Study|Physician Decision|2|||
147153414|NCT00420004|530724211|FG000|Overall Study|Protocol Violation|5|||
147153415|NCT00420004|530724212|FG001|Overall Study|Protocol Violation|4|||
147153416|NCT00420004|530724213|FG002|Overall Study|Protocol Violation|3|||
147153417|NCT00420004|530724211|FG000|Overall Study|Withdrawal by Subject|67|||
147153418|NCT00420004|530724212|FG001|Overall Study|Withdrawal by Subject|42|||
147153419|NCT00420004|530724213|FG002|Overall Study|Withdrawal by Subject|14|||
147153420|NCT00420004|530724211|FG000|Overall Study|Sponsor Decision|3|||
147153421|NCT00420004|530724212|FG001|Overall Study|Sponsor Decision|3|||
147153422|NCT00420004|530724213|FG002|Overall Study|Sponsor Decision|1|||
147153423|NCT03215758|530724221|FG000|Overall Study|Technical Problems|1|||
147153424|NCT03215758|530724222|FG001|Overall Study|Technical Problems|0|||
147153425|NCT03215758|530724221|FG000|Overall Study|Protocol deviation|0|||
147153426|NCT03215758|530724222|FG001|Overall Study|Protocol deviation|1|||
147153427|NCT03215758|530724221|FG000|Overall Study|Physician Decision|0|||
147153428|NCT03215758|530724222|FG001|Overall Study|Physician Decision|1|||
147153429|NCT03215758|530724221|FG000|Overall Study|Death|0|||
147153430|NCT03215758|530724222|FG001|Overall Study|Death|1|||
147153431|NCT03215758|530724221|FG000|Overall Study|Adverse Event|1|||
147579791|NCT04729101|532278627|FG000|Overall Study|Physician Decision|1|||
147579792|NCT04729101|532278628|FG001|Overall Study|Physician Decision|0|||
147579793|NCT04729101|532278627|FG000|Overall Study|Withdrawal by Subject|1|||
147579794|NCT04729101|532278628|FG001|Overall Study|Withdrawal by Subject|0|||
147579795|NCT00274625|532278629|FG000|Overall Study|Lost to Follow-up|46|||
147579796|NCT00274625|532278630|FG001|Overall Study|Lost to Follow-up|54|||
147579797|NCT00274625|532278629|FG000|Overall Study|Excluded from analysis|14|||
147579798|NCT00274625|532278630|FG001|Overall Study|Excluded from analysis|8|||
147579799|NCT02940522|532278631|FG000|Overall Study|Lost to Follow-up|1|||
147653433|NCT00313586|532554544|FG002|Overall Study|Other complicating disease|0|||
147153432|NCT03215758|530724222|FG001|Overall Study|Adverse Event|2|||
147153433|NCT03215758|530724221|FG000|Overall Study|Subject/Guardian Decision|3|||
147153434|NCT03215758|530724222|FG001|Overall Study|Subject/Guardian Decision|3|||
147153435|NCT03931382|530724229|FG000|Overall Study|Equipment malfunction|2|||
147153436|NCT03931382|530724230|FG001|Overall Study|Equipment malfunction|0|||
147579800|NCT02940522|532278632|FG001|Overall Study|Lost to Follow-up|2|||
147579801|NCT02940522|532278631|FG000|Overall Study|Withdrawal by Subject|1|||
147240016|NCT00730405|531051515|FG001|Overall Study-Treatment Phase|Change of location|0|||
147240017|NCT00730405|531051516|FG002|Overall Study-Treatment Phase|Change of location|0|||
147240018|NCT00730405|531051517|FG003|Overall Study-Treatment Phase|Change of location|1|||
147240019|NCT00730405|531051518|FG004|Overall Study-Treatment Phase|Change of location|0|||
147240020|NCT00730405|531051514|FG000|Overall Study-Treatment Phase|Pregnancy|0|||
147240021|NCT00730405|531051515|FG001|Overall Study-Treatment Phase|Pregnancy|1|||
147240022|NCT00730405|531051516|FG002|Overall Study-Treatment Phase|Pregnancy|0|||
147321597|NCT00772928|531340094|FG000|Overall Study|Withdrawal by Subject|25|||
147321598|NCT00772928|531340095|FG001|Overall Study|Withdrawal by Subject|22|||
147321599|NCT00772928|531340094|FG000|Overall Study|Did not receive vaccine|0|||
147321600|NCT00772928|531340095|FG001|Overall Study|Did not receive vaccine|1|||
147579802|NCT02940522|532278632|FG001|Overall Study|Withdrawal by Subject|0|||
147579803|NCT00762411|532278635|FG000|Initial Treatment|Death|7|||
147579804|NCT00762411|532278636|FG001|Initial Treatment|Death|6|||
147579805|NCT00762411|532278635|FG000|Initial Treatment|Adverse Event|132|||
147579806|NCT00762411|532278636|FG001|Initial Treatment|Adverse Event|40|||
147579807|NCT00762411|532278635|FG000|Initial Treatment|Protocol Violation|4|||
147579808|NCT00762411|532278636|FG001|Initial Treatment|Protocol Violation|1|||
147579809|NCT00762411|532278635|FG000|Initial Treatment|Withdrawal by Subject|65|||
147579810|NCT00762411|532278636|FG001|Initial Treatment|Withdrawal by Subject|52|||
147579811|NCT00762411|532278635|FG000|Initial Treatment|Physician Decision|1|||
147579812|NCT00762411|532278636|FG001|Initial Treatment|Physician Decision|0|||
147579813|NCT00762411|532278635|FG000|Initial Treatment|Sponsor Decision|293|||
147579814|NCT00762411|532278636|FG001|Initial Treatment|Sponsor Decision|401|||
147579815|NCT00762411|532278635|FG000|Initial Treatment|Lost to Follow-up|5|||
147579816|NCT00762411|532278636|FG001|Initial Treatment|Lost to Follow-up|0|||
147579817|NCT00762411|532278635|FG000|Initial Treatment|Caregiver Decision|21|||
147579818|NCT00762411|532278636|FG001|Initial Treatment|Caregiver Decision|16|||
147579819|NCT00762411|532278635|FG000|Initial Treatment|Abnormal Lab/ECG Result|6|||
147579820|NCT00762411|532278636|FG001|Initial Treatment|Abnormal Lab/ECG Result|4|||
147579821|NCT00762411|532278635|FG000|Initial Treatment|Entry Criteria Exclusion|0|||
147579822|NCT00762411|532278636|FG001|Initial Treatment|Entry Criteria Exclusion|1|||
147579823|NCT00762411|532278635|FG000|Delayed Start|Adverse Event|0|||
147579824|NCT00762411|532278636|FG001|Delayed Start|Adverse Event|4|||
147579825|NCT00762411|532278635|FG000|Delayed Start|Protocol Violation|0|||
147579826|NCT00762411|532278636|FG001|Delayed Start|Protocol Violation|1|||
147579827|NCT00762411|532278635|FG000|Delayed Start|Sponsor Decision|16|||
147579828|NCT00762411|532278636|FG001|Delayed Start|Sponsor Decision|20|||
147579829|NCT00762411|532278635|FG000|Delayed Start|Caregiver Decision|1|||
147579830|NCT00762411|532278636|FG001|Delayed Start|Caregiver Decision|1|||
147579831|NCT00762411|532278635|FG000|Safety Follow Up (SFU)-Optional|Death|1|||
147579832|NCT00762411|532278636|FG001|Safety Follow Up (SFU)-Optional|Death|8|||
147579833|NCT00762411|532278635|FG000|Safety Follow Up (SFU)-Optional|Adverse Event|0|||
147579834|NCT00762411|532278636|FG001|Safety Follow Up (SFU)-Optional|Adverse Event|1|||
147579835|NCT00762411|532278635|FG000|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|21|||
147579836|NCT00762411|532278636|FG001|Safety Follow Up (SFU)-Optional|Withdrawal by Subject|46|||
147579837|NCT00762411|532278635|FG000|Safety Follow Up (SFU)-Optional|Lost to Follow-up|6|||
147579838|NCT00762411|532278636|FG001|Safety Follow Up (SFU)-Optional|Lost to Follow-up|1|||
147579839|NCT00762411|532278635|FG000|Safety Follow Up (SFU)-Optional|Caregiver Decision|8|||
147579840|NCT00762411|532278636|FG001|Safety Follow Up (SFU)-Optional|Caregiver Decision|8|||
147579841|NCT00762411|532278635|FG000|Safety Follow Up (SFU)-Optional|No safety visit or SFU|48|||
147579842|NCT00762411|532278636|FG001|Safety Follow Up (SFU)-Optional|No safety visit or SFU|54|||
147579843|NCT02710214|532278640|FG000|Overall Study|Lost to Follow-up|1|||
147579844|NCT02710214|532278641|FG001|Overall Study|Lost to Follow-up|0|||
147579845|NCT02710214|532278640|FG000|Overall Study|Lack of Efficacy|0|||
147579846|NCT02710214|532278641|FG001|Overall Study|Lack of Efficacy|1|||
147579847|NCT02710214|532278640|FG000|Overall Study|Death|0|||
147579848|NCT02710214|532278641|FG001|Overall Study|Death|1|||
147579849|NCT02832167|532278642|FG000|Treatment Period 1|Disease progression|90|||
147579850|NCT02832167|532278642|FG000|Treatment Period 1|Adverse event unrelated to study drug|12|||
147653434|NCT00313586|532554545|FG003|Overall Study|Other complicating disease|0|||
147240023|NCT00730405|531051517|FG003|Overall Study-Treatment Phase|Pregnancy|0|||
147240024|NCT00730405|531051518|FG004|Overall Study-Treatment Phase|Pregnancy|0|||
147240025|NCT00730405|531051514|FG000|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0|||
147240026|NCT00730405|531051515|FG001|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0|||
147321601|NCT01653847|531340096|FG000|Overall Study|Withdrawal by Subject|1|||
147579851|NCT02832167|532278642|FG000|Treatment Period 1|Death|2|||
147579852|NCT02832167|532278642|FG000|Treatment Period 1|Study Drug Toxicity|6|||
147579853|NCT02832167|532278642|FG000|Treatment Period 1|Participant request to discontinue|9|||
147579854|NCT02832167|532278642|FG000|Treatment Period 1|No longer meet study criteria|1|||
147579855|NCT02832167|532278642|FG000|Treatment Period 1|Participant withdrew consent|3|||
147579856|NCT02832167|532278642|FG000|Treatment Period 1|Other reasons|6|||
147579857|NCT02832167|532278642|FG000|Transition From Period 1 to Period 2|Other reasons|1|||
147579858|NCT02832167|532278642|FG000|Transition From Period 1 to Period 2|Participant withdrew consent|1|||
147579859|NCT02832167|532278642|FG000|Transition From Period 1 to Period 2|Death|2|||
147579860|NCT02832167|532278642|FG000|Transition From Period 1 to Period 2|Lost to Follow-up|3|||
147579861|NCT02832167|532278642|FG000|Treatment Period 2|Disease progression|69|||
147579862|NCT02832167|532278642|FG000|Treatment Period 2|Adverse event unrelated to study drug|1|||
147579863|NCT02832167|532278642|FG000|Treatment Period 2|Maximum clinical benefit|1|||
147579864|NCT02832167|532278642|FG000|Treatment Period 2|Study Drug Toxicity|5|||
147579865|NCT02832167|532278642|FG000|Treatment Period 2|Participant request to discontinue|2|||
147579866|NCT02832167|532278642|FG000|Treatment Period 2|Participant withdrew consent|3|||
147579867|NCT02832167|532278642|FG000|Treatment Period 2|Other reasons|3|||
147579868|NCT01754376|532278643|FG000|Overall Study|Adverse Event|1|||
147579869|NCT01754376|532278643|FG000|Overall Study|Lack of Efficacy|2|||
147579870|NCT04556734|532278644|FG000|DB Treatment Period (24 Weeks)|Withdrawal by Subject|4|||
147579871|NCT04556734|532278645|FG001|DB Treatment Period (24 Weeks)|Withdrawal by Subject|1|||
147579872|NCT04556734|532278646|FG002|DB Treatment Period (24 Weeks)|Withdrawal by Subject|5|||
147579873|NCT04556734|532278647|FG003|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
147579874|NCT04556734|532278648|FG004|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
147579875|NCT04556734|532278649|FG005|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
147579876|NCT04556734|532278650|FG006|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
147579877|NCT04556734|532278651|FG007|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
147579878|NCT04556734|532278644|FG000|DB Treatment Period (24 Weeks)|Protocol Violation|1|||
147579879|NCT04556734|532278645|FG001|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
147579880|NCT04556734|532278646|FG002|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
147153437|NCT03931382|530724231|FG002|Overall Study|Equipment malfunction|2|||
147153438|NCT03931382|530724229|FG000|Overall Study|Withdrawal by Subject|0|||
147579881|NCT04556734|532278647|FG003|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
147579882|NCT04556734|532278648|FG004|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
147579883|NCT04556734|532278649|FG005|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
147579884|NCT04556734|532278650|FG006|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
147579885|NCT04556734|532278651|FG007|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
147579886|NCT04556734|532278644|FG000|DB Treatment Period (24 Weeks)|Lost to Follow-up|1|||
147579887|NCT04556734|532278645|FG001|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
147579888|NCT04556734|532278646|FG002|DB Treatment Period (24 Weeks)|Lost to Follow-up|1|||
147579889|NCT04556734|532278647|FG003|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
147579890|NCT04556734|532278648|FG004|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
147579891|NCT04556734|532278649|FG005|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
147579892|NCT04556734|532278650|FG006|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
147579893|NCT04556734|532278651|FG007|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
147579894|NCT04556734|532278644|FG000|DB Treatment Period (24 Weeks)|Adverse Event|1|||
147579895|NCT04556734|532278645|FG001|DB Treatment Period (24 Weeks)|Adverse Event|0|||
147579896|NCT04556734|532278646|FG002|DB Treatment Period (24 Weeks)|Adverse Event|0|||
147579897|NCT04556734|532278647|FG003|DB Treatment Period (24 Weeks)|Adverse Event|0|||
147579898|NCT04556734|532278648|FG004|DB Treatment Period (24 Weeks)|Adverse Event|0|||
147579899|NCT04556734|532278649|FG005|DB Treatment Period (24 Weeks)|Adverse Event|0|||
147579900|NCT04556734|532278650|FG006|DB Treatment Period (24 Weeks)|Adverse Event|0|||
147579901|NCT04556734|532278651|FG007|DB Treatment Period (24 Weeks)|Adverse Event|0|||
147579902|NCT04556734|532278644|FG000|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
147579903|NCT04556734|532278645|FG001|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
147579904|NCT04556734|532278646|FG002|DB Treatment Period (24 Weeks)|Randomized but not treated|1|||
147579905|NCT04556734|532278647|FG003|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
147579906|NCT04556734|532278648|FG004|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
147579907|NCT04556734|532278649|FG005|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
147579908|NCT04556734|532278650|FG006|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
147579909|NCT04556734|532278651|FG007|DB Treatment Period (24 Weeks)|Randomized but not treated|0|||
147579910|NCT04556734|532278644|FG000|OLE Period (28 Weeks)|Not reported|0|||
147579911|NCT04556734|532278645|FG001|OLE Period (28 Weeks)|Not reported|0|||
147579912|NCT04556734|532278646|FG002|OLE Period (28 Weeks)|Not reported|0|||
147579913|NCT04556734|532278647|FG003|OLE Period (28 Weeks)|Not reported|0|||
147579914|NCT04556734|532278648|FG004|OLE Period (28 Weeks)|Not reported|0|||
147153439|NCT03931382|530724230|FG001|Overall Study|Withdrawal by Subject|1|||
147153440|NCT03931382|530724231|FG002|Overall Study|Withdrawal by Subject|0|||
147153441|NCT01106651|530724237|FG000|Overall Study|Adverse Event|17|||
147153442|NCT01106651|530724238|FG001|Overall Study|Adverse Event|9|||
147153443|NCT01106651|530724239|FG002|Overall Study|Adverse Event|23|||
147153444|NCT01106651|530724237|FG000|Overall Study|Lost to Follow-up|8|||
147153445|NCT01106651|530724238|FG001|Overall Study|Lost to Follow-up|2|||
147153446|NCT01106651|530724239|FG002|Overall Study|Lost to Follow-up|6|||
147579915|NCT04556734|532278649|FG005|OLE Period (28 Weeks)|Not reported|1|||
147153447|NCT01106651|530724237|FG000|Overall Study|Physician Decision|4|||
147153448|NCT01106651|530724238|FG001|Overall Study|Physician Decision|3|||
147153449|NCT01106651|530724239|FG002|Overall Study|Physician Decision|1|||
147446310|NCT02287623|531798916|FG001|Overall Study|Protocol Violation|1|||
147579916|NCT04556734|532278650|FG006|OLE Period (28 Weeks)|Not reported|0|||
147579917|NCT04556734|532278651|FG007|OLE Period (28 Weeks)|Not reported|0|||
147579918|NCT04556734|532278644|FG000|OLE Period (28 Weeks)|Lost to Follow-up|0|||
147579919|NCT04556734|532278645|FG001|OLE Period (28 Weeks)|Lost to Follow-up|0|||
147579920|NCT04556734|532278646|FG002|OLE Period (28 Weeks)|Lost to Follow-up|0|||
147579921|NCT04556734|532278647|FG003|OLE Period (28 Weeks)|Lost to Follow-up|0|||
147579922|NCT04556734|532278648|FG004|OLE Period (28 Weeks)|Lost to Follow-up|0|||
147579923|NCT04556734|532278649|FG005|OLE Period (28 Weeks)|Lost to Follow-up|0|||
147579924|NCT04556734|532278650|FG006|OLE Period (28 Weeks)|Lost to Follow-up|0|||
147579925|NCT04556734|532278651|FG007|OLE Period (28 Weeks)|Lost to Follow-up|2|||
147579926|NCT04556734|532278644|FG000|OLE Period (28 Weeks)|Adverse Event|0|||
147579927|NCT04556734|532278645|FG001|OLE Period (28 Weeks)|Adverse Event|0|||
147579928|NCT04556734|532278646|FG002|OLE Period (28 Weeks)|Adverse Event|0|||
147579929|NCT04556734|532278647|FG003|OLE Period (28 Weeks)|Adverse Event|1|||
147579930|NCT04556734|532278648|FG004|OLE Period (28 Weeks)|Adverse Event|0|||
147579931|NCT04556734|532278649|FG005|OLE Period (28 Weeks)|Adverse Event|0|||
147579932|NCT04556734|532278650|FG006|OLE Period (28 Weeks)|Adverse Event|0|||
147579933|NCT04556734|532278651|FG007|OLE Period (28 Weeks)|Adverse Event|2|||
147579934|NCT04556734|532278644|FG000|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
147579935|NCT04556734|532278645|FG001|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
147579936|NCT04556734|532278646|FG002|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
147579937|NCT04556734|532278647|FG003|OLE Period (28 Weeks)|Withdrawal by Subject|1|||
147579938|NCT04556734|532278648|FG004|OLE Period (28 Weeks)|Withdrawal by Subject|3|||
147579939|NCT04556734|532278649|FG005|OLE Period (28 Weeks)|Withdrawal by Subject|2|||
147579940|NCT04556734|532278650|FG006|OLE Period (28 Weeks)|Withdrawal by Subject|1|||
147579941|NCT04556734|532278651|FG007|OLE Period (28 Weeks)|Withdrawal by Subject|0|||
147579942|NCT04264819|532278657|FG000|Overall Study|Physician Decision|19|||
147579943|NCT04264819|532278657|FG000|Overall Study|Adverse Event|12|||
147579944|NCT04264819|532278657|FG000|Overall Study|Withdrawal by Subject|11|||
147579945|NCT04264819|532278657|FG000|Overall Study|Lost to Follow-up|2|||
147579946|NCT04264819|532278657|FG000|Overall Study|Death|2|||
147579947|NCT01680016|532278658|FG000|Overall Study|Adverse Event|0|||
147579948|NCT01680016|532278659|FG001|Overall Study|Adverse Event|0|||
147579949|NCT01680016|532278660|FG002|Overall Study|Adverse Event|1|||
147579950|NCT01680016|532278661|FG003|Overall Study|Adverse Event|4|||
147579951|NCT01680016|532278658|FG000|Overall Study|The Subject went out of The Trial|1|||
147579952|NCT01680016|532278659|FG001|Overall Study|The Subject went out of The Trial|0|||
147579953|NCT01680016|532278660|FG002|Overall Study|The Subject went out of The Trial|3|||
147579954|NCT01680016|532278661|FG003|Overall Study|The Subject went out of The Trial|0|||
147579955|NCT01680016|532278658|FG000|Overall Study|Protocol Violation|0|||
147579956|NCT01680016|532278659|FG001|Overall Study|Protocol Violation|1|||
147579957|NCT01680016|532278660|FG002|Overall Study|Protocol Violation|0|||
147579958|NCT01680016|532278661|FG003|Overall Study|Protocol Violation|0|||
147579959|NCT01680016|532278658|FG000|Overall Study|Withdrawal by Subject|5|||
147579960|NCT01680016|532278659|FG001|Overall Study|Withdrawal by Subject|7|||
147579961|NCT01680016|532278660|FG002|Overall Study|Withdrawal by Subject|1|||
147579962|NCT01680016|532278661|FG003|Overall Study|Withdrawal by Subject|1|||
147579963|NCT02846883|532278667|FG000|Overall Study|Death|0|||
147579964|NCT02846883|532278668|FG001|Overall Study|Death|1|||
147579965|NCT02846883|532278669|FG002|Overall Study|Death|1|||
147579966|NCT02846883|532278667|FG000|Overall Study|Lost to Follow-up|0|||
147579967|NCT02846883|532278668|FG001|Overall Study|Lost to Follow-up|0|||
147653435|NCT00313586|532554542|FG000|Overall Study|Did not achieve HI-major/better response|10|||
147153450|NCT01106651|530724237|FG000|Overall Study|Protocol Violation|1|||
147153451|NCT01106651|530724238|FG001|Overall Study|Protocol Violation|2|||
147153452|NCT01106651|530724239|FG002|Overall Study|Protocol Violation|1|||
147153453|NCT01106651|530724237|FG000|Overall Study|Withdrawal by Subject|14|||
147153454|NCT01106651|530724238|FG001|Overall Study|Withdrawal by Subject|7|||
147579968|NCT02846883|532278669|FG002|Overall Study|Lost to Follow-up|1|||
147579969|NCT02846883|532278667|FG000|Overall Study|Withdrawal by Subject|1|||
147579970|NCT02846883|532278668|FG001|Overall Study|Withdrawal by Subject|0|||
147579971|NCT02846883|532278669|FG002|Overall Study|Withdrawal by Subject|0|||
147579972|NCT02846883|532278667|FG000|Overall Study|Study terminated by VA DSMB due to low enrollment|5|||
147579973|NCT02846883|532278668|FG001|Overall Study|Study terminated by VA DSMB due to low enrollment|9|||
147579974|NCT02846883|532278669|FG002|Overall Study|Study terminated by VA DSMB due to low enrollment|9|||
147579975|NCT02846883|532278667|FG000|Overall Study|Primary endpoint - endovascular aortic repair|0|||
147579976|NCT02846883|532278668|FG001|Overall Study|Primary endpoint - endovascular aortic repair|0|||
147153455|NCT01106651|530724239|FG002|Overall Study|Withdrawal by Subject|4|||
147153456|NCT01106651|530724237|FG000|Overall Study|Noncompliance with study drug|1|||
147153457|NCT01106651|530724238|FG001|Overall Study|Noncompliance with study drug|0|||
147153458|NCT01106651|530724239|FG002|Overall Study|Noncompliance with study drug|2|||
147153459|NCT01106651|530724237|FG000|Overall Study|Other|34|||
147153460|NCT01106651|530724238|FG001|Overall Study|Other|31|||
147153461|NCT01106651|530724239|FG002|Overall Study|Other|21|||
147579977|NCT02846883|532278669|FG002|Overall Study|Primary endpoint - endovascular aortic repair|1|||
147579978|NCT04768296|532278671|FG000|Overall Study|STOP LONG-TERM FOLLOW-UP AS PER SPONSOR'S DECISION|1|||
147579979|NCT04768296|532278672|FG001|Overall Study|STOP LONG-TERM FOLLOW-UP AS PER SPONSOR'S DECISION|7|||
147579980|NCT00452348|532278676|FG000|Overall Study|Adverse Event|6|||
147579981|NCT00452348|532278677|FG001|Overall Study|Adverse Event|9|||
147579982|NCT00452348|532278676|FG000|Overall Study|Lack of Efficacy|10|||
147579983|NCT00452348|532278677|FG001|Overall Study|Lack of Efficacy|9|||
147579984|NCT00452348|532278676|FG000|Overall Study|Lost to Follow-up|14|||
147579985|NCT00452348|532278677|FG001|Overall Study|Lost to Follow-up|8|||
147579986|NCT00452348|532278676|FG000|Overall Study|Protocol Violation|22|||
147579987|NCT00452348|532278677|FG001|Overall Study|Protocol Violation|28|||
147653436|NCT00313586|532554543|FG001|Overall Study|Did not achieve HI-major/better response|7|||
147653437|NCT00313586|532554544|FG002|Overall Study|Did not achieve HI-major/better response|2|||
147653438|NCT00313586|532554545|FG003|Overall Study|Did not achieve HI-major/better response|1|||
147653439|NCT00313586|532554542|FG000|Overall Study|Physician Decision|2|||
147653440|NCT00313586|532554543|FG001|Overall Study|Physician Decision|1|||
147653441|NCT00313586|532554544|FG002|Overall Study|Physician Decision|0|||
147653442|NCT00313586|532554545|FG003|Overall Study|Physician Decision|0|||
147653443|NCT00313586|532554542|FG000|Overall Study|Absolute neutrophil count not recovered|2|||
147653444|NCT00313586|532554543|FG001|Overall Study|Absolute neutrophil count not recovered|1|||
147153462|NCT01106651|530724237|FG000|Overall Study|Death|0|||
147153463|NCT01106651|530724238|FG001|Overall Study|Death|3|||
147153464|NCT01106651|530724239|FG002|Overall Study|Death|0|||
147153465|NCT03768089|530724240|FG000|Part A|Lost to Follow-up|0|||
147153466|NCT03768089|530724241|FG001|Part A|Lost to Follow-up|0|||
147153467|NCT03768089|530724242|FG002|Part A|Lost to Follow-up|0|||
147153468|NCT03768089|530724243|FG003|Part A|Lost to Follow-up|0|||
147153469|NCT03768089|530724244|FG004|Part A|Lost to Follow-up|1|||
147153470|NCT03768089|530724245|FG005|Part A|Lost to Follow-up|0|||
147153471|NCT03768089|530724246|FG006|Part A|Lost to Follow-up|0|||
147153472|NCT03768089|530724247|FG007|Part A|Lost to Follow-up|0|||
147153473|NCT03768089|530724248|FG008|Part A|Lost to Follow-up|0|||
147153474|NCT03768089|530724249|FG009|Part A|Lost to Follow-up|0|||
147153475|NCT03768089|530724250|FG010|Part A|Lost to Follow-up|0|||
147153476|NCT03768089|530724251|FG011|Part A|Lost to Follow-up|0|||
147153477|NCT03768089|530724252|FG012|Part A|Lost to Follow-up|0|||
147153478|NCT03768089|530724253|FG013|Part A|Lost to Follow-up|0|||
147153479|NCT03768089|530724254|FG014|Part A|Lost to Follow-up|0|||
147153480|NCT03768089|530724255|FG015|Part A|Lost to Follow-up|0|||
147153481|NCT03768089|530724256|FG016|Part A|Lost to Follow-up|0|||
147153482|NCT03768089|530724257|FG017|Part A|Lost to Follow-up|0|||
147153483|NCT03768089|530724240|FG000|Part C|Randomized, Never Dosed|0|||
147153484|NCT03768089|530724241|FG001|Part C|Randomized, Never Dosed|0|||
147153485|NCT03768089|530724242|FG002|Part C|Randomized, Never Dosed|0|||
147153486|NCT03768089|530724243|FG003|Part C|Randomized, Never Dosed|0|||
147240027|NCT00730405|531051516|FG002|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0|||
147240028|NCT00730405|531051517|FG003|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|0|||
147240029|NCT00730405|531051518|FG004|Overall Study-Treatment Phase|QTCF: 454 millisecond, withdrew consent|1|||
147240030|NCT00730405|531051514|FG000|Overall Study-Treatment Phase|Atrial fibrillation history|1|||
147240031|NCT00730405|531051515|FG001|Overall Study-Treatment Phase|Atrial fibrillation history|0|||
147240032|NCT00730405|531051516|FG002|Overall Study-Treatment Phase|Atrial fibrillation history|0|||
147240033|NCT00730405|531051517|FG003|Overall Study-Treatment Phase|Atrial fibrillation history|0|||
147240034|NCT00730405|531051518|FG004|Overall Study-Treatment Phase|Atrial fibrillation history|0|||
147240035|NCT00730405|531051514|FG000|Overall Study-follow-up Phase|Adverse Event|2|||
147240036|NCT00730405|531051515|FG001|Overall Study-follow-up Phase|Adverse Event|6|||
147240037|NCT00730405|531051516|FG002|Overall Study-follow-up Phase|Adverse Event|2|||
147240038|NCT00730405|531051517|FG003|Overall Study-follow-up Phase|Adverse Event|3|||
147240039|NCT00730405|531051518|FG004|Overall Study-follow-up Phase|Adverse Event|4|||
147240040|NCT00730405|531051514|FG000|Overall Study-follow-up Phase|Lost to Follow-up|7|||
147240041|NCT00730405|531051515|FG001|Overall Study-follow-up Phase|Lost to Follow-up|6|||
147240042|NCT00730405|531051516|FG002|Overall Study-follow-up Phase|Lost to Follow-up|8|||
147240043|NCT00730405|531051517|FG003|Overall Study-follow-up Phase|Lost to Follow-up|4|||
147240044|NCT00730405|531051518|FG004|Overall Study-follow-up Phase|Lost to Follow-up|6|||
147579988|NCT00452348|532278676|FG000|Overall Study|Withdrawal by Subject|18|||
147579989|NCT00452348|532278677|FG001|Overall Study|Withdrawal by Subject|21|||
147153487|NCT03768089|530724244|FG004|Part C|Randomized, Never Dosed|0|||
147153488|NCT03768089|530724245|FG005|Part C|Randomized, Never Dosed|0|||
147153489|NCT03768089|530724246|FG006|Part C|Randomized, Never Dosed|0|||
147153490|NCT03768089|530724247|FG007|Part C|Randomized, Never Dosed|0|||
147153491|NCT03768089|530724248|FG008|Part C|Randomized, Never Dosed|0|||
147153492|NCT03768089|530724249|FG009|Part C|Randomized, Never Dosed|0|||
147153493|NCT03768089|530724250|FG010|Part C|Randomized, Never Dosed|0|||
147153494|NCT03768089|530724251|FG011|Part C|Randomized, Never Dosed|0|||
147153495|NCT03768089|530724252|FG012|Part C|Randomized, Never Dosed|0|||
147579990|NCT00452348|532278676|FG000|Overall Study|Other|9|||
147579991|NCT00452348|532278677|FG001|Overall Study|Other|9|||
147653445|NCT00313586|532554544|FG002|Overall Study|Absolute neutrophil count not recovered|0|||
147653446|NCT00313586|532554545|FG003|Overall Study|Absolute neutrophil count not recovered|0|||
147653447|NCT00313586|532554542|FG000|Overall Study|Lost insurance|0|||
147653448|NCT00313586|532554543|FG001|Overall Study|Lost insurance|1|||
147653449|NCT00313586|532554544|FG002|Overall Study|Lost insurance|0|||
147653450|NCT00313586|532554545|FG003|Overall Study|Lost insurance|0|||
147653451|NCT00313586|532554542|FG000|Overall Study|Moved|0|||
147653452|NCT00313586|532554543|FG001|Overall Study|Moved|1|||
147653453|NCT00313586|532554544|FG002|Overall Study|Moved|0|||
147653454|NCT00313586|532554545|FG003|Overall Study|Moved|0|||
147653455|NCT00313586|532554542|FG000|Overall Study|Death before starting treatment|1|||
147653456|NCT00313586|532554543|FG001|Overall Study|Death before starting treatment|0|||
147653457|NCT00313586|532554544|FG002|Overall Study|Death before starting treatment|0|||
147653458|NCT00313586|532554545|FG003|Overall Study|Death before starting treatment|0|||
147653459|NCT02087670|532554546|FG000|Overall Study|Withdrawal by Subject|3|||
147653460|NCT02087670|532554547|FG001|Overall Study|Withdrawal by Subject|2|||
147653461|NCT04472494|532554549|FG000|Pre-treatment|Other reasons|2|||
147653462|NCT04472494|532554550|FG001|Pre-treatment|Other reasons|0|||
147653463|NCT04472494|532554549|FG000|Treatment|Death|5|||
147653464|NCT04472494|532554550|FG001|Treatment|Death|2|||
147653465|NCT04472494|532554549|FG000|Treatment|Hospital discharge|1|||
147653466|NCT04472494|532554550|FG001|Treatment|Hospital discharge|1|||
147653467|NCT03519919|532554551|FG000|Overall Study|Withdrawal by Subject|1|||
147653468|NCT03519919|532554551|FG000|Overall Study|Lack of Efficacy|1|||
147653469|NCT03519919|532554551|FG000|Overall Study|Screen Failure|1|||
147653470|NCT03076996|532554552|FG000|Overall Study|Withdrawal by Subject|2|||
147653471|NCT03076996|532554552|FG000|Overall Study|Lost to Follow-up|3|||
147653472|NCT03076996|532554552|FG000|Overall Study|Literacy precluded participation|1|||
147653473|NCT02144077|532554557|FG000|Overall Study|Withdrawal by Subject|3|||
147653474|NCT02144077|532554558|FG001|Overall Study|Withdrawal by Subject|3|||
147653475|NCT02144077|532554557|FG000|Overall Study|Adverse Event|2|||
147653476|NCT02144077|532554558|FG001|Overall Study|Adverse Event|3|||
147653477|NCT02144077|532554557|FG000|Overall Study|Lost to Follow-up|2|||
147653478|NCT02144077|532554558|FG001|Overall Study|Lost to Follow-up|2|||
147653479|NCT02144077|532554557|FG000|Overall Study|Protocol Violation|1|||
147653480|NCT02144077|532554558|FG001|Overall Study|Protocol Violation|2|||
147653481|NCT02144077|532554557|FG000|Overall Study|Death|0|||
147653482|NCT02144077|532554558|FG001|Overall Study|Death|1|||
147321602|NCT01653847|531340097|FG001|Overall Study|Withdrawal by Subject|0|||
147653483|NCT02144077|532554557|FG000|Overall Study|no visits 7 & 8/no visits after visit 4|2|||
147321603|NCT00801242|531340102|FG000|Overall Study|Adverse Event|10|||
147321604|NCT00801242|531340102|FG000|Overall Study|Withdrawal by Subject|13|||
147321605|NCT00801242|531340102|FG000|Overall Study|Protocol Violation|5|||
147321606|NCT00801242|531340102|FG000|Overall Study|Physician Decision|3|||
147321607|NCT00801242|531340102|FG000|Overall Study|Lost to Follow-up|1|||
147321608|NCT00801242|531340102|FG000|Overall Study|Miscellaneous reasons|20|||
147321609|NCT02015195|531340104|FG000|Overall Study|Adverse Event|0|||
147321610|NCT02015195|531340105|FG001|Overall Study|Adverse Event|0|||
147321611|NCT02015195|531340106|FG002|Overall Study|Adverse Event|0|||
147321612|NCT02015195|531340107|FG003|Overall Study|Adverse Event|1|||
147321613|NCT02015195|531340108|FG004|Overall Study|Adverse Event|0|||
147653484|NCT02144077|532554558|FG001|Overall Study|no visits 7 & 8/no visits after visit 4|0|||
147653485|NCT01909973|532554559|FG000|Overall Study|Lost to Follow-up|1|||
147653486|NCT01909973|532554560|FG001|Overall Study|Lost to Follow-up|0|||
147653487|NCT00169104|532554563|FG000|Overall Study|Withdrawal by Subject|2|||
147653488|NCT00169104|532554564|FG001|Overall Study|Withdrawal by Subject|0|||
147653489|NCT00169104|532554563|FG000|Overall Study|Protocol Violation|0|||
147653490|NCT00169104|532554564|FG001|Overall Study|Protocol Violation|1|||
147653491|NCT00169104|532554563|FG000|Overall Study|Physician Decision|0|||
147653492|NCT00169104|532554564|FG001|Overall Study|Physician Decision|1|||
147321614|NCT02015195|531340109|FG005|Overall Study|Adverse Event|0|||
147321615|NCT02015195|531340110|FG006|Overall Study|Adverse Event|0|||
147321616|NCT00131911|531340111|FG000|Overall Study|Withdrawal by Subject|1|||
147321617|NCT00131911|531340112|FG001|Overall Study|Withdrawal by Subject|0|||
147321618|NCT02554513|531340113|FG000|First Treatment Phase (7 Weeks)|Withdrawal by Subject|0|||
147321619|NCT02554513|531340114|FG001|First Treatment Phase (7 Weeks)|Withdrawal by Subject|1|||
147321620|NCT01606189|531340117|FG000|Second Intenvention (14-20 Days)|Adverse Event|0|||
147321621|NCT01606189|531340118|FG001|Second Intenvention (14-20 Days)|Adverse Event|0|||
147653493|NCT00715299|532554572|FG000|Overall Study|Withdrawal by Subject|1|||
147653494|NCT00715299|532554572|FG000|Overall Study|Adverse Event|3|||
147653495|NCT00715299|532554572|FG000|Overall Study|failed the pre-screen exercise test|2|||
147653496|NCT02020889|532554573|FG000|Overall Study|Adverse Event|0|||
147653497|NCT02020889|532554574|FG001|Overall Study|Adverse Event|1|||
147653498|NCT02020889|532554573|FG000|Overall Study|Lack of Efficacy|1|||
147653499|NCT02020889|532554574|FG001|Overall Study|Lack of Efficacy|0|||
147653500|NCT02020889|532554573|FG000|Overall Study|Lost to Follow-up|1|||
147653501|NCT02020889|532554574|FG001|Overall Study|Lost to Follow-up|0|||
147653502|NCT02020889|532554573|FG000|Overall Study|Physician Decision|2|||
147579992|NCT02655224|532278681|FG000|Overall Study|Adverse Event|1|||
147579993|NCT02655224|532278682|FG001|Overall Study|Adverse Event|1|||
147579994|NCT01119625|532278683|FG000|Overall Study|Lost to Follow-up|1|||
147579995|NCT01119625|532278684|FG001|Overall Study|Lost to Follow-up|2|||
147579996|NCT01119625|532278683|FG000|Overall Study|Withdrawal by Subject|2|||
147579997|NCT01119625|532278684|FG001|Overall Study|Withdrawal by Subject|1|||
147579998|NCT01119625|532278683|FG000|Overall Study|Other|0|||
147579999|NCT01119625|532278684|FG001|Overall Study|Other|1|||
147580000|NCT03073798|532278687|FG000|Overall Study|Adverse Event|1|||
147580001|NCT03073798|532278687|FG000|Overall Study|Withdrawal by Subject|1|||
147580002|NCT02372006|532278693|FG000|Overall Study|Progressive disease|8|||
147580003|NCT02372006|532278694|FG001|Overall Study|Progressive disease|7|||
147580004|NCT02372006|532278695|FG002|Overall Study|Progressive disease|34|||
147580005|NCT02372006|532278693|FG000|Overall Study|Dose limiting toxicity|0|||
147580006|NCT02372006|532278694|FG001|Overall Study|Dose limiting toxicity|1|||
147580007|NCT02372006|532278695|FG002|Overall Study|Dose limiting toxicity|0|||
147580008|NCT02372006|532278693|FG000|Overall Study|Adverse Event|0|||
147580009|NCT02372006|532278694|FG001|Overall Study|Adverse Event|0|||
147580010|NCT02372006|532278695|FG002|Overall Study|Adverse Event|3|||
147580011|NCT02372006|532278693|FG000|Overall Study|Withdrawal by Subject|0|||
147580012|NCT02372006|532278694|FG001|Overall Study|Withdrawal by Subject|1|||
147580013|NCT02372006|532278695|FG002|Overall Study|Withdrawal by Subject|1|||
147580014|NCT02372006|532278693|FG000|Overall Study|Other reason for not completing|0|||
147580015|NCT02372006|532278694|FG001|Overall Study|Other reason for not completing|0|||
147580016|NCT02372006|532278695|FG002|Overall Study|Other reason for not completing|1|||
147580017|NCT02611362|532278700|FG000|Overall Study|Withdrawal by Subject|7|||
147580018|NCT02611362|532278701|FG001|Overall Study|Withdrawal by Subject|2|||
147580019|NCT02611362|532278700|FG000|Overall Study|Lost to Follow-up|2|||
147580020|NCT02611362|532278701|FG001|Overall Study|Lost to Follow-up|4|||
147580021|NCT02229084|532278703|FG000|Overall Study|Adverse Event|1|||
147580022|NCT02229084|532278704|FG001|Overall Study|Adverse Event|0|||
147580023|NCT02229084|532278705|FG002|Overall Study|Adverse Event|0|||
147580024|NCT02229084|532278706|FG003|Overall Study|Adverse Event|0|||
147580025|NCT02229084|532278707|FG004|Overall Study|Adverse Event|0|||
147580026|NCT02229084|532278708|FG005|Overall Study|Adverse Event|0|||
147580027|NCT02229084|532278709|FG006|Overall Study|Adverse Event|0|||
147580028|NCT02229084|532278703|FG000|Overall Study|Lost to Follow-up|0|||
147580029|NCT02229084|532278704|FG001|Overall Study|Lost to Follow-up|0|||
147580030|NCT02229084|532278705|FG002|Overall Study|Lost to Follow-up|1|||
147580031|NCT02229084|532278706|FG003|Overall Study|Lost to Follow-up|1|||
147580032|NCT02229084|532278707|FG004|Overall Study|Lost to Follow-up|0|||
147580033|NCT02229084|532278708|FG005|Overall Study|Lost to Follow-up|0|||
147580034|NCT02229084|532278709|FG006|Overall Study|Lost to Follow-up|1|||
147580035|NCT02229084|532278703|FG000|Overall Study|Physician Decision|0|||
147153496|NCT03768089|530724253|FG013|Part C|Randomized, Never Dosed|0|||
147321622|NCT01606189|531340119|FG002|Second Intenvention (14-20 Days)|Adverse Event|0|||
147580036|NCT02229084|532278704|FG001|Overall Study|Physician Decision|0|||
147580037|NCT02229084|532278705|FG002|Overall Study|Physician Decision|0|||
147580038|NCT02229084|532278706|FG003|Overall Study|Physician Decision|1|||
147580039|NCT02229084|532278707|FG004|Overall Study|Physician Decision|3|||
147580040|NCT02229084|532278708|FG005|Overall Study|Physician Decision|0|||
147580041|NCT02229084|532278709|FG006|Overall Study|Physician Decision|1|||
147580042|NCT02229084|532278703|FG000|Overall Study|Withdrawal by Subject|0|||
147580043|NCT02229084|532278704|FG001|Overall Study|Withdrawal by Subject|0|||
147580044|NCT02229084|532278705|FG002|Overall Study|Withdrawal by Subject|1|||
147580045|NCT02229084|532278706|FG003|Overall Study|Withdrawal by Subject|0|||
147580046|NCT02229084|532278707|FG004|Overall Study|Withdrawal by Subject|1|||
147580047|NCT02229084|532278708|FG005|Overall Study|Withdrawal by Subject|1|||
147580048|NCT02229084|532278709|FG006|Overall Study|Withdrawal by Subject|1|||
147580049|NCT02229084|532278703|FG000|Overall Study|Death|0|||
147580050|NCT02229084|532278704|FG001|Overall Study|Death|0|||
147580051|NCT02229084|532278705|FG002|Overall Study|Death|0|||
147580052|NCT02229084|532278706|FG003|Overall Study|Death|0|||
147580053|NCT02229084|532278707|FG004|Overall Study|Death|0|||
147580054|NCT02229084|532278708|FG005|Overall Study|Death|0|||
147580055|NCT02229084|532278709|FG006|Overall Study|Death|1|||
147580056|NCT01559116|532278719|FG000|Overall Study|Adverse Event|10|||
147580057|NCT01559116|532278719|FG000|Overall Study|Lack of Efficacy|1|||
147153497|NCT03768089|530724254|FG014|Part C|Randomized, Never Dosed|1|||
147153498|NCT03768089|530724255|FG015|Part C|Randomized, Never Dosed|0|||
147321623|NCT01606189|531340120|FG003|Second Intenvention (14-20 Days)|Adverse Event|0|||
147580058|NCT01559116|532278719|FG000|Overall Study|Lost to Follow-up|1|||
147580059|NCT01559116|532278719|FG000|Overall Study|Protocol Violation|1|||
147580060|NCT01559116|532278719|FG000|Overall Study|Withdrawal by Subject|4|||
147580061|NCT01559116|532278719|FG000|Overall Study|other than stated above|9|||
147580062|NCT04610580|532278720|FG000|Two-way Crossover Period|Adverse Event|1|||
147580063|NCT04610580|532278721|FG001|Two-way Crossover Period|Adverse Event|0|||
147580064|NCT04610580|532278722|FG002|Two-way Crossover Period|Adverse Event|0|||
147580065|NCT04610580|532278723|FG003|Two-way Crossover Period|Adverse Event|0|||
147153499|NCT03768089|530724256|FG016|Part C|Randomized, Never Dosed|0|||
147153500|NCT03768089|530724257|FG017|Part C|Randomized, Never Dosed|0|||
147446311|NCT02700997|531798917|FG000|Overall Study|Did not undergo CT imaging|1|||
147446312|NCT02700997|531798917|FG000|Overall Study|No CT measurement - pelvic calcification|1|||
147446313|NCT00506883|531798922|FG000|Overall Study|Lost to Follow-up|1|||
147446314|NCT00506883|531798923|FG001|Overall Study|Lost to Follow-up|1|||
147153505|NCT04154605|530724262|FG000|Overall Study|Procedure Canceled|1|||
147153506|NCT04154605|530724263|FG001|Overall Study|Procedure Canceled|1|||
147153507|NCT04154605|530724262|FG000|Overall Study|Missed follow up|1|||
147153508|NCT04154605|530724263|FG001|Overall Study|Missed follow up|1|||
147153509|NCT04154605|530724262|FG000|Overall Study|Withdrawal by Subject|1|||
147153510|NCT04154605|530724263|FG001|Overall Study|Withdrawal by Subject|0|||
147153511|NCT00675441|530724266|FG000|Overall Study|Withdrawal by Subject|2|||
147153512|NCT00675441|530724266|FG000|Overall Study|Death|1|||
147153513|NCT04154293|530724271|FG000|Overall Study|Withdrawal by Subject|2|||
147153514|NCT04154293|530724272|FG001|Overall Study|Withdrawal by Subject|3|||
147153515|NCT04154293|530724273|FG002|Overall Study|Withdrawal by Subject|1|||
147153516|NCT04154293|530724271|FG000|Overall Study|Physician Decision|0|||
147153517|NCT04154293|530724272|FG001|Overall Study|Physician Decision|0|||
147153518|NCT04154293|530724273|FG002|Overall Study|Physician Decision|1|||
147153519|NCT03703817|530724275|FG000|Overall Study|Not meeting eligibility criteria|7|||
147153520|NCT03703817|530724276|FG001|Overall Study|Not meeting eligibility criteria|4|||
147153521|NCT03194568|530724279|FG000|Overall Study|Withdrawn due to need for re-operation related to an anticipated device SAE|4|||
147153522|NCT03515551|530724282|FG000|Overall Study|Death|4|||
147153523|NCT03515551|530724283|FG001|Overall Study|Death|1|||
147580066|NCT04610580|532278724|FG004|Two-way Crossover Period|Adverse Event|0|||
147580067|NCT04610580|532278725|FG005|Two-way Crossover Period|Adverse Event|0|||
147580068|NCT04610580|532278720|FG000|Two-way Crossover Period|Physician Decision|1|||
147580069|NCT04610580|532278721|FG001|Two-way Crossover Period|Physician Decision|0|||
147580070|NCT04610580|532278722|FG002|Two-way Crossover Period|Physician Decision|0|||
147580071|NCT04610580|532278723|FG003|Two-way Crossover Period|Physician Decision|0|||
147580072|NCT04610580|532278724|FG004|Two-way Crossover Period|Physician Decision|0|||
147580073|NCT04610580|532278725|FG005|Two-way Crossover Period|Physician Decision|0|||
147580074|NCT04610580|532278720|FG000|Two-way Crossover Period|Withdrawal by Subject|0|||
147580075|NCT04610580|532278721|FG001|Two-way Crossover Period|Withdrawal by Subject|1|||
147580076|NCT04610580|532278722|FG002|Two-way Crossover Period|Withdrawal by Subject|0|||
147580077|NCT04610580|532278723|FG003|Two-way Crossover Period|Withdrawal by Subject|0|||
147580078|NCT04610580|532278724|FG004|Two-way Crossover Period|Withdrawal by Subject|0|||
147580079|NCT04610580|532278725|FG005|Two-way Crossover Period|Withdrawal by Subject|0|||
147580080|NCT04610580|532278720|FG000|Two-way Crossover Period|Other than specified|0|||
147580081|NCT04610580|532278721|FG001|Two-way Crossover Period|Other than specified|1|||
147580082|NCT04610580|532278722|FG002|Two-way Crossover Period|Other than specified|0|||
147580083|NCT04610580|532278723|FG003|Two-way Crossover Period|Other than specified|0|||
147580084|NCT04610580|532278724|FG004|Two-way Crossover Period|Other than specified|0|||
147580085|NCT04610580|532278725|FG005|Two-way Crossover Period|Other than specified|0|||
147580086|NCT04610580|532278720|FG000|Washout Before Extension Period|Other than specified|0|||
147580087|NCT04610580|532278721|FG001|Washout Before Extension Period|Other than specified|1|||
147580088|NCT04610580|532278722|FG002|Washout Before Extension Period|Other than specified|0|||
147580089|NCT04610580|532278723|FG003|Washout Before Extension Period|Other than specified|0|||
147153524|NCT03515551|530724284|FG002|Overall Study|Death|2|||
147153525|NCT03515551|530724285|FG003|Overall Study|Death|2|||
147153526|NCT03515551|530724286|FG004|Overall Study|Death|2|||
147153527|NCT03515551|530724287|FG005|Overall Study|Death|4|||
147153528|NCT03515551|530724288|FG006|Overall Study|Death|1|||
147153529|NCT03515551|530724282|FG000|Overall Study|Lost to Follow-up|0|||
147153530|NCT03515551|530724283|FG001|Overall Study|Lost to Follow-up|0|||
147153531|NCT03515551|530724284|FG002|Overall Study|Lost to Follow-up|1|||
147153532|NCT03515551|530724285|FG003|Overall Study|Lost to Follow-up|0|||
147153533|NCT03515551|530724286|FG004|Overall Study|Lost to Follow-up|0|||
147153534|NCT03515551|530724287|FG005|Overall Study|Lost to Follow-up|0|||
147153535|NCT03515551|530724288|FG006|Overall Study|Lost to Follow-up|0|||
147153536|NCT03515551|530724282|FG000|Overall Study|Withdrawal by Subject|0|||
147446315|NCT00506883|531798924|FG002|Overall Study|Lost to Follow-up|1|||
147153537|NCT03515551|530724283|FG001|Overall Study|Withdrawal by Subject|1|||
147153538|NCT03515551|530724284|FG002|Overall Study|Withdrawal by Subject|0|||
147153539|NCT03515551|530724285|FG003|Overall Study|Withdrawal by Subject|0|||
147153540|NCT03515551|530724286|FG004|Overall Study|Withdrawal by Subject|0|||
147153541|NCT03515551|530724287|FG005|Overall Study|Withdrawal by Subject|0|||
147153542|NCT03515551|530724288|FG006|Overall Study|Withdrawal by Subject|1|||
147153543|NCT03515551|530724282|FG000|Overall Study|Study ended by sponsor|0|||
147153544|NCT03515551|530724283|FG001|Overall Study|Study ended by sponsor|0|||
147153545|NCT03515551|530724284|FG002|Overall Study|Study ended by sponsor|2|||
147153546|NCT03515551|530724285|FG003|Overall Study|Study ended by sponsor|1|||
147153547|NCT03515551|530724286|FG004|Overall Study|Study ended by sponsor|3|||
147580090|NCT04610580|532278724|FG004|Washout Before Extension Period|Other than specified|0|||
147580091|NCT04610580|532278725|FG005|Washout Before Extension Period|Other than specified|0|||
147580092|NCT04610580|532278720|FG000|Washout Before Extension Period|Withdrawal by Subject|0|||
147580093|NCT04610580|532278721|FG001|Washout Before Extension Period|Withdrawal by Subject|2|||
147580094|NCT04610580|532278722|FG002|Washout Before Extension Period|Withdrawal by Subject|0|||
147580095|NCT04610580|532278723|FG003|Washout Before Extension Period|Withdrawal by Subject|0|||
147580096|NCT04610580|532278724|FG004|Washout Before Extension Period|Withdrawal by Subject|0|||
147580097|NCT04610580|532278725|FG005|Washout Before Extension Period|Withdrawal by Subject|0|||
147580098|NCT04610580|532278720|FG000|Dose-Proportionality Extension Period|Lost to Follow-up|0|||
147580099|NCT04610580|532278721|FG001|Dose-Proportionality Extension Period|Lost to Follow-up|0|||
147580100|NCT04610580|532278722|FG002|Dose-Proportionality Extension Period|Lost to Follow-up|0|||
147580101|NCT04610580|532278723|FG003|Dose-Proportionality Extension Period|Lost to Follow-up|0|||
147580102|NCT04610580|532278724|FG004|Dose-Proportionality Extension Period|Lost to Follow-up|1|||
147580103|NCT04610580|532278725|FG005|Dose-Proportionality Extension Period|Lost to Follow-up|0|||
147580104|NCT02179190|532278726|FG000|Enrollment|Exit Prior to Device Attempt|11|||
147580105|NCT02179190|532278726|FG000|Index Procedure With Barrel VRD Attempt|Did not receive Barrel VRD|7|||
147580106|NCT02179190|532278726|FG000|Follow-Up Post Barrel VRD Implanted|Death|3|||
147580107|NCT02179190|532278726|FG000|Follow-Up Post Barrel VRD Implanted|Withdrawal by Subject|3|||
147580108|NCT02179190|532278726|FG000|Follow-Up Post Barrel VRD Implanted|Physician Decision|2|||
147580109|NCT02179190|532278726|FG000|Follow-Up Post Barrel VRD Implanted|Lost to Follow-up|1|||
147580110|NCT00881569|532278729|FG000|Overall Study|Disease progression|1|||
147580111|NCT00881569|532278730|FG001|Overall Study|Disease progression|1|||
147153548|NCT03515551|530724287|FG005|Overall Study|Study ended by sponsor|0|||
147153549|NCT03515551|530724288|FG006|Overall Study|Study ended by sponsor|3|||
147153550|NCT03515551|530724282|FG000|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
147153551|NCT03515551|530724283|FG001|Overall Study|Sequential enrollment in 30-100 mcg cohort|1|||
147153552|NCT03515551|530724284|FG002|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
147153553|NCT03515551|530724285|FG003|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
147153554|NCT03515551|530724286|FG004|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
147153555|NCT03515551|530724287|FG005|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
147153556|NCT03515551|530724288|FG006|Overall Study|Sequential enrollment in 30-100 mcg cohort|0|||
147153557|NCT00920387|530724295|FG000|Stage 1|Adverse Event|1|||
147153558|NCT00920387|530724296|FG001|Stage 1|Adverse Event|0|||
147153559|NCT00920387|530724297|FG002|Stage 1|Adverse Event|0|||
147153560|NCT02241733|530724308|FG000|Overall Study|Lost to Follow-up|9|||
147153561|NCT02241733|530724309|FG001|Overall Study|Lost to Follow-up|4|||
147153562|NCT02241733|530724308|FG000|Overall Study|Physician Decision|6|||
147153563|NCT02241733|530724309|FG001|Overall Study|Physician Decision|2|||
147153564|NCT02241733|530724308|FG000|Overall Study|Withdrawal by Subject|0|||
147153565|NCT02241733|530724309|FG001|Overall Study|Withdrawal by Subject|2|||
147580112|NCT03480022|532278731|FG000|Overall Study|Pregnancy|2|||
147580113|NCT03480022|532278732|FG001|Overall Study|Pregnancy|0|||
147580114|NCT03480022|532278731|FG000|Overall Study|Adverse Event|6|||
147580115|NCT03480022|532278732|FG001|Overall Study|Adverse Event|0|||
147580116|NCT03480022|532278731|FG000|Overall Study|Lack of Efficacy|0|||
147580117|NCT03480022|532278732|FG001|Overall Study|Lack of Efficacy|2|||
147580118|NCT03480022|532278731|FG000|Overall Study|Physician Decision|0|||
147580119|NCT03480022|532278732|FG001|Overall Study|Physician Decision|1|||
147580120|NCT03480022|532278731|FG000|Overall Study|Withdrawal by Subject|2|||
147580121|NCT03480022|532278732|FG001|Overall Study|Withdrawal by Subject|0|||
147580122|NCT03480022|532278731|FG000|Overall Study|Medication concerns|1|||
147580123|NCT03480022|532278732|FG001|Overall Study|Medication concerns|0|||
147580124|NCT03480022|532278731|FG000|Overall Study|Family member COVID exposure|0|||
147580125|NCT03480022|532278732|FG001|Overall Study|Family member COVID exposure|1|||
147580126|NCT01670097|532278737|FG000|Overall Study|Started Phase 1 cancer treatment|1|||
147580127|NCT01670097|532278738|FG001|Overall Study|Started Phase 1 cancer treatment|0|||
147580128|NCT01670097|532278737|FG000|Overall Study|Study burden|1|||
147580129|NCT01670097|532278738|FG001|Overall Study|Study burden|0|||
147580130|NCT01670097|532278737|FG000|Overall Study|COPD exacerbation|0|||
147653503|NCT02020889|532554574|FG001|Overall Study|Physician Decision|0|||
147580131|NCT01670097|532278738|FG001|Overall Study|COPD exacerbation|1|||
147580132|NCT01670097|532278737|FG000|Overall Study|Neutropenia|0|||
147580133|NCT01670097|532278738|FG001|Overall Study|Neutropenia|1|||
147580134|NCT01670097|532278737|FG000|Overall Study|Clinical deterioration|0|||
147580135|NCT01670097|532278738|FG001|Overall Study|Clinical deterioration|1|||
147580136|NCT01670097|532278737|FG000|Overall Study|Disease progression|0|||
147580137|NCT01670097|532278738|FG001|Overall Study|Disease progression|1|||
147580138|NCT03259165|532278739|FG000|Overall Study|COVID 19 pandemic|1|||
147153566|NCT02241733|530724308|FG000|Overall Study|Death|0|||
147153567|NCT02241733|530724309|FG001|Overall Study|Death|2|||
147580139|NCT03259165|532278740|FG001|Overall Study|COVID 19 pandemic|1|||
147153568|NCT01866111|530724310|FG000|Double-blind Period of Study YKP3089C017|Adverse Event|5|||
147153569|NCT01866111|530724311|FG001|Double-blind Period of Study YKP3089C017|Adverse Event|12|||
147580140|NCT01949532|532278741|FG000|Overall Study|On-study at the Data Cut-off Date|3|||
147580141|NCT01949532|532278742|FG001|Overall Study|On-study at the Data Cut-off Date|3|||
147580142|NCT05665387|532278743|FG000|Overall Study|Withdrawal by Subject|1|||
147580143|NCT05665387|532278744|FG001|Overall Study|Withdrawal by Subject|0|||
147580144|NCT05665387|532278745|FG002|Overall Study|Withdrawal by Subject|1|||
147580145|NCT00884390|532278746|FG000|Overall Study|Adverse Event|0|||
147580146|NCT00884390|532278747|FG001|Overall Study|Adverse Event|1|||
147580147|NCT00884390|532278746|FG000|Overall Study|Lost to Follow-up|0|||
147580148|NCT00884390|532278747|FG001|Overall Study|Lost to Follow-up|1|||
147580149|NCT00884390|532278746|FG000|Overall Study|Physician Decision|2|||
147580150|NCT00884390|532278747|FG001|Overall Study|Physician Decision|1|||
147580151|NCT00884390|532278746|FG000|Overall Study|Protocol Violation|4|||
147580152|NCT00884390|532278747|FG001|Overall Study|Protocol Violation|1|||
147580153|NCT00884390|532278746|FG000|Overall Study|Withdrawal by Subject|4|||
147580154|NCT00884390|532278747|FG001|Overall Study|Withdrawal by Subject|1|||
147580155|NCT00884390|532278746|FG000|Overall Study|Discontinuation of Study by Sponsor|2|||
147580156|NCT00884390|532278747|FG001|Overall Study|Discontinuation of Study by Sponsor|2|||
147240045|NCT00730405|531051514|FG000|Overall Study-follow-up Phase|Withdrawal by Subject|7|||
147240046|NCT00730405|531051515|FG001|Overall Study-follow-up Phase|Withdrawal by Subject|3|||
147240047|NCT00730405|531051516|FG002|Overall Study-follow-up Phase|Withdrawal by Subject|3|||
147240048|NCT00730405|531051517|FG003|Overall Study-follow-up Phase|Withdrawal by Subject|6|||
147240049|NCT00730405|531051518|FG004|Overall Study-follow-up Phase|Withdrawal by Subject|10|||
147240050|NCT00730405|531051514|FG000|Overall Study-follow-up Phase|Death|0|||
147240051|NCT00730405|531051515|FG001|Overall Study-follow-up Phase|Death|1|||
147240052|NCT00730405|531051516|FG002|Overall Study-follow-up Phase|Death|0|||
147240053|NCT00730405|531051517|FG003|Overall Study-follow-up Phase|Death|1|||
147240054|NCT00730405|531051518|FG004|Overall Study-follow-up Phase|Death|0|||
147240055|NCT00730405|531051514|FG000|Overall Study-follow-up Phase|Change of location|1|||
147240056|NCT00730405|531051515|FG001|Overall Study-follow-up Phase|Change of location|1|||
147240057|NCT00730405|531051516|FG002|Overall Study-follow-up Phase|Change of location|0|||
147240058|NCT00730405|531051517|FG003|Overall Study-follow-up Phase|Change of location|1|||
147240059|NCT00730405|531051518|FG004|Overall Study-follow-up Phase|Change of location|0|||
147580157|NCT00884390|532278746|FG000|Overall Study|Other|11|||
147580158|NCT00884390|532278747|FG001|Overall Study|Other|1|||
147580159|NCT03980522|532278751|FG000|Treatment Period|Adverse Event|1|||
147580160|NCT03980522|532278752|FG001|Treatment Period|Adverse Event|0|||
147580161|NCT03980522|532278753|FG002|Treatment Period|Adverse Event|0|||
147580162|NCT03980522|532278754|FG003|Treatment Period|Adverse Event|0|||
147580163|NCT03980522|532278755|FG004|Treatment Period|Adverse Event|0|||
147580164|NCT01091363|532278756|FG000|Overall Study|Withdrawal by Subject|11|||
147580165|NCT01091363|532278757|FG001|Overall Study|Withdrawal by Subject|15|||
147580166|NCT01091363|532278756|FG000|Overall Study|Lost to Follow-up|2|||
147580167|NCT01091363|532278757|FG001|Overall Study|Lost to Follow-up|2|||
147580168|NCT01874535|532278758|FG000|Overall Study|Lost to Follow-up|10|||
147580169|NCT01874535|532278759|FG001|Overall Study|Lost to Follow-up|9|||
147580170|NCT01874535|532278758|FG000|Overall Study|incomplete symptom resolution|45|||
147580171|NCT01874535|532278759|FG001|Overall Study|incomplete symptom resolution|35|||
147580172|NCT01215721|532278760|FG000|Overall Study|Adverse Event|2|||
147580173|NCT00045162|532278761|FG000|Overall Study|Ineligible|12|||
147580174|NCT00045162|532278762|FG001|Overall Study|Ineligible|8|||
147580175|NCT00045162|532278761|FG000|Overall Study|Not treated|7|||
147580176|NCT00045162|532278762|FG001|Overall Study|Not treated|2|||
147580177|NCT00045162|532278761|FG000|Overall Study|Adverse Event|55|||
147580178|NCT00045162|532278762|FG001|Overall Study|Adverse Event|50|||
147580179|NCT00045162|532278761|FG000|Overall Study|Lack of Efficacy|32|||
147580180|NCT00045162|532278762|FG001|Overall Study|Lack of Efficacy|29|||
147580181|NCT00045162|532278761|FG000|Overall Study|Death|10|||
147580182|NCT00045162|532278762|FG001|Overall Study|Death|10|||
147580183|NCT00045162|532278761|FG000|Overall Study|Withdrawal by Subject|5|||
147580184|NCT00045162|532278762|FG001|Overall Study|Withdrawal by Subject|3|||
147580185|NCT00045162|532278761|FG000|Overall Study|Other|21|||
147580186|NCT00045162|532278762|FG001|Overall Study|Other|16|||
147580187|NCT01044433|532278763|FG000|Overall Study|Lost to Follow-up|3|||
147580188|NCT01044433|532278763|FG000|Overall Study|Withdrawal by Subject|3|||
147580189|NCT02616380|532278764|FG000|Overall Study|Lost to Follow-up|1|||
147580190|NCT02616380|532278764|FG000|Overall Study|Other|2|||
147580191|NCT00939523|532278769|FG000|Overall Study|Lack of Efficacy|1|||
147240060|NCT00730405|531051514|FG000|Overall Study-follow-up Phase|Did not met eligibility|0|||
147240061|NCT00730405|531051515|FG001|Overall Study-follow-up Phase|Did not met eligibility|0|||
147321624|NCT01606189|531340121|FG004|Second Intenvention (14-20 Days)|Adverse Event|0|||
147580192|NCT00939523|532278769|FG000|Overall Study|Physician Decision|2|||
147580193|NCT00024258|532278770|FG000|Overall Study|Withdrawal by Subject|1|||
147580194|NCT00024258|532278770|FG000|Overall Study|Disease Progression|8|||
147580195|NCT00442351|532280236|FG000|Overall Study|Administrative|6|||
147580196|NCT00442351|532280237|FG001|Overall Study|Administrative|5|||
147580197|NCT00442351|532280236|FG000|Overall Study|Did not meet protocol eligibility|1|||
147580198|NCT00442351|532280237|FG001|Overall Study|Did not meet protocol eligibility|0|||
147580199|NCT00442351|532280236|FG000|Overall Study|Other|0|||
147580200|NCT00442351|532280237|FG001|Overall Study|Other|1|||
147580201|NCT00108628|532280244|FG000|Overall Study|Withdrawal by Subject|17|||
147580202|NCT00108628|532280245|FG001|Overall Study|Withdrawal by Subject|9|||
147580203|NCT00108628|532280244|FG000|Overall Study|Lack of Efficacy|2|||
147580204|NCT00108628|532280245|FG001|Overall Study|Lack of Efficacy|1|||
147580205|NCT00108628|532280244|FG000|Overall Study|Death|1|||
147580206|NCT00108628|532280245|FG001|Overall Study|Death|0|||
147580207|NCT01453153|532280246|FG000|Overall Study|Physician Decision|0|||
147580208|NCT01453153|532280247|FG001|Overall Study|Physician Decision|0|||
147580209|NCT01453153|532280248|FG002|Overall Study|Physician Decision|1|||
147580210|NCT01453153|532280246|FG000|Overall Study|Progressive Disease|3|||
147580211|NCT01453153|532280247|FG001|Overall Study|Progressive Disease|2|||
147580212|NCT01453153|532280248|FG002|Overall Study|Progressive Disease|16|||
147580213|NCT01453153|532280246|FG000|Overall Study|Withdrawal by Subject|0|||
147580214|NCT01453153|532280247|FG001|Overall Study|Withdrawal by Subject|1|||
147580215|NCT01453153|532280248|FG002|Overall Study|Withdrawal by Subject|2|||
147580216|NCT01453153|532280246|FG000|Overall Study|Adverse Event|1|||
147580217|NCT01453153|532280247|FG001|Overall Study|Adverse Event|1|||
147580218|NCT01453153|532280248|FG002|Overall Study|Adverse Event|1|||
147580219|NCT03547635|532280249|FG000|Overall Study|Adverse Event|5|||
147580220|NCT03547635|532280250|FG001|Overall Study|Adverse Event|2|||
147580221|NCT03547635|532280251|FG002|Overall Study|Adverse Event|3|||
147580222|NCT03547635|532280249|FG000|Overall Study|Lost to Follow-up|1|||
147580223|NCT03547635|532280250|FG001|Overall Study|Lost to Follow-up|3|||
147580224|NCT03547635|532280251|FG002|Overall Study|Lost to Follow-up|4|||
147580225|NCT03547635|532280249|FG000|Overall Study|Withdrawal by Subject|1|||
147580226|NCT03547635|532280250|FG001|Overall Study|Withdrawal by Subject|0|||
147580227|NCT03547635|532280251|FG002|Overall Study|Withdrawal by Subject|0|||
147580228|NCT03547635|532280249|FG000|Overall Study|Withdrawal By PI|0|||
147580229|NCT03547635|532280250|FG001|Overall Study|Withdrawal By PI|1|||
147580230|NCT03547635|532280251|FG002|Overall Study|Withdrawal By PI|0|||
147580231|NCT03547635|532280249|FG000|Overall Study|Withdrawal by Sponsor|0|||
147580232|NCT03547635|532280250|FG001|Overall Study|Withdrawal by Sponsor|0|||
147580233|NCT03547635|532280251|FG002|Overall Study|Withdrawal by Sponsor|1|||
147580234|NCT03547635|532280249|FG000|Overall Study|Errant Randomization before Treatment|0|||
147580235|NCT03547635|532280250|FG001|Overall Study|Errant Randomization before Treatment|1|||
147580236|NCT03547635|532280251|FG002|Overall Study|Errant Randomization before Treatment|0|||
147580237|NCT03547635|532280249|FG000|Overall Study|Withdrawal by Subject|1|||
147580238|NCT03547635|532280250|FG001|Overall Study|Withdrawal by Subject|0|||
147580239|NCT03547635|532280251|FG002|Overall Study|Withdrawal by Subject|0|||
147580240|NCT02415387|532280256|FG000|Overall Study|Withdrawal by Subject|6|||
147580241|NCT02415387|532280257|FG001|Overall Study|Withdrawal by Subject|1|||
147580242|NCT02415387|532280256|FG000|Overall Study|blood draw problem|0|||
147580243|NCT02415387|532280257|FG001|Overall Study|blood draw problem|1|||
147580244|NCT02415387|532280256|FG000|Overall Study|Protocol Violation|1|||
147580245|NCT02415387|532280257|FG001|Overall Study|Protocol Violation|0|||
147580246|NCT03035890|532280258|FG000|Overall Study|Death|1|||
147580247|NCT03243396|532280259|FG000|Overall Study|Lost to Follow-up|2|||
147580248|NCT03243396|532280260|FG001|Overall Study|Lost to Follow-up|3|||
147580249|NCT03243396|532280261|FG002|Overall Study|Lost to Follow-up|15|||
147580250|NCT03243396|532280262|FG003|Overall Study|Lost to Follow-up|8|||
147580251|NCT03243396|532280263|FG004|Overall Study|Lost to Follow-up|1|||
147580252|NCT03243396|532280264|FG005|Overall Study|Lost to Follow-up|4|||
147580253|NCT03243396|532280265|FG006|Overall Study|Lost to Follow-up|9|||
147580254|NCT00544167|532280271|FG000|Overall Study|Adverse Event|21|||
147580255|NCT00544167|532280271|FG000|Overall Study|Physician Decision|8|||
147580256|NCT03343639|532280274|FG000|Overall Study|Withdrawal by Subject|10|||
147580257|NCT03343639|532280275|FG001|Overall Study|Withdrawal by Subject|6|||
147580258|NCT03343639|532280274|FG000|Overall Study|Lost to Follow-up|4|||
147580259|NCT03343639|532280275|FG001|Overall Study|Lost to Follow-up|5|||
147580260|NCT03343639|532280274|FG000|Overall Study|Protocol Violation|0|||
147580261|NCT03343639|532280275|FG001|Overall Study|Protocol Violation|1|||
147580262|NCT00735696|532280282|FG000|Overall Study|Withdrawal by Subject|1|||
147580263|NCT00735696|532280282|FG000|Overall Study|Enrolled but never Treated|1|||
147580264|NCT02274558|532280284|FG000|Overall Study|Adverse Event|2|||
147580265|NCT02274558|532280285|FG001|Overall Study|Adverse Event|4|||
147580266|NCT02274558|532280286|FG002|Overall Study|Adverse Event|2|||
147580267|NCT02274558|532280284|FG000|Overall Study|Non-compliance|2|||
147580268|NCT02274558|532280285|FG001|Overall Study|Non-compliance|1|||
147580269|NCT02274558|532280286|FG002|Overall Study|Non-compliance|0|||
147580270|NCT02274558|532280284|FG000|Overall Study|Withdrawal by Subject|1|||
147580271|NCT02274558|532280285|FG001|Overall Study|Withdrawal by Subject|5|||
147580272|NCT02274558|532280286|FG002|Overall Study|Withdrawal by Subject|4|||
147580273|NCT02274558|532280284|FG000|Overall Study|Death|0|||
147580274|NCT02274558|532280285|FG001|Overall Study|Death|0|||
147580275|NCT02274558|532280286|FG002|Overall Study|Death|1|||
147580276|NCT02274558|532280284|FG000|Overall Study|Lost to Follow-up|2|||
147580277|NCT02274558|532280285|FG001|Overall Study|Lost to Follow-up|1|||
147580278|NCT02274558|532280286|FG002|Overall Study|Lost to Follow-up|1|||
147580279|NCT02274558|532280284|FG000|Overall Study|Physician Decision|0|||
147580280|NCT02274558|532280285|FG001|Overall Study|Physician Decision|2|||
147580281|NCT02274558|532280286|FG002|Overall Study|Physician Decision|1|||
147580282|NCT02460835|532280287|FG000|Overall Study|Disease progression prior to treatment|3|||
147653504|NCT02020889|532554573|FG000|Overall Study|Withdrawal by Subject|3|||
147653505|NCT02020889|532554574|FG001|Overall Study|Withdrawal by Subject|2|||
147653506|NCT01540981|532554575|FG000|Overall Study|Withdrawal by Subject|1|||
147653507|NCT01540981|532554576|FG001|Overall Study|Withdrawal by Subject|0|||
147653508|NCT00809094|532554577|FG000|Overall Study|Lost to Follow-up|0|||
147653509|NCT00809094|532554578|FG001|Overall Study|Lost to Follow-up|1|||
147653510|NCT01535443|532554582|FG000|Overall Study|Physician Decision|3|||
147653511|NCT00232557|532554583|FG000|Overall Study|Lost to Follow-up|3|||
147653512|NCT00232557|532554584|FG001|Overall Study|Lost to Follow-up|5|||
147653513|NCT02260817|532554586|FG000|Overall Study|Lost to Follow-up|0|||
147653514|NCT02260817|532554587|FG001|Overall Study|Lost to Follow-up|14|||
147653515|NCT02260817|532554586|FG000|Overall Study|Androgen deprivation therapy, no biopsy|0|||
147653516|NCT02260817|532554587|FG001|Overall Study|Androgen deprivation therapy, no biopsy|7|||
147653517|NCT02260817|532554586|FG000|Overall Study|Observation, no biopsy|0|||
147653518|NCT02260817|532554587|FG001|Overall Study|Observation, no biopsy|1|||
147653519|NCT02260817|532554586|FG000|Overall Study|Biopsy infeasible, ADT & rad. therapy|0|||
147653520|NCT02260817|532554587|FG001|Overall Study|Biopsy infeasible, ADT & rad. therapy|1|||
147653521|NCT02260817|532554586|FG000|Overall Study|Protocol Violation|0|||
147653522|NCT02260817|532554587|FG001|Overall Study|Protocol Violation|14|||
147653523|NCT04435808|532554590|FG000|Overall Study|Study stopped by DSMB|0|||
147653524|NCT04435808|532554591|FG001|Overall Study|Study stopped by DSMB|1|||
147653525|NCT03299101|532554592|FG000|Overall Study|Lost to Follow-up|1|||
147653526|NCT03299101|532554592|FG000|Overall Study|Withdrawal by Subject|5|||
147653527|NCT03299101|532554592|FG000|Overall Study|Surgery was changed|3|||
147653528|NCT03299101|532554592|FG000|Overall Study|Not enough time to complete prehab|1|||
147653529|NCT03882957|532554596|FG000|Overall Study|Did not complete all three arms|1|||
147653530|NCT03337048|532554597|FG000|Overall Study|Withdrawal by Subject|2|||
147653531|NCT03337048|532554598|FG001|Overall Study|Withdrawal by Subject|0|||
147653532|NCT03337048|532554599|FG002|Overall Study|Withdrawal by Subject|0|||
147653533|NCT04399538|532554601|FG000|Double-Blind Treatment|Work schedule conflicts|0|||
147653534|NCT04399538|532554602|FG001|Double-Blind Treatment|Work schedule conflicts|0|||
147653535|NCT04399538|532554603|FG002|Double-Blind Treatment|Work schedule conflicts|0|||
147653536|NCT04399538|532554604|FG003|Double-Blind Treatment|Work schedule conflicts|1|||
147653537|NCT04399538|532554605|FG004|Double-Blind Treatment|Work schedule conflicts|1|||
147653538|NCT04399538|532554601|FG000|Double-Blind Treatment|Adverse Event|0|||
147653539|NCT04399538|532554602|FG001|Double-Blind Treatment|Adverse Event|0|||
147653540|NCT04399538|532554603|FG002|Double-Blind Treatment|Adverse Event|0|||
147653541|NCT04399538|532554604|FG003|Double-Blind Treatment|Adverse Event|0|||
147653542|NCT04399538|532554605|FG004|Double-Blind Treatment|Adverse Event|1|||
147653543|NCT04399538|532554601|FG000|Follow-Up|Adverse Event|0|||
147653544|NCT04399538|532554602|FG001|Follow-Up|Adverse Event|0|||
147653545|NCT04399538|532554603|FG002|Follow-Up|Adverse Event|0|||
147653546|NCT04399538|532554604|FG003|Follow-Up|Adverse Event|0|||
147653547|NCT04399538|532554605|FG004|Follow-Up|Adverse Event|1|||
147653548|NCT04399538|532554601|FG000|Follow-Up|Withdrawal by Subject|0|||
147653549|NCT04399538|532554602|FG001|Follow-Up|Withdrawal by Subject|0|||
147653550|NCT04399538|532554603|FG002|Follow-Up|Withdrawal by Subject|0|||
147580283|NCT02460835|532280287|FG000|Overall Study|Unable to complete planning scans|2|||
147580284|NCT02460835|532280287|FG000|Overall Study|Decrease in performance status|1|||
147580285|NCT02460835|532280287|FG000|Overall Study|Withdrawal by Subject|3|||
147580286|NCT02460835|532280287|FG000|Overall Study|Underwent fractionated RT|10|||
147580287|NCT02460835|532280287|FG000|Overall Study|Unable to complete follow-up lab draws|2|||
147580288|NCT02733627|532280294|FG000|Overall Study|Adverse Event|0|||
147580289|NCT02733627|532280295|FG001|Overall Study|Adverse Event|1|||
147580290|NCT02733627|532280296|FG002|Overall Study|Adverse Event|1|||
147580291|NCT02733627|532280297|FG003|Overall Study|Adverse Event|0|||
147580292|NCT02733627|532280294|FG000|Overall Study|Withdrawn due laboratory reason concerning neutrophils in agreement with the sponsor|0|||
147580293|NCT02733627|532280295|FG001|Overall Study|Withdrawn due laboratory reason concerning neutrophils in agreement with the sponsor|0|||
147580294|NCT02733627|532280296|FG002|Overall Study|Withdrawn due laboratory reason concerning neutrophils in agreement with the sponsor|1|||
147580295|NCT02733627|532280297|FG003|Overall Study|Withdrawn due laboratory reason concerning neutrophils in agreement with the sponsor|0|||
147653551|NCT04399538|532554604|FG003|Follow-Up|Withdrawal by Subject|2|||
147653552|NCT04399538|532554605|FG004|Follow-Up|Withdrawal by Subject|0|||
147653553|NCT00893971|532554606|FG000|Overall Study|Physician Decision|3|||
147653554|NCT00492232|532554607|FG000|Placebo Run-in|Adverse Event|0|||
147653555|NCT00492232|532554608|FG001|Placebo Run-in|Adverse Event|2|||
147653556|NCT00492232|532554607|FG000|Placebo Run-in|Protocol Violation|0|||
147653557|NCT00492232|532554608|FG001|Placebo Run-in|Protocol Violation|3|||
147653558|NCT00492232|532554607|FG000|Placebo Run-in|Lost to Follow-up|0|||
147653559|NCT00492232|532554608|FG001|Placebo Run-in|Lost to Follow-up|3|||
147653560|NCT00492232|532554607|FG000|Placebo Run-in|Withdrawal by Subject|0|||
147653561|NCT00492232|532554608|FG001|Placebo Run-in|Withdrawal by Subject|8|||
147580296|NCT00059332|532280298|FG000|Overall Study|Withdrawal by Subject|2|||
147580297|NCT00059332|532280299|FG001|Overall Study|Withdrawal by Subject|1|||
147580298|NCT00059332|532280298|FG000|Overall Study|Lost to Follow-up|1|||
147580299|NCT00059332|532280299|FG001|Overall Study|Lost to Follow-up|1|||
147580300|NCT02483416|532280300|FG000|Overall Study|Other reason|0|||
147580301|NCT02483416|532280301|FG001|Overall Study|Other reason|1|||
147580302|NCT02483416|532280300|FG000|Overall Study|Treatment stop|3|||
147580303|NCT02483416|532280301|FG001|Overall Study|Treatment stop|0|||
147580304|NCT02587143|532280302|FG000|Overall Study|Adverse Event|1|||
147580305|NCT02587143|532280303|FG001|Overall Study|Adverse Event|0|||
147580306|NCT02754492|532280304|FG000|Overall Study|Protocol Violation|2|||
147580307|NCT02754492|532280305|FG001|Overall Study|Protocol Violation|2|||
147580308|NCT02754492|532280306|FG002|Overall Study|Protocol Violation|0|||
147580309|NCT02754492|532280307|FG003|Overall Study|Protocol Violation|1|||
147580310|NCT02754492|532280304|FG000|Overall Study|Withdrawal by Subject|2|||
147580311|NCT02754492|532280305|FG001|Overall Study|Withdrawal by Subject|0|||
147580312|NCT02754492|532280306|FG002|Overall Study|Withdrawal by Subject|0|||
147580313|NCT02754492|532280307|FG003|Overall Study|Withdrawal by Subject|0|||
147580314|NCT02754492|532280304|FG000|Overall Study|Equipment malfuntion|0|||
147580315|NCT02754492|532280305|FG001|Overall Study|Equipment malfuntion|0|||
147580316|NCT02754492|532280306|FG002|Overall Study|Equipment malfuntion|2|||
147580317|NCT02754492|532280307|FG003|Overall Study|Equipment malfuntion|5|||
147580318|NCT02754492|532280304|FG000|Overall Study|Adverse Event|0|||
147580319|NCT02754492|532280305|FG001|Overall Study|Adverse Event|0|||
147580320|NCT02754492|532280306|FG002|Overall Study|Adverse Event|0|||
147580321|NCT02754492|532280307|FG003|Overall Study|Adverse Event|13|||
147580322|NCT02754492|532280304|FG000|Overall Study|Venous access issues not resulting in AE|0|||
147580323|NCT02754492|532280305|FG001|Overall Study|Venous access issues not resulting in AE|0|||
147580324|NCT02754492|532280306|FG002|Overall Study|Venous access issues not resulting in AE|0|||
147580325|NCT02754492|532280307|FG003|Overall Study|Venous access issues not resulting in AE|4|||
147580326|NCT00487695|532280308|FG000|First Procedure|invasive cancer on EGD (excl criteria)|1|||
147580327|NCT00487695|532280309|FG001|First Procedure|invasive cancer on EGD (excl criteria)|0|||
147580328|NCT00487695|532280308|FG000|First Procedure|active wheezing (did not have procedure)|1|||
147580329|NCT00487695|532280309|FG001|First Procedure|active wheezing (did not have procedure)|0|||
147580330|NCT00487695|532280308|FG000|First Procedure|esophageal stricture found (excl crit)|1|||
147580331|NCT00487695|532280309|FG001|First Procedure|esophageal stricture found (excl crit)|0|||
147580332|NCT00487695|532280308|FG000|Second Procedure|active wheezing|0|||
147580333|NCT00487695|532280309|FG001|Second Procedure|active wheezing|1|||
147580334|NCT00487695|532280308|FG000|Second Procedure|Withdrawal by Subject|1|||
147580335|NCT00487695|532280309|FG001|Second Procedure|Withdrawal by Subject|2|||
147580336|NCT01186458|532280314|FG000|Overall Study|Adverse Event|1|||
147580337|NCT04281472|532280315|FG000|Stage A|Lack of Efficacy|8|||
147580338|NCT04281472|532280316|FG001|Stage A|Lack of Efficacy|0|||
147580339|NCT04281472|532280317|FG002|Stage A|Lack of Efficacy|0|||
147580340|NCT04281472|532280315|FG000|Stage A|All events required for primary analysis achieved (rolled over to ARGX-1113-1902)|22|||
147580341|NCT04281472|532280316|FG001|Stage A|All events required for primary analysis achieved (rolled over to ARGX-1113-1902)|0|||
147580342|NCT04281472|532280317|FG002|Stage A|All events required for primary analysis achieved (rolled over to ARGX-1113-1902)|0|||
147580343|NCT04281472|532280315|FG000|Stage A|Adverse Event|20|||
147580344|NCT04281472|532280316|FG001|Stage A|Adverse Event|0|||
147580345|NCT04281472|532280317|FG002|Stage A|Adverse Event|0|||
147580346|NCT04281472|532280315|FG000|Stage A|Death|1|||
147240062|NCT00730405|531051516|FG002|Overall Study-follow-up Phase|Did not met eligibility|1|||
147240063|NCT00730405|531051517|FG003|Overall Study-follow-up Phase|Did not met eligibility|0|||
147240064|NCT00730405|531051518|FG004|Overall Study-follow-up Phase|Did not met eligibility|0|||
147240065|NCT00730405|531051514|FG000|Overall Study-follow-up Phase|Non-compliance with study treatment|0|||
147240066|NCT00730405|531051515|FG001|Overall Study-follow-up Phase|Non-compliance with study treatment|0|||
147240067|NCT00730405|531051516|FG002|Overall Study-follow-up Phase|Non-compliance with study treatment|1|||
147240068|NCT00730405|531051517|FG003|Overall Study-follow-up Phase|Non-compliance with study treatment|0|||
147240069|NCT00730405|531051518|FG004|Overall Study-follow-up Phase|Non-compliance with study treatment|0|||
147240070|NCT00730405|531051514|FG000|Overall Study-follow-up Phase|Participant meets exclusion criteria|0|||
147240071|NCT00730405|531051515|FG001|Overall Study-follow-up Phase|Participant meets exclusion criteria|0|||
147240072|NCT00730405|531051516|FG002|Overall Study-follow-up Phase|Participant meets exclusion criteria|1|||
147249863|NCT01018186|531083795|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
147249864|NCT01018186|531083796|FG003|2-week Run-in Period|Withdrawal by Subject|0|||
147580347|NCT04281472|532280316|FG001|Stage A|Death|0|||
147580348|NCT04281472|532280317|FG002|Stage A|Death|0|||
147580349|NCT04281472|532280315|FG000|Stage A|Lack of efficacy before end of Stage A|28|||
147580350|NCT04281472|532280316|FG001|Stage A|Lack of efficacy before end of Stage A|0|||
147580351|NCT04281472|532280317|FG002|Stage A|Lack of efficacy before end of Stage A|0|||
147580352|NCT04281472|532280315|FG000|Stage A|Lost to Follow-up|2|||
147580353|NCT04281472|532280316|FG001|Stage A|Lost to Follow-up|0|||
147580354|NCT04281472|532280317|FG002|Stage A|Lost to Follow-up|0|||
147580355|NCT04281472|532280315|FG000|Stage A|Non-compliance with study drug|1|||
147580356|NCT04281472|532280316|FG001|Stage A|Non-compliance with study drug|0|||
147321625|NCT01606189|531340122|FG005|Second Intenvention (14-20 Days)|Adverse Event|1|||
147321626|NCT01606189|531340117|FG000|Third Intenvention (14-20 Days)|Withdrawal by Subject|0|||
147321627|NCT01606189|531340118|FG001|Third Intenvention (14-20 Days)|Withdrawal by Subject|0|||
147321628|NCT01606189|531340119|FG002|Third Intenvention (14-20 Days)|Withdrawal by Subject|0|||
147321629|NCT01606189|531340120|FG003|Third Intenvention (14-20 Days)|Withdrawal by Subject|0|||
147321630|NCT01606189|531340121|FG004|Third Intenvention (14-20 Days)|Withdrawal by Subject|0|||
147321631|NCT01606189|531340122|FG005|Third Intenvention (14-20 Days)|Withdrawal by Subject|1|||
147321632|NCT01354938|531340123|FG000|Overall Study|Lost to Follow-up|1|||
147321633|NCT01167023|531340124|FG000|Overall Study|Lost to Follow-up|0|||
147321634|NCT01167023|531340125|FG001|Overall Study|Lost to Follow-up|1|||
147321635|NCT01167023|531340126|FG002|Overall Study|Lost to Follow-up|1|||
147321636|NCT01167023|531340124|FG000|Overall Study|Screen Failure|0|||
147321637|NCT01167023|531340125|FG001|Overall Study|Screen Failure|1|||
147321638|NCT01167023|531340126|FG002|Overall Study|Screen Failure|0|||
147321639|NCT01167023|531340124|FG000|Overall Study|Sponsor Decision|0|||
147321640|NCT01167023|531340125|FG001|Overall Study|Sponsor Decision|1|||
147321641|NCT01167023|531340126|FG002|Overall Study|Sponsor Decision|0|||
147321642|NCT01167023|531340124|FG000|Overall Study|Withdrawal by Subject|0|||
147321643|NCT01167023|531340125|FG001|Overall Study|Withdrawal by Subject|0|||
147321644|NCT01167023|531340126|FG002|Overall Study|Withdrawal by Subject|1|||
147321645|NCT03803774|531340130|FG000|Dose Escalation|Withdrawal by Subject|0|||
147321646|NCT03803774|531340131|FG001|Dose Escalation|Withdrawal by Subject|0|||
147321647|NCT03803774|531340132|FG002|Dose Escalation|Withdrawal by Subject|0|||
147321648|NCT03803774|531340133|FG003|Dose Escalation|Withdrawal by Subject|1|||
147321649|NCT03803774|531340134|FG004|Dose Escalation|Withdrawal by Subject|0|||
147580357|NCT04281472|532280317|FG002|Stage A|Non-compliance with study drug|0|||
147580358|NCT04281472|532280315|FG000|Stage A|Physician Decision|1|||
147580359|NCT04281472|532280316|FG001|Stage A|Physician Decision|0|||
147580360|NCT04281472|532280317|FG002|Stage A|Physician Decision|0|||
147580361|NCT04281472|532280315|FG000|Stage A|Prohibited medications|2|||
147580362|NCT04281472|532280316|FG001|Stage A|Prohibited medications|0|||
147580363|NCT04281472|532280317|FG002|Stage A|Prohibited medications|0|||
147580364|NCT04281472|532280315|FG000|Stage A|Withdrawal by Subject|11|||
147580365|NCT04281472|532280316|FG001|Stage A|Withdrawal by Subject|0|||
147580366|NCT04281472|532280317|FG002|Stage A|Withdrawal by Subject|0|||
147580367|NCT04281472|532280315|FG000|Stage A|Other|5|||
147580368|NCT04281472|532280316|FG001|Stage A|Other|0|||
147580369|NCT04281472|532280317|FG002|Stage A|Other|0|||
147580370|NCT04281472|532280315|FG000|Stage B|All events required for primary analysis achieved (rolled over to ARGX-1113-1902)|0|||
147580371|NCT04281472|532280316|FG001|Stage B|All events required for primary analysis achieved (rolled over to ARGX-1113-1902)|35|||
147580372|NCT04281472|532280317|FG002|Stage B|All events required for primary analysis achieved (rolled over to ARGX-1113-1902)|26|||
147580373|NCT04281472|532280315|FG000|Stage B|Adverse Event|0|||
147580374|NCT04281472|532280316|FG001|Stage B|Adverse Event|3|||
147580375|NCT04281472|532280317|FG002|Stage B|Adverse Event|0|||
147580376|NCT04281472|532280315|FG000|Stage B|Death|0|||
147580377|NCT04281472|532280316|FG001|Stage B|Death|0|||
147580378|NCT04281472|532280317|FG002|Stage B|Death|1|||
147580379|NCT04281472|532280315|FG000|Stage B|Lack of Efficacy|0|||
147580380|NCT04281472|532280316|FG001|Stage B|Lack of Efficacy|0|||
147580381|NCT04281472|532280317|FG002|Stage B|Lack of Efficacy|1|||
147580382|NCT04281472|532280315|FG000|Stage B|Lost to Follow-up|0|||
147580383|NCT04281472|532280316|FG001|Stage B|Lost to Follow-up|0|||
147580384|NCT04281472|532280317|FG002|Stage B|Lost to Follow-up|2|||
147321650|NCT02491411|531341620|FG000|Overall Study|Physician Decision|4|||
147321651|NCT04034238|531341621|FG000|Dose Escalation Phase|Withdrawal by Subject|1|||
147321652|NCT04034238|531341622|FG001|Dose Escalation Phase|Withdrawal by Subject|0|||
147580385|NCT04281472|532280315|FG000|Stage B|Prohibited medications|0|||
147580386|NCT04281472|532280316|FG001|Stage B|Prohibited medications|2|||
147580387|NCT04281472|532280317|FG002|Stage B|Prohibited medications|1|||
147580388|NCT04281472|532280315|FG000|Stage B|Protocol Violation|0|||
147580389|NCT04281472|532280316|FG001|Stage B|Protocol Violation|1|||
147580390|NCT04281472|532280317|FG002|Stage B|Protocol Violation|1|||
147580391|NCT04281472|532280315|FG000|Stage B|Sponsor decision|0|||
147580392|NCT04281472|532280316|FG001|Stage B|Sponsor decision|0|||
147321653|NCT04034238|531341623|FG002|Dose Escalation Phase|Withdrawal by Subject|0|||
147321654|NCT04034238|531341624|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
147580393|NCT04281472|532280317|FG002|Stage B|Sponsor decision|1|||
147580394|NCT04281472|532280315|FG000|Stage B|Withdrawal by Subject|0|||
147580395|NCT04281472|532280316|FG001|Stage B|Withdrawal by Subject|3|||
147580396|NCT04281472|532280317|FG002|Stage B|Withdrawal by Subject|3|||
147580397|NCT04281472|532280315|FG000|Stage B|Other|0|||
147580398|NCT04281472|532280316|FG001|Stage B|Other|3|||
147580399|NCT04281472|532280317|FG002|Stage B|Other|0|||
147580400|NCT00152451|532280318|FG000|Overall Study|Adverse Event|4|||
147580401|NCT00323258|532280320|FG000|Primary Outcome (Phone Call at 6 Months)|Death|1|||
147580402|NCT00323258|532280321|FG001|Primary Outcome (Phone Call at 6 Months)|Death|2|||
147580403|NCT00323258|532280320|FG000|Primary Outcome (Phone Call at 6 Months)|Lost to Follow-up|12|||
147321655|NCT04034238|531341621|FG000|Dose Escalation Phase|Screen failures|0|||
147321656|NCT04034238|531341622|FG001|Dose Escalation Phase|Screen failures|0|||
147321657|NCT04034238|531341623|FG002|Dose Escalation Phase|Screen failures|0|||
147321658|NCT04034238|531341624|FG003|Dose Escalation Phase|Screen failures|2|||
147321659|NCT04034238|531341621|FG000|Dose Expansion Phase|Not treated due to study hold.|0|||
147321660|NCT04034238|531341622|FG001|Dose Expansion Phase|Not treated due to study hold.|0|||
147321661|NCT04034238|531341623|FG002|Dose Expansion Phase|Not treated due to study hold.|0|||
147321662|NCT04034238|531341624|FG003|Dose Expansion Phase|Not treated due to study hold.|1|||
147321663|NCT04034238|531341621|FG000|Dose Expansion Phase|Discontinued treatment before received LMB-100 during first cycle|0|||
147321664|NCT04034238|531341622|FG001|Dose Expansion Phase|Discontinued treatment before received LMB-100 during first cycle|0|||
147321665|NCT04034238|531341623|FG002|Dose Expansion Phase|Discontinued treatment before received LMB-100 during first cycle|1|||
147580404|NCT00323258|532280321|FG001|Primary Outcome (Phone Call at 6 Months)|Lost to Follow-up|11|||
147580405|NCT00323258|532280320|FG000|Primary Outcome (Phone Call at 6 Months)|Withdrawal by Subject|1|||
147580406|NCT00323258|532280321|FG001|Primary Outcome (Phone Call at 6 Months)|Withdrawal by Subject|5|||
147580407|NCT00323258|532280320|FG000|Primary Outcome (Phone Call at 6 Months)|Died between 180-240 days (call period)|2|||
147580408|NCT00323258|532280321|FG001|Primary Outcome (Phone Call at 6 Months)|Died between 180-240 days (call period)|1|||
147580409|NCT00323258|532280320|FG000|Secondary Outcome (6 Mon Refill Records)|Death|1|||
147580410|NCT00323258|532280321|FG001|Secondary Outcome (6 Mon Refill Records)|Death|2|||
147580411|NCT00323258|532280320|FG000|Secondary Outcome (6 Mon Refill Records)|Lost to Follow-up|12|||
147580412|NCT00323258|532280321|FG001|Secondary Outcome (6 Mon Refill Records)|Lost to Follow-up|10|||
147580413|NCT00323258|532280320|FG000|Secondary Outcome (6 Mon Refill Records)|Withdrawal by Subject|1|||
147580414|NCT00323258|532280321|FG001|Secondary Outcome (6 Mon Refill Records)|Withdrawal by Subject|2|||
147580415|NCT01055834|532280322|FG000|Treatment Period I|Adverse Event|1|||
147580416|NCT01055834|532280323|FG001|Treatment Period I|Adverse Event|0|||
147580417|NCT01717313|532280324|FG000|Phase A (Weeks 0 to 24)|Death|0|||
147580418|NCT01717313|532280325|FG001|Phase A (Weeks 0 to 24)|Death|1|||
147580419|NCT01717313|532280324|FG000|Phase A (Weeks 0 to 24)|Lost to Follow-up|1|||
147580420|NCT01717313|532280325|FG001|Phase A (Weeks 0 to 24)|Lost to Follow-up|3|||
147580421|NCT01717313|532280324|FG000|Phase A (Weeks 0 to 24)|Withdrawal by Subject|12|||
147580422|NCT01717313|532280325|FG001|Phase A (Weeks 0 to 24)|Withdrawal by Subject|6|||
147580423|NCT01717313|532280324|FG000|Phase A (Weeks 0 to 24)|Adverse Event|4|||
147580424|NCT01717313|532280325|FG001|Phase A (Weeks 0 to 24)|Adverse Event|2|||
147580425|NCT01717313|532280324|FG000|Phase A (Weeks 0 to 24)|Non-Compliance with Study Drug|1|||
147580426|NCT01717313|532280325|FG001|Phase A (Weeks 0 to 24)|Non-Compliance with Study Drug|1|||
147580427|NCT01717313|532280324|FG000|Interphase|Completed Phase A Did Not Enter Phase B|1|||
147580428|NCT01717313|532280325|FG001|Interphase|Completed Phase A Did Not Enter Phase B|0|||
147580429|NCT01717313|532280324|FG000|Phase B (Weeks 24 to 54)|Study Terminated by Sponsor|4|||
147580430|NCT01717313|532280325|FG001|Phase B (Weeks 24 to 54)|Study Terminated by Sponsor|4|||
147580431|NCT01717313|532280324|FG000|Phase B (Weeks 24 to 54)|Withdrawal by Subject|7|||
147580432|NCT01717313|532280325|FG001|Phase B (Weeks 24 to 54)|Withdrawal by Subject|9|||
147580433|NCT01717313|532280324|FG000|Phase B (Weeks 24 to 54)|Lost to Follow-up|1|||
147580434|NCT01717313|532280325|FG001|Phase B (Weeks 24 to 54)|Lost to Follow-up|3|||
147580435|NCT00743145|532280327|FG000|Overall Study|Withdrawal by Subject|1|||
147580436|NCT00743145|532280327|FG000|Overall Study|Adverse Event|2|||
147580437|NCT00743145|532280327|FG000|Overall Study|Pregnancy|1|||
147580438|NCT01745094|532280328|FG000|Overall Study|Not Meeting the Eligibility Criteria|1|||
147580439|NCT01745094|532280329|FG001|Overall Study|Not Meeting the Eligibility Criteria|0|||
147580440|NCT01745094|532280330|FG002|Overall Study|Not Meeting the Eligibility Criteria|3|||
147580441|NCT01745094|532280331|FG003|Overall Study|Not Meeting the Eligibility Criteria|0|||
147580442|NCT01745094|532280328|FG000|Overall Study|Adverse Event|0|||
147580443|NCT01745094|532280329|FG001|Overall Study|Adverse Event|0|||
147580444|NCT01745094|532280330|FG002|Overall Study|Adverse Event|3|||
147580445|NCT01745094|532280331|FG003|Overall Study|Adverse Event|0|||
147580446|NCT01745094|532280328|FG000|Overall Study|Withdrawal by Subject|2|||
147580447|NCT01745094|532280329|FG001|Overall Study|Withdrawal by Subject|0|||
147580448|NCT01745094|532280330|FG002|Overall Study|Withdrawal by Subject|1|||
147580449|NCT01745094|532280331|FG003|Overall Study|Withdrawal by Subject|2|||
147580450|NCT01745094|532280328|FG000|Overall Study|Protocol Violation|1|||
147580451|NCT01745094|532280329|FG001|Overall Study|Protocol Violation|0|||
147580452|NCT01745094|532280330|FG002|Overall Study|Protocol Violation|3|||
147580453|NCT01745094|532280331|FG003|Overall Study|Protocol Violation|1|||
147580454|NCT01745094|532280328|FG000|Overall Study|Need Further Examinations Due to Biopsy|0|||
147580455|NCT01745094|532280329|FG001|Overall Study|Need Further Examinations Due to Biopsy|0|||
147580456|NCT01745094|532280330|FG002|Overall Study|Need Further Examinations Due to Biopsy|1|||
147580457|NCT01745094|532280331|FG003|Overall Study|Need Further Examinations Due to Biopsy|0|||
147580458|NCT01745094|532280328|FG000|Overall Study|Show no Stable Solifenacin Intake|0|||
147580459|NCT01745094|532280329|FG001|Overall Study|Show no Stable Solifenacin Intake|0|||
147580460|NCT01745094|532280330|FG002|Overall Study|Show no Stable Solifenacin Intake|1|||
147580461|NCT01745094|532280331|FG003|Overall Study|Show no Stable Solifenacin Intake|0|||
147580462|NCT01745094|532280328|FG000|Overall Study|Untenable Due to Recurrent Cystitis|1|||
147580463|NCT01745094|532280329|FG001|Overall Study|Untenable Due to Recurrent Cystitis|0|||
147580464|NCT01745094|532280330|FG002|Overall Study|Untenable Due to Recurrent Cystitis|0|||
147580465|NCT01745094|532280331|FG003|Overall Study|Untenable Due to Recurrent Cystitis|0|||
147580466|NCT01097694|532280332|FG000|Overall Study|Adverse Event|5|||
147580467|NCT01097694|532280333|FG001|Overall Study|Adverse Event|0|||
147580468|NCT01097694|532280332|FG000|Overall Study|Lost to Follow-up|0|||
147580469|NCT01097694|532280333|FG001|Overall Study|Lost to Follow-up|3|||
147580470|NCT01097694|532280332|FG000|Overall Study|Withdrawal by Subject|3|||
147580471|NCT01097694|532280333|FG001|Overall Study|Withdrawal by Subject|1|||
147580472|NCT03922750|532280334|FG000|Overall Study|Unclassified|0|||
147580473|NCT03922750|532280335|FG001|Overall Study|Unclassified|0|||
147580474|NCT03922750|532280336|FG002|Overall Study|Unclassified|1|||
147580475|NCT03922750|532280334|FG000|Overall Study|Adverse Event|0|||
147580476|NCT03922750|532280335|FG001|Overall Study|Adverse Event|1|||
147580477|NCT03922750|532280336|FG002|Overall Study|Adverse Event|0|||
147580478|NCT00668395|532280337|FG000|Overall Study|Withdrawal by Subject|4|||
147580479|NCT00668395|532280338|FG001|Overall Study|Withdrawal by Subject|4|||
147580480|NCT00668395|532280339|FG002|Overall Study|Withdrawal by Subject|1|||
147580481|NCT00668395|532280337|FG000|Overall Study|Adverse Event|1|||
147580482|NCT00668395|532280338|FG001|Overall Study|Adverse Event|1|||
147580483|NCT00668395|532280339|FG002|Overall Study|Adverse Event|0|||
147580484|NCT00668395|532280337|FG000|Overall Study|Physician Decision|1|||
147580485|NCT00668395|532280338|FG001|Overall Study|Physician Decision|1|||
147580486|NCT00668395|532280339|FG002|Overall Study|Physician Decision|0|||
147580487|NCT00697827|532280340|FG000|Overall Study|enrolled but not treated|2|||
147580488|NCT00697827|532280341|FG001|Overall Study|enrolled but not treated|1|||
147580489|NCT03732833|532280346|FG000|Overall Study|Adverse Event|0|||
147580490|NCT03732833|532280347|FG001|Overall Study|Adverse Event|3|||
147580491|NCT03732833|532280348|FG002|Overall Study|Adverse Event|1|||
147580492|NCT03732833|532280346|FG000|Overall Study|Withdrawal by Subject|11|||
147580493|NCT03732833|532280347|FG001|Overall Study|Withdrawal by Subject|13|||
147580494|NCT03732833|532280348|FG002|Overall Study|Withdrawal by Subject|8|||
147580495|NCT03732833|532280346|FG000|Overall Study|Lost to Follow-up|3|||
147580496|NCT03732833|532280347|FG001|Overall Study|Lost to Follow-up|5|||
147580497|NCT03732833|532280348|FG002|Overall Study|Lost to Follow-up|4|||
147580498|NCT03732833|532280346|FG000|Overall Study|Pregnancy|0|||
147580499|NCT03732833|532280347|FG001|Overall Study|Pregnancy|2|||
147580500|NCT03732833|532280348|FG002|Overall Study|Pregnancy|0|||
147580501|NCT03732833|532280346|FG000|Overall Study|Physician Decision|2|||
147580502|NCT03732833|532280347|FG001|Overall Study|Physician Decision|3|||
147580503|NCT03732833|532280348|FG002|Overall Study|Physician Decision|1|||
147580504|NCT03732833|532280346|FG000|Overall Study|Covid-19 related and other reasons|2|||
147580505|NCT03732833|532280347|FG001|Overall Study|Covid-19 related and other reasons|7|||
147580506|NCT03732833|532280348|FG002|Overall Study|Covid-19 related and other reasons|3|||
147580507|NCT01691612|532280351|FG000|Overall Study|deemed ineligible after 1st visit|6|||
147580508|NCT01691612|532280351|FG000|Overall Study|Adverse Event|1|||
147580509|NCT02623218|532280352|FG000|Overall Study|Lost to Follow-up|0|||
147580510|NCT02623218|532280353|FG001|Overall Study|Lost to Follow-up|1|||
147580511|NCT02623218|532280354|FG002|Overall Study|Lost to Follow-up|0|||
147580512|NCT02623218|532280355|FG003|Overall Study|Lost to Follow-up|0|||
147580513|NCT02623218|532280356|FG004|Overall Study|Lost to Follow-up|0|||
147580514|NCT01726803|532280357|FG000|Overall Study|Lost to Follow-up|6|||
147580515|NCT01726803|532280358|FG001|Overall Study|Lost to Follow-up|1|||
147580516|NCT01726803|532280357|FG000|Overall Study|Withdrawal by Subject|1|||
147580517|NCT01726803|532280358|FG001|Overall Study|Withdrawal by Subject|0|||
147580518|NCT01211262|532280360|FG000|Overall Study|Progressive Disease|18|||
147580519|NCT01211262|532280361|FG001|Overall Study|Progressive Disease|9|||
147580520|NCT01211262|532280360|FG000|Overall Study|Adverse Event|4|||
147580521|NCT01211262|532280361|FG001|Overall Study|Adverse Event|0|||
147580522|NCT01211262|532280360|FG000|Overall Study|Withdrawal of Consent|1|||
147580523|NCT01211262|532280361|FG001|Overall Study|Withdrawal of Consent|0|||
147580524|NCT01211262|532280360|FG000|Overall Study|Other|0|||
147580525|NCT01211262|532280361|FG001|Overall Study|Other|1|||
147580526|NCT02005276|532280362|FG000|Overall Study|No longer interested|5|||
147580527|NCT02005276|532280363|FG001|Overall Study|No longer interested|2|||
147580528|NCT02005276|532280364|FG002|Overall Study|No longer interested|3|||
147580529|NCT02005276|532280365|FG003|Overall Study|No longer interested|3|||
147580530|NCT01970592|532280366|FG000|Overall Study|Withdrawal by Subject|4|||
147580531|NCT01970592|532280366|FG000|Overall Study|Physician Decision|1|||
147580532|NCT01970592|532280366|FG000|Overall Study|Adverse Event|1|||
147580533|NCT00021541|532280369|FG000|Period 1-First Treatment|Withdrawal by Subject|3|||
147580534|NCT00021541|532280370|FG001|Period 1-First Treatment|Withdrawal by Subject|3|||
147580535|NCT00021541|532280369|FG000|Period 1-First Treatment|Adverse Event|2|||
147580536|NCT00021541|532280370|FG001|Period 1-First Treatment|Adverse Event|1|||
147580537|NCT00021541|532280369|FG000|Period 1-First Treatment|non-adherence|3|||
147580538|NCT00021541|532280370|FG001|Period 1-First Treatment|non-adherence|0|||
147580539|NCT00021541|532280369|FG000|Period 1-First Treatment|Death|1|||
147580540|NCT00021541|532280370|FG001|Period 1-First Treatment|Death|0|||
147580541|NCT00021541|532280369|FG000|Period 1-First Treatment|Pts that did not progress|2|||
147580542|NCT00021541|532280370|FG001|Period 1-First Treatment|Pts that did not progress|2|||
147580543|NCT00021541|532280369|FG000|Period 1-First Treatment|Ineligible|0|||
147580544|NCT00021541|532280370|FG001|Period 1-First Treatment|Ineligible|2|||
147580545|NCT00021541|532280369|FG000|Period 2-crossover|refused phase B|2|||
147580546|NCT00021541|532280370|FG001|Period 2-crossover|refused phase B|2|||
147580547|NCT00021541|532280369|FG000|Period 2-crossover|Withdrawal by Subject|3|||
147580548|NCT00021541|532280370|FG001|Period 2-crossover|Withdrawal by Subject|4|||
147580549|NCT00021541|532280369|FG000|Period 2-crossover|Adverse Event|2|||
147580550|NCT00021541|532280370|FG001|Period 2-crossover|Adverse Event|2|||
147580551|NCT00021541|532280369|FG000|Period 2-crossover|non-adherence|1|||
147580552|NCT00021541|532280370|FG001|Period 2-crossover|non-adherence|0|||
147580553|NCT00021541|532280369|FG000|Period 2-crossover|Pts that did not progress|2|||
147580554|NCT00021541|532280370|FG001|Period 2-crossover|Pts that did not progress|3|||
147580555|NCT01341405|532280374|FG000|Overall Study|Adverse Event|0|||
147580556|NCT01341405|532280375|FG001|Overall Study|Adverse Event|1|||
147580557|NCT01341405|532280376|FG002|Overall Study|Adverse Event|1|||
147580558|NCT01341405|532280374|FG000|Overall Study|Withdrawal by Subject|3|||
147580559|NCT01341405|532280375|FG001|Overall Study|Withdrawal by Subject|2|||
147580560|NCT01341405|532280376|FG002|Overall Study|Withdrawal by Subject|1|||
147580561|NCT05263505|532280377|FG000|Overall Study|Adverse Event|0|||
147580562|NCT05263505|532280378|FG001|Overall Study|Adverse Event|1|||
147580563|NCT00826241|532280379|FG000|Overall Study|Withdrawal from Follow-up|1|||
147580564|NCT00826241|532280379|FG000|Overall Study|Withdrew consent|2|||
147580565|NCT00826241|532280379|FG000|Overall Study|Death|4|||
147580566|NCT00826241|532280379|FG000|Overall Study|Non-reportable(not qualify as Gr. 5 SAE)|1|||
147580567|NCT00826241|532280379|FG000|Overall Study|Non-compliance|1|||
147580568|NCT00826241|532280379|FG000|Overall Study|Progression of disease|1|||
147580569|NCT00826241|532280379|FG000|Overall Study|Patient refused follow-up|3|||
147580570|NCT00826241|532280379|FG000|Overall Study|Lost to Follow-up|9|||
147580571|NCT00826241|532280379|FG000|Overall Study|Could not obtain records|1|||
147580572|NCT00826241|532280379|FG000|Overall Study|Screen failure|2|||
147580573|NCT00826241|532280379|FG000|Overall Study|Pt unable to proceed to registration|1|||
147580574|NCT00826241|532280379|FG000|Overall Study|Pt opt not to proceed w/trmt|1|||
147580575|NCT03407729|532280380|FG000|Overall Study|Lost to Follow-up|2|||
147580576|NCT03407729|532280381|FG001|Overall Study|Lost to Follow-up|0|||
147580577|NCT03407729|532280380|FG000|Overall Study|Unable to schedule|0|||
147580578|NCT03407729|532280381|FG001|Overall Study|Unable to schedule|3|||
147580579|NCT01898598|532280382|FG000|Overall Study|Adverse Event|1|||
147580580|NCT01898598|532280383|FG001|Overall Study|Adverse Event|0|||
147580581|NCT01898598|532280382|FG000|Overall Study|Withdrawal by Subject|3|||
147580582|NCT01898598|532280383|FG001|Overall Study|Withdrawal by Subject|0|||
147580583|NCT01898598|532280382|FG000|Overall Study|Lost to Follow-up|0|||
147580584|NCT01898598|532280383|FG001|Overall Study|Lost to Follow-up|1|||
147580585|NCT01898598|532280382|FG000|Overall Study|Other|0|||
147580586|NCT01898598|532280383|FG001|Overall Study|Other|1|||
147580587|NCT03833427|532280384|FG000|Overall Study|Death|4|||
147580588|NCT03833427|532280385|FG001|Overall Study|Death|2|||
147580589|NCT03833427|532280386|FG002|Overall Study|Death|9|||
147580590|NCT03833427|532280387|FG003|Overall Study|Death|11|||
147580591|NCT03833427|532280388|FG004|Overall Study|Death|0|||
147580592|NCT03833427|532280389|FG005|Overall Study|Death|0|||
147580593|NCT03833427|532280390|FG006|Overall Study|Death|0|||
147580594|NCT03833427|532280384|FG000|Overall Study|Withdrawal by Subject|0|||
147580595|NCT03833427|532280385|FG001|Overall Study|Withdrawal by Subject|1|||
147580596|NCT03833427|532280386|FG002|Overall Study|Withdrawal by Subject|1|||
147580597|NCT03833427|532280387|FG003|Overall Study|Withdrawal by Subject|0|||
147580598|NCT03833427|532280388|FG004|Overall Study|Withdrawal by Subject|0|||
147580599|NCT03833427|532280389|FG005|Overall Study|Withdrawal by Subject|0|||
147580600|NCT03833427|532280390|FG006|Overall Study|Withdrawal by Subject|0|||
147580601|NCT03833427|532280384|FG000|Overall Study|Sponsor Decision|0|||
147580602|NCT03833427|532280385|FG001|Overall Study|Sponsor Decision|0|||
147580603|NCT03833427|532280386|FG002|Overall Study|Sponsor Decision|1|||
147580604|NCT03833427|532280387|FG003|Overall Study|Sponsor Decision|3|||
147580605|NCT03833427|532280388|FG004|Overall Study|Sponsor Decision|0|||
147580606|NCT03833427|532280389|FG005|Overall Study|Sponsor Decision|0|||
147580607|NCT03833427|532280390|FG006|Overall Study|Sponsor Decision|0|||
147580608|NCT03428945|532280396|FG000|Overall Study|Lost to Follow-up|5|||
147580609|NCT03428945|532280397|FG001|Overall Study|Lost to Follow-up|3|||
147580610|NCT03428945|532280396|FG000|Overall Study|Withdrawal by Subject|10|||
147580611|NCT03428945|532280397|FG001|Overall Study|Withdrawal by Subject|10|||
147580612|NCT00950300|532280398|FG000|Neoadjuvant/Adjuvant Treatment Periods|Adverse Event or Intercurrent Illness|6|||
147580613|NCT00950300|532280399|FG001|Neoadjuvant/Adjuvant Treatment Periods|Adverse Event or Intercurrent Illness|15|||
147580614|NCT00950300|532280398|FG000|Neoadjuvant/Adjuvant Treatment Periods|Death|1|||
147580615|NCT00950300|532280399|FG001|Neoadjuvant/Adjuvant Treatment Periods|Death|3|||
147580616|NCT00950300|532280398|FG000|Neoadjuvant/Adjuvant Treatment Periods|Insufficient Therapeutic Response|3|||
147580617|NCT00950300|532280399|FG001|Neoadjuvant/Adjuvant Treatment Periods|Insufficient Therapeutic Response|0|||
147580618|NCT00950300|532280398|FG000|Neoadjuvant/Adjuvant Treatment Periods|Violation of Selection Criteria|2|||
147580619|NCT00950300|532280399|FG001|Neoadjuvant/Adjuvant Treatment Periods|Violation of Selection Criteria|1|||
147580620|NCT00950300|532280398|FG000|Neoadjuvant/Adjuvant Treatment Periods|Protocol Violation|1|||
147580621|NCT00950300|532280399|FG001|Neoadjuvant/Adjuvant Treatment Periods|Protocol Violation|0|||
147580622|NCT00950300|532280398|FG000|Neoadjuvant/Adjuvant Treatment Periods|Participant Refusal/Withdrawal|4|||
147580623|NCT00950300|532280399|FG001|Neoadjuvant/Adjuvant Treatment Periods|Participant Refusal/Withdrawal|5|||
147580624|NCT00950300|532280398|FG000|Neoadjuvant/Adjuvant Treatment Periods|Lost to Follow-up|2|||
147580625|NCT00950300|532280399|FG001|Neoadjuvant/Adjuvant Treatment Periods|Lost to Follow-up|1|||
147580626|NCT00950300|532280398|FG000|Neoadjuvant/Adjuvant Treatment Periods|Progression of Disease|12|||
147580627|NCT00950300|532280399|FG001|Neoadjuvant/Adjuvant Treatment Periods|Progression of Disease|11|||
147240073|NCT00730405|531051517|FG003|Overall Study-follow-up Phase|Participant meets exclusion criteria|0|||
147580628|NCT00950300|532280398|FG000|Neoadjuvant/Adjuvant Treatment Periods|Recurrence of Disease|10|||
147580629|NCT00950300|532280399|FG001|Neoadjuvant/Adjuvant Treatment Periods|Recurrence of Disease|5|||
147580630|NCT00950300|532280398|FG000|Neoadjuvant/Adjuvant Treatment Periods|Other|1|||
147580631|NCT00950300|532280399|FG001|Neoadjuvant/Adjuvant Treatment Periods|Other|1|||
147580632|NCT00950300|532280398|FG000|TFFU Period|Adverse Event or Intercurrent Illness|3|||
147580633|NCT00950300|532280399|FG001|TFFU Period|Adverse Event or Intercurrent Illness|4|||
147580634|NCT00950300|532280398|FG000|TFFU Period|Death|4|||
147580635|NCT00950300|532280399|FG001|TFFU Period|Death|1|||
147580636|NCT00950300|532280398|FG000|TFFU Period|Refused Treatment|10|||
147580637|NCT00950300|532280399|FG001|TFFU Period|Refused Treatment|11|||
147580638|NCT00950300|532280398|FG000|TFFU Period|Failure to Return|16|||
147580639|NCT00950300|532280399|FG001|TFFU Period|Failure to Return|16|||
147580640|NCT00950300|532280398|FG000|TFFU Period|Recurrence of Disease|63|||
147580641|NCT00950300|532280399|FG001|TFFU Period|Recurrence of Disease|72|||
147580642|NCT00950300|532280398|FG000|TFFU Period|Other|4|||
147580643|NCT00950300|532280399|FG001|TFFU Period|Other|3|||
147580644|NCT00950300|532280398|FG000|SFU Period|Death|44|||
147240074|NCT00730405|531051518|FG004|Overall Study-follow-up Phase|Participant meets exclusion criteria|0|||
147240075|NCT00730405|531051514|FG000|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0|||
147240076|NCT00730405|531051515|FG001|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0|||
147240077|NCT00730405|531051516|FG002|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0|||
147240078|NCT00730405|531051517|FG003|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|0|||
147240079|NCT00730405|531051518|FG004|Overall Study-follow-up Phase|Terminated due to adverse event (AE)|1|||
147240080|NCT00730405|531051514|FG000|Overall Study-follow-up Phase|Prohibited concomitant medication|1|||
147240081|NCT00730405|531051515|FG001|Overall Study-follow-up Phase|Prohibited concomitant medication|0|||
147240082|NCT00730405|531051516|FG002|Overall Study-follow-up Phase|Prohibited concomitant medication|0|||
147240083|NCT00730405|531051517|FG003|Overall Study-follow-up Phase|Prohibited concomitant medication|0|||
147240084|NCT00730405|531051518|FG004|Overall Study-follow-up Phase|Prohibited concomitant medication|0|||
147240085|NCT00730405|531051514|FG000|Overall Study-follow-up Phase|Refused follow-up due to AE|0|||
147240086|NCT00730405|531051515|FG001|Overall Study-follow-up Phase|Refused follow-up due to AE|0|||
147240087|NCT00730405|531051516|FG002|Overall Study-follow-up Phase|Refused follow-up due to AE|0|||
147240088|NCT00730405|531051517|FG003|Overall Study-follow-up Phase|Refused follow-up due to AE|1|||
147240089|NCT00730405|531051518|FG004|Overall Study-follow-up Phase|Refused follow-up due to AE|0|||
147240090|NCT00730405|531051514|FG000|Overall Study-follow-up Phase|Requested to withdraw from follow-up|0|||
147240091|NCT00730405|531051515|FG001|Overall Study-follow-up Phase|Requested to withdraw from follow-up|1|||
147240092|NCT00730405|531051516|FG002|Overall Study-follow-up Phase|Requested to withdraw from follow-up|1|||
147240093|NCT00730405|531051517|FG003|Overall Study-follow-up Phase|Requested to withdraw from follow-up|0|||
147240094|NCT00730405|531051518|FG004|Overall Study-follow-up Phase|Requested to withdraw from follow-up|0|||
147240095|NCT00730405|531051514|FG000|Overall Study-follow-up Phase|Declined to continue with follow-up|1|||
147240096|NCT00730405|531051515|FG001|Overall Study-follow-up Phase|Declined to continue with follow-up|1|||
147240097|NCT00730405|531051516|FG002|Overall Study-follow-up Phase|Declined to continue with follow-up|0|||
147240098|NCT00730405|531051517|FG003|Overall Study-follow-up Phase|Declined to continue with follow-up|0|||
147240099|NCT00730405|531051518|FG004|Overall Study-follow-up Phase|Declined to continue with follow-up|0|||
147240100|NCT00730405|531051514|FG000|Overall Study-follow-up Phase|Use of restricted medication|0|||
147240101|NCT00730405|531051515|FG001|Overall Study-follow-up Phase|Use of restricted medication|1|||
147240102|NCT00730405|531051516|FG002|Overall Study-follow-up Phase|Use of restricted medication|0|||
147240103|NCT00730405|531051517|FG003|Overall Study-follow-up Phase|Use of restricted medication|0|||
147240104|NCT00730405|531051518|FG004|Overall Study-follow-up Phase|Use of restricted medication|0|||
147240105|NCT00730405|531051514|FG000|Overall Study-follow-up Phase|Non-compliance|1|||
147321666|NCT04034238|531341624|FG003|Dose Expansion Phase|Discontinued treatment before received LMB-100 during first cycle|0|||
147321667|NCT00751790|531341635|FG000|Overall Study|Lost to Follow-up|1|||
147580645|NCT00950300|532280399|FG001|SFU Period|Death|42|||
147580646|NCT00950300|532280398|FG000|SFU Period|Lost to Follow-up|30|||
147580647|NCT00950300|532280399|FG001|SFU Period|Lost to Follow-up|28|||
147653562|NCT00492232|532554607|FG000|Placebo Run-in|Pregnancy|0|||
147653563|NCT00492232|532554608|FG001|Placebo Run-in|Pregnancy|1|||
147653564|NCT00492232|532554607|FG000|Placebo Run-in|Entrance criteria not met|0|||
147653565|NCT00492232|532554608|FG001|Placebo Run-in|Entrance criteria not met|45|||
147653566|NCT00492232|532554607|FG000|Placebo Run-in|Other|0|||
147653567|NCT00492232|532554608|FG001|Placebo Run-in|Other|6|||
147653568|NCT00492232|532554607|FG000|Placebo Run-in|Missing|0|||
147653569|NCT00492232|532554608|FG001|Placebo Run-in|Missing|2|||
147653570|NCT00492232|532554607|FG000|Double-Blind Treatment|Adverse Event|1|||
147653571|NCT00492232|532554608|FG001|Double-Blind Treatment|Adverse Event|2|||
147653572|NCT00492232|532554607|FG000|Double-Blind Treatment|Protocol Violation|3|||
147653573|NCT00492232|532554608|FG001|Double-Blind Treatment|Protocol Violation|7|||
147653574|NCT00492232|532554607|FG000|Double-Blind Treatment|Lost to Follow-up|2|||
147653575|NCT00492232|532554608|FG001|Double-Blind Treatment|Lost to Follow-up|3|||
147653576|NCT00492232|532554607|FG000|Double-Blind Treatment|Withdrawal by Subject|4|||
147653577|NCT00492232|532554608|FG001|Double-Blind Treatment|Withdrawal by Subject|8|||
147653578|NCT00492232|532554607|FG000|Double-Blind Treatment|Lack of Efficacy|1|||
147653579|NCT00492232|532554608|FG001|Double-Blind Treatment|Lack of Efficacy|0|||
147653580|NCT00492232|532554607|FG000|Double-Blind Treatment|Other|6|||
147653581|NCT00492232|532554608|FG001|Double-Blind Treatment|Other|5|||
147653582|NCT00492232|532554607|FG000|Double-Blind Treatment|Randomized not treated|1|||
147653583|NCT00492232|532554608|FG001|Double-Blind Treatment|Randomized not treated|0|||
147653584|NCT00492232|532554607|FG000|Open-Label Treatment|Withdrawal by Subject|1|||
147653585|NCT00492232|532554608|FG001|Open-Label Treatment|Withdrawal by Subject|0|||
147653586|NCT02756364|532554610|FG000|Overall Study|Site Terminated by Sponsor|24|||
147653587|NCT02756364|532554611|FG001|Overall Study|Site Terminated by Sponsor|30|||
147653588|NCT02756364|532554612|FG002|Overall Study|Site Terminated by Sponsor|21|||
147653589|NCT02756364|532554610|FG000|Overall Study|Death|20|||
147653590|NCT02756364|532554611|FG001|Overall Study|Death|15|||
147653591|NCT02756364|532554612|FG002|Overall Study|Death|18|||
147653592|NCT02756364|532554610|FG000|Overall Study|Withdrawal by Patient|2|||
147653593|NCT02756364|532554611|FG001|Overall Study|Withdrawal by Patient|1|||
147653594|NCT02756364|532554612|FG002|Overall Study|Withdrawal by Patient|8|||
147653595|NCT02756364|532554610|FG000|Overall Study|Lost to Follow-up|0|||
147653596|NCT02756364|532554611|FG001|Overall Study|Lost to Follow-up|1|||
147653597|NCT02756364|532554612|FG002|Overall Study|Lost to Follow-up|1|||
147653598|NCT02223364|532554613|FG000|Overall Study|Protocol Violation|3|||
147653599|NCT02223364|532554614|FG001|Overall Study|Protocol Violation|0|||
147653600|NCT02223364|532554615|FG002|Overall Study|Protocol Violation|3|||
147653601|NCT02223364|532554613|FG000|Overall Study|subject expired before surgery|1|||
147653602|NCT02223364|532554614|FG001|Overall Study|subject expired before surgery|0|||
147653603|NCT02223364|532554615|FG002|Overall Study|subject expired before surgery|0|||
147653604|NCT02223364|532554613|FG000|Overall Study|Physician Decision|1|||
147653605|NCT02223364|532554614|FG001|Overall Study|Physician Decision|0|||
147653606|NCT02223364|532554615|FG002|Overall Study|Physician Decision|0|||
147653607|NCT01416155|532554616|FG000|Overall Study|Adverse Event|8|||
147653608|NCT01416155|532554616|FG000|Overall Study|Positive for anti-BG00002 antibodies|2|||
147653609|NCT01416155|532554616|FG000|Overall Study|Withdrawal by Subject|33|||
147653610|NCT01416155|532554616|FG000|Overall Study|Investigator decision|8|||
147580648|NCT00950300|532280398|FG000|SFU Period|Withdrawal by Subject|4|||
147580649|NCT00950300|532280399|FG001|SFU Period|Withdrawal by Subject|8|||
147580650|NCT01596127|532280400|FG000|Overall Study|Patient Ineligible|1|||
147580651|NCT00438633|532280401|FG000|Overall Study|Withdrawal by Subject|1|||
147580652|NCT00438633|532280402|FG001|Overall Study|Withdrawal by Subject|0|||
147580653|NCT00438633|532280401|FG000|Overall Study|Lost to Follow-up|15|||
147580654|NCT00438633|532280402|FG001|Overall Study|Lost to Follow-up|17|||
147580655|NCT01539239|532280403|FG000|Overall Study|Death|5|||
147580656|NCT01539239|532280404|FG001|Overall Study|Death|5|||
147580657|NCT01539239|532280403|FG000|Overall Study|Lost to Follow-up|7|||
147580658|NCT01539239|532280404|FG001|Overall Study|Lost to Follow-up|12|||
147580659|NCT05135273|532282108|FG000|Overall Study|Recruited into the army|0|||
147580660|NCT05135273|532282109|FG001|Overall Study|Recruited into the army|0|||
147580661|NCT05135273|532282110|FG002|Overall Study|Recruited into the army|0|||
147580662|NCT05135273|532282111|FG003|Overall Study|Recruited into the army|0|||
147580663|NCT05135273|532282112|FG004|Overall Study|Recruited into the army|1|||
147580664|NCT05135273|532282113|FG005|Overall Study|Recruited into the army|0|||
147653611|NCT01416155|532554616|FG000|Overall Study|Other|7|||
147653612|NCT03597139|532554620|FG000|Overall Study|Adverse Event|3|||
147653613|NCT03597139|532554621|FG001|Overall Study|Adverse Event|0|||
147653614|NCT03597139|532554620|FG000|Overall Study|Protocol Non-compliance|1|||
147653615|NCT03597139|532554621|FG001|Overall Study|Protocol Non-compliance|0|||
147653616|NCT04811664|532554624|FG000|Overall Study|Lost to Follow-up|78|||
147580665|NCT05135273|532282114|FG006|Overall Study|Recruited into the army|0|||
147580666|NCT05135273|532282115|FG007|Overall Study|Recruited into the army|0|||
147653617|NCT04811664|532554625|FG001|Overall Study|Lost to Follow-up|125|||
147653618|NCT04811664|532554626|FG002|Overall Study|Lost to Follow-up|46|||
147580667|NCT05135273|532282108|FG000|Overall Study|Moved away from study site|0|||
147580668|NCT05135273|532282109|FG001|Overall Study|Moved away from study site|0|||
147580669|NCT05135273|532282110|FG002|Overall Study|Moved away from study site|0|||
147580670|NCT05135273|532282111|FG003|Overall Study|Moved away from study site|0|||
147580671|NCT05135273|532282112|FG004|Overall Study|Moved away from study site|0|||
147580672|NCT05135273|532282113|FG005|Overall Study|Moved away from study site|1|||
147580673|NCT05135273|532282114|FG006|Overall Study|Moved away from study site|1|||
147446316|NCT00506883|531798922|FG000|Overall Study|Withdrawal by Subject|1|||
147446317|NCT00506883|531798923|FG001|Overall Study|Withdrawal by Subject|0|||
147580674|NCT05135273|532282115|FG007|Overall Study|Moved away from study site|0|||
147580675|NCT05135273|532282108|FG000|Overall Study|Travel|0|||
147580676|NCT05135273|532282109|FG001|Overall Study|Travel|0|||
147580677|NCT05135273|532282110|FG002|Overall Study|Travel|0|||
147580678|NCT05135273|532282111|FG003|Overall Study|Travel|0|||
147580679|NCT05135273|532282112|FG004|Overall Study|Travel|0|||
147580680|NCT05135273|532282113|FG005|Overall Study|Travel|0|||
147580681|NCT05135273|532282114|FG006|Overall Study|Travel|0|||
147580682|NCT05135273|532282115|FG007|Overall Study|Travel|1|||
147580683|NCT01350934|532282146|FG000|Base Study|Adverse Event|6|||
147580684|NCT01350934|532282147|FG001|Base Study|Adverse Event|0|||
147580685|NCT01350934|532282146|FG000|Base Study|Lost to Follow-up|1|||
147580686|NCT01350934|532282147|FG001|Base Study|Lost to Follow-up|0|||
147580687|NCT01350934|532282146|FG000|Base Study|Protocol Violation|1|||
147580688|NCT01350934|532282147|FG001|Base Study|Protocol Violation|1|||
147446318|NCT00506883|531798924|FG002|Overall Study|Withdrawal by Subject|1|||
147446319|NCT00506883|531798922|FG000|Overall Study|Lack of Efficacy|0|||
147446320|NCT00506883|531798923|FG001|Overall Study|Lack of Efficacy|1|||
147446321|NCT00506883|531798924|FG002|Overall Study|Lack of Efficacy|1|||
147446322|NCT00506883|531798922|FG000|Overall Study|Other|5|||
147446323|NCT00506883|531798923|FG001|Overall Study|Other|1|||
147446324|NCT00506883|531798924|FG002|Overall Study|Other|1|||
147446325|NCT01473563|531798926|FG000|Overall Study|Lost to FU post tx discontinuation|1|||
147446326|NCT03610724|531798927|FG000|Overall Study|Death|17|||
147446327|NCT03610724|531798927|FG000|Overall Study|Lost to Follow-up|1|||
147446328|NCT03610724|531798927|FG000|Overall Study|Physician Decision|1|||
147446329|NCT03610724|531798927|FG000|Overall Study|Died prior to infusion|1|||
147446330|NCT00786565|531798928|FG000|Enrollment Prior to Surgery|Site Closed|3|||
147446331|NCT00786565|531798928|FG000|Enrollment Prior to Surgery|Protocol Violation|3|||
147446332|NCT00786565|531798928|FG000|Post Surgery|Abnormal macular pucker|1|||
147446333|NCT00786565|531798928|FG000|Post Surgery|Adapt AO implanted posterior side up|1|||
147446334|NCT02943564|531798931|FG000|Overall Study|Miscellaneous Reasons|0|||
147446335|NCT02943564|531798932|FG001|Overall Study|Miscellaneous Reasons|0|||
147446336|NCT02943564|531798933|FG002|Overall Study|Miscellaneous Reasons|3|||
147446337|NCT02943564|531798931|FG000|Overall Study|Site terminated by sponsor|0|||
147446338|NCT02943564|531798932|FG001|Overall Study|Site terminated by sponsor|1|||
147446339|NCT02943564|531798933|FG002|Overall Study|Site terminated by sponsor|0|||
147446340|NCT02943564|531798931|FG000|Overall Study|Non-compliance with study drug|0|||
147446341|NCT02943564|531798932|FG001|Overall Study|Non-compliance with study drug|1|||
147446342|NCT02943564|531798933|FG002|Overall Study|Non-compliance with study drug|0|||
147446343|NCT02943564|531798931|FG000|Overall Study|Pregnancy|0|||
147446344|NCT02943564|531798932|FG001|Overall Study|Pregnancy|1|||
147446345|NCT02943564|531798933|FG002|Overall Study|Pregnancy|1|||
147446346|NCT02943564|531798931|FG000|Overall Study|Protocol Violation|2|||
147446347|NCT02943564|531798932|FG001|Overall Study|Protocol Violation|2|||
147446348|NCT02943564|531798933|FG002|Overall Study|Protocol Violation|2|||
147446349|NCT02943564|531798931|FG000|Overall Study|Lost to Follow-up|1|||
147446350|NCT02943564|531798932|FG001|Overall Study|Lost to Follow-up|0|||
147446351|NCT02943564|531798933|FG002|Overall Study|Lost to Follow-up|0|||
147446352|NCT02943564|531798931|FG000|Overall Study|Withdrawal by Subject|6|||
147580689|NCT01350934|532282146|FG000|Base Study|Withdrawal by Subject|1|||
147580690|NCT01350934|532282147|FG001|Base Study|Withdrawal by Subject|2|||
147580691|NCT01350934|532282146|FG000|Base Study|Non-Compliance With Study Drug|2|||
147446353|NCT02943564|531798932|FG001|Overall Study|Withdrawal by Subject|5|||
147446354|NCT02943564|531798933|FG002|Overall Study|Withdrawal by Subject|2|||
147446355|NCT02943564|531798931|FG000|Overall Study|Adverse Event|1|||
147446356|NCT02943564|531798932|FG001|Overall Study|Adverse Event|2|||
147446357|NCT02943564|531798933|FG002|Overall Study|Adverse Event|1|||
147446358|NCT02943564|531798931|FG000|Overall Study|Lack of Efficacy|0|||
147580692|NCT01350934|532282147|FG001|Base Study|Non-Compliance With Study Drug|0|||
147580693|NCT01350934|532282146|FG000|Extension Study|Adverse Event|2|||
147580694|NCT01350934|532282147|FG001|Extension Study|Adverse Event|1|||
147446359|NCT02943564|531798932|FG001|Overall Study|Lack of Efficacy|1|||
147446360|NCT02943564|531798933|FG002|Overall Study|Lack of Efficacy|0|||
147446361|NCT04143009|531798934|FG000|Pilot Trial|Lost to Follow-up|0|||
147446362|NCT04143009|531798935|FG001|Pilot Trial|Lost to Follow-up|1|||
147580695|NCT01350934|532282146|FG000|Extension Study|Lost to Follow-up|2|||
147580696|NCT01350934|532282147|FG001|Extension Study|Lost to Follow-up|0|||
147580697|NCT01350934|532282146|FG000|Extension Study|Protocol Violation|1|||
147580698|NCT01350934|532282147|FG001|Extension Study|Protocol Violation|1|||
147580699|NCT01350934|532282146|FG000|Extension Study|Lack of Efficacy|0|||
147580700|NCT01350934|532282147|FG001|Extension Study|Lack of Efficacy|1|||
147580701|NCT01350934|532282146|FG000|Extension Study|Withdrawal by Subject|0|||
147321668|NCT00751790|531341635|FG000|Overall Study|Death|3|||
147321669|NCT00751790|531341635|FG000|Overall Study|Withdrawal by Subject|1|||
147321670|NCT03302910|531341636|FG000|Overall Study|Protocol Violation|1|||
147321671|NCT03302910|531341637|FG001|Overall Study|Protocol Violation|0|||
147321672|NCT01106976|531341638|FG000|Overall Study|Lost to Follow-up|8|||
147321673|NCT04170023|531341645|FG000|LTE Period|Withdrawal by Subject|1|||
147321674|NCT04170023|531341646|FG001|LTE Period|Withdrawal by Subject|0|||
147321675|NCT04170023|531341647|FG002|LTE Period|Withdrawal by Subject|0|||
147321676|NCT04170023|531341645|FG000|LTE Period|Study Termination|11|||
147321677|NCT04170023|531341646|FG001|LTE Period|Study Termination|11|||
147321678|NCT04170023|531341647|FG002|LTE Period|Study Termination|5|||
147321679|NCT00953160|531341650|FG000|Overall Study|Lost to Follow-up|23|||
147580702|NCT01350934|532282147|FG001|Extension Study|Withdrawal by Subject|1|||
147580703|NCT01011335|532282148|FG000|Overall Study|Lost to Follow-up|0|||
147580704|NCT01011335|532282149|FG001|Overall Study|Lost to Follow-up|0|||
147580705|NCT01011335|532282150|FG002|Overall Study|Lost to Follow-up|1|||
147580706|NCT01011335|532282151|FG003|Overall Study|Lost to Follow-up|1|||
147580707|NCT01011335|532282152|FG004|Overall Study|Lost to Follow-up|1|||
147580708|NCT01011335|532282153|FG005|Overall Study|Lost to Follow-up|1|||
147580709|NCT01011335|532282154|FG006|Overall Study|Lost to Follow-up|2|||
147580710|NCT01011335|532282155|FG007|Overall Study|Lost to Follow-up|2|||
147580711|NCT01011335|532282156|FG008|Overall Study|Lost to Follow-up|1|||
147580712|NCT01011335|532282157|FG009|Overall Study|Lost to Follow-up|0|||
147580713|NCT01011335|532282158|FG010|Overall Study|Lost to Follow-up|0|||
147580714|NCT01011335|532282159|FG011|Overall Study|Lost to Follow-up|1|||
147580715|NCT01011335|532282160|FG012|Overall Study|Lost to Follow-up|2|||
147580716|NCT01011335|532282148|FG000|Overall Study|Protocol Violation|0|||
147580717|NCT01011335|532282149|FG001|Overall Study|Protocol Violation|1|||
147580718|NCT01011335|532282150|FG002|Overall Study|Protocol Violation|0|||
147580719|NCT01011335|532282151|FG003|Overall Study|Protocol Violation|0|||
147580720|NCT01011335|532282152|FG004|Overall Study|Protocol Violation|0|||
147580721|NCT01011335|532282153|FG005|Overall Study|Protocol Violation|0|||
147580722|NCT01011335|532282154|FG006|Overall Study|Protocol Violation|0|||
147580723|NCT01011335|532282155|FG007|Overall Study|Protocol Violation|0|||
147580724|NCT01011335|532282156|FG008|Overall Study|Protocol Violation|0|||
147580725|NCT01011335|532282157|FG009|Overall Study|Protocol Violation|0|||
147580726|NCT01011335|532282158|FG010|Overall Study|Protocol Violation|0|||
147580727|NCT01011335|532282159|FG011|Overall Study|Protocol Violation|0|||
147580728|NCT01011335|532282160|FG012|Overall Study|Protocol Violation|0|||
147580729|NCT01011335|532282148|FG000|Overall Study|Moved/deployed or no booster|1|||
147580730|NCT01011335|532282149|FG001|Overall Study|Moved/deployed or no booster|0|||
147580731|NCT01011335|532282150|FG002|Overall Study|Moved/deployed or no booster|0|||
147580732|NCT01011335|532282151|FG003|Overall Study|Moved/deployed or no booster|1|||
147580733|NCT01011335|532282152|FG004|Overall Study|Moved/deployed or no booster|0|||
147580734|NCT01011335|532282153|FG005|Overall Study|Moved/deployed or no booster|0|||
147580735|NCT01011335|532282154|FG006|Overall Study|Moved/deployed or no booster|1|||
147580736|NCT01011335|532282155|FG007|Overall Study|Moved/deployed or no booster|0|||
147321680|NCT00953160|531341650|FG000|Overall Study|Withdrawal by Subject|4|||
147321681|NCT03836664|531341653|FG000|Overall Study|Didn't complete forms and lost drug|3|||
147321682|NCT03836664|531341654|FG001|Overall Study|Didn't complete forms and lost drug|3|||
147321683|NCT03566680|531341655|FG000|Overall Study|Pregnancy|1|||
147321684|NCT03566680|531341655|FG000|Overall Study|Lost to Follow-up|13|||
147321685|NCT03566680|531341655|FG000|Overall Study|Withdrawal by Subject|3|||
147321686|NCT02724020|531341656|FG000|Overall Study|Death|16|||
147321687|NCT02724020|531341657|FG001|Overall Study|Death|18|||
147321688|NCT02724020|531341658|FG002|Overall Study|Death|19|||
147321689|NCT02724020|531341656|FG000|Overall Study|Lost to Follow-up|0|||
147321690|NCT02724020|531341657|FG001|Overall Study|Lost to Follow-up|3|||
147321691|NCT02724020|531341658|FG002|Overall Study|Lost to Follow-up|0|||
147321692|NCT02724020|531341656|FG000|Overall Study|Site Terminated by Sponsor|15|||
147321693|NCT02724020|531341657|FG001|Overall Study|Site Terminated by Sponsor|8|||
147446363|NCT04143009|531798936|FG002|Pilot Trial|Lost to Follow-up|1|||
147580737|NCT01011335|532282156|FG008|Overall Study|Moved/deployed or no booster|1|||
147321694|NCT02724020|531341658|FG002|Overall Study|Site Terminated by Sponsor|8|||
147321695|NCT02724020|531341656|FG000|Overall Study|Withdrawal by Subject|1|||
147321696|NCT02724020|531341657|FG001|Overall Study|Withdrawal by Subject|3|||
147321697|NCT02724020|531341658|FG002|Overall Study|Withdrawal by Subject|5|||
147321698|NCT00425503|531341659|FG000|Overall Study|Adverse Event|2|||
147321699|NCT00425503|531341659|FG000|Overall Study|Protocol Violation|1|||
147321700|NCT02179918|531341660|FG000|Overall Study|Death|0|||
147321701|NCT02179918|531341661|FG001|Overall Study|Death|0|||
147321702|NCT02179918|531341662|FG002|Overall Study|Death|0|||
147580738|NCT01011335|532282157|FG009|Overall Study|Moved/deployed or no booster|0|||
147580739|NCT01011335|532282158|FG010|Overall Study|Moved/deployed or no booster|2|||
147580740|NCT01011335|532282159|FG011|Overall Study|Moved/deployed or no booster|0|||
147580741|NCT01011335|532282160|FG012|Overall Study|Moved/deployed or no booster|0|||
147580742|NCT01011335|532282148|FG000|Overall Study|Adverse Event|0|||
147580743|NCT01011335|532282149|FG001|Overall Study|Adverse Event|0|||
147580744|NCT01011335|532282150|FG002|Overall Study|Adverse Event|0|||
147446364|NCT03765138|531798937|FG000|Overall Study|Lost to Follow-up|1|||
147446365|NCT04013529|531798941|FG000|Overall Study|Withdrawal by Subject|1|||
147446366|NCT04013529|531798942|FG001|Overall Study|Withdrawal by Subject|1|||
147446367|NCT03116698|531798943|FG000|Overall Study|Adverse Event|1|||
147446368|NCT03116698|531798944|FG001|Overall Study|Adverse Event|1|||
147446369|NCT03116698|531798945|FG002|Overall Study|Adverse Event|1|||
147446370|NCT03116698|531798946|FG003|Overall Study|Adverse Event|0|||
147446371|NCT03116698|531798943|FG000|Overall Study|Withdrawal by Subject|1|||
147446372|NCT03116698|531798944|FG001|Overall Study|Withdrawal by Subject|4|||
147446373|NCT03116698|531798945|FG002|Overall Study|Withdrawal by Subject|5|||
147446374|NCT03116698|531798946|FG003|Overall Study|Withdrawal by Subject|2|||
147446375|NCT03116698|531798943|FG000|Overall Study|Lost to Follow-up|2|||
147446376|NCT03116698|531798944|FG001|Overall Study|Lost to Follow-up|0|||
147446377|NCT03116698|531798945|FG002|Overall Study|Lost to Follow-up|0|||
147446378|NCT03116698|531798946|FG003|Overall Study|Lost to Follow-up|0|||
147446379|NCT03116698|531798943|FG000|Overall Study|Physician Decision|1|||
147446380|NCT03116698|531798944|FG001|Overall Study|Physician Decision|1|||
147446381|NCT03116698|531798945|FG002|Overall Study|Physician Decision|0|||
147446382|NCT03116698|531798946|FG003|Overall Study|Physician Decision|0|||
147446383|NCT03116698|531798943|FG000|Overall Study|Protocol Violation|1|||
147446384|NCT03116698|531798944|FG001|Overall Study|Protocol Violation|0|||
147446385|NCT03116698|531798945|FG002|Overall Study|Protocol Violation|0|||
147446386|NCT03116698|531798946|FG003|Overall Study|Protocol Violation|0|||
147446387|NCT03116698|531798943|FG000|Overall Study|Death|0|||
147446388|NCT03116698|531798944|FG001|Overall Study|Death|0|||
147446389|NCT03116698|531798945|FG002|Overall Study|Death|2|||
147446390|NCT03116698|531798946|FG003|Overall Study|Death|0|||
147446391|NCT00788372|531798947|FG000|Period 1 (up to 4 Weeks)|Adverse Event|18|||
147446392|NCT00788372|531798947|FG000|Period 1 (up to 4 Weeks)|Ineligible for transfer to period 2|9|||
147446393|NCT00788372|531798947|FG000|Period 1 (up to 4 Weeks)|Withdrawal of informed consent|4|||
147446394|NCT00788372|531798947|FG000|Period 2 (Week 4 to Week 52)|Adverse Event|13|||
147446395|NCT00788372|531798947|FG000|Period 2 (Week 4 to Week 52)|Physician Decision|9|||
147446396|NCT00788372|531798947|FG000|Period 2 (Week 4 to Week 52)|Withdrawal of informed consent|9|||
147446397|NCT00788372|531798947|FG000|Period 2 (Week 4 to Week 52)|Aggravated symptoms|1|||
147446398|NCT02116777|531798950|FG000|Overall Study|Adverse Event|0|||
147446399|NCT02116777|531798951|FG001|Overall Study|Adverse Event|0|||
147446400|NCT02116777|531798952|FG002|Overall Study|Adverse Event|0|||
147446401|NCT02116777|531798953|FG003|Overall Study|Adverse Event|0|||
147446402|NCT02116777|531798954|FG004|Overall Study|Adverse Event|2|||
147446403|NCT02116777|531798955|FG005|Overall Study|Adverse Event|2|||
147446404|NCT02116777|531798956|FG006|Overall Study|Adverse Event|0|||
147446405|NCT02116777|531798950|FG000|Overall Study|Death|0|||
147446406|NCT02116777|531798951|FG001|Overall Study|Death|0|||
147446407|NCT02116777|531798952|FG002|Overall Study|Death|0|||
147446408|NCT02116777|531798953|FG003|Overall Study|Death|1|||
147446409|NCT02116777|531798954|FG004|Overall Study|Death|0|||
147446410|NCT02116777|531798955|FG005|Overall Study|Death|0|||
147446411|NCT02116777|531798956|FG006|Overall Study|Death|0|||
147446412|NCT02116777|531798950|FG000|Overall Study|Lack of Efficacy|3|||
147446413|NCT02116777|531798951|FG001|Overall Study|Lack of Efficacy|3|||
147446414|NCT02116777|531798952|FG002|Overall Study|Lack of Efficacy|3|||
147446415|NCT02116777|531798953|FG003|Overall Study|Lack of Efficacy|8|||
147580745|NCT01011335|532282151|FG003|Overall Study|Adverse Event|0|||
147580746|NCT01011335|532282152|FG004|Overall Study|Adverse Event|0|||
147580747|NCT01011335|532282153|FG005|Overall Study|Adverse Event|0|||
147580748|NCT01011335|532282154|FG006|Overall Study|Adverse Event|0|||
147580749|NCT01011335|532282155|FG007|Overall Study|Adverse Event|0|||
147580750|NCT01011335|532282156|FG008|Overall Study|Adverse Event|0|||
147580751|NCT01011335|532282157|FG009|Overall Study|Adverse Event|0|||
147580752|NCT01011335|532282158|FG010|Overall Study|Adverse Event|4|||
147580753|NCT01011335|532282159|FG011|Overall Study|Adverse Event|0|||
147580754|NCT01011335|532282160|FG012|Overall Study|Adverse Event|1|||
147580755|NCT01765751|532282168|FG000|Overall Study|Lost to Follow-up|0|||
147580756|NCT01765751|532282169|FG001|Overall Study|Lost to Follow-up|2|||
147580757|NCT01765751|532282170|FG002|Overall Study|Lost to Follow-up|1|||
147580758|NCT01257581|532282174|FG000|Overall Study|Early Termination|3|||
147580759|NCT01257581|532282175|FG001|Overall Study|Early Termination|1|||
147446416|NCT02116777|531798954|FG004|Overall Study|Lack of Efficacy|4|||
147446417|NCT02116777|531798955|FG005|Overall Study|Lack of Efficacy|1|||
147446418|NCT02116777|531798956|FG006|Overall Study|Lack of Efficacy|9|||
147446419|NCT02116777|531798950|FG000|Overall Study|Physician Decision|0|||
147446420|NCT02116777|531798951|FG001|Overall Study|Physician Decision|0|||
147446421|NCT02116777|531798952|FG002|Overall Study|Physician Decision|0|||
147446422|NCT02116777|531798953|FG003|Overall Study|Physician Decision|2|||
147446423|NCT02116777|531798954|FG004|Overall Study|Physician Decision|0|||
147446424|NCT02116777|531798955|FG005|Overall Study|Physician Decision|0|||
147446425|NCT02116777|531798956|FG006|Overall Study|Physician Decision|0|||
147580760|NCT01257581|532282176|FG002|Overall Study|Early Termination|2|||
147580761|NCT01257581|532282174|FG000|Overall Study|Death|2|||
147580762|NCT01257581|532282175|FG001|Overall Study|Death|2|||
147446426|NCT02116777|531798950|FG000|Overall Study|Protocol Violation|0|||
147580763|NCT01257581|532282176|FG002|Overall Study|Death|4|||
147446427|NCT02116777|531798951|FG001|Overall Study|Protocol Violation|0|||
147580764|NCT00517192|532282183|FG000|Overall Study|Adverse Event|1|||
147580765|NCT00517192|532282184|FG001|Overall Study|Adverse Event|1|||
147580766|NCT00517192|532282183|FG000|Overall Study|Lost to Follow-up|1|||
147580767|NCT00517192|532282184|FG001|Overall Study|Lost to Follow-up|1|||
147580768|NCT00517192|532282183|FG000|Overall Study|Withdrawal by Subject|1|||
147580769|NCT00517192|532282184|FG001|Overall Study|Withdrawal by Subject|0|||
147580770|NCT00517192|532282183|FG000|Overall Study|Early termination of the trial|16|||
147580771|NCT00517192|532282184|FG001|Overall Study|Early termination of the trial|18|||
147580772|NCT03167606|532282193|FG000|Overall Study|Lost to Follow-up|73|||
147580773|NCT03167606|532282194|FG001|Overall Study|Lost to Follow-up|64|||
147580774|NCT03167606|532282193|FG000|Overall Study|Withdrawal by Subject|6|||
147580775|NCT03167606|532282194|FG001|Overall Study|Withdrawal by Subject|5|||
147580776|NCT03167606|532282193|FG000|Overall Study|Withdrawal by Investigator|0|||
147580777|NCT03167606|532282194|FG001|Overall Study|Withdrawal by Investigator|2|||
147580778|NCT02104817|532282198|FG000|Overall Study|Death|363|||
147580779|NCT02104817|532282199|FG001|Overall Study|Death|330|||
147580780|NCT02104817|532282198|FG000|Overall Study|Lost to Follow-up|3|||
147580781|NCT02104817|532282199|FG001|Overall Study|Lost to Follow-up|2|||
147580782|NCT02104817|532282198|FG000|Overall Study|Protocol Violation|0|||
147580783|NCT02104817|532282199|FG001|Overall Study|Protocol Violation|1|||
147580784|NCT02104817|532282198|FG000|Overall Study|Study terminated by sponsor|5854|||
147580785|NCT02104817|532282199|FG001|Overall Study|Study terminated by sponsor|5901|||
147580786|NCT02104817|532282198|FG000|Overall Study|Withdrawal by Subject|111|||
147580787|NCT02104817|532282199|FG001|Overall Study|Withdrawal by Subject|78|||
147580788|NCT02104817|532282198|FG000|Overall Study|Other reasons|128|||
147580789|NCT02104817|532282199|FG001|Overall Study|Other reasons|135|||
147580790|NCT04633642|532282200|FG000|Overall Study|Chronic renal disease, critical limb ischemia and heart attack|1|||
147580791|NCT04633642|532282201|FG001|Overall Study|Chronic renal disease, critical limb ischemia and heart attack|2|||
147580792|NCT00611884|532282202|FG000|Overall Study|Adverse Event|1|||
147580793|NCT00611884|532282203|FG001|Overall Study|Adverse Event|0|||
147580794|NCT00611884|532282204|FG002|Overall Study|Adverse Event|0|||
147580795|NCT00611884|532282205|FG003|Overall Study|Adverse Event|1|||
147580796|NCT00611884|532282202|FG000|Overall Study|Non-Compliance|1|||
147580797|NCT00611884|532282203|FG001|Overall Study|Non-Compliance|4|||
147580798|NCT00611884|532282204|FG002|Overall Study|Non-Compliance|2|||
147580799|NCT00611884|532282205|FG003|Overall Study|Non-Compliance|2|||
147580800|NCT00611884|532282202|FG000|Overall Study|Lack of Efficacy|0|||
147580801|NCT00611884|532282203|FG001|Overall Study|Lack of Efficacy|1|||
147580802|NCT00611884|532282204|FG002|Overall Study|Lack of Efficacy|0|||
147580803|NCT00611884|532282205|FG003|Overall Study|Lack of Efficacy|0|||
147580804|NCT00611884|532282202|FG000|Overall Study|Unclassified|7|||
147580805|NCT00611884|532282203|FG001|Overall Study|Unclassified|4|||
147580806|NCT00611884|532282204|FG002|Overall Study|Unclassified|2|||
147580807|NCT00611884|532282205|FG003|Overall Study|Unclassified|3|||
147580808|NCT00981799|532282206|FG000|Overall Study|Adverse Event|1|||
147580809|NCT00981799|532282207|FG001|Overall Study|Adverse Event|1|||
147580810|NCT00981799|532282208|FG002|Overall Study|Adverse Event|0|||
147580811|NCT00981799|532282209|FG003|Overall Study|Adverse Event|0|||
147580812|NCT02167594|532282210|FG000|Overall Study|Withdrawal by Subject|2|||
147580813|NCT02167594|532282211|FG001|Overall Study|Withdrawal by Subject|0|||
147580814|NCT02167594|532282212|FG002|Overall Study|Withdrawal by Subject|0|||
147446428|NCT02116777|531798952|FG002|Overall Study|Protocol Violation|0|||
147446429|NCT02116777|531798953|FG003|Overall Study|Protocol Violation|1|||
147446430|NCT02116777|531798954|FG004|Overall Study|Protocol Violation|0|||
147446431|NCT02116777|531798955|FG005|Overall Study|Protocol Violation|0|||
147446432|NCT02116777|531798956|FG006|Overall Study|Protocol Violation|0|||
147446433|NCT02116777|531798950|FG000|Overall Study|Withdrawal by Subject|0|||
147446434|NCT02116777|531798951|FG001|Overall Study|Withdrawal by Subject|0|||
147580815|NCT02167594|532282210|FG000|Overall Study|Death|0|||
147580816|NCT02167594|532282211|FG001|Overall Study|Death|1|||
147580817|NCT02167594|532282212|FG002|Overall Study|Death|0|||
147580818|NCT03433703|532282213|FG000|Overall Study|Study terminated by Sponsor|2|||
147580819|NCT01943435|532282226|FG000|Baseline Eligibility and Randomization|Withdrawal by Subject|4|||
147580820|NCT01943435|532282227|FG001|Baseline Eligibility and Randomization|Withdrawal by Subject|12|||
147446435|NCT02116777|531798952|FG002|Overall Study|Withdrawal by Subject|0|||
147580821|NCT01943435|532282228|FG002|Baseline Eligibility and Randomization|Withdrawal by Subject|3|||
147580822|NCT01943435|532282226|FG000|Intervention Period|Withdrawal by Subject|3|||
147446436|NCT02116777|531798953|FG003|Overall Study|Withdrawal by Subject|1|||
147446437|NCT02116777|531798954|FG004|Overall Study|Withdrawal by Subject|0|||
147580823|NCT01943435|532282227|FG001|Intervention Period|Withdrawal by Subject|3|||
147580824|NCT01943435|532282228|FG002|Intervention Period|Withdrawal by Subject|4|||
147580825|NCT01943435|532282226|FG000|2 Month Follow up|Lost to Follow-up|2|||
147580826|NCT01943435|532282227|FG001|2 Month Follow up|Lost to Follow-up|3|||
147580827|NCT01943435|532282228|FG002|2 Month Follow up|Lost to Follow-up|0|||
147446438|NCT02116777|531798955|FG005|Overall Study|Withdrawal by Subject|0|||
147446439|NCT02116777|531798956|FG006|Overall Study|Withdrawal by Subject|0|||
147446440|NCT01423851|531798959|FG000|Whole Study|Disease progression|2|||
147446441|NCT01423851|531798960|FG001|Whole Study|Disease progression|1|||
147446442|NCT01423851|531798961|FG002|Whole Study|Disease progression|1|||
147446443|NCT01423851|531798962|FG003|Whole Study|Disease progression|4|||
147446444|NCT01423851|531798963|FG004|Whole Study|Disease progression|1|||
147446445|NCT01423851|531798964|FG005|Whole Study|Disease progression|3|||
147580828|NCT01943435|532282226|FG000|6 Month Follow up|Lost to Follow-up|12|||
147580829|NCT01943435|532282227|FG001|6 Month Follow up|Lost to Follow-up|7|||
147580830|NCT01943435|532282228|FG002|6 Month Follow up|Lost to Follow-up|15|||
147580831|NCT01617096|532282235|FG000|Overall Study|Withdrawal by Subject|96|||
147580832|NCT01617096|532282236|FG001|Overall Study|Withdrawal by Subject|81|||
147580833|NCT01617096|532282235|FG000|Overall Study|Lost to Follow-up|37|||
147580834|NCT01617096|532282236|FG001|Overall Study|Lost to Follow-up|32|||
147580835|NCT01617096|532282235|FG000|Overall Study|Physician Decision|10|||
147580836|NCT01617096|532282236|FG001|Overall Study|Physician Decision|18|||
147580837|NCT01617096|532282235|FG000|Overall Study|Death|4|||
147580838|NCT01617096|532282236|FG001|Overall Study|Death|3|||
147580839|NCT01617096|532282235|FG000|Overall Study|Other|1|||
147580840|NCT01617096|532282236|FG001|Overall Study|Other|3|||
147580841|NCT02046122|532282241|FG000|Overall Study|Physician Decision|8|||
147580842|NCT02046122|532282241|FG000|Overall Study|Withdrawal by Subject|1|||
147580843|NCT04535986|532282244|FG000|Overall Study|Death|4|||
147580844|NCT04535986|532282245|FG001|Overall Study|Death|5|||
147580845|NCT04535986|532282244|FG000|Overall Study|COPD exacerbation withdrawal criteria|7|||
147580846|NCT04535986|532282245|FG001|Overall Study|COPD exacerbation withdrawal criteria|5|||
147580847|NCT04535986|532282244|FG000|Overall Study|Coronavirus disease 2019 (COVID-19)|8|||
147580848|NCT04535986|532282245|FG001|Overall Study|Coronavirus disease 2019 (COVID-19)|6|||
147580849|NCT04535986|532282244|FG000|Overall Study|Adverse Event|10|||
147580850|NCT04535986|532282245|FG001|Overall Study|Adverse Event|1|||
147580851|NCT04535986|532282244|FG000|Overall Study|Lack of Efficacy|3|||
147580852|NCT04535986|532282245|FG001|Overall Study|Lack of Efficacy|2|||
147580853|NCT04535986|532282244|FG000|Overall Study|Investigator discretion|3|||
147580854|NCT04535986|532282245|FG001|Overall Study|Investigator discretion|0|||
147580855|NCT04535986|532282244|FG000|Overall Study|Withdrawal by Subject|32|||
147580856|NCT04535986|532282245|FG001|Overall Study|Withdrawal by Subject|14|||
147580857|NCT04535986|532282244|FG000|Overall Study|Lost to Follow-up|5|||
147580858|NCT04535986|532282245|FG001|Overall Study|Lost to Follow-up|3|||
147580859|NCT04535986|532282244|FG000|Overall Study|Other|7|||
147580860|NCT04535986|532282245|FG001|Overall Study|Other|3|||
147580861|NCT01196390|532282246|FG000|Overall Study|Protocol Violation|4|||
147580862|NCT01196390|532282247|FG001|Overall Study|Protocol Violation|5|||
147580863|NCT03141151|532282256|FG000|Overall Study|Lost to Follow-up|3|||
147580864|NCT03141151|532282257|FG001|Overall Study|Lost to Follow-up|2|||
147580865|NCT03141151|532282256|FG000|Overall Study|Withdrawal by Subject|3|||
147580866|NCT03141151|532282257|FG001|Overall Study|Withdrawal by Subject|2|||
147580867|NCT04561115|532282258|FG000|GC Run-In + PK Phase (Up to 6 Months)|Withdrawal by Subject|1|||
147580868|NCT04561115|532282259|FG001|GC Run-In + PK Phase (Up to 6 Months)|Withdrawal by Subject|0|||
147580869|NCT04561115|532282258|FG000|IVIG-PEG Treatment (Up to 4.5 Months)|The Dose Changed Back and Forth 800-600 Mg/Kg During GC Phase Fulfilling Discontinuation Criteria|0|||
147580870|NCT04561115|532282259|FG001|IVIG-PEG Treatment (Up to 4.5 Months)|The Dose Changed Back and Forth 800-600 Mg/Kg During GC Phase Fulfilling Discontinuation Criteria|1|||
147580871|NCT04561115|532282258|FG000|IVIG-PEG + PK Phase (Up to 6 Months)|The Dose Changed Back and Forth 800-600 Mg/Kg During GC Phase Fulfilling Discontinuation Criteria|0|||
147580872|NCT04561115|532282259|FG001|IVIG-PEG + PK Phase (Up to 6 Months)|The Dose Changed Back and Forth 800-600 Mg/Kg During GC Phase Fulfilling Discontinuation Criteria|1|||
147580873|NCT02985398|532282260|FG000|Overall Study|Adverse Event|1|||
147580874|NCT02985398|532282260|FG000|Overall Study|Lost to Follow-up|4|||
147580875|NCT02985398|532282260|FG000|Overall Study|Withdrawal by Subject|8|||
147580876|NCT02985398|532282260|FG000|Overall Study|Study Burden|9|||
147580877|NCT00283842|532282263|FG000|Overall Study|Adverse Event|8|||
147580878|NCT00283842|532282264|FG001|Overall Study|Adverse Event|7|||
147580879|NCT00283842|532282265|FG002|Overall Study|Adverse Event|21|||
147580880|NCT00283842|532282266|FG003|Overall Study|Adverse Event|21|||
147580881|NCT00283842|532282267|FG004|Overall Study|Adverse Event|5|||
147580882|NCT00283842|532282263|FG000|Overall Study|Protocol Violation|1|||
147580883|NCT00283842|532282264|FG001|Overall Study|Protocol Violation|5|||
147580884|NCT00283842|532282265|FG002|Overall Study|Protocol Violation|4|||
147580885|NCT00283842|532282266|FG003|Overall Study|Protocol Violation|0|||
147580886|NCT00283842|532282267|FG004|Overall Study|Protocol Violation|0|||
147580887|NCT00283842|532282263|FG000|Overall Study|Protocol deviation|0|||
147446446|NCT01423851|531798965|FG006|Whole Study|Disease progression|1|||
147580888|NCT00283842|532282264|FG001|Overall Study|Protocol deviation|0|||
147580889|NCT00283842|532282265|FG002|Overall Study|Protocol deviation|0|||
147580890|NCT00283842|532282266|FG003|Overall Study|Protocol deviation|0|||
147321703|NCT02179918|531341663|FG003|Overall Study|Death|1|||
147580891|NCT00283842|532282267|FG004|Overall Study|Protocol deviation|2|||
147446447|NCT01423851|531798966|FG007|Whole Study|Disease progression|4|||
147580892|NCT00283842|532282263|FG000|Overall Study|Withdrawal by Subject|2|||
147446448|NCT01423851|531798967|FG008|Whole Study|Disease progression|0|||
147580893|NCT00283842|532282264|FG001|Overall Study|Withdrawal by Subject|1|||
147580894|NCT00283842|532282265|FG002|Overall Study|Withdrawal by Subject|1|||
147580895|NCT00283842|532282266|FG003|Overall Study|Withdrawal by Subject|5|||
147580896|NCT00283842|532282267|FG004|Overall Study|Withdrawal by Subject|4|||
147580897|NCT00283842|532282263|FG000|Overall Study|Lack of Efficacy|1|||
147580898|NCT00283842|532282264|FG001|Overall Study|Lack of Efficacy|3|||
147580899|NCT00283842|532282265|FG002|Overall Study|Lack of Efficacy|1|||
147580900|NCT00283842|532282266|FG003|Overall Study|Lack of Efficacy|0|||
147580901|NCT00283842|532282267|FG004|Overall Study|Lack of Efficacy|3|||
147580902|NCT00283842|532282263|FG000|Overall Study|Lost to Follow-up|0|||
147580903|NCT00283842|532282264|FG001|Overall Study|Lost to Follow-up|2|||
147580904|NCT00283842|532282265|FG002|Overall Study|Lost to Follow-up|4|||
147580905|NCT00283842|532282266|FG003|Overall Study|Lost to Follow-up|1|||
147580906|NCT00283842|532282267|FG004|Overall Study|Lost to Follow-up|1|||
147580907|NCT02004691|532282268|FG000|PAP: Up to 52 Weeks|Poor compliance|1|||
147446449|NCT01423851|531798968|FG009|Whole Study|Disease progression|2|||
147446450|NCT01423851|531798969|FG010|Whole Study|Disease progression|10|||
147446451|NCT01423851|531798959|FG000|Whole Study|Physician Decision|0|||
147446452|NCT01423851|531798960|FG001|Whole Study|Physician Decision|1|||
147446453|NCT01423851|531798961|FG002|Whole Study|Physician Decision|2|||
147446454|NCT01423851|531798962|FG003|Whole Study|Physician Decision|0|||
147446455|NCT01423851|531798963|FG004|Whole Study|Physician Decision|2|||
147446456|NCT01423851|531798964|FG005|Whole Study|Physician Decision|0|||
147446457|NCT01423851|531798965|FG006|Whole Study|Physician Decision|2|||
147446458|NCT01423851|531798966|FG007|Whole Study|Physician Decision|1|||
147446459|NCT01423851|531798967|FG008|Whole Study|Physician Decision|3|||
147446460|NCT01423851|531798968|FG009|Whole Study|Physician Decision|4|||
147446461|NCT01423851|531798969|FG010|Whole Study|Physician Decision|12|||
147446462|NCT01423851|531798959|FG000|Whole Study|Withdrawal by Subject|1|||
147446463|NCT01423851|531798960|FG001|Whole Study|Withdrawal by Subject|1|||
147446464|NCT01423851|531798961|FG002|Whole Study|Withdrawal by Subject|0|||
147446465|NCT01423851|531798962|FG003|Whole Study|Withdrawal by Subject|0|||
147446466|NCT01423851|531798963|FG004|Whole Study|Withdrawal by Subject|0|||
147446467|NCT01423851|531798964|FG005|Whole Study|Withdrawal by Subject|0|||
147446468|NCT01423851|531798965|FG006|Whole Study|Withdrawal by Subject|0|||
147446469|NCT01423851|531798966|FG007|Whole Study|Withdrawal by Subject|0|||
147446470|NCT01423851|531798967|FG008|Whole Study|Withdrawal by Subject|2|||
147446471|NCT01423851|531798968|FG009|Whole Study|Withdrawal by Subject|0|||
147446472|NCT01423851|531798969|FG010|Whole Study|Withdrawal by Subject|4|||
147446473|NCT01423851|531798959|FG000|Whole Study|Adverse Event|0|||
147446474|NCT01423851|531798960|FG001|Whole Study|Adverse Event|0|||
147446475|NCT01423851|531798961|FG002|Whole Study|Adverse Event|0|||
147446476|NCT01423851|531798962|FG003|Whole Study|Adverse Event|2|||
147446477|NCT01423851|531798963|FG004|Whole Study|Adverse Event|0|||
147446478|NCT01423851|531798964|FG005|Whole Study|Adverse Event|0|||
147446479|NCT01423851|531798965|FG006|Whole Study|Adverse Event|0|||
147446480|NCT01423851|531798966|FG007|Whole Study|Adverse Event|3|||
147446481|NCT01423851|531798967|FG008|Whole Study|Adverse Event|3|||
147446482|NCT01423851|531798968|FG009|Whole Study|Adverse Event|2|||
147446483|NCT01423851|531798969|FG010|Whole Study|Adverse Event|3|||
147446484|NCT00733954|531798973|FG000|Overall Study|Lost to Follow-up|5|||
147446485|NCT00733954|531798974|FG001|Overall Study|Lost to Follow-up|2|||
147446486|NCT00733954|531798973|FG000|Overall Study|Protocol Violation|1|||
147446487|NCT00733954|531798974|FG001|Overall Study|Protocol Violation|0|||
147446488|NCT00733954|531798973|FG000|Overall Study|Withdrawal by Subject|2|||
147446489|NCT00733954|531798974|FG001|Overall Study|Withdrawal by Subject|0|||
147446490|NCT02663453|531798975|FG000|Overall Study|Death|4|||
147446491|NCT02663453|531798976|FG001|Overall Study|Death|4|||
147580908|NCT02004691|532282269|FG001|PAP: Up to 52 Weeks|Poor compliance|0|||
147580909|NCT02004691|532282268|FG000|ETP: From Week 52 up to 5 Years|Related to Coronavirus Disease (COVID-19)|1|||
147580910|NCT02004691|532282269|FG001|ETP: From Week 52 up to 5 Years|Related to Coronavirus Disease (COVID-19)|0|||
147580911|NCT02004691|532282268|FG000|ETP: From Week 52 up to 5 Years|Withdrawal by Subject|1|||
147580912|NCT02004691|532282269|FG001|ETP: From Week 52 up to 5 Years|Withdrawal by Subject|1|||
147580913|NCT02004691|532282268|FG000|ETP: From Week 52 up to 5 Years|Pregnancy|1|||
147580914|NCT02004691|532282269|FG001|ETP: From Week 52 up to 5 Years|Pregnancy|0|||
147446492|NCT02663453|531798975|FG000|Overall Study|Withdrawal by Subject|1|||
147446493|NCT02663453|531798976|FG001|Overall Study|Withdrawal by Subject|0|||
147446494|NCT03416153|531798977|FG000|Overall Study|Physician Decision|1|||
147446495|NCT03416153|531798978|FG001|Overall Study|Physician Decision|1|||
147446496|NCT03416153|531798977|FG000|Overall Study|Withdrawal by Subject|1|||
147446497|NCT03416153|531798978|FG001|Overall Study|Withdrawal by Subject|0|||
147446498|NCT04649255|531800236|FG000|Overall Study|Death|9|||
147446499|NCT04649255|531800236|FG000|Overall Study|Withdrawal by Subject|1|||
147446500|NCT02484911|531800237|FG000|Overall Study|Withdrawal by Subject|2|||
147446501|NCT02484911|531800238|FG001|Overall Study|Withdrawal by Subject|1|||
147446502|NCT02484911|531800237|FG000|Overall Study|Protocol Violation|2|||
147446503|NCT02484911|531800238|FG001|Overall Study|Protocol Violation|1|||
147446504|NCT04129528|531800239|FG000|Overall Study|Adverse Event|1|||
147580915|NCT02004691|532282268|FG000|ETP: From Week 52 up to 5 Years|Adverse Event not Related to COVID-19|1|||
147580916|NCT02004691|532282269|FG001|ETP: From Week 52 up to 5 Years|Adverse Event not Related to COVID-19|0|||
147580917|NCT02004691|532282268|FG000|ETP: From Week 52 up to 5 Years|Not Related to COVID-19|0|||
147580918|NCT02004691|532282269|FG001|ETP: From Week 52 up to 5 Years|Not Related to COVID-19|1|||
147580919|NCT02472639|532282270|FG000|Overall Study|Physician Decision|4|||
147580920|NCT02472639|532282271|FG001|Overall Study|Physician Decision|3|||
147580921|NCT00751023|532282272|FG000|Overall Study|Lost to Follow-up|11|||
147580922|NCT00751023|532282273|FG001|Overall Study|Lost to Follow-up|7|||
147580923|NCT01277510|532282279|FG000|Double-blind Phase|Non-compliance|0|||
147580924|NCT01277510|532282280|FG001|Double-blind Phase|Non-compliance|1|||
147580925|NCT01277510|532282279|FG000|Double-blind Phase|Adverse Event|1|||
147580926|NCT01277510|532282280|FG001|Double-blind Phase|Adverse Event|0|||
147580927|NCT01277510|532282279|FG000|Double-blind Phase|Withdrawal by Subject|2|||
147580928|NCT01277510|532282280|FG001|Double-blind Phase|Withdrawal by Subject|0|||
147580929|NCT01277510|532282279|FG000|Double-blind Phase|Administrative decision|7|||
147580930|NCT01277510|532282280|FG001|Double-blind Phase|Administrative decision|9|||
147580931|NCT01277510|532282279|FG000|Double-blind Phase|Death|0|||
147580932|NCT01277510|532282280|FG001|Double-blind Phase|Death|1|||
147580933|NCT01277510|532282279|FG000|Double-blind Phase|Protocol-specified criteria|2|||
147580934|NCT01277510|532282280|FG001|Double-blind Phase|Protocol-specified criteria|6|||
147580935|NCT01277510|532282279|FG000|Double-blind Phase|Other|1|||
147580936|NCT01277510|532282280|FG001|Double-blind Phase|Other|1|||
147580937|NCT01277510|532282279|FG000|Open-label Phase|Administrative decision|4|||
147580938|NCT01277510|532282280|FG001|Open-label Phase|Administrative decision|3|||
147580939|NCT01277510|532282279|FG000|Open-label Phase|Protocol-specified criteria|1|||
147580940|NCT01277510|532282280|FG001|Open-label Phase|Protocol-specified criteria|0|||
147580941|NCT01277510|532282279|FG000|Open-label Phase|Never received investigational product|2|||
147580942|NCT01277510|532282280|FG001|Open-label Phase|Never received investigational product|0|||
147580943|NCT01685008|532282281|FG000|Main Study Treatment (Cycles 1 - 2)|Adverse Event|2|||
147580944|NCT01685008|532282282|FG001|Main Study Treatment (Cycles 1 - 2)|Adverse Event|0|||
147580945|NCT01685008|532282283|FG002|Main Study Treatment (Cycles 1 - 2)|Adverse Event|0|||
147580946|NCT01685008|532282284|FG003|Main Study Treatment (Cycles 1 - 2)|Adverse Event|1|||
147580947|NCT01685008|532282281|FG000|Main Study Treatment (Cycles 1 - 2)|Physician Decision|0|||
147580948|NCT01685008|532282282|FG001|Main Study Treatment (Cycles 1 - 2)|Physician Decision|2|||
147580949|NCT01685008|532282283|FG002|Main Study Treatment (Cycles 1 - 2)|Physician Decision|0|||
147580950|NCT01685008|532282284|FG003|Main Study Treatment (Cycles 1 - 2)|Physician Decision|0|||
147580951|NCT01685008|532282281|FG000|Main Study Treatment (Cycles 1 - 2)|Protocol Violation|0|||
147580952|NCT01685008|532282282|FG001|Main Study Treatment (Cycles 1 - 2)|Protocol Violation|1|||
147580953|NCT01685008|532282283|FG002|Main Study Treatment (Cycles 1 - 2)|Protocol Violation|0|||
147580954|NCT01685008|532282284|FG003|Main Study Treatment (Cycles 1 - 2)|Protocol Violation|0|||
147580955|NCT01685008|532282281|FG000|Main Study Treatment (Cycles 1 - 2)|Progressive Disease|2|||
147580956|NCT01685008|532282282|FG001|Main Study Treatment (Cycles 1 - 2)|Progressive Disease|4|||
147580957|NCT01685008|532282283|FG002|Main Study Treatment (Cycles 1 - 2)|Progressive Disease|1|||
147580958|NCT01685008|532282284|FG003|Main Study Treatment (Cycles 1 - 2)|Progressive Disease|0|||
147580959|NCT01685008|532282281|FG000|Main Study Treatment (Cycles 1 - 2)|Death|0|||
147580960|NCT01685008|532282282|FG001|Main Study Treatment (Cycles 1 - 2)|Death|3|||
147580961|NCT01685008|532282283|FG002|Main Study Treatment (Cycles 1 - 2)|Death|1|||
147580962|NCT01685008|532282284|FG003|Main Study Treatment (Cycles 1 - 2)|Death|0|||
147580963|NCT04049097|532282285|FG000|Overall Study|Adverse Event|18|||
147580964|NCT04049097|532282285|FG000|Overall Study|Death|2|||
147580965|NCT04049097|532282285|FG000|Overall Study|Lost to Follow-up|1|||
147580966|NCT04049097|532282285|FG000|Overall Study|Physician Decision|2|||
147580967|NCT04049097|532282285|FG000|Overall Study|Withdrawal by Subject|9|||
147580968|NCT04049097|532282285|FG000|Overall Study|Protocol Violation|2|||
147580969|NCT04049097|532282285|FG000|Overall Study|Other|1|||
147580970|NCT04049097|532282285|FG000|Overall Study|The trial was terminated early by the sponsor|86|||
147580971|NCT01320722|532282286|FG000|Overall Study|Did not Receive Intervention|3|||
147580972|NCT01320722|532282287|FG001|Overall Study|Did not Receive Intervention|2|||
147580973|NCT01320722|532282288|FG002|Overall Study|Did not Receive Intervention|1|||
147580974|NCT01320722|532282289|FG003|Overall Study|Did not Receive Intervention|1|||
147580975|NCT01320722|532282290|FG004|Overall Study|Did not Receive Intervention|2|||
147580976|NCT01320722|532282286|FG000|Overall Study|Lost to Follow-up|0|||
147580977|NCT01320722|532282287|FG001|Overall Study|Lost to Follow-up|1|||
147580978|NCT01320722|532282288|FG002|Overall Study|Lost to Follow-up|0|||
147580979|NCT01320722|532282289|FG003|Overall Study|Lost to Follow-up|1|||
147580980|NCT01320722|532282290|FG004|Overall Study|Lost to Follow-up|3|||
147580981|NCT01320722|532282286|FG000|Overall Study|Not Available for the 8 Week Visit|0|||
147580982|NCT01320722|532282287|FG001|Overall Study|Not Available for the 8 Week Visit|3|||
147580983|NCT01320722|532282288|FG002|Overall Study|Not Available for the 8 Week Visit|0|||
147580984|NCT01320722|532282289|FG003|Overall Study|Not Available for the 8 Week Visit|0|||
147580985|NCT01320722|532282290|FG004|Overall Study|Not Available for the 8 Week Visit|0|||
147580986|NCT01320722|532282286|FG000|Overall Study|Participant Developed a Rash|0|||
147580987|NCT01320722|532282287|FG001|Overall Study|Participant Developed a Rash|0|||
147580988|NCT01320722|532282288|FG002|Overall Study|Participant Developed a Rash|2|||
147580989|NCT01320722|532282289|FG003|Overall Study|Participant Developed a Rash|1|||
147580990|NCT01320722|532282290|FG004|Overall Study|Participant Developed a Rash|1|||
147580991|NCT01320722|532282286|FG000|Overall Study|Non-compliant with Medication|0|||
147580992|NCT01320722|532282287|FG001|Overall Study|Non-compliant with Medication|0|||
147580993|NCT01320722|532282288|FG002|Overall Study|Non-compliant with Medication|1|||
147580994|NCT01320722|532282289|FG003|Overall Study|Non-compliant with Medication|0|||
147580995|NCT01320722|532282290|FG004|Overall Study|Non-compliant with Medication|0|||
147580996|NCT01320722|532282286|FG000|Overall Study|Adverse Event|0|||
147580997|NCT01320722|532282287|FG001|Overall Study|Adverse Event|0|||
147580998|NCT01320722|532282288|FG002|Overall Study|Adverse Event|3|||
147580999|NCT01320722|532282289|FG003|Overall Study|Adverse Event|6|||
147581000|NCT01320722|532282290|FG004|Overall Study|Adverse Event|0|||
147581001|NCT01320722|532282286|FG000|Overall Study|Not Compliant with Study Procedures|0|||
147581002|NCT01320722|532282287|FG001|Overall Study|Not Compliant with Study Procedures|0|||
147581003|NCT01320722|532282288|FG002|Overall Study|Not Compliant with Study Procedures|0|||
147581004|NCT01320722|532282289|FG003|Overall Study|Not Compliant with Study Procedures|4|||
147581005|NCT01320722|532282290|FG004|Overall Study|Not Compliant with Study Procedures|0|||
147581006|NCT01320722|532282286|FG000|Overall Study|Pregnancy|0|||
147581007|NCT01320722|532282287|FG001|Overall Study|Pregnancy|0|||
147581008|NCT01320722|532282288|FG002|Overall Study|Pregnancy|0|||
147581009|NCT01320722|532282289|FG003|Overall Study|Pregnancy|1|||
147581010|NCT01320722|532282290|FG004|Overall Study|Pregnancy|0|||
147581011|NCT01320722|532282286|FG000|Overall Study|Started an Exclusionary Medication|0|||
147581012|NCT01320722|532282287|FG001|Overall Study|Started an Exclusionary Medication|0|||
147581013|NCT01320722|532282288|FG002|Overall Study|Started an Exclusionary Medication|0|||
147581014|NCT01320722|532282289|FG003|Overall Study|Started an Exclusionary Medication|0|||
147581015|NCT01320722|532282290|FG004|Overall Study|Started an Exclusionary Medication|1|||
147581016|NCT01320722|532282286|FG000|Overall Study|Withdrew due to Health Condition|0|||
147581017|NCT01320722|532282287|FG001|Overall Study|Withdrew due to Health Condition|0|||
147581018|NCT01320722|532282288|FG002|Overall Study|Withdrew due to Health Condition|0|||
147581019|NCT01320722|532282289|FG003|Overall Study|Withdrew due to Health Condition|0|||
147581020|NCT01320722|532282290|FG004|Overall Study|Withdrew due to Health Condition|1|||
147581021|NCT03828539|532282295|FG000|Overall Study|Adverse Event|3|||
147581022|NCT03828539|532282296|FG001|Overall Study|Adverse Event|12|||
147581023|NCT03828539|532282295|FG000|Overall Study|Patient's/guardian's decision|3|||
147581024|NCT03828539|532282296|FG001|Overall Study|Patient's/guardian's decision|5|||
147581025|NCT03828539|532282295|FG000|Overall Study|Lost to Follow-up|4|||
147581026|NCT03828539|532282296|FG001|Overall Study|Lost to Follow-up|2|||
147581027|NCT03828539|532282295|FG000|Overall Study|Protocol Violation|3|||
147581028|NCT03828539|532282296|FG001|Overall Study|Protocol Violation|2|||
147581029|NCT03828539|532282295|FG000|Overall Study|Withdrawal of informed consent|2|||
147581030|NCT03828539|532282296|FG001|Overall Study|Withdrawal of informed consent|1|||
147581031|NCT03828539|532282295|FG000|Overall Study|New therapy for study indication|1|||
147581032|NCT03828539|532282296|FG001|Overall Study|New therapy for study indication|0|||
147240106|NCT00730405|531051515|FG001|Overall Study-follow-up Phase|Non-compliance|0|||
147240107|NCT00730405|531051516|FG002|Overall Study-follow-up Phase|Non-compliance|2|||
147240108|NCT00730405|531051517|FG003|Overall Study-follow-up Phase|Non-compliance|0|||
147581033|NCT01849458|532282297|FG000|Overall Study|Lost to Follow-up|4|||
147581034|NCT03950674|532282298|FG000|Overall Study|Death|16|||
147581035|NCT03950674|532282299|FG001|Overall Study|Death|15|||
147581036|NCT03950674|532282298|FG000|Overall Study|Participation in the study terminated by the sponsor|9|||
147581037|NCT03950674|532282299|FG001|Overall Study|Participation in the study terminated by the sponsor|0|||
147581038|NCT00982228|532282300|FG000|Main: Week 0 to 52 (NN1250-3583)|Adverse Event|12|||
147581039|NCT00982228|532282301|FG001|Main: Week 0 to 52 (NN1250-3583)|Adverse Event|2|||
147581040|NCT00982228|532282300|FG000|Main: Week 0 to 52 (NN1250-3583)|Lack of Efficacy|2|||
147581041|NCT00982228|532282301|FG001|Main: Week 0 to 52 (NN1250-3583)|Lack of Efficacy|0|||
147581042|NCT00982228|532282300|FG000|Main: Week 0 to 52 (NN1250-3583)|Protocol Violation|11|||
147581043|NCT00982228|532282301|FG001|Main: Week 0 to 52 (NN1250-3583)|Protocol Violation|2|||
147581044|NCT00982228|532282300|FG000|Main: Week 0 to 52 (NN1250-3583)|Withdrawal criteria|15|||
147581045|NCT00982228|532282301|FG001|Main: Week 0 to 52 (NN1250-3583)|Withdrawal criteria|3|||
147240109|NCT00730405|531051518|FG004|Overall Study-follow-up Phase|Non-compliance|0|||
147240110|NCT00730405|531051514|FG000|Overall Study-follow-up Phase|Missing|0|||
147240111|NCT00730405|531051515|FG001|Overall Study-follow-up Phase|Missing|0|||
147581046|NCT00982228|532282300|FG000|Main: Week 0 to 52 (NN1250-3583)|Unclassified|28|||
147581047|NCT00982228|532282301|FG001|Main: Week 0 to 52 (NN1250-3583)|Unclassified|13|||
147581048|NCT00982228|532282300|FG000|Extension: Week 53 to 104 (NN1250-3644)|Adverse Event|3|||
147581049|NCT00982228|532282301|FG001|Extension: Week 53 to 104 (NN1250-3644)|Adverse Event|2|||
147581050|NCT00982228|532282300|FG000|Extension: Week 53 to 104 (NN1250-3644)|Lack of Efficacy|1|||
147581051|NCT00982228|532282301|FG001|Extension: Week 53 to 104 (NN1250-3644)|Lack of Efficacy|0|||
147581052|NCT00982228|532282300|FG000|Extension: Week 53 to 104 (NN1250-3644)|Protocol Violation|1|||
147653619|NCT04811664|532554624|FG000|Overall Study|Withdrawal by Subject|39|||
147653620|NCT04811664|532554625|FG001|Overall Study|Withdrawal by Subject|76|||
147653621|NCT04811664|532554626|FG002|Overall Study|Withdrawal by Subject|12|||
147653622|NCT04811664|532554624|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|6|||
147653623|NCT04811664|532554625|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|13|||
147653624|NCT04811664|532554626|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|17|||
147653625|NCT04811664|532554624|FG000|Overall Study|Participant is unwilling or unable to comply with required study|24|||
147653626|NCT04811664|532554625|FG001|Overall Study|Participant is unwilling or unable to comply with required study|47|||
147653627|NCT04811664|532554626|FG002|Overall Study|Participant is unwilling or unable to comply with required study|16|||
147653628|NCT04811664|532554624|FG000|Overall Study|Protocol Violation|0|||
147653629|NCT04811664|532554625|FG001|Overall Study|Protocol Violation|5|||
147653630|NCT04811664|532554626|FG002|Overall Study|Protocol Violation|11|||
147653631|NCT04811664|532554624|FG000|Overall Study|Study Terminated by Sponsor|4|||
147653632|NCT04811664|532554625|FG001|Overall Study|Study Terminated by Sponsor|3|||
147653633|NCT04811664|532554626|FG002|Overall Study|Study Terminated by Sponsor|34|||
147653634|NCT04811664|532554624|FG000|Overall Study|Early Study Closure|3|||
147653635|NCT04811664|532554625|FG001|Overall Study|Early Study Closure|7|||
147653636|NCT04811664|532554626|FG002|Overall Study|Early Study Closure|79|||
147653637|NCT04811664|532554624|FG000|Overall Study|Other (Unable to receive payment visa status)|0|||
147653638|NCT04811664|532554625|FG001|Overall Study|Other (Unable to receive payment visa status)|2|||
147446505|NCT04129528|531800240|FG001|Overall Study|Adverse Event|0|||
147446506|NCT04129528|531800239|FG000|Overall Study|Physician Decision|1|||
147446507|NCT04129528|531800240|FG001|Overall Study|Physician Decision|1|||
147653639|NCT04811664|532554626|FG002|Overall Study|Other (Unable to receive payment visa status)|0|||
147653640|NCT02717442|532554627|FG000|Overall Study|Study Terminated by Sponsor|31|||
147653641|NCT02717442|532554628|FG001|Overall Study|Study Terminated by Sponsor|29|||
147653642|NCT02717442|532554627|FG000|Overall Study|Subject Randomized, but Did not Receive Drug|2|||
147653643|NCT02717442|532554628|FG001|Overall Study|Subject Randomized, but Did not Receive Drug|0|||
147653644|NCT02717442|532554627|FG000|Overall Study|Other - Not Specified|2|||
147653645|NCT02717442|532554628|FG001|Overall Study|Other - Not Specified|0|||
147653646|NCT00382109|532554629|FG000|Overall Study|Adverse Event|3|||
147653647|NCT00382109|532554630|FG001|Overall Study|Adverse Event|0|||
147653648|NCT00382109|532554629|FG000|Overall Study|Physician Decision|6|||
147653649|NCT00382109|532554630|FG001|Overall Study|Physician Decision|1|||
147581053|NCT00982228|532282301|FG001|Extension: Week 53 to 104 (NN1250-3644)|Protocol Violation|2|||
147581054|NCT00982228|532282300|FG000|Extension: Week 53 to 104 (NN1250-3644)|Withdrawal criteria|5|||
147581055|NCT00982228|532282301|FG001|Extension: Week 53 to 104 (NN1250-3644)|Withdrawal criteria|0|||
147581056|NCT00982228|532282300|FG000|Extension: Week 53 to 104 (NN1250-3644)|Unclassified|11|||
147581057|NCT00982228|532282301|FG001|Extension: Week 53 to 104 (NN1250-3644)|Unclassified|1|||
147581058|NCT00360490|532282305|FG000|Overall Study|Adverse Event|4|||
147581059|NCT00360490|532282306|FG001|Overall Study|Adverse Event|2|||
147581060|NCT00360490|532282305|FG000|Overall Study|Lost to Follow-up|2|||
147581061|NCT00360490|532282306|FG001|Overall Study|Lost to Follow-up|1|||
147581062|NCT00360490|532282305|FG000|Overall Study|Physician Decision|2|||
147581063|NCT00360490|532282306|FG001|Overall Study|Physician Decision|1|||
147581064|NCT00360490|532282305|FG000|Overall Study|Protocol Violation|0|||
147581065|NCT00360490|532282306|FG001|Overall Study|Protocol Violation|4|||
147581066|NCT00360490|532282305|FG000|Overall Study|Withdrawal by Subject|1|||
147581067|NCT00360490|532282306|FG001|Overall Study|Withdrawal by Subject|3|||
147581068|NCT00633022|532282308|FG000|Overall Study|Adverse Event|1|||
147581069|NCT00633022|532282309|FG001|Overall Study|Adverse Event|0|||
147581070|NCT00633022|532282310|FG002|Overall Study|Adverse Event|5|||
147581071|NCT00633022|532282308|FG000|Overall Study|Physician Decision|0|||
147581072|NCT00633022|532282309|FG001|Overall Study|Physician Decision|1|||
147581073|NCT00633022|532282310|FG002|Overall Study|Physician Decision|0|||
147581074|NCT01958060|532283796|FG000|Overall Study|Not treated|2|||
147581075|NCT01958060|532283797|FG001|Overall Study|Not treated|0|||
147581076|NCT01958060|532283798|FG002|Overall Study|Not treated|0|||
147581077|NCT01958060|532283799|FG003|Overall Study|Not treated|0|||
147581078|NCT01958060|532283800|FG004|Overall Study|Not treated|1|||
147581079|NCT01958060|532283801|FG005|Overall Study|Not treated|0|||
147581080|NCT01705717|532283802|FG000|Overall Study|Adverse Event|2|||
147581081|NCT01705717|532283803|FG001|Overall Study|Adverse Event|2|||
147653650|NCT00382109|532554629|FG000|Overall Study|Withdrawal by Subject|1|||
147653651|NCT00382109|532554630|FG001|Overall Study|Withdrawal by Subject|0|||
147446508|NCT04129528|531800239|FG000|Overall Study|Withdrawal by Subject|1|||
147653652|NCT00382109|532554629|FG000|Overall Study|ineligible|2|||
147321704|NCT02179918|531341664|FG004|Overall Study|Death|0|||
147581082|NCT01705717|532283802|FG000|Overall Study|Lack of Efficacy|0|||
147581083|NCT01705717|532283803|FG001|Overall Study|Lack of Efficacy|1|||
147581084|NCT01705717|532283802|FG000|Overall Study|Other|0|||
147581085|NCT01705717|532283803|FG001|Overall Study|Other|2|||
147581086|NCT02293460|532283804|FG000|Overall Study|Protocol Violation|1|||
147581087|NCT02293460|532283804|FG000|Overall Study|Lack of Efficacy|2|||
147581088|NCT02293460|532283804|FG000|Overall Study|Adverse Event|2|||
147581089|NCT02293460|532283804|FG000|Overall Study|Withdrawal by Subject|1|||
147581090|NCT00500318|532283806|FG000|Overall Study|Adverse Event|3|||
147581091|NCT00500318|532283807|FG001|Overall Study|Adverse Event|8|||
147581092|NCT00500318|532283806|FG000|Overall Study|Protocol Violation|1|||
147581093|NCT00500318|532283807|FG001|Overall Study|Protocol Violation|3|||
147581094|NCT00500318|532283806|FG000|Overall Study|Withdrawal by Subject|1|||
147581095|NCT00500318|532283807|FG001|Overall Study|Withdrawal by Subject|2|||
147581096|NCT00500318|532283806|FG000|Overall Study|Lack of Efficacy|0|||
147581097|NCT00500318|532283807|FG001|Overall Study|Lack of Efficacy|3|||
147581098|NCT00500318|532283806|FG000|Overall Study|Other Reason|0|||
147581099|NCT00500318|532283807|FG001|Overall Study|Other Reason|1|||
147581100|NCT00799708|532283811|FG000|Overall Study|non-compliance|1|||
147581101|NCT00799708|532283812|FG001|Overall Study|non-compliance|0|||
147581102|NCT00799708|532283813|FG002|Overall Study|non-compliance|0|||
147581103|NCT00880334|532283814|FG000|Randomized Phase|Physician Decision|1|||
147581104|NCT00880334|532283815|FG001|Randomized Phase|Physician Decision|0|||
147581105|NCT00880334|532283814|FG000|Randomized Phase|Withdrawal by Subject|2|||
147581106|NCT00880334|532283815|FG001|Randomized Phase|Withdrawal by Subject|1|||
147581107|NCT00880334|532283814|FG000|Randomized Phase|Inadequate Labs|1|||
147581108|NCT00880334|532283815|FG001|Randomized Phase|Inadequate Labs|1|||
147581109|NCT00880334|532283814|FG000|Randomized Phase|Brain Metastasis|0|||
147581110|NCT00880334|532283815|FG001|Randomized Phase|Brain Metastasis|1|||
147581111|NCT00880334|532283814|FG000|Randomized Phase|Crossover Participants|0|||
147581112|NCT00880334|532283815|FG001|Randomized Phase|Crossover Participants|37|||
147581113|NCT02473393|532283816|FG000|Overall Study|Adverse Event|0|||
147581114|NCT02473393|532283817|FG001|Overall Study|Adverse Event|0|||
147581115|NCT02473393|532283818|FG002|Overall Study|Adverse Event|1|||
147581116|NCT02473393|532283819|FG003|Overall Study|Adverse Event|0|||
147581117|NCT02473393|532283816|FG000|Overall Study|Withdrawal by Subject|0|||
147581118|NCT02473393|532283817|FG001|Overall Study|Withdrawal by Subject|0|||
147581119|NCT02473393|532283818|FG002|Overall Study|Withdrawal by Subject|1|||
147581120|NCT02473393|532283819|FG003|Overall Study|Withdrawal by Subject|1|||
147581121|NCT01157234|532283824|FG000|Overall Study|Withdrawal by Subject|1|||
147581122|NCT01157234|532283825|FG001|Overall Study|Withdrawal by Subject|0|||
147581123|NCT00063258|532283829|FG000|Overall Study|Physician Decision|2|||
147581124|NCT00063258|532283830|FG001|Overall Study|Physician Decision|0|||
147581125|NCT00063258|532283829|FG000|Overall Study|Lack of Efficacy|2|||
147581126|NCT00063258|532283830|FG001|Overall Study|Lack of Efficacy|0|||
147581127|NCT02246764|532283831|FG000|Overall Study|Adverse Event|15|||
147581128|NCT02246764|532283832|FG001|Overall Study|Adverse Event|29|||
147581129|NCT02246764|532283833|FG002|Overall Study|Adverse Event|1|||
147581130|NCT02246764|532283831|FG000|Overall Study|Withdrawal by Subject|0|||
147581131|NCT02246764|532283832|FG001|Overall Study|Withdrawal by Subject|0|||
147581132|NCT02246764|532283833|FG002|Overall Study|Withdrawal by Subject|1|||
147581133|NCT02246764|532283831|FG000|Overall Study|Disallowed Concomitant Medication|1|||
147581134|NCT02246764|532283832|FG001|Overall Study|Disallowed Concomitant Medication|0|||
147581135|NCT02246764|532283833|FG002|Overall Study|Disallowed Concomitant Medication|0|||
147581136|NCT02246764|532283831|FG000|Overall Study|Physician Decision|0|||
147581137|NCT02246764|532283832|FG001|Overall Study|Physician Decision|2|||
147581138|NCT02246764|532283833|FG002|Overall Study|Physician Decision|1|||
147581139|NCT02246764|532283831|FG000|Overall Study|Protocol Violation|2|||
147581140|NCT02246764|532283832|FG001|Overall Study|Protocol Violation|1|||
147581141|NCT02246764|532283833|FG002|Overall Study|Protocol Violation|1|||
147581142|NCT05393271|532283834|FG000|Overall Study|Physician Decision|0|||
147581143|NCT05393271|532283835|FG001|Overall Study|Physician Decision|0|||
147581144|NCT05393271|532283836|FG002|Overall Study|Physician Decision|0|||
147581145|NCT05393271|532283837|FG003|Overall Study|Physician Decision|0|||
147581146|NCT05393271|532283838|FG004|Overall Study|Physician Decision|0|||
147581147|NCT05393271|532283839|FG005|Overall Study|Physician Decision|0|||
147581148|NCT05393271|532283840|FG006|Overall Study|Physician Decision|1|||
147581149|NCT05393271|532283841|FG007|Overall Study|Physician Decision|0|||
147581150|NCT05393271|532283842|FG008|Overall Study|Physician Decision|0|||
147581151|NCT05393271|532283843|FG009|Overall Study|Physician Decision|0|||
147581152|NCT05393271|532283844|FG010|Overall Study|Physician Decision|0|||
147581153|NCT00413049|532283849|FG000|Overall Study|Adverse Event|10|||
147240112|NCT00730405|531051516|FG002|Overall Study-follow-up Phase|Missing|2|||
147240113|NCT00730405|531051517|FG003|Overall Study-follow-up Phase|Missing|0|||
147581154|NCT00413049|532283850|FG001|Overall Study|Adverse Event|8|||
147581155|NCT00413049|532283849|FG000|Overall Study|Withdrawal by Subject|7|||
147581156|NCT00413049|532283850|FG001|Overall Study|Withdrawal by Subject|5|||
147581157|NCT00413049|532283849|FG000|Overall Study|Lost to Follow-up|2|||
147581158|NCT00413049|532283850|FG001|Overall Study|Lost to Follow-up|3|||
147581159|NCT00413049|532283849|FG000|Overall Study|Protocol Violation|3|||
147581160|NCT00413049|532283850|FG001|Overall Study|Protocol Violation|1|||
147581161|NCT00413049|532283849|FG000|Overall Study|Subject no longer requires study drug|0|||
147581162|NCT00413049|532283850|FG001|Overall Study|Subject no longer requires study drug|1|||
147581163|NCT00413049|532283849|FG000|Overall Study|Abnormal laboratory value(s)|1|||
147581164|NCT00413049|532283850|FG001|Overall Study|Abnormal laboratory value(s)|0|||
147581165|NCT00413049|532283849|FG000|Overall Study|Lack of Efficacy|1|||
147581166|NCT00413049|532283850|FG001|Overall Study|Lack of Efficacy|0|||
147581167|NCT03314857|532283853|FG000|Overall Study|Death|4|||
147581168|NCT03314857|532283853|FG000|Overall Study|Physician Decision|1|||
147581169|NCT01408888|532283856|FG000|First Intervention|Adverse Event|0|||
147581170|NCT01408888|532283857|FG001|First Intervention|Adverse Event|1|||
147581171|NCT01408888|532283856|FG000|First Intervention|Withdrawal by Subject|0|||
147581172|NCT01408888|532283857|FG001|First Intervention|Withdrawal by Subject|2|||
147581173|NCT01408888|532283856|FG000|Second Intervention|Withdrawal by Subject|1|||
147581174|NCT01408888|532283857|FG001|Second Intervention|Withdrawal by Subject|0|||
147581175|NCT01408888|532283856|FG000|Second Intervention|Adverse Event|1|||
147581176|NCT01408888|532283857|FG001|Second Intervention|Adverse Event|0|||
147581177|NCT00695110|532283860|FG000|Treatment Period 1|Adverse Event|1|||
147581178|NCT00695110|532283860|FG000|Treatment Period 1|Withdrawal by Subject|2|||
147581179|NCT00695110|532283860|FG000|Treatment Period 3|Withdrawal by Subject|1|||
147581180|NCT00695110|532283860|FG000|Treatment Period 4|Adverse Event|1|||
147581181|NCT02575339|532283866|FG000|Study Treatment|Patient Withdrawal After Therapy Start|1|||
147581182|NCT02575339|532283867|FG001|Study Treatment|Patient Withdrawal After Therapy Start|0|||
147581183|NCT02575339|532283868|FG002|Study Treatment|Patient Withdrawal After Therapy Start|0|||
147581184|NCT02575339|532283866|FG000|Study Treatment|Disease Progression|5|||
147581185|NCT02575339|532283867|FG001|Study Treatment|Disease Progression|2|||
147581186|NCT02575339|532283868|FG002|Study Treatment|Disease Progression|0|||
147581187|NCT02575339|532283866|FG000|Study Treatment|Adverse Event|1|||
147581188|NCT02575339|532283867|FG001|Study Treatment|Adverse Event|2|||
147581189|NCT02575339|532283868|FG002|Study Treatment|Adverse Event|0|||
147581190|NCT02575339|532283866|FG000|Follow up|Death|6|||
147581191|NCT02575339|532283867|FG001|Follow up|Death|2|||
147581192|NCT02575339|532283868|FG002|Follow up|Death|0|||
147581193|NCT02575339|532283866|FG000|Follow up|Study Terminated|0|||
147581194|NCT02575339|532283867|FG001|Follow up|Study Terminated|2|||
147581195|NCT02575339|532283868|FG002|Follow up|Study Terminated|0|||
147581196|NCT02575339|532283866|FG000|Follow up|Death due to progressive disease after coming off treatment early|1|||
147581197|NCT02575339|532283867|FG001|Follow up|Death due to progressive disease after coming off treatment early|0|||
147581198|NCT02575339|532283868|FG002|Follow up|Death due to progressive disease after coming off treatment early|0|||
147581199|NCT00550147|532283869|FG000|OROS Methylphenidate Monotherapy|significant improvement at visit 5|4|||
147581200|NCT00550147|532283869|FG000|OROS Methylphenidate Monotherapy|Withdrawal by Subject|2|||
147653653|NCT00382109|532554630|FG001|Overall Study|ineligible|0|||
147240114|NCT00730405|531051518|FG004|Overall Study-follow-up Phase|Missing|0|||
147240115|NCT00730405|531051514|FG000|Overall Study-follow-up Phase|Use an exclusionary medication|0|||
147240116|NCT00730405|531051515|FG001|Overall Study-follow-up Phase|Use an exclusionary medication|0|||
147240117|NCT00730405|531051516|FG002|Overall Study-follow-up Phase|Use an exclusionary medication|0|||
147240118|NCT00730405|531051517|FG003|Overall Study-follow-up Phase|Use an exclusionary medication|0|||
147653654|NCT00382109|532554629|FG000|Overall Study|Other|0|||
147653655|NCT00382109|532554630|FG001|Overall Study|Other|2|||
147653656|NCT00382109|532554629|FG000|Overall Study|consent withdrawal|0|||
147653657|NCT00382109|532554630|FG001|Overall Study|consent withdrawal|1|||
147653658|NCT05052697|532554631|FG000|Substudy A|Lost to Follow-up|0|||
147653659|NCT05052697|532554632|FG001|Substudy A|Lost to Follow-up|0|||
147653660|NCT05052697|532554633|FG002|Substudy A|Lost to Follow-up|0|||
147653661|NCT05052697|532554634|FG003|Substudy A|Lost to Follow-up|0|||
147653662|NCT05052697|532554635|FG004|Substudy A|Lost to Follow-up|0|||
147653663|NCT05052697|532554636|FG005|Substudy A|Lost to Follow-up|1|||
147653664|NCT05052697|532554637|FG006|Substudy A|Lost to Follow-up|0|||
147653665|NCT05052697|532554638|FG007|Substudy A|Lost to Follow-up|0|||
147653666|NCT05052697|532554639|FG008|Substudy A|Lost to Follow-up|0|||
147653667|NCT05052697|532554640|FG009|Substudy A|Lost to Follow-up|0|||
147653668|NCT05052697|532554641|FG010|Substudy A|Lost to Follow-up|0|||
147653669|NCT05052697|532554642|FG011|Substudy A|Lost to Follow-up|0|||
147240119|NCT00730405|531051518|FG004|Overall Study-follow-up Phase|Use an exclusionary medication|1|||
147240120|NCT00730405|531051514|FG000|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0|||
147240121|NCT00730405|531051515|FG001|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0|||
147321705|NCT02179918|531341660|FG000|Overall Study|Lost to Follow-up|0|||
147653670|NCT05052697|532554643|FG012|Substudy A|Lost to Follow-up|0|||
147653671|NCT05052697|532554644|FG013|Substudy A|Lost to Follow-up|0|||
147240122|NCT00730405|531051516|FG002|Overall Study-follow-up Phase|Human immunodeficiency virus positive|1|||
147321706|NCT02179918|531341661|FG001|Overall Study|Lost to Follow-up|0|||
147321707|NCT02179918|531341662|FG002|Overall Study|Lost to Follow-up|1|||
147581201|NCT00550147|532283869|FG000|Quetiapine Addition Treatment Period|Adverse Event|3|||
147581202|NCT00550147|532283869|FG000|Quetiapine Addition Treatment Period|Noncompliance|2|||
147581203|NCT00550147|532283869|FG000|Quetiapine Addition Treatment Period|Moved out of state|1|||
147581204|NCT04768114|532283870|FG000|Overall Study|Lost to Follow-up|5|||
147581205|NCT04768114|532283871|FG001|Overall Study|Lost to Follow-up|10|||
147581206|NCT04768114|532283870|FG000|Overall Study|Withdrawal by Subject|0|||
147653672|NCT05052697|532554645|FG014|Substudy A|Lost to Follow-up|0|||
147653673|NCT05052697|532554646|FG015|Substudy A|Lost to Follow-up|2|||
147240123|NCT00730405|531051517|FG003|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0|||
147240124|NCT00730405|531051518|FG004|Overall Study-follow-up Phase|Human immunodeficiency virus positive|0|||
147240125|NCT00730405|531051514|FG000|Overall Study-follow-up Phase|Mis-randomized|0|||
147240126|NCT00730405|531051515|FG001|Overall Study-follow-up Phase|Mis-randomized|1|||
147240127|NCT00730405|531051516|FG002|Overall Study-follow-up Phase|Mis-randomized|0|||
147446509|NCT04129528|531800240|FG001|Overall Study|Withdrawal by Subject|1|||
147446510|NCT00490568|531800249|FG000|Overall Study|Adverse Event|116|||
147653674|NCT05052697|532554647|FG016|Substudy A|Lost to Follow-up|0|||
147581207|NCT04768114|532283871|FG001|Overall Study|Withdrawal by Subject|1|||
147653675|NCT05052697|532554648|FG017|Substudy A|Lost to Follow-up|0|||
147653676|NCT05052697|532554649|FG018|Substudy A|Lost to Follow-up|0|||
147653677|NCT05052697|532554650|FG019|Substudy A|Lost to Follow-up|0|||
147653678|NCT05052697|532554651|FG020|Substudy A|Lost to Follow-up|0|||
147653679|NCT05052697|532554652|FG021|Substudy A|Lost to Follow-up|0|||
147653680|NCT05052697|532554653|FG022|Substudy A|Lost to Follow-up|0|||
147653681|NCT05052697|532554654|FG023|Substudy A|Lost to Follow-up|0|||
147653682|NCT05052697|532554655|FG024|Substudy A|Lost to Follow-up|0|||
147653683|NCT05052697|532554656|FG025|Substudy A|Lost to Follow-up|0|||
147653684|NCT05052697|532554657|FG026|Substudy A|Lost to Follow-up|0|||
147653685|NCT05052697|532554658|FG027|Substudy A|Lost to Follow-up|0|||
147653686|NCT05052697|532554659|FG028|Substudy A|Lost to Follow-up|0|||
147653687|NCT05052697|532554660|FG029|Substudy A|Lost to Follow-up|0|||
147653688|NCT05052697|532554661|FG030|Substudy A|Lost to Follow-up|0|||
147653689|NCT05052697|532554662|FG031|Substudy A|Lost to Follow-up|0|||
147653690|NCT05052697|532554663|FG032|Substudy A|Lost to Follow-up|0|||
147653691|NCT05052697|532554664|FG033|Substudy A|Lost to Follow-up|0|||
147581208|NCT01963260|532283876|FG000|Overall Study|Withdrawal by Subject|2|||
147581209|NCT01963260|532283877|FG001|Overall Study|Withdrawal by Subject|0|||
147581210|NCT01963260|532283878|FG002|Overall Study|Withdrawal by Subject|0|||
147581211|NCT01963260|532283879|FG003|Overall Study|Withdrawal by Subject|1|||
147581212|NCT01963260|532283880|FG004|Overall Study|Withdrawal by Subject|2|||
147581213|NCT01963260|532283881|FG005|Overall Study|Withdrawal by Subject|0|||
147581214|NCT01963260|532283882|FG006|Overall Study|Withdrawal by Subject|0|||
147581215|NCT01963260|532283883|FG007|Overall Study|Withdrawal by Subject|0|||
147581216|NCT01963260|532283884|FG008|Overall Study|Withdrawal by Subject|0|||
147581217|NCT01963260|532283885|FG009|Overall Study|Withdrawal by Subject|0|||
147581218|NCT04994431|532283886|FG000|Overall Study|Adverse Event|1|||
147581219|NCT04994431|532283887|FG001|Overall Study|Adverse Event|0|||
147581220|NCT00160524|532283888|FG000|Overall Study|Adverse Event|119|||
147581221|NCT00160524|532283888|FG000|Overall Study|Adverse Event and Other|94|||
147581222|NCT00160524|532283888|FG000|Overall Study|Protocol Violation|16|||
147653692|NCT05052697|532554631|FG000|Substudy A|No longer met eligibility criteria|0|||
147653693|NCT05052697|532554632|FG001|Substudy A|No longer met eligibility criteria|0|||
147653694|NCT05052697|532554633|FG002|Substudy A|No longer met eligibility criteria|0|||
147653695|NCT05052697|532554634|FG003|Substudy A|No longer met eligibility criteria|0|||
147653696|NCT05052697|532554635|FG004|Substudy A|No longer met eligibility criteria|0|||
147653697|NCT05052697|532554636|FG005|Substudy A|No longer met eligibility criteria|0|||
147653698|NCT05052697|532554637|FG006|Substudy A|No longer met eligibility criteria|0|||
147653699|NCT05052697|532554638|FG007|Substudy A|No longer met eligibility criteria|0|||
147653700|NCT05052697|532554639|FG008|Substudy A|No longer met eligibility criteria|0|||
147653701|NCT05052697|532554640|FG009|Substudy A|No longer met eligibility criteria|0|||
147653702|NCT05052697|532554641|FG010|Substudy A|No longer met eligibility criteria|0|||
147653703|NCT05052697|532554642|FG011|Substudy A|No longer met eligibility criteria|0|||
147653704|NCT05052697|532554643|FG012|Substudy A|No longer met eligibility criteria|0|||
147653705|NCT05052697|532554644|FG013|Substudy A|No longer met eligibility criteria|1|||
147653706|NCT05052697|532554645|FG014|Substudy A|No longer met eligibility criteria|0|||
147581223|NCT00160524|532283888|FG000|Overall Study|Protocol Violation and Other|2|||
147653707|NCT05052697|532554646|FG015|Substudy A|No longer met eligibility criteria|0|||
147653708|NCT05052697|532554647|FG016|Substudy A|No longer met eligibility criteria|0|||
147240128|NCT00730405|531051517|FG003|Overall Study-follow-up Phase|Mis-randomized|0|||
147240129|NCT00730405|531051518|FG004|Overall Study-follow-up Phase|Mis-randomized|0|||
147653709|NCT05052697|532554648|FG017|Substudy A|No longer met eligibility criteria|0|||
147653710|NCT05052697|532554649|FG018|Substudy A|No longer met eligibility criteria|0|||
147653711|NCT05052697|532554650|FG019|Substudy A|No longer met eligibility criteria|0|||
147653712|NCT05052697|532554651|FG020|Substudy A|No longer met eligibility criteria|0|||
147653713|NCT05052697|532554652|FG021|Substudy A|No longer met eligibility criteria|0|||
147240130|NCT00730405|531051514|FG000|Overall Study-follow-up Phase|Other Protocol violation|0|||
147240131|NCT00730405|531051515|FG001|Overall Study-follow-up Phase|Other Protocol violation|0|||
147581224|NCT00160524|532283888|FG000|Overall Study|Withdrawal by Subject|141|||
147581225|NCT00160524|532283888|FG000|Overall Study|Withdrawal by Subject and Other|17|||
147581226|NCT00160524|532283888|FG000|Overall Study|Physician Decision|27|||
147581227|NCT00160524|532283888|FG000|Overall Study|Physician Decision and Other|6|||
147653714|NCT05052697|532554653|FG022|Substudy A|No longer met eligibility criteria|0|||
147653715|NCT05052697|532554654|FG023|Substudy A|No longer met eligibility criteria|0|||
147446511|NCT00490568|531800249|FG000|Overall Study|Lost to Follow-up|13|||
147446512|NCT00490568|531800249|FG000|Overall Study|Protocol Violation|45|||
147446513|NCT00490568|531800249|FG000|Overall Study|Withdrawal by Subject|135|||
147446514|NCT00490568|531800249|FG000|Overall Study|Still in the study at termination|974|||
147446515|NCT00490568|531800249|FG000|Overall Study|Other|1|||
147446516|NCT00490568|531800249|FG000|Overall Study|Exclusion criteria met|1|||
147446517|NCT00490568|531800249|FG000|Overall Study|Caregiver related|20|||
147581228|NCT00160524|532283888|FG000|Overall Study|Lost to Follow-up|13|||
147581229|NCT00160524|532283888|FG000|Overall Study|Lost to Follow-up and Other|1|||
147581230|NCT00160524|532283888|FG000|Overall Study|Lack of Efficacy|21|||
147581231|NCT00160524|532283888|FG000|Overall Study|Lack of Efficacy and Other|1|||
147581232|NCT00160524|532283888|FG000|Overall Study|Other|20|||
147581233|NCT04892147|532283889|FG000|Overall Study|Withdrawal by Subject|2|||
147581234|NCT04892147|532283890|FG001|Overall Study|Withdrawal by Subject|0|||
147581235|NCT00057941|532283894|FG000|Overall Study|Death|1|||
147581236|NCT00057941|532283895|FG001|Overall Study|Death|2|||
147581237|NCT00057941|532283894|FG000|Overall Study|Adverse Event|7|||
147581238|NCT00057941|532283895|FG001|Overall Study|Adverse Event|9|||
147581239|NCT00057941|532283894|FG000|Overall Study|Lack of Efficacy|54|||
147581240|NCT00057941|532283895|FG001|Overall Study|Lack of Efficacy|53|||
147581241|NCT00057941|532283894|FG000|Overall Study|Withdrawal by Subject|6|||
147581242|NCT00057941|532283895|FG001|Overall Study|Withdrawal by Subject|1|||
147581243|NCT00057941|532283894|FG000|Overall Study|still on treatment|3|||
147581244|NCT00057941|532283895|FG001|Overall Study|still on treatment|1|||
147581245|NCT00057941|532283894|FG000|Overall Study|insurance, symptomatic deterioration|1|||
147581246|NCT00057941|532283895|FG001|Overall Study|insurance, symptomatic deterioration|3|||
147446518|NCT00490568|531800249|FG000|Overall Study|Abnormal ECG|25|||
147446519|NCT00490568|531800249|FG000|Overall Study|Participant refused follow-up|9|||
147446520|NCT00490568|531800249|FG000|Overall Study|Legal representative withdrew consent|1|||
147446521|NCT00490568|531800249|FG000|Overall Study|Disease progression|4|||
147446522|NCT00490568|531800249|FG000|Overall Study|Unmet inclusion-exclusion criteria|5|||
147446523|NCT00490568|531800249|FG000|Overall Study|Investigator decision|3|||
147446524|NCT00490568|531800249|FG000|Overall Study|Non-Compliance|7|||
147446525|NCT00490568|531800249|FG000|Overall Study|Efficacy related|3|||
147446526|NCT00490568|531800249|FG000|Overall Study|Participant died|1|||
147446527|NCT00490568|531800249|FG000|Overall Study|Participant withdrawal due to surgery|1|||
147446528|NCT01395394|531800250|FG000|Baseline Study Visit|Protocol Violation|1|||
147446529|NCT01395394|531800251|FG001|Baseline Study Visit|Protocol Violation|0|||
147446530|NCT01395394|531800252|FG002|Baseline Study Visit|Protocol Violation|0|||
147446531|NCT05121480|531800255|FG000|Overall Study|Lack of Efficacy|2|||
147446532|NCT05121480|531800256|FG001|Overall Study|Lack of Efficacy|2|||
147446533|NCT05121480|531800257|FG002|Overall Study|Lack of Efficacy|1|||
147446534|NCT05121480|531800258|FG003|Overall Study|Lack of Efficacy|4|||
147446535|NCT05121480|531800259|FG004|Overall Study|Lack of Efficacy|0|||
147446536|NCT05121480|531800260|FG005|Overall Study|Lack of Efficacy|1|||
147581247|NCT00057941|532283894|FG000|Overall Study|Ineligible|2|||
147581248|NCT00057941|532283895|FG001|Overall Study|Ineligible|5|||
147581249|NCT02760433|532283896|FG000|Overall Study|Lost to Follow-up|1|||
147581250|NCT02760433|532283897|FG001|Overall Study|Lost to Follow-up|0|||
147581251|NCT02760433|532283898|FG002|Overall Study|Lost to Follow-up|1|||
147581252|NCT02760433|532283899|FG003|Overall Study|Lost to Follow-up|0|||
147581253|NCT02760433|532283900|FG004|Overall Study|Lost to Follow-up|0|||
147581254|NCT02760433|532283896|FG000|Overall Study|Withdrawal by Subject|23|||
147581255|NCT02760433|532283897|FG001|Overall Study|Withdrawal by Subject|9|||
147581256|NCT02760433|532283898|FG002|Overall Study|Withdrawal by Subject|0|||
147581257|NCT02760433|532283899|FG003|Overall Study|Withdrawal by Subject|2|||
147581258|NCT02760433|532283900|FG004|Overall Study|Withdrawal by Subject|9|||
147581259|NCT02760433|532283896|FG000|Overall Study|Lack of Response At Week 14|0|||
147581260|NCT02760433|532283897|FG001|Overall Study|Lack of Response At Week 14|0|||
147581261|NCT02760433|532283898|FG002|Overall Study|Lack of Response At Week 14|0|||
147581262|NCT02760433|532283899|FG003|Overall Study|Lack of Response At Week 14|0|||
147581263|NCT02760433|532283900|FG004|Overall Study|Lack of Response At Week 14|1|||
147581264|NCT02760433|532283896|FG000|Overall Study|Subject refused to continue the study|1|||
147581265|NCT02760433|532283897|FG001|Overall Study|Subject refused to continue the study|0|||
147581266|NCT02760433|532283898|FG002|Overall Study|Subject refused to continue the study|0|||
147446537|NCT05121480|531800261|FG006|Overall Study|Lack of Efficacy|0|||
147581267|NCT02760433|532283899|FG003|Overall Study|Subject refused to continue the study|0|||
147581268|NCT02760433|532283900|FG004|Overall Study|Subject refused to continue the study|0|||
147581269|NCT02760433|532283896|FG000|Overall Study|Subject was taking prohibited medications and refused to stop.|2|||
147321708|NCT02179918|531341663|FG003|Overall Study|Lost to Follow-up|0|||
147446538|NCT05121480|531800262|FG007|Overall Study|Lack of Efficacy|2|||
147446539|NCT05121480|531800255|FG000|Overall Study|Treatment Failure|0|||
147446540|NCT05121480|531800256|FG001|Overall Study|Treatment Failure|2|||
147581270|NCT02760433|532283897|FG001|Overall Study|Subject was taking prohibited medications and refused to stop.|0|||
147581271|NCT02760433|532283898|FG002|Overall Study|Subject was taking prohibited medications and refused to stop.|0|||
147595960|NCT01875471|532338756|FG000|Overall Study|Unsatisfactory Lens Fitting|1|||
147653716|NCT05052697|532554655|FG024|Substudy A|No longer met eligibility criteria|0|||
147653717|NCT05052697|532554656|FG025|Substudy A|No longer met eligibility criteria|0|||
147653718|NCT05052697|532554657|FG026|Substudy A|No longer met eligibility criteria|0|||
147653719|NCT05052697|532554658|FG027|Substudy A|No longer met eligibility criteria|0|||
147653720|NCT05052697|532554659|FG028|Substudy A|No longer met eligibility criteria|0|||
147581272|NCT02760433|532283899|FG003|Overall Study|Subject was taking prohibited medications and refused to stop.|0|||
147581273|NCT02760433|532283900|FG004|Overall Study|Subject was taking prohibited medications and refused to stop.|0|||
147581274|NCT02760433|532283896|FG000|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|0|||
147581275|NCT02760433|532283897|FG001|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|1|||
147581276|NCT02760433|532283898|FG002|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|0|||
147581277|NCT02760433|532283899|FG003|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|0|||
147581278|NCT02760433|532283900|FG004|Overall Study|Ongoing Adverse Events (low platelet count) with long interruptions of investigational product|0|||
147581279|NCT00766493|532283901|FG000|30 Days Post-Procedure|Discontinued|7|||
147581280|NCT00766493|532283901|FG000|30 Days Post-Procedure|Missed Visit - Phone Contact f/u|4|||
147581281|NCT00766493|532283901|FG000|30 Days Post-Procedure|Missed Visit - No Phone Contact|1|||
147581282|NCT03439085|532283903|FG000|Overall Study|Death|2|||
147581283|NCT03439085|532283903|FG000|Overall Study|Screen Failure|20|||
147581284|NCT01863433|532283904|FG000|Overall Study|Protocol Violation|1|||
147581285|NCT02224053|532283905|FG000|AZD9291 and Omeprazole Co-administration|Exceeding PK limits after Period 1|11|||
147581286|NCT02224053|532283905|FG000|AZD9291 and Omeprazole Co-administration|Protocol Violation|4|||
147581287|NCT02224053|532283905|FG000|AZD9291 and Omeprazole Co-administration|Adverse Event|3|||
147581288|NCT02224053|532283905|FG000|AZD9291 and Omeprazole Co-administration|Withdrawal by Subject|1|||
147581289|NCT02224053|532283905|FG000|AZD9291 and Omeprazole Co-administration|Protocol non-compliance|2|||
147581290|NCT03448692|532283906|FG000|Investigational Treatment Period:Upto24W|Adverse Event|1|||
147581291|NCT03448692|532283907|FG001|Investigational Treatment Period:Upto24W|Adverse Event|0|||
147581292|NCT03448692|532283906|FG000|Investigational Treatment Period:Upto24W|Lack of Efficacy|0|||
147581293|NCT03448692|532283907|FG001|Investigational Treatment Period:Upto24W|Lack of Efficacy|1|||
147581294|NCT03448692|532283906|FG000|Investigational Treatment Period:Upto24W|Physician's decision|0|||
147581295|NCT03448692|532283907|FG001|Investigational Treatment Period:Upto24W|Physician's decision|1|||
147581296|NCT03448692|532283906|FG000|Investigational Treatment Period:Upto24W|Study terminated by sponsor|0|||
147581297|NCT03448692|532283907|FG001|Investigational Treatment Period:Upto24W|Study terminated by sponsor|5|||
147581298|NCT03448692|532283906|FG000|Investigational Treatment Period:Upto24W|Withdrawal by Subject|0|||
147581299|NCT03448692|532283907|FG001|Investigational Treatment Period:Upto24W|Withdrawal by Subject|2|||
147581300|NCT02289820|532283908|FG000|Overall Study|Withdrawal by Subject|2|||
147581301|NCT02289820|532283909|FG001|Overall Study|Withdrawal by Subject|1|||
147581302|NCT02289820|532283910|FG002|Overall Study|Withdrawal by Subject|2|||
147581303|NCT02289820|532283911|FG003|Overall Study|Withdrawal by Subject|1|||
147581304|NCT02289820|532283912|FG004|Overall Study|Withdrawal by Subject|0|||
147581305|NCT02289820|532283913|FG005|Overall Study|Withdrawal by Subject|0|||
147581306|NCT02289820|532283914|FG006|Overall Study|Withdrawal by Subject|1|||
147581307|NCT02289820|532283908|FG000|Overall Study|Death|0|||
147581308|NCT02289820|532283909|FG001|Overall Study|Death|0|||
147581309|NCT02289820|532283910|FG002|Overall Study|Death|1|||
147581310|NCT02289820|532283911|FG003|Overall Study|Death|0|||
147581311|NCT02289820|532283912|FG004|Overall Study|Death|0|||
147581312|NCT02289820|532283913|FG005|Overall Study|Death|0|||
147581313|NCT02289820|532283914|FG006|Overall Study|Death|0|||
147581314|NCT02289820|532283908|FG000|Overall Study|Lost to Follow-up|0|||
147581315|NCT02289820|532283909|FG001|Overall Study|Lost to Follow-up|0|||
147581316|NCT02289820|532283910|FG002|Overall Study|Lost to Follow-up|3|||
147581317|NCT02289820|532283911|FG003|Overall Study|Lost to Follow-up|1|||
147581318|NCT02289820|532283912|FG004|Overall Study|Lost to Follow-up|0|||
147581319|NCT02289820|532283913|FG005|Overall Study|Lost to Follow-up|1|||
147581320|NCT02289820|532283914|FG006|Overall Study|Lost to Follow-up|1|||
147581321|NCT02289820|532283908|FG000|Overall Study|withdrawal of consent|0|||
147581322|NCT02289820|532283909|FG001|Overall Study|withdrawal of consent|1|||
147581323|NCT02289820|532283910|FG002|Overall Study|withdrawal of consent|0|||
147581324|NCT02289820|532283911|FG003|Overall Study|withdrawal of consent|0|||
147581325|NCT02289820|532283912|FG004|Overall Study|withdrawal of consent|0|||
147581326|NCT02289820|532283913|FG005|Overall Study|withdrawal of consent|0|||
147653721|NCT05052697|532554660|FG029|Substudy A|No longer met eligibility criteria|0|||
147653722|NCT05052697|532554661|FG030|Substudy A|No longer met eligibility criteria|0|||
147581327|NCT02289820|532283914|FG006|Overall Study|withdrawal of consent|0|||
147653723|NCT05052697|532554662|FG031|Substudy A|No longer met eligibility criteria|0|||
147581328|NCT02786927|532283921|FG000|Overall Study|Adverse Event|1|||
147581329|NCT02786927|532283921|FG000|Overall Study|Protocol Violation|4|||
147581330|NCT01801917|532283922|FG000|Period 1 - Randomized|Adverse Event|1|||
147653724|NCT05052697|532554663|FG032|Substudy A|No longer met eligibility criteria|0|||
147653725|NCT05052697|532554664|FG033|Substudy A|No longer met eligibility criteria|0|||
147581331|NCT01801917|532283923|FG001|Period 1 - Randomized|Adverse Event|0|||
147581332|NCT01801917|532283924|FG002|Period 1 - Randomized|Adverse Event|1|||
147581333|NCT01801917|532283925|FG003|Period 1 - Randomized|Adverse Event|0|||
147581334|NCT01924364|532283926|FG000|Overall Study|Physician Decision|3|||
147581335|NCT00265785|532283927|FG000|Overall Study|Adverse Event|4|||
147581336|NCT00265785|532283927|FG000|Overall Study|Withdrawal by Subject|3|||
147446541|NCT05121480|531800257|FG002|Overall Study|Treatment Failure|0|||
147446542|NCT05121480|531800258|FG003|Overall Study|Treatment Failure|1|||
147446543|NCT05121480|531800259|FG004|Overall Study|Treatment Failure|0|||
147446544|NCT05121480|531800260|FG005|Overall Study|Treatment Failure|0|||
147446545|NCT05121480|531800261|FG006|Overall Study|Treatment Failure|0|||
147446546|NCT05121480|531800262|FG007|Overall Study|Treatment Failure|0|||
147446547|NCT05121480|531800255|FG000|Overall Study|Adverse Event|0|||
147446548|NCT05121480|531800256|FG001|Overall Study|Adverse Event|1|||
147446549|NCT05121480|531800257|FG002|Overall Study|Adverse Event|0|||
147446550|NCT05121480|531800258|FG003|Overall Study|Adverse Event|5|||
147446551|NCT05121480|531800259|FG004|Overall Study|Adverse Event|3|||
147446552|NCT05121480|531800260|FG005|Overall Study|Adverse Event|2|||
147446553|NCT05121480|531800261|FG006|Overall Study|Adverse Event|0|||
147446554|NCT05121480|531800262|FG007|Overall Study|Adverse Event|4|||
147446555|NCT05121480|531800255|FG000|Overall Study|Withdrawal by Subject|4|||
147446556|NCT05121480|531800256|FG001|Overall Study|Withdrawal by Subject|9|||
147446557|NCT05121480|531800257|FG002|Overall Study|Withdrawal by Subject|1|||
147446558|NCT05121480|531800258|FG003|Overall Study|Withdrawal by Subject|8|||
147446559|NCT05121480|531800259|FG004|Overall Study|Withdrawal by Subject|0|||
147446560|NCT05121480|531800260|FG005|Overall Study|Withdrawal by Subject|9|||
147446561|NCT05121480|531800261|FG006|Overall Study|Withdrawal by Subject|0|||
147446562|NCT05121480|531800262|FG007|Overall Study|Withdrawal by Subject|4|||
147446563|NCT05121480|531800255|FG000|Overall Study|Non-compliance with the protocol|0|||
147446564|NCT05121480|531800256|FG001|Overall Study|Non-compliance with the protocol|0|||
147446565|NCT05121480|531800257|FG002|Overall Study|Non-compliance with the protocol|0|||
147446566|NCT05121480|531800258|FG003|Overall Study|Non-compliance with the protocol|0|||
147446567|NCT05121480|531800259|FG004|Overall Study|Non-compliance with the protocol|1|||
147446568|NCT05121480|531800260|FG005|Overall Study|Non-compliance with the protocol|6|||
147446569|NCT05121480|531800261|FG006|Overall Study|Non-compliance with the protocol|0|||
147446570|NCT05121480|531800262|FG007|Overall Study|Non-compliance with the protocol|1|||
147446571|NCT05121480|531800255|FG000|Overall Study|Lost to Follow-up|0|||
147446572|NCT05121480|531800256|FG001|Overall Study|Lost to Follow-up|4|||
147446573|NCT05121480|531800257|FG002|Overall Study|Lost to Follow-up|1|||
147446574|NCT05121480|531800258|FG003|Overall Study|Lost to Follow-up|3|||
147446575|NCT05121480|531800259|FG004|Overall Study|Lost to Follow-up|1|||
147446576|NCT05121480|531800260|FG005|Overall Study|Lost to Follow-up|1|||
147446577|NCT05121480|531800261|FG006|Overall Study|Lost to Follow-up|1|||
147446578|NCT05121480|531800262|FG007|Overall Study|Lost to Follow-up|4|||
147446579|NCT05121480|531800255|FG000|Overall Study|Physician Decision|0|||
147446580|NCT05121480|531800256|FG001|Overall Study|Physician Decision|0|||
147446581|NCT05121480|531800257|FG002|Overall Study|Physician Decision|0|||
147446582|NCT05121480|531800258|FG003|Overall Study|Physician Decision|0|||
147446583|NCT05121480|531800259|FG004|Overall Study|Physician Decision|0|||
147446584|NCT05121480|531800260|FG005|Overall Study|Physician Decision|1|||
147446585|NCT05121480|531800261|FG006|Overall Study|Physician Decision|0|||
147446586|NCT05121480|531800262|FG007|Overall Study|Physician Decision|1|||
147446587|NCT05121480|531800255|FG000|Overall Study|Other Reason|0|||
147446588|NCT05121480|531800256|FG001|Overall Study|Other Reason|0|||
147446589|NCT05121480|531800257|FG002|Overall Study|Other Reason|0|||
147446590|NCT05121480|531800258|FG003|Overall Study|Other Reason|0|||
147446591|NCT05121480|531800259|FG004|Overall Study|Other Reason|0|||
147446592|NCT05121480|531800260|FG005|Overall Study|Other Reason|1|||
147446593|NCT05121480|531800261|FG006|Overall Study|Other Reason|1|||
147446594|NCT05121480|531800262|FG007|Overall Study|Other Reason|1|||
147446595|NCT00105443|531800263|FG000|Double-Blind Treatment|Adverse Event|1|||
147446596|NCT00105443|531800264|FG001|Double-Blind Treatment|Adverse Event|0|||
147446597|NCT00105443|531800265|FG002|Double-Blind Treatment|Adverse Event|0|||
147446598|NCT00105443|531800266|FG003|Double-Blind Treatment|Adverse Event|0|||
147581337|NCT00265785|532283927|FG000|Overall Study|Progression/Relapse|15|||
147581338|NCT00265785|532283927|FG000|Overall Study|Not protocol specified|2|||
147581339|NCT00265785|532283927|FG000|Overall Study|Ineligible|1|||
147446599|NCT00105443|531800263|FG000|Double-Blind Treatment|Lost to Follow-up|0|||
147446600|NCT00105443|531800264|FG001|Double-Blind Treatment|Lost to Follow-up|0|||
147446601|NCT00105443|531800265|FG002|Double-Blind Treatment|Lost to Follow-up|1|||
147446602|NCT00105443|531800266|FG003|Double-Blind Treatment|Lost to Follow-up|0|||
147446603|NCT00105443|531800263|FG000|Double-Blind Treatment|Withdrawal by Subject|8|||
147446604|NCT00105443|531800264|FG001|Double-Blind Treatment|Withdrawal by Subject|0|||
147446605|NCT00105443|531800265|FG002|Double-Blind Treatment|Withdrawal by Subject|7|||
147446606|NCT00105443|531800266|FG003|Double-Blind Treatment|Withdrawal by Subject|0|||
147446607|NCT00105443|531800263|FG000|Double-Blind Treatment|Physician Decision|1|||
147581340|NCT00265785|532283927|FG000|Overall Study|Did not receive protocol treatment|2|||
147240132|NCT00730405|531051516|FG002|Overall Study-follow-up Phase|Other Protocol violation|1|||
147653726|NCT05052697|532554631|FG000|Substudy A|Not vaccinated|0|||
147653727|NCT05052697|532554632|FG001|Substudy A|Not vaccinated|0|||
147653728|NCT05052697|532554633|FG002|Substudy A|Not vaccinated|0|||
147653729|NCT05052697|532554634|FG003|Substudy A|Not vaccinated|1|||
147653730|NCT05052697|532554635|FG004|Substudy A|Not vaccinated|0|||
147653731|NCT05052697|532554636|FG005|Substudy A|Not vaccinated|0|||
147653732|NCT05052697|532554637|FG006|Substudy A|Not vaccinated|0|||
147653733|NCT05052697|532554638|FG007|Substudy A|Not vaccinated|0|||
147653734|NCT05052697|532554639|FG008|Substudy A|Not vaccinated|1|||
147653735|NCT05052697|532554640|FG009|Substudy A|Not vaccinated|0|||
147653736|NCT05052697|532554641|FG010|Substudy A|Not vaccinated|0|||
147653737|NCT05052697|532554642|FG011|Substudy A|Not vaccinated|0|||
147653738|NCT05052697|532554643|FG012|Substudy A|Not vaccinated|0|||
147653739|NCT05052697|532554644|FG013|Substudy A|Not vaccinated|0|||
147653740|NCT05052697|532554645|FG014|Substudy A|Not vaccinated|0|||
147653741|NCT05052697|532554646|FG015|Substudy A|Not vaccinated|0|||
147653742|NCT05052697|532554647|FG016|Substudy A|Not vaccinated|0|||
147653743|NCT05052697|532554648|FG017|Substudy A|Not vaccinated|0|||
147653744|NCT05052697|532554649|FG018|Substudy A|Not vaccinated|0|||
147653745|NCT05052697|532554650|FG019|Substudy A|Not vaccinated|0|||
147653746|NCT05052697|532554651|FG020|Substudy A|Not vaccinated|0|||
147653747|NCT05052697|532554652|FG021|Substudy A|Not vaccinated|0|||
147653748|NCT05052697|532554653|FG022|Substudy A|Not vaccinated|0|||
147653749|NCT05052697|532554654|FG023|Substudy A|Not vaccinated|0|||
147653750|NCT05052697|532554655|FG024|Substudy A|Not vaccinated|0|||
147653751|NCT05052697|532554656|FG025|Substudy A|Not vaccinated|0|||
147653752|NCT05052697|532554657|FG026|Substudy A|Not vaccinated|0|||
147653753|NCT05052697|532554658|FG027|Substudy A|Not vaccinated|0|||
147653754|NCT05052697|532554659|FG028|Substudy A|Not vaccinated|0|||
147653755|NCT05052697|532554660|FG029|Substudy A|Not vaccinated|0|||
147653756|NCT05052697|532554661|FG030|Substudy A|Not vaccinated|0|||
147653757|NCT05052697|532554662|FG031|Substudy A|Not vaccinated|0|||
147653758|NCT05052697|532554663|FG032|Substudy A|Not vaccinated|0|||
147653759|NCT05052697|532554664|FG033|Substudy A|Not vaccinated|0|||
147240133|NCT00730405|531051517|FG003|Overall Study-follow-up Phase|Other Protocol violation|0|||
147240134|NCT00730405|531051518|FG004|Overall Study-follow-up Phase|Other Protocol violation|0|||
147240135|NCT00730405|531051514|FG000|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0|||
147240136|NCT00730405|531051515|FG001|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0|||
147240137|NCT00730405|531051516|FG002|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0|||
147240138|NCT00730405|531051517|FG003|Overall Study-follow-up Phase|discontinued AE, investigator discretion|1|||
147240139|NCT00730405|531051518|FG004|Overall Study-follow-up Phase|discontinued AE, investigator discretion|0|||
147240140|NCT00730405|531051514|FG000|Overall Study-follow-up Phase|Atrial fibrillation history|1|||
147653760|NCT05052697|532554631|FG000|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
147653761|NCT05052697|532554632|FG001|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
147653762|NCT05052697|532554633|FG002|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
147653763|NCT05052697|532554634|FG003|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
147653764|NCT05052697|532554635|FG004|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
147653765|NCT05052697|532554636|FG005|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
147653766|NCT05052697|532554637|FG006|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
147653767|NCT05052697|532554638|FG007|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
147653768|NCT05052697|532554639|FG008|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
147653769|NCT05052697|532554640|FG009|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
147653770|NCT05052697|532554641|FG010|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
147653771|NCT05052697|532554642|FG011|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
147653772|NCT05052697|532554643|FG012|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
147653773|NCT05052697|532554644|FG013|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
147653774|NCT05052697|532554645|FG014|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
147653775|NCT05052697|532554646|FG015|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
147653776|NCT05052697|532554647|FG016|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
147653777|NCT05052697|532554648|FG017|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
147653778|NCT05052697|532554649|FG018|SubStudy B: Initial Enrollment|Withdrawal by Subject|1|||
147240141|NCT00730405|531051515|FG001|Overall Study-follow-up Phase|Atrial fibrillation history|0|||
147653779|NCT05052697|532554650|FG019|SubStudy B: Initial Enrollment|Withdrawal by Subject|1|||
147653780|NCT05052697|532554651|FG020|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
147653781|NCT05052697|532554652|FG021|SubStudy B: Initial Enrollment|Withdrawal by Subject|1|||
147653782|NCT05052697|532554653|FG022|SubStudy B: Initial Enrollment|Withdrawal by Subject|2|||
147653783|NCT05052697|532554654|FG023|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
147653784|NCT05052697|532554655|FG024|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
147653785|NCT05052697|532554656|FG025|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
147653786|NCT05052697|532554657|FG026|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
147653787|NCT05052697|532554658|FG027|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
147653788|NCT05052697|532554659|FG028|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
147653789|NCT05052697|532554660|FG029|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
147581341|NCT04979858|532283928|FG000|Pre-Treatment|The participant was in quarantine at start of study and contracted COVID-19.|1|||
147581342|NCT04979858|532283929|FG001|Pre-Treatment|The participant was in quarantine at start of study and contracted COVID-19.|0|||
147581343|NCT04253236|532283930|FG000|Overall Study|Adverse Event|1|||
147446608|NCT00105443|531800264|FG001|Double-Blind Treatment|Physician Decision|0|||
147446609|NCT00105443|531800265|FG002|Double-Blind Treatment|Physician Decision|2|||
147446610|NCT00105443|531800266|FG003|Double-Blind Treatment|Physician Decision|0|||
147446611|NCT00105443|531800263|FG000|Double-Blind Treatment|Radiological and symptomatic progression|4|||
147581344|NCT04253236|532283931|FG001|Overall Study|Adverse Event|0|||
147581345|NCT04253236|532283930|FG000|Overall Study|Safety Concerns|1|||
147581346|NCT04253236|532283931|FG001|Overall Study|Safety Concerns|0|||
147581347|NCT04253236|532283930|FG000|Overall Study|Study Terminated by Sponsor|1|||
147581348|NCT04253236|532283931|FG001|Overall Study|Study Terminated by Sponsor|0|||
147581349|NCT03919695|532283932|FG000|3-month Follow-up|Death|1|||
147581350|NCT03919695|532283933|FG001|3-month Follow-up|Death|1|||
147581351|NCT03919695|532283932|FG000|3-month Follow-up|unable to contact|0|||
147581352|NCT03919695|532283933|FG001|3-month Follow-up|unable to contact|3|||
147581353|NCT03919695|532283932|FG000|3-month Follow-up|in prison|0|||
147581354|NCT03919695|532283933|FG001|3-month Follow-up|in prison|1|||
147581355|NCT03919695|532283932|FG000|6-month Follow-up|Death|0|||
147581356|NCT03919695|532283933|FG001|6-month Follow-up|Death|1|||
147581357|NCT03919695|532283932|FG000|6-month Follow-up|Lost to Follow-up|1|||
147581358|NCT03919695|532283933|FG001|6-month Follow-up|Lost to Follow-up|2|||
147581359|NCT03919695|532283932|FG000|6-month Follow-up|in prison|0|||
147581360|NCT03919695|532283933|FG001|6-month Follow-up|in prison|2|||
147581361|NCT03919695|532283932|FG000|Any Follow-up (3 and/or 6 Month)|Death|1|||
147581362|NCT03919695|532283933|FG001|Any Follow-up (3 and/or 6 Month)|Death|1|||
147581363|NCT03919695|532283932|FG000|Any Follow-up (3 and/or 6 Month)|Lost to Follow-up|0|||
147581364|NCT03919695|532283933|FG001|Any Follow-up (3 and/or 6 Month)|Lost to Follow-up|2|||
147581365|NCT02416934|532283935|FG000|Overall Study|given steroids|1|||
147581366|NCT02416934|532283936|FG001|Overall Study|given steroids|2|||
147581367|NCT02416934|532283935|FG000|Overall Study|Lost to Follow-up|0|||
147581368|NCT02416934|532283936|FG001|Overall Study|Lost to Follow-up|2|||
147581369|NCT02416934|532283935|FG000|Overall Study|Withdrawal by Subject|1|||
147581370|NCT02416934|532283936|FG001|Overall Study|Withdrawal by Subject|0|||
147581371|NCT02416934|532283935|FG000|Overall Study|recruited during continuing renewal proc|0|||
147581372|NCT02416934|532283936|FG001|Overall Study|recruited during continuing renewal proc|1|||
147581373|NCT02416934|532283935|FG000|Overall Study|Protocol Violation|0|||
147581374|NCT02416934|532283936|FG001|Overall Study|Protocol Violation|1|||
147581375|NCT02416934|532283935|FG000|Overall Study|surgery started late|0|||
147581376|NCT02416934|532283936|FG001|Overall Study|surgery started late|1|||
147581377|NCT02416934|532283935|FG000|Overall Study|re-operation|1|||
147581378|NCT02416934|532283936|FG001|Overall Study|re-operation|0|||
147581379|NCT01337596|532283948|FG000|Overall Study|Withdrawal by Subject|0|||
147581380|NCT01337596|532283949|FG001|Overall Study|Withdrawal by Subject|0|||
147581381|NCT01337596|532283950|FG002|Overall Study|Withdrawal by Subject|0|||
147581382|NCT01337596|532283951|FG003|Overall Study|Withdrawal by Subject|0|||
147581383|NCT01337596|532283952|FG004|Overall Study|Withdrawal by Subject|2|||
147581384|NCT01337596|532283953|FG005|Overall Study|Withdrawal by Subject|0|||
147581385|NCT01337596|532283954|FG006|Overall Study|Withdrawal by Subject|0|||
147446612|NCT00105443|531800264|FG001|Double-Blind Treatment|Radiological and symptomatic progression|0|||
147446613|NCT00105443|531800265|FG002|Double-Blind Treatment|Radiological and symptomatic progression|1|||
147446614|NCT00105443|531800266|FG003|Double-Blind Treatment|Radiological and symptomatic progression|0|||
147446615|NCT00105443|531800263|FG000|Follow-up and/or Open Label Nexavar|Death|180|||
147446616|NCT00105443|531800264|FG001|Follow-up and/or Open Label Nexavar|Death|7|||
147446617|NCT00105443|531800265|FG002|Follow-up and/or Open Label Nexavar|Death|219|||
147446618|NCT00105443|531800266|FG003|Follow-up and/or Open Label Nexavar|Death|4|||
147446619|NCT00105443|531800263|FG000|Follow-up and/or Open Label Nexavar|Lost to Follow-up|14|||
147446620|NCT00105443|531800264|FG001|Follow-up and/or Open Label Nexavar|Lost to Follow-up|0|||
147446621|NCT00105443|531800265|FG002|Follow-up and/or Open Label Nexavar|Lost to Follow-up|10|||
147446622|NCT00105443|531800266|FG003|Follow-up and/or Open Label Nexavar|Lost to Follow-up|0|||
147446623|NCT00105443|531800263|FG000|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|24|||
147446624|NCT00105443|531800264|FG001|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|3|||
147581386|NCT01337596|532283955|FG007|Overall Study|Withdrawal by Subject|0|||
147581387|NCT01337596|532283956|FG008|Overall Study|Withdrawal by Subject|0|||
147581388|NCT03201003|532283960|FG000|Overall Study|Adverse Event|14|||
147581389|NCT03201003|532283961|FG001|Overall Study|Adverse Event|1|||
147581390|NCT03201003|532283960|FG000|Overall Study|Other reasons|5|||
147446625|NCT00105443|531800265|FG002|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|13|||
147446626|NCT00105443|531800266|FG003|Follow-up and/or Open Label Nexavar|Withdrawal by Subject|4|||
147581391|NCT03201003|532283961|FG001|Overall Study|Other reasons|1|||
147581392|NCT03201003|532283960|FG000|Overall Study|Withdrawal by Subject|4|||
147581393|NCT03201003|532283961|FG001|Overall Study|Withdrawal by Subject|1|||
147581394|NCT03201003|532283960|FG000|Overall Study|Lost to Follow-up|2|||
147581395|NCT03201003|532283961|FG001|Overall Study|Lost to Follow-up|0|||
147240142|NCT00730405|531051516|FG002|Overall Study-follow-up Phase|Atrial fibrillation history|0|||
147581396|NCT03201003|532283960|FG000|Overall Study|Protocol Violation|1|||
147581397|NCT03201003|532283961|FG001|Overall Study|Protocol Violation|0|||
147581398|NCT00834613|532283962|FG000|First Intervention|Protocol Violation|1|||
147581399|NCT00834613|532283963|FG001|First Intervention|Protocol Violation|0|||
147581400|NCT00697619|532283967|FG000|Overall Study|Lack of Efficacy|2|||
147581401|NCT00697619|532283968|FG001|Overall Study|Lack of Efficacy|2|||
147581402|NCT00697619|532283967|FG000|Overall Study|Adverse Event|4|||
147581403|NCT00697619|532283968|FG001|Overall Study|Adverse Event|6|||
147581404|NCT01188226|532285454|FG000|Overall Study|Withdrawal by Subject|4|||
147581405|NCT04980456|532285455|FG000|Period 1 (Approximately 30 Days)|Adverse Event|2|||
147581406|NCT04980456|532285456|FG001|Period 1 (Approximately 30 Days)|Adverse Event|0|||
147581407|NCT04980456|532285455|FG000|Period 1 (Approximately 30 Days)|Lost to Follow-up|0|||
147581408|NCT04980456|532285456|FG001|Period 1 (Approximately 30 Days)|Lost to Follow-up|1|||
147581409|NCT04980456|532285455|FG000|Period 1 (Approximately 30 Days)|Withdrawal by Subject|1|||
147581410|NCT04980456|532285456|FG001|Period 1 (Approximately 30 Days)|Withdrawal by Subject|2|||
147581411|NCT04980456|532285455|FG000|Period 2 (Approximately 30 Days)|Adverse Event|0|||
147581412|NCT04980456|532285456|FG001|Period 2 (Approximately 30 Days)|Adverse Event|1|||
147581413|NCT00224484|532285457|FG000|Overall Study|Serious Adverse Event|1|||
147581414|NCT00224484|532285458|FG001|Overall Study|Serious Adverse Event|1|||
147581415|NCT00224484|532285459|FG002|Overall Study|Serious Adverse Event|0|||
147581416|NCT00224484|532285457|FG000|Overall Study|Non-Serious Adverse Event|5|||
147581417|NCT00224484|532285458|FG001|Overall Study|Non-Serious Adverse Event|7|||
147581418|NCT00224484|532285459|FG002|Overall Study|Non-Serious Adverse Event|3|||
147581419|NCT00224484|532285457|FG000|Overall Study|Protocol Violation|2|||
147581420|NCT00224484|532285458|FG001|Overall Study|Protocol Violation|2|||
147581421|NCT00224484|532285459|FG002|Overall Study|Protocol Violation|0|||
147581422|NCT00224484|532285457|FG000|Overall Study|Withdrawal by Subject|49|||
147581423|NCT00224484|532285458|FG001|Overall Study|Withdrawal by Subject|18|||
147581424|NCT00224484|532285459|FG002|Overall Study|Withdrawal by Subject|16|||
147581425|NCT00224484|532285457|FG000|Overall Study|Migrated/moved from study area|18|||
147581426|NCT00224484|532285458|FG001|Overall Study|Migrated/moved from study area|5|||
147581427|NCT00224484|532285459|FG002|Overall Study|Migrated/moved from study area|5|||
147581428|NCT00224484|532285457|FG000|Overall Study|Lost to Follow-up|66|||
147581429|NCT00224484|532285458|FG001|Overall Study|Lost to Follow-up|28|||
147581430|NCT00224484|532285459|FG002|Overall Study|Lost to Follow-up|36|||
147581431|NCT00224484|532285457|FG000|Overall Study|Reason not specified|5|||
147581432|NCT00224484|532285458|FG001|Overall Study|Reason not specified|4|||
147581433|NCT00224484|532285459|FG002|Overall Study|Reason not specified|2|||
147581434|NCT01074008|532285462|FG000|Overall Study|Adverse Event|0|||
147581435|NCT01074008|532285463|FG001|Overall Study|Adverse Event|1|||
147581436|NCT01074008|532285464|FG002|Overall Study|Adverse Event|0|||
147581437|NCT01074008|532285465|FG003|Overall Study|Adverse Event|0|||
147581438|NCT01074008|532285466|FG004|Overall Study|Adverse Event|0|||
147581439|NCT01074008|532285467|FG005|Overall Study|Adverse Event|0|||
147581440|NCT01074008|532285468|FG006|Overall Study|Adverse Event|0|||
147581441|NCT01074008|532285469|FG007|Overall Study|Adverse Event|0|||
147581442|NCT01074008|532285470|FG008|Overall Study|Adverse Event|0|||
147581443|NCT01074008|532285462|FG000|Overall Study|Withdrawal by Subject|1|||
147581444|NCT01074008|532285463|FG001|Overall Study|Withdrawal by Subject|1|||
147581445|NCT01074008|532285464|FG002|Overall Study|Withdrawal by Subject|1|||
147581446|NCT01074008|532285465|FG003|Overall Study|Withdrawal by Subject|0|||
147581447|NCT01074008|532285466|FG004|Overall Study|Withdrawal by Subject|1|||
147581448|NCT01074008|532285467|FG005|Overall Study|Withdrawal by Subject|0|||
147581449|NCT01074008|532285468|FG006|Overall Study|Withdrawal by Subject|0|||
147581450|NCT01074008|532285469|FG007|Overall Study|Withdrawal by Subject|0|||
147581451|NCT01074008|532285470|FG008|Overall Study|Withdrawal by Subject|0|||
147581452|NCT01074008|532285462|FG000|Overall Study|Lost to Follow-up|0|||
147581453|NCT01074008|532285463|FG001|Overall Study|Lost to Follow-up|1|||
147581454|NCT01074008|532285464|FG002|Overall Study|Lost to Follow-up|1|||
147581455|NCT01074008|532285465|FG003|Overall Study|Lost to Follow-up|1|||
147581456|NCT01074008|532285466|FG004|Overall Study|Lost to Follow-up|1|||
147581457|NCT01074008|532285467|FG005|Overall Study|Lost to Follow-up|0|||
147581458|NCT01074008|532285468|FG006|Overall Study|Lost to Follow-up|1|||
147581459|NCT01074008|532285469|FG007|Overall Study|Lost to Follow-up|0|||
147581460|NCT01074008|532285470|FG008|Overall Study|Lost to Follow-up|4|||
147581461|NCT02805309|532285471|FG000|Overall Study|Lost to Follow-up|2|||
147581462|NCT02805309|532285472|FG001|Overall Study|Lost to Follow-up|2|||
147240143|NCT00730405|531051517|FG003|Overall Study-follow-up Phase|Atrial fibrillation history|0|||
147240144|NCT00730405|531051518|FG004|Overall Study-follow-up Phase|Atrial fibrillation history|0|||
147581463|NCT02805309|532285473|FG002|Overall Study|Lost to Follow-up|2|||
147581464|NCT02805309|532285471|FG000|Overall Study|Post-Randomization Exclusion|0|||
147581465|NCT02805309|532285472|FG001|Overall Study|Post-Randomization Exclusion|2|||
147581466|NCT02805309|532285473|FG002|Overall Study|Post-Randomization Exclusion|1|||
147581467|NCT01636934|532285474|FG000|Overall Study|Withdrawal by Subject|3|||
147581468|NCT01636934|532285475|FG001|Overall Study|Withdrawal by Subject|2|||
147581469|NCT01636934|532285474|FG000|Overall Study|Chemo cancel|1|||
147581470|NCT01636934|532285475|FG001|Overall Study|Chemo cancel|0|||
147581471|NCT01636934|532285474|FG000|Overall Study|Too ill to continue|1|||
147581472|NCT01636934|532285475|FG001|Overall Study|Too ill to continue|0|||
147581473|NCT01636934|532285474|FG000|Overall Study|Never started study medication|1|||
147581474|NCT01636934|532285475|FG001|Overall Study|Never started study medication|1|||
147446627|NCT00105443|531800263|FG000|Follow-up and/or Open Label Nexavar|Adverse Event|0|||
147446628|NCT00105443|531800264|FG001|Follow-up and/or Open Label Nexavar|Adverse Event|14|||
147446629|NCT00105443|531800265|FG002|Follow-up and/or Open Label Nexavar|Adverse Event|0|||
147446630|NCT00105443|531800266|FG003|Follow-up and/or Open Label Nexavar|Adverse Event|16|||
147446631|NCT00105443|531800263|FG000|Follow-up and/or Open Label Nexavar|Physician Decision|1|||
147446632|NCT00105443|531800264|FG001|Follow-up and/or Open Label Nexavar|Physician Decision|0|||
147446633|NCT00105443|531800265|FG002|Follow-up and/or Open Label Nexavar|Physician Decision|1|||
147446634|NCT00105443|531800266|FG003|Follow-up and/or Open Label Nexavar|Physician Decision|0|||
147446635|NCT00105443|531800263|FG000|Follow-up and/or Open Label Nexavar|Protocol Violation|0|||
147446636|NCT00105443|531800264|FG001|Follow-up and/or Open Label Nexavar|Protocol Violation|2|||
147446637|NCT00105443|531800265|FG002|Follow-up and/or Open Label Nexavar|Protocol Violation|0|||
147446638|NCT00105443|531800266|FG003|Follow-up and/or Open Label Nexavar|Protocol Violation|0|||
147446639|NCT00105443|531800263|FG000|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|0|||
147446640|NCT00105443|531800264|FG001|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|2|||
147446641|NCT00105443|531800265|FG002|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|0|||
147581475|NCT03687242|532285480|FG000|Overall Study|Adverse Event|1|||
147581476|NCT00377156|532285483|FG000|Overall Study|Death|23|||
147581477|NCT00377156|532285484|FG001|Overall Study|Death|19|||
147446642|NCT00105443|531800266|FG003|Follow-up and/or Open Label Nexavar|Progression by clinical judgment|5|||
147446643|NCT00105443|531800263|FG000|Follow-up and/or Open Label Nexavar|Progression, measurement proven|0|||
147446644|NCT00105443|531800264|FG001|Follow-up and/or Open Label Nexavar|Progression, measurement proven|3|||
147446645|NCT00105443|531800265|FG002|Follow-up and/or Open Label Nexavar|Progression, measurement proven|0|||
147446646|NCT00105443|531800266|FG003|Follow-up and/or Open Label Nexavar|Progression, measurement proven|3|||
147446647|NCT00105443|531800263|FG000|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|6|||
147446648|NCT00105443|531800264|FG001|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|0|||
147446649|NCT00105443|531800265|FG002|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|1|||
147446650|NCT00105443|531800266|FG003|Follow-up and/or Open Label Nexavar|Disease progression, recurrence, relapse|0|||
147446651|NCT00105443|531800263|FG000|Follow-up and/or Open Label Nexavar|Endpoint record not completed|2|||
147446652|NCT00105443|531800264|FG001|Follow-up and/or Open Label Nexavar|Endpoint record not completed|2|||
147446653|NCT00105443|531800265|FG002|Follow-up and/or Open Label Nexavar|Endpoint record not completed|1|||
147446654|NCT00105443|531800266|FG003|Follow-up and/or Open Label Nexavar|Endpoint record not completed|2|||
147446655|NCT00105443|531800263|FG000|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|1|||
147446656|NCT00105443|531800264|FG001|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|0|||
147446657|NCT00105443|531800265|FG002|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|0|||
147446658|NCT00105443|531800266|FG003|Follow-up and/or Open Label Nexavar|Planned switch to OL; record incomplete|0|||
147446659|NCT00105443|531800263|FG000|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|0|||
147446660|NCT00105443|531800264|FG001|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|0|||
147446661|NCT00105443|531800265|FG002|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|0|||
147446662|NCT00105443|531800266|FG003|Follow-up and/or Open Label Nexavar|Non-compliant with study medication|1|||
147446663|NCT00105443|531800263|FG000|Follow-up and/or Open Label Nexavar|Reached ECOG 4|0|||
147446664|NCT00105443|531800264|FG001|Follow-up and/or Open Label Nexavar|Reached ECOG 4|1|||
147446665|NCT00105443|531800265|FG002|Follow-up and/or Open Label Nexavar|Reached ECOG 4|0|||
147446666|NCT00105443|531800266|FG003|Follow-up and/or Open Label Nexavar|Reached ECOG 4|1|||
147446667|NCT00105443|531800263|FG000|Follow-up and/or Open Label Nexavar|Switch to commercial drug|0|||
147446668|NCT00105443|531800264|FG001|Follow-up and/or Open Label Nexavar|Switch to commercial drug|23|||
147446669|NCT00105443|531800265|FG002|Follow-up and/or Open Label Nexavar|Switch to commercial drug|0|||
147446670|NCT00105443|531800266|FG003|Follow-up and/or Open Label Nexavar|Switch to commercial drug|11|||
147446671|NCT01157078|531800267|FG000|Overall Study|Withdrawal by Subject|12|||
147446672|NCT01157078|531800268|FG001|Overall Study|Withdrawal by Subject|14|||
147446673|NCT01157078|531800267|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
147446674|NCT01157078|531800268|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
147446675|NCT01157078|531800267|FG000|Overall Study|Adverse Event|6|||
147446676|NCT01157078|531800268|FG001|Overall Study|Adverse Event|6|||
147446677|NCT01157078|531800267|FG000|Overall Study|Severe non-compliance to protocol|2|||
147581478|NCT00377156|532285483|FG000|Overall Study|Withdrawal by Subject|16|||
147581479|NCT00377156|532285484|FG001|Overall Study|Withdrawal by Subject|24|||
147581480|NCT00377156|532285483|FG000|Overall Study|Had follow-up <90 d|3|||
147581481|NCT00377156|532285484|FG001|Overall Study|Had follow-up <90 d|6|||
147581482|NCT00377156|532285483|FG000|Overall Study|Cancellation|1|||
147581483|NCT00377156|532285484|FG001|Overall Study|Cancellation|0|||
147653790|NCT05052697|532554661|FG030|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
147653791|NCT05052697|532554662|FG031|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
147653792|NCT05052697|532554663|FG032|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
147653793|NCT05052697|532554664|FG033|SubStudy B: Initial Enrollment|Withdrawal by Subject|0|||
147653794|NCT05052697|532554631|FG000|SubStudy B: Initial Enrollment|Physician Decision|0|||
147653795|NCT05052697|532554632|FG001|SubStudy B: Initial Enrollment|Physician Decision|0|||
147653796|NCT05052697|532554633|FG002|SubStudy B: Initial Enrollment|Physician Decision|0|||
147653797|NCT05052697|532554634|FG003|SubStudy B: Initial Enrollment|Physician Decision|0|||
147653798|NCT05052697|532554635|FG004|SubStudy B: Initial Enrollment|Physician Decision|0|||
147653799|NCT05052697|532554636|FG005|SubStudy B: Initial Enrollment|Physician Decision|0|||
147653800|NCT05052697|532554637|FG006|SubStudy B: Initial Enrollment|Physician Decision|0|||
147653801|NCT05052697|532554638|FG007|SubStudy B: Initial Enrollment|Physician Decision|0|||
147653802|NCT05052697|532554639|FG008|SubStudy B: Initial Enrollment|Physician Decision|0|||
147653803|NCT05052697|532554640|FG009|SubStudy B: Initial Enrollment|Physician Decision|0|||
147653804|NCT05052697|532554641|FG010|SubStudy B: Initial Enrollment|Physician Decision|0|||
147653805|NCT05052697|532554642|FG011|SubStudy B: Initial Enrollment|Physician Decision|0|||
147653806|NCT05052697|532554643|FG012|SubStudy B: Initial Enrollment|Physician Decision|0|||
147653807|NCT05052697|532554644|FG013|SubStudy B: Initial Enrollment|Physician Decision|0|||
147653808|NCT05052697|532554645|FG014|SubStudy B: Initial Enrollment|Physician Decision|0|||
147653809|NCT05052697|532554646|FG015|SubStudy B: Initial Enrollment|Physician Decision|0|||
147653810|NCT05052697|532554647|FG016|SubStudy B: Initial Enrollment|Physician Decision|0|||
147653811|NCT05052697|532554648|FG017|SubStudy B: Initial Enrollment|Physician Decision|1|||
147653812|NCT05052697|532554649|FG018|SubStudy B: Initial Enrollment|Physician Decision|0|||
147653813|NCT05052697|532554650|FG019|SubStudy B: Initial Enrollment|Physician Decision|0|||
147653814|NCT05052697|532554651|FG020|SubStudy B: Initial Enrollment|Physician Decision|0|||
147653815|NCT05052697|532554652|FG021|SubStudy B: Initial Enrollment|Physician Decision|0|||
147653816|NCT05052697|532554653|FG022|SubStudy B: Initial Enrollment|Physician Decision|0|||
147653817|NCT05052697|532554654|FG023|SubStudy B: Initial Enrollment|Physician Decision|0|||
147653818|NCT05052697|532554655|FG024|SubStudy B: Initial Enrollment|Physician Decision|0|||
147653819|NCT05052697|532554656|FG025|SubStudy B: Initial Enrollment|Physician Decision|0|||
147653820|NCT05052697|532554657|FG026|SubStudy B: Initial Enrollment|Physician Decision|0|||
147653821|NCT05052697|532554658|FG027|SubStudy B: Initial Enrollment|Physician Decision|0|||
147653822|NCT05052697|532554659|FG028|SubStudy B: Initial Enrollment|Physician Decision|0|||
147653823|NCT05052697|532554660|FG029|SubStudy B: Initial Enrollment|Physician Decision|0|||
147653824|NCT05052697|532554661|FG030|SubStudy B: Initial Enrollment|Physician Decision|0|||
147653825|NCT05052697|532554662|FG031|SubStudy B: Initial Enrollment|Physician Decision|0|||
147653826|NCT05052697|532554663|FG032|SubStudy B: Initial Enrollment|Physician Decision|0|||
147653827|NCT05052697|532554664|FG033|SubStudy B: Initial Enrollment|Physician Decision|0|||
147653828|NCT05052697|532554631|FG000|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
147653829|NCT05052697|532554632|FG001|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
147653830|NCT05052697|532554633|FG002|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
147653831|NCT05052697|532554634|FG003|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
147653832|NCT05052697|532554635|FG004|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
147653833|NCT05052697|532554636|FG005|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
147653834|NCT05052697|532554637|FG006|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
147653835|NCT05052697|532554638|FG007|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
147653836|NCT05052697|532554639|FG008|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
147653837|NCT05052697|532554640|FG009|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
147653838|NCT05052697|532554641|FG010|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
147653839|NCT05052697|532554642|FG011|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
147653840|NCT05052697|532554643|FG012|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
147653841|NCT05052697|532554644|FG013|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
147653842|NCT05052697|532554645|FG014|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
147581484|NCT00377156|532285483|FG000|Overall Study|Refused testing|0|||
147581485|NCT00377156|532285484|FG001|Overall Study|Refused testing|1|||
147581486|NCT00377156|532285483|FG000|Overall Study|Ineligible|0|||
147581487|NCT00377156|532285484|FG001|Overall Study|Ineligible|1|||
147653843|NCT05052697|532554646|FG015|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
147653844|NCT05052697|532554647|FG016|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
147581488|NCT00377156|532285483|FG000|Overall Study|Disability or language problem|0|||
147581489|NCT00377156|532285484|FG001|Overall Study|Disability or language problem|1|||
147581490|NCT00377156|532285483|FG000|Overall Study|Other|5|||
147446678|NCT01157078|531800268|FG001|Overall Study|Severe non-compliance to protocol|4|||
147653845|NCT05052697|532554648|FG017|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
147653846|NCT05052697|532554649|FG018|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
147653847|NCT05052697|532554650|FG019|SubStudy B: Initial Enrollment|Lost to Follow-up|1|||
147240145|NCT01496807|531051522|FG000|Overall Study|Progressive Disease|21|||
147240146|NCT01496807|531051522|FG000|Overall Study|Participant preference/toxicity|8|||
147240147|NCT01496807|531051522|FG000|Overall Study|Change in diagnosis|1|||
147240148|NCT01390649|531051526|FG000|Overall Study|Physician Decision|1|||
147581491|NCT00377156|532285484|FG001|Overall Study|Other|2|||
147581492|NCT00288704|532285485|FG000|Part A, Double Blind, Weeks 1-6|Pre-dose Condition|0|||
147581493|NCT00288704|532285486|FG001|Part A, Double Blind, Weeks 1-6|Pre-dose Condition|1|||
147581494|NCT00288704|532285487|FG002|Part A, Double Blind, Weeks 1-6|Pre-dose Condition|0|||
147581495|NCT00288704|532285485|FG000|Part B, Randomized Withdrawal, Wks 15-24|Adverse Event|0|||
147581496|NCT00288704|532285486|FG001|Part B, Randomized Withdrawal, Wks 15-24|Adverse Event|1|||
147581497|NCT00288704|532285487|FG002|Part B, Randomized Withdrawal, Wks 15-24|Adverse Event|0|||
147581498|NCT00288704|532285485|FG000|Open-Label Extension (OLE) Weeks 24-117|Adverse Event|0|||
147581499|NCT00288704|532285486|FG001|Open-Label Extension (OLE) Weeks 24-117|Adverse Event|0|||
147581500|NCT00288704|532285487|FG002|Open-Label Extension (OLE) Weeks 24-117|Adverse Event|1|||
147581501|NCT00288704|532285485|FG000|Open-Label Extension (OLE) Weeks 24-117|Withdrawal by Subject|0|||
147581502|NCT00288704|532285486|FG001|Open-Label Extension (OLE) Weeks 24-117|Withdrawal by Subject|0|||
147581503|NCT00288704|532285487|FG002|Open-Label Extension (OLE) Weeks 24-117|Withdrawal by Subject|1|||
147581504|NCT00288704|532285485|FG000|Open-Label Extension (OLE) Weeks 24-117|Death|0|||
147581505|NCT00288704|532285486|FG001|Open-Label Extension (OLE) Weeks 24-117|Death|0|||
147240149|NCT00389597|531051527|FG000|Overall Study|Lost to Follow-up|8|||
147240150|NCT00389597|531051528|FG001|Overall Study|Lost to Follow-up|6|||
147240151|NCT00389597|531051529|FG002|Overall Study|Lost to Follow-up|4|||
147240152|NCT00389597|531051530|FG003|Overall Study|Lost to Follow-up|6|||
147240153|NCT00334958|531051531|FG000|Overall Study|Medication Noncompliance|0|||
147240154|NCT00334958|531051532|FG001|Overall Study|Medication Noncompliance|3|||
147240155|NCT00334958|531051531|FG000|Overall Study|Protocol Violation|2|||
147240156|NCT00334958|531051532|FG001|Overall Study|Protocol Violation|2|||
147240157|NCT00334958|531051531|FG000|Overall Study|Request of the investigator or sponsor|0|||
147240158|NCT00334958|531051532|FG001|Overall Study|Request of the investigator or sponsor|1|||
147240159|NCT00334958|531051531|FG000|Overall Study|Withdrawal by Subject|7|||
147240160|NCT00334958|531051532|FG001|Overall Study|Withdrawal by Subject|4|||
147240161|NCT00334958|531051531|FG000|Overall Study|Adverse Event|27|||
147240162|NCT00334958|531051532|FG001|Overall Study|Adverse Event|12|||
147240163|NCT00334958|531051531|FG000|Overall Study|Other|1|||
147240164|NCT00334958|531051532|FG001|Overall Study|Other|2|||
147240165|NCT04431453|531051533|FG000|Overall Study|Withdrew Consent|0|||
147240166|NCT04431453|531051534|FG001|Overall Study|Withdrew Consent|1|||
147240167|NCT04431453|531051535|FG002|Overall Study|Withdrew Consent|0|||
147240168|NCT04431453|531051536|FG003|Overall Study|Withdrew Consent|2|||
147240169|NCT04431453|531051537|FG004|Overall Study|Withdrew Consent|0|||
147240170|NCT04431453|531051538|FG005|Overall Study|Withdrew Consent|0|||
147240171|NCT04431453|531051539|FG006|Overall Study|Withdrew Consent|0|||
147240172|NCT04431453|531051540|FG007|Overall Study|Withdrew Consent|0|||
147240173|NCT04431453|531051533|FG000|Overall Study|Death|1|||
147240174|NCT04431453|531051534|FG001|Overall Study|Death|0|||
147240175|NCT04431453|531051535|FG002|Overall Study|Death|0|||
147240176|NCT04431453|531051536|FG003|Overall Study|Death|0|||
147240177|NCT04431453|531051537|FG004|Overall Study|Death|0|||
147240178|NCT04431453|531051538|FG005|Overall Study|Death|0|||
147240179|NCT04431453|531051539|FG006|Overall Study|Death|0|||
147240180|NCT04431453|531051540|FG007|Overall Study|Death|1|||
147240181|NCT04431453|531051533|FG000|Overall Study|Lost to Follow-up|0|||
147240182|NCT04431453|531051534|FG001|Overall Study|Lost to Follow-up|0|||
147240183|NCT04431453|531051535|FG002|Overall Study|Lost to Follow-up|1|||
147240184|NCT04431453|531051536|FG003|Overall Study|Lost to Follow-up|1|||
147240185|NCT04431453|531051537|FG004|Overall Study|Lost to Follow-up|0|||
147240186|NCT04431453|531051538|FG005|Overall Study|Lost to Follow-up|0|||
147240187|NCT04431453|531051539|FG006|Overall Study|Lost to Follow-up|0|||
147240188|NCT04431453|531051540|FG007|Overall Study|Lost to Follow-up|0|||
147240189|NCT04431453|531051533|FG000|Overall Study|Enrolled but Never Treated|0|||
147240190|NCT04431453|531051534|FG001|Overall Study|Enrolled but Never Treated|0|||
147240191|NCT04431453|531051535|FG002|Overall Study|Enrolled but Never Treated|0|||
147240192|NCT04431453|531051536|FG003|Overall Study|Enrolled but Never Treated|0|||
147240193|NCT04431453|531051537|FG004|Overall Study|Enrolled but Never Treated|1|||
147240194|NCT04431453|531051538|FG005|Overall Study|Enrolled but Never Treated|0|||
147240195|NCT04431453|531051539|FG006|Overall Study|Enrolled but Never Treated|0|||
147240196|NCT04431453|531051540|FG007|Overall Study|Enrolled but Never Treated|0|||
147240197|NCT00622401|531051541|FG000|Overall Study|Disease progression prior to treatment|3|||
147240198|NCT00622401|531051542|FG001|Overall Study|Disease progression prior to treatment|2|||
147240199|NCT00622401|531051543|FG002|Overall Study|Disease progression prior to treatment|0|||
147240200|NCT02021773|531051550|FG000|Overall Study|Adverse Event|1|||
147240201|NCT02021773|531051551|FG001|Overall Study|Adverse Event|4|||
147240202|NCT02021773|531051552|FG002|Overall Study|Adverse Event|3|||
147240203|NCT02021773|531051550|FG000|Overall Study|Lack of Efficacy|2|||
147240204|NCT02021773|531051551|FG001|Overall Study|Lack of Efficacy|2|||
147240205|NCT02021773|531051552|FG002|Overall Study|Lack of Efficacy|2|||
147240206|NCT02021773|531051550|FG000|Overall Study|Protocol Violation|2|||
147240207|NCT02021773|531051551|FG001|Overall Study|Protocol Violation|3|||
147240208|NCT02021773|531051552|FG002|Overall Study|Protocol Violation|1|||
147240209|NCT02021773|531051550|FG000|Overall Study|Withdrawal by Subject|3|||
147321709|NCT02179918|531341664|FG004|Overall Study|Lost to Follow-up|0|||
147581506|NCT00288704|532285487|FG002|Open-Label Extension (OLE) Weeks 24-117|Death|2|||
147581507|NCT00288704|532285485|FG000|Open-Label Extension (OLE) Weeks 24-117|Sponsor Decision|0|||
147581508|NCT00288704|532285486|FG001|Open-Label Extension (OLE) Weeks 24-117|Sponsor Decision|0|||
147581509|NCT00288704|532285487|FG002|Open-Label Extension (OLE) Weeks 24-117|Sponsor Decision|15|||
147581510|NCT00288704|532285485|FG000|Open-Label Extension (OLE) Weeks 24-117|Pregnancy|0|||
147581511|NCT00288704|532285486|FG001|Open-Label Extension (OLE) Weeks 24-117|Pregnancy|0|||
147581512|NCT00288704|532285487|FG002|Open-Label Extension (OLE) Weeks 24-117|Pregnancy|1|||
147581513|NCT01579006|532285488|FG000|Overall Study|Lack of Efficacy|10|||
147581514|NCT01579006|532285488|FG000|Overall Study|Adverse Event|13|||
147581515|NCT01579006|532285488|FG000|Overall Study|Withdrawal by Subject|5|||
147581516|NCT01579006|532285488|FG000|Overall Study|Non-compliance|3|||
147581517|NCT01579006|532285488|FG000|Overall Study|Due to participant's health fund|1|||
147581518|NCT01579006|532285488|FG000|Overall Study|Scheduled surgery|1|||
147581519|NCT01802216|532285491|FG000|4 Month Visit|Participant did not show to visit|3|||
147581520|NCT01802216|532285492|FG001|4 Month Visit|Participant did not show to visit|4|||
147581521|NCT01802216|532285491|FG000|8 Month Visit|Participant did not show to visit|3|||
147581522|NCT01802216|532285492|FG001|8 Month Visit|Participant did not show to visit|5|||
147581523|NCT01802216|532285491|FG000|12 Month Visit|Participant did not show to visit|3|||
147581524|NCT01802216|532285492|FG001|12 Month Visit|Participant did not show to visit|4|||
147581525|NCT04675775|532285493|FG000|Overall Study|Withdrawal by Subject|7|||
147581526|NCT02340780|532285495|FG000|Overall Study|Ineligible|1|||
147581527|NCT01957150|532285496|FG000|Overall Study|Adverse Event|23|||
147581528|NCT01957150|532285497|FG001|Overall Study|Adverse Event|20|||
147581529|NCT01957150|532285496|FG000|Overall Study|Withdrawal by Subject|13|||
147581530|NCT01957150|532285497|FG001|Overall Study|Withdrawal by Subject|17|||
147581531|NCT01957150|532285496|FG000|Overall Study|Physician Decision|3|||
147581532|NCT01957150|532285497|FG001|Overall Study|Physician Decision|6|||
147581533|NCT01957150|532285496|FG000|Overall Study|Lost to Follow-up|4|||
147581534|NCT01957150|532285497|FG001|Overall Study|Lost to Follow-up|4|||
147581535|NCT01957150|532285496|FG000|Overall Study|Protocol Violation|1|||
147581536|NCT01957150|532285497|FG001|Overall Study|Protocol Violation|0|||
147581537|NCT01957150|532285496|FG000|Overall Study|Lack of Efficacy|11|||
147446679|NCT01157078|531800267|FG000|Overall Study|Condition under investigation worsened|0|||
147446680|NCT01157078|531800268|FG001|Overall Study|Condition under investigation worsened|1|||
147446681|NCT01157078|531800267|FG000|Overall Study|Lack of Efficacy|2|||
147446682|NCT01157078|531800268|FG001|Overall Study|Lack of Efficacy|0|||
147446683|NCT01157078|531800267|FG000|Overall Study|Study-specific withdrawal criteria|2|||
147446684|NCT01157078|531800268|FG001|Overall Study|Study-specific withdrawal criteria|2|||
147446685|NCT01157078|531800267|FG000|Overall Study|Lost to Follow-up|7|||
147446686|NCT01157078|531800268|FG001|Overall Study|Lost to Follow-up|5|||
147446687|NCT01157078|531800267|FG000|Overall Study|Other|2|||
147446688|NCT01157078|531800268|FG001|Overall Study|Other|4|||
147446689|NCT00772954|531800269|FG000|Overall Study|Adverse Event|0|||
147581538|NCT01957150|532285497|FG001|Overall Study|Lack of Efficacy|11|||
147581539|NCT03223909|532285498|FG000|Overall Study|Protocol Violation|48|||
147581540|NCT03223909|532285499|FG001|Overall Study|Protocol Violation|45|||
147581541|NCT03223909|532285500|FG002|Overall Study|Protocol Violation|16|||
147581542|NCT01856192|532285503|FG000|Overall Study|Adverse Event|12|||
147581543|NCT01856192|532285504|FG001|Overall Study|Adverse Event|4|||
147581544|NCT01856192|532285503|FG000|Overall Study|Alternative therapy|0|||
147446690|NCT00772954|531800270|FG001|Overall Study|Adverse Event|0|||
147446691|NCT00772954|531800271|FG002|Overall Study|Adverse Event|1|||
147446692|NCT00789529|531800277|FG000|Overall Study|Withdrawal by Subject|0|||
147446693|NCT00789529|531800278|FG001|Overall Study|Withdrawal by Subject|1|||
147446694|NCT00789529|531800277|FG000|Overall Study|Other Reason|1|||
147446695|NCT00789529|531800278|FG001|Overall Study|Other Reason|0|||
147446696|NCT01135498|531800279|FG000|Overall Study|Adverse Event|20|||
147581545|NCT01856192|532285504|FG001|Overall Study|Alternative therapy|3|||
147240210|NCT02021773|531051551|FG001|Overall Study|Withdrawal by Subject|4|||
147240211|NCT02021773|531051552|FG002|Overall Study|Withdrawal by Subject|5|||
147240212|NCT02021773|531051550|FG000|Overall Study|Lost to Follow-up|1|||
147240213|NCT02021773|531051551|FG001|Overall Study|Lost to Follow-up|3|||
147581546|NCT01856192|532285503|FG000|Overall Study|Death|3|||
147446697|NCT01135498|531800279|FG000|Overall Study|Progressive disease|38|||
147446698|NCT01135498|531800279|FG000|Overall Study|Investigator judgement|25|||
147581547|NCT01856192|532285504|FG001|Overall Study|Death|5|||
147581548|NCT01856192|532285503|FG000|Overall Study|Lack of Efficacy|0|||
147581549|NCT01856192|532285504|FG001|Overall Study|Lack of Efficacy|5|||
147446699|NCT01135498|531800279|FG000|Overall Study|Withdrawal by Subject|4|||
147581550|NCT01856192|532285503|FG000|Overall Study|Withdrawal by Subject|1|||
147581551|NCT01856192|532285504|FG001|Overall Study|Withdrawal by Subject|1|||
147240214|NCT02021773|531051552|FG002|Overall Study|Lost to Follow-up|0|||
147446700|NCT01135498|531800279|FG000|Overall Study|Death|1|||
147446701|NCT01135498|531800279|FG000|Overall Study|Ongoing at time of analysis|2|||
147446702|NCT00129766|531800280|FG000|Overall Study|Death|3|||
147581552|NCT01856192|532285503|FG000|Overall Study|Other diseases|1|||
147581553|NCT01856192|532285504|FG001|Overall Study|Other diseases|0|||
147581554|NCT01856192|532285503|FG000|Overall Study|Never started treatment|7|||
147581555|NCT01856192|532285504|FG001|Overall Study|Never started treatment|5|||
147581556|NCT01856192|532285503|FG000|Overall Study|Path ineligible|20|||
147581557|NCT01856192|532285504|FG001|Overall Study|Path ineligible|34|||
147581558|NCT01856192|532285503|FG000|Overall Study|Non-path ineligible|2|||
147581559|NCT01856192|532285504|FG001|Overall Study|Non-path ineligible|2|||
147581560|NCT01856192|532285503|FG000|Overall Study|Physician Decision|1|||
147581561|NCT01856192|532285504|FG001|Overall Study|Physician Decision|1|||
147581562|NCT01856192|532285503|FG000|Overall Study|Suspicion of progressive disease|1|||
147581563|NCT01856192|532285504|FG001|Overall Study|Suspicion of progressive disease|0|||
147653848|NCT05052697|532554651|FG020|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
147653849|NCT05052697|532554652|FG021|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
147653850|NCT05052697|532554653|FG022|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
147653851|NCT05052697|532554654|FG023|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
147653852|NCT05052697|532554655|FG024|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
147653853|NCT05052697|532554656|FG025|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
147653854|NCT05052697|532554657|FG026|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
147653855|NCT05052697|532554658|FG027|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
147653856|NCT05052697|532554659|FG028|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
147653857|NCT05052697|532554660|FG029|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
147653858|NCT05052697|532554661|FG030|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
147653859|NCT05052697|532554662|FG031|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
147653860|NCT05052697|532554663|FG032|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
147653861|NCT05052697|532554664|FG033|SubStudy B: Initial Enrollment|Lost to Follow-up|0|||
147653862|NCT05052697|532554631|FG000|SubStudy B: Initial Enrollment|Not vaccinated|0|||
147653863|NCT05052697|532554632|FG001|SubStudy B: Initial Enrollment|Not vaccinated|0|||
147653864|NCT05052697|532554633|FG002|SubStudy B: Initial Enrollment|Not vaccinated|0|||
147653865|NCT05052697|532554634|FG003|SubStudy B: Initial Enrollment|Not vaccinated|0|||
147653866|NCT05052697|532554635|FG004|SubStudy B: Initial Enrollment|Not vaccinated|0|||
147653867|NCT05052697|532554636|FG005|SubStudy B: Initial Enrollment|Not vaccinated|0|||
147653868|NCT05052697|532554637|FG006|SubStudy B: Initial Enrollment|Not vaccinated|0|||
147653869|NCT05052697|532554638|FG007|SubStudy B: Initial Enrollment|Not vaccinated|0|||
147653870|NCT05052697|532554639|FG008|SubStudy B: Initial Enrollment|Not vaccinated|0|||
147653871|NCT05052697|532554640|FG009|SubStudy B: Initial Enrollment|Not vaccinated|0|||
147653872|NCT05052697|532554641|FG010|SubStudy B: Initial Enrollment|Not vaccinated|0|||
147653873|NCT05052697|532554642|FG011|SubStudy B: Initial Enrollment|Not vaccinated|0|||
147653874|NCT05052697|532554643|FG012|SubStudy B: Initial Enrollment|Not vaccinated|0|||
147653875|NCT05052697|532554644|FG013|SubStudy B: Initial Enrollment|Not vaccinated|0|||
147653876|NCT05052697|532554645|FG014|SubStudy B: Initial Enrollment|Not vaccinated|0|||
147653877|NCT05052697|532554646|FG015|SubStudy B: Initial Enrollment|Not vaccinated|0|||
147653878|NCT05052697|532554647|FG016|SubStudy B: Initial Enrollment|Not vaccinated|0|||
147653879|NCT05052697|532554648|FG017|SubStudy B: Initial Enrollment|Not vaccinated|1|||
147653880|NCT05052697|532554649|FG018|SubStudy B: Initial Enrollment|Not vaccinated|0|||
147653881|NCT05052697|532554650|FG019|SubStudy B: Initial Enrollment|Not vaccinated|0|||
147581564|NCT01856192|532285503|FG000|Overall Study|Non-compliance|1|||
147581565|NCT01856192|532285504|FG001|Overall Study|Non-compliance|0|||
147581566|NCT01698554|532285505|FG000|Overall Study|Adverse Event|2|||
147581567|NCT01698554|532285506|FG001|Overall Study|Adverse Event|5|||
147581568|NCT01698554|532285507|FG002|Overall Study|Adverse Event|0|||
147581569|NCT01698554|532285508|FG003|Overall Study|Adverse Event|1|||
147581570|NCT01698554|532285505|FG000|Overall Study|Lost to Follow-up|1|||
147581571|NCT01698554|532285506|FG001|Overall Study|Lost to Follow-up|0|||
147653882|NCT05052697|532554651|FG020|SubStudy B: Initial Enrollment|Not vaccinated|0|||
147653883|NCT05052697|532554652|FG021|SubStudy B: Initial Enrollment|Not vaccinated|0|||
147653884|NCT05052697|532554653|FG022|SubStudy B: Initial Enrollment|Not vaccinated|0|||
147653885|NCT05052697|532554654|FG023|SubStudy B: Initial Enrollment|Not vaccinated|0|||
147653886|NCT05052697|532554655|FG024|SubStudy B: Initial Enrollment|Not vaccinated|0|||
147653887|NCT05052697|532554656|FG025|SubStudy B: Initial Enrollment|Not vaccinated|1|||
147653888|NCT05052697|532554657|FG026|SubStudy B: Initial Enrollment|Not vaccinated|0|||
147653889|NCT05052697|532554658|FG027|SubStudy B: Initial Enrollment|Not vaccinated|1|||
147446703|NCT00129766|531800281|FG001|Overall Study|Death|8|||
147581572|NCT01698554|532285507|FG002|Overall Study|Lost to Follow-up|0|||
147653890|NCT05052697|532554659|FG028|SubStudy B: Initial Enrollment|Not vaccinated|0|||
147653891|NCT05052697|532554660|FG029|SubStudy B: Initial Enrollment|Not vaccinated|0|||
147653892|NCT05052697|532554661|FG030|SubStudy B: Initial Enrollment|Not vaccinated|0|||
147653893|NCT05052697|532554662|FG031|SubStudy B: Initial Enrollment|Not vaccinated|0|||
147653894|NCT05052697|532554663|FG032|SubStudy B: Initial Enrollment|Not vaccinated|0|||
147653895|NCT05052697|532554664|FG033|SubStudy B: Initial Enrollment|Not vaccinated|0|||
147581573|NCT01698554|532285508|FG003|Overall Study|Lost to Follow-up|0|||
147581574|NCT01698554|532285505|FG000|Overall Study|Personal Reasons|0|||
147581575|NCT01698554|532285506|FG001|Overall Study|Personal Reasons|5|||
147581576|NCT01698554|532285507|FG002|Overall Study|Personal Reasons|1|||
147581577|NCT01698554|532285508|FG003|Overall Study|Personal Reasons|1|||
147240215|NCT02021773|531051550|FG000|Overall Study|Reason not specified|3|||
147240216|NCT02021773|531051551|FG001|Overall Study|Reason not specified|0|||
147240217|NCT02021773|531051552|FG002|Overall Study|Reason not specified|0|||
147240218|NCT00282984|531051553|FG000|Overall Study|Death|2|||
147240219|NCT00282984|531051554|FG001|Overall Study|Death|5|||
147240220|NCT00282984|531051553|FG000|Overall Study|Adverse Event|8|||
147240221|NCT00282984|531051554|FG001|Overall Study|Adverse Event|5|||
147240222|NCT00282984|531051553|FG000|Overall Study|Lack of Efficacy|0|||
147581578|NCT01698554|532285505|FG000|Overall Study|Protocol Violation|2|||
147581579|NCT01698554|532285506|FG001|Overall Study|Protocol Violation|0|||
147581580|NCT01698554|532285507|FG002|Overall Study|Protocol Violation|1|||
147581581|NCT01698554|532285508|FG003|Overall Study|Protocol Violation|0|||
147581582|NCT01698554|532285505|FG000|Overall Study|Other Miscellaneous Reasons|1|||
147581583|NCT01698554|532285506|FG001|Overall Study|Other Miscellaneous Reasons|0|||
147581584|NCT01698554|532285507|FG002|Overall Study|Other Miscellaneous Reasons|0|||
147581585|NCT01698554|532285508|FG003|Overall Study|Other Miscellaneous Reasons|0|||
147581586|NCT00252564|532285509|FG000|Overall Study|Adverse Event|17|||
147581587|NCT00252564|532285510|FG001|Overall Study|Adverse Event|13|||
147581588|NCT00252564|532285509|FG000|Overall Study|Unrelated Complication|2|||
147581589|NCT00252564|532285510|FG001|Overall Study|Unrelated Complication|1|||
147581590|NCT00252564|532285509|FG000|Overall Study|Disease Progression|14|||
147581591|NCT00252564|532285510|FG001|Overall Study|Disease Progression|20|||
147581592|NCT00252564|532285509|FG000|Overall Study|Death|0|||
147581593|NCT00252564|532285510|FG001|Overall Study|Death|3|||
147581594|NCT00252564|532285509|FG000|Overall Study|Physician Decision|1|||
147581595|NCT00252564|532285510|FG001|Overall Study|Physician Decision|0|||
147581596|NCT00252564|532285509|FG000|Overall Study|Lost to Follow-up|1|||
147581597|NCT00252564|532285510|FG001|Overall Study|Lost to Follow-up|0|||
147581598|NCT00252564|532285509|FG000|Overall Study|Patient Request|4|||
147581599|NCT00252564|532285510|FG001|Overall Study|Patient Request|5|||
147581600|NCT00252564|532285509|FG000|Overall Study|Withdrawal by Subject|0|||
147581601|NCT00252564|532285510|FG001|Overall Study|Withdrawal by Subject|2|||
147581602|NCT01583530|532285511|FG000|Overall Study|Adverse Event|0|||
147581603|NCT01583530|532285512|FG001|Overall Study|Adverse Event|0|||
147581604|NCT01583530|532285513|FG002|Overall Study|Adverse Event|0|||
147581605|NCT01583530|532285514|FG003|Overall Study|Adverse Event|0|||
147581606|NCT01583530|532285515|FG004|Overall Study|Adverse Event|0|||
147581607|NCT01583530|532285516|FG005|Overall Study|Adverse Event|1|||
147581608|NCT01583530|532285511|FG000|Overall Study|Withdrawal by Subject|0|||
147581609|NCT01583530|532285512|FG001|Overall Study|Withdrawal by Subject|3|||
147581610|NCT01583530|532285513|FG002|Overall Study|Withdrawal by Subject|0|||
147581611|NCT01583530|532285514|FG003|Overall Study|Withdrawal by Subject|1|||
147581612|NCT01583530|532285515|FG004|Overall Study|Withdrawal by Subject|1|||
147581613|NCT01583530|532285516|FG005|Overall Study|Withdrawal by Subject|2|||
147581614|NCT01583530|532285511|FG000|Overall Study|Lost to Follow-up|0|||
147581615|NCT01583530|532285512|FG001|Overall Study|Lost to Follow-up|0|||
147581616|NCT01583530|532285513|FG002|Overall Study|Lost to Follow-up|0|||
147581617|NCT01583530|532285514|FG003|Overall Study|Lost to Follow-up|0|||
147581618|NCT01583530|532285515|FG004|Overall Study|Lost to Follow-up|3|||
147581619|NCT01583530|532285516|FG005|Overall Study|Lost to Follow-up|0|||
147581620|NCT01583530|532285511|FG000|Overall Study|Lack of compliance|0|||
147581621|NCT01583530|532285512|FG001|Overall Study|Lack of compliance|0|||
147581622|NCT01583530|532285513|FG002|Overall Study|Lack of compliance|0|||
147581623|NCT01583530|532285514|FG003|Overall Study|Lack of compliance|0|||
147581624|NCT01583530|532285515|FG004|Overall Study|Lack of compliance|1|||
147581625|NCT01583530|532285516|FG005|Overall Study|Lack of compliance|0|||
147581626|NCT02416180|532285517|FG000|Overall Study|Withdrawal by Subject|1|||
147581627|NCT00640926|532285518|FG000|Overall Study|Adverse Event|2|||
147581628|NCT00640926|532285519|FG001|Overall Study|Adverse Event|3|||
147581629|NCT00640926|532285520|FG002|Overall Study|Adverse Event|2|||
147581630|NCT00640926|532285518|FG000|Overall Study|Lack of Efficacy|0|||
147581631|NCT00640926|532285519|FG001|Overall Study|Lack of Efficacy|2|||
147581632|NCT00640926|532285520|FG002|Overall Study|Lack of Efficacy|1|||
147581633|NCT00640926|532285518|FG000|Overall Study|Protocol Violation|2|||
147581634|NCT00640926|532285519|FG001|Overall Study|Protocol Violation|0|||
147581635|NCT00640926|532285520|FG002|Overall Study|Protocol Violation|2|||
147581636|NCT00640926|532285518|FG000|Overall Study|Lost to Follow-up|3|||
147581637|NCT00640926|532285519|FG001|Overall Study|Lost to Follow-up|1|||
147581638|NCT00640926|532285520|FG002|Overall Study|Lost to Follow-up|2|||
147581639|NCT00640926|532285518|FG000|Overall Study|Withdrawal by Subject|1|||
147581640|NCT00640926|532285519|FG001|Overall Study|Withdrawal by Subject|0|||
147581641|NCT00640926|532285520|FG002|Overall Study|Withdrawal by Subject|1|||
147581642|NCT01841073|532285521|FG000|Overall Study|Adverse Event|1|||
147581643|NCT01841073|532285522|FG001|Overall Study|Adverse Event|1|||
147581644|NCT01841073|532285521|FG000|Overall Study|Physician Decision|1|||
147581645|NCT01841073|532285522|FG001|Overall Study|Physician Decision|0|||
147581646|NCT01841073|532285521|FG000|Overall Study|Lost to Follow-up|0|||
147581647|NCT01841073|532285522|FG001|Overall Study|Lost to Follow-up|2|||
147581648|NCT02858037|532285527|FG000|Overall Study|Death|1|||
147581649|NCT02858037|532285527|FG000|Overall Study|Withdrawal by Subject|18|||
147581650|NCT02858037|532285527|FG000|Overall Study|Participant Relocated, no follow-up planned|26|||
147581651|NCT02858037|532285527|FG000|Overall Study|Lost to Follow-up|3|||
147581652|NCT02858037|532285527|FG000|Overall Study|Other|4|||
147581653|NCT04320745|532285528|FG000|Overall Study|Adverse Event|26|||
147581654|NCT04320745|532285528|FG000|Overall Study|Withdrawal by Subject|4|||
147581655|NCT04320745|532285528|FG000|Overall Study|Lost to Follow-up|12|||
147581656|NCT04320745|532285528|FG000|Overall Study|Protocol Deviation|2|||
147240223|NCT00282984|531051554|FG001|Overall Study|Lack of Efficacy|2|||
147240224|NCT00282984|531051553|FG000|Overall Study|Lost to Follow-up|14|||
147240225|NCT00282984|531051554|FG001|Overall Study|Lost to Follow-up|10|||
147240226|NCT00282984|531051553|FG000|Overall Study|Withdrawal by Participant|22|||
147240227|NCT00282984|531051554|FG001|Overall Study|Withdrawal by Participant|34|||
147240228|NCT00282984|531051553|FG000|Overall Study|Participant stopped study medication|2|||
147240229|NCT00282984|531051554|FG001|Overall Study|Participant stopped study medication|2|||
147240230|NCT00282984|531051553|FG000|Overall Study|Participant only allowed phone follow-up|0|||
147240231|NCT00282984|531051554|FG001|Overall Study|Participant only allowed phone follow-up|1|||
147240232|NCT00282984|531051553|FG000|Overall Study|Participant used antipsychosis meds|0|||
147240233|NCT00282984|531051554|FG001|Overall Study|Participant used antipsychosis meds|1|||
147240234|NCT00282984|531051553|FG000|Overall Study|lack of motivation|1|||
147240235|NCT00282984|531051554|FG001|Overall Study|lack of motivation|0|||
147240236|NCT00282984|531051553|FG000|Overall Study|in prison|0|||
147240237|NCT00282984|531051554|FG001|Overall Study|in prison|1|||
147240238|NCT00282984|531051553|FG000|Overall Study|Protocol Violation|2|||
147240239|NCT00282984|531051554|FG001|Overall Study|Protocol Violation|0|||
147240240|NCT00191269|531051555|FG000|Overall Study|Protocol Violation|0|||
147240241|NCT00191269|531051556|FG001|Overall Study|Protocol Violation|2|||
147240242|NCT00191269|531051555|FG000|Overall Study|Adverse Event|1|||
147240243|NCT00191269|531051556|FG001|Overall Study|Adverse Event|4|||
147240244|NCT00191269|531051555|FG000|Overall Study|Progression of Disease|4|||
147240245|NCT00191269|531051556|FG001|Overall Study|Progression of Disease|42|||
147240246|NCT00191269|531051555|FG000|Overall Study|Lack of Efficacy|1|||
147240247|NCT00191269|531051556|FG001|Overall Study|Lack of Efficacy|5|||
147240248|NCT00191269|531051555|FG000|Overall Study|Withdrawal by Subject|0|||
147240249|NCT00191269|531051556|FG001|Overall Study|Withdrawal by Subject|1|||
147240250|NCT00191269|531051555|FG000|Overall Study|Pathologic Aggrevation|0|||
147240251|NCT00191269|531051556|FG001|Overall Study|Pathologic Aggrevation|1|||
147240252|NCT00191269|531051555|FG000|Overall Study|Physician Decision|0|||
147240253|NCT00191269|531051556|FG001|Overall Study|Physician Decision|3|||
147240254|NCT00915278|531051564|FG000|Overall Study|Death|1|||
147240255|NCT00915278|531051565|FG001|Overall Study|Death|0|||
147240256|NCT00915278|531051566|FG002|Overall Study|Death|0|||
147240257|NCT00915278|531051567|FG003|Overall Study|Death|0|||
147240258|NCT00915278|531051568|FG004|Overall Study|Death|0|||
147240259|NCT00915278|531051569|FG005|Overall Study|Death|0|||
147240260|NCT00915278|531051564|FG000|Overall Study|Lost to Follow-up|0|||
147240261|NCT00915278|531051565|FG001|Overall Study|Lost to Follow-up|1|||
147240262|NCT00915278|531051566|FG002|Overall Study|Lost to Follow-up|0|||
147240263|NCT00915278|531051567|FG003|Overall Study|Lost to Follow-up|0|||
147240264|NCT00915278|531051568|FG004|Overall Study|Lost to Follow-up|0|||
147240265|NCT00915278|531051569|FG005|Overall Study|Lost to Follow-up|0|||
147581657|NCT04320745|532285528|FG000|Overall Study|Non-compliance With Study Drug|2|||
147581658|NCT04320745|532285528|FG000|Overall Study|Reason Not Specified|1|||
147581659|NCT00046839|532285529|FG000|Overall Study|Ineligible / No protocol treatment|0|||
147581660|NCT00046839|532285530|FG001|Overall Study|Ineligible / No protocol treatment|2|||
147581661|NCT00046839|532285529|FG000|Overall Study|Withdrawal of consent|1|||
147581662|NCT00046839|532285530|FG001|Overall Study|Withdrawal of consent|0|||
147581663|NCT02050321|532285533|FG000|Overall Study|Withdrawal by Subject|1|||
147581664|NCT02050321|532285533|FG000|Overall Study|Adverse Event|1|||
147581665|NCT00715676|532285538|FG000|Overall Study|Adverse Event|3|||
147581666|NCT00715676|532285539|FG001|Overall Study|Adverse Event|5|||
147581667|NCT00715676|532285540|FG002|Overall Study|Adverse Event|21|||
147581668|NCT00715676|532285538|FG000|Overall Study|Withdrawal by Subject|1|||
147581669|NCT00715676|532285539|FG001|Overall Study|Withdrawal by Subject|3|||
147581670|NCT00715676|532285540|FG002|Overall Study|Withdrawal by Subject|8|||
147240266|NCT00915278|531051564|FG000|Overall Study|Withdrawal by Subject|0|||
147240267|NCT00915278|531051565|FG001|Overall Study|Withdrawal by Subject|1|||
147240268|NCT00915278|531051566|FG002|Overall Study|Withdrawal by Subject|0|||
147240269|NCT00915278|531051567|FG003|Overall Study|Withdrawal by Subject|0|||
147240270|NCT00915278|531051568|FG004|Overall Study|Withdrawal by Subject|1|||
147240271|NCT00915278|531051569|FG005|Overall Study|Withdrawal by Subject|4|||
147240272|NCT00915278|531051564|FG000|Overall Study|Adverse Event|4|||
147240273|NCT00915278|531051565|FG001|Overall Study|Adverse Event|1|||
147581671|NCT00715676|532285538|FG000|Overall Study|Lost to Follow-up|1|||
147581672|NCT00715676|532285539|FG001|Overall Study|Lost to Follow-up|2|||
147240274|NCT00915278|531051566|FG002|Overall Study|Adverse Event|0|||
147240275|NCT00915278|531051567|FG003|Overall Study|Adverse Event|0|||
147581673|NCT00715676|532285540|FG002|Overall Study|Lost to Follow-up|1|||
147581674|NCT00715676|532285538|FG000|Overall Study|Terminated by Sponsor|1|||
147446704|NCT00129766|531800280|FG000|Overall Study|Withdrawal of consent|31|||
147446705|NCT00129766|531800281|FG001|Overall Study|Withdrawal of consent|30|||
147446706|NCT00129766|531800280|FG000|Overall Study|Lost to Follow-up|26|||
147446707|NCT00129766|531800281|FG001|Overall Study|Lost to Follow-up|21|||
147446708|NCT01081912|531800283|FG000|Conversion/Titration|Adverse Event|47|||
147446709|NCT01081912|531800284|FG001|Conversion/Titration|Adverse Event|0|||
147446710|NCT01081912|531800285|FG002|Conversion/Titration|Adverse Event|0|||
147446711|NCT01081912|531800283|FG000|Conversion/Titration|Lack of Efficacy|17|||
147446712|NCT01081912|531800284|FG001|Conversion/Titration|Lack of Efficacy|0|||
147446713|NCT01081912|531800285|FG002|Conversion/Titration|Lack of Efficacy|0|||
147446714|NCT01081912|531800283|FG000|Conversion/Titration|Lost to Follow-up|5|||
147446715|NCT01081912|531800284|FG001|Conversion/Titration|Lost to Follow-up|0|||
147446716|NCT01081912|531800285|FG002|Conversion/Titration|Lost to Follow-up|0|||
147446717|NCT01081912|531800283|FG000|Conversion/Titration|Physician Decision|2|||
147446718|NCT01081912|531800284|FG001|Conversion/Titration|Physician Decision|0|||
147446719|NCT01081912|531800285|FG002|Conversion/Titration|Physician Decision|0|||
147446720|NCT01081912|531800283|FG000|Conversion/Titration|Protocol Violation|67|||
147446721|NCT01081912|531800284|FG001|Conversion/Titration|Protocol Violation|0|||
147446722|NCT01081912|531800285|FG002|Conversion/Titration|Protocol Violation|0|||
147446723|NCT01081912|531800283|FG000|Conversion/Titration|Withdrawal by Subject|23|||
147446724|NCT01081912|531800284|FG001|Conversion/Titration|Withdrawal by Subject|0|||
147446725|NCT01081912|531800285|FG002|Conversion/Titration|Withdrawal by Subject|0|||
147446726|NCT01081912|531800283|FG000|Conversion/Titration|Non-Compliance|47|||
147446727|NCT01081912|531800284|FG001|Conversion/Titration|Non-Compliance|0|||
147446728|NCT01081912|531800285|FG002|Conversion/Titration|Non-Compliance|0|||
147446729|NCT01081912|531800283|FG000|Maintenance Treatment|Adverse Event|0|||
147446730|NCT01081912|531800284|FG001|Maintenance Treatment|Adverse Event|2|||
147446731|NCT01081912|531800285|FG002|Maintenance Treatment|Adverse Event|12|||
147446732|NCT01081912|531800283|FG000|Maintenance Treatment|Lack of Efficacy|0|||
147446733|NCT01081912|531800284|FG001|Maintenance Treatment|Lack of Efficacy|14|||
147446734|NCT01081912|531800285|FG002|Maintenance Treatment|Lack of Efficacy|64|||
147446735|NCT01081912|531800283|FG000|Maintenance Treatment|Lost to Follow-up|0|||
147446736|NCT01081912|531800284|FG001|Maintenance Treatment|Lost to Follow-up|1|||
147446737|NCT01081912|531800285|FG002|Maintenance Treatment|Lost to Follow-up|0|||
147446738|NCT01081912|531800283|FG000|Maintenance Treatment|Physician Decision|0|||
147446739|NCT01081912|531800284|FG001|Maintenance Treatment|Physician Decision|0|||
147446740|NCT01081912|531800285|FG002|Maintenance Treatment|Physician Decision|1|||
147446741|NCT01081912|531800283|FG000|Maintenance Treatment|Protocol Violation|0|||
147446742|NCT01081912|531800284|FG001|Maintenance Treatment|Protocol Violation|1|||
147446743|NCT01081912|531800285|FG002|Maintenance Treatment|Protocol Violation|2|||
147446744|NCT01081912|531800283|FG000|Maintenance Treatment|Withdrawal by Subject|0|||
147446745|NCT01081912|531800284|FG001|Maintenance Treatment|Withdrawal by Subject|5|||
147446746|NCT01081912|531800285|FG002|Maintenance Treatment|Withdrawal by Subject|5|||
147446747|NCT01081912|531800283|FG000|Maintenance Treatment|Non-Compliance|0|||
147446748|NCT01081912|531800284|FG001|Maintenance Treatment|Non-Compliance|4|||
147446749|NCT01081912|531800285|FG002|Maintenance Treatment|Non-Compliance|7|||
147446750|NCT01081912|531800283|FG000|Maintenance Treatment|Withdrawal by Medical Monitor|0|||
147446751|NCT01081912|531800284|FG001|Maintenance Treatment|Withdrawal by Medical Monitor|0|||
147446752|NCT01081912|531800285|FG002|Maintenance Treatment|Withdrawal by Medical Monitor|1|||
147446753|NCT02770547|531800291|FG000|Overall Study|Patient non-compliant|1|||
147446754|NCT02770547|531800292|FG001|Overall Study|Patient non-compliant|0|||
147446755|NCT02770547|531800291|FG000|Overall Study|Adverse Event|0|||
147446756|NCT02770547|531800292|FG001|Overall Study|Adverse Event|1|||
147446757|NCT01324232|531800298|FG000|Overall Study|Protocol Violation|0|||
147446758|NCT01324232|531800299|FG001|Overall Study|Protocol Violation|0|||
147446759|NCT01324232|531800300|FG002|Overall Study|Protocol Violation|0|||
147446760|NCT01324232|531800301|FG003|Overall Study|Protocol Violation|2|||
147446761|NCT01324232|531800298|FG000|Overall Study|Missing|0|||
147446762|NCT01324232|531800299|FG001|Overall Study|Missing|0|||
147446763|NCT01324232|531800300|FG002|Overall Study|Missing|1|||
147581675|NCT00715676|532285539|FG001|Overall Study|Terminated by Sponsor|0|||
147581676|NCT00715676|532285540|FG002|Overall Study|Terminated by Sponsor|0|||
147581677|NCT00715676|532285538|FG000|Overall Study|Did Not Meet Entry Criteria|0|||
147581678|NCT00715676|532285539|FG001|Overall Study|Did Not Meet Entry Criteria|0|||
147581679|NCT00715676|532285540|FG002|Overall Study|Did Not Meet Entry Criteria|1|||
147446764|NCT01324232|531800301|FG003|Overall Study|Missing|0|||
147446765|NCT01324232|531800298|FG000|Overall Study|Participant's Personal Reason/Decision|0|||
147446766|NCT01324232|531800299|FG001|Overall Study|Participant's Personal Reason/Decision|1|||
147581680|NCT00715676|532285538|FG000|Overall Study|Use of Exclusionary Medication|0|||
147581681|NCT00715676|532285539|FG001|Overall Study|Use of Exclusionary Medication|0|||
147446767|NCT01324232|531800300|FG002|Overall Study|Participant's Personal Reason/Decision|0|||
147446768|NCT01324232|531800301|FG003|Overall Study|Participant's Personal Reason/Decision|0|||
147446769|NCT01324232|531800298|FG000|Overall Study|Lack of Efficacy|2|||
147446770|NCT01324232|531800299|FG001|Overall Study|Lack of Efficacy|1|||
147446771|NCT01324232|531800300|FG002|Overall Study|Lack of Efficacy|2|||
147581682|NCT00715676|532285540|FG002|Overall Study|Use of Exclusionary Medication|1|||
147581683|NCT00715676|532285538|FG000|Overall Study|Elevated Blood Glucose|0|||
147581684|NCT00715676|532285539|FG001|Overall Study|Elevated Blood Glucose|1|||
147653896|NCT05052697|532554631|FG000|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
147653897|NCT05052697|532554632|FG001|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
147653898|NCT05052697|532554633|FG002|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
147653899|NCT05052697|532554634|FG003|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
147653900|NCT05052697|532554635|FG004|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
147653901|NCT05052697|532554636|FG005|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
147653902|NCT05052697|532554637|FG006|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
147653903|NCT05052697|532554638|FG007|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
147653904|NCT05052697|532554639|FG008|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
147653905|NCT05052697|532554640|FG009|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
147653906|NCT05052697|532554641|FG010|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
147653907|NCT05052697|532554642|FG011|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
147581685|NCT00715676|532285540|FG002|Overall Study|Elevated Blood Glucose|0|||
147581686|NCT01067521|532285542|FG000|Double-Blind Placebo-Controlled Period|Death|0|||
147581687|NCT01067521|532285543|FG001|Double-Blind Placebo-Controlled Period|Death|1|||
147581688|NCT01067521|532285542|FG000|Double-Blind Placebo-Controlled Period|Adverse Event|29|||
147581689|NCT01067521|532285543|FG001|Double-Blind Placebo-Controlled Period|Adverse Event|6|||
147653908|NCT05052697|532554643|FG012|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
147653909|NCT05052697|532554644|FG013|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
147653910|NCT05052697|532554645|FG014|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
147653911|NCT05052697|532554646|FG015|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
147653912|NCT05052697|532554647|FG016|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
147653913|NCT05052697|532554648|FG017|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
147653914|NCT05052697|532554649|FG018|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
147653915|NCT05052697|532554650|FG019|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
147653916|NCT05052697|532554651|FG020|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
147653917|NCT05052697|532554652|FG021|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
147653918|NCT05052697|532554653|FG022|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
147653919|NCT05052697|532554654|FG023|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
147653920|NCT05052697|532554655|FG024|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
147653921|NCT05052697|532554656|FG025|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
147653922|NCT05052697|532554657|FG026|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
147653923|NCT05052697|532554658|FG027|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
147653924|NCT05052697|532554659|FG028|Substudy B: Expanded Enrollment|Withdrawal by Subject|2|||
147653925|NCT05052697|532554660|FG029|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
147653926|NCT05052697|532554661|FG030|Substudy B: Expanded Enrollment|Withdrawal by Subject|3|||
147653927|NCT05052697|532554662|FG031|Substudy B: Expanded Enrollment|Withdrawal by Subject|3|||
147653928|NCT05052697|532554663|FG032|Substudy B: Expanded Enrollment|Withdrawal by Subject|3|||
147653929|NCT05052697|532554664|FG033|Substudy B: Expanded Enrollment|Withdrawal by Subject|0|||
147653930|NCT05052697|532554631|FG000|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
147653931|NCT05052697|532554632|FG001|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
147653932|NCT05052697|532554633|FG002|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
147653933|NCT05052697|532554634|FG003|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
147653934|NCT05052697|532554635|FG004|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
147653935|NCT05052697|532554636|FG005|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
147581690|NCT01067521|532285542|FG000|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|34|||
147581691|NCT01067521|532285543|FG001|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|17|||
147581692|NCT01067521|532285542|FG000|Double-Blind Placebo-Controlled Period|Physician Decision|1|||
147581693|NCT01067521|532285543|FG001|Double-Blind Placebo-Controlled Period|Physician Decision|1|||
147581694|NCT01067521|532285542|FG000|Double-Blind Placebo-Controlled Period|Refused to sign informed consent|4|||
147581695|NCT01067521|532285543|FG001|Double-Blind Placebo-Controlled Period|Refused to sign informed consent|1|||
147581696|NCT01067521|532285542|FG000|Double-Blind Placebo-Controlled Period|Noncompliance with study drug|2|||
147581697|NCT01067521|532285543|FG001|Double-Blind Placebo-Controlled Period|Noncompliance with study drug|0|||
147581698|NCT01067521|532285542|FG000|Double-Blind Placebo-Controlled Period|Protocol Violation|2|||
147581699|NCT01067521|532285543|FG001|Double-Blind Placebo-Controlled Period|Protocol Violation|0|||
147581700|NCT01067521|532285542|FG000|Double-Blind Placebo-Controlled Period|Pregnancy|7|||
147581701|NCT01067521|532285543|FG001|Double-Blind Placebo-Controlled Period|Pregnancy|4|||
147581702|NCT01067521|532285542|FG000|Double-Blind Placebo-Controlled Period|Lost to Follow-up|5|||
147581703|NCT01067521|532285543|FG001|Double-Blind Placebo-Controlled Period|Lost to Follow-up|1|||
147581704|NCT01067521|532285542|FG000|Open-Label Period|Death|3|||
147653936|NCT05052697|532554637|FG006|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
147653937|NCT05052697|532554638|FG007|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
147581705|NCT01067521|532285543|FG001|Open-Label Period|Death|1|||
147581706|NCT01067521|532285542|FG000|Open-Label Period|Adverse Event|30|||
147581707|NCT01067521|532285543|FG001|Open-Label Period|Adverse Event|28|||
147581708|NCT01067521|532285542|FG000|Open-Label Period|Withdrawal by Subject|160|||
147581709|NCT01067521|532285543|FG001|Open-Label Period|Withdrawal by Subject|88|||
147581710|NCT01067521|532285542|FG000|Open-Label Period|Physician Decision|13|||
147581711|NCT01067521|532285543|FG001|Open-Label Period|Physician Decision|11|||
147581712|NCT01067521|532285542|FG000|Open-Label Period|Non-compliance with study drug|5|||
147581713|NCT01067521|532285543|FG001|Open-Label Period|Non-compliance with study drug|0|||
147581714|NCT01067521|532285542|FG000|Open-Label Period|Protocol Violation|3|||
147581715|NCT01067521|532285543|FG001|Open-Label Period|Protocol Violation|0|||
147581716|NCT01067521|532285542|FG000|Open-Label Period|Pregnancy|14|||
147581717|NCT01067521|532285543|FG001|Open-Label Period|Pregnancy|8|||
147581718|NCT01067521|532285542|FG000|Open-Label Period|Teva requested subject to be withdrawn|5|||
147581719|NCT01067521|532285543|FG001|Open-Label Period|Teva requested subject to be withdrawn|2|||
147581720|NCT01067521|532285542|FG000|Open-Label Period|Lost to Follow-up|21|||
147581721|NCT01067521|532285543|FG001|Open-Label Period|Lost to Follow-up|20|||
147581722|NCT01547728|532285544|FG000|Overall Study|Change in procedure and equipment|1|||
147581723|NCT01547728|532285544|FG000|Overall Study|Drug not ready for subject|1|||
147581724|NCT01547728|532285544|FG000|Overall Study|Screen failure|39|||
147581725|NCT02151149|532285545|FG000|Treatment Period|Death|2|||
147581726|NCT02151149|532285546|FG001|Treatment Period|Death|3|||
147581727|NCT02151149|532285545|FG000|Treatment Period|Adverse Event|17|||
147581728|NCT02151149|532285546|FG001|Treatment Period|Adverse Event|14|||
147581729|NCT02151149|532285545|FG000|Treatment Period|Progressive Disease|25|||
147581730|NCT02151149|532285546|FG001|Treatment Period|Progressive Disease|24|||
147581731|NCT02151149|532285545|FG000|Treatment Period|Symptomatic Deterioration|2|||
147581732|NCT02151149|532285546|FG001|Treatment Period|Symptomatic Deterioration|10|||
147581733|NCT02151149|532285545|FG000|Treatment Period|Withdrawal by Subject|13|||
147581734|NCT02151149|532285546|FG001|Treatment Period|Withdrawal by Subject|11|||
147581735|NCT02151149|532285545|FG000|Treatment Period|Miscellaneous|8|||
147581736|NCT02151149|532285546|FG001|Treatment Period|Miscellaneous|7|||
147581737|NCT02151149|532285545|FG000|Treatment Period|Participants randomized but not treated|3|||
147581738|NCT02151149|532285546|FG001|Treatment Period|Participants randomized but not treated|2|||
147581739|NCT02151149|532285545|FG000|Follow-Up Period|Lost to Follow-up|2|||
147581740|NCT02151149|532285546|FG001|Follow-Up Period|Lost to Follow-up|3|||
147581741|NCT02151149|532285545|FG000|Follow-Up Period|Death|37|||
147581742|NCT02151149|532285546|FG001|Follow-Up Period|Death|34|||
147581743|NCT03419962|532285549|FG000|Overall Study|Change to other medication|1|||
147581744|NCT03419962|532285549|FG000|Overall Study|Refusal of continuing with trial drug|1|||
147581745|NCT03419962|532285549|FG000|Overall Study|Lost to Follow-up|3|||
147581746|NCT03419962|532285549|FG000|Overall Study|Difficulty in inhaling the doses|1|||
147581747|NCT03419962|532285549|FG000|Overall Study|Missing completion data|31|||
147581748|NCT04142658|532285550|FG000|Overall Study|Death|2|||
147581749|NCT04142658|532285551|FG001|Overall Study|Death|1|||
147581750|NCT04142658|532285550|FG000|Overall Study|Lost to Follow-up|4|||
147581751|NCT04142658|532285551|FG001|Overall Study|Lost to Follow-up|13|||
147581752|NCT04142658|532285550|FG000|Overall Study|Withdrawal by Subject|9|||
147581753|NCT04142658|532285551|FG001|Overall Study|Withdrawal by Subject|16|||
147581754|NCT01781234|532285552|FG000|Overall Study|Adverse Event|2|||
147581755|NCT01781234|532285553|FG001|Overall Study|Adverse Event|0|||
147581756|NCT01781234|532285552|FG000|Overall Study|Protocol Violation|3|||
147581757|NCT01781234|532285553|FG001|Overall Study|Protocol Violation|0|||
147581758|NCT01781234|532285552|FG000|Overall Study|Withdrawal by Subject|4|||
147581759|NCT01781234|532285553|FG001|Overall Study|Withdrawal by Subject|3|||
147581760|NCT00830167|532285556|FG000|Overall Study|Lack of Efficacy|26|||
147581761|NCT00830167|532285557|FG001|Overall Study|Lack of Efficacy|10|||
147581762|NCT00830167|532285556|FG000|Overall Study|Adverse Event|8|||
147581763|NCT00830167|532285557|FG001|Overall Study|Adverse Event|24|||
147581764|NCT00830167|532285556|FG000|Overall Study|Not meeting entrance criteria|2|||
147581765|NCT00830167|532285557|FG001|Overall Study|Not meeting entrance criteria|5|||
147581766|NCT00830167|532285556|FG000|Overall Study|Withdrawal by Subject|2|||
147581767|NCT00830167|532285557|FG001|Overall Study|Withdrawal by Subject|0|||
147581768|NCT00830167|532285556|FG000|Overall Study|Lost to Follow-up|0|||
147581769|NCT00830167|532285557|FG001|Overall Study|Lost to Follow-up|1|||
147581770|NCT00830167|532285556|FG000|Overall Study|Protocol Violation|0|||
147581771|NCT00830167|532285557|FG001|Overall Study|Protocol Violation|1|||
147581772|NCT00830167|532285556|FG000|Overall Study|Other|2|||
147581773|NCT00830167|532285557|FG001|Overall Study|Other|2|||
147581774|NCT01499160|532285561|FG000|Overall Study|Adverse Event|1|||
147581775|NCT01499160|532285561|FG000|Overall Study|Withdrawal by Subject|1|||
147581776|NCT01438476|532285562|FG000|Overall Study|Protocol Violation|1|||
147581777|NCT01438476|532285563|FG001|Overall Study|Protocol Violation|0|||
147581778|NCT01438476|532285562|FG000|Overall Study|Withdrawal by Subject|1|||
147153570|NCT01866111|530724312|FG002|Double-blind Period of Study YKP3089C017|Adverse Event|15|||
147581779|NCT01438476|532285563|FG001|Overall Study|Withdrawal by Subject|0|||
147581780|NCT01438476|532285562|FG000|Overall Study|No Surgery- Disease|8|||
147581781|NCT01438476|532285563|FG001|Overall Study|No Surgery- Disease|10|||
147581782|NCT01438476|532285562|FG000|Overall Study|Communication barrier|0|||
147240276|NCT00915278|531051568|FG004|Overall Study|Adverse Event|0|||
147240277|NCT00915278|531051569|FG005|Overall Study|Adverse Event|0|||
147240278|NCT00915278|531051564|FG000|Overall Study|Progressive disease/clinical progression|0|||
147240279|NCT00915278|531051565|FG001|Overall Study|Progressive disease/clinical progression|0|||
147240280|NCT00915278|531051566|FG002|Overall Study|Progressive disease/clinical progression|0|||
147240281|NCT00915278|531051567|FG003|Overall Study|Progressive disease/clinical progression|3|||
147240282|NCT00915278|531051568|FG004|Overall Study|Progressive disease/clinical progression|1|||
147240283|NCT00915278|531051569|FG005|Overall Study|Progressive disease/clinical progression|2|||
147240284|NCT00915278|531051564|FG000|Overall Study|Infusion related AEs|0|||
147240285|NCT00915278|531051565|FG001|Overall Study|Infusion related AEs|0|||
147240286|NCT00915278|531051566|FG002|Overall Study|Infusion related AEs|0|||
147240287|NCT00915278|531051567|FG003|Overall Study|Infusion related AEs|0|||
147240288|NCT00915278|531051568|FG004|Overall Study|Infusion related AEs|0|||
147581783|NCT01438476|532285563|FG001|Overall Study|Communication barrier|1|||
147581784|NCT00603512|532285564|FG000|Overall Study|Adverse Event|0|||
147240289|NCT00915278|531051569|FG005|Overall Study|Infusion related AEs|2|||
147240290|NCT00915278|531051564|FG000|Overall Study|Admission to hospice|0|||
147581785|NCT00603512|532285565|FG001|Overall Study|Adverse Event|2|||
147240291|NCT00915278|531051565|FG001|Overall Study|Admission to hospice|0|||
147240292|NCT00915278|531051566|FG002|Overall Study|Admission to hospice|1|||
147240293|NCT00915278|531051567|FG003|Overall Study|Admission to hospice|0|||
147240294|NCT00915278|531051568|FG004|Overall Study|Admission to hospice|0|||
147240295|NCT00915278|531051569|FG005|Overall Study|Admission to hospice|0|||
147240296|NCT00674362|531051577|FG000|Double Blind|Adverse Event|6|||
147240297|NCT00674362|531051578|FG001|Double Blind|Adverse Event|6|||
147240298|NCT00674362|531051577|FG000|Double Blind|Lack of Efficacy|2|||
147240299|NCT00674362|531051578|FG001|Double Blind|Lack of Efficacy|6|||
147240300|NCT00674362|531051577|FG000|Double Blind|Loss of efficacy|0|||
147240301|NCT00674362|531051578|FG001|Double Blind|Loss of efficacy|1|||
147240302|NCT00674362|531051577|FG000|Double Blind|Withdrawal by Subject|4|||
147240303|NCT00674362|531051578|FG001|Double Blind|Withdrawal by Subject|3|||
147240304|NCT00674362|531051577|FG000|Double Blind|Other: Loss of Patient Compliance|0|||
147240305|NCT00674362|531051578|FG001|Double Blind|Other: Loss of Patient Compliance|1|||
147240306|NCT00674362|531051577|FG000|Double Blind|Other: Surgery|0|||
147240307|NCT00674362|531051578|FG001|Double Blind|Other: Surgery|1|||
147240308|NCT00674362|531051577|FG000|Open Label|Adverse Event|1|||
147240309|NCT00674362|531051578|FG001|Open Label|Adverse Event|0|||
147240310|NCT00674362|531051577|FG000|Open Label|Other: Subject moved to extension study|1|||
147240311|NCT00674362|531051578|FG001|Open Label|Other: Subject moved to extension study|0|||
147240312|NCT00923156|531051579|FG000|Overall Study|Adverse Event|0|||
147240313|NCT00923156|531051580|FG001|Overall Study|Adverse Event|2|||
147240314|NCT00923156|531051581|FG002|Overall Study|Adverse Event|1|||
147240315|NCT00923156|531051579|FG000|Overall Study|Abnormal laboratory values|0|||
147240316|NCT00923156|531051580|FG001|Overall Study|Abnormal laboratory values|0|||
147240317|NCT00923156|531051581|FG002|Overall Study|Abnormal laboratory values|1|||
147240318|NCT00923156|531051579|FG000|Overall Study|Withdrawal by Subject|0|||
147240319|NCT00923156|531051580|FG001|Overall Study|Withdrawal by Subject|1|||
147240320|NCT00923156|531051581|FG002|Overall Study|Withdrawal by Subject|0|||
147240321|NCT00923156|531051579|FG000|Overall Study|Death|0|||
147240322|NCT00923156|531051580|FG001|Overall Study|Death|1|||
147240323|NCT00923156|531051581|FG002|Overall Study|Death|0|||
147240324|NCT00923156|531051579|FG000|Overall Study|Lack of Efficacy|0|||
147240325|NCT00923156|531051580|FG001|Overall Study|Lack of Efficacy|0|||
147240326|NCT00923156|531051581|FG002|Overall Study|Lack of Efficacy|1|||
147240327|NCT01201850|531051584|FG000|Overall Study|Tumor progression|4|||
147240328|NCT03137537|531051585|FG000|Overall Study|Adverse Event|0|||
147581786|NCT00603512|532285566|FG002|Overall Study|Adverse Event|4|||
147581787|NCT00603512|532285567|FG003|Overall Study|Adverse Event|4|||
147581788|NCT00603512|532285568|FG004|Overall Study|Adverse Event|2|||
147581789|NCT00603512|532285564|FG000|Overall Study|Lack of Efficacy|0|||
147581790|NCT00603512|532285565|FG001|Overall Study|Lack of Efficacy|1|||
147581791|NCT00603512|532285566|FG002|Overall Study|Lack of Efficacy|0|||
147581792|NCT00603512|532285567|FG003|Overall Study|Lack of Efficacy|0|||
147581793|NCT00603512|532285568|FG004|Overall Study|Lack of Efficacy|1|||
147581794|NCT00603512|532285564|FG000|Overall Study|Other|2|||
147581795|NCT00603512|532285565|FG001|Overall Study|Other|1|||
147581796|NCT00603512|532285566|FG002|Overall Study|Other|0|||
147581797|NCT00603512|532285567|FG003|Overall Study|Other|1|||
147581798|NCT00603512|532285568|FG004|Overall Study|Other|1|||
147240329|NCT03137537|531051586|FG001|Overall Study|Adverse Event|1|||
147240330|NCT04066023|531051587|FG000|Overall Study|Adverse Event|0|||
147240331|NCT04066023|531051588|FG001|Overall Study|Adverse Event|0|||
147581799|NCT00603512|532285564|FG000|Overall Study|Withdrawal by Subject|0|||
147581800|NCT00603512|532285565|FG001|Overall Study|Withdrawal by Subject|0|||
147240332|NCT04066023|531051589|FG002|Overall Study|Adverse Event|1|||
147581801|NCT00603512|532285566|FG002|Overall Study|Withdrawal by Subject|0|||
147581802|NCT00603512|532285567|FG003|Overall Study|Withdrawal by Subject|0|||
147581803|NCT00603512|532285568|FG004|Overall Study|Withdrawal by Subject|1|||
147653938|NCT05052697|532554639|FG008|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
147653939|NCT05052697|532554640|FG009|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
147653940|NCT05052697|532554641|FG010|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
147653941|NCT05052697|532554642|FG011|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
147653942|NCT05052697|532554643|FG012|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
147653943|NCT05052697|532554644|FG013|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
147653944|NCT05052697|532554645|FG014|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
147653945|NCT05052697|532554646|FG015|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
147653946|NCT05052697|532554647|FG016|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
147653947|NCT05052697|532554648|FG017|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
147653948|NCT05052697|532554649|FG018|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
147653949|NCT05052697|532554650|FG019|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
147653950|NCT05052697|532554651|FG020|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
147653951|NCT05052697|532554652|FG021|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
147653952|NCT05052697|532554653|FG022|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
147653953|NCT05052697|532554654|FG023|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
147653954|NCT05052697|532554655|FG024|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
147653955|NCT05052697|532554656|FG025|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
147653956|NCT05052697|532554657|FG026|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
147653957|NCT05052697|532554658|FG027|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
147653958|NCT05052697|532554659|FG028|Substudy B: Expanded Enrollment|Lost to Follow-up|1|||
147653959|NCT05052697|532554660|FG029|Substudy B: Expanded Enrollment|Lost to Follow-up|1|||
147653960|NCT05052697|532554661|FG030|Substudy B: Expanded Enrollment|Lost to Follow-up|3|||
147653961|NCT05052697|532554662|FG031|Substudy B: Expanded Enrollment|Lost to Follow-up|3|||
147653962|NCT05052697|532554663|FG032|Substudy B: Expanded Enrollment|Lost to Follow-up|2|||
147653963|NCT05052697|532554664|FG033|Substudy B: Expanded Enrollment|Lost to Follow-up|0|||
147653964|NCT05052697|532554631|FG000|Substudy B: Expanded Enrollment|Refused study procedure|0|||
147653965|NCT05052697|532554632|FG001|Substudy B: Expanded Enrollment|Refused study procedure|0|||
147653966|NCT05052697|532554633|FG002|Substudy B: Expanded Enrollment|Refused study procedure|0|||
147653967|NCT05052697|532554634|FG003|Substudy B: Expanded Enrollment|Refused study procedure|0|||
147653968|NCT05052697|532554635|FG004|Substudy B: Expanded Enrollment|Refused study procedure|0|||
147653969|NCT05052697|532554636|FG005|Substudy B: Expanded Enrollment|Refused study procedure|0|||
147653970|NCT05052697|532554637|FG006|Substudy B: Expanded Enrollment|Refused study procedure|0|||
147653971|NCT05052697|532554638|FG007|Substudy B: Expanded Enrollment|Refused study procedure|0|||
147653972|NCT05052697|532554639|FG008|Substudy B: Expanded Enrollment|Refused study procedure|0|||
147653973|NCT05052697|532554640|FG009|Substudy B: Expanded Enrollment|Refused study procedure|0|||
147653974|NCT05052697|532554641|FG010|Substudy B: Expanded Enrollment|Refused study procedure|0|||
147653975|NCT05052697|532554642|FG011|Substudy B: Expanded Enrollment|Refused study procedure|0|||
147653976|NCT05052697|532554643|FG012|Substudy B: Expanded Enrollment|Refused study procedure|0|||
147653977|NCT05052697|532554644|FG013|Substudy B: Expanded Enrollment|Refused study procedure|0|||
147653978|NCT05052697|532554645|FG014|Substudy B: Expanded Enrollment|Refused study procedure|0|||
147653979|NCT05052697|532554646|FG015|Substudy B: Expanded Enrollment|Refused study procedure|0|||
147653980|NCT05052697|532554647|FG016|Substudy B: Expanded Enrollment|Refused study procedure|0|||
147653981|NCT05052697|532554648|FG017|Substudy B: Expanded Enrollment|Refused study procedure|0|||
147653982|NCT05052697|532554649|FG018|Substudy B: Expanded Enrollment|Refused study procedure|0|||
147653983|NCT05052697|532554650|FG019|Substudy B: Expanded Enrollment|Refused study procedure|0|||
147653984|NCT05052697|532554651|FG020|Substudy B: Expanded Enrollment|Refused study procedure|0|||
147653985|NCT05052697|532554652|FG021|Substudy B: Expanded Enrollment|Refused study procedure|0|||
147653986|NCT05052697|532554653|FG022|Substudy B: Expanded Enrollment|Refused study procedure|0|||
147653987|NCT05052697|532554654|FG023|Substudy B: Expanded Enrollment|Refused study procedure|0|||
147653988|NCT05052697|532554655|FG024|Substudy B: Expanded Enrollment|Refused study procedure|0|||
147653989|NCT05052697|532554656|FG025|Substudy B: Expanded Enrollment|Refused study procedure|0|||
147653990|NCT05052697|532554657|FG026|Substudy B: Expanded Enrollment|Refused study procedure|0|||
147653991|NCT05052697|532554658|FG027|Substudy B: Expanded Enrollment|Refused study procedure|0|||
147653992|NCT05052697|532554659|FG028|Substudy B: Expanded Enrollment|Refused study procedure|0|||
147653993|NCT05052697|532554660|FG029|Substudy B: Expanded Enrollment|Refused study procedure|0|||
147653994|NCT05052697|532554661|FG030|Substudy B: Expanded Enrollment|Refused study procedure|0|||
147653995|NCT05052697|532554662|FG031|Substudy B: Expanded Enrollment|Refused study procedure|0|||
147653996|NCT05052697|532554663|FG032|Substudy B: Expanded Enrollment|Refused study procedure|1|||
147653997|NCT05052697|532554664|FG033|Substudy B: Expanded Enrollment|Refused study procedure|0|||
147240333|NCT04066023|531051587|FG000|Overall Study|Sponsor decision|3|||
147240334|NCT04066023|531051588|FG001|Overall Study|Sponsor decision|6|||
147653998|NCT05052697|532554631|FG000|Substudy B: Expanded Enrollment|Not vaccinated|0|||
147653999|NCT05052697|532554632|FG001|Substudy B: Expanded Enrollment|Not vaccinated|0|||
147654000|NCT05052697|532554633|FG002|Substudy B: Expanded Enrollment|Not vaccinated|0|||
147654001|NCT05052697|532554634|FG003|Substudy B: Expanded Enrollment|Not vaccinated|0|||
147654002|NCT05052697|532554635|FG004|Substudy B: Expanded Enrollment|Not vaccinated|0|||
147240335|NCT04066023|531051589|FG002|Overall Study|Sponsor decision|2|||
147654003|NCT05052697|532554636|FG005|Substudy B: Expanded Enrollment|Not vaccinated|0|||
147654004|NCT05052697|532554637|FG006|Substudy B: Expanded Enrollment|Not vaccinated|0|||
147654005|NCT05052697|532554638|FG007|Substudy B: Expanded Enrollment|Not vaccinated|0|||
147654006|NCT05052697|532554639|FG008|Substudy B: Expanded Enrollment|Not vaccinated|0|||
147654007|NCT05052697|532554640|FG009|Substudy B: Expanded Enrollment|Not vaccinated|0|||
147654008|NCT05052697|532554641|FG010|Substudy B: Expanded Enrollment|Not vaccinated|0|||
147654009|NCT05052697|532554642|FG011|Substudy B: Expanded Enrollment|Not vaccinated|0|||
147654010|NCT05052697|532554643|FG012|Substudy B: Expanded Enrollment|Not vaccinated|0|||
147654011|NCT05052697|532554644|FG013|Substudy B: Expanded Enrollment|Not vaccinated|0|||
147654012|NCT05052697|532554645|FG014|Substudy B: Expanded Enrollment|Not vaccinated|0|||
147654013|NCT05052697|532554646|FG015|Substudy B: Expanded Enrollment|Not vaccinated|0|||
147654014|NCT05052697|532554647|FG016|Substudy B: Expanded Enrollment|Not vaccinated|0|||
147654015|NCT05052697|532554648|FG017|Substudy B: Expanded Enrollment|Not vaccinated|0|||
147654016|NCT05052697|532554649|FG018|Substudy B: Expanded Enrollment|Not vaccinated|0|||
147654017|NCT05052697|532554650|FG019|Substudy B: Expanded Enrollment|Not vaccinated|0|||
147654018|NCT05052697|532554651|FG020|Substudy B: Expanded Enrollment|Not vaccinated|0|||
147654019|NCT05052697|532554652|FG021|Substudy B: Expanded Enrollment|Not vaccinated|0|||
147581804|NCT00603512|532285564|FG000|Overall Study|Randomized but not treated|0|||
147581805|NCT00603512|532285565|FG001|Overall Study|Randomized but not treated|1|||
147581806|NCT00603512|532285566|FG002|Overall Study|Randomized but not treated|1|||
147581807|NCT00603512|532285567|FG003|Overall Study|Randomized but not treated|2|||
147581808|NCT00603512|532285568|FG004|Overall Study|Randomized but not treated|0|||
147581809|NCT01688882|532285569|FG000|Overall Study|Adverse Event|1|||
147321710|NCT02179918|531341660|FG000|Overall Study|Progressive Disease|4|||
147321711|NCT02179918|531341661|FG001|Overall Study|Progressive Disease|1|||
147321712|NCT02179918|531341662|FG002|Overall Study|Progressive Disease|1|||
147321713|NCT02179918|531341663|FG003|Overall Study|Progressive Disease|2|||
147321714|NCT02179918|531341664|FG004|Overall Study|Progressive Disease|6|||
147321715|NCT02179918|531341660|FG000|Overall Study|Other|0|||
147321716|NCT02179918|531341661|FG001|Overall Study|Other|1|||
147321717|NCT02179918|531341662|FG002|Overall Study|Other|0|||
147321718|NCT02179918|531341663|FG003|Overall Study|Other|0|||
147321719|NCT02179918|531341664|FG004|Overall Study|Other|1|||
147581810|NCT01688882|532285570|FG001|Overall Study|Adverse Event|0|||
147581811|NCT01688882|532285569|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
147581812|NCT01688882|532285570|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
147581813|NCT01688882|532285569|FG000|Overall Study|Administrative problems|1|||
147581814|NCT01688882|532285570|FG001|Overall Study|Administrative problems|0|||
147581815|NCT00860262|532285574|FG000|Overall Study|Adverse Event|9|||
147581816|NCT00860262|532285575|FG001|Overall Study|Adverse Event|6|||
147581817|NCT00860262|532285576|FG002|Overall Study|Adverse Event|7|||
147581818|NCT00860262|532285574|FG000|Overall Study|Protocol Violation|0|||
147321720|NCT02179918|531341660|FG000|Overall Study|Subject refused further follow-up|0|||
147581819|NCT00860262|532285575|FG001|Overall Study|Protocol Violation|1|||
147654020|NCT05052697|532554653|FG022|Substudy B: Expanded Enrollment|Not vaccinated|0|||
147240336|NCT04066023|531051587|FG000|Overall Study|Physician Decision|0|||
147321721|NCT02179918|531341661|FG001|Overall Study|Subject refused further follow-up|1|||
147321722|NCT02179918|531341662|FG002|Overall Study|Subject refused further follow-up|0|||
147321723|NCT02179918|531341663|FG003|Overall Study|Subject refused further follow-up|0|||
147321724|NCT02179918|531341664|FG004|Overall Study|Subject refused further follow-up|1|||
147321725|NCT03890120|531341669|FG000|Blinded Treatment Phase (100.3 Weeks)|Study terminated by sponsor|119|||
147321726|NCT03890120|531341670|FG001|Blinded Treatment Phase (100.3 Weeks)|Study terminated by sponsor|57|||
147321727|NCT03890120|531341671|FG002|Blinded Treatment Phase (100.3 Weeks)|Study terminated by sponsor|0|||
147321728|NCT03890120|531341672|FG003|Blinded Treatment Phase (100.3 Weeks)|Study terminated by sponsor|0|||
147321729|NCT03890120|531341669|FG000|Blinded Treatment Phase (100.3 Weeks)|Adverse Event|17|||
147321730|NCT03890120|531341670|FG001|Blinded Treatment Phase (100.3 Weeks)|Adverse Event|7|||
147321731|NCT03890120|531341671|FG002|Blinded Treatment Phase (100.3 Weeks)|Adverse Event|0|||
147321732|NCT03890120|531341672|FG003|Blinded Treatment Phase (100.3 Weeks)|Adverse Event|0|||
147321733|NCT03890120|531341669|FG000|Blinded Treatment Phase (100.3 Weeks)|Withdrew consent|12|||
147321734|NCT03890120|531341670|FG001|Blinded Treatment Phase (100.3 Weeks)|Withdrew consent|4|||
147321735|NCT03890120|531341671|FG002|Blinded Treatment Phase (100.3 Weeks)|Withdrew consent|0|||
147581820|NCT00860262|532285576|FG002|Overall Study|Protocol Violation|0|||
147581821|NCT00860262|532285574|FG000|Overall Study|Lost to Follow-up|2|||
147581822|NCT00860262|532285575|FG001|Overall Study|Lost to Follow-up|0|||
147581823|NCT00860262|532285576|FG002|Overall Study|Lost to Follow-up|1|||
147240337|NCT04066023|531051588|FG001|Overall Study|Physician Decision|0|||
147240338|NCT04066023|531051589|FG002|Overall Study|Physician Decision|1|||
147240339|NCT04066023|531051587|FG000|Overall Study|Lost to Follow-up|0|||
147240340|NCT04066023|531051588|FG001|Overall Study|Lost to Follow-up|1|||
147240341|NCT04066023|531051589|FG002|Overall Study|Lost to Follow-up|1|||
147240342|NCT04066023|531051587|FG000|Overall Study|Noncompliance|0|||
147240343|NCT04066023|531051588|FG001|Overall Study|Noncompliance|1|||
147240344|NCT04066023|531051589|FG002|Overall Study|Noncompliance|1|||
147240345|NCT04665856|531051590|FG000|Overall Study|Site Terminated by Sponsor|1|||
147581824|NCT00860262|532285574|FG000|Overall Study|Withdrawal by Subject|4|||
147321736|NCT03890120|531341672|FG003|Blinded Treatment Phase (100.3 Weeks)|Withdrew consent|0|||
147581825|NCT00860262|532285575|FG001|Overall Study|Withdrawal by Subject|8|||
147581826|NCT00860262|532285576|FG002|Overall Study|Withdrawal by Subject|6|||
147581827|NCT00860262|532285574|FG000|Overall Study|Lack of Efficacy|0|||
147581828|NCT00860262|532285575|FG001|Overall Study|Lack of Efficacy|4|||
147581829|NCT00860262|532285576|FG002|Overall Study|Lack of Efficacy|3|||
147581830|NCT00860262|532285574|FG000|Overall Study|Other|5|||
147581831|NCT00860262|532285575|FG001|Overall Study|Other|3|||
147581832|NCT00860262|532285576|FG002|Overall Study|Other|1|||
147581833|NCT00124618|532285577|FG000|Overall Study|Ineligible|1|||
147581834|NCT04640194|532285583|FG000|Overall Study|Adverse Event|3|||
147581835|NCT04640194|532285584|FG001|Overall Study|Adverse Event|7|||
147581836|NCT04640194|532285585|FG002|Overall Study|Adverse Event|0|||
147581837|NCT04640194|532285586|FG003|Overall Study|Adverse Event|5|||
147581838|NCT04640194|532285587|FG004|Overall Study|Adverse Event|0|||
147581839|NCT04640194|532285588|FG005|Overall Study|Adverse Event|4|||
147581840|NCT04640194|532285589|FG006|Overall Study|Adverse Event|0|||
147581841|NCT04640194|532285583|FG000|Overall Study|pO2/FIO2 ratio too high|0|||
147581842|NCT04640194|532285584|FG001|Overall Study|pO2/FIO2 ratio too high|0|||
147581843|NCT04640194|532285585|FG002|Overall Study|pO2/FIO2 ratio too high|0|||
147581844|NCT04640194|532285586|FG003|Overall Study|pO2/FIO2 ratio too high|1|||
147581845|NCT04640194|532285587|FG004|Overall Study|pO2/FIO2 ratio too high|0|||
147581846|NCT04640194|532285588|FG005|Overall Study|pO2/FIO2 ratio too high|0|||
147581847|NCT04640194|532285589|FG006|Overall Study|pO2/FIO2 ratio too high|0|||
147581848|NCT04640194|532285583|FG000|Overall Study|fibrinogen level too low|0|||
147581849|NCT04640194|532285584|FG001|Overall Study|fibrinogen level too low|0|||
147581850|NCT04640194|532285585|FG002|Overall Study|fibrinogen level too low|0|||
147581851|NCT04640194|532285586|FG003|Overall Study|fibrinogen level too low|1|||
147581852|NCT04640194|532285587|FG004|Overall Study|fibrinogen level too low|0|||
147581853|NCT04640194|532285588|FG005|Overall Study|fibrinogen level too low|0|||
147581854|NCT04640194|532285589|FG006|Overall Study|fibrinogen level too low|0|||
147581855|NCT04640194|532285583|FG000|Overall Study|mild bleeding|0|||
147581856|NCT04640194|532285584|FG001|Overall Study|mild bleeding|0|||
147581857|NCT04640194|532285585|FG002|Overall Study|mild bleeding|0|||
147581858|NCT04640194|532285586|FG003|Overall Study|mild bleeding|1|||
147581859|NCT04640194|532285587|FG004|Overall Study|mild bleeding|0|||
147581860|NCT04640194|532285588|FG005|Overall Study|mild bleeding|0|||
147581861|NCT04640194|532285589|FG006|Overall Study|mild bleeding|0|||
147581862|NCT04640194|532285583|FG000|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|0|||
147581863|NCT04640194|532285584|FG001|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|1|||
147581864|NCT04640194|532285585|FG002|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|0|||
147581865|NCT04640194|532285586|FG003|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|0|||
147581866|NCT04640194|532285587|FG004|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|0|||
147581867|NCT04640194|532285588|FG005|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|0|||
147581868|NCT04640194|532285589|FG006|Overall Study|Transferred from Intensive Care Unit to Hospital Ward|0|||
147581869|NCT01709903|532285590|FG000|Overall Study|administrative problems|2|||
147581870|NCT01709903|532285591|FG001|Overall Study|administrative problems|6|||
147581871|NCT01709903|532285590|FG000|Overall Study|Abnormal test procedure results|1|||
147581872|NCT01709903|532285591|FG001|Overall Study|Abnormal test procedure results|0|||
147581873|NCT01709903|532285590|FG000|Overall Study|In ability to use device|1|||
147581874|NCT01709903|532285591|FG001|Overall Study|In ability to use device|1|||
147581875|NCT01709903|532285590|FG000|Overall Study|no longer needed study drug|0|||
147581876|NCT01709903|532285591|FG001|Overall Study|no longer needed study drug|1|||
147581877|NCT01709903|532285590|FG000|Overall Study|Lost to Follow-up|0|||
147581878|NCT01709903|532285591|FG001|Overall Study|Lost to Follow-up|2|||
147581879|NCT01709903|532285590|FG000|Overall Study|Death|2|||
147581880|NCT01709903|532285591|FG001|Overall Study|Death|0|||
147581881|NCT01709903|532285590|FG000|Overall Study|Protocol Violation|3|||
147581882|NCT01709903|532285591|FG001|Overall Study|Protocol Violation|2|||
147581883|NCT01709903|532285590|FG000|Overall Study|Lack of Efficacy|3|||
147581884|NCT01709903|532285591|FG001|Overall Study|Lack of Efficacy|3|||
147321737|NCT03890120|531341669|FG000|Blinded Treatment Phase (100.3 Weeks)|Lost to Follow-up|4|||
147581885|NCT01709903|532285590|FG000|Overall Study|Withdrawal by Subject|6|||
147581886|NCT01709903|532285591|FG001|Overall Study|Withdrawal by Subject|6|||
147581887|NCT01709903|532285590|FG000|Overall Study|Adverse Event|11|||
147581888|NCT01709903|532285591|FG001|Overall Study|Adverse Event|18|||
147581889|NCT02061280|532285592|FG000|Overall Study|Protocol Violation|12|||
147581890|NCT02061280|532285593|FG001|Overall Study|Protocol Violation|8|||
147581891|NCT02061280|532285592|FG000|Overall Study|moved out of state|0|||
147581892|NCT02061280|532285593|FG001|Overall Study|moved out of state|1|||
147581893|NCT02061280|532285592|FG000|Overall Study|Withdrawal by Subject|1|||
147581894|NCT02061280|532285593|FG001|Overall Study|Withdrawal by Subject|2|||
147581895|NCT02061280|532285592|FG000|Overall Study|Lost to Follow-up|5|||
147581896|NCT02061280|532285593|FG001|Overall Study|Lost to Follow-up|1|||
147581897|NCT04662710|532286822|FG000|Overall Study|Death|14|||
147321738|NCT03890120|531341670|FG001|Blinded Treatment Phase (100.3 Weeks)|Lost to Follow-up|1|||
147321739|NCT03890120|531341671|FG002|Blinded Treatment Phase (100.3 Weeks)|Lost to Follow-up|0|||
147321740|NCT03890120|531341672|FG003|Blinded Treatment Phase (100.3 Weeks)|Lost to Follow-up|0|||
147321741|NCT03890120|531341669|FG000|Blinded Treatment Phase (100.3 Weeks)|Investigator's discretion|1|||
147321742|NCT03890120|531341670|FG001|Blinded Treatment Phase (100.3 Weeks)|Investigator's discretion|2|||
147321743|NCT03890120|531341671|FG002|Blinded Treatment Phase (100.3 Weeks)|Investigator's discretion|0|||
147321744|NCT03890120|531341672|FG003|Blinded Treatment Phase (100.3 Weeks)|Investigator's discretion|0|||
147321745|NCT03890120|531341669|FG000|Blinded Treatment Phase (100.3 Weeks)|Randomized but never treated|1|||
147321746|NCT03890120|531341670|FG001|Blinded Treatment Phase (100.3 Weeks)|Randomized but never treated|2|||
147321747|NCT03890120|531341671|FG002|Blinded Treatment Phase (100.3 Weeks)|Randomized but never treated|0|||
147321748|NCT03890120|531341672|FG003|Blinded Treatment Phase (100.3 Weeks)|Randomized but never treated|0|||
147321749|NCT03890120|531341669|FG000|Blinded Treatment Phase (100.3 Weeks)|Death|1|||
147321750|NCT03890120|531341670|FG001|Blinded Treatment Phase (100.3 Weeks)|Death|0|||
147321751|NCT03890120|531341671|FG002|Blinded Treatment Phase (100.3 Weeks)|Death|0|||
147321752|NCT03890120|531341672|FG003|Blinded Treatment Phase (100.3 Weeks)|Death|0|||
147321753|NCT03890120|531341669|FG000|Blinded Treatment Phase (100.3 Weeks)|Non-compliance with study drug|0|||
147321754|NCT03890120|531341670|FG001|Blinded Treatment Phase (100.3 Weeks)|Non-compliance with study drug|1|||
147321755|NCT03890120|531341671|FG002|Blinded Treatment Phase (100.3 Weeks)|Non-compliance with study drug|0|||
147321756|NCT03890120|531341672|FG003|Blinded Treatment Phase (100.3 Weeks)|Non-compliance with study drug|0|||
147321757|NCT03890120|531341669|FG000|Blinded Treatment Phase (100.3 Weeks)|Pregnancy|0|||
147321758|NCT03890120|531341670|FG001|Blinded Treatment Phase (100.3 Weeks)|Pregnancy|1|||
147321759|NCT03890120|531341671|FG002|Blinded Treatment Phase (100.3 Weeks)|Pregnancy|0|||
147321760|NCT03890120|531341672|FG003|Blinded Treatment Phase (100.3 Weeks)|Pregnancy|0|||
147321761|NCT03890120|531341669|FG000|Open-Label Extension Phase (45 Weeks)|Study terminated by sponsor|0|||
147321762|NCT03890120|531341670|FG001|Open-Label Extension Phase (45 Weeks)|Study terminated by sponsor|0|||
147321763|NCT03890120|531341671|FG002|Open-Label Extension Phase (45 Weeks)|Study terminated by sponsor|76|||
147321764|NCT03890120|531341672|FG003|Open-Label Extension Phase (45 Weeks)|Study terminated by sponsor|42|||
147321765|NCT03890120|531341669|FG000|Open-Label Extension Phase (45 Weeks)|Adverse Event|0|||
147321766|NCT03890120|531341670|FG001|Open-Label Extension Phase (45 Weeks)|Adverse Event|0|||
147321767|NCT03890120|531341671|FG002|Open-Label Extension Phase (45 Weeks)|Adverse Event|3|||
147321768|NCT03890120|531341672|FG003|Open-Label Extension Phase (45 Weeks)|Adverse Event|1|||
147321769|NCT03890120|531341669|FG000|Open-Label Extension Phase (45 Weeks)|Lost to Follow-up|0|||
147321770|NCT03890120|531341670|FG001|Open-Label Extension Phase (45 Weeks)|Lost to Follow-up|0|||
147321771|NCT03890120|531341671|FG002|Open-Label Extension Phase (45 Weeks)|Lost to Follow-up|0|||
147321772|NCT03890120|531341672|FG003|Open-Label Extension Phase (45 Weeks)|Lost to Follow-up|2|||
147321773|NCT03890120|531341669|FG000|Open-Label Extension Phase (45 Weeks)|Withdrew consent|0|||
147321774|NCT03890120|531341670|FG001|Open-Label Extension Phase (45 Weeks)|Withdrew consent|0|||
147321775|NCT03890120|531341671|FG002|Open-Label Extension Phase (45 Weeks)|Withdrew consent|1|||
147321776|NCT03890120|531341672|FG003|Open-Label Extension Phase (45 Weeks)|Withdrew consent|0|||
147321777|NCT04537949|531341673|FG000|Treatment Phase|personal reasons not related to the IMP|1|||
147321778|NCT04537949|531341674|FG001|Treatment Phase|personal reasons not related to the IMP|0|||
147581898|NCT04662710|532286823|FG001|Overall Study|Death|331|||
147581899|NCT04662710|532286824|FG002|Overall Study|Death|367|||
147581900|NCT04662710|532286822|FG000|Overall Study|Ongoing|1|||
147581901|NCT04662710|532286823|FG001|Overall Study|Ongoing|109|||
147581902|NCT04662710|532286824|FG002|Overall Study|Ongoing|56|||
147581903|NCT04662710|532286822|FG000|Overall Study|Withdrawal by Subject|0|||
147581904|NCT04662710|532286823|FG001|Overall Study|Withdrawal by Subject|3|||
147581905|NCT04662710|532286824|FG002|Overall Study|Withdrawal by Subject|14|||
147581906|NCT05480800|532286830|FG000|Overall Study|Withdrawal by Subject|0|||
147581907|NCT05480800|532286831|FG001|Overall Study|Withdrawal by Subject|0|||
147581908|NCT05480800|532286832|FG002|Overall Study|Withdrawal by Subject|2|||
147654021|NCT05052697|532554654|FG023|Substudy B: Expanded Enrollment|Not vaccinated|0|||
147321779|NCT04537949|531341675|FG002|Treatment Phase|personal reasons not related to the IMP|0|||
147321780|NCT04537949|531341676|FG003|Treatment Phase|personal reasons not related to the IMP|0|||
147321781|NCT04537949|531341677|FG004|Treatment Phase|personal reasons not related to the IMP|0|||
147321782|NCT04537949|531341678|FG005|Treatment Phase|personal reasons not related to the IMP|0|||
147321783|NCT04537949|531341679|FG006|Treatment Phase|personal reasons not related to the IMP|0|||
147321784|NCT04537949|531341680|FG007|Treatment Phase|personal reasons not related to the IMP|0|||
147321785|NCT04537949|531341673|FG000|Follow-up Phase|Roll-over into trial BNT162-14|3|||
147321786|NCT04537949|531341674|FG001|Follow-up Phase|Roll-over into trial BNT162-14|1|||
147321787|NCT04537949|531341675|FG002|Follow-up Phase|Roll-over into trial BNT162-14|0|||
147321788|NCT04537949|531341676|FG003|Follow-up Phase|Roll-over into trial BNT162-14|2|||
147321789|NCT04537949|531341677|FG004|Follow-up Phase|Roll-over into trial BNT162-14|1|||
147581909|NCT05480800|532286833|FG003|Overall Study|Withdrawal by Subject|1|||
147581910|NCT05480800|532286834|FG004|Overall Study|Withdrawal by Subject|0|||
147581911|NCT05480800|532286835|FG005|Overall Study|Withdrawal by Subject|0|||
147581912|NCT05480800|532286836|FG006|Overall Study|Withdrawal by Subject|1|||
147581913|NCT05480800|532286837|FG007|Overall Study|Withdrawal by Subject|0|||
147581914|NCT05480800|532286830|FG000|Overall Study|Other|0|||
147581915|NCT05480800|532286831|FG001|Overall Study|Other|0|||
147581916|NCT05480800|532286832|FG002|Overall Study|Other|0|||
147581917|NCT05480800|532286833|FG003|Overall Study|Other|0|||
147581918|NCT05480800|532286834|FG004|Overall Study|Other|0|||
147581919|NCT05480800|532286835|FG005|Overall Study|Other|0|||
147581920|NCT05480800|532286836|FG006|Overall Study|Other|1|||
147581921|NCT05480800|532286837|FG007|Overall Study|Other|0|||
147581922|NCT05693805|532286840|FG000|Overall Study|Completed is defined as being engaged at the 3-month follow up..|5|||
147581923|NCT05693805|532286841|FG001|Overall Study|Completed is defined as being engaged at the 3-month follow up..|2|||
147581924|NCT02152982|532286846|FG000|Overall Study|Withdrawal by Subject|17|||
147581925|NCT02152982|532286847|FG001|Overall Study|Withdrawal by Subject|16|||
147581926|NCT02152982|532286846|FG000|Overall Study|Did not start treatment|11|||
147581927|NCT02152982|532286847|FG001|Overall Study|Did not start treatment|5|||
147581928|NCT02152982|532286846|FG000|Overall Study|Disease progression|41|||
147581929|NCT02152982|532286847|FG001|Overall Study|Disease progression|52|||
147581930|NCT02152982|532286846|FG000|Overall Study|Adverse Event|7|||
147581931|NCT02152982|532286847|FG001|Overall Study|Adverse Event|12|||
147581932|NCT02152982|532286846|FG000|Overall Study|Complicating disease|1|||
147581933|NCT02152982|532286847|FG001|Overall Study|Complicating disease|1|||
147581934|NCT02152982|532286846|FG000|Overall Study|Death|0|||
147581935|NCT02152982|532286847|FG001|Overall Study|Death|3|||
147581936|NCT02152982|532286846|FG000|Overall Study|Physician Decision|3|||
147581937|NCT02152982|532286847|FG001|Overall Study|Physician Decision|0|||
147581938|NCT03230487|532286853|FG000|Overall Study|Adverse Event|0|||
147581939|NCT03230487|532286854|FG001|Overall Study|Adverse Event|0|||
147581940|NCT03230487|532286855|FG002|Overall Study|Adverse Event|0|||
147581941|NCT03230487|532286856|FG003|Overall Study|Adverse Event|1|||
147581942|NCT03230487|532286857|FG004|Overall Study|Adverse Event|0|||
147581943|NCT03230487|532286858|FG005|Overall Study|Adverse Event|0|||
147581944|NCT05212948|532286859|FG000|Initial Vaccination Period|Withdrawal by Subject|409|||
147581945|NCT05212948|532286860|FG001|Initial Vaccination Period|Withdrawal by Subject|199|||
147581946|NCT05212948|532286859|FG000|Initial Vaccination Period|Suspected Pregnancy|1|||
147581947|NCT05212948|532286860|FG001|Initial Vaccination Period|Suspected Pregnancy|0|||
147581948|NCT05212948|532286859|FG000|Initial Vaccination Period|Pregnancy|20|||
147581949|NCT05212948|532286860|FG001|Initial Vaccination Period|Pregnancy|14|||
147581950|NCT05212948|532286859|FG000|Initial Vaccination Period|Physician Decision|686|||
147321790|NCT04537949|531341678|FG005|Follow-up Phase|Roll-over into trial BNT162-14|1|||
147321791|NCT04537949|531341679|FG006|Follow-up Phase|Roll-over into trial BNT162-14|5|||
147446772|NCT01324232|531800301|FG003|Overall Study|Lack of Efficacy|2|||
147581951|NCT05212948|532286860|FG001|Initial Vaccination Period|Physician Decision|401|||
147581952|NCT05212948|532286859|FG000|Initial Vaccination Period|Lost to Follow-up|106|||
147581953|NCT05212948|532286860|FG001|Initial Vaccination Period|Lost to Follow-up|42|||
147581954|NCT05212948|532286859|FG000|Initial Vaccination Period|Death|23|||
147581955|NCT05212948|532286860|FG001|Initial Vaccination Period|Death|18|||
147581956|NCT05212948|532286859|FG000|Initial Vaccination Period|Coronavirus Disease 2019 (COVID-19)|4|||
147581957|NCT05212948|532286860|FG001|Initial Vaccination Period|Coronavirus Disease 2019 (COVID-19)|3|||
147581958|NCT05212948|532286859|FG000|Initial Vaccination Period|Adverse Event|36|||
147581959|NCT05212948|532286860|FG001|Initial Vaccination Period|Adverse Event|23|||
147581960|NCT05212948|532286859|FG000|Crossover Vaccination Period|Withdrawal by Subject|95|||
147581961|NCT05212948|532286860|FG001|Crossover Vaccination Period|Withdrawal by Subject|57|||
147581962|NCT05212948|532286859|FG000|Crossover Vaccination Period|Pregnancy|6|||
147581963|NCT05212948|532286860|FG001|Crossover Vaccination Period|Pregnancy|1|||
147581964|NCT05212948|532286859|FG000|Crossover Vaccination Period|Physician Decision|49|||
147581965|NCT05212948|532286860|FG001|Crossover Vaccination Period|Physician Decision|24|||
147581966|NCT05212948|532286859|FG000|Crossover Vaccination Period|Lost to Follow-up|23|||
147581967|NCT05212948|532286860|FG001|Crossover Vaccination Period|Lost to Follow-up|8|||
147581968|NCT05212948|532286859|FG000|Crossover Vaccination Period|Death|10|||
147581969|NCT05212948|532286860|FG001|Crossover Vaccination Period|Death|5|||
147581970|NCT05212948|532286859|FG000|Crossover Vaccination Period|Adverse Event|9|||
147581971|NCT05212948|532286860|FG001|Crossover Vaccination Period|Adverse Event|4|||
147581972|NCT05347693|532286861|FG000|Inpatient Period|Participant was discharged from the hospital but did not inform the site|1|||
147581973|NCT05347693|532286862|FG001|Inpatient Period|Participant was discharged from the hospital but did not inform the site|0|||
147581974|NCT05347693|532286863|FG002|Inpatient Period|Participant was discharged from the hospital but did not inform the site|0|||
147581975|NCT05347693|532286861|FG000|Inpatient Period|Withdrawal of consent|10|||
147581976|NCT05347693|532286862|FG001|Inpatient Period|Withdrawal of consent|0|||
147581977|NCT05347693|532286863|FG002|Inpatient Period|Withdrawal of consent|0|||
147581978|NCT05347693|532286861|FG000|Inpatient Period|Failure to meet inclusion/exclusion criteria|19|||
147581979|NCT05347693|532286862|FG001|Inpatient Period|Failure to meet inclusion/exclusion criteria|0|||
147654022|NCT05052697|532554655|FG024|Substudy B: Expanded Enrollment|Not vaccinated|0|||
147654023|NCT05052697|532554656|FG025|Substudy B: Expanded Enrollment|Not vaccinated|0|||
147581980|NCT05347693|532286863|FG002|Inpatient Period|Failure to meet inclusion/exclusion criteria|0|||
147581981|NCT05347693|532286861|FG000|Inpatient Period|Screening Failure|8|||
147581982|NCT05347693|532286862|FG001|Inpatient Period|Screening Failure|0|||
147581983|NCT05347693|532286863|FG002|Inpatient Period|Screening Failure|0|||
147581984|NCT05347693|532286861|FG000|Inpatient Period|Death|2|||
147581985|NCT05347693|532286862|FG001|Inpatient Period|Death|0|||
147654024|NCT05052697|532554657|FG026|Substudy B: Expanded Enrollment|Not vaccinated|0|||
147654025|NCT05052697|532554658|FG027|Substudy B: Expanded Enrollment|Not vaccinated|0|||
147654026|NCT05052697|532554659|FG028|Substudy B: Expanded Enrollment|Not vaccinated|1|||
147654027|NCT05052697|532554660|FG029|Substudy B: Expanded Enrollment|Not vaccinated|2|||
147654028|NCT05052697|532554661|FG030|Substudy B: Expanded Enrollment|Not vaccinated|1|||
147654029|NCT05052697|532554662|FG031|Substudy B: Expanded Enrollment|Not vaccinated|0|||
147654030|NCT05052697|532554663|FG032|Substudy B: Expanded Enrollment|Not vaccinated|0|||
147654031|NCT05052697|532554664|FG033|Substudy B: Expanded Enrollment|Not vaccinated|0|||
147654032|NCT01900899|532554667|FG000|Overall Study|Withdrawal by Subject|7|||
147654033|NCT01900899|532554668|FG001|Overall Study|Withdrawal by Subject|1|||
147654034|NCT01900899|532554667|FG000|Overall Study|Migrated from study area|2|||
147654035|NCT01900899|532554668|FG001|Overall Study|Migrated from study area|0|||
147654036|NCT02772809|532554671|FG000|Overall Study|not completed some tasks|6|||
147654037|NCT00723697|532554672|FG000|Overall Study|Physician questionnaires not received|2|||
147654038|NCT00723697|532554672|FG000|Overall Study|Missing Informed Consent Form|10|||
147654039|NCT00723697|532554672|FG000|Overall Study|Other exclusion criteria applied|6|||
147654040|NCT00534105|532554673|FG000|Overall Study|Lost to Follow-up|23|||
147654041|NCT00534105|532554674|FG001|Overall Study|Lost to Follow-up|39|||
147654042|NCT02774005|532554675|FG000|Overall Study|Adverse Event|8|||
147446773|NCT01324232|531800298|FG000|Overall Study|Participant Refused Medication|0|||
147446774|NCT01324232|531800299|FG001|Overall Study|Participant Refused Medication|1|||
147446775|NCT01324232|531800300|FG002|Overall Study|Participant Refused Medication|0|||
147446776|NCT01324232|531800301|FG003|Overall Study|Participant Refused Medication|0|||
147446777|NCT01324232|531800298|FG000|Overall Study|Intercurrent illness|0|||
147446778|NCT01324232|531800299|FG001|Overall Study|Intercurrent illness|0|||
147446779|NCT01324232|531800300|FG002|Overall Study|Intercurrent illness|0|||
147446780|NCT01324232|531800301|FG003|Overall Study|Intercurrent illness|1|||
147581986|NCT05347693|532286863|FG002|Inpatient Period|Death|0|||
147581987|NCT05347693|532286861|FG000|Inpatient Period|Physician Decision|5|||
147581988|NCT05347693|532286862|FG001|Inpatient Period|Physician Decision|0|||
147581989|NCT05347693|532286863|FG002|Inpatient Period|Physician Decision|0|||
147654043|NCT02774005|532554675|FG000|Overall Study|Withdrawal by Subject|23|||
147654044|NCT02774005|532554675|FG000|Overall Study|Lost to Follow-up|7|||
147654045|NCT02774005|532554675|FG000|Overall Study|Genetic diagnosis reveals that a patient does not harbour a LHON-specific mtDNA mutation|12|||
147654046|NCT02774005|532554675|FG000|Overall Study|Due to Covid-19 lockdown V9 was not completed|1|||
147654047|NCT02774005|532554675|FG000|Overall Study|Pt not willing to perform onsite V9,did not withdraw consent,not triggered by Covid19 situation|1|||
147654048|NCT02774005|532554675|FG000|Overall Study|Death|1|||
147654049|NCT02774005|532554675|FG000|Overall Study|Patient unable to return for visits. Sent medication back to site|1|||
147654050|NCT02774005|532554675|FG000|Overall Study|Lack of compliance with study medication|4|||
147654051|NCT02774005|532554675|FG000|Overall Study|subject is enrolling in a different LHON study that excludes use of idebenone|1|||
147654052|NCT02774005|532554675|FG000|Overall Study|another study|1|||
147654053|NCT02774005|532554675|FG000|Overall Study|cardiologist imposed travel restriction|1|||
147581990|NCT05347693|532286861|FG000|Inpatient Period|Adverse Event|3|||
147654054|NCT00978341|532554676|FG000|Washout Period of 2 Weeks|Adverse Event|1|||
147654055|NCT00978341|532554677|FG001|Washout Period of 2 Weeks|Adverse Event|0|||
147654056|NCT03035916|532554678|FG000|Overall Study|Puncture failed|0|||
147654057|NCT03035916|532554679|FG001|Overall Study|Puncture failed|2|||
147654058|NCT03035916|532554680|FG002|Overall Study|Puncture failed|0|||
147654059|NCT01451554|532554681|FG000|Overall Study|Withdrawal by Subject|14|||
147654060|NCT01451554|532554682|FG001|Overall Study|Withdrawal by Subject|9|||
147654061|NCT01402986|532554683|FG000|Overall Study|Withdrawal by Subject|7|||
147654062|NCT01402986|532554684|FG001|Overall Study|Withdrawal by Subject|10|||
147654063|NCT01402986|532554685|FG002|Overall Study|Withdrawal by Subject|7|||
147446781|NCT01324232|531800298|FG000|Overall Study|Adverse Event|2|||
147581991|NCT05347693|532286862|FG001|Inpatient Period|Adverse Event|0|||
147581992|NCT05347693|532286863|FG002|Inpatient Period|Adverse Event|0|||
147446782|NCT01324232|531800299|FG001|Overall Study|Adverse Event|5|||
147581993|NCT05347693|532286861|FG000|Inpatient Period|Withdrawn from study due to a mistaken request for study termination|1|||
147581994|NCT05347693|532286862|FG001|Inpatient Period|Withdrawn from study due to a mistaken request for study termination|0|||
147581995|NCT05347693|532286863|FG002|Inpatient Period|Withdrawn from study due to a mistaken request for study termination|0|||
147581996|NCT05347693|532286861|FG000|Outpatient Period|Adverse Event|0|||
147581997|NCT05347693|532286862|FG001|Outpatient Period|Adverse Event|9|||
147581998|NCT05347693|532286863|FG002|Outpatient Period|Adverse Event|0|||
147654064|NCT01402986|532554686|FG003|Overall Study|Withdrawal by Subject|13|||
147654065|NCT01402986|532554683|FG000|Overall Study|Death|0|||
147446783|NCT01324232|531800300|FG002|Overall Study|Adverse Event|6|||
147581999|NCT05347693|532286861|FG000|Outpatient Period|Death|0|||
147582000|NCT05347693|532286862|FG001|Outpatient Period|Death|6|||
147582001|NCT05347693|532286863|FG002|Outpatient Period|Death|2|||
147582002|NCT05347693|532286861|FG000|Outpatient Period|Development of study-specific withdrawal criteria: Severe HK|0|||
147582003|NCT05347693|532286862|FG001|Outpatient Period|Development of study-specific withdrawal criteria: Severe HK|0|||
147582004|NCT05347693|532286863|FG002|Outpatient Period|Development of study-specific withdrawal criteria: Severe HK|1|||
147582005|NCT05347693|532286861|FG000|Outpatient Period|Lost to Follow-up|0|||
147582006|NCT05347693|532286862|FG001|Outpatient Period|Lost to Follow-up|0|||
147582007|NCT05347693|532286863|FG002|Outpatient Period|Lost to Follow-up|1|||
147582008|NCT05347693|532286861|FG000|Outpatient Period|Participant's study compliance was impossible to monitor and they had a complex private situation.|0|||
147582009|NCT05347693|532286862|FG001|Outpatient Period|Participant's study compliance was impossible to monitor and they had a complex private situation.|1|||
147582010|NCT05347693|532286863|FG002|Outpatient Period|Participant's study compliance was impossible to monitor and they had a complex private situation.|0|||
147582011|NCT05347693|532286861|FG000|Outpatient Period|Scheduled hemodialysis|0|||
147582012|NCT05347693|532286862|FG001|Outpatient Period|Scheduled hemodialysis|1|||
147582013|NCT05347693|532286863|FG002|Outpatient Period|Scheduled hemodialysis|0|||
147582014|NCT05347693|532286861|FG000|Outpatient Period|Severe HK|0|||
147582015|NCT05347693|532286862|FG001|Outpatient Period|Severe HK|0|||
147582016|NCT05347693|532286863|FG002|Outpatient Period|Severe HK|1|||
147582017|NCT05347693|532286861|FG000|Outpatient Period|Started dialysis on 16 Feb 2023|0|||
147582018|NCT05347693|532286862|FG001|Outpatient Period|Started dialysis on 16 Feb 2023|1|||
147582019|NCT05347693|532286863|FG002|Outpatient Period|Started dialysis on 16 Feb 2023|0|||
147582020|NCT05347693|532286861|FG000|Outpatient Period|Start of dialysis|0|||
147582021|NCT05347693|532286862|FG001|Outpatient Period|Start of dialysis|0|||
147582022|NCT05347693|532286863|FG002|Outpatient Period|Start of dialysis|1|||
147582023|NCT05347693|532286861|FG000|Outpatient Period|The participant entered hemodialysis|0|||
147582024|NCT05347693|532286862|FG001|Outpatient Period|The participant entered hemodialysis|0|||
147582025|NCT05347693|532286863|FG002|Outpatient Period|The participant entered hemodialysis|1|||
147582026|NCT05347693|532286861|FG000|Outpatient Period|The participant moved to another city and could not attend the study visits|0|||
147582027|NCT05347693|532286862|FG001|Outpatient Period|The participant moved to another city and could not attend the study visits|0|||
147582028|NCT05347693|532286863|FG002|Outpatient Period|The participant moved to another city and could not attend the study visits|1|||
147582029|NCT05347693|532286861|FG000|Outpatient Period|Withdrawal by Subject|0|||
147582030|NCT05347693|532286862|FG001|Outpatient Period|Withdrawal by Subject|8|||
147582031|NCT05347693|532286863|FG002|Outpatient Period|Withdrawal by Subject|5|||
147582032|NCT02048813|532286864|FG000|Overall Study|Still on treatment|279|||
147582033|NCT02048813|532286865|FG001|Overall Study|Still on treatment|0|||
147582034|NCT02048813|532286864|FG000|Overall Study|Adverse Event|40|||
147582035|NCT02048813|532286865|FG001|Overall Study|Adverse Event|38|||
147582036|NCT02048813|532286864|FG000|Overall Study|Disease progression|13|||
147582037|NCT02048813|532286865|FG001|Overall Study|Disease progression|3|||
147582038|NCT02048813|532286864|FG000|Overall Study|Withdrawal by Subject|7|||
147582039|NCT02048813|532286865|FG001|Overall Study|Withdrawal by Subject|8|||
147582040|NCT02048813|532286864|FG000|Overall Study|Death|2|||
147582041|NCT02048813|532286865|FG001|Overall Study|Death|1|||
147582042|NCT02048813|532286864|FG000|Overall Study|Complication|2|||
147582043|NCT02048813|532286865|FG001|Overall Study|Complication|2|||
147582044|NCT02048813|532286864|FG000|Overall Study|Non-protocol therapy|0|||
147582045|NCT02048813|532286865|FG001|Overall Study|Non-protocol therapy|1|||
147582046|NCT02048813|532286864|FG000|Overall Study|Second primary cancer|2|||
147582047|NCT02048813|532286865|FG001|Overall Study|Second primary cancer|0|||
147582048|NCT02048813|532286864|FG000|Overall Study|Insurance|2|||
147582049|NCT02048813|532286865|FG001|Overall Study|Insurance|0|||
147582050|NCT02048813|532286864|FG000|Overall Study|Wound infection/healing|2|||
147582051|NCT02048813|532286865|FG001|Overall Study|Wound infection/healing|0|||
147582052|NCT02048813|532286864|FG000|Overall Study|Missed appointment|3|||
147582053|NCT02048813|532286865|FG001|Overall Study|Missed appointment|0|||
147582054|NCT02048813|532286864|FG000|Overall Study|Never started treatment|2|||
147582055|NCT02048813|532286865|FG001|Overall Study|Never started treatment|17|||
147582056|NCT01708954|532286866|FG000|Step 1|Disease progression|26|||
147582057|NCT01708954|532286867|FG001|Step 1|Disease progression|17|||
147582058|NCT01708954|532286868|FG002|Step 1|Disease progression|14|||
147582059|NCT01708954|532286866|FG000|Step 1|Adverse Event|3|||
147582060|NCT01708954|532286867|FG001|Step 1|Adverse Event|11|||
147582061|NCT01708954|532286868|FG002|Step 1|Adverse Event|13|||
147582062|NCT01708954|532286866|FG000|Step 1|Death|3|||
147582063|NCT01708954|532286867|FG001|Step 1|Death|2|||
147582064|NCT01708954|532286868|FG002|Step 1|Death|3|||
147582065|NCT01708954|532286866|FG000|Step 1|Withdrawal by Subject|2|||
147582066|NCT01708954|532286867|FG001|Step 1|Withdrawal by Subject|5|||
147582067|NCT01708954|532286868|FG002|Step 1|Withdrawal by Subject|3|||
147582068|NCT01708954|532286866|FG000|Step 1|Other complicating disease|0|||
147654066|NCT01402986|532554684|FG001|Overall Study|Death|0|||
147153571|NCT01866111|530724313|FG003|Double-blind Period of Study YKP3089C017|Adverse Event|23|||
147582069|NCT01708954|532286867|FG001|Step 1|Other complicating disease|2|||
147582070|NCT01708954|532286868|FG002|Step 1|Other complicating disease|0|||
147582071|NCT01708954|532286866|FG000|Step 1|Crossed over to Step 2|2|||
147582072|NCT01708954|532286867|FG001|Step 1|Crossed over to Step 2|0|||
147582073|NCT01708954|532286868|FG002|Step 1|Crossed over to Step 2|0|||
147582074|NCT01708954|532286866|FG000|Step 1|Symptomatic deterioration|1|||
147582075|NCT01708954|532286867|FG001|Step 1|Symptomatic deterioration|0|||
147582076|NCT01708954|532286868|FG002|Step 1|Symptomatic deterioration|1|||
147582077|NCT01708954|532286866|FG000|Step 1|Off-treatment reason not submitted|1|||
147582078|NCT01708954|532286867|FG001|Step 1|Off-treatment reason not submitted|1|||
147582079|NCT01708954|532286868|FG002|Step 1|Off-treatment reason not submitted|1|||
147582080|NCT01708954|532286866|FG000|Step 1|Ineligible or never received treatment|4|||
147582081|NCT01708954|532286867|FG001|Step 1|Ineligible or never received treatment|2|||
147582082|NCT01708954|532286868|FG002|Step 1|Ineligible or never received treatment|8|||
147582083|NCT01708954|532286866|FG000|Step 2|Disease progression|9|||
147582084|NCT01708954|532286867|FG001|Step 2|Disease progression|4|||
147582085|NCT01708954|532286868|FG002|Step 2|Disease progression|0|||
147582086|NCT01708954|532286866|FG000|Step 2|Adverse Event|3|||
147582087|NCT01708954|532286867|FG001|Step 2|Adverse Event|2|||
147582088|NCT01708954|532286868|FG002|Step 2|Adverse Event|0|||
147582089|NCT01708954|532286866|FG000|Step 2|Withdrawal by Subject|1|||
147582090|NCT01708954|532286867|FG001|Step 2|Withdrawal by Subject|1|||
147582091|NCT01708954|532286868|FG002|Step 2|Withdrawal by Subject|0|||
147582092|NCT05996198|532286869|FG000|Overall Study|Withdrawal by Subject|1|||
147582093|NCT05996198|532286870|FG001|Overall Study|Withdrawal by Subject|0|||
147582094|NCT01192776|532286871|FG000|Overall Study|Death|8|||
147582095|NCT01192776|532286872|FG001|Overall Study|Death|15|||
147582096|NCT01192776|532286873|FG002|Overall Study|Death|18|||
147582097|NCT01192776|532286874|FG003|Overall Study|Death|15|||
147582098|NCT01192776|532286871|FG000|Overall Study|Lost to Follow-up|3|||
147582099|NCT01192776|532286872|FG001|Overall Study|Lost to Follow-up|6|||
147582100|NCT01192776|532286873|FG002|Overall Study|Lost to Follow-up|3|||
147582101|NCT01192776|532286874|FG003|Overall Study|Lost to Follow-up|5|||
147582102|NCT05552261|532286878|FG000|Overall Study|Withdrawal by Subject|1|||
147582103|NCT05552261|532286878|FG000|Overall Study|Failure to return to the study clinic within the allowed study window for the Month 30 visit|2|||
147582104|NCT04941768|532286883|FG000|Overall Study|Lost to Follow-up|10|||
147582105|NCT04941768|532286883|FG000|Overall Study|Death|24|||
147582106|NCT04941768|532286883|FG000|Overall Study|Progressive Disease|4|||
147582107|NCT04941768|532286883|FG000|Overall Study|Withdrawal by Subject|4|||
147582108|NCT04941768|532286883|FG000|Overall Study|Other|3|||
147582109|NCT04941768|532286883|FG000|Overall Study|Treatment ongoing|21|||
147582110|NCT04941768|532286883|FG000|Overall Study|Off treatment and in follow-up|21|||
147582111|NCT03302078|532286885|FG000|Washout Period|Adverse Event|0|||
147582112|NCT03302078|532286886|FG001|Washout Period|Adverse Event|1|||
147582113|NCT01886872|532286887|FG000|Overall Study|Ineligible|7|||
147582114|NCT01886872|532286888|FG001|Overall Study|Ineligible|4|||
147582115|NCT01886872|532286889|FG002|Overall Study|Ineligible|12|||
147582116|NCT00098475|532286890|FG000|Step 1|Progressive disease|33|||
147582117|NCT00098475|532286891|FG001|Step 1|Progressive disease|35|||
147582118|NCT00098475|532286892|FG002|Step 1|Progressive disease|2|||
147582119|NCT00098475|532286893|FG003|Step 1|Progressive disease|1|||
147582120|NCT00098475|532286890|FG000|Step 1|Adverse Event|56|||
147582121|NCT00098475|532286891|FG001|Step 1|Adverse Event|37|||
147582122|NCT00098475|532286892|FG002|Step 1|Adverse Event|0|||
147582123|NCT00098475|532286893|FG003|Step 1|Adverse Event|1|||
147582124|NCT00098475|532286890|FG000|Step 1|Death|8|||
147582125|NCT00098475|532286891|FG001|Step 1|Death|5|||
147582126|NCT00098475|532286892|FG002|Step 1|Death|0|||
147582127|NCT00098475|532286893|FG003|Step 1|Death|1|||
147446784|NCT01324232|531800301|FG003|Overall Study|Adverse Event|6|||
147446785|NCT01324232|531800298|FG000|Overall Study|Withdrawal by Subject|0|||
147446786|NCT01324232|531800299|FG001|Overall Study|Withdrawal by Subject|3|||
147446787|NCT01324232|531800300|FG002|Overall Study|Withdrawal by Subject|4|||
147446788|NCT01324232|531800301|FG003|Overall Study|Withdrawal by Subject|0|||
147446789|NCT01324232|531800298|FG000|Overall Study|Lost to Follow-up|1|||
147446790|NCT01324232|531800299|FG001|Overall Study|Lost to Follow-up|0|||
147446791|NCT01324232|531800300|FG002|Overall Study|Lost to Follow-up|0|||
147582128|NCT00098475|532286890|FG000|Step 1|Withdrawal by Subject|14|||
147582129|NCT00098475|532286891|FG001|Step 1|Withdrawal by Subject|11|||
147321792|NCT04537949|531341680|FG007|Follow-up Phase|Roll-over into trial BNT162-14|6|||
147321793|NCT04537949|531341673|FG000|Follow-up Phase|Lost to Follow-up|0|||
147582130|NCT00098475|532286892|FG002|Step 1|Withdrawal by Subject|0|||
147582131|NCT00098475|532286893|FG003|Step 1|Withdrawal by Subject|0|||
147446792|NCT01324232|531800301|FG003|Overall Study|Lost to Follow-up|0|||
147582132|NCT00098475|532286890|FG000|Step 1|Physician Decision|5|||
147321794|NCT04537949|531341674|FG001|Follow-up Phase|Lost to Follow-up|3|||
147321795|NCT04537949|531341675|FG002|Follow-up Phase|Lost to Follow-up|0|||
147582133|NCT00098475|532286891|FG001|Step 1|Physician Decision|2|||
147582134|NCT00098475|532286892|FG002|Step 1|Physician Decision|0|||
147582135|NCT00098475|532286893|FG003|Step 1|Physician Decision|0|||
147582136|NCT00098475|532286890|FG000|Step 1|Alternative therapy|31|||
147582137|NCT00098475|532286891|FG001|Step 1|Alternative therapy|43|||
147582138|NCT00098475|532286892|FG002|Step 1|Alternative therapy|1|||
147582139|NCT00098475|532286893|FG003|Step 1|Alternative therapy|0|||
147582140|NCT00098475|532286890|FG000|Step 1|Other disease|2|||
147582141|NCT00098475|532286891|FG001|Step 1|Other disease|1|||
147582142|NCT00098475|532286892|FG002|Step 1|Other disease|1|||
147582143|NCT00098475|532286893|FG003|Step 1|Other disease|0|||
147582144|NCT00098475|532286890|FG000|Step 1|Never started treatment|0|||
147582145|NCT00098475|532286891|FG001|Step 1|Never started treatment|2|||
147582146|NCT00098475|532286892|FG002|Step 1|Never started treatment|0|||
147582147|NCT00098475|532286893|FG003|Step 1|Never started treatment|0|||
147582148|NCT00098475|532286890|FG000|Step 1|Still on treatment as of this analysis|14|||
147582149|NCT00098475|532286891|FG001|Step 1|Still on treatment as of this analysis|27|||
147582150|NCT00098475|532286892|FG002|Step 1|Still on treatment as of this analysis|0|||
147582151|NCT00098475|532286893|FG003|Step 1|Still on treatment as of this analysis|0|||
147582152|NCT00098475|532286890|FG000|Step 1|Knee surgery|1|||
147582153|NCT00098475|532286891|FG001|Step 1|Knee surgery|0|||
147582154|NCT00098475|532286892|FG002|Step 1|Knee surgery|0|||
147582155|NCT00098475|532286893|FG003|Step 1|Knee surgery|0|||
147582156|NCT00098475|532286890|FG000|Step 1|Complications|1|||
147582157|NCT00098475|532286891|FG001|Step 1|Complications|0|||
147582158|NCT00098475|532286892|FG002|Step 1|Complications|0|||
147582159|NCT00098475|532286893|FG003|Step 1|Complications|0|||
147582160|NCT00098475|532286890|FG000|Step 1|Cannot comply due to other tx|0|||
147582161|NCT00098475|532286891|FG001|Step 1|Cannot comply due to other tx|1|||
147582162|NCT00098475|532286892|FG002|Step 1|Cannot comply due to other tx|0|||
147582163|NCT00098475|532286893|FG003|Step 1|Cannot comply due to other tx|0|||
147582164|NCT00098475|532286890|FG000|Step 1|Both patient and physician's decision|2|||
147582165|NCT00098475|532286891|FG001|Step 1|Both patient and physician's decision|1|||
147582166|NCT00098475|532286892|FG002|Step 1|Both patient and physician's decision|0|||
147582167|NCT00098475|532286893|FG003|Step 1|Both patient and physician's decision|0|||
147582168|NCT00098475|532286890|FG000|Step 1|Incorrect disease assessment|2|||
147582169|NCT00098475|532286891|FG001|Step 1|Incorrect disease assessment|0|||
147582170|NCT00098475|532286892|FG002|Step 1|Incorrect disease assessment|0|||
147582171|NCT00098475|532286893|FG003|Step 1|Incorrect disease assessment|0|||
147582172|NCT00098475|532286890|FG000|Step 1|Off treatment for > specified timeframe|1|||
147582173|NCT00098475|532286891|FG001|Step 1|Off treatment for > specified timeframe|1|||
147582174|NCT00098475|532286892|FG002|Step 1|Off treatment for > specified timeframe|0|||
147582175|NCT00098475|532286893|FG003|Step 1|Off treatment for > specified timeframe|0|||
147582176|NCT00098475|532286890|FG000|Step 1|Declining performance status|0|||
147582177|NCT00098475|532286891|FG001|Step 1|Declining performance status|1|||
147582178|NCT00098475|532286892|FG002|Step 1|Declining performance status|0|||
147582179|NCT00098475|532286893|FG003|Step 1|Declining performance status|0|||
147582180|NCT00098475|532286890|FG000|Step 1|Insurance issue|0|||
147582181|NCT00098475|532286891|FG001|Step 1|Insurance issue|1|||
147582182|NCT00098475|532286892|FG002|Step 1|Insurance issue|0|||
147582183|NCT00098475|532286893|FG003|Step 1|Insurance issue|0|||
147582184|NCT00098475|532286890|FG000|Step 1|Rising paraprotein|0|||
147582185|NCT00098475|532286891|FG001|Step 1|Rising paraprotein|1|||
147582186|NCT00098475|532286892|FG002|Step 1|Rising paraprotein|0|||
147582187|NCT00098475|532286893|FG003|Step 1|Rising paraprotein|0|||
147582188|NCT00098475|532286890|FG000|Step 1|Referred to other physicians|0|||
147582189|NCT00098475|532286891|FG001|Step 1|Referred to other physicians|1|||
147582190|NCT00098475|532286892|FG002|Step 1|Referred to other physicians|0|||
147582191|NCT00098475|532286893|FG003|Step 1|Referred to other physicians|0|||
147582192|NCT00098475|532286890|FG000|Step 1|Criteria to continue treatment not met|0|||
147582193|NCT00098475|532286891|FG001|Step 1|Criteria to continue treatment not met|1|||
147582194|NCT00098475|532286892|FG002|Step 1|Criteria to continue treatment not met|0|||
147582195|NCT00098475|532286893|FG003|Step 1|Criteria to continue treatment not met|0|||
147582196|NCT00098475|532286890|FG000|Step 1|Misinterpretation of lab data|0|||
147582197|NCT00098475|532286891|FG001|Step 1|Misinterpretation of lab data|1|||
147582198|NCT00098475|532286892|FG002|Step 1|Misinterpretation of lab data|0|||
147582199|NCT00098475|532286893|FG003|Step 1|Misinterpretation of lab data|0|||
147582200|NCT00098475|532286890|FG000|Step 1|Patient fell with fracture|1|||
147582201|NCT00098475|532286891|FG001|Step 1|Patient fell with fracture|0|||
147582202|NCT00098475|532286892|FG002|Step 1|Patient fell with fracture|0|||
147582203|NCT00098475|532286893|FG003|Step 1|Patient fell with fracture|0|||
147582204|NCT00098475|532286890|FG000|Step 1|Not documented|0|||
147582205|NCT00098475|532286891|FG001|Step 1|Not documented|1|||
147582206|NCT00098475|532286892|FG002|Step 1|Not documented|0|||
147582207|NCT00098475|532286893|FG003|Step 1|Not documented|0|||
147582208|NCT00098475|532286890|FG000|Step 2|Disease progression|1|||
147582209|NCT00098475|532286891|FG001|Step 2|Disease progression|4|||
147582210|NCT00098475|532286892|FG002|Step 2|Disease progression|0|||
147582211|NCT00098475|532286893|FG003|Step 2|Disease progression|0|||
147582212|NCT00098475|532286890|FG000|Step 2|Adverse Event|2|||
147582213|NCT00098475|532286891|FG001|Step 2|Adverse Event|0|||
147582214|NCT00098475|532286892|FG002|Step 2|Adverse Event|0|||
147582215|NCT00098475|532286893|FG003|Step 2|Adverse Event|0|||
147582216|NCT00098475|532286890|FG000|Step 2|Withdrawal by Subject|0|||
147582217|NCT00098475|532286891|FG001|Step 2|Withdrawal by Subject|2|||
147582218|NCT00098475|532286892|FG002|Step 2|Withdrawal by Subject|0|||
147582219|NCT00098475|532286893|FG003|Step 2|Withdrawal by Subject|0|||
147582220|NCT00098475|532286890|FG000|Step 2|Physician Decision|0|||
147582221|NCT00098475|532286891|FG001|Step 2|Physician Decision|1|||
147582222|NCT00098475|532286892|FG002|Step 2|Physician Decision|0|||
147582223|NCT00098475|532286893|FG003|Step 2|Physician Decision|0|||
147582224|NCT00098475|532286890|FG000|Step 2|Alternative therapy|1|||
147582225|NCT00098475|532286891|FG001|Step 2|Alternative therapy|2|||
147582226|NCT00098475|532286892|FG002|Step 2|Alternative therapy|0|||
147582227|NCT00098475|532286893|FG003|Step 2|Alternative therapy|0|||
147582228|NCT00098475|532286890|FG000|Step 2|Never started treatment|1|||
147582229|NCT00098475|532286891|FG001|Step 2|Never started treatment|1|||
147582230|NCT00098475|532286892|FG002|Step 2|Never started treatment|0|||
147582231|NCT00098475|532286893|FG003|Step 2|Never started treatment|0|||
147582232|NCT03422068|532286894|FG000|Overall Study|Adverse Event|0|||
147582233|NCT03422068|532286895|FG001|Overall Study|Adverse Event|1|||
147582234|NCT03422068|532286894|FG000|Overall Study|Inconvenience to frequent study visits|0|||
147582235|NCT03422068|532286895|FG001|Overall Study|Inconvenience to frequent study visits|1|||
147582236|NCT06128525|532286903|FG000|Overall Study|Patient withdrew consent|1|||
147582237|NCT03294317|532286905|FG000|Overall Study|Physician Decision|1|||
147582238|NCT03294317|532286905|FG000|Overall Study|Withdrawal by Subject|6|||
147582239|NCT03294317|532286905|FG000|Overall Study|Lost to Follow-up|1|||
147582240|NCT03294317|532286905|FG000|Overall Study|Did not meet inclusion/exclusion criteria|1|||
147582241|NCT03294317|532286905|FG000|Overall Study|Failed HB lead implant|8|||
147582242|NCT03294317|532286905|FG000|Overall Study|Received CRT instead|1|||
147582243|NCT03294317|532286905|FG000|Overall Study|Exited after lead revision|2|||
147582244|NCT03566238|532286906|FG000|Overall Study|Adverse Event|0|||
147582245|NCT03566238|532286907|FG001|Overall Study|Adverse Event|0|||
147582246|NCT03566238|532286908|FG002|Overall Study|Adverse Event|1|||
147582247|NCT03566238|532286906|FG000|Overall Study|Lack of Efficacy|5|||
147582248|NCT03566238|532286907|FG001|Overall Study|Lack of Efficacy|4|||
147582249|NCT03566238|532286908|FG002|Overall Study|Lack of Efficacy|2|||
147582250|NCT03566238|532286906|FG000|Overall Study|Other|0|||
147582251|NCT03566238|532286907|FG001|Overall Study|Other|1|||
147582252|NCT03566238|532286908|FG002|Overall Study|Other|0|||
147582253|NCT04490057|532286924|FG000|Stage 1|Death|1|||
147582254|NCT04490057|532286925|FG001|Stage 1|Death|2|||
147582255|NCT04490057|532286926|FG002|Stage 1|Death|0|||
147582256|NCT04490057|532286927|FG003|Stage 1|Death|0|||
147582257|NCT04490057|532286928|FG004|Stage 1|Death|0|||
147582258|NCT04490057|532286929|FG005|Stage 1|Death|0|||
147582259|NCT04490057|532286930|FG006|Stage 1|Death|0|||
147582260|NCT04490057|532286931|FG007|Stage 1|Death|0|||
147582261|NCT04490057|532286924|FG000|Stage 1|Withdrawal by Subject|2|||
147582262|NCT04490057|532286925|FG001|Stage 1|Withdrawal by Subject|0|||
147582263|NCT04490057|532286926|FG002|Stage 1|Withdrawal by Subject|0|||
147582264|NCT04490057|532286927|FG003|Stage 1|Withdrawal by Subject|0|||
147582265|NCT04490057|532286928|FG004|Stage 1|Withdrawal by Subject|0|||
147582266|NCT04490057|532286929|FG005|Stage 1|Withdrawal by Subject|0|||
147582267|NCT04490057|532286930|FG006|Stage 1|Withdrawal by Subject|0|||
147582268|NCT04490057|532286931|FG007|Stage 1|Withdrawal by Subject|0|||
147654067|NCT01402986|532554685|FG002|Overall Study|Death|0|||
147654068|NCT01402986|532554686|FG003|Overall Study|Death|2|||
147654069|NCT01402986|532554683|FG000|Overall Study|Lost to Follow-up|0|||
147654070|NCT01402986|532554684|FG001|Overall Study|Lost to Follow-up|0|||
147654071|NCT01402986|532554685|FG002|Overall Study|Lost to Follow-up|0|||
147654072|NCT01402986|532554686|FG003|Overall Study|Lost to Follow-up|1|||
147654073|NCT01402986|532554683|FG000|Overall Study|Other|2|||
147654074|NCT01402986|532554684|FG001|Overall Study|Other|5|||
147582269|NCT04490057|532286924|FG000|Stage 2|Death|0|||
147582270|NCT04490057|532286925|FG001|Stage 2|Death|0|||
147582271|NCT04490057|532286926|FG002|Stage 2|Death|0|||
147582272|NCT04490057|532286927|FG003|Stage 2|Death|0|||
147582273|NCT04490057|532286928|FG004|Stage 2|Death|1|||
147582274|NCT04490057|532286929|FG005|Stage 2|Death|0|||
147582275|NCT04490057|532286930|FG006|Stage 2|Death|0|||
147582276|NCT04490057|532286931|FG007|Stage 2|Death|0|||
147654075|NCT01402986|532554685|FG002|Overall Study|Other|1|||
147582277|NCT04490057|532286924|FG000|Stage 2|Lost to Follow-up|0|||
147582278|NCT04490057|532286925|FG001|Stage 2|Lost to Follow-up|0|||
147582279|NCT04490057|532286926|FG002|Stage 2|Lost to Follow-up|0|||
147582280|NCT04490057|532286927|FG003|Stage 2|Lost to Follow-up|11|||
147654076|NCT01402986|532554686|FG003|Overall Study|Other|6|||
147582281|NCT04490057|532286928|FG004|Stage 2|Lost to Follow-up|17|||
147582282|NCT04490057|532286929|FG005|Stage 2|Lost to Follow-up|4|||
147582283|NCT04490057|532286930|FG006|Stage 2|Lost to Follow-up|21|||
147582284|NCT04490057|532286931|FG007|Stage 2|Lost to Follow-up|14|||
147582285|NCT04584983|532286934|FG000|Overall Study|Parental request for withdraw|2|||
147582286|NCT04584983|532286935|FG001|Overall Study|Parental request for withdraw|0|||
147582287|NCT05377489|532286936|FG000|Overall Study|Withdrawal by Subject|122|||
147582288|NCT05377489|532286936|FG000|Overall Study|Lost to Follow-up|21|||
147582289|NCT05377489|532286936|FG000|Overall Study|Lack of Efficacy|10|||
147654077|NCT02634983|532554687|FG000|Period 2 (Second Treatment, 8-10 Days)|Adverse Event|2|||
147582290|NCT05377489|532286936|FG000|Overall Study|Adverse Event|5|||
147582291|NCT05377489|532286936|FG000|Overall Study|Death|4|||
147582292|NCT05377489|532286936|FG000|Overall Study|Physician Decision|3|||
147582293|NCT05377489|532286936|FG000|Overall Study|Protocol Violation|1|||
147582294|NCT05377489|532286936|FG000|Overall Study|Other|9|||
147582295|NCT02722616|532287918|FG000|Overall Study|Sponsor closed study after one month|2|||
147240346|NCT04665856|531051591|FG001|Overall Study|Site Terminated by Sponsor|0|||
147240347|NCT04665856|531051590|FG000|Overall Study|Withdrawal by Subject|2|||
147240348|NCT04665856|531051591|FG001|Overall Study|Withdrawal by Subject|0|||
147240349|NCT04665856|531051590|FG000|Overall Study|Lost to Follow-up|3|||
147240350|NCT04665856|531051591|FG001|Overall Study|Lost to Follow-up|2|||
147240351|NCT04665856|531051590|FG000|Overall Study|Death|39|||
147240352|NCT04665856|531051591|FG001|Overall Study|Death|44|||
147240353|NCT04665856|531051590|FG000|Overall Study|Ongoing in study|17|||
147240354|NCT04665856|531051591|FG001|Overall Study|Ongoing in study|15|||
147240355|NCT01552694|531051592|FG000|Overall Study|Lost to Follow-up|0|||
147446793|NCT05440539|531800302|FG000|Overall Study|Lost to Follow-up|4|||
147446794|NCT05440539|531800303|FG001|Overall Study|Lost to Follow-up|4|||
147582296|NCT02722616|532287919|FG001|Overall Study|Sponsor closed study after one month|0|||
147582297|NCT02722616|532287920|FG002|Overall Study|Sponsor closed study after one month|0|||
147582298|NCT02031237|532287921|FG000|Overall Study|Death|1|||
147582299|NCT02031237|532287922|FG001|Overall Study|Death|5|||
147582300|NCT02031237|532287923|FG002|Overall Study|Death|0|||
147582301|NCT02031237|532287921|FG000|Overall Study|Physician Decision|0|||
147582302|NCT02031237|532287922|FG001|Overall Study|Physician Decision|1|||
147582303|NCT02031237|532287923|FG002|Overall Study|Physician Decision|0|||
147582304|NCT02031237|532287921|FG000|Overall Study|Withdrawal by Subject|2|||
147582305|NCT02031237|532287922|FG001|Overall Study|Withdrawal by Subject|2|||
147582306|NCT02031237|532287923|FG002|Overall Study|Withdrawal by Subject|0|||
147582307|NCT02031237|532287921|FG000|Overall Study|Protocol Violation|2|||
147582308|NCT02031237|532287922|FG001|Overall Study|Protocol Violation|6|||
147582309|NCT02031237|532287923|FG002|Overall Study|Protocol Violation|0|||
147582310|NCT02031237|532287921|FG000|Overall Study|Alternate Treatment Given|0|||
147582311|NCT02031237|532287922|FG001|Overall Study|Alternate Treatment Given|0|||
147582312|NCT02031237|532287923|FG002|Overall Study|Alternate Treatment Given|3|||
147582313|NCT00676650|532287926|FG000|Overall Study|Death|45|||
147582314|NCT00676650|532287927|FG001|Overall Study|Death|14|||
147582315|NCT00676650|532287926|FG000|Overall Study|Adverse Event|159|||
147582316|NCT00676650|532287927|FG001|Overall Study|Adverse Event|21|||
147582317|NCT00676650|532287926|FG000|Overall Study|Global deterioration of health status|66|||
147582318|NCT00676650|532287927|FG001|Overall Study|Global deterioration of health status|31|||
147582319|NCT00676650|532287926|FG000|Overall Study|Lost to Follow-up|0|||
147582320|NCT00676650|532287927|FG001|Overall Study|Lost to Follow-up|1|||
147582321|NCT00676650|532287926|FG000|Overall Study|Objective progression or relapse|189|||
147582322|NCT00676650|532287927|FG001|Overall Study|Objective progression or relapse|140|||
147582323|NCT00676650|532287926|FG000|Overall Study|Other|14|||
147582324|NCT00676650|532287927|FG001|Overall Study|Other|10|||
147582325|NCT00676650|532287926|FG000|Overall Study|Protocol Violation|3|||
147582326|NCT00676650|532287927|FG001|Overall Study|Protocol Violation|1|||
147582327|NCT00676650|532287926|FG000|Overall Study|Study terminated by sponsor|57|||
147582328|NCT00676650|532287927|FG001|Overall Study|Study terminated by sponsor|43|||
147582329|NCT00676650|532287926|FG000|Overall Study|Withdrawal by Subject|48|||
147582330|NCT00676650|532287927|FG001|Overall Study|Withdrawal by Subject|24|||
147582331|NCT00676650|532287926|FG000|Overall Study|Randomized but not treated|3|||
147446795|NCT05440539|531800302|FG000|Overall Study|Fetal demise, no longer pregnant|3|||
147582332|NCT00676650|532287927|FG001|Overall Study|Randomized but not treated|4|||
147582333|NCT02297841|532287931|FG000|Overall Study|Withdrawal by Subject|1|||
147582334|NCT02297841|532287931|FG000|Overall Study|Protocol Violation|7|||
147582335|NCT05061992|532287932|FG000|Overall Study|Excess bowel movements|1|||
147582336|NCT05061992|532287933|FG001|Overall Study|Excess bowel movements|0|||
147582337|NCT05061992|532287932|FG000|Overall Study|Complications of Medical Care|1|||
147582338|NCT05061992|532287933|FG001|Overall Study|Complications of Medical Care|0|||
147446796|NCT05440539|531800303|FG001|Overall Study|Fetal demise, no longer pregnant|4|||
147582339|NCT05061992|532287932|FG000|Overall Study|Diarrhea Prior to Starting Therapy|1|||
147582340|NCT05061992|532287933|FG001|Overall Study|Diarrhea Prior to Starting Therapy|0|||
147582341|NCT05061992|532287932|FG000|Overall Study|Withdrawal by Subject|0|||
147582342|NCT05061992|532287933|FG001|Overall Study|Withdrawal by Subject|1|||
147582343|NCT01358877|532287942|FG000|Overall Study|Withdrawal by Subject|475|||
147582344|NCT01358877|532287943|FG001|Overall Study|Withdrawal by Subject|466|||
147240356|NCT01552694|531051593|FG001|Overall Study|Lost to Follow-up|1|||
147240357|NCT01552694|531051592|FG000|Overall Study|Protocol Violation|0|||
147240358|NCT01552694|531051593|FG001|Overall Study|Protocol Violation|1|||
147582345|NCT01358877|532287942|FG000|Overall Study|Recurrence of disease|181|||
147582346|NCT01358877|532287943|FG001|Overall Study|Recurrence of disease|269|||
147240359|NCT00191139|531051595|FG000|Overall Study|Adverse Event|2|||
147582347|NCT01358877|532287942|FG000|Overall Study|Lost to Follow-up|181|||
147582348|NCT01358877|532287943|FG001|Overall Study|Lost to Follow-up|176|||
147582349|NCT01358877|532287942|FG000|Overall Study|Death|41|||
147582350|NCT01358877|532287943|FG001|Overall Study|Death|46|||
147582351|NCT01358877|532287942|FG000|Overall Study|Adverse Event|39|||
147582352|NCT01358877|532287943|FG001|Overall Study|Adverse Event|42|||
147582353|NCT01358877|532287942|FG000|Overall Study|Physician Decision|43|||
147582354|NCT01358877|532287943|FG001|Overall Study|Physician Decision|32|||
147582355|NCT01358877|532287942|FG000|Overall Study|Contralateral breast cancer|42|||
147582356|NCT01358877|532287943|FG001|Overall Study|Contralateral breast cancer|28|||
147582357|NCT01358877|532287942|FG000|Overall Study|Reason not specified|37|||
147582358|NCT01358877|532287943|FG001|Overall Study|Reason not specified|29|||
147582359|NCT02003222|532287947|FG000|Induction|Never started treatment|0|||
147582360|NCT02003222|532287948|FG001|Induction|Never started treatment|0|||
147582361|NCT02003222|532287949|FG002|Induction|Never started treatment|0|||
147582362|NCT02003222|532287950|FG003|Induction|Never started treatment|0|||
147582363|NCT02003222|532287951|FG004|Induction|Never started treatment|8|||
147582364|NCT02003222|532287947|FG000|Induction|Complete remission or complete remission incomplete not achieved|0|||
147582365|NCT02003222|532287948|FG001|Induction|Complete remission or complete remission incomplete not achieved|0|||
147582366|NCT02003222|532287949|FG002|Induction|Complete remission or complete remission incomplete not achieved|0|||
147582367|NCT02003222|532287950|FG003|Induction|Complete remission or complete remission incomplete not achieved|0|||
147582368|NCT02003222|532287951|FG004|Induction|Complete remission or complete remission incomplete not achieved|67|||
147582369|NCT02003222|532287947|FG000|Induction|Adverse Event|0|||
147582370|NCT02003222|532287948|FG001|Induction|Adverse Event|0|||
147582371|NCT02003222|532287949|FG002|Induction|Adverse Event|0|||
147582372|NCT02003222|532287950|FG003|Induction|Adverse Event|0|||
147582373|NCT02003222|532287951|FG004|Induction|Adverse Event|13|||
147582374|NCT02003222|532287947|FG000|Induction|Alternative therapy|0|||
147582375|NCT02003222|532287948|FG001|Induction|Alternative therapy|0|||
147582376|NCT02003222|532287949|FG002|Induction|Alternative therapy|0|||
147582377|NCT02003222|532287950|FG003|Induction|Alternative therapy|0|||
147582378|NCT02003222|532287951|FG004|Induction|Alternative therapy|12|||
147582379|NCT02003222|532287947|FG000|Induction|Disease progression|0|||
147582380|NCT02003222|532287948|FG001|Induction|Disease progression|0|||
147582381|NCT02003222|532287949|FG002|Induction|Disease progression|0|||
147582382|NCT02003222|532287950|FG003|Induction|Disease progression|0|||
147582383|NCT02003222|532287951|FG004|Induction|Disease progression|22|||
147582384|NCT02003222|532287947|FG000|Induction|Death|0|||
147582385|NCT02003222|532287948|FG001|Induction|Death|0|||
147582386|NCT02003222|532287949|FG002|Induction|Death|0|||
147582387|NCT02003222|532287950|FG003|Induction|Death|0|||
147582388|NCT02003222|532287951|FG004|Induction|Death|3|||
147582389|NCT02003222|532287947|FG000|Induction|Withdrawal by Subject|0|||
147582390|NCT02003222|532287948|FG001|Induction|Withdrawal by Subject|0|||
147582391|NCT02003222|532287949|FG002|Induction|Withdrawal by Subject|0|||
147582392|NCT02003222|532287950|FG003|Induction|Withdrawal by Subject|0|||
147582393|NCT02003222|532287951|FG004|Induction|Withdrawal by Subject|8|||
147582394|NCT02003222|532287947|FG000|Induction|Other reasons|0|||
147582395|NCT02003222|532287948|FG001|Induction|Other reasons|0|||
147582396|NCT02003222|532287949|FG002|Induction|Other reasons|0|||
147582397|NCT02003222|532287950|FG003|Induction|Other reasons|0|||
147582398|NCT02003222|532287951|FG004|Induction|Other reasons|22|||
147582399|NCT02003222|532287947|FG000|Intensification|Never started treatment|0|||
147582400|NCT02003222|532287948|FG001|Intensification|Never started treatment|0|||
147582401|NCT02003222|532287949|FG002|Intensification|Never started treatment|0|||
147582402|NCT02003222|532287950|FG003|Intensification|Never started treatment|0|||
147582403|NCT02003222|532287951|FG004|Intensification|Never started treatment|2|||
147582404|NCT02003222|532287947|FG000|Intensification|Adverse Event|0|||
147582405|NCT02003222|532287948|FG001|Intensification|Adverse Event|0|||
147582406|NCT02003222|532287949|FG002|Intensification|Adverse Event|0|||
147582407|NCT02003222|532287950|FG003|Intensification|Adverse Event|0|||
147582408|NCT02003222|532287951|FG004|Intensification|Adverse Event|6|||
147582409|NCT02003222|532287947|FG000|Intensification|Alternative therapy|0|||
147582410|NCT02003222|532287948|FG001|Intensification|Alternative therapy|0|||
147582411|NCT02003222|532287949|FG002|Intensification|Alternative therapy|0|||
147582412|NCT02003222|532287950|FG003|Intensification|Alternative therapy|0|||
147446797|NCT00393887|531800304|FG000|Overall Study|Physician Decision|5|||
147446798|NCT00393887|531800305|FG001|Overall Study|Physician Decision|0|||
147446799|NCT00393887|531800304|FG000|Overall Study|Lost to Follow-up|11|||
147446800|NCT00393887|531800305|FG001|Overall Study|Lost to Follow-up|9|||
147582413|NCT02003222|532287951|FG004|Intensification|Alternative therapy|8|||
147582414|NCT02003222|532287947|FG000|Intensification|Disease progression|0|||
147582415|NCT02003222|532287948|FG001|Intensification|Disease progression|0|||
147582416|NCT02003222|532287949|FG002|Intensification|Disease progression|0|||
147582417|NCT02003222|532287950|FG003|Intensification|Disease progression|0|||
147582418|NCT02003222|532287951|FG004|Intensification|Disease progression|18|||
147582419|NCT02003222|532287947|FG000|Intensification|Withdrawal by Subject|0|||
147582420|NCT02003222|532287948|FG001|Intensification|Withdrawal by Subject|0|||
147582421|NCT02003222|532287949|FG002|Intensification|Withdrawal by Subject|0|||
147582422|NCT02003222|532287950|FG003|Intensification|Withdrawal by Subject|0|||
147446801|NCT01732796|531800306|FG000|Overall Study|Adverse Event|16|||
147582423|NCT02003222|532287951|FG004|Intensification|Withdrawal by Subject|5|||
147321796|NCT04537949|531341676|FG003|Follow-up Phase|Lost to Follow-up|0|||
147321797|NCT04537949|531341677|FG004|Follow-up Phase|Lost to Follow-up|0|||
147321798|NCT04537949|531341678|FG005|Follow-up Phase|Lost to Follow-up|0|||
147321799|NCT04537949|531341679|FG006|Follow-up Phase|Lost to Follow-up|0|||
147321800|NCT04537949|531341680|FG007|Follow-up Phase|Lost to Follow-up|0|||
147321801|NCT04537949|531341673|FG000|Follow-up Phase|personal reasons|0|||
147582424|NCT02003222|532287947|FG000|Intensification|Other reasons|0|||
147582425|NCT02003222|532287948|FG001|Intensification|Other reasons|0|||
147582426|NCT02003222|532287949|FG002|Intensification|Other reasons|0|||
147582427|NCT02003222|532287950|FG003|Intensification|Other reasons|0|||
147582428|NCT02003222|532287951|FG004|Intensification|Other reasons|8|||
147582429|NCT05148299|532287952|FG000|Treatment Period|Adverse Event|1|||
147582430|NCT05148299|532287952|FG000|Treatment Period|Physician Decision|1|||
147582431|NCT05148299|532287952|FG000|Treatment Period|Death|1|||
147582432|NCT05148299|532287952|FG000|Follow-up Period|Death|3|||
147582433|NCT03807440|532287958|FG000|Overall Study|No documentation of index date 2|320|||
147582434|NCT03807440|532287958|FG000|Overall Study|No informed consent for index date 2|117|||
147582435|NCT02451358|532287959|FG000|Overall Study|Withdrawal by Subject|1|||
147582436|NCT02451358|532287960|FG001|Overall Study|Withdrawal by Subject|1|||
147582437|NCT02451358|532287961|FG002|Overall Study|Withdrawal by Subject|0|||
147582438|NCT02451358|532287962|FG003|Overall Study|Withdrawal by Subject|0|||
147582439|NCT02451358|532287959|FG000|Overall Study|Protocol Violation|0|||
147582440|NCT02451358|532287960|FG001|Overall Study|Protocol Violation|1|||
147582441|NCT02451358|532287961|FG002|Overall Study|Protocol Violation|1|||
147582442|NCT02451358|532287962|FG003|Overall Study|Protocol Violation|0|||
147582443|NCT04010227|532287965|FG000|Overall Study|Death|1|||
147582444|NCT04010227|532287966|FG001|Overall Study|Death|2|||
147582445|NCT04010227|532287965|FG000|Overall Study|Medical Reasons|4|||
147582446|NCT04010227|532287966|FG001|Overall Study|Medical Reasons|3|||
147582447|NCT04010227|532287965|FG000|Overall Study|Withdrawal by Subject|2|||
147582448|NCT04010227|532287966|FG001|Overall Study|Withdrawal by Subject|0|||
147582449|NCT04010227|532287965|FG000|Overall Study|Caregiver withdrawn because patient was withdrawn for any reason|5|||
147582450|NCT04010227|532287966|FG001|Overall Study|Caregiver withdrawn because patient was withdrawn for any reason|5|||
147582451|NCT04307849|532287969|FG000|Overall Study|Took a paid position and/or work schedule no longer allowed participation|2|||
147582452|NCT04307849|532287970|FG001|Overall Study|Took a paid position and/or work schedule no longer allowed participation|2|||
147582453|NCT04307849|532287971|FG002|Overall Study|Took a paid position and/or work schedule no longer allowed participation|1|||
147582454|NCT04307849|532287972|FG003|Overall Study|Took a paid position and/or work schedule no longer allowed participation|2|||
147582455|NCT04307849|532287973|FG004|Overall Study|Took a paid position and/or work schedule no longer allowed participation|4|||
147582456|NCT04307849|532287974|FG005|Overall Study|Took a paid position and/or work schedule no longer allowed participation|1|||
147582457|NCT04307849|532287969|FG000|Overall Study|Travelled out of Mumbai to natal place/village|0|||
147582458|NCT04307849|532287970|FG001|Overall Study|Travelled out of Mumbai to natal place/village|0|||
147582459|NCT04307849|532287971|FG002|Overall Study|Travelled out of Mumbai to natal place/village|3|||
147582460|NCT04307849|532287972|FG003|Overall Study|Travelled out of Mumbai to natal place/village|0|||
147582461|NCT04307849|532287973|FG004|Overall Study|Travelled out of Mumbai to natal place/village|0|||
147582462|NCT04307849|532287974|FG005|Overall Study|Travelled out of Mumbai to natal place/village|0|||
147582463|NCT04307849|532287969|FG000|Overall Study|Family member did not want them to continue|0|||
147582464|NCT04307849|532287970|FG001|Overall Study|Family member did not want them to continue|0|||
147582465|NCT04307849|532287971|FG002|Overall Study|Family member did not want them to continue|1|||
147582466|NCT04307849|532287972|FG003|Overall Study|Family member did not want them to continue|0|||
147582467|NCT04307849|532287973|FG004|Overall Study|Family member did not want them to continue|0|||
147582468|NCT04307849|532287974|FG005|Overall Study|Family member did not want them to continue|0|||
147582469|NCT04307849|532287969|FG000|Overall Study|Medical reason (gave birth, became ill)|0|||
147582470|NCT04307849|532287970|FG001|Overall Study|Medical reason (gave birth, became ill)|0|||
147582471|NCT04307849|532287971|FG002|Overall Study|Medical reason (gave birth, became ill)|1|||
147582472|NCT04307849|532287972|FG003|Overall Study|Medical reason (gave birth, became ill)|1|||
147582473|NCT04307849|532287973|FG004|Overall Study|Medical reason (gave birth, became ill)|0|||
147582474|NCT04307849|532287974|FG005|Overall Study|Medical reason (gave birth, became ill)|0|||
147321802|NCT04537949|531341674|FG001|Follow-up Phase|personal reasons|0|||
147321803|NCT04537949|531341675|FG002|Follow-up Phase|personal reasons|0|||
147321804|NCT04537949|531341676|FG003|Follow-up Phase|personal reasons|1|||
147321805|NCT04537949|531341677|FG004|Follow-up Phase|personal reasons|1|||
147582475|NCT01294449|532287975|FG000|Overall Study|Death|11|||
147582476|NCT01294449|532287976|FG001|Overall Study|Death|12|||
147582477|NCT01294449|532287975|FG000|Overall Study|Withdrawal by Subject|1|||
147582478|NCT01294449|532287976|FG001|Overall Study|Withdrawal by Subject|3|||
147582479|NCT02911935|532287977|FG000|Overall Study|Lost to Follow-up|5|||
147582480|NCT02911935|532287978|FG001|Overall Study|Lost to Follow-up|7|||
147582481|NCT05317195|532287979|FG000|Randomization|Withdrawal by Subject|1|||
147321806|NCT04537949|531341678|FG005|Follow-up Phase|personal reasons|0|||
147321807|NCT04537949|531341679|FG006|Follow-up Phase|personal reasons|0|||
147321808|NCT04537949|531341680|FG007|Follow-up Phase|personal reasons|0|||
147582482|NCT05317195|532287979|FG000|Randomization|Discontinued|6|||
147582483|NCT05317195|532287979|FG000|Admission|Withdrawal by Subject|2|||
147582484|NCT05467540|532287980|FG000|3-Month Follow-up|Withdrawal by Subject|1|||
147582485|NCT05467540|532287980|FG000|3-Month Follow-up|Lost to Follow-up|4|||
147582486|NCT05467540|532287980|FG000|3-Month Follow-up|Death|5|||
147582487|NCT05467540|532287980|FG000|12-Month Follow-up|Lost to Follow-up|6|||
147582488|NCT05467540|532287980|FG000|12-Month Follow-up|Death|8|||
147582489|NCT05467540|532287980|FG000|12-Month Follow-up|Withdrawal by Subject|1|||
147582490|NCT03370510|532287983|FG000|Overall Study|COVID-19|2|||
147582491|NCT03370510|532287984|FG001|Overall Study|COVID-19|0|||
147582492|NCT03382041|532287985|FG000|Overall Study|Consent Form Lost|2|||
147582493|NCT03382041|532287986|FG001|Overall Study|Consent Form Lost|1|||
147582494|NCT03382041|532287985|FG000|Overall Study|Withdrawal by Subject|1|||
147582495|NCT03382041|532287986|FG001|Overall Study|Withdrawal by Subject|4|||
147582496|NCT03382041|532287985|FG000|Overall Study|Lost to Follow-up|1|||
147582497|NCT03382041|532287986|FG001|Overall Study|Lost to Follow-up|4|||
147582498|NCT01374451|532287987|FG000|Overall Study|Administrative problems|1|||
147582499|NCT01374451|532287988|FG001|Overall Study|Administrative problems|0|||
147582500|NCT01977456|532287989|FG000|Overall Study|Death|5|||
147582501|NCT02459418|532289384|FG000|Overall Study|Exclusion Criteria|4|||
147582502|NCT02459418|532289385|FG001|Overall Study|Exclusion Criteria|0|||
147582503|NCT02459418|532289384|FG000|Overall Study|Protocol Violation|0|||
147582504|NCT02459418|532289385|FG001|Overall Study|Protocol Violation|2|||
147582505|NCT02459418|532289384|FG000|Overall Study|Physician Decision|0|||
147582506|NCT02459418|532289385|FG001|Overall Study|Physician Decision|2|||
147582507|NCT02459418|532289384|FG000|Overall Study|Endometrial thickness of >5 mm|1|||
147582508|NCT02459418|532289385|FG001|Overall Study|Endometrial thickness of >5 mm|0|||
147582509|NCT02459418|532289384|FG000|Overall Study|Adverse Event|0|||
147582510|NCT02459418|532289385|FG001|Overall Study|Adverse Event|1|||
147582511|NCT02459418|532289384|FG000|Overall Study|Withdrawal by Subject|1|||
147582512|NCT02459418|532289385|FG001|Overall Study|Withdrawal by Subject|1|||
147582513|NCT02459418|532289384|FG000|Overall Study|Elevated Creatine Kinase|1|||
147582514|NCT02459418|532289385|FG001|Overall Study|Elevated Creatine Kinase|0|||
147582515|NCT02459418|532289384|FG000|Overall Study|Abnormal Transvaginal Ultrasound|1|||
147582516|NCT02459418|532289385|FG001|Overall Study|Abnormal Transvaginal Ultrasound|0|||
147582517|NCT00653159|532289386|FG000|Overall Study|Adverse Event|4|||
147582518|NCT00653159|532289387|FG001|Overall Study|Adverse Event|1|||
147582519|NCT00653159|532289386|FG000|Overall Study|Lost to Follow-up|1|||
147582520|NCT00653159|532289387|FG001|Overall Study|Lost to Follow-up|2|||
147582521|NCT01872715|532289388|FG000|Overall Study|Adverse Event|1|||
147582522|NCT01872715|532289388|FG000|Overall Study|Protocol Violation|1|||
147582523|NCT01872715|532289388|FG000|Overall Study|Withdrawal by Subject|2|||
147582524|NCT00683592|532289389|FG000|Overall Study|Adverse Event|12|||
147582525|NCT00683592|532289390|FG001|Overall Study|Adverse Event|4|||
147582526|NCT00683592|532289389|FG000|Overall Study|Withdrawal by Subject|11|||
147582527|NCT00683592|532289390|FG001|Overall Study|Withdrawal by Subject|11|||
147582528|NCT00683592|532289389|FG000|Overall Study|Lost to Follow-up|17|||
147582529|NCT00683592|532289390|FG001|Overall Study|Lost to Follow-up|17|||
147582530|NCT00683592|532289389|FG000|Overall Study|Lack of Efficacy|3|||
147582531|NCT00683592|532289390|FG001|Overall Study|Lack of Efficacy|7|||
147582532|NCT00683592|532289389|FG000|Overall Study|Physician Decision|0|||
147582533|NCT00683592|532289390|FG001|Overall Study|Physician Decision|1|||
147582534|NCT00683592|532289389|FG000|Overall Study|Non-compliance|3|||
147582535|NCT00683592|532289390|FG001|Overall Study|Non-compliance|5|||
147582536|NCT00683592|532289389|FG000|Overall Study|Other|1|||
147582537|NCT00683592|532289390|FG001|Overall Study|Other|1|||
147582538|NCT02697617|532289398|FG000|Overall Study|Withdrawal by Subject|0|||
147582539|NCT02697617|532289399|FG001|Overall Study|Withdrawal by Subject|2|||
147582540|NCT02697617|532289398|FG000|Overall Study|Pregnancy|1|||
147582541|NCT02697617|532289399|FG001|Overall Study|Pregnancy|0|||
147582542|NCT03303417|532289400|FG000|Overall Study|Withdrawal by Subject|1|||
147582543|NCT03303417|532289401|FG001|Overall Study|Withdrawal by Subject|1|||
147582544|NCT00381849|532289404|FG000|Wash Out|Withdrawal by Subject|0|||
147582545|NCT00381849|532289405|FG001|Wash Out|Withdrawal by Subject|1|||
147240360|NCT00191139|531051596|FG001|Overall Study|Adverse Event|6|||
147240361|NCT00191139|531051595|FG000|Overall Study|Death|2|||
147240362|NCT00191139|531051596|FG001|Overall Study|Death|0|||
147240363|NCT00191139|531051595|FG000|Overall Study|Withdrawal by Subject|0|||
147240364|NCT00191139|531051596|FG001|Overall Study|Withdrawal by Subject|3|||
147240365|NCT00191139|531051595|FG000|Overall Study|Disease Progression|0|||
147240366|NCT00191139|531051596|FG001|Overall Study|Disease Progression|1|||
147240367|NCT00191139|531051595|FG000|Overall Study|Other|1|||
147240368|NCT00191139|531051596|FG001|Overall Study|Other|2|||
147240369|NCT03386448|531051597|FG000|Overall Study|Adverse Event|0|||
147240370|NCT03386448|531051598|FG001|Overall Study|Adverse Event|2|||
147582546|NCT01765270|532289409|FG000|Overall Study|Physician Decision|1|||
147582547|NCT01765270|532289410|FG001|Overall Study|Physician Decision|0|||
147582548|NCT01765270|532289409|FG000|Overall Study|Withdrawal by Subject|0|||
147582549|NCT01765270|532289410|FG001|Overall Study|Withdrawal by Subject|1|||
147582550|NCT00329160|532289411|FG000|Overall Study|Adverse Event|27|||
147582551|NCT00329160|532289411|FG000|Overall Study|Withdrawal by Subject|13|||
147582552|NCT00329160|532289411|FG000|Overall Study|Protocol Violation|2|||
147582553|NCT00329160|532289411|FG000|Overall Study|Did not Receive Study Drug|1|||
147582554|NCT00329160|532289411|FG000|Overall Study|Incomplete IVUS|45|||
147582555|NCT02419573|532289412|FG000|Overall Study|Lost to Follow-up|3|||
147582556|NCT02419573|532289413|FG001|Overall Study|Lost to Follow-up|0|||
147582557|NCT02419573|532289412|FG000|Overall Study|Withdrawal by Subject|1|||
147582558|NCT02419573|532289413|FG001|Overall Study|Withdrawal by Subject|0|||
147582559|NCT00493792|532289414|FG000|Overall Study|Death|55|||
147582560|NCT00493792|532289415|FG001|Overall Study|Death|50|||
147582561|NCT00493792|532289414|FG000|Overall Study|Lost to Follow Up or Lack of Efficacy|36|||
147582562|NCT00493792|532289415|FG001|Overall Study|Lost to Follow Up or Lack of Efficacy|51|||
147582563|NCT02426541|532289419|FG000|Overall Study|Protocol Violation|1|||
147582564|NCT02426541|532289420|FG001|Overall Study|Protocol Violation|0|||
147582565|NCT04167618|532289423|FG000|Overall Study|Trial terminated by sponsor|1|||
147582566|NCT04167618|532289424|FG001|Overall Study|Trial terminated by sponsor|1|||
147582567|NCT02943993|532289427|FG000|Overall Study|Withdrawal by Subject|52|||
147582568|NCT02943993|532289427|FG000|Overall Study|Transfer to another institution|6|||
147582569|NCT02943993|532289427|FG000|Overall Study|Lost to Follow-up|135|||
147582570|NCT02943993|532289427|FG000|Overall Study|Death|98|||
147582571|NCT02943993|532289427|FG000|Overall Study|Other reason for premature termination|32|||
147582572|NCT02943993|532289427|FG000|Overall Study|Missing reason for termination|7|||
147582573|NCT00876265|532289431|FG000|Overall Study|Miscellaneous reasons|4|||
147582574|NCT00876265|532289431|FG000|Overall Study|Lost to Follow-up|6|||
147582575|NCT00876265|532289431|FG000|Overall Study|Withdrawal by Subject|2|||
147582576|NCT00996437|532289434|FG000|Overall Study|Death|1|||
147582577|NCT00996437|532289435|FG001|Overall Study|Death|0|||
147582578|NCT00996437|532289434|FG000|Overall Study|Dropped|2|||
147582579|NCT00996437|532289435|FG001|Overall Study|Dropped|2|||
147582580|NCT00996437|532289434|FG000|Overall Study|Missed|2|||
147582581|NCT00996437|532289435|FG001|Overall Study|Missed|5|||
147582582|NCT01755975|532289436|FG000|Overall Study|Adverse Event|0|||
147582583|NCT01755975|532289437|FG001|Overall Study|Adverse Event|0|||
147582584|NCT01755975|532289438|FG002|Overall Study|Adverse Event|1|||
147582585|NCT01755975|532289439|FG003|Overall Study|Adverse Event|0|||
147582586|NCT01755975|532289440|FG004|Overall Study|Adverse Event|2|||
147582587|NCT03653026|532289441|FG000|Part 1: Placebo-controlled Period|Adverse Event|5|||
147582588|NCT03653026|532289442|FG001|Part 1: Placebo-controlled Period|Adverse Event|6|||
147582589|NCT03653026|532289443|FG002|Part 1: Placebo-controlled Period|Adverse Event|0|||
147582590|NCT03653026|532289444|FG003|Part 1: Placebo-controlled Period|Adverse Event|0|||
147582591|NCT03653026|532289441|FG000|Part 1: Placebo-controlled Period|Withdrawal by Subject|6|||
147582592|NCT03653026|532289442|FG001|Part 1: Placebo-controlled Period|Withdrawal by Subject|4|||
147582593|NCT03653026|532289443|FG002|Part 1: Placebo-controlled Period|Withdrawal by Subject|0|||
147582594|NCT03653026|532289444|FG003|Part 1: Placebo-controlled Period|Withdrawal by Subject|0|||
147582595|NCT03653026|532289441|FG000|Part 1: Placebo-controlled Period|Other|0|||
147582596|NCT03653026|532289442|FG001|Part 1: Placebo-controlled Period|Other|3|||
147582597|NCT03653026|532289443|FG002|Part 1: Placebo-controlled Period|Other|0|||
147582598|NCT03653026|532289444|FG003|Part 1: Placebo-controlled Period|Other|0|||
147582599|NCT03653026|532289441|FG000|Part 2: Open-label Extension|Adverse Event|0|||
147582600|NCT03653026|532289442|FG001|Part 2: Open-label Extension|Adverse Event|0|||
147582601|NCT03653026|532289443|FG002|Part 2: Open-label Extension|Adverse Event|1|||
147582602|NCT03653026|532289444|FG003|Part 2: Open-label Extension|Adverse Event|1|||
147582603|NCT03653026|532289441|FG000|Part 2: Open-label Extension|Withdrawal by Subject|0|||
147582604|NCT03653026|532289442|FG001|Part 2: Open-label Extension|Withdrawal by Subject|0|||
147582605|NCT03653026|532289443|FG002|Part 2: Open-label Extension|Withdrawal by Subject|1|||
147582606|NCT03653026|532289444|FG003|Part 2: Open-label Extension|Withdrawal by Subject|2|||
147582607|NCT03653026|532289441|FG000|Part 2: Open-label Extension|Other|0|||
147582608|NCT03653026|532289442|FG001|Part 2: Open-label Extension|Other|0|||
147582609|NCT03653026|532289443|FG002|Part 2: Open-label Extension|Other|1|||
147582610|NCT03653026|532289444|FG003|Part 2: Open-label Extension|Other|2|||
147153572|NCT01866111|530724310|FG000|Double-blind Period of Study YKP3089C017|Withdrawal by Subject|5|||
147153573|NCT01866111|530724311|FG001|Double-blind Period of Study YKP3089C017|Withdrawal by Subject|0|||
147153574|NCT01866111|530724312|FG002|Double-blind Period of Study YKP3089C017|Withdrawal by Subject|4|||
147153575|NCT01866111|530724313|FG003|Double-blind Period of Study YKP3089C017|Withdrawal by Subject|3|||
147153576|NCT01866111|530724310|FG000|Double-blind Period of Study YKP3089C017|Protocol Violation|0|||
147153577|NCT01866111|530724311|FG001|Double-blind Period of Study YKP3089C017|Protocol Violation|0|||
147153578|NCT01866111|530724312|FG002|Double-blind Period of Study YKP3089C017|Protocol Violation|1|||
147153579|NCT01866111|530724313|FG003|Double-blind Period of Study YKP3089C017|Protocol Violation|1|||
147153580|NCT01866111|530724310|FG000|Double-blind Period of Study YKP3089C017|Lack of Efficacy|0|||
147153581|NCT01866111|530724311|FG001|Double-blind Period of Study YKP3089C017|Lack of Efficacy|1|||
147153582|NCT01866111|530724312|FG002|Double-blind Period of Study YKP3089C017|Lack of Efficacy|0|||
147153583|NCT01866111|530724313|FG003|Double-blind Period of Study YKP3089C017|Lack of Efficacy|1|||
147582611|NCT00852917|532289447|FG000|Overall Study|Adverse Event|13|||
147582612|NCT00852917|532289448|FG001|Overall Study|Adverse Event|20|||
147582613|NCT00852917|532289449|FG002|Overall Study|Adverse Event|35|||
147582614|NCT00852917|532289450|FG003|Overall Study|Adverse Event|17|||
147582615|NCT00852917|532289447|FG000|Overall Study|Lack of Efficacy|21|||
147582616|NCT00852917|532289448|FG001|Overall Study|Lack of Efficacy|11|||
147582617|NCT00852917|532289449|FG002|Overall Study|Lack of Efficacy|11|||
147582618|NCT00852917|532289450|FG003|Overall Study|Lack of Efficacy|47|||
147582619|NCT00852917|532289447|FG000|Overall Study|Withdrawal by Subject|4|||
147582620|NCT00852917|532289448|FG001|Overall Study|Withdrawal by Subject|8|||
147582621|NCT00852917|532289449|FG002|Overall Study|Withdrawal by Subject|10|||
147582622|NCT00852917|532289450|FG003|Overall Study|Withdrawal by Subject|9|||
147582623|NCT00852917|532289447|FG000|Overall Study|Physician Decision|6|||
147582624|NCT00852917|532289448|FG001|Overall Study|Physician Decision|7|||
147582625|NCT00852917|532289449|FG002|Overall Study|Physician Decision|2|||
147582626|NCT00852917|532289450|FG003|Overall Study|Physician Decision|19|||
147582627|NCT00852917|532289447|FG000|Overall Study|Death|0|||
147582628|NCT00852917|532289448|FG001|Overall Study|Death|0|||
147582629|NCT00852917|532289449|FG002|Overall Study|Death|0|||
147582630|NCT00852917|532289450|FG003|Overall Study|Death|1|||
147582631|NCT02510261|532289451|FG000|Overall Study|Adverse Event|5|||
147582632|NCT02510261|532289452|FG001|Overall Study|Adverse Event|8|||
147582633|NCT02510261|532289453|FG002|Overall Study|Adverse Event|0|||
147582634|NCT02510261|532289451|FG000|Overall Study|Physician Decision|1|||
147582635|NCT02510261|532289452|FG001|Overall Study|Physician Decision|5|||
147582636|NCT02510261|532289453|FG002|Overall Study|Physician Decision|0|||
147582637|NCT02510261|532289451|FG000|Overall Study|Death|19|||
147582638|NCT02510261|532289452|FG001|Overall Study|Death|19|||
147582639|NCT02510261|532289453|FG002|Overall Study|Death|0|||
147582640|NCT02510261|532289451|FG000|Overall Study|Withdrawal by Subject|3|||
147582641|NCT02510261|532289452|FG001|Overall Study|Withdrawal by Subject|10|||
147582642|NCT02510261|532289453|FG002|Overall Study|Withdrawal by Subject|3|||
147582643|NCT02161549|532289454|FG000|Overall Study|Physician Decision|6|||
147582644|NCT02161549|532289455|FG001|Overall Study|Physician Decision|2|||
147582645|NCT00979212|532289456|FG000|Overall Study|Protocol Violation|1|||
147582646|NCT00979212|532289457|FG001|Overall Study|Protocol Violation|8|||
147582647|NCT00979212|532289456|FG000|Overall Study|No protocol therapy received|1|||
147582648|NCT00979212|532289457|FG001|Overall Study|No protocol therapy received|0|||
147582649|NCT04886063|532289460|FG000|Overall Study|Adverse Event|50|||
147582650|NCT04886063|532289460|FG000|Overall Study|Lack of Efficacy|31|||
147582651|NCT04886063|532289460|FG000|Overall Study|Withdrawal by Subject|45|||
147582652|NCT04886063|532289460|FG000|Overall Study|Physician Decision|3|||
147582653|NCT04886063|532289460|FG000|Overall Study|Protocol Violation|3|||
147582654|NCT04886063|532289460|FG000|Overall Study|Site closure|4|||
147582655|NCT04886063|532289460|FG000|Overall Study|Nursing home replacement|3|||
147582656|NCT04886063|532289460|FG000|Overall Study|Lost to Follow-up|5|||
147582657|NCT04886063|532289460|FG000|Overall Study|Early study termination or other undetermined reasons|224|||
147582658|NCT04886063|532289460|FG000|Overall Study|>1 reason|20|||
147582659|NCT00965757|532289466|FG000|Double-blind Phase|Progression of concomitant disease|1|||
147582660|NCT00965757|532289467|FG001|Double-blind Phase|Progression of concomitant disease|2|||
147582661|NCT00965757|532289468|FG002|Double-blind Phase|Progression of concomitant disease|0|||
147582662|NCT00965757|532289469|FG003|Double-blind Phase|Progression of concomitant disease|0|||
147582663|NCT00965757|532289466|FG000|Double-blind Phase|Adverse drug reaction|2|||
147582664|NCT00965757|532289467|FG001|Double-blind Phase|Adverse drug reaction|1|||
147582665|NCT00965757|532289468|FG002|Double-blind Phase|Adverse drug reaction|0|||
147582666|NCT00965757|532289469|FG003|Double-blind Phase|Adverse drug reaction|0|||
147582667|NCT00965757|532289466|FG000|Double-blind Phase|Abnormal Laboratory Value|2|||
147582668|NCT00965757|532289467|FG001|Double-blind Phase|Abnormal Laboratory Value|0|||
147582669|NCT00965757|532289468|FG002|Double-blind Phase|Abnormal Laboratory Value|0|||
147582670|NCT00965757|532289469|FG003|Double-blind Phase|Abnormal Laboratory Value|0|||
147582671|NCT00965757|532289466|FG000|Double-blind Phase|Lack of Efficacy|7|||
147582672|NCT00965757|532289467|FG001|Double-blind Phase|Lack of Efficacy|11|||
147582673|NCT00965757|532289468|FG002|Double-blind Phase|Lack of Efficacy|0|||
147582674|NCT00965757|532289469|FG003|Double-blind Phase|Lack of Efficacy|0|||
147582675|NCT00965757|532289466|FG000|Double-blind Phase|Drug Refusal Due to Adverse Event|2|||
147582676|NCT00965757|532289467|FG001|Double-blind Phase|Drug Refusal Due to Adverse Event|0|||
147582677|NCT00965757|532289468|FG002|Double-blind Phase|Drug Refusal Due to Adverse Event|0|||
147582678|NCT00965757|532289469|FG003|Double-blind Phase|Drug Refusal Due to Adverse Event|0|||
147582679|NCT00965757|532289466|FG000|Double-blind Phase|Lost to Follow-up|0|||
147582680|NCT00965757|532289467|FG001|Double-blind Phase|Lost to Follow-up|1|||
147582681|NCT00965757|532289468|FG002|Double-blind Phase|Lost to Follow-up|0|||
147582682|NCT00965757|532289469|FG003|Double-blind Phase|Lost to Follow-up|0|||
147582683|NCT00965757|532289466|FG000|Double-blind Phase|Ineligible after Taking Study Drug|2|||
147582684|NCT00965757|532289467|FG001|Double-blind Phase|Ineligible after Taking Study Drug|3|||
147582685|NCT00965757|532289468|FG002|Double-blind Phase|Ineligible after Taking Study Drug|0|||
147582686|NCT00965757|532289469|FG003|Double-blind Phase|Ineligible after Taking Study Drug|0|||
147582687|NCT00965757|532289466|FG000|Double-blind Phase|Other|1|||
147582688|NCT00965757|532289467|FG001|Double-blind Phase|Other|0|||
147582689|NCT00965757|532289468|FG002|Double-blind Phase|Other|0|||
147582690|NCT00965757|532289469|FG003|Double-blind Phase|Other|0|||
147582691|NCT00965757|532289466|FG000|Extension Phase|Progression of concomitant disease|0|||
147582692|NCT00965757|532289467|FG001|Extension Phase|Progression of concomitant disease|0|||
147582693|NCT00965757|532289468|FG002|Extension Phase|Progression of concomitant disease|4|||
147582694|NCT00965757|532289469|FG003|Extension Phase|Progression of concomitant disease|2|||
147582695|NCT00965757|532289466|FG000|Extension Phase|Adverse drug reaction|0|||
147582696|NCT00965757|532289467|FG001|Extension Phase|Adverse drug reaction|0|||
147582697|NCT00965757|532289468|FG002|Extension Phase|Adverse drug reaction|6|||
147582698|NCT00965757|532289469|FG003|Extension Phase|Adverse drug reaction|3|||
147582699|NCT00965757|532289466|FG000|Extension Phase|Abnormal Laboratory Value|0|||
147582700|NCT00965757|532289467|FG001|Extension Phase|Abnormal Laboratory Value|0|||
147582701|NCT00965757|532289468|FG002|Extension Phase|Abnormal Laboratory Value|6|||
147582702|NCT00965757|532289469|FG003|Extension Phase|Abnormal Laboratory Value|1|||
147582703|NCT00965757|532289466|FG000|Extension Phase|Lack of Efficacy|0|||
147582704|NCT00965757|532289467|FG001|Extension Phase|Lack of Efficacy|0|||
147582705|NCT00965757|532289468|FG002|Extension Phase|Lack of Efficacy|8|||
147582706|NCT00965757|532289469|FG003|Extension Phase|Lack of Efficacy|12|||
147582707|NCT00965757|532289466|FG000|Extension Phase|Drug Refusal Due to Adverse Event|0|||
147582708|NCT00965757|532289467|FG001|Extension Phase|Drug Refusal Due to Adverse Event|0|||
147582709|NCT00965757|532289468|FG002|Extension Phase|Drug Refusal Due to Adverse Event|4|||
147582710|NCT00965757|532289469|FG003|Extension Phase|Drug Refusal Due to Adverse Event|0|||
147582711|NCT00965757|532289466|FG000|Extension Phase|Lost to Follow-up|0|||
147582712|NCT00965757|532289467|FG001|Extension Phase|Lost to Follow-up|0|||
147582713|NCT00965757|532289468|FG002|Extension Phase|Lost to Follow-up|0|||
147582714|NCT00965757|532289469|FG003|Extension Phase|Lost to Follow-up|1|||
147582715|NCT00965757|532289466|FG000|Extension Phase|Ineligible after Taking Study Drug|0|||
147582716|NCT00965757|532289467|FG001|Extension Phase|Ineligible after Taking Study Drug|0|||
147582717|NCT00965757|532289468|FG002|Extension Phase|Ineligible after Taking Study Drug|3|||
147582718|NCT00965757|532289469|FG003|Extension Phase|Ineligible after Taking Study Drug|3|||
147582719|NCT00965757|532289466|FG000|Extension Phase|Protocol Violation|0|||
147582720|NCT00965757|532289467|FG001|Extension Phase|Protocol Violation|0|||
147582721|NCT00965757|532289468|FG002|Extension Phase|Protocol Violation|0|||
147582722|NCT00965757|532289469|FG003|Extension Phase|Protocol Violation|1|||
147582723|NCT00965757|532289466|FG000|Extension Phase|Other|0|||
147582724|NCT00965757|532289467|FG001|Extension Phase|Other|0|||
147582725|NCT00965757|532289468|FG002|Extension Phase|Other|2|||
147582726|NCT00965757|532289469|FG003|Extension Phase|Other|1|||
147582727|NCT01398787|532289470|FG000|Overall Study|Adverse Event|1|||
147582728|NCT03414034|532289471|FG000|Overall Study|Adverse Event|6|||
147582729|NCT03414034|532289472|FG001|Overall Study|Adverse Event|1|||
147582730|NCT03414034|532289473|FG002|Overall Study|Adverse Event|1|||
147582731|NCT03414034|532289471|FG000|Overall Study|Death|0|||
147582732|NCT03414034|532289472|FG001|Overall Study|Death|0|||
147582733|NCT03414034|532289473|FG002|Overall Study|Death|1|||
147582734|NCT03414034|532289471|FG000|Overall Study|Non-compliance With Study Drug|0|||
147582735|NCT03414034|532289472|FG001|Overall Study|Non-compliance With Study Drug|0|||
147582736|NCT03414034|532289473|FG002|Overall Study|Non-compliance With Study Drug|1|||
147582737|NCT03414034|532289471|FG000|Overall Study|Physician Decision|1|||
147582738|NCT03414034|532289472|FG001|Overall Study|Physician Decision|3|||
147582739|NCT03414034|532289473|FG002|Overall Study|Physician Decision|2|||
147582740|NCT03414034|532289471|FG000|Overall Study|Withdrawal of Informed Consent|2|||
147582741|NCT03414034|532289472|FG001|Overall Study|Withdrawal of Informed Consent|1|||
147582742|NCT03414034|532289473|FG002|Overall Study|Withdrawal of Informed Consent|4|||
147582743|NCT03414034|532289471|FG000|Overall Study|Progressive Disease|15|||
147582744|NCT03414034|532289472|FG001|Overall Study|Progressive Disease|15|||
147240371|NCT03338010|531051599|FG000|Overall Study|Withdrawal by Subject|14|||
147240372|NCT03338010|531051600|FG001|Overall Study|Withdrawal by Subject|8|||
147240373|NCT03338010|531051599|FG000|Overall Study|Lost to Follow-up|4|||
147240374|NCT03338010|531051600|FG001|Overall Study|Lost to Follow-up|2|||
147582745|NCT03414034|532289473|FG002|Overall Study|Progressive Disease|17|||
147582746|NCT03414034|532289471|FG000|Overall Study|Miscellaneous|0|||
147240375|NCT03338010|531051599|FG000|Overall Study|Adverse Event|3|||
147240376|NCT03338010|531051600|FG001|Overall Study|Adverse Event|2|||
147240377|NCT03338010|531051599|FG000|Overall Study|Physician Decision|2|||
147240378|NCT03338010|531051600|FG001|Overall Study|Physician Decision|2|||
147582747|NCT03414034|532289472|FG001|Overall Study|Miscellaneous|0|||
147582748|NCT03414034|532289473|FG002|Overall Study|Miscellaneous|2|||
147582749|NCT02351167|532289475|FG000|Overall Study|Withdrawal by Subject|19|||
147582750|NCT02351167|532289476|FG001|Overall Study|Withdrawal by Subject|18|||
147582751|NCT02351167|532289477|FG002|Overall Study|Withdrawal by Subject|21|||
147582752|NCT01332968|532289478|FG000|Induction Period|Adverse Event|23|||
147582753|NCT01332968|532289479|FG001|Induction Period|Adverse Event|26|||
147582754|NCT01332968|532289480|FG002|Induction Period|Adverse Event|0|||
147582755|NCT01332968|532289481|FG003|Induction Period|Adverse Event|0|||
147582756|NCT01332968|532289482|FG004|Induction Period|Adverse Event|0|||
147582757|NCT01332968|532289483|FG005|Induction Period|Adverse Event|0|||
147582758|NCT01332968|532289484|FG006|Induction Period|Adverse Event|0|||
147582759|NCT01332968|532289485|FG007|Induction Period|Adverse Event|0|||
147582760|NCT01332968|532289478|FG000|Induction Period|Death|1|||
147582761|NCT01332968|532289479|FG001|Induction Period|Death|4|||
147582762|NCT01332968|532289480|FG002|Induction Period|Death|0|||
147582763|NCT01332968|532289481|FG003|Induction Period|Death|0|||
147582764|NCT01332968|532289482|FG004|Induction Period|Death|0|||
147240379|NCT03338010|531051599|FG000|Overall Study|Non-Compliance with Study Drug|0|||
147321809|NCT04537949|531341673|FG000|Follow-up Phase|Withdrawal by Subject|0|||
147321810|NCT04537949|531341674|FG001|Follow-up Phase|Withdrawal by Subject|0|||
147321811|NCT04537949|531341675|FG002|Follow-up Phase|Withdrawal by Subject|0|||
147321812|NCT04537949|531341676|FG003|Follow-up Phase|Withdrawal by Subject|0|||
147321813|NCT04537949|531341677|FG004|Follow-up Phase|Withdrawal by Subject|1|||
147321814|NCT04537949|531341678|FG005|Follow-up Phase|Withdrawal by Subject|0|||
147321815|NCT04537949|531341679|FG006|Follow-up Phase|Withdrawal by Subject|0|||
147321816|NCT04537949|531341680|FG007|Follow-up Phase|Withdrawal by Subject|0|||
147321817|NCT04003974|531341681|FG000|Overall Study|Missing|1|||
147321818|NCT04003974|531341682|FG001|Overall Study|Missing|0|||
147321819|NCT04003974|531341681|FG000|Overall Study|Withdrawal by Subject|0|||
147321820|NCT04003974|531341682|FG001|Overall Study|Withdrawal by Subject|2|||
147321821|NCT02400307|531341683|FG000|Overall Study|Enrolled and Never Dosed|1|||
147321822|NCT02400307|531341684|FG001|Overall Study|Enrolled and Never Dosed|0|||
147321823|NCT03023332|531341688|FG000|Overall Study|Withdrawal by Subject|10|||
147321824|NCT03023332|531341689|FG001|Overall Study|Withdrawal by Subject|5|||
147321825|NCT03023332|531341690|FG002|Overall Study|Withdrawal by Subject|4|||
147321826|NCT03023332|531341691|FG003|Overall Study|Withdrawal by Subject|7|||
147321827|NCT03023332|531341688|FG000|Overall Study|Lost to Follow-up|13|||
147321828|NCT03023332|531341689|FG001|Overall Study|Lost to Follow-up|16|||
147321829|NCT03023332|531341690|FG002|Overall Study|Lost to Follow-up|8|||
147321830|NCT03023332|531341691|FG003|Overall Study|Lost to Follow-up|13|||
147321831|NCT03023332|531341688|FG000|Overall Study|Death|1|||
147321832|NCT03023332|531341689|FG001|Overall Study|Death|0|||
147321833|NCT03023332|531341690|FG002|Overall Study|Death|0|||
147321834|NCT03023332|531341691|FG003|Overall Study|Death|0|||
147321835|NCT01657682|531341692|FG000|Overall Study|Lost to Follow-up|1|||
147321836|NCT01657682|531341693|FG001|Overall Study|Lost to Follow-up|0|||
147321837|NCT01657682|531341694|FG002|Overall Study|Lost to Follow-up|0|||
147321838|NCT01657682|531341692|FG000|Overall Study|Withdrawal by Subject|0|||
147321839|NCT01657682|531341693|FG001|Overall Study|Withdrawal by Subject|1|||
147321840|NCT01657682|531341694|FG002|Overall Study|Withdrawal by Subject|1|||
147321841|NCT01657682|531341692|FG000|Overall Study|Adverse Event|0|||
147321842|NCT01657682|531341693|FG001|Overall Study|Adverse Event|1|||
147321843|NCT01657682|531341694|FG002|Overall Study|Adverse Event|0|||
147321844|NCT01719861|531341696|FG000|Cycle 1|Death|4|||
147321845|NCT01719861|531341696|FG000|Cycle 2|Death|1|||
147240380|NCT03338010|531051600|FG001|Overall Study|Non-Compliance with Study Drug|3|||
147240381|NCT03338010|531051599|FG000|Overall Study|Protocol Violation|0|||
147240382|NCT03338010|531051600|FG001|Overall Study|Protocol Violation|1|||
147240383|NCT02465515|531051603|FG000|Overall Study|Investigator site closed|4|||
147240384|NCT02465515|531051604|FG001|Overall Study|Investigator site closed|5|||
147240385|NCT02465515|531051603|FG000|Overall Study|Withdrawal by Subject|74|||
147240386|NCT02465515|531051604|FG001|Overall Study|Withdrawal by Subject|43|||
147240387|NCT02465515|531051603|FG000|Overall Study|Physician Decision|8|||
147240388|NCT02465515|531051604|FG001|Overall Study|Physician Decision|12|||
147240389|NCT02465515|531051603|FG000|Overall Study|Lost to Follow-up|68|||
147240390|NCT02465515|531051604|FG001|Overall Study|Lost to Follow-up|51|||
147240391|NCT02564796|531051605|FG000|Overall Study|Physician Decision|2|||
147240392|NCT02564796|531051606|FG001|Overall Study|Physician Decision|2|||
147240393|NCT00293033|531051607|FG000|Open-label Titration Period|Adverse Event|10|||
147240394|NCT00293033|531051607|FG000|Open-label Titration Period|Death|3|||
147240395|NCT00293033|531051607|FG000|Open-label Titration Period|Lack of Efficacy|5|||
147240396|NCT00293033|531051607|FG000|Open-label Titration Period|Protocol Violation|2|||
147240397|NCT00293033|531051607|FG000|Open-label Titration Period|Withdrawal by Subject|22|||
147240398|NCT00293033|531051607|FG000|Open-label Titration Period|Noncompliance and other|27|||
147321846|NCT00958009|531341697|FG000|Overall Study|Adverse Event|1|||
147321847|NCT00958009|531341697|FG000|Overall Study|Subject found device difficult to use|1|||
147321848|NCT00087490|531341700|FG000|Overall Study|Death|6|||
147321849|NCT00087490|531341701|FG001|Overall Study|Death|4|||
147321850|NCT00087490|531341700|FG000|Overall Study|Adverse Event|3|||
147321851|NCT00087490|531341701|FG001|Overall Study|Adverse Event|8|||
147321852|NCT00087490|531341700|FG000|Overall Study|Lack of Efficacy|0|||
147582765|NCT01332968|532289483|FG005|Induction Period|Death|0|||
147582766|NCT01332968|532289484|FG006|Induction Period|Death|0|||
147582767|NCT01332968|532289485|FG007|Induction Period|Death|0|||
147582768|NCT01332968|532289478|FG000|Induction Period|Non-compliance|1|||
147582769|NCT01332968|532289479|FG001|Induction Period|Non-compliance|0|||
147582770|NCT01332968|532289480|FG002|Induction Period|Non-compliance|0|||
147582771|NCT01332968|532289481|FG003|Induction Period|Non-compliance|0|||
147582772|NCT01332968|532289482|FG004|Induction Period|Non-compliance|0|||
147582773|NCT01332968|532289483|FG005|Induction Period|Non-compliance|0|||
147582774|NCT01332968|532289484|FG006|Induction Period|Non-compliance|0|||
147582775|NCT01332968|532289485|FG007|Induction Period|Non-compliance|0|||
147582776|NCT01332968|532289478|FG000|Induction Period|Other|2|||
147582777|NCT01332968|532289479|FG001|Induction Period|Other|2|||
147582778|NCT01332968|532289480|FG002|Induction Period|Other|0|||
147582779|NCT01332968|532289481|FG003|Induction Period|Other|0|||
147582780|NCT01332968|532289482|FG004|Induction Period|Other|0|||
147582781|NCT01332968|532289483|FG005|Induction Period|Other|0|||
147582782|NCT01332968|532289484|FG006|Induction Period|Other|0|||
147582783|NCT01332968|532289485|FG007|Induction Period|Other|0|||
147582784|NCT01332968|532289478|FG000|Induction Period|Physician Decision|6|||
147582785|NCT01332968|532289479|FG001|Induction Period|Physician Decision|1|||
147582786|NCT01332968|532289480|FG002|Induction Period|Physician Decision|0|||
147582787|NCT01332968|532289481|FG003|Induction Period|Physician Decision|0|||
147321853|NCT00087490|531341701|FG001|Overall Study|Lack of Efficacy|2|||
147321854|NCT00087490|531341700|FG000|Overall Study|Protocol Violation or (/) Unspecified|214|||
147321855|NCT00087490|531341701|FG001|Overall Study|Protocol Violation or (/) Unspecified|201|||
147321856|NCT00087490|531341700|FG000|Overall Study|Lost to Follow-Up/participant withdrawal|28|||
147321857|NCT00087490|531341701|FG001|Overall Study|Lost to Follow-Up/participant withdrawal|36|||
147321858|NCT00087490|531341700|FG000|Overall Study|Randomized but not treated|7|||
147321859|NCT00087490|531341701|FG001|Overall Study|Randomized but not treated|18|||
147321860|NCT00761774|531341702|FG000|Overall Study|Adverse Event|17|||
147321861|NCT00761774|531341702|FG000|Overall Study|Lack of Efficacy|37|||
147321862|NCT00761774|531341702|FG000|Overall Study|Lost to Follow-up|2|||
147321863|NCT00761774|531341702|FG000|Overall Study|Withdrawal by Subject|9|||
147321864|NCT00761774|531341702|FG000|Overall Study|Non-compliance|4|||
147321865|NCT00761774|531341702|FG000|Overall Study|End of study|2|||
147321866|NCT00761774|531341702|FG000|Overall Study|Reclassification of seizures|1|||
147321867|NCT00761774|531341702|FG000|Overall Study|Medical decision to read SUSAR reports|1|||
147321868|NCT00761774|531341702|FG000|Overall Study|Sponsor decision|1|||
147321869|NCT00761774|531341702|FG000|Overall Study|Investigator clinical judgement|1|||
147582788|NCT01332968|532289482|FG004|Induction Period|Physician Decision|0|||
147582789|NCT01332968|532289483|FG005|Induction Period|Physician Decision|0|||
147582790|NCT01332968|532289484|FG006|Induction Period|Physician Decision|0|||
147582791|NCT01332968|532289485|FG007|Induction Period|Physician Decision|0|||
147582792|NCT01332968|532289478|FG000|Induction Period|Progressive Disease|15|||
147582793|NCT01332968|532289479|FG001|Induction Period|Progressive Disease|7|||
147240399|NCT00293033|531051607|FG000|Double-blind Treatment Period|Adverse Event|3|||
147240400|NCT00293033|531051607|FG000|Double-blind Treatment Period|Lack of Efficacy|1|||
147240401|NCT00293033|531051607|FG000|Double-blind Treatment Period|Withdrawal by Subject|4|||
147240402|NCT00293033|531051607|FG000|Double-blind Treatment Period|Noncompliance|4|||
147240403|NCT00816595|531051608|FG000|Overall Study|Withdrawal by Subject|2|||
147240404|NCT00816595|531051609|FG001|Overall Study|Withdrawal by Subject|0|||
147240405|NCT03583697|531051610|FG000|Overall Study|Withdrawal by Subject|0|||
147321870|NCT00761774|531341702|FG000|Overall Study|Patient moved out of study area|1|||
147321871|NCT00761774|531341702|FG000|Overall Study|Coordinator leaving site|1|||
147582794|NCT01332968|532289480|FG002|Induction Period|Progressive Disease|0|||
147582795|NCT01332968|532289481|FG003|Induction Period|Progressive Disease|0|||
147582796|NCT01332968|532289482|FG004|Induction Period|Progressive Disease|0|||
147582797|NCT01332968|532289483|FG005|Induction Period|Progressive Disease|0|||
147582798|NCT01332968|532289484|FG006|Induction Period|Progressive Disease|0|||
147582799|NCT01332968|532289485|FG007|Induction Period|Progressive Disease|0|||
147582800|NCT01332968|532289478|FG000|Induction Period|Protocol Violation|3|||
147582801|NCT01332968|532289479|FG001|Induction Period|Protocol Violation|4|||
147582802|NCT01332968|532289480|FG002|Induction Period|Protocol Violation|0|||
147582803|NCT01332968|532289481|FG003|Induction Period|Protocol Violation|0|||
147582804|NCT01332968|532289482|FG004|Induction Period|Protocol Violation|0|||
147654078|NCT02634983|532554688|FG001|Period 2 (Second Treatment, 8-10 Days)|Adverse Event|0|||
147240406|NCT03583697|531051611|FG001|Overall Study|Withdrawal by Subject|0|||
147321872|NCT00761774|531341702|FG000|Overall Study|Subject IP non-compliance|1|||
147240407|NCT03583697|531051612|FG002|Overall Study|Withdrawal by Subject|1|||
147321873|NCT00761774|531341702|FG000|Overall Study|IP stopped by hospital physician|1|||
147582805|NCT01332968|532289483|FG005|Induction Period|Protocol Violation|0|||
147582806|NCT01332968|532289484|FG006|Induction Period|Protocol Violation|0|||
147582807|NCT01332968|532289485|FG007|Induction Period|Protocol Violation|0|||
147582808|NCT01332968|532289478|FG000|Induction Period|Withdrawal by Subject|3|||
147582809|NCT01332968|532289479|FG001|Induction Period|Withdrawal by Subject|5|||
147582810|NCT01332968|532289480|FG002|Induction Period|Withdrawal by Subject|0|||
147582811|NCT01332968|532289481|FG003|Induction Period|Withdrawal by Subject|0|||
147582812|NCT01332968|532289482|FG004|Induction Period|Withdrawal by Subject|0|||
147582813|NCT01332968|532289483|FG005|Induction Period|Withdrawal by Subject|0|||
147582814|NCT01332968|532289484|FG006|Induction Period|Withdrawal by Subject|0|||
147582815|NCT01332968|532289485|FG007|Induction Period|Withdrawal by Subject|0|||
147240408|NCT03583697|531051610|FG000|Overall Study|AE of sudden infant death syndrome, not related|0|||
147240409|NCT03583697|531051611|FG001|Overall Study|AE of sudden infant death syndrome, not related|1|||
147240410|NCT03583697|531051612|FG002|Overall Study|AE of sudden infant death syndrome, not related|0|||
147240411|NCT00453063|531051613|FG000|Overall Study|Adverse Event|1|||
147240412|NCT00453063|531051614|FG001|Overall Study|Adverse Event|2|||
147240413|NCT00453063|531051613|FG000|Overall Study|Withdrawal by Subject|1|||
147240414|NCT00453063|531051614|FG001|Overall Study|Withdrawal by Subject|1|||
147240415|NCT00453063|531051613|FG000|Overall Study|Protocol Violation|1|||
147240416|NCT00453063|531051614|FG001|Overall Study|Protocol Violation|0|||
147240417|NCT00114530|531051616|FG000|Overall Study|Death|3|||
147240418|NCT00114530|531051617|FG001|Overall Study|Death|11|||
147240419|NCT00114530|531051616|FG000|Overall Study|Lost to Follow-up|1|||
147582816|NCT01332968|532289478|FG000|Induction Period|Randomised but not treated|4|||
147582817|NCT01332968|532289479|FG001|Induction Period|Randomised but not treated|7|||
147582818|NCT01332968|532289480|FG002|Induction Period|Randomised but not treated|0|||
147582819|NCT01332968|532289481|FG003|Induction Period|Randomised but not treated|0|||
147582820|NCT01332968|532289482|FG004|Induction Period|Randomised but not treated|0|||
147582821|NCT01332968|532289483|FG005|Induction Period|Randomised but not treated|0|||
147582822|NCT01332968|532289484|FG006|Induction Period|Randomised but not treated|0|||
147582823|NCT01332968|532289485|FG007|Induction Period|Randomised but not treated|0|||
147582824|NCT01332968|532289478|FG000|Maintenance/Observation Period|Adverse Event|0|||
147582825|NCT01332968|532289479|FG001|Maintenance/Observation Period|Adverse Event|0|||
147582826|NCT01332968|532289480|FG002|Maintenance/Observation Period|Adverse Event|53|||
147582827|NCT01332968|532289481|FG003|Maintenance/Observation Period|Adverse Event|66|||
147582828|NCT01332968|532289482|FG004|Maintenance/Observation Period|Adverse Event|0|||
147582829|NCT01332968|532289483|FG005|Maintenance/Observation Period|Adverse Event|0|||
147582830|NCT01332968|532289484|FG006|Maintenance/Observation Period|Adverse Event|0|||
147582831|NCT01332968|532289485|FG007|Maintenance/Observation Period|Adverse Event|0|||
147582832|NCT01332968|532289478|FG000|Maintenance/Observation Period|Death|0|||
147582833|NCT01332968|532289479|FG001|Maintenance/Observation Period|Death|0|||
147582834|NCT01332968|532289480|FG002|Maintenance/Observation Period|Death|5|||
147582835|NCT01332968|532289481|FG003|Maintenance/Observation Period|Death|6|||
147582836|NCT01332968|532289482|FG004|Maintenance/Observation Period|Death|0|||
147582837|NCT01332968|532289483|FG005|Maintenance/Observation Period|Death|0|||
147582838|NCT01332968|532289484|FG006|Maintenance/Observation Period|Death|0|||
147582839|NCT01332968|532289485|FG007|Maintenance/Observation Period|Death|0|||
147582840|NCT01332968|532289478|FG000|Maintenance/Observation Period|Lost to Follow-up|0|||
147582841|NCT01332968|532289479|FG001|Maintenance/Observation Period|Lost to Follow-up|0|||
147582842|NCT01332968|532289480|FG002|Maintenance/Observation Period|Lost to Follow-up|1|||
147582843|NCT01332968|532289481|FG003|Maintenance/Observation Period|Lost to Follow-up|2|||
147582844|NCT01332968|532289482|FG004|Maintenance/Observation Period|Lost to Follow-up|0|||
147582845|NCT01332968|532289483|FG005|Maintenance/Observation Period|Lost to Follow-up|0|||
147582846|NCT01332968|532289484|FG006|Maintenance/Observation Period|Lost to Follow-up|0|||
147582847|NCT01332968|532289485|FG007|Maintenance/Observation Period|Lost to Follow-up|0|||
147582848|NCT01332968|532289478|FG000|Maintenance/Observation Period|Non-compliance|0|||
147582849|NCT01332968|532289479|FG001|Maintenance/Observation Period|Non-compliance|0|||
147582850|NCT01332968|532289480|FG002|Maintenance/Observation Period|Non-compliance|4|||
147582851|NCT01332968|532289481|FG003|Maintenance/Observation Period|Non-compliance|3|||
147582852|NCT01332968|532289482|FG004|Maintenance/Observation Period|Non-compliance|0|||
147582853|NCT01332968|532289483|FG005|Maintenance/Observation Period|Non-compliance|0|||
147582854|NCT01332968|532289484|FG006|Maintenance/Observation Period|Non-compliance|0|||
147582855|NCT01332968|532289485|FG007|Maintenance/Observation Period|Non-compliance|0|||
147582856|NCT01332968|532289478|FG000|Maintenance/Observation Period|Other|0|||
147240420|NCT00114530|531051617|FG001|Overall Study|Lost to Follow-up|1|||
147240421|NCT00114530|531051616|FG000|Overall Study|Physician Decision|1|||
147240422|NCT00114530|531051617|FG001|Overall Study|Physician Decision|1|||
147240423|NCT00114530|531051616|FG000|Overall Study|Withdrawal by Subject|2|||
147240424|NCT00114530|531051617|FG001|Overall Study|Withdrawal by Subject|6|||
147240425|NCT00114530|531051616|FG000|Overall Study|Breast Cancer|1|||
147240426|NCT00114530|531051617|FG001|Overall Study|Breast Cancer|0|||
147240427|NCT00114530|531051616|FG000|Overall Study|Subject decision after endpoint failure|0|||
147240428|NCT00114530|531051617|FG001|Overall Study|Subject decision after endpoint failure|1|||
147240429|NCT00114530|531051616|FG000|Overall Study|Ineligible|1|||
147240430|NCT00114530|531051617|FG001|Overall Study|Ineligible|0|||
147240431|NCT03724032|531051620|FG000|Overall Study|Physician Decision|1|||
147240432|NCT03724032|531051621|FG001|Overall Study|Physician Decision|0|||
147240433|NCT03724032|531051622|FG002|Overall Study|Physician Decision|0|||
147446802|NCT01732796|531800307|FG001|Overall Study|Adverse Event|16|||
147446803|NCT01732796|531800308|FG002|Overall Study|Adverse Event|4|||
147582857|NCT01332968|532289479|FG001|Maintenance/Observation Period|Other|0|||
147582858|NCT01332968|532289480|FG002|Maintenance/Observation Period|Other|4|||
147582859|NCT01332968|532289481|FG003|Maintenance/Observation Period|Other|7|||
147582860|NCT01332968|532289482|FG004|Maintenance/Observation Period|Other|0|||
147582861|NCT01332968|532289483|FG005|Maintenance/Observation Period|Other|0|||
147582862|NCT01332968|532289484|FG006|Maintenance/Observation Period|Other|0|||
147582863|NCT01332968|532289485|FG007|Maintenance/Observation Period|Other|0|||
147582864|NCT01332968|532289478|FG000|Maintenance/Observation Period|Physician Decision|0|||
147582865|NCT01332968|532289479|FG001|Maintenance/Observation Period|Physician Decision|0|||
147582866|NCT01332968|532289480|FG002|Maintenance/Observation Period|Physician Decision|14|||
147582867|NCT01332968|532289481|FG003|Maintenance/Observation Period|Physician Decision|19|||
147582868|NCT01332968|532289482|FG004|Maintenance/Observation Period|Physician Decision|0|||
147582869|NCT01332968|532289483|FG005|Maintenance/Observation Period|Physician Decision|1|||
147582870|NCT01332968|532289484|FG006|Maintenance/Observation Period|Physician Decision|0|||
147582871|NCT01332968|532289485|FG007|Maintenance/Observation Period|Physician Decision|0|||
147582872|NCT01332968|532289478|FG000|Maintenance/Observation Period|Progressive Disease|0|||
147582873|NCT01332968|532289479|FG001|Maintenance/Observation Period|Progressive Disease|0|||
147582874|NCT01332968|532289480|FG002|Maintenance/Observation Period|Progressive Disease|72|||
147582875|NCT01332968|532289481|FG003|Maintenance/Observation Period|Progressive Disease|40|||
147582876|NCT01332968|532289482|FG004|Maintenance/Observation Period|Progressive Disease|0|||
147582877|NCT01332968|532289483|FG005|Maintenance/Observation Period|Progressive Disease|0|||
147582878|NCT01332968|532289484|FG006|Maintenance/Observation Period|Progressive Disease|0|||
147582879|NCT01332968|532289485|FG007|Maintenance/Observation Period|Progressive Disease|0|||
147582880|NCT01332968|532289478|FG000|Maintenance/Observation Period|Protocol Violation|0|||
147582881|NCT01332968|532289479|FG001|Maintenance/Observation Period|Protocol Violation|0|||
147582882|NCT01332968|532289480|FG002|Maintenance/Observation Period|Protocol Violation|1|||
147582883|NCT01332968|532289481|FG003|Maintenance/Observation Period|Protocol Violation|1|||
147582884|NCT01332968|532289482|FG004|Maintenance/Observation Period|Protocol Violation|0|||
147582885|NCT01332968|532289483|FG005|Maintenance/Observation Period|Protocol Violation|0|||
147582886|NCT01332968|532289484|FG006|Maintenance/Observation Period|Protocol Violation|0|||
147582887|NCT01332968|532289485|FG007|Maintenance/Observation Period|Protocol Violation|0|||
147582888|NCT01332968|532289478|FG000|Maintenance/Observation Period|Withdrawal by Subject|0|||
147582889|NCT01332968|532289479|FG001|Maintenance/Observation Period|Withdrawal by Subject|0|||
147582890|NCT01332968|532289480|FG002|Maintenance/Observation Period|Withdrawal by Subject|7|||
147582891|NCT01332968|532289481|FG003|Maintenance/Observation Period|Withdrawal by Subject|5|||
147582892|NCT01332968|532289482|FG004|Maintenance/Observation Period|Withdrawal by Subject|0|||
147582893|NCT01332968|532289483|FG005|Maintenance/Observation Period|Withdrawal by Subject|0|||
147582894|NCT01332968|532289484|FG006|Maintenance/Observation Period|Withdrawal by Subject|0|||
147582895|NCT01332968|532289485|FG007|Maintenance/Observation Period|Withdrawal by Subject|0|||
147582896|NCT01332968|532289478|FG000|Follow-Up Period|Adverse Event|0|||
147582897|NCT01332968|532289479|FG001|Follow-Up Period|Adverse Event|0|||
147582898|NCT01332968|532289480|FG002|Follow-Up Period|Adverse Event|0|||
147582899|NCT01332968|532289481|FG003|Follow-Up Period|Adverse Event|0|||
147582900|NCT01332968|532289482|FG004|Follow-Up Period|Adverse Event|0|||
147582901|NCT01332968|532289483|FG005|Follow-Up Period|Adverse Event|0|||
147582902|NCT01332968|532289484|FG006|Follow-Up Period|Adverse Event|0|||
147582903|NCT01332968|532289485|FG007|Follow-Up Period|Adverse Event|4|||
147582904|NCT01332968|532289478|FG000|Follow-Up Period|Death|0|||
147582905|NCT01332968|532289479|FG001|Follow-Up Period|Death|0|||
147582906|NCT01332968|532289480|FG002|Follow-Up Period|Death|0|||
147582907|NCT01332968|532289481|FG003|Follow-Up Period|Death|0|||
147582908|NCT01332968|532289482|FG004|Follow-Up Period|Death|0|||
147582909|NCT01332968|532289483|FG005|Follow-Up Period|Death|0|||
147582910|NCT01332968|532289484|FG006|Follow-Up Period|Death|27|||
147582911|NCT01332968|532289485|FG007|Follow-Up Period|Death|30|||
147582912|NCT01332968|532289478|FG000|Follow-Up Period|Lost to Follow-up|0|||
147582913|NCT01332968|532289479|FG001|Follow-Up Period|Lost to Follow-up|0|||
147582914|NCT01332968|532289480|FG002|Follow-Up Period|Lost to Follow-up|0|||
147582915|NCT01332968|532289481|FG003|Follow-Up Period|Lost to Follow-up|0|||
147582916|NCT01332968|532289482|FG004|Follow-Up Period|Lost to Follow-up|0|||
147582917|NCT01332968|532289483|FG005|Follow-Up Period|Lost to Follow-up|0|||
147582918|NCT01332968|532289484|FG006|Follow-Up Period|Lost to Follow-up|11|||
147321874|NCT01318811|531341706|FG000|Overall Study|Physician Decision|1|||
147582919|NCT01332968|532289485|FG007|Follow-Up Period|Lost to Follow-up|15|||
147582920|NCT01332968|532289478|FG000|Follow-Up Period|Non-compliance|0|||
147582921|NCT01332968|532289479|FG001|Follow-Up Period|Non-compliance|0|||
147582922|NCT01332968|532289480|FG002|Follow-Up Period|Non-compliance|0|||
147582923|NCT01332968|532289481|FG003|Follow-Up Period|Non-compliance|0|||
147582924|NCT01332968|532289482|FG004|Follow-Up Period|Non-compliance|0|||
147582925|NCT01332968|532289483|FG005|Follow-Up Period|Non-compliance|0|||
147582926|NCT01332968|532289484|FG006|Follow-Up Period|Non-compliance|4|||
147321875|NCT01318811|531341707|FG001|Overall Study|Physician Decision|1|||
147321876|NCT01318811|531341706|FG000|Overall Study|CRRT stopped for head CT|0|||
147582927|NCT01332968|532289485|FG007|Follow-Up Period|Non-compliance|9|||
147582928|NCT01332968|532289478|FG000|Follow-Up Period|Other|0|||
147582929|NCT01332968|532289479|FG001|Follow-Up Period|Other|0|||
147582930|NCT01332968|532289480|FG002|Follow-Up Period|Other|0|||
147582931|NCT01332968|532289481|FG003|Follow-Up Period|Other|0|||
147582932|NCT01332968|532289482|FG004|Follow-Up Period|Other|0|||
147582933|NCT01332968|532289483|FG005|Follow-Up Period|Other|0|||
147321877|NCT01318811|531341707|FG001|Overall Study|CRRT stopped for head CT|1|||
147582934|NCT01332968|532289484|FG006|Follow-Up Period|Other|18|||
147582935|NCT01332968|532289485|FG007|Follow-Up Period|Other|21|||
147582936|NCT01332968|532289478|FG000|Follow-Up Period|Physician Decision|0|||
147582937|NCT01332968|532289479|FG001|Follow-Up Period|Physician Decision|0|||
147582938|NCT01332968|532289480|FG002|Follow-Up Period|Physician Decision|0|||
147582939|NCT01332968|532289481|FG003|Follow-Up Period|Physician Decision|0|||
147582940|NCT01332968|532289482|FG004|Follow-Up Period|Physician Decision|0|||
147582941|NCT01332968|532289483|FG005|Follow-Up Period|Physician Decision|0|||
147582942|NCT01332968|532289484|FG006|Follow-Up Period|Physician Decision|12|||
147582943|NCT01332968|532289485|FG007|Follow-Up Period|Physician Decision|15|||
147582944|NCT01332968|532289478|FG000|Follow-Up Period|Progressive Disease|0|||
147582945|NCT01332968|532289479|FG001|Follow-Up Period|Progressive Disease|0|||
147582946|NCT01332968|532289480|FG002|Follow-Up Period|Progressive Disease|0|||
147582947|NCT01332968|532289481|FG003|Follow-Up Period|Progressive Disease|0|||
147582948|NCT01332968|532289482|FG004|Follow-Up Period|Progressive Disease|0|||
147582949|NCT01332968|532289483|FG005|Follow-Up Period|Progressive Disease|0|||
147582950|NCT01332968|532289484|FG006|Follow-Up Period|Progressive Disease|126|||
147582951|NCT01332968|532289485|FG007|Follow-Up Period|Progressive Disease|106|||
147582952|NCT01332968|532289478|FG000|Follow-Up Period|Protocol Violation|0|||
147582953|NCT01332968|532289479|FG001|Follow-Up Period|Protocol Violation|0|||
147582954|NCT01332968|532289480|FG002|Follow-Up Period|Protocol Violation|0|||
147582955|NCT01332968|532289481|FG003|Follow-Up Period|Protocol Violation|0|||
147582956|NCT01332968|532289482|FG004|Follow-Up Period|Protocol Violation|0|||
147582957|NCT01332968|532289483|FG005|Follow-Up Period|Protocol Violation|0|||
147582958|NCT01332968|532289484|FG006|Follow-Up Period|Protocol Violation|1|||
147582959|NCT01332968|532289485|FG007|Follow-Up Period|Protocol Violation|0|||
147582960|NCT01332968|532289478|FG000|Follow-Up Period|Withdrawal by Subject|0|||
147582961|NCT01332968|532289479|FG001|Follow-Up Period|Withdrawal by Subject|0|||
147582962|NCT01332968|532289480|FG002|Follow-Up Period|Withdrawal by Subject|0|||
147582963|NCT01332968|532289481|FG003|Follow-Up Period|Withdrawal by Subject|0|||
147582964|NCT01332968|532289482|FG004|Follow-Up Period|Withdrawal by Subject|0|||
147582965|NCT01332968|532289483|FG005|Follow-Up Period|Withdrawal by Subject|0|||
147582966|NCT01332968|532289484|FG006|Follow-Up Period|Withdrawal by Subject|29|||
147582967|NCT01332968|532289485|FG007|Follow-Up Period|Withdrawal by Subject|32|||
147582968|NCT01332968|532289478|FG000|Follow-Up Period|No reason provided|0|||
147582969|NCT01332968|532289479|FG001|Follow-Up Period|No reason provided|0|||
147582970|NCT01332968|532289480|FG002|Follow-Up Period|No reason provided|0|||
147582971|NCT01332968|532289481|FG003|Follow-Up Period|No reason provided|0|||
147582972|NCT01332968|532289482|FG004|Follow-Up Period|No reason provided|0|||
147582973|NCT01332968|532289483|FG005|Follow-Up Period|No reason provided|0|||
147582974|NCT01332968|532289484|FG006|Follow-Up Period|No reason provided|2|||
147582975|NCT01332968|532289485|FG007|Follow-Up Period|No reason provided|3|||
147582976|NCT00702507|532289486|FG000|Initial Treatment Phase|Adverse Event|2|||
147582977|NCT00702507|532289486|FG000|Initial Treatment Phase|Participant's Caretaker Withdrew Consent|3|||
147582978|NCT00702507|532289486|FG000|Initial Treatment Phase|Lost to Follow-up|2|||
147582979|NCT00702507|532289486|FG000|Initial Treatment Phase|Negative Candida Culture|34|||
147582980|NCT00702507|532289486|FG000|Follow-up Phase|Participant's Caretaker Withdrew Consent|1|||
147582981|NCT00702507|532289486|FG000|Follow-up Phase|Protocol Violation|2|||
147582982|NCT00702507|532289486|FG000|Follow-up Phase|Lost to Follow-up|23|||
147582983|NCT00702507|532289486|FG000|Follow-up Phase|Late Enrollment|1|||
147582984|NCT02308696|532289487|FG000|Overall Study|Lost to Follow-up|28|||
147582985|NCT02308696|532289488|FG001|Overall Study|Lost to Follow-up|21|||
147582986|NCT02308696|532289487|FG000|Overall Study|Death|8|||
147582987|NCT02308696|532289488|FG001|Overall Study|Death|4|||
147582988|NCT02308696|532289487|FG000|Overall Study|Moved to a Higher Level of Care|17|||
147582989|NCT02308696|532289488|FG001|Overall Study|Moved to a Higher Level of Care|6|||
147582990|NCT01055886|532289493|FG000|Overall Study|Withdrawal by Subject|4|||
147321878|NCT01318811|531341706|FG000|Overall Study|Death|0|||
147321879|NCT01318811|531341707|FG001|Overall Study|Death|1|||
147321880|NCT01318811|531341706|FG000|Overall Study|CRRT stopped for head MRI|0|||
147582991|NCT01055886|532289494|FG001|Overall Study|Withdrawal by Subject|9|||
147582992|NCT01055886|532289493|FG000|Overall Study|Lost to Follow-up|1|||
147321881|NCT01318811|531341707|FG001|Overall Study|CRRT stopped for head MRI|1|||
147321882|NCT02303574|531341712|FG000|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
147321883|NCT02303574|531341713|FG001|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
147582993|NCT01055886|532289494|FG001|Overall Study|Lost to Follow-up|1|||
147582994|NCT01055886|532289493|FG000|Overall Study|Withdrawal by PI|0|||
147582995|NCT01055886|532289494|FG001|Overall Study|Withdrawal by PI|1|||
147582996|NCT04194008|532289495|FG000|Baseline (Run-in) Phase|Fail to comply with Run-in phase criteria|19|||
147582997|NCT04194008|532289495|FG000|Baseline (Run-in) Phase|Withdrawal by Subject|6|||
147582998|NCT04194008|532289495|FG000|Baseline (Run-in) Phase|Lost to Follow-up|2|||
147582999|NCT04194008|532289495|FG000|Treatment Phase With Nerivio|Withdrawal by Subject|3|||
147583000|NCT04194008|532289495|FG000|Treatment Phase With Nerivio|Missing data|4|||
147654079|NCT03178851|532554689|FG000|Overall Study|Death|48|||
147446804|NCT01732796|531800306|FG000|Overall Study|Lack of Efficacy|21|||
147583001|NCT04194008|532289495|FG000|Treatment Phase With Nerivio|Lost to Follow-up|1|||
147583002|NCT02522780|532289499|FG000|Overall Study|Consent withdrawn by subject|5|||
147583003|NCT02522780|532289500|FG001|Overall Study|Consent withdrawn by subject|7|||
147583004|NCT02522780|532289499|FG000|Overall Study|Protocol deviation|1|||
147583005|NCT02522780|532289500|FG001|Overall Study|Protocol deviation|3|||
147583006|NCT02522780|532289499|FG000|Overall Study|Subject refused endoscopic procedure|0|||
147583007|NCT02522780|532289500|FG001|Overall Study|Subject refused endoscopic procedure|1|||
147583008|NCT02522780|532289499|FG000|Overall Study|Adverse event, non-fatal|11|||
147583009|NCT02522780|532289500|FG001|Overall Study|Adverse event, non-fatal|16|||
147583010|NCT02260635|532289501|FG000|Double-Blind Treatment Period|Failure to Meet Randomization Criteria|1|||
147583011|NCT02260635|532289502|FG001|Double-Blind Treatment Period|Failure to Meet Randomization Criteria|2|||
147583012|NCT02260635|532289501|FG000|Open-Label Extension|Study Termination|25|||
147583013|NCT02260635|532289502|FG001|Open-Label Extension|Study Termination|25|||
147583014|NCT02260635|532289501|FG000|Open-Label Extension|Withdrawal by Subject|1|||
147583015|NCT02260635|532289502|FG001|Open-Label Extension|Withdrawal by Subject|0|||
147583016|NCT00926367|532289506|FG000|Overall Study|Withdrawal by Subject|0|||
147583017|NCT00926367|532289507|FG001|Overall Study|Withdrawal by Subject|1|||
147583018|NCT00926367|532289506|FG000|Overall Study|Lost to Follow-up|1|||
147583019|NCT00926367|532289507|FG001|Overall Study|Lost to Follow-up|0|||
147583020|NCT00926367|532289506|FG000|Overall Study|Skin Irritation|1|||
147583021|NCT00926367|532289507|FG001|Overall Study|Skin Irritation|2|||
147583022|NCT01517867|532289508|FG000|Overall Study|never started treatment|29|||
147583023|NCT01517867|532289509|FG001|Overall Study|never started treatment|32|||
147583024|NCT01517867|532289508|FG000|Overall Study|Withdrawal by Subject|34|||
147583025|NCT01517867|532289509|FG001|Overall Study|Withdrawal by Subject|30|||
147583026|NCT01517867|532289508|FG000|Overall Study|Still in treatment at study end|0|||
147583027|NCT01517867|532289509|FG001|Overall Study|Still in treatment at study end|3|||
147583028|NCT01685216|532289510|FG000|Overall Study|Did not receive study drug|1|||
147583029|NCT00756717|532289513|FG000|Overall Study|Withdrawal by Subject|2|||
147583030|NCT02466386|532289516|FG000|Overall Study|Adverse Event|5|||
147583031|NCT02466386|532289516|FG000|Overall Study|Protocol Violation|2|||
147583032|NCT02466386|532289516|FG000|Overall Study|Withdrawal by Subject|14|||
147583033|NCT02466386|532289516|FG000|Overall Study|Lost to Follow-up|5|||
147583034|NCT02466386|532289516|FG000|Overall Study|Lack of Efficacy|8|||
147583035|NCT02466386|532289516|FG000|Overall Study|Other|10|||
147583036|NCT00889252|532289517|FG000|Overall Study|Adverse Event|2|||
147583037|NCT00889252|532289518|FG001|Overall Study|Adverse Event|4|||
147583038|NCT00889252|532289517|FG000|Overall Study|Withdrawal by Subject|3|||
147583039|NCT00889252|532289518|FG001|Overall Study|Withdrawal by Subject|0|||
147583040|NCT00889252|532289517|FG000|Overall Study|Protocol Violation|2|||
147583041|NCT00889252|532289518|FG001|Overall Study|Protocol Violation|0|||
147583042|NCT02387762|532289525|FG000|Overall Study|Withdrawal by Subject|1|||
147583043|NCT02387762|532289526|FG001|Overall Study|Withdrawal by Subject|0|||
147583044|NCT00593827|532289527|FG000|Overall Study|On Active Treatment/Pending|0|||
147583045|NCT00593827|532289528|FG001|Overall Study|On Active Treatment/Pending|2|||
147583046|NCT01160640|532289529|FG000|Overall Study|Physician Decision|3|||
147583047|NCT01160640|532289530|FG001|Overall Study|Physician Decision|3|||
147583048|NCT01160640|532289529|FG000|Overall Study|Incarceration|1|||
147583049|NCT01160640|532289530|FG001|Overall Study|Incarceration|0|||
147583050|NCT01160640|532289529|FG000|Overall Study|Withdrawal by Subject|0|||
147583051|NCT01160640|532289530|FG001|Overall Study|Withdrawal by Subject|3|||
147583052|NCT02169336|532289531|FG000|Overall Study|Lack of Efficacy|1|||
147583053|NCT02169336|532289532|FG001|Overall Study|Lack of Efficacy|1|||
147583054|NCT02169336|532289533|FG002|Overall Study|Lack of Efficacy|0|||
147583055|NCT02169336|532289531|FG000|Overall Study|Adverse Event|2|||
147583056|NCT02169336|532289532|FG001|Overall Study|Adverse Event|3|||
147321884|NCT02303574|531341714|FG002|Part 1a (Fasted State)- SAD|Withdrawal by Subject|1|||
147321885|NCT02303574|531341715|FG003|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
147321886|NCT02303574|531341716|FG004|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
147583057|NCT02169336|532289533|FG002|Overall Study|Adverse Event|1|||
147583058|NCT02169336|532289531|FG000|Overall Study|Withdrawal by Subject|1|||
147583059|NCT02169336|532289532|FG001|Overall Study|Withdrawal by Subject|0|||
147583060|NCT02169336|532289533|FG002|Overall Study|Withdrawal by Subject|0|||
147583061|NCT02169336|532289531|FG000|Overall Study|Physician Decision|0|||
147583062|NCT02169336|532289532|FG001|Overall Study|Physician Decision|0|||
147583063|NCT02169336|532289533|FG002|Overall Study|Physician Decision|1|||
147583064|NCT02169336|532289531|FG000|Overall Study|Subject declined to continue dosing|0|||
147583065|NCT02169336|532289532|FG001|Overall Study|Subject declined to continue dosing|0|||
147583066|NCT02169336|532289533|FG002|Overall Study|Subject declined to continue dosing|1|||
147583067|NCT01598896|532289534|FG000|Overall Study|Withdrawal by Subject|0|||
147583068|NCT01598896|532289535|FG001|Overall Study|Withdrawal by Subject|1|||
147583069|NCT01598896|532289534|FG000|Overall Study|Lack of Efficacy|0|||
147583070|NCT01598896|532289535|FG001|Overall Study|Lack of Efficacy|1|||
147583071|NCT00239005|532289537|FG000|Overall Study|Adverse Event|6|||
147583072|NCT00239005|532289538|FG001|Overall Study|Adverse Event|6|||
147583073|NCT00239005|532289537|FG000|Overall Study|Withdrawal by Subject|3|||
147583074|NCT00239005|532289538|FG001|Overall Study|Withdrawal by Subject|4|||
147583075|NCT00239005|532289537|FG000|Overall Study|Unsatisfactory Therapeutic effect|2|||
147583076|NCT00239005|532289538|FG001|Overall Study|Unsatisfactory Therapeutic effect|0|||
147583077|NCT00239005|532289537|FG000|Overall Study|Protocol Violation|1|||
147583078|NCT00239005|532289538|FG001|Overall Study|Protocol Violation|0|||
147583079|NCT00239005|532289537|FG000|Overall Study|Subj. cond. no longer needs study drug|0|||
147583080|NCT00239005|532289538|FG001|Overall Study|Subj. cond. no longer needs study drug|1|||
147583081|NCT00239005|532289537|FG000|Overall Study|Lost to Follow-up|0|||
147583082|NCT00239005|532289538|FG001|Overall Study|Lost to Follow-up|1|||
147583083|NCT02614898|532289539|FG000|Overall Study|Participated until study termination|10|||
147583084|NCT02614898|532289540|FG001|Overall Study|Participated until study termination|26|||
147654080|NCT03178851|532554690|FG001|Overall Study|Death|2|||
147654081|NCT03178851|532554691|FG002|Overall Study|Death|25|||
147654082|NCT03178851|532554689|FG000|Overall Study|Withdrawal by Subject|8|||
147583085|NCT02614898|532289539|FG000|Overall Study|Lost to Follow-up|0|||
147583086|NCT02614898|532289540|FG001|Overall Study|Lost to Follow-up|2|||
147583087|NCT02614898|532289539|FG000|Overall Study|Physician Decision|1|||
147583088|NCT02614898|532289540|FG001|Overall Study|Physician Decision|8|||
147583089|NCT02614898|532289539|FG000|Overall Study|Study Terminated by Sponsor|3|||
147583090|NCT02614898|532289540|FG001|Overall Study|Study Terminated by Sponsor|0|||
147583091|NCT02614898|532289539|FG000|Overall Study|Withdrawal by Subject|0|||
147583092|NCT02614898|532289540|FG001|Overall Study|Withdrawal by Subject|2|||
147583093|NCT02614898|532289539|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
147583094|NCT02614898|532289540|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
147583095|NCT02614898|532289539|FG000|Overall Study|Other-Additional Information Unavailable|0|||
147583096|NCT02614898|532289540|FG001|Overall Study|Other-Additional Information Unavailable|11|||
147583097|NCT02614898|532289539|FG000|Overall Study|Missing|0|||
147583098|NCT02614898|532289540|FG001|Overall Study|Missing|1|||
147583099|NCT00688844|532289541|FG000|Overall Study|Lost to Follow-up|10|||
147583100|NCT03493919|532289543|FG000|Overall Study|Other|2|||
147321887|NCT02303574|531341717|FG005|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
147321888|NCT02303574|531341718|FG006|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
147321889|NCT02303574|531341719|FG007|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
147321890|NCT02303574|531341720|FG008|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
147321891|NCT02303574|531341721|FG009|Part 1a (Fasted State)- SAD|Withdrawal by Subject|0|||
147321892|NCT02303574|531341712|FG000|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
147321893|NCT02303574|531341713|FG001|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
147321894|NCT02303574|531341714|FG002|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
147321895|NCT02303574|531341715|FG003|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
147321896|NCT02303574|531341716|FG004|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
147321897|NCT02303574|531341717|FG005|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
147321898|NCT02303574|531341718|FG006|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
147321899|NCT02303574|531341719|FG007|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|1|||
147321900|NCT02303574|531341720|FG008|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
147321901|NCT02303574|531341721|FG009|Part 2 - Multiple Ascending Dose (MAD)|Adverse Event|0|||
147321902|NCT00994279|531341726|FG000|Overall Study|Withdrawal by Subject|2|||
147321903|NCT00994279|531341727|FG001|Overall Study|Withdrawal by Subject|2|||
147321904|NCT00994279|531341726|FG000|Overall Study|Toxicity|1|||
147321905|NCT00994279|531341727|FG001|Overall Study|Toxicity|0|||
147321906|NCT00994279|531341726|FG000|Overall Study|Multiple reasons|1|||
147583101|NCT03493919|532289544|FG001|Overall Study|Other|0|||
147583102|NCT03493919|532289545|FG002|Overall Study|Other|1|||
147654083|NCT03178851|532554690|FG001|Overall Study|Withdrawal by Subject|0|||
147654084|NCT03178851|532554691|FG002|Overall Study|Withdrawal by Subject|0|||
147583103|NCT03493919|532289546|FG003|Overall Study|Other|0|||
147583104|NCT03493919|532289543|FG000|Overall Study|Withdrawal by Subject|9|||
147583105|NCT03493919|532289544|FG001|Overall Study|Withdrawal by Subject|3|||
147583106|NCT03493919|532289545|FG002|Overall Study|Withdrawal by Subject|1|||
147583107|NCT03493919|532289546|FG003|Overall Study|Withdrawal by Subject|1|||
147583108|NCT03493919|532289543|FG000|Overall Study|Lost to Follow-up|5|||
147583109|NCT03493919|532289544|FG001|Overall Study|Lost to Follow-up|0|||
147654085|NCT03178851|532554689|FG000|Overall Study|Lost to Follow-up|5|||
147583110|NCT03493919|532289545|FG002|Overall Study|Lost to Follow-up|0|||
147583111|NCT03493919|532289546|FG003|Overall Study|Lost to Follow-up|3|||
147583112|NCT03493919|532289543|FG000|Overall Study|Adverse Event|0|||
147583113|NCT03493919|532289544|FG001|Overall Study|Adverse Event|1|||
147583114|NCT03493919|532289545|FG002|Overall Study|Adverse Event|0|||
147583115|NCT03493919|532289546|FG003|Overall Study|Adverse Event|0|||
147583116|NCT00724958|532289547|FG000|Overall Study|Adverse Event|28|||
147321907|NCT00994279|531341727|FG001|Overall Study|Multiple reasons|3|||
147583117|NCT00724958|532289547|FG000|Overall Study|Loss of Response|40|||
147583118|NCT00724958|532289547|FG000|Overall Study|No Response|18|||
147583119|NCT00724958|532289547|FG000|Overall Study|Remission|7|||
147583120|NCT00724958|532289547|FG000|Overall Study|Other Reason|76|||
147654086|NCT03178851|532554690|FG001|Overall Study|Lost to Follow-up|2|||
147654087|NCT03178851|532554691|FG002|Overall Study|Lost to Follow-up|0|||
147583121|NCT00724958|532289547|FG000|Overall Study|No documentation for end of therapy|13|||
147583122|NCT00965731|532289548|FG000|Overall Study|Death|0|||
147583123|NCT00965731|532289549|FG001|Overall Study|Death|4|||
147583124|NCT00965731|532289548|FG000|Overall Study|Withdrawal by Subject|0|||
147583125|NCT00965731|532289549|FG001|Overall Study|Withdrawal by Subject|1|||
147583126|NCT00965731|532289548|FG000|Overall Study|Other|7|||
147583127|NCT00965731|532289549|FG001|Overall Study|Other|15|||
147583128|NCT04773600|532289550|FG000|Overall Study|Withdrawal by Subject|15|||
147583129|NCT04773600|532289551|FG001|Overall Study|Withdrawal by Subject|9|||
147583130|NCT04773600|532289550|FG000|Overall Study|Lost to Follow-up|10|||
147583131|NCT04773600|532289551|FG001|Overall Study|Lost to Follow-up|6|||
147583132|NCT04773600|532289550|FG000|Overall Study|Adverse Event|8|||
147583133|NCT04773600|532289551|FG001|Overall Study|Adverse Event|2|||
147583134|NCT04773600|532289550|FG000|Overall Study|Lack of Efficacy|2|||
147583135|NCT04773600|532289551|FG001|Overall Study|Lack of Efficacy|3|||
147583136|NCT04773600|532289550|FG000|Overall Study|Noncompliance|2|||
147583137|NCT04773600|532289551|FG001|Overall Study|Noncompliance|0|||
147583138|NCT04773600|532289550|FG000|Overall Study|Protocol Violation|2|||
147583139|NCT04773600|532289551|FG001|Overall Study|Protocol Violation|0|||
147583140|NCT04773600|532289550|FG000|Overall Study|Physician Decision|0|||
147583141|NCT04773600|532289551|FG001|Overall Study|Physician Decision|1|||
147583142|NCT04773600|532289550|FG000|Overall Study|Caregiver Elected Other Therapy|1|||
147583143|NCT04773600|532289551|FG001|Overall Study|Caregiver Elected Other Therapy|0|||
147583144|NCT04773600|532289550|FG000|Overall Study|Emergency Travel Out of Country|1|||
147583145|NCT04773600|532289551|FG001|Overall Study|Emergency Travel Out of Country|0|||
147583146|NCT02129062|532291519|FG000|Overall Study|Death|1|||
147583147|NCT02129062|532291519|FG000|Overall Study|Disease Progression|2|||
147583148|NCT01841060|532291523|FG000|Overall Study|Protocol Violation|10|||
147583149|NCT01848210|532291524|FG000|Overall Study|Informed Consent Form Withdrawal|28|||
147583150|NCT01848210|532291525|FG001|Overall Study|Informed Consent Form Withdrawal|24|||
147583151|NCT01848210|532291524|FG000|Overall Study|Lost to Follow-up|24|||
147583152|NCT01848210|532291525|FG001|Overall Study|Lost to Follow-up|12|||
147583153|NCT01848210|532291524|FG000|Overall Study|Protocol Violation|3|||
147583154|NCT01848210|532291525|FG001|Overall Study|Protocol Violation|5|||
147583155|NCT01848210|532291524|FG000|Overall Study|Use of Forbidden Drugs|9|||
147583156|NCT01848210|532291525|FG001|Overall Study|Use of Forbidden Drugs|10|||
147583157|NCT01848210|532291524|FG000|Overall Study|Impedition Condition|5|||
147583158|NCT01848210|532291525|FG001|Overall Study|Impedition Condition|9|||
147583159|NCT01848210|532291524|FG000|Overall Study|Adverse Event|7|||
147583160|NCT01848210|532291525|FG001|Overall Study|Adverse Event|9|||
147583161|NCT01848210|532291524|FG000|Overall Study|Discontinuation Criterion|5|||
147583162|NCT01848210|532291525|FG001|Overall Study|Discontinuation Criterion|7|||
147583163|NCT01848210|532291524|FG000|Overall Study|Hypesensitivity|1|||
147583164|NCT01848210|532291525|FG001|Overall Study|Hypesensitivity|0|||
147583165|NCT01848210|532291524|FG000|Overall Study|Hepatic Function Alteration|4|||
147583166|NCT01848210|532291525|FG001|Overall Study|Hepatic Function Alteration|0|||
147583167|NCT01848210|532291524|FG000|Overall Study|Chronic Venous Insufficiency Course|1|||
147583168|NCT01848210|532291525|FG001|Overall Study|Chronic Venous Insufficiency Course|2|||
147583169|NCT01848210|532291524|FG000|Overall Study|Administrative|1|||
147583170|NCT01848210|532291525|FG001|Overall Study|Administrative|0|||
147583171|NCT04592419|532291526|FG000|Primary Study (Through Year 1)|Adverse Event|10|||
147583172|NCT04592419|532291527|FG001|Primary Study (Through Year 1)|Adverse Event|3|||
147583173|NCT04592419|532291526|FG000|Primary Study (Through Year 1)|Non-compliance with Study Schedule|0|||
147583174|NCT04592419|532291527|FG001|Primary Study (Through Year 1)|Non-compliance with Study Schedule|1|||
147583175|NCT04592419|532291526|FG000|Primary Study (Through Year 1)|Withdrawal by Subject|7|||
147583176|NCT04592419|532291527|FG001|Primary Study (Through Year 1)|Withdrawal by Subject|13|||
147583177|NCT04592419|532291526|FG000|Primary Study (Through Year 1)|Lost to Follow-up|5|||
147240434|NCT03724032|531051620|FG000|Overall Study|Protocol Violation|2|||
147240435|NCT03724032|531051621|FG001|Overall Study|Protocol Violation|2|||
147240436|NCT03724032|531051622|FG002|Overall Study|Protocol Violation|1|||
147240437|NCT00751933|531051623|FG000|Overall Study|Withdrawal by Subject|0|||
147240438|NCT00751933|531051624|FG001|Overall Study|Withdrawal by Subject|1|||
147583178|NCT04592419|532291527|FG001|Primary Study (Through Year 1)|Lost to Follow-up|5|||
147583179|NCT04592419|532291526|FG000|Primary Study (Through Year 1)|Progressive Disease|1|||
147583180|NCT04592419|532291527|FG001|Primary Study (Through Year 1)|Progressive Disease|1|||
147583181|NCT04592419|532291526|FG000|Primary Study (Through Year 1)|Sponsor Request|4|||
147583182|NCT04592419|532291527|FG001|Primary Study (Through Year 1)|Sponsor Request|5|||
147240439|NCT00751933|531051625|FG002|Overall Study|Withdrawal by Subject|0|||
147240440|NCT00751933|531051626|FG003|Overall Study|Withdrawal by Subject|0|||
147583183|NCT04592419|532291526|FG000|Primary Study (Through Year 1)|Participant left the country|2|||
147583184|NCT04592419|532291527|FG001|Primary Study (Through Year 1)|Participant left the country|0|||
147583185|NCT04592419|532291526|FG000|Primary Study (Through Year 1)|Participant moved to another city with no available site|0|||
147583186|NCT04592419|532291527|FG001|Primary Study (Through Year 1)|Participant moved to another city with no available site|1|||
147583187|NCT04592419|532291526|FG000|Open-Label Extension Period|Adverse Event|1|||
147240441|NCT00751933|531051623|FG000|Overall Study|Physician Decision|0|||
147240442|NCT00751933|531051624|FG001|Overall Study|Physician Decision|0|||
147240443|NCT00751933|531051625|FG002|Overall Study|Physician Decision|1|||
147240444|NCT00751933|531051626|FG003|Overall Study|Physician Decision|1|||
147240445|NCT01817530|531051628|FG000|Overall Study|Exclusionary Medication Received|0|||
147240446|NCT01817530|531051629|FG001|Overall Study|Exclusionary Medication Received|0|||
147240447|NCT01817530|531051630|FG002|Overall Study|Exclusionary Medication Received|0|||
147240448|NCT01817530|531051631|FG003|Overall Study|Exclusionary Medication Received|0|||
147240449|NCT01817530|531051632|FG004|Overall Study|Exclusionary Medication Received|1|||
147240450|NCT01817530|531051633|FG005|Overall Study|Exclusionary Medication Received|0|||
147240451|NCT01817530|531051634|FG006|Overall Study|Exclusionary Medication Received|0|||
147240452|NCT01817530|531051635|FG007|Overall Study|Exclusionary Medication Received|0|||
147240453|NCT01817530|531051628|FG000|Overall Study|Adverse Event|6|||
147240454|NCT01817530|531051629|FG001|Overall Study|Adverse Event|3|||
147240455|NCT01817530|531051630|FG002|Overall Study|Adverse Event|2|||
147240456|NCT01817530|531051631|FG003|Overall Study|Adverse Event|5|||
147240457|NCT01817530|531051632|FG004|Overall Study|Adverse Event|0|||
147583188|NCT04592419|532291527|FG001|Open-Label Extension Period|Adverse Event|2|||
147583189|NCT04592419|532291526|FG000|Open-Label Extension Period|Non-compliance with Study Schedule|1|||
147583190|NCT04592419|532291527|FG001|Open-Label Extension Period|Non-compliance with Study Schedule|0|||
147583191|NCT04592419|532291526|FG000|Open-Label Extension Period|Withdrawal by Subject|5|||
147583192|NCT04592419|532291527|FG001|Open-Label Extension Period|Withdrawal by Subject|7|||
147583193|NCT04592419|532291526|FG000|Open-Label Extension Period|Lost to Follow-up|1|||
147583194|NCT04592419|532291527|FG001|Open-Label Extension Period|Lost to Follow-up|5|||
147583195|NCT04592419|532291526|FG000|Open-Label Extension Period|Sponsor Request|73|||
147583196|NCT04592419|532291527|FG001|Open-Label Extension Period|Sponsor Request|84|||
147583197|NCT04501094|532291528|FG000|Overall Study|Death (unrelated to research)|1|||
147583198|NCT04501094|532291529|FG001|Overall Study|Death (unrelated to research)|0|||
147583199|NCT00685035|532291534|FG000|Period 1: First Intervention: 30 Minutes|Pulmonary lab plethysmography malfunctio|1|||
147583200|NCT00685035|532291535|FG001|Period 1: First Intervention: 30 Minutes|Pulmonary lab plethysmography malfunctio|0|||
147583201|NCT00784979|532291536|FG000|Overall Study|incomplete data|6|||
147583202|NCT00894933|532291537|FG000|Overall Study|Lost to Follow-up|2|||
147583203|NCT00894933|532291537|FG000|Overall Study|Cancelled Procedure|1|||
147583204|NCT00894933|532291537|FG000|Overall Study|Did not meeting incl/excl criteria|1|||
147583205|NCT00631007|532291542|FG000|Overall Study|Adverse Event|0|||
147583206|NCT00631007|532291543|FG001|Overall Study|Adverse Event|2|||
147583207|NCT00631007|532291544|FG002|Overall Study|Adverse Event|0|||
147583208|NCT00631007|532291545|FG003|Overall Study|Adverse Event|2|||
147583209|NCT00631007|532291546|FG004|Overall Study|Adverse Event|3|||
147583210|NCT00631007|532291547|FG005|Overall Study|Adverse Event|2|||
147583211|NCT00631007|532291542|FG000|Overall Study|Lost to Follow-up|2|||
147583212|NCT00631007|532291543|FG001|Overall Study|Lost to Follow-up|1|||
147583213|NCT00631007|532291544|FG002|Overall Study|Lost to Follow-up|2|||
147583214|NCT00631007|532291545|FG003|Overall Study|Lost to Follow-up|4|||
147583215|NCT00631007|532291546|FG004|Overall Study|Lost to Follow-up|5|||
147583216|NCT00631007|532291547|FG005|Overall Study|Lost to Follow-up|3|||
147583217|NCT00631007|532291542|FG000|Overall Study|Physician Decision|1|||
147583218|NCT00631007|532291543|FG001|Overall Study|Physician Decision|0|||
147583219|NCT00631007|532291544|FG002|Overall Study|Physician Decision|1|||
147583220|NCT00631007|532291545|FG003|Overall Study|Physician Decision|0|||
147583221|NCT00631007|532291546|FG004|Overall Study|Physician Decision|0|||
147583222|NCT00631007|532291547|FG005|Overall Study|Physician Decision|2|||
147583223|NCT00631007|532291542|FG000|Overall Study|Persistent Hyperglycemia|2|||
147583224|NCT00631007|532291543|FG001|Overall Study|Persistent Hyperglycemia|2|||
147583225|NCT00631007|532291544|FG002|Overall Study|Persistent Hyperglycemia|5|||
147583226|NCT00631007|532291545|FG003|Overall Study|Persistent Hyperglycemia|1|||
147583227|NCT00631007|532291546|FG004|Overall Study|Persistent Hyperglycemia|2|||
147583228|NCT00631007|532291547|FG005|Overall Study|Persistent Hyperglycemia|5|||
147583229|NCT00631007|532291542|FG000|Overall Study|Withdrawal by Subject|4|||
147240458|NCT01817530|531051633|FG005|Overall Study|Adverse Event|10|||
147240459|NCT01817530|531051634|FG006|Overall Study|Adverse Event|5|||
147240460|NCT01817530|531051635|FG007|Overall Study|Adverse Event|8|||
147240461|NCT01817530|531051628|FG000|Overall Study|Subject Noncompliant|3|||
147240462|NCT01817530|531051629|FG001|Overall Study|Subject Noncompliant|1|||
147240463|NCT01817530|531051630|FG002|Overall Study|Subject Noncompliant|0|||
147583230|NCT00631007|532291543|FG001|Overall Study|Withdrawal by Subject|5|||
147583231|NCT00631007|532291544|FG002|Overall Study|Withdrawal by Subject|2|||
147240464|NCT01817530|531051631|FG003|Overall Study|Subject Noncompliant|4|||
147240465|NCT01817530|531051632|FG004|Overall Study|Subject Noncompliant|0|||
147240466|NCT01817530|531051633|FG005|Overall Study|Subject Noncompliant|1|||
147583232|NCT00631007|532291545|FG003|Overall Study|Withdrawal by Subject|2|||
147583233|NCT00631007|532291546|FG004|Overall Study|Withdrawal by Subject|1|||
147583234|NCT00631007|532291547|FG005|Overall Study|Withdrawal by Subject|3|||
147583235|NCT00631007|532291542|FG000|Overall Study|Other|2|||
147583236|NCT00631007|532291543|FG001|Overall Study|Other|1|||
147583237|NCT00631007|532291544|FG002|Overall Study|Other|0|||
147583238|NCT00631007|532291545|FG003|Overall Study|Other|0|||
147583239|NCT00631007|532291546|FG004|Overall Study|Other|1|||
147583240|NCT00631007|532291547|FG005|Overall Study|Other|0|||
147583241|NCT00683787|532291548|FG000|Overall Study|Progression|3|||
147583242|NCT00683787|532291549|FG001|Overall Study|Progression|3|||
147583243|NCT00683787|532291550|FG002|Overall Study|Progression|0|||
147583244|NCT00683787|532291548|FG000|Overall Study|Adverse Event|0|||
147583245|NCT00683787|532291549|FG001|Overall Study|Adverse Event|0|||
147583246|NCT00683787|532291550|FG002|Overall Study|Adverse Event|2|||
147583247|NCT02674633|532291551|FG000|Overall Study|Lost to Follow-up|3|||
147583248|NCT02674633|532291552|FG001|Overall Study|Lost to Follow-up|2|||
147583249|NCT02674633|532291551|FG000|Overall Study|Physician Decision|1|||
147583250|NCT02674633|532291552|FG001|Overall Study|Physician Decision|0|||
147583251|NCT02674633|532291551|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
147583252|NCT02674633|532291552|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
147583253|NCT00460109|532291553|FG000|Overall Study|Death|1|||
147583254|NCT01235715|532291554|FG000|Overall Study|Physician Decision|0|||
147583255|NCT01235715|532291555|FG001|Overall Study|Physician Decision|2|||
147583256|NCT03619876|532291556|FG000|Overall Study|Withdrawal by Subject|1|||
147583257|NCT03619876|532291557|FG001|Overall Study|Withdrawal by Subject|2|||
147583258|NCT03619876|532291556|FG000|Overall Study|Withdrawal due to incidental finding|0|||
147583259|NCT03619876|532291557|FG001|Overall Study|Withdrawal due to incidental finding|2|||
147583260|NCT02344745|532291558|FG000|Overall Study|Data collection sheets were lost|2|||
147583261|NCT02344745|532291559|FG001|Overall Study|Data collection sheets were lost|0|||
147583262|NCT02788513|532291560|FG000|Overall Study|Withdrawal by Subject|3|||
147583263|NCT02788513|532291561|FG001|Overall Study|Withdrawal by Subject|0|||
147583264|NCT02788513|532291562|FG002|Overall Study|Withdrawal by Subject|2|||
147583265|NCT02788513|532291563|FG003|Overall Study|Withdrawal by Subject|3|||
147583266|NCT02788513|532291564|FG004|Overall Study|Withdrawal by Subject|1|||
147583267|NCT02788513|532291560|FG000|Overall Study|Lost to Follow-up|1|||
147583268|NCT02788513|532291561|FG001|Overall Study|Lost to Follow-up|0|||
147583269|NCT02788513|532291562|FG002|Overall Study|Lost to Follow-up|0|||
147583270|NCT02788513|532291563|FG003|Overall Study|Lost to Follow-up|0|||
147583271|NCT02788513|532291564|FG004|Overall Study|Lost to Follow-up|1|||
147583272|NCT02788513|532291560|FG000|Overall Study|Adverse Event|5|||
147583273|NCT02788513|532291561|FG001|Overall Study|Adverse Event|8|||
147583274|NCT02788513|532291562|FG002|Overall Study|Adverse Event|4|||
147583275|NCT02788513|532291563|FG003|Overall Study|Adverse Event|2|||
147583276|NCT02788513|532291564|FG004|Overall Study|Adverse Event|2|||
147583277|NCT02788513|532291560|FG000|Overall Study|Protocol Violation|0|||
147583278|NCT02788513|532291561|FG001|Overall Study|Protocol Violation|0|||
147583279|NCT02788513|532291562|FG002|Overall Study|Protocol Violation|1|||
147583280|NCT02788513|532291563|FG003|Overall Study|Protocol Violation|1|||
147583281|NCT02788513|532291564|FG004|Overall Study|Protocol Violation|0|||
147583282|NCT02788513|532291560|FG000|Overall Study|Subject decided to stop taking treatment|0|||
147583283|NCT02788513|532291561|FG001|Overall Study|Subject decided to stop taking treatment|0|||
147583284|NCT02788513|532291562|FG002|Overall Study|Subject decided to stop taking treatment|1|||
147583285|NCT02788513|532291563|FG003|Overall Study|Subject decided to stop taking treatment|0|||
147583286|NCT02788513|532291564|FG004|Overall Study|Subject decided to stop taking treatment|0|||
147583287|NCT02788513|532291560|FG000|Overall Study|Decision by the study team|0|||
147583288|NCT02788513|532291561|FG001|Overall Study|Decision by the study team|0|||
147583289|NCT02788513|532291562|FG002|Overall Study|Decision by the study team|0|||
147583290|NCT02788513|532291563|FG003|Overall Study|Decision by the study team|0|||
147583291|NCT02788513|532291564|FG004|Overall Study|Decision by the study team|1|||
147583292|NCT04982445|532291565|FG000|Overall Study|Protocol Violation|1|||
147583293|NCT04982445|532291565|FG000|Overall Study|Withdrawal by Subject|4|||
147583294|NCT04982445|532291565|FG000|Overall Study|Lost to Follow-up|1|||
147583295|NCT04968925|532291568|FG000|Phase I- Period 1|COVID-19 related|0|||
147583296|NCT04968925|532291569|FG001|Phase I- Period 1|COVID-19 related|1|||
147583297|NCT04968925|532291570|FG002|Phase I- Period 1|COVID-19 related|0|||
147583298|NCT04968925|532291571|FG003|Phase I- Period 1|COVID-19 related|0|||
147583299|NCT04968925|532291568|FG000|Phase I- Period 1|Subject enrolled in error|1|||
147583300|NCT04968925|532291569|FG001|Phase I- Period 1|Subject enrolled in error|1|||
147583301|NCT04968925|532291570|FG002|Phase I- Period 1|Subject enrolled in error|0|||
147583302|NCT04968925|532291571|FG003|Phase I- Period 1|Subject enrolled in error|0|||
147583303|NCT04968925|532291568|FG000|Phase II- Period 1|COVID-19 Related|0|||
147583304|NCT04968925|532291569|FG001|Phase II- Period 1|COVID-19 Related|0|||
147583305|NCT04968925|532291570|FG002|Phase II- Period 1|COVID-19 Related|6|||
147583306|NCT04968925|532291571|FG003|Phase II- Period 1|COVID-19 Related|6|||
147583307|NCT04968925|532291568|FG000|Phase II- Period 1|Subject enrolled in error|0|||
147583308|NCT04968925|532291569|FG001|Phase II- Period 1|Subject enrolled in error|0|||
147583309|NCT04968925|532291570|FG002|Phase II- Period 1|Subject enrolled in error|1|||
147583310|NCT04968925|532291571|FG003|Phase II- Period 1|Subject enrolled in error|0|||
147583311|NCT04968925|532291568|FG000|Phase II -Period 2|COVID-19 related|0|||
147583312|NCT04968925|532291569|FG001|Phase II -Period 2|COVID-19 related|0|||
147583313|NCT04968925|532291570|FG002|Phase II -Period 2|COVID-19 related|4|||
147583314|NCT04968925|532291571|FG003|Phase II -Period 2|COVID-19 related|3|||
147583315|NCT04968925|532291568|FG000|Phase II -Period 2|Incorrectly dispensed|0|||
147583316|NCT04968925|532291569|FG001|Phase II -Period 2|Incorrectly dispensed|0|||
147583317|NCT04968925|532291570|FG002|Phase II -Period 2|Incorrectly dispensed|0|||
147583318|NCT04968925|532291571|FG003|Phase II -Period 2|Incorrectly dispensed|1|||
147583319|NCT00835796|532291573|FG000|First Intervention|Withdrawal by Subject|0|||
147583320|NCT00835796|532291574|FG001|First Intervention|Withdrawal by Subject|1|||
147583321|NCT02327325|532291575|FG000|Overall Study|Withdrawal by Subject|1|||
147583322|NCT02327325|532291576|FG001|Overall Study|Withdrawal by Subject|4|||
147583323|NCT02327325|532291577|FG002|Overall Study|Withdrawal by Subject|4|||
147583324|NCT02327325|532291575|FG000|Overall Study|Excluded by Study Team|0|||
147583325|NCT02327325|532291576|FG001|Overall Study|Excluded by Study Team|0|||
147583326|NCT02327325|532291577|FG002|Overall Study|Excluded by Study Team|1|||
147583327|NCT02457819|532291578|FG000|Overall Study|reason not given|8|||
147583328|NCT02457819|532291578|FG000|Overall Study|Withdrawal by Subject|24|||
147583329|NCT02457819|532291578|FG000|Overall Study|Protocol Violation|1|||
147583330|NCT02457819|532291578|FG000|Overall Study|non compliance with study drug|4|||
147583331|NCT02457819|532291578|FG000|Overall Study|Lost to Follow-up|10|||
147583332|NCT02457819|532291578|FG000|Overall Study|Lack of Efficacy|19|||
147583333|NCT02457819|532291578|FG000|Overall Study|Adverse Event|33|||
147583334|NCT01933919|532291579|FG000|Double-blind Placebo-controlled Phase|Adverse Event|0|||
147583335|NCT01933919|532291580|FG001|Double-blind Placebo-controlled Phase|Adverse Event|1|||
147583336|NCT01933919|532291579|FG000|Double-blind Placebo-controlled Phase|Withdrawal by Subject|0|||
147583337|NCT01933919|532291580|FG001|Double-blind Placebo-controlled Phase|Withdrawal by Subject|1|||
147583338|NCT01933919|532291579|FG000|Double-blind Placebo-controlled Phase|Lack of Efficacy|0|||
147583339|NCT01933919|532291580|FG001|Double-blind Placebo-controlled Phase|Lack of Efficacy|2|||
147583340|NCT01933919|532291579|FG000|Open-label Long-term Phase|Adverse Event|2|||
147583341|NCT01933919|532291580|FG001|Open-label Long-term Phase|Adverse Event|0|||
147583342|NCT01933919|532291579|FG000|Open-label Long-term Phase|Withdrawal by Subject|3|||
147583343|NCT01933919|532291580|FG001|Open-label Long-term Phase|Withdrawal by Subject|4|||
147583344|NCT01933919|532291579|FG000|Open-label Long-term Phase|Lost to Follow-up|1|||
147583345|NCT01933919|532291580|FG001|Open-label Long-term Phase|Lost to Follow-up|0|||
147583346|NCT01933919|532291579|FG000|Open-label Long-term Phase|Other|1|||
147583347|NCT01933919|532291580|FG001|Open-label Long-term Phase|Other|2|||
147583348|NCT00763555|532291581|FG000|Overall Study|Adverse Event|2|||
147583349|NCT00763555|532291582|FG001|Overall Study|Adverse Event|1|||
147583350|NCT00763555|532291581|FG000|Overall Study|Withdrawal by Subject|2|||
147583351|NCT00763555|532291582|FG001|Overall Study|Withdrawal by Subject|6|||
147583352|NCT00763555|532291581|FG000|Overall Study|Lost to Follow-up|0|||
147583353|NCT00763555|532291582|FG001|Overall Study|Lost to Follow-up|3|||
147583354|NCT00177164|532291585|FG000|Overall Study|Protocol Violation|0|||
147583355|NCT00177164|532291586|FG001|Overall Study|Protocol Violation|7|||
147583356|NCT00177164|532291585|FG000|Overall Study|Lost to Follow-up|4|||
147583357|NCT00177164|532291586|FG001|Overall Study|Lost to Follow-up|5|||
147583358|NCT00177164|532291585|FG000|Overall Study|increase in alcohol and drug use|1|||
147583359|NCT00177164|532291586|FG001|Overall Study|increase in alcohol and drug use|2|||
147583360|NCT00177164|532291585|FG000|Overall Study|Adverse Event|1|||
147583361|NCT00177164|532291586|FG001|Overall Study|Adverse Event|0|||
147583362|NCT00177164|532291585|FG000|Overall Study|discharge from hospital|1|||
147583363|NCT00177164|532291586|FG001|Overall Study|discharge from hospital|0|||
147583364|NCT00177164|532291585|FG000|Overall Study|Lack of Efficacy|2|||
147583365|NCT00177164|532291586|FG001|Overall Study|Lack of Efficacy|1|||
147583366|NCT00177164|532291585|FG000|Overall Study|Pregnancy|0|||
147583367|NCT00177164|532291586|FG001|Overall Study|Pregnancy|1|||
147583368|NCT01344018|532291592|FG000|Overall Study|Death|22|||
147583369|NCT01344018|532291593|FG001|Overall Study|Death|25|||
147583370|NCT01344018|532291592|FG000|Overall Study|Lost to Follow-up|4|||
147583371|NCT01344018|532291593|FG001|Overall Study|Lost to Follow-up|7|||
147583372|NCT05070754|532291594|FG000|Overall Study|Withdrawal by Subject|0|||
147583373|NCT05070754|532291595|FG001|Overall Study|Withdrawal by Subject|0|||
147583374|NCT05070754|532291596|FG002|Overall Study|Withdrawal by Subject|0|||
147583375|NCT05070754|532291597|FG003|Overall Study|Withdrawal by Subject|1|||
147583376|NCT05070754|532291594|FG000|Overall Study|Protocol Violation|0|||
147583377|NCT05070754|532291595|FG001|Overall Study|Protocol Violation|0|||
147583378|NCT05070754|532291596|FG002|Overall Study|Protocol Violation|0|||
147583379|NCT05070754|532291597|FG003|Overall Study|Protocol Violation|1|||
147583380|NCT00194792|532291598|FG000|Overall Study|Withdrawal by Subject|1|||
147583381|NCT02340962|532291600|FG000|Overall Study|Lost to Follow-up|1|||
147583382|NCT02340962|532291601|FG001|Overall Study|Lost to Follow-up|0|||
147583383|NCT00434837|532291602|FG000|Overall Study|Lost to Follow-up|20|||
147583384|NCT00434837|532291603|FG001|Overall Study|Lost to Follow-up|23|||
147583385|NCT00434837|532291604|FG002|Overall Study|Lost to Follow-up|30|||
147583386|NCT00726895|532291605|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
147583387|NCT00726895|532291606|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
147583388|NCT01266603|532291609|FG000|Overall Study|Adverse Event|1|||
147583389|NCT01266603|532291609|FG000|Overall Study|Lack of Efficacy|14|||
147240467|NCT01817530|531051634|FG006|Overall Study|Subject Noncompliant|1|||
147240468|NCT01817530|531051635|FG007|Overall Study|Subject Noncompliant|1|||
147240469|NCT01817530|531051628|FG000|Overall Study|Lack of Efficacy|1|||
147240470|NCT01817530|531051629|FG001|Overall Study|Lack of Efficacy|0|||
147240471|NCT01817530|531051630|FG002|Overall Study|Lack of Efficacy|0|||
147240472|NCT01817530|531051631|FG003|Overall Study|Lack of Efficacy|0|||
147240473|NCT01817530|531051632|FG004|Overall Study|Lack of Efficacy|0|||
147240474|NCT01817530|531051633|FG005|Overall Study|Lack of Efficacy|1|||
147240475|NCT01817530|531051634|FG006|Overall Study|Lack of Efficacy|0|||
147240476|NCT01817530|531051635|FG007|Overall Study|Lack of Efficacy|1|||
147240477|NCT01817530|531051628|FG000|Overall Study|Pregnancy|0|||
147240478|NCT01817530|531051629|FG001|Overall Study|Pregnancy|0|||
147240479|NCT01817530|531051630|FG002|Overall Study|Pregnancy|0|||
147240480|NCT01817530|531051631|FG003|Overall Study|Pregnancy|0|||
147240481|NCT01817530|531051632|FG004|Overall Study|Pregnancy|0|||
147240482|NCT01817530|531051633|FG005|Overall Study|Pregnancy|1|||
147240483|NCT01817530|531051634|FG006|Overall Study|Pregnancy|0|||
147153584|NCT01866111|530724310|FG000|Double-blind Period of Study YKP3089C017|Lost to Follow-up|0|||
147153585|NCT01866111|530724311|FG001|Double-blind Period of Study YKP3089C017|Lost to Follow-up|0|||
147153586|NCT01866111|530724312|FG002|Double-blind Period of Study YKP3089C017|Lost to Follow-up|0|||
147153587|NCT01866111|530724313|FG003|Double-blind Period of Study YKP3089C017|Lost to Follow-up|1|||
147153588|NCT01866111|530724310|FG000|Double-blind Period of Study YKP3089C017|Pregnancy|1|||
147153589|NCT01866111|530724311|FG001|Double-blind Period of Study YKP3089C017|Pregnancy|0|||
147153590|NCT01866111|530724312|FG002|Double-blind Period of Study YKP3089C017|Pregnancy|0|||
147153591|NCT01866111|530724313|FG003|Double-blind Period of Study YKP3089C017|Pregnancy|0|||
147153592|NCT01866111|530724310|FG000|Double-blind Period of Study YKP3089C017|Reason Unknown|3|||
147153593|NCT01866111|530724311|FG001|Double-blind Period of Study YKP3089C017|Reason Unknown|0|||
147153594|NCT01866111|530724312|FG002|Double-blind Period of Study YKP3089C017|Reason Unknown|0|||
147153595|NCT01866111|530724313|FG003|Double-blind Period of Study YKP3089C017|Reason Unknown|1|||
147153596|NCT01866111|530724310|FG000|Open-label Extension Study YKP3089C017|Adverse Event|9|||
147153597|NCT01866111|530724311|FG001|Open-label Extension Study YKP3089C017|Adverse Event|6|||
147153598|NCT01866111|530724312|FG002|Open-label Extension Study YKP3089C017|Adverse Event|6|||
147153599|NCT01866111|530724313|FG003|Open-label Extension Study YKP3089C017|Adverse Event|7|||
147153600|NCT01866111|530724310|FG000|Open-label Extension Study YKP3089C017|Withdrawal by Subject|16|||
147153601|NCT01866111|530724311|FG001|Open-label Extension Study YKP3089C017|Withdrawal by Subject|7|||
147153602|NCT01866111|530724312|FG002|Open-label Extension Study YKP3089C017|Withdrawal by Subject|9|||
147153603|NCT01866111|530724313|FG003|Open-label Extension Study YKP3089C017|Withdrawal by Subject|3|||
147153604|NCT01866111|530724310|FG000|Open-label Extension Study YKP3089C017|Protocol Violation|1|||
147153605|NCT01866111|530724311|FG001|Open-label Extension Study YKP3089C017|Protocol Violation|0|||
147153606|NCT01866111|530724312|FG002|Open-label Extension Study YKP3089C017|Protocol Violation|0|||
147153607|NCT01866111|530724313|FG003|Open-label Extension Study YKP3089C017|Protocol Violation|2|||
147153608|NCT01866111|530724310|FG000|Open-label Extension Study YKP3089C017|Lost to Follow-up|2|||
147153609|NCT01866111|530724311|FG001|Open-label Extension Study YKP3089C017|Lost to Follow-up|1|||
147153610|NCT01866111|530724312|FG002|Open-label Extension Study YKP3089C017|Lost to Follow-up|1|||
147153611|NCT01866111|530724313|FG003|Open-label Extension Study YKP3089C017|Lost to Follow-up|3|||
147153612|NCT01866111|530724310|FG000|Open-label Extension Study YKP3089C017|Death|1|||
147153613|NCT01866111|530724311|FG001|Open-label Extension Study YKP3089C017|Death|1|||
147153614|NCT01866111|530724312|FG002|Open-label Extension Study YKP3089C017|Death|3|||
147153615|NCT01866111|530724313|FG003|Open-label Extension Study YKP3089C017|Death|2|||
147153616|NCT01866111|530724310|FG000|Open-label Extension Study YKP3089C017|Entered Expanded Access Program|30|||
147153617|NCT01866111|530724311|FG001|Open-label Extension Study YKP3089C017|Entered Expanded Access Program|39|||
147153618|NCT01866111|530724312|FG002|Open-label Extension Study YKP3089C017|Entered Expanded Access Program|28|||
147153619|NCT01866111|530724313|FG003|Open-label Extension Study YKP3089C017|Entered Expanded Access Program|32|||
147153620|NCT01866111|530724310|FG000|Open-label Extension Study YKP3089C017|Lack of Efficacy|13|||
147240484|NCT01817530|531051635|FG007|Overall Study|Pregnancy|0|||
147240485|NCT01817530|531051628|FG000|Overall Study|Other|0|||
147240486|NCT01817530|531051629|FG001|Overall Study|Other|1|||
147240487|NCT01817530|531051630|FG002|Overall Study|Other|0|||
147240488|NCT01817530|531051631|FG003|Overall Study|Other|0|||
147240489|NCT01817530|531051632|FG004|Overall Study|Other|1|||
147153621|NCT01866111|530724311|FG001|Open-label Extension Study YKP3089C017|Lack of Efficacy|17|||
147153622|NCT01866111|530724312|FG002|Open-label Extension Study YKP3089C017|Lack of Efficacy|23|||
147240490|NCT01817530|531051633|FG005|Overall Study|Other|0|||
147240491|NCT01817530|531051634|FG006|Overall Study|Other|5|||
147446805|NCT01732796|531800307|FG001|Overall Study|Lack of Efficacy|18|||
147446806|NCT01732796|531800308|FG002|Overall Study|Lack of Efficacy|5|||
147240492|NCT01817530|531051635|FG007|Overall Study|Other|0|||
147240493|NCT01817530|531051628|FG000|Overall Study|Surgery or Invasive Intervention|1|||
147446807|NCT01732796|531800306|FG000|Overall Study|Lost to Follow-up|2|||
147240494|NCT01817530|531051629|FG001|Overall Study|Surgery or Invasive Intervention|0|||
147240495|NCT01817530|531051630|FG002|Overall Study|Surgery or Invasive Intervention|0|||
147153623|NCT01866111|530724313|FG003|Open-label Extension Study YKP3089C017|Lack of Efficacy|14|||
147153624|NCT01866111|530724310|FG000|Open-label Extension Study YKP3089C017|Reason Unknown|3|||
147153625|NCT01866111|530724311|FG001|Open-label Extension Study YKP3089C017|Reason Unknown|3|||
147153626|NCT01866111|530724312|FG002|Open-label Extension Study YKP3089C017|Reason Unknown|1|||
147153627|NCT01866111|530724313|FG003|Open-label Extension Study YKP3089C017|Reason Unknown|3|||
147153628|NCT00157196|530724314|FG000|Overall Study|Ongoing at data cut-off|9|||
147153629|NCT01252186|530724315|FG000|Overall Study|Adverse Event|9|||
147153630|NCT01252186|530724316|FG001|Overall Study|Adverse Event|6|||
147153631|NCT01252186|530724317|FG002|Overall Study|Adverse Event|8|||
147153632|NCT01252186|530724315|FG000|Overall Study|Withdrawal by Subject|2|||
147153633|NCT01252186|530724316|FG001|Overall Study|Withdrawal by Subject|5|||
147153634|NCT01252186|530724317|FG002|Overall Study|Withdrawal by Subject|2|||
147153635|NCT01252186|530724315|FG000|Overall Study|Physician Decision|0|||
147153636|NCT01252186|530724316|FG001|Overall Study|Physician Decision|0|||
147153637|NCT01252186|530724317|FG002|Overall Study|Physician Decision|1|||
147153638|NCT01252186|530724315|FG000|Overall Study|Non-compliance|0|||
147153639|NCT01252186|530724316|FG001|Overall Study|Non-compliance|3|||
147153640|NCT01252186|530724317|FG002|Overall Study|Non-compliance|4|||
147153641|NCT01252186|530724315|FG000|Overall Study|Protocol Violation|0|||
147153642|NCT01252186|530724316|FG001|Overall Study|Protocol Violation|0|||
147153643|NCT01252186|530724317|FG002|Overall Study|Protocol Violation|1|||
147153644|NCT01252186|530724315|FG000|Overall Study|Pregnancy|2|||
147153645|NCT01252186|530724316|FG001|Overall Study|Pregnancy|2|||
147153646|NCT01252186|530724317|FG002|Overall Study|Pregnancy|0|||
147153647|NCT01252186|530724315|FG000|Overall Study|Sponsor Request|2|||
147153648|NCT01252186|530724316|FG001|Overall Study|Sponsor Request|1|||
147153649|NCT01252186|530724317|FG002|Overall Study|Sponsor Request|0|||
147153650|NCT01252186|530724315|FG000|Overall Study|Lost to Follow-up|10|||
147153651|NCT01252186|530724316|FG001|Overall Study|Lost to Follow-up|10|||
147153652|NCT01252186|530724317|FG002|Overall Study|Lost to Follow-up|11|||
147153653|NCT01252186|530724315|FG000|Overall Study|Other - Miscellaneous Reasons|5|||
147153654|NCT01252186|530724316|FG001|Overall Study|Other - Miscellaneous Reasons|5|||
147153655|NCT01252186|530724317|FG002|Overall Study|Other - Miscellaneous Reasons|7|||
147153656|NCT02791516|530724318|FG000|Overall Study|Withdrawal by Subject|1|||
147153657|NCT02791516|530724319|FG001|Overall Study|Withdrawal by Subject|1|||
147153658|NCT01439971|530724320|FG000|Overall Study|Required number in cohort dosed|0|||
147153659|NCT01439971|530724321|FG001|Overall Study|Required number in cohort dosed|1|||
147153660|NCT01439971|530724322|FG002|Overall Study|Required number in cohort dosed|2|||
147153661|NCT01439971|530724323|FG003|Overall Study|Required number in cohort dosed|0|||
147153662|NCT01439971|530724324|FG004|Overall Study|Required number in cohort dosed|1|||
147153663|NCT02628600|530724325|FG000|Overall Study|Death|2|||
147153664|NCT02628600|530724326|FG001|Overall Study|Death|1|||
147153665|NCT02628600|530724325|FG000|Overall Study|Adverse Event|3|||
147153666|NCT02628600|530724326|FG001|Overall Study|Adverse Event|20|||
147153667|NCT02628600|530724325|FG000|Overall Study|Protocol Violation|0|||
147153668|NCT02628600|530724326|FG001|Overall Study|Protocol Violation|1|||
147153669|NCT02628600|530724325|FG000|Overall Study|Lack of Efficacy|2|||
147153670|NCT02628600|530724326|FG001|Overall Study|Lack of Efficacy|0|||
147153671|NCT02628600|530724325|FG000|Overall Study|Withdrawal by Subject|13|||
147153672|NCT02628600|530724326|FG001|Overall Study|Withdrawal by Subject|8|||
147153673|NCT02628600|530724325|FG000|Overall Study|Lost to Follow-up|1|||
147240496|NCT01817530|531051631|FG003|Overall Study|Surgery or Invasive Intervention|0|||
147240497|NCT01817530|531051632|FG004|Overall Study|Surgery or Invasive Intervention|1|||
147240498|NCT01817530|531051633|FG005|Overall Study|Surgery or Invasive Intervention|1|||
147240499|NCT01817530|531051634|FG006|Overall Study|Surgery or Invasive Intervention|1|||
147240500|NCT01817530|531051635|FG007|Overall Study|Surgery or Invasive Intervention|0|||
147240501|NCT01817530|531051628|FG000|Overall Study|Consent Withdrawn by Subject|3|||
147240502|NCT01817530|531051629|FG001|Overall Study|Consent Withdrawn by Subject|4|||
147240503|NCT01817530|531051630|FG002|Overall Study|Consent Withdrawn by Subject|7|||
147583390|NCT01266603|532291609|FG000|Overall Study|Withdrawal by Subject|1|||
147583391|NCT01266603|532291609|FG000|Overall Study|Failed screening; MAGE-A3 negative|26|||
147583392|NCT02725411|532291610|FG000|Treatment Period (56 Weeks)|Adverse Event|3|||
147153674|NCT02628600|530724326|FG001|Overall Study|Lost to Follow-up|0|||
147153675|NCT02628600|530724325|FG000|Overall Study|Physician Decision|2|||
147153676|NCT02628600|530724326|FG001|Overall Study|Physician Decision|2|||
147153677|NCT02628600|530724325|FG000|Overall Study|Other not specified|1|||
147153678|NCT02628600|530724326|FG001|Overall Study|Other not specified|0|||
147153679|NCT04283994|530724328|FG000|Overall Study|Death|11|||
147153680|NCT04283994|530724329|FG001|Overall Study|Death|20|||
147153681|NCT04283994|530724330|FG002|Overall Study|Death|11|||
147153682|NCT04283994|530724331|FG003|Overall Study|Death|0|||
147240504|NCT01817530|531051631|FG003|Overall Study|Consent Withdrawn by Subject|3|||
147153683|NCT04283994|530724332|FG004|Overall Study|Death|0|||
147153684|NCT04283994|530724333|FG005|Overall Study|Death|0|||
147153685|NCT04283994|530724334|FG006|Overall Study|Death|0|||
147153686|NCT04283994|530724328|FG000|Overall Study|Withdrawal by Subject|16|||
147240505|NCT01817530|531051632|FG004|Overall Study|Consent Withdrawn by Subject|5|||
147240506|NCT01817530|531051633|FG005|Overall Study|Consent Withdrawn by Subject|3|||
147240507|NCT01817530|531051634|FG006|Overall Study|Consent Withdrawn by Subject|3|||
147240508|NCT01817530|531051635|FG007|Overall Study|Consent Withdrawn by Subject|10|||
147240509|NCT01817530|531051628|FG000|Overall Study|Lost to Follow-up|1|||
147240510|NCT01817530|531051629|FG001|Overall Study|Lost to Follow-up|4|||
147153687|NCT04283994|530724329|FG001|Overall Study|Withdrawal by Subject|4|||
147153688|NCT04283994|530724330|FG002|Overall Study|Withdrawal by Subject|6|||
147153689|NCT04283994|530724331|FG003|Overall Study|Withdrawal by Subject|1|||
147153690|NCT04283994|530724332|FG004|Overall Study|Withdrawal by Subject|0|||
147153691|NCT04283994|530724333|FG005|Overall Study|Withdrawal by Subject|1|||
147153692|NCT04283994|530724334|FG006|Overall Study|Withdrawal by Subject|0|||
147153693|NCT02578680|530725440|FG000|Overall Study|Death|329|||
147153694|NCT02578680|530725441|FG001|Overall Study|Death|181|||
147153695|NCT02578680|530725440|FG000|Overall Study|Lost to Follow-up|3|||
147153696|NCT02578680|530725441|FG001|Overall Study|Lost to Follow-up|1|||
147153697|NCT02578680|530725440|FG000|Overall Study|Physician Decision|0|||
147153698|NCT02578680|530725441|FG001|Overall Study|Physician Decision|1|||
147153699|NCT02578680|530725440|FG000|Overall Study|Protocol Violation|1|||
147153700|NCT02578680|530725441|FG001|Overall Study|Protocol Violation|1|||
147153701|NCT02578680|530725440|FG000|Overall Study|Sponsor Decision|64|||
147153702|NCT02578680|530725441|FG001|Overall Study|Sponsor Decision|13|||
147153703|NCT02578680|530725440|FG000|Overall Study|Withdrawal by Subject|13|||
147153704|NCT02578680|530725441|FG001|Overall Study|Withdrawal by Subject|9|||
147153705|NCT00306293|530725444|FG000|Period 1 (Day 1 to Day 60)|Adverse Event|1|||
147153706|NCT00306293|530725445|FG001|Period 1 (Day 1 to Day 60)|Adverse Event|0|||
147153707|NCT00306293|530725444|FG000|Period 1 (Day 1 to Day 60)|Lost to Follow-up|3|||
147153708|NCT00306293|530725445|FG001|Period 1 (Day 1 to Day 60)|Lost to Follow-up|4|||
147153709|NCT00306293|530725444|FG000|Period 1 (Day 1 to Day 60)|Withdrawal by Subject|2|||
147153710|NCT00306293|530725445|FG001|Period 1 (Day 1 to Day 60)|Withdrawal by Subject|2|||
147153711|NCT00306293|530725444|FG000|Period 1 (Day 1 to Day 60)|Positive pregnancy Test|2|||
147153712|NCT00306293|530725445|FG001|Period 1 (Day 1 to Day 60)|Positive pregnancy Test|2|||
147153713|NCT00306293|530725444|FG000|Period 2 (Day 67 to Day 126 )|Adverse Event|1|||
147153714|NCT00306293|530725445|FG001|Period 2 (Day 67 to Day 126 )|Adverse Event|0|||
147153715|NCT00306293|530725444|FG000|Period 2 (Day 67 to Day 126 )|Lost to Follow-up|1|||
147153716|NCT00306293|530725445|FG001|Period 2 (Day 67 to Day 126 )|Lost to Follow-up|0|||
147153717|NCT00306293|530725444|FG000|Period 2 (Day 67 to Day 126 )|Participant determined HSV-2 negative|0|||
147153718|NCT00306293|530725445|FG001|Period 2 (Day 67 to Day 126 )|Participant determined HSV-2 negative|1|||
147153719|NCT00306293|530725444|FG000|Period 2 (Day 67 to Day 126 )|Pregnancy|1|||
147153720|NCT00306293|530725445|FG001|Period 2 (Day 67 to Day 126 )|Pregnancy|0|||
147153721|NCT00185380|530725449|FG000|Overall Study|Adverse Event|41|||
147153722|NCT00185380|530725450|FG001|Overall Study|Adverse Event|43|||
147153723|NCT00185380|530725451|FG002|Overall Study|Adverse Event|48|||
147153724|NCT00185380|530725449|FG000|Overall Study|Lost to Follow-up|0|||
147153725|NCT00185380|530725450|FG001|Overall Study|Lost to Follow-up|4|||
147153726|NCT00185380|530725451|FG002|Overall Study|Lost to Follow-up|3|||
147153727|NCT00185380|530725449|FG000|Overall Study|Pregnancy|1|||
147153728|NCT00185380|530725450|FG001|Overall Study|Pregnancy|4|||
147153729|NCT00185380|530725451|FG002|Overall Study|Pregnancy|0|||
147153730|NCT00185380|530725449|FG000|Overall Study|Protocol Violation|2|||
147153731|NCT00185380|530725450|FG001|Overall Study|Protocol Violation|2|||
147153732|NCT00185380|530725451|FG002|Overall Study|Protocol Violation|1|||
147153733|NCT00185380|530725449|FG000|Overall Study|Withdrawal by Subject|1|||
147153734|NCT00185380|530725450|FG001|Overall Study|Withdrawal by Subject|2|||
147240511|NCT01817530|531051630|FG002|Overall Study|Lost to Follow-up|2|||
147240512|NCT01817530|531051631|FG003|Overall Study|Lost to Follow-up|1|||
147240513|NCT01817530|531051632|FG004|Overall Study|Lost to Follow-up|3|||
147240514|NCT01817530|531051633|FG005|Overall Study|Lost to Follow-up|2|||
147240515|NCT01817530|531051634|FG006|Overall Study|Lost to Follow-up|8|||
147240516|NCT01817530|531051635|FG007|Overall Study|Lost to Follow-up|4|||
147240517|NCT00679432|531051637|FG000|Overall Study|Adverse Event|5|||
147240518|NCT00679432|531051638|FG001|Overall Study|Adverse Event|6|||
147240519|NCT00679432|531051639|FG002|Overall Study|Adverse Event|10|||
147240520|NCT00679432|531051640|FG003|Overall Study|Adverse Event|7|||
147240521|NCT00679432|531051637|FG000|Overall Study|Protocol Violation|1|||
147240522|NCT00679432|531051638|FG001|Overall Study|Protocol Violation|1|||
147153735|NCT00185380|530725451|FG002|Overall Study|Withdrawal by Subject|0|||
147153736|NCT00185380|530725449|FG000|Overall Study|Failed insertion|1|||
147153737|NCT00185380|530725450|FG001|Overall Study|Failed insertion|1|||
147153738|NCT00185380|530725451|FG002|Overall Study|Failed insertion|2|||
147153739|NCT00185380|530725449|FG000|Overall Study|Planned pregnancy|9|||
147153740|NCT00185380|530725450|FG001|Overall Study|Planned pregnancy|12|||
147153741|NCT00185380|530725451|FG002|Overall Study|Planned pregnancy|12|||
147153742|NCT00185380|530725449|FG000|Overall Study|No need for contraception|3|||
147153743|NCT00185380|530725450|FG001|Overall Study|No need for contraception|3|||
147240523|NCT00679432|531051639|FG002|Overall Study|Protocol Violation|2|||
147240524|NCT00679432|531051640|FG003|Overall Study|Protocol Violation|1|||
147240525|NCT00679432|531051637|FG000|Overall Study|Withdrawal by Subject|8|||
147654088|NCT03178851|532554689|FG000|Overall Study|Adverse Event|0|||
147654089|NCT03178851|532554690|FG001|Overall Study|Adverse Event|0|||
147654090|NCT03178851|532554691|FG002|Overall Study|Adverse Event|1|||
147654091|NCT03178851|532554689|FG000|Overall Study|Study Termination by Sponsor|31|||
147654092|NCT03178851|532554690|FG001|Overall Study|Study Termination by Sponsor|7|||
147654093|NCT03178851|532554691|FG002|Overall Study|Study Termination by Sponsor|26|||
147654094|NCT02226120|532554692|FG000|Overall Study|Adverse Event|60|||
147654095|NCT02226120|532554692|FG000|Overall Study|Death|172|||
147654096|NCT02226120|532554692|FG000|Overall Study|Study terminated by sponsor|1|||
147654097|NCT02226120|532554692|FG000|Overall Study|Technical problems|4|||
147654098|NCT02226120|532554692|FG000|Overall Study|Lost to Follow-up|13|||
147654099|NCT02226120|532554692|FG000|Overall Study|Physician Decision|21|||
147654100|NCT02226120|532554692|FG000|Overall Study|Withdrawal by parent/guardian|36|||
147654101|NCT02226120|532554692|FG000|Overall Study|Non-compliance with study drug|10|||
147654102|NCT02226120|532554692|FG000|Overall Study|Protocol deviation|1|||
147654103|NCT02226120|532554692|FG000|Overall Study|missing treatment disposition pages|2|||
147654104|NCT00401193|532556622|FG000|Overall Study|Adverse Event|1|||
147654105|NCT00401193|532556623|FG001|Overall Study|Adverse Event|3|||
147654106|NCT00401193|532556624|FG002|Overall Study|Adverse Event|1|||
147654107|NCT00401193|532556622|FG000|Overall Study|Protocol Violation|3|||
147654108|NCT00401193|532556623|FG001|Overall Study|Protocol Violation|1|||
147153744|NCT00185380|530725451|FG002|Overall Study|No need for contraception|3|||
147153745|NCT00185380|530725449|FG000|Overall Study|Could not attend visits|2|||
147153746|NCT00185380|530725450|FG001|Overall Study|Could not attend visits|0|||
147153747|NCT00185380|530725451|FG002|Overall Study|Could not attend visits|4|||
147153748|NCT00185380|530725449|FG000|Overall Study|personal reason|6|||
147153749|NCT00185380|530725450|FG001|Overall Study|personal reason|1|||
147153750|NCT00185380|530725451|FG002|Overall Study|personal reason|1|||
147153751|NCT00733291|530725452|FG000|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|1|||
147153752|NCT00733291|530725453|FG001|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|0|||
147153753|NCT00733291|530725454|FG002|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|0|||
147153754|NCT00733291|530725455|FG003|Washout Period, 3 Days (+/-1 Day)|Failed inc criteria Second Intervention|0|||
147153755|NCT01089413|530725458|FG000|Overall Study|Lost to Follow-up|1|||
147153756|NCT01089413|530725458|FG000|Overall Study|Progressive Disease|93|||
147153757|NCT01089413|530725458|FG000|Overall Study|Participant Withdrew Consent|1|||
147153758|NCT01089413|530725458|FG000|Overall Study|Unacceptable Toxicity|12|||
147153759|NCT01089413|530725458|FG000|Overall Study|Death|10|||
147153760|NCT01089413|530725458|FG000|Overall Study|Metastasectomy|13|||
147153761|NCT01089413|530725458|FG000|Overall Study|Other|71|||
147153762|NCT00470093|530725463|FG000|Overall Study|Adverse Event|2|||
147153763|NCT01610557|530725464|FG000|36-Week Randomized Crossover Phase|Withdrawal by Subject|0|||
147153764|NCT01610557|530725465|FG001|36-Week Randomized Crossover Phase|Withdrawal by Subject|1|||
147153765|NCT01610557|530725466|FG002|36-Week Randomized Crossover Phase|Withdrawal by Subject|0|||
147153766|NCT01610557|530725467|FG003|36-Week Randomized Crossover Phase|Withdrawal by Subject|0|||
147153767|NCT01610557|530725468|FG004|36-Week Randomized Crossover Phase|Withdrawal by Subject|0|||
147153768|NCT01610557|530725464|FG000|Post-36-Week Extension Phase|Withdrawal by Subject|0|||
147153769|NCT01610557|530725465|FG001|Post-36-Week Extension Phase|Withdrawal by Subject|0|||
147153770|NCT01610557|530725466|FG002|Post-36-Week Extension Phase|Withdrawal by Subject|0|||
147153771|NCT01610557|530725467|FG003|Post-36-Week Extension Phase|Withdrawal by Subject|0|||
147153772|NCT01610557|530725468|FG004|Post-36-Week Extension Phase|Withdrawal by Subject|3|||
147153773|NCT02039219|530725469|FG000|Treatment|Withdrawal by Subject|1|||
147153774|NCT02039219|530725470|FG001|Treatment|Withdrawal by Subject|0|||
147153775|NCT02039219|530725469|FG000|Treatment|Adverse Event|0|||
147153776|NCT02039219|530725470|FG001|Treatment|Adverse Event|1|||
147153777|NCT02039219|530725469|FG000|Treatment|Physician Decision|1|||
147153778|NCT02039219|530725470|FG001|Treatment|Physician Decision|0|||
147153779|NCT02039219|530725469|FG000|Treatment|Lost to Follow-up|0|||
147153780|NCT02039219|530725470|FG001|Treatment|Lost to Follow-up|1|||
147153781|NCT02039219|530725469|FG000|Treatment|Protocol Violation|1|||
147153782|NCT02039219|530725470|FG001|Treatment|Protocol Violation|0|||
147153783|NCT02039219|530725469|FG000|Treatment|Death|1|||
147153784|NCT02039219|530725470|FG001|Treatment|Death|0|||
147153785|NCT02039219|530725469|FG000|Follow up|Adverse Event|0|||
147153786|NCT02039219|530725470|FG001|Follow up|Adverse Event|1|||
147321908|NCT00577629|531341728|FG000|Treatment Period|Death|1|||
147153787|NCT02226562|530725471|FG000|Overall Study|Lost to Follow-up|0|||
147153788|NCT02226562|530725472|FG001|Overall Study|Lost to Follow-up|1|||
147153789|NCT01466660|530725473|FG000|Overall Study|Progressive Disease (RECIST 1.1)|120|||
147153790|NCT01466660|530725474|FG001|Overall Study|Progressive Disease (RECIST 1.1)|127|||
147153791|NCT01466660|530725473|FG000|Overall Study|Worsening of underlying cancer disease|5|||
147153792|NCT01466660|530725474|FG001|Overall Study|Worsening of underlying cancer disease|2|||
147654109|NCT00401193|532556624|FG002|Overall Study|Protocol Violation|1|||
147654110|NCT00401193|532556622|FG000|Overall Study|Lost to Follow-up|6|||
147654111|NCT00401193|532556623|FG001|Overall Study|Lost to Follow-up|5|||
147321909|NCT00577629|531341728|FG000|Long Term Follow-Up|Death|15|||
147654112|NCT00401193|532556624|FG002|Overall Study|Lost to Follow-up|1|||
147153793|NCT01466660|530725473|FG000|Overall Study|Other adverse event|19|||
147153794|NCT01466660|530725474|FG001|Overall Study|Other adverse event|18|||
147153795|NCT01466660|530725473|FG000|Overall Study|Protocol Violation|2|||
147153796|NCT01466660|530725474|FG001|Overall Study|Protocol Violation|1|||
147153797|NCT01466660|530725473|FG000|Overall Study|Refused continuation of trial medication|4|||
147153798|NCT01466660|530725474|FG001|Overall Study|Refused continuation of trial medication|3|||
147153799|NCT01466660|530725473|FG000|Overall Study|Other reason not defined above|10|||
147153800|NCT01466660|530725474|FG001|Overall Study|Other reason not defined above|8|||
147153801|NCT02750345|530725475|FG000|Intervention 1|Adverse Event|0|||
147153802|NCT02750345|530725476|FG001|Intervention 1|Adverse Event|0|||
147153803|NCT02750345|530725477|FG002|Intervention 1|Adverse Event|0|||
147153804|NCT02750345|530725478|FG003|Intervention 1|Adverse Event|0|||
147153805|NCT02750345|530725479|FG004|Intervention 1|Adverse Event|1|||
147153806|NCT02750345|530725480|FG005|Intervention 1|Adverse Event|0|||
147153807|NCT00608023|530725481|FG000|Overall Study|Withdrawal by Subject|8|||
147153808|NCT00608023|530725482|FG001|Overall Study|Withdrawal by Subject|10|||
147153809|NCT00608023|530725483|FG002|Overall Study|Withdrawal by Subject|7|||
147153810|NCT00608023|530725481|FG000|Overall Study|Adverse Event|1|||
147153811|NCT00608023|530725482|FG001|Overall Study|Adverse Event|4|||
147153812|NCT00608023|530725483|FG002|Overall Study|Adverse Event|5|||
147153813|NCT00608023|530725481|FG000|Overall Study|Lost to Follow-up|2|||
147153814|NCT00608023|530725482|FG001|Overall Study|Lost to Follow-up|2|||
147153815|NCT00608023|530725483|FG002|Overall Study|Lost to Follow-up|1|||
147153816|NCT00608023|530725481|FG000|Overall Study|Protocol Violation|1|||
147153817|NCT00608023|530725482|FG001|Overall Study|Protocol Violation|3|||
147153818|NCT00608023|530725483|FG002|Overall Study|Protocol Violation|1|||
147153819|NCT00608023|530725481|FG000|Overall Study|Unknown reason|0|||
147153820|NCT00608023|530725482|FG001|Overall Study|Unknown reason|3|||
147153821|NCT00608023|530725483|FG002|Overall Study|Unknown reason|0|||
147153822|NCT01328535|530725484|FG000|Overall Study|Ineligible|1|||
147153823|NCT03655054|530725487|FG000|Overall Study|Lost to Follow-up|1|||
147153824|NCT01054560|530725492|FG000|Overall Study|Death|10|||
147153825|NCT01054560|530725493|FG001|Overall Study|Death|21|||
147153826|NCT01054560|530725492|FG000|Overall Study|Lost to Follow-up|2|||
147153827|NCT01054560|530725493|FG001|Overall Study|Lost to Follow-up|5|||
147153828|NCT01054560|530725492|FG000|Overall Study|Withdrawal by Subject|0|||
147153829|NCT01054560|530725493|FG001|Overall Study|Withdrawal by Subject|2|||
147153830|NCT01054560|530725492|FG000|Overall Study|Physician Decision|1|||
147153831|NCT01054560|530725493|FG001|Overall Study|Physician Decision|0|||
147153832|NCT02135029|530725498|FG000|Overall Study|Adverse Event|2|||
147153833|NCT02135029|530725499|FG001|Overall Study|Adverse Event|2|||
147153834|NCT02135029|530725500|FG002|Overall Study|Adverse Event|2|||
147153835|NCT02135029|530725498|FG000|Overall Study|Lost to Follow-up|0|||
147153836|NCT02135029|530725499|FG001|Overall Study|Lost to Follow-up|1|||
147153837|NCT02135029|530725500|FG002|Overall Study|Lost to Follow-up|0|||
147153838|NCT02135029|530725498|FG000|Overall Study|Withdrawal by Subject|2|||
147153839|NCT02135029|530725499|FG001|Overall Study|Withdrawal by Subject|0|||
147153840|NCT02135029|530725500|FG002|Overall Study|Withdrawal by Subject|1|||
147153841|NCT02135029|530725498|FG000|Overall Study|Other|0|||
147153842|NCT02135029|530725499|FG001|Overall Study|Other|1|||
147153843|NCT02135029|530725500|FG002|Overall Study|Other|0|||
147153844|NCT02135029|530725498|FG000|Overall Study|Death|0|||
147153845|NCT02135029|530725499|FG001|Overall Study|Death|1|||
147153846|NCT02135029|530725500|FG002|Overall Study|Death|0|||
147153847|NCT00712725|530725501|FG000|Overall Study|Adverse Event|1|||
147153848|NCT00712725|530725502|FG001|Overall Study|Adverse Event|0|||
147153849|NCT00712725|530725503|FG002|Overall Study|Adverse Event|0|||
147153850|NCT00712725|530725504|FG003|Overall Study|Adverse Event|1|||
147153851|NCT00712725|530725505|FG004|Overall Study|Adverse Event|0|||
147153852|NCT00712725|530725506|FG005|Overall Study|Adverse Event|0|||
147153853|NCT00712725|530725507|FG006|Overall Study|Adverse Event|0|||
147153854|NCT00712725|530725508|FG007|Overall Study|Adverse Event|0|||
147153855|NCT00712725|530725501|FG000|Overall Study|Lost to Follow-up|3|||
147153856|NCT00712725|530725502|FG001|Overall Study|Lost to Follow-up|2|||
147153857|NCT00712725|530725503|FG002|Overall Study|Lost to Follow-up|1|||
147153858|NCT00712725|530725504|FG003|Overall Study|Lost to Follow-up|1|||
147153859|NCT00712725|530725505|FG004|Overall Study|Lost to Follow-up|2|||
147153860|NCT00712725|530725506|FG005|Overall Study|Lost to Follow-up|2|||
147153861|NCT00712725|530725507|FG006|Overall Study|Lost to Follow-up|3|||
147153862|NCT00712725|530725508|FG007|Overall Study|Lost to Follow-up|1|||
147153863|NCT00712725|530725501|FG000|Overall Study|Physician Decision|2|||
147153864|NCT00712725|530725502|FG001|Overall Study|Physician Decision|0|||
147153865|NCT00712725|530725503|FG002|Overall Study|Physician Decision|0|||
147153866|NCT00712725|530725504|FG003|Overall Study|Physician Decision|0|||
147153867|NCT00712725|530725505|FG004|Overall Study|Physician Decision|1|||
147153868|NCT00712725|530725506|FG005|Overall Study|Physician Decision|0|||
147153869|NCT00712725|530725507|FG006|Overall Study|Physician Decision|2|||
147153870|NCT00712725|530725508|FG007|Overall Study|Physician Decision|0|||
147153871|NCT00712725|530725501|FG000|Overall Study|Pregnancy|0|||
147153872|NCT00712725|530725502|FG001|Overall Study|Pregnancy|1|||
147153873|NCT00712725|530725503|FG002|Overall Study|Pregnancy|0|||
147153874|NCT00712725|530725504|FG003|Overall Study|Pregnancy|0|||
147153875|NCT00712725|530725505|FG004|Overall Study|Pregnancy|1|||
147153876|NCT00712725|530725506|FG005|Overall Study|Pregnancy|0|||
147153877|NCT00712725|530725507|FG006|Overall Study|Pregnancy|2|||
147153878|NCT00712725|530725508|FG007|Overall Study|Pregnancy|0|||
147153879|NCT00712725|530725501|FG000|Overall Study|Protocol Violation|2|||
147153880|NCT00712725|530725502|FG001|Overall Study|Protocol Violation|0|||
147153881|NCT00712725|530725503|FG002|Overall Study|Protocol Violation|1|||
147153882|NCT00712725|530725504|FG003|Overall Study|Protocol Violation|3|||
147153883|NCT00712725|530725505|FG004|Overall Study|Protocol Violation|2|||
147153884|NCT00712725|530725506|FG005|Overall Study|Protocol Violation|0|||
147153885|NCT00712725|530725507|FG006|Overall Study|Protocol Violation|1|||
147153886|NCT00712725|530725508|FG007|Overall Study|Protocol Violation|1|||
147153887|NCT00712725|530725501|FG000|Overall Study|Withdrawal by Subject|2|||
147153888|NCT00712725|530725502|FG001|Overall Study|Withdrawal by Subject|1|||
147153889|NCT00712725|530725503|FG002|Overall Study|Withdrawal by Subject|1|||
147153890|NCT00712725|530725504|FG003|Overall Study|Withdrawal by Subject|2|||
147153891|NCT00712725|530725505|FG004|Overall Study|Withdrawal by Subject|1|||
147321910|NCT00577629|531341728|FG000|Long Term Follow-Up|Lost to Follow-up|5|||
147321911|NCT00577629|531341728|FG000|Long Term Follow-Up|Withdrawal by Subject|4|||
147321912|NCT00577629|531341728|FG000|Long Term Follow-Up|Physician Decision|1|||
147153892|NCT00712725|530725506|FG005|Overall Study|Withdrawal by Subject|1|||
147153893|NCT00712725|530725507|FG006|Overall Study|Withdrawal by Subject|1|||
147153894|NCT00712725|530725508|FG007|Overall Study|Withdrawal by Subject|2|||
147153895|NCT00712725|530725501|FG000|Overall Study|Lack of Qualifying Event|16|||
147153896|NCT00712725|530725502|FG001|Overall Study|Lack of Qualifying Event|2|||
147153897|NCT00712725|530725503|FG002|Overall Study|Lack of Qualifying Event|6|||
147153898|NCT00712725|530725504|FG003|Overall Study|Lack of Qualifying Event|8|||
147153899|NCT00712725|530725505|FG004|Overall Study|Lack of Qualifying Event|11|||
147153900|NCT00712725|530725506|FG005|Overall Study|Lack of Qualifying Event|13|||
147153901|NCT00712725|530725507|FG006|Overall Study|Lack of Qualifying Event|11|||
147153902|NCT00712725|530725508|FG007|Overall Study|Lack of Qualifying Event|6|||
147153903|NCT00712725|530725501|FG000|Overall Study|Protocol Specified Criteria|3|||
147153904|NCT00712725|530725502|FG001|Overall Study|Protocol Specified Criteria|0|||
147153905|NCT00712725|530725503|FG002|Overall Study|Protocol Specified Criteria|1|||
147153906|NCT00712725|530725504|FG003|Overall Study|Protocol Specified Criteria|2|||
147153907|NCT00712725|530725505|FG004|Overall Study|Protocol Specified Criteria|1|||
147153908|NCT00712725|530725506|FG005|Overall Study|Protocol Specified Criteria|0|||
147153909|NCT00712725|530725507|FG006|Overall Study|Protocol Specified Criteria|2|||
147153910|NCT00712725|530725508|FG007|Overall Study|Protocol Specified Criteria|1|||
147153911|NCT03466099|530725509|FG000|Overall Study|Adverse Event|1|||
147153912|NCT03466099|530725510|FG001|Overall Study|Adverse Event|1|||
147153913|NCT03466099|530725511|FG002|Overall Study|Adverse Event|1|||
147153914|NCT03466099|530725509|FG000|Overall Study|Withdrawal by Subject|2|||
147153915|NCT03466099|530725510|FG001|Overall Study|Withdrawal by Subject|3|||
147153916|NCT03466099|530725511|FG002|Overall Study|Withdrawal by Subject|1|||
147153917|NCT03466099|530725509|FG000|Overall Study|Use of rescue medication|8|||
147153918|NCT03466099|530725510|FG001|Overall Study|Use of rescue medication|9|||
147153919|NCT03466099|530725511|FG002|Overall Study|Use of rescue medication|13|||
147153920|NCT03466099|530725509|FG000|Overall Study|Rescued without meeting criteria|4|||
147153921|NCT03466099|530725510|FG001|Overall Study|Rescued without meeting criteria|1|||
147153922|NCT03466099|530725511|FG002|Overall Study|Rescued without meeting criteria|1|||
147153923|NCT03466099|530725509|FG000|Overall Study|Subject compliance|2|||
147153924|NCT03466099|530725510|FG001|Overall Study|Subject compliance|0|||
147153925|NCT03466099|530725511|FG002|Overall Study|Subject compliance|0|||
147153926|NCT03466099|530725509|FG000|Overall Study|Worsening disease|0|||
147153927|NCT03466099|530725510|FG001|Overall Study|Worsening disease|0|||
147153928|NCT03466099|530725511|FG002|Overall Study|Worsening disease|1|||
147153929|NCT03525600|530725514|FG000|Overall Study|Adverse Event|9|||
147153930|NCT03525600|530725515|FG001|Overall Study|Adverse Event|6|||
147153931|NCT03525600|530725516|FG002|Overall Study|Adverse Event|5|||
147153932|NCT03525600|530725517|FG003|Overall Study|Adverse Event|3|||
147321913|NCT01449721|531341730|FG000|Overall Study|Physician Decision|0|||
147583393|NCT02725411|532291611|FG001|Treatment Period (56 Weeks)|Adverse Event|5|||
147321914|NCT01449721|531341731|FG001|Overall Study|Physician Decision|1|||
147583394|NCT02725411|532291612|FG002|Treatment Period (56 Weeks)|Adverse Event|4|||
147153933|NCT03525600|530725514|FG000|Overall Study|Lost to Follow-up|2|||
147153934|NCT03525600|530725515|FG001|Overall Study|Lost to Follow-up|4|||
147153935|NCT03525600|530725516|FG002|Overall Study|Lost to Follow-up|4|||
147153936|NCT03525600|530725517|FG003|Overall Study|Lost to Follow-up|0|||
147153937|NCT03525600|530725514|FG000|Overall Study|Physician Decision|1|||
147153938|NCT03525600|530725515|FG001|Overall Study|Physician Decision|0|||
147153939|NCT03525600|530725516|FG002|Overall Study|Physician Decision|2|||
147153940|NCT03525600|530725517|FG003|Overall Study|Physician Decision|0|||
147153941|NCT03525600|530725514|FG000|Overall Study|Consent withdrawal|36|||
147153942|NCT03525600|530725515|FG001|Overall Study|Consent withdrawal|20|||
147153943|NCT03525600|530725516|FG002|Overall Study|Consent withdrawal|6|||
147153944|NCT03525600|530725517|FG003|Overall Study|Consent withdrawal|13|||
147583395|NCT02725411|532291610|FG000|Treatment Period (56 Weeks)|Lack of Efficacy|1|||
147583396|NCT02725411|532291611|FG001|Treatment Period (56 Weeks)|Lack of Efficacy|4|||
147583397|NCT02725411|532291612|FG002|Treatment Period (56 Weeks)|Lack of Efficacy|1|||
147153945|NCT03525600|530725514|FG000|Overall Study|Death|7|||
147153946|NCT03525600|530725515|FG001|Overall Study|Death|6|||
147153947|NCT03525600|530725516|FG002|Overall Study|Death|4|||
147153948|NCT03525600|530725517|FG003|Overall Study|Death|3|||
147153949|NCT03525600|530725514|FG000|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|4|||
147153950|NCT03525600|530725515|FG001|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|10|||
147153951|NCT03525600|530725516|FG002|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|3|||
147153952|NCT03525600|530725517|FG003|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|3|||
147153953|NCT03525600|530725514|FG000|Overall Study|Other|0|||
147153954|NCT03525600|530725515|FG001|Overall Study|Other|1|||
147153955|NCT03525600|530725516|FG002|Overall Study|Other|0|||
147153956|NCT03525600|530725517|FG003|Overall Study|Other|0|||
147153957|NCT01923363|530725520|FG000|Overall Study|Protocol Violation|1|||
147153958|NCT00290771|530725521|FG000|Overall Study|Disease progression|95|||
147153959|NCT00290771|530725522|FG001|Overall Study|Disease progression|73|||
147153960|NCT00290771|530725521|FG000|Overall Study|Death|11|||
147153961|NCT00290771|530725522|FG001|Overall Study|Death|10|||
147153962|NCT00290771|530725521|FG000|Overall Study|Adverse Event|12|||
147153963|NCT00290771|530725522|FG001|Overall Study|Adverse Event|6|||
147153964|NCT00290771|530725521|FG000|Overall Study|Withdrawal by Subject|5|||
147153965|NCT00290771|530725522|FG001|Overall Study|Withdrawal by Subject|6|||
147153966|NCT00290771|530725521|FG000|Overall Study|Administrative problems|2|||
147153967|NCT00290771|530725522|FG001|Overall Study|Administrative problems|1|||
147153968|NCT00290771|530725521|FG000|Overall Study|Protocol Violation|2|||
147153969|NCT00290771|530725522|FG001|Overall Study|Protocol Violation|0|||
147153970|NCT00290771|530725521|FG000|Overall Study|Lost to Follow-up|0|||
147153971|NCT00290771|530725522|FG001|Overall Study|Lost to Follow-up|1|||
147153972|NCT05129449|530725523|FG000|Overall Study|Protocol Violation|1|||
147153973|NCT01818258|530725527|FG000|Overall Study|Death|3|||
147153974|NCT01818258|530725528|FG001|Overall Study|Death|0|||
147153975|NCT01818258|530725527|FG000|Overall Study|Withdrawal by Subject|0|||
147153976|NCT01818258|530725528|FG001|Overall Study|Withdrawal by Subject|1|||
147153977|NCT01818258|530725527|FG000|Overall Study|Lost to Follow-up|0|||
147153978|NCT01818258|530725528|FG001|Overall Study|Lost to Follow-up|1|||
147153979|NCT01818258|530725527|FG000|Overall Study|Unable to Travel to Clinic|0|||
147153980|NCT01818258|530725528|FG001|Overall Study|Unable to Travel to Clinic|1|||
147153981|NCT02099344|530725529|FG000|Overall Study|Physician Decision|1|||
147153982|NCT02099344|530725530|FG001|Overall Study|Physician Decision|0|||
147153983|NCT03802630|530725533|FG000|Overall Study|Study terminated by sponsor|130|||
147153984|NCT03802630|530725534|FG001|Overall Study|Study terminated by sponsor|134|||
147153985|NCT03802630|530725533|FG000|Overall Study|Subject decision|16|||
147153986|NCT03802630|530725534|FG001|Overall Study|Subject decision|9|||
147153987|NCT03802630|530725533|FG000|Overall Study|Adverse Event|3|||
147153988|NCT03802630|530725534|FG001|Overall Study|Adverse Event|1|||
147153989|NCT03802630|530725533|FG000|Overall Study|Lost to Follow-up|2|||
147153990|NCT03802630|530725534|FG001|Overall Study|Lost to Follow-up|2|||
147153991|NCT03802630|530725533|FG000|Overall Study|Physician Decision|2|||
147153992|NCT03802630|530725534|FG001|Overall Study|Physician Decision|0|||
147153993|NCT03802630|530725533|FG000|Overall Study|Death|0|||
147153994|NCT03802630|530725534|FG001|Overall Study|Death|2|||
147153995|NCT01221623|530725540|FG000|Overall Study|Withdrawal by Subject|19|||
147153996|NCT01221623|530725541|FG001|Overall Study|Withdrawal by Subject|8|||
147153997|NCT01221623|530725540|FG000|Overall Study|Lost to Follow-up|7|||
147153998|NCT01221623|530725541|FG001|Overall Study|Lost to Follow-up|1|||
147153999|NCT01221623|530725540|FG000|Overall Study|Adverse Event|6|||
147154000|NCT01221623|530725541|FG001|Overall Study|Adverse Event|3|||
147154001|NCT01221623|530725540|FG000|Overall Study|Death|1|||
147154002|NCT01221623|530725541|FG001|Overall Study|Death|0|||
147154003|NCT01221623|530725540|FG000|Overall Study|Other|5|||
147154004|NCT01221623|530725541|FG001|Overall Study|Other|2|||
147154005|NCT00661726|530725542|FG000|Overall Study|Adverse Event|1|||
147154006|NCT00780143|530725543|FG000|Overall Study|Progressive disease|1|||
147154007|NCT00780143|530725543|FG000|Overall Study|Toxicity|1|||
147154008|NCT00780143|530725543|FG000|Overall Study|Adverse Event|1|||
147154009|NCT02644096|530725544|FG000|Overall Study|Withdrawal by Subject|28|||
147154010|NCT02644096|530725545|FG001|Overall Study|Withdrawal by Subject|25|||
147154011|NCT00322452|530725546|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
147154012|NCT00322452|530725547|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
147154013|NCT00322452|530725546|FG000|Overall Study|Lost to Follow-up|5|||
147154014|NCT00322452|530725547|FG001|Overall Study|Lost to Follow-up|2|||
147154015|NCT00322452|530725546|FG000|Overall Study|Withdrawal by Subject|19|||
147154016|NCT00322452|530725547|FG001|Overall Study|Withdrawal by Subject|46|||
147154017|NCT00322452|530725546|FG000|Overall Study|Death|223|||
147154018|NCT00322452|530725547|FG001|Overall Study|Death|227|||
147154019|NCT00526656|530725548|FG000|Overall Study|Death|1|||
147154020|NCT00526656|530725548|FG000|Overall Study|Refused surgery|1|||
147154021|NCT04091581|530725549|FG000|Overall Study|Lost to Follow-up|0|||
147154022|NCT04091581|530725550|FG001|Overall Study|Lost to Follow-up|1|||
147154023|NCT02438384|530725551|FG000|Overall Study|Lost to Follow-up|8|||
147154024|NCT02438384|530725552|FG001|Overall Study|Lost to Follow-up|6|||
147154025|NCT02438384|530725553|FG002|Overall Study|Lost to Follow-up|4|||
147154026|NCT03319953|530725554|FG000|Period 2 (Day 49 to 154)|Withdrawal by Subject|1|||
147154027|NCT03319953|530725555|FG001|Period 2 (Day 49 to 154)|Withdrawal by Subject|0|||
147154028|NCT03319953|530725556|FG002|Period 2 (Day 49 to 154)|Withdrawal by Subject|0|||
147154029|NCT03319953|530725557|FG003|Period 2 (Day 49 to 154)|Withdrawal by Subject|0|||
147154030|NCT03319953|530725554|FG000|Period 2 (Day 49 to 154)|Reason not Specified|0|||
147154031|NCT03319953|530725555|FG001|Period 2 (Day 49 to 154)|Reason not Specified|0|||
147154032|NCT03319953|530725556|FG002|Period 2 (Day 49 to 154)|Reason not Specified|1|||
147154033|NCT03319953|530725557|FG003|Period 2 (Day 49 to 154)|Reason not Specified|1|||
147154034|NCT01795495|530725559|FG000|Overall Study|Protocol Violation|1|||
147154035|NCT01795495|530725560|FG001|Overall Study|Protocol Violation|0|||
147154036|NCT01795495|530725561|FG002|Overall Study|Protocol Violation|1|||
147154037|NCT01795495|530725559|FG000|Overall Study|Physician Decision|0|||
147154038|NCT01795495|530725560|FG001|Overall Study|Physician Decision|0|||
147583398|NCT02725411|532291610|FG000|Treatment Period (56 Weeks)|Lost to Follow-up|0|||
147583399|NCT02725411|532291611|FG001|Treatment Period (56 Weeks)|Lost to Follow-up|1|||
147154039|NCT01795495|530725561|FG002|Overall Study|Physician Decision|1|||
147154040|NCT03315793|530725562|FG000|Overall Study|Adverse Event|4|||
147154041|NCT03315793|530725563|FG001|Overall Study|Adverse Event|2|||
147154042|NCT03315793|530725562|FG000|Overall Study|Protocol Deviation|1|||
147154043|NCT03315793|530725563|FG001|Overall Study|Protocol Deviation|0|||
147154044|NCT03315793|530725562|FG000|Overall Study|Difficult for regular visit|0|||
147154045|NCT03315793|530725563|FG001|Overall Study|Difficult for regular visit|1|||
147154046|NCT00790868|530727617|FG000|Overall Study|Withdrawal by Subject|4|||
147154047|NCT00790868|530727618|FG001|Overall Study|Withdrawal by Subject|5|||
147154048|NCT00790868|530727617|FG000|Overall Study|Lost to Follow-up|2|||
147154049|NCT00790868|530727618|FG001|Overall Study|Lost to Follow-up|12|||
147154050|NCT01579565|530727619|FG000|Randomized|Adverse Event|1|||
147154051|NCT01579565|530727620|FG001|Randomized|Adverse Event|3|||
147154052|NCT01579565|530727619|FG000|Randomized|Withdrawal by Subject|3|||
147154053|NCT01579565|530727620|FG001|Randomized|Withdrawal by Subject|0|||
147154054|NCT01579565|530727619|FG000|Randomized|inadequate preoperative pupil dilation|0|||
147154055|NCT01579565|530727620|FG001|Randomized|inadequate preoperative pupil dilation|1|||
147154056|NCT01579565|530727619|FG000|Randomized|prohibited preoperative eating|1|||
147154057|NCT01579565|530727620|FG001|Randomized|prohibited preoperative eating|0|||
147154058|NCT01579565|530727619|FG000|Randomized|prohibited preoperative medication|0|||
147154059|NCT01579565|530727620|FG001|Randomized|prohibited preoperative medication|1|||
147154060|NCT01579565|530727619|FG000|Treated|Physician Decision|0|||
147154061|NCT01579565|530727620|FG001|Treated|Physician Decision|1|||
147154062|NCT01579565|530727619|FG000|Treated|Lost to Follow-up|2|||
147154063|NCT01579565|530727620|FG001|Treated|Lost to Follow-up|1|||
147154064|NCT01579565|530727619|FG000|Treated|declined to return for final visit|0|||
147154065|NCT01579565|530727620|FG001|Treated|declined to return for final visit|1|||
147154066|NCT02791191|530727621|FG000|Overall Study|Adverse Event|2|||
147154067|NCT02791191|530727622|FG001|Overall Study|Adverse Event|4|||
147154068|NCT02791191|530727623|FG002|Overall Study|Adverse Event|5|||
147154069|NCT02791191|530727621|FG000|Overall Study|Lack of Efficacy|0|||
147240526|NCT00679432|531051638|FG001|Overall Study|Withdrawal by Subject|11|||
147583400|NCT02725411|532291612|FG002|Treatment Period (56 Weeks)|Lost to Follow-up|0|||
147583401|NCT02725411|532291610|FG000|Treatment Period (56 Weeks)|Other|1|||
147583402|NCT02725411|532291611|FG001|Treatment Period (56 Weeks)|Other|4|||
147583403|NCT02725411|532291612|FG002|Treatment Period (56 Weeks)|Other|5|||
147583404|NCT02725411|532291610|FG000|Treatment Period (56 Weeks)|Withdrawal by Subject|0|||
147583405|NCT02725411|532291611|FG001|Treatment Period (56 Weeks)|Withdrawal by Subject|1|||
147583406|NCT02725411|532291612|FG002|Treatment Period (56 Weeks)|Withdrawal by Subject|4|||
147583407|NCT02725411|532291610|FG000|Treatment Period (56 Weeks)|Not Met Protocol-Specified Criteria|25|||
147583408|NCT02725411|532291611|FG001|Treatment Period (56 Weeks)|Not Met Protocol-Specified Criteria|35|||
147583409|NCT02725411|532291612|FG002|Treatment Period (56 Weeks)|Not Met Protocol-Specified Criteria|35|||
147583410|NCT02725411|532291610|FG000|Follow-up Period (24 Weeks)|Adverse Event|1|||
147154070|NCT02791191|530727622|FG001|Overall Study|Lack of Efficacy|1|||
147154071|NCT02791191|530727623|FG002|Overall Study|Lack of Efficacy|0|||
147154072|NCT02791191|530727621|FG000|Overall Study|Study Drug Non-Compliance|0|||
147154073|NCT02791191|530727622|FG001|Overall Study|Study Drug Non-Compliance|2|||
147154074|NCT02791191|530727623|FG002|Overall Study|Study Drug Non-Compliance|0|||
147154075|NCT02791191|530727621|FG000|Overall Study|Site Closed by Sponsor|1|||
147154076|NCT02791191|530727622|FG001|Overall Study|Site Closed by Sponsor|1|||
147154077|NCT02791191|530727623|FG002|Overall Study|Site Closed by Sponsor|3|||
147154078|NCT02791191|530727621|FG000|Overall Study|Progressive Disease|1|||
147154079|NCT02791191|530727622|FG001|Overall Study|Progressive Disease|0|||
147583411|NCT02725411|532291611|FG001|Follow-up Period (24 Weeks)|Adverse Event|1|||
147154080|NCT02791191|530727623|FG002|Overall Study|Progressive Disease|0|||
147154081|NCT02791191|530727621|FG000|Overall Study|Study Terminated by Sponsor|29|||
147321915|NCT01449721|531341730|FG000|Overall Study|Physician Decision|0|||
147321916|NCT01449721|531341731|FG001|Overall Study|Physician Decision|1|||
147321917|NCT00114959|531341737|FG000|Overall Study|Lack of Efficacy|6|||
147321918|NCT00114959|531341737|FG000|Overall Study|Physician Decision|1|||
147321919|NCT00114959|531341737|FG000|Overall Study|Death|1|||
147321920|NCT03212365|531341745|FG000|Overall Study|Discharged prior to Xa level|12|||
147321921|NCT03212365|531341746|FG001|Overall Study|Discharged prior to Xa level|8|||
147321922|NCT03212365|531341745|FG000|Overall Study|Bled requiring enoxaparin cessation|4|||
147321923|NCT03212365|531341746|FG001|Overall Study|Bled requiring enoxaparin cessation|2|||
147154082|NCT02791191|530727622|FG001|Overall Study|Study Terminated by Sponsor|101|||
147154083|NCT02791191|530727623|FG002|Overall Study|Study Terminated by Sponsor|109|||
147154084|NCT02791191|530727621|FG000|Overall Study|Withdrawal by Subject|3|||
147154085|NCT02791191|530727622|FG001|Overall Study|Withdrawal by Subject|1|||
147154086|NCT02791191|530727623|FG002|Overall Study|Withdrawal by Subject|3|||
147154087|NCT02791191|530727621|FG000|Overall Study|Subject Withdrew Caregiver Circumstances|2|||
147154088|NCT02791191|530727622|FG001|Overall Study|Subject Withdrew Caregiver Circumstances|1|||
147154089|NCT02791191|530727623|FG002|Overall Study|Subject Withdrew Caregiver Circumstances|0|||
147154090|NCT02290691|530727626|FG000|Overall Study|Noncompliance|0|||
147154091|NCT02290691|530727627|FG001|Overall Study|Noncompliance|1|||
147154092|NCT02290691|530727626|FG000|Overall Study|Withdrawal by Subject|1|||
147154093|NCT02290691|530727627|FG001|Overall Study|Withdrawal by Subject|1|||
147154094|NCT02290691|530727626|FG000|Overall Study|Lost to Follow-up|7|||
147154095|NCT02290691|530727627|FG001|Overall Study|Lost to Follow-up|7|||
147154096|NCT00978380|530727628|FG000|Overall Study|Protocol Violation|2|||
147154097|NCT00978380|530727628|FG000|Overall Study|Withdrawal criteria|9|||
147154098|NCT00978380|530727628|FG000|Overall Study|Unclassified|8|||
147154099|NCT02199314|530727629|FG000|Overall Study|Withdrawal by Subject|6|||
147154100|NCT02199314|530727629|FG000|Overall Study|Physician Decision|10|||
147154101|NCT01461928|530727630|FG000|Induction (up to 8 Months)|Adverse Event|76|||
147154102|NCT01461928|530727631|FG001|Induction (up to 8 Months)|Adverse Event|0|||
147154103|NCT01461928|530727632|FG002|Induction (up to 8 Months)|Adverse Event|0|||
147240527|NCT00679432|531051639|FG002|Overall Study|Withdrawal by Subject|10|||
147240528|NCT00679432|531051640|FG003|Overall Study|Withdrawal by Subject|9|||
147240529|NCT00679432|531051637|FG000|Overall Study|Lost to Follow-up|1|||
147240530|NCT00679432|531051638|FG001|Overall Study|Lost to Follow-up|5|||
147240531|NCT00679432|531051639|FG002|Overall Study|Lost to Follow-up|4|||
147240532|NCT00679432|531051640|FG003|Overall Study|Lost to Follow-up|2|||
147240533|NCT00679432|531051637|FG000|Overall Study|Physician Decision|3|||
147240534|NCT00679432|531051638|FG001|Overall Study|Physician Decision|2|||
147240535|NCT00679432|531051639|FG002|Overall Study|Physician Decision|2|||
147240536|NCT00679432|531051640|FG003|Overall Study|Physician Decision|2|||
147240537|NCT00679432|531051637|FG000|Overall Study|Sponsor decision|1|||
147321924|NCT03212365|531341745|FG000|Overall Study|Refused study medication|3|||
147321925|NCT03212365|531341746|FG001|Overall Study|Refused study medication|0|||
147321926|NCT03212365|531341745|FG000|Overall Study|Initiated heparin infusion on floor|1|||
147321927|NCT03212365|531341746|FG001|Overall Study|Initiated heparin infusion on floor|1|||
147321928|NCT03212365|531341745|FG000|Overall Study|Unexpected return to OR|1|||
147321929|NCT03212365|531341746|FG001|Overall Study|Unexpected return to OR|1|||
147321930|NCT03212365|531341745|FG000|Overall Study|Medication distribution error|1|||
147321931|NCT03212365|531341746|FG001|Overall Study|Medication distribution error|0|||
147321932|NCT03212365|531341745|FG000|Overall Study|Required epidural placement|1|||
147321933|NCT03212365|531341746|FG001|Overall Study|Required epidural placement|0|||
147321934|NCT03212365|531341745|FG000|Overall Study|Withdrawal by Subject|0|||
147321935|NCT03212365|531341746|FG001|Overall Study|Withdrawal by Subject|1|||
147321936|NCT03212365|531341745|FG000|Overall Study|developed acute renal failure|0|||
147583412|NCT02725411|532291612|FG002|Follow-up Period (24 Weeks)|Adverse Event|0|||
147583413|NCT02725411|532291610|FG000|Follow-up Period (24 Weeks)|Lack of Efficacy|0|||
147583414|NCT02725411|532291611|FG001|Follow-up Period (24 Weeks)|Lack of Efficacy|2|||
147583415|NCT02725411|532291612|FG002|Follow-up Period (24 Weeks)|Lack of Efficacy|0|||
147583416|NCT02725411|532291610|FG000|Follow-up Period (24 Weeks)|Lost to Follow-up|1|||
147154104|NCT01461928|530727630|FG000|Induction (up to 8 Months)|Death|3|||
147154105|NCT01461928|530727631|FG001|Induction (up to 8 Months)|Death|0|||
147240538|NCT00679432|531051638|FG001|Overall Study|Sponsor decision|0|||
147240539|NCT00679432|531051639|FG002|Overall Study|Sponsor decision|0|||
147321937|NCT03212365|531341746|FG001|Overall Study|developed acute renal failure|1|||
147154106|NCT01461928|530727632|FG002|Induction (up to 8 Months)|Death|0|||
147154107|NCT01461928|530727630|FG000|Induction (up to 8 Months)|Lost to Follow-up|5|||
147154108|NCT01461928|530727631|FG001|Induction (up to 8 Months)|Lost to Follow-up|0|||
147154109|NCT01461928|530727632|FG002|Induction (up to 8 Months)|Lost to Follow-up|0|||
147154110|NCT01461928|530727630|FG000|Induction (up to 8 Months)|Physician Decision|9|||
147154111|NCT01461928|530727631|FG001|Induction (up to 8 Months)|Physician Decision|0|||
147321938|NCT00333138|531341748|FG000|Core Study (6 Months)|Adverse Event|4|||
147321939|NCT00333138|531341749|FG001|Core Study (6 Months)|Adverse Event|5|||
147240540|NCT00679432|531051640|FG003|Overall Study|Sponsor decision|0|||
147240541|NCT00679432|531051637|FG000|Overall Study|Lack of Efficacy|13|||
147321940|NCT00333138|531341750|FG002|Core Study (6 Months)|Adverse Event|8|||
147321941|NCT00333138|531341748|FG000|Core Study (6 Months)|Withdrawal by Subject|1|||
147321942|NCT00333138|531341749|FG001|Core Study (6 Months)|Withdrawal by Subject|1|||
147321943|NCT00333138|531341750|FG002|Core Study (6 Months)|Withdrawal by Subject|2|||
147321944|NCT00333138|531341748|FG000|Core Study (6 Months)|Lack of Efficacy|1|||
147321945|NCT00333138|531341749|FG001|Core Study (6 Months)|Lack of Efficacy|0|||
147321946|NCT00333138|531341750|FG002|Core Study (6 Months)|Lack of Efficacy|0|||
147446808|NCT01732796|531800307|FG001|Overall Study|Lost to Follow-up|0|||
147154112|NCT01461928|530727632|FG002|Induction (up to 8 Months)|Physician Decision|0|||
147154113|NCT01461928|530727630|FG000|Induction (up to 8 Months)|Withdrawal by Subject|18|||
147154114|NCT01461928|530727631|FG001|Induction (up to 8 Months)|Withdrawal by Subject|0|||
147154115|NCT01461928|530727632|FG002|Induction (up to 8 Months)|Withdrawal by Subject|0|||
147154116|NCT01461928|530727630|FG000|Induction (up to 8 Months)|Disease progression|45|||
147154117|NCT01461928|530727631|FG001|Induction (up to 8 Months)|Disease progression|0|||
147154118|NCT01461928|530727632|FG002|Induction (up to 8 Months)|Disease progression|0|||
147154119|NCT01461928|530727630|FG000|Induction (up to 8 Months)|Eligibility criteria deviation|10|||
147154120|NCT01461928|530727631|FG001|Induction (up to 8 Months)|Eligibility criteria deviation|0|||
147154121|NCT01461928|530727632|FG002|Induction (up to 8 Months)|Eligibility criteria deviation|0|||
147154122|NCT01461928|530727630|FG000|Induction (up to 8 Months)|Completed Induction, no Maint I received|11|||
147154123|NCT01461928|530727631|FG001|Induction (up to 8 Months)|Completed Induction, no Maint I received|0|||
147154124|NCT01461928|530727632|FG002|Induction (up to 8 Months)|Completed Induction, no Maint I received|0|||
147154125|NCT01461928|530727630|FG000|Induction (up to 8 Months)|Not responding to treatment|11|||
147154126|NCT01461928|530727631|FG001|Induction (up to 8 Months)|Not responding to treatment|0|||
147154127|NCT01461928|530727632|FG002|Induction (up to 8 Months)|Not responding to treatment|0|||
147154128|NCT01461928|530727630|FG000|Induction (up to 8 Months)|Termination of study in Switzerland|1|||
147154129|NCT01461928|530727631|FG001|Induction (up to 8 Months)|Termination of study in Switzerland|0|||
147154130|NCT01461928|530727632|FG002|Induction (up to 8 Months)|Termination of study in Switzerland|0|||
147154131|NCT01461928|530727630|FG000|Induction (up to 8 Months)|Treated before eligibility was confirmed|1|||
147154132|NCT01461928|530727631|FG001|Induction (up to 8 Months)|Treated before eligibility was confirmed|0|||
147154133|NCT01461928|530727632|FG002|Induction (up to 8 Months)|Treated before eligibility was confirmed|0|||
147154134|NCT01461928|530727630|FG000|Induction (up to 8 Months)|Sponsor decision|1|||
147154135|NCT01461928|530727631|FG001|Induction (up to 8 Months)|Sponsor decision|0|||
147154136|NCT01461928|530727632|FG002|Induction (up to 8 Months)|Sponsor decision|0|||
147154137|NCT01461928|530727630|FG000|Induction (up to 8 Months)|Protocol deviation|2|||
147154138|NCT01461928|530727631|FG001|Induction (up to 8 Months)|Protocol deviation|0|||
147154139|NCT01461928|530727632|FG002|Induction (up to 8 Months)|Protocol deviation|0|||
147154140|NCT01461928|530727630|FG000|Induction (up to 8 Months)|Prednisolone given prior to enrolment|1|||
147154141|NCT01461928|530727631|FG001|Induction (up to 8 Months)|Prednisolone given prior to enrolment|0|||
147154142|NCT01461928|530727632|FG002|Induction (up to 8 Months)|Prednisolone given prior to enrolment|0|||
147154143|NCT01461928|530727630|FG000|Induction (up to 8 Months)|Cycle 7 rituximab not given in error|1|||
147154144|NCT01461928|530727631|FG001|Induction (up to 8 Months)|Cycle 7 rituximab not given in error|0|||
147154145|NCT01461928|530727632|FG002|Induction (up to 8 Months)|Cycle 7 rituximab not given in error|0|||
147154146|NCT01461928|530727630|FG000|Induction (up to 8 Months)|Promotor request|1|||
147154147|NCT01461928|530727631|FG001|Induction (up to 8 Months)|Promotor request|0|||
147154148|NCT01461928|530727632|FG002|Induction (up to 8 Months)|Promotor request|0|||
147154149|NCT01461928|530727630|FG000|Induction (up to 8 Months)|Exceeded time limit for next cycle|1|||
147154150|NCT01461928|530727631|FG001|Induction (up to 8 Months)|Exceeded time limit for next cycle|0|||
147154151|NCT01461928|530727632|FG002|Induction (up to 8 Months)|Exceeded time limit for next cycle|0|||
147154152|NCT01461928|530727630|FG000|Induction (up to 8 Months)|Medical advisor request|1|||
147154153|NCT01461928|530727631|FG001|Induction (up to 8 Months)|Medical advisor request|0|||
147154154|NCT01461928|530727632|FG002|Induction (up to 8 Months)|Medical advisor request|0|||
147154155|NCT01461928|530727630|FG000|Maintenance I (24 Months)|Death|3|||
147154156|NCT01461928|530727631|FG001|Maintenance I (24 Months)|Death|0|||
147154157|NCT01461928|530727632|FG002|Maintenance I (24 Months)|Death|0|||
147154158|NCT01461928|530727630|FG000|Maintenance I (24 Months)|Withdrawal by Subject|32|||
147154159|NCT01461928|530727631|FG001|Maintenance I (24 Months)|Withdrawal by Subject|0|||
147154160|NCT01461928|530727632|FG002|Maintenance I (24 Months)|Withdrawal by Subject|0|||
147154161|NCT01461928|530727630|FG000|Maintenance I (24 Months)|Lost to Follow-up|2|||
147154162|NCT01461928|530727631|FG001|Maintenance I (24 Months)|Lost to Follow-up|0|||
147154163|NCT01461928|530727632|FG002|Maintenance I (24 Months)|Lost to Follow-up|0|||
147154164|NCT01461928|530727630|FG000|Maintenance I (24 Months)|Diseases progression|91|||
147154165|NCT01461928|530727631|FG001|Maintenance I (24 Months)|Diseases progression|0|||
147154166|NCT01461928|530727632|FG002|Maintenance I (24 Months)|Diseases progression|0|||
147154167|NCT01461928|530727630|FG000|Maintenance I (24 Months)|Adverse Event|70|||
147154168|NCT01461928|530727631|FG001|Maintenance I (24 Months)|Adverse Event|0|||
147154169|NCT01461928|530727632|FG002|Maintenance I (24 Months)|Adverse Event|0|||
147321947|NCT00333138|531341748|FG000|Core Study (6 Months)|Protocol Violation|1|||
147321948|NCT00333138|531341749|FG001|Core Study (6 Months)|Protocol Violation|0|||
147583417|NCT02725411|532291611|FG001|Follow-up Period (24 Weeks)|Lost to Follow-up|1|||
147583418|NCT02725411|532291612|FG002|Follow-up Period (24 Weeks)|Lost to Follow-up|0|||
147583419|NCT02725411|532291610|FG000|Follow-up Period (24 Weeks)|Other|1|||
147583420|NCT02725411|532291611|FG001|Follow-up Period (24 Weeks)|Other|4|||
147583421|NCT02725411|532291612|FG002|Follow-up Period (24 Weeks)|Other|2|||
147583422|NCT02725411|532291610|FG000|Follow-up Period (24 Weeks)|Withdrawal by Subject|1|||
147154170|NCT01461928|530727630|FG000|Maintenance I (24 Months)|Physician Decision|9|||
147154171|NCT01461928|530727631|FG001|Maintenance I (24 Months)|Physician Decision|0|||
147154172|NCT01461928|530727632|FG002|Maintenance I (24 Months)|Physician Decision|0|||
147154173|NCT01461928|530727630|FG000|Maintenance I (24 Months)|Did not meet randomization criteria|2|||
147154174|NCT01461928|530727631|FG001|Maintenance I (24 Months)|Did not meet randomization criteria|0|||
147154175|NCT01461928|530727632|FG002|Maintenance I (24 Months)|Did not meet randomization criteria|0|||
147154176|NCT01461928|530727630|FG000|Maintenance I (24 Months)|Did not perform scheduled assessment|2|||
147154177|NCT01461928|530727631|FG001|Maintenance I (24 Months)|Did not perform scheduled assessment|0|||
147154178|NCT01461928|530727632|FG002|Maintenance I (24 Months)|Did not perform scheduled assessment|0|||
147154179|NCT01461928|530727630|FG000|Maintenance I (24 Months)|Delay in rituximab administration|1|||
147154180|NCT01461928|530727631|FG001|Maintenance I (24 Months)|Delay in rituximab administration|0|||
147154181|NCT01461928|530727632|FG002|Maintenance I (24 Months)|Delay in rituximab administration|0|||
147154182|NCT01461928|530727630|FG000|Maintenance I (24 Months)|Not compliant|1|||
147154183|NCT01461928|530727631|FG001|Maintenance I (24 Months)|Not compliant|0|||
147154184|NCT01461928|530727632|FG002|Maintenance I (24 Months)|Not compliant|0|||
147154185|NCT01461928|530727630|FG000|Maintenance I (24 Months)|Did not meet criteria|5|||
147154186|NCT01461928|530727631|FG001|Maintenance I (24 Months)|Did not meet criteria|0|||
147154187|NCT01461928|530727632|FG002|Maintenance I (24 Months)|Did not meet criteria|0|||
147154188|NCT01461928|530727630|FG000|Maintenance II (15 Months)|Adverse Event|0|||
147154189|NCT01461928|530727631|FG001|Maintenance II (15 Months)|Adverse Event|2|||
147154190|NCT01461928|530727632|FG002|Maintenance II (15 Months)|Adverse Event|0|||
147583423|NCT02725411|532291611|FG001|Follow-up Period (24 Weeks)|Withdrawal by Subject|3|||
147154191|NCT01461928|530727630|FG000|Maintenance II (15 Months)|Death|0|||
147154192|NCT01461928|530727631|FG001|Maintenance II (15 Months)|Death|10|||
147154193|NCT01461928|530727632|FG002|Maintenance II (15 Months)|Death|8|||
147154194|NCT01461928|530727630|FG000|Maintenance II (15 Months)|Physician Decision|0|||
147154195|NCT01461928|530727631|FG001|Maintenance II (15 Months)|Physician Decision|0|||
147154196|NCT01461928|530727632|FG002|Maintenance II (15 Months)|Physician Decision|4|||
147154197|NCT01461928|530727630|FG000|Maintenance II (15 Months)|Lost to Follow-up|0|||
147154198|NCT01461928|530727631|FG001|Maintenance II (15 Months)|Lost to Follow-up|1|||
147154199|NCT01461928|530727632|FG002|Maintenance II (15 Months)|Lost to Follow-up|0|||
147154200|NCT01461928|530727630|FG000|Maintenance II (15 Months)|Moved to another town|0|||
147154201|NCT01461928|530727631|FG001|Maintenance II (15 Months)|Moved to another town|1|||
147154202|NCT01461928|530727632|FG002|Maintenance II (15 Months)|Moved to another town|0|||
147154203|NCT01461928|530727630|FG000|Maintenance II (15 Months)|Disease progression|0|||
147154204|NCT01461928|530727631|FG001|Maintenance II (15 Months)|Disease progression|0|||
147154205|NCT01461928|530727632|FG002|Maintenance II (15 Months)|Disease progression|3|||
147154206|NCT01461928|530727630|FG000|Maintenance II (15 Months)|Withdrawal by Subject|0|||
147154207|NCT01461928|530727631|FG001|Maintenance II (15 Months)|Withdrawal by Subject|9|||
147154208|NCT01461928|530727632|FG002|Maintenance II (15 Months)|Withdrawal by Subject|8|||
147154209|NCT01461928|530727630|FG000|Maintenance II (15 Months)|Changed physician in another hospital|0|||
147154210|NCT01461928|530727631|FG001|Maintenance II (15 Months)|Changed physician in another hospital|0|||
147154211|NCT01461928|530727632|FG002|Maintenance II (15 Months)|Changed physician in another hospital|1|||
147154212|NCT01461928|530727630|FG000|Maintenance II (15 Months)|Squamous lung carcinoma|0|||
147154213|NCT01461928|530727631|FG001|Maintenance II (15 Months)|Squamous lung carcinoma|0|||
147154214|NCT01461928|530727632|FG002|Maintenance II (15 Months)|Squamous lung carcinoma|1|||
147154215|NCT01461928|530727630|FG000|Maintenance II (15 Months)|Withdrew informed consent|0|||
147154216|NCT01461928|530727631|FG001|Maintenance II (15 Months)|Withdrew informed consent|0|||
147154217|NCT01461928|530727632|FG002|Maintenance II (15 Months)|Withdrew informed consent|1|||
147154218|NCT01461928|530727630|FG000|Maintenance II (15 Months)|Refused to be transferred to other site|0|||
147154219|NCT01461928|530727631|FG001|Maintenance II (15 Months)|Refused to be transferred to other site|0|||
147154220|NCT01461928|530727632|FG002|Maintenance II (15 Months)|Refused to be transferred to other site|1|||
147154221|NCT02526524|530727634|FG000|Overall Study|Withdrawal by Subject|3|||
147154222|NCT02526524|530727635|FG001|Overall Study|Withdrawal by Subject|3|||
147154223|NCT02526524|530727636|FG002|Overall Study|Withdrawal by Subject|6|||
147154224|NCT02526524|530727637|FG003|Overall Study|Withdrawal by Subject|1|||
147154225|NCT02526524|530727638|FG004|Overall Study|Withdrawal by Subject|9|||
147154226|NCT02526524|530727639|FG005|Overall Study|Withdrawal by Subject|5|||
147154227|NCT02526524|530727634|FG000|Overall Study|Adverse Event|3|||
147154228|NCT02526524|530727635|FG001|Overall Study|Adverse Event|2|||
147154229|NCT02526524|530727636|FG002|Overall Study|Adverse Event|4|||
147446809|NCT01732796|531800308|FG002|Overall Study|Lost to Follow-up|0|||
147446810|NCT01732796|531800306|FG000|Overall Study|Withdrawal by Subject|6|||
147446811|NCT01732796|531800307|FG001|Overall Study|Withdrawal by Subject|8|||
147583424|NCT02725411|532291612|FG002|Follow-up Period (24 Weeks)|Withdrawal by Subject|3|||
147583425|NCT03847974|532291613|FG000|Overall Study|relocated out of region|3|||
147154230|NCT02526524|530727637|FG003|Overall Study|Adverse Event|2|||
147154231|NCT02526524|530727638|FG004|Overall Study|Adverse Event|6|||
147154232|NCT02526524|530727639|FG005|Overall Study|Adverse Event|8|||
147154233|NCT02526524|530727634|FG000|Overall Study|Lost to Follow-up|2|||
147154234|NCT02526524|530727635|FG001|Overall Study|Lost to Follow-up|3|||
147154235|NCT02526524|530727636|FG002|Overall Study|Lost to Follow-up|8|||
147154236|NCT02526524|530727637|FG003|Overall Study|Lost to Follow-up|1|||
147154237|NCT02526524|530727638|FG004|Overall Study|Lost to Follow-up|2|||
147154238|NCT02526524|530727639|FG005|Overall Study|Lost to Follow-up|5|||
147154239|NCT02526524|530727634|FG000|Overall Study|Protocol Violation|3|||
147154240|NCT02526524|530727635|FG001|Overall Study|Protocol Violation|1|||
147154241|NCT02526524|530727636|FG002|Overall Study|Protocol Violation|5|||
147154242|NCT02526524|530727637|FG003|Overall Study|Protocol Violation|3|||
147154243|NCT02526524|530727638|FG004|Overall Study|Protocol Violation|4|||
147154244|NCT02526524|530727639|FG005|Overall Study|Protocol Violation|3|||
147154245|NCT02526524|530727634|FG000|Overall Study|Loss of Glucose Control|0|||
147154246|NCT02526524|530727635|FG001|Overall Study|Loss of Glucose Control|0|||
147154247|NCT02526524|530727636|FG002|Overall Study|Loss of Glucose Control|3|||
147154248|NCT02526524|530727637|FG003|Overall Study|Loss of Glucose Control|0|||
147154249|NCT02526524|530727638|FG004|Overall Study|Loss of Glucose Control|2|||
147154250|NCT02526524|530727639|FG005|Overall Study|Loss of Glucose Control|0|||
147154251|NCT02526524|530727634|FG000|Overall Study|Physician Decision|0|||
147154252|NCT02526524|530727635|FG001|Overall Study|Physician Decision|0|||
147154253|NCT02526524|530727636|FG002|Overall Study|Physician Decision|0|||
147154254|NCT02526524|530727637|FG003|Overall Study|Physician Decision|0|||
147154255|NCT02526524|530727638|FG004|Overall Study|Physician Decision|1|||
147154256|NCT02526524|530727639|FG005|Overall Study|Physician Decision|0|||
147154257|NCT02526524|530727634|FG000|Overall Study|Sponsor Decision|1|||
147583426|NCT03847974|532291613|FG000|Overall Study|Withdrawal by Subject|2|||
147583427|NCT03847974|532291613|FG000|Overall Study|Adverse Event|1|||
147154258|NCT02526524|530727635|FG001|Overall Study|Sponsor Decision|0|||
147154259|NCT02526524|530727636|FG002|Overall Study|Sponsor Decision|0|||
147154260|NCT02526524|530727637|FG003|Overall Study|Sponsor Decision|0|||
147154261|NCT02526524|530727638|FG004|Overall Study|Sponsor Decision|0|||
147154262|NCT02526524|530727639|FG005|Overall Study|Sponsor Decision|0|||
147154263|NCT00664560|530727640|FG000|Overall Study|Adverse Event|19|||
147154264|NCT00664560|530727641|FG001|Overall Study|Adverse Event|16|||
147154265|NCT00664560|530727642|FG002|Overall Study|Adverse Event|7|||
147154266|NCT00664560|530727640|FG000|Overall Study|Withdrawal by Subject|9|||
147154267|NCT00664560|530727641|FG001|Overall Study|Withdrawal by Subject|13|||
147154268|NCT00664560|530727642|FG002|Overall Study|Withdrawal by Subject|7|||
147154269|NCT00664560|530727640|FG000|Overall Study|Lost to Follow-up|0|||
147154270|NCT00664560|530727641|FG001|Overall Study|Lost to Follow-up|2|||
147154271|NCT00664560|530727642|FG002|Overall Study|Lost to Follow-up|0|||
147154272|NCT00664560|530727640|FG000|Overall Study|Other|11|||
147154273|NCT00664560|530727641|FG001|Overall Study|Other|4|||
147154274|NCT00664560|530727642|FG002|Overall Study|Other|5|||
147154275|NCT01289353|530727645|FG000|Overall Study|Lost to Follow-up|2|||
147583428|NCT02654015|532291614|FG000|Overall Study|Death|12|||
147154276|NCT01549886|530727646|FG000|Overall Study|Sponsor's decision|2|||
147154277|NCT01549886|530727647|FG001|Overall Study|Sponsor's decision|3|||
147154278|NCT00473668|530727648|FG000|Overall Study|Withdrawal by Subject|0|||
147154279|NCT00473668|530727649|FG001|Overall Study|Withdrawal by Subject|2|||
147154280|NCT00473668|530727650|FG002|Overall Study|Withdrawal by Subject|0|||
147154281|NCT00473668|530727648|FG000|Overall Study|Migrated/moved from study area|3|||
147154282|NCT00473668|530727649|FG001|Overall Study|Migrated/moved from study area|2|||
147154283|NCT00473668|530727650|FG002|Overall Study|Migrated/moved from study area|0|||
147154284|NCT00473668|530727648|FG000|Overall Study|Lost to Follow-up|0|||
147583429|NCT02654015|532291614|FG000|Overall Study|Lost to Follow-up|3|||
147154285|NCT00473668|530727649|FG001|Overall Study|Lost to Follow-up|4|||
147154286|NCT00473668|530727650|FG002|Overall Study|Lost to Follow-up|6|||
147154287|NCT00473668|530727648|FG000|Overall Study|Other|2|||
147240542|NCT00679432|531051638|FG001|Overall Study|Lack of Efficacy|9|||
147240543|NCT00679432|531051639|FG002|Overall Study|Lack of Efficacy|14|||
147240544|NCT00679432|531051640|FG003|Overall Study|Lack of Efficacy|8|||
147240545|NCT00679432|531051637|FG000|Overall Study|Infectious colitis, normal histology|5|||
147154288|NCT00473668|530727649|FG001|Overall Study|Other|3|||
147154289|NCT00473668|530727650|FG002|Overall Study|Other|4|||
147154290|NCT04569136|530727651|FG000|Overall Study|Lost to Follow-up|2|||
147154291|NCT04569136|530727652|FG001|Overall Study|Lost to Follow-up|0|||
147154292|NCT04569136|530727653|FG002|Overall Study|Lost to Follow-up|1|||
147240546|NCT00679432|531051638|FG001|Overall Study|Infectious colitis, normal histology|4|||
147154293|NCT00129701|530727655|FG000|Overall Study|Withdrawal by Subject|33|||
147154294|NCT03576066|530727656|FG000|Overall Study|Noncompliance with study drug|0|||
147154295|NCT03576066|530727657|FG001|Overall Study|Noncompliance with study drug|1|||
147446812|NCT01732796|531800308|FG002|Overall Study|Withdrawal by Subject|2|||
147583430|NCT02418754|532291615|FG000|Period 1 (Day 1 to Week 12)|Adverse Event|0|||
147154296|NCT00006164|530727658|FG000|Overall Study|Withdrew or lost to follow-up|70|||
147154297|NCT00006164|530727659|FG001|Overall Study|Withdrew or lost to follow-up|81|||
147154298|NCT00223808|530727660|FG000|Overall Study|<5 hrs therapy before discharge|3|||
147154299|NCT00223808|530727661|FG001|Overall Study|<5 hrs therapy before discharge|5|||
147154300|NCT00223808|530727662|FG002|Overall Study|<5 hrs therapy before discharge|5|||
147154301|NCT00365105|530727663|FG000|Overall Study|Protocol Violation|5|||
147154302|NCT00365105|530727664|FG001|Overall Study|Protocol Violation|8|||
147154303|NCT00191724|530727667|FG000|Overall Study|Adverse Event|0|||
147154304|NCT00191724|530727668|FG001|Overall Study|Adverse Event|0|||
147154305|NCT00191724|530727669|FG002|Overall Study|Adverse Event|1|||
147154306|NCT00191724|530727670|FG003|Overall Study|Adverse Event|0|||
147154307|NCT00191724|530727671|FG004|Overall Study|Adverse Event|0|||
147154308|NCT00191724|530727667|FG000|Overall Study|Lost to Follow-up|1|||
147154309|NCT00191724|530727668|FG001|Overall Study|Lost to Follow-up|1|||
147154310|NCT00191724|530727669|FG002|Overall Study|Lost to Follow-up|0|||
147154311|NCT00191724|530727670|FG003|Overall Study|Lost to Follow-up|2|||
147154312|NCT00191724|530727671|FG004|Overall Study|Lost to Follow-up|3|||
147154313|NCT00191724|530727667|FG000|Overall Study|Withdrawal by Subject|0|||
147154314|NCT00191724|530727668|FG001|Overall Study|Withdrawal by Subject|0|||
147154315|NCT00191724|530727669|FG002|Overall Study|Withdrawal by Subject|0|||
147154316|NCT00191724|530727670|FG003|Overall Study|Withdrawal by Subject|1|||
147154317|NCT00191724|530727671|FG004|Overall Study|Withdrawal by Subject|0|||
147154318|NCT06422364|530727672|FG000|Overall Study|Withdrawn due to study closure|0|||
147154319|NCT06422364|530727673|FG001|Overall Study|Withdrawn due to study closure|2|||
147154320|NCT05260073|530727675|FG000|Overall Study|Physician Decision|1|||
147154321|NCT05260073|530727675|FG000|Overall Study|Withdrawal by Subject|6|||
147154322|NCT05260073|530727675|FG000|Overall Study|Lost to Follow-up|14|||
147154323|NCT03458910|530727676|FG000|Overall Study|Withdrawal by Subject|7|||
147154324|NCT03458910|530727677|FG001|Overall Study|Withdrawal by Subject|8|||
147154325|NCT03458910|530727678|FG002|Overall Study|Withdrawal by Subject|6|||
147154326|NCT03458910|530727679|FG003|Overall Study|Withdrawal by Subject|4|||
147154327|NCT03458910|530727676|FG000|Overall Study|Study halted due to risk of catching COVID-19|0|||
147154328|NCT03458910|530727677|FG001|Overall Study|Study halted due to risk of catching COVID-19|0|||
147154329|NCT03458910|530727678|FG002|Overall Study|Study halted due to risk of catching COVID-19|3|||
147154330|NCT03458910|530727679|FG003|Overall Study|Study halted due to risk of catching COVID-19|3|||
147154331|NCT06004895|530727680|FG000|Overall Study|Development of a stye in the upper left eyelid detected at the second visit|1|||
147154332|NCT06004895|530727680|FG000|Overall Study|Prescribed with corticosteroid eyedrops by their eye care clinician following the baseline visit|1|||
147154333|NCT01463696|530727689|FG000|Overall Study|Adverse Event|0|||
147154334|NCT01463696|530727690|FG001|Overall Study|Adverse Event|1|||
147154335|NCT01463696|530727691|FG002|Overall Study|Adverse Event|0|||
147154336|NCT01463696|530727692|FG003|Overall Study|Adverse Event|2|||
147154337|NCT01463696|530727693|FG004|Overall Study|Adverse Event|0|||
147154338|NCT01463696|530727694|FG005|Overall Study|Adverse Event|1|||
147154339|NCT01463696|530727695|FG006|Overall Study|Adverse Event|3|||
147154340|NCT01463696|530727696|FG007|Overall Study|Adverse Event|2|||
147154341|NCT01463696|530727689|FG000|Overall Study|Lost to Follow-up|0|||
147154342|NCT01463696|530727690|FG001|Overall Study|Lost to Follow-up|0|||
147154343|NCT01463696|530727691|FG002|Overall Study|Lost to Follow-up|1|||
147154344|NCT01463696|530727692|FG003|Overall Study|Lost to Follow-up|0|||
147154345|NCT01463696|530727693|FG004|Overall Study|Lost to Follow-up|0|||
147154346|NCT01463696|530727694|FG005|Overall Study|Lost to Follow-up|0|||
147154347|NCT01463696|530727695|FG006|Overall Study|Lost to Follow-up|0|||
147154348|NCT01463696|530727696|FG007|Overall Study|Lost to Follow-up|0|||
147154349|NCT01463696|530727689|FG000|Overall Study|Progressive Disease|0|||
147154350|NCT01463696|530727690|FG001|Overall Study|Progressive Disease|1|||
147154351|NCT01463696|530727691|FG002|Overall Study|Progressive Disease|0|||
147154352|NCT01463696|530727692|FG003|Overall Study|Progressive Disease|1|||
147154353|NCT01463696|530727693|FG004|Overall Study|Progressive Disease|0|||
147154354|NCT01463696|530727694|FG005|Overall Study|Progressive Disease|1|||
147154355|NCT01463696|530727695|FG006|Overall Study|Progressive Disease|4|||
147154356|NCT01463696|530727696|FG007|Overall Study|Progressive Disease|2|||
147154357|NCT01463696|530727689|FG000|Overall Study|Withdrawal by Subject|0|||
147154358|NCT01463696|530727690|FG001|Overall Study|Withdrawal by Subject|0|||
147154359|NCT01463696|530727691|FG002|Overall Study|Withdrawal by Subject|0|||
147583431|NCT02418754|532291616|FG001|Period 1 (Day 1 to Week 12)|Adverse Event|2|||
147583432|NCT02418754|532291617|FG002|Period 1 (Day 1 to Week 12)|Adverse Event|0|||
147583433|NCT02418754|532291618|FG003|Period 1 (Day 1 to Week 12)|Adverse Event|0|||
147583434|NCT02418754|532291619|FG004|Period 1 (Day 1 to Week 12)|Adverse Event|0|||
147154360|NCT01463696|530727692|FG003|Overall Study|Withdrawal by Subject|1|||
147154361|NCT01463696|530727693|FG004|Overall Study|Withdrawal by Subject|1|||
147154362|NCT01463696|530727694|FG005|Overall Study|Withdrawal by Subject|1|||
147154363|NCT01463696|530727695|FG006|Overall Study|Withdrawal by Subject|2|||
147154364|NCT01463696|530727696|FG007|Overall Study|Withdrawal by Subject|0|||
147154365|NCT01463696|530727689|FG000|Overall Study|Not Treated|0|||
147446813|NCT01732796|531800306|FG000|Overall Study|Other reason not defined above|1|||
147583435|NCT02418754|532291615|FG000|Period 1 (Day 1 to Week 12)|Death|1|||
147154366|NCT01463696|530727690|FG001|Overall Study|Not Treated|0|||
147154367|NCT01463696|530727691|FG002|Overall Study|Not Treated|0|||
147154368|NCT01463696|530727692|FG003|Overall Study|Not Treated|0|||
147154369|NCT01463696|530727693|FG004|Overall Study|Not Treated|0|||
147154370|NCT01463696|530727694|FG005|Overall Study|Not Treated|0|||
147154371|NCT01463696|530727695|FG006|Overall Study|Not Treated|1|||
147154372|NCT01463696|530727696|FG007|Overall Study|Not Treated|0|||
147154373|NCT00967694|530727698|FG000|Overall Study|Withdrawal by Subject|6|||
147154374|NCT00152477|530727701|FG000|Chemotherapy Period|Adverse Event|9|||
147154375|NCT00152477|530727702|FG001|Chemotherapy Period|Adverse Event|4|||
147154376|NCT00152477|530727703|FG002|Chemotherapy Period|Adverse Event|5|||
147154377|NCT00152477|530727701|FG000|Chemotherapy Period|Death|1|||
147154378|NCT00152477|530727702|FG001|Chemotherapy Period|Death|3|||
147154379|NCT00152477|530727703|FG002|Chemotherapy Period|Death|3|||
147154380|NCT00152477|530727701|FG000|Chemotherapy Period|Lack of Efficacy|4|||
147154381|NCT00152477|530727702|FG001|Chemotherapy Period|Lack of Efficacy|5|||
147154382|NCT00152477|530727703|FG002|Chemotherapy Period|Lack of Efficacy|6|||
147154383|NCT00152477|530727701|FG000|Chemotherapy Period|Lost to Follow-up|1|||
147154384|NCT00152477|530727702|FG001|Chemotherapy Period|Lost to Follow-up|0|||
147154385|NCT00152477|530727703|FG002|Chemotherapy Period|Lost to Follow-up|1|||
147154386|NCT00152477|530727701|FG000|Chemotherapy Period|Protocol Violation|1|||
147154387|NCT00152477|530727702|FG001|Chemotherapy Period|Protocol Violation|1|||
147154388|NCT00152477|530727703|FG002|Chemotherapy Period|Protocol Violation|0|||
147154389|NCT00152477|530727701|FG000|Chemotherapy Period|Withdrawal by Subject|5|||
147154390|NCT00152477|530727702|FG001|Chemotherapy Period|Withdrawal by Subject|1|||
147154391|NCT00152477|530727703|FG002|Chemotherapy Period|Withdrawal by Subject|0|||
147154392|NCT00152477|530727701|FG000|Chemotherapy Period|Progression of Disease|6|||
147154393|NCT00152477|530727702|FG001|Chemotherapy Period|Progression of Disease|8|||
147154394|NCT00152477|530727703|FG002|Chemotherapy Period|Progression of Disease|4|||
147154395|NCT00152477|530727701|FG000|Chemotherapy Period|Investigator decision|0|||
147154396|NCT00152477|530727702|FG001|Chemotherapy Period|Investigator decision|0|||
147154397|NCT00152477|530727703|FG002|Chemotherapy Period|Investigator decision|1|||
147154398|NCT00152477|530727701|FG000|Chemotherapy Period|Patient condition worsened|1|||
147154399|NCT00152477|530727702|FG001|Chemotherapy Period|Patient condition worsened|0|||
147154400|NCT00152477|530727703|FG002|Chemotherapy Period|Patient condition worsened|0|||
147154401|NCT00152477|530727701|FG000|Monotherapy Period|Adverse Event|1|||
147154402|NCT00152477|530727702|FG001|Monotherapy Period|Adverse Event|0|||
147154403|NCT00152477|530727703|FG002|Monotherapy Period|Adverse Event|5|||
147154404|NCT00152477|530727701|FG000|Monotherapy Period|Death|2|||
147154405|NCT00152477|530727702|FG001|Monotherapy Period|Death|0|||
147154406|NCT00152477|530727703|FG002|Monotherapy Period|Death|1|||
147154407|NCT00152477|530727701|FG000|Monotherapy Period|Lack of Efficacy|7|||
147154408|NCT00152477|530727702|FG001|Monotherapy Period|Lack of Efficacy|16|||
147154409|NCT00152477|530727703|FG002|Monotherapy Period|Lack of Efficacy|10|||
147154410|NCT00152477|530727701|FG000|Monotherapy Period|Protocol Violation|0|||
147154411|NCT00152477|530727702|FG001|Monotherapy Period|Protocol Violation|1|||
147154412|NCT00152477|530727703|FG002|Monotherapy Period|Protocol Violation|0|||
147154413|NCT00152477|530727701|FG000|Monotherapy Period|Withdrawal by Subject|0|||
147154414|NCT00152477|530727702|FG001|Monotherapy Period|Withdrawal by Subject|0|||
147154415|NCT00152477|530727703|FG002|Monotherapy Period|Withdrawal by Subject|4|||
147154416|NCT00152477|530727701|FG000|Monotherapy Period|Progression of Disease|5|||
147154417|NCT00152477|530727702|FG001|Monotherapy Period|Progression of Disease|11|||
147154418|NCT00152477|530727703|FG002|Monotherapy Period|Progression of Disease|12|||
147154419|NCT00152477|530727701|FG000|Monotherapy Period|Patient decision|0|||
147240547|NCT00679432|531051639|FG002|Overall Study|Infectious colitis, normal histology|8|||
147240548|NCT00679432|531051640|FG003|Overall Study|Infectious colitis, normal histology|3|||
147240549|NCT00679432|531051637|FG000|Overall Study|Randomization error, return to prior Rx|0|||
147240550|NCT00679432|531051638|FG001|Overall Study|Randomization error, return to prior Rx|0|||
147240551|NCT00679432|531051639|FG002|Overall Study|Randomization error, return to prior Rx|3|||
147240552|NCT00679432|531051640|FG003|Overall Study|Randomization error, return to prior Rx|0|||
147240553|NCT01558271|531051641|FG000|Overall Study|Adverse Event|6|||
147240554|NCT01558271|531051642|FG001|Overall Study|Adverse Event|3|||
147240555|NCT01558271|531051643|FG002|Overall Study|Adverse Event|4|||
147154420|NCT00152477|530727702|FG001|Monotherapy Period|Patient decision|1|||
147240556|NCT01558271|531051641|FG000|Overall Study|Lost to Follow-up|1|||
147154421|NCT00152477|530727703|FG002|Monotherapy Period|Patient decision|1|||
147154422|NCT00152477|530727701|FG000|Monotherapy Period|Study personel decision|0|||
147583436|NCT02418754|532291616|FG001|Period 1 (Day 1 to Week 12)|Death|0|||
147154423|NCT00152477|530727702|FG001|Monotherapy Period|Study personel decision|0|||
147154424|NCT00152477|530727703|FG002|Monotherapy Period|Study personel decision|1|||
147154425|NCT00425698|530727704|FG000|Overall Study|Adverse Event|3|||
147154426|NCT00425698|530727705|FG001|Overall Study|Adverse Event|1|||
147154427|NCT00425698|530727704|FG000|Overall Study|Withdrawal by Subject|0|||
147154428|NCT00425698|530727705|FG001|Overall Study|Withdrawal by Subject|1|||
147154429|NCT03905265|530727713|FG000|Overall Study|Withdrawal by Subject|1|||
147154430|NCT03905265|530727714|FG001|Overall Study|Withdrawal by Subject|1|||
147154431|NCT03905265|530727715|FG002|Overall Study|Withdrawal by Subject|0|||
147154432|NCT03905265|530727716|FG003|Overall Study|Withdrawal by Subject|0|||
147154433|NCT00960011|530727717|FG000|Overall Study|Death|5|||
147154434|NCT00960011|530727718|FG001|Overall Study|Death|0|||
147154435|NCT00960011|530727717|FG000|Overall Study|Lost to Follow-up|6|||
147154436|NCT00960011|530727718|FG001|Overall Study|Lost to Follow-up|2|||
147154437|NCT00758264|530727719|FG000|Active Phase|Withdrawal by Subject|0|||
147154438|NCT00758264|530727720|FG001|Active Phase|Withdrawal by Subject|0|||
147154439|NCT00758264|530727721|FG002|Active Phase|Withdrawal by Subject|1|||
147154440|NCT00758264|530727719|FG000|Active Phase|Lost to Follow-up|1|||
147154441|NCT00758264|530727720|FG001|Active Phase|Lost to Follow-up|0|||
147154442|NCT00758264|530727721|FG002|Active Phase|Lost to Follow-up|0|||
147154443|NCT00758264|530727719|FG000|Active Phase|Other|0|||
147154444|NCT00758264|530727720|FG001|Active Phase|Other|0|||
147154445|NCT00758264|530727721|FG002|Active Phase|Other|4|||
147154446|NCT00889603|530727722|FG000|Overall Study|Adverse Event|7|||
147154447|NCT00889603|530727722|FG000|Overall Study|Death|3|||
147154448|NCT00889603|530727722|FG000|Overall Study|Lost to Follow-up|19|||
147154449|NCT00889603|530727722|FG000|Overall Study|No longer willing to participant in stud|4|||
147154450|NCT00889603|530727722|FG000|Overall Study|Other|4|||
147154451|NCT02901054|530727728|FG000|Overall Study|Physician Decision|1|||
147154452|NCT02901054|530727728|FG000|Overall Study|Withdrawal by Subject|3|||
147154453|NCT00616018|530727729|FG000|Overall Study|Protocol Violation|3|||
147154454|NCT03718884|530727730|FG000|Period 2 (120 Days)|Withdrawal by Subject|0|||
147154455|NCT03718884|530727731|FG001|Period 2 (120 Days)|Withdrawal by Subject|1|||
147154456|NCT03718884|530727730|FG000|Period 2 (120 Days)|Lost to Follow-up|0|||
147154457|NCT03718884|530727731|FG001|Period 2 (120 Days)|Lost to Follow-up|2|||
147154458|NCT02839720|530727733|FG000|Overall Study|Adverse Event|2|||
147154459|NCT02839720|530727733|FG000|Overall Study|Non-compliance|2|||
147154460|NCT02839720|530727733|FG000|Overall Study|Intercurrent Illness|1|||
147154461|NCT02839720|530727733|FG000|Overall Study|Non-compliance due to COVID-19 pandemic|2|||
147154462|NCT05248997|530727736|FG000|Overall Study|Lost to Follow-up|1|||
147154463|NCT05248997|530727737|FG001|Overall Study|Lost to Follow-up|1|||
147154464|NCT05248997|530727736|FG000|Overall Study|Randomized but not treated|32|||
147154465|NCT05248997|530727737|FG001|Overall Study|Randomized but not treated|25|||
147154466|NCT01453205|530727738|FG000|Overall Study|Lost to Follow-up|3|||
147154467|NCT01453205|530727739|FG001|Overall Study|Lost to Follow-up|0|||
147154468|NCT01453205|530727740|FG002|Overall Study|Lost to Follow-up|1|||
147154469|NCT01453205|530727738|FG000|Overall Study|Withdrawal by Subject|8|||
147154470|NCT01453205|530727739|FG001|Overall Study|Withdrawal by Subject|3|||
147154471|NCT01453205|530727740|FG002|Overall Study|Withdrawal by Subject|0|||
147154472|NCT01453205|530727738|FG000|Overall Study|Death|24|||
147154473|NCT01453205|530727739|FG001|Overall Study|Death|22|||
147154474|NCT01453205|530727740|FG002|Overall Study|Death|18|||
147154475|NCT01453205|530727738|FG000|Overall Study|Other|45|||
147154476|NCT01453205|530727739|FG001|Overall Study|Other|27|||
147154477|NCT01453205|530727740|FG002|Overall Study|Other|35|||
147154478|NCT05593913|530727741|FG000|Overall Study|Insufficient image quality|39|||
147154479|NCT02602275|530727742|FG000|Day 1|Physician Decision|0|||
147154480|NCT02602275|530727743|FG001|Day 1|Physician Decision|1|||
147154481|NCT04113018|530727750|FG000|Overall Study|Death|2|||
147154482|NCT04113018|530727750|FG000|Overall Study|Lost to Follow-up|1|||
147154483|NCT04113018|530727750|FG000|Overall Study|Still On Study (on study treatment)|24|||
147154484|NCT04113018|530727750|FG000|Overall Study|Still On Study (in follow up)|12|||
147154485|NCT05005013|530727751|FG000|Overall Study|Withdrawal by Subject|5|||
147154486|NCT05005013|530727752|FG001|Overall Study|Withdrawal by Subject|1|||
147154487|NCT05005013|530727751|FG000|Overall Study|Lost to Follow-up|3|||
147154488|NCT05005013|530727752|FG001|Overall Study|Lost to Follow-up|1|||
147154489|NCT05005013|530727751|FG000|Overall Study|Ineligibility|1|||
147154490|NCT05005013|530727752|FG001|Overall Study|Ineligibility|1|||
147154491|NCT02059499|530727753|FG000|Upto Week 20|Lost to Follow-up|2|||
147154492|NCT02059499|530727754|FG001|Upto Week 20|Lost to Follow-up|6|||
147154493|NCT02059499|530727755|FG002|Upto Week 20|Lost to Follow-up|0|||
147154494|NCT02059499|530727753|FG000|Upto Week 20|Treatment completed per protocol criteria|0|||
147154495|NCT02059499|530727754|FG001|Upto Week 20|Treatment completed per protocol criteria|2|||
147154496|NCT02059499|530727755|FG002|Upto Week 20|Treatment completed per protocol criteria|0|||
147154497|NCT02059499|530727753|FG000|Upto Week 20|Withdrawal by Subject|1|||
147154498|NCT02059499|530727754|FG001|Upto Week 20|Withdrawal by Subject|1|||
147154499|NCT02059499|530727755|FG002|Upto Week 20|Withdrawal by Subject|0|||
147154500|NCT02059499|530727753|FG000|Upto Week 20|No treatment per protocol criteria|0|||
147154501|NCT02059499|530727754|FG001|Upto Week 20|No treatment per protocol criteria|0|||
147154502|NCT02059499|530727755|FG002|Upto Week 20|No treatment per protocol criteria|5|||
147446814|NCT01732796|531800307|FG001|Overall Study|Other reason not defined above|0|||
147154503|NCT02059499|530727753|FG000|Post-week 20|Treatment not as per protocol criteria|3|||
147154504|NCT02059499|530727754|FG001|Post-week 20|Treatment not as per protocol criteria|4|||
147154505|NCT02059499|530727755|FG002|Post-week 20|Treatment not as per protocol criteria|9|||
147154506|NCT02059499|530727753|FG000|Post-week 20|Lost to Follow-up|0|||
147154507|NCT02059499|530727754|FG001|Post-week 20|Lost to Follow-up|2|||
147154508|NCT02059499|530727755|FG002|Post-week 20|Lost to Follow-up|0|||
147154509|NCT02059499|530727753|FG000|Post-week 20|Withdrawal by Subject|0|||
147154510|NCT02059499|530727754|FG001|Post-week 20|Withdrawal by Subject|1|||
147154511|NCT02059499|530727755|FG002|Post-week 20|Withdrawal by Subject|0|||
147154512|NCT02059499|530727753|FG000|Cross-over Post-week 20 (Re-randomized)|Lost to Follow-up|0|||
147154513|NCT02059499|530727754|FG001|Cross-over Post-week 20 (Re-randomized)|Lost to Follow-up|3|||
147654113|NCT00401193|532556622|FG000|Overall Study|Withdrawal by Subject|2|||
147654114|NCT00401193|532556623|FG001|Overall Study|Withdrawal by Subject|0|||
147654115|NCT00401193|532556624|FG002|Overall Study|Withdrawal by Subject|1|||
147654116|NCT00401193|532556622|FG000|Overall Study|Other Event|3|||
147654117|NCT00401193|532556623|FG001|Overall Study|Other Event|2|||
147654118|NCT00401193|532556624|FG002|Overall Study|Other Event|2|||
147654119|NCT02526160|532556625|FG000|Double-Blind (Placebo-Controlled) Period|Withdrawal by Subject|0|||
147654120|NCT02526160|532556626|FG001|Double-Blind (Placebo-Controlled) Period|Withdrawal by Subject|1|||
147654121|NCT02526160|532556625|FG000|Open-label Treatment Continuation Period|Withdrawal by Subject|0|||
147654122|NCT02526160|532556626|FG001|Open-label Treatment Continuation Period|Withdrawal by Subject|1|||
147654123|NCT02526160|532556625|FG000|Open-label Treatment Continuation Period|Other, Not Specified|3|||
147654124|NCT02526160|532556626|FG001|Open-label Treatment Continuation Period|Other, Not Specified|3|||
147654125|NCT02526160|532556625|FG000|Open-Label Treatment Extension Period I|Death|0|||
147654126|NCT02526160|532556626|FG001|Open-Label Treatment Extension Period I|Death|1|||
147654127|NCT02526160|532556625|FG000|Open-Label Treatment Extension Period I|Other, Not Specified|3|||
147654128|NCT02526160|532556626|FG001|Open-Label Treatment Extension Period I|Other, Not Specified|1|||
147654129|NCT02526160|532556625|FG000|Open-Label Treatment Extension Period I|Withdrawal by Subject|0|||
147654130|NCT02526160|532556626|FG001|Open-Label Treatment Extension Period I|Withdrawal by Subject|1|||
147654131|NCT02526160|532556625|FG000|Open-Label Treatment Extension Period I|Lost to Follow-up|0|||
147654132|NCT02526160|532556626|FG001|Open-Label Treatment Extension Period I|Lost to Follow-up|1|||
147654133|NCT02526160|532556625|FG000|Open-Label Treatment Extension Period II|Other, Not Specified|1|||
147240557|NCT01558271|531051642|FG001|Overall Study|Lost to Follow-up|0|||
147240558|NCT01558271|531051643|FG002|Overall Study|Lost to Follow-up|0|||
147240559|NCT01558271|531051641|FG000|Overall Study|Protocol Violation|1|||
147240560|NCT01558271|531051642|FG001|Overall Study|Protocol Violation|0|||
147240561|NCT01558271|531051643|FG002|Overall Study|Protocol Violation|0|||
147240562|NCT01558271|531051641|FG000|Overall Study|Withdrawal by Subject|10|||
147240563|NCT01558271|531051642|FG001|Overall Study|Withdrawal by Subject|6|||
147654134|NCT02526160|532556626|FG001|Open-Label Treatment Extension Period II|Other, Not Specified|0|||
147154514|NCT02059499|530727755|FG002|Cross-over Post-week 20 (Re-randomized)|Lost to Follow-up|0|||
147154515|NCT04210245|530727756|FG000|Overall Study|Adverse Event|0|||
147154516|NCT04210245|530727757|FG001|Overall Study|Adverse Event|3|||
147154517|NCT04210245|530727758|FG002|Overall Study|Adverse Event|6|||
147154518|NCT04210245|530727759|FG003|Overall Study|Adverse Event|0|||
147154519|NCT04210245|530727756|FG000|Overall Study|Withdrawal by Subject|0|||
147154520|NCT04210245|530727757|FG001|Overall Study|Withdrawal by Subject|1|||
147154521|NCT04210245|530727758|FG002|Overall Study|Withdrawal by Subject|4|||
147154522|NCT04210245|530727759|FG003|Overall Study|Withdrawal by Subject|4|||
147154523|NCT04210245|530727756|FG000|Overall Study|Lost to Follow-up|0|||
147154524|NCT04210245|530727757|FG001|Overall Study|Lost to Follow-up|1|||
147154525|NCT04210245|530727758|FG002|Overall Study|Lost to Follow-up|1|||
147154526|NCT04210245|530727759|FG003|Overall Study|Lost to Follow-up|1|||
147154527|NCT04210245|530727756|FG000|Overall Study|1 due to life stressors and injection site discomfort and 1 subject started prohibited medication|0|||
147154528|NCT04210245|530727757|FG001|Overall Study|1 due to life stressors and injection site discomfort and 1 subject started prohibited medication|0|||
147154529|NCT04210245|530727758|FG002|Overall Study|1 due to life stressors and injection site discomfort and 1 subject started prohibited medication|0|||
147154530|NCT04210245|530727759|FG003|Overall Study|1 due to life stressors and injection site discomfort and 1 subject started prohibited medication|2|||
147154531|NCT06099223|530727760|FG000|Overall Study|Preoperative surveys missed|0|||
147154532|NCT06099223|530727761|FG001|Overall Study|Preoperative surveys missed|1|||
147154533|NCT02248649|530727762|FG000|Overall Study|Death|7|||
147154534|NCT02248649|530727763|FG001|Overall Study|Death|11|||
147154535|NCT02248649|530727762|FG000|Overall Study|Lost to Follow-up|14|||
147240564|NCT01558271|531051643|FG002|Overall Study|Withdrawal by Subject|12|||
147240565|NCT01558271|531051641|FG000|Overall Study|Physician Decision|0|||
147240566|NCT01558271|531051642|FG001|Overall Study|Physician Decision|2|||
147240567|NCT01558271|531051643|FG002|Overall Study|Physician Decision|1|||
147240568|NCT01084083|531051644|FG000|Overall Study|Adverse Event|5|||
147240569|NCT01084083|531051644|FG000|Overall Study|Death|1|||
147240570|NCT01084083|531051644|FG000|Overall Study|Withdrawal by Subject|2|||
147240571|NCT01084083|531051644|FG000|Overall Study|Complicating disease|1|||
147240572|NCT01084083|531051644|FG000|Overall Study|Other|2|||
147240573|NCT01084083|531051644|FG000|Overall Study|Never started assigned therapy|1|||
147240574|NCT00873912|531051645|FG000|Overall Study|Withdrawal by Subject|1|||
147240575|NCT00873912|531051646|FG001|Overall Study|Withdrawal by Subject|0|||
147240576|NCT00873912|531051645|FG000|Overall Study|Lost to Follow-up|2|||
147654135|NCT00398216|532556627|FG000|Overall Study|Adverse Event|4|||
147654136|NCT00398216|532556628|FG001|Overall Study|Adverse Event|2|||
147583437|NCT02418754|532291617|FG002|Period 1 (Day 1 to Week 12)|Death|0|||
147583438|NCT02418754|532291618|FG003|Period 1 (Day 1 to Week 12)|Death|0|||
147583439|NCT02418754|532291619|FG004|Period 1 (Day 1 to Week 12)|Death|0|||
147583440|NCT02418754|532291615|FG000|Period 1 (Day 1 to Week 12)|Physician Decision|1|||
147583441|NCT02418754|532291616|FG001|Period 1 (Day 1 to Week 12)|Physician Decision|0|||
147583442|NCT02418754|532291617|FG002|Period 1 (Day 1 to Week 12)|Physician Decision|0|||
147583443|NCT02418754|532291618|FG003|Period 1 (Day 1 to Week 12)|Physician Decision|0|||
147583444|NCT02418754|532291619|FG004|Period 1 (Day 1 to Week 12)|Physician Decision|0|||
147583445|NCT02418754|532291615|FG000|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|0|||
147154536|NCT02248649|530727763|FG001|Overall Study|Lost to Follow-up|10|||
147154537|NCT01202188|530727772|FG000|Overall Study|Protocol deviation|14|||
147154538|NCT01202188|530727773|FG001|Overall Study|Protocol deviation|8|||
147154539|NCT01202188|530727774|FG002|Overall Study|Protocol deviation|12|||
147154540|NCT01202188|530727775|FG003|Overall Study|Protocol deviation|10|||
147154541|NCT01202188|530727776|FG004|Overall Study|Protocol deviation|11|||
147583446|NCT02418754|532291616|FG001|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|2|||
147154542|NCT01202188|530727772|FG000|Overall Study|Subject withdrew consent|12|||
147154543|NCT01202188|530727773|FG001|Overall Study|Subject withdrew consent|13|||
147154544|NCT01202188|530727774|FG002|Overall Study|Subject withdrew consent|22|||
147154545|NCT01202188|530727775|FG003|Overall Study|Subject withdrew consent|11|||
147154546|NCT01202188|530727776|FG004|Overall Study|Subject withdrew consent|13|||
147154547|NCT01202188|530727772|FG000|Overall Study|Adverse Event|5|||
147154548|NCT01202188|530727773|FG001|Overall Study|Adverse Event|23|||
147154549|NCT01202188|530727774|FG002|Overall Study|Adverse Event|13|||
147154550|NCT01202188|530727775|FG003|Overall Study|Adverse Event|10|||
147154551|NCT01202188|530727776|FG004|Overall Study|Adverse Event|10|||
147154552|NCT01202188|530727772|FG000|Overall Study|Administrative problems|3|||
147154553|NCT01202188|530727773|FG001|Overall Study|Administrative problems|2|||
147154554|NCT01202188|530727774|FG002|Overall Study|Administrative problems|1|||
147154555|NCT01202188|530727775|FG003|Overall Study|Administrative problems|1|||
147240577|NCT00873912|531051646|FG001|Overall Study|Lost to Follow-up|0|||
147583447|NCT02418754|532291617|FG002|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|1|||
147583448|NCT02418754|532291618|FG003|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|0|||
147583449|NCT02418754|532291619|FG004|Period 1 (Day 1 to Week 12)|Withdrawal by Subject|0|||
147583450|NCT02418754|532291615|FG000|Period 1 (Day 1 to Week 12)|Lost to Follow-up|0|||
147583451|NCT02418754|532291616|FG001|Period 1 (Day 1 to Week 12)|Lost to Follow-up|0|||
147583452|NCT02418754|532291617|FG002|Period 1 (Day 1 to Week 12)|Lost to Follow-up|1|||
147583453|NCT02418754|532291618|FG003|Period 1 (Day 1 to Week 12)|Lost to Follow-up|0|||
147583454|NCT02418754|532291619|FG004|Period 1 (Day 1 to Week 12)|Lost to Follow-up|0|||
147583455|NCT02418754|532291615|FG000|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|3|||
147583456|NCT02418754|532291616|FG001|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|7|||
147583457|NCT02418754|532291617|FG002|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|6|||
147583458|NCT02418754|532291618|FG003|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|2|||
147583459|NCT02418754|532291619|FG004|Period 2 (Day 1 to Week 52/End of Study)|Adverse Event|2|||
147583460|NCT02418754|532291615|FG000|Period 2 (Day 1 to Week 52/End of Study)|Death|1|||
147583461|NCT02418754|532291616|FG001|Period 2 (Day 1 to Week 52/End of Study)|Death|0|||
147583462|NCT02418754|532291617|FG002|Period 2 (Day 1 to Week 52/End of Study)|Death|0|||
147583463|NCT02418754|532291618|FG003|Period 2 (Day 1 to Week 52/End of Study)|Death|0|||
147583464|NCT02418754|532291619|FG004|Period 2 (Day 1 to Week 52/End of Study)|Death|0|||
147583465|NCT02418754|532291615|FG000|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|26|||
147583466|NCT02418754|532291616|FG001|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|28|||
147583467|NCT02418754|532291617|FG002|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|26|||
147583468|NCT02418754|532291618|FG003|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|21|||
147583469|NCT02418754|532291619|FG004|Period 2 (Day 1 to Week 52/End of Study)|Physician Decision|24|||
147583470|NCT02418754|532291615|FG000|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|3|||
147583471|NCT02418754|532291616|FG001|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|4|||
147583472|NCT02418754|532291617|FG002|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|4|||
147583473|NCT02418754|532291618|FG003|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|1|||
147583474|NCT02418754|532291619|FG004|Period 2 (Day 1 to Week 52/End of Study)|Withdrawal by Subject|0|||
147583475|NCT02418754|532291615|FG000|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|0|||
147583476|NCT02418754|532291616|FG001|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|2|||
147583477|NCT02418754|532291617|FG002|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|1|||
147583478|NCT02418754|532291618|FG003|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|2|||
147583479|NCT02418754|532291619|FG004|Period 2 (Day 1 to Week 52/End of Study)|Lost to Follow-up|1|||
147583480|NCT02418754|532291615|FG000|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|0|||
147154556|NCT01202188|530727776|FG004|Overall Study|Administrative problems|2|||
147240578|NCT01466153|531051647|FG000|Overall Study|Disease Progression|2|||
147154557|NCT01202188|530727772|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
147154558|NCT01202188|530727773|FG001|Overall Study|Unsatisfactory therapeutic effect|8|||
147154559|NCT01202188|530727774|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
147154560|NCT01202188|530727775|FG003|Overall Study|Unsatisfactory therapeutic effect|5|||
147154561|NCT01202188|530727776|FG004|Overall Study|Unsatisfactory therapeutic effect|8|||
147154562|NCT01202188|530727772|FG000|Overall Study|Lost to Follow-up|1|||
147154563|NCT01202188|530727773|FG001|Overall Study|Lost to Follow-up|1|||
147154564|NCT01202188|530727774|FG002|Overall Study|Lost to Follow-up|0|||
147154565|NCT01202188|530727775|FG003|Overall Study|Lost to Follow-up|4|||
147154566|NCT01202188|530727776|FG004|Overall Study|Lost to Follow-up|1|||
147154567|NCT01202188|530727772|FG000|Overall Study|Death|1|||
147154568|NCT01202188|530727773|FG001|Overall Study|Death|1|||
147154569|NCT01202188|530727774|FG002|Overall Study|Death|1|||
147154570|NCT01202188|530727775|FG003|Overall Study|Death|1|||
147154571|NCT01202188|530727776|FG004|Overall Study|Death|0|||
147154572|NCT01202188|530727772|FG000|Overall Study|Abnormal test procedure result (s)|0|||
147154573|NCT01202188|530727773|FG001|Overall Study|Abnormal test procedure result (s)|0|||
147154574|NCT01202188|530727774|FG002|Overall Study|Abnormal test procedure result (s)|2|||
147154575|NCT01202188|530727775|FG003|Overall Study|Abnormal test procedure result (s)|0|||
147154576|NCT01202188|530727776|FG004|Overall Study|Abnormal test procedure result (s)|0|||
147154577|NCT00487942|530727777|FG000|Overall Study|Adverse Event|1|||
147154578|NCT00487942|530727778|FG001|Overall Study|Adverse Event|1|||
147154579|NCT00487942|530727779|FG002|Overall Study|Adverse Event|1|||
147154580|NCT00487942|530727780|FG003|Overall Study|Adverse Event|1|||
147154581|NCT00487942|530727777|FG000|Overall Study|Lost to Follow-up|1|||
147154582|NCT00487942|530727778|FG001|Overall Study|Lost to Follow-up|0|||
147154583|NCT00487942|530727779|FG002|Overall Study|Lost to Follow-up|0|||
147154584|NCT00487942|530727780|FG003|Overall Study|Lost to Follow-up|1|||
147583481|NCT02418754|532291616|FG001|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|1|||
147583482|NCT02418754|532291617|FG002|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|0|||
147583483|NCT02418754|532291618|FG003|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|1|||
147583484|NCT02418754|532291619|FG004|Period 2 (Day 1 to Week 52/End of Study)|Other Un-specified|0|||
147583485|NCT01896505|532291620|FG000|Overall Study|Adverse Event|1|||
147583486|NCT01896505|532291621|FG001|Overall Study|Adverse Event|0|||
147583487|NCT01896505|532291622|FG002|Overall Study|Adverse Event|2|||
147583488|NCT01896505|532291623|FG003|Overall Study|Adverse Event|1|||
147583489|NCT01896505|532291624|FG004|Overall Study|Adverse Event|1|||
147583490|NCT01896505|532291625|FG005|Overall Study|Adverse Event|0|||
147583491|NCT01896505|532291620|FG000|Overall Study|Physician Decision|1|||
147583492|NCT01896505|532291621|FG001|Overall Study|Physician Decision|3|||
147583493|NCT01896505|532291622|FG002|Overall Study|Physician Decision|2|||
147583494|NCT01896505|532291623|FG003|Overall Study|Physician Decision|0|||
147583495|NCT01896505|532291624|FG004|Overall Study|Physician Decision|0|||
147583496|NCT01896505|532291625|FG005|Overall Study|Physician Decision|1|||
147583497|NCT01896505|532291620|FG000|Overall Study|Withdrawal by Subject|1|||
147583498|NCT01896505|532291621|FG001|Overall Study|Withdrawal by Subject|0|||
147583499|NCT01896505|532291622|FG002|Overall Study|Withdrawal by Subject|3|||
147583500|NCT01896505|532291623|FG003|Overall Study|Withdrawal by Subject|1|||
147583501|NCT01896505|532291624|FG004|Overall Study|Withdrawal by Subject|0|||
147583502|NCT01896505|532291625|FG005|Overall Study|Withdrawal by Subject|0|||
147583503|NCT01896505|532291620|FG000|Overall Study|Disease Progression|7|||
147583504|NCT01896505|532291621|FG001|Overall Study|Disease Progression|5|||
147583505|NCT01896505|532291622|FG002|Overall Study|Disease Progression|8|||
147583506|NCT01896505|532291623|FG003|Overall Study|Disease Progression|4|||
147583507|NCT01896505|532291624|FG004|Overall Study|Disease Progression|4|||
147583508|NCT01896505|532291625|FG005|Overall Study|Disease Progression|4|||
147583509|NCT01896505|532291620|FG000|Overall Study|Need of treatment not allowed per protocol|0|||
147583510|NCT01896505|532291621|FG001|Overall Study|Need of treatment not allowed per protocol|0|||
147583511|NCT01896505|532291622|FG002|Overall Study|Need of treatment not allowed per protocol|1|||
147583512|NCT01896505|532291623|FG003|Overall Study|Need of treatment not allowed per protocol|0|||
147583513|NCT01896505|532291624|FG004|Overall Study|Need of treatment not allowed per protocol|0|||
147583514|NCT01896505|532291625|FG005|Overall Study|Need of treatment not allowed per protocol|0|||
147583515|NCT01896505|532291620|FG000|Overall Study|Intercurrent illness|0|||
147583516|NCT01896505|532291621|FG001|Overall Study|Intercurrent illness|1|||
147583517|NCT01896505|532291622|FG002|Overall Study|Intercurrent illness|0|||
147583518|NCT01896505|532291623|FG003|Overall Study|Intercurrent illness|0|||
147154585|NCT00487942|530727777|FG000|Overall Study|Protocol Violation|1|||
147154586|NCT00487942|530727778|FG001|Overall Study|Protocol Violation|1|||
147154587|NCT00487942|530727779|FG002|Overall Study|Protocol Violation|0|||
147583519|NCT01896505|532291624|FG004|Overall Study|Intercurrent illness|0|||
147583520|NCT01896505|532291625|FG005|Overall Study|Intercurrent illness|0|||
147154588|NCT00487942|530727780|FG003|Overall Study|Protocol Violation|0|||
147583521|NCT01896505|532291620|FG000|Overall Study|Death|0|||
147583522|NCT01896505|532291621|FG001|Overall Study|Death|0|||
147583523|NCT01896505|532291622|FG002|Overall Study|Death|1|||
147583524|NCT01896505|532291623|FG003|Overall Study|Death|1|||
147154589|NCT00487942|530727777|FG000|Overall Study|Withdrawal by Subject|0|||
147154590|NCT00487942|530727778|FG001|Overall Study|Withdrawal by Subject|1|||
147154591|NCT00487942|530727779|FG002|Overall Study|Withdrawal by Subject|2|||
147154592|NCT00487942|530727780|FG003|Overall Study|Withdrawal by Subject|0|||
147154593|NCT00211757|530727781|FG000|Overall Study|Withdrawal by Subject|1|||
147154594|NCT00211757|530727782|FG001|Overall Study|Withdrawal by Subject|1|||
147154595|NCT00211757|530727781|FG000|Overall Study|Lack of Efficacy|0|||
147154596|NCT00211757|530727782|FG001|Overall Study|Lack of Efficacy|1|||
147154597|NCT02461290|530727786|FG000|Overall Study|Withdrawn for Inadequate Clinical Stage|7|||
147583525|NCT01896505|532291624|FG004|Overall Study|Death|0|||
147583526|NCT01896505|532291625|FG005|Overall Study|Death|1|||
147583527|NCT03259789|532291628|FG000|Overall Study|Adverse Event|3|||
147583528|NCT03259789|532291629|FG001|Overall Study|Adverse Event|2|||
147583529|NCT03259789|532291630|FG002|Overall Study|Adverse Event|1|||
147583530|NCT03259789|532291628|FG000|Overall Study|Withdrawal by Subject|9|||
147583531|NCT03259789|532291629|FG001|Overall Study|Withdrawal by Subject|5|||
147583532|NCT03259789|532291630|FG002|Overall Study|Withdrawal by Subject|1|||
147583533|NCT03259789|532291628|FG000|Overall Study|Lost to Follow-up|5|||
147583534|NCT03259789|532291629|FG001|Overall Study|Lost to Follow-up|9|||
147583535|NCT03259789|532291630|FG002|Overall Study|Lost to Follow-up|4|||
147583536|NCT03259789|532291628|FG000|Overall Study|Physician Decision|0|||
147583537|NCT03259789|532291629|FG001|Overall Study|Physician Decision|1|||
147583538|NCT03259789|532291630|FG002|Overall Study|Physician Decision|0|||
147583539|NCT02063217|532291631|FG000|Overall Study|Withdrawal by Subject|1|||
147583540|NCT02063217|532291632|FG001|Overall Study|Withdrawal by Subject|0|||
147583541|NCT02063217|532291633|FG002|Overall Study|Withdrawal by Subject|0|||
147583542|NCT04203667|532291634|FG000|Overall Study|Withdrawal by Subject|1|||
147583543|NCT04203667|532291634|FG000|Overall Study|Lost to Follow-up|1|||
147583544|NCT04203667|532291634|FG000|Overall Study|Death|1|||
147583545|NCT04203667|532291634|FG000|Overall Study|PI left center and never scheduled 90 day follow-up visit.|1|||
147583546|NCT01833169|532291638|FG000|Overall Study|Disease Progression|99|||
147583547|NCT01833169|532291638|FG000|Overall Study|Adverse Event|33|||
147583548|NCT01833169|532291638|FG000|Overall Study|Withdrawal by Subject|9|||
147583549|NCT01833169|532291638|FG000|Overall Study|Death|3|||
147583550|NCT01833169|532291638|FG000|Overall Study|Physician Decision|2|||
147583551|NCT01183884|532291639|FG000|Overall Study|Progressive Disease|26|||
147583552|NCT01183884|532291639|FG000|Overall Study|Adverse Event|3|||
147583553|NCT01183884|532291639|FG000|Overall Study|Withdrawal by Subject|1|||
147583554|NCT01183884|532291639|FG000|Overall Study|Other Complicating Disease|3|||
147583555|NCT01183884|532291639|FG000|Overall Study|Not Treated|1|||
147583556|NCT01183884|532291639|FG000|Overall Study|Other|4|||
147583557|NCT04718129|532291644|FG000|Overall Study|Lost to Follow-up|6|||
147583558|NCT04718129|532291645|FG001|Overall Study|Lost to Follow-up|7|||
147583559|NCT02212457|532291646|FG000|Overall Study|Adverse Event|1|||
147583560|NCT02212457|532291647|FG001|Overall Study|Adverse Event|2|||
147583561|NCT02212457|532291648|FG002|Overall Study|Adverse Event|2|||
147583562|NCT02212457|532291649|FG003|Overall Study|Adverse Event|2|||
147583563|NCT02212457|532291650|FG004|Overall Study|Adverse Event|0|||
147583564|NCT02212457|532291651|FG005|Overall Study|Adverse Event|1|||
147583565|NCT02212457|532291646|FG000|Overall Study|Withdrawal by Subject|8|||
147583566|NCT02212457|532291647|FG001|Overall Study|Withdrawal by Subject|10|||
147583567|NCT02212457|532291648|FG002|Overall Study|Withdrawal by Subject|8|||
147583568|NCT02212457|532291649|FG003|Overall Study|Withdrawal by Subject|6|||
147583569|NCT02212457|532291650|FG004|Overall Study|Withdrawal by Subject|5|||
147583570|NCT02212457|532291651|FG005|Overall Study|Withdrawal by Subject|4|||
147583571|NCT02212457|532291646|FG000|Overall Study|Lost to Follow-up|6|||
147583572|NCT02212457|532291647|FG001|Overall Study|Lost to Follow-up|7|||
147583573|NCT02212457|532291648|FG002|Overall Study|Lost to Follow-up|4|||
147583574|NCT02212457|532291649|FG003|Overall Study|Lost to Follow-up|1|||
147583575|NCT02212457|532291650|FG004|Overall Study|Lost to Follow-up|8|||
147583576|NCT02212457|532291651|FG005|Overall Study|Lost to Follow-up|4|||
147583577|NCT02212457|532291646|FG000|Overall Study|Protocol Violation|2|||
147583578|NCT02212457|532291647|FG001|Overall Study|Protocol Violation|1|||
147583579|NCT02212457|532291648|FG002|Overall Study|Protocol Violation|0|||
147583580|NCT02212457|532291649|FG003|Overall Study|Protocol Violation|1|||
147583581|NCT02212457|532291650|FG004|Overall Study|Protocol Violation|2|||
147583582|NCT02212457|532291651|FG005|Overall Study|Protocol Violation|3|||
147583583|NCT02212457|532291646|FG000|Overall Study|Other|2|||
147154598|NCT02461290|530727786|FG000|Overall Study|Lost to Follow-up|3|||
147154599|NCT01457014|530727787|FG000|First Night|Didn't meet inclusion/exclusion criteria|37|||
147583584|NCT02212457|532291647|FG001|Overall Study|Other|1|||
147583585|NCT02212457|532291648|FG002|Overall Study|Other|2|||
147654137|NCT00398216|532556629|FG002|Overall Study|Adverse Event|5|||
147654138|NCT00398216|532556630|FG003|Overall Study|Adverse Event|7|||
147583586|NCT02212457|532291649|FG003|Overall Study|Other|1|||
147583587|NCT02212457|532291650|FG004|Overall Study|Other|0|||
147583588|NCT02212457|532291651|FG005|Overall Study|Other|1|||
147240579|NCT01466153|531051648|FG001|Overall Study|Disease Progression|2|||
147583589|NCT00420095|532291653|FG000|Overall Study|Adverse Event|1|||
147583590|NCT00420095|532291654|FG001|Overall Study|Adverse Event|0|||
147583591|NCT00420095|532291653|FG000|Overall Study|Protocol Violation|1|||
147583592|NCT00420095|532291654|FG001|Overall Study|Protocol Violation|1|||
147583593|NCT00420095|532291653|FG000|Overall Study|Lost to Follow-up|1|||
147583594|NCT00420095|532291654|FG001|Overall Study|Lost to Follow-up|0|||
147154600|NCT01457014|530727788|FG001|First Night|Didn't meet inclusion/exclusion criteria|0|||
147154601|NCT01457014|530727789|FG002|First Night|Didn't meet inclusion/exclusion criteria|0|||
147154602|NCT01457014|530727790|FG003|First Night|Didn't meet inclusion/exclusion criteria|0|||
147154603|NCT01457014|530727787|FG000|First Night|Withdrawal by Subject|3|||
147154604|NCT01457014|530727788|FG001|First Night|Withdrawal by Subject|0|||
147154605|NCT01457014|530727789|FG002|First Night|Withdrawal by Subject|0|||
147154606|NCT01457014|530727790|FG003|First Night|Withdrawal by Subject|0|||
147154607|NCT04027049|530727791|FG000|Overall Study|Withdrawn by family|1|||
147154608|NCT04027049|530727792|FG001|Overall Study|Withdrawn by family|0|||
147154609|NCT04027049|530727791|FG000|Overall Study|Participant safety|1|||
147154610|NCT04027049|530727792|FG001|Overall Study|Participant safety|0|||
147154611|NCT02650128|530727793|FG000|Overall Study|Death|2|||
147154612|NCT00218634|530729202|FG000|Overall Study|Lost to Follow-up|8|||
147154613|NCT00218634|530729203|FG001|Overall Study|Lost to Follow-up|15|||
147154614|NCT00734604|530729204|FG000|Overall Study|Adverse Event|0|||
147154615|NCT00734604|530729205|FG001|Overall Study|Adverse Event|2|||
147154616|NCT00734604|530729206|FG002|Overall Study|Adverse Event|0|||
147154617|NCT00734604|530729207|FG003|Overall Study|Adverse Event|2|||
147154618|NCT00734604|530729208|FG004|Overall Study|Adverse Event|1|||
147154619|NCT00734604|530729209|FG005|Overall Study|Adverse Event|1|||
147154620|NCT00734604|530729204|FG000|Overall Study|Serious Adverse Event|1|||
147154621|NCT00734604|530729205|FG001|Overall Study|Serious Adverse Event|0|||
147154622|NCT00734604|530729206|FG002|Overall Study|Serious Adverse Event|1|||
147154623|NCT00734604|530729207|FG003|Overall Study|Serious Adverse Event|2|||
147154624|NCT00734604|530729208|FG004|Overall Study|Serious Adverse Event|0|||
147154625|NCT00734604|530729209|FG005|Overall Study|Serious Adverse Event|1|||
147154626|NCT00734604|530729204|FG000|Overall Study|Lost to Follow-up|1|||
147154627|NCT00734604|530729205|FG001|Overall Study|Lost to Follow-up|2|||
147154628|NCT00734604|530729206|FG002|Overall Study|Lost to Follow-up|2|||
147154629|NCT00734604|530729207|FG003|Overall Study|Lost to Follow-up|4|||
147154630|NCT00734604|530729208|FG004|Overall Study|Lost to Follow-up|2|||
147154631|NCT00734604|530729209|FG005|Overall Study|Lost to Follow-up|3|||
147240580|NCT01466153|531051649|FG002|Overall Study|Disease Progression|0|||
147240581|NCT01466153|531051647|FG000|Overall Study|Adverse Event|14|||
147240582|NCT01466153|531051648|FG001|Overall Study|Adverse Event|13|||
147240583|NCT01466153|531051649|FG002|Overall Study|Adverse Event|17|||
147240584|NCT01466153|531051647|FG000|Overall Study|Withdrawal of Consent|2|||
147240585|NCT01466153|531051648|FG001|Overall Study|Withdrawal of Consent|0|||
147583595|NCT00393705|532291655|FG000|Overall Study|Adverse Event|0|||
147583596|NCT00393705|532291656|FG001|Overall Study|Adverse Event|2|||
147583597|NCT00393705|532291655|FG000|Overall Study|Death|0|||
147583598|NCT00393705|532291656|FG001|Overall Study|Death|1|||
147583599|NCT00393705|532291655|FG000|Overall Study|Lost to Follow-up|2|||
147583600|NCT00393705|532291656|FG001|Overall Study|Lost to Follow-up|2|||
147583601|NCT00393705|532291655|FG000|Overall Study|Entry Criteria Not Met|10|||
147583602|NCT00393705|532291656|FG001|Overall Study|Entry Criteria Not Met|10|||
147583603|NCT00393705|532291655|FG000|Overall Study|Protocol Violation|4|||
147583604|NCT00393705|532291656|FG001|Overall Study|Protocol Violation|3|||
147583605|NCT00393705|532291655|FG000|Overall Study|Withdrawal by Subject|5|||
147583606|NCT00393705|532291656|FG001|Overall Study|Withdrawal by Subject|3|||
147583607|NCT00393705|532291655|FG000|Overall Study|Physician Decision|2|||
147583608|NCT00393705|532291656|FG001|Overall Study|Physician Decision|2|||
147583609|NCT01120691|532291659|FG000|Overall Study|Adverse Event|59|||
147583610|NCT01120691|532291660|FG001|Overall Study|Adverse Event|67|||
147583611|NCT01120691|532291661|FG002|Overall Study|Adverse Event|47|||
147583612|NCT01120691|532291659|FG000|Overall Study|Subject withdrew consent|33|||
147583613|NCT01120691|532291660|FG001|Overall Study|Subject withdrew consent|50|||
147583614|NCT01120691|532291661|FG002|Overall Study|Subject withdrew consent|44|||
147583615|NCT01120691|532291659|FG000|Overall Study|Death|21|||
147583616|NCT01120691|532291660|FG001|Overall Study|Death|22|||
147583617|NCT01120691|532291661|FG002|Overall Study|Death|24|||
147583618|NCT01120691|532291659|FG000|Overall Study|Unsatisfactory therapeutic effect|18|||
147583619|NCT01120691|532291660|FG001|Overall Study|Unsatisfactory therapeutic effect|32|||
147583620|NCT01120691|532291661|FG002|Overall Study|Unsatisfactory therapeutic effect|38|||
147583621|NCT01120691|532291659|FG000|Overall Study|Administrative problems|15|||
147583622|NCT01120691|532291660|FG001|Overall Study|Administrative problems|8|||
147154632|NCT00734604|530729204|FG000|Overall Study|Physician Decision|0|||
147240586|NCT01466153|531051649|FG002|Overall Study|Withdrawal of Consent|0|||
147583623|NCT01120691|532291661|FG002|Overall Study|Administrative problems|9|||
147583624|NCT01120691|532291659|FG000|Overall Study|Protocol deviation|13|||
147583625|NCT01120691|532291660|FG001|Overall Study|Protocol deviation|12|||
147583626|NCT01120691|532291661|FG002|Overall Study|Protocol deviation|12|||
147154633|NCT00734604|530729205|FG001|Overall Study|Physician Decision|1|||
147154634|NCT00734604|530729206|FG002|Overall Study|Physician Decision|1|||
147154635|NCT00734604|530729207|FG003|Overall Study|Physician Decision|0|||
147154636|NCT00734604|530729208|FG004|Overall Study|Physician Decision|0|||
147154637|NCT00734604|530729209|FG005|Overall Study|Physician Decision|0|||
147154638|NCT00734604|530729204|FG000|Overall Study|Protocol Violation|0|||
147154639|NCT00734604|530729205|FG001|Overall Study|Protocol Violation|2|||
147654139|NCT00398216|532556631|FG004|Overall Study|Adverse Event|2|||
147654140|NCT00398216|532556627|FG000|Overall Study|Protocol Violation|2|||
147654141|NCT00398216|532556628|FG001|Overall Study|Protocol Violation|4|||
147654142|NCT00398216|532556629|FG002|Overall Study|Protocol Violation|5|||
147654143|NCT00398216|532556630|FG003|Overall Study|Protocol Violation|7|||
147654144|NCT00398216|532556631|FG004|Overall Study|Protocol Violation|5|||
147654145|NCT00398216|532556627|FG000|Overall Study|Lost to Follow-up|1|||
147654146|NCT00398216|532556628|FG001|Overall Study|Lost to Follow-up|6|||
147654147|NCT00398216|532556629|FG002|Overall Study|Lost to Follow-up|4|||
147654148|NCT00398216|532556630|FG003|Overall Study|Lost to Follow-up|4|||
147654149|NCT00398216|532556631|FG004|Overall Study|Lost to Follow-up|1|||
147654150|NCT00398216|532556627|FG000|Overall Study|Death|0|||
147654151|NCT00398216|532556628|FG001|Overall Study|Death|3|||
147654152|NCT00398216|532556629|FG002|Overall Study|Death|0|||
147654153|NCT00398216|532556630|FG003|Overall Study|Death|0|||
147154640|NCT00734604|530729206|FG002|Overall Study|Protocol Violation|0|||
147154641|NCT00734604|530729207|FG003|Overall Study|Protocol Violation|0|||
147154642|NCT00734604|530729208|FG004|Overall Study|Protocol Violation|1|||
147154643|NCT00734604|530729209|FG005|Overall Study|Protocol Violation|0|||
147154644|NCT00734604|530729204|FG000|Overall Study|Sponsor Decision|1|||
147154645|NCT00734604|530729205|FG001|Overall Study|Sponsor Decision|2|||
147154646|NCT00734604|530729206|FG002|Overall Study|Sponsor Decision|1|||
147154647|NCT00734604|530729207|FG003|Overall Study|Sponsor Decision|0|||
147154648|NCT00734604|530729208|FG004|Overall Study|Sponsor Decision|2|||
147154649|NCT00734604|530729209|FG005|Overall Study|Sponsor Decision|0|||
147240587|NCT01466153|531051647|FG000|Overall Study|Investigator Discretion|3|||
147240588|NCT01466153|531051648|FG001|Overall Study|Investigator Discretion|2|||
147240589|NCT01466153|531051649|FG002|Overall Study|Investigator Discretion|2|||
147240590|NCT01466153|531051647|FG000|Overall Study|Randomized-Not Treated|2|||
147240591|NCT01466153|531051648|FG001|Overall Study|Randomized-Not Treated|3|||
147240592|NCT01466153|531051649|FG002|Overall Study|Randomized-Not Treated|4|||
147240593|NCT01466153|531051647|FG000|Overall Study|Other-Unspecified|6|||
147240594|NCT01466153|531051648|FG001|Overall Study|Other-Unspecified|4|||
147240595|NCT01466153|531051649|FG002|Overall Study|Other-Unspecified|2|||
147240596|NCT02955602|531053425|FG000|Overall Study|Adverse Event|0|||
147240597|NCT02955602|531053426|FG001|Overall Study|Adverse Event|3|||
147240598|NCT02955602|531053427|FG002|Overall Study|Adverse Event|0|||
147240599|NCT02955602|531053425|FG000|Overall Study|Withdrawal of informed consent|1|||
147240600|NCT02955602|531053426|FG001|Overall Study|Withdrawal of informed consent|3|||
147154650|NCT00734604|530729204|FG000|Overall Study|Withdrawal by Subject|0|||
147154651|NCT00734604|530729205|FG001|Overall Study|Withdrawal by Subject|2|||
147154652|NCT00734604|530729206|FG002|Overall Study|Withdrawal by Subject|0|||
147154653|NCT00734604|530729207|FG003|Overall Study|Withdrawal by Subject|1|||
147154654|NCT00734604|530729208|FG004|Overall Study|Withdrawal by Subject|2|||
147154655|NCT00734604|530729209|FG005|Overall Study|Withdrawal by Subject|1|||
147154656|NCT00734604|530729204|FG000|Overall Study|Lack of Efficacy|0|||
147154657|NCT00734604|530729205|FG001|Overall Study|Lack of Efficacy|1|||
147154658|NCT00734604|530729206|FG002|Overall Study|Lack of Efficacy|1|||
147154659|NCT00734604|530729207|FG003|Overall Study|Lack of Efficacy|0|||
147154660|NCT00734604|530729208|FG004|Overall Study|Lack of Efficacy|0|||
147154661|NCT00734604|530729209|FG005|Overall Study|Lack of Efficacy|0|||
147154662|NCT01044745|530729210|FG000|Overall Study|Ineiligible|2|||
147154663|NCT00591149|530729217|FG000|Overall Study|Adverse Event|4|||
147154664|NCT00591149|530729217|FG000|Overall Study|Withdrawal by Subject|1|||
147154665|NCT02456636|530729218|FG000|Overall Study|Death|0|||
147154666|NCT02456636|530729219|FG001|Overall Study|Death|3|||
147154667|NCT02456636|530729220|FG002|Overall Study|Death|0|||
147154668|NCT02456636|530729218|FG000|Overall Study|Pregnancy|1|||
147154669|NCT02456636|530729219|FG001|Overall Study|Pregnancy|3|||
147154670|NCT02456636|530729220|FG002|Overall Study|Pregnancy|5|||
147154671|NCT02456636|530729218|FG000|Overall Study|Physician Decision|4|||
147154672|NCT02456636|530729219|FG001|Overall Study|Physician Decision|5|||
147154673|NCT02456636|530729220|FG002|Overall Study|Physician Decision|4|||
147240601|NCT02955602|531053427|FG002|Overall Study|Withdrawal of informed consent|2|||
147240602|NCT02955602|531053425|FG000|Overall Study|Lost to Follow-up|0|||
147154674|NCT02456636|530729218|FG000|Overall Study|Withdrawal by Subject|13|||
147240603|NCT02955602|531053426|FG001|Overall Study|Lost to Follow-up|0|||
147240604|NCT02955602|531053427|FG002|Overall Study|Lost to Follow-up|1|||
147240605|NCT02955602|531053425|FG000|Overall Study|Other|0|||
147654154|NCT00398216|532556631|FG004|Overall Study|Death|0|||
147654155|NCT00398216|532556627|FG000|Overall Study|Withdrawal by Subject|1|||
147654156|NCT00398216|532556628|FG001|Overall Study|Withdrawal by Subject|0|||
147654157|NCT00398216|532556629|FG002|Overall Study|Withdrawal by Subject|3|||
147654158|NCT00398216|532556630|FG003|Overall Study|Withdrawal by Subject|1|||
147154675|NCT02456636|530729219|FG001|Overall Study|Withdrawal by Subject|14|||
147154676|NCT02456636|530729220|FG002|Overall Study|Withdrawal by Subject|16|||
147154677|NCT02456636|530729218|FG000|Overall Study|Lost to Follow-up|50|||
147154678|NCT02456636|530729219|FG001|Overall Study|Lost to Follow-up|44|||
147154679|NCT02456636|530729220|FG002|Overall Study|Lost to Follow-up|50|||
147154680|NCT02379221|530729221|FG000|Overall Study|Lost to Follow-up|1|||
147583627|NCT01120691|532291659|FG000|Overall Study|Lost to Follow-up|5|||
147583628|NCT01120691|532291660|FG001|Overall Study|Lost to Follow-up|6|||
147583629|NCT01120691|532291661|FG002|Overall Study|Lost to Follow-up|4|||
147583630|NCT01120691|532291659|FG000|Overall Study|Abnormal test procedure result(s)|3|||
147583631|NCT01120691|532291660|FG001|Overall Study|Abnormal test procedure result(s)|2|||
147583632|NCT01120691|532291661|FG002|Overall Study|Abnormal test procedure result(s)|1|||
147583633|NCT01120691|532291659|FG000|Overall Study|Patient's inability to use the device|3|||
147154681|NCT02019108|530729222|FG000|Overall Study|Lost to Follow-up|5|||
147154682|NCT02019108|530729223|FG001|Overall Study|Lost to Follow-up|7|||
147154683|NCT05275010|530729233|FG000|Overall Study|Reason Not Specified|4|||
147154684|NCT05275010|530729234|FG001|Overall Study|Reason Not Specified|1|||
147154685|NCT05275010|530729233|FG000|Overall Study|Withdrawal by Subject|1|||
147154686|NCT05275010|530729234|FG001|Overall Study|Withdrawal by Subject|0|||
147154687|NCT05275010|530729233|FG000|Overall Study|Lost to Follow-up|0|||
147154688|NCT05275010|530729234|FG001|Overall Study|Lost to Follow-up|1|||
147154689|NCT04484649|530729237|FG000|Overall Study|Lost to Follow-up|2|||
147154690|NCT04484649|530729238|FG001|Overall Study|Lost to Follow-up|1|||
147154691|NCT04484649|530729237|FG000|Overall Study|Did not submit actigraphy post interc\vention|6|||
147154692|NCT04484649|530729238|FG001|Overall Study|Did not submit actigraphy post interc\vention|4|||
147154693|NCT04417218|530729249|FG000|First Intervention (1 Week))|Withdrawal by Subject|1|||
147154694|NCT04417218|530729250|FG001|First Intervention (1 Week))|Withdrawal by Subject|0|||
147154695|NCT01082874|530729254|FG000|Overall Study|Lost to Follow-up|10|||
147154696|NCT01082874|530729255|FG001|Overall Study|Lost to Follow-up|10|||
147154697|NCT01082874|530729256|FG002|Overall Study|Lost to Follow-up|6|||
147154698|NCT01082874|530729257|FG003|Overall Study|Lost to Follow-up|10|||
147154699|NCT01082874|530729254|FG000|Overall Study|Withdrawal by Subject|1|||
147154700|NCT01082874|530729255|FG001|Overall Study|Withdrawal by Subject|2|||
147240606|NCT02955602|531053426|FG001|Overall Study|Other|1|||
147240607|NCT02955602|531053427|FG002|Overall Study|Other|3|||
147240608|NCT02501473|531053430|FG000|Overall Study|Study Terminated|2|||
147240609|NCT02501473|531053431|FG001|Overall Study|Study Terminated|3|||
147240610|NCT02501473|531053432|FG002|Overall Study|Study Terminated|7|||
147240611|NCT02501473|531053433|FG003|Overall Study|Study Terminated|9|||
147240612|NCT02501473|531053434|FG004|Overall Study|Study Terminated|2|||
147240613|NCT02501473|531053435|FG005|Overall Study|Study Terminated|10|||
147240614|NCT02501473|531053436|FG006|Overall Study|Study Terminated|1|||
147240615|NCT02501473|531053437|FG007|Overall Study|Study Terminated|0|||
147240616|NCT02501473|531053430|FG000|Overall Study|Withdrawal by Subject|0|||
147240617|NCT02501473|531053431|FG001|Overall Study|Withdrawal by Subject|0|||
147240618|NCT02501473|531053432|FG002|Overall Study|Withdrawal by Subject|3|||
147240619|NCT02501473|531053433|FG003|Overall Study|Withdrawal by Subject|3|||
147240620|NCT02501473|531053434|FG004|Overall Study|Withdrawal by Subject|2|||
147240621|NCT02501473|531053435|FG005|Overall Study|Withdrawal by Subject|2|||
147240622|NCT02501473|531053436|FG006|Overall Study|Withdrawal by Subject|0|||
147240623|NCT02501473|531053437|FG007|Overall Study|Withdrawal by Subject|0|||
147240624|NCT02501473|531053430|FG000|Overall Study|Death|0|||
147240625|NCT02501473|531053431|FG001|Overall Study|Death|0|||
147240626|NCT02501473|531053432|FG002|Overall Study|Death|1|||
147240627|NCT02501473|531053433|FG003|Overall Study|Death|1|||
147240628|NCT02501473|531053434|FG004|Overall Study|Death|0|||
147240629|NCT02501473|531053435|FG005|Overall Study|Death|1|||
147240630|NCT02501473|531053436|FG006|Overall Study|Death|0|||
147240631|NCT02501473|531053437|FG007|Overall Study|Death|0|||
147240632|NCT02501473|531053430|FG000|Overall Study|Lost to Follow-up|1|||
147240633|NCT02501473|531053431|FG001|Overall Study|Lost to Follow-up|0|||
147240634|NCT02501473|531053432|FG002|Overall Study|Lost to Follow-up|1|||
147240635|NCT02501473|531053433|FG003|Overall Study|Lost to Follow-up|0|||
147240636|NCT02501473|531053434|FG004|Overall Study|Lost to Follow-up|0|||
147240637|NCT02501473|531053435|FG005|Overall Study|Lost to Follow-up|1|||
147240638|NCT02501473|531053436|FG006|Overall Study|Lost to Follow-up|0|||
147240639|NCT02501473|531053437|FG007|Overall Study|Lost to Follow-up|0|||
147240640|NCT02501473|531053430|FG000|Overall Study|Reason not specified|0|||
147240641|NCT02501473|531053431|FG001|Overall Study|Reason not specified|0|||
147240642|NCT02501473|531053432|FG002|Overall Study|Reason not specified|1|||
147240643|NCT02501473|531053433|FG003|Overall Study|Reason not specified|1|||
147240644|NCT02501473|531053434|FG004|Overall Study|Reason not specified|0|||
147240645|NCT02501473|531053435|FG005|Overall Study|Reason not specified|0|||
147240646|NCT02501473|531053436|FG006|Overall Study|Reason not specified|0|||
147240647|NCT02501473|531053437|FG007|Overall Study|Reason not specified|0|||
147154701|NCT01082874|530729256|FG002|Overall Study|Withdrawal by Subject|5|||
147154702|NCT01082874|530729257|FG003|Overall Study|Withdrawal by Subject|3|||
147154703|NCT00939029|530729264|FG000|Overall Study|Withdrawal by Subject|3|||
147154704|NCT00939029|530729265|FG001|Overall Study|Withdrawal by Subject|7|||
147240648|NCT01581931|531053438|FG000|Washout|Adverse Event|0|||
147240649|NCT01581931|531053439|FG001|Washout|Adverse Event|1|||
147240650|NCT04160195|531053444|FG000|Overall Study|Principal investigator stopped study due to instability of chimeric antigen receptor gene.|1|||
147240651|NCT04160195|531053445|FG001|Overall Study|Principal investigator stopped study due to instability of chimeric antigen receptor gene.|0|||
147583634|NCT01120691|532291660|FG001|Overall Study|Patient's inability to use the device|1|||
147583635|NCT01120691|532291661|FG002|Overall Study|Patient's inability to use the device|0|||
147583636|NCT01120691|532291659|FG000|Overall Study|Abnormal laboratory value(s)|1|||
147583637|NCT01120691|532291660|FG001|Overall Study|Abnormal laboratory value(s)|3|||
147583638|NCT01120691|532291661|FG002|Overall Study|Abnormal laboratory value(s)|4|||
147583639|NCT00642811|532291662|FG000|Overall Study|Adverse Event|2|||
147583640|NCT00642811|532291663|FG001|Overall Study|Adverse Event|3|||
147154705|NCT00939029|530729264|FG000|Overall Study|Lost to Follow-up|3|||
147154706|NCT00939029|530729265|FG001|Overall Study|Lost to Follow-up|4|||
147154707|NCT00939029|530729264|FG000|Overall Study|Adverse Event|0|||
147154708|NCT00939029|530729265|FG001|Overall Study|Adverse Event|1|||
147154709|NCT03305419|530729267|FG000|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
147154710|NCT03305419|530729268|FG001|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|1|||
147154711|NCT03305419|530729269|FG002|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
147154712|NCT03305419|530729270|FG003|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
147154713|NCT03305419|530729271|FG004|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
147154714|NCT03305419|530729272|FG005|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
147154715|NCT03305419|530729273|FG006|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
147154716|NCT03305419|530729274|FG007|Part A Period 1 (1Day) + Washout (7days)|Adverse Event|0|||
147154717|NCT03305419|530729267|FG000|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|1|||
147154718|NCT03305419|530729268|FG001|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
147154719|NCT03305419|530729269|FG002|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
147154720|NCT03305419|530729270|FG003|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
147154721|NCT03305419|530729271|FG004|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
147154722|NCT03305419|530729272|FG005|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
147154723|NCT03305419|530729273|FG006|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
147154724|NCT03305419|530729274|FG007|Part A Period 2 (1Day) + Washout (7days)|Adverse Event|0|||
147154725|NCT03305419|530729267|FG000|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|1|||
147154726|NCT03305419|530729268|FG001|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
147154727|NCT03305419|530729269|FG002|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
147154728|NCT03305419|530729270|FG003|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
147154729|NCT03305419|530729271|FG004|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
147154730|NCT03305419|530729272|FG005|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
147154731|NCT03305419|530729273|FG006|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
147154732|NCT03305419|530729274|FG007|Part A Period 2 (1Day) + Washout (7days)|Physician Decision|0|||
147154733|NCT03305419|530729267|FG000|Part B (14 Days)|Adverse Event|0|||
147154734|NCT03305419|530729268|FG001|Part B (14 Days)|Adverse Event|0|||
147154735|NCT03305419|530729269|FG002|Part B (14 Days)|Adverse Event|0|||
147154736|NCT03305419|530729270|FG003|Part B (14 Days)|Adverse Event|0|||
147154737|NCT03305419|530729271|FG004|Part B (14 Days)|Adverse Event|1|||
147154738|NCT03305419|530729272|FG005|Part B (14 Days)|Adverse Event|2|||
147154739|NCT03305419|530729273|FG006|Part B (14 Days)|Adverse Event|4|||
147154740|NCT03305419|530729274|FG007|Part B (14 Days)|Adverse Event|0|||
147154741|NCT03305419|530729267|FG000|Part B (14 Days)|Physician Decision|0|||
147154742|NCT03305419|530729268|FG001|Part B (14 Days)|Physician Decision|0|||
147154743|NCT03305419|530729269|FG002|Part B (14 Days)|Physician Decision|0|||
147154744|NCT03305419|530729270|FG003|Part B (14 Days)|Physician Decision|0|||
147154745|NCT03305419|530729271|FG004|Part B (14 Days)|Physician Decision|2|||
147154746|NCT03305419|530729272|FG005|Part B (14 Days)|Physician Decision|8|||
147154747|NCT03305419|530729273|FG006|Part B (14 Days)|Physician Decision|1|||
147154748|NCT03305419|530729274|FG007|Part B (14 Days)|Physician Decision|0|||
147154749|NCT02210689|530729275|FG000|Overall Study|Withdrawal by Subject|7|||
147154750|NCT02210689|530729276|FG001|Overall Study|Withdrawal by Subject|4|||
147154751|NCT02210689|530729277|FG002|Overall Study|Withdrawal by Subject|2|||
147154752|NCT02210689|530729275|FG000|Overall Study|Adverse Event|0|||
147154753|NCT02210689|530729276|FG001|Overall Study|Adverse Event|1|||
147154754|NCT02210689|530729277|FG002|Overall Study|Adverse Event|0|||
147154755|NCT02210689|530729275|FG000|Overall Study|Protocol Violation|1|||
147154756|NCT02210689|530729276|FG001|Overall Study|Protocol Violation|0|||
147154757|NCT02210689|530729277|FG002|Overall Study|Protocol Violation|0|||
147154758|NCT02210689|530729275|FG000|Overall Study|Lost to Follow-up|11|||
147154759|NCT02210689|530729276|FG001|Overall Study|Lost to Follow-up|9|||
147154760|NCT02210689|530729277|FG002|Overall Study|Lost to Follow-up|5|||
147154761|NCT02210689|530729275|FG000|Overall Study|Pregnancy|0|||
147154762|NCT02210689|530729276|FG001|Overall Study|Pregnancy|1|||
147154763|NCT02210689|530729277|FG002|Overall Study|Pregnancy|0|||
147240652|NCT03068130|531053450|FG000|Overall Study|Adverse Event|19|||
147240653|NCT03068130|531053450|FG000|Overall Study|Death|14|||
147240654|NCT03068130|531053450|FG000|Overall Study|Lost to Follow-up|4|||
147240655|NCT03068130|531053450|FG000|Overall Study|Withdrawal by Subject|26|||
147240656|NCT03068130|531053450|FG000|Overall Study|Administrative Reasons|3|||
147240657|NCT03068130|531053450|FG000|Overall Study|Protocol specified withdrawal criterion|1|||
147154764|NCT02210689|530729275|FG000|Overall Study|Lack of Efficacy|0|||
147154765|NCT02210689|530729276|FG001|Overall Study|Lack of Efficacy|1|||
147154766|NCT02210689|530729277|FG002|Overall Study|Lack of Efficacy|5|||
147154767|NCT02210689|530729275|FG000|Overall Study|Prohibited medication|2|||
147154768|NCT02210689|530729276|FG001|Overall Study|Prohibited medication|8|||
147154769|NCT02210689|530729277|FG002|Overall Study|Prohibited medication|1|||
147154770|NCT02210689|530729275|FG000|Overall Study|Negative Nugent score at baseline|6|||
147154771|NCT02210689|530729276|FG001|Overall Study|Negative Nugent score at baseline|2|||
147154772|NCT02210689|530729277|FG002|Overall Study|Negative Nugent score at baseline|2|||
147154773|NCT02210689|530729275|FG000|Overall Study|Other|25|||
147154774|NCT02210689|530729276|FG001|Overall Study|Other|21|||
147154775|NCT02210689|530729277|FG002|Overall Study|Other|8|||
147154776|NCT00075946|530729278|FG000|Overall Study|Path ineligible: undetermined histology|0|||
147154777|NCT00075946|530729279|FG001|Overall Study|Path ineligible: undetermined histology|0|||
147154778|NCT00075946|530729280|FG002|Overall Study|Path ineligible: undetermined histology|0|||
147154779|NCT00075946|530729281|FG003|Overall Study|Path ineligible: undetermined histology|0|||
147154780|NCT00075946|530729282|FG004|Overall Study|Path ineligible: undetermined histology|6|||
147154781|NCT00075946|530729278|FG000|Overall Study|Did not achieve response after induction|0|||
147154782|NCT00075946|530729279|FG001|Overall Study|Did not achieve response after induction|0|||
147154783|NCT00075946|530729280|FG002|Overall Study|Did not achieve response after induction|0|||
147154784|NCT00075946|530729281|FG003|Overall Study|Did not achieve response after induction|0|||
147154785|NCT00075946|530729282|FG004|Overall Study|Did not achieve response after induction|182|||
147154786|NCT00075946|530729278|FG000|Overall Study|Incorrectly randomized (no response)|5|||
147154787|NCT00075946|530729279|FG001|Overall Study|Incorrectly randomized (no response)|5|||
147154788|NCT00075946|530729280|FG002|Overall Study|Incorrectly randomized (no response)|5|||
147154789|NCT00075946|530729281|FG003|Overall Study|Incorrectly randomized (no response)|1|||
147154790|NCT00075946|530729282|FG004|Overall Study|Incorrectly randomized (no response)|0|||
147154791|NCT00075946|530729278|FG000|Overall Study|Adverse Event|2|||
147654159|NCT00398216|532556631|FG004|Overall Study|Withdrawal by Subject|2|||
147654160|NCT00398216|532556627|FG000|Overall Study|administrative reasons|3|||
147654161|NCT00398216|532556628|FG001|Overall Study|administrative reasons|4|||
147654162|NCT00398216|532556629|FG002|Overall Study|administrative reasons|4|||
147654163|NCT00398216|532556630|FG003|Overall Study|administrative reasons|3|||
147654164|NCT00398216|532556631|FG004|Overall Study|administrative reasons|3|||
147654165|NCT00398216|532556627|FG000|Overall Study|entrance criteria|0|||
147654166|NCT00398216|532556628|FG001|Overall Study|entrance criteria|0|||
147654167|NCT00398216|532556629|FG002|Overall Study|entrance criteria|0|||
147654168|NCT00398216|532556630|FG003|Overall Study|entrance criteria|0|||
147654169|NCT00398216|532556631|FG004|Overall Study|entrance criteria|2|||
147654170|NCT01962948|532556634|FG000|Overall Study|Study was closed because grantor stopped supplying study drug. Study did not progress to Phase II.|3|||
147654171|NCT01962948|532556635|FG001|Overall Study|Study was closed because grantor stopped supplying study drug. Study did not progress to Phase II.|3|||
147154792|NCT00075946|530729279|FG001|Overall Study|Adverse Event|10|||
147154793|NCT00075946|530729280|FG002|Overall Study|Adverse Event|0|||
147154794|NCT00075946|530729281|FG003|Overall Study|Adverse Event|2|||
147154795|NCT00075946|530729282|FG004|Overall Study|Adverse Event|0|||
147154796|NCT00075946|530729278|FG000|Overall Study|Death|0|||
147154797|NCT00075946|530729279|FG001|Overall Study|Death|1|||
147154798|NCT00075946|530729280|FG002|Overall Study|Death|0|||
147154799|NCT00075946|530729281|FG003|Overall Study|Death|0|||
147154800|NCT00075946|530729282|FG004|Overall Study|Death|0|||
147154801|NCT00075946|530729278|FG000|Overall Study|Withdrawal by Subject|23|||
147154802|NCT00075946|530729279|FG001|Overall Study|Withdrawal by Subject|58|||
147154803|NCT00075946|530729280|FG002|Overall Study|Withdrawal by Subject|4|||
147154804|NCT00075946|530729281|FG003|Overall Study|Withdrawal by Subject|9|||
147154805|NCT00075946|530729282|FG004|Overall Study|Withdrawal by Subject|0|||
147154806|NCT00075946|530729278|FG000|Overall Study|Alternative therapy|16|||
147154807|NCT00075946|530729279|FG001|Overall Study|Alternative therapy|2|||
147240658|NCT03068130|531053450|FG000|Overall Study|Study terminated by sponsor|194|||
147240659|NCT05275400|531053453|FG000|Treatment Period|Adverse Event|7|||
147240660|NCT05275400|531053454|FG001|Treatment Period|Adverse Event|1|||
147240661|NCT05275400|531053453|FG000|Treatment Period|Assigned Treatment by Mistake|6|||
147240662|NCT05275400|531053454|FG001|Treatment Period|Assigned Treatment by Mistake|3|||
147240663|NCT05275400|531053453|FG000|Treatment Period|Death|5|||
147240664|NCT05275400|531053454|FG001|Treatment Period|Death|2|||
147654172|NCT01962948|532556636|FG002|Overall Study|Study was closed because grantor stopped supplying study drug. Study did not progress to Phase II.|6|||
147654173|NCT01962948|532556637|FG003|Overall Study|Study was closed because grantor stopped supplying study drug. Study did not progress to Phase II.|0|||
147154808|NCT00075946|530729280|FG002|Overall Study|Alternative therapy|5|||
147154809|NCT00075946|530729281|FG003|Overall Study|Alternative therapy|0|||
147154810|NCT00075946|530729282|FG004|Overall Study|Alternative therapy|0|||
147154811|NCT00075946|530729278|FG000|Overall Study|Other complicating disease|7|||
147154812|NCT00075946|530729279|FG001|Overall Study|Other complicating disease|13|||
147154813|NCT00075946|530729280|FG002|Overall Study|Other complicating disease|1|||
147154814|NCT00075946|530729281|FG003|Overall Study|Other complicating disease|4|||
147240665|NCT05275400|531053453|FG000|Treatment Period|Protocol Violation|1|||
147154815|NCT00075946|530729282|FG004|Overall Study|Other complicating disease|0|||
147154816|NCT00075946|530729278|FG000|Overall Study|No response to retreatment|23|||
147154817|NCT00075946|530729279|FG001|Overall Study|No response to retreatment|0|||
147154818|NCT00075946|530729280|FG002|Overall Study|No response to retreatment|2|||
147154819|NCT00075946|530729281|FG003|Overall Study|No response to retreatment|0|||
147154820|NCT00075946|530729282|FG004|Overall Study|No response to retreatment|0|||
147154821|NCT00075946|530729278|FG000|Overall Study|Time to progression less than 6 months|15|||
147154822|NCT00075946|530729279|FG001|Overall Study|Time to progression less than 6 months|30|||
147154823|NCT00075946|530729280|FG002|Overall Study|Time to progression less than 6 months|8|||
147154824|NCT00075946|530729281|FG003|Overall Study|Time to progression less than 6 months|3|||
147154825|NCT00075946|530729282|FG004|Overall Study|Time to progression less than 6 months|0|||
147154826|NCT00075946|530729278|FG000|Overall Study|Other|57|||
147154827|NCT00075946|530729279|FG001|Overall Study|Other|32|||
147154828|NCT00075946|530729280|FG002|Overall Study|Other|3|||
147154829|NCT00075946|530729281|FG003|Overall Study|Other|11|||
147154830|NCT00075946|530729282|FG004|Overall Study|Other|0|||
147154831|NCT02231892|530729283|FG000|Overall Study|Lost to Follow-up|1|||
147154832|NCT02231892|530729284|FG001|Overall Study|Lost to Follow-up|0|||
147154833|NCT02231892|530729285|FG002|Overall Study|Lost to Follow-up|3|||
147154834|NCT02231892|530729283|FG000|Overall Study|Withdrawal by Subject|4|||
147154835|NCT02231892|530729284|FG001|Overall Study|Withdrawal by Subject|3|||
147154836|NCT02231892|530729285|FG002|Overall Study|Withdrawal by Subject|15|||
147154837|NCT02231892|530729283|FG000|Overall Study|Physician Decision|0|||
147583641|NCT00642811|532291664|FG002|Overall Study|Adverse Event|0|||
147583642|NCT00642811|532291665|FG003|Overall Study|Adverse Event|0|||
147583643|NCT00642811|532291666|FG004|Overall Study|Adverse Event|0|||
147583644|NCT00642811|532291667|FG005|Overall Study|Adverse Event|1|||
147583645|NCT00642811|532291662|FG000|Overall Study|Developement of discontinuation criteria|0|||
147583646|NCT00642811|532291663|FG001|Overall Study|Developement of discontinuation criteria|0|||
147583647|NCT00642811|532291664|FG002|Overall Study|Developement of discontinuation criteria|0|||
147583648|NCT00642811|532291665|FG003|Overall Study|Developement of discontinuation criteria|0|||
147583649|NCT00642811|532291666|FG004|Overall Study|Developement of discontinuation criteria|1|||
147583650|NCT00642811|532291667|FG005|Overall Study|Developement of discontinuation criteria|0|||
147154838|NCT02231892|530729284|FG001|Overall Study|Physician Decision|2|||
147154839|NCT02231892|530729285|FG002|Overall Study|Physician Decision|4|||
147154840|NCT02231892|530729283|FG000|Overall Study|Motor activity when stimulating ante ACC|4|||
147154841|NCT02231892|530729284|FG001|Overall Study|Motor activity when stimulating ante ACC|7|||
147154842|NCT02231892|530729285|FG002|Overall Study|Motor activity when stimulating ante ACC|12|||
147154843|NCT02231892|530729283|FG000|Overall Study|Participant motor threshold was >83%|0|||
147154844|NCT02231892|530729284|FG001|Overall Study|Participant motor threshold was >83%|0|||
147154845|NCT02231892|530729285|FG002|Overall Study|Participant motor threshold was >83%|9|||
147154846|NCT02231892|530729283|FG000|Overall Study|Could not find motor threshold|2|||
147154847|NCT02231892|530729284|FG001|Overall Study|Could not find motor threshold|0|||
147154848|NCT02231892|530729285|FG002|Overall Study|Could not find motor threshold|1|||
147154849|NCT02231892|530729283|FG000|Overall Study|Could not find reliable motor hotspot|0|||
147154850|NCT02231892|530729284|FG001|Overall Study|Could not find reliable motor hotspot|0|||
147154851|NCT02231892|530729285|FG002|Overall Study|Could not find reliable motor hotspot|1|||
147154852|NCT03832322|530729286|FG000|Overall Study|Failed cecal intubation in 2nd exam|3|||
147154853|NCT03832322|530729287|FG001|Overall Study|Failed cecal intubation in 2nd exam|1|||
147154854|NCT02186652|530729296|FG000|Overall Study|Lost to Follow-up|2|||
147154855|NCT02186652|530729297|FG001|Overall Study|Lost to Follow-up|0|||
147154856|NCT02247011|530729300|FG000|Overall Study|Poor quality of radiological results|125|||
147154857|NCT04470908|530729306|FG000|Zanubrutinib + Rifabutin on Day 11|Lost to Follow-up|1|||
147154858|NCT01974206|530729307|FG000|Overall Study|Did Not Take Study Drug|0|||
147154859|NCT01974206|530729308|FG001|Overall Study|Did Not Take Study Drug|1|||
147240666|NCT05275400|531053454|FG001|Treatment Period|Protocol Violation|0|||
147240667|NCT05275400|531053453|FG000|Treatment Period|Physician Decision|5|||
147240668|NCT05275400|531053454|FG001|Treatment Period|Physician Decision|4|||
147240669|NCT05275400|531053453|FG000|Treatment Period|Non-Compliance with Study Drug|5|||
147240670|NCT05275400|531053454|FG001|Treatment Period|Non-Compliance with Study Drug|1|||
147240671|NCT05275400|531053453|FG000|Treatment Period|Withdrawal by Subject|30|||
147240672|NCT05275400|531053454|FG001|Treatment Period|Withdrawal by Subject|12|||
147240673|NCT05275400|531053453|FG000|Treatment Period|Lost to Follow-up|1|||
147240674|NCT05275400|531053454|FG001|Treatment Period|Lost to Follow-up|5|||
147240675|NCT05275400|531053453|FG000|Treatment Period|Lack of Efficacy|1|||
147240676|NCT05275400|531053454|FG001|Treatment Period|Lack of Efficacy|0|||
147583651|NCT00642811|532291662|FG000|Overall Study|Severe Non-compliance to protocol|1|||
147154860|NCT01974206|530729307|FG000|Overall Study|Physician Decision|1|||
147583652|NCT00642811|532291663|FG001|Overall Study|Severe Non-compliance to protocol|0|||
147154861|NCT01974206|530729308|FG001|Overall Study|Physician Decision|0|||
147154862|NCT01974206|530729307|FG000|Overall Study|Withdrawal by Subject|3|||
147154863|NCT01974206|530729308|FG001|Overall Study|Withdrawal by Subject|0|||
147240677|NCT05275400|531053453|FG000|Treatment Period|Sponsor Decision|1|||
147154864|NCT01974206|530729307|FG000|Overall Study|Lost to Follow-up|1|||
147154865|NCT01974206|530729308|FG001|Overall Study|Lost to Follow-up|0|||
147154866|NCT01974206|530729307|FG000|Overall Study|Death|1|||
147154867|NCT01974206|530729308|FG001|Overall Study|Death|0|||
147154868|NCT03989349|530729311|FG000|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|3|||
147154869|NCT03989349|530729312|FG001|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
147154870|NCT03989349|530729313|FG002|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
147154871|NCT03989349|530729314|FG003|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
147154872|NCT03989349|530729315|FG004|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
147154873|NCT03989349|530729316|FG005|Initial Treatment(Day 1-Week 16 Predose)|Lack of Efficacy|0|||
147154874|NCT03989349|530729311|FG000|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|17|||
147154875|NCT03989349|530729312|FG001|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|4|||
147154876|NCT03989349|530729313|FG002|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
147154877|NCT03989349|530729314|FG003|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
147154878|NCT03989349|530729315|FG004|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
147154879|NCT03989349|530729316|FG005|Initial Treatment(Day 1-Week 16 Predose)|Adverse Event|0|||
147154880|NCT03989349|530729311|FG000|Initial Treatment(Day 1-Week 16 Predose)|Withdrawal by Subject|24|||
147154881|NCT03989349|530729312|FG001|Initial Treatment(Day 1-Week 16 Predose)|Withdrawal by Subject|15|||
147154882|NCT03989349|530729313|FG002|Initial Treatment(Day 1-Week 16 Predose)|Withdrawal by Subject|0|||
147154883|NCT03989349|530729314|FG003|Initial Treatment(Day 1-Week 16 Predose)|Withdrawal by Subject|0|||
147154884|NCT03989349|530729315|FG004|Initial Treatment(Day 1-Week 16 Predose)|Withdrawal by Subject|0|||
147154885|NCT03989349|530729316|FG005|Initial Treatment(Day 1-Week 16 Predose)|Withdrawal by Subject|0|||
147154886|NCT03989349|530729311|FG000|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|1|||
147154887|NCT03989349|530729312|FG001|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|1|||
147154888|NCT03989349|530729313|FG002|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
147154889|NCT03989349|530729314|FG003|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
147154890|NCT03989349|530729315|FG004|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
147154891|NCT03989349|530729316|FG005|Initial Treatment(Day 1-Week 16 Predose)|Lost to Follow-up|0|||
147154892|NCT03989349|530729311|FG000|Initial Treatment(Day 1-Week 16 Predose)|Protocol Deviation|3|||
147154893|NCT03989349|530729312|FG001|Initial Treatment(Day 1-Week 16 Predose)|Protocol Deviation|2|||
147154894|NCT03989349|530729313|FG002|Initial Treatment(Day 1-Week 16 Predose)|Protocol Deviation|0|||
147154895|NCT03989349|530729314|FG003|Initial Treatment(Day 1-Week 16 Predose)|Protocol Deviation|0|||
147154896|NCT03989349|530729315|FG004|Initial Treatment(Day 1-Week 16 Predose)|Protocol Deviation|0|||
147154897|NCT03989349|530729316|FG005|Initial Treatment(Day 1-Week 16 Predose)|Protocol Deviation|0|||
147154898|NCT03989349|530729311|FG000|Initial Treatment(Day 1-Week 16 Predose)|Physician/principal investigator decision|1|||
147154899|NCT03989349|530729312|FG001|Initial Treatment(Day 1-Week 16 Predose)|Physician/principal investigator decision|0|||
147154900|NCT03989349|530729313|FG002|Initial Treatment(Day 1-Week 16 Predose)|Physician/principal investigator decision|0|||
147154901|NCT03989349|530729314|FG003|Initial Treatment(Day 1-Week 16 Predose)|Physician/principal investigator decision|0|||
147154902|NCT03989349|530729315|FG004|Initial Treatment(Day 1-Week 16 Predose)|Physician/principal investigator decision|0|||
147154903|NCT03989349|530729316|FG005|Initial Treatment(Day 1-Week 16 Predose)|Physician/principal investigator decision|0|||
147154904|NCT03989349|530729311|FG000|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not Treated|3|||
147154905|NCT03989349|530729312|FG001|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not Treated|2|||
147154906|NCT03989349|530729313|FG002|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not Treated|0|||
147154907|NCT03989349|530729314|FG003|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not Treated|0|||
147154908|NCT03989349|530729315|FG004|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not Treated|0|||
147154909|NCT03989349|530729316|FG005|Initial Treatment(Day 1-Week 16 Predose)|Randomized but not Treated|0|||
147154910|NCT03989349|530729311|FG000|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
147154911|NCT03989349|530729312|FG001|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
147154912|NCT03989349|530729313|FG002|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|2|||
147154913|NCT03989349|530729314|FG003|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|2|||
147154914|NCT03989349|530729315|FG004|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|3|||
147154915|NCT03989349|530729316|FG005|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|3|||
147154916|NCT03989349|530729311|FG000|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
147154917|NCT03989349|530729312|FG001|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
147154918|NCT03989349|530729313|FG002|Maintenance Period (Week 16-Week 48)|Adverse Event|3|||
147154919|NCT03989349|530729314|FG003|Maintenance Period (Week 16-Week 48)|Adverse Event|2|||
147154920|NCT03989349|530729315|FG004|Maintenance Period (Week 16-Week 48)|Adverse Event|3|||
147154921|NCT03989349|530729316|FG005|Maintenance Period (Week 16-Week 48)|Adverse Event|2|||
147154922|NCT03989349|530729311|FG000|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|0|||
147154923|NCT03989349|530729312|FG001|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|0|||
147154924|NCT03989349|530729313|FG002|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|2|||
147154925|NCT03989349|530729314|FG003|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|3|||
147240678|NCT05275400|531053454|FG001|Treatment Period|Sponsor Decision|0|||
147154926|NCT03989349|530729315|FG004|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|1|||
147154927|NCT03989349|530729316|FG005|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|4|||
147154928|NCT03989349|530729311|FG000|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
147154929|NCT03989349|530729312|FG001|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
147154930|NCT03989349|530729313|FG002|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|1|||
147154931|NCT03989349|530729314|FG003|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
147154932|NCT03989349|530729315|FG004|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|3|||
147154933|NCT03989349|530729316|FG005|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
147154934|NCT03989349|530729311|FG000|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
147154935|NCT03989349|530729312|FG001|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
147154936|NCT03989349|530729313|FG002|Maintenance Period (Week 16-Week 48)|Physician Decision|1|||
147154937|NCT03989349|530729314|FG003|Maintenance Period (Week 16-Week 48)|Physician Decision|1|||
147154938|NCT03989349|530729315|FG004|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
147154939|NCT03989349|530729316|FG005|Maintenance Period (Week 16-Week 48)|Physician Decision|1|||
147154940|NCT03989349|530729311|FG000|Maintenance Period (Week 16-Week 48)|Other|0|||
147154941|NCT03989349|530729312|FG001|Maintenance Period (Week 16-Week 48)|Other|0|||
147154942|NCT03989349|530729313|FG002|Maintenance Period (Week 16-Week 48)|Other|4|||
147154943|NCT03989349|530729314|FG003|Maintenance Period (Week 16-Week 48)|Other|2|||
147154944|NCT03989349|530729315|FG004|Maintenance Period (Week 16-Week 48)|Other|2|||
147154945|NCT03989349|530729316|FG005|Maintenance Period (Week 16-Week 48)|Other|0|||
147154946|NCT03989349|530729311|FG000|Maintenance Period (Week 16-Week 48)|Re-randomized/Re-assigned but not Treated|0|||
147154947|NCT03989349|530729312|FG001|Maintenance Period (Week 16-Week 48)|Re-randomized/Re-assigned but not Treated|0|||
147154948|NCT03989349|530729313|FG002|Maintenance Period (Week 16-Week 48)|Re-randomized/Re-assigned but not Treated|1|||
147154949|NCT03989349|530729314|FG003|Maintenance Period (Week 16-Week 48)|Re-randomized/Re-assigned but not Treated|0|||
147154950|NCT03989349|530729315|FG004|Maintenance Period (Week 16-Week 48)|Re-randomized/Re-assigned but not Treated|1|||
147154951|NCT03989349|530729316|FG005|Maintenance Period (Week 16-Week 48)|Re-randomized/Re-assigned but not Treated|1|||
147154952|NCT01802580|530729319|FG000|Overall Study|Physician Decision|1|||
147154953|NCT01802580|530729320|FG001|Overall Study|Physician Decision|0|||
147154954|NCT01802580|530729319|FG000|Overall Study|Protocol Violation|2|||
147154955|NCT01802580|530729320|FG001|Overall Study|Protocol Violation|0|||
147154956|NCT01802580|530729319|FG000|Overall Study|Withdrawal by Subject|5|||
147583653|NCT00642811|532291664|FG002|Overall Study|Severe Non-compliance to protocol|0|||
147583654|NCT00642811|532291665|FG003|Overall Study|Severe Non-compliance to protocol|0|||
147583655|NCT00642811|532291666|FG004|Overall Study|Severe Non-compliance to protocol|0|||
147583656|NCT00642811|532291667|FG005|Overall Study|Severe Non-compliance to protocol|0|||
147583657|NCT00642811|532291662|FG000|Overall Study|Other|0|||
147583658|NCT00642811|532291663|FG001|Overall Study|Other|1|||
147583659|NCT00642811|532291664|FG002|Overall Study|Other|0|||
147583660|NCT00642811|532291665|FG003|Overall Study|Other|1|||
147583661|NCT00642811|532291666|FG004|Overall Study|Other|0|||
147583662|NCT00642811|532291667|FG005|Overall Study|Other|0|||
147583663|NCT04553406|532291670|FG000|Overall Study|Study Discontinuation|0|||
147583664|NCT04553406|532291671|FG001|Overall Study|Study Discontinuation|1|||
147583665|NCT00772148|532291672|FG000|Pharmacokinetic Phase (14 Days)|Adverse Event|3|||
147583666|NCT00772148|532291673|FG001|Pharmacokinetic Phase (14 Days)|Adverse Event|1|||
147583667|NCT00772148|532291672|FG000|Pharmacokinetic Phase (14 Days)|Withdrawal by Subject|3|||
147583668|NCT00772148|532291673|FG001|Pharmacokinetic Phase (14 Days)|Withdrawal by Subject|5|||
147583669|NCT00772148|532291672|FG000|Pharmacokinetic Phase (14 Days)|Administrative/other|2|||
147583670|NCT00772148|532291673|FG001|Pharmacokinetic Phase (14 Days)|Administrative/other|0|||
147583671|NCT00772148|532291672|FG000|Maintenance Phase (Week 52)|Death|2|||
147583672|NCT00772148|532291673|FG001|Maintenance Phase (Week 52)|Death|2|||
147583673|NCT00772148|532291672|FG000|Maintenance Phase (Week 52)|Adverse Event|1|||
147583674|NCT00772148|532291673|FG001|Maintenance Phase (Week 52)|Adverse Event|0|||
147583675|NCT00772148|532291672|FG000|Maintenance Phase (Week 52)|Withdrawal by Subject|0|||
147583676|NCT00772148|532291673|FG001|Maintenance Phase (Week 52)|Withdrawal by Subject|1|||
147583677|NCT00772148|532291672|FG000|Maintenance Phase (Week 52)|Administrative/other|1|||
147583678|NCT00772148|532291673|FG001|Maintenance Phase (Week 52)|Administrative/other|2|||
147583679|NCT03573336|532291676|FG000|Overall Study|Study terminated|2|||
147583680|NCT03573336|532291677|FG001|Overall Study|Study terminated|4|||
147583681|NCT03573336|532291678|FG002|Overall Study|Study terminated|2|||
147583682|NCT01525628|532291679|FG000|Overall Study|Adverse Event|1|||
147583683|NCT01525628|532291680|FG001|Overall Study|Adverse Event|1|||
147583684|NCT01525628|532291681|FG002|Overall Study|Adverse Event|2|||
147583685|NCT01525628|532291682|FG003|Overall Study|Adverse Event|0|||
147583686|NCT01525628|532291683|FG004|Overall Study|Adverse Event|1|||
147583687|NCT01525628|532291679|FG000|Overall Study|Lack of Efficacy|0|||
147583688|NCT01525628|532291680|FG001|Overall Study|Lack of Efficacy|2|||
147583689|NCT01525628|532291681|FG002|Overall Study|Lack of Efficacy|2|||
147583690|NCT01525628|532291682|FG003|Overall Study|Lack of Efficacy|1|||
147583691|NCT01525628|532291683|FG004|Overall Study|Lack of Efficacy|2|||
147583692|NCT01525628|532291679|FG000|Overall Study|Protocol Violation|0|||
147583693|NCT01525628|532291680|FG001|Overall Study|Protocol Violation|0|||
147583694|NCT01525628|532291681|FG002|Overall Study|Protocol Violation|1|||
147583695|NCT01525628|532291682|FG003|Overall Study|Protocol Violation|0|||
147583696|NCT01525628|532291683|FG004|Overall Study|Protocol Violation|0|||
147583697|NCT01525628|532291679|FG000|Overall Study|Lost to Follow-up|1|||
147583698|NCT01525628|532291680|FG001|Overall Study|Lost to Follow-up|1|||
147583699|NCT01525628|532291681|FG002|Overall Study|Lost to Follow-up|0|||
147583700|NCT01525628|532291682|FG003|Overall Study|Lost to Follow-up|0|||
147583701|NCT01525628|532291683|FG004|Overall Study|Lost to Follow-up|0|||
147583702|NCT01525628|532291679|FG000|Overall Study|Withdrawal by Subject|0|||
147583703|NCT01525628|532291680|FG001|Overall Study|Withdrawal by Subject|1|||
147583704|NCT01525628|532291681|FG002|Overall Study|Withdrawal by Subject|0|||
147583705|NCT01525628|532291682|FG003|Overall Study|Withdrawal by Subject|0|||
147583706|NCT01525628|532291683|FG004|Overall Study|Withdrawal by Subject|0|||
147154957|NCT01802580|530729320|FG001|Overall Study|Withdrawal by Subject|6|||
147154958|NCT01802580|530729319|FG000|Overall Study|Other|1|||
147154959|NCT01802580|530729320|FG001|Overall Study|Other|3|||
147154960|NCT01802580|530729319|FG000|Overall Study|Lack of Efficacy|0|||
147154961|NCT01802580|530729320|FG001|Overall Study|Lack of Efficacy|2|||
147154962|NCT03255967|530729321|FG000|Overall Study|Adverse Event|26|||
147154963|NCT03255967|530729322|FG001|Overall Study|Adverse Event|30|||
147154964|NCT03255967|530729321|FG000|Overall Study|Withdrawal by Subject|6|||
147154965|NCT03255967|530729322|FG001|Overall Study|Withdrawal by Subject|6|||
147154966|NCT03255967|530729321|FG000|Overall Study|Schedule conflict|6|||
147154967|NCT03255967|530729322|FG001|Overall Study|Schedule conflict|4|||
147154968|NCT03255967|530729321|FG000|Overall Study|POA did not sign consent form|2|||
147154969|NCT03255967|530729322|FG001|Overall Study|POA did not sign consent form|0|||
147154970|NCT00778258|530729325|FG000|Overall Study|Adverse Event|1|||
147154971|NCT00778258|530729326|FG001|Overall Study|Adverse Event|0|||
147154972|NCT00778258|530729327|FG002|Overall Study|Adverse Event|0|||
147154973|NCT00778258|530729328|FG003|Overall Study|Adverse Event|0|||
147154974|NCT00778258|530729329|FG004|Overall Study|Adverse Event|0|||
147154975|NCT00778258|530729330|FG005|Overall Study|Adverse Event|1|||
147154976|NCT00778258|530729331|FG006|Overall Study|Adverse Event|0|||
147154977|NCT00778258|530729332|FG007|Overall Study|Adverse Event|0|||
147154978|NCT00778258|530729333|FG008|Overall Study|Adverse Event|0|||
147154979|NCT00778258|530729325|FG000|Overall Study|Lost to Follow-up|0|||
147154980|NCT00778258|530729326|FG001|Overall Study|Lost to Follow-up|0|||
147154981|NCT00778258|530729327|FG002|Overall Study|Lost to Follow-up|2|||
147154982|NCT00778258|530729328|FG003|Overall Study|Lost to Follow-up|0|||
147154983|NCT00778258|530729329|FG004|Overall Study|Lost to Follow-up|0|||
147154984|NCT00778258|530729330|FG005|Overall Study|Lost to Follow-up|3|||
147154985|NCT00778258|530729331|FG006|Overall Study|Lost to Follow-up|2|||
147154986|NCT00778258|530729332|FG007|Overall Study|Lost to Follow-up|2|||
147154987|NCT00778258|530729333|FG008|Overall Study|Lost to Follow-up|0|||
147154988|NCT00778258|530729325|FG000|Overall Study|Withdrawal by Subject|6|||
147154989|NCT00778258|530729326|FG001|Overall Study|Withdrawal by Subject|2|||
147154990|NCT00778258|530729327|FG002|Overall Study|Withdrawal by Subject|8|||
147154991|NCT00778258|530729328|FG003|Overall Study|Withdrawal by Subject|2|||
147154992|NCT00778258|530729329|FG004|Overall Study|Withdrawal by Subject|0|||
147154993|NCT00778258|530729330|FG005|Overall Study|Withdrawal by Subject|6|||
147154994|NCT00778258|530729331|FG006|Overall Study|Withdrawal by Subject|12|||
147154995|NCT00778258|530729332|FG007|Overall Study|Withdrawal by Subject|12|||
147154996|NCT00778258|530729333|FG008|Overall Study|Withdrawal by Subject|4|||
147154997|NCT00778258|530729325|FG000|Overall Study|New Contraindication|0|||
147154998|NCT00778258|530729326|FG001|Overall Study|New Contraindication|0|||
147154999|NCT00778258|530729327|FG002|Overall Study|New Contraindication|0|||
147155000|NCT00778258|530729328|FG003|Overall Study|New Contraindication|0|||
147155001|NCT00778258|530729329|FG004|Overall Study|New Contraindication|0|||
147155002|NCT00778258|530729330|FG005|Overall Study|New Contraindication|0|||
147155003|NCT00778258|530729331|FG006|Overall Study|New Contraindication|0|||
147155004|NCT00778258|530729332|FG007|Overall Study|New Contraindication|1|||
147155005|NCT00778258|530729333|FG008|Overall Study|New Contraindication|0|||
147155006|NCT00778258|530729325|FG000|Overall Study|Non-compliance|0|||
147155007|NCT00778258|530729326|FG001|Overall Study|Non-compliance|0|||
147155008|NCT00778258|530729327|FG002|Overall Study|Non-compliance|0|||
147155009|NCT00778258|530729328|FG003|Overall Study|Non-compliance|1|||
147155010|NCT00778258|530729329|FG004|Overall Study|Non-compliance|0|||
147155011|NCT00778258|530729330|FG005|Overall Study|Non-compliance|0|||
147155012|NCT00778258|530729331|FG006|Overall Study|Non-compliance|0|||
147155013|NCT00778258|530729332|FG007|Overall Study|Non-compliance|0|||
147155014|NCT00778258|530729333|FG008|Overall Study|Non-compliance|0|||
147583707|NCT01525628|532291679|FG000|Overall Study|Other reason not defined above|0|||
147583708|NCT01525628|532291680|FG001|Overall Study|Other reason not defined above|0|||
147155015|NCT00778258|530729325|FG000|Overall Study|Other|0|||
147155016|NCT00778258|530729326|FG001|Overall Study|Other|0|||
147155017|NCT00778258|530729327|FG002|Overall Study|Other|0|||
147583709|NCT01525628|532291681|FG002|Overall Study|Other reason not defined above|0|||
147155018|NCT00778258|530729328|FG003|Overall Study|Other|0|||
147583710|NCT01525628|532291682|FG003|Overall Study|Other reason not defined above|3|||
147583711|NCT01525628|532291683|FG004|Overall Study|Other reason not defined above|0|||
147583712|NCT03108820|532291684|FG000|Overall Study|Lost to Follow-up|30|||
147583713|NCT03108820|532291685|FG001|Overall Study|Lost to Follow-up|28|||
147583714|NCT03108820|532291684|FG000|Overall Study|Withdrawal by Subject|32|||
147583715|NCT03108820|532291685|FG001|Overall Study|Withdrawal by Subject|24|||
147583716|NCT03108820|532291684|FG000|Overall Study|Death|6|||
147654174|NCT03396822|532556638|FG000|Overall Study|No meningeal enhancement on baseline scan|8|||
147654175|NCT03396822|532556638|FG000|Overall Study|Physician Decision|1|||
147654176|NCT02849704|532556641|FG000|Assessment on PERT - CP Subj - 16 Days|Lost to Follow-up|1|||
147654177|NCT02849704|532556642|FG001|Assessment on PERT - CP Subj - 16 Days|Lost to Follow-up|0|||
147654178|NCT02849704|532556641|FG000|Assessment on PERT - CP Subj - 16 Days|Adverse Event|1|||
147654179|NCT02849704|532556642|FG001|Assessment on PERT - CP Subj - 16 Days|Adverse Event|0|||
147654180|NCT02849704|532556641|FG000|Assessment on PERT - CP Subj - 16 Days|Unable to complete study procedures|1|||
147654181|NCT02849704|532556642|FG001|Assessment on PERT - CP Subj - 16 Days|Unable to complete study procedures|0|||
147654182|NCT02579382|532556643|FG000|Main Study Phase|Lost to Follow-up|0|||
147654183|NCT02579382|532556644|FG001|Main Study Phase|Lost to Follow-up|0|||
147654184|NCT02579382|532556645|FG002|Main Study Phase|Lost to Follow-up|2|||
147654185|NCT02579382|532556646|FG003|Main Study Phase|Lost to Follow-up|0|||
147654186|NCT02579382|532556643|FG000|Main Study Phase|Withdrew Consent|0|||
147654187|NCT02579382|532556644|FG001|Main Study Phase|Withdrew Consent|0|||
147654188|NCT02579382|532556645|FG002|Main Study Phase|Withdrew Consent|0|||
147654189|NCT02579382|532556646|FG003|Main Study Phase|Withdrew Consent|2|||
147654190|NCT02579382|532556643|FG000|Main Study Phase|Lack of Efficacy|0|||
147654191|NCT02579382|532556644|FG001|Main Study Phase|Lack of Efficacy|0|||
147654192|NCT02579382|532556645|FG002|Main Study Phase|Lack of Efficacy|0|||
147654193|NCT02579382|532556646|FG003|Main Study Phase|Lack of Efficacy|1|||
147654194|NCT02579382|532556643|FG000|Optional Treatment Extension Phase(OTEP)|Withdrew Consent|0|||
147654195|NCT02579382|532556644|FG001|Optional Treatment Extension Phase(OTEP)|Withdrew Consent|3|||
147654196|NCT02579382|532556645|FG002|Optional Treatment Extension Phase(OTEP)|Withdrew Consent|1|||
147654197|NCT02579382|532556646|FG003|Optional Treatment Extension Phase(OTEP)|Withdrew Consent|4|||
147654198|NCT02579382|532556643|FG000|Optional Treatment Extension Phase(OTEP)|Investigator's discretion|1|||
147654199|NCT02579382|532556644|FG001|Optional Treatment Extension Phase(OTEP)|Investigator's discretion|0|||
147654200|NCT02579382|532556645|FG002|Optional Treatment Extension Phase(OTEP)|Investigator's discretion|2|||
147654201|NCT02579382|532556646|FG003|Optional Treatment Extension Phase(OTEP)|Investigator's discretion|0|||
147654202|NCT02579382|532556643|FG000|Optional Treatment Extension Phase(OTEP)|Lost to Follow-up|0|||
147654203|NCT02579382|532556644|FG001|Optional Treatment Extension Phase(OTEP)|Lost to Follow-up|1|||
147654204|NCT02579382|532556645|FG002|Optional Treatment Extension Phase(OTEP)|Lost to Follow-up|1|||
147654205|NCT02579382|532556646|FG003|Optional Treatment Extension Phase(OTEP)|Lost to Follow-up|1|||
147654206|NCT02579382|532556643|FG000|Optional Treatment Extension Phase(OTEP)|Adverse Event|0|||
147654207|NCT02579382|532556644|FG001|Optional Treatment Extension Phase(OTEP)|Adverse Event|1|||
147654208|NCT02579382|532556645|FG002|Optional Treatment Extension Phase(OTEP)|Adverse Event|0|||
147654209|NCT02579382|532556646|FG003|Optional Treatment Extension Phase(OTEP)|Adverse Event|0|||
147654210|NCT02579382|532556643|FG000|Optional Treatment Extension Phase(OTEP)|Pregnancy|0|||
147654211|NCT02579382|532556644|FG001|Optional Treatment Extension Phase(OTEP)|Pregnancy|1|||
147654212|NCT02579382|532556645|FG002|Optional Treatment Extension Phase(OTEP)|Pregnancy|0|||
147654213|NCT02579382|532556646|FG003|Optional Treatment Extension Phase(OTEP)|Pregnancy|0|||
147654214|NCT02579382|532556643|FG000|Optional Treatment Extension Phase(OTEP)|Non-compliance with Study Drug|0|||
147654215|NCT02579382|532556644|FG001|Optional Treatment Extension Phase(OTEP)|Non-compliance with Study Drug|1|||
147654216|NCT02579382|532556645|FG002|Optional Treatment Extension Phase(OTEP)|Non-compliance with Study Drug|0|||
147654217|NCT02579382|532556646|FG003|Optional Treatment Extension Phase(OTEP)|Non-compliance with Study Drug|0|||
147654218|NCT00412932|532556653|FG000|Olmesartan (Olm) 20 mg|Adverse Event|1|||
147654219|NCT00412932|532556653|FG000|Olmesartan (Olm) 20 mg|Lack of Efficacy|2|||
147654220|NCT00412932|532556653|FG000|Olmesartan (Olm) 20 mg|Protocol Violation|1|||
147654221|NCT00412932|532556653|FG000|Olmesartan (Olm) 20 mg|Withdrawal by Subject|2|||
147654222|NCT00412932|532556653|FG000|Olmesartan (Olm) 20 mg|Other|1|||
147654223|NCT00412932|532556653|FG000|Olmesartan 40 mg|Adverse Event|4|||
147654224|NCT00412932|532556653|FG000|Olmesartan 40 mg|Lack of Efficacy|3|||
147654225|NCT00412932|532556653|FG000|Olmesartan 40 mg|Withdrawal by Subject|1|||
147654226|NCT00412932|532556653|FG000|Olm+Hydrochlorothiazide 12.5 mg|Adverse Event|3|||
147155019|NCT00778258|530729329|FG004|Overall Study|Other|0|||
147583717|NCT03108820|532291685|FG001|Overall Study|Death|11|||
147583718|NCT00787605|532291686|FG000|Overall Study|Administrative Problems|3|||
147583719|NCT00787605|532291687|FG001|Overall Study|Administrative Problems|0|||
147654227|NCT00412932|532556653|FG000|Olm+Hydrochlorothiazide 12.5 mg|Withdrawal by Subject|3|||
147654228|NCT00412932|532556653|FG000|Olm+ Hydrochlorothiazide 25 mg|Adverse Event|1|||
147654229|NCT00412932|532556653|FG000|Olm+ Hydrochlorothiazide 25 mg|Lost to Follow-up|1|||
147654230|NCT02259400|532556654|FG000|Overall Study|Death|0|||
147654231|NCT02259400|532556655|FG001|Overall Study|Death|2|||
147583720|NCT00787605|532291686|FG000|Overall Study|Adverse Event|14|||
147654232|NCT01763203|532556662|FG000|Overall Study|Death|4|||
147654233|NCT01763203|532556663|FG001|Overall Study|Death|7|||
147654234|NCT01763203|532556662|FG000|Overall Study|Lost to Follow-up|12|||
147654235|NCT01763203|532556663|FG001|Overall Study|Lost to Follow-up|12|||
147654236|NCT01763203|532556662|FG000|Overall Study|Withdrawal by Subject|8|||
147654237|NCT01763203|532556663|FG001|Overall Study|Withdrawal by Subject|12|||
147155020|NCT00778258|530729330|FG005|Overall Study|Other|0|||
147155021|NCT00778258|530729331|FG006|Overall Study|Other|1|||
147155022|NCT00778258|530729332|FG007|Overall Study|Other|0|||
147155023|NCT00778258|530729333|FG008|Overall Study|Other|0|||
147155024|NCT04621240|530729334|FG000|Overall Study|Withdrawal by Subject|36|||
147155025|NCT02867813|530731200|FG000|Overall Study|Withdrawal by Subject|57|||
147155026|NCT02867813|530731201|FG001|Overall Study|Withdrawal by Subject|56|||
147155027|NCT02867813|530731200|FG000|Overall Study|Decision by Sponsor|7|||
147155028|NCT02867813|530731201|FG001|Overall Study|Decision by Sponsor|7|||
147155029|NCT02867813|530731200|FG000|Overall Study|Lost to Follow-up|91|||
147155030|NCT02867813|530731201|FG001|Overall Study|Lost to Follow-up|78|||
147155031|NCT02867813|530731200|FG000|Overall Study|Missing|2|||
147155032|NCT02867813|530731201|FG001|Overall Study|Missing|1|||
147155033|NCT02867813|530731200|FG000|Overall Study|Death|294|||
147155034|NCT02867813|530731201|FG001|Overall Study|Death|268|||
147155035|NCT02013206|530731202|FG000|Overall Study|Progressive disease (PD)|14|||
147155036|NCT02013206|530731203|FG001|Overall Study|Progressive disease (PD)|17|||
147155037|NCT02013206|530731202|FG000|Overall Study|Symptomatic deterioration|3|||
147155038|NCT02013206|530731203|FG001|Overall Study|Symptomatic deterioration|1|||
147155039|NCT02013206|530731202|FG000|Overall Study|Adverse Event|1|||
147155040|NCT02013206|530731203|FG001|Overall Study|Adverse Event|0|||
147654238|NCT01763203|532556662|FG000|Overall Study|Moved out of study region|7|||
147654239|NCT01763203|532556663|FG001|Overall Study|Moved out of study region|10|||
147654240|NCT01763203|532556662|FG000|Overall Study|Physician Decision|2|||
147654241|NCT01763203|532556663|FG001|Overall Study|Physician Decision|1|||
147654242|NCT02187861|532556664|FG000|Overall Study|Adverse Event|2|||
147654243|NCT02187861|532556665|FG001|Overall Study|Adverse Event|1|||
147654244|NCT02187861|532556666|FG002|Overall Study|Adverse Event|2|||
147654245|NCT02187861|532556667|FG003|Overall Study|Adverse Event|1|||
147654246|NCT02187861|532556664|FG000|Overall Study|Death|0|||
147654247|NCT02187861|532556665|FG001|Overall Study|Death|3|||
147654248|NCT02187861|532556666|FG002|Overall Study|Death|1|||
147654249|NCT02187861|532556667|FG003|Overall Study|Death|2|||
147654250|NCT02187861|532556664|FG000|Overall Study|Physician Decision|0|||
147654251|NCT02187861|532556665|FG001|Overall Study|Physician Decision|1|||
147654252|NCT02187861|532556666|FG002|Overall Study|Physician Decision|0|||
147654253|NCT02187861|532556667|FG003|Overall Study|Physician Decision|3|||
147654254|NCT02187861|532556664|FG000|Overall Study|Progressive Disease|4|||
147654255|NCT02187861|532556665|FG001|Overall Study|Progressive Disease|42|||
147654256|NCT02187861|532556666|FG002|Overall Study|Progressive Disease|19|||
147654257|NCT02187861|532556667|FG003|Overall Study|Progressive Disease|22|||
147654258|NCT02187861|532556664|FG000|Overall Study|Withdrawal by Subject|0|||
147654259|NCT02187861|532556665|FG001|Overall Study|Withdrawal by Subject|0|||
147654260|NCT02187861|532556666|FG002|Overall Study|Withdrawal by Subject|3|||
147654261|NCT02187861|532556667|FG003|Overall Study|Withdrawal by Subject|3|||
147654262|NCT02187861|532556664|FG000|Overall Study|Other|0|||
147654263|NCT02187861|532556665|FG001|Overall Study|Other|1|||
147654264|NCT02187861|532556666|FG002|Overall Study|Other|7|||
147155041|NCT02013206|530731202|FG000|Overall Study|Patient refusal|2|||
147155042|NCT02013206|530731203|FG001|Overall Study|Patient refusal|0|||
147155043|NCT02013206|530731202|FG000|Overall Study|Patient non-compliance|1|||
147155044|NCT02013206|530731203|FG001|Overall Study|Patient non-compliance|0|||
147155045|NCT02013206|530731202|FG000|Overall Study|Death|1|||
147155046|NCT02013206|530731203|FG001|Overall Study|Death|2|||
147155047|NCT02013206|530731202|FG000|Overall Study|Other reasons off treatment|5|||
147155048|NCT02013206|530731203|FG001|Overall Study|Other reasons off treatment|2|||
147155049|NCT01952665|530731204|FG000|Overall Study|Physician Decision|3|||
147155050|NCT01952665|530731205|FG001|Overall Study|Physician Decision|2|||
147155051|NCT01952665|530731204|FG000|Overall Study|Lost to Follow-up|1|||
147155052|NCT01952665|530731205|FG001|Overall Study|Lost to Follow-up|2|||
147155053|NCT01952665|530731204|FG000|Overall Study|Adverse Event|2|||
147155054|NCT01952665|530731205|FG001|Overall Study|Adverse Event|1|||
147654265|NCT02187861|532556667|FG003|Overall Study|Other|1|||
147654266|NCT02756819|532556668|FG000|Overall Study|Lost for observation|23|||
147654267|NCT02756819|532556668|FG000|Overall Study|Patient's unwillingness|16|||
147654268|NCT02756819|532556668|FG000|Overall Study|Insufficient efficacy|2|||
147654269|NCT02756819|532556668|FG000|Overall Study|Adverse Event|2|||
147654270|NCT02756819|532556668|FG000|Overall Study|Reason not Specified|9|||
147654271|NCT01491841|532556670|FG000|Overall Study|Screen Failure|10|||
147654272|NCT01491841|532556670|FG000|Overall Study|Withdrawal by Subject|1|||
147654273|NCT02933528|532556671|FG000|Overall Study|Lost to Follow-up|2|||
147654274|NCT00741598|532556672|FG000|Overall Study|Lost to Follow-up|3|||
147155055|NCT01952665|530731204|FG000|Overall Study|Protocol Violation|0|||
147155056|NCT01952665|530731205|FG001|Overall Study|Protocol Violation|1|||
147654275|NCT00741598|532556673|FG001|Overall Study|Lost to Follow-up|4|||
147240679|NCT05275400|531053453|FG000|Follow-Up Period|Death|2|||
147240680|NCT05275400|531053454|FG001|Follow-Up Period|Death|0|||
147240681|NCT05275400|531053453|FG000|Follow-Up Period|Protocol Violation|1|||
147240682|NCT05275400|531053454|FG001|Follow-Up Period|Protocol Violation|0|||
147240683|NCT05275400|531053453|FG000|Follow-Up Period|Withdrawal by Subject|3|||
147240684|NCT05275400|531053454|FG001|Follow-Up Period|Withdrawal by Subject|0|||
147240685|NCT02585960|531053455|FG000|PK/Safety Assessment Period|Physician Decision|0|||
147240686|NCT02585960|531053456|FG001|PK/Safety Assessment Period|Physician Decision|1|||
147240687|NCT02585960|531053457|FG002|PK/Safety Assessment Period|Physician Decision|0|||
147240688|NCT02585960|531053455|FG000|PK/Safety Assessment Period|Withdrawal by Subject|1|||
147240689|NCT02585960|531053456|FG001|PK/Safety Assessment Period|Withdrawal by Subject|2|||
147240690|NCT02585960|531053457|FG002|PK/Safety Assessment Period|Withdrawal by Subject|5|||
147240691|NCT02585960|531053455|FG000|PK/Safety Assessment Period|Non-compliance to study procedures|0|||
147240692|NCT02585960|531053456|FG001|PK/Safety Assessment Period|Non-compliance to study procedures|2|||
147240693|NCT02585960|531053457|FG002|PK/Safety Assessment Period|Non-compliance to study procedures|0|||
147240694|NCT02585960|531053455|FG000|PK/Safety Assessment Period|Other|4|||
147240695|NCT02585960|531053456|FG001|PK/Safety Assessment Period|Other|4|||
147240696|NCT02585960|531053457|FG002|PK/Safety Assessment Period|Other|0|||
147240697|NCT02585960|531053455|FG000|PK/Safety Assessment Period|Withdrawn by sponsor|0|||
147240698|NCT02585960|531053456|FG001|PK/Safety Assessment Period|Withdrawn by sponsor|1|||
147240699|NCT02585960|531053457|FG002|PK/Safety Assessment Period|Withdrawn by sponsor|0|||
147240700|NCT02585960|531053455|FG000|PK/Safety Assessment Period|Screen Failure|0|||
147240701|NCT02585960|531053456|FG001|PK/Safety Assessment Period|Screen Failure|0|||
147240702|NCT02585960|531053457|FG002|PK/Safety Assessment Period|Screen Failure|1|||
147240703|NCT02585960|531053455|FG000|Prophylactic Treatment Period|Major protocol deviation|0|||
147240704|NCT02585960|531053456|FG001|Prophylactic Treatment Period|Major protocol deviation|4|||
147240705|NCT02585960|531053457|FG002|Prophylactic Treatment Period|Major protocol deviation|0|||
147240706|NCT02585960|531053455|FG000|Prophylactic Treatment Period|Subject less than 75% exposed to BAX 855|0|||
147240707|NCT02585960|531053456|FG001|Prophylactic Treatment Period|Subject less than 75% exposed to BAX 855|1|||
147240708|NCT02585960|531053457|FG002|Prophylactic Treatment Period|Subject less than 75% exposed to BAX 855|0|||
147240709|NCT06333613|531053458|FG000|Overall Study|Doesn't Like Wearing Contacts|1|||
147240710|NCT00709761|531053459|FG000|Overall Study|Withdrawal by Subject|8|||
147240711|NCT00709761|531053459|FG000|Overall Study|study closed/terminated|17|||
147240712|NCT00709761|531053459|FG000|Overall Study|Lost to Follow-up|2|||
147240713|NCT04930965|531053462|FG000|Overall Study|Lost to Follow-up|7|||
147240714|NCT04930965|531053463|FG001|Overall Study|Lost to Follow-up|5|||
147240715|NCT05587296|531053464|FG000|Overall Study|Adverse Event|15|||
147240716|NCT05587296|531053465|FG001|Overall Study|Adverse Event|7|||
147240717|NCT05587296|531053464|FG000|Overall Study|Lack of Efficacy|2|||
147240718|NCT05587296|531053465|FG001|Overall Study|Lack of Efficacy|0|||
147155057|NCT01537081|530731206|FG000|Overall Study|Adverse Event|5|||
147155058|NCT01537081|530731207|FG001|Overall Study|Adverse Event|2|||
147155059|NCT01537081|530731208|FG002|Overall Study|Adverse Event|2|||
147155060|NCT01537081|530731206|FG000|Overall Study|Lack of Efficacy|2|||
147155061|NCT01537081|530731207|FG001|Overall Study|Lack of Efficacy|1|||
147155062|NCT01537081|530731208|FG002|Overall Study|Lack of Efficacy|0|||
147155063|NCT01537081|530731206|FG000|Overall Study|Lost to Follow-up|17|||
147155064|NCT01537081|530731207|FG001|Overall Study|Lost to Follow-up|15|||
147155065|NCT01537081|530731208|FG002|Overall Study|Lost to Follow-up|9|||
147155066|NCT01537081|530731206|FG000|Overall Study|Protocol Violation|3|||
147155067|NCT01537081|530731207|FG001|Overall Study|Protocol Violation|2|||
147155068|NCT01537081|530731208|FG002|Overall Study|Protocol Violation|2|||
147155069|NCT01537081|530731206|FG000|Overall Study|Withdrawal by Subject|6|||
147155070|NCT01537081|530731207|FG001|Overall Study|Withdrawal by Subject|11|||
147155071|NCT01537081|530731208|FG002|Overall Study|Withdrawal by Subject|3|||
147155072|NCT01537081|530731206|FG000|Overall Study|Physician Decision|5|||
147155073|NCT01537081|530731207|FG001|Overall Study|Physician Decision|6|||
147155074|NCT01537081|530731208|FG002|Overall Study|Physician Decision|0|||
147155075|NCT01537081|530731206|FG000|Overall Study|Sponsor decision|0|||
147155076|NCT01537081|530731207|FG001|Overall Study|Sponsor decision|1|||
147155077|NCT01537081|530731208|FG002|Overall Study|Sponsor decision|0|||
147155078|NCT01537081|530731206|FG000|Overall Study|Assigned but never dosed|1|||
147155079|NCT01537081|530731207|FG001|Overall Study|Assigned but never dosed|0|||
147240719|NCT05587296|531053464|FG000|Overall Study|Lost to Follow-up|1|||
147240720|NCT05587296|531053465|FG001|Overall Study|Lost to Follow-up|0|||
147240721|NCT05587296|531053464|FG000|Overall Study|Withdrawal by Subject|14|||
147240722|NCT05587296|531053465|FG001|Overall Study|Withdrawal by Subject|4|||
147155080|NCT01537081|530731208|FG002|Overall Study|Assigned but never dosed|0|||
147155081|NCT01463111|530731211|FG000|Overall Study|Withdrawal by Subject|2|||
147155082|NCT01463111|530731211|FG000|Overall Study|Lost to Follow-up|5|||
147155083|NCT01463111|530731211|FG000|Overall Study|Physician Decision|2|||
147155084|NCT01559259|530731216|FG000|Overall Study|Withdrawal by Subject|0|||
147155085|NCT01559259|530731217|FG001|Overall Study|Withdrawal by Subject|0|||
147155086|NCT01559259|530731218|FG002|Overall Study|Withdrawal by Subject|0|||
147155087|NCT01559259|530731219|FG003|Overall Study|Withdrawal by Subject|1|||
147583721|NCT00787605|532291687|FG001|Overall Study|Adverse Event|25|||
147155088|NCT01559259|530731220|FG004|Overall Study|Withdrawal by Subject|0|||
147155089|NCT01559259|530731216|FG000|Overall Study|Adverse Event|0|||
147155090|NCT01559259|530731217|FG001|Overall Study|Adverse Event|1|||
147155091|NCT01559259|530731218|FG002|Overall Study|Adverse Event|1|||
147583722|NCT00787605|532291686|FG000|Overall Study|Lost to Follow-up|3|||
147583723|NCT00787605|532291687|FG001|Overall Study|Lost to Follow-up|6|||
147583724|NCT00787605|532291686|FG000|Overall Study|Protocol Violation|7|||
147583725|NCT00787605|532291687|FG001|Overall Study|Protocol Violation|3|||
147583726|NCT00787605|532291686|FG000|Overall Study|Withdrawal by Subject|6|||
147583727|NCT00787605|532291687|FG001|Overall Study|Withdrawal by Subject|13|||
147583728|NCT00787605|532291686|FG000|Overall Study|Lack of Efficacy|13|||
147583729|NCT00787605|532291687|FG001|Overall Study|Lack of Efficacy|9|||
147583730|NCT00089973|532291695|FG000|Overall Study|Adverse Event|3|||
147583731|NCT00089973|532291695|FG000|Overall Study|Withdrawal by Subject|1|||
147583732|NCT00089973|532291695|FG000|Overall Study|Disease progression|45|||
147583733|NCT00089973|532291695|FG000|Overall Study|Death|1|||
147583734|NCT01223027|532291696|FG000|Overall Study|Adverse Event|20|||
147583735|NCT01223027|532291697|FG001|Overall Study|Adverse Event|10|||
147583736|NCT01223027|532291696|FG000|Overall Study|Death|42|||
147583737|NCT01223027|532291697|FG001|Overall Study|Death|42|||
147583738|NCT01223027|532291696|FG000|Overall Study|Lost to Follow-up|2|||
147583739|NCT01223027|532291697|FG001|Overall Study|Lost to Follow-up|1|||
147583740|NCT01223027|532291696|FG000|Overall Study|Physician Decision|4|||
147583741|NCT01223027|532291697|FG001|Overall Study|Physician Decision|8|||
147583742|NCT01223027|532291696|FG000|Overall Study|Progressive Disease|167|||
147583743|NCT01223027|532291697|FG001|Overall Study|Progressive Disease|183|||
147155092|NCT01559259|530731219|FG003|Overall Study|Adverse Event|0|||
147155093|NCT01559259|530731220|FG004|Overall Study|Adverse Event|0|||
147155094|NCT01995669|530731221|FG000|Overall Study|Progression|2|||
147583744|NCT01223027|532291696|FG000|Overall Study|Protocol Violation|2|||
147583745|NCT01223027|532291697|FG001|Overall Study|Protocol Violation|1|||
147583746|NCT01223027|532291696|FG000|Overall Study|Subject/guardian decicion|18|||
147583747|NCT01223027|532291697|FG001|Overall Study|Subject/guardian decicion|16|||
147583748|NCT01223027|532291696|FG000|Overall Study|New therapy for study indication|17|||
147583749|NCT01223027|532291697|FG001|Overall Study|New therapy for study indication|8|||
147583750|NCT01223027|532291696|FG000|Overall Study|Study terminated by sponsor|2|||
147583751|NCT01223027|532291697|FG001|Overall Study|Study terminated by sponsor|8|||
147583752|NCT01214239|532291698|FG000|Overall Study|Adverse Event|3|||
147583753|NCT01214239|532291699|FG001|Overall Study|Adverse Event|4|||
147583754|NCT01214239|532291698|FG000|Overall Study|Protocol Violation|2|||
147583755|NCT01214239|532291699|FG001|Overall Study|Protocol Violation|1|||
147583756|NCT01214239|532291698|FG000|Overall Study|Lost to Follow-up|1|||
147583757|NCT01214239|532291699|FG001|Overall Study|Lost to Follow-up|1|||
147583758|NCT01214239|532291698|FG000|Overall Study|Withdrawal by Subject|4|||
147583759|NCT01214239|532291699|FG001|Overall Study|Withdrawal by Subject|9|||
147583760|NCT01214239|532291698|FG000|Overall Study|Lack of Efficacy|1|||
147583761|NCT01214239|532291699|FG001|Overall Study|Lack of Efficacy|2|||
147583762|NCT01214239|532291698|FG000|Overall Study|patient's private reason|1|||
147583763|NCT01214239|532291699|FG001|Overall Study|patient's private reason|1|||
147583764|NCT01321697|532291700|FG000|Overall Study|Study Terminated|7|||
147583765|NCT00857818|532291703|FG000|Overall Study|Lack of Efficacy|1|||
147583766|NCT00857818|532291704|FG001|Overall Study|Lack of Efficacy|0|||
147583767|NCT00857818|532291703|FG000|Overall Study|Adverse Event|3|||
147583768|NCT00857818|532291704|FG001|Overall Study|Adverse Event|0|||
147583769|NCT00857818|532291703|FG000|Overall Study|Withdrawal by Subject|0|||
147583770|NCT00857818|532291704|FG001|Overall Study|Withdrawal by Subject|4|||
147583771|NCT00857818|532291703|FG000|Overall Study|Sponsor terminated study|6|||
147583772|NCT00857818|532291704|FG001|Overall Study|Sponsor terminated study|4|||
147583773|NCT00857818|532291703|FG000|Overall Study|Investigator decision|1|||
147583774|NCT00857818|532291704|FG001|Overall Study|Investigator decision|0|||
147583775|NCT01049581|532291705|FG000|Overall Study|Lost to Follow-up|2|||
147583776|NCT01049581|532291706|FG001|Overall Study|Lost to Follow-up|1|||
147446815|NCT01732796|531800308|FG002|Overall Study|Other reason not defined above|2|||
147583777|NCT00559637|532293594|FG000|Overall Study|Adverse Event|22|||
147583778|NCT00559637|532293594|FG000|Overall Study|Withdrawal by Subject|4|||
147583779|NCT00559637|532293594|FG000|Overall Study|Protocol Violation|6|||
147583780|NCT00559637|532293594|FG000|Overall Study|Withdrawal criteria fulfilled|4|||
147583781|NCT00559637|532293594|FG000|Overall Study|Failure to return|6|||
147583782|NCT00559637|532293594|FG000|Overall Study|Insufficient response|3|||
147583783|NCT00559637|532293594|FG000|Overall Study|Started requiring dialysis after month 7|2|||
147583784|NCT00559637|532293594|FG000|Overall Study|Suspected lung cancer|1|||
147155095|NCT01995669|530731222|FG001|Overall Study|Progression|1|||
147155096|NCT01995669|530731223|FG002|Overall Study|Progression|1|||
147583785|NCT00559637|532293594|FG000|Overall Study|Participation in another study|1|||
147583786|NCT00559637|532293594|FG000|Overall Study|Delayed administration of C.E.R.A|1|||
147583787|NCT00559637|532293594|FG000|Overall Study|Change of center|1|||
147583788|NCT00559637|532293594|FG000|Overall Study|Change of home|1|||
147583789|NCT00559637|532293594|FG000|Overall Study|Inclusion or exclusion criteria violated|2|||
147240723|NCT05587296|531053464|FG000|Overall Study|miscellaneous|3|||
147240724|NCT05587296|531053465|FG001|Overall Study|miscellaneous|6|||
147240725|NCT05587296|531053464|FG000|Overall Study|Did not complete study treatment but completed post-treatment phase/follow-up|19|||
147240726|NCT05587296|531053465|FG001|Overall Study|Did not complete study treatment but completed post-treatment phase/follow-up|8|||
147240727|NCT02849678|531053466|FG000|Overall Study|Protocol Violation|3|||
147240728|NCT02849678|531053467|FG001|Overall Study|Protocol Violation|6|||
147240729|NCT00288054|531053468|FG000|Overall Study|Protocol Violation|2|||
147240730|NCT00288054|531053468|FG000|Overall Study|Lack of Efficacy|16|||
147240731|NCT00288054|531053468|FG000|Overall Study|Adverse Event|3|||
147240732|NCT00288054|531053468|FG000|Overall Study|Withdrawal by Subject|1|||
147240733|NCT00288054|531053468|FG000|Overall Study|Not protocol specified|2|||
147240734|NCT00289991|531053469|FG000|Overall Study|Death|35|||
147240735|NCT00289991|531053470|FG001|Overall Study|Death|38|||
147240736|NCT00289991|531053469|FG000|Overall Study|Adverse Event|15|||
147240737|NCT00289991|531053470|FG001|Overall Study|Adverse Event|13|||
147240738|NCT00289991|531053469|FG000|Overall Study|Failure of prophylaxis|1|||
147240739|NCT00289991|531053470|FG001|Overall Study|Failure of prophylaxis|1|||
147240740|NCT00289991|531053469|FG000|Overall Study|Fungal breakthrough infection|0|||
147240741|NCT00289991|531053470|FG001|Overall Study|Fungal breakthrough infection|1|||
147240742|NCT00289991|531053469|FG000|Overall Study|Lost to Follow-up|0|||
147240743|NCT00289991|531053470|FG001|Overall Study|Lost to Follow-up|1|||
147240744|NCT00289991|531053469|FG000|Overall Study|Withdrawal by Subject|2|||
147240745|NCT00289991|531053470|FG001|Overall Study|Withdrawal by Subject|12|||
147240746|NCT00289991|531053469|FG000|Overall Study|Other|5|||
147240747|NCT00289991|531053470|FG001|Overall Study|Other|14|||
147240748|NCT00444912|531053488|FG000|Overall Study|Death|1|||
147240749|NCT00444912|531053489|FG001|Overall Study|Death|2|||
147240750|NCT00444912|531053488|FG000|Overall Study|Lost to Follow-up|1|||
147240751|NCT00444912|531053489|FG001|Overall Study|Lost to Follow-up|0|||
147240752|NCT00444912|531053488|FG000|Overall Study|Participant Failed Mobilization|1|||
147240753|NCT00444912|531053489|FG001|Overall Study|Participant Failed Mobilization|0|||
147240754|NCT02340975|531053492|FG000|Overall Study|Death|6|||
147583790|NCT04129944|532293599|FG000|Overall Study|Death|0|||
147583791|NCT04129944|532293600|FG001|Overall Study|Death|0|||
147583792|NCT04129944|532293601|FG002|Overall Study|Death|0|||
147583793|NCT04129944|532293602|FG003|Overall Study|Death|1|||
147583794|NCT04129944|532293599|FG000|Overall Study|Lost to Follow-up|1|||
147583795|NCT04129944|532293600|FG001|Overall Study|Lost to Follow-up|0|||
147240755|NCT02340975|531053493|FG001|Overall Study|Death|23|||
147240756|NCT02340975|531053494|FG002|Overall Study|Death|21|||
147240757|NCT02340975|531053495|FG003|Overall Study|Death|7|||
147240758|NCT02340975|531053496|FG004|Overall Study|Death|21|||
147240759|NCT02340975|531053497|FG005|Overall Study|Death|13|||
147240760|NCT02340975|531053492|FG000|Overall Study|Lost to Follow-up|0|||
147240761|NCT02340975|531053493|FG001|Overall Study|Lost to Follow-up|0|||
147240762|NCT02340975|531053494|FG002|Overall Study|Lost to Follow-up|0|||
147240763|NCT02340975|531053495|FG003|Overall Study|Lost to Follow-up|0|||
147240764|NCT02340975|531053496|FG004|Overall Study|Lost to Follow-up|2|||
147240765|NCT02340975|531053497|FG005|Overall Study|Lost to Follow-up|0|||
147240766|NCT02340975|531053492|FG000|Overall Study|Withdrawal by Subject|0|||
147240767|NCT02340975|531053493|FG001|Overall Study|Withdrawal by Subject|0|||
147240768|NCT02340975|531053494|FG002|Overall Study|Withdrawal by Subject|3|||
147240769|NCT02340975|531053495|FG003|Overall Study|Withdrawal by Subject|3|||
147240770|NCT02340975|531053496|FG004|Overall Study|Withdrawal by Subject|2|||
147240771|NCT02340975|531053497|FG005|Overall Study|Withdrawal by Subject|0|||
147240772|NCT02340975|531053492|FG000|Overall Study|Other|0|||
147240773|NCT02340975|531053493|FG001|Overall Study|Other|4|||
147240774|NCT02340975|531053494|FG002|Overall Study|Other|0|||
147240775|NCT02340975|531053495|FG003|Overall Study|Other|2|||
147240776|NCT02340975|531053496|FG004|Overall Study|Other|0|||
147240777|NCT02340975|531053497|FG005|Overall Study|Other|6|||
147240778|NCT01007812|531053498|FG000|Period 1, One Week|Lost to Follow-up|0|||
147240779|NCT01007812|531053499|FG001|Period 1, One Week|Lost to Follow-up|1|||
147240780|NCT01007812|531053498|FG000|Period 1, One Week|Discomfort|1|||
147240781|NCT01007812|531053499|FG001|Period 1, One Week|Discomfort|0|||
147240782|NCT01091974|531053502|FG000|Overall Study|Did not start intervention|3|||
147583796|NCT04129944|532293601|FG002|Overall Study|Lost to Follow-up|0|||
147240783|NCT01091974|531053503|FG001|Overall Study|Did not start intervention|1|||
147240784|NCT01091974|531053504|FG002|Overall Study|Did not start intervention|3|||
147583797|NCT04129944|532293602|FG003|Overall Study|Lost to Follow-up|0|||
147240785|NCT01091974|531053505|FG003|Overall Study|Did not start intervention|1|||
147240786|NCT01091974|531053502|FG000|Overall Study|resumed sleep medication|0|||
147240787|NCT01091974|531053503|FG001|Overall Study|resumed sleep medication|0|||
147240788|NCT01091974|531053504|FG002|Overall Study|resumed sleep medication|1|||
147240789|NCT01091974|531053505|FG003|Overall Study|resumed sleep medication|2|||
147240790|NCT01091974|531053502|FG000|Overall Study|Withdrawal by Subject|1|||
147240791|NCT01091974|531053503|FG001|Overall Study|Withdrawal by Subject|3|||
147240792|NCT01091974|531053504|FG002|Overall Study|Withdrawal by Subject|2|||
147583798|NCT04129944|532293599|FG000|Overall Study|Withdrawal by Subject|1|||
147654276|NCT00741598|532556672|FG000|Overall Study|Lack of Efficacy|1|||
147654277|NCT00741598|532556673|FG001|Overall Study|Lack of Efficacy|2|||
147654278|NCT00741598|532556672|FG000|Overall Study|Physician Decision|1|||
147654279|NCT00741598|532556673|FG001|Overall Study|Physician Decision|1|||
147654280|NCT00741598|532556672|FG000|Overall Study|Pregnancy|1|||
147654281|NCT00741598|532556673|FG001|Overall Study|Pregnancy|0|||
147654282|NCT00741598|532556672|FG000|Overall Study|Withdrawal by Subject|3|||
147654283|NCT00741598|532556673|FG001|Overall Study|Withdrawal by Subject|2|||
147654284|NCT01301079|532556674|FG000|Overall Study|Lost to Follow-up|2|||
147654285|NCT01301079|532556675|FG001|Overall Study|Lost to Follow-up|2|||
147654286|NCT04105842|532556676|FG000|Overall Study|Withdrawal by Subject|2|||
147654287|NCT01639703|532556679|FG000|Overall Study|Withdrawal by Subject|5|||
147654288|NCT01639703|532556679|FG000|Overall Study|Other reason|7|||
147654289|NCT02768792|532556680|FG000|Overall Study|Adverse Event|1|||
147654290|NCT01690299|532556681|FG000|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|2|||
147654291|NCT01690299|532556682|FG001|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|2|||
147654292|NCT01690299|532556683|FG002|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|1|||
147654293|NCT01690299|532556684|FG003|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|0|||
147654294|NCT01690299|532556685|FG004|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|0|||
147654295|NCT01690299|532556686|FG005|Placebo-controlled Phase (Weeks 0-16)|Adverse Event|0|||
147654296|NCT01690299|532556681|FG000|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|4|||
147654297|NCT01690299|532556682|FG001|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
147654298|NCT01690299|532556683|FG002|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
147654299|NCT01690299|532556684|FG003|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
147654300|NCT01690299|532556685|FG004|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
147654301|NCT01690299|532556686|FG005|Placebo-controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
147654302|NCT01690299|532556681|FG000|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|1|||
147654303|NCT01690299|532556682|FG001|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|3|||
147654304|NCT01690299|532556683|FG002|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
147654305|NCT01690299|532556684|FG003|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
147654306|NCT01690299|532556685|FG004|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
147654307|NCT01690299|532556686|FG005|Placebo-controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
147654308|NCT01690299|532556681|FG000|Placebo-controlled Phase (Weeks 0-16)|Other|2|||
147654309|NCT01690299|532556682|FG001|Placebo-controlled Phase (Weeks 0-16)|Other|1|||
147654310|NCT01690299|532556683|FG002|Placebo-controlled Phase (Weeks 0-16)|Other|1|||
147654311|NCT01690299|532556684|FG003|Placebo-controlled Phase (Weeks 0-16)|Other|0|||
147654312|NCT01690299|532556685|FG004|Placebo-controlled Phase (Weeks 0-16)|Other|0|||
147654313|NCT01690299|532556686|FG005|Placebo-controlled Phase (Weeks 0-16)|Other|0|||
147654314|NCT01690299|532556681|FG000|Apremilast Extension Phase (Weeks16-104)|Adverse Event|0|||
147654315|NCT01690299|532556682|FG001|Apremilast Extension Phase (Weeks16-104)|Adverse Event|0|||
147654316|NCT01690299|532556683|FG002|Apremilast Extension Phase (Weeks16-104)|Adverse Event|0|||
147654317|NCT01690299|532556684|FG003|Apremilast Extension Phase (Weeks16-104)|Adverse Event|3|||
147654318|NCT01690299|532556685|FG004|Apremilast Extension Phase (Weeks16-104)|Adverse Event|4|||
147654319|NCT01690299|532556686|FG005|Apremilast Extension Phase (Weeks16-104)|Adverse Event|3|||
147654320|NCT01690299|532556681|FG000|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|0|||
147654321|NCT01690299|532556682|FG001|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|0|||
147654322|NCT01690299|532556683|FG002|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|0|||
147654323|NCT01690299|532556684|FG003|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|9|||
147654324|NCT01690299|532556685|FG004|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|10|||
147654325|NCT01690299|532556686|FG005|Apremilast Extension Phase (Weeks16-104)|Lack of Efficacy|8|||
147654326|NCT01690299|532556681|FG000|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0|||
147654327|NCT01690299|532556682|FG001|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0|||
147654328|NCT01690299|532556683|FG002|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0|||
147654329|NCT01690299|532556684|FG003|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|0|||
147654330|NCT01690299|532556685|FG004|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|1|||
147654331|NCT01690299|532556686|FG005|Apremilast Extension Phase (Weeks16-104)|Non-compliance With Study Drug|1|||
147654332|NCT01690299|532556681|FG000|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|0|||
147654333|NCT01690299|532556682|FG001|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|0|||
147654334|NCT01690299|532556683|FG002|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|0|||
147654335|NCT01690299|532556684|FG003|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|8|||
147155097|NCT01995669|530731224|FG003|Overall Study|Progression|13|||
147155098|NCT01995669|530731221|FG000|Overall Study|Adverse Event|0|||
147155099|NCT01995669|530731222|FG001|Overall Study|Adverse Event|0|||
147155100|NCT01995669|530731223|FG002|Overall Study|Adverse Event|0|||
147155101|NCT01995669|530731224|FG003|Overall Study|Adverse Event|3|||
147155102|NCT01995669|530731221|FG000|Overall Study|Death|0|||
147155103|NCT01995669|530731222|FG001|Overall Study|Death|0|||
147155104|NCT01995669|530731223|FG002|Overall Study|Death|0|||
147155105|NCT01995669|530731224|FG003|Overall Study|Death|6|||
147583799|NCT04129944|532293600|FG001|Overall Study|Withdrawal by Subject|0|||
147583800|NCT04129944|532293601|FG002|Overall Study|Withdrawal by Subject|1|||
147155106|NCT01995669|530731221|FG000|Overall Study|Withdrawal by Subject|0|||
147155107|NCT01995669|530731222|FG001|Overall Study|Withdrawal by Subject|0|||
147155108|NCT01995669|530731223|FG002|Overall Study|Withdrawal by Subject|0|||
147155109|NCT01995669|530731224|FG003|Overall Study|Withdrawal by Subject|6|||
147155110|NCT01995669|530731221|FG000|Overall Study|Insurance Expired|0|||
147155111|NCT01995669|530731222|FG001|Overall Study|Insurance Expired|0|||
147155112|NCT01995669|530731223|FG002|Overall Study|Insurance Expired|0|||
147155113|NCT01995669|530731224|FG003|Overall Study|Insurance Expired|1|||
147155114|NCT05425732|530731225|FG000|Overall Study|Death|4|||
147155115|NCT05425732|530731226|FG001|Overall Study|Death|2|||
147155116|NCT05425732|530731227|FG002|Overall Study|Death|0|||
147155117|NCT05425732|530731228|FG003|Overall Study|Death|0|||
147155118|NCT05425732|530731225|FG000|Overall Study|Lost to Follow-up|10|||
147155119|NCT05425732|530731226|FG001|Overall Study|Lost to Follow-up|15|||
147155120|NCT05425732|530731227|FG002|Overall Study|Lost to Follow-up|5|||
147155121|NCT05425732|530731228|FG003|Overall Study|Lost to Follow-up|3|||
147155122|NCT05425732|530731225|FG000|Overall Study|Physician Decision|0|||
147155123|NCT05425732|530731226|FG001|Overall Study|Physician Decision|2|||
147155124|NCT05425732|530731227|FG002|Overall Study|Physician Decision|0|||
147446816|NCT01967628|531800313|FG000|Overall Study|Withdrawal by Subject|2|||
147446817|NCT01967628|531800314|FG001|Overall Study|Withdrawal by Subject|0|||
147446818|NCT01967628|531800313|FG000|Overall Study|Unable to complete bronchoscopy|4|||
147583801|NCT04129944|532293602|FG003|Overall Study|Withdrawal by Subject|2|||
147583802|NCT00396630|532293608|FG000|Overall Study|Lost to Follow-up|1|||
147583803|NCT00396630|532293609|FG001|Overall Study|Lost to Follow-up|1|||
147583804|NCT00396630|532293608|FG000|Overall Study|Withdrawal by Subject|1|||
147583805|NCT00396630|532293609|FG001|Overall Study|Withdrawal by Subject|1|||
147583806|NCT00396630|532293608|FG000|Overall Study|Not vaccinated at Visit 3|3|||
147583807|NCT00396630|532293609|FG001|Overall Study|Not vaccinated at Visit 3|3|||
147583808|NCT00651183|532293610|FG000|Overall Study|Lack of Efficacy|1|||
147583809|NCT00651183|532293611|FG001|Overall Study|Lack of Efficacy|0|||
147583810|NCT00651183|532293610|FG000|Overall Study|Efficacy insufficient + patients wish|0|||
147583811|NCT00651183|532293611|FG001|Overall Study|Efficacy insufficient + patients wish|1|||
147583812|NCT00651183|532293610|FG000|Overall Study|Tolerability insufficient|5|||
147583813|NCT00651183|532293611|FG001|Overall Study|Tolerability insufficient|2|||
147583814|NCT00651183|532293610|FG000|Overall Study|Tolerability insufficient +Patients wish|0|||
147583815|NCT00651183|532293611|FG001|Overall Study|Tolerability insufficient +Patients wish|1|||
147583816|NCT00651183|532293610|FG000|Overall Study|Withdrawal by Subject|6|||
147583817|NCT00651183|532293611|FG001|Overall Study|Withdrawal by Subject|3|||
147583818|NCT00651183|532293610|FG000|Overall Study|Lost to Follow-up|3|||
147583819|NCT00651183|532293611|FG001|Overall Study|Lost to Follow-up|1|||
147583820|NCT00651183|532293610|FG000|Overall Study|Other reasons|4|||
147583821|NCT00651183|532293611|FG001|Overall Study|Other reasons|2|||
147583822|NCT00651183|532293610|FG000|Overall Study|missing|1|||
147583823|NCT00651183|532293611|FG001|Overall Study|missing|0|||
147583824|NCT03330236|532293618|FG000|Overall Study|Death|2|||
147583825|NCT03330236|532293619|FG001|Overall Study|Death|1|||
147583826|NCT03330236|532293618|FG000|Overall Study|Withdrawal by Subject|2|||
147583827|NCT03330236|532293619|FG001|Overall Study|Withdrawal by Subject|4|||
147583828|NCT03330236|532293618|FG000|Overall Study|Lost to Follow-up|0|||
147583829|NCT03330236|532293619|FG001|Overall Study|Lost to Follow-up|2|||
147583830|NCT03330236|532293618|FG000|Overall Study|Physician Decision|2|||
147583831|NCT03330236|532293619|FG001|Overall Study|Physician Decision|0|||
147583832|NCT03330236|532293618|FG000|Overall Study|Protocol Violation|4|||
147583833|NCT03330236|532293619|FG001|Overall Study|Protocol Violation|3|||
147583834|NCT03330236|532293618|FG000|Overall Study|SedLine malfunction/blinding|19|||
147583835|NCT03330236|532293619|FG001|Overall Study|SedLine malfunction/blinding|14|||
147583836|NCT03330236|532293618|FG000|Overall Study|Volatile anesthetics used|11|||
147155125|NCT05425732|530731228|FG003|Overall Study|Physician Decision|0|||
147446819|NCT01967628|531800314|FG001|Overall Study|Unable to complete bronchoscopy|6|||
147446820|NCT01967628|531800313|FG000|Overall Study|Lost to Follow-up|1|||
147583837|NCT03330236|532293619|FG001|Overall Study|Volatile anesthetics used|8|||
147583838|NCT03330236|532293618|FG000|Overall Study|Surgery aborted/converted to open|60|||
147583839|NCT03330236|532293619|FG001|Overall Study|Surgery aborted/converted to open|52|||
147583840|NCT03449199|532293624|FG000|Overall Study|Lost to Follow-up|1|||
147583841|NCT03449199|532293625|FG001|Overall Study|Lost to Follow-up|1|||
147583842|NCT03449199|532293626|FG002|Overall Study|Lost to Follow-up|0|||
147583843|NCT03449199|532293624|FG000|Overall Study|Protocol Deviation|0|||
147583844|NCT03449199|532293625|FG001|Overall Study|Protocol Deviation|0|||
147583845|NCT03449199|532293626|FG002|Overall Study|Protocol Deviation|1|||
147155126|NCT05425732|530731225|FG000|Overall Study|Randomized By Mistake Without Study Treatment|1|||
147155127|NCT05425732|530731226|FG001|Overall Study|Randomized By Mistake Without Study Treatment|2|||
147583846|NCT03449199|532293624|FG000|Overall Study|Withdrawal by Subject|0|||
147583847|NCT03449199|532293625|FG001|Overall Study|Withdrawal by Subject|0|||
147155128|NCT05425732|530731227|FG002|Overall Study|Randomized By Mistake Without Study Treatment|0|||
147155129|NCT05425732|530731228|FG003|Overall Study|Randomized By Mistake Without Study Treatment|0|||
147155130|NCT05425732|530731225|FG000|Overall Study|Withdrawal by Subject|4|||
147155131|NCT05425732|530731226|FG001|Overall Study|Withdrawal by Subject|8|||
147155132|NCT05425732|530731227|FG002|Overall Study|Withdrawal by Subject|1|||
147155133|NCT05425732|530731228|FG003|Overall Study|Withdrawal by Subject|1|||
147155134|NCT05425732|530731225|FG000|Overall Study|Randomized to PCV20 first, discontinued; then randomized to V116 second|2|||
147155135|NCT05425732|530731226|FG001|Overall Study|Randomized to PCV20 first, discontinued; then randomized to V116 second|0|||
147155136|NCT05425732|530731227|FG002|Overall Study|Randomized to PCV20 first, discontinued; then randomized to V116 second|0|||
147155137|NCT05425732|530731228|FG003|Overall Study|Randomized to PCV20 first, discontinued; then randomized to V116 second|0|||
147155138|NCT00539513|530731231|FG000|Overall Study|Withdrawal by Subject|2|||
147155139|NCT00539513|530731232|FG001|Overall Study|Withdrawal by Subject|1|||
147155140|NCT00539513|530731231|FG000|Overall Study|Lost to Follow-up|0|||
147155141|NCT00539513|530731232|FG001|Overall Study|Lost to Follow-up|1|||
147155142|NCT01328041|530731233|FG000|Overall Study|Adverse Event|7|||
147155143|NCT01328041|530731233|FG000|Overall Study|Lack of Efficacy|27|||
147155144|NCT01328041|530731233|FG000|Overall Study|Protocol Violation|7|||
147155145|NCT01328041|530731233|FG000|Overall Study|Lost to Follow-up|7|||
147583848|NCT03449199|532293626|FG002|Overall Study|Withdrawal by Subject|1|||
147583849|NCT01190930|532293629|FG000|Induction|Adverse Event|17|||
147583850|NCT01190930|532293630|FG001|Induction|Adverse Event|0|||
147583851|NCT01190930|532293631|FG002|Induction|Adverse Event|0|||
147583852|NCT01190930|532293632|FG003|Induction|Adverse Event|0|||
147583853|NCT01190930|532293633|FG004|Induction|Adverse Event|0|||
147583854|NCT01190930|532293634|FG005|Induction|Adverse Event|0|||
147583855|NCT01190930|532293635|FG006|Induction|Adverse Event|0|||
147583856|NCT01190930|532293636|FG007|Induction|Adverse Event|0|||
147583857|NCT01190930|532293637|FG008|Induction|Adverse Event|0|||
147583858|NCT01190930|532293638|FG009|Induction|Adverse Event|0|||
147583859|NCT01190930|532293629|FG000|Induction|Death|34|||
147583860|NCT01190930|532293630|FG001|Induction|Death|0|||
147583861|NCT01190930|532293631|FG002|Induction|Death|0|||
147583862|NCT01190930|532293632|FG003|Induction|Death|0|||
147583863|NCT01190930|532293633|FG004|Induction|Death|0|||
147583864|NCT01190930|532293634|FG005|Induction|Death|0|||
147583865|NCT01190930|532293635|FG006|Induction|Death|0|||
147583866|NCT01190930|532293636|FG007|Induction|Death|0|||
147583867|NCT01190930|532293637|FG008|Induction|Death|0|||
147583868|NCT01190930|532293638|FG009|Induction|Death|0|||
147583869|NCT01190930|532293629|FG000|Induction|Lost to Follow-up|1|||
147583870|NCT01190930|532293630|FG001|Induction|Lost to Follow-up|0|||
147583871|NCT01190930|532293631|FG002|Induction|Lost to Follow-up|0|||
147583872|NCT01190930|532293632|FG003|Induction|Lost to Follow-up|0|||
147583873|NCT01190930|532293633|FG004|Induction|Lost to Follow-up|0|||
147583874|NCT01190930|532293634|FG005|Induction|Lost to Follow-up|0|||
147583875|NCT01190930|532293635|FG006|Induction|Lost to Follow-up|0|||
147583876|NCT01190930|532293636|FG007|Induction|Lost to Follow-up|0|||
147583877|NCT01190930|532293637|FG008|Induction|Lost to Follow-up|0|||
147583878|NCT01190930|532293638|FG009|Induction|Lost to Follow-up|0|||
147583879|NCT01190930|532293629|FG000|Induction|Physician Decision|125|||
147583880|NCT01190930|532293630|FG001|Induction|Physician Decision|3|||
147583881|NCT01190930|532293631|FG002|Induction|Physician Decision|0|||
147583882|NCT01190930|532293632|FG003|Induction|Physician Decision|0|||
147583883|NCT01190930|532293633|FG004|Induction|Physician Decision|0|||
147583884|NCT01190930|532293634|FG005|Induction|Physician Decision|0|||
147583885|NCT01190930|532293635|FG006|Induction|Physician Decision|0|||
147583886|NCT01190930|532293636|FG007|Induction|Physician Decision|0|||
147155146|NCT01328041|530731233|FG000|Overall Study|Physician Decision|2|||
147155147|NCT01328041|530731233|FG000|Overall Study|Withdrawal by Subject|7|||
147155148|NCT00711113|530731234|FG000|Overall Study|Lost to Follow-up|9|||
147155149|NCT00711113|530731234|FG000|Overall Study|Implant lost|2|||
147155150|NCT00519376|530731239|FG000|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
147155151|NCT00519376|530731240|FG001|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
147155152|NCT00519376|530731241|FG002|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
147155153|NCT00519376|530731242|FG003|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
147155154|NCT00519376|530731243|FG004|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
147583887|NCT01190930|532293637|FG008|Induction|Physician Decision|0|||
147583888|NCT01190930|532293638|FG009|Induction|Physician Decision|0|||
147583889|NCT01190930|532293629|FG000|Induction|Withdrawal by Subject|9|||
147583890|NCT01190930|532293630|FG001|Induction|Withdrawal by Subject|0|||
147583891|NCT01190930|532293631|FG002|Induction|Withdrawal by Subject|0|||
147583892|NCT01190930|532293632|FG003|Induction|Withdrawal by Subject|0|||
147583893|NCT01190930|532293633|FG004|Induction|Withdrawal by Subject|0|||
147583894|NCT01190930|532293634|FG005|Induction|Withdrawal by Subject|0|||
147583895|NCT01190930|532293635|FG006|Induction|Withdrawal by Subject|0|||
147583896|NCT01190930|532293636|FG007|Induction|Withdrawal by Subject|0|||
147583897|NCT01190930|532293637|FG008|Induction|Withdrawal by Subject|0|||
147583898|NCT01190930|532293638|FG009|Induction|Withdrawal by Subject|0|||
147583899|NCT01190930|532293629|FG000|Induction|Refusal|235|||
147583900|NCT01190930|532293630|FG001|Induction|Refusal|0|||
147155155|NCT00519376|530731244|FG005|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
147155156|NCT00519376|530731245|FG006|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
147155157|NCT00519376|530731246|FG007|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
147155158|NCT00519376|530731247|FG008|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
147155159|NCT00519376|530731248|FG009|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
147155160|NCT00519376|530731249|FG010|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
147155161|NCT00519376|530731250|FG011|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
147155162|NCT00519376|530731251|FG012|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|1|||
147155163|NCT00519376|530731252|FG013|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
147155164|NCT00519376|530731253|FG014|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
147155165|NCT00519376|530731254|FG015|Treatment Period 2|Unable Evaluate Cardiovascular Endpoints|0|||
147155166|NCT00519376|530731239|FG000|Treatment Period 4|Lost to Follow-up|0|||
147155167|NCT00519376|530731240|FG001|Treatment Period 4|Lost to Follow-up|0|||
147155168|NCT00519376|530731241|FG002|Treatment Period 4|Lost to Follow-up|1|||
147155169|NCT00519376|530731242|FG003|Treatment Period 4|Lost to Follow-up|0|||
147155170|NCT00519376|530731243|FG004|Treatment Period 4|Lost to Follow-up|0|||
147155171|NCT00519376|530731244|FG005|Treatment Period 4|Lost to Follow-up|0|||
147155172|NCT00519376|530731245|FG006|Treatment Period 4|Lost to Follow-up|0|||
147155173|NCT00519376|530731246|FG007|Treatment Period 4|Lost to Follow-up|0|||
147155174|NCT00519376|530731247|FG008|Treatment Period 4|Lost to Follow-up|0|||
147155175|NCT00519376|530731248|FG009|Treatment Period 4|Lost to Follow-up|0|||
147155176|NCT00519376|530731249|FG010|Treatment Period 4|Lost to Follow-up|0|||
147155177|NCT00519376|530731250|FG011|Treatment Period 4|Lost to Follow-up|0|||
147155178|NCT00519376|530731251|FG012|Treatment Period 4|Lost to Follow-up|0|||
147155179|NCT00519376|530731252|FG013|Treatment Period 4|Lost to Follow-up|0|||
147155180|NCT00519376|530731253|FG014|Treatment Period 4|Lost to Follow-up|0|||
147155181|NCT00519376|530731254|FG015|Treatment Period 4|Lost to Follow-up|0|||
147155182|NCT02688088|530731255|FG000|Abemaciclib + Drug Cocktail - Period 2|Adverse Event|0|||
147155183|NCT02688088|530731256|FG001|Abemaciclib + Drug Cocktail - Period 2|Adverse Event|1|||
147155184|NCT02688088|530731257|FG002|Abemaciclib + Drug Cocktail - Period 2|Adverse Event|0|||
147155185|NCT02688088|530731258|FG003|Abemaciclib + Drug Cocktail - Period 2|Adverse Event|0|||
147155186|NCT02688088|530731259|FG004|Abemaciclib + Drug Cocktail - Period 2|Adverse Event|0|||
147155187|NCT02688088|530731255|FG000|Abemaciclib + Drug Cocktail - Period 2|Death|0|||
147155188|NCT02688088|530731256|FG001|Abemaciclib + Drug Cocktail - Period 2|Death|1|||
147155189|NCT02688088|530731257|FG002|Abemaciclib + Drug Cocktail - Period 2|Death|0|||
147155190|NCT02688088|530731258|FG003|Abemaciclib + Drug Cocktail - Period 2|Death|0|||
147155191|NCT02688088|530731259|FG004|Abemaciclib + Drug Cocktail - Period 2|Death|0|||
147155192|NCT02688088|530731255|FG000|Abemaciclib + Drug Cocktail - Period 2|Withdrawal by Subject|0|||
147155193|NCT02688088|530731256|FG001|Abemaciclib + Drug Cocktail - Period 2|Withdrawal by Subject|3|||
147155194|NCT02688088|530731257|FG002|Abemaciclib + Drug Cocktail - Period 2|Withdrawal by Subject|0|||
147155195|NCT02688088|530731258|FG003|Abemaciclib + Drug Cocktail - Period 2|Withdrawal by Subject|0|||
147155196|NCT02688088|530731259|FG004|Abemaciclib + Drug Cocktail - Period 2|Withdrawal by Subject|0|||
147155197|NCT02688088|530731255|FG000|Abemaciclib + Drug Cocktail - Period 2|Physician Decision|0|||
147155198|NCT02688088|530731256|FG001|Abemaciclib + Drug Cocktail - Period 2|Physician Decision|2|||
147155199|NCT02688088|530731257|FG002|Abemaciclib + Drug Cocktail - Period 2|Physician Decision|0|||
147155200|NCT02688088|530731258|FG003|Abemaciclib + Drug Cocktail - Period 2|Physician Decision|0|||
147155201|NCT02688088|530731259|FG004|Abemaciclib + Drug Cocktail - Period 2|Physician Decision|0|||
147155202|NCT02688088|530731255|FG000|Abemaciclib Days 13 to 28 - Period 3|Physician Decision|0|||
147155203|NCT02688088|530731256|FG001|Abemaciclib Days 13 to 28 - Period 3|Physician Decision|0|||
147155204|NCT02688088|530731257|FG002|Abemaciclib Days 13 to 28 - Period 3|Physician Decision|7|||
147155205|NCT02688088|530731258|FG003|Abemaciclib Days 13 to 28 - Period 3|Physician Decision|0|||
147155206|NCT02688088|530731259|FG004|Abemaciclib Days 13 to 28 - Period 3|Physician Decision|0|||
147155207|NCT02688088|530731255|FG000|Abemaciclib Days 13 to 28 - Period 3|Withdrawal by Subject|0|||
147155208|NCT02688088|530731256|FG001|Abemaciclib Days 13 to 28 - Period 3|Withdrawal by Subject|0|||
147583901|NCT01190930|532293631|FG002|Induction|Refusal|0|||
147583902|NCT01190930|532293632|FG003|Induction|Refusal|0|||
147583903|NCT01190930|532293633|FG004|Induction|Refusal|0|||
147583904|NCT01190930|532293634|FG005|Induction|Refusal|0|||
147583905|NCT01190930|532293635|FG006|Induction|Refusal|0|||
147155209|NCT02688088|530731257|FG002|Abemaciclib Days 13 to 28 - Period 3|Withdrawal by Subject|1|||
147155210|NCT02688088|530731258|FG003|Abemaciclib Days 13 to 28 - Period 3|Withdrawal by Subject|0|||
147155211|NCT02688088|530731259|FG004|Abemaciclib Days 13 to 28 - Period 3|Withdrawal by Subject|0|||
147155212|NCT02688088|530731255|FG000|Abemaciclib Days 1 to 28 - Period 4|Physician Decision|0|||
147155213|NCT02688088|530731256|FG001|Abemaciclib Days 1 to 28 - Period 4|Physician Decision|0|||
147155214|NCT02688088|530731257|FG002|Abemaciclib Days 1 to 28 - Period 4|Physician Decision|0|||
147583906|NCT01190930|532293636|FG007|Induction|Refusal|0|||
147583907|NCT01190930|532293637|FG008|Induction|Refusal|0|||
147583908|NCT01190930|532293638|FG009|Induction|Refusal|0|||
147583909|NCT01190930|532293629|FG000|Induction|Inevaluable|23|||
147155215|NCT02688088|530731258|FG003|Abemaciclib Days 1 to 28 - Period 4|Physician Decision|7|||
147155216|NCT02688088|530731259|FG004|Abemaciclib Days 1 to 28 - Period 4|Physician Decision|0|||
147155217|NCT02688088|530731255|FG000|Abemaciclib Days 1 to 28 - Period 4|Withdrawal by Subject|0|||
147155218|NCT02688088|530731256|FG001|Abemaciclib Days 1 to 28 - Period 4|Withdrawal by Subject|0|||
147155219|NCT02688088|530731257|FG002|Abemaciclib Days 1 to 28 - Period 4|Withdrawal by Subject|0|||
147155220|NCT02688088|530731258|FG003|Abemaciclib Days 1 to 28 - Period 4|Withdrawal by Subject|1|||
147155221|NCT02688088|530731259|FG004|Abemaciclib Days 1 to 28 - Period 4|Withdrawal by Subject|0|||
147155222|NCT02688088|530731255|FG000|Abemaciclib Safety Extension Period|Met Discontinuation Criteria|0|||
147155223|NCT02688088|530731256|FG001|Abemaciclib Safety Extension Period|Met Discontinuation Criteria|0|||
147155224|NCT02688088|530731257|FG002|Abemaciclib Safety Extension Period|Met Discontinuation Criteria|0|||
147155225|NCT02688088|530731258|FG003|Abemaciclib Safety Extension Period|Met Discontinuation Criteria|0|||
147155226|NCT02688088|530731259|FG004|Abemaciclib Safety Extension Period|Met Discontinuation Criteria|18|||
147155227|NCT01231321|530731263|FG000|Overall Study|Adverse Event|3|||
147155228|NCT01231321|530731263|FG000|Overall Study|Lack of Efficacy|2|||
147155229|NCT04021524|530731264|FG000|Overall Study|Change in surgical intervention|0|||
147155230|NCT04021524|530731265|FG001|Overall Study|Change in surgical intervention|1|||
147155231|NCT00730041|530731269|FG000|Overall Study|Lost to Follow-up|0|||
147155232|NCT00730041|530731270|FG001|Overall Study|Lost to Follow-up|2|||
147155233|NCT02301546|530731271|FG000|Short-term Effectiveness (~13 Weeks)|Withdrawal by Subject|7|||
147155234|NCT02301546|530731272|FG001|Short-term Effectiveness (~13 Weeks)|Withdrawal by Subject|8|||
147155235|NCT02301546|530731271|FG000|Short-term Effectiveness (~13 Weeks)|non-compliant|10|||
147155236|NCT02301546|530731272|FG001|Short-term Effectiveness (~13 Weeks)|non-compliant|7|||
147155237|NCT02301546|530731271|FG000|Short-term Effectiveness (~13 Weeks)|screen fail|1|||
147155238|NCT02301546|530731272|FG001|Short-term Effectiveness (~13 Weeks)|screen fail|0|||
147155239|NCT02301546|530731271|FG000|Long Term Effectiveness (~1 Year)|Lost to Follow-up|3|||
147155240|NCT02301546|530731272|FG001|Long Term Effectiveness (~1 Year)|Lost to Follow-up|3|||
147155241|NCT02301546|530731271|FG000|Long Term Effectiveness (~1 Year)|Death|2|||
147155242|NCT02301546|530731272|FG001|Long Term Effectiveness (~1 Year)|Death|0|||
147155243|NCT02301546|530731271|FG000|Long Term Effectiveness (~1 Year)|Withdrawal by Subject|6|||
147155244|NCT02301546|530731272|FG001|Long Term Effectiveness (~1 Year)|Withdrawal by Subject|2|||
147155245|NCT02301546|530731271|FG000|Long Term Effectiveness (~1 Year)|moved away|1|||
147155246|NCT02301546|530731272|FG001|Long Term Effectiveness (~1 Year)|moved away|2|||
147155247|NCT01801436|530731275|FG000|Overall Study|Withdrawal by Subject|3|||
147155248|NCT01801436|530731275|FG000|Overall Study|Adverse Event|2|||
147155249|NCT01801436|530731275|FG000|Overall Study|Progressive disease|4|||
147155250|NCT02447250|530731278|FG000|Second Dose (270 mcg Albuterol)|elevated HR with first dose|1|||
147155251|NCT02447250|530731278|FG000|Third Dose (360 mcg Albuterol)|Clinically unstable, unable to do PFT|1|||
147155252|NCT02447250|530731278|FG000|Third Dose (360 mcg Albuterol)|Elevated HR with 2nd dose|4|||
147155253|NCT03632993|530731279|FG000|Overall Study|Withdrawal by Subject|1|||
147155254|NCT03632993|530731280|FG001|Overall Study|Withdrawal by Subject|0|||
147155255|NCT03632993|530731281|FG002|Overall Study|Withdrawal by Subject|0|||
147155256|NCT03632993|530731282|FG003|Overall Study|Withdrawal by Subject|0|||
147155257|NCT03632993|530731283|FG004|Overall Study|Withdrawal by Subject|0|||
147155258|NCT03632993|530731284|FG005|Overall Study|Withdrawal by Subject|0|||
147155259|NCT03632993|530731285|FG006|Overall Study|Withdrawal by Subject|0|||
147155260|NCT03632993|530731286|FG007|Overall Study|Withdrawal by Subject|0|||
147155261|NCT03632993|530731287|FG008|Overall Study|Withdrawal by Subject|0|||
147155262|NCT03632993|530731288|FG009|Overall Study|Withdrawal by Subject|1|||
147155263|NCT03632993|530731279|FG000|Overall Study|Protocol Non-compliance|0|||
147155264|NCT03632993|530731280|FG001|Overall Study|Protocol Non-compliance|1|||
147155265|NCT03632993|530731281|FG002|Overall Study|Protocol Non-compliance|0|||
147155266|NCT03632993|530731282|FG003|Overall Study|Protocol Non-compliance|0|||
147155267|NCT03632993|530731283|FG004|Overall Study|Protocol Non-compliance|0|||
147155268|NCT03632993|530731284|FG005|Overall Study|Protocol Non-compliance|0|||
147155269|NCT03632993|530731285|FG006|Overall Study|Protocol Non-compliance|0|||
147155270|NCT03632993|530731286|FG007|Overall Study|Protocol Non-compliance|0|||
147155271|NCT03632993|530731287|FG008|Overall Study|Protocol Non-compliance|0|||
147155272|NCT03632993|530731288|FG009|Overall Study|Protocol Non-compliance|0|||
147155273|NCT03632993|530731279|FG000|Overall Study|Lost to Follow-up|0|||
147155274|NCT03632993|530731280|FG001|Overall Study|Lost to Follow-up|0|||
147155275|NCT03632993|530731281|FG002|Overall Study|Lost to Follow-up|0|||
147155276|NCT03632993|530731282|FG003|Overall Study|Lost to Follow-up|0|||
147155277|NCT03632993|530731283|FG004|Overall Study|Lost to Follow-up|0|||
147155278|NCT03632993|530731284|FG005|Overall Study|Lost to Follow-up|1|||
147155279|NCT03632993|530731285|FG006|Overall Study|Lost to Follow-up|0|||
147321949|NCT00333138|531341750|FG002|Core Study (6 Months)|Protocol Violation|1|||
147583910|NCT01190930|532293630|FG001|Induction|Inevaluable|1|||
147155280|NCT03632993|530731286|FG007|Overall Study|Lost to Follow-up|1|||
147155281|NCT03632993|530731287|FG008|Overall Study|Lost to Follow-up|0|||
147155282|NCT03632993|530731288|FG009|Overall Study|Lost to Follow-up|0|||
147155283|NCT03632993|530731279|FG000|Overall Study|Adverse Event|0|||
147155284|NCT03632993|530731280|FG001|Overall Study|Adverse Event|0|||
147583911|NCT01190930|532293631|FG002|Induction|Inevaluable|0|||
147583912|NCT01190930|532293632|FG003|Induction|Inevaluable|0|||
147583913|NCT01190930|532293633|FG004|Induction|Inevaluable|0|||
147583914|NCT01190930|532293634|FG005|Induction|Inevaluable|0|||
147583915|NCT01190930|532293635|FG006|Induction|Inevaluable|0|||
147583916|NCT01190930|532293636|FG007|Induction|Inevaluable|0|||
147583917|NCT01190930|532293637|FG008|Induction|Inevaluable|0|||
147155285|NCT03632993|530731281|FG002|Overall Study|Adverse Event|0|||
147155286|NCT03632993|530731282|FG003|Overall Study|Adverse Event|0|||
147155287|NCT03632993|530731283|FG004|Overall Study|Adverse Event|0|||
147155288|NCT03632993|530731284|FG005|Overall Study|Adverse Event|1|||
147155289|NCT03632993|530731285|FG006|Overall Study|Adverse Event|0|||
147155290|NCT03632993|530731286|FG007|Overall Study|Adverse Event|1|||
147155291|NCT03632993|530731287|FG008|Overall Study|Adverse Event|0|||
147155292|NCT03632993|530731288|FG009|Overall Study|Adverse Event|0|||
147155293|NCT00920218|530731289|FG000|Overall Study|Serious Adverse Event|2|||
147155294|NCT00920218|530731290|FG001|Overall Study|Serious Adverse Event|0|||
147155295|NCT00920218|530731291|FG002|Overall Study|Serious Adverse Event|2|||
147155296|NCT00920218|530731292|FG003|Overall Study|Serious Adverse Event|1|||
147155297|NCT00920218|530731289|FG000|Overall Study|Withdrawal by Subject|0|||
147155298|NCT00920218|530731290|FG001|Overall Study|Withdrawal by Subject|3|||
147155299|NCT00920218|530731291|FG002|Overall Study|Withdrawal by Subject|2|||
147155300|NCT00920218|530731292|FG003|Overall Study|Withdrawal by Subject|0|||
147155301|NCT00920218|530731289|FG000|Overall Study|Migrated/moved from study area|0|||
147155302|NCT00920218|530731290|FG001|Overall Study|Migrated/moved from study area|0|||
147155303|NCT00920218|530731291|FG002|Overall Study|Migrated/moved from study area|1|||
147155304|NCT00920218|530731292|FG003|Overall Study|Migrated/moved from study area|0|||
147155305|NCT00920218|530731289|FG000|Overall Study|Lost to Follow-up|0|||
147155306|NCT00920218|530731290|FG001|Overall Study|Lost to Follow-up|1|||
147155307|NCT00920218|530731291|FG002|Overall Study|Lost to Follow-up|0|||
147155308|NCT00920218|530731292|FG003|Overall Study|Lost to Follow-up|3|||
147155309|NCT00920218|530731289|FG000|Overall Study|Transplant failed/malignancy recurrence|0|||
147155310|NCT00920218|530731290|FG001|Overall Study|Transplant failed/malignancy recurrence|1|||
147155311|NCT00920218|530731291|FG002|Overall Study|Transplant failed/malignancy recurrence|2|||
147155312|NCT00920218|530731292|FG003|Overall Study|Transplant failed/malignancy recurrence|3|||
147155313|NCT00920218|530731289|FG000|Overall Study|Other|0|||
147155314|NCT00920218|530731290|FG001|Overall Study|Other|0|||
147155315|NCT00920218|530731291|FG002|Overall Study|Other|1|||
147155316|NCT00920218|530731292|FG003|Overall Study|Other|0|||
147155317|NCT00873041|530731293|FG000|Core Study|Adverse Event|2|||
147155318|NCT00873041|530731294|FG001|Core Study|Adverse Event|3|||
147155319|NCT00873041|530731295|FG002|Core Study|Adverse Event|1|||
147155320|NCT00873041|530731293|FG000|Core Study|Withdrawal by Subject|1|||
147155321|NCT00873041|530731294|FG001|Core Study|Withdrawal by Subject|2|||
147155322|NCT00873041|530731295|FG002|Core Study|Withdrawal by Subject|2|||
147155323|NCT00873041|530731293|FG000|Core Study|Lost to Follow-up|3|||
147155324|NCT00873041|530731294|FG001|Core Study|Lost to Follow-up|1|||
147155325|NCT00873041|530731295|FG002|Core Study|Lost to Follow-up|0|||
147240793|NCT01091974|531053505|FG003|Overall Study|Withdrawal by Subject|2|||
147240794|NCT01091974|531053502|FG000|Overall Study|side-effects|1|||
147240795|NCT01091974|531053503|FG001|Overall Study|side-effects|1|||
147240796|NCT01091974|531053504|FG002|Overall Study|side-effects|0|||
147240797|NCT01091974|531053505|FG003|Overall Study|side-effects|2|||
147240798|NCT02499783|531053506|FG000|DB Period/Placebo-Controlled: Weeks 0-4|Adverse Event|2|||
147240799|NCT02499783|531053507|FG001|DB Period/Placebo-Controlled: Weeks 0-4|Adverse Event|4|||
147240800|NCT02499783|531053508|FG002|DB Period/Placebo-Controlled: Weeks 0-4|Adverse Event|0|||
147240801|NCT02499783|531053506|FG000|DB Period/Placebo-Controlled: Weeks 0-4|Withdrew Consent|1|||
147240802|NCT02499783|531053507|FG001|DB Period/Placebo-Controlled: Weeks 0-4|Withdrew Consent|0|||
147240803|NCT02499783|531053508|FG002|DB Period/Placebo-Controlled: Weeks 0-4|Withdrew Consent|0|||
147583918|NCT01190930|532293638|FG009|Induction|Inevaluable|0|||
147583919|NCT01190930|532293629|FG000|Induction|BM MRD >= 0.01% on Day 29 of Induction|61|||
147654336|NCT01690299|532556685|FG004|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|5|||
147155326|NCT00873041|530731293|FG000|Core Study|Abnormal laboratory value|0|||
147155327|NCT00873041|530731294|FG001|Core Study|Abnormal laboratory value|0|||
147155328|NCT00873041|530731295|FG002|Core Study|Abnormal laboratory value|1|||
147155329|NCT00873041|530731293|FG000|Core Study|Protocol deviation|1|||
147155330|NCT00873041|530731294|FG001|Core Study|Protocol deviation|0|||
147583920|NCT01190930|532293630|FG001|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
147583921|NCT01190930|532293631|FG002|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
147155331|NCT00873041|530731295|FG002|Core Study|Protocol deviation|1|||
147155332|NCT00873041|530731293|FG000|Extension Study|Adverse Event|1|||
147155333|NCT00873041|530731294|FG001|Extension Study|Adverse Event|0|||
147155334|NCT00873041|530731295|FG002|Extension Study|Adverse Event|1|||
147155335|NCT00873041|530731293|FG000|Extension Study|Administrative reasons|0|||
147240804|NCT02499783|531053506|FG000|DB Period/Placebo-Controlled: Weeks 0-4|Other|1|||
147583922|NCT01190930|532293632|FG003|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
147155336|NCT00873041|530731294|FG001|Extension Study|Administrative reasons|0|||
147155337|NCT00873041|530731295|FG002|Extension Study|Administrative reasons|1|||
147155338|NCT00313313|530731296|FG000|Overall Study|Lack of Efficacy|14|||
147155339|NCT00313313|530731297|FG001|Overall Study|Lack of Efficacy|9|||
147155340|NCT00313313|530731298|FG002|Overall Study|Lack of Efficacy|20|||
147155341|NCT00313313|530731296|FG000|Overall Study|Withdrawal of consent by subject|18|||
147155342|NCT00313313|530731297|FG001|Overall Study|Withdrawal of consent by subject|17|||
147155343|NCT00313313|530731298|FG002|Overall Study|Withdrawal of consent by subject|31|||
147155344|NCT00313313|530731296|FG000|Overall Study|Lost to Follow-up|10|||
147155345|NCT00313313|530731297|FG001|Overall Study|Lost to Follow-up|7|||
147155346|NCT00313313|530731298|FG002|Overall Study|Lost to Follow-up|9|||
147155347|NCT00313313|530731296|FG000|Overall Study|Adverse Event|15|||
147155348|NCT00313313|530731297|FG001|Overall Study|Adverse Event|16|||
147155349|NCT00313313|530731298|FG002|Overall Study|Adverse Event|12|||
147155350|NCT00313313|530731296|FG000|Overall Study|Physician Decision|2|||
147155351|NCT00313313|530731297|FG001|Overall Study|Physician Decision|6|||
147155352|NCT00313313|530731298|FG002|Overall Study|Physician Decision|4|||
147155353|NCT00313313|530731296|FG000|Overall Study|Poor/Noncompliance|3|||
147155354|NCT00313313|530731297|FG001|Overall Study|Poor/Noncompliance|6|||
147155355|NCT00313313|530731298|FG002|Overall Study|Poor/Noncompliance|2|||
147155356|NCT00313313|530731296|FG000|Overall Study|Pregnancy|1|||
147155357|NCT00313313|530731297|FG001|Overall Study|Pregnancy|2|||
147155358|NCT00313313|530731298|FG002|Overall Study|Pregnancy|0|||
147155359|NCT00313313|530731296|FG000|Overall Study|Death|0|||
147155360|NCT00313313|530731297|FG001|Overall Study|Death|0|||
147155361|NCT00313313|530731298|FG002|Overall Study|Death|2|||
147155362|NCT00313313|530731296|FG000|Overall Study|Subject No Longer Meets Study Criteria|0|||
147155363|NCT00313313|530731297|FG001|Overall Study|Subject No Longer Meets Study Criteria|3|||
147155364|NCT00313313|530731298|FG002|Overall Study|Subject No Longer Meets Study Criteria|2|||
147155365|NCT00368836|530731301|FG000|Phase II|Screen Failure|1|||
147155366|NCT00368836|530731301|FG000|Phase II|Withdrawal by Subject|1|||
147155367|NCT00368836|530731301|FG000|Phase II|unable to collect blood and/or breath|17|||
147155368|NCT00368836|530731301|FG000|Phase II|Protocol Violation|2|||
147155369|NCT01345591|530731311|FG000|Overall Study|Lost to Follow-up|1|||
147155370|NCT00090142|530731312|FG000|Treatment Period I|Lost to Follow-up|1|||
147155371|NCT00090142|530731313|FG001|Treatment Period I|Lost to Follow-up|2|||
147155372|NCT00090142|530731312|FG000|Treatment Period I|Protocol Violation|2|||
147155373|NCT00090142|530731313|FG001|Treatment Period I|Protocol Violation|0|||
147155374|NCT00090142|530731312|FG000|Treatment Period I|Withdrawal by Subject|2|||
147155375|NCT00090142|530731313|FG001|Treatment Period I|Withdrawal by Subject|0|||
147155376|NCT00090142|530731312|FG000|Treatment Period I|Other|0|||
147155377|NCT00090142|530731313|FG001|Treatment Period I|Other|1|||
147155378|NCT00090142|530731312|FG000|Treatment Period II|Other|1|||
147155379|NCT00090142|530731313|FG001|Treatment Period II|Other|0|||
147155380|NCT02442310|530731314|FG000|Overall Study|Adverse Event|2|||
147155381|NCT02442310|530731314|FG000|Overall Study|Withdrawal by Subject|1|||
147155382|NCT01126437|530731315|FG000|Overall Study|Not treated|11|||
147155383|NCT01126437|530731316|FG001|Overall Study|Not treated|18|||
147155384|NCT01126437|530731317|FG002|Overall Study|Not treated|19|||
147155385|NCT01126437|530731315|FG000|Overall Study|Sites with data irregularities/fraud|6|||
147155386|NCT01126437|530731316|FG001|Overall Study|Sites with data irregularities/fraud|6|||
147155387|NCT01126437|530731317|FG002|Overall Study|Sites with data irregularities/fraud|7|||
147155388|NCT01126437|530731315|FG000|Overall Study|Adverse Event|602|||
147155389|NCT01126437|530731316|FG001|Overall Study|Adverse Event|606|||
147155390|NCT01126437|530731317|FG002|Overall Study|Adverse Event|635|||
147155391|NCT01126437|530731315|FG000|Overall Study|Lack of Efficacy|65|||
147155392|NCT01126437|530731316|FG001|Overall Study|Lack of Efficacy|60|||
147155393|NCT01126437|530731317|FG002|Overall Study|Lack of Efficacy|59|||
147155394|NCT01126437|530731315|FG000|Overall Study|Protocol Violation|64|||
147155395|NCT01126437|530731316|FG001|Overall Study|Protocol Violation|66|||
147155396|NCT01126437|530731317|FG002|Overall Study|Protocol Violation|41|||
147155397|NCT01126437|530731315|FG000|Overall Study|Lost to Follow-up|52|||
147155398|NCT01126437|530731316|FG001|Overall Study|Lost to Follow-up|63|||
147155399|NCT01126437|530731317|FG002|Overall Study|Lost to Follow-up|55|||
147155400|NCT01126437|530731315|FG000|Overall Study|Withdrawal by Subject|331|||
147155401|NCT01126437|530731316|FG001|Overall Study|Withdrawal by Subject|335|||
147321950|NCT00333138|531341748|FG000|Core Study (6 Months)|Laboratory abnormality|0|||
147321951|NCT00333138|531341749|FG001|Core Study (6 Months)|Laboratory abnormality|0|||
147155402|NCT01126437|530731317|FG002|Overall Study|Withdrawal by Subject|319|||
147155403|NCT01126437|530731315|FG000|Overall Study|Other reason not specified|210|||
147155404|NCT01126437|530731316|FG001|Overall Study|Other reason not specified|176|||
147155405|NCT01126437|530731317|FG002|Overall Study|Other reason not specified|178|||
147155406|NCT00006046|530731323|FG000|Overall Study|Adverse Event|3|||
147155407|NCT00006046|530731324|FG001|Overall Study|Adverse Event|0|||
147155408|NCT00006046|530731325|FG002|Overall Study|Adverse Event|0|||
147155409|NCT00006046|530731326|FG003|Overall Study|Adverse Event|0|||
147155410|NCT00006046|530731327|FG004|Overall Study|Adverse Event|0|||
147321952|NCT00333138|531341750|FG002|Core Study (6 Months)|Laboratory abnormality|1|||
147155411|NCT00006046|530731323|FG000|Overall Study|Disease Progression|2|||
147155412|NCT00006046|530731324|FG001|Overall Study|Disease Progression|0|||
147583923|NCT01190930|532293633|FG004|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
147583924|NCT01190930|532293634|FG005|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
147583925|NCT01190930|532293635|FG006|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
147583926|NCT01190930|532293636|FG007|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
147583927|NCT01190930|532293637|FG008|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
147155413|NCT00006046|530731325|FG002|Overall Study|Disease Progression|0|||
147155414|NCT00006046|530731326|FG003|Overall Study|Disease Progression|0|||
147155415|NCT00006046|530731327|FG004|Overall Study|Disease Progression|0|||
147155416|NCT00596154|530731328|FG000|Overall Study|Not Evaluable|2|||
147155417|NCT01846663|530731329|FG000|Overall Study|Hepatic encephalopathy breakthrough|1|||
147155418|NCT01846663|530731330|FG001|Overall Study|Hepatic encephalopathy breakthrough|0|||
147155419|NCT01846663|530731329|FG000|Overall Study|Withdrawal by Subject|1|||
147155420|NCT01846663|530731330|FG001|Overall Study|Withdrawal by Subject|0|||
147155421|NCT01846663|530731329|FG000|Overall Study|Adverse Event|1|||
147155422|NCT01846663|530731330|FG001|Overall Study|Adverse Event|2|||
147155423|NCT03888235|530731348|FG000|Overall Study|Lost to Follow-up|1|||
147155424|NCT03888235|530731349|FG001|Overall Study|Lost to Follow-up|1|||
147155425|NCT03888235|530731350|FG002|Overall Study|Lost to Follow-up|0|||
147155426|NCT01535599|530731351|FG000|Overall Study|Adverse Event|6|||
147155427|NCT01535599|530731352|FG001|Overall Study|Adverse Event|15|||
147155428|NCT01535599|530731351|FG000|Overall Study|Lost to Follow-up|3|||
147155429|NCT01535599|530731352|FG001|Overall Study|Lost to Follow-up|4|||
147155430|NCT01535599|530731351|FG000|Overall Study|Subj Decision Unrelated to Adverse Event|4|||
147155431|NCT01535599|530731352|FG001|Overall Study|Subj Decision Unrelated to Adverse Event|3|||
147155432|NCT01535599|530731351|FG000|Overall Study|Treatment Failure|33|||
147155433|NCT01535599|530731352|FG001|Overall Study|Treatment Failure|66|||
147155434|NCT01535599|530731351|FG000|Overall Study|BL Culture + for Group A Strep|0|||
147155435|NCT01535599|530731352|FG001|Overall Study|BL Culture + for Group A Strep|1|||
147155436|NCT01535599|530731351|FG000|Overall Study|BL Culture + for Yeast//Fungi|0|||
147155437|NCT01535599|530731352|FG001|Overall Study|BL Culture + for Yeast//Fungi|1|||
147155438|NCT01535599|530731351|FG000|Overall Study|Randomized in Error|2|||
147155439|NCT01535599|530731352|FG001|Overall Study|Randomized in Error|4|||
147155440|NCT01535599|530731351|FG000|Overall Study|Did not use product|1|||
147155441|NCT01535599|530731352|FG001|Overall Study|Did not use product|0|||
147155442|NCT01535599|530731351|FG000|Overall Study|Other|1|||
147155443|NCT01535599|530731352|FG001|Overall Study|Other|0|||
147155444|NCT01535599|530731351|FG000|Overall Study|Stopped medication|0|||
147155445|NCT01535599|530731352|FG001|Overall Study|Stopped medication|1|||
147155446|NCT01535599|530731351|FG000|Overall Study|Noncompliance|0|||
147155447|NCT01535599|530731352|FG001|Overall Study|Noncompliance|1|||
147155448|NCT02928029|530731366|FG000|Overall Study|Withdrawal by Subject|0|||
147155449|NCT02928029|530731367|FG001|Overall Study|Withdrawal by Subject|1|||
147155450|NCT02928029|530731366|FG000|Overall Study|Radiological progression|1|||
147155451|NCT02928029|530731367|FG001|Overall Study|Radiological progression|0|||
147155452|NCT02928029|530731366|FG000|Overall Study|Clinical progression|1|||
147155453|NCT02928029|530731367|FG001|Overall Study|Clinical progression|2|||
147155454|NCT02928029|530731366|FG000|Overall Study|AE not related to clinical progression|1|||
147155455|NCT02928029|530731367|FG001|Overall Study|AE not related to clinical progression|1|||
147155456|NCT05427539|530731370|FG000|Period 1|Unsatisfactory Lens Fitting due to Test Article|1|||
147155457|NCT05427539|530731371|FG001|Period 1|Unsatisfactory Lens Fitting due to Test Article|1|||
147155458|NCT05427539|530731370|FG000|Period 1|Withdrawal by Subject|1|||
147155459|NCT05427539|530731371|FG001|Period 1|Withdrawal by Subject|0|||
147155460|NCT02649218|530731379|FG000|Overall Study|Adverse Event|8|||
147155461|NCT02649218|530731379|FG000|Overall Study|Lack of Efficacy|8|||
147155462|NCT02649218|530731379|FG000|Overall Study|Pregnancy|3|||
147155463|NCT02649218|530731379|FG000|Overall Study|Protocol Violation|3|||
147155464|NCT02649218|530731379|FG000|Overall Study|Physician Decision|1|||
147155465|NCT02649218|530731379|FG000|Overall Study|Withdrawal by Subject|2|||
147155466|NCT02438683|530731383|FG000|Overall Study|Adverse Event|1|||
147155467|NCT02438683|530731384|FG001|Overall Study|Adverse Event|0|||
147155468|NCT02438683|530731385|FG002|Overall Study|Adverse Event|0|||
147155469|NCT02438683|530731386|FG003|Overall Study|Adverse Event|0|||
147155470|NCT02438683|530731387|FG004|Overall Study|Adverse Event|0|||
147240805|NCT02499783|531053507|FG001|DB Period/Placebo-Controlled: Weeks 0-4|Other|1|||
147446821|NCT01967628|531800314|FG001|Overall Study|Lost to Follow-up|0|||
147155471|NCT02438683|530731388|FG005|Overall Study|Adverse Event|0|||
147155472|NCT01846299|530731393|FG000|Overall Study|Physician Decision|4|||
147155473|NCT01846299|530731394|FG001|Overall Study|Physician Decision|2|||
147155474|NCT01846299|530731393|FG000|Overall Study|Protocol deviation|1|||
147155475|NCT01846299|530731394|FG001|Overall Study|Protocol deviation|0|||
147155476|NCT01846299|530731393|FG000|Overall Study|Death|1|||
147155477|NCT01846299|530731394|FG001|Overall Study|Death|2|||
147155478|NCT01846299|530731393|FG000|Overall Study|Lost to Follow-up|3|||
147155479|NCT01846299|530731394|FG001|Overall Study|Lost to Follow-up|0|||
147155480|NCT01846299|530731393|FG000|Overall Study|Withdrawal by Subject|1|||
147155481|NCT01846299|530731394|FG001|Overall Study|Withdrawal by Subject|6|||
147155482|NCT01846299|530731393|FG000|Overall Study|Adverse Event|2|||
147155483|NCT01846299|530731394|FG001|Overall Study|Adverse Event|0|||
147155484|NCT00082368|530731395|FG000|Overall Study|Not treated-pt had poor IV access|1|||
147155485|NCT01330628|530731396|FG000|Overall Study|Death|2|||
147155486|NCT01330628|530731397|FG001|Overall Study|Death|3|||
147155487|NCT01330628|530731396|FG000|Overall Study|Lost to Follow-up|5|||
147155488|NCT01330628|530731397|FG001|Overall Study|Lost to Follow-up|6|||
147155489|NCT01330628|530731396|FG000|Overall Study|Adverse Event|44|||
147155490|NCT01330628|530731397|FG001|Overall Study|Adverse Event|25|||
147155491|NCT01330628|530731396|FG000|Overall Study|Withdrawn|18|||
147155492|NCT01330628|530731397|FG001|Overall Study|Withdrawn|6|||
147155493|NCT01330628|530731396|FG000|Overall Study|Didn't receive study treatment|1|||
147155494|NCT01330628|530731397|FG001|Overall Study|Didn't receive study treatment|0|||
147155495|NCT01740089|530733491|FG000|First 12 Weeks of Treatment|Adverse Event|0|||
147155496|NCT01740089|530733492|FG001|First 12 Weeks of Treatment|Adverse Event|1|||
147155497|NCT01740089|530733493|FG002|First 12 Weeks of Treatment|Adverse Event|2|||
147155498|NCT01740089|530733491|FG000|First 12 Weeks of Treatment|Withdrawal by Subject|0|||
147155499|NCT01740089|530733492|FG001|First 12 Weeks of Treatment|Withdrawal by Subject|1|||
147155500|NCT01740089|530733493|FG002|First 12 Weeks of Treatment|Withdrawal by Subject|0|||
147155501|NCT01740089|530733491|FG000|After 12 Weeks|Lack of Efficacy|3|||
147155502|NCT01740089|530733492|FG001|After 12 Weeks|Lack of Efficacy|1|||
147155503|NCT01740089|530733493|FG002|After 12 Weeks|Lack of Efficacy|4|||
147155504|NCT01740089|530733491|FG000|After 12 Weeks|Adverse Event|2|||
147155505|NCT01740089|530733492|FG001|After 12 Weeks|Adverse Event|0|||
147155506|NCT01740089|530733493|FG002|After 12 Weeks|Adverse Event|5|||
147155507|NCT01740089|530733491|FG000|After 12 Weeks|Protocol Violation|1|||
147155508|NCT01740089|530733492|FG001|After 12 Weeks|Protocol Violation|1|||
147155509|NCT01740089|530733493|FG002|After 12 Weeks|Protocol Violation|1|||
147654337|NCT01690299|532556686|FG005|Apremilast Extension Phase (Weeks16-104)|Withdrawal by Subject|11|||
147654338|NCT01690299|532556681|FG000|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|0|||
147654339|NCT01690299|532556682|FG001|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|0|||
147654340|NCT01690299|532556683|FG002|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|0|||
147654341|NCT01690299|532556684|FG003|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|6|||
147654342|NCT01690299|532556685|FG004|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|13|||
147654343|NCT01690299|532556686|FG005|Apremilast Extension Phase (Weeks16-104)|Lost to Follow-up|6|||
147155510|NCT01740089|530733491|FG000|After 12 Weeks|Withdrawal by Subject|1|||
147155511|NCT01740089|530733492|FG001|After 12 Weeks|Withdrawal by Subject|1|||
147155512|NCT01740089|530733493|FG002|After 12 Weeks|Withdrawal by Subject|1|||
147155513|NCT01448824|530733496|FG000|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
147155514|NCT01448824|530733497|FG001|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
147155515|NCT01448824|530733498|FG002|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
147155516|NCT01448824|530733499|FG003|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
147155517|NCT01448824|530733500|FG004|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
147155518|NCT01448824|530733501|FG005|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
147155519|NCT01448824|530733502|FG006|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|1|||
147155520|NCT01448824|530733503|FG007|Part 1 Period 1: Multiple Ascending Dose|Adverse Event|0|||
147155521|NCT01448824|530733496|FG000|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0|||
147155522|NCT01448824|530733497|FG001|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0|||
147155523|NCT01448824|530733498|FG002|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0|||
147155524|NCT01448824|530733499|FG003|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|1|||
147155525|NCT01448824|530733500|FG004|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|2|||
147155526|NCT01448824|530733501|FG005|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|1|||
147155527|NCT01448824|530733502|FG006|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0|||
147155528|NCT01448824|530733503|FG007|Part 1 Period 1: Multiple Ascending Dose|Withdrawal by Subject|0|||
147155529|NCT01448824|530733496|FG000|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
147155530|NCT01448824|530733497|FG001|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
147155531|NCT01448824|530733498|FG002|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
147155532|NCT01448824|530733499|FG003|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
147155533|NCT01448824|530733500|FG004|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
147240806|NCT02499783|531053508|FG002|DB Period/Placebo-Controlled: Weeks 0-4|Other|0|||
147240807|NCT02499783|531053506|FG000|DB Period: Weeks 0-8|Adverse Event|8|||
147240808|NCT02499783|531053507|FG001|DB Period: Weeks 0-8|Adverse Event|6|||
147240809|NCT02499783|531053508|FG002|DB Period: Weeks 0-8|Adverse Event|0|||
147240810|NCT02499783|531053506|FG000|DB Period: Weeks 0-8|Withdrew Consent|1|||
147240811|NCT02499783|531053507|FG001|DB Period: Weeks 0-8|Withdrew Consent|0|||
147240812|NCT02499783|531053508|FG002|DB Period: Weeks 0-8|Withdrew Consent|0|||
147155534|NCT01448824|530733501|FG005|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|1|||
147155535|NCT01448824|530733502|FG006|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
147155536|NCT01448824|530733503|FG007|Part 1 Period 1: Multiple Ascending Dose|Lost to Follow-up|0|||
147155537|NCT01448824|530733496|FG000|Part 1: Washout Period|Lost to Follow-up|1|||
147240813|NCT02499783|531053506|FG000|DB Period: Weeks 0-8|Other|1|||
147583928|NCT01190930|532293638|FG009|Induction|BM MRD >= 0.01% on Day 29 of Induction|0|||
147155538|NCT01448824|530733497|FG001|Part 1: Washout Period|Lost to Follow-up|0|||
147155539|NCT01448824|530733498|FG002|Part 1: Washout Period|Lost to Follow-up|0|||
147155540|NCT01448824|530733499|FG003|Part 1: Washout Period|Lost to Follow-up|0|||
147155541|NCT01448824|530733500|FG004|Part 1: Washout Period|Lost to Follow-up|0|||
147155542|NCT01448824|530733501|FG005|Part 1: Washout Period|Lost to Follow-up|0|||
147155543|NCT01448824|530733502|FG006|Part 1: Washout Period|Lost to Follow-up|0|||
147155544|NCT01448824|530733503|FG007|Part 1: Washout Period|Lost to Follow-up|0|||
147155545|NCT01448824|530733496|FG000|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
147155546|NCT01448824|530733497|FG001|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
147155547|NCT01448824|530733498|FG002|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
147155548|NCT01448824|530733499|FG003|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
147155549|NCT01448824|530733500|FG004|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
147155550|NCT01448824|530733501|FG005|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
147155551|NCT01448824|530733502|FG006|Part 2 Period 1: Drug-drug Interaction|Adverse Event|0|||
147155552|NCT01448824|530733503|FG007|Part 2 Period 1: Drug-drug Interaction|Adverse Event|1|||
147155553|NCT01448824|530733496|FG000|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
147155554|NCT01448824|530733497|FG001|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
147155555|NCT01448824|530733498|FG002|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
147155556|NCT01448824|530733499|FG003|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
147155557|NCT01448824|530733500|FG004|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
147155558|NCT01448824|530733501|FG005|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
147155559|NCT01448824|530733502|FG006|Part 2 Period 2: Drug-drug Interaction|Adverse Event|0|||
147155560|NCT01448824|530733503|FG007|Part 2 Period 2: Drug-drug Interaction|Adverse Event|1|||
147155561|NCT01448824|530733496|FG000|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
147155562|NCT01448824|530733497|FG001|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
147155563|NCT01448824|530733498|FG002|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
147155564|NCT01448824|530733499|FG003|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
147155565|NCT01448824|530733500|FG004|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
147155566|NCT01448824|530733501|FG005|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
147155567|NCT01448824|530733502|FG006|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|0|||
147155568|NCT01448824|530733503|FG007|Part 2 Period 2: Drug-drug Interaction|Lost to Follow-up|1|||
147155569|NCT01448824|530733496|FG000|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
147155570|NCT01448824|530733497|FG001|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
147155571|NCT01448824|530733498|FG002|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
147155572|NCT01448824|530733499|FG003|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
147155573|NCT01448824|530733500|FG004|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
147155574|NCT01448824|530733501|FG005|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
147155575|NCT01448824|530733502|FG006|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|0|||
147155576|NCT01448824|530733503|FG007|Part 2 Period 2: Drug-drug Interaction|Withdrawal by Subject|1|||
147155577|NCT03285958|530733505|FG000|Overall Study|Lost to Follow-up|1|||
147155578|NCT03285958|530733506|FG001|Overall Study|Lost to Follow-up|1|||
147155579|NCT03285958|530733505|FG000|Overall Study|Withdrawal by Subject|1|||
147155580|NCT03285958|530733506|FG001|Overall Study|Withdrawal by Subject|0|||
147155581|NCT03285958|530733505|FG000|Overall Study|Not able to attend required orientation|3|||
147155582|NCT03285958|530733506|FG001|Overall Study|Not able to attend required orientation|0|||
147155583|NCT03116828|530733507|FG000|Overall Study|Adverse Event|1|||
147155584|NCT03116828|530733508|FG001|Overall Study|Adverse Event|10|||
147155585|NCT03116828|530733507|FG000|Overall Study|Withdrawal by Subject|4|||
147155586|NCT03116828|530733508|FG001|Overall Study|Withdrawal by Subject|8|||
147155587|NCT03116828|530733507|FG000|Overall Study|OTHER|3|||
147155588|NCT03116828|530733508|FG001|Overall Study|OTHER|3|||
147155589|NCT03002818|530733509|FG000|Overall Study|Decision of the investigator|1|||
147155590|NCT01606787|530733514|FG000|Overall Study|Withdrawal by Subject|4|||
147155591|NCT01606787|530733515|FG001|Overall Study|Withdrawal by Subject|5|||
147155592|NCT01606787|530733514|FG000|Overall Study|Surgery canceled|0|||
147155593|NCT01606787|530733515|FG001|Overall Study|Surgery canceled|2|||
147155594|NCT05312632|530733517|FG000|Overall Study|Adverse Event|12|||
147155595|NCT05312632|530733517|FG000|Overall Study|Withdrawal by Subject|10|||
147155596|NCT05312632|530733517|FG000|Overall Study|Lack of Efficacy|4|||
147155597|NCT05312632|530733517|FG000|Overall Study|Non-compliance with study procedures|9|||
147155598|NCT05312632|530733517|FG000|Overall Study|Other|4|||
147155599|NCT00489736|530733518|FG000|Overall Study|Lack of Efficacy|53|||
147155600|NCT00489736|530733519|FG001|Overall Study|Lack of Efficacy|14|||
147155601|NCT00489736|530733518|FG000|Overall Study|Adverse Event|32|||
147155602|NCT00489736|530733519|FG001|Overall Study|Adverse Event|45|||
147155603|NCT00489736|530733518|FG000|Overall Study|Poor compliance|6|||
147583929|NCT01190930|532293629|FG000|Induction|High Risk Downs|80|||
147583930|NCT01190930|532293630|FG001|Induction|High Risk Downs|0|||
147583931|NCT01190930|532293631|FG002|Induction|High Risk Downs|0|||
147583932|NCT01190930|532293632|FG003|Induction|High Risk Downs|0|||
147155604|NCT00489736|530733519|FG001|Overall Study|Poor compliance|2|||
147155605|NCT00489736|530733518|FG000|Overall Study|Not coded/ Not pre-specified|5|||
147155606|NCT00489736|530733519|FG001|Overall Study|Not coded/ Not pre-specified|8|||
147155607|NCT03883165|530733520|FG000|Overall Study|Withdrawal by Subject|4|||
147155608|NCT03883165|530733521|FG001|Overall Study|Withdrawal by Subject|3|||
147155609|NCT00245050|530733522|FG000|Overall Study|Adverse Event|3|||
147155610|NCT00245050|530733523|FG001|Overall Study|Adverse Event|2|||
147155611|NCT05526781|530733524|FG000|Overall Study|Lost to Follow-up|1|||
147155612|NCT02743949|530733525|FG000|Overall Study|Adverse Event|0|||
147155613|NCT02743949|530733526|FG001|Overall Study|Adverse Event|0|||
147155614|NCT02743949|530733527|FG002|Overall Study|Adverse Event|2|||
147155615|NCT02743949|530733525|FG000|Overall Study|Significant Protocol Deviation|2|||
147155616|NCT02743949|530733526|FG001|Overall Study|Significant Protocol Deviation|0|||
147155617|NCT02743949|530733527|FG002|Overall Study|Significant Protocol Deviation|1|||
147155618|NCT02743949|530733525|FG000|Overall Study|Voluntary Withdrawal|2|||
147155619|NCT02743949|530733526|FG001|Overall Study|Voluntary Withdrawal|1|||
147155620|NCT02743949|530733527|FG002|Overall Study|Voluntary Withdrawal|0|||
147155621|NCT01498575|530733528|FG000|Overall Sample|Withdrawal by Subject|60|||
147155622|NCT01498575|530733529|FG001|Overall Sample|Withdrawal by Subject|14|||
147155623|NCT01498575|530733528|FG000|On the Road Driving Assessment (ODA)|Withdrawal by Subject|19|||
147155624|NCT01498575|530733529|FG001|On the Road Driving Assessment (ODA)|Withdrawal by Subject|6|||
147155625|NCT01498575|530733528|FG000|On the Road Driving Assessment (ODA)|Protocol Violation|23|||
147155626|NCT01498575|530733529|FG001|On the Road Driving Assessment (ODA)|Protocol Violation|18|||
147155627|NCT01425359|530733548|FG000|Overall Study|Randomized but Not Treated|2|||
147155628|NCT01425359|530733549|FG001|Overall Study|Randomized but Not Treated|3|||
147155629|NCT01425359|530733548|FG000|Overall Study|Adverse Event|9|||
147155630|NCT01425359|530733549|FG001|Overall Study|Adverse Event|8|||
147155631|NCT01425359|530733548|FG000|Overall Study|Revascularization|0|||
147155632|NCT01425359|530733549|FG001|Overall Study|Revascularization|1|||
147155633|NCT01425359|530733548|FG000|Overall Study|Death|0|||
147155634|NCT01425359|530733549|FG001|Overall Study|Death|1|||
147155635|NCT01425359|530733548|FG000|Overall Study|Unsatisfactory Response|1|||
147155636|NCT01425359|530733549|FG001|Overall Study|Unsatisfactory Response|0|||
147155637|NCT01425359|530733548|FG000|Overall Study|Protocol Violation|1|||
147155638|NCT01425359|530733549|FG001|Overall Study|Protocol Violation|2|||
147155639|NCT01425359|530733548|FG000|Overall Study|Subject Withdrew Consent|1|||
147155640|NCT01425359|530733549|FG001|Overall Study|Subject Withdrew Consent|2|||
147155641|NCT01425359|530733548|FG000|Overall Study|Investigator's Discretion|2|||
147155642|NCT01425359|530733549|FG001|Overall Study|Investigator's Discretion|0|||
147155643|NCT01425359|530733548|FG000|Overall Study|Did Not Meet Qualifying Criteria|3|||
147155644|NCT01425359|530733549|FG001|Overall Study|Did Not Meet Qualifying Criteria|5|||
147155645|NCT03172325|530733550|FG000|Overall Study|Adverse Event|2|||
147155646|NCT03172325|530733551|FG001|Overall Study|Adverse Event|3|||
147155647|NCT03172325|530733550|FG000|Overall Study|Positive PPD|1|||
147155648|NCT03172325|530733551|FG001|Overall Study|Positive PPD|0|||
147155649|NCT03172325|530733550|FG000|Overall Study|Poor Compliance|1|||
147155650|NCT03172325|530733551|FG001|Overall Study|Poor Compliance|1|||
147155651|NCT01229254|530733560|FG000|Overall Study|Not Continuing Into Safety Extension|3|||
147155652|NCT01229254|530733561|FG001|Overall Study|Not Continuing Into Safety Extension|1|||
147155653|NCT01229254|530733562|FG002|Overall Study|Not Continuing Into Safety Extension|1|||
147155654|NCT01229254|530733560|FG000|Overall Study|Adverse Event|4|||
147155655|NCT01229254|530733561|FG001|Overall Study|Adverse Event|5|||
147155656|NCT01229254|530733562|FG002|Overall Study|Adverse Event|3|||
147155657|NCT01229254|530733560|FG000|Overall Study|Lost to Follow-up|3|||
147155658|NCT01229254|530733561|FG001|Overall Study|Lost to Follow-up|0|||
147155659|NCT01229254|530733562|FG002|Overall Study|Lost to Follow-up|1|||
147155660|NCT01229254|530733560|FG000|Overall Study|Physician Decision|0|||
147155661|NCT01229254|530733561|FG001|Overall Study|Physician Decision|3|||
147240814|NCT02499783|531053507|FG001|DB Period: Weeks 0-8|Other|1|||
147240815|NCT02499783|531053508|FG002|DB Period: Weeks 0-8|Other|0|||
147240816|NCT02499783|531053506|FG000|Open Label Period: Weeks 8 to 26|Adverse Event|0|||
147240817|NCT02499783|531053507|FG001|Open Label Period: Weeks 8 to 26|Adverse Event|0|||
147240818|NCT02499783|531053508|FG002|Open Label Period: Weeks 8 to 26|Adverse Event|16|||
147240819|NCT02499783|531053506|FG000|Open Label Period: Weeks 8 to 26|Withdrew Consent|0|||
147654344|NCT01690299|532556681|FG000|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0|||
147240820|NCT02499783|531053507|FG001|Open Label Period: Weeks 8 to 26|Withdrew Consent|0|||
147155662|NCT01229254|530733562|FG002|Overall Study|Physician Decision|0|||
147155663|NCT01229254|530733560|FG000|Overall Study|Protocol Violation|4|||
147155664|NCT01229254|530733561|FG001|Overall Study|Protocol Violation|6|||
147155665|NCT01229254|530733562|FG002|Overall Study|Protocol Violation|5|||
147155666|NCT01229254|530733560|FG000|Overall Study|Withdrawal by Subject|1|||
147155667|NCT01229254|530733561|FG001|Overall Study|Withdrawal by Subject|0|||
147155668|NCT01229254|530733562|FG002|Overall Study|Withdrawal by Subject|1|||
147155669|NCT01229254|530733560|FG000|Overall Study|Non-compliance with Study Drug|0|||
147155670|NCT01229254|530733561|FG001|Overall Study|Non-compliance with Study Drug|1|||
147240821|NCT02499783|531053508|FG002|Open Label Period: Weeks 8 to 26|Withdrew Consent|2|||
147240822|NCT02499783|531053506|FG000|Open Label Period: Weeks 8 to 26|Lack of Efficacy|0|||
147240823|NCT02499783|531053507|FG001|Open Label Period: Weeks 8 to 26|Lack of Efficacy|0|||
147240824|NCT02499783|531053508|FG002|Open Label Period: Weeks 8 to 26|Lack of Efficacy|9|||
147240825|NCT02499783|531053506|FG000|Open Label Period: Weeks 8 to 26|Subject Noncompliance|0|||
147240826|NCT02499783|531053507|FG001|Open Label Period: Weeks 8 to 26|Subject Noncompliance|0|||
147240827|NCT02499783|531053508|FG002|Open Label Period: Weeks 8 to 26|Subject Noncompliance|2|||
147240828|NCT02228460|531053509|FG000|Overall Study|Adverse Event|1|||
147240829|NCT02228460|531053509|FG000|Overall Study|Lost to Follow-up|1|||
147240830|NCT01243892|531053510|FG000|Overall Study|Did not meet eligibility criteria|2|||
147240831|NCT01243892|531053511|FG001|Overall Study|Did not meet eligibility criteria|0|||
147240832|NCT01866293|531053516|FG000|Overall Study|Adverse Event|2|||
147240833|NCT03066804|531053517|FG000|Overall Study|Physician Decision|0|||
147240834|NCT03066804|531053518|FG001|Overall Study|Physician Decision|4|||
147240835|NCT03066804|531053517|FG000|Overall Study|Death|23|||
147240836|NCT03066804|531053518|FG001|Overall Study|Death|17|||
147240837|NCT03066804|531053517|FG000|Overall Study|Withdrawal by Subject|19|||
147240838|NCT03066804|531053518|FG001|Overall Study|Withdrawal by Subject|25|||
147240839|NCT03066804|531053517|FG000|Overall Study|Lost to Follow-up|2|||
147240840|NCT03066804|531053518|FG001|Overall Study|Lost to Follow-up|0|||
147583933|NCT01190930|532293633|FG004|Induction|High Risk Downs|0|||
147583934|NCT01190930|532293634|FG005|Induction|High Risk Downs|0|||
147583935|NCT01190930|532293635|FG006|Induction|High Risk Downs|0|||
147583936|NCT01190930|532293636|FG007|Induction|High Risk Downs|0|||
147583937|NCT01190930|532293637|FG008|Induction|High Risk Downs|0|||
147583938|NCT01190930|532293638|FG009|Induction|High Risk Downs|0|||
147155671|NCT01229254|530733562|FG002|Overall Study|Non-compliance with Study Drug|1|||
147155672|NCT01694121|530733563|FG000|Overall Study|Participant used false ID, was withdrawn|1|||
147155673|NCT01694121|530733564|FG001|Overall Study|Participant used false ID, was withdrawn|0|||
147155674|NCT00744978|530733567|FG000|Period 1|Lost to Follow-up|1|||
147155675|NCT00744978|530733568|FG001|Period 1|Lost to Follow-up|0|||
147155676|NCT00744978|530733567|FG000|Period 1|Withdrawal by Subject|0|||
147155677|NCT00744978|530733568|FG001|Period 1|Withdrawal by Subject|2|||
147155678|NCT00744978|530733567|FG000|Period 1|Other|0|||
147155679|NCT00744978|530733568|FG001|Period 1|Other|2|||
147155680|NCT00744978|530733567|FG000|Period 1|Adverse Event|4|||
147155681|NCT00744978|530733568|FG001|Period 1|Adverse Event|0|||
147155682|NCT00744978|530733567|FG000|Period 1|Randomized but not Treated|1|||
147155683|NCT00744978|530733568|FG001|Period 1|Randomized but not Treated|1|||
147155684|NCT00744978|530733567|FG000|Period 2|Adverse Event|0|||
147155685|NCT00744978|530733568|FG001|Period 2|Adverse Event|1|||
147155686|NCT00503776|530733569|FG000|Overall Study|Withdrawal by Subject|1|||
147155687|NCT00503776|530733570|FG001|Overall Study|Withdrawal by Subject|0|||
147155688|NCT00503776|530733571|FG002|Overall Study|Withdrawal by Subject|1|||
147155689|NCT00503776|530733572|FG003|Overall Study|Withdrawal by Subject|1|||
147155690|NCT00503776|530733569|FG000|Overall Study|Physician Decision|0|||
147155691|NCT00503776|530733570|FG001|Overall Study|Physician Decision|0|||
147155692|NCT00503776|530733571|FG002|Overall Study|Physician Decision|1|||
147155693|NCT00503776|530733572|FG003|Overall Study|Physician Decision|1|||
147155694|NCT03359785|530733575|FG000|Overall Study|Protocol Violation|0|||
147155695|NCT03359785|530733576|FG001|Overall Study|Protocol Violation|1|||
147155696|NCT03359785|530733577|FG002|Overall Study|Protocol Violation|0|||
147155697|NCT03359785|530733578|FG003|Overall Study|Protocol Violation|0|||
147155698|NCT03359785|530733575|FG000|Overall Study|Early study termination due to study pause|0|||
147155699|NCT03359785|530733576|FG001|Overall Study|Early study termination due to study pause|0|||
147155700|NCT03359785|530733577|FG002|Overall Study|Early study termination due to study pause|2|||
147155701|NCT03359785|530733578|FG003|Overall Study|Early study termination due to study pause|0|||
147155702|NCT03359785|530733575|FG000|Overall Study|Withdrawal by Subject|2|||
147155703|NCT03359785|530733576|FG001|Overall Study|Withdrawal by Subject|2|||
147155704|NCT03359785|530733577|FG002|Overall Study|Withdrawal by Subject|0|||
147155705|NCT03359785|530733578|FG003|Overall Study|Withdrawal by Subject|0|||
147155706|NCT00223977|530733579|FG000|Overall Study|Adverse Event|7|||
147155707|NCT00223977|530733580|FG001|Overall Study|Adverse Event|10|||
147155708|NCT00223977|530733581|FG002|Overall Study|Adverse Event|0|||
147155709|NCT00223977|530733579|FG000|Overall Study|Protocol Violation|0|||
147155710|NCT00223977|530733580|FG001|Overall Study|Protocol Violation|0|||
147155711|NCT00223977|530733581|FG002|Overall Study|Protocol Violation|1|||
147155712|NCT00223977|530733579|FG000|Overall Study|Withdrawal by Subject|1|||
147240841|NCT03066804|531053517|FG000|Overall Study|Adverse Event|2|||
147240842|NCT03066804|531053518|FG001|Overall Study|Adverse Event|3|||
147240843|NCT03066804|531053517|FG000|Overall Study|Technical problems|5|||
147583939|NCT01190930|532293629|FG000|Induction|Enrollment onto another COG Protocol|1|||
147155713|NCT00223977|530733580|FG001|Overall Study|Withdrawal by Subject|1|||
147155714|NCT00223977|530733581|FG002|Overall Study|Withdrawal by Subject|2|||
147155715|NCT00223977|530733579|FG000|Overall Study|Other|1|||
147155716|NCT00223977|530733580|FG001|Overall Study|Other|0|||
147155717|NCT00223977|530733581|FG002|Overall Study|Other|0|||
147155718|NCT01895543|530733582|FG000|Overall Study|Withdrawal by Subject|43|||
147155719|NCT01895543|530733582|FG000|Overall Study|Lost to Follow-up|25|||
147155720|NCT01895543|530733582|FG000|Overall Study|Adverse Event|28|||
147155721|NCT01895543|530733582|FG000|Overall Study|Subject's substantial non-compliance|6|||
147155722|NCT01895543|530733582|FG000|Overall Study|Protocol Violation|1|||
147155723|NCT01895543|530733582|FG000|Overall Study|Physician Decision|2|||
147155724|NCT01895543|530733582|FG000|Overall Study|Other (Not fulfilling above criteria)|24|||
147155725|NCT03276026|530733590|FG000|Overall Study|Protocol Violation|1|||
147155726|NCT03276026|530733591|FG001|Overall Study|Protocol Violation|0|||
147155727|NCT03650803|530733593|FG000|Overall Study|Lost to Follow-up|6|||
147155728|NCT01534260|530733594|FG000|Overall Study|Adverse Event|1|||
147155729|NCT01534260|530733595|FG001|Overall Study|Adverse Event|8|||
147155730|NCT01534260|530733594|FG000|Overall Study|Death|2|||
147155731|NCT01534260|530733595|FG001|Overall Study|Death|0|||
147155732|NCT01534260|530733594|FG000|Overall Study|Lack of Efficacy|1|||
147155733|NCT01534260|530733595|FG001|Overall Study|Lack of Efficacy|1|||
147155734|NCT01534260|530733594|FG000|Overall Study|Withdrawal by Subject|1|||
147155735|NCT01534260|530733595|FG001|Overall Study|Withdrawal by Subject|3|||
147155736|NCT01534260|530733594|FG000|Overall Study|Disease Progression|8|||
147155737|NCT01534260|530733595|FG001|Overall Study|Disease Progression|6|||
147155738|NCT01534260|530733594|FG000|Overall Study|Physician Decision|3|||
147155739|NCT01534260|530733595|FG001|Overall Study|Physician Decision|1|||
147155740|NCT01534260|530733594|FG000|Overall Study|No treatment, per protocol|0|||
147155741|NCT01534260|530733595|FG001|Overall Study|No treatment, per protocol|1|||
147155742|NCT02359045|530733596|FG000|Overall Study|Eligibility criteria not fulfilled|3|||
147155743|NCT02359045|530733597|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
147155744|NCT02359045|530733596|FG000|Overall Study|Lost to Follow-up|1|||
147155745|NCT02359045|530733597|FG001|Overall Study|Lost to Follow-up|1|||
147155746|NCT02359045|530733596|FG000|Overall Study|Adverse Event|0|||
147155747|NCT02359045|530733597|FG001|Overall Study|Adverse Event|1|||
147155748|NCT01639339|530733601|FG000|Double-blind Period (Up to Week 104)|Withdrawal by Subject|26|||
147155749|NCT01639339|530733602|FG001|Double-blind Period (Up to Week 104)|Withdrawal by Subject|19|||
147155750|NCT01639339|530733601|FG000|Double-blind Period (Up to Week 104)|Physician Decision|11|||
147155751|NCT01639339|530733602|FG001|Double-blind Period (Up to Week 104)|Physician Decision|5|||
147155752|NCT01639339|530733601|FG000|Double-blind Period (Up to Week 104)|Lost to Follow-up|5|||
147155753|NCT01639339|530733602|FG001|Double-blind Period (Up to Week 104)|Lost to Follow-up|4|||
147155754|NCT01639339|530733601|FG000|Double-blind Period (Up to Week 104)|Protocol Violation|0|||
147155755|NCT01639339|530733602|FG001|Double-blind Period (Up to Week 104)|Protocol Violation|2|||
147155756|NCT01639339|530733601|FG000|Double-blind Period (Up to Week 104)|Lack of Efficacy|2|||
147155757|NCT01639339|530733602|FG001|Double-blind Period (Up to Week 104)|Lack of Efficacy|1|||
147155758|NCT01639339|530733601|FG000|Double-blind Period (Up to Week 104)|Adverse Event|10|||
147155759|NCT01639339|530733602|FG001|Double-blind Period (Up to Week 104)|Adverse Event|7|||
147155760|NCT01639339|530733601|FG000|Open-label Period (Up to Week 28)|Withdrawal by Subject|0|||
147321953|NCT00333138|531341748|FG000|Extension Study (Month6 to End of Study)|Abnormal laboratory value|3|||
147654345|NCT01690299|532556682|FG001|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0|||
147155761|NCT01639339|530733602|FG001|Open-label Period (Up to Week 28)|Withdrawal by Subject|2|||
147155762|NCT01639339|530733601|FG000|Open-label Period (Up to Week 28)|Lost to Follow-up|0|||
147155763|NCT01639339|530733602|FG001|Open-label Period (Up to Week 28)|Lost to Follow-up|1|||
147155764|NCT01639339|530733601|FG000|Open-label Period (Up to Week 28)|Protocol Violation|0|||
147155765|NCT01639339|530733602|FG001|Open-label Period (Up to Week 28)|Protocol Violation|1|||
147155766|NCT01639339|530733601|FG000|Open-label Period (Up to Week 28)|Adverse Event|1|||
147155767|NCT01639339|530733602|FG001|Open-label Period (Up to Week 28)|Adverse Event|4|||
147155768|NCT00367744|530733603|FG000|Overall Study|Lost to Follow-up|4|||
147155769|NCT00367744|530733604|FG001|Overall Study|Lost to Follow-up|5|||
147155770|NCT00503581|530733611|FG000|Overall Study|Study closed|3|||
147155771|NCT00503581|530733612|FG001|Overall Study|Study closed|4|||
147155772|NCT00503581|530733613|FG002|Overall Study|Study closed|2|||
147155773|NCT04376684|530733614|FG000|Part 1 (Up to Day 60)|Withdrawal by Subject|7|||
147155774|NCT04376684|530733615|FG001|Part 1 (Up to Day 60)|Withdrawal by Subject|8|||
147155775|NCT04376684|530733616|FG002|Part 1 (Up to Day 60)|Withdrawal by Subject|0|||
147155776|NCT04376684|530733617|FG003|Part 1 (Up to Day 60)|Withdrawal by Subject|0|||
147155777|NCT04376684|530733614|FG000|Part 1 (Up to Day 60)|Protocol Violation|2|||
147155778|NCT04376684|530733615|FG001|Part 1 (Up to Day 60)|Protocol Violation|3|||
147155779|NCT04376684|530733616|FG002|Part 1 (Up to Day 60)|Protocol Violation|0|||
147155780|NCT04376684|530733617|FG003|Part 1 (Up to Day 60)|Protocol Violation|0|||
147155781|NCT04376684|530733614|FG000|Part 1 (Up to Day 60)|Physician Decision|2|||
147155782|NCT04376684|530733615|FG001|Part 1 (Up to Day 60)|Physician Decision|5|||
147155783|NCT04376684|530733616|FG002|Part 1 (Up to Day 60)|Physician Decision|0|||
147155784|NCT04376684|530733617|FG003|Part 1 (Up to Day 60)|Physician Decision|0|||
147155785|NCT04376684|530733614|FG000|Part 1 (Up to Day 60)|Lost to Follow-up|4|||
147155786|NCT04376684|530733615|FG001|Part 1 (Up to Day 60)|Lost to Follow-up|8|||
147155787|NCT04376684|530733616|FG002|Part 1 (Up to Day 60)|Lost to Follow-up|0|||
147155788|NCT04376684|530733617|FG003|Part 1 (Up to Day 60)|Lost to Follow-up|0|||
147155789|NCT04376684|530733614|FG000|Part 2 (Up to Day 60)|Withdrawal by Subject|0|||
147155790|NCT04376684|530733615|FG001|Part 2 (Up to Day 60)|Withdrawal by Subject|0|||
147155791|NCT04376684|530733616|FG002|Part 2 (Up to Day 60)|Withdrawal by Subject|1|||
147155792|NCT04376684|530733617|FG003|Part 2 (Up to Day 60)|Withdrawal by Subject|1|||
147155793|NCT04376684|530733614|FG000|Part 2 (Up to Day 60)|Physician Decision|0|||
147155794|NCT04376684|530733615|FG001|Part 2 (Up to Day 60)|Physician Decision|0|||
147155795|NCT04376684|530733616|FG002|Part 2 (Up to Day 60)|Physician Decision|1|||
147155796|NCT04376684|530733617|FG003|Part 2 (Up to Day 60)|Physician Decision|1|||
147155797|NCT04376684|530733614|FG000|Part 2 (Up to Day 60)|Lost to Follow-up|0|||
147155798|NCT04376684|530733615|FG001|Part 2 (Up to Day 60)|Lost to Follow-up|0|||
147155799|NCT04376684|530733616|FG002|Part 2 (Up to Day 60)|Lost to Follow-up|3|||
147155800|NCT04376684|530733617|FG003|Part 2 (Up to Day 60)|Lost to Follow-up|2|||
147155801|NCT01666119|530733618|FG000|Overall Study|Adverse Event|6|||
147155802|NCT01666119|530733618|FG000|Overall Study|Withdrawal by Subject|16|||
147155803|NCT01666119|530733618|FG000|Overall Study|Lost to Follow-up|7|||
147155804|NCT01666119|530733618|FG000|Overall Study|non compliance with study medication, pa|18|||
147155805|NCT01666119|530733618|FG000|Overall Study|Subject experiencing withdrawal symptoms|5|||
147155806|NCT01301066|530733625|FG000|Overall Study|Lost to Follow-up|5|||
147155807|NCT01301066|530733626|FG001|Overall Study|Lost to Follow-up|11|||
147155808|NCT01301066|530733625|FG000|Overall Study|Protocol Violation|8|||
147155809|NCT01301066|530733626|FG001|Overall Study|Protocol Violation|7|||
147155810|NCT01301066|530733625|FG000|Overall Study|Withdrawal by Subject|4|||
147155811|NCT01301066|530733626|FG001|Overall Study|Withdrawal by Subject|9|||
147155812|NCT01301066|530733625|FG000|Overall Study|Adverse Event|6|||
147155813|NCT01301066|530733626|FG001|Overall Study|Adverse Event|6|||
147155814|NCT01301066|530733625|FG000|Overall Study|Sponsor Decision|2|||
147155815|NCT01301066|530733626|FG001|Overall Study|Sponsor Decision|1|||
147155816|NCT01301066|530733625|FG000|Overall Study|Physician Decision|0|||
147155817|NCT01301066|530733626|FG001|Overall Study|Physician Decision|1|||
147155818|NCT01301066|530733625|FG000|Overall Study|Other|2|||
147155819|NCT01301066|530733626|FG001|Overall Study|Other|0|||
147155820|NCT02979093|530733637|FG000|First Scan Session|Scanning data problems|1|||
147155821|NCT02979093|530733638|FG001|First Scan Session|Scanning data problems|2|||
147155822|NCT02979093|530733639|FG002|First Scan Session|Scanning data problems|2|||
147155823|NCT02979093|530733640|FG003|First Scan Session|Scanning data problems|0|||
147155824|NCT02979093|530733637|FG000|Second Scan Session|Scanning data problems|3|||
147155825|NCT02979093|530733638|FG001|Second Scan Session|Scanning data problems|0|||
147155826|NCT02979093|530733639|FG002|Second Scan Session|Scanning data problems|1|||
147155827|NCT02979093|530733640|FG003|Second Scan Session|Scanning data problems|3|||
147155828|NCT06107803|530733641|FG000|Overall Study|Adverse Event|1|||
147155829|NCT06107803|530733641|FG000|Overall Study|Withdrawal by Subject|2|||
147155830|NCT06107803|530733641|FG000|Overall Study|Protocol Violation|1|||
147155831|NCT05596734|530733642|FG000|Substudy A|Withdrawal by Subject|1|||
147155832|NCT05596734|530733643|FG001|Substudy A|Withdrawal by Subject|0|||
147155833|NCT05596734|530733644|FG002|Substudy A|Withdrawal by Subject|0|||
147155834|NCT05596734|530733645|FG003|Substudy A|Withdrawal by Subject|0|||
147155835|NCT05596734|530733646|FG004|Substudy A|Withdrawal by Subject|0|||
147155836|NCT05596734|530733647|FG005|Substudy A|Withdrawal by Subject|0|||
147155837|NCT05596734|530733648|FG006|Substudy A|Withdrawal by Subject|1|||
147155838|NCT05596734|530733649|FG007|Substudy A|Withdrawal by Subject|0|||
147155839|NCT05596734|530733650|FG008|Substudy A|Withdrawal by Subject|0|||
147155840|NCT05596734|530733651|FG009|Substudy A|Withdrawal by Subject|0|||
147155841|NCT05596734|530733652|FG010|Substudy A|Withdrawal by Subject|0|||
147155842|NCT05596734|530733653|FG011|Substudy A|Withdrawal by Subject|0|||
147155843|NCT05596734|530733654|FG012|Substudy A|Withdrawal by Subject|0|||
147155844|NCT05596734|530733655|FG013|Substudy A|Withdrawal by Subject|0|||
147155845|NCT05596734|530733656|FG014|Substudy A|Withdrawal by Subject|0|||
147155846|NCT05596734|530733657|FG015|Substudy A|Withdrawal by Subject|0|||
147155847|NCT05596734|530733658|FG016|Substudy A|Withdrawal by Subject|0|||
147155848|NCT05596734|530733659|FG017|Substudy A|Withdrawal by Subject|0|||
147155849|NCT05596734|530733660|FG018|Substudy A|Withdrawal by Subject|0|||
147240844|NCT03066804|531053518|FG001|Overall Study|Technical problems|1|||
147240845|NCT00555971|531053520|FG000|Overall Study|Adverse Event|1|||
147155850|NCT05596734|530733661|FG019|Substudy A|Withdrawal by Subject|0|||
147155851|NCT05596734|530733662|FG020|Substudy A|Withdrawal by Subject|0|||
147155852|NCT05596734|530733663|FG021|Substudy A|Withdrawal by Subject|0|||
147155853|NCT05596734|530733664|FG022|Substudy A|Withdrawal by Subject|0|||
147155854|NCT05596734|530733665|FG023|Substudy A|Withdrawal by Subject|0|||
147240846|NCT00555971|531053521|FG001|Overall Study|Adverse Event|1|||
147155855|NCT05596734|530733642|FG000|Substudy A|Lost to Follow-up|1|||
147240847|NCT03982368|531053522|FG000|Overall Study|Adverse Event|6|||
147155856|NCT05596734|530733643|FG001|Substudy A|Lost to Follow-up|0|||
147155857|NCT05596734|530733644|FG002|Substudy A|Lost to Follow-up|1|||
147240848|NCT03982368|531053523|FG001|Overall Study|Adverse Event|4|||
147240849|NCT03982368|531053524|FG002|Overall Study|Adverse Event|3|||
147240850|NCT03982368|531053522|FG000|Overall Study|Lost to Follow-up|2|||
147155858|NCT05596734|530733645|FG003|Substudy A|Lost to Follow-up|0|||
147155859|NCT05596734|530733646|FG004|Substudy A|Lost to Follow-up|0|||
147155860|NCT05596734|530733647|FG005|Substudy A|Lost to Follow-up|0|||
147155861|NCT05596734|530733648|FG006|Substudy A|Lost to Follow-up|0|||
147155862|NCT05596734|530733649|FG007|Substudy A|Lost to Follow-up|0|||
147155863|NCT05596734|530733650|FG008|Substudy A|Lost to Follow-up|0|||
147155864|NCT05596734|530733651|FG009|Substudy A|Lost to Follow-up|0|||
147155865|NCT05596734|530733652|FG010|Substudy A|Lost to Follow-up|0|||
147155866|NCT05596734|530733653|FG011|Substudy A|Lost to Follow-up|0|||
147155867|NCT05596734|530733654|FG012|Substudy A|Lost to Follow-up|0|||
147155868|NCT05596734|530733655|FG013|Substudy A|Lost to Follow-up|0|||
147155869|NCT05596734|530733656|FG014|Substudy A|Lost to Follow-up|0|||
147155870|NCT05596734|530733657|FG015|Substudy A|Lost to Follow-up|0|||
147155871|NCT05596734|530733658|FG016|Substudy A|Lost to Follow-up|0|||
147155872|NCT05596734|530733659|FG017|Substudy A|Lost to Follow-up|0|||
147155873|NCT05596734|530733660|FG018|Substudy A|Lost to Follow-up|0|||
147155874|NCT05596734|530733661|FG019|Substudy A|Lost to Follow-up|0|||
147155875|NCT05596734|530733662|FG020|Substudy A|Lost to Follow-up|0|||
147155876|NCT05596734|530733663|FG021|Substudy A|Lost to Follow-up|0|||
147155877|NCT05596734|530733664|FG022|Substudy A|Lost to Follow-up|0|||
147155878|NCT05596734|530733665|FG023|Substudy A|Lost to Follow-up|0|||
147155879|NCT05596734|530733642|FG000|Substudy B|Withdrawal by Subject|0|||
147155880|NCT05596734|530733643|FG001|Substudy B|Withdrawal by Subject|0|||
147155881|NCT05596734|530733644|FG002|Substudy B|Withdrawal by Subject|0|||
147155882|NCT05596734|530733645|FG003|Substudy B|Withdrawal by Subject|0|||
147155883|NCT05596734|530733646|FG004|Substudy B|Withdrawal by Subject|0|||
147155884|NCT05596734|530733647|FG005|Substudy B|Withdrawal by Subject|0|||
147155885|NCT05596734|530733648|FG006|Substudy B|Withdrawal by Subject|0|||
147155886|NCT05596734|530733649|FG007|Substudy B|Withdrawal by Subject|0|||
147240851|NCT03982368|531053523|FG001|Overall Study|Lost to Follow-up|1|||
147240852|NCT03982368|531053524|FG002|Overall Study|Lost to Follow-up|0|||
147240853|NCT03982368|531053522|FG000|Overall Study|Withdrawal by Subject|1|||
147240854|NCT03982368|531053523|FG001|Overall Study|Withdrawal by Subject|2|||
147240855|NCT03982368|531053524|FG002|Overall Study|Withdrawal by Subject|0|||
147240856|NCT03982368|531053522|FG000|Overall Study|unknow|4|||
147240857|NCT03982368|531053523|FG001|Overall Study|unknow|0|||
147240858|NCT03982368|531053524|FG002|Overall Study|unknow|2|||
147240859|NCT00518284|531053525|FG000|Overall Study|Adverse Event|0|||
147240860|NCT00518284|531053526|FG001|Overall Study|Adverse Event|1|||
147240861|NCT00518284|531053527|FG002|Overall Study|Adverse Event|0|||
147321954|NCT00333138|531341749|FG001|Extension Study (Month6 to End of Study)|Abnormal laboratory value|2|||
147321955|NCT00333138|531341750|FG002|Extension Study (Month6 to End of Study)|Abnormal laboratory value|2|||
147321956|NCT00333138|531341748|FG000|Extension Study (Month6 to End of Study)|Administrative problems|1|||
147321957|NCT00333138|531341749|FG001|Extension Study (Month6 to End of Study)|Administrative problems|1|||
147321958|NCT00333138|531341750|FG002|Extension Study (Month6 to End of Study)|Administrative problems|2|||
147321959|NCT00333138|531341748|FG000|Extension Study (Month6 to End of Study)|Adverse Event|15|||
147321960|NCT00333138|531341749|FG001|Extension Study (Month6 to End of Study)|Adverse Event|19|||
147321961|NCT00333138|531341750|FG002|Extension Study (Month6 to End of Study)|Adverse Event|15|||
147321962|NCT00333138|531341748|FG000|Extension Study (Month6 to End of Study)|Protocol Violation|0|||
147321963|NCT00333138|531341749|FG001|Extension Study (Month6 to End of Study)|Protocol Violation|0|||
147321964|NCT00333138|531341750|FG002|Extension Study (Month6 to End of Study)|Protocol Violation|3|||
147321965|NCT00333138|531341748|FG000|Extension Study (Month6 to End of Study)|Withdrawal by Subject|14|||
147321966|NCT00333138|531341749|FG001|Extension Study (Month6 to End of Study)|Withdrawal by Subject|13|||
147321967|NCT00333138|531341750|FG002|Extension Study (Month6 to End of Study)|Withdrawal by Subject|14|||
147321968|NCT00333138|531341748|FG000|Extension Study (Month6 to End of Study)|Lack of Efficacy|7|||
147321969|NCT00333138|531341749|FG001|Extension Study (Month6 to End of Study)|Lack of Efficacy|4|||
147321970|NCT00333138|531341750|FG002|Extension Study (Month6 to End of Study)|Lack of Efficacy|7|||
147321971|NCT00333138|531341748|FG000|Extension Study (Month6 to End of Study)|Patient no longer required study drug|2|||
147321972|NCT00333138|531341749|FG001|Extension Study (Month6 to End of Study)|Patient no longer required study drug|1|||
147321973|NCT00333138|531341750|FG002|Extension Study (Month6 to End of Study)|Patient no longer required study drug|0|||
147321974|NCT00333138|531341748|FG000|Extension Study (Month6 to End of Study)|Lost to Follow-up|1|||
147321975|NCT00333138|531341749|FG001|Extension Study (Month6 to End of Study)|Lost to Follow-up|1|||
147321976|NCT00333138|531341750|FG002|Extension Study (Month6 to End of Study)|Lost to Follow-up|0|||
147321977|NCT00333138|531341748|FG000|Extension Study (Month6 to End of Study)|Death|0|||
147321978|NCT00333138|531341749|FG001|Extension Study (Month6 to End of Study)|Death|1|||
147321979|NCT00333138|531341750|FG002|Extension Study (Month6 to End of Study)|Death|0|||
147321980|NCT01342887|531341751|FG000|Overall Study|Death|2|||
147155887|NCT05596734|530733650|FG008|Substudy B|Withdrawal by Subject|0|||
147155888|NCT05596734|530733651|FG009|Substudy B|Withdrawal by Subject|0|||
147155889|NCT05596734|530733652|FG010|Substudy B|Withdrawal by Subject|0|||
147155890|NCT05596734|530733653|FG011|Substudy B|Withdrawal by Subject|0|||
147155891|NCT05596734|530733654|FG012|Substudy B|Withdrawal by Subject|1|||
147240862|NCT00518284|531053528|FG003|Overall Study|Adverse Event|0|||
147155892|NCT05596734|530733655|FG013|Substudy B|Withdrawal by Subject|0|||
147155893|NCT05596734|530733656|FG014|Substudy B|Withdrawal by Subject|1|||
147155894|NCT05596734|530733657|FG015|Substudy B|Withdrawal by Subject|2|||
147240863|NCT00518284|531053525|FG000|Overall Study|Study Termination|0|||
147240864|NCT00518284|531053526|FG001|Overall Study|Study Termination|2|||
147240865|NCT00518284|531053527|FG002|Overall Study|Study Termination|1|||
147240866|NCT00518284|531053528|FG003|Overall Study|Study Termination|2|||
147240867|NCT03768414|531053529|FG000|Overall Study|Adverse Event or side effects|72|||
147240868|NCT03768414|531053530|FG001|Overall Study|Adverse Event or side effects|28|||
147240869|NCT03768414|531053529|FG000|Overall Study|Refusal unrelated to adverse event|33|||
147240870|NCT03768414|531053530|FG001|Overall Study|Refusal unrelated to adverse event|33|||
147240871|NCT03768414|531053529|FG000|Overall Study|Progression/relapse|132|||
147240872|NCT03768414|531053530|FG001|Overall Study|Progression/relapse|60|||
147240873|NCT03768414|531053529|FG000|Overall Study|Death|9|||
147155895|NCT05596734|530733658|FG016|Substudy B|Withdrawal by Subject|2|||
147155896|NCT05596734|530733659|FG017|Substudy B|Withdrawal by Subject|1|||
147155897|NCT05596734|530733660|FG018|Substudy B|Withdrawal by Subject|2|||
147155898|NCT05596734|530733661|FG019|Substudy B|Withdrawal by Subject|0|||
147155899|NCT05596734|530733662|FG020|Substudy B|Withdrawal by Subject|0|||
147155900|NCT05596734|530733663|FG021|Substudy B|Withdrawal by Subject|0|||
147155901|NCT05596734|530733664|FG022|Substudy B|Withdrawal by Subject|0|||
147155902|NCT05596734|530733665|FG023|Substudy B|Withdrawal by Subject|1|||
147155903|NCT05596734|530733642|FG000|Substudy B|Physician Decision|0|||
147155904|NCT05596734|530733643|FG001|Substudy B|Physician Decision|0|||
147155905|NCT05596734|530733644|FG002|Substudy B|Physician Decision|0|||
147155906|NCT05596734|530733645|FG003|Substudy B|Physician Decision|0|||
147155907|NCT05596734|530733646|FG004|Substudy B|Physician Decision|0|||
147155908|NCT05596734|530733647|FG005|Substudy B|Physician Decision|0|||
147155909|NCT05596734|530733648|FG006|Substudy B|Physician Decision|0|||
147155910|NCT05596734|530733649|FG007|Substudy B|Physician Decision|0|||
147155911|NCT05596734|530733650|FG008|Substudy B|Physician Decision|0|||
147155912|NCT05596734|530733651|FG009|Substudy B|Physician Decision|0|||
147155913|NCT05596734|530733652|FG010|Substudy B|Physician Decision|0|||
147155914|NCT05596734|530733653|FG011|Substudy B|Physician Decision|0|||
147155915|NCT05596734|530733654|FG012|Substudy B|Physician Decision|0|||
147155916|NCT05596734|530733655|FG013|Substudy B|Physician Decision|0|||
147155917|NCT05596734|530733656|FG014|Substudy B|Physician Decision|0|||
147155918|NCT05596734|530733657|FG015|Substudy B|Physician Decision|1|||
147155919|NCT05596734|530733658|FG016|Substudy B|Physician Decision|0|||
147155920|NCT05596734|530733659|FG017|Substudy B|Physician Decision|0|||
147155921|NCT05596734|530733660|FG018|Substudy B|Physician Decision|0|||
147155922|NCT05596734|530733661|FG019|Substudy B|Physician Decision|0|||
147155923|NCT05596734|530733662|FG020|Substudy B|Physician Decision|0|||
147155924|NCT05596734|530733663|FG021|Substudy B|Physician Decision|0|||
147155925|NCT05596734|530733664|FG022|Substudy B|Physician Decision|0|||
147155926|NCT05596734|530733665|FG023|Substudy B|Physician Decision|0|||
147155927|NCT05596734|530733642|FG000|Substudy B|Lost to Follow-up|0|||
147155928|NCT05596734|530733643|FG001|Substudy B|Lost to Follow-up|0|||
147155929|NCT05596734|530733644|FG002|Substudy B|Lost to Follow-up|0|||
147155930|NCT05596734|530733645|FG003|Substudy B|Lost to Follow-up|0|||
147155931|NCT05596734|530733646|FG004|Substudy B|Lost to Follow-up|0|||
147155932|NCT05596734|530733647|FG005|Substudy B|Lost to Follow-up|0|||
147155933|NCT05596734|530733648|FG006|Substudy B|Lost to Follow-up|0|||
147155934|NCT05596734|530733649|FG007|Substudy B|Lost to Follow-up|0|||
147155935|NCT05596734|530733650|FG008|Substudy B|Lost to Follow-up|0|||
147155936|NCT05596734|530733651|FG009|Substudy B|Lost to Follow-up|0|||
147155937|NCT05596734|530733652|FG010|Substudy B|Lost to Follow-up|0|||
147240874|NCT03768414|531053530|FG001|Overall Study|Death|6|||
147240875|NCT03768414|531053529|FG000|Overall Study|Other - not protocol specified|45|||
147240876|NCT03768414|531053530|FG001|Overall Study|Other - not protocol specified|18|||
147240877|NCT03768414|531053529|FG000|Overall Study|Reason under review|3|||
147240878|NCT03768414|531053530|FG001|Overall Study|Reason under review|2|||
147240879|NCT02571777|531053532|FG000|Overall Study|Subject/guardian decision|34|||
147240880|NCT02571777|531053533|FG001|Overall Study|Subject/guardian decision|26|||
147240881|NCT02571777|531053534|FG002|Overall Study|Subject/guardian decision|26|||
147240882|NCT02571777|531053535|FG003|Overall Study|Subject/guardian decision|25|||
147240883|NCT02571777|531053536|FG004|Overall Study|Subject/guardian decision|27|||
147240884|NCT02571777|531053532|FG000|Overall Study|Protocol Deviation|2|||
147240885|NCT02571777|531053533|FG001|Overall Study|Protocol Deviation|3|||
147240886|NCT02571777|531053534|FG002|Overall Study|Protocol Deviation|4|||
147240887|NCT02571777|531053535|FG003|Overall Study|Protocol Deviation|8|||
147240888|NCT02571777|531053536|FG004|Overall Study|Protocol Deviation|4|||
147155938|NCT05596734|530733653|FG011|Substudy B|Lost to Follow-up|0|||
147155939|NCT05596734|530733654|FG012|Substudy B|Lost to Follow-up|1|||
147155940|NCT05596734|530733655|FG013|Substudy B|Lost to Follow-up|0|||
147155941|NCT05596734|530733656|FG014|Substudy B|Lost to Follow-up|1|||
147155942|NCT05596734|530733657|FG015|Substudy B|Lost to Follow-up|1|||
147155943|NCT05596734|530733658|FG016|Substudy B|Lost to Follow-up|0|||
147155944|NCT05596734|530733659|FG017|Substudy B|Lost to Follow-up|0|||
147155945|NCT05596734|530733660|FG018|Substudy B|Lost to Follow-up|0|||
147155946|NCT05596734|530733661|FG019|Substudy B|Lost to Follow-up|0|||
147155947|NCT05596734|530733662|FG020|Substudy B|Lost to Follow-up|0|||
147155948|NCT05596734|530733663|FG021|Substudy B|Lost to Follow-up|0|||
147155949|NCT05596734|530733664|FG022|Substudy B|Lost to Follow-up|0|||
147155950|NCT05596734|530733665|FG023|Substudy B|Lost to Follow-up|0|||
147155951|NCT03219034|530733668|FG000|Overall Study|Lost to Follow-up|9|||
147155952|NCT03219034|530733669|FG001|Overall Study|Lost to Follow-up|13|||
147155953|NCT03219034|530733668|FG000|Overall Study|Additional dental work needed|1|||
147155954|NCT03219034|530733669|FG001|Overall Study|Additional dental work needed|0|||
147155955|NCT03219034|530733668|FG000|Overall Study|UPPP Surgery|1|||
147155956|NCT03219034|530733669|FG001|Overall Study|UPPP Surgery|0|||
147155957|NCT03219034|530733668|FG000|Overall Study|Dental sensitivity|0|||
147155958|NCT03219034|530733669|FG001|Overall Study|Dental sensitivity|1|||
147155959|NCT03219034|530733668|FG000|Overall Study|Death in family|0|||
147155960|NCT03219034|530733669|FG001|Overall Study|Death in family|1|||
147155961|NCT02136680|530733673|FG000|Overall Study|No Longer Interested|1|||
147155962|NCT02136680|530733674|FG001|Overall Study|No Longer Interested|1|||
147155963|NCT02136680|530733673|FG000|Overall Study|No longer receiving care at clinic|3|||
147155964|NCT02136680|530733674|FG001|Overall Study|No longer receiving care at clinic|5|||
147155965|NCT02136680|530733673|FG000|Overall Study|Moved away|5|||
147155966|NCT02136680|530733674|FG001|Overall Study|Moved away|4|||
147155967|NCT02136680|530733673|FG000|Overall Study|Unable to schedule|17|||
147155968|NCT02136680|530733674|FG001|Overall Study|Unable to schedule|16|||
147155969|NCT02136680|530733673|FG000|Overall Study|Study ended before interview due|6|||
147155970|NCT02136680|530733674|FG001|Overall Study|Study ended before interview due|3|||
147155971|NCT03559517|530733675|FG000|Overall Study|Withdrawal by Subject|1|||
147155972|NCT03559517|530733676|FG001|Overall Study|Withdrawal by Subject|0|||
147155973|NCT03559517|530733677|FG002|Overall Study|Withdrawal by Subject|0|||
147155974|NCT02825420|530733681|FG000|Overall Study|Death|30|||
147155975|NCT02825420|530733682|FG001|Overall Study|Death|12|||
147155976|NCT02825420|530733681|FG000|Overall Study|Progressive disease|6|||
147155977|NCT02825420|530733682|FG001|Overall Study|Progressive disease|1|||
147155978|NCT02825420|530733681|FG000|Overall Study|Lost to Follow-up|2|||
147155979|NCT02825420|530733682|FG001|Overall Study|Lost to Follow-up|2|||
147155980|NCT02825420|530733681|FG000|Overall Study|Withdrawal by Subject|1|||
147155981|NCT02825420|530733682|FG001|Overall Study|Withdrawal by Subject|1|||
147155982|NCT02825420|530733681|FG000|Overall Study|Protocol amendment not signed|1|||
147155983|NCT02825420|530733682|FG001|Overall Study|Protocol amendment not signed|1|||
147155984|NCT02825420|530733681|FG000|Overall Study|Physician Decision|1|||
147155985|NCT02825420|530733682|FG001|Overall Study|Physician Decision|0|||
147155986|NCT02825420|530733681|FG000|Overall Study|Did not receive PLD|2|||
147155987|NCT02825420|530733682|FG001|Overall Study|Did not receive PLD|0|||
147155988|NCT05243745|530735618|FG000|Overall Study|Withdrawal by Subject|0|||
147155989|NCT05243745|530735619|FG001|Overall Study|Withdrawal by Subject|0|||
147155990|NCT05243745|530735620|FG002|Overall Study|Withdrawal by Subject|0|||
147240889|NCT02571777|531053532|FG000|Overall Study|Death|1|||
147240890|NCT02571777|531053533|FG001|Overall Study|Death|1|||
147240891|NCT02571777|531053534|FG002|Overall Study|Death|4|||
147240892|NCT02571777|531053535|FG003|Overall Study|Death|0|||
147240893|NCT02571777|531053536|FG004|Overall Study|Death|0|||
147240894|NCT02571777|531053532|FG000|Overall Study|Lost to Follow-up|1|||
147240895|NCT02571777|531053533|FG001|Overall Study|Lost to Follow-up|1|||
147240896|NCT02571777|531053534|FG002|Overall Study|Lost to Follow-up|2|||
147240897|NCT02571777|531053535|FG003|Overall Study|Lost to Follow-up|0|||
147240898|NCT02571777|531053536|FG004|Overall Study|Lost to Follow-up|1|||
147240899|NCT02571777|531053532|FG000|Overall Study|Physician Decision|1|||
147240900|NCT02571777|531053533|FG001|Overall Study|Physician Decision|7|||
147240901|NCT02571777|531053534|FG002|Overall Study|Physician Decision|5|||
147240902|NCT02571777|531053535|FG003|Overall Study|Physician Decision|2|||
147240903|NCT02571777|531053536|FG004|Overall Study|Physician Decision|4|||
147240904|NCT02571777|531053532|FG000|Overall Study|Pregnancy|0|||
147240905|NCT02571777|531053533|FG001|Overall Study|Pregnancy|0|||
147240906|NCT02571777|531053534|FG002|Overall Study|Pregnancy|0|||
147240907|NCT02571777|531053535|FG003|Overall Study|Pregnancy|2|||
147240908|NCT02571777|531053536|FG004|Overall Study|Pregnancy|0|||
147240909|NCT03706079|531053537|FG000|Predecessor Study|Death|0|||
147240910|NCT03706079|531053538|FG001|Predecessor Study|Death|2|||
147240911|NCT03706079|531053539|FG002|Predecessor Study|Death|0|||
147240912|NCT03706079|531053540|FG003|Predecessor Study|Death|1|||
147240913|NCT03706079|531053541|FG004|Predecessor Study|Death|0|||
147240914|NCT03706079|531053542|FG005|Predecessor Study|Death|0|||
147240915|NCT03706079|531053537|FG000|Predecessor Study|Lost to Follow-up|5|||
147155991|NCT05243745|530735621|FG003|Overall Study|Withdrawal by Subject|1|||
147155992|NCT05243745|530735618|FG000|Overall Study|Unable to Attend Visit 6|0|||
147155993|NCT05243745|530735619|FG001|Overall Study|Unable to Attend Visit 6|0|||
147155994|NCT05243745|530735620|FG002|Overall Study|Unable to Attend Visit 6|1|||
147155995|NCT05243745|530735621|FG003|Overall Study|Unable to Attend Visit 6|0|||
147155996|NCT02998203|530735622|FG000|First Period (40 Days)|Withdrawal by Subject|24|||
147155997|NCT02998203|530735623|FG001|First Period (40 Days)|Withdrawal by Subject|0|||
147155998|NCT02998203|530735622|FG000|Second Period (40 Days)|Withdrawal by Subject|0|||
147240916|NCT03706079|531053538|FG001|Predecessor Study|Lost to Follow-up|2|||
147240917|NCT03706079|531053539|FG002|Predecessor Study|Lost to Follow-up|0|||
147240918|NCT03706079|531053540|FG003|Predecessor Study|Lost to Follow-up|0|||
147155999|NCT02998203|530735623|FG001|Second Period (40 Days)|Withdrawal by Subject|18|||
147156000|NCT04187144|530735634|FG000|Overall Study|Lost to Follow-up|12|||
147156001|NCT04187144|530735635|FG001|Overall Study|Lost to Follow-up|11|||
147156002|NCT04187144|530735634|FG000|Overall Study|Withdrawal by Subject|20|||
147156003|NCT04187144|530735635|FG001|Overall Study|Withdrawal by Subject|18|||
147156004|NCT04187144|530735634|FG000|Overall Study|Adverse Event|19|||
147156005|NCT04187144|530735635|FG001|Overall Study|Adverse Event|4|||
147156006|NCT04187144|530735634|FG000|Overall Study|Physician Decision|5|||
147156007|NCT04187144|530735635|FG001|Overall Study|Physician Decision|3|||
147156008|NCT04187144|530735634|FG000|Overall Study|Screening Failure due to creatinine clearance and body mass index|0|||
147156009|NCT04187144|530735635|FG001|Overall Study|Screening Failure due to creatinine clearance and body mass index|1|||
147156010|NCT04187144|530735634|FG000|Overall Study|Protocol Deviation|1|||
147156011|NCT04187144|530735635|FG001|Overall Study|Protocol Deviation|4|||
147156012|NCT02264665|530735636|FG000|Overall Study|Other|0|||
147156013|NCT02264665|530735637|FG001|Overall Study|Other|0|||
147156014|NCT02264665|530735638|FG002|Overall Study|Other|3|||
147156015|NCT02264665|530735639|FG003|Overall Study|Other|0|||
147156016|NCT02264665|530735640|FG004|Overall Study|Other|0|||
147156017|NCT02264665|530735641|FG005|Overall Study|Other|0|||
147156018|NCT02264665|530735642|FG006|Overall Study|Other|0|||
147156019|NCT02264665|530735636|FG000|Overall Study|Death|9|||
147156020|NCT02264665|530735637|FG001|Overall Study|Death|8|||
147156021|NCT02264665|530735638|FG002|Overall Study|Death|13|||
147156022|NCT02264665|530735639|FG003|Overall Study|Death|5|||
147156023|NCT02264665|530735640|FG004|Overall Study|Death|0|||
147156024|NCT02264665|530735641|FG005|Overall Study|Death|0|||
147156025|NCT02264665|530735642|FG006|Overall Study|Death|1|||
147156026|NCT02264665|530735636|FG000|Overall Study|Lost to Follow-up|1|||
147156027|NCT02264665|530735637|FG001|Overall Study|Lost to Follow-up|0|||
147156028|NCT02264665|530735638|FG002|Overall Study|Lost to Follow-up|2|||
147156029|NCT02264665|530735639|FG003|Overall Study|Lost to Follow-up|1|||
147156030|NCT02264665|530735640|FG004|Overall Study|Lost to Follow-up|0|||
147156031|NCT02264665|530735641|FG005|Overall Study|Lost to Follow-up|0|||
147156032|NCT02264665|530735642|FG006|Overall Study|Lost to Follow-up|0|||
147156033|NCT02264665|530735636|FG000|Overall Study|Participant decision|0|||
147156034|NCT02264665|530735637|FG001|Overall Study|Participant decision|0|||
147156035|NCT02264665|530735638|FG002|Overall Study|Participant decision|0|||
147156036|NCT02264665|530735639|FG003|Overall Study|Participant decision|1|||
147156037|NCT02264665|530735640|FG004|Overall Study|Participant decision|0|||
147156038|NCT02264665|530735641|FG005|Overall Study|Participant decision|0|||
147156039|NCT02264665|530735642|FG006|Overall Study|Participant decision|0|||
147156040|NCT02264665|530735636|FG000|Overall Study|Inclusion/non-inclusion criteria not respected|3|||
147156041|NCT02264665|530735637|FG001|Overall Study|Inclusion/non-inclusion criteria not respected|0|||
147156042|NCT02264665|530735638|FG002|Overall Study|Inclusion/non-inclusion criteria not respected|2|||
147156043|NCT02264665|530735639|FG003|Overall Study|Inclusion/non-inclusion criteria not respected|2|||
147156044|NCT02264665|530735640|FG004|Overall Study|Inclusion/non-inclusion criteria not respected|0|||
147156045|NCT02264665|530735641|FG005|Overall Study|Inclusion/non-inclusion criteria not respected|0|||
147156046|NCT02264665|530735642|FG006|Overall Study|Inclusion/non-inclusion criteria not respected|2|||
147156047|NCT02264665|530735636|FG000|Overall Study|Data Missing|0|||
147156048|NCT02264665|530735637|FG001|Overall Study|Data Missing|0|||
147156049|NCT02264665|530735638|FG002|Overall Study|Data Missing|1|||
147156050|NCT02264665|530735639|FG003|Overall Study|Data Missing|0|||
147156051|NCT02264665|530735640|FG004|Overall Study|Data Missing|0|||
147156052|NCT02264665|530735641|FG005|Overall Study|Data Missing|0|||
147156053|NCT02264665|530735642|FG006|Overall Study|Data Missing|0|||
147156054|NCT00789581|530735643|FG000|AC Therapy|Adverse Event|2|||
147156055|NCT00789581|530735644|FG001|AC Therapy|Adverse Event|3|||
147156056|NCT00789581|530735643|FG000|AC Therapy|Withdrawal by Subject|4|||
147156057|NCT00789581|530735644|FG001|AC Therapy|Withdrawal by Subject|7|||
147156058|NCT00789581|530735643|FG000|AC Therapy|Disease recurrence|3|||
147156059|NCT00789581|530735644|FG001|AC Therapy|Disease recurrence|1|||
147156060|NCT00789581|530735643|FG000|AC Therapy|Intercurrent Illness|1|||
147156061|NCT00789581|530735644|FG001|AC Therapy|Intercurrent Illness|0|||
147156062|NCT00789581|530735643|FG000|AC Therapy|Never Treated|1|||
147156063|NCT00789581|530735644|FG001|AC Therapy|Never Treated|4|||
147240919|NCT03706079|531053541|FG004|Predecessor Study|Lost to Follow-up|1|||
147240920|NCT03706079|531053542|FG005|Predecessor Study|Lost to Follow-up|0|||
147156064|NCT00789581|530735643|FG000|AC Therapy|Other|0|||
147156065|NCT00789581|530735644|FG001|AC Therapy|Other|2|||
147240921|NCT03706079|531053537|FG000|Predecessor Study|Withdrawal by Subject|8|||
147240922|NCT03706079|531053538|FG001|Predecessor Study|Withdrawal by Subject|15|||
147654346|NCT01690299|532556683|FG002|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0|||
147156066|NCT00789581|530735643|FG000|Adjuvant Therapy|Never treated|2|||
147156067|NCT00789581|530735644|FG001|Adjuvant Therapy|Never treated|2|||
147156068|NCT00789581|530735643|FG000|Adjuvant Therapy|Adverse Event|20|||
147156069|NCT00789581|530735644|FG001|Adjuvant Therapy|Adverse Event|44|||
147156070|NCT00789581|530735643|FG000|Adjuvant Therapy|Withdrawal by Subject|14|||
147156071|NCT00789581|530735644|FG001|Adjuvant Therapy|Withdrawal by Subject|5|||
147583940|NCT01190930|532293630|FG001|Induction|Enrollment onto another COG Protocol|0|||
147583941|NCT01190930|532293631|FG002|Induction|Enrollment onto another COG Protocol|0|||
147583942|NCT01190930|532293632|FG003|Induction|Enrollment onto another COG Protocol|0|||
147583943|NCT01190930|532293633|FG004|Induction|Enrollment onto another COG Protocol|0|||
147583944|NCT01190930|532293634|FG005|Induction|Enrollment onto another COG Protocol|0|||
147583945|NCT01190930|532293635|FG006|Induction|Enrollment onto another COG Protocol|0|||
147156072|NCT00789581|530735643|FG000|Adjuvant Therapy|Disease recurrence|2|||
147156073|NCT00789581|530735644|FG001|Adjuvant Therapy|Disease recurrence|1|||
147156074|NCT00789581|530735643|FG000|Adjuvant Therapy|Intercurrent Illness|1|||
147156075|NCT00789581|530735644|FG001|Adjuvant Therapy|Intercurrent Illness|3|||
147156076|NCT00789581|530735643|FG000|Adjuvant Therapy|Protocol Violation|1|||
147156077|NCT00789581|530735644|FG001|Adjuvant Therapy|Protocol Violation|1|||
147156078|NCT00789581|530735643|FG000|Adjuvant Therapy|Other|0|||
147156079|NCT00789581|530735644|FG001|Adjuvant Therapy|Other|1|||
147156080|NCT01468207|530735645|FG000|Treatment Period 1|Adverse Event|1|||
147156081|NCT01468207|530735646|FG001|Treatment Period 1|Adverse Event|0|||
147156082|NCT01468207|530735647|FG002|Treatment Period 1|Adverse Event|0|||
147156083|NCT01468207|530735648|FG003|Treatment Period 1|Adverse Event|0|||
147156084|NCT01468207|530735649|FG004|Treatment Period 1|Adverse Event|0|||
147156085|NCT01468207|530735650|FG005|Treatment Period 1|Adverse Event|0|||
147156086|NCT01468207|530735645|FG000|Treatment Period 1|Protocol Violation|1|||
147156087|NCT01468207|530735646|FG001|Treatment Period 1|Protocol Violation|1|||
147156088|NCT01468207|530735647|FG002|Treatment Period 1|Protocol Violation|0|||
147156089|NCT01468207|530735648|FG003|Treatment Period 1|Protocol Violation|0|||
147156090|NCT01468207|530735649|FG004|Treatment Period 1|Protocol Violation|0|||
147156091|NCT01468207|530735650|FG005|Treatment Period 1|Protocol Violation|0|||
147156092|NCT01468207|530735645|FG000|Treatment Period 1|Withdrawal by Subject|5|||
147156093|NCT01468207|530735646|FG001|Treatment Period 1|Withdrawal by Subject|4|||
147156094|NCT01468207|530735647|FG002|Treatment Period 1|Withdrawal by Subject|0|||
147156095|NCT01468207|530735648|FG003|Treatment Period 1|Withdrawal by Subject|0|||
147156096|NCT01468207|530735649|FG004|Treatment Period 1|Withdrawal by Subject|0|||
147156097|NCT01468207|530735650|FG005|Treatment Period 1|Withdrawal by Subject|0|||
147156098|NCT01468207|530735645|FG000|Treatment Period 1|Lost to Follow-up|2|||
147156099|NCT01468207|530735646|FG001|Treatment Period 1|Lost to Follow-up|1|||
147156100|NCT01468207|530735647|FG002|Treatment Period 1|Lost to Follow-up|0|||
147156101|NCT01468207|530735648|FG003|Treatment Period 1|Lost to Follow-up|0|||
147156102|NCT01468207|530735649|FG004|Treatment Period 1|Lost to Follow-up|0|||
147156103|NCT01468207|530735650|FG005|Treatment Period 1|Lost to Follow-up|0|||
147156104|NCT01468207|530735645|FG000|Treatment Period 1|Other|0|||
147156105|NCT01468207|530735646|FG001|Treatment Period 1|Other|2|||
147156106|NCT01468207|530735647|FG002|Treatment Period 1|Other|0|||
147156107|NCT01468207|530735648|FG003|Treatment Period 1|Other|0|||
147156108|NCT01468207|530735649|FG004|Treatment Period 1|Other|0|||
147156109|NCT01468207|530735650|FG005|Treatment Period 1|Other|0|||
147156110|NCT01468207|530735645|FG000|Treatment Period 2|Adverse Event|0|||
147156111|NCT01468207|530735646|FG001|Treatment Period 2|Adverse Event|0|||
147156112|NCT01468207|530735647|FG002|Treatment Period 2|Adverse Event|6|||
147156113|NCT01468207|530735648|FG003|Treatment Period 2|Adverse Event|1|||
147156114|NCT01468207|530735649|FG004|Treatment Period 2|Adverse Event|2|||
147156115|NCT01468207|530735650|FG005|Treatment Period 2|Adverse Event|1|||
147156116|NCT01468207|530735645|FG000|Treatment Period 2|Lack of Efficacy|0|||
147156117|NCT01468207|530735646|FG001|Treatment Period 2|Lack of Efficacy|0|||
147156118|NCT01468207|530735647|FG002|Treatment Period 2|Lack of Efficacy|1|||
147156119|NCT01468207|530735648|FG003|Treatment Period 2|Lack of Efficacy|1|||
147156120|NCT01468207|530735649|FG004|Treatment Period 2|Lack of Efficacy|0|||
147156121|NCT01468207|530735650|FG005|Treatment Period 2|Lack of Efficacy|2|||
147156122|NCT01468207|530735645|FG000|Treatment Period 2|Withdrawal by Subject|0|||
147156123|NCT01468207|530735646|FG001|Treatment Period 2|Withdrawal by Subject|0|||
147156124|NCT01468207|530735647|FG002|Treatment Period 2|Withdrawal by Subject|5|||
147156125|NCT01468207|530735648|FG003|Treatment Period 2|Withdrawal by Subject|0|||
147156126|NCT01468207|530735649|FG004|Treatment Period 2|Withdrawal by Subject|0|||
147156127|NCT01468207|530735650|FG005|Treatment Period 2|Withdrawal by Subject|2|||
147156128|NCT01468207|530735645|FG000|Treatment Period 2|Loss/abscence of response (per protocol)|0|||
147156129|NCT01468207|530735646|FG001|Treatment Period 2|Loss/abscence of response (per protocol)|0|||
147156130|NCT01468207|530735647|FG002|Treatment Period 2|Loss/abscence of response (per protocol)|30|||
147156131|NCT01468207|530735648|FG003|Treatment Period 2|Loss/abscence of response (per protocol)|23|||
147156132|NCT01468207|530735649|FG004|Treatment Period 2|Loss/abscence of response (per protocol)|18|||
147156133|NCT01468207|530735650|FG005|Treatment Period 2|Loss/abscence of response (per protocol)|13|||
147156134|NCT01468207|530735645|FG000|Treatment Period 2|Lost to Follow-up|0|||
147156135|NCT01468207|530735646|FG001|Treatment Period 2|Lost to Follow-up|0|||
147156136|NCT01468207|530735647|FG002|Treatment Period 2|Lost to Follow-up|5|||
147156137|NCT01468207|530735648|FG003|Treatment Period 2|Lost to Follow-up|1|||
147156138|NCT01468207|530735649|FG004|Treatment Period 2|Lost to Follow-up|0|||
147240923|NCT03706079|531053539|FG002|Predecessor Study|Withdrawal by Subject|0|||
147583946|NCT01190930|532293636|FG007|Induction|Enrollment onto another COG Protocol|0|||
147654347|NCT01690299|532556684|FG003|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0|||
147654348|NCT01690299|532556685|FG004|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|0|||
147156139|NCT01468207|530735650|FG005|Treatment Period 2|Lost to Follow-up|0|||
147156140|NCT01468207|530735645|FG000|Treatment Period 2|Other|0|||
147156141|NCT01468207|530735646|FG001|Treatment Period 2|Other|0|||
147156142|NCT01468207|530735647|FG002|Treatment Period 2|Other|5|||
147156143|NCT01468207|530735648|FG003|Treatment Period 2|Other|1|||
147156144|NCT01468207|530735649|FG004|Treatment Period 2|Other|1|||
147156145|NCT01468207|530735650|FG005|Treatment Period 2|Other|2|||
147156146|NCT04225676|530735657|FG000|Overall Study|Physician Decision|1|||
147156147|NCT04225676|530735657|FG000|Overall Study|Lack of Efficacy|1|||
147156148|NCT04225676|530735657|FG000|Overall Study|Study terminated by sponsor|3|||
147156149|NCT03812185|530735665|FG000|TEE Imaging Before Suctioning|Physician Decision|3|||
147156150|NCT01681069|530735666|FG000|Overall Study|Withdrawal by Subject|4|||
147156151|NCT01681069|530735667|FG001|Overall Study|Withdrawal by Subject|5|||
147156152|NCT01681069|530735666|FG000|Overall Study|Protocol Violation|1|||
147156153|NCT01681069|530735667|FG001|Overall Study|Protocol Violation|1|||
147156154|NCT01681069|530735666|FG000|Overall Study|Adverse Event|0|||
147156155|NCT01681069|530735667|FG001|Overall Study|Adverse Event|1|||
147156156|NCT04085458|530735668|FG000|Overall Study|Other|1|||
147156157|NCT04085458|530735668|FG000|Overall Study|Withdrawal by Subject|2|||
147156158|NCT04085458|530735668|FG000|Overall Study|Adverse Event|2|||
147156159|NCT01921218|530735669|FG000|Overall Study|Death|2|||
147156160|NCT01921218|530735670|FG001|Overall Study|Death|1|||
147156161|NCT01921218|530735669|FG000|Overall Study|Withdrawal by Subject|0|||
147156162|NCT01921218|530735670|FG001|Overall Study|Withdrawal by Subject|2|||
147156163|NCT01921218|530735669|FG000|Overall Study|Kidney transplant|1|||
147156164|NCT01921218|530735670|FG001|Overall Study|Kidney transplant|1|||
147156165|NCT03389555|530735671|FG000|Overall Study|Protocol Violation|1|||
147156166|NCT03389555|530735672|FG001|Overall Study|Protocol Violation|3|||
147156167|NCT03389555|530735671|FG000|Overall Study|Death|1|||
147156168|NCT03389555|530735672|FG001|Overall Study|Death|0|||
147156169|NCT01885208|530735673|FG000|Overall Study|Unclassified|32|||
147156170|NCT01885208|530735674|FG001|Overall Study|Unclassified|38|||
147156171|NCT03224507|530735678|FG000|Overall Study|Death|3|||
147156172|NCT03224507|530735679|FG001|Overall Study|Death|0|||
147156173|NCT03224507|530735678|FG000|Overall Study|Lack of Efficacy|6|||
147156174|NCT03224507|530735679|FG001|Overall Study|Lack of Efficacy|0|||
147156175|NCT03224507|530735678|FG000|Overall Study|Withdrawal by Subject|6|||
147156176|NCT03224507|530735679|FG001|Overall Study|Withdrawal by Subject|0|||
147156177|NCT01032291|530735680|FG000|Safety Lead-in|Adverse Event|1|||
147156178|NCT01032291|530735681|FG001|Safety Lead-in|Adverse Event|0|||
147156179|NCT01032291|530735682|FG002|Safety Lead-in|Adverse Event|0|||
147156180|NCT01032291|530735680|FG000|Safety Lead-in|Death|1|||
147156181|NCT01032291|530735681|FG001|Safety Lead-in|Death|0|||
147156182|NCT01032291|530735682|FG002|Safety Lead-in|Death|0|||
147156183|NCT01032291|530735680|FG000|Proof of Concept|Adverse Event|0|||
147156184|NCT01032291|530735681|FG001|Proof of Concept|Adverse Event|5|||
147156185|NCT01032291|530735682|FG002|Proof of Concept|Adverse Event|1|||
147156186|NCT01032291|530735680|FG000|Proof of Concept|Death|0|||
147156187|NCT01032291|530735681|FG001|Proof of Concept|Death|1|||
147156188|NCT01032291|530735682|FG002|Proof of Concept|Death|2|||
147156189|NCT01032291|530735680|FG000|Proof of Concept|Lack of Efficacy|0|||
147156190|NCT01032291|530735681|FG001|Proof of Concept|Lack of Efficacy|1|||
147156191|NCT01032291|530735682|FG002|Proof of Concept|Lack of Efficacy|0|||
147156192|NCT01032291|530735680|FG000|Proof of Concept|Never Received Study Drug|0|||
147156193|NCT01032291|530735681|FG001|Proof of Concept|Never Received Study Drug|1|||
147156194|NCT01032291|530735682|FG002|Proof of Concept|Never Received Study Drug|0|||
147156195|NCT02449889|530735683|FG000|Overall Study|Adverse Event|1|||
147654349|NCT01690299|532556686|FG005|Apremilast Extension Phase (Weeks16-104)|Protocol Violation|1|||
147654350|NCT01882803|532556687|FG000|Overall Study|Disease Progression|1|||
147156196|NCT02449889|530735684|FG001|Overall Study|Adverse Event|2|||
147156197|NCT02449889|530735685|FG002|Overall Study|Adverse Event|0|||
147156198|NCT02449889|530735683|FG000|Overall Study|Protocol Violation|0|||
147654351|NCT01882803|532556687|FG000|Overall Study|Withdrawal by Subject|9|||
147156199|NCT02449889|530735684|FG001|Overall Study|Protocol Violation|4|||
147156200|NCT02449889|530735685|FG002|Overall Study|Protocol Violation|1|||
147156201|NCT01973387|530735686|FG000|Overall Study|Adverse Event|14|||
147156202|NCT01973387|530735687|FG001|Overall Study|Adverse Event|4|||
147156203|NCT01973387|530735686|FG000|Overall Study|Withdrawal by Subject|7|||
147156204|NCT01973387|530735687|FG001|Overall Study|Withdrawal by Subject|4|||
147156205|NCT01973387|530735686|FG000|Overall Study|Study terminated by sponsor|63|||
147156206|NCT01973387|530735687|FG001|Overall Study|Study terminated by sponsor|0|||
147156207|NCT01973387|530735686|FG000|Overall Study|Progressive disease or relapse|16|||
147654352|NCT01882803|532556687|FG000|Overall Study|Death|68|||
147156208|NCT01973387|530735687|FG001|Overall Study|Progressive disease or relapse|5|||
147156209|NCT01973387|530735686|FG000|Overall Study|Death|4|||
147156210|NCT01973387|530735687|FG001|Overall Study|Death|3|||
147156211|NCT01973387|530735686|FG000|Overall Study|Randomized, not treated|2|||
147156212|NCT01973387|530735687|FG001|Overall Study|Randomized, not treated|2|||
147156213|NCT03327220|530735688|FG000|Overall Study|Adverse Event (AE)/Serious Adverse Event (SAE)|1|||
147156214|NCT03327220|530735689|FG001|Overall Study|Adverse Event (AE)/Serious Adverse Event (SAE)|2|||
147156215|NCT03327220|530735688|FG000|Overall Study|Investigator Decision|2|||
147156216|NCT03327220|530735689|FG001|Overall Study|Investigator Decision|0|||
147156217|NCT03327220|530735688|FG000|Overall Study|Missed Visit 6 (Week 6 Visit)|0|||
147156218|NCT03327220|530735689|FG001|Overall Study|Missed Visit 6 (Week 6 Visit)|1|||
147156219|NCT03327220|530735688|FG000|Overall Study|Fungal infection|1|||
147156220|NCT03327220|530735689|FG001|Overall Study|Fungal infection|0|||
147156221|NCT03327220|530735688|FG000|Overall Study|Discharged to Rehabilitation|0|||
147156222|NCT03327220|530735689|FG001|Overall Study|Discharged to Rehabilitation|1|||
147156223|NCT03327220|530735688|FG000|Overall Study|Missing|1|||
147156224|NCT03327220|530735689|FG001|Overall Study|Missing|0|||
147156225|NCT00693017|530735690|FG000|Overall Study|Sponsor Decision|2|||
147156226|NCT00693017|530735691|FG001|Overall Study|Sponsor Decision|1|||
147156227|NCT00693017|530735690|FG000|Overall Study|Death|0|||
147156228|NCT00693017|530735691|FG001|Overall Study|Death|1|||
147156229|NCT00688324|530735693|FG000|Overall Study|Withdrawal by Subject|2|||
147156230|NCT00688324|530735693|FG000|Overall Study|Physician Decision|5|||
147156231|NCT00688324|530735693|FG000|Overall Study|Lost to Follow-up|1|||
147156232|NCT03176472|530735696|FG000|Double Blind Treatment Period|Withdrawal by Subject|5|||
147156233|NCT03176472|530735697|FG001|Double Blind Treatment Period|Withdrawal by Subject|10|||
147156234|NCT03176472|530735696|FG000|Double Blind Treatment Period|Adverse Event|0|||
147156235|NCT03176472|530735697|FG001|Double Blind Treatment Period|Adverse Event|5|||
147156236|NCT03176472|530735696|FG000|Double Blind Treatment Period|Lost to Follow-up|3|||
147156237|NCT03176472|530735697|FG001|Double Blind Treatment Period|Lost to Follow-up|0|||
147156238|NCT03176472|530735696|FG000|Double Blind Treatment Period|Physician Decision|0|||
147156239|NCT03176472|530735697|FG001|Double Blind Treatment Period|Physician Decision|1|||
147156240|NCT03176472|530735696|FG000|Double Blind Treatment Period|Protocol Violation|1|||
147156241|NCT03176472|530735697|FG001|Double Blind Treatment Period|Protocol Violation|0|||
147156242|NCT03176472|530735696|FG000|Double Blind Treatment Period|Not Provided|1|||
147156243|NCT03176472|530735697|FG001|Double Blind Treatment Period|Not Provided|0|||
147156244|NCT03176472|530735696|FG000|Open Label Extension|Withdrawal by Subject|3|||
147156245|NCT03176472|530735697|FG001|Open Label Extension|Withdrawal by Subject|4|||
147156246|NCT03176472|530735696|FG000|Open Label Extension|Adverse Event|2|||
147156247|NCT03176472|530735697|FG001|Open Label Extension|Adverse Event|4|||
147156248|NCT03176472|530735696|FG000|Open Label Extension|Lost to Follow-up|1|||
147156249|NCT03176472|530735697|FG001|Open Label Extension|Lost to Follow-up|2|||
147156250|NCT03176472|530735696|FG000|Open Label Extension|Protocol Violation|0|||
147156251|NCT03176472|530735697|FG001|Open Label Extension|Protocol Violation|1|||
147156252|NCT03176472|530735696|FG000|Open Label Extension|Not Provided|2|||
147156253|NCT03176472|530735697|FG001|Open Label Extension|Not Provided|1|||
147156254|NCT01972308|530735698|FG000|Overall Study|Withdrawal by Subject|0|||
147156255|NCT01972308|530735699|FG001|Overall Study|Withdrawal by Subject|1|||
147156256|NCT01972308|530735698|FG000|Overall Study|Lost to Follow-up|4|||
147156257|NCT01972308|530735699|FG001|Overall Study|Lost to Follow-up|6|||
147156258|NCT01972308|530735698|FG000|Overall Study|Death|4|||
147156259|NCT01972308|530735699|FG001|Overall Study|Death|1|||
147156260|NCT03272828|530735700|FG000|Overall Study|Lost to Follow-up|7|||
147156261|NCT03272828|530735701|FG001|Overall Study|Lost to Follow-up|7|||
147156262|NCT03272828|530735700|FG000|Overall Study|Withdrawal by Subject|2|||
147156263|NCT03272828|530735701|FG001|Overall Study|Withdrawal by Subject|0|||
147156264|NCT03272828|530735700|FG000|Overall Study|Deceased|1|||
147156265|NCT03272828|530735701|FG001|Overall Study|Deceased|1|||
147156266|NCT03272828|530735700|FG000|Overall Study|Failed implant|1|||
147156267|NCT03272828|530735701|FG001|Overall Study|Failed implant|2|||
147156268|NCT00847665|530735702|FG000|Overall Study|Withdrawal by Subject|1|||
147156269|NCT00847665|530735703|FG001|Overall Study|Withdrawal by Subject|0|||
147156270|NCT01562314|530735704|FG000|Overall Study|Adverse Event|10|||
147156271|NCT01562314|530735705|FG001|Overall Study|Adverse Event|5|||
147156272|NCT01562314|530735704|FG000|Overall Study|Met Withdrawal Criteria|3|||
147156273|NCT01562314|530735705|FG001|Overall Study|Met Withdrawal Criteria|2|||
147156274|NCT01562314|530735704|FG000|Overall Study|Withdrawal by Subject|0|||
147156275|NCT01562314|530735705|FG001|Overall Study|Withdrawal by Subject|1|||
147156276|NCT00585546|530735706|FG000|Clenbuterol Treatment - up to 12 Months|Death|1|||
147156277|NCT00585546|530735706|FG000|Clenbuterol Treatment - up to 12 Months|Adverse Event|3|||
147156278|NCT02851797|530735707|FG000|Overall Study|Withdrawal by Subject|4|||
147156279|NCT02851797|530735708|FG001|Overall Study|Withdrawal by Subject|2|||
147156280|NCT02851797|530735707|FG000|Overall Study|Adverse Event|3|||
147156281|NCT02851797|530735708|FG001|Overall Study|Adverse Event|0|||
147156282|NCT03077438|530735709|FG000|Overall Study|Protocol Violation|3|||
147156283|NCT03077438|530735710|FG001|Overall Study|Protocol Violation|5|||
147156284|NCT03077438|530735709|FG000|Overall Study|Withdrawal by Subject|3|||
147156285|NCT03077438|530735710|FG001|Overall Study|Withdrawal by Subject|6|||
147156286|NCT03077438|530735709|FG000|Overall Study|Lost to Follow-up|6|||
147156287|NCT03077438|530735710|FG001|Overall Study|Lost to Follow-up|3|||
147156288|NCT00813865|530735711|FG000|Overall Study|Failure to Respond|3|||
147156289|NCT00813865|530735711|FG000|Overall Study|Lost to Follow-up|3|||
147156290|NCT00813865|530735711|FG000|Overall Study|Withdrawal by Subject|1|||
147156291|NCT00624585|530735714|FG000|Overall Study|Death|3|||
147156292|NCT00624585|530735714|FG000|Overall Study|Disease Progression|6|||
147156293|NCT00624585|530735714|FG000|Overall Study|Adverse Event|3|||
147156294|NCT02256384|530735715|FG000|Overall Study|Withdrawal by Subject|12|||
147156295|NCT02256384|530735715|FG000|Overall Study|Equipment not capturing data|2|||
147156296|NCT04295681|530735720|FG000|Overall Study|Eligibility error|1|||
147156297|NCT04295681|530735721|FG001|Overall Study|Eligibility error|3|||
147156298|NCT04154345|530735722|FG000|Overall Study|Covid-19 pandemic|4|||
147156299|NCT04686084|530735727|FG000|Overall Study|Lost to Follow-up|1|||
147156300|NCT00676520|530735732|FG000|Overall Study|Withdrawal by Subject|163|||
147156301|NCT00676520|530735732|FG000|Overall Study|Lost to Follow-up|162|||
147156302|NCT00676520|530735732|FG000|Overall Study|Death|159|||
147156303|NCT00676520|530735732|FG000|Overall Study|Physician Decision|20|||
147156304|NCT00676520|530735732|FG000|Overall Study|Ineligible for Randomization to DAPT|209|||
147156305|NCT00676520|530735732|FG000|Overall Study|Other Reason|18|||
147156306|NCT00866047|530735734|FG000|Treatment Period|Progressive disease|13|||
147156307|NCT00866047|530735734|FG000|Treatment Period|Adverse Event|16|||
147156308|NCT00866047|530735734|FG000|Treatment Period|Physician Decision|14|||
147156309|NCT00866047|530735734|FG000|Treatment Period|Withdrawal by Subject|5|||
147156310|NCT00866047|530735734|FG000|Follow-up Period|Lost to Follow-up|5|||
147156311|NCT03773133|530735735|FG000|Overall Study|Screen Failure|8|||
147156312|NCT04659174|530735736|FG000|Overall Study|Sponsor decision to discontinue study|0|||
147156313|NCT04659174|530735737|FG001|Overall Study|Sponsor decision to discontinue study|2|||
147156314|NCT04659174|530735736|FG000|Overall Study|Lost to Follow-up|9|||
147156315|NCT04659174|530735737|FG001|Overall Study|Lost to Follow-up|11|||
147156316|NCT04659174|530735736|FG000|Overall Study|Adverse Event|8|||
147156317|NCT04659174|530735737|FG001|Overall Study|Adverse Event|5|||
147156318|NCT04659174|530735736|FG000|Overall Study|Withdrawal by Subject|17|||
147156319|NCT04659174|530735737|FG001|Overall Study|Withdrawal by Subject|33|||
147156320|NCT04659174|530735736|FG000|Overall Study|Progressive disease|0|||
147156321|NCT04659174|530735737|FG001|Overall Study|Progressive disease|2|||
147156322|NCT04659174|530735736|FG000|Overall Study|Other reasons|0|||
147156323|NCT04659174|530735737|FG001|Overall Study|Other reasons|2|||
147156324|NCT04659174|530735736|FG000|Overall Study|Participant fails to adhere to the protocol requirements|14|||
147156325|NCT04659174|530735737|FG001|Overall Study|Participant fails to adhere to the protocol requirements|9|||
147156326|NCT04659174|530735736|FG000|Overall Study|Alcohol or illegal drug use|0|||
147156327|NCT04659174|530735737|FG001|Overall Study|Alcohol or illegal drug use|3|||
147156328|NCT04659174|530735736|FG000|Overall Study|Violation of entry criteria|1|||
147156329|NCT04659174|530735737|FG001|Overall Study|Violation of entry criteria|0|||
147156330|NCT04659174|530735736|FG000|Overall Study|Death|0|||
147156331|NCT04659174|530735737|FG001|Overall Study|Death|1|||
147156332|NCT03070223|530735738|FG000|Overall Study|Lost to Follow-up|34|||
147156333|NCT03070223|530735739|FG001|Overall Study|Lost to Follow-up|27|||
147156334|NCT03070223|530735738|FG000|Overall Study|Withdrawal by Subject|12|||
147156335|NCT03070223|530735739|FG001|Overall Study|Withdrawal by Subject|22|||
147156336|NCT03070223|530735738|FG000|Overall Study|Protocol Violation|0|||
147156337|NCT03070223|530735739|FG001|Overall Study|Protocol Violation|1|||
147156338|NCT04934800|530735740|FG000|Overall Study|Other|1|||
147156339|NCT04934800|530735740|FG000|Overall Study|Withdrawal by Subject|5|||
147156340|NCT04934800|530735740|FG000|Overall Study|Lack of Efficacy|1|||
147156341|NCT04934800|530735740|FG000|Overall Study|Adverse Event|9|||
147156342|NCT04934800|530735740|FG000|Overall Study|Lost to Follow-up|5|||
147156343|NCT04934800|530735740|FG000|Overall Study|Enrolled but not treated|1|||
147156344|NCT00516906|530735741|FG000|Overall Study|Final Dressing Removal Data not captured|6|||
147156345|NCT00516906|530735742|FG001|Overall Study|Final Dressing Removal Data not captured|2|||
147156346|NCT02684058|530735750|FG000|Treatment Period|Progressive disease|4|||
147156347|NCT02684058|530735751|FG001|Treatment Period|Progressive disease|10|||
147240924|NCT03706079|531053540|FG003|Predecessor Study|Withdrawal by Subject|5|||
147156348|NCT02684058|530735752|FG002|Treatment Period|Progressive disease|19|||
147156349|NCT02684058|530735750|FG000|Treatment Period|Adverse Event|3|||
147156350|NCT02684058|530735751|FG001|Treatment Period|Adverse Event|8|||
147240925|NCT03706079|531053541|FG004|Predecessor Study|Withdrawal by Subject|2|||
147156351|NCT02684058|530735752|FG002|Treatment Period|Adverse Event|1|||
147156352|NCT02684058|530735750|FG000|Treatment Period|Physician Decision|5|||
147156353|NCT02684058|530735751|FG001|Treatment Period|Physician Decision|1|||
147156354|NCT02684058|530735752|FG002|Treatment Period|Physician Decision|2|||
147156355|NCT02684058|530735750|FG000|Treatment Period|New therapy for study indication|1|||
147156356|NCT02684058|530735751|FG001|Treatment Period|New therapy for study indication|0|||
147156357|NCT02684058|530735752|FG002|Treatment Period|New therapy for study indication|0|||
147156358|NCT02684058|530735750|FG000|Treatment Period|Protocol deviation|0|||
147156359|NCT02684058|530735751|FG001|Treatment Period|Protocol deviation|1|||
147156360|NCT02684058|530735752|FG002|Treatment Period|Protocol deviation|0|||
147156361|NCT02684058|530735750|FG000|Treatment Period|Subject/guardian decision|4|||
147156362|NCT02684058|530735751|FG001|Treatment Period|Subject/guardian decision|3|||
147156363|NCT02684058|530735752|FG002|Treatment Period|Subject/guardian decision|0|||
147156364|NCT02684058|530735750|FG000|Treatment Period|Death|0|||
147156365|NCT02684058|530735751|FG001|Treatment Period|Death|0|||
147156366|NCT02684058|530735752|FG002|Treatment Period|Death|2|||
147156367|NCT02684058|530735750|FG000|Post-treatment Efficacy Follow-up|Physician Decision|1|||
147156368|NCT02684058|530735751|FG001|Post-treatment Efficacy Follow-up|Physician Decision|2|||
147156369|NCT02684058|530735752|FG002|Post-treatment Efficacy Follow-up|Physician Decision|0|||
147156370|NCT02684058|530735750|FG000|Post-treatment Efficacy Follow-up|Progressive disease|4|||
147156371|NCT02684058|530735751|FG001|Post-treatment Efficacy Follow-up|Progressive disease|3|||
147156372|NCT02684058|530735752|FG002|Post-treatment Efficacy Follow-up|Progressive disease|0|||
147156373|NCT02684058|530735750|FG000|Post-treatment Efficacy Follow-up|Subject/guardian decision|2|||
147156374|NCT02684058|530735751|FG001|Post-treatment Efficacy Follow-up|Subject/guardian decision|2|||
147156375|NCT02684058|530735752|FG002|Post-treatment Efficacy Follow-up|Subject/guardian decision|0|||
147156376|NCT02684058|530735750|FG000|Post-treatment Efficacy Follow-up|Death|0|||
147156377|NCT02684058|530735751|FG001|Post-treatment Efficacy Follow-up|Death|0|||
147156378|NCT02684058|530735752|FG002|Post-treatment Efficacy Follow-up|Death|3|||
147156379|NCT02684058|530735750|FG000|Post-treatment Efficacy Follow-up|New therapy for study indication|0|||
147156380|NCT02684058|530735751|FG001|Post-treatment Efficacy Follow-up|New therapy for study indication|1|||
147156381|NCT02684058|530735752|FG002|Post-treatment Efficacy Follow-up|New therapy for study indication|0|||
147156382|NCT02684058|530735750|FG000|Post-treatment Survival Follow-up|Death|0|||
147156383|NCT02684058|530735751|FG001|Post-treatment Survival Follow-up|Death|0|||
147156384|NCT02684058|530735752|FG002|Post-treatment Survival Follow-up|Death|7|||
147156385|NCT02684058|530735750|FG000|Post-treatment Survival Follow-up|Lack of Efficacy|1|||
147156386|NCT02684058|530735751|FG001|Post-treatment Survival Follow-up|Lack of Efficacy|0|||
147156387|NCT02684058|530735752|FG002|Post-treatment Survival Follow-up|Lack of Efficacy|0|||
147156388|NCT02684058|530735750|FG000|Crossover Treatment Period|Progressive disease|0|||
147156389|NCT02684058|530735751|FG001|Crossover Treatment Period|Progressive disease|1|||
147156390|NCT02684058|530735752|FG002|Crossover Treatment Period|Progressive disease|0|||
147156391|NCT05032690|530735761|FG000|Period 1|Adverse Event|0|||
147156392|NCT05032690|530735762|FG001|Period 1|Adverse Event|1|||
147156393|NCT05032690|530735763|FG002|Period 1|Adverse Event|0|||
147156394|NCT05032690|530735764|FG003|Period 1|Adverse Event|0|||
147156395|NCT05032690|530735761|FG000|Period 1|Withdrawal by Subject|1|||
147156396|NCT05032690|530735762|FG001|Period 1|Withdrawal by Subject|0|||
147156397|NCT05032690|530735763|FG002|Period 1|Withdrawal by Subject|0|||
147156398|NCT05032690|530735764|FG003|Period 1|Withdrawal by Subject|0|||
147156399|NCT05032690|530735761|FG000|Period 1|No longer meets eligibility criteria|0|||
147156400|NCT05032690|530735762|FG001|Period 1|No longer meets eligibility criteria|1|||
147156401|NCT05032690|530735763|FG002|Period 1|No longer meets eligibility criteria|0|||
147156402|NCT05032690|530735764|FG003|Period 1|No longer meets eligibility criteria|0|||
147156403|NCT05032690|530735761|FG000|Period 2|Adverse Event|1|||
147156404|NCT05032690|530735762|FG001|Period 2|Adverse Event|0|||
147156405|NCT05032690|530735763|FG002|Period 2|Adverse Event|0|||
147156406|NCT05032690|530735764|FG003|Period 2|Adverse Event|0|||
147156407|NCT05032690|530735761|FG000|Period 2|Withdrawal by Subject|0|||
147156408|NCT05032690|530735762|FG001|Period 2|Withdrawal by Subject|1|||
147156409|NCT05032690|530735763|FG002|Period 2|Withdrawal by Subject|0|||
147156410|NCT05032690|530735764|FG003|Period 2|Withdrawal by Subject|0|||
147156411|NCT05032690|530735761|FG000|Period 2|No longer meets eligibility criteria|0|||
147156412|NCT05032690|530735762|FG001|Period 2|No longer meets eligibility criteria|1|||
147156413|NCT05032690|530735763|FG002|Period 2|No longer meets eligibility criteria|0|||
147156414|NCT05032690|530735764|FG003|Period 2|No longer meets eligibility criteria|0|||
147156415|NCT05032690|530735761|FG000|Period 3|Adverse Event|0|||
147156416|NCT05032690|530735762|FG001|Period 3|Adverse Event|1|||
147156417|NCT05032690|530735763|FG002|Period 3|Adverse Event|0|||
147156418|NCT05032690|530735764|FG003|Period 3|Adverse Event|0|||
147156419|NCT05151445|530735765|FG000|Overall Study|Withdrawal by Subject|3|||
147156420|NCT00303446|530737759|FG000|Overall Study|Withdrawal by Subject|2|||
147156421|NCT00303446|530737760|FG001|Overall Study|Withdrawal by Subject|2|||
147156422|NCT00303446|530737759|FG000|Overall Study|Death|0|||
147156423|NCT00303446|530737760|FG001|Overall Study|Death|1|||
147156424|NCT00303446|530737759|FG000|Overall Study|Physician Decision|0|||
147156425|NCT00303446|530737760|FG001|Overall Study|Physician Decision|1|||
147156426|NCT04258995|530737761|FG000|Overall Study|Lost to Follow-up|1|||
147156427|NCT04258995|530737762|FG001|Overall Study|Lost to Follow-up|1|||
147156428|NCT00983515|530737768|FG000|Ritonavir Alone|liver panel out of range|6|||
147156429|NCT00983515|530737768|FG000|Colchicine With Ritonavir|Lost to Follow-up|1|||
147156430|NCT03842969|530737771|FG000|Overall Study|Participant declined follow-up visit|0|||
147156431|NCT03842969|530737772|FG001|Overall Study|Participant declined follow-up visit|1|||
147156432|NCT03842969|530737773|FG002|Overall Study|Participant declined follow-up visit|0|||
147156433|NCT03842969|530737771|FG000|Overall Study|Sponsor's decision|12|||
147156434|NCT03842969|530737772|FG001|Overall Study|Sponsor's decision|99|||
147156435|NCT03842969|530737773|FG002|Overall Study|Sponsor's decision|61|||
147156436|NCT03842969|530737771|FG000|Overall Study|Pregnancy|0|||
147156437|NCT03842969|530737772|FG001|Overall Study|Pregnancy|0|||
147156438|NCT03842969|530737773|FG002|Overall Study|Pregnancy|1|||
147156439|NCT03842969|530737771|FG000|Overall Study|Death|1|||
147156440|NCT03842969|530737772|FG001|Overall Study|Death|0|||
147156441|NCT03842969|530737773|FG002|Overall Study|Death|1|||
147156442|NCT03842969|530737771|FG000|Overall Study|Withdrawal by Subject|3|||
147156443|NCT03842969|530737772|FG001|Overall Study|Withdrawal by Subject|30|||
147156444|NCT03842969|530737773|FG002|Overall Study|Withdrawal by Subject|18|||
147156445|NCT03842969|530737771|FG000|Overall Study|Protocol Violation|1|||
147156446|NCT03842969|530737772|FG001|Overall Study|Protocol Violation|1|||
147156447|NCT03842969|530737773|FG002|Overall Study|Protocol Violation|0|||
147156448|NCT03842969|530737771|FG000|Overall Study|Physician Decision|0|||
147156449|NCT03842969|530737772|FG001|Overall Study|Physician Decision|3|||
147156450|NCT03842969|530737773|FG002|Overall Study|Physician Decision|0|||
147156451|NCT03842969|530737771|FG000|Overall Study|Lost to Follow-up|0|||
147156452|NCT03842969|530737772|FG001|Overall Study|Lost to Follow-up|2|||
147156453|NCT03842969|530737773|FG002|Overall Study|Lost to Follow-up|0|||
147156454|NCT03842969|530737771|FG000|Overall Study|Adverse Event|0|||
147156455|NCT03842969|530737772|FG001|Overall Study|Adverse Event|2|||
147156456|NCT03842969|530737773|FG002|Overall Study|Adverse Event|0|||
147156457|NCT01962987|530737776|FG000|Overall Study|Adverse Event|4|||
147156458|NCT01962987|530737777|FG001|Overall Study|Adverse Event|4|||
147156459|NCT01962987|530737778|FG002|Overall Study|Adverse Event|0|||
147156460|NCT01962987|530737776|FG000|Overall Study|Lost to Follow-up|0|||
147156461|NCT01962987|530737777|FG001|Overall Study|Lost to Follow-up|0|||
147156462|NCT01962987|530737778|FG002|Overall Study|Lost to Follow-up|1|||
147156463|NCT01962987|530737776|FG000|Overall Study|Non compliance with dosing requirements|4|||
147156464|NCT01962987|530737777|FG001|Overall Study|Non compliance with dosing requirements|2|||
147156465|NCT01962987|530737778|FG002|Overall Study|Non compliance with dosing requirements|0|||
147156466|NCT01962987|530737776|FG000|Overall Study|Miscellaneous|1|||
147156467|NCT01962987|530737777|FG001|Overall Study|Miscellaneous|9|||
147156468|NCT01962987|530737778|FG002|Overall Study|Miscellaneous|2|||
147156469|NCT01962987|530737776|FG000|Overall Study|Restricted medication|5|||
147156470|NCT01962987|530737777|FG001|Overall Study|Restricted medication|1|||
147156471|NCT01962987|530737778|FG002|Overall Study|Restricted medication|1|||
147156472|NCT01962987|530737776|FG000|Overall Study|Serious Adverse Event|1|||
147156473|NCT01962987|530737777|FG001|Overall Study|Serious Adverse Event|0|||
147156474|NCT01962987|530737778|FG002|Overall Study|Serious Adverse Event|0|||
147156475|NCT01962987|530737776|FG000|Overall Study|Withdrawal by Subject|11|||
147156476|NCT01962987|530737777|FG001|Overall Study|Withdrawal by Subject|10|||
147156477|NCT01962987|530737778|FG002|Overall Study|Withdrawal by Subject|6|||
147156478|NCT01962987|530737776|FG000|Overall Study|Randomized in Error|4|||
147156479|NCT01962987|530737777|FG001|Overall Study|Randomized in Error|2|||
147156480|NCT01962987|530737778|FG002|Overall Study|Randomized in Error|2|||
147156481|NCT01967823|530737779|FG000|Overall Study|Died prior to completing therapy (before the six-week mark).|1|||
147156482|NCT00413894|530737780|FG000|Overall Study|Withdrawal by Subject|10|||
147156483|NCT00413894|530737780|FG000|Overall Study|Administrative Reasons|1|||
147156484|NCT00413894|530737780|FG000|Overall Study|Hb <10 grams/deciliter|12|||
147156485|NCT00413894|530737780|FG000|Overall Study|Adverse Event|28|||
147156486|NCT00413894|530737780|FG000|Overall Study|Protocol Violation|11|||
147156487|NCT00413894|530737780|FG000|Overall Study|Other|18|||
147156488|NCT01942161|530737781|FG000|Overall Study|Adverse Event|1|||
147156489|NCT01942161|530737782|FG001|Overall Study|Adverse Event|2|||
147156490|NCT01942161|530737783|FG002|Overall Study|Adverse Event|5|||
147156491|NCT01942161|530737781|FG000|Overall Study|Physician Decision|3|||
147156492|NCT01942161|530737782|FG001|Overall Study|Physician Decision|1|||
147156493|NCT01942161|530737783|FG002|Overall Study|Physician Decision|0|||
147156494|NCT01942161|530737781|FG000|Overall Study|Protocol Violation|1|||
147156495|NCT01942161|530737782|FG001|Overall Study|Protocol Violation|0|||
147156496|NCT01942161|530737783|FG002|Overall Study|Protocol Violation|0|||
147156497|NCT01942161|530737781|FG000|Overall Study|Withdrawal by Subject|3|||
147583947|NCT01190930|532293637|FG008|Induction|Enrollment onto another COG Protocol|0|||
147156498|NCT01942161|530737782|FG001|Overall Study|Withdrawal by Subject|3|||
147583948|NCT01190930|532293638|FG009|Induction|Enrollment onto another COG Protocol|0|||
147156499|NCT01942161|530737783|FG002|Overall Study|Withdrawal by Subject|1|||
147156500|NCT05289271|530737784|FG000|Overall Study|Mistakenly allocated, untreated|1|||
147156501|NCT05289271|530737785|FG001|Overall Study|Mistakenly allocated, untreated|0|||
147156502|NCT01257568|530737786|FG000|Overall Study|Lost to Follow-up|2|||
147156503|NCT01257568|530737786|FG000|Overall Study|Withdrawal by Subject|6|||
147156504|NCT01257568|530737786|FG000|Overall Study|Terminated|1|||
147156505|NCT01257568|530737786|FG000|Overall Study|Component Revision|24|||
147156506|NCT00416715|530737788|FG000|Overall Study|Not evaluable for joint aches|7|||
147156507|NCT00416715|530737788|FG000|Overall Study|Vitamin D levels not evaluable|8|||
147156508|NCT00347438|530737789|FG000|Overall Study|Withdrawal by Subject|1|||
147156509|NCT00347438|530737789|FG000|Overall Study|Physician Decision|1|||
147156510|NCT03334851|530737790|FG000|Overall Study|Other|0|||
147156511|NCT03334851|530737791|FG001|Overall Study|Other|0|||
147156512|NCT03334851|530737792|FG002|Overall Study|Other|0|||
147156513|NCT03334851|530737793|FG003|Overall Study|Other|0|||
147156514|NCT03334851|530737794|FG004|Overall Study|Other|0|||
147156515|NCT03334851|530737795|FG005|Overall Study|Other|0|||
147156516|NCT03334851|530737796|FG006|Overall Study|Other|0|||
147156517|NCT03334851|530737797|FG007|Overall Study|Other|1|||
147156518|NCT03334851|530737798|FG008|Overall Study|Other|0|||
147156519|NCT03334851|530737799|FG009|Overall Study|Other|0|||
147156520|NCT03334851|530737800|FG010|Overall Study|Other|0|||
147156521|NCT03334851|530737801|FG011|Overall Study|Other|0|||
147156522|NCT03334851|530737802|FG012|Overall Study|Other|0|||
147156523|NCT03334851|530737790|FG000|Overall Study|Adverse Event|0|||
147156524|NCT03334851|530737791|FG001|Overall Study|Adverse Event|0|||
147156525|NCT03334851|530737792|FG002|Overall Study|Adverse Event|0|||
147156526|NCT03334851|530737793|FG003|Overall Study|Adverse Event|0|||
147156527|NCT03334851|530737794|FG004|Overall Study|Adverse Event|0|||
147156528|NCT03334851|530737795|FG005|Overall Study|Adverse Event|0|||
147156529|NCT03334851|530737796|FG006|Overall Study|Adverse Event|0|||
147156530|NCT03334851|530737797|FG007|Overall Study|Adverse Event|1|||
147156531|NCT03334851|530737798|FG008|Overall Study|Adverse Event|0|||
147156532|NCT03334851|530737799|FG009|Overall Study|Adverse Event|0|||
147156533|NCT03334851|530737800|FG010|Overall Study|Adverse Event|0|||
147156534|NCT03334851|530737801|FG011|Overall Study|Adverse Event|0|||
147156535|NCT03334851|530737802|FG012|Overall Study|Adverse Event|0|||
147156536|NCT03334851|530737790|FG000|Overall Study|Withdrawal by Subject|0|||
147156537|NCT03334851|530737791|FG001|Overall Study|Withdrawal by Subject|0|||
147156538|NCT03334851|530737792|FG002|Overall Study|Withdrawal by Subject|0|||
147156539|NCT03334851|530737793|FG003|Overall Study|Withdrawal by Subject|0|||
147156540|NCT03334851|530737794|FG004|Overall Study|Withdrawal by Subject|0|||
147156541|NCT03334851|530737795|FG005|Overall Study|Withdrawal by Subject|0|||
147156542|NCT03334851|530737796|FG006|Overall Study|Withdrawal by Subject|0|||
147156543|NCT03334851|530737797|FG007|Overall Study|Withdrawal by Subject|0|||
147156544|NCT03334851|530737798|FG008|Overall Study|Withdrawal by Subject|0|||
147156545|NCT03334851|530737799|FG009|Overall Study|Withdrawal by Subject|0|||
147156546|NCT03334851|530737800|FG010|Overall Study|Withdrawal by Subject|1|||
147156547|NCT03334851|530737801|FG011|Overall Study|Withdrawal by Subject|0|||
147156548|NCT03334851|530737802|FG012|Overall Study|Withdrawal by Subject|1|||
147156549|NCT03334851|530737790|FG000|Overall Study|Lost to Follow-up|0|||
147156550|NCT03334851|530737791|FG001|Overall Study|Lost to Follow-up|0|||
147156551|NCT03334851|530737792|FG002|Overall Study|Lost to Follow-up|0|||
147156552|NCT03334851|530737793|FG003|Overall Study|Lost to Follow-up|0|||
147156553|NCT03334851|530737794|FG004|Overall Study|Lost to Follow-up|0|||
147156554|NCT03334851|530737795|FG005|Overall Study|Lost to Follow-up|0|||
147156555|NCT03334851|530737796|FG006|Overall Study|Lost to Follow-up|0|||
147156556|NCT03334851|530737797|FG007|Overall Study|Lost to Follow-up|0|||
147156557|NCT03334851|530737798|FG008|Overall Study|Lost to Follow-up|0|||
147156558|NCT03334851|530737799|FG009|Overall Study|Lost to Follow-up|0|||
147156559|NCT03334851|530737800|FG010|Overall Study|Lost to Follow-up|2|||
147156560|NCT03334851|530737801|FG011|Overall Study|Lost to Follow-up|1|||
147156561|NCT03334851|530737802|FG012|Overall Study|Lost to Follow-up|0|||
147156562|NCT00666588|530737803|FG000|Overall Study|ineligible|2|||
147156563|NCT00666588|530737804|FG001|Overall Study|ineligible|0|||
147156564|NCT00666588|530737805|FG002|Overall Study|ineligible|0|||
147156565|NCT00666588|530737806|FG003|Overall Study|ineligible|2|||
147156566|NCT00666588|530737803|FG000|Overall Study|inevaluable|2|||
147156567|NCT00666588|530737804|FG001|Overall Study|inevaluable|0|||
147156568|NCT00666588|530737805|FG002|Overall Study|inevaluable|0|||
147156569|NCT00666588|530737806|FG003|Overall Study|inevaluable|0|||
147156570|NCT04043234|530737809|FG000|Overall Study|Lost to Follow-up|1|||
147156571|NCT04043234|530737809|FG000|Overall Study|Withdrawal by Subject|1|||
147156572|NCT03622112|530737813|FG000|Overall Study|Withdrawal by Subject|6|||
147156573|NCT03622112|530737814|FG001|Overall Study|Withdrawal by Subject|2|||
147156574|NCT03622112|530737815|FG002|Overall Study|Withdrawal by Subject|4|||
147156575|NCT03622112|530737816|FG003|Overall Study|Withdrawal by Subject|2|||
147156576|NCT03622112|530737817|FG004|Overall Study|Withdrawal by Subject|1|||
147156577|NCT03622112|530737818|FG005|Overall Study|Withdrawal by Subject|2|||
147156578|NCT03622112|530737819|FG006|Overall Study|Withdrawal by Subject|2|||
147156579|NCT03622112|530737813|FG000|Overall Study|Death|0|||
147156580|NCT03622112|530737814|FG001|Overall Study|Death|0|||
147156581|NCT03622112|530737815|FG002|Overall Study|Death|0|||
147156582|NCT03622112|530737816|FG003|Overall Study|Death|1|||
147156583|NCT03622112|530737817|FG004|Overall Study|Death|0|||
147156584|NCT03622112|530737818|FG005|Overall Study|Death|0|||
147156585|NCT03622112|530737819|FG006|Overall Study|Death|0|||
147156586|NCT03622112|530737813|FG000|Overall Study|Lost to Follow-up|1|||
147156587|NCT03622112|530737814|FG001|Overall Study|Lost to Follow-up|1|||
147156588|NCT03622112|530737815|FG002|Overall Study|Lost to Follow-up|0|||
147156589|NCT03622112|530737816|FG003|Overall Study|Lost to Follow-up|0|||
147156590|NCT03622112|530737817|FG004|Overall Study|Lost to Follow-up|0|||
147156591|NCT03622112|530737818|FG005|Overall Study|Lost to Follow-up|0|||
147156592|NCT03622112|530737819|FG006|Overall Study|Lost to Follow-up|0|||
147156593|NCT03622112|530737813|FG000|Overall Study|Study-specific withdrawal criteria|10|||
147156594|NCT03622112|530737814|FG001|Overall Study|Study-specific withdrawal criteria|8|||
147321981|NCT04880161|531341753|FG000|Overall Study|Withdrawal by Subject|1|||
147321982|NCT04880161|531341754|FG001|Overall Study|Withdrawal by Subject|0|||
147583949|NCT01190930|532293629|FG000|Induction|Average Risk|1847|||
147583950|NCT01190930|532293630|FG001|Induction|Average Risk|0|||
147583951|NCT01190930|532293631|FG002|Induction|Average Risk|0|||
147583952|NCT01190930|532293632|FG003|Induction|Average Risk|0|||
147583953|NCT01190930|532293633|FG004|Induction|Average Risk|0|||
147583954|NCT01190930|532293634|FG005|Induction|Average Risk|0|||
147156595|NCT03622112|530737815|FG002|Overall Study|Study-specific withdrawal criteria|7|||
147156596|NCT03622112|530737816|FG003|Overall Study|Study-specific withdrawal criteria|6|||
147156597|NCT03622112|530737817|FG004|Overall Study|Study-specific withdrawal criteria|4|||
147156598|NCT03622112|530737818|FG005|Overall Study|Study-specific withdrawal criteria|18|||
147156599|NCT03622112|530737819|FG006|Overall Study|Study-specific withdrawal criteria|4|||
147156600|NCT03622112|530737813|FG000|Overall Study|Protocol Violation|2|||
147156601|NCT03622112|530737814|FG001|Overall Study|Protocol Violation|0|||
147156602|NCT03622112|530737815|FG002|Overall Study|Protocol Violation|1|||
147156603|NCT03622112|530737816|FG003|Overall Study|Protocol Violation|1|||
147156604|NCT03622112|530737817|FG004|Overall Study|Protocol Violation|0|||
147156605|NCT03622112|530737818|FG005|Overall Study|Protocol Violation|0|||
147156606|NCT03622112|530737819|FG006|Overall Study|Protocol Violation|0|||
147156607|NCT03622112|530737813|FG000|Overall Study|Adverse Event|6|||
147156608|NCT03622112|530737814|FG001|Overall Study|Adverse Event|8|||
147156609|NCT03622112|530737815|FG002|Overall Study|Adverse Event|4|||
147156610|NCT03622112|530737816|FG003|Overall Study|Adverse Event|11|||
147156611|NCT03622112|530737817|FG004|Overall Study|Adverse Event|4|||
147156612|NCT03622112|530737818|FG005|Overall Study|Adverse Event|20|||
147156613|NCT03622112|530737819|FG006|Overall Study|Adverse Event|2|||
147156614|NCT03622112|530737813|FG000|Overall Study|Reason not specified|0|||
147156615|NCT03622112|530737814|FG001|Overall Study|Reason not specified|1|||
147156616|NCT03622112|530737815|FG002|Overall Study|Reason not specified|0|||
147156617|NCT03622112|530737816|FG003|Overall Study|Reason not specified|1|||
147156618|NCT03622112|530737817|FG004|Overall Study|Reason not specified|1|||
147156619|NCT03622112|530737818|FG005|Overall Study|Reason not specified|2|||
147156620|NCT03622112|530737819|FG006|Overall Study|Reason not specified|1|||
147156621|NCT01165320|530737820|FG000|Overall Study|Clinical adverse experience|2|||
147156622|NCT01165320|530737821|FG001|Overall Study|Clinical adverse experience|1|||
147156623|NCT01165320|530737822|FG002|Overall Study|Clinical adverse experience|0|||
147156624|NCT01165320|530737820|FG000|Overall Study|Laboratory adverse experience|1|||
147156625|NCT01165320|530737821|FG001|Overall Study|Laboratory adverse experience|0|||
147156626|NCT01165320|530737822|FG002|Overall Study|Laboratory adverse experience|0|||
147156627|NCT01165320|530737820|FG000|Overall Study|Lack of Efficacy|0|||
147156628|NCT01165320|530737821|FG001|Overall Study|Lack of Efficacy|2|||
147156629|NCT01165320|530737822|FG002|Overall Study|Lack of Efficacy|0|||
147156630|NCT01165320|530737820|FG000|Overall Study|Reason unknown|0|||
147156631|NCT01165320|530737821|FG001|Overall Study|Reason unknown|1|||
147156632|NCT01165320|530737822|FG002|Overall Study|Reason unknown|0|||
147156633|NCT00385944|530737823|FG000|1st Maintenance Dose Period|Physician Decision|1|||
147156634|NCT00385944|530737824|FG001|1st Maintenance Dose Period|Physician Decision|0|||
147156635|NCT00385944|530737825|FG002|1st Maintenance Dose Period|Physician Decision|0|||
147156636|NCT00385944|530737823|FG000|1st Maintenance Dose Period|Entry Criteria Exclusion|0|||
147156637|NCT00385944|530737824|FG001|1st Maintenance Dose Period|Entry Criteria Exclusion|1|||
147156638|NCT00385944|530737825|FG002|1st Maintenance Dose Period|Entry Criteria Exclusion|0|||
147156639|NCT00385944|530737823|FG000|1st Maintenance Dose Period|Invalid Pharmacodynamic Data|3|||
147156640|NCT00385944|530737824|FG001|1st Maintenance Dose Period|Invalid Pharmacodynamic Data|0|||
147156641|NCT00385944|530737825|FG002|1st Maintenance Dose Period|Invalid Pharmacodynamic Data|0|||
147156642|NCT00385944|530737823|FG000|2nd Maintenance Dose Period|Invalid PD Data|2|||
147156643|NCT00385944|530737824|FG001|2nd Maintenance Dose Period|Invalid PD Data|3|||
147156644|NCT00385944|530737825|FG002|2nd Maintenance Dose Period|Invalid PD Data|0|||
147156645|NCT01155466|530737826|FG000|Overall Study|Adverse Event|13|||
147156646|NCT01155466|530737827|FG001|Overall Study|Adverse Event|15|||
147156647|NCT01155466|530737828|FG002|Overall Study|Adverse Event|6|||
147156648|NCT01155466|530737829|FG003|Overall Study|Adverse Event|17|||
147156649|NCT01155466|530737830|FG004|Overall Study|Adverse Event|18|||
147156650|NCT01155466|530737826|FG000|Overall Study|Lost to Follow-up|0|||
147156651|NCT01155466|530737827|FG001|Overall Study|Lost to Follow-up|0|||
147156652|NCT01155466|530737828|FG002|Overall Study|Lost to Follow-up|0|||
147156653|NCT01155466|530737829|FG003|Overall Study|Lost to Follow-up|0|||
147156654|NCT01155466|530737830|FG004|Overall Study|Lost to Follow-up|2|||
147156655|NCT01155466|530737826|FG000|Overall Study|Withdrawal by Subject|7|||
147156656|NCT01155466|530737827|FG001|Overall Study|Withdrawal by Subject|5|||
147156657|NCT01155466|530737828|FG002|Overall Study|Withdrawal by Subject|9|||
147156658|NCT01155466|530737829|FG003|Overall Study|Withdrawal by Subject|4|||
147156659|NCT01155466|530737830|FG004|Overall Study|Withdrawal by Subject|4|||
147156660|NCT01155466|530737826|FG000|Overall Study|Protocol Violation|0|||
147156661|NCT01155466|530737827|FG001|Overall Study|Protocol Violation|0|||
147583955|NCT01190930|532293635|FG006|Induction|Average Risk|0|||
147583956|NCT01190930|532293636|FG007|Induction|Average Risk|0|||
147156662|NCT01155466|530737828|FG002|Overall Study|Protocol Violation|2|||
147156663|NCT01155466|530737829|FG003|Overall Study|Protocol Violation|0|||
147156664|NCT01155466|530737830|FG004|Overall Study|Protocol Violation|1|||
147156665|NCT01155466|530737826|FG000|Overall Study|Administrative|0|||
147156666|NCT01155466|530737827|FG001|Overall Study|Administrative|3|||
147156667|NCT01155466|530737828|FG002|Overall Study|Administrative|0|||
147156668|NCT01155466|530737829|FG003|Overall Study|Administrative|0|||
147156669|NCT01155466|530737830|FG004|Overall Study|Administrative|0|||
147156670|NCT01155466|530737826|FG000|Overall Study|Randomized not treated|2|||
147156671|NCT01155466|530737827|FG001|Overall Study|Randomized not treated|2|||
147156672|NCT01155466|530737828|FG002|Overall Study|Randomized not treated|3|||
147156673|NCT01155466|530737829|FG003|Overall Study|Randomized not treated|0|||
147156674|NCT01155466|530737830|FG004|Overall Study|Randomized not treated|2|||
147156675|NCT02075047|530737831|FG000|Treatment Phase (4 Weeks)|Adverse Event|14|||
147156676|NCT02075047|530737832|FG001|Treatment Phase (4 Weeks)|Adverse Event|4|||
147156677|NCT02075047|530737831|FG000|Treatment Phase (4 Weeks)|Lack of Efficacy|2|||
147156678|NCT02075047|530737832|FG001|Treatment Phase (4 Weeks)|Lack of Efficacy|2|||
147156679|NCT02075047|530737831|FG000|Treatment Phase (4 Weeks)|Lost to Follow-up|0|||
147156680|NCT02075047|530737832|FG001|Treatment Phase (4 Weeks)|Lost to Follow-up|1|||
147156681|NCT02075047|530737831|FG000|Treatment Phase (4 Weeks)|Medication Error Without Associated Adverse Event|1|||
147156682|NCT02075047|530737832|FG001|Treatment Phase (4 Weeks)|Medication Error Without Associated Adverse Event|0|||
147156683|NCT02075047|530737831|FG000|Treatment Phase (4 Weeks)|Screen Failure|1|||
147156684|NCT02075047|530737832|FG001|Treatment Phase (4 Weeks)|Screen Failure|0|||
147156685|NCT02075047|530737831|FG000|Treatment Phase (4 Weeks)|Other|1|||
147156686|NCT02075047|530737832|FG001|Treatment Phase (4 Weeks)|Other|1|||
147156687|NCT02075047|530737831|FG000|Treatment Phase (4 Weeks)|Withdrawal By Parent/Guardian|4|||
147156688|NCT02075047|530737832|FG001|Treatment Phase (4 Weeks)|Withdrawal By Parent/Guardian|2|||
147156689|NCT02075047|530737831|FG000|Follow up Phase (5 Weeks)|Adverse Event|14|||
147156690|NCT02075047|530737832|FG001|Follow up Phase (5 Weeks)|Adverse Event|4|||
147156691|NCT02075047|530737831|FG000|Follow up Phase (5 Weeks)|Lack of Efficacy|2|||
147156692|NCT02075047|530737832|FG001|Follow up Phase (5 Weeks)|Lack of Efficacy|2|||
147156693|NCT02075047|530737831|FG000|Follow up Phase (5 Weeks)|Lost to Follow-up|0|||
147156694|NCT02075047|530737832|FG001|Follow up Phase (5 Weeks)|Lost to Follow-up|1|||
147156695|NCT02075047|530737831|FG000|Follow up Phase (5 Weeks)|Medication Error Without Associated Adverse Event|1|||
147156696|NCT02075047|530737832|FG001|Follow up Phase (5 Weeks)|Medication Error Without Associated Adverse Event|0|||
147156697|NCT02075047|530737831|FG000|Follow up Phase (5 Weeks)|Screen Failure|1|||
147156698|NCT02075047|530737832|FG001|Follow up Phase (5 Weeks)|Screen Failure|0|||
147156699|NCT02075047|530737831|FG000|Follow up Phase (5 Weeks)|Other|1|||
147156700|NCT02075047|530737832|FG001|Follow up Phase (5 Weeks)|Other|2|||
147156701|NCT02075047|530737831|FG000|Follow up Phase (5 Weeks)|Withdrawal By Parent/Guardian|7|||
147156702|NCT02075047|530737832|FG001|Follow up Phase (5 Weeks)|Withdrawal By Parent/Guardian|4|||
147156703|NCT00590824|530737833|FG000|Overall Study|Disease could not be resected|0|||
147156704|NCT00590824|530737834|FG001|Overall Study|Disease could not be resected|2|||
147156705|NCT00590824|530737835|FG002|Overall Study|Disease could not be resected|1|||
147156706|NCT00590824|530737836|FG003|Overall Study|Disease could not be resected|0|||
147156707|NCT00590824|530737833|FG000|Overall Study|Adverse Event|0|||
147156708|NCT00590824|530737834|FG001|Overall Study|Adverse Event|0|||
147156709|NCT00590824|530737835|FG002|Overall Study|Adverse Event|0|||
147156710|NCT00590824|530737836|FG003|Overall Study|Adverse Event|1|||
147156711|NCT01778049|530737844|FG000|Open Label Treatment Period|Adverse Event|5|||
147156712|NCT01778049|530737845|FG001|Open Label Treatment Period|Adverse Event|15|||
147156713|NCT01778049|530737846|FG002|Open Label Treatment Period|Adverse Event|0|||
147156714|NCT01778049|530737847|FG003|Open Label Treatment Period|Adverse Event|0|||
147156715|NCT01778049|530737848|FG004|Open Label Treatment Period|Adverse Event|0|||
147156716|NCT01778049|530737849|FG005|Open Label Treatment Period|Adverse Event|0|||
147156717|NCT01778049|530737844|FG000|Open Label Treatment Period|Lack of Efficacy|1|||
147156718|NCT01778049|530737845|FG001|Open Label Treatment Period|Lack of Efficacy|1|||
147156719|NCT01778049|530737846|FG002|Open Label Treatment Period|Lack of Efficacy|0|||
147156720|NCT01778049|530737847|FG003|Open Label Treatment Period|Lack of Efficacy|0|||
147156721|NCT01778049|530737848|FG004|Open Label Treatment Period|Lack of Efficacy|0|||
147156722|NCT01778049|530737849|FG005|Open Label Treatment Period|Lack of Efficacy|0|||
147156723|NCT01778049|530737844|FG000|Open Label Treatment Period|Protocol Violation|5|||
147156724|NCT01778049|530737845|FG001|Open Label Treatment Period|Protocol Violation|5|||
147156725|NCT01778049|530737846|FG002|Open Label Treatment Period|Protocol Violation|0|||
147156726|NCT01778049|530737847|FG003|Open Label Treatment Period|Protocol Violation|0|||
147156727|NCT01778049|530737848|FG004|Open Label Treatment Period|Protocol Violation|0|||
147156728|NCT01778049|530737849|FG005|Open Label Treatment Period|Protocol Violation|0|||
147321983|NCT04880161|531341753|FG000|Overall Study|Lack of Compliance|1|||
147156729|NCT01778049|530737844|FG000|Open Label Treatment Period|Lost to Follow-up|4|||
147156730|NCT01778049|530737845|FG001|Open Label Treatment Period|Lost to Follow-up|3|||
147156731|NCT01778049|530737846|FG002|Open Label Treatment Period|Lost to Follow-up|0|||
147156732|NCT01778049|530737847|FG003|Open Label Treatment Period|Lost to Follow-up|0|||
147156733|NCT01778049|530737848|FG004|Open Label Treatment Period|Lost to Follow-up|0|||
147156734|NCT01778049|530737849|FG005|Open Label Treatment Period|Lost to Follow-up|0|||
147156735|NCT01778049|530737844|FG000|Open Label Treatment Period|Withdrawal by Subject|4|||
147156736|NCT01778049|530737845|FG001|Open Label Treatment Period|Withdrawal by Subject|10|||
147156737|NCT01778049|530737846|FG002|Open Label Treatment Period|Withdrawal by Subject|0|||
147156738|NCT01778049|530737847|FG003|Open Label Treatment Period|Withdrawal by Subject|0|||
147156739|NCT01778049|530737848|FG004|Open Label Treatment Period|Withdrawal by Subject|0|||
147156740|NCT01778049|530737849|FG005|Open Label Treatment Period|Withdrawal by Subject|0|||
147156741|NCT01778049|530737844|FG000|Open Label Treatment Period|Not treated|2|||
147156742|NCT01778049|530737845|FG001|Open Label Treatment Period|Not treated|1|||
147156743|NCT01778049|530737846|FG002|Open Label Treatment Period|Not treated|0|||
147156744|NCT01778049|530737847|FG003|Open Label Treatment Period|Not treated|0|||
147156745|NCT01778049|530737848|FG004|Open Label Treatment Period|Not treated|0|||
147156746|NCT01778049|530737849|FG005|Open Label Treatment Period|Not treated|0|||
147156747|NCT01778049|530737844|FG000|Open Label Treatment Period|Other reason not defined above|77|||
147156748|NCT01778049|530737845|FG001|Open Label Treatment Period|Other reason not defined above|94|||
147156749|NCT01778049|530737846|FG002|Open Label Treatment Period|Other reason not defined above|0|||
147156750|NCT01778049|530737847|FG003|Open Label Treatment Period|Other reason not defined above|0|||
147156751|NCT01778049|530737848|FG004|Open Label Treatment Period|Other reason not defined above|0|||
147156752|NCT01778049|530737849|FG005|Open Label Treatment Period|Other reason not defined above|0|||
147156753|NCT01778049|530737844|FG000|Double Blind Treatment Period|Adverse Event|0|||
147156754|NCT01778049|530737845|FG001|Double Blind Treatment Period|Adverse Event|0|||
147156755|NCT01778049|530737846|FG002|Double Blind Treatment Period|Adverse Event|4|||
147156756|NCT01778049|530737847|FG003|Double Blind Treatment Period|Adverse Event|5|||
147156757|NCT01778049|530737848|FG004|Double Blind Treatment Period|Adverse Event|3|||
147156758|NCT01778049|530737849|FG005|Double Blind Treatment Period|Adverse Event|2|||
147156759|NCT01778049|530737844|FG000|Double Blind Treatment Period|Lack of Efficacy|0|||
147156760|NCT01778049|530737845|FG001|Double Blind Treatment Period|Lack of Efficacy|0|||
147156761|NCT01778049|530737846|FG002|Double Blind Treatment Period|Lack of Efficacy|0|||
147156762|NCT01778049|530737847|FG003|Double Blind Treatment Period|Lack of Efficacy|0|||
147156763|NCT01778049|530737848|FG004|Double Blind Treatment Period|Lack of Efficacy|0|||
147156764|NCT01778049|530737849|FG005|Double Blind Treatment Period|Lack of Efficacy|1|||
147156765|NCT01778049|530737844|FG000|Double Blind Treatment Period|Protocol Violation|0|||
147156766|NCT01778049|530737845|FG001|Double Blind Treatment Period|Protocol Violation|0|||
147156767|NCT01778049|530737846|FG002|Double Blind Treatment Period|Protocol Violation|2|||
147156768|NCT01778049|530737847|FG003|Double Blind Treatment Period|Protocol Violation|0|||
147156769|NCT01778049|530737848|FG004|Double Blind Treatment Period|Protocol Violation|0|||
147156770|NCT01778049|530737849|FG005|Double Blind Treatment Period|Protocol Violation|0|||
147156771|NCT01778049|530737844|FG000|Double Blind Treatment Period|Lost to Follow-up|0|||
147156772|NCT01778049|530737845|FG001|Double Blind Treatment Period|Lost to Follow-up|0|||
147156773|NCT01778049|530737846|FG002|Double Blind Treatment Period|Lost to Follow-up|4|||
147156774|NCT01778049|530737847|FG003|Double Blind Treatment Period|Lost to Follow-up|1|||
147156775|NCT01778049|530737848|FG004|Double Blind Treatment Period|Lost to Follow-up|5|||
147156776|NCT01778049|530737849|FG005|Double Blind Treatment Period|Lost to Follow-up|2|||
147156777|NCT01778049|530737844|FG000|Double Blind Treatment Period|Withdrawal by Subject|0|||
147156778|NCT01778049|530737845|FG001|Double Blind Treatment Period|Withdrawal by Subject|0|||
147156779|NCT01778049|530737846|FG002|Double Blind Treatment Period|Withdrawal by Subject|1|||
147156780|NCT01778049|530737847|FG003|Double Blind Treatment Period|Withdrawal by Subject|2|||
147156781|NCT01778049|530737848|FG004|Double Blind Treatment Period|Withdrawal by Subject|0|||
147156782|NCT01778049|530737849|FG005|Double Blind Treatment Period|Withdrawal by Subject|1|||
147156783|NCT01778049|530737844|FG000|Double Blind Treatment Period|Not treated|0|||
147156784|NCT01778049|530737845|FG001|Double Blind Treatment Period|Not treated|0|||
147156785|NCT01778049|530737846|FG002|Double Blind Treatment Period|Not treated|0|||
147156786|NCT01778049|530737847|FG003|Double Blind Treatment Period|Not treated|2|||
147156787|NCT01778049|530737848|FG004|Double Blind Treatment Period|Not treated|2|||
147156788|NCT01778049|530737849|FG005|Double Blind Treatment Period|Not treated|0|||
147156789|NCT01778049|530737844|FG000|Double Blind Treatment Period|Other reason not defined above|0|||
147156790|NCT01778049|530737845|FG001|Double Blind Treatment Period|Other reason not defined above|0|||
147156791|NCT01778049|530737846|FG002|Double Blind Treatment Period|Other reason not defined above|4|||
147156792|NCT01778049|530737847|FG003|Double Blind Treatment Period|Other reason not defined above|2|||
147156793|NCT01778049|530737848|FG004|Double Blind Treatment Period|Other reason not defined above|2|||
147156794|NCT01778049|530737849|FG005|Double Blind Treatment Period|Other reason not defined above|1|||
147156795|NCT00515294|530737853|FG000|Overall Study|Lost to Follow-up|3|||
147156796|NCT00515294|530737854|FG001|Overall Study|Lost to Follow-up|2|||
147321984|NCT04880161|531341754|FG001|Overall Study|Lack of Compliance|1|||
147156797|NCT00515294|530737855|FG002|Overall Study|Lost to Follow-up|3|||
147156798|NCT00515294|530737856|FG003|Overall Study|Lost to Follow-up|1|||
147156799|NCT00515294|530737853|FG000|Overall Study|Driver simulator problems|1|||
147156800|NCT00515294|530737854|FG001|Overall Study|Driver simulator problems|1|||
147156801|NCT00515294|530737855|FG002|Overall Study|Driver simulator problems|1|||
147156802|NCT00515294|530737856|FG003|Overall Study|Driver simulator problems|3|||
147156803|NCT00515294|530737853|FG000|Overall Study|Caffeine amount inaccurate|5|||
147156804|NCT00515294|530737854|FG001|Overall Study|Caffeine amount inaccurate|0|||
147156805|NCT00515294|530737855|FG002|Overall Study|Caffeine amount inaccurate|7|||
147156806|NCT00515294|530737856|FG003|Overall Study|Caffeine amount inaccurate|0|||
147156807|NCT03770728|530737859|FG000|Overall Study|Adverse Event|1|||
147156808|NCT03770728|530737860|FG001|Overall Study|Adverse Event|0|||
147156809|NCT03770728|530737861|FG002|Overall Study|Adverse Event|1|||
147156810|NCT03770728|530737862|FG003|Overall Study|Adverse Event|0|||
147156811|NCT03770728|530737859|FG000|Overall Study|Poor compliance to protocol|0|||
147156812|NCT03770728|530737860|FG001|Overall Study|Poor compliance to protocol|0|||
147156813|NCT03770728|530737861|FG002|Overall Study|Poor compliance to protocol|1|||
147156814|NCT03770728|530737862|FG003|Overall Study|Poor compliance to protocol|0|||
147156815|NCT03770728|530737859|FG000|Overall Study|Withdrawal by Subject|13|||
147156816|NCT03770728|530737860|FG001|Overall Study|Withdrawal by Subject|8|||
147156817|NCT03770728|530737861|FG002|Overall Study|Withdrawal by Subject|9|||
147156818|NCT03770728|530737862|FG003|Overall Study|Withdrawal by Subject|13|||
147156819|NCT03770728|530737859|FG000|Overall Study|Other than specified|24|||
147156820|NCT03770728|530737860|FG001|Overall Study|Other than specified|23|||
147156821|NCT03770728|530737861|FG002|Overall Study|Other than specified|21|||
147156822|NCT03770728|530737862|FG003|Overall Study|Other than specified|22|||
147156823|NCT02778555|530737866|FG000|Overall Study|Withdrawal by Subject|55|||
147156824|NCT02778555|530737867|FG001|Overall Study|Withdrawal by Subject|32|||
147156825|NCT02778555|530737868|FG002|Overall Study|Withdrawal by Subject|107|||
147156826|NCT02379988|530737869|FG000|Overall Study|Not eligible|1|||
147156827|NCT00107315|530737870|FG000|Overall Study|Disease Progression|9|||
147156828|NCT00107315|530737870|FG000|Overall Study|Adverse Event|4|||
147156829|NCT00107315|530737870|FG000|Overall Study|Withdrawal by Subject|2|||
147156830|NCT02509039|530737871|FG000|Overall Study|Adverse Event|0|||
147156831|NCT02509039|530737872|FG001|Overall Study|Adverse Event|1|||
147156832|NCT02509039|530737873|FG002|Overall Study|Adverse Event|1|||
147156833|NCT02509039|530737874|FG003|Overall Study|Adverse Event|1|||
147156834|NCT02509039|530737871|FG000|Overall Study|Withdrawal by Subject|0|||
147156835|NCT02509039|530737872|FG001|Overall Study|Withdrawal by Subject|0|||
147156836|NCT02509039|530737873|FG002|Overall Study|Withdrawal by Subject|1|||
147156837|NCT02509039|530737874|FG003|Overall Study|Withdrawal by Subject|0|||
147156838|NCT02509039|530737871|FG000|Overall Study|Progressive disease|2|||
147156839|NCT02509039|530737872|FG001|Overall Study|Progressive disease|2|||
147156840|NCT02509039|530737873|FG002|Overall Study|Progressive disease|1|||
147156841|NCT02509039|530737874|FG003|Overall Study|Progressive disease|5|||
147156842|NCT02509039|530737871|FG000|Overall Study|Study terminated by Sponsor|1|||
147156843|NCT02509039|530737872|FG001|Overall Study|Study terminated by Sponsor|0|||
147156844|NCT02509039|530737873|FG002|Overall Study|Study terminated by Sponsor|0|||
147156845|NCT02509039|530737874|FG003|Overall Study|Study terminated by Sponsor|0|||
147156846|NCT03943550|530737879|FG000|Overall Study|Adverse Event|0|||
147156847|NCT03943550|530737880|FG001|Overall Study|Adverse Event|0|||
147156848|NCT03943550|530737881|FG002|Overall Study|Adverse Event|1|||
147156849|NCT03943550|530737879|FG000|Overall Study|Lost to Follow-up|0|||
147156850|NCT03943550|530737880|FG001|Overall Study|Lost to Follow-up|0|||
147156851|NCT03943550|530737881|FG002|Overall Study|Lost to Follow-up|1|||
147156852|NCT03943550|530737879|FG000|Overall Study|Progressive Disease|0|||
147156853|NCT03943550|530737880|FG001|Overall Study|Progressive Disease|0|||
147156854|NCT03943550|530737881|FG002|Overall Study|Progressive Disease|2|||
147156855|NCT03943550|530737879|FG000|Overall Study|Participant Moved Out of the Country|0|||
147156856|NCT03943550|530737880|FG001|Overall Study|Participant Moved Out of the Country|1|||
147156857|NCT03943550|530737881|FG002|Overall Study|Participant Moved Out of the Country|0|||
147156858|NCT00096226|530737882|FG000|Overall Study|Ineligible|2|||
147156859|NCT00096226|530737882|FG000|Overall Study|Protocol treatment not started|1|||
147156860|NCT04262882|530737883|FG000|Overall Study|Investigator withdrawal due to non-attendance of session 1 (at least 1 person in couple)|14|||
147156861|NCT04262882|530737884|FG001|Overall Study|Investigator withdrawal due to non-attendance of session 1 (at least 1 person in couple)|6|||
147156862|NCT04262882|530737883|FG000|Overall Study|Lost to Follow-up|1|||
147156863|NCT04262882|530737884|FG001|Overall Study|Lost to Follow-up|0|||
147156864|NCT04730635|530737885|FG000|Overall Study|Lost to Follow-up|1|||
147156865|NCT04730635|530737886|FG001|Overall Study|Lost to Follow-up|0|||
147156866|NCT04730635|530737885|FG000|Overall Study|Withdrawal by Subject|0|||
147583957|NCT01190930|532293637|FG008|Induction|Average Risk|0|||
147583958|NCT01190930|532293638|FG009|Induction|Average Risk|0|||
147156867|NCT04730635|530737886|FG001|Overall Study|Withdrawal by Subject|1|||
147156868|NCT01327053|530737887|FG000|Overall Study|Adverse Event|23|||
147156869|NCT01327053|530737888|FG001|Overall Study|Adverse Event|57|||
147156870|NCT01327053|530737887|FG000|Overall Study|Patient/guardian decision|11|||
147156871|NCT01327053|530737888|FG001|Overall Study|Patient/guardian decision|35|||
147156872|NCT01327053|530737887|FG000|Overall Study|Physician Decision|10|||
147156873|NCT01327053|530737888|FG001|Overall Study|Physician Decision|14|||
147156874|NCT01327053|530737887|FG000|Overall Study|Death|1|||
147156875|NCT01327053|530737888|FG001|Overall Study|Death|5|||
147583959|NCT01190930|532293629|FG000|Induction|High Risk|1227|||
147240926|NCT03706079|531053542|FG005|Predecessor Study|Withdrawal by Subject|0|||
147240927|NCT03706079|531053537|FG000|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|3|||
147240928|NCT03706079|531053538|FG001|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|4|||
147240929|NCT03706079|531053539|FG002|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|0|||
147240930|NCT03706079|531053540|FG003|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|0|||
147240931|NCT03706079|531053541|FG004|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|0|||
147240932|NCT03706079|531053542|FG005|Predecessor Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|0|||
147240933|NCT03706079|531053537|FG000|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|0|||
147240934|NCT03706079|531053538|FG001|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|0|||
147240935|NCT03706079|531053539|FG002|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|0|||
147240936|NCT03706079|531053540|FG003|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|0|||
147240937|NCT03706079|531053541|FG004|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|0|||
147240938|NCT03706079|531053542|FG005|Long Term Extension (DESTINATION)|Due to COVID-19 pandemic|1|||
147240939|NCT03706079|531053537|FG000|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|1|||
147240940|NCT03706079|531053538|FG001|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|0|||
147240941|NCT03706079|531053539|FG002|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|2|||
147240942|NCT03706079|531053540|FG003|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|0|||
147240943|NCT03706079|531053541|FG004|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|0|||
147240944|NCT03706079|531053542|FG005|Long Term Extension (DESTINATION)|Did not complete safety follow-up visits|0|||
147240945|NCT03706079|531053537|FG000|Long Term Extension (DESTINATION)|Pregnancy|1|||
147240946|NCT03706079|531053538|FG001|Long Term Extension (DESTINATION)|Pregnancy|0|||
147240947|NCT03706079|531053539|FG002|Long Term Extension (DESTINATION)|Pregnancy|0|||
147240948|NCT03706079|531053540|FG003|Long Term Extension (DESTINATION)|Pregnancy|0|||
147240949|NCT03706079|531053541|FG004|Long Term Extension (DESTINATION)|Pregnancy|0|||
147240950|NCT03706079|531053542|FG005|Long Term Extension (DESTINATION)|Pregnancy|0|||
147240951|NCT03706079|531053537|FG000|Long Term Extension (DESTINATION)|Withdrawal by Subject|3|||
147240952|NCT03706079|531053538|FG001|Long Term Extension (DESTINATION)|Withdrawal by Subject|3|||
147240953|NCT03706079|531053539|FG002|Long Term Extension (DESTINATION)|Withdrawal by Subject|3|||
147240954|NCT03706079|531053540|FG003|Long Term Extension (DESTINATION)|Withdrawal by Subject|1|||
147240955|NCT03706079|531053541|FG004|Long Term Extension (DESTINATION)|Withdrawal by Subject|3|||
147240956|NCT03706079|531053542|FG005|Long Term Extension (DESTINATION)|Withdrawal by Subject|0|||
147240957|NCT03706079|531053537|FG000|Long Term Extension (DESTINATION)|Lost to Follow-up|2|||
147240958|NCT03706079|531053538|FG001|Long Term Extension (DESTINATION)|Lost to Follow-up|1|||
147156876|NCT01327053|530737887|FG000|Overall Study|Lost to Follow-up|2|||
147156877|NCT01327053|530737888|FG001|Overall Study|Lost to Follow-up|4|||
147156878|NCT01327053|530737887|FG000|Overall Study|Non-compliance with study treatment|0|||
147156879|NCT01327053|530737888|FG001|Overall Study|Non-compliance with study treatment|5|||
147156880|NCT01327053|530737887|FG000|Overall Study|Study terminated by Sponsor|1|||
147156881|NCT01327053|530737888|FG001|Overall Study|Study terminated by Sponsor|3|||
147156882|NCT01327053|530737887|FG000|Overall Study|Progressive disease|31|||
147156883|NCT01327053|530737888|FG001|Overall Study|Progressive disease|26|||
147156884|NCT01327053|530737887|FG000|Overall Study|Protocol Violation|0|||
147156885|NCT01327053|530737888|FG001|Overall Study|Protocol Violation|1|||
147156886|NCT01327053|530737887|FG000|Overall Study|Untreated|0|||
147156887|NCT01327053|530737888|FG001|Overall Study|Untreated|1|||
147156888|NCT00721578|530737893|FG000|Overall Study|Death|1|||
147156889|NCT00721578|530737894|FG001|Overall Study|Death|1|||
147240959|NCT03706079|531053539|FG002|Long Term Extension (DESTINATION)|Lost to Follow-up|1|||
147240960|NCT03706079|531053540|FG003|Long Term Extension (DESTINATION)|Lost to Follow-up|0|||
147240961|NCT03706079|531053541|FG004|Long Term Extension (DESTINATION)|Lost to Follow-up|1|||
147240962|NCT03706079|531053542|FG005|Long Term Extension (DESTINATION)|Lost to Follow-up|0|||
147240963|NCT03706079|531053537|FG000|Long Term Extension (DESTINATION)|Death|8|||
147240964|NCT03706079|531053538|FG001|Long Term Extension (DESTINATION)|Death|2|||
147240965|NCT03706079|531053539|FG002|Long Term Extension (DESTINATION)|Death|2|||
147240966|NCT03706079|531053540|FG003|Long Term Extension (DESTINATION)|Death|1|||
147240967|NCT03706079|531053541|FG004|Long Term Extension (DESTINATION)|Death|0|||
147240968|NCT03706079|531053542|FG005|Long Term Extension (DESTINATION)|Death|0|||
147240969|NCT00329238|531053543|FG000|Overall Study|Adverse Event|147|||
147240970|NCT00329238|531053544|FG001|Overall Study|Adverse Event|129|||
147156890|NCT00721578|530737893|FG000|Overall Study|Withdrawal by Subject|1|||
147156891|NCT00721578|530737894|FG001|Overall Study|Withdrawal by Subject|1|||
147156892|NCT01638013|530737895|FG000|Overall Study|Adverse Event|36|||
147156893|NCT01638013|530737896|FG001|Overall Study|Adverse Event|29|||
147156894|NCT01638013|530737897|FG002|Overall Study|Adverse Event|48|||
147156895|NCT01638013|530737895|FG000|Overall Study|Lack of Efficacy|39|||
147156896|NCT01638013|530737896|FG001|Overall Study|Lack of Efficacy|11|||
147156897|NCT01638013|530737897|FG002|Overall Study|Lack of Efficacy|14|||
147156898|NCT01638013|530737895|FG000|Overall Study|Protocol Violation|10|||
147156899|NCT01638013|530737896|FG001|Overall Study|Protocol Violation|7|||
147156900|NCT01638013|530737897|FG002|Overall Study|Protocol Violation|11|||
147156901|NCT01638013|530737895|FG000|Overall Study|Met discontinuation criteria|4|||
147156902|NCT01638013|530737896|FG001|Overall Study|Met discontinuation criteria|0|||
147156903|NCT01638013|530737897|FG002|Overall Study|Met discontinuation criteria|7|||
147156904|NCT01638013|530737895|FG000|Overall Study|Subject Lost to Follow up|1|||
147156905|NCT01638013|530737896|FG001|Overall Study|Subject Lost to Follow up|0|||
147156906|NCT01638013|530737897|FG002|Overall Study|Subject Lost to Follow up|1|||
147156907|NCT01638013|530737895|FG000|Overall Study|Miscellaneous|25|||
147156908|NCT01638013|530737896|FG001|Overall Study|Miscellaneous|19|||
147156909|NCT01638013|530737897|FG002|Overall Study|Miscellaneous|23|||
147156910|NCT01638013|530737895|FG000|Overall Study|Withdrawal of Consent|16|||
147156911|NCT01638013|530737896|FG001|Overall Study|Withdrawal of Consent|12|||
147156912|NCT01638013|530737897|FG002|Overall Study|Withdrawal of Consent|16|||
147156913|NCT01638013|530737895|FG000|Overall Study|Not met inclusion or exclusion criteria|0|||
147156914|NCT01638013|530737896|FG001|Overall Study|Not met inclusion or exclusion criteria|0|||
147156915|NCT01638013|530737897|FG002|Overall Study|Not met inclusion or exclusion criteria|1|||
147156916|NCT02298179|530737898|FG000|Overall Study|Lost to Follow-up|0|||
147156917|NCT02298179|530737899|FG001|Overall Study|Lost to Follow-up|0|||
147156918|NCT02298179|530737900|FG002|Overall Study|Lost to Follow-up|1|||
147156919|NCT02298179|530737901|FG003|Overall Study|Lost to Follow-up|0|||
147156920|NCT02298179|530737902|FG004|Overall Study|Lost to Follow-up|0|||
147156921|NCT02298179|530737903|FG005|Overall Study|Lost to Follow-up|0|||
147156922|NCT02298179|530737904|FG006|Overall Study|Lost to Follow-up|0|||
147156923|NCT02298179|530737905|FG007|Overall Study|Lost to Follow-up|1|||
147156924|NCT02298179|530737906|FG008|Overall Study|Lost to Follow-up|0|||
147156925|NCT02298179|530737907|FG009|Overall Study|Lost to Follow-up|0|||
147156926|NCT02298179|530737908|FG010|Overall Study|Lost to Follow-up|0|||
147156927|NCT02298179|530737909|FG011|Overall Study|Lost to Follow-up|0|||
147156928|NCT02226198|530739714|FG000|Lead-in Phase|Protocol Violation|1|||
147156929|NCT02226198|530739715|FG001|Lead-in Phase|Protocol Violation|0|||
147156930|NCT02226198|530739716|FG002|Lead-in Phase|Protocol Violation|0|||
147156931|NCT02226198|530739714|FG000|Cross-Over: First Intervention (6 Weeks)|No possibility to draw blood|0|||
147156932|NCT02226198|530739715|FG001|Cross-Over: First Intervention (6 Weeks)|No possibility to draw blood|1|||
147156933|NCT02226198|530739716|FG002|Cross-Over: First Intervention (6 Weeks)|No possibility to draw blood|0|||
147156934|NCT01440517|530739720|FG000|Overall Study|Subject withdrawn prior to dosing|1|||
147156935|NCT00871923|530739721|FG000|Overall Study|Death|1|||
147156936|NCT00871923|530739721|FG000|Overall Study|Withdrawal by Subject|1|||
147156937|NCT05599451|530739726|FG000|Overall Study|Not randomized|11|||
147156938|NCT05599451|530739727|FG001|Overall Study|Not randomized|0|||
147156939|NCT05599451|530739728|FG002|Overall Study|Not randomized|0|||
147156940|NCT05599451|530739729|FG003|Overall Study|Not randomized|0|||
147156941|NCT05599451|530739730|FG004|Overall Study|Not randomized|0|||
147156942|NCT05599451|530739726|FG000|Overall Study|Physician Decision|0|||
147156943|NCT05599451|530739727|FG001|Overall Study|Physician Decision|0|||
147156944|NCT05599451|530739728|FG002|Overall Study|Physician Decision|0|||
147156945|NCT05599451|530739729|FG003|Overall Study|Physician Decision|1|||
147156946|NCT05599451|530739730|FG004|Overall Study|Physician Decision|0|||
147156947|NCT02723006|530739731|FG000|Overall Study|Withdrawal by Subject|0|||
147156948|NCT02723006|530739732|FG001|Overall Study|Withdrawal by Subject|1|||
147156949|NCT02723006|530739733|FG002|Overall Study|Withdrawal by Subject|1|||
147156950|NCT02723006|530739731|FG000|Overall Study|Study Terminated by Sponsor|1|||
147156951|NCT02723006|530739732|FG001|Overall Study|Study Terminated by Sponsor|6|||
147156952|NCT02723006|530739733|FG002|Overall Study|Study Terminated by Sponsor|6|||
147156953|NCT03392883|530739740|FG000|Overall Study|Lost to Follow-up|122|||
147156954|NCT03392883|530739741|FG001|Overall Study|Lost to Follow-up|13|||
147156955|NCT03392883|530739742|FG002|Overall Study|Lost to Follow-up|9|||
147156956|NCT03392883|530739740|FG000|Overall Study|Death|4|||
147156957|NCT03392883|530739741|FG001|Overall Study|Death|0|||
147156958|NCT03392883|530739742|FG002|Overall Study|Death|0|||
147156959|NCT03392883|530739740|FG000|Overall Study|Lack of Efficacy|29|||
147156960|NCT03392883|530739741|FG001|Overall Study|Lack of Efficacy|0|||
147156961|NCT03392883|530739742|FG002|Overall Study|Lack of Efficacy|0|||
147156962|NCT03392883|530739740|FG000|Overall Study|Withdrawal by Subject|180|||
147156963|NCT03392883|530739741|FG001|Overall Study|Withdrawal by Subject|0|||
147156964|NCT03392883|530739742|FG002|Overall Study|Withdrawal by Subject|0|||
147156965|NCT03392883|530739740|FG000|Overall Study|Adverse Event|1|||
147156966|NCT03392883|530739741|FG001|Overall Study|Adverse Event|0|||
147156967|NCT03392883|530739742|FG002|Overall Study|Adverse Event|0|||
147156968|NCT01739933|530739752|FG000|Overall Study|Death|89|||
147156969|NCT01739933|530739753|FG001|Overall Study|Death|86|||
147156970|NCT01739933|530739752|FG000|Overall Study|Withdrawal by Subject|10|||
147156971|NCT01739933|530739753|FG001|Overall Study|Withdrawal by Subject|8|||
147156972|NCT01739933|530739752|FG000|Overall Study|Lost to Follow-up|3|||
147156973|NCT01739933|530739753|FG001|Overall Study|Lost to Follow-up|10|||
147240971|NCT00329238|531053543|FG000|Overall Study|Protocol Violation|23|||
147156974|NCT01739933|530739752|FG000|Overall Study|Did not speak English required for neurospychological testing|4|||
147156975|NCT01739933|530739753|FG001|Overall Study|Did not speak English required for neurospychological testing|3|||
147156976|NCT03356977|530739754|FG000|Overall Study|Lost to Follow-up|3|||
147156977|NCT03356977|530739754|FG000|Overall Study|Withdrawal by parent/guardian|2|||
147156978|NCT00908115|530739760|FG000|Overall Study|Other|14|||
147156979|NCT01728077|530739761|FG000|Overall Study|Lack of Efficacy|3|||
147156980|NCT01728077|530739762|FG001|Overall Study|Lack of Efficacy|1|||
147156981|NCT01728077|530739761|FG000|Overall Study|Lost to Follow-up|1|||
147156982|NCT01728077|530739762|FG001|Overall Study|Lost to Follow-up|0|||
147156983|NCT01728077|530739761|FG000|Overall Study|Subject choice|2|||
147156984|NCT01728077|530739762|FG001|Overall Study|Subject choice|3|||
147156985|NCT01728077|530739761|FG000|Overall Study|Death|0|||
147156986|NCT01728077|530739762|FG001|Overall Study|Death|1|||
147156987|NCT01728077|530739761|FG000|Overall Study|Patient moving|1|||
147156988|NCT01728077|530739762|FG001|Overall Study|Patient moving|0|||
147156989|NCT01728077|530739761|FG000|Overall Study|Non compliance|1|||
147156990|NCT01728077|530739762|FG001|Overall Study|Non compliance|0|||
147156991|NCT00378599|530739766|FG000|Overall Study|Adverse Event|38|||
147156992|NCT00378599|530739766|FG000|Overall Study|Protocol Violation|2|||
147156993|NCT00378599|530739766|FG000|Overall Study|Treatment failure|7|||
147156994|NCT00378599|530739766|FG000|Overall Study|Withdrawal by Subject|5|||
147156995|NCT01007435|530739769|FG000|Overall Study|Adverse Event|16|||
147156996|NCT01007435|530739770|FG001|Overall Study|Adverse Event|25|||
147156997|NCT01007435|530739771|FG002|Overall Study|Adverse Event|47|||
147156998|NCT01007435|530739772|FG003|Overall Study|Adverse Event|31|||
147156999|NCT01007435|530739769|FG000|Overall Study|Death|2|||
147157000|NCT01007435|530739770|FG001|Overall Study|Death|4|||
147157001|NCT01007435|530739771|FG002|Overall Study|Death|2|||
147157002|NCT01007435|530739772|FG003|Overall Study|Death|1|||
147157003|NCT01007435|530739769|FG000|Overall Study|Insufficient Therapeutic Response|21|||
147157004|NCT01007435|530739770|FG001|Overall Study|Insufficient Therapeutic Response|7|||
147157005|NCT01007435|530739771|FG002|Overall Study|Insufficient Therapeutic Response|2|||
147157006|NCT01007435|530739772|FG003|Overall Study|Insufficient Therapeutic Response|9|||
147157007|NCT01007435|530739769|FG000|Overall Study|Violation of Selection Criteria at Entry|3|||
147157008|NCT01007435|530739770|FG001|Overall Study|Violation of Selection Criteria at Entry|5|||
147157009|NCT01007435|530739771|FG002|Overall Study|Violation of Selection Criteria at Entry|2|||
147157010|NCT01007435|530739772|FG003|Overall Study|Violation of Selection Criteria at Entry|0|||
147157011|NCT01007435|530739769|FG000|Overall Study|Other Protocol Violation|2|||
147157012|NCT01007435|530739770|FG001|Overall Study|Other Protocol Violation|0|||
147157013|NCT01007435|530739771|FG002|Overall Study|Other Protocol Violation|1|||
147157014|NCT01007435|530739772|FG003|Overall Study|Other Protocol Violation|0|||
147157015|NCT01007435|530739769|FG000|Overall Study|Refused Treatment|13|||
147157016|NCT01007435|530739770|FG001|Overall Study|Refused Treatment|13|||
147157017|NCT01007435|530739771|FG002|Overall Study|Refused Treatment|5|||
147157018|NCT01007435|530739772|FG003|Overall Study|Refused Treatment|8|||
147157019|NCT01007435|530739769|FG000|Overall Study|Failure to Return|5|||
147157020|NCT01007435|530739770|FG001|Overall Study|Failure to Return|4|||
147157021|NCT01007435|530739771|FG002|Overall Study|Failure to Return|3|||
147157022|NCT01007435|530739772|FG003|Overall Study|Failure to Return|6|||
147157023|NCT01007435|530739769|FG000|Overall Study|Reason not Specified|1|||
147157024|NCT01007435|530739770|FG001|Overall Study|Reason not Specified|1|||
147157025|NCT01007435|530739771|FG002|Overall Study|Reason not Specified|2|||
147157026|NCT01007435|530739772|FG003|Overall Study|Reason not Specified|1|||
147157027|NCT02545517|530739773|FG000|Overall Study|Death|2|||
147157028|NCT02545517|530739774|FG001|Overall Study|Death|2|||
147157029|NCT02545517|530739775|FG002|Overall Study|Death|1|||
147157030|NCT02545517|530739773|FG000|Overall Study|Lost to Follow-up|14|||
147157031|NCT02545517|530739774|FG001|Overall Study|Lost to Follow-up|13|||
147157032|NCT02545517|530739775|FG002|Overall Study|Lost to Follow-up|17|||
147157033|NCT02545517|530739773|FG000|Overall Study|Protocol Violation|0|||
147157034|NCT02545517|530739774|FG001|Overall Study|Protocol Violation|1|||
147240972|NCT00329238|531053544|FG001|Overall Study|Protocol Violation|34|||
147157035|NCT02545517|530739775|FG002|Overall Study|Protocol Violation|1|||
147240973|NCT00329238|531053543|FG000|Overall Study|Lost to Follow-up|2|||
147157036|NCT02545517|530739773|FG000|Overall Study|Withdrawal by Subject|5|||
147157037|NCT02545517|530739774|FG001|Overall Study|Withdrawal by Subject|8|||
147157038|NCT02545517|530739775|FG002|Overall Study|Withdrawal by Subject|9|||
147157039|NCT02545517|530739773|FG000|Overall Study|Administrative reason|5|||
147157040|NCT02545517|530739774|FG001|Overall Study|Administrative reason|6|||
147157041|NCT02545517|530739775|FG002|Overall Study|Administrative reason|10|||
147240974|NCT00329238|531053544|FG001|Overall Study|Lost to Follow-up|6|||
147157042|NCT02545517|530739773|FG000|Overall Study|Other|2|||
147157043|NCT02545517|530739774|FG001|Overall Study|Other|4|||
147157044|NCT02545517|530739775|FG002|Overall Study|Other|3|||
147157045|NCT01529515|530739776|FG000|TRANSITION PHASE|Adverse Event|16|||
147240975|NCT00329238|531053543|FG000|Overall Study|Withdrawal by Subject|64|||
147157046|NCT01529515|530739777|FG001|TRANSITION PHASE|Adverse Event|0|||
147157047|NCT01529515|530739778|FG002|TRANSITION PHASE|Adverse Event|0|||
147321985|NCT04880161|531341753|FG000|Overall Study|Incorrectly Randomized followed for Safety|0|||
147157048|NCT01529515|530739779|FG003|TRANSITION PHASE|Adverse Event|0|||
147157049|NCT01529515|530739776|FG000|TRANSITION PHASE|Death|1|||
147157050|NCT01529515|530739777|FG001|TRANSITION PHASE|Death|0|||
147157051|NCT01529515|530739778|FG002|TRANSITION PHASE|Death|0|||
147157052|NCT01529515|530739779|FG003|TRANSITION PHASE|Death|0|||
147157053|NCT01529515|530739776|FG000|TRANSITION PHASE|Lack of Efficacy|19|||
147157054|NCT01529515|530739777|FG001|TRANSITION PHASE|Lack of Efficacy|0|||
147157055|NCT01529515|530739778|FG002|TRANSITION PHASE|Lack of Efficacy|0|||
147157056|NCT01529515|530739779|FG003|TRANSITION PHASE|Lack of Efficacy|0|||
147157057|NCT01529515|530739776|FG000|TRANSITION PHASE|Lost to Follow-up|19|||
147157058|NCT01529515|530739777|FG001|TRANSITION PHASE|Lost to Follow-up|0|||
147157059|NCT01529515|530739778|FG002|TRANSITION PHASE|Lost to Follow-up|0|||
147157060|NCT01529515|530739779|FG003|TRANSITION PHASE|Lost to Follow-up|0|||
147157061|NCT01529515|530739776|FG000|TRANSITION PHASE|Protocol Violation|4|||
147157062|NCT01529515|530739777|FG001|TRANSITION PHASE|Protocol Violation|0|||
147157063|NCT01529515|530739778|FG002|TRANSITION PHASE|Protocol Violation|0|||
147157064|NCT01529515|530739779|FG003|TRANSITION PHASE|Protocol Violation|0|||
147157065|NCT01529515|530739776|FG000|TRANSITION PHASE|Withdrawal by Subject|51|||
147157066|NCT01529515|530739777|FG001|TRANSITION PHASE|Withdrawal by Subject|0|||
147157067|NCT01529515|530739778|FG002|TRANSITION PHASE|Withdrawal by Subject|0|||
147157068|NCT01529515|530739779|FG003|TRANSITION PHASE|Withdrawal by Subject|0|||
147157069|NCT01529515|530739776|FG000|TRANSITION PHASE|Failed Maintenance Phase Criteria|8|||
147157070|NCT01529515|530739777|FG001|TRANSITION PHASE|Failed Maintenance Phase Criteria|0|||
147157071|NCT01529515|530739778|FG002|TRANSITION PHASE|Failed Maintenance Phase Criteria|0|||
147157072|NCT01529515|530739779|FG003|TRANSITION PHASE|Failed Maintenance Phase Criteria|0|||
147157073|NCT01529515|530739776|FG000|TRANSITION PHASE|Other|9|||
147157074|NCT01529515|530739777|FG001|TRANSITION PHASE|Other|0|||
147157075|NCT01529515|530739778|FG002|TRANSITION PHASE|Other|0|||
147157076|NCT01529515|530739779|FG003|TRANSITION PHASE|Other|0|||
147157077|NCT01529515|530739776|FG000|MAINTENANCE PHASE|Adverse Event|0|||
147157078|NCT01529515|530739777|FG001|MAINTENANCE PHASE|Adverse Event|10|||
147157079|NCT01529515|530739778|FG002|MAINTENANCE PHASE|Adverse Event|0|||
147157080|NCT01529515|530739779|FG003|MAINTENANCE PHASE|Adverse Event|0|||
147157081|NCT01529515|530739776|FG000|MAINTENANCE PHASE|Lack of Efficacy|0|||
147157082|NCT01529515|530739777|FG001|MAINTENANCE PHASE|Lack of Efficacy|9|||
147157083|NCT01529515|530739778|FG002|MAINTENANCE PHASE|Lack of Efficacy|0|||
147157084|NCT01529515|530739779|FG003|MAINTENANCE PHASE|Lack of Efficacy|0|||
147157085|NCT01529515|530739776|FG000|MAINTENANCE PHASE|Lost to Follow-up|0|||
147157086|NCT01529515|530739777|FG001|MAINTENANCE PHASE|Lost to Follow-up|5|||
147157087|NCT01529515|530739778|FG002|MAINTENANCE PHASE|Lost to Follow-up|0|||
147157088|NCT01529515|530739779|FG003|MAINTENANCE PHASE|Lost to Follow-up|0|||
147157089|NCT01529515|530739776|FG000|MAINTENANCE PHASE|Protocol Violation|0|||
147157090|NCT01529515|530739777|FG001|MAINTENANCE PHASE|Protocol Violation|12|||
147157091|NCT01529515|530739778|FG002|MAINTENANCE PHASE|Protocol Violation|0|||
147157092|NCT01529515|530739779|FG003|MAINTENANCE PHASE|Protocol Violation|0|||
147157093|NCT01529515|530739776|FG000|MAINTENANCE PHASE|Withdrawal by Subject|0|||
147157094|NCT01529515|530739777|FG001|MAINTENANCE PHASE|Withdrawal by Subject|15|||
147157095|NCT01529515|530739778|FG002|MAINTENANCE PHASE|Withdrawal by Subject|0|||
147157096|NCT01529515|530739779|FG003|MAINTENANCE PHASE|Withdrawal by Subject|0|||
147157097|NCT01529515|530739776|FG000|MAINTENANCE PHASE|Failed Randomization Criteria|0|||
147157098|NCT01529515|530739777|FG001|MAINTENANCE PHASE|Failed Randomization Criteria|13|||
147157099|NCT01529515|530739778|FG002|MAINTENANCE PHASE|Failed Randomization Criteria|0|||
147157100|NCT01529515|530739779|FG003|MAINTENANCE PHASE|Failed Randomization Criteria|0|||
147157101|NCT01529515|530739776|FG000|MAINTENANCE PHASE|Other|0|||
147157102|NCT01529515|530739777|FG001|MAINTENANCE PHASE|Other|10|||
147157103|NCT01529515|530739778|FG002|MAINTENANCE PHASE|Other|0|||
147157104|NCT01529515|530739779|FG003|MAINTENANCE PHASE|Other|0|||
147157105|NCT01529515|530739776|FG000|DOUBLE BLIND PHASE|Adverse Event|0|||
147157106|NCT01529515|530739777|FG001|DOUBLE BLIND PHASE|Adverse Event|0|||
147157107|NCT01529515|530739778|FG002|DOUBLE BLIND PHASE|Adverse Event|1|||
147157108|NCT01529515|530739779|FG003|DOUBLE BLIND PHASE|Adverse Event|0|||
147157109|NCT01529515|530739776|FG000|DOUBLE BLIND PHASE|Lost to Follow-up|0|||
147157110|NCT01529515|530739777|FG001|DOUBLE BLIND PHASE|Lost to Follow-up|0|||
147157111|NCT01529515|530739778|FG002|DOUBLE BLIND PHASE|Lost to Follow-up|1|||
147157112|NCT01529515|530739779|FG003|DOUBLE BLIND PHASE|Lost to Follow-up|3|||
147157113|NCT01529515|530739776|FG000|DOUBLE BLIND PHASE|Pregnancy|0|||
147157114|NCT01529515|530739777|FG001|DOUBLE BLIND PHASE|Pregnancy|0|||
147157115|NCT01529515|530739778|FG002|DOUBLE BLIND PHASE|Pregnancy|1|||
147157116|NCT01529515|530739779|FG003|DOUBLE BLIND PHASE|Pregnancy|0|||
147157117|NCT01529515|530739776|FG000|DOUBLE BLIND PHASE|Withdrawal by Subject|0|||
147157118|NCT01529515|530739777|FG001|DOUBLE BLIND PHASE|Withdrawal by Subject|0|||
147157119|NCT01529515|530739778|FG002|DOUBLE BLIND PHASE|Withdrawal by Subject|10|||
147157120|NCT01529515|530739779|FG003|DOUBLE BLIND PHASE|Withdrawal by Subject|7|||
147157121|NCT01529515|530739776|FG000|DOUBLE BLIND PHASE|Protocol Violation|0|||
147157122|NCT01529515|530739777|FG001|DOUBLE BLIND PHASE|Protocol Violation|0|||
147157123|NCT01529515|530739778|FG002|DOUBLE BLIND PHASE|Protocol Violation|1|||
147321986|NCT04880161|531341754|FG001|Overall Study|Incorrectly Randomized followed for Safety|1|||
147321987|NCT04880161|531341753|FG000|Overall Study|Screen Failure|0|||
147321988|NCT04880161|531341754|FG001|Overall Study|Screen Failure|1|||
147321989|NCT01354106|531341755|FG000|Overall Study|Withdrawal by Subject|2|||
147321990|NCT00465361|531343532|FG000|Baseline Assessment|Personal Issues/Scheduling|4|||
147321991|NCT01511536|531343533|FG000|Phase 1|Other|0|||
147321992|NCT01511536|531343534|FG001|Phase 1|Other|1|||
147321993|NCT01511536|531343535|FG002|Phase 1|Other|0|||
147321994|NCT01511536|531343533|FG000|Phase 2|Other|0|||
147157124|NCT01529515|530739779|FG003|DOUBLE BLIND PHASE|Protocol Violation|0|||
147157125|NCT01529515|530739776|FG000|DOUBLE BLIND PHASE|Other|0|||
147157126|NCT01529515|530739777|FG001|DOUBLE BLIND PHASE|Other|0|||
147157127|NCT01529515|530739778|FG002|DOUBLE BLIND PHASE|Other|9|||
147157128|NCT01529515|530739779|FG003|DOUBLE BLIND PHASE|Other|2|||
147157129|NCT00523705|530739781|FG000|Overall Study|No time for study.|0|||
147157130|NCT00523705|530739782|FG001|Overall Study|No time for study.|1|||
147157131|NCT00642369|530739784|FG000|Overall Study|Adverse Event|2|||
147157132|NCT00642369|530739785|FG001|Overall Study|Adverse Event|3|||
147157133|NCT00642369|530739784|FG000|Overall Study|Withdrawal by Subject|1|||
147157134|NCT00642369|530739785|FG001|Overall Study|Withdrawal by Subject|0|||
147157135|NCT00642369|530739784|FG000|Overall Study|misdiagnosis|0|||
147157136|NCT00642369|530739785|FG001|Overall Study|misdiagnosis|1|||
147157137|NCT00642369|530739784|FG000|Overall Study|Lack of Efficacy|2|||
147157138|NCT00642369|530739785|FG001|Overall Study|Lack of Efficacy|2|||
147157139|NCT01190475|530739792|FG000|Overall Study|Withdrawal by Subject|0|||
147157140|NCT01190475|530739793|FG001|Overall Study|Withdrawal by Subject|0|||
147157141|NCT01190475|530739794|FG002|Overall Study|Withdrawal by Subject|1|||
147157142|NCT00543803|530739795|FG000|Overall Study|Adverse Event|14|||
147157143|NCT00543803|530739795|FG000|Overall Study|Lack of Efficacy|22|||
147157144|NCT00543803|530739795|FG000|Overall Study|Lost to Follow-up|20|||
147157145|NCT00543803|530739795|FG000|Overall Study|Other|86|||
147157146|NCT01779856|530739796|FG000|Overall Study|Withdrawal by Subject|15|||
147157147|NCT01779856|530739796|FG000|Overall Study|Death|3|||
147157148|NCT01779856|530739796|FG000|Overall Study|Physician Decision|1|||
147157149|NCT01779856|530739796|FG000|Overall Study|Inclusion/Exclusion Not Met|2|||
147157150|NCT01779856|530739796|FG000|Overall Study|Delays in scheduling implant|1|||
147157151|NCT01779856|530739796|FG000|Overall Study|Subject ineligible for Implant|2|||
147157152|NCT02680041|530739797|FG000|Overall Study|Withdrawal prior to 18F-fluciclovine PET|8|||
147157153|NCT02680041|530739797|FG000|Overall Study|Lost to Follow-up|2|||
147157154|NCT00521599|530739798|FG000|Overall Study|Adverse Event|5|||
147157155|NCT00521599|530739799|FG001|Overall Study|Adverse Event|7|||
147157156|NCT00521599|530739800|FG002|Overall Study|Adverse Event|6|||
147157157|NCT00521599|530739798|FG000|Overall Study|Treatment Failure|8|||
147157158|NCT00521599|530739799|FG001|Overall Study|Treatment Failure|9|||
147157159|NCT00521599|530739800|FG002|Overall Study|Treatment Failure|22|||
147157160|NCT00521599|530739798|FG000|Overall Study|Lost to Follow-up|2|||
147157161|NCT00521599|530739799|FG001|Overall Study|Lost to Follow-up|1|||
147157162|NCT00521599|530739800|FG002|Overall Study|Lost to Follow-up|2|||
147157163|NCT00521599|530739798|FG000|Overall Study|Withdrawal by Subject|3|||
147157164|NCT00521599|530739799|FG001|Overall Study|Withdrawal by Subject|5|||
147157165|NCT00521599|530739800|FG002|Overall Study|Withdrawal by Subject|1|||
147157166|NCT00521599|530739798|FG000|Overall Study|Withdrawal by subject treatment related|3|||
147157167|NCT00521599|530739799|FG001|Overall Study|Withdrawal by subject treatment related|1|||
147157168|NCT00521599|530739800|FG002|Overall Study|Withdrawal by subject treatment related|2|||
147157169|NCT00521599|530739798|FG000|Overall Study|Protocol Violation|2|||
147157170|NCT00521599|530739799|FG001|Overall Study|Protocol Violation|4|||
147157171|NCT00521599|530739800|FG002|Overall Study|Protocol Violation|2|||
147157172|NCT00521599|530739798|FG000|Overall Study|Did not meet protocol eligibility|2|||
147157173|NCT00521599|530739799|FG001|Overall Study|Did not meet protocol eligibility|2|||
147157174|NCT00521599|530739800|FG002|Overall Study|Did not meet protocol eligibility|1|||
147157175|NCT01610713|530739801|FG000|Overall Study|Adverse Event|3|||
147157176|NCT01610713|530739802|FG001|Overall Study|Adverse Event|0|||
147157177|NCT01610713|530739801|FG000|Overall Study|Lack of Efficacy|1|||
147157178|NCT01610713|530739802|FG001|Overall Study|Lack of Efficacy|0|||
147157179|NCT01610713|530739801|FG000|Overall Study|low mood and poor motivation|1|||
147157180|NCT01610713|530739802|FG001|Overall Study|low mood and poor motivation|0|||
147157181|NCT01610713|530739801|FG000|Overall Study|adv. to use original dose/amitriptyline|1|||
147157182|NCT01610713|530739802|FG001|Overall Study|adv. to use original dose/amitriptyline|0|||
147157183|NCT01610713|530739801|FG000|Overall Study|Lost to Follow-up|0|||
147157184|NCT01610713|530739802|FG001|Overall Study|Lost to Follow-up|1|||
147157185|NCT01774097|530739807|FG000|Overall Study|Withdrawal by Subject|1|||
147157186|NCT01774097|530739808|FG001|Overall Study|Withdrawal by Subject|1|||
147157187|NCT01774097|530739807|FG000|Overall Study|Adverse Event|1|||
147157188|NCT01774097|530739808|FG001|Overall Study|Adverse Event|1|||
147157189|NCT00557310|530739809|FG000|Main Study (0 - 18 Months)|Adverse Event|4|||
147157190|NCT00557310|530739809|FG000|Main Study (0 - 18 Months)|Withdrawal by Subject|1|||
147321995|NCT01511536|531343534|FG001|Phase 2|Other|0|||
147321996|NCT01511536|531343535|FG002|Phase 2|Other|9|||
147157191|NCT00557310|530739809|FG000|Extension Phase (18 - 24 Months)|Adverse Event|1|||
147157192|NCT00557310|530739809|FG000|Extension Phase (18 - 24 Months)|Lost to Follow-up|1|||
147157193|NCT00557310|530739809|FG000|Extension Phase (18 - 24 Months)|Physician Decision|2|||
147157194|NCT00557310|530739809|FG000|Extension Phase (18 - 24 Months)|Protocol Violation|1|||
147157195|NCT01271712|530739816|FG000|Double Blind Treatment|Death|2|||
147157196|NCT01271712|530739817|FG001|Double Blind Treatment|Death|0|||
147157197|NCT01271712|530739816|FG000|Double Blind Treatment|Lack of Efficacy|1|||
147157198|NCT01271712|530739817|FG001|Double Blind Treatment|Lack of Efficacy|0|||
147157199|NCT01271712|530739816|FG000|Double Blind Treatment|Adverse Event|9|||
147157200|NCT01271712|530739817|FG001|Double Blind Treatment|Adverse Event|4|||
147157201|NCT01271712|530739816|FG000|Double Blind Treatment|Progressive disease|23|||
147157202|NCT01271712|530739817|FG001|Double Blind Treatment|Progressive disease|3|||
147157203|NCT01271712|530739816|FG000|Double Blind Treatment|Withdrawal by Subject|4|||
147157204|NCT01271712|530739817|FG001|Double Blind Treatment|Withdrawal by Subject|1|||
147157205|NCT01271712|530739816|FG000|Double Blind Treatment|Non compliance with study drug|2|||
147157206|NCT01271712|530739817|FG001|Double Blind Treatment|Non compliance with study drug|0|||
147157207|NCT01271712|530739816|FG000|Double Blind Treatment|receive no study drug|1|||
147157208|NCT01271712|530739817|FG001|Double Blind Treatment|receive no study drug|0|||
147157209|NCT01271712|530739816|FG000|Open Label Treatment|Death|6|||
147157210|NCT01271712|530739817|FG001|Open Label Treatment|Death|5|||
147157211|NCT01271712|530739816|FG000|Open Label Treatment|Withdrawal by Subject|6|||
147157212|NCT01271712|530739817|FG001|Open Label Treatment|Withdrawal by Subject|11|||
147157213|NCT01271712|530739816|FG000|Open Label Treatment|Physician Decision|2|||
147157214|NCT01271712|530739817|FG001|Open Label Treatment|Physician Decision|0|||
147157215|NCT01271712|530739816|FG000|Open Label Treatment|Adverse Event|14|||
147157216|NCT01271712|530739817|FG001|Open Label Treatment|Adverse Event|8|||
147157217|NCT01271712|530739816|FG000|Open Label Treatment|Progressive disease|59|||
147157218|NCT01271712|530739817|FG001|Open Label Treatment|Progressive disease|32|||
147157219|NCT01271712|530739816|FG000|Open Label Treatment|transferred to rollover study|1|||
147157220|NCT01271712|530739817|FG001|Open Label Treatment|transferred to rollover study|0|||
147157221|NCT01271712|530739816|FG000|Open Label Treatment|Non-compliance with study drug|1|||
147157222|NCT01271712|530739817|FG001|Open Label Treatment|Non-compliance with study drug|0|||
147157223|NCT01271712|530739816|FG000|Open Label Treatment|Protocol Violation|0|||
147157224|NCT01271712|530739817|FG001|Open Label Treatment|Protocol Violation|1|||
147157225|NCT01271712|530739816|FG000|Open Label Treatment|Switching to other therapy|2|||
147157226|NCT01271712|530739817|FG001|Open Label Treatment|Switching to other therapy|1|||
147157227|NCT01271712|530739816|FG000|Safety Follow-up|Death|11|||
147157228|NCT01271712|530739817|FG001|Safety Follow-up|Death|7|||
147157229|NCT01271712|530739816|FG000|Safety Follow-up|Withdrawal by Subject|4|||
147157230|NCT01271712|530739817|FG001|Safety Follow-up|Withdrawal by Subject|2|||
147157231|NCT01271712|530739816|FG000|Safety Follow-up|Protocol Violation|1|||
147157232|NCT01271712|530739817|FG001|Safety Follow-up|Protocol Violation|1|||
147157233|NCT01271712|530739816|FG000|Safety Follow-up|Not analyzed after cutoff 08Jun2015|3|||
147157234|NCT01271712|530739817|FG001|Safety Follow-up|Not analyzed after cutoff 08Jun2015|4|||
147157235|NCT01271712|530739816|FG000|Safety Follow-up|No follow-up|1|||
147157236|NCT01271712|530739817|FG001|Safety Follow-up|No follow-up|1|||
147157237|NCT01271712|530739816|FG000|Safety Follow-up|Progressive disease|1|||
147157238|NCT01271712|530739817|FG001|Safety Follow-up|Progressive disease|0|||
147157239|NCT01271712|530739816|FG000|Survival Follow-up|Not analyzed after cutoff 08Jun2015|15|||
147157240|NCT01271712|530739817|FG001|Survival Follow-up|Not analyzed after cutoff 08Jun2015|6|||
147157241|NCT03099174|530739819|FG000|Overall Study|Withdrawal by Subject|0|||
147157242|NCT03099174|530739820|FG001|Overall Study|Withdrawal by Subject|0|||
147157243|NCT03099174|530739821|FG002|Overall Study|Withdrawal by Subject|1|||
147157244|NCT03099174|530739822|FG003|Overall Study|Withdrawal by Subject|0|||
147157245|NCT03099174|530739823|FG004|Overall Study|Withdrawal by Subject|2|||
147157246|NCT03099174|530739824|FG005|Overall Study|Withdrawal by Subject|2|||
147157247|NCT03099174|530739825|FG006|Overall Study|Withdrawal by Subject|1|||
147157248|NCT03099174|530739826|FG007|Overall Study|Withdrawal by Subject|4|||
147157249|NCT03099174|530739819|FG000|Overall Study|Adverse Event|0|||
147157250|NCT03099174|530739820|FG001|Overall Study|Adverse Event|1|||
147157251|NCT03099174|530739821|FG002|Overall Study|Adverse Event|1|||
147157252|NCT03099174|530739822|FG003|Overall Study|Adverse Event|2|||
147157253|NCT03099174|530739823|FG004|Overall Study|Adverse Event|5|||
147240976|NCT00329238|531053544|FG001|Overall Study|Withdrawal by Subject|58|||
147240977|NCT00329238|531053543|FG000|Overall Study|Other reason (not specified)|40|||
147157254|NCT03099174|530739824|FG005|Overall Study|Adverse Event|3|||
147157255|NCT03099174|530739825|FG006|Overall Study|Adverse Event|6|||
147157256|NCT03099174|530739826|FG007|Overall Study|Adverse Event|4|||
147157257|NCT03099174|530739819|FG000|Overall Study|Other than listed|6|||
147157258|NCT03099174|530739820|FG001|Overall Study|Other than listed|6|||
147157259|NCT03099174|530739821|FG002|Overall Study|Other than listed|5|||
147157260|NCT03099174|530739822|FG003|Overall Study|Other than listed|6|||
147157261|NCT03099174|530739823|FG004|Overall Study|Other than listed|19|||
147157262|NCT03099174|530739824|FG005|Overall Study|Other than listed|10|||
147157263|NCT03099174|530739825|FG006|Overall Study|Other than listed|26|||
147157264|NCT03099174|530739826|FG007|Overall Study|Other than listed|23|||
147157265|NCT04173260|530739827|FG000|Overall Study|Early termination|4|||
147157266|NCT02308163|530739828|FG000|Overall Study|Not fulfill eligible criteria|1|||
147157267|NCT02308163|530739829|FG001|Overall Study|Not fulfill eligible criteria|2|||
147157268|NCT02308163|530739830|FG002|Overall Study|Not fulfill eligible criteria|0|||
147157269|NCT02308163|530739831|FG003|Overall Study|Not fulfill eligible criteria|1|||
147157270|NCT02308163|530739832|FG004|Overall Study|Not fulfill eligible criteria|1|||
147157271|NCT02308163|530739828|FG000|Overall Study|Adverse Event|9|||
147157272|NCT02308163|530739829|FG001|Overall Study|Adverse Event|5|||
147157273|NCT02308163|530739830|FG002|Overall Study|Adverse Event|2|||
147157274|NCT02308163|530739831|FG003|Overall Study|Adverse Event|2|||
147157275|NCT02308163|530739832|FG004|Overall Study|Adverse Event|11|||
147157276|NCT02308163|530739828|FG000|Overall Study|Lack of Efficacy|11|||
147157277|NCT02308163|530739829|FG001|Overall Study|Lack of Efficacy|3|||
147157278|NCT02308163|530739830|FG002|Overall Study|Lack of Efficacy|8|||
147157279|NCT02308163|530739831|FG003|Overall Study|Lack of Efficacy|4|||
147157280|NCT02308163|530739832|FG004|Overall Study|Lack of Efficacy|6|||
147157281|NCT02308163|530739828|FG000|Overall Study|Withdrawal of consent|2|||
147157282|NCT02308163|530739829|FG001|Overall Study|Withdrawal of consent|3|||
147157283|NCT02308163|530739830|FG002|Overall Study|Withdrawal of consent|0|||
147157284|NCT02308163|530739831|FG003|Overall Study|Withdrawal of consent|2|||
147157285|NCT02308163|530739832|FG004|Overall Study|Withdrawal of consent|6|||
147157286|NCT02308163|530739828|FG000|Overall Study|Protocol Violation|3|||
147157287|NCT02308163|530739829|FG001|Overall Study|Protocol Violation|3|||
147157288|NCT02308163|530739830|FG002|Overall Study|Protocol Violation|3|||
147157289|NCT02308163|530739831|FG003|Overall Study|Protocol Violation|2|||
147157290|NCT02308163|530739832|FG004|Overall Study|Protocol Violation|5|||
147157291|NCT02308163|530739828|FG000|Overall Study|Lab data met discontinuation criteria|3|||
147157292|NCT02308163|530739829|FG001|Overall Study|Lab data met discontinuation criteria|0|||
147157293|NCT02308163|530739830|FG002|Overall Study|Lab data met discontinuation criteria|0|||
147157294|NCT02308163|530739831|FG003|Overall Study|Lab data met discontinuation criteria|2|||
147157295|NCT02308163|530739832|FG004|Overall Study|Lab data met discontinuation criteria|0|||
147157296|NCT02308163|530739828|FG000|Overall Study|Miscellaneous|2|||
147157297|NCT02308163|530739829|FG001|Overall Study|Miscellaneous|2|||
147157298|NCT02308163|530739830|FG002|Overall Study|Miscellaneous|1|||
147157299|NCT02308163|530739831|FG003|Overall Study|Miscellaneous|0|||
147157300|NCT02308163|530739832|FG004|Overall Study|Miscellaneous|5|||
147157301|NCT02118766|530739838|FG000|Overall Study|Adverse Event|7|||
147157302|NCT02118766|530739839|FG001|Overall Study|Adverse Event|2|||
147157303|NCT02118766|530739838|FG000|Overall Study|Withdrawal by Subject|3|||
147157304|NCT02118766|530739839|FG001|Overall Study|Withdrawal by Subject|6|||
147157305|NCT02118766|530739838|FG000|Overall Study|Lost to Follow-up|5|||
147157306|NCT02118766|530739839|FG001|Overall Study|Lost to Follow-up|4|||
147157307|NCT02118766|530739838|FG000|Overall Study|Withdrawal by parent/guardian|12|||
147157308|NCT02118766|530739839|FG001|Overall Study|Withdrawal by parent/guardian|18|||
147157309|NCT02118766|530739838|FG000|Overall Study|Other|3|||
147157310|NCT02118766|530739839|FG001|Overall Study|Other|1|||
147157311|NCT03941964|530739840|FG000|Overall Study|Adverse Event|1|||
147157312|NCT03941964|530739841|FG001|Overall Study|Adverse Event|8|||
147157313|NCT03941964|530739840|FG000|Overall Study|Progressive disease|7|||
147240978|NCT00329238|531053544|FG001|Overall Study|Other reason (not specified)|54|||
147240979|NCT00801632|531053545|FG000|Overall Study|Re-transplant|1|||
147240980|NCT00963937|531053550|FG000|Overall Study|Protocol Violation|1|||
147240981|NCT00963937|531053551|FG001|Overall Study|Protocol Violation|1|||
147240982|NCT00963937|531053552|FG002|Overall Study|Protocol Violation|0|||
147240983|NCT00963937|531053550|FG000|Overall Study|Physician Decision|18|||
147240984|NCT00963937|531053551|FG001|Overall Study|Physician Decision|10|||
147240985|NCT00963937|531053552|FG002|Overall Study|Physician Decision|4|||
147240986|NCT03846804|531053553|FG000|Overall Study|Refused blood draw|1|||
147240987|NCT03846804|531053553|FG000|Overall Study|Protocol Violation|1|||
147240988|NCT00824720|531053554|FG000|Overall Study|failed plug insertion|3|||
147240989|NCT00824720|531053555|FG001|Overall Study|failed plug insertion|1|||
147240990|NCT00824720|531053556|FG002|Overall Study|failed plug insertion|0|||
147240991|NCT00824720|531053554|FG000|Overall Study|Protocol Violation|0|||
147240992|NCT00824720|531053555|FG001|Overall Study|Protocol Violation|0|||
147240993|NCT00824720|531053556|FG002|Overall Study|Protocol Violation|1|||
147240994|NCT02339584|531053557|FG000|Overall Study|Adverse Event|11|||
147157314|NCT03941964|530739841|FG001|Overall Study|Progressive disease|3|||
147446822|NCT01967628|531800313|FG000|Overall Study|Low protein concentration in sample|20|||
147157315|NCT03941964|530739840|FG000|Overall Study|Lack of Efficacy|0|||
147157316|NCT03941964|530739841|FG001|Overall Study|Lack of Efficacy|1|||
147157317|NCT03941964|530739840|FG000|Overall Study|Death|3|||
147240995|NCT02339584|531053558|FG001|Overall Study|Adverse Event|7|||
147157318|NCT03941964|530739841|FG001|Overall Study|Death|1|||
147157319|NCT03941964|530739840|FG000|Overall Study|Withdrew consent|1|||
147157320|NCT03941964|530739841|FG001|Overall Study|Withdrew consent|3|||
147240996|NCT02339584|531053557|FG000|Overall Study|Lack of Efficacy|0|||
147157321|NCT03941964|530739840|FG000|Overall Study|Physician Decision|9|||
147157322|NCT03941964|530739841|FG001|Overall Study|Physician Decision|2|||
147157323|NCT03941964|530739840|FG000|Overall Study|Other, not specified|2|||
147157324|NCT03941964|530739841|FG001|Overall Study|Other, not specified|1|||
147157325|NCT00118846|530739843|FG000|Overall Study|Gastrointestinal (GI) intolerance|3|||
147157326|NCT00118846|530739844|FG001|Overall Study|Gastrointestinal (GI) intolerance|3|||
147157327|NCT00118846|530739843|FG000|Overall Study|Started menopausal hormone replacement therapy (HRT)|3|||
147157328|NCT00118846|530739844|FG001|Overall Study|Started menopausal hormone replacement therapy (HRT)|0|||
147157329|NCT00118846|530739843|FG000|Overall Study|Physician Decision|1|||
147157330|NCT00118846|530739844|FG001|Overall Study|Physician Decision|0|||
147157331|NCT00118846|530739843|FG000|Overall Study|Medical condition|2|||
147157332|NCT00118846|530739844|FG001|Overall Study|Medical condition|2|||
147157333|NCT00118846|530739843|FG000|Overall Study|Lost to Follow-up|0|||
147157334|NCT00118846|530739844|FG001|Overall Study|Lost to Follow-up|2|||
147157335|NCT00118846|530739843|FG000|Overall Study|Personal reason|4|||
147157336|NCT00118846|530739844|FG001|Overall Study|Personal reason|5|||
147157337|NCT04669262|530739848|FG000|Overall Study|Withdrawal by Subject|0|||
147157338|NCT04669262|530739849|FG001|Overall Study|Withdrawal by Subject|0|||
147157339|NCT04669262|530739850|FG002|Overall Study|Withdrawal by Subject|0|||
147157340|NCT04669262|530739851|FG003|Overall Study|Withdrawal by Subject|1|||
147157341|NCT04669262|530739848|FG000|Overall Study|Randomized but Not Treated|0|||
147157342|NCT04669262|530739849|FG001|Overall Study|Randomized but Not Treated|1|||
147157343|NCT04669262|530739850|FG002|Overall Study|Randomized but Not Treated|0|||
147157344|NCT04669262|530739851|FG003|Overall Study|Randomized but Not Treated|0|||
147157345|NCT05463744|530739852|FG000|Treatment Period|Withdrawal by Subject|19|||
147157346|NCT05463744|530739853|FG001|Treatment Period|Withdrawal by Subject|16|||
147157347|NCT05463744|530739852|FG000|Treatment Period|Adverse Event|4|||
147157348|NCT05463744|530739853|FG001|Treatment Period|Adverse Event|4|||
147157349|NCT05463744|530739852|FG000|Treatment Period|Pregnancy|0|||
147157350|NCT05463744|530739853|FG001|Treatment Period|Pregnancy|3|||
147157351|NCT05463744|530739852|FG000|Treatment Period|Lost to Follow-up|1|||
147157352|NCT05463744|530739853|FG001|Treatment Period|Lost to Follow-up|3|||
147157353|NCT05463744|530739852|FG000|Treatment Period|Inadvertent enrollment|2|||
147157354|NCT05463744|530739853|FG001|Treatment Period|Inadvertent enrollment|1|||
147157355|NCT05463744|530739852|FG000|Treatment Period|Death|0|||
147157356|NCT05463744|530739853|FG001|Treatment Period|Death|1|||
147157357|NCT05463744|530739852|FG000|Treatment Period|Non-compliance with Study Drug|1|||
147157358|NCT05463744|530739853|FG001|Treatment Period|Non-compliance with Study Drug|0|||
147157359|NCT05463744|530739852|FG000|Treatment Period|Subject Terminated by Sponsor|0|||
147157360|NCT05463744|530739853|FG001|Treatment Period|Subject Terminated by Sponsor|1|||
147157361|NCT05463744|530739852|FG000|Treatment Period|Physician Decision|0|||
147157362|NCT05463744|530739853|FG001|Treatment Period|Physician Decision|1|||
147157363|NCT05463744|530739852|FG000|Follow-Up Period|Withdrawal by Subject|3|||
147157364|NCT05463744|530739853|FG001|Follow-Up Period|Withdrawal by Subject|1|||
147157365|NCT05463744|530739852|FG000|Follow-Up Period|Lost to Follow-up|1|||
147157366|NCT05463744|530739853|FG001|Follow-Up Period|Lost to Follow-up|1|||
147157367|NCT00068250|530739856|FG000|Phase I: Dose Level 2|Protocol Violation|0|||
147583960|NCT01190930|532293630|FG001|Induction|High Risk|0|||
147583961|NCT01190930|532293631|FG002|Induction|High Risk|0|||
147583962|NCT01190930|532293632|FG003|Induction|High Risk|0|||
147583963|NCT01190930|532293633|FG004|Induction|High Risk|0|||
147583964|NCT01190930|532293634|FG005|Induction|High Risk|0|||
147583965|NCT01190930|532293635|FG006|Induction|High Risk|0|||
147583966|NCT01190930|532293636|FG007|Induction|High Risk|0|||
147583967|NCT01190930|532293637|FG008|Induction|High Risk|0|||
147583968|NCT01190930|532293638|FG009|Induction|High Risk|0|||
147583969|NCT01190930|532293629|FG000|Induction|Low Risk|443|||
147583970|NCT01190930|532293630|FG001|Induction|Low Risk|0|||
147583971|NCT01190930|532293631|FG002|Induction|Low Risk|0|||
147583972|NCT01190930|532293632|FG003|Induction|Low Risk|0|||
147583973|NCT01190930|532293633|FG004|Induction|Low Risk|0|||
147583974|NCT01190930|532293634|FG005|Induction|Low Risk|0|||
147157368|NCT00068250|530739857|FG001|Phase I: Dose Level 2|Protocol Violation|1|||
147157369|NCT00068250|530739858|FG002|Phase I: Dose Level 2|Protocol Violation|0|||
147157370|NCT00068250|530739859|FG003|Phase I: Dose Level 2|Protocol Violation|0|||
147157371|NCT01357161|530739860|FG000|Part 1 (Open Label Run-in)|Death|5|||
147157372|NCT01357161|530739861|FG001|Part 1 (Open Label Run-in)|Death|0|||
147157373|NCT01357161|530739862|FG002|Part 1 (Open Label Run-in)|Death|0|||
147157374|NCT01357161|530739860|FG000|Part 1 (Open Label Run-in)|Lost to Follow-up|3|||
147157375|NCT01357161|530739861|FG001|Part 1 (Open Label Run-in)|Lost to Follow-up|0|||
147157376|NCT01357161|530739862|FG002|Part 1 (Open Label Run-in)|Lost to Follow-up|0|||
147157377|NCT01357161|530739860|FG000|Part 1 (Open Label Run-in)|Physician Decision|1|||
147583975|NCT01190930|532293635|FG006|Induction|Low Risk|0|||
147583976|NCT01190930|532293636|FG007|Induction|Low Risk|0|||
147583977|NCT01190930|532293637|FG008|Induction|Low Risk|0|||
147583978|NCT01190930|532293638|FG009|Induction|Low Risk|0|||
147583979|NCT01190930|532293629|FG000|Induction|Very High Risk|1012|||
147583980|NCT01190930|532293630|FG001|Induction|Very High Risk|0|||
147583981|NCT01190930|532293631|FG002|Induction|Very High Risk|0|||
147583982|NCT01190930|532293632|FG003|Induction|Very High Risk|0|||
147583983|NCT01190930|532293633|FG004|Induction|Very High Risk|0|||
147583984|NCT01190930|532293634|FG005|Induction|Very High Risk|0|||
147157378|NCT01357161|530739861|FG001|Part 1 (Open Label Run-in)|Physician Decision|0|||
147157379|NCT01357161|530739862|FG002|Part 1 (Open Label Run-in)|Physician Decision|0|||
147157380|NCT01357161|530739860|FG000|Part 1 (Open Label Run-in)|Study Terminated By Sponsor|5|||
147157381|NCT01357161|530739861|FG001|Part 1 (Open Label Run-in)|Study Terminated By Sponsor|0|||
147157382|NCT01357161|530739862|FG002|Part 1 (Open Label Run-in)|Study Terminated By Sponsor|0|||
147157383|NCT01357161|530739860|FG000|Part 1 (Open Label Run-in)|Withdrawal by Subject|1|||
147157384|NCT01357161|530739861|FG001|Part 1 (Open Label Run-in)|Withdrawal by Subject|0|||
147157385|NCT01357161|530739862|FG002|Part 1 (Open Label Run-in)|Withdrawal by Subject|0|||
147157386|NCT01357161|530739860|FG000|Part 2 (Double-Blind Comparison)|Death|0|||
147157387|NCT01357161|530739861|FG001|Part 2 (Double-Blind Comparison)|Death|22|||
147157388|NCT01357161|530739862|FG002|Part 2 (Double-Blind Comparison)|Death|19|||
147157389|NCT01357161|530739860|FG000|Part 2 (Double-Blind Comparison)|Lost to Follow-up|0|||
147157390|NCT01357161|530739861|FG001|Part 2 (Double-Blind Comparison)|Lost to Follow-up|1|||
147157391|NCT01357161|530739862|FG002|Part 2 (Double-Blind Comparison)|Lost to Follow-up|6|||
147157392|NCT01357161|530739860|FG000|Part 2 (Double-Blind Comparison)|Physician Decision|0|||
147157393|NCT01357161|530739861|FG001|Part 2 (Double-Blind Comparison)|Physician Decision|1|||
147157394|NCT01357161|530739862|FG002|Part 2 (Double-Blind Comparison)|Physician Decision|4|||
147157395|NCT01357161|530739860|FG000|Part 2 (Double-Blind Comparison)|Progressive Disease|0|||
147157396|NCT01357161|530739861|FG001|Part 2 (Double-Blind Comparison)|Progressive Disease|1|||
147157397|NCT01357161|530739862|FG002|Part 2 (Double-Blind Comparison)|Progressive Disease|3|||
147157398|NCT01357161|530739860|FG000|Part 2 (Double-Blind Comparison)|Study Terminated By Sponsor|0|||
147157399|NCT01357161|530739861|FG001|Part 2 (Double-Blind Comparison)|Study Terminated By Sponsor|29|||
147157400|NCT01357161|530739862|FG002|Part 2 (Double-Blind Comparison)|Study Terminated By Sponsor|26|||
147157401|NCT01357161|530739860|FG000|Part 2 (Double-Blind Comparison)|Withdrawal by Subject|0|||
147157402|NCT01357161|530739861|FG001|Part 2 (Double-Blind Comparison)|Withdrawal by Subject|5|||
147157403|NCT01357161|530739862|FG002|Part 2 (Double-Blind Comparison)|Withdrawal by Subject|4|||
147157404|NCT01824823|530739863|FG000|Overall Study|Lack of Efficacy|1|||
147157405|NCT01824823|530739864|FG001|Overall Study|Lack of Efficacy|1|||
147157406|NCT01824823|530739863|FG000|Overall Study|Off-treatment reason not submitted|1|||
147157407|NCT01824823|530739864|FG001|Overall Study|Off-treatment reason not submitted|0|||
147157408|NCT00098748|530739866|FG000|Assigned to Study Treatment|Randomized, but not treated|0|||
147157409|NCT00098748|530739867|FG001|Assigned to Study Treatment|Randomized, but not treated|2|||
147157410|NCT00098748|530739868|FG002|Assigned to Study Treatment|Randomized, but not treated|2|||
147157411|NCT00098748|530739866|FG000|Received Study Treatment|Death|2|||
147157412|NCT00098748|530739867|FG001|Received Study Treatment|Death|1|||
147157413|NCT00098748|530739868|FG002|Received Study Treatment|Death|2|||
147157414|NCT00098748|530739866|FG000|Received Study Treatment|Adverse Event|1|||
147157415|NCT00098748|530739867|FG001|Received Study Treatment|Adverse Event|2|||
147157416|NCT00098748|530739868|FG002|Received Study Treatment|Adverse Event|5|||
147157417|NCT00098748|530739866|FG000|Received Study Treatment|Lack of Efficacy|40|||
147157418|NCT00098748|530739867|FG001|Received Study Treatment|Lack of Efficacy|27|||
147157419|NCT00098748|530739868|FG002|Received Study Treatment|Lack of Efficacy|27|||
147157420|NCT00098748|530739866|FG000|Received Study Treatment|Other|2|||
147157421|NCT00098748|530739867|FG001|Received Study Treatment|Other|2|||
147157422|NCT00098748|530739868|FG002|Received Study Treatment|Other|6|||
147157423|NCT00098748|530739866|FG000|Received Study Treatment|Subject defaulted|3|||
147157424|NCT00098748|530739867|FG001|Received Study Treatment|Subject defaulted|4|||
147157425|NCT00098748|530739868|FG002|Received Study Treatment|Subject defaulted|4|||
147157426|NCT00098748|530739866|FG000|Continued on Open-Label Treatment|Adverse Event|0|||
147157427|NCT00098748|530739867|FG001|Continued on Open-Label Treatment|Adverse Event|1|||
147157428|NCT00098748|530739868|FG002|Continued on Open-Label Treatment|Adverse Event|0|||
147157429|NCT00098748|530739866|FG000|Continued on Open-Label Treatment|Lack of Efficacy|1|||
147157430|NCT00098748|530739867|FG001|Continued on Open-Label Treatment|Lack of Efficacy|2|||
147157431|NCT00098748|530739868|FG002|Continued on Open-Label Treatment|Lack of Efficacy|0|||
147157432|NCT00098748|530739866|FG000|Continued on Open-Label Treatment|Other reason includes protocol violation|6|||
147157433|NCT00098748|530739867|FG001|Continued on Open-Label Treatment|Other reason includes protocol violation|7|||
147583985|NCT01190930|532293635|FG006|Induction|Very High Risk|0|||
147583986|NCT01190930|532293636|FG007|Induction|Very High Risk|0|||
147583987|NCT01190930|532293637|FG008|Induction|Very High Risk|0|||
147157434|NCT00098748|530739868|FG002|Continued on Open-Label Treatment|Other reason includes protocol violation|0|||
147157435|NCT00098748|530739866|FG000|Continued on Open-Label Treatment|Lost to Follow-up|1|||
147157436|NCT00098748|530739867|FG001|Continued on Open-Label Treatment|Lost to Follow-up|1|||
147157437|NCT00098748|530739868|FG002|Continued on Open-Label Treatment|Lost to Follow-up|0|||
147240997|NCT02339584|531053558|FG001|Overall Study|Lack of Efficacy|1|||
147583988|NCT01190930|532293638|FG009|Induction|Very High Risk|0|||
147583989|NCT01190930|532293629|FG000|Induction|Philadelphia chromosome-positive|99|||
147583990|NCT01190930|532293630|FG001|Induction|Philadelphia chromosome-positive|0|||
147157438|NCT00098748|530739866|FG000|Continued on Open-Label Treatment|Withdrawal by Subject|0|||
147157439|NCT00098748|530739867|FG001|Continued on Open-Label Treatment|Withdrawal by Subject|4|||
147157440|NCT00098748|530739868|FG002|Continued on Open-Label Treatment|Withdrawal by Subject|0|||
147157441|NCT00433160|530739873|FG000|52-Week Double-Blind (DB) Period|Adverse Event|6|||
147157442|NCT00433160|530739874|FG001|52-Week Double-Blind (DB) Period|Adverse Event|2|||
147157443|NCT00433160|530739873|FG000|52-Week Double-Blind (DB) Period|Death|0|||
147157444|NCT00433160|530739874|FG001|52-Week Double-Blind (DB) Period|Death|0|||
147157445|NCT00433160|530739873|FG000|52-Week Double-Blind (DB) Period|Lost to Follow-up|0|||
147157446|NCT00433160|530739874|FG001|52-Week Double-Blind (DB) Period|Lost to Follow-up|0|||
147157447|NCT00433160|530739873|FG000|52-Week Double-Blind (DB) Period|Entry Criteria Exclusion|0|||
147157448|NCT00433160|530739874|FG001|52-Week Double-Blind (DB) Period|Entry Criteria Exclusion|1|||
147157449|NCT00433160|530739873|FG000|52-Week Double-Blind (DB) Period|Protocol Violation|0|||
147157450|NCT00433160|530739874|FG001|52-Week Double-Blind (DB) Period|Protocol Violation|2|||
147157451|NCT00433160|530739873|FG000|52-Week Double-Blind (DB) Period|Withdrawal by Subject|6|||
147157452|NCT00433160|530739874|FG001|52-Week Double-Blind (DB) Period|Withdrawal by Subject|1|||
147157453|NCT00433160|530739873|FG000|52-Week Double-Blind (DB) Period|Physician Decision|4|||
147157454|NCT00433160|530739874|FG001|52-Week Double-Blind (DB) Period|Physician Decision|2|||
147157455|NCT00433160|530739873|FG000|52-Week Double-Blind (DB) Period|Sponsor Decision|0|||
147157456|NCT00433160|530739874|FG001|52-Week Double-Blind (DB) Period|Sponsor Decision|0|||
147157457|NCT00433160|530739873|FG000|52-Week Double-Blind (DB) Period|Lack of Efficacy|1|||
147157458|NCT00433160|530739874|FG001|52-Week Double-Blind (DB) Period|Lack of Efficacy|2|||
147157459|NCT00433160|530739873|FG000|76 Weeks, 24-Week Open Label (OL) Period|Adverse Event|3|||
147157460|NCT00433160|530739874|FG001|76 Weeks, 24-Week Open Label (OL) Period|Adverse Event|1|||
147157461|NCT00433160|530739873|FG000|76 Weeks, 24-Week Open Label (OL) Period|Withdrawal by Subject|1|||
147157462|NCT00433160|530739874|FG001|76 Weeks, 24-Week Open Label (OL) Period|Withdrawal by Subject|2|||
147157463|NCT00433160|530739873|FG000|76 Weeks, 24-Week Open Label (OL) Period|Physician Decision|2|||
147157464|NCT00433160|530739874|FG001|76 Weeks, 24-Week Open Label (OL) Period|Physician Decision|0|||
147157465|NCT00433160|530739873|FG000|76 Weeks, 24-Week Open Label (OL) Period|Lack of Efficacy|0|||
147157466|NCT00433160|530739874|FG001|76 Weeks, 24-Week Open Label (OL) Period|Lack of Efficacy|1|||
147157467|NCT00433160|530739873|FG000|104 Weeks, 28-Week OL Period|Adverse Event|2|||
147157468|NCT00433160|530739874|FG001|104 Weeks, 28-Week OL Period|Adverse Event|0|||
147157469|NCT00433160|530739873|FG000|104 Weeks, 28-Week OL Period|Withdrawal by Subject|8|||
147157470|NCT00433160|530739874|FG001|104 Weeks, 28-Week OL Period|Withdrawal by Subject|2|||
147157471|NCT00433160|530739873|FG000|104 Weeks, 28-Week OL Period|Physician Decision|0|||
147157472|NCT00433160|530739874|FG001|104 Weeks, 28-Week OL Period|Physician Decision|1|||
147157473|NCT01288612|530741761|FG000|Overall Study|Unable to contact|11|||
147157474|NCT01288612|530741762|FG001|Overall Study|Unable to contact|16|||
147157475|NCT01288612|530741763|FG002|Overall Study|Unable to contact|20|||
147157476|NCT01288612|530741761|FG000|Overall Study|Declined|78|||
147157477|NCT01288612|530741762|FG001|Overall Study|Declined|63|||
147157478|NCT01288612|530741763|FG002|Overall Study|Declined|62|||
147157479|NCT01288612|530741761|FG000|Overall Study|Unable to intubate|0|||
147157480|NCT01288612|530741762|FG001|Overall Study|Unable to intubate|3|||
147157481|NCT01288612|530741763|FG002|Overall Study|Unable to intubate|0|||
147157482|NCT00840060|530741764|FG000|Overall Study|Withdrawal by Subject|1|||
147157483|NCT00840060|530741765|FG001|Overall Study|Withdrawal by Subject|0|||
147157484|NCT00840060|530741764|FG000|Overall Study|Change in emotional/behavioral status|0|||
147157485|NCT00840060|530741765|FG001|Overall Study|Change in emotional/behavioral status|1|||
147157486|NCT01263015|530741766|FG000|Double-blind Phase: 96 Weeks Duration|Adverse Event|13|||
147157487|NCT01263015|530741767|FG001|Double-blind Phase: 96 Weeks Duration|Adverse Event|48|||
147157488|NCT01263015|530741766|FG000|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|18|||
147157489|NCT01263015|530741767|FG001|Double-blind Phase: 96 Weeks Duration|Lack of Efficacy|14|||
147157490|NCT01263015|530741766|FG000|Double-blind Phase: 96 Weeks Duration|Protocol Violation|14|||
147157491|NCT01263015|530741767|FG001|Double-blind Phase: 96 Weeks Duration|Protocol Violation|12|||
147157492|NCT01263015|530741766|FG000|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|17|||
147157493|NCT01263015|530741767|FG001|Double-blind Phase: 96 Weeks Duration|Lost to Follow-up|18|||
147157494|NCT01263015|530741766|FG000|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|9|||
147157495|NCT01263015|530741767|FG001|Double-blind Phase: 96 Weeks Duration|Withdrawal by Subject|15|||
147157496|NCT01263015|530741766|FG000|Double-blind Phase: 96 Weeks Duration|Physician Decision|1|||
147157497|NCT01263015|530741767|FG001|Double-blind Phase: 96 Weeks Duration|Physician Decision|2|||
147157498|NCT01263015|530741766|FG000|Open-label Phase: 48 Weeks Duration|Adverse Event|3|||
147157499|NCT01263015|530741767|FG001|Open-label Phase: 48 Weeks Duration|Adverse Event|10|||
147240998|NCT02339584|531053557|FG000|Overall Study|Physician Decision|1|||
147240999|NCT02339584|531053558|FG001|Overall Study|Physician Decision|2|||
147241000|NCT02339584|531053557|FG000|Overall Study|Protocol Violation|1|||
147241001|NCT02339584|531053558|FG001|Overall Study|Protocol Violation|1|||
147241002|NCT02339584|531053557|FG000|Overall Study|Withdrawal by Subject|2|||
147241003|NCT02339584|531053558|FG001|Overall Study|Withdrawal by Subject|4|||
147241004|NCT00743483|531053559|FG000|Baseline Period|Physician Decision|1|||
147241005|NCT00743483|531053559|FG000|Treatment Period|Adverse Event|1|||
147157500|NCT01263015|530741766|FG000|Open-label Phase: 48 Weeks Duration|Lack of Efficacy|7|||
147157501|NCT01263015|530741767|FG001|Open-label Phase: 48 Weeks Duration|Lack of Efficacy|2|||
147157502|NCT01263015|530741766|FG000|Open-label Phase: 48 Weeks Duration|Protocol Violation|3|||
147157503|NCT01263015|530741767|FG001|Open-label Phase: 48 Weeks Duration|Protocol Violation|2|||
147157504|NCT01263015|530741766|FG000|Open-label Phase: 48 Weeks Duration|Lost to Follow-up|8|||
147157505|NCT01263015|530741767|FG001|Open-label Phase: 48 Weeks Duration|Lost to Follow-up|8|||
147157506|NCT01263015|530741766|FG000|Open-label Phase: 48 Weeks Duration|Physician Decision|0|||
147157507|NCT01263015|530741767|FG001|Open-label Phase: 48 Weeks Duration|Physician Decision|2|||
147157508|NCT01263015|530741766|FG000|Open-label Phase: 48 Weeks Duration|Withdrawal by Subject|3|||
147157509|NCT01263015|530741767|FG001|Open-label Phase: 48 Weeks Duration|Withdrawal by Subject|7|||
147157510|NCT00445939|530741768|FG000|Period A - Week 0 - Week 4|Adverse Event|1|||
147157511|NCT00445939|530741769|FG001|Period A - Week 0 - Week 4|Adverse Event|2|||
147157512|NCT00445939|530741770|FG002|Period A - Week 0 - Week 4|Adverse Event|0|||
147157513|NCT00445939|530741771|FG003|Period A - Week 0 - Week 4|Adverse Event|0|||
147157514|NCT00445939|530741768|FG000|Period B - Week 4 - Week 8|Adverse Event|2|||
147157515|NCT00445939|530741769|FG001|Period B - Week 4 - Week 8|Adverse Event|0|||
147157516|NCT00445939|530741770|FG002|Period B - Week 4 - Week 8|Adverse Event|0|||
147157517|NCT00445939|530741771|FG003|Period B - Week 4 - Week 8|Adverse Event|1|||
147157518|NCT02576535|530741785|FG000|Overall Study|Withdrawal by Subject|2|||
147157519|NCT01691885|530741787|FG000|Treatment Period 1(7-14 Days)|Adverse Event|1|||
147157520|NCT01691885|530741788|FG001|Treatment Period 1(7-14 Days)|Adverse Event|1|||
147157521|NCT01691885|530741787|FG000|Washout Period (7-9 Days)|Adverse Event|0|||
147157522|NCT01691885|530741788|FG001|Washout Period (7-9 Days)|Adverse Event|1|||
147157523|NCT03555981|530741789|FG000|Overall Study|Lost to Follow-up|0|||
147157524|NCT03555981|530741790|FG001|Overall Study|Lost to Follow-up|2|||
147157525|NCT00354107|530741791|FG000|Overall Study|Adverse Event|2|||
147157526|NCT00354107|530741791|FG000|Overall Study|Physician Decision|2|||
147157527|NCT00354107|530741791|FG000|Overall Study|Withdrawal by Subject|1|||
147157528|NCT04035564|530741793|FG000|Overall Study|Protocol Violation|1|||
147157529|NCT04035564|530741794|FG001|Overall Study|Protocol Violation|2|||
147157530|NCT04035564|530741793|FG000|Overall Study|No laboratory available|2|||
147157531|NCT04035564|530741794|FG001|Overall Study|No laboratory available|2|||
147157532|NCT04035564|530741793|FG000|Overall Study|Guardian declined consent|1|||
147157533|NCT04035564|530741794|FG001|Overall Study|Guardian declined consent|2|||
147157534|NCT00996281|530741798|FG000|Overall Study|Adverse Event|75|||
147157535|NCT00996281|530741799|FG001|Overall Study|Adverse Event|37|||
147157536|NCT00996281|530741798|FG000|Overall Study|Major Protocol Deviation|6|||
147157537|NCT00996281|530741799|FG001|Overall Study|Major Protocol Deviation|7|||
147157538|NCT00996281|530741798|FG000|Overall Study|Lost to Follow-up|14|||
147157539|NCT00996281|530741799|FG001|Overall Study|Lost to Follow-up|16|||
147157540|NCT00996281|530741798|FG000|Overall Study|Withdrawal by Subject|31|||
147157541|NCT00996281|530741799|FG001|Overall Study|Withdrawal by Subject|20|||
147157542|NCT00996281|530741798|FG000|Overall Study|Lack of Efficacy|0|||
147157543|NCT00996281|530741799|FG001|Overall Study|Lack of Efficacy|2|||
147157544|NCT00996281|530741798|FG000|Overall Study|Other|5|||
147157545|NCT00996281|530741799|FG001|Overall Study|Other|7|||
147157546|NCT03505788|530741802|FG000|Overall Study|Lost to Follow-up|2|||
147157547|NCT03505788|530741803|FG001|Overall Study|Lost to Follow-up|1|||
147157548|NCT03505788|530741802|FG000|Overall Study|Withdrawal by Subject|1|||
147157549|NCT03505788|530741803|FG001|Overall Study|Withdrawal by Subject|3|||
147157550|NCT03505788|530741802|FG000|Overall Study|Physician Decision|0|||
147157551|NCT03505788|530741803|FG001|Overall Study|Physician Decision|1|||
147157552|NCT03575065|530741804|FG000|Overall Study|Death|31|||
147157553|NCT03575065|530741805|FG001|Overall Study|Death|12|||
147157554|NCT03575065|530741804|FG000|Overall Study|Sponsor's Decision|28|||
147157555|NCT03575065|530741805|FG001|Overall Study|Sponsor's Decision|13|||
147157556|NCT03575065|530741804|FG000|Overall Study|Withdrawal by Subject|2|||
147157557|NCT03575065|530741805|FG001|Overall Study|Withdrawal by Subject|1|||
147157558|NCT03575065|530741804|FG000|Overall Study|Lost to Follow-up|1|||
147157559|NCT03575065|530741805|FG001|Overall Study|Lost to Follow-up|0|||
147157560|NCT00113399|530741810|FG000|Overall Study|Death|1|||
147157561|NCT00113399|530741811|FG001|Overall Study|Death|1|||
147157562|NCT00113399|530741810|FG000|Overall Study|Withdrawal by Subject|1|||
147157563|NCT00113399|530741811|FG001|Overall Study|Withdrawal by Subject|2|||
147157564|NCT00113399|530741810|FG000|Overall Study|Complete Response|0|||
147157565|NCT00113399|530741811|FG001|Overall Study|Complete Response|1|||
147157566|NCT00113399|530741810|FG000|Overall Study|Other|0|||
147157567|NCT00113399|530741811|FG001|Overall Study|Other|1|||
147157568|NCT00396136|530741812|FG000|Overall Study|Death|43|||
147157569|NCT00396136|530741812|FG000|Overall Study|Withdrawal by Subject|59|||
147157570|NCT00396136|530741812|FG000|Overall Study|Lost to Follow-up|15|||
147157571|NCT00396136|530741812|FG000|Overall Study|Study device explanted|8|||
147157572|NCT03447314|530741813|FG000|Part 1 (Up to 47 Months and 13 Days)|Death|6|||
147157573|NCT03447314|530741814|FG001|Part 1 (Up to 47 Months and 13 Days)|Death|5|||
147157574|NCT03447314|530741815|FG002|Part 1 (Up to 47 Months and 13 Days)|Death|4|||
147157575|NCT03447314|530741816|FG003|Part 1 (Up to 47 Months and 13 Days)|Death|3|||
147157576|NCT03447314|530741817|FG004|Part 1 (Up to 47 Months and 13 Days)|Death|1|||
147157577|NCT03447314|530741818|FG005|Part 1 (Up to 47 Months and 13 Days)|Death|4|||
147157578|NCT03447314|530741819|FG006|Part 1 (Up to 47 Months and 13 Days)|Death|2|||
147157579|NCT03447314|530741820|FG007|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
147157580|NCT03447314|530741821|FG008|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
147157581|NCT03447314|530741822|FG009|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
147157582|NCT03447314|530741823|FG010|Part 1 (Up to 47 Months and 13 Days)|Death|4|||
147157583|NCT03447314|530741824|FG011|Part 1 (Up to 47 Months and 13 Days)|Death|3|||
147157584|NCT03447314|530741825|FG012|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
147157585|NCT03447314|530741826|FG013|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
147157586|NCT03447314|530741827|FG014|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
147157587|NCT03447314|530741828|FG015|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
147157588|NCT03447314|530741829|FG016|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
147157589|NCT03447314|530741830|FG017|Part 1 (Up to 47 Months and 13 Days)|Death|0|||
147157590|NCT03447314|530741813|FG000|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|1|||
147157591|NCT03447314|530741814|FG001|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
147157592|NCT03447314|530741815|FG002|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|1|||
147157593|NCT03447314|530741816|FG003|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
147157594|NCT03447314|530741817|FG004|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
147157595|NCT03447314|530741818|FG005|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|1|||
147157596|NCT03447314|530741819|FG006|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|1|||
147157597|NCT03447314|530741820|FG007|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
147157598|NCT03447314|530741821|FG008|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
147157599|NCT03447314|530741822|FG009|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
147157600|NCT03447314|530741823|FG010|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
147157601|NCT03447314|530741824|FG011|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
147157602|NCT03447314|530741825|FG012|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
147157603|NCT03447314|530741826|FG013|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
147157604|NCT03447314|530741827|FG014|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
147157605|NCT03447314|530741828|FG015|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
147157606|NCT03447314|530741829|FG016|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
147157607|NCT03447314|530741830|FG017|Part 1 (Up to 47 Months and 13 Days)|Withdrawal by Subject|0|||
147157608|NCT03447314|530741813|FG000|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
147157609|NCT03447314|530741814|FG001|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
147157610|NCT03447314|530741815|FG002|Part 1 (Up to 47 Months and 13 Days)|Disease progression|1|||
147157611|NCT03447314|530741816|FG003|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
147157612|NCT03447314|530741817|FG004|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
147157613|NCT03447314|530741818|FG005|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
147157614|NCT03447314|530741819|FG006|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
147157615|NCT03447314|530741820|FG007|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
147157616|NCT03447314|530741821|FG008|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
147157617|NCT03447314|530741822|FG009|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
147157618|NCT03447314|530741823|FG010|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
147157619|NCT03447314|530741824|FG011|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
147157620|NCT03447314|530741825|FG012|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
147157621|NCT03447314|530741826|FG013|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
147157622|NCT03447314|530741827|FG014|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
147157623|NCT03447314|530741828|FG015|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
147157624|NCT03447314|530741829|FG016|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
147157625|NCT03447314|530741830|FG017|Part 1 (Up to 47 Months and 13 Days)|Disease progression|0|||
147157626|NCT03447314|530741813|FG000|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
147157627|NCT03447314|530741814|FG001|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
147157628|NCT03447314|530741815|FG002|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|1|||
147157629|NCT03447314|530741816|FG003|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
147157630|NCT03447314|530741817|FG004|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
147157631|NCT03447314|530741818|FG005|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
147157632|NCT03447314|530741819|FG006|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
147157633|NCT03447314|530741820|FG007|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
147583991|NCT01190930|532293631|FG002|Induction|Philadelphia chromosome-positive|0|||
147583992|NCT01190930|532293632|FG003|Induction|Philadelphia chromosome-positive|0|||
147583993|NCT01190930|532293633|FG004|Induction|Philadelphia chromosome-positive|0|||
147157634|NCT03447314|530741821|FG008|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
147157635|NCT03447314|530741822|FG009|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
147157636|NCT03447314|530741823|FG010|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
147241006|NCT01273597|531053560|FG000|Overall Study|Adverse Event|5|||
147583994|NCT01190930|532293634|FG005|Induction|Philadelphia chromosome-positive|0|||
147157637|NCT03447314|530741824|FG011|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
147157638|NCT03447314|530741825|FG012|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
147157639|NCT03447314|530741826|FG013|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
147157640|NCT03447314|530741827|FG014|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
147157641|NCT03447314|530741828|FG015|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
147157642|NCT03447314|530741829|FG016|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
147157643|NCT03447314|530741830|FG017|Part 1 (Up to 47 Months and 13 Days)|Lost to Follow-up|0|||
147157644|NCT03447314|530741813|FG000|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
147157645|NCT03447314|530741814|FG001|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
147157646|NCT03447314|530741815|FG002|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
147157647|NCT03447314|530741816|FG003|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
147157648|NCT03447314|530741817|FG004|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
147157649|NCT03447314|530741818|FG005|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
147157650|NCT03447314|530741819|FG006|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
147157651|NCT03447314|530741820|FG007|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
147157652|NCT03447314|530741821|FG008|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
147157653|NCT03447314|530741822|FG009|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
147157654|NCT03447314|530741823|FG010|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|1|||
147157655|NCT03447314|530741824|FG011|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
147157656|NCT03447314|530741825|FG012|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
147157657|NCT03447314|530741826|FG013|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
147157658|NCT03447314|530741827|FG014|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
147157659|NCT03447314|530741828|FG015|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
147157660|NCT03447314|530741829|FG016|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
147157661|NCT03447314|530741830|FG017|Part 1 (Up to 47 Months and 13 Days)|Reason for discontinuation was not recorded in the case report form|0|||
147157662|NCT03447314|530741813|FG000|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
147157663|NCT03447314|530741814|FG001|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
147157664|NCT03447314|530741815|FG002|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
147157665|NCT03447314|530741816|FG003|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|1|||
147157666|NCT03447314|530741817|FG004|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
147157667|NCT03447314|530741818|FG005|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|1|||
147157668|NCT03447314|530741819|FG006|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
147157669|NCT03447314|530741820|FG007|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
147157670|NCT03447314|530741821|FG008|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
147157671|NCT03447314|530741822|FG009|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
147157672|NCT03447314|530741823|FG010|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
147157673|NCT03447314|530741824|FG011|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
147157674|NCT03447314|530741825|FG012|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
147157675|NCT03447314|530741826|FG013|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
147157676|NCT03447314|530741827|FG014|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
147157677|NCT03447314|530741828|FG015|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
147157678|NCT03447314|530741829|FG016|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
147157679|NCT03447314|530741830|FG017|Part 1 (Up to 47 Months and 13 Days)|Investigator discretion|0|||
147157680|NCT01703208|530741831|FG000|Overall Study|Death|61|||
147157681|NCT01703208|530741832|FG001|Overall Study|Death|48|||
147157682|NCT01703208|530741831|FG000|Overall Study|Lack of Efficacy|1|||
147157683|NCT01703208|530741832|FG001|Overall Study|Lack of Efficacy|2|||
147157684|NCT01703208|530741831|FG000|Overall Study|Lost to Follow-up|68|||
147157685|NCT01703208|530741832|FG001|Overall Study|Lost to Follow-up|62|||
147157686|NCT01703208|530741831|FG000|Overall Study|Non-Compliance with Study Drug|1|||
147157687|NCT01703208|530741832|FG001|Overall Study|Non-Compliance with Study Drug|0|||
147157688|NCT01703208|530741831|FG000|Overall Study|Excluded Medication|1|||
147157689|NCT01703208|530741832|FG001|Overall Study|Excluded Medication|2|||
147446823|NCT01967628|531800314|FG001|Overall Study|Low protein concentration in sample|25|||
147446824|NCT00838331|531800315|FG000|Aged Blood Transfusion|Withdrawal by Subject|9|||
147157690|NCT01703208|530741831|FG000|Overall Study|Site Discontinued Study Participation|23|||
147157691|NCT01703208|530741832|FG001|Overall Study|Site Discontinued Study Participation|27|||
147157692|NCT01703208|530741831|FG000|Overall Study|Physician Decision|11|||
147157693|NCT01703208|530741832|FG001|Overall Study|Physician Decision|13|||
147157694|NCT01703208|530741831|FG000|Overall Study|Progressive disease|2|||
147583995|NCT01190930|532293635|FG006|Induction|Philadelphia chromosome-positive|0|||
147583996|NCT01190930|532293636|FG007|Induction|Philadelphia chromosome-positive|0|||
147583997|NCT01190930|532293637|FG008|Induction|Philadelphia chromosome-positive|0|||
147583998|NCT01190930|532293638|FG009|Induction|Philadelphia chromosome-positive|0|||
147583999|NCT01190930|532293629|FG000|Induction|Incomplete Induction data|63|||
147584000|NCT01190930|532293630|FG001|Induction|Incomplete Induction data|0|||
147584001|NCT01190930|532293631|FG002|Induction|Incomplete Induction data|0|||
147584002|NCT01190930|532293632|FG003|Induction|Incomplete Induction data|0|||
147584003|NCT01190930|532293633|FG004|Induction|Incomplete Induction data|0|||
147584004|NCT01190930|532293634|FG005|Induction|Incomplete Induction data|0|||
147584005|NCT01190930|532293635|FG006|Induction|Incomplete Induction data|0|||
147584006|NCT01190930|532293636|FG007|Induction|Incomplete Induction data|0|||
147584007|NCT01190930|532293637|FG008|Induction|Incomplete Induction data|0|||
147584008|NCT01190930|532293638|FG009|Induction|Incomplete Induction data|0|||
147584009|NCT01190930|532293629|FG000|Induction|Progressive disease|0|||
147584010|NCT01190930|532293630|FG001|Induction|Progressive disease|1|||
147584011|NCT01190930|532293631|FG002|Induction|Progressive disease|0|||
147584012|NCT01190930|532293632|FG003|Induction|Progressive disease|0|||
147584013|NCT01190930|532293633|FG004|Induction|Progressive disease|0|||
147584014|NCT01190930|532293634|FG005|Induction|Progressive disease|0|||
147584015|NCT01190930|532293635|FG006|Induction|Progressive disease|0|||
147584016|NCT01190930|532293636|FG007|Induction|Progressive disease|0|||
147584017|NCT01190930|532293637|FG008|Induction|Progressive disease|0|||
147584018|NCT01190930|532293638|FG009|Induction|Progressive disease|0|||
147157695|NCT01703208|530741832|FG001|Overall Study|Progressive disease|2|||
147157696|NCT01703208|530741831|FG000|Overall Study|Protocol Violation|1|||
147157697|NCT01703208|530741832|FG001|Overall Study|Protocol Violation|1|||
147157698|NCT01703208|530741831|FG000|Overall Study|Study Terminated by Sponsor|1710|||
147157699|NCT01703208|530741832|FG001|Overall Study|Study Terminated by Sponsor|1716|||
147157700|NCT01703208|530741831|FG000|Overall Study|Withdrawal by Subject|205|||
147157701|NCT01703208|530741832|FG001|Overall Study|Withdrawal by Subject|209|||
147157702|NCT01703208|530741831|FG000|Overall Study|Adverse Event|14|||
147157703|NCT01703208|530741832|FG001|Overall Study|Adverse Event|19|||
147157704|NCT01703208|530741831|FG000|Overall Study|Technical Problems|0|||
147157705|NCT01703208|530741832|FG001|Overall Study|Technical Problems|1|||
147157706|NCT01703208|530741831|FG000|Overall Study|Protocol Deviation|2|||
147157707|NCT01703208|530741832|FG001|Overall Study|Protocol Deviation|0|||
147157708|NCT00252694|530741833|FG000|Overall Study|Withdrawal by Subject|83|||
147157709|NCT00252694|530741834|FG001|Overall Study|Withdrawal by Subject|91|||
147157710|NCT00252694|530741833|FG000|Overall Study|Death|36|||
147157711|NCT00252694|530741834|FG001|Overall Study|Death|34|||
147157712|NCT00252694|530741833|FG000|Overall Study|Mostly Lost to Follow Up|8|||
147157713|NCT00252694|530741834|FG001|Overall Study|Mostly Lost to Follow Up|13|||
147157714|NCT00252694|530741833|FG000|Overall Study|Patient Moving|17|||
147157715|NCT00252694|530741834|FG001|Overall Study|Patient Moving|16|||
147157716|NCT04003207|530741837|FG000|Overall Study|Protocol Violation|1|||
147157717|NCT00443053|530741838|FG000|Overall Study|Adverse Event|2|||
147157718|NCT00443053|530741839|FG001|Overall Study|Adverse Event|1|||
147157719|NCT00443053|530741838|FG000|Overall Study|Withdrawal by Subject|9|||
147157720|NCT00443053|530741839|FG001|Overall Study|Withdrawal by Subject|18|||
147157721|NCT00443053|530741838|FG000|Overall Study|Lost to Follow-up|4|||
147157722|NCT00443053|530741839|FG001|Overall Study|Lost to Follow-up|5|||
147157723|NCT00443053|530741838|FG000|Overall Study|Did Not Meet Eligibility Criteria|1|||
147157724|NCT00443053|530741839|FG001|Overall Study|Did Not Meet Eligibility Criteria|0|||
147584019|NCT01190930|532293629|FG000|Induction|No treatment|3|||
147584020|NCT01190930|532293630|FG001|Induction|No treatment|0|||
147584021|NCT01190930|532293631|FG002|Induction|No treatment|0|||
147584022|NCT01190930|532293632|FG003|Induction|No treatment|0|||
147584023|NCT01190930|532293633|FG004|Induction|No treatment|0|||
147584024|NCT01190930|532293634|FG005|Induction|No treatment|0|||
147584025|NCT01190930|532293635|FG006|Induction|No treatment|0|||
147157725|NCT00443053|530741838|FG000|Overall Study|Noncompliance|2|||
147157726|NCT00443053|530741839|FG001|Overall Study|Noncompliance|1|||
147157727|NCT00443053|530741838|FG000|Overall Study|Other|3|||
147584026|NCT01190930|532293636|FG007|Induction|No treatment|0|||
147584027|NCT01190930|532293637|FG008|Induction|No treatment|0|||
147584028|NCT01190930|532293638|FG009|Induction|No treatment|0|||
147584029|NCT01190930|532293629|FG000|Induction|Ineligible|69|||
147157728|NCT00443053|530741839|FG001|Overall Study|Other|4|||
147157729|NCT00443053|530741838|FG000|Overall Study|Physician Decision|0|||
147157730|NCT00443053|530741839|FG001|Overall Study|Physician Decision|4|||
147157731|NCT00541866|530741840|FG000|Overall Study|Adverse Event|3|||
147157732|NCT00541866|530741841|FG001|Overall Study|Adverse Event|0|||
147157733|NCT00541866|530741842|FG002|Overall Study|Adverse Event|0|||
147157734|NCT00541866|530741843|FG003|Overall Study|Adverse Event|0|||
147157735|NCT00541866|530741844|FG004|Overall Study|Adverse Event|0|||
147157736|NCT00541866|530741840|FG000|Overall Study|Death|1|||
147157737|NCT00541866|530741841|FG001|Overall Study|Death|0|||
147584030|NCT01190930|532293630|FG001|Induction|Ineligible|4|||
147584031|NCT01190930|532293631|FG002|Induction|Ineligible|0|||
147584032|NCT01190930|532293632|FG003|Induction|Ineligible|0|||
147584033|NCT01190930|532293633|FG004|Induction|Ineligible|0|||
147584034|NCT01190930|532293634|FG005|Induction|Ineligible|0|||
147584035|NCT01190930|532293635|FG006|Induction|Ineligible|0|||
147584036|NCT01190930|532293636|FG007|Induction|Ineligible|0|||
147584037|NCT01190930|532293637|FG008|Induction|Ineligible|0|||
147584038|NCT01190930|532293638|FG009|Induction|Ineligible|0|||
147157738|NCT00541866|530741842|FG002|Overall Study|Death|0|||
147157739|NCT00541866|530741843|FG003|Overall Study|Death|0|||
147157740|NCT00541866|530741844|FG004|Overall Study|Death|0|||
147157741|NCT00541866|530741840|FG000|Overall Study|Lack of Efficacy|19|||
147157742|NCT00541866|530741841|FG001|Overall Study|Lack of Efficacy|15|||
147157743|NCT00541866|530741842|FG002|Overall Study|Lack of Efficacy|10|||
147157744|NCT00541866|530741843|FG003|Overall Study|Lack of Efficacy|12|||
147157745|NCT00541866|530741844|FG004|Overall Study|Lack of Efficacy|14|||
147157746|NCT00541866|530741840|FG000|Overall Study|Not Reported or Other|11|||
147157747|NCT00541866|530741841|FG001|Overall Study|Not Reported or Other|3|||
147157748|NCT00541866|530741842|FG002|Overall Study|Not Reported or Other|3|||
147157749|NCT00541866|530741843|FG003|Overall Study|Not Reported or Other|3|||
147157750|NCT00541866|530741844|FG004|Overall Study|Not Reported or Other|1|||
147157751|NCT00541866|530741840|FG000|Overall Study|Physician Decision|0|||
147157752|NCT00541866|530741841|FG001|Overall Study|Physician Decision|0|||
147157753|NCT00541866|530741842|FG002|Overall Study|Physician Decision|2|||
147584039|NCT01190930|532293629|FG000|Post Induction Pre-Maintenance|Adverse Event|0|||
147584040|NCT01190930|532293630|FG001|Post Induction Pre-Maintenance|Adverse Event|0|||
147654353|NCT01882803|532556687|FG000|Overall Study|Physician Decision|3|||
147654354|NCT01882803|532556687|FG000|Overall Study|Lost to Follow-up|3|||
147654355|NCT01882803|532556687|FG000|Overall Study|Follow-up Completed|39|||
147654356|NCT01882803|532556687|FG000|Overall Study|Study Terminated by the Sponsor|6|||
147654357|NCT01563913|532556688|FG000|Overall Study|Physician Decision|1|||
147654358|NCT01563913|532556689|FG001|Overall Study|Physician Decision|0|||
147654359|NCT01563913|532556688|FG000|Overall Study|Spouse Passed Away|1|||
147654360|NCT01563913|532556689|FG001|Overall Study|Spouse Passed Away|0|||
147654361|NCT00551525|532556692|FG000|Overall Study|Protocol Violation|5|||
147654362|NCT04676724|532556693|FG000|Overall Study|Adverse Event|2|||
147157754|NCT00541866|530741843|FG003|Overall Study|Physician Decision|1|||
147157755|NCT00541866|530741844|FG004|Overall Study|Physician Decision|0|||
147157756|NCT00522418|530741845|FG000|Overall Study|Local IRB Consent Violation|5|||
147157757|NCT00522418|530741846|FG001|Overall Study|Local IRB Consent Violation|5|||
147157758|NCT00522418|530741845|FG000|Overall Study|Early Study Termination|46|||
147157759|NCT00522418|530741846|FG001|Overall Study|Early Study Termination|47|||
147157760|NCT00522418|530741845|FG000|Overall Study|Noncompliance|2|||
147157761|NCT00522418|530741846|FG001|Overall Study|Noncompliance|2|||
147157762|NCT00522418|530741845|FG000|Overall Study|Reason Not Specified|3|||
147157763|NCT00522418|530741846|FG001|Overall Study|Reason Not Specified|1|||
147157764|NCT00522418|530741845|FG000|Overall Study|Consent Withdraw|1|||
147157765|NCT00522418|530741846|FG001|Overall Study|Consent Withdraw|2|||
147157766|NCT00522418|530741845|FG000|Overall Study|Lack of Efficacy|0|||
147157767|NCT00522418|530741846|FG001|Overall Study|Lack of Efficacy|1|||
147157768|NCT01574157|530741847|FG000|Overall Study|Withdrawal by Subject|4|||
147157769|NCT01574157|530741848|FG001|Overall Study|Withdrawal by Subject|5|||
147157770|NCT01574157|530741847|FG000|Overall Study|Lost to Follow-up|0|||
147157771|NCT01574157|530741848|FG001|Overall Study|Lost to Follow-up|3|||
147157772|NCT00578877|530741851|FG000|Overall Study|Lost to Follow-up|8|||
147157773|NCT00578877|530741852|FG001|Overall Study|Lost to Follow-up|10|||
147654363|NCT04676724|532556694|FG001|Overall Study|Adverse Event|0|||
147654364|NCT04676724|532556693|FG000|Overall Study|Lost to Follow-up|1|||
147654365|NCT04676724|532556694|FG001|Overall Study|Lost to Follow-up|0|||
147654366|NCT04676724|532556693|FG000|Overall Study|Physician Decision|0|||
147654367|NCT04676724|532556694|FG001|Overall Study|Physician Decision|1|||
147654368|NCT04676724|532556693|FG000|Overall Study|Withdrawal by Subject|3|||
147654369|NCT04676724|532556694|FG001|Overall Study|Withdrawal by Subject|2|||
147157774|NCT00578877|530741851|FG000|Overall Study|early discontinue|61|||
147157775|NCT00578877|530741852|FG001|Overall Study|early discontinue|101|||
147241007|NCT01273597|531053560|FG000|Overall Study|Underwent Kidney Transplantation|2|||
147584041|NCT01190930|532293631|FG002|Post Induction Pre-Maintenance|Adverse Event|8|||
147584042|NCT01190930|532293632|FG003|Post Induction Pre-Maintenance|Adverse Event|0|||
147241008|NCT01273597|531053560|FG000|Overall Study|Reason Not Reported|1|||
147241009|NCT01785069|531053566|FG000|Overall Study|Implanted with nonstudy device|1|||
147584043|NCT01190930|532293633|FG004|Post Induction Pre-Maintenance|Adverse Event|0|||
147157776|NCT00578877|530741851|FG000|Overall Study|did not provide follow-up data|12|||
147157777|NCT00578877|530741852|FG001|Overall Study|did not provide follow-up data|17|||
147157778|NCT01944098|530741857|FG000|Overall Study|Physician Decision|1|||
147157779|NCT01944098|530741858|FG001|Overall Study|Physician Decision|0|||
147157780|NCT01632241|530741859|FG000|Double-blinded (Up to Week 52)|Site Closed|3|||
147157781|NCT01632241|530741860|FG001|Double-blinded (Up to Week 52)|Site Closed|5|||
147584044|NCT01190930|532293634|FG005|Post Induction Pre-Maintenance|Adverse Event|0|||
147654370|NCT02521792|532556700|FG000|Overall Study|Study Terminated|6|||
147584045|NCT01190930|532293635|FG006|Post Induction Pre-Maintenance|Adverse Event|0|||
147584046|NCT01190930|532293636|FG007|Post Induction Pre-Maintenance|Adverse Event|0|||
147584047|NCT01190930|532293637|FG008|Post Induction Pre-Maintenance|Adverse Event|0|||
147584048|NCT01190930|532293638|FG009|Post Induction Pre-Maintenance|Adverse Event|0|||
147584049|NCT01190930|532293629|FG000|Post Induction Pre-Maintenance|Death|0|||
147584050|NCT01190930|532293630|FG001|Post Induction Pre-Maintenance|Death|0|||
147584051|NCT01190930|532293631|FG002|Post Induction Pre-Maintenance|Death|8|||
147584052|NCT01190930|532293632|FG003|Post Induction Pre-Maintenance|Death|4|||
147584053|NCT01190930|532293633|FG004|Post Induction Pre-Maintenance|Death|0|||
147584054|NCT01190930|532293634|FG005|Post Induction Pre-Maintenance|Death|0|||
147584055|NCT01190930|532293635|FG006|Post Induction Pre-Maintenance|Death|0|||
147584056|NCT01190930|532293636|FG007|Post Induction Pre-Maintenance|Death|0|||
147584057|NCT01190930|532293637|FG008|Post Induction Pre-Maintenance|Death|0|||
147584058|NCT01190930|532293638|FG009|Post Induction Pre-Maintenance|Death|0|||
147584059|NCT01190930|532293629|FG000|Post Induction Pre-Maintenance|Physician Decision|0|||
147584060|NCT01190930|532293630|FG001|Post Induction Pre-Maintenance|Physician Decision|2|||
147584061|NCT01190930|532293631|FG002|Post Induction Pre-Maintenance|Physician Decision|35|||
147157782|NCT01632241|530741859|FG000|Double-blinded (Up to Week 52)|Protocol Violation|2|||
147157783|NCT01632241|530741860|FG001|Double-blinded (Up to Week 52)|Protocol Violation|6|||
147157784|NCT01632241|530741859|FG000|Double-blinded (Up to Week 52)|Lost to Follow-up|1|||
147157785|NCT01632241|530741860|FG001|Double-blinded (Up to Week 52)|Lost to Follow-up|8|||
147157786|NCT01632241|530741859|FG000|Double-blinded (Up to Week 52)|Physician Decision|9|||
147157787|NCT01632241|530741860|FG001|Double-blinded (Up to Week 52)|Physician Decision|12|||
147157788|NCT01632241|530741859|FG000|Double-blinded (Up to Week 52)|Lack of Efficacy|9|||
147157789|NCT01632241|530741860|FG001|Double-blinded (Up to Week 52)|Lack of Efficacy|15|||
147157790|NCT01632241|530741859|FG000|Double-blinded (Up to Week 52)|Withdrawal by Subject|10|||
147157791|NCT01632241|530741860|FG001|Double-blinded (Up to Week 52)|Withdrawal by Subject|14|||
147157792|NCT01632241|530741859|FG000|Double-blinded (Up to Week 52)|Adverse Event|10|||
147157793|NCT01632241|530741860|FG001|Double-blinded (Up to Week 52)|Adverse Event|19|||
147157794|NCT01632241|530741859|FG000|Open-label (Week 52 to Week 76)|Withdrawal by Subject|5|||
147157795|NCT01632241|530741860|FG001|Open-label (Week 52 to Week 76)|Withdrawal by Subject|2|||
147157796|NCT01632241|530741859|FG000|Open-label (Week 52 to Week 76)|Physician Decision|1|||
147157797|NCT01632241|530741860|FG001|Open-label (Week 52 to Week 76)|Physician Decision|4|||
147157798|NCT01632241|530741859|FG000|Open-label (Week 52 to Week 76)|Lost to Follow-up|1|||
147157799|NCT01632241|530741860|FG001|Open-label (Week 52 to Week 76)|Lost to Follow-up|4|||
147157800|NCT01632241|530741859|FG000|Open-label (Week 52 to Week 76)|Site Closed|2|||
147157801|NCT01632241|530741860|FG001|Open-label (Week 52 to Week 76)|Site Closed|8|||
147157802|NCT01632241|530741859|FG000|Open-label (Week 52 to Week 76)|Protocol Violation|0|||
147157803|NCT01632241|530741860|FG001|Open-label (Week 52 to Week 76)|Protocol Violation|2|||
147157804|NCT01632241|530741859|FG000|Open-label (Week 52 to Week 76)|Lack of Efficacy|0|||
147157805|NCT01632241|530741860|FG001|Open-label (Week 52 to Week 76)|Lack of Efficacy|2|||
147157806|NCT01632241|530741859|FG000|Open-label (Week 52 to Week 76)|Adverse Event|1|||
147157807|NCT01632241|530741860|FG001|Open-label (Week 52 to Week 76)|Adverse Event|0|||
147157808|NCT01904149|530741862|FG000|Overall Study|Adverse Event|3|||
147157809|NCT01904149|530741863|FG001|Overall Study|Adverse Event|4|||
147157810|NCT01904149|530741864|FG002|Overall Study|Adverse Event|0|||
147157811|NCT01904149|530741865|FG003|Overall Study|Adverse Event|1|||
147157812|NCT01904149|530741866|FG004|Overall Study|Adverse Event|1|||
147157813|NCT01904149|530741867|FG005|Overall Study|Adverse Event|2|||
147157814|NCT01904149|530741862|FG000|Overall Study|Lack of Efficacy|0|||
147157815|NCT01904149|530741863|FG001|Overall Study|Lack of Efficacy|3|||
147157816|NCT01904149|530741864|FG002|Overall Study|Lack of Efficacy|1|||
147157817|NCT01904149|530741865|FG003|Overall Study|Lack of Efficacy|3|||
147157818|NCT01904149|530741866|FG004|Overall Study|Lack of Efficacy|3|||
147157819|NCT01904149|530741867|FG005|Overall Study|Lack of Efficacy|1|||
147157820|NCT01904149|530741862|FG000|Overall Study|Withdrawal by Subject|1|||
147157821|NCT01904149|530741863|FG001|Overall Study|Withdrawal by Subject|3|||
147157822|NCT01904149|530741864|FG002|Overall Study|Withdrawal by Subject|1|||
147584062|NCT01190930|532293632|FG003|Post Induction Pre-Maintenance|Physician Decision|7|||
147584063|NCT01190930|532293633|FG004|Post Induction Pre-Maintenance|Physician Decision|5|||
147157823|NCT01904149|530741865|FG003|Overall Study|Withdrawal by Subject|0|||
147157824|NCT01904149|530741866|FG004|Overall Study|Withdrawal by Subject|1|||
147157825|NCT01904149|530741867|FG005|Overall Study|Withdrawal by Subject|0|||
147157826|NCT01904149|530741862|FG000|Overall Study|Protocol Violation|0|||
147654371|NCT00398047|532556701|FG000|Overall Study|all patient progressed before completion|3|||
147157827|NCT01904149|530741863|FG001|Overall Study|Protocol Violation|1|||
147157828|NCT01904149|530741864|FG002|Overall Study|Protocol Violation|0|||
147157829|NCT01904149|530741865|FG003|Overall Study|Protocol Violation|0|||
147584064|NCT01190930|532293634|FG005|Post Induction Pre-Maintenance|Physician Decision|3|||
147654372|NCT00237692|532556702|FG000|Overall Study|Lost to Follow-up|9|||
147584065|NCT01190930|532293635|FG006|Post Induction Pre-Maintenance|Physician Decision|0|||
147157830|NCT01904149|530741866|FG004|Overall Study|Protocol Violation|0|||
147157831|NCT01904149|530741867|FG005|Overall Study|Protocol Violation|0|||
147584066|NCT01190930|532293636|FG007|Post Induction Pre-Maintenance|Physician Decision|0|||
147584067|NCT01190930|532293637|FG008|Post Induction Pre-Maintenance|Physician Decision|0|||
147584068|NCT01190930|532293638|FG009|Post Induction Pre-Maintenance|Physician Decision|0|||
147584069|NCT01190930|532293629|FG000|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
147584070|NCT01190930|532293630|FG001|Post Induction Pre-Maintenance|Withdrawal by Subject|1|||
147584071|NCT01190930|532293631|FG002|Post Induction Pre-Maintenance|Withdrawal by Subject|5|||
147584072|NCT01190930|532293632|FG003|Post Induction Pre-Maintenance|Withdrawal by Subject|2|||
147584073|NCT01190930|532293633|FG004|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
147584074|NCT01190930|532293634|FG005|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
147584075|NCT01190930|532293635|FG006|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
147584076|NCT01190930|532293636|FG007|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
147584077|NCT01190930|532293637|FG008|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
147584078|NCT01190930|532293638|FG009|Post Induction Pre-Maintenance|Withdrawal by Subject|0|||
147584079|NCT01190930|532293629|FG000|Post Induction Pre-Maintenance|Refusal|0|||
147584080|NCT01190930|532293630|FG001|Post Induction Pre-Maintenance|Refusal|2|||
147584081|NCT01190930|532293631|FG002|Post Induction Pre-Maintenance|Refusal|694|||
147584082|NCT01190930|532293632|FG003|Post Induction Pre-Maintenance|Refusal|4|||
147584083|NCT01190930|532293633|FG004|Post Induction Pre-Maintenance|Refusal|0|||
147584084|NCT01190930|532293634|FG005|Post Induction Pre-Maintenance|Refusal|3|||
147584085|NCT01190930|532293635|FG006|Post Induction Pre-Maintenance|Refusal|0|||
147584086|NCT01190930|532293636|FG007|Post Induction Pre-Maintenance|Refusal|0|||
147584087|NCT01190930|532293637|FG008|Post Induction Pre-Maintenance|Refusal|0|||
147584088|NCT01190930|532293638|FG009|Post Induction Pre-Maintenance|Refusal|0|||
147584089|NCT01190930|532293629|FG000|Post Induction Pre-Maintenance|Inevaluable|0|||
147584090|NCT01190930|532293630|FG001|Post Induction Pre-Maintenance|Inevaluable|0|||
147584091|NCT01190930|532293631|FG002|Post Induction Pre-Maintenance|Inevaluable|6|||
147584092|NCT01190930|532293632|FG003|Post Induction Pre-Maintenance|Inevaluable|0|||
147584093|NCT01190930|532293633|FG004|Post Induction Pre-Maintenance|Inevaluable|0|||
147584094|NCT01190930|532293634|FG005|Post Induction Pre-Maintenance|Inevaluable|0|||
147584095|NCT01190930|532293635|FG006|Post Induction Pre-Maintenance|Inevaluable|0|||
147584096|NCT01190930|532293636|FG007|Post Induction Pre-Maintenance|Inevaluable|0|||
147584097|NCT01190930|532293637|FG008|Post Induction Pre-Maintenance|Inevaluable|0|||
147584098|NCT01190930|532293638|FG009|Post Induction Pre-Maintenance|Inevaluable|0|||
147584099|NCT01190930|532293629|FG000|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
147584100|NCT01190930|532293630|FG001|Post Induction Pre-Maintenance|CR failure at the end of consolidation|1|||
147584101|NCT01190930|532293631|FG002|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
147584102|NCT01190930|532293632|FG003|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
147584103|NCT01190930|532293633|FG004|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
147584104|NCT01190930|532293634|FG005|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
147584105|NCT01190930|532293635|FG006|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
147584106|NCT01190930|532293636|FG007|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
147584107|NCT01190930|532293637|FG008|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
147584108|NCT01190930|532293638|FG009|Post Induction Pre-Maintenance|CR failure at the end of consolidation|0|||
147584109|NCT01190930|532293629|FG000|Post Induction Pre-Maintenance|Progressive disease|0|||
147584110|NCT01190930|532293630|FG001|Post Induction Pre-Maintenance|Progressive disease|0|||
147584111|NCT01190930|532293631|FG002|Post Induction Pre-Maintenance|Progressive disease|1|||
147584112|NCT01190930|532293632|FG003|Post Induction Pre-Maintenance|Progressive disease|0|||
147584113|NCT01190930|532293633|FG004|Post Induction Pre-Maintenance|Progressive disease|0|||
147157832|NCT01904149|530741862|FG000|Overall Study|non compliance with study drug|1|||
147157833|NCT01904149|530741863|FG001|Overall Study|non compliance with study drug|0|||
147157834|NCT01904149|530741864|FG002|Overall Study|non compliance with study drug|0|||
147157835|NCT01904149|530741865|FG003|Overall Study|non compliance with study drug|0|||
147157836|NCT01904149|530741866|FG004|Overall Study|non compliance with study drug|0|||
147157837|NCT01904149|530741867|FG005|Overall Study|non compliance with study drug|0|||
147157838|NCT00350272|530741868|FG000|Blinded 12-Week Treatment|Adverse Event|1|||
147157839|NCT00350272|530741869|FG001|Blinded 12-Week Treatment|Adverse Event|0|||
147157840|NCT00350272|530741868|FG000|Blinded 12-Week Treatment|Death|1|||
147157841|NCT00350272|530741869|FG001|Blinded 12-Week Treatment|Death|0|||
147157842|NCT00350272|530741868|FG000|Blinded 12-Week Treatment|Lost to Follow-up|2|||
147157843|NCT00350272|530741869|FG001|Blinded 12-Week Treatment|Lost to Follow-up|0|||
147157844|NCT00350272|530741868|FG000|Blinded 12-Week Treatment|Withdrawal by Subject|3|||
147446825|NCT01379274|531800316|FG000|Overall Study|funding withdrawn|1|||
147584114|NCT01190930|532293634|FG005|Post Induction Pre-Maintenance|Progressive disease|0|||
147157845|NCT00350272|530741869|FG001|Blinded 12-Week Treatment|Withdrawal by Subject|0|||
147157846|NCT00350272|530741868|FG000|Blinded 12-Week Treatment|Physician Decision|2|||
147157847|NCT00350272|530741869|FG001|Blinded 12-Week Treatment|Physician Decision|1|||
147446826|NCT02055820|531800318|FG000|Phase I: Dose-Finding|Death|1|||
147584115|NCT01190930|532293635|FG006|Post Induction Pre-Maintenance|Progressive disease|0|||
147584116|NCT01190930|532293636|FG007|Post Induction Pre-Maintenance|Progressive disease|0|||
147584117|NCT01190930|532293637|FG008|Post Induction Pre-Maintenance|Progressive disease|0|||
147584118|NCT01190930|532293638|FG009|Post Induction Pre-Maintenance|Progressive disease|0|||
147584119|NCT01190930|532293629|FG000|Post Induction Pre-Maintenance|Relapse|0|||
147584120|NCT01190930|532293630|FG001|Post Induction Pre-Maintenance|Relapse|0|||
147584121|NCT01190930|532293631|FG002|Post Induction Pre-Maintenance|Relapse|1|||
147584122|NCT01190930|532293632|FG003|Post Induction Pre-Maintenance|Relapse|0|||
147584123|NCT01190930|532293633|FG004|Post Induction Pre-Maintenance|Relapse|0|||
147584124|NCT01190930|532293634|FG005|Post Induction Pre-Maintenance|Relapse|0|||
147584125|NCT01190930|532293635|FG006|Post Induction Pre-Maintenance|Relapse|0|||
147584126|NCT01190930|532293636|FG007|Post Induction Pre-Maintenance|Relapse|0|||
147584127|NCT01190930|532293637|FG008|Post Induction Pre-Maintenance|Relapse|0|||
147584128|NCT01190930|532293638|FG009|Post Induction Pre-Maintenance|Relapse|0|||
147584129|NCT01190930|532293629|FG000|Maintenance|Adverse Event|0|||
147584130|NCT01190930|532293630|FG001|Maintenance|Adverse Event|0|||
147584131|NCT01190930|532293631|FG002|Maintenance|Adverse Event|0|||
147584132|NCT01190930|532293632|FG003|Maintenance|Adverse Event|0|||
147584133|NCT01190930|532293633|FG004|Maintenance|Adverse Event|0|||
147584134|NCT01190930|532293634|FG005|Maintenance|Adverse Event|1|||
147584135|NCT01190930|532293635|FG006|Maintenance|Adverse Event|1|||
147584136|NCT01190930|532293636|FG007|Maintenance|Adverse Event|3|||
147584137|NCT01190930|532293637|FG008|Maintenance|Adverse Event|3|||
147584138|NCT01190930|532293638|FG009|Maintenance|Adverse Event|0|||
147584139|NCT01190930|532293629|FG000|Maintenance|Death|0|||
147584140|NCT01190930|532293630|FG001|Maintenance|Death|0|||
147584141|NCT01190930|532293631|FG002|Maintenance|Death|0|||
147584142|NCT01190930|532293632|FG003|Maintenance|Death|1|||
147584143|NCT01190930|532293633|FG004|Maintenance|Death|0|||
147584144|NCT01190930|532293634|FG005|Maintenance|Death|0|||
147584145|NCT01190930|532293635|FG006|Maintenance|Death|2|||
147584146|NCT01190930|532293636|FG007|Maintenance|Death|2|||
147584147|NCT01190930|532293637|FG008|Maintenance|Death|2|||
147584148|NCT01190930|532293638|FG009|Maintenance|Death|2|||
147584149|NCT01190930|532293629|FG000|Maintenance|Lost to Follow-up|0|||
147584150|NCT01190930|532293630|FG001|Maintenance|Lost to Follow-up|0|||
147584151|NCT01190930|532293631|FG002|Maintenance|Lost to Follow-up|0|||
147584152|NCT01190930|532293632|FG003|Maintenance|Lost to Follow-up|0|||
147584153|NCT01190930|532293633|FG004|Maintenance|Lost to Follow-up|0|||
147584154|NCT01190930|532293634|FG005|Maintenance|Lost to Follow-up|0|||
147584155|NCT01190930|532293635|FG006|Maintenance|Lost to Follow-up|1|||
147584156|NCT01190930|532293636|FG007|Maintenance|Lost to Follow-up|1|||
147584157|NCT01190930|532293637|FG008|Maintenance|Lost to Follow-up|1|||
147584158|NCT01190930|532293638|FG009|Maintenance|Lost to Follow-up|0|||
147584159|NCT01190930|532293629|FG000|Maintenance|Physician Decision|0|||
147584160|NCT01190930|532293630|FG001|Maintenance|Physician Decision|1|||
147584161|NCT01190930|532293631|FG002|Maintenance|Physician Decision|0|||
147157848|NCT00350272|530741868|FG000|Blinded 12-Week Treatment|Sponsor decision|0|||
147157849|NCT00350272|530741869|FG001|Blinded 12-Week Treatment|Sponsor decision|1|||
147157850|NCT00350272|530741868|FG000|Open-Label 84 Week Treatment|Adverse Event|2|||
147157851|NCT00350272|530741869|FG001|Open-Label 84 Week Treatment|Adverse Event|1|||
147157852|NCT00350272|530741868|FG000|Open-Label 84 Week Treatment|Lost to Follow-up|3|||
147157853|NCT00350272|530741869|FG001|Open-Label 84 Week Treatment|Lost to Follow-up|2|||
147157854|NCT00350272|530741868|FG000|Open-Label 84 Week Treatment|Withdrawal by Subject|1|||
147157855|NCT00350272|530741869|FG001|Open-Label 84 Week Treatment|Withdrawal by Subject|2|||
147157856|NCT00350272|530741868|FG000|Open-Label 84 Week Treatment|Physician Decision|1|||
147157857|NCT00350272|530741869|FG001|Open-Label 84 Week Treatment|Physician Decision|2|||
147157858|NCT00350272|530741868|FG000|Open-Label 84 Week Treatment|Sponsor decision|2|||
147157859|NCT00350272|530741869|FG001|Open-Label 84 Week Treatment|Sponsor decision|1|||
147157860|NCT03349645|530741872|FG000|Overall Study|Sponsor Terminated Study|75|||
147157861|NCT03349645|530741872|FG000|Overall Study|Withdrawal by Subject|4|||
147157862|NCT03349645|530741872|FG000|Overall Study|Protocol Violation|1|||
147157863|NCT03349645|530741872|FG000|Overall Study|Other|2|||
147157864|NCT01939002|530741884|FG000|Overall Study|Adverse Event|13|||
147157865|NCT01939002|530741885|FG001|Overall Study|Adverse Event|13|||
147157866|NCT01939002|530741884|FG000|Overall Study|Withdrawal by Subject|5|||
147584162|NCT01190930|532293632|FG003|Maintenance|Physician Decision|5|||
147584163|NCT01190930|532293633|FG004|Maintenance|Physician Decision|9|||
147584164|NCT01190930|532293634|FG005|Maintenance|Physician Decision|4|||
147584165|NCT01190930|532293635|FG006|Maintenance|Physician Decision|8|||
147584166|NCT01190930|532293636|FG007|Maintenance|Physician Decision|8|||
147584167|NCT01190930|532293637|FG008|Maintenance|Physician Decision|10|||
147584168|NCT01190930|532293638|FG009|Maintenance|Physician Decision|17|||
147584169|NCT01190930|532293629|FG000|Maintenance|Withdrawal by Subject|0|||
147584170|NCT01190930|532293630|FG001|Maintenance|Withdrawal by Subject|0|||
147584171|NCT01190930|532293631|FG002|Maintenance|Withdrawal by Subject|0|||
147584172|NCT01190930|532293632|FG003|Maintenance|Withdrawal by Subject|0|||
147584173|NCT01190930|532293633|FG004|Maintenance|Withdrawal by Subject|0|||
147584174|NCT01190930|532293634|FG005|Maintenance|Withdrawal by Subject|0|||
147584175|NCT01190930|532293635|FG006|Maintenance|Withdrawal by Subject|2|||
147584176|NCT01190930|532293636|FG007|Maintenance|Withdrawal by Subject|1|||
147241010|NCT01785069|531053567|FG001|Overall Study|Implanted with nonstudy device|2|||
147241011|NCT01785069|531053568|FG002|Overall Study|Implanted with nonstudy device|1|||
147241012|NCT01785069|531053569|FG003|Overall Study|Implanted with nonstudy device|0|||
147241013|NCT01785069|531053566|FG000|Overall Study|Death|0|||
147241014|NCT01785069|531053567|FG001|Overall Study|Death|0|||
147241015|NCT01785069|531053568|FG002|Overall Study|Death|2|||
147241016|NCT01785069|531053569|FG003|Overall Study|Death|0|||
147241017|NCT01785069|531053566|FG000|Overall Study|Subject choice|2|||
147241018|NCT01785069|531053567|FG001|Overall Study|Subject choice|2|||
147241019|NCT01785069|531053568|FG002|Overall Study|Subject choice|0|||
147241020|NCT01785069|531053569|FG003|Overall Study|Subject choice|1|||
147241021|NCT01785069|531053566|FG000|Overall Study|Lost to Follow-up|1|||
147584177|NCT01190930|532293637|FG008|Maintenance|Withdrawal by Subject|4|||
147584178|NCT01190930|532293638|FG009|Maintenance|Withdrawal by Subject|1|||
147584179|NCT01190930|532293629|FG000|Maintenance|Refusal|0|||
147584180|NCT01190930|532293630|FG001|Maintenance|Refusal|1|||
147584181|NCT01190930|532293631|FG002|Maintenance|Refusal|0|||
147584182|NCT01190930|532293632|FG003|Maintenance|Refusal|2|||
147584183|NCT01190930|532293633|FG004|Maintenance|Refusal|0|||
147157867|NCT01939002|530741885|FG001|Overall Study|Withdrawal by Subject|3|||
147157868|NCT01939002|530741884|FG000|Overall Study|Other|1|||
147157869|NCT01939002|530741885|FG001|Overall Study|Other|2|||
147157870|NCT02910401|530741888|FG000|Overall Study|Study closure Study closure|0|||
147157871|NCT02910401|530741889|FG001|Overall Study|Study closure Study closure|0|||
147157872|NCT02910401|530741890|FG002|Overall Study|Study closure Study closure|2|||
147157873|NCT02910401|530741888|FG000|Overall Study|Physician Decision|1|||
147157874|NCT02910401|530741889|FG001|Overall Study|Physician Decision|0|||
147157875|NCT02910401|530741890|FG002|Overall Study|Physician Decision|0|||
147157876|NCT01774253|530741892|FG000|Overall Study|Lack of Efficacy|4|||
147157877|NCT01774253|530741892|FG000|Overall Study|Physician Decision|2|||
147157878|NCT01774253|530741892|FG000|Overall Study|Withdrawal by Subject|2|||
147157879|NCT01774253|530741892|FG000|Overall Study|Death|1|||
147157880|NCT02240368|530741896|FG000|Overall Study|Surgery lasted less then 20 minutes|1|||
147157881|NCT02240368|530741897|FG001|Overall Study|Surgery lasted less then 20 minutes|0|||
147157882|NCT02240368|530741898|FG002|Overall Study|Surgery lasted less then 20 minutes|0|||
147157883|NCT02240368|530741896|FG000|Overall Study|Entropy failed to detect more than 50%|0|||
147157884|NCT02240368|530741897|FG001|Overall Study|Entropy failed to detect more than 50%|0|||
147157885|NCT02240368|530741898|FG002|Overall Study|Entropy failed to detect more than 50%|1|||
147157886|NCT00871117|530741904|FG000|Overall Study|Lost to Follow-up|5|||
147157887|NCT00871117|530741905|FG001|Overall Study|Lost to Follow-up|6|||
147157888|NCT00871117|530741904|FG000|Overall Study|Other|0|||
147157889|NCT00871117|530741905|FG001|Overall Study|Other|4|||
147157890|NCT03222973|530741906|FG000|Part 1 (Week 0 to Week 72)|Adverse Event|3|||
147157891|NCT03222973|530741907|FG001|Part 1 (Week 0 to Week 72)|Adverse Event|0|||
147157892|NCT03222973|530741908|FG002|Part 1 (Week 0 to Week 72)|Adverse Event|0|||
147157893|NCT03222973|530741909|FG003|Part 1 (Week 0 to Week 72)|Adverse Event|0|||
147157894|NCT03222973|530741906|FG000|Part 1 (Week 0 to Week 72)|Lost to Follow-up|1|||
147157895|NCT03222973|530741907|FG001|Part 1 (Week 0 to Week 72)|Lost to Follow-up|1|||
147157896|NCT03222973|530741908|FG002|Part 1 (Week 0 to Week 72)|Lost to Follow-up|0|||
147157897|NCT03222973|530741909|FG003|Part 1 (Week 0 to Week 72)|Lost to Follow-up|0|||
147157898|NCT03222973|530741906|FG000|Part 1 (Week 0 to Week 72)|Consent Withdrawn|12|||
147157899|NCT03222973|530741907|FG001|Part 1 (Week 0 to Week 72)|Consent Withdrawn|9|||
147157900|NCT03222973|530741908|FG002|Part 1 (Week 0 to Week 72)|Consent Withdrawn|0|||
147157901|NCT03222973|530741909|FG003|Part 1 (Week 0 to Week 72)|Consent Withdrawn|0|||
147157902|NCT03222973|530741906|FG000|Part 1 (Week 0 to Week 72)|Death|0|||
147157903|NCT03222973|530741907|FG001|Part 1 (Week 0 to Week 72)|Death|1|||
147157904|NCT03222973|530741908|FG002|Part 1 (Week 0 to Week 72)|Death|0|||
147157905|NCT03222973|530741909|FG003|Part 1 (Week 0 to Week 72)|Death|0|||
147157906|NCT03222973|530741906|FG000|Part 1 (Week 0 to Week 72)|Pregnancy|0|||
147157907|NCT03222973|530741907|FG001|Part 1 (Week 0 to Week 72)|Pregnancy|1|||
147241022|NCT01785069|531053567|FG001|Overall Study|Lost to Follow-up|2|||
147241023|NCT01785069|531053568|FG002|Overall Study|Lost to Follow-up|4|||
147157908|NCT03222973|530741908|FG002|Part 1 (Week 0 to Week 72)|Pregnancy|0|||
147157909|NCT03222973|530741909|FG003|Part 1 (Week 0 to Week 72)|Pregnancy|0|||
147157910|NCT03222973|530741906|FG000|Part 1 (Week 0 to Week 72)|Other|8|||
147157911|NCT03222973|530741907|FG001|Part 1 (Week 0 to Week 72)|Other|2|||
147157912|NCT03222973|530741908|FG002|Part 1 (Week 0 to Week 72)|Other|0|||
147241024|NCT01785069|531053569|FG003|Overall Study|Lost to Follow-up|1|||
147241025|NCT01785069|531053566|FG000|Overall Study|Reason not Specified|1|||
147584184|NCT01190930|532293634|FG005|Maintenance|Refusal|4|||
147241026|NCT01785069|531053567|FG001|Overall Study|Reason not Specified|2|||
147584185|NCT01190930|532293635|FG006|Maintenance|Refusal|5|||
147584186|NCT01190930|532293636|FG007|Maintenance|Refusal|17|||
147584187|NCT01190930|532293637|FG008|Maintenance|Refusal|13|||
147157913|NCT03222973|530741909|FG003|Part 1 (Week 0 to Week 72)|Other|0|||
147157914|NCT03222973|530741906|FG000|Part 2 (Week 73 to Week 168)|Adverse Event|0|||
147157915|NCT03222973|530741907|FG001|Part 2 (Week 73 to Week 168)|Adverse Event|0|||
147241027|NCT01785069|531053568|FG002|Overall Study|Reason not Specified|1|||
147584188|NCT01190930|532293638|FG009|Maintenance|Refusal|6|||
147584189|NCT01190930|532293629|FG000|Maintenance|second malignant neoplasm|0|||
147584190|NCT01190930|532293630|FG001|Maintenance|second malignant neoplasm|0|||
147584191|NCT01190930|532293631|FG002|Maintenance|second malignant neoplasm|0|||
147584192|NCT01190930|532293632|FG003|Maintenance|second malignant neoplasm|1|||
147584193|NCT01190930|532293633|FG004|Maintenance|second malignant neoplasm|0|||
147584194|NCT01190930|532293634|FG005|Maintenance|second malignant neoplasm|1|||
147157916|NCT03222973|530741908|FG002|Part 2 (Week 73 to Week 168)|Adverse Event|2|||
147157917|NCT03222973|530741909|FG003|Part 2 (Week 73 to Week 168)|Adverse Event|0|||
147157918|NCT03222973|530741906|FG000|Part 2 (Week 73 to Week 168)|Consent Withdrawn|0|||
147157919|NCT03222973|530741907|FG001|Part 2 (Week 73 to Week 168)|Consent Withdrawn|0|||
147584195|NCT01190930|532293635|FG006|Maintenance|second malignant neoplasm|0|||
147584196|NCT01190930|532293636|FG007|Maintenance|second malignant neoplasm|0|||
147584197|NCT01190930|532293637|FG008|Maintenance|second malignant neoplasm|1|||
147584198|NCT01190930|532293638|FG009|Maintenance|second malignant neoplasm|0|||
147584199|NCT01190930|532293629|FG000|Maintenance|Inevaluable|0|||
147584200|NCT01190930|532293630|FG001|Maintenance|Inevaluable|0|||
147584201|NCT01190930|532293631|FG002|Maintenance|Inevaluable|0|||
147584202|NCT01190930|532293632|FG003|Maintenance|Inevaluable|0|||
147584203|NCT01190930|532293633|FG004|Maintenance|Inevaluable|0|||
147584204|NCT01190930|532293634|FG005|Maintenance|Inevaluable|1|||
147584205|NCT01190930|532293635|FG006|Maintenance|Inevaluable|1|||
147584206|NCT01190930|532293636|FG007|Maintenance|Inevaluable|1|||
147584207|NCT01190930|532293637|FG008|Maintenance|Inevaluable|0|||
147584208|NCT01190930|532293638|FG009|Maintenance|Inevaluable|0|||
147584209|NCT01190930|532293629|FG000|Maintenance|Enrollment onto another COG Protocol|0|||
147584210|NCT01190930|532293630|FG001|Maintenance|Enrollment onto another COG Protocol|0|||
147584211|NCT01190930|532293631|FG002|Maintenance|Enrollment onto another COG Protocol|0|||
147584212|NCT01190930|532293632|FG003|Maintenance|Enrollment onto another COG Protocol|0|||
147584213|NCT01190930|532293633|FG004|Maintenance|Enrollment onto another COG Protocol|0|||
147584214|NCT01190930|532293634|FG005|Maintenance|Enrollment onto another COG Protocol|0|||
147584215|NCT01190930|532293635|FG006|Maintenance|Enrollment onto another COG Protocol|0|||
147584216|NCT01190930|532293636|FG007|Maintenance|Enrollment onto another COG Protocol|0|||
147584217|NCT01190930|532293637|FG008|Maintenance|Enrollment onto another COG Protocol|1|||
147584218|NCT01190930|532293638|FG009|Maintenance|Enrollment onto another COG Protocol|0|||
147584219|NCT01190930|532293629|FG000|Maintenance|Relapse|0|||
147584220|NCT01190930|532293630|FG001|Maintenance|Relapse|0|||
147584221|NCT01190930|532293631|FG002|Maintenance|Relapse|0|||
147584222|NCT01190930|532293632|FG003|Maintenance|Relapse|2|||
147584223|NCT01190930|532293633|FG004|Maintenance|Relapse|0|||
147584224|NCT01190930|532293634|FG005|Maintenance|Relapse|1|||
147584225|NCT01190930|532293635|FG006|Maintenance|Relapse|6|||
147584226|NCT01190930|532293636|FG007|Maintenance|Relapse|13|||
147584227|NCT01190930|532293637|FG008|Maintenance|Relapse|11|||
147584228|NCT01190930|532293638|FG009|Maintenance|Relapse|11|||
147584229|NCT01190930|532293629|FG000|Maintenance|Still on therapy|0|||
147584230|NCT01190930|532293630|FG001|Maintenance|Still on therapy|8|||
147584231|NCT01190930|532293631|FG002|Maintenance|Still on therapy|0|||
147584232|NCT01190930|532293632|FG003|Maintenance|Still on therapy|29|||
147584233|NCT01190930|532293633|FG004|Maintenance|Still on therapy|0|||
147584234|NCT01190930|532293634|FG005|Maintenance|Still on therapy|0|||
147584235|NCT01190930|532293635|FG006|Maintenance|Still on therapy|0|||
147584236|NCT01190930|532293636|FG007|Maintenance|Still on therapy|0|||
147584237|NCT01190930|532293637|FG008|Maintenance|Still on therapy|0|||
147584238|NCT01190930|532293638|FG009|Maintenance|Still on therapy|0|||
147584239|NCT00113919|532293641|FG000|Overall Study|Physician Decision|8|||
147584240|NCT00113919|532293641|FG000|Overall Study|Death|6|||
147584241|NCT02914457|532293644|FG000|Overall Study|Withdrawal by Subject|1|||
147584242|NCT02914457|532293644|FG000|Overall Study|Physician Decision|1|||
147584243|NCT02914457|532293644|FG000|Overall Study|No veins available for lead placement|1|||
147157920|NCT03222973|530741908|FG002|Part 2 (Week 73 to Week 168)|Consent Withdrawn|10|||
147157921|NCT03222973|530741909|FG003|Part 2 (Week 73 to Week 168)|Consent Withdrawn|11|||
147157922|NCT03222973|530741906|FG000|Part 2 (Week 73 to Week 168)|Investigator Decision|0|||
147157923|NCT03222973|530741907|FG001|Part 2 (Week 73 to Week 168)|Investigator Decision|0|||
147157924|NCT03222973|530741908|FG002|Part 2 (Week 73 to Week 168)|Investigator Decision|2|||
147157925|NCT03222973|530741909|FG003|Part 2 (Week 73 to Week 168)|Investigator Decision|1|||
147157926|NCT03222973|530741906|FG000|Part 2 (Week 73 to Week 168)|Pregnancy|0|||
147584244|NCT02914457|532293644|FG000|Overall Study|Electrical instability of patient|1|||
147157927|NCT03222973|530741907|FG001|Part 2 (Week 73 to Week 168)|Pregnancy|0|||
147584245|NCT02914457|532293644|FG000|Overall Study|ECG acquisition error due to sweating|1|||
147584246|NCT02914457|532293644|FG000|Overall Study|Protocol Violation|1|||
147584247|NCT01292837|532293650|FG000|Overall Study|Adverse Event|1|||
147584248|NCT01292837|532293650|FG000|Overall Study|Further treatment determined|1|||
147584249|NCT02174276|532293651|FG000|Study Treatment Phase (Weeks 1 to 48)|Lost to Follow-up|1|||
147584250|NCT02174276|532293652|FG001|Study Treatment Phase (Weeks 1 to 48)|Lost to Follow-up|0|||
147584251|NCT02174276|532293653|FG002|Study Treatment Phase (Weeks 1 to 48)|Lost to Follow-up|0|||
147584252|NCT02174276|532293654|FG003|Study Treatment Phase (Weeks 1 to 48)|Lost to Follow-up|0|||
147584253|NCT02174276|532293651|FG000|Study Treatment Phase (Weeks 1 to 48)|Pregnancy|0|||
147157928|NCT03222973|530741908|FG002|Part 2 (Week 73 to Week 168)|Pregnancy|2|||
147157929|NCT03222973|530741909|FG003|Part 2 (Week 73 to Week 168)|Pregnancy|1|||
147157930|NCT03222973|530741906|FG000|Part 2 (Week 73 to Week 168)|Other|0|||
147157931|NCT03222973|530741907|FG001|Part 2 (Week 73 to Week 168)|Other|0|||
147157932|NCT03222973|530741908|FG002|Part 2 (Week 73 to Week 168)|Other|84|||
147584254|NCT02174276|532293652|FG001|Study Treatment Phase (Weeks 1 to 48)|Pregnancy|0|||
147584255|NCT02174276|532293653|FG002|Study Treatment Phase (Weeks 1 to 48)|Pregnancy|1|||
147584256|NCT02174276|532293654|FG003|Study Treatment Phase (Weeks 1 to 48)|Pregnancy|0|||
147584257|NCT02174276|532293651|FG000|Study Treatment Phase (Weeks 1 to 48)|Withdrawal by Subject|0|||
147584258|NCT02174276|532293652|FG001|Study Treatment Phase (Weeks 1 to 48)|Withdrawal by Subject|1|||
147584259|NCT02174276|532293653|FG002|Study Treatment Phase (Weeks 1 to 48)|Withdrawal by Subject|2|||
147584260|NCT02174276|532293654|FG003|Study Treatment Phase (Weeks 1 to 48)|Withdrawal by Subject|0|||
147584261|NCT02174276|532293651|FG000|OTEP (Weeks 48 to 144)|Lost to Follow-up|0|||
147584262|NCT02174276|532293652|FG001|OTEP (Weeks 48 to 144)|Lost to Follow-up|0|||
147584263|NCT02174276|532293653|FG002|OTEP (Weeks 48 to 144)|Lost to Follow-up|1|||
147584264|NCT02174276|532293654|FG003|OTEP (Weeks 48 to 144)|Lost to Follow-up|0|||
147584265|NCT02174276|532293651|FG000|OTEP (Weeks 48 to 144)|Pregnancy|0|||
147584266|NCT02174276|532293652|FG001|OTEP (Weeks 48 to 144)|Pregnancy|0|||
147584267|NCT02174276|532293653|FG002|OTEP (Weeks 48 to 144)|Pregnancy|1|||
147584268|NCT02174276|532293654|FG003|OTEP (Weeks 48 to 144)|Pregnancy|0|||
147584269|NCT02174276|532293651|FG000|OTEP (Weeks 48 to 144)|Withdrew Consent|1|||
147584270|NCT02174276|532293652|FG001|OTEP (Weeks 48 to 144)|Withdrew Consent|0|||
147584271|NCT02174276|532293653|FG002|OTEP (Weeks 48 to 144)|Withdrew Consent|1|||
147584272|NCT02174276|532293654|FG003|OTEP (Weeks 48 to 144)|Withdrew Consent|2|||
147584273|NCT01206439|532293657|FG000|Overall Study|subject did not meet inclusion criteria|1|||
147584274|NCT05889039|532293658|FG000|Overall Study|error in completing survey|0|||
147584275|NCT05889039|532293659|FG001|Overall Study|error in completing survey|2|||
147584276|NCT05889039|532293660|FG002|Overall Study|error in completing survey|0|||
147584277|NCT05889039|532293661|FG003|Overall Study|error in completing survey|0|||
147584278|NCT05889039|532293658|FG000|Overall Study|Lost to Follow-up|4|||
147584279|NCT05889039|532293659|FG001|Overall Study|Lost to Follow-up|0|||
147584280|NCT05889039|532293660|FG002|Overall Study|Lost to Follow-up|0|||
147584281|NCT05889039|532293661|FG003|Overall Study|Lost to Follow-up|0|||
147584282|NCT02661022|532293662|FG000|Overall Study|Withdrawal by Subject|3|||
147584283|NCT02661022|532293663|FG001|Overall Study|Withdrawal by Subject|0|||
147584284|NCT02661022|532293662|FG000|Overall Study|Adverse Event|1|||
147584285|NCT02661022|532293663|FG001|Overall Study|Adverse Event|1|||
147584286|NCT02661022|532293662|FG000|Overall Study|Physician Decision|1|||
147584287|NCT02661022|532293663|FG001|Overall Study|Physician Decision|0|||
147584288|NCT02661022|532293662|FG000|Overall Study|Progressive Disease|2|||
147584289|NCT02661022|532293663|FG001|Overall Study|Progressive Disease|1|||
147584290|NCT00609154|532293667|FG000|Overall Study|Protocol Violation|1|||
147584291|NCT00609154|532293668|FG001|Overall Study|Protocol Violation|2|||
147584292|NCT00609154|532293667|FG000|Overall Study|Unable to establish IV access|0|||
147584293|NCT00609154|532293668|FG001|Overall Study|Unable to establish IV access|4|||
147584294|NCT00609154|532293667|FG000|Overall Study|Adverse Event|0|||
147584295|NCT00609154|532293668|FG001|Overall Study|Adverse Event|2|||
147584296|NCT04531527|532293669|FG000|Overall Study|Found to be Ineligible|3|||
147584297|NCT01785615|532293680|FG000|Dietary Phase|Lost to Follow-up|0|||
147584298|NCT01785615|532293681|FG001|Dietary Phase|Lost to Follow-up|0|||
147584299|NCT01785615|532293682|FG002|Dietary Phase|Lost to Follow-up|0|||
147584300|NCT01785615|532293683|FG003|Dietary Phase|Lost to Follow-up|24|||
147584301|NCT01881737|532293686|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|3|||
147584302|NCT01881737|532293686|FG000|Overall Study|Withdrawal by Subject|1|||
147584303|NCT01881737|532293686|FG000|Overall Study|Worsening of baseline behavior|1|||
147584304|NCT01450800|532293695|FG000|Overall Study|Protocol Violation|1|||
147584305|NCT01450800|532293696|FG001|Overall Study|Protocol Violation|3|||
147584306|NCT03496298|532293699|FG000|Overall Study|Adverse Event|49|||
147584307|NCT03496298|532293700|FG001|Overall Study|Adverse Event|68|||
147584308|NCT03496298|532293701|FG002|Overall Study|Adverse Event|79|||
147584309|NCT03496298|532293699|FG000|Overall Study|Study terminated by Sponsor|1050|||
147584310|NCT03496298|532293700|FG001|Overall Study|Study terminated by Sponsor|1063|||
147584311|NCT03496298|532293701|FG002|Overall Study|Study terminated by Sponsor|1071|||
147584312|NCT03496298|532293699|FG000|Overall Study|Physician decision (other than Adverse event)|12|||
147157933|NCT03222973|530741909|FG003|Part 2 (Week 73 to Week 168)|Other|100|||
147584313|NCT03496298|532293700|FG001|Overall Study|Physician decision (other than Adverse event)|17|||
147584314|NCT03496298|532293701|FG002|Overall Study|Physician decision (other than Adverse event)|10|||
147584315|NCT03496298|532293699|FG000|Overall Study|Withdrawal by Subject|176|||
147584316|NCT03496298|532293700|FG001|Overall Study|Withdrawal by Subject|154|||
147584317|NCT03496298|532293701|FG002|Overall Study|Withdrawal by Subject|151|||
147584318|NCT03496298|532293699|FG000|Overall Study|Other|29|||
147584319|NCT03496298|532293700|FG001|Overall Study|Other|20|||
147584320|NCT03496298|532293701|FG002|Overall Study|Other|23|||
147584321|NCT03496298|532293699|FG000|Overall Study|Randomized and not treated|1|||
147584322|NCT03496298|532293700|FG001|Overall Study|Randomized and not treated|1|||
147584323|NCT03496298|532293701|FG002|Overall Study|Randomized and not treated|1|||
147584324|NCT02608476|532293708|FG000|Overall Study|Withdrawal by Subject|30|||
147584325|NCT02608476|532293709|FG001|Overall Study|Withdrawal by Subject|37|||
147584326|NCT02608476|532293708|FG000|Overall Study|Lost to Follow-up|24|||
147584327|NCT02608476|532293709|FG001|Overall Study|Lost to Follow-up|24|||
147584328|NCT02608476|532293708|FG000|Overall Study|Adverse Event|2|||
147584329|NCT02608476|532293709|FG001|Overall Study|Adverse Event|8|||
147584330|NCT02608476|532293708|FG000|Overall Study|Withdrawal by Parent/Guardian|5|||
147584331|NCT02608476|532293709|FG001|Overall Study|Withdrawal by Parent/Guardian|4|||
147584332|NCT02608476|532293708|FG000|Overall Study|Noncompliance with treatment|1|||
147584333|NCT02608476|532293709|FG001|Overall Study|Noncompliance with treatment|5|||
147584334|NCT02608476|532293708|FG000|Overall Study|Lack of Efficacy|3|||
147584335|NCT02608476|532293709|FG001|Overall Study|Lack of Efficacy|1|||
147584336|NCT02608476|532293708|FG000|Overall Study|Other|0|||
147584337|NCT02608476|532293709|FG001|Overall Study|Other|1|||
147584338|NCT02608476|532293708|FG000|Overall Study|Physician Decision|1|||
147584339|NCT02608476|532293709|FG001|Overall Study|Physician Decision|0|||
147584340|NCT02608476|532293708|FG000|Overall Study|Pregnancy|0|||
147584341|NCT02608476|532293709|FG001|Overall Study|Pregnancy|1|||
147584342|NCT02608476|532293708|FG000|Overall Study|Progressive disease|1|||
147584343|NCT02608476|532293709|FG001|Overall Study|Progressive disease|0|||
147584344|NCT02058160|532293710|FG000|Overall Study|Randomized but not treated|2|||
147584345|NCT02058160|532293711|FG001|Overall Study|Randomized but not treated|4|||
147584346|NCT02058160|532293710|FG000|Overall Study|Poor compliance to protocol|4|||
147584347|NCT02058160|532293711|FG001|Overall Study|Poor compliance to protocol|1|||
147584348|NCT02058160|532293710|FG000|Overall Study|Adverse Event|12|||
147584349|NCT02058160|532293711|FG001|Overall Study|Adverse Event|3|||
147584350|NCT02058160|532293710|FG000|Overall Study|Lost to Follow-up|1|||
147584351|NCT02058160|532293711|FG001|Overall Study|Lost to Follow-up|0|||
147584352|NCT02058160|532293710|FG000|Overall Study|Other than specified above|12|||
147584353|NCT02058160|532293711|FG001|Overall Study|Other than specified above|6|||
147584354|NCT04106817|532293712|FG000|Overall Study|Lost to Follow-up|1|||
147584355|NCT04106817|532293713|FG001|Overall Study|Lost to Follow-up|0|||
147584356|NCT04106817|532293714|FG002|Overall Study|Lost to Follow-up|0|||
147584357|NCT03310619|532293715|FG000|Pre-Treatment Period|Death|1|||
147584358|NCT03310619|532293716|FG001|Pre-Treatment Period|Death|0|||
147584359|NCT03310619|532293717|FG002|Pre-Treatment Period|Death|0|||
147584360|NCT03310619|532293718|FG003|Pre-Treatment Period|Death|0|||
147584361|NCT03310619|532293719|FG004|Pre-Treatment Period|Death|1|||
147584362|NCT03310619|532293720|FG005|Pre-Treatment Period|Death|0|||
147584363|NCT03310619|532293721|FG006|Pre-Treatment Period|Death|0|||
147584364|NCT03310619|532293722|FG007|Pre-Treatment Period|Death|0|||
147584365|NCT03310619|532293715|FG000|Pre-Treatment Period|Other reasons|2|||
147584366|NCT03310619|532293716|FG001|Pre-Treatment Period|Other reasons|1|||
147584367|NCT03310619|532293717|FG002|Pre-Treatment Period|Other reasons|2|||
147584368|NCT03310619|532293718|FG003|Pre-Treatment Period|Other reasons|0|||
147584369|NCT03310619|532293719|FG004|Pre-Treatment Period|Other reasons|0|||
147584370|NCT03310619|532293720|FG005|Pre-Treatment Period|Other reasons|0|||
147584371|NCT03310619|532293721|FG006|Pre-Treatment Period|Other reasons|2|||
147584372|NCT03310619|532293722|FG007|Pre-Treatment Period|Other reasons|0|||
147584373|NCT03310619|532293715|FG000|Treatment Period|Death|1|||
147584374|NCT03310619|532293716|FG001|Treatment Period|Death|2|||
147584375|NCT03310619|532293717|FG002|Treatment Period|Death|0|||
147584376|NCT03310619|532293718|FG003|Treatment Period|Death|0|||
147584377|NCT03310619|532293719|FG004|Treatment Period|Death|1|||
147584378|NCT03310619|532293720|FG005|Treatment Period|Death|0|||
147584379|NCT03310619|532293721|FG006|Treatment Period|Death|2|||
147584380|NCT03310619|532293722|FG007|Treatment Period|Death|0|||
147584381|NCT03310619|532293715|FG000|Treatment Period|Adverse Event|0|||
147584382|NCT03310619|532293716|FG001|Treatment Period|Adverse Event|1|||
147584383|NCT03310619|532293717|FG002|Treatment Period|Adverse Event|4|||
147584384|NCT03310619|532293718|FG003|Treatment Period|Adverse Event|1|||
147584385|NCT03310619|532293719|FG004|Treatment Period|Adverse Event|0|||
147584386|NCT03310619|532293720|FG005|Treatment Period|Adverse Event|0|||
147584387|NCT03310619|532293721|FG006|Treatment Period|Adverse Event|0|||
147584388|NCT03310619|532293722|FG007|Treatment Period|Adverse Event|0|||
147584389|NCT03310619|532293715|FG000|Treatment Period|Withdrawal by participant|0|||
147584390|NCT03310619|532293716|FG001|Treatment Period|Withdrawal by participant|0|||
147584391|NCT03310619|532293717|FG002|Treatment Period|Withdrawal by participant|1|||
147584392|NCT03310619|532293718|FG003|Treatment Period|Withdrawal by participant|0|||
147584393|NCT03310619|532293719|FG004|Treatment Period|Withdrawal by participant|0|||
147584394|NCT03310619|532293720|FG005|Treatment Period|Withdrawal by participant|0|||
147584395|NCT03310619|532293721|FG006|Treatment Period|Withdrawal by participant|0|||
147584396|NCT03310619|532293722|FG007|Treatment Period|Withdrawal by participant|0|||
147584397|NCT03310619|532293715|FG000|Treatment Period|Lost to Follow-up|0|||
147584398|NCT03310619|532293716|FG001|Treatment Period|Lost to Follow-up|0|||
147584399|NCT03310619|532293717|FG002|Treatment Period|Lost to Follow-up|0|||
147654373|NCT00237692|532556703|FG001|Overall Study|Lost to Follow-up|3|||
147584400|NCT03310619|532293718|FG003|Treatment Period|Lost to Follow-up|0|||
147584401|NCT03310619|532293719|FG004|Treatment Period|Lost to Follow-up|0|||
147584402|NCT03310619|532293720|FG005|Treatment Period|Lost to Follow-up|0|||
147584403|NCT03310619|532293721|FG006|Treatment Period|Lost to Follow-up|0|||
147584404|NCT03310619|532293722|FG007|Treatment Period|Lost to Follow-up|1|||
147584405|NCT03310619|532293715|FG000|Treatment Period|Study terminated by sponsor|0|||
147584406|NCT03310619|532293716|FG001|Treatment Period|Study terminated by sponsor|0|||
147584407|NCT03310619|532293717|FG002|Treatment Period|Study terminated by sponsor|0|||
147584408|NCT03310619|532293718|FG003|Treatment Period|Study terminated by sponsor|0|||
147584409|NCT03310619|532293719|FG004|Treatment Period|Study terminated by sponsor|0|||
147584410|NCT03310619|532293720|FG005|Treatment Period|Study terminated by sponsor|0|||
147584411|NCT03310619|532293721|FG006|Treatment Period|Study terminated by sponsor|0|||
147584412|NCT03310619|532293722|FG007|Treatment Period|Study terminated by sponsor|1|||
147584413|NCT03310619|532293715|FG000|Treatment Period|Physician Decision|0|||
147584414|NCT03310619|532293716|FG001|Treatment Period|Physician Decision|0|||
147584415|NCT03310619|532293717|FG002|Treatment Period|Physician Decision|0|||
147584416|NCT03310619|532293718|FG003|Treatment Period|Physician Decision|0|||
147584417|NCT03310619|532293719|FG004|Treatment Period|Physician Decision|3|||
147584418|NCT03310619|532293720|FG005|Treatment Period|Physician Decision|0|||
147584419|NCT03310619|532293721|FG006|Treatment Period|Physician Decision|0|||
147584420|NCT03310619|532293722|FG007|Treatment Period|Physician Decision|0|||
147584421|NCT03310619|532293715|FG000|Treatment Period|Other reasons|1|||
147584422|NCT03310619|532293716|FG001|Treatment Period|Other reasons|0|||
147584423|NCT03310619|532293717|FG002|Treatment Period|Other reasons|2|||
147584424|NCT03310619|532293718|FG003|Treatment Period|Other reasons|0|||
147584425|NCT03310619|532293719|FG004|Treatment Period|Other reasons|0|||
147584426|NCT03310619|532293720|FG005|Treatment Period|Other reasons|0|||
147584427|NCT03310619|532293721|FG006|Treatment Period|Other reasons|0|||
147584428|NCT03310619|532293722|FG007|Treatment Period|Other reasons|0|||
147584429|NCT00152516|532293723|FG000|Overall Study|Adverse Event|18|||
147584430|NCT00152516|532293723|FG000|Overall Study|Lack and Loss of Efficacy|30|||
147584431|NCT00152516|532293723|FG000|Overall Study|Lost to Follow-up|5|||
147584432|NCT00152516|532293723|FG000|Overall Study|Withdrawal by Subject|8|||
147584433|NCT00152516|532293723|FG000|Overall Study|Protocol Violation|3|||
147584434|NCT00152516|532293723|FG000|Overall Study|Other: Mother Refused To Cooperate|1|||
147584435|NCT00152516|532293723|FG000|Overall Study|Other: Given Commercial Drug in Error|2|||
147584436|NCT00152516|532293723|FG000|Overall Study|Other: Parents Withdrew Consent|2|||
147584437|NCT00152516|532293723|FG000|Overall Study|Other: Non-Compliance|2|||
147584438|NCT00152516|532293723|FG000|Overall Study|Other: Primary Care Physician's Decision|1|||
147584439|NCT00152516|532293723|FG000|Overall Study|Other: Moved Out Of State|1|||
147584440|NCT00152516|532293723|FG000|Overall Study|Other: Underwent Surgery for Epilepsy|1|||
147584441|NCT00152516|532293723|FG000|Overall Study|Other: Sz Worsening, Seeking 2nd Opinion|1|||
147584442|NCT04291508|532293724|FG000|Overall Study|Withdrawal by Subject|1|||
147584443|NCT04291508|532293725|FG001|Overall Study|Withdrawal by Subject|0|||
147584444|NCT04291508|532293726|FG002|Overall Study|Withdrawal by Subject|1|||
147584445|NCT04291508|532293727|FG003|Overall Study|Withdrawal by Subject|0|||
147584446|NCT04291508|532293724|FG000|Overall Study|lost to follow up|4|||
147584447|NCT04291508|532293725|FG001|Overall Study|lost to follow up|0|||
147584448|NCT04291508|532293726|FG002|Overall Study|lost to follow up|1|||
147584449|NCT04291508|532293727|FG003|Overall Study|lost to follow up|0|||
147584450|NCT00398073|532293728|FG000|Overall Study|Withdrawal by Subject|1|||
147584451|NCT00398073|532293729|FG001|Overall Study|Withdrawal by Subject|0|||
147584452|NCT01263561|532293730|FG000|Overall Study|Death|1|||
147584453|NCT01263561|532293731|FG001|Overall Study|Death|2|||
147584454|NCT03185741|532293734|FG000|Baseline|Withdrawal by Subject|1|||
147584455|NCT03185741|532293735|FG001|Baseline|Withdrawal by Subject|3|||
147584456|NCT03185741|532293736|FG002|Baseline|Withdrawal by Subject|2|||
147584457|NCT03185741|532293734|FG000|Baseline|Lost to Follow-up|1|||
147584458|NCT03185741|532293735|FG001|Baseline|Lost to Follow-up|2|||
147584459|NCT03185741|532293736|FG002|Baseline|Lost to Follow-up|3|||
147584460|NCT03185741|532293734|FG000|3Month|Death|1|||
147241028|NCT01785069|531053569|FG003|Overall Study|Reason not Specified|4|||
147584461|NCT03185741|532293735|FG001|3Month|Death|1|||
147584462|NCT03185741|532293736|FG002|3Month|Death|2|||
147584463|NCT03185741|532293734|FG000|3Month|Withdrawal by Subject|1|||
147584464|NCT03185741|532293735|FG001|3Month|Withdrawal by Subject|5|||
147584465|NCT03185741|532293736|FG002|3Month|Withdrawal by Subject|1|||
147584466|NCT03185741|532293734|FG000|3Month|Lost to Follow-up|7|||
147584467|NCT03185741|532293735|FG001|3Month|Lost to Follow-up|9|||
147584468|NCT03185741|532293736|FG002|3Month|Lost to Follow-up|8|||
147584469|NCT03185741|532293734|FG000|3Month|Unavailable for 3Month|11|||
147584470|NCT03185741|532293735|FG001|3Month|Unavailable for 3Month|10|||
147584471|NCT03185741|532293736|FG002|3Month|Unavailable for 3Month|11|||
147584472|NCT03185741|532293734|FG000|3Month|Protocol Violation|0|||
147584473|NCT03185741|532293735|FG001|3Month|Protocol Violation|0|||
147584474|NCT03185741|532293736|FG002|3Month|Protocol Violation|3|||
147584475|NCT03185741|532293734|FG000|6Month|Death|1|||
147584476|NCT03185741|532293735|FG001|6Month|Death|1|||
147584477|NCT03185741|532293736|FG002|6Month|Death|2|||
147584478|NCT03185741|532293734|FG000|6Month|Withdrawal by Subject|2|||
147584479|NCT03185741|532293735|FG001|6Month|Withdrawal by Subject|3|||
147584480|NCT03185741|532293736|FG002|6Month|Withdrawal by Subject|1|||
147584481|NCT03185741|532293734|FG000|6Month|Lost to Follow-up|16|||
147584482|NCT03185741|532293735|FG001|6Month|Lost to Follow-up|15|||
147584483|NCT03185741|532293736|FG002|6Month|Lost to Follow-up|16|||
147584484|NCT01488448|532293737|FG000|Overall Study|Withdrawal by Subject|3|||
147584485|NCT01488448|532293738|FG001|Overall Study|Withdrawal by Subject|1|||
147584486|NCT01488448|532293737|FG000|Overall Study|Adverse Event|9|||
147584487|NCT01488448|532293738|FG001|Overall Study|Adverse Event|4|||
147584488|NCT01488448|532293737|FG000|Overall Study|Physician Decision|4|||
147584489|NCT01488448|532293738|FG001|Overall Study|Physician Decision|9|||
147584490|NCT01488448|532293737|FG000|Overall Study|Protocol Violation|4|||
147584491|NCT01488448|532293738|FG001|Overall Study|Protocol Violation|3|||
147584492|NCT00654641|532293739|FG000|Overall Study|Lost to Follow-up|2|||
147584493|NCT00654641|532293740|FG001|Overall Study|Lost to Follow-up|3|||
147584494|NCT01992094|532293741|FG000|Overall Study|ADMINISTRATIVE REASON|6|||
147584495|NCT01992094|532293742|FG001|Overall Study|ADMINISTRATIVE REASON|7|||
147584496|NCT01992094|532293743|FG002|Overall Study|ADMINISTRATIVE REASON|1|||
147584497|NCT01992094|532293741|FG000|Overall Study|Adverse Event|1|||
147584498|NCT01992094|532293742|FG001|Overall Study|Adverse Event|0|||
147584499|NCT01992094|532293743|FG002|Overall Study|Adverse Event|0|||
147584500|NCT01992094|532293741|FG000|Overall Study|Death|5|||
147584501|NCT01992094|532293742|FG001|Overall Study|Death|5|||
147584502|NCT01992094|532293743|FG002|Overall Study|Death|2|||
147584503|NCT01992094|532293741|FG000|Overall Study|Lost to Follow-up|26|||
147584504|NCT01992094|532293742|FG001|Overall Study|Lost to Follow-up|9|||
147584505|NCT01992094|532293743|FG002|Overall Study|Lost to Follow-up|13|||
147584506|NCT01992094|532293741|FG000|Overall Study|OTHER|4|||
147584507|NCT01992094|532293742|FG001|Overall Study|OTHER|0|||
147584508|NCT01992094|532293743|FG002|Overall Study|OTHER|0|||
147584509|NCT01992094|532293741|FG000|Overall Study|Protocol Violation|1|||
147584510|NCT01992094|532293742|FG001|Overall Study|Protocol Violation|0|||
147584511|NCT01992094|532293743|FG002|Overall Study|Protocol Violation|1|||
147584512|NCT01992094|532293741|FG000|Overall Study|Withdrawal by Subject|7|||
147584513|NCT01992094|532293742|FG001|Overall Study|Withdrawal by Subject|3|||
147584514|NCT01992094|532293743|FG002|Overall Study|Withdrawal by Subject|4|||
147584515|NCT01475487|532293744|FG000|Overall Study|had to leave early for personal reasons|2|||
147584516|NCT01475487|532293745|FG001|Overall Study|had to leave early for personal reasons|1|||
147584517|NCT04428645|532293750|FG000|Second at Home Period (8 Weeks)|Withdrawal by Subject|1|||
147584518|NCT03168906|532293751|FG000|Overall Study|Lack of Efficacy|6|||
147584519|NCT03168906|532293752|FG001|Overall Study|Lack of Efficacy|6|||
147584520|NCT00810602|532293753|FG000|Overall Study|Withdrawal by Subject|8|||
147584521|NCT00810602|532293754|FG001|Overall Study|Withdrawal by Subject|3|||
147584522|NCT03840382|532293758|FG000|Overall Study|Lost to Follow-up|11|||
147584523|NCT02625974|532293759|FG000|Part 1|Lost to Follow-up|9|||
147584524|NCT02625974|532293760|FG001|Part 1|Lost to Follow-up|3|||
147584525|NCT02625974|532293759|FG000|Part 2|Lost to Follow-up|4|||
147584526|NCT02625974|532293760|FG001|Part 2|Lost to Follow-up|6|||
147584527|NCT02625974|532293759|FG000|Part 2|Other, including due to the COVID-19 Pandemic|2|||
147584528|NCT02625974|532293760|FG001|Part 2|Other, including due to the COVID-19 Pandemic|1|||
147584529|NCT01142661|532293761|FG000|Overall Study|Adverse Event|2|||
147584530|NCT01142661|532293761|FG000|Overall Study|Withdrawal by Subject|1|||
147584531|NCT01142661|532293761|FG000|Overall Study|Physician Decision|1|||
147584532|NCT01923311|532295442|FG000|Overall Study|Pregnancy|1|||
147584533|NCT01923311|532295443|FG001|Overall Study|Pregnancy|0|||
147584534|NCT01923311|532295442|FG000|Overall Study|Investigator's Discretion|1|||
147584535|NCT01923311|532295443|FG001|Overall Study|Investigator's Discretion|0|||
147584536|NCT01923311|532295442|FG000|Overall Study|Non-Compliance with Study Drug|2|||
147584537|NCT01923311|532295443|FG001|Overall Study|Non-Compliance with Study Drug|1|||
147584538|NCT01923311|532295442|FG000|Overall Study|Withdrew Consent|1|||
147446827|NCT02055820|531800319|FG001|Phase I: Dose-Finding|Death|0|||
147584539|NCT01923311|532295443|FG001|Overall Study|Withdrew Consent|0|||
147584540|NCT01923311|532295442|FG000|Overall Study|Study Terminated by Sponsor|12|||
147584541|NCT01923311|532295443|FG001|Overall Study|Study Terminated by Sponsor|0|||
147584542|NCT03429049|532295444|FG000|Overall Study|Adverse Event|2|||
147584543|NCT03429049|532295445|FG001|Overall Study|Adverse Event|3|||
147584544|NCT03429049|532295444|FG000|Overall Study|Death|0|||
147584545|NCT03429049|532295445|FG001|Overall Study|Death|1|||
147584546|NCT03429049|532295444|FG000|Overall Study|Lack of Efficacy|4|||
147584547|NCT03429049|532295445|FG001|Overall Study|Lack of Efficacy|2|||
147584548|NCT03429049|532295444|FG000|Overall Study|Lost to Follow-up|9|||
147584549|NCT03429049|532295445|FG001|Overall Study|Lost to Follow-up|8|||
147584550|NCT03429049|532295444|FG000|Overall Study|Physician Decision|1|||
147584551|NCT03429049|532295445|FG001|Overall Study|Physician Decision|0|||
147584552|NCT03429049|532295444|FG000|Overall Study|Protocol Violation|3|||
147584553|NCT03429049|532295445|FG001|Overall Study|Protocol Violation|0|||
147584554|NCT03429049|532295444|FG000|Overall Study|Sponsor Decision|2|||
147584555|NCT03429049|532295445|FG001|Overall Study|Sponsor Decision|0|||
147584556|NCT03429049|532295444|FG000|Overall Study|Withdrawal by Subject|4|||
147584557|NCT03429049|532295445|FG001|Overall Study|Withdrawal by Subject|20|||
147584558|NCT03429049|532295444|FG000|Overall Study|Other reasons: UNABLE TO ADMINISTER IP, COLLECT ASPIRATE|3|||
147584559|NCT03429049|532295445|FG001|Overall Study|Other reasons: UNABLE TO ADMINISTER IP, COLLECT ASPIRATE|8|||
147584560|NCT04703855|532295446|FG000|Overall Study|Heart Transplant|1|||
147584561|NCT04241133|532295447|FG000|Overall Study|COVID19 Precautions|14|||
147584562|NCT04241133|532295448|FG001|Overall Study|COVID19 Precautions|34|||
147584563|NCT02994394|532295449|FG000|Period 1 (Days 1 to 3)|Adverse Event|0|||
147584564|NCT02994394|532295450|FG001|Period 1 (Days 1 to 3)|Adverse Event|0|||
147584565|NCT02994394|532295451|FG002|Period 1 (Days 1 to 3)|Adverse Event|1|||
147584566|NCT02994394|532295452|FG003|Period 1 (Days 1 to 3)|Adverse Event|0|||
147584567|NCT02994394|532295453|FG004|Period 1 (Days 1 to 3)|Adverse Event|0|||
147584568|NCT02994394|532295454|FG005|Period 1 (Days 1 to 3)|Adverse Event|0|||
147584569|NCT02994394|532295449|FG000|Period 2 (Days 4 to 6)|Adverse Event|0|||
147584570|NCT02994394|532295450|FG001|Period 2 (Days 4 to 6)|Adverse Event|1|||
147584571|NCT02994394|532295451|FG002|Period 2 (Days 4 to 6)|Adverse Event|0|||
147584572|NCT02994394|532295452|FG003|Period 2 (Days 4 to 6)|Adverse Event|0|||
147584573|NCT02994394|532295453|FG004|Period 2 (Days 4 to 6)|Adverse Event|1|||
147584574|NCT02994394|532295454|FG005|Period 2 (Days 4 to 6)|Adverse Event|0|||
147584575|NCT02576717|532295455|FG000|Overall Study|Other Reasons|16|||
147584576|NCT02576717|532295456|FG001|Overall Study|Other Reasons|18|||
147584577|NCT02576717|532295457|FG002|Overall Study|Other Reasons|15|||
147584578|NCT02576717|532295455|FG000|Overall Study|Covid-19 Pandemic|0|||
147584579|NCT02576717|532295456|FG001|Overall Study|Covid-19 Pandemic|1|||
147584580|NCT02576717|532295457|FG002|Overall Study|Covid-19 Pandemic|1|||
147584581|NCT02576717|532295455|FG000|Overall Study|Sponsor Decision|0|||
147584582|NCT02576717|532295456|FG001|Overall Study|Sponsor Decision|0|||
147584583|NCT02576717|532295457|FG002|Overall Study|Sponsor Decision|1|||
147584584|NCT02576717|532295455|FG000|Overall Study|Physician Decision|3|||
147584585|NCT02576717|532295456|FG001|Overall Study|Physician Decision|8|||
147584586|NCT02576717|532295457|FG002|Overall Study|Physician Decision|9|||
147584587|NCT02576717|532295455|FG000|Overall Study|Participant Voluntarily Withdrew from Study|91|||
147584588|NCT02576717|532295456|FG001|Overall Study|Participant Voluntarily Withdrew from Study|82|||
147584589|NCT02576717|532295457|FG002|Overall Study|Participant Voluntarily Withdrew from Study|85|||
147584590|NCT02576717|532295455|FG000|Overall Study|Death|3|||
147584591|NCT02576717|532295456|FG001|Overall Study|Death|5|||
147584592|NCT02576717|532295457|FG002|Overall Study|Death|3|||
147584593|NCT02576717|532295455|FG000|Overall Study|Lost to Follow-up|9|||
147241029|NCT01785069|531053566|FG000|Overall Study|Not evaluable|7|||
147241030|NCT01785069|531053567|FG001|Overall Study|Not evaluable|4|||
147241031|NCT01785069|531053568|FG002|Overall Study|Not evaluable|5|||
147241032|NCT01785069|531053569|FG003|Overall Study|Not evaluable|8|||
147241033|NCT01088997|531053570|FG000|Overall Study|Physician Decision|1|||
147241034|NCT01088997|531053571|FG001|Overall Study|Physician Decision|1|||
147241035|NCT01088997|531053570|FG000|Overall Study|Req. Extracorporeal membrane oxygenation|1|||
147241036|NCT01088997|531053571|FG001|Overall Study|Req. Extracorporeal membrane oxygenation|1|||
147241037|NCT01088997|531053570|FG000|Overall Study|Excluded prior to receiving drug|1|||
147241038|NCT01088997|531053571|FG001|Overall Study|Excluded prior to receiving drug|1|||
147241039|NCT05570500|531053574|FG000|Overall Study|Lost to Follow-up|7|||
147241040|NCT05570500|531053575|FG001|Overall Study|Lost to Follow-up|5|||
147241041|NCT01133522|531053579|FG000|Overall Study|Withdrawal by Subject|0|||
147241042|NCT01133522|531053580|FG001|Overall Study|Withdrawal by Subject|1|||
147241043|NCT01133522|531053581|FG002|Overall Study|Withdrawal by Subject|0|||
147241044|NCT01133522|531053582|FG003|Overall Study|Withdrawal by Subject|1|||
147241045|NCT01133522|531053583|FG004|Overall Study|Withdrawal by Subject|0|||
147241046|NCT01133522|531053584|FG005|Overall Study|Withdrawal by Subject|0|||
147241047|NCT01133522|531053585|FG006|Overall Study|Withdrawal by Subject|0|||
147241048|NCT01133522|531053586|FG007|Overall Study|Withdrawal by Subject|0|||
147241049|NCT01133522|531053587|FG008|Overall Study|Withdrawal by Subject|0|||
147241050|NCT01133522|531053588|FG009|Overall Study|Withdrawal by Subject|0|||
147241051|NCT01133522|531053579|FG000|Overall Study|Physician Decision|0|||
147241052|NCT01133522|531053580|FG001|Overall Study|Physician Decision|0|||
147241053|NCT01133522|531053581|FG002|Overall Study|Physician Decision|0|||
147241054|NCT01133522|531053582|FG003|Overall Study|Physician Decision|0|||
147584594|NCT02576717|532295456|FG001|Overall Study|Lost to Follow-up|10|||
147584595|NCT02576717|532295457|FG002|Overall Study|Lost to Follow-up|19|||
147584596|NCT02576717|532295455|FG000|Overall Study|Protocol Violation|4|||
147584597|NCT02576717|532295456|FG001|Overall Study|Protocol Violation|0|||
147584598|NCT02576717|532295457|FG002|Overall Study|Protocol Violation|5|||
147584599|NCT02576717|532295455|FG000|Overall Study|Lack of Efficacy|24|||
147584600|NCT02576717|532295456|FG001|Overall Study|Lack of Efficacy|28|||
147584601|NCT02576717|532295457|FG002|Overall Study|Lack of Efficacy|20|||
147584602|NCT02576717|532295455|FG000|Overall Study|Adverse Event|26|||
147241055|NCT01133522|531053583|FG004|Overall Study|Physician Decision|1|||
147241056|NCT01133522|531053584|FG005|Overall Study|Physician Decision|0|||
147241057|NCT01133522|531053585|FG006|Overall Study|Physician Decision|0|||
147241058|NCT01133522|531053586|FG007|Overall Study|Physician Decision|0|||
147241059|NCT01133522|531053587|FG008|Overall Study|Physician Decision|0|||
147241060|NCT01133522|531053588|FG009|Overall Study|Physician Decision|0|||
147241061|NCT04997304|531053589|FG000|Overall Study|Lost to Follow-up|11|||
147241062|NCT04997304|531053589|FG000|Overall Study|Death|1|||
147241063|NCT04997304|531053589|FG000|Overall Study|Withdrawal by Subject|14|||
147241064|NCT00688753|531055747|FG000|Overall Study|Disease progression|55|||
147321997|NCT02297503|531343539|FG000|Overall Study|Withdrawal by Subject|1|||
147321998|NCT02297503|531343540|FG001|Overall Study|Withdrawal by Subject|1|||
147321999|NCT02297503|531343539|FG000|Overall Study|Protocol Violation|1|||
147322000|NCT02297503|531343540|FG001|Overall Study|Protocol Violation|0|||
147322001|NCT02297503|531343539|FG000|Overall Study|Pregnancy|0|||
147322002|NCT02297503|531343540|FG001|Overall Study|Pregnancy|1|||
147322003|NCT02297503|531343539|FG000|Overall Study|Lost to Follow-up|0|||
147322004|NCT02297503|531343540|FG001|Overall Study|Lost to Follow-up|1|||
147322005|NCT02297503|531343539|FG000|Overall Study|Medical reason|0|||
147322006|NCT02297503|531343540|FG001|Overall Study|Medical reason|1|||
147322007|NCT02703532|531343542|FG000|Overall Study|Withdrawal by Subject|0|||
147322008|NCT02703532|531343543|FG001|Overall Study|Withdrawal by Subject|1|||
147322009|NCT02703532|531343544|FG002|Overall Study|Withdrawal by Subject|0|||
147322010|NCT02703532|531343545|FG003|Overall Study|Withdrawal by Subject|1|||
147322011|NCT02703532|531343542|FG000|Overall Study|Lost to Follow-up|2|||
147322012|NCT02703532|531343543|FG001|Overall Study|Lost to Follow-up|0|||
147446828|NCT02055820|531800320|FG002|Phase I: Dose-Finding|Death|1|||
147446829|NCT02055820|531800321|FG003|Phase I: Dose-Finding|Death|2|||
147584603|NCT02576717|532295456|FG001|Overall Study|Adverse Event|32|||
147584604|NCT02576717|532295457|FG002|Overall Study|Adverse Event|26|||
147584605|NCT01363011|532295458|FG000|Main Study|Adverse Event|2|||
147584606|NCT01363011|532295459|FG001|Main Study|Adverse Event|3|||
147584607|NCT01363011|532295458|FG000|Main Study|Investigator's Discretion|1|||
147584608|NCT01363011|532295459|FG001|Main Study|Investigator's Discretion|1|||
147584609|NCT01363011|532295458|FG000|Main Study|Withdrew Consent|1|||
147584610|NCT01363011|532295459|FG001|Main Study|Withdrew Consent|4|||
147241065|NCT00688753|531055747|FG000|Overall Study|Missing|1|||
147241066|NCT00688753|531055747|FG000|Overall Study|Death|9|||
147241067|NCT00688753|531055747|FG000|Overall Study|Withdrawal by Subject|3|||
147241068|NCT00688753|531055747|FG000|Overall Study|Adverse Event|20|||
147241069|NCT00688753|531055747|FG000|Overall Study|Protocol Violation|1|||
147241070|NCT00688753|531055747|FG000|Overall Study|Lost to Follow-up|3|||
147241071|NCT05996718|531055748|FG000|Overall Study|Lost to Follow-up|3|||
147241072|NCT01713686|531055749|FG000|Overall Study|Lost to Follow-up|9|||
147241073|NCT01713686|531055749|FG000|Overall Study|Withdrawal by Subject|6|||
147241074|NCT03187197|531055753|FG000|Overall Study|Stopped Pradaxa®/VKA|11|||
147241075|NCT03187197|531055754|FG001|Overall Study|Stopped Pradaxa®/VKA|65|||
147241076|NCT03187197|531055755|FG002|Overall Study|Stopped Pradaxa®/VKA|4|||
147241077|NCT03187197|531055753|FG000|Overall Study|Withdrawal by Subject|8|||
147241078|NCT03187197|531055754|FG001|Overall Study|Withdrawal by Subject|63|||
147241079|NCT03187197|531055755|FG002|Overall Study|Withdrawal by Subject|4|||
147241080|NCT03187197|531055753|FG000|Overall Study|Lost to Follow-up|1|||
147241081|NCT03187197|531055754|FG001|Overall Study|Lost to Follow-up|60|||
147241082|NCT03187197|531055755|FG002|Overall Study|Lost to Follow-up|7|||
147241083|NCT03187197|531055753|FG000|Overall Study|Adverse Event|6|||
147241084|NCT03187197|531055754|FG001|Overall Study|Adverse Event|29|||
147241085|NCT03187197|531055755|FG002|Overall Study|Adverse Event|0|||
147241086|NCT03187197|531055753|FG000|Overall Study|Death|0|||
147241087|NCT03187197|531055754|FG001|Overall Study|Death|11|||
147241088|NCT03187197|531055755|FG002|Overall Study|Death|0|||
147241089|NCT03187197|531055753|FG000|Overall Study|Administrative problem|1|||
147241090|NCT03187197|531055754|FG001|Overall Study|Administrative problem|1|||
147241091|NCT03187197|531055755|FG002|Overall Study|Administrative problem|0|||
147241092|NCT03187197|531055753|FG000|Overall Study|Reason not listed|2|||
147241093|NCT03187197|531055754|FG001|Overall Study|Reason not listed|54|||
147241094|NCT03187197|531055755|FG002|Overall Study|Reason not listed|1|||
147241095|NCT03187197|531055753|FG000|Overall Study|Missing|1|||
147241096|NCT03187197|531055754|FG001|Overall Study|Missing|32|||
147241097|NCT03187197|531055755|FG002|Overall Study|Missing|3|||
147241098|NCT03187197|531055753|FG000|Overall Study|Status missing|2|||
147241099|NCT03187197|531055754|FG001|Overall Study|Status missing|33|||
147241100|NCT03187197|531055755|FG002|Overall Study|Status missing|3|||
147241101|NCT03187197|531055753|FG000|Overall Study|NA in incl/excl criteria, not analyzed.|14|||
147322013|NCT02703532|531343544|FG002|Overall Study|Lost to Follow-up|2|||
147584611|NCT01363011|532295458|FG000|Main Study|Protocol Violation|0|||
147584612|NCT01363011|532295459|FG001|Main Study|Protocol Violation|1|||
147241102|NCT03187197|531055754|FG001|Overall Study|NA in incl/excl criteria, not analyzed.|45|||
147241103|NCT03187197|531055755|FG002|Overall Study|NA in incl/excl criteria, not analyzed.|1|||
147241104|NCT02385045|531055756|FG000|Overall Study|Endoscopy could not be completed|4|||
147241105|NCT02200211|531055757|FG000|Overall Study|Lost to Follow-up|7|||
147241106|NCT02200211|531055758|FG001|Overall Study|Lost to Follow-up|7|||
147241107|NCT02200211|531055759|FG002|Overall Study|Lost to Follow-up|1|||
147322014|NCT02703532|531343545|FG003|Overall Study|Lost to Follow-up|0|||
147322015|NCT03738241|531343549|FG000|Overall Study|Withdrawal by Subject|0|||
147584613|NCT01363011|532295458|FG000|Extension Phase|Adverse Event|1|||
147584614|NCT01363011|532295459|FG001|Extension Phase|Adverse Event|1|||
147584615|NCT01363011|532295458|FG000|Extension Phase|Lack of Efficacy|0|||
147584616|NCT01363011|532295459|FG001|Extension Phase|Lack of Efficacy|1|||
147584617|NCT01363011|532295458|FG000|Extension Phase|Investigator's Discretion|2|||
147584618|NCT01363011|532295459|FG001|Extension Phase|Investigator's Discretion|2|||
147584619|NCT01363011|532295458|FG000|Extension Phase|Withdrew Consent|0|||
147584620|NCT01363011|532295459|FG001|Extension Phase|Withdrew Consent|1|||
147584621|NCT01363011|532295458|FG000|Extension Phase|Lost to Follow-up|0|||
147584622|NCT01363011|532295459|FG001|Extension Phase|Lost to Follow-up|2|||
147584623|NCT01363011|532295458|FG000|Extension Phase|Rolled Over to Another Gilead Study|2|||
147584624|NCT01363011|532295459|FG001|Extension Phase|Rolled Over to Another Gilead Study|1|||
147584625|NCT00399893|532295460|FG000|Overall Study|Withdrawal by Subject|1|||
147584626|NCT00399893|532295461|FG001|Overall Study|Withdrawal by Subject|0|||
147584627|NCT04412057|532295462|FG000|Overall Study|Death|3|||
147584628|NCT04412057|532295463|FG001|Overall Study|Death|7|||
147584629|NCT04412057|532295462|FG000|Overall Study|Discharged prior to receiving study treatment|1|||
147584630|NCT04412057|532295463|FG001|Overall Study|Discharged prior to receiving study treatment|0|||
147584631|NCT03710590|532295470|FG000|Overall Study|Lost to follow up, study stopped due to COVID-19, other reasons|10|||
147584632|NCT03710590|532295471|FG001|Overall Study|Lost to follow up, study stopped due to COVID-19, other reasons|8|||
147584633|NCT00407745|532295472|FG000|Overall Study|Lack of Efficacy|1|||
147584634|NCT00407745|532295473|FG001|Overall Study|Lack of Efficacy|2|||
147584635|NCT00407745|532295472|FG000|Overall Study|Withdrawal by Subject|3|||
147584636|NCT00407745|532295473|FG001|Overall Study|Withdrawal by Subject|3|||
147584637|NCT00407745|532295472|FG000|Overall Study|Protocol Violation|5|||
147584638|NCT00407745|532295473|FG001|Overall Study|Protocol Violation|3|||
147584639|NCT00407745|532295472|FG000|Overall Study|Adverse Event|8|||
147584640|NCT00407745|532295473|FG001|Overall Study|Adverse Event|8|||
147584641|NCT00407745|532295472|FG000|Overall Study|Other|2|||
147584642|NCT00407745|532295473|FG001|Overall Study|Other|0|||
147584643|NCT00407745|532295472|FG000|Overall Study|Randomized, unknown if treated|0|||
147584644|NCT00407745|532295473|FG001|Overall Study|Randomized, unknown if treated|1|||
147584645|NCT00108082|532295474|FG000|Overall Study|Adverse Event|14|||
147584646|NCT00108082|532295475|FG001|Overall Study|Adverse Event|12|||
147584647|NCT00108082|532295476|FG002|Overall Study|Adverse Event|17|||
147584648|NCT00108082|532295474|FG000|Overall Study|Lost to Follow-up|6|||
147584649|NCT00108082|532295475|FG001|Overall Study|Lost to Follow-up|3|||
147584650|NCT00108082|532295476|FG002|Overall Study|Lost to Follow-up|7|||
147584651|NCT00108082|532295474|FG000|Overall Study|Consent Withdrawn|3|||
147584652|NCT00108082|532295475|FG001|Overall Study|Consent Withdrawn|3|||
147584653|NCT00108082|532295476|FG002|Overall Study|Consent Withdrawn|5|||
147584654|NCT00108082|532295474|FG000|Overall Study|Protocol Violation|1|||
147584655|NCT00108082|532295475|FG001|Overall Study|Protocol Violation|2|||
147584656|NCT00108082|532295476|FG002|Overall Study|Protocol Violation|0|||
147584657|NCT00108082|532295474|FG000|Overall Study|Lack of Efficacy|3|||
147584658|NCT00108082|532295475|FG001|Overall Study|Lack of Efficacy|1|||
147584659|NCT00108082|532295476|FG002|Overall Study|Lack of Efficacy|2|||
147584660|NCT00108082|532295474|FG000|Overall Study|Amendment 4: > Month 12|5|||
147584661|NCT00108082|532295475|FG001|Overall Study|Amendment 4: > Month 12|7|||
147584662|NCT00108082|532295476|FG002|Overall Study|Amendment 4: > Month 12|5|||
147584663|NCT00108082|532295474|FG000|Overall Study|Woman of Child-bearing Potential|2|||
147584664|NCT00108082|532295475|FG001|Overall Study|Woman of Child-bearing Potential|0|||
147584665|NCT00108082|532295476|FG002|Overall Study|Woman of Child-bearing Potential|2|||
147584666|NCT00108082|532295474|FG000|Overall Study|Incorrectly Randomized|0|||
147584667|NCT00108082|532295475|FG001|Overall Study|Incorrectly Randomized|0|||
147584668|NCT00108082|532295476|FG002|Overall Study|Incorrectly Randomized|2|||
147322016|NCT03738241|531343550|FG001|Overall Study|Withdrawal by Subject|0|||
147584669|NCT00108082|532295474|FG000|Overall Study|Non-compliance|1|||
147584670|NCT00108082|532295475|FG001|Overall Study|Non-compliance|0|||
147584671|NCT00108082|532295476|FG002|Overall Study|Non-compliance|2|||
147584672|NCT00108082|532295474|FG000|Overall Study|Stopped Study Medication|0|||
147584673|NCT00108082|532295475|FG001|Overall Study|Stopped Study Medication|0|||
147584674|NCT00108082|532295476|FG002|Overall Study|Stopped Study Medication|1|||
147584675|NCT00108082|532295474|FG000|Overall Study|Site Closed Study|0|||
147584676|NCT00108082|532295475|FG001|Overall Study|Site Closed Study|2|||
147584677|NCT00108082|532295476|FG002|Overall Study|Site Closed Study|0|||
147584678|NCT00108082|532295474|FG000|Overall Study|Protocol Amendment|0|||
147446830|NCT02055820|531800322|FG004|Phase I: Dose-Finding|Death|0|||
147584679|NCT00108082|532295475|FG001|Overall Study|Protocol Amendment|1|||
147584680|NCT00108082|532295476|FG002|Overall Study|Protocol Amendment|0|||
147584681|NCT00108082|532295474|FG000|Overall Study|Study Medication Not Tapered|0|||
147584682|NCT00108082|532295475|FG001|Overall Study|Study Medication Not Tapered|1|||
147584683|NCT00108082|532295476|FG002|Overall Study|Study Medication Not Tapered|0|||
147584684|NCT00108082|532295474|FG000|Overall Study|Subject Left Site Location|1|||
147584685|NCT00108082|532295475|FG001|Overall Study|Subject Left Site Location|0|||
147584686|NCT00108082|532295476|FG002|Overall Study|Subject Left Site Location|0|||
147584687|NCT00108082|532295474|FG000|Overall Study|Investigator Not at Site|1|||
147584688|NCT00108082|532295475|FG001|Overall Study|Investigator Not at Site|0|||
147584689|NCT00108082|532295476|FG002|Overall Study|Investigator Not at Site|0|||
147584690|NCT00108082|532295474|FG000|Overall Study|Blood Pressure Not Controlled|1|||
147584691|NCT00108082|532295475|FG001|Overall Study|Blood Pressure Not Controlled|0|||
147584692|NCT00108082|532295476|FG002|Overall Study|Blood Pressure Not Controlled|0|||
147584693|NCT02940730|532295480|FG000|Intervention 2|Physician Decision|7|||
147584694|NCT02940730|532295481|FG001|Intervention 2|Physician Decision|0|||
147584695|NCT01522950|532295482|FG000|Overall Study|Withdrawal by Subject|3|||
147584696|NCT01522950|532295483|FG001|Overall Study|Withdrawal by Subject|2|||
147584697|NCT01522950|532295484|FG002|Overall Study|Withdrawal by Subject|1|||
147584698|NCT01522950|532295482|FG000|Overall Study|Adverse Event|3|||
147584699|NCT01522950|532295483|FG001|Overall Study|Adverse Event|1|||
147584700|NCT01522950|532295484|FG002|Overall Study|Adverse Event|1|||
147584701|NCT01522950|532295482|FG000|Overall Study|Protocol Violation|0|||
147584702|NCT01522950|532295483|FG001|Overall Study|Protocol Violation|0|||
147584703|NCT01522950|532295484|FG002|Overall Study|Protocol Violation|2|||
147584704|NCT01522950|532295482|FG000|Overall Study|Death|0|||
147584705|NCT01522950|532295483|FG001|Overall Study|Death|1|||
147584706|NCT01522950|532295484|FG002|Overall Study|Death|1|||
147584707|NCT01522950|532295482|FG000|Overall Study|Study Medication Sensitivity|0|||
147584708|NCT01522950|532295483|FG001|Overall Study|Study Medication Sensitivity|1|||
147584709|NCT01522950|532295484|FG002|Overall Study|Study Medication Sensitivity|0|||
147584710|NCT00298740|532295488|FG000|Overall Study|Lack of Efficacy|6|||
147584711|NCT00298740|532295488|FG000|Overall Study|Withdrawal by Subject|3|||
147584712|NCT01064531|532295489|FG000|Overall Study|Lost to Follow-up|0|||
147584713|NCT01064531|532295490|FG001|Overall Study|Lost to Follow-up|2|||
147584714|NCT01064531|532295489|FG000|Overall Study|Physician Decision|0|||
147584715|NCT01064531|532295490|FG001|Overall Study|Physician Decision|1|||
147584716|NCT01064531|532295489|FG000|Overall Study|Withdrawal by Subject|2|||
147584717|NCT01064531|532295490|FG001|Overall Study|Withdrawal by Subject|2|||
147584718|NCT01064531|532295489|FG000|Overall Study|Revision due to femoral stem loosening|1|||
147584719|NCT01064531|532295490|FG001|Overall Study|Revision due to femoral stem loosening|0|||
147584720|NCT01064531|532295489|FG000|Overall Study|Revision due to dislocation|0|||
147584721|NCT01064531|532295490|FG001|Overall Study|Revision due to dislocation|1|||
147584722|NCT01064531|532295489|FG000|Overall Study|Death|0|||
147584723|NCT01064531|532295490|FG001|Overall Study|Death|1|||
147584724|NCT01091103|532295491|FG000|Overall Study|Adverse Event|1|||
147584725|NCT01091103|532295491|FG000|Overall Study|Progressive Disease|3|||
147584726|NCT01270620|532295492|FG000|Overall Study|Withdrawal by Subject|1|||
147584727|NCT01270620|532295493|FG001|Overall Study|Withdrawal by Subject|3|||
147584728|NCT00684567|532295494|FG000|Concomitant Radiotherapy Period|Adverse Event|2|||
147584729|NCT00684567|532295494|FG000|Monotherapy Period|Adverse Event|2|||
147584730|NCT00684567|532295494|FG000|Monotherapy Period|Death|1|||
147584731|NCT00684567|532295494|FG000|Monotherapy Period|Progression of primary disease|11|||
147584732|NCT03136406|532295495|FG000|Overall Study|Treatment Discontinued-Investigator Decision|3|||
147584733|NCT00906373|532295496|FG000|Overall Study|Withdrawal by Subject|0|||
147584734|NCT00906373|532295497|FG001|Overall Study|Withdrawal by Subject|5|||
147584735|NCT00906373|532295496|FG000|Overall Study|Other|0|||
147584736|NCT00906373|532295497|FG001|Overall Study|Other|1|||
147584737|NCT00906373|532295496|FG000|Overall Study|Still on treatment at cutoff date|0|||
147584738|NCT00906373|532295497|FG001|Overall Study|Still on treatment at cutoff date|2|||
147157934|NCT03222973|530741906|FG000|Part 2 (Week 73 to Week 168)|Participants Not Dosed|0|||
147157935|NCT03222973|530741907|FG001|Part 2 (Week 73 to Week 168)|Participants Not Dosed|0|||
147157936|NCT03222973|530741908|FG002|Part 2 (Week 73 to Week 168)|Participants Not Dosed|1|||
147157937|NCT03222973|530741909|FG003|Part 2 (Week 73 to Week 168)|Participants Not Dosed|0|||
147157938|NCT02080481|530741910|FG000|Overall Study|Never received a block.|1|||
147157939|NCT02080481|530741911|FG001|Overall Study|Never received a block.|0|||
147157940|NCT01444027|530741914|FG000|Overall Study|Withdrawal by Subject|4|||
147157941|NCT01444027|530741915|FG001|Overall Study|Withdrawal by Subject|10|||
147157942|NCT01444027|530741916|FG002|Overall Study|Withdrawal by Subject|24|||
147157943|NCT01444027|530741914|FG000|Overall Study|Lost to Follow-up|26|||
147157944|NCT01444027|530741915|FG001|Overall Study|Lost to Follow-up|20|||
147157945|NCT01444027|530741916|FG002|Overall Study|Lost to Follow-up|14|||
147157946|NCT00428220|530743318|FG000|Overall Study|Participant died|8|||
147157947|NCT00428220|530743318|FG000|Overall Study|Global deterioration of health status|7|||
147157948|NCT00428220|530743318|FG000|Overall Study|Lost to Follow-up|4|||
147584739|NCT01597479|532295498|FG000|Overall Study|Protocol Violation|1|||
147584740|NCT01597479|532295499|FG001|Overall Study|Protocol Violation|0|||
147584741|NCT01597479|532295498|FG000|Overall Study|Lost to Follow-up|1|||
147584742|NCT01597479|532295499|FG001|Overall Study|Lost to Follow-up|0|||
147584743|NCT01045707|532295500|FG000|Main: Week 0 to 26 (NN5401-3590)|Adverse Event|5|||
147241108|NCT02200211|531055760|FG003|Overall Study|Lost to Follow-up|2|||
147584744|NCT01045707|532295501|FG001|Main: Week 0 to 26 (NN5401-3590)|Adverse Event|3|||
147584745|NCT01045707|532295500|FG000|Main: Week 0 to 26 (NN5401-3590)|Lack of Efficacy|4|||
147584746|NCT01045707|532295501|FG001|Main: Week 0 to 26 (NN5401-3590)|Lack of Efficacy|2|||
147584747|NCT01045707|532295500|FG000|Main: Week 0 to 26 (NN5401-3590)|Protocol Violation|6|||
147584748|NCT01045707|532295501|FG001|Main: Week 0 to 26 (NN5401-3590)|Protocol Violation|5|||
147584749|NCT01045707|532295500|FG000|Main: Week 0 to 26 (NN5401-3590)|Withdrawal Criteria|22|||
147584750|NCT01045707|532295501|FG001|Main: Week 0 to 26 (NN5401-3590)|Withdrawal Criteria|11|||
147584751|NCT01045707|532295500|FG000|Main: Week 0 to 26 (NN5401-3590)|Unclassified|10|||
147584752|NCT01045707|532295501|FG001|Main: Week 0 to 26 (NN5401-3590)|Unclassified|11|||
147584753|NCT01045707|532295500|FG000|Extension: Week 27 to 52 (NN5401-3726)|Adverse Event|3|||
147584754|NCT01045707|532295501|FG001|Extension: Week 27 to 52 (NN5401-3726)|Adverse Event|3|||
147584755|NCT01045707|532295500|FG000|Extension: Week 27 to 52 (NN5401-3726)|Protocol Violation|2|||
147584756|NCT01045707|532295501|FG001|Extension: Week 27 to 52 (NN5401-3726)|Protocol Violation|3|||
147584757|NCT01045707|532295500|FG000|Extension: Week 27 to 52 (NN5401-3726)|Withdrawal criteria|2|||
147584758|NCT01045707|532295501|FG001|Extension: Week 27 to 52 (NN5401-3726)|Withdrawal criteria|1|||
147584759|NCT01045707|532295500|FG000|Extension: Week 27 to 52 (NN5401-3726)|Unclassified|6|||
147584760|NCT01045707|532295501|FG001|Extension: Week 27 to 52 (NN5401-3726)|Unclassified|5|||
147584761|NCT00348816|532295502|FG000|Overall Study|Noncompliance with radiation treatment|1|||
147584762|NCT00848042|532295503|FG000|Overall Study|Death|1|||
147157949|NCT00428220|530743318|FG000|Overall Study|Objective progression or relapse|123|||
147157950|NCT00428220|530743318|FG000|Overall Study|Participant refused continued treatment|7|||
147157951|NCT00428220|530743318|FG000|Overall Study|Adverse Event|51|||
147157952|NCT00428220|530743318|FG000|Overall Study|Other|23|||
147157953|NCT00642174|530743325|FG000|Period 1 - Initial Drug|Entry Criteria Not Met|0|||
147157954|NCT00642174|530743326|FG001|Period 1 - Initial Drug|Entry Criteria Not Met|1|||
147157955|NCT01730339|530743327|FG000|Overall Study|Withdrawal by Subject|3|||
147157956|NCT01730339|530743328|FG001|Overall Study|Withdrawal by Subject|2|||
147157957|NCT01730339|530743327|FG000|Overall Study|Lost to Follow-up|1|||
147157958|NCT01730339|530743328|FG001|Overall Study|Lost to Follow-up|1|||
147157959|NCT01730339|530743327|FG000|Overall Study|Un-specified|1|||
147157960|NCT01730339|530743328|FG001|Overall Study|Un-specified|0|||
147157961|NCT01145352|530743333|FG000|Overall Study|Found to have been registered twice|6|||
147157962|NCT01145352|530743333|FG000|Overall Study|Treated before marketing approval|4|||
147157963|NCT01145352|530743333|FG000|Overall Study|Syringe formulation was used|1|||
147157964|NCT03095027|530743334|FG000|Period 2, Second Week of Wear|Adverse Event|1|||
147157965|NCT03095027|530743335|FG001|Period 2, Second Week of Wear|Adverse Event|0|||
147157966|NCT00316693|530743336|FG000|Overall Study|Adverse Event|6|||
147157967|NCT00316693|530743337|FG001|Overall Study|Adverse Event|1|||
147157968|NCT00316693|530743336|FG000|Overall Study|Protocol Violation|1|||
147157969|NCT00316693|530743337|FG001|Overall Study|Protocol Violation|0|||
147241109|NCT02200211|531055757|FG000|Overall Study|Withdrawal by Subject|1|||
147241110|NCT02200211|531055758|FG001|Overall Study|Withdrawal by Subject|0|||
147584763|NCT00848042|532295504|FG001|Overall Study|Death|2|||
147584764|NCT00848042|532295505|FG002|Overall Study|Death|0|||
147584765|NCT00848042|532295503|FG000|Overall Study|Other Therapy|3|||
147584766|NCT00848042|532295504|FG001|Overall Study|Other Therapy|0|||
147584767|NCT00848042|532295505|FG002|Overall Study|Other Therapy|0|||
147584768|NCT01628549|532295506|FG000|Overall Study|Adverse Event|1|||
147584769|NCT01628549|532295507|FG001|Overall Study|Adverse Event|1|||
147584770|NCT01628549|532295508|FG002|Overall Study|Adverse Event|0|||
147584771|NCT01628549|532295509|FG003|Overall Study|Adverse Event|4|||
147584772|NCT01628549|532295506|FG000|Overall Study|Lost to Follow-up|3|||
147584773|NCT01628549|532295507|FG001|Overall Study|Lost to Follow-up|4|||
147584774|NCT01628549|532295508|FG002|Overall Study|Lost to Follow-up|3|||
147584775|NCT01628549|532295509|FG003|Overall Study|Lost to Follow-up|3|||
147584776|NCT01628549|532295506|FG000|Overall Study|Withdrawal by Subject|3|||
147584777|NCT01628549|532295507|FG001|Overall Study|Withdrawal by Subject|4|||
147584778|NCT01628549|532295508|FG002|Overall Study|Withdrawal by Subject|4|||
147584779|NCT01628549|532295509|FG003|Overall Study|Withdrawal by Subject|1|||
147584780|NCT01628549|532295506|FG000|Overall Study|Protocol Violation|2|||
147584781|NCT01628549|532295507|FG001|Overall Study|Protocol Violation|1|||
147584782|NCT01628549|532295508|FG002|Overall Study|Protocol Violation|1|||
147241111|NCT02200211|531055759|FG002|Overall Study|Withdrawal by Subject|0|||
147584783|NCT01628549|532295509|FG003|Overall Study|Protocol Violation|0|||
147584784|NCT01628549|532295506|FG000|Overall Study|withdrawn for noncompliance|0|||
147584785|NCT01628549|532295507|FG001|Overall Study|withdrawn for noncompliance|2|||
147584786|NCT01628549|532295508|FG002|Overall Study|withdrawn for noncompliance|1|||
147584787|NCT01628549|532295509|FG003|Overall Study|withdrawn for noncompliance|0|||
147584788|NCT01628549|532295506|FG000|Overall Study|abnormal laboratory test results|0|||
147584789|NCT01628549|532295507|FG001|Overall Study|abnormal laboratory test results|0|||
147584790|NCT01628549|532295508|FG002|Overall Study|abnormal laboratory test results|1|||
147584791|NCT01628549|532295509|FG003|Overall Study|abnormal laboratory test results|0|||
147157970|NCT00316693|530743336|FG000|Overall Study|Withdrawal by Subject|6|||
147157971|NCT00316693|530743337|FG001|Overall Study|Withdrawal by Subject|6|||
147157972|NCT00316693|530743336|FG000|Overall Study|Lost to Follow-up|26|||
147157973|NCT00316693|530743337|FG001|Overall Study|Lost to Follow-up|34|||
147584792|NCT01628549|532295506|FG000|Overall Study|positive pregnancy test|0|||
147584793|NCT01628549|532295507|FG001|Overall Study|positive pregnancy test|0|||
147157974|NCT00316693|530743336|FG000|Overall Study|Other|38|||
147584794|NCT01628549|532295508|FG002|Overall Study|positive pregnancy test|0|||
147584795|NCT01628549|532295509|FG003|Overall Study|positive pregnancy test|1|||
147584796|NCT01999894|532295512|FG000|Overall Study|Adverse Event|9|||
147584797|NCT01999894|532295512|FG000|Overall Study|Lack of Efficacy|5|||
147584798|NCT01999894|532295512|FG000|Overall Study|Protocol Violation|1|||
147584799|NCT01999894|532295512|FG000|Overall Study|Withdrawal by Subject|7|||
147584800|NCT01999894|532295512|FG000|Overall Study|Lost to Follow-up|10|||
147584801|NCT01999894|532295512|FG000|Overall Study|Other Reason|3|||
147584802|NCT01999894|532295512|FG000|Overall Study|Inclusion/exclusion criteria not met|1|||
147584803|NCT02448563|532295515|FG000|Overall Study|Lost to Follow-up|16|||
147584804|NCT02448563|532295516|FG001|Overall Study|Lost to Follow-up|10|||
147584805|NCT02448563|532295515|FG000|Overall Study|Withdrawal by Subject|0|||
147584806|NCT02448563|532295516|FG001|Overall Study|Withdrawal by Subject|1|||
147584807|NCT00721955|532295517|FG000|Overall Study|Adverse Event|0|||
147584808|NCT00721955|532295518|FG001|Overall Study|Adverse Event|0|||
147584809|NCT00721955|532295519|FG002|Overall Study|Adverse Event|2|||
147584810|NCT01077258|532295522|FG000|Overall Study|Lost to Follow-up|1390|||
147584811|NCT01077258|532295522|FG000|Overall Study|Adverse drug reaction|218|||
147584812|NCT01077258|532295522|FG000|Overall Study|Lack of Efficacy|663|||
147584813|NCT01077258|532295522|FG000|Overall Study|Clinical remission|37|||
147584814|NCT01077258|532295522|FG000|Overall Study|Other reasons|260|||
147584815|NCT00515216|532295523|FG000|Overall Study|Withdrawal by Subject|1|||
147584816|NCT01115933|532295526|FG000|Overall Study|Did not receive XIENCE PRIME SV|1|||
147584817|NCT01086969|532295535|FG000|Overall Study|Withdrawal by Subject|1|||
147584818|NCT01086969|532295536|FG001|Overall Study|Withdrawal by Subject|2|||
147584819|NCT01086969|532295537|FG002|Overall Study|Withdrawal by Subject|0|||
147584820|NCT01466036|532295540|FG000|Overall Study|Death|1|||
147584821|NCT01466036|532295541|FG001|Overall Study|Death|1|||
147584822|NCT01466036|532295540|FG000|Overall Study|Physician Decision|0|||
147584823|NCT01466036|532295541|FG001|Overall Study|Physician Decision|4|||
147584824|NCT01466036|532295540|FG000|Overall Study|Adverse Event|2|||
147584825|NCT01466036|532295541|FG001|Overall Study|Adverse Event|6|||
147584826|NCT01466036|532295540|FG000|Overall Study|Withdrawal by Subject|2|||
147584827|NCT01466036|532295541|FG001|Overall Study|Withdrawal by Subject|8|||
147584828|NCT01466036|532295540|FG000|Overall Study|progression/relapse|14|||
147157975|NCT00316693|530743337|FG001|Overall Study|Other|44|||
147157976|NCT02982018|530743338|FG000|Overall Study|Incorrect Lens Dispensed|1|||
147157977|NCT02982018|530743339|FG001|Overall Study|Incorrect Lens Dispensed|0|||
147157978|NCT02982018|530743338|FG000|Overall Study|Protocol Violation|1|||
147157979|NCT02982018|530743339|FG001|Overall Study|Protocol Violation|1|||
147157980|NCT02982018|530743338|FG000|Overall Study|Adverse Event|1|||
147157981|NCT02982018|530743339|FG001|Overall Study|Adverse Event|1|||
147584829|NCT01466036|532295541|FG001|Overall Study|progression/relapse|21|||
147584830|NCT01466036|532295540|FG000|Overall Study|prolonged treatment delay|1|||
147584831|NCT01466036|532295541|FG001|Overall Study|prolonged treatment delay|1|||
147584832|NCT00250705|532295546|FG000|Overall Study|Lack of Efficacy|2|||
147584833|NCT00129116|532295555|FG000|Primary Phase|Lost to Follow-up|1|||
147584834|NCT00129116|532295556|FG001|Primary Phase|Lost to Follow-up|1|||
147584835|NCT00129116|532295557|FG002|Primary Phase|Lost to Follow-up|0|||
147584836|NCT00129116|532295558|FG003|Primary Phase|Lost to Follow-up|1|||
147584837|NCT00129116|532295559|FG004|Primary Phase|Lost to Follow-up|1|||
147584838|NCT00129116|532295555|FG000|Primary Phase|Protocol Violation|0|||
147241112|NCT02200211|531055760|FG003|Overall Study|Withdrawal by Subject|0|||
147157982|NCT02982018|530743338|FG000|Overall Study|Lens Discomfort|2|||
147584839|NCT00129116|532295556|FG001|Primary Phase|Protocol Violation|1|||
147584840|NCT00129116|532295557|FG002|Primary Phase|Protocol Violation|0|||
147584841|NCT00129116|532295558|FG003|Primary Phase|Protocol Violation|0|||
147584842|NCT00129116|532295559|FG004|Primary Phase|Protocol Violation|0|||
147584843|NCT00129116|532295555|FG000|Primary Phase|Adverse Event|1|||
147584844|NCT00129116|532295556|FG001|Primary Phase|Adverse Event|1|||
147584845|NCT00129116|532295557|FG002|Primary Phase|Adverse Event|0|||
147584846|NCT00129116|532295558|FG003|Primary Phase|Adverse Event|0|||
147584847|NCT00129116|532295559|FG004|Primary Phase|Adverse Event|0|||
147157983|NCT02982018|530743339|FG001|Overall Study|Lens Discomfort|0|||
147241113|NCT00381485|531055761|FG000|Open-Label Run-In Period|Adverse Event|9|||
147584848|NCT00129116|532295555|FG000|Primary Phase|Withdrawal by Subject|0|||
147584849|NCT00129116|532295556|FG001|Primary Phase|Withdrawal by Subject|1|||
147584850|NCT00129116|532295557|FG002|Primary Phase|Withdrawal by Subject|0|||
147584851|NCT00129116|532295558|FG003|Primary Phase|Withdrawal by Subject|0|||
147584852|NCT00129116|532295559|FG004|Primary Phase|Withdrawal by Subject|0|||
147584853|NCT00129116|532295555|FG000|Primary Phase|Other|0|||
147584854|NCT00129116|532295556|FG001|Primary Phase|Other|0|||
147157984|NCT02982018|530743338|FG000|Overall Study|Withdrawal by Subject|0|||
147157985|NCT02982018|530743339|FG001|Overall Study|Withdrawal by Subject|1|||
147584855|NCT00129116|532295557|FG002|Primary Phase|Other|1|||
147584856|NCT00129116|532295558|FG003|Primary Phase|Other|0|||
147584857|NCT00129116|532295559|FG004|Primary Phase|Other|0|||
147584858|NCT00129116|532295555|FG000|Booster Phase|Lost to Follow-up|2|||
147584859|NCT00129116|532295556|FG001|Booster Phase|Lost to Follow-up|0|||
147584860|NCT00129116|532295557|FG002|Booster Phase|Lost to Follow-up|0|||
147584861|NCT00129116|532295558|FG003|Booster Phase|Lost to Follow-up|0|||
147584862|NCT00129116|532295559|FG004|Booster Phase|Lost to Follow-up|1|||
147584863|NCT00879684|532295560|FG000|Stage 1: Dose Escalation|Adverse Event|1|||
147584864|NCT00879684|532295561|FG001|Stage 1: Dose Escalation|Adverse Event|0|||
147584865|NCT00879684|532295562|FG002|Stage 1: Dose Escalation|Adverse Event|0|||
147584866|NCT00879684|532295563|FG003|Stage 1: Dose Escalation|Adverse Event|0|||
147584867|NCT00879684|532295564|FG004|Stage 1: Dose Escalation|Adverse Event|0|||
147322017|NCT03738241|531343551|FG002|Overall Study|Withdrawal by Subject|0|||
147584868|NCT00879684|532295565|FG005|Stage 1: Dose Escalation|Adverse Event|0|||
147584869|NCT00879684|532295566|FG006|Stage 1: Dose Escalation|Adverse Event|0|||
147584870|NCT00879684|532295560|FG000|Stage 1: Dose Escalation|Progressive Disease|2|||
147584871|NCT00879684|532295561|FG001|Stage 1: Dose Escalation|Progressive Disease|3|||
147584872|NCT00879684|532295562|FG002|Stage 1: Dose Escalation|Progressive Disease|0|||
147584873|NCT00879684|532295563|FG003|Stage 1: Dose Escalation|Progressive Disease|4|||
147157986|NCT03245736|530743340|FG000|Overall Study|Adverse Event|1|||
147157987|NCT03245736|530743340|FG000|Overall Study|Progressive Disease|4|||
147157988|NCT00132691|530743342|FG000|Overall Study|Lost to Follow-up|5|||
147157989|NCT00132691|530743343|FG001|Overall Study|Lost to Follow-up|8|||
147157990|NCT00132691|530743342|FG000|Overall Study|Missed 2-year visit|4|||
147157991|NCT00132691|530743343|FG001|Overall Study|Missed 2-year visit|4|||
147157992|NCT00132691|530743342|FG000|Overall Study|Death|2|||
147157993|NCT00132691|530743343|FG001|Overall Study|Death|0|||
147157994|NCT04098367|530743344|FG000|Overall Study|Adverse Event|0|||
147157995|NCT04098367|530743345|FG001|Overall Study|Adverse Event|0|||
147157996|NCT04098367|530743346|FG002|Overall Study|Adverse Event|1|||
147157997|NCT04098367|530743344|FG000|Overall Study|Lost to Follow-up|1|||
147157998|NCT04098367|530743345|FG001|Overall Study|Lost to Follow-up|5|||
147157999|NCT04098367|530743346|FG002|Overall Study|Lost to Follow-up|2|||
147158000|NCT04098367|530743344|FG000|Overall Study|Withdrawal by Subject|0|||
147158001|NCT04098367|530743345|FG001|Overall Study|Withdrawal by Subject|0|||
147158002|NCT04098367|530743346|FG002|Overall Study|Withdrawal by Subject|1|||
147158003|NCT04098367|530743344|FG000|Overall Study|Sick . Could not attend visit|1|||
147158004|NCT04098367|530743345|FG001|Overall Study|Sick . Could not attend visit|0|||
147158005|NCT04098367|530743346|FG002|Overall Study|Sick . Could not attend visit|0|||
147158006|NCT02251717|530743347|FG000|Overall Study|Adverse Event|0|||
147158007|NCT02251717|530743348|FG001|Overall Study|Adverse Event|1|||
147158008|NCT02251717|530743347|FG000|Overall Study|Withdrew Consent|1|||
147158009|NCT02251717|530743348|FG001|Overall Study|Withdrew Consent|0|||
147158010|NCT00322023|530743355|FG000|Overall Study|various|0|||
147158011|NCT00322023|530743356|FG001|Overall Study|various|2|||
147158012|NCT00322023|530743357|FG002|Overall Study|various|6|||
147322018|NCT03738241|531343552|FG003|Overall Study|Withdrawal by Subject|0|||
147322019|NCT03738241|531343553|FG004|Overall Study|Withdrawal by Subject|0|||
147322020|NCT03738241|531343554|FG005|Overall Study|Withdrawal by Subject|0|||
147322021|NCT03738241|531343555|FG006|Overall Study|Withdrawal by Subject|0|||
147322022|NCT03738241|531343556|FG007|Overall Study|Withdrawal by Subject|0|||
147322023|NCT03738241|531343557|FG008|Overall Study|Withdrawal by Subject|0|||
147322024|NCT03738241|531343558|FG009|Overall Study|Withdrawal by Subject|1|||
147322025|NCT03738241|531343549|FG000|Overall Study|Physician Decision|0|||
147322026|NCT03738241|531343550|FG001|Overall Study|Physician Decision|0|||
147322027|NCT03738241|531343551|FG002|Overall Study|Physician Decision|0|||
147322028|NCT03738241|531343552|FG003|Overall Study|Physician Decision|0|||
147322029|NCT03738241|531343553|FG004|Overall Study|Physician Decision|0|||
147322030|NCT03738241|531343554|FG005|Overall Study|Physician Decision|0|||
147322031|NCT03738241|531343555|FG006|Overall Study|Physician Decision|0|||
147322032|NCT03738241|531343556|FG007|Overall Study|Physician Decision|0|||
147322033|NCT03738241|531343557|FG008|Overall Study|Physician Decision|1|||
147446831|NCT02055820|531800323|FG005|Phase I: Dose-Finding|Death|1|||
147446832|NCT02055820|531800324|FG006|Phase I: Dose-Finding|Death|1|||
147446833|NCT02055820|531800325|FG007|Phase I: Dose-Finding|Death|0|||
147584874|NCT00879684|532295564|FG004|Stage 1: Dose Escalation|Progressive Disease|3|||
147584875|NCT00879684|532295565|FG005|Stage 1: Dose Escalation|Progressive Disease|3|||
147584876|NCT00879684|532295566|FG006|Stage 1: Dose Escalation|Progressive Disease|0|||
147584877|NCT00879684|532295560|FG000|Stage 1: Dose Escalation|Investigator declined participation|0|||
147158013|NCT03920293|530743358|FG000|Randomized-Controlled Period|Withdrawal by Subject|2|||
147158014|NCT03920293|530743359|FG001|Randomized-Controlled Period|Withdrawal by Subject|1|||
147158015|NCT03920293|530743358|FG000|Randomized-Controlled Period|Physician Decision|1|||
147158016|NCT03920293|530743359|FG001|Randomized-Controlled Period|Physician Decision|2|||
147158017|NCT03920293|530743358|FG000|Randomized-Controlled Period|Adverse Event|0|||
147158018|NCT03920293|530743359|FG001|Randomized-Controlled Period|Adverse Event|2|||
147322034|NCT03738241|531343558|FG009|Overall Study|Physician Decision|0|||
147158019|NCT03920293|530743358|FG000|Randomized-Controlled Period|Sponsor Decision|0|||
147322035|NCT03738241|531343549|FG000|Overall Study|Adverse Event|1|||
147446834|NCT02055820|531800326|FG008|Phase I: Dose-Finding|Death|0|||
147584878|NCT00879684|532295561|FG001|Stage 1: Dose Escalation|Investigator declined participation|0|||
147654374|NCT00237692|532556704|FG002|Overall Study|Lost to Follow-up|5|||
147584879|NCT00879684|532295562|FG002|Stage 1: Dose Escalation|Investigator declined participation|2|||
147584880|NCT00879684|532295563|FG003|Stage 1: Dose Escalation|Investigator declined participation|2|||
147158020|NCT03920293|530743359|FG001|Randomized-Controlled Period|Sponsor Decision|1|||
147158021|NCT03920293|530743358|FG000|Randomized-Controlled Period|Death|2|||
147158022|NCT03920293|530743359|FG001|Randomized-Controlled Period|Death|0|||
147158023|NCT03920293|530743358|FG000|Randomized-Controlled Period|Protocol Violation|1|||
147158024|NCT03920293|530743359|FG001|Randomized-Controlled Period|Protocol Violation|0|||
147158025|NCT03920293|530743358|FG000|Randomized-Controlled Period|Noncompliance|1|||
147158026|NCT03920293|530743359|FG001|Randomized-Controlled Period|Noncompliance|0|||
147158027|NCT03920293|530743358|FG000|Open- Label Extension Period|Participants who transitioned to alternative treatment by the Investigator when the study closed|3|||
147158028|NCT03920293|530743359|FG001|Open- Label Extension Period|Participants who transitioned to alternative treatment by the Investigator when the study closed|5|||
147158029|NCT03920293|530743358|FG000|Open- Label Extension Period|Death|3|||
147158030|NCT03920293|530743359|FG001|Open- Label Extension Period|Death|3|||
147158031|NCT03920293|530743358|FG000|Open- Label Extension Period|Physician Decision|5|||
147158032|NCT03920293|530743359|FG001|Open- Label Extension Period|Physician Decision|3|||
147158033|NCT03920293|530743358|FG000|Open- Label Extension Period|Withdrawal by Subject|7|||
147158034|NCT03920293|530743359|FG001|Open- Label Extension Period|Withdrawal by Subject|9|||
147158035|NCT03361189|530743364|FG000|Overall Study|Received heart transplant|1|||
147158036|NCT03361189|530743365|FG001|Overall Study|Received heart transplant|0|||
147158037|NCT03361189|530743364|FG000|Overall Study|Pacemake replacement|0|||
147158038|NCT03361189|530743365|FG001|Overall Study|Pacemake replacement|1|||
147158039|NCT03344549|530743366|FG000|Overall Study|Withdrawal by Subject|3|||
147158040|NCT03344549|530743367|FG001|Overall Study|Withdrawal by Subject|2|||
147158041|NCT03344549|530743366|FG000|Overall Study|Dialysis|2|||
147158042|NCT03344549|530743367|FG001|Overall Study|Dialysis|0|||
147158043|NCT03344549|530743366|FG000|Overall Study|Cancer|1|||
147158044|NCT03344549|530743367|FG001|Overall Study|Cancer|0|||
147158045|NCT03344549|530743366|FG000|Overall Study|Lack of electronic device|1|||
147158046|NCT03344549|530743367|FG001|Overall Study|Lack of electronic device|0|||
147158047|NCT03344549|530743366|FG000|Overall Study|Transportation difficulty|0|||
147158048|NCT03344549|530743367|FG001|Overall Study|Transportation difficulty|13|||
147158049|NCT02323126|530743368|FG000|Overall Study|Patient / guardian decision|0|||
147158050|NCT02323126|530743369|FG001|Overall Study|Patient / guardian decision|1|||
147158051|NCT02323126|530743370|FG002|Overall Study|Patient / guardian decision|2|||
147158052|NCT02323126|530743368|FG000|Overall Study|Progressive disease|14|||
147158053|NCT02323126|530743369|FG001|Overall Study|Progressive disease|8|||
147158054|NCT02323126|530743370|FG002|Overall Study|Progressive disease|14|||
147158055|NCT02323126|530743368|FG000|Overall Study|Physician Decision|0|||
147158056|NCT02323126|530743369|FG001|Overall Study|Physician Decision|1|||
147158057|NCT02323126|530743370|FG002|Overall Study|Physician Decision|3|||
147158058|NCT02323126|530743368|FG000|Overall Study|Death|1|||
147158059|NCT02323126|530743369|FG001|Overall Study|Death|1|||
147158060|NCT02323126|530743370|FG002|Overall Study|Death|4|||
147158061|NCT02323126|530743368|FG000|Overall Study|Adverse Event|3|||
147158062|NCT02323126|530743369|FG001|Overall Study|Adverse Event|5|||
147158063|NCT02323126|530743370|FG002|Overall Study|Adverse Event|7|||
147158064|NCT01685801|530743376|FG000|Cycle 1 Period 2 (2 Weeks)|Adverse Event|0|||
147158065|NCT01685801|530743377|FG001|Cycle 1 Period 2 (2 Weeks)|Adverse Event|0|||
147158066|NCT01685801|530743378|FG002|Cycle 1 Period 2 (2 Weeks)|Adverse Event|0|||
147584881|NCT00879684|532295564|FG004|Stage 1: Dose Escalation|Investigator declined participation|0|||
147584882|NCT00879684|532295565|FG005|Stage 1: Dose Escalation|Investigator declined participation|0|||
147584883|NCT00879684|532295566|FG006|Stage 1: Dose Escalation|Investigator declined participation|0|||
147584884|NCT00879684|532295560|FG000|Stage 1: Dose Escalation|Death|0|||
147584885|NCT00879684|532295561|FG001|Stage 1: Dose Escalation|Death|0|||
147584886|NCT00879684|532295562|FG002|Stage 1: Dose Escalation|Death|1|||
147584887|NCT00879684|532295563|FG003|Stage 1: Dose Escalation|Death|0|||
147584888|NCT00879684|532295564|FG004|Stage 1: Dose Escalation|Death|0|||
147584889|NCT00879684|532295565|FG005|Stage 1: Dose Escalation|Death|0|||
147584890|NCT00879684|532295566|FG006|Stage 1: Dose Escalation|Death|0|||
147584891|NCT00879684|532295560|FG000|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
147584892|NCT00879684|532295561|FG001|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
147158067|NCT01685801|530743379|FG003|Cycle 1 Period 2 (2 Weeks)|Adverse Event|1|||
147158068|NCT01685801|530743376|FG000|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|0|||
147158069|NCT01685801|530743377|FG001|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|1|||
147584893|NCT00879684|532295562|FG002|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
147158070|NCT01685801|530743378|FG002|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|0|||
147158071|NCT01685801|530743379|FG003|Cycle 2 Period 2 (2 Weeks)|Non-compliance with Study Drug|1|||
147158072|NCT03350256|530743380|FG000|Overall Study|Inclusion/exclusion violation|4|||
147158073|NCT03350256|530743380|FG000|Overall Study|Recommended for other therapies|2|||
147158074|NCT03350256|530743380|FG000|Overall Study|Protocol Violation|3|||
147584894|NCT00879684|532295563|FG003|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
147158075|NCT03350256|530743380|FG000|Overall Study|Non compliance|2|||
147584895|NCT00879684|532295564|FG004|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
147241114|NCT00381485|531055762|FG001|Open-Label Run-In Period|Adverse Event|0|||
147241115|NCT00381485|531055763|FG002|Open-Label Run-In Period|Adverse Event|0|||
147241116|NCT00381485|531055764|FG003|Open-Label Run-In Period|Adverse Event|0|||
147241117|NCT00381485|531055761|FG000|Open-Label Run-In Period|Did not meet protocol eligibility|76|||
147241118|NCT00381485|531055762|FG001|Open-Label Run-In Period|Did not meet protocol eligibility|0|||
147241119|NCT00381485|531055763|FG002|Open-Label Run-In Period|Did not meet protocol eligibility|0|||
147241120|NCT00381485|531055764|FG003|Open-Label Run-In Period|Did not meet protocol eligibility|0|||
147241121|NCT00381485|531055761|FG000|Open-Label Run-In Period|Withdrawal by Subject-reasons related|16|||
147241122|NCT00381485|531055762|FG001|Open-Label Run-In Period|Withdrawal by Subject-reasons related|0|||
147241123|NCT00381485|531055763|FG002|Open-Label Run-In Period|Withdrawal by Subject-reasons related|0|||
147241124|NCT00381485|531055764|FG003|Open-Label Run-In Period|Withdrawal by Subject-reasons related|0|||
147241125|NCT00381485|531055761|FG000|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|1|||
147241126|NCT00381485|531055762|FG001|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|0|||
147241127|NCT00381485|531055763|FG002|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|0|||
147241128|NCT00381485|531055764|FG003|Open-Label Run-In Period|Withdrawal by Subject-reasons unrelated|0|||
147241129|NCT00381485|531055761|FG000|Open-Label Run-In Period|Lost to Follow-up|3|||
147241130|NCT00381485|531055762|FG001|Open-Label Run-In Period|Lost to Follow-up|0|||
147241131|NCT00381485|531055763|FG002|Open-Label Run-In Period|Lost to Follow-up|0|||
147241132|NCT00381485|531055764|FG003|Open-Label Run-In Period|Lost to Follow-up|0|||
147241133|NCT00381485|531055761|FG000|Open-Label Run-In Period|Treatment failure|1|||
147241134|NCT00381485|531055762|FG001|Open-Label Run-In Period|Treatment failure|0|||
147241135|NCT00381485|531055763|FG002|Open-Label Run-In Period|Treatment failure|0|||
147241136|NCT00381485|531055764|FG003|Open-Label Run-In Period|Treatment failure|0|||
147241137|NCT00381485|531055761|FG000|Double-Blind Treatment Period|Adverse Event|0|||
147241138|NCT00381485|531055762|FG001|Double-Blind Treatment Period|Adverse Event|2|||
147241139|NCT00381485|531055763|FG002|Double-Blind Treatment Period|Adverse Event|2|||
147241140|NCT00381485|531055764|FG003|Double-Blind Treatment Period|Adverse Event|5|||
147241141|NCT00381485|531055761|FG000|Double-Blind Treatment Period|Lack of Efficacy|0|||
147241142|NCT00381485|531055762|FG001|Double-Blind Treatment Period|Lack of Efficacy|8|||
147241143|NCT00381485|531055763|FG002|Double-Blind Treatment Period|Lack of Efficacy|11|||
147241144|NCT00381485|531055764|FG003|Double-Blind Treatment Period|Lack of Efficacy|13|||
147241145|NCT00381485|531055761|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
147241146|NCT00381485|531055762|FG001|Double-Blind Treatment Period|Lost to Follow-up|0|||
147241147|NCT00381485|531055763|FG002|Double-Blind Treatment Period|Lost to Follow-up|1|||
147241148|NCT00381485|531055764|FG003|Double-Blind Treatment Period|Lost to Follow-up|1|||
147241149|NCT00381485|531055761|FG000|Double-Blind Treatment Period|Noncompliance with protocol|0|||
147241150|NCT00381485|531055762|FG001|Double-Blind Treatment Period|Noncompliance with protocol|9|||
147241151|NCT00381485|531055763|FG002|Double-Blind Treatment Period|Noncompliance with protocol|3|||
147241152|NCT00381485|531055764|FG003|Double-Blind Treatment Period|Noncompliance with protocol|3|||
147241153|NCT00381485|531055761|FG000|Double-Blind Treatment Period|Did not meet protocol eligibility|0|||
147241154|NCT00381485|531055762|FG001|Double-Blind Treatment Period|Did not meet protocol eligibility|5|||
147241155|NCT00381485|531055763|FG002|Double-Blind Treatment Period|Did not meet protocol eligibility|7|||
147241156|NCT00381485|531055764|FG003|Double-Blind Treatment Period|Did not meet protocol eligibility|5|||
147241157|NCT00381485|531055761|FG000|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|0|||
147241158|NCT00381485|531055762|FG001|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|2|||
147241159|NCT00381485|531055763|FG002|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|1|||
147241160|NCT00381485|531055764|FG003|Double-Blind Treatment Period|Withdrawal by Subject-reasons unrelated|4|||
147241161|NCT00381485|531055761|FG000|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|0|||
147241162|NCT00381485|531055762|FG001|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|0|||
147241163|NCT00381485|531055763|FG002|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|0|||
147241164|NCT00381485|531055764|FG003|Double-Blind Treatment Period|Withdrawal by Subject-reasons related|1|||
147241165|NCT00381485|531055761|FG000|Double-Blind Treatment Period|Administrative|0|||
147241166|NCT00381485|531055762|FG001|Double-Blind Treatment Period|Administrative|1|||
147241167|NCT00381485|531055763|FG002|Double-Blind Treatment Period|Administrative|0|||
147241168|NCT00381485|531055764|FG003|Double-Blind Treatment Period|Administrative|1|||
147241169|NCT01235351|531055765|FG000|Initial Treatment With 75 mg and 150 mg|No follow-up sample|10|||
147241170|NCT01235351|531055766|FG001|Initial Treatment With 75 mg and 150 mg|No follow-up sample|4|||
147241171|NCT01918774|531055767|FG000|Overall Study|Lost prior to first CBTw session|4|||
147241172|NCT01918774|531055767|FG000|Overall Study|Lost to Follow-up|1|||
147241173|NCT01606800|531055768|FG000|Overall Study|Adverse Event|3|||
147241174|NCT01606800|531055769|FG001|Overall Study|Adverse Event|1|||
147322036|NCT03738241|531343550|FG001|Overall Study|Adverse Event|0|||
147322037|NCT03738241|531343551|FG002|Overall Study|Adverse Event|0|||
147322038|NCT03738241|531343552|FG003|Overall Study|Adverse Event|0|||
147446835|NCT02055820|531800327|FG009|Phase I: Dose-Finding|Death|0|||
147446836|NCT02055820|531800318|FG000|Phase I: Dose-Finding|Withdrawal by Subject|0|||
147446837|NCT02055820|531800319|FG001|Phase I: Dose-Finding|Withdrawal by Subject|0|||
147584896|NCT00879684|532295565|FG005|Stage 2: Expanded Cohort|Lost to Follow-up|0|||
147584897|NCT00879684|532295566|FG006|Stage 2: Expanded Cohort|Lost to Follow-up|1|||
147584898|NCT00879684|532295560|FG000|Stage 2: Expanded Cohort|Progressive Disease|0|||
147584899|NCT00879684|532295561|FG001|Stage 2: Expanded Cohort|Progressive Disease|0|||
147584900|NCT00879684|532295562|FG002|Stage 2: Expanded Cohort|Progressive Disease|0|||
147584901|NCT00879684|532295563|FG003|Stage 2: Expanded Cohort|Progressive Disease|0|||
147584902|NCT00879684|532295564|FG004|Stage 2: Expanded Cohort|Progressive Disease|0|||
147584903|NCT00879684|532295565|FG005|Stage 2: Expanded Cohort|Progressive Disease|0|||
147584904|NCT00879684|532295566|FG006|Stage 2: Expanded Cohort|Progressive Disease|11|||
147584905|NCT00879684|532295560|FG000|Stage 2: Expanded Cohort|Investigator declined participation|0|||
147584906|NCT00879684|532295561|FG001|Stage 2: Expanded Cohort|Investigator declined participation|0|||
147584907|NCT00879684|532295562|FG002|Stage 2: Expanded Cohort|Investigator declined participation|0|||
147584908|NCT00879684|532295563|FG003|Stage 2: Expanded Cohort|Investigator declined participation|0|||
147584909|NCT00879684|532295564|FG004|Stage 2: Expanded Cohort|Investigator declined participation|0|||
147584910|NCT00879684|532295565|FG005|Stage 2: Expanded Cohort|Investigator declined participation|0|||
147584911|NCT00879684|532295566|FG006|Stage 2: Expanded Cohort|Investigator declined participation|1|||
147584912|NCT00708682|532295567|FG000|Infant Series|Adverse Event|1|||
147584913|NCT00708682|532295567|FG000|Infant Series|Lost to Follow-up|4|||
147584914|NCT00708682|532295567|FG000|Infant Series|Protocol Violation|1|||
147584915|NCT00708682|532295567|FG000|Infant Series|Parent/legal guardian request|6|||
147584916|NCT00708682|532295567|FG000|Infant Series|Failed to return|2|||
147584917|NCT00708682|532295567|FG000|Infant Series|Other|19|||
147584918|NCT00708682|532295567|FG000|After Infant Series|Parent/Legal Guardian Request|1|||
147584919|NCT00708682|532295567|FG000|Toddler Dose|Parent/Legal Guardian Request|1|||
147584920|NCT00708682|532295567|FG000|Toddler Dose|Lost to Follow-up|3|||
147584921|NCT00708682|532295567|FG000|Toddler Dose|Failed to Return|4|||
147584922|NCT01148225|532295570|FG000|Overall Study|Other|185|||
147584923|NCT03689894|532295571|FG000|Overall Study|Adverse Event|1|||
147584924|NCT02839798|532296922|FG000|Overall Study|Withdrawal by Subject|2|||
147584925|NCT05258630|532296924|FG000|Overall Study|Protocol Deviation w/o increased risk to pt|1|||
147584926|NCT05258630|532296925|FG001|Overall Study|Protocol Deviation w/o increased risk to pt|1|||
147584927|NCT05258630|532296924|FG000|Overall Study|Lost to Follow-up|0|||
147584928|NCT05258630|532296925|FG001|Overall Study|Lost to Follow-up|2|||
147584929|NCT03431337|532296926|FG000|Overall Study|Lost to Follow-up|21|||
147584930|NCT03431337|532296927|FG001|Overall Study|Lost to Follow-up|19|||
147584931|NCT03431337|532296926|FG000|Overall Study|Withdrawal by Subject|8|||
147584932|NCT03431337|532296927|FG001|Overall Study|Withdrawal by Subject|3|||
147158076|NCT03350256|530743380|FG000|Overall Study|Denial by insurance|1|||
147158077|NCT03350256|530743380|FG000|Overall Study|Adverse Event|2|||
147158078|NCT03350256|530743380|FG000|Overall Study|Trial failure|12|||
147158079|NCT03350256|530743380|FG000|Overall Study|Did not proceed to permanent implant|3|||
147158080|NCT03350256|530743380|FG000|Overall Study|Withdrawal by Subject|3|||
147158081|NCT03350256|530743380|FG000|Overall Study|Subject moving out of state|1|||
147158082|NCT03350256|530743380|FG000|Overall Study|Lost to Follow-up|1|||
147158083|NCT03350256|530743380|FG000|Overall Study|Lack of Efficacy|2|||
147158084|NCT03960580|530743381|FG000|Overall Study|Adverse Event|2|||
147158085|NCT03960580|530743382|FG001|Overall Study|Adverse Event|1|||
147158086|NCT03960580|530743383|FG002|Overall Study|Adverse Event|1|||
147158087|NCT03960580|530743381|FG000|Overall Study|Lost to Follow-up|1|||
147158088|NCT03960580|530743382|FG001|Overall Study|Lost to Follow-up|0|||
147158089|NCT03960580|530743383|FG002|Overall Study|Lost to Follow-up|0|||
147158090|NCT03960580|530743381|FG000|Overall Study|Lack of Efficacy|2|||
147158091|NCT03960580|530743382|FG001|Overall Study|Lack of Efficacy|1|||
147158092|NCT03960580|530743383|FG002|Overall Study|Lack of Efficacy|0|||
147158093|NCT03960580|530743381|FG000|Overall Study|Protocol Violation|0|||
147158094|NCT03960580|530743382|FG001|Overall Study|Protocol Violation|0|||
147158095|NCT03960580|530743383|FG002|Overall Study|Protocol Violation|1|||
147158096|NCT03960580|530743381|FG000|Overall Study|Withdrawal by Subject|1|||
147158097|NCT03960580|530743382|FG001|Overall Study|Withdrawal by Subject|1|||
147158098|NCT03960580|530743383|FG002|Overall Study|Withdrawal by Subject|1|||
147158099|NCT03960580|530743381|FG000|Overall Study|Marked Randomized in error (patient did not receive study drug)|0|||
147158100|NCT03960580|530743382|FG001|Overall Study|Marked Randomized in error (patient did not receive study drug)|1|||
147158101|NCT03960580|530743383|FG002|Overall Study|Marked Randomized in error (patient did not receive study drug)|0|||
147584933|NCT00401245|532296928|FG000|Double Blind Titration Phase|Adverse Event|3|||
147584934|NCT00401245|532296929|FG001|Double Blind Titration Phase|Adverse Event|2|||
147584935|NCT00401245|532296930|FG002|Double Blind Titration Phase|Adverse Event|5|||
147584936|NCT00401245|532296931|FG003|Double Blind Titration Phase|Adverse Event|12|||
147158102|NCT00791479|530743391|FG000|Overall Study|Dose Discontinued per Sponsor Decision|0|||
147158103|NCT00791479|530743392|FG001|Overall Study|Dose Discontinued per Sponsor Decision|0|||
147584937|NCT00401245|532296932|FG004|Double Blind Titration Phase|Adverse Event|0|||
147584938|NCT00401245|532296933|FG005|Double Blind Titration Phase|Adverse Event|0|||
147584939|NCT00401245|532296934|FG006|Double Blind Titration Phase|Adverse Event|0|||
147584940|NCT00401245|532296935|FG007|Double Blind Titration Phase|Adverse Event|0|||
147158104|NCT00791479|530743393|FG002|Overall Study|Dose Discontinued per Sponsor Decision|0|||
147158105|NCT00791479|530743394|FG003|Overall Study|Dose Discontinued per Sponsor Decision|0|||
147158106|NCT00791479|530743395|FG004|Overall Study|Dose Discontinued per Sponsor Decision|3|||
147158107|NCT00791479|530743396|FG005|Overall Study|Dose Discontinued per Sponsor Decision|0|||
147158108|NCT00791479|530743391|FG000|Overall Study|Adverse Event|0|||
147158109|NCT00791479|530743392|FG001|Overall Study|Adverse Event|1|||
147158110|NCT00791479|530743393|FG002|Overall Study|Adverse Event|0|||
147158111|NCT00791479|530743394|FG003|Overall Study|Adverse Event|2|||
147584941|NCT00401245|532296928|FG000|Double Blind Titration Phase|Other|0|||
147584942|NCT00401245|532296929|FG001|Double Blind Titration Phase|Other|0|||
147584943|NCT00401245|532296930|FG002|Double Blind Titration Phase|Other|1|||
147584944|NCT00401245|532296931|FG003|Double Blind Titration Phase|Other|0|||
147158112|NCT00791479|530743395|FG004|Overall Study|Adverse Event|0|||
147158113|NCT00791479|530743396|FG005|Overall Study|Adverse Event|1|||
147158114|NCT00791479|530743391|FG000|Overall Study|Lost to Follow-up|0|||
147158115|NCT00791479|530743392|FG001|Overall Study|Lost to Follow-up|1|||
147158116|NCT00791479|530743393|FG002|Overall Study|Lost to Follow-up|0|||
147158117|NCT00791479|530743394|FG003|Overall Study|Lost to Follow-up|0|||
147158118|NCT00791479|530743395|FG004|Overall Study|Lost to Follow-up|0|||
147158119|NCT00791479|530743396|FG005|Overall Study|Lost to Follow-up|1|||
147158120|NCT00791479|530743391|FG000|Overall Study|Protocol Violation|2|||
147158121|NCT00791479|530743392|FG001|Overall Study|Protocol Violation|1|||
147158122|NCT00791479|530743393|FG002|Overall Study|Protocol Violation|0|||
147158123|NCT00791479|530743394|FG003|Overall Study|Protocol Violation|1|||
147158124|NCT00791479|530743395|FG004|Overall Study|Protocol Violation|0|||
147158125|NCT00791479|530743396|FG005|Overall Study|Protocol Violation|0|||
147158126|NCT00791479|530743391|FG000|Overall Study|Withdrawal by Subject|0|||
147158127|NCT00791479|530743392|FG001|Overall Study|Withdrawal by Subject|0|||
147158128|NCT00791479|530743393|FG002|Overall Study|Withdrawal by Subject|0|||
147158129|NCT00791479|530743394|FG003|Overall Study|Withdrawal by Subject|1|||
147158130|NCT00791479|530743395|FG004|Overall Study|Withdrawal by Subject|0|||
147158131|NCT00791479|530743396|FG005|Overall Study|Withdrawal by Subject|1|||
147584945|NCT00401245|532296932|FG004|Double Blind Titration Phase|Other|0|||
147584946|NCT00401245|532296933|FG005|Double Blind Titration Phase|Other|0|||
147584947|NCT00401245|532296934|FG006|Double Blind Titration Phase|Other|0|||
147584948|NCT00401245|532296935|FG007|Double Blind Titration Phase|Other|0|||
147584949|NCT00401245|532296928|FG000|Double Blind Titration Phase|Protocol Violation|0|||
147584950|NCT00401245|532296929|FG001|Double Blind Titration Phase|Protocol Violation|0|||
147584951|NCT00401245|532296930|FG002|Double Blind Titration Phase|Protocol Violation|0|||
147584952|NCT00401245|532296931|FG003|Double Blind Titration Phase|Protocol Violation|1|||
147584953|NCT00401245|532296932|FG004|Double Blind Titration Phase|Protocol Violation|0|||
147584954|NCT00401245|532296933|FG005|Double Blind Titration Phase|Protocol Violation|0|||
147584955|NCT00401245|532296934|FG006|Double Blind Titration Phase|Protocol Violation|0|||
147584956|NCT00401245|532296935|FG007|Double Blind Titration Phase|Protocol Violation|0|||
147584957|NCT00401245|532296928|FG000|Double Blind Titration Phase|Withdrawal by Subject|1|||
147584958|NCT00401245|532296929|FG001|Double Blind Titration Phase|Withdrawal by Subject|1|||
147584959|NCT00401245|532296930|FG002|Double Blind Titration Phase|Withdrawal by Subject|0|||
147584960|NCT00401245|532296931|FG003|Double Blind Titration Phase|Withdrawal by Subject|2|||
147584961|NCT00401245|532296932|FG004|Double Blind Titration Phase|Withdrawal by Subject|0|||
147584962|NCT00401245|532296933|FG005|Double Blind Titration Phase|Withdrawal by Subject|0|||
147584963|NCT00401245|532296934|FG006|Double Blind Titration Phase|Withdrawal by Subject|0|||
147584964|NCT00401245|532296935|FG007|Double Blind Titration Phase|Withdrawal by Subject|0|||
147584965|NCT00401245|532296928|FG000|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
147584966|NCT00401245|532296929|FG001|Between Titration and Open Label Phase|Did not enter the open label phase|2|||
147584967|NCT00401245|532296930|FG002|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
147241175|NCT01606800|531055768|FG000|Overall Study|Participant withdrew consent|0|||
147241176|NCT01606800|531055769|FG001|Overall Study|Participant withdrew consent|1|||
147584968|NCT00401245|532296931|FG003|Between Titration and Open Label Phase|Did not enter the open label phase|2|||
147584969|NCT00401245|532296932|FG004|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
147584970|NCT00401245|532296933|FG005|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
147584971|NCT00401245|532296934|FG006|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
147584972|NCT00401245|532296935|FG007|Between Titration and Open Label Phase|Did not enter the open label phase|0|||
147158132|NCT00543296|530743399|FG000|Overall Study|Physician Decision|7|||
147241177|NCT01606800|531055768|FG000|Overall Study|Missing completion status|2|||
147584973|NCT00401245|532296928|FG000|Open Label Phase|Adverse Event|5|||
147584974|NCT00401245|532296929|FG001|Open Label Phase|Adverse Event|14|||
147584975|NCT00401245|532296930|FG002|Open Label Phase|Adverse Event|6|||
147584976|NCT00401245|532296931|FG003|Open Label Phase|Adverse Event|7|||
147158133|NCT00934947|530743402|FG000|Overall Study|Adverse Event|0|||
147158134|NCT00934947|530743403|FG001|Overall Study|Adverse Event|2|||
147158135|NCT01920568|530743405|FG000|Overall Study|Adverse Event|27|||
147158136|NCT01920568|530743406|FG001|Overall Study|Adverse Event|8|||
147241178|NCT01606800|531055769|FG001|Overall Study|Missing completion status|0|||
147241179|NCT00717197|531055774|FG000|Overall Study|Unable to purchase study drug|5|||
147241180|NCT00717197|531055774|FG000|Overall Study|Tumor Progression|1|||
147241181|NCT00717197|531055774|FG000|Overall Study|Physician Decision|1|||
147241182|NCT00982137|531055775|FG000|Overall Study|Lost to Follow-up|0|||
147241183|NCT00982137|531055776|FG001|Overall Study|Lost to Follow-up|0|||
147241184|NCT00982137|531055777|FG002|Overall Study|Lost to Follow-up|0|||
147241185|NCT00982137|531055778|FG003|Overall Study|Lost to Follow-up|1|||
147241186|NCT00982137|531055775|FG000|Overall Study|Withdrawal by Subject|0|||
147241187|NCT00982137|531055776|FG001|Overall Study|Withdrawal by Subject|1|||
147241188|NCT00982137|531055777|FG002|Overall Study|Withdrawal by Subject|0|||
147241189|NCT00982137|531055778|FG003|Overall Study|Withdrawal by Subject|0|||
147241190|NCT00126191|531055781|FG000|Overall Study|Physician Decision|0|||
147241191|NCT00126191|531055782|FG001|Overall Study|Physician Decision|1|||
147241192|NCT00126191|531055781|FG000|Overall Study|Death|0|||
147241193|NCT00126191|531055782|FG001|Overall Study|Death|1|||
147241194|NCT01648101|531055783|FG000|Titration Phase (4 Weeks)|Protocol Violation|2|||
147241195|NCT01648101|531055784|FG001|Titration Phase (4 Weeks)|Protocol Violation|1|||
147241196|NCT01648101|531055785|FG002|Titration Phase (4 Weeks)|Protocol Violation|2|||
147241197|NCT01648101|531055783|FG000|Titration Phase (4 Weeks)|Adverse Event|0|||
147241198|NCT01648101|531055784|FG001|Titration Phase (4 Weeks)|Adverse Event|2|||
147241199|NCT01648101|531055785|FG002|Titration Phase (4 Weeks)|Adverse Event|3|||
147241200|NCT01648101|531055783|FG000|Titration Phase (4 Weeks)|Reached Protocol Defined Criteria|0|||
147241201|NCT01648101|531055784|FG001|Titration Phase (4 Weeks)|Reached Protocol Defined Criteria|0|||
147241202|NCT01648101|531055785|FG002|Titration Phase (4 Weeks)|Reached Protocol Defined Criteria|1|||
147241203|NCT01648101|531055783|FG000|Maintenance Phase (12 Weeks)|Withdrew Consent|1|||
147241204|NCT01648101|531055784|FG001|Maintenance Phase (12 Weeks)|Withdrew Consent|0|||
147241205|NCT01648101|531055785|FG002|Maintenance Phase (12 Weeks)|Withdrew Consent|1|||
147241206|NCT01648101|531055783|FG000|Maintenance Phase (12 Weeks)|Lack of Efficacy|1|||
147241207|NCT01648101|531055784|FG001|Maintenance Phase (12 Weeks)|Lack of Efficacy|0|||
147241208|NCT01648101|531055785|FG002|Maintenance Phase (12 Weeks)|Lack of Efficacy|1|||
147241209|NCT01648101|531055783|FG000|Maintenance Phase (12 Weeks)|Adverse Event|1|||
147241210|NCT01648101|531055784|FG001|Maintenance Phase (12 Weeks)|Adverse Event|3|||
147241211|NCT01648101|531055785|FG002|Maintenance Phase (12 Weeks)|Adverse Event|4|||
147241212|NCT01648101|531055783|FG000|Transition Phase (4 Weeks)|Adverse Event|4|||
147241213|NCT01648101|531055784|FG001|Transition Phase (4 Weeks)|Adverse Event|3|||
147241214|NCT01648101|531055785|FG002|Transition Phase (4 Weeks)|Adverse Event|2|||
147241215|NCT01648101|531055783|FG000|Transition Phase (4 Weeks)|Lack of Efficacy|0|||
147241216|NCT01648101|531055784|FG001|Transition Phase (4 Weeks)|Lack of Efficacy|2|||
147241217|NCT01648101|531055785|FG002|Transition Phase (4 Weeks)|Lack of Efficacy|0|||
147241218|NCT01648101|531055783|FG000|Transition Phase (4 Weeks)|Withdrawal by Subject|0|||
147241219|NCT01648101|531055784|FG001|Transition Phase (4 Weeks)|Withdrawal by Subject|0|||
147241220|NCT01648101|531055785|FG002|Transition Phase (4 Weeks)|Withdrawal by Subject|2|||
147241221|NCT01648101|531055783|FG000|Transition Phase (4 Weeks)|Study Terminated|1|||
147241222|NCT01648101|531055784|FG001|Transition Phase (4 Weeks)|Study Terminated|0|||
147241223|NCT01648101|531055785|FG002|Transition Phase (4 Weeks)|Study Terminated|0|||
147241224|NCT01648101|531055783|FG000|Taper/Follow-up Phase (4 Weeks)|Lack of Efficacy|0|||
147241225|NCT01648101|531055784|FG001|Taper/Follow-up Phase (4 Weeks)|Lack of Efficacy|1|||
147241226|NCT01648101|531055785|FG002|Taper/Follow-up Phase (4 Weeks)|Lack of Efficacy|0|||
147241227|NCT02469298|531055801|FG000|Overall Study|Protocol Violation|0|||
147584977|NCT00401245|532296932|FG004|Open Label Phase|Adverse Event|0|||
147584978|NCT00401245|532296933|FG005|Open Label Phase|Adverse Event|0|||
147584979|NCT00401245|532296934|FG006|Open Label Phase|Adverse Event|0|||
147584980|NCT00401245|532296935|FG007|Open Label Phase|Adverse Event|0|||
147241228|NCT02469298|531055802|FG001|Overall Study|Protocol Violation|1|||
147241229|NCT02469298|531055803|FG002|Overall Study|Protocol Violation|1|||
147241230|NCT02469298|531055804|FG003|Overall Study|Protocol Violation|0|||
147241231|NCT02469298|531055801|FG000|Overall Study|Lost to Follow-up|1|||
147241232|NCT02469298|531055802|FG001|Overall Study|Lost to Follow-up|0|||
147241233|NCT02469298|531055803|FG002|Overall Study|Lost to Follow-up|1|||
147241234|NCT02469298|531055804|FG003|Overall Study|Lost to Follow-up|0|||
147241235|NCT02469298|531055801|FG000|Overall Study|Physician Decision|0|||
147241236|NCT02469298|531055802|FG001|Overall Study|Physician Decision|0|||
147241237|NCT02469298|531055803|FG002|Overall Study|Physician Decision|0|||
147241238|NCT02469298|531055804|FG003|Overall Study|Physician Decision|1|||
147241239|NCT02469298|531055801|FG000|Overall Study|Withdrawal by Subject|0|||
147241240|NCT02469298|531055802|FG001|Overall Study|Withdrawal by Subject|0|||
147241241|NCT02469298|531055803|FG002|Overall Study|Withdrawal by Subject|0|||
147241242|NCT02469298|531055804|FG003|Overall Study|Withdrawal by Subject|1|||
147241243|NCT00307294|531055805|FG000|Overall Study|Withdrawal by Subject|1|||
147584981|NCT00401245|532296928|FG000|Open Label Phase|Lost to Follow-up|5|||
147241244|NCT03311724|531055814|FG000|Overall Study|Physician Decision|0|||
147241245|NCT03311724|531055815|FG001|Overall Study|Physician Decision|0|||
147241246|NCT03311724|531055816|FG002|Overall Study|Physician Decision|0|||
147241247|NCT03311724|531055817|FG003|Overall Study|Physician Decision|1|||
147158137|NCT01920568|530743405|FG000|Overall Study|Protocol Violation|5|||
147158138|NCT01920568|530743406|FG001|Overall Study|Protocol Violation|3|||
147158139|NCT01920568|530743405|FG000|Overall Study|Lost to Follow-up|2|||
147158140|NCT01920568|530743406|FG001|Overall Study|Lost to Follow-up|2|||
147158141|NCT01920568|530743405|FG000|Overall Study|Physician Decision|13|||
147158142|NCT01920568|530743406|FG001|Overall Study|Physician Decision|4|||
147158143|NCT01920568|530743405|FG000|Overall Study|Withdrawal by Subject|79|||
147158144|NCT01920568|530743406|FG001|Overall Study|Withdrawal by Subject|55|||
147158145|NCT01920568|530743405|FG000|Overall Study|Death due to disease progression|25|||
147158146|NCT01920568|530743406|FG001|Overall Study|Death due to disease progression|12|||
147158147|NCT03664674|530743409|FG000|Overall Study|Adverse Event|1|||
147158148|NCT03664674|530743410|FG001|Overall Study|Adverse Event|1|||
147158149|NCT03664674|530743409|FG000|Overall Study|Physician Decision|0|||
147158150|NCT03664674|530743410|FG001|Overall Study|Physician Decision|1|||
147158151|NCT03664674|530743409|FG000|Overall Study|Withdrawal by Subject|2|||
147158152|NCT03664674|530743410|FG001|Overall Study|Withdrawal by Subject|0|||
147584982|NCT00401245|532296929|FG001|Open Label Phase|Lost to Follow-up|7|||
147584983|NCT00401245|532296930|FG002|Open Label Phase|Lost to Follow-up|5|||
147584984|NCT00401245|532296931|FG003|Open Label Phase|Lost to Follow-up|4|||
147584985|NCT00401245|532296932|FG004|Open Label Phase|Lost to Follow-up|0|||
147584986|NCT00401245|532296933|FG005|Open Label Phase|Lost to Follow-up|0|||
147584987|NCT00401245|532296934|FG006|Open Label Phase|Lost to Follow-up|0|||
147584988|NCT00401245|532296935|FG007|Open Label Phase|Lost to Follow-up|0|||
147584989|NCT00401245|532296928|FG000|Open Label Phase|Other|4|||
147584990|NCT00401245|532296929|FG001|Open Label Phase|Other|8|||
147584991|NCT00401245|532296930|FG002|Open Label Phase|Other|7|||
147584992|NCT00401245|532296931|FG003|Open Label Phase|Other|8|||
147584993|NCT00401245|532296932|FG004|Open Label Phase|Other|0|||
147584994|NCT00401245|532296933|FG005|Open Label Phase|Other|0|||
147584995|NCT00401245|532296934|FG006|Open Label Phase|Other|0|||
147584996|NCT00401245|532296935|FG007|Open Label Phase|Other|0|||
147584997|NCT00401245|532296928|FG000|Open Label Phase|Protocol Violation|0|||
147584998|NCT00401245|532296929|FG001|Open Label Phase|Protocol Violation|1|||
147584999|NCT00401245|532296930|FG002|Open Label Phase|Protocol Violation|0|||
147585000|NCT00401245|532296931|FG003|Open Label Phase|Protocol Violation|1|||
147585001|NCT00401245|532296932|FG004|Open Label Phase|Protocol Violation|0|||
147585002|NCT00401245|532296933|FG005|Open Label Phase|Protocol Violation|0|||
147585003|NCT00401245|532296934|FG006|Open Label Phase|Protocol Violation|0|||
147585004|NCT00401245|532296935|FG007|Open Label Phase|Protocol Violation|0|||
147585005|NCT00401245|532296928|FG000|Open Label Phase|Withdrawal by Subject|3|||
147585006|NCT00401245|532296929|FG001|Open Label Phase|Withdrawal by Subject|3|||
147585007|NCT00401245|532296930|FG002|Open Label Phase|Withdrawal by Subject|2|||
147585008|NCT00401245|532296931|FG003|Open Label Phase|Withdrawal by Subject|1|||
147585009|NCT00401245|532296932|FG004|Open Label Phase|Withdrawal by Subject|0|||
147585010|NCT00401245|532296933|FG005|Open Label Phase|Withdrawal by Subject|0|||
147585011|NCT00401245|532296934|FG006|Open Label Phase|Withdrawal by Subject|0|||
147585012|NCT00401245|532296935|FG007|Open Label Phase|Withdrawal by Subject|0|||
147585013|NCT00401245|532296928|FG000|Open Label Phase|Lack of Efficacy|4|||
147585014|NCT00401245|532296929|FG001|Open Label Phase|Lack of Efficacy|2|||
147585015|NCT00401245|532296930|FG002|Open Label Phase|Lack of Efficacy|3|||
147585016|NCT00401245|532296931|FG003|Open Label Phase|Lack of Efficacy|0|||
147585017|NCT00401245|532296932|FG004|Open Label Phase|Lack of Efficacy|0|||
147585018|NCT00401245|532296933|FG005|Open Label Phase|Lack of Efficacy|0|||
147585019|NCT00401245|532296934|FG006|Open Label Phase|Lack of Efficacy|0|||
147585020|NCT00401245|532296935|FG007|Open Label Phase|Lack of Efficacy|0|||
147585021|NCT00401245|532296928|FG000|Double Blind Tapering Phase|Adverse Event|0|||
147585022|NCT00401245|532296929|FG001|Double Blind Tapering Phase|Adverse Event|0|||
147585023|NCT00401245|532296930|FG002|Double Blind Tapering Phase|Adverse Event|0|||
147585024|NCT00401245|532296931|FG003|Double Blind Tapering Phase|Adverse Event|0|||
147585025|NCT00401245|532296932|FG004|Double Blind Tapering Phase|Adverse Event|1|||
147585026|NCT00401245|532296933|FG005|Double Blind Tapering Phase|Adverse Event|1|||
147585027|NCT00401245|532296934|FG006|Double Blind Tapering Phase|Adverse Event|2|||
147585028|NCT00401245|532296935|FG007|Double Blind Tapering Phase|Adverse Event|4|||
147585029|NCT00401245|532296928|FG000|Double Blind Tapering Phase|Investigator request|0|||
147585030|NCT00401245|532296929|FG001|Double Blind Tapering Phase|Investigator request|0|||
147585031|NCT00401245|532296930|FG002|Double Blind Tapering Phase|Investigator request|0|||
147585032|NCT00401245|532296931|FG003|Double Blind Tapering Phase|Investigator request|0|||
147585033|NCT00401245|532296932|FG004|Double Blind Tapering Phase|Investigator request|0|||
147158153|NCT01342965|530743412|FG000|Overall Study|Death|58|||
147158154|NCT01342965|530743413|FG001|Overall Study|Death|57|||
147585034|NCT00401245|532296933|FG005|Double Blind Tapering Phase|Investigator request|0|||
147585035|NCT00401245|532296934|FG006|Double Blind Tapering Phase|Investigator request|0|||
147585036|NCT00401245|532296935|FG007|Double Blind Tapering Phase|Investigator request|1|||
147585037|NCT00401245|532296928|FG000|Double Blind Tapering Phase|Other|0|||
147585038|NCT00401245|532296929|FG001|Double Blind Tapering Phase|Other|0|||
147585039|NCT00401245|532296930|FG002|Double Blind Tapering Phase|Other|0|||
147585040|NCT00401245|532296931|FG003|Double Blind Tapering Phase|Other|0|||
147585041|NCT00401245|532296932|FG004|Double Blind Tapering Phase|Other|1|||
147585042|NCT00401245|532296933|FG005|Double Blind Tapering Phase|Other|0|||
147585043|NCT00401245|532296934|FG006|Double Blind Tapering Phase|Other|2|||
147585044|NCT00401245|532296935|FG007|Double Blind Tapering Phase|Other|2|||
147585045|NCT00401245|532296928|FG000|Double Blind Tapering Phase|Withdrawal by Subject|0|||
147585046|NCT00401245|532296929|FG001|Double Blind Tapering Phase|Withdrawal by Subject|0|||
147585047|NCT00401245|532296930|FG002|Double Blind Tapering Phase|Withdrawal by Subject|0|||
147585048|NCT00401245|532296931|FG003|Double Blind Tapering Phase|Withdrawal by Subject|0|||
147585049|NCT00401245|532296932|FG004|Double Blind Tapering Phase|Withdrawal by Subject|2|||
147585050|NCT00401245|532296933|FG005|Double Blind Tapering Phase|Withdrawal by Subject|2|||
147585051|NCT00401245|532296934|FG006|Double Blind Tapering Phase|Withdrawal by Subject|3|||
147585052|NCT00401245|532296935|FG007|Double Blind Tapering Phase|Withdrawal by Subject|0|||
147585053|NCT00401245|532296928|FG000|Double Blind Tapering Phase|Lack of Efficacy|0|||
147585054|NCT00401245|532296929|FG001|Double Blind Tapering Phase|Lack of Efficacy|0|||
147158155|NCT01342965|530743412|FG000|Overall Study|Lost to Follow-up|5|||
147158156|NCT01342965|530743413|FG001|Overall Study|Lost to Follow-up|3|||
147585055|NCT00401245|532296930|FG002|Double Blind Tapering Phase|Lack of Efficacy|0|||
147585056|NCT00401245|532296931|FG003|Double Blind Tapering Phase|Lack of Efficacy|0|||
147585057|NCT00401245|532296932|FG004|Double Blind Tapering Phase|Lack of Efficacy|0|||
147585058|NCT00401245|532296933|FG005|Double Blind Tapering Phase|Lack of Efficacy|1|||
147585059|NCT00401245|532296934|FG006|Double Blind Tapering Phase|Lack of Efficacy|0|||
147585060|NCT00401245|532296935|FG007|Double Blind Tapering Phase|Lack of Efficacy|0|||
147585061|NCT01560819|532296939|FG000|Overall Study|Physician Decision|1|||
147585062|NCT01560819|532296940|FG001|Overall Study|Physician Decision|0|||
147585063|NCT02014441|532296941|FG000|Overall Study|Withdrawal by Subject|12|||
147585064|NCT00114231|532296942|FG000|Overall Study|No consent|2|||
147585065|NCT00114231|532296943|FG001|Overall Study|No consent|0|||
147585066|NCT00114231|532296942|FG000|Overall Study|QARC requirement not met|1|||
147585067|NCT00114231|532296943|FG001|Overall Study|QARC requirement not met|0|||
147585068|NCT00114231|532296942|FG000|Overall Study|Suspected metastatic disease|1|||
147585069|NCT00114231|532296943|FG001|Overall Study|Suspected metastatic disease|0|||
147585070|NCT00114231|532296942|FG000|Overall Study|No adenocarcinoma|1|||
147158157|NCT01342965|530743412|FG000|Overall Study|Other Reasons- Unspecified|44|||
147158158|NCT01342965|530743413|FG001|Overall Study|Other Reasons- Unspecified|38|||
147158159|NCT01342965|530743412|FG000|Overall Study|Withdrawal by Subject|2|||
147158160|NCT01342965|530743413|FG001|Overall Study|Withdrawal by Subject|9|||
147158161|NCT01170598|530743414|FG000|Overall Study|Withdrawal by Subject|1|||
147158162|NCT01170598|530743414|FG000|Overall Study|Death|3|||
147158163|NCT01170598|530743414|FG000|Overall Study|Lost to Follow-up|1|||
147158164|NCT01170598|530743414|FG000|Overall Study|Refused|1|||
147158165|NCT03022097|530743415|FG000|Overall Study|Adverse Event|3|||
147158166|NCT03022097|530743416|FG001|Overall Study|Adverse Event|4|||
147158167|NCT03022097|530743417|FG002|Overall Study|Adverse Event|1|||
147158168|NCT03022097|530743418|FG003|Overall Study|Adverse Event|3|||
147158169|NCT03022097|530743415|FG000|Overall Study|Progressive Disease|2|||
147158170|NCT03022097|530743416|FG001|Overall Study|Progressive Disease|0|||
147158171|NCT03022097|530743417|FG002|Overall Study|Progressive Disease|5|||
147158172|NCT03022097|530743418|FG003|Overall Study|Progressive Disease|2|||
147158173|NCT03022097|530743415|FG000|Overall Study|Lack of Efficacy|0|||
147158174|NCT03022097|530743416|FG001|Overall Study|Lack of Efficacy|0|||
147585071|NCT00114231|532296943|FG001|Overall Study|No adenocarcinoma|0|||
147585072|NCT00114231|532296942|FG000|Overall Study|Low creatinine clearance|0|||
147158175|NCT03022097|530743417|FG002|Overall Study|Lack of Efficacy|3|||
147158176|NCT03022097|530743418|FG003|Overall Study|Lack of Efficacy|3|||
147158177|NCT03022097|530743415|FG000|Overall Study|Protocol Violation|1|||
147158178|NCT03022097|530743416|FG001|Overall Study|Protocol Violation|0|||
147158179|NCT03022097|530743417|FG002|Overall Study|Protocol Violation|1|||
147158180|NCT03022097|530743418|FG003|Overall Study|Protocol Violation|0|||
147158181|NCT03022097|530743415|FG000|Overall Study|Withdrawal by Subject|11|||
147322039|NCT03738241|531343553|FG004|Overall Study|Adverse Event|0|||
147585073|NCT00114231|532296943|FG001|Overall Study|Low creatinine clearance|1|||
147585074|NCT00114231|532296942|FG000|Overall Study|Tumor size > 4cm|1|||
147322040|NCT03738241|531343554|FG005|Overall Study|Adverse Event|0|||
147585075|NCT00114231|532296943|FG001|Overall Study|Tumor size > 4cm|0|||
147158182|NCT03022097|530743416|FG001|Overall Study|Withdrawal by Subject|13|||
147158183|NCT03022097|530743417|FG002|Overall Study|Withdrawal by Subject|15|||
147158184|NCT03022097|530743418|FG003|Overall Study|Withdrawal by Subject|21|||
147158185|NCT03022097|530743415|FG000|Overall Study|Lost to Follow-up|0|||
147158186|NCT03022097|530743416|FG001|Overall Study|Lost to Follow-up|0|||
147158187|NCT03022097|530743417|FG002|Overall Study|Lost to Follow-up|1|||
147158188|NCT03022097|530743418|FG003|Overall Study|Lost to Follow-up|1|||
147158189|NCT03022097|530743415|FG000|Overall Study|Other|4|||
147158190|NCT03022097|530743416|FG001|Overall Study|Other|1|||
147158191|NCT03022097|530743417|FG002|Overall Study|Other|6|||
147585076|NCT00114231|532296942|FG000|Overall Study|Tumor fixed on digital exam|0|||
147158192|NCT03022097|530743418|FG003|Overall Study|Other|4|||
147158193|NCT03022097|530743415|FG000|Overall Study|Due to COVID-19 pandemic|0|||
147158194|NCT03022097|530743416|FG001|Overall Study|Due to COVID-19 pandemic|1|||
147585077|NCT00114231|532296943|FG001|Overall Study|Tumor fixed on digital exam|1|||
147158195|NCT03022097|530743417|FG002|Overall Study|Due to COVID-19 pandemic|0|||
147158196|NCT03022097|530743418|FG003|Overall Study|Due to COVID-19 pandemic|0|||
147158197|NCT01451931|530743419|FG000|Overall Study|Lost to Follow-up|17|||
147158198|NCT01451931|530743420|FG001|Overall Study|Lost to Follow-up|36|||
147158199|NCT01451931|530743421|FG002|Overall Study|Lost to Follow-up|21|||
147158200|NCT01451931|530743419|FG000|Overall Study|Withdrawal by Subject|16|||
147158201|NCT01451931|530743420|FG001|Overall Study|Withdrawal by Subject|22|||
147158202|NCT01451931|530743421|FG002|Overall Study|Withdrawal by Subject|22|||
147158203|NCT00855933|530743428|FG000|Overall Study|Withdrawal by Subject|0|||
147158204|NCT00855933|530743429|FG001|Overall Study|Withdrawal by Subject|1|||
147158205|NCT00951080|530743430|FG000|Overall Study|Adverse Event|3|||
147158206|NCT00951080|530743431|FG001|Overall Study|Adverse Event|3|||
147158207|NCT00951080|530743430|FG000|Overall Study|Lost to Follow-up|0|||
147158208|NCT00951080|530743431|FG001|Overall Study|Lost to Follow-up|1|||
147158209|NCT00951080|530743430|FG000|Overall Study|Physician Decision|4|||
147158210|NCT00951080|530743431|FG001|Overall Study|Physician Decision|1|||
147158211|NCT00951080|530743430|FG000|Overall Study|Other|19|||
147158212|NCT00951080|530743431|FG001|Overall Study|Other|22|||
147158213|NCT01960998|530743432|FG000|Overall Study|Lost to Follow-up|3|||
147158214|NCT01960998|530743433|FG001|Overall Study|Lost to Follow-up|7|||
147158215|NCT01960998|530743432|FG000|Overall Study|Death|0|||
147158216|NCT01960998|530743433|FG001|Overall Study|Death|1|||
147158217|NCT01960998|530743432|FG000|Overall Study|Withdrawal by Subject|8|||
147158218|NCT01960998|530743433|FG001|Overall Study|Withdrawal by Subject|2|||
147158219|NCT01960998|530743432|FG000|Overall Study|lost computer access|0|||
147158220|NCT01960998|530743433|FG001|Overall Study|lost computer access|1|||
147158221|NCT00835640|530743434|FG000|Second Intervention|Protocol Violation|1|||
147158222|NCT00835640|530743435|FG001|Second Intervention|Protocol Violation|0|||
147158223|NCT00812006|530743436|FG000|Overall Study|Lost to Follow-up|0|||
147158224|NCT00812006|530743437|FG001|Overall Study|Lost to Follow-up|0|||
147158225|NCT00812006|530743438|FG002|Overall Study|Lost to Follow-up|2|||
147158226|NCT00812006|530743436|FG000|Overall Study|Physician Decision|0|||
147158227|NCT00812006|530743437|FG001|Overall Study|Physician Decision|0|||
147158228|NCT00812006|530743438|FG002|Overall Study|Physician Decision|1|||
147158229|NCT00812006|530743436|FG000|Overall Study|Withdrawal by Subject|2|||
147158230|NCT00812006|530743437|FG001|Overall Study|Withdrawal by Subject|1|||
147241248|NCT03311724|531055814|FG000|Overall Study|Protocol Violation|1|||
147241249|NCT03311724|531055815|FG001|Overall Study|Protocol Violation|0|||
147241250|NCT03311724|531055816|FG002|Overall Study|Protocol Violation|1|||
147241251|NCT03311724|531055817|FG003|Overall Study|Protocol Violation|0|||
147446838|NCT02055820|531800320|FG002|Phase I: Dose-Finding|Withdrawal by Subject|0|||
147446839|NCT02055820|531800321|FG003|Phase I: Dose-Finding|Withdrawal by Subject|0|||
147446840|NCT02055820|531800322|FG004|Phase I: Dose-Finding|Withdrawal by Subject|0|||
147446841|NCT02055820|531800323|FG005|Phase I: Dose-Finding|Withdrawal by Subject|1|||
147446842|NCT02055820|531800324|FG006|Phase I: Dose-Finding|Withdrawal by Subject|0|||
147446843|NCT02055820|531800325|FG007|Phase I: Dose-Finding|Withdrawal by Subject|0|||
147446844|NCT02055820|531800326|FG008|Phase I: Dose-Finding|Withdrawal by Subject|0|||
147446845|NCT02055820|531800327|FG009|Phase I: Dose-Finding|Withdrawal by Subject|0|||
147446846|NCT02055820|531800318|FG000|Phase I: Dose-Finding|Lost to Follow-up|0|||
147446847|NCT02055820|531800319|FG001|Phase I: Dose-Finding|Lost to Follow-up|0|||
147446848|NCT02055820|531800320|FG002|Phase I: Dose-Finding|Lost to Follow-up|0|||
147446849|NCT02055820|531800321|FG003|Phase I: Dose-Finding|Lost to Follow-up|1|||
147446850|NCT02055820|531800322|FG004|Phase I: Dose-Finding|Lost to Follow-up|0|||
147446851|NCT02055820|531800323|FG005|Phase I: Dose-Finding|Lost to Follow-up|0|||
147446852|NCT02055820|531800324|FG006|Phase I: Dose-Finding|Lost to Follow-up|1|||
147446853|NCT02055820|531800325|FG007|Phase I: Dose-Finding|Lost to Follow-up|0|||
147446854|NCT02055820|531800326|FG008|Phase I: Dose-Finding|Lost to Follow-up|0|||
147446855|NCT02055820|531800327|FG009|Phase I: Dose-Finding|Lost to Follow-up|0|||
147446856|NCT02055820|531800318|FG000|Phase II: Expansion|Death|0|||
147446857|NCT02055820|531800319|FG001|Phase II: Expansion|Death|0|||
147446858|NCT02055820|531800320|FG002|Phase II: Expansion|Death|0|||
147446859|NCT02055820|531800321|FG003|Phase II: Expansion|Death|0|||
147446860|NCT02055820|531800322|FG004|Phase II: Expansion|Death|33|||
147446861|NCT02055820|531800323|FG005|Phase II: Expansion|Death|0|||
147158231|NCT00812006|530743438|FG002|Overall Study|Withdrawal by Subject|1|||
147158232|NCT00812006|530743436|FG000|Overall Study|Lack of Qualifying Event|4|||
147241252|NCT03311724|531055814|FG000|Overall Study|Withdrawal by Subject|1|||
147446862|NCT02055820|531800324|FG006|Phase II: Expansion|Death|0|||
147446863|NCT02055820|531800325|FG007|Phase II: Expansion|Death|0|||
147446864|NCT02055820|531800326|FG008|Phase II: Expansion|Death|0|||
147446865|NCT02055820|531800327|FG009|Phase II: Expansion|Death|0|||
147446866|NCT02055820|531800318|FG000|Phase II: Expansion|Lost to Follow-up|0|||
147158233|NCT00812006|530743437|FG001|Overall Study|Lack of Qualifying Event|2|||
147158234|NCT00812006|530743438|FG002|Overall Study|Lack of Qualifying Event|2|||
147158235|NCT00235391|530743439|FG000|Overall Study|Adverse Event|4|||
147158236|NCT00235391|530743440|FG001|Overall Study|Adverse Event|5|||
147158237|NCT00235391|530743441|FG002|Overall Study|Adverse Event|10|||
147241253|NCT03311724|531055815|FG001|Overall Study|Withdrawal by Subject|1|||
147446867|NCT02055820|531800319|FG001|Phase II: Expansion|Lost to Follow-up|0|||
147446868|NCT02055820|531800320|FG002|Phase II: Expansion|Lost to Follow-up|0|||
147446869|NCT02055820|531800321|FG003|Phase II: Expansion|Lost to Follow-up|0|||
147446870|NCT02055820|531800322|FG004|Phase II: Expansion|Lost to Follow-up|4|||
147446871|NCT02055820|531800323|FG005|Phase II: Expansion|Lost to Follow-up|0|||
147446872|NCT02055820|531800324|FG006|Phase II: Expansion|Lost to Follow-up|0|||
147446873|NCT02055820|531800325|FG007|Phase II: Expansion|Lost to Follow-up|0|||
147446874|NCT02055820|531800326|FG008|Phase II: Expansion|Lost to Follow-up|0|||
147446875|NCT02055820|531800327|FG009|Phase II: Expansion|Lost to Follow-up|0|||
147446876|NCT02055820|531800318|FG000|Phase II: Expansion|Withdrawal by Subject|0|||
147446877|NCT02055820|531800319|FG001|Phase II: Expansion|Withdrawal by Subject|0|||
147446878|NCT02055820|531800320|FG002|Phase II: Expansion|Withdrawal by Subject|0|||
147446879|NCT02055820|531800321|FG003|Phase II: Expansion|Withdrawal by Subject|0|||
147446880|NCT02055820|531800322|FG004|Phase II: Expansion|Withdrawal by Subject|12|||
147446881|NCT02055820|531800323|FG005|Phase II: Expansion|Withdrawal by Subject|0|||
147446882|NCT02055820|531800324|FG006|Phase II: Expansion|Withdrawal by Subject|0|||
147446883|NCT02055820|531800325|FG007|Phase II: Expansion|Withdrawal by Subject|0|||
147446884|NCT02055820|531800326|FG008|Phase II: Expansion|Withdrawal by Subject|0|||
147446885|NCT02055820|531800327|FG009|Phase II: Expansion|Withdrawal by Subject|0|||
147446886|NCT00930761|531800330|FG000|Overall Study|3 newborns died; 1 mother quit the study|4|||
147446887|NCT00930761|531800331|FG001|Overall Study|3 newborns died; 1 mother quit the study|0|||
147446888|NCT00930761|531800330|FG000|Overall Study|less than 3 music therapy sessions|0|||
147446889|NCT00930761|531800331|FG001|Overall Study|less than 3 music therapy sessions|3|||
147446890|NCT00631020|531800332|FG000|Overall Study|Lost to Follow-up|7|||
147446891|NCT00631020|531800332|FG000|Overall Study|Incarcerated|1|||
147446892|NCT03571646|531800334|FG000|Overall Study|Adverse Event|1|||
147446893|NCT03571646|531800335|FG001|Overall Study|Adverse Event|0|||
147446894|NCT03571646|531800334|FG000|Overall Study|Withdrawal by Subject|1|||
147446895|NCT03571646|531800335|FG001|Overall Study|Withdrawal by Subject|1|||
147446896|NCT03548935|531800336|FG000|Overall Study|Withdrawal by Subject|26|||
147446897|NCT03548935|531800337|FG001|Overall Study|Withdrawal by Subject|17|||
147446898|NCT03548935|531800336|FG000|Overall Study|Lost to Follow-up|39|||
147446899|NCT03548935|531800337|FG001|Overall Study|Lost to Follow-up|28|||
147446900|NCT03548935|531800336|FG000|Overall Study|Death|1|||
147446901|NCT03548935|531800337|FG001|Overall Study|Death|1|||
147446902|NCT01970995|531800338|FG000|Confinement Period (Population at Day 5)|Withdrawal by Subject|1|||
147446903|NCT01970995|531800339|FG001|Confinement Period (Population at Day 5)|Withdrawal by Subject|1|||
147446904|NCT01970995|531800340|FG002|Confinement Period (Population at Day 5)|Withdrawal by Subject|1|||
147446905|NCT01970995|531800338|FG000|End of Study (Population at Day 90)|Withdrawal by Subject|1|||
147446906|NCT01970995|531800339|FG001|End of Study (Population at Day 90)|Withdrawal by Subject|0|||
147446907|NCT01970995|531800340|FG002|End of Study (Population at Day 90)|Withdrawal by Subject|1|||
147446908|NCT00845728|531800343|FG000|Overall Study|Abnormal laboratory value (s)|2|||
147446909|NCT00845728|531800344|FG001|Overall Study|Abnormal laboratory value (s)|2|||
147446910|NCT00845728|531800343|FG000|Overall Study|Patient's inability to use the device|4|||
147446911|NCT00845728|531800344|FG001|Overall Study|Patient's inability to use the device|6|||
147446912|NCT00845728|531800343|FG000|Overall Study|Abnormal test procedure result (s)|7|||
147446913|NCT00845728|531800344|FG001|Overall Study|Abnormal test procedure result (s)|2|||
147446914|NCT00845728|531800343|FG000|Overall Study|Lost to Follow-up|22|||
147446915|NCT00845728|531800344|FG001|Overall Study|Lost to Follow-up|13|||
147446916|NCT00845728|531800343|FG000|Overall Study|Death|24|||
147446917|NCT00845728|531800344|FG001|Overall Study|Death|26|||
147446918|NCT00845728|531800343|FG000|Overall Study|Administrative Problems|34|||
147446919|NCT00845728|531800344|FG001|Overall Study|Administrative Problems|26|||
147446920|NCT00845728|531800343|FG000|Overall Study|Protocol Violation|36|||
147446921|NCT00845728|531800344|FG001|Overall Study|Protocol Violation|24|||
147446922|NCT00845728|531800343|FG000|Overall Study|Lack of Efficacy|51|||
147241254|NCT03311724|531055816|FG002|Overall Study|Withdrawal by Subject|0|||
147241255|NCT03311724|531055817|FG003|Overall Study|Withdrawal by Subject|0|||
147241256|NCT03311724|531055814|FG000|Overall Study|Lost to Follow-up|1|||
147241257|NCT03311724|531055815|FG001|Overall Study|Lost to Follow-up|0|||
147241258|NCT03311724|531055816|FG002|Overall Study|Lost to Follow-up|0|||
147241259|NCT03311724|531055817|FG003|Overall Study|Lost to Follow-up|0|||
147241260|NCT03311724|531055814|FG000|Overall Study|Sponsor Decision|0|||
147446923|NCT00845728|531800344|FG001|Overall Study|Lack of Efficacy|39|||
147446924|NCT00845728|531800343|FG000|Overall Study|Adverse Event|101|||
147446925|NCT00845728|531800344|FG001|Overall Study|Adverse Event|96|||
147446926|NCT00845728|531800343|FG000|Overall Study|Withdrawal by Subject|105|||
147446927|NCT00845728|531800344|FG001|Overall Study|Withdrawal by Subject|108|||
147446928|NCT01157364|531800345|FG000|Overall Study|Other Reasons|1|||
147446929|NCT01157364|531800346|FG001|Overall Study|Other Reasons|1|||
147241261|NCT03311724|531055815|FG001|Overall Study|Sponsor Decision|0|||
147241262|NCT03311724|531055816|FG002|Overall Study|Sponsor Decision|1|||
147446930|NCT01157364|531800347|FG002|Overall Study|Other Reasons|2|||
147446931|NCT01157364|531800348|FG003|Overall Study|Other Reasons|1|||
147446932|NCT01157364|531800349|FG004|Overall Study|Other Reasons|0|||
147446933|NCT01157364|531800350|FG005|Overall Study|Other Reasons|0|||
147446934|NCT01157364|531800345|FG000|Overall Study|Personal Reasons|0|||
147446935|NCT01157364|531800346|FG001|Overall Study|Personal Reasons|2|||
147446936|NCT01157364|531800347|FG002|Overall Study|Personal Reasons|0|||
147446937|NCT01157364|531800348|FG003|Overall Study|Personal Reasons|0|||
147446938|NCT01157364|531800349|FG004|Overall Study|Personal Reasons|1|||
147446939|NCT01157364|531800350|FG005|Overall Study|Personal Reasons|1|||
147446940|NCT01157364|531800345|FG000|Overall Study|Lost to Follow-up|1|||
147446941|NCT01157364|531800346|FG001|Overall Study|Lost to Follow-up|0|||
147446942|NCT01157364|531800347|FG002|Overall Study|Lost to Follow-up|1|||
147446943|NCT01157364|531800348|FG003|Overall Study|Lost to Follow-up|0|||
147446944|NCT01157364|531800349|FG004|Overall Study|Lost to Follow-up|0|||
147446945|NCT01157364|531800350|FG005|Overall Study|Lost to Follow-up|0|||
147446946|NCT01157364|531800345|FG000|Overall Study|Lack of Efficacy|0|||
147446947|NCT01157364|531800346|FG001|Overall Study|Lack of Efficacy|0|||
147446948|NCT01157364|531800347|FG002|Overall Study|Lack of Efficacy|0|||
147446949|NCT01157364|531800348|FG003|Overall Study|Lack of Efficacy|1|||
147446950|NCT01157364|531800349|FG004|Overall Study|Lack of Efficacy|0|||
147446951|NCT01157364|531800350|FG005|Overall Study|Lack of Efficacy|0|||
147446952|NCT01157364|531800345|FG000|Overall Study|Adverse Event|0|||
147446953|NCT01157364|531800346|FG001|Overall Study|Adverse Event|1|||
147446954|NCT01157364|531800347|FG002|Overall Study|Adverse Event|1|||
147446955|NCT01157364|531800348|FG003|Overall Study|Adverse Event|0|||
147446956|NCT01157364|531800349|FG004|Overall Study|Adverse Event|1|||
147446957|NCT01157364|531800350|FG005|Overall Study|Adverse Event|0|||
147446958|NCT01780662|531800351|FG000|Overall Study|Adverse Event|1|||
147446959|NCT01780662|531800352|FG001|Overall Study|Adverse Event|0|||
147446960|NCT01780662|531800353|FG002|Overall Study|Adverse Event|2|||
147446961|NCT01780662|531800351|FG000|Overall Study|Physician Decision|0|||
147446962|NCT01780662|531800352|FG001|Overall Study|Physician Decision|5|||
147446963|NCT01780662|531800353|FG002|Overall Study|Physician Decision|7|||
147446964|NCT01780662|531800351|FG000|Overall Study|Protocol Violation|0|||
147446965|NCT01780662|531800352|FG001|Overall Study|Protocol Violation|1|||
147446966|NCT01780662|531800353|FG002|Overall Study|Protocol Violation|0|||
147446967|NCT01780662|531800351|FG000|Overall Study|Ineligible|0|||
147446968|NCT01780662|531800352|FG001|Overall Study|Ineligible|0|||
147446969|NCT01780662|531800353|FG002|Overall Study|Ineligible|1|||
147446970|NCT01263639|531800354|FG000|Overall Study|Lost to Follow-up|66|||
147446971|NCT01263639|531800355|FG001|Overall Study|Lost to Follow-up|70|||
147446972|NCT01263639|531800354|FG000|Overall Study|Exclusion =Admission greater than 7 days|7|||
147446973|NCT01263639|531800355|FG001|Overall Study|Exclusion =Admission greater than 7 days|9|||
147446974|NCT01576549|531800356|FG000|Overall Study|Sponsor Decision|2|||
147446975|NCT04081363|531800359|FG000|Overall Study|Withdrawal by Subject|1|||
147446976|NCT04081363|531800360|FG001|Overall Study|Withdrawal by Subject|0|||
147446977|NCT00586495|531800361|FG000|Treatment Period|Adverse Event|11|||
147446978|NCT00586495|531800361|FG000|Treatment Period|Death|1|||
147446979|NCT00586495|531800361|FG000|Treatment Period|Protocol Violation|1|||
147446980|NCT00586495|531800361|FG000|Treatment Period|Withdrawal by Subject|1|||
147446981|NCT00586495|531800361|FG000|Treatment Period|Disease progression, recurrence/relapse|71|||
147446982|NCT00586495|531800361|FG000|Treatment Period|Switch to commercial drug|10|||
147446983|NCT00586495|531800361|FG000|Follow-up|Death|40|||
147446984|NCT00586495|531800361|FG000|Follow-up|Lost to Follow-up|1|||
147446985|NCT00586495|531800361|FG000|Follow-up|Withdrawal by Subject|4|||
147446986|NCT00586495|531800361|FG000|Follow-up|Protocol driven decision point|37|||
147446987|NCT00586495|531800361|FG000|Follow-up|Switch to commercial drug|10|||
147446988|NCT03099187|531800364|FG000|Double-blind Treatment|Adverse Event|19|||
147446989|NCT03099187|531800365|FG001|Double-blind Treatment|Adverse Event|1|||
147446990|NCT03099187|531800366|FG002|Double-blind Treatment|Adverse Event|0|||
147241263|NCT03311724|531055817|FG003|Overall Study|Sponsor Decision|0|||
147241264|NCT02980601|531055818|FG000|Overall Study|Lost to Follow-up|2|||
147241265|NCT02980601|531055819|FG001|Overall Study|Lost to Follow-up|2|||
147241266|NCT02980601|531055818|FG000|Overall Study|Death|0|||
147241267|NCT02980601|531055819|FG001|Overall Study|Death|1|||
147446991|NCT03099187|531800367|FG003|Double-blind Treatment|Adverse Event|0|||
147241268|NCT02980601|531055818|FG000|Overall Study|Graft loss|1|||
147241269|NCT02980601|531055819|FG001|Overall Study|Graft loss|0|||
147241270|NCT02980601|531055818|FG000|Overall Study|Failed to sign consent|2|||
147446992|NCT03099187|531800364|FG000|Double-blind Treatment|Death|1|||
147446993|NCT03099187|531800365|FG001|Double-blind Treatment|Death|3|||
147241271|NCT02980601|531055819|FG001|Overall Study|Failed to sign consent|0|||
147446994|NCT03099187|531800366|FG002|Double-blind Treatment|Death|0|||
147446995|NCT03099187|531800367|FG003|Double-blind Treatment|Death|0|||
147446996|NCT03099187|531800364|FG000|Double-blind Treatment|Lack of Efficacy|1|||
147241272|NCT01575769|531055820|FG000|Overall Study|Adverse Event|1|||
147241273|NCT01575769|531055820|FG000|Overall Study|Study terminated by sponsor|40|||
147446997|NCT03099187|531800365|FG001|Double-blind Treatment|Lack of Efficacy|0|||
147446998|NCT03099187|531800366|FG002|Double-blind Treatment|Lack of Efficacy|0|||
147446999|NCT03099187|531800367|FG003|Double-blind Treatment|Lack of Efficacy|0|||
147447000|NCT03099187|531800364|FG000|Double-blind Treatment|Physician Decision|2|||
147447001|NCT03099187|531800365|FG001|Double-blind Treatment|Physician Decision|1|||
147447002|NCT03099187|531800366|FG002|Double-blind Treatment|Physician Decision|0|||
147158238|NCT00235391|530743442|FG003|Overall Study|Adverse Event|72|||
147158239|NCT00235391|530743443|FG004|Overall Study|Adverse Event|5|||
147158240|NCT00235391|530743444|FG005|Overall Study|Adverse Event|2|||
147158241|NCT00235391|530743439|FG000|Overall Study|Abnormal laboratory value(s)|3|||
147158242|NCT00235391|530743440|FG001|Overall Study|Abnormal laboratory value(s)|5|||
147158243|NCT00235391|530743441|FG002|Overall Study|Abnormal laboratory value(s)|4|||
147158244|NCT00235391|530743442|FG003|Overall Study|Abnormal laboratory value(s)|27|||
147158245|NCT00235391|530743443|FG004|Overall Study|Abnormal laboratory value(s)|1|||
147158246|NCT00235391|530743444|FG005|Overall Study|Abnormal laboratory value(s)|2|||
147158247|NCT00235391|530743439|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
147158248|NCT00235391|530743440|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
147158249|NCT00235391|530743441|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
147158250|NCT00235391|530743442|FG003|Overall Study|Unsatisfactory therapeutic effect|17|||
147158251|NCT00235391|530743443|FG004|Overall Study|Unsatisfactory therapeutic effect|0|||
147158252|NCT00235391|530743444|FG005|Overall Study|Unsatisfactory therapeutic effect|0|||
147158253|NCT00235391|530743439|FG000|Overall Study|Condition no longer requires treatment|3|||
147158254|NCT00235391|530743440|FG001|Overall Study|Condition no longer requires treatment|0|||
147158255|NCT00235391|530743441|FG002|Overall Study|Condition no longer requires treatment|0|||
147158256|NCT00235391|530743442|FG003|Overall Study|Condition no longer requires treatment|11|||
147158257|NCT00235391|530743443|FG004|Overall Study|Condition no longer requires treatment|1|||
147158258|NCT00235391|530743444|FG005|Overall Study|Condition no longer requires treatment|0|||
147158259|NCT00235391|530743439|FG000|Overall Study|Protocol deviation|0|||
147158260|NCT00235391|530743440|FG001|Overall Study|Protocol deviation|0|||
147158261|NCT00235391|530743441|FG002|Overall Study|Protocol deviation|1|||
147158262|NCT00235391|530743442|FG003|Overall Study|Protocol deviation|11|||
147158263|NCT00235391|530743443|FG004|Overall Study|Protocol deviation|0|||
147158264|NCT00235391|530743444|FG005|Overall Study|Protocol deviation|0|||
147158265|NCT00235391|530743439|FG000|Overall Study|Withdrawal by Subject|2|||
147158266|NCT00235391|530743440|FG001|Overall Study|Withdrawal by Subject|3|||
147158267|NCT00235391|530743441|FG002|Overall Study|Withdrawal by Subject|3|||
147158268|NCT00235391|530743442|FG003|Overall Study|Withdrawal by Subject|61|||
147158269|NCT00235391|530743443|FG004|Overall Study|Withdrawal by Subject|5|||
147158270|NCT00235391|530743444|FG005|Overall Study|Withdrawal by Subject|0|||
147158271|NCT00235391|530743439|FG000|Overall Study|Lost to Follow-up|0|||
147158272|NCT00235391|530743440|FG001|Overall Study|Lost to Follow-up|3|||
147158273|NCT00235391|530743441|FG002|Overall Study|Lost to Follow-up|3|||
147158274|NCT00235391|530743442|FG003|Overall Study|Lost to Follow-up|16|||
147158275|NCT00235391|530743443|FG004|Overall Study|Lost to Follow-up|0|||
147158276|NCT00235391|530743444|FG005|Overall Study|Lost to Follow-up|0|||
147158277|NCT00235391|530743439|FG000|Overall Study|Administrative problems|0|||
147158278|NCT00235391|530743440|FG001|Overall Study|Administrative problems|0|||
147158279|NCT00235391|530743441|FG002|Overall Study|Administrative problems|0|||
147158280|NCT00235391|530743442|FG003|Overall Study|Administrative problems|1|||
147322041|NCT03738241|531343555|FG006|Overall Study|Adverse Event|0|||
147322042|NCT03738241|531343556|FG007|Overall Study|Adverse Event|0|||
147322043|NCT03738241|531343557|FG008|Overall Study|Adverse Event|0|||
147322044|NCT03738241|531343558|FG009|Overall Study|Adverse Event|0|||
147322045|NCT01244763|531343559|FG000|Overall Study|Adverse Event|1|||
147322046|NCT01244763|531343560|FG001|Overall Study|Adverse Event|0|||
147322047|NCT01244763|531343561|FG002|Overall Study|Adverse Event|0|||
147322048|NCT01244763|531343562|FG003|Overall Study|Adverse Event|0|||
147322049|NCT01244763|531343563|FG004|Overall Study|Adverse Event|0|||
147322050|NCT01244763|531343564|FG005|Overall Study|Adverse Event|1|||
147322051|NCT01244763|531343559|FG000|Overall Study|Death|1|||
147322052|NCT01244763|531343560|FG001|Overall Study|Death|0|||
147322053|NCT01244763|531343561|FG002|Overall Study|Death|1|||
147322054|NCT01244763|531343562|FG003|Overall Study|Death|0|||
147322055|NCT01244763|531343563|FG004|Overall Study|Death|2|||
147322056|NCT01244763|531343564|FG005|Overall Study|Death|0|||
147322057|NCT01244763|531343559|FG000|Overall Study|Physician Decision|0|||
147322058|NCT01244763|531343560|FG001|Overall Study|Physician Decision|0|||
147322059|NCT01244763|531343561|FG002|Overall Study|Physician Decision|1|||
147322060|NCT01244763|531343562|FG003|Overall Study|Physician Decision|0|||
147158281|NCT00235391|530743443|FG004|Overall Study|Administrative problems|0|||
147158282|NCT00235391|530743444|FG005|Overall Study|Administrative problems|0|||
147322061|NCT01244763|531343563|FG004|Overall Study|Physician Decision|0|||
147322062|NCT01244763|531343564|FG005|Overall Study|Physician Decision|0|||
147322063|NCT01244763|531343559|FG000|Overall Study|Withdrawal by Subject|1|||
147585078|NCT00114231|532296942|FG000|Overall Study|No Absolute Neutrophil Count|2|||
147158283|NCT00235391|530743439|FG000|Overall Study|Death|0|||
147158284|NCT00235391|530743440|FG001|Overall Study|Death|0|||
147158285|NCT00235391|530743441|FG002|Overall Study|Death|1|||
147158286|NCT00235391|530743442|FG003|Overall Study|Death|4|||
147158287|NCT00235391|530743443|FG004|Overall Study|Death|0|||
147322064|NCT01244763|531343560|FG001|Overall Study|Withdrawal by Subject|2|||
147322065|NCT01244763|531343561|FG002|Overall Study|Withdrawal by Subject|0|||
147322066|NCT01244763|531343562|FG003|Overall Study|Withdrawal by Subject|1|||
147585079|NCT00114231|532296943|FG001|Overall Study|No Absolute Neutrophil Count|0|||
147585080|NCT00114231|532296942|FG000|Overall Study|Biopsy done after registration|1|||
147585081|NCT00114231|532296943|FG001|Overall Study|Biopsy done after registration|0|||
147585082|NCT01961882|532296948|FG000|Overall Study|Adverse Event|3|||
147585083|NCT01961882|532296949|FG001|Overall Study|Adverse Event|2|||
147158288|NCT00235391|530743444|FG005|Overall Study|Death|0|||
147158289|NCT02927925|530743449|FG000|Overall Study|Death|16|||
147158290|NCT02927925|530743449|FG000|Overall Study|Physician Decision|1|||
147158291|NCT02927925|530743449|FG000|Overall Study|Withdrawal by Subject|11|||
147158292|NCT02927925|530743449|FG000|Overall Study|Other|3|||
147158293|NCT02927925|530743449|FG000|Overall Study|Disease progression at clinical cutoff|1|||
147158294|NCT00580034|530743450|FG000|Overall Study|Toxicity|10|||
147158295|NCT00580034|530743451|FG001|Overall Study|Toxicity|0|||
147158296|NCT00916058|530743453|FG000|Phase 1|Screen Failure|0|||
147158297|NCT00916058|530743454|FG001|Phase 1|Screen Failure|0|||
147158298|NCT00916058|530743455|FG002|Phase 1|Screen Failure|0|||
147158299|NCT00916058|530743456|FG003|Phase 1|Screen Failure|0|||
147158300|NCT00916058|530743457|FG004|Phase 1|Screen Failure|0|||
147158301|NCT00916058|530743458|FG005|Phase 1|Screen Failure|1|||
147158302|NCT00916058|530743459|FG006|Phase 1|Screen Failure|0|||
147158303|NCT00916058|530743453|FG000|Phase 2|Screen Failure|0|||
147158304|NCT00916058|530743454|FG001|Phase 2|Screen Failure|0|||
147158305|NCT00916058|530743455|FG002|Phase 2|Screen Failure|0|||
147158306|NCT00916058|530743456|FG003|Phase 2|Screen Failure|0|||
147158307|NCT00916058|530743457|FG004|Phase 2|Screen Failure|0|||
147158308|NCT00916058|530743458|FG005|Phase 2|Screen Failure|0|||
147158309|NCT00916058|530743459|FG006|Phase 2|Screen Failure|3|||
147158310|NCT02439450|530743460|FG000|Overall Study|Adverse Event|4|||
147158311|NCT02439450|530743461|FG001|Overall Study|Adverse Event|1|||
147158312|NCT02439450|530743462|FG002|Overall Study|Adverse Event|0|||
147158313|NCT02439450|530743463|FG003|Overall Study|Adverse Event|0|||
147158314|NCT02439450|530743460|FG000|Overall Study|Withdrawal by Subject|1|||
147158315|NCT02439450|530743461|FG001|Overall Study|Withdrawal by Subject|2|||
147158316|NCT02439450|530743462|FG002|Overall Study|Withdrawal by Subject|0|||
147158317|NCT02439450|530743463|FG003|Overall Study|Withdrawal by Subject|0|||
147158318|NCT02439450|530743460|FG000|Overall Study|Death|3|||
147158319|NCT02439450|530743461|FG001|Overall Study|Death|0|||
147158320|NCT02439450|530743462|FG002|Overall Study|Death|0|||
147158321|NCT02439450|530743463|FG003|Overall Study|Death|1|||
147158322|NCT02439450|530743460|FG000|Overall Study|Progressive Disease|18|||
147585084|NCT01961882|532296948|FG000|Overall Study|Physician Decision|1|||
147158323|NCT02439450|530743461|FG001|Overall Study|Progressive Disease|41|||
147158324|NCT02439450|530743462|FG002|Overall Study|Progressive Disease|2|||
147158325|NCT02439450|530743463|FG003|Overall Study|Progressive Disease|3|||
147158326|NCT01170065|530743464|FG000|Overall Study|Adverse Event|17|||
147158327|NCT01170065|530743465|FG001|Overall Study|Adverse Event|50|||
147158328|NCT01170065|530743466|FG002|Overall Study|Adverse Event|10|||
147585085|NCT01961882|532296949|FG001|Overall Study|Physician Decision|0|||
147585086|NCT01961882|532296948|FG000|Overall Study|Withdrawal by Subject|4|||
147585087|NCT01961882|532296949|FG001|Overall Study|Withdrawal by Subject|1|||
147585088|NCT01961882|532296948|FG000|Overall Study|Relapse of AML|39|||
147585089|NCT01961882|532296949|FG001|Overall Study|Relapse of AML|37|||
147585090|NCT01961882|532296948|FG000|Overall Study|Use of prohibited concomitant drug or therapy|2|||
147585091|NCT01961882|532296949|FG001|Overall Study|Use of prohibited concomitant drug or therapy|2|||
147585092|NCT01961882|532296948|FG000|Overall Study|Subject found to be ineligible for the trial after registration|1|||
147585093|NCT01961882|532296949|FG001|Overall Study|Subject found to be ineligible for the trial after registration|0|||
147585094|NCT01901848|532296950|FG000|Randomized and Treated|Lost to Follow-up|3|||
147585095|NCT01901848|532296951|FG001|Randomized and Treated|Lost to Follow-up|6|||
147585096|NCT01901848|532296950|FG000|Removed From Analyses|CPT practice cases to establish fidelity|10|||
147585097|NCT01901848|532296951|FG001|Removed From Analyses|CPT practice cases to establish fidelity|0|||
147585098|NCT01729026|532296952|FG000|Randomization to 3-month Follow-up|Lost to Follow-up|2|||
147585099|NCT01729026|532296953|FG001|Randomization to 3-month Follow-up|Lost to Follow-up|2|||
147585100|NCT01729026|532296952|FG000|3-month to 6-month (Final) Follow-up|Lost to Follow-up|1|||
147585101|NCT01729026|532296953|FG001|3-month to 6-month (Final) Follow-up|Lost to Follow-up|2|||
147585102|NCT02488824|532296954|FG000|Overall Study|Adverse Event|1|||
147241274|NCT03000439|531055823|FG000|Open Label Part 1|Adverse Event|6|||
147447003|NCT03099187|531800367|FG003|Double-blind Treatment|Physician Decision|0|||
147447004|NCT03099187|531800364|FG000|Double-blind Treatment|Withdrawal by Subject|9|||
147585103|NCT02488824|532296955|FG001|Overall Study|Adverse Event|1|||
147585104|NCT02668822|532296960|FG000|Overall Study|Protocol Violation|2|||
147585105|NCT02668822|532296961|FG001|Overall Study|Protocol Violation|0|||
147585106|NCT02668822|532296960|FG000|Overall Study|Study Terminated by Sponsor|7|||
147585107|NCT02668822|532296961|FG001|Overall Study|Study Terminated by Sponsor|9|||
147241275|NCT03000439|531055824|FG001|Open Label Part 1|Adverse Event|0|||
147158329|NCT01170065|530743464|FG000|Overall Study|Lost to Follow-up|1|||
147158330|NCT01170065|530743465|FG001|Overall Study|Lost to Follow-up|4|||
147158331|NCT01170065|530743466|FG002|Overall Study|Lost to Follow-up|1|||
147241276|NCT03000439|531055825|FG002|Open Label Part 1|Adverse Event|0|||
147585108|NCT03036839|532296962|FG000|Overall Study|Adverse Event|0|||
147585109|NCT03036839|532296963|FG001|Overall Study|Adverse Event|0|||
147585110|NCT03036839|532296964|FG002|Overall Study|Adverse Event|1|||
147585111|NCT03036839|532296962|FG000|Overall Study|Death|3|||
147585112|NCT03036839|532296963|FG001|Overall Study|Death|0|||
147585113|NCT03036839|532296964|FG002|Overall Study|Death|3|||
147585114|NCT03036839|532296962|FG000|Overall Study|Withdrew Consent|0|||
147585115|NCT03036839|532296963|FG001|Overall Study|Withdrew Consent|0|||
147585116|NCT03036839|532296964|FG002|Overall Study|Withdrew Consent|1|||
147585117|NCT00412737|532296965|FG000|Overall Study|Death|1|||
147585118|NCT00412737|532296966|FG001|Overall Study|Death|0|||
147585119|NCT00412737|532296965|FG000|Overall Study|Adverse Event|3|||
147585120|NCT00412737|532296966|FG001|Overall Study|Adverse Event|2|||
147585121|NCT00412737|532296965|FG000|Overall Study|Refused Treatment|6|||
147585122|NCT00412737|532296966|FG001|Overall Study|Refused Treatment|2|||
147585123|NCT00412737|532296965|FG000|Overall Study|Failure to Return|6|||
147585124|NCT00412737|532296966|FG001|Overall Study|Failure to Return|2|||
147585125|NCT01201759|532296973|FG000|Visit 1 Wash-in ( Untreated)|Lost to Follow-up|2|||
147585126|NCT01201759|532296974|FG001|Visit 1 Wash-in ( Untreated)|Lost to Follow-up|1|||
147585127|NCT01201759|532296973|FG000|Visit 3 - Washout|Adverse Event|0|||
147585128|NCT01201759|532296974|FG001|Visit 3 - Washout|Adverse Event|3|||
147585129|NCT01201759|532296973|FG000|Visit 3 - Washout|Lost to Follow-up|1|||
147585130|NCT01201759|532296974|FG001|Visit 3 - Washout|Lost to Follow-up|0|||
147585131|NCT01201759|532296973|FG000|Visit 4 Crossover|Lost to Follow-up|0|||
147585132|NCT01201759|532296974|FG001|Visit 4 Crossover|Lost to Follow-up|1|||
147585133|NCT02744755|532296975|FG000|Study Period 1|Protocol Violation|2|||
147585134|NCT02744755|532296976|FG001|Study Period 1|Protocol Violation|1|||
147585135|NCT02744755|532296975|FG000|Study Period 1|not defined|0|||
147585136|NCT02744755|532296976|FG001|Study Period 1|not defined|1|||
147585137|NCT02744755|532296975|FG000|Study Period 1|Pregnancy|1|||
147585138|NCT02744755|532296976|FG001|Study Period 1|Pregnancy|0|||
147585139|NCT02744755|532296975|FG000|Study Period 1|Adverse Event|1|||
147585140|NCT02744755|532296976|FG001|Study Period 1|Adverse Event|1|||
147158332|NCT01170065|530743464|FG000|Overall Study|Consent withdrawn, not due to AE|2|||
147158333|NCT01170065|530743465|FG001|Overall Study|Consent withdrawn, not due to AE|4|||
147158334|NCT01170065|530743466|FG002|Overall Study|Consent withdrawn, not due to AE|2|||
147158335|NCT01170065|530743464|FG000|Overall Study|Reason other than specified|3|||
147158336|NCT01170065|530743465|FG001|Overall Study|Reason other than specified|8|||
147158337|NCT01170065|530743466|FG002|Overall Study|Reason other than specified|3|||
147158338|NCT01170065|530743464|FG000|Overall Study|Ongoing after planned observation time|5|||
147158339|NCT01170065|530743465|FG001|Overall Study|Ongoing after planned observation time|26|||
147158340|NCT01170065|530743466|FG002|Overall Study|Ongoing after planned observation time|10|||
147158341|NCT00717522|530743469|FG000|Overall Study|Disease Progression|5|||
147158342|NCT00717522|530743469|FG000|Overall Study|Adverse Event|1|||
147158343|NCT00717522|530743469|FG000|Overall Study|Death|1|||
147158344|NCT03551665|530743472|FG000|Overall Study|Lost to Follow-up|11|||
147158345|NCT03551665|530743473|FG001|Overall Study|Lost to Follow-up|2|||
147158346|NCT00496483|530745385|FG000|Overall Study|Not dosed|9|||
147158347|NCT00496483|530745385|FG000|Overall Study|Adverse Event|2|||
147158348|NCT00496483|530745385|FG000|Overall Study|Lack of Efficacy|1|||
147158349|NCT00896363|530745386|FG000|Overall Study|Adverse Event|3|||
147158350|NCT00896363|530745387|FG001|Overall Study|Adverse Event|4|||
147158351|NCT00896363|530745388|FG002|Overall Study|Adverse Event|2|||
147158352|NCT00896363|530745386|FG000|Overall Study|Lack of Efficacy|0|||
147158353|NCT00896363|530745387|FG001|Overall Study|Lack of Efficacy|2|||
147158354|NCT00896363|530745388|FG002|Overall Study|Lack of Efficacy|1|||
147158355|NCT00896363|530745386|FG000|Overall Study|Withdrawal by Subject|3|||
147158356|NCT00896363|530745387|FG001|Overall Study|Withdrawal by Subject|5|||
147158357|NCT00896363|530745388|FG002|Overall Study|Withdrawal by Subject|5|||
147158358|NCT04143217|530745389|FG000|Overall Study|Withdrawal by Subject|42|||
147158359|NCT04143217|530745389|FG000|Overall Study|Adverse Event|29|||
147158360|NCT04143217|530745389|FG000|Overall Study|Lost to Follow-up|29|||
147158361|NCT04143217|530745389|FG000|Overall Study|Lack of Efficacy|15|||
147158362|NCT04143217|530745389|FG000|Overall Study|Physician Decision|1|||
147241277|NCT03000439|531055826|FG003|Open Label Part 1|Adverse Event|0|||
147585141|NCT02744755|532296975|FG000|Study Period 1|Lost to Follow-up|1|||
147241278|NCT03000439|531055823|FG000|Open Label Part 1|Other|2|||
147241279|NCT03000439|531055824|FG001|Open Label Part 1|Other|0|||
147241280|NCT03000439|531055825|FG002|Open Label Part 1|Other|0|||
147241281|NCT03000439|531055826|FG003|Open Label Part 1|Other|0|||
147585142|NCT02744755|532296976|FG001|Study Period 1|Lost to Follow-up|1|||
147158363|NCT04143217|530745389|FG000|Overall Study|Non-Compliance With Study Drug|6|||
147241282|NCT03000439|531055823|FG000|Open Label Part 1|Insufficient clinical response|16|||
147241283|NCT03000439|531055824|FG001|Open Label Part 1|Insufficient clinical response|0|||
147241284|NCT03000439|531055825|FG002|Open Label Part 1|Insufficient clinical response|0|||
147241285|NCT03000439|531055826|FG003|Open Label Part 1|Insufficient clinical response|0|||
147241286|NCT03000439|531055823|FG000|Open Label Part 2|Other|0|||
147241287|NCT03000439|531055824|FG001|Open Label Part 2|Other|5|||
147241288|NCT03000439|531055825|FG002|Open Label Part 2|Other|0|||
147585143|NCT02744755|532296975|FG000|Study Period 1|Lack of Efficacy|1|||
147585144|NCT02744755|532296976|FG001|Study Period 1|Lack of Efficacy|0|||
147585145|NCT02744755|532296975|FG000|Study Period 1|Withdrawal by Subject|8|||
147585146|NCT02744755|532296976|FG001|Study Period 1|Withdrawal by Subject|4|||
147585147|NCT02744755|532296975|FG000|Study Period 2|Adverse Event|5|||
147585148|NCT02744755|532296976|FG001|Study Period 2|Adverse Event|0|||
147585149|NCT02744755|532296975|FG000|Study Period 2|Protocol Violation|1|||
147585150|NCT02744755|532296976|FG001|Study Period 2|Protocol Violation|0|||
147585151|NCT02744755|532296975|FG000|Study Period 2|not defined|3|||
147585152|NCT02744755|532296976|FG001|Study Period 2|not defined|2|||
147585153|NCT02744755|532296975|FG000|Study Period 2|Lost to Follow-up|0|||
147585154|NCT02744755|532296976|FG001|Study Period 2|Lost to Follow-up|2|||
147585155|NCT02744755|532296975|FG000|Study Period 2|Withdrawal by Subject|2|||
147585156|NCT02744755|532296976|FG001|Study Period 2|Withdrawal by Subject|2|||
147585157|NCT02744755|532296975|FG000|Study Period 2|Lack of Efficacy|3|||
147585158|NCT02744755|532296976|FG001|Study Period 2|Lack of Efficacy|2|||
147585159|NCT04317599|532296977|FG000|Overall Study|ineligible due to inclusion/exclusion criteria|15|||
147585160|NCT04317599|532296977|FG000|Overall Study|treatment outside standard of care|4|||
147585161|NCT00809965|532296978|FG000|Overall Study|Death|194|||
147585162|NCT00809965|532296979|FG001|Overall Study|Death|147|||
147585163|NCT00809965|532296980|FG002|Overall Study|Death|196|||
147585164|NCT00809965|532296978|FG000|Overall Study|Lost to Follow-up|17|||
147585165|NCT00809965|532296979|FG001|Overall Study|Lost to Follow-up|10|||
147585166|NCT00809965|532296980|FG002|Overall Study|Lost to Follow-up|18|||
147585167|NCT00809965|532296978|FG000|Overall Study|Withdrawal by Subject|405|||
147585168|NCT00809965|532296979|FG001|Overall Study|Withdrawal by Subject|448|||
147585169|NCT00809965|532296980|FG002|Overall Study|Withdrawal by Subject|441|||
147585170|NCT00809965|532296978|FG000|Overall Study|Other Reason|167|||
147585171|NCT00809965|532296979|FG001|Overall Study|Other Reason|170|||
147585172|NCT00809965|532296980|FG002|Overall Study|Other Reason|189|||
147585173|NCT02780167|532296981|FG000|Overall Study|Adverse Event|9|||
147585174|NCT02780167|532296982|FG001|Overall Study|Adverse Event|8|||
147585175|NCT02780167|532296983|FG002|Overall Study|Adverse Event|8|||
147585176|NCT02780167|532296984|FG003|Overall Study|Adverse Event|12|||
147585177|NCT02780167|532296985|FG004|Overall Study|Adverse Event|8|||
147585178|NCT02780167|532296981|FG000|Overall Study|Lack of Efficacy|6|||
147585179|NCT02780167|532296982|FG001|Overall Study|Lack of Efficacy|5|||
147585180|NCT02780167|532296983|FG002|Overall Study|Lack of Efficacy|6|||
147585181|NCT02780167|532296984|FG003|Overall Study|Lack of Efficacy|1|||
147585182|NCT02780167|532296985|FG004|Overall Study|Lack of Efficacy|0|||
147585183|NCT02780167|532296981|FG000|Overall Study|Lost to Follow-up|2|||
147585184|NCT02780167|532296982|FG001|Overall Study|Lost to Follow-up|0|||
147585185|NCT02780167|532296983|FG002|Overall Study|Lost to Follow-up|1|||
147585186|NCT02780167|532296984|FG003|Overall Study|Lost to Follow-up|0|||
147585187|NCT02780167|532296985|FG004|Overall Study|Lost to Follow-up|0|||
147585188|NCT02780167|532296981|FG000|Overall Study|Does not meet entrance criteria|0|||
147585189|NCT02780167|532296982|FG001|Overall Study|Does not meet entrance criteria|0|||
147585190|NCT02780167|532296983|FG002|Overall Study|Does not meet entrance criteria|1|||
147585191|NCT02780167|532296984|FG003|Overall Study|Does not meet entrance criteria|0|||
147585192|NCT02780167|532296985|FG004|Overall Study|Does not meet entrance criteria|0|||
147585193|NCT02780167|532296981|FG000|Overall Study|No longer meets eligibility criteria|0|||
147585194|NCT02780167|532296982|FG001|Overall Study|No longer meets eligibility criteria|0|||
147585195|NCT02780167|532296983|FG002|Overall Study|No longer meets eligibility criteria|0|||
147585196|NCT02780167|532296984|FG003|Overall Study|No longer meets eligibility criteria|1|||
147585197|NCT02780167|532296985|FG004|Overall Study|No longer meets eligibility criteria|1|||
147585198|NCT02780167|532296981|FG000|Overall Study|Protocol Violation|5|||
147585199|NCT02780167|532296982|FG001|Overall Study|Protocol Violation|5|||
147585200|NCT02780167|532296983|FG002|Overall Study|Protocol Violation|1|||
147585201|NCT02780167|532296984|FG003|Overall Study|Protocol Violation|1|||
147585202|NCT02780167|532296985|FG004|Overall Study|Protocol Violation|2|||
147585203|NCT02780167|532296981|FG000|Overall Study|Withdrawal by Subject|6|||
147585204|NCT02780167|532296982|FG001|Overall Study|Withdrawal by Subject|4|||
147585205|NCT02780167|532296983|FG002|Overall Study|Withdrawal by Subject|4|||
147322067|NCT01244763|531343563|FG004|Overall Study|Withdrawal by Subject|1|||
147322068|NCT01244763|531343564|FG005|Overall Study|Withdrawal by Subject|2|||
147585206|NCT02780167|532296984|FG003|Overall Study|Withdrawal by Subject|3|||
147585207|NCT02780167|532296985|FG004|Overall Study|Withdrawal by Subject|4|||
147585208|NCT02780167|532296981|FG000|Overall Study|Other|0|||
147585209|NCT02780167|532296982|FG001|Overall Study|Other|0|||
147585210|NCT02780167|532296983|FG002|Overall Study|Other|3|||
147585211|NCT02780167|532296984|FG003|Overall Study|Other|1|||
147585212|NCT02780167|532296985|FG004|Overall Study|Other|2|||
147585213|NCT02916693|532296986|FG000|Overall Study|Lost to Follow-up|7|||
147585214|NCT04205162|532296989|FG000|Overall Study|Lost to Follow-up|1|||
147585215|NCT04205162|532296990|FG001|Overall Study|Lost to Follow-up|0|||
147585216|NCT04205162|532296989|FG000|Overall Study|Withdrawal by Subject|2|||
147585217|NCT04205162|532296990|FG001|Overall Study|Withdrawal by Subject|0|||
147585218|NCT04205162|532296989|FG000|Overall Study|University closure due to COVID-19|1|||
147585219|NCT04205162|532296990|FG001|Overall Study|University closure due to COVID-19|0|||
147585220|NCT01519947|532296992|FG000|Overall Study|Death|0|||
147585221|NCT01519947|532296993|FG001|Overall Study|Death|0|||
147585222|NCT01519947|532296994|FG002|Overall Study|Death|0|||
147585223|NCT01519947|532296995|FG003|Overall Study|Death|1|||
147585224|NCT01519947|532296992|FG000|Overall Study|Protocol Violation|0|||
147585225|NCT01519947|532296993|FG001|Overall Study|Protocol Violation|0|||
147585226|NCT01519947|532296994|FG002|Overall Study|Protocol Violation|2|||
147585227|NCT01519947|532296995|FG003|Overall Study|Protocol Violation|1|||
147585228|NCT01519947|532296992|FG000|Overall Study|Peritoneal Dialysis Needed|0|||
147585229|NCT01519947|532296993|FG001|Overall Study|Peritoneal Dialysis Needed|1|||
147585230|NCT01519947|532296994|FG002|Overall Study|Peritoneal Dialysis Needed|0|||
147585231|NCT01519947|532296995|FG003|Overall Study|Peritoneal Dialysis Needed|0|||
147585232|NCT01519947|532296992|FG000|Overall Study|Development of Anemia|0|||
147585233|NCT01519947|532296993|FG001|Overall Study|Development of Anemia|1|||
147585234|NCT01519947|532296994|FG002|Overall Study|Development of Anemia|0|||
147585235|NCT01519947|532296995|FG003|Overall Study|Development of Anemia|1|||
147585236|NCT01519947|532296992|FG000|Overall Study|Blood Transfusion|0|||
147585237|NCT01519947|532296993|FG001|Overall Study|Blood Transfusion|1|||
147585238|NCT01519947|532296994|FG002|Overall Study|Blood Transfusion|1|||
147585239|NCT01519947|532296995|FG003|Overall Study|Blood Transfusion|0|||
147585240|NCT01519947|532296992|FG000|Overall Study|Withdrawal by Subject|0|||
147585241|NCT01519947|532296993|FG001|Overall Study|Withdrawal by Subject|1|||
147585242|NCT01519947|532296994|FG002|Overall Study|Withdrawal by Subject|0|||
147585243|NCT01519947|532296995|FG003|Overall Study|Withdrawal by Subject|1|||
147585244|NCT01519947|532296992|FG000|Overall Study|Lost to Follow-up|0|||
147585245|NCT01519947|532296993|FG001|Overall Study|Lost to Follow-up|0|||
147585246|NCT01519947|532296994|FG002|Overall Study|Lost to Follow-up|3|||
147585247|NCT01519947|532296995|FG003|Overall Study|Lost to Follow-up|2|||
147585248|NCT01519947|532296992|FG000|Overall Study|Poor Response|1|||
147585249|NCT01519947|532296993|FG001|Overall Study|Poor Response|0|||
147585250|NCT01519947|532296994|FG002|Overall Study|Poor Response|0|||
147585251|NCT01519947|532296995|FG003|Overall Study|Poor Response|1|||
147585252|NCT01519947|532296992|FG000|Overall Study|Adverse Event|1|||
147585253|NCT01519947|532296993|FG001|Overall Study|Adverse Event|0|||
147585254|NCT01519947|532296994|FG002|Overall Study|Adverse Event|1|||
147585255|NCT01519947|532296995|FG003|Overall Study|Adverse Event|1|||
147585256|NCT00693225|532296996|FG000|Overall Study|Lost to Follow-up|1|||
147585257|NCT00693225|532296997|FG001|Overall Study|Lost to Follow-up|2|||
147585258|NCT00693225|532296996|FG000|Overall Study|Adverse Event|1|||
147585259|NCT00693225|532296997|FG001|Overall Study|Adverse Event|3|||
147585260|NCT00372996|532296999|FG000|Overall Study|Death|11|||
147585261|NCT00372996|532297000|FG001|Overall Study|Death|4|||
147585262|NCT00372996|532297001|FG002|Overall Study|Death|8|||
147585263|NCT00372996|532297002|FG003|Overall Study|Death|7|||
147585264|NCT00372996|532296999|FG000|Overall Study|Lost to Follow-up|0|||
147585265|NCT00372996|532297000|FG001|Overall Study|Lost to Follow-up|2|||
147585266|NCT00372996|532297001|FG002|Overall Study|Lost to Follow-up|0|||
147585267|NCT00372996|532297002|FG003|Overall Study|Lost to Follow-up|1|||
147585268|NCT00372996|532296999|FG000|Overall Study|Withdrawal by Subject|12|||
147585269|NCT00372996|532297000|FG001|Overall Study|Withdrawal by Subject|6|||
147585270|NCT00372996|532297001|FG002|Overall Study|Withdrawal by Subject|9|||
147585271|NCT00372996|532297002|FG003|Overall Study|Withdrawal by Subject|5|||
147585272|NCT00372996|532296999|FG000|Overall Study|Study Terminated by Sponsor|4|||
147585273|NCT00372996|532297000|FG001|Overall Study|Study Terminated by Sponsor|0|||
147585274|NCT00372996|532297001|FG002|Overall Study|Study Terminated by Sponsor|4|||
147585275|NCT00372996|532297002|FG003|Overall Study|Study Terminated by Sponsor|0|||
147585276|NCT00372996|532296999|FG000|Overall Study|Other|10|||
147585277|NCT00372996|532297000|FG001|Overall Study|Other|2|||
147585278|NCT00372996|532297001|FG002|Overall Study|Other|7|||
147585279|NCT00372996|532297002|FG003|Overall Study|Other|7|||
147585280|NCT01186016|532297003|FG000|Overall Study|Withdrawal by Subject|46|||
147585281|NCT01186016|532297004|FG001|Overall Study|Withdrawal by Subject|29|||
147585282|NCT02250651|532297009|FG000|Treatment Period 1 (Day 1 to Week 15)|Adverse Event|0|||
147585283|NCT02250651|532297010|FG001|Treatment Period 1 (Day 1 to Week 15)|Adverse Event|2|||
147585284|NCT02250651|532297011|FG002|Treatment Period 1 (Day 1 to Week 15)|Adverse Event|2|||
147585285|NCT02250651|532297009|FG000|Treatment Period 1 (Day 1 to Week 15)|Lost to Follow-up|1|||
147585286|NCT02250651|532297010|FG001|Treatment Period 1 (Day 1 to Week 15)|Lost to Follow-up|0|||
147585287|NCT02250651|532297011|FG002|Treatment Period 1 (Day 1 to Week 15)|Lost to Follow-up|0|||
147585288|NCT02250651|532297009|FG000|Treatment Period 1 (Day 1 to Week 15)|Personal Reasons|2|||
147585289|NCT02250651|532297010|FG001|Treatment Period 1 (Day 1 to Week 15)|Personal Reasons|3|||
147585290|NCT02250651|532297011|FG002|Treatment Period 1 (Day 1 to Week 15)|Personal Reasons|5|||
147585291|NCT02250651|532297009|FG000|Treatment Period 1 (Day 1 to Week 15)|Protocol Deviation|1|||
147585292|NCT02250651|532297010|FG001|Treatment Period 1 (Day 1 to Week 15)|Protocol Deviation|0|||
147585293|NCT02250651|532297011|FG002|Treatment Period 1 (Day 1 to Week 15)|Protocol Deviation|0|||
147585294|NCT02250651|532297009|FG000|Treatment Period 1 (Day 1 to Week 15)|Reason not Specified|0|||
147585295|NCT02250651|532297010|FG001|Treatment Period 1 (Day 1 to Week 15)|Reason not Specified|0|||
147585296|NCT02250651|532297011|FG002|Treatment Period 1 (Day 1 to Week 15)|Reason not Specified|1|||
147585297|NCT02250651|532297009|FG000|Treatment Period 1 (Day 1 to Week 15)|Randomized but not Treated|0|||
147585298|NCT02250651|532297010|FG001|Treatment Period 1 (Day 1 to Week 15)|Randomized but not Treated|1|||
147585299|NCT02250651|532297011|FG002|Treatment Period 1 (Day 1 to Week 15)|Randomized but not Treated|3|||
147585300|NCT02250651|532297009|FG000|Treatment Period 2 (Week 16 to Week 31)|Adverse Event|4|||
147585301|NCT02250651|532297010|FG001|Treatment Period 2 (Week 16 to Week 31)|Adverse Event|1|||
147585302|NCT02250651|532297011|FG002|Treatment Period 2 (Week 16 to Week 31)|Adverse Event|0|||
147585303|NCT02250651|532297009|FG000|Treatment Period 2 (Week 16 to Week 31)|Lost to Follow-up|0|||
147585304|NCT02250651|532297010|FG001|Treatment Period 2 (Week 16 to Week 31)|Lost to Follow-up|0|||
147585305|NCT02250651|532297011|FG002|Treatment Period 2 (Week 16 to Week 31)|Lost to Follow-up|3|||
147585306|NCT02250651|532297009|FG000|Treatment Period 2 (Week 16 to Week 31)|Personal Reasons|2|||
147585307|NCT02250651|532297010|FG001|Treatment Period 2 (Week 16 to Week 31)|Personal Reasons|3|||
147585308|NCT02250651|532297011|FG002|Treatment Period 2 (Week 16 to Week 31)|Personal Reasons|2|||
147585309|NCT02250651|532297009|FG000|Treatment Period 2 (Week 16 to Week 31)|Protocol Deviation|0|||
147585310|NCT02250651|532297010|FG001|Treatment Period 2 (Week 16 to Week 31)|Protocol Deviation|1|||
147585311|NCT02250651|532297011|FG002|Treatment Period 2 (Week 16 to Week 31)|Protocol Deviation|0|||
147585312|NCT02250651|532297009|FG000|Treatment Period 2 (Week 16 to Week 31)|Reason not Specified|0|||
147585313|NCT02250651|532297010|FG001|Treatment Period 2 (Week 16 to Week 31)|Reason not Specified|1|||
147585314|NCT02250651|532297011|FG002|Treatment Period 2 (Week 16 to Week 31)|Reason not Specified|0|||
147585315|NCT02250651|532297009|FG000|Treatment Period 3 (Week 32 to Week 52)|Adverse Event|4|||
147585316|NCT02250651|532297010|FG001|Treatment Period 3 (Week 32 to Week 52)|Adverse Event|1|||
147585317|NCT02250651|532297011|FG002|Treatment Period 3 (Week 32 to Week 52)|Adverse Event|1|||
147585318|NCT02250651|532297009|FG000|Treatment Period 3 (Week 32 to Week 52)|Lost to Follow-up|1|||
147585319|NCT02250651|532297010|FG001|Treatment Period 3 (Week 32 to Week 52)|Lost to Follow-up|2|||
147585320|NCT02250651|532297011|FG002|Treatment Period 3 (Week 32 to Week 52)|Lost to Follow-up|1|||
147585321|NCT02250651|532297009|FG000|Treatment Period 3 (Week 32 to Week 52)|Personal Reasons|2|||
147585322|NCT02250651|532297010|FG001|Treatment Period 3 (Week 32 to Week 52)|Personal Reasons|0|||
147585323|NCT02250651|532297011|FG002|Treatment Period 3 (Week 32 to Week 52)|Personal Reasons|2|||
147585324|NCT02250651|532297009|FG000|Treatment Period 3 (Week 32 to Week 52)|Reason not Specified|2|||
147585325|NCT02250651|532297010|FG001|Treatment Period 3 (Week 32 to Week 52)|Reason not Specified|1|||
147585326|NCT02250651|532297011|FG002|Treatment Period 3 (Week 32 to Week 52)|Reason not Specified|1|||
147585327|NCT02795676|532297015|FG000|Overall Study|Adverse Event|2|||
147585328|NCT02795676|532297016|FG001|Overall Study|Adverse Event|0|||
147585329|NCT02795676|532297015|FG000|Overall Study|Withdrawal by Subject|3|||
147585330|NCT02795676|532297016|FG001|Overall Study|Withdrawal by Subject|1|||
147585331|NCT00676494|532297017|FG000|Overall Study|Missed Visit|8|||
147585332|NCT00676494|532297017|FG000|Overall Study|Withdrawal by Subject|6|||
147585333|NCT00732160|532297018|FG000|Overall Study|Adverse Event|1|||
147585334|NCT00732160|532297019|FG001|Overall Study|Adverse Event|0|||
147585335|NCT00732160|532297020|FG002|Overall Study|Adverse Event|1|||
147585336|NCT00732160|532297021|FG003|Overall Study|Adverse Event|1|||
147585337|NCT00732160|532297018|FG000|Overall Study|scheduling|4|||
147585338|NCT00732160|532297019|FG001|Overall Study|scheduling|4|||
147585339|NCT00732160|532297020|FG002|Overall Study|scheduling|2|||
147585340|NCT00732160|532297021|FG003|Overall Study|scheduling|1|||
147585341|NCT01203917|532297022|FG000|Overall Study|Death|29|||
147585342|NCT01203917|532297022|FG000|Overall Study|Lost to Follow-up|2|||
147585343|NCT01203917|532297022|FG000|Overall Study|Withdrawal by Subject|3|||
147585344|NCT01203917|532297022|FG000|Overall Study|Due to objective disease progression|1|||
147585345|NCT01203917|532297022|FG000|Overall Study|Due to EGFR M+I patient|1|||
147585346|NCT01264835|532297023|FG000|Overall Study|Lost to Follow-up|1|||
147585347|NCT02427399|532297031|FG000|Overall Study|Protocol Violation|14|||
147585348|NCT02427399|532297032|FG001|Overall Study|Protocol Violation|16|||
147585349|NCT02427399|532297033|FG002|Overall Study|Protocol Violation|12|||
147241289|NCT03000439|531055826|FG003|Open Label Part 2|Other|0|||
147241290|NCT03000439|531055823|FG000|Open Label Part 2|Insufficient clinical response|0|||
147241291|NCT03000439|531055824|FG001|Open Label Part 2|Insufficient clinical response|12|||
147241292|NCT03000439|531055825|FG002|Open Label Part 2|Insufficient clinical response|0|||
147241293|NCT03000439|531055826|FG003|Open Label Part 2|Insufficient clinical response|0|||
147241294|NCT03000439|531055823|FG000|Double Blind Phase|Adverse Event|0|||
147241295|NCT03000439|531055824|FG001|Double Blind Phase|Adverse Event|0|||
147241296|NCT03000439|531055825|FG002|Double Blind Phase|Adverse Event|2|||
147241297|NCT03000439|531055826|FG003|Double Blind Phase|Adverse Event|1|||
147241298|NCT03000439|531055823|FG000|Double Blind Phase|Withdrawal by parent/guardian|0|||
147241299|NCT03000439|531055824|FG001|Double Blind Phase|Withdrawal by parent/guardian|0|||
147585350|NCT02427399|532297034|FG003|Overall Study|Protocol Violation|18|||
147585351|NCT02427399|532297035|FG004|Overall Study|Protocol Violation|15|||
147585352|NCT04660032|532297036|FG000|Overall Study|Protocol Violation|1|||
147585353|NCT04660032|532297037|FG001|Overall Study|Protocol Violation|1|||
147241300|NCT03000439|531055825|FG002|Double Blind Phase|Withdrawal by parent/guardian|2|||
147322069|NCT01244763|531343559|FG000|Overall Study|Lost to Follow-up|0|||
147585354|NCT00090753|532297038|FG000|First Treatment Period|Adverse Event|20|||
147585355|NCT00090753|532297039|FG001|First Treatment Period|Adverse Event|8|||
147585356|NCT00090753|532297038|FG000|First Treatment Period|Death|88|||
147585357|NCT00090753|532297039|FG001|First Treatment Period|Death|62|||
147585358|NCT00090753|532297038|FG000|First Treatment Period|Lack of Efficacy|2|||
147585359|NCT00090753|532297039|FG001|First Treatment Period|Lack of Efficacy|1|||
147585360|NCT00090753|532297038|FG000|First Treatment Period|Refused Treatment|32|||
147585361|NCT00090753|532297039|FG001|First Treatment Period|Refused Treatment|25|||
147585362|NCT00090753|532297038|FG000|First Treatment Period|Lost to Follow-up|4|||
147585363|NCT00090753|532297039|FG001|First Treatment Period|Lost to Follow-up|4|||
147585364|NCT00090753|532297038|FG000|First Treatment Period|Renal Transplant|70|||
147585365|NCT00090753|532297039|FG001|First Treatment Period|Renal Transplant|50|||
147585366|NCT00090753|532297038|FG000|First Treatment Period|Mircera Commercialization|1|||
147585367|NCT00090753|532297039|FG001|First Treatment Period|Mircera Commercialization|0|||
147585368|NCT00090753|532297038|FG000|First Treatment Period|Other Unrelated to Safety and Efficacy|39|||
147585369|NCT00090753|532297039|FG001|First Treatment Period|Other Unrelated to Safety and Efficacy|28|||
147585370|NCT00090753|532297038|FG000|Extended Treatment Period|Adverse Event|11|||
147585371|NCT00090753|532297039|FG001|Extended Treatment Period|Adverse Event|0|||
147585372|NCT00090753|532297038|FG000|Extended Treatment Period|Death|58|||
147585373|NCT00090753|532297039|FG001|Extended Treatment Period|Death|30|||
147585374|NCT00090753|532297038|FG000|Extended Treatment Period|Lack of Efficacy|1|||
147585375|NCT00090753|532297039|FG001|Extended Treatment Period|Lack of Efficacy|0|||
147585376|NCT00090753|532297038|FG000|Extended Treatment Period|Refused Treatment|18|||
147585377|NCT00090753|532297039|FG001|Extended Treatment Period|Refused Treatment|12|||
147585378|NCT00090753|532297038|FG000|Extended Treatment Period|Lost to Follow-up|3|||
147585379|NCT00090753|532297039|FG001|Extended Treatment Period|Lost to Follow-up|1|||
147585380|NCT00090753|532297038|FG000|Extended Treatment Period|Renal Transplant|15|||
147585381|NCT00090753|532297039|FG001|Extended Treatment Period|Renal Transplant|12|||
147585382|NCT00090753|532297038|FG000|Extended Treatment Period|Mircera Commercialization|188|||
147585383|NCT00090753|532297039|FG001|Extended Treatment Period|Mircera Commercialization|93|||
147585384|NCT00090753|532297038|FG000|Extended Treatment Period|Other Unrelated to Safety and Efficacy|65|||
147585385|NCT00090753|532297039|FG001|Extended Treatment Period|Other Unrelated to Safety and Efficacy|43|||
147585386|NCT01609582|532297042|FG000|Overall Study|Adverse Event|20|||
147585387|NCT01609582|532297043|FG001|Overall Study|Adverse Event|18|||
147585388|NCT01609582|532297042|FG000|Overall Study|Lost to Follow-up|10|||
147585389|NCT01609582|532297043|FG001|Overall Study|Lost to Follow-up|10|||
147585390|NCT01609582|532297042|FG000|Overall Study|Withdrawal by Subject|21|||
147585391|NCT01609582|532297043|FG001|Overall Study|Withdrawal by Subject|15|||
147585392|NCT01609582|532297042|FG000|Overall Study|Study Terminated by Sponsor|1543|||
147585393|NCT01609582|532297043|FG001|Overall Study|Study Terminated by Sponsor|1548|||
147585394|NCT01609582|532297042|FG000|Overall Study|Other|9|||
147585395|NCT01609582|532297043|FG001|Overall Study|Other|10|||
147585396|NCT01609582|532297042|FG000|Overall Study|Randomized, but not treated|0|||
147585397|NCT01609582|532297043|FG001|Overall Study|Randomized, but not treated|3|||
147585398|NCT00819767|532297044|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
147585399|NCT00819767|532297045|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
147585400|NCT02030535|532297052|FG000|Washout Period 1 (21 Days)|Adverse Event|1|||
147585401|NCT01169038|532297054|FG000|Overall Study|Death|1|||
147585402|NCT01169038|532297054|FG000|Overall Study|Adverse Event|5|||
147585403|NCT01169038|532297054|FG000|Overall Study|Required antibiotic administration|1|||
147585404|NCT03257254|532297055|FG000|Overall Study|Withdrawal by Subject|7|||
147585405|NCT03257254|532297055|FG000|Overall Study|Lost to Follow-up|9|||
147585406|NCT03257254|532297055|FG000|Overall Study|Study discontinued by sponsor|5|||
147585407|NCT02329431|532297056|FG000|Overall Study|Lost to Follow-up|20|||
147585408|NCT02329431|532297057|FG001|Overall Study|Lost to Follow-up|13|||
147585409|NCT01557582|532297058|FG000|Overall Study|Protocol Violation|4|||
147585410|NCT01557582|532297058|FG000|Overall Study|Operator error|2|||
147585411|NCT03203642|532297059|FG000|Overall Study|Adverse Event|3|||
147322070|NCT01244763|531343560|FG001|Overall Study|Lost to Follow-up|1|||
147322071|NCT01244763|531343561|FG002|Overall Study|Lost to Follow-up|0|||
147322072|NCT01244763|531343562|FG003|Overall Study|Lost to Follow-up|0|||
147322073|NCT01244763|531343563|FG004|Overall Study|Lost to Follow-up|0|||
147585412|NCT03203642|532297060|FG001|Overall Study|Adverse Event|1|||
147585413|NCT03203642|532297059|FG000|Overall Study|Withdrawal by Subject|6|||
147585414|NCT03203642|532297060|FG001|Overall Study|Withdrawal by Subject|6|||
147585415|NCT03203642|532297059|FG000|Overall Study|Lost to Follow-up|2|||
147585416|NCT03203642|532297060|FG001|Overall Study|Lost to Follow-up|1|||
147585417|NCT03203642|532297059|FG000|Overall Study|Termination of the study by sponsor|1|||
147585418|NCT03203642|532297060|FG001|Overall Study|Termination of the study by sponsor|1|||
147585419|NCT03203642|532297059|FG000|Overall Study|Participant moved|0|||
147585420|NCT03203642|532297060|FG001|Overall Study|Participant moved|1|||
147585421|NCT03203642|532297059|FG000|Overall Study|Investigator's decision|3|||
147585422|NCT03203642|532297060|FG001|Overall Study|Investigator's decision|0|||
147322074|NCT01244763|531343564|FG005|Overall Study|Lost to Follow-up|0|||
147322075|NCT01244763|531343559|FG000|Overall Study|Enrolled into the Extension Study|0|||
147241301|NCT03000439|531055826|FG003|Double Blind Phase|Withdrawal by parent/guardian|0|||
147241302|NCT03000439|531055823|FG000|Double Blind Phase|Other|0|||
147241303|NCT03000439|531055824|FG001|Double Blind Phase|Other|0|||
147241304|NCT03000439|531055825|FG002|Double Blind Phase|Other|10|||
147241305|NCT03000439|531055826|FG003|Double Blind Phase|Other|11|||
147241306|NCT03000439|531055823|FG000|Double Blind Phase|Insufficient clinical response|0|||
147241307|NCT03000439|531055824|FG001|Double Blind Phase|Insufficient clinical response|0|||
147241308|NCT03000439|531055825|FG002|Double Blind Phase|Insufficient clinical response|0|||
147241309|NCT03000439|531055826|FG003|Double Blind Phase|Insufficient clinical response|2|||
147241310|NCT02370160|531055827|FG000|Overall Study|Death|3|||
147241311|NCT02370160|531055828|FG001|Overall Study|Death|4|||
147241312|NCT02370160|531055829|FG002|Overall Study|Death|1|||
147241313|NCT01473836|531055834|FG000|Overall Study|Adverse Event|4|||
147241314|NCT01473836|531055834|FG000|Overall Study|Lack of Efficacy|1|||
147241315|NCT01473836|531055834|FG000|Overall Study|Does not meet entrance criteria|1|||
147241316|NCT02954237|531055840|FG000|Overall Study|Withdrawal by Subject|25|||
147241317|NCT02954237|531055840|FG000|Overall Study|Missed visit|16|||
147241318|NCT02954237|531055840|FG000|Overall Study|Death|2|||
147241319|NCT00599924|531055842|FG000|Overall Study|Lack of Efficacy|3|||
147241320|NCT00599924|531055843|FG001|Overall Study|Lack of Efficacy|5|||
147241321|NCT00599924|531055844|FG002|Overall Study|Lack of Efficacy|1|||
147241322|NCT00599924|531055845|FG003|Overall Study|Lack of Efficacy|2|||
147241323|NCT00599924|531055846|FG004|Overall Study|Lack of Efficacy|3|||
147241324|NCT00599924|531055847|FG005|Overall Study|Lack of Efficacy|2|||
147241325|NCT00599924|531055848|FG006|Overall Study|Lack of Efficacy|0|||
147241326|NCT00599924|531055842|FG000|Overall Study|Adverse Event|0|||
147241327|NCT00599924|531055843|FG001|Overall Study|Adverse Event|0|||
147241328|NCT00599924|531055844|FG002|Overall Study|Adverse Event|0|||
147241329|NCT00599924|531055845|FG003|Overall Study|Adverse Event|2|||
147241330|NCT00599924|531055846|FG004|Overall Study|Adverse Event|0|||
147241331|NCT00599924|531055847|FG005|Overall Study|Adverse Event|0|||
147241332|NCT00599924|531055848|FG006|Overall Study|Adverse Event|2|||
147241333|NCT00599924|531055842|FG000|Overall Study|Death|0|||
147241334|NCT00599924|531055843|FG001|Overall Study|Death|0|||
147241335|NCT00599924|531055844|FG002|Overall Study|Death|0|||
147322076|NCT01244763|531343560|FG001|Overall Study|Enrolled into the Extension Study|0|||
147322077|NCT01244763|531343561|FG002|Overall Study|Enrolled into the Extension Study|0|||
147447005|NCT03099187|531800365|FG001|Double-blind Treatment|Withdrawal by Subject|4|||
147447006|NCT03099187|531800366|FG002|Double-blind Treatment|Withdrawal by Subject|0|||
147585423|NCT03203642|532297059|FG000|Overall Study|Other than above specified|0|||
147585424|NCT03203642|532297060|FG001|Overall Study|Other than above specified|1|||
147585425|NCT02413294|532297061|FG000|Overall Study|Withdrawal by Subject|1|||
147585426|NCT00434590|532297062|FG000|Overall Study|Administrative problems|5|||
147585427|NCT00434590|532297063|FG001|Overall Study|Administrative problems|5|||
147585428|NCT00317642|532299195|FG000|Overall Study|Not Received Either Study Drug|1|||
147585429|NCT00317642|532299196|FG001|Overall Study|Not Received Either Study Drug|3|||
147585430|NCT00317642|532299195|FG000|Overall Study|Physician Decision|15|||
147585431|NCT00317642|532299196|FG001|Overall Study|Physician Decision|7|||
147585432|NCT00317642|532299195|FG000|Overall Study|Participant declined treatment|14|||
147585433|NCT00317642|532299196|FG001|Overall Study|Participant declined treatment|3|||
147585434|NCT00317642|532299195|FG000|Overall Study|Adverse Event|17|||
147585435|NCT00317642|532299196|FG001|Overall Study|Adverse Event|5|||
147585436|NCT00317642|532299195|FG000|Overall Study|Treatment Failure|56|||
147585437|NCT00317642|532299196|FG001|Overall Study|Treatment Failure|102|||
147585438|NCT00317642|532299195|FG000|Overall Study|Disease Recurrence|1|||
147585439|NCT00317642|532299196|FG001|Overall Study|Disease Recurrence|2|||
147585440|NCT00317642|532299195|FG000|Overall Study|Death|14|||
147585441|NCT00317642|532299196|FG001|Overall Study|Death|7|||
147585442|NCT00317642|532299195|FG000|Overall Study|Not Continue to Consolidation|2|||
147585443|NCT00317642|532299196|FG001|Overall Study|Not Continue to Consolidation|0|||
147585444|NCT00317642|532299195|FG000|Overall Study|Withdrawal by Subject|0|||
147585445|NCT00317642|532299196|FG001|Overall Study|Withdrawal by Subject|1|||
147585446|NCT00317642|532299195|FG000|Overall Study|Referred For Transplantation|1|||
147585447|NCT00317642|532299196|FG001|Overall Study|Referred For Transplantation|0|||
147585448|NCT00317642|532299195|FG000|Overall Study|AML Not Centrally Confirmed|1|||
147585449|NCT00317642|532299196|FG001|Overall Study|AML Not Centrally Confirmed|5|||
147585450|NCT02315066|532299197|FG000|Overall Study|Lost to Follow-up|0|||
147585451|NCT02315066|532299198|FG001|Overall Study|Lost to Follow-up|1|||
147585452|NCT02315066|532299199|FG002|Overall Study|Lost to Follow-up|1|||
147585453|NCT02315066|532299200|FG003|Overall Study|Lost to Follow-up|0|||
147585454|NCT02315066|532299201|FG004|Overall Study|Lost to Follow-up|1|||
147241336|NCT00599924|531055845|FG003|Overall Study|Death|2|||
147241337|NCT00599924|531055846|FG004|Overall Study|Death|0|||
147585455|NCT02315066|532299202|FG005|Overall Study|Lost to Follow-up|0|||
147585456|NCT02315066|532299203|FG006|Overall Study|Lost to Follow-up|2|||
147241338|NCT00599924|531055847|FG005|Overall Study|Death|2|||
147585457|NCT02315066|532299204|FG007|Overall Study|Lost to Follow-up|1|||
147585458|NCT02315066|532299205|FG008|Overall Study|Lost to Follow-up|0|||
147585459|NCT02315066|532299206|FG009|Overall Study|Lost to Follow-up|0|||
147585460|NCT02315066|532299207|FG010|Overall Study|Lost to Follow-up|1|||
147585461|NCT02315066|532299208|FG011|Overall Study|Lost to Follow-up|2|||
147585462|NCT02315066|532299209|FG012|Overall Study|Lost to Follow-up|0|||
147585463|NCT02315066|532299210|FG013|Overall Study|Lost to Follow-up|4|||
147585464|NCT02315066|532299197|FG000|Overall Study|Death|2|||
147585465|NCT02315066|532299198|FG001|Overall Study|Death|7|||
147585466|NCT02315066|532299199|FG002|Overall Study|Death|6|||
147585467|NCT02315066|532299200|FG003|Overall Study|Death|11|||
147585468|NCT02315066|532299201|FG004|Overall Study|Death|10|||
147585469|NCT02315066|532299202|FG005|Overall Study|Death|3|||
147585470|NCT02315066|532299203|FG006|Overall Study|Death|9|||
147585471|NCT02315066|532299204|FG007|Overall Study|Death|9|||
147585472|NCT02315066|532299205|FG008|Overall Study|Death|10|||
147585473|NCT02315066|532299206|FG009|Overall Study|Death|8|||
147585474|NCT02315066|532299207|FG010|Overall Study|Death|10|||
147585475|NCT02315066|532299208|FG011|Overall Study|Death|7|||
147585476|NCT02315066|532299209|FG012|Overall Study|Death|8|||
147585477|NCT02315066|532299210|FG013|Overall Study|Death|21|||
147585478|NCT02315066|532299197|FG000|Overall Study|Other|0|||
147585479|NCT02315066|532299198|FG001|Overall Study|Other|0|||
147585480|NCT02315066|532299199|FG002|Overall Study|Other|0|||
147585481|NCT02315066|532299200|FG003|Overall Study|Other|0|||
147585482|NCT02315066|532299201|FG004|Overall Study|Other|0|||
147585483|NCT02315066|532299202|FG005|Overall Study|Other|0|||
147654375|NCT00237692|532556705|FG003|Overall Study|Lost to Follow-up|3|||
147654376|NCT00237692|532556702|FG000|Overall Study|Death|1|||
147654377|NCT00237692|532556703|FG001|Overall Study|Death|2|||
147654378|NCT00237692|532556704|FG002|Overall Study|Death|2|||
147654379|NCT00237692|532556705|FG003|Overall Study|Death|3|||
147585484|NCT02315066|532299203|FG006|Overall Study|Other|0|||
147585485|NCT02315066|532299204|FG007|Overall Study|Other|1|||
147585486|NCT02315066|532299205|FG008|Overall Study|Other|1|||
147585487|NCT02315066|532299206|FG009|Overall Study|Other|2|||
147585488|NCT02315066|532299207|FG010|Overall Study|Other|0|||
147585489|NCT02315066|532299208|FG011|Overall Study|Other|0|||
147585490|NCT02315066|532299209|FG012|Overall Study|Other|0|||
147158364|NCT04143217|530745389|FG000|Overall Study|Other, Multiple Categories|11|||
147158365|NCT00919867|530745390|FG000|First Intervention|Withdrawal by Subject|0|||
147585491|NCT02315066|532299210|FG013|Overall Study|Other|0|||
147585492|NCT02315066|532299197|FG000|Overall Study|Subject refused further follow-up|0|||
147585493|NCT02315066|532299198|FG001|Overall Study|Subject refused further follow-up|2|||
147585494|NCT02315066|532299199|FG002|Overall Study|Subject refused further follow-up|2|||
147585495|NCT02315066|532299200|FG003|Overall Study|Subject refused further follow-up|0|||
147585496|NCT02315066|532299201|FG004|Overall Study|Subject refused further follow-up|0|||
147585497|NCT02315066|532299202|FG005|Overall Study|Subject refused further follow-up|0|||
147585498|NCT02315066|532299203|FG006|Overall Study|Subject refused further follow-up|2|||
147585499|NCT02315066|532299204|FG007|Overall Study|Subject refused further follow-up|3|||
147585500|NCT02315066|532299205|FG008|Overall Study|Subject refused further follow-up|0|||
147585501|NCT02315066|532299206|FG009|Overall Study|Subject refused further follow-up|1|||
147585502|NCT02315066|532299207|FG010|Overall Study|Subject refused further follow-up|1|||
147585503|NCT02315066|532299208|FG011|Overall Study|Subject refused further follow-up|2|||
147585504|NCT02315066|532299209|FG012|Overall Study|Subject refused further follow-up|2|||
147585505|NCT02315066|532299210|FG013|Overall Study|Subject refused further follow-up|4|||
147585506|NCT02315066|532299197|FG000|Overall Study|Study ongoing at date of cut-off|0|||
147585507|NCT02315066|532299198|FG001|Overall Study|Study ongoing at date of cut-off|0|||
147585508|NCT02315066|532299199|FG002|Overall Study|Study ongoing at date of cut-off|0|||
147585509|NCT02315066|532299200|FG003|Overall Study|Study ongoing at date of cut-off|0|||
147585510|NCT02315066|532299201|FG004|Overall Study|Study ongoing at date of cut-off|0|||
147585511|NCT02315066|532299202|FG005|Overall Study|Study ongoing at date of cut-off|0|||
147585512|NCT02315066|532299203|FG006|Overall Study|Study ongoing at date of cut-off|0|||
147585513|NCT02315066|532299204|FG007|Overall Study|Study ongoing at date of cut-off|0|||
147158366|NCT00919867|530745391|FG001|First Intervention|Withdrawal by Subject|0|||
147158367|NCT00919867|530745392|FG002|First Intervention|Withdrawal by Subject|1|||
147585514|NCT02315066|532299205|FG008|Overall Study|Study ongoing at date of cut-off|0|||
147585515|NCT02315066|532299206|FG009|Overall Study|Study ongoing at date of cut-off|0|||
147158368|NCT00919867|530745393|FG003|First Intervention|Withdrawal by Subject|0|||
147158369|NCT00919867|530745394|FG004|First Intervention|Withdrawal by Subject|0|||
147585516|NCT02315066|532299207|FG010|Overall Study|Study ongoing at date of cut-off|0|||
147585517|NCT02315066|532299208|FG011|Overall Study|Study ongoing at date of cut-off|0|||
147585518|NCT02315066|532299209|FG012|Overall Study|Study ongoing at date of cut-off|0|||
147158370|NCT00919867|530745395|FG005|First Intervention|Withdrawal by Subject|0|||
147158371|NCT00919867|530745390|FG000|First Intervention|Physician Decision|0|||
147158372|NCT00919867|530745391|FG001|First Intervention|Physician Decision|0|||
147585519|NCT02315066|532299210|FG013|Overall Study|Study ongoing at date of cut-off|1|||
147158373|NCT00919867|530745392|FG002|First Intervention|Physician Decision|0|||
147585520|NCT03180801|532299211|FG000|Overall Study|Physician Decision|3|||
147585521|NCT03180801|532299212|FG001|Overall Study|Physician Decision|3|||
147585522|NCT03180801|532299213|FG002|Overall Study|Physician Decision|1|||
147585523|NCT03180801|532299211|FG000|Overall Study|Non-compliance|1|||
147585524|NCT03180801|532299212|FG001|Overall Study|Non-compliance|4|||
147585525|NCT03180801|532299213|FG002|Overall Study|Non-compliance|0|||
147585526|NCT03180801|532299211|FG000|Overall Study|Inoculation Target Reached|1|||
147585527|NCT03180801|532299212|FG001|Overall Study|Inoculation Target Reached|1|||
147585528|NCT03180801|532299213|FG002|Overall Study|Inoculation Target Reached|3|||
147585529|NCT03180801|532299211|FG000|Overall Study|Adverse Event|1|||
147158374|NCT00919867|530745393|FG003|First Intervention|Physician Decision|0|||
147158375|NCT00919867|530745394|FG004|First Intervention|Physician Decision|0|||
147158376|NCT00919867|530745395|FG005|First Intervention|Physician Decision|1|||
147158377|NCT03333252|530745396|FG000|Overall Study|Adverse Event|10|||
147585530|NCT03180801|532299212|FG001|Overall Study|Adverse Event|0|||
147158378|NCT03333252|530745397|FG001|Overall Study|Adverse Event|6|||
147158379|NCT03333252|530745398|FG002|Overall Study|Adverse Event|5|||
147158380|NCT03333252|530745399|FG003|Overall Study|Adverse Event|2|||
147158381|NCT03333252|530745396|FG000|Overall Study|Death|1|||
147158382|NCT03333252|530745397|FG001|Overall Study|Death|3|||
147158383|NCT03333252|530745398|FG002|Overall Study|Death|0|||
147158384|NCT03333252|530745399|FG003|Overall Study|Death|0|||
147158385|NCT03333252|530745396|FG000|Overall Study|Lack of Efficacy|8|||
147158386|NCT03333252|530745397|FG001|Overall Study|Lack of Efficacy|4|||
147158387|NCT03333252|530745398|FG002|Overall Study|Lack of Efficacy|0|||
147158388|NCT03333252|530745399|FG003|Overall Study|Lack of Efficacy|7|||
147158389|NCT03333252|530745396|FG000|Overall Study|Lost to Follow-up|0|||
147158390|NCT03333252|530745397|FG001|Overall Study|Lost to Follow-up|5|||
147158391|NCT03333252|530745398|FG002|Overall Study|Lost to Follow-up|9|||
147158392|NCT03333252|530745399|FG003|Overall Study|Lost to Follow-up|3|||
147158393|NCT03333252|530745396|FG000|Overall Study|Withdrawal by Subject|14|||
147158394|NCT03333252|530745397|FG001|Overall Study|Withdrawal by Subject|24|||
147158395|NCT03333252|530745398|FG002|Overall Study|Withdrawal by Subject|11|||
147158396|NCT03333252|530745399|FG003|Overall Study|Withdrawal by Subject|17|||
147158397|NCT04049266|530745402|FG000|Overall Study|Adverse Event|16|||
147158398|NCT04049266|530745403|FG001|Overall Study|Adverse Event|9|||
147158399|NCT04049266|530745402|FG000|Overall Study|Non-compliance with study drug|0|||
147158400|NCT04049266|530745403|FG001|Overall Study|Non-compliance with study drug|3|||
147158401|NCT04049266|530745402|FG000|Overall Study|Withdrawal by Subject|6|||
147158402|NCT04049266|530745403|FG001|Overall Study|Withdrawal by Subject|10|||
147158403|NCT04049266|530745402|FG000|Overall Study|Lost to Follow-up|2|||
147158404|NCT04049266|530745403|FG001|Overall Study|Lost to Follow-up|2|||
147158405|NCT04049266|530745402|FG000|Overall Study|Progressive disease|11|||
147158406|NCT04049266|530745403|FG001|Overall Study|Progressive disease|2|||
147158407|NCT04049266|530745402|FG000|Overall Study|Physician Decision|1|||
147158408|NCT04049266|530745403|FG001|Overall Study|Physician Decision|0|||
147158409|NCT04049266|530745402|FG000|Overall Study|Patient moved out of state|1|||
147158410|NCT04049266|530745403|FG001|Overall Study|Patient moved out of state|0|||
147158411|NCT04600076|530745405|FG000|Overall Study|Lost to Follow-up|3|||
147158412|NCT02891681|530745406|FG000|Overall Study|Did not complete all timepoints in Endocrine Cohort|0|||
147158413|NCT02891681|530745407|FG001|Overall Study|Did not complete all timepoints in Endocrine Cohort|0|||
147158414|NCT02891681|530745408|FG002|Overall Study|Did not complete all timepoints in Endocrine Cohort|1|||
147158415|NCT02891681|530745406|FG000|Overall Study|Developed metastases prior to completing neoadjuvant therapy|2|||
147158416|NCT02891681|530745407|FG001|Overall Study|Developed metastases prior to completing neoadjuvant therapy|0|||
147158417|NCT02891681|530745408|FG002|Overall Study|Developed metastases prior to completing neoadjuvant therapy|0|||
147158418|NCT02891681|530745406|FG000|Overall Study|Taken off study after first imaging appointment|1|||
147158419|NCT02891681|530745407|FG001|Overall Study|Taken off study after first imaging appointment|0|||
147158420|NCT02891681|530745408|FG002|Overall Study|Taken off study after first imaging appointment|0|||
147158421|NCT02174523|530745409|FG000|Overall Study|Withdrawal by Subject|1|||
147158422|NCT02174523|530745410|FG001|Overall Study|Withdrawal by Subject|0|||
147158423|NCT02780856|530745417|FG000|Overall Study|Lost to Follow-up|1|||
147158424|NCT03894969|530745420|FG000|Overall Study|Adverse Event|0|||
147158425|NCT03894969|530745421|FG001|Overall Study|Adverse Event|2|||
147158426|NCT03894969|530745422|FG002|Overall Study|Adverse Event|0|||
147585531|NCT03180801|532299213|FG002|Overall Study|Adverse Event|2|||
147585532|NCT03180801|532299211|FG000|Overall Study|Withdrawal by Subject|2|||
147158427|NCT03894969|530745423|FG003|Overall Study|Adverse Event|1|||
147158428|NCT03894969|530745424|FG004|Overall Study|Adverse Event|2|||
147158429|NCT03894969|530745420|FG000|Overall Study|Lost to Follow-up|3|||
147158430|NCT03894969|530745421|FG001|Overall Study|Lost to Follow-up|1|||
147158431|NCT03894969|530745422|FG002|Overall Study|Lost to Follow-up|1|||
147158432|NCT03894969|530745423|FG003|Overall Study|Lost to Follow-up|0|||
147158433|NCT03894969|530745424|FG004|Overall Study|Lost to Follow-up|0|||
147158434|NCT03894969|530745420|FG000|Overall Study|Withdrawal by Subject|2|||
147158435|NCT03894969|530745421|FG001|Overall Study|Withdrawal by Subject|1|||
147158436|NCT03894969|530745422|FG002|Overall Study|Withdrawal by Subject|3|||
147158437|NCT03894969|530745423|FG003|Overall Study|Withdrawal by Subject|4|||
147158438|NCT03894969|530745424|FG004|Overall Study|Withdrawal by Subject|8|||
147585533|NCT03180801|532299212|FG001|Overall Study|Withdrawal by Subject|2|||
147585534|NCT03180801|532299213|FG002|Overall Study|Withdrawal by Subject|1|||
147585535|NCT03180801|532299211|FG000|Overall Study|Lost to Follow-up|0|||
147585536|NCT03180801|532299212|FG001|Overall Study|Lost to Follow-up|2|||
147585537|NCT03180801|532299213|FG002|Overall Study|Lost to Follow-up|3|||
147585538|NCT01142908|532299215|FG000|Overall Study|Lost to Follow-up|19|||
147585539|NCT01142908|532299216|FG001|Overall Study|Lost to Follow-up|13|||
147585540|NCT01142908|532299215|FG000|Overall Study|Death|1|||
147585541|NCT01142908|532299216|FG001|Overall Study|Death|4|||
147585542|NCT01142908|532299215|FG000|Overall Study|Excluded - did not meet criteria|9|||
147585543|NCT01142908|532299216|FG001|Overall Study|Excluded - did not meet criteria|5|||
147585544|NCT01142908|532299215|FG000|Overall Study|Withdrawal by Subject|3|||
147585545|NCT01142908|532299216|FG001|Overall Study|Withdrawal by Subject|0|||
147585546|NCT00035555|532299218|FG000|Overall Study|Adverse Event|5|||
147585547|NCT00035555|532299219|FG001|Overall Study|Adverse Event|8|||
147585548|NCT00035555|532299220|FG002|Overall Study|Adverse Event|9|||
147585549|NCT00035555|532299218|FG000|Overall Study|Allograft loss|1|||
147585550|NCT00035555|532299219|FG001|Overall Study|Allograft loss|1|||
147585551|NCT00035555|532299220|FG002|Overall Study|Allograft loss|2|||
147158439|NCT03894969|530745420|FG000|Overall Study|Other|0|||
147158440|NCT03894969|530745421|FG001|Overall Study|Other|0|||
147158441|NCT03894969|530745422|FG002|Overall Study|Other|0|||
147158442|NCT03894969|530745423|FG003|Overall Study|Other|0|||
147158443|NCT03894969|530745424|FG004|Overall Study|Other|3|||
147158444|NCT03894969|530745420|FG000|Overall Study|Unsolicited Non-Serious Advers Event|0|||
147158445|NCT03894969|530745421|FG001|Overall Study|Unsolicited Non-Serious Advers Event|0|||
147158446|NCT03894969|530745422|FG002|Overall Study|Unsolicited Non-Serious Advers Event|0|||
147158447|NCT03894969|530745423|FG003|Overall Study|Unsolicited Non-Serious Advers Event|2|||
147158448|NCT03894969|530745424|FG004|Overall Study|Unsolicited Non-Serious Advers Event|1|||
147158449|NCT03894969|530745420|FG000|Overall Study|Solicited Adverse Event|0|||
147158450|NCT03894969|530745421|FG001|Overall Study|Solicited Adverse Event|1|||
147158451|NCT03894969|530745422|FG002|Overall Study|Solicited Adverse Event|0|||
147158452|NCT03894969|530745423|FG003|Overall Study|Solicited Adverse Event|0|||
147158453|NCT03894969|530745424|FG004|Overall Study|Solicited Adverse Event|0|||
147158454|NCT00468676|530745426|FG000|Overall Study|Lost to Follow-up|14|||
147158455|NCT00468676|530745427|FG001|Overall Study|Lost to Follow-up|11|||
147158456|NCT00468676|530745426|FG000|Overall Study|Death|2|||
147158457|NCT00468676|530745427|FG001|Overall Study|Death|1|||
147158458|NCT02378298|530745428|FG000|Run-In (0-4 Weeks)|development of dysthyroid optic neuropathy|0|||
147158459|NCT02378298|530745429|FG001|Run-In (0-4 Weeks)|development of dysthyroid optic neuropathy|2|||
147158460|NCT02378298|530745430|FG002|Run-In (0-4 Weeks)|development of dysthyroid optic neuropathy|0|||
147158461|NCT02378298|530745428|FG000|Intervention (5-12 Weeks)|As a deviation from the clinical praxis, withdrew the subject from the regular therapy|0|||
147158462|NCT02378298|530745429|FG001|Intervention (5-12 Weeks)|As a deviation from the clinical praxis, withdrew the subject from the regular therapy|0|||
147158463|NCT02378298|530745430|FG002|Intervention (5-12 Weeks)|As a deviation from the clinical praxis, withdrew the subject from the regular therapy|1|||
147158464|NCT02378298|530745428|FG000|Surveillance (19-68 Weeks)|Death|1|||
147158465|NCT02378298|530745429|FG001|Surveillance (19-68 Weeks)|Death|0|||
147158466|NCT02378298|530745430|FG002|Surveillance (19-68 Weeks)|Death|0|||
147158467|NCT03006458|530745433|FG000|First Intervention|Unsatisfied Vision|0|||
147158468|NCT03006458|530745434|FG001|First Intervention|Unsatisfied Vision|3|||
147158469|NCT01468233|530745435|FG000|Treatment Period 1|Adverse Event|5|||
147158470|NCT01468233|530745436|FG001|Treatment Period 1|Adverse Event|3|||
147158471|NCT01468233|530745437|FG002|Treatment Period 1|Adverse Event|0|||
147158472|NCT01468233|530745438|FG003|Treatment Period 1|Adverse Event|0|||
147158473|NCT01468233|530745439|FG004|Treatment Period 1|Adverse Event|0|||
147158474|NCT01468233|530745440|FG005|Treatment Period 1|Adverse Event|0|||
147158475|NCT01468233|530745435|FG000|Treatment Period 1|Withdrawal by Subject|3|||
147158476|NCT01468233|530745436|FG001|Treatment Period 1|Withdrawal by Subject|4|||
147158477|NCT01468233|530745437|FG002|Treatment Period 1|Withdrawal by Subject|0|||
147158478|NCT01468233|530745438|FG003|Treatment Period 1|Withdrawal by Subject|0|||
147158479|NCT01468233|530745439|FG004|Treatment Period 1|Withdrawal by Subject|0|||
147158480|NCT01468233|530745440|FG005|Treatment Period 1|Withdrawal by Subject|0|||
147158481|NCT01468233|530745435|FG000|Treatment Period 1|Lost to Follow-up|3|||
147158482|NCT01468233|530745436|FG001|Treatment Period 1|Lost to Follow-up|0|||
147158483|NCT01468233|530745437|FG002|Treatment Period 1|Lost to Follow-up|0|||
147158484|NCT01468233|530745438|FG003|Treatment Period 1|Lost to Follow-up|0|||
147158485|NCT01468233|530745439|FG004|Treatment Period 1|Lost to Follow-up|0|||
147158486|NCT01468233|530745440|FG005|Treatment Period 1|Lost to Follow-up|0|||
147158487|NCT01468233|530745435|FG000|Treatment Period 1|Other|1|||
147158488|NCT01468233|530745436|FG001|Treatment Period 1|Other|1|||
147158489|NCT01468233|530745437|FG002|Treatment Period 1|Other|0|||
147158490|NCT01468233|530745438|FG003|Treatment Period 1|Other|0|||
147158491|NCT01468233|530745439|FG004|Treatment Period 1|Other|0|||
147158492|NCT01468233|530745440|FG005|Treatment Period 1|Other|0|||
147585552|NCT00035555|532299218|FG000|Overall Study|Death|0|||
147585553|NCT00035555|532299219|FG001|Overall Study|Death|0|||
147585554|NCT00035555|532299220|FG002|Overall Study|Death|2|||
147585555|NCT00035555|532299218|FG000|Overall Study|Lost to Follow-up|0|||
147585556|NCT00035555|532299219|FG001|Overall Study|Lost to Follow-up|0|||
147585557|NCT00035555|532299220|FG002|Overall Study|Lost to Follow-up|1|||
147585558|NCT00035555|532299218|FG000|Overall Study|Noncompliance|0|||
147585559|NCT00035555|532299219|FG001|Overall Study|Noncompliance|1|||
147585560|NCT00035555|532299220|FG002|Overall Study|Noncompliance|1|||
147585561|NCT00035555|532299218|FG000|Overall Study|Prohibited medication|1|||
147585562|NCT00035555|532299219|FG001|Overall Study|Prohibited medication|1|||
147585563|NCT00035555|532299220|FG002|Overall Study|Prohibited medication|0|||
147585564|NCT00035555|532299218|FG000|Overall Study|Treatment failure/lack of efficacy|7|||
147585565|NCT00035555|532299219|FG001|Overall Study|Treatment failure/lack of efficacy|5|||
147585566|NCT00035555|532299220|FG002|Overall Study|Treatment failure/lack of efficacy|3|||
147585567|NCT00035555|532299218|FG000|Overall Study|Withdrawal by Subject|2|||
147585568|NCT00035555|532299219|FG001|Overall Study|Withdrawal by Subject|0|||
147585569|NCT00035555|532299220|FG002|Overall Study|Withdrawal by Subject|2|||
147585570|NCT00035555|532299218|FG000|Overall Study|Investigator deemed not a good candidate|0|||
147585571|NCT00035555|532299219|FG001|Overall Study|Investigator deemed not a good candidate|0|||
147585572|NCT00035555|532299220|FG002|Overall Study|Investigator deemed not a good candidate|1|||
147585573|NCT00035555|532299218|FG000|Overall Study|Received cyclosporin in error|0|||
147585574|NCT00035555|532299219|FG001|Overall Study|Received cyclosporin in error|0|||
147585575|NCT00035555|532299220|FG002|Overall Study|Received cyclosporin in error|1|||
147585576|NCT00337428|532299221|FG000|Overall Study|Withdrawal by Subject|1|||
147585577|NCT00337428|532299222|FG001|Overall Study|Withdrawal by Subject|2|||
147585578|NCT00337428|532299221|FG000|Overall Study|Lack of Time|1|||
147585579|NCT00337428|532299222|FG001|Overall Study|Lack of Time|1|||
147585580|NCT00337428|532299221|FG000|Overall Study|Unwilling to Continue|1|||
147585581|NCT00337428|532299222|FG001|Overall Study|Unwilling to Continue|0|||
147585582|NCT00337428|532299221|FG000|Overall Study|Anorexia|1|||
147585583|NCT00337428|532299222|FG001|Overall Study|Anorexia|0|||
147585584|NCT02618382|532299223|FG000|Overall Study|Physician Decision|1|||
147585585|NCT02618382|532299223|FG000|Overall Study|Withdrawal by Subject|1|||
147585586|NCT02618382|532299223|FG000|Overall Study|Protocol Violation|1|||
147585587|NCT00529217|532299228|FG000|Overall Study|Lack of Efficacy|2|||
147585588|NCT00529217|532299228|FG000|Overall Study|Unable to adhere to study schedule|2|||
147585589|NCT00779402|532299229|FG000|Treatment Phase 1|Disease Progression|1|||
147585590|NCT00779402|532299230|FG001|Treatment Phase 1|Disease Progression|0|||
147585591|NCT00779402|532299229|FG000|Treatment Phase 1|Adverse Event|2|||
147585592|NCT00779402|532299230|FG001|Treatment Phase 1|Adverse Event|0|||
147585593|NCT00779402|532299229|FG000|Treatment Phase 1|Protocol Violation|1|||
147585594|NCT00779402|532299230|FG001|Treatment Phase 1|Protocol Violation|0|||
147585595|NCT00779402|532299229|FG000|Treatment Phase 1|Patient Refused to Continue|17|||
147585596|NCT00779402|532299230|FG001|Treatment Phase 1|Patient Refused to Continue|2|||
147585597|NCT00779402|532299229|FG000|Treatment Phase 1|Lost to Follow-up|0|||
147585598|NCT00779402|532299230|FG001|Treatment Phase 1|Lost to Follow-up|1|||
147585599|NCT00779402|532299229|FG000|Treatment Phase 1|Death|0|||
147585600|NCT00779402|532299230|FG001|Treatment Phase 1|Death|1|||
147585601|NCT00779402|532299229|FG000|Treatment Phase 1|Intercurrent Illness|1|||
147585602|NCT00779402|532299230|FG001|Treatment Phase 1|Intercurrent Illness|1|||
147585603|NCT00779402|532299229|FG000|Treatment Phase 1|Withdrawal by Subject|1|||
147585604|NCT00779402|532299230|FG001|Treatment Phase 1|Withdrawal by Subject|0|||
147585605|NCT00779402|532299229|FG000|Treatment Phase 1|Other|4|||
147585606|NCT00779402|532299230|FG001|Treatment Phase 1|Other|2|||
147585607|NCT00779402|532299229|FG000|Treatment Phase 1|Closure of Study|3|||
147585608|NCT00779402|532299230|FG001|Treatment Phase 1|Closure of Study|2|||
147585609|NCT00779402|532299229|FG000|Treatment Phase 1|Completed Protocol Visits|3|||
147585610|NCT00779402|532299230|FG001|Treatment Phase 1|Completed Protocol Visits|6|||
147585611|NCT00779402|532299229|FG000|Surveillance Phase|Protocol Violation|0|||
147654380|NCT00237692|532556702|FG000|Overall Study|Excluded - did not meet criteria|4|||
147241339|NCT00599924|531055848|FG006|Overall Study|Death|1|||
147241340|NCT00599924|531055842|FG000|Overall Study|Protocol Violation|0|||
147241341|NCT00599924|531055843|FG001|Overall Study|Protocol Violation|0|||
147241342|NCT00599924|531055844|FG002|Overall Study|Protocol Violation|0|||
147241343|NCT00599924|531055845|FG003|Overall Study|Protocol Violation|1|||
147241344|NCT00599924|531055846|FG004|Overall Study|Protocol Violation|0|||
147241345|NCT00599924|531055847|FG005|Overall Study|Protocol Violation|0|||
147241346|NCT00599924|531055848|FG006|Overall Study|Protocol Violation|0|||
147585612|NCT00779402|532299230|FG001|Surveillance Phase|Protocol Violation|1|||
147585613|NCT00779402|532299229|FG000|Surveillance Phase|Patient refused to continue|22|||
147585614|NCT00779402|532299230|FG001|Surveillance Phase|Patient refused to continue|14|||
147585615|NCT00779402|532299229|FG000|Surveillance Phase|Lost to Follow-up|2|||
147585616|NCT00779402|532299230|FG001|Surveillance Phase|Lost to Follow-up|1|||
147585617|NCT00779402|532299229|FG000|Surveillance Phase|Death|0|||
147585618|NCT00779402|532299230|FG001|Surveillance Phase|Death|1|||
147585619|NCT00779402|532299229|FG000|Surveillance Phase|Intercurrent Illness|2|||
147585620|NCT00779402|532299230|FG001|Surveillance Phase|Intercurrent Illness|0|||
147585621|NCT00779402|532299229|FG000|Surveillance Phase|Other|5|||
147585622|NCT00779402|532299230|FG001|Surveillance Phase|Other|5|||
147585623|NCT00779402|532299229|FG000|Surveillance Phase|Withdrawal by Subject|4|||
147585624|NCT00779402|532299230|FG001|Surveillance Phase|Withdrawal by Subject|1|||
147585625|NCT00779402|532299229|FG000|Surveillance Phase|Closure of study|5|||
147585626|NCT00779402|532299230|FG001|Surveillance Phase|Closure of study|6|||
147585627|NCT00779402|532299229|FG000|Surveillance Phase|Completed Protocol Visits|3|||
147585628|NCT00779402|532299230|FG001|Surveillance Phase|Completed Protocol Visits|2|||
147585629|NCT00779402|532299229|FG000|Long-term Follow-up|Patient refused to continue|2|||
147585630|NCT00779402|532299230|FG001|Long-term Follow-up|Patient refused to continue|0|||
147585631|NCT00779402|532299229|FG000|Long-term Follow-up|Other|5|||
147585632|NCT00779402|532299230|FG001|Long-term Follow-up|Other|0|||
147585633|NCT00779402|532299229|FG000|Long-term Follow-up|Closure of Study|8|||
147585634|NCT00779402|532299230|FG001|Long-term Follow-up|Closure of Study|4|||
147585635|NCT00779402|532299229|FG000|Long-term Follow-up|Completed Protocol Visits|6|||
147585636|NCT00779402|532299230|FG001|Long-term Follow-up|Completed Protocol Visits|2|||
147585637|NCT01315028|532299235|FG000|Overall Study|Lost to Follow-up|1|||
147585638|NCT01315028|532299236|FG001|Overall Study|Lost to Follow-up|0|||
147585639|NCT01315028|532299235|FG000|Overall Study|Death|0|||
147585640|NCT01315028|532299236|FG001|Overall Study|Death|1|||
147585641|NCT02274948|532299241|FG000|Overall Study|Lost to Follow-up|28|||
147585642|NCT02274948|532299242|FG001|Overall Study|Lost to Follow-up|25|||
147585643|NCT02274948|532299241|FG000|Overall Study|Withdrawal by Subject|64|||
147585644|NCT02274948|532299242|FG001|Overall Study|Withdrawal by Subject|58|||
147585645|NCT02274948|532299241|FG000|Overall Study|Stopped on family Practitioner advice|2|||
147585646|NCT02274948|532299242|FG001|Overall Study|Stopped on family Practitioner advice|5|||
147585647|NCT02274948|532299241|FG000|Overall Study|Left the area|4|||
147585648|NCT02274948|532299242|FG001|Overall Study|Left the area|3|||
147585649|NCT03843125|532299245|FG000|Overall Study|Adverse Event|17|||
147585650|NCT03843125|532299246|FG001|Overall Study|Adverse Event|13|||
147585651|NCT03843125|532299247|FG002|Overall Study|Adverse Event|5|||
147585652|NCT03843125|532299248|FG003|Overall Study|Adverse Event|9|||
147158493|NCT01468233|530745435|FG000|Treatment Period 2|Adverse Event|0|||
147158494|NCT01468233|530745436|FG001|Treatment Period 2|Adverse Event|0|||
147158495|NCT01468233|530745437|FG002|Treatment Period 2|Adverse Event|3|||
147158496|NCT01468233|530745438|FG003|Treatment Period 2|Adverse Event|0|||
147158497|NCT01468233|530745439|FG004|Treatment Period 2|Adverse Event|2|||
147158498|NCT01468233|530745440|FG005|Treatment Period 2|Adverse Event|1|||
147158499|NCT01468233|530745435|FG000|Treatment Period 2|Lack of Efficacy|0|||
147158500|NCT01468233|530745436|FG001|Treatment Period 2|Lack of Efficacy|0|||
147158501|NCT01468233|530745437|FG002|Treatment Period 2|Lack of Efficacy|9|||
147585653|NCT03843125|532299245|FG000|Overall Study|Death|0|||
147585654|NCT03843125|532299246|FG001|Overall Study|Death|6|||
147585655|NCT03843125|532299247|FG002|Overall Study|Death|2|||
147585656|NCT03843125|532299248|FG003|Overall Study|Death|0|||
147585657|NCT03843125|532299245|FG000|Overall Study|Lack of Efficacy|14|||
147585658|NCT03843125|532299246|FG001|Overall Study|Lack of Efficacy|11|||
147585659|NCT03843125|532299247|FG002|Overall Study|Lack of Efficacy|9|||
147585660|NCT03843125|532299248|FG003|Overall Study|Lack of Efficacy|4|||
147585661|NCT03843125|532299245|FG000|Overall Study|Lost to Follow-up|3|||
147585662|NCT03843125|532299246|FG001|Overall Study|Lost to Follow-up|4|||
147585663|NCT03843125|532299247|FG002|Overall Study|Lost to Follow-up|0|||
147585664|NCT03843125|532299248|FG003|Overall Study|Lost to Follow-up|2|||
147585665|NCT03843125|532299245|FG000|Overall Study|Other|12|||
147585666|NCT03843125|532299246|FG001|Overall Study|Other|14|||
147585667|NCT03843125|532299247|FG002|Overall Study|Other|3|||
147585668|NCT03843125|532299248|FG003|Overall Study|Other|4|||
147585669|NCT03843125|532299245|FG000|Overall Study|Due to Epidemic/Pandemic|1|||
147585670|NCT03843125|532299246|FG001|Overall Study|Due to Epidemic/Pandemic|0|||
147585671|NCT03843125|532299247|FG002|Overall Study|Due to Epidemic/Pandemic|0|||
147585672|NCT03843125|532299248|FG003|Overall Study|Due to Epidemic/Pandemic|0|||
147585673|NCT03843125|532299245|FG000|Overall Study|Study Terminated by Sponsor|318|||
147585674|NCT03843125|532299246|FG001|Overall Study|Study Terminated by Sponsor|318|||
147585675|NCT03843125|532299247|FG002|Overall Study|Study Terminated by Sponsor|163|||
147585676|NCT03843125|532299248|FG003|Overall Study|Study Terminated by Sponsor|163|||
147585677|NCT03843125|532299245|FG000|Overall Study|Withdrawal by Subject|23|||
147585678|NCT03843125|532299246|FG001|Overall Study|Withdrawal by Subject|12|||
147585679|NCT03843125|532299247|FG002|Overall Study|Withdrawal by Subject|6|||
147585680|NCT03843125|532299248|FG003|Overall Study|Withdrawal by Subject|9|||
147158502|NCT01468233|530745438|FG003|Treatment Period 2|Lack of Efficacy|2|||
147158503|NCT01468233|530745439|FG004|Treatment Period 2|Lack of Efficacy|0|||
147241347|NCT00599924|531055842|FG000|Overall Study|Withdrawal by Subject|0|||
147585681|NCT03843125|532299245|FG000|Overall Study|Missing data|0|||
147585682|NCT03843125|532299246|FG001|Overall Study|Missing data|1|||
147585683|NCT03843125|532299247|FG002|Overall Study|Missing data|1|||
147585684|NCT03843125|532299248|FG003|Overall Study|Missing data|0|||
147585685|NCT01098539|532299249|FG000|Overall Study|Adverse Event|26|||
147585686|NCT01098539|532299250|FG001|Overall Study|Adverse Event|26|||
147158504|NCT01468233|530745440|FG005|Treatment Period 2|Lack of Efficacy|1|||
147585687|NCT01098539|532299249|FG000|Overall Study|Protocol Violation|1|||
147585688|NCT01098539|532299250|FG001|Overall Study|Protocol Violation|4|||
147585689|NCT01098539|532299249|FG000|Overall Study|Noncompliance|3|||
147158505|NCT01468233|530745435|FG000|Treatment Period 2|Withdrawal by Subject|0|||
147158506|NCT01468233|530745436|FG001|Treatment Period 2|Withdrawal by Subject|0|||
147158507|NCT01468233|530745437|FG002|Treatment Period 2|Withdrawal by Subject|9|||
147158508|NCT01468233|530745438|FG003|Treatment Period 2|Withdrawal by Subject|1|||
147158509|NCT01468233|530745439|FG004|Treatment Period 2|Withdrawal by Subject|1|||
147158510|NCT01468233|530745440|FG005|Treatment Period 2|Withdrawal by Subject|1|||
147158511|NCT01468233|530745435|FG000|Treatment Period 2|Loss/absence of response (per protocol)|0|||
147158512|NCT01468233|530745436|FG001|Treatment Period 2|Loss/absence of response (per protocol)|0|||
147158513|NCT01468233|530745437|FG002|Treatment Period 2|Loss/absence of response (per protocol)|84|||
147158514|NCT01468233|530745438|FG003|Treatment Period 2|Loss/absence of response (per protocol)|25|||
147158515|NCT01468233|530745439|FG004|Treatment Period 2|Loss/absence of response (per protocol)|22|||
147158516|NCT01468233|530745440|FG005|Treatment Period 2|Loss/absence of response (per protocol)|20|||
147158517|NCT01468233|530745435|FG000|Treatment Period 2|Lost to Follow-up|0|||
147158518|NCT01468233|530745436|FG001|Treatment Period 2|Lost to Follow-up|0|||
147158519|NCT01468233|530745437|FG002|Treatment Period 2|Lost to Follow-up|3|||
147158520|NCT01468233|530745438|FG003|Treatment Period 2|Lost to Follow-up|0|||
147158521|NCT01468233|530745439|FG004|Treatment Period 2|Lost to Follow-up|2|||
147158522|NCT01468233|530745440|FG005|Treatment Period 2|Lost to Follow-up|0|||
147158523|NCT01468233|530745435|FG000|Treatment Period 2|Other|0|||
147158524|NCT01468233|530745436|FG001|Treatment Period 2|Other|0|||
147158525|NCT01468233|530745437|FG002|Treatment Period 2|Other|3|||
147158526|NCT01468233|530745438|FG003|Treatment Period 2|Other|0|||
147158527|NCT01468233|530745439|FG004|Treatment Period 2|Other|1|||
147158528|NCT01468233|530745440|FG005|Treatment Period 2|Other|0|||
147158529|NCT00457821|530745444|FG000|Part 2|Withdrawal by Subject|0|||
147158530|NCT00457821|530745445|FG001|Part 2|Withdrawal by Subject|0|||
147158531|NCT00457821|530745446|FG002|Part 2|Withdrawal by Subject|0|||
147158532|NCT00457821|530745447|FG003|Part 2|Withdrawal by Subject|0|||
147158533|NCT00457821|530745448|FG004|Part 2|Withdrawal by Subject|0|||
147158534|NCT00457821|530745449|FG005|Part 2|Withdrawal by Subject|0|||
147158535|NCT00457821|530745450|FG006|Part 2|Withdrawal by Subject|0|||
147158536|NCT00457821|530745451|FG007|Part 2|Withdrawal by Subject|1|||
147158537|NCT02437409|530745454|FG000|Overall Study|Withdrawal by Subject|3|||
147158538|NCT02437409|530745454|FG000|Overall Study|Screening failure|12|||
147158539|NCT03549871|530745470|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Withdrawal by Subject|0|||
147158540|NCT03549871|530745471|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Withdrawal by Subject|2|||
147158541|NCT03549871|530745470|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Adverse Event|1|||
147158542|NCT03549871|530745471|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Adverse Event|0|||
147158543|NCT03549871|530745470|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Parent withdrew consent|1|||
147158544|NCT03549871|530745471|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Parent withdrew consent|0|||
147158545|NCT03549871|530745470|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Switched to treatment not per protocol|4|||
147158546|NCT03549871|530745471|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Switched to treatment not per protocol|0|||
147158547|NCT03549871|530745470|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Related to Coronavrus Disease 2019|1|||
147158548|NCT03549871|530745471|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Related to Coronavrus Disease 2019|0|||
147158549|NCT03549871|530745470|FG000|Factor/BPA Prophylaxis: Day -168 to -1|Did not meet trial eligibility|0|||
147158550|NCT03549871|530745471|FG001|Factor/BPA Prophylaxis: Day -168 to -1|Did not meet trial eligibility|2|||
147158551|NCT03549871|530745470|FG000|Fitusiran Treatment: Day 1 to Day 190|Withdrawal by Subject|1|||
147158552|NCT03549871|530745471|FG001|Fitusiran Treatment: Day 1 to Day 190|Withdrawal by Subject|0|||
147158553|NCT03549871|530745470|FG000|Fitusiran Treatment: Day 1 to Day 190|More than 1 antithrombin (AT) measurement less than 15%|1|||
147158554|NCT03549871|530745471|FG001|Fitusiran Treatment: Day 1 to Day 190|More than 1 antithrombin (AT) measurement less than 15%|0|||
147158555|NCT03549871|530745470|FG000|Fitusiran Treatment: Day 1 to Day 190|Study drug on hold|4|||
147158556|NCT03549871|530745471|FG001|Fitusiran Treatment: Day 1 to Day 190|Study drug on hold|5|||
147585690|NCT01098539|532299250|FG001|Overall Study|Noncompliance|5|||
147585691|NCT01098539|532299249|FG000|Overall Study|Lost to Follow-up|4|||
147585692|NCT01098539|532299250|FG001|Overall Study|Lost to Follow-up|4|||
147585693|NCT01098539|532299249|FG000|Overall Study|Withdrawal by Subject|12|||
147158557|NCT03549871|530745470|FG000|Fitusiran Treatment: Day 1 to Day 190|Participant's decision|0|||
147158558|NCT03549871|530745471|FG001|Fitusiran Treatment: Day 1 to Day 190|Participant's decision|2|||
147158559|NCT03549871|530745470|FG000|Fitusiran Treatment: Day 1 to Day 190|Adverse Event|0|||
147158560|NCT03549871|530745471|FG001|Fitusiran Treatment: Day 1 to Day 190|Adverse Event|2|||
147158561|NCT00737568|530745475|FG000|Treatment Period Through Week 240|Investigator's Discretion|6|||
147158562|NCT00737568|530745476|FG001|Treatment Period Through Week 240|Investigator's Discretion|5|||
147585694|NCT01098539|532299250|FG001|Overall Study|Withdrawal by Subject|26|||
147585695|NCT01098539|532299249|FG000|Overall Study|Physician Decision|5|||
147158563|NCT00737568|530745475|FG000|Treatment Period Through Week 240|Withdrew Consent|5|||
147158564|NCT00737568|530745476|FG001|Treatment Period Through Week 240|Withdrew Consent|6|||
147158565|NCT00737568|530745475|FG000|Treatment Period Through Week 240|Safety, Tolerability, or Efficacy Reason|3|||
147241348|NCT00599924|531055843|FG001|Overall Study|Withdrawal by Subject|0|||
147241349|NCT00599924|531055844|FG002|Overall Study|Withdrawal by Subject|1|||
147158566|NCT00737568|530745476|FG001|Treatment Period Through Week 240|Safety, Tolerability, or Efficacy Reason|4|||
147158567|NCT00737568|530745475|FG000|Treatment Period Through Week 240|Lost to Follow-up|3|||
147158568|NCT00737568|530745476|FG001|Treatment Period Through Week 240|Lost to Follow-up|3|||
147158569|NCT00737568|530745475|FG000|Treatment Period Through Week 240|Protocol Violation|2|||
147158570|NCT00737568|530745476|FG001|Treatment Period Through Week 240|Protocol Violation|3|||
147158571|NCT00737568|530745475|FG000|Treatment Period Through Week 240|Study Discontinued by Sponsor|1|||
147158572|NCT00737568|530745476|FG001|Treatment Period Through Week 240|Study Discontinued by Sponsor|0|||
147158573|NCT00737568|530745475|FG000|Treatment-Free Follow-up (TFFU) Period|Started Commercial Therapy|25|||
147158574|NCT00737568|530745476|FG001|Treatment-Free Follow-up (TFFU) Period|Started Commercial Therapy|17|||
147158575|NCT00737568|530745475|FG000|Treatment-Free Follow-up (TFFU) Period|Death|0|||
147158576|NCT00737568|530745476|FG001|Treatment-Free Follow-up (TFFU) Period|Death|1|||
147158577|NCT00737568|530745475|FG000|Treatment-Free Follow-up (TFFU) Period|Withdrew Consent|1|||
147158578|NCT00737568|530745476|FG001|Treatment-Free Follow-up (TFFU) Period|Withdrew Consent|0|||
147158579|NCT01133626|530745477|FG000|Overall Study|Adverse Event|0|||
147158580|NCT01133626|530745478|FG001|Overall Study|Adverse Event|1|||
147158581|NCT01133626|530745479|FG002|Overall Study|Adverse Event|0|||
147158582|NCT01133626|530745477|FG000|Overall Study|Withdrawal by Subject|1|||
147158583|NCT01133626|530745478|FG001|Overall Study|Withdrawal by Subject|2|||
147158584|NCT01133626|530745479|FG002|Overall Study|Withdrawal by Subject|2|||
147158585|NCT01133626|530745477|FG000|Overall Study|Other|0|||
147158586|NCT01133626|530745478|FG001|Overall Study|Other|2|||
147158587|NCT01133626|530745479|FG002|Overall Study|Other|0|||
147158588|NCT02851407|530745480|FG000|Overall Study|Withdrawal by parent/guardian|2|||
147158589|NCT02851407|530745481|FG001|Overall Study|Withdrawal by parent/guardian|7|||
147158590|NCT02851407|530745480|FG000|Overall Study|Protocol deviation|0|||
147158591|NCT02851407|530745481|FG001|Overall Study|Protocol deviation|1|||
147158592|NCT02851407|530745480|FG000|Overall Study|Transferred to another hospital to continue|1|||
147158593|NCT02851407|530745481|FG001|Overall Study|Transferred to another hospital to continue|0|||
147158594|NCT02851407|530745480|FG000|Overall Study|Other Death|30|||
147158595|NCT02851407|530745481|FG001|Overall Study|Other Death|20|||
147158596|NCT02851407|530745480|FG000|Overall Study|Adverse event, serious fatal|6|||
147158597|NCT02851407|530745481|FG001|Overall Study|Adverse event, serious fatal|8|||
147158598|NCT02851407|530745480|FG000|Overall Study|Consent withdrawn by participant|5|||
147158599|NCT02851407|530745481|FG001|Overall Study|Consent withdrawn by participant|3|||
147158600|NCT02851407|530745480|FG000|Overall Study|Screen failure|2|||
147158601|NCT02851407|530745481|FG001|Overall Study|Screen failure|1|||
147158602|NCT02851407|530745480|FG000|Overall Study|Disease relapse|9|||
147158603|NCT02851407|530745481|FG001|Overall Study|Disease relapse|6|||
147158604|NCT02851407|530745480|FG000|Overall Study|Physician Decision|7|||
147158605|NCT02851407|530745481|FG001|Overall Study|Physician Decision|6|||
147158606|NCT02851407|530745480|FG000|Overall Study|Transferred to hospital closer to home|0|||
147158607|NCT02851407|530745481|FG001|Overall Study|Transferred to hospital closer to home|1|||
147158608|NCT02851407|530745480|FG000|Overall Study|Enrolled in an investigational study|0|||
147158609|NCT02851407|530745481|FG001|Overall Study|Enrolled in an investigational study|1|||
147158610|NCT02851407|530745480|FG000|Overall Study|Early recovery|1|||
147585696|NCT01098539|532299250|FG001|Overall Study|Physician Decision|3|||
147585697|NCT01386125|532299251|FG000|Overall Study|Lost to Follow-up|3|||
147585698|NCT01386125|532299252|FG001|Overall Study|Lost to Follow-up|9|||
147585699|NCT01386125|532299251|FG000|Overall Study|Physician Decision|0|||
147585700|NCT01386125|532299252|FG001|Overall Study|Physician Decision|1|||
147585701|NCT01386125|532299251|FG000|Overall Study|Protocol Violation|5|||
147158611|NCT02851407|530745481|FG001|Overall Study|Early recovery|0|||
147158612|NCT02851407|530745480|FG000|Overall Study|Adverse event, non-fatal|7|||
147158613|NCT02851407|530745481|FG001|Overall Study|Adverse event, non-fatal|5|||
147158614|NCT02851407|530745480|FG000|Overall Study|Lost to Follow-up|0|||
147158615|NCT02851407|530745481|FG001|Overall Study|Lost to Follow-up|2|||
147158616|NCT01713283|530745485|FG000|Overall Study|Lack of Efficacy|10|||
147158617|NCT01713283|530745486|FG001|Overall Study|Lack of Efficacy|2|||
147158618|NCT01713283|530745485|FG000|Overall Study|Lost to Follow-up|1|||
147158619|NCT01713283|530745486|FG001|Overall Study|Lost to Follow-up|1|||
147241350|NCT00599924|531055845|FG003|Overall Study|Withdrawal by Subject|0|||
147585702|NCT01386125|532299252|FG001|Overall Study|Protocol Violation|7|||
147158620|NCT03761394|530745488|FG000|14-day Intervention & Control Period|Lost to Follow-up|0|||
147158621|NCT03761394|530745489|FG001|14-day Intervention & Control Period|Lost to Follow-up|1|||
147158622|NCT03761394|530745490|FG002|14-day Intervention & Control Period|Lost to Follow-up|0|||
147158623|NCT03761394|530745491|FG003|14-day Intervention & Control Period|Lost to Follow-up|0|||
147158624|NCT03761394|530745488|FG000|14-day Intervention & Control Period|Withdrawal by Subject|3|||
147158625|NCT03761394|530745489|FG001|14-day Intervention & Control Period|Withdrawal by Subject|1|||
147158626|NCT03761394|530745490|FG002|14-day Intervention & Control Period|Withdrawal by Subject|0|||
147158627|NCT03761394|530745491|FG003|14-day Intervention & Control Period|Withdrawal by Subject|0|||
147158628|NCT03761394|530745488|FG000|30-day Period (Extension 44 Days)|Lost to Follow-up|0|||
147158629|NCT03761394|530745489|FG001|30-day Period (Extension 44 Days)|Lost to Follow-up|0|||
147585703|NCT01386125|532299251|FG000|Overall Study|Disease Progress|1|||
147585704|NCT01386125|532299252|FG001|Overall Study|Disease Progress|2|||
147585705|NCT01386125|532299251|FG000|Overall Study|Withdrawal by Subject|13|||
147585706|NCT01386125|532299252|FG001|Overall Study|Withdrawal by Subject|12|||
147585707|NCT01386125|532299251|FG000|Overall Study|Adverse Event|2|||
147585708|NCT01386125|532299252|FG001|Overall Study|Adverse Event|5|||
147585709|NCT01386125|532299251|FG000|Overall Study|Lack of Efficacy|0|||
147585710|NCT01386125|532299252|FG001|Overall Study|Lack of Efficacy|1|||
147585711|NCT01386125|532299251|FG000|Overall Study|Participant Leaving Country|1|||
147585712|NCT01386125|532299252|FG001|Overall Study|Participant Leaving Country|0|||
147585713|NCT03173560|532299253|FG000|Overall Study|Death|70|||
147585714|NCT03173560|532299254|FG001|Overall Study|Death|60|||
147585715|NCT03173560|532299253|FG000|Overall Study|Lost to Follow-up|1|||
147585716|NCT03173560|532299254|FG001|Overall Study|Lost to Follow-up|4|||
147585717|NCT03173560|532299253|FG000|Overall Study|Withdrawal by Subject|10|||
147585718|NCT03173560|532299254|FG001|Overall Study|Withdrawal by Subject|5|||
147585719|NCT03173560|532299253|FG000|Overall Study|Other|0|||
147158630|NCT03761394|530745490|FG002|30-day Period (Extension 44 Days)|Lost to Follow-up|2|||
147158631|NCT03761394|530745491|FG003|30-day Period (Extension 44 Days)|Lost to Follow-up|0|||
147158632|NCT03761394|530745488|FG000|30-day Period (Extension 44 Days)|Withdrawal by Subject|0|||
147158633|NCT03761394|530745489|FG001|30-day Period (Extension 44 Days)|Withdrawal by Subject|0|||
147158634|NCT03761394|530745490|FG002|30-day Period (Extension 44 Days)|Withdrawal by Subject|0|||
147158635|NCT03761394|530745491|FG003|30-day Period (Extension 44 Days)|Withdrawal by Subject|3|||
147158636|NCT01080768|530745492|FG000|Overall Study|Protocol Deviation|2|||
147158637|NCT01080768|530745493|FG001|Overall Study|Protocol Deviation|1|||
147158638|NCT03054350|530745495|FG000|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|4|||
147158639|NCT03054350|530745496|FG001|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|2|||
147158640|NCT03054350|530745497|FG002|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|1|||
147585720|NCT03173560|532299254|FG001|Overall Study|Other|1|||
147585721|NCT04254809|532299256|FG000|Overall Study|Lost to Follow-up|5|||
147585722|NCT04254809|532299257|FG001|Overall Study|Lost to Follow-up|10|||
147585723|NCT02972515|532299258|FG000|Overall Study|Lost to Follow-up|78|||
147585724|NCT01928615|532299259|FG000|Overall Study|Study Terminated by Sponsor|2|||
147585725|NCT03023137|532299264|FG000|Overall Study|Multiple pregnancy|2|||
147585726|NCT03023137|532299265|FG001|Overall Study|Multiple pregnancy|4|||
147585727|NCT03023137|532299264|FG000|Overall Study|Lost to Follow-up|1|||
147585728|NCT03023137|532299265|FG001|Overall Study|Lost to Follow-up|1|||
147585729|NCT03023137|532299264|FG000|Overall Study|Protocol Violation|0|||
147585730|NCT03023137|532299265|FG001|Overall Study|Protocol Violation|4|||
147585731|NCT03023137|532299264|FG000|Overall Study|Lost the baby in a car accident|1|||
147585732|NCT03023137|532299265|FG001|Overall Study|Lost the baby in a car accident|0|||
147585733|NCT01808248|532299267|FG000|Overall Study|Lack of Efficacy|3|||
147585734|NCT01808248|532299267|FG000|Overall Study|Withdrawal by Subject|1|||
147585735|NCT01808248|532299267|FG000|Overall Study|Lost to Follow-up|1|||
147585736|NCT00685750|532299268|FG000|Overall Study|Tumor sampling failure|0|||
147585737|NCT00685750|532299269|FG001|Overall Study|Tumor sampling failure|0|||
147585738|NCT00685750|532299270|FG002|Overall Study|Tumor sampling failure|1|||
147585739|NCT00685750|532299271|FG003|Overall Study|Tumor sampling failure|0|||
147585740|NCT00685750|532299272|FG004|Overall Study|Tumor sampling failure|0|||
147585741|NCT00685750|532299273|FG005|Overall Study|Tumor sampling failure|0|||
147585742|NCT00685750|532299274|FG006|Overall Study|Tumor sampling failure|0|||
147585743|NCT00685750|532299268|FG000|Overall Study|Patient didn't receive the treatment|0|||
147585744|NCT00685750|532299269|FG001|Overall Study|Patient didn't receive the treatment|0|||
147585745|NCT00685750|532299270|FG002|Overall Study|Patient didn't receive the treatment|0|||
147585746|NCT00685750|532299271|FG003|Overall Study|Patient didn't receive the treatment|0|||
147585747|NCT00685750|532299272|FG004|Overall Study|Patient didn't receive the treatment|0|||
147585748|NCT00685750|532299273|FG005|Overall Study|Patient didn't receive the treatment|0|||
147585749|NCT00685750|532299274|FG006|Overall Study|Patient didn't receive the treatment|1|||
147585750|NCT00685750|532299268|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
147585751|NCT00685750|532299269|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
147585752|NCT00685750|532299270|FG002|Overall Study|Eligibility criteria not fulfilled|1|||
147585753|NCT00685750|532299271|FG003|Overall Study|Eligibility criteria not fulfilled|0|||
147585754|NCT00685750|532299272|FG004|Overall Study|Eligibility criteria not fulfilled|0|||
147585755|NCT00685750|532299273|FG005|Overall Study|Eligibility criteria not fulfilled|0|||
147158641|NCT03054350|530745498|FG003|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|2|||
147158642|NCT03054350|530745499|FG004|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|4|||
147585756|NCT00685750|532299274|FG006|Overall Study|Eligibility criteria not fulfilled|0|||
147585757|NCT04974580|532299275|FG000|Overall Study|Lost to Follow-up|33|||
147585758|NCT04974580|532299276|FG001|Overall Study|Lost to Follow-up|39|||
147585759|NCT04974580|532299277|FG002|Overall Study|Lost to Follow-up|30|||
147585760|NCT04974580|532299278|FG003|Overall Study|Lost to Follow-up|29|||
147585761|NCT00587431|532299279|FG000|Overall Study|Adverse Event|1|||
147585762|NCT00587431|532299280|FG001|Overall Study|Adverse Event|0|||
147585763|NCT00587431|532299279|FG000|Overall Study|Withdrawal by Subject|0|||
147585764|NCT00587431|532299280|FG001|Overall Study|Withdrawal by Subject|1|||
147585765|NCT05467982|532299281|FG000|Overall Study|Death|0|||
147585766|NCT05467982|532299282|FG001|Overall Study|Death|1|||
147585767|NCT05467982|532299281|FG000|Overall Study|Lost to Follow-up|3|||
147585768|NCT05467982|532299282|FG001|Overall Study|Lost to Follow-up|1|||
147585769|NCT00761176|532299308|FG000|Overall Study|Death|1|||
147585770|NCT00761176|532299309|FG001|Overall Study|Death|0|||
147585771|NCT00761176|532299308|FG000|Overall Study|Withdrawal by Subject|1|||
147585772|NCT00761176|532299309|FG001|Overall Study|Withdrawal by Subject|1|||
147585773|NCT02762994|532299310|FG000|Overall Study|Withdrawal by Subject|0|||
147585774|NCT02762994|532299311|FG001|Overall Study|Withdrawal by Subject|1|||
147585775|NCT02762994|532299312|FG002|Overall Study|Withdrawal by Subject|2|||
147585776|NCT02762994|532299313|FG003|Overall Study|Withdrawal by Subject|0|||
147585777|NCT02762994|532299310|FG000|Overall Study|Protocol Violation|1|||
147585778|NCT02762994|532299311|FG001|Overall Study|Protocol Violation|0|||
147585779|NCT02762994|532299312|FG002|Overall Study|Protocol Violation|0|||
147585780|NCT02762994|532299313|FG003|Overall Study|Protocol Violation|2|||
147585781|NCT05103657|532299316|FG000|Overall Study|Other reasons than listed|9|||
147585782|NCT05103657|532299317|FG001|Overall Study|Other reasons than listed|8|||
147585783|NCT05103657|532299316|FG000|Overall Study|Protocol deviation|2|||
147585784|NCT05103657|532299317|FG001|Overall Study|Protocol deviation|2|||
147585785|NCT05103657|532299316|FG000|Overall Study|No reason available|5|||
147585786|NCT05103657|532299317|FG001|Overall Study|No reason available|4|||
147585787|NCT05103657|532299316|FG000|Overall Study|Burden of study procedures|3|||
147585788|NCT05103657|532299317|FG001|Overall Study|Burden of study procedures|1|||
147585789|NCT05103657|532299316|FG000|Overall Study|Perceived lack of efficacy|1|||
147585790|NCT05103657|532299317|FG001|Overall Study|Perceived lack of efficacy|1|||
147585791|NCT05103657|532299316|FG000|Overall Study|Adverse Event|6|||
147585792|NCT05103657|532299317|FG001|Overall Study|Adverse Event|14|||
147585793|NCT05103657|532299316|FG000|Overall Study|Not Treated|1|||
147585794|NCT05103657|532299317|FG001|Overall Study|Not Treated|1|||
147585795|NCT02020967|532299318|FG000|Overall Study|Withdrawal by Subject|51|||
147585796|NCT03507686|532299319|FG000|Treatment Period 1(Day 1 up to Month 12)|Serious Adverse Event|4|||
147585797|NCT03507686|532299320|FG001|Treatment Period 1(Day 1 up to Month 12)|Serious Adverse Event|0|||
147585798|NCT03507686|532299319|FG000|Treatment Period 1(Day 1 up to Month 12)|Withdrawal by Subject|2|||
147585799|NCT03507686|532299320|FG001|Treatment Period 1(Day 1 up to Month 12)|Withdrawal by Subject|0|||
147585800|NCT03507686|532299319|FG000|Treatment Period 1(Day 1 up to Month 12)|Site Terminated by Sponsor|2|||
147585801|NCT03507686|532299320|FG001|Treatment Period 1(Day 1 up to Month 12)|Site Terminated by Sponsor|0|||
147585802|NCT03507686|532299319|FG000|Treatment Period 1(Day 1 up to Month 12)|Reason not Specified|2|||
147585803|NCT03507686|532299320|FG001|Treatment Period 1(Day 1 up to Month 12)|Reason not Specified|0|||
147585804|NCT03507686|532299319|FG000|Treatment Period 2 (Month13 to Month24)|Death|0|||
147585805|NCT03507686|532299320|FG001|Treatment Period 2 (Month13 to Month24)|Death|1|||
147585806|NCT03507686|532299319|FG000|Treatment Period 2 (Month13 to Month24)|Reason not Specified|0|||
147585807|NCT03507686|532299320|FG001|Treatment Period 2 (Month13 to Month24)|Reason not Specified|2|||
147585808|NCT00585312|532299321|FG000|Overall Study|Adverse Event|3|||
147585809|NCT00585312|532299322|FG001|Overall Study|Adverse Event|0|||
147585810|NCT00585312|532299321|FG000|Overall Study|Lack of Efficacy|6|||
147585811|NCT00585312|532299322|FG001|Overall Study|Lack of Efficacy|11|||
147585812|NCT00585312|532299321|FG000|Overall Study|Lost to Follow-up|1|||
147585813|NCT00585312|532299322|FG001|Overall Study|Lost to Follow-up|1|||
147585814|NCT00585312|532299321|FG000|Overall Study|Reason not specified|2|||
147585815|NCT00585312|532299322|FG001|Overall Study|Reason not specified|0|||
147585816|NCT00585312|532299321|FG000|Overall Study|Withdrawal by Subject|5|||
147585817|NCT00585312|532299322|FG001|Overall Study|Withdrawal by Subject|1|||
147585818|NCT00585312|532299321|FG000|Overall Study|Study terminated by the sponsor|34|||
147585819|NCT00585312|532299322|FG001|Overall Study|Study terminated by the sponsor|31|||
147585820|NCT04234464|532299323|FG000|Period 2 (Second Treatment Intervention)|Subject did not meet the pre-dose FEV₁ criterion of >70% predicted at Visit 4/Visit 4 repeat.|1|||
147585821|NCT04234464|532299324|FG001|Period 2 (Second Treatment Intervention)|Subject did not meet the pre-dose FEV₁ criterion of >70% predicted at Visit 4/Visit 4 repeat.|0|||
147585822|NCT00983528|532299325|FG000|Overall Study|Death|4|||
147585823|NCT00983528|532299325|FG000|Overall Study|Lost to Follow-up|1|||
147585824|NCT00983528|532299325|FG000|Overall Study|Study Terminated|1|||
147585825|NCT00330460|532299330|FG000|Overall Study|Physician Decision|1|||
147585826|NCT00330460|532299331|FG001|Overall Study|Physician Decision|0|||
147585827|NCT00330460|532299330|FG000|Overall Study|Adverse Event|10|||
147585828|NCT00330460|532299331|FG001|Overall Study|Adverse Event|8|||
147585829|NCT00330460|532299330|FG000|Overall Study|Withdrawal by Subject|18|||
147585830|NCT00330460|532299331|FG001|Overall Study|Withdrawal by Subject|17|||
147585831|NCT00330460|532299330|FG000|Overall Study|Death|1|||
147585832|NCT00330460|532299331|FG001|Overall Study|Death|1|||
147585833|NCT00330460|532299330|FG000|Overall Study|Ineligibility determined|1|||
147585834|NCT00330460|532299331|FG001|Overall Study|Ineligibility determined|3|||
147585835|NCT00330460|532299330|FG000|Overall Study|Lost to Follow-up|8|||
147585836|NCT00330460|532299331|FG001|Overall Study|Lost to Follow-up|3|||
147585837|NCT00330460|532299330|FG000|Overall Study|Noncompliance|2|||
147585838|NCT00330460|532299331|FG001|Overall Study|Noncompliance|1|||
147585839|NCT00330460|532299330|FG000|Overall Study|Other|1|||
147585840|NCT00330460|532299331|FG001|Overall Study|Other|0|||
147585841|NCT03712124|532299332|FG000|Overall Study|Protocol Violation|1|||
147585842|NCT03712124|532299333|FG001|Overall Study|Protocol Violation|0|||
147585843|NCT02941523|532299335|FG000|Monotherapy|Withdrawal by Subject|0|||
147585844|NCT02941523|532299336|FG001|Monotherapy|Withdrawal by Subject|1|||
147585845|NCT02941523|532299335|FG000|Carboplatin Combination Therapy|Adverse Event|0|||
147585846|NCT02941523|532299336|FG001|Carboplatin Combination Therapy|Adverse Event|1|||
147585847|NCT02941523|532299335|FG000|Carboplatin Combination Therapy|Death|1|||
147585848|NCT02941523|532299336|FG001|Carboplatin Combination Therapy|Death|2|||
147585849|NCT02941523|532299335|FG000|Carboplatin Combination Therapy|Disease progression|2|||
147585850|NCT02941523|532299336|FG001|Carboplatin Combination Therapy|Disease progression|0|||
147158643|NCT03054350|530745500|FG005|Primary Efficacy Period (6 Weeks)|ESA Rescue/Blood Transfusion for Anemia|3|||
147158644|NCT03054350|530745495|FG000|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0|||
147158645|NCT03054350|530745496|FG001|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0|||
147158646|NCT03054350|530745497|FG002|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|1|||
147158647|NCT03054350|530745498|FG003|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0|||
147158648|NCT03054350|530745499|FG004|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0|||
147158649|NCT03054350|530745500|FG005|Primary Efficacy Period (6 Weeks)|Withdrawal by Subject|0|||
147158650|NCT03054350|530745495|FG000|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|1|||
147585851|NCT02941523|532299335|FG000|Carboplatin Combination Therapy|Withdrawal by Subject|2|||
147585852|NCT02941523|532299336|FG001|Carboplatin Combination Therapy|Withdrawal by Subject|1|||
147585853|NCT02539368|532299337|FG000|Overall Study|Death|4|||
147585854|NCT02539368|532299338|FG001|Overall Study|Death|2|||
147585855|NCT02539368|532299339|FG002|Overall Study|Death|1|||
147585856|NCT02539368|532299340|FG003|Overall Study|Death|0|||
147585857|NCT02539368|532299341|FG004|Overall Study|Death|0|||
147585858|NCT02539368|532299337|FG000|Overall Study|Withdrawal by Subject|44|||
147585859|NCT02539368|532299338|FG001|Overall Study|Withdrawal by Subject|35|||
147585860|NCT02539368|532299339|FG002|Overall Study|Withdrawal by Subject|9|||
147585861|NCT02539368|532299340|FG003|Overall Study|Withdrawal by Subject|1|||
147585862|NCT02539368|532299341|FG004|Overall Study|Withdrawal by Subject|3|||
147585863|NCT02539368|532299337|FG000|Overall Study|Physician Decision|49|||
147585864|NCT02539368|532299338|FG001|Overall Study|Physician Decision|15|||
147585865|NCT02539368|532299339|FG002|Overall Study|Physician Decision|7|||
147158651|NCT03054350|530745496|FG001|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|0|||
147158652|NCT03054350|530745497|FG002|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|0|||
147585866|NCT02539368|532299340|FG003|Overall Study|Physician Decision|0|||
147585867|NCT02539368|532299341|FG004|Overall Study|Physician Decision|2|||
147585868|NCT02539368|532299337|FG000|Overall Study|Lost to Follow-up|96|||
147585869|NCT02539368|532299338|FG001|Overall Study|Lost to Follow-up|21|||
147585870|NCT02539368|532299339|FG002|Overall Study|Lost to Follow-up|16|||
147585871|NCT02539368|532299340|FG003|Overall Study|Lost to Follow-up|4|||
147585872|NCT02539368|532299341|FG004|Overall Study|Lost to Follow-up|3|||
147585873|NCT02539368|532299337|FG000|Overall Study|Adverse Event|44|||
147585874|NCT02539368|532299338|FG001|Overall Study|Adverse Event|5|||
147585875|NCT02539368|532299339|FG002|Overall Study|Adverse Event|9|||
147585876|NCT02539368|532299340|FG003|Overall Study|Adverse Event|0|||
147585877|NCT02539368|532299341|FG004|Overall Study|Adverse Event|3|||
147585878|NCT02539368|532299337|FG000|Overall Study|Participant Non-compliant|13|||
147585879|NCT02539368|532299338|FG001|Overall Study|Participant Non-compliant|2|||
147158653|NCT03054350|530745498|FG003|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|1|||
147158654|NCT03054350|530745499|FG004|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|0|||
147158655|NCT03054350|530745500|FG005|Dose Adjustment and Maintenance Period|ESA Rescue/Blood Transfusion for Anemia|0|||
147585880|NCT02539368|532299339|FG002|Overall Study|Participant Non-compliant|1|||
147585881|NCT02539368|532299340|FG003|Overall Study|Participant Non-compliant|1|||
147585882|NCT02539368|532299341|FG004|Overall Study|Participant Non-compliant|0|||
147585883|NCT02539368|532299337|FG000|Overall Study|Other|145|||
147585884|NCT02539368|532299338|FG001|Overall Study|Other|18|||
147585885|NCT02539368|532299339|FG002|Overall Study|Other|24|||
147654381|NCT00237692|532556703|FG001|Overall Study|Excluded - did not meet criteria|3|||
147654382|NCT00237692|532556704|FG002|Overall Study|Excluded - did not meet criteria|5|||
147158656|NCT03054350|530745495|FG000|Dose Adjustment and Maintenance Period|Captured as Other|0|||
147585886|NCT02539368|532299340|FG003|Overall Study|Other|1|||
147585887|NCT02539368|532299341|FG004|Overall Study|Other|3|||
147585888|NCT02539368|532299337|FG000|Overall Study|Missing|10|||
147654383|NCT00237692|532556705|FG003|Overall Study|Excluded - did not meet criteria|9|||
147585889|NCT02539368|532299338|FG001|Overall Study|Missing|3|||
147585890|NCT02539368|532299339|FG002|Overall Study|Missing|0|||
147585891|NCT02539368|532299340|FG003|Overall Study|Missing|0|||
147585892|NCT02539368|532299341|FG004|Overall Study|Missing|0|||
147585893|NCT00105157|532299343|FG000|Double-Blind (DB)|Never Treated|1|||
147585894|NCT00105157|532299344|FG001|Double-Blind (DB)|Never Treated|0|||
147585895|NCT00105157|532299345|FG002|Double-Blind (DB)|Never Treated|0|||
147585896|NCT00105157|532299346|FG003|Double-Blind (DB)|Never Treated|0|||
147585897|NCT00105157|532299343|FG000|Double-Blind (DB)|Adverse Event|2|||
147585898|NCT00105157|532299344|FG001|Double-Blind (DB)|Adverse Event|0|||
147585899|NCT00105157|532299345|FG002|Double-Blind (DB)|Adverse Event|1|||
147585900|NCT00105157|532299346|FG003|Double-Blind (DB)|Adverse Event|1|||
147585901|NCT00105157|532299343|FG000|Double-Blind (DB)|Lack of Efficacy|11|||
147585902|NCT00105157|532299344|FG001|Double-Blind (DB)|Lack of Efficacy|14|||
147585903|NCT00105157|532299345|FG002|Double-Blind (DB)|Lack of Efficacy|11|||
147585904|NCT00105157|532299346|FG003|Double-Blind (DB)|Lack of Efficacy|38|||
147585905|NCT00105157|532299343|FG000|Open-Label Continuation of DB|Adverse Event|3|||
147585906|NCT00105157|532299344|FG001|Open-Label Continuation of DB|Adverse Event|1|||
147585907|NCT00105157|532299345|FG002|Open-Label Continuation of DB|Adverse Event|0|||
147585908|NCT00105157|532299346|FG003|Open-Label Continuation of DB|Adverse Event|0|||
147585909|NCT00105157|532299343|FG000|Open-Label Continuation of DB|Lack of Efficacy|1|||
147585910|NCT00105157|532299344|FG001|Open-Label Continuation of DB|Lack of Efficacy|4|||
147585911|NCT00105157|532299345|FG002|Open-Label Continuation of DB|Lack of Efficacy|3|||
147585912|NCT00105157|532299346|FG003|Open-Label Continuation of DB|Lack of Efficacy|1|||
147585913|NCT00105157|532299343|FG000|Open-Label Continuation of DB|Lost to Follow-up|1|||
147585914|NCT00105157|532299344|FG001|Open-Label Continuation of DB|Lost to Follow-up|1|||
147585915|NCT00105157|532299345|FG002|Open-Label Continuation of DB|Lost to Follow-up|1|||
147585916|NCT00105157|532299346|FG003|Open-Label Continuation of DB|Lost to Follow-up|0|||
147585917|NCT00105157|532299343|FG000|Open-Label Continuation of DB|Withdrawal by Subject|0|||
147585918|NCT00105157|532299344|FG001|Open-Label Continuation of DB|Withdrawal by Subject|1|||
147585919|NCT00105157|532299345|FG002|Open-Label Continuation of DB|Withdrawal by Subject|3|||
147585920|NCT00105157|532299346|FG003|Open-Label Continuation of DB|Withdrawal by Subject|0|||
147585921|NCT00105157|532299343|FG000|Open-Label Continuation of DB|Patient did not continue in extension|1|||
147585922|NCT00105157|532299344|FG001|Open-Label Continuation of DB|Patient did not continue in extension|0|||
147585923|NCT00105157|532299345|FG002|Open-Label Continuation of DB|Patient did not continue in extension|0|||
147585924|NCT00105157|532299346|FG003|Open-Label Continuation of DB|Patient did not continue in extension|0|||
147585925|NCT00105157|532299343|FG000|Open-Label Continuation of DB|Patient moved/site stopped trial|1|||
147585926|NCT00105157|532299344|FG001|Open-Label Continuation of DB|Patient moved/site stopped trial|3|||
147585927|NCT00105157|532299345|FG002|Open-Label Continuation of DB|Patient moved/site stopped trial|2|||
147585928|NCT00105157|532299346|FG003|Open-Label Continuation of DB|Patient moved/site stopped trial|0|||
147585929|NCT00105157|532299343|FG000|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|0|||
147585930|NCT00105157|532299344|FG001|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|0|||
147585931|NCT00105157|532299345|FG002|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|0|||
147585932|NCT00105157|532299346|FG003|Open-Label Post Virologic Failure(OLPVF)|Adverse Event|1|||
147585933|NCT00105157|532299343|FG000|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|7|||
147585934|NCT00105157|532299344|FG001|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|6|||
147585935|NCT00105157|532299345|FG002|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|5|||
147585936|NCT00105157|532299346|FG003|Open-Label Post Virologic Failure(OLPVF)|Lack of Efficacy|10|||
147585937|NCT00105157|532299343|FG000|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|1|||
147585938|NCT00105157|532299344|FG001|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|0|||
147585939|NCT00105157|532299345|FG002|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|0|||
147585940|NCT00105157|532299346|FG003|Open-Label Post Virologic Failure(OLPVF)|Lost to Follow-up|1|||
147585941|NCT00105157|532299343|FG000|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|0|||
147585942|NCT00105157|532299344|FG001|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|0|||
147585943|NCT00105157|532299345|FG002|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|0|||
147585944|NCT00105157|532299346|FG003|Open-Label Post Virologic Failure(OLPVF)|Withdrawal by Subject|5|||
147585945|NCT00105157|532299343|FG000|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|1|||
147585946|NCT00105157|532299344|FG001|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|0|||
147585947|NCT00105157|532299345|FG002|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|1|||
147585948|NCT00105157|532299346|FG003|Open-Label Post Virologic Failure(OLPVF)|Patient moved/Site stopped trial|1|||
147585949|NCT00127166|532299347|FG000|Period I|Protocol Violation|0|||
147585950|NCT00127166|532299348|FG001|Period I|Protocol Violation|2|||
147585951|NCT00127166|532299347|FG000|Period I|Withdrawal by Subject|2|||
147585952|NCT00127166|532299348|FG001|Period I|Withdrawal by Subject|0|||
147585953|NCT00127166|532299347|FG000|Period I|Patient did not meet inclusion criteria|1|||
147585954|NCT00127166|532299348|FG001|Period I|Patient did not meet inclusion criteria|0|||
147158657|NCT03054350|530745496|FG001|Dose Adjustment and Maintenance Period|Captured as Other|0|||
147158658|NCT03054350|530745497|FG002|Dose Adjustment and Maintenance Period|Captured as Other|1|||
147158659|NCT03054350|530745498|FG003|Dose Adjustment and Maintenance Period|Captured as Other|0|||
147158660|NCT03054350|530745499|FG004|Dose Adjustment and Maintenance Period|Captured as Other|0|||
147158661|NCT03054350|530745500|FG005|Dose Adjustment and Maintenance Period|Captured as Other|0|||
147158662|NCT00772369|530745501|FG000|Overall Study|Did not return record release form|1|||
147158663|NCT03510468|530745502|FG000|Overall Study|Lost to Follow-up|1|||
147158664|NCT03510468|530745502|FG000|Overall Study|Adverse Event|5|||
147585955|NCT00127166|532299347|FG000|Washout Period|Patient did not meet inclusion criteria|0|||
147585956|NCT00127166|532299348|FG001|Washout Period|Patient did not meet inclusion criteria|1|||
147585957|NCT00127166|532299347|FG000|Period II|Withdrawal by Subject|2|||
147585958|NCT00127166|532299348|FG001|Period II|Withdrawal by Subject|0|||
147585959|NCT00127166|532299347|FG000|Period II|Patient did not perform Visit 6 exercise|1|||
147158665|NCT03510468|530745502|FG000|Overall Study|Physician Decision|1|||
147585960|NCT00127166|532299348|FG001|Period II|Patient did not perform Visit 6 exercise|0|||
147585961|NCT01396421|532299351|FG000|Overall Study|Lost to Follow-up|0|||
147585962|NCT01396421|532299352|FG001|Overall Study|Lost to Follow-up|0|||
147585963|NCT01396421|532299353|FG002|Overall Study|Lost to Follow-up|0|||
147585964|NCT01396421|532299354|FG003|Overall Study|Lost to Follow-up|1|||
147585965|NCT01396421|532299351|FG000|Overall Study|Adverse Event|17|||
147585966|NCT01396421|532299352|FG001|Overall Study|Adverse Event|15|||
147585967|NCT01396421|532299353|FG002|Overall Study|Adverse Event|12|||
147585968|NCT01396421|532299354|FG003|Overall Study|Adverse Event|32|||
147585969|NCT01396421|532299351|FG000|Overall Study|Participant Met Withdrawal Criteria|1|||
147585970|NCT01396421|532299352|FG001|Overall Study|Participant Met Withdrawal Criteria|0|||
147585971|NCT01396421|532299353|FG002|Overall Study|Participant Met Withdrawal Criteria|1|||
147585972|NCT01396421|532299354|FG003|Overall Study|Participant Met Withdrawal Criteria|0|||
147585973|NCT01396421|532299351|FG000|Overall Study|Physician Decision|1|||
147585974|NCT01396421|532299352|FG001|Overall Study|Physician Decision|1|||
147585975|NCT01396421|532299353|FG002|Overall Study|Physician Decision|0|||
147585976|NCT01396421|532299354|FG003|Overall Study|Physician Decision|3|||
147585977|NCT01396421|532299351|FG000|Overall Study|Withdrawal by Subject|31|||
147158666|NCT03510468|530745502|FG000|Overall Study|non-compliant with treatment|2|||
147158667|NCT03510468|530745502|FG000|Overall Study|Missed visit|1|||
147158668|NCT03372460|530745503|FG000|Overall Study|Discontinued due to stimulation site discomfort|0|||
147158669|NCT03372460|530745504|FG001|Overall Study|Discontinued due to stimulation site discomfort|1|||
147158670|NCT02499900|530745505|FG000|Core Study Period|Other|1|||
147158671|NCT02499900|530745506|FG001|Core Study Period|Other|4|||
147158672|NCT02499900|530745505|FG000|Core Study Period|Lost to Follow-up|1|||
147158673|NCT02499900|530745506|FG001|Core Study Period|Lost to Follow-up|2|||
147158674|NCT02499900|530745505|FG000|Core Study Period|Per sponsor request|0|||
147158675|NCT02499900|530745506|FG001|Core Study Period|Per sponsor request|1|||
147158676|NCT02499900|530745505|FG000|Core Study Period|Pregnancy|1|||
147158677|NCT02499900|530745506|FG001|Core Study Period|Pregnancy|0|||
147158678|NCT02499900|530745505|FG000|Core Study Period|Protocol Violation|3|||
147158679|NCT02499900|530745506|FG001|Core Study Period|Protocol Violation|0|||
147158680|NCT02499900|530745505|FG000|Core Study Period|Withdrawal by Subject|11|||
147158681|NCT02499900|530745506|FG001|Core Study Period|Withdrawal by Subject|10|||
147158682|NCT02499900|530745505|FG000|Core Study Period|Adverse Event|18|||
147158683|NCT02499900|530745506|FG001|Core Study Period|Adverse Event|14|||
147585978|NCT01396421|532299352|FG001|Overall Study|Withdrawal by Subject|24|||
147158684|NCT02499900|530745505|FG000|Core Study Period|Death|0|||
147241351|NCT00599924|531055846|FG004|Overall Study|Withdrawal by Subject|1|||
147241352|NCT00599924|531055847|FG005|Overall Study|Withdrawal by Subject|0|||
147241353|NCT00599924|531055848|FG006|Overall Study|Withdrawal by Subject|0|||
147241354|NCT00599924|531055842|FG000|Overall Study|Other|0|||
147241355|NCT00599924|531055843|FG001|Overall Study|Other|0|||
147241356|NCT00599924|531055844|FG002|Overall Study|Other|0|||
147241357|NCT00599924|531055845|FG003|Overall Study|Other|1|||
147241358|NCT00599924|531055846|FG004|Overall Study|Other|2|||
147241359|NCT00599924|531055847|FG005|Overall Study|Other|0|||
147241360|NCT00599924|531055848|FG006|Overall Study|Other|2|||
147241361|NCT01806298|531055849|FG000|Overall Study|Adverse Event|3|||
147241362|NCT01806298|531055849|FG000|Overall Study|Protocol Non-compliance|1|||
147241363|NCT01806298|531055849|FG000|Overall Study|Withdrawal by Subject|1|||
147241364|NCT01806298|531055849|FG000|Overall Study|Other|5|||
147241365|NCT00980057|531055854|FG000|Overall Study|Death|13|||
147585979|NCT01396421|532299353|FG002|Overall Study|Withdrawal by Subject|13|||
147585980|NCT01396421|532299354|FG003|Overall Study|Withdrawal by Subject|21|||
147585981|NCT01396421|532299351|FG000|Overall Study|Protocol Deviation|2|||
147654384|NCT00237692|532556702|FG000|Overall Study|Withdrawal by Subject|4|||
147654385|NCT00237692|532556703|FG001|Overall Study|Withdrawal by Subject|6|||
147158685|NCT02499900|530745506|FG001|Core Study Period|Death|1|||
147158686|NCT02499900|530745505|FG000|Completed Core, Continued Into Extension|Physician Decision|1|||
147158687|NCT02499900|530745506|FG001|Completed Core, Continued Into Extension|Physician Decision|0|||
147241366|NCT00980057|531055855|FG001|Overall Study|Death|3|||
147241367|NCT00980057|531055854|FG000|Overall Study|Adverse Event|0|||
147241368|NCT00980057|531055855|FG001|Overall Study|Adverse Event|1|||
147241369|NCT00980057|531055854|FG000|Overall Study|Physician Decision|4|||
147585982|NCT01396421|532299352|FG001|Overall Study|Protocol Deviation|1|||
147585983|NCT01396421|532299353|FG002|Overall Study|Protocol Deviation|1|||
147585984|NCT01396421|532299354|FG003|Overall Study|Protocol Deviation|0|||
147585985|NCT01396421|532299351|FG000|Overall Study|Lack of Efficacy|7|||
147585986|NCT01396421|532299352|FG001|Overall Study|Lack of Efficacy|17|||
147585987|NCT01396421|532299353|FG002|Overall Study|Lack of Efficacy|7|||
147585988|NCT01396421|532299354|FG003|Overall Study|Lack of Efficacy|18|||
147241370|NCT00980057|531055855|FG001|Overall Study|Physician Decision|0|||
147241371|NCT00980057|531055854|FG000|Overall Study|Lost to Follow-up|1|||
147241372|NCT00980057|531055855|FG001|Overall Study|Lost to Follow-up|0|||
147241373|NCT00980057|531055854|FG000|Overall Study|Withdrawal by Subject|1|||
147241374|NCT00980057|531055855|FG001|Overall Study|Withdrawal by Subject|1|||
147241375|NCT04980040|531055856|FG000|Overall Study|Violated the Inclusion Criteria|260|||
147241376|NCT04980040|531055856|FG000|Overall Study|Violated the Administration & Dosage|225|||
147241377|NCT04980040|531055856|FG000|Overall Study|Lost to Safety-Follow-up|4|||
147241378|NCT04980040|531055856|FG000|Overall Study|Administered the study drug prior to signing the informed consent form|3|||
147241379|NCT00691015|531055860|FG000|Overall Study|Refused further treatment|1|||
147241380|NCT00592384|531055865|FG000|Overall Study|Withdrawal by Subject|5|||
147241381|NCT00592384|531055866|FG001|Overall Study|Withdrawal by Subject|6|||
147241382|NCT03600818|531055867|FG000|Overall Study|Adverse Event|4|||
147241383|NCT03600818|531055868|FG001|Overall Study|Adverse Event|7|||
147241384|NCT03600818|531055867|FG000|Overall Study|Lack of Efficacy|9|||
147241385|NCT03600818|531055868|FG001|Overall Study|Lack of Efficacy|4|||
147241386|NCT03600818|531055867|FG000|Overall Study|Withdrawal by Subject|4|||
147241387|NCT03600818|531055868|FG001|Overall Study|Withdrawal by Subject|3|||
147241388|NCT03600818|531055867|FG000|Overall Study|Other-unspecified|5|||
147241389|NCT03600818|531055868|FG001|Overall Study|Other-unspecified|3|||
147241390|NCT03600818|531055867|FG000|Overall Study|Randomized and not treated|0|||
147241391|NCT03600818|531055868|FG001|Overall Study|Randomized and not treated|1|||
147241392|NCT03478930|531055872|FG000|Overall Study|Adverse Event|0|||
147241393|NCT03478930|531055873|FG001|Overall Study|Adverse Event|1|||
147241394|NCT03478930|531055872|FG000|Overall Study|Lack of Efficacy|3|||
147241395|NCT03478930|531055873|FG001|Overall Study|Lack of Efficacy|3|||
147241396|NCT03478930|531055872|FG000|Overall Study|Withdrawal by Subject|6|||
147241397|NCT03478930|531055873|FG001|Overall Study|Withdrawal by Subject|5|||
147241398|NCT04189081|531055874|FG000|Overall Study|Lost to Follow-up|1|||
147241399|NCT04189081|531055875|FG001|Overall Study|Lost to Follow-up|0|||
147241400|NCT04189081|531055876|FG002|Overall Study|Lost to Follow-up|0|||
147241401|NCT04189081|531055874|FG000|Overall Study|Withdrawal by Subject|0|||
147241402|NCT04189081|531055875|FG001|Overall Study|Withdrawal by Subject|0|||
147241403|NCT04189081|531055876|FG002|Overall Study|Withdrawal by Subject|1|||
147241404|NCT00044083|531055877|FG000|First Intervention (One Week)- HV's|Adverse Event|1|||
147241405|NCT00044083|531055878|FG001|First Intervention (One Week)- HV's|Adverse Event|0|||
147241406|NCT00044083|531055877|FG000|First Intervention (One Week)- HV's|Not follow directions|2|||
147241407|NCT00044083|531055878|FG001|First Intervention (One Week)- HV's|Not follow directions|2|||
147241408|NCT00044083|531055877|FG000|First Intervention (One Week)- HV's|Withdrawal by Subject|5|||
147241409|NCT00044083|531055878|FG001|First Intervention (One Week)- HV's|Withdrawal by Subject|3|||
147241410|NCT00044083|531055877|FG000|First Intervention (One Week)- HV's|Pregnancy|1|||
147241411|NCT00044083|531055878|FG001|First Intervention (One Week)- HV's|Pregnancy|0|||
147241412|NCT00044083|531055877|FG000|First Intervention (One Week)- HV's|Used illegal drugs|1|||
147241413|NCT00044083|531055878|FG001|First Intervention (One Week)- HV's|Used illegal drugs|0|||
147241414|NCT00044083|531055877|FG000|First Intervention (One Week)- HV's|Abnormal MRI|0|||
147241415|NCT00044083|531055878|FG001|First Intervention (One Week)- HV's|Abnormal MRI|1|||
147241416|NCT00044083|531055877|FG000|First Intervention (One Week)- HV's|Drank while on protocol|0|||
147241417|NCT00044083|531055878|FG001|First Intervention (One Week)- HV's|Drank while on protocol|1|||
147241418|NCT00044083|531055877|FG000|First Intervention (One Week) Patients|Not follow directions|0|||
147241419|NCT00044083|531055878|FG001|First Intervention (One Week) Patients|Not follow directions|2|||
147241420|NCT00044083|531055877|FG000|First Intervention (One Week) Patients|Used illegal drug|1|||
147241421|NCT00044083|531055878|FG001|First Intervention (One Week) Patients|Used illegal drug|0|||
147241422|NCT00044083|531055877|FG000|Second Intervention (One Week) Patients|Withdrawal by Subject|0|||
147585989|NCT00569777|532299356|FG000|Overall Study|Withdrawal by Subject|4|||
147585990|NCT00569777|532299357|FG001|Overall Study|Withdrawal by Subject|0|||
147585991|NCT00569777|532299356|FG000|Overall Study|Adverse Event|3|||
147585992|NCT00569777|532299357|FG001|Overall Study|Adverse Event|0|||
147585993|NCT00569777|532299356|FG000|Overall Study|Lost to Follow-up|1|||
147585994|NCT00569777|532299357|FG001|Overall Study|Lost to Follow-up|0|||
147585995|NCT00569777|532299356|FG000|Overall Study|scheduled eye surgery|0|||
147241423|NCT00044083|531055878|FG001|Second Intervention (One Week) Patients|Withdrawal by Subject|1|||
147241424|NCT00851747|531055879|FG000|Overall Study|Physician Decision|6|||
147241425|NCT00851747|531055880|FG001|Overall Study|Physician Decision|6|||
147241426|NCT00851747|531055881|FG002|Overall Study|Physician Decision|6|||
147241427|NCT02197520|531055886|FG000|Period 1|Withdrawal by Subject|1|||
147241428|NCT02197520|531055887|FG001|Period 1|Withdrawal by Subject|0|||
147241429|NCT02197520|531055886|FG000|Period 2|Adverse Event|0|||
147241430|NCT02197520|531055887|FG001|Period 2|Adverse Event|2|||
147241431|NCT02197520|531055886|FG000|Period 2|Withdrawal by Subject|1|||
147241432|NCT02197520|531055887|FG001|Period 2|Withdrawal by Subject|0|||
147241433|NCT00913497|531055888|FG000|Overall Study|Adverse Event|1|||
147241434|NCT00913497|531055888|FG000|Overall Study|Withdrawal by Subject|2|||
147585996|NCT00569777|532299357|FG001|Overall Study|scheduled eye surgery|1|||
147585997|NCT00569777|532299356|FG000|Overall Study|did not meet exclusion criteria|1|||
147241435|NCT03385564|531055889|FG000|Overall Study|Adverse Event|0|||
147241436|NCT03385564|531055890|FG001|Overall Study|Adverse Event|0|||
147241437|NCT03385564|531055891|FG002|Overall Study|Adverse Event|3|||
147241438|NCT03385564|531055892|FG003|Overall Study|Adverse Event|3|||
147241439|NCT03385564|531055889|FG000|Overall Study|Other than listed|0|||
147241440|NCT03385564|531055890|FG001|Overall Study|Other than listed|0|||
147241441|NCT03385564|531055891|FG002|Overall Study|Other than listed|0|||
147241442|NCT03385564|531055892|FG003|Overall Study|Other than listed|5|||
147241443|NCT03385564|531055889|FG000|Overall Study|Withdrawal by Subject|0|||
147241444|NCT03385564|531055890|FG001|Overall Study|Withdrawal by Subject|1|||
147241445|NCT03385564|531055891|FG002|Overall Study|Withdrawal by Subject|1|||
147241446|NCT03385564|531055892|FG003|Overall Study|Withdrawal by Subject|0|||
147241447|NCT03385564|531055889|FG000|Overall Study|Lack of Efficacy|0|||
147241448|NCT03385564|531055890|FG001|Overall Study|Lack of Efficacy|0|||
147241449|NCT03385564|531055891|FG002|Overall Study|Lack of Efficacy|0|||
147241450|NCT03385564|531055892|FG003|Overall Study|Lack of Efficacy|1|||
147241451|NCT03385564|531055889|FG000|Overall Study|Death|0|||
147241452|NCT03385564|531055890|FG001|Overall Study|Death|0|||
147241453|NCT03385564|531055891|FG002|Overall Study|Death|1|||
147241454|NCT03385564|531055892|FG003|Overall Study|Death|0|||
147241455|NCT03087643|531055897|FG000|Overall Study|Withdrawal by Subject|2|||
147241456|NCT03087643|531055898|FG001|Overall Study|Withdrawal by Subject|4|||
147241457|NCT03087643|531055897|FG000|Overall Study|Death|2|||
147241458|NCT03087643|531055898|FG001|Overall Study|Death|2|||
147241459|NCT01546883|531055902|FG000|Overall Study|Withdrawal by Subject|3|||
147241460|NCT01546883|531055902|FG000|Overall Study|Adverse Event|4|||
147241461|NCT01546883|531055902|FG000|Overall Study|Lost to Follow-up|2|||
147241462|NCT01546883|531055902|FG000|Overall Study|early closure of study|2|||
147241463|NCT01546883|531055902|FG000|Overall Study|other unrelated illness|1|||
147241464|NCT02256631|531055907|FG000|Overall Study|Lost to Follow-up|1|||
147241465|NCT02256631|531055908|FG001|Overall Study|Lost to Follow-up|1|||
147241466|NCT02256631|531055909|FG002|Overall Study|Lost to Follow-up|0|||
147241467|NCT02256631|531055910|FG003|Overall Study|Lost to Follow-up|2|||
147241468|NCT02256631|531055911|FG004|Overall Study|Lost to Follow-up|0|||
147158688|NCT02499900|530745505|FG000|Completed Core, Continued Into Extension|Withdrawal by Subject|0|||
147158689|NCT02499900|530745506|FG001|Completed Core, Continued Into Extension|Withdrawal by Subject|2|||
147158690|NCT02499900|530745505|FG000|Completed Core, Continued Into Extension|Did not wish to take injectables drugs|1|||
147158691|NCT02499900|530745506|FG001|Completed Core, Continued Into Extension|Did not wish to take injectables drugs|0|||
147158692|NCT02499900|530745505|FG000|Completed Core, Continued Into Extension|Personal motivation|1|||
147158693|NCT02499900|530745506|FG001|Completed Core, Continued Into Extension|Personal motivation|0|||
147158694|NCT02499900|530745505|FG000|Extension Study Period|Adverse Event|2|||
147158695|NCT02499900|530745506|FG001|Extension Study Period|Adverse Event|4|||
147158696|NCT02499900|530745505|FG000|Extension Study Period|Withdrawal by Subject|5|||
147158697|NCT02499900|530745506|FG001|Extension Study Period|Withdrawal by Subject|2|||
147158698|NCT02499900|530745505|FG000|Extension Study Period|Physician Decision|2|||
147158699|NCT02499900|530745506|FG001|Extension Study Period|Physician Decision|5|||
147158700|NCT02499900|530745505|FG000|Extension Study Period|Pregnancy|1|||
147158701|NCT02499900|530745506|FG001|Extension Study Period|Pregnancy|2|||
147158702|NCT02499900|530745505|FG000|Extension Study Period|Lost to Follow-up|2|||
147158703|NCT02499900|530745506|FG001|Extension Study Period|Lost to Follow-up|5|||
147158704|NCT02499900|530745505|FG000|Extension Study Period|Other|0|||
147158705|NCT02499900|530745506|FG001|Extension Study Period|Other|2|||
147158706|NCT01071200|530745529|FG000|Overall Study|Lack of ovarian response|1|||
147158707|NCT01071200|530745530|FG001|Overall Study|Lack of ovarian response|1|||
147158708|NCT01071200|530745529|FG000|Overall Study|No fertilization|4|||
147158709|NCT01071200|530745530|FG001|Overall Study|No fertilization|0|||
147158710|NCT01071200|530745529|FG000|Overall Study|No oocytes retrieved|1|||
147158711|NCT01071200|530745530|FG001|Overall Study|No oocytes retrieved|1|||
147158712|NCT01071200|530745529|FG000|Overall Study|Ovarian Hyper Stimulation Syndrome|1|||
147158713|NCT01071200|530745530|FG001|Overall Study|Ovarian Hyper Stimulation Syndrome|0|||
147158714|NCT01071200|530745529|FG000|Overall Study|No viable embryos|0|||
147158715|NCT01071200|530745530|FG001|Overall Study|No viable embryos|1|||
147158716|NCT02323204|530745538|FG000|Baseline Survey Completion|Withdrawal by Subject|10|||
147241469|NCT02256631|531055912|FG005|Overall Study|Lost to Follow-up|4|||
147241470|NCT02256631|531055913|FG006|Overall Study|Lost to Follow-up|1|||
147241471|NCT02256631|531055907|FG000|Overall Study|Withdrawal by Subject|0|||
147241472|NCT02256631|531055908|FG001|Overall Study|Withdrawal by Subject|0|||
147241473|NCT02256631|531055909|FG002|Overall Study|Withdrawal by Subject|0|||
147241474|NCT02256631|531055910|FG003|Overall Study|Withdrawal by Subject|1|||
147241475|NCT02256631|531055911|FG004|Overall Study|Withdrawal by Subject|1|||
147241476|NCT02256631|531055912|FG005|Overall Study|Withdrawal by Subject|0|||
147241477|NCT02256631|531055913|FG006|Overall Study|Withdrawal by Subject|1|||
147241478|NCT02256631|531055907|FG000|Overall Study|Unable to get to clinic|0|||
147241479|NCT02256631|531055908|FG001|Overall Study|Unable to get to clinic|2|||
147241480|NCT02256631|531055909|FG002|Overall Study|Unable to get to clinic|0|||
147241481|NCT02256631|531055910|FG003|Overall Study|Unable to get to clinic|1|||
147158717|NCT02323204|530745539|FG001|Baseline Survey Completion|Withdrawal by Subject|9|||
147158718|NCT02323204|530745540|FG002|Baseline Survey Completion|Withdrawal by Subject|5|||
147158719|NCT02323204|530745541|FG003|Baseline Survey Completion|Withdrawal by Subject|3|||
147158720|NCT02323204|530745538|FG000|6-week Follow-up Survey Completion|Lost to Follow-up|29|||
147158721|NCT02323204|530745539|FG001|6-week Follow-up Survey Completion|Lost to Follow-up|28|||
147158722|NCT02323204|530745540|FG002|6-week Follow-up Survey Completion|Lost to Follow-up|39|||
147158723|NCT02323204|530745541|FG003|6-week Follow-up Survey Completion|Lost to Follow-up|35|||
147158724|NCT02323204|530745538|FG000|6-week Follow-up Survey Completion|Withdrawal by Subject|12|||
147158725|NCT02323204|530745539|FG001|6-week Follow-up Survey Completion|Withdrawal by Subject|8|||
147158726|NCT02323204|530745540|FG002|6-week Follow-up Survey Completion|Withdrawal by Subject|3|||
147158727|NCT02323204|530745541|FG003|6-week Follow-up Survey Completion|Withdrawal by Subject|2|||
147158728|NCT02323204|530745538|FG000|6-week Follow-up Intervention Booster|Lost to Follow-up|0|||
147158729|NCT02323204|530745539|FG001|6-week Follow-up Intervention Booster|Lost to Follow-up|35|||
147158730|NCT02323204|530745540|FG002|6-week Follow-up Intervention Booster|Lost to Follow-up|0|||
147158731|NCT02323204|530745541|FG003|6-week Follow-up Intervention Booster|Lost to Follow-up|34|||
147158732|NCT02323204|530745538|FG000|6-week Follow-up Intervention Booster|Withdrawal by Subject|0|||
147158733|NCT02323204|530745539|FG001|6-week Follow-up Intervention Booster|Withdrawal by Subject|8|||
147158734|NCT02323204|530745540|FG002|6-week Follow-up Intervention Booster|Withdrawal by Subject|0|||
147158735|NCT02323204|530745541|FG003|6-week Follow-up Intervention Booster|Withdrawal by Subject|2|||
147158736|NCT02323204|530745538|FG000|3-month Follow-up Survey Completion|Lost to Follow-up|54|||
147158737|NCT02323204|530745539|FG001|3-month Follow-up Survey Completion|Lost to Follow-up|45|||
147158738|NCT02323204|530745540|FG002|3-month Follow-up Survey Completion|Lost to Follow-up|41|||
147158739|NCT02323204|530745541|FG003|3-month Follow-up Survey Completion|Lost to Follow-up|42|||
147158740|NCT02323204|530745538|FG000|3-month Follow-up Survey Completion|Withdrawal by Subject|0|||
147158741|NCT02323204|530745539|FG001|3-month Follow-up Survey Completion|Withdrawal by Subject|2|||
147158742|NCT02323204|530745540|FG002|3-month Follow-up Survey Completion|Withdrawal by Subject|0|||
147158743|NCT02323204|530745541|FG003|3-month Follow-up Survey Completion|Withdrawal by Subject|2|||
147158744|NCT02323204|530745538|FG000|6-month Follow-up Survey Completion|Lost to Follow-up|49|||
147158745|NCT02323204|530745539|FG001|6-month Follow-up Survey Completion|Lost to Follow-up|50|||
147158746|NCT02323204|530745540|FG002|6-month Follow-up Survey Completion|Lost to Follow-up|38|||
147158747|NCT02323204|530745541|FG003|6-month Follow-up Survey Completion|Lost to Follow-up|43|||
147158748|NCT02323204|530745538|FG000|6-month Follow-up Survey Completion|Withdrawal by Subject|0|||
147158749|NCT02323204|530745539|FG001|6-month Follow-up Survey Completion|Withdrawal by Subject|0|||
147158750|NCT02323204|530745540|FG002|6-month Follow-up Survey Completion|Withdrawal by Subject|3|||
147158751|NCT02323204|530745541|FG003|6-month Follow-up Survey Completion|Withdrawal by Subject|1|||
147158752|NCT04508751|530745544|FG000|Overall Study|Discontinued study early due to maternal discomfort|0|||
147158753|NCT04508751|530745545|FG001|Overall Study|Discontinued study early due to maternal discomfort|0|||
147158754|NCT04508751|530745546|FG002|Overall Study|Discontinued study early due to maternal discomfort|2|||
147158755|NCT02752958|530745547|FG000|Overall Study|Adverse Event|3|||
147158756|NCT02752958|530745547|FG000|Overall Study|Lost to Follow-up|1|||
147158757|NCT02752958|530745547|FG000|Overall Study|Protocol Violation|1|||
147158758|NCT02752958|530745547|FG000|Overall Study|Withdrawal by Subject|2|||
147158759|NCT02752958|530745547|FG000|Overall Study|Other (Reason not specified)|2|||
147158760|NCT03023826|530745549|FG000|Period 1|Withdrawal by Subject|0|||
147158761|NCT03023826|530745550|FG001|Period 1|Withdrawal by Subject|0|||
147158762|NCT03023826|530745551|FG002|Period 1|Withdrawal by Subject|0|||
147158763|NCT03023826|530745552|FG003|Period 1|Withdrawal by Subject|0|||
147585998|NCT00569777|532299357|FG001|Overall Study|did not meet exclusion criteria|2|||
147585999|NCT00569777|532299356|FG000|Overall Study|pregnant|1|||
147586000|NCT00569777|532299357|FG001|Overall Study|pregnant|0|||
147586001|NCT02843659|532299362|FG000|Overall Study|Subject Withdrew Consent|0|||
147586002|NCT02843659|532299363|FG001|Overall Study|Subject Withdrew Consent|0|||
147586003|NCT02843659|532299364|FG002|Overall Study|Subject Withdrew Consent|1|||
147586004|NCT02843659|532299362|FG000|Overall Study|Administrative Reason by Sponsor|4|||
147586005|NCT02843659|532299363|FG001|Overall Study|Administrative Reason by Sponsor|5|||
147586006|NCT02843659|532299364|FG002|Overall Study|Administrative Reason by Sponsor|4|||
147586007|NCT02843659|532299362|FG000|Overall Study|Adverse Event|0|||
147586008|NCT02843659|532299363|FG001|Overall Study|Adverse Event|1|||
147586009|NCT02843659|532299364|FG002|Overall Study|Adverse Event|0|||
147586010|NCT03180528|532300956|FG000|Overall Study|Adverse Event|1|||
147586011|NCT03180528|532300956|FG000|Overall Study|Withdrawal by Subject|1|||
147586012|NCT03180528|532300956|FG000|Overall Study|Eligible and enrolled, but withdrawn due to abnormal baseline laboratory values.|1|||
147586013|NCT02447887|532300957|FG000|Overall Study|Study was terminated|3|||
147586014|NCT00109837|532300958|FG000|Overall Study|Adverse Event|2|||
147586015|NCT00109837|532300958|FG000|Overall Study|Refusal unrelated to adverse effects|1|||
147586016|NCT00109837|532300958|FG000|Overall Study|Death|1|||
147586017|NCT00109837|532300958|FG000|Overall Study|BCR/ABL+ or Ph+|17|||
147586018|NCT00109837|532300958|FG000|Overall Study|Not treated|1|||
147586019|NCT00109837|532300958|FG000|Overall Study|Ineligible|1|||
147586020|NCT01563237|532300960|FG000|Overall Study|Lost to Follow-up|6|||
147158764|NCT03023826|530745553|FG004|Period 1|Withdrawal by Subject|1|||
147158765|NCT03023826|530745554|FG005|Period 1|Withdrawal by Subject|0|||
147158766|NCT01646645|530745555|FG000|Overall Study|No Treated|1|||
147158767|NCT01646645|530745555|FG000|Overall Study|Inevaluable Donor|29|||
147158768|NCT00072293|530745556|FG000|Overall Study|Lost to Follow-up|1|||
147158769|NCT00072293|530745557|FG001|Overall Study|Lost to Follow-up|1|||
147158770|NCT00072293|530745556|FG000|Overall Study|Withdrawal by Subject|0|||
147158771|NCT00072293|530745557|FG001|Overall Study|Withdrawal by Subject|1|||
147158772|NCT01896271|530745565|FG000|Overall Study|Physician Decision|10|||
147158773|NCT01514240|530747092|FG000|Overall Study|Adverse Event|4|||
147158774|NCT01514240|530747093|FG001|Overall Study|Adverse Event|4|||
147158775|NCT01514240|530747092|FG000|Overall Study|Subject Decision|2|||
147447007|NCT03099187|531800367|FG003|Double-blind Treatment|Withdrawal by Subject|0|||
147586021|NCT01563237|532300961|FG001|Overall Study|Lost to Follow-up|0|||
147586022|NCT01563237|532300960|FG000|Overall Study|Withdrawal by Subject|1|||
147586023|NCT01563237|532300961|FG001|Overall Study|Withdrawal by Subject|0|||
147586024|NCT01563237|532300960|FG000|Overall Study|Adverse Event|1|||
147586025|NCT01563237|532300961|FG001|Overall Study|Adverse Event|0|||
147586026|NCT01563237|532300960|FG000|Overall Study|Medical Reasons|1|||
147586027|NCT01563237|532300961|FG001|Overall Study|Medical Reasons|0|||
147586028|NCT01563237|532300960|FG000|Overall Study|Death|1|||
147586029|NCT01563237|532300961|FG001|Overall Study|Death|0|||
147586030|NCT00988208|532300962|FG000|Overall Study|Adverse Event|71|||
147586031|NCT00988208|532300963|FG001|Overall Study|Adverse Event|122|||
147586032|NCT00988208|532300962|FG000|Overall Study|Disease Progression|103|||
147586033|NCT00988208|532300963|FG001|Overall Study|Disease Progression|89|||
147447008|NCT03099187|531800364|FG000|Double-blind Treatment|Lung transplantation|0|||
147586034|NCT00988208|532300962|FG000|Overall Study|Withdrawal by Subject|50|||
147586035|NCT00988208|532300963|FG001|Overall Study|Withdrawal by Subject|57|||
147586036|NCT00988208|532300962|FG000|Overall Study|Death|9|||
147586037|NCT00988208|532300963|FG001|Overall Study|Death|15|||
147586038|NCT00988208|532300962|FG000|Overall Study|Lost to Follow-up|2|||
147586039|NCT00988208|532300963|FG001|Overall Study|Lost to Follow-up|3|||
147447009|NCT03099187|531800365|FG001|Double-blind Treatment|Lung transplantation|1|||
147447010|NCT03099187|531800366|FG002|Double-blind Treatment|Lung transplantation|0|||
147447011|NCT03099187|531800367|FG003|Double-blind Treatment|Lung transplantation|0|||
147586040|NCT00988208|532300962|FG000|Overall Study|Protocol Violation|9|||
147586041|NCT00988208|532300963|FG001|Overall Study|Protocol Violation|2|||
147654386|NCT00237692|532556704|FG002|Overall Study|Withdrawal by Subject|10|||
147654387|NCT00237692|532556705|FG003|Overall Study|Withdrawal by Subject|4|||
147654388|NCT01151345|532556712|FG000|First Intervention Period|Protocol Violation|0|||
147654389|NCT01151345|532556713|FG001|First Intervention Period|Protocol Violation|1|||
147654390|NCT02588092|532556714|FG000|Overall Study|Death|4|||
147654391|NCT02588092|532556715|FG001|Overall Study|Death|3|||
147654392|NCT02588092|532556716|FG002|Overall Study|Death|3|||
147586042|NCT00988208|532300962|FG000|Overall Study|Sponsor Decision|102|||
147586043|NCT00988208|532300963|FG001|Overall Study|Sponsor Decision|78|||
147586044|NCT00988208|532300962|FG000|Overall Study|Clinical Progression|17|||
147654393|NCT02588092|532556717|FG003|Overall Study|Death|3|||
147654394|NCT02588092|532556718|FG004|Overall Study|Death|2|||
147158776|NCT01514240|530747093|FG001|Overall Study|Subject Decision|7|||
147158777|NCT00509093|530747094|FG000|Overall Study|Adverse Event|10|||
147158778|NCT00509093|530747094|FG000|Overall Study|Disease Progression|9|||
147158779|NCT00509093|530747094|FG000|Overall Study|Transformed into MDS|1|||
147158780|NCT00509093|530747094|FG000|Overall Study|Withdrawal by Subject|3|||
147158781|NCT00509093|530747094|FG000|Overall Study|Physician Decision|1|||
147158782|NCT01103063|530747095|FG000|Overall Study|Adverse Event|3|||
147158783|NCT01103063|530747096|FG001|Overall Study|Adverse Event|1|||
147158784|NCT01103063|530747095|FG000|Overall Study|Lost to Follow-up|68|||
147158785|NCT01103063|530747096|FG001|Overall Study|Lost to Follow-up|51|||
147158786|NCT01103063|530747095|FG000|Overall Study|Withdrawal by Subject|60|||
147158787|NCT01103063|530747096|FG001|Overall Study|Withdrawal by Subject|15|||
147158788|NCT01103063|530747095|FG000|Overall Study|Other|16|||
147158789|NCT01103063|530747096|FG001|Overall Study|Other|11|||
147158790|NCT01103063|530747095|FG000|Overall Study|Protocol Violation|1|||
147158791|NCT01103063|530747096|FG001|Overall Study|Protocol Violation|0|||
147158792|NCT01103063|530747095|FG000|Overall Study|Study terminated by Sponsor|326|||
147158793|NCT01103063|530747096|FG001|Overall Study|Study terminated by Sponsor|342|||
147158794|NCT01103063|530747095|FG000|Overall Study|Death|3|||
147158795|NCT01103063|530747096|FG001|Overall Study|Death|1|||
147158796|NCT05320393|530747097|FG000|Overall Study|Withdrawal by Subject|1|||
147158797|NCT05320393|530747098|FG001|Overall Study|Withdrawal by Subject|0|||
147158798|NCT05320393|530747099|FG002|Overall Study|Withdrawal by Subject|2|||
147586045|NCT00988208|532300963|FG001|Overall Study|Clinical Progression|16|||
147654395|NCT02588092|532556719|FG005|Overall Study|Death|2|||
147654396|NCT02588092|532556720|FG006|Overall Study|Death|2|||
147158799|NCT05320393|530747097|FG000|Overall Study|Lost to Follow-up|1|||
147158800|NCT05320393|530747098|FG001|Overall Study|Lost to Follow-up|2|||
147158801|NCT05320393|530747099|FG002|Overall Study|Lost to Follow-up|1|||
147586046|NCT00988208|532300962|FG000|Overall Study|Biochemical Progression|21|||
147158802|NCT05320393|530747097|FG000|Overall Study|Moved; too much driving|0|||
147158803|NCT05320393|530747098|FG001|Overall Study|Moved; too much driving|0|||
147158804|NCT05320393|530747099|FG002|Overall Study|Moved; too much driving|2|||
147158805|NCT05320393|530747097|FG000|Overall Study|Did not receive treatment|0|||
147158806|NCT05320393|530747098|FG001|Overall Study|Did not receive treatment|0|||
147158807|NCT05320393|530747099|FG002|Overall Study|Did not receive treatment|1|||
147158808|NCT03283098|530747100|FG000|Overall Study|Withdrawal by Subject|0|||
147158809|NCT03283098|530747101|FG001|Overall Study|Withdrawal by Subject|1|||
147158810|NCT00798317|530747102|FG000|Overall Study|Physician Decision|0|||
147158811|NCT00798317|530747103|FG001|Overall Study|Physician Decision|1|||
147158812|NCT00798317|530747102|FG000|Overall Study|Withdrawal by Subject|5|||
147158813|NCT00798317|530747103|FG001|Overall Study|Withdrawal by Subject|4|||
147158814|NCT00798317|530747102|FG000|Overall Study|Lost to Follow-up|2|||
147158815|NCT00798317|530747103|FG001|Overall Study|Lost to Follow-up|2|||
147158816|NCT00798317|530747102|FG000|Overall Study|Adverse Event|2|||
147158817|NCT00798317|530747103|FG001|Overall Study|Adverse Event|0|||
147158818|NCT00798317|530747102|FG000|Overall Study|Death|1|||
147158819|NCT00798317|530747103|FG001|Overall Study|Death|0|||
147158820|NCT01069861|530747105|FG000|Overall Study|Death|1|||
147158821|NCT01069861|530747105|FG000|Overall Study|Adverse Event|1|||
147158822|NCT01069861|530747105|FG000|Overall Study|Did not meet entrance criteria|1|||
147158823|NCT01187446|530747106|FG000|Overall Study|Patient started non-protocol therapy|0|||
147158824|NCT01187446|530747107|FG001|Overall Study|Patient started non-protocol therapy|1|||
147158825|NCT00823212|530747108|FG000|Overall Study|Death|8|||
147158826|NCT00823212|530747109|FG001|Overall Study|Death|10|||
147158827|NCT00823212|530747108|FG000|Overall Study|Withdrawal by Subject|6|||
147158828|NCT00823212|530747109|FG001|Overall Study|Withdrawal by Subject|1|||
147158829|NCT00823212|530747108|FG000|Overall Study|Incarcerated|0|||
147158830|NCT00823212|530747109|FG001|Overall Study|Incarcerated|1|||
147158831|NCT00823212|530747108|FG000|Overall Study|Missed 12-month visit|21|||
147158832|NCT00823212|530747109|FG001|Overall Study|Missed 12-month visit|21|||
147158833|NCT00496197|530747110|FG000|Overall Study|Discontinued study due to death|43|||
147158834|NCT00496197|530747110|FG000|Overall Study|Adverse Event|13|||
147158835|NCT00496197|530747110|FG000|Overall Study|Does not meet entrance criteria|5|||
147158836|NCT00496197|530747110|FG000|Overall Study|Insufficient clinical response|3|||
147158837|NCT00496197|530747110|FG000|Overall Study|Insufficient bacteriological response|10|||
147158838|NCT00496197|530747110|FG000|Overall Study|Lost to Follow-up|11|||
147158839|NCT00496197|530747110|FG000|Overall Study|Withdrawal by Subject|11|||
147158840|NCT00496197|530747110|FG000|Overall Study|Pathogen not isolated baseline specimen|4|||
147158841|NCT00496197|530747110|FG000|Overall Study|Other|14|||
147158842|NCT00496197|530747110|FG000|Overall Study|Protocol Violation|8|||
147158843|NCT04431713|530747111|FG000|Overall Study|Withdrawal by Subject|2|||
147158844|NCT04431713|530747112|FG001|Overall Study|Withdrawal by Subject|0|||
147586047|NCT00988208|532300963|FG001|Overall Study|Biochemical Progression|7|||
147586048|NCT00988208|532300962|FG000|Overall Study|Clinical Deterioration|7|||
147586049|NCT00988208|532300963|FG001|Overall Study|Clinical Deterioration|14|||
147586050|NCT00988208|532300962|FG000|Overall Study|Subject Decision/Investigator Discretion|32|||
147586051|NCT00988208|532300963|FG001|Overall Study|Subject Decision/Investigator Discretion|32|||
147586052|NCT00988208|532300962|FG000|Overall Study|Other|8|||
147586053|NCT00988208|532300963|FG001|Overall Study|Other|3|||
147586054|NCT04364737|532300965|FG000|Overall Study|Withdrawal by Subject|4|||
147586055|NCT04364737|532300966|FG001|Overall Study|Withdrawal by Subject|9|||
147586056|NCT04364737|532300965|FG000|Overall Study|Lost to Follow-up|1|||
147586057|NCT04364737|532300966|FG001|Overall Study|Lost to Follow-up|1|||
147586058|NCT01220609|532300967|FG000|Overall Study|Ineligible-Wrong primary cancer site|1|||
147586059|NCT01220609|532300967|FG000|Overall Study|Ineligible- Wrong cell type|1|||
147586060|NCT01220609|532300967|FG000|Overall Study|Ineligible-Never treated|1|||
147158845|NCT04431713|530747111|FG000|Overall Study|Death|2|||
147158846|NCT04431713|530747112|FG001|Overall Study|Death|2|||
147158847|NCT00149994|530747113|FG000|Overall Study|Administrative problems:|1|||
147158848|NCT00149994|530747114|FG001|Overall Study|Administrative problems:|0|||
147158849|NCT00149994|530747113|FG000|Overall Study|Protocol Violation|0|||
147158850|NCT00149994|530747114|FG001|Overall Study|Protocol Violation|1|||
147158851|NCT01344538|530747115|FG000|Overall Study|Adverse Event|1|||
147158852|NCT01344538|530747116|FG001|Overall Study|Adverse Event|1|||
147158853|NCT01344538|530747115|FG000|Overall Study|Lost to Follow-up|1|||
147158854|NCT01344538|530747116|FG001|Overall Study|Lost to Follow-up|0|||
147586061|NCT00868296|532300970|FG000|Overall Study|Adverse Event|0|||
147586062|NCT00868296|532300971|FG001|Overall Study|Adverse Event|2|||
147586063|NCT00868296|532300970|FG000|Overall Study|Withdrawal by Subject|0|||
147586064|NCT00868296|532300971|FG001|Overall Study|Withdrawal by Subject|1|||
147586065|NCT00112294|532300972|FG000|Overall Study|Still on study|5|||
147158855|NCT01655381|530747119|FG000|Overall Study|Investigator Decision|1|||
147158856|NCT01655381|530747119|FG000|Overall Study|Moved to Another City|1|||
147586066|NCT00112294|532300973|FG001|Overall Study|Still on study|0|||
147586067|NCT02418455|532300974|FG000|48-Week Treatment Period|Other- Not Specified|1|||
147586068|NCT02418455|532300974|FG000|Continuation Period|Sponsor Decision|7|||
147586069|NCT03235479|532300977|FG000|Overall Study|Lost to Follow-up|8|||
147586070|NCT03235479|532300978|FG001|Overall Study|Lost to Follow-up|11|||
147586071|NCT03235479|532300977|FG000|Overall Study|Not Experienced Moderate/Severe Migraine|23|||
147586072|NCT03235479|532300978|FG001|Overall Study|Not Experienced Moderate/Severe Migraine|17|||
147586073|NCT03235479|532300977|FG000|Overall Study|Pregnancy|1|||
147586074|NCT03235479|532300978|FG001|Overall Study|Pregnancy|0|||
147586075|NCT03235479|532300977|FG000|Overall Study|Protocol Deviation|1|||
147586076|NCT03235479|532300978|FG001|Overall Study|Protocol Deviation|3|||
147586077|NCT03235479|532300977|FG000|Overall Study|Technical Problems|3|||
147586078|NCT03235479|532300978|FG001|Overall Study|Technical Problems|2|||
147586079|NCT03235479|532300977|FG000|Overall Study|Withdrawal by Subject|2|||
147586080|NCT03235479|532300978|FG001|Overall Study|Withdrawal by Subject|2|||
147586081|NCT03235479|532300977|FG000|Overall Study|Other Reasons|3|||
147586082|NCT03235479|532300978|FG001|Overall Study|Other Reasons|5|||
147586083|NCT02001051|532300981|FG000|Overall Study|Deemed not eligible following enrollment|0|||
147586084|NCT02001051|532300982|FG001|Overall Study|Deemed not eligible following enrollment|1|||
147586085|NCT03750695|532300989|FG000|Overall Study|Lost to Follow-up|0|||
147586086|NCT03750695|532300990|FG001|Overall Study|Lost to Follow-up|1|||
147586087|NCT04480307|532300991|FG000|Overall Study|Withdrawal by Subject|0|||
147586088|NCT04480307|532300992|FG001|Overall Study|Withdrawal by Subject|1|||
147586089|NCT04480307|532300993|FG002|Overall Study|Withdrawal by Subject|0|||
147586090|NCT04480307|532300994|FG003|Overall Study|Withdrawal by Subject|0|||
147586091|NCT04480307|532300991|FG000|Overall Study|Adverse Event|0|||
147586092|NCT04480307|532300992|FG001|Overall Study|Adverse Event|0|||
147586093|NCT04480307|532300993|FG002|Overall Study|Adverse Event|0|||
147586094|NCT04480307|532300994|FG003|Overall Study|Adverse Event|1|||
147586095|NCT00605176|532300997|FG000|Overall Study|Adverse Event|2|||
147586096|NCT00605176|532300998|FG001|Overall Study|Adverse Event|1|||
147586097|NCT00605176|532300999|FG002|Overall Study|Adverse Event|3|||
147586098|NCT00605176|532300997|FG000|Overall Study|Withdrawal by Subject|4|||
147586099|NCT00605176|532300998|FG001|Overall Study|Withdrawal by Subject|2|||
147586100|NCT00605176|532300999|FG002|Overall Study|Withdrawal by Subject|4|||
147586101|NCT00605176|532300997|FG000|Overall Study|Lost to Follow-up|2|||
147586102|NCT00605176|532300998|FG001|Overall Study|Lost to Follow-up|2|||
147586103|NCT00605176|532300999|FG002|Overall Study|Lost to Follow-up|1|||
147586104|NCT00605176|532300997|FG000|Overall Study|Non-complicance with study procedures|1|||
147586105|NCT00605176|532300998|FG001|Overall Study|Non-complicance with study procedures|0|||
147586106|NCT00605176|532300999|FG002|Overall Study|Non-complicance with study procedures|0|||
147586107|NCT00605176|532300997|FG000|Overall Study|Use of concomitant therapy|1|||
147586108|NCT00605176|532300998|FG001|Overall Study|Use of concomitant therapy|0|||
147586109|NCT00605176|532300999|FG002|Overall Study|Use of concomitant therapy|1|||
147586110|NCT00605176|532300997|FG000|Overall Study|Other (not due to AE)|1|||
147586111|NCT00605176|532300998|FG001|Overall Study|Other (not due to AE)|1|||
147586112|NCT00605176|532300999|FG002|Overall Study|Other (not due to AE)|0|||
147586113|NCT01256060|532301000|FG000|Overall Study|Lost to Follow-up|0|||
147586114|NCT01256060|532301001|FG001|Overall Study|Lost to Follow-up|1|||
147586115|NCT01256060|532301002|FG002|Overall Study|Lost to Follow-up|0|||
147586116|NCT01256060|532301003|FG003|Overall Study|Lost to Follow-up|0|||
147586117|NCT00220727|532301004|FG000|Second Infusion (Week <6)|Pt did not meet study requirement|1|||
147586118|NCT00220727|532301005|FG001|Second Infusion (Week <6)|Pt did not meet study requirement|0|||
147586119|NCT02508116|532301008|FG000|Overall Study|Lost to Follow-up|2|||
147586120|NCT02508116|532301009|FG001|Overall Study|Lost to Follow-up|3|||
147586121|NCT02508116|532301008|FG000|Overall Study|Withdrawal by Subject|3|||
147586122|NCT02508116|532301009|FG001|Overall Study|Withdrawal by Subject|2|||
147586123|NCT02508116|532301008|FG000|Overall Study|Protocol Violation|1|||
147586124|NCT02508116|532301009|FG001|Overall Study|Protocol Violation|2|||
147586125|NCT02508116|532301008|FG000|Overall Study|Physician Decision|2|||
147586126|NCT02508116|532301009|FG001|Overall Study|Physician Decision|0|||
147586127|NCT00109850|532301010|FG000|Overall Study|Adverse Event|1|||
147586128|NCT00109850|532301010|FG000|Overall Study|Death|2|||
147586129|NCT00109850|532301010|FG000|Overall Study|Ineligible|1|||
147586130|NCT00476593|532301011|FG000|Overall Study|Lost to Follow-up|10|||
147586131|NCT00476593|532301012|FG001|Overall Study|Lost to Follow-up|2|||
147586132|NCT00476593|532301013|FG002|Overall Study|Lost to Follow-up|8|||
147586133|NCT00476593|532301014|FG003|Overall Study|Lost to Follow-up|22|||
147586134|NCT03635983|532301015|FG000|Pre-Treatment Period|Withdrawal by Subject|0|||
147586135|NCT03635983|532301016|FG001|Pre-Treatment Period|Withdrawal by Subject|7|||
147586136|NCT03635983|532301015|FG000|Pre-Treatment Period|Participant no longer meets study criteria|1|||
147586137|NCT03635983|532301016|FG001|Pre-Treatment Period|Participant no longer meets study criteria|0|||
147586138|NCT03635983|532301015|FG000|Pre-Treatment Period|Other reasons|0|||
147586139|NCT03635983|532301016|FG001|Pre-Treatment Period|Other reasons|1|||
147586140|NCT03635983|532301015|FG000|Pre-Treatment Period|Disease Progression|0|||
147586141|NCT03635983|532301016|FG001|Pre-Treatment Period|Disease Progression|1|||
147586142|NCT03635983|532301015|FG000|Pre-Treatment Period|Adverse Event unrelated to Study drug|2|||
147586143|NCT03635983|532301016|FG001|Pre-Treatment Period|Adverse Event unrelated to Study drug|1|||
147586144|NCT03635983|532301015|FG000|Treatment Period|Participant request to discontinue Study treatment|6|||
147586145|NCT03635983|532301016|FG001|Treatment Period|Participant request to discontinue Study treatment|7|||
147586146|NCT03635983|532301015|FG000|Treatment Period|Withdrawal by Subject|3|||
147586147|NCT03635983|532301016|FG001|Treatment Period|Withdrawal by Subject|5|||
147586148|NCT03635983|532301015|FG000|Treatment Period|Death|3|||
147586149|NCT03635983|532301016|FG001|Treatment Period|Death|5|||
147586150|NCT03635983|532301015|FG000|Treatment Period|Poor/Non-compliance|2|||
147586151|NCT03635983|532301016|FG001|Treatment Period|Poor/Non-compliance|1|||
147586152|NCT03635983|532301015|FG000|Treatment Period|Participant no longer meets Study criteria|1|||
147586153|NCT03635983|532301016|FG001|Treatment Period|Participant no longer meets Study criteria|4|||
147586154|NCT03635983|532301015|FG000|Treatment Period|Other reasons|7|||
147586155|NCT03635983|532301016|FG001|Treatment Period|Other reasons|4|||
147586156|NCT03635983|532301015|FG000|Treatment Period|Disease progression|230|||
147586157|NCT03635983|532301016|FG001|Treatment Period|Disease progression|201|||
147586158|NCT03635983|532301015|FG000|Treatment Period|Study drug toxicity|35|||
147586159|NCT03635983|532301016|FG001|Treatment Period|Study drug toxicity|36|||
147586160|NCT03635983|532301015|FG000|Treatment Period|Adverse event unrelated to Study drug|15|||
147586161|NCT03635983|532301016|FG001|Treatment Period|Adverse event unrelated to Study drug|15|||
147586162|NCT03635983|532301015|FG000|Treatment Period|Maximum clinical benefit|3|||
147586163|NCT03635983|532301016|FG001|Treatment Period|Maximum clinical benefit|5|||
147586164|NCT03635983|532301015|FG000|Treatment Period|Administrative reason by the sponsor|1|||
147586165|NCT03635983|532301016|FG001|Treatment Period|Administrative reason by the sponsor|2|||
147586166|NCT03635983|532301015|FG000|Treatment Period|Lost to Follow-up|0|||
147586167|NCT03635983|532301016|FG001|Treatment Period|Lost to Follow-up|1|||
147586168|NCT03430011|532301017|FG000|Pre-Treatment|Death|1|||
147586169|NCT03430011|532301018|FG001|Pre-Treatment|Death|0|||
147586170|NCT03430011|532301019|FG002|Pre-Treatment|Death|0|||
147586171|NCT03430011|532301020|FG003|Pre-Treatment|Death|0|||
147586172|NCT03430011|532301021|FG004|Pre-Treatment|Death|1|||
147586173|NCT03430011|532301022|FG005|Pre-Treatment|Death|0|||
147586174|NCT03430011|532301023|FG006|Pre-Treatment|Death|1|||
147586175|NCT03430011|532301024|FG007|Pre-Treatment|Death|0|||
147586176|NCT03430011|532301017|FG000|Pre-Treatment|Screen Fail|0|||
147586177|NCT03430011|532301018|FG001|Pre-Treatment|Screen Fail|0|||
147586178|NCT03430011|532301019|FG002|Pre-Treatment|Screen Fail|0|||
147586179|NCT03430011|532301020|FG003|Pre-Treatment|Screen Fail|0|||
147586180|NCT03430011|532301021|FG004|Pre-Treatment|Screen Fail|1|||
147586181|NCT03430011|532301022|FG005|Pre-Treatment|Screen Fail|0|||
147586182|NCT03430011|532301023|FG006|Pre-Treatment|Screen Fail|0|||
147586183|NCT03430011|532301024|FG007|Pre-Treatment|Screen Fail|0|||
147586184|NCT03430011|532301017|FG000|Pre-Treatment|No JCARH125 - disease related complications|0|||
147586185|NCT03430011|532301018|FG001|Pre-Treatment|No JCARH125 - disease related complications|0|||
147158857|NCT01655381|530747119|FG000|Overall Study|Insufficient Treatment Response|1|||
147158858|NCT02324205|530747120|FG000|Overall Study|Withdrawal by Subject|37|||
147158859|NCT04195438|530747121|FG000|Overall Study|Withdrawal by Subject|1|||
147158860|NCT00613925|530747126|FG000|Overall Study|1 did not tolerate outpatient biopsy|0|||
147158861|NCT00613925|530747127|FG001|Overall Study|1 did not tolerate outpatient biopsy|1|||
147158862|NCT03136497|530747128|FG000|Overall Study|Screen Failure|1|||
147158863|NCT03136497|530747129|FG001|Overall Study|Screen Failure|0|||
147158864|NCT03136497|530747130|FG002|Overall Study|Screen Failure|0|||
147158865|NCT00856206|530747132|FG000|Overall Study|Protocol Violation|6|||
147158866|NCT00856206|530747133|FG001|Overall Study|Protocol Violation|18|||
147158867|NCT00856206|530747132|FG000|Overall Study|Adverse Event|10|||
147158868|NCT00856206|530747133|FG001|Overall Study|Adverse Event|46|||
147158869|NCT00856206|530747132|FG000|Overall Study|Lack of Efficacy|1|||
147158870|NCT00856206|530747133|FG001|Overall Study|Lack of Efficacy|2|||
147158871|NCT00856206|530747132|FG000|Overall Study|Withdrawal by Subject|15|||
147158872|NCT00856206|530747133|FG001|Overall Study|Withdrawal by Subject|36|||
147158873|NCT00856206|530747132|FG000|Overall Study|Lost to Follow-up|13|||
147158874|NCT00856206|530747133|FG001|Overall Study|Lost to Follow-up|39|||
147158875|NCT00856206|530747132|FG000|Overall Study|Death|2|||
147158876|NCT00856206|530747133|FG001|Overall Study|Death|2|||
147158877|NCT00856206|530747132|FG000|Overall Study|Decision by the Sponsor|4|||
147158878|NCT00856206|530747133|FG001|Overall Study|Decision by the Sponsor|8|||
147158879|NCT00856206|530747132|FG000|Overall Study|Other than specified above|3|||
147158880|NCT00856206|530747133|FG001|Overall Study|Other than specified above|10|||
147158881|NCT04584346|530747145|FG000|Phase 2 - At Home (Unblinded)|Withdrawal by Subject|0|||
147158882|NCT04584346|530747146|FG001|Phase 2 - At Home (Unblinded)|Withdrawal by Subject|1|||
147158883|NCT03640052|530747151|FG000|Overall Study|Lost to Follow-up|0|||
147158884|NCT03640052|530747152|FG001|Overall Study|Lost to Follow-up|1|||
147586186|NCT03430011|532301019|FG002|Pre-Treatment|No JCARH125 - disease related complications|1|||
147586187|NCT03430011|532301020|FG003|Pre-Treatment|No JCARH125 - disease related complications|0|||
147586188|NCT03430011|532301021|FG004|Pre-Treatment|No JCARH125 - disease related complications|0|||
147586189|NCT03430011|532301022|FG005|Pre-Treatment|No JCARH125 - disease related complications|0|||
147586190|NCT03430011|532301023|FG006|Pre-Treatment|No JCARH125 - disease related complications|0|||
147158885|NCT03640052|530747153|FG002|Overall Study|Lost to Follow-up|0|||
147586191|NCT03430011|532301024|FG007|Pre-Treatment|No JCARH125 - disease related complications|0|||
147586192|NCT03430011|532301017|FG000|Pre-Treatment|Participant not eligible - other reasons|0|||
147586193|NCT03430011|532301018|FG001|Pre-Treatment|Participant not eligible - other reasons|0|||
147586194|NCT03430011|532301019|FG002|Pre-Treatment|Participant not eligible - other reasons|0|||
147586195|NCT03430011|532301020|FG003|Pre-Treatment|Participant not eligible - other reasons|1|||
147586196|NCT03430011|532301021|FG004|Pre-Treatment|Participant not eligible - other reasons|0|||
147586197|NCT03430011|532301022|FG005|Pre-Treatment|Participant not eligible - other reasons|0|||
147586198|NCT03430011|532301023|FG006|Pre-Treatment|Participant not eligible - other reasons|0|||
147586199|NCT03430011|532301024|FG007|Pre-Treatment|Participant not eligible - other reasons|0|||
147586200|NCT03430011|532301017|FG000|JCARH125 Treatment|Withdrawal by Subject|1|||
147586201|NCT03430011|532301018|FG001|JCARH125 Treatment|Withdrawal by Subject|1|||
147586202|NCT03430011|532301019|FG002|JCARH125 Treatment|Withdrawal by Subject|5|||
147586203|NCT03430011|532301020|FG003|JCARH125 Treatment|Withdrawal by Subject|5|||
147586204|NCT03430011|532301021|FG004|JCARH125 Treatment|Withdrawal by Subject|3|||
147586205|NCT03430011|532301022|FG005|JCARH125 Treatment|Withdrawal by Subject|4|||
147586206|NCT03430011|532301023|FG006|JCARH125 Treatment|Withdrawal by Subject|5|||
147586207|NCT03430011|532301024|FG007|JCARH125 Treatment|Withdrawal by Subject|3|||
147586208|NCT03430011|532301017|FG000|JCARH125 Treatment|Lost to Follow-up|0|||
147586209|NCT03430011|532301018|FG001|JCARH125 Treatment|Lost to Follow-up|1|||
147586210|NCT03430011|532301019|FG002|JCARH125 Treatment|Lost to Follow-up|0|||
147586211|NCT03430011|532301020|FG003|JCARH125 Treatment|Lost to Follow-up|0|||
147586212|NCT03430011|532301021|FG004|JCARH125 Treatment|Lost to Follow-up|1|||
147586213|NCT03430011|532301022|FG005|JCARH125 Treatment|Lost to Follow-up|0|||
147586214|NCT03430011|532301023|FG006|JCARH125 Treatment|Lost to Follow-up|1|||
147586215|NCT03430011|532301024|FG007|JCARH125 Treatment|Lost to Follow-up|0|||
147586216|NCT03430011|532301017|FG000|JCARH125 Treatment|Death|4|||
147586217|NCT03430011|532301018|FG001|JCARH125 Treatment|Death|19|||
147586218|NCT03430011|532301019|FG002|JCARH125 Treatment|Death|10|||
147586219|NCT03430011|532301020|FG003|JCARH125 Treatment|Death|8|||
147586220|NCT03430011|532301021|FG004|JCARH125 Treatment|Death|5|||
147586221|NCT03430011|532301022|FG005|JCARH125 Treatment|Death|3|||
147586222|NCT03430011|532301023|FG006|JCARH125 Treatment|Death|4|||
147586223|NCT03430011|532301024|FG007|JCARH125 Treatment|Death|2|||
147586224|NCT03430011|532301017|FG000|JCARH125 Treatment|Other reasons|1|||
147586225|NCT03430011|532301018|FG001|JCARH125 Treatment|Other reasons|0|||
147586226|NCT03430011|532301019|FG002|JCARH125 Treatment|Other reasons|4|||
147586227|NCT03430011|532301020|FG003|JCARH125 Treatment|Other reasons|2|||
147586228|NCT03430011|532301021|FG004|JCARH125 Treatment|Other reasons|2|||
147586229|NCT03430011|532301022|FG005|JCARH125 Treatment|Other reasons|1|||
147586230|NCT03430011|532301023|FG006|JCARH125 Treatment|Other reasons|3|||
147586231|NCT03430011|532301024|FG007|JCARH125 Treatment|Other reasons|2|||
147586232|NCT04126343|532301026|FG000|Overall Study|Adverse Event|0|||
147586233|NCT04126343|532301027|FG001|Overall Study|Adverse Event|0|||
147158886|NCT03640052|530747154|FG003|Overall Study|Lost to Follow-up|0|||
147158887|NCT03640052|530747155|FG004|Overall Study|Lost to Follow-up|0|||
147158888|NCT05479097|530747156|FG000|Overall Study|Withdrawal by Subject|2|||
147158889|NCT01779869|530747159|FG000|Overall Study|Physician Decision|2|||
147158890|NCT00957944|530747162|FG000|First Intervention- 24 Hours|Withdrawal by Subject|0|||
147158891|NCT00957944|530747163|FG001|First Intervention- 24 Hours|Withdrawal by Subject|1|||
147158892|NCT01482169|530747165|FG000|Overall Study|Physician Decision|2|||
147158893|NCT01369680|530747168|FG000|Overall Study|Lost to Follow-up|0|||
147158894|NCT01369680|530747169|FG001|Overall Study|Lost to Follow-up|0|||
147158895|NCT01369680|530747170|FG002|Overall Study|Lost to Follow-up|1|||
147158896|NCT01369680|530747171|FG003|Overall Study|Lost to Follow-up|2|||
147158897|NCT00759356|530747172|FG000|Overall Study|Adverse Event|0|||
147158898|NCT00759356|530747173|FG001|Overall Study|Adverse Event|1|||
147158899|NCT00759356|530747172|FG000|Overall Study|Withdrawal by Subject|0|||
147586234|NCT04126343|532301028|FG002|Overall Study|Adverse Event|0|||
147586235|NCT04126343|532301029|FG003|Overall Study|Adverse Event|0|||
147158900|NCT00759356|530747173|FG001|Overall Study|Withdrawal by Subject|2|||
147241482|NCT02256631|531055911|FG004|Overall Study|Unable to get to clinic|0|||
147586236|NCT04126343|532301030|FG004|Overall Study|Adverse Event|0|||
147586237|NCT04126343|532301031|FG005|Overall Study|Adverse Event|1|||
147586238|NCT04126343|532301026|FG000|Overall Study|Withdrawal by Subject|0|||
147241483|NCT02256631|531055912|FG005|Overall Study|Unable to get to clinic|1|||
147586239|NCT04126343|532301027|FG001|Overall Study|Withdrawal by Subject|0|||
147586240|NCT04126343|532301028|FG002|Overall Study|Withdrawal by Subject|0|||
147586241|NCT04126343|532301029|FG003|Overall Study|Withdrawal by Subject|1|||
147241484|NCT02256631|531055913|FG006|Overall Study|Unable to get to clinic|2|||
147586242|NCT04126343|532301030|FG004|Overall Study|Withdrawal by Subject|0|||
147586243|NCT04126343|532301031|FG005|Overall Study|Withdrawal by Subject|0|||
147586244|NCT04126343|532301026|FG000|Overall Study|Related to COVID-19 pandemic|3|||
147586245|NCT04126343|532301027|FG001|Overall Study|Related to COVID-19 pandemic|4|||
147586246|NCT04126343|532301028|FG002|Overall Study|Related to COVID-19 pandemic|3|||
147586247|NCT04126343|532301029|FG003|Overall Study|Related to COVID-19 pandemic|3|||
147586248|NCT04126343|532301030|FG004|Overall Study|Related to COVID-19 pandemic|3|||
147586249|NCT04126343|532301031|FG005|Overall Study|Related to COVID-19 pandemic|3|||
147586250|NCT00388037|532301040|FG000|Overall Study|Protocol Violation|1|||
147586251|NCT00602537|532301041|FG000|12 Week Double Blind Comparison|Adverse Event|2|||
147586252|NCT00602537|532301042|FG001|12 Week Double Blind Comparison|Adverse Event|5|||
147586253|NCT00602537|532301041|FG000|12 Week Double Blind Comparison|Lack of Efficacy|13|||
147586254|NCT00602537|532301042|FG001|12 Week Double Blind Comparison|Lack of Efficacy|23|||
147586255|NCT00602537|532301041|FG000|12 Week Double Blind Comparison|Lost to Follow-up|5|||
147586256|NCT00602537|532301042|FG001|12 Week Double Blind Comparison|Lost to Follow-up|6|||
147586257|NCT00602537|532301041|FG000|12 Week Double Blind Comparison|Withdrawal by Subject|3|||
147586258|NCT00602537|532301042|FG001|12 Week Double Blind Comparison|Withdrawal by Subject|13|||
147586259|NCT00602537|532301041|FG000|Follow Up Study Comparison|Adverse Event|1|||
147586260|NCT00602537|532301042|FG001|Follow Up Study Comparison|Adverse Event|0|||
147586261|NCT00602537|532301041|FG000|Follow Up Study Comparison|Lost to Follow-up|8|||
147586262|NCT00602537|532301042|FG001|Follow Up Study Comparison|Lost to Follow-up|1|||
147586263|NCT00602537|532301041|FG000|Follow Up Study Comparison|Withdrawal by Subject|2|||
147586264|NCT00602537|532301042|FG001|Follow Up Study Comparison|Withdrawal by Subject|2|||
147586265|NCT04330157|532301043|FG000|Overall Study|Protocol Violation|4|||
147586266|NCT04330157|532301043|FG000|Overall Study|Not extubated within 24 h postoperatively|3|||
147586267|NCT04314843|532301045|FG000|Overall Study|Death|2|||
147586268|NCT04314843|532301046|FG001|Overall Study|Death|2|||
147586269|NCT04314843|532301045|FG000|Overall Study|Rolled over to long-term follow-up study after study terminated|1|||
147586270|NCT04314843|532301046|FG001|Overall Study|Rolled over to long-term follow-up study after study terminated|1|||
147586271|NCT01899326|532301047|FG000|Overall Study|Withdrawal by Subject|1|||
147586272|NCT01899326|532301047|FG000|Overall Study|Adverse Event|2|||
147586273|NCT01899326|532301047|FG000|Overall Study|Disease Relapse (patient with previously undiagnosed relapsing disease)|1|||
147586274|NCT01020526|532301048|FG000|Overall Study|Withdrawal by Subject|5|||
147586275|NCT01020526|532301048|FG000|Overall Study|Other reasons|3|||
147586276|NCT01020526|532301048|FG000|Overall Study|Insufficient clinical response|3|||
147586277|NCT01020526|532301048|FG000|Overall Study|Lost to Follow-up|1|||
147586278|NCT01020526|532301048|FG000|Overall Study|Adverse Event|2|||
147586279|NCT03558139|532301049|FG000|Overall Study|Consent Withdrawn|1|||
147586280|NCT03558139|532301050|FG001|Overall Study|Consent Withdrawn|1|||
147586281|NCT03558139|532301051|FG002|Overall Study|Consent Withdrawn|4|||
147586282|NCT03558139|532301049|FG000|Overall Study|Death|5|||
147586283|NCT03558139|532301050|FG001|Overall Study|Death|3|||
147586284|NCT03558139|532301051|FG002|Overall Study|Death|8|||
147586285|NCT03558139|532301049|FG000|Overall Study|Lost to Follow-up|0|||
147586286|NCT03558139|532301050|FG001|Overall Study|Lost to Follow-up|0|||
147586287|NCT03558139|532301051|FG002|Overall Study|Lost to Follow-up|3|||
147586288|NCT03558139|532301049|FG000|Overall Study|Study Ended Per Protocol|0|||
147586289|NCT03558139|532301050|FG001|Overall Study|Study Ended Per Protocol|3|||
147586290|NCT03558139|532301051|FG002|Overall Study|Study Ended Per Protocol|6|||
147586291|NCT00373425|532301052|FG000|Overall Study|Relapse of NSCLC|116|||
147586292|NCT00373425|532301053|FG001|Overall Study|Relapse of NSCLC|104|||
147586293|NCT00373425|532301054|FG002|Overall Study|Relapse of NSCLC|19|||
147586294|NCT00373425|532301055|FG003|Overall Study|Relapse of NSCLC|2|||
147586295|NCT00373425|532301056|FG004|Overall Study|Relapse of NSCLC|26|||
147586296|NCT00373425|532301052|FG000|Overall Study|Adverse Event|191|||
147586297|NCT00373425|532301053|FG001|Overall Study|Adverse Event|22|||
147586298|NCT00373425|532301054|FG002|Overall Study|Adverse Event|59|||
147586299|NCT00373425|532301055|FG003|Overall Study|Adverse Event|0|||
147586300|NCT00373425|532301056|FG004|Overall Study|Adverse Event|34|||
147586301|NCT00373425|532301052|FG000|Overall Study|Patient request|35|||
147586302|NCT00373425|532301053|FG001|Overall Study|Patient request|18|||
147586303|NCT00373425|532301054|FG002|Overall Study|Patient request|43|||
147322078|NCT01244763|531343562|FG003|Overall Study|Enrolled into the Extension Study|0|||
147322079|NCT01244763|531343563|FG004|Overall Study|Enrolled into the Extension Study|0|||
147322080|NCT01244763|531343564|FG005|Overall Study|Enrolled into the Extension Study|1|||
147322081|NCT03169361|531343565|FG000|Overall Study|Protocol Violation|32|||
147322082|NCT02788656|531343566|FG000|Overall Study|Withdrawal by Subject|1|||
147322083|NCT02788656|531343567|FG001|Overall Study|Withdrawal by Subject|0|||
147322084|NCT02263885|531343568|FG000|Overall Study|Withdrawal by Subject|7|||
147586304|NCT00373425|532301055|FG003|Overall Study|Patient request|6|||
147586305|NCT00373425|532301056|FG004|Overall Study|Patient request|7|||
147586306|NCT00373425|532301052|FG000|Overall Study|Medical/ethical/noncompliance reason|21|||
147586307|NCT00373425|532301053|FG001|Overall Study|Medical/ethical/noncompliance reason|9|||
147586308|NCT00373425|532301054|FG002|Overall Study|Medical/ethical/noncompliance reason|10|||
147586309|NCT00373425|532301055|FG003|Overall Study|Medical/ethical/noncompliance reason|2|||
147586310|NCT00373425|532301056|FG004|Overall Study|Medical/ethical/noncompliance reason|5|||
147586311|NCT00373425|532301052|FG000|Overall Study|Death|7|||
147586312|NCT00373425|532301053|FG001|Overall Study|Death|0|||
147322085|NCT02263885|531343568|FG000|Overall Study|Alternative Treatment|3|||
147586313|NCT00373425|532301054|FG002|Overall Study|Death|3|||
147586314|NCT00373425|532301055|FG003|Overall Study|Death|1|||
147586315|NCT00373425|532301056|FG004|Overall Study|Death|0|||
147586316|NCT00551616|532301059|FG000|Overall Study|Lost to Follow-up|48|||
147586317|NCT00551616|532301060|FG001|Overall Study|Lost to Follow-up|40|||
147586318|NCT02808819|532301061|FG000|Overall Study|eg. no treatment efficacy on asthma|5|||
147586319|NCT02808819|532301062|FG001|Overall Study|eg. no treatment efficacy on asthma|4|||
147586320|NCT02808819|532301061|FG000|Overall Study|Withdrawal by Subject|10|||
147586321|NCT02808819|532301062|FG001|Overall Study|Withdrawal by Subject|13|||
147586322|NCT02808819|532301061|FG000|Overall Study|Site terminated by sponsor|2|||
147586323|NCT02808819|532301062|FG001|Overall Study|Site terminated by sponsor|0|||
147586324|NCT02808819|532301061|FG000|Overall Study|Pregnancy|1|||
147586325|NCT02808819|532301062|FG001|Overall Study|Pregnancy|0|||
147586326|NCT02808819|532301061|FG000|Overall Study|Lost to Follow-up|1|||
147586327|NCT02808819|532301062|FG001|Overall Study|Lost to Follow-up|6|||
147586328|NCT02808819|532301061|FG000|Overall Study|Protocol Violation|0|||
147586329|NCT02808819|532301062|FG001|Overall Study|Protocol Violation|1|||
147586330|NCT02808819|532301061|FG000|Overall Study|Development of study-specific withdrawal criteria|8|||
147586331|NCT02808819|532301062|FG001|Overall Study|Development of study-specific withdrawal criteria|3|||
147586332|NCT02808819|532301061|FG000|Overall Study|Death|1|||
147586333|NCT02808819|532301062|FG001|Overall Study|Death|0|||
147586334|NCT02808819|532301061|FG000|Overall Study|Adverse Event|3|||
147586335|NCT02808819|532301062|FG001|Overall Study|Adverse Event|4|||
147586336|NCT02752802|532301063|FG000|Overall Study|Contrast Volume Not Collected|1|||
147586337|NCT02752802|532301064|FG001|Overall Study|Contrast Volume Not Collected|0|||
147586338|NCT00251316|532301065|FG000|Overall Study|Physician Decision|2|||
147586339|NCT00251316|532301066|FG001|Overall Study|Physician Decision|3|||
147586340|NCT03139240|532301067|FG000|Overall Study|Lost to Follow-up|0|||
147158901|NCT00759356|530747172|FG000|Overall Study|Subject was unable to return|1|||
147158902|NCT00759356|530747173|FG001|Overall Study|Subject was unable to return|0|||
147586341|NCT03139240|532301068|FG001|Overall Study|Lost to Follow-up|1|||
147586342|NCT03139240|532301069|FG002|Overall Study|Lost to Follow-up|1|||
147586343|NCT03139240|532301070|FG003|Overall Study|Lost to Follow-up|0|||
147586344|NCT01610063|532301077|FG000|Overall Study|Lost to Follow-up|42|||
147586345|NCT01610063|532301078|FG001|Overall Study|Lost to Follow-up|20|||
147586346|NCT03314662|532301079|FG000|Overall Study|Withdrawal by Subject|1|||
147586347|NCT03314662|532301080|FG001|Overall Study|Withdrawal by Subject|1|||
147586348|NCT03314662|532301081|FG002|Overall Study|Withdrawal by Subject|1|||
147586349|NCT03314662|532301079|FG000|Overall Study|Lost to Follow-up|5|||
147586350|NCT03314662|532301080|FG001|Overall Study|Lost to Follow-up|4|||
147158903|NCT03385265|530747183|FG000|Overall Study|Withdrawal by Subject|5|||
147158904|NCT03385265|530747184|FG001|Overall Study|Withdrawal by Subject|2|||
147158905|NCT03385265|530747185|FG002|Overall Study|Withdrawal by Subject|5|||
147586351|NCT03314662|532301081|FG002|Overall Study|Lost to Follow-up|4|||
147586352|NCT03314662|532301079|FG000|Overall Study|Death|2|||
147586353|NCT03314662|532301080|FG001|Overall Study|Death|0|||
147586354|NCT03314662|532301081|FG002|Overall Study|Death|0|||
147586355|NCT01867606|532301084|FG000|Overall Study|Withdrawal by Subject|10|||
147586356|NCT01867606|532301085|FG001|Overall Study|Withdrawal by Subject|14|||
147586357|NCT01867606|532301084|FG000|Overall Study|Protocol Violation|0|||
147586358|NCT01867606|532301085|FG001|Overall Study|Protocol Violation|1|||
147586359|NCT01378962|532301086|FG000|Overall Study|Death|14|||
147586360|NCT01378962|532301086|FG000|Overall Study|Lost to Follow-up|1|||
147586361|NCT01378962|532301086|FG000|Overall Study|Other|2|||
147586362|NCT01835548|532301093|FG000|Dose Optimization Period|Adverse Event|0|||
147586363|NCT01835548|532301094|FG001|Dose Optimization Period|Adverse Event|0|||
147586364|NCT01835548|532301095|FG002|Dose Optimization Period|Adverse Event|1|||
147586365|NCT01835548|532301093|FG000|Dose Optimization Period|Withdrawal by Subject|0|||
147586366|NCT01835548|532301094|FG001|Dose Optimization Period|Withdrawal by Subject|0|||
147586367|NCT01835548|532301095|FG002|Dose Optimization Period|Withdrawal by Subject|1|||
147586368|NCT01835548|532301093|FG000|Double-Blind Treatment Period|Adverse Event|0|||
147586369|NCT01835548|532301094|FG001|Double-Blind Treatment Period|Adverse Event|1|||
147586370|NCT01835548|532301095|FG002|Double-Blind Treatment Period|Adverse Event|0|||
147586371|NCT01835548|532301093|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
147586372|NCT01835548|532301094|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
147586373|NCT01835548|532301095|FG002|Double-Blind Treatment Period|Withdrawal by Subject|0|||
147586374|NCT01634854|532301096|FG000|Overall Study|Cesarean delivery|2|||
147586375|NCT01634854|532301097|FG001|Overall Study|Cesarean delivery|7|||
147586376|NCT02490800|532301098|FG000|Overall Study|Adverse Event|0|||
147586377|NCT02490800|532301099|FG001|Overall Study|Adverse Event|0|||
147586378|NCT02490800|532301100|FG002|Overall Study|Adverse Event|0|||
147586379|NCT02490800|532301101|FG003|Overall Study|Adverse Event|2|||
147586380|NCT02490800|532301102|FG004|Overall Study|Adverse Event|3|||
147586381|NCT02490800|532301103|FG005|Overall Study|Adverse Event|2|||
147586382|NCT02490800|532301104|FG006|Overall Study|Adverse Event|0|||
147586383|NCT02490800|532301105|FG007|Overall Study|Adverse Event|0|||
147586384|NCT02490800|532301106|FG008|Overall Study|Adverse Event|0|||
147586385|NCT02490800|532301107|FG009|Overall Study|Adverse Event|0|||
147586386|NCT02490800|532301108|FG010|Overall Study|Adverse Event|0|||
147586387|NCT02490800|532301109|FG011|Overall Study|Adverse Event|2|||
147586388|NCT02490800|532301110|FG012|Overall Study|Adverse Event|2|||
147654397|NCT02588092|532556721|FG007|Overall Study|Death|1|||
147654398|NCT02588092|532556722|FG008|Overall Study|Death|5|||
147654399|NCT02588092|532556723|FG009|Overall Study|Death|2|||
147586389|NCT02490800|532301098|FG000|Overall Study|Withdrawal by Subject|0|||
147586390|NCT02490800|532301099|FG001|Overall Study|Withdrawal by Subject|0|||
147586391|NCT02490800|532301100|FG002|Overall Study|Withdrawal by Subject|0|||
147586392|NCT02490800|532301101|FG003|Overall Study|Withdrawal by Subject|1|||
147586393|NCT02490800|532301102|FG004|Overall Study|Withdrawal by Subject|0|||
147586394|NCT02490800|532301103|FG005|Overall Study|Withdrawal by Subject|0|||
147586395|NCT02490800|532301104|FG006|Overall Study|Withdrawal by Subject|0|||
147586396|NCT02490800|532301105|FG007|Overall Study|Withdrawal by Subject|0|||
147586397|NCT02490800|532301106|FG008|Overall Study|Withdrawal by Subject|1|||
147586398|NCT02490800|532301107|FG009|Overall Study|Withdrawal by Subject|0|||
147586399|NCT02490800|532301108|FG010|Overall Study|Withdrawal by Subject|0|||
147586400|NCT02490800|532301109|FG011|Overall Study|Withdrawal by Subject|0|||
147586401|NCT02490800|532301110|FG012|Overall Study|Withdrawal by Subject|0|||
147586402|NCT02490800|532301098|FG000|Overall Study|Progressive disease|3|||
147586403|NCT02490800|532301099|FG001|Overall Study|Progressive disease|3|||
147586404|NCT02490800|532301100|FG002|Overall Study|Progressive disease|3|||
147586405|NCT02490800|532301101|FG003|Overall Study|Progressive disease|4|||
147586406|NCT02490800|532301102|FG004|Overall Study|Progressive disease|4|||
147586407|NCT02490800|532301103|FG005|Overall Study|Progressive disease|1|||
147586408|NCT02490800|532301104|FG006|Overall Study|Progressive disease|4|||
147586409|NCT02490800|532301105|FG007|Overall Study|Progressive disease|3|||
147586410|NCT02490800|532301106|FG008|Overall Study|Progressive disease|6|||
147586411|NCT02490800|532301107|FG009|Overall Study|Progressive disease|2|||
147586412|NCT02490800|532301108|FG010|Overall Study|Progressive disease|7|||
147586413|NCT02490800|532301109|FG011|Overall Study|Progressive disease|1|||
147586414|NCT02490800|532301110|FG012|Overall Study|Progressive disease|10|||
147586415|NCT02490800|532301098|FG000|Overall Study|Patient enrolled in post-trial access|0|||
147586416|NCT02490800|532301099|FG001|Overall Study|Patient enrolled in post-trial access|0|||
147586417|NCT02490800|532301100|FG002|Overall Study|Patient enrolled in post-trial access|0|||
147586418|NCT02490800|532301101|FG003|Overall Study|Patient enrolled in post-trial access|0|||
147586419|NCT02490800|532301102|FG004|Overall Study|Patient enrolled in post-trial access|0|||
147586420|NCT02490800|532301103|FG005|Overall Study|Patient enrolled in post-trial access|0|||
147586421|NCT02490800|532301104|FG006|Overall Study|Patient enrolled in post-trial access|0|||
147586422|NCT02490800|532301105|FG007|Overall Study|Patient enrolled in post-trial access|0|||
147586423|NCT02490800|532301106|FG008|Overall Study|Patient enrolled in post-trial access|0|||
147586424|NCT02490800|532301107|FG009|Overall Study|Patient enrolled in post-trial access|1|||
147586425|NCT02490800|532301108|FG010|Overall Study|Patient enrolled in post-trial access|1|||
147586426|NCT02490800|532301109|FG011|Overall Study|Patient enrolled in post-trial access|0|||
147586427|NCT02490800|532301110|FG012|Overall Study|Patient enrolled in post-trial access|6|||
147586428|NCT00537017|532301111|FG000|Treatment Phase|Adverse Event|19|||
147586429|NCT00537017|532301111|FG000|Treatment Phase|Withdrawal by Subject|13|||
147586430|NCT00537017|532301111|FG000|Treatment Phase|Protocol Violation|2|||
147586431|NCT00537017|532301111|FG000|Follow-up Phase|Withdrawal by Subject|9|||
147586432|NCT03365791|532301113|FG000|Overall Study|Adverse Event|5|||
147586433|NCT03365791|532301113|FG000|Overall Study|Death|1|||
147586434|NCT03365791|532301113|FG000|Overall Study|Lost to Follow-up|1|||
147586435|NCT03365791|532301113|FG000|Overall Study|Physician Decision|9|||
147654400|NCT02588092|532556714|FG000|Overall Study|Withdrawal by Subject|0|||
147654401|NCT02588092|532556715|FG001|Overall Study|Withdrawal by Subject|0|||
147654402|NCT02588092|532556716|FG002|Overall Study|Withdrawal by Subject|0|||
147654403|NCT02588092|532556717|FG003|Overall Study|Withdrawal by Subject|0|||
147654404|NCT02588092|532556718|FG004|Overall Study|Withdrawal by Subject|0|||
147654405|NCT02588092|532556719|FG005|Overall Study|Withdrawal by Subject|1|||
147654406|NCT02588092|532556720|FG006|Overall Study|Withdrawal by Subject|1|||
147654407|NCT02588092|532556721|FG007|Overall Study|Withdrawal by Subject|2|||
147654408|NCT02588092|532556722|FG008|Overall Study|Withdrawal by Subject|0|||
147654409|NCT02588092|532556723|FG009|Overall Study|Withdrawal by Subject|0|||
147586436|NCT03365791|532301113|FG000|Overall Study|Progressive disease|51|||
147241485|NCT01427972|531055914|FG000|Treatment Period 1 (21 Days)|Protocol Violation|0|||
147241486|NCT01427972|531055915|FG001|Treatment Period 1 (21 Days)|Protocol Violation|0|||
147586437|NCT03365791|532301113|FG000|Overall Study|Subject/guardian decision|5|||
147586438|NCT00739973|532301114|FG000|Single-blind Period (2 to 4 Weeks)|Adverse Event|35|||
147586439|NCT00739973|532301115|FG001|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
147586440|NCT00739973|532301116|FG002|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
147586441|NCT00739973|532301117|FG003|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
147586442|NCT00739973|532301118|FG004|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
147586443|NCT00739973|532301119|FG005|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
147586444|NCT00739973|532301120|FG006|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
147586445|NCT00739973|532301121|FG007|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
147654410|NCT02588092|532556714|FG000|Overall Study|Started Another Treatment|0|||
147654411|NCT02588092|532556715|FG001|Overall Study|Started Another Treatment|0|||
147586446|NCT00739973|532301122|FG008|Single-blind Period (2 to 4 Weeks)|Adverse Event|0|||
147586447|NCT00739973|532301114|FG000|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|38|||
147586448|NCT00739973|532301115|FG001|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
147586449|NCT00739973|532301116|FG002|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
147586450|NCT00739973|532301117|FG003|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
147586451|NCT00739973|532301118|FG004|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
147586452|NCT00739973|532301119|FG005|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
147586453|NCT00739973|532301120|FG006|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
147586454|NCT00739973|532301121|FG007|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
147586455|NCT00739973|532301122|FG008|Single-blind Period (2 to 4 Weeks)|Abnormal laboratory value(s)|0|||
147586456|NCT00739973|532301114|FG000|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|810|||
147586457|NCT00739973|532301115|FG001|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
147586458|NCT00739973|532301116|FG002|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
147158906|NCT03385265|530747186|FG003|Overall Study|Withdrawal by Subject|2|||
147158907|NCT03220581|530747187|FG000|Overall Study|Withdrawal by Subject|0|||
147158908|NCT03220581|530747188|FG001|Overall Study|Withdrawal by Subject|1|||
147158909|NCT03220581|530747187|FG000|Overall Study|Lost to Follow-up|3|||
147158910|NCT03220581|530747188|FG001|Overall Study|Lost to Follow-up|6|||
147158911|NCT02434354|530747189|FG000|Overall Study|screen fail|3|||
147158912|NCT03730961|530747190|FG000|Overall Study|Adverse Event|0|||
147158913|NCT03730961|530747191|FG001|Overall Study|Adverse Event|1|||
147158914|NCT01920893|530747192|FG000|Overall Study|Adverse Event|5|||
147586459|NCT00739973|532301117|FG003|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
147586460|NCT00739973|532301118|FG004|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
147586461|NCT00739973|532301119|FG005|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
147586462|NCT00739973|532301120|FG006|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
147586463|NCT00739973|532301121|FG007|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
147586464|NCT00739973|532301122|FG008|Single-blind Period (2 to 4 Weeks)|Abnormal test procedure result(s)|0|||
147586465|NCT00739973|532301114|FG000|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|86|||
147586466|NCT00739973|532301115|FG001|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
147586467|NCT00739973|532301116|FG002|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
147586468|NCT00739973|532301117|FG003|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
147586469|NCT00739973|532301118|FG004|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
147586470|NCT00739973|532301119|FG005|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
147586471|NCT00739973|532301120|FG006|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
147586472|NCT00739973|532301121|FG007|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
147586473|NCT00739973|532301122|FG008|Single-blind Period (2 to 4 Weeks)|Patient withdrew consent|0|||
147586474|NCT00739973|532301114|FG000|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|17|||
147586475|NCT00739973|532301115|FG001|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
147586476|NCT00739973|532301116|FG002|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
147586477|NCT00739973|532301117|FG003|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
147586478|NCT00739973|532301118|FG004|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
147586479|NCT00739973|532301119|FG005|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
147586480|NCT00739973|532301120|FG006|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
147586481|NCT00739973|532301121|FG007|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
147586482|NCT00739973|532301122|FG008|Single-blind Period (2 to 4 Weeks)|Lost to Follow-up|0|||
147586483|NCT00739973|532301114|FG000|Single-blind Period (2 to 4 Weeks)|Administrative problems|12|||
147586484|NCT00739973|532301115|FG001|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
147586485|NCT00739973|532301116|FG002|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
147586486|NCT00739973|532301117|FG003|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
147586487|NCT00739973|532301118|FG004|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
147586488|NCT00739973|532301119|FG005|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
147586489|NCT00739973|532301120|FG006|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
147586490|NCT00739973|532301121|FG007|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
147586491|NCT00739973|532301122|FG008|Single-blind Period (2 to 4 Weeks)|Administrative problems|0|||
147586492|NCT00739973|532301114|FG000|Single-blind Period (2 to 4 Weeks)|Protocol deviation|11|||
147586493|NCT00739973|532301115|FG001|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
147586494|NCT00739973|532301116|FG002|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
147586495|NCT00739973|532301117|FG003|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
147586496|NCT00739973|532301118|FG004|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
147586497|NCT00739973|532301119|FG005|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
147586498|NCT00739973|532301120|FG006|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
147586499|NCT00739973|532301121|FG007|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
147158915|NCT01920893|530747193|FG001|Overall Study|Adverse Event|2|||
147586500|NCT00739973|532301122|FG008|Single-blind Period (2 to 4 Weeks)|Protocol deviation|0|||
147586501|NCT00739973|532301114|FG000|Double-blind:Randomized Period (8 Weeks)|Adverse Event|3|||
147586502|NCT00739973|532301115|FG001|Double-blind:Randomized Period (8 Weeks)|Adverse Event|3|||
147586503|NCT00739973|532301116|FG002|Double-blind:Randomized Period (8 Weeks)|Adverse Event|1|||
147586504|NCT00739973|532301117|FG003|Double-blind:Randomized Period (8 Weeks)|Adverse Event|2|||
147586505|NCT00739973|532301118|FG004|Double-blind:Randomized Period (8 Weeks)|Adverse Event|7|||
147586506|NCT00739973|532301119|FG005|Double-blind:Randomized Period (8 Weeks)|Adverse Event|3|||
147586507|NCT00739973|532301120|FG006|Double-blind:Randomized Period (8 Weeks)|Adverse Event|4|||
147586508|NCT00739973|532301121|FG007|Double-blind:Randomized Period (8 Weeks)|Adverse Event|1|||
147586509|NCT00739973|532301122|FG008|Double-blind:Randomized Period (8 Weeks)|Adverse Event|4|||
147586510|NCT00739973|532301114|FG000|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
147586511|NCT00739973|532301115|FG001|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
147586512|NCT00739973|532301116|FG002|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
147586513|NCT00739973|532301117|FG003|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
147586514|NCT00739973|532301118|FG004|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|1|||
147586515|NCT00739973|532301119|FG005|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
147586516|NCT00739973|532301120|FG006|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
147586517|NCT00739973|532301121|FG007|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|1|||
147586518|NCT00739973|532301122|FG008|Double-blind:Randomized Period (8 Weeks)|Abnormal laboratory values|0|||
147586519|NCT00739973|532301114|FG000|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|1|||
147586520|NCT00739973|532301115|FG001|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|1|||
147586521|NCT00739973|532301116|FG002|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
147586522|NCT00739973|532301117|FG003|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
147586523|NCT00739973|532301118|FG004|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
147586524|NCT00739973|532301119|FG005|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
147586525|NCT00739973|532301120|FG006|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
147586526|NCT00739973|532301121|FG007|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
147586527|NCT00739973|532301122|FG008|Double-blind:Randomized Period (8 Weeks)|Abnormal test procedure results|0|||
147586528|NCT00739973|532301114|FG000|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|17|||
147586529|NCT00739973|532301115|FG001|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|8|||
147586530|NCT00739973|532301116|FG002|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|8|||
147586531|NCT00739973|532301117|FG003|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|4|||
147586532|NCT00739973|532301118|FG004|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|2|||
147586533|NCT00739973|532301119|FG005|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|2|||
147586534|NCT00739973|532301120|FG006|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|1|||
147586535|NCT00739973|532301121|FG007|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|1|||
147586536|NCT00739973|532301122|FG008|Double-blind:Randomized Period (8 Weeks)|Unsatisfactory therapeutic effect|2|||
147586537|NCT00739973|532301114|FG000|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
147586538|NCT00739973|532301115|FG001|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
147586539|NCT00739973|532301116|FG002|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|1|||
147586540|NCT00739973|532301117|FG003|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
147586541|NCT00739973|532301118|FG004|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
147586542|NCT00739973|532301119|FG005|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
147586543|NCT00739973|532301120|FG006|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
147586544|NCT00739973|532301121|FG007|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
147586545|NCT00739973|532301122|FG008|Double-blind:Randomized Period (8 Weeks)|Patient no longer needs study drug|0|||
147586546|NCT00739973|532301114|FG000|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4|||
147586547|NCT00739973|532301115|FG001|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|2|||
147586548|NCT00739973|532301116|FG002|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4|||
147586549|NCT00739973|532301117|FG003|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|3|||
147586550|NCT00739973|532301118|FG004|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4|||
147586551|NCT00739973|532301119|FG005|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4|||
147586552|NCT00739973|532301120|FG006|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|3|||
147586553|NCT00739973|532301121|FG007|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|2|||
147586554|NCT00739973|532301122|FG008|Double-blind:Randomized Period (8 Weeks)|Patient withdrew consent|4|||
147586555|NCT00739973|532301114|FG000|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|0|||
147586556|NCT00739973|532301115|FG001|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|2|||
147586557|NCT00739973|532301116|FG002|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|4|||
147586558|NCT00739973|532301117|FG003|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|1|||
147586559|NCT00739973|532301118|FG004|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|2|||
147586560|NCT00739973|532301119|FG005|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|2|||
147586561|NCT00739973|532301120|FG006|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|0|||
147586562|NCT00739973|532301121|FG007|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|3|||
147586563|NCT00739973|532301122|FG008|Double-blind:Randomized Period (8 Weeks)|Lost to Follow-up|1|||
147586564|NCT00739973|532301114|FG000|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
147586565|NCT00739973|532301115|FG001|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
147586566|NCT00739973|532301116|FG002|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
147586567|NCT00739973|532301117|FG003|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
147586568|NCT00739973|532301118|FG004|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
147586569|NCT00739973|532301119|FG005|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
147586570|NCT00739973|532301120|FG006|Double-blind:Randomized Period (8 Weeks)|Administrative problems|1|||
147586571|NCT00739973|532301121|FG007|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
147586572|NCT00739973|532301122|FG008|Double-blind:Randomized Period (8 Weeks)|Administrative problems|0|||
147586573|NCT00739973|532301114|FG000|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|5|||
147586574|NCT00739973|532301115|FG001|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|3|||
147586575|NCT00739973|532301116|FG002|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|1|||
147586576|NCT00739973|532301117|FG003|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|2|||
147586577|NCT00739973|532301118|FG004|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|3|||
147586578|NCT00739973|532301119|FG005|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|1|||
147586579|NCT00739973|532301120|FG006|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|2|||
147586580|NCT00739973|532301121|FG007|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|2|||
147586581|NCT00739973|532301122|FG008|Double-blind:Randomized Period (8 Weeks)|Protocol deviation|3|||
147586582|NCT00739973|532301114|FG000|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
147586583|NCT00739973|532301115|FG001|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|1|||
147586584|NCT00739973|532301116|FG002|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
147586585|NCT00739973|532301117|FG003|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
147586586|NCT00739973|532301118|FG004|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
147586587|NCT00739973|532301119|FG005|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
147586588|NCT00739973|532301120|FG006|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|2|||
147586589|NCT00739973|532301121|FG007|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
147586590|NCT00739973|532301122|FG008|Double-blind:Randomized Period (8 Weeks)|Discont. single-blind, Mis- randomized|0|||
147586591|NCT00987831|532301123|FG000|Overall Study|Never flared in 12 months|1|||
147586592|NCT00987831|532301124|FG001|Overall Study|Never flared in 12 months|0|||
147586593|NCT00987831|532301125|FG002|Overall Study|Never flared in 12 months|0|||
147586594|NCT00987831|532301123|FG000|Overall Study|Lost to Follow-up|0|||
147586595|NCT00987831|532301124|FG001|Overall Study|Lost to Follow-up|3|||
147586596|NCT00987831|532301125|FG002|Overall Study|Lost to Follow-up|0|||
147586597|NCT02219308|532301126|FG000|Overall Study|Withdrawal by Subject|1|||
147586598|NCT02219308|532301127|FG001|Overall Study|Withdrawal by Subject|2|||
147586599|NCT04149535|532301128|FG000|Overall Study|Death|11|||
147586600|NCT04149535|532301129|FG001|Overall Study|Death|7|||
147586601|NCT04149535|532301128|FG000|Overall Study|Physician Decision|10|||
147586602|NCT04149535|532301129|FG001|Overall Study|Physician Decision|4|||
147586603|NCT04149535|532301128|FG000|Overall Study|Withdrawal by Subject|6|||
147586604|NCT04149535|532301129|FG001|Overall Study|Withdrawal by Subject|7|||
147586605|NCT04149535|532301128|FG000|Overall Study|Not described|2|||
147586606|NCT04149535|532301129|FG001|Overall Study|Not described|0|||
147586607|NCT02175368|532301130|FG000|Overall Study|Lost to Follow-up|1|||
147586608|NCT02875028|532301131|FG000|Washout Period|Withdrawal by Subject|0|||
147586609|NCT02875028|532301132|FG001|Washout Period|Withdrawal by Subject|1|||
147586610|NCT05068284|532301133|FG000|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|2|||
147586611|NCT05068284|532301134|FG001|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|3|||
147586612|NCT05068284|532301135|FG002|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|0|||
147586613|NCT05068284|532301136|FG003|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|0|||
147586614|NCT05068284|532301137|FG004|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|0|||
147586615|NCT05068284|532301138|FG005|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|0|||
147586616|NCT05068284|532301139|FG006|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|0|||
147586617|NCT05068284|532301140|FG007|Double-Blind Induction (12 Weeks)|Withdrawal by Subject|0|||
147586618|NCT05068284|532301133|FG000|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
147586619|NCT05068284|532301134|FG001|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
147586620|NCT05068284|532301135|FG002|Double-Blind Induction (12 Weeks)|Adverse Event|3|||
147586621|NCT05068284|532301136|FG003|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
147586622|NCT05068284|532301137|FG004|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
147586623|NCT05068284|532301138|FG005|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
147586624|NCT05068284|532301139|FG006|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
147586625|NCT05068284|532301140|FG007|Double-Blind Induction (12 Weeks)|Adverse Event|0|||
147586626|NCT05068284|532301133|FG000|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|7|||
147586627|NCT05068284|532301134|FG001|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|2|||
147586628|NCT05068284|532301135|FG002|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|6|||
147586629|NCT05068284|532301136|FG003|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|5|||
147586630|NCT05068284|532301137|FG004|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|10|||
147586631|NCT05068284|532301138|FG005|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|0|||
147586632|NCT05068284|532301139|FG006|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|0|||
147586633|NCT05068284|532301140|FG007|Double-Blind Induction (12 Weeks)|Study terminated by sponsor|0|||
147586634|NCT05068284|532301133|FG000|Double-Blind Induction (12 Weeks)|Lack of Efficacy|0|||
147586635|NCT05068284|532301134|FG001|Double-Blind Induction (12 Weeks)|Lack of Efficacy|0|||
147586636|NCT05068284|532301135|FG002|Double-Blind Induction (12 Weeks)|Lack of Efficacy|1|||
147586637|NCT05068284|532301136|FG003|Double-Blind Induction (12 Weeks)|Lack of Efficacy|0|||
147586638|NCT05068284|532301137|FG004|Double-Blind Induction (12 Weeks)|Lack of Efficacy|1|||
147586639|NCT05068284|532301138|FG005|Double-Blind Induction (12 Weeks)|Lack of Efficacy|0|||
147586640|NCT05068284|532301139|FG006|Double-Blind Induction (12 Weeks)|Lack of Efficacy|0|||
147586641|NCT05068284|532301140|FG007|Double-Blind Induction (12 Weeks)|Lack of Efficacy|0|||
147586642|NCT05068284|532301133|FG000|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
147586643|NCT05068284|532301134|FG001|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
147586644|NCT05068284|532301135|FG002|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
147586645|NCT05068284|532301136|FG003|Double-Blind Re-Induction (12 Weeks)|Adverse Event|2|||
147586646|NCT05068284|532301137|FG004|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
147586647|NCT05068284|532301138|FG005|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
147586648|NCT05068284|532301139|FG006|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
147586649|NCT05068284|532301140|FG007|Double-Blind Re-Induction (12 Weeks)|Adverse Event|0|||
147586650|NCT05068284|532301133|FG000|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|0|||
147586651|NCT05068284|532301134|FG001|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|0|||
147586652|NCT05068284|532301135|FG002|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|1|||
147586653|NCT05068284|532301136|FG003|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|4|||
147586654|NCT05068284|532301137|FG004|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|0|||
147586655|NCT05068284|532301138|FG005|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|0|||
147586656|NCT05068284|532301139|FG006|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|0|||
147586657|NCT05068284|532301140|FG007|Double-Blind Re-Induction (12 Weeks)|Study terminated by sponsor|0|||
147586658|NCT05068284|532301133|FG000|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
147586659|NCT05068284|532301134|FG001|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
147586660|NCT05068284|532301135|FG002|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|2|||
147586661|NCT05068284|532301136|FG003|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
147586662|NCT05068284|532301137|FG004|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
147586663|NCT05068284|532301138|FG005|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
147586664|NCT05068284|532301139|FG006|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
147586665|NCT05068284|532301140|FG007|Double-Blind Re-Induction (12 Weeks)|Lack of Efficacy|0|||
147586666|NCT05068284|532301133|FG000|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|1|||
147586667|NCT05068284|532301134|FG001|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
147586668|NCT05068284|532301135|FG002|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
147586669|NCT05068284|532301136|FG003|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
147586670|NCT05068284|532301137|FG004|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
147586671|NCT05068284|532301138|FG005|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
147586672|NCT05068284|532301139|FG006|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
147586673|NCT05068284|532301140|FG007|Double-Blind Maintenance (40 Weeks)|Lack of efficacy w/o receiving ABBV-154 rescue|0|||
147586674|NCT05068284|532301133|FG000|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|8|||
147586675|NCT05068284|532301134|FG001|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|0|||
147586676|NCT05068284|532301135|FG002|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|0|||
147586677|NCT05068284|532301136|FG003|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|0|||
147586678|NCT05068284|532301137|FG004|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|0|||
147586679|NCT05068284|532301138|FG005|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|3|||
147586680|NCT05068284|532301139|FG006|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|1|||
147586681|NCT05068284|532301140|FG007|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor after ABBV-154|0|||
147158916|NCT01920893|530747192|FG000|Overall Study|Lack of Efficacy|2|||
147322086|NCT02459964|531343573|FG000|Overall Study|Withdrawal by Subject|0|||
147322087|NCT02459964|531343574|FG001|Overall Study|Withdrawal by Subject|0|||
147322088|NCT02459964|531343575|FG002|Overall Study|Withdrawal by Subject|1|||
147586682|NCT05068284|532301133|FG000|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|1|||
147586683|NCT05068284|532301134|FG001|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|0|||
147586684|NCT05068284|532301135|FG002|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|0|||
147586685|NCT05068284|532301136|FG003|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|0|||
147586686|NCT05068284|532301137|FG004|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|0|||
147586687|NCT05068284|532301138|FG005|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|0|||
147586688|NCT05068284|532301139|FG006|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|1|||
147586689|NCT05068284|532301140|FG007|Double-Blind Maintenance (40 Weeks)|AE w/o receiving ABBV-154 rescue|0|||
147586690|NCT05068284|532301133|FG000|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|1|||
147586691|NCT05068284|532301134|FG001|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
147586692|NCT05068284|532301135|FG002|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
147586693|NCT05068284|532301136|FG003|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
147586694|NCT05068284|532301137|FG004|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
147586695|NCT05068284|532301138|FG005|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
147586696|NCT05068284|532301139|FG006|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
147586697|NCT05068284|532301140|FG007|Double-Blind Maintenance (40 Weeks)|WD by subject w/o receiving ABBV-154 rescue|0|||
147586698|NCT05068284|532301133|FG000|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|1|||
147586699|NCT05068284|532301134|FG001|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
147586700|NCT05068284|532301135|FG002|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
147586701|NCT05068284|532301136|FG003|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
147586702|NCT05068284|532301137|FG004|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
147158917|NCT01920893|530747193|FG001|Overall Study|Lack of Efficacy|0|||
147158918|NCT03576755|530747194|FG000|Overall Study|Withdrawal by Subject|1|||
147158919|NCT03576755|530747195|FG001|Overall Study|Withdrawal by Subject|0|||
147158920|NCT03576755|530747196|FG002|Overall Study|Withdrawal by Subject|0|||
147158921|NCT03576755|530747197|FG003|Overall Study|Withdrawal by Subject|0|||
147158922|NCT01767493|530747198|FG000|Overall Study|screen failures|3|||
147158923|NCT00853125|530747199|FG000|Overall Study|Study participant's donor was CMV +|1|||
147158924|NCT03746600|530747200|FG000|Overall Study|Withdrawal by Subject|3|||
147158925|NCT03746600|530747201|FG001|Overall Study|Withdrawal by Subject|3|||
147158926|NCT03746600|530747200|FG000|Overall Study|dismissed from study|1|||
147158927|NCT03746600|530747201|FG001|Overall Study|dismissed from study|0|||
147158928|NCT03746600|530747200|FG000|Overall Study|Lost to Follow-up|1|||
147158929|NCT03746600|530747201|FG001|Overall Study|Lost to Follow-up|0|||
147158930|NCT00884039|530747202|FG000|Overall Study|Withdrawal by Subject|0|||
147158931|NCT00884039|530747203|FG001|Overall Study|Withdrawal by Subject|1|||
147158932|NCT00884039|530747202|FG000|Overall Study|Lack of Efficacy|2|||
147158933|NCT00884039|530747203|FG001|Overall Study|Lack of Efficacy|0|||
147158934|NCT04209114|530747206|FG000|Pre-Treatment Phase|Completed without radical cystectomy|0|||
147158935|NCT04209114|530747207|FG001|Pre-Treatment Phase|Completed without radical cystectomy|0|||
147158936|NCT04209114|530747208|FG002|Pre-Treatment Phase|Completed without radical cystectomy|5|||
147158937|NCT04209114|530747206|FG000|Pre-Treatment Phase|Other reasons|0|||
147158938|NCT04209114|530747207|FG001|Pre-Treatment Phase|Other reasons|0|||
147158939|NCT04209114|530747208|FG002|Pre-Treatment Phase|Other reasons|1|||
147158940|NCT04209114|530747206|FG000|Pre-Treatment Phase|Death|0|||
147158941|NCT04209114|530747207|FG001|Pre-Treatment Phase|Death|0|||
147158942|NCT04209114|530747208|FG002|Pre-Treatment Phase|Death|1|||
147586703|NCT05068284|532301138|FG005|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
147586704|NCT05068284|532301139|FG006|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
147586705|NCT05068284|532301140|FG007|Double-Blind Maintenance (40 Weeks)|Lack of efficacy after receiving ABBV-154 rescue|0|||
147586706|NCT05068284|532301133|FG000|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|6|||
147158943|NCT04209114|530747206|FG000|Pre-Treatment Phase|Participant withdrew consent|0|||
147158944|NCT04209114|530747207|FG001|Pre-Treatment Phase|Participant withdrew consent|0|||
147158945|NCT04209114|530747208|FG002|Pre-Treatment Phase|Participant withdrew consent|1|||
147158946|NCT04209114|530747206|FG000|Treatment Phase|Other reasons|5|||
147158947|NCT04209114|530747207|FG001|Treatment Phase|Other reasons|3|||
147158948|NCT04209114|530747208|FG002|Treatment Phase|Other reasons|0|||
147322089|NCT02459964|531343573|FG000|Overall Study|Abnormal EKG changes|0|||
147322090|NCT02459964|531343574|FG001|Overall Study|Abnormal EKG changes|0|||
147322091|NCT02459964|531343575|FG002|Overall Study|Abnormal EKG changes|1|||
147447012|NCT03099187|531800364|FG000|Double-blind Treatment|Non-compliance with study drug|0|||
147158949|NCT04209114|530747206|FG000|Treatment Phase|Lost to Follow-up|1|||
147158950|NCT04209114|530747207|FG001|Treatment Phase|Lost to Follow-up|0|||
147158951|NCT04209114|530747208|FG002|Treatment Phase|Lost to Follow-up|0|||
147158952|NCT04209114|530747206|FG000|Treatment Phase|Participant withdrew consent|1|||
147322092|NCT00550732|531343576|FG000|Overall Study|Death|4|||
147158953|NCT04209114|530747207|FG001|Treatment Phase|Participant withdrew consent|0|||
147158954|NCT04209114|530747208|FG002|Treatment Phase|Participant withdrew consent|0|||
147158955|NCT04209114|530747206|FG000|Treatment Phase|Adverse event unrelated to study drug|1|||
147158956|NCT04209114|530747207|FG001|Treatment Phase|Adverse event unrelated to study drug|5|||
147158957|NCT04209114|530747208|FG002|Treatment Phase|Adverse event unrelated to study drug|0|||
147158958|NCT04209114|530747206|FG000|Treatment Phase|Death|4|||
147158959|NCT04209114|530747207|FG001|Treatment Phase|Death|1|||
147158960|NCT04209114|530747208|FG002|Treatment Phase|Death|0|||
147158961|NCT04209114|530747206|FG000|Treatment Phase|Study drug toxicity|4|||
147158962|NCT04209114|530747207|FG001|Treatment Phase|Study drug toxicity|6|||
147158963|NCT04209114|530747208|FG002|Treatment Phase|Study drug toxicity|0|||
147158964|NCT04209114|530747206|FG000|Treatment Phase|Disease progression|6|||
147158965|NCT04209114|530747207|FG001|Treatment Phase|Disease progression|9|||
147158966|NCT04209114|530747208|FG002|Treatment Phase|Disease progression|0|||
147158967|NCT00405964|530747210|FG000|Overall Study|Treatment Failure|17|||
147158968|NCT00405964|530747211|FG001|Overall Study|Treatment Failure|45|||
147158969|NCT00405964|530747210|FG000|Overall Study|Adverse Event|7|||
147158970|NCT00405964|530747211|FG001|Overall Study|Adverse Event|16|||
147158971|NCT00405964|530747210|FG000|Overall Study|Lost to Follow-up|5|||
147158972|NCT00405964|530747211|FG001|Overall Study|Lost to Follow-up|5|||
147158973|NCT00405964|530747210|FG000|Overall Study|Withdrawal by Subject|19|||
147586707|NCT05068284|532301134|FG001|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|0|||
147586708|NCT05068284|532301135|FG002|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|0|||
147586709|NCT05068284|532301136|FG003|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|0|||
147586710|NCT05068284|532301137|FG004|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|0|||
147158974|NCT00405964|530747211|FG001|Overall Study|Withdrawal by Subject|23|||
147158975|NCT00405964|530747210|FG000|Overall Study|Protocol Violation|11|||
147158976|NCT00405964|530747211|FG001|Overall Study|Protocol Violation|6|||
147158977|NCT02981407|530747214|FG000|Overall Study|Withdrawal by Subject|2|||
147158978|NCT02981407|530747215|FG001|Overall Study|Withdrawal by Subject|0|||
147158979|NCT01300819|530747218|FG000|Overall Study|Adverse Event|9|||
147158980|NCT01300819|530747219|FG001|Overall Study|Adverse Event|27|||
147158981|NCT01300819|530747218|FG000|Overall Study|Lack of Efficacy|2|||
147158982|NCT01300819|530747219|FG001|Overall Study|Lack of Efficacy|1|||
147158983|NCT01300819|530747218|FG000|Overall Study|Withdrawal by Subject|10|||
147158984|NCT01300819|530747219|FG001|Overall Study|Withdrawal by Subject|12|||
147158985|NCT01300819|530747218|FG000|Overall Study|Patient was 1 month late for Visit 10|0|||
147158986|NCT01300819|530747219|FG001|Overall Study|Patient was 1 month late for Visit 10|1|||
147158987|NCT01300819|530747218|FG000|Overall Study|Refusal to down titrate study drug|0|||
147158988|NCT01300819|530747219|FG001|Overall Study|Refusal to down titrate study drug|1|||
147158989|NCT01300819|530747218|FG000|Overall Study|Administrative reason|0|||
147158990|NCT01300819|530747219|FG001|Overall Study|Administrative reason|1|||
147158991|NCT01300819|530747218|FG000|Overall Study|Safety follow up not done by mistake|0|||
147158992|NCT01300819|530747219|FG001|Overall Study|Safety follow up not done by mistake|1|||
147158993|NCT01300819|530747218|FG000|Overall Study|Follow up call was not done|1|||
147158994|NCT01300819|530747219|FG001|Overall Study|Follow up call was not done|0|||
147158995|NCT02818036|530747225|FG000|Overall Study|head did not fit in fMRI scanner headres|1|||
147586711|NCT05068284|532301138|FG005|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|10|||
147158996|NCT02818036|530747226|FG001|Overall Study|head did not fit in fMRI scanner headres|0|||
147158997|NCT02818036|530747225|FG000|Overall Study|Withdrawal by Subject|1|||
147158998|NCT02818036|530747226|FG001|Overall Study|Withdrawal by Subject|0|||
147158999|NCT01319721|530747233|FG000|Overall Study|Lost to Follow-up|1|||
147241487|NCT01427972|531055916|FG002|Treatment Period 1 (21 Days)|Protocol Violation|0|||
147586712|NCT05068284|532301139|FG006|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|11|||
147586713|NCT05068284|532301140|FG007|Double-Blind Maintenance (40 Weeks)|Study terminated by sponsor w/o receiving ABBV-154 rescue|3|||
147586714|NCT05068284|532301133|FG000|Double-Blind Maintenance (40 Weeks)|Other|0|||
147586715|NCT05068284|532301134|FG001|Double-Blind Maintenance (40 Weeks)|Other|0|||
147586716|NCT05068284|532301135|FG002|Double-Blind Maintenance (40 Weeks)|Other|0|||
147586717|NCT05068284|532301136|FG003|Double-Blind Maintenance (40 Weeks)|Other|0|||
147586718|NCT05068284|532301137|FG004|Double-Blind Maintenance (40 Weeks)|Other|0|||
147586719|NCT05068284|532301138|FG005|Double-Blind Maintenance (40 Weeks)|Other|0|||
147241488|NCT01427972|531055917|FG003|Treatment Period 1 (21 Days)|Protocol Violation|0|||
147159000|NCT01319721|530747234|FG001|Overall Study|Lost to Follow-up|6|||
147159001|NCT00468845|530747236|FG000|Overall Study|Adverse Event|9|||
147159002|NCT00468845|530747237|FG001|Overall Study|Adverse Event|14|||
147586720|NCT05068284|532301139|FG006|Double-Blind Maintenance (40 Weeks)|Other|0|||
147159003|NCT00468845|530747238|FG002|Overall Study|Adverse Event|11|||
147159004|NCT00468845|530747236|FG000|Overall Study|Lost to Follow-up|2|||
147241489|NCT01427972|531055918|FG004|Treatment Period 1 (21 Days)|Protocol Violation|0|||
147159005|NCT00468845|530747237|FG001|Overall Study|Lost to Follow-up|1|||
147159006|NCT00468845|530747238|FG002|Overall Study|Lost to Follow-up|2|||
147159007|NCT00468845|530747236|FG000|Overall Study|Other|4|||
147159008|NCT00468845|530747237|FG001|Overall Study|Other|9|||
147159009|NCT00468845|530747238|FG002|Overall Study|Other|5|||
147159010|NCT00468845|530747236|FG000|Overall Study|No longer willing to participate|5|||
147159011|NCT00468845|530747237|FG001|Overall Study|No longer willing to participate|6|||
147159012|NCT00468845|530747238|FG002|Overall Study|No longer willing to participate|10|||
147159013|NCT00468845|530747236|FG000|Overall Study|Randomized, not treated|1|||
147159014|NCT00468845|530747237|FG001|Overall Study|Randomized, not treated|4|||
147322093|NCT00550732|531343576|FG000|Overall Study|Withdrawal by Subject|2|||
147322094|NCT00550732|531343576|FG000|Overall Study|Physician Decision|2|||
147322095|NCT00550732|531343576|FG000|Overall Study|Lost to Follow-up|1|||
147322096|NCT00550732|531343576|FG000|Overall Study|Palliative care|1|||
147322097|NCT00550732|531343576|FG000|Overall Study|Adverse Event|1|||
147322098|NCT01813422|531343578|FG000|Overall Study|Withdrawal by Subject|14|||
147322099|NCT01813422|531343579|FG001|Overall Study|Withdrawal by Subject|8|||
147322100|NCT01813422|531343578|FG000|Overall Study|Death|2|||
147322101|NCT01813422|531343579|FG001|Overall Study|Death|3|||
147322102|NCT01813422|531343578|FG000|Overall Study|Sponsor Decision|2|||
147322103|NCT01813422|531343579|FG001|Overall Study|Sponsor Decision|1|||
147322104|NCT01813422|531343578|FG000|Overall Study|Lost to Follow-up|2|||
147322105|NCT01813422|531343579|FG001|Overall Study|Lost to Follow-up|4|||
147447013|NCT03099187|531800365|FG001|Double-blind Treatment|Non-compliance with study drug|2|||
147447014|NCT03099187|531800366|FG002|Double-blind Treatment|Non-compliance with study drug|0|||
147447015|NCT03099187|531800367|FG003|Double-blind Treatment|Non-compliance with study drug|0|||
147586721|NCT05068284|532301140|FG007|Double-Blind Maintenance (40 Weeks)|Other|1|||
147586722|NCT01989676|532303272|FG000|Overall Study|Death|52|||
147586723|NCT01989676|532303273|FG001|Overall Study|Death|60|||
147586724|NCT01989676|532303272|FG000|Overall Study|Protocol Violation|2|||
147586725|NCT01989676|532303273|FG001|Overall Study|Protocol Violation|1|||
147586726|NCT01989676|532303272|FG000|Overall Study|Lost to Follow-up|8|||
147586727|NCT01989676|532303273|FG001|Overall Study|Lost to Follow-up|18|||
147586728|NCT01989676|532303272|FG000|Overall Study|No longer willing to participate in study|26|||
147586729|NCT01989676|532303273|FG001|Overall Study|No longer willing to participate in study|26|||
147586730|NCT01989676|532303272|FG000|Overall Study|Participants terminated from study by Sponsor|26|||
147586731|NCT01989676|532303273|FG001|Overall Study|Participants terminated from study by Sponsor|30|||
147586732|NCT01989676|532303272|FG000|Overall Study|Other|4|||
147586733|NCT01989676|532303273|FG001|Overall Study|Other|3|||
147586734|NCT03941834|532303274|FG000|DBT Phase: 1st Treatment Period (2Weeks)|Randomized but not treated|0|||
147586735|NCT03941834|532303275|FG001|DBT Phase: 1st Treatment Period (2Weeks)|Randomized but not treated|1|||
147586736|NCT03941834|532303276|FG002|DBT Phase: 1st Treatment Period (2Weeks)|Randomized but not treated|0|||
147586737|NCT03941834|532303274|FG000|DBT Phase: 1st Treatment Period (2Weeks)|Non compliance|1|||
147586738|NCT03941834|532303275|FG001|DBT Phase: 1st Treatment Period (2Weeks)|Non compliance|0|||
147586739|NCT03941834|532303276|FG002|DBT Phase: 1st Treatment Period (2Weeks)|Non compliance|0|||
147586740|NCT03941834|532303274|FG000|OLE Phase (12 Weeks)|Study terminated by sponsor|0|||
147586741|NCT03941834|532303275|FG001|OLE Phase (12 Weeks)|Study terminated by sponsor|0|||
147586742|NCT03941834|532303276|FG002|OLE Phase (12 Weeks)|Study terminated by sponsor|1|||
147586743|NCT03941834|532303274|FG000|OLE Phase (12 Weeks)|Lack of Efficacy|0|||
147586744|NCT03941834|532303275|FG001|OLE Phase (12 Weeks)|Lack of Efficacy|0|||
147586745|NCT03941834|532303276|FG002|OLE Phase (12 Weeks)|Lack of Efficacy|1|||
147586746|NCT03941834|532303274|FG000|OLE Phase (12 Weeks)|Sponsor decision|0|||
147586747|NCT03941834|532303275|FG001|OLE Phase (12 Weeks)|Sponsor decision|0|||
147586748|NCT03941834|532303276|FG002|OLE Phase (12 Weeks)|Sponsor decision|1|||
147586749|NCT03941834|532303274|FG000|OLE Phase (12 Weeks)|Withdrawal by Subject|0|||
147586750|NCT03941834|532303275|FG001|OLE Phase (12 Weeks)|Withdrawal by Subject|0|||
147586751|NCT03941834|532303276|FG002|OLE Phase (12 Weeks)|Withdrawal by Subject|1|||
147586752|NCT02688387|532303279|FG000|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
147586753|NCT02688387|532303280|FG001|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
147586754|NCT02688387|532303281|FG002|Part 1, Period 1 (up to 6 Days)|Adverse Event|1|||
147586755|NCT02688387|532303282|FG003|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
147586756|NCT02688387|532303283|FG004|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
147586757|NCT02688387|532303284|FG005|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
147586758|NCT02688387|532303285|FG006|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
147586759|NCT02688387|532303286|FG007|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
147586760|NCT02688387|532303287|FG008|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
147159015|NCT00468845|530747238|FG002|Overall Study|Randomized, not treated|2|||
147159016|NCT00549900|530749489|FG000|Overall Study|Adverse Event|1|||
147159017|NCT02210832|530749491|FG000|Overall Study|Pregnancy termination .|3|||
147322106|NCT01653743|531343580|FG000|Overall Study|Withdrawal by Subject|1|||
147586761|NCT02688387|532303288|FG009|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
147159018|NCT02210832|530749492|FG001|Overall Study|Pregnancy termination .|4|||
147159019|NCT02210832|530749493|FG002|Overall Study|Pregnancy termination .|1|||
147322107|NCT01653743|531343581|FG001|Overall Study|Withdrawal by Subject|0|||
147322108|NCT01653743|531343580|FG000|Overall Study|Investigator discretion|3|||
147322109|NCT01653743|531343581|FG001|Overall Study|Investigator discretion|0|||
147159020|NCT02210832|530749491|FG000|Overall Study|Lost to Follow-up|26|||
147159021|NCT02210832|530749492|FG001|Overall Study|Lost to Follow-up|32|||
147159022|NCT02210832|530749493|FG002|Overall Study|Lost to Follow-up|17|||
147159023|NCT02754141|530749498|FG000|Overall Study|Disease progression|11|||
147159024|NCT02754141|530749499|FG001|Overall Study|Disease progression|7|||
147159025|NCT02754141|530749500|FG002|Overall Study|Disease progression|8|||
147159026|NCT02754141|530749501|FG003|Overall Study|Disease progression|5|||
147159027|NCT02754141|530749502|FG004|Overall Study|Disease progression|7|||
147159028|NCT02754141|530749503|FG005|Overall Study|Disease progression|7|||
147159029|NCT02754141|530749504|FG006|Overall Study|Disease progression|7|||
147159030|NCT02754141|530749505|FG007|Overall Study|Disease progression|6|||
147159031|NCT02754141|530749506|FG008|Overall Study|Disease progression|11|||
147159032|NCT02754141|530749507|FG009|Overall Study|Disease progression|16|||
147159033|NCT02754141|530749508|FG010|Overall Study|Disease progression|18|||
147159034|NCT02754141|530749509|FG011|Overall Study|Disease progression|13|||
147586762|NCT02688387|532303289|FG010|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
147586763|NCT02688387|532303290|FG011|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
147586764|NCT02688387|532303291|FG012|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
147586765|NCT02688387|532303292|FG013|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
147586766|NCT02688387|532303293|FG014|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
147586767|NCT02688387|532303294|FG015|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
147586768|NCT02688387|532303295|FG016|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
147586769|NCT02688387|532303296|FG017|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
147586770|NCT02688387|532303297|FG018|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
147159035|NCT02754141|530749510|FG012|Overall Study|Disease progression|10|||
147159036|NCT02754141|530749511|FG013|Overall Study|Disease progression|12|||
147159037|NCT02754141|530749512|FG014|Overall Study|Disease progression|12|||
147159038|NCT02754141|530749513|FG015|Overall Study|Disease progression|14|||
147159039|NCT02754141|530749514|FG016|Overall Study|Disease progression|0|||
147159040|NCT02754141|530749515|FG017|Overall Study|Disease progression|1|||
147159041|NCT02754141|530749498|FG000|Overall Study|Study drug toxicity|1|||
147159042|NCT02754141|530749499|FG001|Overall Study|Study drug toxicity|1|||
147159043|NCT02754141|530749500|FG002|Overall Study|Study drug toxicity|0|||
147159044|NCT02754141|530749501|FG003|Overall Study|Study drug toxicity|0|||
147159045|NCT02754141|530749502|FG004|Overall Study|Study drug toxicity|0|||
147159046|NCT02754141|530749503|FG005|Overall Study|Study drug toxicity|0|||
147159047|NCT02754141|530749504|FG006|Overall Study|Study drug toxicity|0|||
147159048|NCT02754141|530749505|FG007|Overall Study|Study drug toxicity|0|||
147159049|NCT02754141|530749506|FG008|Overall Study|Study drug toxicity|0|||
147159050|NCT02754141|530749507|FG009|Overall Study|Study drug toxicity|0|||
147159051|NCT02754141|530749508|FG010|Overall Study|Study drug toxicity|2|||
147159052|NCT02754141|530749509|FG011|Overall Study|Study drug toxicity|1|||
147159053|NCT02754141|530749510|FG012|Overall Study|Study drug toxicity|1|||
147159054|NCT02754141|530749511|FG013|Overall Study|Study drug toxicity|0|||
147159055|NCT02754141|530749512|FG014|Overall Study|Study drug toxicity|0|||
147159056|NCT02754141|530749513|FG015|Overall Study|Study drug toxicity|0|||
147159057|NCT02754141|530749514|FG016|Overall Study|Study drug toxicity|0|||
147159058|NCT02754141|530749515|FG017|Overall Study|Study drug toxicity|0|||
147159059|NCT02754141|530749498|FG000|Overall Study|AE unrelated to study drug|1|||
147159060|NCT02754141|530749499|FG001|Overall Study|AE unrelated to study drug|1|||
147159061|NCT02754141|530749500|FG002|Overall Study|AE unrelated to study drug|0|||
147586771|NCT02688387|532303298|FG019|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
147586772|NCT02688387|532303299|FG020|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
147586773|NCT02688387|532303300|FG021|Part 1, Period 1 (up to 6 Days)|Adverse Event|0|||
147586774|NCT02688387|532303279|FG000|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
147586775|NCT02688387|532303280|FG001|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
147586776|NCT02688387|532303281|FG002|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
147586777|NCT02688387|532303282|FG003|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|1|||
147586778|NCT02688387|532303283|FG004|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
147586779|NCT02688387|532303284|FG005|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
147586780|NCT02688387|532303285|FG006|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
147586781|NCT02688387|532303286|FG007|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
147586782|NCT02688387|532303287|FG008|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
147586783|NCT02688387|532303288|FG009|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
147586784|NCT02688387|532303289|FG010|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
147586785|NCT02688387|532303290|FG011|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
147586786|NCT02688387|532303291|FG012|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
147586787|NCT02688387|532303292|FG013|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
147159062|NCT02754141|530749501|FG003|Overall Study|AE unrelated to study drug|1|||
147159063|NCT02754141|530749502|FG004|Overall Study|AE unrelated to study drug|3|||
147159064|NCT02754141|530749503|FG005|Overall Study|AE unrelated to study drug|2|||
147159065|NCT02754141|530749504|FG006|Overall Study|AE unrelated to study drug|1|||
147159066|NCT02754141|530749505|FG007|Overall Study|AE unrelated to study drug|0|||
147159067|NCT02754141|530749506|FG008|Overall Study|AE unrelated to study drug|0|||
147159068|NCT02754141|530749507|FG009|Overall Study|AE unrelated to study drug|0|||
147159069|NCT02754141|530749508|FG010|Overall Study|AE unrelated to study drug|0|||
147159070|NCT02754141|530749509|FG011|Overall Study|AE unrelated to study drug|0|||
147159071|NCT02754141|530749510|FG012|Overall Study|AE unrelated to study drug|0|||
147159072|NCT02754141|530749511|FG013|Overall Study|AE unrelated to study drug|0|||
147159073|NCT02754141|530749512|FG014|Overall Study|AE unrelated to study drug|0|||
147159074|NCT02754141|530749513|FG015|Overall Study|AE unrelated to study drug|0|||
147159075|NCT02754141|530749514|FG016|Overall Study|AE unrelated to study drug|0|||
147159076|NCT02754141|530749515|FG017|Overall Study|AE unrelated to study drug|0|||
147159077|NCT02754141|530749498|FG000|Overall Study|Request to discontinue|0|||
147159078|NCT02754141|530749499|FG001|Overall Study|Request to discontinue|0|||
147159079|NCT02754141|530749500|FG002|Overall Study|Request to discontinue|0|||
147159080|NCT02754141|530749501|FG003|Overall Study|Request to discontinue|0|||
147159081|NCT02754141|530749502|FG004|Overall Study|Request to discontinue|0|||
147159082|NCT02754141|530749503|FG005|Overall Study|Request to discontinue|0|||
147586788|NCT02688387|532303293|FG014|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
147586789|NCT02688387|532303294|FG015|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
147586790|NCT02688387|532303295|FG016|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
147586791|NCT02688387|532303296|FG017|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
147586792|NCT02688387|532303297|FG018|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
147586793|NCT02688387|532303298|FG019|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
147159083|NCT02754141|530749504|FG006|Overall Study|Request to discontinue|0|||
147159084|NCT02754141|530749505|FG007|Overall Study|Request to discontinue|0|||
147159085|NCT02754141|530749506|FG008|Overall Study|Request to discontinue|1|||
147159086|NCT02754141|530749507|FG009|Overall Study|Request to discontinue|0|||
147159087|NCT02754141|530749508|FG010|Overall Study|Request to discontinue|0|||
147159088|NCT02754141|530749509|FG011|Overall Study|Request to discontinue|0|||
147586794|NCT02688387|532303299|FG020|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
147586795|NCT02688387|532303300|FG021|Part 1, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
147586796|NCT02688387|532303279|FG000|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
147586797|NCT02688387|532303280|FG001|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|1|||
147586798|NCT02688387|532303281|FG002|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
147586799|NCT02688387|532303282|FG003|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
147586800|NCT02688387|532303283|FG004|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
147586801|NCT02688387|532303284|FG005|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
147586802|NCT02688387|532303285|FG006|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
147586803|NCT02688387|532303286|FG007|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
147586804|NCT02688387|532303287|FG008|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
147586805|NCT02688387|532303288|FG009|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
147586806|NCT02688387|532303289|FG010|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
147586807|NCT02688387|532303290|FG011|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
147586808|NCT02688387|532303291|FG012|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
147586809|NCT02688387|532303292|FG013|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
147586810|NCT02688387|532303293|FG014|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
147586811|NCT02688387|532303294|FG015|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
147586812|NCT02688387|532303295|FG016|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
147586813|NCT02688387|532303296|FG017|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
147586814|NCT02688387|532303297|FG018|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
147586815|NCT02688387|532303298|FG019|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
147586816|NCT02688387|532303299|FG020|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
147586817|NCT02688387|532303300|FG021|Part 1, Washout Period 1 (7 Days)|Protocol defined stop criteria reached|0|||
147586818|NCT02688387|532303279|FG000|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
147586819|NCT02688387|532303280|FG001|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
147586820|NCT02688387|532303281|FG002|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|1|||
147586821|NCT02688387|532303282|FG003|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
147586822|NCT02688387|532303283|FG004|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|1|||
147586823|NCT02688387|532303284|FG005|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
147586824|NCT02688387|532303285|FG006|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
147586825|NCT02688387|532303286|FG007|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
147586826|NCT02688387|532303287|FG008|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
147586827|NCT02688387|532303288|FG009|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
147159089|NCT02754141|530749510|FG012|Overall Study|Request to discontinue|0|||
147159090|NCT02754141|530749511|FG013|Overall Study|Request to discontinue|1|||
147159091|NCT02754141|530749512|FG014|Overall Study|Request to discontinue|1|||
147159092|NCT02754141|530749513|FG015|Overall Study|Request to discontinue|0|||
147159093|NCT02754141|530749514|FG016|Overall Study|Request to discontinue|0|||
147159094|NCT02754141|530749515|FG017|Overall Study|Request to discontinue|0|||
147159095|NCT02754141|530749498|FG000|Overall Study|Withdrew consent|0|||
147159096|NCT02754141|530749499|FG001|Overall Study|Withdrew consent|0|||
147159097|NCT02754141|530749500|FG002|Overall Study|Withdrew consent|0|||
147159098|NCT02754141|530749501|FG003|Overall Study|Withdrew consent|0|||
147159099|NCT02754141|530749502|FG004|Overall Study|Withdrew consent|0|||
147159100|NCT02754141|530749503|FG005|Overall Study|Withdrew consent|0|||
147159101|NCT02754141|530749504|FG006|Overall Study|Withdrew consent|0|||
147159102|NCT02754141|530749505|FG007|Overall Study|Withdrew consent|0|||
147159103|NCT02754141|530749506|FG008|Overall Study|Withdrew consent|0|||
147159104|NCT02754141|530749507|FG009|Overall Study|Withdrew consent|1|||
147159105|NCT02754141|530749508|FG010|Overall Study|Withdrew consent|0|||
147159106|NCT02754141|530749509|FG011|Overall Study|Withdrew consent|0|||
147159107|NCT02754141|530749510|FG012|Overall Study|Withdrew consent|0|||
147159108|NCT02754141|530749511|FG013|Overall Study|Withdrew consent|0|||
147159109|NCT02754141|530749512|FG014|Overall Study|Withdrew consent|0|||
147159110|NCT02754141|530749513|FG015|Overall Study|Withdrew consent|0|||
147159111|NCT02754141|530749514|FG016|Overall Study|Withdrew consent|0|||
147159112|NCT02754141|530749515|FG017|Overall Study|Withdrew consent|0|||
147159113|NCT02754141|530749498|FG000|Overall Study|Maximum clinical benefit|0|||
147159114|NCT02754141|530749499|FG001|Overall Study|Maximum clinical benefit|0|||
147159115|NCT02754141|530749500|FG002|Overall Study|Maximum clinical benefit|0|||
147159116|NCT02754141|530749501|FG003|Overall Study|Maximum clinical benefit|1|||
147159117|NCT02754141|530749502|FG004|Overall Study|Maximum clinical benefit|0|||
147159118|NCT02754141|530749503|FG005|Overall Study|Maximum clinical benefit|0|||
147159119|NCT02754141|530749504|FG006|Overall Study|Maximum clinical benefit|0|||
147159120|NCT02754141|530749505|FG007|Overall Study|Maximum clinical benefit|0|||
147159121|NCT02754141|530749506|FG008|Overall Study|Maximum clinical benefit|0|||
147159122|NCT02754141|530749507|FG009|Overall Study|Maximum clinical benefit|0|||
147159123|NCT02754141|530749508|FG010|Overall Study|Maximum clinical benefit|0|||
147159124|NCT02754141|530749509|FG011|Overall Study|Maximum clinical benefit|0|||
147159125|NCT02754141|530749510|FG012|Overall Study|Maximum clinical benefit|0|||
147159126|NCT02754141|530749511|FG013|Overall Study|Maximum clinical benefit|0|||
147159127|NCT02754141|530749512|FG014|Overall Study|Maximum clinical benefit|0|||
147159128|NCT02754141|530749513|FG015|Overall Study|Maximum clinical benefit|0|||
147159129|NCT02754141|530749514|FG016|Overall Study|Maximum clinical benefit|0|||
147159130|NCT02754141|530749515|FG017|Overall Study|Maximum clinical benefit|0|||
147159131|NCT02754141|530749498|FG000|Overall Study|No longer meets study criteria|0|||
147159132|NCT02754141|530749499|FG001|Overall Study|No longer meets study criteria|0|||
147159133|NCT02754141|530749500|FG002|Overall Study|No longer meets study criteria|0|||
147159134|NCT02754141|530749501|FG003|Overall Study|No longer meets study criteria|1|||
147159135|NCT02754141|530749502|FG004|Overall Study|No longer meets study criteria|0|||
147159136|NCT02754141|530749503|FG005|Overall Study|No longer meets study criteria|0|||
147159137|NCT02754141|530749504|FG006|Overall Study|No longer meets study criteria|0|||
147159138|NCT02754141|530749505|FG007|Overall Study|No longer meets study criteria|0|||
147159139|NCT02754141|530749506|FG008|Overall Study|No longer meets study criteria|0|||
147159140|NCT02754141|530749507|FG009|Overall Study|No longer meets study criteria|0|||
147159141|NCT02754141|530749508|FG010|Overall Study|No longer meets study criteria|0|||
147159142|NCT02754141|530749509|FG011|Overall Study|No longer meets study criteria|0|||
147159143|NCT02754141|530749510|FG012|Overall Study|No longer meets study criteria|0|||
147159144|NCT02754141|530749511|FG013|Overall Study|No longer meets study criteria|0|||
147159145|NCT02754141|530749512|FG014|Overall Study|No longer meets study criteria|0|||
147159146|NCT02754141|530749513|FG015|Overall Study|No longer meets study criteria|0|||
147586828|NCT02688387|532303289|FG010|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
147586829|NCT02688387|532303290|FG011|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
147586830|NCT02688387|532303291|FG012|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
147586831|NCT02688387|532303292|FG013|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
147586832|NCT02688387|532303293|FG014|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
147586833|NCT02688387|532303294|FG015|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
147586834|NCT02688387|532303295|FG016|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
147159147|NCT02754141|530749514|FG016|Overall Study|No longer meets study criteria|0|||
147586835|NCT02688387|532303296|FG017|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
147586836|NCT02688387|532303297|FG018|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
147159148|NCT02754141|530749515|FG017|Overall Study|No longer meets study criteria|0|||
147159149|NCT02754141|530749498|FG000|Overall Study|Other reasons|0|||
147159150|NCT02754141|530749499|FG001|Overall Study|Other reasons|0|||
147322110|NCT00811187|531343583|FG000|Overall Study|Unable to place device / procedure abort|3|||
147159151|NCT02754141|530749500|FG002|Overall Study|Other reasons|0|||
147159152|NCT02754141|530749501|FG003|Overall Study|Other reasons|0|||
147159153|NCT02754141|530749502|FG004|Overall Study|Other reasons|0|||
147159154|NCT02754141|530749503|FG005|Overall Study|Other reasons|0|||
147159155|NCT02754141|530749504|FG006|Overall Study|Other reasons|0|||
147159156|NCT02754141|530749505|FG007|Overall Study|Other reasons|1|||
147159157|NCT02754141|530749506|FG008|Overall Study|Other reasons|0|||
147159158|NCT02754141|530749507|FG009|Overall Study|Other reasons|0|||
147159159|NCT02754141|530749508|FG010|Overall Study|Other reasons|0|||
147159160|NCT02754141|530749509|FG011|Overall Study|Other reasons|0|||
147159161|NCT02754141|530749510|FG012|Overall Study|Other reasons|2|||
147159162|NCT02754141|530749511|FG013|Overall Study|Other reasons|0|||
147159163|NCT02754141|530749512|FG014|Overall Study|Other reasons|0|||
147159164|NCT02754141|530749513|FG015|Overall Study|Other reasons|0|||
147159165|NCT02754141|530749514|FG016|Overall Study|Other reasons|0|||
147159166|NCT02754141|530749515|FG017|Overall Study|Other reasons|0|||
147159167|NCT02754141|530749498|FG000|Overall Study|Completed treatment as per protocol|0|||
147159168|NCT02754141|530749499|FG001|Overall Study|Completed treatment as per protocol|1|||
147159169|NCT02754141|530749500|FG002|Overall Study|Completed treatment as per protocol|0|||
147159170|NCT02754141|530749501|FG003|Overall Study|Completed treatment as per protocol|0|||
147159171|NCT02754141|530749502|FG004|Overall Study|Completed treatment as per protocol|0|||
147159172|NCT02754141|530749503|FG005|Overall Study|Completed treatment as per protocol|0|||
147159173|NCT02754141|530749504|FG006|Overall Study|Completed treatment as per protocol|0|||
147159174|NCT02754141|530749505|FG007|Overall Study|Completed treatment as per protocol|0|||
147159175|NCT02754141|530749506|FG008|Overall Study|Completed treatment as per protocol|0|||
147159176|NCT02754141|530749507|FG009|Overall Study|Completed treatment as per protocol|0|||
147159177|NCT02754141|530749508|FG010|Overall Study|Completed treatment as per protocol|0|||
147159178|NCT02754141|530749509|FG011|Overall Study|Completed treatment as per protocol|0|||
147159179|NCT02754141|530749510|FG012|Overall Study|Completed treatment as per protocol|1|||
147159180|NCT02754141|530749511|FG013|Overall Study|Completed treatment as per protocol|0|||
147159181|NCT02754141|530749512|FG014|Overall Study|Completed treatment as per protocol|0|||
147159182|NCT02754141|530749513|FG015|Overall Study|Completed treatment as per protocol|0|||
147159183|NCT02754141|530749514|FG016|Overall Study|Completed treatment as per protocol|0|||
147159184|NCT02754141|530749515|FG017|Overall Study|Completed treatment as per protocol|0|||
147159185|NCT02754141|530749498|FG000|Overall Study|Not completing monotherapy|0|||
147159186|NCT02754141|530749499|FG001|Overall Study|Not completing monotherapy|0|||
147159187|NCT02754141|530749500|FG002|Overall Study|Not completing monotherapy|0|||
147159188|NCT02754141|530749501|FG003|Overall Study|Not completing monotherapy|0|||
147159189|NCT02754141|530749502|FG004|Overall Study|Not completing monotherapy|0|||
147159190|NCT02754141|530749503|FG005|Overall Study|Not completing monotherapy|0|||
147159191|NCT02754141|530749504|FG006|Overall Study|Not completing monotherapy|0|||
147159192|NCT02754141|530749505|FG007|Overall Study|Not completing monotherapy|0|||
147159193|NCT02754141|530749506|FG008|Overall Study|Not completing monotherapy|0|||
147159194|NCT02754141|530749507|FG009|Overall Study|Not completing monotherapy|0|||
147159195|NCT02754141|530749508|FG010|Overall Study|Not completing monotherapy|0|||
147159196|NCT02754141|530749509|FG011|Overall Study|Not completing monotherapy|0|||
147159197|NCT02754141|530749510|FG012|Overall Study|Not completing monotherapy|0|||
147159198|NCT02754141|530749511|FG013|Overall Study|Not completing monotherapy|1|||
147159199|NCT02754141|530749512|FG014|Overall Study|Not completing monotherapy|0|||
147159200|NCT02754141|530749513|FG015|Overall Study|Not completing monotherapy|0|||
147159201|NCT02754141|530749514|FG016|Overall Study|Not completing monotherapy|0|||
147159202|NCT02754141|530749515|FG017|Overall Study|Not completing monotherapy|0|||
147159203|NCT00794365|530749522|FG000|Overall Study|Lost to Follow-up|38|||
147159204|NCT00794365|530749522|FG000|Overall Study|Other|17|||
147159205|NCT00794365|530749522|FG000|Overall Study|Poor Compliance|11|||
147159206|NCT00794365|530749522|FG000|Overall Study|Adverse Event|10|||
147159207|NCT00794365|530749522|FG000|Overall Study|Lack of Efficacy|3|||
147159208|NCT03538444|530749523|FG000|Overall Study|opioid withdrawal|1|||
147159209|NCT03538444|530749524|FG001|Overall Study|opioid withdrawal|0|||
147159210|NCT00623545|530749527|FG000|Overall Study|Adverse Event|6|||
147159211|NCT00623545|530749527|FG000|Overall Study|Withdrawal by Subject|4|||
147159212|NCT04239222|530749528|FG000|Baseline|Withdrawal by Subject|0|||
147159213|NCT04239222|530749529|FG001|Baseline|Withdrawal by Subject|0|||
147159214|NCT04239222|530749530|FG002|Baseline|Withdrawal by Subject|1|||
147159215|NCT04239222|530749531|FG003|Baseline|Withdrawal by Subject|1|||
147159216|NCT04239222|530749528|FG000|First Foot Assignment|Withdrawal by Subject|0|||
147159217|NCT04239222|530749529|FG001|First Foot Assignment|Withdrawal by Subject|0|||
147159218|NCT04239222|530749530|FG002|First Foot Assignment|Withdrawal by Subject|1|||
147159219|NCT04239222|530749531|FG003|First Foot Assignment|Withdrawal by Subject|0|||
147159220|NCT04239222|530749528|FG000|Crossover to Alternate Foot Assignment|Protocol Violation|0|||
147159221|NCT04239222|530749529|FG001|Crossover to Alternate Foot Assignment|Protocol Violation|0|||
147241490|NCT01427972|531055919|FG005|Treatment Period 1 (21 Days)|Protocol Violation|0|||
147159222|NCT04239222|530749530|FG002|Crossover to Alternate Foot Assignment|Protocol Violation|1|||
147159223|NCT04239222|530749531|FG003|Crossover to Alternate Foot Assignment|Protocol Violation|0|||
147159224|NCT00937404|530749540|FG000|Overall Study|Protocol Violation|1|||
147159225|NCT00937404|530749540|FG000|Overall Study|Withdrawal by Subject|1|||
147159226|NCT00230282|530749542|FG000|Fludarabine + Cyclophosphamide|Lost to Follow-up|4|||
147159227|NCT00230282|530749542|FG000|Fludarabine + Cyclophosphamide|Withdrawal by Subject|1|||
147586837|NCT02688387|532303298|FG019|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
147586838|NCT02688387|532303299|FG020|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
147159228|NCT00230282|530749542|FG000|Fludarabine + Cyclophosphamide|Change in diagnosis|1|||
147159229|NCT00230282|530749542|FG000|Fludarabine + Cyclophosphamide|Richters transformation (progression)|2|||
147159230|NCT01691105|530749546|FG000|1 Month Follow-up|Lost to Follow-up|41|||
147159231|NCT01691105|530749547|FG001|1 Month Follow-up|Lost to Follow-up|38|||
147159232|NCT01691105|530749546|FG000|1 Month Follow-up|Death|2|||
147159233|NCT01691105|530749547|FG001|1 Month Follow-up|Death|3|||
147159234|NCT01691105|530749546|FG000|6 Month Follow-up|Lost to Follow-up|39|||
147159235|NCT01691105|530749547|FG001|6 Month Follow-up|Lost to Follow-up|58|||
147159236|NCT01691105|530749546|FG000|6 Month Follow-up|Death|13|||
147159237|NCT01691105|530749547|FG001|6 Month Follow-up|Death|13|||
147159238|NCT01691105|530749546|FG000|12 Month Follow-up|Lost to Follow-up|50|||
147159239|NCT01691105|530749547|FG001|12 Month Follow-up|Lost to Follow-up|71|||
147159240|NCT01691105|530749546|FG000|12 Month Follow-up|Death|22|||
147159241|NCT01691105|530749547|FG001|12 Month Follow-up|Death|30|||
147159242|NCT01691105|530749546|FG000|12 Month Biochemical Verification|Death|22|||
147159243|NCT01691105|530749547|FG001|12 Month Biochemical Verification|Death|30|||
147159244|NCT01691105|530749546|FG000|12 Month Biochemical Verification|Lost to Follow-up|50|||
147586839|NCT02688387|532303300|FG021|Part 1, Period 2 (up to 6 Days)|Protocol defined stop criteria reached|0|||
147159245|NCT01691105|530749547|FG001|12 Month Biochemical Verification|Lost to Follow-up|71|||
147241491|NCT01427972|531055920|FG006|Treatment Period 1 (21 Days)|Protocol Violation|0|||
147241492|NCT01427972|531055921|FG007|Treatment Period 1 (21 Days)|Protocol Violation|1|||
147586840|NCT02688387|532303279|FG000|Part 1, Washout Period 3 (7 Days)|Protocol Violation|1|||
147586841|NCT02688387|532303280|FG001|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
147586842|NCT02688387|532303281|FG002|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
147586843|NCT02688387|532303282|FG003|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
147586844|NCT02688387|532303283|FG004|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
147586845|NCT02688387|532303284|FG005|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
147586846|NCT02688387|532303285|FG006|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
147586847|NCT02688387|532303286|FG007|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
147586848|NCT02688387|532303287|FG008|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
147586849|NCT02688387|532303288|FG009|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
147241493|NCT01427972|531055922|FG008|Treatment Period 1 (21 Days)|Protocol Violation|0|||
147241494|NCT01427972|531055923|FG009|Treatment Period 1 (21 Days)|Protocol Violation|0|||
147241495|NCT01427972|531055924|FG010|Treatment Period 1 (21 Days)|Protocol Violation|0|||
147241496|NCT01427972|531055925|FG011|Treatment Period 1 (21 Days)|Protocol Violation|0|||
147241497|NCT01427972|531055914|FG000|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
147241498|NCT01427972|531055915|FG001|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
147241499|NCT01427972|531055916|FG002|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
147241500|NCT01427972|531055917|FG003|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
147241501|NCT01427972|531055918|FG004|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
147241502|NCT01427972|531055919|FG005|Washout (at Least 28 Days)|Withdrawal by Subject|2|||
147241503|NCT01427972|531055920|FG006|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
147241504|NCT01427972|531055921|FG007|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
147241505|NCT01427972|531055922|FG008|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
147241506|NCT01427972|531055923|FG009|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
147241507|NCT01427972|531055924|FG010|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
147241508|NCT01427972|531055925|FG011|Washout (at Least 28 Days)|Withdrawal by Subject|0|||
147241509|NCT01427972|531055914|FG000|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
147241510|NCT01427972|531055915|FG001|Treatment Period 2 (21 Days)|Withdrawal by Subject|1|||
147241511|NCT01427972|531055916|FG002|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
147241512|NCT01427972|531055917|FG003|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
147241513|NCT01427972|531055918|FG004|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
147241514|NCT01427972|531055919|FG005|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
147241515|NCT01427972|531055920|FG006|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
147241516|NCT01427972|531055921|FG007|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
147241517|NCT01427972|531055922|FG008|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
147447016|NCT03099187|531800364|FG000|Double-blind Treatment|Disease progression|0|||
147586850|NCT02688387|532303289|FG010|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
147586851|NCT02688387|532303290|FG011|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
147586852|NCT02688387|532303291|FG012|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
147654412|NCT02588092|532556716|FG002|Overall Study|Started Another Treatment|0|||
147159246|NCT01691105|530749546|FG000|12 Month Biochemical Verification|subject did not self-report abstinence|352|||
147159247|NCT01691105|530749547|FG001|12 Month Biochemical Verification|subject did not self-report abstinence|401|||
147159248|NCT00445848|530749548|FG000|Overall Study|Adverse Event|14|||
147159249|NCT00445848|530749548|FG000|Overall Study|Withdrawal by Subject|4|||
147159250|NCT00445848|530749548|FG000|Overall Study|Progression|62|||
147159251|NCT00445848|530749548|FG000|Overall Study|Other-Not protocol specified|5|||
147159252|NCT00790647|530749551|FG000|Overall Study|Adverse Event|1|||
147159253|NCT01777542|530749554|FG000|Second Intervention (20 Weeks)|Adverse Event|0|||
147159254|NCT01777542|530749555|FG001|Second Intervention (20 Weeks)|Adverse Event|1|||
147159255|NCT04706273|530749559|FG000|Overall Study|Withdrawal by Subject|27|||
147159256|NCT04706273|530749559|FG000|Overall Study|Physician Decision|1|||
147586853|NCT02688387|532303292|FG013|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
147586854|NCT02688387|532303293|FG014|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
147586855|NCT02688387|532303294|FG015|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
147586856|NCT02688387|532303295|FG016|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
147159257|NCT04706273|530749559|FG000|Overall Study|Lost to Follow-up|42|||
147159258|NCT04706273|530749559|FG000|Overall Study|Death|85|||
147159259|NCT04706273|530749559|FG000|Overall Study|Amputation that removes study device|2|||
147159260|NCT04706273|530749559|FG000|Overall Study|Surgical bypass|3|||
147159261|NCT04706273|530749559|FG000|Overall Study|Changing hospital|23|||
147159262|NCT04706273|530749559|FG000|Overall Study|Unable to attend hospital|2|||
147159263|NCT03199053|530749562|FG000|ST Period|Withdrawal by Subject|2|||
147159264|NCT03199053|530749563|FG001|ST Period|Withdrawal by Subject|4|||
147159265|NCT03199053|530749564|FG002|ST Period|Withdrawal by Subject|6|||
147159266|NCT03199053|530749562|FG000|ST Period|Withdrawal by parent/guardian|1|||
147159267|NCT03199053|530749563|FG001|ST Period|Withdrawal by parent/guardian|1|||
147159268|NCT03199053|530749564|FG002|ST Period|Withdrawal by parent/guardian|1|||
147159269|NCT03199053|530749562|FG000|ST Period|Lost to Follow-up|2|||
147159270|NCT03199053|530749563|FG001|ST Period|Lost to Follow-up|0|||
147159271|NCT03199053|530749564|FG002|ST Period|Lost to Follow-up|1|||
147159272|NCT03199053|530749562|FG000|LT Period|Withdrawal by Subject|1|||
147159273|NCT03199053|530749563|FG001|LT Period|Withdrawal by Subject|3|||
147159274|NCT03199053|530749564|FG002|LT Period|Withdrawal by Subject|3|||
147159275|NCT03199053|530749562|FG000|LT Period|Withdrawal by parent/guardian|0|||
147159276|NCT03199053|530749563|FG001|LT Period|Withdrawal by parent/guardian|0|||
147159277|NCT03199053|530749564|FG002|LT Period|Withdrawal by parent/guardian|1|||
147159278|NCT03199053|530749562|FG000|LT Period|Lost to Follow-up|0|||
147159279|NCT03199053|530749563|FG001|LT Period|Lost to Follow-up|1|||
147159280|NCT03199053|530749564|FG002|LT Period|Lost to Follow-up|1|||
147159281|NCT03199053|530749562|FG000|LT Period|Miscellaneous|0|||
147159282|NCT03199053|530749563|FG001|LT Period|Miscellaneous|0|||
147159283|NCT03199053|530749564|FG002|LT Period|Miscellaneous|2|||
147159284|NCT03199053|530749562|FG000|Non-treatment Follow-up Period|Withdrawal by Subject|2|||
147159285|NCT03199053|530749563|FG001|Non-treatment Follow-up Period|Withdrawal by Subject|1|||
147159286|NCT03199053|530749564|FG002|Non-treatment Follow-up Period|Withdrawal by Subject|0|||
147159287|NCT03199053|530749562|FG000|Non-treatment Follow-up Period|Withdrawal by parent/guardian|2|||
147159288|NCT03199053|530749563|FG001|Non-treatment Follow-up Period|Withdrawal by parent/guardian|3|||
147159289|NCT03199053|530749564|FG002|Non-treatment Follow-up Period|Withdrawal by parent/guardian|2|||
147159290|NCT03199053|530749562|FG000|Non-treatment Follow-up Period|Lost to Follow-up|3|||
147159291|NCT03199053|530749563|FG001|Non-treatment Follow-up Period|Lost to Follow-up|4|||
147159292|NCT03199053|530749564|FG002|Non-treatment Follow-up Period|Lost to Follow-up|5|||
147159293|NCT03199053|530749562|FG000|Non-treatment Follow-up Period|Miscellaneous|0|||
147159294|NCT03199053|530749563|FG001|Non-treatment Follow-up Period|Miscellaneous|1|||
147159295|NCT03199053|530749564|FG002|Non-treatment Follow-up Period|Miscellaneous|0|||
147159296|NCT03298984|530749565|FG000|Overall Study|Physician Decision|1|||
147159297|NCT03298984|530749566|FG001|Overall Study|Physician Decision|0|||
147159298|NCT03298984|530749567|FG002|Overall Study|Physician Decision|0|||
147159299|NCT03298984|530749568|FG003|Overall Study|Physician Decision|6|||
147159300|NCT03298984|530749565|FG000|Overall Study|Lack of Efficacy|0|||
147159301|NCT03298984|530749566|FG001|Overall Study|Lack of Efficacy|1|||
147159302|NCT03298984|530749567|FG002|Overall Study|Lack of Efficacy|1|||
147159303|NCT03298984|530749568|FG003|Overall Study|Lack of Efficacy|4|||
147159304|NCT03298984|530749565|FG000|Overall Study|Relapsed disease (following remission)|0|||
147159305|NCT03298984|530749566|FG001|Overall Study|Relapsed disease (following remission)|0|||
147159306|NCT03298984|530749567|FG002|Overall Study|Relapsed disease (following remission)|1|||
147159307|NCT03298984|530749568|FG003|Overall Study|Relapsed disease (following remission)|1|||
147159308|NCT03298984|530749565|FG000|Overall Study|Adverse Event|0|||
147241518|NCT01427972|531055923|FG009|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
147586857|NCT02688387|532303296|FG017|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
147586858|NCT02688387|532303297|FG018|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
147586859|NCT02688387|532303298|FG019|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
147586860|NCT02688387|532303299|FG020|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
147159309|NCT03298984|530749566|FG001|Overall Study|Adverse Event|0|||
147159310|NCT03298984|530749567|FG002|Overall Study|Adverse Event|0|||
147159311|NCT03298984|530749568|FG003|Overall Study|Adverse Event|1|||
147159312|NCT03298984|530749565|FG000|Overall Study|Death|0|||
147586861|NCT02688387|532303300|FG021|Part 1, Washout Period 3 (7 Days)|Protocol Violation|0|||
147159313|NCT03298984|530749566|FG001|Overall Study|Death|0|||
147159314|NCT03298984|530749567|FG002|Overall Study|Death|0|||
147159315|NCT03298984|530749568|FG003|Overall Study|Death|2|||
147159316|NCT03298984|530749565|FG000|Overall Study|Insurance Company Decision|0|||
147159317|NCT03298984|530749566|FG001|Overall Study|Insurance Company Decision|0|||
147159318|NCT03298984|530749567|FG002|Overall Study|Insurance Company Decision|0|||
147159319|NCT03298984|530749568|FG003|Overall Study|Insurance Company Decision|1|||
147159320|NCT02403635|530749571|FG000|Overall Study|Not eligible|9|||
147159321|NCT00585221|530749575|FG000|Overall Study|Protocol Violation|8|||
147159322|NCT02509052|530749576|FG000|Overall Study|Non compliance|0|||
147159323|NCT02509052|530749577|FG001|Overall Study|Non compliance|0|||
147159324|NCT02509052|530749578|FG002|Overall Study|Non compliance|1|||
147159325|NCT02585830|530749579|FG000|Overall Study|Withdrawal by Subject|3|||
147159326|NCT03263923|530749580|FG000|Overall Study|Withdrawal by Subject|10|||
147159327|NCT03263923|530749581|FG001|Overall Study|Withdrawal by Subject|8|||
147159328|NCT03263923|530749580|FG000|Overall Study|Lost to Follow-up|15|||
147159329|NCT03263923|530749581|FG001|Overall Study|Lost to Follow-up|13|||
147159330|NCT01323270|530749582|FG000|Overall Study|Withdrawal by Subject|19|||
147159331|NCT01323270|530749583|FG001|Overall Study|Withdrawal by Subject|10|||
147159332|NCT01323270|530749582|FG000|Overall Study|Protocol Violation|9|||
147159333|NCT01323270|530749583|FG001|Overall Study|Protocol Violation|7|||
147159334|NCT01323270|530749582|FG000|Overall Study|Lost to Follow-up|4|||
147159335|NCT01323270|530749583|FG001|Overall Study|Lost to Follow-up|6|||
147159336|NCT01323270|530749582|FG000|Overall Study|Adverse Event|8|||
147159337|NCT01323270|530749583|FG001|Overall Study|Adverse Event|0|||
147159338|NCT01323270|530749582|FG000|Overall Study|Other|0|||
147159339|NCT01323270|530749583|FG001|Overall Study|Other|3|||
147159340|NCT01323270|530749582|FG000|Overall Study|Physician Decision|0|||
147159341|NCT01323270|530749583|FG001|Overall Study|Physician Decision|2|||
147159342|NCT01323270|530749582|FG000|Overall Study|Not eligible|1|||
147159343|NCT01323270|530749583|FG001|Overall Study|Not eligible|1|||
147159344|NCT01323270|530749582|FG000|Overall Study|Death|1|||
147159345|NCT01323270|530749583|FG001|Overall Study|Death|0|||
147159346|NCT01323270|530749582|FG000|Overall Study|Randomized, but not vaccinated|1|||
147159347|NCT01323270|530749583|FG001|Overall Study|Randomized, but not vaccinated|0|||
147159348|NCT00075725|530749591|FG000|Overall Study|Adverse Event|6|||
147159349|NCT00075725|530749592|FG001|Overall Study|Adverse Event|6|||
147159350|NCT00075725|530749593|FG002|Overall Study|Adverse Event|20|||
147159351|NCT00075725|530749594|FG003|Overall Study|Adverse Event|8|||
147159352|NCT00075725|530749595|FG004|Overall Study|Adverse Event|4|||
147159353|NCT00075725|530749596|FG005|Overall Study|Adverse Event|38|||
147159354|NCT00075725|530749597|FG006|Overall Study|Adverse Event|3|||
147159355|NCT00075725|530749598|FG007|Overall Study|Adverse Event|51|||
147159356|NCT00075725|530749599|FG008|Overall Study|Adverse Event|15|||
147159357|NCT00075725|530749600|FG009|Overall Study|Adverse Event|4|||
147159358|NCT00075725|530749601|FG010|Overall Study|Adverse Event|2|||
147159359|NCT00075725|530749602|FG011|Overall Study|Adverse Event|2|||
147159360|NCT00075725|530749591|FG000|Overall Study|Death|3|||
147159361|NCT00075725|530749592|FG001|Overall Study|Death|5|||
147159362|NCT00075725|530749593|FG002|Overall Study|Death|10|||
147159363|NCT00075725|530749594|FG003|Overall Study|Death|2|||
147159364|NCT00075725|530749595|FG004|Overall Study|Death|3|||
147159365|NCT00075725|530749596|FG005|Overall Study|Death|25|||
147159366|NCT00075725|530749597|FG006|Overall Study|Death|4|||
147159367|NCT00075725|530749598|FG007|Overall Study|Death|22|||
147159368|NCT00075725|530749599|FG008|Overall Study|Death|14|||
147159369|NCT00075725|530749600|FG009|Overall Study|Death|4|||
147159370|NCT00075725|530749601|FG010|Overall Study|Death|3|||
147159371|NCT00075725|530749602|FG011|Overall Study|Death|0|||
147159372|NCT00075725|530749591|FG000|Overall Study|Lost to Follow-up|1|||
147159373|NCT00075725|530749592|FG001|Overall Study|Lost to Follow-up|1|||
147159374|NCT00075725|530749593|FG002|Overall Study|Lost to Follow-up|4|||
147159375|NCT00075725|530749594|FG003|Overall Study|Lost to Follow-up|1|||
147159376|NCT00075725|530749595|FG004|Overall Study|Lost to Follow-up|0|||
147586862|NCT02688387|532303279|FG000|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
147586863|NCT02688387|532303280|FG001|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
147159377|NCT00075725|530749596|FG005|Overall Study|Lost to Follow-up|13|||
147159378|NCT00075725|530749597|FG006|Overall Study|Lost to Follow-up|2|||
147586864|NCT02688387|532303281|FG002|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
147159379|NCT00075725|530749598|FG007|Overall Study|Lost to Follow-up|4|||
147159380|NCT00075725|530749599|FG008|Overall Study|Lost to Follow-up|1|||
147586865|NCT02688387|532303282|FG003|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
147159381|NCT00075725|530749600|FG009|Overall Study|Lost to Follow-up|0|||
147159382|NCT00075725|530749601|FG010|Overall Study|Lost to Follow-up|0|||
147159383|NCT00075725|530749602|FG011|Overall Study|Lost to Follow-up|0|||
147159384|NCT00075725|530749591|FG000|Overall Study|Physician Decision|2|||
147159385|NCT00075725|530749592|FG001|Overall Study|Physician Decision|6|||
147159386|NCT00075725|530749593|FG002|Overall Study|Physician Decision|5|||
147159387|NCT00075725|530749594|FG003|Overall Study|Physician Decision|8|||
147159388|NCT00075725|530749595|FG004|Overall Study|Physician Decision|4|||
147159389|NCT00075725|530749596|FG005|Overall Study|Physician Decision|19|||
147159390|NCT00075725|530749597|FG006|Overall Study|Physician Decision|3|||
147159391|NCT00075725|530749598|FG007|Overall Study|Physician Decision|17|||
147159392|NCT00075725|530749599|FG008|Overall Study|Physician Decision|5|||
147159393|NCT00075725|530749600|FG009|Overall Study|Physician Decision|0|||
147447017|NCT03099187|531800365|FG001|Double-blind Treatment|Disease progression|1|||
147447018|NCT03099187|531800366|FG002|Double-blind Treatment|Disease progression|0|||
147447019|NCT03099187|531800367|FG003|Double-blind Treatment|Disease progression|0|||
147586866|NCT02688387|532303283|FG004|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
147586867|NCT02688387|532303284|FG005|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
147586868|NCT02688387|532303285|FG006|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
147586869|NCT02688387|532303286|FG007|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
147586870|NCT02688387|532303287|FG008|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
147159394|NCT00075725|530749601|FG010|Overall Study|Physician Decision|1|||
147159395|NCT00075725|530749602|FG011|Overall Study|Physician Decision|0|||
147159396|NCT00075725|530749591|FG000|Overall Study|Pregnancy|0|||
147159397|NCT00075725|530749592|FG001|Overall Study|Pregnancy|0|||
147159398|NCT00075725|530749593|FG002|Overall Study|Pregnancy|0|||
147159399|NCT00075725|530749594|FG003|Overall Study|Pregnancy|0|||
147159400|NCT00075725|530749595|FG004|Overall Study|Pregnancy|0|||
147159401|NCT00075725|530749596|FG005|Overall Study|Pregnancy|1|||
147159402|NCT00075725|530749597|FG006|Overall Study|Pregnancy|0|||
147159403|NCT00075725|530749598|FG007|Overall Study|Pregnancy|1|||
147159404|NCT00075725|530749599|FG008|Overall Study|Pregnancy|0|||
147159405|NCT00075725|530749600|FG009|Overall Study|Pregnancy|0|||
147159406|NCT00075725|530749601|FG010|Overall Study|Pregnancy|0|||
147159407|NCT00075725|530749602|FG011|Overall Study|Pregnancy|0|||
147159408|NCT00075725|530749591|FG000|Overall Study|Protocol Violation|1|||
147159409|NCT00075725|530749592|FG001|Overall Study|Protocol Violation|1|||
147159410|NCT00075725|530749593|FG002|Overall Study|Protocol Violation|0|||
147159411|NCT00075725|530749594|FG003|Overall Study|Protocol Violation|3|||
147159412|NCT00075725|530749595|FG004|Overall Study|Protocol Violation|3|||
147159413|NCT00075725|530749596|FG005|Overall Study|Protocol Violation|2|||
147159414|NCT00075725|530749597|FG006|Overall Study|Protocol Violation|1|||
147159415|NCT00075725|530749598|FG007|Overall Study|Protocol Violation|2|||
147159416|NCT00075725|530749599|FG008|Overall Study|Protocol Violation|3|||
147159417|NCT00075725|530749600|FG009|Overall Study|Protocol Violation|0|||
147159418|NCT00075725|530749601|FG010|Overall Study|Protocol Violation|0|||
147159419|NCT00075725|530749602|FG011|Overall Study|Protocol Violation|1|||
147159420|NCT00075725|530749591|FG000|Overall Study|Withdrawal by Subject|12|||
147159421|NCT00075725|530749592|FG001|Overall Study|Withdrawal by Subject|3|||
147159422|NCT00075725|530749593|FG002|Overall Study|Withdrawal by Subject|6|||
147159423|NCT00075725|530749594|FG003|Overall Study|Withdrawal by Subject|10|||
147159424|NCT00075725|530749595|FG004|Overall Study|Withdrawal by Subject|6|||
147159425|NCT00075725|530749596|FG005|Overall Study|Withdrawal by Subject|27|||
147159426|NCT00075725|530749597|FG006|Overall Study|Withdrawal by Subject|7|||
147159427|NCT00075725|530749598|FG007|Overall Study|Withdrawal by Subject|31|||
147159428|NCT00075725|530749599|FG008|Overall Study|Withdrawal by Subject|10|||
147159429|NCT00075725|530749600|FG009|Overall Study|Withdrawal by Subject|2|||
147159430|NCT00075725|530749601|FG010|Overall Study|Withdrawal by Subject|0|||
147159431|NCT00075725|530749602|FG011|Overall Study|Withdrawal by Subject|0|||
147159432|NCT00075725|530749591|FG000|Overall Study|Disease Progression, all other reasons|17|||
147159433|NCT00075725|530749592|FG001|Overall Study|Disease Progression, all other reasons|5|||
147159434|NCT00075725|530749593|FG002|Overall Study|Disease Progression, all other reasons|33|||
147159435|NCT00075725|530749594|FG003|Overall Study|Disease Progression, all other reasons|6|||
147159436|NCT00075725|530749595|FG004|Overall Study|Disease Progression, all other reasons|21|||
147159437|NCT00075725|530749596|FG005|Overall Study|Disease Progression, all other reasons|59|||
147159438|NCT00075725|530749597|FG006|Overall Study|Disease Progression, all other reasons|20|||
147159439|NCT00075725|530749598|FG007|Overall Study|Disease Progression, all other reasons|46|||
147159440|NCT00075725|530749599|FG008|Overall Study|Disease Progression, all other reasons|21|||
147159441|NCT00075725|530749600|FG009|Overall Study|Disease Progression, all other reasons|4|||
147159442|NCT00075725|530749601|FG010|Overall Study|Disease Progression, all other reasons|0|||
147159443|NCT00075725|530749602|FG011|Overall Study|Disease Progression, all other reasons|5|||
147159444|NCT00075725|530749591|FG000|Overall Study|Patient off treatment|0|||
147159445|NCT00075725|530749592|FG001|Overall Study|Patient off treatment|0|||
147159446|NCT00075725|530749593|FG002|Overall Study|Patient off treatment|1|||
147159447|NCT00075725|530749594|FG003|Overall Study|Patient off treatment|2|||
147159448|NCT00075725|530749595|FG004|Overall Study|Patient off treatment|1|||
147159449|NCT00075725|530749596|FG005|Overall Study|Patient off treatment|0|||
147159450|NCT00075725|530749597|FG006|Overall Study|Patient off treatment|0|||
147159451|NCT00075725|530749598|FG007|Overall Study|Patient off treatment|2|||
147159452|NCT00075725|530749599|FG008|Overall Study|Patient off treatment|1|||
147159453|NCT00075725|530749600|FG009|Overall Study|Patient off treatment|0|||
147159454|NCT00075725|530749601|FG010|Overall Study|Patient off treatment|0|||
147159455|NCT00075725|530749602|FG011|Overall Study|Patient off treatment|0|||
147159456|NCT00075725|530749591|FG000|Overall Study|Ineligible or wrong diagnosis|8|||
147159457|NCT00075725|530749592|FG001|Overall Study|Ineligible or wrong diagnosis|3|||
147159458|NCT00075725|530749593|FG002|Overall Study|Ineligible or wrong diagnosis|3|||
147159459|NCT00075725|530749594|FG003|Overall Study|Ineligible or wrong diagnosis|10|||
147159460|NCT00075725|530749595|FG004|Overall Study|Ineligible or wrong diagnosis|3|||
147159461|NCT00075725|530749596|FG005|Overall Study|Ineligible or wrong diagnosis|17|||
147159462|NCT00075725|530749597|FG006|Overall Study|Ineligible or wrong diagnosis|6|||
147159463|NCT00075725|530749598|FG007|Overall Study|Ineligible or wrong diagnosis|9|||
147159464|NCT00075725|530749599|FG008|Overall Study|Ineligible or wrong diagnosis|10|||
147159465|NCT00075725|530749600|FG009|Overall Study|Ineligible or wrong diagnosis|1|||
147159466|NCT00075725|530749601|FG010|Overall Study|Ineligible or wrong diagnosis|2|||
147159467|NCT00075725|530749602|FG011|Overall Study|Ineligible or wrong diagnosis|4|||
147159468|NCT00075725|530749591|FG000|Overall Study|Pt/Guardian refused RT therapy|1|||
147159469|NCT00075725|530749592|FG001|Overall Study|Pt/Guardian refused RT therapy|0|||
147586871|NCT02688387|532303288|FG009|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
147159470|NCT00075725|530749593|FG002|Overall Study|Pt/Guardian refused RT therapy|1|||
147159471|NCT00075725|530749594|FG003|Overall Study|Pt/Guardian refused RT therapy|2|||
147159472|NCT00075725|530749595|FG004|Overall Study|Pt/Guardian refused RT therapy|1|||
147159473|NCT00075725|530749596|FG005|Overall Study|Pt/Guardian refused RT therapy|0|||
147159474|NCT00075725|530749597|FG006|Overall Study|Pt/Guardian refused RT therapy|0|||
147159475|NCT00075725|530749598|FG007|Overall Study|Pt/Guardian refused RT therapy|0|||
147159476|NCT00075725|530749599|FG008|Overall Study|Pt/Guardian refused RT therapy|0|||
147159477|NCT00075725|530749600|FG009|Overall Study|Pt/Guardian refused RT therapy|0|||
147159478|NCT00075725|530749601|FG010|Overall Study|Pt/Guardian refused RT therapy|0|||
147159479|NCT00075725|530749602|FG011|Overall Study|Pt/Guardian refused RT therapy|0|||
147159480|NCT00075725|530749591|FG000|Overall Study|Pt non compliant with therapy|2|||
147159481|NCT00075725|530749592|FG001|Overall Study|Pt non compliant with therapy|1|||
147159482|NCT00075725|530749593|FG002|Overall Study|Pt non compliant with therapy|1|||
147159483|NCT00075725|530749594|FG003|Overall Study|Pt non compliant with therapy|0|||
147159484|NCT00075725|530749595|FG004|Overall Study|Pt non compliant with therapy|2|||
147159485|NCT00075725|530749596|FG005|Overall Study|Pt non compliant with therapy|14|||
147159486|NCT00075725|530749597|FG006|Overall Study|Pt non compliant with therapy|2|||
147159487|NCT00075725|530749598|FG007|Overall Study|Pt non compliant with therapy|5|||
147159488|NCT00075725|530749599|FG008|Overall Study|Pt non compliant with therapy|3|||
147159489|NCT00075725|530749600|FG009|Overall Study|Pt non compliant with therapy|0|||
147159490|NCT00075725|530749601|FG010|Overall Study|Pt non compliant with therapy|0|||
147159491|NCT00075725|530749602|FG011|Overall Study|Pt non compliant with therapy|0|||
147159492|NCT00075725|530749591|FG000|Overall Study|Pt age out of range for treatment|0|||
147159493|NCT00075725|530749592|FG001|Overall Study|Pt age out of range for treatment|1|||
147159494|NCT00075725|530749593|FG002|Overall Study|Pt age out of range for treatment|0|||
147159495|NCT00075725|530749594|FG003|Overall Study|Pt age out of range for treatment|0|||
147159496|NCT00075725|530749595|FG004|Overall Study|Pt age out of range for treatment|0|||
147159497|NCT00075725|530749596|FG005|Overall Study|Pt age out of range for treatment|1|||
147159498|NCT00075725|530749597|FG006|Overall Study|Pt age out of range for treatment|0|||
147159499|NCT00075725|530749598|FG007|Overall Study|Pt age out of range for treatment|1|||
147159500|NCT00075725|530749599|FG008|Overall Study|Pt age out of range for treatment|0|||
147159501|NCT00075725|530749600|FG009|Overall Study|Pt age out of range for treatment|0|||
147322111|NCT00811187|531343584|FG001|Overall Study|Unable to place device / procedure abort|3|||
147322112|NCT02825043|531343585|FG000|Overall Study|Lost to Follow-up|4|||
147322113|NCT00329303|531343586|FG000|Overall Study|Lack of Efficacy|1|||
147322114|NCT00329303|531343587|FG001|Overall Study|Lack of Efficacy|0|||
147322115|NCT00329303|531343586|FG000|Overall Study|Decision of the sponsor|0|||
147322116|NCT00329303|531343587|FG001|Overall Study|Decision of the sponsor|1|||
147322117|NCT00329303|531343586|FG000|Overall Study|Patient no longer available|1|||
147447020|NCT03099187|531800364|FG000|Double-blind Treatment|Randomization error|0|||
147447021|NCT03099187|531800365|FG001|Double-blind Treatment|Randomization error|2|||
147447022|NCT03099187|531800366|FG002|Double-blind Treatment|Randomization error|0|||
147586872|NCT02688387|532303289|FG010|Part 2, Period 1 (up to 6 Days)|Adverse Event|1|||
147159502|NCT00075725|530749601|FG010|Overall Study|Pt age out of range for treatment|0|||
147159503|NCT00075725|530749602|FG011|Overall Study|Pt age out of range for treatment|0|||
147159504|NCT00075725|530749591|FG000|Overall Study|Insurance issues|0|||
147159505|NCT00075725|530749592|FG001|Overall Study|Insurance issues|1|||
147159506|NCT00075725|530749593|FG002|Overall Study|Insurance issues|0|||
147159507|NCT00075725|530749594|FG003|Overall Study|Insurance issues|1|||
147159508|NCT00075725|530749595|FG004|Overall Study|Insurance issues|1|||
147159509|NCT00075725|530749596|FG005|Overall Study|Insurance issues|1|||
147159510|NCT00075725|530749597|FG006|Overall Study|Insurance issues|0|||
147159511|NCT00075725|530749598|FG007|Overall Study|Insurance issues|1|||
147159512|NCT00075725|530749599|FG008|Overall Study|Insurance issues|0|||
147159513|NCT00075725|530749600|FG009|Overall Study|Insurance issues|0|||
147159514|NCT00075725|530749601|FG010|Overall Study|Insurance issues|0|||
147159515|NCT00075725|530749602|FG011|Overall Study|Insurance issues|0|||
147159516|NCT00075725|530749591|FG000|Overall Study|MRD positive after extended ind|0|||
147159517|NCT00075725|530749592|FG001|Overall Study|MRD positive after extended ind|1|||
147159518|NCT00075725|530749593|FG002|Overall Study|MRD positive after extended ind|1|||
147159519|NCT00075725|530749594|FG003|Overall Study|MRD positive after extended ind|0|||
147322118|NCT00329303|531343587|FG001|Overall Study|Patient no longer available|0|||
147159520|NCT00075725|530749595|FG004|Overall Study|MRD positive after extended ind|1|||
147159521|NCT00075725|530749596|FG005|Overall Study|MRD positive after extended ind|2|||
147159522|NCT00075725|530749597|FG006|Overall Study|MRD positive after extended ind|0|||
147159523|NCT00075725|530749598|FG007|Overall Study|MRD positive after extended ind|1|||
147159524|NCT00075725|530749599|FG008|Overall Study|MRD positive after extended ind|0|||
147159525|NCT00075725|530749600|FG009|Overall Study|MRD positive after extended ind|0|||
147159526|NCT00075725|530749601|FG010|Overall Study|MRD positive after extended ind|0|||
147159527|NCT00075725|530749602|FG011|Overall Study|MRD positive after extended ind|0|||
147159528|NCT00075725|530749591|FG000|Overall Study|Pt has very high risk ALL characteristic|15|||
147159529|NCT00075725|530749592|FG001|Overall Study|Pt has very high risk ALL characteristic|11|||
147159530|NCT00075725|530749593|FG002|Overall Study|Pt has very high risk ALL characteristic|26|||
147159531|NCT00075725|530749594|FG003|Overall Study|Pt has very high risk ALL characteristic|18|||
147159532|NCT00075725|530749595|FG004|Overall Study|Pt has very high risk ALL characteristic|11|||
147159533|NCT00075725|530749596|FG005|Overall Study|Pt has very high risk ALL characteristic|75|||
147159534|NCT00075725|530749597|FG006|Overall Study|Pt has very high risk ALL characteristic|23|||
147159535|NCT00075725|530749598|FG007|Overall Study|Pt has very high risk ALL characteristic|74|||
147159536|NCT00075725|530749599|FG008|Overall Study|Pt has very high risk ALL characteristic|29|||
147159537|NCT00075725|530749600|FG009|Overall Study|Pt has very high risk ALL characteristic|1|||
147159538|NCT00075725|530749601|FG010|Overall Study|Pt has very high risk ALL characteristic|0|||
147159539|NCT00075725|530749602|FG011|Overall Study|Pt has very high risk ALL characteristic|3|||
147159540|NCT00075725|530749591|FG000|Overall Study|Inevaluable|1|||
147159541|NCT00075725|530749592|FG001|Overall Study|Inevaluable|1|||
147159542|NCT00075725|530749593|FG002|Overall Study|Inevaluable|4|||
147159543|NCT00075725|530749594|FG003|Overall Study|Inevaluable|2|||
147159544|NCT00075725|530749595|FG004|Overall Study|Inevaluable|2|||
147159545|NCT00075725|530749596|FG005|Overall Study|Inevaluable|9|||
147159546|NCT00075725|530749597|FG006|Overall Study|Inevaluable|1|||
147159547|NCT00075725|530749598|FG007|Overall Study|Inevaluable|11|||
147159548|NCT00075725|530749599|FG008|Overall Study|Inevaluable|2|||
147159549|NCT00075725|530749600|FG009|Overall Study|Inevaluable|0|||
147159550|NCT00075725|530749601|FG010|Overall Study|Inevaluable|1|||
147159551|NCT00075725|530749602|FG011|Overall Study|Inevaluable|0|||
147159552|NCT00075725|530749591|FG000|Overall Study|Other|4|||
147159553|NCT00075725|530749592|FG001|Overall Study|Other|2|||
147159554|NCT00075725|530749593|FG002|Overall Study|Other|1|||
147159555|NCT00075725|530749594|FG003|Overall Study|Other|1|||
147159556|NCT00075725|530749595|FG004|Overall Study|Other|1|||
147159557|NCT00075725|530749596|FG005|Overall Study|Other|4|||
147159558|NCT00075725|530749597|FG006|Overall Study|Other|2|||
147159559|NCT00075725|530749598|FG007|Overall Study|Other|9|||
147159560|NCT00075725|530749599|FG008|Overall Study|Other|2|||
147159561|NCT00075725|530749600|FG009|Overall Study|Other|1|||
147159562|NCT00075725|530749601|FG010|Overall Study|Other|0|||
147159563|NCT00075725|530749602|FG011|Overall Study|Other|3|||
147159564|NCT00075725|530749591|FG000|Overall Study|Pt trying to find a BM donor|0|||
147159565|NCT00075725|530749592|FG001|Overall Study|Pt trying to find a BM donor|1|||
147159566|NCT00075725|530749593|FG002|Overall Study|Pt trying to find a BM donor|0|||
147159567|NCT00075725|530749594|FG003|Overall Study|Pt trying to find a BM donor|0|||
147159568|NCT00075725|530749595|FG004|Overall Study|Pt trying to find a BM donor|0|||
147159569|NCT00075725|530749596|FG005|Overall Study|Pt trying to find a BM donor|0|||
147159570|NCT00075725|530749597|FG006|Overall Study|Pt trying to find a BM donor|0|||
147159571|NCT00075725|530749598|FG007|Overall Study|Pt trying to find a BM donor|0|||
147159572|NCT00075725|530749599|FG008|Overall Study|Pt trying to find a BM donor|0|||
147159573|NCT00075725|530749600|FG009|Overall Study|Pt trying to find a BM donor|0|||
147159574|NCT00075725|530749601|FG010|Overall Study|Pt trying to find a BM donor|0|||
147159575|NCT00075725|530749602|FG011|Overall Study|Pt trying to find a BM donor|0|||
147159576|NCT00075725|530749591|FG000|Overall Study|Clinic chart lost unable to recreate|0|||
147159577|NCT00075725|530749592|FG001|Overall Study|Clinic chart lost unable to recreate|0|||
147159578|NCT00075725|530749593|FG002|Overall Study|Clinic chart lost unable to recreate|1|||
147159579|NCT00075725|530749594|FG003|Overall Study|Clinic chart lost unable to recreate|0|||
147159580|NCT00075725|530749595|FG004|Overall Study|Clinic chart lost unable to recreate|0|||
147159581|NCT00075725|530749596|FG005|Overall Study|Clinic chart lost unable to recreate|0|||
147159582|NCT00075725|530749597|FG006|Overall Study|Clinic chart lost unable to recreate|0|||
147159583|NCT00075725|530749598|FG007|Overall Study|Clinic chart lost unable to recreate|0|||
147159584|NCT00075725|530749599|FG008|Overall Study|Clinic chart lost unable to recreate|0|||
147159585|NCT00075725|530749600|FG009|Overall Study|Clinic chart lost unable to recreate|0|||
147159586|NCT00075725|530749601|FG010|Overall Study|Clinic chart lost unable to recreate|0|||
147159587|NCT00075725|530749602|FG011|Overall Study|Clinic chart lost unable to recreate|0|||
147159588|NCT00075725|530749591|FG000|Overall Study|Unsuccessful institutional transfer|0|||
147159589|NCT00075725|530749592|FG001|Overall Study|Unsuccessful institutional transfer|0|||
147159590|NCT00075725|530749593|FG002|Overall Study|Unsuccessful institutional transfer|2|||
147159591|NCT00075725|530749594|FG003|Overall Study|Unsuccessful institutional transfer|0|||
147159592|NCT00075725|530749595|FG004|Overall Study|Unsuccessful institutional transfer|0|||
147159593|NCT00075725|530749596|FG005|Overall Study|Unsuccessful institutional transfer|0|||
147159594|NCT00075725|530749597|FG006|Overall Study|Unsuccessful institutional transfer|0|||
147159595|NCT00075725|530749598|FG007|Overall Study|Unsuccessful institutional transfer|0|||
147159596|NCT00075725|530749599|FG008|Overall Study|Unsuccessful institutional transfer|0|||
147159597|NCT00075725|530749600|FG009|Overall Study|Unsuccessful institutional transfer|1|||
147159598|NCT00075725|530749601|FG010|Overall Study|Unsuccessful institutional transfer|0|||
147159599|NCT00075725|530749602|FG011|Overall Study|Unsuccessful institutional transfer|0|||
147159600|NCT00075725|530749591|FG000|Overall Study|specimen(s) not submitted|0|||
147159601|NCT00075725|530749592|FG001|Overall Study|specimen(s) not submitted|0|||
147159602|NCT00075725|530749593|FG002|Overall Study|specimen(s) not submitted|2|||
147159603|NCT00075725|530749594|FG003|Overall Study|specimen(s) not submitted|0|||
147159604|NCT00075725|530749595|FG004|Overall Study|specimen(s) not submitted|0|||
147159605|NCT00075725|530749596|FG005|Overall Study|specimen(s) not submitted|0|||
147159606|NCT00075725|530749597|FG006|Overall Study|specimen(s) not submitted|0|||
147159607|NCT00075725|530749598|FG007|Overall Study|specimen(s) not submitted|0|||
147159608|NCT00075725|530749599|FG008|Overall Study|specimen(s) not submitted|0|||
147159609|NCT00075725|530749600|FG009|Overall Study|specimen(s) not submitted|0|||
147159610|NCT00075725|530749601|FG010|Overall Study|specimen(s) not submitted|0|||
147159611|NCT00075725|530749602|FG011|Overall Study|specimen(s) not submitted|0|||
147159612|NCT00075725|530749591|FG000|Overall Study|Pt went to transplant|0|||
147159613|NCT00075725|530749592|FG001|Overall Study|Pt went to transplant|0|||
147159614|NCT00075725|530749593|FG002|Overall Study|Pt went to transplant|0|||
147159615|NCT00075725|530749594|FG003|Overall Study|Pt went to transplant|1|||
147159616|NCT00075725|530749595|FG004|Overall Study|Pt went to transplant|0|||
147159617|NCT00075725|530749596|FG005|Overall Study|Pt went to transplant|1|||
147159618|NCT00075725|530749597|FG006|Overall Study|Pt went to transplant|0|||
147159619|NCT00075725|530749598|FG007|Overall Study|Pt went to transplant|0|||
147159620|NCT00075725|530749599|FG008|Overall Study|Pt went to transplant|0|||
147159621|NCT00075725|530749600|FG009|Overall Study|Pt went to transplant|0|||
147241519|NCT01427972|531055924|FG010|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
147241520|NCT01427972|531055925|FG011|Treatment Period 2 (21 Days)|Withdrawal by Subject|0|||
147241521|NCT00530946|531055927|FG000|Overall Study|Adverse Event|1|||
147241522|NCT00530946|531055928|FG001|Overall Study|Adverse Event|2|||
147241523|NCT00530946|531055929|FG002|Overall Study|Adverse Event|1|||
147241524|NCT00530946|531055930|FG003|Overall Study|Adverse Event|1|||
147241525|NCT00530946|531055927|FG000|Overall Study|Protocol Violation|0|||
147241526|NCT00530946|531055928|FG001|Overall Study|Protocol Violation|0|||
147241527|NCT00530946|531055929|FG002|Overall Study|Protocol Violation|0|||
147241528|NCT00530946|531055930|FG003|Overall Study|Protocol Violation|1|||
147241529|NCT00530946|531055927|FG000|Overall Study|Noncompliance|1|||
147241530|NCT00530946|531055928|FG001|Overall Study|Noncompliance|0|||
147241531|NCT00530946|531055929|FG002|Overall Study|Noncompliance|0|||
147241532|NCT00530946|531055930|FG003|Overall Study|Noncompliance|0|||
147241533|NCT01534962|531055931|FG000|Overall Study|Randomized but did not start treatment|2|||
147241534|NCT01534962|531055932|FG001|Overall Study|Randomized but did not start treatment|0|||
147241535|NCT01534962|531055933|FG002|Overall Study|Randomized but did not start treatment|0|||
147241536|NCT01534962|531055934|FG003|Overall Study|Randomized but did not start treatment|1|||
147241537|NCT01534962|531055931|FG000|Overall Study|Discontinued at AF recurrence|35|||
147241538|NCT01534962|531055932|FG001|Overall Study|Discontinued at AF recurrence|26|||
147241539|NCT01534962|531055933|FG002|Overall Study|Discontinued at AF recurrence|24|||
147241540|NCT01534962|531055934|FG003|Overall Study|Discontinued at AF recurrence|31|||
147241541|NCT02243696|531055935|FG000|Overall Study|Death|282|||
147241542|NCT02243696|531055935|FG000|Overall Study|Withdrawal by Subject|79|||
147241543|NCT02243696|531055935|FG000|Overall Study|Lost to Follow-up|57|||
147241544|NCT02243696|531055935|FG000|Overall Study|Subject No Longer has Study System|42|||
147241545|NCT02243696|531055935|FG000|Overall Study|Subject Withdrawn by Investigator|273|||
147241546|NCT02243696|531055935|FG000|Overall Study|Study Terminated for EP PASSION|961|||
147241547|NCT00622284|531055936|FG000|Overall Study|Lack of Efficacy|45|||
147586873|NCT02688387|532303290|FG011|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
147586874|NCT02688387|532303291|FG012|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
147586875|NCT02688387|532303292|FG013|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
147159622|NCT00075725|530749601|FG010|Overall Study|Pt went to transplant|0|||
147241548|NCT00622284|531055937|FG001|Overall Study|Lack of Efficacy|15|||
147241549|NCT00622284|531055936|FG000|Overall Study|Adverse Event|61|||
147241550|NCT00622284|531055937|FG001|Overall Study|Adverse Event|90|||
147241551|NCT00622284|531055936|FG000|Overall Study|Protocol Violation|12|||
147241552|NCT00622284|531055937|FG001|Overall Study|Protocol Violation|5|||
147241553|NCT00622284|531055936|FG000|Overall Study|Lost to Follow-up|11|||
147241554|NCT00622284|531055937|FG001|Overall Study|Lost to Follow-up|13|||
147241555|NCT00622284|531055936|FG000|Overall Study|Withdrawal by Subject|27|||
147159623|NCT00075725|530749602|FG011|Overall Study|Pt went to transplant|0|||
147159624|NCT00075725|530749591|FG000|Overall Study|Pt received additional steroids|0|||
147159625|NCT00075725|530749592|FG001|Overall Study|Pt received additional steroids|0|||
147159626|NCT00075725|530749593|FG002|Overall Study|Pt received additional steroids|0|||
147159627|NCT00075725|530749594|FG003|Overall Study|Pt received additional steroids|1|||
147159628|NCT00075725|530749595|FG004|Overall Study|Pt received additional steroids|0|||
147159629|NCT00075725|530749596|FG005|Overall Study|Pt received additional steroids|0|||
147159630|NCT00075725|530749597|FG006|Overall Study|Pt received additional steroids|0|||
147159631|NCT00075725|530749598|FG007|Overall Study|Pt received additional steroids|0|||
147159632|NCT00075725|530749599|FG008|Overall Study|Pt received additional steroids|0|||
147159633|NCT00075725|530749600|FG009|Overall Study|Pt received additional steroids|0|||
147159634|NCT00075725|530749601|FG010|Overall Study|Pt received additional steroids|0|||
147159635|NCT00075725|530749602|FG011|Overall Study|Pt received additional steroids|0|||
147159636|NCT00075725|530749591|FG000|Overall Study|Pt relocated|0|||
147322119|NCT00329303|531343586|FG000|Overall Study|Patient relocated|0|||
147322120|NCT00329303|531343587|FG001|Overall Study|Patient relocated|1|||
147322121|NCT03582137|531343593|FG000|Overall Study|Adverse Event|1|||
147322122|NCT03582137|531343594|FG001|Overall Study|Adverse Event|0|||
147322123|NCT03704298|531343595|FG000|Overall Study|Death|3|||
147322124|NCT03704298|531343596|FG001|Overall Study|Death|1|||
147322125|NCT03704298|531343597|FG002|Overall Study|Death|1|||
147322126|NCT03704298|531343598|FG003|Overall Study|Death|0|||
147322127|NCT03704298|531343595|FG000|Overall Study|Rollover to Long-term Follow-up Study Criteria|1|||
147322128|NCT03704298|531343596|FG001|Overall Study|Rollover to Long-term Follow-up Study Criteria|2|||
147322129|NCT03704298|531343597|FG002|Overall Study|Rollover to Long-term Follow-up Study Criteria|2|||
147322130|NCT03704298|531343598|FG003|Overall Study|Rollover to Long-term Follow-up Study Criteria|3|||
147322131|NCT03704298|531343595|FG000|Overall Study|Withdrawal by Subject|1|||
147322132|NCT03704298|531343596|FG001|Overall Study|Withdrawal by Subject|0|||
147322133|NCT03704298|531343597|FG002|Overall Study|Withdrawal by Subject|0|||
147322134|NCT03704298|531343598|FG003|Overall Study|Withdrawal by Subject|0|||
147322135|NCT03704298|531343595|FG000|Overall Study|Developed Other Infection Before Starting the Treatment|0|||
147322136|NCT03704298|531343596|FG001|Overall Study|Developed Other Infection Before Starting the Treatment|1|||
147322137|NCT03704298|531343597|FG002|Overall Study|Developed Other Infection Before Starting the Treatment|0|||
147322138|NCT03704298|531343598|FG003|Overall Study|Developed Other Infection Before Starting the Treatment|0|||
147322139|NCT00859014|531343600|FG000|Overall Study|Death|4|||
147322140|NCT00859014|531343600|FG000|Overall Study|Lost to Follow-up|1|||
147322141|NCT00162942|531343601|FG000|Overall Study|Adverse Event|10|||
147322142|NCT00162942|531343602|FG001|Overall Study|Adverse Event|6|||
147322143|NCT00162942|531343601|FG000|Overall Study|Death|1|||
147322144|NCT00162942|531343602|FG001|Overall Study|Death|0|||
147322145|NCT00162942|531343601|FG000|Overall Study|Withdrawal by Subject|3|||
147322146|NCT00162942|531343602|FG001|Overall Study|Withdrawal by Subject|6|||
147586876|NCT02688387|532303293|FG014|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
147586877|NCT02688387|532303294|FG015|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
147586878|NCT02688387|532303295|FG016|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
147586879|NCT02688387|532303296|FG017|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
147586880|NCT02688387|532303297|FG018|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
147586881|NCT02688387|532303298|FG019|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
147586882|NCT02688387|532303299|FG020|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
147586883|NCT02688387|532303300|FG021|Part 2, Period 1 (up to 6 Days)|Adverse Event|0|||
147586884|NCT02688387|532303279|FG000|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
147586885|NCT02688387|532303280|FG001|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
147586886|NCT02688387|532303281|FG002|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
147586887|NCT02688387|532303282|FG003|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
147586888|NCT02688387|532303283|FG004|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
147586889|NCT02688387|532303284|FG005|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
147586890|NCT02688387|532303285|FG006|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
147586891|NCT02688387|532303286|FG007|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
147586892|NCT02688387|532303287|FG008|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
147586893|NCT02688387|532303288|FG009|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
147586894|NCT02688387|532303289|FG010|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
147159637|NCT00075725|530749592|FG001|Overall Study|Pt relocated|0|||
147159638|NCT00075725|530749593|FG002|Overall Study|Pt relocated|0|||
147159639|NCT00075725|530749594|FG003|Overall Study|Pt relocated|2|||
147159640|NCT00075725|530749595|FG004|Overall Study|Pt relocated|0|||
147322147|NCT00162942|531343601|FG000|Overall Study|Physician Decision|1|||
147322148|NCT00162942|531343602|FG001|Overall Study|Physician Decision|0|||
147159641|NCT00075725|530749596|FG005|Overall Study|Pt relocated|1|||
147159642|NCT00075725|530749597|FG006|Overall Study|Pt relocated|1|||
147159643|NCT00075725|530749598|FG007|Overall Study|Pt relocated|2|||
147159644|NCT00075725|530749599|FG008|Overall Study|Pt relocated|1|||
147159645|NCT00075725|530749600|FG009|Overall Study|Pt relocated|0|||
147322149|NCT00162942|531343601|FG000|Overall Study|Enter Open-Label Study|76|||
147322150|NCT00162942|531343602|FG001|Overall Study|Enter Open-Label Study|35|||
147322151|NCT00162942|531343601|FG000|Overall Study|Alternate Therapy|6|||
147322152|NCT00162942|531343602|FG001|Overall Study|Alternate Therapy|2|||
147322153|NCT00162942|531343601|FG000|Overall Study|Lack of Efficacy|1|||
147159646|NCT00075725|530749601|FG010|Overall Study|Pt relocated|0|||
147159647|NCT00075725|530749602|FG011|Overall Study|Pt relocated|0|||
147159648|NCT00075725|530749591|FG000|Overall Study|Institution Terminated|0|||
147159649|NCT00075725|530749592|FG001|Overall Study|Institution Terminated|0|||
147159650|NCT00075725|530749593|FG002|Overall Study|Institution Terminated|0|||
147159651|NCT00075725|530749594|FG003|Overall Study|Institution Terminated|0|||
147159652|NCT00075725|530749595|FG004|Overall Study|Institution Terminated|1|||
147159653|NCT00075725|530749596|FG005|Overall Study|Institution Terminated|0|||
147159654|NCT00075725|530749597|FG006|Overall Study|Institution Terminated|0|||
147159655|NCT00075725|530749598|FG007|Overall Study|Institution Terminated|3|||
147159656|NCT00075725|530749599|FG008|Overall Study|Institution Terminated|0|||
147159657|NCT00075725|530749600|FG009|Overall Study|Institution Terminated|0|||
147159658|NCT00075725|530749601|FG010|Overall Study|Institution Terminated|0|||
147159659|NCT00075725|530749602|FG011|Overall Study|Institution Terminated|0|||
147159660|NCT00075725|530749591|FG000|Overall Study|Study Closure|1|||
147159661|NCT00075725|530749592|FG001|Overall Study|Study Closure|0|||
147159662|NCT00075725|530749593|FG002|Overall Study|Study Closure|0|||
147159663|NCT00075725|530749594|FG003|Overall Study|Study Closure|0|||
147159664|NCT00075725|530749595|FG004|Overall Study|Study Closure|1|||
147159665|NCT00075725|530749596|FG005|Overall Study|Study Closure|3|||
147159666|NCT00075725|530749597|FG006|Overall Study|Study Closure|0|||
147159667|NCT00075725|530749598|FG007|Overall Study|Study Closure|1|||
147159668|NCT00075725|530749599|FG008|Overall Study|Study Closure|0|||
147159669|NCT00075725|530749600|FG009|Overall Study|Study Closure|0|||
147159670|NCT00075725|530749601|FG010|Overall Study|Study Closure|0|||
147159671|NCT00075725|530749602|FG011|Overall Study|Study Closure|0|||
147159672|NCT00075725|530749591|FG000|Overall Study|Other complications|0|||
147159673|NCT00075725|530749592|FG001|Overall Study|Other complications|0|||
147159674|NCT00075725|530749593|FG002|Overall Study|Other complications|0|||
147159675|NCT00075725|530749594|FG003|Overall Study|Other complications|0|||
147159676|NCT00075725|530749595|FG004|Overall Study|Other complications|0|||
147159677|NCT00075725|530749596|FG005|Overall Study|Other complications|1|||
147159678|NCT00075725|530749597|FG006|Overall Study|Other complications|0|||
147159679|NCT00075725|530749598|FG007|Overall Study|Other complications|0|||
147159680|NCT00075725|530749599|FG008|Overall Study|Other complications|0|||
147159681|NCT00075725|530749600|FG009|Overall Study|Other complications|0|||
147159682|NCT00075725|530749601|FG010|Overall Study|Other complications|0|||
147159683|NCT00075725|530749602|FG011|Overall Study|Other complications|0|||
147159684|NCT00075725|530749591|FG000|Overall Study|Pt care terminated due to pt behavior|0|||
147159685|NCT00075725|530749592|FG001|Overall Study|Pt care terminated due to pt behavior|0|||
147159686|NCT00075725|530749593|FG002|Overall Study|Pt care terminated due to pt behavior|0|||
147159687|NCT00075725|530749594|FG003|Overall Study|Pt care terminated due to pt behavior|0|||
147159688|NCT00075725|530749595|FG004|Overall Study|Pt care terminated due to pt behavior|0|||
147159689|NCT00075725|530749596|FG005|Overall Study|Pt care terminated due to pt behavior|0|||
147322154|NCT00162942|531343602|FG001|Overall Study|Lack of Efficacy|0|||
147322155|NCT00162942|531343601|FG000|Overall Study|Flare During Active Treatment|7|||
147322156|NCT00162942|531343602|FG001|Overall Study|Flare During Active Treatment|3|||
147322157|NCT00162942|531343601|FG000|Overall Study|2 or more consecutive treatments missed|1|||
147322158|NCT00162942|531343602|FG001|Overall Study|2 or more consecutive treatments missed|0|||
147322159|NCT04796935|531343603|FG000|Overall Study|Withdrawal by Subject|0|||
147322160|NCT04796935|531343604|FG001|Overall Study|Withdrawal by Subject|1|||
147322161|NCT04796935|531343603|FG000|Overall Study|Physician Decision|0|||
147322162|NCT04796935|531343604|FG001|Overall Study|Physician Decision|1|||
147322163|NCT04796935|531343603|FG000|Overall Study|Device not available|1|||
147322164|NCT04796935|531343604|FG001|Overall Study|Device not available|0|||
147322165|NCT04796935|531343603|FG000|Overall Study|Trained provider not available|1|||
147322166|NCT04796935|531343604|FG001|Overall Study|Trained provider not available|0|||
147322167|NCT00410384|531343605|FG000|Overall Study|Withdrawal by Subject|28|||
147322168|NCT00410384|531343606|FG001|Overall Study|Withdrawal by Subject|17|||
147322169|NCT00410384|531343607|FG002|Overall Study|Withdrawal by Subject|20|||
147322170|NCT00410384|531343605|FG000|Overall Study|Adverse Event|23|||
147322171|NCT00410384|531343606|FG001|Overall Study|Adverse Event|18|||
147322172|NCT00410384|531343607|FG002|Overall Study|Adverse Event|23|||
147322173|NCT00410384|531343605|FG000|Overall Study|Lack of Efficacy|20|||
147322174|NCT00410384|531343606|FG001|Overall Study|Lack of Efficacy|12|||
147322175|NCT00410384|531343607|FG002|Overall Study|Lack of Efficacy|17|||
147322176|NCT00410384|531343605|FG000|Overall Study|Lack of Compliance|2|||
147159690|NCT00075725|530749597|FG006|Overall Study|Pt care terminated due to pt behavior|0|||
147159691|NCT00075725|530749598|FG007|Overall Study|Pt care terminated due to pt behavior|1|||
147159692|NCT00075725|530749599|FG008|Overall Study|Pt care terminated due to pt behavior|0|||
147159693|NCT00075725|530749600|FG009|Overall Study|Pt care terminated due to pt behavior|0|||
147159694|NCT00075725|530749601|FG010|Overall Study|Pt care terminated due to pt behavior|0|||
147322177|NCT00410384|531343606|FG001|Overall Study|Lack of Compliance|2|||
147322178|NCT00410384|531343607|FG002|Overall Study|Lack of Compliance|2|||
147322179|NCT00410384|531343605|FG000|Overall Study|Lost to Follow-up|4|||
147322180|NCT00410384|531343606|FG001|Overall Study|Lost to Follow-up|6|||
147322181|NCT00410384|531343607|FG002|Overall Study|Lost to Follow-up|6|||
147322182|NCT00410384|531343605|FG000|Overall Study|Protocol Violation|6|||
147322183|NCT00410384|531343606|FG001|Overall Study|Protocol Violation|6|||
147322184|NCT00410384|531343607|FG002|Overall Study|Protocol Violation|6|||
147322185|NCT00410384|531343605|FG000|Overall Study|Physician Decision|3|||
147322186|NCT00410384|531343606|FG001|Overall Study|Physician Decision|3|||
147322187|NCT00410384|531343607|FG002|Overall Study|Physician Decision|4|||
147586895|NCT02688387|532303290|FG011|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
147586896|NCT02688387|532303291|FG012|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
147586897|NCT02688387|532303292|FG013|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
147586898|NCT02688387|532303293|FG014|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|1|||
147586899|NCT02688387|532303294|FG015|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
147586900|NCT02688387|532303295|FG016|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
147586901|NCT02688387|532303296|FG017|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
147586902|NCT02688387|532303297|FG018|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
147586903|NCT02688387|532303298|FG019|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
147586904|NCT02688387|532303299|FG020|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
147586905|NCT02688387|532303300|FG021|Part 3A, Period 1 (up to 6 Days)|Withdrawal by Subject|0|||
147586906|NCT02688387|532303279|FG000|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
147586907|NCT02688387|532303280|FG001|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
147586908|NCT02688387|532303281|FG002|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
147586909|NCT02688387|532303282|FG003|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
147586910|NCT02688387|532303283|FG004|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
147586911|NCT02688387|532303284|FG005|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
147586912|NCT02688387|532303285|FG006|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
147586913|NCT02688387|532303286|FG007|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
147586914|NCT02688387|532303287|FG008|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
147586915|NCT02688387|532303288|FG009|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
147586916|NCT02688387|532303289|FG010|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
147586917|NCT02688387|532303290|FG011|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
147586918|NCT02688387|532303291|FG012|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
147586919|NCT02688387|532303292|FG013|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
147586920|NCT02688387|532303293|FG014|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
147586921|NCT02688387|532303294|FG015|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
147586922|NCT02688387|532303295|FG016|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
147586923|NCT02688387|532303296|FG017|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
147586924|NCT02688387|532303297|FG018|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
147586925|NCT02688387|532303298|FG019|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
147586926|NCT02688387|532303299|FG020|Part 3B, Period 3 (up to 6 Days)|Physician Decision|1|||
147586927|NCT02688387|532303300|FG021|Part 3B, Period 3 (up to 6 Days)|Physician Decision|0|||
147586928|NCT02688387|532303279|FG000|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
147586929|NCT02688387|532303280|FG001|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
147586930|NCT02688387|532303281|FG002|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
147159695|NCT00075725|530749602|FG011|Overall Study|Pt care terminated due to pt behavior|0|||
147159696|NCT00075725|530749591|FG000|Overall Study|Pt incarcerated|0|||
147159697|NCT00075725|530749592|FG001|Overall Study|Pt incarcerated|0|||
147159698|NCT00075725|530749593|FG002|Overall Study|Pt incarcerated|0|||
147159699|NCT00075725|530749594|FG003|Overall Study|Pt incarcerated|0|||
147322188|NCT00410384|531343605|FG000|Overall Study|Other|3|||
147322189|NCT00410384|531343606|FG001|Overall Study|Other|8|||
147322190|NCT00410384|531343607|FG002|Overall Study|Other|4|||
147322191|NCT01253200|531343608|FG000|Overall Study|Death|1|||
147322192|NCT01253200|531343609|FG001|Overall Study|Death|0|||
147322193|NCT01253200|531343610|FG002|Overall Study|Death|0|||
147322194|NCT01253200|531343611|FG003|Overall Study|Death|0|||
147322195|NCT01253200|531343612|FG004|Overall Study|Death|0|||
147322196|NCT01253200|531343608|FG000|Overall Study|Lost to Follow-up|1|||
147322197|NCT01253200|531343609|FG001|Overall Study|Lost to Follow-up|1|||
147322198|NCT01253200|531343610|FG002|Overall Study|Lost to Follow-up|0|||
147322199|NCT01253200|531343611|FG003|Overall Study|Lost to Follow-up|0|||
147447023|NCT03099187|531800367|FG003|Double-blind Treatment|Randomization error|0|||
147447024|NCT03099187|531800364|FG000|Double-blind Treatment|Non-compliance with Protocol procedure|1|||
147159700|NCT00075725|530749595|FG004|Overall Study|Pt incarcerated|0|||
147322200|NCT01253200|531343612|FG004|Overall Study|Lost to Follow-up|0|||
147322201|NCT01253200|531343608|FG000|Overall Study|Withdrawal by Subject|2|||
147447025|NCT03099187|531800365|FG001|Double-blind Treatment|Non-compliance with Protocol procedure|1|||
147159701|NCT00075725|530749596|FG005|Overall Study|Pt incarcerated|0|||
147159702|NCT00075725|530749597|FG006|Overall Study|Pt incarcerated|0|||
147322202|NCT01253200|531343609|FG001|Overall Study|Withdrawal by Subject|0|||
147322203|NCT01253200|531343610|FG002|Overall Study|Withdrawal by Subject|0|||
147322204|NCT01253200|531343611|FG003|Overall Study|Withdrawal by Subject|0|||
147322205|NCT01253200|531343612|FG004|Overall Study|Withdrawal by Subject|0|||
147159703|NCT00075725|530749598|FG007|Overall Study|Pt incarcerated|1|||
147159704|NCT00075725|530749599|FG008|Overall Study|Pt incarcerated|0|||
147159705|NCT00075725|530749600|FG009|Overall Study|Pt incarcerated|0|||
147159706|NCT00075725|530749601|FG010|Overall Study|Pt incarcerated|0|||
147159707|NCT00075725|530749602|FG011|Overall Study|Pt incarcerated|0|||
147159708|NCT03242772|530749603|FG000|Overall Study|Lost to Follow-up|2|||
147159709|NCT03242772|530749604|FG001|Overall Study|Lost to Follow-up|0|||
147159710|NCT03242772|530749603|FG000|Overall Study|Physician Decision|0|||
147159711|NCT03242772|530749604|FG001|Overall Study|Physician Decision|1|||
147159712|NCT03242772|530749603|FG000|Overall Study|Withdrawal by Subject|1|||
147159713|NCT03242772|530749604|FG001|Overall Study|Withdrawal by Subject|0|||
147159714|NCT02437305|530749606|FG000|Overall Study|Lost to Follow-up|18|||
147159715|NCT02437305|530749607|FG001|Overall Study|Lost to Follow-up|12|||
147159716|NCT01560637|530749608|FG000|Overall Study|Adverse Event|63|||
147159717|NCT01560637|530749608|FG000|Overall Study|Death|69|||
147159718|NCT01560637|530749608|FG000|Overall Study|Lost to Follow-up|8|||
147159719|NCT01560637|530749608|FG000|Overall Study|Protocol Violation|8|||
147159720|NCT01560637|530749608|FG000|Overall Study|Withdrawal by Subject|24|||
147159721|NCT01560637|530749608|FG000|Overall Study|Progressive Disease|20|||
147159722|NCT01560637|530749608|FG000|Overall Study|Other Reason Not Specified|6|||
147159723|NCT01185964|530749609|FG000|Phase 1b and Phase 2|Withdrawal by Subject|1|||
147159724|NCT01185964|530749610|FG001|Phase 1b and Phase 2|Withdrawal by Subject|6|||
147159725|NCT01185964|530749611|FG002|Phase 1b and Phase 2|Withdrawal by Subject|2|||
147159726|NCT01185964|530749612|FG003|Phase 1b and Phase 2|Withdrawal by Subject|0|||
147159727|NCT01185964|530749609|FG000|Phase 1b and Phase 2|Other Therapy Started|0|||
147159728|NCT01185964|530749610|FG001|Phase 1b and Phase 2|Other Therapy Started|3|||
147159729|NCT01185964|530749611|FG002|Phase 1b and Phase 2|Other Therapy Started|3|||
147159730|NCT01185964|530749612|FG003|Phase 1b and Phase 2|Other Therapy Started|0|||
147159731|NCT01185964|530749609|FG000|Phase 1b and Phase 2|Participant was beyond maximum weight|0|||
147159732|NCT01185964|530749610|FG001|Phase 1b and Phase 2|Participant was beyond maximum weight|0|||
147159733|NCT01185964|530749611|FG002|Phase 1b and Phase 2|Participant was beyond maximum weight|1|||
147159734|NCT01185964|530749612|FG003|Phase 1b and Phase 2|Participant was beyond maximum weight|0|||
147159735|NCT01185964|530749609|FG000|Phase 1b and Phase 2|Adverse Event|1|||
147159736|NCT01185964|530749610|FG001|Phase 1b and Phase 2|Adverse Event|0|||
147159737|NCT01185964|530749611|FG002|Phase 1b and Phase 2|Adverse Event|2|||
147159738|NCT01185964|530749612|FG003|Phase 1b and Phase 2|Adverse Event|0|||
147159739|NCT01185964|530749609|FG000|Phase 1b and Phase 2|Off Treatment but alive and on study|0|||
147159740|NCT01185964|530749610|FG001|Phase 1b and Phase 2|Off Treatment but alive and on study|1|||
147159741|NCT01185964|530749611|FG002|Phase 1b and Phase 2|Off Treatment but alive and on study|1|||
147159742|NCT01185964|530749612|FG003|Phase 1b and Phase 2|Off Treatment but alive and on study|0|||
147159743|NCT01185964|530749609|FG000|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|0|||
147159744|NCT01185964|530749610|FG001|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|0|||
147159745|NCT01185964|530749611|FG002|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|0|||
147159746|NCT01185964|530749612|FG003|Optional Olaratumab Monotherapy on Dox|Withdrawal by Subject|2|||
147159747|NCT01185964|530749609|FG000|Optional Olaratumab Monotherapy on Dox|Adverse Event|0|||
147159748|NCT01185964|530749610|FG001|Optional Olaratumab Monotherapy on Dox|Adverse Event|0|||
147159749|NCT01185964|530749611|FG002|Optional Olaratumab Monotherapy on Dox|Adverse Event|0|||
147159750|NCT01185964|530749612|FG003|Optional Olaratumab Monotherapy on Dox|Adverse Event|1|||
147159751|NCT01185964|530749609|FG000|Optional Olaratumab Monotherapy on Dox|On Study Treatment|0|||
147159752|NCT01185964|530749610|FG001|Optional Olaratumab Monotherapy on Dox|On Study Treatment|0|||
147159753|NCT01185964|530749611|FG002|Optional Olaratumab Monotherapy on Dox|On Study Treatment|0|||
147159754|NCT01185964|530749612|FG003|Optional Olaratumab Monotherapy on Dox|On Study Treatment|2|||
147159755|NCT03440918|530749613|FG000|Overall Study|Protocol Violation|0|||
147159756|NCT03440918|530749614|FG001|Overall Study|Protocol Violation|16|||
147159757|NCT01396265|530749626|FG000|Rifa+Afatinib|Withdrawal by Subject|1|||
147241556|NCT00622284|531055937|FG001|Overall Study|Withdrawal by Subject|24|||
147241557|NCT00622284|531055936|FG000|Overall Study|Other reason (not specified)|33|||
147241558|NCT00622284|531055937|FG001|Overall Study|Other reason (not specified)|24|||
147241559|NCT00457301|531055938|FG000|Overall Study|Withdrawal by Subject|3|||
147241560|NCT00457301|531055939|FG001|Overall Study|Withdrawal by Subject|3|||
147241561|NCT00457301|531055938|FG000|Overall Study|Censored out of the study|15|||
147241562|NCT00457301|531055939|FG001|Overall Study|Censored out of the study|14|||
147241563|NCT00457301|531055938|FG000|Overall Study|Death|5|||
147241564|NCT00457301|531055939|FG001|Overall Study|Death|7|||
147159758|NCT03444766|530749627|FG000|Overall Study|Other Reasons|2|||
147159759|NCT03444766|530749627|FG000|Overall Study|Participant Withdrew Consent|5|||
147159760|NCT03444766|530749627|FG000|Overall Study|Lost to Follow-up|2|||
147159761|NCT03444766|530749627|FG000|Overall Study|Death|2|||
147159762|NCT03444766|530749627|FG000|Overall Study|Adverse Event Unrelated to Study Drug|6|||
147241565|NCT02094677|531055948|FG000|Overall Study|Screening|3|||
147241566|NCT02094677|531055949|FG001|Overall Study|Screening|1|||
147241567|NCT03408483|531055950|FG000|Overall Study|Physician Decision|3|||
147241568|NCT03408483|531055951|FG001|Overall Study|Physician Decision|3|||
147586931|NCT02688387|532303282|FG003|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
147586932|NCT02688387|532303283|FG004|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
147586933|NCT02688387|532303284|FG005|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
147586934|NCT02688387|532303285|FG006|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
147586935|NCT02688387|532303286|FG007|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
147586936|NCT02688387|532303287|FG008|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
147586937|NCT02688387|532303288|FG009|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
147586938|NCT02688387|532303289|FG010|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
147586939|NCT02688387|532303290|FG011|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
147586940|NCT02688387|532303291|FG012|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
147586941|NCT02688387|532303292|FG013|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
147586942|NCT02688387|532303293|FG014|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
147586943|NCT02688387|532303294|FG015|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
147586944|NCT02688387|532303295|FG016|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
147586945|NCT02688387|532303296|FG017|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
147586946|NCT02688387|532303297|FG018|Part 3B, Washout Period 3 (10 Days)|Adverse Event|1|||
147586947|NCT02688387|532303298|FG019|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
147586948|NCT02688387|532303299|FG020|Part 3B, Washout Period 3 (10 Days)|Adverse Event|1|||
147586949|NCT02688387|532303300|FG021|Part 3B, Washout Period 3 (10 Days)|Adverse Event|0|||
147586950|NCT02688387|532303279|FG000|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
147586951|NCT02688387|532303280|FG001|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
147586952|NCT02688387|532303281|FG002|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
147586953|NCT02688387|532303282|FG003|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
147586954|NCT02688387|532303283|FG004|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
147586955|NCT02688387|532303284|FG005|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
147586956|NCT02688387|532303285|FG006|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
147447026|NCT03099187|531800366|FG002|Double-blind Treatment|Non-compliance with Protocol procedure|0|||
147447027|NCT03099187|531800367|FG003|Double-blind Treatment|Non-compliance with Protocol procedure|0|||
147447028|NCT03099187|531800364|FG000|12-month Safety Follow-up|Adverse Event|0|||
147447029|NCT03099187|531800365|FG001|12-month Safety Follow-up|Adverse Event|0|||
147159763|NCT03444766|530749627|FG000|Overall Study|Disease Progression|49|||
147159764|NCT04346108|530749628|FG000|Epoch 2 (24 Weeks After Epoch 1)|Withdrawal by Parent/Guardian|0|||
147159765|NCT04346108|530749629|FG001|Epoch 2 (24 Weeks After Epoch 1)|Withdrawal by Parent/Guardian|1|||
147159766|NCT04346108|530749630|FG002|Epoch 2 (24 Weeks After Epoch 1)|Withdrawal by Parent/Guardian|0|||
147159767|NCT04346108|530749628|FG000|Epoch 2 (24 Weeks After Epoch 1)|Withdrawal by Subject|0|||
147447030|NCT03099187|531800366|FG002|12-month Safety Follow-up|Adverse Event|5|||
147447031|NCT03099187|531800367|FG003|12-month Safety Follow-up|Adverse Event|12|||
147447032|NCT03099187|531800364|FG000|12-month Safety Follow-up|Death|0|||
147447033|NCT03099187|531800365|FG001|12-month Safety Follow-up|Death|0|||
147586957|NCT02688387|532303286|FG007|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
147586958|NCT02688387|532303287|FG008|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
147586959|NCT02688387|532303288|FG009|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
147586960|NCT02688387|532303289|FG010|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
147586961|NCT02688387|532303290|FG011|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
147586962|NCT02688387|532303291|FG012|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
147586963|NCT02688387|532303292|FG013|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
147586964|NCT02688387|532303293|FG014|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
147586965|NCT02688387|532303294|FG015|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
147586966|NCT02688387|532303295|FG016|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
147586967|NCT02688387|532303296|FG017|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
147586968|NCT02688387|532303297|FG018|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
147586969|NCT02688387|532303298|FG019|Part 3B, Washout Period 3 (10 Days)|Study terminated|1|||
147586970|NCT02688387|532303299|FG020|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
147586971|NCT02688387|532303300|FG021|Part 3B, Washout Period 3 (10 Days)|Study terminated|0|||
147586972|NCT00802178|532303303|FG000|Overall Study|Lack of Efficacy|36|||
147586973|NCT00802178|532303303|FG000|Overall Study|Insufficient tolerability (IT)|17|||
147241569|NCT03408483|531055950|FG000|Overall Study|Lost to Follow-up|3|||
147241570|NCT03408483|531055951|FG001|Overall Study|Lost to Follow-up|0|||
147241571|NCT05399641|531055952|FG000|Overall Study|Adverse Event|0|||
147241572|NCT05399641|531055953|FG001|Overall Study|Adverse Event|1|||
147241573|NCT05399641|531055954|FG002|Overall Study|Adverse Event|1|||
147241574|NCT05399641|531055952|FG000|Overall Study|Lost to Follow-up|1|||
147241575|NCT05399641|531055953|FG001|Overall Study|Lost to Follow-up|2|||
147241576|NCT05399641|531055954|FG002|Overall Study|Lost to Follow-up|2|||
147241577|NCT05399641|531055952|FG000|Overall Study|Physician Decision|1|||
147241578|NCT05399641|531055953|FG001|Overall Study|Physician Decision|3|||
147241579|NCT05399641|531055954|FG002|Overall Study|Physician Decision|3|||
147241580|NCT05399641|531055952|FG000|Overall Study|Withdrawal by Subject|4|||
147241581|NCT05399641|531055953|FG001|Overall Study|Withdrawal by Subject|11|||
147241582|NCT05399641|531055954|FG002|Overall Study|Withdrawal by Subject|7|||
147241583|NCT05399641|531055952|FG000|Overall Study|Reason not defined|3|||
147241584|NCT05399641|531055953|FG001|Overall Study|Reason not defined|5|||
147241585|NCT05399641|531055954|FG002|Overall Study|Reason not defined|6|||
147241586|NCT00478231|531055955|FG000|Overall Study|Death|7|||
147241587|NCT00478231|531055955|FG000|Overall Study|Lack of Efficacy|47|||
147241588|NCT00478231|531055955|FG000|Overall Study|Lost to Follow-up|7|||
147241589|NCT00478231|531055955|FG000|Overall Study|Withdrawal by Subject|6|||
147241590|NCT00478231|531055955|FG000|Overall Study|Other|9|||
147241591|NCT00478231|531055955|FG000|Overall Study|Adverse Event|5|||
147241592|NCT00478231|531055955|FG000|Overall Study|Randomized, not treated|3|||
147241593|NCT01300650|531055956|FG000|Overall Study|Adverse Event|1|||
147241594|NCT01702961|531055957|FG000|Overall Study|Additional treatment|3|||
147241595|NCT01702961|531055957|FG000|Overall Study|Progressive disease|5|||
147241596|NCT01702961|531055957|FG000|Overall Study|Relapse|20|||
147241597|NCT01702961|531055957|FG000|Overall Study|Death|6|||
147241598|NCT01702961|531055957|FG000|Overall Study|Lost to Follow-up|2|||
147241599|NCT01702961|531055957|FG000|Overall Study|Ongoing|11|||
147447034|NCT03099187|531800366|FG002|12-month Safety Follow-up|Death|7|||
147447035|NCT03099187|531800367|FG003|12-month Safety Follow-up|Death|9|||
147447036|NCT03099187|531800364|FG000|12-month Safety Follow-up|Lung transplantation|0|||
147447037|NCT03099187|531800365|FG001|12-month Safety Follow-up|Lung transplantation|0|||
147447038|NCT03099187|531800366|FG002|12-month Safety Follow-up|Lung transplantation|2|||
147159768|NCT04346108|530749629|FG001|Epoch 2 (24 Weeks After Epoch 1)|Withdrawal by Subject|1|||
147159769|NCT04346108|530749630|FG002|Epoch 2 (24 Weeks After Epoch 1)|Withdrawal by Subject|0|||
147159770|NCT01081301|530749631|FG000|Overall Study|Bereaved|3|||
147159771|NCT01081301|530749631|FG000|Overall Study|Too busy|5|||
147159772|NCT01081301|530749631|FG000|Overall Study|Patient too ill|2|||
147159773|NCT01081301|530749631|FG000|Overall Study|Lost to Follow-up|4|||
147159774|NCT00724854|530749632|FG000|Overall Study|Lack of Efficacy|187|||
147159775|NCT00724854|530749633|FG001|Overall Study|Lack of Efficacy|13|||
147159776|NCT00724854|530749632|FG000|Overall Study|Lost to Follow-up|87|||
147159777|NCT00724854|530749633|FG001|Overall Study|Lost to Follow-up|10|||
147159778|NCT00724854|530749632|FG000|Overall Study|Adverse Event|62|||
147159779|NCT00724854|530749633|FG001|Overall Study|Adverse Event|4|||
147159780|NCT00724854|530749632|FG000|Overall Study|Other|42|||
147159781|NCT00724854|530749633|FG001|Overall Study|Other|3|||
147159782|NCT00724854|530749632|FG000|Overall Study|Death|11|||
147159783|NCT00724854|530749633|FG001|Overall Study|Death|0|||
147159784|NCT00724854|530749632|FG000|Overall Study|Change of treatment|7|||
147159785|NCT00724854|530749633|FG001|Overall Study|Change of treatment|0|||
147159786|NCT00724854|530749632|FG000|Overall Study|Withdrawal by Subject|5|||
147159787|NCT00724854|530749633|FG001|Overall Study|Withdrawal by Subject|0|||
147159788|NCT00724854|530749632|FG000|Overall Study|Adverse event + lack of efficacy|2|||
147241600|NCT02610725|531055960|FG000|Overall Study|Lost to Follow-up|197|||
147322206|NCT01253200|531343608|FG000|Overall Study|Protocol Violation|1|||
147322207|NCT01253200|531343609|FG001|Overall Study|Protocol Violation|4|||
147322208|NCT01253200|531343610|FG002|Overall Study|Protocol Violation|0|||
147322209|NCT01253200|531343611|FG003|Overall Study|Protocol Violation|0|||
147322210|NCT01253200|531343612|FG004|Overall Study|Protocol Violation|5|||
147322211|NCT01253200|531343608|FG000|Overall Study|intents|10|||
147322212|NCT01253200|531343609|FG001|Overall Study|intents|10|||
147322213|NCT01253200|531343610|FG002|Overall Study|intents|1|||
147322214|NCT01253200|531343611|FG003|Overall Study|intents|3|||
147322215|NCT01253200|531343612|FG004|Overall Study|intents|0|||
147322216|NCT01253200|531343608|FG000|Overall Study|Attempts|6|||
147322217|NCT01253200|531343609|FG001|Overall Study|Attempts|4|||
147322218|NCT01253200|531343610|FG002|Overall Study|Attempts|1|||
147322219|NCT01253200|531343611|FG003|Overall Study|Attempts|2|||
147322220|NCT01253200|531343612|FG004|Overall Study|Attempts|0|||
147322221|NCT02049437|531343613|FG000|Period 1|Adverse Event|1|||
147322222|NCT02049437|531343614|FG001|Period 1|Adverse Event|1|||
147322223|NCT02049437|531343613|FG000|Period 1|Adverse Event|1|||
147322224|NCT02049437|531343614|FG001|Period 1|Adverse Event|0|||
147586974|NCT00802178|532303303|FG000|Overall Study|Withdrawal by Subject|18|||
147159789|NCT00724854|530749633|FG001|Overall Study|Adverse event + lack of efficacy|1|||
147241601|NCT02610725|531055960|FG000|Overall Study|self-reported contraindication|9|||
147322225|NCT01163149|531343620|FG000|Extension Treatment Period|Withdrawal by Subject|2|||
147322226|NCT01163149|531343621|FG001|Extension Treatment Period|Withdrawal by Subject|0|||
147322227|NCT01163149|531343622|FG002|Extension Treatment Period|Withdrawal by Subject|1|||
147322228|NCT01163149|531343620|FG000|Extension Treatment Period|Adverse Event|0|||
147322229|NCT01163149|531343621|FG001|Extension Treatment Period|Adverse Event|1|||
147322230|NCT01163149|531343622|FG002|Extension Treatment Period|Adverse Event|0|||
147159790|NCT02046226|530749634|FG000|Overall Study|Lost to Follow-up|7|||
147159791|NCT01095653|530749635|FG000|Overall Study|Lack of Efficacy|3|||
147241602|NCT04094883|531055961|FG000|Overall Study|Withdrawal by Subject|1|||
147241603|NCT02302807|531055964|FG000|Overall Study|Withdrawal by Subject|28|||
147322231|NCT01163149|531343620|FG000|Extension Treatment Period|Noncompliance|0|||
147241604|NCT02302807|531055965|FG001|Overall Study|Withdrawal by Subject|11|||
147322232|NCT01163149|531343621|FG001|Extension Treatment Period|Noncompliance|0|||
147447039|NCT03099187|531800367|FG003|12-month Safety Follow-up|Lung transplantation|1|||
147447040|NCT03099187|531800364|FG000|12-month Safety Follow-up|Lost to Follow-up|0|||
147447041|NCT03099187|531800365|FG001|12-month Safety Follow-up|Lost to Follow-up|0|||
147447042|NCT03099187|531800366|FG002|12-month Safety Follow-up|Lost to Follow-up|1|||
147447043|NCT03099187|531800367|FG003|12-month Safety Follow-up|Lost to Follow-up|0|||
147447044|NCT03099187|531800364|FG000|12-month Safety Follow-up|Symptomatic deterioration|0|||
147447045|NCT03099187|531800365|FG001|12-month Safety Follow-up|Symptomatic deterioration|0|||
147447046|NCT03099187|531800366|FG002|12-month Safety Follow-up|Symptomatic deterioration|1|||
147447047|NCT03099187|531800367|FG003|12-month Safety Follow-up|Symptomatic deterioration|1|||
147447048|NCT03099187|531800364|FG000|12-month Safety Follow-up|Withdrawal by Subject|0|||
147447049|NCT03099187|531800365|FG001|12-month Safety Follow-up|Withdrawal by Subject|0|||
147447050|NCT03099187|531800366|FG002|12-month Safety Follow-up|Withdrawal by Subject|3|||
147447051|NCT03099187|531800367|FG003|12-month Safety Follow-up|Withdrawal by Subject|2|||
147447052|NCT03099187|531800364|FG000|12-month Safety Follow-up|Due to hospitalization|0|||
147447053|NCT03099187|531800365|FG001|12-month Safety Follow-up|Due to hospitalization|0|||
147447054|NCT03099187|531800366|FG002|12-month Safety Follow-up|Due to hospitalization|0|||
147447055|NCT03099187|531800367|FG003|12-month Safety Follow-up|Due to hospitalization|1|||
147449489|NCT00440947|531809505|FG000|36-Week Induction Phase|Genotype Had Exclusionary Mutations|1|||
147449490|NCT00440947|531809506|FG001|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0|||
147449491|NCT00440947|531809507|FG002|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0|||
147449492|NCT00440947|531809508|FG003|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0|||
147449493|NCT00440947|531809509|FG004|36-Week Induction Phase|Genotype Had Exclusionary Mutations|0|||
147449494|NCT00440947|531809505|FG000|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|1|||
147449495|NCT00440947|531809506|FG001|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0|||
147449496|NCT00440947|531809507|FG002|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0|||
147449497|NCT00440947|531809508|FG003|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0|||
147449498|NCT00440947|531809509|FG004|36-Week Induction Phase|Fleeing Police; Outstanding Warrants|0|||
147449499|NCT00440947|531809505|FG000|36-Week Induction Phase|Incarceration|3|||
147449500|NCT00440947|531809506|FG001|36-Week Induction Phase|Incarceration|0|||
147654413|NCT02588092|532556717|FG003|Overall Study|Started Another Treatment|0|||
147654414|NCT02588092|532556718|FG004|Overall Study|Started Another Treatment|1|||
147654415|NCT02588092|532556719|FG005|Overall Study|Started Another Treatment|0|||
147159792|NCT01095653|530749636|FG001|Overall Study|Lack of Efficacy|0|||
147159793|NCT01095653|530749637|FG002|Overall Study|Lack of Efficacy|0|||
147159794|NCT01095653|530749635|FG000|Overall Study|Adverse Event|1|||
147159795|NCT01095653|530749636|FG001|Overall Study|Adverse Event|4|||
147159796|NCT01095653|530749637|FG002|Overall Study|Adverse Event|4|||
147159797|NCT01095653|530749635|FG000|Overall Study|Lost to Follow-up|1|||
147159798|NCT01095653|530749636|FG001|Overall Study|Lost to Follow-up|0|||
147159799|NCT01095653|530749637|FG002|Overall Study|Lost to Follow-up|4|||
147159800|NCT01095653|530749635|FG000|Overall Study|Withdrawal by Subject|4|||
147159801|NCT01095653|530749636|FG001|Overall Study|Withdrawal by Subject|5|||
147159802|NCT01095653|530749637|FG002|Overall Study|Withdrawal by Subject|3|||
147159803|NCT01095653|530749635|FG000|Overall Study|non-compliance, not met criteria, etc.|10|||
147159804|NCT01095653|530749636|FG001|Overall Study|non-compliance, not met criteria, etc.|6|||
147159805|NCT01095653|530749637|FG002|Overall Study|non-compliance, not met criteria, etc.|5|||
147159806|NCT00171925|530749638|FG000|Overall Study|Adverse Event|10|||
147159807|NCT00171925|530749639|FG001|Overall Study|Adverse Event|6|||
147159808|NCT00171925|530749638|FG000|Overall Study|Protocol Violation|1|||
147159809|NCT00171925|530749639|FG001|Overall Study|Protocol Violation|1|||
147159810|NCT00171925|530749638|FG000|Overall Study|Withdrawal by Subject|6|||
147159811|NCT00171925|530749639|FG001|Overall Study|Withdrawal by Subject|9|||
147159812|NCT00171925|530749638|FG000|Overall Study|Lost to Follow-up|2|||
147159813|NCT00171925|530749639|FG001|Overall Study|Lost to Follow-up|2|||
147159814|NCT00171925|530749638|FG000|Overall Study|Administrative problems|10|||
147159815|NCT00171925|530749639|FG001|Overall Study|Administrative problems|11|||
147159816|NCT00171925|530749638|FG000|Overall Study|Death|1|||
147159817|NCT00171925|530749639|FG001|Overall Study|Death|2|||
147159818|NCT02182440|530749640|FG000|Overall Study|Adverse Event|0|||
147159819|NCT02182440|530749641|FG001|Overall Study|Adverse Event|1|||
147159820|NCT02182440|530749642|FG002|Overall Study|Adverse Event|0|||
147159821|NCT02182440|530749643|FG003|Overall Study|Adverse Event|0|||
147159822|NCT02182440|530749640|FG000|Overall Study|Death|31|||
147159823|NCT02182440|530749641|FG001|Overall Study|Death|8|||
147159824|NCT02182440|530749642|FG002|Overall Study|Death|5|||
147159825|NCT02182440|530749643|FG003|Overall Study|Death|16|||
147159826|NCT02182440|530749640|FG000|Overall Study|Protocol Violation|0|||
147159827|NCT02182440|530749641|FG001|Overall Study|Protocol Violation|1|||
147159828|NCT02182440|530749642|FG002|Overall Study|Protocol Violation|0|||
147159829|NCT02182440|530749643|FG003|Overall Study|Protocol Violation|0|||
147159830|NCT02182440|530749640|FG000|Overall Study|Physician Decision|1|||
147159831|NCT02182440|530749641|FG001|Overall Study|Physician Decision|0|||
147159832|NCT02182440|530749642|FG002|Overall Study|Physician Decision|0|||
147159833|NCT02182440|530749643|FG003|Overall Study|Physician Decision|0|||
147159834|NCT02182440|530749640|FG000|Overall Study|Withdrawal by Subject|1|||
147447056|NCT01611974|531802048|FG000|Overall Study|Death|10|||
147586975|NCT00802178|532303303|FG000|Overall Study|Other|32|||
147586976|NCT00802178|532303303|FG000|Overall Study|Lack of efficacy and patient wish|1|||
147586977|NCT00802178|532303303|FG000|Overall Study|IT and patient wish|8|||
147586978|NCT00802178|532303303|FG000|Overall Study|Patients wish and other reason|1|||
147586979|NCT01606228|532303304|FG000|Overall Study|Lost to Follow-up|20|||
147586980|NCT01606228|532303304|FG000|Overall Study|Withdrawal by Subject|3|||
147586981|NCT01606228|532303304|FG000|Overall Study|Non-compliant|3|||
147586982|NCT01606228|532303304|FG000|Overall Study|Lack of Efficacy|2|||
147159835|NCT02182440|530749641|FG001|Overall Study|Withdrawal by Subject|1|||
147159836|NCT02182440|530749642|FG002|Overall Study|Withdrawal by Subject|3|||
147159837|NCT02182440|530749643|FG003|Overall Study|Withdrawal by Subject|4|||
147159838|NCT02182440|530749640|FG000|Overall Study|different, e.g adm other hospital|12|||
147159839|NCT02182440|530749641|FG001|Overall Study|different, e.g adm other hospital|3|||
147159840|NCT02182440|530749642|FG002|Overall Study|different, e.g adm other hospital|3|||
147159841|NCT02182440|530749643|FG003|Overall Study|different, e.g adm other hospital|10|||
147159842|NCT01799239|530749644|FG000|Period 1 (7 Days)|Lack of Efficacy|1|||
147159843|NCT01799239|530749645|FG001|Period 1 (7 Days)|Lack of Efficacy|0|||
147159844|NCT01799239|530749644|FG000|Period 1 (7 Days)|Withdrawal by Subject|2|||
147159845|NCT01799239|530749645|FG001|Period 1 (7 Days)|Withdrawal by Subject|0|||
147159846|NCT01799239|530749644|FG000|Period 1 (7 Days)|Protocol Violation|0|||
147159847|NCT01799239|530749645|FG001|Period 1 (7 Days)|Protocol Violation|1|||
147159848|NCT01799239|530749644|FG000|Period 2 (7 Days)|Withdrawal by Subject|1|||
147159849|NCT01799239|530749645|FG001|Period 2 (7 Days)|Withdrawal by Subject|1|||
147159850|NCT01799239|530749644|FG000|Period 2 (7 Days)|Protocol Violation|1|||
147159851|NCT01799239|530749645|FG001|Period 2 (7 Days)|Protocol Violation|0|||
147159852|NCT03754582|530749646|FG000|Treatment Phase|Adverse Event|0|||
147159853|NCT03754582|530749647|FG001|Treatment Phase|Adverse Event|1|||
147159854|NCT03754582|530749648|FG002|Treatment Phase|Adverse Event|0|||
147159855|NCT03754582|530749646|FG000|Follow-up Phase|Other|0|||
147159856|NCT03754582|530749647|FG001|Follow-up Phase|Other|0|||
147159857|NCT03754582|530749648|FG002|Follow-up Phase|Other|1|||
147159858|NCT01561755|530749651|FG000|Overall Study|Lost to Follow-up|0|||
147159859|NCT01561755|530749652|FG001|Overall Study|Lost to Follow-up|1|||
147159860|NCT02680574|530749653|FG000|Overall Study|Death|137|||
147159861|NCT02680574|530749654|FG001|Overall Study|Death|137|||
147159862|NCT02680574|530749653|FG000|Overall Study|Withdrawal by Subject|17|||
147159863|NCT02680574|530749654|FG001|Overall Study|Withdrawal by Subject|9|||
147159864|NCT02680574|530749653|FG000|Overall Study|Lost to Follow-up|4|||
147159865|NCT02680574|530749654|FG001|Overall Study|Lost to Follow-up|6|||
147159866|NCT01166958|530749655|FG000|Overall Study|Withdrawal by Subject|1|||
147159867|NCT01166958|530749656|FG001|Overall Study|Withdrawal by Subject|0|||
147159868|NCT01286987|530749657|FG000|Part 1: Dose Escalation|Clinical Progression|1|||
147159869|NCT01286987|530749658|FG001|Part 1: Dose Escalation|Clinical Progression|1|||
147159870|NCT01286987|530749659|FG002|Part 1: Dose Escalation|Clinical Progression|0|||
147241605|NCT02302807|531055964|FG000|Overall Study|Lost to Follow-up|4|||
147241606|NCT02302807|531055965|FG001|Overall Study|Lost to Follow-up|6|||
147241607|NCT02302807|531055964|FG000|Overall Study|Death|397|||
147241608|NCT02302807|531055965|FG001|Overall Study|Death|385|||
147241609|NCT02302807|531055964|FG000|Overall Study|Study Terminated By Sponsor|35|||
147241610|NCT02302807|531055965|FG001|Overall Study|Study Terminated By Sponsor|64|||
147241611|NCT02302807|531055964|FG000|Overall Study|Physician Decision|0|||
147241612|NCT02302807|531055965|FG001|Overall Study|Physician Decision|1|||
147241613|NCT01408485|531057699|FG000|Overall Study|Withdrawal by Subject|21|||
147241614|NCT01397084|531057700|FG000|Overall Study|Severe Non-Compliance to Protocol|1|||
147241615|NCT01397084|531057700|FG000|Overall Study|Protocol Violation|2|||
147241616|NCT01397084|531057700|FG000|Overall Study|Adverse Event|2|||
147241617|NCT01397084|531057700|FG000|Overall Study|Withdrawal by Subject|1|||
147241618|NCT01397084|531057700|FG000|Overall Study|Lost to Follow-up|1|||
147241619|NCT01397084|531057700|FG000|Overall Study|Used other proton pump inhibitor|1|||
147241620|NCT01751867|531057702|FG000|Overall Study|Completed treatment,dropped in follow-up|4|||
147241621|NCT01751867|531057703|FG001|Overall Study|Completed treatment,dropped in follow-up|8|||
147241622|NCT01751867|531057702|FG000|Overall Study|Diease Progression|4|||
147241623|NCT01751867|531057703|FG001|Overall Study|Diease Progression|18|||
147241624|NCT01751867|531057702|FG000|Overall Study|Adverse Event|8|||
147241625|NCT01751867|531057703|FG001|Overall Study|Adverse Event|15|||
147241626|NCT01751867|531057702|FG000|Overall Study|Poor Compliance|0|||
147241627|NCT01751867|531057703|FG001|Overall Study|Poor Compliance|5|||
147241628|NCT01751867|531057702|FG000|Overall Study|Withdrawal by Subject|3|||
147241629|NCT01751867|531057703|FG001|Overall Study|Withdrawal by Subject|1|||
147241630|NCT01751867|531057702|FG000|Overall Study|Physician Decision|4|||
147241631|NCT01751867|531057703|FG001|Overall Study|Physician Decision|7|||
147241632|NCT01751867|531057702|FG000|Overall Study|Protocol Violation|0|||
147241633|NCT01751867|531057703|FG001|Overall Study|Protocol Violation|2|||
147241634|NCT01751867|531057702|FG000|Overall Study|Death|0|||
147241635|NCT01751867|531057703|FG001|Overall Study|Death|5|||
147241636|NCT01751867|531057702|FG000|Overall Study|Other|11|||
147159871|NCT01286987|530749660|FG003|Part 1: Dose Escalation|Clinical Progression|1|||
147159872|NCT01286987|530749661|FG004|Part 1: Dose Escalation|Clinical Progression|1|||
147159873|NCT01286987|530749662|FG005|Part 1: Dose Escalation|Clinical Progression|1|||
147159874|NCT01286987|530749663|FG006|Part 1: Dose Escalation|Clinical Progression|0|||
147159875|NCT01286987|530749664|FG007|Part 1: Dose Escalation|Clinical Progression|2|||
147159876|NCT01286987|530749665|FG008|Part 1: Dose Escalation|Clinical Progression|1|||
147586983|NCT01606228|532303304|FG000|Overall Study|Adverse Event|1|||
147586984|NCT04100096|532303305|FG000|Overall Study|Adverse Event|19|||
147586985|NCT04100096|532303306|FG001|Overall Study|Adverse Event|7|||
147586986|NCT04100096|532303305|FG000|Overall Study|Lack of Efficacy|0|||
147586987|NCT04100096|532303306|FG001|Overall Study|Lack of Efficacy|1|||
147586988|NCT04100096|532303305|FG000|Overall Study|Lost to Follow-up|13|||
147586989|NCT04100096|532303306|FG001|Overall Study|Lost to Follow-up|11|||
147586990|NCT04100096|532303305|FG000|Overall Study|Non-Compliance With Study Drug|1|||
147586991|NCT04100096|532303306|FG001|Overall Study|Non-Compliance With Study Drug|3|||
147586992|NCT04100096|532303305|FG000|Overall Study|Protocol Deviation|1|||
147586993|NCT04100096|532303306|FG001|Overall Study|Protocol Deviation|1|||
147586994|NCT04100096|532303305|FG000|Overall Study|Withdrawal by Participant|13|||
147586995|NCT04100096|532303306|FG001|Overall Study|Withdrawal by Participant|15|||
147586996|NCT00991510|532303309|FG000|Period I (Days 1-14)|Adverse Event|1|||
147586997|NCT00991510|532303310|FG001|Period I (Days 1-14)|Adverse Event|0|||
147586998|NCT00991510|532303309|FG000|Period III (Days 29-112)|Adverse Event|1|||
147586999|NCT00991510|532303310|FG001|Period III (Days 29-112)|Adverse Event|1|||
147587000|NCT01976728|532303311|FG000|Overall Study|Subject missed multiple doses of IMP|1|||
147587001|NCT01976728|532303312|FG001|Overall Study|Subject missed multiple doses of IMP|0|||
147587002|NCT01976728|532303313|FG002|Overall Study|Subject missed multiple doses of IMP|0|||
147587003|NCT01976728|532303314|FG003|Overall Study|Subject missed multiple doses of IMP|0|||
147587004|NCT02356211|532303315|FG000|Overall Study|Withdrawal by Subject|2|||
147587005|NCT02356211|532303316|FG001|Overall Study|Withdrawal by Subject|2|||
147587006|NCT02356211|532303315|FG000|Overall Study|ineligible|1|||
147587007|NCT02356211|532303316|FG001|Overall Study|ineligible|8|||
147587008|NCT02211014|532303317|FG000|Overall Study|Adverse Event|0|||
147159877|NCT01286987|530749666|FG009|Part 1: Dose Escalation|Clinical Progression|0|||
147159878|NCT01286987|530749667|FG010|Part 1: Dose Escalation|Clinical Progression|0|||
147159879|NCT01286987|530749668|FG011|Part 1: Dose Escalation|Clinical Progression|0|||
147159880|NCT01286987|530749669|FG012|Part 1: Dose Escalation|Clinical Progression|0|||
147159881|NCT01286987|530749670|FG013|Part 1: Dose Escalation|Clinical Progression|0|||
147159882|NCT01286987|530749671|FG014|Part 1: Dose Escalation|Clinical Progression|0|||
147159883|NCT01286987|530749657|FG000|Part 1: Dose Escalation|Progressive Disease|2|||
147159884|NCT01286987|530749658|FG001|Part 1: Dose Escalation|Progressive Disease|2|||
147159885|NCT01286987|530749659|FG002|Part 1: Dose Escalation|Progressive Disease|3|||
147159886|NCT01286987|530749660|FG003|Part 1: Dose Escalation|Progressive Disease|2|||
147159887|NCT01286987|530749661|FG004|Part 1: Dose Escalation|Progressive Disease|1|||
147159888|NCT01286987|530749662|FG005|Part 1: Dose Escalation|Progressive Disease|5|||
147159889|NCT01286987|530749663|FG006|Part 1: Dose Escalation|Progressive Disease|5|||
147159890|NCT01286987|530749664|FG007|Part 1: Dose Escalation|Progressive Disease|3|||
147159891|NCT01286987|530749665|FG008|Part 1: Dose Escalation|Progressive Disease|5|||
147159892|NCT01286987|530749666|FG009|Part 1: Dose Escalation|Progressive Disease|0|||
147159893|NCT01286987|530749667|FG010|Part 1: Dose Escalation|Progressive Disease|0|||
147159894|NCT01286987|530749668|FG011|Part 1: Dose Escalation|Progressive Disease|0|||
147159895|NCT01286987|530749669|FG012|Part 1: Dose Escalation|Progressive Disease|0|||
147159896|NCT01286987|530749670|FG013|Part 1: Dose Escalation|Progressive Disease|0|||
147159897|NCT01286987|530749671|FG014|Part 1: Dose Escalation|Progressive Disease|0|||
147159898|NCT01286987|530749657|FG000|Part 1: Dose Escalation|Physician Decision|0|||
147159899|NCT01286987|530749658|FG001|Part 1: Dose Escalation|Physician Decision|0|||
147159900|NCT01286987|530749659|FG002|Part 1: Dose Escalation|Physician Decision|0|||
147159901|NCT01286987|530749660|FG003|Part 1: Dose Escalation|Physician Decision|0|||
147159902|NCT01286987|530749661|FG004|Part 1: Dose Escalation|Physician Decision|1|||
147159903|NCT01286987|530749662|FG005|Part 1: Dose Escalation|Physician Decision|0|||
147159904|NCT01286987|530749663|FG006|Part 1: Dose Escalation|Physician Decision|0|||
147159905|NCT01286987|530749664|FG007|Part 1: Dose Escalation|Physician Decision|0|||
147159906|NCT01286987|530749665|FG008|Part 1: Dose Escalation|Physician Decision|0|||
147159907|NCT01286987|530749666|FG009|Part 1: Dose Escalation|Physician Decision|0|||
147159908|NCT01286987|530749667|FG010|Part 1: Dose Escalation|Physician Decision|0|||
147159909|NCT01286987|530749668|FG011|Part 1: Dose Escalation|Physician Decision|0|||
147159910|NCT01286987|530749669|FG012|Part 1: Dose Escalation|Physician Decision|0|||
147587009|NCT02211014|532303318|FG001|Overall Study|Adverse Event|2|||
147587010|NCT02211014|532303317|FG000|Overall Study|Physician Decision|1|||
147587011|NCT02211014|532303318|FG001|Overall Study|Physician Decision|2|||
147159911|NCT01286987|530749670|FG013|Part 1: Dose Escalation|Physician Decision|0|||
147159912|NCT01286987|530749671|FG014|Part 1: Dose Escalation|Physician Decision|0|||
147159913|NCT01286987|530749657|FG000|Part 2: Dose Expansion|Death|0|||
147587012|NCT02211014|532303317|FG000|Overall Study|Started another cancer therapy|1|||
147447057|NCT01611974|531802049|FG001|Overall Study|Death|12|||
147447058|NCT01611974|531802050|FG002|Overall Study|Death|10|||
147447059|NCT01611974|531802048|FG000|Overall Study|Lost to Follow-up|0|||
147447060|NCT01611974|531802049|FG001|Overall Study|Lost to Follow-up|1|||
147447061|NCT01611974|531802050|FG002|Overall Study|Lost to Follow-up|0|||
147447062|NCT01611974|531802048|FG000|Overall Study|Physician Decision|5|||
147447063|NCT01611974|531802049|FG001|Overall Study|Physician Decision|1|||
147447064|NCT01611974|531802050|FG002|Overall Study|Physician Decision|2|||
147447065|NCT01611974|531802048|FG000|Overall Study|Withdrawal by Subject|0|||
147447066|NCT01611974|531802049|FG001|Overall Study|Withdrawal by Subject|1|||
147447067|NCT01611974|531802050|FG002|Overall Study|Withdrawal by Subject|4|||
147447068|NCT00001379|531802051|FG000|Initial Treatment|Disease progression|21|||
147447069|NCT00001379|531802052|FG001|Initial Treatment|Disease progression|3|||
147447070|NCT00001379|531802053|FG002|Initial Treatment|Disease progression|0|||
147447071|NCT00001379|531802054|FG003|Initial Treatment|Disease progression|0|||
147447072|NCT00001379|531802051|FG000|Initial Treatment|Complicating disease/intercurrent illness|6|||
147447073|NCT00001379|531802052|FG001|Initial Treatment|Complicating disease/intercurrent illness|1|||
147447074|NCT00001379|531802053|FG002|Initial Treatment|Complicating disease/intercurrent illness|0|||
147447075|NCT00001379|531802054|FG003|Initial Treatment|Complicating disease/intercurrent illness|0|||
147447076|NCT00001379|531802051|FG000|Initial Treatment|Received alternative treatment|2|||
147447077|NCT00001379|531802052|FG001|Initial Treatment|Received alternative treatment|1|||
147447078|NCT00001379|531802053|FG002|Initial Treatment|Received alternative treatment|0|||
147447079|NCT00001379|531802054|FG003|Initial Treatment|Received alternative treatment|0|||
147447080|NCT00001379|531802051|FG000|Initial Treatment|Refused further treatment|2|||
147447081|NCT00001379|531802052|FG001|Initial Treatment|Refused further treatment|0|||
147447082|NCT00001379|531802053|FG002|Initial Treatment|Refused further treatment|0|||
147447083|NCT00001379|531802054|FG003|Initial Treatment|Refused further treatment|0|||
147159914|NCT01286987|530749658|FG001|Part 2: Dose Expansion|Death|0|||
147159915|NCT01286987|530749659|FG002|Part 2: Dose Expansion|Death|0|||
147159916|NCT01286987|530749660|FG003|Part 2: Dose Expansion|Death|0|||
147159917|NCT01286987|530749661|FG004|Part 2: Dose Expansion|Death|0|||
147159918|NCT01286987|530749662|FG005|Part 2: Dose Expansion|Death|0|||
147159919|NCT01286987|530749663|FG006|Part 2: Dose Expansion|Death|0|||
147159920|NCT01286987|530749664|FG007|Part 2: Dose Expansion|Death|0|||
147159921|NCT01286987|530749665|FG008|Part 2: Dose Expansion|Death|0|||
147159922|NCT01286987|530749666|FG009|Part 2: Dose Expansion|Death|0|||
147159923|NCT01286987|530749667|FG010|Part 2: Dose Expansion|Death|0|||
147159924|NCT01286987|530749668|FG011|Part 2: Dose Expansion|Death|0|||
147159925|NCT01286987|530749669|FG012|Part 2: Dose Expansion|Death|1|||
147159926|NCT01286987|530749670|FG013|Part 2: Dose Expansion|Death|1|||
147159927|NCT01286987|530749671|FG014|Part 2: Dose Expansion|Death|0|||
147159928|NCT01286987|530749657|FG000|Part 2: Dose Expansion|Physician Decision|0|||
147159929|NCT01286987|530749658|FG001|Part 2: Dose Expansion|Physician Decision|0|||
147159930|NCT01286987|530749659|FG002|Part 2: Dose Expansion|Physician Decision|0|||
147159931|NCT01286987|530749660|FG003|Part 2: Dose Expansion|Physician Decision|0|||
147159932|NCT01286987|530749661|FG004|Part 2: Dose Expansion|Physician Decision|0|||
147159933|NCT01286987|530749662|FG005|Part 2: Dose Expansion|Physician Decision|0|||
147159934|NCT01286987|530749663|FG006|Part 2: Dose Expansion|Physician Decision|0|||
147159935|NCT01286987|530749664|FG007|Part 2: Dose Expansion|Physician Decision|0|||
147159936|NCT01286987|530749665|FG008|Part 2: Dose Expansion|Physician Decision|0|||
147159937|NCT01286987|530749666|FG009|Part 2: Dose Expansion|Physician Decision|0|||
147159938|NCT01286987|530749667|FG010|Part 2: Dose Expansion|Physician Decision|1|||
147159939|NCT01286987|530749668|FG011|Part 2: Dose Expansion|Physician Decision|1|||
147159940|NCT01286987|530749669|FG012|Part 2: Dose Expansion|Physician Decision|0|||
147159941|NCT01286987|530749670|FG013|Part 2: Dose Expansion|Physician Decision|1|||
147159942|NCT01286987|530749671|FG014|Part 2: Dose Expansion|Physician Decision|0|||
147159943|NCT01286987|530749657|FG000|Part 2: Dose Expansion|Other|0|||
147447084|NCT00001379|531802051|FG000|Initial Treatment|Did not receive protocol treatment|0|||
147447085|NCT00001379|531802052|FG001|Initial Treatment|Did not receive protocol treatment|0|||
147447086|NCT00001379|531802053|FG002|Initial Treatment|Did not receive protocol treatment|5|||
147447087|NCT00001379|531802054|FG003|Initial Treatment|Did not receive protocol treatment|0|||
147447088|NCT00001379|531802051|FG000|Initial Treatment|Received treatment with whole brain radiation therapy (WBRT) + Rituximab|0|||
147447089|NCT00001379|531802052|FG001|Initial Treatment|Received treatment with whole brain radiation therapy (WBRT) + Rituximab|0|||
147447090|NCT00001379|531802053|FG002|Initial Treatment|Received treatment with whole brain radiation therapy (WBRT) + Rituximab|0|||
147447091|NCT00001379|531802054|FG003|Initial Treatment|Received treatment with whole brain radiation therapy (WBRT) + Rituximab|1|||
147447092|NCT00001379|531802051|FG000|Cross-Over After Initial Treatment|Disease progression|4|||
147447093|NCT00001379|531802052|FG001|Cross-Over After Initial Treatment|Disease progression|2|||
147159944|NCT01286987|530749658|FG001|Part 2: Dose Expansion|Other|0|||
147159945|NCT01286987|530749659|FG002|Part 2: Dose Expansion|Other|0|||
147159946|NCT01286987|530749660|FG003|Part 2: Dose Expansion|Other|0|||
147159947|NCT01286987|530749661|FG004|Part 2: Dose Expansion|Other|0|||
147159948|NCT01286987|530749662|FG005|Part 2: Dose Expansion|Other|0|||
147159949|NCT01286987|530749663|FG006|Part 2: Dose Expansion|Other|0|||
147587013|NCT02211014|532303318|FG001|Overall Study|Started another cancer therapy|0|||
147587014|NCT02211014|532303317|FG000|Overall Study|Withdrawal by Subject|0|||
147587015|NCT02211014|532303318|FG001|Overall Study|Withdrawal by Subject|1|||
147587016|NCT02211014|532303317|FG000|Overall Study|In agreement with patient, no benefit|0|||
147587017|NCT02211014|532303318|FG001|Overall Study|In agreement with patient, no benefit|1|||
147587018|NCT00966381|532303319|FG000|Overall Study|Withdrawal by Subject|2|||
147587019|NCT00966381|532303320|FG001|Overall Study|Withdrawal by Subject|2|||
147587020|NCT01124695|532303321|FG000|Overall Study|Disease progression|77|||
147159950|NCT01286987|530749664|FG007|Part 2: Dose Expansion|Other|0|||
147159951|NCT01286987|530749665|FG008|Part 2: Dose Expansion|Other|0|||
147159952|NCT01286987|530749666|FG009|Part 2: Dose Expansion|Other|0|||
147159953|NCT01286987|530749667|FG010|Part 2: Dose Expansion|Other|0|||
147159954|NCT01286987|530749668|FG011|Part 2: Dose Expansion|Other|0|||
147159955|NCT01286987|530749669|FG012|Part 2: Dose Expansion|Other|0|||
147159956|NCT01286987|530749670|FG013|Part 2: Dose Expansion|Other|1|||
147159957|NCT01286987|530749671|FG014|Part 2: Dose Expansion|Other|0|||
147159958|NCT01286987|530749657|FG000|Part 2: Dose Expansion|Progressive Disease|0|||
147159959|NCT01286987|530749658|FG001|Part 2: Dose Expansion|Progressive Disease|0|||
147587021|NCT01124695|532303321|FG000|Overall Study|Adverse Event|11|||
147587022|NCT01124695|532303321|FG000|Overall Study|Death|1|||
147159960|NCT01286987|530749659|FG002|Part 2: Dose Expansion|Progressive Disease|0|||
147159961|NCT01286987|530749660|FG003|Part 2: Dose Expansion|Progressive Disease|0|||
147159962|NCT01286987|530749661|FG004|Part 2: Dose Expansion|Progressive Disease|0|||
147159963|NCT01286987|530749662|FG005|Part 2: Dose Expansion|Progressive Disease|0|||
147159964|NCT01286987|530749663|FG006|Part 2: Dose Expansion|Progressive Disease|0|||
147159965|NCT01286987|530749664|FG007|Part 2: Dose Expansion|Progressive Disease|0|||
147159966|NCT01286987|530749665|FG008|Part 2: Dose Expansion|Progressive Disease|0|||
147159967|NCT01286987|530749666|FG009|Part 2: Dose Expansion|Progressive Disease|11|||
147159968|NCT01286987|530749667|FG010|Part 2: Dose Expansion|Progressive Disease|6|||
147159969|NCT01286987|530749668|FG011|Part 2: Dose Expansion|Progressive Disease|7|||
147159970|NCT01286987|530749669|FG012|Part 2: Dose Expansion|Progressive Disease|11|||
147159971|NCT01286987|530749670|FG013|Part 2: Dose Expansion|Progressive Disease|19|||
147159972|NCT01286987|530749671|FG014|Part 2: Dose Expansion|Progressive Disease|2|||
147159973|NCT01286987|530749657|FG000|Part 2: Dose Expansion|Clinical Progression|0|||
147159974|NCT01286987|530749658|FG001|Part 2: Dose Expansion|Clinical Progression|0|||
147159975|NCT01286987|530749659|FG002|Part 2: Dose Expansion|Clinical Progression|0|||
147159976|NCT01286987|530749660|FG003|Part 2: Dose Expansion|Clinical Progression|0|||
147159977|NCT01286987|530749661|FG004|Part 2: Dose Expansion|Clinical Progression|0|||
147159978|NCT01286987|530749662|FG005|Part 2: Dose Expansion|Clinical Progression|0|||
147159979|NCT01286987|530749663|FG006|Part 2: Dose Expansion|Clinical Progression|0|||
147159980|NCT01286987|530749664|FG007|Part 2: Dose Expansion|Clinical Progression|0|||
147159981|NCT01286987|530749665|FG008|Part 2: Dose Expansion|Clinical Progression|0|||
147159982|NCT01286987|530749666|FG009|Part 2: Dose Expansion|Clinical Progression|0|||
147159983|NCT01286987|530749667|FG010|Part 2: Dose Expansion|Clinical Progression|2|||
147159984|NCT01286987|530749668|FG011|Part 2: Dose Expansion|Clinical Progression|2|||
147159985|NCT01286987|530749669|FG012|Part 2: Dose Expansion|Clinical Progression|0|||
147241637|NCT01751867|531057703|FG001|Overall Study|Other|37|||
147241638|NCT01751867|531057702|FG000|Overall Study|Randomized but not treated.|2|||
147241639|NCT01751867|531057703|FG001|Overall Study|Randomized but not treated.|1|||
147241640|NCT04932096|531057704|FG000|Overall Study|Withdrawal by Subject|1|||
147241641|NCT04932096|531057705|FG001|Overall Study|Withdrawal by Subject|1|||
147241642|NCT04932096|531057704|FG000|Overall Study|Partial completion (did not complete primary outcome survey)|0|||
147587023|NCT01124695|532303321|FG000|Overall Study|Withdrawal by Subject|7|||
147587024|NCT01124695|532303321|FG000|Overall Study|Physician Decision|3|||
147587025|NCT01124695|532303321|FG000|Overall Study|Alternative therapy|9|||
147587026|NCT01124695|532303321|FG000|Overall Study|No documentation that patient went off treatment|4|||
147587027|NCT01124695|532303321|FG000|Overall Study|Ineligible|9|||
147241643|NCT04932096|531057705|FG001|Overall Study|Partial completion (did not complete primary outcome survey)|1|||
147241644|NCT01508650|531057706|FG000|Overall Study|Lost to Follow-up|0|||
147241645|NCT01508650|531057707|FG001|Overall Study|Lost to Follow-up|3|||
147241646|NCT02064894|531057708|FG000|Overall Study|Withdrawal by Subject|43|||
147241647|NCT02064894|531057709|FG001|Overall Study|Withdrawal by Subject|102|||
147159986|NCT01286987|530749670|FG013|Part 2: Dose Expansion|Clinical Progression|2|||
147159987|NCT01286987|530749671|FG014|Part 2: Dose Expansion|Clinical Progression|0|||
147241648|NCT02064894|531057710|FG002|Overall Study|Withdrawal by Subject|115|||
147587028|NCT01124695|532303321|FG000|Overall Study|Ineligible and never start treatment|2|||
147159988|NCT01286987|530749657|FG000|Part 2: Dose Expansion|Withdrawal by Subject|0|||
147159989|NCT01286987|530749658|FG001|Part 2: Dose Expansion|Withdrawal by Subject|0|||
147159990|NCT01286987|530749659|FG002|Part 2: Dose Expansion|Withdrawal by Subject|0|||
147159991|NCT01286987|530749660|FG003|Part 2: Dose Expansion|Withdrawal by Subject|0|||
147159992|NCT01286987|530749661|FG004|Part 2: Dose Expansion|Withdrawal by Subject|0|||
147159993|NCT01286987|530749662|FG005|Part 2: Dose Expansion|Withdrawal by Subject|0|||
147159994|NCT01286987|530749663|FG006|Part 2: Dose Expansion|Withdrawal by Subject|0|||
147159995|NCT01286987|530749664|FG007|Part 2: Dose Expansion|Withdrawal by Subject|0|||
147159996|NCT01286987|530749665|FG008|Part 2: Dose Expansion|Withdrawal by Subject|0|||
147159997|NCT01286987|530749666|FG009|Part 2: Dose Expansion|Withdrawal by Subject|0|||
147159998|NCT01286987|530749667|FG010|Part 2: Dose Expansion|Withdrawal by Subject|1|||
147159999|NCT01286987|530749668|FG011|Part 2: Dose Expansion|Withdrawal by Subject|0|||
147160000|NCT01286987|530749669|FG012|Part 2: Dose Expansion|Withdrawal by Subject|0|||
147160001|NCT01286987|530749670|FG013|Part 2: Dose Expansion|Withdrawal by Subject|0|||
147160002|NCT01286987|530749671|FG014|Part 2: Dose Expansion|Withdrawal by Subject|0|||
147160003|NCT00681564|530749676|FG000|Overall Study|Lost to Follow-up|6|||
147160004|NCT00681564|530749677|FG001|Overall Study|Lost to Follow-up|6|||
147160005|NCT00681564|530749676|FG000|Overall Study|Withdrawal by Subject|0|||
147160006|NCT00681564|530749677|FG001|Overall Study|Withdrawal by Subject|1|||
147160007|NCT00681564|530749676|FG000|Overall Study|Death|0|||
147160008|NCT00681564|530749677|FG001|Overall Study|Death|1|||
147160009|NCT02826421|530749678|FG000|Overall Study|Adverse Event|1|||
147160010|NCT02826421|530749679|FG001|Overall Study|Adverse Event|0|||
147160011|NCT02826421|530749680|FG002|Overall Study|Adverse Event|0|||
147160012|NCT02826421|530749681|FG003|Overall Study|Adverse Event|1|||
147160013|NCT02826421|530749678|FG000|Overall Study|Withdrawal by Subject|1|||
147160014|NCT02826421|530749679|FG001|Overall Study|Withdrawal by Subject|3|||
147160015|NCT02826421|530749680|FG002|Overall Study|Withdrawal by Subject|1|||
147160016|NCT02826421|530749681|FG003|Overall Study|Withdrawal by Subject|1|||
147160017|NCT02826421|530749678|FG000|Overall Study|Reason not given|1|||
147160018|NCT02826421|530749679|FG001|Overall Study|Reason not given|0|||
147160019|NCT02826421|530749680|FG002|Overall Study|Reason not given|1|||
147160020|NCT02826421|530749681|FG003|Overall Study|Reason not given|0|||
147160021|NCT02210221|530749684|FG000|Overall Study|Lack of Efficacy|7|||
147160022|NCT02210221|530749684|FG000|Overall Study|Withdrawal by Subject|43|||
147160023|NCT02185014|530749689|FG000|Overall Study|Adverse Event|18|||
147160024|NCT02185014|530749689|FG000|Overall Study|Withdrew Consent|8|||
147587029|NCT01796964|532303326|FG000|Overall Study|Adverse Event|1|||
147587030|NCT01796964|532303327|FG001|Overall Study|Adverse Event|1|||
147160025|NCT02185014|530749689|FG000|Overall Study|Lost to Follow-up|4|||
147160026|NCT02185014|530749689|FG000|Overall Study|Lack of Efficacy|14|||
147160027|NCT02185014|530749689|FG000|Overall Study|Requires Alternative/Prohibited Therapy|5|||
147160028|NCT02185014|530749689|FG000|Overall Study|Subject Noncompliance|1|||
147160029|NCT02185014|530749689|FG000|Overall Study|Other|4|||
147160030|NCT00392808|530749690|FG000|Overall Study|Lost to Follow-up|3|||
147160031|NCT00392808|530749691|FG001|Overall Study|Lost to Follow-up|2|||
147160032|NCT00392808|530749692|FG002|Overall Study|Lost to Follow-up|1|||
147160033|NCT00392808|530749693|FG003|Overall Study|Lost to Follow-up|2|||
147160034|NCT00392808|530749690|FG000|Overall Study|Unable to withdraw blood|3|||
147160035|NCT00392808|530749691|FG001|Overall Study|Unable to withdraw blood|1|||
147160036|NCT00392808|530749692|FG002|Overall Study|Unable to withdraw blood|1|||
147160037|NCT00392808|530749693|FG003|Overall Study|Unable to withdraw blood|2|||
147160038|NCT02649855|530749694|FG000|Overall Study|Refused further treatment|2|||
147160039|NCT02649855|530749695|FG001|Overall Study|Refused further treatment|1|||
147160040|NCT02649855|530749696|FG002|Overall Study|Refused further treatment|1|||
147160041|NCT02649855|530749694|FG000|Overall Study|Withdrew consent|0|||
147160042|NCT02649855|530749695|FG001|Overall Study|Withdrew consent|1|||
147160043|NCT02649855|530749696|FG002|Overall Study|Withdrew consent|0|||
147160044|NCT02649855|530749694|FG000|Overall Study|Switched to alternative treatment|0|||
147160045|NCT02649855|530749695|FG001|Overall Study|Switched to alternative treatment|1|||
147160046|NCT02649855|530749696|FG002|Overall Study|Switched to alternative treatment|1|||
147160047|NCT02649855|530749694|FG000|Overall Study|Principal investigator discretion|0|||
147160048|NCT02649855|530749695|FG001|Overall Study|Principal investigator discretion|1|||
147160049|NCT02649855|530749696|FG002|Overall Study|Principal investigator discretion|1|||
147160050|NCT02649855|530749694|FG000|Overall Study|No treatment, per protocol|1|||
147160051|NCT02649855|530749695|FG001|Overall Study|No treatment, per protocol|0|||
147160052|NCT02649855|530749696|FG002|Overall Study|No treatment, per protocol|0|||
147160053|NCT02649855|530749694|FG000|Overall Study|Initiate new treatment|1|||
147160054|NCT02649855|530749695|FG001|Overall Study|Initiate new treatment|0|||
147160055|NCT02649855|530749696|FG002|Overall Study|Initiate new treatment|0|||
147587031|NCT01796964|532303326|FG000|Overall Study|Death|1|||
147160056|NCT02653495|530749697|FG000|Overall Study|Lost to Follow-up|2|||
147160057|NCT02653495|530749698|FG001|Overall Study|Lost to Follow-up|0|||
147160058|NCT02653495|530749697|FG000|Overall Study|Screening Failure|10|||
147160059|NCT02653495|530749698|FG001|Overall Study|Screening Failure|0|||
147160060|NCT00461305|530749699|FG000|Treatment|Adverse Event|26|||
147160061|NCT00461305|530749700|FG001|Treatment|Adverse Event|3|||
147160062|NCT00461305|530749699|FG000|Treatment|Lost to Follow-up|4|||
147160063|NCT00461305|530749700|FG001|Treatment|Lost to Follow-up|2|||
147160064|NCT00461305|530749699|FG000|Treatment|Protocol Violation|13|||
147160065|NCT00461305|530749700|FG001|Treatment|Protocol Violation|2|||
147160066|NCT00461305|530749699|FG000|Treatment|Withdrawal by Subject|48|||
147160067|NCT00461305|530749700|FG001|Treatment|Withdrawal by Subject|2|||
147160068|NCT00461305|530749699|FG000|Treatment|Never dispensed|5|||
147160069|NCT00461305|530749700|FG001|Treatment|Never dispensed|0|||
147160070|NCT00461305|530749699|FG000|Treatment|Study drug not taken|1|||
147160071|NCT00461305|530749700|FG001|Treatment|Study drug not taken|0|||
147160072|NCT00461305|530749699|FG000|Treatment|Partially missing diary|2|||
147160073|NCT00461305|530749700|FG001|Treatment|Partially missing diary|0|||
147160074|NCT00461305|530749699|FG000|Treatment|Other (missing drug etc)|2|||
147160075|NCT00461305|530749700|FG001|Treatment|Other (missing drug etc)|0|||
147160076|NCT00461305|530749699|FG000|Continued Treatment|Adverse Event|26|||
147160077|NCT00461305|530749700|FG001|Continued Treatment|Adverse Event|0|||
147160078|NCT00461305|530749699|FG000|Continued Treatment|Lost to Follow-up|4|||
147160079|NCT00461305|530749700|FG001|Continued Treatment|Lost to Follow-up|0|||
147160080|NCT00461305|530749699|FG000|Continued Treatment|Protocol Violation|13|||
147160081|NCT00461305|530749700|FG001|Continued Treatment|Protocol Violation|0|||
147160082|NCT00461305|530749699|FG000|Continued Treatment|Withdrawal by Subject|48|||
147160083|NCT00461305|530749700|FG001|Continued Treatment|Withdrawal by Subject|0|||
147160084|NCT00461305|530749699|FG000|Continued Treatment|Partially missing diary|2|||
147160085|NCT00461305|530749700|FG001|Continued Treatment|Partially missing diary|0|||
147160086|NCT00461305|530749699|FG000|Continued Treatment|Other (missing drug etc)|2|||
147160087|NCT00461305|530749700|FG001|Continued Treatment|Other (missing drug etc)|0|||
147160088|NCT00953680|530749704|FG000|Period 1|Withdrawal by Subject|0|||
147160089|NCT00953680|530749705|FG001|Period 1|Withdrawal by Subject|1|||
147160090|NCT03966885|530751857|FG000|Overall Study|Death|1|||
147160091|NCT03966885|530751858|FG001|Overall Study|Death|0|||
147160092|NCT03966885|530751857|FG000|Overall Study|Lost to Follow-up|1|||
147322233|NCT01163149|531343622|FG002|Extension Treatment Period|Noncompliance|1|||
147322234|NCT01192295|531343623|FG000|Overall Study|Adverse Event|3|||
147322235|NCT01192295|531343624|FG001|Overall Study|Adverse Event|7|||
147322236|NCT01192295|531343623|FG000|Overall Study|Withdrawal by Subject|3|||
147322237|NCT01192295|531343624|FG001|Overall Study|Withdrawal by Subject|4|||
147322238|NCT01192295|531343623|FG000|Overall Study|Lost to Follow-up|0|||
147322239|NCT01192295|531343624|FG001|Overall Study|Lost to Follow-up|1|||
147322240|NCT01192295|531343623|FG000|Overall Study|Lack of Efficacy|0|||
147322241|NCT01192295|531343624|FG001|Overall Study|Lack of Efficacy|5|||
147322242|NCT01192295|531343623|FG000|Overall Study|Administrative|4|||
147322243|NCT01192295|531343624|FG001|Overall Study|Administrative|6|||
147322244|NCT00630539|531343625|FG000|Overall Study|Adverse Event|1|||
147322245|NCT00630539|531343626|FG001|Overall Study|Adverse Event|3|||
147322246|NCT00630539|531343627|FG002|Overall Study|Adverse Event|1|||
147322247|NCT00630539|531343628|FG003|Overall Study|Adverse Event|2|||
147322248|NCT00630539|531343625|FG000|Overall Study|Withdrawal by Subject|0|||
147322249|NCT00630539|531343626|FG001|Overall Study|Withdrawal by Subject|1|||
147322250|NCT00630539|531343627|FG002|Overall Study|Withdrawal by Subject|0|||
147322251|NCT00630539|531343628|FG003|Overall Study|Withdrawal by Subject|1|||
147322252|NCT01700530|531343631|FG000|Overall Study|Withdrawal by Subject|0|||
147322253|NCT01700530|531343632|FG001|Overall Study|Withdrawal by Subject|3|||
147322254|NCT01700530|531343633|FG002|Overall Study|Withdrawal by Subject|1|||
147322255|NCT02806336|531343644|FG000|Overall Study|Physician Decision|1|||
147322256|NCT02806336|531343645|FG001|Overall Study|Physician Decision|0|||
147322257|NCT02806336|531343644|FG000|Overall Study|Withdrawal by Subject|2|||
147322258|NCT02806336|531343645|FG001|Overall Study|Withdrawal by Subject|4|||
147322259|NCT02806336|531343644|FG000|Overall Study|COVID-19 research shut down|3|||
147322260|NCT02806336|531343645|FG001|Overall Study|COVID-19 research shut down|4|||
147322261|NCT02806336|531343644|FG000|Overall Study|Lack of Efficacy|0|||
147322262|NCT02806336|531343645|FG001|Overall Study|Lack of Efficacy|1|||
147322263|NCT04159896|531343646|FG000|Overall Study|Lack of Efficacy|7|||
147322264|NCT04159896|531343646|FG000|Overall Study|Withdrawal by Subject|1|||
147587032|NCT01796964|532303327|FG001|Overall Study|Death|0|||
147587033|NCT01796964|532303326|FG000|Overall Study|Protocol Violation|0|||
147160093|NCT03966885|530751858|FG001|Overall Study|Lost to Follow-up|2|||
147322265|NCT04159896|531343646|FG000|Overall Study|Adverse Event|1|||
147322266|NCT04159896|531343646|FG000|Overall Study|A transient ischaemic attack|1|||
147322267|NCT05705167|531343647|FG000|Overall Study|Randomised but not Treated|0|||
147322268|NCT05705167|531343648|FG001|Overall Study|Randomised but not Treated|2|||
147322269|NCT05705167|531343649|FG002|Overall Study|Randomised but not Treated|0|||
147322270|NCT05705167|531343650|FG003|Overall Study|Randomised but not Treated|7|||
147160094|NCT03966885|530751857|FG000|Overall Study|Not post-assessed. Study ended early due to COVID-19|20|||
147160095|NCT03966885|530751858|FG001|Overall Study|Not post-assessed. Study ended early due to COVID-19|16|||
147160096|NCT03966885|530751857|FG000|Overall Study|Moved from study area.|0|||
147160097|NCT03966885|530751858|FG001|Overall Study|Moved from study area.|2|||
147160098|NCT03187834|530751859|FG000|Overall Study|Lost to Follow-up|0|||
147160099|NCT03187834|530751860|FG001|Overall Study|Lost to Follow-up|1|||
147160100|NCT03187834|530751861|FG002|Overall Study|Lost to Follow-up|2|||
147160101|NCT03187834|530751862|FG003|Overall Study|Lost to Follow-up|2|||
147322271|NCT05705167|531343651|FG004|Overall Study|Randomised but not Treated|0|||
147322272|NCT05705167|531343652|FG005|Overall Study|Randomised but not Treated|0|||
147160102|NCT03187834|530751859|FG000|Overall Study|Had invalid anthropometric measurements|5|||
147447094|NCT00001379|531802053|FG002|Cross-Over After Initial Treatment|Disease progression|0|||
147447095|NCT00001379|531802054|FG003|Cross-Over After Initial Treatment|Disease progression|0|||
147447096|NCT00001379|531802051|FG000|Cross-Over After Initial Treatment|Complicating disease/intercurrent illness|1|||
147447097|NCT00001379|531802052|FG001|Cross-Over After Initial Treatment|Complicating disease/intercurrent illness|1|||
147447098|NCT00001379|531802053|FG002|Cross-Over After Initial Treatment|Complicating disease/intercurrent illness|0|||
147447099|NCT00001379|531802054|FG003|Cross-Over After Initial Treatment|Complicating disease/intercurrent illness|0|||
147587034|NCT01796964|532303327|FG001|Overall Study|Protocol Violation|1|||
147587035|NCT01796964|532303326|FG000|Overall Study|Withdrawal by Subject|1|||
147587036|NCT01796964|532303327|FG001|Overall Study|Withdrawal by Subject|1|||
147587037|NCT04025684|532303328|FG000|Overall Study|Withdrawal by Subject|1|||
147587038|NCT04025684|532303329|FG001|Overall Study|Withdrawal by Subject|1|||
147587039|NCT04025684|532303330|FG002|Overall Study|Withdrawal by Subject|0|||
147587040|NCT04025684|532303331|FG003|Overall Study|Withdrawal by Subject|0|||
147587041|NCT04025684|532303328|FG000|Overall Study|Multiple reasons|1|||
147160103|NCT03187834|530751860|FG001|Overall Study|Had invalid anthropometric measurements|3|||
147160104|NCT03187834|530751861|FG002|Overall Study|Had invalid anthropometric measurements|4|||
147160105|NCT03187834|530751862|FG003|Overall Study|Had invalid anthropometric measurements|2|||
147160106|NCT03710876|530751863|FG000|Overall Study|Death|0|||
147160107|NCT03710876|530751864|FG001|Overall Study|Death|2|||
147160108|NCT03710876|530751863|FG000|Overall Study|Withdrawal by Subject|0|||
147160109|NCT03710876|530751864|FG001|Overall Study|Withdrawal by Subject|2|||
147160110|NCT01007123|530751865|FG000|Overall Study|Adverse Event|3|||
147160111|NCT01007123|530751866|FG001|Overall Study|Adverse Event|4|||
147160112|NCT01007123|530751867|FG002|Overall Study|Adverse Event|7|||
147160113|NCT01007123|530751868|FG003|Overall Study|Adverse Event|1|||
147160114|NCT01007123|530751865|FG000|Overall Study|Lack of Efficacy|1|||
147160115|NCT01007123|530751866|FG001|Overall Study|Lack of Efficacy|0|||
147160116|NCT01007123|530751867|FG002|Overall Study|Lack of Efficacy|1|||
147160117|NCT01007123|530751868|FG003|Overall Study|Lack of Efficacy|4|||
147160118|NCT01007123|530751865|FG000|Overall Study|Protocol Violation|1|||
147160119|NCT01007123|530751866|FG001|Overall Study|Protocol Violation|1|||
147160120|NCT01007123|530751867|FG002|Overall Study|Protocol Violation|2|||
147160121|NCT01007123|530751868|FG003|Overall Study|Protocol Violation|1|||
147160122|NCT01007123|530751865|FG000|Overall Study|Withdrawal by Subject|1|||
147160123|NCT01007123|530751866|FG001|Overall Study|Withdrawal by Subject|0|||
147160124|NCT01007123|530751867|FG002|Overall Study|Withdrawal by Subject|1|||
147160125|NCT01007123|530751868|FG003|Overall Study|Withdrawal by Subject|0|||
147160126|NCT01007123|530751865|FG000|Overall Study|Lost to Follow-up|0|||
147160127|NCT01007123|530751866|FG001|Overall Study|Lost to Follow-up|1|||
147160128|NCT01007123|530751867|FG002|Overall Study|Lost to Follow-up|0|||
147160129|NCT01007123|530751868|FG003|Overall Study|Lost to Follow-up|0|||
147160130|NCT02838901|530751869|FG000|Overall Study|Withdrawal by Subject|1|||
147160131|NCT02838901|530751870|FG001|Overall Study|Withdrawal by Subject|1|||
147160132|NCT02838901|530751869|FG000|Overall Study|Lost to Follow-up|1|||
147160133|NCT02838901|530751870|FG001|Overall Study|Lost to Follow-up|1|||
147160134|NCT00320255|530751871|FG000|Overall Study|Lack of Efficacy|1|||
147160135|NCT00320255|530751872|FG001|Overall Study|Lack of Efficacy|0|||
147160136|NCT00320255|530751873|FG002|Overall Study|Lack of Efficacy|0|||
147160137|NCT00320255|530751874|FG003|Overall Study|Lack of Efficacy|0|||
147160138|NCT00320255|530751875|FG004|Overall Study|Lack of Efficacy|0|||
147160139|NCT00320255|530751876|FG005|Overall Study|Lack of Efficacy|0|||
147160140|NCT00320255|530751871|FG000|Overall Study|Adverse Event|5|||
147160141|NCT00320255|530751872|FG001|Overall Study|Adverse Event|2|||
147160142|NCT00320255|530751873|FG002|Overall Study|Adverse Event|3|||
147160143|NCT00320255|530751874|FG003|Overall Study|Adverse Event|2|||
147160144|NCT00320255|530751875|FG004|Overall Study|Adverse Event|0|||
147160145|NCT00320255|530751876|FG005|Overall Study|Adverse Event|0|||
147160146|NCT00320255|530751871|FG000|Overall Study|Withdrawal by Subject|1|||
147241649|NCT01396148|531057711|FG000|Overall Study|Patient Decision|1|||
147160147|NCT00320255|530751872|FG001|Overall Study|Withdrawal by Subject|2|||
147160148|NCT00320255|530751873|FG002|Overall Study|Withdrawal by Subject|2|||
147160149|NCT00320255|530751874|FG003|Overall Study|Withdrawal by Subject|4|||
147160150|NCT00320255|530751875|FG004|Overall Study|Withdrawal by Subject|0|||
147160151|NCT00320255|530751876|FG005|Overall Study|Withdrawal by Subject|0|||
147241650|NCT00160693|531057716|FG000|Overall Study|Adverse Event|97|||
147241651|NCT00160693|531057716|FG000|Overall Study|Lack of Efficacy|30|||
147160152|NCT00320255|530751871|FG000|Overall Study|Poor compliance/noncompliance|1|||
147160153|NCT00320255|530751872|FG001|Overall Study|Poor compliance/noncompliance|1|||
147160154|NCT00320255|530751873|FG002|Overall Study|Poor compliance/noncompliance|0|||
147160155|NCT00320255|530751874|FG003|Overall Study|Poor compliance/noncompliance|1|||
147160156|NCT00320255|530751875|FG004|Overall Study|Poor compliance/noncompliance|0|||
147160157|NCT00320255|530751876|FG005|Overall Study|Poor compliance/noncompliance|0|||
147160158|NCT00320255|530751871|FG000|Overall Study|No longer meets study criteria|0|||
147160159|NCT00320255|530751872|FG001|Overall Study|No longer meets study criteria|0|||
147160160|NCT00320255|530751873|FG002|Overall Study|No longer meets study criteria|0|||
147241652|NCT00160693|531057716|FG000|Overall Study|Protocol Violation|24|||
147241653|NCT00160693|531057716|FG000|Overall Study|Lost to Follow-up|15|||
147654416|NCT02588092|532556720|FG006|Overall Study|Started Another Treatment|0|||
147241654|NCT00160693|531057716|FG000|Overall Study|Withdrawal by Subject|54|||
147241655|NCT00160693|531057716|FG000|Overall Study|Study terminated by sponsor|15|||
147241656|NCT05988619|531057718|FG000|Overall Study|Lost to Follow-up|1|||
147241657|NCT05988619|531057719|FG001|Overall Study|Lost to Follow-up|4|||
147241658|NCT05988619|531057718|FG000|Overall Study|Withdrawal by Subject|2|||
147241659|NCT05988619|531057719|FG001|Overall Study|Withdrawal by Subject|9|||
147241660|NCT03616600|531057722|FG000|Overall Study|Withdrawal by Subject|1|||
147654417|NCT02588092|532556721|FG007|Overall Study|Started Another Treatment|1|||
147654418|NCT02588092|532556722|FG008|Overall Study|Started Another Treatment|0|||
147654419|NCT02588092|532556723|FG009|Overall Study|Started Another Treatment|0|||
147654420|NCT02588092|532556714|FG000|Overall Study|Sponsor Decision|0|||
147654421|NCT02588092|532556715|FG001|Overall Study|Sponsor Decision|0|||
147654422|NCT02588092|532556716|FG002|Overall Study|Sponsor Decision|0|||
147654423|NCT02588092|532556717|FG003|Overall Study|Sponsor Decision|0|||
147241661|NCT03616600|531057723|FG001|Overall Study|Withdrawal by Subject|0|||
147241662|NCT00587054|531057724|FG000|Overall Study|Patient not treated|9|||
147241663|NCT03984994|531057725|FG000|Overall Study|Withdrawal by Subject|2|||
147241664|NCT03984994|531057726|FG001|Overall Study|Withdrawal by Subject|1|||
147241665|NCT03010176|531057728|FG000|Overall Study|Death|21|||
147241666|NCT03010176|531057729|FG001|Overall Study|Death|35|||
147241667|NCT03010176|531057730|FG002|Overall Study|Death|19|||
147241668|NCT03010176|531057731|FG003|Overall Study|Death|19|||
147241669|NCT03010176|531057732|FG004|Overall Study|Death|14|||
147241670|NCT03010176|531057733|FG005|Overall Study|Death|0|||
147241671|NCT03010176|531057728|FG000|Overall Study|Lost to Follow-up|0|||
147241672|NCT03010176|531057729|FG001|Overall Study|Lost to Follow-up|0|||
147241673|NCT03010176|531057730|FG002|Overall Study|Lost to Follow-up|0|||
147241674|NCT03010176|531057731|FG003|Overall Study|Lost to Follow-up|0|||
147241675|NCT03010176|531057732|FG004|Overall Study|Lost to Follow-up|1|||
147241676|NCT03010176|531057733|FG005|Overall Study|Lost to Follow-up|0|||
147241677|NCT03010176|531057728|FG000|Overall Study|Physician Decision|0|||
147241678|NCT03010176|531057729|FG001|Overall Study|Physician Decision|4|||
147241679|NCT03010176|531057730|FG002|Overall Study|Physician Decision|0|||
147241680|NCT03010176|531057731|FG003|Overall Study|Physician Decision|1|||
147241681|NCT03010176|531057732|FG004|Overall Study|Physician Decision|0|||
147241682|NCT03010176|531057733|FG005|Overall Study|Physician Decision|0|||
147241683|NCT03010176|531057728|FG000|Overall Study|Sponsor Decision|0|||
147241684|NCT03010176|531057729|FG001|Overall Study|Sponsor Decision|4|||
147241685|NCT03010176|531057730|FG002|Overall Study|Sponsor Decision|4|||
147241686|NCT03010176|531057731|FG003|Overall Study|Sponsor Decision|1|||
147241687|NCT03010176|531057732|FG004|Overall Study|Sponsor Decision|6|||
147241688|NCT03010176|531057733|FG005|Overall Study|Sponsor Decision|0|||
147241689|NCT03010176|531057728|FG000|Overall Study|Withdrawal by Subject|11|||
147241690|NCT03010176|531057729|FG001|Overall Study|Withdrawal by Subject|9|||
147241691|NCT03010176|531057730|FG002|Overall Study|Withdrawal by Subject|3|||
147241692|NCT03010176|531057731|FG003|Overall Study|Withdrawal by Subject|0|||
147241693|NCT03010176|531057732|FG004|Overall Study|Withdrawal by Subject|4|||
147241694|NCT03010176|531057733|FG005|Overall Study|Withdrawal by Subject|0|||
147241695|NCT00726232|531057736|FG000|Initial Phase (Dose-finding)|Death|0|||
147241696|NCT00726232|531057737|FG001|Initial Phase (Dose-finding)|Death|0|||
147241697|NCT00726232|531057738|FG002|Initial Phase (Dose-finding)|Death|0|||
147241698|NCT00726232|531057739|FG003|Initial Phase (Dose-finding)|Death|0|||
147241699|NCT00726232|531057740|FG004|Initial Phase (Dose-finding)|Death|1|||
147241700|NCT00726232|531057741|FG005|Initial Phase (Dose-finding)|Death|0|||
147241701|NCT00726232|531057742|FG006|Initial Phase (Dose-finding)|Death|0|||
147241702|NCT00726232|531057743|FG007|Initial Phase (Dose-finding)|Death|0|||
147241703|NCT00726232|531057736|FG000|Initial Phase (Dose-finding)|Adverse Event|2|||
147241704|NCT00726232|531057737|FG001|Initial Phase (Dose-finding)|Adverse Event|2|||
147241705|NCT00726232|531057738|FG002|Initial Phase (Dose-finding)|Adverse Event|2|||
147241706|NCT00726232|531057739|FG003|Initial Phase (Dose-finding)|Adverse Event|1|||
147241707|NCT00726232|531057740|FG004|Initial Phase (Dose-finding)|Adverse Event|7|||
147241708|NCT00726232|531057741|FG005|Initial Phase (Dose-finding)|Adverse Event|3|||
147241709|NCT00726232|531057742|FG006|Initial Phase (Dose-finding)|Adverse Event|0|||
147241710|NCT00726232|531057743|FG007|Initial Phase (Dose-finding)|Adverse Event|0|||
147241711|NCT00726232|531057736|FG000|Initial Phase (Dose-finding)|Withdrawal by Subject|2|||
147654424|NCT02588092|532556718|FG004|Overall Study|Sponsor Decision|0|||
147241712|NCT00726232|531057737|FG001|Initial Phase (Dose-finding)|Withdrawal by Subject|0|||
147241713|NCT00726232|531057738|FG002|Initial Phase (Dose-finding)|Withdrawal by Subject|0|||
147241714|NCT00726232|531057739|FG003|Initial Phase (Dose-finding)|Withdrawal by Subject|1|||
147241715|NCT00726232|531057740|FG004|Initial Phase (Dose-finding)|Withdrawal by Subject|0|||
147241716|NCT00726232|531057741|FG005|Initial Phase (Dose-finding)|Withdrawal by Subject|2|||
147241717|NCT00726232|531057742|FG006|Initial Phase (Dose-finding)|Withdrawal by Subject|0|||
147322273|NCT05705167|531343653|FG006|Overall Study|Randomised but not Treated|0|||
147322274|NCT05705167|531343647|FG000|Overall Study|Death|0|||
147160161|NCT00320255|530751874|FG003|Overall Study|No longer meets study criteria|1|||
147160162|NCT00320255|530751875|FG004|Overall Study|No longer meets study criteria|0|||
147160163|NCT00320255|530751876|FG005|Overall Study|No longer meets study criteria|0|||
147160164|NCT00320255|530751871|FG000|Overall Study|Other|3|||
147160165|NCT00320255|530751872|FG001|Overall Study|Other|2|||
147160166|NCT00320255|530751873|FG002|Overall Study|Other|1|||
147160167|NCT00320255|530751874|FG003|Overall Study|Other|0|||
147160168|NCT00320255|530751875|FG004|Overall Study|Other|0|||
147160169|NCT00320255|530751876|FG005|Overall Study|Other|0|||
147160170|NCT03405935|530751878|FG000|Overall Study|Adverse Event|3|||
147160171|NCT03405935|530751878|FG000|Overall Study|Death|2|||
147160172|NCT03405935|530751878|FG000|Overall Study|Withdrawal by Subject|1|||
147160173|NCT03405935|530751878|FG000|Overall Study|Lost to Follow-up|2|||
147160174|NCT04979897|530751879|FG000|Overall Study|Death|1|||
147160175|NCT04979897|530751880|FG001|Overall Study|Death|8|||
147160176|NCT04979897|530751879|FG000|Overall Study|Lost to Follow-up|111|||
147160177|NCT04979897|530751880|FG001|Overall Study|Lost to Follow-up|56|||
147160178|NCT04979897|530751879|FG000|Overall Study|Withdrawal by Subject|7|||
147241718|NCT00726232|531057743|FG007|Initial Phase (Dose-finding)|Withdrawal by Subject|0|||
147241719|NCT00726232|531057736|FG000|Initial Phase (Dose-finding)|Disease progression|3|||
147241720|NCT00726232|531057737|FG001|Initial Phase (Dose-finding)|Disease progression|1|||
147241721|NCT00726232|531057738|FG002|Initial Phase (Dose-finding)|Disease progression|0|||
147241722|NCT00726232|531057739|FG003|Initial Phase (Dose-finding)|Disease progression|0|||
147241723|NCT00726232|531057740|FG004|Initial Phase (Dose-finding)|Disease progression|0|||
147241724|NCT00726232|531057741|FG005|Initial Phase (Dose-finding)|Disease progression|0|||
147241725|NCT00726232|531057742|FG006|Initial Phase (Dose-finding)|Disease progression|0|||
147241726|NCT00726232|531057743|FG007|Initial Phase (Dose-finding)|Disease progression|0|||
147241727|NCT00726232|531057736|FG000|Initial Phase (Dose-finding)|Termination of the trial by sponsor|4|||
147241728|NCT00726232|531057737|FG001|Initial Phase (Dose-finding)|Termination of the trial by sponsor|3|||
147241729|NCT00726232|531057738|FG002|Initial Phase (Dose-finding)|Termination of the trial by sponsor|3|||
147241730|NCT00726232|531057739|FG003|Initial Phase (Dose-finding)|Termination of the trial by sponsor|4|||
147241731|NCT00726232|531057740|FG004|Initial Phase (Dose-finding)|Termination of the trial by sponsor|9|||
147241732|NCT00726232|531057741|FG005|Initial Phase (Dose-finding)|Termination of the trial by sponsor|3|||
147241733|NCT00726232|531057742|FG006|Initial Phase (Dose-finding)|Termination of the trial by sponsor|0|||
147241734|NCT00726232|531057743|FG007|Initial Phase (Dose-finding)|Termination of the trial by sponsor|0|||
147241735|NCT00726232|531057736|FG000|Initial Phase (Dose-finding)|Per Investigator: lack of response|1|||
147241736|NCT00726232|531057737|FG001|Initial Phase (Dose-finding)|Per Investigator: lack of response|0|||
147241737|NCT00726232|531057738|FG002|Initial Phase (Dose-finding)|Per Investigator: lack of response|0|||
147241738|NCT00726232|531057739|FG003|Initial Phase (Dose-finding)|Per Investigator: lack of response|2|||
147241739|NCT00726232|531057740|FG004|Initial Phase (Dose-finding)|Per Investigator: lack of response|4|||
147241740|NCT00726232|531057741|FG005|Initial Phase (Dose-finding)|Per Investigator: lack of response|1|||
147241741|NCT00726232|531057742|FG006|Initial Phase (Dose-finding)|Per Investigator: lack of response|0|||
147241742|NCT00726232|531057743|FG007|Initial Phase (Dose-finding)|Per Investigator: lack of response|0|||
147241743|NCT00726232|531057736|FG000|Initial Phase (Dose-finding)|Unspecified reason|1|||
147241744|NCT00726232|531057737|FG001|Initial Phase (Dose-finding)|Unspecified reason|0|||
147241745|NCT00726232|531057738|FG002|Initial Phase (Dose-finding)|Unspecified reason|0|||
147241746|NCT00726232|531057739|FG003|Initial Phase (Dose-finding)|Unspecified reason|0|||
147241747|NCT00726232|531057740|FG004|Initial Phase (Dose-finding)|Unspecified reason|0|||
147241748|NCT00726232|531057741|FG005|Initial Phase (Dose-finding)|Unspecified reason|0|||
147241749|NCT00726232|531057742|FG006|Initial Phase (Dose-finding)|Unspecified reason|0|||
147241750|NCT00726232|531057743|FG007|Initial Phase (Dose-finding)|Unspecified reason|0|||
147241751|NCT00726232|531057736|FG000|Expansion Phase|Death|0|||
147241752|NCT00726232|531057737|FG001|Expansion Phase|Death|0|||
147241753|NCT00726232|531057738|FG002|Expansion Phase|Death|0|||
147241754|NCT00726232|531057739|FG003|Expansion Phase|Death|0|||
147241755|NCT00726232|531057740|FG004|Expansion Phase|Death|0|||
147241756|NCT00726232|531057741|FG005|Expansion Phase|Death|0|||
147241757|NCT00726232|531057742|FG006|Expansion Phase|Death|0|||
147241758|NCT00726232|531057743|FG007|Expansion Phase|Death|1|||
147241759|NCT00726232|531057736|FG000|Expansion Phase|Adverse Event|0|||
147160179|NCT04979897|530751880|FG001|Overall Study|Withdrawal by Subject|2|||
147160180|NCT02781792|530751889|FG000|Overall Study|Adverse Event|1|||
147241760|NCT00726232|531057737|FG001|Expansion Phase|Adverse Event|0|||
147241761|NCT00726232|531057738|FG002|Expansion Phase|Adverse Event|0|||
147160181|NCT02781792|530751890|FG001|Overall Study|Adverse Event|2|||
147160182|NCT02781792|530751889|FG000|Overall Study|Withdrawal by Subject|3|||
147160183|NCT02781792|530751890|FG001|Overall Study|Withdrawal by Subject|1|||
147160184|NCT02781792|530751889|FG000|Overall Study|Lack of Efficacy|1|||
147241762|NCT00726232|531057739|FG003|Expansion Phase|Adverse Event|0|||
147241763|NCT00726232|531057740|FG004|Expansion Phase|Adverse Event|0|||
147241764|NCT00726232|531057741|FG005|Expansion Phase|Adverse Event|0|||
147241765|NCT00726232|531057742|FG006|Expansion Phase|Adverse Event|6|||
147241766|NCT00726232|531057743|FG007|Expansion Phase|Adverse Event|11|||
147241767|NCT00726232|531057736|FG000|Expansion Phase|Withdrawal by Subject|0|||
147160185|NCT02781792|530751890|FG001|Overall Study|Lack of Efficacy|1|||
147160186|NCT02781792|530751889|FG000|Overall Study|Hospice|0|||
147160187|NCT02781792|530751890|FG001|Overall Study|Hospice|1|||
147160188|NCT01224821|530751898|FG000|Dosimetric and Therapeutic Treatment|Adverse Event|1|||
147160189|NCT01224821|530751898|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|38|||
147160190|NCT01224821|530751898|FG000|Dosimetric and Therapeutic Treatment|Continued Follow-up in Study BEX104526|3|||
147160191|NCT01224821|530751898|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|2|||
147160192|NCT01224821|530751898|FG000|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|1|||
147160193|NCT01224821|530751898|FG000|Dosimetric and Therapeutic Treatment|Started Other Treatment|1|||
147160194|NCT01224821|530751898|FG000|Long-Term Follow-Up|Death|2|||
147160195|NCT01224821|530751898|FG000|Long-Term Follow-Up|Completion of 10 Year Follow-up|9|||
147160196|NCT00683917|530751899|FG000|Overall Study|Study prematurely terminated|10|||
147160197|NCT04422561|530751903|FG000|Overall Study|Lost to Follow-up|25|||
147160198|NCT04422561|530751904|FG001|Overall Study|Lost to Follow-up|11|||
147160199|NCT02685748|530751905|FG000|Overall Study|Withdrawal by Subject|3|||
147160200|NCT02685748|530751906|FG001|Overall Study|Withdrawal by Subject|2|||
147160201|NCT03500172|530751907|FG000|Period 1: Baseline Randomization|Death|0|||
147160202|NCT03500172|530751908|FG001|Period 1: Baseline Randomization|Death|0|||
147160203|NCT03500172|530751909|FG002|Period 1: Baseline Randomization|Death|0|||
147160204|NCT03500172|530751910|FG003|Period 1: Baseline Randomization|Death|0|||
147160205|NCT03500172|530751911|FG004|Period 1: Baseline Randomization|Death|0|||
147160206|NCT03500172|530751912|FG005|Period 1: Baseline Randomization|Death|0|||
147160207|NCT03500172|530751913|FG006|Period 1: Baseline Randomization|Death|0|||
147160208|NCT03500172|530751914|FG007|Period 1: Baseline Randomization|Death|0|||
147160209|NCT03500172|530751915|FG008|Period 1: Baseline Randomization|Death|0|||
147160210|NCT03500172|530751916|FG009|Period 1: Baseline Randomization|Death|2|||
147160211|NCT03500172|530751917|FG010|Period 1: Baseline Randomization|Death|0|||
147160212|NCT03500172|530751907|FG000|Period 1: Baseline Randomization|Protocol Violation|0|||
147160213|NCT03500172|530751908|FG001|Period 1: Baseline Randomization|Protocol Violation|0|||
147160214|NCT03500172|530751909|FG002|Period 1: Baseline Randomization|Protocol Violation|0|||
147160215|NCT03500172|530751910|FG003|Period 1: Baseline Randomization|Protocol Violation|0|||
147160216|NCT03500172|530751911|FG004|Period 1: Baseline Randomization|Protocol Violation|0|||
147160217|NCT03500172|530751912|FG005|Period 1: Baseline Randomization|Protocol Violation|0|||
147160218|NCT03500172|530751913|FG006|Period 1: Baseline Randomization|Protocol Violation|0|||
147160219|NCT03500172|530751914|FG007|Period 1: Baseline Randomization|Protocol Violation|0|||
147160220|NCT03500172|530751915|FG008|Period 1: Baseline Randomization|Protocol Violation|0|||
147160221|NCT03500172|530751916|FG009|Period 1: Baseline Randomization|Protocol Violation|1|||
147160222|NCT03500172|530751917|FG010|Period 1: Baseline Randomization|Protocol Violation|0|||
147160223|NCT03500172|530751907|FG000|Period 2: Re-Randomization|Lost to Follow-up|8|||
147160224|NCT03500172|530751908|FG001|Period 2: Re-Randomization|Lost to Follow-up|6|||
147160225|NCT03500172|530751909|FG002|Period 2: Re-Randomization|Lost to Follow-up|87|||
147160226|NCT03500172|530751910|FG003|Period 2: Re-Randomization|Lost to Follow-up|68|||
147160227|NCT03500172|530751911|FG004|Period 2: Re-Randomization|Lost to Follow-up|4|||
147447100|NCT00001379|531802051|FG000|Cross-Over After Initial Treatment|Received alternative treatment|4|||
147447101|NCT00001379|531802052|FG001|Cross-Over After Initial Treatment|Received alternative treatment|0|||
147587042|NCT04025684|532303329|FG001|Overall Study|Multiple reasons|3|||
147587043|NCT04025684|532303330|FG002|Overall Study|Multiple reasons|0|||
147160228|NCT03500172|530751912|FG005|Period 2: Re-Randomization|Lost to Follow-up|6|||
147160229|NCT03500172|530751913|FG006|Period 2: Re-Randomization|Lost to Follow-up|63|||
147160230|NCT03500172|530751914|FG007|Period 2: Re-Randomization|Lost to Follow-up|74|||
147160231|NCT03500172|530751915|FG008|Period 2: Re-Randomization|Lost to Follow-up|0|||
147160232|NCT03500172|530751916|FG009|Period 2: Re-Randomization|Lost to Follow-up|0|||
147160233|NCT03500172|530751917|FG010|Period 2: Re-Randomization|Lost to Follow-up|0|||
147160234|NCT03500172|530751907|FG000|Period 2: Re-Randomization|Death|0|||
147160235|NCT03500172|530751908|FG001|Period 2: Re-Randomization|Death|0|||
147160236|NCT03500172|530751909|FG002|Period 2: Re-Randomization|Death|0|||
147160237|NCT03500172|530751910|FG003|Period 2: Re-Randomization|Death|4|||
147160238|NCT03500172|530751911|FG004|Period 2: Re-Randomization|Death|2|||
147160239|NCT03500172|530751912|FG005|Period 2: Re-Randomization|Death|0|||
147160240|NCT03500172|530751913|FG006|Period 2: Re-Randomization|Death|5|||
147587044|NCT04025684|532303331|FG003|Overall Study|Multiple reasons|1|||
147587045|NCT01613378|532303339|FG000|Overall Study|Lack of Efficacy|13|||
147160241|NCT03500172|530751914|FG007|Period 2: Re-Randomization|Death|2|||
147160242|NCT03500172|530751915|FG008|Period 2: Re-Randomization|Death|0|||
147160243|NCT03500172|530751916|FG009|Period 2: Re-Randomization|Death|0|||
147160244|NCT03500172|530751917|FG010|Period 2: Re-Randomization|Death|0|||
147160245|NCT00090233|530751922|FG000|Overall Study|Randomized Not Vaccinated (Visit 1)|609|||
147160246|NCT00090233|530751923|FG001|Overall Study|Randomized Not Vaccinated (Visit 1)|627|||
147160247|NCT00090233|530751922|FG000|Overall Study|Adverse Event|214|||
147160248|NCT00090233|530751923|FG001|Overall Study|Adverse Event|198|||
147160249|NCT00090233|530751922|FG000|Overall Study|Lost to Follow-up|68|||
147160250|NCT00090233|530751923|FG001|Overall Study|Lost to Follow-up|95|||
147160251|NCT00090233|530751922|FG000|Overall Study|Protocol Violation|960|||
147241768|NCT00726232|531057737|FG001|Expansion Phase|Withdrawal by Subject|0|||
147241769|NCT00726232|531057738|FG002|Expansion Phase|Withdrawal by Subject|0|||
147241770|NCT00726232|531057739|FG003|Expansion Phase|Withdrawal by Subject|0|||
147241771|NCT00726232|531057740|FG004|Expansion Phase|Withdrawal by Subject|0|||
147241772|NCT00726232|531057741|FG005|Expansion Phase|Withdrawal by Subject|0|||
147241773|NCT00726232|531057742|FG006|Expansion Phase|Withdrawal by Subject|2|||
147587046|NCT01613378|532303339|FG000|Overall Study|Adverse Event|11|||
147587047|NCT01613378|532303339|FG000|Overall Study|Withdrawal by Subject|8|||
147587048|NCT01613378|532303339|FG000|Overall Study|Death|2|||
147587049|NCT01613378|532303339|FG000|Overall Study|Lost to Follow-up|1|||
147587050|NCT01613378|532303339|FG000|Overall Study|Other Reason|4|||
147587051|NCT02000531|532303345|FG000|Overall Study|Lost to Follow-up|1|||
147587052|NCT02000531|532303346|FG001|Overall Study|Lost to Follow-up|0|||
147587053|NCT02000531|532303345|FG000|Overall Study|Discontinued due to data cut-off|3|||
147587054|NCT02000531|532303346|FG001|Overall Study|Discontinued due to data cut-off|8|||
147587055|NCT00794417|532303351|FG000|Phase 1: Baseline (Day 1) up to Day 751|Death|0|||
147587056|NCT00794417|532303352|FG001|Phase 1: Baseline (Day 1) up to Day 751|Death|0|||
147587057|NCT00794417|532303353|FG002|Phase 1: Baseline (Day 1) up to Day 751|Death|2|||
147241774|NCT00726232|531057743|FG007|Expansion Phase|Withdrawal by Subject|3|||
147241775|NCT00726232|531057736|FG000|Expansion Phase|Disease progression|0|||
147241776|NCT00726232|531057737|FG001|Expansion Phase|Disease progression|0|||
147241777|NCT00726232|531057738|FG002|Expansion Phase|Disease progression|0|||
147241778|NCT00726232|531057739|FG003|Expansion Phase|Disease progression|0|||
147241779|NCT00726232|531057740|FG004|Expansion Phase|Disease progression|0|||
147241780|NCT00726232|531057741|FG005|Expansion Phase|Disease progression|0|||
147241781|NCT00726232|531057742|FG006|Expansion Phase|Disease progression|4|||
147241782|NCT00726232|531057743|FG007|Expansion Phase|Disease progression|0|||
147241783|NCT00726232|531057736|FG000|Expansion Phase|Termination of the trial by sponsor|0|||
147587058|NCT00794417|532303354|FG003|Phase 1: Baseline (Day 1) up to Day 751|Death|0|||
147160252|NCT00090233|530751923|FG001|Overall Study|Protocol Violation|1022|||
147241784|NCT00726232|531057737|FG001|Expansion Phase|Termination of the trial by sponsor|0|||
147241785|NCT00726232|531057738|FG002|Expansion Phase|Termination of the trial by sponsor|0|||
147241786|NCT00726232|531057739|FG003|Expansion Phase|Termination of the trial by sponsor|0|||
147241787|NCT00726232|531057740|FG004|Expansion Phase|Termination of the trial by sponsor|0|||
147241788|NCT00726232|531057741|FG005|Expansion Phase|Termination of the trial by sponsor|0|||
147241789|NCT00726232|531057742|FG006|Expansion Phase|Termination of the trial by sponsor|10|||
147241790|NCT00726232|531057743|FG007|Expansion Phase|Termination of the trial by sponsor|16|||
147241791|NCT00726232|531057736|FG000|Expansion Phase|Per Investigator: lack of response|0|||
147241792|NCT00726232|531057737|FG001|Expansion Phase|Per Investigator: lack of response|0|||
147241793|NCT00726232|531057738|FG002|Expansion Phase|Per Investigator: lack of response|0|||
147241794|NCT00726232|531057739|FG003|Expansion Phase|Per Investigator: lack of response|0|||
147241795|NCT00726232|531057740|FG004|Expansion Phase|Per Investigator: lack of response|0|||
147241796|NCT00726232|531057741|FG005|Expansion Phase|Per Investigator: lack of response|0|||
147241797|NCT00726232|531057742|FG006|Expansion Phase|Per Investigator: lack of response|1|||
147241798|NCT00726232|531057743|FG007|Expansion Phase|Per Investigator: lack of response|7|||
147241799|NCT00726232|531057736|FG000|Expansion Phase|Unspecified reason|0|||
147241800|NCT00726232|531057737|FG001|Expansion Phase|Unspecified reason|0|||
147241801|NCT00726232|531057738|FG002|Expansion Phase|Unspecified reason|0|||
147241802|NCT00726232|531057739|FG003|Expansion Phase|Unspecified reason|0|||
147241803|NCT00726232|531057740|FG004|Expansion Phase|Unspecified reason|0|||
147241804|NCT00726232|531057741|FG005|Expansion Phase|Unspecified reason|0|||
147587059|NCT00794417|532303351|FG000|Phase 1: Baseline (Day 1) up to Day 751|Other un-specified|3|||
147587060|NCT00794417|532303352|FG001|Phase 1: Baseline (Day 1) up to Day 751|Other un-specified|3|||
147587061|NCT00794417|532303353|FG002|Phase 1: Baseline (Day 1) up to Day 751|Other un-specified|1|||
147160253|NCT00090233|530751922|FG000|Overall Study|Withdrawal by Subject|182|||
147587062|NCT00794417|532303354|FG003|Phase 1: Baseline (Day 1) up to Day 751|Other un-specified|0|||
147160254|NCT00090233|530751923|FG001|Overall Study|Withdrawal by Subject|211|||
147160255|NCT00090233|530751922|FG000|Overall Study|Moved|203|||
147160256|NCT00090233|530751923|FG001|Overall Study|Moved|189|||
147160257|NCT00090233|530751922|FG000|Overall Study|Other|1211|||
147160258|NCT00090233|530751923|FG001|Overall Study|Other|1160|||
147160259|NCT00090233|530751922|FG000|Overall Study|Data not available at data cut-off point|1552|||
147160260|NCT00090233|530751923|FG001|Overall Study|Data not available at data cut-off point|1563|||
147587063|NCT00794417|532303351|FG000|Phase 2: Baseline (Day 421) to Day 972|Death|0|||
147160261|NCT04863248|530751924|FG000|Overall Study|Sponsor Terminated|4|||
147241805|NCT00726232|531057742|FG006|Expansion Phase|Unspecified reason|1|||
147241806|NCT00726232|531057743|FG007|Expansion Phase|Unspecified reason|0|||
147241807|NCT01651039|531057744|FG000|Overall Study|Non-evaluables|5|||
147322275|NCT05705167|531343648|FG001|Overall Study|Death|0|||
147322276|NCT05705167|531343649|FG002|Overall Study|Death|3|||
147160262|NCT04863248|530751925|FG001|Overall Study|Sponsor Terminated|1|||
147160263|NCT04863248|530751924|FG000|Overall Study|Death|0|||
147160264|NCT04863248|530751925|FG001|Overall Study|Death|1|||
147587064|NCT00794417|532303352|FG001|Phase 2: Baseline (Day 421) to Day 972|Death|0|||
147587065|NCT00794417|532303353|FG002|Phase 2: Baseline (Day 421) to Day 972|Death|0|||
147587066|NCT00794417|532303354|FG003|Phase 2: Baseline (Day 421) to Day 972|Death|7|||
147587067|NCT00794417|532303351|FG000|Phase 2: Baseline (Day 421) to Day 972|Physician Decision|0|||
147587068|NCT00794417|532303352|FG001|Phase 2: Baseline (Day 421) to Day 972|Physician Decision|0|||
147587069|NCT00794417|532303353|FG002|Phase 2: Baseline (Day 421) to Day 972|Physician Decision|0|||
147587070|NCT00794417|532303354|FG003|Phase 2: Baseline (Day 421) to Day 972|Physician Decision|11|||
147587071|NCT00794417|532303351|FG000|Phase 2: Baseline (Day 421) to Day 972|Withdrawal by Subject|0|||
147587072|NCT00794417|532303352|FG001|Phase 2: Baseline (Day 421) to Day 972|Withdrawal by Subject|0|||
147587073|NCT00794417|532303353|FG002|Phase 2: Baseline (Day 421) to Day 972|Withdrawal by Subject|0|||
147587074|NCT00794417|532303354|FG003|Phase 2: Baseline (Day 421) to Day 972|Withdrawal by Subject|4|||
147587075|NCT00794417|532303351|FG000|Phase 2: Baseline (Day 421) to Day 972|Other unspecified|0|||
147587076|NCT00794417|532303352|FG001|Phase 2: Baseline (Day 421) to Day 972|Other unspecified|0|||
147587077|NCT00794417|532303353|FG002|Phase 2: Baseline (Day 421) to Day 972|Other unspecified|0|||
147587078|NCT00794417|532303354|FG003|Phase 2: Baseline (Day 421) to Day 972|Other unspecified|13|||
147587079|NCT01345318|532303360|FG000|Overall Study|Adverse Event|16|||
147587080|NCT01345318|532303360|FG000|Overall Study|Lack of Efficacy|17|||
147587081|NCT01345318|532303360|FG000|Overall Study|Lost to Follow-up|2|||
147587082|NCT01345318|532303360|FG000|Overall Study|Protocol Violation|1|||
147587083|NCT01345318|532303360|FG000|Overall Study|Withdrawal by Subject|41|||
147587084|NCT01345318|532303360|FG000|Overall Study|Other|3|||
147587085|NCT01239472|532303363|FG000|Overall Study|Withdrawal by Subject|5|||
147587086|NCT01239472|532303364|FG001|Overall Study|Withdrawal by Subject|1|||
147587087|NCT01239472|532303363|FG000|Overall Study|Adverse Event|0|||
147587088|NCT01239472|532303364|FG001|Overall Study|Adverse Event|1|||
147587089|NCT01239472|532303363|FG000|Overall Study|Lack of Efficacy|0|||
147587090|NCT01239472|532303364|FG001|Overall Study|Lack of Efficacy|1|||
147587091|NCT02695719|532303365|FG000|Overall Study|Pretreatment Event/Adverse Event|2|||
147587092|NCT02695719|532303366|FG001|Overall Study|Pretreatment Event/Adverse Event|9|||
147587093|NCT02695719|532303365|FG000|Overall Study|Significant Protocol Deviation|0|||
147587094|NCT02695719|532303366|FG001|Overall Study|Significant Protocol Deviation|1|||
147587095|NCT02695719|532303365|FG000|Overall Study|Voluntary Withdrawal|1|||
147587096|NCT02695719|532303366|FG001|Overall Study|Voluntary Withdrawal|0|||
147587097|NCT01534078|532303369|FG000|Overall Study|Death|1|||
147587098|NCT01534078|532303369|FG000|Overall Study|Withdrawal by Subject|1|||
147587099|NCT01049412|532303370|FG000|Period I|Withdrawal by Subject|4|||
147587100|NCT01049412|532303371|FG001|Period I|Withdrawal by Subject|6|||
147587101|NCT01049412|532303370|FG000|Period I|Lost to Follow-up|2|||
147587102|NCT01049412|532303371|FG001|Period I|Lost to Follow-up|2|||
147587103|NCT01049412|532303370|FG000|Period I|Physician Decision|0|||
147587104|NCT01049412|532303371|FG001|Period I|Physician Decision|3|||
147587105|NCT01049412|532303370|FG000|Period I|Protocol Violation|1|||
147587106|NCT01049412|532303371|FG001|Period I|Protocol Violation|2|||
147587107|NCT01049412|532303370|FG000|Period I|Adverse Event|1|||
147587108|NCT01049412|532303371|FG001|Period I|Adverse Event|0|||
147587109|NCT01049412|532303370|FG000|Period II|Withdrawal by Subject|2|||
147587110|NCT01049412|532303371|FG001|Period II|Withdrawal by Subject|3|||
147587111|NCT01049412|532303370|FG000|Period II|Adverse Event|1|||
147587112|NCT01049412|532303371|FG001|Period II|Adverse Event|0|||
147587113|NCT01049412|532303370|FG000|Period II|Lost to Follow-up|1|||
147587114|NCT01049412|532303371|FG001|Period II|Lost to Follow-up|0|||
147587115|NCT05966090|532303375|FG000|Overall Study|Lost to Follow-up|6|||
147587116|NCT05966090|532303376|FG001|Overall Study|Lost to Follow-up|6|||
147587117|NCT05966090|532303375|FG000|Overall Study|Adverse Event|1|||
147587118|NCT05966090|532303376|FG001|Overall Study|Adverse Event|1|||
147587119|NCT05966090|532303375|FG000|Overall Study|Withdrawal by Subject|1|||
147587120|NCT05966090|532303376|FG001|Overall Study|Withdrawal by Subject|1|||
147587121|NCT05966090|532303375|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
147587122|NCT05966090|532303376|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|1|||
147587123|NCT05966090|532303375|FG000|Overall Study|Other|1|||
147587124|NCT05966090|532303376|FG001|Overall Study|Other|1|||
147587125|NCT00804141|532303377|FG000|Overall Study|Adverse Event|157|||
147587126|NCT00804141|532303377|FG000|Overall Study|Death|4|||
147241808|NCT01651039|531057744|FG000|Overall Study|Physician Decision|2|||
147241809|NCT01651039|531057744|FG000|Overall Study|Withdrawal by Subject|1|||
147241810|NCT01651039|531057744|FG000|Overall Study|Progressive Disease|22|||
147587127|NCT00804141|532303377|FG000|Overall Study|Failed to return|96|||
147654425|NCT02588092|532556719|FG005|Overall Study|Sponsor Decision|0|||
147241811|NCT01488370|531057745|FG000|Overall Study|Protocol Violation|0|||
147241812|NCT01488370|531057746|FG001|Overall Study|Protocol Violation|1|||
147587128|NCT00804141|532303377|FG000|Overall Study|Investigator request|8|||
147587129|NCT00804141|532303377|FG000|Overall Study|Protocol Violation|85|||
147587130|NCT00804141|532303377|FG000|Overall Study|Withdrawal by Subject|131|||
147587131|NCT00804141|532303377|FG000|Overall Study|Lack of Efficacy|46|||
147587132|NCT00804141|532303377|FG000|Overall Study|Other than specified|30|||
147587133|NCT00804141|532303377|FG000|Overall Study|Enrolled but not treated|6|||
147587134|NCT00309985|532303378|FG000|Overall Study|Disease progression|12|||
147587135|NCT00309985|532303379|FG001|Overall Study|Disease progression|0|||
147587136|NCT00309985|532303378|FG000|Overall Study|Adverse Event|30|||
147587137|NCT00309985|532303379|FG001|Overall Study|Adverse Event|0|||
147587138|NCT00309985|532303378|FG000|Overall Study|Death|2|||
147587139|NCT00309985|532303379|FG001|Overall Study|Death|0|||
147587140|NCT00309985|532303378|FG000|Overall Study|Withdrawal by Subject|5|||
147587141|NCT00309985|532303379|FG001|Overall Study|Withdrawal by Subject|1|||
147587142|NCT00309985|532303378|FG000|Overall Study|Physician Decision|3|||
147587143|NCT00309985|532303379|FG001|Overall Study|Physician Decision|0|||
147587144|NCT00309985|532303378|FG000|Overall Study|Never started treatment|7|||
147587145|NCT00309985|532303379|FG001|Overall Study|Never started treatment|0|||
147587146|NCT00309985|532303378|FG000|Overall Study|Complicating disease|1|||
147587147|NCT00309985|532303379|FG001|Overall Study|Complicating disease|0|||
147587148|NCT00309985|532303378|FG000|Overall Study|Non-compliance|1|||
147587149|NCT00309985|532303379|FG001|Overall Study|Non-compliance|0|||
147587150|NCT00309985|532303378|FG000|Overall Study|Chemotherapy discontinued only|1|||
147587151|NCT00309985|532303379|FG001|Overall Study|Chemotherapy discontinued only|0|||
147587152|NCT03110380|532303392|FG000|Double-Blind Treatment Phase|Withdrew Consent|10|||
147587153|NCT03110380|532303393|FG001|Double-Blind Treatment Phase|Withdrew Consent|16|||
147587154|NCT03110380|532303394|FG002|Double-Blind Treatment Phase|Withdrew Consent|0|||
147587155|NCT03110380|532303395|FG003|Double-Blind Treatment Phase|Withdrew Consent|0|||
147587156|NCT03110380|532303392|FG000|Double-Blind Treatment Phase|Lost to Follow-up|4|||
147587157|NCT03110380|532303393|FG001|Double-Blind Treatment Phase|Lost to Follow-up|3|||
147587158|NCT03110380|532303394|FG002|Double-Blind Treatment Phase|Lost to Follow-up|0|||
147587159|NCT03110380|532303395|FG003|Double-Blind Treatment Phase|Lost to Follow-up|0|||
147587160|NCT03110380|532303392|FG000|Double-Blind Treatment Phase|Adverse Event|3|||
147587161|NCT03110380|532303393|FG001|Double-Blind Treatment Phase|Adverse Event|3|||
147587162|NCT03110380|532303394|FG002|Double-Blind Treatment Phase|Adverse Event|0|||
147587163|NCT03110380|532303395|FG003|Double-Blind Treatment Phase|Adverse Event|0|||
147587164|NCT03110380|532303392|FG000|Double-Blind Treatment Phase|Investigator's Discretion|1|||
147241813|NCT01488370|531057747|FG002|Overall Study|Protocol Violation|1|||
147241814|NCT01471171|531057748|FG000|Treatment Period 1|Adverse Event|4|||
147241815|NCT01471171|531057749|FG001|Treatment Period 1|Adverse Event|1|||
147241816|NCT01471171|531057748|FG000|Treatment Period 2|Adverse Event|1|||
147241817|NCT01471171|531057749|FG001|Treatment Period 2|Adverse Event|0|||
147241818|NCT00553644|531057752|FG000|Overall Study|Adverse Event|17|||
147241819|NCT00553644|531057752|FG000|Overall Study|Withdrawal by Subject|4|||
147241820|NCT00553644|531057752|FG000|Overall Study|Physician Decision|1|||
147241821|NCT00553644|531057752|FG000|Overall Study|Alternative therapy|6|||
147241822|NCT00705484|531057753|FG000|Overall Study|Adverse Event|28|||
147241823|NCT00705484|531057754|FG001|Overall Study|Adverse Event|27|||
147241824|NCT00705484|531057753|FG000|Overall Study|Lost to Follow-up|169|||
147241825|NCT00705484|531057754|FG001|Overall Study|Lost to Follow-up|250|||
147241826|NCT00705484|531057753|FG000|Overall Study|Withdrawal by Subject|96|||
147241827|NCT00705484|531057754|FG001|Overall Study|Withdrawal by Subject|72|||
147241828|NCT00705484|531057753|FG000|Overall Study|Administrative|89|||
147241829|NCT00705484|531057754|FG001|Overall Study|Administrative|59|||
147241830|NCT00119106|531057756|FG000|Overall Study|HIV infected at baseline|179|||
147241831|NCT00119106|531057757|FG001|Overall Study|HIV infected at baseline|178|||
147241832|NCT01010061|531057758|FG000|Overall Study|Adverse Events or Intercurrent Illness|33|||
147241833|NCT01010061|531057759|FG001|Overall Study|Adverse Events or Intercurrent Illness|16|||
147241834|NCT01010061|531057758|FG000|Overall Study|Disease Progression|2|||
147241835|NCT01010061|531057759|FG001|Overall Study|Disease Progression|8|||
147241836|NCT01010061|531057758|FG000|Overall Study|Withdrew Consent|5|||
147241837|NCT01010061|531057759|FG001|Overall Study|Withdrew Consent|1|||
147241838|NCT01010061|531057758|FG000|Overall Study|Death|3|||
147241839|NCT01010061|531057759|FG001|Overall Study|Death|6|||
147241840|NCT01010061|531057758|FG000|Overall Study|Administrative/Other|0|||
147322277|NCT05705167|531343650|FG003|Overall Study|Death|0|||
147322278|NCT05705167|531343651|FG004|Overall Study|Death|1|||
147587165|NCT03110380|532303393|FG001|Double-Blind Treatment Phase|Investigator's Discretion|3|||
147587166|NCT03110380|532303394|FG002|Double-Blind Treatment Phase|Investigator's Discretion|0|||
147587167|NCT03110380|532303395|FG003|Double-Blind Treatment Phase|Investigator's Discretion|0|||
147587168|NCT03110380|532303392|FG000|Double-Blind Treatment Phase|Death|2|||
147587169|NCT03110380|532303393|FG001|Double-Blind Treatment Phase|Death|1|||
147241841|NCT01010061|531057759|FG001|Overall Study|Administrative/Other|1|||
147241842|NCT01010061|531057758|FG000|Overall Study|Refused Treatment/Did Not Cooperate|2|||
147241843|NCT01010061|531057759|FG001|Overall Study|Refused Treatment/Did Not Cooperate|0|||
147241844|NCT01010061|531057758|FG000|Overall Study|Insufficient Therapeutic Response|1|||
147322279|NCT05705167|531343652|FG005|Overall Study|Death|1|||
147241845|NCT01010061|531057759|FG001|Overall Study|Insufficient Therapeutic Response|5|||
147241846|NCT01010061|531057758|FG000|Overall Study|Violation of Selection Criteria|0|||
147587170|NCT03110380|532303394|FG002|Double-Blind Treatment Phase|Death|0|||
147587171|NCT03110380|532303395|FG003|Double-Blind Treatment Phase|Death|0|||
147587172|NCT03110380|532303392|FG000|Double-Blind Treatment Phase|Non-Compliance with Study Drug|1|||
147587173|NCT03110380|532303393|FG001|Double-Blind Treatment Phase|Non-Compliance with Study Drug|1|||
147587174|NCT03110380|532303394|FG002|Double-Blind Treatment Phase|Non-Compliance with Study Drug|0|||
147587175|NCT03110380|532303395|FG003|Double-Blind Treatment Phase|Non-Compliance with Study Drug|0|||
147587176|NCT03110380|532303392|FG000|Double-Blind Treatment Phase|Protocol Violation|0|||
147587177|NCT03110380|532303393|FG001|Double-Blind Treatment Phase|Protocol Violation|1|||
147587178|NCT03110380|532303394|FG002|Double-Blind Treatment Phase|Protocol Violation|0|||
147587179|NCT03110380|532303395|FG003|Double-Blind Treatment Phase|Protocol Violation|0|||
147587180|NCT03110380|532303392|FG000|Double-Blind Treatment Phase|Randomized but not Treated|0|||
147587181|NCT03110380|532303393|FG001|Double-Blind Treatment Phase|Randomized but not Treated|2|||
147587182|NCT03110380|532303394|FG002|Double-Blind Treatment Phase|Randomized but not Treated|0|||
147587183|NCT03110380|532303395|FG003|Double-Blind Treatment Phase|Randomized but not Treated|0|||
147587184|NCT03110380|532303392|FG000|Open-label B/F/TAF Extension Phase|Lost to Follow-up|0|||
147587185|NCT03110380|532303393|FG001|Open-label B/F/TAF Extension Phase|Lost to Follow-up|0|||
147587186|NCT03110380|532303394|FG002|Open-label B/F/TAF Extension Phase|Lost to Follow-up|3|||
147587187|NCT03110380|532303395|FG003|Open-label B/F/TAF Extension Phase|Lost to Follow-up|1|||
147587188|NCT03110380|532303392|FG000|Open-label B/F/TAF Extension Phase|Withdrew Consent|0|||
147587189|NCT03110380|532303393|FG001|Open-label B/F/TAF Extension Phase|Withdrew Consent|0|||
147587190|NCT03110380|532303394|FG002|Open-label B/F/TAF Extension Phase|Withdrew Consent|1|||
147587191|NCT03110380|532303395|FG003|Open-label B/F/TAF Extension Phase|Withdrew Consent|1|||
147587192|NCT03110380|532303392|FG000|Open-label B/F/TAF Extension Phase|Adverse Event|0|||
147587193|NCT03110380|532303393|FG001|Open-label B/F/TAF Extension Phase|Adverse Event|0|||
147587194|NCT03110380|532303394|FG002|Open-label B/F/TAF Extension Phase|Adverse Event|0|||
147587195|NCT03110380|532303395|FG003|Open-label B/F/TAF Extension Phase|Adverse Event|1|||
147587196|NCT01546519|532303396|FG000|Overall Study|Adverse Event|0|||
147587197|NCT01546519|532303397|FG001|Overall Study|Adverse Event|0|||
147160265|NCT04863248|530751924|FG000|Overall Study|Withdrawal by Subject|0|||
147160266|NCT04863248|530751925|FG001|Overall Study|Withdrawal by Subject|1|||
147160267|NCT00027378|530751928|FG000|Overall Study|Physician Decision|0|||
147160268|NCT00027378|530751929|FG001|Overall Study|Physician Decision|3|||
147160269|NCT05605691|530751930|FG000|Overall Study|Lost to Follow-up|1|||
147160270|NCT02279719|530751931|FG000|Overall Study|Patients randomized but never treated|0|||
147160271|NCT02279719|530751932|FG001|Overall Study|Patients randomized but never treated|0|||
147160272|NCT02279719|530751933|FG002|Overall Study|Patients randomized but never treated|0|||
147160273|NCT02279719|530751934|FG003|Overall Study|Patients randomized but never treated|0|||
147160274|NCT02279719|530751935|FG004|Overall Study|Patients randomized but never treated|3|||
147160275|NCT02279719|530751936|FG005|Overall Study|Patients randomized but never treated|0|||
147160276|NCT02279719|530751937|FG006|Overall Study|Patients randomized but never treated|3|||
147160277|NCT03541187|530751938|FG000|Overall Study|Lost to Follow-up|2|||
147322280|NCT05705167|531343653|FG006|Overall Study|Death|1|||
147322281|NCT05705167|531343647|FG000|Overall Study|Discontinued Prior to FAS Eligibility|0|||
147322282|NCT05705167|531343648|FG001|Overall Study|Discontinued Prior to FAS Eligibility|0|||
147322283|NCT05705167|531343649|FG002|Overall Study|Discontinued Prior to FAS Eligibility|1|||
147322284|NCT05705167|531343650|FG003|Overall Study|Discontinued Prior to FAS Eligibility|1|||
147322285|NCT05705167|531343651|FG004|Overall Study|Discontinued Prior to FAS Eligibility|0|||
147322286|NCT05705167|531343652|FG005|Overall Study|Discontinued Prior to FAS Eligibility|0|||
147322287|NCT05705167|531343653|FG006|Overall Study|Discontinued Prior to FAS Eligibility|1|||
147322288|NCT04529538|531343654|FG000|Overall Study|Lost to Follow-up|3|||
147322289|NCT04529538|531343655|FG001|Overall Study|Lost to Follow-up|2|||
147322290|NCT04529538|531343656|FG002|Overall Study|Lost to Follow-up|1|||
147322291|NCT04529538|531343657|FG003|Overall Study|Lost to Follow-up|0|||
147322292|NCT04529538|531343658|FG004|Overall Study|Lost to Follow-up|1|||
147322293|NCT04529538|531343659|FG005|Overall Study|Lost to Follow-up|1|||
147322294|NCT04529538|531343660|FG006|Overall Study|Lost to Follow-up|2|||
147322295|NCT04529538|531343661|FG007|Overall Study|Lost to Follow-up|0|||
147322296|NCT04529538|531343654|FG000|Overall Study|Not eligible at enrollment|0|||
147322297|NCT04529538|531343655|FG001|Overall Study|Not eligible at enrollment|1|||
147322298|NCT04529538|531343656|FG002|Overall Study|Not eligible at enrollment|2|||
147322299|NCT04529538|531343657|FG003|Overall Study|Not eligible at enrollment|1|||
147322300|NCT04529538|531343658|FG004|Overall Study|Not eligible at enrollment|0|||
147322301|NCT04529538|531343659|FG005|Overall Study|Not eligible at enrollment|0|||
147587198|NCT01546519|532303398|FG002|Overall Study|Adverse Event|1|||
147587199|NCT01546519|532303399|FG003|Overall Study|Adverse Event|1|||
147587200|NCT01546519|532303396|FG000|Overall Study|Death|0|||
147160278|NCT03541187|530751939|FG001|Overall Study|Lost to Follow-up|6|||
147160279|NCT03541187|530751938|FG000|Overall Study|Pregnancy|0|||
147160280|NCT03541187|530751939|FG001|Overall Study|Pregnancy|1|||
147160281|NCT03541187|530751938|FG000|Overall Study|Withdrawal by Subject|6|||
147160282|NCT03541187|530751939|FG001|Overall Study|Withdrawal by Subject|2|||
147322302|NCT04529538|531343660|FG006|Overall Study|Not eligible at enrollment|0|||
147322303|NCT04529538|531343661|FG007|Overall Study|Not eligible at enrollment|1|||
147322304|NCT04529538|531343654|FG000|Overall Study|Withdrawal by Subject|0|||
147322305|NCT04529538|531343655|FG001|Overall Study|Withdrawal by Subject|1|||
147587201|NCT01546519|532303397|FG001|Overall Study|Death|1|||
147587202|NCT01546519|532303398|FG002|Overall Study|Death|3|||
147587203|NCT01546519|532303399|FG003|Overall Study|Death|1|||
147587204|NCT01546519|532303396|FG000|Overall Study|related to disease progression|2|||
147587205|NCT01546519|532303397|FG001|Overall Study|related to disease progression|2|||
147587206|NCT01546519|532303398|FG002|Overall Study|related to disease progression|2|||
147587207|NCT01546519|532303399|FG003|Overall Study|related to disease progression|1|||
147587208|NCT01546519|532303396|FG000|Overall Study|Physician Decision|6|||
147587209|NCT01546519|532303397|FG001|Overall Study|Physician Decision|5|||
147587210|NCT01546519|532303398|FG002|Overall Study|Physician Decision|2|||
147587211|NCT01546519|532303399|FG003|Overall Study|Physician Decision|3|||
147587212|NCT01546519|532303396|FG000|Overall Study|Withdrawal by Subject|1|||
147587213|NCT01546519|532303397|FG001|Overall Study|Withdrawal by Subject|0|||
147587214|NCT01546519|532303398|FG002|Overall Study|Withdrawal by Subject|0|||
147587215|NCT01546519|532303399|FG003|Overall Study|Withdrawal by Subject|0|||
147587216|NCT01714739|532303400|FG000|Overall Study|Disease progression|3|||
147587217|NCT01714739|532303401|FG001|Overall Study|Disease progression|5|||
147587218|NCT01714739|532303402|FG002|Overall Study|Disease progression|5|||
147587219|NCT01714739|532303403|FG003|Overall Study|Disease progression|204|||
147587220|NCT01714739|532303404|FG004|Overall Study|Disease progression|1|||
147587221|NCT01714739|532303405|FG005|Overall Study|Disease progression|3|||
147587222|NCT01714739|532303406|FG006|Overall Study|Disease progression|5|||
147587223|NCT01714739|532303400|FG000|Overall Study|Study drug toxicity|1|||
147587224|NCT01714739|532303401|FG001|Overall Study|Study drug toxicity|1|||
147587225|NCT01714739|532303402|FG002|Overall Study|Study drug toxicity|1|||
147587226|NCT01714739|532303403|FG003|Overall Study|Study drug toxicity|15|||
147587227|NCT01714739|532303404|FG004|Overall Study|Study drug toxicity|0|||
147587228|NCT01714739|532303405|FG005|Overall Study|Study drug toxicity|0|||
147587229|NCT01714739|532303406|FG006|Overall Study|Study drug toxicity|5|||
147587230|NCT01714739|532303400|FG000|Overall Study|Death|0|||
147160283|NCT03541187|530751938|FG000|Overall Study|Moved out of town|1|||
147160284|NCT03541187|530751939|FG001|Overall Study|Moved out of town|0|||
147160285|NCT03541187|530751938|FG000|Overall Study|>2 bursts of systemic corticosteroids for asthma during treatment period (Starting Nov 2020)|1|||
147160286|NCT03541187|530751939|FG001|Overall Study|>2 bursts of systemic corticosteroids for asthma during treatment period (Starting Nov 2020)|2|||
147160287|NCT03541187|530751938|FG000|Overall Study|Did not meet randomization criteria|1|||
147160288|NCT03541187|530751939|FG001|Overall Study|Did not meet randomization criteria|1|||
147160289|NCT03541187|530751938|FG000|Overall Study|Potential inability to tolerate maintenance dose|1|||
147160290|NCT03541187|530751939|FG001|Overall Study|Potential inability to tolerate maintenance dose|0|||
147160291|NCT03541187|530751938|FG000|Overall Study|Need for dose >500 mcg of fluticasone for 6 months|0|||
147160292|NCT03541187|530751939|FG001|Overall Study|Need for dose >500 mcg of fluticasone for 6 months|1|||
147160293|NCT02701777|530751940|FG000|Overall Study|Some subjects did not like the stimulation.|4|||
147160294|NCT02701777|530751941|FG001|Overall Study|Some subjects did not like the stimulation.|0|||
147160295|NCT02701777|530751942|FG002|Overall Study|Some subjects did not like the stimulation.|0|||
147160296|NCT02701777|530751943|FG003|Overall Study|Some subjects did not like the stimulation.|2|||
147160297|NCT02701777|530751940|FG000|Overall Study|Some subjects were unable to commit to the training study.|0|||
147160298|NCT02701777|530751941|FG001|Overall Study|Some subjects were unable to commit to the training study.|3|||
147160299|NCT02701777|530751942|FG002|Overall Study|Some subjects were unable to commit to the training study.|4|||
147160300|NCT02701777|530751943|FG003|Overall Study|Some subjects were unable to commit to the training study.|0|||
147160301|NCT00869050|530751944|FG000|Overall Study|Screen Failure|3|||
147160302|NCT02098369|530751945|FG000|Overall Study|Withdrawal by Subject|1|||
147160303|NCT02098369|530751946|FG001|Overall Study|Withdrawal by Subject|5|||
147160304|NCT02098369|530751947|FG002|Overall Study|Withdrawal by Subject|0|||
147160305|NCT02098369|530751945|FG000|Overall Study|Lost to Follow-up|5|||
147160306|NCT02098369|530751946|FG001|Overall Study|Lost to Follow-up|1|||
147160307|NCT02098369|530751947|FG002|Overall Study|Lost to Follow-up|3|||
147160308|NCT02098369|530751945|FG000|Overall Study|Death|1|||
147587231|NCT01714739|532303401|FG001|Overall Study|Death|0|||
147587232|NCT01714739|532303402|FG002|Overall Study|Death|0|||
147587233|NCT01714739|532303403|FG003|Overall Study|Death|1|||
147587234|NCT01714739|532303404|FG004|Overall Study|Death|0|||
147587235|NCT01714739|532303405|FG005|Overall Study|Death|0|||
147587236|NCT01714739|532303406|FG006|Overall Study|Death|0|||
147587237|NCT01714739|532303400|FG000|Overall Study|Adverse Event unrelated to drug|0|||
147587238|NCT01714739|532303401|FG001|Overall Study|Adverse Event unrelated to drug|0|||
147587239|NCT01714739|532303402|FG002|Overall Study|Adverse Event unrelated to drug|3|||
147587240|NCT01714739|532303403|FG003|Overall Study|Adverse Event unrelated to drug|21|||
147587241|NCT01714739|532303404|FG004|Overall Study|Adverse Event unrelated to drug|0|||
147160309|NCT02098369|530751946|FG001|Overall Study|Death|1|||
147160310|NCT02098369|530751947|FG002|Overall Study|Death|1|||
147160311|NCT02098369|530751945|FG000|Overall Study|Other|0|||
147587242|NCT01714739|532303405|FG005|Overall Study|Adverse Event unrelated to drug|0|||
147587243|NCT01714739|532303406|FG006|Overall Study|Adverse Event unrelated to drug|0|||
147587244|NCT01714739|532303400|FG000|Overall Study|Participant request to stop therapy|0|||
147587245|NCT01714739|532303401|FG001|Overall Study|Participant request to stop therapy|1|||
147241847|NCT01010061|531057759|FG001|Overall Study|Violation of Selection Criteria|1|||
147241848|NCT01010061|531057758|FG000|Overall Study|Did Not Receive Treatment|2|||
147241849|NCT01010061|531057759|FG001|Overall Study|Did Not Receive Treatment|2|||
147241850|NCT03470441|531057763|FG000|Overall Study|Death|0|||
147241851|NCT03470441|531057764|FG001|Overall Study|Death|1|||
147241852|NCT03470441|531057765|FG002|Overall Study|Death|1|||
147241853|NCT03470441|531057766|FG003|Overall Study|Death|0|||
147241854|NCT03470441|531057763|FG000|Overall Study|Adverse Event|0|||
147241855|NCT03470441|531057764|FG001|Overall Study|Adverse Event|0|||
147241856|NCT03470441|531057765|FG002|Overall Study|Adverse Event|0|||
147241857|NCT03470441|531057766|FG003|Overall Study|Adverse Event|1|||
147241858|NCT03470441|531057763|FG000|Overall Study|Withdrawal by Subject|1|||
147241859|NCT03470441|531057764|FG001|Overall Study|Withdrawal by Subject|4|||
147241860|NCT03470441|531057765|FG002|Overall Study|Withdrawal by Subject|1|||
147160312|NCT02098369|530751946|FG001|Overall Study|Other|2|||
147160313|NCT02098369|530751947|FG002|Overall Study|Other|1|||
147160314|NCT03362931|530751949|FG000|Overall Study|Adverse Event|1|||
147160315|NCT03362931|530751949|FG000|Overall Study|Death|2|||
147160316|NCT02229214|530751953|FG000|Overall Study|Adverse Event|2|||
147160317|NCT02229214|530751954|FG001|Overall Study|Adverse Event|0|||
147160318|NCT02229214|530751953|FG000|Overall Study|Withdrawal by Subject|4|||
147160319|NCT02229214|530751954|FG001|Overall Study|Withdrawal by Subject|0|||
147160320|NCT00246025|530751955|FG000|Overall Study|Adverse Event|7|||
147160321|NCT00246025|530751956|FG001|Overall Study|Adverse Event|9|||
147160322|NCT00246025|530751957|FG002|Overall Study|Adverse Event|9|||
147160323|NCT00246025|530751958|FG003|Overall Study|Adverse Event|10|||
147160324|NCT00246025|530751955|FG000|Overall Study|Withdrawal by Subject|3|||
147160325|NCT00246025|530751956|FG001|Overall Study|Withdrawal by Subject|0|||
147160326|NCT00246025|530751957|FG002|Overall Study|Withdrawal by Subject|1|||
147160327|NCT00246025|530751958|FG003|Overall Study|Withdrawal by Subject|2|||
147160328|NCT00246025|530751955|FG000|Overall Study|unsuitable medical history was found|0|||
147160329|NCT00246025|530751956|FG001|Overall Study|unsuitable medical history was found|0|||
147160330|NCT00246025|530751957|FG002|Overall Study|unsuitable medical history was found|0|||
147160331|NCT00246025|530751958|FG003|Overall Study|unsuitable medical history was found|1|||
147160332|NCT00931723|530751959|FG000|Overall Study|Withdrawal by Subject|11|||
147160333|NCT00931723|530751960|FG001|Overall Study|Withdrawal by Subject|13|||
147160334|NCT00931723|530751959|FG000|Overall Study|Adverse Event|6|||
147160335|NCT00931723|530751960|FG001|Overall Study|Adverse Event|13|||
147160336|NCT00931723|530751959|FG000|Overall Study|Lithium found in blood|0|||
147160337|NCT00931723|530751960|FG001|Overall Study|Lithium found in blood|1|||
147160338|NCT00931723|530751959|FG000|Overall Study|Condition under investigation worsened|1|||
147241861|NCT03470441|531057766|FG003|Overall Study|Withdrawal by Subject|3|||
147241862|NCT01203098|531057770|FG000|Overall Study|Adverse Event|3|||
147241863|NCT01203098|531057771|FG001|Overall Study|Adverse Event|1|||
147241864|NCT01203098|531057772|FG002|Overall Study|Adverse Event|7|||
147241865|NCT01203098|531057770|FG000|Overall Study|Lost to Follow-up|0|||
147241866|NCT01203098|531057771|FG001|Overall Study|Lost to Follow-up|0|||
147241867|NCT01203098|531057772|FG002|Overall Study|Lost to Follow-up|1|||
147241868|NCT01203098|531057770|FG000|Overall Study|Physician Decision|2|||
147241869|NCT01203098|531057771|FG001|Overall Study|Physician Decision|2|||
147241870|NCT01203098|531057772|FG002|Overall Study|Physician Decision|0|||
147241871|NCT01203098|531057770|FG000|Overall Study|Withdrawal by Subject|1|||
147241872|NCT01203098|531057771|FG001|Overall Study|Withdrawal by Subject|1|||
147241873|NCT01203098|531057772|FG002|Overall Study|Withdrawal by Subject|3|||
147241874|NCT03851705|531057777|FG000|Part 1: Double-Blind Period|Withdrawal by Subject|2|||
147241875|NCT03851705|531057778|FG001|Part 1: Double-Blind Period|Withdrawal by Subject|0|||
147241876|NCT03851705|531057779|FG002|Part 1: Double-Blind Period|Withdrawal by Subject|0|||
147241877|NCT03851705|531057780|FG003|Part 1: Double-Blind Period|Withdrawal by Subject|0|||
147322306|NCT04529538|531343656|FG002|Overall Study|Withdrawal by Subject|1|||
147160339|NCT00931723|530751960|FG001|Overall Study|Condition under investigation worsened|2|||
147241878|NCT03851705|531057777|FG000|Part 1: Double-Blind Period|Other reason|1|||
147322307|NCT04529538|531343657|FG003|Overall Study|Withdrawal by Subject|2|||
147322308|NCT04529538|531343658|FG004|Overall Study|Withdrawal by Subject|0|||
147160340|NCT00931723|530751959|FG000|Overall Study|Lost to Follow-up|1|||
147160341|NCT00931723|530751960|FG001|Overall Study|Lost to Follow-up|2|||
147160342|NCT00931723|530751959|FG000|Overall Study|Study-specific discontinuation criteria|1|||
147160343|NCT00931723|530751960|FG001|Overall Study|Study-specific discontinuation criteria|1|||
147160344|NCT00931723|530751959|FG000|Overall Study|Severe non-compliance to protocol|2|||
147160345|NCT00931723|530751960|FG001|Overall Study|Severe non-compliance to protocol|0|||
147160346|NCT00931723|530751959|FG000|Overall Study|Safety reasons|0|||
147241879|NCT03851705|531057778|FG001|Part 1: Double-Blind Period|Other reason|0|||
147241880|NCT03851705|531057779|FG002|Part 1: Double-Blind Period|Other reason|0|||
147241881|NCT03851705|531057780|FG003|Part 1: Double-Blind Period|Other reason|0|||
147241882|NCT03851705|531057777|FG000|Part 2: Open-Label Period|Other reason|0|||
147160347|NCT00931723|530751960|FG001|Overall Study|Safety reasons|1|||
147322309|NCT04529538|531343659|FG005|Overall Study|Withdrawal by Subject|2|||
147322310|NCT04529538|531343660|FG006|Overall Study|Withdrawal by Subject|3|||
147322311|NCT04529538|531343661|FG007|Overall Study|Withdrawal by Subject|0|||
147322312|NCT04529538|531343654|FG000|Overall Study|Other|0|||
147322313|NCT04529538|531343655|FG001|Overall Study|Other|1|||
147322314|NCT04529538|531343656|FG002|Overall Study|Other|0|||
147322315|NCT04529538|531343657|FG003|Overall Study|Other|0|||
147322316|NCT04529538|531343658|FG004|Overall Study|Other|0|||
147322317|NCT04529538|531343659|FG005|Overall Study|Other|0|||
147322318|NCT04529538|531343660|FG006|Overall Study|Other|0|||
147322319|NCT04529538|531343661|FG007|Overall Study|Other|0|||
147654426|NCT02588092|532556720|FG006|Overall Study|Sponsor Decision|0|||
147654427|NCT02588092|532556721|FG007|Overall Study|Sponsor Decision|0|||
147160348|NCT00931723|530751959|FG000|Overall Study|Took prohibited concomitant medication|0|||
147160349|NCT00931723|530751960|FG001|Overall Study|Took prohibited concomitant medication|1|||
147160350|NCT00931723|530751959|FG000|Overall Study|Lack or insufficient theraputic response|2|||
147160351|NCT00931723|530751960|FG001|Overall Study|Lack or insufficient theraputic response|5|||
147160352|NCT00931723|530751959|FG000|Overall Study|Sponsor decision|1|||
147160353|NCT00931723|530751960|FG001|Overall Study|Sponsor decision|0|||
147160354|NCT00931723|530751959|FG000|Overall Study|Late hospital discharge|1|||
147160355|NCT00931723|530751960|FG001|Overall Study|Late hospital discharge|0|||
147160356|NCT01643850|530751963|FG000|Overall Study|Withdrawal by Subject|0|||
147160357|NCT01643850|530751964|FG001|Overall Study|Withdrawal by Subject|0|||
147160358|NCT01643850|530751965|FG002|Overall Study|Withdrawal by Subject|0|||
147160359|NCT01643850|530751966|FG003|Overall Study|Withdrawal by Subject|0|||
147160360|NCT01643850|530751967|FG004|Overall Study|Withdrawal by Subject|1|||
147160361|NCT01643850|530751968|FG005|Overall Study|Withdrawal by Subject|0|||
147160362|NCT01643850|530751969|FG006|Overall Study|Withdrawal by Subject|0|||
147160363|NCT01643850|530751970|FG007|Overall Study|Withdrawal by Subject|0|||
147160364|NCT01643850|530751971|FG008|Overall Study|Withdrawal by Subject|0|||
147160365|NCT01643850|530751963|FG000|Overall Study|Lost to Follow-up|0|||
147160366|NCT01643850|530751964|FG001|Overall Study|Lost to Follow-up|0|||
147160367|NCT01643850|530751965|FG002|Overall Study|Lost to Follow-up|0|||
147160368|NCT01643850|530751966|FG003|Overall Study|Lost to Follow-up|0|||
147160369|NCT01643850|530751967|FG004|Overall Study|Lost to Follow-up|0|||
147160370|NCT01643850|530751968|FG005|Overall Study|Lost to Follow-up|0|||
147160371|NCT01643850|530751969|FG006|Overall Study|Lost to Follow-up|1|||
147160372|NCT01643850|530751970|FG007|Overall Study|Lost to Follow-up|0|||
147160373|NCT01643850|530751971|FG008|Overall Study|Lost to Follow-up|1|||
147160374|NCT01643850|530751963|FG000|Overall Study|Adverse Event|0|||
147160375|NCT01643850|530751964|FG001|Overall Study|Adverse Event|0|||
147160376|NCT01643850|530751965|FG002|Overall Study|Adverse Event|0|||
147160377|NCT01643850|530751966|FG003|Overall Study|Adverse Event|0|||
147160378|NCT01643850|530751967|FG004|Overall Study|Adverse Event|1|||
147160379|NCT01643850|530751968|FG005|Overall Study|Adverse Event|0|||
147160380|NCT01643850|530751969|FG006|Overall Study|Adverse Event|0|||
147160381|NCT01643850|530751970|FG007|Overall Study|Adverse Event|0|||
147160382|NCT01643850|530751971|FG008|Overall Study|Adverse Event|0|||
147160383|NCT01643850|530751963|FG000|Overall Study|Administrative Problems|0|||
147160384|NCT01643850|530751964|FG001|Overall Study|Administrative Problems|0|||
147160385|NCT01643850|530751965|FG002|Overall Study|Administrative Problems|1|||
147160386|NCT01643850|530751966|FG003|Overall Study|Administrative Problems|0|||
147160387|NCT01643850|530751967|FG004|Overall Study|Administrative Problems|1|||
147160388|NCT01643850|530751968|FG005|Overall Study|Administrative Problems|0|||
147160389|NCT01643850|530751969|FG006|Overall Study|Administrative Problems|0|||
147160390|NCT01643850|530751970|FG007|Overall Study|Administrative Problems|0|||
147160391|NCT01643850|530751971|FG008|Overall Study|Administrative Problems|0|||
147160392|NCT03300024|530751972|FG000|Overall Study|Physician Decision|4|||
147160393|NCT03300024|530751973|FG001|Overall Study|Physician Decision|6|||
147160394|NCT03305081|530751974|FG000|Overall Study|Lost to Follow-up|10|||
147160395|NCT03305081|530751975|FG001|Overall Study|Lost to Follow-up|15|||
147160396|NCT00570037|530751976|FG000|Overall Study|Could not reach for 6-8 week contact|44|||
147322320|NCT04529538|531343654|FG000|Overall Study|Adverse Event|0|||
147322321|NCT04529538|531343655|FG001|Overall Study|Adverse Event|0|||
147322322|NCT04529538|531343656|FG002|Overall Study|Adverse Event|0|||
147160397|NCT00570037|530751977|FG001|Overall Study|Could not reach for 6-8 week contact|69|||
147160398|NCT00554619|530751978|FG000|Overall Study|Adverse Event|1|||
147160399|NCT00554619|530751978|FG000|Overall Study|Physician Decision|1|||
147160400|NCT00554619|530751978|FG000|Overall Study|Liver Function Test Abnormality|1|||
147160401|NCT01571284|530751979|FG000|Overall Study|Participant's decision|84|||
147160402|NCT01571284|530751979|FG000|Overall Study|Lost to Follow-up|3|||
147322323|NCT04529538|531343657|FG003|Overall Study|Adverse Event|1|||
147322324|NCT04529538|531343658|FG004|Overall Study|Adverse Event|0|||
147654428|NCT02588092|532556722|FG008|Overall Study|Sponsor Decision|1|||
147160403|NCT01571284|530751979|FG000|Overall Study|Enrolled but not treated|2|||
147322325|NCT04529538|531343659|FG005|Overall Study|Adverse Event|0|||
147322326|NCT04529538|531343660|FG006|Overall Study|Adverse Event|0|||
147322327|NCT04529538|531343661|FG007|Overall Study|Adverse Event|0|||
147322328|NCT04529538|531343654|FG000|Overall Study|Protocol Deviation|0|||
147160404|NCT01571284|530751979|FG000|Overall Study|Other than specified above|80|||
147160405|NCT04677660|530751980|FG000|Overall Study|Lost to Follow-up|0|||
147160406|NCT04677660|530751981|FG001|Overall Study|Lost to Follow-up|2|||
147160407|NCT04677660|530751980|FG000|Overall Study|Withdrawal by Subject|0|||
147160408|NCT04677660|530751981|FG001|Overall Study|Withdrawal by Subject|1|||
147160409|NCT04677660|530751980|FG000|Overall Study|Chose Publicly Available Vaccine|43|||
147160410|NCT04677660|530751981|FG001|Overall Study|Chose Publicly Available Vaccine|10|||
147160411|NCT04065074|530751982|FG000|Overall Study|Adverse Event|1|||
147160412|NCT04065074|530751982|FG000|Overall Study|Protocol Non-Compliance after injection|1|||
147160413|NCT01218100|530751983|FG000|Overall Study|Did not meet InclusionExclusion criteria|1|||
147160414|NCT01218100|530751984|FG001|Overall Study|Did not meet InclusionExclusion criteria|1|||
147160415|NCT01218100|530751985|FG002|Overall Study|Did not meet InclusionExclusion criteria|1|||
147160416|NCT01218100|530751986|FG003|Overall Study|Did not meet InclusionExclusion criteria|2|||
147160417|NCT01218100|530751983|FG000|Overall Study|Adverse Event|4|||
147160418|NCT01218100|530751984|FG001|Overall Study|Adverse Event|6|||
147160419|NCT01218100|530751985|FG002|Overall Study|Adverse Event|6|||
147160420|NCT01218100|530751986|FG003|Overall Study|Adverse Event|7|||
147160421|NCT01218100|530751983|FG000|Overall Study|Lack of Efficacy|9|||
147160422|NCT01218100|530751984|FG001|Overall Study|Lack of Efficacy|6|||
147160423|NCT01218100|530751985|FG002|Overall Study|Lack of Efficacy|5|||
147160424|NCT01218100|530751986|FG003|Overall Study|Lack of Efficacy|12|||
147160425|NCT01218100|530751983|FG000|Overall Study|Protocol Violation|0|||
147160426|NCT01218100|530751984|FG001|Overall Study|Protocol Violation|0|||
147160427|NCT01218100|530751985|FG002|Overall Study|Protocol Violation|1|||
147160428|NCT01218100|530751986|FG003|Overall Study|Protocol Violation|1|||
147160429|NCT01218100|530751983|FG000|Overall Study|Withdrawal by Subject|5|||
147160430|NCT01218100|530751984|FG001|Overall Study|Withdrawal by Subject|2|||
147160431|NCT01218100|530751985|FG002|Overall Study|Withdrawal by Subject|6|||
147160432|NCT01218100|530751986|FG003|Overall Study|Withdrawal by Subject|7|||
147160433|NCT01218100|530751983|FG000|Overall Study|Lost to Follow-up|3|||
147160434|NCT01218100|530751984|FG001|Overall Study|Lost to Follow-up|8|||
147160435|NCT01218100|530751985|FG002|Overall Study|Lost to Follow-up|2|||
147160436|NCT01218100|530751986|FG003|Overall Study|Lost to Follow-up|1|||
147160437|NCT01218100|530751983|FG000|Overall Study|Other Reason|2|||
147160438|NCT01218100|530751984|FG001|Overall Study|Other Reason|2|||
147160439|NCT01218100|530751985|FG002|Overall Study|Other Reason|6|||
147160440|NCT01218100|530751986|FG003|Overall Study|Other Reason|4|||
147160441|NCT01118520|530751989|FG000|Overall Study|AAA repair|9|||
147587246|NCT01714739|532303402|FG002|Overall Study|Participant request to stop therapy|0|||
147587247|NCT01714739|532303403|FG003|Overall Study|Participant request to stop therapy|6|||
147160442|NCT01118520|530751990|FG001|Overall Study|AAA repair|7|||
147160443|NCT01118520|530751991|FG002|Overall Study|AAA repair|9|||
147160444|NCT01118520|530751989|FG000|Overall Study|Adverse Event|3|||
147160445|NCT01118520|530751990|FG001|Overall Study|Adverse Event|3|||
147160446|NCT01118520|530751991|FG002|Overall Study|Adverse Event|3|||
147160447|NCT01118520|530751989|FG000|Overall Study|Withdrawal by Subject|8|||
147160448|NCT01118520|530751990|FG001|Overall Study|Withdrawal by Subject|13|||
147160449|NCT01118520|530751991|FG002|Overall Study|Withdrawal by Subject|8|||
147160450|NCT01089023|530751992|FG000|Overall Study|Lost to Follow-up|3|||
147160451|NCT01089023|530751992|FG000|Overall Study|Adverse Event|1|||
147160452|NCT01089023|530751992|FG000|Overall Study|Withdrawal by Subject|1|||
147160453|NCT01089023|530751992|FG000|Overall Study|Protocol Violation|1|||
147160454|NCT01089023|530751992|FG000|Overall Study|Lack of Efficacy|1|||
147160455|NCT03883113|530751997|FG000|Overall Study|Physician Decision|4|||
147160456|NCT03883113|530751998|FG001|Overall Study|Physician Decision|2|||
147160457|NCT03883113|530751997|FG000|Overall Study|Challenge Criteria Not Met / Sponsor Decision|9|||
147160458|NCT03883113|530751998|FG001|Overall Study|Challenge Criteria Not Met / Sponsor Decision|7|||
147160459|NCT03883113|530751997|FG000|Overall Study|Pregnancy|1|||
147587248|NCT01714739|532303404|FG004|Overall Study|Participant request to stop therapy|0|||
147587249|NCT01714739|532303405|FG005|Overall Study|Participant request to stop therapy|0|||
147587250|NCT01714739|532303406|FG006|Overall Study|Participant request to stop therapy|0|||
147587251|NCT01714739|532303400|FG000|Overall Study|Participant withdrew consent|0|||
147587252|NCT01714739|532303401|FG001|Overall Study|Participant withdrew consent|1|||
147587253|NCT01714739|532303402|FG002|Overall Study|Participant withdrew consent|0|||
147160460|NCT03883113|530751998|FG001|Overall Study|Pregnancy|0|||
147160461|NCT03883113|530751997|FG000|Overall Study|Adverse Event|0|||
147160462|NCT03883113|530751998|FG001|Overall Study|Adverse Event|1|||
147160463|NCT03883113|530751997|FG000|Overall Study|Withdrawal by Subject|1|||
147160464|NCT03883113|530751998|FG001|Overall Study|Withdrawal by Subject|2|||
147160465|NCT03883113|530751997|FG000|Overall Study|Lost to Follow-up|1|||
147160466|NCT03883113|530751998|FG001|Overall Study|Lost to Follow-up|0|||
147160467|NCT04465877|530751999|FG000|Overall Study|Noncompliant with study requirements|0|||
147160468|NCT04465877|530752000|FG001|Overall Study|Noncompliant with study requirements|0|||
147160469|NCT04465877|530752001|FG002|Overall Study|Noncompliant with study requirements|1|||
147587254|NCT01714739|532303403|FG003|Overall Study|Participant withdrew consent|8|||
147160470|NCT04465877|530752002|FG003|Overall Study|Noncompliant with study requirements|0|||
147160471|NCT04962230|530752008|FG000|Carbamazepine+PF-07321332/Ritonavir|Withdrawal by Subject|1|||
147160472|NCT04962230|530752008|FG000|Carbamazepine+PF-07321332/Ritonavir|Adverse Event|1|||
147160473|NCT01598753|530752009|FG000|Overall Study|Adverse Event|1|||
147160474|NCT01598753|530752010|FG001|Overall Study|Adverse Event|9|||
147160475|NCT01598753|530752011|FG002|Overall Study|Adverse Event|1|||
147160476|NCT01598753|530752012|FG003|Overall Study|Adverse Event|7|||
147160477|NCT01598753|530752009|FG000|Overall Study|Lost to Follow-up|4|||
147160478|NCT01598753|530752010|FG001|Overall Study|Lost to Follow-up|3|||
147160479|NCT01598753|530752011|FG002|Overall Study|Lost to Follow-up|7|||
147160480|NCT01598753|530752012|FG003|Overall Study|Lost to Follow-up|5|||
147160481|NCT01598753|530752009|FG000|Overall Study|Physician Decision|0|||
147160482|NCT01598753|530752010|FG001|Overall Study|Physician Decision|1|||
147160483|NCT01598753|530752011|FG002|Overall Study|Physician Decision|0|||
147160484|NCT01598753|530752012|FG003|Overall Study|Physician Decision|2|||
147160485|NCT01598753|530752009|FG000|Overall Study|Withdrawal by Subject|7|||
147160486|NCT01598753|530752010|FG001|Overall Study|Withdrawal by Subject|2|||
147160487|NCT01598753|530752011|FG002|Overall Study|Withdrawal by Subject|0|||
147160488|NCT01598753|530752012|FG003|Overall Study|Withdrawal by Subject|1|||
147160489|NCT02275117|530752013|FG000|Overall Study|Adverse Event|0|||
147160490|NCT02275117|530752014|FG001|Overall Study|Adverse Event|0|||
147160491|NCT02275117|530752015|FG002|Overall Study|Adverse Event|0|||
147160492|NCT02275117|530752016|FG003|Overall Study|Adverse Event|0|||
147160493|NCT02275117|530752017|FG004|Overall Study|Adverse Event|1|||
147160494|NCT02275117|530752013|FG000|Overall Study|Lack of Efficacy|6|||
147160495|NCT02275117|530752014|FG001|Overall Study|Lack of Efficacy|7|||
147160496|NCT02275117|530752015|FG002|Overall Study|Lack of Efficacy|5|||
147160497|NCT02275117|530752016|FG003|Overall Study|Lack of Efficacy|2|||
147160498|NCT02275117|530752017|FG004|Overall Study|Lack of Efficacy|10|||
147160499|NCT02275117|530752013|FG000|Overall Study|Lost to Follow-up|11|||
147160500|NCT02275117|530752014|FG001|Overall Study|Lost to Follow-up|16|||
147160501|NCT02275117|530752015|FG002|Overall Study|Lost to Follow-up|15|||
147160502|NCT02275117|530752016|FG003|Overall Study|Lost to Follow-up|16|||
147160503|NCT02275117|530752017|FG004|Overall Study|Lost to Follow-up|8|||
147160504|NCT02275117|530752013|FG000|Overall Study|Physician Decision|0|||
147160505|NCT02275117|530752014|FG001|Overall Study|Physician Decision|1|||
147160506|NCT02275117|530752015|FG002|Overall Study|Physician Decision|1|||
147160507|NCT02275117|530752016|FG003|Overall Study|Physician Decision|0|||
147160508|NCT02275117|530752017|FG004|Overall Study|Physician Decision|1|||
147160509|NCT02275117|530752013|FG000|Overall Study|Protocol Violation|1|||
147160510|NCT02275117|530752014|FG001|Overall Study|Protocol Violation|0|||
147160511|NCT02275117|530752015|FG002|Overall Study|Protocol Violation|1|||
147160512|NCT02275117|530752016|FG003|Overall Study|Protocol Violation|1|||
147160513|NCT02275117|530752017|FG004|Overall Study|Protocol Violation|0|||
147160514|NCT02275117|530752013|FG000|Overall Study|Withdrawal by Subject|6|||
147160515|NCT02275117|530752014|FG001|Overall Study|Withdrawal by Subject|4|||
147160516|NCT02275117|530752015|FG002|Overall Study|Withdrawal by Subject|7|||
147160517|NCT02275117|530752016|FG003|Overall Study|Withdrawal by Subject|3|||
147160518|NCT02275117|530752017|FG004|Overall Study|Withdrawal by Subject|3|||
147160519|NCT02275117|530752013|FG000|Overall Study|Terminated by Sponsor|4|||
147160520|NCT02275117|530752014|FG001|Overall Study|Terminated by Sponsor|4|||
147160521|NCT02275117|530752015|FG002|Overall Study|Terminated by Sponsor|4|||
147160522|NCT02275117|530752016|FG003|Overall Study|Terminated by Sponsor|6|||
147160523|NCT02275117|530752017|FG004|Overall Study|Terminated by Sponsor|4|||
147160524|NCT02275117|530752013|FG000|Overall Study|Worsening of Study Indication|0|||
147587255|NCT01714739|532303404|FG004|Overall Study|Participant withdrew consent|0|||
147587256|NCT01714739|532303405|FG005|Overall Study|Participant withdrew consent|0|||
147587257|NCT01714739|532303406|FG006|Overall Study|Participant withdrew consent|0|||
147587258|NCT01714739|532303400|FG000|Overall Study|Lost to Follow-up|0|||
147587259|NCT01714739|532303401|FG001|Overall Study|Lost to Follow-up|0|||
147587260|NCT01714739|532303402|FG002|Overall Study|Lost to Follow-up|0|||
147587261|NCT01714739|532303403|FG003|Overall Study|Lost to Follow-up|1|||
147587262|NCT01714739|532303404|FG004|Overall Study|Lost to Follow-up|0|||
147587263|NCT01714739|532303405|FG005|Overall Study|Lost to Follow-up|0|||
147587264|NCT01714739|532303406|FG006|Overall Study|Lost to Follow-up|0|||
147587265|NCT01714739|532303400|FG000|Overall Study|Maximum clinical benefit|0|||
147160525|NCT02275117|530752014|FG001|Overall Study|Worsening of Study Indication|1|||
147160526|NCT02275117|530752015|FG002|Overall Study|Worsening of Study Indication|2|||
147160527|NCT02275117|530752016|FG003|Overall Study|Worsening of Study Indication|0|||
147160528|NCT02275117|530752017|FG004|Overall Study|Worsening of Study Indication|0|||
147160529|NCT02275117|530752013|FG000|Overall Study|Study Burden|5|||
147587266|NCT01714739|532303401|FG001|Overall Study|Maximum clinical benefit|1|||
147160530|NCT02275117|530752014|FG001|Overall Study|Study Burden|4|||
147160531|NCT02275117|530752015|FG002|Overall Study|Study Burden|7|||
147160532|NCT02275117|530752016|FG003|Overall Study|Study Burden|5|||
147160533|NCT02275117|530752017|FG004|Overall Study|Study Burden|7|||
147160534|NCT02275117|530752013|FG000|Overall Study|Other|1|||
147160535|NCT02275117|530752014|FG001|Overall Study|Other|0|||
147160536|NCT02275117|530752015|FG002|Overall Study|Other|0|||
147160537|NCT02275117|530752016|FG003|Overall Study|Other|0|||
147160538|NCT02275117|530752017|FG004|Overall Study|Other|2|||
147160539|NCT02142283|530752021|FG000|Overall Study|Death|20|||
147160540|NCT02142283|530752022|FG001|Overall Study|Death|18|||
147160541|NCT02142283|530752021|FG000|Overall Study|Withdrawal by Subject|1|||
147160542|NCT02142283|530752022|FG001|Overall Study|Withdrawal by Subject|3|||
147160543|NCT02374814|530752023|FG000|Overall Study|Lost to Follow-up|1|||
147160544|NCT02374814|530752024|FG001|Overall Study|Lost to Follow-up|1|||
147160545|NCT02374814|530752025|FG002|Overall Study|Lost to Follow-up|0|||
147587267|NCT01714739|532303402|FG002|Overall Study|Maximum clinical benefit|1|||
147160546|NCT02374814|530752026|FG003|Overall Study|Lost to Follow-up|1|||
147160547|NCT02374814|530752027|FG004|Overall Study|Lost to Follow-up|0|||
147160548|NCT02374814|530752028|FG005|Overall Study|Lost to Follow-up|0|||
147160549|NCT02374814|530752023|FG000|Overall Study|Withdrawal by Subject|0|||
147160550|NCT02374814|530752024|FG001|Overall Study|Withdrawal by Subject|0|||
147160551|NCT02374814|530752025|FG002|Overall Study|Withdrawal by Subject|1|||
147160552|NCT02374814|530752026|FG003|Overall Study|Withdrawal by Subject|1|||
147160553|NCT02374814|530752027|FG004|Overall Study|Withdrawal by Subject|0|||
147160554|NCT02374814|530752028|FG005|Overall Study|Withdrawal by Subject|0|||
147160555|NCT03093974|530752029|FG000|Overall Study|Withdrawal by Subject|32|||
147160556|NCT03093974|530752030|FG001|Overall Study|Withdrawal by Subject|27|||
147160557|NCT03093974|530752029|FG000|Overall Study|Adverse Event|17|||
147160558|NCT03093974|530752030|FG001|Overall Study|Adverse Event|24|||
147241883|NCT03851705|531057778|FG001|Part 2: Open-Label Period|Other reason|0|||
147241884|NCT03851705|531057779|FG002|Part 2: Open-Label Period|Other reason|0|||
147241885|NCT03851705|531057780|FG003|Part 2: Open-Label Period|Other reason|1|||
147241886|NCT03851705|531057777|FG000|Part 2: Open-Label Period|Death|0|||
147241887|NCT03851705|531057778|FG001|Part 2: Open-Label Period|Death|0|||
147241888|NCT03851705|531057779|FG002|Part 2: Open-Label Period|Death|3|||
147241889|NCT03851705|531057780|FG003|Part 2: Open-Label Period|Death|0|||
147241890|NCT03851705|531057777|FG000|Part 2: Open-Label Period|Withdrawal by Subject|0|||
147241891|NCT03851705|531057778|FG001|Part 2: Open-Label Period|Withdrawal by Subject|0|||
147241892|NCT03851705|531057779|FG002|Part 2: Open-Label Period|Withdrawal by Subject|2|||
147241893|NCT03851705|531057780|FG003|Part 2: Open-Label Period|Withdrawal by Subject|0|||
147241894|NCT00621582|531057784|FG000|Overall Study|Adverse Event|7|||
147241895|NCT00621582|531057784|FG000|Overall Study|Protocol Violation|57|||
147241896|NCT00621582|531057784|FG000|Overall Study|Lost to Follow-up|24|||
147241897|NCT00621582|531057784|FG000|Overall Study|issues not identified by investigators|18|||
147241898|NCT01387932|531057786|FG000|Randomized and Treated|Physician Decision|3|||
147241899|NCT01387932|531057787|FG001|Randomized and Treated|Physician Decision|2|||
147241900|NCT01387932|531057786|FG000|Randomized and Treated|Withdrawal by Subject|4|||
147241901|NCT01387932|531057787|FG001|Randomized and Treated|Withdrawal by Subject|2|||
147241902|NCT01387932|531057786|FG000|Survival Follow-up|Liver Transplant|24|||
147241903|NCT01387932|531057787|FG001|Survival Follow-up|Liver Transplant|28|||
147241904|NCT01387932|531057786|FG000|Survival Follow-up|Additional treatment excluding liver transplant|52|||
147241905|NCT01387932|531057787|FG001|Survival Follow-up|Additional treatment excluding liver transplant|53|||
147241906|NCT01387932|531057786|FG000|Survival Follow-up|Withdrawal by Subject|2|||
147241907|NCT01387932|531057787|FG001|Survival Follow-up|Withdrawal by Subject|4|||
147241908|NCT01387932|531057786|FG000|Survival Follow-up|Lost to Follow-up|6|||
147241909|NCT01387932|531057787|FG001|Survival Follow-up|Lost to Follow-up|5|||
147241910|NCT02591290|531057788|FG000|Overall Study|Withdrawal by Subject|2|||
147241911|NCT02571075|531057789|FG000|Overall Study|Lost to Follow-up|20|||
147241912|NCT02571075|531057790|FG001|Overall Study|Lost to Follow-up|24|||
147241913|NCT01306942|531057796|FG000|Phase I|Adverse Event|2|||
147241914|NCT01306942|531057797|FG001|Phase I|Adverse Event|2|||
147241915|NCT01306942|531057798|FG002|Phase I|Adverse Event|0|||
147241916|NCT01306942|531057799|FG003|Phase I|Adverse Event|0|||
147241917|NCT01306942|531057796|FG000|Phase I|Physician Decision|3|||
147241918|NCT01306942|531057797|FG001|Phase I|Physician Decision|1|||
147241919|NCT01306942|531057798|FG002|Phase I|Physician Decision|0|||
147241920|NCT01306942|531057799|FG003|Phase I|Physician Decision|0|||
147241921|NCT01306942|531057796|FG000|Phase II|Adverse Event|0|||
147241922|NCT01306942|531057797|FG001|Phase II|Adverse Event|0|||
147241923|NCT01306942|531057798|FG002|Phase II|Adverse Event|0|||
147587268|NCT01714739|532303403|FG003|Overall Study|Maximum clinical benefit|3|||
147587269|NCT01714739|532303404|FG004|Overall Study|Maximum clinical benefit|0|||
147587270|NCT01714739|532303405|FG005|Overall Study|Maximum clinical benefit|0|||
147241924|NCT01306942|531057799|FG003|Phase II|Adverse Event|6|||
147241925|NCT01306942|531057796|FG000|Phase II|Physician Decision|2|||
147160559|NCT03093974|530752029|FG000|Overall Study|Death|0|||
147241926|NCT01306942|531057797|FG001|Phase II|Physician Decision|0|||
147241927|NCT01306942|531057798|FG002|Phase II|Physician Decision|0|||
147160560|NCT03093974|530752030|FG001|Overall Study|Death|1|||
147160561|NCT03093974|530752029|FG000|Overall Study|Non-Compliance with Study Drug|1|||
147160562|NCT03093974|530752030|FG001|Overall Study|Non-Compliance with Study Drug|0|||
147241928|NCT01306942|531057799|FG003|Phase II|Physician Decision|5|||
147241929|NCT01306942|531057796|FG000|Phase II|Withdrawal by Subject|0|||
147241930|NCT01306942|531057797|FG001|Phase II|Withdrawal by Subject|0|||
147587271|NCT01714739|532303406|FG006|Overall Study|Maximum clinical benefit|0|||
147587272|NCT01714739|532303400|FG000|Overall Study|Poor/non-comliance|0|||
147587273|NCT01714739|532303401|FG001|Overall Study|Poor/non-comliance|1|||
147587274|NCT01714739|532303402|FG002|Overall Study|Poor/non-comliance|0|||
147160563|NCT03093974|530752029|FG000|Overall Study|Protocol-Specified withdrawal criterion met|3|||
147160564|NCT03093974|530752030|FG001|Overall Study|Protocol-Specified withdrawal criterion met|16|||
147160565|NCT03093974|530752029|FG000|Overall Study|Lost to Follow-up|0|||
147160566|NCT03093974|530752030|FG001|Overall Study|Lost to Follow-up|1|||
147160567|NCT03093974|530752029|FG000|Overall Study|Other|1|||
147160568|NCT03093974|530752030|FG001|Overall Study|Other|2|||
147160569|NCT02141490|530752031|FG000|Overall Study|Screening failures|4|||
147160570|NCT02141490|530752032|FG001|Overall Study|Screening failures|0|||
147160571|NCT02141490|530752033|FG002|Overall Study|Screening failures|0|||
147160572|NCT00033540|530752036|FG000|Overall Study|Adverse Event|14|||
147160573|NCT00033540|530752036|FG000|Overall Study|Death|1|||
147160574|NCT00033540|530752036|FG000|Overall Study|Progression|26|||
147160575|NCT00033540|530752036|FG000|Overall Study|Withdrawal by Subject|6|||
147160576|NCT00033540|530752036|FG000|Overall Study|Other|5|||
147160577|NCT00033540|530752036|FG000|Overall Study|Ineligible|3|||
147160578|NCT00033540|530752036|FG000|Overall Study|Never received treatment|2|||
147160579|NCT01253265|530752039|FG000|Overall Study|Met Predefined Discontinuation Criteria|1|||
147160580|NCT01253265|530752040|FG001|Overall Study|Met Predefined Discontinuation Criteria|0|||
147160581|NCT01253265|530752041|FG002|Overall Study|Met Predefined Discontinuation Criteria|0|||
147160582|NCT01253265|530752042|FG003|Overall Study|Met Predefined Discontinuation Criteria|0|||
147160583|NCT01253265|530752043|FG004|Overall Study|Met Predefined Discontinuation Criteria|0|||
147160584|NCT01253265|530752039|FG000|Overall Study|Withdrawal by Subject|0|||
147160585|NCT01253265|530752040|FG001|Overall Study|Withdrawal by Subject|0|||
147160586|NCT01253265|530752041|FG002|Overall Study|Withdrawal by Subject|0|||
147160587|NCT01253265|530752042|FG003|Overall Study|Withdrawal by Subject|0|||
147160588|NCT01253265|530752043|FG004|Overall Study|Withdrawal by Subject|1|||
147160589|NCT00434759|530752046|FG000|Overall Study|Lack of Efficacy|5|||
147160590|NCT00434759|530752047|FG001|Overall Study|Lack of Efficacy|4|||
147160591|NCT00434759|530752046|FG000|Overall Study|Withdrawal by Subject|17|||
147160592|NCT00434759|530752047|FG001|Overall Study|Withdrawal by Subject|1|||
147160593|NCT00434759|530752046|FG000|Overall Study|family affairs|2|||
147160594|NCT00434759|530752047|FG001|Overall Study|family affairs|0|||
147160595|NCT00495521|530752048|FG000|Overall Study|Physician Decision|0|||
147160596|NCT00495521|530752049|FG001|Overall Study|Physician Decision|1|||
147160597|NCT02410824|530752050|FG000|First Intervention (One Week)|Headache|0|||
147160598|NCT02410824|530752051|FG001|First Intervention (One Week)|Headache|1|||
147160599|NCT02782325|530752052|FG000|Blinded FMT Treatment (up to 24 Weeks)|Lack of Efficacy|4|||
147160600|NCT02782325|530752053|FG001|Blinded FMT Treatment (up to 24 Weeks)|Lack of Efficacy|2|||
147160601|NCT02782325|530752054|FG002|Blinded FMT Treatment (up to 24 Weeks)|Lack of Efficacy|0|||
147160602|NCT02782325|530752052|FG000|Open Label FMT Period (up to 24 Weeks)|Lack of Efficacy|0|||
147160603|NCT02782325|530752053|FG001|Open Label FMT Period (up to 24 Weeks)|Lack of Efficacy|0|||
147160604|NCT02782325|530752054|FG002|Open Label FMT Period (up to 24 Weeks)|Lack of Efficacy|4|||
147160605|NCT01038713|530752055|FG000|Overall Study|Patient to hospice|1|||
147160606|NCT01038713|530752056|FG001|Overall Study|Patient to hospice|1|||
147160607|NCT01038713|530752057|FG002|Overall Study|Patient to hospice|1|||
147160608|NCT01038713|530752055|FG000|Overall Study|Lost to Follow-up|3|||
147160609|NCT01038713|530752056|FG001|Overall Study|Lost to Follow-up|0|||
147160610|NCT01038713|530752057|FG002|Overall Study|Lost to Follow-up|0|||
147160611|NCT01038713|530752055|FG000|Overall Study|Neuroendocrine Tumor|0|||
147160612|NCT01038713|530752056|FG001|Overall Study|Neuroendocrine Tumor|1|||
147160613|NCT01038713|530752057|FG002|Overall Study|Neuroendocrine Tumor|0|||
147160614|NCT01038713|530752055|FG000|Overall Study|died from PEP|0|||
147160615|NCT01038713|530752056|FG001|Overall Study|died from PEP|1|||
147160616|NCT01038713|530752057|FG002|Overall Study|died from PEP|0|||
147160617|NCT01038713|530752055|FG000|Overall Study|Autoimmune Pancreatitis|1|||
147160618|NCT01038713|530752056|FG001|Overall Study|Autoimmune Pancreatitis|0|||
147587275|NCT01714739|532303403|FG003|Overall Study|Poor/non-comliance|1|||
147587276|NCT01714739|532303404|FG004|Overall Study|Poor/non-comliance|0|||
147160619|NCT01038713|530752057|FG002|Overall Study|Autoimmune Pancreatitis|0|||
147160620|NCT03777917|530752058|FG000|Overall Study|Withdrawal by Subject|1|||
147160621|NCT03777917|530752059|FG001|Overall Study|Withdrawal by Subject|0|||
147160622|NCT03777917|530752058|FG000|Overall Study|Physician Decision|1|||
147160623|NCT03777917|530752059|FG001|Overall Study|Physician Decision|0|||
147160624|NCT03777917|530752058|FG000|Overall Study|Lost to Follow-up|6|||
147160625|NCT03777917|530752059|FG001|Overall Study|Lost to Follow-up|2|||
147160626|NCT03777917|530752058|FG000|Overall Study|Other|1|||
147160627|NCT03777917|530752059|FG001|Overall Study|Other|0|||
147160628|NCT00930969|530752060|FG000|Overall Study|Death|5|||
147160629|NCT00930969|530752060|FG000|Overall Study|Lost to Follow-up|1|||
147160630|NCT00930969|530752060|FG000|Overall Study|Physician Decision|13|||
147160631|NCT00930969|530752060|FG000|Overall Study|Withdrawal by Subject|19|||
147587277|NCT01714739|532303405|FG005|Overall Study|Poor/non-comliance|0|||
147587278|NCT01714739|532303406|FG006|Overall Study|Poor/non-comliance|0|||
147322329|NCT04529538|531343655|FG001|Overall Study|Protocol Deviation|0|||
147587279|NCT01714739|532303400|FG000|Overall Study|No longer meets study criteria|0|||
147587280|NCT01714739|532303401|FG001|Overall Study|No longer meets study criteria|0|||
147160632|NCT00657150|530752061|FG000|Overall Study|Adverse Event|19|||
147160633|NCT00657150|530752062|FG001|Overall Study|Adverse Event|10|||
147160634|NCT00657150|530752061|FG000|Overall Study|Non-compliant with protocol|5|||
147160635|NCT00657150|530752062|FG001|Overall Study|Non-compliant with protocol|9|||
147160636|NCT00657150|530752061|FG000|Overall Study|Lost to Follow-up|2|||
147160637|NCT00657150|530752062|FG001|Overall Study|Lost to Follow-up|0|||
147160638|NCT00657150|530752061|FG000|Overall Study|Withdrawal by Subject|51|||
147160639|NCT00657150|530752062|FG001|Overall Study|Withdrawal by Subject|36|||
147160640|NCT00657150|530752061|FG000|Overall Study|Other|38|||
147160641|NCT00657150|530752062|FG001|Overall Study|Other|38|||
147160642|NCT00657150|530752061|FG000|Treatment|Adverse Event|60|||
147160643|NCT00657150|530752062|FG001|Treatment|Adverse Event|53|||
147160644|NCT00657150|530752061|FG000|Treatment|Non-compliant with protocol|10|||
147160645|NCT00657150|530752062|FG001|Treatment|Non-compliant with protocol|9|||
147160646|NCT00657150|530752061|FG000|Treatment|Lost to Follow-up|1|||
147241931|NCT01306942|531057798|FG002|Phase II|Withdrawal by Subject|0|||
147241932|NCT01306942|531057799|FG003|Phase II|Withdrawal by Subject|2|||
147241933|NCT01306942|531057796|FG000|Phase II|Death|0|||
147241934|NCT01306942|531057797|FG001|Phase II|Death|0|||
147241935|NCT01306942|531057798|FG002|Phase II|Death|0|||
147241936|NCT01306942|531057799|FG003|Phase II|Death|1|||
147241937|NCT01306942|531057796|FG000|Phase II|Not finished treatment|0|||
147241938|NCT01306942|531057797|FG001|Phase II|Not finished treatment|0|||
147241939|NCT01306942|531057798|FG002|Phase II|Not finished treatment|0|||
147241940|NCT01306942|531057799|FG003|Phase II|Not finished treatment|1|||
147241941|NCT01306942|531057796|FG000|Phase II|Protocol Violation|0|||
147241942|NCT01306942|531057797|FG001|Phase II|Protocol Violation|0|||
147241943|NCT01306942|531057798|FG002|Phase II|Protocol Violation|0|||
147241944|NCT01306942|531057799|FG003|Phase II|Protocol Violation|1|||
147241945|NCT03190915|531057806|FG000|Overall Study|Physician Determines It Is In Patient's Best Interest|4|||
147241946|NCT03190915|531057806|FG000|Overall Study|Progressive Disease|3|||
147241947|NCT04545385|531057807|FG000|Overall Study|Withdrawal by Subject|2|||
147241948|NCT04545385|531057808|FG001|Overall Study|Withdrawal by Subject|0|||
147241949|NCT04545385|531057807|FG000|Overall Study|Loss of asthma control (LoAC)|0|||
147241950|NCT04545385|531057808|FG001|Overall Study|Loss of asthma control (LoAC)|1|||
147241951|NCT04545385|531057807|FG000|Overall Study|Study termination|10|||
147241952|NCT04545385|531057808|FG001|Overall Study|Study termination|10|||
147241953|NCT04545385|531057807|FG000|Overall Study|Sponsor decision|2|||
147241954|NCT04545385|531057808|FG001|Overall Study|Sponsor decision|2|||
147241955|NCT04545385|531057807|FG000|Overall Study|Other than specified|1|||
147241956|NCT04545385|531057808|FG001|Overall Study|Other than specified|0|||
147241957|NCT01128842|531057809|FG000|Overall Study|Adverse Event|1|||
147241958|NCT01128842|531057809|FG000|Overall Study|Disease Progression|6|||
147241959|NCT04528732|531057810|FG000|Overall Study|Death|1|||
147241960|NCT04528732|531057811|FG001|Overall Study|Death|0|||
147241961|NCT04528732|531057812|FG002|Overall Study|Death|1|||
147241962|NCT04528732|531057810|FG000|Overall Study|Lost to Follow-up|0|||
147241963|NCT04528732|531057811|FG001|Overall Study|Lost to Follow-up|1|||
147241964|NCT04528732|531057812|FG002|Overall Study|Lost to Follow-up|2|||
147241965|NCT00668707|531057813|FG000|Overall Study|Cancer Recurrence|58|||
147241966|NCT00668707|531057814|FG001|Overall Study|Cancer Recurrence|58|||
147241967|NCT00668707|531057813|FG000|Overall Study|Withdrawal by Subject|117|||
147241968|NCT00668707|531057814|FG001|Overall Study|Withdrawal by Subject|100|||
147241969|NCT00668707|531057813|FG000|Overall Study|Lost to Follow-up|3|||
147241970|NCT00668707|531057814|FG001|Overall Study|Lost to Follow-up|6|||
147241971|NCT00668707|531057813|FG000|Overall Study|Protocol Violation|10|||
147241972|NCT00668707|531057814|FG001|Overall Study|Protocol Violation|12|||
147241973|NCT00668707|531057813|FG000|Overall Study|Death|11|||
147241974|NCT00668707|531057814|FG001|Overall Study|Death|4|||
147587281|NCT01714739|532303402|FG002|Overall Study|No longer meets study criteria|0|||
147160647|NCT00657150|530752062|FG001|Treatment|Lost to Follow-up|0|||
147160648|NCT00657150|530752061|FG000|Treatment|Withdrawal by Subject|23|||
147160649|NCT00657150|530752062|FG001|Treatment|Withdrawal by Subject|20|||
147160650|NCT00657150|530752061|FG000|Treatment|Other|13|||
147241975|NCT02605824|531057815|FG000|Overall Study|Physician Decision|1|||
147241976|NCT02605824|531057816|FG001|Overall Study|Physician Decision|0|||
147241977|NCT00826943|531057817|FG000|Overall Study|Withdrawal by Subject|0|||
147241978|NCT00826943|531057818|FG001|Overall Study|Withdrawal by Subject|0|||
147241979|NCT00826943|531057819|FG002|Overall Study|Withdrawal by Subject|0|||
147241980|NCT00826943|531057820|FG003|Overall Study|Withdrawal by Subject|0|||
147241981|NCT00826943|531057821|FG004|Overall Study|Withdrawal by Subject|1|||
147241982|NCT00826943|531057822|FG005|Overall Study|Withdrawal by Subject|0|||
147241983|NCT01382212|531057823|FG000|Overall Study|Kidney transplant|1|||
147241984|NCT01382212|531057823|FG000|Overall Study|Withdrew consent|1|||
147241985|NCT01095731|531057824|FG000|Overall Study|Protocol Violation|1|||
147160651|NCT00657150|530752062|FG001|Treatment|Other|15|||
147241986|NCT01095731|531057825|FG001|Overall Study|Protocol Violation|1|||
147587282|NCT01714739|532303403|FG003|Overall Study|No longer meets study criteria|1|||
147587283|NCT01714739|532303404|FG004|Overall Study|No longer meets study criteria|0|||
147587284|NCT01714739|532303405|FG005|Overall Study|No longer meets study criteria|0|||
147587285|NCT01714739|532303406|FG006|Overall Study|No longer meets study criteria|0|||
147587286|NCT01714739|532303400|FG000|Overall Study|Other reason|0|||
147587287|NCT01714739|532303401|FG001|Overall Study|Other reason|0|||
147587288|NCT01714739|532303402|FG002|Overall Study|Other reason|0|||
147587289|NCT01714739|532303403|FG003|Overall Study|Other reason|3|||
147587290|NCT01714739|532303404|FG004|Overall Study|Other reason|1|||
147587291|NCT01714739|532303405|FG005|Overall Study|Other reason|0|||
147587292|NCT01714739|532303406|FG006|Overall Study|Other reason|0|||
147587293|NCT00707434|532303409|FG000|Overall Study|Adverse Event|1|||
147587294|NCT03585959|532303410|FG000|Overall Study|Physician Decision|1|||
147587295|NCT03585959|532303410|FG000|Overall Study|Unsuccessful Procedure|2|||
147587296|NCT02531594|532303411|FG000|Overall Study|Withdrawal by Subject|7|||
147587297|NCT02531594|532303412|FG001|Overall Study|Withdrawal by Subject|8|||
147587298|NCT00614822|532303413|FG000|Overall Study|Adverse Event|3|||
147587299|NCT02359864|532303415|FG000|Overall Study|Withdrawal by Subject|1|||
147587300|NCT02359864|532303416|FG001|Overall Study|Withdrawal by Subject|0|||
147587301|NCT00725764|532303417|FG000|Overall Study|Withdrawal by Subject|2|||
147587302|NCT00725764|532303417|FG000|Overall Study|Physician Decision|1|||
147587303|NCT00725764|532303417|FG000|Overall Study|Progressive Disease|7|||
147587304|NCT00725764|532303417|FG000|Overall Study|Lost to Follow-up|1|||
147160652|NCT02966795|530752063|FG000|Overall Study|Patient Left the Country|0|||
147160653|NCT02966795|530752064|FG001|Overall Study|Patient Left the Country|1|||
147160654|NCT00432744|530752065|FG000|Months 0-6|Withdrawal by Subject|4|||
147160655|NCT00432744|530752066|FG001|Months 0-6|Withdrawal by Subject|4|||
147160656|NCT00432744|530752065|FG000|Months 0-6|Too disabled to score|1|||
147160657|NCT00432744|530752066|FG001|Months 0-6|Too disabled to score|0|||
147160658|NCT00432744|530752065|FG000|Months 7 - 12|Withdrawal by Subject|1|||
147160659|NCT00432744|530752066|FG001|Months 7 - 12|Withdrawal by Subject|0|||
147160660|NCT00432744|530752065|FG000|Months 7 - 12|Too disabled to score|0|||
147160661|NCT00432744|530752066|FG001|Months 7 - 12|Too disabled to score|1|||
147160662|NCT01460719|530753990|FG000|Overall Study|Adverse Event|1|||
147160663|NCT01460719|530753990|FG000|Overall Study|Withdrawal by Subject|1|||
147160664|NCT00350623|530753998|FG000|Overall Study|Lost to Follow-up|8|||
147160665|NCT00350623|530753999|FG001|Overall Study|Lost to Follow-up|3|||
147322330|NCT04529538|531343656|FG002|Overall Study|Protocol Deviation|0|||
147322331|NCT04529538|531343657|FG003|Overall Study|Protocol Deviation|1|||
147322332|NCT04529538|531343658|FG004|Overall Study|Protocol Deviation|0|||
147322333|NCT04529538|531343659|FG005|Overall Study|Protocol Deviation|0|||
147322334|NCT04529538|531343660|FG006|Overall Study|Protocol Deviation|0|||
147322335|NCT04529538|531343661|FG007|Overall Study|Protocol Deviation|0|||
147322336|NCT04529538|531343654|FG000|Overall Study|Physician Decision|0|||
147322337|NCT04529538|531343655|FG001|Overall Study|Physician Decision|0|||
147322338|NCT04529538|531343656|FG002|Overall Study|Physician Decision|0|||
147322339|NCT04529538|531343657|FG003|Overall Study|Physician Decision|0|||
147322340|NCT04529538|531343658|FG004|Overall Study|Physician Decision|0|||
147322341|NCT04529538|531343659|FG005|Overall Study|Physician Decision|1|||
147322342|NCT04529538|531343660|FG006|Overall Study|Physician Decision|0|||
147322343|NCT04529538|531343661|FG007|Overall Study|Physician Decision|1|||
147322344|NCT02223182|531343662|FG000|Double-Blind Period|Adverse Event|0|||
147322345|NCT02223182|531343663|FG001|Double-Blind Period|Adverse Event|2|||
147322346|NCT02223182|531343664|FG002|Double-Blind Period|Adverse Event|1|||
147322347|NCT02223182|531343665|FG003|Double-Blind Period|Adverse Event|0|||
147322348|NCT02223182|531343662|FG000|Double-Blind Period|Withdrawal by Subject|1|||
147322349|NCT02223182|531343663|FG001|Double-Blind Period|Withdrawal by Subject|1|||
147322350|NCT02223182|531343664|FG002|Double-Blind Period|Withdrawal by Subject|1|||
147322351|NCT02223182|531343665|FG003|Double-Blind Period|Withdrawal by Subject|0|||
147322352|NCT02223182|531343662|FG000|Double-Blind Period|Lost to Follow-up|0|||
147322353|NCT02223182|531343663|FG001|Double-Blind Period|Lost to Follow-up|1|||
147587305|NCT00725764|532303417|FG000|Overall Study|Death|1|||
147587306|NCT00725764|532303417|FG000|Overall Study|Participant non compliant with protocol|1|||
147587307|NCT00725764|532303417|FG000|Overall Study|Decline in performance status|1|||
147587308|NCT01857206|532303423|FG000|Overall Study|ADMINISTRATIVE REASON|0|||
147587309|NCT01857206|532303424|FG001|Overall Study|ADMINISTRATIVE REASON|1|||
147654429|NCT02588092|532556723|FG009|Overall Study|Sponsor Decision|1|||
147160666|NCT00350623|530754000|FG002|Overall Study|Lost to Follow-up|4|||
147160667|NCT00350623|530753998|FG000|Overall Study|Withdrawal by Subject|0|||
147322354|NCT02223182|531343664|FG002|Double-Blind Period|Lost to Follow-up|0|||
147322355|NCT02223182|531343665|FG003|Double-Blind Period|Lost to Follow-up|0|||
147322356|NCT02223182|531343662|FG000|Double-Blind Period|Non Compliance|0|||
147322357|NCT02223182|531343663|FG001|Double-Blind Period|Non Compliance|0|||
147587310|NCT01857206|532303423|FG000|Overall Study|Lost to Follow-up|9|||
147587311|NCT01857206|532303424|FG001|Overall Study|Lost to Follow-up|6|||
147587312|NCT01857206|532303423|FG000|Overall Study|Unclassified|3|||
147587313|NCT01857206|532303424|FG001|Overall Study|Unclassified|3|||
147587314|NCT01857206|532303423|FG000|Overall Study|Withdrawal by Subject|1|||
147447102|NCT00001379|531802053|FG002|Cross-Over After Initial Treatment|Received alternative treatment|0|||
147447103|NCT00001379|531802054|FG003|Cross-Over After Initial Treatment|Received alternative treatment|0|||
147447104|NCT00001379|531802051|FG000|Cross-Over After Initial Treatment|Refused further treatment|1|||
147447105|NCT00001379|531802052|FG001|Cross-Over After Initial Treatment|Refused further treatment|0|||
147447106|NCT00001379|531802053|FG002|Cross-Over After Initial Treatment|Refused further treatment|0|||
147447107|NCT00001379|531802054|FG003|Cross-Over After Initial Treatment|Refused further treatment|0|||
147447108|NCT03703102|531802059|FG000|Overall Study|Adverse Event|4|||
147447109|NCT03703102|531802060|FG001|Overall Study|Adverse Event|3|||
147447110|NCT03703102|531802061|FG002|Overall Study|Adverse Event|7|||
147447111|NCT03703102|531802062|FG003|Overall Study|Adverse Event|3|||
147447112|NCT03703102|531802063|FG004|Overall Study|Adverse Event|13|||
147447113|NCT03703102|531802059|FG000|Overall Study|Lack of Efficacy|4|||
147447114|NCT03703102|531802060|FG001|Overall Study|Lack of Efficacy|0|||
147447115|NCT03703102|531802061|FG002|Overall Study|Lack of Efficacy|1|||
147447116|NCT03703102|531802062|FG003|Overall Study|Lack of Efficacy|4|||
147447117|NCT03703102|531802063|FG004|Overall Study|Lack of Efficacy|1|||
147447118|NCT03703102|531802059|FG000|Overall Study|Lost to Follow-up|0|||
147447119|NCT03703102|531802060|FG001|Overall Study|Lost to Follow-up|0|||
147447120|NCT03703102|531802061|FG002|Overall Study|Lost to Follow-up|1|||
147447121|NCT03703102|531802062|FG003|Overall Study|Lost to Follow-up|2|||
147447122|NCT03703102|531802063|FG004|Overall Study|Lost to Follow-up|2|||
147447123|NCT03703102|531802059|FG000|Overall Study|Physician Decision|2|||
147447124|NCT03703102|531802060|FG001|Overall Study|Physician Decision|2|||
147447125|NCT03703102|531802061|FG002|Overall Study|Physician Decision|2|||
147447126|NCT03703102|531802062|FG003|Overall Study|Physician Decision|2|||
147447127|NCT03703102|531802063|FG004|Overall Study|Physician Decision|4|||
147447128|NCT03703102|531802059|FG000|Overall Study|Withdrawal by Subject|7|||
147447129|NCT03703102|531802060|FG001|Overall Study|Withdrawal by Subject|5|||
147447130|NCT03703102|531802061|FG002|Overall Study|Withdrawal by Subject|5|||
147447131|NCT03703102|531802062|FG003|Overall Study|Withdrawal by Subject|5|||
147447132|NCT03703102|531802063|FG004|Overall Study|Withdrawal by Subject|9|||
147447133|NCT03703102|531802059|FG000|Overall Study|Ineligibility|0|||
147447134|NCT03703102|531802060|FG001|Overall Study|Ineligibility|0|||
147447135|NCT03703102|531802061|FG002|Overall Study|Ineligibility|1|||
147447136|NCT03703102|531802062|FG003|Overall Study|Ineligibility|0|||
147447137|NCT03703102|531802063|FG004|Overall Study|Ineligibility|0|||
147447138|NCT03703102|531802059|FG000|Overall Study|Protocol Deviation|4|||
147447139|NCT03703102|531802060|FG001|Overall Study|Protocol Deviation|4|||
147447140|NCT03703102|531802061|FG002|Overall Study|Protocol Deviation|3|||
147447141|NCT03703102|531802062|FG003|Overall Study|Protocol Deviation|0|||
147447142|NCT03703102|531802063|FG004|Overall Study|Protocol Deviation|0|||
147447143|NCT03703102|531802059|FG000|Overall Study|Non-Compliance with Study Drug|1|||
147447144|NCT03703102|531802060|FG001|Overall Study|Non-Compliance with Study Drug|1|||
147447145|NCT03703102|531802061|FG002|Overall Study|Non-Compliance with Study Drug|2|||
147447146|NCT03703102|531802062|FG003|Overall Study|Non-Compliance with Study Drug|1|||
147447147|NCT03703102|531802063|FG004|Overall Study|Non-Compliance with Study Drug|4|||
147447148|NCT00876187|531802064|FG000|Overall Study|Adverse Event|14|||
147447149|NCT00876187|531802065|FG001|Overall Study|Adverse Event|12|||
147447150|NCT00876187|531802066|FG002|Overall Study|Adverse Event|19|||
147447151|NCT00876187|531802067|FG003|Overall Study|Adverse Event|29|||
147447152|NCT00876187|531802068|FG004|Overall Study|Adverse Event|10|||
147587315|NCT01857206|532303424|FG001|Overall Study|Withdrawal by Subject|0|||
147447153|NCT00876187|531802064|FG000|Overall Study|Lack of Efficacy|59|||
147447154|NCT00876187|531802065|FG001|Overall Study|Lack of Efficacy|34|||
147447155|NCT00876187|531802066|FG002|Overall Study|Lack of Efficacy|45|||
147447156|NCT00876187|531802067|FG003|Overall Study|Lack of Efficacy|34|||
147447157|NCT00876187|531802068|FG004|Overall Study|Lack of Efficacy|59|||
147447158|NCT00876187|531802064|FG000|Overall Study|Lost to Follow-up|9|||
147447159|NCT00876187|531802065|FG001|Overall Study|Lost to Follow-up|10|||
147447160|NCT00876187|531802066|FG002|Overall Study|Lost to Follow-up|8|||
147241987|NCT01095731|531057824|FG000|Overall Study|Withdrawal by Subject|0|||
147241988|NCT01095731|531057825|FG001|Overall Study|Withdrawal by Subject|1|||
147241989|NCT01446289|531057826|FG000|Overall Study|Withdrawal by Subject|1|||
147241990|NCT01446289|531057827|FG001|Overall Study|Withdrawal by Subject|0|||
147241991|NCT01446289|531057828|FG002|Overall Study|Withdrawal by Subject|1|||
147241992|NCT01446289|531057829|FG003|Overall Study|Withdrawal by Subject|0|||
147241993|NCT03329573|531057830|FG000|Treatment Period 1 (Up to 5 Days)|Adverse Event|0|||
147241994|NCT03329573|531057831|FG001|Treatment Period 1 (Up to 5 Days)|Adverse Event|1|||
147241995|NCT03329573|531057832|FG002|Treatment Period 1 (Up to 5 Days)|Adverse Event|0|||
147241996|NCT03329573|531057833|FG003|Treatment Period 1 (Up to 5 Days)|Adverse Event|0|||
147241997|NCT03329573|531057830|FG000|Treatment Period 1 (Up to 5 Days)|Withdrawal by Subject|1|||
147241998|NCT03329573|531057831|FG001|Treatment Period 1 (Up to 5 Days)|Withdrawal by Subject|2|||
147447161|NCT00876187|531802067|FG003|Overall Study|Lost to Follow-up|8|||
147447162|NCT00876187|531802068|FG004|Overall Study|Lost to Follow-up|11|||
147447163|NCT00876187|531802064|FG000|Overall Study|Protocol Violation|6|||
147447164|NCT00876187|531802065|FG001|Overall Study|Protocol Violation|7|||
147160668|NCT00350623|530753999|FG001|Overall Study|Withdrawal by Subject|1|||
147160669|NCT00350623|530754000|FG002|Overall Study|Withdrawal by Subject|1|||
147160670|NCT00350623|530753998|FG000|Overall Study|patient traveling outside the country|0|||
147160671|NCT00350623|530753999|FG001|Overall Study|patient traveling outside the country|0|||
147160672|NCT00350623|530754000|FG002|Overall Study|patient traveling outside the country|1|||
147160673|NCT04126564|530754002|FG000|Overall Study|Withdrawal by Subject|0|||
147160674|NCT04126564|530754003|FG001|Overall Study|Withdrawal by Subject|2|||
147160675|NCT04126564|530754002|FG000|Overall Study|Lost to Follow-up|0|||
147160676|NCT04126564|530754003|FG001|Overall Study|Lost to Follow-up|1|||
147160677|NCT02536300|530754004|FG000|Overall Study|Investigator's Discretion|17|||
147160678|NCT02536300|530754005|FG001|Overall Study|Investigator's Discretion|11|||
147160679|NCT02536300|530754006|FG002|Overall Study|Investigator's Discretion|2|||
147160680|NCT02536300|530754004|FG000|Overall Study|Progressive Disease|11|||
147160681|NCT02536300|530754005|FG001|Overall Study|Progressive Disease|7|||
147160682|NCT02536300|530754006|FG002|Overall Study|Progressive Disease|6|||
147160683|NCT02536300|530754004|FG000|Overall Study|Study Terminated by Sponsor|6|||
147160684|NCT02536300|530754005|FG001|Overall Study|Study Terminated by Sponsor|4|||
147160685|NCT02536300|530754006|FG002|Overall Study|Study Terminated by Sponsor|7|||
147160686|NCT02536300|530754004|FG000|Overall Study|Death|7|||
147160687|NCT02536300|530754005|FG001|Overall Study|Death|0|||
147160688|NCT02536300|530754006|FG002|Overall Study|Death|5|||
147160689|NCT02536300|530754004|FG000|Overall Study|Withdrew Consent|4|||
147160690|NCT02536300|530754005|FG001|Overall Study|Withdrew Consent|2|||
147160691|NCT02536300|530754006|FG002|Overall Study|Withdrew Consent|0|||
147160692|NCT02536300|530754004|FG000|Overall Study|Initiation of Non-study Specific Anti-cancer Therapy in the Absence of Progression|1|||
147241999|NCT03329573|531057832|FG002|Treatment Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
147242000|NCT03329573|531057833|FG003|Treatment Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
147242001|NCT03329573|531057830|FG000|Treatment Period 2 (Day 12 to Day 26)|Withdrawal by Subject|1|||
147242002|NCT03329573|531057831|FG001|Treatment Period 2 (Day 12 to Day 26)|Withdrawal by Subject|0|||
147242003|NCT03329573|531057832|FG002|Treatment Period 2 (Day 12 to Day 26)|Withdrawal by Subject|0|||
147242004|NCT03329573|531057833|FG003|Treatment Period 2 (Day 12 to Day 26)|Withdrawal by Subject|0|||
147242005|NCT03329573|531057830|FG000|Treatment Period 2 (Day 12 to Day 26)|Adverse Event|0|||
147242006|NCT03329573|531057831|FG001|Treatment Period 2 (Day 12 to Day 26)|Adverse Event|1|||
147242007|NCT03329573|531057832|FG002|Treatment Period 2 (Day 12 to Day 26)|Adverse Event|0|||
147242008|NCT03329573|531057833|FG003|Treatment Period 2 (Day 12 to Day 26)|Adverse Event|0|||
147242009|NCT02777333|531057836|FG000|Overall Study|Withdrawal by Subject|0|||
147322358|NCT02223182|531343664|FG002|Double-Blind Period|Non Compliance|0|||
147322359|NCT02223182|531343665|FG003|Double-Blind Period|Non Compliance|1|||
147322360|NCT02223182|531343662|FG000|Double-Blind Period|Sponsor or Regulatory Authorities Decision|1|||
147322361|NCT02223182|531343663|FG001|Double-Blind Period|Sponsor or Regulatory Authorities Decision|0|||
147322362|NCT02223182|531343664|FG002|Double-Blind Period|Sponsor or Regulatory Authorities Decision|0|||
147322363|NCT02223182|531343665|FG003|Double-Blind Period|Sponsor or Regulatory Authorities Decision|0|||
147322364|NCT02223182|531343662|FG000|Open-Label 500 Period|Adverse Event|1|||
147322365|NCT02223182|531343663|FG001|Open-Label 500 Period|Adverse Event|0|||
147322366|NCT02223182|531343664|FG002|Open-Label 500 Period|Adverse Event|2|||
147322367|NCT02223182|531343665|FG003|Open-Label 500 Period|Adverse Event|1|||
147322368|NCT02223182|531343662|FG000|Open-Label 500 Period|Withdrawal by Subject|5|||
147322369|NCT02223182|531343663|FG001|Open-Label 500 Period|Withdrawal by Subject|2|||
147322370|NCT02223182|531343664|FG002|Open-Label 500 Period|Withdrawal by Subject|9|||
147322371|NCT02223182|531343665|FG003|Open-Label 500 Period|Withdrawal by Subject|8|||
147322372|NCT02223182|531343662|FG000|Open-Label 500 Period|Physician Decision|0|||
147322373|NCT02223182|531343663|FG001|Open-Label 500 Period|Physician Decision|0|||
147322374|NCT02223182|531343664|FG002|Open-Label 500 Period|Physician Decision|0|||
147322375|NCT02223182|531343665|FG003|Open-Label 500 Period|Physician Decision|1|||
147322376|NCT02223182|531343662|FG000|Open-Label 500 Period|Sponsor or Regulatory Authorities Decision|0|||
147322377|NCT02223182|531343663|FG001|Open-Label 500 Period|Sponsor or Regulatory Authorities Decision|0|||
147322378|NCT02223182|531343664|FG002|Open-Label 500 Period|Sponsor or Regulatory Authorities Decision|1|||
147322379|NCT02223182|531343665|FG003|Open-Label 500 Period|Sponsor or Regulatory Authorities Decision|0|||
147322380|NCT02223182|531343662|FG000|Open-Label 300 Period|Withdrawal by Subject|10|||
147322381|NCT02223182|531343663|FG001|Open-Label 300 Period|Withdrawal by Subject|13|||
147322382|NCT02223182|531343664|FG002|Open-Label 300 Period|Withdrawal by Subject|13|||
147322383|NCT02223182|531343665|FG003|Open-Label 300 Period|Withdrawal by Subject|15|||
147322384|NCT02223182|531343662|FG000|Open-Label 300 Period|Lost to Follow-up|1|||
147322385|NCT02223182|531343663|FG001|Open-Label 300 Period|Lost to Follow-up|0|||
147322386|NCT02223182|531343664|FG002|Open-Label 300 Period|Lost to Follow-up|1|||
147322387|NCT02223182|531343665|FG003|Open-Label 300 Period|Lost to Follow-up|0|||
147160693|NCT02536300|530754005|FG001|Overall Study|Initiation of Non-study Specific Anti-cancer Therapy in the Absence of Progression|2|||
147160694|NCT02536300|530754006|FG002|Overall Study|Initiation of Non-study Specific Anti-cancer Therapy in the Absence of Progression|1|||
147160695|NCT02536300|530754004|FG000|Overall Study|Enrolled but Never Treated|0|||
147160696|NCT02536300|530754005|FG001|Overall Study|Enrolled but Never Treated|0|||
147587316|NCT00575380|532303431|FG000|Overall Study|Withdrawal by Subject|1|||
147587317|NCT00575380|532303432|FG001|Overall Study|Withdrawal by Subject|0|||
147587318|NCT00575380|532303431|FG000|Overall Study|Adverse Event|0|||
147587319|NCT00575380|532303432|FG001|Overall Study|Adverse Event|1|||
147160697|NCT02536300|530754006|FG002|Overall Study|Enrolled but Never Treated|1|||
147160698|NCT02536300|530754004|FG000|Overall Study|Non-compliance With Study Drug|1|||
147160699|NCT02536300|530754005|FG001|Overall Study|Non-compliance With Study Drug|0|||
147160700|NCT02536300|530754006|FG002|Overall Study|Non-compliance With Study Drug|0|||
147160701|NCT02536300|530754004|FG000|Overall Study|Protocol Violation|0|||
147587320|NCT00575380|532303431|FG000|Overall Study|Various|0|||
147587321|NCT00575380|532303432|FG001|Overall Study|Various|2|||
147587322|NCT00559364|532303434|FG000|Overall Study|Inclusion/exclusion criteria failure|1|||
147587323|NCT00559364|532303435|FG001|Overall Study|Inclusion/exclusion criteria failure|0|||
147587324|NCT01235442|532303436|FG000|Overall Study|Lost to Follow-up|12|||
147587325|NCT01235442|532303437|FG001|Overall Study|Lost to Follow-up|10|||
147587326|NCT01235442|532303436|FG000|Overall Study|Death|0|||
147587327|NCT01235442|532303437|FG001|Overall Study|Death|2|||
147587328|NCT01235442|532303436|FG000|Overall Study|Pregnancy|1|||
147587329|NCT01235442|532303437|FG001|Overall Study|Pregnancy|1|||
147587330|NCT01235442|532303436|FG000|Overall Study|Ineligibility determined|5|||
147587331|NCT01235442|532303437|FG001|Overall Study|Ineligibility determined|4|||
147587332|NCT01235442|532303436|FG000|Overall Study|Protocol Violation|3|||
147587333|NCT01235442|532303437|FG001|Overall Study|Protocol Violation|3|||
147160702|NCT02536300|530754005|FG001|Overall Study|Protocol Violation|1|||
147160703|NCT02536300|530754006|FG002|Overall Study|Protocol Violation|0|||
147160704|NCT00294645|530754016|FG000|Overall Study|Death|10|||
147160705|NCT00294645|530754017|FG001|Overall Study|Death|18|||
147160706|NCT00294645|530754016|FG000|Overall Study|Lost to Follow-up|1|||
147160707|NCT00294645|530754017|FG001|Overall Study|Lost to Follow-up|10|||
147160708|NCT00294645|530754016|FG000|Overall Study|Withdrawal by Subject|18|||
147160709|NCT00294645|530754017|FG001|Overall Study|Withdrawal by Subject|34|||
147160710|NCT00294645|530754016|FG000|Overall Study|Physician Decision|15|||
147160711|NCT00294645|530754017|FG001|Overall Study|Physician Decision|20|||
147160712|NCT00294645|530754016|FG000|Overall Study|Other|4|||
147160713|NCT00294645|530754017|FG001|Overall Study|Other|10|||
147160714|NCT01238835|530754028|FG000|Overall Study|Death|124|||
147160715|NCT01238835|530754028|FG000|Overall Study|Withdrawal by Subject|9|||
147160716|NCT01238835|530754028|FG000|Overall Study|Lost to Follow-up|1|||
147160717|NCT01238835|530754028|FG000|Overall Study|Site early discontinuation|2|||
147160718|NCT03352557|530754032|FG000|PC Period: Day 1 to Week 78|Death|1|||
147160719|NCT03352557|530754033|FG001|PC Period: Day 1 to Week 78|Death|1|||
147160720|NCT03352557|530754034|FG002|PC Period: Day 1 to Week 78|Death|0|||
147160721|NCT03352557|530754035|FG003|PC Period: Day 1 to Week 78|Death|0|||
147160722|NCT03352557|530754036|FG004|PC Period: Day 1 to Week 78|Death|1|||
147160723|NCT03352557|530754037|FG005|PC Period: Day 1 to Week 78|Death|0|||
147160724|NCT03352557|530754038|FG006|PC Period: Day 1 to Week 78|Death|0|||
147160725|NCT03352557|530754039|FG007|PC Period: Day 1 to Week 78|Death|0|||
147160726|NCT03352557|530754040|FG008|PC Period: Day 1 to Week 78|Death|0|||
147160727|NCT03352557|530754041|FG009|PC Period: Day 1 to Week 78|Death|0|||
147160728|NCT03352557|530754032|FG000|PC Period: Day 1 to Week 78|Adverse Event|10|||
147160729|NCT03352557|530754033|FG001|PC Period: Day 1 to Week 78|Adverse Event|1|||
147160730|NCT03352557|530754034|FG002|PC Period: Day 1 to Week 78|Adverse Event|1|||
147160731|NCT03352557|530754035|FG003|PC Period: Day 1 to Week 78|Adverse Event|0|||
147160732|NCT03352557|530754036|FG004|PC Period: Day 1 to Week 78|Adverse Event|5|||
147160733|NCT03352557|530754037|FG005|PC Period: Day 1 to Week 78|Adverse Event|0|||
147160734|NCT03352557|530754038|FG006|PC Period: Day 1 to Week 78|Adverse Event|0|||
147160735|NCT03352557|530754039|FG007|PC Period: Day 1 to Week 78|Adverse Event|0|||
147160736|NCT03352557|530754040|FG008|PC Period: Day 1 to Week 78|Adverse Event|0|||
147654430|NCT03883477|532556724|FG000|Overall Study|Death|1|||
147654431|NCT03883477|532556725|FG001|Overall Study|Death|0|||
147160737|NCT03352557|530754041|FG009|PC Period: Day 1 to Week 78|Adverse Event|0|||
147160738|NCT03352557|530754032|FG000|PC Period: Day 1 to Week 78|Progressive Disease|0|||
147160739|NCT03352557|530754033|FG001|PC Period: Day 1 to Week 78|Progressive Disease|0|||
147160740|NCT03352557|530754034|FG002|PC Period: Day 1 to Week 78|Progressive Disease|0|||
147242010|NCT02777333|531057837|FG001|Overall Study|Withdrawal by Subject|1|||
147587334|NCT01235442|532303436|FG000|Overall Study|Adverse Event|4|||
147160741|NCT03352557|530754035|FG003|PC Period: Day 1 to Week 78|Progressive Disease|0|||
147160742|NCT03352557|530754036|FG004|PC Period: Day 1 to Week 78|Progressive Disease|1|||
147160743|NCT03352557|530754037|FG005|PC Period: Day 1 to Week 78|Progressive Disease|0|||
147160744|NCT03352557|530754038|FG006|PC Period: Day 1 to Week 78|Progressive Disease|0|||
147160745|NCT03352557|530754039|FG007|PC Period: Day 1 to Week 78|Progressive Disease|0|||
147160746|NCT03352557|530754040|FG008|PC Period: Day 1 to Week 78|Progressive Disease|0|||
147242011|NCT02777333|531057836|FG000|Overall Study|Lost to Follow-up|0|||
147587335|NCT01235442|532303437|FG001|Overall Study|Adverse Event|6|||
147587336|NCT01235442|532303436|FG000|Overall Study|Withdrawal by Subject|15|||
147587337|NCT01235442|532303437|FG001|Overall Study|Withdrawal by Subject|9|||
147587338|NCT01235442|532303436|FG000|Overall Study|Lack of Efficacy|1|||
147654432|NCT03883477|532556724|FG000|Overall Study|Protocol Violation|0|||
147587339|NCT01235442|532303437|FG001|Overall Study|Lack of Efficacy|3|||
147587340|NCT01235442|532303436|FG000|Overall Study|Noncompliance|1|||
147587341|NCT01235442|532303437|FG001|Overall Study|Noncompliance|2|||
147587342|NCT01235442|532303436|FG000|Overall Study|Administrative decision|1|||
147587343|NCT01235442|532303437|FG001|Overall Study|Administrative decision|2|||
147587344|NCT01235442|532303436|FG000|Overall Study|Other unspecified|1|||
147587345|NCT01235442|532303437|FG001|Overall Study|Other unspecified|2|||
147587346|NCT00084799|532303438|FG000|Overall Study|Disease Progression|1|||
147587347|NCT00084799|532303439|FG001|Overall Study|Disease Progression|0|||
147587348|NCT01857973|532303440|FG000|Overall Study|Subject did not meet required BG range|3|||
147587349|NCT01857973|532303440|FG000|Overall Study|drop out after 3 failed attempts|1|||
147587350|NCT01857973|532303440|FG000|Overall Study|Physician Decision|1|||
147587351|NCT02663882|532303441|FG000|Overall Study|Lost to Follow-up|4|||
147587352|NCT02663882|532303442|FG001|Overall Study|Lost to Follow-up|2|||
147587353|NCT01701973|532303443|FG000|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
147587354|NCT01701973|532303444|FG001|Aim 1: First Intervention (1 Day)|Adverse Event|1|||
147587355|NCT01701973|532303445|FG002|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
147587356|NCT01701973|532303446|FG003|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
147587357|NCT01701973|532303447|FG004|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
147587358|NCT01701973|532303448|FG005|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
147587359|NCT01701973|532303449|FG006|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
147587360|NCT01701973|532303450|FG007|Aim 1: First Intervention (1 Day)|Adverse Event|0|||
147587361|NCT02412722|532303457|FG000|Overall Study|Adverse Event|0|||
147587362|NCT02412722|532303458|FG001|Overall Study|Adverse Event|2|||
147160747|NCT03352557|530754041|FG009|PC Period: Day 1 to Week 78|Progressive Disease|0|||
147160748|NCT03352557|530754032|FG000|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|1|||
147160749|NCT03352557|530754033|FG001|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
147587363|NCT02412722|532303459|FG002|Overall Study|Adverse Event|0|||
147587364|NCT02412722|532303460|FG003|Overall Study|Adverse Event|3|||
147587365|NCT02412722|532303461|FG004|Overall Study|Adverse Event|0|||
147587366|NCT02412722|532303462|FG005|Overall Study|Adverse Event|3|||
147587367|NCT02412722|532303457|FG000|Overall Study|Progressive Disease|6|||
147587368|NCT02412722|532303458|FG001|Overall Study|Progressive Disease|4|||
147587369|NCT02412722|532303459|FG002|Overall Study|Progressive Disease|4|||
147587370|NCT02412722|532303460|FG003|Overall Study|Progressive Disease|9|||
147587371|NCT02412722|532303461|FG004|Overall Study|Progressive Disease|3|||
147587372|NCT02412722|532303462|FG005|Overall Study|Progressive Disease|3|||
147587373|NCT02412722|532303457|FG000|Overall Study|Withdrawal by Subject|2|||
147587374|NCT02412722|532303458|FG001|Overall Study|Withdrawal by Subject|0|||
147587375|NCT02412722|532303459|FG002|Overall Study|Withdrawal by Subject|1|||
147587376|NCT02412722|532303460|FG003|Overall Study|Withdrawal by Subject|2|||
147587377|NCT02412722|532303461|FG004|Overall Study|Withdrawal by Subject|1|||
147160750|NCT03352557|530754034|FG002|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
147160751|NCT03352557|530754035|FG003|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
147160752|NCT03352557|530754036|FG004|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
147160753|NCT03352557|530754037|FG005|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
147160754|NCT03352557|530754038|FG006|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
147160755|NCT03352557|530754039|FG007|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
147160756|NCT03352557|530754040|FG008|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
147160757|NCT03352557|530754041|FG009|PC Period: Day 1 to Week 78|Noncompliance with Study Drug|0|||
147160758|NCT03352557|530754032|FG000|PC Period: Day 1 to Week 78|Protocol Deviation|1|||
147160759|NCT03352557|530754033|FG001|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
147160760|NCT03352557|530754034|FG002|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
147242012|NCT02777333|531057837|FG001|Overall Study|Lost to Follow-up|1|||
147242013|NCT00837811|531057838|FG000|Overall Study|Adverse Event|4|||
147242014|NCT00837811|531057839|FG001|Overall Study|Adverse Event|6|||
147242015|NCT00837811|531057840|FG002|Overall Study|Adverse Event|0|||
147242016|NCT00837811|531057838|FG000|Overall Study|Death|1|||
147242017|NCT00837811|531057839|FG001|Overall Study|Death|1|||
147242018|NCT00837811|531057840|FG002|Overall Study|Death|0|||
147587378|NCT02412722|532303462|FG005|Overall Study|Withdrawal by Subject|1|||
147587379|NCT02412722|532303457|FG000|Overall Study|Lost to Follow-up|0|||
147587380|NCT02412722|532303458|FG001|Overall Study|Lost to Follow-up|0|||
147587381|NCT02412722|532303459|FG002|Overall Study|Lost to Follow-up|0|||
147587382|NCT02412722|532303460|FG003|Overall Study|Lost to Follow-up|0|||
147587383|NCT02412722|532303461|FG004|Overall Study|Lost to Follow-up|1|||
147587384|NCT02412722|532303462|FG005|Overall Study|Lost to Follow-up|0|||
147587385|NCT02412722|532303457|FG000|Overall Study|Received drug in run-in and discontinued|0|||
147587386|NCT02412722|532303458|FG001|Overall Study|Received drug in run-in and discontinued|2|||
147587387|NCT02412722|532303459|FG002|Overall Study|Received drug in run-in and discontinued|0|||
147587388|NCT02412722|532303460|FG003|Overall Study|Received drug in run-in and discontinued|0|||
147160761|NCT03352557|530754035|FG003|PC Period: Day 1 to Week 78|Protocol Deviation|1|||
147587389|NCT02412722|532303461|FG004|Overall Study|Received drug in run-in and discontinued|0|||
147654433|NCT03883477|532556725|FG001|Overall Study|Protocol Violation|1|||
147242019|NCT00837811|531057838|FG000|Overall Study|Lack of Efficacy|0|||
147160762|NCT03352557|530754036|FG004|PC Period: Day 1 to Week 78|Protocol Deviation|2|||
147587390|NCT02412722|532303462|FG005|Overall Study|Received drug in run-in and discontinued|0|||
147587391|NCT02412722|532303457|FG000|Overall Study|Reason not Specified|3|||
147587392|NCT02412722|532303458|FG001|Overall Study|Reason not Specified|0|||
147587393|NCT02412722|532303459|FG002|Overall Study|Reason not Specified|2|||
147587394|NCT02412722|532303460|FG003|Overall Study|Reason not Specified|1|||
147587395|NCT02412722|532303461|FG004|Overall Study|Reason not Specified|2|||
147587396|NCT02412722|532303462|FG005|Overall Study|Reason not Specified|6|||
147587397|NCT04449341|532303463|FG000|Overall Study|Protocol Violation|1|||
147587398|NCT04449341|532303464|FG001|Overall Study|Protocol Violation|0|||
147587399|NCT04499482|532303465|FG000|Foods Containing 10 g Soy Flour|One subject dropped from the study at Day 3 as the subject could not meet the demands of the study|1|||
147587400|NCT00869440|532303466|FG000|Overall Study|Withdrawal by Subject|1|||
147160763|NCT03352557|530754037|FG005|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
147160764|NCT03352557|530754038|FG006|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
147160765|NCT03352557|530754039|FG007|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
147160766|NCT03352557|530754040|FG008|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
147160767|NCT03352557|530754041|FG009|PC Period: Day 1 to Week 78|Protocol Deviation|0|||
147160768|NCT03352557|530754032|FG000|PC Period: Day 1 to Week 78|Randomized by Mistake|2|||
147160769|NCT03352557|530754033|FG001|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
147160770|NCT03352557|530754034|FG002|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
147160771|NCT03352557|530754035|FG003|PC Period: Day 1 to Week 78|Randomized by Mistake|1|||
147160772|NCT03352557|530754036|FG004|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
147160773|NCT03352557|530754037|FG005|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
147160774|NCT03352557|530754038|FG006|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
147160775|NCT03352557|530754039|FG007|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
147160776|NCT03352557|530754040|FG008|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
147160777|NCT03352557|530754041|FG009|PC Period: Day 1 to Week 78|Randomized by Mistake|0|||
147160778|NCT03352557|530754032|FG000|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|2|||
147160779|NCT03352557|530754033|FG001|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|1|||
147160780|NCT03352557|530754034|FG002|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|1|||
147160781|NCT03352557|530754035|FG003|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|1|||
147160782|NCT03352557|530754036|FG004|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|2|||
147160783|NCT03352557|530754037|FG005|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|0|||
147160784|NCT03352557|530754038|FG006|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|0|||
147160785|NCT03352557|530754039|FG007|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|0|||
147160786|NCT03352557|530754040|FG008|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|0|||
147160787|NCT03352557|530754041|FG009|PC Period: Day 1 to Week 78|Site Terminated by Sponsor|0|||
147242020|NCT00837811|531057839|FG001|Overall Study|Lack of Efficacy|11|||
147242021|NCT00837811|531057840|FG002|Overall Study|Lack of Efficacy|0|||
147242022|NCT00837811|531057838|FG000|Overall Study|Lost to Follow-up|1|||
147242023|NCT00837811|531057839|FG001|Overall Study|Lost to Follow-up|3|||
147242024|NCT00837811|531057840|FG002|Overall Study|Lost to Follow-up|0|||
147242025|NCT00837811|531057838|FG000|Overall Study|Physician Decision|0|||
147242026|NCT00837811|531057839|FG001|Overall Study|Physician Decision|2|||
147242027|NCT00837811|531057840|FG002|Overall Study|Physician Decision|1|||
147242028|NCT00837811|531057838|FG000|Overall Study|Withdrawal by Subject|1|||
147242029|NCT00837811|531057839|FG001|Overall Study|Withdrawal by Subject|9|||
147242030|NCT00837811|531057840|FG002|Overall Study|Withdrawal by Subject|0|||
147242031|NCT00837811|531057838|FG000|Overall Study|Sponsor Decision|0|||
147242032|NCT00837811|531057839|FG001|Overall Study|Sponsor Decision|2|||
147242033|NCT00837811|531057840|FG002|Overall Study|Sponsor Decision|0|||
147242034|NCT03307967|531057841|FG000|Overall Study|Lost to Follow-up|4|||
147242035|NCT02578316|531057842|FG000|Extension Phase|Progression of disease|6|||
147242036|NCT05243641|531057846|FG000|Overall Study|Adverse Event|3|||
147242037|NCT05243641|531057847|FG001|Overall Study|Adverse Event|0|||
147242038|NCT05243641|531057848|FG002|Overall Study|Adverse Event|0|||
147242039|NCT05243641|531057849|FG003|Overall Study|Adverse Event|1|||
147242040|NCT05243641|531057850|FG004|Overall Study|Adverse Event|0|||
147242041|NCT05243641|531057851|FG005|Overall Study|Adverse Event|0|||
147242042|NCT05243641|531057846|FG000|Overall Study|Disease progression|4|||
147242043|NCT05243641|531057847|FG001|Overall Study|Disease progression|0|||
147242044|NCT05243641|531057848|FG002|Overall Study|Disease progression|0|||
147587401|NCT00869440|532303467|FG001|Overall Study|Withdrawal by Subject|0|||
147587402|NCT00869440|532303468|FG002|Overall Study|Withdrawal by Subject|0|||
147587403|NCT00869440|532303469|FG003|Overall Study|Withdrawal by Subject|0|||
147587404|NCT00869440|532303466|FG000|Overall Study|Physician Decision|1|||
147160788|NCT03352557|530754032|FG000|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|7|||
147242045|NCT05243641|531057849|FG003|Overall Study|Disease progression|2|||
147242046|NCT05243641|531057850|FG004|Overall Study|Disease progression|0|||
147587405|NCT00869440|532303467|FG001|Overall Study|Physician Decision|1|||
147242047|NCT05243641|531057851|FG005|Overall Study|Disease progression|0|||
147242048|NCT03268954|531057853|FG000|Overall Study|Withdrawal by Subject|27|||
147242049|NCT03268954|531057854|FG001|Overall Study|Withdrawal by Subject|17|||
147160789|NCT03352557|530754033|FG001|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|1|||
147160790|NCT03352557|530754034|FG002|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|1|||
147160791|NCT03352557|530754035|FG003|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
147160792|NCT03352557|530754036|FG004|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|5|||
147160793|NCT03352557|530754037|FG005|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
147160794|NCT03352557|530754038|FG006|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
147160795|NCT03352557|530754039|FG007|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
147160796|NCT03352557|530754040|FG008|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
147160797|NCT03352557|530754041|FG009|PC Period: Day 1 to Week 78|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
147160798|NCT03352557|530754032|FG000|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|1|||
147160799|NCT03352557|530754033|FG001|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
147160800|NCT03352557|530754034|FG002|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
147160801|NCT03352557|530754035|FG003|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|1|||
147160802|NCT03352557|530754036|FG004|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|2|||
147160803|NCT03352557|530754037|FG005|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
147160804|NCT03352557|530754038|FG006|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
147160805|NCT03352557|530754039|FG007|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
147160806|NCT03352557|530754040|FG008|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
147160807|NCT03352557|530754041|FG009|PC Period: Day 1 to Week 78|Withdrawal by Participant-Concern About Study Procedures/Perceived Risks|0|||
147160808|NCT03352557|530754032|FG000|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
147160809|NCT03352557|530754033|FG001|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
147160810|NCT03352557|530754034|FG002|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
147160811|NCT03352557|530754035|FG003|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
147160812|NCT03352557|530754036|FG004|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
147160813|NCT03352557|530754037|FG005|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
147160814|NCT03352557|530754038|FG006|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
147160815|NCT03352557|530754039|FG007|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
147160816|NCT03352557|530754040|FG008|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
147160817|NCT03352557|530754041|FG009|PC Period: Day 1 to Week 78|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
147160818|NCT03352557|530754032|FG000|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
147160819|NCT03352557|530754033|FG001|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
147160820|NCT03352557|530754034|FG002|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|1|||
147160821|NCT03352557|530754035|FG003|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
147160822|NCT03352557|530754036|FG004|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|1|||
147160823|NCT03352557|530754037|FG005|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
147447165|NCT00876187|531802066|FG002|Overall Study|Protocol Violation|7|||
147447166|NCT00876187|531802067|FG003|Overall Study|Protocol Violation|6|||
147447167|NCT00876187|531802068|FG004|Overall Study|Protocol Violation|3|||
147447168|NCT00876187|531802064|FG000|Overall Study|Withdrawal by Subject|16|||
147160824|NCT03352557|530754038|FG006|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
147160825|NCT03352557|530754039|FG007|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
147160826|NCT03352557|530754040|FG008|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
147160827|NCT03352557|530754041|FG009|PC Period: Day 1 to Week 78|Withdrawal by Participant-Desire for Change in Treatment (Unrelated to Safety)|0|||
147160828|NCT03352557|530754032|FG000|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|6|||
147160829|NCT03352557|530754033|FG001|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|2|||
147160830|NCT03352557|530754034|FG002|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|2|||
147160831|NCT03352557|530754035|FG003|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|5|||
147160832|NCT03352557|530754036|FG004|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|7|||
147242050|NCT03268954|531057853|FG000|Overall Study|Lost to Follow-up|2|||
147242051|NCT03268954|531057854|FG001|Overall Study|Lost to Follow-up|3|||
147587406|NCT00869440|532303468|FG002|Overall Study|Physician Decision|0|||
147587407|NCT00869440|532303469|FG003|Overall Study|Physician Decision|0|||
147587408|NCT03546647|532303471|FG000|Overall Study|Adverse Event|1|||
147160833|NCT03352557|530754037|FG005|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|0|||
147160834|NCT03352557|530754038|FG006|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|0|||
147160835|NCT03352557|530754039|FG007|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|0|||
147160836|NCT03352557|530754040|FG008|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|0|||
147160837|NCT03352557|530754041|FG009|PC Period: Day 1 to Week 78|Withdrawal by Participant-Other|0|||
147160838|NCT03352557|530754032|FG000|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
147160839|NCT03352557|530754033|FG001|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
147322388|NCT02223182|531343662|FG000|Open-Label 300 Period|Non Compliance|0|||
147322389|NCT02223182|531343663|FG001|Open-Label 300 Period|Non Compliance|2|||
147322390|NCT02223182|531343664|FG002|Open-Label 300 Period|Non Compliance|1|||
147322391|NCT02223182|531343665|FG003|Open-Label 300 Period|Non Compliance|0|||
147322392|NCT00231179|531345335|FG000|Overall Study|Lost to Follow-up|21|||
147322393|NCT00231179|531345336|FG001|Overall Study|Lost to Follow-up|21|||
147587409|NCT03546647|532303472|FG001|Overall Study|Adverse Event|0|||
147587410|NCT00124462|532303473|FG000|Overall Study|Lost to Follow-up|3|||
147587411|NCT00124462|532303474|FG001|Overall Study|Lost to Follow-up|3|||
147587412|NCT00124462|532303473|FG000|Overall Study|Physician Decision|3|||
147587413|NCT00124462|532303474|FG001|Overall Study|Physician Decision|4|||
147587414|NCT00124462|532303473|FG000|Overall Study|Withdrawal by Subject|4|||
147587415|NCT00124462|532303474|FG001|Overall Study|Withdrawal by Subject|5|||
147587416|NCT00124462|532303473|FG000|Overall Study|Device fitting, n=2, other hlth issues|1|||
147587417|NCT00124462|532303474|FG001|Overall Study|Device fitting, n=2, other hlth issues|1|||
147587418|NCT02400476|532303475|FG000|Overall Study|Adverse Event|57|||
147322394|NCT00231179|531345335|FG000|Overall Study|Withdrawal by Subject|3|||
147587419|NCT02400476|532303476|FG001|Overall Study|Adverse Event|10|||
147587420|NCT02400476|532303477|FG002|Overall Study|Adverse Event|22|||
147587421|NCT02400476|532303478|FG003|Overall Study|Adverse Event|19|||
147322395|NCT00231179|531345336|FG001|Overall Study|Withdrawal by Subject|3|||
147322396|NCT02206685|531345337|FG000|Overall Study|Surgery cancelled/changed|2|||
147322397|NCT02206685|531345338|FG001|Overall Study|Surgery cancelled/changed|3|||
147322398|NCT02206685|531345337|FG000|Overall Study|Withdrawal by Subject|1|||
147322399|NCT02206685|531345338|FG001|Overall Study|Withdrawal by Subject|2|||
147322400|NCT02206685|531345337|FG000|Overall Study|Protocol Violation|2|||
147322401|NCT02206685|531345338|FG001|Overall Study|Protocol Violation|2|||
147322402|NCT01345292|531345339|FG000|Overall Study|Withdrawal by Subject|2|||
147322403|NCT01345292|531345340|FG001|Overall Study|Withdrawal by Subject|0|||
147322404|NCT01345292|531345341|FG002|Overall Study|Withdrawal by Subject|1|||
147322405|NCT05406791|531345345|FG000|Overall Study|Lost to Follow-up|13|||
147322406|NCT05406791|531345346|FG001|Overall Study|Lost to Follow-up|10|||
147322407|NCT00515086|531345347|FG000|Overall Study|Adverse Event|1|||
147322408|NCT00515086|531345348|FG001|Overall Study|Adverse Event|1|||
147322409|NCT00515086|531345349|FG002|Overall Study|Adverse Event|2|||
147322410|NCT00515086|531345350|FG003|Overall Study|Adverse Event|3|||
147322411|NCT00515086|531345347|FG000|Overall Study|Administrative|1|||
147322412|NCT00515086|531345348|FG001|Overall Study|Administrative|1|||
147322413|NCT00515086|531345349|FG002|Overall Study|Administrative|0|||
147322414|NCT00515086|531345350|FG003|Overall Study|Administrative|0|||
147322415|NCT00515086|531345347|FG000|Overall Study|Withdrawal by Subject|1|||
147322416|NCT00515086|531345348|FG001|Overall Study|Withdrawal by Subject|0|||
147322417|NCT00515086|531345349|FG002|Overall Study|Withdrawal by Subject|0|||
147322418|NCT00515086|531345350|FG003|Overall Study|Withdrawal by Subject|1|||
147322419|NCT00515086|531345347|FG000|Overall Study|Unsatisfactory therapeutic effect|18|||
147322420|NCT00515086|531345348|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
147322421|NCT00515086|531345349|FG002|Overall Study|Unsatisfactory therapeutic effect|3|||
147322422|NCT00515086|531345350|FG003|Overall Study|Unsatisfactory therapeutic effect|2|||
147587422|NCT02400476|532303479|FG004|Overall Study|Adverse Event|5|||
147587423|NCT02400476|532303480|FG005|Overall Study|Adverse Event|8|||
147587424|NCT02400476|532303475|FG000|Overall Study|Withdrawal by Subject|4|||
147587425|NCT02400476|532303476|FG001|Overall Study|Withdrawal by Subject|1|||
147587426|NCT02400476|532303477|FG002|Overall Study|Withdrawal by Subject|12|||
147322423|NCT00515086|531345347|FG000|Overall Study|Lost to Follow-up|1|||
147447169|NCT00876187|531802065|FG001|Overall Study|Withdrawal by Subject|26|||
147587427|NCT02400476|532303478|FG003|Overall Study|Withdrawal by Subject|7|||
147587428|NCT02400476|532303479|FG004|Overall Study|Withdrawal by Subject|5|||
147322424|NCT00515086|531345348|FG001|Overall Study|Lost to Follow-up|0|||
147322425|NCT00515086|531345349|FG002|Overall Study|Lost to Follow-up|0|||
147587429|NCT02400476|532303480|FG005|Overall Study|Withdrawal by Subject|5|||
147322426|NCT00515086|531345350|FG003|Overall Study|Lost to Follow-up|0|||
147322427|NCT00515086|531345347|FG000|Overall Study|Study drug no longer required|0|||
147322428|NCT00515086|531345348|FG001|Overall Study|Study drug no longer required|1|||
147587430|NCT02400476|532303475|FG000|Overall Study|Lost to Follow-up|0|||
147587431|NCT02400476|532303476|FG001|Overall Study|Lost to Follow-up|0|||
147587432|NCT02400476|532303477|FG002|Overall Study|Lost to Follow-up|0|||
147322429|NCT00515086|531345349|FG002|Overall Study|Study drug no longer required|0|||
147587433|NCT02400476|532303478|FG003|Overall Study|Lost to Follow-up|1|||
147322430|NCT00515086|531345350|FG003|Overall Study|Study drug no longer required|0|||
147322431|NCT00515086|531345347|FG000|Overall Study|Death|2|||
147447170|NCT00876187|531802066|FG002|Overall Study|Withdrawal by Subject|32|||
147447171|NCT00876187|531802067|FG003|Overall Study|Withdrawal by Subject|38|||
147447172|NCT00876187|531802068|FG004|Overall Study|Withdrawal by Subject|37|||
147587434|NCT02400476|532303479|FG004|Overall Study|Lost to Follow-up|3|||
147587435|NCT02400476|532303480|FG005|Overall Study|Lost to Follow-up|1|||
147587436|NCT02400476|532303475|FG000|Overall Study|Physician Decision|0|||
147587437|NCT02400476|532303476|FG001|Overall Study|Physician Decision|0|||
147587438|NCT02400476|532303477|FG002|Overall Study|Physician Decision|1|||
147587439|NCT02400476|532303478|FG003|Overall Study|Physician Decision|1|||
147587440|NCT02400476|532303479|FG004|Overall Study|Physician Decision|0|||
147587441|NCT02400476|532303480|FG005|Overall Study|Physician Decision|1|||
147322432|NCT00515086|531345348|FG001|Overall Study|Death|0|||
147322433|NCT00515086|531345349|FG002|Overall Study|Death|0|||
147322434|NCT00515086|531345350|FG003|Overall Study|Death|0|||
147322435|NCT02373813|531345351|FG000|Run-In Period|Other, Not Specified|5|||
147322436|NCT02373813|531345352|FG001|Run-In Period|Other, Not Specified|0|||
147322437|NCT02373813|531345353|FG002|Run-In Period|Other, Not Specified|0|||
147322438|NCT02373813|531345354|FG003|Run-In Period|Other, Not Specified|0|||
147322439|NCT02373813|531345351|FG000|Run-In Period|Withdrawal by Subject|16|||
147322440|NCT02373813|531345352|FG001|Run-In Period|Withdrawal by Subject|0|||
147322441|NCT02373813|531345353|FG002|Run-In Period|Withdrawal by Subject|0|||
147322442|NCT02373813|531345354|FG003|Run-In Period|Withdrawal by Subject|0|||
147322443|NCT02373813|531345351|FG000|Run-In Period|Decision by Sponsor|11|||
147322444|NCT02373813|531345352|FG001|Run-In Period|Decision by Sponsor|0|||
147322445|NCT02373813|531345353|FG002|Run-In Period|Decision by Sponsor|0|||
147322446|NCT02373813|531345354|FG003|Run-In Period|Decision by Sponsor|0|||
147322447|NCT02373813|531345351|FG000|Run-In Period|Protocol Violation|75|||
147322448|NCT02373813|531345352|FG001|Run-In Period|Protocol Violation|0|||
147322449|NCT02373813|531345353|FG002|Run-In Period|Protocol Violation|0|||
147322450|NCT02373813|531345354|FG003|Run-In Period|Protocol Violation|0|||
147322451|NCT02373813|531345351|FG000|Run-In Period|Lost to Follow-up|2|||
147322452|NCT02373813|531345352|FG001|Run-In Period|Lost to Follow-up|0|||
147322453|NCT02373813|531345353|FG002|Run-In Period|Lost to Follow-up|0|||
147322454|NCT02373813|531345354|FG003|Run-In Period|Lost to Follow-up|0|||
147587442|NCT02400476|532303475|FG000|Overall Study|Other, Disease Progression|0|||
147587443|NCT02400476|532303476|FG001|Overall Study|Other, Disease Progression|1|||
147587444|NCT02400476|532303477|FG002|Overall Study|Other, Disease Progression|2|||
147587445|NCT02400476|532303478|FG003|Overall Study|Other, Disease Progression|1|||
147587446|NCT02400476|532303479|FG004|Overall Study|Other, Disease Progression|2|||
147587447|NCT02400476|532303480|FG005|Overall Study|Other, Disease Progression|1|||
147587448|NCT02400476|532303475|FG000|Overall Study|Other, Decreased Quality of Life|0|||
147587449|NCT02400476|532303476|FG001|Overall Study|Other, Decreased Quality of Life|0|||
147587450|NCT02400476|532303477|FG002|Overall Study|Other, Decreased Quality of Life|2|||
147587451|NCT02400476|532303478|FG003|Overall Study|Other, Decreased Quality of Life|0|||
147587452|NCT02400476|532303479|FG004|Overall Study|Other, Decreased Quality of Life|0|||
147587453|NCT02400476|532303480|FG005|Overall Study|Other, Decreased Quality of Life|0|||
147587454|NCT02400476|532303475|FG000|Overall Study|Other, Noncompliance to Protocol Requirements|0|||
147587455|NCT02400476|532303476|FG001|Overall Study|Other, Noncompliance to Protocol Requirements|0|||
147587456|NCT02400476|532303477|FG002|Overall Study|Other, Noncompliance to Protocol Requirements|2|||
147587457|NCT02400476|532303478|FG003|Overall Study|Other, Noncompliance to Protocol Requirements|1|||
147587458|NCT02400476|532303479|FG004|Overall Study|Other, Noncompliance to Protocol Requirements|0|||
147587459|NCT02400476|532303480|FG005|Overall Study|Other, Noncompliance to Protocol Requirements|0|||
147160840|NCT03352557|530754034|FG002|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
147322455|NCT02373813|531345351|FG000|Run-In Period|Adverse Event|3|||
147322456|NCT02373813|531345352|FG001|Run-In Period|Adverse Event|0|||
147322457|NCT02373813|531345353|FG002|Run-In Period|Adverse Event|0|||
147322458|NCT02373813|531345354|FG003|Run-In Period|Adverse Event|0|||
147447173|NCT00876187|531802064|FG000|Overall Study|Entered extension study|101|||
147322459|NCT02373813|531345351|FG000|Run-In Period|Noncompliance|1|||
147322460|NCT02373813|531345352|FG001|Run-In Period|Noncompliance|0|||
147322461|NCT02373813|531345353|FG002|Run-In Period|Noncompliance|0|||
147322462|NCT02373813|531345354|FG003|Run-In Period|Noncompliance|0|||
147322463|NCT02373813|531345351|FG000|Run-In Period|Ineligibility Determined|3|||
147447174|NCT00876187|531802065|FG001|Overall Study|Entered extension study|120|||
147587460|NCT02487082|532303481|FG000|Run-In Phase (5 Weeks)|Withdrawal by Subject|1|||
147587461|NCT02487082|532303482|FG001|Run-In Phase (5 Weeks)|Withdrawal by Subject|2|||
147587462|NCT02487082|532303481|FG000|Phase 1 (5 Weeks)|Withdrawal by Subject|1|||
147654434|NCT03853291|532556726|FG000|Overall Study|Lost to Follow-up|1|||
147322464|NCT02373813|531345352|FG001|Run-In Period|Ineligibility Determined|0|||
147322465|NCT02373813|531345353|FG002|Run-In Period|Ineligibility Determined|0|||
147322466|NCT02373813|531345354|FG003|Run-In Period|Ineligibility Determined|0|||
147322467|NCT02373813|531345351|FG000|Double-Blind Treatment Period|Decision by Sponsor|0|||
147322468|NCT02373813|531345352|FG001|Double-Blind Treatment Period|Decision by Sponsor|1|||
147587463|NCT02487082|532303482|FG001|Phase 1 (5 Weeks)|Withdrawal by Subject|0|||
147587464|NCT01588548|532303484|FG000|Overall Study|Withdrawal by Subject|0|||
147160841|NCT03352557|530754035|FG003|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|1|||
147160842|NCT03352557|530754036|FG004|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|3|||
147160843|NCT03352557|530754037|FG005|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
147160844|NCT03352557|530754038|FG006|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
147160845|NCT03352557|530754039|FG007|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
147160846|NCT03352557|530754040|FG008|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
147160847|NCT03352557|530754041|FG009|PC Period: Day 1 to Week 78|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
147160848|NCT03352557|530754032|FG000|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|1|||
147160849|NCT03352557|530754033|FG001|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
147160850|NCT03352557|530754034|FG002|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|1|||
147160851|NCT03352557|530754035|FG003|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|1|||
147160852|NCT03352557|530754036|FG004|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|1|||
147160853|NCT03352557|530754037|FG005|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
147160854|NCT03352557|530754038|FG006|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
147160855|NCT03352557|530754039|FG007|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
147160856|NCT03352557|530754040|FG008|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
147160857|NCT03352557|530754041|FG009|PC Period: Day 1 to Week 78|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
147160858|NCT03352557|530754032|FG000|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|1|||
147160859|NCT03352557|530754033|FG001|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
147160860|NCT03352557|530754034|FG002|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
147160861|NCT03352557|530754035|FG003|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
147160862|NCT03352557|530754036|FG004|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|1|||
147160863|NCT03352557|530754037|FG005|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
147160864|NCT03352557|530754038|FG006|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
147160865|NCT03352557|530754039|FG007|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
147160866|NCT03352557|530754040|FG008|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
147160867|NCT03352557|530754041|FG009|PC Period: Day 1 to Week 78|WBP/G-Desire for Change in Treatment (Unrelated to Safety)|0|||
147160868|NCT03352557|530754032|FG000|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
147160869|NCT03352557|530754033|FG001|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
147160870|NCT03352557|530754034|FG002|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
147160871|NCT03352557|530754035|FG003|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
147160872|NCT03352557|530754036|FG004|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|1|||
147160873|NCT03352557|530754037|FG005|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
147160874|NCT03352557|530754038|FG006|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
147160875|NCT03352557|530754039|FG007|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
147160876|NCT03352557|530754040|FG008|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
147160877|NCT03352557|530754041|FG009|PC Period: Day 1 to Week 78|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
147160878|NCT03352557|530754032|FG000|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
147160879|NCT03352557|530754033|FG001|PC Period: Day 1 to Week 78|WBP/G-Other|2|||
147322469|NCT02373813|531345353|FG002|Double-Blind Treatment Period|Decision by Sponsor|2|||
147322470|NCT02373813|531345354|FG003|Double-Blind Treatment Period|Decision by Sponsor|0|||
147322471|NCT02373813|531345351|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
147322472|NCT02373813|531345352|FG001|Double-Blind Treatment Period|Protocol Violation|2|||
147322473|NCT02373813|531345353|FG002|Double-Blind Treatment Period|Protocol Violation|0|||
147322474|NCT02373813|531345354|FG003|Double-Blind Treatment Period|Protocol Violation|0|||
147322475|NCT02373813|531345351|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
147322476|NCT02373813|531345352|FG001|Double-Blind Treatment Period|Lost to Follow-up|0|||
147322477|NCT02373813|531345353|FG002|Double-Blind Treatment Period|Lost to Follow-up|1|||
147322478|NCT02373813|531345354|FG003|Double-Blind Treatment Period|Lost to Follow-up|1|||
147587465|NCT01588548|532303485|FG001|Overall Study|Withdrawal by Subject|1|||
147587466|NCT01588548|532303486|FG002|Overall Study|Withdrawal by Subject|1|||
147587467|NCT01588548|532303487|FG003|Overall Study|Withdrawal by Subject|1|||
147587468|NCT01588548|532303488|FG004|Overall Study|Withdrawal by Subject|2|||
147587469|NCT01588548|532303489|FG005|Overall Study|Withdrawal by Subject|3|||
147587470|NCT01588548|532303484|FG000|Overall Study|Adverse Event|0|||
147587471|NCT01588548|532303485|FG001|Overall Study|Adverse Event|0|||
147587472|NCT01588548|532303486|FG002|Overall Study|Adverse Event|1|||
147587473|NCT01588548|532303487|FG003|Overall Study|Adverse Event|2|||
147587474|NCT01588548|532303488|FG004|Overall Study|Adverse Event|1|||
147587475|NCT01588548|532303489|FG005|Overall Study|Adverse Event|0|||
147160880|NCT03352557|530754034|FG002|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
147160881|NCT03352557|530754035|FG003|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
147160882|NCT03352557|530754036|FG004|PC Period: Day 1 to Week 78|WBP/G-Other|3|||
147160883|NCT03352557|530754037|FG005|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
147160884|NCT03352557|530754038|FG006|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
147160885|NCT03352557|530754039|FG007|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
147160886|NCT03352557|530754040|FG008|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
147160887|NCT03352557|530754041|FG009|PC Period: Day 1 to Week 78|WBP/G-Other|0|||
147160888|NCT03352557|530754032|FG000|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|2|||
147160889|NCT03352557|530754033|FG001|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
147160890|NCT03352557|530754034|FG002|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
147160891|NCT03352557|530754035|FG003|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
147160892|NCT03352557|530754036|FG004|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|1|||
147160893|NCT03352557|530754037|FG005|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
147160894|NCT03352557|530754038|FG006|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
147160895|NCT03352557|530754039|FG007|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
147160896|NCT03352557|530754040|FG008|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
147160897|NCT03352557|530754041|FG009|PC Period: Day 1 to Week 78|Physician Decision-Unrelated to Safety|0|||
147160898|NCT03352557|530754032|FG000|PC Period: Day 1 to Week 78|Lost to Follow-up|1|||
147160899|NCT03352557|530754033|FG001|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
147160900|NCT03352557|530754034|FG002|PC Period: Day 1 to Week 78|Lost to Follow-up|1|||
147160901|NCT03352557|530754035|FG003|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
147160902|NCT03352557|530754036|FG004|PC Period: Day 1 to Week 78|Lost to Follow-up|2|||
147160903|NCT03352557|530754037|FG005|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
147160904|NCT03352557|530754038|FG006|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
147160905|NCT03352557|530754039|FG007|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
147322479|NCT02373813|531345351|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
147322480|NCT02373813|531345352|FG001|Double-Blind Treatment Period|Withdrawal by Subject|10|||
147322481|NCT02373813|531345353|FG002|Double-Blind Treatment Period|Withdrawal by Subject|6|||
147322482|NCT02373813|531345354|FG003|Double-Blind Treatment Period|Withdrawal by Subject|3|||
147322483|NCT01764386|531345362|FG000|Controlled Treatment Period (CTP)|Adverse Event|35|||
147322484|NCT01764386|531345363|FG001|Controlled Treatment Period (CTP)|Adverse Event|0|||
147322485|NCT01764386|531345362|FG000|Controlled Treatment Period (CTP)|Wk 16 Efficacy and BP Criteria|32|||
147322486|NCT01764386|531345363|FG001|Controlled Treatment Period (CTP)|Wk 16 Efficacy and BP Criteria|0|||
147322487|NCT01764386|531345362|FG000|Controlled Treatment Period (CTP)|Lost to Follow-up|9|||
147322488|NCT01764386|531345363|FG001|Controlled Treatment Period (CTP)|Lost to Follow-up|5|||
147322489|NCT01764386|531345362|FG000|Controlled Treatment Period (CTP)|Withdrawal of Consent,Protocol Deviation|6|||
147322490|NCT01764386|531345363|FG001|Controlled Treatment Period (CTP)|Withdrawal of Consent,Protocol Deviation|2|||
147322491|NCT01764386|531345362|FG000|Uncontrolled Treatment Period (UTP)|Adverse Event|2|||
147322492|NCT01764386|531345363|FG001|Uncontrolled Treatment Period (UTP)|Adverse Event|13|||
147322493|NCT01764386|531345362|FG000|Uncontrolled Treatment Period (UTP)|Wk 42 Efficacy and BP Criteria|0|||
147322494|NCT01764386|531345363|FG001|Uncontrolled Treatment Period (UTP)|Wk 42 Efficacy and BP Criteria|26|||
147322495|NCT01764386|531345362|FG000|Uncontrolled Treatment Period (UTP)|Lost to Follow-up|9|||
147322496|NCT01764386|531345363|FG001|Uncontrolled Treatment Period (UTP)|Lost to Follow-up|9|||
147322497|NCT01764386|531345362|FG000|Uncontrolled Treatment Period (UTP)|Withdrawal of Consent,Protocol Deviation|5|||
147322498|NCT01764386|531345363|FG001|Uncontrolled Treatment Period (UTP)|Withdrawal of Consent,Protocol Deviation|5|||
147322499|NCT02271594|531345364|FG000|Overall Study|Study closed; recruiting failure|19|||
147322500|NCT02271594|531345365|FG001|Overall Study|Study closed; recruiting failure|12|||
147322501|NCT00495469|531345366|FG000|Overall Study|Adverse Event|0|||
147322502|NCT00495469|531345367|FG001|Overall Study|Adverse Event|1|||
147322503|NCT00495469|531345368|FG002|Overall Study|Adverse Event|3|||
147322504|NCT00495469|531345369|FG003|Overall Study|Adverse Event|0|||
147322505|NCT00495469|531345370|FG004|Overall Study|Adverse Event|1|||
147322506|NCT00495469|531345371|FG005|Overall Study|Adverse Event|1|||
147322507|NCT00495469|531345372|FG006|Overall Study|Adverse Event|1|||
147322508|NCT00495469|531345366|FG000|Overall Study|Lost to Follow-up|1|||
147447175|NCT00876187|531802066|FG002|Overall Study|Entered extension study|156|||
147447176|NCT00876187|531802067|FG003|Overall Study|Entered extension study|151|||
147587476|NCT01588548|532303484|FG000|Overall Study|Condition Under Investigation Worsened|3|||
147587477|NCT01588548|532303485|FG001|Overall Study|Condition Under Investigation Worsened|6|||
147447177|NCT00876187|531802068|FG004|Overall Study|Entered extension study|144|||
147447178|NCT00876187|531802064|FG000|Overall Study|Randomized but not treated|3|||
147160906|NCT03352557|530754040|FG008|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
147160907|NCT03352557|530754041|FG009|PC Period: Day 1 to Week 78|Lost to Follow-up|0|||
147322509|NCT00495469|531345367|FG001|Overall Study|Lost to Follow-up|1|||
147322510|NCT00495469|531345368|FG002|Overall Study|Lost to Follow-up|3|||
147322511|NCT00495469|531345369|FG003|Overall Study|Lost to Follow-up|1|||
147322512|NCT00495469|531345370|FG004|Overall Study|Lost to Follow-up|0|||
147322513|NCT00495469|531345371|FG005|Overall Study|Lost to Follow-up|0|||
147322514|NCT00495469|531345372|FG006|Overall Study|Lost to Follow-up|0|||
147322515|NCT00495469|531345366|FG000|Overall Study|Protocol Violation|0|||
147322516|NCT00495469|531345367|FG001|Overall Study|Protocol Violation|0|||
147322517|NCT00495469|531345368|FG002|Overall Study|Protocol Violation|0|||
147322518|NCT00495469|531345369|FG003|Overall Study|Protocol Violation|0|||
147322519|NCT00495469|531345370|FG004|Overall Study|Protocol Violation|1|||
147322520|NCT00495469|531345371|FG005|Overall Study|Protocol Violation|2|||
147322521|NCT00495469|531345372|FG006|Overall Study|Protocol Violation|0|||
147322522|NCT00495469|531345366|FG000|Overall Study|Withdrawal by Subject|5|||
147322523|NCT00495469|531345367|FG001|Overall Study|Withdrawal by Subject|3|||
147322524|NCT00495469|531345368|FG002|Overall Study|Withdrawal by Subject|1|||
147322525|NCT00495469|531345369|FG003|Overall Study|Withdrawal by Subject|3|||
147322526|NCT00495469|531345370|FG004|Overall Study|Withdrawal by Subject|3|||
147322527|NCT00495469|531345371|FG005|Overall Study|Withdrawal by Subject|2|||
147322528|NCT00495469|531345372|FG006|Overall Study|Withdrawal by Subject|3|||
147322529|NCT00495469|531345366|FG000|Overall Study|Lack of Efficacy|0|||
147160908|NCT03352557|530754032|FG000|PC Period: Day 1 to Week 78|Other|5|||
147160909|NCT03352557|530754033|FG001|PC Period: Day 1 to Week 78|Other|1|||
147160910|NCT03352557|530754034|FG002|PC Period: Day 1 to Week 78|Other|0|||
147160911|NCT03352557|530754035|FG003|PC Period: Day 1 to Week 78|Other|3|||
147160912|NCT03352557|530754036|FG004|PC Period: Day 1 to Week 78|Other|0|||
147160913|NCT03352557|530754037|FG005|PC Period: Day 1 to Week 78|Other|0|||
147160914|NCT03352557|530754038|FG006|PC Period: Day 1 to Week 78|Other|0|||
147160915|NCT03352557|530754039|FG007|PC Period: Day 1 to Week 78|Other|0|||
147160916|NCT03352557|530754040|FG008|PC Period: Day 1 to Week 78|Other|0|||
147160917|NCT03352557|530754041|FG009|PC Period: Day 1 to Week 78|Other|0|||
147160918|NCT03352557|530754032|FG000|PC Period: Day 1 to Week 78|Not Dosed|0|||
147160919|NCT03352557|530754033|FG001|PC Period: Day 1 to Week 78|Not Dosed|0|||
147160920|NCT03352557|530754034|FG002|PC Period: Day 1 to Week 78|Not Dosed|0|||
147160921|NCT03352557|530754035|FG003|PC Period: Day 1 to Week 78|Not Dosed|0|||
147160922|NCT03352557|530754036|FG004|PC Period: Day 1 to Week 78|Not Dosed|4|||
147160923|NCT03352557|530754037|FG005|PC Period: Day 1 to Week 78|Not Dosed|0|||
147160924|NCT03352557|530754038|FG006|PC Period: Day 1 to Week 78|Not Dosed|0|||
147160925|NCT03352557|530754039|FG007|PC Period: Day 1 to Week 78|Not Dosed|0|||
147160926|NCT03352557|530754040|FG008|PC Period: Day 1 to Week 78|Not Dosed|0|||
147160927|NCT03352557|530754041|FG009|PC Period: Day 1 to Week 78|Not Dosed|0|||
147160928|NCT03352557|530754032|FG000|LTE Period: Week 80 to Week 173|Death|0|||
147160929|NCT03352557|530754033|FG001|LTE Period: Week 80 to Week 173|Death|0|||
147160930|NCT03352557|530754034|FG002|LTE Period: Week 80 to Week 173|Death|0|||
147160931|NCT03352557|530754035|FG003|LTE Period: Week 80 to Week 173|Death|0|||
147160932|NCT03352557|530754036|FG004|LTE Period: Week 80 to Week 173|Death|0|||
147160933|NCT03352557|530754037|FG005|LTE Period: Week 80 to Week 173|Death|1|||
147160934|NCT03352557|530754038|FG006|LTE Period: Week 80 to Week 173|Death|0|||
147160935|NCT03352557|530754039|FG007|LTE Period: Week 80 to Week 173|Death|1|||
147160936|NCT03352557|530754040|FG008|LTE Period: Week 80 to Week 173|Death|1|||
147160937|NCT03352557|530754041|FG009|LTE Period: Week 80 to Week 173|Death|1|||
147322530|NCT00495469|531345367|FG001|Overall Study|Lack of Efficacy|0|||
147322531|NCT00495469|531345368|FG002|Overall Study|Lack of Efficacy|0|||
147322532|NCT00495469|531345369|FG003|Overall Study|Lack of Efficacy|0|||
147322533|NCT00495469|531345370|FG004|Overall Study|Lack of Efficacy|0|||
147322534|NCT00495469|531345371|FG005|Overall Study|Lack of Efficacy|0|||
147322535|NCT00495469|531345372|FG006|Overall Study|Lack of Efficacy|1|||
147322536|NCT00495469|531345366|FG000|Overall Study|Liver function test abnormality|0|||
147322537|NCT00495469|531345367|FG001|Overall Study|Liver function test abnormality|1|||
147322538|NCT00495469|531345368|FG002|Overall Study|Liver function test abnormality|0|||
147322539|NCT00495469|531345369|FG003|Overall Study|Liver function test abnormality|0|||
147160938|NCT03352557|530754032|FG000|LTE Period: Week 80 to Week 173|Adverse Event|0|||
147160939|NCT03352557|530754033|FG001|LTE Period: Week 80 to Week 173|Adverse Event|0|||
147322540|NCT00495469|531345370|FG004|Overall Study|Liver function test abnormality|0|||
147322541|NCT00495469|531345371|FG005|Overall Study|Liver function test abnormality|0|||
147322542|NCT00495469|531345372|FG006|Overall Study|Liver function test abnormality|0|||
147322543|NCT00495469|531345366|FG000|Overall Study|ST depression at randomisation in ECG|0|||
147160940|NCT03352557|530754034|FG002|LTE Period: Week 80 to Week 173|Adverse Event|0|||
147160941|NCT03352557|530754035|FG003|LTE Period: Week 80 to Week 173|Adverse Event|0|||
147160942|NCT03352557|530754036|FG004|LTE Period: Week 80 to Week 173|Adverse Event|0|||
147160943|NCT03352557|530754037|FG005|LTE Period: Week 80 to Week 173|Adverse Event|3|||
147160944|NCT03352557|530754038|FG006|LTE Period: Week 80 to Week 173|Adverse Event|0|||
147160945|NCT03352557|530754039|FG007|LTE Period: Week 80 to Week 173|Adverse Event|0|||
147160946|NCT03352557|530754040|FG008|LTE Period: Week 80 to Week 173|Adverse Event|0|||
147160947|NCT03352557|530754041|FG009|LTE Period: Week 80 to Week 173|Adverse Event|0|||
147160948|NCT03352557|530754032|FG000|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
147160949|NCT03352557|530754033|FG001|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
147160950|NCT03352557|530754034|FG002|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
147587478|NCT01588548|532303486|FG002|Overall Study|Condition Under Investigation Worsened|4|||
147587479|NCT01588548|532303487|FG003|Overall Study|Condition Under Investigation Worsened|4|||
147587480|NCT01588548|532303488|FG004|Overall Study|Condition Under Investigation Worsened|3|||
147587481|NCT01588548|532303489|FG005|Overall Study|Condition Under Investigation Worsened|3|||
147587482|NCT02190279|532305486|FG000|Overall Study|Withdrawal consent|1|||
147587483|NCT02190279|532305487|FG001|Overall Study|Withdrawal consent|0|||
147587484|NCT02190279|532305488|FG002|Overall Study|Withdrawal consent|1|||
147587485|NCT02190279|532305486|FG000|Overall Study|Lost to Follow-up|2|||
147160951|NCT03352557|530754035|FG003|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
147160952|NCT03352557|530754036|FG004|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
147160953|NCT03352557|530754037|FG005|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
147160954|NCT03352557|530754038|FG006|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
147160955|NCT03352557|530754039|FG007|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
147160956|NCT03352557|530754040|FG008|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|2|||
147160957|NCT03352557|530754041|FG009|LTE Period: Week 80 to Week 173|Site Terminated by Sponsor|0|||
147160958|NCT03352557|530754032|FG000|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|0|||
147160959|NCT03352557|530754033|FG001|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|0|||
147160960|NCT03352557|530754034|FG002|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|0|||
147160961|NCT03352557|530754035|FG003|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|0|||
147160962|NCT03352557|530754036|FG004|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|0|||
147160963|NCT03352557|530754037|FG005|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|38|||
147160964|NCT03352557|530754038|FG006|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|49|||
147160965|NCT03352557|530754039|FG007|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|75|||
147160966|NCT03352557|530754040|FG008|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|151|||
147160967|NCT03352557|530754041|FG009|LTE Period: Week 80 to Week 173|Study Terminated by Sponsor|154|||
147160968|NCT03352557|530754032|FG000|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
147160969|NCT03352557|530754033|FG001|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
147160970|NCT03352557|530754034|FG002|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
147160971|NCT03352557|530754035|FG003|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
147160972|NCT03352557|530754036|FG004|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
147160973|NCT03352557|530754037|FG005|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|1|||
147160974|NCT03352557|530754038|FG006|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|0|||
147160975|NCT03352557|530754039|FG007|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|5|||
147160976|NCT03352557|530754040|FG008|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|3|||
147160977|NCT03352557|530754041|FG009|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Study Visit Burden/Scheduling Conflicts|3|||
147587486|NCT02190279|532305487|FG001|Overall Study|Lost to Follow-up|0|||
147587487|NCT02190279|532305488|FG002|Overall Study|Lost to Follow-up|0|||
147160978|NCT03352557|530754032|FG000|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
147160979|NCT03352557|530754033|FG001|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
147160980|NCT03352557|530754034|FG002|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
147160981|NCT03352557|530754035|FG003|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
147160982|NCT03352557|530754036|FG004|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
147160983|NCT03352557|530754037|FG005|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
147160984|NCT03352557|530754038|FG006|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
147160985|NCT03352557|530754039|FG007|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
147160986|NCT03352557|530754040|FG008|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|1|||
147160987|NCT03352557|530754041|FG009|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Relocation (Moving or Has Moved)|0|||
147160988|NCT03352557|530754032|FG000|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
147160989|NCT03352557|530754033|FG001|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
147160990|NCT03352557|530754034|FG002|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
147160991|NCT03352557|530754035|FG003|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
147160992|NCT03352557|530754036|FG004|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
147160993|NCT03352557|530754037|FG005|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|1|||
147160994|NCT03352557|530754038|FG006|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|0|||
147587488|NCT02190279|532305486|FG000|Overall Study|Refused further treatment|0|||
147587489|NCT02190279|532305487|FG001|Overall Study|Refused further treatment|0|||
147587490|NCT02190279|532305488|FG002|Overall Study|Refused further treatment|1|||
147587491|NCT02190279|532305486|FG000|Overall Study|Screening failure|0|||
147587492|NCT02190279|532305487|FG001|Overall Study|Screening failure|0|||
147587493|NCT02190279|532305488|FG002|Overall Study|Screening failure|1|||
147587494|NCT02938442|532305489|FG000|Overall Study|Death|0|||
147587495|NCT02938442|532305490|FG001|Overall Study|Death|1|||
147160995|NCT03352557|530754039|FG007|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|1|||
147160996|NCT03352557|530754040|FG008|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|1|||
147160997|NCT03352557|530754041|FG009|LTE Period: Week 80 to Week 173|Withdrawal by Participant-Other|4|||
147160998|NCT03352557|530754032|FG000|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
147160999|NCT03352557|530754033|FG001|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
147161000|NCT03352557|530754034|FG002|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
147161001|NCT03352557|530754035|FG003|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
147161002|NCT03352557|530754036|FG004|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
147161003|NCT03352557|530754037|FG005|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
147161004|NCT03352557|530754038|FG006|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
147161005|NCT03352557|530754039|FG007|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|0|||
147161006|NCT03352557|530754040|FG008|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|2|||
147161007|NCT03352557|530754041|FG009|LTE Period: Week 80 to Week 173|WBP/G-Study Visit Burden/Scheduling Conflicts|1|||
147161008|NCT03352557|530754032|FG000|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
147161009|NCT03352557|530754033|FG001|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
147161010|NCT03352557|530754034|FG002|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
147161011|NCT03352557|530754035|FG003|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
147161012|NCT03352557|530754036|FG004|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
147161013|NCT03352557|530754037|FG005|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
147161014|NCT03352557|530754038|FG006|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
147161015|NCT03352557|530754039|FG007|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|1|||
147161016|NCT03352557|530754040|FG008|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
147161017|NCT03352557|530754041|FG009|LTE Period: Week 80 to Week 173|WBP/G-Concern About Study Procedures/Perceived Risks|0|||
147161018|NCT03352557|530754032|FG000|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
147161019|NCT03352557|530754033|FG001|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
147161020|NCT03352557|530754034|FG002|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
147161021|NCT03352557|530754035|FG003|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
147161022|NCT03352557|530754036|FG004|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
147161023|NCT03352557|530754037|FG005|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
147161024|NCT03352557|530754038|FG006|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
147161025|NCT03352557|530754039|FG007|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|2|||
147161026|NCT03352557|530754040|FG008|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
147161027|NCT03352557|530754041|FG009|LTE Period: Week 80 to Week 173|WBP/G-Relocation (Moving or Has Moved)|0|||
147242052|NCT03268954|531057853|FG000|Overall Study|Reason Not Specified|3|||
147242053|NCT03268954|531057854|FG001|Overall Study|Reason Not Specified|8|||
147242054|NCT04698187|531057859|FG000|Overall Study|Withdrawal by Subject|7|||
147242055|NCT04698187|531057859|FG000|Overall Study|Death|21|||
147242056|NCT04698187|531057859|FG000|Overall Study|Sponsor Decision|15|||
147447179|NCT00876187|531802065|FG001|Overall Study|Randomized but not treated|1|||
147447180|NCT00876187|531802066|FG002|Overall Study|Randomized but not treated|3|||
147447181|NCT00876187|531802067|FG003|Overall Study|Randomized but not treated|2|||
147447182|NCT00876187|531802068|FG004|Overall Study|Randomized but not treated|3|||
147242057|NCT04698187|531057859|FG000|Overall Study|In-transit Disease|1|||
147242058|NCT03820986|531057860|FG000|Overall Study|Death|201|||
147242059|NCT03820986|531057861|FG001|Overall Study|Death|175|||
147242060|NCT03820986|531057860|FG000|Overall Study|Lost to Follow-up|1|||
147587496|NCT02938442|532305489|FG000|Overall Study|Lost to Follow-up|0|||
147242061|NCT03820986|531057861|FG001|Overall Study|Lost to Follow-up|1|||
147242062|NCT03820986|531057860|FG000|Overall Study|Physician Decision|1|||
147242063|NCT03820986|531057861|FG001|Overall Study|Physician Decision|0|||
147242064|NCT03820986|531057860|FG000|Overall Study|Sponsor Decision|122|||
147242065|NCT03820986|531057861|FG001|Overall Study|Sponsor Decision|160|||
147447183|NCT00876187|531802064|FG000|Overall Study|Other|2|||
147587497|NCT02938442|532305490|FG001|Overall Study|Lost to Follow-up|1|||
147587498|NCT02938442|532305489|FG000|Overall Study|Physician Decision|0|||
147242066|NCT03820986|531057860|FG000|Overall Study|Withdrawal by Subject|9|||
147587499|NCT02938442|532305490|FG001|Overall Study|Physician Decision|1|||
147242067|NCT03820986|531057861|FG001|Overall Study|Withdrawal by Subject|4|||
147242068|NCT02993146|531057862|FG000|Overall Study|Withdrawal by Subject|0|||
147587500|NCT02938442|532305489|FG000|Overall Study|Withdrawal by Subject|2|||
147161028|NCT03352557|530754032|FG000|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
147161029|NCT03352557|530754033|FG001|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
147161030|NCT03352557|530754034|FG002|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
147161031|NCT03352557|530754035|FG003|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
147161032|NCT03352557|530754036|FG004|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
147161033|NCT03352557|530754037|FG005|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
147161034|NCT03352557|530754038|FG006|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
147161035|NCT03352557|530754039|FG007|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|2|||
147161036|NCT03352557|530754040|FG008|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|1|||
147161037|NCT03352557|530754041|FG009|LTE Period: Week 80 to Week 173|WBP/G-Unable to Continue to Enable Participation due to Illness/Hospitalization/Death|0|||
147161038|NCT03352557|530754032|FG000|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
147161039|NCT03352557|530754033|FG001|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
147161040|NCT03352557|530754034|FG002|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
147161041|NCT03352557|530754035|FG003|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
147161042|NCT03352557|530754036|FG004|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
147161043|NCT03352557|530754037|FG005|LTE Period: Week 80 to Week 173|WBP/G-Other|1|||
147161044|NCT03352557|530754038|FG006|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
147161045|NCT03352557|530754039|FG007|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
147161046|NCT03352557|530754040|FG008|LTE Period: Week 80 to Week 173|WBP/G-Other|2|||
147161047|NCT03352557|530754041|FG009|LTE Period: Week 80 to Week 173|WBP/G-Other|0|||
147161048|NCT03352557|530754032|FG000|LTE Period: Week 80 to Week 173|Physician Decision|0|||
147161049|NCT03352557|530754033|FG001|LTE Period: Week 80 to Week 173|Physician Decision|0|||
147161050|NCT03352557|530754034|FG002|LTE Period: Week 80 to Week 173|Physician Decision|0|||
147161051|NCT03352557|530754035|FG003|LTE Period: Week 80 to Week 173|Physician Decision|0|||
147161052|NCT03352557|530754036|FG004|LTE Period: Week 80 to Week 173|Physician Decision|0|||
147242069|NCT02993146|531057863|FG001|Overall Study|Withdrawal by Subject|0|||
147242070|NCT02993146|531057864|FG002|Overall Study|Withdrawal by Subject|1|||
147242071|NCT02993146|531057865|FG003|Overall Study|Withdrawal by Subject|1|||
147242072|NCT02513394|531057870|FG000|Overall Study|Withdrawal by Subject|11|||
147654435|NCT03853291|532556727|FG001|Overall Study|Lost to Follow-up|2|||
147242073|NCT02513394|531057871|FG001|Overall Study|Withdrawal by Subject|23|||
147242074|NCT02513394|531057870|FG000|Overall Study|Ineligible|1|||
147242075|NCT02513394|531057871|FG001|Overall Study|Ineligible|0|||
147242076|NCT03192462|531059541|FG000|Overall Study|Death|13|||
147242077|NCT03192462|531059542|FG001|Overall Study|Death|11|||
147242078|NCT03192462|531059543|FG002|Overall Study|Death|10|||
147242079|NCT03192462|531059541|FG000|Overall Study|Lost to Follow-up|0|||
147242080|NCT03192462|531059542|FG001|Overall Study|Lost to Follow-up|1|||
147242081|NCT03192462|531059543|FG002|Overall Study|Lost to Follow-up|0|||
147242082|NCT04840615|531059544|FG000|Overall Study|None of the participants completed all 4 cycles.|0|||
147242083|NCT04840615|531059545|FG001|Overall Study|None of the participants completed all 4 cycles.|2|||
147242084|NCT04840615|531059546|FG002|Overall Study|None of the participants completed all 4 cycles.|0|||
147242085|NCT01898806|531059549|FG000|Overall Study|Withdrawal by Subject|2|||
147242086|NCT01898806|531059549|FG000|Overall Study|Physician Decision|1|||
147242087|NCT03003390|531059550|FG000|Overall Study|Physician Decision|2|||
147242088|NCT03003390|531059551|FG001|Overall Study|Physician Decision|0|||
147242089|NCT03003390|531059550|FG000|Overall Study|Parent refused intervention|2|||
147242090|NCT03003390|531059551|FG001|Overall Study|Parent refused intervention|0|||
147242091|NCT03156543|531059555|FG000|Overall Study|Withdrawal by Subject|1|||
147242092|NCT03156543|531059556|FG001|Overall Study|Withdrawal by Subject|0|||
147242093|NCT03364023|531059557|FG000|Overall Study|Lost to Follow-up|3|||
147242094|NCT03364023|531059557|FG000|Overall Study|Death|14|||
147242095|NCT00674700|531059562|FG000|Year 1|Adverse Event|17|||
147242096|NCT00674700|531059563|FG001|Year 1|Adverse Event|20|||
147242097|NCT00674700|531059564|FG002|Year 1|Adverse Event|5|||
147242098|NCT00674700|531059562|FG000|Year 1|Withdrawal by Subject|7|||
147322544|NCT00495469|531345367|FG001|Overall Study|ST depression at randomisation in ECG|1|||
147322545|NCT00495469|531345368|FG002|Overall Study|ST depression at randomisation in ECG|0|||
147242099|NCT00674700|531059563|FG001|Year 1|Withdrawal by Subject|7|||
147242100|NCT00674700|531059564|FG002|Year 1|Withdrawal by Subject|6|||
147242101|NCT00674700|531059562|FG000|Year 1|Any other reason not above-mentioned|7|||
147242102|NCT00674700|531059563|FG001|Year 1|Any other reason not above-mentioned|7|||
147242103|NCT00674700|531059564|FG002|Year 1|Any other reason not above-mentioned|6|||
147242104|NCT00674700|531059562|FG000|Year 2 Follow-up Without Treatment|Adverse Event|0|||
147242105|NCT00674700|531059563|FG001|Year 2 Follow-up Without Treatment|Adverse Event|1|||
147322546|NCT00495469|531345369|FG003|Overall Study|ST depression at randomisation in ECG|0|||
147242106|NCT00674700|531059564|FG002|Year 2 Follow-up Without Treatment|Adverse Event|1|||
147587501|NCT02938442|532305490|FG001|Overall Study|Withdrawal by Subject|0|||
147587502|NCT01115855|532305491|FG000|Overall Study|Adverse Event|16|||
147587503|NCT01115855|532305492|FG001|Overall Study|Adverse Event|18|||
147587504|NCT01115855|532305491|FG000|Overall Study|Death|6|||
147587505|NCT01115855|532305492|FG001|Overall Study|Death|5|||
147587506|NCT01115855|532305491|FG000|Overall Study|Lab Abnormality|1|||
147587507|NCT01115855|532305492|FG001|Overall Study|Lab Abnormality|1|||
147587508|NCT01115855|532305491|FG000|Overall Study|Protocol Violation|0|||
147587509|NCT01115855|532305492|FG001|Overall Study|Protocol Violation|1|||
147587510|NCT01115855|532305491|FG000|Overall Study|Withdrawal by Subject|5|||
147161053|NCT03352557|530754037|FG005|LTE Period: Week 80 to Week 173|Physician Decision|0|||
147161054|NCT03352557|530754038|FG006|LTE Period: Week 80 to Week 173|Physician Decision|0|||
147161055|NCT03352557|530754039|FG007|LTE Period: Week 80 to Week 173|Physician Decision|0|||
147161056|NCT03352557|530754040|FG008|LTE Period: Week 80 to Week 173|Physician Decision|0|||
147161057|NCT03352557|530754041|FG009|LTE Period: Week 80 to Week 173|Physician Decision|3|||
147161058|NCT03352557|530754032|FG000|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
147161059|NCT03352557|530754033|FG001|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
147161060|NCT03352557|530754034|FG002|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
147161061|NCT03352557|530754035|FG003|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
147161062|NCT03352557|530754036|FG004|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
147161063|NCT03352557|530754037|FG005|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
147161064|NCT03352557|530754038|FG006|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
147161065|NCT03352557|530754039|FG007|LTE Period: Week 80 to Week 173|Lost to Follow-up|0|||
147161066|NCT03352557|530754040|FG008|LTE Period: Week 80 to Week 173|Lost to Follow-up|3|||
147161067|NCT03352557|530754041|FG009|LTE Period: Week 80 to Week 173|Lost to Follow-up|1|||
147161068|NCT03352557|530754032|FG000|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
147161069|NCT03352557|530754033|FG001|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
147161070|NCT03352557|530754034|FG002|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
147161071|NCT03352557|530754035|FG003|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
147161072|NCT03352557|530754036|FG004|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
147161073|NCT03352557|530754037|FG005|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
147161074|NCT03352557|530754038|FG006|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
147161075|NCT03352557|530754039|FG007|LTE Period: Week 80 to Week 173|Progressive Disease|1|||
147161076|NCT03352557|530754040|FG008|LTE Period: Week 80 to Week 173|Progressive Disease|2|||
147161077|NCT03352557|530754041|FG009|LTE Period: Week 80 to Week 173|Progressive Disease|0|||
147161078|NCT03352557|530754032|FG000|LTE Period: Week 80 to Week 173|Other|0|||
147161079|NCT03352557|530754033|FG001|LTE Period: Week 80 to Week 173|Other|0|||
147587511|NCT01115855|532305492|FG001|Overall Study|Withdrawal by Subject|5|||
147587512|NCT01115855|532305491|FG000|Overall Study|Other|8|||
147587513|NCT01115855|532305492|FG001|Overall Study|Other|6|||
147587514|NCT00831233|532305493|FG000|Overall Study|Adverse Event|0|||
147587515|NCT00831233|532305494|FG001|Overall Study|Adverse Event|1|||
147587516|NCT00831233|532305493|FG000|Overall Study|Protocol Violation|1|||
147587517|NCT00831233|532305494|FG001|Overall Study|Protocol Violation|0|||
147587518|NCT00831233|532305493|FG000|Overall Study|Selection Criteria Not Met|2|||
147587519|NCT00831233|532305494|FG001|Overall Study|Selection Criteria Not Met|0|||
147587520|NCT00480324|532305495|FG000|Overall Study|Adverse Event|1|||
147587521|NCT00480324|532305496|FG001|Overall Study|Adverse Event|1|||
147587522|NCT00480324|532305495|FG000|Overall Study|Protocol Violation|0|||
147587523|NCT00480324|532305496|FG001|Overall Study|Protocol Violation|1|||
147587524|NCT00480324|532305495|FG000|Overall Study|Withdrawal by Subject|14|||
147161080|NCT03352557|530754034|FG002|LTE Period: Week 80 to Week 173|Other|0|||
147161081|NCT03352557|530754035|FG003|LTE Period: Week 80 to Week 173|Other|0|||
147161082|NCT03352557|530754036|FG004|LTE Period: Week 80 to Week 173|Other|0|||
147161083|NCT03352557|530754037|FG005|LTE Period: Week 80 to Week 173|Other|0|||
147161084|NCT03352557|530754038|FG006|LTE Period: Week 80 to Week 173|Other|0|||
147161085|NCT03352557|530754039|FG007|LTE Period: Week 80 to Week 173|Other|1|||
147587525|NCT00480324|532305496|FG001|Overall Study|Withdrawal by Subject|5|||
147587526|NCT00480324|532305495|FG000|Overall Study|Lost to Follow-up|17|||
147161086|NCT03352557|530754040|FG008|LTE Period: Week 80 to Week 173|Other|0|||
147161087|NCT03352557|530754041|FG009|LTE Period: Week 80 to Week 173|Other|0|||
147161088|NCT00907803|530754042|FG000|Overall Study|Withdrawal of consent - long commute|1|||
147161089|NCT00907803|530754043|FG001|Overall Study|Withdrawal of consent - long commute|0|||
147161090|NCT00907803|530754044|FG002|Overall Study|Withdrawal of consent - long commute|0|||
147161091|NCT00907803|530754042|FG000|Overall Study|Adverse Event|2|||
147322547|NCT00495469|531345370|FG004|Overall Study|ST depression at randomisation in ECG|0|||
147161092|NCT00907803|530754043|FG001|Overall Study|Adverse Event|0|||
147587527|NCT00480324|532305496|FG001|Overall Study|Lost to Follow-up|8|||
147587528|NCT00480324|532305495|FG000|Overall Study|Subject's mother pregnant|0|||
147587529|NCT00480324|532305496|FG001|Overall Study|Subject's mother pregnant|1|||
147587530|NCT00784134|532305497|FG000|Overall Study|Lost to Follow-up|3|||
147161093|NCT00907803|530754044|FG002|Overall Study|Adverse Event|0|||
147587531|NCT00784134|532305498|FG001|Overall Study|Lost to Follow-up|6|||
147587532|NCT03785145|532305499|FG000|Cycle 1 - Double Blind (Days 1-180)|Adverse Event|0|||
147161094|NCT00907803|530754042|FG000|Overall Study|Withdrawal by Subject|0|||
147161095|NCT00907803|530754043|FG001|Overall Study|Withdrawal by Subject|1|||
147161096|NCT00907803|530754044|FG002|Overall Study|Withdrawal by Subject|0|||
147161097|NCT00907803|530754042|FG000|Overall Study|Lost to Follow-up|0|||
147161098|NCT00907803|530754043|FG001|Overall Study|Lost to Follow-up|1|||
147161099|NCT00907803|530754044|FG002|Overall Study|Lost to Follow-up|0|||
147161100|NCT00907803|530754042|FG000|Overall Study|Protocol Violation|0|||
147161101|NCT00907803|530754043|FG001|Overall Study|Protocol Violation|1|||
147161102|NCT00907803|530754044|FG002|Overall Study|Protocol Violation|0|||
147161103|NCT04612842|530754045|FG000|Overall Study|Lost to Follow-up|20|||
147161104|NCT04612842|530754046|FG001|Overall Study|Lost to Follow-up|11|||
147161105|NCT04612842|530754045|FG000|Overall Study|Withdrawal by Subject|26|||
147161106|NCT04612842|530754046|FG001|Overall Study|Withdrawal by Subject|15|||
147161107|NCT04612842|530754045|FG000|Overall Study|Death|2|||
147161108|NCT04612842|530754046|FG001|Overall Study|Death|2|||
147161109|NCT05426031|530754047|FG000|Overall Study|Circulatory Arrest|3|||
147161110|NCT05426031|530754048|FG001|Overall Study|Circulatory Arrest|2|||
147161111|NCT02419131|530754049|FG000|Consent and Randomization|Did not receive treatment after randomization|10|||
147161112|NCT02419131|530754050|FG001|Consent and Randomization|Did not receive treatment after randomization|16|||
147161113|NCT02419131|530754051|FG002|Consent and Randomization|Did not receive treatment after randomization|7|||
147161114|NCT02419131|530754049|FG000|Randomization and Treatment|Withdrawn or lost to follow-up|22|||
147161115|NCT02419131|530754050|FG001|Randomization and Treatment|Withdrawn or lost to follow-up|25|||
147161116|NCT02419131|530754051|FG002|Randomization and Treatment|Withdrawn or lost to follow-up|9|||
147161117|NCT03060512|530754052|FG000|Overall Study|Adverse Event|4|||
147161118|NCT03060512|530754053|FG001|Overall Study|Adverse Event|6|||
147161119|NCT03060512|530754052|FG000|Overall Study|Lost to Follow-up|1|||
147161120|NCT03060512|530754053|FG001|Overall Study|Lost to Follow-up|1|||
147161121|NCT03060512|530754052|FG000|Overall Study|Withdrawal by Subject|1|||
147161122|NCT03060512|530754053|FG001|Overall Study|Withdrawal by Subject|0|||
147161123|NCT03060512|530754052|FG000|Overall Study|Non-compliance with study medication|1|||
147161124|NCT03060512|530754053|FG001|Overall Study|Non-compliance with study medication|2|||
147161125|NCT03831880|530754058|FG000|Period 1 (12 Weeks)|Adverse event, not serious|0|||
147161126|NCT03831880|530754059|FG001|Period 1 (12 Weeks)|Adverse event, not serious|1|||
147161127|NCT03831880|530754058|FG000|Period 2 (12 Weeks)|Protocol Deviation|0|||
147161128|NCT03831880|530754059|FG001|Period 2 (12 Weeks)|Protocol Deviation|1|||
147161129|NCT03958656|530754060|FG000|Overall Study|Received anti-myeloma prescription (Rx)|0|||
147161130|NCT03958656|530754061|FG001|Overall Study|Received anti-myeloma prescription (Rx)|1|||
147161131|NCT03958656|530754062|FG002|Overall Study|Received anti-myeloma prescription (Rx)|0|||
147161132|NCT03958656|530754063|FG003|Overall Study|Received anti-myeloma prescription (Rx)|0|||
147242107|NCT00674700|531059562|FG000|Year 2 Follow-up Without Treatment|Withdrawal by Subject|1|||
147242108|NCT00674700|531059563|FG001|Year 2 Follow-up Without Treatment|Withdrawal by Subject|1|||
147242109|NCT00674700|531059564|FG002|Year 2 Follow-up Without Treatment|Withdrawal by Subject|4|||
147242110|NCT00674700|531059562|FG000|Year 2 Follow-up Without Treatment|Any other reason not above-mentioned|5|||
147242111|NCT00674700|531059563|FG001|Year 2 Follow-up Without Treatment|Any other reason not above-mentioned|10|||
147242112|NCT00674700|531059564|FG002|Year 2 Follow-up Without Treatment|Any other reason not above-mentioned|7|||
147242113|NCT00395304|531059565|FG000|Treatment Period 1|Withdrawal by Subject|0|||
147242114|NCT00395304|531059566|FG001|Treatment Period 1|Withdrawal by Subject|3|||
147242115|NCT00395304|531059567|FG002|Treatment Period 1|Withdrawal by Subject|0|||
147242116|NCT00395304|531059568|FG003|Treatment Period 1|Withdrawal by Subject|2|||
147242117|NCT00395304|531059569|FG004|Treatment Period 1|Withdrawal by Subject|1|||
147242118|NCT00395304|531059570|FG005|Treatment Period 1|Withdrawal by Subject|1|||
147242119|NCT00395304|531059565|FG000|Treatment Period 1|Lost to Follow-up|1|||
147242120|NCT00395304|531059566|FG001|Treatment Period 1|Lost to Follow-up|0|||
147242121|NCT00395304|531059567|FG002|Treatment Period 1|Lost to Follow-up|0|||
147242122|NCT00395304|531059568|FG003|Treatment Period 1|Lost to Follow-up|1|||
147242123|NCT00395304|531059569|FG004|Treatment Period 1|Lost to Follow-up|0|||
147242124|NCT00395304|531059570|FG005|Treatment Period 1|Lost to Follow-up|1|||
147242125|NCT00395304|531059565|FG000|Treatment Period 1|Physician Decision|0|||
147161133|NCT03958656|530754060|FG000|Overall Study|No longer meets eligibility criteria|0|||
147161134|NCT03958656|530754061|FG001|Overall Study|No longer meets eligibility criteria|0|||
147161135|NCT03958656|530754062|FG002|Overall Study|No longer meets eligibility criteria|1|||
147161136|NCT03958656|530754063|FG003|Overall Study|No longer meets eligibility criteria|0|||
147161137|NCT03958656|530754060|FG000|Overall Study|Started anti-cancer treatment|0|||
147161138|NCT03958656|530754061|FG001|Overall Study|Started anti-cancer treatment|0|||
147161139|NCT03958656|530754062|FG002|Overall Study|Started anti-cancer treatment|1|||
147161140|NCT03958656|530754063|FG003|Overall Study|Started anti-cancer treatment|0|||
147161141|NCT03158012|530754066|FG000|Overall Study|Withdrawal by Subject|0|||
147161142|NCT03158012|530754067|FG001|Overall Study|Withdrawal by Subject|1|||
147161143|NCT02446418|530754073|FG000|Overall Study|Adverse Event|4|||
147161144|NCT02446418|530754074|FG001|Overall Study|Adverse Event|8|||
147161145|NCT02446418|530754073|FG000|Overall Study|Physician Decision|5|||
147242126|NCT00395304|531059566|FG001|Treatment Period 1|Physician Decision|1|||
147587533|NCT03785145|532305500|FG001|Cycle 1 - Double Blind (Days 1-180)|Adverse Event|1|||
147161146|NCT02446418|530754074|FG001|Overall Study|Physician Decision|1|||
147161147|NCT02446418|530754073|FG000|Overall Study|Withdrawal by Subject|3|||
147161148|NCT02446418|530754074|FG001|Overall Study|Withdrawal by Subject|3|||
147161149|NCT02446418|530754073|FG000|Overall Study|Lost to Follow-up|2|||
147161150|NCT02446418|530754074|FG001|Overall Study|Lost to Follow-up|2|||
147161151|NCT02446418|530754073|FG000|Overall Study|Protocol Violation|1|||
147161152|NCT02446418|530754074|FG001|Overall Study|Protocol Violation|2|||
147161153|NCT02446418|530754073|FG000|Overall Study|Lack of Efficacy|2|||
147161154|NCT02446418|530754074|FG001|Overall Study|Lack of Efficacy|0|||
147161155|NCT02446418|530754073|FG000|Overall Study|Protocol defined stopping criteria reach|1|||
147161156|NCT02446418|530754074|FG001|Overall Study|Protocol defined stopping criteria reach|0|||
147161157|NCT02014480|530754075|FG000|Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
147161158|NCT02014480|530754076|FG001|Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
147161159|NCT02014480|530754077|FG002|Treatment Period 1 (14 Days)|Lack of Efficacy|1|||
147161160|NCT02014480|530754078|FG003|Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
147161161|NCT02014480|530754079|FG004|Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
147161162|NCT02014480|530754080|FG005|Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
147161163|NCT02014480|530754075|FG000|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
147161164|NCT02014480|530754076|FG001|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
147161165|NCT02014480|530754077|FG002|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
147161166|NCT02014480|530754078|FG003|Treatment Period 1 (14 Days)|Withdrawal by Subject|2|||
147161167|NCT02014480|530754079|FG004|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
147161168|NCT02014480|530754080|FG005|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
147161169|NCT02014480|530754075|FG000|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
147161170|NCT02014480|530754076|FG001|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
147161171|NCT02014480|530754077|FG002|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|1|||
147161172|NCT02014480|530754078|FG003|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
147161173|NCT02014480|530754079|FG004|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
147161174|NCT02014480|530754080|FG005|Washout Period 1 (10 to 14 Days)|Lack of Efficacy|0|||
147161175|NCT02014480|530754075|FG000|Treatment Period 2 (14 Days)|Protocol Violation|1|||
147161176|NCT02014480|530754076|FG001|Treatment Period 2 (14 Days)|Protocol Violation|1|||
147161177|NCT02014480|530754077|FG002|Treatment Period 2 (14 Days)|Protocol Violation|2|||
147161178|NCT02014480|530754078|FG003|Treatment Period 2 (14 Days)|Protocol Violation|1|||
147161179|NCT02014480|530754079|FG004|Treatment Period 2 (14 Days)|Protocol Violation|0|||
147161180|NCT02014480|530754080|FG005|Treatment Period 2 (14 Days)|Protocol Violation|0|||
147161181|NCT02014480|530754075|FG000|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
147161182|NCT02014480|530754076|FG001|Treatment Period 3 (14 Days)|Withdrawal by Subject|1|||
147161183|NCT02014480|530754077|FG002|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
147161184|NCT02014480|530754078|FG003|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
147322548|NCT00495469|531345371|FG005|Overall Study|ST depression at randomisation in ECG|0|||
147322549|NCT00495469|531345372|FG006|Overall Study|ST depression at randomisation in ECG|0|||
147322550|NCT04454567|531345374|FG000|Overall Study|Study Terminated by Sponsor|1|||
147322551|NCT04454567|531345375|FG001|Overall Study|Study Terminated by Sponsor|1|||
147322552|NCT01123161|531345379|FG000|Overall Study|Lost to Follow-up|1|||
147322553|NCT01123161|531345380|FG001|Overall Study|Lost to Follow-up|0|||
147322554|NCT01123161|531345379|FG000|Overall Study|Withdrawal by Subject|1|||
147322555|NCT01123161|531345380|FG001|Overall Study|Withdrawal by Subject|0|||
147447184|NCT00876187|531802065|FG001|Overall Study|Other|5|||
147447185|NCT00876187|531802066|FG002|Overall Study|Other|9|||
147587534|NCT03785145|532305499|FG000|Cycle 1 - Double Blind (Days 1-180)|Withdrawal by Subject|6|||
147587535|NCT03785145|532305500|FG001|Cycle 1 - Double Blind (Days 1-180)|Withdrawal by Subject|9|||
147587536|NCT03785145|532305499|FG000|Cycle 1 - Double Blind (Days 1-180)|Lost to Follow-up|2|||
147587537|NCT03785145|532305500|FG001|Cycle 1 - Double Blind (Days 1-180)|Lost to Follow-up|2|||
147587538|NCT03785145|532305499|FG000|Cycle 1 - Double Blind (Days 1-180)|Death|0|||
147587539|NCT03785145|532305500|FG001|Cycle 1 - Double Blind (Days 1-180)|Death|1|||
147161185|NCT02014480|530754079|FG004|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
147161186|NCT02014480|530754080|FG005|Treatment Period 3 (14 Days)|Withdrawal by Subject|0|||
147161187|NCT02014480|530754075|FG000|Treatment Period 3 (14 Days)|Adverse Event|0|||
147161188|NCT02014480|530754076|FG001|Treatment Period 3 (14 Days)|Adverse Event|0|||
147161189|NCT02014480|530754077|FG002|Treatment Period 3 (14 Days)|Adverse Event|1|||
147161190|NCT02014480|530754078|FG003|Treatment Period 3 (14 Days)|Adverse Event|0|||
147161191|NCT02014480|530754079|FG004|Treatment Period 3 (14 Days)|Adverse Event|0|||
147161192|NCT02014480|530754080|FG005|Treatment Period 3 (14 Days)|Adverse Event|1|||
147161193|NCT02014480|530754075|FG000|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
147161194|NCT02014480|530754076|FG001|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
147161195|NCT02014480|530754077|FG002|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
147161196|NCT02014480|530754078|FG003|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
147161197|NCT02014480|530754079|FG004|Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
147161198|NCT02014480|530754080|FG005|Treatment Period 3 (14 Days)|Lack of Efficacy|1|||
147161199|NCT01338610|530754083|FG000|Overall Study|Patient Decision Unrelated to Advs Event|1|||
147587540|NCT03785145|532305499|FG000|Cycle 1 - Double Blind (Days 1-180)|1 participant was randomized to the placebo group but was not treated. This is counted in 'Other '.|1|||
147587541|NCT03785145|532305500|FG001|Cycle 1 - Double Blind (Days 1-180)|1 participant was randomized to the placebo group but was not treated. This is counted in 'Other '.|0|||
147587542|NCT03785145|532305499|FG000|Cycle 2 - Open Label Treatment 1|Withdrawal by Subject|1|||
147587543|NCT03785145|532305500|FG001|Cycle 2 - Open Label Treatment 1|Withdrawal by Subject|5|||
147587544|NCT03785145|532305499|FG000|Cycle 2 - Open Label Treatment 1|Lost to Follow-up|1|||
147587545|NCT03785145|532305500|FG001|Cycle 2 - Open Label Treatment 1|Lost to Follow-up|6|||
147587546|NCT03785145|532305499|FG000|Cycle 2 - Open Label Treatment 1|COVID-19; Enrolled in a different study|2|||
147587547|NCT03785145|532305500|FG001|Cycle 2 - Open Label Treatment 1|COVID-19; Enrolled in a different study|3|||
147161200|NCT01338610|530754084|FG001|Overall Study|Patient Decision Unrelated to Advs Event|1|||
147161201|NCT01338610|530754085|FG002|Overall Study|Patient Decision Unrelated to Advs Event|0|||
147161202|NCT01338610|530754083|FG000|Overall Study|Protocol Violation|1|||
147161203|NCT01338610|530754084|FG001|Overall Study|Protocol Violation|0|||
147161204|NCT01338610|530754085|FG002|Overall Study|Protocol Violation|1|||
147161205|NCT01338610|530754083|FG000|Overall Study|Adverse Event|3|||
147161206|NCT01338610|530754084|FG001|Overall Study|Adverse Event|0|||
147161207|NCT01338610|530754085|FG002|Overall Study|Adverse Event|0|||
147161208|NCT01865812|530754086|FG000|Primary Treatment Phase|Adverse Event|2|||
147161209|NCT01865812|530754087|FG001|Primary Treatment Phase|Adverse Event|0|||
147161210|NCT01865812|530754086|FG000|Long-term Safety Extension Phase|Withdrawal by Subject|0|||
147161211|NCT01865812|530754087|FG001|Long-term Safety Extension Phase|Withdrawal by Subject|1|||
147161212|NCT01865812|530754086|FG000|Long-term Safety Extension Phase|Pruritus|0|||
147161213|NCT01865812|530754087|FG001|Long-term Safety Extension Phase|Pruritus|3|||
147161214|NCT01865812|530754086|FG000|Long-term Safety Extension Phase|Physician Decision|0|||
147161215|NCT01865812|530754087|FG001|Long-term Safety Extension Phase|Physician Decision|1|||
147161216|NCT01865812|530754086|FG000|Long-term Safety Extension Phase|Participant Unavailable for Final Study Visit|0|||
147161217|NCT01865812|530754087|FG001|Long-term Safety Extension Phase|Participant Unavailable for Final Study Visit|1|||
147161218|NCT02692040|530754091|FG000|Overall Study|Protocol Violation|0|||
147161219|NCT02692040|530754092|FG001|Overall Study|Protocol Violation|0|||
147161220|NCT02692040|530754093|FG002|Overall Study|Protocol Violation|0|||
147161221|NCT02692040|530754094|FG003|Overall Study|Protocol Violation|0|||
147161222|NCT02692040|530754095|FG004|Overall Study|Protocol Violation|0|||
147161223|NCT02692040|530754096|FG005|Overall Study|Protocol Violation|0|||
147161224|NCT02692040|530754097|FG006|Overall Study|Protocol Violation|0|||
147161225|NCT02692040|530754098|FG007|Overall Study|Protocol Violation|0|||
147161226|NCT02692040|530754099|FG008|Overall Study|Protocol Violation|0|||
147161227|NCT02692040|530754100|FG009|Overall Study|Protocol Violation|0|||
147161228|NCT02692040|530754101|FG010|Overall Study|Protocol Violation|0|||
147161229|NCT02692040|530754102|FG011|Overall Study|Protocol Violation|0|||
147322556|NCT00926393|531345381|FG000|Overall Study|Withdrawal by Subject|1|||
147322557|NCT00926393|531345382|FG001|Overall Study|Withdrawal by Subject|2|||
147322558|NCT00926393|531345381|FG000|Overall Study|Adverse Event|1|||
147322559|NCT00926393|531345382|FG001|Overall Study|Adverse Event|1|||
147322560|NCT02851511|531345390|FG000|Overall (Phase I + Phase II)|Physician Decision|18|||
147322561|NCT02851511|531345391|FG001|Overall (Phase I + Phase II)|Physician Decision|16|||
147322562|NCT02851511|531345392|FG002|Overall (Phase I + Phase II)|Physician Decision|0|||
147322563|NCT02851511|531345393|FG003|Overall (Phase I + Phase II)|Physician Decision|1|||
147322564|NCT02851511|531345390|FG000|Overall (Phase I + Phase II)|Withdrawal by Subject|20|||
147322565|NCT02851511|531345391|FG001|Overall (Phase I + Phase II)|Withdrawal by Subject|17|||
147322566|NCT02851511|531345392|FG002|Overall (Phase I + Phase II)|Withdrawal by Subject|0|||
147322567|NCT02851511|531345393|FG003|Overall (Phase I + Phase II)|Withdrawal by Subject|3|||
147322568|NCT02851511|531345390|FG000|Overall (Phase I + Phase II)|COVID-19 lockdown, no reason specified|4|||
147322569|NCT02851511|531345391|FG001|Overall (Phase I + Phase II)|COVID-19 lockdown, no reason specified|5|||
147322570|NCT02851511|531345392|FG002|Overall (Phase I + Phase II)|COVID-19 lockdown, no reason specified|0|||
147322571|NCT02851511|531345393|FG003|Overall (Phase I + Phase II)|COVID-19 lockdown, no reason specified|0|||
147322572|NCT02851511|531345390|FG000|Overall (Phase I + Phase II)|Lost to Follow-up|0|||
147322573|NCT02851511|531345391|FG001|Overall (Phase I + Phase II)|Lost to Follow-up|1|||
147322574|NCT02851511|531345392|FG002|Overall (Phase I + Phase II)|Lost to Follow-up|0|||
147322575|NCT02851511|531345393|FG003|Overall (Phase I + Phase II)|Lost to Follow-up|0|||
147447186|NCT00876187|531802067|FG003|Overall Study|Other|7|||
147447187|NCT00876187|531802068|FG004|Overall Study|Other|4|||
147654436|NCT03853291|532556728|FG002|Overall Study|Lost to Follow-up|0|||
147161230|NCT02692040|530754103|FG012|Overall Study|Protocol Violation|1|||
147161231|NCT02692040|530754104|FG013|Overall Study|Protocol Violation|0|||
147161232|NCT02692040|530754105|FG014|Overall Study|Protocol Violation|0|||
147161233|NCT02692040|530754106|FG015|Overall Study|Protocol Violation|0|||
147161234|NCT02692040|530754107|FG016|Overall Study|Protocol Violation|0|||
147161235|NCT02692040|530754091|FG000|Overall Study|Adverse Event|0|||
147161236|NCT02692040|530754092|FG001|Overall Study|Adverse Event|0|||
147161237|NCT02692040|530754093|FG002|Overall Study|Adverse Event|0|||
147161238|NCT02692040|530754094|FG003|Overall Study|Adverse Event|0|||
147161239|NCT02692040|530754095|FG004|Overall Study|Adverse Event|0|||
147587548|NCT03785145|532305499|FG000|Cycle 3 - Open Label Treatment 2|Withdrawal by Subject|0|||
147587549|NCT03785145|532305500|FG001|Cycle 3 - Open Label Treatment 2|Withdrawal by Subject|1|||
147587550|NCT03785145|532305499|FG000|Cycle 3 - Open Label Treatment 2|Lost to Follow-up|0|||
147587551|NCT03785145|532305500|FG001|Cycle 3 - Open Label Treatment 2|Lost to Follow-up|1|||
147587552|NCT03785145|532305499|FG000|Cycle 3 - Open Label Treatment 2|COVID-19, Enrolled in a different study|0|||
147587553|NCT03785145|532305500|FG001|Cycle 3 - Open Label Treatment 2|COVID-19, Enrolled in a different study|1|||
147587554|NCT00097786|532305501|FG000|Overall Study|lost to follow-up for all-cause death|296|||
147587555|NCT00097786|532305502|FG001|Overall Study|lost to follow-up for all-cause death|292|||
147587556|NCT00097786|532305503|FG002|Overall Study|lost to follow-up for all-cause death|313|||
147587557|NCT00097786|532305504|FG003|Overall Study|lost to follow-up for all-cause death|310|||
147587558|NCT02960438|532305505|FG000|Treatment Phase (Double-blind): 24 Weeks|Inadequate Therapeutic Effect|2|||
147587559|NCT02960438|532305506|FG001|Treatment Phase (Double-blind): 24 Weeks|Inadequate Therapeutic Effect|1|||
147587560|NCT02960438|532305507|FG002|Treatment Phase (Double-blind): 24 Weeks|Inadequate Therapeutic Effect|2|||
147587561|NCT02960438|532305508|FG003|Treatment Phase (Double-blind): 24 Weeks|Inadequate Therapeutic Effect|5|||
147587562|NCT02960438|532305505|FG000|Treatment Phase (Double-blind): 24 Weeks|Adverse Event|2|||
147587563|NCT02960438|532305506|FG001|Treatment Phase (Double-blind): 24 Weeks|Adverse Event|1|||
147587564|NCT02960438|532305507|FG002|Treatment Phase (Double-blind): 24 Weeks|Adverse Event|0|||
147587565|NCT02960438|532305508|FG003|Treatment Phase (Double-blind): 24 Weeks|Adverse Event|3|||
147587566|NCT02960438|532305505|FG000|Treatment Phase (Double-blind): 24 Weeks|Progression of Disease|2|||
147587567|NCT02960438|532305506|FG001|Treatment Phase (Double-blind): 24 Weeks|Progression of Disease|0|||
147587568|NCT02960438|532305507|FG002|Treatment Phase (Double-blind): 24 Weeks|Progression of Disease|0|||
147587569|NCT02960438|532305508|FG003|Treatment Phase (Double-blind): 24 Weeks|Progression of Disease|0|||
147587570|NCT02960438|532305505|FG000|Treatment Phase (Double-blind): 24 Weeks|Withdrawal by Subject|1|||
147587571|NCT02960438|532305506|FG001|Treatment Phase (Double-blind): 24 Weeks|Withdrawal by Subject|0|||
147587572|NCT02960438|532305507|FG002|Treatment Phase (Double-blind): 24 Weeks|Withdrawal by Subject|1|||
147587573|NCT02960438|532305508|FG003|Treatment Phase (Double-blind): 24 Weeks|Withdrawal by Subject|0|||
147587574|NCT02960438|532305505|FG000|Treatment Phase (Double-blind): 24 Weeks|Other|0|||
147587575|NCT02960438|532305506|FG001|Treatment Phase (Double-blind): 24 Weeks|Other|0|||
147587576|NCT02960438|532305507|FG002|Treatment Phase (Double-blind): 24 Weeks|Other|1|||
147587577|NCT02960438|532305508|FG003|Treatment Phase (Double-blind): 24 Weeks|Other|0|||
147587578|NCT02960438|532305505|FG000|Treatment Phase (Double-blind): 24 Weeks|Not Treated|2|||
147587579|NCT02960438|532305506|FG001|Treatment Phase (Double-blind): 24 Weeks|Not Treated|1|||
147587580|NCT02960438|532305507|FG002|Treatment Phase (Double-blind): 24 Weeks|Not Treated|0|||
147587581|NCT02960438|532305508|FG003|Treatment Phase (Double-blind): 24 Weeks|Not Treated|1|||
147587582|NCT02960438|532305505|FG000|Extension Phase (Open-label): 80 Weeks|Adverse Event|1|||
147587583|NCT02960438|532305506|FG001|Extension Phase (Open-label): 80 Weeks|Adverse Event|2|||
147587584|NCT02960438|532305507|FG002|Extension Phase (Open-label): 80 Weeks|Adverse Event|4|||
147587585|NCT02960438|532305508|FG003|Extension Phase (Open-label): 80 Weeks|Adverse Event|1|||
147587586|NCT02960438|532305505|FG000|Extension Phase (Open-label): 80 Weeks|Lost to Follow-up|0|||
147587587|NCT02960438|532305506|FG001|Extension Phase (Open-label): 80 Weeks|Lost to Follow-up|0|||
147587588|NCT02960438|532305507|FG002|Extension Phase (Open-label): 80 Weeks|Lost to Follow-up|1|||
147587589|NCT02960438|532305508|FG003|Extension Phase (Open-label): 80 Weeks|Lost to Follow-up|0|||
147587590|NCT02960438|532305505|FG000|Extension Phase (Open-label): 80 Weeks|Withdrawal by Subject|1|||
147587591|NCT02960438|532305506|FG001|Extension Phase (Open-label): 80 Weeks|Withdrawal by Subject|1|||
147587592|NCT02960438|532305507|FG002|Extension Phase (Open-label): 80 Weeks|Withdrawal by Subject|0|||
147587593|NCT02960438|532305508|FG003|Extension Phase (Open-label): 80 Weeks|Withdrawal by Subject|1|||
147587594|NCT02960438|532305505|FG000|Extension Phase (Open-label): 80 Weeks|Inadequate Therapeutic Effect|7|||
147587595|NCT02960438|532305506|FG001|Extension Phase (Open-label): 80 Weeks|Inadequate Therapeutic Effect|5|||
147587596|NCT02960438|532305507|FG002|Extension Phase (Open-label): 80 Weeks|Inadequate Therapeutic Effect|7|||
147161240|NCT02692040|530754096|FG005|Overall Study|Adverse Event|0|||
147161241|NCT02692040|530754097|FG006|Overall Study|Adverse Event|0|||
147161242|NCT02692040|530754098|FG007|Overall Study|Adverse Event|0|||
147161243|NCT02692040|530754099|FG008|Overall Study|Adverse Event|0|||
147161244|NCT02692040|530754100|FG009|Overall Study|Adverse Event|0|||
147161245|NCT02692040|530754101|FG010|Overall Study|Adverse Event|0|||
147161246|NCT02692040|530754102|FG011|Overall Study|Adverse Event|0|||
147161247|NCT02692040|530754103|FG012|Overall Study|Adverse Event|0|||
147161248|NCT02692040|530754104|FG013|Overall Study|Adverse Event|3|||
147587597|NCT02960438|532305508|FG003|Extension Phase (Open-label): 80 Weeks|Inadequate Therapeutic Effect|6|||
147587598|NCT02960438|532305505|FG000|Extension Phase (Open-label): 80 Weeks|Progression of Disease|2|||
147161249|NCT02692040|530754105|FG014|Overall Study|Adverse Event|1|||
147161250|NCT02692040|530754106|FG015|Overall Study|Adverse Event|1|||
147161251|NCT02692040|530754107|FG016|Overall Study|Adverse Event|0|||
147161252|NCT00435162|530754108|FG000|Period 2 (2 Weeks)|Adverse Event|0|||
147161253|NCT00435162|530754109|FG001|Period 2 (2 Weeks)|Adverse Event|1|||
147161254|NCT00435162|530754110|FG002|Period 2 (2 Weeks)|Adverse Event|0|||
147587599|NCT02960438|532305506|FG001|Extension Phase (Open-label): 80 Weeks|Progression of Disease|1|||
147587600|NCT02960438|532305507|FG002|Extension Phase (Open-label): 80 Weeks|Progression of Disease|1|||
147161255|NCT00435162|530754111|FG003|Period 2 (2 Weeks)|Adverse Event|0|||
147587601|NCT02960438|532305508|FG003|Extension Phase (Open-label): 80 Weeks|Progression of Disease|2|||
147587602|NCT02960438|532305505|FG000|Extension Phase (Open-label): 80 Weeks|Other|0|||
147587603|NCT02960438|532305506|FG001|Extension Phase (Open-label): 80 Weeks|Other|0|||
147587604|NCT02960438|532305507|FG002|Extension Phase (Open-label): 80 Weeks|Other|1|||
147587605|NCT02960438|532305508|FG003|Extension Phase (Open-label): 80 Weeks|Other|1|||
147587606|NCT03686150|532305509|FG000|Overall Study|Withdrawal by Subject|1|||
147587607|NCT03686150|532305510|FG001|Overall Study|Withdrawal by Subject|1|||
147587608|NCT03686150|532305511|FG002|Overall Study|Withdrawal by Subject|1|||
147587609|NCT03686150|532305512|FG003|Overall Study|Withdrawal by Subject|0|||
147587610|NCT03686150|532305513|FG004|Overall Study|Withdrawal by Subject|1|||
147587611|NCT03686150|532305514|FG005|Overall Study|Withdrawal by Subject|2|||
147587612|NCT03686150|532305509|FG000|Overall Study|Physician Decision|1|||
147587613|NCT03686150|532305510|FG001|Overall Study|Physician Decision|0|||
147587614|NCT03686150|532305511|FG002|Overall Study|Physician Decision|0|||
147587615|NCT03686150|532305512|FG003|Overall Study|Physician Decision|0|||
147587616|NCT03686150|532305513|FG004|Overall Study|Physician Decision|0|||
147587617|NCT03686150|532305514|FG005|Overall Study|Physician Decision|1|||
147587618|NCT03686150|532305509|FG000|Overall Study|Lost to Follow-up|0|||
147587619|NCT03686150|532305510|FG001|Overall Study|Lost to Follow-up|1|||
147587620|NCT03686150|532305511|FG002|Overall Study|Lost to Follow-up|0|||
147161256|NCT00435162|530754112|FG004|Period 2 (2 Weeks)|Adverse Event|0|||
147161257|NCT00435162|530754113|FG005|Period 2 (2 Weeks)|Adverse Event|0|||
147161258|NCT01819129|530754114|FG000|Overall Study|Other, Subject wanted HbA1c to be > 7%|1|||
147161259|NCT01819129|530754115|FG001|Overall Study|Other, Subject wanted HbA1c to be > 7%|0|||
147161260|NCT01819129|530754114|FG000|Overall Study|Other, weight gain, hypoglycaemic events|1|||
147161261|NCT01819129|530754115|FG001|Overall Study|Other, weight gain, hypoglycaemic events|0|||
147161262|NCT01819129|530754114|FG000|Overall Study|Other, Subject moved out of the country|0|||
147161263|NCT01819129|530754115|FG001|Overall Study|Other, Subject moved out of the country|1|||
147161264|NCT01819129|530754114|FG000|Overall Study|Withdrawal by Subject|15|||
147161265|NCT01819129|530754115|FG001|Overall Study|Withdrawal by Subject|15|||
147161266|NCT01819129|530754114|FG000|Overall Study|Lost to Follow-up|5|||
147161267|NCT01819129|530754115|FG001|Overall Study|Lost to Follow-up|2|||
147161268|NCT01819129|530754114|FG000|Overall Study|Lack of Efficacy|0|||
147161269|NCT01819129|530754115|FG001|Overall Study|Lack of Efficacy|1|||
147161270|NCT01819129|530754114|FG000|Overall Study|Adverse Event|1|||
147161271|NCT01819129|530754115|FG001|Overall Study|Adverse Event|4|||
147161272|NCT01819129|530754114|FG000|Overall Study|Death|1|||
147161273|NCT01819129|530754115|FG001|Overall Study|Death|1|||
147161274|NCT01819129|530754114|FG000|Overall Study|Withdrawal Criteria|20|||
147161275|NCT01819129|530754115|FG001|Overall Study|Withdrawal Criteria|15|||
147161276|NCT00054691|530754120|FG000|Overall Study|Unmeasurable Disease|2|||
147161277|NCT00054691|530754120|FG000|Overall Study|Noncompliant|1|||
147161278|NCT02836873|530754121|FG000|Overall Study|Protocol Violation|0|||
147161279|NCT02836873|530754122|FG001|Overall Study|Protocol Violation|1|||
147161280|NCT02836873|530754121|FG000|Overall Study|Adverse Event|1|||
147161281|NCT02836873|530754122|FG001|Overall Study|Adverse Event|4|||
147161282|NCT02836873|530754121|FG000|Overall Study|Withdrawal by Subject|2|||
147161283|NCT02836873|530754122|FG001|Overall Study|Withdrawal by Subject|2|||
147161284|NCT02836873|530754121|FG000|Overall Study|Lost to Follow-up|1|||
147161285|NCT02836873|530754122|FG001|Overall Study|Lost to Follow-up|3|||
147161286|NCT02836873|530754121|FG000|Overall Study|Physician Decision|0|||
147242127|NCT00395304|531059567|FG002|Treatment Period 1|Physician Decision|0|||
147242128|NCT00395304|531059568|FG003|Treatment Period 1|Physician Decision|0|||
147242129|NCT00395304|531059569|FG004|Treatment Period 1|Physician Decision|0|||
147242130|NCT00395304|531059570|FG005|Treatment Period 1|Physician Decision|0|||
147587621|NCT03686150|532305512|FG003|Overall Study|Lost to Follow-up|0|||
147587622|NCT03686150|532305513|FG004|Overall Study|Lost to Follow-up|0|||
147587623|NCT03686150|532305514|FG005|Overall Study|Lost to Follow-up|0|||
147587624|NCT02443324|532305516|FG000|Overall Study|Death|4|||
147587625|NCT02443324|532305517|FG001|Overall Study|Death|1|||
147587626|NCT02443324|532305518|FG002|Overall Study|Death|0|||
147161287|NCT02836873|530754122|FG001|Overall Study|Physician Decision|1|||
147161288|NCT02836873|530754121|FG000|Overall Study|Other|1|||
147161289|NCT02836873|530754122|FG001|Overall Study|Other|0|||
147161290|NCT00694096|530754129|FG000|Overall Study|Withdrawal by Subject|5|||
147161291|NCT02914548|530754139|FG000|Overall Study|Adverse Event|15|||
147161292|NCT02914548|530754140|FG001|Overall Study|Adverse Event|7|||
147161293|NCT02914548|530754141|FG002|Overall Study|Adverse Event|15|||
147161294|NCT02914548|530754139|FG000|Overall Study|Physician Decision|2|||
147161295|NCT02914548|530754140|FG001|Overall Study|Physician Decision|2|||
147587627|NCT02443324|532305519|FG003|Overall Study|Death|3|||
147587628|NCT02443324|532305520|FG004|Overall Study|Death|1|||
147161296|NCT02914548|530754141|FG002|Overall Study|Physician Decision|0|||
147161297|NCT02914548|530754139|FG000|Overall Study|Protocol Violation|1|||
147161298|NCT02914548|530754140|FG001|Overall Study|Protocol Violation|0|||
147161299|NCT02914548|530754141|FG002|Overall Study|Protocol Violation|0|||
147161300|NCT02914548|530754139|FG000|Overall Study|Withdrawal by Subject|3|||
147161301|NCT02914548|530754140|FG001|Overall Study|Withdrawal by Subject|4|||
147161302|NCT02914548|530754141|FG002|Overall Study|Withdrawal by Subject|4|||
147161303|NCT02914548|530754139|FG000|Overall Study|>40% of body surface area|0|||
147161304|NCT02914548|530754140|FG001|Overall Study|>40% of body surface area|1|||
147161305|NCT02914548|530754141|FG002|Overall Study|>40% of body surface area|1|||
147161306|NCT00977938|530754147|FG000|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|132|||
147161307|NCT00977938|530754148|FG001|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|116|||
147161308|NCT00977938|530754149|FG002|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|13|||
147161309|NCT00977938|530754150|FG003|Treatment (12-30 mo. Post Procedure)|Withdrawal by Subject|20|||
147161310|NCT00977938|530754147|FG000|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|88|||
147161311|NCT00977938|530754148|FG001|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|91|||
147161312|NCT00977938|530754149|FG002|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|30|||
147161313|NCT00977938|530754150|FG003|Treatment (12-30 mo. Post Procedure)|Lost to Follow-up|37|||
147161314|NCT00977938|530754147|FG000|Treatment (12-30 mo. Post Procedure)|Other|17|||
147161315|NCT00977938|530754148|FG001|Treatment (12-30 mo. Post Procedure)|Other|18|||
147161316|NCT00977938|530754149|FG002|Treatment (12-30 mo. Post Procedure)|Other|3|||
147161317|NCT00977938|530754150|FG003|Treatment (12-30 mo. Post Procedure)|Other|4|||
147161318|NCT00977938|530754147|FG000|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|9|||
147161319|NCT00977938|530754148|FG001|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|12|||
147161320|NCT00977938|530754149|FG002|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|2|||
147161321|NCT00977938|530754150|FG003|Observation (30-33 mo. Post Procedure)|Withdrawal by Subject|0|||
147161322|NCT00977938|530754147|FG000|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|34|||
147161323|NCT00977938|530754148|FG001|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|42|||
147161324|NCT00977938|530754149|FG002|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|10|||
147161325|NCT00977938|530754150|FG003|Observation (30-33 mo. Post Procedure)|Lost to Follow-up|3|||
147161326|NCT00977938|530754147|FG000|Observation (30-33 mo. Post Procedure)|Other|8|||
147161327|NCT00977938|530754148|FG001|Observation (30-33 mo. Post Procedure)|Other|4|||
147161328|NCT00977938|530754149|FG002|Observation (30-33 mo. Post Procedure)|Other|0|||
147161329|NCT00977938|530754150|FG003|Observation (30-33 mo. Post Procedure)|Other|0|||
147161330|NCT01484834|530754156|FG000|Overall Study|Lost to Follow-up|5|||
147161331|NCT01484834|530754157|FG001|Overall Study|Lost to Follow-up|8|||
147161332|NCT01484834|530754158|FG002|Overall Study|Lost to Follow-up|1|||
147161333|NCT01484834|530754159|FG003|Overall Study|Lost to Follow-up|4|||
147161334|NCT02460783|530754160|FG000|Overall Study|Withdrawal by Subject|1|||
147242131|NCT00395304|531059565|FG000|Treatment Period 2|Withdrawal by Subject|0|||
147242132|NCT00395304|531059566|FG001|Treatment Period 2|Withdrawal by Subject|0|||
147242133|NCT00395304|531059567|FG002|Treatment Period 2|Withdrawal by Subject|0|||
147242134|NCT00395304|531059568|FG003|Treatment Period 2|Withdrawal by Subject|1|||
147587629|NCT02443324|532305521|FG005|Overall Study|Death|3|||
147587630|NCT02443324|532305522|FG006|Overall Study|Death|2|||
147587631|NCT02443324|532305516|FG000|Overall Study|Lost to Follow-up|0|||
147587632|NCT02443324|532305517|FG001|Overall Study|Lost to Follow-up|0|||
147587633|NCT02443324|532305518|FG002|Overall Study|Lost to Follow-up|0|||
147587634|NCT02443324|532305519|FG003|Overall Study|Lost to Follow-up|1|||
147587635|NCT02443324|532305520|FG004|Overall Study|Lost to Follow-up|0|||
147587636|NCT02443324|532305521|FG005|Overall Study|Lost to Follow-up|1|||
147587637|NCT02443324|532305522|FG006|Overall Study|Lost to Follow-up|0|||
147587638|NCT02443324|532305516|FG000|Overall Study|Physician Decision|0|||
147587639|NCT02443324|532305517|FG001|Overall Study|Physician Decision|3|||
147587640|NCT02443324|532305518|FG002|Overall Study|Physician Decision|5|||
147587641|NCT02443324|532305519|FG003|Overall Study|Physician Decision|1|||
147587642|NCT02443324|532305520|FG004|Overall Study|Physician Decision|1|||
147587643|NCT02443324|532305521|FG005|Overall Study|Physician Decision|0|||
147587644|NCT02443324|532305522|FG006|Overall Study|Physician Decision|2|||
147587645|NCT02443324|532305516|FG000|Overall Study|Progressive Disease|20|||
147587646|NCT02443324|532305517|FG001|Overall Study|Progressive Disease|20|||
147587647|NCT02443324|532305518|FG002|Overall Study|Progressive Disease|13|||
147587648|NCT02443324|532305519|FG003|Overall Study|Progressive Disease|10|||
147587649|NCT02443324|532305520|FG004|Overall Study|Progressive Disease|13|||
147587650|NCT02443324|532305521|FG005|Overall Study|Progressive Disease|17|||
147587651|NCT02443324|532305522|FG006|Overall Study|Progressive Disease|10|||
147161335|NCT02460783|530754161|FG001|Overall Study|Withdrawal by Subject|3|||
147161336|NCT02460783|530754160|FG000|Overall Study|Lost to Follow-up|1|||
147161337|NCT02460783|530754161|FG001|Overall Study|Lost to Follow-up|1|||
147161338|NCT00747344|530754162|FG000|Controlled Period|Adverse Event|3|||
147161339|NCT00747344|530754163|FG001|Controlled Period|Adverse Event|0|||
147161340|NCT00747344|530754164|FG002|Controlled Period|Adverse Event|0|||
147161341|NCT00747344|530754165|FG003|Controlled Period|Adverse Event|0|||
147161342|NCT00747344|530754162|FG000|Controlled Period|Lack of Efficacy|2|||
147161343|NCT00747344|530754163|FG001|Controlled Period|Lack of Efficacy|1|||
147242135|NCT00395304|531059569|FG004|Treatment Period 2|Withdrawal by Subject|0|||
147587652|NCT02443324|532305516|FG000|Overall Study|Withdrawal by Subject|0|||
147161344|NCT00747344|530754164|FG002|Controlled Period|Lack of Efficacy|0|||
147161345|NCT00747344|530754165|FG003|Controlled Period|Lack of Efficacy|0|||
147161346|NCT00747344|530754162|FG000|Controlled Period|Other|0|||
147161347|NCT00747344|530754163|FG001|Controlled Period|Other|3|||
147161348|NCT00747344|530754164|FG002|Controlled Period|Other|0|||
147161349|NCT00747344|530754165|FG003|Controlled Period|Other|0|||
147161350|NCT00747344|530754162|FG000|After Controlled Period|Adverse Event|0|||
147161351|NCT00747344|530754163|FG001|After Controlled Period|Adverse Event|0|||
147161352|NCT00747344|530754164|FG002|After Controlled Period|Adverse Event|0|||
147161353|NCT00747344|530754165|FG003|After Controlled Period|Adverse Event|1|||
147161354|NCT01371643|530754171|FG000|Overall Study|Withdrawal by Subject|3|||
147161355|NCT01371643|530754172|FG001|Overall Study|Withdrawal by Subject|0|||
147161356|NCT02214225|530754173|FG000|Overall Study|Lost to Follow-up|46|||
147161357|NCT02214225|530754174|FG001|Overall Study|Lost to Follow-up|18|||
147161358|NCT02214225|530754175|FG002|Overall Study|Lost to Follow-up|18|||
147161359|NCT02214225|530754173|FG000|Overall Study|Withdrawal by Subject|2|||
147161360|NCT02214225|530754174|FG001|Overall Study|Withdrawal by Subject|0|||
147161361|NCT02214225|530754175|FG002|Overall Study|Withdrawal by Subject|2|||
147161362|NCT02214225|530754173|FG000|Overall Study|Death|5|||
147161363|NCT02214225|530754174|FG001|Overall Study|Death|0|||
147161364|NCT02214225|530754175|FG002|Overall Study|Death|1|||
147161365|NCT02214225|530754173|FG000|Overall Study|randomized in error, not vaccinated|2|||
147161366|NCT02214225|530754174|FG001|Overall Study|randomized in error, not vaccinated|1|||
147161367|NCT02214225|530754175|FG002|Overall Study|randomized in error, not vaccinated|1|||
147161368|NCT03987932|530754180|FG000|Overall Study|Lost to Follow-up|2|||
147161369|NCT03987932|530754181|FG001|Overall Study|Lost to Follow-up|1|||
147161370|NCT03987932|530754182|FG002|Overall Study|Lost to Follow-up|1|||
147161371|NCT03987932|530754180|FG000|Overall Study|Non-study related elective surgery|0|||
147161372|NCT03987932|530754181|FG001|Overall Study|Non-study related elective surgery|0|||
147161373|NCT03987932|530754182|FG002|Overall Study|Non-study related elective surgery|1|||
147161374|NCT01605227|530754183|FG000|Overall Study|Did not receive study treatment|2|||
147161375|NCT01605227|530754184|FG001|Overall Study|Did not receive study treatment|3|||
147587653|NCT02443324|532305517|FG001|Overall Study|Withdrawal by Subject|0|||
147587654|NCT02443324|532305518|FG002|Overall Study|Withdrawal by Subject|3|||
147587655|NCT02443324|532305519|FG003|Overall Study|Withdrawal by Subject|1|||
147587656|NCT02443324|532305520|FG004|Overall Study|Withdrawal by Subject|1|||
147161376|NCT01605227|530754183|FG000|Overall Study|Adverse Event|228|||
147161377|NCT01605227|530754184|FG001|Overall Study|Adverse Event|42|||
147587657|NCT02443324|532305521|FG005|Overall Study|Withdrawal by Subject|0|||
147587658|NCT02443324|532305522|FG006|Overall Study|Withdrawal by Subject|1|||
147161378|NCT01605227|530754183|FG000|Overall Study|Progressive Disease|132|||
147161379|NCT01605227|530754184|FG001|Overall Study|Progressive Disease|128|||
147161380|NCT01605227|530754183|FG000|Overall Study|Clinical Deterioration|227|||
147161381|NCT01605227|530754184|FG001|Overall Study|Clinical Deterioration|133|||
147161382|NCT01605227|530754183|FG000|Overall Study|Lost to Follow-up|1|||
147161383|NCT01605227|530754184|FG001|Overall Study|Lost to Follow-up|0|||
147161384|NCT01605227|530754183|FG000|Overall Study|Protocol Violation|1|||
147161385|NCT01605227|530754184|FG001|Overall Study|Protocol Violation|0|||
147161386|NCT01605227|530754183|FG000|Overall Study|Physician Decision|9|||
147161387|NCT01605227|530754184|FG001|Overall Study|Physician Decision|7|||
147161388|NCT01605227|530754183|FG000|Overall Study|Withdrawal by Subject|18|||
147161389|NCT01605227|530754184|FG001|Overall Study|Withdrawal by Subject|14|||
147161390|NCT01605227|530754183|FG000|Overall Study|Sponsor Decision|2|||
147161391|NCT01605227|530754184|FG001|Overall Study|Sponsor Decision|0|||
147161392|NCT01605227|530754183|FG000|Overall Study|Started New Therapy|1|||
147161393|NCT01605227|530754184|FG001|Overall Study|Started New Therapy|0|||
147161394|NCT01605227|530754183|FG000|Overall Study|Subject Decision|0|||
147242136|NCT00395304|531059570|FG005|Treatment Period 2|Withdrawal by Subject|2|||
147322576|NCT02851511|531345390|FG000|Phase I|Physician Decision|0|||
147587659|NCT02443324|532305516|FG000|Overall Study|Adverse Event|0|||
147161395|NCT01605227|530754184|FG001|Overall Study|Subject Decision|1|||
147161396|NCT01605227|530754183|FG000|Overall Study|Dose Held >6 weeks|0|||
147161397|NCT01605227|530754184|FG001|Overall Study|Dose Held >6 weeks|1|||
147161398|NCT00624819|530754186|FG000|Follow-up Period: Year 4|Parents decision|0|||
147161399|NCT00624819|530754187|FG001|Follow-up Period: Year 4|Parents decision|0|||
147161400|NCT00624819|530754188|FG002|Follow-up Period: Year 4|Parents decision|1|||
147161401|NCT00624819|530754189|FG003|Follow-up Period: Year 4|Parents decision|0|||
147161402|NCT00624819|530754186|FG000|Follow-up Period: Year 4|Lost to Follow-up|1|||
147161403|NCT00624819|530754187|FG001|Follow-up Period: Year 4|Lost to Follow-up|1|||
147161404|NCT00624819|530754188|FG002|Follow-up Period: Year 4|Lost to Follow-up|0|||
147161405|NCT00624819|530754189|FG003|Follow-up Period: Year 4|Lost to Follow-up|0|||
147161406|NCT02847858|530754190|FG000|Overall Study|Lost to Follow-up|401|||
147161407|NCT02847858|530754191|FG001|Overall Study|Lost to Follow-up|269|||
147161408|NCT02387164|530754192|FG000|Overall Study|Lost to Follow-up|2|||
147161409|NCT02387164|530754193|FG001|Overall Study|Lost to Follow-up|0|||
147587660|NCT02443324|532305517|FG001|Overall Study|Adverse Event|1|||
147161410|NCT02387164|530754192|FG000|Overall Study|Diagnosed|1|||
147161411|NCT02387164|530754193|FG001|Overall Study|Diagnosed|2|||
147587661|NCT02443324|532305518|FG002|Overall Study|Adverse Event|3|||
147587662|NCT02443324|532305519|FG003|Overall Study|Adverse Event|0|||
147587663|NCT02443324|532305520|FG004|Overall Study|Adverse Event|4|||
147587664|NCT02443324|532305521|FG005|Overall Study|Adverse Event|3|||
147587665|NCT02443324|532305522|FG006|Overall Study|Adverse Event|3|||
147587666|NCT02443324|532305516|FG000|Overall Study|Enrolled but Never Treated|0|||
147322577|NCT02851511|531345391|FG001|Phase I|Physician Decision|0|||
147322578|NCT02851511|531345392|FG002|Phase I|Physician Decision|0|||
147322579|NCT02851511|531345393|FG003|Phase I|Physician Decision|1|||
147322580|NCT02851511|531345390|FG000|Phase I|Withdrawal by Subject|2|||
147322581|NCT02851511|531345391|FG001|Phase I|Withdrawal by Subject|1|||
147322582|NCT02851511|531345392|FG002|Phase I|Withdrawal by Subject|0|||
147322583|NCT02851511|531345393|FG003|Phase I|Withdrawal by Subject|3|||
147322584|NCT02851511|531345390|FG000|Phase II|Physician Decision|18|||
147322585|NCT02851511|531345391|FG001|Phase II|Physician Decision|16|||
147587667|NCT02443324|532305517|FG001|Overall Study|Enrolled but Never Treated|0|||
147587668|NCT02443324|532305518|FG002|Overall Study|Enrolled but Never Treated|1|||
147587669|NCT02443324|532305519|FG003|Overall Study|Enrolled but Never Treated|0|||
147587670|NCT02443324|532305520|FG004|Overall Study|Enrolled but Never Treated|1|||
147587671|NCT02443324|532305521|FG005|Overall Study|Enrolled but Never Treated|0|||
147587672|NCT02443324|532305522|FG006|Overall Study|Enrolled but Never Treated|1|||
147587673|NCT01647711|532305523|FG000|Overall Study|Progressive disease|6|||
147587674|NCT01647711|532305524|FG001|Overall Study|Progressive disease|2|||
147161412|NCT03271047|530754194|FG000|Phase 1b: Dose Finding Period|Death|8|||
147161413|NCT03271047|530754195|FG001|Phase 1b: Dose Finding Period|Death|8|||
147161414|NCT03271047|530754196|FG002|Phase 1b: Dose Finding Period|Death|0|||
147161415|NCT03271047|530754197|FG003|Phase 1b: Dose Finding Period|Death|0|||
147161416|NCT03271047|530754194|FG000|Phase 1b: Dose Finding Period|Lost to Follow-up|1|||
147161417|NCT03271047|530754195|FG001|Phase 1b: Dose Finding Period|Lost to Follow-up|0|||
147161418|NCT03271047|530754196|FG002|Phase 1b: Dose Finding Period|Lost to Follow-up|0|||
147161419|NCT03271047|530754197|FG003|Phase 1b: Dose Finding Period|Lost to Follow-up|0|||
147161420|NCT03271047|530754194|FG000|Phase 1b: Dose Finding Period|Withdrawal by Subject|0|||
147161421|NCT03271047|530754195|FG001|Phase 1b: Dose Finding Period|Withdrawal by Subject|2|||
147161422|NCT03271047|530754196|FG002|Phase 1b: Dose Finding Period|Withdrawal by Subject|0|||
147322586|NCT02851511|531345392|FG002|Phase II|Physician Decision|0|||
147322587|NCT02851511|531345393|FG003|Phase II|Physician Decision|0|||
147322588|NCT02851511|531345390|FG000|Phase II|Withdrawal by Subject|18|||
147322589|NCT02851511|531345391|FG001|Phase II|Withdrawal by Subject|16|||
147322590|NCT02851511|531345392|FG002|Phase II|Withdrawal by Subject|0|||
147587675|NCT01647711|532305525|FG002|Overall Study|Progressive disease|6|||
147587676|NCT01647711|532305526|FG003|Overall Study|Progressive disease|8|||
147587677|NCT01647711|532305527|FG004|Overall Study|Progressive disease|2|||
147587678|NCT01647711|532305523|FG000|Overall Study|Other adverse event|0|||
147587679|NCT01647711|532305524|FG001|Overall Study|Other adverse event|0|||
147587680|NCT01647711|532305525|FG002|Overall Study|Other adverse event|2|||
147587681|NCT01647711|532305526|FG003|Overall Study|Other adverse event|0|||
147587682|NCT01647711|532305527|FG004|Overall Study|Other adverse event|2|||
147322591|NCT02851511|531345393|FG003|Phase II|Withdrawal by Subject|0|||
147322592|NCT02851511|531345390|FG000|Phase II|COVID-19 lockdown, no reason specified|4|||
147587683|NCT01647711|532305523|FG000|Overall Study|Protocol Violation|0|||
147587684|NCT01647711|532305524|FG001|Overall Study|Protocol Violation|0|||
147587685|NCT01647711|532305525|FG002|Overall Study|Protocol Violation|0|||
147587686|NCT01647711|532305526|FG003|Overall Study|Protocol Violation|0|||
147587687|NCT01647711|532305527|FG004|Overall Study|Protocol Violation|1|||
147587688|NCT01647711|532305523|FG000|Overall Study|Refused to continue taking medication|0|||
147587689|NCT01647711|532305524|FG001|Overall Study|Refused to continue taking medication|0|||
147587690|NCT01647711|532305525|FG002|Overall Study|Refused to continue taking medication|0|||
147587691|NCT01647711|532305526|FG003|Overall Study|Refused to continue taking medication|2|||
147587692|NCT01647711|532305527|FG004|Overall Study|Refused to continue taking medication|1|||
147587693|NCT01647711|532305523|FG000|Overall Study|Other reason not defined|0|||
147587694|NCT01647711|532305524|FG001|Overall Study|Other reason not defined|1|||
147587695|NCT01647711|532305525|FG002|Overall Study|Other reason not defined|1|||
147587696|NCT01647711|532305526|FG003|Overall Study|Other reason not defined|1|||
147161423|NCT03271047|530754197|FG003|Phase 1b: Dose Finding Period|Withdrawal by Subject|0|||
147161424|NCT03271047|530754194|FG000|Phase 1b: Dose Finding Period|Completed follow-up per protocol|1|||
147161425|NCT03271047|530754195|FG001|Phase 1b: Dose Finding Period|Completed follow-up per protocol|1|||
147161426|NCT03271047|530754196|FG002|Phase 1b: Dose Finding Period|Completed follow-up per protocol|0|||
147322593|NCT02851511|531345391|FG001|Phase II|COVID-19 lockdown, no reason specified|5|||
147322594|NCT02851511|531345392|FG002|Phase II|COVID-19 lockdown, no reason specified|0|||
147587697|NCT01647711|532305527|FG004|Overall Study|Other reason not defined|0|||
147587698|NCT01844531|532305534|FG000|Overall Study|Withdrawal by Subject|0|||
147587699|NCT01844531|532305535|FG001|Overall Study|Withdrawal by Subject|1|||
147587700|NCT01844531|532305536|FG002|Overall Study|Withdrawal by Subject|0|||
147587701|NCT01844531|532305537|FG003|Overall Study|Withdrawal by Subject|0|||
147587702|NCT02070757|532305538|FG000|Overall Study|Adverse Event|107|||
147587703|NCT02070757|532305539|FG001|Overall Study|Adverse Event|99|||
147587704|NCT02070757|532305538|FG000|Overall Study|Lost to Follow-up|7|||
147161427|NCT03271047|530754197|FG003|Phase 1b: Dose Finding Period|Completed follow-up per protocol|0|||
147161428|NCT03271047|530754194|FG000|Randomized Phase 2 Period|Other|0|||
147161429|NCT03271047|530754195|FG001|Randomized Phase 2 Period|Other|0|||
147161430|NCT03271047|530754196|FG002|Randomized Phase 2 Period|Other|0|||
147161431|NCT03271047|530754197|FG003|Randomized Phase 2 Period|Other|1|||
147161432|NCT03271047|530754194|FG000|Randomized Phase 2 Period|Death|0|||
147161433|NCT03271047|530754195|FG001|Randomized Phase 2 Period|Death|0|||
147161434|NCT03271047|530754196|FG002|Randomized Phase 2 Period|Death|20|||
147161435|NCT03271047|530754197|FG003|Randomized Phase 2 Period|Death|21|||
147161436|NCT03271047|530754194|FG000|Randomized Phase 2 Period|Lost to Follow-up|0|||
147161437|NCT03271047|530754195|FG001|Randomized Phase 2 Period|Lost to Follow-up|0|||
147161438|NCT03271047|530754196|FG002|Randomized Phase 2 Period|Lost to Follow-up|2|||
147161439|NCT03271047|530754197|FG003|Randomized Phase 2 Period|Lost to Follow-up|1|||
147161440|NCT03271047|530754194|FG000|Randomized Phase 2 Period|Withdrawal by Subject|0|||
147161441|NCT03271047|530754195|FG001|Randomized Phase 2 Period|Withdrawal by Subject|0|||
147161442|NCT03271047|530754196|FG002|Randomized Phase 2 Period|Withdrawal by Subject|5|||
147161443|NCT03271047|530754197|FG003|Randomized Phase 2 Period|Withdrawal by Subject|0|||
147161444|NCT03271047|530754194|FG000|Randomized Phase 2 Period|Completed follow-up per protocol|0|||
147161445|NCT03271047|530754195|FG001|Randomized Phase 2 Period|Completed follow-up per protocol|0|||
147161446|NCT03271047|530754196|FG002|Randomized Phase 2 Period|Completed follow-up per protocol|0|||
147161447|NCT03271047|530754197|FG003|Randomized Phase 2 Period|Completed follow-up per protocol|4|||
147161448|NCT01416441|530754198|FG000|Overall Study|Lost to Follow-up|5|||
147161449|NCT01416441|530754198|FG000|Overall Study|Adverse Event|6|||
147161450|NCT01416441|530754198|FG000|Overall Study|Sponsor Discontinued Trial Site|43|||
147161451|NCT01416441|530754198|FG000|Overall Study|Subject Met Withdrawal Criteria|10|||
147161452|NCT01416441|530754198|FG000|Overall Study|Investigator Withdrew Subject|2|||
147161453|NCT01416441|530754198|FG000|Overall Study|Subject Withdrew Consent|12|||
147161454|NCT01416441|530754198|FG000|Overall Study|Lack of Efficacy as Determined by the Investigator|3|||
147161455|NCT00526110|530754201|FG000|Overall Study|Adverse Event|2|||
147161456|NCT00526110|530754202|FG001|Overall Study|Adverse Event|9|||
147161457|NCT00526110|530754201|FG000|Overall Study|Disease Progression|0|||
147161458|NCT00526110|530754202|FG001|Overall Study|Disease Progression|19|||
147161459|NCT00526110|530754201|FG000|Overall Study|Maximal Response|0|||
147161460|NCT00526110|530754202|FG001|Overall Study|Maximal Response|6|||
147161461|NCT00526110|530754201|FG000|Overall Study|Withdrawal by Subject|0|||
147161462|NCT00526110|530754202|FG001|Overall Study|Withdrawal by Subject|2|||
147161463|NCT00526110|530754201|FG000|Overall Study|Poor Tolerance|0|||
147161464|NCT00526110|530754202|FG001|Overall Study|Poor Tolerance|5|||
147161465|NCT01400243|530754203|FG000|Overall Study|Protocol Violation|8|||
147161466|NCT01400243|530754204|FG001|Overall Study|Protocol Violation|11|||
147447188|NCT00405067|531802069|FG000|Overall Study|Adverse Event|4|||
147447189|NCT00405067|531802070|FG001|Overall Study|Adverse Event|9|||
147587705|NCT02070757|532305539|FG001|Overall Study|Lost to Follow-up|4|||
147161467|NCT02278614|530754207|FG000|Overall Study|Withdrawal by Subject|3|||
147161468|NCT02278614|530754208|FG001|Overall Study|Withdrawal by Subject|5|||
147161469|NCT02278614|530754207|FG000|Overall Study|Adverse Event|1|||
147161470|NCT02278614|530754208|FG001|Overall Study|Adverse Event|0|||
147161471|NCT02278614|530754207|FG000|Overall Study|left eye was not eligible|1|||
147161472|NCT02278614|530754208|FG001|Overall Study|left eye was not eligible|0|||
147161473|NCT03762616|530754210|FG000|Overall Study|Protocol Violation|2|||
147161474|NCT04030247|530756845|FG000|Overall Study|Withdrawal by Subject|4|||
147161475|NCT04030247|530756845|FG000|Overall Study|Lost to Follow-up|13|||
147161476|NCT03559699|530756846|FG000|Overall Study|Withdrawal by Subject|6|||
147161477|NCT03559699|530756846|FG000|Overall Study|Lost to Follow-up|1|||
147161478|NCT00031460|530756847|FG000|Overall Study|Lost to Follow-up|0|||
147161479|NCT00031460|530756848|FG001|Overall Study|Lost to Follow-up|1|||
147161480|NCT00031460|530756847|FG000|Overall Study|Withdrawal by Subject|1|||
147161481|NCT00031460|530756848|FG001|Overall Study|Withdrawal by Subject|1|||
147161482|NCT00031460|530756847|FG000|Overall Study|Non-Compliant|1|||
147161483|NCT00031460|530756848|FG001|Overall Study|Non-Compliant|1|||
147161484|NCT00031460|530756847|FG000|Overall Study|Death|0|||
147161485|NCT00031460|530756848|FG001|Overall Study|Death|1|||
147161486|NCT00031460|530756847|FG000|Overall Study|Reactivation of Disease|5|||
147161487|NCT00031460|530756848|FG001|Overall Study|Reactivation of Disease|9|||
147161488|NCT00031460|530756847|FG000|Overall Study|Disruption of blinded drug supply|2|||
147161489|NCT00031460|530756848|FG001|Overall Study|Disruption of blinded drug supply|0|||
147161490|NCT00031460|530756847|FG000|Overall Study|Confirmed unevaluable|0|||
147161491|NCT00031460|530756848|FG001|Overall Study|Confirmed unevaluable|1|||
147161492|NCT01930890|530756851|FG000|Overall Study|Study Termination|14|||
147161493|NCT01930890|530756852|FG001|Overall Study|Study Termination|28|||
147161494|NCT01930890|530756853|FG002|Overall Study|Study Termination|13|||
147161495|NCT01930890|530756854|FG003|Overall Study|Study Termination|25|||
147161496|NCT01930890|530756851|FG000|Overall Study|Death|0|||
147161497|NCT01930890|530756852|FG001|Overall Study|Death|0|||
147587706|NCT02070757|532305538|FG000|Overall Study|Protocol Violation|0|||
147587707|NCT02070757|532305539|FG001|Overall Study|Protocol Violation|4|||
147587708|NCT02070757|532305538|FG000|Overall Study|Withdrawal by Subject|1|||
147587709|NCT02070757|532305539|FG001|Overall Study|Withdrawal by Subject|3|||
147587710|NCT02070757|532305538|FG000|Overall Study|Investigator Decision|0|||
147161498|NCT01930890|530756853|FG002|Overall Study|Death|0|||
147161499|NCT01930890|530756854|FG003|Overall Study|Death|1|||
147161500|NCT01930890|530756851|FG000|Overall Study|Investigator Decision|0|||
147161501|NCT01930890|530756852|FG001|Overall Study|Investigator Decision|1|||
147161502|NCT01930890|530756853|FG002|Overall Study|Investigator Decision|0|||
147161503|NCT01930890|530756854|FG003|Overall Study|Investigator Decision|0|||
147161504|NCT01930890|530756851|FG000|Overall Study|Consent Withdrawn|0|||
147161505|NCT01930890|530756852|FG001|Overall Study|Consent Withdrawn|3|||
147161506|NCT01930890|530756853|FG002|Overall Study|Consent Withdrawn|0|||
147161507|NCT01930890|530756854|FG003|Overall Study|Consent Withdrawn|1|||
147161508|NCT01930890|530756851|FG000|Overall Study|Adverse Event|0|||
147161509|NCT01930890|530756852|FG001|Overall Study|Adverse Event|1|||
147161510|NCT01930890|530756853|FG002|Overall Study|Adverse Event|0|||
147161511|NCT01930890|530756854|FG003|Overall Study|Adverse Event|0|||
147161512|NCT01278407|530756855|FG000|Confirmatory Phase|Adverse Event|5|||
147161513|NCT01278407|530756856|FG001|Confirmatory Phase|Adverse Event|10|||
147161514|NCT01278407|530756857|FG002|Confirmatory Phase|Adverse Event|1|||
147161515|NCT01278407|530756858|FG003|Confirmatory Phase|Adverse Event|0|||
147161516|NCT01278407|530756859|FG004|Confirmatory Phase|Adverse Event|0|||
147161517|NCT01278407|530756855|FG000|Confirmatory Phase|Participant's Choice|3|||
147161518|NCT01278407|530756856|FG001|Confirmatory Phase|Participant's Choice|5|||
147161519|NCT01278407|530756857|FG002|Confirmatory Phase|Participant's Choice|3|||
147161520|NCT01278407|530756858|FG003|Confirmatory Phase|Participant's Choice|0|||
147161521|NCT01278407|530756859|FG004|Confirmatory Phase|Participant's Choice|0|||
147161522|NCT01278407|530756855|FG000|Confirmatory Phase|Other|1|||
147161523|NCT01278407|530756856|FG001|Confirmatory Phase|Other|1|||
147161524|NCT01278407|530756857|FG002|Confirmatory Phase|Other|2|||
147161525|NCT01278407|530756858|FG003|Confirmatory Phase|Other|0|||
147161526|NCT01278407|530756859|FG004|Confirmatory Phase|Other|0|||
147161527|NCT01278407|530756855|FG000|Extension Phase|Adverse Event|0|||
147161528|NCT01278407|530756856|FG001|Extension Phase|Adverse Event|0|||
147161529|NCT01278407|530756857|FG002|Extension Phase|Adverse Event|0|||
147161530|NCT01278407|530756858|FG003|Extension Phase|Adverse Event|7|||
147161531|NCT01278407|530756859|FG004|Extension Phase|Adverse Event|16|||
147161532|NCT01278407|530756855|FG000|Extension Phase|Participant's Choice|0|||
147161533|NCT01278407|530756856|FG001|Extension Phase|Participant's Choice|0|||
147161534|NCT01278407|530756857|FG002|Extension Phase|Participant's Choice|0|||
147161535|NCT01278407|530756858|FG003|Extension Phase|Participant's Choice|4|||
147161536|NCT01278407|530756859|FG004|Extension Phase|Participant's Choice|11|||
147161537|NCT01278407|530756855|FG000|Extension Phase|Other|0|||
147161538|NCT01278407|530756856|FG001|Extension Phase|Other|0|||
147161539|NCT01278407|530756857|FG002|Extension Phase|Other|0|||
147161540|NCT01278407|530756858|FG003|Extension Phase|Other|1|||
147161541|NCT01278407|530756859|FG004|Extension Phase|Other|3|||
147161542|NCT02534935|530756860|FG000|Stage 1: 24 Months|Withdrawal by Subject|0|||
147161543|NCT02534935|530756861|FG001|Stage 1: 24 Months|Withdrawal by Subject|3|||
147242137|NCT00395304|531059565|FG000|Treatment Period 2|Lost to Follow-up|0|||
147587711|NCT02070757|532305539|FG001|Overall Study|Investigator Decision|2|||
147587712|NCT02070757|532305538|FG000|Overall Study|Discharged from Study Hospital|2|||
147447190|NCT00405067|531802071|FG002|Overall Study|Adverse Event|4|||
147587713|NCT02070757|532305539|FG001|Overall Study|Discharged from Study Hospital|2|||
147587714|NCT01546922|532305540|FG000|First Period of 10 Weeks|Protocol Violation|3|||
147587715|NCT01546922|532305541|FG001|First Period of 10 Weeks|Protocol Violation|1|||
147587716|NCT01546922|532305540|FG000|First Period of 10 Weeks|Withdrawal by Subject|1|||
147161544|NCT02534935|530756862|FG002|Stage 1: 24 Months|Withdrawal by Subject|3|||
147161545|NCT02534935|530756860|FG000|Stage 1: 24 Months|No longer willing to participate in study|0|||
147161546|NCT02534935|530756861|FG001|Stage 1: 24 Months|No longer willing to participate in study|1|||
147161547|NCT02534935|530756862|FG002|Stage 1: 24 Months|No longer willing to participate in study|1|||
147161548|NCT02534935|530756860|FG000|Stage 1: 24 Months|No longer meets eligibility criteria|0|||
147161549|NCT02534935|530756861|FG001|Stage 1: 24 Months|No longer meets eligibility criteria|3|||
147161550|NCT02534935|530756862|FG002|Stage 1: 24 Months|No longer meets eligibility criteria|0|||
147161551|NCT02534935|530756860|FG000|Stage 1: 24 Months|Lost to Follow-up|0|||
147161552|NCT02534935|530756861|FG001|Stage 1: 24 Months|Lost to Follow-up|1|||
147161553|NCT02534935|530756862|FG002|Stage 1: 24 Months|Lost to Follow-up|1|||
147161554|NCT02534935|530756860|FG000|Stage 1: 24 Months|Adverse Event|0|||
147161555|NCT02534935|530756861|FG001|Stage 1: 24 Months|Adverse Event|2|||
147161556|NCT02534935|530756862|FG002|Stage 1: 24 Months|Adverse Event|0|||
147161557|NCT02534935|530756860|FG000|Stage 2: 8 Months|Moved away/parents resigned from study|0|||
147242138|NCT00395304|531059566|FG001|Treatment Period 2|Lost to Follow-up|3|||
147161558|NCT02534935|530756861|FG001|Stage 2: 8 Months|Moved away/parents resigned from study|4|||
147161559|NCT02534935|530756862|FG002|Stage 2: 8 Months|Moved away/parents resigned from study|0|||
147587717|NCT01546922|532305541|FG001|First Period of 10 Weeks|Withdrawal by Subject|1|||
147447191|NCT00405067|531802069|FG000|Overall Study|Lost to Follow-up|0|||
147654437|NCT03853291|532556729|FG003|Overall Study|Lost to Follow-up|0|||
147161560|NCT02534935|530756860|FG000|Stage 2: Booster Phase (6 Months)|Not received booster vaccination|0|||
147161561|NCT02534935|530756861|FG001|Stage 2: Booster Phase (6 Months)|Not received booster vaccination|1|||
147161562|NCT02534935|530756862|FG002|Stage 2: Booster Phase (6 Months)|Not received booster vaccination|0|||
147161563|NCT01596335|530756863|FG000|Overall Study|exacerbation of primary disease|5|||
147161564|NCT01596335|530756864|FG001|Overall Study|exacerbation of primary disease|9|||
147161565|NCT01176565|530756867|FG000|Overall Study|Lost to Follow-up|12|||
147161566|NCT01176565|530756868|FG001|Overall Study|Lost to Follow-up|16|||
147161567|NCT01176565|530756867|FG000|Overall Study|Withdrawal by Subject|7|||
147161568|NCT01176565|530756868|FG001|Overall Study|Withdrawal by Subject|1|||
147161569|NCT01176565|530756867|FG000|Overall Study|Not Analyzed (any other reason)|1|||
147161570|NCT01176565|530756868|FG001|Overall Study|Not Analyzed (any other reason)|2|||
147161571|NCT03602885|530756870|FG000|Overall Study|Lost to Follow-up|3|||
147161572|NCT03602885|530756871|FG001|Overall Study|Lost to Follow-up|0|||
147161573|NCT02285114|530756876|FG000|Main Phase|Investigator's Discretion|0|||
147161574|NCT02285114|530756877|FG001|Main Phase|Investigator's Discretion|2|||
147161575|NCT02285114|530756878|FG002|Main Phase|Investigator's Discretion|0|||
147161576|NCT02285114|530756879|FG003|Main Phase|Investigator's Discretion|0|||
147161577|NCT02285114|530756880|FG004|Main Phase|Investigator's Discretion|0|||
147161578|NCT02285114|530756881|FG005|Main Phase|Investigator's Discretion|0|||
147161579|NCT02285114|530756876|FG000|Main Phase|Enrolled but Never Treated|1|||
147161580|NCT02285114|530756877|FG001|Main Phase|Enrolled but Never Treated|0|||
147161581|NCT02285114|530756878|FG002|Main Phase|Enrolled but Never Treated|0|||
147161582|NCT02285114|530756879|FG003|Main Phase|Enrolled but Never Treated|0|||
147161583|NCT02285114|530756880|FG004|Main Phase|Enrolled but Never Treated|0|||
147161584|NCT02285114|530756881|FG005|Main Phase|Enrolled but Never Treated|0|||
147161585|NCT02285114|530756876|FG000|Main Phase|Withdrew Consent|0|||
147161586|NCT02285114|530756877|FG001|Main Phase|Withdrew Consent|0|||
147161587|NCT02285114|530756878|FG002|Main Phase|Withdrew Consent|1|||
147161588|NCT02285114|530756879|FG003|Main Phase|Withdrew Consent|0|||
147161589|NCT02285114|530756880|FG004|Main Phase|Withdrew Consent|0|||
147161590|NCT02285114|530756881|FG005|Main Phase|Withdrew Consent|0|||
147161591|NCT02285114|530756876|FG000|Extension Phase|Investigator's Discretion|0|||
147161592|NCT02285114|530756877|FG001|Extension Phase|Investigator's Discretion|0|||
147161593|NCT02285114|530756878|FG002|Extension Phase|Investigator's Discretion|0|||
147161594|NCT02285114|530756879|FG003|Extension Phase|Investigator's Discretion|14|||
147161595|NCT02285114|530756880|FG004|Extension Phase|Investigator's Discretion|1|||
147161596|NCT02285114|530756881|FG005|Extension Phase|Investigator's Discretion|0|||
147161597|NCT02285114|530756876|FG000|Extension Phase|Lost to Follow-up|0|||
147161598|NCT02285114|530756877|FG001|Extension Phase|Lost to Follow-up|0|||
147161599|NCT02285114|530756878|FG002|Extension Phase|Lost to Follow-up|0|||
147161600|NCT02285114|530756879|FG003|Extension Phase|Lost to Follow-up|1|||
147161601|NCT02285114|530756880|FG004|Extension Phase|Lost to Follow-up|1|||
147161602|NCT02285114|530756881|FG005|Extension Phase|Lost to Follow-up|0|||
147161603|NCT02285114|530756876|FG000|Extension Phase|Non-compliance with Study Drug|0|||
147161604|NCT02285114|530756877|FG001|Extension Phase|Non-compliance with Study Drug|0|||
147161605|NCT02285114|530756878|FG002|Extension Phase|Non-compliance with Study Drug|0|||
147242139|NCT00395304|531059567|FG002|Treatment Period 2|Lost to Follow-up|0|||
147242140|NCT00395304|531059568|FG003|Treatment Period 2|Lost to Follow-up|0|||
147242141|NCT00395304|531059569|FG004|Treatment Period 2|Lost to Follow-up|0|||
147242142|NCT00395304|531059570|FG005|Treatment Period 2|Lost to Follow-up|0|||
147242143|NCT00395304|531059565|FG000|Treatment Period 2|Physician Decision|0|||
147242144|NCT00395304|531059566|FG001|Treatment Period 2|Physician Decision|0|||
147242145|NCT00395304|531059567|FG002|Treatment Period 2|Physician Decision|1|||
147242146|NCT00395304|531059568|FG003|Treatment Period 2|Physician Decision|0|||
147242147|NCT00395304|531059569|FG004|Treatment Period 2|Physician Decision|0|||
147242148|NCT00395304|531059570|FG005|Treatment Period 2|Physician Decision|0|||
147242149|NCT00395304|531059565|FG000|Treatment Period 2|Other|0|||
147242150|NCT00395304|531059566|FG001|Treatment Period 2|Other|1|||
147242151|NCT00395304|531059567|FG002|Treatment Period 2|Other|0|||
147242152|NCT00395304|531059568|FG003|Treatment Period 2|Other|0|||
147242153|NCT00395304|531059569|FG004|Treatment Period 2|Other|0|||
147242154|NCT00395304|531059570|FG005|Treatment Period 2|Other|0|||
147161606|NCT02285114|530756879|FG003|Extension Phase|Non-compliance with Study Drug|2|||
147161607|NCT02285114|530756880|FG004|Extension Phase|Non-compliance with Study Drug|0|||
147161608|NCT02285114|530756881|FG005|Extension Phase|Non-compliance with Study Drug|0|||
147161609|NCT02285114|530756876|FG000|Extension Phase|Pregnancy|0|||
147161610|NCT02285114|530756877|FG001|Extension Phase|Pregnancy|0|||
147161611|NCT02285114|530756878|FG002|Extension Phase|Pregnancy|0|||
147161612|NCT02285114|530756879|FG003|Extension Phase|Pregnancy|1|||
147242155|NCT00395304|531059565|FG000|Treatment Period 3|Withdrawal by Subject|0|||
147242156|NCT00395304|531059566|FG001|Treatment Period 3|Withdrawal by Subject|0|||
147654438|NCT03853291|532556730|FG004|Overall Study|Lost to Follow-up|0|||
147161613|NCT02285114|530756880|FG004|Extension Phase|Pregnancy|0|||
147161614|NCT02285114|530756881|FG005|Extension Phase|Pregnancy|0|||
147161615|NCT01156389|530756882|FG000|Overall Study|Elevated liver enzymes|4|||
147161616|NCT01156389|530756883|FG001|Overall Study|Elevated liver enzymes|0|||
147161617|NCT01156389|530756882|FG000|Overall Study|Vomiting|0|||
147161618|NCT01156389|530756883|FG001|Overall Study|Vomiting|1|||
147161619|NCT03383783|530756884|FG000|Overall Study|Withdrawal by Subject|2|||
147161620|NCT02233738|530756891|FG000|Overall Study|Lost to Follow-up|5|||
147161621|NCT02233738|530756892|FG001|Overall Study|Lost to Follow-up|12|||
147161622|NCT02233738|530756891|FG000|Overall Study|Death|0|||
147161623|NCT02233738|530756892|FG001|Overall Study|Death|1|||
147161624|NCT02233738|530756891|FG000|Overall Study|Withdrawal by Subject|0|||
147161625|NCT02233738|530756892|FG001|Overall Study|Withdrawal by Subject|1|||
147161626|NCT02233738|530756891|FG000|Overall Study|Did not return after Baseline|3|||
147161627|NCT02233738|530756892|FG001|Overall Study|Did not return after Baseline|2|||
147161628|NCT00096174|530756893|FG000|Overall Study|Lack of Efficacy|9|||
147161629|NCT00096174|530756893|FG000|Overall Study|Adverse Event|15|||
147161630|NCT00096174|530756893|FG000|Overall Study|Death|6|||
147161631|NCT00096174|530756893|FG000|Overall Study|Withdrawal by Subject|15|||
147161632|NCT00096174|530756893|FG000|Overall Study|Not started protocol therapy|3|||
147161633|NCT00096174|530756893|FG000|Overall Study|Ineligible|6|||
147161634|NCT00096174|530756893|FG000|Overall Study|other reason|8|||
147161635|NCT00330928|530756894|FG000|Overall Study|Lost to Follow-up|6|||
147161636|NCT00330928|530756894|FG000|Overall Study|Physician Decision|9|||
147161637|NCT00330928|530756894|FG000|Overall Study|Death|1|||
147161638|NCT00330928|530756894|FG000|Overall Study|IVUS could not be performed.|1|||
147161639|NCT03028480|530756897|FG000|Overall Study|No revisit after the first prescription date|2|||
147161640|NCT03028480|530756897|FG000|Overall Study|Did not use the drug|1|||
147161641|NCT03028480|530756897|FG000|Overall Study|Violation of the enrollment deadline|10|||
147161642|NCT03028480|530756897|FG000|Overall Study|Case report forms were not collected|21|||
147161643|NCT01030874|530756898|FG000|Overall Study|Withdrawal by Subject|1|||
147587718|NCT01546922|532305540|FG000|First Period of 10 Weeks|Investigator's judgment|1|||
147161644|NCT01030874|530756899|FG001|Overall Study|Withdrawal by Subject|0|||
147161645|NCT01030874|530756898|FG000|Overall Study|Discharged in first 2 weeks|17|||
147161646|NCT01030874|530756899|FG001|Overall Study|Discharged in first 2 weeks|16|||
147161647|NCT03554772|530756902|FG000|Overall Study|Lost to Follow-up|0|||
147161648|NCT03554772|530756903|FG001|Overall Study|Lost to Follow-up|0|||
147161649|NCT03554772|530756904|FG002|Overall Study|Lost to Follow-up|0|||
147161650|NCT03554772|530756905|FG003|Overall Study|Lost to Follow-up|2|||
147161651|NCT01133405|530756909|FG000|Period 1|Withdrawal by Subject|0|||
147161652|NCT01133405|530756910|FG001|Period 1|Withdrawal by Subject|1|||
147161653|NCT01133405|530756911|FG002|Period 1|Withdrawal by Subject|0|||
147161654|NCT01133405|530756912|FG003|Period 1|Withdrawal by Subject|1|||
147161655|NCT01133405|530756913|FG004|Period 1|Withdrawal by Subject|0|||
147161656|NCT01133405|530756914|FG005|Period 1|Withdrawal by Subject|1|||
147161657|NCT01133405|530756915|FG006|Period 1|Withdrawal by Subject|0|||
147161658|NCT01133405|530756916|FG007|Period 1|Withdrawal by Subject|0|||
147242157|NCT00395304|531059567|FG002|Treatment Period 3|Withdrawal by Subject|0|||
147242158|NCT00395304|531059568|FG003|Treatment Period 3|Withdrawal by Subject|1|||
147242159|NCT00395304|531059569|FG004|Treatment Period 3|Withdrawal by Subject|0|||
147242160|NCT00395304|531059570|FG005|Treatment Period 3|Withdrawal by Subject|1|||
147242161|NCT00395304|531059565|FG000|Treatment Period 3|Lost to Follow-up|1|||
147242162|NCT00395304|531059566|FG001|Treatment Period 3|Lost to Follow-up|1|||
147242163|NCT00395304|531059567|FG002|Treatment Period 3|Lost to Follow-up|0|||
147242164|NCT00395304|531059568|FG003|Treatment Period 3|Lost to Follow-up|0|||
147161659|NCT01133405|530756917|FG008|Period 1|Withdrawal by Subject|0|||
147242165|NCT00395304|531059569|FG004|Treatment Period 3|Lost to Follow-up|0|||
147242166|NCT00395304|531059570|FG005|Treatment Period 3|Lost to Follow-up|0|||
147242167|NCT00395304|531059565|FG000|Treatment Period 3|Physician Decision|0|||
147242168|NCT00395304|531059566|FG001|Treatment Period 3|Physician Decision|1|||
147161660|NCT01133405|530756918|FG009|Period 1|Withdrawal by Subject|0|||
147161661|NCT01133405|530756909|FG000|Period 1|Physician Decision|0|||
147161662|NCT01133405|530756910|FG001|Period 1|Physician Decision|0|||
147161663|NCT01133405|530756911|FG002|Period 1|Physician Decision|0|||
147161664|NCT01133405|530756912|FG003|Period 1|Physician Decision|1|||
147242169|NCT00395304|531059567|FG002|Treatment Period 3|Physician Decision|0|||
147161665|NCT01133405|530756913|FG004|Period 1|Physician Decision|0|||
147161666|NCT01133405|530756914|FG005|Period 1|Physician Decision|0|||
147161667|NCT01133405|530756915|FG006|Period 1|Physician Decision|0|||
147161668|NCT01133405|530756916|FG007|Period 1|Physician Decision|0|||
147161669|NCT01133405|530756917|FG008|Period 1|Physician Decision|0|||
147161670|NCT01133405|530756918|FG009|Period 1|Physician Decision|0|||
147161671|NCT01133405|530756909|FG000|Period 1|Discontinued after randomization|1|||
147161672|NCT01133405|530756910|FG001|Period 1|Discontinued after randomization|0|||
147161673|NCT01133405|530756911|FG002|Period 1|Discontinued after randomization|0|||
147161674|NCT01133405|530756912|FG003|Period 1|Discontinued after randomization|0|||
147242170|NCT00395304|531059568|FG003|Treatment Period 3|Physician Decision|0|||
147654439|NCT03853291|532556731|FG005|Overall Study|Lost to Follow-up|0|||
147161675|NCT01133405|530756913|FG004|Period 1|Discontinued after randomization|0|||
147161676|NCT01133405|530756914|FG005|Period 1|Discontinued after randomization|0|||
147161677|NCT01133405|530756915|FG006|Period 1|Discontinued after randomization|1|||
147161678|NCT01133405|530756916|FG007|Period 1|Discontinued after randomization|0|||
147161679|NCT01133405|530756917|FG008|Period 1|Discontinued after randomization|0|||
147161680|NCT01133405|530756918|FG009|Period 1|Discontinued after randomization|0|||
147161681|NCT01133405|530756909|FG000|Period 1|Received drug only in period 2|0|||
147161682|NCT01133405|530756910|FG001|Period 1|Received drug only in period 2|1|||
147161683|NCT01133405|530756911|FG002|Period 1|Received drug only in period 2|0|||
147161684|NCT01133405|530756912|FG003|Period 1|Received drug only in period 2|2|||
147161685|NCT01133405|530756913|FG004|Period 1|Received drug only in period 2|0|||
147161686|NCT01133405|530756914|FG005|Period 1|Received drug only in period 2|1|||
147161687|NCT01133405|530756915|FG006|Period 1|Received drug only in period 2|0|||
147161688|NCT01133405|530756916|FG007|Period 1|Received drug only in period 2|0|||
147161689|NCT01133405|530756917|FG008|Period 1|Received drug only in period 2|0|||
147161690|NCT01133405|530756918|FG009|Period 1|Received drug only in period 2|0|||
147161691|NCT01133405|530756909|FG000|Period 1|Received drug only in period 3|0|||
147161692|NCT01133405|530756910|FG001|Period 1|Received drug only in period 3|1|||
147161693|NCT01133405|530756911|FG002|Period 1|Received drug only in period 3|1|||
147161694|NCT01133405|530756912|FG003|Period 1|Received drug only in period 3|0|||
147161695|NCT01133405|530756913|FG004|Period 1|Received drug only in period 3|0|||
147161696|NCT01133405|530756914|FG005|Period 1|Received drug only in period 3|0|||
147161697|NCT01133405|530756915|FG006|Period 1|Received drug only in period 3|0|||
147161698|NCT01133405|530756916|FG007|Period 1|Received drug only in period 3|0|||
147161699|NCT01133405|530756917|FG008|Period 1|Received drug only in period 3|0|||
147161700|NCT01133405|530756918|FG009|Period 1|Received drug only in period 3|0|||
147161701|NCT01133405|530756909|FG000|Period 2|Adverse Event|0|||
147161702|NCT01133405|530756910|FG001|Period 2|Adverse Event|0|||
147161703|NCT01133405|530756911|FG002|Period 2|Adverse Event|1|||
147161704|NCT01133405|530756912|FG003|Period 2|Adverse Event|0|||
147161705|NCT01133405|530756913|FG004|Period 2|Adverse Event|0|||
147161706|NCT01133405|530756914|FG005|Period 2|Adverse Event|0|||
147161707|NCT01133405|530756915|FG006|Period 2|Adverse Event|0|||
147161708|NCT01133405|530756916|FG007|Period 2|Adverse Event|0|||
147242171|NCT00395304|531059569|FG004|Treatment Period 3|Physician Decision|0|||
147242172|NCT00395304|531059570|FG005|Treatment Period 3|Physician Decision|0|||
147242173|NCT00395304|531059565|FG000|Treatment Period 3|Other|0|||
147242174|NCT00395304|531059566|FG001|Treatment Period 3|Other|0|||
147242175|NCT00395304|531059567|FG002|Treatment Period 3|Other|0|||
147242176|NCT00395304|531059568|FG003|Treatment Period 3|Other|1|||
147242177|NCT00395304|531059569|FG004|Treatment Period 3|Other|0|||
147242178|NCT00395304|531059570|FG005|Treatment Period 3|Other|0|||
147242179|NCT01389817|531059577|FG000|Overall Study|Physician Decision|1|||
147242180|NCT01389817|531059578|FG001|Overall Study|Physician Decision|0|||
147242181|NCT01389817|531059577|FG000|Overall Study|Lost to Follow-up|1|||
147242182|NCT01389817|531059578|FG001|Overall Study|Lost to Follow-up|0|||
147242183|NCT01389817|531059577|FG000|Overall Study|Withdrawal by Subject|2|||
147242184|NCT01389817|531059578|FG001|Overall Study|Withdrawal by Subject|0|||
147242185|NCT01749137|531059579|FG000|Overall Study|Adverse Event|4|||
147242186|NCT01749137|531059580|FG001|Overall Study|Adverse Event|4|||
147242187|NCT01749137|531059579|FG000|Overall Study|Lost to Follow-up|2|||
147161709|NCT01133405|530756917|FG008|Period 2|Adverse Event|0|||
147161710|NCT01133405|530756918|FG009|Period 2|Adverse Event|0|||
147161711|NCT01133405|530756909|FG000|Period 2|Withdrawal by Subject|0|||
147161712|NCT01133405|530756910|FG001|Period 2|Withdrawal by Subject|0|||
147161713|NCT01133405|530756911|FG002|Period 2|Withdrawal by Subject|0|||
147242188|NCT01749137|531059580|FG001|Overall Study|Lost to Follow-up|3|||
147242189|NCT01749137|531059579|FG000|Overall Study|Physician Decision|1|||
147242190|NCT01749137|531059580|FG001|Overall Study|Physician Decision|0|||
147242191|NCT01749137|531059579|FG000|Overall Study|Withdrawal by Subject|8|||
147242192|NCT01749137|531059580|FG001|Overall Study|Withdrawal by Subject|4|||
147242193|NCT02871297|531059588|FG000|Overall Study|Adverse Event|34|||
147242194|NCT02871297|531059588|FG000|Overall Study|Lack of Efficacy|10|||
147161714|NCT01133405|530756912|FG003|Period 2|Withdrawal by Subject|1|||
147161715|NCT01133405|530756913|FG004|Period 2|Withdrawal by Subject|0|||
147161716|NCT01133405|530756914|FG005|Period 2|Withdrawal by Subject|1|||
147161717|NCT01133405|530756915|FG006|Period 2|Withdrawal by Subject|0|||
147161718|NCT01133405|530756916|FG007|Period 2|Withdrawal by Subject|0|||
147161719|NCT01133405|530756917|FG008|Period 2|Withdrawal by Subject|0|||
147161720|NCT01133405|530756918|FG009|Period 2|Withdrawal by Subject|0|||
147161721|NCT01133405|530756909|FG000|Period 2|Entry Criteria Not Met|0|||
147161722|NCT01133405|530756910|FG001|Period 2|Entry Criteria Not Met|1|||
147161723|NCT01133405|530756911|FG002|Period 2|Entry Criteria Not Met|0|||
147161724|NCT01133405|530756912|FG003|Period 2|Entry Criteria Not Met|0|||
147161725|NCT01133405|530756913|FG004|Period 2|Entry Criteria Not Met|0|||
147161726|NCT01133405|530756914|FG005|Period 2|Entry Criteria Not Met|0|||
147161727|NCT01133405|530756915|FG006|Period 2|Entry Criteria Not Met|0|||
147242195|NCT02871297|531059588|FG000|Overall Study|Non-compliance with study drug|15|||
147242196|NCT02871297|531059588|FG000|Overall Study|Protocol Violation|3|||
147242197|NCT02871297|531059588|FG000|Overall Study|Withdrawal by Subject|20|||
147161728|NCT01133405|530756916|FG007|Period 2|Entry Criteria Not Met|0|||
147161729|NCT01133405|530756917|FG008|Period 2|Entry Criteria Not Met|0|||
147242198|NCT02871297|531059588|FG000|Overall Study|Lost to Follow-up|13|||
147242199|NCT02871297|531059588|FG000|Overall Study|Rolled over to 13546A|2|||
147242200|NCT02871297|531059588|FG000|Overall Study|Other than specified|39|||
147242201|NCT02966028|531059589|FG000|Overall Study|Adverse Event|7|||
147242202|NCT02966028|531059590|FG001|Overall Study|Adverse Event|13|||
147242203|NCT02966028|531059591|FG002|Overall Study|Adverse Event|10|||
147242204|NCT02966028|531059589|FG000|Overall Study|Physician Decision|1|||
147242205|NCT02966028|531059590|FG001|Overall Study|Physician Decision|0|||
147242206|NCT02966028|531059591|FG002|Overall Study|Physician Decision|2|||
147242207|NCT02966028|531059589|FG000|Overall Study|Withdrawal by Subject|7|||
147242208|NCT02966028|531059590|FG001|Overall Study|Withdrawal by Subject|5|||
147242209|NCT02966028|531059591|FG002|Overall Study|Withdrawal by Subject|5|||
147242210|NCT02966028|531059589|FG000|Overall Study|Kidney transplant Changed dialysis units|9|||
147242211|NCT02966028|531059590|FG001|Overall Study|Kidney transplant Changed dialysis units|16|||
147322595|NCT02851511|531345393|FG003|Phase II|COVID-19 lockdown, no reason specified|0|||
147322596|NCT02851511|531345390|FG000|Phase II|Lost to Follow-up|0|||
147322597|NCT02851511|531345391|FG001|Phase II|Lost to Follow-up|1|||
147322598|NCT02851511|531345392|FG002|Phase II|Lost to Follow-up|0|||
147322599|NCT02851511|531345393|FG003|Phase II|Lost to Follow-up|0|||
147322600|NCT00051311|531345394|FG000|Overall Study|Starting new study|0|||
147322601|NCT00051311|531345395|FG001|Overall Study|Starting new study|1|||
147322602|NCT00051311|531345394|FG000|Overall Study|Pt. to pursue treatment for progressive disease|0|||
147322603|NCT00051311|531345395|FG001|Overall Study|Pt. to pursue treatment for progressive disease|1|||
147322604|NCT00051311|531345394|FG000|Overall Study|Death of recipient|8|||
147322605|NCT00051311|531345395|FG001|Overall Study|Death of recipient|8|||
147322606|NCT00051311|531345394|FG000|Overall Study|Recipient taken off study|4|||
147322607|NCT00051311|531345395|FG001|Overall Study|Recipient taken off study|4|||
147322608|NCT02256969|531345396|FG000|Overall Study|Screenfailed or withdrew|2|||
147322609|NCT02256969|531345397|FG001|Overall Study|Screenfailed or withdrew|1|||
147322610|NCT02256969|531345398|FG002|Overall Study|Screenfailed or withdrew|1|||
147322611|NCT01427907|531345399|FG000|Overall Study|Withdrawal by Subject|3|||
147322612|NCT01427907|531345400|FG001|Overall Study|Withdrawal by Subject|4|||
147322613|NCT04337489|531345401|FG000|Overall Study|Withdrawal by Subject|1|||
147322614|NCT00335153|531345406|FG000|Nasojejunal (NJ) Test Period|Adverse Event|5|||
147322615|NCT00335153|531345406|FG000|Nasojejunal (NJ) Test Period|Lack of Efficacy|5|||
147322616|NCT00335153|531345406|FG000|Nasojejunal (NJ) Test Period|Withdrawal by Subject|12|||
147322617|NCT00335153|531345406|FG000|Nasojejunal (NJ) Test Period|Administrative|1|||
147322618|NCT00335153|531345406|FG000|Nasojejunal (NJ) Test Period|Protocol Violation|7|||
147322619|NCT00335153|531345406|FG000|Post-PEG-J Long-Term Treatment Period|Adverse Event|22|||
147322620|NCT00335153|531345406|FG000|Post-PEG-J Long-Term Treatment Period|Lack of Efficacy|2|||
147322621|NCT00335153|531345406|FG000|Post-PEG-J Long-Term Treatment Period|Withdrawal by Subject|13|||
147322622|NCT00335153|531345406|FG000|Post-PEG-J Long-Term Treatment Period|Administrative|13|||
147322623|NCT00335153|531345406|FG000|Post-PEG-J Long-Term Treatment Period|Protocol Violation|2|||
147322624|NCT01113463|531345412|FG000|Overall Study|Physician Decision|5|||
147322625|NCT02478359|531345413|FG000|Overall Study|Disenrolled from health plan|106|||
147322626|NCT02478359|531345414|FG001|Overall Study|Disenrolled from health plan|65|||
147322627|NCT00372528|531345415|FG000|Overall Study|Lack of Efficacy|1|||
147322628|NCT00372528|531345415|FG000|Overall Study|Adverse Event|1|||
147322629|NCT00372528|531345415|FG000|Overall Study|Study Terminated by Sponsor|18|||
147322630|NCT00372528|531345415|FG000|Overall Study|Other|1|||
147322631|NCT01818700|531345416|FG000|Overall Study|Adverse Event|67|||
147322632|NCT01818700|531345416|FG000|Overall Study|Lack of Efficacy|2|||
147322633|NCT01818700|531345416|FG000|Overall Study|Lost to Follow-up|5|||
147322634|NCT01818700|531345416|FG000|Overall Study|Withdrawal by Subject|27|||
147322635|NCT01818700|531345416|FG000|Overall Study|Protocol Violation|2|||
147322636|NCT01818700|531345416|FG000|Overall Study|Other|1|||
147322637|NCT02412761|531345417|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
147322638|NCT02412761|531345418|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
147322639|NCT02412761|531345419|FG002|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
147322640|NCT02412761|531345420|FG003|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
147322641|NCT02412761|531345421|FG004|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
147242212|NCT02966028|531059591|FG002|Overall Study|Kidney transplant Changed dialysis units|14|||
147322642|NCT02412761|531345422|FG005|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
147322643|NCT01417000|531345423|FG000|Overall Study|Death|59|||
147322644|NCT01417000|531345424|FG001|Overall Study|Death|28|||
147322645|NCT01417000|531345423|FG000|Overall Study|Lost to Follow-up|1|||
147447192|NCT00405067|531802070|FG001|Overall Study|Lost to Follow-up|0|||
147242213|NCT00621985|531059592|FG000|Dexamethasone Admission|Adverse Event|1|||
147242214|NCT00573469|531059593|FG000|Overall Study|Adverse Event|1|||
147242215|NCT00573469|531059594|FG001|Overall Study|Adverse Event|1|||
147242216|NCT00573469|531059595|FG002|Overall Study|Adverse Event|1|||
147242217|NCT00573469|531059593|FG000|Overall Study|Withdrawal by Subject|0|||
147322646|NCT01417000|531345424|FG001|Overall Study|Lost to Follow-up|0|||
147322647|NCT01417000|531345423|FG000|Overall Study|Study Terminated by Sponsor|1|||
147322648|NCT01417000|531345424|FG001|Overall Study|Study Terminated by Sponsor|1|||
147447193|NCT00405067|531802071|FG002|Overall Study|Lost to Follow-up|1|||
147161730|NCT01133405|530756918|FG009|Period 2|Entry Criteria Not Met|0|||
147161731|NCT01133405|530756909|FG000|Period 2|Physician Decision|0|||
147161732|NCT01133405|530756910|FG001|Period 2|Physician Decision|0|||
147161733|NCT01133405|530756911|FG002|Period 2|Physician Decision|0|||
147161734|NCT01133405|530756912|FG003|Period 2|Physician Decision|0|||
147161735|NCT01133405|530756913|FG004|Period 2|Physician Decision|0|||
147161736|NCT01133405|530756914|FG005|Period 2|Physician Decision|1|||
147161737|NCT01133405|530756915|FG006|Period 2|Physician Decision|0|||
147161738|NCT01133405|530756916|FG007|Period 2|Physician Decision|0|||
147161739|NCT01133405|530756917|FG008|Period 2|Physician Decision|0|||
147161740|NCT01133405|530756918|FG009|Period 2|Physician Decision|0|||
147161741|NCT00089986|530756921|FG000|Overall Study|Adverse Event|6|||
147161742|NCT00089986|530756922|FG001|Overall Study|Adverse Event|9|||
147161743|NCT00089986|530756923|FG002|Overall Study|Adverse Event|6|||
147161744|NCT00089986|530756921|FG000|Overall Study|Lost to Follow-up|3|||
147161745|NCT00089986|530756922|FG001|Overall Study|Lost to Follow-up|1|||
147161746|NCT00089986|530756923|FG002|Overall Study|Lost to Follow-up|1|||
147161747|NCT00089986|530756921|FG000|Overall Study|Protocol Violation|0|||
147161748|NCT00089986|530756922|FG001|Overall Study|Protocol Violation|1|||
147161749|NCT00089986|530756923|FG002|Overall Study|Protocol Violation|0|||
147161750|NCT00089986|530756921|FG000|Overall Study|Patient transferred to another hospital|2|||
147161751|NCT00089986|530756922|FG001|Overall Study|Patient transferred to another hospital|1|||
147161752|NCT00089986|530756923|FG002|Overall Study|Patient transferred to another hospital|0|||
147161753|NCT00089986|530756921|FG000|Overall Study|Subject withdrew but agreed follow up|1|||
147161754|NCT00089986|530756922|FG001|Overall Study|Subject withdrew but agreed follow up|2|||
147161755|NCT00089986|530756923|FG002|Overall Study|Subject withdrew but agreed follow up|0|||
147161756|NCT00089986|530756921|FG000|Overall Study|Hemohlobin stopping rule|0|||
147161757|NCT00089986|530756922|FG001|Overall Study|Hemohlobin stopping rule|1|||
147161758|NCT00089986|530756923|FG002|Overall Study|Hemohlobin stopping rule|0|||
147161759|NCT00089986|530756921|FG000|Overall Study|Investigator decision to withdrew|0|||
147161760|NCT00089986|530756922|FG001|Overall Study|Investigator decision to withdrew|1|||
147161761|NCT00089986|530756923|FG002|Overall Study|Investigator decision to withdrew|0|||
147161762|NCT00089986|530756921|FG000|Overall Study|Enrollment in another study|0|||
147161763|NCT00089986|530756922|FG001|Overall Study|Enrollment in another study|1|||
147161764|NCT00089986|530756923|FG002|Overall Study|Enrollment in another study|0|||
147161765|NCT00089986|530756921|FG000|Overall Study|Family decision|0|||
147161766|NCT00089986|530756922|FG001|Overall Study|Family decision|1|||
147161767|NCT00089986|530756923|FG002|Overall Study|Family decision|0|||
147161768|NCT00089986|530756921|FG000|Overall Study|Do not resuscitate (DNR)|0|||
147161769|NCT00089986|530756922|FG001|Overall Study|Do not resuscitate (DNR)|0|||
147161770|NCT00089986|530756923|FG002|Overall Study|Do not resuscitate (DNR)|1|||
147161771|NCT00089986|530756921|FG000|Overall Study|Withdrawal by Subject|3|||
147161772|NCT00089986|530756922|FG001|Overall Study|Withdrawal by Subject|6|||
147161773|NCT00089986|530756923|FG002|Overall Study|Withdrawal by Subject|2|||
147161774|NCT03946124|530756924|FG000|Overall Study|Withdrawal by Subject|19|||
147161775|NCT00241631|530756925|FG000|Run in (2 Weeks)|Physician Decision|3|||
147161776|NCT00241631|530756926|FG001|Run in (2 Weeks)|Physician Decision|3|||
147161777|NCT00241631|530756925|FG000|Phase 1 (4 Weeks)|sore throat|1|||
147161778|NCT00241631|530756926|FG001|Phase 1 (4 Weeks)|sore throat|0|||
147161779|NCT00241631|530756925|FG000|Phase 1 (4 Weeks)|Withdrawal by Subject|4|||
147161780|NCT00241631|530756926|FG001|Phase 1 (4 Weeks)|Withdrawal by Subject|4|||
147161781|NCT00241631|530756925|FG000|Phase 1 (4 Weeks)|Lost to Follow-up|3|||
147242218|NCT00573469|531059594|FG001|Overall Study|Withdrawal by Subject|2|||
147242219|NCT00573469|531059595|FG002|Overall Study|Withdrawal by Subject|0|||
147242220|NCT00573469|531059593|FG000|Overall Study|Other|5|||
147242221|NCT00573469|531059594|FG001|Overall Study|Other|1|||
147242222|NCT00573469|531059595|FG002|Overall Study|Other|3|||
147242223|NCT03130257|531059600|FG000|Overall Study|Withdrawal by Subject|1|||
147242224|NCT03130257|531059601|FG001|Overall Study|Withdrawal by Subject|0|||
147242225|NCT03130257|531059602|FG002|Overall Study|Withdrawal by Subject|2|||
147242226|NCT03095066|531059609|FG000|Overall Study (Baseline to Week 12)|Adverse Event|3|||
147161782|NCT00241631|530756926|FG001|Phase 1 (4 Weeks)|Lost to Follow-up|0|||
147161783|NCT00241631|530756925|FG000|Phase 1 (4 Weeks)|Lack of Efficacy|0|||
147161784|NCT00241631|530756926|FG001|Phase 1 (4 Weeks)|Lack of Efficacy|1|||
147161785|NCT00413920|530756930|FG000|Overall Study|Adverse Event|9|||
147161786|NCT00413920|530756931|FG001|Overall Study|Adverse Event|11|||
147161787|NCT00413920|530756930|FG000|Overall Study|Lack of Efficacy|11|||
147161788|NCT00413920|530756931|FG001|Overall Study|Lack of Efficacy|9|||
147161789|NCT00413920|530756930|FG000|Overall Study|Death|3|||
147161790|NCT00413920|530756931|FG001|Overall Study|Death|5|||
147242227|NCT03095066|531059610|FG001|Overall Study (Baseline to Week 12)|Adverse Event|6|||
147242228|NCT03095066|531059611|FG002|Overall Study (Baseline to Week 12)|Adverse Event|0|||
147161791|NCT00413920|530756930|FG000|Overall Study|Graft Loss|5|||
147161792|NCT00413920|530756931|FG001|Overall Study|Graft Loss|3|||
147161793|NCT02788201|530756932|FG000|Overall Study|Death|1|||
147161794|NCT02788201|530756933|FG001|Overall Study|Death|1|||
147242229|NCT03095066|531059612|FG003|Overall Study (Baseline to Week 12)|Adverse Event|0|||
147587719|NCT01546922|532305541|FG001|First Period of 10 Weeks|Investigator's judgment|0|||
147587720|NCT01546922|532305540|FG000|Second Period of 10 Weeks|Protocol Violation|3|||
147587721|NCT01546922|532305541|FG001|Second Period of 10 Weeks|Protocol Violation|1|||
147587722|NCT01546922|532305540|FG000|Second Period of 10 Weeks|Withdrawal by Subject|0|||
147587723|NCT01546922|532305541|FG001|Second Period of 10 Weeks|Withdrawal by Subject|2|||
147587724|NCT00792623|532305543|FG000|Overall Study|Adverse Event|2|||
147587725|NCT00792623|532305543|FG000|Overall Study|Withdrawal by Subject|5|||
147587726|NCT00743509|532305544|FG000|Overall Study|Withdrawal by Subject|2|||
147587727|NCT00418522|532305545|FG000|Overall Study|Adverse Event|7|||
147587728|NCT00418522|532305546|FG001|Overall Study|Adverse Event|1|||
147587729|NCT00418522|532305545|FG000|Overall Study|Lack of Efficacy|1|||
147587730|NCT00418522|532305546|FG001|Overall Study|Lack of Efficacy|3|||
147587731|NCT00418522|532305545|FG000|Overall Study|Lost to Follow-up|10|||
147587732|NCT00418522|532305546|FG001|Overall Study|Lost to Follow-up|4|||
147587733|NCT00418522|532305545|FG000|Overall Study|Withdrawal by Subject|31|||
147587734|NCT00418522|532305546|FG001|Overall Study|Withdrawal by Subject|7|||
147587735|NCT00418522|532305545|FG000|Overall Study|Other|27|||
147587736|NCT00418522|532305546|FG001|Overall Study|Other|23|||
147587737|NCT00418522|532305545|FG000|Overall Study|Randomized but did not receive treatment|7|||
147587738|NCT00418522|532305546|FG001|Overall Study|Randomized but did not receive treatment|4|||
147587739|NCT01652729|532305547|FG000|Overall Study|Withdrawal by Subject|14|||
147587740|NCT01652729|532305548|FG001|Overall Study|Withdrawal by Subject|7|||
147587741|NCT01652729|532305549|FG002|Overall Study|Withdrawal by Subject|7|||
147587742|NCT01652729|532305547|FG000|Overall Study|Adverse Event|4|||
147587743|NCT01652729|532305548|FG001|Overall Study|Adverse Event|0|||
147587744|NCT01652729|532305549|FG002|Overall Study|Adverse Event|3|||
147587745|NCT01652729|532305547|FG000|Overall Study|Physician Decision|1|||
147587746|NCT01652729|532305548|FG001|Overall Study|Physician Decision|0|||
147587747|NCT01652729|532305549|FG002|Overall Study|Physician Decision|1|||
147587748|NCT01652729|532305547|FG000|Overall Study|Protocol Violation|1|||
147587749|NCT01652729|532305548|FG001|Overall Study|Protocol Violation|0|||
147587750|NCT01652729|532305549|FG002|Overall Study|Protocol Violation|0|||
147587751|NCT01652729|532305547|FG000|Overall Study|Lost to Follow-up|6|||
147161795|NCT02788201|530756934|FG002|Overall Study|Death|1|||
147161796|NCT02788201|530756935|FG003|Overall Study|Death|1|||
147161797|NCT02788201|530756936|FG004|Overall Study|Death|0|||
147161798|NCT02788201|530756937|FG005|Overall Study|Death|1|||
147161799|NCT02788201|530756932|FG000|Overall Study|Ineligible|0|||
147161800|NCT02788201|530756933|FG001|Overall Study|Ineligible|0|||
147161801|NCT02788201|530756934|FG002|Overall Study|Ineligible|0|||
147161802|NCT02788201|530756935|FG003|Overall Study|Ineligible|0|||
147161803|NCT02788201|530756936|FG004|Overall Study|Ineligible|0|||
147161804|NCT02788201|530756937|FG005|Overall Study|Ineligible|1|||
147161805|NCT02788201|530756932|FG000|Overall Study|Withdrawal by Subject|0|||
147161806|NCT02788201|530756933|FG001|Overall Study|Withdrawal by Subject|0|||
147161807|NCT02788201|530756934|FG002|Overall Study|Withdrawal by Subject|0|||
147161808|NCT02788201|530756935|FG003|Overall Study|Withdrawal by Subject|0|||
147161809|NCT02788201|530756936|FG004|Overall Study|Withdrawal by Subject|0|||
147161810|NCT02788201|530756937|FG005|Overall Study|Withdrawal by Subject|1|||
147161811|NCT01852825|530756938|FG000|Overall Study|Withdrawal by Subject|2|||
147161812|NCT01852825|530756939|FG001|Overall Study|Withdrawal by Subject|0|||
147161813|NCT01852825|530756940|FG002|Overall Study|Withdrawal by Subject|0|||
147161814|NCT03421743|530756945|FG000|Overall Study|Lack of Efficacy|1|||
147161815|NCT03421743|530756946|FG001|Overall Study|Lack of Efficacy|0|||
147161816|NCT03421743|530756945|FG000|Overall Study|Adverse Event|2|||
147161817|NCT03421743|530756946|FG001|Overall Study|Adverse Event|1|||
147161818|NCT03421743|530756945|FG000|Overall Study|Withdrawal by Subject|0|||
147161819|NCT03421743|530756946|FG001|Overall Study|Withdrawal by Subject|1|||
147161820|NCT01457950|530756947|FG000|Double-Blind Phase|Continuation Criteria Not Met|1|||
147161821|NCT01457950|530756948|FG001|Double-Blind Phase|Continuation Criteria Not Met|0|||
147161822|NCT01457950|530756949|FG002|Double-Blind Phase|Continuation Criteria Not Met|0|||
147161823|NCT01457950|530756950|FG003|Double-Blind Phase|Continuation Criteria Not Met|0|||
147161824|NCT01457950|530756947|FG000|Double-Blind Phase|Protocol Violation|2|||
147161825|NCT01457950|530756948|FG001|Double-Blind Phase|Protocol Violation|1|||
147161826|NCT01457950|530756949|FG002|Double-Blind Phase|Protocol Violation|0|||
147161827|NCT01457950|530756950|FG003|Double-Blind Phase|Protocol Violation|0|||
147161828|NCT01457950|530756947|FG000|Double-Blind Phase|Withdrawal by Subject|6|||
147161829|NCT01457950|530756948|FG001|Double-Blind Phase|Withdrawal by Subject|2|||
147161830|NCT01457950|530756949|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
147161831|NCT01457950|530756950|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
147161832|NCT01457950|530756947|FG000|Open-Label Phase|Adverse Event|0|||
147161833|NCT01457950|530756948|FG001|Open-Label Phase|Adverse Event|0|||
147587752|NCT01652729|532305548|FG001|Overall Study|Lost to Follow-up|6|||
147587753|NCT01652729|532305549|FG002|Overall Study|Lost to Follow-up|3|||
147587754|NCT01652729|532305547|FG000|Overall Study|Administrative|1|||
147587755|NCT01652729|532305548|FG001|Overall Study|Administrative|0|||
147587756|NCT01652729|532305549|FG002|Overall Study|Administrative|0|||
147587757|NCT00483548|532305550|FG000|Overall Study|Randomized; not treated with study drug|1|||
147161834|NCT01457950|530756949|FG002|Open-Label Phase|Adverse Event|0|||
147161835|NCT01457950|530756950|FG003|Open-Label Phase|Adverse Event|1|||
147161836|NCT01457950|530756947|FG000|Open-Label Phase|Protocol Violation|0|||
147161837|NCT01457950|530756948|FG001|Open-Label Phase|Protocol Violation|0|||
147161838|NCT01457950|530756949|FG002|Open-Label Phase|Protocol Violation|0|||
147161839|NCT01457950|530756950|FG003|Open-Label Phase|Protocol Violation|1|||
147161840|NCT01457950|530756947|FG000|Open-Label Phase|Withdrawal by Subject|0|||
147161841|NCT01457950|530756948|FG001|Open-Label Phase|Withdrawal by Subject|0|||
147161842|NCT01457950|530756949|FG002|Open-Label Phase|Withdrawal by Subject|2|||
147161843|NCT01457950|530756950|FG003|Open-Label Phase|Withdrawal by Subject|0|||
147161844|NCT01765426|530756951|FG000|Overall Study|Lost to Follow-up|0|||
147161845|NCT01765426|530756952|FG001|Overall Study|Lost to Follow-up|1|||
147161846|NCT01765426|530756953|FG002|Overall Study|Lost to Follow-up|0|||
147161847|NCT01765426|530756954|FG003|Overall Study|Lost to Follow-up|0|||
147161848|NCT01166373|530756955|FG000|Overall Study|Lost to Follow-up|3|||
147161849|NCT01166373|530756956|FG001|Overall Study|Lost to Follow-up|2|||
147161850|NCT01166373|530756957|FG002|Overall Study|Lost to Follow-up|2|||
147161851|NCT01166373|530756958|FG003|Overall Study|Lost to Follow-up|2|||
147161852|NCT01166373|530756955|FG000|Overall Study|Withdrawal by Subject|1|||
147161853|NCT01166373|530756956|FG001|Overall Study|Withdrawal by Subject|2|||
147161854|NCT01166373|530756957|FG002|Overall Study|Withdrawal by Subject|2|||
147161855|NCT01166373|530756958|FG003|Overall Study|Withdrawal by Subject|3|||
147161856|NCT01166373|530756955|FG000|Overall Study|Physician Decision|1|||
147161857|NCT01166373|530756956|FG001|Overall Study|Physician Decision|0|||
147161858|NCT01166373|530756957|FG002|Overall Study|Physician Decision|0|||
147161859|NCT01166373|530756958|FG003|Overall Study|Physician Decision|0|||
147161860|NCT01510184|530756959|FG000|Overall Study|Sponsor discretion|28|||
147161861|NCT01510184|530756960|FG001|Overall Study|Sponsor discretion|28|||
147161862|NCT01510184|530756959|FG000|Overall Study|Death|1|||
147161863|NCT01510184|530756960|FG001|Overall Study|Death|2|||
147161864|NCT01510184|530756959|FG000|Overall Study|Withdrawal by Subject|1|||
147161865|NCT01510184|530756960|FG001|Overall Study|Withdrawal by Subject|4|||
147161866|NCT01510184|530756959|FG000|Overall Study|Other|0|||
147161867|NCT01510184|530756960|FG001|Overall Study|Other|1|||
147161868|NCT02310230|530756961|FG000|Overall Study|Physician Decision|1|||
147161869|NCT02310230|530756962|FG001|Overall Study|Physician Decision|3|||
147161870|NCT02310230|530756961|FG000|Overall Study|monitor baseline taken after induction|2|||
147161871|NCT02310230|530756962|FG001|Overall Study|monitor baseline taken after induction|7|||
147161872|NCT02310230|530756961|FG000|Overall Study|Poor signal quality|5|||
147161873|NCT02310230|530756962|FG001|Overall Study|Poor signal quality|8|||
147161874|NCT02310230|530756961|FG000|Overall Study|Case cancelled|1|||
147161875|NCT02310230|530756962|FG001|Overall Study|Case cancelled|0|||
147161876|NCT03593681|530756966|FG000|Overall Study|Inadequate sample collected|12|||
147161877|NCT03593681|530756966|FG000|Overall Study|Hysteroscope attempted but unable to find ostia|11|||
147161878|NCT03593681|530756966|FG000|Overall Study|Protocol Violation|3|||
147161879|NCT03593681|530756966|FG000|Overall Study|Withdrawal by Subject|3|||
147161880|NCT03593681|530756966|FG000|Overall Study|Procedure not attempted|3|||
147161881|NCT03593681|530756966|FG000|Overall Study|Adverse Event|2|||
147161882|NCT03593681|530756966|FG000|Overall Study|Physician Decision|1|||
147161883|NCT02078102|530756967|FG000|Overall Study|Adverse Event|1|||
147161884|NCT02078102|530756968|FG001|Overall Study|Adverse Event|0|||
147161885|NCT02078102|530756967|FG000|Overall Study|Withdrawal by Subject|1|||
147161886|NCT02078102|530756968|FG001|Overall Study|Withdrawal by Subject|0|||
147161887|NCT02078102|530756967|FG000|Overall Study|Physician Decision|0|||
147161888|NCT02078102|530756968|FG001|Overall Study|Physician Decision|1|||
147161889|NCT02370641|530756971|FG000|Overall Study|dropped study|4|||
147161890|NCT02370641|530756972|FG001|Overall Study|dropped study|2|||
147161891|NCT05291936|530756976|FG000|Period 1|Unsatisfactory Visual Response due to Test Article|0|||
147161892|NCT05291936|530756977|FG001|Period 1|Unsatisfactory Visual Response due to Test Article|1|||
147242230|NCT03095066|531059613|FG004|Overall Study (Baseline to Week 12)|Adverse Event|0|||
147242231|NCT03095066|531059614|FG005|Overall Study (Baseline to Week 12)|Adverse Event|0|||
147242232|NCT03095066|531059615|FG006|Overall Study (Baseline to Week 12)|Adverse Event|0|||
147161893|NCT05291936|530756976|FG000|Period 1|Withdrew Consent during study|1|||
147161894|NCT05291936|530756977|FG001|Period 1|Withdrew Consent during study|0|||
147161895|NCT05291936|530756976|FG000|Period 2|Adverse Event|0|||
147161896|NCT05291936|530756977|FG001|Period 2|Adverse Event|1|||
147161897|NCT05291936|530756976|FG000|Period 2|Unsatisfactory Visual Response due to Test Article|1|||
147161898|NCT05291936|530756977|FG001|Period 2|Unsatisfactory Visual Response due to Test Article|0|||
147161899|NCT02436408|530756982|FG000|Overall Study|Death|1|||
147161900|NCT01154283|530756983|FG000|0-6 Weeks|Withdrawal by Subject|7|||
147161901|NCT01154283|530756984|FG001|0-6 Weeks|Withdrawal by Subject|2|||
147161902|NCT01154283|530756983|FG000|0-6 Weeks|Death|0|||
147161903|NCT01154283|530756984|FG001|0-6 Weeks|Death|1|||
147161904|NCT01154283|530756983|FG000|7-12 Weeks|Death|1|||
147161905|NCT01154283|530756984|FG001|7-12 Weeks|Death|0|||
147161906|NCT01154283|530756983|FG000|7-12 Weeks|Withdrawal by Subject|0|||
147161907|NCT01154283|530756984|FG001|7-12 Weeks|Withdrawal by Subject|1|||
147161908|NCT00042432|530756985|FG000|Overall Study|Adverse Event|4|||
147161909|NCT00042432|530756986|FG001|Overall Study|Adverse Event|1|||
147161910|NCT00042432|530756985|FG000|Overall Study|Withdrawal by Subject|1|||
147161911|NCT00042432|530756986|FG001|Overall Study|Withdrawal by Subject|3|||
147161912|NCT00042432|530756985|FG000|Overall Study|Death|0|||
147161913|NCT00042432|530756986|FG001|Overall Study|Death|2|||
147161914|NCT00042432|530756985|FG000|Overall Study|Ineligibility determined|1|||
147161915|NCT00042432|530756986|FG001|Overall Study|Ineligibility determined|0|||
147161916|NCT00042432|530756985|FG000|Overall Study|Initiation of maintenance dialysis|1|||
147161917|NCT00042432|530756986|FG001|Overall Study|Initiation of maintenance dialysis|1|||
147161918|NCT00042432|530756985|FG000|Overall Study|Other|2|||
147161919|NCT00042432|530756986|FG001|Overall Study|Other|0|||
147161920|NCT00320372|530756987|FG000|Overall Study|Physician Decision|4|||
147161921|NCT00320372|530756988|FG001|Overall Study|Physician Decision|7|||
147161922|NCT00320372|530756987|FG000|Overall Study|Death|7|||
147161923|NCT00320372|530756988|FG001|Overall Study|Death|8|||
147161924|NCT00320372|530756987|FG000|Overall Study|Withdrawal by Subject|55|||
147161925|NCT00320372|530756988|FG001|Overall Study|Withdrawal by Subject|37|||
147161926|NCT00320372|530756987|FG000|Overall Study|Non-Compliance|40|||
147161927|NCT00320372|530756988|FG001|Overall Study|Non-Compliance|39|||
147161928|NCT00320372|530756987|FG000|Overall Study|Did not Meet (I/E)|3|||
147161929|NCT00320372|530756988|FG001|Overall Study|Did not Meet (I/E)|1|||
147161930|NCT00320372|530756987|FG000|Overall Study|Other (i.e. lost to f/u, site closure)|86|||
147161931|NCT00320372|530756988|FG001|Overall Study|Other (i.e. lost to f/u, site closure)|71|||
147161932|NCT01853072|530756989|FG000|Overall Study|Adverse event prior to treatment|0|||
147161933|NCT01853072|530756990|FG001|Overall Study|Adverse event prior to treatment|1|||
147161934|NCT01853072|530756989|FG000|Overall Study|Adverse Event|0|||
147161935|NCT01853072|530756990|FG001|Overall Study|Adverse Event|3|||
147161936|NCT01853072|530756989|FG000|Overall Study|Death|1|||
147161937|NCT01853072|530756990|FG001|Overall Study|Death|4|||
147161938|NCT01853072|530756989|FG000|Overall Study|Lost to Follow-up|0|||
147161939|NCT01853072|530756990|FG001|Overall Study|Lost to Follow-up|3|||
147161940|NCT01853072|530756989|FG000|Overall Study|Non-compliance with study drug|0|||
147161941|NCT01853072|530756990|FG001|Overall Study|Non-compliance with study drug|1|||
147161942|NCT01853072|530756989|FG000|Overall Study|Physician Decision|1|||
147161943|NCT01853072|530756990|FG001|Overall Study|Physician Decision|1|||
147161944|NCT01853072|530756989|FG000|Overall Study|Withdrawal by Subject|1|||
147161945|NCT01853072|530756990|FG001|Overall Study|Withdrawal by Subject|2|||
147161946|NCT01853072|530756989|FG000|Overall Study|Reason not specified|9|||
147322649|NCT00562965|531345431|FG000|Overall Study|Withdrawal by Subject|0|||
147322650|NCT00562965|531345432|FG001|Overall Study|Withdrawal by Subject|1|||
147322651|NCT00562965|531345431|FG000|Overall Study|Death|2|||
147322652|NCT00562965|531345432|FG001|Overall Study|Death|4|||
147322653|NCT00562965|531345431|FG000|Overall Study|Lost to Follow-up|1|||
147322654|NCT00562965|531345432|FG001|Overall Study|Lost to Follow-up|0|||
147322655|NCT00562965|531345431|FG000|Overall Study|Other|0|||
147322656|NCT00562965|531345432|FG001|Overall Study|Other|1|||
147322657|NCT03379233|531345434|FG000|Overall Study|Technical issues with Concept 2 inhalers|1|||
147447194|NCT03287219|531802072|FG000|Overall Study|Protocol Violation|0|||
147447195|NCT03287219|531802073|FG001|Overall Study|Protocol Violation|2|||
147447196|NCT00957008|531802074|FG000|Overall Study|Withdrawal by Subject|13|||
147447197|NCT00957008|531802075|FG001|Overall Study|Withdrawal by Subject|10|||
147447198|NCT00957008|531802076|FG002|Overall Study|Withdrawal by Subject|12|||
147447199|NCT00957008|531802077|FG003|Overall Study|Withdrawal by Subject|16|||
147447200|NCT00957008|531802074|FG000|Overall Study|Lost to Follow-up|3|||
147447201|NCT00957008|531802075|FG001|Overall Study|Lost to Follow-up|1|||
147447202|NCT00957008|531802076|FG002|Overall Study|Lost to Follow-up|3|||
147447203|NCT00957008|531802077|FG003|Overall Study|Lost to Follow-up|4|||
147587758|NCT00483548|532305551|FG001|Overall Study|Randomized; not treated with study drug|3|||
147161947|NCT01853072|530756990|FG001|Overall Study|Reason not specified|6|||
147161948|NCT01287221|530756991|FG000|Overall Study|Lack of Perceived Benefit|1|||
147161949|NCT01287221|530756992|FG001|Overall Study|Lack of Perceived Benefit|1|||
147161950|NCT01287221|530756991|FG000|Overall Study|Adverse Event|3|||
147587759|NCT00483548|532305550|FG000|Overall Study|Adverse Event|25|||
147161951|NCT01287221|530756992|FG001|Overall Study|Adverse Event|3|||
147161952|NCT01287221|530756991|FG000|Overall Study|Withdrawal by Subject|0|||
147161953|NCT01287221|530756992|FG001|Overall Study|Withdrawal by Subject|1|||
147161954|NCT02761694|530757004|FG000|Overall Study|Lack of Efficacy|0|||
147587760|NCT00483548|532305551|FG001|Overall Study|Adverse Event|14|||
147161955|NCT02761694|530757005|FG001|Overall Study|Lack of Efficacy|0|||
147161956|NCT02761694|530757006|FG002|Overall Study|Lack of Efficacy|0|||
147161957|NCT02761694|530757007|FG003|Overall Study|Lack of Efficacy|0|||
147161958|NCT02761694|530757008|FG004|Overall Study|Lack of Efficacy|0|||
147161959|NCT02761694|530757009|FG005|Overall Study|Lack of Efficacy|0|||
147161960|NCT02761694|530757010|FG006|Overall Study|Lack of Efficacy|6|||
147161961|NCT02761694|530757011|FG007|Overall Study|Lack of Efficacy|0|||
147322658|NCT03379233|531345435|FG001|Overall Study|Technical issues with Concept 2 inhalers|6|||
147322659|NCT00965484|531345436|FG000|Overall Study|Protocol Violation|1|||
147322660|NCT00965484|531345436|FG000|Overall Study|Withdrawal by Subject|1|||
147161962|NCT02761694|530757012|FG008|Overall Study|Lack of Efficacy|0|||
147161963|NCT02761694|530757013|FG009|Overall Study|Lack of Efficacy|1|||
147161964|NCT02761694|530757014|FG010|Overall Study|Lack of Efficacy|1|||
147161965|NCT02761694|530757015|FG011|Overall Study|Lack of Efficacy|4|||
147161966|NCT02761694|530757004|FG000|Overall Study|Death|0|||
147161967|NCT02761694|530757005|FG001|Overall Study|Death|0|||
147161968|NCT02761694|530757006|FG002|Overall Study|Death|0|||
147161969|NCT02761694|530757007|FG003|Overall Study|Death|0|||
147161970|NCT02761694|530757008|FG004|Overall Study|Death|0|||
147161971|NCT02761694|530757009|FG005|Overall Study|Death|0|||
147161972|NCT02761694|530757010|FG006|Overall Study|Death|2|||
147161973|NCT02761694|530757011|FG007|Overall Study|Death|0|||
147161974|NCT02761694|530757012|FG008|Overall Study|Death|2|||
147161975|NCT02761694|530757013|FG009|Overall Study|Death|2|||
147161976|NCT02761694|530757014|FG010|Overall Study|Death|1|||
147161977|NCT02761694|530757015|FG011|Overall Study|Death|0|||
147161978|NCT02761694|530757004|FG000|Overall Study|Physician Decision|0|||
147161979|NCT02761694|530757005|FG001|Overall Study|Physician Decision|0|||
147161980|NCT02761694|530757006|FG002|Overall Study|Physician Decision|0|||
147161981|NCT02761694|530757007|FG003|Overall Study|Physician Decision|0|||
147161982|NCT02761694|530757008|FG004|Overall Study|Physician Decision|0|||
147161983|NCT02761694|530757009|FG005|Overall Study|Physician Decision|0|||
147161984|NCT02761694|530757010|FG006|Overall Study|Physician Decision|1|||
147161985|NCT02761694|530757011|FG007|Overall Study|Physician Decision|0|||
147161986|NCT02761694|530757012|FG008|Overall Study|Physician Decision|0|||
147161987|NCT02761694|530757013|FG009|Overall Study|Physician Decision|0|||
147161988|NCT02761694|530757014|FG010|Overall Study|Physician Decision|0|||
147161989|NCT02761694|530757015|FG011|Overall Study|Physician Decision|0|||
147161990|NCT02761694|530757004|FG000|Overall Study|Withdrawal by Subject|0|||
147242233|NCT03095066|531059616|FG007|Overall Study (Baseline to Week 12)|Adverse Event|0|||
147242234|NCT03095066|531059609|FG000|Overall Study (Baseline to Week 12)|Lost to Follow-up|6|||
147242235|NCT03095066|531059610|FG001|Overall Study (Baseline to Week 12)|Lost to Follow-up|1|||
147242236|NCT03095066|531059611|FG002|Overall Study (Baseline to Week 12)|Lost to Follow-up|0|||
147242237|NCT03095066|531059612|FG003|Overall Study (Baseline to Week 12)|Lost to Follow-up|0|||
147242238|NCT03095066|531059613|FG004|Overall Study (Baseline to Week 12)|Lost to Follow-up|0|||
147242239|NCT03095066|531059614|FG005|Overall Study (Baseline to Week 12)|Lost to Follow-up|0|||
147242240|NCT03095066|531059615|FG006|Overall Study (Baseline to Week 12)|Lost to Follow-up|0|||
147242241|NCT03095066|531059616|FG007|Overall Study (Baseline to Week 12)|Lost to Follow-up|0|||
147242242|NCT03095066|531059609|FG000|Overall Study (Baseline to Week 12)|Non-compliance With Study Drug|2|||
147242243|NCT03095066|531059610|FG001|Overall Study (Baseline to Week 12)|Non-compliance With Study Drug|1|||
147242244|NCT03095066|531059611|FG002|Overall Study (Baseline to Week 12)|Non-compliance With Study Drug|0|||
147242245|NCT03095066|531059612|FG003|Overall Study (Baseline to Week 12)|Non-compliance With Study Drug|0|||
147242246|NCT03095066|531059613|FG004|Overall Study (Baseline to Week 12)|Non-compliance With Study Drug|0|||
147242247|NCT03095066|531059614|FG005|Overall Study (Baseline to Week 12)|Non-compliance With Study Drug|0|||
147242248|NCT03095066|531059615|FG006|Overall Study (Baseline to Week 12)|Non-compliance With Study Drug|0|||
147242249|NCT03095066|531059616|FG007|Overall Study (Baseline to Week 12)|Non-compliance With Study Drug|0|||
147242250|NCT03095066|531059609|FG000|Overall Study (Baseline to Week 12)|Physician Decision|0|||
147242251|NCT03095066|531059610|FG001|Overall Study (Baseline to Week 12)|Physician Decision|1|||
147242252|NCT03095066|531059611|FG002|Overall Study (Baseline to Week 12)|Physician Decision|0|||
147242253|NCT03095066|531059612|FG003|Overall Study (Baseline to Week 12)|Physician Decision|0|||
147242254|NCT03095066|531059613|FG004|Overall Study (Baseline to Week 12)|Physician Decision|0|||
147242255|NCT03095066|531059614|FG005|Overall Study (Baseline to Week 12)|Physician Decision|0|||
147242256|NCT03095066|531059615|FG006|Overall Study (Baseline to Week 12)|Physician Decision|0|||
147161991|NCT02761694|530757005|FG001|Overall Study|Withdrawal by Subject|0|||
147161992|NCT02761694|530757006|FG002|Overall Study|Withdrawal by Subject|0|||
147161993|NCT02761694|530757007|FG003|Overall Study|Withdrawal by Subject|1|||
147161994|NCT02761694|530757008|FG004|Overall Study|Withdrawal by Subject|0|||
147161995|NCT02761694|530757009|FG005|Overall Study|Withdrawal by Subject|0|||
147161996|NCT02761694|530757010|FG006|Overall Study|Withdrawal by Subject|4|||
147161997|NCT02761694|530757011|FG007|Overall Study|Withdrawal by Subject|0|||
147161998|NCT02761694|530757012|FG008|Overall Study|Withdrawal by Subject|2|||
147161999|NCT02761694|530757013|FG009|Overall Study|Withdrawal by Subject|1|||
147242257|NCT03095066|531059616|FG007|Overall Study (Baseline to Week 12)|Physician Decision|0|||
147242258|NCT03095066|531059609|FG000|Overall Study (Baseline to Week 12)|Protocol Deviation|1|||
147242259|NCT03095066|531059610|FG001|Overall Study (Baseline to Week 12)|Protocol Deviation|2|||
147242260|NCT03095066|531059611|FG002|Overall Study (Baseline to Week 12)|Protocol Deviation|0|||
147162000|NCT02761694|530757014|FG010|Overall Study|Withdrawal by Subject|0|||
147162001|NCT02761694|530757015|FG011|Overall Study|Withdrawal by Subject|0|||
147162002|NCT02761694|530757004|FG000|Overall Study|Lost to Follow-up|0|||
147162003|NCT02761694|530757005|FG001|Overall Study|Lost to Follow-up|0|||
147162004|NCT02761694|530757006|FG002|Overall Study|Lost to Follow-up|0|||
147162005|NCT02761694|530757007|FG003|Overall Study|Lost to Follow-up|0|||
147162006|NCT02761694|530757008|FG004|Overall Study|Lost to Follow-up|0|||
147587761|NCT00483548|532305550|FG000|Overall Study|Laboratory abnormality|1|||
147587762|NCT00483548|532305551|FG001|Overall Study|Laboratory abnormality|2|||
147587763|NCT00483548|532305550|FG000|Overall Study|Lack of Efficacy|4|||
147587764|NCT00483548|532305551|FG001|Overall Study|Lack of Efficacy|8|||
147587765|NCT00483548|532305550|FG000|Overall Study|Protocol Violation|11|||
147587766|NCT00483548|532305551|FG001|Overall Study|Protocol Violation|7|||
147587767|NCT00483548|532305550|FG000|Overall Study|Pregnancy|1|||
147587768|NCT00483548|532305551|FG001|Overall Study|Pregnancy|0|||
147587769|NCT00483548|532305550|FG000|Overall Study|Protocol required discontinuation|6|||
147587770|NCT00483548|532305551|FG001|Overall Study|Protocol required discontinuation|6|||
147587771|NCT00483548|532305550|FG000|Overall Study|Unable to comply with protocol schedule|1|||
147587772|NCT00483548|532305551|FG001|Overall Study|Unable to comply with protocol schedule|0|||
147587773|NCT00483548|532305550|FG000|Overall Study|Non-compliance with medication|2|||
147587774|NCT00483548|532305551|FG001|Overall Study|Non-compliance with medication|0|||
147587775|NCT00483548|532305550|FG000|Overall Study|Lost to Follow-up|3|||
147587776|NCT00483548|532305551|FG001|Overall Study|Lost to Follow-up|4|||
147587777|NCT00483548|532305550|FG000|Overall Study|Withdrawal by Subject|5|||
147587778|NCT00483548|532305551|FG001|Overall Study|Withdrawal by Subject|2|||
147587779|NCT01280617|532305554|FG000|Overall Study|Adverse Event|0|||
147587780|NCT01280617|532305555|FG001|Overall Study|Adverse Event|1|||
147587781|NCT00573170|532305556|FG000|First Treatment Period|Did Not Treat Attack 1|0|||
147587782|NCT00573170|532305557|FG001|First Treatment Period|Did Not Treat Attack 1|0|||
147587783|NCT00573170|532305558|FG002|First Treatment Period|Did Not Treat Attack 1|0|||
147587784|NCT00573170|532305559|FG003|First Treatment Period|Did Not Treat Attack 1|0|||
147587785|NCT00573170|532305560|FG004|First Treatment Period|Did Not Treat Attack 1|1|||
147587786|NCT00573170|532305561|FG005|First Treatment Period|Did Not Treat Attack 1|0|||
147587787|NCT00573170|532305556|FG000|First Washout Period|Adverse Event|1|||
147587788|NCT00573170|532305557|FG001|First Washout Period|Adverse Event|1|||
147587789|NCT00573170|532305558|FG002|First Washout Period|Adverse Event|0|||
147587790|NCT00573170|532305559|FG003|First Washout Period|Adverse Event|0|||
147587791|NCT00573170|532305560|FG004|First Washout Period|Adverse Event|0|||
147587792|NCT00573170|532305561|FG005|First Washout Period|Adverse Event|1|||
147587793|NCT00573170|532305556|FG000|First Washout Period|Lack of Efficacy|0|||
147587794|NCT00573170|532305557|FG001|First Washout Period|Lack of Efficacy|0|||
147587795|NCT00573170|532305558|FG002|First Washout Period|Lack of Efficacy|0|||
147587796|NCT00573170|532305559|FG003|First Washout Period|Lack of Efficacy|0|||
147587797|NCT00573170|532305560|FG004|First Washout Period|Lack of Efficacy|0|||
147587798|NCT00573170|532305561|FG005|First Washout Period|Lack of Efficacy|1|||
147587799|NCT00573170|532305556|FG000|First Washout Period|Lost to Follow-up|1|||
147587800|NCT00573170|532305557|FG001|First Washout Period|Lost to Follow-up|1|||
147587801|NCT00573170|532305558|FG002|First Washout Period|Lost to Follow-up|0|||
147587802|NCT00573170|532305559|FG003|First Washout Period|Lost to Follow-up|2|||
147587803|NCT00573170|532305560|FG004|First Washout Period|Lost to Follow-up|0|||
147587804|NCT00573170|532305561|FG005|First Washout Period|Lost to Follow-up|2|||
147587805|NCT00573170|532305556|FG000|First Washout Period|Withdrawal by Subject|2|||
147587806|NCT00573170|532305557|FG001|First Washout Period|Withdrawal by Subject|0|||
147587807|NCT00573170|532305558|FG002|First Washout Period|Withdrawal by Subject|0|||
147587808|NCT00573170|532305559|FG003|First Washout Period|Withdrawal by Subject|2|||
147587809|NCT00573170|532305560|FG004|First Washout Period|Withdrawal by Subject|3|||
147162007|NCT02761694|530757009|FG005|Overall Study|Lost to Follow-up|0|||
147162008|NCT02761694|530757010|FG006|Overall Study|Lost to Follow-up|1|||
147162009|NCT02761694|530757011|FG007|Overall Study|Lost to Follow-up|0|||
147162010|NCT02761694|530757012|FG008|Overall Study|Lost to Follow-up|0|||
147162011|NCT02761694|530757013|FG009|Overall Study|Lost to Follow-up|0|||
147162012|NCT02761694|530757014|FG010|Overall Study|Lost to Follow-up|0|||
147162013|NCT02761694|530757015|FG011|Overall Study|Lost to Follow-up|1|||
147162014|NCT02761694|530757004|FG000|Overall Study|Adverse Event|0|||
147242261|NCT03095066|531059612|FG003|Overall Study (Baseline to Week 12)|Protocol Deviation|0|||
147242262|NCT03095066|531059613|FG004|Overall Study (Baseline to Week 12)|Protocol Deviation|0|||
147587810|NCT00573170|532305561|FG005|First Washout Period|Withdrawal by Subject|3|||
147162015|NCT02761694|530757005|FG001|Overall Study|Adverse Event|0|||
147162016|NCT02761694|530757006|FG002|Overall Study|Adverse Event|0|||
147162017|NCT02761694|530757007|FG003|Overall Study|Adverse Event|0|||
147242263|NCT03095066|531059614|FG005|Overall Study (Baseline to Week 12)|Protocol Deviation|0|||
147587811|NCT00573170|532305556|FG000|First Washout Period|Other|4|||
147587812|NCT00573170|532305557|FG001|First Washout Period|Other|0|||
147587813|NCT00573170|532305558|FG002|First Washout Period|Other|1|||
147587814|NCT00573170|532305559|FG003|First Washout Period|Other|1|||
147587815|NCT00573170|532305560|FG004|First Washout Period|Other|0|||
147587816|NCT00573170|532305561|FG005|First Washout Period|Other|0|||
147587817|NCT00573170|532305556|FG000|Second Washout Period|Adverse Event|1|||
147587818|NCT00573170|532305557|FG001|Second Washout Period|Adverse Event|0|||
147587819|NCT00573170|532305558|FG002|Second Washout Period|Adverse Event|0|||
147162018|NCT02761694|530757008|FG004|Overall Study|Adverse Event|0|||
147162019|NCT02761694|530757009|FG005|Overall Study|Adverse Event|0|||
147587820|NCT00573170|532305559|FG003|Second Washout Period|Adverse Event|0|||
147587821|NCT00573170|532305560|FG004|Second Washout Period|Adverse Event|1|||
147587822|NCT00573170|532305561|FG005|Second Washout Period|Adverse Event|0|||
147587823|NCT00573170|532305556|FG000|Second Washout Period|Protocol Violation|2|||
147587824|NCT00573170|532305557|FG001|Second Washout Period|Protocol Violation|1|||
147587825|NCT00573170|532305558|FG002|Second Washout Period|Protocol Violation|1|||
147587826|NCT00573170|532305559|FG003|Second Washout Period|Protocol Violation|0|||
147162020|NCT02761694|530757010|FG006|Overall Study|Adverse Event|1|||
147162021|NCT02761694|530757011|FG007|Overall Study|Adverse Event|0|||
147162022|NCT02761694|530757012|FG008|Overall Study|Adverse Event|1|||
147162023|NCT02761694|530757013|FG009|Overall Study|Adverse Event|0|||
147162024|NCT02761694|530757014|FG010|Overall Study|Adverse Event|0|||
147162025|NCT02761694|530757015|FG011|Overall Study|Adverse Event|1|||
147162026|NCT02761694|530757004|FG000|Overall Study|Other|4|||
147162027|NCT02761694|530757005|FG001|Overall Study|Other|4|||
147162028|NCT02761694|530757006|FG002|Overall Study|Other|1|||
147162029|NCT02761694|530757007|FG003|Overall Study|Other|2|||
147162030|NCT02761694|530757008|FG004|Overall Study|Other|3|||
147162031|NCT02761694|530757009|FG005|Overall Study|Other|3|||
147162032|NCT02761694|530757010|FG006|Overall Study|Other|18|||
147162033|NCT02761694|530757011|FG007|Overall Study|Other|8|||
147242264|NCT03095066|531059615|FG006|Overall Study (Baseline to Week 12)|Protocol Deviation|0|||
147322661|NCT00848211|531345437|FG000|Overall Study|Protocol Violation|0|||
147242265|NCT03095066|531059616|FG007|Overall Study (Baseline to Week 12)|Protocol Deviation|0|||
147242266|NCT03095066|531059609|FG000|Overall Study (Baseline to Week 12)|Trial Site Terminated by Sponsor|1|||
147242267|NCT03095066|531059610|FG001|Overall Study (Baseline to Week 12)|Trial Site Terminated by Sponsor|0|||
147242268|NCT03095066|531059611|FG002|Overall Study (Baseline to Week 12)|Trial Site Terminated by Sponsor|0|||
147242269|NCT03095066|531059612|FG003|Overall Study (Baseline to Week 12)|Trial Site Terminated by Sponsor|0|||
147242270|NCT03095066|531059613|FG004|Overall Study (Baseline to Week 12)|Trial Site Terminated by Sponsor|0|||
147242271|NCT03095066|531059614|FG005|Overall Study (Baseline to Week 12)|Trial Site Terminated by Sponsor|0|||
147242272|NCT03095066|531059615|FG006|Overall Study (Baseline to Week 12)|Trial Site Terminated by Sponsor|0|||
147242273|NCT03095066|531059616|FG007|Overall Study (Baseline to Week 12)|Trial Site Terminated by Sponsor|0|||
147242274|NCT03095066|531059609|FG000|Overall Study (Baseline to Week 12)|Withdrawal by Subject|4|||
147242275|NCT03095066|531059610|FG001|Overall Study (Baseline to Week 12)|Withdrawal by Subject|4|||
147242276|NCT03095066|531059611|FG002|Overall Study (Baseline to Week 12)|Withdrawal by Subject|0|||
147242277|NCT03095066|531059612|FG003|Overall Study (Baseline to Week 12)|Withdrawal by Subject|0|||
147242278|NCT03095066|531059613|FG004|Overall Study (Baseline to Week 12)|Withdrawal by Subject|0|||
147242279|NCT03095066|531059614|FG005|Overall Study (Baseline to Week 12)|Withdrawal by Subject|0|||
147242280|NCT03095066|531059615|FG006|Overall Study (Baseline to Week 12)|Withdrawal by Subject|0|||
147242281|NCT03095066|531059616|FG007|Overall Study (Baseline to Week 12)|Withdrawal by Subject|0|||
147242282|NCT03095066|531059609|FG000|Overall Study (Baseline to Week 12)|Reason not Specified|8|||
147242283|NCT03095066|531059610|FG001|Overall Study (Baseline to Week 12)|Reason not Specified|2|||
147242284|NCT03095066|531059611|FG002|Overall Study (Baseline to Week 12)|Reason not Specified|0|||
147242285|NCT03095066|531059612|FG003|Overall Study (Baseline to Week 12)|Reason not Specified|0|||
147242286|NCT03095066|531059613|FG004|Overall Study (Baseline to Week 12)|Reason not Specified|0|||
147242287|NCT03095066|531059614|FG005|Overall Study (Baseline to Week 12)|Reason not Specified|0|||
147242288|NCT03095066|531059615|FG006|Overall Study (Baseline to Week 12)|Reason not Specified|0|||
147242289|NCT03095066|531059616|FG007|Overall Study (Baseline to Week 12)|Reason not Specified|0|||
147242290|NCT03095066|531059609|FG000|Stage 1 (Baseline to Week 6)|Adverse Event|0|||
147242291|NCT03095066|531059610|FG001|Stage 1 (Baseline to Week 6)|Adverse Event|0|||
147242292|NCT03095066|531059611|FG002|Stage 1 (Baseline to Week 6)|Adverse Event|2|||
147242293|NCT03095066|531059612|FG003|Stage 1 (Baseline to Week 6)|Adverse Event|0|||
147242294|NCT03095066|531059613|FG004|Stage 1 (Baseline to Week 6)|Adverse Event|0|||
147242295|NCT03095066|531059614|FG005|Stage 1 (Baseline to Week 6)|Adverse Event|0|||
147242296|NCT03095066|531059615|FG006|Stage 1 (Baseline to Week 6)|Adverse Event|0|||
147242297|NCT03095066|531059616|FG007|Stage 1 (Baseline to Week 6)|Adverse Event|6|||
147242298|NCT03095066|531059609|FG000|Stage 1 (Baseline to Week 6)|Lost to Follow-up|0|||
147242299|NCT03095066|531059610|FG001|Stage 1 (Baseline to Week 6)|Lost to Follow-up|0|||
147242300|NCT03095066|531059611|FG002|Stage 1 (Baseline to Week 6)|Lost to Follow-up|3|||
147242301|NCT03095066|531059612|FG003|Stage 1 (Baseline to Week 6)|Lost to Follow-up|0|||
147242302|NCT03095066|531059613|FG004|Stage 1 (Baseline to Week 6)|Lost to Follow-up|0|||
147242303|NCT03095066|531059614|FG005|Stage 1 (Baseline to Week 6)|Lost to Follow-up|0|||
147322662|NCT00848211|531345438|FG001|Overall Study|Protocol Violation|1|||
147322663|NCT00848211|531345439|FG002|Overall Study|Protocol Violation|1|||
147587827|NCT00573170|532305560|FG004|Second Washout Period|Protocol Violation|0|||
147162034|NCT02761694|530757012|FG008|Overall Study|Other|0|||
147162035|NCT02761694|530757013|FG009|Overall Study|Other|1|||
147162036|NCT02761694|530757014|FG010|Overall Study|Other|1|||
147162037|NCT02761694|530757015|FG011|Overall Study|Other|0|||
147162038|NCT00787930|530757020|FG000|Continuation Treatment -- up to 12 Month|Withdrawal by Subject|3|||
147162039|NCT02395055|530757021|FG000|Overall Study|Withdrawal by Subject|7|||
147162040|NCT02395055|530757022|FG001|Overall Study|Withdrawal by Subject|3|||
147162041|NCT02513823|530757023|FG000|Overall Study|Lost to Follow-up|4|||
147162042|NCT02513823|530757023|FG000|Overall Study|Physician Decision|1|||
147162043|NCT01294462|530757025|FG000|Overall Study|Lost to Follow-up|1|||
147162044|NCT01294462|530757026|FG001|Overall Study|Lost to Follow-up|0|||
147162045|NCT01294462|530757025|FG000|Overall Study|Withdrawal by Subject|65|||
147322664|NCT00848211|531345440|FG003|Overall Study|Protocol Violation|0|||
147322665|NCT00848211|531345437|FG000|Overall Study|Adverse Event|0|||
147322666|NCT00848211|531345438|FG001|Overall Study|Adverse Event|0|||
147322667|NCT00848211|531345439|FG002|Overall Study|Adverse Event|0|||
147322668|NCT00848211|531345440|FG003|Overall Study|Adverse Event|0|||
147322669|NCT02531438|531345441|FG000|Overall Study|Adverse Event|7|||
147322670|NCT02531438|531345442|FG001|Overall Study|Adverse Event|9|||
147322671|NCT02531438|531345441|FG000|Overall Study|Lost to Follow-up|0|||
147322672|NCT02531438|531345442|FG001|Overall Study|Lost to Follow-up|3|||
147322673|NCT02531438|531345441|FG000|Overall Study|Withdrawal by Subject|7|||
147322674|NCT02531438|531345442|FG001|Overall Study|Withdrawal by Subject|8|||
147322675|NCT02531438|531345441|FG000|Overall Study|Physician Decision|0|||
147322676|NCT02531438|531345442|FG001|Overall Study|Physician Decision|1|||
147322677|NCT02531438|531345441|FG000|Overall Study|Death|6|||
147322678|NCT02531438|531345442|FG001|Overall Study|Death|3|||
147322679|NCT02531438|531345441|FG000|Overall Study|Randomized, but Not Treated|4|||
147322680|NCT02531438|531345442|FG001|Overall Study|Randomized, but Not Treated|0|||
147322681|NCT02531438|531345441|FG000|Overall Study|Missed EOT/PTE Visit|5|||
147322682|NCT02531438|531345442|FG001|Overall Study|Missed EOT/PTE Visit|2|||
147322683|NCT02531438|531345441|FG000|Overall Study|Randomized with Exclusion Criteria|1|||
147322684|NCT02531438|531345442|FG001|Overall Study|Randomized with Exclusion Criteria|0|||
147322685|NCT01124617|531345443|FG000|Overall Study|Adverse Event|5|||
147322686|NCT01124617|531345444|FG001|Overall Study|Adverse Event|2|||
147322687|NCT01124617|531345443|FG000|Overall Study|Lack of Efficacy|2|||
147322688|NCT01124617|531345444|FG001|Overall Study|Lack of Efficacy|1|||
147322689|NCT01124617|531345443|FG000|Overall Study|Protocol Violation|1|||
147322690|NCT01124617|531345444|FG001|Overall Study|Protocol Violation|1|||
147322691|NCT01124617|531345443|FG000|Overall Study|Withdrawal by Subject|9|||
147322692|NCT01124617|531345444|FG001|Overall Study|Withdrawal by Subject|1|||
147322693|NCT01124617|531345443|FG000|Overall Study|Other|2|||
147322694|NCT01124617|531345444|FG001|Overall Study|Other|1|||
147322695|NCT00945477|531345445|FG000|Overall Study|Adverse Event|3|||
147322696|NCT00945477|531345445|FG000|Overall Study|Lack of Efficacy|2|||
147322697|NCT00945477|531345445|FG000|Overall Study|Withdrawal by Subject|1|||
147322698|NCT00558753|531345447|FG000|Overall Study|Lost to Follow-up|5|||
147322699|NCT00558753|531345448|FG001|Overall Study|Lost to Follow-up|7|||
147162046|NCT01294462|530757026|FG001|Overall Study|Withdrawal by Subject|63|||
147162047|NCT02743780|530757027|FG000|Part 3 (7 Days)|Adverse Event|0|||
147162048|NCT02743780|530757028|FG001|Part 3 (7 Days)|Adverse Event|0|||
147322700|NCT00783718|531345455|FG000|Induction Phase|Adverse Event|4|||
147322701|NCT00783718|531345456|FG001|Induction Phase|Adverse Event|0|||
147322702|NCT00783718|531345457|FG002|Induction Phase|Adverse Event|7|||
147322703|NCT00783718|531345458|FG003|Induction Phase|Adverse Event|0|||
147322704|NCT00783718|531345459|FG004|Induction Phase|Adverse Event|0|||
147322705|NCT00783718|531345460|FG005|Induction Phase|Adverse Event|0|||
147322706|NCT00783718|531345461|FG006|Induction Phase|Adverse Event|0|||
147322707|NCT00783718|531345455|FG000|Induction Phase|Protocol Violation|1|||
147322708|NCT00783718|531345456|FG001|Induction Phase|Protocol Violation|1|||
147322709|NCT00783718|531345457|FG002|Induction Phase|Protocol Violation|6|||
147322710|NCT00783718|531345458|FG003|Induction Phase|Protocol Violation|0|||
147322711|NCT00783718|531345459|FG004|Induction Phase|Protocol Violation|0|||
147322712|NCT00783718|531345460|FG005|Induction Phase|Protocol Violation|0|||
147322713|NCT00783718|531345461|FG006|Induction Phase|Protocol Violation|0|||
147322714|NCT00783718|531345455|FG000|Induction Phase|Lack of Efficacy|5|||
147322715|NCT00783718|531345456|FG001|Induction Phase|Lack of Efficacy|2|||
147322716|NCT00783718|531345457|FG002|Induction Phase|Lack of Efficacy|14|||
147322717|NCT00783718|531345458|FG003|Induction Phase|Lack of Efficacy|0|||
147322718|NCT00783718|531345459|FG004|Induction Phase|Lack of Efficacy|0|||
147322719|NCT00783718|531345460|FG005|Induction Phase|Lack of Efficacy|0|||
147322720|NCT00783718|531345461|FG006|Induction Phase|Lack of Efficacy|0|||
147587828|NCT00573170|532305561|FG005|Second Washout Period|Protocol Violation|0|||
147587829|NCT00573170|532305556|FG000|Second Washout Period|Withdrawal by Subject|1|||
147587830|NCT00573170|532305557|FG001|Second Washout Period|Withdrawal by Subject|1|||
147587831|NCT00573170|532305558|FG002|Second Washout Period|Withdrawal by Subject|2|||
147587832|NCT00573170|532305559|FG003|Second Washout Period|Withdrawal by Subject|0|||
147162049|NCT02743780|530757029|FG002|Part 3 (7 Days)|Adverse Event|1|||
147162050|NCT02743780|530757030|FG003|Part 3 (7 Days)|Adverse Event|0|||
147322721|NCT00783718|531345455|FG000|Induction Phase|Withdrawal by Subject|3|||
147322722|NCT00783718|531345456|FG001|Induction Phase|Withdrawal by Subject|4|||
147322723|NCT00783718|531345457|FG002|Induction Phase|Withdrawal by Subject|8|||
147322724|NCT00783718|531345458|FG003|Induction Phase|Withdrawal by Subject|0|||
147447204|NCT00957008|531802074|FG000|Overall Study|Physician Decision|1|||
147447205|NCT00957008|531802075|FG001|Overall Study|Physician Decision|0|||
147447206|NCT00957008|531802076|FG002|Overall Study|Physician Decision|1|||
147447207|NCT00957008|531802077|FG003|Overall Study|Physician Decision|1|||
147447208|NCT00957008|531802074|FG000|Overall Study|Relocated; Family conflict|4|||
147447209|NCT00957008|531802075|FG001|Overall Study|Relocated; Family conflict|1|||
147447210|NCT00957008|531802076|FG002|Overall Study|Relocated; Family conflict|1|||
147447211|NCT00957008|531802077|FG003|Overall Study|Relocated; Family conflict|3|||
147447212|NCT00811135|531802078|FG000|Overall Study|Adverse Event/Intercurrent Illness|8|||
147447213|NCT00811135|531802078|FG000|Overall Study|Death|3|||
147447214|NCT00811135|531802078|FG000|Overall Study|Protocol Violation|2|||
147447215|NCT00811135|531802078|FG000|Overall Study|Violation of Selection Criteria|1|||
147447216|NCT00811135|531802078|FG000|Overall Study|Refused Treatment|1|||
147447217|NCT00811135|531802078|FG000|Overall Study|Withdrawal by Subject|3|||
147447218|NCT00811135|531802078|FG000|Overall Study|Administrative/Other Unspecified|11|||
147447219|NCT00811135|531802078|FG000|Overall Study|Ongoing|59|||
147447220|NCT01118351|531802079|FG000|Overall Study|Adverse Event|3|||
147447221|NCT01118351|531802079|FG000|Overall Study|Withdrawal by Subject|1|||
147447222|NCT02797808|531802080|FG000|Overall Study|Withdrawal by Subject|1|||
147447223|NCT02797808|531802081|FG001|Overall Study|Withdrawal by Subject|1|||
147447224|NCT02797808|531802080|FG000|Overall Study|Physician Decision|6|||
147447225|NCT02797808|531802081|FG001|Overall Study|Physician Decision|2|||
147447226|NCT00708500|531802084|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Adverse Event|1|||
147447227|NCT00708500|531802085|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Adverse Event|3|||
147447228|NCT00708500|531802086|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Adverse Event|1|||
147447229|NCT00708500|531802084|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal unrelated to Tx|1|||
147447230|NCT00708500|531802085|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal unrelated to Tx|0|||
147447231|NCT00708500|531802086|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal unrelated to Tx|0|||
147447232|NCT00708500|531802084|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal related to Tx|0|||
147447233|NCT00708500|531802085|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal related to Tx|1|||
147447234|NCT00708500|531802086|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrawal related to Tx|0|||
147447235|NCT00708500|531802084|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrew consent|0|||
147447236|NCT00708500|531802085|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrew consent|2|||
147447237|NCT00708500|531802086|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Subject withdrew consent|0|||
147447238|NCT00708500|531802084|FG000|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Randomized but not treated|0|||
147447239|NCT00708500|531802085|FG001|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Randomized but not treated|0|||
147447240|NCT00708500|531802086|FG002|Treatment (Tx): 4 WEEK LEAD-IN PERIOD|Randomized but not treated|1|||
147447241|NCT00708500|531802084|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Adverse Event|1|||
147447242|NCT00708500|531802085|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Adverse Event|10|||
147447243|NCT00708500|531802086|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Adverse Event|19|||
147447244|NCT00708500|531802084|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Treatment Failure|49|||
147447245|NCT00708500|531802085|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Treatment Failure|36|||
147447246|NCT00708500|531802086|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Treatment Failure|29|||
147447247|NCT00708500|531802084|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Lost to Follow-up|0|||
147447248|NCT00708500|531802085|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Lost to Follow-up|1|||
147447249|NCT00708500|531802086|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Lost to Follow-up|0|||
147447250|NCT00708500|531802084|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal unrelated to Tx|3|||
147447251|NCT00708500|531802085|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal unrelated to Tx|1|||
147447252|NCT00708500|531802086|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal unrelated to Tx|4|||
147447253|NCT00708500|531802084|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal related to Tx|2|||
147447254|NCT00708500|531802085|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal related to Tx|0|||
147447255|NCT00708500|531802086|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrawal related to Tx|1|||
147447256|NCT00708500|531802084|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrew consent|0|||
147447257|NCT00708500|531802085|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrew consent|2|||
147447258|NCT00708500|531802086|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Subject withdrew consent|1|||
147447259|NCT00708500|531802084|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Non-compliance with protocol|0|||
147447260|NCT00708500|531802085|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Non-compliance with protocol|1|||
147447261|NCT00708500|531802086|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Non-compliance with protocol|1|||
147162051|NCT02743780|530757031|FG004|Part 3 (7 Days)|Adverse Event|0|||
147162052|NCT01460407|530757035|FG000|Period 2: Day 6 to Day 14|Adverse Event|0|||
147162053|NCT01460407|530757036|FG001|Period 2: Day 6 to Day 14|Adverse Event|1|||
147162054|NCT04070326|530757039|FG000|Treatment Period A (Weeks 1 to 26)|Withdrawal by Parent/Guardian|1|||
147447262|NCT00708500|531802084|FG000|Tx: RECEIVING BOCEPREVIR/PLACEBO|Administrative|0|||
147447263|NCT00708500|531802085|FG001|Tx: RECEIVING BOCEPREVIR/PLACEBO|Administrative|1|||
147447264|NCT00708500|531802086|FG002|Tx: RECEIVING BOCEPREVIR/PLACEBO|Administrative|0|||
147447265|NCT00708500|531802084|FG000|FOLLOWUP|Adverse Event|0|||
147447266|NCT00708500|531802085|FG001|FOLLOWUP|Adverse Event|1|||
147447267|NCT00708500|531802086|FG002|FOLLOWUP|Adverse Event|0|||
147162055|NCT04070326|530757040|FG001|Treatment Period A (Weeks 1 to 26)|Withdrawal by Parent/Guardian|0|||
147587833|NCT00573170|532305560|FG004|Second Washout Period|Withdrawal by Subject|1|||
147587834|NCT00573170|532305561|FG005|Second Washout Period|Withdrawal by Subject|0|||
147587835|NCT00573170|532305556|FG000|Second Washout Period|Lost to Follow-up|0|||
147587836|NCT00573170|532305557|FG001|Second Washout Period|Lost to Follow-up|0|||
147587837|NCT00573170|532305558|FG002|Second Washout Period|Lost to Follow-up|0|||
147587838|NCT00573170|532305559|FG003|Second Washout Period|Lost to Follow-up|1|||
147587839|NCT00573170|532305560|FG004|Second Washout Period|Lost to Follow-up|0|||
147587840|NCT00573170|532305561|FG005|Second Washout Period|Lost to Follow-up|0|||
147587841|NCT00573170|532305556|FG000|Second Washout Period|Other|1|||
147587842|NCT00573170|532305557|FG001|Second Washout Period|Other|2|||
147587843|NCT00573170|532305558|FG002|Second Washout Period|Other|1|||
147587844|NCT00573170|532305559|FG003|Second Washout Period|Other|4|||
147587845|NCT00573170|532305560|FG004|Second Washout Period|Other|6|||
147587846|NCT00573170|532305561|FG005|Second Washout Period|Other|2|||
147587847|NCT00573170|532305556|FG000|Third Treatment Period|Withdrawal by Subject|1|||
147587848|NCT00573170|532305557|FG001|Third Treatment Period|Withdrawal by Subject|0|||
147587849|NCT00573170|532305558|FG002|Third Treatment Period|Withdrawal by Subject|0|||
147587850|NCT00573170|532305559|FG003|Third Treatment Period|Withdrawal by Subject|0|||
147587851|NCT00573170|532305560|FG004|Third Treatment Period|Withdrawal by Subject|0|||
147587852|NCT00573170|532305561|FG005|Third Treatment Period|Withdrawal by Subject|0|||
147587853|NCT00573170|532305556|FG000|Third Treatment Period|Lost to Follow-up|0|||
147587854|NCT00573170|532305557|FG001|Third Treatment Period|Lost to Follow-up|0|||
147587855|NCT00573170|532305558|FG002|Third Treatment Period|Lost to Follow-up|0|||
147587856|NCT00573170|532305559|FG003|Third Treatment Period|Lost to Follow-up|0|||
147587857|NCT00573170|532305560|FG004|Third Treatment Period|Lost to Follow-up|0|||
147587858|NCT00573170|532305561|FG005|Third Treatment Period|Lost to Follow-up|2|||
147587859|NCT00263887|532305562|FG000|Overall Study|Withdrawal by Subject|1|||
147587860|NCT00263887|532305563|FG001|Overall Study|Withdrawal by Subject|1|||
147587861|NCT00263887|532305562|FG000|Overall Study|Lung transplantation|1|||
147587862|NCT00263887|532305563|FG001|Overall Study|Lung transplantation|2|||
147587863|NCT00263887|532305562|FG000|Overall Study|Too ill to attend visit|1|||
147587864|NCT00263887|532305563|FG001|Overall Study|Too ill to attend visit|0|||
147587865|NCT00263887|532305562|FG000|Overall Study|Adverse Event|0|||
147587866|NCT00263887|532305563|FG001|Overall Study|Adverse Event|2|||
147587867|NCT00263887|532305562|FG000|Overall Study|Disease progression|0|||
147587868|NCT00263887|532305563|FG001|Overall Study|Disease progression|1|||
147587869|NCT00263887|532305562|FG000|Overall Study|Lack of Efficacy|0|||
147587870|NCT00263887|532305563|FG001|Overall Study|Lack of Efficacy|1|||
147587871|NCT04364763|532305564|FG000|Overall Study|Death|1|||
147587872|NCT04364763|532305565|FG001|Overall Study|Death|2|||
147587873|NCT04364763|532305564|FG000|Overall Study|Lost to Follow-up|1|||
147587874|NCT04364763|532305565|FG001|Overall Study|Lost to Follow-up|0|||
147587875|NCT00985231|532305576|FG000|Overall Study|ineligible|1|||
147587876|NCT00985231|532305577|FG001|Overall Study|ineligible|0|||
147587877|NCT00985231|532305576|FG000|Overall Study|Protocol Violation|1|||
147587878|NCT00985231|532305577|FG001|Overall Study|Protocol Violation|0|||
147587879|NCT00985231|532305576|FG000|Overall Study|Withdrawal by Subject|1|||
147587880|NCT00985231|532305577|FG001|Overall Study|Withdrawal by Subject|0|||
147162056|NCT02193087|530757045|FG000|Overall Study|Adverse Event|2|||
147162057|NCT02193087|530757046|FG001|Overall Study|Adverse Event|0|||
147162058|NCT02193087|530757047|FG002|Overall Study|Adverse Event|0|||
147162059|NCT02193087|530757048|FG003|Overall Study|Adverse Event|11|||
147162060|NCT02193087|530757045|FG000|Overall Study|Lost to Follow-up|14|||
147162061|NCT02193087|530757046|FG001|Overall Study|Lost to Follow-up|6|||
147162062|NCT02193087|530757047|FG002|Overall Study|Lost to Follow-up|4|||
147162063|NCT02193087|530757048|FG003|Overall Study|Lost to Follow-up|37|||
147162064|NCT02193087|530757045|FG000|Overall Study|Protocol Violation|2|||
147162065|NCT02193087|530757046|FG001|Overall Study|Protocol Violation|0|||
147162066|NCT02193087|530757047|FG002|Overall Study|Protocol Violation|1|||
147162067|NCT02193087|530757048|FG003|Overall Study|Protocol Violation|2|||
147162068|NCT02193087|530757045|FG000|Overall Study|Withdrawal by Subject|10|||
147162069|NCT02193087|530757046|FG001|Overall Study|Withdrawal by Subject|3|||
147162070|NCT02193087|530757047|FG002|Overall Study|Withdrawal by Subject|1|||
147162071|NCT02193087|530757048|FG003|Overall Study|Withdrawal by Subject|19|||
147162072|NCT02193087|530757045|FG000|Overall Study|Other Reason Not Specified|7|||
147162073|NCT02193087|530757046|FG001|Overall Study|Other Reason Not Specified|2|||
147162074|NCT02193087|530757047|FG002|Overall Study|Other Reason Not Specified|1|||
147162075|NCT02193087|530757048|FG003|Overall Study|Other Reason Not Specified|9|||
147162076|NCT02193087|530757045|FG000|Overall Study|Did Not Receive Any Vaccination|2|||
147162077|NCT02193087|530757046|FG001|Overall Study|Did Not Receive Any Vaccination|3|||
147587881|NCT00985231|532305576|FG000|Overall Study|Lost to Follow-up|0|||
147587882|NCT00985231|532305577|FG001|Overall Study|Lost to Follow-up|1|||
147587883|NCT00985231|532305576|FG000|Overall Study|Study related symptoms & complaints|0|||
147162078|NCT02193087|530757047|FG002|Overall Study|Did Not Receive Any Vaccination|0|||
147587884|NCT00985231|532305577|FG001|Overall Study|Study related symptoms & complaints|2|||
147587885|NCT00983476|532305587|FG000|Overall Study|Did not receive intervention|17|||
147587886|NCT00983476|532305588|FG001|Overall Study|Did not receive intervention|22|||
147162079|NCT02193087|530757048|FG003|Overall Study|Did Not Receive Any Vaccination|1|||
147162080|NCT02279498|530757049|FG000|Overall Study|Adverse Event|3|||
147162081|NCT02279498|530757050|FG001|Overall Study|Adverse Event|0|||
147162082|NCT02279498|530757049|FG000|Overall Study|Lack of Efficacy|4|||
147162083|NCT02279498|530757050|FG001|Overall Study|Lack of Efficacy|0|||
147162084|NCT02279498|530757049|FG000|Overall Study|Lost to Follow-up|0|||
147162085|NCT02279498|530757050|FG001|Overall Study|Lost to Follow-up|1|||
147162086|NCT02279498|530757049|FG000|Overall Study|Withdrawal by Subject|9|||
147162087|NCT02279498|530757050|FG001|Overall Study|Withdrawal by Subject|2|||
147162088|NCT02279498|530757049|FG000|Overall Study|Undefined|2|||
147162089|NCT02279498|530757050|FG001|Overall Study|Undefined|1|||
147162090|NCT00737711|530757051|FG000|Overall Study|Adverse Event|2|||
147162091|NCT00737711|530757051|FG000|Overall Study|Death|8|||
147162092|NCT00737711|530757051|FG000|Overall Study|Failure to return|4|||
147162093|NCT00737711|530757051|FG000|Overall Study|Protocol Violation|1|||
147162094|NCT00737711|530757051|FG000|Overall Study|Withdrawal by Subject|5|||
147162095|NCT00737711|530757051|FG000|Overall Study|Blood transfusion|6|||
147162096|NCT00737711|530757051|FG000|Overall Study|Other|5|||
147242304|NCT03095066|531059615|FG006|Stage 1 (Baseline to Week 6)|Lost to Follow-up|0|||
147242305|NCT03095066|531059616|FG007|Stage 1 (Baseline to Week 6)|Lost to Follow-up|1|||
147242306|NCT03095066|531059609|FG000|Stage 1 (Baseline to Week 6)|Non-compliance With Study Drug|0|||
147242307|NCT03095066|531059610|FG001|Stage 1 (Baseline to Week 6)|Non-compliance With Study Drug|0|||
147242308|NCT03095066|531059611|FG002|Stage 1 (Baseline to Week 6)|Non-compliance With Study Drug|2|||
147242309|NCT03095066|531059612|FG003|Stage 1 (Baseline to Week 6)|Non-compliance With Study Drug|0|||
147242310|NCT03095066|531059613|FG004|Stage 1 (Baseline to Week 6)|Non-compliance With Study Drug|0|||
147242311|NCT03095066|531059614|FG005|Stage 1 (Baseline to Week 6)|Non-compliance With Study Drug|0|||
147242312|NCT03095066|531059615|FG006|Stage 1 (Baseline to Week 6)|Non-compliance With Study Drug|0|||
147242313|NCT03095066|531059616|FG007|Stage 1 (Baseline to Week 6)|Non-compliance With Study Drug|1|||
147242314|NCT03095066|531059609|FG000|Stage 1 (Baseline to Week 6)|Withdrawal by Subject|0|||
147242315|NCT03095066|531059610|FG001|Stage 1 (Baseline to Week 6)|Withdrawal by Subject|0|||
147242316|NCT03095066|531059611|FG002|Stage 1 (Baseline to Week 6)|Withdrawal by Subject|2|||
147242317|NCT03095066|531059612|FG003|Stage 1 (Baseline to Week 6)|Withdrawal by Subject|0|||
147242318|NCT03095066|531059613|FG004|Stage 1 (Baseline to Week 6)|Withdrawal by Subject|0|||
147242319|NCT03095066|531059614|FG005|Stage 1 (Baseline to Week 6)|Withdrawal by Subject|0|||
147242320|NCT03095066|531059615|FG006|Stage 1 (Baseline to Week 6)|Withdrawal by Subject|0|||
147242321|NCT03095066|531059616|FG007|Stage 1 (Baseline to Week 6)|Withdrawal by Subject|3|||
147242322|NCT03095066|531059609|FG000|Stage 1 (Baseline to Week 6)|Trial Site Terminated by Sponsor|0|||
147242323|NCT03095066|531059610|FG001|Stage 1 (Baseline to Week 6)|Trial Site Terminated by Sponsor|0|||
147242324|NCT03095066|531059611|FG002|Stage 1 (Baseline to Week 6)|Trial Site Terminated by Sponsor|1|||
147242325|NCT03095066|531059612|FG003|Stage 1 (Baseline to Week 6)|Trial Site Terminated by Sponsor|0|||
147242326|NCT03095066|531059613|FG004|Stage 1 (Baseline to Week 6)|Trial Site Terminated by Sponsor|0|||
147242327|NCT03095066|531059614|FG005|Stage 1 (Baseline to Week 6)|Trial Site Terminated by Sponsor|0|||
147242328|NCT03095066|531059615|FG006|Stage 1 (Baseline to Week 6)|Trial Site Terminated by Sponsor|0|||
147242329|NCT03095066|531059616|FG007|Stage 1 (Baseline to Week 6)|Trial Site Terminated by Sponsor|0|||
147242330|NCT03095066|531059609|FG000|Stage 1 (Baseline to Week 6)|Reason Not Specified|0|||
147242331|NCT03095066|531059610|FG001|Stage 1 (Baseline to Week 6)|Reason Not Specified|0|||
147242332|NCT03095066|531059611|FG002|Stage 1 (Baseline to Week 6)|Reason Not Specified|5|||
147242333|NCT03095066|531059612|FG003|Stage 1 (Baseline to Week 6)|Reason Not Specified|0|||
147242334|NCT03095066|531059613|FG004|Stage 1 (Baseline to Week 6)|Reason Not Specified|0|||
147242335|NCT03095066|531059614|FG005|Stage 1 (Baseline to Week 6)|Reason Not Specified|0|||
147242336|NCT03095066|531059615|FG006|Stage 1 (Baseline to Week 6)|Reason Not Specified|0|||
147242337|NCT03095066|531059616|FG007|Stage 1 (Baseline to Week 6)|Reason Not Specified|2|||
147242338|NCT03095066|531059609|FG000|Stage 1 (Baseline to Week 6)|Physician Decision|0|||
147242339|NCT03095066|531059610|FG001|Stage 1 (Baseline to Week 6)|Physician Decision|0|||
147242340|NCT03095066|531059611|FG002|Stage 1 (Baseline to Week 6)|Physician Decision|0|||
147242341|NCT03095066|531059612|FG003|Stage 1 (Baseline to Week 6)|Physician Decision|0|||
147242342|NCT03095066|531059613|FG004|Stage 1 (Baseline to Week 6)|Physician Decision|0|||
147242343|NCT03095066|531059614|FG005|Stage 1 (Baseline to Week 6)|Physician Decision|0|||
147242344|NCT03095066|531059615|FG006|Stage 1 (Baseline to Week 6)|Physician Decision|0|||
147242345|NCT03095066|531059616|FG007|Stage 1 (Baseline to Week 6)|Physician Decision|1|||
147242346|NCT03095066|531059609|FG000|Stage 2 (Week 7 to Week 12)|Adverse Event|0|||
147322725|NCT00783718|531345459|FG004|Induction Phase|Withdrawal by Subject|0|||
147162097|NCT00624780|530757052|FG000|Treatment Optimization (Up to Week 12)|Adverse Event|7|||
147162098|NCT00624780|530757053|FG001|Treatment Optimization (Up to Week 12)|Adverse Event|5|||
147162099|NCT00624780|530757054|FG002|Treatment Optimization (Up to Week 12)|Adverse Event|15|||
147162100|NCT00624780|530757055|FG003|Treatment Optimization (Up to Week 12)|Adverse Event|3|||
147162101|NCT00624780|530757056|FG004|Treatment Optimization (Up to Week 12)|Adverse Event|9|||
147162102|NCT00624780|530757057|FG005|Treatment Optimization (Up to Week 12)|Adverse Event|5|||
147162103|NCT00624780|530757052|FG000|Treatment Optimization (Up to Week 12)|Lack of Efficacy|5|||
147162104|NCT00624780|530757053|FG001|Treatment Optimization (Up to Week 12)|Lack of Efficacy|2|||
147162105|NCT00624780|530757054|FG002|Treatment Optimization (Up to Week 12)|Lack of Efficacy|10|||
147162106|NCT00624780|530757055|FG003|Treatment Optimization (Up to Week 12)|Lack of Efficacy|5|||
147162107|NCT00624780|530757056|FG004|Treatment Optimization (Up to Week 12)|Lack of Efficacy|9|||
147162108|NCT00624780|530757057|FG005|Treatment Optimization (Up to Week 12)|Lack of Efficacy|1|||
147162109|NCT00624780|530757052|FG000|Treatment Optimization (Up to Week 12)|Lost to Follow-up|1|||
147162110|NCT00624780|530757053|FG001|Treatment Optimization (Up to Week 12)|Lost to Follow-up|0|||
147162111|NCT00624780|530757054|FG002|Treatment Optimization (Up to Week 12)|Lost to Follow-up|2|||
147162112|NCT00624780|530757055|FG003|Treatment Optimization (Up to Week 12)|Lost to Follow-up|0|||
147162113|NCT00624780|530757056|FG004|Treatment Optimization (Up to Week 12)|Lost to Follow-up|2|||
147162114|NCT00624780|530757057|FG005|Treatment Optimization (Up to Week 12)|Lost to Follow-up|1|||
147162115|NCT00624780|530757052|FG000|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|10|||
147162116|NCT00624780|530757053|FG001|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|2|||
147162117|NCT00624780|530757054|FG002|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|7|||
147162118|NCT00624780|530757055|FG003|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|4|||
147162119|NCT00624780|530757056|FG004|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|10|||
147162120|NCT00624780|530757057|FG005|Treatment Optimization (Up to Week 12)|Withdrawal by Subject|4|||
147162121|NCT00624780|530757052|FG000|Treatment Optimization (Up to Week 12)|Other|10|||
147162122|NCT00624780|530757053|FG001|Treatment Optimization (Up to Week 12)|Other|4|||
147162123|NCT00624780|530757054|FG002|Treatment Optimization (Up to Week 12)|Other|8|||
147162124|NCT00624780|530757055|FG003|Treatment Optimization (Up to Week 12)|Other|2|||
147162125|NCT00624780|530757056|FG004|Treatment Optimization (Up to Week 12)|Other|9|||
147162126|NCT00624780|530757057|FG005|Treatment Optimization (Up to Week 12)|Other|0|||
147162127|NCT00624780|530757052|FG000|Fixed Dosing (Week 13 to Week 24)|Adverse Event|5|||
147162128|NCT00624780|530757053|FG001|Fixed Dosing (Week 13 to Week 24)|Adverse Event|4|||
147162129|NCT00624780|530757054|FG002|Fixed Dosing (Week 13 to Week 24)|Adverse Event|5|||
147162130|NCT00624780|530757055|FG003|Fixed Dosing (Week 13 to Week 24)|Adverse Event|2|||
147162131|NCT00624780|530757056|FG004|Fixed Dosing (Week 13 to Week 24)|Adverse Event|3|||
147162132|NCT00624780|530757057|FG005|Fixed Dosing (Week 13 to Week 24)|Adverse Event|1|||
147162133|NCT00624780|530757052|FG000|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|2|||
147162134|NCT00624780|530757053|FG001|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|1|||
147162135|NCT00624780|530757054|FG002|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|2|||
147162136|NCT00624780|530757055|FG003|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|5|||
147162137|NCT00624780|530757056|FG004|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|5|||
147162138|NCT00624780|530757057|FG005|Fixed Dosing (Week 13 to Week 24)|Lack of Efficacy|2|||
147162139|NCT00624780|530757052|FG000|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1|||
147162140|NCT00624780|530757053|FG001|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|0|||
147162141|NCT00624780|530757054|FG002|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1|||
147162142|NCT00624780|530757055|FG003|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|0|||
147162143|NCT00624780|530757056|FG004|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1|||
147162144|NCT00624780|530757057|FG005|Fixed Dosing (Week 13 to Week 24)|Lost to Follow-up|1|||
147162145|NCT00624780|530757052|FG000|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|2|||
147162146|NCT00624780|530757053|FG001|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|3|||
147162147|NCT00624780|530757054|FG002|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|6|||
147162148|NCT00624780|530757055|FG003|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|3|||
147162149|NCT00624780|530757056|FG004|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|6|||
147162150|NCT00624780|530757057|FG005|Fixed Dosing (Week 13 to Week 24)|Withdrawal by Subject|2|||
147162151|NCT00624780|530757052|FG000|Fixed Dosing (Week 13 to Week 24)|Other|5|||
147162152|NCT00624780|530757053|FG001|Fixed Dosing (Week 13 to Week 24)|Other|3|||
147162153|NCT00624780|530757054|FG002|Fixed Dosing (Week 13 to Week 24)|Other|4|||
147162154|NCT00624780|530757055|FG003|Fixed Dosing (Week 13 to Week 24)|Other|1|||
147162155|NCT00624780|530757056|FG004|Fixed Dosing (Week 13 to Week 24)|Other|4|||
147162156|NCT00624780|530757057|FG005|Fixed Dosing (Week 13 to Week 24)|Other|3|||
147162157|NCT00624780|530757052|FG000|Treatment Discontinuation (Week 25)|Adverse Event|1|||
147162158|NCT00624780|530757053|FG001|Treatment Discontinuation (Week 25)|Adverse Event|0|||
147162159|NCT00624780|530757054|FG002|Treatment Discontinuation (Week 25)|Adverse Event|2|||
147162160|NCT00624780|530757055|FG003|Treatment Discontinuation (Week 25)|Adverse Event|1|||
147162161|NCT00624780|530757056|FG004|Treatment Discontinuation (Week 25)|Adverse Event|0|||
147162162|NCT00624780|530757057|FG005|Treatment Discontinuation (Week 25)|Adverse Event|1|||
147162163|NCT00624780|530757052|FG000|Treatment Discontinuation (Week 25)|Lack of Efficacy|1|||
147162164|NCT00624780|530757053|FG001|Treatment Discontinuation (Week 25)|Lack of Efficacy|0|||
147162165|NCT00624780|530757054|FG002|Treatment Discontinuation (Week 25)|Lack of Efficacy|0|||
147162166|NCT00624780|530757055|FG003|Treatment Discontinuation (Week 25)|Lack of Efficacy|0|||
147162167|NCT00624780|530757056|FG004|Treatment Discontinuation (Week 25)|Lack of Efficacy|0|||
147162168|NCT00624780|530757057|FG005|Treatment Discontinuation (Week 25)|Lack of Efficacy|0|||
147162169|NCT00624780|530757052|FG000|Treatment Discontinuation (Week 25)|Lost to Follow-up|0|||
147162170|NCT00624780|530757053|FG001|Treatment Discontinuation (Week 25)|Lost to Follow-up|0|||
147242347|NCT03095066|531059610|FG001|Stage 2 (Week 7 to Week 12)|Adverse Event|0|||
147447268|NCT00708500|531802084|FG000|FOLLOWUP|Lost to Follow-up|1|||
147447269|NCT00708500|531802085|FG001|FOLLOWUP|Lost to Follow-up|6|||
147447270|NCT00708500|531802086|FG002|FOLLOWUP|Lost to Follow-up|4|||
147447271|NCT00708500|531802084|FG000|FOLLOWUP|Subject withdrawal unrelated to Tx|3|||
147447272|NCT00708500|531802085|FG001|FOLLOWUP|Subject withdrawal unrelated to Tx|4|||
147447273|NCT00708500|531802086|FG002|FOLLOWUP|Subject withdrawal unrelated to Tx|5|||
147447274|NCT00708500|531802084|FG000|FOLLOWUP|Subject withdrew consent|31|||
147447275|NCT00708500|531802085|FG001|FOLLOWUP|Subject withdrew consent|4|||
147447276|NCT00708500|531802086|FG002|FOLLOWUP|Subject withdrew consent|5|||
147447277|NCT00708500|531802084|FG000|FOLLOWUP|Non-compliance with protocol|5|||
147447278|NCT00708500|531802085|FG001|FOLLOWUP|Non-compliance with protocol|0|||
147447279|NCT00708500|531802086|FG002|FOLLOWUP|Non-compliance with protocol|1|||
147447280|NCT03975920|531802089|FG000|Overall Study|Lost to Follow-up|1|||
147447281|NCT03975920|531802090|FG001|Overall Study|Lost to Follow-up|2|||
147447282|NCT03975920|531802089|FG000|Overall Study|Protocol Violation|1|||
147447283|NCT03975920|531802090|FG001|Overall Study|Protocol Violation|1|||
147447284|NCT03975920|531802089|FG000|Overall Study|Did not complete survey|2|||
147447285|NCT03975920|531802090|FG001|Overall Study|Did not complete survey|1|||
147447286|NCT02182687|531802097|FG000|Overall Study|Withdrawal by Subject|4|||
147447287|NCT02182687|531802098|FG001|Overall Study|Withdrawal by Subject|0|||
147447288|NCT02182687|531802097|FG000|Overall Study|Adverse Event|1|||
147447289|NCT02182687|531802098|FG001|Overall Study|Adverse Event|0|||
147447290|NCT02182687|531802097|FG000|Overall Study|Lost to Follow-up|0|||
147447291|NCT02182687|531802098|FG001|Overall Study|Lost to Follow-up|1|||
147447292|NCT00794677|531802103|FG000|First Intervention|Withdrawal by Subject|2|||
147447293|NCT00794677|531802104|FG001|First Intervention|Withdrawal by Subject|0|||
147447294|NCT03882970|531802105|FG000|Overall Study|Adverse Event|5|||
147447295|NCT03882970|531802106|FG001|Overall Study|Adverse Event|7|||
147447296|NCT03882970|531802107|FG002|Overall Study|Adverse Event|3|||
147447297|NCT03882970|531802108|FG003|Overall Study|Adverse Event|1|||
147447298|NCT03882970|531802105|FG000|Overall Study|Death|1|||
147447299|NCT03882970|531802106|FG001|Overall Study|Death|2|||
147447300|NCT03882970|531802107|FG002|Overall Study|Death|1|||
147447301|NCT03882970|531802108|FG003|Overall Study|Death|1|||
147447302|NCT03882970|531802105|FG000|Overall Study|Lost to Follow-up|8|||
147447303|NCT03882970|531802106|FG001|Overall Study|Lost to Follow-up|9|||
147447304|NCT03882970|531802107|FG002|Overall Study|Lost to Follow-up|5|||
147447305|NCT03882970|531802108|FG003|Overall Study|Lost to Follow-up|5|||
147447306|NCT03882970|531802105|FG000|Overall Study|Physician Decision|0|||
147587887|NCT00983476|532305589|FG002|Overall Study|Did not receive intervention|0|||
147587888|NCT01175473|532305590|FG000|Overall Study|Adverse Event|2|||
147587889|NCT01175473|532305591|FG001|Overall Study|Adverse Event|2|||
147587890|NCT01083680|532305592|FG000|Overall Study|Lost to Follow-up|2758|||
147587891|NCT01083680|532305592|FG000|Overall Study|Withdrawal by Subject|1086|||
147587892|NCT00003531|532305595|FG000|Overall Study|Not evaluable|10|||
147587893|NCT00588731|532305596|FG000|Overall Study|Withdrawal by Subject|3|||
147587894|NCT00588731|532305597|FG001|Overall Study|Withdrawal by Subject|2|||
147587895|NCT00346164|532305598|FG000|Overall Study|Adverse Event|0|||
147587896|NCT00346164|532305599|FG001|Overall Study|Adverse Event|0|||
147242348|NCT03095066|531059611|FG002|Stage 2 (Week 7 to Week 12)|Adverse Event|0|||
147242349|NCT03095066|531059612|FG003|Stage 2 (Week 7 to Week 12)|Adverse Event|0|||
147242350|NCT03095066|531059613|FG004|Stage 2 (Week 7 to Week 12)|Adverse Event|0|||
147242351|NCT03095066|531059614|FG005|Stage 2 (Week 7 to Week 12)|Adverse Event|1|||
147242352|NCT03095066|531059615|FG006|Stage 2 (Week 7 to Week 12)|Adverse Event|0|||
147242353|NCT03095066|531059616|FG007|Stage 2 (Week 7 to Week 12)|Adverse Event|0|||
147242354|NCT03095066|531059609|FG000|Stage 2 (Week 7 to Week 12)|Lost to Follow-up|0|||
147242355|NCT03095066|531059610|FG001|Stage 2 (Week 7 to Week 12)|Lost to Follow-up|0|||
147242356|NCT03095066|531059611|FG002|Stage 2 (Week 7 to Week 12)|Lost to Follow-up|0|||
147242357|NCT03095066|531059612|FG003|Stage 2 (Week 7 to Week 12)|Lost to Follow-up|0|||
147242358|NCT03095066|531059613|FG004|Stage 2 (Week 7 to Week 12)|Lost to Follow-up|1|||
147242359|NCT03095066|531059614|FG005|Stage 2 (Week 7 to Week 12)|Lost to Follow-up|0|||
147242360|NCT03095066|531059615|FG006|Stage 2 (Week 7 to Week 12)|Lost to Follow-up|2|||
147242361|NCT03095066|531059616|FG007|Stage 2 (Week 7 to Week 12)|Lost to Follow-up|0|||
147447307|NCT03882970|531802106|FG001|Overall Study|Physician Decision|2|||
147447308|NCT03882970|531802107|FG002|Overall Study|Physician Decision|2|||
147447309|NCT03882970|531802108|FG003|Overall Study|Physician Decision|2|||
147447310|NCT03882970|531802105|FG000|Overall Study|Protocol Violation|2|||
147447311|NCT03882970|531802106|FG001|Overall Study|Protocol Violation|0|||
147447312|NCT03882970|531802107|FG002|Overall Study|Protocol Violation|0|||
147447313|NCT03882970|531802108|FG003|Overall Study|Protocol Violation|0|||
147447314|NCT03882970|531802105|FG000|Overall Study|Withdrawal by Subject|8|||
147587897|NCT00346164|532305600|FG002|Overall Study|Adverse Event|0|||
147242362|NCT03095066|531059609|FG000|Stage 2 (Week 7 to Week 12)|Protocol Deviation|0|||
147242363|NCT03095066|531059610|FG001|Stage 2 (Week 7 to Week 12)|Protocol Deviation|0|||
147447315|NCT03882970|531802106|FG001|Overall Study|Withdrawal by Subject|17|||
147587898|NCT00346164|532305601|FG003|Overall Study|Adverse Event|1|||
147587899|NCT00346164|532305598|FG000|Overall Study|Lack of Efficacy|0|||
147587900|NCT00346164|532305599|FG001|Overall Study|Lack of Efficacy|1|||
147587901|NCT00346164|532305600|FG002|Overall Study|Lack of Efficacy|7|||
147587902|NCT00346164|532305601|FG003|Overall Study|Lack of Efficacy|25|||
147587903|NCT00346164|532305598|FG000|Overall Study|Physician Decision|0|||
147587904|NCT00346164|532305599|FG001|Overall Study|Physician Decision|1|||
147587905|NCT00346164|532305600|FG002|Overall Study|Physician Decision|2|||
147587906|NCT00346164|532305601|FG003|Overall Study|Physician Decision|27|||
147587907|NCT00346164|532305598|FG000|Overall Study|Protocol Violation|6|||
147587908|NCT00346164|532305599|FG001|Overall Study|Protocol Violation|2|||
147587909|NCT00346164|532305600|FG002|Overall Study|Protocol Violation|10|||
147587910|NCT00346164|532305601|FG003|Overall Study|Protocol Violation|4|||
147587911|NCT00346164|532305598|FG000|Overall Study|Withdrawal by Subject|0|||
147587912|NCT00346164|532305599|FG001|Overall Study|Withdrawal by Subject|0|||
147587913|NCT00346164|532305600|FG002|Overall Study|Withdrawal by Subject|2|||
147587914|NCT00346164|532305601|FG003|Overall Study|Withdrawal by Subject|0|||
147587915|NCT00346164|532305598|FG000|Overall Study|Ineligible|11|||
147587916|NCT00346164|532305599|FG001|Overall Study|Ineligible|2|||
147587917|NCT00346164|532305600|FG002|Overall Study|Ineligible|2|||
147587918|NCT00346164|532305601|FG003|Overall Study|Ineligible|23|||
147587919|NCT00346164|532305598|FG000|Overall Study|Refusal of further protocol therapy|0|||
147587920|NCT00346164|532305599|FG001|Overall Study|Refusal of further protocol therapy|1|||
147587921|NCT00346164|532305600|FG002|Overall Study|Refusal of further protocol therapy|3|||
147587922|NCT00346164|532305601|FG003|Overall Study|Refusal of further protocol therapy|15|||
147587923|NCT00346164|532305598|FG000|Overall Study|Inability to start week 16 tx on time|0|||
147587924|NCT00346164|532305599|FG001|Overall Study|Inability to start week 16 tx on time|0|||
147587925|NCT00346164|532305600|FG002|Overall Study|Inability to start week 16 tx on time|0|||
147587926|NCT00346164|532305601|FG003|Overall Study|Inability to start week 16 tx on time|11|||
147587927|NCT03297294|532305602|FG000|Double-Blind Treatment Period (DB)|Study terminated by sponsor|30|||
147587928|NCT03297294|532305603|FG001|Double-Blind Treatment Period (DB)|Study terminated by sponsor|31|||
147587929|NCT03297294|532305604|FG002|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
147587930|NCT03297294|532305605|FG003|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
147587931|NCT03297294|532305606|FG004|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
147587932|NCT03297294|532305602|FG000|Double-Blind Treatment Period (DB)|Withdrawal by Subject|4|||
147587933|NCT03297294|532305603|FG001|Double-Blind Treatment Period (DB)|Withdrawal by Subject|4|||
147587934|NCT03297294|532305604|FG002|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
147587935|NCT03297294|532305605|FG003|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
147587936|NCT03297294|532305606|FG004|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
147587937|NCT03297294|532305602|FG000|Double-Blind Treatment Period (DB)|Adverse Event|3|||
147587938|NCT03297294|532305603|FG001|Double-Blind Treatment Period (DB)|Adverse Event|1|||
147587939|NCT03297294|532305604|FG002|Double-Blind Treatment Period (DB)|Adverse Event|0|||
147587940|NCT03297294|532305605|FG003|Double-Blind Treatment Period (DB)|Adverse Event|0|||
147587941|NCT03297294|532305606|FG004|Double-Blind Treatment Period (DB)|Adverse Event|0|||
147587942|NCT03297294|532305602|FG000|Double-Blind Treatment Period (DB)|Physician Decision|1|||
147587943|NCT03297294|532305603|FG001|Double-Blind Treatment Period (DB)|Physician Decision|1|||
147587944|NCT03297294|532305604|FG002|Double-Blind Treatment Period (DB)|Physician Decision|0|||
147587945|NCT03297294|532305605|FG003|Double-Blind Treatment Period (DB)|Physician Decision|0|||
147587946|NCT03297294|532305606|FG004|Double-Blind Treatment Period (DB)|Physician Decision|0|||
147587947|NCT03297294|532305602|FG000|Treatment Withdrawal Period (TW)|Study terminated by sponsor|0|||
147587948|NCT03297294|532305603|FG001|Treatment Withdrawal Period (TW)|Study terminated by sponsor|0|||
147587949|NCT03297294|532305604|FG002|Treatment Withdrawal Period (TW)|Study terminated by sponsor|0|||
147587950|NCT03297294|532305605|FG003|Treatment Withdrawal Period (TW)|Study terminated by sponsor|1|||
147587951|NCT03297294|532305606|FG004|Treatment Withdrawal Period (TW)|Study terminated by sponsor|0|||
147587952|NCT01198873|532305607|FG000|Overall Study|Adverse Event|4|||
147587953|NCT01198873|532305608|FG001|Overall Study|Adverse Event|7|||
147587954|NCT01198873|532305607|FG000|Overall Study|Study closure|29|||
147587955|NCT01198873|532305608|FG001|Overall Study|Study closure|23|||
147162171|NCT00624780|530757054|FG002|Treatment Discontinuation (Week 25)|Lost to Follow-up|1|||
147162172|NCT00624780|530757055|FG003|Treatment Discontinuation (Week 25)|Lost to Follow-up|0|||
147162173|NCT00624780|530757056|FG004|Treatment Discontinuation (Week 25)|Lost to Follow-up|0|||
147162174|NCT00624780|530757057|FG005|Treatment Discontinuation (Week 25)|Lost to Follow-up|0|||
147162175|NCT00624780|530757052|FG000|Follow-up (Week 26)|Death|0|||
147162176|NCT00624780|530757053|FG001|Follow-up (Week 26)|Death|0|||
147587956|NCT01198873|532305607|FG000|Overall Study|Other than above|4|||
147587957|NCT01198873|532305608|FG001|Overall Study|Other than above|2|||
147587958|NCT04569786|532305609|FG000|Overall Study|Lost to Follow-up|1|||
147162177|NCT00624780|530757054|FG002|Follow-up (Week 26)|Death|1|||
147162178|NCT00624780|530757055|FG003|Follow-up (Week 26)|Death|0|||
147322726|NCT00783718|531345460|FG005|Induction Phase|Withdrawal by Subject|0|||
147587959|NCT04569786|532305610|FG001|Overall Study|Lost to Follow-up|0|||
147587960|NCT04569786|532305611|FG002|Overall Study|Lost to Follow-up|4|||
147587961|NCT04569786|532305612|FG003|Overall Study|Lost to Follow-up|1|||
147654440|NCT03853291|532556726|FG000|Overall Study|Determined to be ineligible|1|||
147162179|NCT00624780|530757056|FG004|Follow-up (Week 26)|Death|0|||
147162180|NCT00624780|530757057|FG005|Follow-up (Week 26)|Death|0|||
147162181|NCT00624780|530757052|FG000|Follow-up (Week 26)|Adverse Event|0|||
147162182|NCT00624780|530757053|FG001|Follow-up (Week 26)|Adverse Event|0|||
147162183|NCT00624780|530757054|FG002|Follow-up (Week 26)|Adverse Event|0|||
147162184|NCT00624780|530757055|FG003|Follow-up (Week 26)|Adverse Event|0|||
147162185|NCT00624780|530757056|FG004|Follow-up (Week 26)|Adverse Event|1|||
147162186|NCT00624780|530757057|FG005|Follow-up (Week 26)|Adverse Event|0|||
147162187|NCT00624780|530757052|FG000|Follow-up (Week 26)|Lost to Follow-up|0|||
147162188|NCT00624780|530757053|FG001|Follow-up (Week 26)|Lost to Follow-up|0|||
147162189|NCT00624780|530757054|FG002|Follow-up (Week 26)|Lost to Follow-up|1|||
147162190|NCT00624780|530757055|FG003|Follow-up (Week 26)|Lost to Follow-up|0|||
147162191|NCT00624780|530757056|FG004|Follow-up (Week 26)|Lost to Follow-up|1|||
147162192|NCT00624780|530757057|FG005|Follow-up (Week 26)|Lost to Follow-up|0|||
147242364|NCT03095066|531059611|FG002|Stage 2 (Week 7 to Week 12)|Protocol Deviation|0|||
147162193|NCT00624780|530757052|FG000|Follow-up (Week 26)|Withdrawal by Subject|1|||
147242365|NCT03095066|531059612|FG003|Stage 2 (Week 7 to Week 12)|Protocol Deviation|0|||
147242366|NCT03095066|531059613|FG004|Stage 2 (Week 7 to Week 12)|Protocol Deviation|1|||
147242367|NCT03095066|531059614|FG005|Stage 2 (Week 7 to Week 12)|Protocol Deviation|0|||
147242368|NCT03095066|531059615|FG006|Stage 2 (Week 7 to Week 12)|Protocol Deviation|0|||
147242369|NCT03095066|531059616|FG007|Stage 2 (Week 7 to Week 12)|Protocol Deviation|2|||
147242370|NCT03095066|531059609|FG000|Stage 2 (Week 7 to Week 12)|Withdrawal by Subject|0|||
147242371|NCT03095066|531059610|FG001|Stage 2 (Week 7 to Week 12)|Withdrawal by Subject|0|||
147242372|NCT03095066|531059611|FG002|Stage 2 (Week 7 to Week 12)|Withdrawal by Subject|0|||
147242373|NCT03095066|531059612|FG003|Stage 2 (Week 7 to Week 12)|Withdrawal by Subject|0|||
147242374|NCT03095066|531059613|FG004|Stage 2 (Week 7 to Week 12)|Withdrawal by Subject|2|||
147242375|NCT03095066|531059614|FG005|Stage 2 (Week 7 to Week 12)|Withdrawal by Subject|0|||
147242376|NCT03095066|531059615|FG006|Stage 2 (Week 7 to Week 12)|Withdrawal by Subject|0|||
147242377|NCT03095066|531059616|FG007|Stage 2 (Week 7 to Week 12)|Withdrawal by Subject|1|||
147242378|NCT03095066|531059609|FG000|Stage 2 (Week 7 to Week 12)|Reason Not Specified|0|||
147242379|NCT03095066|531059610|FG001|Stage 2 (Week 7 to Week 12)|Reason Not Specified|0|||
147242380|NCT03095066|531059611|FG002|Stage 2 (Week 7 to Week 12)|Reason Not Specified|0|||
147242381|NCT03095066|531059612|FG003|Stage 2 (Week 7 to Week 12)|Reason Not Specified|2|||
147242382|NCT03095066|531059613|FG004|Stage 2 (Week 7 to Week 12)|Reason Not Specified|0|||
147242383|NCT03095066|531059614|FG005|Stage 2 (Week 7 to Week 12)|Reason Not Specified|1|||
147242384|NCT03095066|531059615|FG006|Stage 2 (Week 7 to Week 12)|Reason Not Specified|0|||
147242385|NCT03095066|531059616|FG007|Stage 2 (Week 7 to Week 12)|Reason Not Specified|0|||
147242386|NCT01976338|531059621|FG000|Overall Study|Physician Decision|0|||
147242387|NCT01976338|531059622|FG001|Overall Study|Physician Decision|1|||
147242388|NCT01976338|531059621|FG000|Overall Study|Lost to Follow-up|3|||
147242389|NCT01976338|531059622|FG001|Overall Study|Lost to Follow-up|0|||
147242390|NCT01976338|531059621|FG000|Overall Study|Withdrawal by Subject|5|||
147242391|NCT01976338|531059622|FG001|Overall Study|Withdrawal by Subject|2|||
147242392|NCT01976338|531059621|FG000|Overall Study|Adverse Event|5|||
147242393|NCT01976338|531059622|FG001|Overall Study|Adverse Event|1|||
147242394|NCT02853604|531059623|FG000|Overall Study|Withdrawal by Subject|12|||
147242395|NCT02853604|531059624|FG001|Overall Study|Withdrawal by Subject|35|||
147242396|NCT02853604|531059623|FG000|Overall Study|Lost to Follow-up|4|||
147242397|NCT02853604|531059624|FG001|Overall Study|Lost to Follow-up|8|||
147242398|NCT02853604|531059623|FG000|Overall Study|Death|1|||
147242399|NCT02853604|531059624|FG001|Overall Study|Death|5|||
147242400|NCT02853604|531059623|FG000|Overall Study|Miscellaneous|11|||
147242401|NCT02853604|531059624|FG001|Overall Study|Miscellaneous|2|||
147242402|NCT02853604|531059623|FG000|Overall Study|Progressive Disease|0|||
147242403|NCT02853604|531059624|FG001|Overall Study|Progressive Disease|2|||
147242404|NCT03766581|531059625|FG000|Randomization|Other reasons|2|||
147242405|NCT03766581|531059626|FG001|Randomization|Other reasons|1|||
147242406|NCT03766581|531059627|FG002|Randomization|Other reasons|0|||
147242407|NCT03766581|531059628|FG003|Randomization|Other reasons|1|||
147242408|NCT03766581|531059629|FG004|Randomization|Other reasons|0|||
147242409|NCT03766581|531059630|FG005|Randomization|Other reasons|0|||
147242410|NCT03766581|531059631|FG006|Randomization|Other reasons|0|||
147242411|NCT03766581|531059632|FG007|Randomization|Other reasons|0|||
147242412|NCT03766581|531059625|FG000|Randomization|Participant no longer meets study criteria|5|||
147242413|NCT03766581|531059626|FG001|Randomization|Participant no longer meets study criteria|3|||
147242414|NCT03766581|531059627|FG002|Randomization|Participant no longer meets study criteria|4|||
147242415|NCT03766581|531059628|FG003|Randomization|Participant no longer meets study criteria|0|||
147242416|NCT03766581|531059629|FG004|Randomization|Participant no longer meets study criteria|2|||
147242417|NCT03766581|531059630|FG005|Randomization|Participant no longer meets study criteria|3|||
147162194|NCT00624780|530757053|FG001|Follow-up (Week 26)|Withdrawal by Subject|0|||
147322727|NCT00783718|531345461|FG006|Induction Phase|Withdrawal by Subject|0|||
147162195|NCT00624780|530757054|FG002|Follow-up (Week 26)|Withdrawal by Subject|0|||
147162196|NCT00624780|530757055|FG003|Follow-up (Week 26)|Withdrawal by Subject|0|||
147162197|NCT00624780|530757056|FG004|Follow-up (Week 26)|Withdrawal by Subject|0|||
147242418|NCT03766581|531059631|FG006|Randomization|Participant no longer meets study criteria|0|||
147162198|NCT00624780|530757057|FG005|Follow-up (Week 26)|Withdrawal by Subject|0|||
147162199|NCT00624780|530757052|FG000|Follow-up (Week 26)|Other|1|||
147162200|NCT00624780|530757053|FG001|Follow-up (Week 26)|Other|1|||
147162201|NCT00624780|530757054|FG002|Follow-up (Week 26)|Other|0|||
147162202|NCT00624780|530757055|FG003|Follow-up (Week 26)|Other|0|||
147162203|NCT00624780|530757056|FG004|Follow-up (Week 26)|Other|0|||
147162204|NCT00624780|530757057|FG005|Follow-up (Week 26)|Other|0|||
147162205|NCT04068519|530757058|FG000|Dose Verification|Death|15|||
147162206|NCT04068519|530757058|FG000|Dose Verification|Withdrawal by Subject|1|||
147162207|NCT04068519|530757058|FG000|Pharmacokinetic Sub-study|Death|35|||
147162208|NCT04068519|530757058|FG000|Pharmacokinetic Sub-study|Withdrawal by Subject|1|||
147162209|NCT04068519|530757058|FG000|Pharmacokinetic Sub-study|Lost to Follow-up|4|||
147162210|NCT04068519|530757058|FG000|Pharmacokinetic Sub-study|Other not specified|1|||
147162211|NCT04068519|530757058|FG000|Indication Expansion|Death|152|||
147162212|NCT04068519|530757058|FG000|Indication Expansion|Withdrawal by Subject|10|||
147162213|NCT04068519|530757058|FG000|Indication Expansion|Lost to Follow-up|7|||
147162214|NCT00969761|530757059|FG000|Discont. Before Start of Treat. Cycle 2|Progressive Disease|1|||
147162215|NCT00969761|530757060|FG001|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
147162216|NCT00969761|530757061|FG002|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
147162217|NCT00969761|530757062|FG003|Discont. Before Start of Treat. Cycle 2|Progressive Disease|1|||
147162218|NCT00969761|530757063|FG004|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
147162219|NCT00969761|530757064|FG005|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
147162220|NCT00969761|530757065|FG006|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
147322728|NCT00783718|531345455|FG000|Induction Phase|Lost to Follow-up|1|||
147322729|NCT00783718|531345456|FG001|Induction Phase|Lost to Follow-up|0|||
147322730|NCT00783718|531345457|FG002|Induction Phase|Lost to Follow-up|1|||
147322731|NCT00783718|531345458|FG003|Induction Phase|Lost to Follow-up|0|||
147322732|NCT00783718|531345459|FG004|Induction Phase|Lost to Follow-up|0|||
147322733|NCT00783718|531345460|FG005|Induction Phase|Lost to Follow-up|0|||
147322734|NCT00783718|531345461|FG006|Induction Phase|Lost to Follow-up|0|||
147322735|NCT00783718|531345455|FG000|Maintenance Phase|Adverse Event|12|||
147322736|NCT00783718|531345456|FG001|Maintenance Phase|Adverse Event|0|||
147322737|NCT00783718|531345457|FG002|Maintenance Phase|Adverse Event|0|||
147322738|NCT00783718|531345458|FG003|Maintenance Phase|Adverse Event|15|||
147322739|NCT00783718|531345459|FG004|Maintenance Phase|Adverse Event|7|||
147322740|NCT00783718|531345460|FG005|Maintenance Phase|Adverse Event|6|||
147322741|NCT00783718|531345461|FG006|Maintenance Phase|Adverse Event|16|||
147322742|NCT00783718|531345455|FG000|Maintenance Phase|Protocol Violation|1|||
147322743|NCT00783718|531345456|FG001|Maintenance Phase|Protocol Violation|0|||
147322744|NCT00783718|531345457|FG002|Maintenance Phase|Protocol Violation|0|||
147322745|NCT00783718|531345458|FG003|Maintenance Phase|Protocol Violation|0|||
147322746|NCT00783718|531345459|FG004|Maintenance Phase|Protocol Violation|0|||
147322747|NCT00783718|531345460|FG005|Maintenance Phase|Protocol Violation|0|||
147322748|NCT00783718|531345461|FG006|Maintenance Phase|Protocol Violation|2|||
147322749|NCT00783718|531345455|FG000|Maintenance Phase|Lack of Efficacy|83|||
147322750|NCT00783718|531345456|FG001|Maintenance Phase|Lack of Efficacy|0|||
147322751|NCT00783718|531345457|FG002|Maintenance Phase|Lack of Efficacy|0|||
147322752|NCT00783718|531345458|FG003|Maintenance Phase|Lack of Efficacy|61|||
147322753|NCT00783718|531345459|FG004|Maintenance Phase|Lack of Efficacy|31|||
147322754|NCT00783718|531345460|FG005|Maintenance Phase|Lack of Efficacy|33|||
147322755|NCT00783718|531345461|FG006|Maintenance Phase|Lack of Efficacy|155|||
147322756|NCT00783718|531345455|FG000|Maintenance Phase|Withdrawal by Subject|6|||
147322757|NCT00783718|531345456|FG001|Maintenance Phase|Withdrawal by Subject|0|||
147322758|NCT00783718|531345457|FG002|Maintenance Phase|Withdrawal by Subject|0|||
147322759|NCT00783718|531345458|FG003|Maintenance Phase|Withdrawal by Subject|2|||
147322760|NCT00783718|531345459|FG004|Maintenance Phase|Withdrawal by Subject|5|||
147322761|NCT00783718|531345460|FG005|Maintenance Phase|Withdrawal by Subject|2|||
147322762|NCT00783718|531345461|FG006|Maintenance Phase|Withdrawal by Subject|20|||
147322763|NCT00783718|531345455|FG000|Maintenance Phase|Lost to Follow-up|3|||
147322764|NCT00783718|531345456|FG001|Maintenance Phase|Lost to Follow-up|0|||
147322765|NCT00783718|531345457|FG002|Maintenance Phase|Lost to Follow-up|0|||
147322766|NCT00783718|531345458|FG003|Maintenance Phase|Lost to Follow-up|0|||
147162221|NCT00969761|530757066|FG007|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
147162222|NCT00969761|530757067|FG008|Discont. Before Start of Treat. Cycle 2|Progressive Disease|1|||
147162223|NCT00969761|530757068|FG009|Discont. Before Start of Treat. Cycle 2|Progressive Disease|1|||
147322767|NCT00783718|531345459|FG004|Maintenance Phase|Lost to Follow-up|2|||
147322768|NCT00783718|531345460|FG005|Maintenance Phase|Lost to Follow-up|0|||
147322769|NCT00783718|531345461|FG006|Maintenance Phase|Lost to Follow-up|2|||
147322770|NCT01027871|531345463|FG000|Overall Study|Physician Decision|1|||
147654441|NCT03853291|532556727|FG001|Overall Study|Determined to be ineligible|1|||
147162224|NCT00969761|530757069|FG010|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
147322771|NCT01027871|531345464|FG001|Overall Study|Physician Decision|5|||
147322772|NCT01027871|531345465|FG002|Overall Study|Physician Decision|0|||
147322773|NCT01027871|531345463|FG000|Overall Study|Protocol Violation|0|||
147322774|NCT01027871|531345464|FG001|Overall Study|Protocol Violation|2|||
147447316|NCT03882970|531802107|FG002|Overall Study|Withdrawal by Subject|7|||
147162225|NCT00969761|530757070|FG011|Discont. Before Start of Treat. Cycle 2|Progressive Disease|0|||
147162226|NCT00969761|530757059|FG000|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
147162227|NCT00969761|530757060|FG001|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
147162228|NCT00969761|530757061|FG002|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|1|||
147162229|NCT00969761|530757062|FG003|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
147162230|NCT00969761|530757063|FG004|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
147162231|NCT00969761|530757064|FG005|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
147162232|NCT00969761|530757065|FG006|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
147162233|NCT00969761|530757066|FG007|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
147162234|NCT00969761|530757067|FG008|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
147162235|NCT00969761|530757068|FG009|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
147162236|NCT00969761|530757069|FG010|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
147162237|NCT00969761|530757070|FG011|Discont. Before Start of Treat. Cycle 2|Dose Limiting Toxicity (DLT)|0|||
147162238|NCT00969761|530757059|FG000|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
147162239|NCT00969761|530757060|FG001|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
147162240|NCT00969761|530757061|FG002|Discont. Before Start of Treat. Cycle 2|Other adverse events|1|||
147162241|NCT00969761|530757062|FG003|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
147162242|NCT00969761|530757063|FG004|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
147162243|NCT00969761|530757064|FG005|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
147162244|NCT00969761|530757065|FG006|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
147162245|NCT00969761|530757066|FG007|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
147162246|NCT00969761|530757067|FG008|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
147162247|NCT00969761|530757068|FG009|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
147162248|NCT00969761|530757069|FG010|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
147162249|NCT00969761|530757070|FG011|Discont. Before Start of Treat. Cycle 2|Other adverse events|0|||
147162250|NCT00969761|530757059|FG000|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
147162251|NCT00969761|530757060|FG001|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
147162252|NCT00969761|530757061|FG002|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
147162253|NCT00969761|530757062|FG003|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
147162254|NCT00969761|530757063|FG004|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
147162255|NCT00969761|530757064|FG005|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
147447317|NCT03882970|531802108|FG003|Overall Study|Withdrawal by Subject|22|||
147447318|NCT03882970|531802105|FG000|Overall Study|Personal Reason|2|||
147447319|NCT03882970|531802106|FG001|Overall Study|Personal Reason|3|||
147447320|NCT03882970|531802107|FG002|Overall Study|Personal Reason|1|||
147447321|NCT03882970|531802108|FG003|Overall Study|Personal Reason|3|||
147447322|NCT02863809|531802122|FG000|Overall Study|Adverse Event|8|||
147162256|NCT00969761|530757065|FG006|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
147162257|NCT00969761|530757066|FG007|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
147162258|NCT00969761|530757067|FG008|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|1|||
147162259|NCT00969761|530757068|FG009|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
147162260|NCT00969761|530757069|FG010|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
147447323|NCT02863809|531802123|FG001|Overall Study|Adverse Event|8|||
147447324|NCT02863809|531802122|FG000|Overall Study|Withdrawal by Subject|0|||
147447325|NCT02863809|531802123|FG001|Overall Study|Withdrawal by Subject|1|||
147447326|NCT02863809|531802122|FG000|Overall Study|Lost to Follow-up|1|||
147447327|NCT02863809|531802123|FG001|Overall Study|Lost to Follow-up|1|||
147447328|NCT02863809|531802122|FG000|Overall Study|Death|1|||
147447329|NCT02863809|531802123|FG001|Overall Study|Death|0|||
147587962|NCT04569786|532305613|FG004|Overall Study|Lost to Follow-up|0|||
147162261|NCT00969761|530757070|FG011|Discont. Before Start of Treat. Cycle 2|Withdrawal by Subject|0|||
147162262|NCT00969761|530757059|FG000|Treated in and Beyond Treat. Cycle 2|Progressive disease|2|||
147162263|NCT00969761|530757060|FG001|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
147162264|NCT00969761|530757061|FG002|Treated in and Beyond Treat. Cycle 2|Progressive disease|10|||
147162265|NCT00969761|530757062|FG003|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
147447330|NCT00607386|531802124|FG000|Overall Study|Physician Decision|1|||
147447331|NCT01439204|531802129|FG000|Overall Study|Withdrawal by Subject|0|||
147447332|NCT01439204|531802130|FG001|Overall Study|Withdrawal by Subject|1|||
147587963|NCT04569786|532305609|FG000|Overall Study|Withdrawal by Subject|0|||
147447333|NCT01439204|531802129|FG000|Overall Study|Lost to Follow-up|0|||
147587964|NCT04569786|532305610|FG001|Overall Study|Withdrawal by Subject|0|||
147587965|NCT04569786|532305611|FG002|Overall Study|Withdrawal by Subject|0|||
147447334|NCT01439204|531802130|FG001|Overall Study|Lost to Follow-up|2|||
147447335|NCT01439204|531802129|FG000|Overall Study|No longer meets study criteria|1|||
147587966|NCT04569786|532305612|FG003|Overall Study|Withdrawal by Subject|5|||
147587967|NCT04569786|532305613|FG004|Overall Study|Withdrawal by Subject|1|||
147447336|NCT01439204|531802130|FG001|Overall Study|No longer meets study criteria|0|||
147447337|NCT01439204|531802129|FG000|Overall Study|poor/non-compliance|3|||
147447338|NCT01439204|531802130|FG001|Overall Study|poor/non-compliance|0|||
147447339|NCT01227044|531802134|FG000|Overall Study|Lost to Follow-up|5|||
147447340|NCT01227044|531802135|FG001|Overall Study|Lost to Follow-up|7|||
147447341|NCT01227044|531802134|FG000|Overall Study|Discontinued Intervention|1|||
147447342|NCT01227044|531802135|FG001|Overall Study|Discontinued Intervention|2|||
147447343|NCT04247061|531802136|FG000|Overall Study|Could not attend dental clinic visit due to state mandated closure due to Covid-19 pandemic|6|||
147447344|NCT04247061|531802136|FG000|Overall Study|Subjects canceled their dental hygiene appt. (& thus the research visit) due to Covid-19 concerns|2|||
147447345|NCT04247061|531802136|FG000|Overall Study|Participant indicated inability to wear VR headset at dental appt.|1|||
147447346|NCT00205855|531802147|FG000|Overall Study|Only received temporary implants|16|||
147447347|NCT00205855|531802147|FG000|Overall Study|Withdrawal by Subject|5|||
147447348|NCT05513625|531802148|FG000|Overall Study|Withdrawal by Subject|1|||
147447349|NCT01073267|531802152|FG000|Overall Study|Disease Progression|3|||
147447350|NCT00917150|531802157|FG000|Overall Study|Adverse Event|12|||
147447351|NCT00917150|531802158|FG001|Overall Study|Adverse Event|7|||
147447352|NCT00917150|531802159|FG002|Overall Study|Adverse Event|12|||
147447353|NCT00917150|531802160|FG003|Overall Study|Adverse Event|11|||
147447354|NCT00917150|531802157|FG000|Overall Study|Death|1|||
147447355|NCT00917150|531802158|FG001|Overall Study|Death|4|||
147447356|NCT00917150|531802159|FG002|Overall Study|Death|3|||
147447357|NCT00917150|531802160|FG003|Overall Study|Death|2|||
147447358|NCT00917150|531802157|FG000|Overall Study|Lost to Follow-up|1|||
147447359|NCT00917150|531802158|FG001|Overall Study|Lost to Follow-up|0|||
147447360|NCT00917150|531802159|FG002|Overall Study|Lost to Follow-up|4|||
147447361|NCT00917150|531802160|FG003|Overall Study|Lost to Follow-up|2|||
147447362|NCT00917150|531802157|FG000|Overall Study|Physician Decision|0|||
147447363|NCT00917150|531802158|FG001|Overall Study|Physician Decision|2|||
147447364|NCT00917150|531802159|FG002|Overall Study|Physician Decision|0|||
147447365|NCT00917150|531802160|FG003|Overall Study|Physician Decision|1|||
147447366|NCT00917150|531802157|FG000|Overall Study|Protocol Violation|5|||
147447367|NCT00917150|531802158|FG001|Overall Study|Protocol Violation|5|||
147447368|NCT00917150|531802159|FG002|Overall Study|Protocol Violation|3|||
147447369|NCT00917150|531802160|FG003|Overall Study|Protocol Violation|5|||
147447370|NCT00917150|531802157|FG000|Overall Study|Withdrawal by Subject|15|||
147447371|NCT00917150|531802158|FG001|Overall Study|Withdrawal by Subject|16|||
147447372|NCT00917150|531802159|FG002|Overall Study|Withdrawal by Subject|18|||
147447373|NCT00917150|531802160|FG003|Overall Study|Withdrawal by Subject|11|||
147447374|NCT00917150|531802157|FG000|Overall Study|Other than specified|3|||
147447375|NCT00917150|531802158|FG001|Overall Study|Other than specified|3|||
147447376|NCT00917150|531802159|FG002|Overall Study|Other than specified|2|||
147447377|NCT00917150|531802160|FG003|Overall Study|Other than specified|2|||
147447378|NCT02039375|531802161|FG000|Overall Study|Lost to Follow-up|2|||
147447379|NCT03891264|531802162|FG000|Overall Study|Adverse Event|1|||
147447380|NCT03891264|531802162|FG000|Overall Study|Withdrawal by Subject|2|||
147447381|NCT03891264|531802162|FG000|Overall Study|Physician Decision|2|||
147447382|NCT01505634|531802163|FG000|Overall Study|Withdrawal by Subject|2|||
147447383|NCT01505634|531802164|FG001|Overall Study|Withdrawal by Subject|5|||
147447384|NCT01505634|531802165|FG002|Overall Study|Withdrawal by Subject|1|||
147447385|NCT01505634|531802163|FG000|Overall Study|Physician Decision|1|||
147447386|NCT01505634|531802164|FG001|Overall Study|Physician Decision|1|||
147447387|NCT01505634|531802165|FG002|Overall Study|Physician Decision|0|||
147447388|NCT01505634|531802163|FG000|Overall Study|Adverse Event|1|||
147447389|NCT01505634|531802164|FG001|Overall Study|Adverse Event|0|||
147447390|NCT01505634|531802165|FG002|Overall Study|Adverse Event|0|||
147447391|NCT01505634|531802163|FG000|Overall Study|Insufficient supply of drug at site|1|||
147447392|NCT01505634|531802164|FG001|Overall Study|Insufficient supply of drug at site|0|||
147447393|NCT01505634|531802165|FG002|Overall Study|Insufficient supply of drug at site|0|||
147447394|NCT01505634|531802163|FG000|Overall Study|Protocol Violation|2|||
147447395|NCT01505634|531802164|FG001|Overall Study|Protocol Violation|0|||
147447396|NCT01505634|531802165|FG002|Overall Study|Protocol Violation|0|||
147447397|NCT01505634|531802163|FG000|Overall Study|Lost to Follow-up|1|||
147447398|NCT01505634|531802164|FG001|Overall Study|Lost to Follow-up|4|||
147447399|NCT01505634|531802165|FG002|Overall Study|Lost to Follow-up|4|||
147447400|NCT01505634|531802163|FG000|Overall Study|Death|1|||
147447401|NCT01505634|531802164|FG001|Overall Study|Death|0|||
147447402|NCT01505634|531802165|FG002|Overall Study|Death|0|||
147447403|NCT01505634|531802163|FG000|Overall Study|In a conflict zone|0|||
147447404|NCT01505634|531802164|FG001|Overall Study|In a conflict zone|0|||
147447405|NCT01505634|531802165|FG002|Overall Study|In a conflict zone|1|||
147447406|NCT01624662|531802169|FG000|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|2|||
147447407|NCT01624662|531802170|FG001|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|1|||
147447408|NCT01624662|531802171|FG002|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|1|||
147447409|NCT01624662|531802172|FG003|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|0|||
147447410|NCT01624662|531802169|FG000|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|5|||
147447411|NCT01624662|531802170|FG001|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|1|||
147162266|NCT00969761|530757063|FG004|Treated in and Beyond Treat. Cycle 2|Progressive disease|2|||
147162267|NCT00969761|530757064|FG005|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
147162268|NCT00969761|530757065|FG006|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
147162269|NCT00969761|530757066|FG007|Treated in and Beyond Treat. Cycle 2|Progressive disease|6|||
147162270|NCT00969761|530757067|FG008|Treated in and Beyond Treat. Cycle 2|Progressive disease|9|||
147162271|NCT00969761|530757068|FG009|Treated in and Beyond Treat. Cycle 2|Progressive disease|2|||
147162272|NCT00969761|530757069|FG010|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
147162273|NCT00969761|530757070|FG011|Treated in and Beyond Treat. Cycle 2|Progressive disease|3|||
147162274|NCT00969761|530757059|FG000|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
147162275|NCT00969761|530757060|FG001|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
147162276|NCT00969761|530757061|FG002|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
147242419|NCT03766581|531059632|FG007|Randomization|Participant no longer meets study criteria|1|||
147242420|NCT03766581|531059625|FG000|Randomization|Participant request to discontinue study treatment|1|||
147242421|NCT03766581|531059626|FG001|Randomization|Participant request to discontinue study treatment|0|||
147242422|NCT03766581|531059627|FG002|Randomization|Participant request to discontinue study treatment|0|||
147242423|NCT03766581|531059628|FG003|Randomization|Participant request to discontinue study treatment|0|||
147242424|NCT03766581|531059629|FG004|Randomization|Participant request to discontinue study treatment|1|||
147242425|NCT03766581|531059630|FG005|Randomization|Participant request to discontinue study treatment|2|||
147242426|NCT03766581|531059631|FG006|Randomization|Participant request to discontinue study treatment|0|||
147242427|NCT03766581|531059632|FG007|Randomization|Participant request to discontinue study treatment|0|||
147242428|NCT03766581|531059625|FG000|Randomization|Participant withdrew consent|1|||
147242429|NCT03766581|531059626|FG001|Randomization|Participant withdrew consent|0|||
147242430|NCT03766581|531059627|FG002|Randomization|Participant withdrew consent|1|||
147242431|NCT03766581|531059628|FG003|Randomization|Participant withdrew consent|2|||
147242432|NCT03766581|531059629|FG004|Randomization|Participant withdrew consent|1|||
147242433|NCT03766581|531059630|FG005|Randomization|Participant withdrew consent|1|||
147242434|NCT03766581|531059631|FG006|Randomization|Participant withdrew consent|0|||
147242435|NCT03766581|531059632|FG007|Randomization|Participant withdrew consent|0|||
147242436|NCT03766581|531059625|FG000|Treatment|Adverse Event|82|||
147242437|NCT03766581|531059626|FG001|Treatment|Adverse Event|44|||
147242438|NCT03766581|531059627|FG002|Treatment|Adverse Event|47|||
147242439|NCT03766581|531059628|FG003|Treatment|Adverse Event|46|||
147242440|NCT03766581|531059629|FG004|Treatment|Adverse Event|50|||
147242441|NCT03766581|531059630|FG005|Treatment|Adverse Event|77|||
147242442|NCT03766581|531059631|FG006|Treatment|Adverse Event|5|||
147242443|NCT03766581|531059632|FG007|Treatment|Adverse Event|2|||
147242444|NCT03766581|531059625|FG000|Treatment|Participant request to discontinue treatment|34|||
147242445|NCT03766581|531059626|FG001|Treatment|Participant request to discontinue treatment|6|||
147242446|NCT03766581|531059627|FG002|Treatment|Participant request to discontinue treatment|10|||
147242447|NCT03766581|531059628|FG003|Treatment|Participant request to discontinue treatment|10|||
147242448|NCT03766581|531059629|FG004|Treatment|Participant request to discontinue treatment|14|||
147242449|NCT03766581|531059630|FG005|Treatment|Participant request to discontinue treatment|15|||
147242450|NCT03766581|531059631|FG006|Treatment|Participant request to discontinue treatment|0|||
147242451|NCT03766581|531059632|FG007|Treatment|Participant request to discontinue treatment|1|||
147242452|NCT03766581|531059625|FG000|Treatment|Participant withdrew consent|11|||
147242453|NCT03766581|531059626|FG001|Treatment|Participant withdrew consent|4|||
147242454|NCT03766581|531059627|FG002|Treatment|Participant withdrew consent|5|||
147242455|NCT03766581|531059628|FG003|Treatment|Participant withdrew consent|5|||
147242456|NCT03766581|531059629|FG004|Treatment|Participant withdrew consent|4|||
147242457|NCT03766581|531059630|FG005|Treatment|Participant withdrew consent|4|||
147242458|NCT03766581|531059631|FG006|Treatment|Participant withdrew consent|0|||
147242459|NCT03766581|531059632|FG007|Treatment|Participant withdrew consent|0|||
147242460|NCT03766581|531059625|FG000|Treatment|Death|1|||
147242461|NCT03766581|531059626|FG001|Treatment|Death|0|||
147242462|NCT03766581|531059627|FG002|Treatment|Death|0|||
147242463|NCT03766581|531059628|FG003|Treatment|Death|0|||
147242464|NCT03766581|531059629|FG004|Treatment|Death|0|||
147242465|NCT03766581|531059630|FG005|Treatment|Death|0|||
147242466|NCT03766581|531059631|FG006|Treatment|Death|0|||
147242467|NCT03766581|531059632|FG007|Treatment|Death|0|||
147242468|NCT03766581|531059625|FG000|Treatment|Lost to Follow-up|1|||
147242469|NCT03766581|531059626|FG001|Treatment|Lost to Follow-up|0|||
147242470|NCT03766581|531059627|FG002|Treatment|Lost to Follow-up|0|||
147242471|NCT03766581|531059628|FG003|Treatment|Lost to Follow-up|1|||
147162277|NCT00969761|530757062|FG003|Treated in and Beyond Treat. Cycle 2|Other adverse events|2|||
147242472|NCT03766581|531059629|FG004|Treatment|Lost to Follow-up|0|||
147242473|NCT03766581|531059630|FG005|Treatment|Lost to Follow-up|0|||
147242474|NCT03766581|531059631|FG006|Treatment|Lost to Follow-up|0|||
147242475|NCT03766581|531059632|FG007|Treatment|Lost to Follow-up|0|||
147162278|NCT00969761|530757063|FG004|Treated in and Beyond Treat. Cycle 2|Other adverse events|1|||
147242476|NCT03766581|531059625|FG000|Treatment|Poor/Non compliance|2|||
147242477|NCT03766581|531059626|FG001|Treatment|Poor/Non compliance|2|||
147242478|NCT03766581|531059627|FG002|Treatment|Poor/Non compliance|1|||
147654442|NCT03853291|532556728|FG002|Overall Study|Determined to be ineligible|0|||
147654443|NCT03853291|532556729|FG003|Overall Study|Determined to be ineligible|0|||
147654444|NCT03853291|532556730|FG004|Overall Study|Determined to be ineligible|0|||
147654445|NCT03853291|532556731|FG005|Overall Study|Determined to be ineligible|0|||
147654446|NCT01658904|532556732|FG000|Overall Study|Principal Investigator discretion|2|||
147654447|NCT01658904|532556733|FG001|Overall Study|Principal Investigator discretion|0|||
147654448|NCT01658904|532556734|FG002|Overall Study|Principal Investigator discretion|0|||
147162279|NCT00969761|530757064|FG005|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
147162280|NCT00969761|530757065|FG006|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
147162281|NCT00969761|530757066|FG007|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
147162282|NCT00969761|530757067|FG008|Treated in and Beyond Treat. Cycle 2|Other adverse events|2|||
147162283|NCT00969761|530757068|FG009|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
147162284|NCT00969761|530757069|FG010|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
147162285|NCT00969761|530757070|FG011|Treated in and Beyond Treat. Cycle 2|Other adverse events|0|||
147162286|NCT03959982|530759048|FG000|Overall Study|Withdrawal by Subject|1|||
147162287|NCT03959982|530759049|FG001|Overall Study|Withdrawal by Subject|0|||
147162288|NCT03959982|530759048|FG000|Overall Study|Physician Decision|2|||
147162289|NCT03959982|530759049|FG001|Overall Study|Physician Decision|0|||
147162290|NCT03959982|530759048|FG000|Overall Study|Lost to Follow-up|1|||
147162291|NCT03959982|530759049|FG001|Overall Study|Lost to Follow-up|0|||
147162292|NCT00262847|530759050|FG000|Overall Study|Disease Progression|309|||
147162293|NCT00262847|530759051|FG001|Overall Study|Disease Progression|274|||
147162294|NCT00262847|530759052|FG002|Overall Study|Disease Progression|195|||
147162295|NCT00262847|530759050|FG000|Overall Study|Patient Refusal|41|||
147162296|NCT00262847|530759051|FG001|Overall Study|Patient Refusal|52|||
147162297|NCT00262847|530759052|FG002|Overall Study|Patient Refusal|47|||
147162298|NCT00262847|530759050|FG000|Overall Study|Adverse Event|74|||
147162299|NCT00262847|530759051|FG001|Overall Study|Adverse Event|88|||
147162300|NCT00262847|530759052|FG002|Overall Study|Adverse Event|108|||
147162301|NCT00262847|530759050|FG000|Overall Study|Death|8|||
147242479|NCT03766581|531059628|FG003|Treatment|Poor/Non compliance|1|||
147242480|NCT03766581|531059629|FG004|Treatment|Poor/Non compliance|1|||
147242481|NCT03766581|531059630|FG005|Treatment|Poor/Non compliance|1|||
147242482|NCT03766581|531059631|FG006|Treatment|Poor/Non compliance|0|||
147242483|NCT03766581|531059632|FG007|Treatment|Poor/Non compliance|0|||
147242484|NCT03766581|531059625|FG000|Treatment|Participant no longer meets study criteria|9|||
147242485|NCT03766581|531059626|FG001|Treatment|Participant no longer meets study criteria|1|||
147242486|NCT03766581|531059627|FG002|Treatment|Participant no longer meets study criteria|5|||
147242487|NCT03766581|531059628|FG003|Treatment|Participant no longer meets study criteria|4|||
147242488|NCT03766581|531059629|FG004|Treatment|Participant no longer meets study criteria|4|||
147242489|NCT03766581|531059630|FG005|Treatment|Participant no longer meets study criteria|4|||
147242490|NCT03766581|531059631|FG006|Treatment|Participant no longer meets study criteria|2|||
147242491|NCT03766581|531059632|FG007|Treatment|Participant no longer meets study criteria|0|||
147242492|NCT03766581|531059625|FG000|Treatment|Other reasons|13|||
147242493|NCT03766581|531059626|FG001|Treatment|Other reasons|8|||
147242494|NCT03766581|531059627|FG002|Treatment|Other reasons|3|||
147242495|NCT03766581|531059628|FG003|Treatment|Other reasons|7|||
147242496|NCT03766581|531059629|FG004|Treatment|Other reasons|3|||
147242497|NCT03766581|531059630|FG005|Treatment|Other reasons|3|||
147242498|NCT03766581|531059631|FG006|Treatment|Other reasons|0|||
147242499|NCT03766581|531059632|FG007|Treatment|Other reasons|0|||
147242500|NCT00520936|531059633|FG000|Overall Study|Physician Decision|0|||
147242501|NCT00520936|531059634|FG001|Overall Study|Physician Decision|2|||
147242502|NCT00520936|531059635|FG002|Overall Study|Physician Decision|1|||
147242503|NCT00520936|531059636|FG003|Overall Study|Physician Decision|0|||
147242504|NCT00520936|531059637|FG004|Overall Study|Physician Decision|0|||
147242505|NCT00520936|531059638|FG005|Overall Study|Physician Decision|0|||
147242506|NCT00520936|531059639|FG006|Overall Study|Physician Decision|0|||
147242507|NCT00520936|531059640|FG007|Overall Study|Physician Decision|0|||
147242508|NCT00520936|531059633|FG000|Overall Study|Withdrawal by Subject|0|||
147242509|NCT00520936|531059634|FG001|Overall Study|Withdrawal by Subject|0|||
147242510|NCT00520936|531059635|FG002|Overall Study|Withdrawal by Subject|0|||
147242511|NCT00520936|531059636|FG003|Overall Study|Withdrawal by Subject|0|||
147242512|NCT00520936|531059637|FG004|Overall Study|Withdrawal by Subject|0|||
147242513|NCT00520936|531059638|FG005|Overall Study|Withdrawal by Subject|0|||
147242514|NCT00520936|531059639|FG006|Overall Study|Withdrawal by Subject|0|||
147242515|NCT00520936|531059640|FG007|Overall Study|Withdrawal by Subject|1|||
147242516|NCT00520936|531059633|FG000|Overall Study|Toxicity Requiring Removal from Study|0|||
147242517|NCT00520936|531059634|FG001|Overall Study|Toxicity Requiring Removal from Study|1|||
147242518|NCT00520936|531059635|FG002|Overall Study|Toxicity Requiring Removal from Study|0|||
147242519|NCT00520936|531059636|FG003|Overall Study|Toxicity Requiring Removal from Study|0|||
147242520|NCT00520936|531059637|FG004|Overall Study|Toxicity Requiring Removal from Study|0|||
147242521|NCT00520936|531059638|FG005|Overall Study|Toxicity Requiring Removal from Study|0|||
147447412|NCT01624662|531802171|FG002|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|0|||
147654449|NCT03148067|532556736|FG000|Overall Study|Lost to Follow-up|3|||
147587968|NCT04569786|532305609|FG000|Overall Study|Physician Decision|0|||
147162302|NCT00262847|530759051|FG001|Overall Study|Death|8|||
147162303|NCT00262847|530759052|FG002|Overall Study|Death|11|||
147162304|NCT00262847|530759050|FG000|Overall Study|Concomitant disease|3|||
147162305|NCT00262847|530759051|FG001|Overall Study|Concomitant disease|2|||
147162306|NCT00262847|530759052|FG002|Overall Study|Concomitant disease|4|||
147162307|NCT00262847|530759050|FG000|Overall Study|Other Reasons|79|||
147162308|NCT00262847|530759051|FG001|Overall Study|Other Reasons|88|||
147162309|NCT00262847|530759052|FG002|Overall Study|Other Reasons|27|||
147162310|NCT00262847|530759050|FG000|Overall Study|Did not receive study treatment|4|||
147162311|NCT00262847|530759051|FG001|Overall Study|Did not receive study treatment|1|||
147162312|NCT00262847|530759052|FG002|Overall Study|Did not receive study treatment|4|||
147162313|NCT00758589|530759053|FG000|Overall Study|Adverse Event|3|||
147162314|NCT00758589|530759054|FG001|Overall Study|Adverse Event|2|||
147162315|NCT00758589|530759055|FG002|Overall Study|Adverse Event|5|||
147162316|NCT00758589|530759056|FG003|Overall Study|Adverse Event|4|||
147162317|NCT00758589|530759053|FG000|Overall Study|Withdrawal by Subject|0|||
147162318|NCT00758589|530759054|FG001|Overall Study|Withdrawal by Subject|1|||
147162319|NCT00758589|530759055|FG002|Overall Study|Withdrawal by Subject|1|||
147162320|NCT00758589|530759056|FG003|Overall Study|Withdrawal by Subject|1|||
147162321|NCT00758589|530759053|FG000|Overall Study|Palm stopped to work|0|||
147162322|NCT00758589|530759054|FG001|Overall Study|Palm stopped to work|0|||
147162323|NCT00758589|530759055|FG002|Overall Study|Palm stopped to work|0|||
147162324|NCT00758589|530759056|FG003|Overall Study|Palm stopped to work|1|||
147162325|NCT05013424|530759071|FG000|Overall Study|Lost to Follow-up|1|||
147162326|NCT05013424|530759072|FG001|Overall Study|Lost to Follow-up|1|||
147162327|NCT05013424|530759073|FG002|Overall Study|Lost to Follow-up|1|||
147162328|NCT05013424|530759071|FG000|Overall Study|Withdrawal by Subject|0|||
147162329|NCT05013424|530759072|FG001|Overall Study|Withdrawal by Subject|1|||
147162330|NCT05013424|530759073|FG002|Overall Study|Withdrawal by Subject|0|||
147162331|NCT04411420|530759074|FG000|Overall Study (All Participants)|Lost to Follow-up|350|||
147162332|NCT04411420|530759075|FG001|Overall Study (All Participants)|Lost to Follow-up|469|||
147162333|NCT04411420|530759074|FG000|Survey Subset|Lost to Follow-up|134|||
147162334|NCT04411420|530759075|FG001|Survey Subset|Lost to Follow-up|120|||
147162335|NCT00471887|530759081|FG000|Overall Study|Adverse Event|9|||
147162336|NCT05438602|530759082|FG000|Treatment (15 Days)|Adverse Event|2|||
147162337|NCT05438602|530759083|FG001|Treatment (15 Days)|Adverse Event|1|||
147162338|NCT05438602|530759084|FG002|Treatment (15 Days)|Adverse Event|3|||
147162339|NCT05438602|530759082|FG000|Treatment (15 Days)|No longer met eligibility criteria|0|||
147162340|NCT05438602|530759083|FG001|Treatment (15 Days)|No longer met eligibility criteria|1|||
147162341|NCT05438602|530759084|FG002|Treatment (15 Days)|No longer met eligibility criteria|0|||
147162342|NCT05438602|530759082|FG000|Treatment (15 Days)|Other|0|||
147162343|NCT05438602|530759083|FG001|Treatment (15 Days)|Other|0|||
147162344|NCT05438602|530759084|FG002|Treatment (15 Days)|Other|1|||
147162345|NCT05438602|530759082|FG000|Treatment (15 Days)|Withdrawal by Subject|2|||
147162346|NCT05438602|530759083|FG001|Treatment (15 Days)|Withdrawal by Subject|1|||
147162347|NCT05438602|530759084|FG002|Treatment (15 Days)|Withdrawal by Subject|4|||
147162348|NCT05438602|530759082|FG000|Follow-up (Through Day 44)|Adverse Event|1|||
147162349|NCT05438602|530759083|FG001|Follow-up (Through Day 44)|Adverse Event|0|||
147162350|NCT05438602|530759084|FG002|Follow-up (Through Day 44)|Adverse Event|0|||
147162351|NCT05438602|530759082|FG000|Follow-up (Through Day 44)|Withdrawal by Subject|3|||
147162352|NCT05438602|530759083|FG001|Follow-up (Through Day 44)|Withdrawal by Subject|2|||
147162353|NCT05438602|530759084|FG002|Follow-up (Through Day 44)|Withdrawal by Subject|6|||
147162354|NCT05438602|530759082|FG000|Long-term Follow-up (Through Week 24)|Other|1|||
147162355|NCT05438602|530759083|FG001|Long-term Follow-up (Through Week 24)|Other|0|||
147162356|NCT05438602|530759084|FG002|Long-term Follow-up (Through Week 24)|Other|0|||
147162357|NCT05438602|530759082|FG000|Long-term Follow-up (Through Week 24)|Lost to Follow-up|1|||
147162358|NCT05438602|530759083|FG001|Long-term Follow-up (Through Week 24)|Lost to Follow-up|0|||
147162359|NCT05438602|530759084|FG002|Long-term Follow-up (Through Week 24)|Lost to Follow-up|0|||
147162360|NCT05438602|530759082|FG000|Long-term Follow-up (Through Week 24)|Death|1|||
147162361|NCT05438602|530759083|FG001|Long-term Follow-up (Through Week 24)|Death|0|||
147162362|NCT05438602|530759084|FG002|Long-term Follow-up (Through Week 24)|Death|1|||
147162363|NCT05438602|530759082|FG000|Long-term Follow-up (Through Week 24)|Withdrawal by Subject|4|||
147162364|NCT05438602|530759083|FG001|Long-term Follow-up (Through Week 24)|Withdrawal by Subject|5|||
147162365|NCT05438602|530759084|FG002|Long-term Follow-up (Through Week 24)|Withdrawal by Subject|6|||
147162366|NCT02091284|530759085|FG000|Overall Study|Withdrawal by Subject|2|||
147162367|NCT02091284|530759086|FG001|Overall Study|Withdrawal by Subject|1|||
147162368|NCT02091284|530759085|FG000|Overall Study|unreliable data|1|||
147162369|NCT02091284|530759086|FG001|Overall Study|unreliable data|0|||
147162370|NCT04524455|530759091|FG000|Overall Study|Death|3|||
147162371|NCT04524455|530759092|FG001|Overall Study|Death|3|||
147162372|NCT04524455|530759091|FG000|Overall Study|Decision by Sponsor|0|||
147162373|NCT04524455|530759092|FG001|Overall Study|Decision by Sponsor|2|||
147162374|NCT04524455|530759091|FG000|Overall Study|Withdrawal of Consent From Study|1|||
147162375|NCT04524455|530759092|FG001|Overall Study|Withdrawal of Consent From Study|0|||
147587969|NCT04569786|532305610|FG001|Overall Study|Physician Decision|0|||
147587970|NCT04569786|532305611|FG002|Overall Study|Physician Decision|0|||
147162376|NCT04524455|530759091|FG000|Overall Study|Lost to Follow-up|0|||
147162377|NCT04524455|530759092|FG001|Overall Study|Lost to Follow-up|1|||
147162378|NCT00076336|530759095|FG000|Overall Study|Death|13|||
147162379|NCT00076336|530759096|FG001|Overall Study|Death|17|||
147162380|NCT00076336|530759095|FG000|Overall Study|Adverse Event|4|||
147162381|NCT00076336|530759096|FG001|Overall Study|Adverse Event|4|||
147162382|NCT00076336|530759095|FG000|Overall Study|Lost to Follow-up|4|||
147162383|NCT00076336|530759096|FG001|Overall Study|Lost to Follow-up|4|||
147162384|NCT00076336|530759095|FG000|Overall Study|Non-Compliance|2|||
147162385|NCT00076336|530759096|FG001|Overall Study|Non-Compliance|0|||
147162386|NCT00076336|530759095|FG000|Overall Study|Creatinine Clearance < 30 or Dialysis|0|||
147587971|NCT04569786|532305612|FG003|Overall Study|Physician Decision|1|||
147587972|NCT04569786|532305613|FG004|Overall Study|Physician Decision|0|||
147162387|NCT00076336|530759096|FG001|Overall Study|Creatinine Clearance < 30 or Dialysis|1|||
147162388|NCT00076336|530759095|FG000|Overall Study|Patient, Investigator, Sponsor request|8|||
147162389|NCT00076336|530759096|FG001|Overall Study|Patient, Investigator, Sponsor request|6|||
147162390|NCT00076336|530759095|FG000|Overall Study|Liver Transplantation|3|||
147587973|NCT02692482|532305614|FG000|Overall Study|Death|2|||
147587974|NCT02692482|532305615|FG001|Overall Study|Death|2|||
147587975|NCT02692482|532305614|FG000|Overall Study|Withdrawal by Subject|1|||
147587976|NCT02692482|532305615|FG001|Overall Study|Withdrawal by Subject|2|||
147587977|NCT01955044|532305620|FG000|Overall Study|Death|1|||
147587978|NCT01955044|532305621|FG001|Overall Study|Death|1|||
147587979|NCT01955044|532305622|FG002|Overall Study|Death|0|||
147587980|NCT02260258|532305626|FG000|Overall Study|2 patients in NMB arm and 1 in control arm had clinical changes that precluded drug administration|2|||
147587981|NCT02260258|532305627|FG001|Overall Study|2 patients in NMB arm and 1 in control arm had clinical changes that precluded drug administration|1|||
147587982|NCT00690482|532305628|FG000|Overall Study|Adverse Event|2|||
147587983|NCT00690482|532305629|FG001|Overall Study|Adverse Event|1|||
147587984|NCT00690482|532305628|FG000|Overall Study|Incorrect enrolment|0|||
147587985|NCT00690482|532305629|FG001|Overall Study|Incorrect enrolment|1|||
147587986|NCT00690482|532305628|FG000|Overall Study|Study-specific discontinuation criteria|1|||
147587987|NCT00690482|532305629|FG001|Overall Study|Study-specific discontinuation criteria|0|||
147587988|NCT00690482|532305628|FG000|Overall Study|Intake of prohibited medicine|1|||
147587989|NCT00690482|532305629|FG001|Overall Study|Intake of prohibited medicine|0|||
147587990|NCT00690482|532305628|FG000|Overall Study|withdrew consent at rand.day|0|||
147587991|NCT00690482|532305629|FG001|Overall Study|withdrew consent at rand.day|1|||
147587992|NCT00724373|532305630|FG000|Overall Study|Adverse Event|41|||
147587993|NCT00724373|532305630|FG000|Overall Study|Lack of Efficacy|82|||
147162391|NCT00076336|530759096|FG001|Overall Study|Liver Transplantation|3|||
147162392|NCT00076336|530759095|FG000|Overall Study|Virologic Breakthrough|14|||
147162393|NCT00076336|530759096|FG001|Overall Study|Virologic Breakthrough|16|||
147162394|NCT00076336|530759095|FG000|Overall Study|Treatment failure|4|||
147162395|NCT00076336|530759096|FG001|Overall Study|Treatment failure|5|||
147162396|NCT00098722|530759100|FG000|Double Blind Phase|Adverse Event|7|||
147162397|NCT00098722|530759101|FG001|Double Blind Phase|Adverse Event|7|||
147162398|NCT00098722|530759102|FG002|Double Blind Phase|Adverse Event|3|||
147162399|NCT00098722|530759103|FG003|Double Blind Phase|Adverse Event|0|||
147162400|NCT00098722|530759104|FG004|Double Blind Phase|Adverse Event|0|||
147162401|NCT00098722|530759105|FG005|Double Blind Phase|Adverse Event|0|||
147162402|NCT00098722|530759106|FG006|Double Blind Phase|Adverse Event|0|||
147162403|NCT00098722|530759100|FG000|Double Blind Phase|Death|2|||
147162404|NCT00098722|530759101|FG001|Double Blind Phase|Death|5|||
147162405|NCT00098722|530759102|FG002|Double Blind Phase|Death|0|||
147162406|NCT00098722|530759103|FG003|Double Blind Phase|Death|0|||
147162407|NCT00098722|530759104|FG004|Double Blind Phase|Death|0|||
147162408|NCT00098722|530759105|FG005|Double Blind Phase|Death|0|||
147587994|NCT00724373|532305630|FG000|Overall Study|Lost to Follow-up|7|||
147587995|NCT00724373|532305630|FG000|Overall Study|Non-compliance|2|||
147587996|NCT00724373|532305630|FG000|Overall Study|HCV RNA negative after 4 weeks|9|||
147162409|NCT00098722|530759106|FG006|Double Blind Phase|Death|0|||
147162410|NCT00098722|530759100|FG000|Double Blind Phase|Lack of Efficacy|21|||
147162411|NCT00098722|530759101|FG001|Double Blind Phase|Lack of Efficacy|23|||
147162412|NCT00098722|530759102|FG002|Double Blind Phase|Lack of Efficacy|15|||
147162413|NCT00098722|530759103|FG003|Double Blind Phase|Lack of Efficacy|0|||
147162414|NCT00098722|530759104|FG004|Double Blind Phase|Lack of Efficacy|0|||
147162415|NCT00098722|530759105|FG005|Double Blind Phase|Lack of Efficacy|0|||
147162416|NCT00098722|530759106|FG006|Double Blind Phase|Lack of Efficacy|0|||
147162417|NCT00098722|530759100|FG000|Double Blind Phase|Participant defaulted|16|||
147162418|NCT00098722|530759101|FG001|Double Blind Phase|Participant defaulted|11|||
147162419|NCT00098722|530759102|FG002|Double Blind Phase|Participant defaulted|9|||
147162420|NCT00098722|530759103|FG003|Double Blind Phase|Participant defaulted|0|||
147162421|NCT00098722|530759104|FG004|Double Blind Phase|Participant defaulted|0|||
147162422|NCT00098722|530759105|FG005|Double Blind Phase|Participant defaulted|0|||
147162423|NCT00098722|530759106|FG006|Double Blind Phase|Participant defaulted|0|||
147162424|NCT00098722|530759100|FG000|Double Blind Phase|Pregnancy|1|||
147587997|NCT00724373|532305630|FG000|Overall Study|Participant moved away|1|||
147587998|NCT00724373|532305630|FG000|Overall Study|Responder at 12 weeks, PCR + at 24 weeks|2|||
147587999|NCT00724373|532305630|FG000|Overall Study|Only to have 24 week regimen|1|||
147588000|NCT00724373|532305630|FG000|Overall Study|Viral Relapse|1|||
147588001|NCT00724373|532305630|FG000|Overall Study|Acute HCV infection|1|||
147588002|NCT00724373|532305630|FG000|Overall Study|Drug Relapse|1|||
147588003|NCT00724373|532305630|FG000|Overall Study|Tolerability|23|||
147322775|NCT01027871|531345465|FG002|Overall Study|Protocol Violation|2|||
147322776|NCT01027871|531345463|FG000|Overall Study|Withdrawal by Subject|1|||
147322777|NCT01027871|531345464|FG001|Overall Study|Withdrawal by Subject|2|||
147322778|NCT01027871|531345465|FG002|Overall Study|Withdrawal by Subject|2|||
147322779|NCT01027871|531345463|FG000|Overall Study|Adverse Event|0|||
147322780|NCT01027871|531345464|FG001|Overall Study|Adverse Event|2|||
147447413|NCT01624662|531802172|FG003|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|0|||
147447414|NCT01624662|531802169|FG000|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0|||
147447415|NCT01624662|531802170|FG001|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|1|||
147588004|NCT00925301|532305635|FG000|6-Month Double-blind (Stage 1)|Withdrawal by Subject|0|||
147588005|NCT00925301|532305636|FG001|6-Month Double-blind (Stage 1)|Withdrawal by Subject|2|||
147588006|NCT00925301|532305637|FG002|6-Month Double-blind (Stage 1)|Withdrawal by Subject|0|||
147588007|NCT00925301|532305638|FG003|6-Month Double-blind (Stage 1)|Withdrawal by Subject|0|||
147588008|NCT00925301|532305635|FG000|6-Month Double-blind (Stage 1)|Pregnancy|0|||
147588009|NCT00925301|532305636|FG001|6-Month Double-blind (Stage 1)|Pregnancy|1|||
147588010|NCT00925301|532305637|FG002|6-Month Double-blind (Stage 1)|Pregnancy|0|||
147588011|NCT00925301|532305638|FG003|6-Month Double-blind (Stage 1)|Pregnancy|0|||
147588012|NCT00925301|532305635|FG000|6-Month Open-label (Stage 2)|Withdrawal by Subject|0|||
147588013|NCT00925301|532305636|FG001|6-Month Open-label (Stage 2)|Withdrawal by Subject|0|||
147242522|NCT00520936|531059639|FG006|Overall Study|Toxicity Requiring Removal from Study|2|||
147242523|NCT00520936|531059640|FG007|Overall Study|Toxicity Requiring Removal from Study|0|||
147242524|NCT00520936|531059633|FG000|Overall Study|Death|0|||
147242525|NCT00520936|531059634|FG001|Overall Study|Death|0|||
147242526|NCT00520936|531059635|FG002|Overall Study|Death|0|||
147242527|NCT00520936|531059636|FG003|Overall Study|Death|0|||
147242528|NCT00520936|531059637|FG004|Overall Study|Death|0|||
147242529|NCT00520936|531059638|FG005|Overall Study|Death|0|||
147242530|NCT00520936|531059639|FG006|Overall Study|Death|1|||
147242531|NCT00520936|531059640|FG007|Overall Study|Death|0|||
147242532|NCT00520936|531059633|FG000|Overall Study|Protocol Violation|0|||
147242533|NCT00520936|531059634|FG001|Overall Study|Protocol Violation|1|||
147242534|NCT00520936|531059635|FG002|Overall Study|Protocol Violation|1|||
147242535|NCT00520936|531059636|FG003|Overall Study|Protocol Violation|0|||
147242536|NCT00520936|531059637|FG004|Overall Study|Protocol Violation|1|||
147242537|NCT00520936|531059638|FG005|Overall Study|Protocol Violation|0|||
147242538|NCT00520936|531059639|FG006|Overall Study|Protocol Violation|1|||
147242539|NCT00520936|531059640|FG007|Overall Study|Protocol Violation|0|||
147242540|NCT03716024|531059641|FG000|Overall Study|Randomized, not Treated|7|||
147242541|NCT03716024|531059642|FG001|Overall Study|Randomized, not Treated|8|||
147242542|NCT03716024|531059641|FG000|Overall Study|Adverse Event|1|||
147242543|NCT03716024|531059642|FG001|Overall Study|Adverse Event|2|||
147242544|NCT03716024|531059641|FG000|Overall Study|Treatment Failure|1|||
147242545|NCT03716024|531059642|FG001|Overall Study|Treatment Failure|0|||
147242546|NCT03716024|531059641|FG000|Overall Study|Lost to Follow-up|2|||
147242547|NCT03716024|531059642|FG001|Overall Study|Lost to Follow-up|6|||
147242548|NCT03716024|531059641|FG000|Overall Study|Withdrawal by Subject|0|||
147242549|NCT03716024|531059642|FG001|Overall Study|Withdrawal by Subject|1|||
147242550|NCT03716024|531059641|FG000|Overall Study|Missing Reason|0|||
147242551|NCT03716024|531059642|FG001|Overall Study|Missing Reason|1|||
147242552|NCT04343261|531059643|FG000|Overall Study|Adverse Event|1|||
147242553|NCT04343261|531059643|FG000|Overall Study|received inadequate amount of antibodies|7|||
147242554|NCT04182763|531059650|FG000|Double-Blind Period, initial 6 months|Physician Decision|0|||
147242555|NCT04182763|531059651|FG001|Double-Blind Period, initial 6 months|Physician Decision|0|||
147242556|NCT04182763|531059652|FG002|Double-Blind Period, initial 6 months|Physician Decision|0|||
147242557|NCT04182763|531059653|FG003|Double-Blind Period, initial 6 months|Physician Decision|1|||
147242558|NCT04182763|531059654|FG004|Double-Blind Period, initial 6 months|Physician Decision|0|||
147242559|NCT04182763|531059650|FG000|Double-Blind Period, initial 6 months|Death|0|||
147242560|NCT04182763|531059651|FG001|Double-Blind Period, initial 6 months|Death|1|||
147242561|NCT04182763|531059652|FG002|Double-Blind Period, initial 6 months|Death|0|||
147322781|NCT01027871|531345465|FG002|Overall Study|Adverse Event|2|||
147242562|NCT04182763|531059653|FG003|Double-Blind Period, initial 6 months|Death|0|||
147242563|NCT04182763|531059654|FG004|Double-Blind Period, initial 6 months|Death|0|||
147242564|NCT04182763|531059650|FG000|Open-Label Period, subsequent 18 months|Death|3|||
147242565|NCT04182763|531059651|FG001|Open-Label Period, subsequent 18 months|Death|2|||
147242566|NCT04182763|531059652|FG002|Open-Label Period, subsequent 18 months|Death|2|||
147242567|NCT04182763|531059653|FG003|Open-Label Period, subsequent 18 months|Death|0|||
147242568|NCT04182763|531059654|FG004|Open-Label Period, subsequent 18 months|Death|1|||
147588014|NCT00925301|532305637|FG002|6-Month Open-label (Stage 2)|Withdrawal by Subject|1|||
147588015|NCT00925301|532305638|FG003|6-Month Open-label (Stage 2)|Withdrawal by Subject|0|||
147588016|NCT00925301|532305635|FG000|6-Month Open-label (Stage 2)|Adverse Event|0|||
147588017|NCT00925301|532305636|FG001|6-Month Open-label (Stage 2)|Adverse Event|0|||
147588018|NCT00925301|532305637|FG002|6-Month Open-label (Stage 2)|Adverse Event|2|||
147588019|NCT00925301|532305638|FG003|6-Month Open-label (Stage 2)|Adverse Event|0|||
147588020|NCT00925301|532305635|FG000|12-Month Open-label Extension (Optional)|Withdrawal by Subject|0|||
147588021|NCT00925301|532305636|FG001|12-Month Open-label Extension (Optional)|Withdrawal by Subject|0|||
147588022|NCT00925301|532305637|FG002|12-Month Open-label Extension (Optional)|Withdrawal by Subject|0|||
147588023|NCT00925301|532305638|FG003|12-Month Open-label Extension (Optional)|Withdrawal by Subject|1|||
147588024|NCT00925301|532305635|FG000|12-Month Open-label Extension (Optional)|Pregnancy|0|||
147588025|NCT00925301|532305636|FG001|12-Month Open-label Extension (Optional)|Pregnancy|0|||
147588026|NCT00925301|532305637|FG002|12-Month Open-label Extension (Optional)|Pregnancy|0|||
147588027|NCT00925301|532305638|FG003|12-Month Open-label Extension (Optional)|Pregnancy|1|||
147588028|NCT00925301|532305635|FG000|12-Month Open-label Extension (Optional)|Lost to Follow-up|0|||
147588029|NCT00925301|532305636|FG001|12-Month Open-label Extension (Optional)|Lost to Follow-up|0|||
147588030|NCT00925301|532305637|FG002|12-Month Open-label Extension (Optional)|Lost to Follow-up|0|||
147588031|NCT00925301|532305638|FG003|12-Month Open-label Extension (Optional)|Lost to Follow-up|1|||
147588032|NCT03043560|532305639|FG000|Overall Study|Discontinued Intervention|1|||
147588033|NCT03043560|532305640|FG001|Overall Study|Discontinued Intervention|2|||
147588034|NCT03043560|532305639|FG000|Overall Study|Lost to Follow-up|0|||
147588035|NCT03043560|532305640|FG001|Overall Study|Lost to Follow-up|1|||
147588036|NCT00438659|532305641|FG000|Overall Study|Discontinued Mometasone/Placebo|1|||
147588037|NCT00438659|532305642|FG001|Overall Study|Discontinued Mometasone/Placebo|2|||
147588038|NCT00438659|532305641|FG000|Overall Study|Cancel|5|||
147588039|NCT00438659|532305642|FG001|Overall Study|Cancel|2|||
147588040|NCT05766787|532305643|FG000|First Wear Period, Approximately 7 Days|Adverse Event|0|||
147588041|NCT05766787|532305644|FG001|First Wear Period, Approximately 7 Days|Adverse Event|1|||
147447416|NCT01624662|531802171|FG002|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0|||
147447417|NCT01624662|531802172|FG003|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0|||
147447418|NCT01624662|531802169|FG000|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|3|||
147447419|NCT01624662|531802170|FG001|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|0|||
147588042|NCT05766787|532305643|FG000|First Wear Period, Approximately 7 Days|Withdrawal by Subject|1|||
147588043|NCT05766787|532305644|FG001|First Wear Period, Approximately 7 Days|Withdrawal by Subject|2|||
147447420|NCT01624662|531802171|FG002|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|3|||
147447421|NCT01624662|531802172|FG003|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|0|||
147447422|NCT01624662|531802169|FG000|Open-Label Extension Phase (Wks 17-24)|Adverse Event|1|||
147447423|NCT01624662|531802170|FG001|Open-Label Extension Phase (Wks 17-24)|Adverse Event|1|||
147447424|NCT01624662|531802171|FG002|Open-Label Extension Phase (Wks 17-24)|Adverse Event|0|||
147447425|NCT01624662|531802172|FG003|Open-Label Extension Phase (Wks 17-24)|Adverse Event|1|||
147447426|NCT01624662|531802169|FG000|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
147447427|NCT01624662|531802170|FG001|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|1|||
147447428|NCT01624662|531802171|FG002|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
147447429|NCT01624662|531802172|FG003|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
147447430|NCT01624662|531802169|FG000|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|0|||
147447431|NCT01624662|531802170|FG001|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|0|||
147447432|NCT01624662|531802171|FG002|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|1|||
147447433|NCT01624662|531802172|FG003|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|0|||
147447434|NCT01714687|531802175|FG000|Overall Study|Withdrawal by Subject|1|||
147447435|NCT01714687|531802176|FG001|Overall Study|Withdrawal by Subject|0|||
147447436|NCT01714687|531802175|FG000|Overall Study|Lost to Follow-up|2|||
147447437|NCT01714687|531802176|FG001|Overall Study|Lost to Follow-up|4|||
147447438|NCT01439555|531802181|FG000|Overall Study|Protocol Violation|1|||
147447439|NCT04869345|531802185|FG000|Overall Study|Lost to Follow-up|8|||
147447440|NCT04869345|531802186|FG001|Overall Study|Lost to Follow-up|3|||
147447441|NCT05054114|531802203|FG000|Overall Study|Protocol Violation|13|||
147447442|NCT05054114|531802204|FG001|Overall Study|Protocol Violation|1|||
147447443|NCT05054114|531802203|FG000|Overall Study|Pregnancy|0|||
147447444|NCT05054114|531802204|FG001|Overall Study|Pregnancy|1|||
147447445|NCT01806779|531802205|FG000|Overall Study|Physician Decision|2|||
147447446|NCT01806779|531802206|FG001|Overall Study|Physician Decision|0|||
147588044|NCT05766787|532305643|FG000|Second Wear Period, Approximately 7 Days|Adverse Event|0|||
147588045|NCT05766787|532305644|FG001|Second Wear Period, Approximately 7 Days|Adverse Event|1|||
147588046|NCT02056652|532305645|FG000|Overall Study|Withdrawal by Subject|1|||
147588047|NCT02056652|532305646|FG001|Overall Study|Withdrawal by Subject|0|||
147588048|NCT02056652|532305645|FG000|Overall Study|Lost to Follow-up|0|||
147588049|NCT02056652|532305646|FG001|Overall Study|Lost to Follow-up|3|||
147588050|NCT00292227|532305647|FG000|Patch Period|Adverse Event|1|||
147588051|NCT00292227|532305648|FG001|Patch Period|Adverse Event|0|||
147588052|NCT00292227|532305649|FG002|Patch Period|Adverse Event|2|||
147588053|NCT00292227|532305647|FG000|Patch Period|Withdrawal by Subject|0|||
147588054|NCT00292227|532305648|FG001|Patch Period|Withdrawal by Subject|0|||
147588055|NCT00292227|532305649|FG002|Patch Period|Withdrawal by Subject|1|||
147588056|NCT03253094|532305652|FG000|Overall Study|Adverse Event|2|||
147588057|NCT03253094|532305653|FG001|Overall Study|Adverse Event|0|||
147588058|NCT03253094|532305654|FG002|Overall Study|Adverse Event|0|||
147588059|NCT03253094|532305655|FG003|Overall Study|Adverse Event|0|||
147588060|NCT03253094|532305656|FG004|Overall Study|Adverse Event|0|||
147588061|NCT03253094|532305657|FG005|Overall Study|Adverse Event|0|||
147588062|NCT03253094|532305652|FG000|Overall Study|Lack of Efficacy|0|||
147588063|NCT03253094|532305653|FG001|Overall Study|Lack of Efficacy|0|||
147588064|NCT03253094|532305654|FG002|Overall Study|Lack of Efficacy|2|||
147588065|NCT03253094|532305655|FG003|Overall Study|Lack of Efficacy|1|||
147588066|NCT03253094|532305656|FG004|Overall Study|Lack of Efficacy|2|||
147588067|NCT03253094|532305657|FG005|Overall Study|Lack of Efficacy|1|||
147588068|NCT03253094|532305652|FG000|Overall Study|Lost to Follow-up|0|||
147588069|NCT03253094|532305653|FG001|Overall Study|Lost to Follow-up|0|||
147588070|NCT03253094|532305654|FG002|Overall Study|Lost to Follow-up|1|||
147588071|NCT03253094|532305655|FG003|Overall Study|Lost to Follow-up|1|||
147588072|NCT03253094|532305656|FG004|Overall Study|Lost to Follow-up|0|||
147588073|NCT03253094|532305657|FG005|Overall Study|Lost to Follow-up|1|||
147588074|NCT03253094|532305652|FG000|Overall Study|Physician Decision|1|||
147588075|NCT03253094|532305653|FG001|Overall Study|Physician Decision|0|||
147588076|NCT03253094|532305654|FG002|Overall Study|Physician Decision|0|||
147588077|NCT03253094|532305655|FG003|Overall Study|Physician Decision|1|||
147588078|NCT03253094|532305656|FG004|Overall Study|Physician Decision|0|||
147588079|NCT03253094|532305657|FG005|Overall Study|Physician Decision|2|||
147588080|NCT03253094|532305652|FG000|Overall Study|Withdrawal by Subject|1|||
147588081|NCT03253094|532305653|FG001|Overall Study|Withdrawal by Subject|2|||
147588082|NCT03253094|532305654|FG002|Overall Study|Withdrawal by Subject|1|||
147322782|NCT01027871|531345463|FG000|Overall Study|Sponsor Decision|0|||
147322783|NCT01027871|531345464|FG001|Overall Study|Sponsor Decision|2|||
147322784|NCT01027871|531345465|FG002|Overall Study|Sponsor Decision|0|||
147322785|NCT01027871|531345463|FG000|Overall Study|Discontinued Prior to Treatment|0|||
147322786|NCT01027871|531345464|FG001|Overall Study|Discontinued Prior to Treatment|0|||
147322787|NCT01027871|531345465|FG002|Overall Study|Discontinued Prior to Treatment|1|||
147322788|NCT04833855|531345466|FG000|Overall Study|Decision by sponsor|0|||
147322789|NCT04833855|531345467|FG001|Overall Study|Decision by sponsor|1|||
147322790|NCT04833855|531345468|FG002|Overall Study|Decision by sponsor|0|||
147322791|NCT04833855|531345469|FG003|Overall Study|Decision by sponsor|0|||
147322792|NCT04833855|531345466|FG000|Overall Study|Withdrawal by Subject|4|||
147322793|NCT04833855|531345467|FG001|Overall Study|Withdrawal by Subject|1|||
147322794|NCT04833855|531345468|FG002|Overall Study|Withdrawal by Subject|3|||
147322795|NCT04833855|531345469|FG003|Overall Study|Withdrawal by Subject|1|||
147322796|NCT04833855|531345466|FG000|Overall Study|Lost to Follow-up|1|||
147322797|NCT04833855|531345467|FG001|Overall Study|Lost to Follow-up|0|||
147322798|NCT04833855|531345468|FG002|Overall Study|Lost to Follow-up|2|||
147322799|NCT04833855|531345469|FG003|Overall Study|Lost to Follow-up|2|||
147322800|NCT04833855|531345466|FG000|Overall Study|Protocol specified criteria|0|||
147322801|NCT04833855|531345467|FG001|Overall Study|Protocol specified criteria|0|||
147322802|NCT04833855|531345468|FG002|Overall Study|Protocol specified criteria|2|||
147322803|NCT04833855|531345469|FG003|Overall Study|Protocol specified criteria|1|||
147322804|NCT03782727|531345470|FG000|Overall Study|Lost to Follow-up|32|||
147322805|NCT04887285|531345473|FG000|Overall Study|Lost to Follow-up|0|||
147322806|NCT04887285|531345474|FG001|Overall Study|Lost to Follow-up|2|||
147322807|NCT04887285|531345475|FG002|Overall Study|Lost to Follow-up|3|||
147322808|NCT04640571|531345476|FG000|Overall Study|Withdrawal by Subject|0|||
147322809|NCT04640571|531345477|FG001|Overall Study|Withdrawal by Subject|0|||
147322810|NCT04640571|531345478|FG002|Overall Study|Withdrawal by Subject|0|||
147322811|NCT04640571|531345479|FG003|Overall Study|Withdrawal by Subject|0|||
147322812|NCT04640571|531345480|FG004|Overall Study|Withdrawal by Subject|0|||
147322813|NCT04640571|531345481|FG005|Overall Study|Withdrawal by Subject|2|||
147588083|NCT03253094|532305655|FG003|Overall Study|Withdrawal by Subject|0|||
147322814|NCT02099539|531345487|FG000|Overall Study|Progressive Disease|3|||
147322815|NCT02099539|531345488|FG001|Overall Study|Progressive Disease|2|||
147588084|NCT03253094|532305656|FG004|Overall Study|Withdrawal by Subject|3|||
147322816|NCT02099539|531345489|FG002|Overall Study|Progressive Disease|2|||
147322817|NCT02099539|531345490|FG003|Overall Study|Progressive Disease|1|||
147322818|NCT02099539|531345491|FG004|Overall Study|Progressive Disease|4|||
147322819|NCT02099539|531345492|FG005|Overall Study|Progressive Disease|2|||
147322820|NCT02099539|531345493|FG006|Overall Study|Progressive Disease|0|||
147588085|NCT03253094|532305657|FG005|Overall Study|Withdrawal by Subject|0|||
147588086|NCT03253094|532305652|FG000|Overall Study|Other|0|||
147588087|NCT03253094|532305653|FG001|Overall Study|Other|1|||
147588088|NCT03253094|532305654|FG002|Overall Study|Other|2|||
147588089|NCT03253094|532305655|FG003|Overall Study|Other|1|||
147322821|NCT02099539|531345487|FG000|Overall Study|Adverse Event|0|||
147588090|NCT03253094|532305656|FG004|Overall Study|Other|0|||
147588091|NCT03253094|532305657|FG005|Overall Study|Other|0|||
147588092|NCT00576303|532305658|FG000|Dose Titration Period|Early withdrawal|17|||
147162425|NCT00098722|530759101|FG001|Double Blind Phase|Pregnancy|0|||
147162426|NCT00098722|530759102|FG002|Double Blind Phase|Pregnancy|0|||
147162427|NCT00098722|530759103|FG003|Double Blind Phase|Pregnancy|0|||
147162428|NCT00098722|530759104|FG004|Double Blind Phase|Pregnancy|0|||
147162429|NCT00098722|530759105|FG005|Double Blind Phase|Pregnancy|0|||
147162430|NCT00098722|530759106|FG006|Double Blind Phase|Pregnancy|0|||
147162431|NCT00098722|530759100|FG000|Double Blind Phase|Randomized, not treated|4|||
147162432|NCT00098722|530759101|FG001|Double Blind Phase|Randomized, not treated|3|||
147162433|NCT00098722|530759102|FG002|Double Blind Phase|Randomized, not treated|3|||
147162434|NCT00098722|530759103|FG003|Double Blind Phase|Randomized, not treated|0|||
147162435|NCT00098722|530759104|FG004|Double Blind Phase|Randomized, not treated|0|||
147242569|NCT04182763|531059650|FG000|Open-Label Period, subsequent 18 months|Withdrawal by Subject|2|||
147242570|NCT04182763|531059651|FG001|Open-Label Period, subsequent 18 months|Withdrawal by Subject|1|||
147242571|NCT04182763|531059652|FG002|Open-Label Period, subsequent 18 months|Withdrawal by Subject|2|||
147242572|NCT04182763|531059653|FG003|Open-Label Period, subsequent 18 months|Withdrawal by Subject|0|||
147447447|NCT01806779|531802207|FG002|Overall Study|Physician Decision|1|||
147447448|NCT01806779|531802205|FG000|Overall Study|Lack of Efficacy|1|||
147588093|NCT00576303|532305658|FG000|Efficacy Evaluation Period|Early withdrawal|5|||
147588094|NCT00576303|532305658|FG000|Long Term Safety Period|Early withdrawal|16|||
147588095|NCT00824369|532305659|FG000|Overall Study|Nolonger willing to participate in study|1|||
147588096|NCT00824369|532305660|FG001|Overall Study|Nolonger willing to participate in study|0|||
147588097|NCT00824369|532305661|FG002|Overall Study|Nolonger willing to participate in study|1|||
147588098|NCT00824369|532305662|FG003|Overall Study|Nolonger willing to participate in study|2|||
147588099|NCT00824369|532305663|FG004|Overall Study|Nolonger willing to participate in study|0|||
147588100|NCT00824369|532305664|FG005|Overall Study|Nolonger willing to participate in study|1|||
147588101|NCT00824369|532305659|FG000|Overall Study|Lost to Follow-up|0|||
147588102|NCT00824369|532305660|FG001|Overall Study|Lost to Follow-up|0|||
147588103|NCT00824369|532305661|FG002|Overall Study|Lost to Follow-up|0|||
147588104|NCT00824369|532305662|FG003|Overall Study|Lost to Follow-up|0|||
147588105|NCT00824369|532305663|FG004|Overall Study|Lost to Follow-up|1|||
147588106|NCT00824369|532305664|FG005|Overall Study|Lost to Follow-up|0|||
147588107|NCT00442546|532305665|FG000|Overall Study|Adverse Event|11|||
147588108|NCT00442546|532305666|FG001|Overall Study|Adverse Event|17|||
147588109|NCT00442546|532305667|FG002|Overall Study|Adverse Event|13|||
147588110|NCT00442546|532305665|FG000|Overall Study|Lost to Follow-up|1|||
147588111|NCT00442546|532305666|FG001|Overall Study|Lost to Follow-up|2|||
147588112|NCT00442546|532305667|FG002|Overall Study|Lost to Follow-up|1|||
147588113|NCT00442546|532305665|FG000|Overall Study|Other|4|||
147447449|NCT01806779|531802206|FG001|Overall Study|Lack of Efficacy|1|||
147588114|NCT00442546|532305666|FG001|Overall Study|Other|9|||
147588115|NCT00442546|532305667|FG002|Overall Study|Other|6|||
147162436|NCT00098722|530759105|FG005|Double Blind Phase|Randomized, not treated|0|||
147242573|NCT04182763|531059654|FG004|Open-Label Period, subsequent 18 months|Withdrawal by Subject|1|||
147242574|NCT04182763|531059650|FG000|Open-Label Period, subsequent 18 months|Participation ended early due to shortage of study product (COVID 19 supply chain issue)|2|||
147242575|NCT04182763|531059651|FG001|Open-Label Period, subsequent 18 months|Participation ended early due to shortage of study product (COVID 19 supply chain issue)|4|||
147242576|NCT04182763|531059652|FG002|Open-Label Period, subsequent 18 months|Participation ended early due to shortage of study product (COVID 19 supply chain issue)|2|||
147242577|NCT04182763|531059653|FG003|Open-Label Period, subsequent 18 months|Participation ended early due to shortage of study product (COVID 19 supply chain issue)|2|||
147242578|NCT04182763|531059654|FG004|Open-Label Period, subsequent 18 months|Participation ended early due to shortage of study product (COVID 19 supply chain issue)|0|||
147242579|NCT00370032|531059663|FG000|Treatment Period 1|Unable to perform sigmoidoscopy on Day 6|0|||
147242580|NCT00370032|531059664|FG001|Treatment Period 1|Unable to perform sigmoidoscopy on Day 6|1|||
147242581|NCT00370032|531059663|FG000|Washout Period|Withdrawal by Subject|0|||
147242582|NCT00370032|531059664|FG001|Washout Period|Withdrawal by Subject|1|||
147242583|NCT00370032|531059663|FG000|Washout Period|Lost to Follow-up|0|||
147242584|NCT00370032|531059664|FG001|Washout Period|Lost to Follow-up|1|||
147242585|NCT00370032|531059663|FG000|Washout Period|Adverse Event|1|||
147242586|NCT00370032|531059664|FG001|Washout Period|Adverse Event|0|||
147242587|NCT00370032|531059663|FG000|Follow-up Period|Withdrawal by Subject|1|||
147242588|NCT00370032|531059664|FG001|Follow-up Period|Withdrawal by Subject|0|||
147242589|NCT05683249|531059665|FG000|Overall Study|Adverse Event|3|||
147242590|NCT05683249|531059666|FG001|Overall Study|Adverse Event|1|||
147242591|NCT05683249|531059665|FG000|Overall Study|Lack of Efficacy|0|||
147242592|NCT05683249|531059666|FG001|Overall Study|Lack of Efficacy|2|||
147447450|NCT01806779|531802207|FG002|Overall Study|Lack of Efficacy|0|||
147588116|NCT00442546|532305665|FG000|Overall Study|Withdrawal by Subject|5|||
147162437|NCT00098722|530759106|FG006|Double Blind Phase|Randomized, not treated|0|||
147162438|NCT00098722|530759100|FG000|Double Blind Phase|Ongoing at cut-off date|128|||
147588117|NCT00442546|532305666|FG001|Overall Study|Withdrawal by Subject|5|||
147588118|NCT00442546|532305667|FG002|Overall Study|Withdrawal by Subject|7|||
147588119|NCT00442546|532305665|FG000|Overall Study|Randomized But Not Treated|5|||
147588120|NCT00442546|532305666|FG001|Overall Study|Randomized But Not Treated|4|||
147588121|NCT00442546|532305667|FG002|Overall Study|Randomized But Not Treated|6|||
147588122|NCT03581188|532307538|FG000|Overall Study|Inclusion criteria not met|3|||
147588123|NCT03581188|532307539|FG001|Overall Study|Inclusion criteria not met|2|||
147588124|NCT03581188|532307538|FG000|Overall Study|Lost to Follow-up|5|||
147588125|NCT03581188|532307539|FG001|Overall Study|Lost to Follow-up|5|||
147588126|NCT03581188|532307538|FG000|Overall Study|Discontinued intervention|11|||
147588127|NCT03581188|532307539|FG001|Overall Study|Discontinued intervention|8|||
147588128|NCT01619579|532307540|FG000|Overall Study|Withdrawal by Subject|0|||
147588129|NCT01619579|532307541|FG001|Overall Study|Withdrawal by Subject|3|||
147588130|NCT02012452|532307543|FG000|Overall Study|Lost to Follow-up|2|||
147588131|NCT02012452|532307544|FG001|Overall Study|Lost to Follow-up|1|||
147588132|NCT02012452|532307543|FG000|Overall Study|Withdrawal by Subject|4|||
147588133|NCT02012452|532307544|FG001|Overall Study|Withdrawal by Subject|0|||
147588134|NCT04403399|532307545|FG000|Period 2|Physician Decision|0|||
147588135|NCT04403399|532307546|FG001|Period 2|Physician Decision|1|||
147588136|NCT01316419|532307548|FG000|Overall Study|Not treated|103|||
147588137|NCT01316419|532307548|FG000|Overall Study|Violated inclusion/exclusion criterion|143|||
147588138|NCT01316419|532307548|FG000|Overall Study|Lost to Follow-up|19|||
147588139|NCT00983918|532307557|FG000|Overall Study|conversion to open cholecystectomy|0|||
147588140|NCT00983918|532307558|FG001|Overall Study|conversion to open cholecystectomy|2|||
147588141|NCT00983918|532307559|FG002|Overall Study|conversion to open cholecystectomy|2|||
147588142|NCT00983918|532307560|FG003|Overall Study|conversion to open cholecystectomy|2|||
147588143|NCT03346070|532307570|FG000|Overall Study|Death|0|||
147588144|NCT03346070|532307571|FG001|Overall Study|Death|0|||
147588145|NCT03346070|532307572|FG002|Overall Study|Death|0|||
147588146|NCT03346070|532307573|FG003|Overall Study|Death|0|||
147588147|NCT03346070|532307574|FG004|Overall Study|Death|1|||
147588148|NCT03346070|532307570|FG000|Overall Study|Lost to Follow-up|0|||
147162439|NCT00098722|530759101|FG001|Double Blind Phase|Ongoing at cut-off date|137|||
147162440|NCT00098722|530759102|FG002|Double Blind Phase|Ongoing at cut-off date|57|||
147162441|NCT00098722|530759103|FG003|Double Blind Phase|Ongoing at cut-off date|0|||
147162442|NCT00098722|530759104|FG004|Double Blind Phase|Ongoing at cut-off date|0|||
147162443|NCT00098722|530759105|FG005|Double Blind Phase|Ongoing at cut-off date|0|||
147162444|NCT00098722|530759106|FG006|Double Blind Phase|Ongoing at cut-off date|0|||
147162445|NCT00098722|530759100|FG000|Double Blind Phase|Other|7|||
147162446|NCT00098722|530759101|FG001|Double Blind Phase|Other|8|||
147162447|NCT00098722|530759102|FG002|Double Blind Phase|Other|7|||
147162448|NCT00098722|530759103|FG003|Double Blind Phase|Other|0|||
147162449|NCT00098722|530759104|FG004|Double Blind Phase|Other|0|||
147162450|NCT00098722|530759105|FG005|Double Blind Phase|Other|0|||
147162451|NCT00098722|530759106|FG006|Double Blind Phase|Other|0|||
147162452|NCT00098722|530759100|FG000|Open Label Phase|Adverse Event|0|||
147162453|NCT00098722|530759101|FG001|Open Label Phase|Adverse Event|0|||
147162454|NCT00098722|530759102|FG002|Open Label Phase|Adverse Event|0|||
147162455|NCT00098722|530759103|FG003|Open Label Phase|Adverse Event|5|||
147162456|NCT00098722|530759104|FG004|Open Label Phase|Adverse Event|0|||
147162457|NCT00098722|530759105|FG005|Open Label Phase|Adverse Event|0|||
147162458|NCT00098722|530759106|FG006|Open Label Phase|Adverse Event|0|||
147162459|NCT00098722|530759100|FG000|Open Label Phase|Death|0|||
147162460|NCT00098722|530759101|FG001|Open Label Phase|Death|0|||
147162461|NCT00098722|530759102|FG002|Open Label Phase|Death|0|||
147162462|NCT00098722|530759103|FG003|Open Label Phase|Death|2|||
147162463|NCT00098722|530759104|FG004|Open Label Phase|Death|0|||
147242593|NCT05683249|531059665|FG000|Overall Study|Lost to Follow-up|6|||
147588149|NCT03346070|532307571|FG001|Overall Study|Lost to Follow-up|1|||
147588150|NCT03346070|532307572|FG002|Overall Study|Lost to Follow-up|2|||
147588151|NCT03346070|532307573|FG003|Overall Study|Lost to Follow-up|0|||
147588152|NCT03346070|532307574|FG004|Overall Study|Lost to Follow-up|0|||
147588153|NCT03346070|532307570|FG000|Overall Study|Physician Decision|0|||
147162464|NCT00098722|530759105|FG005|Open Label Phase|Death|0|||
147162465|NCT00098722|530759106|FG006|Open Label Phase|Death|0|||
147162466|NCT00098722|530759100|FG000|Open Label Phase|Lack of Efficacy|0|||
147162467|NCT00098722|530759101|FG001|Open Label Phase|Lack of Efficacy|0|||
147242594|NCT05683249|531059666|FG001|Overall Study|Lost to Follow-up|5|||
147588154|NCT03346070|532307571|FG001|Overall Study|Physician Decision|0|||
147588155|NCT03346070|532307572|FG002|Overall Study|Physician Decision|0|||
147162468|NCT00098722|530759102|FG002|Open Label Phase|Lack of Efficacy|0|||
147162469|NCT00098722|530759103|FG003|Open Label Phase|Lack of Efficacy|8|||
147162470|NCT00098722|530759104|FG004|Open Label Phase|Lack of Efficacy|0|||
147242595|NCT05683249|531059665|FG000|Overall Study|Non-compliance with Study Drug|2|||
147588156|NCT03346070|532307573|FG003|Overall Study|Physician Decision|1|||
147588157|NCT03346070|532307574|FG004|Overall Study|Physician Decision|1|||
147588158|NCT03346070|532307570|FG000|Overall Study|Withdrawal by Subject|1|||
147588159|NCT03346070|532307571|FG001|Overall Study|Withdrawal by Subject|0|||
147162471|NCT00098722|530759105|FG005|Open Label Phase|Lack of Efficacy|0|||
147162472|NCT00098722|530759106|FG006|Open Label Phase|Lack of Efficacy|0|||
147162473|NCT00098722|530759100|FG000|Open Label Phase|Pregnancy|0|||
147162474|NCT00098722|530759101|FG001|Open Label Phase|Pregnancy|0|||
147322822|NCT02099539|531345488|FG001|Overall Study|Adverse Event|0|||
147588160|NCT03346070|532307572|FG002|Overall Study|Withdrawal by Subject|0|||
147588161|NCT03346070|532307573|FG003|Overall Study|Withdrawal by Subject|1|||
147162475|NCT00098722|530759102|FG002|Open Label Phase|Pregnancy|0|||
147162476|NCT00098722|530759103|FG003|Open Label Phase|Pregnancy|1|||
147162477|NCT00098722|530759104|FG004|Open Label Phase|Pregnancy|0|||
147162478|NCT00098722|530759105|FG005|Open Label Phase|Pregnancy|0|||
147162479|NCT00098722|530759106|FG006|Open Label Phase|Pregnancy|0|||
147162480|NCT00098722|530759100|FG000|Open Label Phase|Participant defaulted|0|||
147162481|NCT00098722|530759101|FG001|Open Label Phase|Participant defaulted|0|||
147162482|NCT00098722|530759102|FG002|Open Label Phase|Participant defaulted|0|||
147162483|NCT00098722|530759103|FG003|Open Label Phase|Participant defaulted|18|||
147162484|NCT00098722|530759104|FG004|Open Label Phase|Participant defaulted|0|||
147162485|NCT00098722|530759105|FG005|Open Label Phase|Participant defaulted|0|||
147162486|NCT00098722|530759106|FG006|Open Label Phase|Participant defaulted|0|||
147162487|NCT00098722|530759100|FG000|Open Label Phase|Ongoing at cut-off date|0|||
147162488|NCT00098722|530759101|FG001|Open Label Phase|Ongoing at cut-off date|0|||
147162489|NCT00098722|530759102|FG002|Open Label Phase|Ongoing at cut-off date|0|||
147162490|NCT00098722|530759103|FG003|Open Label Phase|Ongoing at cut-off date|220|||
147162491|NCT00098722|530759104|FG004|Open Label Phase|Ongoing at cut-off date|50|||
147162492|NCT00098722|530759105|FG005|Open Label Phase|Ongoing at cut-off date|0|||
147162493|NCT00098722|530759106|FG006|Open Label Phase|Ongoing at cut-off date|0|||
147162494|NCT00098722|530759100|FG000|Open Label Phase|Other|0|||
147162495|NCT00098722|530759101|FG001|Open Label Phase|Other|0|||
147162496|NCT00098722|530759102|FG002|Open Label Phase|Other|0|||
147162497|NCT00098722|530759103|FG003|Open Label Phase|Other|18|||
147162498|NCT00098722|530759104|FG004|Open Label Phase|Other|0|||
147162499|NCT00098722|530759105|FG005|Open Label Phase|Other|0|||
147162500|NCT00098722|530759106|FG006|Open Label Phase|Other|0|||
147162501|NCT00098722|530759100|FG000|Observation Phase|Death|0|||
147162502|NCT00098722|530759101|FG001|Observation Phase|Death|0|||
147162503|NCT00098722|530759102|FG002|Observation Phase|Death|0|||
147162504|NCT00098722|530759103|FG003|Observation Phase|Death|0|||
147162505|NCT00098722|530759104|FG004|Observation Phase|Death|0|||
147162506|NCT00098722|530759105|FG005|Observation Phase|Death|5|||
147162507|NCT00098722|530759106|FG006|Observation Phase|Death|3|||
147162508|NCT00098722|530759100|FG000|Observation Phase|Lack of Efficacy|0|||
147162509|NCT00098722|530759101|FG001|Observation Phase|Lack of Efficacy|0|||
147162510|NCT00098722|530759102|FG002|Observation Phase|Lack of Efficacy|0|||
147162511|NCT00098722|530759103|FG003|Observation Phase|Lack of Efficacy|0|||
147162512|NCT00098722|530759104|FG004|Observation Phase|Lack of Efficacy|0|||
147162513|NCT00098722|530759105|FG005|Observation Phase|Lack of Efficacy|2|||
147162514|NCT00098722|530759106|FG006|Observation Phase|Lack of Efficacy|0|||
147162515|NCT00098722|530759100|FG000|Observation Phase|Participant defaulted|0|||
147162516|NCT00098722|530759101|FG001|Observation Phase|Participant defaulted|0|||
147162517|NCT00098722|530759102|FG002|Observation Phase|Participant defaulted|0|||
147162518|NCT00098722|530759103|FG003|Observation Phase|Participant defaulted|0|||
147162519|NCT00098722|530759104|FG004|Observation Phase|Participant defaulted|0|||
147162520|NCT00098722|530759105|FG005|Observation Phase|Participant defaulted|17|||
147162521|NCT00098722|530759106|FG006|Observation Phase|Participant defaulted|4|||
147162522|NCT00098722|530759100|FG000|Observation Phase|Other|0|||
147162523|NCT00098722|530759101|FG001|Observation Phase|Other|0|||
147162524|NCT00098722|530759102|FG002|Observation Phase|Other|0|||
147162525|NCT00098722|530759103|FG003|Observation Phase|Other|0|||
147162526|NCT00098722|530759104|FG004|Observation Phase|Other|0|||
147162527|NCT00098722|530759105|FG005|Observation Phase|Other|21|||
147162528|NCT00098722|530759106|FG006|Observation Phase|Other|10|||
147162529|NCT02351349|530759112|FG000|Overall Study|Withdrawal by Subject|2|||
147162530|NCT02351349|530759113|FG001|Overall Study|Withdrawal by Subject|3|||
147162531|NCT01703117|530759114|FG000|Overall Study|Adverse Event|4|||
147162532|NCT01703117|530759115|FG001|Overall Study|Adverse Event|3|||
147162533|NCT01703117|530759114|FG000|Overall Study|Withdrawal by Subject|0|||
147162534|NCT01703117|530759115|FG001|Overall Study|Withdrawal by Subject|1|||
147162535|NCT01340937|530759117|FG000|Period 1: Infant Series|Other protocol criterion not met|0|||
147162536|NCT01340937|530759118|FG001|Period 1: Infant Series|Other protocol criterion not met|1|||
147162537|NCT01340937|530759119|FG002|Period 1: Infant Series|Other protocol criterion not met|1|||
147162538|NCT01340937|530759120|FG003|Period 1: Infant Series|Other protocol criterion not met|0|||
147162539|NCT01340937|530759117|FG000|Period 1: Infant Series|Adverse Event|0|||
147162540|NCT01340937|530759118|FG001|Period 1: Infant Series|Adverse Event|1|||
147162541|NCT01340937|530759119|FG002|Period 1: Infant Series|Adverse Event|4|||
147162542|NCT01340937|530759120|FG003|Period 1: Infant Series|Adverse Event|0|||
147162543|NCT01340937|530759117|FG000|Period 1: Infant Series|Death|2|||
147162544|NCT01340937|530759118|FG001|Period 1: Infant Series|Death|0|||
147162545|NCT01340937|530759119|FG002|Period 1: Infant Series|Death|2|||
147162546|NCT01340937|530759120|FG003|Period 1: Infant Series|Death|0|||
147162547|NCT01340937|530759117|FG000|Period 1: Infant Series|Lost to Follow-up|20|||
147162548|NCT01340937|530759118|FG001|Period 1: Infant Series|Lost to Follow-up|14|||
147588162|NCT03346070|532307574|FG004|Overall Study|Withdrawal by Subject|0|||
147588163|NCT03346070|532307570|FG000|Overall Study|Study medication not received as planned|2|||
147588164|NCT03346070|532307571|FG001|Overall Study|Study medication not received as planned|3|||
147588165|NCT03346070|532307572|FG002|Overall Study|Study medication not received as planned|2|||
147588166|NCT03346070|532307573|FG003|Overall Study|Study medication not received as planned|3|||
147588167|NCT03346070|532307574|FG004|Overall Study|Study medication not received as planned|2|||
147588168|NCT03346070|532307570|FG000|Overall Study|Screen Failure|0|||
147588169|NCT03346070|532307571|FG001|Overall Study|Screen Failure|0|||
147588170|NCT03346070|532307572|FG002|Overall Study|Screen Failure|0|||
147588171|NCT03346070|532307573|FG003|Overall Study|Screen Failure|1|||
147588172|NCT03346070|532307574|FG004|Overall Study|Screen Failure|1|||
147588173|NCT04086641|532307577|FG000|Foot 1 (Two Week Utilization)|COVID-19|1|||
147588174|NCT04086641|532307578|FG001|Foot 1 (Two Week Utilization)|COVID-19|2|||
147588175|NCT00255151|532307579|FG000|Overall Study|Adverse Event|10|||
147588176|NCT00255151|532307580|FG001|Overall Study|Adverse Event|6|||
147588177|NCT00255151|532307581|FG002|Overall Study|Adverse Event|9|||
147588178|NCT00255151|532307579|FG000|Overall Study|Lost to Follow-up|4|||
147588179|NCT00255151|532307580|FG001|Overall Study|Lost to Follow-up|3|||
147588180|NCT00255151|532307581|FG002|Overall Study|Lost to Follow-up|4|||
147588181|NCT00255151|532307579|FG000|Overall Study|Withdrawal by Subject|18|||
147588182|NCT00255151|532307580|FG001|Overall Study|Withdrawal by Subject|17|||
147588183|NCT00255151|532307581|FG002|Overall Study|Withdrawal by Subject|8|||
147588184|NCT00255151|532307579|FG000|Overall Study|Noncompliance|0|||
147588185|NCT00255151|532307580|FG001|Overall Study|Noncompliance|1|||
147588186|NCT00255151|532307581|FG002|Overall Study|Noncompliance|2|||
147588187|NCT00255151|532307579|FG000|Overall Study|Subject Request/Subject Unavailable|1|||
147588188|NCT00255151|532307580|FG001|Overall Study|Subject Request/Subject Unavailable|1|||
147588189|NCT00255151|532307581|FG002|Overall Study|Subject Request/Subject Unavailable|2|||
147588190|NCT00255151|532307579|FG000|Overall Study|Relapse of Erosive Esophagitis|78|||
147588191|NCT00255151|532307580|FG001|Overall Study|Relapse of Erosive Esophagitis|16|||
147588192|NCT00255151|532307581|FG002|Overall Study|Relapse of Erosive Esophagitis|12|||
147588193|NCT00255151|532307579|FG000|Overall Study|Possible Barrett's Esophagus|1|||
147588194|NCT00255151|532307580|FG001|Overall Study|Possible Barrett's Esophagus|3|||
147588195|NCT00255151|532307581|FG002|Overall Study|Possible Barrett's Esophagus|8|||
147588196|NCT00255151|532307579|FG000|Overall Study|Esophageal Stricture|0|||
147588197|NCT00255151|532307580|FG001|Overall Study|Esophageal Stricture|0|||
147588198|NCT00255151|532307581|FG002|Overall Study|Esophageal Stricture|1|||
147588199|NCT00255151|532307579|FG000|Overall Study|Therapeutic Failure|11|||
147588200|NCT00255151|532307580|FG001|Overall Study|Therapeutic Failure|2|||
147588201|NCT00255151|532307581|FG002|Overall Study|Therapeutic Failure|3|||
147588202|NCT01685073|532307582|FG000|Overall Study|Lost to Follow-up|6|||
147162549|NCT01340937|530759119|FG002|Period 1: Infant Series|Lost to Follow-up|12|||
147162550|NCT01340937|530759120|FG003|Period 1: Infant Series|Lost to Follow-up|13|||
147162551|NCT01340937|530759117|FG000|Period 1: Infant Series|Physician Decision|2|||
147162552|NCT01340937|530759118|FG001|Period 1: Infant Series|Physician Decision|3|||
147162553|NCT01340937|530759119|FG002|Period 1: Infant Series|Physician Decision|1|||
147162554|NCT01340937|530759120|FG003|Period 1: Infant Series|Physician Decision|0|||
147162555|NCT01340937|530759117|FG000|Period 1: Infant Series|Protocol Violation|1|||
147162556|NCT01340937|530759118|FG001|Period 1: Infant Series|Protocol Violation|4|||
147242596|NCT05683249|531059666|FG001|Overall Study|Non-compliance with Study Drug|0|||
147588203|NCT01685073|532307583|FG001|Overall Study|Lost to Follow-up|8|||
147162557|NCT01340937|530759119|FG002|Period 1: Infant Series|Protocol Violation|4|||
147162558|NCT01340937|530759120|FG003|Period 1: Infant Series|Protocol Violation|3|||
147162559|NCT01340937|530759117|FG000|Period 1: Infant Series|Withdrawal by Subject|33|||
147162560|NCT01340937|530759118|FG001|Period 1: Infant Series|Withdrawal by Subject|32|||
147162561|NCT01340937|530759119|FG002|Period 1: Infant Series|Withdrawal by Subject|30|||
147162562|NCT01340937|530759120|FG003|Period 1: Infant Series|Withdrawal by Subject|15|||
147162563|NCT01340937|530759117|FG000|Period 1: Infant Series|Randomized but not vaccinated|0|||
147162564|NCT01340937|530759118|FG001|Period 1: Infant Series|Randomized but not vaccinated|5|||
147162565|NCT01340937|530759119|FG002|Period 1: Infant Series|Randomized but not vaccinated|2|||
147162566|NCT01340937|530759120|FG003|Period 1: Infant Series|Randomized but not vaccinated|1|||
147162567|NCT01340937|530759117|FG000|Period 2: Interim Period|Withdrawal by Subject|28|||
147162568|NCT01340937|530759118|FG001|Period 2: Interim Period|Withdrawal by Subject|23|||
147162569|NCT01340937|530759119|FG002|Period 2: Interim Period|Withdrawal by Subject|17|||
147447451|NCT01806779|531802205|FG000|Overall Study|Lost to Follow-up|19|||
147588204|NCT01685073|532307582|FG000|Overall Study|Withdrawal by Subject|24|||
147588205|NCT01685073|532307583|FG001|Overall Study|Withdrawal by Subject|24|||
147588206|NCT00572039|532307586|FG000|Overall Study|Withdrawal by Subject|9|||
147588207|NCT00572039|532307587|FG001|Overall Study|Withdrawal by Subject|6|||
147588208|NCT00572039|532307586|FG000|Overall Study|Death|2|||
147588209|NCT00572039|532307587|FG001|Overall Study|Death|3|||
147588210|NCT00572039|532307586|FG000|Overall Study|Ill|5|||
147588211|NCT00572039|532307587|FG001|Overall Study|Ill|1|||
147588212|NCT03756883|532307588|FG000|Overall Study|Adverse Event|2|||
147588213|NCT03756883|532307589|FG001|Overall Study|Adverse Event|2|||
147588214|NCT03756883|532307590|FG002|Overall Study|Adverse Event|2|||
147588215|NCT03756883|532307588|FG000|Overall Study|Lack of Efficacy|0|||
147588216|NCT03756883|532307589|FG001|Overall Study|Lack of Efficacy|1|||
147588217|NCT03756883|532307590|FG002|Overall Study|Lack of Efficacy|2|||
147588218|NCT03756883|532307588|FG000|Overall Study|Lost to Follow-up|3|||
147588219|NCT03756883|532307589|FG001|Overall Study|Lost to Follow-up|3|||
147588220|NCT03756883|532307590|FG002|Overall Study|Lost to Follow-up|0|||
147242597|NCT05683249|531059665|FG000|Overall Study|Protocol Violation|6|||
147588221|NCT03756883|532307588|FG000|Overall Study|Protocol Violation|2|||
147588222|NCT03756883|532307589|FG001|Overall Study|Protocol Violation|0|||
147588223|NCT03756883|532307590|FG002|Overall Study|Protocol Violation|1|||
147588224|NCT03756883|532307588|FG000|Overall Study|Significant Worsening of Condition requiring Therapy|0|||
147588225|NCT03756883|532307589|FG001|Overall Study|Significant Worsening of Condition requiring Therapy|0|||
147588226|NCT03756883|532307590|FG002|Overall Study|Significant Worsening of Condition requiring Therapy|2|||
147588227|NCT03756883|532307588|FG000|Overall Study|Withdrawal by Subject|4|||
147588228|NCT03756883|532307589|FG001|Overall Study|Withdrawal by Subject|1|||
147588229|NCT03756883|532307590|FG002|Overall Study|Withdrawal by Subject|0|||
147588230|NCT03756883|532307588|FG000|Overall Study|Other Reasons|2|||
147588231|NCT03756883|532307589|FG001|Overall Study|Other Reasons|4|||
147588232|NCT03756883|532307590|FG002|Overall Study|Other Reasons|0|||
147588233|NCT01011556|532307597|FG000|Overall Study|Adverse Event|1|||
147588234|NCT01011556|532307598|FG001|Overall Study|Adverse Event|3|||
147588235|NCT01011556|532307599|FG002|Overall Study|Adverse Event|2|||
147588236|NCT01011556|532307600|FG003|Overall Study|Adverse Event|1|||
147588237|NCT01011556|532307597|FG000|Overall Study|Lost to Follow-up|1|||
147588238|NCT01011556|532307598|FG001|Overall Study|Lost to Follow-up|0|||
147588239|NCT01011556|532307599|FG002|Overall Study|Lost to Follow-up|0|||
147588240|NCT01011556|532307600|FG003|Overall Study|Lost to Follow-up|0|||
147588241|NCT01011556|532307597|FG000|Overall Study|Physician Decision|1|||
147588242|NCT01011556|532307598|FG001|Overall Study|Physician Decision|0|||
147588243|NCT01011556|532307599|FG002|Overall Study|Physician Decision|0|||
147588244|NCT01011556|532307600|FG003|Overall Study|Physician Decision|1|||
147588245|NCT01011556|532307597|FG000|Overall Study|Protocol Violation|0|||
147588246|NCT01011556|532307598|FG001|Overall Study|Protocol Violation|1|||
147588247|NCT01011556|532307599|FG002|Overall Study|Protocol Violation|0|||
147588248|NCT01011556|532307600|FG003|Overall Study|Protocol Violation|0|||
147588249|NCT01011556|532307597|FG000|Overall Study|Withdrawal by Subject|1|||
147588250|NCT01011556|532307598|FG001|Overall Study|Withdrawal by Subject|2|||
147588251|NCT01011556|532307599|FG002|Overall Study|Withdrawal by Subject|4|||
147588252|NCT01011556|532307600|FG003|Overall Study|Withdrawal by Subject|4|||
147588253|NCT01011556|532307597|FG000|Overall Study|Sponsor decision|0|||
147588254|NCT01011556|532307598|FG001|Overall Study|Sponsor decision|1|||
147588255|NCT01011556|532307599|FG002|Overall Study|Sponsor decision|1|||
147588256|NCT01011556|532307600|FG003|Overall Study|Sponsor decision|2|||
147588257|NCT01011556|532307597|FG000|Overall Study|Inclusion/exclusion criteria not met|2|||
147588258|NCT01011556|532307598|FG001|Overall Study|Inclusion/exclusion criteria not met|1|||
147588259|NCT01011556|532307599|FG002|Overall Study|Inclusion/exclusion criteria not met|3|||
147588260|NCT01011556|532307600|FG003|Overall Study|Inclusion/exclusion criteria not met|5|||
147588261|NCT02147587|532307602|FG000|Overall Study|Adverse Event|9|||
147588262|NCT02147587|532307603|FG001|Overall Study|Adverse Event|4|||
147588263|NCT02147587|532307602|FG000|Overall Study|Lack of Efficacy|2|||
147588264|NCT02147587|532307603|FG001|Overall Study|Lack of Efficacy|1|||
147588265|NCT01355302|532307604|FG000|Phase 1b|Death|4|||
147588266|NCT01355302|532307605|FG001|Phase 1b|Death|0|||
147588267|NCT01355302|532307606|FG002|Phase 1b|Death|0|||
147588268|NCT01355302|532307604|FG000|Phase 1b|Study terminated by sponsor|2|||
147588269|NCT01355302|532307605|FG001|Phase 1b|Study terminated by sponsor|0|||
147242598|NCT05683249|531059666|FG001|Overall Study|Protocol Violation|3|||
147242599|NCT05683249|531059665|FG000|Overall Study|Withdrawal by Subject|9|||
147242600|NCT05683249|531059666|FG001|Overall Study|Withdrawal by Subject|8|||
147242601|NCT05683249|531059665|FG000|Overall Study|Other|0|||
147242602|NCT05683249|531059666|FG001|Overall Study|Other|2|||
147242603|NCT05393895|531059667|FG000|Overall Study|Adverse Event|2|||
147588270|NCT01355302|532307606|FG002|Phase 1b|Study terminated by sponsor|0|||
147588271|NCT03649412|532307607|FG000|Part A, Washout Period 1 (7 Days)|Physician Decision|1|||
147588272|NCT03649412|532307608|FG001|Part A, Washout Period 1 (7 Days)|Physician Decision|0|||
147588273|NCT03649412|532307607|FG000|Part A, Washout Period 4 (7 Days)|Adverse Event|1|||
147588274|NCT03649412|532307608|FG001|Part A, Washout Period 4 (7 Days)|Adverse Event|0|||
147588275|NCT03649412|532307607|FG000|Part A, Washout Period 4 (7 Days)|Withdrawal by Subject|1|||
147654450|NCT03148067|532556736|FG000|Overall Study|Death|1|||
147588276|NCT03649412|532307608|FG001|Part A, Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
147588277|NCT03649412|532307607|FG000|Part A, Washout Period 5 (7 Days)|Adverse Event|1|||
147588278|NCT03649412|532307608|FG001|Part A, Washout Period 5 (7 Days)|Adverse Event|0|||
147588279|NCT03649412|532307607|FG000|Part B, Washout Period 1 (7 Days)|Adverse Event|0|||
147242604|NCT05393895|531059668|FG001|Overall Study|Adverse Event|3|||
147242605|NCT05393895|531059667|FG000|Overall Study|Lost to Follow-up|4|||
147588280|NCT03649412|532307608|FG001|Part B, Washout Period 1 (7 Days)|Adverse Event|1|||
147588281|NCT03649412|532307607|FG000|Part B, Washout Period 5 (7 Days)|Adverse Event|0|||
147588282|NCT03649412|532307608|FG001|Part B, Washout Period 5 (7 Days)|Adverse Event|1|||
147588283|NCT00865514|532307609|FG000|Overall Study|Infusion cost exceeded funding|2|||
147588284|NCT02865395|532307610|FG000|Overall Study|Physician Decision|6|||
147588285|NCT02865395|532307611|FG001|Overall Study|Physician Decision|10|||
147588286|NCT02865395|532307612|FG002|Overall Study|Physician Decision|7|||
147588287|NCT00530348|532307613|FG000|Overall Study|Adverse Event|5|||
147588288|NCT00530348|532307614|FG001|Overall Study|Adverse Event|1|||
147588289|NCT00530348|532307613|FG000|Overall Study|Death|0|||
147588290|NCT00530348|532307614|FG001|Overall Study|Death|1|||
147588291|NCT00530348|532307613|FG000|Overall Study|Lack of Efficacy|2|||
147588292|NCT00530348|532307614|FG001|Overall Study|Lack of Efficacy|0|||
147588293|NCT00530348|532307613|FG000|Overall Study|Lost to Follow-up|0|||
147588294|NCT00530348|532307614|FG001|Overall Study|Lost to Follow-up|2|||
147588295|NCT00530348|532307613|FG000|Overall Study|Physician Decision|1|||
147588296|NCT00530348|532307614|FG001|Overall Study|Physician Decision|2|||
147588297|NCT00530348|532307613|FG000|Overall Study|Pregnancy|1|||
147588298|NCT00530348|532307614|FG001|Overall Study|Pregnancy|0|||
147588299|NCT00530348|532307613|FG000|Overall Study|Withdrawal by Subject|12|||
147588300|NCT00530348|532307614|FG001|Overall Study|Withdrawal by Subject|12|||
147588301|NCT00530348|532307613|FG000|Overall Study|Randomised in error|1|||
147588302|NCT00530348|532307614|FG001|Overall Study|Randomised in error|0|||
147588303|NCT00530348|532307613|FG000|Overall Study|Noncompliance with inclusion criterion 3|0|||
147588304|NCT00530348|532307614|FG001|Overall Study|Noncompliance with inclusion criterion 3|1|||
147588305|NCT01557920|532307621|FG000|Overall Study|Withdrawal by Subject|2|||
147588306|NCT01557920|532307622|FG001|Overall Study|Withdrawal by Subject|3|||
147588307|NCT01557920|532307621|FG000|Overall Study|Lack of Efficacy|1|||
147588308|NCT01557920|532307622|FG001|Overall Study|Lack of Efficacy|0|||
147588309|NCT04220775|532307625|FG000|Overall Study|Adverse Event|1|||
147588310|NCT04220775|532307626|FG001|Overall Study|Adverse Event|0|||
147588311|NCT04220775|532307625|FG000|Overall Study|Disease Progression|1|||
147588312|NCT04220775|532307626|FG001|Overall Study|Disease Progression|0|||
147588313|NCT00089076|532307627|FG000|Overall Study|Alternate Therapy|1|||
147588314|NCT00089076|532307627|FG000|Overall Study|Withdrawal by Subject|2|||
147588315|NCT00089076|532307627|FG000|Overall Study|Progression|7|||
147588316|NCT00808509|532307628|FG000|Randomized Phase|Did not meet eligibility criteria|1|||
147588317|NCT00808509|532307629|FG001|Randomized Phase|Did not meet eligibility criteria|0|||
147588318|NCT00808509|532307628|FG000|Randomized Phase|Reduced methotrexate dose|1|||
147588319|NCT00808509|532307629|FG001|Randomized Phase|Reduced methotrexate dose|2|||
147588320|NCT00808509|532307628|FG000|Randomized Phase|Patient refused rescue therapy|0|||
147588321|NCT00808509|532307629|FG001|Randomized Phase|Patient refused rescue therapy|3|||
147588322|NCT00931463|532307630|FG000|Overall Study|Death|8|||
147588323|NCT00931463|532307631|FG001|Overall Study|Death|4|||
147588324|NCT00931463|532307630|FG000|Overall Study|Withdrawal by Subject|5|||
147588325|NCT00931463|532307631|FG001|Overall Study|Withdrawal by Subject|0|||
147588326|NCT00931463|532307630|FG000|Overall Study|Lost to Follow-up|4|||
147162570|NCT01340937|530759120|FG003|Period 2: Interim Period|Withdrawal by Subject|12|||
147162571|NCT01340937|530759117|FG000|Period 2: Interim Period|Adverse Event|1|||
147162572|NCT01340937|530759118|FG001|Period 2: Interim Period|Adverse Event|0|||
147162573|NCT01340937|530759119|FG002|Period 2: Interim Period|Adverse Event|1|||
147162574|NCT01340937|530759120|FG003|Period 2: Interim Period|Adverse Event|0|||
147588327|NCT00931463|532307631|FG001|Overall Study|Lost to Follow-up|1|||
147588328|NCT00436917|532307632|FG000|Overall Study|Withdrawal by Subject|13|||
147588329|NCT00436917|532307632|FG000|Overall Study|Adverse Event|2|||
147588330|NCT00436917|532307632|FG000|Overall Study|Physician Decision|1|||
147588331|NCT00436917|532307632|FG000|Overall Study|Death|1|||
147588332|NCT00436917|532307632|FG000|Overall Study|Lost to Follow-up|1|||
147588333|NCT00436917|532307632|FG000|Overall Study|Treatment for polymyalgia rheumatic|1|||
147588334|NCT00436917|532307632|FG000|Overall Study|Increased creatinine|1|||
147588335|NCT00436917|532307632|FG000|Overall Study|Personal conflicts of patient|1|||
147588336|NCT02169791|532307635|FG000|Overall Study|Death|6|||
147588337|NCT02169791|532307635|FG000|Overall Study|patient withdrew consent|1|||
147588338|NCT03170869|532307636|FG000|Overall Study|Protocol Violation|5|||
147588339|NCT03170869|532307636|FG000|Overall Study|Early study termination|3|||
147588340|NCT01040793|532307645|FG000|Overall Study|Adverse Event|5|||
147588341|NCT01040793|532307646|FG001|Overall Study|Adverse Event|3|||
147588342|NCT01040793|532307647|FG002|Overall Study|Adverse Event|0|||
147162575|NCT01340937|530759117|FG000|Period 2: Interim Period|Lost to Follow-up|29|||
147162576|NCT01340937|530759118|FG001|Period 2: Interim Period|Lost to Follow-up|48|||
147162577|NCT01340937|530759119|FG002|Period 2: Interim Period|Lost to Follow-up|53|||
147162578|NCT01340937|530759120|FG003|Period 2: Interim Period|Lost to Follow-up|23|||
147162579|NCT01340937|530759117|FG000|Period 2: Interim Period|Physician Decision|0|||
147162580|NCT01340937|530759118|FG001|Period 2: Interim Period|Physician Decision|1|||
147588343|NCT01040793|532307648|FG003|Overall Study|Adverse Event|2|||
147588344|NCT01040793|532307649|FG004|Overall Study|Adverse Event|2|||
147588345|NCT01040793|532307650|FG005|Overall Study|Adverse Event|1|||
147588346|NCT01040793|532307645|FG000|Overall Study|Protocol Violation|1|||
147588347|NCT01040793|532307646|FG001|Overall Study|Protocol Violation|1|||
147588348|NCT01040793|532307647|FG002|Overall Study|Protocol Violation|1|||
147588349|NCT01040793|532307648|FG003|Overall Study|Protocol Violation|0|||
147588350|NCT01040793|532307649|FG004|Overall Study|Protocol Violation|1|||
147588351|NCT01040793|532307650|FG005|Overall Study|Protocol Violation|0|||
147588352|NCT01040793|532307645|FG000|Overall Study|Lost to Follow-up|0|||
147588353|NCT01040793|532307646|FG001|Overall Study|Lost to Follow-up|1|||
147588354|NCT01040793|532307647|FG002|Overall Study|Lost to Follow-up|1|||
147162581|NCT01340937|530759119|FG002|Period 2: Interim Period|Physician Decision|1|||
147162582|NCT01340937|530759120|FG003|Period 2: Interim Period|Physician Decision|0|||
147162583|NCT01340937|530759117|FG000|Period 2: Interim Period|Protocol Violation|5|||
147162584|NCT01340937|530759118|FG001|Period 2: Interim Period|Protocol Violation|3|||
147162585|NCT01340937|530759119|FG002|Period 2: Interim Period|Protocol Violation|6|||
147162586|NCT01340937|530759120|FG003|Period 2: Interim Period|Protocol Violation|3|||
147162587|NCT01340937|530759117|FG000|Period 2: Interim Period|Technical problems|4|||
147162588|NCT01340937|530759118|FG001|Period 2: Interim Period|Technical problems|4|||
147162589|NCT01340937|530759119|FG002|Period 2: Interim Period|Technical problems|6|||
147162590|NCT01340937|530759120|FG003|Period 2: Interim Period|Technical problems|3|||
147162591|NCT01340937|530759117|FG000|Period 3: Toddler Vaccinations|Withdrawal by Subject|2|||
147162592|NCT01340937|530759118|FG001|Period 3: Toddler Vaccinations|Withdrawal by Subject|2|||
147162593|NCT01340937|530759119|FG002|Period 3: Toddler Vaccinations|Withdrawal by Subject|1|||
147162594|NCT01340937|530759120|FG003|Period 3: Toddler Vaccinations|Withdrawal by Subject|1|||
147162595|NCT01340937|530759117|FG000|Period 3: Toddler Vaccinations|Lost to Follow-up|6|||
147162596|NCT01340937|530759118|FG001|Period 3: Toddler Vaccinations|Lost to Follow-up|14|||
147242606|NCT05393895|531059668|FG001|Overall Study|Lost to Follow-up|3|||
147242607|NCT05393895|531059667|FG000|Overall Study|Protocol Violation|1|||
147242608|NCT05393895|531059668|FG001|Overall Study|Protocol Violation|0|||
147242609|NCT05393895|531059667|FG000|Overall Study|Withdrawal by Subject|1|||
147242610|NCT05393895|531059668|FG001|Overall Study|Withdrawal by Subject|4|||
147242611|NCT00968513|531059669|FG000|Overall Study|Death|4|||
147242612|NCT00968513|531059670|FG001|Overall Study|Death|10|||
147242613|NCT00968513|531059671|FG002|Overall Study|Death|15|||
147242614|NCT01964430|531059674|FG000|Pre-Treatment (Randomization) Period|Protocol Deviation|0|||
147242615|NCT01964430|531059675|FG001|Pre-Treatment (Randomization) Period|Protocol Deviation|2|||
147242616|NCT01964430|531059674|FG000|Pre-Treatment (Randomization) Period|Withdrawal by Subject|2|||
147242617|NCT01964430|531059675|FG001|Pre-Treatment (Randomization) Period|Withdrawal by Subject|9|||
147242618|NCT01964430|531059674|FG000|Pre-Treatment (Randomization) Period|Adverse Event|1|||
147242619|NCT01964430|531059675|FG001|Pre-Treatment (Randomization) Period|Adverse Event|0|||
147242620|NCT01964430|531059674|FG000|Treatment Period|Adverse Event|71|||
147242621|NCT01964430|531059675|FG001|Treatment Period|Adverse Event|37|||
147242622|NCT01964430|531059674|FG000|Treatment Period|Withdrawal by Subject|36|||
147242623|NCT01964430|531059675|FG001|Treatment Period|Withdrawal by Subject|27|||
147242624|NCT01964430|531059674|FG000|Treatment Period|Death|1|||
147242625|NCT01964430|531059675|FG001|Treatment Period|Death|3|||
147242626|NCT01964430|531059674|FG000|Treatment Period|Protocol Deviation|0|||
147242627|NCT01964430|531059675|FG001|Treatment Period|Protocol Deviation|1|||
147242628|NCT01964430|531059674|FG000|Treatment Period|Physician Decision|5|||
147242629|NCT01964430|531059675|FG001|Treatment Period|Physician Decision|4|||
147242630|NCT01964430|531059674|FG000|Treatment Period|Disease Relapse|28|||
147242631|NCT01964430|531059675|FG001|Treatment Period|Disease Relapse|38|||
147242632|NCT01964430|531059674|FG000|Treatment Period|Other reasons|1|||
147242633|NCT01964430|531059675|FG001|Treatment Period|Other reasons|3|||
147242634|NCT02002091|531059680|FG000|Screening|Lost to Follow-up|10|||
147242635|NCT02002091|531059681|FG001|Screening|Lost to Follow-up|12|||
147242636|NCT02002091|531059680|FG000|Screening|Death|3|||
147242637|NCT02002091|531059681|FG001|Screening|Death|2|||
147242638|NCT02083783|531059690|FG000|Overall Study|Withdrawal by Subject|1|||
147447452|NCT01806779|531802206|FG001|Overall Study|Lost to Follow-up|20|||
147162597|NCT01340937|530759119|FG002|Period 3: Toddler Vaccinations|Lost to Follow-up|7|||
147162598|NCT01340937|530759120|FG003|Period 3: Toddler Vaccinations|Lost to Follow-up|8|||
147242639|NCT02083783|531059691|FG001|Overall Study|Withdrawal by Subject|0|||
147322823|NCT02099539|531345489|FG002|Overall Study|Adverse Event|1|||
147588355|NCT01040793|532307648|FG003|Overall Study|Lost to Follow-up|0|||
147588356|NCT01040793|532307649|FG004|Overall Study|Lost to Follow-up|0|||
147162599|NCT01340937|530759117|FG000|Period 3: Toddler Vaccinations|Protocol Violation|0|||
147162600|NCT01340937|530759118|FG001|Period 3: Toddler Vaccinations|Protocol Violation|0|||
147242640|NCT04967443|531059694|FG000|Open Label Treatment|Death|1|||
147242641|NCT04967443|531059695|FG001|Open Label Treatment|Death|0|||
147242642|NCT04967443|531059696|FG002|Open Label Treatment|Death|0|||
147242643|NCT04967443|531059697|FG003|Open Label Treatment|Death|0|||
147242644|NCT04967443|531059698|FG004|Open Label Treatment|Death|0|||
147322824|NCT02099539|531345490|FG003|Overall Study|Adverse Event|1|||
147242645|NCT04967443|531059699|FG005|Open Label Treatment|Death|0|||
147588357|NCT01040793|532307650|FG005|Overall Study|Lost to Follow-up|0|||
147588358|NCT01040793|532307645|FG000|Overall Study|Withdrawal by Subject|0|||
147588359|NCT01040793|532307646|FG001|Overall Study|Withdrawal by Subject|0|||
147588360|NCT01040793|532307647|FG002|Overall Study|Withdrawal by Subject|0|||
147588361|NCT01040793|532307648|FG003|Overall Study|Withdrawal by Subject|2|||
147588362|NCT01040793|532307649|FG004|Overall Study|Withdrawal by Subject|0|||
147588363|NCT01040793|532307650|FG005|Overall Study|Withdrawal by Subject|0|||
147588364|NCT01040793|532307645|FG000|Overall Study|Other reasons not listed above|0|||
147162601|NCT01340937|530759119|FG002|Period 3: Toddler Vaccinations|Protocol Violation|0|||
147162602|NCT01340937|530759120|FG003|Period 3: Toddler Vaccinations|Protocol Violation|1|||
147162603|NCT01340937|530759117|FG000|Period 3: Toddler Vaccinations|Technical problem|1|||
147162604|NCT01340937|530759118|FG001|Period 3: Toddler Vaccinations|Technical problem|1|||
147162605|NCT01340937|530759119|FG002|Period 3: Toddler Vaccinations|Technical problem|1|||
147162606|NCT01340937|530759120|FG003|Period 3: Toddler Vaccinations|Technical problem|0|||
147162607|NCT00440310|530759121|FG000|Overall Study|Lost to Follow-up|4|||
147162608|NCT00440310|530759122|FG001|Overall Study|Lost to Follow-up|5|||
147162609|NCT00440310|530759121|FG000|Overall Study|Protocol Violation|0|||
147162610|NCT00440310|530759122|FG001|Overall Study|Protocol Violation|1|||
147162611|NCT00440310|530759121|FG000|Overall Study|Withdrawal by Subject|15|||
147162612|NCT00440310|530759122|FG001|Overall Study|Withdrawal by Subject|14|||
147162613|NCT00440310|530759121|FG000|Overall Study|No Reply at EOS|7|||
147162614|NCT00440310|530759122|FG001|Overall Study|No Reply at EOS|7|||
147162615|NCT00440310|530759121|FG000|Overall Study|Other|1|||
147242646|NCT04967443|531059700|FG006|Open Label Treatment|Death|0|||
147242647|NCT04967443|531059701|FG007|Open Label Treatment|Death|0|||
147242648|NCT04967443|531059694|FG000|Open Label Treatment|Lost to Follow-up|0|||
147242649|NCT04967443|531059695|FG001|Open Label Treatment|Lost to Follow-up|0|||
147242650|NCT04967443|531059696|FG002|Open Label Treatment|Lost to Follow-up|1|||
147242651|NCT04967443|531059697|FG003|Open Label Treatment|Lost to Follow-up|0|||
147242652|NCT04967443|531059698|FG004|Open Label Treatment|Lost to Follow-up|0|||
147242653|NCT04967443|531059699|FG005|Open Label Treatment|Lost to Follow-up|0|||
147242654|NCT04967443|531059700|FG006|Open Label Treatment|Lost to Follow-up|0|||
147242655|NCT04967443|531059701|FG007|Open Label Treatment|Lost to Follow-up|0|||
147242656|NCT04967443|531059694|FG000|Open Label Treatment|Withdrawal by Subject|0|||
147242657|NCT04967443|531059695|FG001|Open Label Treatment|Withdrawal by Subject|1|||
147242658|NCT04967443|531059696|FG002|Open Label Treatment|Withdrawal by Subject|0|||
147242659|NCT04967443|531059697|FG003|Open Label Treatment|Withdrawal by Subject|1|||
147242660|NCT04967443|531059698|FG004|Open Label Treatment|Withdrawal by Subject|0|||
147242661|NCT04967443|531059699|FG005|Open Label Treatment|Withdrawal by Subject|1|||
147242662|NCT04967443|531059700|FG006|Open Label Treatment|Withdrawal by Subject|2|||
147242663|NCT04967443|531059701|FG007|Open Label Treatment|Withdrawal by Subject|3|||
147242664|NCT04967443|531059694|FG000|Follow-Up|Death|1|||
147242665|NCT04967443|531059695|FG001|Follow-Up|Death|0|||
147242666|NCT04967443|531059696|FG002|Follow-Up|Death|0|||
147242667|NCT04967443|531059697|FG003|Follow-Up|Death|0|||
147242668|NCT04967443|531059698|FG004|Follow-Up|Death|0|||
147242669|NCT04967443|531059699|FG005|Follow-Up|Death|0|||
147242670|NCT04967443|531059700|FG006|Follow-Up|Death|0|||
147242671|NCT04967443|531059701|FG007|Follow-Up|Death|0|||
147242672|NCT04967443|531059694|FG000|Follow-Up|Lost to Follow-up|0|||
147242673|NCT04967443|531059695|FG001|Follow-Up|Lost to Follow-up|0|||
147242674|NCT04967443|531059696|FG002|Follow-Up|Lost to Follow-up|1|||
147242675|NCT04967443|531059697|FG003|Follow-Up|Lost to Follow-up|1|||
147242676|NCT04967443|531059698|FG004|Follow-Up|Lost to Follow-up|0|||
147242677|NCT04967443|531059699|FG005|Follow-Up|Lost to Follow-up|0|||
147242678|NCT04967443|531059700|FG006|Follow-Up|Lost to Follow-up|0|||
147242679|NCT04967443|531059701|FG007|Follow-Up|Lost to Follow-up|0|||
147242680|NCT04967443|531059694|FG000|Follow-Up|Withdrawal by Subject|0|||
147242681|NCT04967443|531059695|FG001|Follow-Up|Withdrawal by Subject|1|||
147242682|NCT04967443|531059696|FG002|Follow-Up|Withdrawal by Subject|0|||
147242683|NCT04967443|531059697|FG003|Follow-Up|Withdrawal by Subject|1|||
147588365|NCT01040793|532307646|FG001|Overall Study|Other reasons not listed above|0|||
147588366|NCT01040793|532307647|FG002|Overall Study|Other reasons not listed above|1|||
147588367|NCT01040793|532307648|FG003|Overall Study|Other reasons not listed above|0|||
147588368|NCT01040793|532307649|FG004|Overall Study|Other reasons not listed above|1|||
147588369|NCT01040793|532307650|FG005|Overall Study|Other reasons not listed above|0|||
147242684|NCT04967443|531059698|FG004|Follow-Up|Withdrawal by Subject|0|||
147242685|NCT04967443|531059699|FG005|Follow-Up|Withdrawal by Subject|1|||
147242686|NCT04967443|531059700|FG006|Follow-Up|Withdrawal by Subject|2|||
147242687|NCT04967443|531059701|FG007|Follow-Up|Withdrawal by Subject|3|||
147242688|NCT01654536|531059702|FG000|Overall Study|Lost to Follow-up|5|||
147162616|NCT00440310|530759122|FG001|Overall Study|Other|0|||
147242689|NCT01654536|531059703|FG001|Overall Study|Lost to Follow-up|5|||
147242690|NCT01654536|531059702|FG000|Overall Study|Physician Decision|12|||
147242691|NCT01654536|531059703|FG001|Overall Study|Physician Decision|8|||
147242692|NCT01654536|531059702|FG000|Overall Study|Withdrawal by Subject|27|||
147242693|NCT01654536|531059703|FG001|Overall Study|Withdrawal by Subject|25|||
147242694|NCT03943147|531059706|FG000|Open-Label MMF Run-in (Part A)|Other reasons|4|||
147242695|NCT03943147|531059707|FG001|Open-Label MMF Run-in (Part A)|Other reasons|0|||
147588370|NCT03942211|532307657|FG000|Overall Study|Death|1|||
147447453|NCT01806779|531802207|FG002|Overall Study|Lost to Follow-up|0|||
147447454|NCT01806779|531802205|FG000|Overall Study|Withdrawal by Subject|20|||
147588371|NCT03942211|532307658|FG001|Overall Study|Death|0|||
147654451|NCT04074330|532556742|FG000|Dose Escalation (up to 19.36 Months)|Death|0|||
147654452|NCT04074330|532556743|FG001|Dose Escalation (up to 19.36 Months)|Death|2|||
147654453|NCT04074330|532556744|FG002|Dose Escalation (up to 19.36 Months)|Death|0|||
147162617|NCT00440310|530759121|FG000|Overall Study|Status Unknown|1|||
147162618|NCT00440310|530759122|FG001|Overall Study|Status Unknown|3|||
147162619|NCT02469415|530759123|FG000|Overall Study|Withdrawal by Subject|1|||
147162620|NCT02469415|530759123|FG000|Overall Study|Investigational agent placed on hold|2|||
147162621|NCT02119156|530759124|FG000|Treatment Phase (Up to 52 Weeks)|Study Terminated By Sponsor|0|||
147588372|NCT03942211|532307657|FG000|Overall Study|Study terminated by sponsor|5|||
147588373|NCT03942211|532307658|FG001|Overall Study|Study terminated by sponsor|3|||
147588374|NCT03942211|532307657|FG000|Overall Study|Adverse Event|0|||
147588375|NCT03942211|532307658|FG001|Overall Study|Adverse Event|1|||
147588376|NCT04798482|532307659|FG000|Overall Study|Physician Decision|1|||
147588377|NCT04798482|532307659|FG000|Overall Study|Lost eligibility|1|||
147588378|NCT01930175|532307664|FG000|Core Study|Lost to Follow-up|0|||
147588379|NCT01930175|532307665|FG001|Core Study|Lost to Follow-up|1|||
147588380|NCT01930175|532307666|FG002|Core Study|Lost to Follow-up|0|||
147162622|NCT02119156|530759125|FG001|Treatment Phase (Up to 52 Weeks)|Study Terminated By Sponsor|0|||
147162623|NCT02119156|530759126|FG002|Treatment Phase (Up to 52 Weeks)|Study Terminated By Sponsor|1|||
147162624|NCT02119156|530759124|FG000|Treatment Phase (Up to 52 Weeks)|Withdrawal by Subject|4|||
147162625|NCT02119156|530759125|FG001|Treatment Phase (Up to 52 Weeks)|Withdrawal by Subject|0|||
147162626|NCT02119156|530759126|FG002|Treatment Phase (Up to 52 Weeks)|Withdrawal by Subject|0|||
147162627|NCT02119156|530759124|FG000|Treatment Phase (Up to 52 Weeks)|Protocol Violation|1|||
147162628|NCT02119156|530759125|FG001|Treatment Phase (Up to 52 Weeks)|Protocol Violation|2|||
147162629|NCT02119156|530759126|FG002|Treatment Phase (Up to 52 Weeks)|Protocol Violation|0|||
147162630|NCT02119156|530759124|FG000|Treatment Phase (Up to 52 Weeks)|Physician Decision|1|||
147162631|NCT02119156|530759125|FG001|Treatment Phase (Up to 52 Weeks)|Physician Decision|0|||
147162632|NCT02119156|530759126|FG002|Treatment Phase (Up to 52 Weeks)|Physician Decision|0|||
147162633|NCT02119156|530759124|FG000|Maintenance (Up to 48 Weeks of Year 2-4)|Study Terminated By Sponsor|0|||
147162634|NCT02119156|530759125|FG001|Maintenance (Up to 48 Weeks of Year 2-4)|Study Terminated By Sponsor|10|||
147162635|NCT02119156|530759126|FG002|Maintenance (Up to 48 Weeks of Year 2-4)|Study Terminated By Sponsor|7|||
147162636|NCT01998893|530759131|FG000|Overall Study|Adverse Event|2|||
147162637|NCT01998893|530759131|FG000|Overall Study|Death|1|||
147162638|NCT01998893|530759131|FG000|Overall Study|Lost to Follow-up|8|||
147162639|NCT01998893|530759131|FG000|Overall Study|Physician Decision|2|||
147162640|NCT01998893|530759131|FG000|Overall Study|Protocol Violation|2|||
147162641|NCT01998893|530759131|FG000|Overall Study|Withdrawal by Subject|1|||
147162642|NCT01998893|530759131|FG000|Overall Study|Transformation to high-grade lymphoma|1|||
147162643|NCT05136898|530759132|FG000|Overall Study|Adverse Event|2|||
147162644|NCT00867087|530759133|FG000|Overall Study|Other|1|||
147162645|NCT00867087|530759133|FG000|Overall Study|Withdrawal by Subject|4|||
147162646|NCT00867087|530759133|FG000|Overall Study|Death|37|||
147162647|NCT02334683|530759142|FG000|First 12 Week Period|Lost to Follow-up|1|||
147162648|NCT02334683|530759143|FG001|First 12 Week Period|Lost to Follow-up|0|||
147162649|NCT02334683|530759142|FG000|Second 12 Week Period|Adverse Event|0|||
147162650|NCT02334683|530759143|FG001|Second 12 Week Period|Adverse Event|1|||
147162651|NCT01891344|530759144|FG000|Overall Study|Ongoing|6|||
147162652|NCT01891344|530759145|FG001|Overall Study|Ongoing|2|||
147162653|NCT01891344|530759146|FG002|Overall Study|Ongoing|0|||
147162654|NCT01891344|530759147|FG003|Overall Study|Ongoing|1|||
147162655|NCT01891344|530759148|FG004|Overall Study|Ongoing|4|||
147162656|NCT01891344|530759149|FG005|Overall Study|Ongoing|1|||
147162657|NCT01891344|530759150|FG006|Overall Study|Ongoing|0|||
147162658|NCT01891344|530759151|FG007|Overall Study|Ongoing|0|||
147162659|NCT02969590|530759152|FG000|Screening Period|Hormones not suppressed post Lupron|1|||
147162660|NCT02969590|530759153|FG001|Screening Period|Hormones not suppressed post Lupron|0|||
147162661|NCT02969590|530759154|FG002|Screening Period|Hormones not suppressed post Lupron|0|||
147162662|NCT01414205|530759155|FG000|Overall Study|Death|5|||
147162663|NCT01414205|530759156|FG001|Overall Study|Death|1|||
147322825|NCT02099539|531345491|FG004|Overall Study|Adverse Event|0|||
147588381|NCT01930175|532307664|FG000|Core Study|Adverse Event|0|||
147654454|NCT04074330|532556745|FG003|Dose Escalation (up to 19.36 Months)|Death|1|||
147162664|NCT01414205|530759155|FG000|Overall Study|Lost to Follow-up|1|||
147162665|NCT01414205|530759156|FG001|Overall Study|Lost to Follow-up|4|||
147162666|NCT01414205|530759155|FG000|Overall Study|Physician Decision|0|||
147162667|NCT01414205|530759156|FG001|Overall Study|Physician Decision|1|||
147322826|NCT02099539|531345492|FG005|Overall Study|Adverse Event|0|||
147322827|NCT02099539|531345493|FG006|Overall Study|Adverse Event|0|||
147447455|NCT01806779|531802206|FG001|Overall Study|Withdrawal by Subject|23|||
147588382|NCT01930175|532307665|FG001|Core Study|Adverse Event|0|||
147588383|NCT01930175|532307666|FG002|Core Study|Adverse Event|1|||
147588384|NCT00605917|532307667|FG000|Overall Study|Protocol Violation|79|||
147588385|NCT00890552|532307669|FG000|Enrollment and Pre-treatment|Death/ lost to follow up|1|||
147588386|NCT00890552|532307669|FG000|On-treatment|Early prog disease/ death|10|||
147588387|NCT01506908|532307670|FG000|Overall Study|Adverse Event|1|||
147588388|NCT01506908|532307671|FG001|Overall Study|Adverse Event|0|||
147588389|NCT01117766|532307678|FG000|First Intervention|Adverse Event|0|||
147588390|NCT01117766|532307679|FG001|First Intervention|Adverse Event|1|||
147588391|NCT01117766|532307678|FG000|First Intervention|Protocol Violation|1|||
147588392|NCT01117766|532307679|FG001|First Intervention|Protocol Violation|0|||
147588393|NCT01117766|532307678|FG000|Washout Period|Protocol Violation|0|||
147588394|NCT01117766|532307679|FG001|Washout Period|Protocol Violation|2|||
147588395|NCT01117766|532307678|FG000|Second Intervention|Lost to Follow-up|1|||
147588396|NCT01117766|532307679|FG001|Second Intervention|Lost to Follow-up|0|||
147588397|NCT01117766|532307678|FG000|Second Intervention|Other|1|||
147588398|NCT01117766|532307679|FG001|Second Intervention|Other|2|||
147588399|NCT01117766|532307678|FG000|Second Intervention|Adverse Event|0|||
147588400|NCT01117766|532307679|FG001|Second Intervention|Adverse Event|2|||
147588401|NCT01117766|532307678|FG000|Second Intervention|Withdrawal by Subject|0|||
147588402|NCT01117766|532307679|FG001|Second Intervention|Withdrawal by Subject|1|||
147588403|NCT04405739|532307680|FG000|Overall Study|Adverse Event|0|||
147588404|NCT04405739|532307681|FG001|Overall Study|Adverse Event|1|||
147588405|NCT04405739|532307682|FG002|Overall Study|Adverse Event|0|||
147588406|NCT04405739|532307683|FG003|Overall Study|Adverse Event|0|||
147588407|NCT04405739|532307680|FG000|Overall Study|Lost to Follow-up|0|||
147588408|NCT04405739|532307681|FG001|Overall Study|Lost to Follow-up|2|||
147588409|NCT04405739|532307682|FG002|Overall Study|Lost to Follow-up|1|||
147588410|NCT04405739|532307683|FG003|Overall Study|Lost to Follow-up|3|||
147588411|NCT04405739|532307680|FG000|Overall Study|Withdrawal by Subject|0|||
147588412|NCT04405739|532307681|FG001|Overall Study|Withdrawal by Subject|2|||
147588413|NCT04405739|532307682|FG002|Overall Study|Withdrawal by Subject|1|||
147588414|NCT04405739|532307683|FG003|Overall Study|Withdrawal by Subject|1|||
147588415|NCT04405739|532307680|FG000|Overall Study|Death|0|||
147588416|NCT04405739|532307681|FG001|Overall Study|Death|0|||
147588417|NCT04405739|532307682|FG002|Overall Study|Death|1|||
147588418|NCT04405739|532307683|FG003|Overall Study|Death|0|||
147588419|NCT04405739|532307680|FG000|Overall Study|Transferred to rehab|0|||
147588420|NCT04405739|532307681|FG001|Overall Study|Transferred to rehab|0|||
147447456|NCT01806779|531802207|FG002|Overall Study|Withdrawal by Subject|22|||
147588421|NCT04405739|532307682|FG002|Overall Study|Transferred to rehab|0|||
147588422|NCT04405739|532307683|FG003|Overall Study|Transferred to rehab|1|||
147588423|NCT04405739|532307680|FG000|Overall Study|Pt. refused IP after 1 dose|0|||
147588424|NCT04405739|532307681|FG001|Overall Study|Pt. refused IP after 1 dose|0|||
147588425|NCT04405739|532307682|FG002|Overall Study|Pt. refused IP after 1 dose|0|||
147588426|NCT04405739|532307683|FG003|Overall Study|Pt. refused IP after 1 dose|1|||
147588427|NCT01436643|532307684|FG000|2-week Pre-treatment|Abnormal test result|0|||
147588428|NCT01436643|532307685|FG001|2-week Pre-treatment|Abnormal test result|0|||
147588429|NCT01436643|532307686|FG002|2-week Pre-treatment|Abnormal test result|0|||
147588430|NCT01436643|532307687|FG003|2-week Pre-treatment|Abnormal test result|1|||
147588431|NCT01436643|532307684|FG000|2-week Pre-treatment|Adverse Event|0|||
147588432|NCT01436643|532307685|FG001|2-week Pre-treatment|Adverse Event|0|||
147588433|NCT01436643|532307686|FG002|2-week Pre-treatment|Adverse Event|0|||
147588434|NCT01436643|532307687|FG003|2-week Pre-treatment|Adverse Event|5|||
147588435|NCT01436643|532307684|FG000|2-week Pre-treatment|Protocol Violation|0|||
147588436|NCT01436643|532307685|FG001|2-week Pre-treatment|Protocol Violation|0|||
147588437|NCT01436643|532307686|FG002|2-week Pre-treatment|Protocol Violation|0|||
147588438|NCT01436643|532307687|FG003|2-week Pre-treatment|Protocol Violation|4|||
147588439|NCT01436643|532307684|FG000|Core Phase (16 Weeks)|Adverse Event|0|||
147588440|NCT01436643|532307685|FG001|Core Phase (16 Weeks)|Adverse Event|3|||
147242696|NCT03943147|531059706|FG000|Open-Label MMF Run-in (Part A)|Adverse Event|1|||
147242697|NCT03943147|531059707|FG001|Open-Label MMF Run-in (Part A)|Adverse Event|0|||
147242698|NCT03943147|531059706|FG000|Open-Label MMF Run-in (Part A)|Non-compliance with study drug|1|||
147242699|NCT03943147|531059707|FG001|Open-Label MMF Run-in (Part A)|Non-compliance with study drug|0|||
147242700|NCT03943147|531059706|FG000|Open-Label MMF Run-in (Part A)|Protocol-specified withdrawal criterion met|1|||
147242701|NCT03943147|531059707|FG001|Open-Label MMF Run-in (Part A)|Protocol-specified withdrawal criterion met|0|||
147242702|NCT03943147|531059706|FG000|Open-Label MMF Run-in (Part A)|Study terminated by sponsor|3|||
147242703|NCT03943147|531059707|FG001|Open-Label MMF Run-in (Part A)|Study terminated by sponsor|0|||
147447457|NCT02595450|531802208|FG000|Overall Study|Unspecified (only completed 1 cycle)|73|||
147588441|NCT01436643|532307686|FG002|Core Phase (16 Weeks)|Adverse Event|1|||
147588442|NCT01436643|532307687|FG003|Core Phase (16 Weeks)|Adverse Event|0|||
147588443|NCT01436643|532307684|FG000|Core Phase (16 Weeks)|Abnormal Test result|0|||
147447458|NCT02595450|531802208|FG000|Overall Study|Enrolled, but not treated|8|||
147447459|NCT01934556|531802211|FG000|Overall Study|Withdrawal by Subject|0|||
147654455|NCT04074330|532556746|FG004|Dose Escalation (up to 19.36 Months)|Death|4|||
147588444|NCT01436643|532307685|FG001|Core Phase (16 Weeks)|Abnormal Test result|0|||
147588445|NCT01436643|532307686|FG002|Core Phase (16 Weeks)|Abnormal Test result|1|||
147588446|NCT01436643|532307687|FG003|Core Phase (16 Weeks)|Abnormal Test result|0|||
147447460|NCT01934556|531802212|FG001|Overall Study|Withdrawal by Subject|1|||
147447461|NCT01934556|531802213|FG002|Overall Study|Withdrawal by Subject|1|||
147447462|NCT01934556|531802211|FG000|Overall Study|Lost to Follow-up|4|||
147447463|NCT01934556|531802212|FG001|Overall Study|Lost to Follow-up|10|||
147447464|NCT01934556|531802213|FG002|Overall Study|Lost to Follow-up|7|||
147447465|NCT01934556|531802211|FG000|Overall Study|Death|1|||
147447466|NCT01934556|531802212|FG001|Overall Study|Death|5|||
147447467|NCT01934556|531802213|FG002|Overall Study|Death|2|||
147447468|NCT00102960|531802216|FG000|Overall Study|Death|23|||
147447469|NCT00102960|531802217|FG001|Overall Study|Death|11|||
147447470|NCT00102960|531802218|FG002|Overall Study|Death|11|||
147447471|NCT00102960|531802216|FG000|Overall Study|Lost to Follow-up|6|||
147447472|NCT00102960|531802217|FG001|Overall Study|Lost to Follow-up|12|||
147447473|NCT00102960|531802218|FG002|Overall Study|Lost to Follow-up|16|||
147447474|NCT00102960|531802216|FG000|Overall Study|Withdrawal by Subject|1|||
147447475|NCT00102960|531802217|FG001|Overall Study|Withdrawal by Subject|0|||
147447476|NCT00102960|531802218|FG002|Overall Study|Withdrawal by Subject|1|||
147447477|NCT03770260|531803849|FG000|Overall Study|Disease progression|0|||
147447478|NCT03770260|531803850|FG001|Overall Study|Disease progression|1|||
147447479|NCT03770260|531803851|FG002|Overall Study|Disease progression|0|||
147447480|NCT03770260|531803852|FG003|Overall Study|Disease progression|0|||
147447481|NCT01908101|531803859|FG000|Overall Study|Physician Decision|1|||
147447482|NCT01908101|531803859|FG000|Overall Study|Withdrawal by Subject|1|||
147447483|NCT01908101|531803859|FG000|Overall Study|Incorrect Diagnosis|2|||
147447484|NCT01908101|531803859|FG000|Overall Study|Incorrect Starting Dose|1|||
147447485|NCT01908101|531803859|FG000|Overall Study|Did not complete the first cycle|4|||
147447486|NCT02356562|531803863|FG000|Overall Study|Withdrawal by Subject|0|||
147447487|NCT02356562|531803864|FG001|Overall Study|Withdrawal by Subject|1|||
147447488|NCT02356562|531803863|FG000|Overall Study|Re-entered treatment in a previous study|1|||
147447489|NCT02356562|531803864|FG001|Overall Study|Re-entered treatment in a previous study|0|||
147447490|NCT02356562|531803863|FG000|Overall Study|site closure|1|||
147447491|NCT02356562|531803864|FG001|Overall Study|site closure|0|||
147447492|NCT00150592|531803865|FG000|Overall Study|Adverse Event|4|||
147447493|NCT00150592|531803866|FG001|Overall Study|Adverse Event|1|||
147447494|NCT00150592|531803865|FG000|Overall Study|Protocol Violation|1|||
147447495|NCT00150592|531803866|FG001|Overall Study|Protocol Violation|0|||
147447496|NCT00150592|531803865|FG000|Overall Study|Withdrawal by Subject|1|||
147447497|NCT00150592|531803866|FG001|Overall Study|Withdrawal by Subject|2|||
147447498|NCT00150592|531803865|FG000|Overall Study|Non-compliance|1|||
147447499|NCT00150592|531803866|FG001|Overall Study|Non-compliance|0|||
147447500|NCT00412750|531803867|FG000|Overall Study|Abnormal laboratory value(s)|1|||
147242704|NCT03943147|531059706|FG000|Blinded Treatment (Part B)|Study terminated by sponsor|3|||
147447501|NCT00412750|531803868|FG001|Overall Study|Abnormal laboratory value(s)|0|||
147447502|NCT00412750|531803869|FG002|Overall Study|Abnormal laboratory value(s)|0|||
147447503|NCT00412750|531803867|FG000|Overall Study|Administrative problems|21|||
147447504|NCT00412750|531803868|FG001|Overall Study|Administrative problems|17|||
147447505|NCT00412750|531803869|FG002|Overall Study|Administrative problems|14|||
147447506|NCT00412750|531803867|FG000|Overall Study|Adverse Event|8|||
147447507|NCT00412750|531803868|FG001|Overall Study|Adverse Event|3|||
147447508|NCT00412750|531803869|FG002|Overall Study|Adverse Event|3|||
147447509|NCT00412750|531803867|FG000|Overall Study|Lost to Follow-up|1|||
147447510|NCT00412750|531803868|FG001|Overall Study|Lost to Follow-up|0|||
147242705|NCT03943147|531059707|FG001|Blinded Treatment (Part B)|Study terminated by sponsor|0|||
147242706|NCT00629707|531059710|FG000|Overall Study|Withdrawal by Subject|0|||
147242707|NCT00629707|531059711|FG001|Overall Study|Withdrawal by Subject|1|||
147242708|NCT00629707|531059710|FG000|Overall Study|Physician Decision|0|||
147242709|NCT00629707|531059711|FG001|Overall Study|Physician Decision|1|||
147242710|NCT00968201|531059714|FG000|Base Study - (Period II)|Adverse Event|8|||
147242711|NCT00968201|531059715|FG001|Base Study - (Period II)|Adverse Event|0|||
147242712|NCT00968201|531059716|FG002|Base Study - (Period II)|Adverse Event|16|||
147242713|NCT00968201|531059714|FG000|Base Study - (Period II)|Lack of Efficacy|0|||
147242714|NCT00968201|531059715|FG001|Base Study - (Period II)|Lack of Efficacy|0|||
147242715|NCT00968201|531059716|FG002|Base Study - (Period II)|Lack of Efficacy|1|||
147242716|NCT00968201|531059714|FG000|Base Study - (Period II)|Lost to Follow-up|2|||
147447511|NCT00412750|531803869|FG002|Overall Study|Lost to Follow-up|1|||
147447512|NCT00412750|531803867|FG000|Overall Study|Withdrawal by Subject|0|||
147242717|NCT00968201|531059715|FG001|Base Study - (Period II)|Lost to Follow-up|0|||
147447513|NCT00412750|531803868|FG001|Overall Study|Withdrawal by Subject|1|||
147447514|NCT00412750|531803869|FG002|Overall Study|Withdrawal by Subject|2|||
147447515|NCT00412750|531803867|FG000|Overall Study|Lack of Efficacy|0|||
147447516|NCT00412750|531803868|FG001|Overall Study|Lack of Efficacy|0|||
147447517|NCT00412750|531803869|FG002|Overall Study|Lack of Efficacy|3|||
147447518|NCT00874120|531803877|FG000|First Intervention|Adverse Event|0|||
147447519|NCT00874120|531803878|FG001|First Intervention|Adverse Event|1|||
147447520|NCT00874120|531803877|FG000|First Intervention|Withdrawal by Subject|2|||
147242718|NCT00968201|531059716|FG002|Base Study - (Period II)|Lost to Follow-up|7|||
147447521|NCT00874120|531803878|FG001|First Intervention|Withdrawal by Subject|0|||
147588447|NCT01436643|532307684|FG000|Core Phase (16 Weeks)|Protocol Violation|1|||
147588448|NCT01436643|532307685|FG001|Core Phase (16 Weeks)|Protocol Violation|1|||
147588449|NCT01436643|532307686|FG002|Core Phase (16 Weeks)|Protocol Violation|1|||
147588450|NCT01436643|532307687|FG003|Core Phase (16 Weeks)|Protocol Violation|0|||
147588451|NCT01917968|532307688|FG000|Overall Study|Death|3|||
147588452|NCT01917968|532307689|FG001|Overall Study|Death|2|||
147588453|NCT01917968|532307688|FG000|Overall Study|Lost to Follow-up|21|||
147588454|NCT01917968|532307689|FG001|Overall Study|Lost to Follow-up|39|||
147588455|NCT01917968|532307688|FG000|Overall Study|Physician Decision|1|||
147588456|NCT01917968|532307689|FG001|Overall Study|Physician Decision|2|||
147162668|NCT01414205|530759155|FG000|Overall Study|Randomized but not Treated|1|||
147162669|NCT01414205|530759156|FG001|Overall Study|Randomized but not Treated|1|||
147162670|NCT02498067|530759157|FG000|Overall Study|Lost to Follow-up|22|||
147162671|NCT02498067|530759157|FG000|Overall Study|Did not meet inclusion criteria|11|||
147162672|NCT00541099|530759165|FG000|Overall Study|Ineligible|3|||
147162673|NCT00066469|530759166|FG000|Overall Study|Death|3|||
147162674|NCT00066469|530759166|FG000|Overall Study|Lack of Efficacy|9|||
147588457|NCT01917968|532307688|FG000|Overall Study|Withdrawal by Subject|20|||
147588458|NCT01917968|532307689|FG001|Overall Study|Withdrawal by Subject|35|||
147588459|NCT01917968|532307688|FG000|Overall Study|Subject Relocation|5|||
147588460|NCT01917968|532307689|FG001|Overall Study|Subject Relocation|1|||
147588461|NCT01917968|532307688|FG000|Overall Study|36M Missed Visit|3|||
147588462|NCT01917968|532307689|FG001|Overall Study|36M Missed Visit|2|||
147588463|NCT01917968|532307688|FG000|Overall Study|Subject Noncompliance to Scheduled 36M Follow Up Visit|1|||
147588464|NCT01917968|532307689|FG001|Overall Study|Subject Noncompliance to Scheduled 36M Follow Up Visit|0|||
147588465|NCT01917968|532307688|FG000|Overall Study|Change in Family Circumstances|0|||
147588466|NCT01917968|532307689|FG001|Overall Study|Change in Family Circumstances|1|||
147162675|NCT00066469|530759166|FG000|Overall Study|Lost to Follow-up|1|||
147162676|NCT00066469|530759166|FG000|Overall Study|Physician Decision|1|||
147588467|NCT01917968|532307688|FG000|Overall Study|No Data Available|0|||
147588468|NCT01917968|532307689|FG001|Overall Study|No Data Available|2|||
147588469|NCT01435928|532307690|FG000|Open Label Phase - up to 24 Weeks|Adverse Event|83|||
147588470|NCT01435928|532307691|FG001|Open Label Phase - up to 24 Weeks|Adverse Event|0|||
147588471|NCT01435928|532307692|FG002|Open Label Phase - up to 24 Weeks|Adverse Event|0|||
147588472|NCT01435928|532307690|FG000|Open Label Phase - up to 24 Weeks|Death|1|||
147588473|NCT01435928|532307691|FG001|Open Label Phase - up to 24 Weeks|Death|0|||
147588474|NCT01435928|532307692|FG002|Open Label Phase - up to 24 Weeks|Death|0|||
147588475|NCT01435928|532307690|FG000|Open Label Phase - up to 24 Weeks|Lack of Efficacy|46|||
147588476|NCT01435928|532307691|FG001|Open Label Phase - up to 24 Weeks|Lack of Efficacy|0|||
147588477|NCT01435928|532307692|FG002|Open Label Phase - up to 24 Weeks|Lack of Efficacy|0|||
147588478|NCT01435928|532307690|FG000|Open Label Phase - up to 24 Weeks|Lost to Follow-up|60|||
147588479|NCT01435928|532307691|FG001|Open Label Phase - up to 24 Weeks|Lost to Follow-up|0|||
147588480|NCT01435928|532307692|FG002|Open Label Phase - up to 24 Weeks|Lost to Follow-up|0|||
147588481|NCT01435928|532307690|FG000|Open Label Phase - up to 24 Weeks|Protocol Violation|39|||
147588482|NCT01435928|532307691|FG001|Open Label Phase - up to 24 Weeks|Protocol Violation|0|||
147162677|NCT00066469|530759166|FG000|Overall Study|Withdrawal by Subject|1|||
147162678|NCT00066469|530759166|FG000|Overall Study|ineligible|1|||
147162679|NCT00711802|530759167|FG000|Overall Study|Not treated (no further detail)|2|||
147162680|NCT00711802|530759168|FG001|Overall Study|Not treated (no further detail)|1|||
147162681|NCT00711802|530759169|FG002|Overall Study|Not treated (no further detail)|2|||
147162682|NCT00711802|530759170|FG003|Overall Study|Not treated (no further detail)|0|||
147162683|NCT00711802|530759171|FG004|Overall Study|Not treated (no further detail)|2|||
147162684|NCT00711802|530759172|FG005|Overall Study|Not treated (no further detail)|0|||
147162685|NCT00711802|530759173|FG006|Overall Study|Not treated (no further detail)|0|||
147162686|NCT00711802|530759174|FG007|Overall Study|Not treated (no further detail)|0|||
147162687|NCT00711802|530759167|FG000|Overall Study|Adverse Event|0|||
147162688|NCT00711802|530759168|FG001|Overall Study|Adverse Event|0|||
147162689|NCT00711802|530759169|FG002|Overall Study|Adverse Event|0|||
147162690|NCT00711802|530759170|FG003|Overall Study|Adverse Event|0|||
147588483|NCT01435928|532307692|FG002|Open Label Phase - up to 24 Weeks|Protocol Violation|0|||
147588484|NCT01435928|532307690|FG000|Open Label Phase - up to 24 Weeks|Withdrawal by Subject|96|||
147588485|NCT01435928|532307691|FG001|Open Label Phase - up to 24 Weeks|Withdrawal by Subject|0|||
147588486|NCT01435928|532307692|FG002|Open Label Phase - up to 24 Weeks|Withdrawal by Subject|0|||
147162691|NCT00711802|530759171|FG004|Overall Study|Adverse Event|1|||
147447522|NCT00874120|531803877|FG000|First Intervention|Lost to Follow-up|0|||
147447523|NCT00874120|531803878|FG001|First Intervention|Lost to Follow-up|1|||
147447524|NCT00874120|531803877|FG000|First Intervention|Protocol Violation|3|||
147162692|NCT00711802|530759172|FG005|Overall Study|Adverse Event|1|||
147162693|NCT00711802|530759173|FG006|Overall Study|Adverse Event|0|||
147447525|NCT00874120|531803878|FG001|First Intervention|Protocol Violation|0|||
147588487|NCT01435928|532307690|FG000|Open Label Phase - up to 24 Weeks|did not meet stabilization criteria|44|||
147588488|NCT01435928|532307691|FG001|Open Label Phase - up to 24 Weeks|did not meet stabilization criteria|0|||
147588489|NCT01435928|532307692|FG002|Open Label Phase - up to 24 Weeks|did not meet stabilization criteria|0|||
147588490|NCT01435928|532307690|FG000|Open Label Phase - up to 24 Weeks|Terminated at study completion|6|||
147588491|NCT01435928|532307691|FG001|Open Label Phase - up to 24 Weeks|Terminated at study completion|0|||
147588492|NCT01435928|532307692|FG002|Open Label Phase - up to 24 Weeks|Terminated at study completion|0|||
147588493|NCT01435928|532307690|FG000|Open Label Phase - up to 24 Weeks|Administrative|14|||
147588494|NCT01435928|532307691|FG001|Open Label Phase - up to 24 Weeks|Administrative|0|||
147588495|NCT01435928|532307692|FG002|Open Label Phase - up to 24 Weeks|Administrative|0|||
147588496|NCT01435928|532307690|FG000|Double Blind Phase - 28 Weeks|Adverse Event|0|||
147588497|NCT01435928|532307691|FG001|Double Blind Phase - 28 Weeks|Adverse Event|3|||
147588498|NCT01435928|532307692|FG002|Double Blind Phase - 28 Weeks|Adverse Event|1|||
147588499|NCT01435928|532307690|FG000|Double Blind Phase - 28 Weeks|Lost to Follow-up|0|||
147588500|NCT01435928|532307691|FG001|Double Blind Phase - 28 Weeks|Lost to Follow-up|2|||
147588501|NCT01435928|532307692|FG002|Double Blind Phase - 28 Weeks|Lost to Follow-up|5|||
147588502|NCT01435928|532307690|FG000|Double Blind Phase - 28 Weeks|Protocol Violation|0|||
147588503|NCT01435928|532307691|FG001|Double Blind Phase - 28 Weeks|Protocol Violation|11|||
147588504|NCT01435928|532307692|FG002|Double Blind Phase - 28 Weeks|Protocol Violation|4|||
147588505|NCT01435928|532307690|FG000|Double Blind Phase - 28 Weeks|Withdrawal by Subject|0|||
147588506|NCT01435928|532307691|FG001|Double Blind Phase - 28 Weeks|Withdrawal by Subject|5|||
147588507|NCT01435928|532307692|FG002|Double Blind Phase - 28 Weeks|Withdrawal by Subject|12|||
147588508|NCT01435928|532307690|FG000|Double Blind Phase - 28 Weeks|Terminated at study completion|0|||
147588509|NCT01435928|532307691|FG001|Double Blind Phase - 28 Weeks|Terminated at study completion|47|||
147588510|NCT01435928|532307692|FG002|Double Blind Phase - 28 Weeks|Terminated at study completion|39|||
147588511|NCT01435928|532307690|FG000|Double Blind Phase - 28 Weeks|Relapse criteria met|0|||
147162694|NCT00711802|530759174|FG007|Overall Study|Adverse Event|0|||
147162695|NCT00711802|530759167|FG000|Overall Study|Microbiological failure|0|||
147162696|NCT00711802|530759168|FG001|Overall Study|Microbiological failure|1|||
147162697|NCT00711802|530759169|FG002|Overall Study|Microbiological failure|0|||
147162698|NCT00711802|530759170|FG003|Overall Study|Microbiological failure|0|||
147588512|NCT01435928|532307691|FG001|Double Blind Phase - 28 Weeks|Relapse criteria met|43|||
147588513|NCT01435928|532307692|FG002|Double Blind Phase - 28 Weeks|Relapse criteria met|58|||
147162699|NCT00711802|530759171|FG004|Overall Study|Microbiological failure|0|||
147162700|NCT00711802|530759172|FG005|Overall Study|Microbiological failure|1|||
147162701|NCT00711802|530759173|FG006|Overall Study|Microbiological failure|0|||
147162702|NCT00711802|530759174|FG007|Overall Study|Microbiological failure|0|||
147162703|NCT00711802|530759167|FG000|Overall Study|Protocol Violation|0|||
147588514|NCT01435928|532307690|FG000|Double Blind Phase - 28 Weeks|Administrative|0|||
147588515|NCT01435928|532307691|FG001|Double Blind Phase - 28 Weeks|Administrative|5|||
147588516|NCT01435928|532307692|FG002|Double Blind Phase - 28 Weeks|Administrative|2|||
147588517|NCT02105701|532307694|FG000|Overall Study|Lost to Follow-up|1|||
147588518|NCT02105701|532307695|FG001|Overall Study|Lost to Follow-up|0|||
147588519|NCT02105701|532307696|FG002|Overall Study|Lost to Follow-up|2|||
147588520|NCT02105701|532307697|FG003|Overall Study|Lost to Follow-up|1|||
147588521|NCT02105701|532307694|FG000|Overall Study|Protocol Violation|0|||
147162704|NCT00711802|530759168|FG001|Overall Study|Protocol Violation|0|||
147162705|NCT00711802|530759169|FG002|Overall Study|Protocol Violation|0|||
147162706|NCT00711802|530759170|FG003|Overall Study|Protocol Violation|1|||
147162707|NCT00711802|530759171|FG004|Overall Study|Protocol Violation|0|||
147162708|NCT00711802|530759172|FG005|Overall Study|Protocol Violation|0|||
147162709|NCT00711802|530759173|FG006|Overall Study|Protocol Violation|0|||
147162710|NCT00711802|530759174|FG007|Overall Study|Protocol Violation|0|||
147162711|NCT00711802|530759167|FG000|Overall Study|Physician Decision|0|||
147162712|NCT00711802|530759168|FG001|Overall Study|Physician Decision|2|||
147162713|NCT00711802|530759169|FG002|Overall Study|Physician Decision|0|||
147162714|NCT00711802|530759170|FG003|Overall Study|Physician Decision|0|||
147162715|NCT00711802|530759171|FG004|Overall Study|Physician Decision|0|||
147162716|NCT00711802|530759172|FG005|Overall Study|Physician Decision|0|||
147162717|NCT00711802|530759173|FG006|Overall Study|Physician Decision|0|||
147162718|NCT00711802|530759174|FG007|Overall Study|Physician Decision|0|||
147162719|NCT00711802|530759167|FG000|Overall Study|Withdrawal by Subject|0|||
147162720|NCT00711802|530759168|FG001|Overall Study|Withdrawal by Subject|1|||
147162721|NCT00711802|530759169|FG002|Overall Study|Withdrawal by Subject|0|||
147162722|NCT00711802|530759170|FG003|Overall Study|Withdrawal by Subject|1|||
147162723|NCT00711802|530759171|FG004|Overall Study|Withdrawal by Subject|0|||
147162724|NCT00711802|530759172|FG005|Overall Study|Withdrawal by Subject|0|||
147162725|NCT00711802|530759173|FG006|Overall Study|Withdrawal by Subject|0|||
147162726|NCT00711802|530759174|FG007|Overall Study|Withdrawal by Subject|0|||
147162727|NCT00711802|530759167|FG000|Overall Study|Lost to Follow-up|0|||
147162728|NCT00711802|530759168|FG001|Overall Study|Lost to Follow-up|0|||
147162729|NCT00711802|530759169|FG002|Overall Study|Lost to Follow-up|3|||
147162730|NCT00711802|530759170|FG003|Overall Study|Lost to Follow-up|1|||
147162731|NCT00711802|530759171|FG004|Overall Study|Lost to Follow-up|10|||
147162732|NCT00711802|530759172|FG005|Overall Study|Lost to Follow-up|6|||
147162733|NCT00711802|530759173|FG006|Overall Study|Lost to Follow-up|4|||
147162734|NCT00711802|530759174|FG007|Overall Study|Lost to Follow-up|2|||
147162735|NCT00711802|530759167|FG000|Overall Study|Reason not reported|0|||
147588522|NCT02105701|532307695|FG001|Overall Study|Protocol Violation|0|||
147588523|NCT02105701|532307696|FG002|Overall Study|Protocol Violation|1|||
147588524|NCT02105701|532307697|FG003|Overall Study|Protocol Violation|0|||
147588525|NCT02105701|532307694|FG000|Overall Study|Withdrawal by Subject|2|||
147588526|NCT02105701|532307695|FG001|Overall Study|Withdrawal by Subject|1|||
147588527|NCT02105701|532307696|FG002|Overall Study|Withdrawal by Subject|0|||
147588528|NCT02105701|532307697|FG003|Overall Study|Withdrawal by Subject|1|||
147588529|NCT02105701|532307694|FG000|Overall Study|Death|1|||
147588530|NCT02105701|532307695|FG001|Overall Study|Death|0|||
147588531|NCT02105701|532307696|FG002|Overall Study|Death|0|||
147588532|NCT02105701|532307697|FG003|Overall Study|Death|0|||
147588533|NCT03234608|532307698|FG000|Overall Study|Lost to Follow-up|23|||
147588534|NCT03234608|532307699|FG001|Overall Study|Lost to Follow-up|21|||
147588535|NCT03693950|532307700|FG000|Overall Study|Withdrawal by Subject|1|||
147588536|NCT03693950|532307701|FG001|Overall Study|Withdrawal by Subject|0|||
147588537|NCT01362296|532307702|FG000|Randomized Phase (RP)|PD including Death due to PD|56|||
147588538|NCT01362296|532307703|FG001|Randomized Phase (RP)|PD including Death due to PD|28|||
147588539|NCT01362296|532307704|FG002|Randomized Phase (RP)|PD including Death due to PD|0|||
147588540|NCT01362296|532307705|FG003|Randomized Phase (RP)|PD including Death due to PD|0|||
147588541|NCT01362296|532307702|FG000|Randomized Phase (RP)|Physician Decision|1|||
147588542|NCT01362296|532307703|FG001|Randomized Phase (RP)|Physician Decision|9|||
147588543|NCT01362296|532307704|FG002|Randomized Phase (RP)|Physician Decision|0|||
147242719|NCT00968201|531059714|FG000|Base Study - (Period II)|Protocol Violation|12|||
147242720|NCT00968201|531059715|FG001|Base Study - (Period II)|Protocol Violation|0|||
147242721|NCT00968201|531059716|FG002|Base Study - (Period II)|Protocol Violation|12|||
147242722|NCT00968201|531059714|FG000|Base Study - (Period II)|Withdrawal by Subject|4|||
147242723|NCT00968201|531059715|FG001|Base Study - (Period II)|Withdrawal by Subject|0|||
147242724|NCT00968201|531059716|FG002|Base Study - (Period II)|Withdrawal by Subject|8|||
147242725|NCT00968201|531059714|FG000|Base Study - (Period II)|Site Error|0|||
147242726|NCT00968201|531059715|FG001|Base Study - (Period II)|Site Error|0|||
147242727|NCT00968201|531059716|FG002|Base Study - (Period II)|Site Error|1|||
147242728|NCT00968201|531059714|FG000|Extension Study - (Period III)|Adverse Event|0|||
147242729|NCT00968201|531059715|FG001|Extension Study - (Period III)|Adverse Event|5|||
147242730|NCT00968201|531059716|FG002|Extension Study - (Period III)|Adverse Event|22|||
147242731|NCT00968201|531059714|FG000|Extension Study - (Period III)|Lost to Follow-up|0|||
147242732|NCT00968201|531059715|FG001|Extension Study - (Period III)|Lost to Follow-up|7|||
147242733|NCT00968201|531059716|FG002|Extension Study - (Period III)|Lost to Follow-up|13|||
147242734|NCT00968201|531059714|FG000|Extension Study - (Period III)|Protocol Violation|0|||
147242735|NCT00968201|531059715|FG001|Extension Study - (Period III)|Protocol Violation|17|||
147242736|NCT00968201|531059716|FG002|Extension Study - (Period III)|Protocol Violation|14|||
147242737|NCT00968201|531059714|FG000|Extension Study - (Period III)|Withdrawal by Subject|0|||
147242738|NCT00968201|531059715|FG001|Extension Study - (Period III)|Withdrawal by Subject|20|||
147242739|NCT00968201|531059716|FG002|Extension Study - (Period III)|Withdrawal by Subject|40|||
147242740|NCT00968201|531059714|FG000|Extension Study - (Period III)|Patient Relocated|0|||
147242741|NCT00968201|531059715|FG001|Extension Study - (Period III)|Patient Relocated|1|||
147242742|NCT00968201|531059716|FG002|Extension Study - (Period III)|Patient Relocated|1|||
147242743|NCT00968201|531059714|FG000|Extension Study - (Period III)|Noncompliance|0|||
147242744|NCT00968201|531059715|FG001|Extension Study - (Period III)|Noncompliance|0|||
147242745|NCT00968201|531059716|FG002|Extension Study - (Period III)|Noncompliance|3|||
147242746|NCT00968201|531059714|FG000|Extension Study - (Period III)|Other|0|||
147242747|NCT00968201|531059715|FG001|Extension Study - (Period III)|Other|0|||
147242748|NCT00968201|531059716|FG002|Extension Study - (Period III)|Other|2|||
147242749|NCT00968201|531059714|FG000|Extension Study - (Period III)|Study Terminated for Admin Reasons|0|||
147242750|NCT00968201|531059715|FG001|Extension Study - (Period III)|Study Terminated for Admin Reasons|74|||
147242751|NCT00968201|531059716|FG002|Extension Study - (Period III)|Study Terminated for Admin Reasons|185|||
147242752|NCT03736447|531059717|FG000|Overall Study|Adverse Event|5|||
147242753|NCT03736447|531059718|FG001|Overall Study|Adverse Event|1|||
147242754|NCT03736447|531059717|FG000|Overall Study|Withdrawal by Subject|5|||
147242755|NCT03736447|531059718|FG001|Overall Study|Withdrawal by Subject|1|||
147242756|NCT03736447|531059717|FG000|Overall Study|Lost to Follow-up|1|||
147242757|NCT03736447|531059718|FG001|Overall Study|Lost to Follow-up|0|||
147588544|NCT01362296|532307705|FG003|Randomized Phase (RP)|Physician Decision|0|||
147588545|NCT01362296|532307702|FG000|Randomized Phase (RP)|Withdrawal by Subject|2|||
147242758|NCT03736447|531059717|FG000|Overall Study|Physician Decision|1|||
147242759|NCT03736447|531059718|FG001|Overall Study|Physician Decision|0|||
147242760|NCT03736447|531059717|FG000|Overall Study|Continued commitment to study treatment|3|||
147242761|NCT03736447|531059718|FG001|Overall Study|Continued commitment to study treatment|0|||
147242762|NCT03736447|531059717|FG000|Overall Study|Taste aversion to study product|0|||
147242763|NCT03736447|531059718|FG001|Overall Study|Taste aversion to study product|1|||
147242764|NCT02619175|531059719|FG000|Overall Study|Withdrawal by Subject|1|||
147588546|NCT01362296|532307703|FG001|Randomized Phase (RP)|Withdrawal by Subject|1|||
147588547|NCT01362296|532307704|FG002|Randomized Phase (RP)|Withdrawal by Subject|0|||
147588548|NCT01362296|532307705|FG003|Randomized Phase (RP)|Withdrawal by Subject|0|||
147588549|NCT01362296|532307702|FG000|Randomized Phase (RP)|Adverse Event|20|||
147588550|NCT01362296|532307703|FG001|Randomized Phase (RP)|Adverse Event|4|||
147588551|NCT01362296|532307704|FG002|Randomized Phase (RP)|Adverse Event|0|||
147588552|NCT01362296|532307705|FG003|Randomized Phase (RP)|Adverse Event|0|||
147588553|NCT01362296|532307702|FG000|Randomized Phase (RP)|Study Closed/Terminated|8|||
147588554|NCT01362296|532307703|FG001|Randomized Phase (RP)|Study Closed/Terminated|1|||
147588555|NCT01362296|532307704|FG002|Randomized Phase (RP)|Study Closed/Terminated|0|||
147588556|NCT01362296|532307705|FG003|Randomized Phase (RP)|Study Closed/Terminated|0|||
147588557|NCT01362296|532307702|FG000|Crossover Phase|PD including Death due to PD|0|||
147588558|NCT01362296|532307703|FG001|Crossover Phase|PD including Death due to PD|0|||
147588559|NCT01362296|532307704|FG002|Crossover Phase|PD including Death due to PD|16|||
147588560|NCT01362296|532307705|FG003|Crossover Phase|PD including Death due to PD|1|||
147588561|NCT01362296|532307702|FG000|Crossover Phase|Withdrawal by Subject|0|||
147588562|NCT01362296|532307703|FG001|Crossover Phase|Withdrawal by Subject|0|||
147162736|NCT00711802|530759168|FG001|Overall Study|Reason not reported|1|||
147162737|NCT00711802|530759169|FG002|Overall Study|Reason not reported|1|||
147162738|NCT00711802|530759170|FG003|Overall Study|Reason not reported|0|||
147162739|NCT00711802|530759171|FG004|Overall Study|Reason not reported|1|||
147162740|NCT00711802|530759172|FG005|Overall Study|Reason not reported|0|||
147162741|NCT00711802|530759173|FG006|Overall Study|Reason not reported|1|||
147162742|NCT00711802|530759174|FG007|Overall Study|Reason not reported|0|||
147162743|NCT02370095|530759175|FG000|Overall Study|Withdrawal by Subject|0|||
147162744|NCT02370095|530759176|FG001|Overall Study|Withdrawal by Subject|1|||
147162745|NCT00581828|530759177|FG000|Overall Study|Protocol Violation|1|||
147162746|NCT01667562|530759178|FG000|Diagnostic Phase|Started Erlotinib in Treatment Period|30|||
147162747|NCT01667562|530759179|FG001|Diagnostic Phase|Started Erlotinib in Treatment Period|0|||
147162748|NCT01667562|530759178|FG000|Erlotinib Phase|Lost to Follow-up|0|||
147162749|NCT01667562|530759179|FG001|Erlotinib Phase|Lost to Follow-up|1|||
147162750|NCT01667562|530759178|FG000|Erlotinib Phase|Adverse Event|0|||
147162751|NCT01667562|530759179|FG001|Erlotinib Phase|Adverse Event|1|||
147162752|NCT01667562|530759178|FG000|Erlotinib Phase|Switch to Commercial Drug|0|||
147162753|NCT01667562|530759179|FG001|Erlotinib Phase|Switch to Commercial Drug|1|||
147162754|NCT01129882|530759180|FG000|Overall Study|Adverse Event|39|||
147162755|NCT01129882|530759180|FG000|Overall Study|Death|6|||
147162756|NCT01129882|530759180|FG000|Overall Study|Lack of Efficacy|5|||
147162757|NCT01129882|530759180|FG000|Overall Study|Lost to Follow-up|13|||
147162758|NCT01129882|530759180|FG000|Overall Study|Physician Decision|27|||
147162759|NCT01129882|530759180|FG000|Overall Study|Protocol Deviation|3|||
147162760|NCT01129882|530759180|FG000|Overall Study|Withdrawal Criteria Met|19|||
147162761|NCT01129882|530759180|FG000|Overall Study|Trial Termination by Sponsor|6|||
147162762|NCT01129882|530759180|FG000|Overall Study|Withdrawal by Subject|160|||
147162763|NCT02130986|530759181|FG000|Overall Study|Withdrawal by Subject|4|||
147162764|NCT02130986|530759182|FG001|Overall Study|Withdrawal by Subject|4|||
147162765|NCT02130986|530759181|FG000|Overall Study|Lost to Follow-up|151|||
147162766|NCT02130986|530759182|FG001|Overall Study|Lost to Follow-up|160|||
147162767|NCT02305849|530759183|FG000|Overall Study|Adverse Event|10|||
147162768|NCT02305849|530759184|FG001|Overall Study|Adverse Event|12|||
147162769|NCT02305849|530759185|FG002|Overall Study|Adverse Event|7|||
147162770|NCT02305849|530759186|FG003|Overall Study|Adverse Event|3|||
147162771|NCT02305849|530759183|FG000|Overall Study|Lack of Efficacy|10|||
147162772|NCT02305849|530759184|FG001|Overall Study|Lack of Efficacy|6|||
147162773|NCT02305849|530759185|FG002|Overall Study|Lack of Efficacy|3|||
147162774|NCT02305849|530759186|FG003|Overall Study|Lack of Efficacy|9|||
147162775|NCT02305849|530759183|FG000|Overall Study|Withdrawal by Subject|2|||
147162776|NCT02305849|530759184|FG001|Overall Study|Withdrawal by Subject|2|||
147162777|NCT02305849|530759185|FG002|Overall Study|Withdrawal by Subject|1|||
147162778|NCT02305849|530759186|FG003|Overall Study|Withdrawal by Subject|4|||
147162779|NCT02305849|530759183|FG000|Overall Study|Lost to Follow-up|0|||
147162780|NCT02305849|530759184|FG001|Overall Study|Lost to Follow-up|2|||
147162781|NCT02305849|530759185|FG002|Overall Study|Lost to Follow-up|0|||
147162782|NCT02305849|530759186|FG003|Overall Study|Lost to Follow-up|0|||
147162783|NCT02305849|530759183|FG000|Overall Study|Protocol Violation|3|||
147162784|NCT02305849|530759184|FG001|Overall Study|Protocol Violation|2|||
147162785|NCT02305849|530759185|FG002|Overall Study|Protocol Violation|1|||
147162786|NCT02305849|530759186|FG003|Overall Study|Protocol Violation|1|||
147242765|NCT02619175|531059720|FG001|Overall Study|Withdrawal by Subject|0|||
147242766|NCT02619175|531059719|FG000|Overall Study|foot pain|1|||
147162787|NCT02305849|530759183|FG000|Overall Study|Lab data met discontinuation criteria|0|||
147242767|NCT02619175|531059720|FG001|Overall Study|foot pain|0|||
147162788|NCT02305849|530759184|FG001|Overall Study|Lab data met discontinuation criteria|1|||
147162789|NCT02305849|530759185|FG002|Overall Study|Lab data met discontinuation criteria|2|||
147162790|NCT02305849|530759186|FG003|Overall Study|Lab data met discontinuation criteria|1|||
147162791|NCT02305849|530759183|FG000|Overall Study|Miscellaneous|1|||
147162792|NCT02305849|530759184|FG001|Overall Study|Miscellaneous|2|||
147242768|NCT02657369|531059721|FG000|Overall Study|Death|27|||
147588563|NCT01362296|532307704|FG002|Crossover Phase|Withdrawal by Subject|2|||
147588564|NCT01362296|532307705|FG003|Crossover Phase|Withdrawal by Subject|1|||
147588565|NCT01362296|532307702|FG000|Crossover Phase|Adverse Event|0|||
147588566|NCT01362296|532307703|FG001|Crossover Phase|Adverse Event|0|||
147588567|NCT01362296|532307704|FG002|Crossover Phase|Adverse Event|4|||
147588568|NCT01362296|532307705|FG003|Crossover Phase|Adverse Event|0|||
147588569|NCT01362296|532307702|FG000|Crossover Phase|Study Closed/Terminated|0|||
147588570|NCT01362296|532307703|FG001|Crossover Phase|Study Closed/Terminated|0|||
147588571|NCT01362296|532307704|FG002|Crossover Phase|Study Closed/Terminated|1|||
147588572|NCT01362296|532307705|FG003|Crossover Phase|Study Closed/Terminated|0|||
147588573|NCT00248170|532307706|FG000|Overall Study|Withdrawal by Subject|71|||
147588574|NCT00248170|532307707|FG001|Overall Study|Withdrawal by Subject|79|||
147588575|NCT00248170|532307706|FG000|Overall Study|Protocol Violation|35|||
147588576|NCT00248170|532307707|FG001|Overall Study|Protocol Violation|30|||
147588577|NCT00248170|532307706|FG000|Overall Study|Lost to Follow-up|28|||
147588578|NCT00248170|532307707|FG001|Overall Study|Lost to Follow-up|35|||
147588579|NCT00248170|532307706|FG000|Overall Study|Disease progression|196|||
147588580|NCT00248170|532307707|FG001|Overall Study|Disease progression|216|||
147588581|NCT00248170|532307706|FG000|Overall Study|Death|28|||
147588582|NCT00248170|532307707|FG001|Overall Study|Death|47|||
147588583|NCT00248170|532307706|FG000|Overall Study|Adverse Event|311|||
147588584|NCT00248170|532307707|FG001|Overall Study|Adverse Event|296|||
147588585|NCT00248170|532307706|FG000|Overall Study|Administrative problems|22|||
147588586|NCT00248170|532307707|FG001|Overall Study|Administrative problems|25|||
147588587|NCT00248170|532307706|FG000|Overall Study|Abnormal test procedure(s) result|49|||
147588588|NCT00248170|532307707|FG001|Overall Study|Abnormal test procedure(s) result|61|||
147588589|NCT00248170|532307706|FG000|Overall Study|Abnormal laboratory values|4|||
147588590|NCT00248170|532307707|FG001|Overall Study|Abnormal laboratory values|0|||
147588591|NCT00248170|532307706|FG000|Overall Study|Protocol deviation|17|||
147588592|NCT00248170|532307707|FG001|Overall Study|Protocol deviation|19|||
147588593|NCT03123783|532307708|FG000|Phase 1b|Removed from treatment prior to APX005M administration|0|||
147588594|NCT03123783|532307709|FG001|Phase 1b|Removed from treatment prior to APX005M administration|1|||
147588595|NCT03123783|532307710|FG002|Phase 1b|Removed from treatment prior to APX005M administration|0|||
147588596|NCT03123783|532307711|FG003|Phase 1b|Removed from treatment prior to APX005M administration|0|||
147588597|NCT03123783|532307712|FG004|Phase 1b|Removed from treatment prior to APX005M administration|0|||
147588598|NCT03123783|532307713|FG005|Phase 1b|Removed from treatment prior to APX005M administration|0|||
147588599|NCT03123783|532307714|FG006|Phase 1b|Removed from treatment prior to APX005M administration|0|||
147588600|NCT03123783|532307708|FG000|Phase 1b|Participants rolled over to Phase 2|0|||
147588601|NCT03123783|532307709|FG001|Phase 1b|Participants rolled over to Phase 2|0|||
147588602|NCT03123783|532307710|FG002|Phase 1b|Participants rolled over to Phase 2|3|||
147588603|NCT03123783|532307711|FG003|Phase 1b|Participants rolled over to Phase 2|0|||
147588604|NCT03123783|532307712|FG004|Phase 1b|Participants rolled over to Phase 2|0|||
147588605|NCT03123783|532307713|FG005|Phase 1b|Participants rolled over to Phase 2|0|||
147588606|NCT03123783|532307714|FG006|Phase 1b|Participants rolled over to Phase 2|0|||
147588607|NCT03123783|532307708|FG000|Phase 2|No post baseline tumor assesment on treatment period|0|||
147588608|NCT03123783|532307709|FG001|Phase 2|No post baseline tumor assesment on treatment period|0|||
147588609|NCT03123783|532307710|FG002|Phase 2|No post baseline tumor assesment on treatment period|0|||
147588610|NCT03123783|532307711|FG003|Phase 2|No post baseline tumor assesment on treatment period|5|||
147588611|NCT03123783|532307712|FG004|Phase 2|No post baseline tumor assesment on treatment period|2|||
147588612|NCT03123783|532307713|FG005|Phase 2|No post baseline tumor assesment on treatment period|2|||
147588613|NCT03123783|532307714|FG006|Phase 2|No post baseline tumor assesment on treatment period|3|||
147588614|NCT03123783|532307708|FG000|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|0|||
147588615|NCT03123783|532307709|FG001|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|0|||
147588616|NCT03123783|532307710|FG002|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|0|||
147588617|NCT03123783|532307711|FG003|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|0|||
147588618|NCT03123783|532307712|FG004|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|3|||
147588619|NCT03123783|532307713|FG005|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|0|||
147588620|NCT03123783|532307714|FG006|Phase 2|Prior systemic therapy not allowed (1 patient did not complete post baseline tumor assessment)|0|||
147162793|NCT02305849|530759185|FG002|Overall Study|Miscellaneous|4|||
147162794|NCT02305849|530759186|FG003|Overall Study|Miscellaneous|1|||
147162795|NCT02305849|530759183|FG000|Overall Study|Not fulfill eligibility criteria|1|||
147162796|NCT02305849|530759184|FG001|Overall Study|Not fulfill eligibility criteria|1|||
147162797|NCT02305849|530759185|FG002|Overall Study|Not fulfill eligibility criteria|0|||
147162798|NCT02305849|530759186|FG003|Overall Study|Not fulfill eligibility criteria|0|||
147162799|NCT00355342|530759187|FG000|Overall Study|Adverse Event|13|||
147162800|NCT00355342|530759188|FG001|Overall Study|Adverse Event|15|||
147242769|NCT02657369|531059721|FG000|Overall Study|Study terminated by sponsor|7|||
147588621|NCT00749411|532307715|FG000|Overall Study|Adverse Event|0|||
147588622|NCT00749411|532307716|FG001|Overall Study|Adverse Event|2|||
147588623|NCT00749411|532307715|FG000|Overall Study|Lack of Efficacy|0|||
147588624|NCT00749411|532307716|FG001|Overall Study|Lack of Efficacy|1|||
147447526|NCT00874120|531803877|FG000|First Intervention|positive drug test|1|||
147447527|NCT00874120|531803878|FG001|First Intervention|positive drug test|0|||
147447528|NCT00874120|531803877|FG000|Second Intervention|Withdrawal by Subject|1|||
147447529|NCT00874120|531803878|FG001|Second Intervention|Withdrawal by Subject|0|||
147447530|NCT00874120|531803877|FG000|Second Intervention|Protocol Violation|1|||
147447531|NCT00874120|531803878|FG001|Second Intervention|Protocol Violation|0|||
147588625|NCT00749411|532307715|FG000|Overall Study|Protocol Violation|1|||
147588626|NCT00749411|532307716|FG001|Overall Study|Protocol Violation|1|||
147588627|NCT00749411|532307715|FG000|Overall Study|Protocol-defined stopping criteria|0|||
147588628|NCT00749411|532307716|FG001|Overall Study|Protocol-defined stopping criteria|1|||
147588629|NCT00880087|532309913|FG000|Overall Study|Lost to Follow-up|0|||
147588630|NCT00880087|532309914|FG001|Overall Study|Lost to Follow-up|2|||
147588631|NCT01005329|532309918|FG000|Overall Study|Ineligible or received no protocol trt.|4|||
147588632|NCT00126126|532309921|FG000|Overall Study|Lost to Follow-up|0|||
147588633|NCT00126126|532309922|FG001|Overall Study|Lost to Follow-up|2|||
147588634|NCT00986570|532309926|FG000|Overall Study|Lost to Follow-up|6|||
147588635|NCT00986570|532309926|FG000|Overall Study|Potential bias for objective assessment|1|||
147588636|NCT02225665|532309927|FG000|Overall Study|Subject moved from area and finds it difficult to return for visits.|1|||
147588637|NCT02225665|532309928|FG001|Overall Study|Subject moved from area and finds it difficult to return for visits.|0|||
147588638|NCT02225665|532309927|FG000|Overall Study|Subject restarted HAART prior to month 18.|0|||
147588639|NCT02225665|532309928|FG001|Overall Study|Subject restarted HAART prior to month 18.|1|||
147588640|NCT01470417|532309931|FG000|Overall Study|Disease progression|0|||
147588641|NCT01470417|532309932|FG001|Overall Study|Disease progression|2|||
147588642|NCT02973321|532309935|FG000|Overall Study|Other than specified|0|||
147588643|NCT02973321|532309936|FG001|Overall Study|Other than specified|5|||
147588644|NCT02973321|532309937|FG002|Overall Study|Other than specified|3|||
147588645|NCT02973321|532309938|FG003|Overall Study|Other than specified|3|||
147588646|NCT02973321|532309939|FG004|Overall Study|Other than specified|1|||
147588647|NCT02973321|532309935|FG000|Overall Study|Lack of Efficacy|0|||
147588648|NCT02973321|532309936|FG001|Overall Study|Lack of Efficacy|0|||
147588649|NCT02973321|532309937|FG002|Overall Study|Lack of Efficacy|0|||
147588650|NCT02973321|532309938|FG003|Overall Study|Lack of Efficacy|0|||
147588651|NCT02973321|532309939|FG004|Overall Study|Lack of Efficacy|1|||
147588652|NCT02973321|532309935|FG000|Overall Study|Adverse Event|1|||
147588653|NCT02973321|532309936|FG001|Overall Study|Adverse Event|10|||
147588654|NCT02973321|532309937|FG002|Overall Study|Adverse Event|11|||
147588655|NCT02973321|532309938|FG003|Overall Study|Adverse Event|13|||
147588656|NCT02973321|532309939|FG004|Overall Study|Adverse Event|3|||
147588657|NCT01098110|532309940|FG000|Overall Study|Withdrawal by Subject|14|||
147588658|NCT01098110|532309941|FG001|Overall Study|Withdrawal by Subject|24|||
147588659|NCT01098110|532309942|FG002|Overall Study|Withdrawal by Subject|19|||
147588660|NCT01098110|532309940|FG000|Overall Study|Adverse Event|30|||
147588661|NCT01098110|532309941|FG001|Overall Study|Adverse Event|32|||
147588662|NCT01098110|532309942|FG002|Overall Study|Adverse Event|43|||
147588663|NCT01098110|532309940|FG000|Overall Study|Lack of Efficacy|13|||
147588664|NCT01098110|532309941|FG001|Overall Study|Lack of Efficacy|9|||
147588665|NCT01098110|532309942|FG002|Overall Study|Lack of Efficacy|27|||
147588666|NCT01098110|532309940|FG000|Overall Study|Other|4|||
147588667|NCT01098110|532309941|FG001|Overall Study|Other|7|||
147588668|NCT01098110|532309942|FG002|Overall Study|Other|5|||
147588669|NCT01098110|532309940|FG000|Overall Study|Untreated|1|||
147588670|NCT01098110|532309941|FG001|Overall Study|Untreated|1|||
147588671|NCT01098110|532309942|FG002|Overall Study|Untreated|0|||
147588672|NCT03920280|532309943|FG000|Overall Study|Adverse Event|2|||
147588673|NCT03920280|532309944|FG001|Overall Study|Adverse Event|3|||
147588674|NCT03920280|532309943|FG000|Overall Study|Lost to Follow-up|0|||
147588675|NCT03920280|532309944|FG001|Overall Study|Lost to Follow-up|1|||
147588676|NCT03920280|532309943|FG000|Overall Study|Withdrawal by Subject|1|||
147588677|NCT03920280|532309944|FG001|Overall Study|Withdrawal by Subject|1|||
147588678|NCT03920280|532309943|FG000|Overall Study|Corneal cylinder greater than 1.00 diopter|0|||
147588679|NCT03920280|532309944|FG001|Overall Study|Corneal cylinder greater than 1.00 diopter|1|||
147588680|NCT01009515|532309951|FG000|Overall Study|Withdrawal by Subject|3|||
147588681|NCT01501110|532309954|FG000|Overall Study|Death|0|||
147588682|NCT01501110|532309955|FG001|Overall Study|Death|1|||
147588683|NCT03573817|532309956|FG000|Overall Study|Adverse Event|0|||
147588684|NCT03573817|532309957|FG001|Overall Study|Adverse Event|2|||
147588685|NCT03573817|532309956|FG000|Overall Study|Protocol Violation|0|||
147588686|NCT03573817|532309957|FG001|Overall Study|Protocol Violation|1|||
147588687|NCT03573817|532309956|FG000|Overall Study|Withdrawal by Subject|1|||
147588688|NCT03573817|532309957|FG001|Overall Study|Withdrawal by Subject|1|||
147588689|NCT03554317|532309958|FG000|Overall Study|Withdrawal by Subject|1|||
147588690|NCT03554317|532309958|FG000|Overall Study|PSA Progression|3|||
147588691|NCT03554317|532309958|FG000|Overall Study|Radiographic Progression|4|||
147588692|NCT01832402|532309961|FG000|Overall Study|Lost to Follow-up|2|||
147654456|NCT04074330|532556747|FG005|Dose Escalation (up to 19.36 Months)|Death|1|||
147447532|NCT01823679|531803879|FG000|Overall Study|Death|1|||
147588693|NCT01832402|532309962|FG001|Overall Study|Lost to Follow-up|0|||
147242770|NCT00361569|531059722|FG000|Overall Study|Protocol Violation|3|||
147242771|NCT00361569|531059723|FG001|Overall Study|Protocol Violation|2|||
147242772|NCT00361569|531059724|FG002|Overall Study|Protocol Violation|4|||
147242773|NCT00361569|531059725|FG003|Overall Study|Protocol Violation|2|||
147242774|NCT00361569|531059722|FG000|Overall Study|Withdrawal by Subject|2|||
147242775|NCT00361569|531059723|FG001|Overall Study|Withdrawal by Subject|1|||
147242776|NCT00361569|531059724|FG002|Overall Study|Withdrawal by Subject|9|||
147242777|NCT00361569|531059725|FG003|Overall Study|Withdrawal by Subject|14|||
147242778|NCT00361569|531059722|FG000|Overall Study|Adverse Event|3|||
147242779|NCT00361569|531059723|FG001|Overall Study|Adverse Event|5|||
147242780|NCT00361569|531059724|FG002|Overall Study|Adverse Event|2|||
147242781|NCT00361569|531059725|FG003|Overall Study|Adverse Event|2|||
147242782|NCT00361569|531059722|FG000|Overall Study|Lost to Follow-up|2|||
147242783|NCT00361569|531059723|FG001|Overall Study|Lost to Follow-up|3|||
147242784|NCT00361569|531059724|FG002|Overall Study|Lost to Follow-up|3|||
147242785|NCT00361569|531059725|FG003|Overall Study|Lost to Follow-up|2|||
147242786|NCT00361569|531059722|FG000|Overall Study|Not specified by investigator|2|||
147242787|NCT00361569|531059723|FG001|Overall Study|Not specified by investigator|0|||
147242788|NCT00361569|531059724|FG002|Overall Study|Not specified by investigator|0|||
147242789|NCT00361569|531059725|FG003|Overall Study|Not specified by investigator|1|||
147242790|NCT04875195|531059726|FG000|Overall Study|Death|9|||
147242791|NCT04875195|531059727|FG001|Overall Study|Death|3|||
147242792|NCT04875195|531059726|FG000|Overall Study|Withdrawal by Subject|2|||
147242793|NCT04875195|531059727|FG001|Overall Study|Withdrawal by Subject|1|||
147242794|NCT04875195|531059726|FG000|Overall Study|Ongoing in study|49|||
147242795|NCT04875195|531059727|FG001|Overall Study|Ongoing in study|2|||
147242796|NCT00074152|531059728|FG000|Overall Study|Death|21|||
147242797|NCT00074152|531059729|FG001|Overall Study|Death|9|||
147242798|NCT00074152|531059728|FG000|Overall Study|Lack of Efficacy|34|||
147242799|NCT00074152|531059729|FG001|Overall Study|Lack of Efficacy|24|||
147242800|NCT01594762|531059733|FG000|Overall Study|Withdrawal by Subject|1|||
147242801|NCT01594762|531059734|FG001|Overall Study|Withdrawal by Subject|0|||
147242802|NCT01594762|531059733|FG000|Overall Study|Lost to Follow-up|10|||
147242803|NCT01594762|531059734|FG001|Overall Study|Lost to Follow-up|10|||
147242804|NCT03338998|531059735|FG000|Treatment Period|Withdrawal by Subject|1|||
147242805|NCT03338998|531059736|FG001|Treatment Period|Withdrawal by Subject|1|||
147242806|NCT03338998|531059735|FG000|Treatment Period|Adverse Event|0|||
147242807|NCT03338998|531059736|FG001|Treatment Period|Adverse Event|2|||
147242808|NCT03338998|531059735|FG000|Treatment Period|Protocol deviation|1|||
147242809|NCT03338998|531059736|FG001|Treatment Period|Protocol deviation|0|||
147242810|NCT03338998|531059735|FG000|Treatment Period|Physician Decision|2|||
147242811|NCT03338998|531059736|FG001|Treatment Period|Physician Decision|0|||
147242812|NCT03338998|531059735|FG000|Treatment Period|Subject failed swallow test|4|||
147242813|NCT03338998|531059736|FG001|Treatment Period|Subject failed swallow test|0|||
147242814|NCT03338998|531059735|FG000|Safety Follow-Up Period|Adverse Event|0|||
147242815|NCT03338998|531059736|FG001|Safety Follow-Up Period|Adverse Event|1|||
147242816|NCT03338998|531059735|FG000|Safety Follow-Up Period|Protocol deviation|1|||
147242817|NCT03338998|531059736|FG001|Safety Follow-Up Period|Protocol deviation|0|||
147242818|NCT03338998|531059735|FG000|Safety Follow-Up Period|Lost to Follow-up|1|||
147242819|NCT03338998|531059736|FG001|Safety Follow-Up Period|Lost to Follow-up|0|||
147242820|NCT02612727|531059737|FG000|Overall Study|Parent request|4|||
147242821|NCT02612727|531059738|FG001|Overall Study|Parent request|1|||
147242822|NCT02612727|531059737|FG000|Overall Study|Needed treatment incompatible with PT|1|||
147242823|NCT02612727|531059738|FG001|Overall Study|Needed treatment incompatible with PT|1|||
147242824|NCT02612727|531059737|FG000|Overall Study|Direct hyperbilirubinemia|0|||
147242825|NCT02612727|531059738|FG001|Overall Study|Direct hyperbilirubinemia|2|||
147242826|NCT04524689|531059739|FG000|Overall Study|Withdrawal by Subject|1|||
147242827|NCT04524689|531059740|FG001|Overall Study|Withdrawal by Subject|1|||
147242828|NCT04524689|531059741|FG002|Overall Study|Withdrawal by Subject|0|||
147242829|NCT04524689|531059742|FG003|Overall Study|Withdrawal by Subject|0|||
147242830|NCT04524689|531059743|FG004|Overall Study|Withdrawal by Subject|2|||
147242831|NCT04524689|531059744|FG005|Overall Study|Withdrawal by Subject|0|||
147242832|NCT04524689|531059739|FG000|Overall Study|Study terminated by Sponsor|6|||
147242833|NCT04524689|531059740|FG001|Overall Study|Study terminated by Sponsor|0|||
147242834|NCT04524689|531059741|FG002|Overall Study|Study terminated by Sponsor|1|||
147242835|NCT04524689|531059742|FG003|Overall Study|Study terminated by Sponsor|0|||
147242836|NCT04524689|531059743|FG004|Overall Study|Study terminated by Sponsor|4|||
147242837|NCT04524689|531059744|FG005|Overall Study|Study terminated by Sponsor|0|||
147242838|NCT04524689|531059739|FG000|Overall Study|Not related to Coronavirus disease 2019|9|||
147242839|NCT04524689|531059740|FG001|Overall Study|Not related to Coronavirus disease 2019|0|||
147242840|NCT04524689|531059741|FG002|Overall Study|Not related to Coronavirus disease 2019|1|||
147242841|NCT04524689|531059742|FG003|Overall Study|Not related to Coronavirus disease 2019|0|||
147242842|NCT04524689|531059743|FG004|Overall Study|Not related to Coronavirus disease 2019|0|||
147242843|NCT04524689|531059744|FG005|Overall Study|Not related to Coronavirus disease 2019|1|||
147242844|NCT00612690|531061920|FG000|Overall Study|Lost to Follow-up|72|||
147242845|NCT00612690|531061921|FG001|Overall Study|Lost to Follow-up|98|||
147322828|NCT02099539|531345487|FG000|Overall Study|Physician Decision|0|||
147322829|NCT02099539|531345488|FG001|Overall Study|Physician Decision|0|||
147322830|NCT02099539|531345489|FG002|Overall Study|Physician Decision|0|||
147322831|NCT02099539|531345490|FG003|Overall Study|Physician Decision|0|||
147322832|NCT02099539|531345491|FG004|Overall Study|Physician Decision|0|||
147322833|NCT02099539|531345492|FG005|Overall Study|Physician Decision|1|||
147322834|NCT02099539|531345493|FG006|Overall Study|Physician Decision|0|||
147322835|NCT03473756|531345495|FG000|Overall Study|Withdrawal by Subject|1|||
147322836|NCT03473756|531345496|FG001|Overall Study|Withdrawal by Subject|4|||
147322837|NCT03473756|531345495|FG000|Overall Study|Adverse Event|6|||
147322838|NCT03473756|531345496|FG001|Overall Study|Adverse Event|7|||
147322839|NCT03473756|531345495|FG000|Overall Study|Lack of Efficacy|3|||
147322840|NCT03473756|531345496|FG001|Overall Study|Lack of Efficacy|10|||
147322841|NCT03473756|531345495|FG000|Overall Study|Physician Decision|0|||
147322842|NCT03473756|531345496|FG001|Overall Study|Physician Decision|2|||
147322843|NCT03473756|531345495|FG000|Overall Study|End of study treatment|0|||
147322844|NCT03473756|531345496|FG001|Overall Study|End of study treatment|2|||
147322845|NCT03473756|531345495|FG000|Overall Study|Lost to Follow-up|0|||
147322846|NCT03473756|531345496|FG001|Overall Study|Lost to Follow-up|1|||
147322847|NCT03714022|531345497|FG000|Overall Study|Adverse Event|1|||
147322848|NCT03714022|531345498|FG001|Overall Study|Adverse Event|0|||
147322849|NCT03714022|531345497|FG000|Overall Study|Consent withdrawal|0|||
147322850|NCT03714022|531345498|FG001|Overall Study|Consent withdrawal|1|||
147322851|NCT03714022|531345497|FG000|Overall Study|Lost to Follow-up|3|||
147322852|NCT03714022|531345498|FG001|Overall Study|Lost to Follow-up|2|||
147322853|NCT01007552|531345499|FG000|Overall Study|Withdrawal by Subject|1|||
147322854|NCT04482855|531345500|FG000|Overall Study|Lost to Follow-up|1|||
147322855|NCT04482855|531345501|FG001|Overall Study|Lost to Follow-up|0|||
147322856|NCT04482855|531345500|FG000|Overall Study|Withdrew from the study before attending the study intervention sessions due to unexpected job duty|1|||
147322857|NCT04482855|531345501|FG001|Overall Study|Withdrew from the study before attending the study intervention sessions due to unexpected job duty|0|||
147322858|NCT04482855|531345500|FG000|Overall Study|Withdrew from the study before attending the study intervention sessions due to new cancer diagnosis|1|||
147322859|NCT04482855|531345501|FG001|Overall Study|Withdrew from the study before attending the study intervention sessions due to new cancer diagnosis|0|||
147322860|NCT00663962|531345502|FG000|Overall Study|somnolence|1|||
147322861|NCT00663962|531345503|FG001|Overall Study|somnolence|0|||
147588694|NCT01832402|532309961|FG000|Overall Study|Withdrawal by Subject|3|||
147588695|NCT01832402|532309962|FG001|Overall Study|Withdrawal by Subject|3|||
147588696|NCT01832402|532309961|FG000|Overall Study|Declining Performance status|2|||
147588697|NCT01832402|532309962|FG001|Overall Study|Declining Performance status|1|||
147162801|NCT00355342|530759187|FG000|Overall Study|Lost to Follow-up|4|||
147162802|NCT00355342|530759188|FG001|Overall Study|Lost to Follow-up|2|||
147162803|NCT00355342|530759187|FG000|Overall Study|Withdrawal by Subject|14|||
147162804|NCT00355342|530759188|FG001|Overall Study|Withdrawal by Subject|11|||
147162805|NCT00355342|530759187|FG000|Overall Study|Sponsor terminated study|2|||
147162806|NCT00355342|530759188|FG001|Overall Study|Sponsor terminated study|2|||
147162807|NCT00355342|530759187|FG000|Overall Study|Overcompliant-PI discretion|1|||
147162808|NCT00355342|530759188|FG001|Overall Study|Overcompliant-PI discretion|0|||
147162809|NCT00355342|530759187|FG000|Overall Study|Use of prohibited medication|1|||
147162810|NCT00355342|530759188|FG001|Overall Study|Use of prohibited medication|0|||
147162811|NCT00355342|530759187|FG000|Overall Study|COPD exacerbation|1|||
147162812|NCT00355342|530759188|FG001|Overall Study|COPD exacerbation|1|||
147162813|NCT00355342|530759187|FG000|Overall Study|Dispensed wrong study drug kit|1|||
147162814|NCT00355342|530759188|FG001|Overall Study|Dispensed wrong study drug kit|0|||
147162815|NCT00355342|530759187|FG000|Overall Study|Non-compliance with Dexa scans|1|||
147162816|NCT00355342|530759188|FG001|Overall Study|Non-compliance with Dexa scans|0|||
147162817|NCT00355342|530759187|FG000|Overall Study|Withdrawal by participant and physician|1|||
147162818|NCT00355342|530759188|FG001|Overall Study|Withdrawal by participant and physician|0|||
147162819|NCT00355342|530759187|FG000|Overall Study|Participant relocated|0|||
147162820|NCT00355342|530759188|FG001|Overall Study|Participant relocated|1|||
147162821|NCT00355342|530759187|FG000|Overall Study|Participant discontinued study drug|0|||
147162822|NCT00355342|530759188|FG001|Overall Study|Participant discontinued study drug|1|||
147162823|NCT00355342|530759187|FG000|Overall Study|Study management|0|||
147162824|NCT00355342|530759188|FG001|Overall Study|Study management|1|||
147162825|NCT00355342|530759187|FG000|Overall Study|Protocol Violation|0|||
147162826|NCT00355342|530759188|FG001|Overall Study|Protocol Violation|1|||
147162827|NCT00355342|530759187|FG000|Overall Study|Use of protocol excluded medication|0|||
147322862|NCT03253653|531345508|FG000|Overall Study|Withdrawal by Subject|4|||
147322863|NCT03253653|531345509|FG001|Overall Study|Withdrawal by Subject|1|||
147322864|NCT03253653|531345508|FG000|Overall Study|Protocol Violation|0|||
147322865|NCT03253653|531345509|FG001|Overall Study|Protocol Violation|5|||
147322866|NCT02624778|531347816|FG000|Overall Study|Lost to Follow-up|0|||
147322867|NCT02624778|531347817|FG001|Overall Study|Lost to Follow-up|0|||
147322868|NCT02624778|531347818|FG002|Overall Study|Lost to Follow-up|1|||
147162828|NCT00355342|530759188|FG001|Overall Study|Use of protocol excluded medication|1|||
147162829|NCT00536874|530759189|FG000|Overall Study|Adverse Event|1|||
147242846|NCT00612690|531061920|FG000|Overall Study|Withdrawal by Subject|32|||
147242847|NCT00612690|531061921|FG001|Overall Study|Withdrawal by Subject|20|||
147242848|NCT00612690|531061920|FG000|Overall Study|Withdrawal by Site|11|||
147242849|NCT00612690|531061921|FG001|Overall Study|Withdrawal by Site|0|||
147242850|NCT04487730|531061924|FG000|Overall Study|Withdrawal by Subject|3|||
147242851|NCT04487730|531061925|FG001|Overall Study|Withdrawal by Subject|1|||
147242852|NCT04487730|531061924|FG000|Overall Study|Lost to Follow-up|0|||
147242853|NCT04487730|531061925|FG001|Overall Study|Lost to Follow-up|1|||
147242854|NCT04487730|531061924|FG000|Overall Study|Physician Decision|0|||
147242855|NCT04487730|531061925|FG001|Overall Study|Physician Decision|1|||
147242856|NCT00907777|531061926|FG000|Overall Study|Withdrawal by Subject|0|||
147242857|NCT00907777|531061927|FG001|Overall Study|Withdrawal by Subject|1|||
147242858|NCT02674529|531061930|FG000|Overall Study|Lost to Follow-up|1|||
147242859|NCT02674529|531061931|FG001|Overall Study|Lost to Follow-up|2|||
147242860|NCT02674529|531061930|FG000|Overall Study|Withdrawal by Subject|2|||
147242861|NCT02674529|531061931|FG001|Overall Study|Withdrawal by Subject|1|||
147242862|NCT02674529|531061930|FG000|Overall Study|Physician Decision|0|||
147242863|NCT02674529|531061931|FG001|Overall Study|Physician Decision|1|||
147242864|NCT02674529|531061930|FG000|Overall Study|Protocol Violation|0|||
147242865|NCT02674529|531061931|FG001|Overall Study|Protocol Violation|1|||
147322869|NCT02624778|531347819|FG003|Overall Study|Lost to Follow-up|0|||
147322870|NCT02624778|531347820|FG004|Overall Study|Lost to Follow-up|0|||
147322871|NCT02624778|531347821|FG005|Overall Study|Lost to Follow-up|0|||
147322872|NCT02624778|531347822|FG006|Overall Study|Lost to Follow-up|0|||
147322873|NCT02624778|531347823|FG007|Overall Study|Lost to Follow-up|0|||
147322874|NCT02624778|531347824|FG008|Overall Study|Lost to Follow-up|0|||
147322875|NCT02624778|531347816|FG000|Overall Study|Withdrawal by Subject|0|||
147322876|NCT02624778|531347817|FG001|Overall Study|Withdrawal by Subject|1|||
147322877|NCT02624778|531347818|FG002|Overall Study|Withdrawal by Subject|0|||
147322878|NCT02624778|531347819|FG003|Overall Study|Withdrawal by Subject|0|||
147322879|NCT02624778|531347820|FG004|Overall Study|Withdrawal by Subject|0|||
147322880|NCT02624778|531347821|FG005|Overall Study|Withdrawal by Subject|1|||
147322881|NCT02624778|531347822|FG006|Overall Study|Withdrawal by Subject|1|||
147322882|NCT02624778|531347823|FG007|Overall Study|Withdrawal by Subject|1|||
147322883|NCT02624778|531347824|FG008|Overall Study|Withdrawal by Subject|1|||
147322884|NCT02624778|531347816|FG000|Overall Study|Adverse Event|0|||
147322885|NCT02624778|531347817|FG001|Overall Study|Adverse Event|0|||
147322886|NCT02624778|531347818|FG002|Overall Study|Adverse Event|0|||
147322887|NCT02624778|531347819|FG003|Overall Study|Adverse Event|0|||
147322888|NCT02624778|531347820|FG004|Overall Study|Adverse Event|0|||
147322889|NCT02624778|531347821|FG005|Overall Study|Adverse Event|0|||
147322890|NCT02624778|531347822|FG006|Overall Study|Adverse Event|0|||
147322891|NCT02624778|531347823|FG007|Overall Study|Adverse Event|0|||
147322892|NCT02624778|531347824|FG008|Overall Study|Adverse Event|2|||
147322893|NCT02624778|531347816|FG000|Overall Study|Death|0|||
147322894|NCT02624778|531347817|FG001|Overall Study|Death|0|||
147322895|NCT02624778|531347818|FG002|Overall Study|Death|0|||
147322896|NCT02624778|531347819|FG003|Overall Study|Death|0|||
147322897|NCT02624778|531347820|FG004|Overall Study|Death|0|||
147322898|NCT02624778|531347821|FG005|Overall Study|Death|0|||
147322899|NCT02624778|531347822|FG006|Overall Study|Death|1|||
147322900|NCT02624778|531347823|FG007|Overall Study|Death|0|||
147322901|NCT02624778|531347824|FG008|Overall Study|Death|0|||
147322902|NCT02624778|531347816|FG000|Overall Study|Physician Decision|0|||
147322903|NCT02624778|531347817|FG001|Overall Study|Physician Decision|0|||
147322904|NCT02624778|531347818|FG002|Overall Study|Physician Decision|0|||
147242866|NCT02891850|531061932|FG000|Overall Study|Adverse Event|3|||
147242867|NCT02891850|531061933|FG001|Overall Study|Adverse Event|0|||
147242868|NCT02891850|531061932|FG000|Overall Study|Death|0|||
147242869|NCT02891850|531061933|FG001|Overall Study|Death|4|||
147242870|NCT02891850|531061932|FG000|Overall Study|Physician Decision|1|||
147242871|NCT02891850|531061933|FG001|Overall Study|Physician Decision|0|||
147242872|NCT02891850|531061932|FG000|Overall Study|Pregnancy|1|||
147322905|NCT02624778|531347819|FG003|Overall Study|Physician Decision|0|||
147322906|NCT02624778|531347820|FG004|Overall Study|Physician Decision|0|||
147322907|NCT02624778|531347821|FG005|Overall Study|Physician Decision|0|||
147322908|NCT02624778|531347822|FG006|Overall Study|Physician Decision|0|||
147322909|NCT02624778|531347823|FG007|Overall Study|Physician Decision|3|||
147322910|NCT02624778|531347824|FG008|Overall Study|Physician Decision|3|||
147322911|NCT04610684|531347827|FG000|Study Treatment|Withdrawal by Subject|1|||
147322912|NCT04610684|531347827|FG000|Study Treatment|Disease Progression|2|||
147322913|NCT04610684|531347827|FG000|Follow up|Death|2|||
147322914|NCT04610684|531347827|FG000|Follow up|Withdrawal by Subject|1|||
147322915|NCT01876043|531347831|FG000|Overall Study|Death|1|||
147322916|NCT01876043|531347831|FG000|Overall Study|Withdrawal by Subject|1|||
147322917|NCT05458102|531347834|FG000|Overall Study|Withdrew consent|2|||
147242873|NCT02891850|531061933|FG001|Overall Study|Pregnancy|0|||
147322918|NCT05458102|531347835|FG001|Overall Study|Withdrew consent|0|||
147322919|NCT05458102|531347834|FG000|Overall Study|Adverse Event|1|||
147322920|NCT05458102|531347835|FG001|Overall Study|Adverse Event|0|||
147322921|NCT05458102|531347834|FG000|Overall Study|Enrolled but never treated|1|||
147588698|NCT00612677|532309963|FG000|Overall Study|study closed before treatment started|1|||
147588699|NCT00860743|532309965|FG000|Overall Study|Withdrawal by Subject|3|||
147588700|NCT00860743|532309966|FG001|Overall Study|Withdrawal by Subject|0|||
147588701|NCT00823199|532309967|FG000|Overall Study|Withdrawal by Subject|2|||
147162830|NCT00536874|530759189|FG000|Overall Study|Death|2|||
147162831|NCT00536874|530759189|FG000|Overall Study|Withdrawal by Subject|1|||
147162832|NCT02084238|530759191|FG000|Overall Study|Lost to Follow-up|2|||
147162833|NCT00391391|530759192|FG000|Overall Study|Adverse Event|0|||
147162834|NCT00391391|530759193|FG001|Overall Study|Adverse Event|0|||
147162835|NCT00391391|530759194|FG002|Overall Study|Adverse Event|0|||
147162836|NCT00391391|530759195|FG003|Overall Study|Adverse Event|1|||
147162837|NCT00391391|530759192|FG000|Overall Study|Lost to Follow-up|1|||
147162838|NCT00391391|530759193|FG001|Overall Study|Lost to Follow-up|3|||
147162839|NCT00391391|530759194|FG002|Overall Study|Lost to Follow-up|7|||
147322922|NCT05458102|531347835|FG001|Overall Study|Enrolled but never treated|0|||
147322923|NCT05458102|531347834|FG000|Overall Study|Protocol Violation|1|||
147322924|NCT05458102|531347835|FG001|Overall Study|Protocol Violation|0|||
147322925|NCT04531540|531347850|FG000|Overall Study|Adverse Event|1|||
147322926|NCT04531540|531347850|FG000|Overall Study|Protocol Violation|3|||
147322927|NCT04531540|531347850|FG000|Overall Study|Withdrawal by Subject|4|||
147322928|NCT04531540|531347850|FG000|Overall Study|Found to be Ineligible|1|||
147322929|NCT03239210|531347851|FG000|Overall Study|Lost to Follow-up|2|||
147322930|NCT03239210|531347852|FG001|Overall Study|Lost to Follow-up|2|||
147322931|NCT03239210|531347851|FG000|Overall Study|Withdrawal by subject (personal reasons)|2|||
147322932|NCT03239210|531347852|FG001|Overall Study|Withdrawal by subject (personal reasons)|2|||
147322933|NCT03239210|531347851|FG000|Overall Study|Withdrawal by subject (reported medical side effects)|2|||
147322934|NCT03239210|531347852|FG001|Overall Study|Withdrawal by subject (reported medical side effects)|1|||
147322935|NCT01575860|531347855|FG000|Overall Study|Withdrawal by Subject|1|||
147322936|NCT01575860|531347855|FG000|Overall Study|Progression Prior to Lenalidomide Maint.|1|||
147322937|NCT01403987|531347856|FG000|Overall Study|Residents forgot their secret PIN|18|||
147322938|NCT01403987|531347857|FG001|Overall Study|Residents forgot their secret PIN|17|||
147322939|NCT01403987|531347858|FG002|Overall Study|Residents forgot their secret PIN|18|||
147322940|NCT00180674|531347859|FG000|Phase 1, Observation Period|Withdrawal by Subject|4|||
147322941|NCT00180674|531347859|FG000|Phase 2, Warfarin Treatment Period|Adverse Event|1|||
147322942|NCT00278564|531347860|FG000|Overall Study|Lack of Efficacy|4|||
147322943|NCT01094743|531347861|FG000|Period 1|Unsatisfactory comfort at lens fitting|2|||
147322944|NCT03606460|531347862|FG000|Overall Study|Lost to Follow-up|1|||
147322945|NCT03606460|531347863|FG001|Overall Study|Lost to Follow-up|8|||
147322946|NCT00003377|531347864|FG000|Period I|Dose Limiting Toxicity(DLT)|0|||
147322947|NCT00003377|531347865|FG001|Period I|Dose Limiting Toxicity(DLT)|0|||
147322948|NCT00003377|531347866|FG002|Period I|Dose Limiting Toxicity(DLT)|1|||
147322949|NCT00003377|531347867|FG003|Period I|Dose Limiting Toxicity(DLT)|1|||
147322950|NCT00003377|531347868|FG004|Period I|Dose Limiting Toxicity(DLT)|0|||
147322951|NCT00003377|531347864|FG000|Period II|Ureteral stent complications|0|||
147322952|NCT00003377|531347865|FG001|Period II|Ureteral stent complications|0|||
147322953|NCT00003377|531347866|FG002|Period II|Ureteral stent complications|0|||
147322954|NCT00003377|531347867|FG003|Period II|Ureteral stent complications|0|||
147322955|NCT00003377|531347868|FG004|Period II|Ureteral stent complications|1|||
147322956|NCT04541186|531347873|FG000|Main Study|Adverse Event|0|||
147322957|NCT04541186|531347874|FG001|Main Study|Adverse Event|0|||
147322958|NCT04541186|531347875|FG002|Main Study|Adverse Event|4|||
147322959|NCT04541186|531347876|FG003|Main Study|Adverse Event|0|||
147322960|NCT04541186|531347877|FG004|Main Study|Adverse Event|0|||
147322961|NCT04541186|531347873|FG000|Main Study|Investigator Decision|0|||
147322962|NCT04541186|531347874|FG001|Main Study|Investigator Decision|0|||
147322963|NCT04541186|531347875|FG002|Main Study|Investigator Decision|1|||
147322964|NCT04541186|531347876|FG003|Main Study|Investigator Decision|1|||
147322965|NCT04541186|531347877|FG004|Main Study|Investigator Decision|0|||
147322966|NCT04541186|531347873|FG000|Main Study|Withdrawal by Subject|1|||
147322967|NCT04541186|531347874|FG001|Main Study|Withdrawal by Subject|1|||
147322968|NCT04541186|531347875|FG002|Main Study|Withdrawal by Subject|0|||
147322969|NCT04541186|531347876|FG003|Main Study|Withdrawal by Subject|0|||
147322970|NCT04541186|531347877|FG004|Main Study|Withdrawal by Subject|0|||
147322971|NCT04541186|531347873|FG000|Main Study|COVID-19-related Dose Interruption|0|||
147322972|NCT04541186|531347874|FG001|Main Study|COVID-19-related Dose Interruption|0|||
147322973|NCT04541186|531347875|FG002|Main Study|COVID-19-related Dose Interruption|0|||
147322974|NCT04541186|531347876|FG003|Main Study|COVID-19-related Dose Interruption|0|||
147322975|NCT04541186|531347877|FG004|Main Study|COVID-19-related Dose Interruption|1|||
147322976|NCT04541186|531347873|FG000|Main Study|Randomized in Error Not Treated|0|||
147322977|NCT04541186|531347874|FG001|Main Study|Randomized in Error Not Treated|0|||
147322978|NCT04541186|531347875|FG002|Main Study|Randomized in Error Not Treated|1|||
147322979|NCT04541186|531347876|FG003|Main Study|Randomized in Error Not Treated|0|||
147322980|NCT04541186|531347877|FG004|Main Study|Randomized in Error Not Treated|0|||
147322981|NCT04541186|531347873|FG000|Fibrate Expansion Study|Other than Specified|0|||
147162840|NCT00391391|530759195|FG003|Overall Study|Lost to Follow-up|4|||
147162841|NCT00391391|530759192|FG000|Overall Study|Protocol Violation|2|||
147588702|NCT02776553|532309968|FG000|Overall Study|Lost to Follow-up|1|||
147588703|NCT02776553|532309969|FG001|Overall Study|Lost to Follow-up|0|||
147588704|NCT02776553|532309968|FG000|Overall Study|got liver transplant|1|||
147588705|NCT02776553|532309969|FG001|Overall Study|got liver transplant|2|||
147588706|NCT02776553|532309968|FG000|Overall Study|had other surgery|1|||
147588707|NCT02776553|532309969|FG001|Overall Study|had other surgery|0|||
147588708|NCT02776553|532309968|FG000|Overall Study|Protocol Violation|0|||
147588709|NCT02776553|532309969|FG001|Overall Study|Protocol Violation|1|||
147588710|NCT01640184|532309974|FG000|Overall Study|Death|1|||
147588711|NCT01640184|532309975|FG001|Overall Study|Death|0|||
147588712|NCT01640184|532309976|FG002|Overall Study|Death|0|||
147588713|NCT01640184|532309974|FG000|Overall Study|Lost to Follow-up|4|||
147588714|NCT01640184|532309975|FG001|Overall Study|Lost to Follow-up|1|||
147588715|NCT01640184|532309976|FG002|Overall Study|Lost to Follow-up|0|||
147588716|NCT01640184|532309974|FG000|Overall Study|Physician Decision|3|||
147588717|NCT01640184|532309975|FG001|Overall Study|Physician Decision|0|||
147588718|NCT01640184|532309976|FG002|Overall Study|Physician Decision|0|||
147588719|NCT01640184|532309974|FG000|Overall Study|Withdrawal by Subject|0|||
147588720|NCT01640184|532309975|FG001|Overall Study|Withdrawal by Subject|1|||
147588721|NCT01640184|532309976|FG002|Overall Study|Withdrawal by Subject|1|||
147588722|NCT01640184|532309974|FG000|Overall Study|Protocol Violation|0|||
147588723|NCT01640184|532309975|FG001|Overall Study|Protocol Violation|0|||
147588724|NCT01640184|532309976|FG002|Overall Study|Protocol Violation|1|||
147588725|NCT01684878|532309977|FG000|Part 1: Safety Run in Phase|Participants withdrawn consent|1|||
147588726|NCT01684878|532309978|FG001|Part 1: Safety Run in Phase|Participants withdrawn consent|1|||
147588727|NCT01684878|532309979|FG002|Part 1: Safety Run in Phase|Participants withdrawn consent|0|||
147588728|NCT01684878|532309980|FG003|Part 1: Safety Run in Phase|Participants withdrawn consent|0|||
147588729|NCT01684878|532309977|FG000|Part 1: Safety Run in Phase|Death|15|||
147588730|NCT01684878|532309978|FG001|Part 1: Safety Run in Phase|Death|20|||
147588731|NCT01684878|532309979|FG002|Part 1: Safety Run in Phase|Death|0|||
147588732|NCT01684878|532309980|FG003|Part 1: Safety Run in Phase|Death|0|||
147588733|NCT01684878|532309977|FG000|Part 1: Safety Run in Phase|Lost to Follow-up|0|||
147588734|NCT01684878|532309978|FG001|Part 1: Safety Run in Phase|Lost to Follow-up|2|||
147588735|NCT01684878|532309979|FG002|Part 1: Safety Run in Phase|Lost to Follow-up|0|||
147588736|NCT01684878|532309980|FG003|Part 1: Safety Run in Phase|Lost to Follow-up|0|||
147588737|NCT01684878|532309977|FG000|Part 2: Randomized Phase|Participant withdrew consent|0|||
147588738|NCT01684878|532309978|FG001|Part 2: Randomized Phase|Participant withdrew consent|0|||
147588739|NCT01684878|532309979|FG002|Part 2: Randomized Phase|Participant withdrew consent|1|||
147588740|NCT01684878|532309980|FG003|Part 2: Randomized Phase|Participant withdrew consent|2|||
147588741|NCT01684878|532309977|FG000|Part 2: Randomized Phase|Lost to Follow-up|0|||
147588742|NCT01684878|532309978|FG001|Part 2: Randomized Phase|Lost to Follow-up|0|||
147588743|NCT01684878|532309979|FG002|Part 2: Randomized Phase|Lost to Follow-up|2|||
147162842|NCT00391391|530759193|FG001|Overall Study|Protocol Violation|3|||
147162843|NCT00391391|530759194|FG002|Overall Study|Protocol Violation|6|||
147162844|NCT00391391|530759195|FG003|Overall Study|Protocol Violation|7|||
147162845|NCT00391391|530759192|FG000|Overall Study|Withdrawal by Subject|6|||
147162846|NCT00391391|530759193|FG001|Overall Study|Withdrawal by Subject|4|||
147162847|NCT00391391|530759194|FG002|Overall Study|Withdrawal by Subject|10|||
147162848|NCT00391391|530759195|FG003|Overall Study|Withdrawal by Subject|7|||
147588744|NCT01684878|532309980|FG003|Part 2: Randomized Phase|Lost to Follow-up|0|||
147588745|NCT01684878|532309977|FG000|Part 2: Randomized Phase|Death|0|||
147588746|NCT01684878|532309978|FG001|Part 2: Randomized Phase|Death|0|||
147588747|NCT01684878|532309979|FG002|Part 2: Randomized Phase|Death|62|||
147588748|NCT01684878|532309980|FG003|Part 2: Randomized Phase|Death|68|||
147588749|NCT01684878|532309977|FG000|Part 2: Randomized Phase|Alive at data-cut|0|||
147588750|NCT01684878|532309978|FG001|Part 2: Randomized Phase|Alive at data-cut|0|||
147588751|NCT01684878|532309979|FG002|Part 2: Randomized Phase|Alive at data-cut|13|||
147162849|NCT04342689|530759199|FG000|Overall Study|Withdrawal by Subject|32|||
147162850|NCT04342689|530759200|FG001|Overall Study|Withdrawal by Subject|33|||
147162851|NCT04342689|530759199|FG000|Overall Study|Lost to Follow-up|10|||
147162852|NCT04342689|530759200|FG001|Overall Study|Lost to Follow-up|12|||
147162853|NCT01367704|530759203|FG000|Overall Study|Lost to Follow-up|47|||
147162854|NCT01367704|530759204|FG001|Overall Study|Lost to Follow-up|161|||
147162855|NCT04096820|530759205|FG000|Overall Study|Did not return for intervention|2|||
147162856|NCT04096820|530759205|FG000|Overall Study|Death|1|||
147162857|NCT00475865|530759206|FG000|Overall Study|Adverse Event|0|||
147162858|NCT00475865|530759207|FG001|Overall Study|Adverse Event|3|||
147162859|NCT00475865|530759208|FG002|Overall Study|Adverse Event|4|||
147162860|NCT00475865|530759206|FG000|Overall Study|Lack of Efficacy|1|||
147162861|NCT00475865|530759207|FG001|Overall Study|Lack of Efficacy|0|||
147162862|NCT00475865|530759208|FG002|Overall Study|Lack of Efficacy|0|||
147162863|NCT00475865|530759206|FG000|Overall Study|Progressive disease|0|||
147162864|NCT00475865|530759207|FG001|Overall Study|Progressive disease|1|||
147162865|NCT00475865|530759208|FG002|Overall Study|Progressive disease|2|||
147162866|NCT00475865|530759206|FG000|Overall Study|Participant did not wish to continue|1|||
147162867|NCT00475865|530759207|FG001|Overall Study|Participant did not wish to continue|0|||
147588752|NCT01684878|532309980|FG003|Part 2: Randomized Phase|Alive at data-cut|7|||
147588753|NCT01684878|532309977|FG000|Part 2: Randomized Phase|Participant noncompliance|0|||
147588754|NCT01684878|532309978|FG001|Part 2: Randomized Phase|Participant noncompliance|0|||
147588755|NCT01684878|532309979|FG002|Part 2: Randomized Phase|Participant noncompliance|0|||
147162868|NCT00475865|530759208|FG002|Overall Study|Participant did not wish to continue|0|||
147162869|NCT00475865|530759206|FG000|Overall Study|Other than above|0|||
147162870|NCT00475865|530759207|FG001|Overall Study|Other than above|1|||
147162871|NCT00475865|530759208|FG002|Overall Study|Other than above|0|||
147162872|NCT01510145|530759209|FG000|Overall Study|Adverse Event|6|||
147162873|NCT01510145|530759209|FG000|Overall Study|Lost to Follow-up|5|||
147162874|NCT01510145|530759209|FG000|Overall Study|Withdrawal by Subject|6|||
147162875|NCT01510145|530759209|FG000|Overall Study|Relative reported subject withdrew|1|||
147162876|NCT01822535|530759214|FG000|Visit 1 - Tetraplegia and Able-Bodied|Adverse Event|2|||
147162877|NCT01822535|530759215|FG001|Visit 1 - Tetraplegia and Able-Bodied|Adverse Event|0|||
147162878|NCT01822535|530759214|FG000|Visit 1 - Tetraplegia and Able-Bodied|Withdrawal by Subject|4|||
147162879|NCT01822535|530759215|FG001|Visit 1 - Tetraplegia and Able-Bodied|Withdrawal by Subject|2|||
147162880|NCT01822535|530759214|FG000|Visit 2 - Tetraplegia Only - Drug|Adverse Event|1|||
147588756|NCT01684878|532309980|FG003|Part 2: Randomized Phase|Participant noncompliance|1|||
147588757|NCT01435031|532309984|FG000|ITT at 1 Month|Withdrawal by Subject|1|||
147588758|NCT01435031|532309984|FG000|ITT at 1 Month|Death|1|||
147588759|NCT01435031|532309984|FG000|ITT at 1 Month|Lost to Follow-up|4|||
147588760|NCT01435031|532309984|FG000|ITT at 6 Months|Death|2|||
147588761|NCT01435031|532309984|FG000|ITT at 6 Months|Lost to Follow-up|3|||
147588762|NCT01435031|532309984|FG000|ITT at 1 Year|Death|1|||
147588763|NCT01435031|532309984|FG000|ITT at 1 Year|Withdrawal by Subject|2|||
147588764|NCT01435031|532309984|FG000|ITT at 1 Year|Lost to Follow-up|6|||
147588765|NCT01435031|532309984|FG000|ITT at 2 Years|Death|7|||
147588766|NCT01435031|532309984|FG000|ITT at 2 Years|Withdrawal by Subject|2|||
147588767|NCT01435031|532309984|FG000|ITT at 2 Years|Lost to Follow-up|4|||
147162881|NCT01822535|530759215|FG001|Visit 2 - Tetraplegia Only - Drug|Adverse Event|0|||
147162882|NCT03582813|530759218|FG000|Overall Study|Lost to Follow-up|18|||
147162883|NCT03582813|530759219|FG001|Overall Study|Lost to Follow-up|21|||
147162884|NCT03582813|530759218|FG000|Overall Study|Withdrawal by Subject|1|||
147162885|NCT03582813|530759219|FG001|Overall Study|Withdrawal by Subject|0|||
147162886|NCT03081858|530760639|FG000|Overall Study|Sponsor Discontinuation - IP issue for investigation (Bacterial Endotoxin level)|2|||
147162887|NCT03081858|530760640|FG001|Overall Study|Sponsor Discontinuation - IP issue for investigation (Bacterial Endotoxin level)|0|||
147162888|NCT03081858|530760641|FG002|Overall Study|Sponsor Discontinuation - IP issue for investigation (Bacterial Endotoxin level)|0|||
147162889|NCT03081858|530760642|FG003|Overall Study|Sponsor Discontinuation - IP issue for investigation (Bacterial Endotoxin level)|0|||
147588768|NCT01435031|532309984|FG000|ITT at 3 Years|Death|5|||
147162890|NCT00387647|530760647|FG000|Overall Study|Death|18|||
147162891|NCT02032407|530760648|FG000|Overall Study|Lost to Follow-up|2|||
147162892|NCT02032407|530760648|FG000|Overall Study|Pregnancy|1|||
147162893|NCT02032407|530760648|FG000|Overall Study|Other Miscellaneous Reasons|2|||
147162894|NCT01309269|530760649|FG000|Overall Study|Adverse Event|56|||
147162895|NCT01309269|530760649|FG000|Overall Study|Withdrawal by Subject|25|||
147162896|NCT01309269|530760649|FG000|Overall Study|Lack of Acceptance|15|||
147162897|NCT01309269|530760649|FG000|Overall Study|Other Erythropoiesis-stimulating Agents|119|||
147162898|NCT01309269|530760649|FG000|Overall Study|Kidney Transplant|25|||
147162899|NCT01309269|530760649|FG000|Overall Study|Administrative Problems|141|||
147162900|NCT01309269|530760649|FG000|Overall Study|Other|256|||
147162901|NCT01309269|530760649|FG000|Overall Study|Other|1|||
147162902|NCT01309269|530760649|FG000|Overall Study|Study Completion Data Not Recorded|95|||
147162903|NCT01309269|530760649|FG000|Overall Study|Enrolled but not Treated|107|||
147162904|NCT03899064|530760652|FG000|Overall Study|Lost to Follow-up|1|||
147162905|NCT03899064|530760652|FG000|Overall Study|Protocol Violation|2|||
147162906|NCT03899064|530760652|FG000|Overall Study|Withdrawal by Subject|2|||
147162907|NCT03899064|530760652|FG000|Overall Study|Other|2|||
147162908|NCT01610596|530760671|FG000|Overall Study|Lost to Follow-up|0|||
147162909|NCT01610596|530760672|FG001|Overall Study|Lost to Follow-up|1|||
147162910|NCT01519674|530760679|FG000|Overall Study|Adverse Event|3|||
147162911|NCT01519674|530760680|FG001|Overall Study|Adverse Event|3|||
147162912|NCT01519674|530760681|FG002|Overall Study|Adverse Event|0|||
147162913|NCT01519674|530760679|FG000|Overall Study|Lack of Efficacy|1|||
147162914|NCT01519674|530760680|FG001|Overall Study|Lack of Efficacy|1|||
147162915|NCT01519674|530760681|FG002|Overall Study|Lack of Efficacy|1|||
147162916|NCT01519674|530760679|FG000|Overall Study|Protocol Violation|0|||
147162917|NCT01519674|530760680|FG001|Overall Study|Protocol Violation|3|||
147162918|NCT01519674|530760681|FG002|Overall Study|Protocol Violation|1|||
147162919|NCT01519674|530760679|FG000|Overall Study|Withdrawal Criteria|7|||
147162920|NCT01519674|530760680|FG001|Overall Study|Withdrawal Criteria|2|||
147162921|NCT01519674|530760681|FG002|Overall Study|Withdrawal Criteria|7|||
147162922|NCT01519674|530760679|FG000|Overall Study|Unsclassified|10|||
147162923|NCT01519674|530760680|FG001|Overall Study|Unsclassified|4|||
147162924|NCT01519674|530760681|FG002|Overall Study|Unsclassified|3|||
147588769|NCT01435031|532309984|FG000|ITT at 3 Years|Withdrawal by Subject|2|||
147588770|NCT01435031|532309984|FG000|ITT at 3 Years|Lost to Follow-up|4|||
147588771|NCT01435031|532309984|FG000|ITT at 4 Years|Death|4|||
147588772|NCT01435031|532309984|FG000|ITT at 4 Years|Withdrawal by Subject|2|||
147588773|NCT01435031|532309984|FG000|ITT at 4 Years|Lost to Follow-up|1|||
147162925|NCT04599166|530760682|FG000|Overall Study|Technological failure connecting to study app|80|||
147162926|NCT01974752|530760683|FG000|Overall Study|Death|33|||
147162927|NCT01974752|530760684|FG001|Overall Study|Death|11|||
147162928|NCT01974752|530760683|FG000|Overall Study|Lost to Follow-up|2|||
147162929|NCT01974752|530760684|FG001|Overall Study|Lost to Follow-up|0|||
147162930|NCT01974752|530760683|FG000|Overall Study|Withdrawal by Subject|2|||
147162931|NCT01974752|530760684|FG001|Overall Study|Withdrawal by Subject|3|||
147162932|NCT01974752|530760683|FG000|Overall Study|Other Eligibility Criteria|0|||
147162933|NCT01974752|530760684|FG001|Overall Study|Other Eligibility Criteria|1|||
147162934|NCT02317809|530760685|FG000|First Intervention Period (8 Days)|Protocol Non-Compliance|2|||
147162935|NCT02317809|530760686|FG001|First Intervention Period (8 Days)|Protocol Non-Compliance|0|||
147162936|NCT02317809|530760685|FG000|First Intervention Period (8 Days)|Withdrawn Due To Multiple Follicles|1|||
147162937|NCT02317809|530760686|FG001|First Intervention Period (8 Days)|Withdrawn Due To Multiple Follicles|0|||
147162938|NCT02435680|530760687|FG000|Overall Study|Physician Decision|3|||
147162939|NCT02435680|530760688|FG001|Overall Study|Physician Decision|0|||
147162940|NCT02435680|530760689|FG002|Overall Study|Physician Decision|0|||
147162941|NCT02435680|530760687|FG000|Overall Study|subject / guardian decision|0|||
147162942|NCT02435680|530760688|FG001|Overall Study|subject / guardian decision|3|||
147162943|NCT02435680|530760689|FG002|Overall Study|subject / guardian decision|2|||
147162944|NCT02435680|530760687|FG000|Overall Study|Adverse Event|8|||
147162945|NCT02435680|530760688|FG001|Overall Study|Adverse Event|3|||
147162946|NCT02435680|530760689|FG002|Overall Study|Adverse Event|2|||
147162947|NCT02435680|530760687|FG000|Overall Study|progressive disease|10|||
147162948|NCT02435680|530760688|FG001|Overall Study|progressive disease|7|||
147162949|NCT02435680|530760689|FG002|Overall Study|progressive disease|11|||
147162950|NCT02435680|530760687|FG000|Overall Study|not treated|0|||
147162951|NCT02435680|530760688|FG001|Overall Study|not treated|0|||
147162952|NCT02435680|530760689|FG002|Overall Study|not treated|1|||
147162953|NCT00953524|530760690|FG000|Overall Study|Adverse Event|2|||
147162954|NCT00953524|530760691|FG001|Overall Study|Adverse Event|0|||
147162955|NCT00953524|530760692|FG002|Overall Study|Adverse Event|1|||
147162956|NCT00953524|530760693|FG003|Overall Study|Adverse Event|2|||
147162957|NCT00953524|530760690|FG000|Overall Study|Protocol Violation|18|||
147162958|NCT00953524|530760691|FG001|Overall Study|Protocol Violation|10|||
147162959|NCT00953524|530760692|FG002|Overall Study|Protocol Violation|11|||
147162960|NCT00953524|530760693|FG003|Overall Study|Protocol Violation|6|||
147162961|NCT00953524|530760690|FG000|Overall Study|Lost to Follow-up|0|||
147162962|NCT00953524|530760691|FG001|Overall Study|Lost to Follow-up|1|||
147162963|NCT00953524|530760692|FG002|Overall Study|Lost to Follow-up|1|||
147162964|NCT00953524|530760693|FG003|Overall Study|Lost to Follow-up|0|||
147162965|NCT00953524|530760690|FG000|Overall Study|Withdrawal by Subject|2|||
147162966|NCT00953524|530760691|FG001|Overall Study|Withdrawal by Subject|4|||
147162967|NCT00953524|530760692|FG002|Overall Study|Withdrawal by Subject|1|||
147162968|NCT00953524|530760693|FG003|Overall Study|Withdrawal by Subject|0|||
147162969|NCT03784846|530760698|FG000|Pre-COVID Study|Lost to Follow-up|3|||
147162970|NCT03784846|530760699|FG001|Pre-COVID Study|Lost to Follow-up|3|||
147162971|NCT03784846|530760700|FG002|Pre-COVID Study|Lost to Follow-up|2|||
147162972|NCT03784846|530760698|FG000|Pre-COVID Study|Withdrawal by Subject|1|||
147162973|NCT03784846|530760699|FG001|Pre-COVID Study|Withdrawal by Subject|2|||
147162974|NCT03784846|530760700|FG002|Pre-COVID Study|Withdrawal by Subject|1|||
147162975|NCT03784846|530760698|FG000|Pre-COVID Study|Discontinued by Researchers|7|||
147162976|NCT03784846|530760699|FG001|Pre-COVID Study|Discontinued by Researchers|6|||
147162977|NCT03784846|530760700|FG002|Pre-COVID Study|Discontinued by Researchers|2|||
147162978|NCT03784846|530760698|FG000|Post-COVID Study|Lost to Follow-up|3|||
147162979|NCT03784846|530760699|FG001|Post-COVID Study|Lost to Follow-up|5|||
147242874|NCT02891850|531061932|FG000|Overall Study|Withdrawal by Subject|2|||
147242875|NCT02891850|531061933|FG001|Overall Study|Withdrawal by Subject|3|||
147588774|NCT02927834|532309985|FG000|Overall Study|Lost to Follow-up|1|||
147162980|NCT03784846|530760700|FG002|Post-COVID Study|Lost to Follow-up|1|||
147242876|NCT03797014|531061939|FG000|Overall Study|Withdrawal by Subject|1|||
147242877|NCT03797014|531061939|FG000|Overall Study|Lost to Follow-up|1|||
147588775|NCT02927834|532309986|FG001|Overall Study|Lost to Follow-up|2|||
147162981|NCT03784846|530760698|FG000|Post-COVID Study|Withdrawal by Subject|1|||
147162982|NCT03784846|530760699|FG001|Post-COVID Study|Withdrawal by Subject|2|||
147162983|NCT03784846|530760700|FG002|Post-COVID Study|Withdrawal by Subject|0|||
147162984|NCT02231762|530760707|FG000|Combination Phase|Adverse Event|10|||
147162985|NCT02231762|530760708|FG001|Combination Phase|Adverse Event|0|||
147162986|NCT02231762|530760709|FG002|Combination Phase|Adverse Event|0|||
147162987|NCT02231762|530760710|FG003|Combination Phase|Adverse Event|0|||
147162988|NCT02231762|530760707|FG000|Combination Phase|Withdrawal by Subject|2|||
147242878|NCT03797014|531061939|FG000|Overall Study|Protocol Violation|1|||
147588776|NCT02927834|532309987|FG002|Overall Study|Lost to Follow-up|2|||
147242879|NCT01970397|531061940|FG000|Overall Study|Adverse Event|0|||
147242880|NCT01970397|531061941|FG001|Overall Study|Adverse Event|1|||
147242881|NCT01970397|531061940|FG000|Overall Study|Lost to Follow-up|0|||
147242882|NCT01970397|531061941|FG001|Overall Study|Lost to Follow-up|1|||
147242883|NCT01970397|531061940|FG000|Overall Study|Personal Reasons|1|||
147242884|NCT01970397|531061941|FG001|Overall Study|Personal Reasons|2|||
147242885|NCT01970397|531061940|FG000|Overall Study|Protocol Violation|1|||
147242886|NCT01970397|531061941|FG001|Overall Study|Protocol Violation|1|||
147242887|NCT03305575|531061944|FG000|Overall Study|Physician Decision|1|||
147242888|NCT03305575|531061945|FG001|Overall Study|Physician Decision|0|||
147242889|NCT00105469|531061946|FG000|Overall Study|Adverse Event|9|||
147242890|NCT00105469|531061947|FG001|Overall Study|Adverse Event|8|||
147242891|NCT00105469|531061946|FG000|Overall Study|Protocol Violation|4|||
147242892|NCT00105469|531061947|FG001|Overall Study|Protocol Violation|0|||
147242893|NCT00105469|531061946|FG000|Overall Study|Withdrawal by Subject|2|||
147242894|NCT00105469|531061947|FG001|Overall Study|Withdrawal by Subject|3|||
147242895|NCT00105469|531061946|FG000|Overall Study|Lost to Follow-up|1|||
147242896|NCT00105469|531061947|FG001|Overall Study|Lost to Follow-up|0|||
147242897|NCT00105469|531061946|FG000|Overall Study|Lack of Efficacy|2|||
147242898|NCT00105469|531061947|FG001|Overall Study|Lack of Efficacy|0|||
147242899|NCT00105469|531061946|FG000|Overall Study|Other Reason|4|||
147242900|NCT00105469|531061947|FG001|Overall Study|Other Reason|0|||
147242901|NCT04115839|531061952|FG000|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|14|||
147242902|NCT04115839|531061953|FG001|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|13|||
147242903|NCT04115839|531061954|FG002|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|14|||
147242904|NCT04115839|531061955|FG003|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|0|||
147242905|NCT04115839|531061956|FG004|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|0|||
147242906|NCT04115839|531061957|FG005|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|0|||
147242907|NCT04115839|531061958|FG006|Main Study (Up to 16 Weeks)|Study Terminated by Sponsor|0|||
147242908|NCT04115839|531061952|FG000|Main Study (Up to 16 Weeks)|Withdrew Consent|2|||
147242909|NCT04115839|531061953|FG001|Main Study (Up to 16 Weeks)|Withdrew Consent|1|||
147242910|NCT04115839|531061954|FG002|Main Study (Up to 16 Weeks)|Withdrew Consent|3|||
147242911|NCT04115839|531061955|FG003|Main Study (Up to 16 Weeks)|Withdrew Consent|0|||
147242912|NCT04115839|531061956|FG004|Main Study (Up to 16 Weeks)|Withdrew Consent|0|||
147242913|NCT04115839|531061957|FG005|Main Study (Up to 16 Weeks)|Withdrew Consent|0|||
147242914|NCT04115839|531061958|FG006|Main Study (Up to 16 Weeks)|Withdrew Consent|0|||
147162989|NCT02231762|530760708|FG001|Combination Phase|Withdrawal by Subject|0|||
147162990|NCT02231762|530760709|FG002|Combination Phase|Withdrawal by Subject|0|||
147162991|NCT02231762|530760710|FG003|Combination Phase|Withdrawal by Subject|0|||
147162992|NCT02231762|530760707|FG000|Combination Phase|Disease Progression|6|||
147162993|NCT02231762|530760708|FG001|Combination Phase|Disease Progression|0|||
147162994|NCT02231762|530760709|FG002|Combination Phase|Disease Progression|0|||
147588777|NCT00613730|532309991|FG000|Overall Study|Disease progression|2|||
147588778|NCT00613730|532309991|FG000|Overall Study|Administrative decision|1|||
147588779|NCT00479388|532309992|FG000|Overall Study|Adverse Event|90|||
147588780|NCT00479388|532309993|FG001|Overall Study|Adverse Event|45|||
147588781|NCT00479388|532309992|FG000|Overall Study|Lost to Follow-up|0|||
147588782|NCT00479388|532309993|FG001|Overall Study|Lost to Follow-up|2|||
147162995|NCT02231762|530760710|FG003|Combination Phase|Disease Progression|0|||
147162996|NCT02231762|530760707|FG000|Combination Phase|Did not meet inclusion criteria|1|||
147162997|NCT02231762|530760708|FG001|Combination Phase|Did not meet inclusion criteria|0|||
147162998|NCT02231762|530760709|FG002|Combination Phase|Did not meet inclusion criteria|0|||
147162999|NCT02231762|530760710|FG003|Combination Phase|Did not meet inclusion criteria|0|||
147163000|NCT02231762|530760707|FG000|Combination Phase|Protocol Violation|1|||
147163001|NCT02231762|530760708|FG001|Combination Phase|Protocol Violation|0|||
147163002|NCT02231762|530760709|FG002|Combination Phase|Protocol Violation|0|||
147163003|NCT02231762|530760710|FG003|Combination Phase|Protocol Violation|0|||
147163004|NCT02231762|530760707|FG000|Maintenance Phase|Disease progression|0|||
147163005|NCT02231762|530760708|FG001|Maintenance Phase|Disease progression|3|||
147163006|NCT02231762|530760709|FG002|Maintenance Phase|Disease progression|4|||
147163007|NCT02231762|530760710|FG003|Maintenance Phase|Disease progression|3|||
147242915|NCT04115839|531061952|FG000|Main Study (Up to 16 Weeks)|Adverse Event|2|||
147242916|NCT04115839|531061953|FG001|Main Study (Up to 16 Weeks)|Adverse Event|0|||
147242917|NCT04115839|531061954|FG002|Main Study (Up to 16 Weeks)|Adverse Event|0|||
147242918|NCT04115839|531061955|FG003|Main Study (Up to 16 Weeks)|Adverse Event|0|||
147242919|NCT04115839|531061956|FG004|Main Study (Up to 16 Weeks)|Adverse Event|0|||
147242920|NCT04115839|531061957|FG005|Main Study (Up to 16 Weeks)|Adverse Event|0|||
147242921|NCT04115839|531061958|FG006|Main Study (Up to 16 Weeks)|Adverse Event|0|||
147163008|NCT02231762|530760707|FG000|Maintenance Phase|Adverse Event|0|||
147588783|NCT00479388|532309992|FG000|Overall Study|Protocol Violation|10|||
147163009|NCT02231762|530760708|FG001|Maintenance Phase|Adverse Event|0|||
147242922|NCT04115839|531061952|FG000|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
147588784|NCT00479388|532309993|FG001|Overall Study|Protocol Violation|9|||
147588785|NCT00479388|532309992|FG000|Overall Study|Withdrawal by Subject|32|||
147588786|NCT00479388|532309993|FG001|Overall Study|Withdrawal by Subject|17|||
147163010|NCT02231762|530760709|FG002|Maintenance Phase|Adverse Event|1|||
147163011|NCT02231762|530760710|FG003|Maintenance Phase|Adverse Event|2|||
147163012|NCT01669421|530760713|FG000|Phase 1: Standard Dose Therapy|Withdrawal by Subject|1|||
147163013|NCT01669421|530760713|FG000|Phase 1: Standard Dose Therapy|Physician Decision|1|||
147163014|NCT01149486|530760714|FG000|First Intervention|Adverse Event|0|||
147163015|NCT01149486|530760715|FG001|First Intervention|Adverse Event|1|||
147163016|NCT02961790|530760720|FG000|Overall Study|Canceled|4|||
147163017|NCT02961790|530760721|FG001|Overall Study|Canceled|5|||
147163018|NCT02961790|530760722|FG002|Overall Study|Canceled|1|||
147163019|NCT02961790|530760723|FG003|Overall Study|Canceled|4|||
147163020|NCT02961790|530760720|FG000|Overall Study|without baseline data|4|||
147163021|NCT02961790|530760721|FG001|Overall Study|without baseline data|0|||
147163022|NCT02961790|530760722|FG002|Overall Study|without baseline data|1|||
147163023|NCT02961790|530760723|FG003|Overall Study|without baseline data|0|||
147163024|NCT02961790|530760720|FG000|Overall Study|without post baseline data|7|||
147163025|NCT02961790|530760721|FG001|Overall Study|without post baseline data|6|||
147163026|NCT02961790|530760722|FG002|Overall Study|without post baseline data|4|||
147163027|NCT02961790|530760723|FG003|Overall Study|without post baseline data|1|||
147163028|NCT02594098|530760726|FG000|Overall Study|Lack of Efficacy|17|||
147163029|NCT02594098|530760727|FG001|Overall Study|Lack of Efficacy|6|||
147163030|NCT02594098|530760726|FG000|Overall Study|Withdrawal by Subject|1|||
147163031|NCT02594098|530760727|FG001|Overall Study|Withdrawal by Subject|3|||
147163032|NCT02594098|530760726|FG000|Overall Study|Terminated participation|6|||
147163033|NCT02594098|530760727|FG001|Overall Study|Terminated participation|2|||
147163034|NCT02594098|530760726|FG000|Overall Study|Seek alternative treatment|2|||
147163035|NCT02594098|530760727|FG001|Overall Study|Seek alternative treatment|1|||
147163036|NCT02594098|530760726|FG000|Overall Study|Other|0|||
147163037|NCT02594098|530760727|FG001|Overall Study|Other|1|||
147163038|NCT03906656|530760731|FG000|Fitting/Assessment Prior to Home Use 1|Withdrawal by Subject|1|||
147163039|NCT03906656|530760732|FG001|Fitting/Assessment Prior to Home Use 1|Withdrawal by Subject|0|||
147163040|NCT03906656|530760731|FG000|Fitting/Assessment Prior to Home Use 1|Adverse Event|0|||
147163041|NCT03906656|530760732|FG001|Fitting/Assessment Prior to Home Use 1|Adverse Event|1|||
147163042|NCT03906656|530760731|FG000|Fitting/Assessment Prior to Home Use 1|Lack of access to site during COVID|0|||
147163043|NCT03906656|530760732|FG001|Fitting/Assessment Prior to Home Use 1|Lack of access to site during COVID|1|||
147163044|NCT03906656|530760731|FG000|Fitting/Assessment Prior to Home Use 1|Lack of Efficacy|0|||
147163045|NCT03906656|530760732|FG001|Fitting/Assessment Prior to Home Use 1|Lack of Efficacy|1|||
147163046|NCT03906656|530760731|FG000|Fitting/Assessment Prior to Home Use 1|Lost to Follow-up|1|||
147163047|NCT03906656|530760732|FG001|Fitting/Assessment Prior to Home Use 1|Lost to Follow-up|0|||
147163048|NCT03906656|530760731|FG000|Home Use 1 (3 Months)|Adverse Event|1|||
147242923|NCT04115839|531061953|FG001|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
147242924|NCT04115839|531061954|FG002|Main Study (Up to 16 Weeks)|Investigator's Discretion|1|||
147242925|NCT04115839|531061955|FG003|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
147588787|NCT01876368|532309996|FG000|Overall Study|Adverse Event|2|||
147588788|NCT01876368|532309997|FG001|Overall Study|Adverse Event|5|||
147588789|NCT01876368|532309996|FG000|Overall Study|Lack of Efficacy|1|||
147588790|NCT01876368|532309997|FG001|Overall Study|Lack of Efficacy|0|||
147588791|NCT01876368|532309996|FG000|Overall Study|Lost to Follow-up|0|||
147588792|NCT01876368|532309997|FG001|Overall Study|Lost to Follow-up|1|||
147588793|NCT01876368|532309996|FG000|Overall Study|Non-compliance with study treatment|0|||
147588794|NCT01876368|532309997|FG001|Overall Study|Non-compliance with study treatment|1|||
147588795|NCT01876368|532309996|FG000|Overall Study|Physician Decision|0|||
147588796|NCT01876368|532309997|FG001|Overall Study|Physician Decision|2|||
147588797|NCT01876368|532309996|FG000|Overall Study|Protocol deviation|3|||
147588798|NCT01876368|532309997|FG001|Overall Study|Protocol deviation|3|||
147588799|NCT01876368|532309996|FG000|Overall Study|Subject/guardian decision|3|||
147588800|NCT01876368|532309997|FG001|Overall Study|Subject/guardian decision|1|||
147588801|NCT02563769|532310000|FG000|Added 750mg Dose of CLAV (Day 5)|Physician Decision|0|||
147588802|NCT02563769|532310001|FG001|Added 750mg Dose of CLAV (Day 5)|Physician Decision|0|||
147588803|NCT02563769|532310002|FG002|Added 750mg Dose of CLAV (Day 5)|Physician Decision|1|||
147588804|NCT01644149|532310003|FG000|Overall Study|Withdrawal by Subject|1|||
147588805|NCT01644149|532310004|FG001|Overall Study|Withdrawal by Subject|0|||
147588806|NCT01644149|532310003|FG000|Overall Study|Lost to Follow-up|3|||
147588807|NCT01644149|532310004|FG001|Overall Study|Lost to Follow-up|1|||
147588808|NCT00104247|532310005|FG000|Overall Study|Withdrawal by Subject|1|||
147163049|NCT03906656|530760732|FG001|Home Use 1 (3 Months)|Adverse Event|2|||
147163050|NCT03906656|530760731|FG000|Home Use 1 (3 Months)|Withdrawal by Subject|1|||
147242926|NCT04115839|531061956|FG004|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
147242927|NCT04115839|531061957|FG005|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
147588809|NCT00104247|532310006|FG001|Overall Study|Withdrawal by Subject|0|||
147588810|NCT00104247|532310005|FG000|Overall Study|Noncompliant with dosing|0|||
147163051|NCT03906656|530760732|FG001|Home Use 1 (3 Months)|Withdrawal by Subject|0|||
147588811|NCT00104247|532310006|FG001|Overall Study|Noncompliant with dosing|1|||
147588812|NCT02820740|532310010|FG000|Overall Study|Did not have procedure|2|||
147588813|NCT04965389|532310011|FG000|Overall Study|Other reasons|1|||
147588814|NCT04965389|532310012|FG001|Overall Study|Other reasons|0|||
147588815|NCT04965389|532310013|FG002|Overall Study|Other reasons|0|||
147588816|NCT04965389|532310014|FG003|Overall Study|Other reasons|0|||
147588817|NCT04965389|532310011|FG000|Overall Study|Participant withdrew consent|0|||
147588818|NCT04965389|532310012|FG001|Overall Study|Participant withdrew consent|1|||
147588819|NCT04965389|532310013|FG002|Overall Study|Participant withdrew consent|0|||
147588820|NCT04965389|532310014|FG003|Overall Study|Participant withdrew consent|0|||
147163052|NCT03906656|530760731|FG000|Home Use 1 (3 Months)|Lack of Efficacy|0|||
147163053|NCT03906656|530760732|FG001|Home Use 1 (3 Months)|Lack of Efficacy|1|||
147163054|NCT03906656|530760731|FG000|Home Use 1 (3 Months)|Protocol Violation|1|||
147163055|NCT03906656|530760732|FG001|Home Use 1 (3 Months)|Protocol Violation|0|||
147163056|NCT03906656|530760731|FG000|Fitting/Assessment Prior to Home Use 2|Adverse Event|2|||
147163057|NCT03906656|530760732|FG001|Fitting/Assessment Prior to Home Use 2|Adverse Event|0|||
147163058|NCT03906656|530760731|FG000|Fitting/Assessment Prior to Home Use 2|Lack of access to site during COVID|1|||
147242928|NCT04115839|531061958|FG006|Main Study (Up to 16 Weeks)|Investigator's Discretion|0|||
147242929|NCT04115839|531061952|FG000|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|0|||
147242930|NCT04115839|531061953|FG001|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|0|||
147588821|NCT04965389|532310011|FG000|Overall Study|Poor/Non-compliance|0|||
147588822|NCT04965389|532310012|FG001|Overall Study|Poor/Non-compliance|1|||
147588823|NCT04965389|532310013|FG002|Overall Study|Poor/Non-compliance|0|||
147588824|NCT04965389|532310014|FG003|Overall Study|Poor/Non-compliance|0|||
147588825|NCT03903159|532310015|FG000|Overall Study|Discharged with Staff Approval|2|||
147588826|NCT03903159|532310015|FG000|Overall Study|Discharged at Staff Request|2|||
147588827|NCT03903159|532310015|FG000|Overall Study|Discharged Against Staff Advice|1|||
147588828|NCT03718117|532310019|FG000|Overall Study|Death|12|||
147588829|NCT03718117|532310020|FG001|Overall Study|Death|11|||
147588830|NCT03718117|532310021|FG002|Overall Study|Death|0|||
147588831|NCT03718117|532310019|FG000|Overall Study|Other|0|||
147588832|NCT03718117|532310020|FG001|Overall Study|Other|1|||
147588833|NCT03718117|532310021|FG002|Overall Study|Other|0|||
147588834|NCT03718117|532310019|FG000|Overall Study|Withdrawn due to adverse event (AE)|2|||
147588835|NCT03718117|532310020|FG001|Overall Study|Withdrawn due to adverse event (AE)|0|||
147588836|NCT03718117|532310021|FG002|Overall Study|Withdrawn due to adverse event (AE)|0|||
147588837|NCT03718117|532310019|FG000|Overall Study|Participant not met eligibility criteria|0|||
147588838|NCT03718117|532310020|FG001|Overall Study|Participant not met eligibility criteria|0|||
147588839|NCT03718117|532310021|FG002|Overall Study|Participant not met eligibility criteria|2|||
147588840|NCT01382251|532310022|FG000|Overall Study|Surgeries cancelled or delayed|16|||
147588841|NCT01382251|532310023|FG001|Overall Study|Surgeries cancelled or delayed|16|||
147588842|NCT01382251|532310022|FG000|Overall Study|Lost to Follow-up|4|||
147588843|NCT01382251|532310023|FG001|Overall Study|Lost to Follow-up|4|||
147588844|NCT01382251|532310022|FG000|Overall Study|Contacted after study closed|1|||
147588845|NCT01382251|532310023|FG001|Overall Study|Contacted after study closed|1|||
147588846|NCT01117987|532310025|FG000|Overall Study|Protocol deviation|0|||
147163059|NCT03906656|530760732|FG001|Fitting/Assessment Prior to Home Use 2|Lack of access to site during COVID|0|||
147242931|NCT04115839|531061954|FG002|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|0|||
147242932|NCT04115839|531061955|FG003|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|17|||
147242933|NCT04115839|531061956|FG004|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|19|||
147242934|NCT04115839|531061957|FG005|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|10|||
147242935|NCT04115839|531061958|FG006|LTE Phase (After Week 16 to Week 63)|Study Terminated by Sponsor|8|||
147242936|NCT04115839|531061952|FG000|LTE Phase (After Week 16 to Week 63)|Adverse Event|0|||
147242937|NCT04115839|531061953|FG001|LTE Phase (After Week 16 to Week 63)|Adverse Event|0|||
147242938|NCT04115839|531061954|FG002|LTE Phase (After Week 16 to Week 63)|Adverse Event|0|||
147242939|NCT04115839|531061955|FG003|LTE Phase (After Week 16 to Week 63)|Adverse Event|1|||
147242940|NCT04115839|531061956|FG004|LTE Phase (After Week 16 to Week 63)|Adverse Event|1|||
147588847|NCT01117987|532310026|FG001|Overall Study|Protocol deviation|1|||
147588848|NCT01117987|532310025|FG000|Overall Study|Subject no longer requires study drug|1|||
147588849|NCT01117987|532310026|FG001|Overall Study|Subject no longer requires study drug|0|||
147588850|NCT01117987|532310025|FG000|Overall Study|Lost to Follow-up|1|||
147588851|NCT01117987|532310026|FG001|Overall Study|Lost to Follow-up|1|||
147588852|NCT01117987|532310025|FG000|Overall Study|Abnormal test procedure result|2|||
147588853|NCT01117987|532310026|FG001|Overall Study|Abnormal test procedure result|0|||
147588854|NCT01117987|532310025|FG000|Overall Study|Lack of Efficacy|3|||
147588855|NCT01117987|532310026|FG001|Overall Study|Lack of Efficacy|4|||
147242941|NCT04115839|531061957|FG005|LTE Phase (After Week 16 to Week 63)|Adverse Event|0|||
147242942|NCT04115839|531061958|FG006|LTE Phase (After Week 16 to Week 63)|Adverse Event|0|||
147242943|NCT03808545|531061959|FG000|Overall Study|Withdrawal by Subject|1|||
147242944|NCT03808545|531061960|FG001|Overall Study|Withdrawal by Subject|1|||
147447533|NCT02135692|531803887|FG000|Overall Study|Adverse Event|3|||
147588856|NCT01117987|532310025|FG000|Overall Study|Death|5|||
147588857|NCT01117987|532310026|FG001|Overall Study|Death|10|||
147588858|NCT01117987|532310025|FG000|Overall Study|Withdrawal by Subject|5|||
147588859|NCT01117987|532310026|FG001|Overall Study|Withdrawal by Subject|10|||
147588860|NCT01117987|532310025|FG000|Overall Study|Adverse Event|19|||
147588861|NCT01117987|532310026|FG001|Overall Study|Adverse Event|26|||
147588862|NCT01117987|532310025|FG000|Overall Study|Administrative problems|25|||
147588863|NCT01117987|532310026|FG001|Overall Study|Administrative problems|22|||
147588864|NCT00206102|532310029|FG000|Overall Study|Adverse Event|119|||
147588865|NCT00206102|532310030|FG001|Overall Study|Adverse Event|82|||
147163060|NCT03906656|530760731|FG000|Fitting/Assessment Prior to Home Use 2|Withdrawal by Subject|1|||
147163061|NCT03906656|530760732|FG001|Fitting/Assessment Prior to Home Use 2|Withdrawal by Subject|0|||
147163062|NCT03906656|530760731|FG000|Fitting/Assessment Prior to Home Use 2|Lack of Efficacy|1|||
147163063|NCT03906656|530760732|FG001|Fitting/Assessment Prior to Home Use 2|Lack of Efficacy|0|||
147163064|NCT03906656|530760731|FG000|Fitting/Assessment Prior to Home Use 2|Personal problems|0|||
147163065|NCT03906656|530760732|FG001|Fitting/Assessment Prior to Home Use 2|Personal problems|1|||
147163066|NCT03906656|530760731|FG000|Fitting/Assessment Prior to Home Use 2|Lost to Follow-up|1|||
147163067|NCT03906656|530760732|FG001|Fitting/Assessment Prior to Home Use 2|Lost to Follow-up|0|||
147163068|NCT03906656|530760731|FG000|Home Use 2 (3 Months)|Adverse Event|1|||
147163069|NCT03906656|530760732|FG001|Home Use 2 (3 Months)|Adverse Event|1|||
147163070|NCT03906656|530760731|FG000|Home Use 2 (3 Months)|Lost to Follow-up|2|||
147163071|NCT03906656|530760732|FG001|Home Use 2 (3 Months)|Lost to Follow-up|0|||
147163072|NCT03906656|530760731|FG000|Home Use 2 (3 Months)|Death|2|||
147163073|NCT03906656|530760732|FG001|Home Use 2 (3 Months)|Death|0|||
147163074|NCT03906656|530760731|FG000|Home Use 2 (3 Months)|Lack of Efficacy|1|||
147322982|NCT04541186|531347874|FG001|Fibrate Expansion Study|Other than Specified|0|||
147322983|NCT04541186|531347875|FG002|Fibrate Expansion Study|Other than Specified|0|||
147322984|NCT04541186|531347876|FG003|Fibrate Expansion Study|Other than Specified|0|||
147322985|NCT04541186|531347877|FG004|Fibrate Expansion Study|Other than Specified|1|||
147322986|NCT00058058|531347885|FG000|Overall Study|Withdrawal by Subject|4|||
147322987|NCT00058058|531347885|FG000|Overall Study|Ineligible|20|||
147322988|NCT00058058|531347885|FG000|Overall Study|Claustrophobic|5|||
147322989|NCT00058058|531347885|FG000|Overall Study|technical issues|6|||
147322990|NCT00058058|531347885|FG000|Overall Study|Poor positioning, illness,pain|3|||
147322991|NCT01605136|531347886|FG000|Study Period|Withdrawal by Subject|2|||
147163075|NCT03906656|530760732|FG001|Home Use 2 (3 Months)|Lack of Efficacy|0|||
147163076|NCT03906656|530760731|FG000|Home Use 2 (3 Months)|Could not cope with KAFO after C-Brace|0|||
147163077|NCT03906656|530760732|FG001|Home Use 2 (3 Months)|Could not cope with KAFO after C-Brace|1|||
147163078|NCT01036529|530760733|FG000|Overall Study|Adverse Event|0|||
147163079|NCT01036529|530760734|FG001|Overall Study|Adverse Event|1|||
147163080|NCT01036529|530760733|FG000|Overall Study|Lost to Follow-up|0|||
147163081|NCT01036529|530760734|FG001|Overall Study|Lost to Follow-up|1|||
147163082|NCT01036529|530760733|FG000|Overall Study|Physician Decision|1|||
147163083|NCT01036529|530760734|FG001|Overall Study|Physician Decision|0|||
147163084|NCT01036529|530760733|FG000|Overall Study|Withdrawal by Subject|1|||
147163085|NCT01036529|530760734|FG001|Overall Study|Withdrawal by Subject|1|||
147163086|NCT01036529|530760733|FG000|Overall Study|Sponsor study termination|11|||
147163087|NCT01036529|530760734|FG001|Overall Study|Sponsor study termination|12|||
147163088|NCT00693472|530760735|FG000|Part 1|Adverse Event|1|||
147163089|NCT00693472|530760736|FG001|Part 1|Adverse Event|1|||
147163090|NCT00693472|530760737|FG002|Part 1|Adverse Event|0|||
147163091|NCT00693472|530760738|FG003|Part 1|Adverse Event|0|||
147163092|NCT00693472|530760735|FG000|Part 1|Lost to Follow-up|0|||
147163093|NCT00693472|530760736|FG001|Part 1|Lost to Follow-up|1|||
147163094|NCT00693472|530760737|FG002|Part 1|Lost to Follow-up|0|||
147163095|NCT00693472|530760738|FG003|Part 1|Lost to Follow-up|0|||
147163096|NCT00693472|530760735|FG000|Part 1|Withdrew - reason unrelated to treatment|5|||
147163097|NCT00693472|530760736|FG001|Part 1|Withdrew - reason unrelated to treatment|2|||
147163098|NCT00693472|530760737|FG002|Part 1|Withdrew - reason unrelated to treatment|0|||
147163099|NCT00693472|530760738|FG003|Part 1|Withdrew - reason unrelated to treatment|0|||
147163100|NCT00693472|530760735|FG000|Part 2|Adverse Event|0|||
147163101|NCT00693472|530760736|FG001|Part 2|Adverse Event|0|||
147163102|NCT00693472|530760737|FG002|Part 2|Adverse Event|1|||
147322992|NCT01605136|531347887|FG001|Study Period|Withdrawal by Subject|0|||
147322993|NCT01605136|531347886|FG000|Study Period|Physician Decision|1|||
147322994|NCT01605136|531347887|FG001|Study Period|Physician Decision|1|||
147322995|NCT01605136|531347886|FG000|Study Period|Lost to Follow-up|0|||
147322996|NCT01605136|531347887|FG001|Study Period|Lost to Follow-up|2|||
147588866|NCT00206102|532310029|FG000|Overall Study|Protocol Violation|0|||
147588867|NCT00206102|532310030|FG001|Overall Study|Protocol Violation|2|||
147588868|NCT00206102|532310029|FG000|Overall Study|Lack of therapeutic response|16|||
147163103|NCT00693472|530760738|FG003|Part 2|Adverse Event|0|||
147163104|NCT00693472|530760735|FG000|Part 2|Withdrew - reason unrelated to treatment|0|||
147163105|NCT00693472|530760736|FG001|Part 2|Withdrew - reason unrelated to treatment|0|||
147163106|NCT00693472|530760737|FG002|Part 2|Withdrew - reason unrelated to treatment|1|||
147163107|NCT00693472|530760738|FG003|Part 2|Withdrew - reason unrelated to treatment|2|||
147163108|NCT03412604|530760739|FG000|Overall Study|Withdrawal by Subject|1|||
147163109|NCT00993499|530760746|FG000|Run-in Period (8 Days)|Adverse Event|0|||
147588869|NCT00206102|532310030|FG001|Overall Study|Lack of therapeutic response|11|||
147588870|NCT00206102|532310029|FG000|Overall Study|Lost to Follow-up|95|||
147163110|NCT00993499|530760747|FG001|Run-in Period (8 Days)|Adverse Event|1|||
147163111|NCT00993499|530760748|FG002|Run-in Period (8 Days)|Adverse Event|0|||
147163112|NCT00993499|530760749|FG003|Run-in Period (8 Days)|Adverse Event|0|||
147163113|NCT00993499|530760750|FG004|Run-in Period (8 Days)|Adverse Event|0|||
147163114|NCT00993499|530760751|FG005|Run-in Period (8 Days)|Adverse Event|0|||
147163115|NCT00993499|530760746|FG000|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|1|||
147588871|NCT00206102|532310030|FG001|Overall Study|Lost to Follow-up|66|||
147588872|NCT00206102|532310029|FG000|Overall Study|Withdrawal by Subject|118|||
147588873|NCT00206102|532310030|FG001|Overall Study|Withdrawal by Subject|101|||
147588874|NCT00206102|532310029|FG000|Overall Study|Study-specific discontinuation criteria|18|||
147588875|NCT00206102|532310030|FG001|Overall Study|Study-specific discontinuation criteria|17|||
147588876|NCT00206102|532310029|FG000|Overall Study|None of those categories|42|||
147163116|NCT00993499|530760747|FG001|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0|||
147588877|NCT00206102|532310030|FG001|Overall Study|None of those categories|36|||
147588878|NCT04232540|532310034|FG000|Overall Study|Lost to Follow-up|1|||
147588879|NCT04232540|532310035|FG001|Overall Study|Lost to Follow-up|0|||
147588880|NCT04230876|532310037|FG000|Overall Study|participant did not complete protocol by not training or not wearing aids.|1|||
147588881|NCT04230876|532310038|FG001|Overall Study|participant did not complete protocol by not training or not wearing aids.|1|||
147588882|NCT02093923|532310039|FG000|Overall Study|Lost to Follow-up|0|||
147588883|NCT02093923|532310040|FG001|Overall Study|Lost to Follow-up|0|||
147588884|NCT02093923|532310041|FG002|Overall Study|Lost to Follow-up|0|||
147588885|NCT02093923|532310042|FG003|Overall Study|Lost to Follow-up|1|||
147588886|NCT02093923|532310043|FG004|Overall Study|Lost to Follow-up|0|||
147588887|NCT02093923|532310039|FG000|Overall Study|Screen failure after randomization|0|||
147588888|NCT02093923|532310040|FG001|Overall Study|Screen failure after randomization|0|||
147588889|NCT02093923|532310041|FG002|Overall Study|Screen failure after randomization|0|||
147588890|NCT02093923|532310042|FG003|Overall Study|Screen failure after randomization|1|||
147588891|NCT02093923|532310043|FG004|Overall Study|Screen failure after randomization|0|||
147588892|NCT01662362|532310048|FG000|Overall Study|Lost to Follow-up|38|||
147588893|NCT02339090|532310054|FG000|Overall Study|Adverse Event|1|||
147588894|NCT02339090|532310055|FG001|Overall Study|Adverse Event|0|||
147588895|NCT02339090|532310054|FG000|Overall Study|Lost to Follow-up|0|||
147588896|NCT02339090|532310055|FG001|Overall Study|Lost to Follow-up|1|||
147588897|NCT02339090|532310054|FG000|Overall Study|Non-compliance With Study Drug|0|||
147588898|NCT02339090|532310055|FG001|Overall Study|Non-compliance With Study Drug|1|||
147588899|NCT02339090|532310054|FG000|Overall Study|Withdrawal by Subject|2|||
147588900|NCT02339090|532310055|FG001|Overall Study|Withdrawal by Subject|1|||
147588901|NCT02339090|532310054|FG000|Overall Study|Poor Growth|3|||
147588902|NCT02339090|532310055|FG001|Overall Study|Poor Growth|0|||
147588903|NCT02339090|532310054|FG000|Overall Study|Randomized but not treated|0|||
147588904|NCT02339090|532310055|FG001|Overall Study|Randomized but not treated|2|||
147588905|NCT02737592|532310056|FG000|Overall Study|Withdrawal by Subject|1|||
147588906|NCT03183141|532310063|FG000|Overall Study|Withdrawal by Subject|2|||
147588907|NCT03183141|532310064|FG001|Overall Study|Withdrawal by Subject|4|||
147588908|NCT03183141|532310063|FG000|Overall Study|Death|0|||
147588909|NCT03183141|532310064|FG001|Overall Study|Death|8|||
147588910|NCT02756637|532310066|FG000|Overall Study|Not eligible for initial SWOG study|10|||
147588911|NCT02756637|532310067|FG001|Overall Study|Not eligible for initial SWOG study|10|||
147588912|NCT02756637|532310066|FG000|Overall Study|No available NLR value|44|||
147588913|NCT02756637|532310067|FG001|Overall Study|No available NLR value|44|||
147588914|NCT02756637|532310066|FG000|Overall Study|Did not complete curative therapy|33|||
147588915|NCT02756637|532310067|FG001|Overall Study|Did not complete curative therapy|0|||
147588916|NCT01507090|532310070|FG000|Overall Study|incomplete dataset|18|||
147588917|NCT04678817|532311465|FG000|Overall Study|Lost to Follow-up|28|||
147588918|NCT04678817|532311466|FG001|Overall Study|Lost to Follow-up|0|||
147588919|NCT04678817|532311467|FG002|Overall Study|Lost to Follow-up|0|||
147588920|NCT02124902|532311473|FG000|Overall Study|Adverse Event|7|||
147588921|NCT02124902|532311474|FG001|Overall Study|Adverse Event|2|||
147588922|NCT02124902|532311473|FG000|Overall Study|Went to alternative treatment|4|||
147588923|NCT02124902|532311474|FG001|Overall Study|Went to alternative treatment|0|||
147588924|NCT02124902|532311473|FG000|Overall Study|Withdrawal by Subject|2|||
147588925|NCT02124902|532311474|FG001|Overall Study|Withdrawal by Subject|1|||
147588926|NCT02124902|532311473|FG000|Overall Study|Physician Decision|2|||
147588927|NCT02124902|532311474|FG001|Overall Study|Physician Decision|0|||
147588928|NCT02124902|532311473|FG000|Overall Study|Not eligible|1|||
147588929|NCT02124902|532311474|FG001|Overall Study|Not eligible|0|||
147588930|NCT02124902|532311473|FG000|Overall Study|Did not receive carboplatin in cycle 6|1|||
147588931|NCT02124902|532311474|FG001|Overall Study|Did not receive carboplatin in cycle 6|3|||
147588932|NCT00546910|532311478|FG000|Overall Study|Adverse Event|2|||
147588933|NCT00546910|532311479|FG001|Overall Study|Adverse Event|3|||
147588934|NCT00546910|532311478|FG000|Overall Study|Lack of Efficacy|5|||
147588935|NCT00546910|532311479|FG001|Overall Study|Lack of Efficacy|7|||
147588936|NCT00546910|532311478|FG000|Overall Study|Physician Decision|0|||
147588937|NCT00546910|532311479|FG001|Overall Study|Physician Decision|1|||
147163117|NCT00993499|530760748|FG002|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0|||
147588938|NCT00546910|532311478|FG000|Overall Study|Withdrawal by Subject|2|||
147588939|NCT00546910|532311479|FG001|Overall Study|Withdrawal by Subject|0|||
147588940|NCT01467479|532311480|FG000|Overall Study|No Study Medication|1|||
147588941|NCT01467479|532311481|FG001|Overall Study|No Study Medication|0|||
147588942|NCT01467479|532311482|FG002|Overall Study|No Study Medication|2|||
147588943|NCT01467479|532311480|FG000|Overall Study|Adverse Event|1|||
147588944|NCT01467479|532311481|FG001|Overall Study|Adverse Event|2|||
147588945|NCT01467479|532311482|FG002|Overall Study|Adverse Event|0|||
147588946|NCT01467479|532311480|FG000|Overall Study|Death|0|||
147588947|NCT01467479|532311481|FG001|Overall Study|Death|0|||
147588948|NCT01467479|532311482|FG002|Overall Study|Death|1|||
147588949|NCT01467479|532311480|FG000|Overall Study|Lost to Follow-up|2|||
147588950|NCT01467479|532311481|FG001|Overall Study|Lost to Follow-up|5|||
147588951|NCT01467479|532311482|FG002|Overall Study|Lost to Follow-up|3|||
147588952|NCT01467479|532311480|FG000|Overall Study|Withdrawal of Consent|3|||
147588953|NCT01467479|532311481|FG001|Overall Study|Withdrawal of Consent|7|||
147588954|NCT01467479|532311482|FG002|Overall Study|Withdrawal of Consent|7|||
147654457|NCT04074330|532556748|FG006|Dose Escalation (up to 19.36 Months)|Death|0|||
147654458|NCT04074330|532556749|FG007|Dose Escalation (up to 19.36 Months)|Death|0|||
147654459|NCT04074330|532556750|FG008|Dose Escalation (up to 19.36 Months)|Death|0|||
147654460|NCT04074330|532556751|FG009|Dose Escalation (up to 19.36 Months)|Death|0|||
147654461|NCT04074330|532556742|FG000|Dose Escalation (up to 19.36 Months)|Progressive Disease|2|||
147654462|NCT04074330|532556743|FG001|Dose Escalation (up to 19.36 Months)|Progressive Disease|0|||
147654463|NCT04074330|532556744|FG002|Dose Escalation (up to 19.36 Months)|Progressive Disease|0|||
147654464|NCT04074330|532556745|FG003|Dose Escalation (up to 19.36 Months)|Progressive Disease|5|||
147654465|NCT04074330|532556746|FG004|Dose Escalation (up to 19.36 Months)|Progressive Disease|2|||
147163118|NCT00993499|530760749|FG003|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0|||
147163119|NCT00993499|530760750|FG004|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0|||
147322997|NCT01605136|531347886|FG000|Safety Follow-Up Period|Withdrawal by Subject|1|||
147654466|NCT04074330|532556747|FG005|Dose Escalation (up to 19.36 Months)|Progressive Disease|2|||
147654467|NCT04074330|532556748|FG006|Dose Escalation (up to 19.36 Months)|Progressive Disease|1|||
147654468|NCT04074330|532556749|FG007|Dose Escalation (up to 19.36 Months)|Progressive Disease|2|||
147654469|NCT04074330|532556750|FG008|Dose Escalation (up to 19.36 Months)|Progressive Disease|0|||
147654470|NCT04074330|532556751|FG009|Dose Escalation (up to 19.36 Months)|Progressive Disease|0|||
147654471|NCT04074330|532556742|FG000|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
147654472|NCT04074330|532556743|FG001|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
147654473|NCT04074330|532556744|FG002|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|1|||
147654474|NCT04074330|532556745|FG003|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
147654475|NCT04074330|532556746|FG004|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
147654476|NCT04074330|532556747|FG005|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
147654477|NCT04074330|532556748|FG006|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
147654478|NCT04074330|532556749|FG007|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
147654479|NCT04074330|532556750|FG008|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
147654480|NCT04074330|532556751|FG009|Dose Escalation (up to 19.36 Months)|Start of New Systemic Treatment|0|||
147654481|NCT04074330|532556742|FG000|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
147654482|NCT04074330|532556743|FG001|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
147654483|NCT04074330|532556744|FG002|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
147654484|NCT04074330|532556745|FG003|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
147163120|NCT00993499|530760751|FG005|Run-in Period (8 Days)|Inclusion/exclusion criteria not met|0|||
147163121|NCT00993499|530760746|FG000|Run-in Period (8 Days)|Consent withdrawn|0|||
147163122|NCT00993499|530760747|FG001|Run-in Period (8 Days)|Consent withdrawn|1|||
147163123|NCT00993499|530760748|FG002|Run-in Period (8 Days)|Consent withdrawn|0|||
147322998|NCT01605136|531347887|FG001|Safety Follow-Up Period|Withdrawal by Subject|2|||
147322999|NCT01072929|531347888|FG000|Overall Study|Adverse Event|8|||
147323000|NCT01072929|531347889|FG001|Overall Study|Adverse Event|11|||
147323001|NCT01072929|531347890|FG002|Overall Study|Adverse Event|2|||
147588955|NCT01467479|532311480|FG000|Overall Study|Study Terminated by Sponsor|1|||
147588956|NCT01467479|532311481|FG001|Overall Study|Study Terminated by Sponsor|3|||
147588957|NCT01467479|532311482|FG002|Overall Study|Study Terminated by Sponsor|3|||
147588958|NCT01467479|532311480|FG000|Overall Study|Other|1|||
147588959|NCT01467479|532311481|FG001|Overall Study|Other|0|||
147654485|NCT04074330|532556746|FG004|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
147654486|NCT04074330|532556747|FG005|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|1|||
147163124|NCT00993499|530760749|FG003|Run-in Period (8 Days)|Consent withdrawn|0|||
147588960|NCT01467479|532311482|FG002|Overall Study|Other|0|||
147588961|NCT02284347|532311492|FG000|Overall Study|Lost to Follow-up|2|||
147588962|NCT02284347|532311492|FG000|Overall Study|Withdrawn prior to treatment|1|||
147588963|NCT01684215|532311496|FG000|Phase 1, Part 1|Adverse Event|1|||
147588964|NCT01684215|532311497|FG001|Phase 1, Part 1|Adverse Event|0|||
147588965|NCT01684215|532311498|FG002|Phase 1, Part 1|Adverse Event|0|||
147163125|NCT00993499|530760750|FG004|Run-in Period (8 Days)|Consent withdrawn|0|||
147163126|NCT00993499|530760751|FG005|Run-in Period (8 Days)|Consent withdrawn|0|||
147163127|NCT00993499|530760746|FG000|Run-in Period (8 Days)|Progressive disease|0|||
147163128|NCT00993499|530760747|FG001|Run-in Period (8 Days)|Progressive disease|1|||
147163129|NCT00993499|530760748|FG002|Run-in Period (8 Days)|Progressive disease|1|||
147163130|NCT00993499|530760749|FG003|Run-in Period (8 Days)|Progressive disease|0|||
147163131|NCT00993499|530760750|FG004|Run-in Period (8 Days)|Progressive disease|0|||
147163132|NCT00993499|530760751|FG005|Run-in Period (8 Days)|Progressive disease|0|||
147163133|NCT00993499|530760746|FG000|Discontinued Before Starting Course 3|Progressive Disease|2|||
147163134|NCT00993499|530760747|FG001|Discontinued Before Starting Course 3|Progressive Disease|2|||
147163135|NCT00993499|530760748|FG002|Discontinued Before Starting Course 3|Progressive Disease|0|||
147163136|NCT00993499|530760749|FG003|Discontinued Before Starting Course 3|Progressive Disease|0|||
147163137|NCT00993499|530760750|FG004|Discontinued Before Starting Course 3|Progressive Disease|0|||
147163138|NCT00993499|530760751|FG005|Discontinued Before Starting Course 3|Progressive Disease|0|||
147163139|NCT00993499|530760746|FG000|Discontinued Before Starting Course 3|Withdrawal by Subject|2|||
147163140|NCT00993499|530760747|FG001|Discontinued Before Starting Course 3|Withdrawal by Subject|2|||
147163141|NCT00993499|530760748|FG002|Discontinued Before Starting Course 3|Withdrawal by Subject|0|||
147163142|NCT00993499|530760749|FG003|Discontinued Before Starting Course 3|Withdrawal by Subject|0|||
147163143|NCT00993499|530760750|FG004|Discontinued Before Starting Course 3|Withdrawal by Subject|0|||
147163144|NCT00993499|530760751|FG005|Discontinued Before Starting Course 3|Withdrawal by Subject|0|||
147163145|NCT00993499|530760746|FG000|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0|||
147163146|NCT00993499|530760747|FG001|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0|||
147163147|NCT00993499|530760748|FG002|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|1|||
147163148|NCT00993499|530760749|FG003|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|1|||
147163149|NCT00993499|530760750|FG004|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0|||
147163150|NCT00993499|530760751|FG005|Discontinued Before Starting Course 3|Dose Limiting Toxicity (DLT)|0|||
147163151|NCT00993499|530760746|FG000|Discontinued Before Starting Course 3|Non compliance with the protocol|0|||
147163152|NCT00993499|530760747|FG001|Discontinued Before Starting Course 3|Non compliance with the protocol|0|||
147163153|NCT00993499|530760748|FG002|Discontinued Before Starting Course 3|Non compliance with the protocol|2|||
147323002|NCT01072929|531347888|FG000|Overall Study|Lack of Efficacy|7|||
147323003|NCT01072929|531347889|FG001|Overall Study|Lack of Efficacy|4|||
147323004|NCT01072929|531347890|FG002|Overall Study|Lack of Efficacy|0|||
147323005|NCT01072929|531347888|FG000|Overall Study|Withdrawal by Subject|7|||
147323006|NCT01072929|531347889|FG001|Overall Study|Withdrawal by Subject|15|||
147323007|NCT01072929|531347890|FG002|Overall Study|Withdrawal by Subject|3|||
147323008|NCT01072929|531347888|FG000|Overall Study|Protocol Violation|13|||
147163154|NCT00993499|530760749|FG003|Discontinued Before Starting Course 3|Non compliance with the protocol|0|||
147242945|NCT00790023|531061961|FG000|Overall Study|Adverse Event|2|||
147242946|NCT00790023|531061962|FG001|Overall Study|Adverse Event|1|||
147242947|NCT00790023|531061963|FG002|Overall Study|Adverse Event|4|||
147242948|NCT00790023|531061961|FG000|Overall Study|Protocol Violation|2|||
147242949|NCT00790023|531061962|FG001|Overall Study|Protocol Violation|4|||
147242950|NCT00790023|531061963|FG002|Overall Study|Protocol Violation|2|||
147242951|NCT00790023|531061961|FG000|Overall Study|Withdrawal by Subject|2|||
147242952|NCT00790023|531061962|FG001|Overall Study|Withdrawal by Subject|0|||
147242953|NCT00790023|531061963|FG002|Overall Study|Withdrawal by Subject|6|||
147242954|NCT00790023|531061961|FG000|Overall Study|Lost to Follow-up|0|||
147242955|NCT00790023|531061962|FG001|Overall Study|Lost to Follow-up|0|||
147242956|NCT00790023|531061963|FG002|Overall Study|Lost to Follow-up|1|||
147242957|NCT00790023|531061961|FG000|Overall Study|Other|5|||
147242958|NCT00790023|531061962|FG001|Overall Study|Other|5|||
147242959|NCT00790023|531061963|FG002|Overall Study|Other|8|||
147242960|NCT01338792|531061964|FG000|Overall Study|Adverse Event|2|||
147242961|NCT01338792|531061964|FG000|Overall Study|Death|1|||
147242962|NCT01338792|531061964|FG000|Overall Study|Withdrawal by Subject|1|||
147242963|NCT00618072|531061965|FG000|Overall Study|Lost to Follow-up|2|||
147242964|NCT00618072|531061966|FG001|Overall Study|Lost to Follow-up|0|||
147242965|NCT00618072|531061967|FG002|Overall Study|Lost to Follow-up|3|||
147242966|NCT00618072|531061965|FG000|Overall Study|Physician Decision|0|||
147242967|NCT00618072|531061966|FG001|Overall Study|Physician Decision|1|||
147242968|NCT00618072|531061967|FG002|Overall Study|Physician Decision|1|||
147242969|NCT02151591|531061968|FG000|Overall Study|Lost to Follow-up|6|||
147242970|NCT02151591|531061969|FG001|Overall Study|Lost to Follow-up|3|||
147242971|NCT03555591|531061972|FG000|Overall Study|Protocol Violation|77|||
147242972|NCT00684593|531061973|FG000|Overall Study|Adverse Event|0|||
147242973|NCT00684593|531061974|FG001|Overall Study|Adverse Event|2|||
147242974|NCT00617773|531061975|FG000|Overall Study|Physician Decision|1|||
147242975|NCT00617773|531061975|FG000|Overall Study|Lack of compliance with the protocol|1|||
147242976|NCT00617773|531061975|FG000|Overall Study|Withdrawal by Subject|1|||
147242977|NCT00617773|531061975|FG000|Overall Study|Death|1|||
147242978|NCT00617773|531061975|FG000|Overall Study|Progressive disease|19|||
147163155|NCT00993499|530760750|FG004|Discontinued Before Starting Course 3|Non compliance with the protocol|0|||
147163156|NCT00993499|530760751|FG005|Discontinued Before Starting Course 3|Non compliance with the protocol|0|||
147163157|NCT00993499|530760746|FG000|Discontinued After Starting Course 3|Withdrawal by Subject|0|||
147163158|NCT00993499|530760747|FG001|Discontinued After Starting Course 3|Withdrawal by Subject|1|||
147163159|NCT00993499|530760748|FG002|Discontinued After Starting Course 3|Withdrawal by Subject|0|||
147163160|NCT00993499|530760749|FG003|Discontinued After Starting Course 3|Withdrawal by Subject|0|||
147163161|NCT00993499|530760750|FG004|Discontinued After Starting Course 3|Withdrawal by Subject|0|||
147163162|NCT00993499|530760751|FG005|Discontinued After Starting Course 3|Withdrawal by Subject|0|||
147654487|NCT04074330|532556748|FG006|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
147654488|NCT04074330|532556749|FG007|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|1|||
147654489|NCT04074330|532556750|FG008|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
147654490|NCT04074330|532556751|FG009|Dose Escalation (up to 19.36 Months)|Site Terminated by Sponsor|0|||
147654491|NCT04074330|532556742|FG000|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|1|||
147654492|NCT04074330|532556743|FG001|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|1|||
147654493|NCT04074330|532556744|FG002|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|1|||
147654494|NCT04074330|532556745|FG003|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|0|||
147654495|NCT04074330|532556746|FG004|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|2|||
147654496|NCT04074330|532556747|FG005|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|1|||
147654497|NCT04074330|532556748|FG006|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|0|||
147654498|NCT04074330|532556749|FG007|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|0|||
147654499|NCT04074330|532556750|FG008|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|0|||
147654500|NCT04074330|532556751|FG009|Dose Escalation (up to 19.36 Months)|Withdrawal by Subject|0|||
147654501|NCT04074330|532556742|FG000|Dose Escalation (up to 19.36 Months)|Reason not Specified|0|||
147654502|NCT04074330|532556743|FG001|Dose Escalation (up to 19.36 Months)|Reason not Specified|1|||
147654503|NCT04074330|532556744|FG002|Dose Escalation (up to 19.36 Months)|Reason not Specified|1|||
147654504|NCT04074330|532556745|FG003|Dose Escalation (up to 19.36 Months)|Reason not Specified|1|||
147654505|NCT04074330|532556746|FG004|Dose Escalation (up to 19.36 Months)|Reason not Specified|0|||
147654506|NCT04074330|532556747|FG005|Dose Escalation (up to 19.36 Months)|Reason not Specified|1|||
147654507|NCT04074330|532556748|FG006|Dose Escalation (up to 19.36 Months)|Reason not Specified|0|||
147654508|NCT04074330|532556749|FG007|Dose Escalation (up to 19.36 Months)|Reason not Specified|0|||
147163163|NCT00993499|530760746|FG000|Discontinued After Starting Course 3|Progressive Disease|6|||
147588966|NCT01684215|532311499|FG003|Phase 1, Part 1|Adverse Event|0|||
147163164|NCT00993499|530760747|FG001|Discontinued After Starting Course 3|Progressive Disease|4|||
147163165|NCT00993499|530760748|FG002|Discontinued After Starting Course 3|Progressive Disease|3|||
147163166|NCT00993499|530760749|FG003|Discontinued After Starting Course 3|Progressive Disease|1|||
147163167|NCT00993499|530760750|FG004|Discontinued After Starting Course 3|Progressive Disease|3|||
147163168|NCT00993499|530760751|FG005|Discontinued After Starting Course 3|Progressive Disease|3|||
147163169|NCT00993499|530760746|FG000|Discontinued After Starting Course 3|DLT|1|||
147163170|NCT00993499|530760747|FG001|Discontinued After Starting Course 3|DLT|0|||
147163171|NCT00993499|530760748|FG002|Discontinued After Starting Course 3|DLT|2|||
147163172|NCT00993499|530760749|FG003|Discontinued After Starting Course 3|DLT|1|||
147163173|NCT00993499|530760750|FG004|Discontinued After Starting Course 3|DLT|0|||
147163174|NCT00993499|530760751|FG005|Discontinued After Starting Course 3|DLT|0|||
147163175|NCT00993499|530760746|FG000|Discontinued After Starting Course 3|Other adverse event|1|||
147163176|NCT00993499|530760747|FG001|Discontinued After Starting Course 3|Other adverse event|0|||
147163177|NCT00993499|530760748|FG002|Discontinued After Starting Course 3|Other adverse event|1|||
147163178|NCT00993499|530760749|FG003|Discontinued After Starting Course 3|Other adverse event|0|||
147163179|NCT00993499|530760750|FG004|Discontinued After Starting Course 3|Other adverse event|0|||
147163180|NCT00993499|530760751|FG005|Discontinued After Starting Course 3|Other adverse event|0|||
147242979|NCT00617773|531061975|FG000|Overall Study|Protocol Violation|1|||
147588967|NCT01684215|532311496|FG000|Phase 1, Part 1|Objective progression or relapse|5|||
147588968|NCT01684215|532311497|FG001|Phase 1, Part 1|Objective progression or relapse|6|||
147588969|NCT01684215|532311498|FG002|Phase 1, Part 1|Objective progression or relapse|0|||
147588970|NCT01684215|532311499|FG003|Phase 1, Part 1|Objective progression or relapse|0|||
147588971|NCT01684215|532311496|FG000|Phase 1, Part 2|Adverse Event|0|||
147588972|NCT01684215|532311497|FG001|Phase 1, Part 2|Adverse Event|0|||
147588973|NCT01684215|532311498|FG002|Phase 1, Part 2|Adverse Event|1|||
147588974|NCT01684215|532311499|FG003|Phase 1, Part 2|Adverse Event|0|||
147242980|NCT05526716|531061976|FG000|Overall Study|Death|1|||
147242981|NCT05526716|531061977|FG001|Overall Study|Death|2|||
147242982|NCT05526716|531061976|FG000|Overall Study|Lost to Follow-up|17|||
147588975|NCT01684215|532311496|FG000|Phase 1, Part 2|Commercial avaliabity of Palbociclib|0|||
147163181|NCT01945775|530760752|FG000|Overall Study|Death|214|||
147163182|NCT01945775|530760753|FG001|Overall Study|Death|98|||
147163183|NCT01945775|530760752|FG000|Overall Study|Lost to Follow-up|12|||
147588976|NCT01684215|532311497|FG001|Phase 1, Part 2|Commercial avaliabity of Palbociclib|0|||
147163184|NCT01945775|530760753|FG001|Overall Study|Lost to Follow-up|7|||
147242983|NCT05526716|531061977|FG001|Overall Study|Lost to Follow-up|15|||
147242984|NCT05526716|531061976|FG000|Overall Study|Physician Decision|0|||
147242985|NCT05526716|531061977|FG001|Overall Study|Physician Decision|1|||
147242986|NCT05526716|531061976|FG000|Overall Study|Randomized by mistake without study treatment|0|||
147242987|NCT05526716|531061977|FG001|Overall Study|Randomized by mistake without study treatment|1|||
147242988|NCT05526716|531061976|FG000|Overall Study|Withdrawal by Subject|12|||
147163185|NCT01945775|530760752|FG000|Overall Study|Withdrawal by Subject|11|||
147163186|NCT01945775|530760753|FG001|Overall Study|Withdrawal by Subject|21|||
147163187|NCT01945775|530760752|FG000|Overall Study|Other|50|||
147163188|NCT01945775|530760753|FG001|Overall Study|Other|18|||
147163189|NCT02876328|530760754|FG000|Overall Study|Death|2|||
147163190|NCT02876328|530760755|FG001|Overall Study|Death|1|||
147163191|NCT02876328|530760756|FG002|Overall Study|Death|3|||
147163192|NCT02876328|530760757|FG003|Overall Study|Death|0|||
147163193|NCT02876328|530760758|FG004|Overall Study|Death|0|||
147163194|NCT02876328|530760759|FG005|Overall Study|Death|0|||
147163195|NCT02876328|530760760|FG006|Overall Study|Death|1|||
147163196|NCT02876328|530760761|FG007|Overall Study|Death|3|||
147163197|NCT02876328|530760762|FG008|Overall Study|Death|0|||
147163198|NCT02876328|530760763|FG009|Overall Study|Death|1|||
147163199|NCT02876328|530760764|FG010|Overall Study|Death|1|||
147163200|NCT02876328|530760765|FG011|Overall Study|Death|0|||
147163201|NCT02876328|530760766|FG012|Overall Study|Death|0|||
147163202|NCT02876328|530760767|FG013|Overall Study|Death|0|||
147163203|NCT02876328|530760768|FG014|Overall Study|Death|0|||
147163204|NCT02876328|530760769|FG015|Overall Study|Death|0|||
147163205|NCT02876328|530760770|FG016|Overall Study|Death|1|||
147163206|NCT02876328|530760771|FG017|Overall Study|Death|1|||
147163207|NCT02876328|530760772|FG018|Overall Study|Death|0|||
147163208|NCT02876328|530760773|FG019|Overall Study|Death|0|||
147163209|NCT02876328|530760774|FG020|Overall Study|Death|0|||
147163210|NCT02876328|530760775|FG021|Overall Study|Death|1|||
147163211|NCT02876328|530760776|FG022|Overall Study|Death|0|||
147242989|NCT05526716|531061977|FG001|Overall Study|Withdrawal by Subject|12|||
147242990|NCT05526716|531061976|FG000|Overall Study|Not reported|0|||
147163212|NCT02876328|530760777|FG023|Overall Study|Death|0|||
147163213|NCT02876328|530760754|FG000|Overall Study|Withdrawal by Subject|0|||
147242991|NCT05526716|531061977|FG001|Overall Study|Not reported|2|||
147242992|NCT02170298|531061979|FG000|Overall Study|Withdrawal by Subject|0|||
147242993|NCT02170298|531061980|FG001|Overall Study|Withdrawal by Subject|1|||
147242994|NCT02170298|531061979|FG000|Overall Study|unblinded, rerandomized to intervention|1|||
147242995|NCT02170298|531061980|FG001|Overall Study|unblinded, rerandomized to intervention|0|||
147242996|NCT00777608|531061981|FG000|Overall Study|Lost to Follow-up|1|||
147242997|NCT00777608|531061982|FG001|Overall Study|Lost to Follow-up|1|||
147242998|NCT00777608|531061981|FG000|Overall Study|Withdrawal by Subject|1|||
147242999|NCT00777608|531061982|FG001|Overall Study|Withdrawal by Subject|3|||
147243000|NCT00777608|531061981|FG000|Overall Study|Protocol Violation|1|||
147243001|NCT00777608|531061982|FG001|Overall Study|Protocol Violation|0|||
147323009|NCT01072929|531347889|FG001|Overall Study|Protocol Violation|11|||
147323010|NCT01072929|531347890|FG002|Overall Study|Protocol Violation|2|||
147323011|NCT01072929|531347888|FG000|Overall Study|Lost to Follow-up|8|||
147323012|NCT01072929|531347889|FG001|Overall Study|Lost to Follow-up|4|||
147323013|NCT01072929|531347890|FG002|Overall Study|Lost to Follow-up|1|||
147323014|NCT01072929|531347888|FG000|Overall Study|Noncompliance with study medication|0|||
147323015|NCT01072929|531347889|FG001|Overall Study|Noncompliance with study medication|3|||
147323016|NCT01072929|531347890|FG002|Overall Study|Noncompliance with study medication|0|||
147323017|NCT01072929|531347888|FG000|Overall Study|Noncompliance with study procedures|1|||
147323018|NCT01072929|531347889|FG001|Overall Study|Noncompliance with study procedures|0|||
147323019|NCT01072929|531347890|FG002|Overall Study|Noncompliance with study procedures|1|||
147323020|NCT01072929|531347888|FG000|Overall Study|Other|0|||
147323021|NCT01072929|531347889|FG001|Overall Study|Other|3|||
147323022|NCT01072929|531347890|FG002|Overall Study|Other|0|||
147323023|NCT01414166|531347891|FG000|Overall Study|Adverse Event|10|||
147323024|NCT01414166|531347892|FG001|Overall Study|Adverse Event|2|||
147323025|NCT01414166|531347891|FG000|Overall Study|Lost to Follow-up|4|||
147323026|NCT01414166|531347892|FG001|Overall Study|Lost to Follow-up|1|||
147323027|NCT01414166|531347891|FG000|Overall Study|Non-compliance with study drug|2|||
147163214|NCT02876328|530760755|FG001|Overall Study|Withdrawal by Subject|2|||
147163215|NCT02876328|530760756|FG002|Overall Study|Withdrawal by Subject|3|||
147163216|NCT02876328|530760757|FG003|Overall Study|Withdrawal by Subject|3|||
147163217|NCT02876328|530760758|FG004|Overall Study|Withdrawal by Subject|0|||
147163218|NCT02876328|530760759|FG005|Overall Study|Withdrawal by Subject|1|||
147163219|NCT02876328|530760760|FG006|Overall Study|Withdrawal by Subject|0|||
147163220|NCT02876328|530760761|FG007|Overall Study|Withdrawal by Subject|1|||
147163221|NCT02876328|530760762|FG008|Overall Study|Withdrawal by Subject|1|||
147163222|NCT02876328|530760763|FG009|Overall Study|Withdrawal by Subject|2|||
147163223|NCT02876328|530760764|FG010|Overall Study|Withdrawal by Subject|0|||
147243002|NCT00777608|531061981|FG000|Overall Study|Investigator Decision|1|||
147243003|NCT00777608|531061982|FG001|Overall Study|Investigator Decision|2|||
147243004|NCT04213079|531061983|FG000|Overall Study|Lost to Follow-up|0|||
147243005|NCT04213079|531061984|FG001|Overall Study|Lost to Follow-up|2|||
147588977|NCT01684215|532311498|FG002|Phase 1, Part 2|Commercial avaliabity of Palbociclib|4|||
147588978|NCT01684215|532311499|FG003|Phase 1, Part 2|Commercial avaliabity of Palbociclib|0|||
147588979|NCT01684215|532311496|FG000|Phase 1, Part 2|Withdrawal by Subject|0|||
147588980|NCT01684215|532311497|FG001|Phase 1, Part 2|Withdrawal by Subject|0|||
147588981|NCT01684215|532311498|FG002|Phase 1, Part 2|Withdrawal by Subject|1|||
147588982|NCT01684215|532311499|FG003|Phase 1, Part 2|Withdrawal by Subject|0|||
147588983|NCT01684215|532311496|FG000|Phase 2|Death|0|||
147588984|NCT01684215|532311497|FG001|Phase 2|Death|0|||
147588985|NCT01684215|532311498|FG002|Phase 2|Death|0|||
147588986|NCT01684215|532311499|FG003|Phase 2|Death|8|||
147588987|NCT01684215|532311496|FG000|Phase 2|Study terminated by sponsor|0|||
147588988|NCT01684215|532311497|FG001|Phase 2|Study terminated by sponsor|0|||
147588989|NCT01684215|532311498|FG002|Phase 2|Study terminated by sponsor|0|||
147588990|NCT01684215|532311499|FG003|Phase 2|Study terminated by sponsor|30|||
147588991|NCT01684215|532311496|FG000|Phase 2|Enrolled but not treated|0|||
147588992|NCT01684215|532311497|FG001|Phase 2|Enrolled but not treated|0|||
147588993|NCT01684215|532311498|FG002|Phase 2|Enrolled but not treated|0|||
147588994|NCT01684215|532311499|FG003|Phase 2|Enrolled but not treated|1|||
147588995|NCT01684215|532311496|FG000|Phase 2|Lost to Follow-up|0|||
147588996|NCT01684215|532311497|FG001|Phase 2|Lost to Follow-up|0|||
147588997|NCT01684215|532311498|FG002|Phase 2|Lost to Follow-up|0|||
147588998|NCT01684215|532311499|FG003|Phase 2|Lost to Follow-up|4|||
147588999|NCT01301482|532311500|FG000|Overall Study|Withdrawal by Subject|1|||
147589000|NCT01915940|532311504|FG000|Pre-randomization Washout Period|Not Qualified for Randomization|39|||
147589001|NCT01915940|532311505|FG001|Pre-randomization Washout Period|Not Qualified for Randomization|0|||
147589002|NCT01915940|532311506|FG002|Pre-randomization Washout Period|Not Qualified for Randomization|0|||
147163224|NCT02876328|530760765|FG011|Overall Study|Withdrawal by Subject|0|||
147163225|NCT02876328|530760766|FG012|Overall Study|Withdrawal by Subject|0|||
147163226|NCT02876328|530760767|FG013|Overall Study|Withdrawal by Subject|0|||
147163227|NCT02876328|530760768|FG014|Overall Study|Withdrawal by Subject|0|||
147163228|NCT02876328|530760769|FG015|Overall Study|Withdrawal by Subject|0|||
147163229|NCT02876328|530760770|FG016|Overall Study|Withdrawal by Subject|1|||
147163230|NCT02876328|530760771|FG017|Overall Study|Withdrawal by Subject|3|||
147163231|NCT02876328|530760772|FG018|Overall Study|Withdrawal by Subject|0|||
147163232|NCT02876328|530760773|FG019|Overall Study|Withdrawal by Subject|0|||
147163233|NCT02876328|530760774|FG020|Overall Study|Withdrawal by Subject|1|||
147163234|NCT02876328|530760775|FG021|Overall Study|Withdrawal by Subject|0|||
147163235|NCT02876328|530760776|FG022|Overall Study|Withdrawal by Subject|0|||
147163236|NCT02876328|530760777|FG023|Overall Study|Withdrawal by Subject|0|||
147163237|NCT02876328|530760754|FG000|Overall Study|Missed 12 Month Visit|15|||
147163238|NCT02876328|530760755|FG001|Overall Study|Missed 12 Month Visit|10|||
147163239|NCT02876328|530760756|FG002|Overall Study|Missed 12 Month Visit|11|||
147163240|NCT02876328|530760757|FG003|Overall Study|Missed 12 Month Visit|6|||
147163241|NCT02876328|530760758|FG004|Overall Study|Missed 12 Month Visit|10|||
147163242|NCT02876328|530760759|FG005|Overall Study|Missed 12 Month Visit|14|||
147163243|NCT02876328|530760760|FG006|Overall Study|Missed 12 Month Visit|3|||
147163244|NCT02876328|530760761|FG007|Overall Study|Missed 12 Month Visit|8|||
147163245|NCT02876328|530760762|FG008|Overall Study|Missed 12 Month Visit|9|||
147163246|NCT02876328|530760763|FG009|Overall Study|Missed 12 Month Visit|5|||
147163247|NCT02876328|530760764|FG010|Overall Study|Missed 12 Month Visit|4|||
147163248|NCT02876328|530760765|FG011|Overall Study|Missed 12 Month Visit|1|||
147163249|NCT02876328|530760766|FG012|Overall Study|Missed 12 Month Visit|5|||
147589003|NCT01915940|532311504|FG000|Treatment Period|Decision of Participant|0|||
147589004|NCT01915940|532311505|FG001|Treatment Period|Decision of Participant|1|||
147589005|NCT01915940|532311506|FG002|Treatment Period|Decision of Participant|3|||
147589006|NCT01915940|532311504|FG000|Treatment Period|Adverse Event|0|||
147589007|NCT01915940|532311505|FG001|Treatment Period|Adverse Event|9|||
147589008|NCT01915940|532311506|FG002|Treatment Period|Adverse Event|1|||
147589009|NCT01915940|532311504|FG000|Treatment Period|Other Miscellaneous Reasons|0|||
147589010|NCT01915940|532311505|FG001|Treatment Period|Other Miscellaneous Reasons|1|||
147589011|NCT01915940|532311506|FG002|Treatment Period|Other Miscellaneous Reasons|0|||
147589012|NCT00614926|532311507|FG000|Overall Study|Burden of travel|1|||
147163250|NCT02876328|530760767|FG013|Overall Study|Missed 12 Month Visit|4|||
147163251|NCT02876328|530760768|FG014|Overall Study|Missed 12 Month Visit|4|||
147163252|NCT02876328|530760769|FG015|Overall Study|Missed 12 Month Visit|4|||
147163253|NCT02876328|530760770|FG016|Overall Study|Missed 12 Month Visit|3|||
147589013|NCT00614926|532311508|FG001|Overall Study|Burden of travel|0|||
147163254|NCT02876328|530760771|FG017|Overall Study|Missed 12 Month Visit|6|||
147163255|NCT02876328|530760772|FG018|Overall Study|Missed 12 Month Visit|2|||
147589014|NCT00614926|532311507|FG000|Overall Study|Adverse Event|3|||
147589015|NCT00614926|532311508|FG001|Overall Study|Adverse Event|0|||
147589016|NCT00706095|532311516|FG000|Overall Study|Progressive Disease|4|||
147163256|NCT02876328|530760773|FG019|Overall Study|Missed 12 Month Visit|2|||
147323028|NCT01414166|531347892|FG001|Overall Study|Non-compliance with study drug|0|||
147323029|NCT01414166|531347891|FG000|Overall Study|Physician Decision|2|||
147323030|NCT01414166|531347892|FG001|Overall Study|Physician Decision|0|||
147323031|NCT01414166|531347891|FG000|Overall Study|Protocol Violation|2|||
147323032|NCT01414166|531347892|FG001|Overall Study|Protocol Violation|0|||
147323033|NCT01414166|531347891|FG000|Overall Study|Study terminated by Sponsor|68|||
147323034|NCT01414166|531347892|FG001|Overall Study|Study terminated by Sponsor|75|||
147323035|NCT01414166|531347891|FG000|Overall Study|Withdrawal by Subject|3|||
147323036|NCT01414166|531347892|FG001|Overall Study|Withdrawal by Subject|5|||
147323037|NCT03682536|531347893|FG000|Randomization|Withdrawal by Subject|0|||
147323038|NCT03682536|531347894|FG001|Randomization|Withdrawal by Subject|2|||
147323039|NCT03682536|531347893|FG000|Treatment|Other Reasons|8|||
147323040|NCT03682536|531347894|FG001|Treatment|Other Reasons|7|||
147323041|NCT03682536|531347893|FG000|Treatment|Physician Decision|5|||
147323042|NCT03682536|531347894|FG001|Treatment|Physician Decision|5|||
147323043|NCT03682536|531347893|FG000|Treatment|Protocol Violation|1|||
147323044|NCT03682536|531347894|FG001|Treatment|Protocol Violation|0|||
147323045|NCT03682536|531347893|FG000|Treatment|Study Terminated by Sponsor|1|||
147323046|NCT03682536|531347894|FG001|Treatment|Study Terminated by Sponsor|2|||
147323047|NCT03682536|531347893|FG000|Treatment|Lost to Follow-up|0|||
147323048|NCT03682536|531347894|FG001|Treatment|Lost to Follow-up|1|||
147323049|NCT03682536|531347893|FG000|Treatment|Withdrawal by Subject|16|||
147323050|NCT03682536|531347894|FG001|Treatment|Withdrawal by Subject|18|||
147323051|NCT03682536|531347893|FG000|Treatment|Lack of Efficacy|41|||
147323052|NCT03682536|531347894|FG001|Treatment|Lack of Efficacy|68|||
147323053|NCT03682536|531347893|FG000|Treatment|Disease Progression|9|||
147323054|NCT03682536|531347894|FG001|Treatment|Disease Progression|7|||
147323055|NCT03682536|531347893|FG000|Treatment|Adverse Event|9|||
147323056|NCT03682536|531347894|FG001|Treatment|Adverse Event|5|||
147323057|NCT03682536|531347893|FG000|Treatment|Death|14|||
147323058|NCT03682536|531347894|FG001|Treatment|Death|13|||
147323059|NCT04824131|531347895|FG000|CAB LA Oral Phase|Adverse Event|1|||
147323060|NCT04824131|531347895|FG000|CAB LA Oral Phase|Withdrawal by Subject|1|||
147323061|NCT04824131|531347895|FG000|Step 3|Withdrawal by Subject|2|||
147323062|NCT05489224|531347896|FG000|Treatment Period I|Withdrawal by Subject|6|||
147323063|NCT05489224|531347897|FG001|Treatment Period I|Withdrawal by Subject|5|||
147323064|NCT05489224|531347898|FG002|Treatment Period I|Withdrawal by Subject|0|||
147323065|NCT05489224|531347896|FG000|Treatment Period I|Adverse Event|3|||
147323066|NCT05489224|531347897|FG001|Treatment Period I|Adverse Event|11|||
147323067|NCT05489224|531347898|FG002|Treatment Period I|Adverse Event|0|||
147323068|NCT05489224|531347896|FG000|Treatment Period I|Lost to Follow-up|0|||
147323069|NCT05489224|531347897|FG001|Treatment Period I|Lost to Follow-up|1|||
147323070|NCT05489224|531347898|FG002|Treatment Period I|Lost to Follow-up|0|||
147323071|NCT05489224|531347896|FG000|Treatment Period I|Physician Decision|0|||
147323072|NCT05489224|531347897|FG001|Treatment Period I|Physician Decision|1|||
147323073|NCT05489224|531347898|FG002|Treatment Period I|Physician Decision|0|||
147323074|NCT05489224|531347896|FG000|Treatment Period II up to Week 32|Ongoing|222|||
147323075|NCT05489224|531347897|FG001|Treatment Period II up to Week 32|Ongoing|107|||
147323076|NCT05489224|531347898|FG002|Treatment Period II up to Week 32|Ongoing|107|||
147323077|NCT05489224|531347896|FG000|Treatment Period II up to Week 32|Adverse Event|3|||
147323078|NCT05489224|531347897|FG001|Treatment Period II up to Week 32|Adverse Event|0|||
147323079|NCT05489224|531347898|FG002|Treatment Period II up to Week 32|Adverse Event|1|||
147323080|NCT05489224|531347896|FG000|Treatment Period II up to Week 32|Withdrawal by Subject|0|||
147323081|NCT05489224|531347897|FG001|Treatment Period II up to Week 32|Withdrawal by Subject|2|||
147323082|NCT05489224|531347898|FG002|Treatment Period II up to Week 32|Withdrawal by Subject|2|||
147323083|NCT03686384|531347900|FG000|Overall Study|Lack of Efficacy|4|||
147323084|NCT03686384|531347901|FG001|Overall Study|Lack of Efficacy|13|||
147323085|NCT03686384|531347900|FG000|Overall Study|Lost to Follow-up|3|||
147323086|NCT03686384|531347901|FG001|Overall Study|Lost to Follow-up|0|||
147323087|NCT03686384|531347900|FG000|Overall Study|Physician Decision|0|||
147323088|NCT03686384|531347901|FG001|Overall Study|Physician Decision|1|||
147323089|NCT03686384|531347900|FG000|Overall Study|Took prohibited medication|0|||
147323090|NCT03686384|531347901|FG001|Overall Study|Took prohibited medication|1|||
147323091|NCT03008122|531347902|FG000|Overall Study|Physician Decision|3|||
147323092|NCT03008122|531347903|FG001|Overall Study|Physician Decision|2|||
147323093|NCT03008122|531347904|FG002|Overall Study|Physician Decision|0|||
147323094|NCT03008122|531347902|FG000|Overall Study|Withdrawal by Subject|1|||
147323095|NCT03008122|531347903|FG001|Overall Study|Withdrawal by Subject|3|||
147323096|NCT03008122|531347904|FG002|Overall Study|Withdrawal by Subject|0|||
147323097|NCT03008122|531347902|FG000|Overall Study|Lost to Follow-up|4|||
147323098|NCT03008122|531347903|FG001|Overall Study|Lost to Follow-up|8|||
147323099|NCT03008122|531347904|FG002|Overall Study|Lost to Follow-up|3|||
147323100|NCT03008122|531347902|FG000|Overall Study|Failure to Meet Randomization Criteria|1|||
147323101|NCT03008122|531347903|FG001|Overall Study|Failure to Meet Randomization Criteria|0|||
147323102|NCT03008122|531347904|FG002|Overall Study|Failure to Meet Randomization Criteria|0|||
147323103|NCT03008122|531347902|FG000|Overall Study|Subject Unable to Attend Clinical Visit|1|||
147323104|NCT03008122|531347903|FG001|Overall Study|Subject Unable to Attend Clinical Visit|0|||
147323105|NCT03008122|531347904|FG002|Overall Study|Subject Unable to Attend Clinical Visit|0|||
147323106|NCT03008122|531347902|FG000|Overall Study|Death|0|||
147323107|NCT03008122|531347903|FG001|Overall Study|Death|0|||
147163257|NCT02876328|530760774|FG020|Overall Study|Missed 12 Month Visit|11|||
147163258|NCT02876328|530760775|FG021|Overall Study|Missed 12 Month Visit|7|||
147163259|NCT02876328|530760776|FG022|Overall Study|Missed 12 Month Visit|1|||
147163260|NCT02876328|530760777|FG023|Overall Study|Missed 12 Month Visit|0|||
147163261|NCT03464422|530760781|FG000|Overall Study|Lost to Follow-up|2|||
147163262|NCT03464422|530760781|FG000|Overall Study|Withdrawal by Subject|2|||
147163263|NCT00844805|530760785|FG000|Treatment Phase|Adverse Event|5|||
147163264|NCT00844805|530760786|FG001|Treatment Phase|Adverse Event|1|||
147163265|NCT00844805|530760787|FG002|Treatment Phase|Adverse Event|0|||
147163266|NCT00844805|530760788|FG003|Treatment Phase|Adverse Event|0|||
147163267|NCT00844805|530760785|FG000|Treatment Phase|Withdrawal by Subject|3|||
147163268|NCT00844805|530760786|FG001|Treatment Phase|Withdrawal by Subject|4|||
147163269|NCT00844805|530760787|FG002|Treatment Phase|Withdrawal by Subject|0|||
147163270|NCT00844805|530760788|FG003|Treatment Phase|Withdrawal by Subject|0|||
147163271|NCT00844805|530760785|FG000|Treatment Phase|Noncompliance With Protocol|1|||
147163272|NCT00844805|530760786|FG001|Treatment Phase|Noncompliance With Protocol|0|||
147163273|NCT00844805|530760787|FG002|Treatment Phase|Noncompliance With Protocol|0|||
147163274|NCT00844805|530760788|FG003|Treatment Phase|Noncompliance With Protocol|0|||
147163275|NCT00844805|530760785|FG000|Treatment Phase|Did Not Meet Protocol Eligibility|1|||
147163276|NCT00844805|530760786|FG001|Treatment Phase|Did Not Meet Protocol Eligibility|2|||
147163277|NCT00844805|530760787|FG002|Treatment Phase|Did Not Meet Protocol Eligibility|0|||
147163278|NCT00844805|530760788|FG003|Treatment Phase|Did Not Meet Protocol Eligibility|0|||
147163279|NCT00844805|530760785|FG000|Follow-Up Phase|Adverse Event|0|||
147163280|NCT00844805|530760786|FG001|Follow-Up Phase|Adverse Event|0|||
147654509|NCT04074330|532556750|FG008|Dose Escalation (up to 19.36 Months)|Reason not Specified|0|||
147654510|NCT04074330|532556751|FG009|Dose Escalation (up to 19.36 Months)|Reason not Specified|0|||
147654511|NCT04074330|532556742|FG000|Dose Expansion (up to 42 Months)|Death|0|||
147654512|NCT04074330|532556743|FG001|Dose Expansion (up to 42 Months)|Death|0|||
147654513|NCT04074330|532556744|FG002|Dose Expansion (up to 42 Months)|Death|0|||
147654514|NCT04074330|532556745|FG003|Dose Expansion (up to 42 Months)|Death|0|||
147654515|NCT04074330|532556746|FG004|Dose Expansion (up to 42 Months)|Death|0|||
147654516|NCT04074330|532556747|FG005|Dose Expansion (up to 42 Months)|Death|0|||
147654517|NCT04074330|532556748|FG006|Dose Expansion (up to 42 Months)|Death|0|||
147654518|NCT04074330|532556749|FG007|Dose Expansion (up to 42 Months)|Death|0|||
147654519|NCT04074330|532556750|FG008|Dose Expansion (up to 42 Months)|Death|1|||
147654520|NCT04074330|532556751|FG009|Dose Expansion (up to 42 Months)|Death|0|||
147163281|NCT00844805|530760787|FG002|Follow-Up Phase|Adverse Event|1|||
147163282|NCT00844805|530760788|FG003|Follow-Up Phase|Adverse Event|0|||
147163283|NCT00844805|530760785|FG000|Follow-Up Phase|Withdrawal by Subject|0|||
147163284|NCT00844805|530760786|FG001|Follow-Up Phase|Withdrawal by Subject|0|||
147163285|NCT00844805|530760787|FG002|Follow-Up Phase|Withdrawal by Subject|6|||
147163286|NCT00844805|530760788|FG003|Follow-Up Phase|Withdrawal by Subject|3|||
147163287|NCT00844805|530760785|FG000|Follow-Up Phase|Noncompliance With Protocol|0|||
147163288|NCT00844805|530760786|FG001|Follow-Up Phase|Noncompliance With Protocol|0|||
147163289|NCT00844805|530760787|FG002|Follow-Up Phase|Noncompliance With Protocol|0|||
147163290|NCT00844805|530760788|FG003|Follow-Up Phase|Noncompliance With Protocol|1|||
147163291|NCT00844805|530760785|FG000|Follow-Up Phase|Relapse/Recurrence|0|||
147163292|NCT00844805|530760786|FG001|Follow-Up Phase|Relapse/Recurrence|0|||
147163293|NCT00844805|530760787|FG002|Follow-Up Phase|Relapse/Recurrence|2|||
147163294|NCT00844805|530760788|FG003|Follow-Up Phase|Relapse/Recurrence|4|||
147163295|NCT00844805|530760785|FG000|Follow-Up Phase|Did Not Meet Protocol Eligibility|0|||
147163296|NCT00844805|530760786|FG001|Follow-Up Phase|Did Not Meet Protocol Eligibility|0|||
147163297|NCT00844805|530760787|FG002|Follow-Up Phase|Did Not Meet Protocol Eligibility|0|||
147163298|NCT00844805|530760788|FG003|Follow-Up Phase|Did Not Meet Protocol Eligibility|1|||
147163299|NCT04316741|530760789|FG000|Baseline Enrollment|Lost to Follow-up|1|||
147163300|NCT04316741|530760790|FG001|Baseline Enrollment|Lost to Follow-up|1|||
147163301|NCT04316741|530760789|FG000|Immediate Post-Test|Lost to Follow-up|5|||
147163302|NCT04316741|530760790|FG001|Immediate Post-Test|Lost to Follow-up|1|||
147163303|NCT04316741|530760789|FG000|1-month Post-test|Lost to Follow-up|7|||
147163304|NCT04316741|530760790|FG001|1-month Post-test|Lost to Follow-up|2|||
147163305|NCT04316741|530760789|FG000|3-month Follow-up|Lost to Follow-up|10|||
147163306|NCT04316741|530760790|FG001|3-month Follow-up|Lost to Follow-up|2|||
147163307|NCT02726880|530760791|FG000|Overall Study|Withdrawal by Subject|2|||
147163308|NCT02726880|530760792|FG001|Overall Study|Withdrawal by Subject|0|||
147163309|NCT02726880|530760791|FG000|Overall Study|Lost to Follow-up|1|||
147243006|NCT04220866|531061990|FG000|Overall Study|Death|4|||
147447534|NCT02135692|531803887|FG000|Overall Study|Lack of Efficacy|2|||
147447535|NCT02135692|531803887|FG000|Overall Study|Protocol Violation|2|||
147447536|NCT02135692|531803887|FG000|Overall Study|Subject met Liver Stopping Criteria|1|||
147163310|NCT02726880|530760792|FG001|Overall Study|Lost to Follow-up|3|||
147163311|NCT00787202|530760793|FG000|Overall Study|Adverse Event|3|||
147163312|NCT00787202|530760794|FG001|Overall Study|Adverse Event|2|||
147163313|NCT00787202|530760795|FG002|Overall Study|Adverse Event|0|||
147447537|NCT02135692|531803887|FG000|Overall Study|Product commercially available|159|||
147654521|NCT04074330|532556742|FG000|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
147163314|NCT00787202|530760796|FG003|Overall Study|Adverse Event|0|||
147163315|NCT00787202|530760797|FG004|Overall Study|Adverse Event|2|||
147163316|NCT00787202|530760793|FG000|Overall Study|Lack of Efficacy|5|||
147163317|NCT00787202|530760794|FG001|Overall Study|Lack of Efficacy|6|||
147163318|NCT00787202|530760795|FG002|Overall Study|Lack of Efficacy|5|||
147163319|NCT00787202|530760796|FG003|Overall Study|Lack of Efficacy|2|||
147163320|NCT00787202|530760797|FG004|Overall Study|Lack of Efficacy|1|||
147163321|NCT00787202|530760793|FG000|Overall Study|Lost to Follow-up|1|||
147163322|NCT00787202|530760794|FG001|Overall Study|Lost to Follow-up|0|||
147163323|NCT00787202|530760795|FG002|Overall Study|Lost to Follow-up|0|||
147163324|NCT00787202|530760796|FG003|Overall Study|Lost to Follow-up|0|||
147163325|NCT00787202|530760797|FG004|Overall Study|Lost to Follow-up|0|||
147163326|NCT00787202|530760793|FG000|Overall Study|Withdrawal by Subject|2|||
147163327|NCT00787202|530760794|FG001|Overall Study|Withdrawal by Subject|2|||
147163328|NCT00787202|530760795|FG002|Overall Study|Withdrawal by Subject|2|||
147163329|NCT00787202|530760796|FG003|Overall Study|Withdrawal by Subject|0|||
147163330|NCT00787202|530760797|FG004|Overall Study|Withdrawal by Subject|0|||
147163331|NCT00787202|530760793|FG000|Overall Study|Protocol Violation|2|||
147163332|NCT00787202|530760794|FG001|Overall Study|Protocol Violation|1|||
147163333|NCT00787202|530760795|FG002|Overall Study|Protocol Violation|0|||
147163334|NCT00787202|530760796|FG003|Overall Study|Protocol Violation|0|||
147163335|NCT00787202|530760797|FG004|Overall Study|Protocol Violation|1|||
147163336|NCT00787202|530760793|FG000|Overall Study|Randomized, not treated|1|||
147163337|NCT00787202|530760794|FG001|Overall Study|Randomized, not treated|0|||
147163338|NCT00787202|530760795|FG002|Overall Study|Randomized, not treated|0|||
147163339|NCT00787202|530760796|FG003|Overall Study|Randomized, not treated|0|||
147163340|NCT00787202|530760797|FG004|Overall Study|Randomized, not treated|0|||
147163341|NCT01360398|530760798|FG000|Overall Study|Withdrawal by Subject|14|||
147163342|NCT01360398|530760798|FG000|Overall Study|Other|7|||
147163343|NCT01360398|530760798|FG000|Overall Study|Migrated/moved from study area|1|||
147163344|NCT01453946|530760799|FG000|Overall Study|Did not receive drug for the taper phase|1|||
147163345|NCT01453946|530760799|FG000|Overall Study|Protocol Violation|2|||
147163346|NCT01453946|530760799|FG000|Overall Study|Lack of Efficacy|3|||
147163347|NCT01453946|530760799|FG000|Overall Study|Adverse Event|3|||
147163348|NCT00846040|530760800|FG000|Baseline: Days 1-5|Withdrawal by Subject|1|||
147163349|NCT00846040|530760801|FG001|Baseline: Days 1-5|Withdrawal by Subject|0|||
147163350|NCT00846040|530760802|FG002|Baseline: Days 1-5|Withdrawal by Subject|0|||
147163351|NCT00846040|530760800|FG000|Washout: 2 Weeks to 10 Weeks|Withdrawal by Subject|0|||
147163352|NCT00846040|530760801|FG001|Washout: 2 Weeks to 10 Weeks|Withdrawal by Subject|2|||
147163353|NCT00846040|530760802|FG002|Washout: 2 Weeks to 10 Weeks|Withdrawal by Subject|0|||
147163354|NCT03158272|530760806|FG000|Overall Study|Disease progression|3|||
147163355|NCT03158272|530760807|FG001|Overall Study|Disease progression|3|||
147163356|NCT03158272|530760808|FG002|Overall Study|Disease progression|4|||
147163357|NCT03158272|530760809|FG003|Overall Study|Disease progression|6|||
147163358|NCT03158272|530760806|FG000|Overall Study|Death|0|||
147163359|NCT03158272|530760807|FG001|Overall Study|Death|0|||
147163360|NCT03158272|530760808|FG002|Overall Study|Death|1|||
147163361|NCT03158272|530760809|FG003|Overall Study|Death|0|||
147163362|NCT03158272|530760806|FG000|Overall Study|Other reasons|0|||
147163363|NCT03158272|530760807|FG001|Overall Study|Other reasons|0|||
147163364|NCT03158272|530760808|FG002|Overall Study|Other reasons|1|||
147163365|NCT03158272|530760809|FG003|Overall Study|Other reasons|0|||
147163366|NCT03158272|530760806|FG000|Overall Study|Adverse event unrelated to the drug|0|||
147163367|NCT03158272|530760807|FG001|Overall Study|Adverse event unrelated to the drug|1|||
147163368|NCT03158272|530760808|FG002|Overall Study|Adverse event unrelated to the drug|0|||
147163369|NCT03158272|530760809|FG003|Overall Study|Adverse event unrelated to the drug|0|||
147163370|NCT03697993|530760810|FG000|Overall Study|Became Ineligible after Enrollment|1|||
147163371|NCT03697993|530760811|FG001|Overall Study|Became Ineligible after Enrollment|3|||
147163372|NCT03697993|530760810|FG000|Overall Study|Enrolled but Treatment not Administered|2|||
147163373|NCT03697993|530760811|FG001|Overall Study|Enrolled but Treatment not Administered|1|||
147163374|NCT03697993|530760810|FG000|Overall Study|Lost to Follow-up|3|||
147163375|NCT03697993|530760811|FG001|Overall Study|Lost to Follow-up|0|||
147163376|NCT03697993|530760810|FG000|Overall Study|Physician Decision|4|||
147163377|NCT03697993|530760811|FG001|Overall Study|Physician Decision|0|||
147163378|NCT03697993|530760810|FG000|Overall Study|Initial Urine Culture Negative|0|||
147163379|NCT03697993|530760811|FG001|Overall Study|Initial Urine Culture Negative|1|||
147243007|NCT04220866|531061991|FG001|Overall Study|Death|5|||
147243008|NCT04220866|531061990|FG000|Overall Study|Participation at the site terminated By Sponsor|2|||
147163380|NCT01048866|530760812|FG000|Overall Study|Adverse Event|1|||
147589017|NCT00706095|532311517|FG001|Overall Study|Progressive Disease|5|||
147163381|NCT01048866|530760813|FG001|Overall Study|Adverse Event|0|||
147589018|NCT00706095|532311518|FG002|Overall Study|Progressive Disease|3|||
147163382|NCT01048866|530760812|FG000|Overall Study|Protocol Violation|1|||
147163383|NCT01048866|530760813|FG001|Overall Study|Protocol Violation|0|||
147163384|NCT01048866|530760812|FG000|Overall Study|Physician Decision|1|||
147163385|NCT01048866|530760813|FG001|Overall Study|Physician Decision|0|||
147163386|NCT01048866|530760812|FG000|Overall Study|Withdrawal by Subject|0|||
147589019|NCT00706095|532311516|FG000|Overall Study|Clinical Progression|1|||
147589020|NCT00706095|532311517|FG001|Overall Study|Clinical Progression|2|||
147589021|NCT00706095|532311518|FG002|Overall Study|Clinical Progression|2|||
147589022|NCT00706095|532311516|FG000|Overall Study|Withdrawal by Subject|1|||
147589023|NCT00706095|532311517|FG001|Overall Study|Withdrawal by Subject|0|||
147589024|NCT00706095|532311518|FG002|Overall Study|Withdrawal by Subject|0|||
147589025|NCT01311557|532311524|FG000|Overall Study|Serious adverse event|0|||
147589026|NCT01311557|532311525|FG001|Overall Study|Serious adverse event|1|||
147589027|NCT01311557|532311524|FG000|Overall Study|Protocol Violation|4|||
147589028|NCT01311557|532311525|FG001|Overall Study|Protocol Violation|2|||
147589029|NCT01311557|532311524|FG000|Overall Study|Lost to Follow-up|0|||
147589030|NCT01311557|532311525|FG001|Overall Study|Lost to Follow-up|1|||
147589031|NCT01311557|532311524|FG000|Overall Study|Withdrawal by Subject|1|||
147589032|NCT01311557|532311525|FG001|Overall Study|Withdrawal by Subject|2|||
147163387|NCT01048866|530760813|FG001|Overall Study|Withdrawal by Subject|2|||
147163388|NCT01048866|530760812|FG000|Overall Study|Lost to Follow-up|0|||
147163389|NCT01048866|530760813|FG001|Overall Study|Lost to Follow-up|2|||
147163390|NCT01048866|530760812|FG000|Overall Study|Other|1|||
147163391|NCT01048866|530760813|FG001|Overall Study|Other|1|||
147163392|NCT02230683|530760814|FG000|Overall Study|Adverse Event|1|||
147243009|NCT04220866|531061991|FG001|Overall Study|Participation at the site terminated By Sponsor|0|||
147243010|NCT04220866|531061990|FG000|Overall Study|Participation in the study terminated By Sponsor|2|||
147243011|NCT04220866|531061991|FG001|Overall Study|Participation in the study terminated By Sponsor|4|||
147243012|NCT04220866|531061990|FG000|Overall Study|Withdrawal by Subject|0|||
147243013|NCT04220866|531061991|FG001|Overall Study|Withdrawal by Subject|1|||
147243014|NCT03858309|531061992|FG000|Overall Study|Withdrawal by Subject|2|||
147243015|NCT03858309|531061993|FG001|Overall Study|Withdrawal by Subject|3|||
147243016|NCT03897465|531061994|FG000|Overall Study|Lost to Follow-up|2|||
147243017|NCT03897465|531061995|FG001|Overall Study|Lost to Follow-up|1|||
147243018|NCT03897465|531061994|FG000|Overall Study|Adverse Event|2|||
147243019|NCT03897465|531061995|FG001|Overall Study|Adverse Event|0|||
147243020|NCT03897465|531061994|FG000|Overall Study|complete healing by V2|1|||
147243021|NCT03897465|531061995|FG001|Overall Study|complete healing by V2|0|||
147243022|NCT03897465|531061994|FG000|Overall Study|occurence of exclusion criterion|1|||
147243023|NCT03897465|531061995|FG001|Overall Study|occurence of exclusion criterion|1|||
147243024|NCT03897465|531061994|FG000|Overall Study|Other|1|||
147243025|NCT03897465|531061995|FG001|Overall Study|Other|0|||
147243026|NCT02197247|531061998|FG000|Part A: Day 29-49 (AZD9291+Rifampicin)|Adverse Event|2|||
147243027|NCT02197247|531061998|FG000|Part A: Day 29-49 (AZD9291+Rifampicin)|Condition under investigation worsened|2|||
147243028|NCT02197247|531061998|FG000|Part A: Day 50-77 (AZD9291 Alone)|Condition under investigation worsened|5|||
147243029|NCT02197247|531061998|FG000|Part B: Day 78 to End Part B (AZD9291)|Adverse Event|2|||
147243030|NCT02197247|531061998|FG000|Part B: Day 78 to End Part B (AZD9291)|Withdrawal by Subject|2|||
147243031|NCT02197247|531061998|FG000|Part B: Day 78 to End Part B (AZD9291)|Newly discovered brain metastases|1|||
147243032|NCT02197247|531061998|FG000|Part B: Day 78 to End Part B (AZD9291)|Death|1|||
147243033|NCT02197247|531061998|FG000|Part B: Day 78 to End Part B (AZD9291)|Condition under investigation worsened|9|||
147243034|NCT00601458|531062004|FG000|Overall Study|Dosing Error|1|||
147243035|NCT00601458|531062005|FG001|Overall Study|Dosing Error|0|||
147243036|NCT00601458|531062006|FG002|Overall Study|Dosing Error|0|||
147243037|NCT00601458|531062004|FG000|Overall Study|Incomplete Data|0|||
147243038|NCT00601458|531062005|FG001|Overall Study|Incomplete Data|2|||
147243039|NCT00601458|531062006|FG002|Overall Study|Incomplete Data|0|||
147243040|NCT00601458|531062004|FG000|Overall Study|Protocol Violation|3|||
147243041|NCT00601458|531062005|FG001|Overall Study|Protocol Violation|2|||
147243042|NCT00601458|531062006|FG002|Overall Study|Protocol Violation|1|||
147243043|NCT00601458|531062004|FG000|Overall Study|Early Termination|0|||
147243044|NCT00601458|531062005|FG001|Overall Study|Early Termination|1|||
147589033|NCT05212883|532311526|FG000|Overall Study|Invalid test result|125|||
147243045|NCT00601458|531062006|FG002|Overall Study|Early Termination|1|||
147243046|NCT05469178|531062007|FG000|Overall Study|Death|1|||
147243047|NCT05469178|531062008|FG001|Overall Study|Death|1|||
147447538|NCT02135692|531803887|FG000|Overall Study|Study closed/terminated|153|||
147447539|NCT02135692|531803887|FG000|Overall Study|Lost to Follow-up|4|||
147447540|NCT02135692|531803887|FG000|Overall Study|Withdrawal by Subject|15|||
147589034|NCT02075606|532311527|FG000|Overall Study|Adverse Event|5|||
147589035|NCT02075606|532311527|FG000|Overall Study|Withdrawal by Subject|1|||
147589036|NCT02075606|532311527|FG000|Overall Study|Death|1|||
147243048|NCT05469178|531062009|FG002|Overall Study|Death|3|||
147243049|NCT05469178|531062010|FG003|Overall Study|Death|6|||
147589037|NCT02075606|532311527|FG000|Overall Study|Investigator's decision|1|||
147243050|NCT05469178|531062007|FG000|Overall Study|Lack of Efficacy|2|||
147447541|NCT01097746|531803888|FG000|Overall Study|Adverse Event|4|||
147589038|NCT02075606|532311527|FG000|Overall Study|Symptom management|1|||
147654522|NCT04074330|532556743|FG001|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
147243051|NCT05469178|531062008|FG001|Overall Study|Lack of Efficacy|2|||
147447542|NCT01097746|531803888|FG000|Overall Study|taken off study before any treatment given|1|||
147589039|NCT02075606|532311527|FG000|Overall Study|Increasing Symptoms|1|||
147589040|NCT01439724|532311530|FG000|Overall Study|missing consultation|9|||
147589041|NCT01439724|532311531|FG001|Overall Study|missing consultation|8|||
147589042|NCT04019054|532311532|FG000|Overall Study|Inadvertent Enrollment, discovered to meet exclusion criteria after enrollment|0|||
147589043|NCT04019054|532311533|FG001|Overall Study|Inadvertent Enrollment, discovered to meet exclusion criteria after enrollment|1|||
147589044|NCT04019054|532311532|FG000|Overall Study|Withdrawal by Subject|3|||
147589045|NCT04019054|532311533|FG001|Overall Study|Withdrawal by Subject|1|||
147589046|NCT01261624|532311539|FG000|Week 0 to Week 12|Disease Progression|1|||
147589047|NCT01261624|532311540|FG001|Week 0 to Week 12|Disease Progression|1|||
147589048|NCT01261624|532311539|FG000|Week 0 to Week 12|Insufficient Response|0|||
147589049|NCT01261624|532311540|FG001|Week 0 to Week 12|Insufficient Response|2|||
147589050|NCT01261624|532311539|FG000|Week 13 to Week 24|Insufficient Response|0|||
147589051|NCT01261624|532311540|FG001|Week 13 to Week 24|Insufficient Response|1|||
147589052|NCT00271024|532311541|FG000|Overall Study|Lost Interest|3|||
147589053|NCT00271024|532311542|FG001|Overall Study|Lost Interest|4|||
147654523|NCT04074330|532556744|FG002|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
147163393|NCT00524589|530762277|FG000|Overall Study|Withdrawal by Subject|2|||
147163394|NCT00524589|530762277|FG000|Overall Study|Disease Progression|16|||
147163395|NCT01266317|530762278|FG000|Overall Study|Withdrawal by Subject|2|||
147163396|NCT00046930|530762279|FG000|Overall Study|Ineligible|12|||
147163397|NCT00046930|530762280|FG001|Overall Study|Ineligible|4|||
147163398|NCT01657760|530762281|FG000|Overall Study|Withdrawal by Subject|0|||
147163399|NCT01657760|530762282|FG001|Overall Study|Withdrawal by Subject|0|||
147163400|NCT01657760|530762283|FG002|Overall Study|Withdrawal by Subject|0|||
147163401|NCT01657760|530762284|FG003|Overall Study|Withdrawal by Subject|1|||
147654524|NCT04074330|532556745|FG003|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
147654525|NCT04074330|532556746|FG004|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
147163402|NCT01657760|530762281|FG000|Overall Study|Physician Decision|1|||
147163403|NCT01657760|530762282|FG001|Overall Study|Physician Decision|1|||
147163404|NCT01657760|530762283|FG002|Overall Study|Physician Decision|1|||
147163405|NCT01657760|530762284|FG003|Overall Study|Physician Decision|2|||
147163406|NCT00799591|530762285|FG000|Overall Study|De-escalation of doses|20|||
147163407|NCT00799591|530762285|FG000|Overall Study|Death|14|||
147654526|NCT04074330|532556747|FG005|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
147654527|NCT04074330|532556748|FG006|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
147654528|NCT04074330|532556749|FG007|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|0|||
147163408|NCT00799591|530762285|FG000|Overall Study|Technical failure|12|||
147163409|NCT00799591|530762285|FG000|Overall Study|Resistant germ|11|||
147163410|NCT00799591|530762285|FG000|Overall Study|New infection|4|||
147163411|NCT00799591|530762285|FG000|Overall Study|Resistance germ and technical failure|2|||
147447543|NCT00522431|531803889|FG000|Overall Study|Adverse Event|5|||
147654529|NCT04074330|532556750|FG008|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|1|||
147654530|NCT04074330|532556751|FG009|Dose Expansion (up to 42 Months)|Study Terminated by Sponsor|1|||
147654531|NCT03124537|532556752|FG000|Overall Study|Lost to Follow-up|3|||
147654532|NCT03124537|532556753|FG001|Overall Study|Lost to Follow-up|5|||
147654533|NCT03124537|532556752|FG000|Overall Study|App Crash, Incomplete Data|7|||
147654534|NCT03124537|532556753|FG001|Overall Study|App Crash, Incomplete Data|8|||
147654535|NCT03301831|532556756|FG000|Overall Study|Lost to Follow-up|5|||
147654536|NCT03301831|532556757|FG001|Overall Study|Lost to Follow-up|3|||
147654537|NCT03301831|532556756|FG000|Overall Study|Protocol Violation|4|||
147654538|NCT03301831|532556757|FG001|Overall Study|Protocol Violation|0|||
147654539|NCT03301831|532556756|FG000|Overall Study|Withdrawal by Subject|11|||
147654540|NCT03301831|532556757|FG001|Overall Study|Withdrawal by Subject|0|||
147654541|NCT00913770|532556761|FG000|Overall Study|Unable to contact|24|||
147654542|NCT00913770|532556762|FG001|Overall Study|Unable to contact|19|||
147654543|NCT00913770|532556763|FG002|Overall Study|Unable to contact|13|||
147447544|NCT00522431|531803889|FG000|Overall Study|Protocol Violation|2|||
147589054|NCT00271024|532311543|FG002|Overall Study|Lost Interest|2|||
147589055|NCT00271024|532311544|FG003|Overall Study|Lost Interest|3|||
147589056|NCT00271024|532311541|FG000|Overall Study|Unknown/Unspecified|11|||
147589057|NCT00271024|532311542|FG001|Overall Study|Unknown/Unspecified|11|||
147589058|NCT00271024|532311543|FG002|Overall Study|Unknown/Unspecified|8|||
147589059|NCT00271024|532311544|FG003|Overall Study|Unknown/Unspecified|4|||
147589060|NCT00271024|532311541|FG000|Overall Study|Protocol Violation|1|||
147589061|NCT00271024|532311542|FG001|Overall Study|Protocol Violation|6|||
147163412|NCT00799591|530762285|FG000|Overall Study|Persistance of fever undetermined origin|1|||
147163413|NCT00799591|530762285|FG000|Overall Study|Antibiotic changed, no apparent reason|1|||
147589062|NCT00271024|532311543|FG002|Overall Study|Protocol Violation|5|||
147589063|NCT00271024|532311544|FG003|Overall Study|Protocol Violation|11|||
147589064|NCT00271024|532311541|FG000|Overall Study|Unpleasant Reaction To Tablet|1|||
147654544|NCT00913770|532556761|FG000|Overall Study|Refused|11|||
147163414|NCT00799591|530762285|FG000|Overall Study|Infectious origin not probable|1|||
147163415|NCT03276052|530762287|FG000|Overall Study|Withdrawal by Subject|5|||
147163416|NCT03276052|530762287|FG000|Overall Study|Screening failure (non-fulfilment of inclusion/exclusion criteria)|18|||
147163417|NCT01994863|530762288|FG000|Period 1|Adverse Event|4|||
147163418|NCT01994863|530762289|FG001|Period 1|Adverse Event|0|||
147163419|NCT01994863|530762288|FG000|Period 1|Withdrawal by Subject|1|||
147163420|NCT01994863|530762289|FG001|Period 1|Withdrawal by Subject|0|||
147163421|NCT01994863|530762288|FG000|Period 1|Trial stopped by sponsor|1|||
147163422|NCT01994863|530762289|FG001|Period 1|Trial stopped by sponsor|3|||
147163423|NCT01994863|530762288|FG000|Period 1|Lack of Efficacy|1|||
147163424|NCT01994863|530762289|FG001|Period 1|Lack of Efficacy|0|||
147163425|NCT01994863|530762288|FG000|Period 2|Adverse Event|0|||
147163426|NCT01994863|530762289|FG001|Period 2|Adverse Event|1|||
147163427|NCT01994863|530762288|FG000|Period 2|Lack of Efficacy|0|||
147163428|NCT01994863|530762289|FG001|Period 2|Lack of Efficacy|2|||
147163429|NCT01994863|530762288|FG000|Period 2|Withdrawal by Subject|1|||
147163430|NCT01994863|530762289|FG001|Period 2|Withdrawal by Subject|1|||
147163431|NCT01062841|530762292|FG000|Overall Study|Indwelling Device Removed|41|||
147163432|NCT01062841|530762293|FG001|Overall Study|Indwelling Device Removed|48|||
147163433|NCT01062841|530762292|FG000|Overall Study|Death|3|||
147163434|NCT01062841|530762293|FG001|Overall Study|Death|5|||
147163435|NCT01062841|530762292|FG000|Overall Study|Withdrawal by Subject|2|||
147163436|NCT01062841|530762293|FG001|Overall Study|Withdrawal by Subject|0|||
147163437|NCT01062841|530762292|FG000|Overall Study|Withdrawal by Study|3|||
147163438|NCT01062841|530762293|FG001|Overall Study|Withdrawal by Study|0|||
147163439|NCT02046174|530762294|FG000|Overall Study|Too many adhesions to receive implant (at time of surgery).|1|||
147163440|NCT02046174|530762295|FG001|Overall Study|Too many adhesions to receive implant (at time of surgery).|0|||
147163441|NCT03294135|530762300|FG000|Overall Study|Serious Adverse Event|1|||
147163442|NCT03294135|530762301|FG001|Overall Study|Serious Adverse Event|0|||
147163443|NCT03294135|530762302|FG002|Overall Study|Serious Adverse Event|0|||
147163444|NCT03294135|530762300|FG000|Overall Study|Lost to Follow-up|1|||
147163445|NCT03294135|530762301|FG001|Overall Study|Lost to Follow-up|0|||
147163446|NCT03294135|530762302|FG002|Overall Study|Lost to Follow-up|1|||
147163447|NCT03294135|530762300|FG000|Overall Study|Withdrawal by Subject|0|||
147163448|NCT03294135|530762301|FG001|Overall Study|Withdrawal by Subject|0|||
147163449|NCT03294135|530762302|FG002|Overall Study|Withdrawal by Subject|1|||
147163450|NCT03294135|530762300|FG000|Overall Study|Other|2|||
147163451|NCT03294135|530762301|FG001|Overall Study|Other|0|||
147163452|NCT03294135|530762302|FG002|Overall Study|Other|0|||
147163453|NCT00186537|530762303|FG000|Overall Study|Withdrawal by Subject|4|||
147163454|NCT00186537|530762304|FG001|Overall Study|Withdrawal by Subject|0|||
147163455|NCT00186537|530762305|FG002|Overall Study|Withdrawal by Subject|3|||
147163456|NCT00186537|530762303|FG000|Overall Study|ALT > 1.5 x ULN|3|||
147163457|NCT00186537|530762304|FG001|Overall Study|ALT > 1.5 x ULN|0|||
147163458|NCT00186537|530762305|FG002|Overall Study|ALT > 1.5 x ULN|0|||
147163459|NCT02763254|530762306|FG000|Overall Study|Adverse Event|1|||
147163460|NCT01143051|530762309|FG000|3-14 Day Washout|Withdrawal by Subject|0|||
147163461|NCT01143051|530762310|FG001|3-14 Day Washout|Withdrawal by Subject|0|||
147163462|NCT01143051|530762311|FG002|3-14 Day Washout|Withdrawal by Subject|1|||
147163463|NCT01143051|530762312|FG003|3-14 Day Washout|Withdrawal by Subject|0|||
147163464|NCT01143051|530762313|FG004|3-14 Day Washout|Withdrawal by Subject|0|||
147163465|NCT01143051|530762314|FG005|3-14 Day Washout|Withdrawal by Subject|0|||
147163466|NCT01143051|530762309|FG000|3-14 Day Washout|Withdrawal by Subject|0|||
147163467|NCT01143051|530762310|FG001|3-14 Day Washout|Withdrawal by Subject|0|||
147163468|NCT01143051|530762311|FG002|3-14 Day Washout|Withdrawal by Subject|0|||
147163469|NCT01143051|530762312|FG003|3-14 Day Washout|Withdrawal by Subject|0|||
147163470|NCT01143051|530762313|FG004|3-14 Day Washout|Withdrawal by Subject|0|||
147163471|NCT01143051|530762314|FG005|3-14 Day Washout|Withdrawal by Subject|1|||
147163472|NCT00765882|530762315|FG000|Overall Study|Adverse Event|10|||
147163473|NCT00765882|530762316|FG001|Overall Study|Adverse Event|21|||
147163474|NCT00765882|530762317|FG002|Overall Study|Adverse Event|20|||
147163475|NCT00765882|530762315|FG000|Overall Study|Lack of Efficacy|4|||
147243052|NCT05469178|531062009|FG002|Overall Study|Lack of Efficacy|1|||
147243053|NCT05469178|531062010|FG003|Overall Study|Lack of Efficacy|10|||
147243054|NCT01328431|531062011|FG000|Baseline|Protocol Violation|0|||
147163476|NCT00765882|530762316|FG001|Overall Study|Lack of Efficacy|0|||
147163477|NCT00765882|530762317|FG002|Overall Study|Lack of Efficacy|1|||
147163478|NCT00765882|530762315|FG000|Overall Study|Protocol Violation|4|||
147243055|NCT01328431|531062012|FG001|Baseline|Protocol Violation|2|||
147243056|NCT01328431|531062011|FG000|1 Month (1M)|Lost to Follow-up|55|||
147447545|NCT00522431|531803889|FG000|Overall Study|Withdrawal by Subject|2|||
147163479|NCT00765882|530762316|FG001|Overall Study|Protocol Violation|3|||
147589065|NCT00271024|532311542|FG001|Overall Study|Unpleasant Reaction To Tablet|3|||
147163480|NCT00765882|530762317|FG002|Overall Study|Protocol Violation|1|||
147163481|NCT00765882|530762315|FG000|Overall Study|Withdrawal by Subject|2|||
147163482|NCT00765882|530762316|FG001|Overall Study|Withdrawal by Subject|6|||
147163483|NCT00765882|530762317|FG002|Overall Study|Withdrawal by Subject|6|||
147163484|NCT00765882|530762315|FG000|Overall Study|Lost to Follow-up|1|||
147163485|NCT00765882|530762316|FG001|Overall Study|Lost to Follow-up|9|||
147163486|NCT00765882|530762317|FG002|Overall Study|Lost to Follow-up|6|||
147243057|NCT01328431|531062012|FG001|1 Month (1M)|Lost to Follow-up|58|||
147243058|NCT01328431|531062011|FG000|3 Month (3M)|Death|2|||
147243059|NCT01328431|531062012|FG001|3 Month (3M)|Death|2|||
147163487|NCT00765882|530762315|FG000|Overall Study|Other Reason|3|||
147447546|NCT00522431|531803889|FG000|Overall Study|Subject non-compliance|1|||
147447547|NCT00522431|531803889|FG000|Overall Study|Other/unknown|1|||
147447548|NCT02495844|531803890|FG000|Overall Study|Lack of Efficacy|1|||
147447549|NCT02495844|531803891|FG001|Overall Study|Lack of Efficacy|2|||
147447550|NCT02495844|531803890|FG000|Overall Study|AE, non-fatal|0|||
147447551|NCT02495844|531803891|FG001|Overall Study|AE, non-fatal|1|||
147447552|NCT02495844|531803890|FG000|Overall Study|Hepatitis Positivity|0|||
147447553|NCT02495844|531803891|FG001|Overall Study|Hepatitis Positivity|1|||
147447554|NCT03927105|531803892|FG000|Overall Study|Death|1|||
147447555|NCT03927105|531803892|FG000|Overall Study|In observation for potential re-treatment|2|||
147447556|NCT03927105|531803892|FG000|Overall Study|Subject was never treated due to new medical problems causing ineligibility prior to treatment.|1|||
147447557|NCT02145741|531803895|FG000|Overall Study|Progressive disease|3|||
147447558|NCT02145741|531803896|FG001|Overall Study|Progressive disease|6|||
147447559|NCT02145741|531803897|FG002|Overall Study|Progressive disease|6|||
147447560|NCT02145741|531803895|FG000|Overall Study|quality issue with the administered drug|3|||
147589066|NCT00271024|532311543|FG002|Overall Study|Unpleasant Reaction To Tablet|4|||
147163488|NCT00765882|530762316|FG001|Overall Study|Other Reason|1|||
147163489|NCT00765882|530762317|FG002|Overall Study|Other Reason|2|||
147163490|NCT01874275|530762318|FG000|Overall Study|Lost to Follow-up|1|||
147163491|NCT01874275|530762319|FG001|Overall Study|Lost to Follow-up|0|||
147163492|NCT03351114|530762320|FG000|Overall Study|Withdrawal by Subject|1|||
147163493|NCT01665430|530762324|FG000|Overall Study|Adverse Event|1|||
147163494|NCT01665430|530762324|FG000|Overall Study|Withdrawal by Subject|6|||
147163495|NCT01665430|530762324|FG000|Overall Study|Other Unspecified|2|||
147163496|NCT00989235|530762329|FG000|Overall Study|Death|0|||
147163497|NCT00989235|530762330|FG001|Overall Study|Death|1|||
147163498|NCT00989235|530762329|FG000|Overall Study|Adverse Event|0|||
147163499|NCT00989235|530762330|FG001|Overall Study|Adverse Event|1|||
147163500|NCT00989235|530762329|FG000|Overall Study|Lack of Efficacy|1|||
147589067|NCT00271024|532311544|FG003|Overall Study|Unpleasant Reaction To Tablet|2|||
147589068|NCT00271024|532311541|FG000|Overall Study|Time Commitment, Scheduling, or Travel|6|||
147589069|NCT00271024|532311542|FG001|Overall Study|Time Commitment, Scheduling, or Travel|2|||
147589070|NCT00271024|532311543|FG002|Overall Study|Time Commitment, Scheduling, or Travel|4|||
147589071|NCT00271024|532311544|FG003|Overall Study|Time Commitment, Scheduling, or Travel|4|||
147589072|NCT01719562|532311555|FG000|Overall Study|Lost to Follow-up|1|||
147589073|NCT01719562|532311556|FG001|Overall Study|Lost to Follow-up|0|||
147589074|NCT01719562|532311555|FG000|Overall Study|Death|1|||
147589075|NCT01719562|532311556|FG001|Overall Study|Death|0|||
147589076|NCT01719562|532311555|FG000|Overall Study|New cancer diagnosis|1|||
147589077|NCT01719562|532311556|FG001|Overall Study|New cancer diagnosis|0|||
147589078|NCT00508027|532311557|FG000|Dose Level 1|Lost to Follow-up|4|||
147589079|NCT00508027|532311557|FG000|Dose Level 1|Withdrawal by Subject|2|||
147589080|NCT00508027|532311557|FG000|Dose Level 1|Physician Decision|2|||
147589081|NCT00508027|532311557|FG000|Dose Level 2|Lost to Follow-up|2|||
147589082|NCT00508027|532311557|FG000|Dose Level 2|Withdrawal by Subject|2|||
147589083|NCT02013531|532311558|FG000|Overall Study|Lost to Follow-up|3|||
147589084|NCT02013531|532311558|FG000|Overall Study|Met Withdrawal Criteria|1|||
147589085|NCT02013531|532311558|FG000|Overall Study|Withdrawal by Subject|1|||
147589086|NCT03877926|532311559|FG000|Overall Study|Adverse Event|1|||
147589087|NCT03877926|532311560|FG001|Overall Study|Adverse Event|0|||
147589088|NCT03877926|532311561|FG002|Overall Study|Adverse Event|0|||
147589089|NCT03877926|532311562|FG003|Overall Study|Adverse Event|0|||
147589090|NCT03877926|532311559|FG000|Overall Study|Death|2|||
147589091|NCT03877926|532311560|FG001|Overall Study|Death|2|||
147589092|NCT03877926|532311561|FG002|Overall Study|Death|2|||
147589093|NCT03877926|532311562|FG003|Overall Study|Death|0|||
147589094|NCT03877926|532311559|FG000|Overall Study|Lost to Follow-up|41|||
147589095|NCT03877926|532311560|FG001|Overall Study|Lost to Follow-up|52|||
147589096|NCT03877926|532311561|FG002|Overall Study|Lost to Follow-up|45|||
147589097|NCT03877926|532311562|FG003|Overall Study|Lost to Follow-up|17|||
147589098|NCT03877926|532311559|FG000|Overall Study|Physician Decision|2|||
147163501|NCT00989235|530762330|FG001|Overall Study|Lack of Efficacy|0|||
147163502|NCT00989235|530762329|FG000|Overall Study|Withdrawal of Consent|1|||
147447561|NCT02145741|531803896|FG001|Overall Study|quality issue with the administered drug|0|||
147447562|NCT02145741|531803897|FG002|Overall Study|quality issue with the administered drug|0|||
147447563|NCT05634577|531803898|FG000|Overall Study|Lost to Follow-up|1|||
147163503|NCT00989235|530762330|FG001|Overall Study|Withdrawal of Consent|1|||
147447564|NCT05634577|531803898|FG000|Overall Study|Withdrawal by Subject|1|||
147589099|NCT03877926|532311560|FG001|Overall Study|Physician Decision|0|||
147589100|NCT03877926|532311561|FG002|Overall Study|Physician Decision|2|||
147589101|NCT03877926|532311562|FG003|Overall Study|Physician Decision|0|||
147589102|NCT03877926|532311559|FG000|Overall Study|Withdrawal by Subject|18|||
147589103|NCT03877926|532311560|FG001|Overall Study|Withdrawal by Subject|21|||
147163504|NCT00989235|530762329|FG000|Overall Study|Desire to Become Pregnant|1|||
147163505|NCT00989235|530762330|FG001|Overall Study|Desire to Become Pregnant|0|||
147589104|NCT03877926|532311561|FG002|Overall Study|Withdrawal by Subject|12|||
147589105|NCT03877926|532311562|FG003|Overall Study|Withdrawal by Subject|4|||
147589106|NCT03877926|532311559|FG000|Overall Study|Other - Various|4|||
147589107|NCT03877926|532311560|FG001|Overall Study|Other - Various|1|||
147589108|NCT03877926|532311561|FG002|Overall Study|Other - Various|1|||
147589109|NCT03877926|532311562|FG003|Overall Study|Other - Various|0|||
147589110|NCT03877926|532311559|FG000|Overall Study|Not Treated|3|||
147589111|NCT03877926|532311560|FG001|Overall Study|Not Treated|1|||
147589112|NCT03877926|532311561|FG002|Overall Study|Not Treated|1|||
147589113|NCT03877926|532311562|FG003|Overall Study|Not Treated|0|||
147589114|NCT00939627|532311566|FG000|Overall Study|Disease Progression|16|||
147589115|NCT00939627|532311567|FG001|Overall Study|Disease Progression|12|||
147589116|NCT00939627|532311568|FG002|Overall Study|Disease Progression|0|||
147589117|NCT00939627|532311566|FG000|Overall Study|Adverse Event|6|||
147589118|NCT00939627|532311567|FG001|Overall Study|Adverse Event|7|||
147589119|NCT00939627|532311568|FG002|Overall Study|Adverse Event|0|||
147589120|NCT00939627|532311566|FG000|Overall Study|Death|0|||
147589121|NCT00939627|532311567|FG001|Overall Study|Death|2|||
147589122|NCT00939627|532311568|FG002|Overall Study|Death|0|||
147589123|NCT00939627|532311566|FG000|Overall Study|Withdrawal by Subject|2|||
147589124|NCT00939627|532311567|FG001|Overall Study|Withdrawal by Subject|4|||
147589125|NCT00939627|532311568|FG002|Overall Study|Withdrawal by Subject|0|||
147589126|NCT00939627|532311566|FG000|Overall Study|Other complicating disease|1|||
147589127|NCT00939627|532311567|FG001|Overall Study|Other complicating disease|1|||
147589128|NCT00939627|532311568|FG002|Overall Study|Other complicating disease|0|||
147589129|NCT00939627|532311566|FG000|Overall Study|Not compliant|2|||
147589130|NCT00939627|532311567|FG001|Overall Study|Not compliant|0|||
147589131|NCT00939627|532311568|FG002|Overall Study|Not compliant|0|||
147589132|NCT00939627|532311566|FG000|Overall Study|No off-tx reason given|0|||
147589133|NCT00939627|532311567|FG001|Overall Study|No off-tx reason given|2|||
147589134|NCT00939627|532311568|FG002|Overall Study|No off-tx reason given|0|||
147589135|NCT00537199|532311571|FG000|Overall Study|Study Terminated|1|||
147589136|NCT02039063|532311573|FG000|Treatment Phase|Inadequate therapeutic effect|3|||
147589137|NCT02039063|532311574|FG001|Treatment Phase|Inadequate therapeutic effect|2|||
147589138|NCT02039063|532311575|FG002|Treatment Phase|Inadequate therapeutic effect|1|||
147589139|NCT02039063|532311576|FG003|Treatment Phase|Inadequate therapeutic effect|1|||
147589140|NCT02039063|532311573|FG000|Treatment Phase|Progression of disease|0|||
147589141|NCT02039063|532311574|FG001|Treatment Phase|Progression of disease|0|||
147589142|NCT02039063|532311575|FG002|Treatment Phase|Progression of disease|1|||
147589143|NCT02039063|532311576|FG003|Treatment Phase|Progression of disease|1|||
147589144|NCT02039063|532311573|FG000|Extension Phase|Inadequate therapeutic effect|0|||
147589145|NCT02039063|532311574|FG001|Extension Phase|Inadequate therapeutic effect|1|||
147589146|NCT02039063|532311575|FG002|Extension Phase|Inadequate therapeutic effect|2|||
147589147|NCT02039063|532311576|FG003|Extension Phase|Inadequate therapeutic effect|0|||
147589148|NCT02039063|532311573|FG000|Extension Phase|Progression of disease|0|||
147589149|NCT02039063|532311574|FG001|Extension Phase|Progression of disease|0|||
147589150|NCT02039063|532311575|FG002|Extension Phase|Progression of disease|0|||
147589151|NCT02039063|532311576|FG003|Extension Phase|Progression of disease|1|||
147589152|NCT02039063|532311573|FG000|Extension Phase|Adverse Event|0|||
147589153|NCT02039063|532311574|FG001|Extension Phase|Adverse Event|0|||
147589154|NCT02039063|532311575|FG002|Extension Phase|Adverse Event|1|||
147589155|NCT02039063|532311576|FG003|Extension Phase|Adverse Event|0|||
147589156|NCT00467831|532311580|FG000|Overall Study|Death|2|||
147654545|NCT00913770|532556762|FG001|Overall Study|Refused|10|||
147654546|NCT00913770|532556763|FG002|Overall Study|Refused|8|||
147654547|NCT02348008|532556764|FG000|Overall Study|Adverse Event|2|||
147654548|NCT02348008|532556765|FG001|Overall Study|Adverse Event|3|||
147654549|NCT02348008|532556766|FG002|Overall Study|Adverse Event|3|||
147654550|NCT02348008|532556764|FG000|Overall Study|Disease Progression|1|||
147654551|NCT02348008|532556765|FG001|Overall Study|Disease Progression|5|||
147589157|NCT00467831|532311580|FG000|Overall Study|Withdrawal by Subject|1|||
147589158|NCT01998243|532311583|FG000|Overall Study|Pregnancy|0|||
147589159|NCT01998243|532311584|FG001|Overall Study|Pregnancy|1|||
147589160|NCT01998243|532311583|FG000|Overall Study|Protocol Violation|5|||
147589161|NCT01998243|532311584|FG001|Overall Study|Protocol Violation|2|||
147589162|NCT01998243|532311583|FG000|Overall Study|Withdrawal by Subject|3|||
147589163|NCT01998243|532311584|FG001|Overall Study|Withdrawal by Subject|4|||
147589164|NCT02492841|532311585|FG000|Overall Study|Lost to Follow-up|34|||
147589165|NCT02492841|532311586|FG001|Overall Study|Lost to Follow-up|31|||
147589166|NCT02492841|532311587|FG002|Overall Study|Lost to Follow-up|35|||
147589167|NCT04117945|532311588|FG000|Overall Study|Death|1|||
147654552|NCT02348008|532556766|FG002|Overall Study|Disease Progression|16|||
147163506|NCT00989235|530762329|FG000|Overall Study|Randomized by Mistake|0|||
147589168|NCT04117945|532311589|FG001|Overall Study|Death|0|||
147589169|NCT04117945|532311588|FG000|Overall Study|Withdrawal by Subject|3|||
147589170|NCT04117945|532311589|FG001|Overall Study|Withdrawal by Subject|1|||
147589171|NCT04117945|532311588|FG000|Overall Study|Disease Progression|0|||
147654553|NCT02348008|532556764|FG000|Overall Study|Withdrawal by Subject|0|||
147589172|NCT04117945|532311589|FG001|Overall Study|Disease Progression|2|||
147589173|NCT04117945|532311588|FG000|Overall Study|Ineligible|8|||
147163507|NCT00989235|530762330|FG001|Overall Study|Randomized by Mistake|2|||
147163508|NCT00989235|530762329|FG000|Overall Study|Lost to Follow-up|0|||
147163509|NCT00989235|530762330|FG001|Overall Study|Lost to Follow-up|1|||
147163510|NCT03249935|530762331|FG000|Overall Study|Discharged from facility early|36|||
147163511|NCT03249935|530762331|FG000|Overall Study|Negative for chlamydia at enrollment|4|||
147163512|NCT03249935|530762331|FG000|Overall Study|Protocol Violation|5|||
147163513|NCT02813668|530762332|FG000|Overall Study|Death|4|||
147163514|NCT02813668|530762332|FG000|Overall Study|Lost to Follow-up|509|||
147163515|NCT02813668|530762332|FG000|Overall Study|Withdrawal by Subject|148|||
147163516|NCT02813668|530762332|FG000|Overall Study|No longer at worksite|85|||
147163517|NCT02813668|530762332|FG000|Overall Study|Medical reasons not related to the study|4|||
147163518|NCT04662073|530762333|FG000|Overall Study|Withdrawal by Subject|1|||
147163519|NCT04662073|530762334|FG001|Overall Study|Withdrawal by Subject|0|||
147163520|NCT01135914|530762335|FG000|Overall Study|Withdrawal by Subject|1|||
147163521|NCT01135914|530762336|FG001|Overall Study|Withdrawal by Subject|3|||
147163522|NCT01135914|530762337|FG002|Overall Study|Withdrawal by Subject|6|||
147163523|NCT01135914|530762335|FG000|Overall Study|Lost to Follow-up|1|||
147163524|NCT01135914|530762336|FG001|Overall Study|Lost to Follow-up|0|||
147163525|NCT01135914|530762337|FG002|Overall Study|Lost to Follow-up|1|||
147163526|NCT01135914|530762335|FG000|Overall Study|Protocol Violation|0|||
147163527|NCT01135914|530762336|FG001|Overall Study|Protocol Violation|0|||
147163528|NCT01135914|530762337|FG002|Overall Study|Protocol Violation|3|||
147163529|NCT01135914|530762335|FG000|Overall Study|Lack of Efficacy|2|||
147163530|NCT01135914|530762336|FG001|Overall Study|Lack of Efficacy|1|||
147163531|NCT01135914|530762337|FG002|Overall Study|Lack of Efficacy|10|||
147163532|NCT01135914|530762335|FG000|Overall Study|Adverse Event|0|||
147163533|NCT01135914|530762336|FG001|Overall Study|Adverse Event|1|||
147243060|NCT01328431|531062011|FG000|3 Month (3M)|Lost to Follow-up|75|||
147243061|NCT01328431|531062012|FG001|3 Month (3M)|Lost to Follow-up|70|||
147243062|NCT01328431|531062011|FG000|12 Month (12M)|Death|2|||
147243063|NCT01328431|531062012|FG001|12 Month (12M)|Death|6|||
147243064|NCT01328431|531062011|FG000|12 Month (12M)|Lost to Follow-up|82|||
147243065|NCT01328431|531062012|FG001|12 Month (12M)|Lost to Follow-up|91|||
147243066|NCT03617185|531062015|FG000|Baseline|Lost to Follow-up|0|||
147447565|NCT01192022|531803899|FG000|Overall Study|Withdrawal of Consent|3|||
147163534|NCT01135914|530762337|FG002|Overall Study|Adverse Event|2|||
147163535|NCT00598078|530762342|FG000|Period 2 (Day 2)|Adverse Event|1|||
147163536|NCT00598078|530762343|FG001|Period 2 (Day 2)|Adverse Event|0|||
147163537|NCT01813721|530762344|FG000|Overall Study|Ineligibility determined|63|||
147163538|NCT01813721|530762344|FG000|Overall Study|Withdrawal by Subject|1|||
147243067|NCT03617185|531062016|FG001|Baseline|Lost to Follow-up|2|||
147243068|NCT03617185|531062017|FG002|Baseline|Lost to Follow-up|1|||
147243069|NCT03617185|531062018|FG003|Baseline|Lost to Follow-up|1|||
147243070|NCT03617185|531062015|FG000|Baseline|Withdrawal by Subject|0|||
147243071|NCT03617185|531062016|FG001|Baseline|Withdrawal by Subject|1|||
147243072|NCT03617185|531062017|FG002|Baseline|Withdrawal by Subject|0|||
147243073|NCT03617185|531062018|FG003|Baseline|Withdrawal by Subject|1|||
147243074|NCT03617185|531062015|FG000|Baseline|Driving Distance/Travel|0|||
147243075|NCT03617185|531062016|FG001|Baseline|Driving Distance/Travel|0|||
147243076|NCT03617185|531062017|FG002|Baseline|Driving Distance/Travel|2|||
147243077|NCT03617185|531062018|FG003|Baseline|Driving Distance/Travel|0|||
147243078|NCT03617185|531062015|FG000|Baseline|Family Obligations|0|||
147243079|NCT03617185|531062016|FG001|Baseline|Family Obligations|0|||
147243080|NCT03617185|531062017|FG002|Baseline|Family Obligations|0|||
147243081|NCT03617185|531062018|FG003|Baseline|Family Obligations|1|||
147243082|NCT03617185|531062015|FG000|3 Months|Lost to Follow-up|4|||
147243083|NCT03617185|531062016|FG001|3 Months|Lost to Follow-up|1|||
147243084|NCT03617185|531062017|FG002|3 Months|Lost to Follow-up|0|||
147243085|NCT03617185|531062018|FG003|3 Months|Lost to Follow-up|2|||
147243086|NCT03617185|531062015|FG000|3 Months|Withdrawal by Subject|1|||
147243087|NCT03617185|531062016|FG001|3 Months|Withdrawal by Subject|3|||
147243088|NCT03617185|531062017|FG002|3 Months|Withdrawal by Subject|0|||
147163539|NCT01479595|530762347|FG000|Overall Study|Protocol deviation|0|||
147243089|NCT03617185|531062018|FG003|3 Months|Withdrawal by Subject|0|||
147243090|NCT03617185|531062015|FG000|3 Months|Driving Distance/Travel|1|||
147243091|NCT03617185|531062016|FG001|3 Months|Driving Distance/Travel|0|||
147243092|NCT03617185|531062017|FG002|3 Months|Driving Distance/Travel|0|||
147243093|NCT03617185|531062018|FG003|3 Months|Driving Distance/Travel|0|||
147243094|NCT03617185|531062015|FG000|3 Months|Family Obligations|0|||
147243095|NCT03617185|531062016|FG001|3 Months|Family Obligations|0|||
147243096|NCT03617185|531062017|FG002|3 Months|Family Obligations|0|||
147243097|NCT03617185|531062018|FG003|3 Months|Family Obligations|1|||
147243098|NCT03617185|531062015|FG000|12 Months|Lost to Follow-up|3|||
147243099|NCT03617185|531062016|FG001|12 Months|Lost to Follow-up|1|||
147243100|NCT03617185|531062017|FG002|12 Months|Lost to Follow-up|3|||
147243101|NCT03617185|531062018|FG003|12 Months|Lost to Follow-up|0|||
147243102|NCT03617185|531062015|FG000|12 Months|Withdrawal by Subject|0|||
147243103|NCT03617185|531062016|FG001|12 Months|Withdrawal by Subject|0|||
147243104|NCT03617185|531062017|FG002|12 Months|Withdrawal by Subject|0|||
147243105|NCT03617185|531062018|FG003|12 Months|Withdrawal by Subject|1|||
147589174|NCT04117945|532311589|FG001|Overall Study|Ineligible|7|||
147589175|NCT00562120|532311595|FG000|First Intervention Period|Adverse Event|1|||
147589176|NCT00562120|532311596|FG001|First Intervention Period|Adverse Event|0|||
147163540|NCT01479595|530762348|FG001|Overall Study|Protocol deviation|1|||
147163541|NCT01479595|530762347|FG000|Overall Study|Adverse Event|2|||
147163542|NCT01479595|530762348|FG001|Overall Study|Adverse Event|1|||
147163543|NCT02133664|530762349|FG000|Overall Study|Lost to Follow-up|2|||
147163544|NCT02133664|530762350|FG001|Overall Study|Lost to Follow-up|1|||
147163545|NCT02133664|530762349|FG000|Overall Study|Adverse Event|3|||
147163546|NCT02133664|530762350|FG001|Overall Study|Adverse Event|6|||
147163547|NCT00810901|530762351|FG000|Overall Study|Lost to Follow-up|88|||
147163548|NCT00810901|530762352|FG001|Overall Study|Lost to Follow-up|58|||
147163549|NCT03366103|530762355|FG000|Overall Study|Disease Progression|3|||
147163550|NCT03366103|530762356|FG001|Overall Study|Disease Progression|1|||
147163551|NCT03366103|530762357|FG002|Overall Study|Disease Progression|0|||
147163552|NCT03366103|530762355|FG000|Overall Study|Adverse Event|0|||
147163553|NCT03366103|530762356|FG001|Overall Study|Adverse Event|1|||
147163554|NCT03366103|530762357|FG002|Overall Study|Adverse Event|0|||
147163555|NCT02120365|530762364|FG000|Overall Study|Withdrawal by Subject|0|||
147163556|NCT02120365|530762365|FG001|Overall Study|Withdrawal by Subject|0|||
147163557|NCT02120365|530762366|FG002|Overall Study|Withdrawal by Subject|2|||
147163558|NCT02120365|530762367|FG003|Overall Study|Withdrawal by Subject|4|||
147163559|NCT02120365|530762368|FG004|Overall Study|Withdrawal by Subject|0|||
147163560|NCT02120365|530762369|FG005|Overall Study|Withdrawal by Subject|2|||
147163561|NCT00343915|530762370|FG000|Primary Study|Withdrawal by Subject|1|||
147163562|NCT00343915|530762371|FG001|Primary Study|Withdrawal by Subject|0|||
147163563|NCT00343915|530762370|FG000|Primary Study|Lost to Follow-up|2|||
147163564|NCT00343915|530762371|FG001|Primary Study|Lost to Follow-up|3|||
147163565|NCT00343915|530762370|FG000|Primary Study|Other|1|||
147163566|NCT00343915|530762371|FG001|Primary Study|Other|0|||
147163567|NCT01719003|530762376|FG000|Overall Study|Non compliant with protocol|1|||
147163568|NCT01719003|530762377|FG001|Overall Study|Non compliant with protocol|1|||
147163569|NCT01719003|530762378|FG002|Overall Study|Non compliant with protocol|0|||
147163570|NCT01719003|530762379|FG003|Overall Study|Non compliant with protocol|1|||
147163571|NCT01719003|530762380|FG004|Overall Study|Non compliant with protocol|2|||
147163572|NCT01719003|530762381|FG005|Overall Study|Non compliant with protocol|1|||
147163573|NCT01719003|530762382|FG006|Overall Study|Non compliant with protocol|2|||
147163574|NCT01719003|530762383|FG007|Overall Study|Non compliant with protocol|3|||
147163575|NCT01719003|530762384|FG008|Overall Study|Non compliant with protocol|0|||
147163576|NCT01719003|530762376|FG000|Overall Study|Adverse Event|6|||
147163577|NCT01719003|530762377|FG001|Overall Study|Adverse Event|5|||
147163578|NCT01719003|530762378|FG002|Overall Study|Adverse Event|4|||
147163579|NCT01719003|530762379|FG003|Overall Study|Adverse Event|3|||
147163580|NCT01719003|530762380|FG004|Overall Study|Adverse Event|4|||
147163581|NCT01719003|530762381|FG005|Overall Study|Adverse Event|3|||
147163582|NCT01719003|530762382|FG006|Overall Study|Adverse Event|6|||
147163583|NCT01719003|530762383|FG007|Overall Study|Adverse Event|5|||
147163584|NCT01719003|530762384|FG008|Overall Study|Adverse Event|0|||
147163585|NCT01719003|530762376|FG000|Overall Study|Lost to Follow-up|0|||
147163586|NCT01719003|530762377|FG001|Overall Study|Lost to Follow-up|6|||
147163587|NCT01719003|530762378|FG002|Overall Study|Lost to Follow-up|7|||
147163588|NCT01719003|530762379|FG003|Overall Study|Lost to Follow-up|2|||
147163589|NCT01719003|530762380|FG004|Overall Study|Lost to Follow-up|3|||
147163590|NCT01719003|530762381|FG005|Overall Study|Lost to Follow-up|4|||
147163591|NCT01719003|530762382|FG006|Overall Study|Lost to Follow-up|3|||
147163592|NCT01719003|530762383|FG007|Overall Study|Lost to Follow-up|2|||
147163593|NCT01719003|530762384|FG008|Overall Study|Lost to Follow-up|2|||
147163594|NCT01719003|530762376|FG000|Overall Study|Refusal to continue, not due to AE|2|||
147163595|NCT01719003|530762377|FG001|Overall Study|Refusal to continue, not due to AE|5|||
147163596|NCT01719003|530762378|FG002|Overall Study|Refusal to continue, not due to AE|4|||
147163597|NCT01719003|530762379|FG003|Overall Study|Refusal to continue, not due to AE|4|||
147163598|NCT01719003|530762380|FG004|Overall Study|Refusal to continue, not due to AE|4|||
147163599|NCT01719003|530762381|FG005|Overall Study|Refusal to continue, not due to AE|3|||
147163600|NCT01719003|530762382|FG006|Overall Study|Refusal to continue, not due to AE|8|||
147163601|NCT01719003|530762383|FG007|Overall Study|Refusal to continue, not due to AE|7|||
147243106|NCT03617185|531062015|FG000|12 Months|Driving Distance/Travel|0|||
147163602|NCT01719003|530762384|FG008|Overall Study|Refusal to continue, not due to AE|1|||
147163603|NCT01719003|530762376|FG000|Overall Study|Reason other than those specified|0|||
147243107|NCT03617185|531062016|FG001|12 Months|Driving Distance/Travel|0|||
147243108|NCT03617185|531062017|FG002|12 Months|Driving Distance/Travel|1|||
147243109|NCT03617185|531062018|FG003|12 Months|Driving Distance/Travel|0|||
147589177|NCT00562120|532311597|FG002|First Intervention Period|Adverse Event|0|||
147163604|NCT01719003|530762377|FG001|Overall Study|Reason other than those specified|0|||
147163605|NCT01719003|530762378|FG002|Overall Study|Reason other than those specified|2|||
147163606|NCT01719003|530762379|FG003|Overall Study|Reason other than those specified|3|||
147163607|NCT01719003|530762380|FG004|Overall Study|Reason other than those specified|4|||
147163608|NCT01719003|530762381|FG005|Overall Study|Reason other than those specified|1|||
147163609|NCT01719003|530762382|FG006|Overall Study|Reason other than those specified|0|||
147163610|NCT01719003|530762383|FG007|Overall Study|Reason other than those specified|3|||
147163611|NCT01719003|530762384|FG008|Overall Study|Reason other than those specified|1|||
147163612|NCT01719003|530762376|FG000|Overall Study|Lack of Efficacy|0|||
147163613|NCT01719003|530762377|FG001|Overall Study|Lack of Efficacy|0|||
147163614|NCT01719003|530762378|FG002|Overall Study|Lack of Efficacy|0|||
147163615|NCT01719003|530762379|FG003|Overall Study|Lack of Efficacy|0|||
147163616|NCT01719003|530762380|FG004|Overall Study|Lack of Efficacy|0|||
147163617|NCT01719003|530762381|FG005|Overall Study|Lack of Efficacy|0|||
147163618|NCT01719003|530762382|FG006|Overall Study|Lack of Efficacy|1|||
147163619|NCT01719003|530762383|FG007|Overall Study|Lack of Efficacy|0|||
147163620|NCT01719003|530762384|FG008|Overall Study|Lack of Efficacy|0|||
147163621|NCT00882908|530762385|FG000|Overall Study|Adverse Event|0|||
147163622|NCT00882908|530762386|FG001|Overall Study|Adverse Event|0|||
147447566|NCT01192022|531803900|FG001|Overall Study|Withdrawal of Consent|1|||
147447567|NCT01192022|531803901|FG002|Overall Study|Withdrawal of Consent|0|||
147447568|NCT01192022|531803902|FG003|Overall Study|Withdrawal of Consent|0|||
147447569|NCT01192022|531803903|FG004|Overall Study|Withdrawal of Consent|0|||
147447570|NCT01192022|531803899|FG000|Overall Study|Lost to Follow-up|4|||
147447571|NCT01192022|531803900|FG001|Overall Study|Lost to Follow-up|2|||
147447572|NCT01192022|531803901|FG002|Overall Study|Lost to Follow-up|1|||
147447573|NCT01192022|531803902|FG003|Overall Study|Lost to Follow-up|1|||
147447574|NCT01192022|531803903|FG004|Overall Study|Lost to Follow-up|0|||
147447575|NCT01192022|531803899|FG000|Overall Study|Adverse Event|1|||
147447576|NCT01192022|531803900|FG001|Overall Study|Adverse Event|0|||
147447577|NCT01192022|531803901|FG002|Overall Study|Adverse Event|0|||
147447578|NCT01192022|531803902|FG003|Overall Study|Adverse Event|0|||
147447579|NCT01192022|531803903|FG004|Overall Study|Adverse Event|0|||
147447580|NCT01192022|531803899|FG000|Overall Study|Fatal Adverse Event|4|||
147447581|NCT01192022|531803900|FG001|Overall Study|Fatal Adverse Event|6|||
147447582|NCT01192022|531803901|FG002|Overall Study|Fatal Adverse Event|0|||
147447583|NCT01192022|531803902|FG003|Overall Study|Fatal Adverse Event|0|||
147447584|NCT01192022|531803903|FG004|Overall Study|Fatal Adverse Event|1|||
147447585|NCT01192022|531803899|FG000|Overall Study|Physician withdrew-patient hardship|1|||
147447586|NCT01192022|531803900|FG001|Overall Study|Physician withdrew-patient hardship|0|||
147447587|NCT01192022|531803901|FG002|Overall Study|Physician withdrew-patient hardship|0|||
147447588|NCT01192022|531803902|FG003|Overall Study|Physician withdrew-patient hardship|0|||
147447589|NCT01192022|531803903|FG004|Overall Study|Physician withdrew-patient hardship|0|||
147447590|NCT01192022|531803899|FG000|Overall Study|Patient too sick from chemotherapy|0|||
147447591|NCT01192022|531803900|FG001|Overall Study|Patient too sick from chemotherapy|1|||
147447592|NCT01192022|531803901|FG002|Overall Study|Patient too sick from chemotherapy|0|||
147447593|NCT01192022|531803902|FG003|Overall Study|Patient too sick from chemotherapy|0|||
147447594|NCT01192022|531803903|FG004|Overall Study|Patient too sick from chemotherapy|0|||
147447595|NCT01192022|531803899|FG000|Overall Study|Patient needed surgery|0|||
147447596|NCT01192022|531803900|FG001|Overall Study|Patient needed surgery|1|||
147447597|NCT01192022|531803901|FG002|Overall Study|Patient needed surgery|0|||
147447598|NCT01192022|531803902|FG003|Overall Study|Patient needed surgery|0|||
147447599|NCT01192022|531803903|FG004|Overall Study|Patient needed surgery|0|||
147447600|NCT01192022|531803899|FG000|Overall Study|Parents did not allow all follow up|0|||
147447601|NCT01192022|531803900|FG001|Overall Study|Parents did not allow all follow up|0|||
147447602|NCT01192022|531803901|FG002|Overall Study|Parents did not allow all follow up|0|||
147447603|NCT01192022|531803902|FG003|Overall Study|Parents did not allow all follow up|1|||
147447604|NCT01192022|531803903|FG004|Overall Study|Parents did not allow all follow up|0|||
147447605|NCT01351389|531803904|FG000|Overall Study|Withdrawal by Subject|7|||
147447606|NCT01351389|531803905|FG001|Overall Study|Withdrawal by Subject|0|||
147447607|NCT01351389|531803904|FG000|Overall Study|did not complete intervention|23|||
147447608|NCT01351389|531803905|FG001|Overall Study|did not complete intervention|15|||
147447609|NCT04839978|531803906|FG000|Overall Study|Lost to Follow-up|135|||
147447610|NCT04839978|531803907|FG001|Overall Study|Lost to Follow-up|147|||
147447611|NCT00623480|531803909|FG000|Overall Study|Lost to Follow-up|0|||
147163623|NCT00882908|530762387|FG002|Overall Study|Adverse Event|1|||
147163624|NCT00882908|530762388|FG003|Overall Study|Adverse Event|0|||
147163625|NCT00882908|530762389|FG004|Overall Study|Adverse Event|1|||
147447612|NCT00623480|531803910|FG001|Overall Study|Lost to Follow-up|1|||
147447613|NCT00623480|531803909|FG000|Overall Study|Withdrawal by Subject|2|||
147447614|NCT00623480|531803910|FG001|Overall Study|Withdrawal by Subject|4|||
147447615|NCT00623480|531803909|FG000|Overall Study|Lack of Efficacy|1|||
147447616|NCT00623480|531803910|FG001|Overall Study|Lack of Efficacy|0|||
147163626|NCT00882908|530762385|FG000|Overall Study|Lost to Follow-up|3|||
147163627|NCT00882908|530762386|FG001|Overall Study|Lost to Follow-up|5|||
147163628|NCT00882908|530762387|FG002|Overall Study|Lost to Follow-up|3|||
147447617|NCT00623480|531803909|FG000|Overall Study|Non-compliant with study medication|4|||
147447618|NCT00623480|531803910|FG001|Overall Study|Non-compliant with study medication|0|||
147447619|NCT00623480|531803909|FG000|Overall Study|Protocol Violation|0|||
147163629|NCT00882908|530762388|FG003|Overall Study|Lost to Follow-up|1|||
147163630|NCT00882908|530762389|FG004|Overall Study|Lost to Follow-up|2|||
147447620|NCT00623480|531803910|FG001|Overall Study|Protocol Violation|1|||
147589178|NCT00562120|532311598|FG003|First Intervention Period|Adverse Event|0|||
147589179|NCT00562120|532311595|FG000|First Intervention Period|Randomized but not Treated|1|||
147163631|NCT00882908|530762385|FG000|Overall Study|Protocol Violation|0|||
147163632|NCT00882908|530762386|FG001|Overall Study|Protocol Violation|1|||
147163633|NCT00882908|530762387|FG002|Overall Study|Protocol Violation|0|||
147163634|NCT00882908|530762388|FG003|Overall Study|Protocol Violation|0|||
147163635|NCT00882908|530762389|FG004|Overall Study|Protocol Violation|0|||
147163636|NCT00882908|530762385|FG000|Overall Study|Withdrawal by Subject|0|||
147163637|NCT00882908|530762386|FG001|Overall Study|Withdrawal by Subject|0|||
147163638|NCT00882908|530762387|FG002|Overall Study|Withdrawal by Subject|3|||
147163639|NCT00882908|530762388|FG003|Overall Study|Withdrawal by Subject|5|||
147163640|NCT00882908|530762389|FG004|Overall Study|Withdrawal by Subject|2|||
147163641|NCT00882908|530762385|FG000|Overall Study|Subject reached a virologic endpoint|0|||
147163642|NCT00882908|530762386|FG001|Overall Study|Subject reached a virologic endpoint|0|||
147163643|NCT00882908|530762387|FG002|Overall Study|Subject reached a virologic endpoint|0|||
147163644|NCT00882908|530762388|FG003|Overall Study|Subject reached a virologic endpoint|0|||
147163645|NCT00882908|530762389|FG004|Overall Study|Subject reached a virologic endpoint|1|||
147163646|NCT00882908|530762385|FG000|Overall Study|Study terminated in error|0|||
147163647|NCT00882908|530762386|FG001|Overall Study|Study terminated in error|0|||
147163648|NCT00882908|530762387|FG002|Overall Study|Study terminated in error|0|||
147163649|NCT00882908|530762388|FG003|Overall Study|Study terminated in error|1|||
147163650|NCT00882908|530762389|FG004|Overall Study|Study terminated in error|0|||
147163651|NCT01344629|530762391|FG000|Crossover Period 2|Withdrawal by Subject|0|||
147163652|NCT01344629|530762392|FG001|Crossover Period 2|Withdrawal by Subject|1|||
147163653|NCT05590000|530762396|FG000|Overall Study|The patient was indicated for peripheral nerve stimulation|1|||
147163654|NCT00762996|530762397|FG000|Period One|Protocol Violation|0|||
147163655|NCT00762996|530762398|FG001|Period One|Protocol Violation|0|||
147163656|NCT00762996|530762399|FG002|Period One|Protocol Violation|1|||
147163657|NCT00762996|530762400|FG003|Period One|Protocol Violation|0|||
147163658|NCT00762996|530762397|FG000|Period One|ineligible|0|||
147163659|NCT00762996|530762398|FG001|Period One|ineligible|0|||
147163660|NCT00762996|530762399|FG002|Period One|ineligible|1|||
147163661|NCT00762996|530762400|FG003|Period One|ineligible|1|||
147163662|NCT00762996|530762397|FG000|Period One|Adverse Event|0|||
147163663|NCT00762996|530762398|FG001|Period One|Adverse Event|0|||
147163664|NCT00762996|530762399|FG002|Period One|Adverse Event|1|||
147163665|NCT00762996|530762400|FG003|Period One|Adverse Event|0|||
147163666|NCT00762996|530762397|FG000|Period One|Withdrawal by Subject|0|||
147163667|NCT00762996|530762398|FG001|Period One|Withdrawal by Subject|0|||
147163668|NCT00762996|530762399|FG002|Period One|Withdrawal by Subject|1|||
147163669|NCT00762996|530762400|FG003|Period One|Withdrawal by Subject|0|||
147163670|NCT02689076|530762403|FG000|Overall Study|Did not have a non-VA encounter during study period (includes death before a non-VA encounter)|172|||
147163671|NCT02689076|530762404|FG001|Overall Study|Did not have a non-VA encounter during study period (includes death before a non-VA encounter)|213|||
147163672|NCT02689076|530762405|FG002|Overall Study|Did not have a non-VA encounter during study period (includes death before a non-VA encounter)|0|||
147163673|NCT02689076|530762403|FG000|Overall Study|Discharged from non-VA facility to long-term care facility for an indefinite period|3|||
147163674|NCT02689076|530762404|FG001|Overall Study|Discharged from non-VA facility to long-term care facility for an indefinite period|1|||
147163675|NCT02689076|530762405|FG002|Overall Study|Discharged from non-VA facility to long-term care facility for an indefinite period|0|||
147163676|NCT02689076|530762403|FG000|Overall Study|Did not have an HIE match|2|||
147589180|NCT00562120|532311596|FG001|First Intervention Period|Randomized but not Treated|0|||
147589181|NCT00562120|532311597|FG002|First Intervention Period|Randomized but not Treated|0|||
147589182|NCT00562120|532311598|FG003|First Intervention Period|Randomized but not Treated|0|||
147589183|NCT02148445|532311599|FG000|Overall Study|Death|1|||
147589184|NCT02148445|532311600|FG001|Overall Study|Death|3|||
147589185|NCT03450629|532311601|FG000|Overall Study|Adverse Event|15|||
147589186|NCT03450629|532311602|FG001|Overall Study|Adverse Event|14|||
147589187|NCT03450629|532311601|FG000|Overall Study|Physician Decision|2|||
147589188|NCT03450629|532311602|FG001|Overall Study|Physician Decision|2|||
147589189|NCT03450629|532311601|FG000|Overall Study|Lack of Efficacy|2|||
147654554|NCT02348008|532556765|FG001|Overall Study|Withdrawal by Subject|1|||
147654555|NCT02348008|532556766|FG002|Overall Study|Withdrawal by Subject|0|||
147654556|NCT02348008|532556764|FG000|Overall Study|Symptomatic Deterioration|0|||
147654557|NCT02348008|532556765|FG001|Overall Study|Symptomatic Deterioration|1|||
147163677|NCT02689076|530762404|FG001|Overall Study|Did not have an HIE match|0|||
147163678|NCT02689076|530762405|FG002|Overall Study|Did not have an HIE match|0|||
147163679|NCT02689076|530762403|FG000|Overall Study|Death during non-VA encounter|2|||
147243110|NCT02801396|531062019|FG000|Period 1|Withdrawal by Subject|0|||
147243111|NCT02801396|531062020|FG001|Period 1|Withdrawal by Subject|0|||
147243112|NCT02801396|531062021|FG002|Period 1|Withdrawal by Subject|0|||
147243113|NCT02801396|531062022|FG003|Period 1|Withdrawal by Subject|0|||
147243114|NCT02801396|531062023|FG004|Period 1|Withdrawal by Subject|1|||
147589190|NCT03450629|532311602|FG001|Overall Study|Lack of Efficacy|0|||
147589191|NCT03450629|532311601|FG000|Overall Study|Lost to Follow-up|4|||
147589192|NCT03450629|532311602|FG001|Overall Study|Lost to Follow-up|2|||
147654558|NCT02348008|532556766|FG002|Overall Study|Symptomatic Deterioration|0|||
147163680|NCT02689076|530762404|FG001|Overall Study|Death during non-VA encounter|5|||
147163681|NCT02689076|530762405|FG002|Overall Study|Death during non-VA encounter|0|||
147163682|NCT02689076|530762403|FG000|Overall Study|Provider declined to participate after participant assignment|1|||
147163683|NCT02689076|530762404|FG001|Overall Study|Provider declined to participate after participant assignment|1|||
147163684|NCT02689076|530762405|FG002|Overall Study|Provider declined to participate after participant assignment|0|||
147163685|NCT02689076|530762403|FG000|Overall Study|Participant no longer active in VA system|1|||
147163686|NCT02689076|530762404|FG001|Overall Study|Participant no longer active in VA system|0|||
147163687|NCT02689076|530762405|FG002|Overall Study|Participant no longer active in VA system|0|||
147163688|NCT02689076|530762403|FG000|Overall Study|Enrolled in GRACE or hospice during non-VA encounter|0|||
147163689|NCT02689076|530762404|FG001|Overall Study|Enrolled in GRACE or hospice during non-VA encounter|2|||
147163690|NCT02689076|530762405|FG002|Overall Study|Enrolled in GRACE or hospice during non-VA encounter|0|||
147163691|NCT04063787|530762411|FG000|Overall Study|Inadequate Doppler data|4|||
147163692|NCT04063787|530762411|FG000|Overall Study|Lost to Follow-up|2|||
147163693|NCT04063787|530762411|FG000|Overall Study|Death|3|||
147163694|NCT01816906|530762412|FG000|Six Months|Did Not Show Up for Baseline Measurement|7|||
147163695|NCT01816906|530762413|FG001|Six Months|Did Not Show Up for Baseline Measurement|6|||
147163696|NCT01816906|530762412|FG000|Six Months|Lost to Follow-up|14|||
147163697|NCT01816906|530762413|FG001|Six Months|Lost to Follow-up|16|||
147163698|NCT01816906|530762412|FG000|12 Months|Adverse Event|2|||
147163699|NCT01816906|530762413|FG001|12 Months|Adverse Event|2|||
147163700|NCT01816906|530762412|FG000|12 Months|Death|0|||
147163701|NCT01816906|530762413|FG001|12 Months|Death|2|||
147163702|NCT01816906|530762412|FG000|12 Months|Lost to Follow-up|2|||
147163703|NCT01816906|530762413|FG001|12 Months|Lost to Follow-up|1|||
147163704|NCT00746733|530762414|FG000|Second Intervention|Adverse Event|1|||
147163705|NCT00746733|530762415|FG001|Second Intervention|Adverse Event|0|||
147163706|NCT00746733|530762414|FG000|Third Intervention|Withdrawal by Subject|1|||
147163707|NCT00746733|530762415|FG001|Third Intervention|Withdrawal by Subject|1|||
147163708|NCT01527383|530762416|FG000|Overall Study|Adverse Event|5|||
147163709|NCT01527383|530762417|FG001|Overall Study|Adverse Event|0|||
147163710|NCT01527383|530762416|FG000|Overall Study|Lost to Follow-up|3|||
147163711|NCT01527383|530762417|FG001|Overall Study|Lost to Follow-up|0|||
147163712|NCT01527383|530762416|FG000|Overall Study|Physician Decision|2|||
147163713|NCT01527383|530762417|FG001|Overall Study|Physician Decision|0|||
147654559|NCT03268005|532556771|FG000|Overall Study|Death|2|||
147654560|NCT03268005|532556772|FG001|Overall Study|Death|1|||
147654561|NCT03268005|532556771|FG000|Overall Study|Lost to Follow-up|2|||
147163714|NCT01527383|530762416|FG000|Overall Study|Pregnancy|1|||
147163715|NCT01527383|530762417|FG001|Overall Study|Pregnancy|0|||
147163716|NCT01527383|530762416|FG000|Overall Study|Protocol Violation|1|||
147163717|NCT01527383|530762417|FG001|Overall Study|Protocol Violation|0|||
147163718|NCT01527383|530762416|FG000|Overall Study|Screen failure|1|||
147163719|NCT01527383|530762417|FG001|Overall Study|Screen failure|0|||
147163720|NCT01527383|530762416|FG000|Overall Study|Participant moved|0|||
147163721|NCT01527383|530762417|FG001|Overall Study|Participant moved|1|||
147163722|NCT01527383|530762416|FG000|Overall Study|Withdrawal by Subject|2|||
147163723|NCT01527383|530762417|FG001|Overall Study|Withdrawal by Subject|3|||
147163724|NCT02558400|530762421|FG000|Overall Study|Adverse Event|47|||
147163725|NCT02558400|530762422|FG001|Overall Study|Adverse Event|53|||
147163726|NCT02558400|530762423|FG002|Overall Study|Adverse Event|4|||
147163727|NCT02558400|530762421|FG000|Overall Study|Withdrawal by Subject|13|||
147163728|NCT02558400|530762422|FG001|Overall Study|Withdrawal by Subject|9|||
147163729|NCT02558400|530762423|FG002|Overall Study|Withdrawal by Subject|8|||
147163730|NCT02558400|530762421|FG000|Overall Study|Non-Compliant|0|||
147163731|NCT02558400|530762422|FG001|Overall Study|Non-Compliant|1|||
147163732|NCT02558400|530762423|FG002|Overall Study|Non-Compliant|3|||
147163733|NCT02558400|530762421|FG000|Overall Study|Lost to Follow-up|5|||
147163734|NCT02558400|530762422|FG001|Overall Study|Lost to Follow-up|5|||
147163735|NCT02558400|530762423|FG002|Overall Study|Lost to Follow-up|4|||
147163736|NCT02558400|530762421|FG000|Overall Study|Lack of Efficacy|0|||
147163737|NCT02558400|530762422|FG001|Overall Study|Lack of Efficacy|13|||
147163738|NCT02558400|530762423|FG002|Overall Study|Lack of Efficacy|1|||
147163739|NCT02558400|530762421|FG000|Overall Study|Disallowed Concurrent Medication|6|||
147163740|NCT02558400|530762422|FG001|Overall Study|Disallowed Concurrent Medication|7|||
147163741|NCT02558400|530762423|FG002|Overall Study|Disallowed Concurrent Medication|5|||
147163742|NCT02558400|530762421|FG000|Overall Study|Physician Decision|2|||
147163743|NCT02558400|530762422|FG001|Overall Study|Physician Decision|2|||
147163744|NCT02558400|530762423|FG002|Overall Study|Physician Decision|0|||
147163745|NCT02558400|530762421|FG000|Overall Study|Protocol Violation|6|||
147163746|NCT02558400|530762422|FG001|Overall Study|Protocol Violation|3|||
147163747|NCT02558400|530762423|FG002|Overall Study|Protocol Violation|8|||
147163748|NCT02558400|530762421|FG000|Overall Study|Death|0|||
147163749|NCT02558400|530762422|FG001|Overall Study|Death|1|||
147163750|NCT02558400|530762423|FG002|Overall Study|Death|0|||
147163751|NCT02558400|530762421|FG000|Overall Study|Ineligible for the study|0|||
147654562|NCT03268005|532556772|FG001|Overall Study|Lost to Follow-up|2|||
147447621|NCT00623480|531803909|FG000|Overall Study|Site closed by sponsor|0|||
147447622|NCT00623480|531803910|FG001|Overall Study|Site closed by sponsor|1|||
147447623|NCT03551509|531803911|FG000|Overall Study|Lost to Follow-up|0|||
147447624|NCT03551509|531803912|FG001|Overall Study|Lost to Follow-up|1|||
147447625|NCT03551509|531803913|FG002|Overall Study|Lost to Follow-up|0|||
147447626|NCT01594853|531803914|FG000|Overall Study|Withdrawal by Subject|1|||
147447627|NCT01594853|531803915|FG001|Overall Study|Withdrawal by Subject|1|||
147447628|NCT01594853|531803914|FG000|Overall Study|Lost to Follow-up|1|||
147447629|NCT01594853|531803915|FG001|Overall Study|Lost to Follow-up|1|||
147447630|NCT01594853|531803914|FG000|Overall Study|noncompliance with exercise|0|||
147447631|NCT01594853|531803915|FG001|Overall Study|noncompliance with exercise|1|||
147447632|NCT02631200|531803918|FG000|First Period|Death|1|||
147447633|NCT02631200|531803919|FG001|First Period|Death|2|||
147447634|NCT02631200|531803918|FG000|First Period|Patient ill-health|2|||
147447635|NCT02631200|531803919|FG001|First Period|Patient ill-health|4|||
147447636|NCT02631200|531803918|FG000|First Period|Withdrawal by Subject|4|||
147447637|NCT02631200|531803919|FG001|First Period|Withdrawal by Subject|1|||
147654563|NCT03268005|532556771|FG000|Overall Study|Withdrawal by Subject|11|||
147654564|NCT03268005|532556772|FG001|Overall Study|Withdrawal by Subject|11|||
147163752|NCT02558400|530762422|FG001|Overall Study|Ineligible for the study|2|||
147163753|NCT02558400|530762423|FG002|Overall Study|Ineligible for the study|0|||
147163754|NCT00456599|530762424|FG000|Overall Study|Non-compliance|1|||
147163755|NCT00456599|530762424|FG000|Overall Study|Withdrawal by Subject|2|||
147163756|NCT02191605|530764419|FG000|Overall Study|Lost to Follow-up|9|||
147163757|NCT02191605|530764420|FG001|Overall Study|Lost to Follow-up|4|||
147163758|NCT02191605|530764421|FG002|Overall Study|Lost to Follow-up|7|||
147163759|NCT02191605|530764422|FG003|Overall Study|Lost to Follow-up|3|||
147163760|NCT02191605|530764423|FG004|Overall Study|Lost to Follow-up|4|||
147163761|NCT00734071|530764424|FG000|Overall Study|Adverse Event|4|||
147163762|NCT00734071|530764425|FG001|Overall Study|Adverse Event|3|||
147163763|NCT00734071|530764424|FG000|Overall Study|Lack of Efficacy|3|||
147163764|NCT00734071|530764425|FG001|Overall Study|Lack of Efficacy|1|||
147163765|NCT00734071|530764424|FG000|Overall Study|Noncompliance|2|||
147163766|NCT00734071|530764425|FG001|Overall Study|Noncompliance|2|||
147163767|NCT00734071|530764424|FG000|Overall Study|Protocol Deviations|3|||
147163768|NCT00734071|530764425|FG001|Overall Study|Protocol Deviations|4|||
147163769|NCT00734071|530764424|FG000|Overall Study|Voluntary Withdrawal|9|||
147163770|NCT00734071|530764425|FG001|Overall Study|Voluntary Withdrawal|7|||
147163771|NCT00734071|530764424|FG000|Overall Study|Lost to Follow-up|16|||
147163772|NCT00734071|530764425|FG001|Overall Study|Lost to Follow-up|8|||
147163773|NCT00734071|530764424|FG000|Overall Study|Other|1|||
147163774|NCT00734071|530764425|FG001|Overall Study|Other|2|||
147163775|NCT05275582|530764426|FG000|Overall Study|Lost to Follow-up|1|||
147163776|NCT05275582|530764427|FG001|Overall Study|Lost to Follow-up|0|||
147163777|NCT05275582|530764426|FG000|Overall Study|Withdrawal by Subject|0|||
147163778|NCT05275582|530764427|FG001|Overall Study|Withdrawal by Subject|2|||
147163779|NCT05275582|530764426|FG000|Overall Study|Did not/could not complete primary care appointment for various reasons|4|||
147163780|NCT05275582|530764427|FG001|Overall Study|Did not/could not complete primary care appointment for various reasons|0|||
147163781|NCT05275582|530764426|FG000|Overall Study|Death|1|||
147163782|NCT05275582|530764427|FG001|Overall Study|Death|0|||
147163783|NCT05275582|530764426|FG000|Overall Study|Protocol Violation|1|||
147163784|NCT05275582|530764427|FG001|Overall Study|Protocol Violation|0|||
147654565|NCT00248833|532556773|FG000|Overall Study|Adverse Event|2|||
147654566|NCT00248833|532556774|FG001|Overall Study|Adverse Event|0|||
147654567|NCT00248833|532556775|FG002|Overall Study|Adverse Event|0|||
147163785|NCT00240110|530764428|FG000|Overall Study|Lost to Follow-up|6|||
147163786|NCT00240110|530764429|FG001|Overall Study|Lost to Follow-up|7|||
147163787|NCT00203021|530764430|FG000|Overall Study|Death|4|||
147163788|NCT00203021|530764431|FG001|Overall Study|Death|1|||
147163789|NCT00203021|530764430|FG000|Overall Study|Adverse Event|10|||
147163790|NCT00203021|530764431|FG001|Overall Study|Adverse Event|5|||
147163791|NCT00203021|530764430|FG000|Overall Study|Withdrawal by Subject|45|||
147163792|NCT00203021|530764431|FG001|Overall Study|Withdrawal by Subject|48|||
147447638|NCT02631200|531803918|FG000|Deferred Period|Death|0|||
147447639|NCT02631200|531803919|FG001|Deferred Period|Death|1|||
147447640|NCT02631200|531803918|FG000|Deferred Period|Received kidney transplant|0|||
147447641|NCT02631200|531803919|FG001|Deferred Period|Received kidney transplant|1|||
147447642|NCT02631200|531803918|FG000|Deferred Period|Withdrawal by Subject|0|||
147447643|NCT02631200|531803919|FG001|Deferred Period|Withdrawal by Subject|2|||
147447644|NCT02631200|531803918|FG000|Deferred Period|Lost to Follow-up|0|||
147163793|NCT00203021|530764430|FG000|Overall Study|Lost to Follow-up|9|||
147163794|NCT00203021|530764431|FG001|Overall Study|Lost to Follow-up|7|||
147163795|NCT00203021|530764430|FG000|Overall Study|Other than specified|11|||
147163796|NCT00203021|530764431|FG001|Overall Study|Other than specified|16|||
147163797|NCT02080260|530764432|FG000|Overall Study|Death|18|||
147163798|NCT02080260|530764432|FG000|Overall Study|Withdrawal by Subject|1|||
147447645|NCT02631200|531803919|FG001|Deferred Period|Lost to Follow-up|1|||
147654568|NCT00248833|532556773|FG000|Overall Study|Withdrawal by Subject|0|||
147654569|NCT00248833|532556774|FG001|Overall Study|Withdrawal by Subject|1|||
147589193|NCT03450629|532311601|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
147589194|NCT03450629|532311602|FG001|Overall Study|No Longer Meets Eligibility Criteria|1|||
147589195|NCT03450629|532311601|FG000|Overall Study|Non-Compliance With Study Drug|2|||
147589196|NCT03450629|532311602|FG001|Overall Study|Non-Compliance With Study Drug|1|||
147589197|NCT03450629|532311601|FG000|Overall Study|Protocol Violation|11|||
147589198|NCT03450629|532311602|FG001|Overall Study|Protocol Violation|8|||
147589199|NCT03450629|532311601|FG000|Overall Study|Withdrawal by Subject|12|||
147589200|NCT03450629|532311602|FG001|Overall Study|Withdrawal by Subject|6|||
147589201|NCT03438006|532311603|FG000|Overall Study|Adverse Event|1|||
147589202|NCT03438006|532311603|FG000|Overall Study|Lost to Follow-up|67|||
147589203|NCT03438006|532311603|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|47|||
147589204|NCT03438006|532311603|FG000|Overall Study|NOT WILLING / NOT ABLE TO BE CONTACTED|3|||
147589205|NCT01181531|532311614|FG000|Overall Study|Other|17|||
147589206|NCT01181531|532311615|FG001|Overall Study|Other|12|||
147589207|NCT01181531|532311614|FG000|Overall Study|Partial consent by subject withdrawn|0|||
147589208|NCT01181531|532311615|FG001|Overall Study|Partial consent by subject withdrawn|1|||
147589209|NCT01181531|532311614|FG000|Overall Study|Physician Decision|3|||
147589210|NCT01181531|532311615|FG001|Overall Study|Physician Decision|1|||
147589211|NCT01181531|532311614|FG000|Overall Study|Noncompliance|2|||
147589212|NCT01181531|532311615|FG001|Overall Study|Noncompliance|2|||
147589213|NCT01181531|532311614|FG000|Overall Study|Ineligibility determined|1|||
147589214|NCT01181531|532311615|FG001|Overall Study|Ineligibility determined|2|||
147589215|NCT01181531|532311614|FG000|Overall Study|Protocol Specified Criteria|15|||
147589216|NCT01181531|532311615|FG001|Overall Study|Protocol Specified Criteria|8|||
147589217|NCT01181531|532311614|FG000|Overall Study|Pregnancy|0|||
147589218|NCT01181531|532311615|FG001|Overall Study|Pregnancy|1|||
147589219|NCT01181531|532311614|FG000|Overall Study|Withdrawal by Subject|8|||
147589220|NCT01181531|532311615|FG001|Overall Study|Withdrawal by Subject|7|||
147589221|NCT01181531|532311614|FG000|Overall Study|Protocol Violation|6|||
147589222|NCT01181531|532311615|FG001|Overall Study|Protocol Violation|6|||
147589223|NCT01181531|532311614|FG000|Overall Study|Death|9|||
147589224|NCT01181531|532311615|FG001|Overall Study|Death|12|||
147589225|NCT01181531|532311614|FG000|Overall Study|Adverse Event|0|||
147589226|NCT01181531|532311615|FG001|Overall Study|Adverse Event|1|||
147323108|NCT03008122|531347904|FG002|Overall Study|Death|1|||
147323109|NCT02338609|531347906|FG000|Overall Study|Physician Decision|1|||
147323110|NCT02338609|531347906|FG000|Overall Study|Death|1|||
147323111|NCT04736056|531347908|FG000|Overall Study|Death|0|||
147323112|NCT04736056|531347909|FG001|Overall Study|Death|0|||
147323113|NCT04736056|531347910|FG002|Overall Study|Death|0|||
147323114|NCT04736056|531347911|FG003|Overall Study|Death|1|||
147323115|NCT04736056|531347908|FG000|Overall Study|Lost to Follow-up|1|||
147323116|NCT04736056|531347909|FG001|Overall Study|Lost to Follow-up|0|||
147323117|NCT04736056|531347910|FG002|Overall Study|Lost to Follow-up|1|||
147323118|NCT04736056|531347911|FG003|Overall Study|Lost to Follow-up|1|||
147323119|NCT04736056|531347908|FG000|Overall Study|Withdrawal by Subject|2|||
147323120|NCT04736056|531347909|FG001|Overall Study|Withdrawal by Subject|0|||
147323121|NCT04736056|531347910|FG002|Overall Study|Withdrawal by Subject|0|||
147323122|NCT04736056|531347911|FG003|Overall Study|Withdrawal by Subject|0|||
147323123|NCT04736056|531347908|FG000|Overall Study|Physician Decision|1|||
147589227|NCT00955721|532311618|FG000|Overall Study|Physician Decision|1|||
147589228|NCT00955721|532311619|FG001|Overall Study|Physician Decision|0|||
147589229|NCT00955721|532311618|FG000|Overall Study|Death|1|||
147589230|NCT00955721|532311619|FG001|Overall Study|Death|0|||
147589231|NCT00955721|532311618|FG000|Overall Study|Withdrawal by Subject|1|||
147589232|NCT00955721|532311619|FG001|Overall Study|Withdrawal by Subject|0|||
147589233|NCT01253317|532311625|FG000|Overall Study|Adverse Event|2|||
147589234|NCT04034355|532311628|FG000|Overall Study|Study terminated by Sponsor|10|||
147589235|NCT04034355|532311629|FG001|Overall Study|Study terminated by Sponsor|17|||
147589236|NCT04034355|532311628|FG000|Overall Study|Withdrawal by Subject|12|||
147323124|NCT04736056|531347909|FG001|Overall Study|Physician Decision|0|||
147589237|NCT04034355|532311629|FG001|Overall Study|Withdrawal by Subject|11|||
147589238|NCT04034355|532311628|FG000|Overall Study|Site terminated by Sponsor|4|||
147589239|NCT04034355|532311629|FG001|Overall Study|Site terminated by Sponsor|5|||
147589240|NCT04034355|532311628|FG000|Overall Study|Adverse Event|2|||
147589241|NCT04034355|532311629|FG001|Overall Study|Adverse Event|0|||
147323125|NCT04736056|531347910|FG002|Overall Study|Physician Decision|1|||
147323126|NCT04736056|531347911|FG003|Overall Study|Physician Decision|0|||
147323127|NCT02148718|531347912|FG000|Overall Study|Protocol Violation|26|||
147323128|NCT02148718|531347912|FG000|Overall Study|Discontinued Study Prematurely|5|||
147589242|NCT04034355|532311628|FG000|Overall Study|Death|1|||
147589243|NCT04034355|532311629|FG001|Overall Study|Death|1|||
147323129|NCT03289455|531347913|FG000|Overall Study|Death|1|||
147163799|NCT03204890|530764437|FG000|Overall Study|Withdrawal by Subject|1|||
147323130|NCT03289455|531347914|FG001|Overall Study|Death|0|||
147589244|NCT04034355|532311628|FG000|Overall Study|Not reported|2|||
147589245|NCT04034355|532311629|FG001|Overall Study|Not reported|0|||
147589246|NCT04034355|532311628|FG000|Overall Study|Lost to Follow-up|1|||
147589247|NCT04034355|532311629|FG001|Overall Study|Lost to Follow-up|0|||
147589248|NCT04034355|532311628|FG000|Overall Study|Physician Decision|1|||
147589249|NCT04034355|532311629|FG001|Overall Study|Physician Decision|0|||
147589250|NCT04034355|532311628|FG000|Overall Study|Protocol Violation|0|||
147589251|NCT04034355|532311629|FG001|Overall Study|Protocol Violation|1|||
147589252|NCT04034355|532311628|FG000|Overall Study|Progressive disease|1|||
147589253|NCT04034355|532311629|FG001|Overall Study|Progressive disease|0|||
147595961|NCT01875471|532338757|FG001|Overall Study|Unsatisfactory Lens Fitting|0|||
147595962|NCT01321008|532338758|FG000|Overall Study|Early Study Termination|1|||
147595963|NCT02749292|532338762|FG000|Overall Study|Physician Decision|1|||
147595964|NCT02749292|532338763|FG001|Overall Study|Physician Decision|0|||
147595965|NCT02749292|532338762|FG000|Overall Study|Withdrawal by Subject|5|||
147595966|NCT02749292|532338763|FG001|Overall Study|Withdrawal by Subject|7|||
147595967|NCT02749292|532338762|FG000|Overall Study|Minor relapse, BVAS-WG = 2|1|||
147595968|NCT02749292|532338763|FG001|Overall Study|Minor relapse, BVAS-WG = 2|7|||
147163800|NCT03747120|530764438|FG000|Overall Study|treatment related toxicity|3|||
147163801|NCT03747120|530764439|FG001|Overall Study|treatment related toxicity|0|||
147163802|NCT03747120|530764440|FG002|Overall Study|treatment related toxicity|0|||
147595969|NCT02749292|532338762|FG000|Overall Study|Major relapse without ILD, BVAS-WG ≥ 3|2|||
147595970|NCT02749292|532338763|FG001|Overall Study|Major relapse without ILD, BVAS-WG ≥ 3|4|||
147595971|NCT02749292|532338762|FG000|Overall Study|Major relapse with ILD, BVAS-WG ≥ 3|2|||
147595972|NCT02749292|532338763|FG001|Overall Study|Major relapse with ILD, BVAS-WG ≥ 3|3|||
147163803|NCT03747120|530764438|FG000|Overall Study|Withdrawal by Subject|0|||
147163804|NCT03747120|530764439|FG001|Overall Study|Withdrawal by Subject|1|||
147163805|NCT03747120|530764440|FG002|Overall Study|Withdrawal by Subject|2|||
147595973|NCT02749292|532338762|FG000|Overall Study|Adverse Event|4|||
147595974|NCT02749292|532338763|FG001|Overall Study|Adverse Event|1|||
147595975|NCT02749292|532338762|FG000|Overall Study|Serious Adverse Event, Related, infection, COVID-19, with death|2|||
147595976|NCT02749292|532338763|FG001|Overall Study|Serious Adverse Event, Related, infection, COVID-19, with death|0|||
147595977|NCT02749292|532338762|FG000|Overall Study|Serious Adverse Event, Related, infection, COVID-19, without death|4|||
147595978|NCT02749292|532338763|FG001|Overall Study|Serious Adverse Event, Related, infection, COVID-19, without death|1|||
147595979|NCT02749292|532338762|FG000|Overall Study|Requiring glucocorticoids|0|||
147595980|NCT02749292|532338763|FG001|Overall Study|Requiring glucocorticoids|3|||
147595981|NCT02749292|532338762|FG000|Overall Study|Cancer|1|||
147595982|NCT02749292|532338763|FG001|Overall Study|Cancer|0|||
147595983|NCT01843348|532338764|FG000|Overall Study|Withdrawal by Subject|4|||
147595984|NCT01843348|532338765|FG001|Overall Study|Withdrawal by Subject|16|||
147595985|NCT01843348|532338766|FG002|Overall Study|Withdrawal by Subject|18|||
147595986|NCT01843348|532338764|FG000|Overall Study|Lost to Follow-up|5|||
147595987|NCT01843348|532338765|FG001|Overall Study|Lost to Follow-up|4|||
147595988|NCT01843348|532338766|FG002|Overall Study|Lost to Follow-up|2|||
147595989|NCT01843348|532338764|FG000|Overall Study|Death|5|||
147595990|NCT01843348|532338765|FG001|Overall Study|Death|3|||
147595991|NCT01843348|532338766|FG002|Overall Study|Death|4|||
147595992|NCT01843348|532338764|FG000|Overall Study|Graft loss/retransplantation|5|||
147595993|NCT01843348|532338765|FG001|Overall Study|Graft loss/retransplantation|8|||
147595994|NCT01843348|532338766|FG002|Overall Study|Graft loss/retransplantation|11|||
147595995|NCT01843348|532338764|FG000|Overall Study|Various reasons|4|||
147595996|NCT01843348|532338765|FG001|Overall Study|Various reasons|9|||
147595997|NCT01843348|532338766|FG002|Overall Study|Various reasons|6|||
147163806|NCT03627065|530764441|FG000|Overall Study|Study Terminated by sponsor|1|||
147163807|NCT03627065|530764441|FG000|Overall Study|Withdrawal by Subject|2|||
147163808|NCT01688739|530764442|FG000|Overall Study|Administrative Decision|1|||
147163809|NCT01688739|530764443|FG001|Overall Study|Administrative Decision|0|||
147163810|NCT01688739|530764444|FG002|Overall Study|Administrative Decision|0|||
147163811|NCT01688739|530764445|FG003|Overall Study|Administrative Decision|0|||
147163812|NCT01688739|530764446|FG004|Overall Study|Administrative Decision|0|||
147163813|NCT01688739|530764447|FG005|Overall Study|Administrative Decision|0|||
147163814|NCT01688739|530764448|FG006|Overall Study|Administrative Decision|0|||
147163815|NCT01688739|530764449|FG007|Overall Study|Administrative Decision|0|||
147163816|NCT01688739|530764450|FG008|Overall Study|Administrative Decision|0|||
147163817|NCT01688739|530764451|FG009|Overall Study|Administrative Decision|0|||
147163818|NCT00996801|530764452|FG000|Overall Study|Adverse Event|6|||
147163819|NCT00996801|530764453|FG001|Overall Study|Adverse Event|4|||
147163820|NCT00996801|530764454|FG002|Overall Study|Adverse Event|12|||
147163821|NCT00996801|530764455|FG003|Overall Study|Adverse Event|17|||
147163822|NCT00996801|530764456|FG004|Overall Study|Adverse Event|31|||
147163823|NCT00996801|530764457|FG005|Overall Study|Adverse Event|3|||
147163824|NCT00996801|530764452|FG000|Overall Study|Lack of Efficacy|3|||
147163825|NCT00996801|530764453|FG001|Overall Study|Lack of Efficacy|0|||
147163826|NCT00996801|530764454|FG002|Overall Study|Lack of Efficacy|1|||
147163827|NCT00996801|530764455|FG003|Overall Study|Lack of Efficacy|3|||
147163828|NCT00996801|530764456|FG004|Overall Study|Lack of Efficacy|0|||
147163829|NCT00996801|530764457|FG005|Overall Study|Lack of Efficacy|1|||
147163830|NCT00996801|530764452|FG000|Overall Study|Lost to Follow-up|0|||
147163831|NCT00996801|530764453|FG001|Overall Study|Lost to Follow-up|0|||
147595998|NCT00251641|532338767|FG000|Overall Study|Adverse Event|80|||
147163832|NCT00996801|530764454|FG002|Overall Study|Lost to Follow-up|0|||
147163833|NCT00996801|530764455|FG003|Overall Study|Lost to Follow-up|3|||
147163834|NCT00996801|530764456|FG004|Overall Study|Lost to Follow-up|3|||
147589254|NCT01552369|532313224|FG000|Overall Study|Did not consent to extended follow up|8|||
147589255|NCT01552369|532313225|FG001|Overall Study|Did not consent to extended follow up|9|||
147589256|NCT02999984|532313233|FG000|Overall Study|Treatment Failure|1|||
147163835|NCT00996801|530764457|FG005|Overall Study|Lost to Follow-up|2|||
147163836|NCT00996801|530764452|FG000|Overall Study|Physician Decision|0|||
147163837|NCT00996801|530764453|FG001|Overall Study|Physician Decision|0|||
147163838|NCT00996801|530764454|FG002|Overall Study|Physician Decision|0|||
147163839|NCT00996801|530764455|FG003|Overall Study|Physician Decision|1|||
147163840|NCT00996801|530764456|FG004|Overall Study|Physician Decision|0|||
147163841|NCT00996801|530764457|FG005|Overall Study|Physician Decision|0|||
147163842|NCT00996801|530764452|FG000|Overall Study|Progressive Disease|0|||
147163843|NCT00996801|530764453|FG001|Overall Study|Progressive Disease|1|||
147163844|NCT00996801|530764454|FG002|Overall Study|Progressive Disease|0|||
147323131|NCT03289455|531347915|FG002|Overall Study|Death|0|||
147323132|NCT03289455|531347913|FG000|Overall Study|Sponsor decision due to covid19 restrictions|0|||
147323133|NCT03289455|531347914|FG001|Overall Study|Sponsor decision due to covid19 restrictions|1|||
147323134|NCT03289455|531347915|FG002|Overall Study|Sponsor decision due to covid19 restrictions|0|||
147323135|NCT03289455|531347913|FG000|Overall Study|No CART persistence in MRD negativity. Patient proceeded with HSCT|0|||
147323136|NCT03289455|531347914|FG001|Overall Study|No CART persistence in MRD negativity. Patient proceeded with HSCT|0|||
147323137|NCT03289455|531347915|FG002|Overall Study|No CART persistence in MRD negativity. Patient proceeded with HSCT|1|||
147323138|NCT03289455|531347913|FG000|Overall Study|Progressive disease|3|||
147323139|NCT03289455|531347914|FG001|Overall Study|Progressive disease|4|||
147323140|NCT03289455|531347915|FG002|Overall Study|Progressive disease|5|||
147323141|NCT00333788|531347916|FG000|Overall Study|Adverse Event|44|||
147323142|NCT00333788|531347916|FG000|Overall Study|Lack of Efficacy|80|||
147323143|NCT00333788|531347916|FG000|Overall Study|Lost to Follow-up|2|||
147323144|NCT00333788|531347916|FG000|Overall Study|Withdrawal by Subject|24|||
147323145|NCT00333788|531347916|FG000|Overall Study|Other: Non-compliance|2|||
147323146|NCT00333788|531347916|FG000|Overall Study|Other: Moved|2|||
147323147|NCT00333788|531347916|FG000|Overall Study|Other: Recurrent squamaous cell cancer|1|||
147323148|NCT00333788|531347916|FG000|Overall Study|Other: Investigator decision|1|||
147323149|NCT00333788|531347916|FG000|Overall Study|Other: Quality of life concern|1|||
147323150|NCT00333788|531347916|FG000|Overall Study|Other: Sponsor decision|1|||
147323151|NCT00333788|531347916|FG000|Overall Study|Other: Subject in need of an Entocort|1|||
147323152|NCT00333788|531347916|FG000|Overall Study|Other: Medical monitor decision|1|||
147323153|NCT00333788|531347916|FG000|Overall Study|Other: Physician decision|1|||
147323154|NCT00333788|531347916|FG000|Overall Study|Other: Signed consent for another study|1|||
147323155|NCT02956967|531347920|FG000|Overall Study|Adverse Event|3|||
147323156|NCT02956967|531347920|FG000|Overall Study|Reason non-related to neutropenia|10|||
147323157|NCT02956967|531347920|FG000|Overall Study|Lost to Follow-up|5|||
147323158|NCT02956967|531347920|FG000|Overall Study|Missing|1|||
147323159|NCT02956967|531347920|FG000|Overall Study|Termination of Nivestim administration|29|||
147323160|NCT02322775|531347921|FG000|Overall Study|Adverse Event|1|||
147323161|NCT02322775|531347922|FG001|Overall Study|Adverse Event|0|||
147323162|NCT02322775|531347921|FG000|Overall Study|Lost to Follow-up|0|||
147323163|NCT02322775|531347922|FG001|Overall Study|Lost to Follow-up|1|||
147323164|NCT02322775|531347921|FG000|Overall Study|Protocol Violation|1|||
147323165|NCT02322775|531347922|FG001|Overall Study|Protocol Violation|0|||
147323166|NCT02322775|531347921|FG000|Overall Study|Withdrawal by Subject|3|||
147323167|NCT02322775|531347922|FG001|Overall Study|Withdrawal by Subject|4|||
147323168|NCT02322775|531347921|FG000|Overall Study|Not willing to perform all FU visits|0|||
147323169|NCT02322775|531347922|FG001|Overall Study|Not willing to perform all FU visits|1|||
147323170|NCT00819234|531347934|FG000|Overall Study|Withdrawal by Subject|8|||
147323171|NCT00819234|531347935|FG001|Overall Study|Withdrawal by Subject|13|||
147323172|NCT00819234|531347936|FG002|Overall Study|Withdrawal by Subject|6|||
147323173|NCT00819234|531347937|FG003|Overall Study|Withdrawal by Subject|3|||
147323174|NCT00819234|531347938|FG004|Overall Study|Withdrawal by Subject|0|||
147589257|NCT00754013|532313236|FG000|Overall Study|Lost to Follow-up|1|||
147163845|NCT00996801|530764455|FG003|Overall Study|Progressive Disease|0|||
147163846|NCT00996801|530764456|FG004|Overall Study|Progressive Disease|0|||
147323175|NCT00819234|531347939|FG005|Overall Study|Withdrawal by Subject|4|||
147323176|NCT00819234|531347940|FG006|Overall Study|Withdrawal by Subject|4|||
147323177|NCT00819234|531347941|FG007|Overall Study|Withdrawal by Subject|8|||
147323178|NCT00819234|531347942|FG008|Overall Study|Withdrawal by Subject|5|||
147323179|NCT00819234|531347943|FG009|Overall Study|Withdrawal by Subject|3|||
147323180|NCT00819234|531347934|FG000|Overall Study|Adverse Event|0|||
147323181|NCT00819234|531347935|FG001|Overall Study|Adverse Event|0|||
147163847|NCT00996801|530764457|FG005|Overall Study|Progressive Disease|0|||
147323182|NCT00819234|531347936|FG002|Overall Study|Adverse Event|1|||
147589258|NCT00754013|532313237|FG001|Overall Study|Lost to Follow-up|1|||
147163848|NCT00996801|530764452|FG000|Overall Study|Protocol Violation|3|||
147163849|NCT00996801|530764453|FG001|Overall Study|Protocol Violation|4|||
147589259|NCT00754013|532313236|FG000|Overall Study|didn't return after study termed|3|||
147163850|NCT00996801|530764454|FG002|Overall Study|Protocol Violation|1|||
147163851|NCT00996801|530764455|FG003|Overall Study|Protocol Violation|2|||
147163852|NCT00996801|530764456|FG004|Overall Study|Protocol Violation|3|||
147163853|NCT00996801|530764457|FG005|Overall Study|Protocol Violation|4|||
147163854|NCT00996801|530764452|FG000|Overall Study|Study Terminated by Sponsor|0|||
147163855|NCT00996801|530764453|FG001|Overall Study|Study Terminated by Sponsor|1|||
147163856|NCT00996801|530764454|FG002|Overall Study|Study Terminated by Sponsor|0|||
147163857|NCT00996801|530764455|FG003|Overall Study|Study Terminated by Sponsor|0|||
147163858|NCT00996801|530764456|FG004|Overall Study|Study Terminated by Sponsor|46|||
147163859|NCT00996801|530764457|FG005|Overall Study|Study Terminated by Sponsor|0|||
147589260|NCT00754013|532313237|FG001|Overall Study|didn't return after study termed|4|||
147589261|NCT04039919|532313238|FG000|Treatment Period 1|Withdrawal by Subject|1|||
147589262|NCT04039919|532313239|FG001|Treatment Period 1|Withdrawal by Subject|0|||
147589263|NCT04039919|532313240|FG002|Treatment Period 1|Withdrawal by Subject|0|||
147589264|NCT04039919|532313241|FG003|Treatment Period 1|Withdrawal by Subject|0|||
147163860|NCT00996801|530764452|FG000|Overall Study|Withdrawal by Subject|8|||
147163861|NCT00996801|530764453|FG001|Overall Study|Withdrawal by Subject|6|||
147163862|NCT00996801|530764454|FG002|Overall Study|Withdrawal by Subject|9|||
147163863|NCT00996801|530764455|FG003|Overall Study|Withdrawal by Subject|5|||
147163864|NCT00996801|530764456|FG004|Overall Study|Withdrawal by Subject|5|||
147163865|NCT00996801|530764457|FG005|Overall Study|Withdrawal by Subject|9|||
147163866|NCT00289198|530764458|FG000|Overall Study|Adverse Event|0|||
147163867|NCT00289198|530764459|FG001|Overall Study|Adverse Event|2|||
147163868|NCT00289198|530764458|FG000|Overall Study|Protocol Violation|2|||
147163869|NCT00289198|530764459|FG001|Overall Study|Protocol Violation|1|||
147163870|NCT00289198|530764458|FG000|Overall Study|Withdrawal by Subject|4|||
147163871|NCT00289198|530764459|FG001|Overall Study|Withdrawal by Subject|1|||
147163872|NCT00289198|530764458|FG000|Overall Study|Lack of Efficacy|2|||
147163873|NCT00289198|530764459|FG001|Overall Study|Lack of Efficacy|0|||
147163874|NCT00289198|530764458|FG000|Overall Study|Other: Low compliance|0|||
147163875|NCT00289198|530764459|FG001|Overall Study|Other: Low compliance|1|||
147163876|NCT00289198|530764458|FG000|Overall Study|Other: Physician's decision|0|||
147163877|NCT00289198|530764459|FG001|Overall Study|Other: Physician's decision|1|||
147163878|NCT00289198|530764458|FG000|Overall Study|Other: Unable to attend on schedule|2|||
147163879|NCT00289198|530764459|FG001|Overall Study|Other: Unable to attend on schedule|1|||
147163880|NCT00289198|530764458|FG000|Overall Study|Other: Miscalculation of the visit date|21|||
147163881|NCT00289198|530764459|FG001|Overall Study|Other: Miscalculation of the visit date|22|||
147163882|NCT00289198|530764458|FG000|Overall Study|Other: Impossible to come on visit|0|||
147163883|NCT00289198|530764459|FG001|Overall Study|Other: Impossible to come on visit|1|||
147163884|NCT03369431|530764460|FG000|Overall Study|Lost to Follow-up|1|||
147163885|NCT03369431|530764461|FG001|Overall Study|Lost to Follow-up|3|||
147163886|NCT03369431|530764460|FG000|Overall Study|Withdrawal by Subject|2|||
147163887|NCT03369431|530764461|FG001|Overall Study|Withdrawal by Subject|3|||
147163888|NCT03369431|530764460|FG000|Overall Study|Protocol Violation|1|||
147163889|NCT03369431|530764461|FG001|Overall Study|Protocol Violation|1|||
147163890|NCT01062061|530764462|FG000|Overall Study|Enrolled more than once|2|||
147163891|NCT01062061|530764462|FG000|Overall Study|Investigated before study start|13|||
147163892|NCT01062061|530764462|FG000|Overall Study|Outside chief indications|10|||
147163893|NCT01062061|530764462|FG000|Overall Study|Failed to meet inclusion criteria|2|||
147163894|NCT00490776|530764463|FG000|Overall Study|Withdrawal by Subject|1|||
147163895|NCT00490776|530764463|FG000|Overall Study|Administrative Problems|1|||
147163896|NCT00490776|530764463|FG000|Overall Study|Death|1|||
147163897|NCT00490776|530764463|FG000|Overall Study|New Cancer Therapy|1|||
147163898|NCT00490776|530764463|FG000|Overall Study|Disease Progression|5|||
147163899|NCT01113580|530764468|FG000|Overall Study|Protocol Violation|1|||
147163900|NCT01113580|530764469|FG001|Overall Study|Protocol Violation|0|||
147163901|NCT01145053|530764470|FG000|Overall Study|Adverse Event|22|||
147163902|NCT01145053|530764470|FG000|Overall Study|Lost to Follow-up|28|||
147163903|NCT01145053|530764470|FG000|Overall Study|Withdrawal by Subject|25|||
147163904|NCT01145053|530764470|FG000|Overall Study|Other|18|||
147163905|NCT02088073|530764471|FG000|Acute Phase|Withdrawal by Subject|5|||
147163906|NCT02088073|530764472|FG001|Acute Phase|Withdrawal by Subject|0|||
147163907|NCT02088073|530764473|FG002|Acute Phase|Withdrawal by Subject|0|||
147163908|NCT02088073|530764474|FG003|Acute Phase|Withdrawal by Subject|0|||
147163909|NCT02088073|530764475|FG004|Acute Phase|Withdrawal by Subject|0|||
147243115|NCT02801396|531062024|FG005|Period 1|Withdrawal by Subject|0|||
147589265|NCT04039919|532313242|FG004|Treatment Period 1|Withdrawal by Subject|0|||
147163910|NCT02088073|530764471|FG000|Acute Phase|Hyperkalemia|2|||
147163911|NCT02088073|530764472|FG001|Acute Phase|Hyperkalemia|0|||
147163912|NCT02088073|530764473|FG002|Acute Phase|Hyperkalemia|0|||
147163913|NCT02088073|530764474|FG003|Acute Phase|Hyperkalemia|0|||
147163914|NCT02088073|530764475|FG004|Acute Phase|Hyperkalemia|0|||
147163915|NCT02088073|530764471|FG000|Maintanance Phase|Withdrawal by Subject|0|||
147163916|NCT02088073|530764472|FG001|Maintanance Phase|Withdrawal by Subject|2|||
147243116|NCT03310021|531062029|FG000|Overall Study|Withdrawal by Subject|0|||
147589266|NCT04039919|532313238|FG000|Treatment Period 1|Sponsor's decision|0|||
147589267|NCT04039919|532313239|FG001|Treatment Period 1|Sponsor's decision|0|||
147589268|NCT04039919|532313240|FG002|Treatment Period 1|Sponsor's decision|0|||
147589269|NCT04039919|532313241|FG003|Treatment Period 1|Sponsor's decision|0|||
147589270|NCT04039919|532313242|FG004|Treatment Period 1|Sponsor's decision|16|||
147589271|NCT04039919|532313238|FG000|Treatment Period 5|Withdrawal by Subject|1|||
147589272|NCT04039919|532313239|FG001|Treatment Period 5|Withdrawal by Subject|0|||
147589273|NCT04039919|532313240|FG002|Treatment Period 5|Withdrawal by Subject|0|||
147589274|NCT04039919|532313241|FG003|Treatment Period 5|Withdrawal by Subject|0|||
147589275|NCT04039919|532313242|FG004|Treatment Period 5|Withdrawal by Subject|0|||
147589276|NCT02310789|532313243|FG000|Overall Study|Adverse Event|1|||
147589277|NCT01197417|532313244|FG000|Overall Study|Physician Decision|3|||
147589278|NCT01197417|532313245|FG001|Overall Study|Physician Decision|2|||
147589279|NCT01197417|532313244|FG000|Overall Study|Withdrawal by Subject|2|||
147589280|NCT01197417|532313245|FG001|Overall Study|Withdrawal by Subject|4|||
147589281|NCT01197417|532313244|FG000|Overall Study|Site miscommunication|0|||
147589282|NCT01197417|532313245|FG001|Overall Study|Site miscommunication|1|||
147589283|NCT01197417|532313244|FG000|Overall Study|Subject transferred to intensive care|0|||
147589284|NCT01197417|532313245|FG001|Overall Study|Subject transferred to intensive care|1|||
147589285|NCT01197417|532313244|FG000|Overall Study|Not consented in time to receive drug|0|||
147589286|NCT01197417|532313245|FG001|Overall Study|Not consented in time to receive drug|1|||
147589287|NCT01197417|532313244|FG000|Overall Study|Hypotension|1|||
147589288|NCT01197417|532313245|FG001|Overall Study|Hypotension|2|||
147589289|NCT01197417|532313244|FG000|Overall Study|Found to be ineligible|2|||
147589290|NCT01197417|532313245|FG001|Overall Study|Found to be ineligible|5|||
147589291|NCT01197417|532313244|FG000|Overall Study|No 25-hour magnesium level|0|||
147589292|NCT01197417|532313245|FG001|Overall Study|No 25-hour magnesium level|2|||
147589293|NCT03250299|532313246|FG000|BAL101553 6 mg Cohort|Disease progression|0|||
147589294|NCT03250299|532313247|FG001|BAL101553 6 mg Cohort|Disease progression|1|||
147589295|NCT03250299|532313248|FG002|BAL101553 6 mg Cohort|Disease progression|0|||
147589296|NCT03250299|532313249|FG003|BAL101553 6 mg Cohort|Disease progression|0|||
147589297|NCT03250299|532313250|FG004|BAL101553 6 mg Cohort|Disease progression|0|||
147589298|NCT03250299|532313246|FG000|BAL101553 8 mg Cohort|Adverse Event|0|||
147589299|NCT03250299|532313247|FG001|BAL101553 8 mg Cohort|Adverse Event|0|||
147589300|NCT03250299|532313248|FG002|BAL101553 8 mg Cohort|Adverse Event|1|||
147589301|NCT03250299|532313249|FG003|BAL101553 8 mg Cohort|Adverse Event|0|||
147589302|NCT03250299|532313250|FG004|BAL101553 8 mg Cohort|Adverse Event|0|||
147589303|NCT03250299|532313246|FG000|BAL101553 8 mg Cohort|Withdrawal by Subject|0|||
147589304|NCT03250299|532313247|FG001|BAL101553 8 mg Cohort|Withdrawal by Subject|0|||
147589305|NCT03250299|532313248|FG002|BAL101553 8 mg Cohort|Withdrawal by Subject|1|||
147589306|NCT03250299|532313249|FG003|BAL101553 8 mg Cohort|Withdrawal by Subject|0|||
147589307|NCT03250299|532313250|FG004|BAL101553 8 mg Cohort|Withdrawal by Subject|0|||
147589308|NCT03250299|532313246|FG000|BAL101553 12 mg Cohort|Adverse Event|0|||
147589309|NCT03250299|532313247|FG001|BAL101553 12 mg Cohort|Adverse Event|0|||
147589310|NCT03250299|532313248|FG002|BAL101553 12 mg Cohort|Adverse Event|0|||
147589311|NCT03250299|532313249|FG003|BAL101553 12 mg Cohort|Adverse Event|2|||
147589312|NCT03250299|532313250|FG004|BAL101553 12 mg Cohort|Adverse Event|0|||
147589313|NCT01546142|532313265|FG000|Overall Study|Consent Withdrawn (Subject Convenience)|15|||
147589314|NCT01546142|532313266|FG001|Overall Study|Consent Withdrawn (Subject Convenience)|15|||
147589315|NCT01546142|532313265|FG000|Overall Study|Subject Noncompliance|1|||
147589316|NCT01546142|532313266|FG001|Overall Study|Subject Noncompliance|1|||
147589317|NCT01546142|532313265|FG000|Overall Study|Adverse Event|6|||
147589318|NCT01546142|532313266|FG001|Overall Study|Adverse Event|3|||
147589319|NCT01546142|532313265|FG000|Overall Study|Lost to Follow-up|20|||
147589320|NCT01546142|532313266|FG001|Overall Study|Lost to Follow-up|15|||
147589321|NCT01546142|532313265|FG000|Overall Study|Consent Withdrawn (Subject Discomfort)|1|||
147589322|NCT01546142|532313266|FG001|Overall Study|Consent Withdrawn (Subject Discomfort)|0|||
147589323|NCT01546142|532313265|FG000|Overall Study|Subject Randomized but Not Treated|1|||
147589324|NCT01546142|532313266|FG001|Overall Study|Subject Randomized but Not Treated|0|||
147589325|NCT01213836|532313267|FG000|Period 1, First Intervention|Adverse Event|2|||
147589326|NCT01213836|532313268|FG001|Period 1, First Intervention|Adverse Event|1|||
147589327|NCT01213836|532313267|FG000|Period 1, First Intervention|Protocol Violation|0|||
147589328|NCT01213836|532313268|FG001|Period 1, First Intervention|Protocol Violation|1|||
147589329|NCT01213836|532313267|FG000|Period 1, First Intervention|Withdrawal by Subject|1|||
147589330|NCT01213836|532313268|FG001|Period 1, First Intervention|Withdrawal by Subject|1|||
147589331|NCT04213209|532313270|FG000|Overall Study|Protocol Violation|1|||
147589332|NCT04213209|532313271|FG001|Overall Study|Protocol Violation|0|||
147323183|NCT00819234|531347937|FG003|Overall Study|Adverse Event|0|||
147589333|NCT04213209|532313272|FG002|Overall Study|Protocol Violation|0|||
147589334|NCT04213209|532313273|FG003|Overall Study|Protocol Violation|0|||
147589335|NCT04213209|532313274|FG004|Overall Study|Protocol Violation|0|||
147589336|NCT04213209|532313275|FG005|Overall Study|Protocol Violation|0|||
147589337|NCT00892281|532313287|FG000|Overall Study|Adverse Event|65|||
147589338|NCT00892281|532313288|FG001|Overall Study|Adverse Event|8|||
147589339|NCT00892281|532313287|FG000|Overall Study|Lost to Follow-up|81|||
147163917|NCT02088073|530764473|FG002|Maintanance Phase|Withdrawal by Subject|0|||
147163918|NCT02088073|530764474|FG003|Maintanance Phase|Withdrawal by Subject|0|||
147163919|NCT02088073|530764475|FG004|Maintanance Phase|Withdrawal by Subject|0|||
147163920|NCT02088073|530764471|FG000|Maintanance Phase|Adverse Event|0|||
147163921|NCT02088073|530764472|FG001|Maintanance Phase|Adverse Event|0|||
147163922|NCT02088073|530764473|FG002|Maintanance Phase|Adverse Event|3|||
147163923|NCT02088073|530764474|FG003|Maintanance Phase|Adverse Event|0|||
147163924|NCT02088073|530764475|FG004|Maintanance Phase|Adverse Event|1|||
147163925|NCT02088073|530764471|FG000|Maintanance Phase|Physician Decision|0|||
147163926|NCT02088073|530764472|FG001|Maintanance Phase|Physician Decision|0|||
147163927|NCT02088073|530764473|FG002|Maintanance Phase|Physician Decision|0|||
147163928|NCT02088073|530764474|FG003|Maintanance Phase|Physician Decision|0|||
147163929|NCT02088073|530764475|FG004|Maintanance Phase|Physician Decision|1|||
147163930|NCT02088073|530764471|FG000|Maintanance Phase|Sponsor's decision|0|||
147163931|NCT02088073|530764472|FG001|Maintanance Phase|Sponsor's decision|2|||
147163932|NCT02088073|530764473|FG002|Maintanance Phase|Sponsor's decision|0|||
147163933|NCT02088073|530764474|FG003|Maintanance Phase|Sponsor's decision|2|||
147163934|NCT02088073|530764475|FG004|Maintanance Phase|Sponsor's decision|1|||
147163935|NCT02088073|530764471|FG000|Maintanance Phase|Hypo- or hyperkalemia|0|||
147163936|NCT02088073|530764472|FG001|Maintanance Phase|Hypo- or hyperkalemia|3|||
147163937|NCT02088073|530764473|FG002|Maintanance Phase|Hypo- or hyperkalemia|0|||
147163938|NCT02088073|530764474|FG003|Maintanance Phase|Hypo- or hyperkalemia|3|||
147163939|NCT02088073|530764475|FG004|Maintanance Phase|Hypo- or hyperkalemia|1|||
147163940|NCT02088073|530764471|FG000|Maintanance Phase|Miscellaneous|0|||
147163941|NCT02088073|530764472|FG001|Maintanance Phase|Miscellaneous|2|||
147163942|NCT02088073|530764473|FG002|Maintanance Phase|Miscellaneous|1|||
147163943|NCT02088073|530764474|FG003|Maintanance Phase|Miscellaneous|2|||
147163944|NCT02088073|530764475|FG004|Maintanance Phase|Miscellaneous|1|||
147163945|NCT02088073|530764471|FG000|Maintanance Phase|Met ECG withdrawal criteria|0|||
147163946|NCT02088073|530764472|FG001|Maintanance Phase|Met ECG withdrawal criteria|0|||
147163947|NCT02088073|530764473|FG002|Maintanance Phase|Met ECG withdrawal criteria|1|||
147163948|NCT02088073|530764474|FG003|Maintanance Phase|Met ECG withdrawal criteria|0|||
147163949|NCT02088073|530764475|FG004|Maintanance Phase|Met ECG withdrawal criteria|2|||
147243117|NCT03310021|531062030|FG001|Overall Study|Withdrawal by Subject|0|||
147243118|NCT03310021|531062031|FG002|Overall Study|Withdrawal by Subject|0|||
147589340|NCT00892281|532313288|FG001|Overall Study|Lost to Follow-up|8|||
147163950|NCT02088073|530764471|FG000|Maintanance Phase|Subject compliance|0|||
147243119|NCT03310021|531062032|FG003|Overall Study|Withdrawal by Subject|0|||
147243120|NCT03310021|531062033|FG004|Overall Study|Withdrawal by Subject|0|||
147243121|NCT03310021|531062034|FG005|Overall Study|Withdrawal by Subject|0|||
147243122|NCT03310021|531062035|FG006|Overall Study|Withdrawal by Subject|1|||
147243123|NCT03310021|531062036|FG007|Overall Study|Withdrawal by Subject|0|||
147243124|NCT03310021|531062037|FG008|Overall Study|Withdrawal by Subject|0|||
147243125|NCT03310021|531062038|FG009|Overall Study|Withdrawal by Subject|0|||
147243126|NCT03310021|531062039|FG010|Overall Study|Withdrawal by Subject|0|||
147243127|NCT03310021|531062040|FG011|Overall Study|Withdrawal by Subject|0|||
147243128|NCT03310021|531062041|FG012|Overall Study|Withdrawal by Subject|0|||
147243129|NCT03310021|531062042|FG013|Overall Study|Withdrawal by Subject|0|||
147243130|NCT03310021|531062043|FG014|Overall Study|Withdrawal by Subject|0|||
147243131|NCT03310021|531062044|FG015|Overall Study|Withdrawal by Subject|0|||
147243132|NCT03310021|531062045|FG016|Overall Study|Withdrawal by Subject|0|||
147243133|NCT03310021|531062046|FG017|Overall Study|Withdrawal by Subject|0|||
147243134|NCT03310021|531062047|FG018|Overall Study|Withdrawal by Subject|0|||
147243135|NCT03310021|531062048|FG019|Overall Study|Withdrawal by Subject|0|||
147243136|NCT03310021|531062029|FG000|Overall Study|Lost to Follow-up|0|||
147243137|NCT03310021|531062030|FG001|Overall Study|Lost to Follow-up|0|||
147243138|NCT03310021|531062031|FG002|Overall Study|Lost to Follow-up|0|||
147243139|NCT03310021|531062032|FG003|Overall Study|Lost to Follow-up|0|||
147243140|NCT03310021|531062033|FG004|Overall Study|Lost to Follow-up|0|||
147243141|NCT03310021|531062034|FG005|Overall Study|Lost to Follow-up|0|||
147243142|NCT03310021|531062035|FG006|Overall Study|Lost to Follow-up|0|||
147243143|NCT03310021|531062036|FG007|Overall Study|Lost to Follow-up|0|||
147243144|NCT03310021|531062037|FG008|Overall Study|Lost to Follow-up|0|||
147243145|NCT03310021|531062038|FG009|Overall Study|Lost to Follow-up|0|||
147243146|NCT03310021|531062039|FG010|Overall Study|Lost to Follow-up|1|||
147243147|NCT03310021|531062040|FG011|Overall Study|Lost to Follow-up|0|||
147243148|NCT03310021|531062041|FG012|Overall Study|Lost to Follow-up|0|||
147243149|NCT03310021|531062042|FG013|Overall Study|Lost to Follow-up|0|||
147243150|NCT03310021|531062043|FG014|Overall Study|Lost to Follow-up|0|||
147163951|NCT02088073|530764472|FG001|Maintanance Phase|Subject compliance|1|||
147163952|NCT02088073|530764473|FG002|Maintanance Phase|Subject compliance|0|||
147163953|NCT02088073|530764474|FG003|Maintanance Phase|Subject compliance|0|||
147243151|NCT03310021|531062044|FG015|Overall Study|Lost to Follow-up|0|||
147243152|NCT03310021|531062045|FG016|Overall Study|Lost to Follow-up|0|||
147243153|NCT03310021|531062046|FG017|Overall Study|Lost to Follow-up|0|||
147243154|NCT03310021|531062047|FG018|Overall Study|Lost to Follow-up|0|||
147243155|NCT03310021|531062048|FG019|Overall Study|Lost to Follow-up|0|||
147589341|NCT00892281|532313287|FG000|Overall Study|Pregnancy|1|||
147589342|NCT00892281|532313288|FG001|Overall Study|Pregnancy|0|||
147163954|NCT02088073|530764475|FG004|Maintanance Phase|Subject compliance|0|||
147163955|NCT03684304|530764476|FG000|Overall Study|Lost to Follow-up|19|||
147163956|NCT03684304|530764477|FG001|Overall Study|Lost to Follow-up|17|||
147163957|NCT01009346|530764478|FG000|Overall Study|Adverse Event|4|||
147163958|NCT02266875|530764483|FG000|Overall Study|Withdrawal by Subject|9|||
147163959|NCT02266875|530764484|FG001|Overall Study|Withdrawal by Subject|0|||
147163960|NCT02266875|530764483|FG000|Overall Study|Lost to Follow-up|2|||
147163961|NCT02266875|530764484|FG001|Overall Study|Lost to Follow-up|0|||
147163962|NCT00849875|530764488|FG000|Overall Study|Death|28|||
147163963|NCT00849875|530764488|FG000|Overall Study|Ongoing (unknown completion status)|11|||
147163964|NCT00849875|530764488|FG000|Overall Study|Others|6|||
147163965|NCT00849875|530764488|FG000|Overall Study|Lost to Follow-up|2|||
147163966|NCT01304329|530764489|FG000|Third Intervention (3 Days)|Adverse Event|0|||
147163967|NCT01304329|530764490|FG001|Third Intervention (3 Days)|Adverse Event|1|||
147163968|NCT01304329|530764491|FG002|Third Intervention (3 Days)|Adverse Event|0|||
147163969|NCT01304329|530764492|FG003|Third Intervention (3 Days)|Adverse Event|0|||
147163970|NCT01304329|530764493|FG004|Third Intervention (3 Days)|Adverse Event|0|||
147163971|NCT01304329|530764494|FG005|Third Intervention (3 Days)|Adverse Event|0|||
147163972|NCT03515941|530764506|FG000|Overall Study|Adverse Event|1|||
147163973|NCT03515941|530764507|FG001|Overall Study|Adverse Event|0|||
147163974|NCT00276094|530764508|FG000|Overall Study|Adverse Event|15|||
147163975|NCT00276094|530764509|FG001|Overall Study|Adverse Event|13|||
147163976|NCT00276094|530764510|FG002|Overall Study|Adverse Event|11|||
147163977|NCT00276094|530764508|FG000|Overall Study|Withdrawal by Subject|14|||
147163978|NCT00276094|530764509|FG001|Overall Study|Withdrawal by Subject|14|||
147163979|NCT00276094|530764510|FG002|Overall Study|Withdrawal by Subject|12|||
147163980|NCT00276094|530764508|FG000|Overall Study|Protocol Violation|16|||
147163981|NCT00276094|530764509|FG001|Overall Study|Protocol Violation|7|||
147163982|NCT00276094|530764510|FG002|Overall Study|Protocol Violation|10|||
147163983|NCT00276094|530764508|FG000|Overall Study|Lost to Follow-up|8|||
147163984|NCT00276094|530764509|FG001|Overall Study|Lost to Follow-up|6|||
147163985|NCT00276094|530764510|FG002|Overall Study|Lost to Follow-up|4|||
147163986|NCT00276094|530764508|FG000|Overall Study|Other-Subject moved out of country|1|||
147163987|NCT00276094|530764509|FG001|Overall Study|Other-Subject moved out of country|0|||
147163988|NCT00276094|530764510|FG002|Overall Study|Other-Subject moved out of country|0|||
147163989|NCT00276094|530764508|FG000|Overall Study|Other-Scheduled gastroplasty|1|||
147163990|NCT00276094|530764509|FG001|Overall Study|Other-Scheduled gastroplasty|0|||
147163991|NCT00276094|530764510|FG002|Overall Study|Other-Scheduled gastroplasty|0|||
147163992|NCT00276094|530764508|FG000|Overall Study|Other-Lack of efficacy|1|||
147163993|NCT00276094|530764509|FG001|Overall Study|Other-Lack of efficacy|0|||
147163994|NCT00276094|530764510|FG002|Overall Study|Other-Lack of efficacy|0|||
147163995|NCT00276094|530764508|FG000|Overall Study|Other-Refused follow-up visit|1|||
147163996|NCT00276094|530764509|FG001|Overall Study|Other-Refused follow-up visit|0|||
147163997|NCT00276094|530764510|FG002|Overall Study|Other-Refused follow-up visit|0|||
147163998|NCT00276094|530764508|FG000|Overall Study|Other-Repeat safety labs-exclusionary|0|||
147163999|NCT00276094|530764509|FG001|Overall Study|Other-Repeat safety labs-exclusionary|1|||
147164000|NCT00276094|530764510|FG002|Overall Study|Other-Repeat safety labs-exclusionary|0|||
147164001|NCT00276094|530764508|FG000|Overall Study|Other-Relocation|0|||
147164002|NCT00276094|530764509|FG001|Overall Study|Other-Relocation|1|||
147164003|NCT00276094|530764510|FG002|Overall Study|Other-Relocation|0|||
147164004|NCT00276094|530764508|FG000|Overall Study|Other-Study medication lost|0|||
147164005|NCT00276094|530764509|FG001|Overall Study|Other-Study medication lost|0|||
147164006|NCT00276094|530764510|FG002|Overall Study|Other-Study medication lost|1|||
147164007|NCT02759315|530764511|FG000|Overall Study|Adverse Event|0|||
147164008|NCT02759315|530764512|FG001|Overall Study|Adverse Event|0|||
147164009|NCT02759315|530764513|FG002|Overall Study|Adverse Event|0|||
147164010|NCT02759315|530764514|FG003|Overall Study|Adverse Event|1|||
147164011|NCT02759315|530764515|FG004|Overall Study|Adverse Event|0|||
147164012|NCT02759315|530764511|FG000|Overall Study|Death|0|||
147164013|NCT02759315|530764512|FG001|Overall Study|Death|0|||
147164014|NCT02759315|530764513|FG002|Overall Study|Death|1|||
147164015|NCT02759315|530764514|FG003|Overall Study|Death|0|||
147164016|NCT02759315|530764515|FG004|Overall Study|Death|0|||
147164017|NCT02759315|530764511|FG000|Overall Study|Lost to Follow-up|2|||
147164018|NCT02759315|530764512|FG001|Overall Study|Lost to Follow-up|0|||
147243156|NCT00702923|531062051|FG000|Overall Study|Adverse Event|1|||
147243157|NCT03322631|531062061|FG000|Overall Study|Withdrawal by Subject|0|||
147589343|NCT00892281|532313287|FG000|Overall Study|Protocol Violation|7|||
147164019|NCT02759315|530764513|FG002|Overall Study|Lost to Follow-up|4|||
147164020|NCT02759315|530764514|FG003|Overall Study|Lost to Follow-up|0|||
147243158|NCT03322631|531062062|FG001|Overall Study|Withdrawal by Subject|1|||
147243159|NCT03322631|531062063|FG002|Overall Study|Withdrawal by Subject|0|||
147164021|NCT02759315|530764515|FG004|Overall Study|Lost to Follow-up|0|||
147164022|NCT02759315|530764511|FG000|Overall Study|Protocol Violation|0|||
147164023|NCT02759315|530764512|FG001|Overall Study|Protocol Violation|1|||
147589344|NCT00892281|532313288|FG001|Overall Study|Protocol Violation|2|||
147589345|NCT00892281|532313287|FG000|Overall Study|Withdrawal by Subject|86|||
147589346|NCT00892281|532313288|FG001|Overall Study|Withdrawal by Subject|14|||
147589347|NCT00892281|532313287|FG000|Overall Study|Subject failed to return for final visit|2|||
147589348|NCT00892281|532313288|FG001|Overall Study|Subject failed to return for final visit|0|||
147589349|NCT00892281|532313287|FG000|Overall Study|Subject unable to keep follow-up visits|1|||
147589350|NCT00892281|532313288|FG001|Overall Study|Subject unable to keep follow-up visits|0|||
147589351|NCT00892281|532313287|FG000|Overall Study|Final visit completed 4 weeks late|0|||
147589352|NCT00892281|532313288|FG001|Overall Study|Final visit completed 4 weeks late|1|||
147589353|NCT00892281|532313287|FG000|Overall Study|Subject completed day after study closed|1|||
147589354|NCT00892281|532313288|FG001|Overall Study|Subject completed day after study closed|0|||
147589355|NCT00892281|532313287|FG000|Overall Study|Family emergency|1|||
147589356|NCT00892281|532313288|FG001|Overall Study|Family emergency|0|||
147589357|NCT00892281|532313287|FG000|Overall Study|Last visit not done - death in family|1|||
147589358|NCT00892281|532313288|FG001|Overall Study|Last visit not done - death in family|0|||
147589359|NCT00892281|532313287|FG000|Overall Study|Did not meet incl/excl criteria|1|||
147589360|NCT00892281|532313288|FG001|Overall Study|Did not meet incl/excl criteria|0|||
147589361|NCT00892281|532313287|FG000|Overall Study|Rosacea cleared; subject D/C'd self|1|||
147589362|NCT00892281|532313288|FG001|Overall Study|Rosacea cleared; subject D/C'd self|0|||
147589363|NCT00892281|532313287|FG000|Overall Study|Unable to redeem the drug voucher|1|||
147589364|NCT00892281|532313288|FG001|Overall Study|Unable to redeem the drug voucher|0|||
147589365|NCT00892281|532313287|FG000|Overall Study|Subject not good candidate for study|1|||
147589366|NCT00892281|532313288|FG001|Overall Study|Subject not good candidate for study|0|||
147589367|NCT00892281|532313287|FG000|Overall Study|Subject did not return for any visits|1|||
147589368|NCT00892281|532313288|FG001|Overall Study|Subject did not return for any visits|0|||
147589369|NCT00892281|532313287|FG000|Overall Study|Subject missed several visits/lost meds|1|||
147589370|NCT00892281|532313288|FG001|Overall Study|Subject missed several visits/lost meds|0|||
147589371|NCT00892281|532313287|FG000|Overall Study|Missed Visit 4 and off meds for 65 days|1|||
147589372|NCT00892281|532313288|FG001|Overall Study|Missed Visit 4 and off meds for 65 days|1|||
147589373|NCT00892281|532313287|FG000|Overall Study|Scheduled for knee replacement|0|||
147589374|NCT00892281|532313288|FG001|Overall Study|Scheduled for knee replacement|1|||
147589375|NCT00892281|532313287|FG000|Overall Study|PI complained of inadequate compensation|3|||
147589376|NCT00892281|532313288|FG001|Overall Study|PI complained of inadequate compensation|0|||
147589377|NCT00892281|532313287|FG000|Overall Study|Subject lost interest in program|0|||
147589378|NCT00892281|532313288|FG001|Overall Study|Subject lost interest in program|1|||
147589379|NCT00892281|532313287|FG000|Overall Study|Bad taste in mouth after taking Oracea®|0|||
147589380|NCT00892281|532313288|FG001|Overall Study|Bad taste in mouth after taking Oracea®|1|||
147589381|NCT00892281|532313287|FG000|Overall Study|Death in family|1|||
147164024|NCT02759315|530764513|FG002|Overall Study|Protocol Violation|0|||
147164025|NCT02759315|530764514|FG003|Overall Study|Protocol Violation|0|||
147164026|NCT02759315|530764515|FG004|Overall Study|Protocol Violation|0|||
147164027|NCT02759315|530764511|FG000|Overall Study|Study terminated prior to completion|2|||
147164028|NCT02759315|530764512|FG001|Overall Study|Study terminated prior to completion|0|||
147164029|NCT02759315|530764513|FG002|Overall Study|Study terminated prior to completion|5|||
147164030|NCT02759315|530764514|FG003|Overall Study|Study terminated prior to completion|0|||
147164031|NCT02759315|530764515|FG004|Overall Study|Study terminated prior to completion|1|||
147164032|NCT01406015|530764518|FG000|Overall Study|Withdrawal by Subject|3|||
147164033|NCT01406015|530764519|FG001|Overall Study|Withdrawal by Subject|3|||
147164034|NCT00787137|530764520|FG000|Overall Study|Study Termination|0|||
147164035|NCT00787137|530764521|FG001|Overall Study|Study Termination|0|||
147164036|NCT00787137|530764522|FG002|Overall Study|Study Termination|1|||
147164037|NCT00554099|530764526|FG000|Treatment Period (12 Weeks)|Adverse Event|3|||
147164038|NCT00554099|530764527|FG001|Treatment Period (12 Weeks)|Adverse Event|5|||
147164039|NCT00554099|530764528|FG002|Treatment Period (12 Weeks)|Adverse Event|1|||
147164040|NCT00554099|530764526|FG000|Treatment Period (12 Weeks)|Physician Decision|3|||
147164041|NCT00554099|530764527|FG001|Treatment Period (12 Weeks)|Physician Decision|0|||
147164042|NCT00554099|530764528|FG002|Treatment Period (12 Weeks)|Physician Decision|0|||
147164043|NCT00554099|530764526|FG000|Treatment Period (12 Weeks)|Lost to Follow-up|1|||
147164044|NCT00554099|530764527|FG001|Treatment Period (12 Weeks)|Lost to Follow-up|0|||
147164045|NCT00554099|530764528|FG002|Treatment Period (12 Weeks)|Lost to Follow-up|2|||
147243160|NCT03322631|531062064|FG003|Overall Study|Withdrawal by Subject|0|||
147243161|NCT03322631|531062061|FG000|Overall Study|Adverse Event|0|||
147164046|NCT00554099|530764526|FG000|Treatment Period (12 Weeks)|Recurrent diverticulitis,surgery require|1|||
147164047|NCT00554099|530764527|FG001|Treatment Period (12 Weeks)|Recurrent diverticulitis,surgery require|2|||
147243162|NCT03322631|531062062|FG001|Overall Study|Adverse Event|0|||
147243163|NCT03322631|531062063|FG002|Overall Study|Adverse Event|1|||
147243164|NCT03322631|531062064|FG003|Overall Study|Adverse Event|0|||
147589382|NCT00892281|532313288|FG001|Overall Study|Death in family|0|||
147589383|NCT00892281|532313287|FG000|Overall Study|Lack of efficacy of study product|2|||
147243165|NCT02412618|531062066|FG000|Overall Study|Withdrawal by Subject|1|||
147243166|NCT02412618|531062067|FG001|Overall Study|Withdrawal by Subject|1|||
147323184|NCT00819234|531347938|FG004|Overall Study|Adverse Event|0|||
147323185|NCT00819234|531347939|FG005|Overall Study|Adverse Event|2|||
147323186|NCT00819234|531347940|FG006|Overall Study|Adverse Event|0|||
147323187|NCT00819234|531347941|FG007|Overall Study|Adverse Event|0|||
147164048|NCT00554099|530764528|FG002|Treatment Period (12 Weeks)|Recurrent diverticulitis,surgery require|0|||
147323188|NCT00819234|531347942|FG008|Overall Study|Adverse Event|0|||
147164049|NCT00554099|530764526|FG000|Treatment Period (12 Weeks)|Protocol Violation|0|||
147164050|NCT00554099|530764527|FG001|Treatment Period (12 Weeks)|Protocol Violation|0|||
147164051|NCT00554099|530764528|FG002|Treatment Period (12 Weeks)|Protocol Violation|2|||
147164052|NCT00554099|530764526|FG000|Treatment Period (12 Weeks)|Withdrawal by Subject|4|||
147164053|NCT00554099|530764527|FG001|Treatment Period (12 Weeks)|Withdrawal by Subject|1|||
147164054|NCT00554099|530764528|FG002|Treatment Period (12 Weeks)|Withdrawal by Subject|4|||
147164055|NCT00554099|530764526|FG000|Non-Treatment Phase (9 Months)|Lost to Follow-up|1|||
147164056|NCT00554099|530764527|FG001|Non-Treatment Phase (9 Months)|Lost to Follow-up|2|||
147164057|NCT00554099|530764528|FG002|Non-Treatment Phase (9 Months)|Lost to Follow-up|0|||
147164058|NCT00554099|530764526|FG000|Non-Treatment Phase (9 Months)|Relapse|2|||
147164059|NCT00554099|530764527|FG001|Non-Treatment Phase (9 Months)|Relapse|1|||
147164060|NCT00554099|530764528|FG002|Non-Treatment Phase (9 Months)|Relapse|1|||
147164061|NCT00554099|530764526|FG000|Non-Treatment Phase (9 Months)|Withdrawal by Subject|4|||
147164062|NCT00554099|530764527|FG001|Non-Treatment Phase (9 Months)|Withdrawal by Subject|2|||
147164063|NCT00554099|530764528|FG002|Non-Treatment Phase (9 Months)|Withdrawal by Subject|2|||
147164064|NCT02075632|530764532|FG000|Overall Study|Adverse Event|1|||
147164065|NCT02075632|530764533|FG001|Overall Study|Adverse Event|1|||
147164066|NCT02075632|530764532|FG000|Overall Study|Lost to Follow-up|0|||
147164067|NCT02075632|530764533|FG001|Overall Study|Lost to Follow-up|3|||
147164068|NCT02075632|530764532|FG000|Overall Study|Withdrawal by Subject|0|||
147164069|NCT02075632|530764533|FG001|Overall Study|Withdrawal by Subject|1|||
147164070|NCT01628367|530764538|FG000|Overall Study|Adverse Event|1|||
147164071|NCT01628367|530764539|FG001|Overall Study|Adverse Event|0|||
147164072|NCT03353922|530764540|FG000|Overall Study|Withdrawal by Subject|1|||
147164073|NCT03353922|530764541|FG001|Overall Study|Withdrawal by Subject|0|||
147164074|NCT03353922|530764542|FG002|Overall Study|Withdrawal by Subject|1|||
147164075|NCT03353922|530764543|FG003|Overall Study|Withdrawal by Subject|1|||
147164076|NCT03353922|530764544|FG004|Overall Study|Withdrawal by Subject|0|||
147164077|NCT03353922|530764545|FG005|Overall Study|Withdrawal by Subject|0|||
147164078|NCT03353922|530764540|FG000|Overall Study|Adverse Event|0|||
147164079|NCT03353922|530764541|FG001|Overall Study|Adverse Event|1|||
147164080|NCT03353922|530764542|FG002|Overall Study|Adverse Event|0|||
147323189|NCT00819234|531347943|FG009|Overall Study|Adverse Event|0|||
147323190|NCT00819234|531347934|FG000|Overall Study|Physician Decision|0|||
147323191|NCT00819234|531347935|FG001|Overall Study|Physician Decision|0|||
147323192|NCT00819234|531347936|FG002|Overall Study|Physician Decision|0|||
147323193|NCT00819234|531347937|FG003|Overall Study|Physician Decision|1|||
147323194|NCT00819234|531347938|FG004|Overall Study|Physician Decision|0|||
147323195|NCT00819234|531347939|FG005|Overall Study|Physician Decision|0|||
147323196|NCT00819234|531347940|FG006|Overall Study|Physician Decision|0|||
147323197|NCT00819234|531347941|FG007|Overall Study|Physician Decision|0|||
147323198|NCT00819234|531347942|FG008|Overall Study|Physician Decision|0|||
147323199|NCT00819234|531347943|FG009|Overall Study|Physician Decision|2|||
147323200|NCT00819234|531347934|FG000|Overall Study|Protocol Violation|0|||
147323201|NCT00819234|531347935|FG001|Overall Study|Protocol Violation|0|||
147323202|NCT00819234|531347936|FG002|Overall Study|Protocol Violation|1|||
147323203|NCT00819234|531347937|FG003|Overall Study|Protocol Violation|0|||
147323204|NCT00819234|531347938|FG004|Overall Study|Protocol Violation|0|||
147323205|NCT00819234|531347939|FG005|Overall Study|Protocol Violation|0|||
147323206|NCT00819234|531347940|FG006|Overall Study|Protocol Violation|0|||
147323207|NCT00819234|531347941|FG007|Overall Study|Protocol Violation|0|||
147323208|NCT00819234|531347942|FG008|Overall Study|Protocol Violation|0|||
147323209|NCT00819234|531347943|FG009|Overall Study|Protocol Violation|0|||
147164081|NCT03353922|530764543|FG003|Overall Study|Adverse Event|0|||
147323210|NCT00819234|531347934|FG000|Overall Study|Lost to Follow-up|2|||
147323211|NCT00819234|531347935|FG001|Overall Study|Lost to Follow-up|2|||
147323212|NCT00819234|531347936|FG002|Overall Study|Lost to Follow-up|0|||
147323213|NCT00819234|531347937|FG003|Overall Study|Lost to Follow-up|2|||
147323214|NCT00819234|531347938|FG004|Overall Study|Lost to Follow-up|1|||
147323215|NCT00819234|531347939|FG005|Overall Study|Lost to Follow-up|1|||
147164082|NCT03353922|530764544|FG004|Overall Study|Adverse Event|0|||
147323216|NCT00819234|531347940|FG006|Overall Study|Lost to Follow-up|1|||
147323217|NCT00819234|531347941|FG007|Overall Study|Lost to Follow-up|1|||
147323218|NCT00819234|531347942|FG008|Overall Study|Lost to Follow-up|1|||
147323219|NCT00819234|531347943|FG009|Overall Study|Lost to Follow-up|2|||
147164083|NCT03353922|530764545|FG005|Overall Study|Adverse Event|0|||
147164084|NCT00740714|530764546|FG000|Overall Study|Withdrawal by Subject|17|||
147164085|NCT00740714|530764547|FG001|Overall Study|Withdrawal by Subject|19|||
147164086|NCT00740714|530764548|FG002|Overall Study|Withdrawal by Subject|29|||
147323220|NCT04438785|531347944|FG000|Overall Study|change of weight, give up intervention|2|||
147323221|NCT04438785|531347945|FG001|Overall Study|change of weight, give up intervention|10|||
147164087|NCT03688555|530764549|FG000|Treatment Period|Adverse Event|0|||
147164088|NCT03688555|530764550|FG001|Treatment Period|Adverse Event|0|||
147164089|NCT03688555|530764551|FG002|Treatment Period|Adverse Event|1|||
147164090|NCT00886119|530764556|FG000|Period 1|Did not meet inclusion criteria|1|||
147164091|NCT00886119|530764557|FG001|Period 1|Did not meet inclusion criteria|0|||
147164092|NCT00394901|530764558|FG000|Baseline Phase|Protocol Violation|0|||
147164093|NCT00394901|530764559|FG001|Baseline Phase|Protocol Violation|0|||
147164094|NCT00394901|530764560|FG002|Baseline Phase|Protocol Violation|1|||
147164095|NCT00394901|530764561|FG003|Baseline Phase|Protocol Violation|0|||
147164096|NCT00394901|530764558|FG000|Double-blind Phase|Adverse Event|5|||
147164097|NCT00394901|530764559|FG001|Double-blind Phase|Adverse Event|7|||
147164098|NCT00394901|530764560|FG002|Double-blind Phase|Adverse Event|16|||
147164099|NCT00394901|530764561|FG003|Double-blind Phase|Adverse Event|20|||
147164100|NCT00394901|530764558|FG000|Double-blind Phase|Lack of Efficacy|6|||
147164101|NCT00394901|530764559|FG001|Double-blind Phase|Lack of Efficacy|4|||
147164102|NCT00394901|530764560|FG002|Double-blind Phase|Lack of Efficacy|1|||
147164103|NCT00394901|530764561|FG003|Double-blind Phase|Lack of Efficacy|3|||
147164104|NCT00394901|530764558|FG000|Double-blind Phase|Withdrawal by Subject|2|||
147164105|NCT00394901|530764559|FG001|Double-blind Phase|Withdrawal by Subject|0|||
147164106|NCT00394901|530764560|FG002|Double-blind Phase|Withdrawal by Subject|0|||
147164107|NCT00394901|530764561|FG003|Double-blind Phase|Withdrawal by Subject|0|||
147164108|NCT00394901|530764558|FG000|Double-blind Phase|Lost to Follow-up|0|||
147164109|NCT00394901|530764559|FG001|Double-blind Phase|Lost to Follow-up|0|||
147164110|NCT00394901|530764560|FG002|Double-blind Phase|Lost to Follow-up|0|||
147164111|NCT00394901|530764561|FG003|Double-blind Phase|Lost to Follow-up|1|||
147164112|NCT00394901|530764558|FG000|Double-blind Phase|Protocol Violation|0|||
147164113|NCT00394901|530764559|FG001|Double-blind Phase|Protocol Violation|0|||
147164114|NCT00394901|530764560|FG002|Double-blind Phase|Protocol Violation|0|||
147164115|NCT00394901|530764561|FG003|Double-blind Phase|Protocol Violation|1|||
147164116|NCT00394901|530764558|FG000|Double-blind Phase|Death|1|||
147164117|NCT00394901|530764559|FG001|Double-blind Phase|Death|0|||
147164118|NCT00394901|530764560|FG002|Double-blind Phase|Death|0|||
147164119|NCT00394901|530764561|FG003|Double-blind Phase|Death|0|||
147164120|NCT00394901|530764558|FG000|Double-blind Phase|Subject's Personal Reason|1|||
147164121|NCT00394901|530764559|FG001|Double-blind Phase|Subject's Personal Reason|0|||
147164122|NCT00394901|530764560|FG002|Double-blind Phase|Subject's Personal Reason|0|||
147164123|NCT00394901|530764561|FG003|Double-blind Phase|Subject's Personal Reason|1|||
147164124|NCT00394901|530764558|FG000|Double-blind Phase|Lack of Compliance|0|||
147164125|NCT00394901|530764559|FG001|Double-blind Phase|Lack of Compliance|3|||
147164126|NCT00394901|530764560|FG002|Double-blind Phase|Lack of Compliance|0|||
147164127|NCT00394901|530764561|FG003|Double-blind Phase|Lack of Compliance|0|||
147164128|NCT00394901|530764558|FG000|Double-blind Phase|Entry into another study was found|0|||
147164129|NCT00394901|530764559|FG001|Double-blind Phase|Entry into another study was found|0|||
147164130|NCT00394901|530764560|FG002|Double-blind Phase|Entry into another study was found|1|||
147164131|NCT00394901|530764561|FG003|Double-blind Phase|Entry into another study was found|0|||
147164132|NCT00394901|530764558|FG000|Double-blind Phase|Found not to meet entrance criteria|0|||
147164133|NCT00394901|530764559|FG001|Double-blind Phase|Found not to meet entrance criteria|0|||
147164134|NCT00394901|530764560|FG002|Double-blind Phase|Found not to meet entrance criteria|0|||
147164135|NCT00394901|530764561|FG003|Double-blind Phase|Found not to meet entrance criteria|1|||
147164136|NCT03002623|530764562|FG000|Overall Study|Lost to Follow-up|1|||
147164137|NCT03002623|530764563|FG001|Overall Study|Lost to Follow-up|0|||
147164138|NCT03002623|530764562|FG000|Overall Study|Physician Decision|1|||
147164139|NCT03002623|530764563|FG001|Overall Study|Physician Decision|1|||
147164140|NCT02256267|530764564|FG000|Period 1 (Day 1; Day 2 to Day 9 Washout)|Adverse Event|1|||
147164141|NCT02256267|530764564|FG000|Period 2 (Day 7 to Day 14)|Adverse Event|1|||
147164142|NCT01352741|530764566|FG000|Open-label Tapentadol Titration Period|Protocol Violation|4|||
147164143|NCT01352741|530764567|FG001|Open-label Tapentadol Titration Period|Protocol Violation|0|||
147164144|NCT01352741|530764566|FG000|Open-label Tapentadol Titration Period|Lack of Efficacy|19|||
147164145|NCT01352741|530764567|FG001|Open-label Tapentadol Titration Period|Lack of Efficacy|0|||
147164146|NCT01352741|530764566|FG000|Open-label Tapentadol Titration Period|Adverse Event|34|||
147164147|NCT01352741|530764567|FG001|Open-label Tapentadol Titration Period|Adverse Event|0|||
147164148|NCT01352741|530764566|FG000|Open-label Tapentadol Titration Period|Withdrawal of consent|7|||
147164149|NCT01352741|530764567|FG001|Open-label Tapentadol Titration Period|Withdrawal of consent|0|||
147164150|NCT01352741|530764566|FG000|Open-label Tapentadol Titration Period|Non-compliance with Trial Requirements|5|||
147164151|NCT01352741|530764567|FG001|Open-label Tapentadol Titration Period|Non-compliance with Trial Requirements|0|||
147164152|NCT01352741|530764566|FG000|Open-label Tapentadol Titration Period|Other|4|||
147164153|NCT01352741|530764567|FG001|Open-label Tapentadol Titration Period|Other|0|||
147164154|NCT01352741|530764566|FG000|Double-blind Comparative Period|Protocol Violation|2|||
147164155|NCT01352741|530764567|FG001|Double-blind Comparative Period|Protocol Violation|0|||
147164156|NCT01352741|530764566|FG000|Double-blind Comparative Period|Lack of Efficacy|0|||
147164157|NCT01352741|530764567|FG001|Double-blind Comparative Period|Lack of Efficacy|3|||
147164158|NCT01352741|530764566|FG000|Double-blind Comparative Period|Adverse Event|16|||
147243167|NCT02412618|531062066|FG000|Overall Study|Expulsion|1|||
147589384|NCT00892281|532313288|FG001|Overall Study|Lack of efficacy of study product|0|||
147589385|NCT00892281|532313287|FG000|Overall Study|Subject not seen by PI at final visit|1|||
147589386|NCT00892281|532313288|FG001|Overall Study|Subject not seen by PI at final visit|0|||
147589387|NCT00892281|532313287|FG000|Overall Study|No show Visit 2; prescription not filled|1|||
147164159|NCT01352741|530764567|FG001|Double-blind Comparative Period|Adverse Event|17|||
147164160|NCT01352741|530764566|FG000|Double-blind Comparative Period|Lost to Follow-up|1|||
147164161|NCT01352741|530764567|FG001|Double-blind Comparative Period|Lost to Follow-up|0|||
147164162|NCT01352741|530764566|FG000|Double-blind Comparative Period|Death|0|||
147164163|NCT01352741|530764567|FG001|Double-blind Comparative Period|Death|1|||
147164164|NCT01352741|530764566|FG000|Double-blind Comparative Period|Withdrawal of consent|8|||
147164165|NCT01352741|530764567|FG001|Double-blind Comparative Period|Withdrawal of consent|3|||
147164166|NCT01352741|530764566|FG000|Double-blind Comparative Period|Other|1|||
147164167|NCT01352741|530764567|FG001|Double-blind Comparative Period|Other|2|||
147164168|NCT01352741|530764566|FG000|Open-Label Tapentadol Continuation Arm|Adverse Event|4|||
147164169|NCT01352741|530764567|FG001|Open-Label Tapentadol Continuation Arm|Adverse Event|0|||
147164170|NCT01352741|530764566|FG000|Open-Label Tapentadol Continuation Arm|Lack of Efficacy|1|||
147164171|NCT01352741|530764567|FG001|Open-Label Tapentadol Continuation Arm|Lack of Efficacy|0|||
147164172|NCT01352741|530764566|FG000|Open-Label Tapentadol Continuation Arm|Withdrawal by Subject|2|||
147164173|NCT01352741|530764567|FG001|Open-Label Tapentadol Continuation Arm|Withdrawal by Subject|0|||
147164174|NCT01352741|530764566|FG000|Open-Label Tapentadol Continuation Arm|Protocol Violation|1|||
147164175|NCT01352741|530764567|FG001|Open-Label Tapentadol Continuation Arm|Protocol Violation|0|||
147164176|NCT00259298|530764569|FG000|Overall Study|Withdrawal by Subject|1|||
147164177|NCT00259298|530764569|FG000|Overall Study|Physician Decision|2|||
147164178|NCT00645528|530764570|FG000|Overall Study|Did not show up for Visit 2|7|||
147164179|NCT03618628|530764574|FG000|Overall Study|Death|1|||
147164180|NCT03618628|530764574|FG000|Overall Study|Lost to Follow-up|1|||
147164181|NCT01969500|530764575|FG000|Overall Study|Death|0|||
147164182|NCT01969500|530764576|FG001|Overall Study|Death|1|||
147164183|NCT01969500|530764575|FG000|Overall Study|extended hospitalization|1|||
147164184|NCT01969500|530764576|FG001|Overall Study|extended hospitalization|1|||
147164185|NCT01741532|530764577|FG000|Overall Study|Adverse Event|4|||
147164186|NCT01741532|530764578|FG001|Overall Study|Adverse Event|0|||
147164187|NCT01741532|530764577|FG000|Overall Study|Withdrawal by Subject|1|||
147164188|NCT01741532|530764578|FG001|Overall Study|Withdrawal by Subject|1|||
147164189|NCT01741532|530764577|FG000|Overall Study|Protocol Violation|0|||
147164190|NCT01741532|530764578|FG001|Overall Study|Protocol Violation|1|||
147164191|NCT01741532|530764577|FG000|Overall Study|Worsening of the disease|3|||
147164192|NCT01741532|530764578|FG001|Overall Study|Worsening of the disease|1|||
147164193|NCT01741532|530764577|FG000|Overall Study|Sponsor decision|1|||
147164194|NCT01741532|530764578|FG001|Overall Study|Sponsor decision|0|||
147164195|NCT01741532|530764577|FG000|Overall Study|Medical event|1|||
147164196|NCT01741532|530764578|FG001|Overall Study|Medical event|0|||
147164197|NCT02463032|530764579|FG000|Overall Study|Lack of Efficacy|61|||
147164198|NCT02463032|530764580|FG001|Overall Study|Lack of Efficacy|50|||
147164199|NCT02463032|530764579|FG000|Overall Study|Death|8|||
147164200|NCT02463032|530764580|FG001|Overall Study|Death|8|||
147164201|NCT02463032|530764579|FG000|Overall Study|Adverse Event|2|||
147164202|NCT02463032|530764580|FG001|Overall Study|Adverse Event|6|||
147164203|NCT00613080|530764581|FG000|Overall Study|Ineligible / no protocol treatment|11|||
147164204|NCT00612508|530764582|FG000|Overall Study|Withdrawal by Subject|3|||
147164205|NCT00612508|530764583|FG001|Overall Study|Withdrawal by Subject|4|||
147164206|NCT02008357|530764584|FG000|Double-blind (Placebo Controlled) Period|Adverse Event|29|||
147164207|NCT02008357|530764585|FG001|Double-blind (Placebo Controlled) Period|Adverse Event|35|||
147164208|NCT02008357|530764584|FG000|Double-blind (Placebo Controlled) Period|Withdrawal by Subject|101|||
147164209|NCT02008357|530764585|FG001|Double-blind (Placebo Controlled) Period|Withdrawal by Subject|88|||
147164210|NCT02008357|530764584|FG000|Double-blind (Placebo Controlled) Period|Death|6|||
147164211|NCT02008357|530764585|FG001|Double-blind (Placebo Controlled) Period|Death|5|||
147164212|NCT02008357|530764584|FG000|Double-blind (Placebo Controlled) Period|Lack of Efficacy|3|||
147164213|NCT02008357|530764585|FG001|Double-blind (Placebo Controlled) Period|Lack of Efficacy|4|||
147164214|NCT02008357|530764584|FG000|Double-blind (Placebo Controlled) Period|Lost to Follow-up|3|||
147164215|NCT02008357|530764585|FG001|Double-blind (Placebo Controlled) Period|Lost to Follow-up|6|||
147164216|NCT02008357|530764584|FG000|Double-blind (Placebo Controlled) Period|Coordinating Center Request|1|||
147164217|NCT02008357|530764585|FG001|Double-blind (Placebo Controlled) Period|Coordinating Center Request|0|||
147164218|NCT02008357|530764584|FG000|Double-blind (Placebo Controlled) Period|Covid-19 Pandemic Disruption|6|||
147164219|NCT02008357|530764585|FG001|Double-blind (Placebo Controlled) Period|Covid-19 Pandemic Disruption|3|||
147164220|NCT02008357|530764584|FG000|Double-blind (Placebo Controlled) Period|Investigator Recommendation|2|||
147243168|NCT02412618|531062067|FG001|Overall Study|Expulsion|1|||
147243169|NCT02378961|531062068|FG000|Overall Study|Lack of Efficacy|4|||
147164221|NCT02008357|530764585|FG001|Double-blind (Placebo Controlled) Period|Investigator Recommendation|2|||
147243170|NCT02378961|531062069|FG001|Overall Study|Lack of Efficacy|2|||
147243171|NCT02378961|531062070|FG002|Overall Study|Lack of Efficacy|0|||
147589388|NCT00892281|532313288|FG001|Overall Study|No show Visit 2; prescription not filled|0|||
147589389|NCT00892281|532313287|FG000|Overall Study|Missed multiple visits|1|||
147589390|NCT00892281|532313288|FG001|Overall Study|Missed multiple visits|0|||
147164222|NCT02008357|530764584|FG000|Double-blind (Placebo Controlled) Period|Non-Compliance|1|||
147164223|NCT02008357|530764585|FG001|Double-blind (Placebo Controlled) Period|Non-Compliance|1|||
147164224|NCT02008357|530764584|FG000|Double-blind (Placebo Controlled) Period|Non-Site Clinician Recommendation|2|||
147164225|NCT02008357|530764585|FG001|Double-blind (Placebo Controlled) Period|Non-Site Clinician Recommendation|0|||
147164226|NCT02008357|530764584|FG000|Double-blind (Placebo Controlled) Period|Safety Risk|2|||
147164227|NCT02008357|530764585|FG001|Double-blind (Placebo Controlled) Period|Safety Risk|6|||
147589391|NCT00892281|532313287|FG000|Overall Study|Missed visits rescheduled out of window|1|||
147589392|NCT00892281|532313288|FG001|Overall Study|Missed visits rescheduled out of window|0|||
147589393|NCT00892281|532313287|FG000|Overall Study|Non-compliant with visits as scheduled|1|||
147589394|NCT00892281|532313288|FG001|Overall Study|Non-compliant with visits as scheduled|0|||
147589395|NCT00892281|532313287|FG000|Overall Study|Subject had history of drug abuse|1|||
147589396|NCT00892281|532313288|FG001|Overall Study|Subject had history of drug abuse|0|||
147589397|NCT00892281|532313287|FG000|Overall Study|Rash on hand|1|||
147589398|NCT00892281|532313288|FG001|Overall Study|Rash on hand|0|||
147589399|NCT00892281|532313287|FG000|Overall Study|Visit 4 date out of window|1|||
147589400|NCT00892281|532313288|FG001|Overall Study|Visit 4 date out of window|0|||
147589401|NCT02129647|532313289|FG000|Overall Study|Adverse Event|2|||
147589402|NCT02129647|532313289|FG000|Overall Study|surgical intervention for clinically progressive disease|1|||
147589403|NCT00608517|532313290|FG000|Overall Study|Death|1|||
147589404|NCT00608517|532313291|FG001|Overall Study|Death|0|||
147589405|NCT00608517|532313292|FG002|Overall Study|Death|0|||
147589406|NCT01833533|532313293|FG000|Overall Study|Adverse Event|0|||
147589407|NCT01833533|532313294|FG001|Overall Study|Adverse Event|1|||
147589408|NCT01833533|532313293|FG000|Overall Study|Lost to Follow-up|4|||
147589409|NCT01833533|532313294|FG001|Overall Study|Lost to Follow-up|9|||
147589410|NCT01833533|532313293|FG000|Overall Study|To Enter an Extension Study|0|||
147589411|NCT01833533|532313294|FG001|Overall Study|To Enter an Extension Study|4|||
147589412|NCT01833533|532313293|FG000|Overall Study|Other|2|||
147589413|NCT01833533|532313294|FG001|Overall Study|Other|7|||
147589414|NCT02502734|532313297|FG000|Double-blind Treatment Period 1|Adverse Event|1|||
147589415|NCT02502734|532313298|FG001|Double-blind Treatment Period 1|Adverse Event|0|||
147589416|NCT02502734|532313297|FG000|Washout Period|Adverse Event|1|||
147589417|NCT02502734|532313298|FG001|Washout Period|Adverse Event|0|||
147589418|NCT01740791|532313302|FG000|Overall Study|Randomized but never treated|5|||
147589419|NCT01740791|532313303|FG001|Overall Study|Randomized but never treated|3|||
147589420|NCT01740791|532313304|FG002|Overall Study|Randomized but never treated|2|||
147589421|NCT01740791|532313305|FG003|Overall Study|Randomized but never treated|2|||
147589422|NCT01740791|532313306|FG004|Overall Study|Randomized but never treated|1|||
147589423|NCT01740791|532313307|FG005|Overall Study|Randomized but never treated|3|||
147589424|NCT01740791|532313302|FG000|Overall Study|Lost to Follow-up|2|||
147589425|NCT01740791|532313303|FG001|Overall Study|Lost to Follow-up|0|||
147589426|NCT01740791|532313304|FG002|Overall Study|Lost to Follow-up|2|||
147589427|NCT01740791|532313305|FG003|Overall Study|Lost to Follow-up|3|||
147589428|NCT01740791|532313306|FG004|Overall Study|Lost to Follow-up|2|||
147589429|NCT01740791|532313307|FG005|Overall Study|Lost to Follow-up|3|||
147589430|NCT01740791|532313302|FG000|Overall Study|Withdrew Consent|4|||
147589431|NCT01740791|532313303|FG001|Overall Study|Withdrew Consent|0|||
147589432|NCT01740791|532313304|FG002|Overall Study|Withdrew Consent|1|||
147589433|NCT01740791|532313305|FG003|Overall Study|Withdrew Consent|2|||
147589434|NCT01740791|532313306|FG004|Overall Study|Withdrew Consent|0|||
147589435|NCT01740791|532313307|FG005|Overall Study|Withdrew Consent|3|||
147589436|NCT01740791|532313302|FG000|Overall Study|Investigator's discretion|1|||
147589437|NCT01740791|532313303|FG001|Overall Study|Investigator's discretion|0|||
147589438|NCT01740791|532313304|FG002|Overall Study|Investigator's discretion|1|||
147589439|NCT01740791|532313305|FG003|Overall Study|Investigator's discretion|0|||
147589440|NCT01740791|532313306|FG004|Overall Study|Investigator's discretion|0|||
147164228|NCT02008357|530764584|FG000|Double-blind (Placebo Controlled) Period|Started Prohibited Medication|0|||
147164229|NCT02008357|530764585|FG001|Double-blind (Placebo Controlled) Period|Started Prohibited Medication|1|||
147164230|NCT02008357|530764584|FG000|Double-blind (Placebo Controlled) Period|Starting A New Treatment For Alzheimer's Disease|1|||
147589441|NCT01740791|532313307|FG005|Overall Study|Investigator's discretion|1|||
147589442|NCT01740791|532313302|FG000|Overall Study|Adverse Event|0|||
147589443|NCT01740791|532313303|FG001|Overall Study|Adverse Event|0|||
147589444|NCT01740791|532313304|FG002|Overall Study|Adverse Event|0|||
147589445|NCT01740791|532313305|FG003|Overall Study|Adverse Event|0|||
147589446|NCT01740791|532313306|FG004|Overall Study|Adverse Event|0|||
147589447|NCT01740791|532313307|FG005|Overall Study|Adverse Event|1|||
147589448|NCT01463982|532313308|FG000|Overall Study|Withdrawal by Subject|0|||
147589449|NCT01463982|532313309|FG001|Overall Study|Withdrawal by Subject|1|||
147589450|NCT01463982|532313310|FG002|Overall Study|Withdrawal by Subject|1|||
147589451|NCT01463982|532313311|FG003|Overall Study|Withdrawal by Subject|0|||
147589452|NCT01463982|532313308|FG000|Overall Study|Treatment delay over 5 week|0|||
147164231|NCT02008357|530764585|FG001|Double-blind (Placebo Controlled) Period|Starting A New Treatment For Alzheimer's Disease|1|||
147164232|NCT02008357|530764584|FG000|Double-blind (Placebo Controlled) Period|Starting New Trial|2|||
147164233|NCT02008357|530764585|FG001|Double-blind (Placebo Controlled) Period|Starting New Trial|0|||
147164234|NCT02008357|530764584|FG000|Double-blind (Placebo Controlled) Period|Study Partner Unwilling Or Unable To Participate|3|||
147589453|NCT01463982|532313309|FG001|Overall Study|Treatment delay over 5 week|0|||
147589454|NCT01463982|532313310|FG002|Overall Study|Treatment delay over 5 week|1|||
147589455|NCT01463982|532313311|FG003|Overall Study|Treatment delay over 5 week|0|||
147589456|NCT03417830|532313314|FG000|Part A (up to 26 Days)|Study Closed/Terminated|1|||
147589457|NCT03417830|532313315|FG001|Part A (up to 26 Days)|Study Closed/Terminated|0|||
147589458|NCT00941720|532313320|FG000|Overall Study|Withdrawal by Subject|1|||
147589459|NCT00941720|532313320|FG000|Overall Study|Insurance denied participation|11|||
147589460|NCT00941720|532313320|FG000|Overall Study|ineligible|2|||
147589461|NCT03827018|532313323|FG000|Overall Study|Adverse Event|1|||
147589462|NCT03827018|532313324|FG001|Overall Study|Adverse Event|0|||
147589463|NCT03827018|532313323|FG000|Overall Study|Withdrawal by Subject|2|||
147589464|NCT03827018|532313324|FG001|Overall Study|Withdrawal by Subject|2|||
147589465|NCT03827018|532313323|FG000|Overall Study|Lack of Efficacy|0|||
147589466|NCT03827018|532313324|FG001|Overall Study|Lack of Efficacy|1|||
147589467|NCT00268892|532313326|FG000|Overall Study|Adverse Event|14|||
147589468|NCT00268892|532313327|FG001|Overall Study|Adverse Event|17|||
147589469|NCT00268892|532313328|FG002|Overall Study|Adverse Event|20|||
147589470|NCT00268892|532313326|FG000|Overall Study|Lack of Efficacy|1|||
147589471|NCT00268892|532313327|FG001|Overall Study|Lack of Efficacy|3|||
147589472|NCT00268892|532313328|FG002|Overall Study|Lack of Efficacy|0|||
147589473|NCT00268892|532313326|FG000|Overall Study|Withdrawal by Subject|14|||
147589474|NCT00268892|532313327|FG001|Overall Study|Withdrawal by Subject|15|||
147589475|NCT00268892|532313328|FG002|Overall Study|Withdrawal by Subject|13|||
147589476|NCT00268892|532313326|FG000|Overall Study|Physician Decision|0|||
147589477|NCT00268892|532313327|FG001|Overall Study|Physician Decision|1|||
147589478|NCT00268892|532313328|FG002|Overall Study|Physician Decision|0|||
147589479|NCT00268892|532313326|FG000|Overall Study|Lost to Follow-up|5|||
147589480|NCT00268892|532313327|FG001|Overall Study|Lost to Follow-up|2|||
147589481|NCT00268892|532313328|FG002|Overall Study|Lost to Follow-up|4|||
147589482|NCT00268892|532313326|FG000|Overall Study|Protocol Violation|0|||
147589483|NCT00268892|532313327|FG001|Overall Study|Protocol Violation|1|||
147589484|NCT00268892|532313328|FG002|Overall Study|Protocol Violation|0|||
147589485|NCT00268892|532313326|FG000|Overall Study|Disease Progression|1|||
147589486|NCT00268892|532313327|FG001|Overall Study|Disease Progression|1|||
147589487|NCT00268892|532313328|FG002|Overall Study|Disease Progression|0|||
147589488|NCT00268892|532313326|FG000|Overall Study|Trial Site Closed|4|||
147589489|NCT00268892|532313327|FG001|Overall Study|Trial Site Closed|2|||
147589490|NCT00268892|532313328|FG002|Overall Study|Trial Site Closed|2|||
147589491|NCT04099641|532313329|FG000|Overall Study|Death|46|||
147589492|NCT04099641|532313330|FG001|Overall Study|Death|12|||
147589493|NCT04099641|532313329|FG000|Overall Study|Lost to Follow-up|1|||
147589494|NCT04099641|532313330|FG001|Overall Study|Lost to Follow-up|0|||
147589495|NCT04099641|532313329|FG000|Overall Study|Withdrawal by Subject|2|||
147589496|NCT04099641|532313330|FG001|Overall Study|Withdrawal by Subject|0|||
147589497|NCT00895037|532313331|FG000|Overall Study|Death|0|||
147589498|NCT00895037|532313332|FG001|Overall Study|Death|2|||
147589499|NCT00895037|532313333|FG002|Overall Study|Death|1|||
147589500|NCT01523587|532313338|FG000|Overall Study|Other than listed|5|||
147589501|NCT01523587|532313339|FG001|Overall Study|Other than listed|5|||
147589502|NCT01523587|532313338|FG000|Overall Study|Worsening of underlying cancer disease|19|||
147589503|NCT01523587|532313339|FG001|Overall Study|Worsening of underlying cancer disease|34|||
147589504|NCT01523587|532313338|FG000|Overall Study|Adverse Event|68|||
147589505|NCT01523587|532313339|FG001|Overall Study|Adverse Event|52|||
147164235|NCT02008357|530764585|FG001|Double-blind (Placebo Controlled) Period|Study Partner Unwilling Or Unable To Participate|1|||
147164236|NCT02008357|530764584|FG000|Double-blind (Placebo Controlled) Period|Family Issues|1|||
147164237|NCT02008357|530764585|FG001|Double-blind (Placebo Controlled) Period|Family Issues|1|||
147164238|NCT02008357|530764584|FG000|Double-blind (Placebo Controlled) Period|Subject Relocated to Another Place|4|||
147589506|NCT01523587|532313338|FG000|Overall Study|Protocol Violation|5|||
147589507|NCT01523587|532313339|FG001|Overall Study|Protocol Violation|3|||
147589508|NCT01523587|532313338|FG000|Overall Study|Lost to Follow-up|2|||
147589509|NCT01523587|532313339|FG001|Overall Study|Lost to Follow-up|2|||
147589510|NCT01523587|532313338|FG000|Overall Study|Withdrawal by Subject|28|||
147589511|NCT01523587|532313339|FG001|Overall Study|Withdrawal by Subject|20|||
147589512|NCT01523587|532313338|FG000|Overall Study|Withdrew due to Progressive disease|265|||
147589513|NCT01523587|532313339|FG001|Overall Study|Withdrew due to Progressive disease|279|||
147589514|NCT01523587|532313338|FG000|Overall Study|Randomised but bot treated|6|||
147589515|NCT01523587|532313339|FG001|Overall Study|Randomised but bot treated|2|||
147589516|NCT02244424|532313341|FG000|Overall Study|Lost to Follow-up|20|||
147589517|NCT02244424|532313342|FG001|Overall Study|Lost to Follow-up|10|||
147589518|NCT03366194|532313343|FG000|Overall Study|Lost to Follow-up|2|||
147589519|NCT03078478|532313344|FG000|Maintenance Period 1 (36 Weeks)|Withdrawal by Subject|36|||
147595999|NCT00251641|532338768|FG001|Overall Study|Adverse Event|8|||
147164239|NCT02008357|530764585|FG001|Double-blind (Placebo Controlled) Period|Subject Relocated to Another Place|2|||
147164240|NCT02008357|530764584|FG000|Double-blind (Placebo Controlled) Period|Subject's Expectation From Study Were not Aligned|0|||
147164241|NCT02008357|530764585|FG001|Double-blind (Placebo Controlled) Period|Subject's Expectation From Study Were not Aligned|3|||
147164242|NCT02008357|530764584|FG000|Double-blind (Placebo Controlled) Period|Personal Reason|0|||
147164243|NCT02008357|530764585|FG001|Double-blind (Placebo Controlled) Period|Personal Reason|1|||
147164244|NCT02008357|530764584|FG000|Double-blind (Placebo Controlled) Period|Discontinued Study due to Health Issues|3|||
147164245|NCT02008357|530764585|FG001|Double-blind (Placebo Controlled) Period|Discontinued Study due to Health Issues|0|||
147164246|NCT02008357|530764584|FG000|Double-blind (Placebo Controlled) Period|Site Closure|0|||
147164247|NCT02008357|530764585|FG001|Double-blind (Placebo Controlled) Period|Site Closure|1|||
147164248|NCT02008357|530764584|FG000|Double-blind (Placebo Controlled) Period|Medical Health of Study Partner|0|||
147164249|NCT02008357|530764585|FG001|Double-blind (Placebo Controlled) Period|Medical Health of Study Partner|1|||
147164250|NCT02008357|530764584|FG000|Double-blind (Placebo Controlled) Period|No Longer Wishes to Participate|1|||
147164251|NCT02008357|530764585|FG001|Double-blind (Placebo Controlled) Period|No Longer Wishes to Participate|2|||
147164252|NCT02008357|530764584|FG000|Double-blind (Placebo Controlled) Period|Subject Concurrently Enrolled in Another Clinical Drug Trial|0|||
147164253|NCT02008357|530764585|FG001|Double-blind (Placebo Controlled) Period|Subject Concurrently Enrolled in Another Clinical Drug Trial|1|||
147164254|NCT02008357|530764584|FG000|Double-blind (Placebo Controlled) Period|Starting Another Treatment for the Disease|0|||
147164255|NCT02008357|530764585|FG001|Double-blind (Placebo Controlled) Period|Starting Another Treatment for the Disease|1|||
147164256|NCT02008357|530764584|FG000|Double-blind (Placebo Controlled) Period|Decision was Taken by Subject's Personal Doctor|1|||
147164257|NCT02008357|530764585|FG001|Double-blind (Placebo Controlled) Period|Decision was Taken by Subject's Personal Doctor|0|||
147164258|NCT02008357|530764584|FG000|Double-blind (Placebo Controlled) Period|Inability to have MRI due to Stimulator Implant|0|||
147164259|NCT02008357|530764585|FG001|Double-blind (Placebo Controlled) Period|Inability to have MRI due to Stimulator Implant|1|||
147589520|NCT03078478|532313345|FG001|Maintenance Period 1 (36 Weeks)|Withdrawal by Subject|36|||
147589521|NCT03078478|532313344|FG000|Maintenance Period 1 (36 Weeks)|Lost to Follow-up|7|||
147589522|NCT03078478|532313345|FG001|Maintenance Period 1 (36 Weeks)|Lost to Follow-up|4|||
147589523|NCT03078478|532313344|FG000|Maintenance Period 1 (36 Weeks)|Death|3|||
147589524|NCT03078478|532313345|FG001|Maintenance Period 1 (36 Weeks)|Death|3|||
147589525|NCT03078478|532313344|FG000|Maintenance Period 1 (36 Weeks)|Subject withdrawal reason not collected|1|||
147589526|NCT03078478|532313345|FG001|Maintenance Period 1 (36 Weeks)|Subject withdrawal reason not collected|0|||
147589527|NCT03078478|532313344|FG000|Maintencance Period 2 (36 Weeks)|Withdrawal by Subject|18|||
147589528|NCT03078478|532313345|FG001|Maintencance Period 2 (36 Weeks)|Withdrawal by Subject|13|||
147589529|NCT03078478|532313344|FG000|Maintencance Period 2 (36 Weeks)|Lost to Follow-up|3|||
147589530|NCT03078478|532313345|FG001|Maintencance Period 2 (36 Weeks)|Lost to Follow-up|6|||
147589531|NCT03078478|532313344|FG000|Maintencance Period 2 (36 Weeks)|Death|4|||
147589532|NCT03078478|532313345|FG001|Maintencance Period 2 (36 Weeks)|Death|6|||
147589533|NCT03078478|532313344|FG000|Maintencance Period 2 (36 Weeks)|Not reconsenting|0|||
147589534|NCT03078478|532313345|FG001|Maintencance Period 2 (36 Weeks)|Not reconsenting|2|||
147589535|NCT00545688|532313346|FG000|Neo-Adjuvant Treatment Period|Protocol Violation|1|||
147589536|NCT00545688|532313347|FG001|Neo-Adjuvant Treatment Period|Protocol Violation|2|||
147589537|NCT00545688|532313348|FG002|Neo-Adjuvant Treatment Period|Protocol Violation|1|||
147589538|NCT00545688|532313349|FG003|Neo-Adjuvant Treatment Period|Protocol Violation|1|||
147589539|NCT00545688|532313346|FG000|Neo-Adjuvant Treatment Period|Refused Treatment|1|||
147589540|NCT00545688|532313347|FG001|Neo-Adjuvant Treatment Period|Refused Treatment|1|||
147589541|NCT00545688|532313348|FG002|Neo-Adjuvant Treatment Period|Refused Treatment|4|||
147589542|NCT00545688|532313349|FG003|Neo-Adjuvant Treatment Period|Refused Treatment|1|||
147589543|NCT00545688|532313346|FG000|Neo-Adjuvant Treatment Period|Lost to Follow-up|1|||
147589544|NCT00545688|532313347|FG001|Neo-Adjuvant Treatment Period|Lost to Follow-up|0|||
147589545|NCT00545688|532313348|FG002|Neo-Adjuvant Treatment Period|Lost to Follow-up|0|||
147589546|NCT00545688|532313349|FG003|Neo-Adjuvant Treatment Period|Lost to Follow-up|0|||
147589547|NCT00545688|532313346|FG000|Neo-Adjuvant Treatment Period|Death|0|||
147589548|NCT00545688|532313347|FG001|Neo-Adjuvant Treatment Period|Death|1|||
147589549|NCT00545688|532313348|FG002|Neo-Adjuvant Treatment Period|Death|0|||
147589550|NCT00545688|532313349|FG003|Neo-Adjuvant Treatment Period|Death|0|||
147589551|NCT00545688|532313346|FG000|Neo-Adjuvant Treatment Period|Disease Progression|0|||
147589552|NCT00545688|532313347|FG001|Neo-Adjuvant Treatment Period|Disease Progression|1|||
147164260|NCT02008357|530764584|FG000|Open-label Extension Period|Adverse Event|8|||
147164261|NCT02008357|530764585|FG001|Open-label Extension Period|Adverse Event|7|||
147164262|NCT02008357|530764584|FG000|Open-label Extension Period|Death|7|||
147164263|NCT02008357|530764585|FG001|Open-label Extension Period|Death|4|||
147243172|NCT02378961|531062071|FG003|Overall Study|Lack of Efficacy|1|||
147243173|NCT02378961|531062068|FG000|Overall Study|Death|0|||
147243174|NCT02378961|531062069|FG001|Overall Study|Death|0|||
147243175|NCT02378961|531062070|FG002|Overall Study|Death|1|||
147243176|NCT02378961|531062071|FG003|Overall Study|Death|0|||
147243177|NCT01253408|531062072|FG000|Overall Study|Adverse Event|0|||
147589553|NCT00545688|532313348|FG002|Neo-Adjuvant Treatment Period|Disease Progression|7|||
147596000|NCT00251641|532338767|FG000|Overall Study|Lack of Efficacy|2|||
147164264|NCT02008357|530764584|FG000|Open-label Extension Period|Lack of Efficacy|9|||
147164265|NCT02008357|530764585|FG001|Open-label Extension Period|Lack of Efficacy|5|||
147164266|NCT02008357|530764584|FG000|Open-label Extension Period|Lost to Follow-up|2|||
147164267|NCT02008357|530764585|FG001|Open-label Extension Period|Lost to Follow-up|2|||
147589554|NCT00545688|532313349|FG003|Neo-Adjuvant Treatment Period|Disease Progression|2|||
147589555|NCT00545688|532313346|FG000|Neo-Adjuvant Treatment Period|Unknown Reason|1|||
147589556|NCT00545688|532313347|FG001|Neo-Adjuvant Treatment Period|Unknown Reason|0|||
147589557|NCT00545688|532313348|FG002|Neo-Adjuvant Treatment Period|Unknown Reason|0|||
147589558|NCT00545688|532313349|FG003|Neo-Adjuvant Treatment Period|Unknown Reason|0|||
147589559|NCT00545688|532313346|FG000|Neo-Adjuvant Treatment Period|Adverse Event|0|||
147589560|NCT00545688|532313347|FG001|Neo-Adjuvant Treatment Period|Adverse Event|0|||
147589561|NCT00545688|532313348|FG002|Neo-Adjuvant Treatment Period|Adverse Event|2|||
147589562|NCT00545688|532313349|FG003|Neo-Adjuvant Treatment Period|Adverse Event|2|||
147589563|NCT00545688|532313346|FG000|Adjuvant Treatment Period|Disease Progression|3|||
147589564|NCT00545688|532313347|FG001|Adjuvant Treatment Period|Disease Progression|3|||
147589565|NCT00545688|532313348|FG002|Adjuvant Treatment Period|Disease Progression|0|||
147589566|NCT00545688|532313349|FG003|Adjuvant Treatment Period|Disease Progression|7|||
147589567|NCT00545688|532313346|FG000|Adjuvant Treatment Period|Refused Treatment|1|||
147589568|NCT00545688|532313347|FG001|Adjuvant Treatment Period|Refused Treatment|1|||
147589569|NCT00545688|532313348|FG002|Adjuvant Treatment Period|Refused Treatment|1|||
147589570|NCT00545688|532313349|FG003|Adjuvant Treatment Period|Refused Treatment|5|||
147589571|NCT00545688|532313346|FG000|Adjuvant Treatment Period|Lost to Follow-up|1|||
147589572|NCT00545688|532313347|FG001|Adjuvant Treatment Period|Lost to Follow-up|0|||
147589573|NCT00545688|532313348|FG002|Adjuvant Treatment Period|Lost to Follow-up|1|||
147589574|NCT00545688|532313349|FG003|Adjuvant Treatment Period|Lost to Follow-up|0|||
147589575|NCT00545688|532313346|FG000|Adjuvant Treatment Period|Adverse Event|0|||
147589576|NCT00545688|532313347|FG001|Adjuvant Treatment Period|Adverse Event|3|||
147589577|NCT00545688|532313348|FG002|Adjuvant Treatment Period|Adverse Event|2|||
147589578|NCT00545688|532313349|FG003|Adjuvant Treatment Period|Adverse Event|2|||
147589579|NCT00545688|532313346|FG000|Adjuvant Treatment Period|Unknown Reason|0|||
147589580|NCT00545688|532313347|FG001|Adjuvant Treatment Period|Unknown Reason|1|||
147589581|NCT00545688|532313348|FG002|Adjuvant Treatment Period|Unknown Reason|0|||
147589582|NCT00545688|532313349|FG003|Adjuvant Treatment Period|Unknown Reason|0|||
147589583|NCT00545688|532313346|FG000|Follow-Up Period|Death|4|||
147589584|NCT00545688|532313347|FG001|Follow-Up Period|Death|2|||
147589585|NCT00545688|532313348|FG002|Follow-Up Period|Death|2|||
147589586|NCT00545688|532313349|FG003|Follow-Up Period|Death|6|||
147589587|NCT00545688|532313346|FG000|Follow-Up Period|Disease Progression|6|||
147589588|NCT00545688|532313347|FG001|Follow-Up Period|Disease Progression|5|||
147589589|NCT00545688|532313348|FG002|Follow-Up Period|Disease Progression|9|||
147589590|NCT00545688|532313349|FG003|Follow-Up Period|Disease Progression|9|||
147589591|NCT00545688|532313346|FG000|Follow-Up Period|Refused Treatment|6|||
147589592|NCT00545688|532313347|FG001|Follow-Up Period|Refused Treatment|2|||
147589593|NCT00545688|532313348|FG002|Follow-Up Period|Refused Treatment|0|||
147589594|NCT00545688|532313349|FG003|Follow-Up Period|Refused Treatment|2|||
147589595|NCT00545688|532313346|FG000|Follow-Up Period|Lost to Follow-up|3|||
147589596|NCT00545688|532313347|FG001|Follow-Up Period|Lost to Follow-up|3|||
147589597|NCT00545688|532313348|FG002|Follow-Up Period|Lost to Follow-up|3|||
147589598|NCT00545688|532313349|FG003|Follow-Up Period|Lost to Follow-up|1|||
147589599|NCT00545688|532313346|FG000|Follow-Up Period|Unspecified Reason|2|||
147589600|NCT00545688|532313347|FG001|Follow-Up Period|Unspecified Reason|5|||
147589601|NCT00545688|532313348|FG002|Follow-Up Period|Unspecified Reason|6|||
147589602|NCT00545688|532313349|FG003|Follow-Up Period|Unspecified Reason|8|||
147589603|NCT00545688|532313346|FG000|Follow-Up Period|Violation of Selection Criteria at Entry|0|||
147589604|NCT00545688|532313347|FG001|Follow-Up Period|Violation of Selection Criteria at Entry|2|||
147589605|NCT00545688|532313348|FG002|Follow-Up Period|Violation of Selection Criteria at Entry|0|||
147589606|NCT00545688|532313349|FG003|Follow-Up Period|Violation of Selection Criteria at Entry|1|||
147589607|NCT02792218|532313350|FG000|Overall Study|Patient/guardian decision|15|||
147589608|NCT02792218|532313351|FG001|Overall Study|Patient/guardian decision|42|||
147589609|NCT02792218|532313350|FG000|Overall Study|Adverse Event|15|||
147164268|NCT02008357|530764584|FG000|Open-label Extension Period|Withdrawal by Subject|27|||
147589610|NCT02792218|532313351|FG001|Overall Study|Adverse Event|14|||
147589611|NCT02792218|532313350|FG000|Overall Study|Lost to Follow-up|10|||
147589612|NCT02792218|532313351|FG001|Overall Study|Lost to Follow-up|5|||
147589613|NCT02792218|532313350|FG000|Overall Study|Lack of Efficacy|1|||
147589614|NCT02792218|532313351|FG001|Overall Study|Lack of Efficacy|12|||
147589615|NCT02792218|532313350|FG000|Overall Study|Physician Decision|4|||
147589616|NCT02792218|532313351|FG001|Overall Study|Physician Decision|4|||
147589617|NCT02792218|532313350|FG000|Overall Study|Protocol deviation|3|||
147589618|NCT02792218|532313351|FG001|Overall Study|Protocol deviation|2|||
147589619|NCT02792218|532313350|FG000|Overall Study|New therapy for study indication|0|||
147589620|NCT02792218|532313351|FG001|Overall Study|New therapy for study indication|1|||
147589621|NCT02792218|532313350|FG000|Overall Study|Non-compliance with study treatment|0|||
147589622|NCT02792218|532313351|FG001|Overall Study|Non-compliance with study treatment|1|||
147589623|NCT02792218|532313350|FG000|Overall Study|Pregnancy|1|||
147589624|NCT02792218|532313351|FG001|Overall Study|Pregnancy|0|||
147589625|NCT02065713|532314281|FG000|Overall Study|Adverse Event|0|||
147589626|NCT02065713|532314282|FG001|Overall Study|Adverse Event|1|||
147589627|NCT02065713|532314281|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
147589628|NCT02065713|532314282|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
147589629|NCT01048502|532314289|FG000|Overall Study|Lost to Follow-up|2|||
147589630|NCT01048502|532314290|FG001|Overall Study|Lost to Follow-up|0|||
147589631|NCT01048502|532314291|FG002|Overall Study|Lost to Follow-up|0|||
147589632|NCT01048502|532314292|FG003|Overall Study|Lost to Follow-up|0|||
147589633|NCT01048502|532314289|FG000|Overall Study|Adverse Event|1|||
147589634|NCT01048502|532314290|FG001|Overall Study|Adverse Event|0|||
147589635|NCT01048502|532314291|FG002|Overall Study|Adverse Event|0|||
147589636|NCT01048502|532314292|FG003|Overall Study|Adverse Event|0|||
147589637|NCT01048502|532314289|FG000|Overall Study|Withdrawal by Subject|1|||
147589638|NCT01048502|532314290|FG001|Overall Study|Withdrawal by Subject|4|||
147589639|NCT01048502|532314291|FG002|Overall Study|Withdrawal by Subject|5|||
147589640|NCT01048502|532314292|FG003|Overall Study|Withdrawal by Subject|3|||
147589641|NCT01048502|532314289|FG000|Overall Study|Physician Decision|0|||
147589642|NCT01048502|532314290|FG001|Overall Study|Physician Decision|3|||
147589643|NCT01048502|532314291|FG002|Overall Study|Physician Decision|0|||
147589644|NCT01048502|532314292|FG003|Overall Study|Physician Decision|1|||
147589645|NCT00685802|532314293|FG000|Washout Period of 7 Days|Protocol Violation|2|||
147589646|NCT00685802|532314294|FG001|Washout Period of 7 Days|Protocol Violation|0|||
147589647|NCT00685802|532314293|FG000|Washout Period of 7 Days|Withdrawal by Subject|0|||
147589648|NCT00685802|532314294|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
147589649|NCT01333072|532314295|FG000|Overall Study|Lost to Follow-up|3|||
147589650|NCT01333072|532314296|FG001|Overall Study|Lost to Follow-up|0|||
147589651|NCT01333072|532314295|FG000|Overall Study|Adverse Event|2|||
147589652|NCT01333072|532314296|FG001|Overall Study|Adverse Event|4|||
147589653|NCT01333072|532314295|FG000|Overall Study|Physician Decision|1|||
147589654|NCT01333072|532314296|FG001|Overall Study|Physician Decision|0|||
147164269|NCT02008357|530764585|FG001|Open-label Extension Period|Withdrawal by Subject|32|||
147164270|NCT02008357|530764584|FG000|Open-label Extension Period|Study Terminated By Sponsor|300|||
147164271|NCT02008357|530764585|FG001|Open-label Extension Period|Study Terminated By Sponsor|313|||
147164272|NCT02008357|530764584|FG000|Open-label Extension Period|Safety Risk|2|||
147164273|NCT02008357|530764585|FG001|Open-label Extension Period|Safety Risk|1|||
147164274|NCT02008357|530764584|FG000|Open-label Extension Period|Non-Compliance|0|||
147164275|NCT02008357|530764585|FG001|Open-label Extension Period|Non-Compliance|1|||
147164276|NCT02008357|530764584|FG000|Open-label Extension Period|Investigator Recommendation|0|||
147164277|NCT02008357|530764585|FG001|Open-label Extension Period|Investigator Recommendation|1|||
147164278|NCT02008357|530764584|FG000|Open-label Extension Period|Covid-19 Pandemic Disruption|0|||
147164279|NCT02008357|530764585|FG001|Open-label Extension Period|Covid-19 Pandemic Disruption|1|||
147164280|NCT02008357|530764584|FG000|Open-label Extension Period|Coordinating Center Request|2|||
147164281|NCT02008357|530764585|FG001|Open-label Extension Period|Coordinating Center Request|4|||
147164282|NCT02008357|530764584|FG000|Open-label Extension Period|No Longer Wishes to Participate|1|||
147164283|NCT02008357|530764585|FG001|Open-label Extension Period|No Longer Wishes to Participate|1|||
147164284|NCT02008357|530764584|FG000|Open-label Extension Period|Study Ended|20|||
147164285|NCT02008357|530764585|FG001|Open-label Extension Period|Study Ended|25|||
147164286|NCT02008357|530764584|FG000|Open-label Extension Period|Personal Reasons|0|||
147164287|NCT02008357|530764585|FG001|Open-label Extension Period|Personal Reasons|1|||
147164288|NCT02008357|530764584|FG000|Open-label Extension Period|Discontinued Study Due to Health Issues|0|||
147164289|NCT02008357|530764585|FG001|Open-label Extension Period|Discontinued Study Due to Health Issues|2|||
147164290|NCT02008357|530764584|FG000|Open-label Extension Period|Travel Issues/Limitations|2|||
147164291|NCT02008357|530764585|FG001|Open-label Extension Period|Travel Issues/Limitations|0|||
147164292|NCT02008357|530764584|FG000|Open-label Extension Period|Other|2|||
147164293|NCT02008357|530764585|FG001|Open-label Extension Period|Other|0|||
147447646|NCT01877187|531803920|FG000|Overall Study|Death|2|||
147447647|NCT01877187|531803920|FG000|Overall Study|Withdrawal by Subject|4|||
147164294|NCT01442064|530764586|FG000|Overall Study|Adverse Event|2|||
147164295|NCT01442064|530764587|FG001|Overall Study|Adverse Event|2|||
147164296|NCT01442064|530764588|FG002|Overall Study|Adverse Event|2|||
147164297|NCT01442064|530764589|FG003|Overall Study|Adverse Event|1|||
147164298|NCT01442064|530764590|FG004|Overall Study|Adverse Event|2|||
147589655|NCT00619359|532314297|FG000|Overall Study|Adverse Event|32|||
147589656|NCT00619359|532314298|FG001|Overall Study|Adverse Event|36|||
147589657|NCT00619359|532314297|FG000|Overall Study|Lost to Follow-up|12|||
147589658|NCT00619359|532314298|FG001|Overall Study|Lost to Follow-up|16|||
147589659|NCT00619359|532314297|FG000|Overall Study|Physician Decision|0|||
147589660|NCT00619359|532314298|FG001|Overall Study|Physician Decision|7|||
147589661|NCT00619359|532314297|FG000|Overall Study|Protocol Violation|1|||
147589662|NCT00619359|532314298|FG001|Overall Study|Protocol Violation|1|||
147589663|NCT00619359|532314297|FG000|Overall Study|Withdrawal by Subject|19|||
147589664|NCT00619359|532314298|FG001|Overall Study|Withdrawal by Subject|20|||
147589665|NCT00619359|532314297|FG000|Overall Study|Progressive Disease|3|||
147164299|NCT01442064|530764591|FG005|Overall Study|Adverse Event|0|||
147164300|NCT01442064|530764586|FG000|Overall Study|Death|0|||
147164301|NCT01442064|530764587|FG001|Overall Study|Death|1|||
147164302|NCT01442064|530764588|FG002|Overall Study|Death|3|||
147164303|NCT01442064|530764589|FG003|Overall Study|Death|3|||
147164304|NCT01442064|530764590|FG004|Overall Study|Death|1|||
147164305|NCT01442064|530764591|FG005|Overall Study|Death|3|||
147164306|NCT01442064|530764586|FG000|Overall Study|Lost to Follow-up|5|||
147164307|NCT01442064|530764587|FG001|Overall Study|Lost to Follow-up|5|||
147164308|NCT01442064|530764588|FG002|Overall Study|Lost to Follow-up|1|||
147164309|NCT01442064|530764589|FG003|Overall Study|Lost to Follow-up|1|||
147164310|NCT01442064|530764590|FG004|Overall Study|Lost to Follow-up|3|||
147164311|NCT01442064|530764591|FG005|Overall Study|Lost to Follow-up|3|||
147164312|NCT01442064|530764586|FG000|Overall Study|Physician Decision|1|||
147164313|NCT01442064|530764587|FG001|Overall Study|Physician Decision|1|||
147164314|NCT01442064|530764588|FG002|Overall Study|Physician Decision|2|||
147164315|NCT01442064|530764589|FG003|Overall Study|Physician Decision|3|||
147164316|NCT01442064|530764590|FG004|Overall Study|Physician Decision|3|||
147164317|NCT01442064|530764591|FG005|Overall Study|Physician Decision|1|||
147164318|NCT01442064|530764586|FG000|Overall Study|Withdrawal by Subject|6|||
147164319|NCT01442064|530764587|FG001|Overall Study|Withdrawal by Subject|3|||
147164320|NCT01442064|530764588|FG002|Overall Study|Withdrawal by Subject|2|||
147164321|NCT01442064|530764589|FG003|Overall Study|Withdrawal by Subject|2|||
147164322|NCT01442064|530764590|FG004|Overall Study|Withdrawal by Subject|2|||
147164323|NCT01442064|530764591|FG005|Overall Study|Withdrawal by Subject|1|||
147164324|NCT01442064|530764586|FG000|Overall Study|Sponsor decision|82|||
147164325|NCT01442064|530764587|FG001|Overall Study|Sponsor decision|88|||
147164326|NCT01442064|530764588|FG002|Overall Study|Sponsor decision|92|||
147164327|NCT01442064|530764589|FG003|Overall Study|Sponsor decision|88|||
147164328|NCT01442064|530764590|FG004|Overall Study|Sponsor decision|95|||
147164329|NCT01442064|530764591|FG005|Overall Study|Sponsor decision|87|||
147164330|NCT01442064|530764586|FG000|Overall Study|Subject non-compliance|0|||
147164331|NCT01442064|530764587|FG001|Overall Study|Subject non-compliance|0|||
147164332|NCT01442064|530764588|FG002|Overall Study|Subject non-compliance|0|||
147164333|NCT01442064|530764589|FG003|Overall Study|Subject non-compliance|0|||
147164334|NCT01442064|530764590|FG004|Overall Study|Subject non-compliance|0|||
147164335|NCT01442064|530764591|FG005|Overall Study|Subject non-compliance|2|||
147164336|NCT01442064|530764586|FG000|Overall Study|Condition mandated other intervention|1|||
147164337|NCT01442064|530764587|FG001|Overall Study|Condition mandated other intervention|1|||
147164338|NCT01442064|530764588|FG002|Overall Study|Condition mandated other intervention|2|||
147164339|NCT01442064|530764589|FG003|Overall Study|Condition mandated other intervention|0|||
147164340|NCT01442064|530764590|FG004|Overall Study|Condition mandated other intervention|0|||
147164341|NCT01442064|530764591|FG005|Overall Study|Condition mandated other intervention|2|||
147164342|NCT02312219|530764592|FG000|Overall Study|Withdrawal by Subject|1|||
147243178|NCT01253408|531062073|FG001|Overall Study|Adverse Event|1|||
147243179|NCT01253408|531062074|FG002|Overall Study|Adverse Event|0|||
147243180|NCT02405780|531062081|FG000|Period I|Adverse Event|8|||
147243181|NCT02405780|531062082|FG001|Period I|Adverse Event|0|||
147243182|NCT02405780|531062083|FG002|Period I|Adverse Event|3|||
147243183|NCT02405780|531062084|FG003|Period I|Adverse Event|7|||
147243184|NCT02405780|531062081|FG000|Period I|Medical reasons|1|||
147243185|NCT02405780|531062082|FG001|Period I|Medical reasons|1|||
147243186|NCT02405780|531062083|FG002|Period I|Medical reasons|0|||
147243187|NCT02405780|531062084|FG003|Period I|Medical reasons|1|||
147243188|NCT02405780|531062081|FG000|Period I|Screening Failure|1|||
147243189|NCT02405780|531062082|FG001|Period I|Screening Failure|0|||
147243190|NCT02405780|531062083|FG002|Period I|Screening Failure|1|||
147243191|NCT02405780|531062084|FG003|Period I|Screening Failure|0|||
147243192|NCT02405780|531062081|FG000|Period I|Withdrawal by Subject|9|||
147243193|NCT02405780|531062082|FG001|Period I|Withdrawal by Subject|1|||
147323222|NCT04011033|531347946|FG000|Overall Study|Physician Decision|2|||
147323223|NCT04011033|531347947|FG001|Overall Study|Physician Decision|3|||
147164343|NCT02312219|530764593|FG001|Overall Study|Withdrawal by Subject|2|||
147164344|NCT02312219|530764592|FG000|Overall Study|could not schedule imaging in time|0|||
147164345|NCT02312219|530764593|FG001|Overall Study|could not schedule imaging in time|2|||
147164346|NCT02312219|530764592|FG000|Overall Study|Other|0|||
147164347|NCT02312219|530764593|FG001|Overall Study|Other|1|||
147164348|NCT02312219|530764592|FG000|Overall Study|Not randomized. Ineligible|0|||
147164349|NCT02312219|530764593|FG001|Overall Study|Not randomized. Ineligible|1|||
147164350|NCT02153346|530764594|FG000|Overall Study|Lost to Follow-up|11|||
147164351|NCT01522404|530764599|FG000|First Intervention (up to Week 29)|Withdrawal by Subject|1|||
147164352|NCT01522404|530764600|FG001|First Intervention (up to Week 29)|Withdrawal by Subject|0|||
147164353|NCT01522404|530764599|FG000|First Intervention (up to Week 29)|Adverse Event|1|||
147243194|NCT02405780|531062083|FG002|Period I|Withdrawal by Subject|3|||
147243195|NCT02405780|531062084|FG003|Period I|Withdrawal by Subject|4|||
147243196|NCT02405780|531062081|FG000|Period I|Non-compliance with study procedures|8|||
147243197|NCT02405780|531062082|FG001|Period I|Non-compliance with study procedures|6|||
147243198|NCT02405780|531062083|FG002|Period I|Non-compliance with study procedures|8|||
147589666|NCT00619359|532314298|FG001|Overall Study|Progressive Disease|1|||
147589667|NCT00103038|532314300|FG000|Overall Study|Withdrawal by Subject|8|||
147164354|NCT01522404|530764600|FG001|First Intervention (up to Week 29)|Adverse Event|0|||
147164355|NCT01522404|530764599|FG000|Second Intervention (up to Week 58)|Withdrawal by Subject|1|||
147164356|NCT01522404|530764600|FG001|Second Intervention (up to Week 58)|Withdrawal by Subject|0|||
147164357|NCT01591863|530764601|FG000|Overall Study|Adverse Event|3|||
147164358|NCT01591863|530764601|FG000|Overall Study|Withdrawal by Subject|1|||
147164359|NCT01591863|530764601|FG000|Overall Study|recurrence|9|||
147164360|NCT01591863|530764601|FG000|Overall Study|Lack of Efficacy|1|||
147164361|NCT02366767|530764604|FG000|Overall Study|left for home after 1 day at camp|1|||
147164362|NCT02366767|530764605|FG001|Overall Study|left for home after 1 day at camp|0|||
147164363|NCT00260065|530764608|FG000|Overall Study|Progressive Disease|22|||
147164364|NCT00260065|530764608|FG000|Overall Study|Adverse Event|17|||
147164365|NCT00260065|530764608|FG000|Overall Study|Death|13|||
147164366|NCT00260065|530764608|FG000|Overall Study|Withdrawal by Subject|13|||
147164367|NCT00260065|530764608|FG000|Overall Study|Physician Decision|19|||
147164368|NCT00260065|530764608|FG000|Overall Study|Not otherwise specified|8|||
147164369|NCT00260065|530764608|FG000|Overall Study|Medication Noncompliance|1|||
147164370|NCT00583791|530766598|FG000|Overall Study|Other|67|||
147164371|NCT00583791|530766598|FG000|Overall Study|Death|6|||
147164372|NCT03769311|530766600|FG000|Overall Study|Withdrawal by Subject|1|||
147164373|NCT02853435|530766601|FG000|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0|||
147164374|NCT02853435|530766602|FG001|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0|||
147164375|NCT02853435|530766603|FG002|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0|||
147589668|NCT00103038|532314300|FG000|Overall Study|Screen failure|3|||
147589669|NCT00103038|532314300|FG000|Overall Study|Death|1|||
147164376|NCT02853435|530766604|FG003|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0|||
147164377|NCT02853435|530766605|FG004|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|1|||
147164378|NCT02853435|530766606|FG005|Part 3, Washout Period 2 (3 Days)|Withdrawal by Subject|0|||
147164379|NCT04912895|530766619|FG000|Overall Study|Unable to provide specimen|2|||
147164380|NCT04912895|530766620|FG001|Overall Study|Unable to provide specimen|0|||
147164381|NCT04912895|530766621|FG002|Overall Study|Unable to provide specimen|0|||
147164382|NCT02785458|530766622|FG000|1 Month|Withdrawal by Subject|2|||
147164383|NCT02785458|530766623|FG001|1 Month|Withdrawal by Subject|1|||
147164384|NCT02785458|530766622|FG000|1 Month|Lost to Follow-up|38|||
147164385|NCT02785458|530766623|FG001|1 Month|Lost to Follow-up|31|||
147164386|NCT02785458|530766622|FG000|1 Month|Deemed Ineligible|1|||
147164387|NCT02785458|530766623|FG001|1 Month|Deemed Ineligible|0|||
147164388|NCT02785458|530766622|FG000|1 Month|Completed Evaluation by Baseline|42|||
147164389|NCT02785458|530766623|FG001|1 Month|Completed Evaluation by Baseline|39|||
147164390|NCT02785458|530766622|FG000|1 Month|Partial Interview|0|||
147164391|NCT02785458|530766623|FG001|1 Month|Partial Interview|4|||
147164392|NCT02785458|530766622|FG000|3 Months|Withdrawal by Subject|3|||
147164393|NCT02785458|530766623|FG001|3 Months|Withdrawal by Subject|1|||
147164394|NCT02785458|530766622|FG000|3 Months|Lost to Follow-up|25|||
147164395|NCT02785458|530766623|FG001|3 Months|Lost to Follow-up|21|||
147164396|NCT02785458|530766622|FG000|3 Months|Completed Evaluation at 1 Month|100|||
147164397|NCT02785458|530766623|FG001|3 Months|Completed Evaluation at 1 Month|89|||
147164398|NCT01146652|530766624|FG000|Overall Study|Adverse Event|506|||
147164399|NCT01146652|530766625|FG001|Overall Study|Adverse Event|15|||
147164400|NCT01146652|530766624|FG000|Overall Study|Lack of Efficacy|91|||
147164401|NCT01146652|530766625|FG001|Overall Study|Lack of Efficacy|7|||
147164402|NCT01146652|530766624|FG000|Overall Study|Poor compliance to protocol|38|||
147164403|NCT01146652|530766625|FG001|Overall Study|Poor compliance to protocol|1|||
147164404|NCT01146652|530766624|FG000|Overall Study|Other unspecified reasons|314|||
147164405|NCT01146652|530766625|FG001|Overall Study|Other unspecified reasons|22|||
147164406|NCT01146652|530766624|FG000|Overall Study|Enrolled but not treated|2|||
147164407|NCT01146652|530766625|FG001|Overall Study|Enrolled but not treated|0|||
147164408|NCT00520013|530766626|FG000|Overall Study|Withdrawal by Subject|0|||
147164409|NCT00520013|530766627|FG001|Overall Study|Withdrawal by Subject|0|||
147164410|NCT00520013|530766628|FG002|Overall Study|Withdrawal by Subject|1|||
147164411|NCT00520013|530766626|FG000|Overall Study|Adverse Event|2|||
147164412|NCT00520013|530766627|FG001|Overall Study|Adverse Event|10|||
147164413|NCT00520013|530766628|FG002|Overall Study|Adverse Event|7|||
147164414|NCT00520013|530766626|FG000|Overall Study|Progressive Disease|7|||
147164415|NCT00520013|530766627|FG001|Overall Study|Progressive Disease|3|||
147589670|NCT00103038|532314300|FG000|Overall Study|Physician Decision|1|||
147164416|NCT00520013|530766628|FG002|Overall Study|Progressive Disease|0|||
147164417|NCT00520013|530766626|FG000|Overall Study|Clinical Progression|3|||
147164418|NCT00520013|530766627|FG001|Overall Study|Clinical Progression|1|||
147164419|NCT00520013|530766628|FG002|Overall Study|Clinical Progression|0|||
147164420|NCT00520013|530766626|FG000|Overall Study|Death|0|||
147164421|NCT00520013|530766627|FG001|Overall Study|Death|1|||
147164422|NCT00520013|530766628|FG002|Overall Study|Death|0|||
147589671|NCT01483625|532314303|FG000|Overall Study|Adverse Event|1|||
147164423|NCT00520013|530766626|FG000|Overall Study|Physician Decision|0|||
147164424|NCT00520013|530766627|FG001|Overall Study|Physician Decision|0|||
147589672|NCT01483625|532314304|FG001|Overall Study|Adverse Event|1|||
147243199|NCT02405780|531062084|FG003|Period I|Non-compliance with study procedures|11|||
147243200|NCT02405780|531062081|FG000|Period II|Adverse Event|3|||
147243201|NCT02405780|531062082|FG001|Period II|Adverse Event|5|||
147243202|NCT02405780|531062083|FG002|Period II|Adverse Event|4|||
147243203|NCT02405780|531062084|FG003|Period II|Adverse Event|11|||
147243204|NCT02405780|531062081|FG000|Period II|Medical reason|0|||
147243205|NCT02405780|531062082|FG001|Period II|Medical reason|1|||
147243206|NCT02405780|531062083|FG002|Period II|Medical reason|0|||
147243207|NCT02405780|531062084|FG003|Period II|Medical reason|0|||
147243208|NCT02405780|531062081|FG000|Period II|Pregnancy|0|||
147243209|NCT02405780|531062082|FG001|Period II|Pregnancy|0|||
147243210|NCT02405780|531062083|FG002|Period II|Pregnancy|1|||
147243211|NCT02405780|531062084|FG003|Period II|Pregnancy|0|||
147243212|NCT02405780|531062081|FG000|Period II|Withdrawal by Subject|7|||
147243213|NCT02405780|531062082|FG001|Period II|Withdrawal by Subject|4|||
147243214|NCT02405780|531062083|FG002|Period II|Withdrawal by Subject|0|||
147243215|NCT02405780|531062084|FG003|Period II|Withdrawal by Subject|3|||
147243216|NCT02405780|531062081|FG000|Period II|Non-compliance with study procedures|5|||
147243217|NCT02405780|531062082|FG001|Period II|Non-compliance with study procedures|2|||
147243218|NCT02405780|531062083|FG002|Period II|Non-compliance with study procedures|7|||
147243219|NCT02405780|531062084|FG003|Period II|Non-compliance with study procedures|4|||
147243220|NCT04502693|531062085|FG000|Overall Study|Adverse Event|7|||
147243221|NCT04502693|531062086|FG001|Overall Study|Adverse Event|6|||
147243222|NCT04502693|531062087|FG002|Overall Study|Adverse Event|11|||
147243223|NCT04502693|531062088|FG003|Overall Study|Adverse Event|1|||
147243224|NCT04502693|531062085|FG000|Overall Study|Lost to Follow-up|32|||
147243225|NCT04502693|531062086|FG001|Overall Study|Lost to Follow-up|36|||
147243226|NCT04502693|531062087|FG002|Overall Study|Lost to Follow-up|69|||
147243227|NCT04502693|531062088|FG003|Overall Study|Lost to Follow-up|4|||
147243228|NCT04502693|531062085|FG000|Overall Study|Protocol Violation|8|||
147243229|NCT04502693|531062086|FG001|Overall Study|Protocol Violation|8|||
147243230|NCT04502693|531062087|FG002|Overall Study|Protocol Violation|16|||
147243231|NCT04502693|531062088|FG003|Overall Study|Protocol Violation|1|||
147243232|NCT04502693|531062085|FG000|Overall Study|Withdrawal by Subject|46|||
147243233|NCT04502693|531062086|FG001|Overall Study|Withdrawal by Subject|38|||
147243234|NCT04502693|531062087|FG002|Overall Study|Withdrawal by Subject|54|||
147243235|NCT04502693|531062088|FG003|Overall Study|Withdrawal by Subject|7|||
147243236|NCT04502693|531062085|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|6|||
147243237|NCT04502693|531062086|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|7|||
147243238|NCT04502693|531062087|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|9|||
147243239|NCT04502693|531062088|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
147243240|NCT04502693|531062085|FG000|Overall Study|Other|1|||
147243241|NCT04502693|531062086|FG001|Overall Study|Other|0|||
147243242|NCT04502693|531062087|FG002|Overall Study|Other|1|||
147243243|NCT04502693|531062088|FG003|Overall Study|Other|1|||
147243244|NCT00602797|531062089|FG000|Overall Study|Adverse Event|1|||
147243245|NCT02784431|531062094|FG000|Overall Study|Unsuccessful Implant Attempt|1|||
147243246|NCT02784431|531062094|FG000|Overall Study|Early Study Termination|19|||
147243247|NCT03715530|531062095|FG000|Overall Study|Lost to Follow-up|3|||
147243248|NCT03715530|531062096|FG001|Overall Study|Lost to Follow-up|1|||
147243249|NCT03715530|531062097|FG002|Overall Study|Lost to Follow-up|2|||
147243250|NCT00382252|531062098|FG000|Overall Study|Death|4|||
147243251|NCT00382252|531062098|FG000|Overall Study|Protocol Violation|8|||
147243252|NCT00382252|531062098|FG000|Overall Study|Not treated by RFA|1|||
147243253|NCT00039130|531062100|FG000|Overall Study|Adverse Event|11|||
147243254|NCT00039130|531062100|FG000|Overall Study|Death|9|||
147243255|NCT00039130|531062100|FG000|Overall Study|Withdrawal by Subject|3|||
147243256|NCT00039130|531062100|FG000|Overall Study|Progression|2|||
147323224|NCT04011033|531347946|FG000|Overall Study|Withdrawal by Subject|1|||
147323225|NCT04011033|531347947|FG001|Overall Study|Withdrawal by Subject|0|||
147323226|NCT01823341|531347948|FG000|Overall Study|Failed run-in|7|||
147323227|NCT01823341|531347948|FG000|Overall Study|Withdrawal by Subject|7|||
147243257|NCT00039130|531062100|FG000|Overall Study|Subsequent treatment|2|||
147243258|NCT00039130|531062100|FG000|Overall Study|Physician Decision|3|||
147243259|NCT03288129|531062101|FG000|Overall Study|Adverse Event|10|||
147243260|NCT03288129|531062101|FG000|Overall Study|Lost to Follow-up|3|||
147243261|NCT03288129|531062101|FG000|Overall Study|Withdrawal by Subject|3|||
147243262|NCT03288129|531062101|FG000|Overall Study|Withdrawal of consent/assent|1|||
147243263|NCT03288129|531062101|FG000|Overall Study|Other|5|||
147243264|NCT01949506|531062107|FG000|Overall Study|Physician Decision|1|||
147243265|NCT02915016|531062108|FG000|Overall Study|Lost to Follow-up|4|||
147243266|NCT02915016|531062109|FG001|Overall Study|Lost to Follow-up|2|||
147243267|NCT02915016|531062110|FG002|Overall Study|Lost to Follow-up|5|||
147243268|NCT02915016|531062111|FG003|Overall Study|Lost to Follow-up|3|||
147243269|NCT02915016|531062112|FG004|Overall Study|Lost to Follow-up|5|||
147243270|NCT02915016|531062113|FG005|Overall Study|Lost to Follow-up|2|||
147243271|NCT02915016|531062114|FG006|Overall Study|Lost to Follow-up|8|||
147243272|NCT02915016|531062115|FG007|Overall Study|Lost to Follow-up|2|||
147243273|NCT02915016|531062108|FG000|Overall Study|Physician Decision|0|||
147243274|NCT02915016|531062109|FG001|Overall Study|Physician Decision|0|||
147164425|NCT00520013|530766628|FG002|Overall Study|Physician Decision|3|||
147589673|NCT01483625|532314303|FG000|Overall Study|Refused to continue medication|2|||
147589674|NCT01483625|532314304|FG001|Overall Study|Refused to continue medication|1|||
147589675|NCT01483625|532314303|FG000|Overall Study|Due to other reason|1|||
147589676|NCT01483625|532314304|FG001|Overall Study|Due to other reason|0|||
147164426|NCT02118597|530766629|FG000|Overall Study|Sponsor terminated the study|14|||
147164427|NCT02118597|530766629|FG000|Overall Study|Serious Adverse Event|1|||
147164428|NCT02118597|530766629|FG000|Overall Study|Investigator's decision|1|||
147164429|NCT02590562|530766634|FG000|Overall Study|Did Not Meet the Inclusion Criteria|6|||
147589677|NCT01731886|532314305|FG000|Overall Study|Death|1|||
147589678|NCT01731886|532314306|FG001|Overall Study|Death|0|||
147589679|NCT01731886|532314305|FG000|Overall Study|Never started treatment|0|||
147589680|NCT01731886|532314306|FG001|Overall Study|Never started treatment|1|||
147589681|NCT01731886|532314305|FG000|Overall Study|Non-compliant|1|||
147589682|NCT01731886|532314306|FG001|Overall Study|Non-compliant|0|||
147589683|NCT02280187|532314307|FG000|Overall Study|Lost to Follow-up|218|||
147589684|NCT02094261|532314308|FG000|Overall Study|Death|24|||
147589685|NCT02094261|532314308|FG000|Overall Study|Lost to Follow-up|1|||
147589686|NCT02094261|532314308|FG000|Overall Study|Withdrawal by Subject|4|||
147589687|NCT02094261|532314308|FG000|Overall Study|Ongoing Study at Data Cut-off|181|||
147589688|NCT04668274|532314309|FG000|Part 1 Study Period 1|Adverse Event|3|||
147589689|NCT04668274|532314310|FG001|Part 1 Study Period 1|Adverse Event|0|||
147589690|NCT04668274|532314311|FG002|Part 1 Study Period 1|Adverse Event|0|||
147589691|NCT04668274|532314312|FG003|Part 1 Study Period 1|Adverse Event|0|||
147589692|NCT04668274|532314309|FG000|Part 1 Study Period 1|Withdrawal by Subject|2|||
147589693|NCT04668274|532314310|FG001|Part 1 Study Period 1|Withdrawal by Subject|0|||
147589694|NCT04668274|532314311|FG002|Part 1 Study Period 1|Withdrawal by Subject|0|||
147589695|NCT04668274|532314312|FG003|Part 1 Study Period 1|Withdrawal by Subject|0|||
147589696|NCT04668274|532314309|FG000|Part 1 Study Period 2|Other|0|||
147589697|NCT04668274|532314310|FG001|Part 1 Study Period 2|Other|1|||
147589698|NCT04668274|532314311|FG002|Part 1 Study Period 2|Other|0|||
147589699|NCT04668274|532314312|FG003|Part 1 Study Period 2|Other|0|||
147589700|NCT04668274|532314309|FG000|Part 1 Study Period 3|Adverse Event|0|||
147589701|NCT04668274|532314310|FG001|Part 1 Study Period 3|Adverse Event|0|||
147589702|NCT04668274|532314311|FG002|Part 1 Study Period 3|Adverse Event|1|||
147589703|NCT04668274|532314312|FG003|Part 1 Study Period 3|Adverse Event|0|||
147589704|NCT04668274|532314309|FG000|Part 1 Study Period 3|Other|0|||
147589705|NCT04668274|532314310|FG001|Part 1 Study Period 3|Other|0|||
147589706|NCT04668274|532314311|FG002|Part 1 Study Period 3|Other|2|||
147589707|NCT04668274|532314312|FG003|Part 1 Study Period 3|Other|0|||
147589708|NCT04668274|532314309|FG000|Part 2 Study Period 4|Other|0|||
147589709|NCT04668274|532314310|FG001|Part 2 Study Period 4|Other|0|||
147589710|NCT04668274|532314311|FG002|Part 2 Study Period 4|Other|0|||
147589711|NCT04668274|532314312|FG003|Part 2 Study Period 4|Other|1|||
147589712|NCT02363439|532314315|FG000|Overall Study|Lack of Efficacy|4|||
147589713|NCT02087176|532314320|FG000|Overall Study|Withdrawal by Subject|1|||
147589714|NCT02087176|532314320|FG000|Overall Study|Death|10|||
147164430|NCT00824005|530766635|FG000|Overall Study|Death|0|||
147164431|NCT00824005|530766636|FG001|Overall Study|Death|1|||
147243275|NCT02915016|531062110|FG002|Overall Study|Physician Decision|1|||
147589715|NCT02087176|532314320|FG000|Overall Study|Censored|19|||
147164432|NCT00824005|530766635|FG000|Overall Study|Lost to Follow-up|0|||
147164433|NCT00824005|530766636|FG001|Overall Study|Lost to Follow-up|1|||
147164434|NCT01866423|530766637|FG000|Overall Study|Lack of Efficacy|3|||
147164435|NCT01866423|530766637|FG000|Overall Study|Sponsor Decision|1|||
147164436|NCT02255565|530766638|FG000|Overall Study|Withdrawal by Subject|0|||
147164437|NCT02255565|530766639|FG001|Overall Study|Withdrawal by Subject|1|||
147164438|NCT02255565|530766640|FG002|Overall Study|Withdrawal by Subject|0|||
147164439|NCT02699450|530766641|FG000|Overall Study|Death|2|||
147243276|NCT02915016|531062111|FG003|Overall Study|Physician Decision|0|||
147243277|NCT02915016|531062112|FG004|Overall Study|Physician Decision|0|||
147164440|NCT02699450|530766642|FG001|Overall Study|Death|1|||
147164441|NCT02699450|530766643|FG002|Overall Study|Death|2|||
147164442|NCT02699450|530766641|FG000|Overall Study|Met Criteria for Study Exit|0|||
147164443|NCT02699450|530766642|FG001|Overall Study|Met Criteria for Study Exit|0|||
147164444|NCT02699450|530766643|FG002|Overall Study|Met Criteria for Study Exit|1|||
147164445|NCT02699450|530766641|FG000|Overall Study|Protocol Violation|4|||
147164446|NCT02699450|530766642|FG001|Overall Study|Protocol Violation|3|||
147164447|NCT02699450|530766643|FG002|Overall Study|Protocol Violation|5|||
147164448|NCT02699450|530766641|FG000|Overall Study|Lost to Follow-up|3|||
147164449|NCT02699450|530766642|FG001|Overall Study|Lost to Follow-up|0|||
147243278|NCT02915016|531062113|FG005|Overall Study|Physician Decision|1|||
147164450|NCT02699450|530766643|FG002|Overall Study|Lost to Follow-up|5|||
147589716|NCT02087176|532314320|FG000|Overall Study|Study Terminated by Sponsor|2|||
147589717|NCT03812991|532314321|FG000|Overall Study|Lost to Follow-up|3|||
147589718|NCT03812991|532314322|FG001|Overall Study|Lost to Follow-up|1|||
147589719|NCT02470091|532314336|FG000|Overall Study|Withdrawal by Subject|1|||
147589720|NCT02470091|532314337|FG001|Overall Study|Withdrawal by Subject|0|||
147589721|NCT02470091|532314336|FG000|Overall Study|Ineligible|0|||
147589722|NCT02470091|532314337|FG001|Overall Study|Ineligible|2|||
147589723|NCT01192399|532314349|FG000|Overall Study|Lack of Efficacy|2|||
147589724|NCT00303667|532314350|FG000|Overall Study|Death|0|||
147589725|NCT00303667|532314351|FG001|Overall Study|Death|4|||
147589726|NCT01029392|532314352|FG000|Overall Study|Withdrawal by Subject|18|||
147589727|NCT01029392|532314353|FG001|Overall Study|Withdrawal by Subject|11|||
147589728|NCT01029392|532314352|FG000|Overall Study|Physician Decision|2|||
147589729|NCT01029392|532314353|FG001|Overall Study|Physician Decision|0|||
147589730|NCT01103479|532314354|FG000|Overall Study|Up to date with CRC screening|1|||
147589731|NCT01103479|532314355|FG001|Overall Study|Up to date with CRC screening|9|||
147589732|NCT01103479|532314356|FG002|Overall Study|Up to date with CRC screening|12|||
147589733|NCT01103479|532314354|FG000|Overall Study|Family history of CRC|1|||
147589734|NCT01103479|532314355|FG001|Overall Study|Family history of CRC|0|||
147589735|NCT01103479|532314356|FG002|Overall Study|Family history of CRC|2|||
147589736|NCT01103479|532314354|FG000|Overall Study|Active cancer|1|||
147589737|NCT01103479|532314355|FG001|Overall Study|Active cancer|0|||
147589738|NCT01103479|532314356|FG002|Overall Study|Active cancer|0|||
147589739|NCT01103479|532314354|FG000|Overall Study|Saw non-study physician|2|||
147589740|NCT01103479|532314355|FG001|Overall Study|Saw non-study physician|0|||
147589741|NCT01103479|532314356|FG002|Overall Study|Saw non-study physician|0|||
147589742|NCT01298778|532314357|FG000|Overall Study|Lost to Follow-up|2|||
147589743|NCT01298778|532314358|FG001|Overall Study|Lost to Follow-up|3|||
147589744|NCT01298778|532314357|FG000|Overall Study|Incorrect use of VAS|1|||
147589745|NCT01298778|532314358|FG001|Overall Study|Incorrect use of VAS|0|||
147589746|NCT01298778|532314357|FG000|Overall Study|Withdrawal by Subject|0|||
147589747|NCT01298778|532314358|FG001|Overall Study|Withdrawal by Subject|1|||
147589748|NCT01298778|532314357|FG000|Overall Study|Protocol Violation|0|||
147589749|NCT01298778|532314358|FG001|Overall Study|Protocol Violation|1|||
147589750|NCT01298778|532314357|FG000|Overall Study|not meet inclusion/exclusion criteria|0|||
147589751|NCT01298778|532314358|FG001|Overall Study|not meet inclusion/exclusion criteria|1|||
147589752|NCT00536484|532314359|FG000|Overall Study|Adverse Event|21|||
147589753|NCT00536484|532314360|FG001|Overall Study|Adverse Event|34|||
147589754|NCT00536484|532314359|FG000|Overall Study|Withdrawal by Subject|11|||
147589755|NCT00536484|532314360|FG001|Overall Study|Withdrawal by Subject|11|||
147589756|NCT00536484|532314359|FG000|Overall Study|Lost to Follow-up|8|||
147589757|NCT00536484|532314360|FG001|Overall Study|Lost to Follow-up|6|||
147589758|NCT00536484|532314359|FG000|Overall Study|Lack of Efficacy|16|||
147589759|NCT00536484|532314360|FG001|Overall Study|Lack of Efficacy|5|||
147589760|NCT00536484|532314359|FG000|Overall Study|Other|4|||
147589761|NCT00536484|532314360|FG001|Overall Study|Other|0|||
147589762|NCT02083926|532314361|FG000|Overall Study|Withdrawal by Subject|1|||
147589763|NCT02083926|532314362|FG001|Overall Study|Withdrawal by Subject|0|||
147589764|NCT00384176|532314363|FG000|Overall Study|Death|239|||
147164451|NCT02699450|530766641|FG000|Overall Study|Physician Decision|2|||
147164452|NCT02699450|530766642|FG001|Overall Study|Physician Decision|0|||
147164453|NCT02699450|530766643|FG002|Overall Study|Physician Decision|0|||
147164454|NCT02699450|530766641|FG000|Overall Study|Withdrawal by Subject|3|||
147164455|NCT02699450|530766642|FG001|Overall Study|Withdrawal by Subject|1|||
147164456|NCT02699450|530766643|FG002|Overall Study|Withdrawal by Subject|2|||
147164457|NCT02699450|530766641|FG000|Overall Study|Adverse Event|1|||
147164458|NCT02699450|530766642|FG001|Overall Study|Adverse Event|0|||
147164459|NCT02699450|530766643|FG002|Overall Study|Adverse Event|0|||
147164460|NCT00900146|530766646|FG000|Dose Finding: Period II (4 Months)|Withdrawal by Subject|2|||
147164461|NCT00900146|530766647|FG001|Dose Finding: Period II (4 Months)|Withdrawal by Subject|2|||
147164462|NCT00900146|530766648|FG002|Dose Finding: Period II (4 Months)|Withdrawal by Subject|5|||
147164463|NCT00900146|530766649|FG003|Dose Finding: Period II (4 Months)|Withdrawal by Subject|1|||
147164464|NCT00900146|530766650|FG004|Dose Finding: Period II (4 Months)|Withdrawal by Subject|9|||
147164465|NCT00900146|530766646|FG000|Dose Finding: Period II (4 Months)|Lost to Follow-up|2|||
147164466|NCT00900146|530766647|FG001|Dose Finding: Period II (4 Months)|Lost to Follow-up|0|||
147164467|NCT00900146|530766648|FG002|Dose Finding: Period II (4 Months)|Lost to Follow-up|0|||
147323228|NCT01823341|531347948|FG000|Overall Study|Adverse Event|1|||
147589765|NCT00384176|532314364|FG001|Overall Study|Death|247|||
147589766|NCT00384176|532314365|FG002|Overall Study|Death|105|||
147589767|NCT00384176|532314363|FG000|Overall Study|Withdrawal by Subject|52|||
147589768|NCT00384176|532314364|FG001|Overall Study|Withdrawal by Subject|48|||
147589769|NCT00384176|532314365|FG002|Overall Study|Withdrawal by Subject|22|||
147589770|NCT00384176|532314363|FG000|Overall Study|Lost to Follow-up|16|||
147589771|NCT00384176|532314364|FG001|Overall Study|Lost to Follow-up|18|||
147589772|NCT00384176|532314365|FG002|Overall Study|Lost to Follow-up|4|||
147589773|NCT00384176|532314363|FG000|Overall Study|Incorrect enrol/elig crit not fulfilled|2|||
147589774|NCT00384176|532314364|FG001|Overall Study|Incorrect enrol/elig crit not fulfilled|3|||
147589775|NCT00384176|532314365|FG002|Overall Study|Incorrect enrol/elig crit not fulfilled|0|||
147589776|NCT00384176|532314363|FG000|Overall Study|Longer QTC as Visit 1|1|||
147589777|NCT00384176|532314364|FG001|Overall Study|Longer QTC as Visit 1|0|||
147589778|NCT00384176|532314365|FG002|Overall Study|Longer QTC as Visit 1|0|||
147589779|NCT00384176|532314363|FG000|Overall Study|Toxicity of treatment|1|||
147164468|NCT00900146|530766649|FG003|Dose Finding: Period II (4 Months)|Lost to Follow-up|1|||
147164469|NCT00900146|530766650|FG004|Dose Finding: Period II (4 Months)|Lost to Follow-up|3|||
147164470|NCT00900146|530766646|FG000|Dose Finding: Period II (4 Months)|Administrative problems|1|||
147164471|NCT00900146|530766647|FG001|Dose Finding: Period II (4 Months)|Administrative problems|0|||
147164472|NCT00900146|530766648|FG002|Dose Finding: Period II (4 Months)|Administrative problems|0|||
147164473|NCT00900146|530766649|FG003|Dose Finding: Period II (4 Months)|Administrative problems|0|||
147164474|NCT00900146|530766650|FG004|Dose Finding: Period II (4 Months)|Administrative problems|0|||
147164475|NCT00900146|530766646|FG000|Intermediate: Period III|Withdrawal by Subject|0|||
147164476|NCT00900146|530766647|FG001|Intermediate: Period III|Withdrawal by Subject|1|||
147164477|NCT00900146|530766648|FG002|Intermediate: Period III|Withdrawal by Subject|0|||
147164478|NCT00900146|530766649|FG003|Intermediate: Period III|Withdrawal by Subject|0|||
147164479|NCT00900146|530766650|FG004|Intermediate: Period III|Withdrawal by Subject|3|||
147164480|NCT00900146|530766646|FG000|Intermediate: Period III|Lost to Follow-up|2|||
147164481|NCT00900146|530766647|FG001|Intermediate: Period III|Lost to Follow-up|0|||
147164482|NCT00900146|530766648|FG002|Intermediate: Period III|Lost to Follow-up|0|||
147164483|NCT00900146|530766649|FG003|Intermediate: Period III|Lost to Follow-up|0|||
147164484|NCT00900146|530766650|FG004|Intermediate: Period III|Lost to Follow-up|1|||
147164485|NCT00900146|530766646|FG000|Intermediate: Period III|Administrative problems|85|||
147164486|NCT00900146|530766647|FG001|Intermediate: Period III|Administrative problems|92|||
147164487|NCT00900146|530766648|FG002|Intermediate: Period III|Administrative problems|84|||
147164488|NCT00900146|530766649|FG003|Intermediate: Period III|Administrative problems|90|||
147164489|NCT00900146|530766650|FG004|Intermediate: Period III|Administrative problems|163|||
147164490|NCT00700102|530766651|FG000|Overall Study|Died|394|||
147164491|NCT00700102|530766652|FG001|Overall Study|Died|385|||
147164492|NCT00700102|530766651|FG000|Overall Study|Lost to Follow-up|8|||
147164493|NCT00700102|530766652|FG001|Overall Study|Lost to Follow-up|10|||
147164494|NCT02525939|530766657|FG000|Overall Study|Lost to Follow-up|27|||
147164495|NCT02525939|530766658|FG001|Overall Study|Lost to Follow-up|24|||
147164496|NCT02525939|530766657|FG000|Overall Study|Physician Decision|0|||
147164497|NCT02525939|530766658|FG001|Overall Study|Physician Decision|1|||
147164498|NCT02525939|530766657|FG000|Overall Study|Withdrawal by Subject|24|||
147164499|NCT02525939|530766658|FG001|Overall Study|Withdrawal by Subject|39|||
147164500|NCT02525939|530766657|FG000|Overall Study|Death|180|||
147164501|NCT02525939|530766658|FG001|Overall Study|Death|179|||
147164502|NCT01635764|530766659|FG000|Overall Study|Adverse Event|46|||
147164503|NCT01635764|530766659|FG000|Overall Study|Lack of Efficacy|76|||
147164504|NCT01635764|530766659|FG000|Overall Study|Exceed Protocol-specified Interventions|2|||
147164505|NCT01635764|530766659|FG000|Overall Study|Protocol Deviation|1|||
147164506|NCT01635764|530766659|FG000|Overall Study|Withdrew Consent|67|||
147164507|NCT01635764|530766659|FG000|Overall Study|Lost to Follow-up|53|||
147164508|NCT01635764|530766659|FG000|Overall Study|Other|28|||
147164509|NCT00933244|530766660|FG000|Overall Study|Withdrawal by Subject|5|||
147164510|NCT00933244|530766661|FG001|Overall Study|Withdrawal by Subject|1|||
147164511|NCT00933244|530766662|FG002|Overall Study|Withdrawal by Subject|3|||
147164512|NCT01174004|530766663|FG000|Overall Study|Adverse Event|2|||
147164513|NCT01174004|530766664|FG001|Overall Study|Adverse Event|10|||
147164514|NCT01174004|530766663|FG000|Overall Study|Withdrawal by Subject|2|||
147164515|NCT01174004|530766664|FG001|Overall Study|Withdrawal by Subject|3|||
147164516|NCT01174004|530766663|FG000|Overall Study|At Discretion of Sponsor|2|||
147164517|NCT01174004|530766664|FG001|Overall Study|At Discretion of Sponsor|2|||
147164518|NCT01174004|530766663|FG000|Overall Study|Protocol Violation|0|||
147164519|NCT01174004|530766664|FG001|Overall Study|Protocol Violation|1|||
147164520|NCT01174004|530766663|FG000|Overall Study|Physician Decision|1|||
147164521|NCT01174004|530766664|FG001|Overall Study|Physician Decision|0|||
147164522|NCT02956850|530766665|FG000|Overall Study|Withdrawal by Subject|0|||
147164523|NCT02956850|530766666|FG001|Overall Study|Withdrawal by Subject|0|||
147164524|NCT02956850|530766667|FG002|Overall Study|Withdrawal by Subject|0|||
147164525|NCT02956850|530766668|FG003|Overall Study|Withdrawal by Subject|0|||
147164526|NCT02956850|530766669|FG004|Overall Study|Withdrawal by Subject|0|||
147589780|NCT00384176|532314364|FG001|Overall Study|Toxicity of treatment|0|||
147589781|NCT00384176|532314365|FG002|Overall Study|Toxicity of treatment|0|||
147164527|NCT02956850|530766670|FG005|Overall Study|Withdrawal by Subject|0|||
147164528|NCT02956850|530766671|FG006|Overall Study|Withdrawal by Subject|0|||
147164529|NCT02956850|530766672|FG007|Overall Study|Withdrawal by Subject|0|||
147164530|NCT02956850|530766673|FG008|Overall Study|Withdrawal by Subject|0|||
147164531|NCT02956850|530766674|FG009|Overall Study|Withdrawal by Subject|0|||
147164532|NCT02956850|530766675|FG010|Overall Study|Withdrawal by Subject|0|||
147164533|NCT02956850|530766676|FG011|Overall Study|Withdrawal by Subject|0|||
147596001|NCT00251641|532338768|FG001|Overall Study|Lack of Efficacy|1|||
147164534|NCT02956850|530766677|FG012|Overall Study|Withdrawal by Subject|0|||
147164535|NCT02956850|530766678|FG013|Overall Study|Withdrawal by Subject|0|||
147164536|NCT02956850|530766679|FG014|Overall Study|Withdrawal by Subject|0|||
147164537|NCT02956850|530766680|FG015|Overall Study|Withdrawal by Subject|0|||
147164538|NCT02956850|530766681|FG016|Overall Study|Withdrawal by Subject|0|||
147164539|NCT02956850|530766682|FG017|Overall Study|Withdrawal by Subject|1|||
147164540|NCT01920152|530766683|FG000|Overall Study|Withdrawal by Subject|1|||
147164541|NCT01920152|530766684|FG001|Overall Study|Withdrawal by Subject|2|||
147164542|NCT01995552|530766686|FG000|Overall Study|Protocol Violation|1|||
147164543|NCT01995552|530766686|FG000|Overall Study|Lack of Efficacy|15|||
147164544|NCT01995552|530766686|FG000|Overall Study|Death|1|||
147164545|NCT01515475|530766687|FG000|Overall Study|Lost to Follow-up|20|||
147164546|NCT01515475|530766688|FG001|Overall Study|Lost to Follow-up|15|||
147164547|NCT01515475|530766689|FG002|Overall Study|Lost to Follow-up|12|||
147164548|NCT01515475|530766690|FG003|Overall Study|Lost to Follow-up|12|||
147164549|NCT04957758|530766694|FG000|Overall Study|Adverse Event|1|||
147164550|NCT04957758|530766695|FG001|Overall Study|Adverse Event|0|||
147164551|NCT04957758|530766694|FG000|Overall Study|Lost to Follow-up|0|||
147164552|NCT04957758|530766695|FG001|Overall Study|Lost to Follow-up|2|||
147164553|NCT04957758|530766694|FG000|Overall Study|Withdrawal by Subject|4|||
147164554|NCT04957758|530766695|FG001|Overall Study|Withdrawal by Subject|2|||
147164555|NCT04957758|530766694|FG000|Overall Study|Protocol Violation|0|||
147164556|NCT04957758|530766695|FG001|Overall Study|Protocol Violation|1|||
147164557|NCT02360293|530766697|FG000|Overall Study|Lost to Follow-up|73|||
147164558|NCT02360293|530766698|FG001|Overall Study|Lost to Follow-up|95|||
147164559|NCT02360293|530766697|FG000|Overall Study|Withdrawal by Subject|2|||
147164560|NCT02360293|530766698|FG001|Overall Study|Withdrawal by Subject|1|||
147164561|NCT02360293|530766697|FG000|Overall Study|Excluded|1|||
147164562|NCT02360293|530766698|FG001|Overall Study|Excluded|0|||
147164563|NCT02226549|530766699|FG000|Overall Study|Randomized but Never Treated|1|||
147164564|NCT02226549|530766700|FG001|Overall Study|Randomized but Never Treated|0|||
147164565|NCT02226549|530766699|FG000|Overall Study|Lost to Follow-up|0|||
147164566|NCT02226549|530766700|FG001|Overall Study|Lost to Follow-up|1|||
147164567|NCT01269385|530766701|FG000|Overall Study|Adverse Event|1|||
147164568|NCT01269385|530766702|FG001|Overall Study|Adverse Event|1|||
147164569|NCT01269385|530766703|FG002|Overall Study|Adverse Event|0|||
147164570|NCT01269385|530766704|FG003|Overall Study|Adverse Event|0|||
147164571|NCT02741570|530766705|FG000|Pre-Treatment Period|Other reasons|0|||
147164572|NCT02741570|530766706|FG001|Pre-Treatment Period|Other reasons|3|||
147164573|NCT02741570|530766705|FG000|Pre-Treatment Period|Participant no longer meets study criteria|3|||
147164574|NCT02741570|530766706|FG001|Pre-Treatment Period|Participant no longer meets study criteria|6|||
147164575|NCT02741570|530766705|FG000|Pre-Treatment Period|Poor/non-compliance|0|||
147164576|NCT02741570|530766706|FG001|Pre-Treatment Period|Poor/non-compliance|1|||
147164577|NCT02741570|530766705|FG000|Pre-Treatment Period|Lost to Follow-up|0|||
147164578|NCT02741570|530766706|FG001|Pre-Treatment Period|Lost to Follow-up|2|||
147164579|NCT02741570|530766705|FG000|Pre-Treatment Period|Participant withdrew consent|0|||
147589782|NCT00384176|532314363|FG000|Overall Study|Did not receive study treatment|0|||
147589783|NCT00384176|532314364|FG001|Overall Study|Did not receive study treatment|1|||
147589784|NCT00384176|532314365|FG002|Overall Study|Did not receive study treatment|1|||
147589785|NCT00384176|532314363|FG000|Overall Study|Physician Decision|0|||
147589786|NCT00384176|532314364|FG001|Overall Study|Physician Decision|2|||
147589787|NCT00384176|532314365|FG002|Overall Study|Physician Decision|0|||
147589788|NCT00384176|532314363|FG000|Overall Study|Liver metastases, colon resec. planned|1|||
147164580|NCT02741570|530766706|FG001|Pre-Treatment Period|Participant withdrew consent|18|||
147164581|NCT02741570|530766705|FG000|Pre-Treatment Period|Participant request to discontinue study treatment|0|||
147164582|NCT02741570|530766706|FG001|Pre-Treatment Period|Participant request to discontinue study treatment|2|||
147164583|NCT02741570|530766705|FG000|Pre-Treatment Period|Adverse event unrelated to study drug|1|||
147589789|NCT00384176|532314364|FG001|Overall Study|Liver metastases, colon resec. planned|0|||
147589790|NCT00384176|532314365|FG002|Overall Study|Liver metastases, colon resec. planned|0|||
147589791|NCT02139124|532314366|FG000|Overall Study|Adverse Event|2|||
147589792|NCT02139124|532314367|FG001|Overall Study|Adverse Event|0|||
147589793|NCT02139124|532314368|FG002|Overall Study|Adverse Event|1|||
147589794|NCT02139124|532314369|FG003|Overall Study|Adverse Event|2|||
147589795|NCT02139124|532314370|FG004|Overall Study|Adverse Event|5|||
147164584|NCT02741570|530766706|FG001|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
147164585|NCT02741570|530766705|FG000|Pre-Treatment Period|Death|0|||
147164586|NCT02741570|530766706|FG001|Pre-Treatment Period|Death|1|||
147243279|NCT02915016|531062114|FG006|Overall Study|Physician Decision|2|||
147243280|NCT02915016|531062115|FG007|Overall Study|Physician Decision|0|||
147243281|NCT02915016|531062108|FG000|Overall Study|Withdrawal by Subject|2|||
147243282|NCT02915016|531062109|FG001|Overall Study|Withdrawal by Subject|0|||
147243283|NCT02915016|531062110|FG002|Overall Study|Withdrawal by Subject|1|||
147243284|NCT02915016|531062111|FG003|Overall Study|Withdrawal by Subject|0|||
147243285|NCT02915016|531062112|FG004|Overall Study|Withdrawal by Subject|1|||
147243286|NCT02915016|531062113|FG005|Overall Study|Withdrawal by Subject|3|||
147243287|NCT02915016|531062114|FG006|Overall Study|Withdrawal by Subject|1|||
147243288|NCT02915016|531062115|FG007|Overall Study|Withdrawal by Subject|1|||
147243289|NCT02915016|531062108|FG000|Overall Study|Elected not to continue|0|||
147243290|NCT02915016|531062109|FG001|Overall Study|Elected not to continue|0|||
147243291|NCT02915016|531062110|FG002|Overall Study|Elected not to continue|0|||
147243292|NCT02915016|531062111|FG003|Overall Study|Elected not to continue|1|||
147589796|NCT02139124|532314366|FG000|Overall Study|Withdrawal by Subject|2|||
147589797|NCT02139124|532314367|FG001|Overall Study|Withdrawal by Subject|2|||
147589798|NCT02139124|532314368|FG002|Overall Study|Withdrawal by Subject|2|||
147589799|NCT02139124|532314369|FG003|Overall Study|Withdrawal by Subject|2|||
147589800|NCT02139124|532314370|FG004|Overall Study|Withdrawal by Subject|3|||
147589801|NCT02139124|532314366|FG000|Overall Study|Protocol Violation|0|||
147589802|NCT02139124|532314367|FG001|Overall Study|Protocol Violation|0|||
147589803|NCT02139124|532314368|FG002|Overall Study|Protocol Violation|0|||
147589804|NCT02139124|532314369|FG003|Overall Study|Protocol Violation|1|||
147589805|NCT02139124|532314370|FG004|Overall Study|Protocol Violation|1|||
147589806|NCT02139124|532314366|FG000|Overall Study|non-compliant|1|||
147589807|NCT02139124|532314367|FG001|Overall Study|non-compliant|0|||
147589808|NCT02139124|532314368|FG002|Overall Study|non-compliant|0|||
147164587|NCT02741570|530766705|FG000|Pre-Treatment Period|Disease progression|0|||
147164588|NCT02741570|530766706|FG001|Pre-Treatment Period|Disease progression|1|||
147589809|NCT02139124|532314369|FG003|Overall Study|non-compliant|2|||
147589810|NCT02139124|532314370|FG004|Overall Study|non-compliant|0|||
147589811|NCT02139124|532314366|FG000|Overall Study|incarceration|0|||
147589812|NCT02139124|532314367|FG001|Overall Study|incarceration|0|||
147589813|NCT02139124|532314368|FG002|Overall Study|incarceration|1|||
147589814|NCT02139124|532314369|FG003|Overall Study|incarceration|0|||
147589815|NCT02139124|532314370|FG004|Overall Study|incarceration|0|||
147589816|NCT02139124|532314366|FG000|Overall Study|subject moved|1|||
147589817|NCT02139124|532314367|FG001|Overall Study|subject moved|0|||
147589818|NCT02139124|532314368|FG002|Overall Study|subject moved|0|||
147589819|NCT02139124|532314369|FG003|Overall Study|subject moved|0|||
147589820|NCT02139124|532314370|FG004|Overall Study|subject moved|0|||
147589821|NCT02139124|532314366|FG000|Overall Study|Lost to Follow-up|3|||
147589822|NCT02139124|532314367|FG001|Overall Study|Lost to Follow-up|2|||
147589823|NCT02139124|532314368|FG002|Overall Study|Lost to Follow-up|0|||
147589824|NCT02139124|532314369|FG003|Overall Study|Lost to Follow-up|5|||
147589825|NCT02139124|532314370|FG004|Overall Study|Lost to Follow-up|4|||
147589826|NCT02691741|532314371|FG000|Overall Study|Adverse Event|0|||
147589827|NCT02691741|532314372|FG001|Overall Study|Adverse Event|2|||
147164589|NCT02741570|530766705|FG000|Treatment Period|Other reasons|47|||
147164590|NCT02741570|530766706|FG001|Treatment Period|Other reasons|12|||
147164591|NCT02741570|530766705|FG000|Treatment Period|Poor/non-compliance|0|||
147164592|NCT02741570|530766706|FG001|Treatment Period|Poor/non-compliance|2|||
147164593|NCT02741570|530766705|FG000|Treatment Period|Maximum clinical benefit|4|||
147164594|NCT02741570|530766706|FG001|Treatment Period|Maximum clinical benefit|6|||
147164595|NCT02741570|530766705|FG000|Treatment Period|Lost to Follow-up|1|||
147164596|NCT02741570|530766706|FG001|Treatment Period|Lost to Follow-up|3|||
147323229|NCT02027935|531347949|FG000|Overall Study|Death|1|||
147323230|NCT02027935|531347949|FG000|Overall Study|Lack of Efficacy|5|||
147323231|NCT02027935|531347949|FG000|Overall Study|Study Closure|1|||
147323232|NCT05174065|531347950|FG000|Placebo-controlled Period|Withdrawal by Subject|1|||
147323233|NCT05174065|531347951|FG001|Placebo-controlled Period|Withdrawal by Subject|0|||
147323234|NCT05174065|531347952|FG002|Placebo-controlled Period|Withdrawal by Subject|0|||
147323235|NCT05174065|531347950|FG000|Placebo-controlled Period|Other|0|||
147164597|NCT02741570|530766705|FG000|Treatment Period|Participant withdrew consent|9|||
147164598|NCT02741570|530766706|FG001|Treatment Period|Participant withdrew consent|13|||
147164599|NCT02741570|530766705|FG000|Treatment Period|Participant request to discontinue treatment|8|||
147164600|NCT02741570|530766706|FG001|Treatment Period|Participant request to discontinue treatment|23|||
147164601|NCT02741570|530766705|FG000|Treatment Period|Adverse event unrelated to study drug|41|||
147164602|NCT02741570|530766706|FG001|Treatment Period|Adverse event unrelated to study drug|26|||
147164603|NCT02741570|530766705|FG000|Treatment Period|Death|9|||
147164604|NCT02741570|530766706|FG001|Treatment Period|Death|7|||
147164605|NCT02741570|530766705|FG000|Treatment Period|Study drug toxicity|55|||
147164606|NCT02741570|530766706|FG001|Treatment Period|Study drug toxicity|47|||
147164607|NCT02741570|530766705|FG000|Treatment Period|Disease progression|294|||
147164608|NCT02741570|530766706|FG001|Treatment Period|Disease progression|301|||
147164609|NCT02741570|530766705|FG000|Treatment Period|Administrative reason by sponsor|0|||
147164610|NCT02741570|530766706|FG001|Treatment Period|Administrative reason by sponsor|1|||
147589828|NCT02691741|532314371|FG000|Overall Study|Lost to Follow-up|1|||
147164611|NCT01498185|530766707|FG000|Overall Study|Adverse Event|0|||
147164612|NCT01498185|530766708|FG001|Overall Study|Adverse Event|0|||
147323236|NCT05174065|531347951|FG001|Placebo-controlled Period|Other|1|||
147323237|NCT05174065|531347952|FG002|Placebo-controlled Period|Other|0|||
147589829|NCT02691741|532314372|FG001|Overall Study|Lost to Follow-up|0|||
147589830|NCT02691741|532314371|FG000|Overall Study|Physician Decision|0|||
147589831|NCT02691741|532314372|FG001|Overall Study|Physician Decision|1|||
147323238|NCT05174065|531347950|FG000|Placebo-controlled Period|Adverse Event|1|||
147323239|NCT05174065|531347951|FG001|Placebo-controlled Period|Adverse Event|1|||
147323240|NCT05174065|531347952|FG002|Placebo-controlled Period|Adverse Event|0|||
147589832|NCT02691741|532314371|FG000|Overall Study|Withdrawal by Subject|0|||
147589833|NCT02691741|532314372|FG001|Overall Study|Withdrawal by Subject|4|||
147589834|NCT01425528|532314373|FG000|Overall Study|Withdrawal by Subject|1|||
147164613|NCT01498185|530766709|FG002|Overall Study|Adverse Event|0|||
147164614|NCT01498185|530766710|FG003|Overall Study|Adverse Event|1|||
147164615|NCT01498185|530766711|FG004|Overall Study|Adverse Event|0|||
147164616|NCT01498185|530766707|FG000|Overall Study|Withdrawal by Subject|1|||
147164617|NCT01498185|530766708|FG001|Overall Study|Withdrawal by Subject|1|||
147164618|NCT01498185|530766709|FG002|Overall Study|Withdrawal by Subject|0|||
147164619|NCT01498185|530766710|FG003|Overall Study|Withdrawal by Subject|2|||
147164620|NCT01498185|530766711|FG004|Overall Study|Withdrawal by Subject|1|||
147164621|NCT01498185|530766707|FG000|Overall Study|No longer met criteria, etc|0|||
147164622|NCT01498185|530766708|FG001|Overall Study|No longer met criteria, etc|0|||
147164623|NCT01498185|530766709|FG002|Overall Study|No longer met criteria, etc|0|||
147164624|NCT01498185|530766710|FG003|Overall Study|No longer met criteria, etc|0|||
147164625|NCT01498185|530766711|FG004|Overall Study|No longer met criteria, etc|2|||
147164626|NCT00946322|530766712|FG000|Pre-treatment|participant failure to follow up|1|||
147164627|NCT00946322|530766712|FG000|Post-treatment|participant failure to follow up|2|||
147164628|NCT00514020|530766716|FG000|Overall Study|Adverse Event|6|||
147164629|NCT00514020|530766716|FG000|Overall Study|Withdrawal by Subject|3|||
147164630|NCT00514020|530766716|FG000|Overall Study|Physician Decision|1|||
147164631|NCT00514020|530766716|FG000|Overall Study|disease progression|9|||
147164632|NCT00514020|530766716|FG000|Overall Study|other complicating disease|2|||
147164633|NCT00514020|530766716|FG000|Overall Study|patient went to radiation treatment|1|||
147164634|NCT00514020|530766716|FG000|Overall Study|"patients moved to the no tx group"|6|||
147164635|NCT01688921|530766717|FG000|Overall Study|Lost to Follow-up|7|||
147164636|NCT01688921|530766718|FG001|Overall Study|Lost to Follow-up|13|||
147164637|NCT01688921|530766717|FG000|Overall Study|Physician Decision|6|||
147164638|NCT01688921|530766718|FG001|Overall Study|Physician Decision|1|||
147164639|NCT01688921|530766717|FG000|Overall Study|Protocol Violation|0|||
147164640|NCT01688921|530766718|FG001|Overall Study|Protocol Violation|1|||
147164641|NCT01688921|530766717|FG000|Overall Study|informed consent|3|||
147164642|NCT01688921|530766718|FG001|Overall Study|informed consent|0|||
147164643|NCT04384107|530766720|FG000|Overall Study|Withdrawal By Parent/Guardian|8|||
147164644|NCT04384107|530766721|FG001|Overall Study|Withdrawal By Parent/Guardian|6|||
147164645|NCT04384107|530766720|FG000|Overall Study|Lost to Follow-up|1|||
147164646|NCT04384107|530766721|FG001|Overall Study|Lost to Follow-up|0|||
147164647|NCT00276614|530766722|FG000|Overall Study|Progression of disease under study|3|||
147164648|NCT00459537|530766723|FG000|Overall Study|Adverse Event|1|||
147164649|NCT00459537|530766724|FG001|Overall Study|Adverse Event|6|||
147164650|NCT00459537|530766723|FG000|Overall Study|Lack of Efficacy|10|||
147164651|NCT00459537|530766724|FG001|Overall Study|Lack of Efficacy|11|||
147164652|NCT00459537|530766723|FG000|Overall Study|Withdrawal by Subject|20|||
147164653|NCT00459537|530766724|FG001|Overall Study|Withdrawal by Subject|26|||
147164654|NCT00459537|530766723|FG000|Overall Study|Lost to Follow-up|27|||
147164655|NCT00459537|530766724|FG001|Overall Study|Lost to Follow-up|30|||
147164656|NCT00459537|530766723|FG000|Overall Study|Administrative problems|3|||
147164657|NCT00459537|530766724|FG001|Overall Study|Administrative problems|0|||
147164658|NCT00459537|530766723|FG000|Overall Study|Protocol Violation|4|||
147164659|NCT00459537|530766724|FG001|Overall Study|Protocol Violation|3|||
147164660|NCT00459537|530766723|FG000|Overall Study|Missing|1|||
147164661|NCT00459537|530766724|FG001|Overall Study|Missing|0|||
147164662|NCT03159104|530766725|FG000|Overall Study|Violation of inclusion criteria|1|||
147164663|NCT03159104|530766726|FG001|Overall Study|Violation of inclusion criteria|2|||
147164664|NCT02198235|530766728|FG000|Overall Study|Lost to Follow-up|3|||
147323241|NCT05174065|531347950|FG000|Apremilast Active Treatment Period|Withdrawal by Subject|0|||
147323242|NCT05174065|531347951|FG001|Apremilast Active Treatment Period|Withdrawal by Subject|0|||
147323243|NCT05174065|531347952|FG002|Apremilast Active Treatment Period|Withdrawal by Subject|3|||
147323244|NCT05174065|531347950|FG000|Apremilast Active Treatment Period|Protocol Violation|0|||
147323245|NCT05174065|531347951|FG001|Apremilast Active Treatment Period|Protocol Violation|0|||
147323246|NCT05174065|531347952|FG002|Apremilast Active Treatment Period|Protocol Violation|1|||
147323247|NCT05174065|531347950|FG000|Apremilast Active Treatment Period|Adverse Event|0|||
147323248|NCT05174065|531347951|FG001|Apremilast Active Treatment Period|Adverse Event|0|||
147164665|NCT02198235|530766729|FG001|Overall Study|Lost to Follow-up|2|||
147164666|NCT02198235|530766730|FG002|Overall Study|Lost to Follow-up|2|||
147164667|NCT04573881|530766733|FG000|Overall Study|Participant in active follow-up at 30 days|24|||
147164668|NCT01999218|530766734|FG000|Overall Study|Hyperglycemia|18|||
147164669|NCT01999218|530766735|FG001|Overall Study|Hyperglycemia|17|||
147164670|NCT01999218|530766736|FG002|Overall Study|Hyperglycemia|17|||
147164671|NCT01999218|530766734|FG000|Overall Study|Lack of Efficacy|1|||
147164672|NCT01999218|530766735|FG001|Overall Study|Lack of Efficacy|0|||
147164673|NCT01999218|530766736|FG002|Overall Study|Lack of Efficacy|1|||
147164674|NCT01999218|530766734|FG000|Overall Study|Lost to Follow-up|22|||
147164675|NCT01999218|530766735|FG001|Overall Study|Lost to Follow-up|17|||
147164676|NCT01999218|530766736|FG002|Overall Study|Lost to Follow-up|18|||
147323249|NCT05174065|531347952|FG002|Apremilast Active Treatment Period|Adverse Event|4|||
147164677|NCT01999218|530766734|FG000|Overall Study|Non-Compliance With Study Drug|6|||
147164678|NCT01999218|530766735|FG001|Overall Study|Non-Compliance With Study Drug|4|||
147164679|NCT01999218|530766736|FG002|Overall Study|Non-Compliance With Study Drug|1|||
147164680|NCT01999218|530766734|FG000|Overall Study|Physician Decision|1|||
147164681|NCT01999218|530766735|FG001|Overall Study|Physician Decision|4|||
147164682|NCT01999218|530766736|FG002|Overall Study|Physician Decision|6|||
147164683|NCT01999218|530766734|FG000|Overall Study|Protocol Violation|4|||
147164684|NCT01999218|530766735|FG001|Overall Study|Protocol Violation|5|||
147164685|NCT01999218|530766736|FG002|Overall Study|Protocol Violation|4|||
147164686|NCT01999218|530766734|FG000|Overall Study|Screen failure|0|||
147164687|NCT01999218|530766735|FG001|Overall Study|Screen failure|1|||
147164688|NCT01999218|530766736|FG002|Overall Study|Screen failure|0|||
147164689|NCT01999218|530766734|FG000|Overall Study|Study Terminated By Sponsor|7|||
147323250|NCT00689104|531347953|FG000|Overall Study|Eligibility criterion not met|5|||
147164690|NCT01999218|530766735|FG001|Overall Study|Study Terminated By Sponsor|5|||
147164691|NCT01999218|530766736|FG002|Overall Study|Study Terminated By Sponsor|12|||
147164692|NCT01999218|530766734|FG000|Overall Study|Participant moves|2|||
147164693|NCT01999218|530766735|FG001|Overall Study|Participant moves|5|||
147164694|NCT01999218|530766736|FG002|Overall Study|Participant moves|3|||
147164695|NCT01999218|530766734|FG000|Overall Study|Withdrawal by Subject|28|||
147164696|NCT01999218|530766735|FG001|Overall Study|Withdrawal by Subject|29|||
147164697|NCT01999218|530766736|FG002|Overall Study|Withdrawal by Subject|34|||
147164698|NCT01999218|530766734|FG000|Overall Study|Creatinine/eGFR|0|||
147164699|NCT01999218|530766735|FG001|Overall Study|Creatinine/eGFR|0|||
147164700|NCT01999218|530766736|FG002|Overall Study|Creatinine/eGFR|1|||
147164701|NCT01999218|530766734|FG000|Overall Study|Death|7|||
147164702|NCT01999218|530766735|FG001|Overall Study|Death|1|||
147164703|NCT01999218|530766736|FG002|Overall Study|Death|2|||
147164704|NCT01999218|530766734|FG000|Overall Study|Excluded Medication|1|||
147164705|NCT01999218|530766735|FG001|Overall Study|Excluded Medication|1|||
147164706|NCT01999218|530766736|FG002|Overall Study|Excluded Medication|2|||
147164707|NCT01999218|530766734|FG000|Overall Study|Adverse Event|9|||
147164708|NCT01999218|530766735|FG001|Overall Study|Adverse Event|7|||
147164709|NCT01999218|530766736|FG002|Overall Study|Adverse Event|7|||
147164710|NCT01999218|530766734|FG000|Overall Study|Treated but excluded at 1 trial site|3|||
147164711|NCT01999218|530766735|FG001|Overall Study|Treated but excluded at 1 trial site|5|||
147164712|NCT01999218|530766736|FG002|Overall Study|Treated but excluded at 1 trial site|2|||
147164713|NCT00546260|530766737|FG000|Overall Study|Drug not given pre diagnostic angiogr|8|||
147164714|NCT00546260|530766738|FG001|Overall Study|Drug not given pre diagnostic angiogr|2|||
147164715|NCT03780959|530766739|FG000|Part 1|Adverse Event|1|||
147164716|NCT03780959|530766740|FG001|Part 1|Adverse Event|0|||
147164717|NCT03780959|530766741|FG002|Part 1|Adverse Event|0|||
147164718|NCT03780959|530766739|FG000|Part 1|Withdrawal by Subject|1|||
147164719|NCT03780959|530766740|FG001|Part 1|Withdrawal by Subject|0|||
147164720|NCT03780959|530766741|FG002|Part 1|Withdrawal by Subject|0|||
147164721|NCT03780959|530766739|FG000|Part 1|Withdrawal by Parent/Guardian|1|||
147164722|NCT03780959|530766740|FG001|Part 1|Withdrawal by Parent/Guardian|0|||
147164723|NCT03780959|530766741|FG002|Part 1|Withdrawal by Parent/Guardian|0|||
147164724|NCT03780959|530766739|FG000|Part 1|Response Status|2|||
147164725|NCT03780959|530766740|FG001|Part 1|Response Status|0|||
147164726|NCT03780959|530766741|FG002|Part 1|Response Status|0|||
147164727|NCT03780959|530766739|FG000|Part 2|Withdrawal by Parent/Guardian|0|||
147164728|NCT03780959|530766740|FG001|Part 2|Withdrawal by Parent/Guardian|1|||
147164729|NCT03780959|530766741|FG002|Part 2|Withdrawal by Parent/Guardian|0|||
147164730|NCT03780959|530766739|FG000|Part 2|Response Status|0|||
147164731|NCT03780959|530766740|FG001|Part 2|Response Status|18|||
147164732|NCT03780959|530766741|FG002|Part 2|Response Status|6|||
147164733|NCT00664326|530768181|FG000|Overall Study|Adverse Event|14|||
147164734|NCT00664326|530768181|FG000|Overall Study|Noncompliance with study medication|3|||
147164735|NCT00664326|530768181|FG000|Overall Study|Withdrawal by Subject|1|||
147164736|NCT00664326|530768181|FG000|Overall Study|Physician Decision|1|||
147589835|NCT01425528|532314374|FG001|Overall Study|Withdrawal by Subject|1|||
147589836|NCT00307931|532314375|FG000|Overall Study|Adverse Event|1|||
147164737|NCT00664326|530768181|FG000|Overall Study|Other Reasons|3|||
147323251|NCT00689104|531347954|FG001|Overall Study|Eligibility criterion not met|8|||
147164738|NCT00664326|530768181|FG000|Overall Study|Death|2|||
147164739|NCT00664326|530768181|FG000|Overall Study|Disease Progression/Recurrence/Relapse|24|||
147164740|NCT03647267|530768184|FG000|Overall Study|Lost to Follow-up|1|||
147589837|NCT03069417|532314376|FG000|Overall Study|Lost to Follow-up|2|||
147164741|NCT03647267|530768185|FG001|Overall Study|Lost to Follow-up|0|||
147589838|NCT03069417|532314377|FG001|Overall Study|Lost to Follow-up|0|||
147164742|NCT05079477|530768186|FG000|Overall Study|Lost to Follow-up|2|||
147164743|NCT05079477|530768187|FG001|Overall Study|Lost to Follow-up|0|||
147164744|NCT05079477|530768186|FG000|Overall Study|Withdrawal by Subject|1|||
147164745|NCT05079477|530768187|FG001|Overall Study|Withdrawal by Subject|0|||
147164746|NCT05079477|530768186|FG000|Overall Study|Ineligible based on baseline survey (eligible based on protocol: recruitment screener)|11|||
147164747|NCT05079477|530768187|FG001|Overall Study|Ineligible based on baseline survey (eligible based on protocol: recruitment screener)|11|||
147164748|NCT05079477|530768186|FG000|Overall Study|Ineligible because pilot participants. The protocol changed after running them.|0|||
147164749|NCT05079477|530768187|FG001|Overall Study|Ineligible because pilot participants. The protocol changed after running them.|2|||
147164750|NCT03131596|530768188|FG000|Overall Study|Protocol Violation|3|||
147164751|NCT03131596|530768189|FG001|Overall Study|Protocol Violation|3|||
147164752|NCT03131596|530768188|FG000|Overall Study|Lost to Follow-up|3|||
147164753|NCT03131596|530768189|FG001|Overall Study|Lost to Follow-up|0|||
147164754|NCT03654885|530768190|FG000|Overall Study|Randomized, Not Treated: Consent Withdrawn|5|||
147164755|NCT03654885|530768191|FG001|Overall Study|Randomized, Not Treated: Consent Withdrawn|3|||
147164756|NCT03654885|530768190|FG000|Overall Study|Randomized, Not Treated: Investigators Decision (Unrelated to Adverse Event [AE])|0|||
147164757|NCT03654885|530768191|FG001|Overall Study|Randomized, Not Treated: Investigators Decision (Unrelated to Adverse Event [AE])|3|||
147164758|NCT03654885|530768190|FG000|Overall Study|Randomized, Not Treated: Study on-hold due to Device Recall|7|||
147164759|NCT03654885|530768191|FG001|Overall Study|Randomized, Not Treated: Study on-hold due to Device Recall|1|||
147164760|NCT03654885|530768190|FG000|Overall Study|Additional Glaucoma Surgery (Secondary Surgical Intervention [SSI])|7|||
147164761|NCT03654885|530768191|FG001|Overall Study|Additional Glaucoma Surgery (Secondary Surgical Intervention [SSI])|1|||
147164762|NCT03654885|530768190|FG000|Overall Study|Additional Ophthalmic Surgery (Not for Intraocular pressure [IOP] Control)|1|||
147164763|NCT03654885|530768191|FG001|Overall Study|Additional Ophthalmic Surgery (Not for Intraocular pressure [IOP] Control)|0|||
147164764|NCT03654885|530768190|FG000|Overall Study|Adverse Event in Study Eye|3|||
147164765|NCT03654885|530768191|FG001|Overall Study|Adverse Event in Study Eye|0|||
147164766|NCT03654885|530768190|FG000|Overall Study|Consent Withdrawn|1|||
147164767|NCT03654885|530768191|FG001|Overall Study|Consent Withdrawn|0|||
147164768|NCT03654885|530768190|FG000|Overall Study|Death|3|||
147164769|NCT03654885|530768191|FG001|Overall Study|Death|1|||
147164770|NCT03654885|530768190|FG000|Overall Study|Did Not Meet Inclusion Criteria (IC) Diagnosis of Ocular Hypertension (Dx OHT)|0|||
147164771|NCT03654885|530768191|FG001|Overall Study|Did Not Meet Inclusion Criteria (IC) Diagnosis of Ocular Hypertension (Dx OHT)|1|||
147164772|NCT03654885|530768190|FG000|Overall Study|Lost to Follow-up|3|||
147164773|NCT03654885|530768191|FG001|Overall Study|Lost to Follow-up|3|||
147164774|NCT00004445|530768192|FG000|Overall Study|Physician Decision|2|||
147164775|NCT00004445|530768192|FG000|Overall Study|Withdrawal by Subject|1|||
147164776|NCT02753127|530768193|FG000|Overall Study|Lost to Follow-up|13|||
147323252|NCT00689104|531347955|FG002|Overall Study|Eligibility criterion not met|0|||
147589839|NCT03069417|532314376|FG000|Overall Study|Reason Unknown|4|||
147589840|NCT03069417|532314377|FG001|Overall Study|Reason Unknown|7|||
147164777|NCT02753127|530768194|FG001|Overall Study|Lost to Follow-up|11|||
147164778|NCT02753127|530768193|FG000|Overall Study|Withdrawal by Subject|37|||
147164779|NCT02753127|530768194|FG001|Overall Study|Withdrawal by Subject|47|||
147164780|NCT02753127|530768193|FG000|Overall Study|Other|3|||
147164781|NCT02753127|530768194|FG001|Overall Study|Other|8|||
147164782|NCT02753127|530768193|FG000|Overall Study|Hospice|0|||
147323253|NCT00689104|531347956|FG003|Overall Study|Eligibility criterion not met|4|||
147323254|NCT00689104|531347953|FG000|Overall Study|Adverse Event|13|||
147323255|NCT00689104|531347954|FG001|Overall Study|Adverse Event|25|||
147323256|NCT00689104|531347955|FG002|Overall Study|Adverse Event|16|||
147323257|NCT00689104|531347956|FG003|Overall Study|Adverse Event|24|||
147323258|NCT00689104|531347953|FG000|Overall Study|Lack of Efficacy|5|||
147323259|NCT00689104|531347954|FG001|Overall Study|Lack of Efficacy|6|||
147323260|NCT00689104|531347955|FG002|Overall Study|Lack of Efficacy|2|||
147323261|NCT00689104|531347956|FG003|Overall Study|Lack of Efficacy|3|||
147323262|NCT00689104|531347953|FG000|Overall Study|Withdrawal by Subject|12|||
147323263|NCT00689104|531347954|FG001|Overall Study|Withdrawal by Subject|11|||
147323264|NCT00689104|531347955|FG002|Overall Study|Withdrawal by Subject|18|||
147323265|NCT00689104|531347956|FG003|Overall Study|Withdrawal by Subject|11|||
147323266|NCT00689104|531347953|FG000|Overall Study|Lost to Follow-up|4|||
147323267|NCT00689104|531347954|FG001|Overall Study|Lost to Follow-up|3|||
147323268|NCT00689104|531347955|FG002|Overall Study|Lost to Follow-up|2|||
147323269|NCT00689104|531347956|FG003|Overall Study|Lost to Follow-up|5|||
147323270|NCT00689104|531347953|FG000|Overall Study|Protocol Violation|2|||
147323271|NCT00689104|531347954|FG001|Overall Study|Protocol Violation|3|||
147323272|NCT00689104|531347955|FG002|Overall Study|Protocol Violation|5|||
147323273|NCT00689104|531347956|FG003|Overall Study|Protocol Violation|3|||
147323274|NCT00689104|531347953|FG000|Overall Study|Randomized but never received study drug|2|||
147323275|NCT00689104|531347954|FG001|Overall Study|Randomized but never received study drug|1|||
147323276|NCT00689104|531347955|FG002|Overall Study|Randomized but never received study drug|1|||
147323277|NCT00689104|531347956|FG003|Overall Study|Randomized but never received study drug|0|||
147323278|NCT00689104|531347953|FG000|Overall Study|Physician Decision|1|||
147323279|NCT00689104|531347954|FG001|Overall Study|Physician Decision|0|||
147323280|NCT00689104|531347955|FG002|Overall Study|Physician Decision|0|||
147323281|NCT00689104|531347956|FG003|Overall Study|Physician Decision|0|||
147164783|NCT02753127|530768194|FG001|Overall Study|Hospice|2|||
147164784|NCT01146288|530768199|FG000|First Intervention(1 Day)|Adverse Event|0|||
147323282|NCT00689104|531347953|FG000|Overall Study|Non-compliance with study procedures|0|||
147323283|NCT00689104|531347954|FG001|Overall Study|Non-compliance with study procedures|0|||
147323284|NCT00689104|531347955|FG002|Overall Study|Non-compliance with study procedures|1|||
147323285|NCT00689104|531347956|FG003|Overall Study|Non-compliance with study procedures|0|||
147323286|NCT04873817|531347957|FG000|Overall Study|Subject and/or Family Request Withdrew Consent|3|||
147589841|NCT00402025|532314378|FG000|Overall Study|Adverse Event|0|||
147323287|NCT04873817|531347957|FG000|Overall Study|Lost to Follow-up|4|||
147323288|NCT04873817|531347957|FG000|Overall Study|Unsuccessful RFA Procedure|1|||
147323289|NCT04873817|531347957|FG000|Overall Study|Additional Chronic Pain Treatment for The Same Anatomical Region|8|||
147323290|NCT04873817|531347957|FG000|Overall Study|Other Reasons|3|||
147323291|NCT00924560|531347961|FG000|Overall Study|Did Not Meet Protocol Requirements|4|||
147323292|NCT00924560|531347962|FG001|Overall Study|Did Not Meet Protocol Requirements|2|||
147323293|NCT00924560|531347963|FG002|Overall Study|Did Not Meet Protocol Requirements|1|||
147323294|NCT00924560|531347961|FG000|Overall Study|Non Compliance with the Protocol|20|||
147323295|NCT00924560|531347962|FG001|Overall Study|Non Compliance with the Protocol|15|||
147323296|NCT00924560|531347963|FG002|Overall Study|Non Compliance with the Protocol|4|||
147323297|NCT00924560|531347961|FG000|Overall Study|Physician Decision|2|||
147323298|NCT00924560|531347962|FG001|Overall Study|Physician Decision|3|||
147323299|NCT00924560|531347963|FG002|Overall Study|Physician Decision|4|||
147323300|NCT00924560|531347961|FG000|Overall Study|Withdrawal by Subject|50|||
147323301|NCT00924560|531347962|FG001|Overall Study|Withdrawal by Subject|44|||
147323302|NCT00924560|531347963|FG002|Overall Study|Withdrawal by Subject|18|||
147323303|NCT00924560|531347961|FG000|Overall Study|Adverse Event|39|||
147323304|NCT00924560|531347962|FG001|Overall Study|Adverse Event|33|||
147323305|NCT00924560|531347963|FG002|Overall Study|Adverse Event|0|||
147323306|NCT00924560|531347961|FG000|Overall Study|Pregnancy|5|||
147323307|NCT00924560|531347962|FG001|Overall Study|Pregnancy|7|||
147323308|NCT00924560|531347963|FG002|Overall Study|Pregnancy|1|||
147323309|NCT00924560|531347961|FG000|Overall Study|Lost to Follow-up|78|||
147323310|NCT00924560|531347962|FG001|Overall Study|Lost to Follow-up|94|||
147323311|NCT00924560|531347963|FG002|Overall Study|Lost to Follow-up|45|||
147323312|NCT00924560|531347961|FG000|Overall Study|Miscellaneous Reasons|13|||
147323313|NCT00924560|531347962|FG001|Overall Study|Miscellaneous Reasons|10|||
147323314|NCT00924560|531347963|FG002|Overall Study|Miscellaneous Reasons|10|||
147323315|NCT00604786|531347966|FG000|Overall Study|Lost to Follow-up|2|||
147323316|NCT00604786|531347967|FG001|Overall Study|Lost to Follow-up|0|||
147323317|NCT00665561|531347972|FG000|Overall Study|Death recorded on subject summary pages|75|||
147323318|NCT00665561|531347973|FG001|Overall Study|Death recorded on subject summary pages|75|||
147323319|NCT00665561|531347972|FG000|Overall Study|Does not meet entrance criteria|19|||
147323320|NCT00665561|531347973|FG001|Overall Study|Does not meet entrance criteria|21|||
147323321|NCT00665561|531347972|FG000|Overall Study|Lost to Follow-up|203|||
147323322|NCT00665561|531347973|FG001|Overall Study|Lost to Follow-up|264|||
147323323|NCT00665561|531347972|FG000|Overall Study|Withdrawal by Subject|74|||
147323324|NCT00665561|531347973|FG001|Overall Study|Withdrawal by Subject|65|||
147323325|NCT00665561|531347972|FG000|Overall Study|Other|123|||
147323326|NCT00665561|531347973|FG001|Overall Study|Other|108|||
147323327|NCT00665561|531347972|FG000|Overall Study|Site closed|8|||
147323328|NCT00665561|531347973|FG001|Overall Study|Site closed|0|||
147323329|NCT00665561|531347972|FG000|Overall Study|Withdrawn due to pregnancy|0|||
147323330|NCT00665561|531347973|FG001|Overall Study|Withdrawn due to pregnancy|1|||
147323331|NCT02337361|531347974|FG000|3-month Follow-up|Lost to Follow-up|19|||
147323332|NCT02337361|531347975|FG001|3-month Follow-up|Lost to Follow-up|14|||
147323333|NCT02337361|531347974|FG000|6-month Follow-up|Lost to Follow-up|2|||
147323334|NCT02337361|531347975|FG001|6-month Follow-up|Lost to Follow-up|4|||
147323335|NCT01641861|531347976|FG000|Overall Study|Lost to Follow-up|21|||
147323336|NCT01641861|531347977|FG001|Overall Study|Lost to Follow-up|16|||
147323337|NCT01641861|531347976|FG000|Overall Study|Lost the tooth due to normal exfoliation|14|||
147323338|NCT01641861|531347977|FG001|Overall Study|Lost the tooth due to normal exfoliation|8|||
147323339|NCT01641861|531347976|FG000|Overall Study|Died due to drowning|0|||
147323340|NCT01641861|531347977|FG001|Overall Study|Died due to drowning|1|||
147323341|NCT01101542|531347978|FG000|Year 3 Surveillance Period|Lost to Follow-up|7|||
147323342|NCT01101542|531347978|FG000|Year 3 Surveillance Period|Withdrawal by Subject|4|||
147323343|NCT01101542|531347978|FG000|Year 4 Surveillance Period|Other|287|||
147323344|NCT01101542|531347978|FG000|Year 5 Surveillance Period|Lost to Follow-up|140|||
147323345|NCT01101542|531347978|FG000|Year 5 Surveillance Period|Pregnancy|1|||
147323346|NCT01101542|531347978|FG000|Year 6 Surveillance Period|Lost to Follow-up|986|||
147323347|NCT01101542|531347978|FG000|Year 6 Surveillance Period|Pregnancy|1|||
147323348|NCT01101542|531347978|FG000|Year 6 Surveillance Period|Withdrawal by Subject|4|||
147323349|NCT00701311|531347979|FG000|Overall Study|Lack of Efficacy|3|||
147323350|NCT00701311|531347979|FG000|Overall Study|Adverse Event|3|||
147323351|NCT00701311|531347979|FG000|Overall Study|Withdrawal by Subject|2|||
147323352|NCT00814489|531347980|FG000|Overall Study|Other|2|||
147589842|NCT00402025|532314379|FG001|Overall Study|Adverse Event|0|||
147589843|NCT00402025|532314380|FG002|Overall Study|Adverse Event|2|||
147323353|NCT00814489|531347981|FG001|Overall Study|Other|0|||
147323354|NCT00814489|531347982|FG002|Overall Study|Other|1|||
147323355|NCT01515319|531348008|FG000|Overall Study|Withdrawal by Subject|0|||
147323356|NCT01515319|531348009|FG001|Overall Study|Withdrawal by Subject|0|||
147323357|NCT01515319|531348010|FG002|Overall Study|Withdrawal by Subject|0|||
147323358|NCT01515319|531348011|FG003|Overall Study|Withdrawal by Subject|0|||
147323359|NCT01515319|531348012|FG004|Overall Study|Withdrawal by Subject|0|||
147589844|NCT00402025|532314378|FG000|Overall Study|Death|0|||
147164785|NCT01146288|530768200|FG001|First Intervention(1 Day)|Adverse Event|1|||
147164786|NCT03532932|530768204|FG000|Overall Study|Protocol Deviation|33|||
147164787|NCT03532932|530768205|FG001|Overall Study|Protocol Deviation|31|||
147164788|NCT03532932|530768204|FG000|Overall Study|Appearance of Exclusion Criteria|9|||
147164789|NCT03532932|530768205|FG001|Overall Study|Appearance of Exclusion Criteria|11|||
147164790|NCT03532932|530768204|FG000|Overall Study|Withdrawal by Subject|2|||
147164791|NCT03532932|530768205|FG001|Overall Study|Withdrawal by Subject|0|||
147164792|NCT03532932|530768204|FG000|Overall Study|Lost to Follow-up|15|||
147589845|NCT00402025|532314379|FG001|Overall Study|Death|1|||
147589846|NCT00402025|532314380|FG002|Overall Study|Death|5|||
147164793|NCT03532932|530768205|FG001|Overall Study|Lost to Follow-up|9|||
147164794|NCT03532932|530768204|FG000|Overall Study|Adverse Event|4|||
147164795|NCT03532932|530768205|FG001|Overall Study|Adverse Event|3|||
147164796|NCT03532932|530768204|FG000|Overall Study|Death|0|||
147164797|NCT03532932|530768205|FG001|Overall Study|Death|2|||
147164798|NCT03532932|530768204|FG000|Overall Study|Other|11|||
147164799|NCT03532932|530768205|FG001|Overall Study|Other|16|||
147164800|NCT00931801|530768206|FG000|Overall Study|Adverse Event|0|||
147164801|NCT00931801|530768207|FG001|Overall Study|Adverse Event|0|||
147164802|NCT00931801|530768208|FG002|Overall Study|Adverse Event|1|||
147164803|NCT00931801|530768206|FG000|Overall Study|Lost to Follow-up|0|||
147164804|NCT00931801|530768207|FG001|Overall Study|Lost to Follow-up|1|||
147164805|NCT00931801|530768208|FG002|Overall Study|Lost to Follow-up|0|||
147164806|NCT00931801|530768206|FG000|Overall Study|Withdrawal by Subject|1|||
147164807|NCT00931801|530768207|FG001|Overall Study|Withdrawal by Subject|0|||
147164808|NCT00931801|530768208|FG002|Overall Study|Withdrawal by Subject|0|||
147164809|NCT00931801|530768206|FG000|Overall Study|Confirmed Virologic Failure|0|||
147164810|NCT00931801|530768207|FG001|Overall Study|Confirmed Virologic Failure|0|||
147164811|NCT00931801|530768208|FG002|Overall Study|Confirmed Virologic Failure|3|||
147164812|NCT03283150|530768209|FG000|Overall Study|Withdrawal by Subject|6|||
147164813|NCT03283150|530768210|FG001|Overall Study|Withdrawal by Subject|0|||
147164814|NCT03283150|530768211|FG002|Overall Study|Withdrawal by Subject|0|||
147164815|NCT01028716|530768212|FG000|Overall Study|Physician Decision|1|||
147164816|NCT00086502|530768213|FG000|Overall Study|Adverse Event|11|||
147164817|NCT00086502|530768214|FG001|Overall Study|Adverse Event|2|||
147164818|NCT00086502|530768213|FG000|Overall Study|Lack of Efficacy|0|||
147164819|NCT00086502|530768214|FG001|Overall Study|Lack of Efficacy|2|||
147164820|NCT00086502|530768213|FG000|Overall Study|Lost to Follow-up|3|||
147164821|NCT00086502|530768214|FG001|Overall Study|Lost to Follow-up|1|||
147164822|NCT00086502|530768213|FG000|Overall Study|Physician Decision|1|||
147164823|NCT00086502|530768214|FG001|Overall Study|Physician Decision|1|||
147164824|NCT00086502|530768213|FG000|Overall Study|Pregnancy|0|||
147164825|NCT00086502|530768214|FG001|Overall Study|Pregnancy|1|||
147164826|NCT00086502|530768213|FG000|Overall Study|Protocol Violation|3|||
147164827|NCT00086502|530768214|FG001|Overall Study|Protocol Violation|3|||
147164828|NCT00086502|530768213|FG000|Overall Study|Withdrawal by Subject|5|||
147164829|NCT00086502|530768214|FG001|Overall Study|Withdrawal by Subject|6|||
147164830|NCT00086502|530768213|FG000|Overall Study|Patient Moved|1|||
147164831|NCT00086502|530768214|FG001|Overall Study|Patient Moved|1|||
147164832|NCT00086502|530768213|FG000|Overall Study|Protocol Discontinuation Criteria|1|||
147164833|NCT00086502|530768214|FG001|Overall Study|Protocol Discontinuation Criteria|3|||
147164834|NCT00086502|530768213|FG000|Overall Study|Patient Accidentally Unblinded|1|||
147164835|NCT00086502|530768214|FG001|Overall Study|Patient Accidentally Unblinded|0|||
147164836|NCT05545644|530768215|FG000|Overall Study|Lost to Follow-up|4|||
147164837|NCT05545644|530768216|FG001|Overall Study|Lost to Follow-up|3|||
147164838|NCT01842581|530768219|FG000|Overall Study|Adverse Event|6|||
147164839|NCT01842581|530768220|FG001|Overall Study|Adverse Event|4|||
147164840|NCT01842581|530768219|FG000|Overall Study|HE breakthrough|26|||
147164841|NCT01842581|530768220|FG001|Overall Study|HE breakthrough|13|||
147164842|NCT01842581|530768219|FG000|Overall Study|Liver transplant|2|||
147164843|NCT01842581|530768220|FG001|Overall Study|Liver transplant|0|||
147164844|NCT01842581|530768219|FG000|Overall Study|Lost to Follow-up|2|||
147164845|NCT01842581|530768220|FG001|Overall Study|Lost to Follow-up|5|||
147589847|NCT00402025|532314378|FG000|Overall Study|Disease Progression|1|||
147164846|NCT01842581|530768219|FG000|Overall Study|Withdrawal by Subject|5|||
147164847|NCT01842581|530768220|FG001|Overall Study|Withdrawal by Subject|7|||
147164848|NCT01842581|530768219|FG000|Overall Study|Other than specified|3|||
147164849|NCT01842581|530768220|FG001|Overall Study|Other than specified|1|||
147164850|NCT00334282|530768221|FG000|Overall Study|Lost to Follow-up|11|||
147164851|NCT00334282|530768222|FG001|Overall Study|Lost to Follow-up|5|||
147164852|NCT00334282|530768221|FG000|Overall Study|Withdrawal by Subject|17|||
147164853|NCT00334282|530768222|FG001|Overall Study|Withdrawal by Subject|3|||
147164854|NCT00334282|530768221|FG000|Overall Study|Death|194|||
147164855|NCT00334282|530768222|FG001|Overall Study|Death|100|||
147164856|NCT01420627|530768223|FG000|EZN-2279 Treatment Period|Adverse Event|1|||
147164857|NCT00837876|530768224|FG000|Overall Study|Death|2|||
147164858|NCT00837876|530768224|FG000|Overall Study|Adverse Event|7|||
147164859|NCT00837876|530768224|FG000|Overall Study|Physician Decision|1|||
147164860|NCT00837876|530768224|FG000|Overall Study|Withdrawal by Subject|3|||
147589848|NCT00402025|532314379|FG001|Overall Study|Disease Progression|1|||
147589849|NCT00402025|532314380|FG002|Overall Study|Disease Progression|2|||
147589850|NCT00402025|532314378|FG000|Overall Study|Physician Decision|1|||
147589851|NCT00402025|532314379|FG001|Overall Study|Physician Decision|1|||
147589852|NCT00402025|532314380|FG002|Overall Study|Physician Decision|0|||
147589853|NCT00402025|532314378|FG000|Overall Study|Participant Decision|0|||
147589854|NCT00402025|532314379|FG001|Overall Study|Participant Decision|0|||
147589855|NCT00402025|532314380|FG002|Overall Study|Participant Decision|1|||
147589856|NCT02953678|532314397|FG000|Overall Study|Adverse Event|20|||
147164861|NCT00837876|530768224|FG000|Overall Study|disease progression|24|||
147164862|NCT01996592|530768231|FG000|Overall Study|no response to text/no diary entry|32|||
147164863|NCT01996592|530768231|FG000|Overall Study|change in surgical date|4|||
147164864|NCT01996592|530768231|FG000|Overall Study|Withdrawal by Subject|5|||
147589857|NCT02953678|532314397|FG000|Overall Study|Death|7|||
147589858|NCT02953678|532314397|FG000|Overall Study|Physician Decision|23|||
147589859|NCT02953678|532314397|FG000|Overall Study|Progressive Disease of GVHD|7|||
147589860|NCT02953678|532314397|FG000|Overall Study|Relapse of Underlying Malignancy|3|||
147589861|NCT02953678|532314397|FG000|Overall Study|Withdrawal by participant|3|||
147589862|NCT02953678|532314397|FG000|Overall Study|Includes 2 participants who discontinued ruxolitinib treatment because of clinical improvement|5|||
147589863|NCT02953678|532314397|FG000|Overall Study|Participants were transferred to commercial product.|3|||
147589864|NCT01961687|532316113|FG000|Overall Study|Lost to Follow-up|19|||
147589865|NCT01961687|532316113|FG000|Overall Study|Re-operation|17|||
147589866|NCT01961687|532316113|FG000|Overall Study|Death|7|||
147589867|NCT01961687|532316113|FG000|Overall Study|Withdrawal by Subject|6|||
147589868|NCT01961687|532316113|FG000|Overall Study|Adverse Event|6|||
147589869|NCT01961687|532316113|FG000|Overall Study|Moved to area without study site|2|||
147589870|NCT01961687|532316113|FG000|Overall Study|Sponsor decision|2|||
147589871|NCT01961687|532316113|FG000|Overall Study|Physician Decision|1|||
147589872|NCT01961687|532316113|FG000|Overall Study|Unable to meet follow-up requirements|1|||
147589873|NCT01730040|532316114|FG000|Overall Study|Randomized but not treated|0|||
147589874|NCT01730040|532316115|FG001|Overall Study|Randomized but not treated|0|||
147589875|NCT01730040|532316116|FG002|Overall Study|Randomized but not treated|0|||
147164865|NCT01996592|530768231|FG000|Overall Study|change in mode of delivery|4|||
147164866|NCT00870194|530768232|FG000|Overall Study|Adverse Event|10|||
147164867|NCT00870194|530768233|FG001|Overall Study|Adverse Event|5|||
147164868|NCT00870194|530768232|FG000|Overall Study|Lack of Efficacy|0|||
147164869|NCT00870194|530768233|FG001|Overall Study|Lack of Efficacy|1|||
147164870|NCT00870194|530768232|FG000|Overall Study|Lost to Follow-up|2|||
147164871|NCT00870194|530768233|FG001|Overall Study|Lost to Follow-up|0|||
147164872|NCT00870194|530768232|FG000|Overall Study|Physician Decision|3|||
147164873|NCT00870194|530768233|FG001|Overall Study|Physician Decision|1|||
147164874|NCT00870194|530768232|FG000|Overall Study|Protocol Violation|3|||
147164875|NCT00870194|530768233|FG001|Overall Study|Protocol Violation|3|||
147164876|NCT00870194|530768232|FG000|Overall Study|Entry Criteria Not Met|1|||
147164877|NCT00870194|530768233|FG001|Overall Study|Entry Criteria Not Met|2|||
147164878|NCT00870194|530768232|FG000|Overall Study|Subject Decision|7|||
147164879|NCT00870194|530768233|FG001|Overall Study|Subject Decision|2|||
147589876|NCT01730040|532316117|FG003|Overall Study|Randomized but not treated|0|||
147164880|NCT00707746|530768234|FG000|Treatment Period|Adverse Event|2|||
147164881|NCT00707746|530768235|FG001|Treatment Period|Adverse Event|4|||
147164882|NCT00707746|530768234|FG000|Treatment Period|Ineligibility|0|||
147164883|NCT00707746|530768235|FG001|Treatment Period|Ineligibility|1|||
147164884|NCT01685983|530768236|FG000|Overall Study|Adverse Event|7|||
147164885|NCT01685983|530768236|FG000|Overall Study|Death|1|||
147164886|NCT01685983|530768236|FG000|Overall Study|Withdrawal by Subject|19|||
147164887|NCT01685983|530768236|FG000|Overall Study|Protocol Violation|2|||
147164888|NCT01685983|530768236|FG000|Overall Study|Physician Decision|13|||
147164889|NCT01685983|530768236|FG000|Overall Study|Other|7|||
147164890|NCT01685983|530768236|FG000|Overall Study|Progressive Disease|32|||
147164891|NCT01685983|530768236|FG000|Overall Study|Noncompliance with Study Drug|1|||
147164892|NCT02642965|530768242|FG000|Overall Study|Lack of Efficacy|4|||
147164893|NCT02642965|530768242|FG000|Overall Study|Physician Decision|9|||
147164894|NCT01167907|530768249|FG000|Overall Study|Protocol Violation|1|||
147164895|NCT01167907|530768250|FG001|Overall Study|Protocol Violation|0|||
147164896|NCT01167907|530768249|FG000|Overall Study|saphenous catheter dislodged before comp|1|||
147164897|NCT01167907|530768250|FG001|Overall Study|saphenous catheter dislodged before comp|1|||
147164898|NCT03077698|530768253|FG000|Progestin Monotherapy|Stable Disease|8|||
147164899|NCT03077698|530768254|FG001|Progestin Monotherapy|Stable Disease|0|||
147164900|NCT03077698|530768253|FG000|Progestin Monotherapy|Adverse Event|1|||
147243293|NCT02915016|531062112|FG004|Overall Study|Elected not to continue|0|||
147589877|NCT01730040|532316118|FG004|Overall Study|Randomized but not treated|0|||
147589878|NCT01730040|532316119|FG005|Overall Study|Randomized but not treated|1|||
147589879|NCT01730040|532316120|FG006|Overall Study|Randomized but not treated|0|||
147589880|NCT01730040|532316114|FG000|Overall Study|Subject moved|0|||
147164901|NCT03077698|530768254|FG001|Progestin Monotherapy|Adverse Event|0|||
147164902|NCT03077698|530768253|FG000|Progestin Monotherapy|Death|1|||
147164903|NCT03077698|530768254|FG001|Progestin Monotherapy|Death|0|||
147164904|NCT03077698|530768253|FG000|Sodium Cridanimod & Progestin Therapy|Withdrawal by Subject|0|||
147164905|NCT03077698|530768254|FG001|Sodium Cridanimod & Progestin Therapy|Withdrawal by Subject|2|||
147164906|NCT03077698|530768253|FG000|Sodium Cridanimod & Progestin Therapy|Disease Progression|6|||
147164907|NCT03077698|530768254|FG001|Sodium Cridanimod & Progestin Therapy|Disease Progression|5|||
147164908|NCT03077698|530768253|FG000|Sodium Cridanimod & Progestin Therapy|Adverse Event|0|||
147164909|NCT03077698|530768254|FG001|Sodium Cridanimod & Progestin Therapy|Adverse Event|2|||
147164910|NCT03077698|530768253|FG000|Safety Follow Up|Withdrawal by Subject|2|||
147164911|NCT03077698|530768254|FG001|Safety Follow Up|Withdrawal by Subject|1|||
147164912|NCT03077698|530768253|FG000|Safety Follow Up|Transfer of care to hospice|1|||
147164913|NCT03077698|530768254|FG001|Safety Follow Up|Transfer of care to hospice|0|||
147164914|NCT01439074|530768255|FG000|Overall Study|Lost to Follow-up|3|||
147164915|NCT01439074|530768256|FG001|Overall Study|Lost to Follow-up|4|||
147164916|NCT01439074|530768255|FG000|Overall Study|Subject shedding|1|||
147164917|NCT01439074|530768256|FG001|Overall Study|Subject shedding|0|||
147164918|NCT01439074|530768255|FG000|Overall Study|Withdrawal by Subject|1|||
147164919|NCT01439074|530768256|FG001|Overall Study|Withdrawal by Subject|5|||
147164920|NCT01439074|530768255|FG000|Overall Study|Other|4|||
147164921|NCT01439074|530768256|FG001|Overall Study|Other|4|||
147164922|NCT01140568|530768257|FG000|Overall Study|disease progression|31|||
147589881|NCT01730040|532316115|FG001|Overall Study|Subject moved|0|||
147164923|NCT01140568|530768257|FG000|Overall Study|Withdrawal by Subject|1|||
147164924|NCT01140568|530768257|FG000|Overall Study|Screen Fail|4|||
147164925|NCT00815191|530768258|FG000|Overall Study|Protocol Violation|1|||
147164926|NCT00815191|530768259|FG001|Overall Study|Protocol Violation|1|||
147164927|NCT02639338|530768260|FG000|Overall Study|Lost to Follow-up|2|||
147164928|NCT02639338|530768261|FG001|Overall Study|Lost to Follow-up|2|||
147164929|NCT02639338|530768260|FG000|Overall Study|Withdrew Consent|1|||
147164930|NCT02639338|530768261|FG001|Overall Study|Withdrew Consent|2|||
147164931|NCT02639338|530768260|FG000|Overall Study|Death|1|||
147164932|NCT02639338|530768261|FG001|Overall Study|Death|0|||
147164933|NCT02639338|530768260|FG000|Overall Study|Randomized but Not Treated|0|||
147164934|NCT02639338|530768261|FG001|Overall Study|Randomized but Not Treated|1|||
147164935|NCT00493636|530768263|FG000|Overall Study|Withdrawal by Subject|1|||
147164936|NCT00493636|530768264|FG001|Overall Study|Withdrawal by Subject|0|||
147164937|NCT00493636|530768263|FG000|Overall Study|Disease progression/recurrence/relapse|0|||
147164938|NCT00493636|530768264|FG001|Overall Study|Disease progression/recurrence/relapse|1|||
147164939|NCT00493636|530768263|FG000|Overall Study|Mis-randomization|1|||
147164940|NCT00493636|530768264|FG001|Overall Study|Mis-randomization|1|||
147164941|NCT01873729|530768268|FG000|Overall Study|Withdrawal by Subject|1|||
147164942|NCT01066780|530768269|FG000|Overall Study|Withdrawn prior to ClearVoice exposure.|1|||
147164943|NCT01066780|530768270|FG001|Overall Study|Withdrawn prior to ClearVoice exposure.|1|||
147164944|NCT03099148|530768272|FG000|Wash-out|scheduling conflict|0|||
147164945|NCT03099148|530768273|FG001|Wash-out|scheduling conflict|1|||
147164946|NCT03099148|530768274|FG002|Wash-out|scheduling conflict|0|||
147164947|NCT03099148|530768275|FG003|Wash-out|scheduling conflict|0|||
147164948|NCT03099148|530768272|FG000|Wash-out|Adverse Event|0|||
147164949|NCT03099148|530768273|FG001|Wash-out|Adverse Event|1|||
147164950|NCT03099148|530768274|FG002|Wash-out|Adverse Event|0|||
147164951|NCT03099148|530768275|FG003|Wash-out|Adverse Event|0|||
147164952|NCT01827332|530768277|FG000|Overall Study|Lost to Follow-up|2|||
147164953|NCT01827332|530768278|FG001|Overall Study|Lost to Follow-up|1|||
147164954|NCT03352453|530768279|FG000|Overall Study|Miscellaneous Reasons|1|||
147164955|NCT03352453|530768280|FG001|Overall Study|Miscellaneous Reasons|2|||
147164956|NCT03352453|530768279|FG000|Overall Study|Lack of Efficacy|1|||
147164957|NCT03352453|530768280|FG001|Overall Study|Lack of Efficacy|0|||
147164958|NCT03352453|530768279|FG000|Overall Study|Withdrawal by Subject|8|||
147164959|NCT03352453|530768280|FG001|Overall Study|Withdrawal by Subject|14|||
147164960|NCT03352453|530768279|FG000|Overall Study|Study Terminated by Sponsor|2|||
147164961|NCT03352453|530768280|FG001|Overall Study|Study Terminated by Sponsor|1|||
147164962|NCT03352453|530768279|FG000|Overall Study|Protocol Deviation|1|||
147164963|NCT03352453|530768280|FG001|Overall Study|Protocol Deviation|0|||
147164964|NCT03352453|530768279|FG000|Overall Study|Lost to Follow-up|7|||
147164965|NCT03352453|530768280|FG001|Overall Study|Lost to Follow-up|6|||
147164966|NCT03352453|530768279|FG000|Overall Study|Adverse Event|2|||
147164967|NCT03352453|530768280|FG001|Overall Study|Adverse Event|9|||
147164968|NCT01241760|530768281|FG000|Overall Study|Adverse Event|1|||
147164969|NCT01241760|530768282|FG001|Overall Study|Adverse Event|0|||
147164970|NCT01241760|530768281|FG000|Overall Study|Lost to Follow-up|18|||
147164971|NCT01241760|530768282|FG001|Overall Study|Lost to Follow-up|22|||
147164972|NCT01241760|530768281|FG000|Overall Study|Withdrawal by Subject|13|||
147164973|NCT01241760|530768282|FG001|Overall Study|Withdrawal by Subject|13|||
147164974|NCT01241760|530768281|FG000|Overall Study|Switch To Commercially Available Medicat|1|||
147164975|NCT01241760|530768282|FG001|Overall Study|Switch To Commercially Available Medicat|4|||
147164976|NCT01241760|530768281|FG000|Overall Study|Other|1|||
147164977|NCT01241760|530768282|FG001|Overall Study|Other|1|||
147164978|NCT02725593|530768283|FG000|Blinded Treatment Period|Withdrawal by Subject|4|||
147164979|NCT02725593|530768284|FG001|Blinded Treatment Period|Withdrawal by Subject|3|||
147589882|NCT01730040|532316116|FG002|Overall Study|Subject moved|1|||
147589883|NCT01730040|532316117|FG003|Overall Study|Subject moved|0|||
147589884|NCT01730040|532316118|FG004|Overall Study|Subject moved|0|||
147589885|NCT01730040|532316119|FG005|Overall Study|Subject moved|0|||
147589886|NCT01730040|532316120|FG006|Overall Study|Subject moved|1|||
147589887|NCT01730040|532316114|FG000|Overall Study|Physician Decision|0|||
147589888|NCT01730040|532316115|FG001|Overall Study|Physician Decision|0|||
147589889|NCT01730040|532316116|FG002|Overall Study|Physician Decision|0|||
147589890|NCT01730040|532316117|FG003|Overall Study|Physician Decision|0|||
147589891|NCT01730040|532316118|FG004|Overall Study|Physician Decision|0|||
147589892|NCT01730040|532316119|FG005|Overall Study|Physician Decision|1|||
147589893|NCT01730040|532316120|FG006|Overall Study|Physician Decision|1|||
147589894|NCT01730040|532316114|FG000|Overall Study|Other than specified|7|||
147589895|NCT01730040|532316115|FG001|Overall Study|Other than specified|8|||
147589896|NCT01730040|532316116|FG002|Overall Study|Other than specified|5|||
147589897|NCT01730040|532316117|FG003|Overall Study|Other than specified|5|||
147589898|NCT01730040|532316118|FG004|Overall Study|Other than specified|5|||
147589899|NCT01730040|532316119|FG005|Overall Study|Other than specified|4|||
147589900|NCT01730040|532316120|FG006|Overall Study|Other than specified|4|||
147589901|NCT01730040|532316114|FG000|Overall Study|Adverse Event|4|||
147589902|NCT01730040|532316115|FG001|Overall Study|Adverse Event|3|||
147589903|NCT01730040|532316116|FG002|Overall Study|Adverse Event|5|||
147589904|NCT01730040|532316117|FG003|Overall Study|Adverse Event|3|||
147589905|NCT01730040|532316118|FG004|Overall Study|Adverse Event|1|||
147589906|NCT01730040|532316119|FG005|Overall Study|Adverse Event|1|||
147589907|NCT01730040|532316120|FG006|Overall Study|Adverse Event|2|||
147589908|NCT01730040|532316114|FG000|Overall Study|Poor compliance to protocol|2|||
147589909|NCT01730040|532316115|FG001|Overall Study|Poor compliance to protocol|4|||
147589910|NCT01730040|532316116|FG002|Overall Study|Poor compliance to protocol|0|||
147589911|NCT01730040|532316117|FG003|Overall Study|Poor compliance to protocol|0|||
147589912|NCT01730040|532316118|FG004|Overall Study|Poor compliance to protocol|0|||
147589913|NCT01730040|532316119|FG005|Overall Study|Poor compliance to protocol|0|||
147589914|NCT01730040|532316120|FG006|Overall Study|Poor compliance to protocol|1|||
147589915|NCT00544817|532316121|FG000|Combined Modality|Lack of Efficacy|2|||
147589916|NCT00544817|532316121|FG000|Combined Modality|Worsening Neurologic Symptoms|2|||
147589917|NCT00544817|532316121|FG000|Combined Modality|Adverse Event|2|||
147589918|NCT00544817|532316121|FG000|Combined Modality|Intercurrent Illness - Pneumonia|1|||
147589919|NCT00544817|532316121|FG000|No Treatment Interval|Lack of Efficacy|8|||
147589920|NCT00544817|532316121|FG000|No Treatment Interval|Physician Decision|3|||
147589921|NCT00544817|532316121|FG000|No Treatment Interval|Adverse Event|1|||
147589922|NCT00544817|532316121|FG000|Follow-up Systemic Therapy|Lack of Efficacy|15|||
147589923|NCT00544817|532316121|FG000|Follow-up Systemic Therapy|Physician Decision|3|||
147589924|NCT00544817|532316121|FG000|Follow-up Systemic Therapy|Intercurrent Illness - Pneumonia|1|||
147589925|NCT02813421|532316122|FG000|Overall Study|Withdrawal by Subject|1|||
147589926|NCT02813421|532316123|FG001|Overall Study|Withdrawal by Subject|2|||
147589927|NCT02813421|532316122|FG000|Overall Study|Lost to Follow-up|1|||
147589928|NCT02813421|532316123|FG001|Overall Study|Lost to Follow-up|1|||
147164980|NCT02725593|530768283|FG000|Blinded Treatment Period|Withdrawal by Parent/Guardian|0|||
147164981|NCT02725593|530768284|FG001|Blinded Treatment Period|Withdrawal by Parent/Guardian|2|||
147164982|NCT02725593|530768283|FG000|Blinded Treatment Period|Lost to Follow-up|1|||
147164983|NCT02725593|530768284|FG001|Blinded Treatment Period|Lost to Follow-up|1|||
147164984|NCT02725593|530768283|FG000|Long Term Extension|Withdrawal by Subject|1|||
147164985|NCT02725593|530768284|FG001|Long Term Extension|Withdrawal by Subject|3|||
147164986|NCT02644356|530768305|FG000|Overall Study|Withdrawal by Subject|2|||
147164987|NCT02210091|530768307|FG000|Overall Study|Physician Decision|0|||
147164988|NCT02210091|530768308|FG001|Overall Study|Physician Decision|1|||
147164989|NCT02210091|530768307|FG000|Overall Study|Withdrawal by Sponsor|0|||
147164990|NCT02210091|530768308|FG001|Overall Study|Withdrawal by Sponsor|1|||
147164991|NCT01711866|530768312|FG000|Overall Study|Noncompliant|3|||
147164992|NCT01711866|530768312|FG000|Overall Study|Withdrawal by Subject|3|||
147164993|NCT01711866|530768312|FG000|Overall Study|Adverse Event|2|||
147164994|NCT01831817|530768313|FG000|Overall Study|Lost to Follow-up|1|||
147164995|NCT01831817|530768314|FG001|Overall Study|Lost to Follow-up|0|||
147164996|NCT01831817|530768315|FG002|Overall Study|Lost to Follow-up|0|||
147164997|NCT01831817|530768316|FG003|Overall Study|Lost to Follow-up|0|||
147164998|NCT01831817|530768313|FG000|Overall Study|Withdrawl of Consent|3|||
147164999|NCT01831817|530768314|FG001|Overall Study|Withdrawl of Consent|0|||
147165000|NCT01831817|530768315|FG002|Overall Study|Withdrawl of Consent|0|||
147165001|NCT01831817|530768316|FG003|Overall Study|Withdrawl of Consent|0|||
147589929|NCT00977548|532316124|FG000|Overall Study|Ineligible|4|||
147589930|NCT00977548|532316124|FG000|Overall Study|Adverse Event|8|||
147589931|NCT00977548|532316124|FG000|Overall Study|Withdrawal by Subject|1|||
147589932|NCT01042535|532316125|FG000|Overall Study|disease progression prior to treatment|3|||
147589933|NCT01042535|532316125|FG000|Overall Study|disease progression during treatment|3|||
147589934|NCT01042535|532316125|FG000|Overall Study|complications from other disease|2|||
147589935|NCT00107042|532316128|FG000|Overall Study|Lost to Follow-up|9|||
147589936|NCT00107042|532316129|FG001|Overall Study|Lost to Follow-up|7|||
147589937|NCT00107042|532316128|FG000|Overall Study|Withdrawal by Subject|6|||
147589938|NCT00107042|532316129|FG001|Overall Study|Withdrawal by Subject|1|||
147589939|NCT00107042|532316128|FG000|Overall Study|Moved out of area|5|||
147589940|NCT00107042|532316129|FG001|Overall Study|Moved out of area|3|||
147589941|NCT00107042|532316128|FG000|Overall Study|Pregnancy|1|||
147589942|NCT00107042|532316129|FG001|Overall Study|Pregnancy|1|||
147654570|NCT00248833|532556775|FG002|Overall Study|Withdrawal by Subject|1|||
147165002|NCT00897390|530768317|FG000|Overall Study|Adverse Event|2|||
147165003|NCT00897390|530768317|FG000|Overall Study|No Longer Met Study Criteria|1|||
147165004|NCT00897390|530768317|FG000|Overall Study|Personal Reasons|1|||
147165005|NCT00897390|530768317|FG000|Overall Study|Did not Return for the Clinic Visit|2|||
147165006|NCT00958217|530768318|FG000|Overall Study|Death|2|||
147165007|NCT00958217|530768319|FG001|Overall Study|Death|1|||
147165008|NCT00958217|530768318|FG000|Overall Study|Withdrawal by Subject|4|||
147165009|NCT00958217|530768319|FG001|Overall Study|Withdrawal by Subject|3|||
147165010|NCT00958217|530768318|FG000|Overall Study|Lost to Follow-up|17|||
147165011|NCT00958217|530768319|FG001|Overall Study|Lost to Follow-up|19|||
147165012|NCT00958217|530768318|FG000|Overall Study|Moved out of area|1|||
147165013|NCT00958217|530768319|FG001|Overall Study|Moved out of area|1|||
147165014|NCT00958217|530768318|FG000|Overall Study|Inpatient hospitalization|0|||
147165015|NCT00958217|530768319|FG001|Overall Study|Inpatient hospitalization|1|||
147165016|NCT00940485|530770354|FG000|Overall Study|HBeAb positive at Baseline|3|||
147165017|NCT00940485|530770355|FG001|Overall Study|HBeAb positive at Baseline|2|||
147165018|NCT00940485|530770354|FG000|Overall Study|Lost to Follow-up|2|||
147165019|NCT00940485|530770355|FG001|Overall Study|Lost to Follow-up|3|||
147165020|NCT00940485|530770354|FG000|Overall Study|Adverse Event|8|||
147165021|NCT00940485|530770355|FG001|Overall Study|Adverse Event|0|||
147243294|NCT02915016|531062113|FG005|Overall Study|Elected not to continue|0|||
147243295|NCT02915016|531062114|FG006|Overall Study|Elected not to continue|1|||
147243296|NCT02915016|531062115|FG007|Overall Study|Elected not to continue|0|||
147243297|NCT02915016|531062108|FG000|Overall Study|HIV infection|1|||
147323360|NCT01515319|531348013|FG005|Overall Study|Withdrawal by Subject|0|||
147323361|NCT01515319|531348014|FG006|Overall Study|Withdrawal by Subject|1|||
147323362|NCT01515319|531348015|FG007|Overall Study|Withdrawal by Subject|0|||
147323363|NCT01515319|531348016|FG008|Overall Study|Withdrawal by Subject|0|||
147323364|NCT01515319|531348017|FG009|Overall Study|Withdrawal by Subject|0|||
147323365|NCT01515319|531348008|FG000|Overall Study|Adverse Event|0|||
147323366|NCT01515319|531348009|FG001|Overall Study|Adverse Event|0|||
147323367|NCT01515319|531348010|FG002|Overall Study|Adverse Event|0|||
147323368|NCT01515319|531348011|FG003|Overall Study|Adverse Event|0|||
147323369|NCT01515319|531348012|FG004|Overall Study|Adverse Event|0|||
147323370|NCT01515319|531348013|FG005|Overall Study|Adverse Event|0|||
147323371|NCT01515319|531348014|FG006|Overall Study|Adverse Event|0|||
147323372|NCT01515319|531348015|FG007|Overall Study|Adverse Event|0|||
147323373|NCT01515319|531348016|FG008|Overall Study|Adverse Event|3|||
147323374|NCT01515319|531348017|FG009|Overall Study|Adverse Event|0|||
147323375|NCT01515319|531348008|FG000|Overall Study|Protocol Violation|0|||
147323376|NCT01515319|531348009|FG001|Overall Study|Protocol Violation|0|||
147323377|NCT01515319|531348010|FG002|Overall Study|Protocol Violation|0|||
147323378|NCT01515319|531348011|FG003|Overall Study|Protocol Violation|0|||
147323379|NCT01515319|531348012|FG004|Overall Study|Protocol Violation|0|||
147323380|NCT01515319|531348013|FG005|Overall Study|Protocol Violation|0|||
147323381|NCT01515319|531348014|FG006|Overall Study|Protocol Violation|0|||
147323382|NCT01515319|531348015|FG007|Overall Study|Protocol Violation|0|||
147165022|NCT00940485|530770354|FG000|Overall Study|Withdrawal by Subject|1|||
147243298|NCT02915016|531062109|FG001|Overall Study|HIV infection|1|||
147243299|NCT02915016|531062110|FG002|Overall Study|HIV infection|1|||
147243300|NCT02915016|531062111|FG003|Overall Study|HIV infection|0|||
147243301|NCT02915016|531062112|FG004|Overall Study|HIV infection|1|||
147243302|NCT02915016|531062113|FG005|Overall Study|HIV infection|0|||
147243303|NCT02915016|531062114|FG006|Overall Study|HIV infection|0|||
147243304|NCT02915016|531062115|FG007|Overall Study|HIV infection|0|||
147243305|NCT02915016|531062108|FG000|Overall Study|Participant unable to adhere|0|||
147243306|NCT02915016|531062109|FG001|Overall Study|Participant unable to adhere|0|||
147323383|NCT01515319|531348016|FG008|Overall Study|Protocol Violation|2|||
147323384|NCT01515319|531348017|FG009|Overall Study|Protocol Violation|0|||
147323385|NCT01449929|531348018|FG000|Randomization Phase 96 Week|Adverse Event|5|||
147589943|NCT00107042|532316128|FG000|Overall Study|Inadvertent enrollment|0|||
147165023|NCT00940485|530770355|FG001|Overall Study|Withdrawal by Subject|1|||
147165024|NCT00940485|530770354|FG000|Overall Study|Others|1|||
147165025|NCT00940485|530770355|FG001|Overall Study|Others|1|||
147323386|NCT01449929|531348019|FG001|Randomization Phase 96 Week|Adverse Event|13|||
147589944|NCT00107042|532316129|FG001|Overall Study|Inadvertent enrollment|1|||
147243307|NCT02915016|531062110|FG002|Overall Study|Participant unable to adhere|0|||
147243308|NCT02915016|531062111|FG003|Overall Study|Participant unable to adhere|0|||
147243309|NCT02915016|531062112|FG004|Overall Study|Participant unable to adhere|0|||
147243310|NCT02915016|531062113|FG005|Overall Study|Participant unable to adhere|0|||
147654571|NCT00248833|532556773|FG000|Overall Study|Lost to Follow-up|1|||
147165026|NCT06250738|530770358|FG000|Overall Study|Lost to Follow-up|1|||
147165027|NCT02936284|530770359|FG000|Overall Study|Withdrawal by Subject|3|||
147165028|NCT02936284|530770360|FG001|Overall Study|Withdrawal by Subject|1|||
147165029|NCT02936284|530770359|FG000|Overall Study|Lost to Follow-up|7|||
147165030|NCT02936284|530770360|FG001|Overall Study|Lost to Follow-up|8|||
147165031|NCT00293709|530770365|FG000|Overall Study|Other|47|||
147165032|NCT02981524|530770366|FG000|Overall Study|Progressive Disease|14|||
147165033|NCT02981524|530770366|FG000|Overall Study|Death (unrelated)|1|||
147165034|NCT02981524|530770366|FG000|Overall Study|Treatment Related Toxicity|1|||
147243311|NCT02915016|531062114|FG006|Overall Study|Participant unable to adhere|0|||
147243312|NCT02915016|531062115|FG007|Overall Study|Participant unable to adhere|1|||
147243313|NCT04292743|531062116|FG000|Overall Study|Physician Decision|1|||
147243314|NCT04292743|531062117|FG001|Overall Study|Physician Decision|3|||
147243315|NCT04292743|531062118|FG002|Overall Study|Physician Decision|0|||
147243316|NCT04292743|531062119|FG003|Overall Study|Physician Decision|0|||
147243317|NCT04292743|531062116|FG000|Overall Study|Withdrawal by Subject|0|||
147243318|NCT04292743|531062117|FG001|Overall Study|Withdrawal by Subject|5|||
147243319|NCT04292743|531062118|FG002|Overall Study|Withdrawal by Subject|0|||
147243320|NCT04292743|531062119|FG003|Overall Study|Withdrawal by Subject|0|||
147243321|NCT04292743|531062116|FG000|Overall Study|Death|0|||
147243322|NCT04292743|531062117|FG001|Overall Study|Death|1|||
147243323|NCT04292743|531062118|FG002|Overall Study|Death|0|||
147243324|NCT04292743|531062119|FG003|Overall Study|Death|0|||
147243325|NCT04292743|531062116|FG000|Overall Study|Progression of Disease|2|||
147243326|NCT04292743|531062117|FG001|Overall Study|Progression of Disease|5|||
147243327|NCT04292743|531062118|FG002|Overall Study|Progression of Disease|0|||
147243328|NCT04292743|531062119|FG003|Overall Study|Progression of Disease|0|||
147243329|NCT04292743|531062116|FG000|Overall Study|No Treatment per protocol|0|||
147243330|NCT04292743|531062117|FG001|Overall Study|No Treatment per protocol|2|||
147243331|NCT04292743|531062118|FG002|Overall Study|No Treatment per protocol|0|||
147243332|NCT04292743|531062119|FG003|Overall Study|No Treatment per protocol|0|||
147243333|NCT05766423|531062120|FG000|Overall Study|Withdrawal by Subject|1|||
147243334|NCT05766423|531062121|FG001|Overall Study|Withdrawal by Subject|0|||
147243335|NCT05766423|531062120|FG000|Overall Study|Consented, not scheduled|3|||
147243336|NCT05766423|531062121|FG001|Overall Study|Consented, not scheduled|5|||
147243337|NCT01664533|531063779|FG000|Overall Study|Death|42|||
147243338|NCT01664533|531063779|FG000|Overall Study|Lost to Follow-up|3|||
147243339|NCT01664533|531063779|FG000|Overall Study|Study termination|9|||
147243340|NCT01664533|531063779|FG000|Overall Study|Protocol Violation|3|||
147243341|NCT00844831|531063780|FG000|Overall Study|Withdrawal by Subject|4|||
147243342|NCT00844831|531063780|FG000|Overall Study|Adverse Event|1|||
147243343|NCT00844831|531063780|FG000|Overall Study|Physician Decision|1|||
147243344|NCT05255068|531063781|FG000|Overall Study|Lost to Follow-up|0|||
147243345|NCT05255068|531063782|FG001|Overall Study|Lost to Follow-up|1|||
147243346|NCT00540514|531063783|FG000|Overall Study|Still on treatment|3|||
147243347|NCT00540514|531063784|FG001|Overall Study|Still on treatment|0|||
147243348|NCT00540514|531063783|FG000|Overall Study|Unacceptable Toxicity|61|||
147243349|NCT00540514|531063784|FG001|Overall Study|Unacceptable Toxicity|62|||
147243350|NCT00540514|531063783|FG000|Overall Study|Adverse Event|20|||
147243351|NCT00540514|531063784|FG001|Overall Study|Adverse Event|24|||
147243352|NCT00540514|531063783|FG000|Overall Study|Physician Decision|86|||
147243353|NCT00540514|531063784|FG001|Overall Study|Physician Decision|99|||
147243354|NCT00540514|531063783|FG000|Overall Study|Protocol Deviation|3|||
147243355|NCT00540514|531063784|FG001|Overall Study|Protocol Deviation|4|||
147243356|NCT00540514|531063783|FG000|Overall Study|Lost to Follow-up|1|||
147243357|NCT00540514|531063784|FG001|Overall Study|Lost to Follow-up|1|||
147243358|NCT00540514|531063783|FG000|Overall Study|Withdrawal by Subject|65|||
147243359|NCT00540514|531063784|FG001|Overall Study|Withdrawal by Subject|67|||
147243360|NCT00540514|531063783|FG000|Overall Study|Excluded prior to treatment|7|||
147323387|NCT01449929|531348020|FG002|Randomization Phase 96 Week|Adverse Event|0|||
147323388|NCT01449929|531348018|FG000|Randomization Phase 96 Week|Lack of Efficacy|3|||
147323389|NCT01449929|531348019|FG001|Randomization Phase 96 Week|Lack of Efficacy|4|||
147323390|NCT01449929|531348020|FG002|Randomization Phase 96 Week|Lack of Efficacy|0|||
147654572|NCT00248833|532556774|FG001|Overall Study|Lost to Follow-up|1|||
147165035|NCT02981524|530770366|FG000|Overall Study|Withdrawal by Subject|1|||
147165036|NCT02677844|530770367|FG000|Period 3|Withdrawal by Subject|0|||
147243361|NCT00540514|531063784|FG001|Overall Study|Excluded prior to treatment|7|||
147243362|NCT00540514|531063783|FG000|Overall Study|Paclitaxel not available|0|||
147243363|NCT00540514|531063784|FG001|Overall Study|Paclitaxel not available|2|||
147243364|NCT03291808|531063785|FG000|Overall Study|Lost to Follow-up|6|||
147243365|NCT03291808|531063785|FG000|Overall Study|Research burden|4|||
147243366|NCT02468414|531063790|FG000|Overall Study|Early Study Termination by Sponsor|1|||
147243367|NCT02468414|531063791|FG001|Overall Study|Early Study Termination by Sponsor|0|||
147243368|NCT02468414|531063790|FG000|Overall Study|Poor in-vitro secreting TARGTs|1|||
147243369|NCT02468414|531063791|FG001|Overall Study|Poor in-vitro secreting TARGTs|0|||
147243370|NCT02468414|531063790|FG000|Overall Study|Screen Failure|1|||
147243371|NCT02468414|531063791|FG001|Overall Study|Screen Failure|0|||
147243372|NCT00004978|531063792|FG000|Overall Study|Death|107|||
147589945|NCT00107042|532316128|FG000|Overall Study|vaccinated outside window|1|||
147589946|NCT00107042|532316129|FG001|Overall Study|vaccinated outside window|1|||
147589947|NCT00107042|532316128|FG000|Overall Study|Disallowed medications|0|||
147589948|NCT00107042|532316129|FG001|Overall Study|Disallowed medications|2|||
147165037|NCT02677844|530770368|FG001|Period 3|Withdrawal by Subject|0|||
147165038|NCT02677844|530770369|FG002|Period 3|Withdrawal by Subject|0|||
147165039|NCT02677844|530770370|FG003|Period 3|Withdrawal by Subject|1|||
147165040|NCT02677844|530770371|FG004|Period 3|Withdrawal by Subject|0|||
147589949|NCT03919448|532316130|FG000|Overall Study|Withdrawal by Subject|1|||
147589950|NCT03919448|532316131|FG001|Overall Study|Withdrawal by Subject|0|||
147589951|NCT03919448|532316132|FG002|Overall Study|Withdrawal by Subject|0|||
147589952|NCT01221090|532316134|FG000|Overall Study|Non-Compliant or Unable to Contact|15|||
147589953|NCT01221090|532316135|FG001|Overall Study|Non-Compliant or Unable to Contact|12|||
147589954|NCT01221090|532316136|FG002|Overall Study|Non-Compliant or Unable to Contact|15|||
147589955|NCT01221090|532316137|FG003|Overall Study|Non-Compliant or Unable to Contact|20|||
147589956|NCT01221090|532316134|FG000|Overall Study|Withdrawal by Subject|0|||
147589957|NCT01221090|532316135|FG001|Overall Study|Withdrawal by Subject|22|||
147589958|NCT01221090|532316136|FG002|Overall Study|Withdrawal by Subject|27|||
147589959|NCT01221090|532316137|FG003|Overall Study|Withdrawal by Subject|2|||
147589960|NCT03438539|532316138|FG000|Overall Study|Lost to Follow-up|8|||
147589961|NCT03438539|532316139|FG001|Overall Study|Lost to Follow-up|4|||
147589962|NCT03438539|532316140|FG002|Overall Study|Lost to Follow-up|10|||
147589963|NCT03438539|532316141|FG003|Overall Study|Lost to Follow-up|9|||
147589964|NCT03438539|532316142|FG004|Overall Study|Lost to Follow-up|3|||
147589965|NCT03438539|532316143|FG005|Overall Study|Lost to Follow-up|8|||
147589966|NCT04776746|532316144|FG000|Overall Study|Study terminated by sponsor|61|||
147589967|NCT04776746|532316144|FG000|Overall Study|Adverse Event|5|||
147589968|NCT04776746|532316144|FG000|Overall Study|Death|4|||
147589969|NCT04776746|532316144|FG000|Overall Study|Lack of Efficacy|3|||
147589970|NCT04776746|532316144|FG000|Overall Study|Noncompliance with study drug|2|||
147589971|NCT04776746|532316144|FG000|Overall Study|Not related to COVID-19|2|||
147589972|NCT00440466|532316145|FG000|Overall Study|Death|3|||
147589973|NCT00440466|532316146|FG001|Overall Study|Death|2|||
147589974|NCT00440466|532316147|FG002|Overall Study|Death|9|||
147589975|NCT00440466|532316145|FG000|Overall Study|Adverse Event|3|||
147589976|NCT00440466|532316146|FG001|Overall Study|Adverse Event|4|||
147589977|NCT00440466|532316147|FG002|Overall Study|Adverse Event|11|||
147589978|NCT00440466|532316145|FG000|Overall Study|Lost to Follow-up|1|||
147589979|NCT00440466|532316146|FG001|Overall Study|Lost to Follow-up|0|||
147589980|NCT00440466|532316147|FG002|Overall Study|Lost to Follow-up|2|||
147589981|NCT00440466|532316145|FG000|Overall Study|Physician Decision|2|||
147589982|NCT00440466|532316146|FG001|Overall Study|Physician Decision|0|||
147589983|NCT00440466|532316147|FG002|Overall Study|Physician Decision|1|||
147589984|NCT00440466|532316145|FG000|Overall Study|Protocol Violation|2|||
147589985|NCT00440466|532316146|FG001|Overall Study|Protocol Violation|0|||
147589986|NCT00440466|532316147|FG002|Overall Study|Protocol Violation|4|||
147589987|NCT00440466|532316145|FG000|Overall Study|Withdrawal by Subject|2|||
147589988|NCT00440466|532316146|FG001|Overall Study|Withdrawal by Subject|5|||
147589989|NCT00440466|532316147|FG002|Overall Study|Withdrawal by Subject|9|||
147589990|NCT00440466|532316145|FG000|Overall Study|Began Dialysis|0|||
147589991|NCT00440466|532316146|FG001|Overall Study|Began Dialysis|0|||
147589992|NCT00440466|532316147|FG002|Overall Study|Began Dialysis|1|||
147589993|NCT00440466|532316145|FG000|Overall Study|Met Hemoglobin Withdrawal Criteria|0|||
147589994|NCT00440466|532316146|FG001|Overall Study|Met Hemoglobin Withdrawal Criteria|4|||
147589995|NCT00440466|532316147|FG002|Overall Study|Met Hemoglobin Withdrawal Criteria|4|||
147589996|NCT00655850|532316152|FG000|Overall Study|Death|2|||
147165041|NCT02677844|530770372|FG005|Period 3|Withdrawal by Subject|0|||
147165042|NCT02677844|530770373|FG006|Period 3|Withdrawal by Subject|0|||
147589997|NCT00655850|532316152|FG000|Overall Study|Withdrawal by Subject|1|||
147589998|NCT02459665|532316153|FG000|Overall Study|Withdrawal by Subject|0|||
147589999|NCT02459665|532316154|FG001|Overall Study|Withdrawal by Subject|1|||
147590000|NCT02459665|532316155|FG002|Overall Study|Withdrawal by Subject|1|||
147590001|NCT02459665|532316156|FG003|Overall Study|Withdrawal by Subject|2|||
147590002|NCT00099268|532316157|FG000|Overall Study|Withdrawal by Subject|46|||
147590003|NCT00099268|532316158|FG001|Overall Study|Withdrawal by Subject|28|||
147590004|NCT00099268|532316157|FG000|Overall Study|Adverse Event|19|||
147590005|NCT00099268|532316158|FG001|Overall Study|Adverse Event|19|||
147590006|NCT00099268|532316157|FG000|Overall Study|Protocol Violation|9|||
147590007|NCT00099268|532316158|FG001|Overall Study|Protocol Violation|8|||
147590008|NCT00099268|532316157|FG000|Overall Study|Lost to Follow-up|6|||
147590009|NCT00099268|532316158|FG001|Overall Study|Lost to Follow-up|4|||
147590010|NCT00099268|532316157|FG000|Overall Study|Lack of Efficacy|5|||
147590011|NCT00099268|532316158|FG001|Overall Study|Lack of Efficacy|18|||
147590012|NCT00099268|532316157|FG000|Overall Study|Administrative problems|4|||
147590013|NCT00099268|532316158|FG001|Overall Study|Administrative problems|4|||
147590014|NCT00099268|532316157|FG000|Overall Study|Death|3|||
147165043|NCT03458702|530770374|FG000|Study Condition A (Yoga or Rest)|Lost to Follow-up|4|||
147243373|NCT00004978|531063793|FG001|Overall Study|Death|116|||
147323391|NCT01449929|531348018|FG000|Randomization Phase 96 Week|Protocol Violation|5|||
147323392|NCT01449929|531348019|FG001|Randomization Phase 96 Week|Protocol Violation|6|||
147323393|NCT01449929|531348020|FG002|Randomization Phase 96 Week|Protocol Violation|0|||
147323394|NCT01449929|531348018|FG000|Randomization Phase 96 Week|Protocol-defined Stopping Criteria|1|||
147323395|NCT01449929|531348019|FG001|Randomization Phase 96 Week|Protocol-defined Stopping Criteria|0|||
147323396|NCT01449929|531348020|FG002|Randomization Phase 96 Week|Protocol-defined Stopping Criteria|0|||
147323397|NCT01449929|531348018|FG000|Randomization Phase 96 Week|Lost to Follow-up|15|||
147323398|NCT01449929|531348019|FG001|Randomization Phase 96 Week|Lost to Follow-up|18|||
147323399|NCT01449929|531348020|FG002|Randomization Phase 96 Week|Lost to Follow-up|0|||
147590015|NCT00099268|532316158|FG001|Overall Study|Death|1|||
147590016|NCT01360866|532316159|FG000|Overall Study|Lost to Follow-up|11|||
147590017|NCT01360866|532316160|FG001|Overall Study|Lost to Follow-up|28|||
147590018|NCT01360866|532316161|FG002|Overall Study|Lost to Follow-up|41|||
147590019|NCT01360866|532316162|FG003|Overall Study|Lost to Follow-up|0|||
147590020|NCT01360866|532316159|FG000|Overall Study|Adverse Event|56|||
147590021|NCT01360866|532316160|FG001|Overall Study|Adverse Event|61|||
147590022|NCT01360866|532316161|FG002|Overall Study|Adverse Event|134|||
147590023|NCT01360866|532316162|FG003|Overall Study|Adverse Event|6|||
147590024|NCT01360866|532316159|FG000|Overall Study|Paticipant met withdrawal criteria|11|||
147590025|NCT01360866|532316160|FG001|Overall Study|Paticipant met withdrawal criteria|28|||
147590026|NCT01360866|532316161|FG002|Overall Study|Paticipant met withdrawal criteria|54|||
147590027|NCT01360866|532316162|FG003|Overall Study|Paticipant met withdrawal criteria|0|||
147590028|NCT01360866|532316159|FG000|Overall Study|Withdrawn by Investigator|9|||
147590029|NCT01360866|532316160|FG001|Overall Study|Withdrawn by Investigator|8|||
147590030|NCT01360866|532316161|FG002|Overall Study|Withdrawn by Investigator|31|||
147590031|NCT01360866|532316162|FG003|Overall Study|Withdrawn by Investigator|2|||
147590032|NCT01360866|532316159|FG000|Overall Study|Withdrawal by participant|79|||
147590033|NCT01360866|532316160|FG001|Overall Study|Withdrawal by participant|89|||
147165044|NCT03458702|530770375|FG001|Study Condition A (Yoga or Rest)|Lost to Follow-up|6|||
147165045|NCT03458702|530770374|FG000|Study Condition B (Yoga or Rest)|Lost to Follow-up|4|||
147165046|NCT03458702|530770375|FG001|Study Condition B (Yoga or Rest)|Lost to Follow-up|2|||
147165047|NCT01697462|530770376|FG000|Overall Study|Disease Progression|1|||
147165048|NCT01697462|530770376|FG000|Overall Study|Adverse Event|6|||
147165049|NCT01697462|530770376|FG000|Overall Study|Lost to Follow-up|21|||
147165050|NCT01697462|530770376|FG000|Overall Study|Withdrawal by Subject|12|||
147165051|NCT01697462|530770376|FG000|Overall Study|Investigator Decision|21|||
147165052|NCT01697462|530770376|FG000|Overall Study|Death|1|||
147165053|NCT01697462|530770376|FG000|Overall Study|Other|10|||
147165054|NCT01697462|530770376|FG000|Overall Study|Missing|5|||
147165055|NCT00168103|530770377|FG000|Overall Study|Withdrawal by Subject|1|||
147165056|NCT00168103|530770378|FG001|Overall Study|Withdrawal by Subject|2|||
147165057|NCT00168103|530770379|FG002|Overall Study|Withdrawal by Subject|1|||
147165058|NCT00168103|530770380|FG003|Overall Study|Withdrawal by Subject|0|||
147165059|NCT00168103|530770377|FG000|Overall Study|Lost to Follow-up|1|||
147165060|NCT00168103|530770378|FG001|Overall Study|Lost to Follow-up|3|||
147165061|NCT00168103|530770379|FG002|Overall Study|Lost to Follow-up|0|||
147165062|NCT00168103|530770380|FG003|Overall Study|Lost to Follow-up|0|||
147165063|NCT00545532|530770381|FG000|Overall Study|Withdrawal by Subject|1|||
147165064|NCT00545532|530770382|FG001|Overall Study|Withdrawal by Subject|3|||
147165065|NCT00545532|530770381|FG000|Overall Study|Lost to Follow-up|5|||
147165066|NCT00545532|530770382|FG001|Overall Study|Lost to Follow-up|6|||
147165067|NCT00545532|530770381|FG000|Overall Study|Death|0|||
147165068|NCT00545532|530770382|FG001|Overall Study|Death|1|||
147165069|NCT03630302|530770383|FG000|Surgery|hardware issue prevented LFP recordings|1|||
147165070|NCT03630302|530770383|FG000|3 Month Visit|Adverse Event|2|||
147165071|NCT03630302|530770383|FG000|Data Post Analyses|IRB issues prevented data from being analyzed and transferred|2|||
147165072|NCT01133275|530770385|FG000|Overall Study|Withdrawal by Subject|1|||
147165073|NCT01133275|530770385|FG000|Overall Study|Cerebrovascular accident (CVA)|1|||
147165074|NCT01143896|530770386|FG000|Overall Study|Did not complete Baseline Interview|5|||
147165075|NCT01143896|530770387|FG001|Overall Study|Did not complete Baseline Interview|4|||
147165076|NCT01143896|530770386|FG000|Overall Study|Lost to Follow-up|18|||
147165077|NCT01143896|530770387|FG001|Overall Study|Lost to Follow-up|13|||
147165078|NCT01143896|530770386|FG000|Overall Study|Withdrawal by Subject|13|||
147165079|NCT01143896|530770387|FG001|Overall Study|Withdrawal by Subject|5|||
147165080|NCT01143896|530770386|FG000|Overall Study|Death|6|||
147165081|NCT01143896|530770387|FG001|Overall Study|Death|3|||
147165082|NCT01318070|530770388|FG000|Overall Study|Adverse Event|1|||
147165083|NCT01318070|530770389|FG001|Overall Study|Adverse Event|1|||
147590034|NCT01360866|532316161|FG002|Overall Study|Withdrawal by participant|168|||
147590035|NCT01360866|532316162|FG003|Overall Study|Withdrawal by participant|8|||
147590036|NCT01360866|532316159|FG000|Overall Study|Protocol Deviation|25|||
147165084|NCT01318070|530770390|FG002|Overall Study|Adverse Event|5|||
147590037|NCT01360866|532316160|FG001|Overall Study|Protocol Deviation|33|||
147590038|NCT01360866|532316161|FG002|Overall Study|Protocol Deviation|61|||
147165085|NCT01318070|530770388|FG000|Overall Study|Withdrawal by Subject|0|||
147165086|NCT01318070|530770389|FG001|Overall Study|Withdrawal by Subject|1|||
147165087|NCT01318070|530770390|FG002|Overall Study|Withdrawal by Subject|1|||
147165088|NCT01318070|530770388|FG000|Overall Study|Lack of Efficacy|0|||
147165089|NCT01318070|530770389|FG001|Overall Study|Lack of Efficacy|0|||
147165090|NCT01318070|530770390|FG002|Overall Study|Lack of Efficacy|1|||
147165091|NCT01318070|530770388|FG000|Overall Study|Principal Investigator Discretion|1|||
147165092|NCT01318070|530770389|FG001|Overall Study|Principal Investigator Discretion|0|||
147165093|NCT01318070|530770390|FG002|Overall Study|Principal Investigator Discretion|0|||
147165094|NCT04375397|530770393|FG000|Overall Study|Death|1|||
147165095|NCT04375397|530770394|FG001|Overall Study|Death|1|||
147165096|NCT04375397|530770393|FG000|Overall Study|Withdrew consent|2|||
147165097|NCT04375397|530770394|FG001|Overall Study|Withdrew consent|0|||
147165098|NCT04375397|530770393|FG000|Overall Study|Lost to Follow-up|6|||
147165099|NCT04375397|530770394|FG001|Overall Study|Lost to Follow-up|4|||
147165100|NCT04375397|530770393|FG000|Overall Study|Other, not specified|0|||
147165101|NCT04375397|530770394|FG001|Overall Study|Other, not specified|1|||
147165102|NCT00610441|530770396|FG000|Treatment Period 1 - 3 Weeks|Adverse Event|1|||
147165103|NCT00610441|530770397|FG001|Treatment Period 1 - 3 Weeks|Adverse Event|1|||
147165104|NCT00610441|530770398|FG002|Treatment Period 1 - 3 Weeks|Adverse Event|4|||
147165105|NCT00610441|530770399|FG003|Treatment Period 1 - 3 Weeks|Adverse Event|1|||
147165106|NCT00610441|530770396|FG000|Treatment Period 1 - 3 Weeks|Lack of Efficacy|0|||
147165107|NCT00610441|530770397|FG001|Treatment Period 1 - 3 Weeks|Lack of Efficacy|0|||
147165108|NCT00610441|530770398|FG002|Treatment Period 1 - 3 Weeks|Lack of Efficacy|1|||
147165109|NCT00610441|530770399|FG003|Treatment Period 1 - 3 Weeks|Lack of Efficacy|0|||
147165110|NCT00610441|530770396|FG000|Treatment Period 1 - 3 Weeks|Lost to Follow-up|1|||
147165111|NCT00610441|530770397|FG001|Treatment Period 1 - 3 Weeks|Lost to Follow-up|1|||
147165112|NCT00610441|530770398|FG002|Treatment Period 1 - 3 Weeks|Lost to Follow-up|1|||
147165113|NCT00610441|530770399|FG003|Treatment Period 1 - 3 Weeks|Lost to Follow-up|0|||
147165114|NCT00610441|530770396|FG000|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|1|||
147165115|NCT00610441|530770397|FG001|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|0|||
147165116|NCT00610441|530770398|FG002|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|1|||
147165117|NCT00610441|530770399|FG003|Treatment Period 1 - 3 Weeks|Withdrawal by Subject|1|||
147165118|NCT00610441|530770396|FG000|Placebo Washout Period - 2 Weeks|Adverse Event|0|||
147165119|NCT00610441|530770397|FG001|Placebo Washout Period - 2 Weeks|Adverse Event|0|||
147165120|NCT00610441|530770398|FG002|Placebo Washout Period - 2 Weeks|Adverse Event|2|||
147165121|NCT00610441|530770399|FG003|Placebo Washout Period - 2 Weeks|Adverse Event|0|||
147165122|NCT00610441|530770396|FG000|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|0|||
147165123|NCT00610441|530770397|FG001|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|1|||
147165124|NCT00610441|530770398|FG002|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|0|||
147165125|NCT00610441|530770399|FG003|Placebo Washout Period - 2 Weeks|Withdrawal by Subject|0|||
147165126|NCT00610441|530770396|FG000|Treatment Period 2 - 3 Weeks|Other|1|||
147165127|NCT00610441|530770397|FG001|Treatment Period 2 - 3 Weeks|Other|1|||
147243374|NCT00004978|531063792|FG000|Overall Study|Lost to Follow-up|101|||
147243375|NCT00004978|531063793|FG001|Overall Study|Lost to Follow-up|108|||
147243376|NCT00004978|531063792|FG000|Overall Study|Withdrawal by Subject|17|||
147243377|NCT00004978|531063793|FG001|Overall Study|Withdrawal by Subject|26|||
147243378|NCT00004978|531063792|FG000|Overall Study|site closure - not in analysis cohort|19|||
147243379|NCT00004978|531063793|FG001|Overall Study|site closure - not in analysis cohort|20|||
147243380|NCT01652703|531063797|FG000|Overall Study|Withdrawal by Subject|0|||
147243381|NCT01652703|531063798|FG001|Overall Study|Withdrawal by Subject|1|||
147243382|NCT01652703|531063799|FG002|Overall Study|Withdrawal by Subject|3|||
147243383|NCT01652703|531063800|FG003|Overall Study|Withdrawal by Subject|1|||
147243384|NCT01652703|531063801|FG004|Overall Study|Withdrawal by Subject|0|||
147243385|NCT01652703|531063802|FG005|Overall Study|Withdrawal by Subject|1|||
147243386|NCT01652703|531063797|FG000|Overall Study|Other|0|||
147243387|NCT01652703|531063798|FG001|Overall Study|Other|0|||
147243388|NCT01652703|531063799|FG002|Overall Study|Other|0|||
147243389|NCT01652703|531063800|FG003|Overall Study|Other|1|||
147243390|NCT01652703|531063801|FG004|Overall Study|Other|1|||
147243391|NCT01652703|531063802|FG005|Overall Study|Other|1|||
147243392|NCT00062374|531063803|FG000|Overall Study|Not treated|12|||
147243393|NCT01532414|531063804|FG000|Overall Study|Lost to Follow-up|3|||
147243394|NCT01532414|531063805|FG001|Overall Study|Lost to Follow-up|0|||
147165128|NCT00610441|530770398|FG002|Treatment Period 2 - 3 Weeks|Other|0|||
147165129|NCT00610441|530770399|FG003|Treatment Period 2 - 3 Weeks|Other|1|||
147243395|NCT01532414|531063806|FG002|Overall Study|Lost to Follow-up|1|||
147243396|NCT01532414|531063804|FG000|Overall Study|Withdrawal by Subject|3|||
147165130|NCT00610441|530770396|FG000|Treatment Period 2 - 3 Weeks|Adverse Event|0|||
147165131|NCT00610441|530770397|FG001|Treatment Period 2 - 3 Weeks|Adverse Event|0|||
147243397|NCT01532414|531063805|FG001|Overall Study|Withdrawal by Subject|0|||
147243398|NCT01532414|531063806|FG002|Overall Study|Withdrawal by Subject|0|||
147243399|NCT01532414|531063804|FG000|Overall Study|No V6 semen sample|0|||
147243400|NCT01532414|531063805|FG001|Overall Study|No V6 semen sample|1|||
147243401|NCT01532414|531063806|FG002|Overall Study|No V6 semen sample|0|||
147243402|NCT01532414|531063804|FG000|Overall Study|Adverse Event|0|||
147447648|NCT01877187|531803920|FG000|Overall Study|Lost to Follow-up|3|||
147165132|NCT00610441|530770398|FG002|Treatment Period 2 - 3 Weeks|Adverse Event|0|||
147165133|NCT00610441|530770399|FG003|Treatment Period 2 - 3 Weeks|Adverse Event|1|||
147165134|NCT00610441|530770396|FG000|Treatment Period 2 - 3 Weeks|Lack of Efficacy|1|||
147165135|NCT00610441|530770397|FG001|Treatment Period 2 - 3 Weeks|Lack of Efficacy|0|||
147165136|NCT00610441|530770398|FG002|Treatment Period 2 - 3 Weeks|Lack of Efficacy|0|||
147165137|NCT00610441|530770399|FG003|Treatment Period 2 - 3 Weeks|Lack of Efficacy|0|||
147165138|NCT01287195|530770405|FG000|Overall Study|Withdrawal by Subject|2|||
147165139|NCT02068118|530770409|FG000|18-month Comparative Study Period|Death|90|||
147165140|NCT02068118|530770410|FG001|18-month Comparative Study Period|Death|97|||
147165141|NCT02068118|530770409|FG000|18-month Comparative Study Period|Withdrawal by Subject|23|||
147165142|NCT02068118|530770410|FG001|18-month Comparative Study Period|Withdrawal by Subject|52|||
147165143|NCT02068118|530770409|FG000|18-month Comparative Study Period|Lost to Follow-up|6|||
147165144|NCT02068118|530770410|FG001|18-month Comparative Study Period|Lost to Follow-up|7|||
147165145|NCT02068118|530770409|FG000|18-month Comparative Study Period|Heart transplant|9|||
147165146|NCT02068118|530770410|FG001|18-month Comparative Study Period|Heart transplant|15|||
147165147|NCT02068118|530770409|FG000|18-month Comparative Study Period|Inclusion in another protocol|0|||
147165148|NCT02068118|530770410|FG001|18-month Comparative Study Period|Inclusion in another protocol|2|||
147165149|NCT02068118|530770409|FG000|18-month Comparative Study Period|Hemiplegia|0|||
147165150|NCT02068118|530770410|FG001|18-month Comparative Study Period|Hemiplegia|1|||
147165151|NCT02068118|530770409|FG000|18-month Comparative Study Period|Alzheimer's disease|0|||
147165152|NCT02068118|530770410|FG001|18-month Comparative Study Period|Alzheimer's disease|1|||
147165153|NCT02068118|530770409|FG000|18-month Comparative Study Period|Move|0|||
147165154|NCT02068118|530770410|FG001|18-month Comparative Study Period|Move|1|||
147165155|NCT02068118|530770409|FG000|18-month Comparative Study Period|Hearing loss|0|||
147165156|NCT02068118|530770410|FG001|18-month Comparative Study Period|Hearing loss|1|||
147165157|NCT02068118|530770409|FG000|Extension Period|Death|0|||
147165158|NCT02068118|530770410|FG001|Extension Period|Death|2|||
147165159|NCT02068118|530770409|FG000|Extension Period|Withdrawal by Subject|1|||
147165160|NCT02068118|530770410|FG001|Extension Period|Withdrawal by Subject|0|||
147590039|NCT01360866|532316162|FG003|Overall Study|Protocol Deviation|2|||
147590040|NCT01360866|532316159|FG000|Overall Study|Lack of Efficacy|30|||
147590041|NCT01360866|532316160|FG001|Overall Study|Lack of Efficacy|40|||
147590042|NCT01360866|532316161|FG002|Overall Study|Lack of Efficacy|30|||
147590043|NCT01360866|532316162|FG003|Overall Study|Lack of Efficacy|4|||
147590044|NCT03702049|532316163|FG000|Overall Study|Lost to Follow-up|4|||
147590045|NCT03702049|532316163|FG000|Overall Study|Physician Decision|1|||
147590046|NCT00918463|532316171|FG000|Overall Study|Death|1|||
147590047|NCT00918463|532316171|FG000|Overall Study|Lack of Efficacy|1|||
147165161|NCT02068118|530770409|FG000|Extension Period|Heart transplant|1|||
147165162|NCT02068118|530770410|FG001|Extension Period|Heart transplant|0|||
147165163|NCT02068118|530770409|FG000|Extension Period|Wrong device use|0|||
147165164|NCT02068118|530770410|FG001|Extension Period|Wrong device use|1|||
147165165|NCT00283868|530770413|FG000|Overall Study|Lost to Follow-up|7|||
147165166|NCT00283868|530770414|FG001|Overall Study|Lost to Follow-up|8|||
147165167|NCT00453973|530770415|FG000|Overall Study|Adverse Event|4|||
147165168|NCT00453973|530770416|FG001|Overall Study|Adverse Event|9|||
147165169|NCT00453973|530770415|FG000|Overall Study|Withdrawal by Subject|7|||
147165170|NCT00453973|530770416|FG001|Overall Study|Withdrawal by Subject|6|||
147165171|NCT00453973|530770415|FG000|Overall Study|PI Decision|0|||
147165172|NCT00453973|530770416|FG001|Overall Study|PI Decision|2|||
147165173|NCT00453973|530770415|FG000|Overall Study|Relocation|1|||
147165174|NCT00453973|530770416|FG001|Overall Study|Relocation|0|||
147165175|NCT00453973|530770415|FG000|Overall Study|Renal transplant|1|||
147165176|NCT00453973|530770416|FG001|Overall Study|Renal transplant|1|||
147165177|NCT00453973|530770415|FG000|Overall Study|Site closed by sponsor|3|||
147165178|NCT00453973|530770416|FG001|Overall Study|Site closed by sponsor|0|||
147165179|NCT00453973|530770415|FG000|Overall Study|Sponsor Decision to Terminate Study|35|||
147165180|NCT00453973|530770416|FG001|Overall Study|Sponsor Decision to Terminate Study|30|||
147165181|NCT01219933|530770420|FG000|Overall Study|Adverse Event|8|||
147165182|NCT01219933|530770420|FG000|Overall Study|No LDA reached|5|||
147165183|NCT01219933|530770420|FG000|Overall Study|No LDA maintained|7|||
147165184|NCT01219933|530770420|FG000|Overall Study|Lost to Follow-up|3|||
147243403|NCT01532414|531063805|FG001|Overall Study|Adverse Event|1|||
147590048|NCT01014624|532316175|FG000|Overall Study|Adverse Event|0|||
147590049|NCT01014624|532316176|FG001|Overall Study|Adverse Event|1|||
147243404|NCT01532414|531063806|FG002|Overall Study|Adverse Event|1|||
147590050|NCT01014624|532316175|FG000|Overall Study|Protocol Violation|1|||
147590051|NCT01014624|532316176|FG001|Overall Study|Protocol Violation|0|||
147590052|NCT01014624|532316175|FG000|Overall Study|Withdrawal by Subject|1|||
147165185|NCT01219933|530770420|FG000|Overall Study|GC free|1|||
147165186|NCT01219933|530770420|FG000|Overall Study|Withdrawal by Subject|5|||
147165187|NCT01219933|530770420|FG000|Overall Study|Protocol Violation|8|||
147165188|NCT01219933|530770420|FG000|Overall Study|Lack of Efficacy|1|||
147165189|NCT01443130|530770422|FG000|Overall Study|Lost to Follow-up|44|||
147165190|NCT01443130|530770423|FG001|Overall Study|Lost to Follow-up|42|||
147243405|NCT01532414|531063804|FG000|Overall Study|Unable to complete 24 hour PK|0|||
147165191|NCT01443130|530770424|FG002|Overall Study|Lost to Follow-up|50|||
147165192|NCT01443130|530770425|FG003|Overall Study|Lost to Follow-up|23|||
147165193|NCT01443130|530770426|FG004|Overall Study|Lost to Follow-up|25|||
147165194|NCT01443130|530770427|FG005|Overall Study|Lost to Follow-up|21|||
147165195|NCT01443130|530770422|FG000|Overall Study|Death|0|||
147165196|NCT01443130|530770423|FG001|Overall Study|Death|1|||
147165197|NCT01443130|530770424|FG002|Overall Study|Death|0|||
147165198|NCT01443130|530770425|FG003|Overall Study|Death|7|||
147165199|NCT01443130|530770426|FG004|Overall Study|Death|10|||
147165200|NCT01443130|530770427|FG005|Overall Study|Death|8|||
147165201|NCT01443130|530770422|FG000|Overall Study|Adverse Event|2|||
147165202|NCT01443130|530770423|FG001|Overall Study|Adverse Event|1|||
147165203|NCT01443130|530770424|FG002|Overall Study|Adverse Event|1|||
147165204|NCT01443130|530770425|FG003|Overall Study|Adverse Event|0|||
147165205|NCT01443130|530770426|FG004|Overall Study|Adverse Event|0|||
147165206|NCT01443130|530770427|FG005|Overall Study|Adverse Event|0|||
147165207|NCT01443130|530770422|FG000|Overall Study|Protocol Violation|2|||
147165208|NCT01443130|530770423|FG001|Overall Study|Protocol Violation|1|||
147165209|NCT01443130|530770424|FG002|Overall Study|Protocol Violation|3|||
147165210|NCT01443130|530770425|FG003|Overall Study|Protocol Violation|2|||
147165211|NCT01443130|530770426|FG004|Overall Study|Protocol Violation|2|||
147165212|NCT01443130|530770427|FG005|Overall Study|Protocol Violation|3|||
147165213|NCT01443130|530770422|FG000|Overall Study|Withdrawal by Subject|15|||
147165214|NCT01443130|530770423|FG001|Overall Study|Withdrawal by Subject|14|||
147165215|NCT01443130|530770424|FG002|Overall Study|Withdrawal by Subject|12|||
147165216|NCT01443130|530770425|FG003|Overall Study|Withdrawal by Subject|7|||
147165217|NCT01443130|530770426|FG004|Overall Study|Withdrawal by Subject|7|||
147165218|NCT01443130|530770427|FG005|Overall Study|Withdrawal by Subject|2|||
147165219|NCT01443130|530770422|FG000|Overall Study|Death of Subject's Infant|5|||
147165220|NCT01443130|530770423|FG001|Overall Study|Death of Subject's Infant|10|||
147165221|NCT01443130|530770424|FG002|Overall Study|Death of Subject's Infant|11|||
147165222|NCT01443130|530770425|FG003|Overall Study|Death of Subject's Infant|0|||
147165223|NCT01443130|530770426|FG004|Overall Study|Death of Subject's Infant|0|||
147165224|NCT01443130|530770427|FG005|Overall Study|Death of Subject's Infant|0|||
147165225|NCT00685373|530770428|FG000|Overall Study|Adverse Event|3|||
147165226|NCT00685373|530770428|FG000|Overall Study|Withdrawal by Subject|5|||
147165227|NCT00685373|530770428|FG000|Overall Study|Lack of Efficacy|3|||
147165228|NCT00685373|530770428|FG000|Overall Study|Condition no longer requires study drug|1|||
147165229|NCT00685373|530770428|FG000|Overall Study|Lost to Follow-up|2|||
147165230|NCT00685373|530770428|FG000|Overall Study|Protocol Violation|1|||
147165231|NCT02758301|530770429|FG000|Overall Study|Death|12|||
147165232|NCT02758301|530770430|FG001|Overall Study|Death|0|||
147165233|NCT02758301|530770429|FG000|Overall Study|Physician Decision|10|||
147165234|NCT02758301|530770430|FG001|Overall Study|Physician Decision|1|||
147165235|NCT02758301|530770429|FG000|Overall Study|Withdrawal by Subject|5|||
147165236|NCT02758301|530770430|FG001|Overall Study|Withdrawal by Subject|6|||
147165237|NCT02758301|530770429|FG000|Overall Study|Lost to Follow-up|7|||
147165238|NCT02758301|530770430|FG001|Overall Study|Lost to Follow-up|0|||
147165239|NCT02758301|530770429|FG000|Overall Study|Protocol Violation|0|||
147165240|NCT02758301|530770430|FG001|Overall Study|Protocol Violation|1|||
147165241|NCT00364533|530770431|FG000|Overall Study|Adverse Event|8|||
147165242|NCT00364533|530770432|FG001|Overall Study|Adverse Event|7|||
147165243|NCT00364533|530770433|FG002|Overall Study|Adverse Event|15|||
147165244|NCT00364533|530770434|FG003|Overall Study|Adverse Event|5|||
147165245|NCT00364533|530770435|FG004|Overall Study|Adverse Event|2|||
147165246|NCT00364533|530770431|FG000|Overall Study|Withdrawal by Subject|4|||
147165247|NCT00364533|530770432|FG001|Overall Study|Withdrawal by Subject|8|||
147165248|NCT00364533|530770433|FG002|Overall Study|Withdrawal by Subject|6|||
147323400|NCT01449929|531348018|FG000|Randomization Phase 96 Week|Withdrawal by Subject|2|||
147323401|NCT01449929|531348019|FG001|Randomization Phase 96 Week|Withdrawal by Subject|8|||
147323402|NCT01449929|531348020|FG002|Randomization Phase 96 Week|Withdrawal by Subject|0|||
147323403|NCT01449929|531348018|FG000|Randomization Phase 96 Week|Physician Decision|2|||
147323404|NCT01449929|531348019|FG001|Randomization Phase 96 Week|Physician Decision|3|||
147323405|NCT01449929|531348020|FG002|Randomization Phase 96 Week|Physician Decision|0|||
147165249|NCT00364533|530770434|FG003|Overall Study|Withdrawal by Subject|6|||
147165250|NCT00364533|530770435|FG004|Overall Study|Withdrawal by Subject|6|||
147165251|NCT00364533|530770431|FG000|Overall Study|Lack of Efficacy|22|||
147165252|NCT00364533|530770432|FG001|Overall Study|Lack of Efficacy|22|||
147165253|NCT00364533|530770433|FG002|Overall Study|Lack of Efficacy|21|||
147165254|NCT00364533|530770434|FG003|Overall Study|Lack of Efficacy|17|||
147165255|NCT00364533|530770435|FG004|Overall Study|Lack of Efficacy|42|||
147165256|NCT00364533|530770431|FG000|Overall Study|Subject discharged from hospital|4|||
147165257|NCT00364533|530770432|FG001|Overall Study|Subject discharged from hospital|1|||
147590053|NCT01014624|532316176|FG001|Overall Study|Withdrawal by Subject|0|||
147165258|NCT00364533|530770433|FG002|Overall Study|Subject discharged from hospital|2|||
147165259|NCT00364533|530770434|FG003|Overall Study|Subject discharged from hospital|3|||
147165260|NCT00364533|530770435|FG004|Overall Study|Subject discharged from hospital|1|||
147165261|NCT00364533|530770431|FG000|Overall Study|Variations in drug compliance|2|||
147165262|NCT00364533|530770432|FG001|Overall Study|Variations in drug compliance|1|||
147165263|NCT00364533|530770433|FG002|Overall Study|Variations in drug compliance|1|||
147165264|NCT00364533|530770434|FG003|Overall Study|Variations in drug compliance|0|||
147165265|NCT00364533|530770435|FG004|Overall Study|Variations in drug compliance|0|||
147165266|NCT00364533|530770431|FG000|Overall Study|Non-compliance|1|||
147165267|NCT00364533|530770432|FG001|Overall Study|Non-compliance|0|||
147165268|NCT00364533|530770433|FG002|Overall Study|Non-compliance|0|||
147165269|NCT00364533|530770434|FG003|Overall Study|Non-compliance|0|||
147165270|NCT00364533|530770435|FG004|Overall Study|Non-compliance|0|||
147165271|NCT00364533|530770431|FG000|Overall Study|Protocol Violation|1|||
147165272|NCT00364533|530770432|FG001|Overall Study|Protocol Violation|1|||
147165273|NCT00364533|530770433|FG002|Overall Study|Protocol Violation|0|||
147165274|NCT00364533|530770434|FG003|Overall Study|Protocol Violation|0|||
147165275|NCT00364533|530770435|FG004|Overall Study|Protocol Violation|0|||
147165276|NCT00582738|530770436|FG000|Overall Study|Administrative Problems|7|||
147165277|NCT00582738|530770437|FG001|Overall Study|Administrative Problems|8|||
147165278|NCT00582738|530770436|FG000|Overall Study|Adverse Event|0|||
147165279|NCT00582738|530770437|FG001|Overall Study|Adverse Event|5|||
147165280|NCT00582738|530770436|FG000|Overall Study|Graft Lost|0|||
147165281|NCT00582738|530770437|FG001|Overall Study|Graft Lost|1|||
147165282|NCT00582738|530770436|FG000|Overall Study|Other|1|||
147165283|NCT00582738|530770437|FG001|Overall Study|Other|0|||
147165284|NCT00582738|530770436|FG000|Overall Study|Protocol Violation|1|||
147165285|NCT00582738|530770437|FG001|Overall Study|Protocol Violation|1|||
147165286|NCT00582738|530770436|FG000|Overall Study|Withdrawal by Subject|0|||
147165287|NCT00582738|530770437|FG001|Overall Study|Withdrawal by Subject|3|||
147165288|NCT03461406|530770439|FG000|Overall Study|Death|1|||
147165289|NCT03461406|530770440|FG001|Overall Study|Death|2|||
147165290|NCT03461406|530770439|FG000|Overall Study|Consent Withdrawn by Participant|0|||
147165291|NCT03461406|530770440|FG001|Overall Study|Consent Withdrawn by Participant|1|||
147165292|NCT03461406|530770439|FG000|Overall Study|Screen Failure|3|||
147165293|NCT03461406|530770440|FG001|Overall Study|Screen Failure|1|||
147165294|NCT03461406|530770439|FG000|Overall Study|Reason not Specified|1|||
147165295|NCT03461406|530770440|FG001|Overall Study|Reason not Specified|3|||
147165296|NCT03461406|530770439|FG000|Overall Study|Lost to Follow-up|3|||
147165297|NCT03461406|530770440|FG001|Overall Study|Lost to Follow-up|0|||
147165298|NCT01011933|530770441|FG000|Overall Study|Wrong cell type|1|||
147165299|NCT01011933|530770441|FG000|Overall Study|Improper pre-protocol Rx|1|||
147165300|NCT01011933|530770441|FG000|Overall Study|Inadequate pathology|1|||
147165301|NCT01011933|530770441|FG000|Overall Study|Never treated|1|||
147165302|NCT01886690|530770442|FG000|Overall Study|Protocol Violation|0|||
147165303|NCT01886690|530770443|FG001|Overall Study|Protocol Violation|1|||
147165304|NCT01886690|530770442|FG000|Overall Study|Personal Reasons|0|||
147165305|NCT01886690|530770443|FG001|Overall Study|Personal Reasons|1|||
147165306|NCT02900170|530770446|FG000|Overall Study|Lost to Follow-up|8|||
147165307|NCT01814670|530770447|FG000|Overall Study|Protocol Violation|12|||
147165308|NCT02012686|530770451|FG000|Overall Study|muscle contraction|0|||
147165309|NCT02012686|530770452|FG001|Overall Study|muscle contraction|1|||
147165310|NCT02012686|530770451|FG000|Overall Study|electrocardiography monitoring noise|0|||
147165311|NCT02012686|530770452|FG001|Overall Study|electrocardiography monitoring noise|1|||
147165312|NCT00966719|530770453|FG000|Overall Study|Lost to Follow-up|6|||
147165313|NCT00966719|530770454|FG001|Overall Study|Lost to Follow-up|11|||
147165314|NCT01703065|530770457|FG000|Overall Study|Lack of Efficacy|1|||
147165315|NCT01703065|530770458|FG001|Overall Study|Lack of Efficacy|0|||
147165316|NCT00160199|530770461|FG000|Overall Study|Adverse Event|5|||
147165317|NCT00160199|530770462|FG001|Overall Study|Adverse Event|14|||
147165318|NCT00160199|530770461|FG000|Overall Study|Lack of Efficacy|0|||
147165319|NCT00160199|530770462|FG001|Overall Study|Lack of Efficacy|1|||
147165320|NCT00160199|530770461|FG000|Overall Study|Lost to Follow-up|7|||
147165321|NCT00160199|530770462|FG001|Overall Study|Lost to Follow-up|7|||
147165322|NCT00160199|530770461|FG000|Overall Study|Withdrawal by Subject|4|||
147165323|NCT00160199|530770462|FG001|Overall Study|Withdrawal by Subject|6|||
147243406|NCT01532414|531063805|FG001|Overall Study|Unable to complete 24 hour PK|0|||
147243407|NCT01532414|531063806|FG002|Overall Study|Unable to complete 24 hour PK|1|||
147243408|NCT01532414|531063804|FG000|Overall Study|Withdrawn by sponsor|1|||
147243409|NCT01532414|531063805|FG001|Overall Study|Withdrawn by sponsor|0|||
147243410|NCT01532414|531063806|FG002|Overall Study|Withdrawn by sponsor|0|||
147243411|NCT03633695|531063809|FG000|Overall Study|Lost to Follow-up|4|||
147243412|NCT03633695|531063810|FG001|Overall Study|Lost to Follow-up|5|||
147243413|NCT03633695|531063809|FG000|Overall Study|Discontinued|8|||
147243414|NCT03633695|531063810|FG001|Overall Study|Discontinued|4|||
147243415|NCT00187486|531063811|FG000|Overall Study|Protocol Violation|1|||
147243416|NCT01438957|531063821|FG000|Overall Study|Physician Decision|1|||
147243417|NCT01438957|531063822|FG001|Overall Study|Physician Decision|1|||
147165324|NCT00160199|530770461|FG000|Overall Study|Administrative|0|||
147165325|NCT00160199|530770462|FG001|Overall Study|Administrative|1|||
147165326|NCT00160199|530770461|FG000|Overall Study|Protocol Violation|8|||
147243418|NCT01438957|531063823|FG002|Overall Study|Physician Decision|0|||
147243419|NCT01438957|531063824|FG003|Overall Study|Physician Decision|1|||
147165327|NCT00160199|530770462|FG001|Overall Study|Protocol Violation|8|||
147165328|NCT01710527|530770463|FG000|Period 2: Washout Period (7 Days)|Personal reasons|0|||
147165329|NCT01710527|530770464|FG001|Period 2: Washout Period (7 Days)|Personal reasons|1|||
147165330|NCT02124772|530770465|FG000|Overall Study|Lack of Efficacy|2|||
147165331|NCT02124772|530770466|FG001|Overall Study|Lack of Efficacy|0|||
147165332|NCT02124772|530770467|FG002|Overall Study|Lack of Efficacy|0|||
147165333|NCT02124772|530770468|FG003|Overall Study|Lack of Efficacy|1|||
147165334|NCT02124772|530770469|FG004|Overall Study|Lack of Efficacy|2|||
147165335|NCT02124772|530770470|FG005|Overall Study|Lack of Efficacy|3|||
147165336|NCT02124772|530770471|FG006|Overall Study|Lack of Efficacy|0|||
147165337|NCT02124772|530770472|FG007|Overall Study|Lack of Efficacy|2|||
147165338|NCT02124772|530770473|FG008|Overall Study|Lack of Efficacy|0|||
147165339|NCT02124772|530770474|FG009|Overall Study|Lack of Efficacy|1|||
147165340|NCT02124772|530770475|FG010|Overall Study|Lack of Efficacy|0|||
147165341|NCT02124772|530770476|FG011|Overall Study|Lack of Efficacy|0|||
147165342|NCT02124772|530770477|FG012|Overall Study|Lack of Efficacy|1|||
147165343|NCT02124772|530770465|FG000|Overall Study|Adverse Event|1|||
147165344|NCT02124772|530770466|FG001|Overall Study|Adverse Event|4|||
147165345|NCT02124772|530770467|FG002|Overall Study|Adverse Event|1|||
147165346|NCT02124772|530770468|FG003|Overall Study|Adverse Event|5|||
147165347|NCT02124772|530770469|FG004|Overall Study|Adverse Event|2|||
147165348|NCT02124772|530770470|FG005|Overall Study|Adverse Event|1|||
147165349|NCT02124772|530770471|FG006|Overall Study|Adverse Event|1|||
147165350|NCT02124772|530770472|FG007|Overall Study|Adverse Event|5|||
147165351|NCT02124772|530770473|FG008|Overall Study|Adverse Event|0|||
147165352|NCT02124772|530770474|FG009|Overall Study|Adverse Event|3|||
147165353|NCT02124772|530770475|FG010|Overall Study|Adverse Event|1|||
147165354|NCT02124772|530770476|FG011|Overall Study|Adverse Event|3|||
147165355|NCT02124772|530770477|FG012|Overall Study|Adverse Event|1|||
147165356|NCT02124772|530770465|FG000|Overall Study|Withdrawal consent|0|||
147165357|NCT02124772|530770466|FG001|Overall Study|Withdrawal consent|1|||
147165358|NCT02124772|530770467|FG002|Overall Study|Withdrawal consent|1|||
147165359|NCT02124772|530770468|FG003|Overall Study|Withdrawal consent|1|||
147165360|NCT02124772|530770469|FG004|Overall Study|Withdrawal consent|0|||
147165361|NCT02124772|530770470|FG005|Overall Study|Withdrawal consent|1|||
147165362|NCT02124772|530770471|FG006|Overall Study|Withdrawal consent|1|||
147165363|NCT02124772|530770472|FG007|Overall Study|Withdrawal consent|0|||
147165364|NCT02124772|530770473|FG008|Overall Study|Withdrawal consent|0|||
147165365|NCT02124772|530770474|FG009|Overall Study|Withdrawal consent|1|||
147165366|NCT02124772|530770475|FG010|Overall Study|Withdrawal consent|0|||
147165367|NCT02124772|530770476|FG011|Overall Study|Withdrawal consent|1|||
147165368|NCT02124772|530770477|FG012|Overall Study|Withdrawal consent|0|||
147165369|NCT02124772|530770465|FG000|Overall Study|Investigator discretion|0|||
147165370|NCT02124772|530770466|FG001|Overall Study|Investigator discretion|2|||
147165371|NCT02124772|530770467|FG002|Overall Study|Investigator discretion|2|||
147165372|NCT02124772|530770468|FG003|Overall Study|Investigator discretion|1|||
147165373|NCT02124772|530770469|FG004|Overall Study|Investigator discretion|1|||
147165374|NCT02124772|530770470|FG005|Overall Study|Investigator discretion|0|||
147165375|NCT02124772|530770471|FG006|Overall Study|Investigator discretion|1|||
147165376|NCT02124772|530770472|FG007|Overall Study|Investigator discretion|0|||
147165377|NCT02124772|530770473|FG008|Overall Study|Investigator discretion|0|||
147165378|NCT02124772|530770474|FG009|Overall Study|Investigator discretion|1|||
147165379|NCT02124772|530770475|FG010|Overall Study|Investigator discretion|0|||
147165380|NCT02124772|530770476|FG011|Overall Study|Investigator discretion|1|||
147165381|NCT02124772|530770477|FG012|Overall Study|Investigator discretion|0|||
147165382|NCT02124772|530770465|FG000|Overall Study|Progressive disease|0|||
147165383|NCT02124772|530770466|FG001|Overall Study|Progressive disease|0|||
147165384|NCT02124772|530770467|FG002|Overall Study|Progressive disease|0|||
147165385|NCT02124772|530770468|FG003|Overall Study|Progressive disease|0|||
147165386|NCT02124772|530770469|FG004|Overall Study|Progressive disease|0|||
147165387|NCT02124772|530770470|FG005|Overall Study|Progressive disease|0|||
147165388|NCT02124772|530770471|FG006|Overall Study|Progressive disease|1|||
147165389|NCT02124772|530770472|FG007|Overall Study|Progressive disease|1|||
147165390|NCT02124772|530770473|FG008|Overall Study|Progressive disease|0|||
147165391|NCT02124772|530770474|FG009|Overall Study|Progressive disease|0|||
147165392|NCT02124772|530770475|FG010|Overall Study|Progressive disease|0|||
147165393|NCT02124772|530770476|FG011|Overall Study|Progressive disease|0|||
147165394|NCT02124772|530770477|FG012|Overall Study|Progressive disease|0|||
147165395|NCT02124772|530770465|FG000|Overall Study|Other|0|||
147165396|NCT02124772|530770466|FG001|Overall Study|Other|7|||
147165397|NCT02124772|530770467|FG002|Overall Study|Other|2|||
147165398|NCT02124772|530770468|FG003|Overall Study|Other|5|||
147165399|NCT02124772|530770469|FG004|Overall Study|Other|4|||
147165400|NCT02124772|530770470|FG005|Overall Study|Other|3|||
147165401|NCT02124772|530770471|FG006|Overall Study|Other|4|||
147165402|NCT02124772|530770472|FG007|Overall Study|Other|1|||
147165403|NCT02124772|530770473|FG008|Overall Study|Other|1|||
147165404|NCT02124772|530770474|FG009|Overall Study|Other|1|||
147165405|NCT02124772|530770475|FG010|Overall Study|Other|1|||
147165406|NCT02124772|530770476|FG011|Overall Study|Other|1|||
147165407|NCT02124772|530770477|FG012|Overall Study|Other|0|||
147590054|NCT01117337|532316184|FG000|Overall Study|Lost to Follow-up|4|||
147590055|NCT01117337|532316185|FG001|Overall Study|Lost to Follow-up|0|||
147590056|NCT01045993|532316186|FG000|Overall Study|Treated-later found eligibility not met|0|||
147590057|NCT01045993|532316187|FG001|Overall Study|Treated-later found eligibility not met|1|||
147165408|NCT02827500|530770478|FG000|Overall Study|Death|7|||
147165409|NCT02827500|530770479|FG001|Overall Study|Death|3|||
147165410|NCT02827500|530770478|FG000|Overall Study|Lost to Follow-up|1|||
147165411|NCT02827500|530770479|FG001|Overall Study|Lost to Follow-up|1|||
147165412|NCT02827500|530770478|FG000|Overall Study|Withdrawal by Subject|3|||
147165413|NCT02827500|530770479|FG001|Overall Study|Withdrawal by Subject|1|||
147165414|NCT02827500|530770478|FG000|Overall Study|Missing primary endpoint data|3|||
147165415|NCT02827500|530770479|FG001|Overall Study|Missing primary endpoint data|1|||
147165416|NCT02827500|530770478|FG000|Overall Study|Other|5|||
147165417|NCT02827500|530770479|FG001|Overall Study|Other|1|||
147165418|NCT03089944|530770482|FG000|Overall Study|Lost to Follow-up|8|||
147590058|NCT01045993|532316188|FG002|Overall Study|Treated-later found eligibility not met|0|||
147590059|NCT01045993|532316189|FG003|Overall Study|Treated-later found eligibility not met|0|||
147590060|NCT01659736|532316190|FG000|Treatment Period|Adverse Event|1|||
147590061|NCT01659736|532316191|FG001|Treatment Period|Adverse Event|1|||
147590062|NCT01659736|532316190|FG000|Treatment Period|Protocol Violation|3|||
147590063|NCT01659736|532316191|FG001|Treatment Period|Protocol Violation|1|||
147590064|NCT01659736|532316190|FG000|Treatment Period|Withdrawal by Subject|1|||
147590065|NCT01659736|532316191|FG001|Treatment Period|Withdrawal by Subject|0|||
147590066|NCT01659736|532316190|FG000|3-month Follow-up|Lost to Follow-up|0|||
147590067|NCT01659736|532316191|FG001|3-month Follow-up|Lost to Follow-up|1|||
147590068|NCT02791893|532316200|FG000|Blinded Phase|Lost to Follow-up|2|||
147590069|NCT02791893|532316201|FG001|Blinded Phase|Lost to Follow-up|2|||
147590070|NCT02791893|532316200|FG000|Blinded Phase|Withdrawal by Subject|1|||
147590071|NCT02791893|532316201|FG001|Blinded Phase|Withdrawal by Subject|2|||
147590072|NCT02791893|532316200|FG000|Open Label Phase|Lost to Follow-up|3|||
147590073|NCT02791893|532316201|FG001|Open Label Phase|Lost to Follow-up|0|||
147590074|NCT02791893|532316200|FG000|Open Label Phase|Withdrawal by Subject|0|||
147590075|NCT02791893|532316201|FG001|Open Label Phase|Withdrawal by Subject|2|||
147590076|NCT01570283|532316202|FG000|Cohort 1: Dose Level 1|Death|0|||
147590077|NCT01570283|532316203|FG001|Cohort 1: Dose Level 1|Death|1|||
147590078|NCT01570283|532316204|FG002|Cohort 1: Dose Level 1|Death|0|||
147590079|NCT01570283|532316205|FG003|Cohort 1: Dose Level 1|Death|0|||
147590080|NCT01570283|532316206|FG004|Cohort 1: Dose Level 1|Death|0|||
147590081|NCT01570283|532316207|FG005|Cohort 1: Dose Level 1|Death|0|||
147590082|NCT01570283|532316202|FG000|Cohort 1: Dose Level 1|Received other hematopoietic cells|0|||
147590083|NCT01570283|532316203|FG001|Cohort 1: Dose Level 1|Received other hematopoietic cells|1|||
147590084|NCT01570283|532316204|FG002|Cohort 1: Dose Level 1|Received other hematopoietic cells|0|||
147590085|NCT01570283|532316205|FG003|Cohort 1: Dose Level 1|Received other hematopoietic cells|0|||
147590086|NCT01570283|532316206|FG004|Cohort 1: Dose Level 1|Received other hematopoietic cells|0|||
147590087|NCT01570283|532316207|FG005|Cohort 1: Dose Level 1|Received other hematopoietic cells|0|||
147590088|NCT01570283|532316202|FG000|Cohort 2: Dose Level 2|Death|0|||
147590089|NCT01570283|532316203|FG001|Cohort 2: Dose Level 2|Death|0|||
147590090|NCT01570283|532316204|FG002|Cohort 2: Dose Level 2|Death|1|||
147590091|NCT01570283|532316205|FG003|Cohort 2: Dose Level 2|Death|0|||
147590092|NCT01570283|532316206|FG004|Cohort 2: Dose Level 2|Death|0|||
147590093|NCT01570283|532316207|FG005|Cohort 2: Dose Level 2|Death|0|||
147590094|NCT01570283|532316202|FG000|Cohort 2: Dose Level 2|Received other hematopoietic cells|0|||
147590095|NCT01570283|532316203|FG001|Cohort 2: Dose Level 2|Received other hematopoietic cells|0|||
147590096|NCT01570283|532316204|FG002|Cohort 2: Dose Level 2|Received other hematopoietic cells|0|||
147590097|NCT01570283|532316205|FG003|Cohort 2: Dose Level 2|Received other hematopoietic cells|1|||
147590098|NCT01570283|532316206|FG004|Cohort 2: Dose Level 2|Received other hematopoietic cells|0|||
147590099|NCT01570283|532316207|FG005|Cohort 2: Dose Level 2|Received other hematopoietic cells|0|||
147590100|NCT01570283|532316202|FG000|Cohort 3: Dose Level 3|Death|0|||
147590101|NCT01570283|532316203|FG001|Cohort 3: Dose Level 3|Death|0|||
147590102|NCT01570283|532316204|FG002|Cohort 3: Dose Level 3|Death|0|||
147590103|NCT01570283|532316205|FG003|Cohort 3: Dose Level 3|Death|0|||
147590104|NCT01570283|532316206|FG004|Cohort 3: Dose Level 3|Death|0|||
147590105|NCT01570283|532316207|FG005|Cohort 3: Dose Level 3|Death|1|||
147590106|NCT01570283|532316202|FG000|Cohort 3: Dose Level 3|Received other hematopoietic cells|0|||
147590107|NCT01570283|532316203|FG001|Cohort 3: Dose Level 3|Received other hematopoietic cells|0|||
147165419|NCT03089944|530770482|FG000|Overall Study|Withdrew Consent|2|||
147590108|NCT01570283|532316204|FG002|Cohort 3: Dose Level 3|Received other hematopoietic cells|0|||
147590109|NCT01570283|532316205|FG003|Cohort 3: Dose Level 3|Received other hematopoietic cells|0|||
147590110|NCT01570283|532316206|FG004|Cohort 3: Dose Level 3|Received other hematopoietic cells|0|||
147165420|NCT03089944|530770482|FG000|Overall Study|Adverse Event|1|||
147165421|NCT03089944|530770482|FG000|Overall Study|Other|1|||
147243420|NCT01438957|531063825|FG004|Overall Study|Physician Decision|0|||
147590111|NCT01570283|532316207|FG005|Cohort 3: Dose Level 3|Received other hematopoietic cells|1|||
147590112|NCT00493454|532316211|FG000|Overall Study|Withdrawal by Subject|1|||
147590113|NCT03095118|532316217|FG000|Overall Study|Adverse Event|1|||
147590114|NCT03095118|532316217|FG000|Overall Study|Diagnosis not associated with monoclonal gammopathy|1|||
147590115|NCT01682148|532316219|FG000|Overall Study|Withdrawal by Subject|2|||
147590116|NCT01682148|532316220|FG001|Overall Study|Withdrawal by Subject|0|||
147590117|NCT01682148|532316219|FG000|Overall Study|Lost to Follow-up|1|||
147165422|NCT01636713|530770483|FG000|Overall Study|Adverse Event|16|||
147165423|NCT01636713|530770484|FG001|Overall Study|Adverse Event|16|||
147165424|NCT01636713|530770485|FG002|Overall Study|Adverse Event|7|||
147165425|NCT01636713|530770483|FG000|Overall Study|Lack of Efficacy|6|||
147165426|NCT01636713|530770484|FG001|Overall Study|Lack of Efficacy|6|||
147165427|NCT01636713|530770485|FG002|Overall Study|Lack of Efficacy|2|||
147165428|NCT01636713|530770483|FG000|Overall Study|Protocol Violation|3|||
147165429|NCT01636713|530770484|FG001|Overall Study|Protocol Violation|0|||
147165430|NCT01636713|530770485|FG002|Overall Study|Protocol Violation|1|||
147165431|NCT01636713|530770483|FG000|Overall Study|Lost to Follow-up|0|||
147165432|NCT01636713|530770484|FG001|Overall Study|Lost to Follow-up|0|||
147165433|NCT01636713|530770485|FG002|Overall Study|Lost to Follow-up|1|||
147165434|NCT01636713|530770483|FG000|Overall Study|Withdrawal by Subject|5|||
147165435|NCT01636713|530770484|FG001|Overall Study|Withdrawal by Subject|4|||
147165436|NCT01636713|530770485|FG002|Overall Study|Withdrawal by Subject|8|||
147165437|NCT01636713|530770483|FG000|Overall Study|Met Protocol-defined Stopping Criteria|2|||
147165438|NCT01636713|530770484|FG001|Overall Study|Met Protocol-defined Stopping Criteria|2|||
147165439|NCT01636713|530770485|FG002|Overall Study|Met Protocol-defined Stopping Criteria|4|||
147165440|NCT03689244|530770486|FG000|Double Blind Period (Up to 27.7 Months)|Withdrawal by Subject|7|||
147165441|NCT03689244|530770487|FG001|Double Blind Period (Up to 27.7 Months)|Withdrawal by Subject|8|||
147165442|NCT03689244|530770488|FG002|Double Blind Period (Up to 27.7 Months)|Withdrawal by Subject|0|||
147165443|NCT03689244|530770489|FG003|Double Blind Period (Up to 27.7 Months)|Withdrawal by Subject|0|||
147165444|NCT03689244|530770486|FG000|Double Blind Period (Up to 27.7 Months)|Other|1|||
147165445|NCT03689244|530770487|FG001|Double Blind Period (Up to 27.7 Months)|Other|1|||
147165446|NCT03689244|530770488|FG002|Double Blind Period (Up to 27.7 Months)|Other|0|||
147165447|NCT03689244|530770489|FG003|Double Blind Period (Up to 27.7 Months)|Other|0|||
147165448|NCT03689244|530770486|FG000|Double Blind Period (Up to 27.7 Months)|Sponsor decision|44|||
147165449|NCT03689244|530770487|FG001|Double Blind Period (Up to 27.7 Months)|Sponsor decision|47|||
147165450|NCT03689244|530770488|FG002|Double Blind Period (Up to 27.7 Months)|Sponsor decision|0|||
147165451|NCT03689244|530770489|FG003|Double Blind Period (Up to 27.7 Months)|Sponsor decision|0|||
147165452|NCT03689244|530770486|FG000|Double Blind Period (Up to 27.7 Months)|Death|1|||
147165453|NCT03689244|530770487|FG001|Double Blind Period (Up to 27.7 Months)|Death|0|||
147165454|NCT03689244|530770488|FG002|Double Blind Period (Up to 27.7 Months)|Death|0|||
147243421|NCT03052725|531063826|FG000|Overall Study|Adverse Event|2|||
147243422|NCT03052725|531063827|FG001|Overall Study|Adverse Event|0|||
147243423|NCT03052725|531063826|FG000|Overall Study|Withdrawal by Subject|3|||
147243424|NCT03052725|531063827|FG001|Overall Study|Withdrawal by Subject|4|||
147243425|NCT03052725|531063826|FG000|Overall Study|Pregnancy|0|||
147243426|NCT03052725|531063827|FG001|Overall Study|Pregnancy|1|||
147243427|NCT03052725|531063826|FG000|Overall Study|Site closure|0|||
147243428|NCT03052725|531063827|FG001|Overall Study|Site closure|1|||
147243429|NCT03052725|531063826|FG000|Overall Study|Study terminated by sponsor|143|||
147243430|NCT03052725|531063827|FG001|Overall Study|Study terminated by sponsor|144|||
147243431|NCT01061177|531063830|FG000|Overall Study|Adverse Event|117|||
147243432|NCT01061177|531063830|FG000|Overall Study|Withdrawal by Subject|27|||
147243433|NCT01061177|531063830|FG000|Overall Study|Disease progression|17|||
147243434|NCT01061177|531063830|FG000|Overall Study|Protocol Violation|11|||
147243435|NCT01061177|531063830|FG000|Overall Study|Lost to Follow-up|9|||
147243436|NCT01061177|531063830|FG000|Overall Study|New cancer therapy|9|||
147243437|NCT01061177|531063830|FG000|Overall Study|Abnormal laboratory values|6|||
147243438|NCT01061177|531063830|FG000|Overall Study|Abnormal test procedure results|4|||
147243439|NCT01061177|531063830|FG000|Overall Study|Administratie problems|4|||
147243440|NCT01061177|531063830|FG000|Overall Study|Death|4|||
147243441|NCT01539538|531063831|FG000|Overall Study|Adverse Event|13|||
147243442|NCT01539538|531063832|FG001|Overall Study|Adverse Event|18|||
147243443|NCT01539538|531063831|FG000|Overall Study|Lack of Efficacy|13|||
147243444|NCT01539538|531063832|FG001|Overall Study|Lack of Efficacy|16|||
147590118|NCT01682148|532316220|FG001|Overall Study|Lost to Follow-up|2|||
147243445|NCT01539538|531063831|FG000|Overall Study|Withdrawal by Subject|2|||
147243446|NCT01539538|531063832|FG001|Overall Study|Withdrawal by Subject|3|||
147243447|NCT01539538|531063831|FG000|Overall Study|PCA no longer required or PCA problem|3|||
147243448|NCT01539538|531063832|FG001|Overall Study|PCA no longer required or PCA problem|7|||
147590119|NCT01682148|532316219|FG000|Overall Study|Protocol Violation|1|||
147590120|NCT01682148|532316220|FG001|Overall Study|Protocol Violation|1|||
147590121|NCT00171340|532316221|FG000|Overall Study|Adverse Event|46|||
147165455|NCT03689244|530770489|FG003|Double Blind Period (Up to 27.7 Months)|Death|0|||
147165456|NCT03689244|530770486|FG000|Double Blind Period (Up to 27.7 Months)|Physician Decision|2|||
147165457|NCT03689244|530770487|FG001|Double Blind Period (Up to 27.7 Months)|Physician Decision|2|||
147243449|NCT00847379|531063833|FG000|Overall Study|Study terminated by Sponsor|59|||
147243450|NCT00847379|531063834|FG001|Overall Study|Study terminated by Sponsor|57|||
147590122|NCT00171340|532316222|FG001|Overall Study|Adverse Event|42|||
147590123|NCT00171340|532316221|FG000|Overall Study|Lack of Efficacy|29|||
147590124|NCT00171340|532316222|FG001|Overall Study|Lack of Efficacy|41|||
147590125|NCT00171340|532316221|FG000|Overall Study|Protocol Violation|7|||
147590126|NCT00171340|532316222|FG001|Overall Study|Protocol Violation|8|||
147590127|NCT00171340|532316221|FG000|Overall Study|Withdrawal by Subject|22|||
147590128|NCT00171340|532316222|FG001|Overall Study|Withdrawal by Subject|19|||
147590129|NCT00171340|532316221|FG000|Overall Study|Lost to Follow-up|0|||
147590130|NCT00171340|532316222|FG001|Overall Study|Lost to Follow-up|5|||
147590131|NCT00171340|532316221|FG000|Overall Study|Abnormal Laboratory Results|2|||
147590132|NCT00171340|532316222|FG001|Overall Study|Abnormal Laboratory Results|0|||
147590133|NCT00171340|532316221|FG000|Overall Study|Abnormal Test Procedure Results|6|||
147590134|NCT00171340|532316222|FG001|Overall Study|Abnormal Test Procedure Results|11|||
147590135|NCT00171340|532316221|FG000|Overall Study|No Longer Required Study Drug|1|||
147165458|NCT03689244|530770488|FG002|Double Blind Period (Up to 27.7 Months)|Physician Decision|0|||
147165459|NCT03689244|530770489|FG003|Double Blind Period (Up to 27.7 Months)|Physician Decision|0|||
147165460|NCT03689244|530770486|FG000|Open Label Period (Up to 20.8 Months)|Withdrawal by Subject|0|||
147165461|NCT03689244|530770487|FG001|Open Label Period (Up to 20.8 Months)|Withdrawal by Subject|0|||
147165462|NCT03689244|530770488|FG002|Open Label Period (Up to 20.8 Months)|Withdrawal by Subject|1|||
147165463|NCT03689244|530770489|FG003|Open Label Period (Up to 20.8 Months)|Withdrawal by Subject|0|||
147165464|NCT03689244|530770486|FG000|Open Label Period (Up to 20.8 Months)|Physician Decision|0|||
147165465|NCT03689244|530770487|FG001|Open Label Period (Up to 20.8 Months)|Physician Decision|0|||
147165466|NCT03689244|530770488|FG002|Open Label Period (Up to 20.8 Months)|Physician Decision|1|||
147165467|NCT03689244|530770489|FG003|Open Label Period (Up to 20.8 Months)|Physician Decision|0|||
147165468|NCT03689244|530770486|FG000|Open Label Period (Up to 20.8 Months)|Sponsor Decision|0|||
147165469|NCT03689244|530770487|FG001|Open Label Period (Up to 20.8 Months)|Sponsor Decision|0|||
147165470|NCT03689244|530770488|FG002|Open Label Period (Up to 20.8 Months)|Sponsor Decision|7|||
147165471|NCT03689244|530770489|FG003|Open Label Period (Up to 20.8 Months)|Sponsor Decision|6|||
147165472|NCT02308488|530770492|FG000|Overall Study|Withdrawal by Subject|2|||
147165473|NCT01541917|530770493|FG000|Overall Study|Lost to Follow-up|2|||
147165474|NCT01541917|530770494|FG001|Overall Study|Lost to Follow-up|2|||
147165475|NCT01541917|530770493|FG000|Overall Study|Withdrawal by Subject|13|||
147165476|NCT01541917|530770494|FG001|Overall Study|Withdrawal by Subject|7|||
147165477|NCT01739803|530770495|FG000|Overall Study|Lost to Follow-up|9|||
147165478|NCT01739803|530770496|FG001|Overall Study|Lost to Follow-up|6|||
147165479|NCT03759041|530770506|FG000|Overall Study|Withdrawal by Subject|4|||
147165480|NCT03759041|530770507|FG001|Overall Study|Withdrawal by Subject|10|||
147165481|NCT03759041|530770508|FG002|Overall Study|Withdrawal by Subject|10|||
147165482|NCT03759041|530770506|FG000|Overall Study|Adverse Event|1|||
147165483|NCT03759041|530770507|FG001|Overall Study|Adverse Event|3|||
147165484|NCT03759041|530770508|FG002|Overall Study|Adverse Event|4|||
147165485|NCT03759041|530770506|FG000|Overall Study|Lack of Efficacy|0|||
147165486|NCT03759041|530770507|FG001|Overall Study|Lack of Efficacy|0|||
147165487|NCT03759041|530770508|FG002|Overall Study|Lack of Efficacy|1|||
147165488|NCT03759041|530770506|FG000|Overall Study|Study Terminated by Sponsor|15|||
147165489|NCT03759041|530770507|FG001|Overall Study|Study Terminated by Sponsor|16|||
147165490|NCT03759041|530770508|FG002|Overall Study|Study Terminated by Sponsor|10|||
147165491|NCT03759041|530770506|FG000|Overall Study|Other reason for discontinuation|0|||
147165492|NCT03759041|530770507|FG001|Overall Study|Other reason for discontinuation|2|||
147165493|NCT03759041|530770508|FG002|Overall Study|Other reason for discontinuation|1|||
147243451|NCT00847379|531063835|FG002|Overall Study|Study terminated by Sponsor|57|||
147243452|NCT02864498|531063836|FG000|Overall Study|Unacceptable Adverse Events (AEs)|0|||
147243453|NCT02864498|531063837|FG001|Overall Study|Unacceptable Adverse Events (AEs)|3|||
147243454|NCT02864498|531063838|FG002|Overall Study|Unacceptable Adverse Events (AEs)|1|||
147243455|NCT02864498|531063836|FG000|Overall Study|Patient Decision (Withdrawal of Consent to Participate)|6|||
147243456|NCT02864498|531063837|FG001|Overall Study|Patient Decision (Withdrawal of Consent to Participate)|10|||
147243457|NCT02864498|531063838|FG002|Overall Study|Patient Decision (Withdrawal of Consent to Participate)|4|||
147323406|NCT01449929|531348018|FG000|Randomization Phase 96 Week|Other: study closed/terminated|0|||
147447649|NCT01877187|531803920|FG000|Overall Study|Declining clinical status|11|||
147165494|NCT03759041|530770506|FG000|Overall Study|Lost to Follow-up|7|||
147165495|NCT03759041|530770507|FG001|Overall Study|Lost to Follow-up|2|||
147165496|NCT03759041|530770508|FG002|Overall Study|Lost to Follow-up|2|||
147165497|NCT03759041|530770506|FG000|Overall Study|Subjects did not have a discontinuation page completed|0|||
147447650|NCT01877187|531803920|FG000|Overall Study|Liver transplant|2|||
147447651|NCT00769002|531803922|FG000|Overall Study|Study was not completed, no data|9|||
147447652|NCT00769002|531803923|FG001|Overall Study|Study was not completed, no data|9|||
147590136|NCT00171340|532316222|FG001|Overall Study|No Longer Required Study Drug|1|||
147590137|NCT00171340|532316221|FG000|Overall Study|Administrative Problems|5|||
147590138|NCT00171340|532316222|FG001|Overall Study|Administrative Problems|2|||
147590139|NCT00171340|532316221|FG000|Overall Study|Death|6|||
147165498|NCT03759041|530770507|FG001|Overall Study|Subjects did not have a discontinuation page completed|1|||
147243458|NCT02864498|531063836|FG000|Overall Study|Investigator Discretion|0|||
147165499|NCT03759041|530770508|FG002|Overall Study|Subjects did not have a discontinuation page completed|0|||
147165500|NCT00525824|530770514|FG000|Overall Study|Adverse Event|7|||
147165501|NCT00525824|530770515|FG001|Overall Study|Adverse Event|11|||
147165502|NCT00525824|530770516|FG002|Overall Study|Adverse Event|6|||
147165503|NCT00525824|530770517|FG003|Overall Study|Adverse Event|7|||
147165504|NCT00525824|530770514|FG000|Overall Study|Withdrawal by Subject|5|||
147165505|NCT00525824|530770515|FG001|Overall Study|Withdrawal by Subject|9|||
147165506|NCT00525824|530770516|FG002|Overall Study|Withdrawal by Subject|3|||
147165507|NCT00525824|530770517|FG003|Overall Study|Withdrawal by Subject|4|||
147165508|NCT00525824|530770514|FG000|Overall Study|Lost to Follow-up|4|||
147165509|NCT00525824|530770515|FG001|Overall Study|Lost to Follow-up|2|||
147165510|NCT00525824|530770516|FG002|Overall Study|Lost to Follow-up|4|||
147165511|NCT00525824|530770517|FG003|Overall Study|Lost to Follow-up|0|||
147165512|NCT00525824|530770514|FG000|Overall Study|Incorrect enrolment/mis-randomisation|1|||
147447653|NCT02699892|531803925|FG000|Overall Study|Other|36|||
147447654|NCT04677712|531803927|FG000|Overall Study|Lost to Follow-up|0|||
147447655|NCT04677712|531803928|FG001|Overall Study|Lost to Follow-up|1|||
147447656|NCT04677712|531803929|FG002|Overall Study|Lost to Follow-up|0|||
147447657|NCT04677712|531803930|FG003|Overall Study|Lost to Follow-up|0|||
147447658|NCT04677712|531803931|FG004|Overall Study|Lost to Follow-up|0|||
147447659|NCT04677712|531803932|FG005|Overall Study|Lost to Follow-up|0|||
147447660|NCT00711100|531803933|FG000|Overall Study|Lack of Efficacy|5|||
147447661|NCT00711100|531803933|FG000|Overall Study|Withdrawal by Subject|8|||
147447662|NCT00847912|531803934|FG000|Overall Study|Protocol Violation|6|||
147447663|NCT00847912|531803935|FG001|Overall Study|Protocol Violation|7|||
147447664|NCT00847912|531803934|FG000|Overall Study|Withdrawal by Subject|3|||
147165513|NCT00525824|530770515|FG001|Overall Study|Incorrect enrolment/mis-randomisation|2|||
147165514|NCT00525824|530770516|FG002|Overall Study|Incorrect enrolment/mis-randomisation|1|||
147165515|NCT00525824|530770517|FG003|Overall Study|Incorrect enrolment/mis-randomisation|2|||
147165516|NCT00525824|530770514|FG000|Overall Study|Severe non-compliance|0|||
147165517|NCT00525824|530770515|FG001|Overall Study|Severe non-compliance|1|||
147165518|NCT00525824|530770516|FG002|Overall Study|Severe non-compliance|1|||
147165519|NCT00525824|530770517|FG003|Overall Study|Severe non-compliance|1|||
147165520|NCT00525824|530770514|FG000|Overall Study|Safety reasons|1|||
147165521|NCT00525824|530770515|FG001|Overall Study|Safety reasons|0|||
147165522|NCT00525824|530770516|FG002|Overall Study|Safety reasons|1|||
147165523|NCT00525824|530770517|FG003|Overall Study|Safety reasons|0|||
147165524|NCT00525824|530770514|FG000|Overall Study|Other|1|||
147165525|NCT00525824|530770515|FG001|Overall Study|Other|3|||
147165526|NCT00525824|530770516|FG002|Overall Study|Other|3|||
147165527|NCT00525824|530770517|FG003|Overall Study|Other|1|||
147165528|NCT01490294|530770522|FG000|Overall Study|Prematurely discontinuation|4|||
147165529|NCT01490294|530770523|FG001|Overall Study|Prematurely discontinuation|0|||
147165530|NCT01490294|530770524|FG002|Overall Study|Prematurely discontinuation|1|||
147165531|NCT01490294|530770525|FG003|Overall Study|Prematurely discontinuation|1|||
147165532|NCT01490294|530770522|FG000|Overall Study|Adverse Event|1|||
147165533|NCT01490294|530770523|FG001|Overall Study|Adverse Event|0|||
147165534|NCT01490294|530770524|FG002|Overall Study|Adverse Event|0|||
147165535|NCT01490294|530770525|FG003|Overall Study|Adverse Event|0|||
147165536|NCT01751776|530770528|FG000|Overall Study|Adverse Event|0|||
147165537|NCT01751776|530770529|FG001|Overall Study|Adverse Event|0|||
147165538|NCT01751776|530770530|FG002|Overall Study|Adverse Event|0|||
147165539|NCT01751776|530770531|FG003|Overall Study|Adverse Event|0|||
147165540|NCT01751776|530770532|FG004|Overall Study|Adverse Event|0|||
147165541|NCT01751776|530770533|FG005|Overall Study|Adverse Event|0|||
147165542|NCT01751776|530770534|FG006|Overall Study|Adverse Event|4|||
147447665|NCT00847912|531803935|FG001|Overall Study|Withdrawal by Subject|6|||
147447666|NCT00783094|531803936|FG000|Randomized Double-Blind Treatment Period|Adverse Event|4|||
147447667|NCT00783094|531803937|FG001|Randomized Double-Blind Treatment Period|Adverse Event|5|||
147165543|NCT01751776|530770535|FG007|Overall Study|Adverse Event|2|||
147165544|NCT01751776|530770528|FG000|Overall Study|Consent withdrawn|0|||
147165545|NCT01751776|530770529|FG001|Overall Study|Consent withdrawn|0|||
147165546|NCT01751776|530770530|FG002|Overall Study|Consent withdrawn|0|||
147165547|NCT01751776|530770531|FG003|Overall Study|Consent withdrawn|0|||
147165548|NCT01751776|530770532|FG004|Overall Study|Consent withdrawn|0|||
147165549|NCT01751776|530770533|FG005|Overall Study|Consent withdrawn|0|||
147165550|NCT01751776|530770534|FG006|Overall Study|Consent withdrawn|0|||
147165551|NCT01751776|530770535|FG007|Overall Study|Consent withdrawn|1|||
147447668|NCT00783094|531803938|FG002|Randomized Double-Blind Treatment Period|Adverse Event|5|||
147447669|NCT00783094|531803936|FG000|Randomized Double-Blind Treatment Period|Lack of Efficacy|0|||
147165552|NCT01751776|530770528|FG000|Overall Study|Other reason not specified above|0|||
147165553|NCT01751776|530770529|FG001|Overall Study|Other reason not specified above|0|||
147165554|NCT01751776|530770530|FG002|Overall Study|Other reason not specified above|0|||
147165555|NCT01751776|530770531|FG003|Overall Study|Other reason not specified above|0|||
147165556|NCT01751776|530770532|FG004|Overall Study|Other reason not specified above|0|||
147165557|NCT01751776|530770533|FG005|Overall Study|Other reason not specified above|0|||
147165558|NCT01751776|530770534|FG006|Overall Study|Other reason not specified above|0|||
147447670|NCT00783094|531803937|FG001|Randomized Double-Blind Treatment Period|Lack of Efficacy|2|||
147165559|NCT01751776|530770535|FG007|Overall Study|Other reason not specified above|1|||
147165560|NCT00160654|530770536|FG000|Overall Study|Adverse Event|14|||
147165561|NCT00160654|530770536|FG000|Overall Study|Lack of Efficacy|4|||
147165562|NCT00160654|530770536|FG000|Overall Study|Lost to Follow-up|2|||
147165563|NCT00160654|530770536|FG000|Overall Study|Intake of expired drug|7|||
147165564|NCT00160654|530770536|FG000|Overall Study|Psychological trauma|1|||
147165565|NCT00160654|530770536|FG000|Overall Study|Sponsor decision|1|||
147165566|NCT00160654|530770536|FG000|Overall Study|Patient met exclusion criteria|1|||
147165567|NCT00160654|530770536|FG000|Overall Study|Patient decision|1|||
147165568|NCT00160654|530770536|FG000|Overall Study|Poor compliance, dilantin toxicity|1|||
147165569|NCT00160654|530770536|FG000|Overall Study|Met exclusion criteria|1|||
147165570|NCT00528996|530772018|FG000|Overall Study|Other reasons than listing|6|||
147165571|NCT00528996|530772019|FG001|Overall Study|Other reasons than listing|7|||
147165572|NCT00528996|530772020|FG002|Overall Study|Other reasons than listing|14|||
147165573|NCT00528996|530772021|FG003|Overall Study|Other reasons than listing|11|||
147165574|NCT00528996|530772022|FG004|Overall Study|Other reasons than listing|5|||
147165575|NCT00528996|530772018|FG000|Overall Study|Refused continue medication|16|||
147165576|NCT00528996|530772019|FG001|Overall Study|Refused continue medication|0|||
147165577|NCT00528996|530772020|FG002|Overall Study|Refused continue medication|3|||
147165578|NCT00528996|530772021|FG003|Overall Study|Refused continue medication|3|||
147165579|NCT00528996|530772022|FG004|Overall Study|Refused continue medication|6|||
147165580|NCT00528996|530772018|FG000|Overall Study|Lost to Follow-up|2|||
147165581|NCT00528996|530772019|FG001|Overall Study|Lost to Follow-up|0|||
147165582|NCT00528996|530772020|FG002|Overall Study|Lost to Follow-up|4|||
147165583|NCT00528996|530772021|FG003|Overall Study|Lost to Follow-up|1|||
147165584|NCT00528996|530772022|FG004|Overall Study|Lost to Follow-up|3|||
147165585|NCT00528996|530772018|FG000|Overall Study|Protocol Violation|1|||
147165586|NCT00528996|530772019|FG001|Overall Study|Protocol Violation|2|||
147165587|NCT00528996|530772020|FG002|Overall Study|Protocol Violation|3|||
147165588|NCT00528996|530772021|FG003|Overall Study|Protocol Violation|3|||
147165589|NCT00528996|530772022|FG004|Overall Study|Protocol Violation|2|||
147165590|NCT00528996|530772018|FG000|Overall Study|Lack of Efficacy|7|||
147243459|NCT02864498|531063837|FG001|Overall Study|Investigator Discretion|2|||
147243460|NCT02864498|531063838|FG002|Overall Study|Investigator Discretion|1|||
147243461|NCT02864498|531063836|FG000|Overall Study|Lost to Follow-up|8|||
147243462|NCT02864498|531063837|FG001|Overall Study|Lost to Follow-up|6|||
147243463|NCT02864498|531063838|FG002|Overall Study|Lost to Follow-up|3|||
147243464|NCT02864498|531063836|FG000|Overall Study|Lack of Efficacy|5|||
147243465|NCT02864498|531063837|FG001|Overall Study|Lack of Efficacy|3|||
147243466|NCT02864498|531063838|FG002|Overall Study|Lack of Efficacy|3|||
147243467|NCT02864498|531063836|FG000|Overall Study|Other - Subject discontinued following database lock.|1|||
147243468|NCT02864498|531063837|FG001|Overall Study|Other - Subject discontinued following database lock.|0|||
147243469|NCT02864498|531063838|FG002|Overall Study|Other - Subject discontinued following database lock.|0|||
147243470|NCT02864498|531063836|FG000|Overall Study|Other - Subject underwent knee surgery and stopped taking study medication.|0|||
147243471|NCT02864498|531063837|FG001|Overall Study|Other - Subject underwent knee surgery and stopped taking study medication.|1|||
147243472|NCT02864498|531063838|FG002|Overall Study|Other - Subject underwent knee surgery and stopped taking study medication.|0|||
147243473|NCT02864498|531063836|FG000|Overall Study|Subject moved out of the country.|0|||
147243474|NCT02864498|531063837|FG001|Overall Study|Subject moved out of the country.|0|||
147243475|NCT02864498|531063838|FG002|Overall Study|Subject moved out of the country.|1|||
147243476|NCT00378378|531063841|FG000|Overall Study|Withdrawal by Subject|0|||
147243477|NCT00378378|531063842|FG001|Overall Study|Withdrawal by Subject|1|||
147243478|NCT00378378|531063843|FG002|Overall Study|Withdrawal by Subject|0|||
147243479|NCT00378378|531063841|FG000|Overall Study|Treatment Failure|0|||
147243480|NCT00378378|531063842|FG001|Overall Study|Treatment Failure|0|||
147243481|NCT00378378|531063843|FG002|Overall Study|Treatment Failure|1|||
147447671|NCT00783094|531803938|FG002|Randomized Double-Blind Treatment Period|Lack of Efficacy|1|||
147447672|NCT00783094|531803936|FG000|Randomized Double-Blind Treatment Period|Physician Decision|0|||
147590140|NCT00171340|532316222|FG001|Overall Study|Death|6|||
147165591|NCT00528996|530772019|FG001|Overall Study|Lack of Efficacy|2|||
147165592|NCT00528996|530772020|FG002|Overall Study|Lack of Efficacy|1|||
147165593|NCT00528996|530772021|FG003|Overall Study|Lack of Efficacy|3|||
147165594|NCT00528996|530772022|FG004|Overall Study|Lack of Efficacy|3|||
147165595|NCT00528996|530772018|FG000|Overall Study|Adverse Event|32|||
147243482|NCT00378378|531063841|FG000|Overall Study|Non-compliance with protocol|0|||
147243483|NCT00378378|531063842|FG001|Overall Study|Non-compliance with protocol|0|||
147243484|NCT00378378|531063843|FG002|Overall Study|Non-compliance with protocol|1|||
147243485|NCT00407797|531063844|FG000|Overall Study|Lost to Follow-up|2|||
147243486|NCT00407797|531063844|FG000|Overall Study|Adverse Event|6|||
147243487|NCT00407797|531063844|FG000|Overall Study|Other|7|||
147165596|NCT00528996|530772019|FG001|Overall Study|Adverse Event|13|||
147165597|NCT00528996|530772020|FG002|Overall Study|Adverse Event|18|||
147165598|NCT00528996|530772021|FG003|Overall Study|Adverse Event|29|||
147165599|NCT00528996|530772022|FG004|Overall Study|Adverse Event|18|||
147165600|NCT02831933|530772024|FG000|Overall Study|Physician Decision|11|||
147243488|NCT00407797|531063844|FG000|Overall Study|Withdrawal by Subject|3|||
147243489|NCT01812174|531063845|FG000|Overall Study|Death|1|||
147243490|NCT01812174|531063846|FG001|Overall Study|Death|0|||
147243491|NCT01812174|531063845|FG000|Overall Study|Protocol Violation|2|||
147243492|NCT01812174|531063846|FG001|Overall Study|Protocol Violation|0|||
147243493|NCT01854710|531063857|FG000|Overall Study|Withdrawal by Subject|2|||
147243494|NCT01854710|531063858|FG001|Overall Study|Withdrawal by Subject|1|||
147243495|NCT01854710|531063859|FG002|Overall Study|Withdrawal by Subject|0|||
147243496|NCT01854710|531063860|FG003|Overall Study|Withdrawal by Subject|0|||
147243497|NCT01854710|531063861|FG004|Overall Study|Withdrawal by Subject|0|||
147243498|NCT01854710|531063862|FG005|Overall Study|Withdrawal by Subject|0|||
147243499|NCT01854710|531063857|FG000|Overall Study|CRI procedural error|2|||
147243500|NCT01854710|531063858|FG001|Overall Study|CRI procedural error|2|||
147243501|NCT01854710|531063859|FG002|Overall Study|CRI procedural error|2|||
147243502|NCT01854710|531063860|FG003|Overall Study|CRI procedural error|2|||
147243503|NCT01854710|531063861|FG004|Overall Study|CRI procedural error|2|||
147243504|NCT01854710|531063862|FG005|Overall Study|CRI procedural error|2|||
147243505|NCT03132220|531063863|FG000|Overall Study|Lost to Follow-up|17|||
147243506|NCT03132220|531063864|FG001|Overall Study|Lost to Follow-up|8|||
147243507|NCT03132220|531063863|FG000|Overall Study|Withdrawal by Subject|1|||
147243508|NCT03132220|531063864|FG001|Overall Study|Withdrawal by Subject|4|||
147243509|NCT00518986|531063865|FG000|Overall Study|Adverse Event|12|||
147243510|NCT00518986|531063866|FG001|Overall Study|Adverse Event|7|||
147243511|NCT00518986|531063865|FG000|Overall Study|Lack of Efficacy|0|||
147243512|NCT00518986|531063866|FG001|Overall Study|Lack of Efficacy|2|||
147243513|NCT00518986|531063865|FG000|Overall Study|Lost to Follow-up|3|||
147243514|NCT00518986|531063866|FG001|Overall Study|Lost to Follow-up|2|||
147243515|NCT00518986|531063865|FG000|Overall Study|Physician Decision|0|||
147243516|NCT00518986|531063866|FG001|Overall Study|Physician Decision|3|||
147243517|NCT00518986|531063865|FG000|Overall Study|Protocol Violation|5|||
147243518|NCT00518986|531063866|FG001|Overall Study|Protocol Violation|7|||
147243519|NCT00518986|531063865|FG000|Overall Study|Withdrawal by Subject|4|||
147590141|NCT01056640|532316223|FG000|Overall Study|Withdrawal by Subject|11|||
147590142|NCT01056640|532316224|FG001|Overall Study|Withdrawal by Subject|8|||
147590143|NCT01056640|532316223|FG000|Overall Study|Death|15|||
147243520|NCT00518986|531063866|FG001|Overall Study|Withdrawal by Subject|4|||
147243521|NCT00518986|531063865|FG000|Overall Study|Non-Specific|2|||
147243522|NCT00518986|531063866|FG001|Overall Study|Non-Specific|1|||
147243523|NCT00393029|531063872|FG000|Overall Study|Not treated|0|||
147243524|NCT00393029|531063873|FG001|Overall Study|Not treated|1|||
147243525|NCT03547583|531063874|FG000|Overall Study|Adverse Event|16|||
147243526|NCT03547583|531063875|FG001|Overall Study|Adverse Event|11|||
147243527|NCT03547583|531063876|FG002|Overall Study|Adverse Event|10|||
147243528|NCT03547583|531063874|FG000|Overall Study|Death|11|||
147243529|NCT03547583|531063875|FG001|Overall Study|Death|7|||
147243530|NCT03547583|531063876|FG002|Overall Study|Death|4|||
147243531|NCT03547583|531063874|FG000|Overall Study|Lost to Follow-up|1|||
147243532|NCT03547583|531063875|FG001|Overall Study|Lost to Follow-up|0|||
147243533|NCT03547583|531063876|FG002|Overall Study|Lost to Follow-up|0|||
147243534|NCT03547583|531063874|FG000|Overall Study|Non-compliance with study drug|0|||
147243535|NCT03547583|531063875|FG001|Overall Study|Non-compliance with study drug|0|||
147243536|NCT03547583|531063876|FG002|Overall Study|Non-compliance with study drug|1|||
147243537|NCT03547583|531063874|FG000|Overall Study|Physician Decision|1|||
147243538|NCT03547583|531063875|FG001|Overall Study|Physician Decision|0|||
147243539|NCT03547583|531063876|FG002|Overall Study|Physician Decision|3|||
147243540|NCT03547583|531063874|FG000|Overall Study|Protocol Violation|2|||
147243541|NCT03547583|531063875|FG001|Overall Study|Protocol Violation|1|||
147590144|NCT01056640|532316224|FG001|Overall Study|Death|4|||
147590145|NCT01803269|532316225|FG000|Overall Study|Withdrawal by Subject|3|||
147590146|NCT01803269|532316226|FG001|Overall Study|Withdrawal by Subject|0|||
147243542|NCT03547583|531063876|FG002|Overall Study|Protocol Violation|1|||
147243543|NCT03547583|531063874|FG000|Overall Study|Withdrawal by Subject|12|||
147243544|NCT03547583|531063875|FG001|Overall Study|Withdrawal by Subject|19|||
147243545|NCT03547583|531063876|FG002|Overall Study|Withdrawal by Subject|10|||
147243546|NCT03547583|531063874|FG000|Overall Study|Other|2|||
147243547|NCT03547583|531063875|FG001|Overall Study|Other|2|||
147243548|NCT03547583|531063876|FG002|Overall Study|Other|3|||
147243549|NCT01744197|531063879|FG000|Overall Study|Received 1 patch|2|||
147243550|NCT01744197|531063880|FG001|Overall Study|Received 1 patch|1|||
147243551|NCT01744197|531063879|FG000|Overall Study|No patch received|2|||
147243552|NCT01744197|531063880|FG001|Overall Study|No patch received|2|||
147243553|NCT04706091|531063881|FG000|Treatment 2|Withdrawal by Subject|1|||
147243554|NCT04706091|531063882|FG001|Treatment 2|Withdrawal by Subject|0|||
147243555|NCT01063868|531063883|FG000|Overall Study|Adverse Event|9|||
147243556|NCT01063868|531063884|FG001|Overall Study|Adverse Event|7|||
147243557|NCT01063868|531063883|FG000|Overall Study|Withdrawal by Subject|3|||
147243558|NCT01063868|531063884|FG001|Overall Study|Withdrawal by Subject|1|||
147243559|NCT01063868|531063883|FG000|Overall Study|Study Terminated By Sponsor|23|||
147243560|NCT01063868|531063884|FG001|Overall Study|Study Terminated By Sponsor|4|||
147165601|NCT05065190|530772028|FG000|Overall Study|Other than listed|2|||
147165602|NCT05065190|530772029|FG001|Overall Study|Other than listed|12|||
147165603|NCT05065190|530772028|FG000|Overall Study|Lack of Efficacy|4|||
147165604|NCT05065190|530772029|FG001|Overall Study|Lack of Efficacy|0|||
147165605|NCT05065190|530772028|FG000|Overall Study|Adverse Event|1|||
147165606|NCT05065190|530772029|FG001|Overall Study|Adverse Event|10|||
147165607|NCT04938037|530772030|FG000|Overall Study|Lost to Follow-up|4|||
147165608|NCT04938037|530772031|FG001|Overall Study|Lost to Follow-up|3|||
147165609|NCT03323736|530772034|FG000|Overall Study|Screen Failure|14|||
147165610|NCT03323736|530772035|FG001|Overall Study|Screen Failure|9|||
147165611|NCT03323736|530772036|FG002|Overall Study|Screen Failure|1|||
147165612|NCT03323736|530772034|FG000|Overall Study|Withdrawal Before Treatment|3|||
147165613|NCT03323736|530772035|FG001|Overall Study|Withdrawal Before Treatment|1|||
147165614|NCT03323736|530772036|FG002|Overall Study|Withdrawal Before Treatment|1|||
147165615|NCT03323736|530772034|FG000|Overall Study|Iontophoresis fill/no iontophoresis|2|||
147165616|NCT03323736|530772035|FG001|Overall Study|Iontophoresis fill/no iontophoresis|2|||
147165617|NCT03323736|530772036|FG002|Overall Study|Iontophoresis fill/no iontophoresis|0|||
147165618|NCT05160766|530772038|FG000|Overall Study|Adverse Event|0|||
147165619|NCT05160766|530772039|FG001|Overall Study|Adverse Event|1|||
147165620|NCT05160766|530772040|FG002|Overall Study|Adverse Event|0|||
147165621|NCT05160766|530772041|FG003|Overall Study|Adverse Event|0|||
147165622|NCT05160766|530772038|FG000|Overall Study|COVID-19 infection|0|||
147165623|NCT05160766|530772039|FG001|Overall Study|COVID-19 infection|1|||
147165624|NCT05160766|530772040|FG002|Overall Study|COVID-19 infection|0|||
147165625|NCT05160766|530772041|FG003|Overall Study|COVID-19 infection|0|||
147165626|NCT05160766|530772038|FG000|Overall Study|travel time|1|||
147165627|NCT05160766|530772039|FG001|Overall Study|travel time|0|||
147165628|NCT05160766|530772040|FG002|Overall Study|travel time|0|||
147165629|NCT05160766|530772041|FG003|Overall Study|travel time|1|||
147165630|NCT05160766|530772038|FG000|Overall Study|Withdrawal by Subject|3|||
147165631|NCT05160766|530772039|FG001|Overall Study|Withdrawal by Subject|5|||
147165632|NCT05160766|530772040|FG002|Overall Study|Withdrawal by Subject|4|||
147165633|NCT05160766|530772041|FG003|Overall Study|Withdrawal by Subject|2|||
147165634|NCT05160766|530772038|FG000|Overall Study|Death|0|||
147165635|NCT05160766|530772039|FG001|Overall Study|Death|0|||
147165636|NCT05160766|530772040|FG002|Overall Study|Death|2|||
147165637|NCT05160766|530772041|FG003|Overall Study|Death|5|||
147165638|NCT05160766|530772038|FG000|Overall Study|Lost to Follow-up|0|||
147165639|NCT05160766|530772039|FG001|Overall Study|Lost to Follow-up|0|||
147165640|NCT05160766|530772040|FG002|Overall Study|Lost to Follow-up|1|||
147165641|NCT05160766|530772041|FG003|Overall Study|Lost to Follow-up|2|||
147165642|NCT05160766|530772038|FG000|Overall Study|No show|0|||
147165643|NCT05160766|530772039|FG001|Overall Study|No show|0|||
147165644|NCT05160766|530772040|FG002|Overall Study|No show|1|||
147165645|NCT05160766|530772041|FG003|Overall Study|No show|1|||
147590147|NCT01803269|532316227|FG002|Overall Study|Withdrawal by Subject|0|||
147590148|NCT01351350|532316230|FG000|Overall Study|Disease Progression|5|||
147165646|NCT05160766|530772038|FG000|Overall Study|Physician Decision|0|||
147165647|NCT05160766|530772039|FG001|Overall Study|Physician Decision|0|||
147165648|NCT05160766|530772040|FG002|Overall Study|Physician Decision|0|||
147165649|NCT05160766|530772041|FG003|Overall Study|Physician Decision|1|||
147165650|NCT05160766|530772038|FG000|Overall Study|Protocol Violation|0|||
147165651|NCT05160766|530772039|FG001|Overall Study|Protocol Violation|0|||
147165652|NCT05160766|530772040|FG002|Overall Study|Protocol Violation|1|||
147165653|NCT05160766|530772041|FG003|Overall Study|Protocol Violation|0|||
147165654|NCT02654236|530772042|FG000|Overall Study|Withdrawal by Subject|0|||
147165655|NCT02654236|530772043|FG001|Overall Study|Withdrawal by Subject|0|||
147165656|NCT02654236|530772044|FG002|Overall Study|Withdrawal by Subject|2|||
147165657|NCT01549873|530772045|FG000|Overall Study|Physician Decision|0|||
147165658|NCT01549873|530772046|FG001|Overall Study|Physician Decision|1|||
147165659|NCT02943915|530772047|FG000|Overall Study|Withdrawal by Subject|2|||
147165660|NCT02943915|530772048|FG001|Overall Study|Withdrawal by Subject|1|||
147165661|NCT02943915|530772049|FG002|Overall Study|Withdrawal by Subject|0|||
147165662|NCT02943915|530772050|FG003|Overall Study|Withdrawal by Subject|0|||
147165663|NCT02943915|530772047|FG000|Overall Study|Lost to Follow-up|3|||
147165664|NCT02943915|530772048|FG001|Overall Study|Lost to Follow-up|1|||
147165665|NCT02943915|530772049|FG002|Overall Study|Lost to Follow-up|0|||
147165666|NCT02943915|530772050|FG003|Overall Study|Lost to Follow-up|0|||
147165667|NCT02943915|530772047|FG000|Overall Study|excluded|0|||
147165668|NCT02943915|530772048|FG001|Overall Study|excluded|1|||
147165669|NCT02943915|530772049|FG002|Overall Study|excluded|0|||
147165670|NCT02943915|530772050|FG003|Overall Study|excluded|0|||
147165671|NCT00701805|530772051|FG000|Overall Study|Withdrawal by Subject|3|||
147165672|NCT00701805|530772052|FG001|Overall Study|Withdrawal by Subject|1|||
147165673|NCT00701805|530772053|FG002|Overall Study|Withdrawal by Subject|4|||
147165674|NCT00701805|530772054|FG003|Overall Study|Withdrawal by Subject|3|||
147165675|NCT00701805|530772051|FG000|Overall Study|Adverse Event|0|||
147165676|NCT00701805|530772052|FG001|Overall Study|Adverse Event|1|||
147165677|NCT00701805|530772053|FG002|Overall Study|Adverse Event|1|||
147165678|NCT00701805|530772054|FG003|Overall Study|Adverse Event|0|||
147323407|NCT01449929|531348019|FG001|Randomization Phase 96 Week|Other: study closed/terminated|1|||
147323408|NCT01449929|531348020|FG002|Randomization Phase 96 Week|Other: study closed/terminated|0|||
147165679|NCT00701805|530772051|FG000|Overall Study|Missed 7 consecutive doses|0|||
147165680|NCT00701805|530772052|FG001|Overall Study|Missed 7 consecutive doses|1|||
147165681|NCT00701805|530772053|FG002|Overall Study|Missed 7 consecutive doses|0|||
147165682|NCT00701805|530772054|FG003|Overall Study|Missed 7 consecutive doses|0|||
147323409|NCT01449929|531348018|FG000|Extension Phase Approximately 3 Years|Adverse Event|0|||
147323410|NCT01449929|531348019|FG001|Extension Phase Approximately 3 Years|Adverse Event|0|||
147590149|NCT01351350|532316231|FG001|Overall Study|Disease Progression|13|||
147165683|NCT00701805|530772051|FG000|Overall Study|Admitted to hospital for 2 weeks|0|||
147165684|NCT00701805|530772052|FG001|Overall Study|Admitted to hospital for 2 weeks|0|||
147165685|NCT00701805|530772053|FG002|Overall Study|Admitted to hospital for 2 weeks|1|||
147165686|NCT00701805|530772054|FG003|Overall Study|Admitted to hospital for 2 weeks|0|||
147165687|NCT00701805|530772051|FG000|Overall Study|Physician decision, change of therapy|0|||
147165688|NCT00701805|530772052|FG001|Overall Study|Physician decision, change of therapy|0|||
147165689|NCT00701805|530772053|FG002|Overall Study|Physician decision, change of therapy|0|||
147165690|NCT00701805|530772054|FG003|Overall Study|Physician decision, change of therapy|1|||
147165691|NCT00701805|530772051|FG000|Overall Study|Difficult to travel to dialysis site|0|||
147165692|NCT00701805|530772052|FG001|Overall Study|Difficult to travel to dialysis site|0|||
147165693|NCT00701805|530772053|FG002|Overall Study|Difficult to travel to dialysis site|1|||
147165694|NCT00701805|530772054|FG003|Overall Study|Difficult to travel to dialysis site|0|||
147165695|NCT00701805|530772051|FG000|Overall Study|Resumption criteria were not met|0|||
147165696|NCT00701805|530772052|FG001|Overall Study|Resumption criteria were not met|1|||
147165697|NCT00701805|530772053|FG002|Overall Study|Resumption criteria were not met|0|||
147165698|NCT00701805|530772054|FG003|Overall Study|Resumption criteria were not met|0|||
147165699|NCT02804750|530772060|FG000|Period 1|Adverse Event|0|||
147165700|NCT02804750|530772061|FG001|Period 1|Adverse Event|2|||
147165701|NCT02804750|530772060|FG000|Period 1|Withdrawal by Subject|0|||
147165702|NCT02804750|530772061|FG001|Period 1|Withdrawal by Subject|1|||
147165703|NCT02804750|530772060|FG000|Period 2|Adverse Event|1|||
147165704|NCT02804750|530772061|FG001|Period 2|Adverse Event|0|||
147165705|NCT02804750|530772060|FG000|Period 3|Adverse Event|0|||
147165706|NCT02804750|530772061|FG001|Period 3|Adverse Event|2|||
147165707|NCT02804750|530772060|FG000|Period 4|Adverse Event|0|||
147165708|NCT02804750|530772061|FG001|Period 4|Adverse Event|5|||
147165709|NCT02559414|530772062|FG000|Overall Study|Lost to Follow-up|0|||
147165710|NCT02559414|530772063|FG001|Overall Study|Lost to Follow-up|1|||
147165711|NCT02559414|530772064|FG002|Overall Study|Lost to Follow-up|0|||
147165712|NCT02559414|530772062|FG000|Overall Study|Withdrawal by Subject|1|||
147165713|NCT02559414|530772063|FG001|Overall Study|Withdrawal by Subject|0|||
147165714|NCT02559414|530772064|FG002|Overall Study|Withdrawal by Subject|1|||
147165715|NCT02559414|530772062|FG000|Overall Study|Other|0|||
147165716|NCT02559414|530772063|FG001|Overall Study|Other|1|||
147165717|NCT02559414|530772064|FG002|Overall Study|Other|1|||
147165718|NCT04692077|530772071|FG000|Cabotegravir Long Acting Injection Phase|Withdrawal by Subject|1|||
147165719|NCT05149313|530772072|FG000|Double-blind Induction Period (16-weeks)|Adverse Event|2|||
147165720|NCT05149313|530772073|FG001|Double-blind Induction Period (16-weeks)|Adverse Event|2|||
147165721|NCT05149313|530772074|FG002|Double-blind Induction Period (16-weeks)|Adverse Event|0|||
147165722|NCT05149313|530772075|FG003|Double-blind Induction Period (16-weeks)|Adverse Event|0|||
147165723|NCT05149313|530772072|FG000|Double-blind Induction Period (16-weeks)|Lost to Follow-up|2|||
147165724|NCT05149313|530772073|FG001|Double-blind Induction Period (16-weeks)|Lost to Follow-up|3|||
147165725|NCT05149313|530772074|FG002|Double-blind Induction Period (16-weeks)|Lost to Follow-up|0|||
147165726|NCT05149313|530772075|FG003|Double-blind Induction Period (16-weeks)|Lost to Follow-up|0|||
147165727|NCT05149313|530772072|FG000|Double-blind Induction Period (16-weeks)|Pregnancy|1|||
147165728|NCT05149313|530772073|FG001|Double-blind Induction Period (16-weeks)|Pregnancy|0|||
147165729|NCT05149313|530772074|FG002|Double-blind Induction Period (16-weeks)|Pregnancy|0|||
147165730|NCT05149313|530772075|FG003|Double-blind Induction Period (16-weeks)|Pregnancy|0|||
147165731|NCT05149313|530772072|FG000|Double-blind Induction Period (16-weeks)|Withdrawal by Subject|2|||
147165732|NCT05149313|530772073|FG001|Double-blind Induction Period (16-weeks)|Withdrawal by Subject|5|||
147165733|NCT05149313|530772074|FG002|Double-blind Induction Period (16-weeks)|Withdrawal by Subject|0|||
147165734|NCT05149313|530772075|FG003|Double-blind Induction Period (16-weeks)|Withdrawal by Subject|0|||
147165735|NCT05149313|530772072|FG000|Double-blind Induction Period (16-weeks)|Physician Decision|1|||
147165736|NCT05149313|530772073|FG001|Double-blind Induction Period (16-weeks)|Physician Decision|0|||
147165737|NCT05149313|530772074|FG002|Double-blind Induction Period (16-weeks)|Physician Decision|0|||
147590150|NCT01351350|532316232|FG002|Overall Study|Disease Progression|6|||
147165738|NCT05149313|530772075|FG003|Double-blind Induction Period (16-weeks)|Physician Decision|0|||
147165739|NCT05149313|530772072|FG000|Double-blind Induction Period (16-weeks)|Other|0|||
147165740|NCT05149313|530772073|FG001|Double-blind Induction Period (16-weeks)|Other|1|||
147165741|NCT05149313|530772074|FG002|Double-blind Induction Period (16-weeks)|Other|0|||
147165742|NCT05149313|530772075|FG003|Double-blind Induction Period (16-weeks)|Other|0|||
147165743|NCT05149313|530772072|FG000|Open-label Maintenance Period (36 Weeks)|Adverse Event|0|||
147165744|NCT05149313|530772073|FG001|Open-label Maintenance Period (36 Weeks)|Adverse Event|0|||
147165745|NCT05149313|530772074|FG002|Open-label Maintenance Period (36 Weeks)|Adverse Event|7|||
147165746|NCT05149313|530772075|FG003|Open-label Maintenance Period (36 Weeks)|Adverse Event|1|||
147165747|NCT05149313|530772072|FG000|Open-label Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
147165748|NCT05149313|530772073|FG001|Open-label Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
147165749|NCT05149313|530772074|FG002|Open-label Maintenance Period (36 Weeks)|Withdrawal by Subject|14|||
147165750|NCT05149313|530772075|FG003|Open-label Maintenance Period (36 Weeks)|Withdrawal by Subject|7|||
147165751|NCT05149313|530772072|FG000|Open-label Maintenance Period (36 Weeks)|Lack of Efficacy|0|||
147165752|NCT05149313|530772073|FG001|Open-label Maintenance Period (36 Weeks)|Lack of Efficacy|0|||
147165753|NCT05149313|530772074|FG002|Open-label Maintenance Period (36 Weeks)|Lack of Efficacy|6|||
147165754|NCT05149313|530772075|FG003|Open-label Maintenance Period (36 Weeks)|Lack of Efficacy|5|||
147165755|NCT05149313|530772072|FG000|Open-label Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
147165756|NCT05149313|530772073|FG001|Open-label Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
147165757|NCT05149313|530772074|FG002|Open-label Maintenance Period (36 Weeks)|Lost to Follow-up|4|||
147165758|NCT05149313|530772075|FG003|Open-label Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
147165759|NCT05149313|530772072|FG000|Open-label Maintenance Period (36 Weeks)|Protocol Deviation|0|||
147165760|NCT05149313|530772073|FG001|Open-label Maintenance Period (36 Weeks)|Protocol Deviation|0|||
147165761|NCT05149313|530772074|FG002|Open-label Maintenance Period (36 Weeks)|Protocol Deviation|1|||
147165762|NCT05149313|530772075|FG003|Open-label Maintenance Period (36 Weeks)|Protocol Deviation|0|||
147165763|NCT01867086|530772076|FG000|Overall Study|Disease Progression|1|||
147165764|NCT04271475|530772077|FG000|DB Period: Day 1 up to EODBT|Death|1|||
147165765|NCT04271475|530772078|FG001|DB Period: Day 1 up to EODBT|Death|0|||
147165766|NCT04271475|530772079|FG002|DB Period: Day 1 up to EODBT|Death|0|||
147165767|NCT04271475|530772080|FG003|DB Period: Day 1 up to EODBT|Death|0|||
147165768|NCT04271475|530772077|FG000|DB Period: Day 1 up to EODBT|Physician Decision|8|||
147165769|NCT04271475|530772078|FG001|DB Period: Day 1 up to EODBT|Physician Decision|1|||
147165770|NCT04271475|530772079|FG002|DB Period: Day 1 up to EODBT|Physician Decision|0|||
147165771|NCT04271475|530772080|FG003|DB Period: Day 1 up to EODBT|Physician Decision|0|||
147165772|NCT04271475|530772077|FG000|DB Period: Day 1 up to EODBT|Withdrawal by Subject|5|||
147165773|NCT04271475|530772078|FG001|DB Period: Day 1 up to EODBT|Withdrawal by Subject|4|||
147165774|NCT04271475|530772079|FG002|DB Period: Day 1 up to EODBT|Withdrawal by Subject|0|||
147165775|NCT04271475|530772080|FG003|DB Period: Day 1 up to EODBT|Withdrawal by Subject|0|||
147165776|NCT04271475|530772077|FG000|DB Period: Day 1 up to EODBT|Study Terminated by Sponsor|41|||
147165777|NCT04271475|530772078|FG001|DB Period: Day 1 up to EODBT|Study Terminated by Sponsor|52|||
147165778|NCT04271475|530772079|FG002|DB Period: Day 1 up to EODBT|Study Terminated by Sponsor|0|||
147165779|NCT04271475|530772080|FG003|DB Period: Day 1 up to EODBT|Study Terminated by Sponsor|0|||
147165780|NCT04271475|530772077|FG000|DB Period: Day 1 up to EODBT|Other|8|||
147165781|NCT04271475|530772078|FG001|DB Period: Day 1 up to EODBT|Other|5|||
147165782|NCT04271475|530772079|FG002|DB Period: Day 1 up to EODBT|Other|0|||
147165783|NCT04271475|530772080|FG003|DB Period: Day 1 up to EODBT|Other|0|||
147165784|NCT04271475|530772077|FG000|OL Period:Day 1 Upto End of OL Treatment|Study Terminated by Sponsor|0|||
147165785|NCT04271475|530772078|FG001|OL Period:Day 1 Upto End of OL Treatment|Study Terminated by Sponsor|0|||
147165786|NCT04271475|530772079|FG002|OL Period:Day 1 Upto End of OL Treatment|Study Terminated by Sponsor|1|||
147165787|NCT04271475|530772080|FG003|OL Period:Day 1 Upto End of OL Treatment|Study Terminated by Sponsor|5|||
147165788|NCT04271475|530772077|FG000|OL Period:Day 1 Upto End of OL Treatment|Other|0|||
147165789|NCT04271475|530772078|FG001|OL Period:Day 1 Upto End of OL Treatment|Other|0|||
147165790|NCT04271475|530772079|FG002|OL Period:Day 1 Upto End of OL Treatment|Other|0|||
147165791|NCT04271475|530772080|FG003|OL Period:Day 1 Upto End of OL Treatment|Other|1|||
147165792|NCT03681678|530772084|FG000|Overall Study|Lost to Follow-up|20|||
147165793|NCT04619004|530772085|FG000|Overall Study|Death|114|||
147165794|NCT04619004|530772086|FG001|Overall Study|Death|28|||
147165795|NCT04619004|530772085|FG000|Overall Study|Lost to Follow-up|1|||
147165796|NCT04619004|530772086|FG001|Overall Study|Lost to Follow-up|1|||
147165797|NCT04619004|530772085|FG000|Overall Study|Withdrawal by Subject|24|||
147165798|NCT04619004|530772086|FG001|Overall Study|Withdrawal by Subject|7|||
147165799|NCT04619004|530772085|FG000|Overall Study|Other - Not specified|0|||
147165800|NCT04619004|530772086|FG001|Overall Study|Other - Not specified|1|||
147165801|NCT01114360|530772094|FG000|Intervention 1 (4 Weeks)|Physician Decision|0|||
147165802|NCT01114360|530772095|FG001|Intervention 1 (4 Weeks)|Physician Decision|1|||
147165803|NCT03106415|530772096|FG000|Phase 1|Withdrawal by Subject|1|||
147165804|NCT03106415|530772097|FG001|Phase 1|Withdrawal by Subject|0|||
147165805|NCT03106415|530772098|FG002|Phase 1|Withdrawal by Subject|0|||
147165806|NCT03106415|530772096|FG000|Phase 1|Adverse Event|1|||
147165807|NCT03106415|530772097|FG001|Phase 1|Adverse Event|1|||
147165808|NCT03106415|530772098|FG002|Phase 1|Adverse Event|0|||
147165809|NCT03106415|530772096|FG000|Phase 1|Protocol Violation|0|||
147165810|NCT03106415|530772097|FG001|Phase 1|Protocol Violation|1|||
147243561|NCT02166905|531063885|FG000|Overall Study|Withdrawal by Subject|1|||
147243562|NCT02166905|531063886|FG001|Overall Study|Withdrawal by Subject|0|||
147590151|NCT01351350|532316233|FG003|Overall Study|Disease Progression|8|||
147590152|NCT01351350|532316234|FG004|Overall Study|Disease Progression|5|||
147590153|NCT01351350|532316230|FG000|Overall Study|Adverse Event|1|||
147590154|NCT01351350|532316231|FG001|Overall Study|Adverse Event|10|||
147165811|NCT03106415|530772098|FG002|Phase 1|Protocol Violation|0|||
147165812|NCT01804582|530772099|FG000|Overall Study|Lost to Follow-up|47|||
147165813|NCT01804582|530772100|FG001|Overall Study|Lost to Follow-up|56|||
147165814|NCT01804582|530772099|FG000|Overall Study|Physician Decision|2|||
147165815|NCT01804582|530772100|FG001|Overall Study|Physician Decision|0|||
147165816|NCT00159913|530772103|FG000|Overall Study|Adverse Event|1|||
147165817|NCT00159913|530772104|FG001|Overall Study|Adverse Event|0|||
147165818|NCT00159913|530772105|FG002|Overall Study|Adverse Event|1|||
147165819|NCT00159913|530772106|FG003|Overall Study|Adverse Event|0|||
147165820|NCT00159913|530772103|FG000|Overall Study|Withdrawal by Subject|0|||
147165821|NCT00159913|530772104|FG001|Overall Study|Withdrawal by Subject|0|||
147165822|NCT00159913|530772105|FG002|Overall Study|Withdrawal by Subject|0|||
147165823|NCT00159913|530772106|FG003|Overall Study|Withdrawal by Subject|1|||
147165824|NCT00159913|530772103|FG000|Overall Study|Lost to Follow-up|0|||
147165825|NCT00159913|530772104|FG001|Overall Study|Lost to Follow-up|0|||
147165826|NCT00159913|530772105|FG002|Overall Study|Lost to Follow-up|0|||
147165827|NCT00159913|530772106|FG003|Overall Study|Lost to Follow-up|1|||
147165828|NCT00159913|530772103|FG000|Overall Study|Protocol Violation|1|||
147165829|NCT00159913|530772104|FG001|Overall Study|Protocol Violation|0|||
147165830|NCT00159913|530772105|FG002|Overall Study|Protocol Violation|1|||
147165831|NCT00159913|530772106|FG003|Overall Study|Protocol Violation|0|||
147165832|NCT00385723|530772107|FG000|Overall Study|Lost to Follow-up|1|||
147165833|NCT00385723|530772108|FG001|Overall Study|Lost to Follow-up|1|||
147165834|NCT00385723|530772109|FG002|Overall Study|Lost to Follow-up|0|||
147165835|NCT00385723|530772107|FG000|Overall Study|Withdrawal by Subject|1|||
147165836|NCT00385723|530772108|FG001|Overall Study|Withdrawal by Subject|0|||
147165837|NCT00385723|530772109|FG002|Overall Study|Withdrawal by Subject|2|||
147165838|NCT01390779|530772110|FG000|Overall Study|Physician Decision|1|||
147165839|NCT03455829|530772111|FG000|Overall Study|Death|2|||
147165840|NCT03455829|530772112|FG001|Overall Study|Death|3|||
147165841|NCT03455829|530772113|FG002|Overall Study|Death|2|||
147165842|NCT03455829|530772114|FG003|Overall Study|Death|4|||
147165843|NCT03455829|530772115|FG004|Overall Study|Death|2|||
147165844|NCT03455829|530772111|FG000|Overall Study|Study terminated and patients did not have progressive disease or died|5|||
147165845|NCT03455829|530772112|FG001|Overall Study|Study terminated and patients did not have progressive disease or died|3|||
147165846|NCT03455829|530772113|FG002|Overall Study|Study terminated and patients did not have progressive disease or died|2|||
147165847|NCT03455829|530772114|FG003|Overall Study|Study terminated and patients did not have progressive disease or died|2|||
147165848|NCT03455829|530772115|FG004|Overall Study|Study terminated and patients did not have progressive disease or died|3|||
147165849|NCT03455829|530772111|FG000|Overall Study|Disease progression|0|||
147165850|NCT03455829|530772112|FG001|Overall Study|Disease progression|0|||
147165851|NCT03455829|530772113|FG002|Overall Study|Disease progression|0|||
147165852|NCT03455829|530772114|FG003|Overall Study|Disease progression|1|||
147165853|NCT03455829|530772115|FG004|Overall Study|Disease progression|1|||
147165854|NCT03689712|530772119|FG000|Overall Study|Adverse Event|1|||
147165855|NCT03689712|530772120|FG001|Overall Study|Adverse Event|0|||
147165856|NCT03689712|530772119|FG000|Overall Study|Death|20|||
147165857|NCT03689712|530772120|FG001|Overall Study|Death|10|||
147165858|NCT03689712|530772119|FG000|Overall Study|Lost to Follow-up|6|||
147165859|NCT03689712|530772120|FG001|Overall Study|Lost to Follow-up|6|||
147165860|NCT03689712|530772119|FG000|Overall Study|Other|1|||
147165861|NCT03689712|530772120|FG001|Overall Study|Other|0|||
147165862|NCT03689712|530772119|FG000|Overall Study|Patient Non-Compliance|0|||
147165863|NCT03689712|530772120|FG001|Overall Study|Patient Non-Compliance|1|||
147165864|NCT03689712|530772119|FG000|Overall Study|Withdrawal by Subject|20|||
147165865|NCT03689712|530772120|FG001|Overall Study|Withdrawal by Subject|4|||
147165866|NCT03689712|530772119|FG000|Overall Study|Patients Continuing in Long Term Follow Up|88|||
147165867|NCT03689712|530772120|FG001|Overall Study|Patients Continuing in Long Term Follow Up|71|||
147165868|NCT03689712|530772119|FG000|Overall Study|Randomized but not Treated|13|||
147165869|NCT03689712|530772120|FG001|Overall Study|Randomized but not Treated|7|||
147165870|NCT03689712|530772119|FG000|Overall Study|Subject Dosing Suspended due to Product Issue|16|||
147165871|NCT03689712|530772120|FG001|Overall Study|Subject Dosing Suspended due to Product Issue|12|||
147165872|NCT00689793|530772121|FG000|Overall Study|Lost to Follow-up|4|||
147165873|NCT00689793|530772122|FG001|Overall Study|Lost to Follow-up|5|||
147165874|NCT00875056|530772123|FG000|Overall Study|Adverse Event|6|||
147165875|NCT00875056|530772124|FG001|Overall Study|Adverse Event|1|||
147165876|NCT00875056|530772125|FG002|Overall Study|Adverse Event|2|||
147165877|NCT00875056|530772123|FG000|Overall Study|Progressive Disease|14|||
147165878|NCT00875056|530772124|FG001|Overall Study|Progressive Disease|8|||
147165879|NCT00875056|530772125|FG002|Overall Study|Progressive Disease|3|||
147165880|NCT00875056|530772123|FG000|Overall Study|Withdrawal by Subject|3|||
147590155|NCT01351350|532316232|FG002|Overall Study|Adverse Event|1|||
147165881|NCT00875056|530772124|FG001|Overall Study|Withdrawal by Subject|0|||
147590156|NCT01351350|532316233|FG003|Overall Study|Adverse Event|2|||
147165882|NCT00875056|530772125|FG002|Overall Study|Withdrawal by Subject|1|||
147165883|NCT02573246|530772131|FG000|Overall Study|Lost to Follow-up|2|||
147165884|NCT02573246|530772132|FG001|Overall Study|Lost to Follow-up|0|||
147165885|NCT02573246|530772133|FG002|Overall Study|Lost to Follow-up|0|||
147165886|NCT02573246|530772134|FG003|Overall Study|Lost to Follow-up|0|||
147165887|NCT02573246|530772135|FG004|Overall Study|Lost to Follow-up|1|||
147165888|NCT02573246|530772131|FG000|Overall Study|Withdrawal by Subject|0|||
147165889|NCT02573246|530772132|FG001|Overall Study|Withdrawal by Subject|0|||
147165890|NCT02573246|530772133|FG002|Overall Study|Withdrawal by Subject|0|||
147165891|NCT02573246|530772134|FG003|Overall Study|Withdrawal by Subject|0|||
147165892|NCT02573246|530772135|FG004|Overall Study|Withdrawal by Subject|1|||
147165893|NCT02573246|530772131|FG000|Overall Study|Physician Decision|1|||
147165894|NCT02573246|530772132|FG001|Overall Study|Physician Decision|1|||
147165895|NCT02573246|530772133|FG002|Overall Study|Physician Decision|3|||
147165896|NCT02573246|530772134|FG003|Overall Study|Physician Decision|2|||
147165897|NCT02573246|530772135|FG004|Overall Study|Physician Decision|2|||
147165898|NCT01902888|530772136|FG000|Overall Study|Study Terminated|3|||
147165899|NCT03149003|530772137|FG000|Overall Study|Randomized but not treated|0|||
147165900|NCT03149003|530772138|FG001|Overall Study|Randomized but not treated|1|||
147165901|NCT03149003|530772139|FG002|Overall Study|Randomized but not treated|18|||
147165902|NCT00973102|530772145|FG000|Overall Study|Protocol Violation|1|||
147165903|NCT00973102|530772146|FG001|Overall Study|Protocol Violation|0|||
147165904|NCT00973102|530772145|FG000|Overall Study|Prisoner|0|||
147165905|NCT00973102|530772146|FG001|Overall Study|Prisoner|1|||
147165906|NCT01100567|530772147|FG000|Overall Study|Withdrawal by Subject|5|||
147165907|NCT01100567|530772148|FG001|Overall Study|Withdrawal by Subject|8|||
147165908|NCT01100567|530772147|FG000|Overall Study|Early Hospital Discharge|6|||
147165909|NCT01100567|530772148|FG001|Overall Study|Early Hospital Discharge|4|||
147165910|NCT01100567|530772147|FG000|Overall Study|Lost to Follow-up|1|||
147165911|NCT01100567|530772148|FG001|Overall Study|Lost to Follow-up|2|||
147165912|NCT01100567|530772147|FG000|Overall Study|Physician Decision|0|||
147165913|NCT01100567|530772148|FG001|Overall Study|Physician Decision|1|||
147165914|NCT01100567|530772147|FG000|Overall Study|Deemed ineligible after consent|0|||
147165915|NCT01100567|530772148|FG001|Overall Study|Deemed ineligible after consent|1|||
147165916|NCT02449018|530772149|FG000|Overall Study|Abnormal laboratory value|0|||
147165917|NCT02449018|530772150|FG001|Overall Study|Abnormal laboratory value|1|||
147165918|NCT02449018|530772149|FG000|Overall Study|Administrative problems|1|||
147165919|NCT02449018|530772150|FG001|Overall Study|Administrative problems|0|||
147165920|NCT02449018|530772149|FG000|Overall Study|Adverse Event|5|||
147165921|NCT02449018|530772150|FG001|Overall Study|Adverse Event|1|||
147165922|NCT02449018|530772149|FG000|Overall Study|Protocol deviation|4|||
147165923|NCT02449018|530772150|FG001|Overall Study|Protocol deviation|0|||
147165924|NCT02449018|530772149|FG000|Overall Study|Patient decision|2|||
147165925|NCT02449018|530772150|FG001|Overall Study|Patient decision|0|||
147165926|NCT00831701|530772175|FG000|Overall Study|Withdrawal by Subject|2|||
147165927|NCT00831701|530772176|FG001|Overall Study|Withdrawal by Subject|0|||
147165928|NCT00831701|530772175|FG000|Overall Study|Stone expulsion before first medication|2|||
147165929|NCT00831701|530772176|FG001|Overall Study|Stone expulsion before first medication|2|||
147165930|NCT00831701|530772175|FG000|Overall Study|Lost to Follow-up|1|||
147165931|NCT00831701|530772176|FG001|Overall Study|Lost to Follow-up|3|||
147165932|NCT01440881|530772177|FG000|Overall Study|Death|0|||
147165933|NCT01440881|530772178|FG001|Overall Study|Death|1|||
147165934|NCT01977690|530772181|FG000|Overall Study|Withdrawal by Subject|0|||
147165935|NCT01977690|530772182|FG001|Overall Study|Withdrawal by Subject|4|||
147165936|NCT02290938|530772184|FG000|Overall Study|Lost to Follow-up|14|||
147165937|NCT02290938|530772185|FG001|Overall Study|Lost to Follow-up|43|||
147165938|NCT02769962|530773708|FG000|Overall Study|Physician Decision|0|||
147165939|NCT02769962|530773709|FG001|Overall Study|Physician Decision|0|||
147165940|NCT02769962|530773710|FG002|Overall Study|Physician Decision|0|||
147165941|NCT02769962|530773711|FG003|Overall Study|Physician Decision|0|||
147165942|NCT02769962|530773712|FG004|Overall Study|Physician Decision|0|||
147654573|NCT00248833|532556775|FG002|Overall Study|Lost to Follow-up|1|||
147654574|NCT00248833|532556773|FG000|Overall Study|Other|0|||
147165943|NCT02769962|530773713|FG005|Overall Study|Physician Decision|1|||
147165944|NCT02769962|530773714|FG006|Overall Study|Physician Decision|0|||
147165945|NCT02769962|530773715|FG007|Overall Study|Physician Decision|1|||
147654575|NCT00248833|532556774|FG001|Overall Study|Other|1|||
147165946|NCT02769962|530773708|FG000|Overall Study|Refused further treatment|0|||
147165947|NCT02769962|530773709|FG001|Overall Study|Refused further treatment|0|||
147165948|NCT02769962|530773710|FG002|Overall Study|Refused further treatment|0|||
147165949|NCT02769962|530773711|FG003|Overall Study|Refused further treatment|0|||
147165950|NCT02769962|530773712|FG004|Overall Study|Refused further treatment|0|||
147165951|NCT02769962|530773713|FG005|Overall Study|Refused further treatment|1|||
147165952|NCT02769962|530773714|FG006|Overall Study|Refused further treatment|1|||
147165953|NCT02769962|530773715|FG007|Overall Study|Refused further treatment|0|||
147165954|NCT03826342|530773719|FG000|Overall Study|Withdrawal by Subject|8|||
147165955|NCT03826342|530773720|FG001|Overall Study|Withdrawal by Subject|1|||
147654576|NCT00248833|532556775|FG002|Overall Study|Other|0|||
147165956|NCT03826342|530773719|FG000|Overall Study|Lost to Follow-up|7|||
147165957|NCT03826342|530773720|FG001|Overall Study|Lost to Follow-up|7|||
147165958|NCT03826342|530773719|FG000|Overall Study|Miscarriage - Loss of Eligibility to Participate|1|||
147165959|NCT03826342|530773720|FG001|Overall Study|Miscarriage - Loss of Eligibility to Participate|3|||
147165960|NCT02212678|530773727|FG000|Overall Study|Adverse Event|1|||
147165961|NCT02337634|530773728|FG000|Overall Study|Protocol Violation|3|||
147165962|NCT02337634|530773729|FG001|Overall Study|Protocol Violation|1|||
147165963|NCT02337634|530773728|FG000|Overall Study|Lost to Follow-up|1|||
147165964|NCT02337634|530773729|FG001|Overall Study|Lost to Follow-up|0|||
147165965|NCT04068610|530773730|FG000|Overall Study|Death|4|||
147165966|NCT04068610|530773731|FG001|Overall Study|Death|8|||
147165967|NCT04068610|530773732|FG002|Overall Study|Death|13|||
147165968|NCT04068610|530773730|FG000|Overall Study|Lost to Follow-up|0|||
147165969|NCT04068610|530773731|FG001|Overall Study|Lost to Follow-up|2|||
147165970|NCT04068610|530773732|FG002|Overall Study|Lost to Follow-up|0|||
147165971|NCT04068610|530773730|FG000|Overall Study|Withdrawal by Subject|0|||
147165972|NCT04068610|530773731|FG001|Overall Study|Withdrawal by Subject|4|||
147165973|NCT04068610|530773732|FG002|Overall Study|Withdrawal by Subject|2|||
147165974|NCT04068610|530773730|FG000|Overall Study|Other|3|||
147165975|NCT04068610|530773731|FG001|Overall Study|Other|12|||
147165976|NCT04068610|530773732|FG002|Overall Study|Other|11|||
147165977|NCT02046070|530773733|FG000|Overall Study|Progressive Disease|18|||
147165978|NCT02046070|530773734|FG001|Overall Study|Progressive Disease|11|||
147165979|NCT02046070|530773735|FG002|Overall Study|Progressive Disease|40|||
147165980|NCT02046070|530773733|FG000|Overall Study|Adverse Event|8|||
147165981|NCT02046070|530773734|FG001|Overall Study|Adverse Event|10|||
147165982|NCT02046070|530773735|FG002|Overall Study|Adverse Event|17|||
147165983|NCT02046070|530773733|FG000|Overall Study|Withdrawal by Subject|1|||
147165984|NCT02046070|530773734|FG001|Overall Study|Withdrawal by Subject|2|||
147165985|NCT02046070|530773735|FG002|Overall Study|Withdrawal by Subject|6|||
147165986|NCT02046070|530773733|FG000|Overall Study|Study Terminated by Sponsor|1|||
147165987|NCT02046070|530773734|FG001|Overall Study|Study Terminated by Sponsor|1|||
147165988|NCT02046070|530773735|FG002|Overall Study|Study Terminated by Sponsor|1|||
147165989|NCT02046070|530773733|FG000|Overall Study|Reason not Specified|4|||
147165990|NCT02046070|530773734|FG001|Overall Study|Reason not Specified|4|||
147165991|NCT02046070|530773735|FG002|Overall Study|Reason not Specified|6|||
147165992|NCT01818284|530773736|FG000|Overall Study|Not eligible due to White Blood Counts|4|||
147165993|NCT01818284|530773737|FG001|Overall Study|Not eligible due to White Blood Counts|4|||
147165994|NCT01818284|530773736|FG000|Overall Study|Death|0|||
147165995|NCT01818284|530773737|FG001|Overall Study|Death|2|||
147165996|NCT04030962|530773738|FG000|Stage 2|Adverse Event|0|||
147165997|NCT04030962|530773739|FG001|Stage 2|Adverse Event|0|||
147165998|NCT04030962|530773740|FG002|Stage 2|Adverse Event|0|||
147165999|NCT04030962|530773741|FG003|Stage 2|Adverse Event|0|||
147166000|NCT04030962|530773742|FG004|Stage 2|Adverse Event|0|||
147243563|NCT02166905|531063887|FG002|Overall Study|Withdrawal by Subject|0|||
147166001|NCT04030962|530773743|FG005|Stage 2|Adverse Event|0|||
147166002|NCT04030962|530773744|FG006|Stage 2|Adverse Event|0|||
147166003|NCT04030962|530773745|FG007|Stage 2|Adverse Event|0|||
147166004|NCT04030962|530773746|FG008|Stage 2|Adverse Event|1|||
147166005|NCT04030962|530773747|FG009|Stage 2|Adverse Event|0|||
147166006|NCT04030962|530773748|FG010|Stage 2|Adverse Event|1|||
147166007|NCT04030962|530773749|FG011|Stage 2|Adverse Event|1|||
147166008|NCT04030962|530773750|FG012|Stage 2|Adverse Event|1|||
147166009|NCT04030962|530773738|FG000|Stage 2|Withdrawal by Subject|0|||
147166010|NCT04030962|530773739|FG001|Stage 2|Withdrawal by Subject|0|||
147166011|NCT04030962|530773740|FG002|Stage 2|Withdrawal by Subject|0|||
147166012|NCT04030962|530773741|FG003|Stage 2|Withdrawal by Subject|0|||
147166013|NCT04030962|530773742|FG004|Stage 2|Withdrawal by Subject|0|||
147166014|NCT04030962|530773743|FG005|Stage 2|Withdrawal by Subject|0|||
147166015|NCT04030962|530773744|FG006|Stage 2|Withdrawal by Subject|0|||
147243564|NCT02166905|531063888|FG003|Overall Study|Withdrawal by Subject|0|||
147243565|NCT02617628|531063889|FG000|Overall Study|Withdr, Transfers-other prisons, dropout|62|||
147243566|NCT02617628|531063890|FG001|Overall Study|Withdr, Transfers-other prisons, dropout|61|||
147243567|NCT03278873|531063891|FG000|Overall Study|Withdrawal by Subject|0|||
147243568|NCT03278873|531063892|FG001|Overall Study|Withdrawal by Subject|1|||
147243569|NCT03278873|531063893|FG002|Overall Study|Withdrawal by Subject|0|||
147243570|NCT03278873|531063894|FG003|Overall Study|Withdrawal by Subject|0|||
147243571|NCT03278873|531063891|FG000|Overall Study|Sponsor's decision|0|||
147166016|NCT04030962|530773745|FG007|Stage 2|Withdrawal by Subject|0|||
147166017|NCT04030962|530773746|FG008|Stage 2|Withdrawal by Subject|1|||
147166018|NCT04030962|530773747|FG009|Stage 2|Withdrawal by Subject|0|||
147166019|NCT04030962|530773748|FG010|Stage 2|Withdrawal by Subject|0|||
147166020|NCT04030962|530773749|FG011|Stage 2|Withdrawal by Subject|2|||
147166021|NCT04030962|530773750|FG012|Stage 2|Withdrawal by Subject|1|||
147166022|NCT04030962|530773738|FG000|Stage 2|Lost to Follow-up|0|||
147166023|NCT04030962|530773739|FG001|Stage 2|Lost to Follow-up|0|||
147166024|NCT04030962|530773740|FG002|Stage 2|Lost to Follow-up|0|||
147166025|NCT04030962|530773741|FG003|Stage 2|Lost to Follow-up|0|||
147166026|NCT04030962|530773742|FG004|Stage 2|Lost to Follow-up|0|||
147243572|NCT03278873|531063892|FG001|Overall Study|Sponsor's decision|1|||
147243573|NCT03278873|531063893|FG002|Overall Study|Sponsor's decision|0|||
147243574|NCT03278873|531063894|FG003|Overall Study|Sponsor's decision|0|||
147243575|NCT03278873|531063891|FG000|Overall Study|Early Termination|2|||
147243576|NCT03278873|531063892|FG001|Overall Study|Early Termination|6|||
147243577|NCT03278873|531063893|FG002|Overall Study|Early Termination|0|||
147243578|NCT03278873|531063894|FG003|Overall Study|Early Termination|4|||
147243579|NCT03278873|531063891|FG000|Overall Study|Lost to Follow-up|0|||
147243580|NCT03278873|531063892|FG001|Overall Study|Lost to Follow-up|0|||
147447673|NCT00783094|531803937|FG001|Randomized Double-Blind Treatment Period|Physician Decision|2|||
147447674|NCT00783094|531803938|FG002|Randomized Double-Blind Treatment Period|Physician Decision|0|||
147447675|NCT00783094|531803936|FG000|Randomized Double-Blind Treatment Period|Protocol Violation|1|||
147447676|NCT00783094|531803937|FG001|Randomized Double-Blind Treatment Period|Protocol Violation|2|||
147590157|NCT01351350|532316234|FG004|Overall Study|Adverse Event|0|||
147590158|NCT01351350|532316230|FG000|Overall Study|Participant Decision|2|||
147590159|NCT01351350|532316231|FG001|Overall Study|Participant Decision|6|||
147590160|NCT01351350|532316232|FG002|Overall Study|Participant Decision|3|||
147590161|NCT01351350|532316233|FG003|Overall Study|Participant Decision|3|||
147590162|NCT01351350|532316234|FG004|Overall Study|Participant Decision|2|||
147590163|NCT01351350|532316230|FG000|Overall Study|Enrolled but not Treated|0|||
147590164|NCT01351350|532316231|FG001|Overall Study|Enrolled but not Treated|0|||
147590165|NCT01351350|532316232|FG002|Overall Study|Enrolled but not Treated|1|||
147590166|NCT01351350|532316233|FG003|Overall Study|Enrolled but not Treated|0|||
147590167|NCT01351350|532316234|FG004|Overall Study|Enrolled but not Treated|0|||
147590168|NCT00775528|532316237|FG000|Overall Study|Protocol Violation|1|||
147590169|NCT04647383|532316238|FG000|Treatment Period 2 (8 Days)|Adverse Event|0|||
147590170|NCT04647383|532316239|FG001|Treatment Period 2 (8 Days)|Adverse Event|1|||
147590171|NCT04647383|532316240|FG002|Treatment Period 2 (8 Days)|Adverse Event|0|||
147590172|NCT04647383|532316241|FG003|Treatment Period 2 (8 Days)|Adverse Event|0|||
147166027|NCT04030962|530773743|FG005|Stage 2|Lost to Follow-up|0|||
147166028|NCT04030962|530773744|FG006|Stage 2|Lost to Follow-up|0|||
147166029|NCT04030962|530773745|FG007|Stage 2|Lost to Follow-up|0|||
147166030|NCT04030962|530773746|FG008|Stage 2|Lost to Follow-up|1|||
147166031|NCT04030962|530773747|FG009|Stage 2|Lost to Follow-up|0|||
147166032|NCT04030962|530773748|FG010|Stage 2|Lost to Follow-up|0|||
147166033|NCT04030962|530773749|FG011|Stage 2|Lost to Follow-up|0|||
147166034|NCT04030962|530773750|FG012|Stage 2|Lost to Follow-up|0|||
147166035|NCT04030962|530773738|FG000|Stage 2|Technical Problems|0|||
147166036|NCT04030962|530773739|FG001|Stage 2|Technical Problems|0|||
147166037|NCT04030962|530773740|FG002|Stage 2|Technical Problems|0|||
147166038|NCT04030962|530773741|FG003|Stage 2|Technical Problems|0|||
147166039|NCT04030962|530773742|FG004|Stage 2|Technical Problems|0|||
147166040|NCT04030962|530773743|FG005|Stage 2|Technical Problems|0|||
147166041|NCT04030962|530773744|FG006|Stage 2|Technical Problems|0|||
147166042|NCT04030962|530773745|FG007|Stage 2|Technical Problems|0|||
147166043|NCT04030962|530773746|FG008|Stage 2|Technical Problems|0|||
147166044|NCT04030962|530773747|FG009|Stage 2|Technical Problems|0|||
147166045|NCT04030962|530773748|FG010|Stage 2|Technical Problems|0|||
147166046|NCT04030962|530773749|FG011|Stage 2|Technical Problems|1|||
147166047|NCT04030962|530773750|FG012|Stage 2|Technical Problems|0|||
147166048|NCT05601102|530773754|FG000|Overall Study|Death|1|||
147166049|NCT05601102|530773755|FG001|Overall Study|Death|2|||
147166050|NCT05601102|530773754|FG000|Overall Study|Withdrawal by Subject|1|||
147166051|NCT05601102|530773755|FG001|Overall Study|Withdrawal by Subject|1|||
147166052|NCT05601102|530773754|FG000|Overall Study|Lost to Follow-up|0|||
147166053|NCT05601102|530773755|FG001|Overall Study|Lost to Follow-up|2|||
147166054|NCT05288166|530773756|FG000|Overall Study|Adverse Event|1|||
147166055|NCT05288166|530773757|FG001|Overall Study|Adverse Event|0|||
147166056|NCT05288166|530773756|FG000|Overall Study|Lost to Follow-up|2|||
147166057|NCT05288166|530773757|FG001|Overall Study|Lost to Follow-up|0|||
147166058|NCT05288166|530773756|FG000|Overall Study|Physician Decision|0|||
147166059|NCT05288166|530773757|FG001|Overall Study|Physician Decision|2|||
147166060|NCT05288166|530773756|FG000|Overall Study|Screen Failure|1|||
147166061|NCT05288166|530773757|FG001|Overall Study|Screen Failure|1|||
147243581|NCT03278873|531063893|FG002|Overall Study|Lost to Follow-up|2|||
147243582|NCT03278873|531063894|FG003|Overall Study|Lost to Follow-up|0|||
147243583|NCT03278873|531063891|FG000|Overall Study|The patient decided to withdraw via email|1|||
147447677|NCT00783094|531803938|FG002|Randomized Double-Blind Treatment Period|Protocol Violation|1|||
147447678|NCT00783094|531803936|FG000|Randomized Double-Blind Treatment Period|Withdrawal by Subject|2|||
147590173|NCT00285584|532316248|FG000|Month 3|Lost to Follow-up|3|||
147590174|NCT00285584|532316249|FG001|Month 3|Lost to Follow-up|3|||
147590175|NCT00285584|532316248|FG000|Month 3|Withdrawal by Subject|1|||
147166062|NCT05288166|530773756|FG000|Overall Study|Withdrawal by Subject|4|||
147166063|NCT05288166|530773757|FG001|Overall Study|Withdrawal by Subject|2|||
147166064|NCT05288166|530773756|FG000|Overall Study|On Study Treatment|408|||
147166065|NCT05288166|530773757|FG001|Overall Study|On Study Treatment|418|||
147243584|NCT03278873|531063892|FG001|Overall Study|The patient decided to withdraw via email|0|||
147590176|NCT00285584|532316249|FG001|Month 3|Withdrawal by Subject|0|||
147590177|NCT00285584|532316248|FG000|Month 6|Lost to Follow-up|0|||
147166066|NCT03007745|530773758|FG000|Overall Study|Sleep test negative for OSA|53|||
147166067|NCT03007745|530773759|FG001|Overall Study|Sleep test negative for OSA|49|||
147166068|NCT03007745|530773758|FG000|Overall Study|Physician Decision|6|||
147166069|NCT03007745|530773759|FG001|Overall Study|Physician Decision|9|||
147166070|NCT03007745|530773758|FG000|Overall Study|Withdrawal by Subject|38|||
147166071|NCT03007745|530773759|FG001|Overall Study|Withdrawal by Subject|16|||
147166072|NCT03007745|530773758|FG000|Overall Study|Lost to Follow-up|19|||
147243585|NCT03278873|531063893|FG002|Overall Study|The patient decided to withdraw via email|0|||
147243586|NCT03278873|531063894|FG003|Overall Study|The patient decided to withdraw via email|0|||
147243587|NCT03278873|531063891|FG000|Overall Study|The patient was unresponsive to contact|0|||
147243588|NCT03278873|531063892|FG001|Overall Study|The patient was unresponsive to contact|0|||
147243589|NCT03278873|531063893|FG002|Overall Study|The patient was unresponsive to contact|0|||
147243590|NCT03278873|531063894|FG003|Overall Study|The patient was unresponsive to contact|4|||
147166073|NCT03007745|530773759|FG001|Overall Study|Lost to Follow-up|25|||
147166074|NCT03007745|530773758|FG000|Overall Study|Unable to login to website|17|||
147166075|NCT03007745|530773759|FG001|Overall Study|Unable to login to website|4|||
147166076|NCT04284813|530773760|FG000|Overall Study|Withdrawal by Subject|1|||
147166077|NCT03968159|530773768|FG000|Overall Study|Adverse Event|4|||
147166078|NCT03968159|530773769|FG001|Overall Study|Adverse Event|4|||
147166079|NCT03968159|530773768|FG000|Overall Study|Lost to Follow-up|1|||
147243591|NCT03278873|531063891|FG000|Overall Study|The patient wished to participate no longer|0|||
147166080|NCT03968159|530773769|FG001|Overall Study|Lost to Follow-up|1|||
147166081|NCT03968159|530773768|FG000|Overall Study|Use of prohibited medication|0|||
147166082|NCT03968159|530773769|FG001|Overall Study|Use of prohibited medication|1|||
147166083|NCT03968159|530773768|FG000|Overall Study|Protocol Violation|2|||
147243592|NCT03278873|531063892|FG001|Overall Study|The patient wished to participate no longer|1|||
147243593|NCT03278873|531063893|FG002|Overall Study|The patient wished to participate no longer|0|||
147243594|NCT03278873|531063894|FG003|Overall Study|The patient wished to participate no longer|0|||
147243595|NCT03278873|531063891|FG000|Overall Study|Patient withdrew as they could no longer participate, as they had moved to Canada|0|||
147243596|NCT03278873|531063892|FG001|Overall Study|Patient withdrew as they could no longer participate, as they had moved to Canada|0|||
147243597|NCT03278873|531063893|FG002|Overall Study|Patient withdrew as they could no longer participate, as they had moved to Canada|1|||
147243598|NCT03278873|531063894|FG003|Overall Study|Patient withdrew as they could no longer participate, as they had moved to Canada|0|||
147243599|NCT04518306|531063909|FG000|Double-Blind Period|Run in failure|0|||
147243600|NCT04518306|531063910|FG001|Double-Blind Period|Run in failure|0|||
147243601|NCT04518306|531063911|FG002|Double-Blind Period|Run in failure|1|||
147243602|NCT04518306|531063909|FG000|Double-Blind Period|Adverse Event|0|||
147243603|NCT04518306|531063910|FG001|Double-Blind Period|Adverse Event|2|||
147243604|NCT04518306|531063911|FG002|Double-Blind Period|Adverse Event|2|||
147243605|NCT04518306|531063909|FG000|Double-Blind Period|Lost to Follow-up|1|||
147243606|NCT04518306|531063910|FG001|Double-Blind Period|Lost to Follow-up|2|||
147243607|NCT04518306|531063911|FG002|Double-Blind Period|Lost to Follow-up|2|||
147243608|NCT04518306|531063909|FG000|Double-Blind Period|Participant moved to open-label extension (OLE) study|21|||
147243609|NCT04518306|531063910|FG001|Double-Blind Period|Participant moved to open-label extension (OLE) study|21|||
147243610|NCT04518306|531063911|FG002|Double-Blind Period|Participant moved to open-label extension (OLE) study|8|||
147243611|NCT04518306|531063909|FG000|Double-Blind Period|Other|0|||
147243612|NCT04518306|531063910|FG001|Double-Blind Period|Other|2|||
147243613|NCT04518306|531063911|FG002|Double-Blind Period|Other|0|||
147243614|NCT04518306|531063909|FG000|Double-Blind Period|Missing|0|||
147243615|NCT04518306|531063910|FG001|Double-Blind Period|Missing|1|||
147243616|NCT04518306|531063911|FG002|Double-Blind Period|Missing|0|||
147243617|NCT02801331|531063912|FG000|Overall Study|Transferred to another hospital|8|||
147243618|NCT02801331|531063913|FG001|Overall Study|Transferred to another hospital|7|||
147243619|NCT02801331|531063912|FG000|Overall Study|Withdrawal by Subject|0|||
147243620|NCT02801331|531063913|FG001|Overall Study|Withdrawal by Subject|4|||
147243621|NCT02801331|531063912|FG000|Overall Study|Subsequently met exclusion/withdrawal criteria|3|||
147243622|NCT02801331|531063913|FG001|Overall Study|Subsequently met exclusion/withdrawal criteria|5|||
147243623|NCT02443987|531063914|FG000|Overall Study|Bladder injury|1|||
147243624|NCT02443987|531063915|FG001|Overall Study|Bladder injury|1|||
147243625|NCT02443987|531063914|FG000|Overall Study|Other|0|||
147243626|NCT02443987|531063915|FG001|Overall Study|Other|1|||
147243627|NCT03069378|531063919|FG000|Overall Study|Withdrawal by Subject|1|||
147243628|NCT01397708|531063920|FG000|Overall Study|Withdrawal by Subject|0|||
147243629|NCT01397708|531063921|FG001|Overall Study|Withdrawal by Subject|0|||
147243630|NCT01397708|531063922|FG002|Overall Study|Withdrawal by Subject|1|||
147243631|NCT01397708|531063923|FG003|Overall Study|Withdrawal by Subject|0|||
147243632|NCT01397708|531063924|FG004|Overall Study|Withdrawal by Subject|0|||
147243633|NCT01397708|531063925|FG005|Overall Study|Withdrawal by Subject|0|||
147243634|NCT01397708|531063926|FG006|Overall Study|Withdrawal by Subject|0|||
147243635|NCT01397708|531063927|FG007|Overall Study|Withdrawal by Subject|1|||
147243636|NCT01397708|531063920|FG000|Overall Study|Death|0|||
147243637|NCT01397708|531063921|FG001|Overall Study|Death|0|||
147590178|NCT00285584|532316249|FG001|Month 6|Lost to Follow-up|1|||
147590179|NCT01884688|532316254|FG000|Overall Study|Screen Failure|2|||
147590180|NCT02549573|532316257|FG000|Overall Study|Withdrawal by Subject|0|||
147590181|NCT02549573|532316258|FG001|Overall Study|Withdrawal by Subject|2|||
147590182|NCT02549573|532316257|FG000|Overall Study|Protocol Violation|0|||
147166084|NCT03968159|530773769|FG001|Overall Study|Protocol Violation|2|||
147166085|NCT03968159|530773768|FG000|Overall Study|Withdrawal by Subject|4|||
147166086|NCT03968159|530773769|FG001|Overall Study|Withdrawal by Subject|6|||
147166087|NCT03968159|530773768|FG000|Overall Study|Lack of Efficacy|0|||
147166088|NCT03968159|530773769|FG001|Overall Study|Lack of Efficacy|1|||
147166089|NCT03968159|530773768|FG000|Overall Study|Not further specified|2|||
147166090|NCT03968159|530773769|FG001|Overall Study|Not further specified|0|||
147166091|NCT00895661|530773777|FG000|Overall Study|Death|1|||
147166092|NCT00895661|530773777|FG000|Overall Study|reason unknown|2|||
147166093|NCT00791557|530773778|FG000|Overall Study|Adverse Event|1|||
147166094|NCT02066129|530773779|FG000|Overall Study|Lost to Follow-up|13|||
147166095|NCT02066129|530773780|FG001|Overall Study|Lost to Follow-up|12|||
147166096|NCT02066129|530773779|FG000|Overall Study|Withdrawal by Subject|7|||
147166097|NCT02066129|530773780|FG001|Overall Study|Withdrawal by Subject|10|||
147166098|NCT02066129|530773779|FG000|Overall Study|Lack of Efficacy|8|||
147166099|NCT02066129|530773780|FG001|Overall Study|Lack of Efficacy|10|||
147166100|NCT02066129|530773779|FG000|Overall Study|Physician Decision|1|||
147166101|NCT02066129|530773780|FG001|Overall Study|Physician Decision|1|||
147166102|NCT02322190|530773781|FG000|Overall Study|Death on study|1|||
147166103|NCT02322190|530773782|FG001|Overall Study|Death on study|0|||
147166104|NCT00357656|530773783|FG000|Overall Study|Other, No surgery performed|0|||
147166105|NCT00357656|530773784|FG001|Overall Study|Other, No surgery performed|3|||
147166106|NCT03553498|530773788|FG000|Overall Study|Missing primary outcome|1|||
147166107|NCT03553498|530773789|FG001|Overall Study|Missing primary outcome|2|||
147166108|NCT04941807|530773790|FG000|Overall Study|Lost to Follow-up|1|||
147166109|NCT04941807|530773791|FG001|Overall Study|Lost to Follow-up|1|||
147166110|NCT02713529|530773794|FG000|Overall Study|Withdrawal by Subject|3|||
147166111|NCT02713529|530773795|FG001|Overall Study|Withdrawal by Subject|1|||
147166112|NCT02713529|530773796|FG002|Overall Study|Withdrawal by Subject|4|||
147166113|NCT02713529|530773797|FG003|Overall Study|Withdrawal by Subject|2|||
147166114|NCT02713529|530773798|FG004|Overall Study|Withdrawal by Subject|0|||
147166115|NCT02713529|530773799|FG005|Overall Study|Withdrawal by Subject|1|||
147166116|NCT02713529|530773800|FG006|Overall Study|Withdrawal by Subject|1|||
147166117|NCT02713529|530773794|FG000|Overall Study|Lost to Follow-up|1|||
147166118|NCT02713529|530773795|FG001|Overall Study|Lost to Follow-up|0|||
147166119|NCT02713529|530773796|FG002|Overall Study|Lost to Follow-up|1|||
147166120|NCT02713529|530773797|FG003|Overall Study|Lost to Follow-up|0|||
147166121|NCT02713529|530773798|FG004|Overall Study|Lost to Follow-up|0|||
147166122|NCT02713529|530773799|FG005|Overall Study|Lost to Follow-up|0|||
147166123|NCT02713529|530773800|FG006|Overall Study|Lost to Follow-up|0|||
147166124|NCT02713529|530773794|FG000|Overall Study|Death|3|||
147166125|NCT02713529|530773795|FG001|Overall Study|Death|3|||
147166126|NCT02713529|530773796|FG002|Overall Study|Death|26|||
147166127|NCT02713529|530773797|FG003|Overall Study|Death|27|||
147166128|NCT02713529|530773798|FG004|Overall Study|Death|3|||
147166129|NCT02713529|530773799|FG005|Overall Study|Death|13|||
147166130|NCT02713529|530773800|FG006|Overall Study|Death|3|||
147166131|NCT01565564|530773804|FG000|Overall Study|Lost to Follow-up|5|||
147166132|NCT01565564|530773805|FG001|Overall Study|Lost to Follow-up|1|||
147166133|NCT03995355|530773806|FG000|Overall Study|Adverse Event|1|||
147166134|NCT03995355|530773807|FG001|Overall Study|Adverse Event|0|||
147166135|NCT03995355|530773806|FG000|Overall Study|Withdrawal by Subject|1|||
147166136|NCT03995355|530773807|FG001|Overall Study|Withdrawal by Subject|0|||
147166137|NCT03995355|530773806|FG000|Overall Study|Scheduling Issues|0|||
147447679|NCT00783094|531803937|FG001|Randomized Double-Blind Treatment Period|Withdrawal by Subject|1|||
147447680|NCT00783094|531803938|FG002|Randomized Double-Blind Treatment Period|Withdrawal by Subject|2|||
147447681|NCT00783094|531803936|FG000|Open-Label Extension Period|Adverse Event|12|||
147590183|NCT02549573|532316258|FG001|Overall Study|Protocol Violation|1|||
147590184|NCT02610816|532316261|FG000|Phase 1|Withdrawal by Subject|2|||
147590185|NCT02610816|532316262|FG001|Phase 1|Withdrawal by Subject|6|||
147166138|NCT03995355|530773807|FG001|Overall Study|Scheduling Issues|1|||
147166139|NCT00094107|530773808|FG000|Overall Study|Lack of Efficacy|23|||
147166140|NCT00094107|530773808|FG000|Overall Study|Death|5|||
147323411|NCT01449929|531348020|FG002|Extension Phase Approximately 3 Years|Adverse Event|2|||
147166141|NCT00094107|530773808|FG000|Overall Study|Adverse Event|3|||
147166142|NCT00094107|530773808|FG000|Overall Study|Withdrawal due to Disease Progression|1|||
147166143|NCT02698371|530773814|FG000|All Participants Flow|Lost to Follow-up|3|||
147166144|NCT02698371|530773814|FG000|FBDC-SE (G1; Control) Arm/Group Flow|Lost to Follow-up|3|||
147166145|NCT02698371|530773814|FG000|FBDC-SE-EE (G2; Control ) Arm/Group Flow|Lost to Follow-up|3|||
147166146|NCT02698371|530773814|FG000|FBU-ER (G3) Arm/Group Flow|Lost to Follow-up|3|||
147166147|NCT02698371|530773814|FG000|FBU-SE (G4) Arm/Group Flow|Lost to Follow-up|3|||
147166148|NCT02698371|530773814|FG000|ADU-ER (G5) Arm/Group Flow|Lost to Follow-up|3|||
147166149|NCT02698371|530773814|FG000|ADU-SE (G6) Arm/Group Flow|Lost to Follow-up|2|||
147166150|NCT02525094|530773815|FG000|Overall Study|Lost to Follow-up|2|||
147243638|NCT01397708|531063922|FG002|Overall Study|Death|1|||
147243639|NCT01397708|531063923|FG003|Overall Study|Death|1|||
147243640|NCT01397708|531063924|FG004|Overall Study|Death|0|||
147166151|NCT02525094|530773816|FG001|Overall Study|Lost to Follow-up|1|||
147166152|NCT02525094|530773815|FG000|Overall Study|Withdrawal by Subject|5|||
147166153|NCT02525094|530773816|FG001|Overall Study|Withdrawal by Subject|6|||
147166154|NCT02525094|530773815|FG000|Overall Study|Not Treated|1|||
147166155|NCT02525094|530773816|FG001|Overall Study|Not Treated|1|||
147166156|NCT00969436|530773818|FG000|Overall Study|Protocol Violation|1|||
147166157|NCT00969436|530773819|FG001|Overall Study|Protocol Violation|3|||
147166158|NCT00969436|530773820|FG002|Overall Study|Protocol Violation|0|||
147166159|NCT00969436|530773818|FG000|Overall Study|Migrated/moved from study area|12|||
147166160|NCT00969436|530773819|FG001|Overall Study|Migrated/moved from study area|10|||
147166161|NCT00969436|530773820|FG002|Overall Study|Migrated/moved from study area|2|||
147243641|NCT01397708|531063925|FG005|Overall Study|Death|0|||
147243642|NCT01397708|531063926|FG006|Overall Study|Death|0|||
147447682|NCT00783094|531803937|FG001|Open-Label Extension Period|Adverse Event|7|||
147166162|NCT00969436|530773818|FG000|Overall Study|Father - serious health problem|0|||
147243643|NCT01397708|531063927|FG007|Overall Study|Death|0|||
147243644|NCT01397708|531063920|FG000|Overall Study|Lost to Follow-up|0|||
147243645|NCT01397708|531063921|FG001|Overall Study|Lost to Follow-up|0|||
147243646|NCT01397708|531063922|FG002|Overall Study|Lost to Follow-up|0|||
147243647|NCT01397708|531063923|FG003|Overall Study|Lost to Follow-up|0|||
147243648|NCT01397708|531063924|FG004|Overall Study|Lost to Follow-up|1|||
147243649|NCT01397708|531063925|FG005|Overall Study|Lost to Follow-up|0|||
147243650|NCT01397708|531063926|FG006|Overall Study|Lost to Follow-up|0|||
147243651|NCT01397708|531063927|FG007|Overall Study|Lost to Follow-up|0|||
147243652|NCT01397708|531063920|FG000|Overall Study|Other|0|||
147243653|NCT01397708|531063921|FG001|Overall Study|Other|0|||
147243654|NCT01397708|531063922|FG002|Overall Study|Other|0|||
147243655|NCT01397708|531063923|FG003|Overall Study|Other|0|||
147243656|NCT01397708|531063924|FG004|Overall Study|Other|0|||
147243657|NCT01397708|531063925|FG005|Overall Study|Other|0|||
147243658|NCT01397708|531063926|FG006|Overall Study|Other|1|||
147243659|NCT01397708|531063927|FG007|Overall Study|Other|0|||
147243660|NCT01638546|531063938|FG000|Overall Study|Adverse Event|1|||
147243661|NCT01638546|531063939|FG001|Overall Study|Adverse Event|3|||
147243662|NCT05330702|531063942|FG000|Overall Study|Study terminated before all 6-month visit data could be collected|9|||
147166163|NCT00969436|530773819|FG001|Overall Study|Father - serious health problem|0|||
147166164|NCT00969436|530773820|FG002|Overall Study|Father - serious health problem|1|||
147166165|NCT00969436|530773818|FG000|Overall Study|Parents personal problem|0|||
147166166|NCT00969436|530773819|FG001|Overall Study|Parents personal problem|0|||
147166167|NCT00969436|530773820|FG002|Overall Study|Parents personal problem|1|||
147166168|NCT00969436|530773818|FG000|Overall Study|Subject eliminated (other vaccine)|1|||
147166169|NCT00969436|530773819|FG001|Overall Study|Subject eliminated (other vaccine)|0|||
147166170|NCT00969436|530773820|FG002|Overall Study|Subject eliminated (other vaccine)|0|||
147166171|NCT00969436|530773818|FG000|Overall Study|Withdrawal by Subject|3|||
147166172|NCT00969436|530773819|FG001|Overall Study|Withdrawal by Subject|0|||
147166173|NCT00969436|530773820|FG002|Overall Study|Withdrawal by Subject|2|||
147166174|NCT00969436|530773818|FG000|Overall Study|Lost to Follow-up|8|||
147166175|NCT00969436|530773819|FG001|Overall Study|Lost to Follow-up|8|||
147166176|NCT00969436|530773820|FG002|Overall Study|Lost to Follow-up|5|||
147166177|NCT02117349|530773824|FG000|Overall Study|Withdrawal by Subject|1|||
147166178|NCT02117349|530773825|FG001|Overall Study|Withdrawal by Subject|0|||
147166179|NCT02117349|530773824|FG000|Overall Study|Lost to Follow-up|1|||
147166180|NCT02117349|530773825|FG001|Overall Study|Lost to Follow-up|1|||
147166181|NCT02117349|530773824|FG000|Overall Study|Death|1|||
147166182|NCT02117349|530773825|FG001|Overall Study|Death|0|||
147166183|NCT02242981|530773828|FG000|Overall Study|Withdrawal by Subject|1|||
147166184|NCT02535416|530773829|FG000|Overall Study|Family bereavement overseas|1|||
147166185|NCT02535416|530773830|FG001|Overall Study|Family bereavement overseas|0|||
147166186|NCT02535416|530773831|FG002|Overall Study|Family bereavement overseas|0|||
147243663|NCT05330702|531063943|FG001|Overall Study|Study terminated before all 6-month visit data could be collected|5|||
147243664|NCT05330702|531063944|FG002|Overall Study|Study terminated before all 6-month visit data could be collected|5|||
147243665|NCT02881554|531063945|FG000|Overall Study|Withdrawal by Subject|2|||
147243666|NCT02881554|531063946|FG001|Overall Study|Withdrawal by Subject|0|||
147447683|NCT00783094|531803938|FG002|Open-Label Extension Period|Adverse Event|16|||
147447684|NCT00783094|531803936|FG000|Open-Label Extension Period|Death|0|||
147166187|NCT02535416|530773832|FG003|Overall Study|Family bereavement overseas|0|||
147166188|NCT02535416|530773833|FG004|Overall Study|Family bereavement overseas|0|||
147166189|NCT02535416|530773834|FG005|Overall Study|Family bereavement overseas|0|||
147243667|NCT02397278|531065385|FG000|Overall Study|Withdrawal by Subject|0|||
147243668|NCT02397278|531065386|FG001|Overall Study|Withdrawal by Subject|2|||
147243669|NCT02397278|531065385|FG000|Overall Study|Deemed ineligible following surgery|1|||
147243670|NCT02397278|531065386|FG001|Overall Study|Deemed ineligible following surgery|1|||
147243671|NCT02820753|531065388|FG000|2 Month|Withdrawal by Subject|3|||
147166190|NCT02535416|530773835|FG006|Overall Study|Family bereavement overseas|0|||
147166191|NCT02535416|530773836|FG007|Overall Study|Family bereavement overseas|0|||
147590186|NCT02610816|532316263|FG002|Phase 1|Withdrawal by Subject|0|||
147590187|NCT02610816|532316264|FG003|Phase 1|Withdrawal by Subject|0|||
147590188|NCT02610816|532316261|FG000|Phase 1|Lost to Follow-up|2|||
147590189|NCT02610816|532316262|FG001|Phase 1|Lost to Follow-up|1|||
147590190|NCT02610816|532316263|FG002|Phase 1|Lost to Follow-up|0|||
147590191|NCT02610816|532316264|FG003|Phase 1|Lost to Follow-up|0|||
147590192|NCT02610816|532316261|FG000|Phase 1|Physician Decision|0|||
147590193|NCT02610816|532316262|FG001|Phase 1|Physician Decision|1|||
147590194|NCT02610816|532316263|FG002|Phase 1|Physician Decision|0|||
147590195|NCT02610816|532316264|FG003|Phase 1|Physician Decision|0|||
147590196|NCT02610816|532316261|FG000|Phase 2|Withdrawal by Subject|0|||
147590197|NCT02610816|532316262|FG001|Phase 2|Withdrawal by Subject|0|||
147590198|NCT02610816|532316263|FG002|Phase 2|Withdrawal by Subject|9|||
147590199|NCT02610816|532316264|FG003|Phase 2|Withdrawal by Subject|3|||
147590200|NCT02610816|532316261|FG000|Phase 2|Lost to Follow-up|0|||
147590201|NCT02610816|532316262|FG001|Phase 2|Lost to Follow-up|0|||
147590202|NCT02610816|532316263|FG002|Phase 2|Lost to Follow-up|2|||
147590203|NCT02610816|532316264|FG003|Phase 2|Lost to Follow-up|0|||
147590204|NCT02610816|532316261|FG000|Phase 2|Physician Decision|0|||
147590205|NCT02610816|532316262|FG001|Phase 2|Physician Decision|0|||
147590206|NCT02610816|532316263|FG002|Phase 2|Physician Decision|0|||
147590207|NCT02610816|532316264|FG003|Phase 2|Physician Decision|2|||
147590208|NCT02610816|532316261|FG000|Phase 2|Pregnancy|0|||
147590209|NCT02610816|532316262|FG001|Phase 2|Pregnancy|0|||
147590210|NCT02610816|532316263|FG002|Phase 2|Pregnancy|0|||
147590211|NCT02610816|532316264|FG003|Phase 2|Pregnancy|1|||
147590212|NCT00854373|532316267|FG000|Overall Study|Withdrawal by Subject|1|||
147590213|NCT00854373|532316268|FG001|Overall Study|Withdrawal by Subject|3|||
147590214|NCT00854373|532316267|FG000|Overall Study|Forgot to take study drug|1|||
147590215|NCT00854373|532316268|FG001|Overall Study|Forgot to take study drug|1|||
147590216|NCT02697773|532316269|FG000|Overall Study|Adverse Event|2|||
147590217|NCT02697773|532316270|FG001|Overall Study|Adverse Event|1|||
147166192|NCT02535416|530773837|FG008|Overall Study|Family bereavement overseas|0|||
147166193|NCT03474081|530773838|FG000|Overall Study|Adverse Event|6|||
147166194|NCT03474081|530773839|FG001|Overall Study|Adverse Event|3|||
147166195|NCT03474081|530773838|FG000|Overall Study|Lost to Follow-up|2|||
147166196|NCT03474081|530773839|FG001|Overall Study|Lost to Follow-up|1|||
147166197|NCT03474081|530773838|FG000|Overall Study|Physician Decision|3|||
147166198|NCT03474081|530773839|FG001|Overall Study|Physician Decision|2|||
147166199|NCT03474081|530773838|FG000|Overall Study|Withdrawal by Subject|5|||
147166200|NCT03474081|530773839|FG001|Overall Study|Withdrawal by Subject|7|||
147166201|NCT03474081|530773838|FG000|Overall Study|Investigator site closed|1|||
147166202|NCT03474081|530773839|FG001|Overall Study|Investigator site closed|0|||
147166203|NCT02739321|530773844|FG000|Overall Study|Lack of Efficacy|1|||
147166204|NCT02739321|530773845|FG001|Overall Study|Lack of Efficacy|1|||
147166205|NCT02739321|530773844|FG000|Overall Study|Lost to Follow-up|1|||
147166206|NCT02739321|530773845|FG001|Overall Study|Lost to Follow-up|1|||
147166207|NCT02739321|530773844|FG000|Overall Study|Withdrawal by Subject|1|||
147166208|NCT02739321|530773845|FG001|Overall Study|Withdrawal by Subject|2|||
147166209|NCT02440789|530773848|FG000|Overall Study|Withdrawal by Subject|3|||
147166210|NCT02440789|530773848|FG000|Overall Study|Not willing to adhere to reqs|1|||
147166211|NCT03172130|530774839|FG000|Overall Study|Failure to tolerate CPAP/Sham CPAP|3|||
147166212|NCT03172130|530774840|FG001|Overall Study|Failure to tolerate CPAP/Sham CPAP|1|||
147166213|NCT01350115|530774844|FG000|Long Term Follow-Up (All Patients)|Lost to Follow-up|0|||
147166214|NCT01350115|530774845|FG001|Long Term Follow-Up (All Patients)|Lost to Follow-up|1|||
147166215|NCT01350115|530774844|FG000|Long Term Follow-Up (All Patients)|Adverse Event|0|||
147166216|NCT01350115|530774845|FG001|Long Term Follow-Up (All Patients)|Adverse Event|1|||
147166217|NCT01350115|530774844|FG000|Long Term Follow-Up (All Patients)|Withdrawal by Subject|1|||
147166218|NCT01350115|530774845|FG001|Long Term Follow-Up (All Patients)|Withdrawal by Subject|0|||
147166219|NCT05565937|530774846|FG000|Overall Study|Adverse Event|0|||
147166220|NCT05565937|530774847|FG001|Overall Study|Adverse Event|1|||
147166221|NCT05565937|530774846|FG000|Overall Study|Persistent study-related symptoms /complaints|1|||
147166222|NCT05565937|530774847|FG001|Overall Study|Persistent study-related symptoms /complaints|1|||
147166223|NCT05565937|530774846|FG000|Overall Study|Lost to Follow-up|2|||
147166224|NCT05565937|530774847|FG001|Overall Study|Lost to Follow-up|0|||
147166225|NCT05565937|530774846|FG000|Overall Study|Pregnancy|0|||
147166226|NCT05565937|530774847|FG001|Overall Study|Pregnancy|2|||
147654577|NCT02427802|532556776|FG000|Overall Study|Adverse Event|11|||
147654578|NCT02427802|532556777|FG001|Overall Study|Adverse Event|3|||
147590218|NCT02697773|532316271|FG002|Overall Study|Adverse Event|2|||
147590219|NCT02697773|532316269|FG000|Overall Study|Death|0|||
147590220|NCT02697773|532316270|FG001|Overall Study|Death|0|||
147590221|NCT02697773|532316271|FG002|Overall Study|Death|2|||
147590222|NCT02697773|532316269|FG000|Overall Study|Lack of Efficacy|4|||
147590223|NCT02697773|532316270|FG001|Overall Study|Lack of Efficacy|6|||
147590224|NCT02697773|532316271|FG002|Overall Study|Lack of Efficacy|6|||
147590225|NCT02697773|532316269|FG000|Overall Study|Lost to Follow-up|5|||
147590226|NCT02697773|532316270|FG001|Overall Study|Lost to Follow-up|5|||
147166227|NCT05565937|530774846|FG000|Overall Study|Anisometropia|0|||
147166228|NCT05565937|530774847|FG001|Overall Study|Anisometropia|1|||
147166229|NCT04544683|530774848|FG000|Overall Study|Lost to Follow-up|2|||
147166230|NCT04544683|530774848|FG000|Overall Study|Underwent cervical spine surgery|6|||
147166231|NCT00151372|530774849|FG000|Overall Study|Death|12|||
147166232|NCT00151372|530774850|FG001|Overall Study|Death|11|||
147166233|NCT00151372|530774849|FG000|Overall Study|Lost to Follow-up|5|||
147166234|NCT00151372|530774850|FG001|Overall Study|Lost to Follow-up|5|||
147166235|NCT00151372|530774849|FG000|Overall Study|Too sick medically to continue|5|||
147166236|NCT00151372|530774850|FG001|Overall Study|Too sick medically to continue|6|||
147166237|NCT00151372|530774849|FG000|Overall Study|Withdrawal by Subject|7|||
147166238|NCT00151372|530774850|FG001|Overall Study|Withdrawal by Subject|7|||
147166239|NCT02783170|530774853|FG000|Overall Study|Randomized but not Vaccinated|1|||
147166240|NCT02783170|530774854|FG001|Overall Study|Randomized but not Vaccinated|0|||
147166241|NCT00541346|530774855|FG000|Follow-up|Adverse Event|1|||
147166242|NCT02008773|530774858|FG000|Overall Study|Adverse Event|3|||
147166243|NCT02008773|530774859|FG001|Overall Study|Adverse Event|3|||
147166244|NCT02008773|530774860|FG002|Overall Study|Adverse Event|1|||
147166245|NCT02008773|530774861|FG003|Overall Study|Adverse Event|2|||
147166246|NCT02008773|530774858|FG000|Overall Study|Medication Non-compliance|2|||
147166247|NCT02008773|530774859|FG001|Overall Study|Medication Non-compliance|1|||
147166248|NCT02008773|530774860|FG002|Overall Study|Medication Non-compliance|3|||
147166249|NCT02008773|530774861|FG003|Overall Study|Medication Non-compliance|2|||
147166250|NCT02008773|530774858|FG000|Overall Study|Withdrawal by Subject|8|||
147166251|NCT02008773|530774859|FG001|Overall Study|Withdrawal by Subject|4|||
147166252|NCT02008773|530774860|FG002|Overall Study|Withdrawal by Subject|7|||
147166253|NCT02008773|530774861|FG003|Overall Study|Withdrawal by Subject|6|||
147166254|NCT02008773|530774858|FG000|Overall Study|Lost to Follow-up|0|||
147166255|NCT02008773|530774859|FG001|Overall Study|Lost to Follow-up|1|||
147166256|NCT02008773|530774860|FG002|Overall Study|Lost to Follow-up|3|||
147166257|NCT02008773|530774861|FG003|Overall Study|Lost to Follow-up|2|||
147166258|NCT04732949|530774862|FG000|Overall Study|Withdrawal by Subject|23|||
147166259|NCT04732949|530774863|FG001|Overall Study|Withdrawal by Subject|27|||
147166260|NCT04732949|530774862|FG000|Overall Study|Protocol Violation|0|||
147166261|NCT04732949|530774863|FG001|Overall Study|Protocol Violation|1|||
147166262|NCT04732949|530774862|FG000|Overall Study|Non-compliance|0|||
147166263|NCT04732949|530774863|FG001|Overall Study|Non-compliance|2|||
147166264|NCT04732949|530774862|FG000|Overall Study|Physician Decision|2|||
147166265|NCT04732949|530774863|FG001|Overall Study|Physician Decision|1|||
147166266|NCT04732949|530774862|FG000|Overall Study|Serious adverse event (Fatal)|16|||
147166267|NCT04732949|530774863|FG001|Overall Study|Serious adverse event (Fatal)|18|||
147166268|NCT04732949|530774862|FG000|Overall Study|Serious adverse event (Non fatal)|2|||
147166269|NCT04732949|530774863|FG001|Overall Study|Serious adverse event (Non fatal)|1|||
147166270|NCT04732949|530774862|FG000|Overall Study|Non-serious adverse event|1|||
147166271|NCT04732949|530774863|FG001|Overall Study|Non-serious adverse event|3|||
147166272|NCT04732949|530774862|FG000|Overall Study|Lost to Follow-up|26|||
147166273|NCT04732949|530774863|FG001|Overall Study|Lost to Follow-up|27|||
147166274|NCT04732949|530774862|FG000|Overall Study|Other|6|||
147166275|NCT04732949|530774863|FG001|Overall Study|Other|3|||
147166276|NCT01806064|530774864|FG000|Overall Study|Randomized Not Enrolled|0|||
147166277|NCT01806064|530774865|FG001|Overall Study|Randomized Not Enrolled|0|||
147166278|NCT01806064|530774866|FG002|Overall Study|Randomized Not Enrolled|0|||
147166279|NCT01806064|530774867|FG003|Overall Study|Randomized Not Enrolled|1|||
147166280|NCT01806064|530774868|FG004|Overall Study|Randomized Not Enrolled|2|||
147166281|NCT01286077|530774871|FG000|Overall Study|Adverse Event|2|||
147166282|NCT01286077|530774872|FG001|Overall Study|Adverse Event|0|||
147166283|NCT01286077|530774871|FG000|Overall Study|Death|1|||
147166284|NCT01286077|530774872|FG001|Overall Study|Death|0|||
147166285|NCT01286077|530774871|FG000|Overall Study|Protocol Violation|1|||
147166286|NCT01286077|530774872|FG001|Overall Study|Protocol Violation|1|||
147166287|NCT01286077|530774871|FG000|Overall Study|Withdrawal by Subject|0|||
147166288|NCT01286077|530774872|FG001|Overall Study|Withdrawal by Subject|2|||
147166289|NCT01286077|530774871|FG000|Overall Study|Intercurrent illness|1|||
147166290|NCT01286077|530774872|FG001|Overall Study|Intercurrent illness|0|||
147166291|NCT01286077|530774871|FG000|Overall Study|Non-compliance|1|||
147166292|NCT01286077|530774872|FG001|Overall Study|Non-compliance|0|||
147166293|NCT01286077|530774871|FG000|Overall Study|The subject starts with alternative MMY|0|||
147166294|NCT01286077|530774872|FG001|Overall Study|The subject starts with alternative MMY|3|||
147166295|NCT01286077|530774871|FG000|Overall Study|Patient's decision to stop treatment|3|||
147166296|NCT01286077|530774872|FG001|Overall Study|Patient's decision to stop treatment|0|||
147166297|NCT01286077|530774871|FG000|Overall Study|Progression of disease|0|||
147166298|NCT01286077|530774872|FG001|Overall Study|Progression of disease|1|||
147166299|NCT01286077|530774871|FG000|Overall Study|refill medication not received in time|1|||
147166300|NCT01286077|530774872|FG001|Overall Study|refill medication not received in time|0|||
147166301|NCT01282294|530774875|FG000|Overall Study|Lost to Follow-up|14|||
147166302|NCT01282294|530774875|FG000|Overall Study|Screening failure|1|||
147166303|NCT01282294|530774875|FG000|Overall Study|Adverse Event|1|||
147166304|NCT01282294|530774875|FG000|Overall Study|Patient non-compliance|2|||
147166305|NCT01282294|530774875|FG000|Overall Study|Physician Decision|1|||
147166306|NCT02408523|530774876|FG000|Overall Study|Adverse Event|4|||
147166307|NCT02408523|530774877|FG001|Overall Study|Adverse Event|10|||
147166308|NCT02408523|530774876|FG000|Overall Study|Lack of Efficacy|0|||
147166309|NCT02408523|530774877|FG001|Overall Study|Lack of Efficacy|1|||
147166310|NCT02408523|530774876|FG000|Overall Study|Protocol Violation|1|||
147166311|NCT02408523|530774877|FG001|Overall Study|Protocol Violation|2|||
147166312|NCT02408523|530774876|FG000|Overall Study|Lost to Follow-up|2|||
147166313|NCT02408523|530774877|FG001|Overall Study|Lost to Follow-up|3|||
147166314|NCT02408523|530774876|FG000|Overall Study|Withdrawal by Subject|3|||
147166315|NCT02408523|530774877|FG001|Overall Study|Withdrawal by Subject|1|||
147166316|NCT02408523|530774876|FG000|Overall Study|Sponsor request|1|||
147166317|NCT02408523|530774877|FG001|Overall Study|Sponsor request|0|||
147166318|NCT02408523|530774876|FG000|Overall Study|Did not satisfy extension conditions|0|||
147166319|NCT02408523|530774877|FG001|Overall Study|Did not satisfy extension conditions|1|||
147166320|NCT04256512|530774878|FG000|Overall Study|Withdrawal by Subject|1|||
147166321|NCT02797184|530774887|FG000|Overall Study|Study was put on hold due to COVID-19. Could not finish these subjects before funding ran out.|18|||
147166322|NCT02797184|530774888|FG001|Overall Study|Study was put on hold due to COVID-19. Could not finish these subjects before funding ran out.|18|||
147166323|NCT03199391|530774893|FG000|Overall Study|Death|1|||
147166324|NCT03199391|530774893|FG000|Overall Study|Lost to Follow-up|3|||
147166325|NCT03199391|530774893|FG000|Overall Study|Adverse Event|2|||
147166326|NCT03199391|530774893|FG000|Overall Study|Withdrawal by Subject|10|||
147166327|NCT03921554|530774900|FG000|Overall Study|Adverse Event|2|||
147166328|NCT03921554|530774900|FG000|Overall Study|Withdrawal by Subject|1|||
147166329|NCT03921554|530774900|FG000|Overall Study|Death|3|||
147166330|NCT00431951|530774901|FG000|Overall Study|Inability to follow study procedures|1|||
147166331|NCT00431951|530774902|FG001|Overall Study|Inability to follow study procedures|0|||
147166332|NCT00431951|530774903|FG002|Overall Study|Inability to follow study procedures|1|||
147166333|NCT00431951|530774904|FG003|Overall Study|Inability to follow study procedures|2|||
147166334|NCT00431951|530774901|FG000|Overall Study|Lost to Follow-up|0|||
147166335|NCT00431951|530774902|FG001|Overall Study|Lost to Follow-up|1|||
147166336|NCT00431951|530774903|FG002|Overall Study|Lost to Follow-up|0|||
147166337|NCT00431951|530774904|FG003|Overall Study|Lost to Follow-up|0|||
147166338|NCT00431951|530774901|FG000|Overall Study|Withdrawal by Subject|0|||
147166339|NCT00431951|530774902|FG001|Overall Study|Withdrawal by Subject|1|||
147166340|NCT00431951|530774903|FG002|Overall Study|Withdrawal by Subject|0|||
147166341|NCT00431951|530774904|FG003|Overall Study|Withdrawal by Subject|0|||
147166342|NCT00431951|530774901|FG000|Overall Study|Adverse Event|0|||
147166343|NCT00431951|530774902|FG001|Overall Study|Adverse Event|0|||
147166344|NCT00431951|530774903|FG002|Overall Study|Adverse Event|1|||
147166345|NCT00431951|530774904|FG003|Overall Study|Adverse Event|0|||
147166346|NCT05824936|530774909|FG000|Overall Study|Lost to Follow-up|1|||
147166347|NCT00673881|530774910|FG000|Overall Study|Withdrawal by Subject|1|||
147166348|NCT00096018|530774911|FG000|Overall Study|Became Ineligible (not treated)|0|||
147166349|NCT00096018|530774912|FG001|Overall Study|Became Ineligible (not treated)|3|||
147166350|NCT00096018|530774911|FG000|Overall Study|Miscellaneous (not treated)|0|||
147166351|NCT00096018|530774912|FG001|Overall Study|Miscellaneous (not treated)|2|||
147166352|NCT00096018|530774911|FG000|Overall Study|Adverse Event|0|||
147166353|NCT00096018|530774912|FG001|Overall Study|Adverse Event|5|||
147166354|NCT00096018|530774911|FG000|Overall Study|Death|0|||
147166355|NCT00096018|530774912|FG001|Overall Study|Death|1|||
147590227|NCT02697773|532316271|FG002|Overall Study|Lost to Follow-up|7|||
147590228|NCT02697773|532316269|FG000|Overall Study|Other|15|||
147166356|NCT00096018|530774911|FG000|Overall Study|Withdrawal by Subject|0|||
147166357|NCT00096018|530774912|FG001|Overall Study|Withdrawal by Subject|2|||
147166358|NCT00096018|530774911|FG000|Overall Study|Miscellaneous|2|||
147166359|NCT00096018|530774912|FG001|Overall Study|Miscellaneous|1|||
147166360|NCT01299571|530774920|FG000|Overall Study|Protocol Violation|107|||
147166361|NCT00413010|530774921|FG000|Overall Study|Adverse Event|8|||
147166362|NCT00413010|530774922|FG001|Overall Study|Adverse Event|4|||
147166363|NCT00413010|530774921|FG000|Overall Study|Laboratory abnormality|0|||
147166364|NCT00413010|530774922|FG001|Overall Study|Laboratory abnormality|2|||
147166365|NCT00413010|530774921|FG000|Overall Study|Lack of Efficacy|0|||
147166366|NCT00413010|530774922|FG001|Overall Study|Lack of Efficacy|3|||
147166367|NCT00413010|530774921|FG000|Overall Study|Lost to Follow-up|3|||
147166368|NCT00413010|530774922|FG001|Overall Study|Lost to Follow-up|0|||
147166369|NCT00413010|530774921|FG000|Overall Study|Withdrawal by Subject|7|||
147166370|NCT00413010|530774922|FG001|Overall Study|Withdrawal by Subject|2|||
147166371|NCT00413010|530774921|FG000|Overall Study|Due to termination of the study|54|||
147447685|NCT00783094|531803937|FG001|Open-Label Extension Period|Death|0|||
147447686|NCT00783094|531803938|FG002|Open-Label Extension Period|Death|1|||
147166372|NCT00413010|530774922|FG001|Overall Study|Due to termination of the study|52|||
147166373|NCT00708734|530774923|FG000|Overall Study|scheduling conflict|2|||
147166374|NCT00708734|530774923|FG000|Overall Study|moved|1|||
147166375|NCT00708734|530774923|FG000|Overall Study|leg injury|1|||
147590229|NCT02697773|532316270|FG001|Overall Study|Other|11|||
147243672|NCT02820753|531065389|FG001|2 Month|Withdrawal by Subject|3|||
147243673|NCT02820753|531065388|FG000|2 Month|Lost to Follow-up|24|||
147447687|NCT00783094|531803936|FG000|Open-Label Extension Period|Protocol Violation|4|||
147447688|NCT00783094|531803937|FG001|Open-Label Extension Period|Protocol Violation|5|||
147166376|NCT00708734|530774923|FG000|Overall Study|knee replacement|1|||
147166377|NCT00708734|530774923|FG000|Overall Study|vertigo|1|||
147243674|NCT02820753|531065389|FG001|2 Month|Lost to Follow-up|26|||
147243675|NCT02820753|531065388|FG000|2 Month|Stopped per NIH Hold|51|||
147243676|NCT02820753|531065389|FG001|2 Month|Stopped per NIH Hold|13|||
147243677|NCT02820753|531065388|FG000|6 Month|Withdrawal by Subject|2|||
147243678|NCT02820753|531065389|FG001|6 Month|Withdrawal by Subject|2|||
147243679|NCT02820753|531065388|FG000|6 Month|Lost to Follow-up|20|||
147243680|NCT02820753|531065389|FG001|6 Month|Lost to Follow-up|27|||
147243681|NCT02820753|531065388|FG000|6 Month|Stopped per NIH Hold|81|||
147243682|NCT02820753|531065389|FG001|6 Month|Stopped per NIH Hold|81|||
147243683|NCT02820753|531065388|FG000|6 Month|Death|0|||
147243684|NCT02820753|531065389|FG001|6 Month|Death|1|||
147243685|NCT02161731|531065390|FG000|Period 2 (Day 7 Dosing to Day 23)|Withdrawal by Subject|0|||
147243686|NCT02161731|531065391|FG001|Period 2 (Day 7 Dosing to Day 23)|Withdrawal by Subject|1|||
147243687|NCT02161731|531065390|FG000|Period 2 (Day 7 Dosing to Day 23)|Adverse Event|0|||
147243688|NCT02161731|531065391|FG001|Period 2 (Day 7 Dosing to Day 23)|Adverse Event|1|||
147243689|NCT01315678|531065396|FG000|Overall Study|Withdrawal by Subject|7|||
147243690|NCT01315678|531065397|FG001|Overall Study|Withdrawal by Subject|3|||
147243691|NCT01315678|531065396|FG000|Overall Study|Adverse Event|3|||
147243692|NCT01315678|531065397|FG001|Overall Study|Adverse Event|1|||
147243693|NCT01315678|531065396|FG000|Overall Study|Lost to Follow-up|1|||
147166378|NCT00708734|530774923|FG000|Overall Study|leg fracture|1|||
147166379|NCT01533922|530774924|FG000|Overall Study|Adverse Event|5|||
147166380|NCT01533922|530774925|FG001|Overall Study|Adverse Event|8|||
147166381|NCT01533922|530774926|FG002|Overall Study|Adverse Event|6|||
147166382|NCT01533922|530774927|FG003|Overall Study|Adverse Event|3|||
147166383|NCT01533922|530774928|FG004|Overall Study|Adverse Event|4|||
147166384|NCT01533922|530774924|FG000|Overall Study|Lack of Efficacy|0|||
147166385|NCT01533922|530774925|FG001|Overall Study|Lack of Efficacy|0|||
147166386|NCT01533922|530774926|FG002|Overall Study|Lack of Efficacy|1|||
147166387|NCT01533922|530774927|FG003|Overall Study|Lack of Efficacy|0|||
147166388|NCT01533922|530774928|FG004|Overall Study|Lack of Efficacy|0|||
147166389|NCT01533922|530774924|FG000|Overall Study|Protocol Violation|0|||
147166390|NCT01533922|530774925|FG001|Overall Study|Protocol Violation|3|||
147166391|NCT01533922|530774926|FG002|Overall Study|Protocol Violation|0|||
147166392|NCT01533922|530774927|FG003|Overall Study|Protocol Violation|0|||
147166393|NCT01533922|530774928|FG004|Overall Study|Protocol Violation|1|||
147166394|NCT01533922|530774924|FG000|Overall Study|Withdrawal by Subject|3|||
147166395|NCT01533922|530774925|FG001|Overall Study|Withdrawal by Subject|1|||
147166396|NCT01533922|530774926|FG002|Overall Study|Withdrawal by Subject|2|||
147166397|NCT01533922|530774927|FG003|Overall Study|Withdrawal by Subject|2|||
147166398|NCT01533922|530774928|FG004|Overall Study|Withdrawal by Subject|1|||
147166399|NCT01533922|530774924|FG000|Overall Study|Other reason not defined above|2|||
147166400|NCT01533922|530774925|FG001|Overall Study|Other reason not defined above|0|||
147166401|NCT01533922|530774926|FG002|Overall Study|Other reason not defined above|1|||
147243694|NCT01315678|531065397|FG001|Overall Study|Lost to Follow-up|0|||
147243695|NCT01315678|531065396|FG000|Overall Study|similar reason to those listed above|3|||
147243696|NCT01315678|531065397|FG001|Overall Study|similar reason to those listed above|2|||
147166402|NCT01533922|530774927|FG003|Overall Study|Other reason not defined above|0|||
147166403|NCT01533922|530774928|FG004|Overall Study|Other reason not defined above|0|||
147166404|NCT05432167|530774929|FG000|Overall Study|Adverse Event|0|||
147243697|NCT00331682|531065401|FG000|Overall Study|Adverse Event|1|||
147243698|NCT02155608|531065402|FG000|1a: 4 Week Double Blind Sham Controlled|Lost to Follow-up|0|||
147243699|NCT02155608|531065403|FG001|1a: 4 Week Double Blind Sham Controlled|Lost to Follow-up|1|||
147243700|NCT02155608|531065402|FG000|1b: 1 Week Blinded Post Treatment|Lost to Follow-up|1|||
147243701|NCT02155608|531065403|FG001|1b: 1 Week Blinded Post Treatment|Lost to Follow-up|1|||
147243702|NCT02380677|531065404|FG000|Overall Study|Adverse Event|0|||
147243703|NCT02380677|531065405|FG001|Overall Study|Adverse Event|0|||
147243704|NCT02380677|531065406|FG002|Overall Study|Adverse Event|0|||
147243705|NCT02380677|531065407|FG003|Overall Study|Adverse Event|1|||
147243706|NCT02380677|531065408|FG004|Overall Study|Adverse Event|1|||
147243707|NCT02380677|531065409|FG005|Overall Study|Adverse Event|4|||
147243708|NCT02380677|531065410|FG006|Overall Study|Adverse Event|2|||
147243709|NCT02380677|531065411|FG007|Overall Study|Adverse Event|2|||
147243710|NCT02380677|531065412|FG008|Overall Study|Adverse Event|2|||
147243711|NCT02380677|531065413|FG009|Overall Study|Adverse Event|1|||
147243712|NCT02380677|531065414|FG010|Overall Study|Adverse Event|2|||
147243713|NCT02380677|531065415|FG011|Overall Study|Adverse Event|1|||
147243714|NCT02380677|531065404|FG000|Overall Study|Physician Decision|1|||
147447689|NCT00783094|531803938|FG002|Open-Label Extension Period|Protocol Violation|7|||
147447690|NCT00783094|531803936|FG000|Open-Label Extension Period|Withdrawal by Subject|1|||
147243715|NCT02380677|531065405|FG001|Overall Study|Physician Decision|0|||
147243716|NCT02380677|531065406|FG002|Overall Study|Physician Decision|1|||
147166405|NCT05432167|530774930|FG001|Overall Study|Adverse Event|2|||
147166406|NCT05432167|530774931|FG002|Overall Study|Adverse Event|1|||
147166407|NCT05432167|530774929|FG000|Overall Study|Lost to Follow-up|3|||
147166408|NCT05432167|530774930|FG001|Overall Study|Lost to Follow-up|3|||
147166409|NCT05432167|530774931|FG002|Overall Study|Lost to Follow-up|2|||
147166410|NCT05432167|530774929|FG000|Overall Study|Inclusion/exclusion criteria not met|1|||
147166411|NCT05432167|530774930|FG001|Overall Study|Inclusion/exclusion criteria not met|1|||
147166412|NCT05432167|530774931|FG002|Overall Study|Inclusion/exclusion criteria not met|0|||
147166413|NCT05432167|530774929|FG000|Overall Study|Physician Decision|1|||
147166414|NCT05432167|530774930|FG001|Overall Study|Physician Decision|0|||
147166415|NCT05432167|530774931|FG002|Overall Study|Physician Decision|0|||
147166416|NCT05432167|530774929|FG000|Overall Study|Withdrawal by Subject|7|||
147166417|NCT05432167|530774930|FG001|Overall Study|Withdrawal by Subject|4|||
147166418|NCT05432167|530774931|FG002|Overall Study|Withdrawal by Subject|11|||
147166419|NCT05432167|530774929|FG000|Overall Study|Other|0|||
147166420|NCT05432167|530774930|FG001|Overall Study|Other|0|||
147166421|NCT05432167|530774931|FG002|Overall Study|Other|1|||
147166422|NCT01267175|530774932|FG000|Overall Study|Withdrawal by Subject|1|||
147166423|NCT01267175|530774932|FG000|Overall Study|Lost to Follow-up|1|||
147166424|NCT02006069|530774933|FG000|Overall Study|MPP other programming|239|||
147166425|NCT02006069|530774934|FG001|Overall Study|MPP other programming|0|||
147166426|NCT02006069|530774933|FG000|Overall Study|RV only pacing|0|||
147166427|NCT02006069|530774934|FG001|Overall Study|RV only pacing|3|||
147166428|NCT02690649|530774937|FG000|Overall Study|Withdrawal by Subject|1|||
147166429|NCT02690649|530774938|FG001|Overall Study|Withdrawal by Subject|1|||
147166430|NCT02690649|530774937|FG000|Overall Study|Protocol Violation|0|||
147166431|NCT02690649|530774938|FG001|Overall Study|Protocol Violation|3|||
147166432|NCT02276547|530774939|FG000|Overall Study|Death|2|||
147166433|NCT02276547|530774939|FG000|Overall Study|Explant|2|||
147166434|NCT00530920|530774940|FG000|Overall Study|Randomized but not treated|0|||
147166435|NCT00530920|530774941|FG001|Overall Study|Randomized but not treated|2|||
147166436|NCT00530920|530774942|FG002|Overall Study|Randomized but not treated|0|||
147166437|NCT00530920|530774940|FG000|Overall Study|Adverse Event|0|||
147166438|NCT00530920|530774941|FG001|Overall Study|Adverse Event|0|||
147166439|NCT00530920|530774942|FG002|Overall Study|Adverse Event|3|||
147166440|NCT00530920|530774940|FG000|Overall Study|Withdrawal by Subject|0|||
147166441|NCT00530920|530774941|FG001|Overall Study|Withdrawal by Subject|0|||
147166442|NCT00530920|530774942|FG002|Overall Study|Withdrawal by Subject|1|||
147166443|NCT00316888|530774947|FG000|Overall Study|Adverse Event|4|||
147166444|NCT00316888|530774948|FG001|Overall Study|Adverse Event|5|||
147166445|NCT00316888|530774947|FG000|Overall Study|Withdrawal by Subject|2|||
147166446|NCT00316888|530774948|FG001|Overall Study|Withdrawal by Subject|2|||
147166447|NCT00316888|530774947|FG000|Overall Study|Not start protocol therapy|0|||
147243717|NCT02380677|531065407|FG003|Overall Study|Physician Decision|1|||
147243718|NCT02380677|531065408|FG004|Overall Study|Physician Decision|0|||
147243719|NCT02380677|531065409|FG005|Overall Study|Physician Decision|0|||
147243720|NCT02380677|531065410|FG006|Overall Study|Physician Decision|0|||
147243721|NCT02380677|531065411|FG007|Overall Study|Physician Decision|0|||
147243722|NCT02380677|531065412|FG008|Overall Study|Physician Decision|0|||
147243723|NCT02380677|531065413|FG009|Overall Study|Physician Decision|0|||
147243724|NCT02380677|531065414|FG010|Overall Study|Physician Decision|0|||
147243725|NCT02380677|531065415|FG011|Overall Study|Physician Decision|0|||
147243726|NCT02380677|531065404|FG000|Overall Study|Lack of Efficacy|0|||
147243727|NCT02380677|531065405|FG001|Overall Study|Lack of Efficacy|1|||
147243728|NCT02380677|531065406|FG002|Overall Study|Lack of Efficacy|2|||
147243729|NCT02380677|531065407|FG003|Overall Study|Lack of Efficacy|0|||
147243730|NCT02380677|531065408|FG004|Overall Study|Lack of Efficacy|4|||
147243731|NCT02380677|531065409|FG005|Overall Study|Lack of Efficacy|1|||
147243732|NCT02380677|531065410|FG006|Overall Study|Lack of Efficacy|1|||
147243733|NCT02380677|531065411|FG007|Overall Study|Lack of Efficacy|2|||
147243734|NCT02380677|531065412|FG008|Overall Study|Lack of Efficacy|2|||
147243735|NCT02380677|531065413|FG009|Overall Study|Lack of Efficacy|0|||
147166448|NCT00316888|530774948|FG001|Overall Study|Not start protocol therapy|1|||
147243736|NCT02380677|531065414|FG010|Overall Study|Lack of Efficacy|2|||
147243737|NCT02380677|531065415|FG011|Overall Study|Lack of Efficacy|1|||
147243738|NCT02380677|531065404|FG000|Overall Study|Withdrawal by Subject|0|||
147243739|NCT02380677|531065405|FG001|Overall Study|Withdrawal by Subject|0|||
147243740|NCT02380677|531065406|FG002|Overall Study|Withdrawal by Subject|0|||
147166449|NCT01672866|530774952|FG000|Blinded Phase (up to 240 Weeks)|Study Terminated by Sponsor|40|||
147166450|NCT01672866|530774953|FG001|Blinded Phase (up to 240 Weeks)|Study Terminated by Sponsor|42|||
147166451|NCT01672866|530774954|FG002|Blinded Phase (up to 240 Weeks)|Study Terminated by Sponsor|35|||
147166452|NCT01672866|530774952|FG000|Blinded Phase (up to 240 Weeks)|Withdrew Consent|9|||
147166453|NCT01672866|530774953|FG001|Blinded Phase (up to 240 Weeks)|Withdrew Consent|8|||
147166454|NCT01672866|530774954|FG002|Blinded Phase (up to 240 Weeks)|Withdrew Consent|12|||
147243741|NCT02380677|531065407|FG003|Overall Study|Withdrawal by Subject|0|||
147243742|NCT02380677|531065408|FG004|Overall Study|Withdrawal by Subject|0|||
147243743|NCT02380677|531065409|FG005|Overall Study|Withdrawal by Subject|0|||
147590230|NCT02697773|532316271|FG002|Overall Study|Other|10|||
147166455|NCT01672866|530774952|FG000|Blinded Phase (up to 240 Weeks)|Lost to Follow-up|3|||
147166456|NCT01672866|530774953|FG001|Blinded Phase (up to 240 Weeks)|Lost to Follow-up|3|||
147166457|NCT01672866|530774954|FG002|Blinded Phase (up to 240 Weeks)|Lost to Follow-up|5|||
147166458|NCT01672866|530774952|FG000|Blinded Phase (up to 240 Weeks)|Adverse Event|3|||
147166459|NCT01672866|530774953|FG001|Blinded Phase (up to 240 Weeks)|Adverse Event|3|||
147166460|NCT01672866|530774954|FG002|Blinded Phase (up to 240 Weeks)|Adverse Event|3|||
147166461|NCT01672866|530774952|FG000|Blinded Phase (up to 240 Weeks)|Investigator's Discretion|3|||
147166462|NCT01672866|530774953|FG001|Blinded Phase (up to 240 Weeks)|Investigator's Discretion|3|||
147166463|NCT01672866|530774954|FG002|Blinded Phase (up to 240 Weeks)|Investigator's Discretion|2|||
147166464|NCT01672866|530774952|FG000|Blinded Phase (up to 240 Weeks)|Protocol Violation|2|||
147166465|NCT01672866|530774953|FG001|Blinded Phase (up to 240 Weeks)|Protocol Violation|0|||
147166466|NCT01672866|530774954|FG002|Blinded Phase (up to 240 Weeks)|Protocol Violation|0|||
147166467|NCT01672866|530774952|FG000|Blinded Phase (up to 240 Weeks)|Death|0|||
147166468|NCT01672866|530774953|FG001|Blinded Phase (up to 240 Weeks)|Death|0|||
147166469|NCT01672866|530774954|FG002|Blinded Phase (up to 240 Weeks)|Death|1|||
147166470|NCT01672866|530774952|FG000|Blinded Phase (up to 240 Weeks)|Randomized but Never Treated|3|||
147166471|NCT01672866|530774953|FG001|Blinded Phase (up to 240 Weeks)|Randomized but Never Treated|0|||
147166472|NCT01672866|530774954|FG002|Blinded Phase (up to 240 Weeks)|Randomized but Never Treated|0|||
147166473|NCT01672866|530774952|FG000|Blinded Phase (up to 240 Weeks)|Met protocol-specified reason(s)|11|||
147166474|NCT01672866|530774953|FG001|Blinded Phase (up to 240 Weeks)|Met protocol-specified reason(s)|15|||
147166475|NCT01672866|530774954|FG002|Blinded Phase (up to 240 Weeks)|Met protocol-specified reason(s)|16|||
147166476|NCT01672866|530774952|FG000|Open-Label Phase (up to 240 Weeks)|Study Terminated by Sponsor|8|||
147166477|NCT01672866|530774953|FG001|Open-Label Phase (up to 240 Weeks)|Study Terminated by Sponsor|15|||
147166478|NCT01672866|530774954|FG002|Open-Label Phase (up to 240 Weeks)|Study Terminated by Sponsor|15|||
147166479|NCT01672866|530774952|FG000|Open-Label Phase (up to 240 Weeks)|Withdrew Consent|1|||
147166480|NCT01672866|530774953|FG001|Open-Label Phase (up to 240 Weeks)|Withdrew Consent|0|||
147166481|NCT01672866|530774954|FG002|Open-Label Phase (up to 240 Weeks)|Withdrew Consent|1|||
147166482|NCT01672866|530774952|FG000|Open-Label Phase (up to 240 Weeks)|Death|1|||
147166483|NCT01672866|530774953|FG001|Open-Label Phase (up to 240 Weeks)|Death|0|||
147166484|NCT01672866|530774954|FG002|Open-Label Phase (up to 240 Weeks)|Death|0|||
147166485|NCT01672866|530774952|FG000|Open-Label Phase (up to 240 Weeks)|Lost to Follow-up|1|||
147166486|NCT01672866|530774953|FG001|Open-Label Phase (up to 240 Weeks)|Lost to Follow-up|0|||
147166487|NCT01672866|530774954|FG002|Open-Label Phase (up to 240 Weeks)|Lost to Follow-up|0|||
147166488|NCT02273960|530774955|FG000|Short Term Period|Lost to Follow-up|1|||
147166489|NCT02273960|530774956|FG001|Short Term Period|Lost to Follow-up|0|||
147166490|NCT02273960|530774957|FG002|Short Term Period|Lost to Follow-up|0|||
147166491|NCT02273960|530774958|FG003|Short Term Period|Lost to Follow-up|0|||
147166492|NCT02273960|530774955|FG000|Short Term Period|Lack of Efficacy|0|||
147166493|NCT02273960|530774956|FG001|Short Term Period|Lack of Efficacy|0|||
147166494|NCT02273960|530774957|FG002|Short Term Period|Lack of Efficacy|0|||
147166495|NCT02273960|530774958|FG003|Short Term Period|Lack of Efficacy|1|||
147166496|NCT02273960|530774955|FG000|Short Term Period|ST complete, not entering LTE|4|||
147166497|NCT02273960|530774956|FG001|Short Term Period|ST complete, not entering LTE|6|||
147166498|NCT02273960|530774957|FG002|Short Term Period|ST complete, not entering LTE|4|||
147166499|NCT02273960|530774958|FG003|Short Term Period|ST complete, not entering LTE|5|||
147166500|NCT02273960|530774955|FG000|Long Term Extension|Death|0|||
147166501|NCT02273960|530774956|FG001|Long Term Extension|Death|0|||
147166502|NCT02273960|530774957|FG002|Long Term Extension|Death|0|||
147166503|NCT02273960|530774958|FG003|Long Term Extension|Death|1|||
147166504|NCT01789606|530774959|FG000|Overall Study|Participant not Purchased the Product|0|||
147166505|NCT01789606|530774960|FG001|Overall Study|Participant not Purchased the Product|20|||
147166506|NCT01789606|530774959|FG000|Overall Study|Withdrawal by Subject|0|||
147166507|NCT01789606|530774960|FG001|Overall Study|Withdrawal by Subject|1|||
147166508|NCT01789606|530774959|FG000|Overall Study|Ineligible|6|||
147166509|NCT01789606|530774960|FG001|Overall Study|Ineligible|2|||
147166510|NCT01789606|530774959|FG000|Overall Study|Administrative Reasons|17|||
147166511|NCT01789606|530774960|FG001|Overall Study|Administrative Reasons|6|||
147166512|NCT01789606|530774959|FG000|Overall Study|No Study Medication Taken|0|||
147166513|NCT01789606|530774960|FG001|Overall Study|No Study Medication Taken|1|||
147166514|NCT01789606|530774959|FG000|Overall Study|Protocol Violation|0|||
147590231|NCT02697773|532316269|FG000|Overall Study|Protocol Violation|1|||
147590232|NCT02697773|532316270|FG001|Overall Study|Protocol Violation|1|||
147166515|NCT01789606|530774960|FG001|Overall Study|Protocol Violation|55|||
147166516|NCT01789606|530774959|FG000|Overall Study|Adverse Event|0|||
147166517|NCT01789606|530774960|FG001|Overall Study|Adverse Event|3|||
147166518|NCT01789606|530774959|FG000|Overall Study|Lost to Follow-up|0|||
147166519|NCT01789606|530774960|FG001|Overall Study|Lost to Follow-up|14|||
147166520|NCT01789606|530774959|FG000|Overall Study|Ineligible or not Willing to Continue|0|||
147166521|NCT01789606|530774960|FG001|Overall Study|Ineligible or not Willing to Continue|348|||
147166522|NCT01105377|530774961|FG000|Overall Study|Withdrawal by Subject|0|||
147447691|NCT00783094|531803937|FG001|Open-Label Extension Period|Withdrawal by Subject|1|||
147590233|NCT02697773|532316271|FG002|Overall Study|Protocol Violation|0|||
147590234|NCT02697773|532316269|FG000|Overall Study|Withdrawal by Subject|10|||
147590235|NCT02697773|532316270|FG001|Overall Study|Withdrawal by Subject|13|||
147590236|NCT02697773|532316271|FG002|Overall Study|Withdrawal by Subject|13|||
147590237|NCT02697773|532316269|FG000|Overall Study|Randomized but not treated|1|||
147590238|NCT02697773|532316270|FG001|Overall Study|Randomized but not treated|1|||
147590239|NCT02697773|532316271|FG002|Overall Study|Randomized but not treated|0|||
147166523|NCT01105377|530774962|FG001|Overall Study|Withdrawal by Subject|1|||
147166524|NCT01825941|530776369|FG000|Overall Study|Lost to Follow-up|4|||
147166525|NCT01825941|530776370|FG001|Overall Study|Lost to Follow-up|1|||
147166526|NCT03495102|530776371|FG000|Overall Study|Adverse Event|5|||
147166527|NCT03495102|530776372|FG001|Overall Study|Adverse Event|7|||
147590240|NCT00613834|532316272|FG000|Overall Study|Withdrawal by Subject|0|||
147590241|NCT00613834|532316273|FG001|Overall Study|Withdrawal by Subject|3|||
147166528|NCT03495102|530776373|FG002|Overall Study|Adverse Event|10|||
147166529|NCT03495102|530776371|FG000|Overall Study|Death|3|||
147166530|NCT03495102|530776372|FG001|Overall Study|Death|4|||
147166531|NCT03495102|530776373|FG002|Overall Study|Death|4|||
147166532|NCT03495102|530776371|FG000|Overall Study|Lost to Follow-up|15|||
147166533|NCT03495102|530776372|FG001|Overall Study|Lost to Follow-up|16|||
147166534|NCT03495102|530776373|FG002|Overall Study|Lost to Follow-up|17|||
147166535|NCT03495102|530776371|FG000|Overall Study|Physician Decision|2|||
147166536|NCT03495102|530776372|FG001|Overall Study|Physician Decision|0|||
147166537|NCT03495102|530776373|FG002|Overall Study|Physician Decision|2|||
147166538|NCT03495102|530776371|FG000|Overall Study|Withdrawal by Subject|25|||
147166539|NCT03495102|530776372|FG001|Overall Study|Withdrawal by Subject|36|||
147166540|NCT03495102|530776373|FG002|Overall Study|Withdrawal by Subject|18|||
147166541|NCT03495102|530776371|FG000|Overall Study|Protocol Violation|1|||
147166542|NCT03495102|530776372|FG001|Overall Study|Protocol Violation|1|||
147166543|NCT03495102|530776373|FG002|Overall Study|Protocol Violation|0|||
147166544|NCT03495102|530776371|FG000|Overall Study|Site Closure|3|||
147166545|NCT03495102|530776372|FG001|Overall Study|Site Closure|1|||
147166546|NCT03495102|530776373|FG002|Overall Study|Site Closure|2|||
147166547|NCT03495102|530776371|FG000|Overall Study|Non-compliance|1|||
147166548|NCT03495102|530776372|FG001|Overall Study|Non-compliance|0|||
147166549|NCT03495102|530776373|FG002|Overall Study|Non-compliance|0|||
147166550|NCT03495102|530776371|FG000|Overall Study|Participant Duplicated at Another Site|0|||
147166551|NCT03495102|530776372|FG001|Overall Study|Participant Duplicated at Another Site|0|||
147166552|NCT03495102|530776373|FG002|Overall Study|Participant Duplicated at Another Site|1|||
147166553|NCT03495102|530776371|FG000|Overall Study|Primary Care Physician Recommendation|0|||
147166554|NCT03495102|530776372|FG001|Overall Study|Primary Care Physician Recommendation|1|||
147166555|NCT03495102|530776373|FG002|Overall Study|Primary Care Physician Recommendation|0|||
147166556|NCT03495102|530776371|FG000|Overall Study|Relocated to Another Country|0|||
147166557|NCT03495102|530776372|FG001|Overall Study|Relocated to Another Country|1|||
147166558|NCT03495102|530776373|FG002|Overall Study|Relocated to Another Country|0|||
147166559|NCT03495102|530776371|FG000|Overall Study|Participant was in Rehabilitation|1|||
147166560|NCT03495102|530776372|FG001|Overall Study|Participant was in Rehabilitation|0|||
147166561|NCT03495102|530776373|FG002|Overall Study|Participant was in Rehabilitation|0|||
147166562|NCT01161537|530776374|FG000|Part B|Withdrawal by Subject|2|||
147166563|NCT00358436|530776377|FG000|Overall Study|Adverse Event|29|||
147166564|NCT00358436|530776378|FG001|Overall Study|Adverse Event|13|||
147166565|NCT00358436|530776377|FG000|Overall Study|Lack of Efficacy|34|||
147166566|NCT00358436|530776378|FG001|Overall Study|Lack of Efficacy|36|||
147166567|NCT00358436|530776377|FG000|Overall Study|Lost to Follow-up|11|||
147166568|NCT00358436|530776378|FG001|Overall Study|Lost to Follow-up|6|||
147166569|NCT00358436|530776377|FG000|Overall Study|Protocol Violation|8|||
147166570|NCT00358436|530776378|FG001|Overall Study|Protocol Violation|3|||
147243744|NCT02380677|531065410|FG006|Overall Study|Withdrawal by Subject|0|||
147243745|NCT02380677|531065411|FG007|Overall Study|Withdrawal by Subject|0|||
147243746|NCT02380677|531065412|FG008|Overall Study|Withdrawal by Subject|0|||
147243747|NCT02380677|531065413|FG009|Overall Study|Withdrawal by Subject|1|||
147243748|NCT02380677|531065414|FG010|Overall Study|Withdrawal by Subject|0|||
147243749|NCT02380677|531065415|FG011|Overall Study|Withdrawal by Subject|3|||
147243750|NCT02380677|531065404|FG000|Overall Study|Other|0|||
147243751|NCT02380677|531065405|FG001|Overall Study|Other|0|||
147243752|NCT02380677|531065406|FG002|Overall Study|Other|0|||
147243753|NCT02380677|531065407|FG003|Overall Study|Other|1|||
147243754|NCT02380677|531065408|FG004|Overall Study|Other|1|||
147447692|NCT00783094|531803938|FG002|Open-Label Extension Period|Withdrawal by Subject|3|||
147447693|NCT00783094|531803936|FG000|Open-Label Extension Period|Physician Decision|4|||
147654579|NCT02427802|532556778|FG002|Overall Study|Adverse Event|7|||
147166571|NCT00358436|530776377|FG000|Overall Study|Withdrawal by Subject|40|||
147166572|NCT00358436|530776378|FG001|Overall Study|Withdrawal by Subject|17|||
147166573|NCT00358436|530776377|FG000|Overall Study|Non-fulfilment of inclusion/exclusion|4|||
147166574|NCT00358436|530776378|FG001|Overall Study|Non-fulfilment of inclusion/exclusion|0|||
147243755|NCT02380677|531065409|FG005|Overall Study|Other|1|||
147243756|NCT02380677|531065410|FG006|Overall Study|Other|0|||
147243757|NCT02380677|531065411|FG007|Overall Study|Other|0|||
147166575|NCT00358436|530776377|FG000|Overall Study|COPD exacerbation|22|||
147166576|NCT00358436|530776378|FG001|Overall Study|COPD exacerbation|10|||
147166577|NCT00358436|530776377|FG000|Overall Study|Other|6|||
147166578|NCT00358436|530776378|FG001|Overall Study|Other|1|||
147166579|NCT03938324|530776380|FG000|Overall Study|Lost to Follow-up|42|||
147166580|NCT03938324|530776381|FG001|Overall Study|Lost to Follow-up|21|||
147166581|NCT03938324|530776380|FG000|Overall Study|Withdrawal by Subject|6|||
147166582|NCT03938324|530776381|FG001|Overall Study|Withdrawal by Subject|1|||
147166583|NCT01300351|530776386|FG000|Overall Study|Did not receive treatment|2|||
147166584|NCT01300351|530776387|FG001|Overall Study|Did not receive treatment|0|||
147166585|NCT01300351|530776386|FG000|Overall Study|Ongoing treatment at data cut-off|27|||
147166586|NCT01300351|530776387|FG001|Overall Study|Ongoing treatment at data cut-off|23|||
147166587|NCT01300351|530776386|FG000|Overall Study|Lost to Follow-up|0|||
147166588|NCT01300351|530776387|FG001|Overall Study|Lost to Follow-up|1|||
147166589|NCT01300351|530776386|FG000|Overall Study|Adverse Event|0|||
147166590|NCT01300351|530776387|FG001|Overall Study|Adverse Event|4|||
147166591|NCT01300351|530776386|FG000|Overall Study|Withdrawal by Subject|7|||
147166592|NCT01300351|530776387|FG001|Overall Study|Withdrawal by Subject|10|||
147166593|NCT02258529|530776391|FG000|Overall Study|Study Terminated by Sponsor|9|||
147166594|NCT02258529|530776391|FG000|Overall Study|Adverse Event|1|||
147166595|NCT00443781|530776392|FG000|Overall Study|Lost to Follow-up|10|||
147166596|NCT00443781|530776392|FG000|Overall Study|Physician Decision|2|||
147166597|NCT00443781|530776392|FG000|Overall Study|Protocol Violation|1|||
147166598|NCT00443781|530776392|FG000|Overall Study|Withdrawal by Subject|6|||
147166599|NCT00443781|530776392|FG000|Overall Study|Unable to comply with study follow up|2|||
147166600|NCT00443781|530776392|FG000|Overall Study|Investigator terminated participation|1|||
147166601|NCT00443781|530776392|FG000|Overall Study|Insurance not covered|2|||
147166602|NCT00443781|530776392|FG000|Overall Study|PD/FAD not done|1|||
147166603|NCT00430937|530776393|FG000|Overall Study|Adverse Event|3|||
147166604|NCT00430937|530776394|FG001|Overall Study|Adverse Event|8|||
147166605|NCT00430937|530776393|FG000|Overall Study|Death|0|||
147166606|NCT00430937|530776394|FG001|Overall Study|Death|1|||
147166607|NCT00430937|530776393|FG000|Overall Study|Lost to Follow-up|6|||
147166608|NCT00430937|530776394|FG001|Overall Study|Lost to Follow-up|6|||
147166609|NCT00430937|530776393|FG000|Overall Study|Withdrawal by Subject|5|||
147166610|NCT00430937|530776394|FG001|Overall Study|Withdrawal by Subject|2|||
147166611|NCT00430937|530776393|FG000|Overall Study|Protocol Violation|3|||
147166612|NCT00430937|530776394|FG001|Overall Study|Protocol Violation|2|||
147166613|NCT00430937|530776393|FG000|Overall Study|Lack of Efficacy|6|||
147166614|NCT00430937|530776394|FG001|Overall Study|Lack of Efficacy|5|||
147166615|NCT00430937|530776393|FG000|Overall Study|Inappropriate enrollment|2|||
147166616|NCT00430937|530776394|FG001|Overall Study|Inappropriate enrollment|1|||
147166617|NCT00430937|530776393|FG000|Overall Study|Administrative reasons|1|||
147166618|NCT00430937|530776394|FG001|Overall Study|Administrative reasons|0|||
147243758|NCT02380677|531065412|FG008|Overall Study|Other|0|||
147243759|NCT02380677|531065413|FG009|Overall Study|Other|0|||
147243760|NCT02380677|531065414|FG010|Overall Study|Other|0|||
147243761|NCT02380677|531065415|FG011|Overall Study|Other|0|||
147243762|NCT02599129|531065421|FG000|Overall Study|Lack of Efficacy|2|||
147243763|NCT02599129|531065422|FG001|Overall Study|Lack of Efficacy|2|||
147243764|NCT02599129|531065421|FG000|Overall Study|Lost to Follow-up|1|||
147243765|NCT02599129|531065422|FG001|Overall Study|Lost to Follow-up|0|||
147243766|NCT02599129|531065421|FG000|Overall Study|Withdrawal by Subject|2|||
147243767|NCT02599129|531065422|FG001|Overall Study|Withdrawal by Subject|1|||
147243768|NCT01029795|531065429|FG000|Overall Study|Entry Criteria Not Met|2|||
147243769|NCT01029795|531065430|FG001|Overall Study|Entry Criteria Not Met|1|||
147243770|NCT01029795|531065429|FG000|Overall Study|Physician Decision|2|||
147243771|NCT01029795|531065430|FG001|Overall Study|Physician Decision|1|||
147243772|NCT01029795|531065429|FG000|Overall Study|Sponsor Decision|11|||
147243773|NCT01029795|531065430|FG001|Overall Study|Sponsor Decision|17|||
147243774|NCT01029795|531065429|FG000|Overall Study|Withdrawal by Subject|1|||
147243775|NCT01029795|531065430|FG001|Overall Study|Withdrawal by Subject|3|||
147243776|NCT03217175|531065431|FG000|Overall Study|Physician Decision|4|||
147243777|NCT03217175|531065432|FG001|Overall Study|Physician Decision|1|||
147243778|NCT05035550|531065440|FG000|Overall Study|Withdrawal by Subject|3|||
147243779|NCT05035550|531065441|FG001|Overall Study|Withdrawal by Subject|0|||
147243780|NCT01806545|531065442|FG000|Overall Study|Adverse Event|2|||
147243781|NCT01806545|531065443|FG001|Overall Study|Adverse Event|3|||
147166619|NCT00430937|530776393|FG000|Overall Study|Protocol discontinuation criteria met|1|||
147166620|NCT00430937|530776394|FG001|Overall Study|Protocol discontinuation criteria met|2|||
147243782|NCT01806545|531065442|FG000|Overall Study|Lost to Follow-up|1|||
147243783|NCT01806545|531065443|FG001|Overall Study|Lost to Follow-up|0|||
147166621|NCT00430937|530776393|FG000|Overall Study|Unable to classify|0|||
147166622|NCT00430937|530776394|FG001|Overall Study|Unable to classify|1|||
147166623|NCT02634606|530776395|FG000|Overall Study|unable to obtain the drug at start|13|||
147166624|NCT00353873|530776398|FG000|Overall Study|Protocol Violation|1|||
147166625|NCT00353873|530776399|FG001|Overall Study|Protocol Violation|2|||
147243784|NCT01806545|531065442|FG000|Overall Study|Withdrawal by Subject|3|||
147590242|NCT00842530|532316274|FG000|Overall Study|Serious adverse event|0|||
147590243|NCT00842530|532316275|FG001|Overall Study|Serious adverse event|6|||
147590244|NCT00842530|532316274|FG000|Overall Study|Other adverse event|6|||
147590245|NCT00842530|532316275|FG001|Overall Study|Other adverse event|1|||
147590246|NCT00842530|532316274|FG000|Overall Study|Protocol Violation|32|||
147590247|NCT00842530|532316275|FG001|Overall Study|Protocol Violation|14|||
147590248|NCT00842530|532316274|FG000|Overall Study|Lost to Follow-up|6|||
147166626|NCT00353873|530776398|FG000|Overall Study|Exacerbation|1|||
147590249|NCT00842530|532316275|FG001|Overall Study|Lost to Follow-up|8|||
147590250|NCT00842530|532316274|FG000|Overall Study|Withdrawal by Subject|73|||
147166627|NCT00353873|530776399|FG001|Overall Study|Exacerbation|0|||
147166628|NCT00353873|530776398|FG000|Overall Study|Adverse Event|1|||
147166629|NCT00353873|530776399|FG001|Overall Study|Adverse Event|0|||
147166630|NCT00353873|530776398|FG000|Overall Study|Physician Decision|2|||
147166631|NCT00353873|530776399|FG001|Overall Study|Physician Decision|0|||
147166632|NCT00353873|530776398|FG000|Overall Study|Withdrawal by Subject|1|||
147166633|NCT00353873|530776399|FG001|Overall Study|Withdrawal by Subject|1|||
147166634|NCT03743064|530776400|FG000|Overall Study|Adverse Event|7|||
147166635|NCT03743064|530776401|FG001|Overall Study|Adverse Event|9|||
147166636|NCT03743064|530776400|FG000|Overall Study|Death|25|||
147166637|NCT03743064|530776401|FG001|Overall Study|Death|28|||
147166638|NCT03743064|530776400|FG000|Overall Study|Lost to Follow-up|3|||
147166639|NCT03743064|530776401|FG001|Overall Study|Lost to Follow-up|6|||
147166640|NCT03743064|530776400|FG000|Overall Study|Withdrawal by Subject|28|||
147166641|NCT03743064|530776401|FG001|Overall Study|Withdrawal by Subject|25|||
147166642|NCT03743064|530776400|FG000|Overall Study|Physician Decision|2|||
147166643|NCT03743064|530776401|FG001|Overall Study|Physician Decision|4|||
147166644|NCT03743064|530776400|FG000|Overall Study|"Reported as Other in Clinical Study Report"|6|||
147166645|NCT03743064|530776401|FG001|Overall Study|"Reported as Other in Clinical Study Report"|2|||
147166646|NCT00286221|530776402|FG000|Overall Study|Protocol Violation|2|||
147166647|NCT00286221|530776403|FG001|Overall Study|Protocol Violation|1|||
147166648|NCT00286221|530776404|FG002|Overall Study|Protocol Violation|6|||
147166649|NCT00286221|530776405|FG003|Overall Study|Protocol Violation|4|||
147166650|NCT00286221|530776402|FG000|Overall Study|Unanticipated Neurosurgical Complication|6|||
147166651|NCT00286221|530776403|FG001|Overall Study|Unanticipated Neurosurgical Complication|3|||
147166652|NCT00286221|530776404|FG002|Overall Study|Unanticipated Neurosurgical Complication|3|||
147166653|NCT00286221|530776405|FG003|Overall Study|Unanticipated Neurosurgical Complication|2|||
147166654|NCT00286221|530776402|FG000|Overall Study|Inability to trigger PCA|2|||
147166655|NCT00286221|530776403|FG001|Overall Study|Inability to trigger PCA|0|||
147166656|NCT00286221|530776404|FG002|Overall Study|Inability to trigger PCA|0|||
147166657|NCT00286221|530776405|FG003|Overall Study|Inability to trigger PCA|0|||
147166658|NCT00286221|530776402|FG000|Overall Study|Unrecognized exclusion criteria met|0|||
147166659|NCT00286221|530776403|FG001|Overall Study|Unrecognized exclusion criteria met|1|||
147166660|NCT00286221|530776404|FG002|Overall Study|Unrecognized exclusion criteria met|0|||
147166661|NCT00286221|530776405|FG003|Overall Study|Unrecognized exclusion criteria met|0|||
147166662|NCT02553538|530776411|FG000|Overall Study|Could Not Reach by Telephone|133|||
147166663|NCT02553538|530776412|FG001|Overall Study|Could Not Reach by Telephone|0|||
147166664|NCT02553538|530776411|FG000|Overall Study|Died or Left Network|54|||
147166665|NCT02553538|530776412|FG001|Overall Study|Died or Left Network|56|||
147166666|NCT02648217|530776413|FG000|Overall Study|Adverse Event|0|||
147166667|NCT02648217|530776414|FG001|Overall Study|Adverse Event|1|||
147166668|NCT02648217|530776413|FG000|Overall Study|Lost to Follow-up|1|||
147166669|NCT02648217|530776414|FG001|Overall Study|Lost to Follow-up|1|||
147166670|NCT02648217|530776413|FG000|Overall Study|Withdrawal by Subject|4|||
147166671|NCT02648217|530776414|FG001|Overall Study|Withdrawal by Subject|3|||
147166672|NCT02648217|530776413|FG000|Overall Study|Unclassified|5|||
147166673|NCT02648217|530776414|FG001|Overall Study|Unclassified|0|||
147166674|NCT00106691|530776415|FG000|Overall Study|Adverse Event|60|||
147166675|NCT00106691|530776416|FG001|Overall Study|Adverse Event|64|||
147166676|NCT00106691|530776415|FG000|Overall Study|Lost to Follow-up|23|||
147166677|NCT00106691|530776416|FG001|Overall Study|Lost to Follow-up|18|||
147166678|NCT00106691|530776415|FG000|Overall Study|Physician Decision|18|||
147590251|NCT00842530|532316275|FG001|Overall Study|Withdrawal by Subject|28|||
147166679|NCT00106691|530776416|FG001|Overall Study|Physician Decision|21|||
147166680|NCT00106691|530776415|FG000|Overall Study|Protocol Violation|13|||
147166681|NCT00106691|530776416|FG001|Overall Study|Protocol Violation|18|||
147166682|NCT00106691|530776415|FG000|Overall Study|Withdrawal by Subject|75|||
147166683|NCT00106691|530776416|FG001|Overall Study|Withdrawal by Subject|70|||
147166684|NCT00106691|530776415|FG000|Overall Study|Failure to comply w/dosing regimen|6|||
147166685|NCT00106691|530776416|FG001|Overall Study|Failure to comply w/dosing regimen|4|||
147166686|NCT00106691|530776415|FG000|Overall Study|QTc>480|3|||
147166687|NCT00106691|530776416|FG001|Overall Study|QTc>480|1|||
147166688|NCT00106691|530776415|FG000|Overall Study|mililtary deployment|2|||
147166689|NCT00106691|530776416|FG001|Overall Study|mililtary deployment|0|||
147166690|NCT00106691|530776415|FG000|Overall Study|Study Site Closing/PI Moved|1|||
147166691|NCT00106691|530776416|FG001|Overall Study|Study Site Closing/PI Moved|2|||
147590252|NCT02939950|532316276|FG000|Overall Study|Lost to Follow-up|13|||
147166692|NCT00106691|530776415|FG000|Overall Study|Cardiologist recommendation|1|||
147166693|NCT00106691|530776416|FG001|Overall Study|Cardiologist recommendation|0|||
147166694|NCT00106691|530776415|FG000|Overall Study|Pt. moved to another state|1|||
147166695|NCT00106691|530776416|FG001|Overall Study|Pt. moved to another state|0|||
147166696|NCT00106691|530776415|FG000|Overall Study|Taking exclusionary avodart|1|||
147166697|NCT00106691|530776416|FG001|Overall Study|Taking exclusionary avodart|0|||
147590253|NCT02939950|532316277|FG001|Overall Study|Lost to Follow-up|16|||
147590254|NCT02939950|532316276|FG000|Overall Study|Positive slit lamp findings|0|||
147590255|NCT02939950|532316277|FG001|Overall Study|Positive slit lamp findings|1|||
147590256|NCT02939950|532316276|FG000|Overall Study|Chalazion upper lid|0|||
147590257|NCT02939950|532316277|FG001|Overall Study|Chalazion upper lid|1|||
147590258|NCT02939950|532316276|FG000|Overall Study|Lack of motivation|0|||
147590259|NCT02939950|532316277|FG001|Overall Study|Lack of motivation|2|||
147590260|NCT02939950|532316276|FG000|Overall Study|Unacceptable distance lens visual acuity|1|||
147590261|NCT02939950|532316277|FG001|Overall Study|Unacceptable distance lens visual acuity|1|||
147590262|NCT02939950|532316276|FG000|Overall Study|Military orders|1|||
147590263|NCT02939950|532316277|FG001|Overall Study|Military orders|0|||
147590264|NCT02939950|532316276|FG000|Overall Study|Participant Relocated|5|||
147590265|NCT02939950|532316277|FG001|Overall Study|Participant Relocated|3|||
147590266|NCT02939950|532316276|FG000|Overall Study|Study related symptoms|8|||
147166698|NCT00106691|530776415|FG000|Overall Study|Not able to discontinue plavix|0|||
147166699|NCT00106691|530776416|FG001|Overall Study|Not able to discontinue plavix|1|||
147166700|NCT01754194|530776417|FG000|Overall Study|Lost to Follow-up|39|||
147166701|NCT01754194|530776418|FG001|Overall Study|Lost to Follow-up|14|||
147166702|NCT01754194|530776417|FG000|Overall Study|Withdrawal by Subject|4|||
147166703|NCT01754194|530776418|FG001|Overall Study|Withdrawal by Subject|5|||
147166704|NCT01754194|530776417|FG000|Overall Study|Other|9|||
147166705|NCT01754194|530776418|FG001|Overall Study|Other|8|||
147166706|NCT00907296|530776419|FG000|Overall Study|Ineligibility Determined|1|||
147166707|NCT00907296|530776420|FG001|Overall Study|Ineligibility Determined|0|||
147166708|NCT00907296|530776421|FG002|Overall Study|Ineligibility Determined|0|||
147166709|NCT00907296|530776422|FG003|Overall Study|Ineligibility Determined|1|||
147166710|NCT00907296|530776423|FG004|Overall Study|Ineligibility Determined|0|||
147166711|NCT00907296|530776424|FG005|Overall Study|Ineligibility Determined|0|||
147166712|NCT00907296|530776425|FG006|Overall Study|Ineligibility Determined|0|||
147166713|NCT00907296|530776426|FG007|Overall Study|Ineligibility Determined|1|||
147166714|NCT00907296|530776427|FG008|Overall Study|Ineligibility Determined|0|||
147166715|NCT00907296|530776428|FG009|Overall Study|Ineligibility Determined|0|||
147243785|NCT01806545|531065443|FG001|Overall Study|Withdrawal by Subject|2|||
147243786|NCT00429273|531065444|FG000|Overall Study|Lost to Follow-up|1|||
147243787|NCT00429273|531065445|FG001|Overall Study|Lost to Follow-up|2|||
147243788|NCT00429273|531065446|FG002|Overall Study|Lost to Follow-up|2|||
147243789|NCT00429273|531065444|FG000|Overall Study|Physician Decision|6|||
147243790|NCT00429273|531065445|FG001|Overall Study|Physician Decision|5|||
147243791|NCT00429273|531065446|FG002|Overall Study|Physician Decision|5|||
147243792|NCT00429273|531065444|FG000|Overall Study|Adverse Event|1|||
147243793|NCT00429273|531065445|FG001|Overall Study|Adverse Event|1|||
147243794|NCT00429273|531065446|FG002|Overall Study|Adverse Event|2|||
147243795|NCT00884312|531065448|FG000|Overall Study|Non-fatal Progressive Disease|0|||
147243796|NCT00884312|531065449|FG001|Overall Study|Non-fatal Progressive Disease|8|||
147243797|NCT00884312|531065448|FG000|Overall Study|Fatal Progressive Disease|0|||
147243798|NCT00884312|531065449|FG001|Overall Study|Fatal Progressive Disease|1|||
147243799|NCT00884312|531065448|FG000|Overall Study|Non-fatal Adverse Event|1|||
147243800|NCT00884312|531065449|FG001|Overall Study|Non-fatal Adverse Event|0|||
147243801|NCT00884312|531065448|FG000|Overall Study|Fatal Adverse Event|1|||
147243802|NCT00884312|531065449|FG001|Overall Study|Fatal Adverse Event|4|||
147243803|NCT00884312|531065448|FG000|Overall Study|Withdrawal by Subject|0|||
147243804|NCT00884312|531065449|FG001|Overall Study|Withdrawal by Subject|6|||
147243805|NCT00884312|531065448|FG000|Overall Study|Physician Decision|0|||
147243806|NCT00884312|531065449|FG001|Overall Study|Physician Decision|1|||
147243807|NCT00884312|531065448|FG000|Overall Study|Other|0|||
147243808|NCT00884312|531065449|FG001|Overall Study|Other|4|||
147243809|NCT00884312|531065448|FG000|Overall Study|Did Not Receive Study Drug|0|||
147243810|NCT00884312|531065449|FG001|Overall Study|Did Not Receive Study Drug|1|||
147243811|NCT00224042|531065450|FG000|Overall Study|Adverse Event|2|||
147243812|NCT00224042|531065451|FG001|Overall Study|Adverse Event|1|||
147243813|NCT00224042|531065450|FG000|Overall Study|Protocol Violation|0|||
147243814|NCT00224042|531065451|FG001|Overall Study|Protocol Violation|1|||
147243815|NCT00224042|531065450|FG000|Overall Study|Physician Decision|0|||
147243816|NCT00224042|531065451|FG001|Overall Study|Physician Decision|1|||
147243817|NCT00224042|531065450|FG000|Overall Study|Did not meet lab incusion criteria|2|||
147243818|NCT00224042|531065451|FG001|Overall Study|Did not meet lab incusion criteria|3|||
147243819|NCT00224042|531065450|FG000|Overall Study|Other|2|||
147243820|NCT00224042|531065451|FG001|Overall Study|Other|0|||
147243821|NCT00840450|531065452|FG000|Overall Study|Adverse Event|1|||
147243822|NCT00840450|531065452|FG000|Overall Study|Lack of Efficacy|2|||
147590267|NCT02939950|532316277|FG001|Overall Study|Study related symptoms|8|||
147590268|NCT02939950|532316276|FG000|Overall Study|Unacceptable lens movement|2|||
147166716|NCT00907296|530776419|FG000|Overall Study|Protocol Deviation|0|||
147166717|NCT00907296|530776420|FG001|Overall Study|Protocol Deviation|1|||
147166718|NCT00907296|530776421|FG002|Overall Study|Protocol Deviation|0|||
147166719|NCT00907296|530776422|FG003|Overall Study|Protocol Deviation|0|||
147166720|NCT00907296|530776423|FG004|Overall Study|Protocol Deviation|0|||
147166721|NCT00907296|530776424|FG005|Overall Study|Protocol Deviation|0|||
147166722|NCT00907296|530776425|FG006|Overall Study|Protocol Deviation|0|||
147166723|NCT00907296|530776426|FG007|Overall Study|Protocol Deviation|0|||
147166724|NCT00907296|530776427|FG008|Overall Study|Protocol Deviation|0|||
147166725|NCT00907296|530776428|FG009|Overall Study|Protocol Deviation|0|||
147166726|NCT00907296|530776419|FG000|Overall Study|Noncompliance|1|||
147166727|NCT00907296|530776420|FG001|Overall Study|Noncompliance|1|||
147166728|NCT00907296|530776421|FG002|Overall Study|Noncompliance|1|||
147166729|NCT00907296|530776422|FG003|Overall Study|Noncompliance|0|||
147166730|NCT00907296|530776423|FG004|Overall Study|Noncompliance|0|||
147166731|NCT00907296|530776424|FG005|Overall Study|Noncompliance|1|||
147166732|NCT00907296|530776425|FG006|Overall Study|Noncompliance|0|||
147166733|NCT00907296|530776426|FG007|Overall Study|Noncompliance|2|||
147166734|NCT00907296|530776427|FG008|Overall Study|Noncompliance|0|||
147166735|NCT00907296|530776428|FG009|Overall Study|Noncompliance|0|||
147166736|NCT00907296|530776419|FG000|Overall Study|Adverse Event|2|||
147166737|NCT00907296|530776420|FG001|Overall Study|Adverse Event|0|||
147166738|NCT00907296|530776421|FG002|Overall Study|Adverse Event|0|||
147166739|NCT00907296|530776422|FG003|Overall Study|Adverse Event|0|||
147166740|NCT00907296|530776423|FG004|Overall Study|Adverse Event|0|||
147166741|NCT00907296|530776424|FG005|Overall Study|Adverse Event|0|||
147166742|NCT00907296|530776425|FG006|Overall Study|Adverse Event|1|||
147166743|NCT00907296|530776426|FG007|Overall Study|Adverse Event|0|||
147166744|NCT00907296|530776427|FG008|Overall Study|Adverse Event|0|||
147166745|NCT00907296|530776428|FG009|Overall Study|Adverse Event|1|||
147166746|NCT00907296|530776419|FG000|Overall Study|Withdrawal by Subject|7|||
147166747|NCT00907296|530776420|FG001|Overall Study|Withdrawal by Subject|2|||
147166748|NCT00907296|530776421|FG002|Overall Study|Withdrawal by Subject|1|||
147166749|NCT00907296|530776422|FG003|Overall Study|Withdrawal by Subject|1|||
147243823|NCT04390191|531065455|FG000|Overall Study|Withdrawal by Subject|1|||
147243824|NCT04390191|531065456|FG001|Overall Study|Withdrawal by Subject|0|||
147243825|NCT03978832|531065457|FG000|Overall Study|Adverse Event|1|||
147590269|NCT02939950|532316277|FG001|Overall Study|Unacceptable lens movement|0|||
147590270|NCT02939950|532316276|FG000|Overall Study|Protocol Violation|6|||
147166750|NCT00907296|530776423|FG004|Overall Study|Withdrawal by Subject|1|||
147243826|NCT03978832|531065457|FG000|Overall Study|Lost to Follow-up|1|||
147243827|NCT03978832|531065457|FG000|Overall Study|Withdrawal by Subject|6|||
147243828|NCT03978832|531065457|FG000|Overall Study|Physician Decision|2|||
147243829|NCT03978832|531065457|FG000|Overall Study|did not pass screening criteria|44|||
147243830|NCT00003499|531065458|FG000|Overall Study|Not evaluable|8|||
147243831|NCT01256008|531065463|FG000|Overall Study|Lost to Follow-up|6|||
147243832|NCT01256008|531065464|FG001|Overall Study|Lost to Follow-up|4|||
147243833|NCT01256008|531065465|FG002|Overall Study|Lost to Follow-up|11|||
147243834|NCT01256008|531065463|FG000|Overall Study|Withdrawal by Subject|2|||
147243835|NCT01256008|531065464|FG001|Overall Study|Withdrawal by Subject|3|||
147243836|NCT01256008|531065465|FG002|Overall Study|Withdrawal by Subject|10|||
147243837|NCT02244606|531065466|FG000|Overall Study|Adverse Event|0|||
147243838|NCT02244606|531065467|FG001|Overall Study|Adverse Event|1|||
147243839|NCT02244606|531065468|FG002|Overall Study|Adverse Event|1|||
147243840|NCT02244606|531065469|FG003|Overall Study|Adverse Event|0|||
147243841|NCT02244606|531065466|FG000|Overall Study|Lost to Follow-up|2|||
147243842|NCT02244606|531065467|FG001|Overall Study|Lost to Follow-up|2|||
147243843|NCT02244606|531065468|FG002|Overall Study|Lost to Follow-up|1|||
147243844|NCT02244606|531065469|FG003|Overall Study|Lost to Follow-up|0|||
147243845|NCT02244606|531065466|FG000|Overall Study|Protocol Violation|0|||
147590271|NCT02939950|532316277|FG001|Overall Study|Protocol Violation|3|||
147166751|NCT00907296|530776424|FG005|Overall Study|Withdrawal by Subject|5|||
147166752|NCT00907296|530776425|FG006|Overall Study|Withdrawal by Subject|3|||
147166753|NCT00907296|530776426|FG007|Overall Study|Withdrawal by Subject|2|||
147166754|NCT00907296|530776427|FG008|Overall Study|Withdrawal by Subject|4|||
147166755|NCT00907296|530776428|FG009|Overall Study|Withdrawal by Subject|2|||
147166756|NCT00907296|530776419|FG000|Overall Study|Lost to Follow-up|9|||
147243846|NCT02244606|531065467|FG001|Overall Study|Protocol Violation|0|||
147243847|NCT02244606|531065468|FG002|Overall Study|Protocol Violation|0|||
147243848|NCT02244606|531065469|FG003|Overall Study|Protocol Violation|1|||
147243849|NCT02244606|531065466|FG000|Overall Study|Withdrawal by Subject|1|||
147243850|NCT02244606|531065467|FG001|Overall Study|Withdrawal by Subject|1|||
147243851|NCT02244606|531065468|FG002|Overall Study|Withdrawal by Subject|0|||
147166757|NCT00907296|530776420|FG001|Overall Study|Lost to Follow-up|1|||
147166758|NCT00907296|530776421|FG002|Overall Study|Lost to Follow-up|0|||
147166759|NCT00907296|530776422|FG003|Overall Study|Lost to Follow-up|2|||
147243852|NCT02244606|531065469|FG003|Overall Study|Withdrawal by Subject|0|||
147166760|NCT00907296|530776423|FG004|Overall Study|Lost to Follow-up|0|||
147243853|NCT02244606|531065466|FG000|Overall Study|Did Not Complete Study for Reason Other:|0|||
147166761|NCT00907296|530776424|FG005|Overall Study|Lost to Follow-up|3|||
147166762|NCT00907296|530776425|FG006|Overall Study|Lost to Follow-up|2|||
147166763|NCT00907296|530776426|FG007|Overall Study|Lost to Follow-up|2|||
147166764|NCT00907296|530776427|FG008|Overall Study|Lost to Follow-up|0|||
147166765|NCT00907296|530776428|FG009|Overall Study|Lost to Follow-up|4|||
147166766|NCT02392403|530776429|FG000|Overall Study|Adverse Event|1|||
147166767|NCT02392403|530776429|FG000|Overall Study|Death|1|||
147166768|NCT02392403|530776429|FG000|Overall Study|Withdrawal by Subject|1|||
147166769|NCT02776033|530776432|FG000|Overall Study|Withdrawal by Subject|0|||
147166770|NCT02776033|530776433|FG001|Overall Study|Withdrawal by Subject|0|||
147166771|NCT02776033|530776434|FG002|Overall Study|Withdrawal by Subject|2|||
147166772|NCT02776033|530776432|FG000|Overall Study|Physician Decision|2|||
147166773|NCT02776033|530776433|FG001|Overall Study|Physician Decision|0|||
147166774|NCT02776033|530776434|FG002|Overall Study|Physician Decision|0|||
147166775|NCT02776033|530776432|FG000|Overall Study|Lost to Follow-up|1|||
147166776|NCT02776033|530776433|FG001|Overall Study|Lost to Follow-up|0|||
147166777|NCT02776033|530776434|FG002|Overall Study|Lost to Follow-up|0|||
147166778|NCT02776033|530776432|FG000|Overall Study|Adverse Event|1|||
147166779|NCT02776033|530776433|FG001|Overall Study|Adverse Event|2|||
147166780|NCT02776033|530776434|FG002|Overall Study|Adverse Event|0|||
147166781|NCT02616393|530776438|FG000|Overall Study|Death|5|||
147166782|NCT02616393|530776439|FG001|Overall Study|Death|12|||
147166783|NCT02616393|530776440|FG002|Overall Study|Death|1|||
147166784|NCT02616393|530776438|FG000|Overall Study|Termination by Sponsor|4|||
147166785|NCT02616393|530776439|FG001|Overall Study|Termination by Sponsor|5|||
147166786|NCT02616393|530776440|FG002|Overall Study|Termination by Sponsor|2|||
147166787|NCT02616393|530776438|FG000|Overall Study|Other|3|||
147166788|NCT02616393|530776439|FG001|Overall Study|Other|0|||
147166789|NCT02616393|530776440|FG002|Overall Study|Other|0|||
147166790|NCT02616393|530776438|FG000|Overall Study|Withdrawal by Subject|1|||
147166791|NCT02616393|530776439|FG001|Overall Study|Withdrawal by Subject|1|||
147166792|NCT02616393|530776440|FG002|Overall Study|Withdrawal by Subject|0|||
147166793|NCT02616393|530776438|FG000|Overall Study|Lost to Follow-up|0|||
147166794|NCT02616393|530776439|FG001|Overall Study|Lost to Follow-up|2|||
147166795|NCT02616393|530776440|FG002|Overall Study|Lost to Follow-up|0|||
147166796|NCT01302054|530776441|FG000|Tolterodine Open-Label Run-In Phase|Lack of Efficacy|4|||
147166797|NCT01302054|530776442|FG001|Tolterodine Open-Label Run-In Phase|Lack of Efficacy|0|||
147166798|NCT01302054|530776443|FG002|Tolterodine Open-Label Run-In Phase|Lack of Efficacy|0|||
147166799|NCT01302054|530776441|FG000|Tolterodine Open-Label Run-In Phase|Lost to Follow-up|17|||
147166800|NCT01302054|530776442|FG001|Tolterodine Open-Label Run-In Phase|Lost to Follow-up|0|||
147166801|NCT01302054|530776443|FG002|Tolterodine Open-Label Run-In Phase|Lost to Follow-up|0|||
147166802|NCT01302054|530776441|FG000|Tolterodine Open-Label Run-In Phase|Withdrawal by Subject|16|||
147166803|NCT01302054|530776442|FG001|Tolterodine Open-Label Run-In Phase|Withdrawal by Subject|0|||
147166804|NCT01302054|530776443|FG002|Tolterodine Open-Label Run-In Phase|Withdrawal by Subject|0|||
147166805|NCT01302054|530776441|FG000|Tolterodine Open-Label Run-In Phase|Protocol Violation|8|||
147166806|NCT01302054|530776442|FG001|Tolterodine Open-Label Run-In Phase|Protocol Violation|0|||
147166807|NCT01302054|530776443|FG002|Tolterodine Open-Label Run-In Phase|Protocol Violation|0|||
147166808|NCT01302054|530776441|FG000|Tolterodine Open-Label Run-In Phase|Adverse Event|13|||
147166809|NCT01302054|530776442|FG001|Tolterodine Open-Label Run-In Phase|Adverse Event|0|||
147166810|NCT01302054|530776443|FG002|Tolterodine Open-Label Run-In Phase|Adverse Event|0|||
147166811|NCT01302054|530776441|FG000|Tolterodine Open-Label Run-In Phase|Did Not Meet Entrance Criteria|314|||
147166812|NCT01302054|530776442|FG001|Tolterodine Open-Label Run-In Phase|Did Not Meet Entrance Criteria|0|||
147166813|NCT01302054|530776443|FG002|Tolterodine Open-Label Run-In Phase|Did Not Meet Entrance Criteria|0|||
147166814|NCT01302054|530776441|FG000|Tolterodine Open-Label Run-In Phase|Other|7|||
147166815|NCT01302054|530776442|FG001|Tolterodine Open-Label Run-In Phase|Other|0|||
147166816|NCT01302054|530776443|FG002|Tolterodine Open-Label Run-In Phase|Other|0|||
147166817|NCT01302054|530776441|FG000|Between Open-Label and Double Blind|Did Not Enter Double-Blind Phase|2|||
147166818|NCT01302054|530776442|FG001|Between Open-Label and Double Blind|Did Not Enter Double-Blind Phase|0|||
147166819|NCT01302054|530776443|FG002|Between Open-Label and Double Blind|Did Not Enter Double-Blind Phase|0|||
147166820|NCT01302054|530776441|FG000|Double-Blind Treatment Phase|Lack of Efficacy|0|||
147166821|NCT01302054|530776442|FG001|Double-Blind Treatment Phase|Lack of Efficacy|2|||
147166822|NCT01302054|530776443|FG002|Double-Blind Treatment Phase|Lack of Efficacy|4|||
147166823|NCT01302054|530776441|FG000|Double-Blind Treatment Phase|Lost to Follow-up|0|||
147166824|NCT01302054|530776442|FG001|Double-Blind Treatment Phase|Lost to Follow-up|2|||
147166825|NCT01302054|530776443|FG002|Double-Blind Treatment Phase|Lost to Follow-up|1|||
147166826|NCT01302054|530776441|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
147166827|NCT01302054|530776442|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|6|||
147166828|NCT01302054|530776443|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|14|||
147166829|NCT01302054|530776441|FG000|Double-Blind Treatment Phase|Protocol Violation|0|||
147166830|NCT01302054|530776442|FG001|Double-Blind Treatment Phase|Protocol Violation|3|||
147166831|NCT01302054|530776443|FG002|Double-Blind Treatment Phase|Protocol Violation|6|||
147166832|NCT01302054|530776441|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
147590272|NCT02939950|532316276|FG000|Overall Study|Physician Decision|2|||
147166833|NCT01302054|530776442|FG001|Double-Blind Treatment Phase|Adverse Event|10|||
147166834|NCT01302054|530776443|FG002|Double-Blind Treatment Phase|Adverse Event|10|||
147166835|NCT01302054|530776441|FG000|Double-Blind Treatment Phase|Did Not Meet Entrance Criteria|0|||
147166836|NCT01302054|530776442|FG001|Double-Blind Treatment Phase|Did Not Meet Entrance Criteria|0|||
147166837|NCT01302054|530776443|FG002|Double-Blind Treatment Phase|Did Not Meet Entrance Criteria|2|||
147166838|NCT01302054|530776441|FG000|Double-Blind Treatment Phase|Other|0|||
147166839|NCT01302054|530776442|FG001|Double-Blind Treatment Phase|Other|4|||
147166840|NCT01302054|530776443|FG002|Double-Blind Treatment Phase|Other|9|||
147166841|NCT00857948|530776444|FG000|Overall Study|Withdrawal by Subject|2|||
147166842|NCT00857948|530776445|FG001|Overall Study|Withdrawal by Subject|0|||
147166843|NCT00857948|530776446|FG002|Overall Study|Withdrawal by Subject|0|||
147166844|NCT00857948|530776447|FG003|Overall Study|Withdrawal by Subject|0|||
147166845|NCT00857948|530776444|FG000|Overall Study|Protocol Violation|1|||
147166846|NCT00857948|530776445|FG001|Overall Study|Protocol Violation|0|||
147166847|NCT00857948|530776446|FG002|Overall Study|Protocol Violation|1|||
147166848|NCT00857948|530776447|FG003|Overall Study|Protocol Violation|0|||
147166849|NCT03757130|530776452|FG000|Overall Study|Lost to Follow-up|0|||
147166850|NCT03757130|530776453|FG001|Overall Study|Lost to Follow-up|0|||
147166851|NCT03757130|530776454|FG002|Overall Study|Lost to Follow-up|0|||
147166852|NCT03757130|530776455|FG003|Overall Study|Lost to Follow-up|1|||
147166853|NCT03757130|530776456|FG004|Overall Study|Lost to Follow-up|0|||
147166854|NCT03757130|530776457|FG005|Overall Study|Lost to Follow-up|0|||
147166855|NCT03757130|530776458|FG006|Overall Study|Lost to Follow-up|0|||
147166856|NCT03757130|530776459|FG007|Overall Study|Lost to Follow-up|1|||
147166857|NCT03757130|530776452|FG000|Overall Study|Withdrawal by Subject|0|||
147166858|NCT03757130|530776453|FG001|Overall Study|Withdrawal by Subject|0|||
147590273|NCT02939950|532316277|FG001|Overall Study|Physician Decision|0|||
147166859|NCT03757130|530776454|FG002|Overall Study|Withdrawal by Subject|0|||
147166860|NCT03757130|530776455|FG003|Overall Study|Withdrawal by Subject|0|||
147166861|NCT03757130|530776456|FG004|Overall Study|Withdrawal by Subject|0|||
147166862|NCT03757130|530776457|FG005|Overall Study|Withdrawal by Subject|0|||
147166863|NCT03757130|530776458|FG006|Overall Study|Withdrawal by Subject|1|||
147166864|NCT03757130|530776459|FG007|Overall Study|Withdrawal by Subject|0|||
147166865|NCT01439126|530776462|FG000|Overall Study|Adverse Event|2|||
147166866|NCT01439126|530776463|FG001|Overall Study|Adverse Event|0|||
147166867|NCT01439126|530776462|FG000|Overall Study|Withdrawal by Subject|5|||
147166868|NCT01439126|530776463|FG001|Overall Study|Withdrawal by Subject|21|||
147166869|NCT01439126|530776462|FG000|Overall Study|Protocol Violation|6|||
147166870|NCT01439126|530776463|FG001|Overall Study|Protocol Violation|4|||
147166871|NCT01439126|530776462|FG000|Overall Study|Lost to Follow-up|6|||
147166872|NCT01439126|530776463|FG001|Overall Study|Lost to Follow-up|3|||
147166873|NCT01439126|530776462|FG000|Overall Study|Other-Use of prohibited treatment|0|||
147166874|NCT01439126|530776463|FG001|Overall Study|Other-Use of prohibited treatment|2|||
147166875|NCT01439126|530776462|FG000|Overall Study|Other-Miscellaneous|12|||
147166876|NCT01439126|530776463|FG001|Overall Study|Other-Miscellaneous|12|||
147166877|NCT03242018|530776464|FG000|Overall Study|Adverse Event|7|||
147166878|NCT03242018|530776465|FG001|Overall Study|Adverse Event|7|||
147166879|NCT03242018|530776466|FG002|Overall Study|Adverse Event|6|||
147166880|NCT03242018|530776464|FG000|Overall Study|Lost to Follow-up|2|||
147166881|NCT03242018|530776465|FG001|Overall Study|Lost to Follow-up|2|||
147166882|NCT03242018|530776466|FG002|Overall Study|Lost to Follow-up|2|||
147166883|NCT03242018|530776464|FG000|Overall Study|At the Participant's Own Request|5|||
147166884|NCT03242018|530776465|FG001|Overall Study|At the Participant's Own Request|1|||
147166885|NCT03242018|530776466|FG002|Overall Study|At the Participant's Own Request|4|||
147166886|NCT03242018|530776464|FG000|Overall Study|Reason Not Specified|3|||
147166887|NCT03242018|530776465|FG001|Overall Study|Reason Not Specified|4|||
147166888|NCT03242018|530776466|FG002|Overall Study|Reason Not Specified|1|||
147166889|NCT03242018|530776464|FG000|Overall Study|Study Terminated by Sponsor|1|||
147166890|NCT03242018|530776465|FG001|Overall Study|Study Terminated by Sponsor|0|||
147166891|NCT03242018|530776466|FG002|Overall Study|Study Terminated by Sponsor|1|||
147166892|NCT00687609|530776467|FG000|Overall Study|Physician Decision|1|||
147166893|NCT00687609|530776467|FG000|Overall Study|Withdrawal by Subject|2|||
147166894|NCT02635347|530776468|FG000|Overall Study|Failed screening|20|||
147166895|NCT02635347|530776469|FG001|Overall Study|Failed screening|7|||
147166896|NCT01617447|530776470|FG000|Overall Study|Adverse Event|0|||
147166897|NCT01617447|530776471|FG001|Overall Study|Adverse Event|1|||
147166898|NCT01617447|530776470|FG000|Overall Study|Physician Decision|0|||
147166899|NCT01617447|530776471|FG001|Overall Study|Physician Decision|2|||
147166900|NCT00780273|530776472|FG000|Overall Study|Death|1|||
147243854|NCT02244606|531065467|FG001|Overall Study|Did Not Complete Study for Reason Other:|1|||
147243855|NCT02244606|531065468|FG002|Overall Study|Did Not Complete Study for Reason Other:|1|||
147166901|NCT00780273|530776472|FG000|Overall Study|Lost to Follow-up|1|||
147166902|NCT00121641|530776473|FG000|24-week Short-term Treatment Period|Lack of Efficacy|15|||
147166903|NCT00121641|530776474|FG001|24-week Short-term Treatment Period|Lack of Efficacy|21|||
147166904|NCT00121641|530776475|FG002|24-week Short-term Treatment Period|Lack of Efficacy|14|||
147243856|NCT02244606|531065469|FG003|Overall Study|Did Not Complete Study for Reason Other:|0|||
147243857|NCT01402492|531065472|FG000|Overall Study|Withdrawal by Subject|17|||
147243858|NCT01402492|531065473|FG001|Overall Study|Withdrawal by Subject|11|||
147243859|NCT01402492|531065474|FG002|Overall Study|Withdrawal by Subject|11|||
147243860|NCT01402492|531065472|FG000|Overall Study|Adverse Event|2|||
147243861|NCT01402492|531065473|FG001|Overall Study|Adverse Event|3|||
147243862|NCT01402492|531065474|FG002|Overall Study|Adverse Event|4|||
147243863|NCT01402492|531065472|FG000|Overall Study|Physician Decision|0|||
147243864|NCT01402492|531065473|FG001|Overall Study|Physician Decision|3|||
147243865|NCT01402492|531065474|FG002|Overall Study|Physician Decision|0|||
147243866|NCT01402492|531065472|FG000|Overall Study|Incarcerated (N=3)|2|||
147166905|NCT00121641|530776476|FG003|24-week Short-term Treatment Period|Lack of Efficacy|25|||
147243867|NCT01402492|531065473|FG001|Overall Study|Incarcerated (N=3)|0|||
147243868|NCT01402492|531065474|FG002|Overall Study|Incarcerated (N=3)|1|||
147243869|NCT00730132|531065475|FG000|Overall Study|Protocol Violation|154|||
147243870|NCT00730132|531065475|FG000|Overall Study|Death|1|||
147243871|NCT02296320|531065477|FG000|Overall Study|Withdrawal by Subject|4|||
147243872|NCT02296320|531065478|FG001|Overall Study|Withdrawal by Subject|0|||
147243873|NCT02296320|531065479|FG002|Overall Study|Withdrawal by Subject|2|||
147243874|NCT02296320|531065477|FG000|Overall Study|Death|24|||
147243875|NCT02296320|531065478|FG001|Overall Study|Death|3|||
147243876|NCT02296320|531065479|FG002|Overall Study|Death|27|||
147243877|NCT02296320|531065477|FG000|Overall Study|Lost to Follow-up|5|||
147243878|NCT02296320|531065478|FG001|Overall Study|Lost to Follow-up|2|||
147243879|NCT02296320|531065479|FG002|Overall Study|Lost to Follow-up|7|||
147243880|NCT02296320|531065477|FG000|Overall Study|Not treated|2|||
147243881|NCT02296320|531065478|FG001|Overall Study|Not treated|0|||
147166906|NCT00121641|530776477|FG004|24-week Short-term Treatment Period|Lack of Efficacy|30|||
147166907|NCT00121641|530776473|FG000|24-week Short-term Treatment Period|Subject Withdrew Consent|9|||
147166908|NCT00121641|530776474|FG001|24-week Short-term Treatment Period|Subject Withdrew Consent|11|||
147166909|NCT00121641|530776475|FG002|24-week Short-term Treatment Period|Subject Withdrew Consent|5|||
147166910|NCT00121641|530776476|FG003|24-week Short-term Treatment Period|Subject Withdrew Consent|10|||
147166911|NCT00121641|530776477|FG004|24-week Short-term Treatment Period|Subject Withdrew Consent|3|||
147166912|NCT00121641|530776473|FG000|24-week Short-term Treatment Period|Adverse Event|3|||
147166913|NCT00121641|530776474|FG001|24-week Short-term Treatment Period|Adverse Event|3|||
147166914|NCT00121641|530776475|FG002|24-week Short-term Treatment Period|Adverse Event|4|||
147243882|NCT02296320|531065479|FG002|Overall Study|Not treated|0|||
147243883|NCT02296320|531065477|FG000|Overall Study|Not - specified|0|||
147243884|NCT02296320|531065478|FG001|Overall Study|Not - specified|0|||
147243885|NCT02296320|531065479|FG002|Overall Study|Not - specified|1|||
147243886|NCT05466682|531065483|FG000|Overall Study|Withdrawal by Subject|0|||
147243887|NCT05466682|531065484|FG001|Overall Study|Withdrawal by Subject|2|||
147243888|NCT05466682|531065483|FG000|Overall Study|Lost to Follow-up|2|||
147243889|NCT05466682|531065484|FG001|Overall Study|Lost to Follow-up|1|||
147243890|NCT01930123|531065485|FG000|Overall Study|Adverse Event|1|||
147243891|NCT01930123|531065486|FG001|Overall Study|Adverse Event|0|||
147243892|NCT01930123|531065485|FG000|Overall Study|Physician Decision|21|||
147243893|NCT01930123|531065486|FG001|Overall Study|Physician Decision|8|||
147243894|NCT01930123|531065485|FG000|Overall Study|Withdrawal by Subject|1|||
147243895|NCT01930123|531065486|FG001|Overall Study|Withdrawal by Subject|0|||
147243896|NCT03208244|531065487|FG000|Overall Study|Death|1|||
147243897|NCT03953820|531065489|FG000|Two-Sequence, Two-Way Crossover|Adverse Event|1|||
147243898|NCT03953820|531065490|FG001|Two-Sequence, Two-Way Crossover|Adverse Event|0|||
147243899|NCT03953820|531065491|FG002|Two-Sequence, Two-Way Crossover|Adverse Event|0|||
147243900|NCT03953820|531065489|FG000|Two-Sequence, Two-Way Crossover|Physician Decision|1|||
147243901|NCT03953820|531065490|FG001|Two-Sequence, Two-Way Crossover|Physician Decision|0|||
147243902|NCT03953820|531065491|FG002|Two-Sequence, Two-Way Crossover|Physician Decision|0|||
147243903|NCT03334539|531065492|FG000|Overall Study|Adverse Event|3|||
147243904|NCT03334539|531065493|FG001|Overall Study|Adverse Event|5|||
147243905|NCT03334539|531065494|FG002|Overall Study|Adverse Event|0|||
147243906|NCT03334539|531065492|FG000|Overall Study|Withdrawal by Subject|0|||
147243907|NCT03334539|531065493|FG001|Overall Study|Withdrawal by Subject|1|||
147243908|NCT03334539|531065494|FG002|Overall Study|Withdrawal by Subject|1|||
147243909|NCT03334539|531065492|FG000|Overall Study|Administrative Reasons|1|||
147243910|NCT03334539|531065493|FG001|Overall Study|Administrative Reasons|0|||
147243911|NCT03334539|531065494|FG002|Overall Study|Administrative Reasons|0|||
147243912|NCT03334539|531065492|FG000|Overall Study|Hypertension Not Controlled|0|||
147166915|NCT00121641|530776476|FG003|24-week Short-term Treatment Period|Adverse Event|0|||
147166916|NCT00121641|530776477|FG004|24-week Short-term Treatment Period|Adverse Event|2|||
147166917|NCT00121641|530776473|FG000|24-week Short-term Treatment Period|Lost to Follow-up|0|||
147243913|NCT03334539|531065493|FG001|Overall Study|Hypertension Not Controlled|1|||
147243914|NCT03334539|531065494|FG002|Overall Study|Hypertension Not Controlled|0|||
147243915|NCT04974697|531065495|FG000|Overall Study|Unsatisfactory lens fitting due to test article|1|||
147243916|NCT04974697|531065495|FG000|Overall Study|Lens discomfort|1|||
147243917|NCT03706456|531065496|FG000|Overall Study|Adverse Event|1|||
147243918|NCT03706456|531065496|FG000|Overall Study|Lack of Efficacy|2|||
147243919|NCT03302234|531065497|FG000|Overall Study|Death|191|||
147166918|NCT00121641|530776474|FG001|24-week Short-term Treatment Period|Lost to Follow-up|2|||
147166919|NCT00121641|530776475|FG002|24-week Short-term Treatment Period|Lost to Follow-up|3|||
147166920|NCT00121641|530776476|FG003|24-week Short-term Treatment Period|Lost to Follow-up|4|||
147166921|NCT00121641|530776477|FG004|24-week Short-term Treatment Period|Lost to Follow-up|4|||
147166922|NCT00121641|530776473|FG000|24-week Short-term Treatment Period|Poor / Non-compliance|0|||
147166923|NCT00121641|530776474|FG001|24-week Short-term Treatment Period|Poor / Non-compliance|0|||
147166924|NCT00121641|530776475|FG002|24-week Short-term Treatment Period|Poor / Non-compliance|3|||
147166925|NCT00121641|530776476|FG003|24-week Short-term Treatment Period|Poor / Non-compliance|1|||
147166926|NCT00121641|530776477|FG004|24-week Short-term Treatment Period|Poor / Non-compliance|1|||
147166927|NCT00121641|530776473|FG000|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|1|||
147166928|NCT00121641|530776474|FG001|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|1|||
147166929|NCT00121641|530776475|FG002|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|0|||
147166930|NCT00121641|530776476|FG003|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|0|||
147166931|NCT00121641|530776477|FG004|24-week Short-term Treatment Period|Subject No Longer Meets Study Criteria|1|||
147166932|NCT00121641|530776473|FG000|24-week Short-term Treatment Period|Other Reason|1|||
147166933|NCT00121641|530776474|FG001|24-week Short-term Treatment Period|Other Reason|0|||
147166934|NCT00121641|530776475|FG002|24-week Short-term Treatment Period|Other Reason|0|||
147166935|NCT00121641|530776476|FG003|24-week Short-term Treatment Period|Other Reason|0|||
147166936|NCT00121641|530776477|FG004|24-week Short-term Treatment Period|Other Reason|0|||
147166937|NCT00121641|530776473|FG000|48-month Short Term + Long Term Period|Lack of Efficacy|26|||
147166938|NCT00121641|530776474|FG001|48-month Short Term + Long Term Period|Lack of Efficacy|27|||
147166939|NCT00121641|530776475|FG002|48-month Short Term + Long Term Period|Lack of Efficacy|21|||
147166940|NCT00121641|530776476|FG003|48-month Short Term + Long Term Period|Lack of Efficacy|26|||
147166941|NCT00121641|530776477|FG004|48-month Short Term + Long Term Period|Lack of Efficacy|25|||
147166942|NCT00121641|530776473|FG000|48-month Short Term + Long Term Period|Subject Withdrew Consent|25|||
147166943|NCT00121641|530776474|FG001|48-month Short Term + Long Term Period|Subject Withdrew Consent|28|||
147166944|NCT00121641|530776475|FG002|48-month Short Term + Long Term Period|Subject Withdrew Consent|17|||
147166945|NCT00121641|530776476|FG003|48-month Short Term + Long Term Period|Subject Withdrew Consent|24|||
147166946|NCT00121641|530776477|FG004|48-month Short Term + Long Term Period|Subject Withdrew Consent|10|||
147166947|NCT00121641|530776473|FG000|48-month Short Term + Long Term Period|Adverse Event|9|||
147166948|NCT00121641|530776474|FG001|48-month Short Term + Long Term Period|Adverse Event|10|||
147166949|NCT00121641|530776475|FG002|48-month Short Term + Long Term Period|Adverse Event|10|||
147166950|NCT00121641|530776476|FG003|48-month Short Term + Long Term Period|Adverse Event|5|||
147166951|NCT00121641|530776477|FG004|48-month Short Term + Long Term Period|Adverse Event|5|||
147166952|NCT00121641|530776473|FG000|48-month Short Term + Long Term Period|Lost to Follow-up|9|||
147166953|NCT00121641|530776474|FG001|48-month Short Term + Long Term Period|Lost to Follow-up|7|||
147166954|NCT00121641|530776475|FG002|48-month Short Term + Long Term Period|Lost to Follow-up|12|||
147166955|NCT00121641|530776476|FG003|48-month Short Term + Long Term Period|Lost to Follow-up|11|||
147166956|NCT00121641|530776477|FG004|48-month Short Term + Long Term Period|Lost to Follow-up|12|||
147166957|NCT00121641|530776473|FG000|48-month Short Term + Long Term Period|Poor / Non-compliance|4|||
147166958|NCT00121641|530776474|FG001|48-month Short Term + Long Term Period|Poor / Non-compliance|1|||
147166959|NCT00121641|530776475|FG002|48-month Short Term + Long Term Period|Poor / Non-compliance|4|||
147166960|NCT00121641|530776476|FG003|48-month Short Term + Long Term Period|Poor / Non-compliance|2|||
147166961|NCT00121641|530776477|FG004|48-month Short Term + Long Term Period|Poor / Non-compliance|2|||
147166962|NCT00121641|530776473|FG000|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|1|||
147166963|NCT00121641|530776474|FG001|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|3|||
147166964|NCT00121641|530776475|FG002|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|2|||
147166965|NCT00121641|530776476|FG003|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|1|||
147166966|NCT00121641|530776477|FG004|48-month Short Term + Long Term Period|Subject No Longer Meets Study Criteria|2|||
147166967|NCT00121641|530776473|FG000|48-month Short Term + Long Term Period|Pregnancy|0|||
147166968|NCT00121641|530776474|FG001|48-month Short Term + Long Term Period|Pregnancy|1|||
147166969|NCT00121641|530776475|FG002|48-month Short Term + Long Term Period|Pregnancy|0|||
147166970|NCT00121641|530776476|FG003|48-month Short Term + Long Term Period|Pregnancy|1|||
147166971|NCT00121641|530776477|FG004|48-month Short Term + Long Term Period|Pregnancy|0|||
147166972|NCT00121641|530776473|FG000|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|0|||
147166973|NCT00121641|530776474|FG001|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|2|||
147166974|NCT00121641|530776475|FG002|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|1|||
147166975|NCT00121641|530776476|FG003|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|0|||
147243920|NCT03302234|531065498|FG001|Overall Study|Death|192|||
147243921|NCT03302234|531065497|FG000|Overall Study|Withdrawal by Subject|2|||
147243922|NCT03302234|531065498|FG001|Overall Study|Withdrawal by Subject|2|||
147243923|NCT03302234|531065497|FG000|Overall Study|Sponsor Decision|90|||
147243924|NCT03302234|531065498|FG001|Overall Study|Sponsor Decision|89|||
147243925|NCT03302234|531065497|FG000|Overall Study|Laryngeal carcinoma|0|||
147166976|NCT00121641|530776477|FG004|48-month Short Term + Long Term Period|Administrative Reason by Sponsor|1|||
147166977|NCT00121641|530776473|FG000|48-month Short Term + Long Term Period|Death|0|||
147166978|NCT00121641|530776474|FG001|48-month Short Term + Long Term Period|Death|0|||
147166979|NCT00121641|530776475|FG002|48-month Short Term + Long Term Period|Death|0|||
147166980|NCT00121641|530776476|FG003|48-month Short Term + Long Term Period|Death|1|||
147166981|NCT00121641|530776477|FG004|48-month Short Term + Long Term Period|Death|0|||
147166982|NCT00121641|530776473|FG000|48-month Short Term + Long Term Period|Missing|0|||
147166983|NCT00121641|530776474|FG001|48-month Short Term + Long Term Period|Missing|0|||
147166984|NCT00121641|530776475|FG002|48-month Short Term + Long Term Period|Missing|1|||
147166985|NCT00121641|530776476|FG003|48-month Short Term + Long Term Period|Missing|0|||
147166986|NCT00121641|530776477|FG004|48-month Short Term + Long Term Period|Missing|0|||
147166987|NCT00121641|530776473|FG000|48-month Short Term + Long Term Period|Other Reason|5|||
147166988|NCT00121641|530776474|FG001|48-month Short Term + Long Term Period|Other Reason|3|||
147166989|NCT00121641|530776475|FG002|48-month Short Term + Long Term Period|Other Reason|2|||
147166990|NCT00121641|530776476|FG003|48-month Short Term + Long Term Period|Other Reason|0|||
147166991|NCT00121641|530776477|FG004|48-month Short Term + Long Term Period|Other Reason|1|||
147166992|NCT00619489|530776483|FG000|Overall Study|Adverse Event|0|||
147166993|NCT00619489|530776484|FG001|Overall Study|Adverse Event|7|||
147166994|NCT00619489|530776483|FG000|Overall Study|Withdrawal by Subject|1|||
147166995|NCT00619489|530776484|FG001|Overall Study|Withdrawal by Subject|1|||
147166996|NCT00619489|530776483|FG000|Overall Study|Lack of Efficacy|0|||
147166997|NCT00619489|530776484|FG001|Overall Study|Lack of Efficacy|11|||
147166998|NCT00619489|530776483|FG000|Overall Study|Rolled over to Study C13008 (NCT00790933|22|||
147166999|NCT00619489|530776484|FG001|Overall Study|Rolled over to Study C13008 (NCT00790933|15|||
147167000|NCT02356887|530776485|FG000|Overall Study|poor compliance|2|||
147167001|NCT02544373|530776489|FG000|Overall Study|Lost to Follow-up|5|||
147167002|NCT02544373|530776490|FG001|Overall Study|Lost to Follow-up|3|||
147167003|NCT02544373|530776489|FG000|Overall Study|Withdrawal by Subject|8|||
147167004|NCT02544373|530776490|FG001|Overall Study|Withdrawal by Subject|2|||
147167005|NCT02404649|530776491|FG000|Overall Study|Adverse Event|1|||
147167006|NCT02404649|530776492|FG001|Overall Study|Adverse Event|2|||
147167007|NCT00162266|530776496|FG000|Double-Blind Period|Adverse Event|5|||
147167008|NCT00162266|530776497|FG001|Double-Blind Period|Adverse Event|9|||
147167009|NCT00162266|530776498|FG002|Double-Blind Period|Adverse Event|11|||
147167010|NCT00162266|530776499|FG003|Double-Blind Period|Adverse Event|0|||
147167011|NCT00162266|530776496|FG000|Double-Blind Period|Death|0|||
147167012|NCT00162266|530776497|FG001|Double-Blind Period|Death|1|||
147167013|NCT00162266|530776498|FG002|Double-Blind Period|Death|0|||
147167014|NCT00162266|530776499|FG003|Double-Blind Period|Death|0|||
147167015|NCT00162266|530776496|FG000|Double-Blind Period|Lost to Follow-up|1|||
147167016|NCT00162266|530776497|FG001|Double-Blind Period|Lost to Follow-up|2|||
147167017|NCT00162266|530776498|FG002|Double-Blind Period|Lost to Follow-up|0|||
147167018|NCT00162266|530776499|FG003|Double-Blind Period|Lost to Follow-up|0|||
147167019|NCT00162266|530776496|FG000|Double-Blind Period|Other Reason|1|||
147167020|NCT00162266|530776497|FG001|Double-Blind Period|Other Reason|0|||
147167021|NCT00162266|530776498|FG002|Double-Blind Period|Other Reason|1|||
147167022|NCT00162266|530776499|FG003|Double-Blind Period|Other Reason|0|||
147167023|NCT00162266|530776496|FG000|Double-Blind Period|Lack of Efficacy|13|||
147167024|NCT00162266|530776497|FG001|Double-Blind Period|Lack of Efficacy|17|||
147167025|NCT00162266|530776498|FG002|Double-Blind Period|Lack of Efficacy|30|||
147167026|NCT00162266|530776499|FG003|Double-Blind Period|Lack of Efficacy|0|||
147167027|NCT00162266|530776496|FG000|Double-Blind Period|Withdrawal by Subject|5|||
147167028|NCT00162266|530776497|FG001|Double-Blind Period|Withdrawal by Subject|2|||
147167029|NCT00162266|530776498|FG002|Double-Blind Period|Withdrawal by Subject|6|||
147167030|NCT00162266|530776499|FG003|Double-Blind Period|Withdrawal by Subject|0|||
147167031|NCT00162266|530776496|FG000|Open-Label Period|Death|0|||
147167032|NCT00162266|530776497|FG001|Open-Label Period|Death|0|||
147167033|NCT00162266|530776498|FG002|Open-Label Period|Death|0|||
147167034|NCT00162266|530776499|FG003|Open-Label Period|Death|7|||
147167035|NCT00162266|530776496|FG000|Open-Label Period|Adverse Event|0|||
147167036|NCT00162266|530776497|FG001|Open-Label Period|Adverse Event|0|||
147167037|NCT00162266|530776498|FG002|Open-Label Period|Adverse Event|0|||
147167038|NCT00162266|530776499|FG003|Open-Label Period|Adverse Event|46|||
147167039|NCT00162266|530776496|FG000|Open-Label Period|Lack of Efficacy|0|||
147243926|NCT03302234|531065498|FG001|Overall Study|Laryngeal carcinoma|1|||
147243927|NCT03302234|531065497|FG000|Overall Study|Not Reported|1|||
147243928|NCT03302234|531065498|FG001|Overall Study|Not Reported|0|||
147590274|NCT02939950|532316276|FG000|Overall Study|Pregnancy|6|||
147167040|NCT00162266|530776497|FG001|Open-Label Period|Lack of Efficacy|0|||
147167041|NCT00162266|530776498|FG002|Open-Label Period|Lack of Efficacy|0|||
147167042|NCT00162266|530776499|FG003|Open-Label Period|Lack of Efficacy|26|||
147167043|NCT00162266|530776496|FG000|Open-Label Period|Lost to Follow-up|0|||
147167044|NCT00162266|530776497|FG001|Open-Label Period|Lost to Follow-up|0|||
147167045|NCT00162266|530776498|FG002|Open-Label Period|Lost to Follow-up|0|||
147167046|NCT00162266|530776499|FG003|Open-Label Period|Lost to Follow-up|3|||
147167047|NCT00162266|530776496|FG000|Open-Label Period|Withdrawal by Subject|0|||
147590275|NCT02939950|532316277|FG001|Overall Study|Pregnancy|7|||
147167048|NCT00162266|530776497|FG001|Open-Label Period|Withdrawal by Subject|0|||
147167049|NCT00162266|530776498|FG002|Open-Label Period|Withdrawal by Subject|0|||
147167050|NCT00162266|530776499|FG003|Open-Label Period|Withdrawal by Subject|31|||
147167051|NCT00162266|530776496|FG000|Open-Label Period|Administrative Reason By Sponsor|0|||
147167052|NCT00162266|530776497|FG001|Open-Label Period|Administrative Reason By Sponsor|0|||
147167053|NCT00162266|530776498|FG002|Open-Label Period|Administrative Reason By Sponsor|0|||
147167054|NCT00162266|530776499|FG003|Open-Label Period|Administrative Reason By Sponsor|9|||
147167055|NCT00162266|530776496|FG000|Open-Label Period|Other Reasons|0|||
147167056|NCT00162266|530776497|FG001|Open-Label Period|Other Reasons|0|||
147167057|NCT00162266|530776498|FG002|Open-Label Period|Other Reasons|0|||
147167058|NCT00162266|530776499|FG003|Open-Label Period|Other Reasons|15|||
147167059|NCT04208087|530776500|FG000|Overall Study|Adverse Event|1|||
147167060|NCT04208087|530776501|FG001|Overall Study|Adverse Event|0|||
147167061|NCT04208087|530776502|FG002|Overall Study|Adverse Event|0|||
147167062|NCT04208087|530776503|FG003|Overall Study|Adverse Event|0|||
147167063|NCT04208087|530776504|FG004|Overall Study|Adverse Event|0|||
147167064|NCT04208087|530776500|FG000|Overall Study|Withdrawal by Subject|0|||
147167065|NCT04208087|530776501|FG001|Overall Study|Withdrawal by Subject|0|||
147167066|NCT04208087|530776502|FG002|Overall Study|Withdrawal by Subject|1|||
147167067|NCT04208087|530776503|FG003|Overall Study|Withdrawal by Subject|0|||
147167068|NCT04208087|530776504|FG004|Overall Study|Withdrawal by Subject|0|||
147167069|NCT04208087|530776500|FG000|Overall Study|Other|0|||
147167070|NCT04208087|530776501|FG001|Overall Study|Other|0|||
147167071|NCT04208087|530776502|FG002|Overall Study|Other|0|||
147167072|NCT04208087|530776503|FG003|Overall Study|Other|0|||
147167073|NCT04208087|530776504|FG004|Overall Study|Other|1|||
147167074|NCT01839656|530776505|FG000|Overall Study|Withdrawal by Subject|1|||
147167075|NCT01839656|530776506|FG001|Overall Study|Withdrawal by Subject|1|||
147167076|NCT01839656|530776505|FG000|Overall Study|Adverse event, serious fatal|1|||
147167077|NCT01839656|530776506|FG001|Overall Study|Adverse event, serious fatal|4|||
147167078|NCT01839656|530776505|FG000|Overall Study|Early study closure|0|||
147167079|NCT01839656|530776506|FG001|Overall Study|Early study closure|11|||
147167080|NCT01839656|530776505|FG000|Overall Study|Adverse Event|1|||
147167081|NCT01839656|530776506|FG001|Overall Study|Adverse Event|0|||
147167082|NCT02621073|530776516|FG000|Overall Study|Lost to Follow-up|0|||
147167083|NCT02621073|530776517|FG001|Overall Study|Lost to Follow-up|1|||
147167084|NCT02621073|530776516|FG000|Overall Study|Physician Decision|3|||
147167085|NCT02621073|530776517|FG001|Overall Study|Physician Decision|2|||
147167086|NCT01595581|530776518|FG000|Overall Study|Withdrawal by Subject|1|||
147167087|NCT01595581|530776519|FG001|Overall Study|Withdrawal by Subject|0|||
147167088|NCT00495755|530776523|FG000|Overall Study|Adverse Event|3|||
147167089|NCT01012323|530776524|FG000|Overall Study|Investigator Judgment|1|||
147167090|NCT01266590|530778064|FG000|Overall Study|Adverse Event|3|||
147167091|NCT01266590|530778064|FG000|Overall Study|Lost to Follow-up|1|||
147167092|NCT01266590|530778064|FG000|Overall Study|Withdrawal by Subject|1|||
147167093|NCT01266590|530778064|FG000|Overall Study|Physician Decision|1|||
147167094|NCT04435600|530778065|FG000|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
147167095|NCT04435600|530778066|FG001|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
147167096|NCT04435600|530778067|FG002|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|1|||
147167097|NCT04435600|530778068|FG003|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
147167098|NCT04435600|530778069|FG004|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
147167099|NCT04435600|530778070|FG005|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
147167100|NCT04435600|530778071|FG006|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
147167101|NCT04435600|530778072|FG007|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
147167102|NCT04435600|530778073|FG008|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
147167103|NCT04435600|530778074|FG009|Part 2: Period A (Baseline to Week 16)|Lost to Follow-up|0|||
147167104|NCT04435600|530778065|FG000|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
147590276|NCT02939950|532316276|FG000|Overall Study|Withdrawal by Subject|12|||
147590277|NCT02939950|532316277|FG001|Overall Study|Withdrawal by Subject|28|||
147167105|NCT04435600|530778066|FG001|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
147167106|NCT04435600|530778067|FG002|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
147167107|NCT04435600|530778068|FG003|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
147167108|NCT04435600|530778069|FG004|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
147167109|NCT04435600|530778070|FG005|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
147167110|NCT04435600|530778071|FG006|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
147167111|NCT04435600|530778072|FG007|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
147243929|NCT02795832|531065502|FG000|Overall Study|Adverse Event|0|||
147243930|NCT02795832|531065503|FG001|Overall Study|Adverse Event|0|||
147243931|NCT02795832|531065504|FG002|Overall Study|Adverse Event|0|||
147243932|NCT02795832|531065505|FG003|Overall Study|Adverse Event|0|||
147243933|NCT02795832|531065506|FG004|Overall Study|Adverse Event|0|||
147243934|NCT02795832|531065507|FG005|Overall Study|Adverse Event|3|||
147243935|NCT01845831|531065508|FG000|Inpatient Phase|Withdrawal by Subject|1|||
147167112|NCT04435600|530778073|FG008|Part 4 (Baseline to Week 52)|Withdrawal by Subject|0|||
147167113|NCT04435600|530778074|FG009|Part 4 (Baseline to Week 52)|Withdrawal by Subject|1|||
147167114|NCT04435600|530778065|FG000|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
147167115|NCT04435600|530778066|FG001|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
147167116|NCT04435600|530778067|FG002|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
147167117|NCT04435600|530778068|FG003|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
147167118|NCT04435600|530778069|FG004|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
147167119|NCT04435600|530778070|FG005|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
147243936|NCT01845831|531065509|FG001|Inpatient Phase|Withdrawal by Subject|1|||
147243937|NCT01845831|531065510|FG002|Inpatient Phase|Withdrawal by Subject|0|||
147243938|NCT01845831|531065511|FG003|Inpatient Phase|Withdrawal by Subject|0|||
147243939|NCT01845831|531065512|FG004|Inpatient Phase|Withdrawal by Subject|0|||
147243940|NCT00221403|531065513|FG000|Overall Study|Protocol Violation|1|||
147243941|NCT00221403|531065514|FG001|Overall Study|Protocol Violation|0|||
147243942|NCT00221403|531065515|FG002|Overall Study|Protocol Violation|0|||
147243943|NCT00221403|531065513|FG000|Overall Study|Physician Decision|1|||
147243944|NCT00221403|531065514|FG001|Overall Study|Physician Decision|0|||
147243945|NCT00221403|531065515|FG002|Overall Study|Physician Decision|0|||
147243946|NCT00221403|531065513|FG000|Overall Study|Withdrawal by Subject|0|||
147243947|NCT00221403|531065514|FG001|Overall Study|Withdrawal by Subject|3|||
147243948|NCT00221403|531065515|FG002|Overall Study|Withdrawal by Subject|0|||
147243949|NCT00221403|531065513|FG000|Overall Study|Lack of Efficacy|0|||
147243950|NCT00221403|531065514|FG001|Overall Study|Lack of Efficacy|1|||
147243951|NCT00221403|531065515|FG002|Overall Study|Lack of Efficacy|0|||
147243952|NCT00221403|531065513|FG000|Overall Study|Adverse Event|0|||
147243953|NCT00221403|531065514|FG001|Overall Study|Adverse Event|1|||
147243954|NCT00221403|531065515|FG002|Overall Study|Adverse Event|0|||
147243955|NCT02695329|531065517|FG000|Overall Study|Adverse Event|1|||
147243956|NCT02695329|531065518|FG001|Overall Study|Adverse Event|0|||
147243957|NCT02695329|531065517|FG000|Overall Study|Poor X-ray quality for measurement|4|||
147243958|NCT02695329|531065518|FG001|Overall Study|Poor X-ray quality for measurement|5|||
147243959|NCT01348165|531065519|FG000|Overall Study|Adverse Event|0|||
147243960|NCT01348165|531065520|FG001|Overall Study|Adverse Event|0|||
147243961|NCT01348165|531065521|FG002|Overall Study|Adverse Event|0|||
147243962|NCT01348165|531065522|FG003|Overall Study|Adverse Event|0|||
147243963|NCT01348165|531065523|FG004|Overall Study|Adverse Event|0|||
147243964|NCT01348165|531065524|FG005|Overall Study|Adverse Event|0|||
147243965|NCT01348165|531065525|FG006|Overall Study|Adverse Event|1|||
147243966|NCT01929343|531065526|FG000|Overall Study|Physician Decision|0|||
147243967|NCT01929343|531065527|FG001|Overall Study|Physician Decision|2|||
147243968|NCT01929343|531065528|FG002|Overall Study|Physician Decision|0|||
147243969|NCT01929343|531065526|FG000|Overall Study|Withdrawal by Subject|1|||
147243970|NCT01929343|531065527|FG001|Overall Study|Withdrawal by Subject|0|||
147243971|NCT01929343|531065528|FG002|Overall Study|Withdrawal by Subject|0|||
147243972|NCT01892293|531066831|FG000|Overall Study|Apheresed but not treated|4|||
147243973|NCT03602482|531066832|FG000|Overall Study|Withdrawal by Subject|6|||
147243974|NCT03602482|531066833|FG001|Overall Study|Withdrawal by Subject|7|||
147243975|NCT03602482|531066834|FG002|Overall Study|Withdrawal by Subject|0|||
147243976|NCT03602482|531066835|FG003|Overall Study|Withdrawal by Subject|0|||
147323412|NCT01449929|531348018|FG000|Extension Phase Approximately 3 Years|Lack of Efficacy|0|||
147323413|NCT01449929|531348019|FG001|Extension Phase Approximately 3 Years|Lack of Efficacy|0|||
147323414|NCT01449929|531348020|FG002|Extension Phase Approximately 3 Years|Lack of Efficacy|2|||
147323415|NCT01449929|531348018|FG000|Extension Phase Approximately 3 Years|Lost to Follow-up|0|||
147323416|NCT01449929|531348019|FG001|Extension Phase Approximately 3 Years|Lost to Follow-up|0|||
147323417|NCT01449929|531348020|FG002|Extension Phase Approximately 3 Years|Lost to Follow-up|4|||
147323418|NCT03015740|531348021|FG000|Overall Study|Adverse Event|1|||
147323419|NCT03015740|531348022|FG001|Overall Study|Adverse Event|0|||
147323420|NCT03015740|531348023|FG002|Overall Study|Adverse Event|0|||
147323421|NCT03015740|531348021|FG000|Overall Study|Death|3|||
147323422|NCT03015740|531348022|FG001|Overall Study|Death|5|||
147323423|NCT03015740|531348023|FG002|Overall Study|Death|0|||
147323424|NCT03015740|531348021|FG000|Overall Study|Withdrawal by Subject|2|||
147447694|NCT00783094|531803937|FG001|Open-Label Extension Period|Physician Decision|2|||
147447695|NCT00783094|531803938|FG002|Open-Label Extension Period|Physician Decision|3|||
147243977|NCT02601469|531066838|FG000|Overall Study|Enrolled in Error|1|||
147167120|NCT04435600|530778071|FG006|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
147243978|NCT02601469|531066839|FG001|Overall Study|Enrolled in Error|0|||
147243979|NCT01411774|531066844|FG000|Overall Study|Withdrawal by Subject|0|||
147243980|NCT01411774|531066845|FG001|Overall Study|Withdrawal by Subject|3|||
147590278|NCT02939950|532316276|FG000|Overall Study|Adverse Event|7|||
147243981|NCT00056316|531066846|FG000|Overall Study|Withdrawal by Subject|2|||
147243982|NCT00056316|531066847|FG001|Overall Study|Withdrawal by Subject|2|||
147243983|NCT00056316|531066846|FG000|Overall Study|Death/NH placement of pt|1|||
147243984|NCT00056316|531066847|FG001|Overall Study|Death/NH placement of pt|1|||
147323425|NCT03015740|531348022|FG001|Overall Study|Withdrawal by Subject|0|||
147323426|NCT03015740|531348023|FG002|Overall Study|Withdrawal by Subject|0|||
147167121|NCT04435600|530778072|FG007|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
147167122|NCT04435600|530778073|FG008|Part 4 (Baseline to Week 52)|Lost to Follow-up|0|||
147167123|NCT04435600|530778074|FG009|Part 4 (Baseline to Week 52)|Lost to Follow-up|1|||
147167124|NCT04435600|530778065|FG000|Part 4 (Baseline to Week 52)|Other than specified|0|||
147167125|NCT04435600|530778066|FG001|Part 4 (Baseline to Week 52)|Other than specified|0|||
147167126|NCT04435600|530778067|FG002|Part 4 (Baseline to Week 52)|Other than specified|0|||
147167127|NCT04435600|530778068|FG003|Part 4 (Baseline to Week 52)|Other than specified|0|||
147167128|NCT04435600|530778069|FG004|Part 4 (Baseline to Week 52)|Other than specified|0|||
147167129|NCT04435600|530778070|FG005|Part 4 (Baseline to Week 52)|Other than specified|0|||
147167130|NCT04435600|530778071|FG006|Part 4 (Baseline to Week 52)|Other than specified|0|||
147167131|NCT04435600|530778072|FG007|Part 4 (Baseline to Week 52)|Other than specified|0|||
147167132|NCT04435600|530778073|FG008|Part 4 (Baseline to Week 52)|Other than specified|0|||
147167133|NCT04435600|530778074|FG009|Part 4 (Baseline to Week 52)|Other than specified|1|||
147167134|NCT03344172|530778078|FG000|Overall Study|Received <1 dose of treatment|1|||
147167135|NCT03344172|530778079|FG001|Overall Study|Received <1 dose of treatment|0|||
147167136|NCT02066415|530778080|FG000|Overall Study|Decision by Sponsor|5|||
147167137|NCT02066415|530778081|FG001|Overall Study|Decision by Sponsor|4|||
147167138|NCT02066415|530778082|FG002|Overall Study|Decision by Sponsor|2|||
147167139|NCT02066415|530778080|FG000|Overall Study|Withdrawal by Subject|9|||
147167140|NCT02066415|530778081|FG001|Overall Study|Withdrawal by Subject|1|||
147167141|NCT02066415|530778082|FG002|Overall Study|Withdrawal by Subject|4|||
147167142|NCT02066415|530778080|FG000|Overall Study|Lost to Follow-up|7|||
147167143|NCT02066415|530778081|FG001|Overall Study|Lost to Follow-up|2|||
147167144|NCT02066415|530778082|FG002|Overall Study|Lost to Follow-up|2|||
147167145|NCT02989805|530778084|FG000|Overall Study|invalid consent|6|||
147167146|NCT02989805|530778085|FG001|Overall Study|invalid consent|4|||
147167147|NCT02771626|530778086|FG000|Overall Study|Adverse Event|1|||
147167148|NCT02771626|530778087|FG001|Overall Study|Adverse Event|5|||
147167149|NCT02771626|530778088|FG002|Overall Study|Adverse Event|3|||
147167150|NCT02771626|530778089|FG003|Overall Study|Adverse Event|0|||
147167151|NCT02771626|530778090|FG004|Overall Study|Adverse Event|1|||
147167152|NCT02771626|530778091|FG005|Overall Study|Adverse Event|1|||
147167153|NCT02771626|530778086|FG000|Overall Study|Radiologic Disease Progression|6|||
147167154|NCT02771626|530778087|FG001|Overall Study|Radiologic Disease Progression|13|||
147167155|NCT02771626|530778088|FG002|Overall Study|Radiologic Disease Progression|10|||
147167156|NCT02771626|530778089|FG003|Overall Study|Radiologic Disease Progression|7|||
147167157|NCT02771626|530778090|FG004|Overall Study|Radiologic Disease Progression|28|||
147167158|NCT02771626|530778091|FG005|Overall Study|Radiologic Disease Progression|15|||
147167159|NCT02771626|530778086|FG000|Overall Study|Symptomatic Deterioration|0|||
147167160|NCT02771626|530778087|FG001|Overall Study|Symptomatic Deterioration|4|||
147167161|NCT02771626|530778088|FG002|Overall Study|Symptomatic Deterioration|2|||
147167162|NCT02771626|530778089|FG003|Overall Study|Symptomatic Deterioration|0|||
147167163|NCT02771626|530778090|FG004|Overall Study|Symptomatic Deterioration|5|||
147167164|NCT02771626|530778091|FG005|Overall Study|Symptomatic Deterioration|2|||
147167165|NCT02771626|530778086|FG000|Overall Study|Participant Request|0|||
147167166|NCT02771626|530778087|FG001|Overall Study|Participant Request|1|||
147167167|NCT02771626|530778088|FG002|Overall Study|Participant Request|0|||
147167168|NCT02771626|530778089|FG003|Overall Study|Participant Request|2|||
147167169|NCT02771626|530778090|FG004|Overall Study|Participant Request|0|||
147167170|NCT02771626|530778091|FG005|Overall Study|Participant Request|1|||
147167171|NCT02771626|530778086|FG000|Overall Study|Investigator Decision|0|||
147167172|NCT02771626|530778087|FG001|Overall Study|Investigator Decision|1|||
147167173|NCT02771626|530778088|FG002|Overall Study|Investigator Decision|0|||
147167174|NCT02771626|530778089|FG003|Overall Study|Investigator Decision|0|||
147167175|NCT02771626|530778090|FG004|Overall Study|Investigator Decision|1|||
147167176|NCT02771626|530778091|FG005|Overall Study|Investigator Decision|0|||
147167177|NCT02771626|530778086|FG000|Overall Study|Study Termination by Sponsor|0|||
147167178|NCT02771626|530778087|FG001|Overall Study|Study Termination by Sponsor|2|||
147167179|NCT02771626|530778088|FG002|Overall Study|Study Termination by Sponsor|1|||
147167180|NCT02771626|530778089|FG003|Overall Study|Study Termination by Sponsor|0|||
147167181|NCT02771626|530778090|FG004|Overall Study|Study Termination by Sponsor|1|||
147167182|NCT02771626|530778091|FG005|Overall Study|Study Termination by Sponsor|0|||
147167183|NCT02771626|530778086|FG000|Overall Study|Informed Consent Withdrawn|0|||
147167184|NCT02771626|530778087|FG001|Overall Study|Informed Consent Withdrawn|0|||
147167185|NCT02771626|530778088|FG002|Overall Study|Informed Consent Withdrawn|1|||
147167186|NCT02771626|530778089|FG003|Overall Study|Informed Consent Withdrawn|0|||
147167187|NCT02771626|530778090|FG004|Overall Study|Informed Consent Withdrawn|1|||
147167188|NCT02771626|530778091|FG005|Overall Study|Informed Consent Withdrawn|1|||
147167189|NCT02771626|530778086|FG000|Overall Study|Other, Not Specified|1|||
147167190|NCT02771626|530778087|FG001|Overall Study|Other, Not Specified|0|||
147167191|NCT02771626|530778088|FG002|Overall Study|Other, Not Specified|0|||
147167192|NCT02771626|530778089|FG003|Overall Study|Other, Not Specified|0|||
147167193|NCT02771626|530778090|FG004|Overall Study|Other, Not Specified|0|||
147167194|NCT02771626|530778091|FG005|Overall Study|Other, Not Specified|1|||
147167195|NCT04094584|530778092|FG000|Overall Study|No interest in study|88|||
147167196|NCT04094584|530778092|FG000|Overall Study|Unwilling to undergo screening tests|36|||
147167197|NCT04094584|530778092|FG000|Overall Study|Liver disease (enzymes >5 times upper limit of cirrhosis)|8|||
147167198|NCT04094584|530778092|FG000|Overall Study|Opioid use|7|||
147167199|NCT04094584|530778092|FG000|Overall Study|Need for major surgery in study period|4|||
147167200|NCT04094584|530778092|FG000|Overall Study|eligible but declined enrollment|4|||
147167201|NCT04094584|530778092|FG000|Overall Study|Chose to stop injections after week 4 but continued case management and provided complete data|2|||
147167202|NCT04094584|530778092|FG000|Overall Study|Missed study visits resulting. in incomplete data but sufficient for a pre-post comparison|2|||
147167203|NCT04094584|530778092|FG000|Overall Study|Lost to Follow-up|3|||
147167204|NCT04094584|530778092|FG000|Overall Study|Withdrawal by Subject|2|||
147167205|NCT02713867|530778093|FG000|Randomization|Other Reason|2|||
147167206|NCT02713867|530778094|FG001|Randomization|Other Reason|1|||
147167207|NCT02713867|530778093|FG000|Randomization|Participant Withdrew consent|0|||
147167208|NCT02713867|530778094|FG001|Randomization|Participant Withdrew consent|2|||
147167209|NCT02713867|530778093|FG000|Treatment Period|Other Reasons|22|||
147323427|NCT02153788|531349895|FG000|Overall Study|Physician Decision|2|||
147167210|NCT02713867|530778094|FG001|Treatment Period|Other Reasons|28|||
147167211|NCT02713867|530778093|FG000|Treatment Period|Administrative reason by sponsor|21|||
147167212|NCT02713867|530778094|FG001|Treatment Period|Administrative reason by sponsor|16|||
147167213|NCT02713867|530778093|FG000|Treatment Period|No longer meets study criteria|2|||
147167214|NCT02713867|530778094|FG001|Treatment Period|No longer meets study criteria|1|||
147167215|NCT02713867|530778093|FG000|Treatment Period|Poor/Non Compliance|1|||
147167216|NCT02713867|530778094|FG001|Treatment Period|Poor/Non Compliance|0|||
147167217|NCT02713867|530778093|FG000|Treatment Period|Maximum Clinical Benefit|5|||
147167218|NCT02713867|530778094|FG001|Treatment Period|Maximum Clinical Benefit|6|||
147167219|NCT02713867|530778093|FG000|Treatment Period|Withdrew consent|3|||
147167220|NCT02713867|530778094|FG001|Treatment Period|Withdrew consent|6|||
147167221|NCT02713867|530778093|FG000|Treatment Period|Requested to Discontinue|8|||
147167222|NCT02713867|530778094|FG001|Treatment Period|Requested to Discontinue|8|||
147167223|NCT02713867|530778093|FG000|Treatment Period|AE unrelated to Study Drug|11|||
147167224|NCT02713867|530778094|FG001|Treatment Period|AE unrelated to Study Drug|10|||
147167225|NCT02713867|530778093|FG000|Treatment Period|Death|7|||
147167226|NCT02713867|530778094|FG001|Treatment Period|Death|3|||
147167227|NCT02713867|530778093|FG000|Treatment Period|Study Drug Toxicity|16|||
147167228|NCT02713867|530778094|FG001|Treatment Period|Study Drug Toxicity|19|||
147167229|NCT02713867|530778093|FG000|Treatment Period|Disease Progression|82|||
147167230|NCT02713867|530778094|FG001|Treatment Period|Disease Progression|83|||
147167231|NCT04135859|530778096|FG000|Overall Study|Withdrawal by Subject|1|||
147167232|NCT04135859|530778097|FG001|Overall Study|Withdrawal by Subject|0|||
147167233|NCT04135859|530778096|FG000|Overall Study|Withdrawal due to screening failure|1|||
147167234|NCT04135859|530778097|FG001|Overall Study|Withdrawal due to screening failure|2|||
147167235|NCT04135859|530778096|FG000|Overall Study|Did not complete stress test|3|||
147167236|NCT04135859|530778097|FG001|Overall Study|Did not complete stress test|3|||
147323428|NCT02153788|531349896|FG001|Overall Study|Physician Decision|1|||
147323429|NCT04672460|531349897|FG000|Bioequivalence Phase: Period 1 (28 Days)|Death|1|||
147323430|NCT04672460|531349898|FG001|Bioequivalence Phase: Period 1 (28 Days)|Death|2|||
147323431|NCT04672460|531349897|FG000|Bioequivalence Phase: Period 1 (28 Days)|Progressive disease|2|||
147323432|NCT04672460|531349898|FG001|Bioequivalence Phase: Period 1 (28 Days)|Progressive disease|4|||
147323433|NCT04672460|531349897|FG000|Bioequivalence Phase: Period 1 (28 Days)|Withdrawal by Subject|0|||
147323434|NCT04672460|531349898|FG001|Bioequivalence Phase: Period 1 (28 Days)|Withdrawal by Subject|3|||
147323435|NCT04672460|531349897|FG000|Bioequivalence Phase: Period 1 (28 Days)|Global deterioration of health status|0|||
147323436|NCT04672460|531349898|FG001|Bioequivalence Phase: Period 1 (28 Days)|Global deterioration of health status|1|||
147323437|NCT04672460|531349897|FG000|Bioequivalence Phase: Period 1 (28 Days)|Adverse Event|3|||
147323438|NCT04672460|531349898|FG001|Bioequivalence Phase: Period 1 (28 Days)|Adverse Event|0|||
147323439|NCT04672460|531349897|FG000|Bioequivalence Phase: Period 1 (28 Days)|Other|1|||
147323440|NCT04672460|531349898|FG001|Bioequivalence Phase: Period 1 (28 Days)|Other|0|||
147323441|NCT04672460|531349897|FG000|Bioequivalence Phase: Period 2 (21 Days)|Progressive disease|1|||
147323442|NCT04672460|531349898|FG001|Bioequivalence Phase: Period 2 (21 Days)|Progressive disease|5|||
147323443|NCT04672460|531349897|FG000|Bioequivalence Phase: Period 2 (21 Days)|Withdrawal by Subject|1|||
147167237|NCT04135859|530778096|FG000|Overall Study|Did not wear accelerometer and did not complete stress test|0|||
147167238|NCT04135859|530778097|FG001|Overall Study|Did not wear accelerometer and did not complete stress test|2|||
147167239|NCT03230292|530778098|FG000|Overall Study|Adverse Event|1|||
147167240|NCT03230292|530778098|FG000|Overall Study|Protocol Violation|1|||
147323444|NCT04672460|531349898|FG001|Bioequivalence Phase: Period 2 (21 Days)|Withdrawal by Subject|0|||
147323445|NCT04672460|531349897|FG000|Food Effect Phase: Period 3 (21 Days)|Adverse Event|1|||
147167241|NCT03230292|530778098|FG000|Overall Study|Lost to Follow-up|1|||
147167242|NCT03230292|530778098|FG000|Overall Study|Withdrawal by Subject|3|||
147167243|NCT04047420|530778099|FG000|Enrollment (Pre-dose) Period|Refused Participation|2|||
147167244|NCT04047420|530778099|FG000|Washout Period|Refused Participation|2|||
147167245|NCT01639755|530778100|FG000|Overall Study|Study Ongoing|15|||
147167246|NCT01639755|530778100|FG000|Overall Study|Patient had device explantation|4|||
147590279|NCT02939950|532316277|FG001|Overall Study|Adverse Event|3|||
147590280|NCT02939950|532316276|FG000|Overall Study|Randomized, not dispensed|1|||
147590281|NCT02939950|532316277|FG001|Overall Study|Randomized, not dispensed|0|||
147590282|NCT02939950|532316276|FG000|Overall Study|Ineligible at Baseline|2|||
147167247|NCT03629912|530778104|FG000|Overall Study|Lost to Follow-up|19|||
147167248|NCT03629912|530778105|FG001|Overall Study|Lost to Follow-up|7|||
147167249|NCT03629912|530778106|FG002|Overall Study|Lost to Follow-up|5|||
147167250|NCT03629912|530778107|FG003|Overall Study|Lost to Follow-up|1|||
147167251|NCT03629912|530778104|FG000|Overall Study|Withdrawal by Subject|6|||
147167252|NCT03629912|530778105|FG001|Overall Study|Withdrawal by Subject|0|||
147167253|NCT03629912|530778106|FG002|Overall Study|Withdrawal by Subject|1|||
147167254|NCT03629912|530778107|FG003|Overall Study|Withdrawal by Subject|2|||
147167255|NCT03629912|530778104|FG000|Overall Study|Illness or Injury Unrelated to Research Study|3|||
147167256|NCT03629912|530778105|FG001|Overall Study|Illness or Injury Unrelated to Research Study|6|||
147167257|NCT03629912|530778106|FG002|Overall Study|Illness or Injury Unrelated to Research Study|3|||
147167258|NCT03629912|530778107|FG003|Overall Study|Illness or Injury Unrelated to Research Study|1|||
147167259|NCT03629912|530778104|FG000|Overall Study|Death|1|||
147167260|NCT03629912|530778105|FG001|Overall Study|Death|0|||
147167261|NCT03629912|530778106|FG002|Overall Study|Death|0|||
147167262|NCT03629912|530778107|FG003|Overall Study|Death|0|||
147167263|NCT03262116|530778110|FG000|Overall Study|Physician Decision|0|||
147167264|NCT03262116|530778111|FG001|Overall Study|Physician Decision|2|||
147167265|NCT03262116|530778112|FG002|Overall Study|Physician Decision|1|||
147167266|NCT03262116|530778113|FG003|Overall Study|Physician Decision|1|||
147167267|NCT03262116|530778114|FG004|Overall Study|Physician Decision|1|||
147167268|NCT03262116|530778115|FG005|Overall Study|Physician Decision|2|||
147167269|NCT02365285|530778116|FG000|Overall Study|Physician Decision|0|||
147167270|NCT02365285|530778117|FG001|Overall Study|Physician Decision|1|||
147167271|NCT02365285|530778118|FG002|Overall Study|Physician Decision|1|||
147167272|NCT02365285|530778119|FG003|Overall Study|Physician Decision|0|||
147167273|NCT02365285|530778116|FG000|Overall Study|Adverse Event|0|||
147167274|NCT02365285|530778117|FG001|Overall Study|Adverse Event|0|||
147167275|NCT02365285|530778118|FG002|Overall Study|Adverse Event|0|||
147167276|NCT02365285|530778119|FG003|Overall Study|Adverse Event|2|||
147167277|NCT02608450|530778120|FG000|Overall Study|Lost to Follow-up|39|||
147167278|NCT02608450|530778121|FG001|Overall Study|Lost to Follow-up|32|||
147167279|NCT02608450|530778120|FG000|Overall Study|Withdrawal by Subject|21|||
147167280|NCT02608450|530778121|FG001|Overall Study|Withdrawal by Subject|15|||
147167281|NCT02608450|530778120|FG000|Overall Study|Adverse Event|3|||
147167282|NCT02608450|530778121|FG001|Overall Study|Adverse Event|6|||
147167283|NCT02608450|530778120|FG000|Overall Study|Withdrawal by parent|2|||
147167284|NCT02608450|530778121|FG001|Overall Study|Withdrawal by parent|3|||
147167285|NCT02608450|530778120|FG000|Overall Study|Lack of Efficacy|0|||
147167286|NCT02608450|530778121|FG001|Overall Study|Lack of Efficacy|3|||
147167287|NCT02608450|530778120|FG000|Overall Study|Noncompliance with study drug|0|||
147167288|NCT02608450|530778121|FG001|Overall Study|Noncompliance with study drug|2|||
147167289|NCT02608450|530778120|FG000|Overall Study|Physician Decision|0|||
147167290|NCT02608450|530778121|FG001|Overall Study|Physician Decision|1|||
147167291|NCT02608450|530778120|FG000|Overall Study|Pregnancy|0|||
147167292|NCT02608450|530778121|FG001|Overall Study|Pregnancy|1|||
147167293|NCT02608450|530778120|FG000|Overall Study|Progressive disease|1|||
147167294|NCT02608450|530778121|FG001|Overall Study|Progressive disease|0|||
147167295|NCT02608450|530778120|FG000|Overall Study|Multiple reasons|0|||
147167296|NCT02608450|530778121|FG001|Overall Study|Multiple reasons|2|||
147167297|NCT00635089|530778125|FG000|Overall Study|Adverse Event|7|||
147167298|NCT00635089|530778125|FG000|Overall Study|Lack of Efficacy|28|||
147167299|NCT00635089|530778125|FG000|Overall Study|Protocol Deviation|4|||
147167300|NCT00635089|530778125|FG000|Overall Study|Lost to Follow-up|8|||
147167301|NCT00635089|530778125|FG000|Overall Study|Other|31|||
147167302|NCT01283542|530778129|FG000|Main Phase|Acute or progressive vision loss|1|||
147167303|NCT01283542|530778129|FG000|Main Phase|Uncontrolled diabetes mellitus|1|||
147167304|NCT01283542|530778129|FG000|Main Phase|abnormal laboratory values|5|||
147167305|NCT01283542|530778129|FG000|Extension Phase|Physician Decision|1|||
147167306|NCT01283542|530778129|FG000|Extension Phase|Adverse Event|1|||
147590283|NCT02939950|532316277|FG001|Overall Study|Ineligible at Baseline|8|||
147167307|NCT01283542|530778129|FG000|Extension Phase|Administrative problems|1|||
147167308|NCT02636946|530778130|FG000|Cycle 1 (Day 1 to Week 15)|Withdrawal of Consent|0|||
147167309|NCT02636946|530778131|FG001|Cycle 1 (Day 1 to Week 15)|Withdrawal of Consent|1|||
147590284|NCT02243293|532316278|FG000|Overall Study|Adverse Event|1|||
147167310|NCT02636946|530778130|FG000|Cycle 1 (Day 1 to Week 15)|Lost to Follow-up|1|||
147167311|NCT02636946|530778131|FG001|Cycle 1 (Day 1 to Week 15)|Lost to Follow-up|0|||
147167312|NCT02636946|530778130|FG000|Cycle 1 (Day 1 to Week 15)|Protocol Violation|0|||
147243985|NCT03292588|531066851|FG000|Overall Study|Death|1|||
147167313|NCT02636946|530778131|FG001|Cycle 1 (Day 1 to Week 15)|Protocol Violation|1|||
147167314|NCT02636946|530778130|FG000|Cycle 1 (Day 1 to Week 15)|Reason not Specified|0|||
147590285|NCT02243293|532316279|FG001|Overall Study|Adverse Event|0|||
147167315|NCT02636946|530778131|FG001|Cycle 1 (Day 1 to Week 15)|Reason not Specified|1|||
147243986|NCT03292588|531066852|FG001|Overall Study|Death|0|||
147590286|NCT02243293|532316280|FG002|Overall Study|Adverse Event|0|||
147590287|NCT02243293|532316281|FG003|Overall Study|Adverse Event|0|||
147590288|NCT02243293|532316282|FG004|Overall Study|Adverse Event|0|||
147590289|NCT02243293|532316283|FG005|Overall Study|Adverse Event|0|||
147590290|NCT02243293|532316284|FG006|Overall Study|Adverse Event|0|||
147590291|NCT02243293|532316285|FG007|Overall Study|Adverse Event|0|||
147590292|NCT02243293|532316286|FG008|Overall Study|Adverse Event|0|||
147590293|NCT02243293|532316287|FG009|Overall Study|Adverse Event|0|||
147590294|NCT02243293|532316288|FG010|Overall Study|Adverse Event|0|||
147590295|NCT02243293|532316289|FG011|Overall Study|Adverse Event|0|||
147590296|NCT02243293|532316290|FG012|Overall Study|Adverse Event|0|||
147590297|NCT02243293|532316291|FG013|Overall Study|Adverse Event|0|||
147590298|NCT02243293|532316292|FG014|Overall Study|Adverse Event|0|||
147590299|NCT02243293|532316293|FG015|Overall Study|Adverse Event|1|||
147590300|NCT02243293|532316294|FG016|Overall Study|Adverse Event|0|||
147590301|NCT02243293|532316295|FG017|Overall Study|Adverse Event|0|||
147590302|NCT02243293|532316296|FG018|Overall Study|Adverse Event|0|||
147590303|NCT02243293|532316297|FG019|Overall Study|Adverse Event|0|||
147590304|NCT02243293|532316298|FG020|Overall Study|Adverse Event|1|||
147590305|NCT02243293|532316299|FG021|Overall Study|Adverse Event|0|||
147590306|NCT02243293|532316278|FG000|Overall Study|Withdrawal by Subject|1|||
147590307|NCT02243293|532316279|FG001|Overall Study|Withdrawal by Subject|0|||
147590308|NCT02243293|532316280|FG002|Overall Study|Withdrawal by Subject|0|||
147590309|NCT02243293|532316281|FG003|Overall Study|Withdrawal by Subject|0|||
147590310|NCT02243293|532316282|FG004|Overall Study|Withdrawal by Subject|0|||
147590311|NCT02243293|532316283|FG005|Overall Study|Withdrawal by Subject|0|||
147590312|NCT02243293|532316284|FG006|Overall Study|Withdrawal by Subject|0|||
147590313|NCT02243293|532316285|FG007|Overall Study|Withdrawal by Subject|0|||
147590314|NCT02243293|532316286|FG008|Overall Study|Withdrawal by Subject|0|||
147590315|NCT02243293|532316287|FG009|Overall Study|Withdrawal by Subject|1|||
147590316|NCT02243293|532316288|FG010|Overall Study|Withdrawal by Subject|0|||
147590317|NCT02243293|532316289|FG011|Overall Study|Withdrawal by Subject|1|||
147590318|NCT02243293|532316290|FG012|Overall Study|Withdrawal by Subject|0|||
147590319|NCT02243293|532316291|FG013|Overall Study|Withdrawal by Subject|0|||
147590320|NCT02243293|532316292|FG014|Overall Study|Withdrawal by Subject|0|||
147590321|NCT02243293|532316293|FG015|Overall Study|Withdrawal by Subject|0|||
147590322|NCT02243293|532316294|FG016|Overall Study|Withdrawal by Subject|0|||
147590323|NCT02243293|532316295|FG017|Overall Study|Withdrawal by Subject|0|||
147590324|NCT02243293|532316296|FG018|Overall Study|Withdrawal by Subject|0|||
147590325|NCT02243293|532316297|FG019|Overall Study|Withdrawal by Subject|0|||
147590326|NCT02243293|532316298|FG020|Overall Study|Withdrawal by Subject|0|||
147590327|NCT02243293|532316299|FG021|Overall Study|Withdrawal by Subject|1|||
147590328|NCT02243293|532316278|FG000|Overall Study|Lost to Follow-up|0|||
147590329|NCT02243293|532316279|FG001|Overall Study|Lost to Follow-up|1|||
147590330|NCT02243293|532316280|FG002|Overall Study|Lost to Follow-up|1|||
147590331|NCT02243293|532316281|FG003|Overall Study|Lost to Follow-up|1|||
147590332|NCT02243293|532316282|FG004|Overall Study|Lost to Follow-up|0|||
147590333|NCT02243293|532316283|FG005|Overall Study|Lost to Follow-up|0|||
147590334|NCT02243293|532316284|FG006|Overall Study|Lost to Follow-up|3|||
147590335|NCT02243293|532316285|FG007|Overall Study|Lost to Follow-up|0|||
147590336|NCT02243293|532316286|FG008|Overall Study|Lost to Follow-up|0|||
147590337|NCT02243293|532316287|FG009|Overall Study|Lost to Follow-up|0|||
147590338|NCT02243293|532316288|FG010|Overall Study|Lost to Follow-up|0|||
147167316|NCT02636946|530778130|FG000|Cycle 1 (Day 1 to Week 15)|Randomized but not Treated|0|||
147167317|NCT02636946|530778131|FG001|Cycle 1 (Day 1 to Week 15)|Randomized but not Treated|2|||
147167318|NCT02636946|530778130|FG000|Cycle 2 (Week 16 to Week 31)|Adverse Event|2|||
147167319|NCT02636946|530778131|FG001|Cycle 2 (Week 16 to Week 31)|Adverse Event|1|||
147167320|NCT05059977|530778132|FG000|Overall Study|Withdrawal by Subject|0|||
147167321|NCT05059977|530778133|FG001|Overall Study|Withdrawal by Subject|0|||
147167322|NCT05059977|530778134|FG002|Overall Study|Withdrawal by Subject|1|||
147590339|NCT02243293|532316289|FG011|Overall Study|Lost to Follow-up|2|||
147167323|NCT04405245|530778135|FG000|Overall Study|Adverse Event|0|||
147590340|NCT02243293|532316290|FG012|Overall Study|Lost to Follow-up|0|||
147590341|NCT02243293|532316291|FG013|Overall Study|Lost to Follow-up|0|||
147590342|NCT02243293|532316292|FG014|Overall Study|Lost to Follow-up|0|||
147654580|NCT02427802|532556776|FG000|Overall Study|Death|0|||
147167324|NCT04405245|530778136|FG001|Overall Study|Adverse Event|1|||
147243987|NCT03292588|531066851|FG000|Overall Study|Lost to Follow-up|12|||
147447696|NCT00783094|531803936|FG000|Open-Label Extension Period|Lack of Efficacy|1|||
147590343|NCT02243293|532316293|FG015|Overall Study|Lost to Follow-up|0|||
147590344|NCT02243293|532316294|FG016|Overall Study|Lost to Follow-up|3|||
147590345|NCT02243293|532316295|FG017|Overall Study|Lost to Follow-up|1|||
147590346|NCT02243293|532316296|FG018|Overall Study|Lost to Follow-up|0|||
147590347|NCT02243293|532316297|FG019|Overall Study|Lost to Follow-up|0|||
147590348|NCT02243293|532316298|FG020|Overall Study|Lost to Follow-up|1|||
147590349|NCT02243293|532316299|FG021|Overall Study|Lost to Follow-up|2|||
147590350|NCT02243293|532316278|FG000|Overall Study|Enrolled into a Re-treatment Study|0|||
147654581|NCT02427802|532556777|FG001|Overall Study|Death|4|||
147590351|NCT02243293|532316279|FG001|Overall Study|Enrolled into a Re-treatment Study|0|||
147590352|NCT02243293|532316280|FG002|Overall Study|Enrolled into a Re-treatment Study|0|||
147590353|NCT02243293|532316281|FG003|Overall Study|Enrolled into a Re-treatment Study|0|||
147590354|NCT02243293|532316282|FG004|Overall Study|Enrolled into a Re-treatment Study|0|||
147590355|NCT02243293|532316283|FG005|Overall Study|Enrolled into a Re-treatment Study|0|||
147590356|NCT02243293|532316284|FG006|Overall Study|Enrolled into a Re-treatment Study|0|||
147590357|NCT02243293|532316285|FG007|Overall Study|Enrolled into a Re-treatment Study|0|||
147590358|NCT02243293|532316286|FG008|Overall Study|Enrolled into a Re-treatment Study|0|||
147590359|NCT02243293|532316287|FG009|Overall Study|Enrolled into a Re-treatment Study|0|||
147590360|NCT02243293|532316288|FG010|Overall Study|Enrolled into a Re-treatment Study|0|||
147590361|NCT02243293|532316289|FG011|Overall Study|Enrolled into a Re-treatment Study|0|||
147590362|NCT02243293|532316290|FG012|Overall Study|Enrolled into a Re-treatment Study|0|||
147590363|NCT02243293|532316291|FG013|Overall Study|Enrolled into a Re-treatment Study|0|||
147590364|NCT02243293|532316292|FG014|Overall Study|Enrolled into a Re-treatment Study|1|||
147590365|NCT02243293|532316293|FG015|Overall Study|Enrolled into a Re-treatment Study|0|||
147590366|NCT02243293|532316294|FG016|Overall Study|Enrolled into a Re-treatment Study|0|||
147590367|NCT02243293|532316295|FG017|Overall Study|Enrolled into a Re-treatment Study|0|||
147590368|NCT02243293|532316296|FG018|Overall Study|Enrolled into a Re-treatment Study|0|||
147590369|NCT02243293|532316297|FG019|Overall Study|Enrolled into a Re-treatment Study|0|||
147167325|NCT04405245|530778137|FG002|Overall Study|Adverse Event|0|||
147167326|NCT03443427|530778138|FG000|Overall Study|Adverse Event|2|||
147167327|NCT03443427|530778139|FG001|Overall Study|Adverse Event|3|||
147167328|NCT03443427|530778138|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|6|||
147167329|NCT03443427|530778139|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|2|||
147167330|NCT03443427|530778138|FG000|Overall Study|Other|4|||
147167331|NCT03443427|530778139|FG001|Overall Study|Other|6|||
147167332|NCT00576472|530778140|FG000|MPH In-Lab Phase|Declined participation in medication pha|0|||
147167333|NCT00576472|530778141|FG001|MPH In-Lab Phase|Declined participation in medication pha|0|||
147167334|NCT00576472|530778142|FG002|MPH In-Lab Phase|Declined participation in medication pha|0|||
147167335|NCT00576472|530778143|FG003|MPH In-Lab Phase|Declined participation in medication pha|75|||
147167336|NCT00576472|530778144|FG004|MPH In-Lab Phase|Declined participation in medication pha|0|||
147167337|NCT00576472|530778145|FG005|MPH In-Lab Phase|Declined participation in medication pha|0|||
147167338|NCT00576472|530778146|FG006|MPH In-Lab Phase|Declined participation in medication pha|0|||
147167339|NCT00576472|530778147|FG007|MPH In-Lab Phase|Declined participation in medication pha|0|||
147167340|NCT00576472|530778148|FG008|MPH In-Lab Phase|Declined participation in medication pha|0|||
147167341|NCT00576472|530778149|FG009|MPH In-Lab Phase|Declined participation in medication pha|0|||
147167342|NCT00576472|530778150|FG010|MPH In-Lab Phase|Declined participation in medication pha|0|||
147167343|NCT00576472|530778151|FG011|MPH In-Lab Phase|Declined participation in medication pha|0|||
147167344|NCT00576472|530778152|FG012|MPH In-Lab Phase|Declined participation in medication pha|0|||
147167345|NCT00576472|530778153|FG013|MPH In-Lab Phase|Declined participation in medication pha|0|||
147167346|NCT00576472|530778154|FG014|MPH In-Lab Phase|Declined participation in medication pha|0|||
147167347|NCT00576472|530778140|FG000|MPH In-Lab Phase|Lost to Follow-up|0|||
147167348|NCT00576472|530778141|FG001|MPH In-Lab Phase|Lost to Follow-up|0|||
147167349|NCT00576472|530778142|FG002|MPH In-Lab Phase|Lost to Follow-up|0|||
147167350|NCT00576472|530778143|FG003|MPH In-Lab Phase|Lost to Follow-up|1|||
147167351|NCT00576472|530778144|FG004|MPH In-Lab Phase|Lost to Follow-up|0|||
147167352|NCT00576472|530778145|FG005|MPH In-Lab Phase|Lost to Follow-up|0|||
147167353|NCT00576472|530778146|FG006|MPH In-Lab Phase|Lost to Follow-up|0|||
147167354|NCT00576472|530778147|FG007|MPH In-Lab Phase|Lost to Follow-up|0|||
147167355|NCT00576472|530778148|FG008|MPH In-Lab Phase|Lost to Follow-up|0|||
147167356|NCT00576472|530778149|FG009|MPH In-Lab Phase|Lost to Follow-up|0|||
147167357|NCT00576472|530778150|FG010|MPH In-Lab Phase|Lost to Follow-up|0|||
147167358|NCT00576472|530778151|FG011|MPH In-Lab Phase|Lost to Follow-up|0|||
147167359|NCT00576472|530778152|FG012|MPH In-Lab Phase|Lost to Follow-up|0|||
147167360|NCT00576472|530778153|FG013|MPH In-Lab Phase|Lost to Follow-up|0|||
147167361|NCT00576472|530778154|FG014|MPH In-Lab Phase|Lost to Follow-up|0|||
147167362|NCT00576472|530778140|FG000|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
147243988|NCT03292588|531066852|FG001|Overall Study|Lost to Follow-up|16|||
147590370|NCT02243293|532316298|FG020|Overall Study|Enrolled into a Re-treatment Study|0|||
147590371|NCT02243293|532316299|FG021|Overall Study|Enrolled into a Re-treatment Study|0|||
147243989|NCT03292588|531066851|FG000|Overall Study|Physician Decision|0|||
147243990|NCT03292588|531066852|FG001|Overall Study|Physician Decision|1|||
147590372|NCT02243293|532316278|FG000|Overall Study|Randomized but did'nt receive study drug|0|||
147590373|NCT02243293|532316279|FG001|Overall Study|Randomized but did'nt receive study drug|0|||
147590374|NCT02243293|532316280|FG002|Overall Study|Randomized but did'nt receive study drug|0|||
147167363|NCT00576472|530778141|FG001|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
147167364|NCT00576472|530778142|FG002|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
147167365|NCT00576472|530778143|FG003|MPH In-Lab Phase|Patients did not qualify - IQ < 50|4|||
147243991|NCT03292588|531066851|FG000|Overall Study|Withdrawal by Subject|4|||
147243992|NCT03292588|531066852|FG001|Overall Study|Withdrawal by Subject|4|||
147243993|NCT03292588|531066851|FG000|Overall Study|Move out of town|1|||
147167366|NCT00576472|530778144|FG004|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
147167367|NCT00576472|530778145|FG005|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
147167368|NCT00576472|530778146|FG006|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
147167369|NCT00576472|530778147|FG007|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
147167370|NCT00576472|530778148|FG008|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
147167371|NCT00576472|530778149|FG009|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
147167372|NCT00576472|530778150|FG010|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
147167373|NCT00576472|530778151|FG011|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
147167374|NCT00576472|530778152|FG012|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
147167375|NCT00576472|530778153|FG013|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
147167376|NCT00576472|530778154|FG014|MPH In-Lab Phase|Patients did not qualify - IQ < 50|0|||
147167377|NCT00576472|530778140|FG000|MPH In-Lab Phase|No attention/academic problems|0|||
147167378|NCT00576472|530778141|FG001|MPH In-Lab Phase|No attention/academic problems|0|||
147167379|NCT00576472|530778142|FG002|MPH In-Lab Phase|No attention/academic problems|0|||
147167380|NCT00576472|530778143|FG003|MPH In-Lab Phase|No attention/academic problems|245|||
147167381|NCT00576472|530778144|FG004|MPH In-Lab Phase|No attention/academic problems|0|||
147167382|NCT00576472|530778145|FG005|MPH In-Lab Phase|No attention/academic problems|0|||
147167383|NCT00576472|530778146|FG006|MPH In-Lab Phase|No attention/academic problems|0|||
147167384|NCT00576472|530778147|FG007|MPH In-Lab Phase|No attention/academic problems|0|||
147167385|NCT00576472|530778148|FG008|MPH In-Lab Phase|No attention/academic problems|0|||
147167386|NCT00576472|530778149|FG009|MPH In-Lab Phase|No attention/academic problems|0|||
147167387|NCT00576472|530778150|FG010|MPH In-Lab Phase|No attention/academic problems|0|||
147167388|NCT00576472|530778151|FG011|MPH In-Lab Phase|No attention/academic problems|0|||
147167389|NCT00576472|530778152|FG012|MPH In-Lab Phase|No attention/academic problems|0|||
147167390|NCT00576472|530778153|FG013|MPH In-Lab Phase|No attention/academic problems|0|||
147167391|NCT00576472|530778154|FG014|MPH In-Lab Phase|No attention/academic problems|0|||
147167392|NCT00576472|530778140|FG000|MPH In-Lab Phase|Psychiatric exclusion|0|||
147167393|NCT00576472|530778141|FG001|MPH In-Lab Phase|Psychiatric exclusion|0|||
147167394|NCT00576472|530778142|FG002|MPH In-Lab Phase|Psychiatric exclusion|0|||
147167395|NCT00576472|530778143|FG003|MPH In-Lab Phase|Psychiatric exclusion|10|||
147167396|NCT00576472|530778144|FG004|MPH In-Lab Phase|Psychiatric exclusion|0|||
147167397|NCT00576472|530778145|FG005|MPH In-Lab Phase|Psychiatric exclusion|0|||
147167398|NCT00576472|530778146|FG006|MPH In-Lab Phase|Psychiatric exclusion|0|||
147167399|NCT00576472|530778147|FG007|MPH In-Lab Phase|Psychiatric exclusion|0|||
147167400|NCT00576472|530778148|FG008|MPH In-Lab Phase|Psychiatric exclusion|0|||
147167401|NCT00576472|530778149|FG009|MPH In-Lab Phase|Psychiatric exclusion|0|||
147167402|NCT00576472|530778150|FG010|MPH In-Lab Phase|Psychiatric exclusion|0|||
147167403|NCT00576472|530778151|FG011|MPH In-Lab Phase|Psychiatric exclusion|0|||
147167404|NCT00576472|530778152|FG012|MPH In-Lab Phase|Psychiatric exclusion|0|||
147167405|NCT00576472|530778153|FG013|MPH In-Lab Phase|Psychiatric exclusion|0|||
147167406|NCT00576472|530778154|FG014|MPH In-Lab Phase|Psychiatric exclusion|0|||
147167407|NCT00576472|530778140|FG000|MPH Cross Over Phase|Withdrawal by Subject|0|||
147167408|NCT00576472|530778141|FG001|MPH Cross Over Phase|Withdrawal by Subject|0|||
147167409|NCT00576472|530778142|FG002|MPH Cross Over Phase|Withdrawal by Subject|0|||
147447697|NCT00783094|531803937|FG001|Open-Label Extension Period|Lack of Efficacy|4|||
147167410|NCT00576472|530778143|FG003|MPH Cross Over Phase|Withdrawal by Subject|0|||
147167411|NCT00576472|530778144|FG004|MPH Cross Over Phase|Withdrawal by Subject|0|||
147167412|NCT00576472|530778145|FG005|MPH Cross Over Phase|Withdrawal by Subject|0|||
147167413|NCT00576472|530778146|FG006|MPH Cross Over Phase|Withdrawal by Subject|6|||
147167414|NCT00576472|530778147|FG007|MPH Cross Over Phase|Withdrawal by Subject|0|||
147167415|NCT00576472|530778148|FG008|MPH Cross Over Phase|Withdrawal by Subject|0|||
147167416|NCT00576472|530778149|FG009|MPH Cross Over Phase|Withdrawal by Subject|0|||
147167417|NCT00576472|530778150|FG010|MPH Cross Over Phase|Withdrawal by Subject|0|||
147167418|NCT00576472|530778151|FG011|MPH Cross Over Phase|Withdrawal by Subject|0|||
147167419|NCT00576472|530778152|FG012|MPH Cross Over Phase|Withdrawal by Subject|0|||
147167420|NCT00576472|530778153|FG013|MPH Cross Over Phase|Withdrawal by Subject|0|||
147447698|NCT00783094|531803938|FG002|Open-Label Extension Period|Lack of Efficacy|0|||
147167421|NCT00576472|530778154|FG014|MPH Cross Over Phase|Withdrawal by Subject|0|||
147167422|NCT00576472|530778140|FG000|MPH Cross Over Phase|Ineligible due to disease|0|||
147167423|NCT00576472|530778141|FG001|MPH Cross Over Phase|Ineligible due to disease|0|||
147167424|NCT00576472|530778142|FG002|MPH Cross Over Phase|Ineligible due to disease|0|||
147167425|NCT00576472|530778143|FG003|MPH Cross Over Phase|Ineligible due to disease|0|||
147167426|NCT00576472|530778144|FG004|MPH Cross Over Phase|Ineligible due to disease|0|||
147167427|NCT00576472|530778145|FG005|MPH Cross Over Phase|Ineligible due to disease|0|||
147167428|NCT00576472|530778146|FG006|MPH Cross Over Phase|Ineligible due to disease|2|||
147167429|NCT00576472|530778147|FG007|MPH Cross Over Phase|Ineligible due to disease|0|||
147167430|NCT00576472|530778148|FG008|MPH Cross Over Phase|Ineligible due to disease|0|||
147447699|NCT02513329|531803939|FG000|Overall Study|Lost to Follow-up|5|||
147447700|NCT02513329|531803940|FG001|Overall Study|Lost to Follow-up|2|||
147590375|NCT02243293|532316281|FG003|Overall Study|Randomized but did'nt receive study drug|0|||
147654582|NCT02427802|532556778|FG002|Overall Study|Death|1|||
147243994|NCT03292588|531066852|FG001|Overall Study|Move out of town|0|||
147243995|NCT03292588|531066851|FG000|Overall Study|>3 bursts of systemic corticosteroids for asthma during treatment period (Starting Nov 2020)|2|||
147243996|NCT03292588|531066852|FG001|Overall Study|>3 bursts of systemic corticosteroids for asthma during treatment period (Starting Nov 2020)|1|||
147243997|NCT00617123|531066853|FG000|Referral Screening Period|Did Not Meet Protocol Eligibility|36|||
147243998|NCT00617123|531066854|FG001|Referral Screening Period|Did Not Meet Protocol Eligibility|24|||
147243999|NCT00617123|531066853|FG000|Referral Screening Period|Did Not Wish To Continue|3|||
147244000|NCT00617123|531066854|FG001|Referral Screening Period|Did Not Wish To Continue|1|||
147244001|NCT00617123|531066853|FG000|Referral Screening Period|Adverse Event|0|||
147244002|NCT00617123|531066854|FG001|Referral Screening Period|Adverse Event|1|||
147244003|NCT00617123|531066853|FG000|Study Treatment Period|Withdrawal by Subject|8|||
147244004|NCT00617123|531066854|FG001|Study Treatment Period|Withdrawal by Subject|12|||
147244005|NCT00617123|531066853|FG000|Study Treatment Period|Adverse Event|7|||
147244006|NCT00617123|531066854|FG001|Study Treatment Period|Adverse Event|3|||
147244007|NCT00617123|531066853|FG000|Study Treatment Period|Did Not Meet Protocol Eligibility|2|||
147244008|NCT00617123|531066854|FG001|Study Treatment Period|Did Not Meet Protocol Eligibility|0|||
147244009|NCT00617123|531066853|FG000|Study Treatment Period|Noncompliance with Protocol|0|||
147244010|NCT00617123|531066854|FG001|Study Treatment Period|Noncompliance with Protocol|1|||
147244011|NCT00133952|531066855|FG000|Overall Study|Adverse Event|1|||
147244012|NCT00133952|531066856|FG001|Overall Study|Adverse Event|2|||
147244013|NCT00133952|531066855|FG000|Overall Study|Death|3|||
147244014|NCT00133952|531066856|FG001|Overall Study|Death|2|||
147244015|NCT00133952|531066855|FG000|Overall Study|Lost to Follow-up|9|||
147244016|NCT00133952|531066856|FG001|Overall Study|Lost to Follow-up|14|||
147244017|NCT00133952|531066855|FG000|Overall Study|Protocol Entry Criteria Exclusion|4|||
147244018|NCT00133952|531066856|FG001|Overall Study|Protocol Entry Criteria Exclusion|1|||
147244019|NCT00133952|531066855|FG000|Overall Study|Protocol Violation|1|||
147244020|NCT00133952|531066856|FG001|Overall Study|Protocol Violation|1|||
147244021|NCT00133952|531066855|FG000|Overall Study|Withdrawal by Subject|20|||
147244022|NCT00133952|531066856|FG001|Overall Study|Withdrawal by Subject|4|||
147244023|NCT00133952|531066855|FG000|Overall Study|Physician Decision|4|||
147244024|NCT00133952|531066856|FG001|Overall Study|Physician Decision|3|||
147244025|NCT00133952|531066855|FG000|Overall Study|Sponsor Decision|0|||
147244026|NCT00133952|531066856|FG001|Overall Study|Sponsor Decision|1|||
147244027|NCT05048784|531066860|FG000|Period 1|Adverse Event|3|||
147244028|NCT05048784|531066861|FG001|Period 1|Adverse Event|1|||
147244029|NCT05048784|531066862|FG002|Period 1|Adverse Event|0|||
147244030|NCT05048784|531066863|FG003|Period 1|Adverse Event|0|||
147244031|NCT05048784|531066860|FG000|Period 2|Lost to Follow-up|0|||
147244032|NCT05048784|531066861|FG001|Period 2|Lost to Follow-up|1|||
147244033|NCT05048784|531066862|FG002|Period 2|Lost to Follow-up|0|||
147244034|NCT05048784|531066863|FG003|Period 2|Lost to Follow-up|0|||
147244035|NCT03462082|531066868|FG000|Open Label Phase|Symptom worsening (Treatment failure)|0|||
147244036|NCT03462082|531066869|FG001|Open Label Phase|Symptom worsening (Treatment failure)|0|||
147244037|NCT03462082|531066870|FG002|Open Label Phase|Symptom worsening (Treatment failure)|0|||
147244038|NCT03462082|531066871|FG003|Open Label Phase|Symptom worsening (Treatment failure)|0|||
147244039|NCT03462082|531066872|FG004|Open Label Phase|Symptom worsening (Treatment failure)|0|||
147244040|NCT03462082|531066873|FG005|Open Label Phase|Symptom worsening (Treatment failure)|0|||
147244041|NCT03462082|531066874|FG006|Open Label Phase|Symptom worsening (Treatment failure)|1|||
147244042|NCT03462082|531066875|FG007|Open Label Phase|Symptom worsening (Treatment failure)|2|||
147244043|NCT00166114|531066878|FG000|Overall Study|Protocol Violation|2|||
147244044|NCT00166114|531066879|FG001|Overall Study|Protocol Violation|1|||
147244045|NCT00166114|531066878|FG000|Overall Study|Withdrawal by Subject|10|||
147244046|NCT00166114|531066879|FG001|Overall Study|Withdrawal by Subject|4|||
147244047|NCT00166114|531066878|FG000|Overall Study|Adverse Event|2|||
147244048|NCT00166114|531066879|FG001|Overall Study|Adverse Event|1|||
147244049|NCT00545168|531066886|FG000|Overall Study|Lost to Follow-up|5|||
147244050|NCT00545168|531066887|FG001|Overall Study|Lost to Follow-up|5|||
147244051|NCT00545168|531066888|FG002|Overall Study|Lost to Follow-up|5|||
147244052|NCT00545168|531066886|FG000|Overall Study|Withdrawal by Subject|9|||
147244053|NCT00545168|531066887|FG001|Overall Study|Withdrawal by Subject|0|||
147244054|NCT00545168|531066888|FG002|Overall Study|Withdrawal by Subject|13|||
147244055|NCT00545168|531066886|FG000|Overall Study|Protocol Violation|1|||
147244056|NCT00545168|531066887|FG001|Overall Study|Protocol Violation|0|||
147244057|NCT00545168|531066888|FG002|Overall Study|Protocol Violation|1|||
147244058|NCT00545168|531066886|FG000|Overall Study|Visit for Day 21 was not done in error|1|||
147244059|NCT00545168|531066887|FG001|Overall Study|Visit for Day 21 was not done in error|0|||
147244060|NCT00545168|531066888|FG002|Overall Study|Visit for Day 21 was not done in error|2|||
147244061|NCT02548650|531066901|FG000|Triple Therapy|Adverse Event|1|||
147244062|NCT02548650|531066902|FG001|Triple Therapy|Adverse Event|0|||
147244063|NCT02548650|531066901|FG000|Triple Therapy|Withdrawal by Subject|0|||
147244064|NCT02548650|531066902|FG001|Triple Therapy|Withdrawal by Subject|4|||
147244065|NCT02548650|531066901|FG000|Double Therapy|Adverse Event|1|||
147244066|NCT02548650|531066902|FG001|Double Therapy|Adverse Event|1|||
147244067|NCT02548650|531066901|FG000|Double Therapy|Withdrawal by Subject|0|||
147167431|NCT00576472|530778149|FG009|MPH Cross Over Phase|Ineligible due to disease|0|||
147167432|NCT00576472|530778150|FG010|MPH Cross Over Phase|Ineligible due to disease|0|||
147167433|NCT00576472|530778151|FG011|MPH Cross Over Phase|Ineligible due to disease|0|||
147590376|NCT02243293|532316282|FG004|Overall Study|Randomized but did'nt receive study drug|1|||
147590377|NCT02243293|532316283|FG005|Overall Study|Randomized but did'nt receive study drug|0|||
147590378|NCT02243293|532316284|FG006|Overall Study|Randomized but did'nt receive study drug|0|||
147590379|NCT02243293|532316285|FG007|Overall Study|Randomized but did'nt receive study drug|0|||
147590380|NCT02243293|532316286|FG008|Overall Study|Randomized but did'nt receive study drug|0|||
147590381|NCT02243293|532316287|FG009|Overall Study|Randomized but did'nt receive study drug|1|||
147590382|NCT02243293|532316288|FG010|Overall Study|Randomized but did'nt receive study drug|0|||
147590383|NCT02243293|532316289|FG011|Overall Study|Randomized but did'nt receive study drug|0|||
147590384|NCT02243293|532316290|FG012|Overall Study|Randomized but did'nt receive study drug|0|||
147167434|NCT00576472|530778152|FG012|MPH Cross Over Phase|Ineligible due to disease|0|||
147167435|NCT00576472|530778153|FG013|MPH Cross Over Phase|Ineligible due to disease|0|||
147167436|NCT00576472|530778154|FG014|MPH Cross Over Phase|Ineligible due to disease|0|||
147167437|NCT00576472|530778140|FG000|MPH Cross Over Phase|Physician Decision|0|||
147167438|NCT00576472|530778141|FG001|MPH Cross Over Phase|Physician Decision|0|||
147167439|NCT00576472|530778142|FG002|MPH Cross Over Phase|Physician Decision|0|||
147167440|NCT00576472|530778143|FG003|MPH Cross Over Phase|Physician Decision|0|||
147167441|NCT00576472|530778144|FG004|MPH Cross Over Phase|Physician Decision|0|||
147167442|NCT00576472|530778145|FG005|MPH Cross Over Phase|Physician Decision|0|||
147167443|NCT00576472|530778146|FG006|MPH Cross Over Phase|Physician Decision|4|||
147167444|NCT00576472|530778147|FG007|MPH Cross Over Phase|Physician Decision|0|||
147167445|NCT00576472|530778148|FG008|MPH Cross Over Phase|Physician Decision|0|||
147167446|NCT00576472|530778149|FG009|MPH Cross Over Phase|Physician Decision|0|||
147167447|NCT00576472|530778150|FG010|MPH Cross Over Phase|Physician Decision|0|||
147167448|NCT00576472|530778151|FG011|MPH Cross Over Phase|Physician Decision|0|||
147167449|NCT00576472|530778152|FG012|MPH Cross Over Phase|Physician Decision|0|||
147167450|NCT00576472|530778153|FG013|MPH Cross Over Phase|Physician Decision|0|||
147167451|NCT00576472|530778154|FG014|MPH Cross Over Phase|Physician Decision|0|||
147167452|NCT00576472|530778140|FG000|MPH Cross Over Phase|Did not complete cross over phase|0|||
147167453|NCT00576472|530778141|FG001|MPH Cross Over Phase|Did not complete cross over phase|0|||
147167454|NCT00576472|530778142|FG002|MPH Cross Over Phase|Did not complete cross over phase|0|||
147167455|NCT00576472|530778143|FG003|MPH Cross Over Phase|Did not complete cross over phase|0|||
147167456|NCT00576472|530778144|FG004|MPH Cross Over Phase|Did not complete cross over phase|0|||
147167457|NCT00576472|530778145|FG005|MPH Cross Over Phase|Did not complete cross over phase|0|||
147167458|NCT00576472|530778146|FG006|MPH Cross Over Phase|Did not complete cross over phase|0|||
147167459|NCT00576472|530778147|FG007|MPH Cross Over Phase|Did not complete cross over phase|0|||
147167460|NCT00576472|530778148|FG008|MPH Cross Over Phase|Did not complete cross over phase|2|||
147167461|NCT00576472|530778149|FG009|MPH Cross Over Phase|Did not complete cross over phase|0|||
147167462|NCT00576472|530778150|FG010|MPH Cross Over Phase|Did not complete cross over phase|1|||
147167463|NCT00576472|530778151|FG011|MPH Cross Over Phase|Did not complete cross over phase|1|||
147167464|NCT00576472|530778152|FG012|MPH Cross Over Phase|Did not complete cross over phase|0|||
147167465|NCT00576472|530778153|FG013|MPH Cross Over Phase|Did not complete cross over phase|0|||
147167466|NCT00576472|530778154|FG014|MPH Cross Over Phase|Did not complete cross over phase|0|||
147167467|NCT00576472|530778140|FG000|MPH Home Maintenance Phase|Did not meet response criteria|0|||
147167468|NCT00576472|530778141|FG001|MPH Home Maintenance Phase|Did not meet response criteria|0|||
147167469|NCT00576472|530778142|FG002|MPH Home Maintenance Phase|Did not meet response criteria|0|||
147167470|NCT00576472|530778143|FG003|MPH Home Maintenance Phase|Did not meet response criteria|0|||
147167471|NCT00576472|530778144|FG004|MPH Home Maintenance Phase|Did not meet response criteria|0|||
147167472|NCT00576472|530778145|FG005|MPH Home Maintenance Phase|Did not meet response criteria|0|||
147167473|NCT00576472|530778146|FG006|MPH Home Maintenance Phase|Did not meet response criteria|0|||
147167474|NCT00576472|530778147|FG007|MPH Home Maintenance Phase|Did not meet response criteria|0|||
147167475|NCT00576472|530778148|FG008|MPH Home Maintenance Phase|Did not meet response criteria|0|||
147590385|NCT02243293|532316291|FG013|Overall Study|Randomized but did'nt receive study drug|0|||
147167476|NCT00576472|530778149|FG009|MPH Home Maintenance Phase|Did not meet response criteria|0|||
147167477|NCT00576472|530778150|FG010|MPH Home Maintenance Phase|Did not meet response criteria|0|||
147167478|NCT00576472|530778151|FG011|MPH Home Maintenance Phase|Did not meet response criteria|0|||
147167479|NCT00576472|530778152|FG012|MPH Home Maintenance Phase|Did not meet response criteria|0|||
147167480|NCT00576472|530778153|FG013|MPH Home Maintenance Phase|Did not meet response criteria|16|||
147167481|NCT00576472|530778154|FG014|MPH Home Maintenance Phase|Did not meet response criteria|0|||
147167482|NCT00576472|530778140|FG000|MPH Home Maintenance Phase|Declined to participate|0|||
147167483|NCT00576472|530778141|FG001|MPH Home Maintenance Phase|Declined to participate|0|||
147167484|NCT00576472|530778142|FG002|MPH Home Maintenance Phase|Declined to participate|0|||
147167485|NCT00576472|530778143|FG003|MPH Home Maintenance Phase|Declined to participate|0|||
147167486|NCT00576472|530778144|FG004|MPH Home Maintenance Phase|Declined to participate|0|||
147167487|NCT00576472|530778145|FG005|MPH Home Maintenance Phase|Declined to participate|0|||
147167488|NCT00576472|530778146|FG006|MPH Home Maintenance Phase|Declined to participate|0|||
147167489|NCT00576472|530778147|FG007|MPH Home Maintenance Phase|Declined to participate|0|||
147167490|NCT00576472|530778148|FG008|MPH Home Maintenance Phase|Declined to participate|0|||
147167491|NCT00576472|530778149|FG009|MPH Home Maintenance Phase|Declined to participate|0|||
147167492|NCT00576472|530778150|FG010|MPH Home Maintenance Phase|Declined to participate|0|||
147167493|NCT00576472|530778151|FG011|MPH Home Maintenance Phase|Declined to participate|0|||
147167494|NCT00576472|530778152|FG012|MPH Home Maintenance Phase|Declined to participate|0|||
147167495|NCT00576472|530778153|FG013|MPH Home Maintenance Phase|Declined to participate|7|||
147167496|NCT00576472|530778154|FG014|MPH Home Maintenance Phase|Declined to participate|0|||
147167497|NCT00576472|530778140|FG000|MPH Home Maintenance Phase|Insufficient data|0|||
147167498|NCT00576472|530778141|FG001|MPH Home Maintenance Phase|Insufficient data|0|||
147167499|NCT00576472|530778142|FG002|MPH Home Maintenance Phase|Insufficient data|0|||
147167500|NCT00576472|530778143|FG003|MPH Home Maintenance Phase|Insufficient data|0|||
147167501|NCT00576472|530778144|FG004|MPH Home Maintenance Phase|Insufficient data|0|||
147167502|NCT00576472|530778145|FG005|MPH Home Maintenance Phase|Insufficient data|0|||
147167503|NCT00576472|530778146|FG006|MPH Home Maintenance Phase|Insufficient data|0|||
147167504|NCT00576472|530778147|FG007|MPH Home Maintenance Phase|Insufficient data|0|||
147167505|NCT00576472|530778148|FG008|MPH Home Maintenance Phase|Insufficient data|0|||
147167506|NCT00576472|530778149|FG009|MPH Home Maintenance Phase|Insufficient data|0|||
147167507|NCT00576472|530778150|FG010|MPH Home Maintenance Phase|Insufficient data|0|||
147167508|NCT00576472|530778151|FG011|MPH Home Maintenance Phase|Insufficient data|0|||
147167509|NCT00576472|530778152|FG012|MPH Home Maintenance Phase|Insufficient data|0|||
147167510|NCT00576472|530778153|FG013|MPH Home Maintenance Phase|Insufficient data|4|||
147167511|NCT00576472|530778154|FG014|MPH Home Maintenance Phase|Insufficient data|0|||
147167512|NCT00576472|530778140|FG000|MPH Home Maintenance Phase|Side effects|0|||
147167513|NCT00576472|530778141|FG001|MPH Home Maintenance Phase|Side effects|0|||
147167514|NCT00576472|530778142|FG002|MPH Home Maintenance Phase|Side effects|0|||
147167515|NCT00576472|530778143|FG003|MPH Home Maintenance Phase|Side effects|0|||
147167516|NCT00576472|530778144|FG004|MPH Home Maintenance Phase|Side effects|0|||
147167517|NCT00576472|530778145|FG005|MPH Home Maintenance Phase|Side effects|0|||
147167518|NCT00576472|530778146|FG006|MPH Home Maintenance Phase|Side effects|0|||
147167519|NCT00576472|530778147|FG007|MPH Home Maintenance Phase|Side effects|0|||
147167520|NCT00576472|530778148|FG008|MPH Home Maintenance Phase|Side effects|0|||
147167521|NCT00576472|530778149|FG009|MPH Home Maintenance Phase|Side effects|0|||
147167522|NCT00576472|530778150|FG010|MPH Home Maintenance Phase|Side effects|0|||
147167523|NCT00576472|530778151|FG011|MPH Home Maintenance Phase|Side effects|0|||
147167524|NCT00576472|530778152|FG012|MPH Home Maintenance Phase|Side effects|0|||
147167525|NCT00576472|530778153|FG013|MPH Home Maintenance Phase|Side effects|0|||
147167526|NCT00576472|530778154|FG014|MPH Home Maintenance Phase|Side effects|8|||
147167527|NCT00576472|530778140|FG000|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
147167528|NCT00576472|530778141|FG001|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
147167529|NCT00576472|530778142|FG002|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
147167530|NCT00576472|530778143|FG003|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
147167531|NCT00576472|530778144|FG004|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
147167532|NCT00576472|530778145|FG005|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
147167533|NCT00576472|530778146|FG006|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
147167534|NCT00576472|530778147|FG007|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
147167535|NCT00576472|530778148|FG008|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
147167536|NCT00576472|530778149|FG009|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
147167537|NCT00576472|530778150|FG010|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
147167538|NCT00576472|530778151|FG011|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
147323446|NCT04672460|531349898|FG001|Food Effect Phase: Period 3 (21 Days)|Adverse Event|0|||
147323447|NCT04672460|531349897|FG000|Food Effect Phase: Period 3 (21 Days)|Progressive disease|3|||
147323448|NCT04672460|531349898|FG001|Food Effect Phase: Period 3 (21 Days)|Progressive disease|1|||
147323449|NCT04672460|531349897|FG000|Food Effect Phase: Period 3 (21 Days)|Withdrawal by Subject|0|||
147323450|NCT04672460|531349898|FG001|Food Effect Phase: Period 3 (21 Days)|Withdrawal by Subject|1|||
147323451|NCT04672460|531349897|FG000|Food Effect Phase: Period 3 (21 Days)|Refused further treatment|0|||
147323452|NCT04672460|531349898|FG001|Food Effect Phase: Period 3 (21 Days)|Refused further treatment|1|||
147323453|NCT04672460|531349897|FG000|Food Effect Phase: Period 3 (21 Days)|Other|1|||
147447701|NCT01294670|531803941|FG000|Overall Study|Not treated|1|||
147447702|NCT01294670|531803942|FG001|Overall Study|Not treated|0|||
147167539|NCT00576472|530778152|FG012|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
147167540|NCT00576472|530778153|FG013|MPH Home Maintenance Phase|Withdrawal by Subject|0|||
147167541|NCT00576472|530778154|FG014|MPH Home Maintenance Phase|Withdrawal by Subject|6|||
147167542|NCT00576472|530778140|FG000|MPH Home Maintenance Phase|Medical reasons|0|||
147654583|NCT02427802|532556776|FG000|Overall Study|Lost to Follow-up|13|||
147167543|NCT00576472|530778141|FG001|MPH Home Maintenance Phase|Medical reasons|0|||
147167544|NCT00576472|530778142|FG002|MPH Home Maintenance Phase|Medical reasons|0|||
147167545|NCT00576472|530778143|FG003|MPH Home Maintenance Phase|Medical reasons|0|||
147167546|NCT00576472|530778144|FG004|MPH Home Maintenance Phase|Medical reasons|0|||
147167547|NCT00576472|530778145|FG005|MPH Home Maintenance Phase|Medical reasons|0|||
147167548|NCT00576472|530778146|FG006|MPH Home Maintenance Phase|Medical reasons|0|||
147167549|NCT00576472|530778147|FG007|MPH Home Maintenance Phase|Medical reasons|0|||
147167550|NCT00576472|530778148|FG008|MPH Home Maintenance Phase|Medical reasons|0|||
147167551|NCT00576472|530778149|FG009|MPH Home Maintenance Phase|Medical reasons|0|||
147167552|NCT00576472|530778150|FG010|MPH Home Maintenance Phase|Medical reasons|0|||
147167553|NCT00576472|530778151|FG011|MPH Home Maintenance Phase|Medical reasons|0|||
147167554|NCT00576472|530778152|FG012|MPH Home Maintenance Phase|Medical reasons|0|||
147167555|NCT00576472|530778153|FG013|MPH Home Maintenance Phase|Medical reasons|0|||
147167556|NCT00576472|530778154|FG014|MPH Home Maintenance Phase|Medical reasons|6|||
147167557|NCT00576472|530778140|FG000|MPH Home Maintenance Phase|Lost to Follow-up|0|||
147167558|NCT00576472|530778141|FG001|MPH Home Maintenance Phase|Lost to Follow-up|0|||
147167559|NCT00576472|530778142|FG002|MPH Home Maintenance Phase|Lost to Follow-up|0|||
147167560|NCT00576472|530778143|FG003|MPH Home Maintenance Phase|Lost to Follow-up|0|||
147167561|NCT00576472|530778144|FG004|MPH Home Maintenance Phase|Lost to Follow-up|0|||
147167562|NCT00576472|530778145|FG005|MPH Home Maintenance Phase|Lost to Follow-up|0|||
147167563|NCT00576472|530778146|FG006|MPH Home Maintenance Phase|Lost to Follow-up|0|||
147167564|NCT00576472|530778147|FG007|MPH Home Maintenance Phase|Lost to Follow-up|0|||
147167565|NCT00576472|530778148|FG008|MPH Home Maintenance Phase|Lost to Follow-up|0|||
147167566|NCT00576472|530778149|FG009|MPH Home Maintenance Phase|Lost to Follow-up|0|||
147167567|NCT00576472|530778150|FG010|MPH Home Maintenance Phase|Lost to Follow-up|0|||
147167568|NCT00576472|530778151|FG011|MPH Home Maintenance Phase|Lost to Follow-up|0|||
147167569|NCT00576472|530778152|FG012|MPH Home Maintenance Phase|Lost to Follow-up|0|||
147167570|NCT00576472|530778153|FG013|MPH Home Maintenance Phase|Lost to Follow-up|0|||
147167571|NCT00576472|530778154|FG014|MPH Home Maintenance Phase|Lost to Follow-up|3|||
147167572|NCT02576860|530778158|FG000|Overall Study|Adverse Event|6|||
147167573|NCT02576860|530778159|FG001|Overall Study|Adverse Event|6|||
147167574|NCT02576860|530778158|FG000|Overall Study|Lost to Follow-up|5|||
147167575|NCT02576860|530778159|FG001|Overall Study|Lost to Follow-up|7|||
147167576|NCT02576860|530778158|FG000|Overall Study|Physician Decision|0|||
147167577|NCT02576860|530778159|FG001|Overall Study|Physician Decision|1|||
147167578|NCT02576860|530778158|FG000|Overall Study|Protocol Violation|0|||
147167579|NCT02576860|530778159|FG001|Overall Study|Protocol Violation|2|||
147167580|NCT02576860|530778158|FG000|Overall Study|Withdrawal by Subject|13|||
147167581|NCT02576860|530778159|FG001|Overall Study|Withdrawal by Subject|8|||
147167582|NCT02576860|530778158|FG000|Overall Study|Disallowed medication|1|||
147167583|NCT02576860|530778159|FG001|Overall Study|Disallowed medication|0|||
147167584|NCT00477269|530778160|FG000|Core Study|Adverse Event|6|||
147167585|NCT00477269|530778161|FG001|Core Study|Adverse Event|4|||
147167586|NCT00477269|530778162|FG002|Core Study|Adverse Event|0|||
147167587|NCT00477269|530778160|FG000|Core Study|Death|3|||
147167588|NCT00477269|530778161|FG001|Core Study|Death|3|||
147167589|NCT00477269|530778162|FG002|Core Study|Death|0|||
147167590|NCT00477269|530778160|FG000|Core Study|Withdrawn Consent|0|||
147167591|NCT00477269|530778161|FG001|Core Study|Withdrawn Consent|1|||
147167592|NCT00477269|530778162|FG002|Core Study|Withdrawn Consent|0|||
147167593|NCT00477269|530778160|FG000|Open Label Extension|Adverse Event|0|||
147167594|NCT00477269|530778161|FG001|Open Label Extension|Adverse Event|0|||
147167595|NCT00477269|530778162|FG002|Open Label Extension|Adverse Event|4|||
147167596|NCT00477269|530778160|FG000|Open Label Extension|Abnormal laboratory values|0|||
147167597|NCT00477269|530778161|FG001|Open Label Extension|Abnormal laboratory values|0|||
147167598|NCT00477269|530778162|FG002|Open Label Extension|Abnormal laboratory values|1|||
147167599|NCT00477269|530778160|FG000|Open Label Extension|unsatisfactory therapeutic effects|0|||
147167600|NCT00477269|530778161|FG001|Open Label Extension|unsatisfactory therapeutic effects|0|||
147167601|NCT00477269|530778162|FG002|Open Label Extension|unsatisfactory therapeutic effects|2|||
147167602|NCT00477269|530778160|FG000|Open Label Extension|Adminiatrative problems|0|||
147167603|NCT00477269|530778161|FG001|Open Label Extension|Adminiatrative problems|0|||
147167604|NCT00477269|530778162|FG002|Open Label Extension|Adminiatrative problems|2|||
147167605|NCT00477269|530778160|FG000|Open Label Extension|Death|0|||
147167606|NCT00477269|530778161|FG001|Open Label Extension|Death|0|||
147244068|NCT02548650|531066902|FG001|Double Therapy|Withdrawal by Subject|1|||
147654584|NCT02427802|532556777|FG001|Overall Study|Lost to Follow-up|8|||
147654585|NCT02427802|532556778|FG002|Overall Study|Lost to Follow-up|8|||
147654586|NCT02427802|532556776|FG000|Overall Study|Physician Decision|4|||
147654587|NCT02427802|532556777|FG001|Overall Study|Physician Decision|2|||
147167607|NCT00477269|530778162|FG002|Open Label Extension|Death|4|||
147244069|NCT02128113|531066904|FG000|Overall Study|Withdrawal by Subject|3|||
147244070|NCT02128113|531066905|FG001|Overall Study|Withdrawal by Subject|1|||
147244071|NCT02128113|531066906|FG002|Overall Study|Withdrawal by Subject|0|||
147244072|NCT02128113|531066904|FG000|Overall Study|Protocol Violation|0|||
147654588|NCT02427802|532556778|FG002|Overall Study|Physician Decision|4|||
147167608|NCT02391961|530778163|FG000|First Intervention (4 Weeks)|Adverse Event|2|||
147167609|NCT02391961|530778164|FG001|First Intervention (4 Weeks)|Adverse Event|0|||
147167610|NCT02391961|530778163|FG000|Washout (2 Weeks)|Withdrawal by Subject|1|||
147167611|NCT02391961|530778164|FG001|Washout (2 Weeks)|Withdrawal by Subject|1|||
147167612|NCT02391961|530778163|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
147167613|NCT02391961|530778164|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
147167614|NCT01792518|530778173|FG000|Overall Study|Adverse Event|3|||
147167615|NCT01792518|530778174|FG001|Overall Study|Adverse Event|4|||
147167616|NCT01792518|530778173|FG000|Overall Study|Protocol Violation|0|||
147167617|NCT01792518|530778174|FG001|Overall Study|Protocol Violation|1|||
147167618|NCT01792518|530778173|FG000|Overall Study|Lost to Follow-up|3|||
147167619|NCT01792518|530778174|FG001|Overall Study|Lost to Follow-up|1|||
147167620|NCT01792518|530778173|FG000|Overall Study|Withdrawal by Subject|2|||
147167621|NCT01792518|530778174|FG001|Overall Study|Withdrawal by Subject|0|||
147167622|NCT01792518|530778173|FG000|Overall Study|Other Reason|0|||
147167623|NCT01792518|530778174|FG001|Overall Study|Other Reason|1|||
147167624|NCT03263780|530778175|FG000|Overall Study|Withdrawal by Subject|3|||
147167625|NCT03263780|530778175|FG000|Overall Study|Ineligible (incomplete post-HIFU)|7|||
147167626|NCT00249613|530778180|FG000|12 Month Follow-up|Death|1|||
147167627|NCT00249613|530778181|FG001|12 Month Follow-up|Death|1|||
147167628|NCT00249613|530778180|FG000|12 Month Follow-up|Withdrawal by Subject|6|||
147167629|NCT00249613|530778181|FG001|12 Month Follow-up|Withdrawal by Subject|6|||
147167630|NCT00249613|530778180|FG000|12 Month Follow-up|Lost to Follow-up|10|||
147167631|NCT00249613|530778181|FG001|12 Month Follow-up|Lost to Follow-up|8|||
147167632|NCT00806442|530778182|FG000|Overall Study|Lost to Follow-up|3|||
147167633|NCT00806442|530778183|FG001|Overall Study|Lost to Follow-up|2|||
147167634|NCT00806442|530778182|FG000|Overall Study|Withdrawal by Subject|1|||
147167635|NCT00806442|530778183|FG001|Overall Study|Withdrawal by Subject|5|||
147167636|NCT00424190|530778198|FG000|Overall Study|Withdrew consent|3|||
147167637|NCT00424190|530778199|FG001|Overall Study|Withdrew consent|4|||
147167638|NCT00424190|530778198|FG000|Overall Study|Death|3|||
147167639|NCT00424190|530778199|FG001|Overall Study|Death|0|||
147167640|NCT00424190|530778198|FG000|Overall Study|Noncompliance|1|||
147167641|NCT00424190|530778199|FG001|Overall Study|Noncompliance|2|||
147167642|NCT00424190|530778198|FG000|Overall Study|Request of sponsor or investigator|0|||
147167643|NCT00424190|530778199|FG001|Overall Study|Request of sponsor or investigator|2|||
147167644|NCT00424190|530778198|FG000|Overall Study|Diagnosis of osteomyelitis|0|||
147167645|NCT00424190|530778199|FG001|Overall Study|Diagnosis of osteomyelitis|1|||
147167646|NCT00424190|530778198|FG000|Overall Study|Other|15|||
147167647|NCT00424190|530778199|FG001|Overall Study|Other|21|||
147167648|NCT00351273|530778200|FG000|Overall Study|Lost to Follow-up|1|||
147167649|NCT00351273|530778201|FG001|Overall Study|Lost to Follow-up|2|||
147167650|NCT00351273|530778202|FG002|Overall Study|Lost to Follow-up|5|||
147167651|NCT02241187|530778203|FG000|Overall Study|Protocol closed due to lack of accrual.|2|||
147167652|NCT00199888|530778204|FG000|Overall Study|Lost to Follow-up|1|||
147167653|NCT05219669|530778207|FG000|Period 1 (1 Day)|Withdrawal by Subject|0|||
147167654|NCT05219669|530778208|FG001|Period 1 (1 Day)|Withdrawal by Subject|0|||
147167655|NCT05219669|530778209|FG002|Period 1 (1 Day)|Withdrawal by Subject|1|||
147167656|NCT05219669|530778210|FG003|Period 1 (1 Day)|Withdrawal by Subject|0|||
147167657|NCT05219669|530778211|FG004|Period 1 (1 Day)|Withdrawal by Subject|0|||
147167658|NCT05219669|530778212|FG005|Period 1 (1 Day)|Withdrawal by Subject|0|||
147167659|NCT00330668|530778213|FG000|BID Dosing Period|Adverse Event|1|||
147167660|NCT00330668|530778213|FG000|BID Dosing Period|Lost to Follow-up|7|||
147167661|NCT00330668|530778213|FG000|BID Dosing Period|Non-Compliance|5|||
147167662|NCT00330668|530778213|FG000|BID Dosing Period|Withdrawal by Subject|19|||
147167663|NCT00330668|530778213|FG000|BID Dosing Period|Sponsor's decision|1|||
147167664|NCT00330668|530778213|FG000|BID Dosing Period|Other|3|||
147167665|NCT00330668|530778213|FG000|QD Dosing Period|Sponsor decision to terminate study|74|||
147167666|NCT00330668|530778213|FG000|QD Dosing Period|Other|1|||
147167667|NCT00330668|530778213|FG000|QD Dosing Period|Withdrawal by Subject|1|||
147167668|NCT00330668|530778213|FG000|QD Dosing Period|Lost to Follow-up|2|||
147167669|NCT02920957|530778214|FG000|First Intervention : 1 Month|Withdrawal by Subject|2|||
147167670|NCT02920957|530778215|FG001|First Intervention : 1 Month|Withdrawal by Subject|0|||
147167671|NCT02920957|530778214|FG000|First Intervention : 1 Month|Lost to Follow-up|1|||
147167672|NCT02920957|530778215|FG001|First Intervention : 1 Month|Lost to Follow-up|0|||
147167673|NCT02920957|530778214|FG000|First Intervention : 1 Month|Adverse Event|1|||
147167674|NCT02920957|530778215|FG001|First Intervention : 1 Month|Adverse Event|0|||
147167675|NCT02920957|530778214|FG000|Second Intervention: 1 Month|Lost to Follow-up|0|||
147167676|NCT02920957|530778215|FG001|Second Intervention: 1 Month|Lost to Follow-up|1|||
147167677|NCT00558272|530778216|FG000|Overall Study|Adverse Event|10|||
147167678|NCT00558272|530778217|FG001|Overall Study|Adverse Event|0|||
147167679|NCT00558272|530778216|FG000|Overall Study|Death|1|||
147167680|NCT00558272|530778217|FG001|Overall Study|Death|0|||
147167681|NCT00558272|530778216|FG000|Overall Study|Dev. of study specific discon. criteria|1|||
147244073|NCT02128113|531066905|FG001|Overall Study|Protocol Violation|1|||
147244074|NCT02128113|531066906|FG002|Overall Study|Protocol Violation|0|||
147167682|NCT00558272|530778217|FG001|Overall Study|Dev. of study specific discon. criteria|0|||
147167683|NCT00558272|530778216|FG000|Overall Study|AZ study team decision|0|||
147167684|NCT00558272|530778217|FG001|Overall Study|AZ study team decision|1|||
147167685|NCT00558272|530778216|FG000|Overall Study|Incorrectly enrolled|1|||
147167686|NCT00558272|530778217|FG001|Overall Study|Incorrectly enrolled|0|||
147167687|NCT00558272|530778216|FG000|Overall Study|Withdrawal by Subject|0|||
147167688|NCT00558272|530778217|FG001|Overall Study|Withdrawal by Subject|1|||
147167689|NCT03442296|530778219|FG000|3 Month Follow-up|Death|3|||
147167690|NCT03442296|530778220|FG001|3 Month Follow-up|Death|1|||
147167691|NCT03442296|530778219|FG000|3 Month Follow-up|Lost to Follow-up|1|||
147167692|NCT03442296|530778220|FG001|3 Month Follow-up|Lost to Follow-up|1|||
147167693|NCT03442296|530778219|FG000|3 Month Follow-up|Withdrawal by Subject|1|||
147167694|NCT03442296|530778220|FG001|3 Month Follow-up|Withdrawal by Subject|0|||
147167695|NCT03442296|530778219|FG000|3 Month Follow-up|Obtained Hearing Aids|0|||
147167696|NCT03442296|530778220|FG001|3 Month Follow-up|Obtained Hearing Aids|1|||
147167697|NCT03442296|530778219|FG000|12 Month Follow-up|Incomplete measurement|1|||
147167698|NCT03442296|530778220|FG001|12 Month Follow-up|Incomplete measurement|1|||
147167699|NCT03684694|530778221|FG000|Phase 1|Withdrawal by Subject|1|||
147167700|NCT03684694|530778222|FG001|Phase 1|Withdrawal by Subject|0|||
147167701|NCT03684694|530778223|FG002|Phase 1|Withdrawal by Subject|0|||
147167702|NCT03684694|530778224|FG003|Phase 1|Withdrawal by Subject|0|||
147167703|NCT03684694|530778225|FG004|Phase 1|Withdrawal by Subject|0|||
147167704|NCT03684694|530778226|FG005|Phase 1|Withdrawal by Subject|0|||
147167705|NCT03684694|530778221|FG000|Phase 1|Investigator/Sponsor Decision|12|||
147167706|NCT03684694|530778222|FG001|Phase 1|Investigator/Sponsor Decision|2|||
147167707|NCT03684694|530778223|FG002|Phase 1|Investigator/Sponsor Decision|1|||
147167708|NCT03684694|530778224|FG003|Phase 1|Investigator/Sponsor Decision|0|||
147167709|NCT03684694|530778225|FG004|Phase 1|Investigator/Sponsor Decision|0|||
147167710|NCT03684694|530778226|FG005|Phase 1|Investigator/Sponsor Decision|0|||
147167711|NCT03684694|530778221|FG000|Phase 1|Death|24|||
147167712|NCT03684694|530778222|FG001|Phase 1|Death|0|||
147167713|NCT03684694|530778223|FG002|Phase 1|Death|3|||
147167714|NCT03684694|530778224|FG003|Phase 1|Death|0|||
147167715|NCT03684694|530778225|FG004|Phase 1|Death|0|||
147167716|NCT03684694|530778226|FG005|Phase 1|Death|0|||
147167717|NCT03684694|530778221|FG000|Phase 1|Lost to Follow-up|0|||
147167718|NCT03684694|530778222|FG001|Phase 1|Lost to Follow-up|0|||
147167719|NCT03684694|530778223|FG002|Phase 1|Lost to Follow-up|1|||
147167720|NCT03684694|530778224|FG003|Phase 1|Lost to Follow-up|0|||
147167721|NCT03684694|530778225|FG004|Phase 1|Lost to Follow-up|0|||
147167722|NCT03684694|530778226|FG005|Phase 1|Lost to Follow-up|0|||
147167723|NCT03684694|530778221|FG000|Phase 1|Miscellaneous|0|||
147167724|NCT03684694|530778222|FG001|Phase 1|Miscellaneous|1|||
147167725|NCT03684694|530778223|FG002|Phase 1|Miscellaneous|0|||
147167726|NCT03684694|530778224|FG003|Phase 1|Miscellaneous|0|||
147167727|NCT03684694|530778225|FG004|Phase 1|Miscellaneous|0|||
147167728|NCT03684694|530778226|FG005|Phase 1|Miscellaneous|0|||
147167729|NCT03684694|530778221|FG000|Phase 2|Withdrawal by Subject|0|||
147167730|NCT03684694|530778222|FG001|Phase 2|Withdrawal by Subject|0|||
147167731|NCT03684694|530778223|FG002|Phase 2|Withdrawal by Subject|0|||
147167732|NCT03684694|530778224|FG003|Phase 2|Withdrawal by Subject|0|||
147167733|NCT03684694|530778225|FG004|Phase 2|Withdrawal by Subject|0|||
147167734|NCT03684694|530778226|FG005|Phase 2|Withdrawal by Subject|1|||
147167735|NCT03684694|530778221|FG000|Phase 2|Investigator/Sponsor Decision|0|||
147167736|NCT03684694|530778222|FG001|Phase 2|Investigator/Sponsor Decision|0|||
147167737|NCT03684694|530778223|FG002|Phase 2|Investigator/Sponsor Decision|0|||
147167738|NCT03684694|530778224|FG003|Phase 2|Investigator/Sponsor Decision|17|||
147167739|NCT03684694|530778225|FG004|Phase 2|Investigator/Sponsor Decision|16|||
147167740|NCT03684694|530778226|FG005|Phase 2|Investigator/Sponsor Decision|6|||
147167741|NCT03684694|530778221|FG000|Phase 2|Death|0|||
147167742|NCT03684694|530778222|FG001|Phase 2|Death|0|||
147167743|NCT03684694|530778223|FG002|Phase 2|Death|0|||
147167744|NCT03684694|530778224|FG003|Phase 2|Death|28|||
147167745|NCT03684694|530778225|FG004|Phase 2|Death|14|||
147167746|NCT03684694|530778226|FG005|Phase 2|Death|3|||
147167747|NCT03684694|530778221|FG000|Phase 2|Lost to Follow-up|0|||
147167748|NCT03684694|530778222|FG001|Phase 2|Lost to Follow-up|0|||
147167749|NCT03684694|530778223|FG002|Phase 2|Lost to Follow-up|0|||
147167750|NCT03684694|530778224|FG003|Phase 2|Lost to Follow-up|1|||
147167751|NCT03684694|530778225|FG004|Phase 2|Lost to Follow-up|0|||
147167752|NCT03684694|530778226|FG005|Phase 2|Lost to Follow-up|0|||
147167753|NCT03684694|530778221|FG000|Phase 2|Miscellaneous|0|||
147167754|NCT03684694|530778222|FG001|Phase 2|Miscellaneous|0|||
147167755|NCT03684694|530778223|FG002|Phase 2|Miscellaneous|0|||
147167756|NCT03684694|530778224|FG003|Phase 2|Miscellaneous|3|||
147167757|NCT03684694|530778225|FG004|Phase 2|Miscellaneous|0|||
147167758|NCT03684694|530778226|FG005|Phase 2|Miscellaneous|0|||
147167759|NCT05011513|530779785|FG000|Overall Study|Death|0|||
147167760|NCT05011513|530779786|FG001|Overall Study|Death|1|||
147167761|NCT05011513|530779785|FG000|Overall Study|Lost to Follow-up|4|||
147167762|NCT05011513|530779786|FG001|Overall Study|Lost to Follow-up|0|||
147167763|NCT05011513|530779785|FG000|Overall Study|Withdrawal by Subject|18|||
147167764|NCT05011513|530779786|FG001|Overall Study|Withdrawal by Subject|17|||
147167765|NCT05011513|530779785|FG000|Overall Study|Other|4|||
147167766|NCT05011513|530779786|FG001|Overall Study|Other|2|||
147167767|NCT03667690|530779787|FG000|Overall Study|Adverse Event|0|||
147167768|NCT03667690|530779788|FG001|Overall Study|Adverse Event|3|||
147167769|NCT03667690|530779787|FG000|Overall Study|Death|22|||
147167770|NCT03667690|530779788|FG001|Overall Study|Death|21|||
147167771|NCT03667690|530779787|FG000|Overall Study|Lost to Follow-up|4|||
147167772|NCT03667690|530779788|FG001|Overall Study|Lost to Follow-up|5|||
147167773|NCT03667690|530779787|FG000|Overall Study|Withdrawal by Subject|7|||
147167774|NCT03667690|530779788|FG001|Overall Study|Withdrawal by Subject|8|||
147167775|NCT03667690|530779787|FG000|Overall Study|Subject could not return for additional investigational product|1|||
147167776|NCT03667690|530779788|FG001|Overall Study|Subject could not return for additional investigational product|0|||
147167777|NCT03667690|530779787|FG000|Overall Study|Subject discharged to hospice care|2|||
147167778|NCT03667690|530779788|FG001|Overall Study|Subject discharged to hospice care|0|||
147167779|NCT03667690|530779787|FG000|Overall Study|Withdrawal of consent by subject's legally authorized representative; subject placed in hospice|1|||
147167780|NCT03667690|530779788|FG001|Overall Study|Withdrawal of consent by subject's legally authorized representative; subject placed in hospice|0|||
147167781|NCT03667690|530779787|FG000|Overall Study|Study visit missed or conducted over the phone due to Coronavirus disease 2019 (COVID-19) pandemic|2|||
147167782|NCT03667690|530779788|FG001|Overall Study|Study visit missed or conducted over the phone due to Coronavirus disease 2019 (COVID-19) pandemic|1|||
147167783|NCT03667690|530779787|FG000|Overall Study|Diagnosis of other types of invasive candidiasis|1|||
147167784|NCT03667690|530779788|FG001|Overall Study|Diagnosis of other types of invasive candidiasis|1|||
147167785|NCT03667690|530779787|FG000|Overall Study|Subject was dropped due to exclusion criterion number 9|1|||
147167786|NCT03667690|530779788|FG001|Overall Study|Subject was dropped due to exclusion criterion number 9|0|||
147167787|NCT03667690|530779787|FG000|Overall Study|Per Medical Monitor, visits performed over the phone were to be considered as early discontinuation|0|||
147167788|NCT03667690|530779788|FG001|Overall Study|Per Medical Monitor, visits performed over the phone were to be considered as early discontinuation|1|||
147167789|NCT04327024|530779790|FG000|Overall Study|Death|1|||
147167790|NCT04327024|530779791|FG001|Overall Study|Death|2|||
147167791|NCT04327024|530779792|FG002|Overall Study|Death|1|||
147167792|NCT04327024|530779790|FG000|Overall Study|Non-compliance with study drug|0|||
147167793|NCT04327024|530779791|FG001|Overall Study|Non-compliance with study drug|1|||
147167794|NCT04327024|530779792|FG002|Overall Study|Non-compliance with study drug|0|||
147167795|NCT04327024|530779790|FG000|Overall Study|Withdrawal by Subject|1|||
147167796|NCT04327024|530779791|FG001|Overall Study|Withdrawal by Subject|1|||
147167797|NCT04327024|530779792|FG002|Overall Study|Withdrawal by Subject|2|||
147167798|NCT00837759|530779794|FG000|Overall Study|Protocol Violation|3|||
147167799|NCT00837759|530779794|FG000|Overall Study|Lost to Follow-up|1|||
147167800|NCT01073930|530779796|FG000|Overall Study|Withdrawal by Subject|3|||
147167801|NCT01073930|530779797|FG001|Overall Study|Withdrawal by Subject|2|||
147167802|NCT01073930|530779796|FG000|Overall Study|Lost to Follow-up|0|||
147167803|NCT01073930|530779797|FG001|Overall Study|Lost to Follow-up|1|||
147167804|NCT01073930|530779796|FG000|Overall Study|Adverse Event|0|||
147167805|NCT01073930|530779797|FG001|Overall Study|Adverse Event|1|||
147167806|NCT01073930|530779796|FG000|Overall Study|Noncompliance with study drug|0|||
147167807|NCT01073930|530779797|FG001|Overall Study|Noncompliance with study drug|1|||
147167808|NCT01073930|530779796|FG000|Overall Study|Inadequate prep; unable to do procedure|0|||
147167809|NCT01073930|530779797|FG001|Overall Study|Inadequate prep; unable to do procedure|1|||
147167810|NCT01022424|530779798|FG000|Overall Study|Adverse Event|1|||
147167811|NCT01022424|530779798|FG000|Overall Study|Physician Decision|1|||
147167812|NCT01022424|530779798|FG000|Overall Study|eGFR under the withdrawal criteria|2|||
147167813|NCT00720343|530779799|FG000|Overall Study|Lost to Follow-up|1|||
147167814|NCT00720343|530779800|FG001|Overall Study|Lost to Follow-up|0|||
147167815|NCT00720343|530779799|FG000|Overall Study|Protocol Violation|0|||
147167816|NCT00720343|530779800|FG001|Overall Study|Protocol Violation|2|||
147167817|NCT03459365|530779801|FG000|Overall Study|Withdrawal by Subject|6|||
147167818|NCT03459365|530779801|FG000|Overall Study|Protocol Violation|8|||
147167819|NCT04037254|530779802|FG000|Overall Study|Protocol Violation|1|||
147167820|NCT04037254|530779803|FG001|Overall Study|Protocol Violation|0|||
147167821|NCT04037254|530779804|FG002|Overall Study|Protocol Violation|0|||
147167822|NCT04037254|530779805|FG003|Overall Study|Protocol Violation|0|||
147167823|NCT04037254|530779806|FG004|Overall Study|Protocol Violation|0|||
147167824|NCT04037254|530779802|FG000|Overall Study|Withdrawal by Subject|0|||
147167825|NCT04037254|530779803|FG001|Overall Study|Withdrawal by Subject|0|||
147167826|NCT04037254|530779804|FG002|Overall Study|Withdrawal by Subject|1|||
147167827|NCT04037254|530779805|FG003|Overall Study|Withdrawal by Subject|0|||
147167828|NCT04037254|530779806|FG004|Overall Study|Withdrawal by Subject|0|||
147167829|NCT04037254|530779802|FG000|Overall Study|Delayed or incomplete treatment|0|||
147323454|NCT04672460|531349898|FG001|Food Effect Phase: Period 3 (21 Days)|Other|0|||
147323455|NCT04672460|531349897|FG000|Maintenance Phase: Period 4 (28 Days)|Adverse Event|1|||
147323456|NCT04672460|531349898|FG001|Maintenance Phase: Period 4 (28 Days)|Adverse Event|0|||
147167830|NCT04037254|530779803|FG001|Overall Study|Delayed or incomplete treatment|2|||
147167831|NCT04037254|530779804|FG002|Overall Study|Delayed or incomplete treatment|1|||
147167832|NCT04037254|530779805|FG003|Overall Study|Delayed or incomplete treatment|0|||
147167833|NCT04037254|530779806|FG004|Overall Study|Delayed or incomplete treatment|0|||
147167834|NCT03320330|530779807|FG000|Overall Study|Lack of Efficacy|5|||
147167835|NCT03320330|530779808|FG001|Overall Study|Lack of Efficacy|5|||
147167836|NCT03320330|530779809|FG002|Overall Study|Lack of Efficacy|14|||
147167837|NCT03320330|530779807|FG000|Overall Study|Physician Decision|1|||
147167838|NCT03320330|530779808|FG001|Overall Study|Physician Decision|0|||
147244075|NCT02128113|531066904|FG000|Overall Study|Surgery cancelled|0|||
147244076|NCT02128113|531066905|FG001|Overall Study|Surgery cancelled|1|||
147244077|NCT02128113|531066906|FG002|Overall Study|Surgery cancelled|0|||
147244078|NCT02128113|531066904|FG000|Overall Study|Adverse Event|0|||
147244079|NCT02128113|531066905|FG001|Overall Study|Adverse Event|0|||
147244080|NCT02128113|531066906|FG002|Overall Study|Adverse Event|1|||
147244081|NCT00299104|531066907|FG000|Treatment Period|Adverse Event|14|||
147244082|NCT00299104|531066908|FG001|Treatment Period|Adverse Event|9|||
147244083|NCT00299104|531066909|FG002|Treatment Period|Adverse Event|7|||
147244084|NCT00299104|531066907|FG000|Treatment Period|Death|1|||
147244085|NCT00299104|531066908|FG001|Treatment Period|Death|1|||
147244086|NCT00299104|531066909|FG002|Treatment Period|Death|1|||
147244087|NCT00299104|531066907|FG000|Treatment Period|Insufficient therapeutic response|34|||
147244088|NCT00299104|531066908|FG001|Treatment Period|Insufficient therapeutic response|13|||
147244089|NCT00299104|531066909|FG002|Treatment Period|Insufficient therapeutic response|8|||
147244090|NCT00299104|531066907|FG000|Treatment Period|Failure to return|9|||
147244091|NCT00299104|531066908|FG001|Treatment Period|Failure to return|8|||
147244092|NCT00299104|531066909|FG002|Treatment Period|Failure to return|8|||
147244093|NCT00299104|531066907|FG000|Treatment Period|Violation of selection criteria|1|||
147244094|NCT00299104|531066908|FG001|Treatment Period|Violation of selection criteria|2|||
147244095|NCT00299104|531066909|FG002|Treatment Period|Violation of selection criteria|0|||
147244096|NCT00299104|531066907|FG000|Treatment Period|Protocol Violation|1|||
147244097|NCT00299104|531066908|FG001|Treatment Period|Protocol Violation|1|||
147244098|NCT00299104|531066909|FG002|Treatment Period|Protocol Violation|0|||
147244099|NCT00299104|531066907|FG000|Treatment Period|Refused treatment|9|||
147244100|NCT00299104|531066908|FG001|Treatment Period|Refused treatment|2|||
147244101|NCT00299104|531066909|FG002|Treatment Period|Refused treatment|2|||
147244102|NCT00299104|531066907|FG000|Treatment Period|Withdrew consent|14|||
147244103|NCT00299104|531066908|FG001|Treatment Period|Withdrew consent|19|||
147244104|NCT00299104|531066909|FG002|Treatment Period|Withdrew consent|9|||
147244105|NCT00299104|531066907|FG000|Treatment Period|Administrative reasons|106|||
147244106|NCT00299104|531066908|FG001|Treatment Period|Administrative reasons|120|||
147244107|NCT00299104|531066909|FG002|Treatment Period|Administrative reasons|137|||
147244108|NCT00299104|531066907|FG000|Safety Follow-Up (SFU) Period|Death|3|||
147244109|NCT00299104|531066908|FG001|Safety Follow-Up (SFU) Period|Death|2|||
147244110|NCT00299104|531066909|FG002|Safety Follow-Up (SFU) Period|Death|1|||
147244111|NCT00299104|531066907|FG000|Safety Follow-Up (SFU) Period|Lost to Follow-up|9|||
147590386|NCT02243293|532316292|FG014|Overall Study|Randomized but did'nt receive study drug|0|||
147590387|NCT02243293|532316293|FG015|Overall Study|Randomized but did'nt receive study drug|0|||
147590388|NCT02243293|532316294|FG016|Overall Study|Randomized but did'nt receive study drug|0|||
147590389|NCT02243293|532316295|FG017|Overall Study|Randomized but did'nt receive study drug|0|||
147590390|NCT02243293|532316296|FG018|Overall Study|Randomized but did'nt receive study drug|0|||
147590391|NCT02243293|532316297|FG019|Overall Study|Randomized but did'nt receive study drug|1|||
147590392|NCT02243293|532316298|FG020|Overall Study|Randomized but did'nt receive study drug|0|||
147590393|NCT02243293|532316299|FG021|Overall Study|Randomized but did'nt receive study drug|0|||
147590394|NCT00440115|532316300|FG000|Overall Study|Death|7|||
147590395|NCT00440115|532316301|FG001|Overall Study|Death|9|||
147590396|NCT00440115|532316302|FG002|Overall Study|Death|5|||
147590397|NCT00440115|532316300|FG000|Overall Study|Incarceration|0|||
147590398|NCT00440115|532316301|FG001|Overall Study|Incarceration|2|||
147590399|NCT00440115|532316302|FG002|Overall Study|Incarceration|1|||
147590400|NCT02377063|532316303|FG000|Overall Study|Non-compliance|5|||
147590401|NCT01524913|532316304|FG000|Overall Study|Lost to Follow-up|4|||
147590402|NCT01524913|532316305|FG001|Overall Study|Lost to Follow-up|0|||
147590403|NCT01524913|532316306|FG002|Overall Study|Lost to Follow-up|0|||
147590404|NCT00702208|532316307|FG000|Overall Study|Lost to Follow-up|28|||
147590405|NCT00702208|532316307|FG000|Overall Study|Did not self-lavage|1|||
147590406|NCT00702208|532316307|FG000|Overall Study|Unsatisfactory colposcopy|2|||
147590407|NCT03064438|532318951|FG000|Overall Study|Lost to Follow-up|1|||
147590408|NCT03064438|532318952|FG001|Overall Study|Lost to Follow-up|0|||
147590409|NCT03064438|532318951|FG000|Overall Study|Withdrawal by Subject|0|||
147590410|NCT03064438|532318952|FG001|Overall Study|Withdrawal by Subject|1|||
147590411|NCT01937351|532318953|FG000|Overall Study|Withdrawal by Subject|4|||
147590412|NCT01937351|532318954|FG001|Overall Study|Withdrawal by Subject|2|||
147590413|NCT01937351|532318953|FG000|Overall Study|Death|1|||
147590414|NCT01937351|532318954|FG001|Overall Study|Death|0|||
147590415|NCT01937351|532318953|FG000|Overall Study|Not treated w device, per protocol fail|4|||
147590416|NCT01937351|532318954|FG001|Overall Study|Not treated w device, per protocol fail|0|||
147590417|NCT01223235|532318955|FG000|Overall Study|Withdrawal by Subject|1|||
147590418|NCT00865098|532318957|FG000|Overall Study|Progressive disease|1|||
147590419|NCT03265288|532318960|FG000|Overall Study|Adverse Event|0|||
147590420|NCT03265288|532318961|FG001|Overall Study|Adverse Event|1|||
147244112|NCT00299104|531066908|FG001|Safety Follow-Up (SFU) Period|Lost to Follow-up|11|||
147244113|NCT00299104|531066909|FG002|Safety Follow-Up (SFU) Period|Lost to Follow-up|20|||
147244114|NCT00299104|531066907|FG000|Safety Follow-Up (SFU) Period|Withdrawal by Subject|16|||
147244115|NCT00299104|531066908|FG001|Safety Follow-Up (SFU) Period|Withdrawal by Subject|21|||
147447703|NCT01294670|531803943|FG002|Overall Study|Not treated|0|||
147447704|NCT01294670|531803944|FG003|Overall Study|Not treated|0|||
147447705|NCT01294670|531803945|FG004|Overall Study|Not treated|0|||
147447706|NCT02083380|531803948|FG000|Overall Study|Lack of Efficacy|68|||
147447707|NCT02083380|531803949|FG001|Overall Study|Lack of Efficacy|79|||
147447708|NCT02083380|531803950|FG002|Overall Study|Lack of Efficacy|64|||
147447709|NCT02083380|531803948|FG000|Overall Study|Withdrawal by Subject|9|||
147447710|NCT02083380|531803949|FG001|Overall Study|Withdrawal by Subject|3|||
147447711|NCT02083380|531803950|FG002|Overall Study|Withdrawal by Subject|7|||
147447712|NCT02083380|531803948|FG000|Overall Study|Physician Decision|1|||
147447713|NCT02083380|531803949|FG001|Overall Study|Physician Decision|6|||
147447714|NCT02083380|531803950|FG002|Overall Study|Physician Decision|3|||
147447715|NCT02083380|531803948|FG000|Overall Study|Adverse Event|0|||
147447716|NCT02083380|531803949|FG001|Overall Study|Adverse Event|0|||
147447717|NCT02083380|531803950|FG002|Overall Study|Adverse Event|1|||
147447718|NCT02083380|531803948|FG000|Overall Study|Lost to Follow-up|5|||
147447719|NCT02083380|531803949|FG001|Overall Study|Lost to Follow-up|3|||
147447720|NCT02083380|531803950|FG002|Overall Study|Lost to Follow-up|3|||
147447721|NCT02083380|531803948|FG000|Overall Study|Other|8|||
147447722|NCT02083380|531803949|FG001|Overall Study|Other|4|||
147447723|NCT02083380|531803950|FG002|Overall Study|Other|6|||
147590421|NCT03265288|532318960|FG000|Overall Study|Withdrawal by Subject|13|||
147590422|NCT03265288|532318961|FG001|Overall Study|Withdrawal by Subject|5|||
147590423|NCT03265288|532318960|FG000|Overall Study|Drug Withdrawn|3|||
147590424|NCT03265288|532318961|FG001|Overall Study|Drug Withdrawn|3|||
147167839|NCT03320330|530779809|FG002|Overall Study|Physician Decision|0|||
147167840|NCT02198794|530779810|FG000|Part A: Open-Label (158 Weeks)|Withdrawal by Subject|79|||
147167841|NCT02198794|530779811|FG001|Part A: Open-Label (158 Weeks)|Withdrawal by Subject|0|||
147167842|NCT02198794|530779812|FG002|Part A: Open-Label (158 Weeks)|Withdrawal by Subject|0|||
147167843|NCT02198794|530779813|FG003|Part A: Open-Label (158 Weeks)|Withdrawal by Subject|0|||
147167844|NCT02198794|530779810|FG000|Part A: Open-Label (158 Weeks)|Adverse Event|33|||
147167845|NCT02198794|530779811|FG001|Part A: Open-Label (158 Weeks)|Adverse Event|0|||
147167846|NCT02198794|530779812|FG002|Part A: Open-Label (158 Weeks)|Adverse Event|0|||
147167847|NCT02198794|530779813|FG003|Part A: Open-Label (158 Weeks)|Adverse Event|0|||
147167848|NCT02198794|530779810|FG000|Part A: Open-Label (158 Weeks)|Lost to Follow-up|24|||
147167849|NCT02198794|530779811|FG001|Part A: Open-Label (158 Weeks)|Lost to Follow-up|0|||
147167850|NCT02198794|530779812|FG002|Part A: Open-Label (158 Weeks)|Lost to Follow-up|0|||
147167851|NCT02198794|530779813|FG003|Part A: Open-Label (158 Weeks)|Lost to Follow-up|0|||
147167852|NCT02198794|530779810|FG000|Part A: Open-Label (158 Weeks)|Lack of Efficacy|9|||
147167853|NCT02198794|530779811|FG001|Part A: Open-Label (158 Weeks)|Lack of Efficacy|0|||
147167854|NCT02198794|530779812|FG002|Part A: Open-Label (158 Weeks)|Lack of Efficacy|0|||
147167855|NCT02198794|530779813|FG003|Part A: Open-Label (158 Weeks)|Lack of Efficacy|0|||
147167856|NCT02198794|530779810|FG000|Part A: Open-Label (158 Weeks)|Death|8|||
147167857|NCT02198794|530779811|FG001|Part A: Open-Label (158 Weeks)|Death|0|||
147167858|NCT02198794|530779812|FG002|Part A: Open-Label (158 Weeks)|Death|0|||
147167859|NCT02198794|530779813|FG003|Part A: Open-Label (158 Weeks)|Death|0|||
147167860|NCT02198794|530779810|FG000|Part A: Open-Label (158 Weeks)|Noncompliance with study drug|3|||
147167861|NCT02198794|530779811|FG001|Part A: Open-Label (158 Weeks)|Noncompliance with study drug|0|||
147167862|NCT02198794|530779812|FG002|Part A: Open-Label (158 Weeks)|Noncompliance with study drug|0|||
147167863|NCT02198794|530779813|FG003|Part A: Open-Label (158 Weeks)|Noncompliance with study drug|0|||
147167864|NCT02198794|530779810|FG000|Part A: Open-Label (158 Weeks)|Other than specified|5|||
147167865|NCT02198794|530779811|FG001|Part A: Open-Label (158 Weeks)|Other than specified|0|||
147167866|NCT02198794|530779812|FG002|Part A: Open-Label (158 Weeks)|Other than specified|0|||
147167867|NCT02198794|530779813|FG003|Part A: Open-Label (158 Weeks)|Other than specified|0|||
147167868|NCT02198794|530779810|FG000|Part A: Open-Label (158 Weeks)|Study terminated|1|||
147167869|NCT02198794|530779811|FG001|Part A: Open-Label (158 Weeks)|Study terminated|0|||
147167870|NCT02198794|530779812|FG002|Part A: Open-Label (158 Weeks)|Study terminated|0|||
147167871|NCT02198794|530779813|FG003|Part A: Open-Label (158 Weeks)|Study terminated|0|||
147167872|NCT02198794|530779810|FG000|Part A: Open-Label (158 Weeks)|Protocol deviation|1|||
147167873|NCT02198794|530779811|FG001|Part A: Open-Label (158 Weeks)|Protocol deviation|0|||
147167874|NCT02198794|530779812|FG002|Part A: Open-Label (158 Weeks)|Protocol deviation|0|||
147167875|NCT02198794|530779813|FG003|Part A: Open-Label (158 Weeks)|Protocol deviation|0|||
147167876|NCT02198794|530779810|FG000|Part A: Open-Label (158 Weeks)|Agreed to continue in Part B|142|||
147167877|NCT02198794|530779811|FG001|Part A: Open-Label (158 Weeks)|Agreed to continue in Part B|0|||
147447724|NCT04091087|531803951|FG000|Overall Study|Not treated|1|||
147447725|NCT04091087|531803952|FG001|Overall Study|Not treated|0|||
147447726|NCT04091087|531803951|FG000|Overall Study|Adverse Event|4|||
147447727|NCT04091087|531803952|FG001|Overall Study|Adverse Event|4|||
147447728|NCT04091087|531803951|FG000|Overall Study|Protocol Violation|0|||
147447729|NCT04091087|531803952|FG001|Overall Study|Protocol Violation|1|||
147447730|NCT04091087|531803951|FG000|Overall Study|Withdrawal by Subject|5|||
147447731|NCT04091087|531803952|FG001|Overall Study|Withdrawal by Subject|2|||
147447732|NCT03808077|531803953|FG000|Overall Study|Physician Decision|2|||
147447733|NCT03808077|531803954|FG001|Overall Study|Physician Decision|3|||
147590425|NCT03265288|532318960|FG000|Overall Study|Any Other Reason|7|||
147590426|NCT03265288|532318961|FG001|Overall Study|Any Other Reason|3|||
147590427|NCT01715896|532318970|FG000|Overall Study|Lost to Follow-up|0|||
147590428|NCT01715896|532318971|FG001|Overall Study|Lost to Follow-up|2|||
147590429|NCT01715896|532318970|FG000|Overall Study|Withdrawal by Subject|1|||
147590430|NCT01715896|532318971|FG001|Overall Study|Withdrawal by Subject|4|||
147590431|NCT01715896|532318970|FG000|Overall Study|Other|2|||
147590432|NCT01715896|532318971|FG001|Overall Study|Other|5|||
147590433|NCT05506358|532318972|FG000|Overall Study|Sickle cell disease with transfusion within 3 months|2|||
147590434|NCT05506358|532318973|FG001|Overall Study|Sickle cell disease with transfusion within 3 months|0|||
147590435|NCT05506358|532318974|FG002|Overall Study|Sickle cell disease with transfusion within 3 months|0|||
147590436|NCT05506358|532318975|FG003|Overall Study|Sickle cell disease with transfusion within 3 months|0|||
147590437|NCT05506358|532318976|FG004|Overall Study|Sickle cell disease with transfusion within 3 months|0|||
147590438|NCT05506358|532318972|FG000|Overall Study|Sickle cell disease with Hereditary persistence of fetal hemoglobin (HPFH)|2|||
147590439|NCT05506358|532318973|FG001|Overall Study|Sickle cell disease with Hereditary persistence of fetal hemoglobin (HPFH)|0|||
147590440|NCT05506358|532318974|FG002|Overall Study|Sickle cell disease with Hereditary persistence of fetal hemoglobin (HPFH)|0|||
147590441|NCT05506358|532318975|FG003|Overall Study|Sickle cell disease with Hereditary persistence of fetal hemoglobin (HPFH)|0|||
147590442|NCT05506358|532318976|FG004|Overall Study|Sickle cell disease with Hereditary persistence of fetal hemoglobin (HPFH)|0|||
147590443|NCT05506358|532318972|FG000|Overall Study|Beta-thalassemia major with transfusion within 2 months|0|||
147590444|NCT05506358|532318973|FG001|Overall Study|Beta-thalassemia major with transfusion within 2 months|0|||
147590445|NCT05506358|532318974|FG002|Overall Study|Beta-thalassemia major with transfusion within 2 months|0|||
147590446|NCT05506358|532318975|FG003|Overall Study|Beta-thalassemia major with transfusion within 2 months|1|||
147590447|NCT05506358|532318976|FG004|Overall Study|Beta-thalassemia major with transfusion within 2 months|0|||
147590448|NCT05506358|532318972|FG000|Overall Study|Sample hemolysis observed under the microscope|0|||
147590449|NCT05506358|532318973|FG001|Overall Study|Sample hemolysis observed under the microscope|0|||
147590450|NCT05506358|532318974|FG002|Overall Study|Sample hemolysis observed under the microscope|0|||
147590451|NCT05506358|532318975|FG003|Overall Study|Sample hemolysis observed under the microscope|1|||
147590452|NCT05506358|532318976|FG004|Overall Study|Sample hemolysis observed under the microscope|0|||
147590453|NCT05506358|532318972|FG000|Overall Study|HbE trait|0|||
147590454|NCT05506358|532318973|FG001|Overall Study|HbE trait|0|||
147590455|NCT05506358|532318974|FG002|Overall Study|HbE trait|0|||
147590456|NCT05506358|532318975|FG003|Overall Study|HbE trait|1|||
147590457|NCT05506358|532318976|FG004|Overall Study|HbE trait|0|||
147590458|NCT03336242|532318982|FG000|Overall Study|Adverse Event|0|||
147590459|NCT03336242|532318983|FG001|Overall Study|Adverse Event|1|||
147590460|NCT02457611|532318987|FG000|Overall Study|Lost to Follow-up|3|||
147590461|NCT00384293|532318988|FG000|MK0524A Active Run-In, Pre-randomization|Adverse Event|120|||
147590462|NCT00384293|532318989|FG001|MK0524A Active Run-In, Pre-randomization|Adverse Event|0|||
147590463|NCT00384293|532318990|FG002|MK0524A Active Run-In, Pre-randomization|Adverse Event|0|||
147590464|NCT00384293|532318988|FG000|MK0524A Active Run-In, Pre-randomization|Lost to Follow-up|1|||
147590465|NCT00384293|532318989|FG001|MK0524A Active Run-In, Pre-randomization|Lost to Follow-up|0|||
147590466|NCT00384293|532318990|FG002|MK0524A Active Run-In, Pre-randomization|Lost to Follow-up|0|||
147590467|NCT00384293|532318988|FG000|MK0524A Active Run-In, Pre-randomization|Withdrawal by Subject|24|||
147590468|NCT00384293|532318989|FG001|MK0524A Active Run-In, Pre-randomization|Withdrawal by Subject|0|||
147654589|NCT02427802|532556776|FG000|Overall Study|Withdrawal by Subject|10|||
147654590|NCT02427802|532556777|FG001|Overall Study|Withdrawal by Subject|5|||
147167878|NCT02198794|530779812|FG002|Part A: Open-Label (158 Weeks)|Agreed to continue in Part B|0|||
147167879|NCT02198794|530779813|FG003|Part A: Open-Label (158 Weeks)|Agreed to continue in Part B|0|||
147167880|NCT02198794|530779810|FG000|Part B: Randomized (13 Weeks)|Withdrawal by Subject|0|||
147167881|NCT02198794|530779811|FG001|Part B: Randomized (13 Weeks)|Withdrawal by Subject|3|||
147167882|NCT02198794|530779812|FG002|Part B: Randomized (13 Weeks)|Withdrawal by Subject|1|||
147167883|NCT02198794|530779813|FG003|Part B: Randomized (13 Weeks)|Withdrawal by Subject|0|||
147167884|NCT02198794|530779810|FG000|Part B: Randomized (13 Weeks)|Lost to Follow-up|0|||
147167885|NCT02198794|530779811|FG001|Part B: Randomized (13 Weeks)|Lost to Follow-up|2|||
147167886|NCT02198794|530779812|FG002|Part B: Randomized (13 Weeks)|Lost to Follow-up|2|||
147167887|NCT02198794|530779813|FG003|Part B: Randomized (13 Weeks)|Lost to Follow-up|0|||
147167888|NCT02198794|530779810|FG000|Part C: Safety Assessment (52 Weeks)|Withdrawal by Subject|0|||
147167889|NCT02198794|530779811|FG001|Part C: Safety Assessment (52 Weeks)|Withdrawal by Subject|0|||
147167890|NCT02198794|530779812|FG002|Part C: Safety Assessment (52 Weeks)|Withdrawal by Subject|0|||
147167891|NCT02198794|530779813|FG003|Part C: Safety Assessment (52 Weeks)|Withdrawal by Subject|3|||
147323457|NCT04672460|531349897|FG000|Maintenance Phase: Period 4 (28 Days)|Progressive disease|10|||
147323458|NCT04672460|531349898|FG001|Maintenance Phase: Period 4 (28 Days)|Progressive disease|12|||
147323459|NCT04672460|531349897|FG000|Maintenance Phase: Period 4 (28 Days)|Refused further treatment|1|||
147654591|NCT02427802|532556778|FG002|Overall Study|Withdrawal by Subject|11|||
147323460|NCT04672460|531349898|FG001|Maintenance Phase: Period 4 (28 Days)|Refused further treatment|0|||
147654592|NCT02427802|532556776|FG000|Overall Study|Protocol Violation|3|||
147167892|NCT02198794|530779810|FG000|Part C: Safety Assessment (52 Weeks)|Adverse Event|0|||
147167893|NCT02198794|530779811|FG001|Part C: Safety Assessment (52 Weeks)|Adverse Event|0|||
147167894|NCT02198794|530779812|FG002|Part C: Safety Assessment (52 Weeks)|Adverse Event|0|||
147167895|NCT02198794|530779813|FG003|Part C: Safety Assessment (52 Weeks)|Adverse Event|2|||
147167896|NCT02198794|530779810|FG000|Part C: Safety Assessment (52 Weeks)|Death|0|||
147167897|NCT02198794|530779811|FG001|Part C: Safety Assessment (52 Weeks)|Death|0|||
147167898|NCT02198794|530779812|FG002|Part C: Safety Assessment (52 Weeks)|Death|0|||
147167899|NCT02198794|530779813|FG003|Part C: Safety Assessment (52 Weeks)|Death|2|||
147167900|NCT01918332|530779815|FG000|Overall Study|Adverse Event|0|||
147167901|NCT01918332|530779816|FG001|Overall Study|Adverse Event|0|||
147167902|NCT01918332|530779817|FG002|Overall Study|Adverse Event|0|||
147167903|NCT01918332|530779818|FG003|Overall Study|Adverse Event|1|||
147167904|NCT01918332|530779815|FG000|Overall Study|Withdrawal by Subject|2|||
147167905|NCT01918332|530779816|FG001|Overall Study|Withdrawal by Subject|3|||
147323461|NCT04672460|531349897|FG000|Maintenance Phase: Period 4 (28 Days)|Other|9|||
147323462|NCT04672460|531349898|FG001|Maintenance Phase: Period 4 (28 Days)|Other|8|||
147323463|NCT00079937|531349900|FG000|Overall Study|Adverse Event|2|||
147323464|NCT00079937|531349901|FG001|Overall Study|Adverse Event|1|||
147323465|NCT00079937|531349900|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
147323466|NCT00079937|531349901|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
147323467|NCT00079937|531349900|FG000|Overall Study|Subject no longer requires study drug|3|||
147323468|NCT00079937|531349901|FG001|Overall Study|Subject no longer requires study drug|0|||
147323469|NCT00079937|531349900|FG000|Overall Study|Protocol Violation|8|||
147323470|NCT00079937|531349901|FG001|Overall Study|Protocol Violation|6|||
147323471|NCT00079937|531349900|FG000|Overall Study|Withdrawal by Subject|21|||
147323472|NCT00079937|531349901|FG001|Overall Study|Withdrawal by Subject|7|||
147323473|NCT00079937|531349900|FG000|Overall Study|Lost to Follow-up|12|||
147323474|NCT00079937|531349901|FG001|Overall Study|Lost to Follow-up|5|||
147323475|NCT00079937|531349900|FG000|Overall Study|Administrative problems|22|||
147167906|NCT01918332|530779817|FG002|Overall Study|Withdrawal by Subject|2|||
147167907|NCT01918332|530779818|FG003|Overall Study|Withdrawal by Subject|3|||
147167908|NCT01918332|530779815|FG000|Overall Study|Protocol Violation|6|||
147167909|NCT01918332|530779816|FG001|Overall Study|Protocol Violation|2|||
147167910|NCT01918332|530779817|FG002|Overall Study|Protocol Violation|6|||
147167911|NCT01918332|530779818|FG003|Overall Study|Protocol Violation|3|||
147167912|NCT01918332|530779815|FG000|Overall Study|lipid result by central lab did not meet|0|||
147167913|NCT01918332|530779816|FG001|Overall Study|lipid result by central lab did not meet|0|||
147167914|NCT01918332|530779817|FG002|Overall Study|lipid result by central lab did not meet|1|||
147167915|NCT01918332|530779818|FG003|Overall Study|lipid result by central lab did not meet|0|||
147167916|NCT02905006|530779819|FG000|Overall Study|Adverse Event|1|||
147167917|NCT02905006|530779820|FG001|Overall Study|Adverse Event|1|||
147167918|NCT02905006|530779821|FG002|Overall Study|Adverse Event|1|||
147167919|NCT02905006|530779822|FG003|Overall Study|Adverse Event|1|||
147167920|NCT02905006|530779823|FG004|Overall Study|Adverse Event|0|||
147167921|NCT02905006|530779824|FG005|Overall Study|Adverse Event|1|||
147167922|NCT02905006|530779819|FG000|Overall Study|Lack of Efficacy|1|||
147167923|NCT02905006|530779820|FG001|Overall Study|Lack of Efficacy|0|||
147167924|NCT02905006|530779821|FG002|Overall Study|Lack of Efficacy|0|||
147323476|NCT00079937|531349901|FG001|Overall Study|Administrative problems|11|||
147323477|NCT02949271|531349902|FG000|Overall Study|Lack of Efficacy|5|||
147323478|NCT02949271|531349903|FG001|Overall Study|Lack of Efficacy|4|||
147323479|NCT02949271|531349902|FG000|Overall Study|Lost to Follow-up|3|||
147323480|NCT02949271|531349903|FG001|Overall Study|Lost to Follow-up|6|||
147323481|NCT02949271|531349902|FG000|Overall Study|Physician Decision|5|||
147167925|NCT02905006|530779822|FG003|Overall Study|Lack of Efficacy|0|||
147167926|NCT02905006|530779823|FG004|Overall Study|Lack of Efficacy|0|||
147167927|NCT02905006|530779824|FG005|Overall Study|Lack of Efficacy|0|||
147167928|NCT02905006|530779819|FG000|Overall Study|Protocol Violation|2|||
147167929|NCT02905006|530779820|FG001|Overall Study|Protocol Violation|0|||
147167930|NCT02905006|530779821|FG002|Overall Study|Protocol Violation|0|||
147167931|NCT02905006|530779822|FG003|Overall Study|Protocol Violation|0|||
147167932|NCT02905006|530779823|FG004|Overall Study|Protocol Violation|0|||
147167933|NCT02905006|530779824|FG005|Overall Study|Protocol Violation|0|||
147323482|NCT02949271|531349903|FG001|Overall Study|Physician Decision|5|||
147323483|NCT02949271|531349902|FG000|Overall Study|Protocol Violation|6|||
147167934|NCT02905006|530779819|FG000|Overall Study|Lost to Follow-up|0|||
147167935|NCT02905006|530779820|FG001|Overall Study|Lost to Follow-up|0|||
147167936|NCT02905006|530779821|FG002|Overall Study|Lost to Follow-up|0|||
147167937|NCT02905006|530779822|FG003|Overall Study|Lost to Follow-up|1|||
147167938|NCT02905006|530779823|FG004|Overall Study|Lost to Follow-up|1|||
147167939|NCT02905006|530779824|FG005|Overall Study|Lost to Follow-up|0|||
147167940|NCT02905006|530779819|FG000|Overall Study|Withdrawal by Subject|0|||
147167941|NCT02905006|530779820|FG001|Overall Study|Withdrawal by Subject|0|||
147323484|NCT02949271|531349903|FG001|Overall Study|Protocol Violation|3|||
147323485|NCT02949271|531349902|FG000|Overall Study|Withdrawal by Subject|1|||
147323486|NCT02949271|531349903|FG001|Overall Study|Withdrawal by Subject|0|||
147654593|NCT02427802|532556777|FG001|Overall Study|Protocol Violation|1|||
147167942|NCT02905006|530779821|FG002|Overall Study|Withdrawal by Subject|1|||
147167943|NCT02905006|530779822|FG003|Overall Study|Withdrawal by Subject|1|||
147167944|NCT02905006|530779823|FG004|Overall Study|Withdrawal by Subject|0|||
147167945|NCT02905006|530779824|FG005|Overall Study|Withdrawal by Subject|1|||
147167946|NCT02905006|530779819|FG000|Overall Study|Screening exclusion criteria met|1|||
147167947|NCT02905006|530779820|FG001|Overall Study|Screening exclusion criteria met|0|||
147167948|NCT02905006|530779821|FG002|Overall Study|Screening exclusion criteria met|0|||
147167949|NCT02905006|530779822|FG003|Overall Study|Screening exclusion criteria met|0|||
147167950|NCT02905006|530779823|FG004|Overall Study|Screening exclusion criteria met|0|||
147167951|NCT02905006|530779824|FG005|Overall Study|Screening exclusion criteria met|0|||
147167952|NCT02905006|530779819|FG000|Overall Study|Lab withdrawal criterion met|0|||
147167953|NCT02905006|530779820|FG001|Overall Study|Lab withdrawal criterion met|1|||
147167954|NCT02905006|530779821|FG002|Overall Study|Lab withdrawal criterion met|2|||
147167955|NCT02905006|530779822|FG003|Overall Study|Lab withdrawal criterion met|2|||
147167956|NCT02905006|530779823|FG004|Overall Study|Lab withdrawal criterion met|2|||
147167957|NCT02905006|530779824|FG005|Overall Study|Lab withdrawal criterion met|1|||
147167958|NCT02905006|530779819|FG000|Overall Study|Positive for Tuberculosis|0|||
147167959|NCT02905006|530779820|FG001|Overall Study|Positive for Tuberculosis|1|||
147167960|NCT02905006|530779821|FG002|Overall Study|Positive for Tuberculosis|0|||
147167961|NCT02905006|530779822|FG003|Overall Study|Positive for Tuberculosis|0|||
147167962|NCT02905006|530779823|FG004|Overall Study|Positive for Tuberculosis|0|||
147167963|NCT02905006|530779824|FG005|Overall Study|Positive for Tuberculosis|0|||
147167964|NCT02905006|530779819|FG000|Overall Study|Subject positive for Hep B|0|||
147167965|NCT02905006|530779820|FG001|Overall Study|Subject positive for Hep B|0|||
147167966|NCT02905006|530779821|FG002|Overall Study|Subject positive for Hep B|1|||
147167967|NCT02905006|530779822|FG003|Overall Study|Subject positive for Hep B|0|||
147323487|NCT02949271|531349902|FG000|Overall Study|Delivered prior to intervention|7|||
147323488|NCT02949271|531349903|FG001|Overall Study|Delivered prior to intervention|9|||
147323489|NCT02949271|531349902|FG000|Overall Study|Outside the window for cervical dilation|2|||
147323490|NCT02949271|531349903|FG001|Overall Study|Outside the window for cervical dilation|3|||
147323491|NCT00852475|531349908|FG000|Overall Study|Lost to Follow-up|3|||
147323492|NCT00852475|531349909|FG001|Overall Study|Lost to Follow-up|4|||
147323493|NCT00498186|531349910|FG000|Overall Study|Protocol Violation|10|||
147323494|NCT00498186|531349910|FG000|Overall Study|Lack of Efficacy|31|||
147323495|NCT00498186|531349910|FG000|Overall Study|Adverse Event|89|||
147323496|NCT00498186|531349910|FG000|Overall Study|Unsatisfactory compliance of subject|12|||
147323497|NCT00498186|531349910|FG000|Overall Study|Withdrawal by Subject|18|||
147323498|NCT00498186|531349910|FG000|Overall Study|Lost to Follow-up|3|||
147323499|NCT00498186|531349910|FG000|Overall Study|Other|10|||
147323500|NCT03929302|531349911|FG000|Intervention - myTAP Mouth Shield|Withdrawal by Subject|5|||
147323501|NCT03929302|531349912|FG001|Intervention - myTAP Mouth Shield|Withdrawal by Subject|8|||
147323502|NCT03929302|531349913|FG002|Intervention - myTAP Mouth Shield|Withdrawal by Subject|4|||
147167968|NCT02905006|530779823|FG004|Overall Study|Subject positive for Hep B|0|||
147167969|NCT02905006|530779824|FG005|Overall Study|Subject positive for Hep B|0|||
147167970|NCT02905006|530779819|FG000|Overall Study|Patient moved abroad|0|||
147167971|NCT02905006|530779820|FG001|Overall Study|Patient moved abroad|0|||
147167972|NCT02905006|530779821|FG002|Overall Study|Patient moved abroad|0|||
147167973|NCT02905006|530779822|FG003|Overall Study|Patient moved abroad|1|||
147323503|NCT03929302|531349911|FG000|Intervention - myTAP Mouth Shield|Time constraints|3|||
147323504|NCT03929302|531349912|FG001|Intervention - myTAP Mouth Shield|Time constraints|0|||
147323505|NCT03929302|531349913|FG002|Intervention - myTAP Mouth Shield|Time constraints|0|||
147323506|NCT03929302|531349911|FG000|Intervention - myTAP Mouth Shield|Device didnot fit|0|||
147323507|NCT03929302|531349912|FG001|Intervention - myTAP Mouth Shield|Device didnot fit|0|||
147323508|NCT03929302|531349913|FG002|Intervention - myTAP Mouth Shield|Device didnot fit|1|||
147323509|NCT00367237|531349914|FG000|Overall Study|Adverse Event|7|||
147323510|NCT00367237|531349915|FG001|Overall Study|Adverse Event|2|||
147590469|NCT00384293|532318990|FG002|MK0524A Active Run-In, Pre-randomization|Withdrawal by Subject|0|||
147590470|NCT00384293|532318988|FG000|MK0524A Active Run-In, Pre-randomization|Not cIMT eligible at Visit 3|340|||
147590471|NCT00384293|532318989|FG001|MK0524A Active Run-In, Pre-randomization|Not cIMT eligible at Visit 3|0|||
147590472|NCT00384293|532318990|FG002|MK0524A Active Run-In, Pre-randomization|Not cIMT eligible at Visit 3|0|||
147590473|NCT00384293|532318988|FG000|MK0524A Active Run-In, Pre-randomization|Trial Termination|16|||
147590474|NCT00384293|532318989|FG001|MK0524A Active Run-In, Pre-randomization|Trial Termination|0|||
147590475|NCT00384293|532318990|FG002|MK0524A Active Run-In, Pre-randomization|Trial Termination|0|||
147590476|NCT00384293|532318988|FG000|MK0524A Active Run-In, Pre-randomization|Certified Sonographer Not Available|2|||
147590477|NCT00384293|532318989|FG001|MK0524A Active Run-In, Pre-randomization|Certified Sonographer Not Available|0|||
147590478|NCT00384293|532318990|FG002|MK0524A Active Run-In, Pre-randomization|Certified Sonographer Not Available|0|||
147590479|NCT00384293|532318988|FG000|MK0524A Active Run-In, Pre-randomization|Patient Unable to Complete cIMT Scan|1|||
147323511|NCT00367237|531349914|FG000|Overall Study|Lost to Follow-up|1|||
147323512|NCT00367237|531349915|FG001|Overall Study|Lost to Follow-up|0|||
147323513|NCT00367237|531349914|FG000|Overall Study|Withdrawal by Subject|0|||
147323514|NCT00367237|531349915|FG001|Overall Study|Withdrawal by Subject|4|||
147323515|NCT00367237|531349914|FG000|Overall Study|Protocol Violation|2|||
147323516|NCT00367237|531349915|FG001|Overall Study|Protocol Violation|5|||
147167974|NCT02905006|530779823|FG004|Overall Study|Patient moved abroad|0|||
147167975|NCT02905006|530779824|FG005|Overall Study|Patient moved abroad|0|||
147167976|NCT02905006|530779819|FG000|Overall Study|Patient randomized by mistake|0|||
147167977|NCT02905006|530779820|FG001|Overall Study|Patient randomized by mistake|0|||
147167978|NCT02905006|530779821|FG002|Overall Study|Patient randomized by mistake|0|||
147167979|NCT02905006|530779822|FG003|Overall Study|Patient randomized by mistake|0|||
147323517|NCT01175707|531349916|FG000|Overall Study|Adverse Event|4|||
147323518|NCT01175707|531349917|FG001|Overall Study|Adverse Event|6|||
147323519|NCT02321540|531349918|FG000|Overall Study|Death|0|||
147167980|NCT02905006|530779823|FG004|Overall Study|Patient randomized by mistake|0|||
147167981|NCT02905006|530779824|FG005|Overall Study|Patient randomized by mistake|1|||
147167982|NCT05063539|530779825|FG000|Overall Study|Adverse Event|1|||
147167983|NCT05063539|530779826|FG001|Overall Study|Adverse Event|2|||
147167984|NCT05063539|530779827|FG002|Overall Study|Adverse Event|1|||
147167985|NCT05063539|530779825|FG000|Overall Study|Death|0|||
147167986|NCT05063539|530779826|FG001|Overall Study|Death|1|||
147167987|NCT05063539|530779827|FG002|Overall Study|Death|1|||
147167988|NCT05063539|530779825|FG000|Overall Study|Lost to Follow-up|0|||
147167989|NCT05063539|530779826|FG001|Overall Study|Lost to Follow-up|1|||
147167990|NCT05063539|530779827|FG002|Overall Study|Lost to Follow-up|0|||
147167991|NCT05063539|530779825|FG000|Overall Study|Physician Decision|4|||
147167992|NCT05063539|530779826|FG001|Overall Study|Physician Decision|3|||
147167993|NCT05063539|530779827|FG002|Overall Study|Physician Decision|1|||
147167994|NCT05063539|530779825|FG000|Overall Study|Progressive Disease|0|||
147167995|NCT05063539|530779826|FG001|Overall Study|Progressive Disease|2|||
147167996|NCT05063539|530779827|FG002|Overall Study|Progressive Disease|0|||
147167997|NCT05063539|530779825|FG000|Overall Study|Withdrawal by Subject|17|||
147167998|NCT05063539|530779826|FG001|Overall Study|Withdrawal by Subject|26|||
147167999|NCT05063539|530779827|FG002|Overall Study|Withdrawal by Subject|14|||
147168000|NCT05063539|530779825|FG000|Overall Study|Withdrawal Due To Caregiver Circumstances|1|||
147168001|NCT05063539|530779826|FG001|Overall Study|Withdrawal Due To Caregiver Circumstances|1|||
147168002|NCT05063539|530779827|FG002|Overall Study|Withdrawal Due To Caregiver Circumstances|0|||
147168003|NCT05063539|530779825|FG000|Overall Study|Subject was Randomized in IWRS prior to Realization that Vital signs would be Exclusionary|1|||
147168004|NCT05063539|530779826|FG001|Overall Study|Subject was Randomized in IWRS prior to Realization that Vital signs would be Exclusionary|0|||
147168005|NCT05063539|530779827|FG002|Overall Study|Subject was Randomized in IWRS prior to Realization that Vital signs would be Exclusionary|0|||
147168006|NCT05063539|530779825|FG000|Overall Study|Subject no longer Wished to Continue with IP or Follow-up Visits|0|||
147168007|NCT05063539|530779826|FG001|Overall Study|Subject no longer Wished to Continue with IP or Follow-up Visits|0|||
147168008|NCT05063539|530779827|FG002|Overall Study|Subject no longer Wished to Continue with IP or Follow-up Visits|1|||
147168009|NCT05063539|530779825|FG000|Overall Study|Discontinued due to Common Close Design|0|||
147168010|NCT05063539|530779826|FG001|Overall Study|Discontinued due to Common Close Design|1|||
147168011|NCT05063539|530779827|FG002|Overall Study|Discontinued due to Common Close Design|0|||
147168012|NCT05063539|530779825|FG000|Overall Study|Participant not co-operative|0|||
147168013|NCT05063539|530779826|FG001|Overall Study|Participant not co-operative|1|||
147168014|NCT05063539|530779827|FG002|Overall Study|Participant not co-operative|0|||
147168015|NCT05063539|530779825|FG000|Overall Study|Patient Moving to Different Place from Where it takes 4 hours to Come to Site to Continue|0|||
147168016|NCT05063539|530779826|FG001|Overall Study|Patient Moving to Different Place from Where it takes 4 hours to Come to Site to Continue|0|||
147168017|NCT05063539|530779827|FG002|Overall Study|Patient Moving to Different Place from Where it takes 4 hours to Come to Site to Continue|1|||
147168018|NCT05063539|530779825|FG000|Overall Study|Caregiver Withdrew Consent due to Participant Moved to Long Term Care Home|0|||
147168019|NCT05063539|530779826|FG001|Overall Study|Caregiver Withdrew Consent due to Participant Moved to Long Term Care Home|1|||
147168020|NCT05063539|530779827|FG002|Overall Study|Caregiver Withdrew Consent due to Participant Moved to Long Term Care Home|0|||
147168021|NCT02017522|530779828|FG000|Overall Study|Withdrawal by Subject|1|||
147168022|NCT05856227|530779829|FG000|Overall Study|Adverse Event|0|||
147168023|NCT05856227|530779830|FG001|Overall Study|Adverse Event|1|||
147168024|NCT05856227|530779829|FG000|Overall Study|Due to Investigator absence|1|||
147168025|NCT05856227|530779830|FG001|Overall Study|Due to Investigator absence|0|||
147168026|NCT05856227|530779829|FG000|Overall Study|Cerebrospinal fluid test positive for S. aureus|1|||
147168027|NCT05856227|530779830|FG001|Overall Study|Cerebrospinal fluid test positive for S. aureus|0|||
147168028|NCT01751139|530779831|FG000|Overall Study|Other|135|||
147168029|NCT01751139|530779831|FG000|Overall Study|Sponsor study termination|1609|||
147168030|NCT01751139|530779831|FG000|Overall Study|Lost to Follow-up|240|||
147168031|NCT01751139|530779831|FG000|Overall Study|Withdrawal by Subject|251|||
147168032|NCT01751139|530779831|FG000|Overall Study|Adverse Event|1|||
147168033|NCT01751139|530779831|FG000|Overall Study|Death|31|||
147323520|NCT02321540|531349919|FG001|Overall Study|Death|1|||
147323521|NCT02321540|531349918|FG000|Overall Study|Progression|3|||
147323522|NCT02321540|531349919|FG001|Overall Study|Progression|9|||
147323523|NCT00372567|531349920|FG000|Phase 3 Study|Adverse Event|5|||
147168034|NCT04736628|530779832|FG000|Overall Study|Not treated|0|||
147168035|NCT04736628|530779833|FG001|Overall Study|Not treated|0|||
147168036|NCT04736628|530779834|FG002|Overall Study|Not treated|0|||
147168037|NCT04736628|530779835|FG003|Overall Study|Not treated|2|||
147168038|NCT04736628|530779832|FG000|Overall Study|Other reason than listed|1|||
147168039|NCT04736628|530779833|FG001|Overall Study|Other reason than listed|2|||
147168040|NCT04736628|530779834|FG002|Overall Study|Other reason than listed|2|||
147168041|NCT04736628|530779835|FG003|Overall Study|Other reason than listed|3|||
147168042|NCT04736628|530779832|FG000|Overall Study|Protocol deviation|0|||
147168043|NCT04736628|530779833|FG001|Overall Study|Protocol deviation|0|||
147654594|NCT02427802|532556778|FG002|Overall Study|Protocol Violation|1|||
147244116|NCT00299104|531066909|FG002|Safety Follow-Up (SFU) Period|Withdrawal by Subject|11|||
147244117|NCT00299104|531066907|FG000|Safety Follow-Up (SFU) Period|Administrative reasons|27|||
147244118|NCT00299104|531066908|FG001|Safety Follow-Up (SFU) Period|Administrative reasons|7|||
147244119|NCT00299104|531066909|FG002|Safety Follow-Up (SFU) Period|Administrative reasons|5|||
147244120|NCT00299104|531066907|FG000|Extended Safety Follow-Up (ESFU) Period|Death|0|||
147244121|NCT00299104|531066908|FG001|Extended Safety Follow-Up (ESFU) Period|Death|1|||
147244122|NCT00299104|531066909|FG002|Extended Safety Follow-Up (ESFU) Period|Death|0|||
147244123|NCT00299104|531066907|FG000|Extended Safety Follow-Up (ESFU) Period|Lost to Follow-up|2|||
147244124|NCT00299104|531066908|FG001|Extended Safety Follow-Up (ESFU) Period|Lost to Follow-up|2|||
147244125|NCT00299104|531066909|FG002|Extended Safety Follow-Up (ESFU) Period|Lost to Follow-up|2|||
147244126|NCT00299104|531066907|FG000|Extended Safety Follow-Up (ESFU) Period|Withdrawal by Subject|2|||
147244127|NCT00299104|531066908|FG001|Extended Safety Follow-Up (ESFU) Period|Withdrawal by Subject|4|||
147244128|NCT00299104|531066909|FG002|Extended Safety Follow-Up (ESFU) Period|Withdrawal by Subject|8|||
147244129|NCT00299104|531066907|FG000|Extended Safety Follow-Up (ESFU) Period|Administrative reasons|1|||
147244130|NCT00299104|531066908|FG001|Extended Safety Follow-Up (ESFU) Period|Administrative reasons|2|||
147244131|NCT00299104|531066909|FG002|Extended Safety Follow-Up (ESFU) Period|Administrative reasons|2|||
147447734|NCT03808077|531803953|FG000|Overall Study|Withdrawal by Subject|1|||
147447735|NCT03808077|531803954|FG001|Overall Study|Withdrawal by Subject|0|||
147447736|NCT03808077|531803953|FG000|Overall Study|Equipment Issues|2|||
147447737|NCT03808077|531803954|FG001|Overall Study|Equipment Issues|1|||
147447738|NCT04152161|531803955|FG000|Overall Study|Death|0|||
147447739|NCT04152161|531803956|FG001|Overall Study|Death|1|||
147447740|NCT04152161|531803955|FG000|Overall Study|Physician Decision|0|||
147447741|NCT04152161|531803956|FG001|Overall Study|Physician Decision|1|||
147447742|NCT04152161|531803955|FG000|Overall Study|Lost to Follow-up|9|||
147447743|NCT04152161|531803956|FG001|Overall Study|Lost to Follow-up|3|||
147447744|NCT04152161|531803955|FG000|Overall Study|Protocol Violation|1|||
147447745|NCT04152161|531803956|FG001|Overall Study|Protocol Violation|0|||
147447746|NCT04152161|531803955|FG000|Overall Study|Withdrawal by Subject|29|||
147447747|NCT04152161|531803956|FG001|Overall Study|Withdrawal by Subject|28|||
147447748|NCT04152161|531803955|FG000|Overall Study|Sponsor termination of study|750|||
147447749|NCT04152161|531803956|FG001|Overall Study|Sponsor termination of study|755|||
147447750|NCT04152161|531803955|FG000|Overall Study|Other|20|||
147447751|NCT04152161|531803956|FG001|Overall Study|Other|18|||
147447752|NCT02412787|531803957|FG000|Overall Study|Withdrawal by Subject|9|||
147447753|NCT02412787|531803957|FG000|Overall Study|Participation Terminated by Investigator|1|||
147654595|NCT02427802|532556776|FG000|Overall Study|protocol specific treatment unrelated|18|||
147654596|NCT02427802|532556777|FG001|Overall Study|protocol specific treatment unrelated|11|||
147654597|NCT02427802|532556778|FG002|Overall Study|protocol specific treatment unrelated|11|||
147654598|NCT00802672|532559044|FG000|Overall Study|Lack of fungal pathogen at baseline|56|||
147654599|NCT00802672|532559045|FG001|Overall Study|Lack of fungal pathogen at baseline|43|||
147654600|NCT00802672|532559046|FG002|Overall Study|Lack of fungal pathogen at baseline|25|||
147654601|NCT00802672|532559044|FG000|Overall Study|Adverse Event|1|||
147654602|NCT00802672|532559045|FG001|Overall Study|Adverse Event|1|||
147654603|NCT00802672|532559046|FG002|Overall Study|Adverse Event|1|||
147654604|NCT00802672|532559044|FG000|Overall Study|Protocol Violation|2|||
147654605|NCT00802672|532559045|FG001|Overall Study|Protocol Violation|1|||
147168044|NCT04736628|530779834|FG002|Overall Study|Protocol deviation|0|||
147168045|NCT04736628|530779835|FG003|Overall Study|Protocol deviation|1|||
147168046|NCT04736628|530779832|FG000|Overall Study|Burden of study procedures|1|||
147654606|NCT00802672|532559046|FG002|Overall Study|Protocol Violation|1|||
147168047|NCT04736628|530779833|FG001|Overall Study|Burden of study procedures|0|||
147168048|NCT04736628|530779834|FG002|Overall Study|Burden of study procedures|0|||
147168049|NCT04736628|530779835|FG003|Overall Study|Burden of study procedures|1|||
147447754|NCT02412787|531803957|FG000|Overall Study|Site Terminated by Sponsor|21|||
147447755|NCT02412787|531803957|FG000|Overall Study|Technical Problems|1|||
147447756|NCT02412787|531803957|FG000|Overall Study|Reason Not Specified|1|||
147447757|NCT03246958|531803958|FG000|Overall Study|Withdrawal by Subject|0|||
147447758|NCT03246958|531803959|FG001|Overall Study|Withdrawal by Subject|1|||
147168050|NCT04736628|530779832|FG000|Overall Study|Change of residence|0|||
147447759|NCT03246958|531803960|FG002|Overall Study|Withdrawal by Subject|0|||
147447760|NCT03246958|531803961|FG003|Overall Study|Withdrawal by Subject|0|||
147447761|NCT03246958|531803962|FG004|Overall Study|Withdrawal by Subject|0|||
147168051|NCT04736628|530779833|FG001|Overall Study|Change of residence|1|||
147168052|NCT04736628|530779834|FG002|Overall Study|Change of residence|0|||
147168053|NCT04736628|530779835|FG003|Overall Study|Change of residence|0|||
147168054|NCT04736628|530779832|FG000|Overall Study|Perceived lack of efficacy|1|||
147168055|NCT04736628|530779833|FG001|Overall Study|Perceived lack of efficacy|0|||
147168056|NCT04736628|530779834|FG002|Overall Study|Perceived lack of efficacy|0|||
147168057|NCT04736628|530779835|FG003|Overall Study|Perceived lack of efficacy|1|||
147168058|NCT04736628|530779832|FG000|Overall Study|Adverse Event|3|||
147168059|NCT04736628|530779833|FG001|Overall Study|Adverse Event|2|||
147168060|NCT04736628|530779834|FG002|Overall Study|Adverse Event|4|||
147168061|NCT04736628|530779835|FG003|Overall Study|Adverse Event|3|||
147168062|NCT02428205|530779838|FG000|Overall Study|Lack of Efficacy|1|||
147168063|NCT02428205|530779839|FG001|Overall Study|Lack of Efficacy|0|||
147168064|NCT02428205|530779838|FG000|Overall Study|Lost to Follow-up|1|||
147168065|NCT02428205|530779839|FG001|Overall Study|Lost to Follow-up|1|||
147168066|NCT02428205|530779838|FG000|Overall Study|Worse behavior|0|||
147168067|NCT02428205|530779839|FG001|Overall Study|Worse behavior|1|||
147168068|NCT00527319|530779840|FG000|Overall Study|Withdrawal by Subject|5|||
147168069|NCT00527319|530779841|FG001|Overall Study|Withdrawal by Subject|0|||
147168070|NCT00527319|530779842|FG002|Overall Study|Withdrawal by Subject|1|||
147168071|NCT00527319|530779840|FG000|Overall Study|Lost to Follow-up|1|||
147168072|NCT00527319|530779841|FG001|Overall Study|Lost to Follow-up|0|||
147168073|NCT00527319|530779842|FG002|Overall Study|Lost to Follow-up|0|||
147168074|NCT00527319|530779840|FG000|Overall Study|Death|0|||
147168075|NCT00527319|530779841|FG001|Overall Study|Death|3|||
147168076|NCT00527319|530779842|FG002|Overall Study|Death|1|||
147168077|NCT00527319|530779840|FG000|Overall Study|Intercurrent Medical Illness|0|||
147168078|NCT00527319|530779841|FG001|Overall Study|Intercurrent Medical Illness|1|||
147168079|NCT00527319|530779842|FG002|Overall Study|Intercurrent Medical Illness|3|||
147168080|NCT00527319|530779840|FG000|Overall Study|Adverse Event|0|||
147168081|NCT00527319|530779841|FG001|Overall Study|Adverse Event|0|||
147168082|NCT00527319|530779842|FG002|Overall Study|Adverse Event|1|||
147168083|NCT00680368|530779844|FG000|Overall Study|not supervised, not eligible|15|||
147168084|NCT00483041|530779845|FG000|Overall Study|ABNORMAL LAB DATA AT SCREENING|0|||
147168085|NCT00483041|530779846|FG001|Overall Study|ABNORMAL LAB DATA AT SCREENING|1|||
147168086|NCT03779503|530779847|FG000|First Intervention|Adverse Event|0|||
147168087|NCT03779503|530779848|FG001|First Intervention|Adverse Event|1|||
147168088|NCT03779503|530779847|FG000|First Intervention|Withdrawal by Subject|1|||
147168089|NCT03779503|530779848|FG001|First Intervention|Withdrawal by Subject|0|||
147168090|NCT00864851|530779849|FG000|Overall Study|Withdrawal by Subject|0|||
147168091|NCT00864851|530779850|FG001|Overall Study|Withdrawal by Subject|1|||
147168092|NCT00864851|530779851|FG002|Overall Study|Withdrawal by Subject|0|||
147168093|NCT00864851|530779849|FG000|Overall Study|Physician Decision|1|||
147168094|NCT00864851|530779850|FG001|Overall Study|Physician Decision|0|||
147168095|NCT00864851|530779851|FG002|Overall Study|Physician Decision|0|||
147168096|NCT00864851|530779849|FG000|Overall Study|Death|1|||
147168097|NCT00864851|530779850|FG001|Overall Study|Death|0|||
147168098|NCT00864851|530779851|FG002|Overall Study|Death|0|||
147168099|NCT00864851|530779849|FG000|Overall Study|Patient uncooperative|1|||
147168100|NCT00864851|530779850|FG001|Overall Study|Patient uncooperative|0|||
147168101|NCT00864851|530779851|FG002|Overall Study|Patient uncooperative|0|||
147168102|NCT03242252|530779853|FG000|Overall Study|At the Participant's own Request|18|||
147168103|NCT03242252|530779854|FG001|Overall Study|At the Participant's own Request|10|||
147168104|NCT03242252|530779855|FG002|Overall Study|At the Participant's own Request|15|||
147168105|NCT03242252|530779853|FG000|Overall Study|Adverse Event|8|||
147168106|NCT03242252|530779854|FG001|Overall Study|Adverse Event|6|||
147168107|NCT03242252|530779855|FG002|Overall Study|Adverse Event|9|||
147168108|NCT03242252|530779853|FG000|Overall Study|Poor Compliance to Protocol|0|||
147168109|NCT03242252|530779854|FG001|Overall Study|Poor Compliance to Protocol|2|||
147168110|NCT03242252|530779855|FG002|Overall Study|Poor Compliance to Protocol|3|||
147168111|NCT03242252|530779853|FG000|Overall Study|Study Terminated by Sponsor|1|||
147168112|NCT03242252|530779854|FG001|Overall Study|Study Terminated by Sponsor|0|||
147168113|NCT03242252|530779855|FG002|Overall Study|Study Terminated by Sponsor|0|||
147168114|NCT03242252|530779853|FG000|Overall Study|Reason not Specified|4|||
147168115|NCT03242252|530779854|FG001|Overall Study|Reason not Specified|4|||
147168116|NCT03242252|530779855|FG002|Overall Study|Reason not Specified|1|||
147168117|NCT03242252|530779853|FG000|Overall Study|Lost to Follow-up|5|||
147168118|NCT03242252|530779854|FG001|Overall Study|Lost to Follow-up|1|||
147168119|NCT03242252|530779855|FG002|Overall Study|Lost to Follow-up|4|||
147168120|NCT01116427|530779856|FG000|Core Phase|Adverse Event|0|||
147168121|NCT01116427|530779857|FG001|Core Phase|Adverse Event|1|||
147168122|NCT01116427|530779856|FG000|Core Phase|Lost to Follow-up|1|||
147168123|NCT01116427|530779857|FG001|Core Phase|Lost to Follow-up|0|||
147168124|NCT01116427|530779856|FG000|Core Phase|Withdrawal by Subject|3|||
147168125|NCT01116427|530779857|FG001|Core Phase|Withdrawal by Subject|0|||
147168126|NCT01116427|530779856|FG000|Core Phase|Worsening Multiple Sclerosis|1|||
147168127|NCT01116427|530779857|FG001|Core Phase|Worsening Multiple Sclerosis|0|||
147168128|NCT01116427|530779856|FG000|Extension Phase|Adverse Event|1|||
147590480|NCT00384293|532318989|FG001|MK0524A Active Run-In, Pre-randomization|Patient Unable to Complete cIMT Scan|0|||
147590481|NCT00384293|532318990|FG002|MK0524A Active Run-In, Pre-randomization|Patient Unable to Complete cIMT Scan|0|||
147590482|NCT00384293|532318988|FG000|Post-randomization Period|Adverse Event|0|||
147590483|NCT00384293|532318989|FG001|Post-randomization Period|Adverse Event|23|||
147590484|NCT00384293|532318990|FG002|Post-randomization Period|Adverse Event|7|||
147590485|NCT00384293|532318988|FG000|Post-randomization Period|Lost to Follow-up|0|||
147590486|NCT00384293|532318989|FG001|Post-randomization Period|Lost to Follow-up|2|||
147590487|NCT00384293|532318990|FG002|Post-randomization Period|Lost to Follow-up|1|||
147590488|NCT00384293|532318988|FG000|Post-randomization Period|Protocol Violation|0|||
147590489|NCT00384293|532318989|FG001|Post-randomization Period|Protocol Violation|1|||
147590490|NCT00384293|532318990|FG002|Post-randomization Period|Protocol Violation|0|||
147590491|NCT00384293|532318988|FG000|Post-randomization Period|Withdrawal by Subject|0|||
147590492|NCT00384293|532318989|FG001|Post-randomization Period|Withdrawal by Subject|8|||
147590493|NCT00384293|532318990|FG002|Post-randomization Period|Withdrawal by Subject|6|||
147590494|NCT00384293|532318988|FG000|Post-randomization Period|Trial Termination|0|||
147590495|NCT00384293|532318989|FG001|Post-randomization Period|Trial Termination|180|||
147590496|NCT00384293|532318990|FG002|Post-randomization Period|Trial Termination|204|||
147590497|NCT00384293|532318988|FG000|Post-randomization Period|Patient Randomized in Error|0|||
147590498|NCT00384293|532318989|FG001|Post-randomization Period|Patient Randomized in Error|0|||
147590499|NCT00384293|532318990|FG002|Post-randomization Period|Patient Randomized in Error|1|||
147590500|NCT03005067|532318991|FG000|Overall Study|Withdrawal by Subject|3|||
147590501|NCT03005067|532318992|FG001|Overall Study|Withdrawal by Subject|2|||
147590502|NCT03005067|532318991|FG000|Overall Study|Adverse Event|4|||
147590503|NCT03005067|532318992|FG001|Overall Study|Adverse Event|3|||
147590504|NCT03005067|532318991|FG000|Overall Study|Other (reason not specified)|3|||
147590505|NCT03005067|532318992|FG001|Overall Study|Other (reason not specified)|1|||
147590506|NCT03005067|532318991|FG000|Overall Study|Protocol Violation|0|||
147590507|NCT03005067|532318992|FG001|Overall Study|Protocol Violation|1|||
147590508|NCT01790113|532318997|FG000|Overall Study|Adverse Event|2|||
147590509|NCT01790113|532318998|FG001|Overall Study|Adverse Event|7|||
147590510|NCT01790113|532318997|FG000|Overall Study|Study ended due to FDA clearance|1|||
147590511|NCT01790113|532318998|FG001|Overall Study|Study ended due to FDA clearance|68|||
147590512|NCT02674386|532319001|FG000|Overall Study|Lost to Follow-up|0|||
147590513|NCT02674386|532319002|FG001|Overall Study|Lost to Follow-up|1|||
147590514|NCT02674386|532319003|FG002|Overall Study|Lost to Follow-up|1|||
147590515|NCT02674386|532319001|FG000|Overall Study|Withdrawal by Subject|0|||
147590516|NCT02674386|532319002|FG001|Overall Study|Withdrawal by Subject|4|||
147590517|NCT02674386|532319003|FG002|Overall Study|Withdrawal by Subject|0|||
147590518|NCT02674386|532319001|FG000|Overall Study|Other|0|||
147590519|NCT02674386|532319002|FG001|Overall Study|Other|1|||
147590520|NCT02674386|532319003|FG002|Overall Study|Other|0|||
147168129|NCT01116427|530779857|FG001|Extension Phase|Adverse Event|1|||
147168130|NCT01116427|530779856|FG000|Extension Phase|Lost to Follow-up|2|||
147168131|NCT01116427|530779857|FG001|Extension Phase|Lost to Follow-up|0|||
147168132|NCT01116427|530779856|FG000|Extension Phase|Withdrawal by Subject|5|||
147168133|NCT01116427|530779857|FG001|Extension Phase|Withdrawal by Subject|1|||
147168134|NCT01116427|530779856|FG000|Extension Phase|Not using appropriate birth control|1|||
147168135|NCT01116427|530779857|FG001|Extension Phase|Not using appropriate birth control|0|||
147168136|NCT02211313|530779858|FG000|Overall Study|Treatment Failure|5|||
147168137|NCT02211313|530779859|FG001|Overall Study|Treatment Failure|2|||
147168138|NCT02211313|530779858|FG000|Overall Study|No Follow up Questionnaires|1|||
147168139|NCT02211313|530779859|FG001|Overall Study|No Follow up Questionnaires|1|||
147168140|NCT02717130|530779860|FG000|Overall Study|Withdrawal by Subject|1|||
147168141|NCT02717130|530779860|FG000|Overall Study|Adverse Event|1|||
147323524|NCT00372567|531349921|FG001|Phase 3 Study|Adverse Event|1|||
147323525|NCT00372567|531349922|FG002|Phase 3 Study|Adverse Event|1|||
147323526|NCT00372567|531349920|FG000|Phase 3 Study|Death|1|||
147323527|NCT00372567|531349921|FG001|Phase 3 Study|Death|1|||
147323528|NCT00372567|531349922|FG002|Phase 3 Study|Death|0|||
147323529|NCT00372567|531349920|FG000|Phase 3 Study|Protocol Violation|0|||
147168142|NCT02717130|530779860|FG000|Overall Study|Physician Decision|1|||
147168143|NCT02717130|530779860|FG000|Overall Study|Study Closure|4|||
147168144|NCT03344640|530779861|FG000|Overall Study|Adverse Event|1|||
147323530|NCT00372567|531349921|FG001|Phase 3 Study|Protocol Violation|0|||
147168145|NCT03344640|530779862|FG001|Overall Study|Adverse Event|0|||
147323531|NCT00372567|531349922|FG002|Phase 3 Study|Protocol Violation|1|||
147590521|NCT02674386|532319001|FG000|Overall Study|Enrolled but not evaluated|0|||
147590522|NCT02674386|532319002|FG001|Overall Study|Enrolled but not evaluated|4|||
147590523|NCT02674386|532319003|FG002|Overall Study|Enrolled but not evaluated|0|||
147590524|NCT02462486|532319004|FG000|Overall Study|Screen Failure:Missed Exclusion Criteria|1|||
147168146|NCT03344640|530779861|FG000|Overall Study|Physician Decision|1|||
147168147|NCT03344640|530779862|FG001|Overall Study|Physician Decision|1|||
147323532|NCT00372567|531349920|FG000|Phase 3 Study|Objective progression or relapse|10|||
147323533|NCT00372567|531349921|FG001|Phase 3 Study|Objective progression or relapse|13|||
147323534|NCT00372567|531349922|FG002|Phase 3 Study|Objective progression or relapse|4|||
147654607|NCT00802672|532559044|FG000|Overall Study|Lost to Follow-up|5|||
147654608|NCT00802672|532559045|FG001|Overall Study|Lost to Follow-up|5|||
147654609|NCT00802672|532559046|FG002|Overall Study|Lost to Follow-up|3|||
147654610|NCT00802672|532559044|FG000|Overall Study|Withdrawal by Subject|1|||
147654611|NCT00802672|532559045|FG001|Overall Study|Withdrawal by Subject|1|||
147654612|NCT00802672|532559046|FG002|Overall Study|Withdrawal by Subject|2|||
147654613|NCT00802672|532559044|FG000|Overall Study|other|3|||
147654614|NCT00802672|532559045|FG001|Overall Study|other|1|||
147654615|NCT00802672|532559046|FG002|Overall Study|other|2|||
147654616|NCT04336475|532559047|FG000|Overall Study|pain|1|||
147654617|NCT04336475|532559048|FG001|Overall Study|pain|0|||
147447762|NCT03246958|531803963|FG005|Overall Study|Withdrawal by Subject|1|||
147447763|NCT03246958|531803964|FG006|Overall Study|Withdrawal by Subject|0|||
147447764|NCT03246958|531803958|FG000|Overall Study|Progression|13|||
147447765|NCT03246958|531803959|FG001|Overall Study|Progression|9|||
147244164|NCT00521014|531066929|FG000|Overall Study|Inevaluable, not treated|1|||
147244165|NCT00982878|531066931|FG000|Overall Study|Physician Decision|1|||
147244166|NCT01336764|531066936|FG000|Overall Study|Withdrawal by Subject|5|||
147244167|NCT01336764|531066937|FG001|Overall Study|Withdrawal by Subject|5|||
147244168|NCT01626391|531066938|FG000|Overall Study|Physician Decision|1|||
147323535|NCT00372567|531349920|FG000|Phase 3 Study|Global deterioration of health status|0|||
147323536|NCT00372567|531349921|FG001|Phase 3 Study|Global deterioration of health status|1|||
147323537|NCT00372567|531349922|FG002|Phase 3 Study|Global deterioration of health status|0|||
147654618|NCT04336475|532559047|FG000|Overall Study|upper respiratory infection|1|||
147654619|NCT04336475|532559048|FG001|Overall Study|upper respiratory infection|0|||
147654620|NCT04336475|532559047|FG000|Overall Study|Lost to Follow-up|0|||
147654621|NCT04336475|532559048|FG001|Overall Study|Lost to Follow-up|2|||
147654622|NCT01990573|532559051|FG000|Overall Study|Physician Decision|0|||
147654623|NCT01990573|532559052|FG001|Overall Study|Physician Decision|0|||
147654624|NCT01990573|532559053|FG002|Overall Study|Physician Decision|1|||
147654625|NCT01763827|532559058|FG000|Overall Study|Withdrawal by Subject|1|||
147654626|NCT01763827|532559059|FG001|Overall Study|Withdrawal by Subject|0|||
147654627|NCT01763827|532559060|FG002|Overall Study|Withdrawal by Subject|0|||
147654628|NCT01763827|532559061|FG003|Overall Study|Withdrawal by Subject|0|||
147654629|NCT01763827|532559062|FG004|Overall Study|Withdrawal by Subject|2|||
147654630|NCT01763827|532559063|FG005|Overall Study|Withdrawal by Subject|0|||
147654631|NCT01763827|532559058|FG000|Overall Study|Decision by sponsor|2|||
147654632|NCT01763827|532559059|FG001|Overall Study|Decision by sponsor|0|||
147654633|NCT01763827|532559060|FG002|Overall Study|Decision by sponsor|3|||
147654634|NCT01763827|532559061|FG003|Overall Study|Decision by sponsor|0|||
147654635|NCT01763827|532559062|FG004|Overall Study|Decision by sponsor|2|||
147654636|NCT01763827|532559063|FG005|Overall Study|Decision by sponsor|1|||
147323538|NCT00372567|531349920|FG000|Phase 3 Study|Other|2|||
147323539|NCT00372567|531349921|FG001|Phase 3 Study|Other|2|||
147323540|NCT00372567|531349922|FG002|Phase 3 Study|Other|1|||
147323541|NCT00372567|531349920|FG000|Phase 3 Study|study terminated by sponsor|13|||
147323542|NCT00372567|531349921|FG001|Phase 3 Study|study terminated by sponsor|8|||
147323543|NCT00372567|531349922|FG002|Phase 3 Study|study terminated by sponsor|5|||
147323544|NCT02347943|531349923|FG000|Overall Study|Study was cancelled|140|||
147323545|NCT02347943|531349924|FG001|Overall Study|Study was cancelled|67|||
147323546|NCT02347943|531349925|FG002|Overall Study|Study was cancelled|45|||
147323547|NCT00303303|531349928|FG000|Overall Study|Withdrawal by Subject|0|||
147323548|NCT00303303|531349929|FG001|Overall Study|Withdrawal by Subject|0|||
147323549|NCT00303303|531349930|FG002|Overall Study|Withdrawal by Subject|1|||
147323550|NCT00691028|531349931|FG000|Open-label Period|Adverse Event|0|||
147323551|NCT00691028|531349932|FG001|Open-label Period|Adverse Event|0|||
147323552|NCT00691028|531349933|FG002|Open-label Period|Adverse Event|0|||
147323553|NCT00691028|531349934|FG003|Open-label Period|Adverse Event|16|||
147323554|NCT00691028|531349931|FG000|Open-label Period|Withdrawal by Subject|0|||
147323555|NCT00691028|531349932|FG001|Open-label Period|Withdrawal by Subject|0|||
147654637|NCT01763827|532559058|FG000|Overall Study|Lost to Follow-up|0|||
147654638|NCT01763827|532559059|FG001|Overall Study|Lost to Follow-up|1|||
147654639|NCT01763827|532559060|FG002|Overall Study|Lost to Follow-up|1|||
147323556|NCT00691028|531349933|FG002|Open-label Period|Withdrawal by Subject|0|||
147654640|NCT01763827|532559061|FG003|Overall Study|Lost to Follow-up|1|||
147654641|NCT01763827|532559062|FG004|Overall Study|Lost to Follow-up|2|||
147654642|NCT01763827|532559063|FG005|Overall Study|Lost to Follow-up|1|||
147654643|NCT02906579|532559064|FG000|Overall Study|Adverse Event|1|||
147654644|NCT02906579|532559064|FG000|Overall Study|Physician Decision|1|||
147654645|NCT00759655|532559065|FG000|Overall Study|Termination of the study by sponsor|1|||
147654646|NCT02213380|532559068|FG000|Underwent Randomization|Withdrawal by Subject|2|||
147654647|NCT02213380|532559069|FG001|Underwent Randomization|Withdrawal by Subject|0|||
147654648|NCT02213380|532559068|FG000|Underwent Randomization|Not treated|3|||
147244169|NCT01626391|531066939|FG001|Overall Study|Physician Decision|0|||
147244170|NCT01626391|531066938|FG000|Overall Study|Withdrawal by Subject|1|||
147654649|NCT02213380|532559069|FG001|Underwent Randomization|Not treated|3|||
147654650|NCT02213380|532559068|FG000|Per-protocol Analysis|Protocol Violation|32|||
147244171|NCT01626391|531066939|FG001|Overall Study|Withdrawal by Subject|0|||
147168148|NCT03344640|530779861|FG000|Overall Study|Withdrawal by Subject|1|||
147168149|NCT03344640|530779862|FG001|Overall Study|Withdrawal by Subject|2|||
147168150|NCT03344640|530779861|FG000|Follow-up Epoch|Withdrawal by Subject|0|||
147168151|NCT03344640|530779862|FG001|Follow-up Epoch|Withdrawal by Subject|2|||
147590525|NCT02462486|532319005|FG001|Overall Study|Screen Failure:Missed Exclusion Criteria|1|||
147168152|NCT00657371|530779866|FG000|Overall Study|Poor bowel preparation|15|||
147168153|NCT00657371|530779866|FG000|Overall Study|Unable to intubate the cecum|5|||
147168154|NCT00657371|530779866|FG000|Overall Study|Protocol Violation|2|||
147590526|NCT02462486|532319006|FG002|Overall Study|Screen Failure:Missed Exclusion Criteria|3|||
147168155|NCT00657371|530779866|FG000|Overall Study|Device- related reasons|13|||
147168156|NCT00657371|530779866|FG000|Overall Study|Pre-existing medical condition|4|||
147168157|NCT00652899|530779872|FG000|Overall Study|Death|1|||
147168158|NCT00652899|530779872|FG000|Overall Study|Treating physician decision|1|||
147168159|NCT01943552|530779873|FG000|Overall Study|Adverse Event|3|||
147168160|NCT01943552|530779874|FG001|Overall Study|Adverse Event|2|||
147168161|NCT01943552|530779873|FG000|Overall Study|Withdrawal by Subject|6|||
147168162|NCT01943552|530779874|FG001|Overall Study|Withdrawal by Subject|6|||
147168163|NCT01943552|530779873|FG000|Overall Study|Other Reasons|16|||
147168164|NCT01943552|530779874|FG001|Overall Study|Other Reasons|17|||
147168165|NCT01600053|530779875|FG000|Overall Study|Adverse Event|2|||
147168166|NCT01600053|530779875|FG000|Overall Study|trial will not meet the interim endpoint|9|||
147168167|NCT02715726|530779876|FG000|Overall Study|Adverse Event|2|||
147168168|NCT02715726|530779877|FG001|Overall Study|Adverse Event|6|||
147168169|NCT02715726|530779876|FG000|Overall Study|Protocol Violation|1|||
147168170|NCT02715726|530779877|FG001|Overall Study|Protocol Violation|0|||
147168171|NCT02715726|530779876|FG000|Overall Study|Death|2|||
147168172|NCT02715726|530779877|FG001|Overall Study|Death|1|||
147168173|NCT02715726|530779876|FG000|Overall Study|Participant moved|1|||
147168174|NCT02715726|530779877|FG001|Overall Study|Participant moved|3|||
147168175|NCT02715726|530779876|FG000|Overall Study|Other than specified above|11|||
147168176|NCT02715726|530779877|FG001|Overall Study|Other than specified above|15|||
147168177|NCT02715726|530779876|FG000|Overall Study|Randomized but not treated|1|||
147168178|NCT02715726|530779877|FG001|Overall Study|Randomized but not treated|2|||
147168179|NCT02445573|530779878|FG000|Overall Study|Withdrawal by Subject|1|||
147168180|NCT02445573|530779879|FG001|Overall Study|Withdrawal by Subject|1|||
147168181|NCT02445573|530779878|FG000|Overall Study|Lost to Follow-up|0|||
147168182|NCT02445573|530779879|FG001|Overall Study|Lost to Follow-up|1|||
147168183|NCT01565941|530779880|FG000|Overall Study|Withdrawn by parent/guardian|3|||
147168184|NCT01565941|530779881|FG001|Overall Study|Withdrawn by parent/guardian|2|||
147168185|NCT01565941|530779880|FG000|Overall Study|Randomized; did not receive intevention|8|||
147168186|NCT01565941|530779881|FG001|Overall Study|Randomized; did not receive intevention|2|||
147168187|NCT02855944|530779882|FG000|Period 1: Treatment|Ongoing|14|||
147168188|NCT02855944|530779883|FG001|Period 1: Treatment|Ongoing|0|||
147168189|NCT02855944|530779882|FG000|Period 1: Treatment|Discontinued prior to starting study drug|1|||
147168190|NCT02855944|530779883|FG001|Period 1: Treatment|Discontinued prior to starting study drug|3|||
147168191|NCT02855944|530779882|FG000|Period 2: Crossover to Rucaparib|Ongoing|0|||
147168192|NCT02855944|530779883|FG001|Period 2: Crossover to Rucaparib|Ongoing|5|||
147168193|NCT02358044|530779886|FG000|Overall Study|Adverse Event|0|||
147168194|NCT02358044|530779887|FG001|Overall Study|Adverse Event|1|||
147168195|NCT02358044|530779886|FG000|Overall Study|Lost to Follow-up|2|||
147168196|NCT02358044|530779887|FG001|Overall Study|Lost to Follow-up|1|||
147168197|NCT02358044|530779886|FG000|Overall Study|Physician Decision|0|||
147168198|NCT02358044|530779887|FG001|Overall Study|Physician Decision|1|||
147168199|NCT02358044|530779886|FG000|Overall Study|Withdrawal by Subject|0|||
147168200|NCT02358044|530779887|FG001|Overall Study|Withdrawal by Subject|4|||
147168201|NCT01455220|530779891|FG000|Overall Study|screen fail|30|||
147168202|NCT00267150|530779892|FG000|Overall Study|Adverse Event|1|||
147168203|NCT04881747|530779894|FG000|Period 2 Washout|Adverse Event|1|||
147168204|NCT04881747|530779895|FG001|Period 2 Washout|Adverse Event|0|||
147168205|NCT04881747|530779896|FG002|Period 2 Washout|Adverse Event|0|||
147168206|NCT04881747|530779897|FG003|Period 2 Washout|Adverse Event|0|||
147168207|NCT04881747|530779898|FG004|Period 2 Washout|Adverse Event|1|||
147168208|NCT04881747|530779899|FG005|Period 2 Washout|Adverse Event|0|||
147168209|NCT04881747|530779894|FG000|Period 2 Washout|Withdrawal by Subject|1|||
147590527|NCT02462486|532319004|FG000|Overall Study|Adverse Event|53|||
147590528|NCT02462486|532319005|FG001|Overall Study|Adverse Event|48|||
147168210|NCT04881747|530779895|FG001|Period 2 Washout|Withdrawal by Subject|0|||
147168211|NCT04881747|530779896|FG002|Period 2 Washout|Withdrawal by Subject|0|||
147168212|NCT04881747|530779897|FG003|Period 2 Washout|Withdrawal by Subject|1|||
147168213|NCT04881747|530779898|FG004|Period 2 Washout|Withdrawal by Subject|0|||
147168214|NCT04881747|530779899|FG005|Period 2 Washout|Withdrawal by Subject|0|||
147590529|NCT02462486|532319006|FG002|Overall Study|Adverse Event|21|||
147168215|NCT00521222|530779900|FG000|Overall Study|Lost to Follow-up|0|||
147168216|NCT00521222|530779901|FG001|Overall Study|Lost to Follow-up|0|||
147168217|NCT00521222|530779902|FG002|Overall Study|Lost to Follow-up|1|||
147168218|NCT00521222|530779903|FG003|Overall Study|Lost to Follow-up|1|||
147168219|NCT00521222|530779900|FG000|Overall Study|Withdrawal by Subject|0|||
147168220|NCT00521222|530779901|FG001|Overall Study|Withdrawal by Subject|0|||
147168221|NCT00521222|530779902|FG002|Overall Study|Withdrawal by Subject|2|||
147168222|NCT00521222|530779903|FG003|Overall Study|Withdrawal by Subject|0|||
147168223|NCT00521222|530779900|FG000|Overall Study|Physician Decision|0|||
147168224|NCT00521222|530779901|FG001|Overall Study|Physician Decision|1|||
147168225|NCT00521222|530779902|FG002|Overall Study|Physician Decision|0|||
147168226|NCT00521222|530779903|FG003|Overall Study|Physician Decision|1|||
147168227|NCT01378429|530779905|FG000|Overall Study|Noncompliance with study drug|1|||
147168228|NCT01378429|530779906|FG001|Overall Study|Noncompliance with study drug|0|||
147168229|NCT02265796|530779909|FG000|Overall Study|Death|1|||
147168230|NCT02265796|530779910|FG001|Overall Study|Death|0|||
147168231|NCT02265796|530779909|FG000|Overall Study|started on excluded medication|1|||
147168232|NCT02265796|530779910|FG001|Overall Study|started on excluded medication|0|||
147168233|NCT02265796|530779909|FG000|Overall Study|Withdrawal by Subject|1|||
147168234|NCT02265796|530779910|FG001|Overall Study|Withdrawal by Subject|1|||
147168235|NCT02014584|530779911|FG000|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
147168236|NCT02014584|530779912|FG001|Double-Blind Period (24 Weeks)|Protocol Violation|1|||
147168237|NCT02014584|530779913|FG002|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
147168238|NCT02014584|530779914|FG003|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
147168239|NCT02014584|530779915|FG004|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
147168240|NCT02014584|530779916|FG005|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
147168241|NCT02014584|530779911|FG000|Double-Blind Period (24 Weeks)|Withdrawal by Subject|2|||
147168242|NCT02014584|530779912|FG001|Double-Blind Period (24 Weeks)|Withdrawal by Subject|5|||
147168243|NCT02014584|530779913|FG002|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
147168244|NCT02014584|530779914|FG003|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
147168245|NCT02014584|530779915|FG004|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
147168246|NCT02014584|530779916|FG005|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
147168247|NCT02014584|530779911|FG000|Open-Label Period (24 Weeks)|Lost to Follow-up|0|||
147168248|NCT02014584|530779912|FG001|Open-Label Period (24 Weeks)|Lost to Follow-up|0|||
147168249|NCT02014584|530779913|FG002|Open-Label Period (24 Weeks)|Lost to Follow-up|2|||
147168250|NCT02014584|530779914|FG003|Open-Label Period (24 Weeks)|Lost to Follow-up|0|||
147168251|NCT02014584|530779915|FG004|Open-Label Period (24 Weeks)|Lost to Follow-up|0|||
147168252|NCT02014584|530779916|FG005|Open-Label Period (24 Weeks)|Lost to Follow-up|0|||
147168253|NCT02014584|530779911|FG000|Open-Label Period (24 Weeks)|Withdrawal by Subject|0|||
147168254|NCT02014584|530779912|FG001|Open-Label Period (24 Weeks)|Withdrawal by Subject|0|||
147168255|NCT02014584|530779913|FG002|Open-Label Period (24 Weeks)|Withdrawal by Subject|3|||
147168256|NCT02014584|530779914|FG003|Open-Label Period (24 Weeks)|Withdrawal by Subject|1|||
147168257|NCT02014584|530779915|FG004|Open-Label Period (24 Weeks)|Withdrawal by Subject|0|||
147168258|NCT02014584|530779916|FG005|Open-Label Period (24 Weeks)|Withdrawal by Subject|0|||
147168259|NCT02014584|530779911|FG000|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0|||
147168260|NCT02014584|530779912|FG001|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0|||
147168261|NCT02014584|530779913|FG002|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0|||
147168262|NCT02014584|530779914|FG003|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0|||
147168263|NCT02014584|530779915|FG004|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|1|||
147168264|NCT02014584|530779916|FG005|Target Follow-up (F/U) Period (24 Weeks)|Withdrawal by Subject|0|||
147168265|NCT00483002|530779917|FG000|Overall Study|Adverse Event|68|||
147168266|NCT00483002|530779917|FG000|Overall Study|Lack of Efficacy|555|||
147168267|NCT00483002|530779917|FG000|Overall Study|Lost to Follow-up|962|||
147168268|NCT00483002|530779917|FG000|Overall Study|Other|2|||
147168269|NCT00483002|530779917|FG000|Overall Study|Other|967|||
147168270|NCT01597635|530781780|FG000|Part A|Adverse Event|3|||
147168271|NCT01597635|530781781|FG001|Part A|Adverse Event|0|||
147168272|NCT01597635|530781782|FG002|Part A|Adverse Event|0|||
147168273|NCT01597635|530781780|FG000|Part B|Adverse Event|0|||
147168274|NCT01597635|530781781|FG001|Part B|Adverse Event|0|||
147168275|NCT01597635|530781782|FG002|Part B|Adverse Event|1|||
147168276|NCT01597635|530781780|FG000|Part B|Protocol Violation|0|||
147168277|NCT01597635|530781781|FG001|Part B|Protocol Violation|1|||
147168278|NCT01597635|530781782|FG002|Part B|Protocol Violation|0|||
147168279|NCT01597635|530781780|FG000|Part B|Protocol-defined stopping criteria|0|||
147168280|NCT01597635|530781781|FG001|Part B|Protocol-defined stopping criteria|4|||
147168281|NCT01597635|530781782|FG002|Part B|Protocol-defined stopping criteria|3|||
147168282|NCT01597635|530781780|FG000|Part B|Withdrawal by Subject|0|||
147168283|NCT01597635|530781781|FG001|Part B|Withdrawal by Subject|1|||
147168284|NCT01597635|530781782|FG002|Part B|Withdrawal by Subject|0|||
147168285|NCT00652951|530781783|FG000|Booster Phase|Adverse event, non-fatal|0|||
147168286|NCT00652951|530781784|FG001|Booster Phase|Adverse event, non-fatal|1|||
147168287|NCT00652951|530781785|FG002|Booster Phase|Adverse event, non-fatal|0|||
147168288|NCT00652951|530781783|FG000|Booster Phase|Other|1|||
147168289|NCT00652951|530781784|FG001|Booster Phase|Other|0|||
147168290|NCT00652951|530781785|FG002|Booster Phase|Other|0|||
147168291|NCT01192568|530781786|FG000|Open Label Pre-Amendment 3|Adverse Event|0|||
147168292|NCT01192568|530781787|FG001|Open Label Pre-Amendment 3|Adverse Event|0|||
147168293|NCT01192568|530781788|FG002|Open Label Pre-Amendment 3|Adverse Event|1|||
147590530|NCT02462486|532319004|FG000|Overall Study|Lack of Efficacy|6|||
147590531|NCT02462486|532319005|FG001|Overall Study|Lack of Efficacy|12|||
147590532|NCT02462486|532319006|FG002|Overall Study|Lack of Efficacy|3|||
147590533|NCT02462486|532319004|FG000|Overall Study|Lost to Follow-up|3|||
147590534|NCT02462486|532319005|FG001|Overall Study|Lost to Follow-up|4|||
147590535|NCT02462486|532319006|FG002|Overall Study|Lost to Follow-up|2|||
147590536|NCT02462486|532319004|FG000|Overall Study|Withdrawal by Subject|25|||
147590537|NCT02462486|532319005|FG001|Overall Study|Withdrawal by Subject|22|||
147590538|NCT02462486|532319006|FG002|Overall Study|Withdrawal by Subject|19|||
147590539|NCT02462486|532319004|FG000|Overall Study|Protocol Violation|3|||
147590540|NCT02462486|532319005|FG001|Overall Study|Protocol Violation|1|||
147590541|NCT02462486|532319006|FG002|Overall Study|Protocol Violation|1|||
147590542|NCT02462486|532319004|FG000|Overall Study|Reason not Specified|3|||
147590543|NCT02462486|532319005|FG001|Overall Study|Reason not Specified|4|||
147168294|NCT01192568|530781789|FG003|Open Label Pre-Amendment 3|Adverse Event|0|||
147590544|NCT02462486|532319006|FG002|Overall Study|Reason not Specified|3|||
147590545|NCT02310763|532319014|FG000|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|1|||
147590546|NCT02310763|532319015|FG001|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|1|||
147590547|NCT02310763|532319016|FG002|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|1|||
147590548|NCT02310763|532319014|FG000|Period 1 (Weeks 1 to 48)|Unable to comply with study procedures|0|||
147590549|NCT02310763|532319015|FG001|Period 1 (Weeks 1 to 48)|Unable to comply with study procedures|1|||
147590550|NCT02310763|532319016|FG002|Period 1 (Weeks 1 to 48)|Unable to comply with study procedures|1|||
147590551|NCT02310763|532319014|FG000|Period 1 (Weeks 1 to 48)|Lost to Follow-up|1|||
147590552|NCT02310763|532319015|FG001|Period 1 (Weeks 1 to 48)|Lost to Follow-up|0|||
147590553|NCT02310763|532319016|FG002|Period 1 (Weeks 1 to 48)|Lost to Follow-up|0|||
147590554|NCT02310763|532319014|FG000|Period 1 (Weeks 1 to 48)|Adverse Event|1|||
147590555|NCT02310763|532319015|FG001|Period 1 (Weeks 1 to 48)|Adverse Event|0|||
147590556|NCT02310763|532319016|FG002|Period 1 (Weeks 1 to 48)|Adverse Event|0|||
147590557|NCT02310763|532319014|FG000|Period 2 (Weeks 49 to 96)|Study terminated by sponsor|16|||
147590558|NCT02310763|532319015|FG001|Period 2 (Weeks 49 to 96)|Study terminated by sponsor|16|||
147168295|NCT01192568|530781786|FG000|Open Label Post-Amendment 3|Adverse Event|0|||
147168296|NCT01192568|530781787|FG001|Open Label Post-Amendment 3|Adverse Event|0|||
147168297|NCT01192568|530781788|FG002|Open Label Post-Amendment 3|Adverse Event|0|||
147168298|NCT01192568|530781789|FG003|Open Label Post-Amendment 3|Adverse Event|1|||
147447766|NCT03246958|531803960|FG002|Overall Study|Progression|3|||
147447767|NCT03246958|531803961|FG003|Overall Study|Progression|2|||
147447768|NCT03246958|531803962|FG004|Overall Study|Progression|1|||
147447769|NCT03246958|531803963|FG005|Overall Study|Progression|2|||
147447770|NCT03246958|531803964|FG006|Overall Study|Progression|1|||
147447771|NCT03246958|531803958|FG000|Overall Study|Adverse Event|2|||
147447772|NCT03246958|531803959|FG001|Overall Study|Adverse Event|2|||
147447773|NCT03246958|531803960|FG002|Overall Study|Adverse Event|0|||
147447774|NCT03246958|531803961|FG003|Overall Study|Adverse Event|1|||
147447775|NCT03246958|531803962|FG004|Overall Study|Adverse Event|1|||
147447776|NCT03246958|531803963|FG005|Overall Study|Adverse Event|0|||
147447777|NCT03246958|531803964|FG006|Overall Study|Adverse Event|2|||
147447778|NCT03246958|531803958|FG000|Overall Study|Death|0|||
147447779|NCT03246958|531803959|FG001|Overall Study|Death|1|||
147447780|NCT03246958|531803960|FG002|Overall Study|Death|0|||
147447781|NCT03246958|531803961|FG003|Overall Study|Death|0|||
147447782|NCT03246958|531803962|FG004|Overall Study|Death|0|||
147590559|NCT02310763|532319016|FG002|Period 2 (Weeks 49 to 96)|Study terminated by sponsor|16|||
147590560|NCT02010255|532319019|FG000|Overall Study|Death|0|||
147590561|NCT02010255|532319020|FG001|Overall Study|Death|1|||
147590562|NCT02010255|532319021|FG002|Overall Study|Death|4|||
147590563|NCT02010255|532319022|FG003|Overall Study|Death|4|||
147590564|NCT02010255|532319023|FG004|Overall Study|Death|2|||
147590565|NCT02010255|532319024|FG005|Overall Study|Death|0|||
147168299|NCT02593825|530781790|FG000|Intervention|Lost to Follow-up|10|||
147168300|NCT02593825|530781791|FG001|Intervention|Lost to Follow-up|12|||
147447783|NCT03246958|531803963|FG005|Overall Study|Death|0|||
147590566|NCT02010255|532319025|FG006|Overall Study|Death|1|||
147590567|NCT02010255|532319026|FG007|Overall Study|Death|1|||
147590568|NCT02010255|532319027|FG008|Overall Study|Death|1|||
147590569|NCT02010255|532319028|FG009|Overall Study|Death|0|||
147654651|NCT02213380|532559069|FG001|Per-protocol Analysis|Protocol Violation|36|||
147168301|NCT02100969|530781792|FG000|Overall Study|Did not pass screening phase|1|||
147168302|NCT06359080|530781793|FG000|Overall Study|Withdrawal by Subject|3|||
147168303|NCT00511134|530781794|FG000|Overall Study|Withdrawal by Subject|0|||
147323557|NCT00691028|531349934|FG003|Open-label Period|Withdrawal by Subject|3|||
147447784|NCT03246958|531803964|FG006|Overall Study|Death|0|||
147447785|NCT03246958|531803958|FG000|Overall Study|Physician Decision|0|||
147447786|NCT03246958|531803959|FG001|Overall Study|Physician Decision|0|||
147447787|NCT03246958|531803960|FG002|Overall Study|Physician Decision|0|||
147590570|NCT02010255|532319029|FG010|Overall Study|Death|1|||
147590571|NCT02010255|532319030|FG011|Overall Study|Death|1|||
147590572|NCT02010255|532319031|FG012|Overall Study|Death|0|||
147590573|NCT02010255|532319032|FG013|Overall Study|Death|0|||
147590574|NCT02010255|532319019|FG000|Overall Study|Lack of Efficacy|4|||
147168304|NCT00511134|530781795|FG001|Overall Study|Withdrawal by Subject|2|||
147168305|NCT01949090|530781796|FG000|Overall Study|Serious Adverse Event|0|||
147168306|NCT01949090|530781797|FG001|Overall Study|Serious Adverse Event|1|||
147168307|NCT01949090|530781798|FG002|Overall Study|Serious Adverse Event|2|||
147168308|NCT01949090|530781799|FG003|Overall Study|Serious Adverse Event|0|||
147168309|NCT01949090|530781800|FG004|Overall Study|Serious Adverse Event|1|||
147168310|NCT01949090|530781796|FG000|Overall Study|Withdrawal by Subject|2|||
147168311|NCT01949090|530781797|FG001|Overall Study|Withdrawal by Subject|0|||
147168312|NCT01949090|530781798|FG002|Overall Study|Withdrawal by Subject|0|||
147168313|NCT01949090|530781799|FG003|Overall Study|Withdrawal by Subject|0|||
147168314|NCT01949090|530781800|FG004|Overall Study|Withdrawal by Subject|1|||
147168315|NCT01949090|530781796|FG000|Overall Study|Protocol non-compliance|0|||
147168316|NCT01949090|530781797|FG001|Overall Study|Protocol non-compliance|0|||
147168317|NCT01949090|530781798|FG002|Overall Study|Protocol non-compliance|0|||
147168318|NCT01949090|530781799|FG003|Overall Study|Protocol non-compliance|0|||
147168319|NCT01949090|530781800|FG004|Overall Study|Protocol non-compliance|1|||
147168320|NCT01949090|530781796|FG000|Overall Study|Lost to Follow-up|2|||
147168321|NCT01949090|530781797|FG001|Overall Study|Lost to Follow-up|1|||
147168322|NCT01949090|530781798|FG002|Overall Study|Lost to Follow-up|0|||
147168323|NCT01949090|530781799|FG003|Overall Study|Lost to Follow-up|1|||
147168324|NCT01949090|530781800|FG004|Overall Study|Lost to Follow-up|1|||
147168325|NCT00707954|530781801|FG000|Overall Study|Physician Decision|0|||
147168326|NCT00707954|530781802|FG001|Overall Study|Physician Decision|0|||
147168327|NCT00707954|530781803|FG002|Overall Study|Physician Decision|0|||
147168328|NCT00707954|530781804|FG003|Overall Study|Physician Decision|0|||
147168329|NCT00707954|530781805|FG004|Overall Study|Physician Decision|1|||
147168330|NCT00599755|530781806|FG000|Overall Study|Adverse Event|11|||
147168331|NCT00599755|530781806|FG000|Overall Study|Withdrawal by Subject|2|||
147168332|NCT00599755|530781806|FG000|Overall Study|Progression of Disease|3|||
147168333|NCT00599755|530781806|FG000|Overall Study|Other Reason|2|||
147168334|NCT00599755|530781806|FG000|Overall Study|No data available|1|||
147168335|NCT01306656|530781807|FG000|Overall Study|Lost to Follow-up|1|||
147168336|NCT01306656|530781808|FG001|Overall Study|Lost to Follow-up|0|||
147168337|NCT00417963|530781814|FG000|Overall Study|Lost to Follow-up|3|||
147168338|NCT00417963|530781814|FG000|Overall Study|Withdrawal by Subject|18|||
147168339|NCT00417963|530781814|FG000|Overall Study|Death|17|||
147168340|NCT00417963|530781814|FG000|Overall Study|Study device could not be deployed|3|||
147168341|NCT00477152|530781815|FG000|Overall Study|Parent withdrew consent|2|||
147168342|NCT00477152|530781815|FG000|Overall Study|Adverse Event|1|||
147168343|NCT01023672|530781816|FG000|Overall Study|Worsening disease|2|||
147168344|NCT01023672|530781816|FG000|Overall Study|Death|1|||
147168345|NCT02504580|530781817|FG000|Overall Study|Other|1|||
147168346|NCT02504580|530781818|FG001|Overall Study|Other|0|||
147168347|NCT02504580|530781819|FG002|Overall Study|Other|0|||
147168348|NCT02504580|530781820|FG003|Overall Study|Other|2|||
147168349|NCT02504580|530781821|FG004|Overall Study|Other|1|||
147168350|NCT02504580|530781822|FG005|Overall Study|Other|1|||
147168351|NCT02504580|530781823|FG006|Overall Study|Other|1|||
147168352|NCT02504580|530781824|FG007|Overall Study|Other|2|||
147168353|NCT02504580|530781825|FG008|Overall Study|Other|0|||
147168354|NCT02504580|530781826|FG009|Overall Study|Other|0|||
147168355|NCT02504580|530781827|FG010|Overall Study|Other|0|||
147168356|NCT02504580|530781828|FG011|Overall Study|Other|2|||
147168357|NCT02504580|530781817|FG000|Overall Study|Subject refusal to continue|0|||
147168358|NCT02504580|530781818|FG001|Overall Study|Subject refusal to continue|1|||
147168359|NCT02504580|530781819|FG002|Overall Study|Subject refusal to continue|0|||
147168360|NCT02504580|530781820|FG003|Overall Study|Subject refusal to continue|0|||
147168361|NCT02504580|530781821|FG004|Overall Study|Subject refusal to continue|0|||
147168362|NCT02504580|530781822|FG005|Overall Study|Subject refusal to continue|0|||
147168363|NCT02504580|530781823|FG006|Overall Study|Subject refusal to continue|0|||
147168364|NCT02504580|530781824|FG007|Overall Study|Subject refusal to continue|0|||
147654652|NCT01490840|532559073|FG000|Phase 1|Lost to Follow-up|1|||
147654653|NCT01490840|532559074|FG001|Phase 1|Lost to Follow-up|0|||
147654654|NCT01490840|532559073|FG000|Phase 1|Adverse Event|2|||
147654655|NCT01490840|532559074|FG001|Phase 1|Adverse Event|1|||
147654656|NCT01490840|532559073|FG000|Phase 1|Withdrawal by Subject|6|||
147654657|NCT01490840|532559074|FG001|Phase 1|Withdrawal by Subject|5|||
147168365|NCT02504580|530781825|FG008|Overall Study|Subject refusal to continue|0|||
147168366|NCT02504580|530781826|FG009|Overall Study|Subject refusal to continue|0|||
147168367|NCT02504580|530781827|FG010|Overall Study|Subject refusal to continue|0|||
147168368|NCT02504580|530781828|FG011|Overall Study|Subject refusal to continue|0|||
147168369|NCT00448747|530781829|FG000|Overall Study|collapsed veins|1|||
147168370|NCT00448747|530781830|FG001|Overall Study|collapsed veins|0|||
147168371|NCT02704689|530781836|FG000|Overall Study|Physician Decision|1|||
147168372|NCT02704689|530781836|FG000|Overall Study|Study device not implanted|2|||
147654658|NCT01490840|532559073|FG000|Phase 1|Visit 6a omitted|1|||
147168373|NCT01646203|530781837|FG000|Overall Study|Adverse Event|2|||
147168374|NCT01646203|530781838|FG001|Overall Study|Adverse Event|0|||
147168375|NCT01646203|530781839|FG002|Overall Study|Adverse Event|1|||
147168376|NCT01646203|530781837|FG000|Overall Study|Withdrawal by Subject|0|||
147590575|NCT02010255|532319020|FG001|Overall Study|Lack of Efficacy|1|||
147590576|NCT02010255|532319021|FG002|Overall Study|Lack of Efficacy|2|||
147590577|NCT02010255|532319022|FG003|Overall Study|Lack of Efficacy|1|||
147168377|NCT01646203|530781838|FG001|Overall Study|Withdrawal by Subject|1|||
147168378|NCT01646203|530781839|FG002|Overall Study|Withdrawal by Subject|0|||
147168379|NCT01646203|530781837|FG000|Overall Study|Physician's Decision|0|||
147168380|NCT01646203|530781838|FG001|Overall Study|Physician's Decision|1|||
147168381|NCT01646203|530781839|FG002|Overall Study|Physician's Decision|0|||
147168382|NCT01100528|530781843|FG000|Overall Study|Death|1|||
147168383|NCT01100528|530781843|FG000|Overall Study|Withdrawal by Subject|2|||
147168384|NCT00551291|530781846|FG000|Overall Study|Physician Decision|1|||
147168385|NCT01177969|530781847|FG000|Overall Study|Protocol Violation|2|||
147168386|NCT01177969|530781848|FG001|Overall Study|Protocol Violation|1|||
147168387|NCT01177969|530781847|FG000|Overall Study|Withdrawal by Subject|1|||
147168388|NCT01177969|530781848|FG001|Overall Study|Withdrawal by Subject|2|||
147168389|NCT01475162|530781852|FG000|Overall Study|Physician Decision|1|||
147168390|NCT01475162|530781852|FG000|Overall Study|Death|10|||
147168391|NCT01475162|530781852|FG000|Overall Study|Study closed for safety|3|||
147168392|NCT00490022|530781853|FG000|Overall Study|Adverse Event|0|||
147168393|NCT00490022|530781854|FG001|Overall Study|Adverse Event|2|||
147168394|NCT00490022|530781853|FG000|Overall Study|Withdrawal by Subject|1|||
147168395|NCT00490022|530781854|FG001|Overall Study|Withdrawal by Subject|0|||
147168396|NCT00490022|530781853|FG000|Overall Study|Subject failed to disclose concommitant|0|||
147168397|NCT00490022|530781854|FG001|Overall Study|Subject failed to disclose concommitant|1|||
147168398|NCT01504204|530781855|FG000|Overall Study|Lost to Follow-up|1|||
147168399|NCT01504204|530781856|FG001|Overall Study|Lost to Follow-up|1|||
147168400|NCT00903331|530781857|FG000|Overall Study|Death|4|||
147168401|NCT00903331|530781858|FG001|Overall Study|Death|8|||
147168402|NCT00903331|530781857|FG000|Overall Study|Withdrawal of consent|1|||
147168403|NCT00903331|530781858|FG001|Overall Study|Withdrawal of consent|8|||
147168404|NCT00903331|530781857|FG000|Overall Study|Lung transplant|0|||
147168405|NCT00903331|530781858|FG001|Overall Study|Lung transplant|2|||
147168406|NCT03426631|530781859|FG000|Overall Study|Lost to Follow-up|0|||
147168407|NCT03426631|530781860|FG001|Overall Study|Lost to Follow-up|1|||
147168408|NCT00654004|530781861|FG000|Overall Study|Lost to Follow-up|1|||
147168409|NCT00654004|530781862|FG001|Overall Study|Lost to Follow-up|0|||
147168410|NCT00444067|530781863|FG000|Overall Study|Lost to Follow-up|0|||
147168411|NCT00444067|530781864|FG001|Overall Study|Lost to Follow-up|1|||
147168412|NCT00710385|530781869|FG000|Overall Study|Did not qualify|1|||
147168413|NCT00710385|530781869|FG000|Overall Study|Withdrawal by Subject|1|||
147168414|NCT00710385|530781869|FG000|Overall Study|Undisclosed back pain|1|||
147168415|NCT00710385|530781869|FG000|Overall Study|Physician Decision|1|||
147168416|NCT00710385|530781869|FG000|Overall Study|Undisclosed excessive methadone use|1|||
147168417|NCT01264770|530781870|FG000|Overall Study|Not reported|0|||
147168418|NCT01264770|530781871|FG001|Overall Study|Not reported|0|||
147168419|NCT01264770|530781872|FG002|Overall Study|Not reported|1|||
147168420|NCT01264770|530781873|FG003|Overall Study|Not reported|0|||
147168421|NCT01264770|530781874|FG004|Overall Study|Not reported|0|||
147168422|NCT01264770|530781875|FG005|Overall Study|Not reported|0|||
147168423|NCT01264770|530781870|FG000|Overall Study|e.g., change in circumstances|8|||
147168424|NCT01264770|530781871|FG001|Overall Study|e.g., change in circumstances|3|||
147168425|NCT01264770|530781872|FG002|Overall Study|e.g., change in circumstances|3|||
147168426|NCT01264770|530781873|FG003|Overall Study|e.g., change in circumstances|3|||
147168427|NCT01264770|530781874|FG004|Overall Study|e.g., change in circumstances|4|||
147168428|NCT01264770|530781875|FG005|Overall Study|e.g., change in circumstances|4|||
147168429|NCT01264770|530781870|FG000|Overall Study|Severe non-compliance to protocol|0|||
147168430|NCT01264770|530781871|FG001|Overall Study|Severe non-compliance to protocol|0|||
147168431|NCT01264770|530781872|FG002|Overall Study|Severe non-compliance to protocol|1|||
147168432|NCT01264770|530781873|FG003|Overall Study|Severe non-compliance to protocol|1|||
147168433|NCT01264770|530781874|FG004|Overall Study|Severe non-compliance to protocol|0|||
147168434|NCT01264770|530781875|FG005|Overall Study|Severe non-compliance to protocol|0|||
147168435|NCT01264770|530781870|FG000|Overall Study|Lack of therapeutic response|1|||
147590578|NCT02010255|532319023|FG004|Overall Study|Lack of Efficacy|1|||
147590579|NCT02010255|532319024|FG005|Overall Study|Lack of Efficacy|0|||
147590580|NCT02010255|532319025|FG006|Overall Study|Lack of Efficacy|0|||
147590581|NCT02010255|532319026|FG007|Overall Study|Lack of Efficacy|0|||
147590582|NCT02010255|532319027|FG008|Overall Study|Lack of Efficacy|0|||
147590583|NCT02010255|532319028|FG009|Overall Study|Lack of Efficacy|0|||
147590584|NCT02010255|532319029|FG010|Overall Study|Lack of Efficacy|1|||
147590585|NCT02010255|532319030|FG011|Overall Study|Lack of Efficacy|0|||
147590586|NCT02010255|532319031|FG012|Overall Study|Lack of Efficacy|0|||
147590587|NCT02010255|532319032|FG013|Overall Study|Lack of Efficacy|0|||
147168436|NCT01264770|530781871|FG001|Overall Study|Lack of therapeutic response|0|||
147168437|NCT01264770|530781872|FG002|Overall Study|Lack of therapeutic response|2|||
147168438|NCT01264770|530781873|FG003|Overall Study|Lack of therapeutic response|1|||
147447788|NCT03246958|531803961|FG003|Overall Study|Physician Decision|1|||
147590588|NCT02010255|532319019|FG000|Overall Study|Withdrew Consent|1|||
147168439|NCT01264770|530781874|FG004|Overall Study|Lack of therapeutic response|1|||
147168440|NCT01264770|530781875|FG005|Overall Study|Lack of therapeutic response|0|||
147168441|NCT01264770|530781870|FG000|Overall Study|Dev. of study specific discont. criteria|2|||
147168442|NCT01264770|530781871|FG001|Overall Study|Dev. of study specific discont. criteria|0|||
147168443|NCT01264770|530781872|FG002|Overall Study|Dev. of study specific discont. criteria|0|||
147168444|NCT01264770|530781873|FG003|Overall Study|Dev. of study specific discont. criteria|0|||
147168445|NCT01264770|530781874|FG004|Overall Study|Dev. of study specific discont. criteria|1|||
147168446|NCT01264770|530781875|FG005|Overall Study|Dev. of study specific discont. criteria|1|||
147168447|NCT01264770|530781870|FG000|Overall Study|Lost to Follow-up|0|||
147168448|NCT01264770|530781871|FG001|Overall Study|Lost to Follow-up|0|||
147168449|NCT01264770|530781872|FG002|Overall Study|Lost to Follow-up|1|||
147168450|NCT01264770|530781873|FG003|Overall Study|Lost to Follow-up|1|||
147168451|NCT01264770|530781874|FG004|Overall Study|Lost to Follow-up|0|||
147168452|NCT01264770|530781875|FG005|Overall Study|Lost to Follow-up|0|||
147168453|NCT01264770|530781870|FG000|Overall Study|Adverse Event|7|||
147168454|NCT01264770|530781871|FG001|Overall Study|Adverse Event|7|||
147168455|NCT01264770|530781872|FG002|Overall Study|Adverse Event|8|||
147168456|NCT01264770|530781873|FG003|Overall Study|Adverse Event|0|||
147168457|NCT01264770|530781874|FG004|Overall Study|Adverse Event|2|||
147168458|NCT01264770|530781875|FG005|Overall Study|Adverse Event|1|||
147168459|NCT02528357|530781878|FG000|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
147168460|NCT02528357|530781879|FG001|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|1|||
147168461|NCT02528357|530781880|FG002|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
147168462|NCT02528357|530781881|FG003|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
147168463|NCT02528357|530781882|FG004|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
147168464|NCT02528357|530781883|FG005|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
147168465|NCT02528357|530781884|FG006|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
147168466|NCT02528357|530781885|FG007|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
147168467|NCT02528357|530781886|FG008|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
147168468|NCT02528357|530781887|FG009|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
147168469|NCT02528357|530781888|FG010|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
147168470|NCT02528357|530781889|FG011|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
147168471|NCT02528357|530781890|FG012|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
147168472|NCT02528357|530781891|FG013|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
147590589|NCT02010255|532319020|FG001|Overall Study|Withdrew Consent|0|||
147168473|NCT02528357|530781892|FG014|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
147168474|NCT02528357|530781893|FG015|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
147168475|NCT02528357|530781894|FG016|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
147168476|NCT02528357|530781895|FG017|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
147168477|NCT02528357|530781896|FG018|Part1:Monotherapy(Up to Maximum 39weeks)|Lost to Follow-up|0|||
147168478|NCT02528357|530781878|FG000|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
147168479|NCT02528357|530781879|FG001|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
147168480|NCT02528357|530781880|FG002|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
147168481|NCT02528357|530781881|FG003|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|1|||
147168482|NCT02528357|530781882|FG004|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
147168483|NCT02528357|530781883|FG005|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|2|||
147168484|NCT02528357|530781884|FG006|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
147168485|NCT02528357|530781885|FG007|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|1|||
147168486|NCT02528357|530781886|FG008|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
147168487|NCT02528357|530781887|FG009|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
147168488|NCT02528357|530781888|FG010|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
147168489|NCT02528357|530781889|FG011|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
147168490|NCT02528357|530781890|FG012|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
147168491|NCT02528357|530781891|FG013|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
147168492|NCT02528357|530781892|FG014|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
147168493|NCT02528357|530781893|FG015|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
147590590|NCT02010255|532319021|FG002|Overall Study|Withdrew Consent|0|||
147590591|NCT02010255|532319022|FG003|Overall Study|Withdrew Consent|1|||
147590592|NCT02010255|532319023|FG004|Overall Study|Withdrew Consent|0|||
147590593|NCT02010255|532319024|FG005|Overall Study|Withdrew Consent|0|||
147590594|NCT02010255|532319025|FG006|Overall Study|Withdrew Consent|0|||
147590595|NCT02010255|532319026|FG007|Overall Study|Withdrew Consent|0|||
147590596|NCT02010255|532319027|FG008|Overall Study|Withdrew Consent|0|||
147590597|NCT02010255|532319028|FG009|Overall Study|Withdrew Consent|0|||
147590598|NCT02010255|532319029|FG010|Overall Study|Withdrew Consent|0|||
147590599|NCT02010255|532319030|FG011|Overall Study|Withdrew Consent|0|||
147590600|NCT02010255|532319031|FG012|Overall Study|Withdrew Consent|0|||
147654659|NCT01490840|532559074|FG001|Phase 1|Visit 6a omitted|0|||
147654660|NCT01490840|532559073|FG000|Phase 2|Withdrawal by Subject|4|||
147654661|NCT01490840|532559074|FG001|Phase 2|Withdrawal by Subject|3|||
147654662|NCT01490840|532559073|FG000|Phase 2|Permanent interruption of fingolimod|0|||
147654663|NCT01490840|532559074|FG001|Phase 2|Permanent interruption of fingolimod|1|||
147654664|NCT01490840|532559073|FG000|Phase 2|Lost to Follow-up|1|||
147654665|NCT01490840|532559074|FG001|Phase 2|Lost to Follow-up|1|||
147654666|NCT01490840|532559073|FG000|Phase 2|Adverse Event|1|||
147654667|NCT01490840|532559074|FG001|Phase 2|Adverse Event|1|||
147654668|NCT01025284|532559081|FG000|Overall Study|Investigator Decision|0|||
147654669|NCT01025284|532559082|FG001|Overall Study|Investigator Decision|1|||
147654670|NCT01025284|532559083|FG002|Overall Study|Investigator Decision|0|||
147654671|NCT01025284|532559081|FG000|Overall Study|Withdrawal by Subject|0|||
147654672|NCT01025284|532559082|FG001|Overall Study|Withdrawal by Subject|1|||
147654673|NCT01025284|532559083|FG002|Overall Study|Withdrawal by Subject|0|||
147654674|NCT00905567|532559085|FG000|Washout|Withdrawal by Subject|0|||
147654675|NCT00905567|532559086|FG001|Washout|Withdrawal by Subject|1|||
147654676|NCT02542397|532559087|FG000|Overall Study|Death|2|||
147654677|NCT02542397|532559087|FG000|Overall Study|Physician Decision|6|||
147654678|NCT02542397|532559087|FG000|Overall Study|Withdrawal by Subject|6|||
147654679|NCT02542397|532559087|FG000|Overall Study|Lost to Follow-up|2|||
147654680|NCT01473940|532559093|FG000|Induction Therapy|Death|0|||
147654681|NCT01473940|532559094|FG001|Induction Therapy|Death|0|||
147654682|NCT01473940|532559095|FG002|Induction Therapy|Death|1|||
147654683|NCT01473940|532559096|FG003|Induction Therapy|Death|1|||
147654684|NCT01473940|532559093|FG000|Induction Therapy|Progressive Disease|0|||
147323558|NCT00691028|531349931|FG000|Open-label Period|not come to a hospital|0|||
147323559|NCT00691028|531349932|FG001|Open-label Period|not come to a hospital|0|||
147323560|NCT00691028|531349933|FG002|Open-label Period|not come to a hospital|0|||
147323561|NCT00691028|531349934|FG003|Open-label Period|not come to a hospital|1|||
147323562|NCT00691028|531349931|FG000|Double-blind Period|Adverse Event|8|||
147323563|NCT00691028|531349932|FG001|Double-blind Period|Adverse Event|9|||
147323564|NCT00691028|531349933|FG002|Double-blind Period|Adverse Event|6|||
147323565|NCT00691028|531349934|FG003|Double-blind Period|Adverse Event|0|||
147323566|NCT00691028|531349931|FG000|Double-blind Period|Lack of Efficacy|4|||
147323567|NCT00691028|531349932|FG001|Double-blind Period|Lack of Efficacy|3|||
147323568|NCT00691028|531349933|FG002|Double-blind Period|Lack of Efficacy|2|||
147323569|NCT00691028|531349934|FG003|Double-blind Period|Lack of Efficacy|0|||
147590601|NCT02010255|532319032|FG013|Overall Study|Withdrew Consent|0|||
147590602|NCT02010255|532319019|FG000|Overall Study|Adverse Event|1|||
147590603|NCT02010255|532319020|FG001|Overall Study|Adverse Event|0|||
147590604|NCT02010255|532319021|FG002|Overall Study|Adverse Event|0|||
147590605|NCT02010255|532319022|FG003|Overall Study|Adverse Event|0|||
147590606|NCT02010255|532319023|FG004|Overall Study|Adverse Event|0|||
147323570|NCT00691028|531349931|FG000|Double-blind Period|Withdrawal by Subject|1|||
147323571|NCT00691028|531349932|FG001|Double-blind Period|Withdrawal by Subject|0|||
147323572|NCT00691028|531349933|FG002|Double-blind Period|Withdrawal by Subject|1|||
147323573|NCT00691028|531349934|FG003|Double-blind Period|Withdrawal by Subject|0|||
147323574|NCT00691028|531349931|FG000|Double-blind Period|not come to a hospital.|0|||
147323575|NCT00691028|531349932|FG001|Double-blind Period|not come to a hospital.|1|||
147323576|NCT00691028|531349933|FG002|Double-blind Period|not come to a hospital.|0|||
147323577|NCT00691028|531349934|FG003|Double-blind Period|not come to a hospital.|0|||
147323578|NCT03085017|531349935|FG000|Overall Study|Death|0|||
147323579|NCT03085017|531349936|FG001|Overall Study|Death|3|||
147323580|NCT00582790|531349950|FG000|Overall Study|Rapid progression of disease|1|||
147323581|NCT02374957|531349951|FG000|Overall Study|Patient did not complete forms correctly|1|||
147323582|NCT02374957|531349952|FG001|Overall Study|Patient did not complete forms correctly|0|||
147323583|NCT02390557|531349953|FG000|Wave 2|Survey non-respondent|72|||
147323584|NCT02390557|531349954|FG001|Wave 2|Survey non-respondent|41|||
147590607|NCT02010255|532319024|FG005|Overall Study|Adverse Event|0|||
147590608|NCT02010255|532319025|FG006|Overall Study|Adverse Event|0|||
147590609|NCT02010255|532319026|FG007|Overall Study|Adverse Event|0|||
147590610|NCT02010255|532319027|FG008|Overall Study|Adverse Event|0|||
147654685|NCT01473940|532559094|FG001|Induction Therapy|Progressive Disease|1|||
147654686|NCT01473940|532559095|FG002|Induction Therapy|Progressive Disease|1|||
147654687|NCT01473940|532559096|FG003|Induction Therapy|Progressive Disease|0|||
147654688|NCT01473940|532559093|FG000|Maintenance Therapy|Progressive Disease|1|||
147654689|NCT01473940|532559094|FG001|Maintenance Therapy|Progressive Disease|2|||
147323585|NCT02390557|531349955|FG002|Wave 2|Survey non-respondent|23|||
147323586|NCT03283553|531349959|FG000|Patient Participant Flow|Death|5|||
147323587|NCT03283553|531349960|FG001|Patient Participant Flow|Death|10|||
147654690|NCT01473940|532559095|FG002|Maintenance Therapy|Progressive Disease|1|||
147323588|NCT03283553|531349959|FG000|Patient Participant Flow|Withdrawal by Subject|4|||
147323589|NCT03283553|531349960|FG001|Patient Participant Flow|Withdrawal by Subject|2|||
147323590|NCT03283553|531349959|FG000|Patient Participant Flow|Lost to Follow-up|1|||
147590611|NCT02010255|532319028|FG009|Overall Study|Adverse Event|0|||
147654691|NCT01473940|532559096|FG003|Maintenance Therapy|Progressive Disease|4|||
147654692|NCT00547248|532559097|FG000|Overall Study|Protocol Violation|0|||
147654693|NCT00547248|532559098|FG001|Overall Study|Protocol Violation|0|||
147168494|NCT02528357|530781894|FG016|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
147168495|NCT02528357|530781895|FG017|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
147168496|NCT02528357|530781896|FG018|Part1:Monotherapy(Up to Maximum 39weeks)|Physician Decision|0|||
147168497|NCT02528357|530781878|FG000|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
147168498|NCT02528357|530781879|FG001|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
147168499|NCT02528357|530781880|FG002|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|2|||
147168500|NCT02528357|530781881|FG003|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
147168501|NCT02528357|530781882|FG004|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|3|||
147168502|NCT02528357|530781883|FG005|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
147168503|NCT02528357|530781884|FG006|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|2|||
147168504|NCT02528357|530781885|FG007|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|1|||
147168505|NCT02528357|530781886|FG008|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
147168506|NCT02528357|530781887|FG009|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
147168507|NCT02528357|530781888|FG010|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
147168508|NCT02528357|530781889|FG011|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
147168509|NCT02528357|530781890|FG012|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
147168510|NCT02528357|530781891|FG013|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
147168511|NCT02528357|530781892|FG014|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
147168512|NCT02528357|530781893|FG015|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
147168513|NCT02528357|530781894|FG016|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
147168514|NCT02528357|530781895|FG017|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
147168515|NCT02528357|530781896|FG018|Part1:Monotherapy(Up to Maximum 39weeks)|Withdrawal by Subject|0|||
147168516|NCT02528357|530781878|FG000|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
147168517|NCT02528357|530781879|FG001|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
147168518|NCT02528357|530781880|FG002|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
147168519|NCT02528357|530781881|FG003|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
147168520|NCT02528357|530781882|FG004|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
147168521|NCT02528357|530781883|FG005|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
147168522|NCT02528357|530781884|FG006|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
147168523|NCT02528357|530781885|FG007|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
147168524|NCT02528357|530781886|FG008|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
147168525|NCT02528357|530781887|FG009|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
147168526|NCT02528357|530781888|FG010|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
147168527|NCT02528357|530781889|FG011|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
147168528|NCT02528357|530781890|FG012|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
147168529|NCT02528357|530781891|FG013|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
147168530|NCT02528357|530781892|FG014|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
147168531|NCT02528357|530781893|FG015|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
147168532|NCT02528357|530781894|FG016|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
147168533|NCT02528357|530781895|FG017|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
147168534|NCT02528357|530781896|FG018|Part1:Monotherapy(Up to Maximum 39weeks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
147168535|NCT02528357|530781878|FG000|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
147168536|NCT02528357|530781879|FG001|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
147168537|NCT02528357|530781880|FG002|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
147168538|NCT02528357|530781881|FG003|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
147168539|NCT02528357|530781882|FG004|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
147168540|NCT02528357|530781883|FG005|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
147168541|NCT02528357|530781884|FG006|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
147168542|NCT02528357|530781885|FG007|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
147168543|NCT02528357|530781886|FG008|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
147168544|NCT02528357|530781887|FG009|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
147168545|NCT02528357|530781888|FG010|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
147168546|NCT02528357|530781889|FG011|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
147168547|NCT02528357|530781890|FG012|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
147168548|NCT02528357|530781891|FG013|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|1|||
147168549|NCT02528357|530781892|FG014|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|5|||
147654694|NCT00547248|532559099|FG002|Overall Study|Protocol Violation|1|||
147168550|NCT02528357|530781893|FG015|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
147168551|NCT02528357|530781894|FG016|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
147168552|NCT02528357|530781895|FG017|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
147168553|NCT02528357|530781896|FG018|Part2A:Comb. Th. (Up to Maximum 105wks)|Investigator site closed|0|||
147168554|NCT02528357|530781878|FG000|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
147168555|NCT02528357|530781879|FG001|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
147168556|NCT02528357|530781880|FG002|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
147168557|NCT02528357|530781881|FG003|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
147168558|NCT02528357|530781882|FG004|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
147168559|NCT02528357|530781883|FG005|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
147168560|NCT02528357|530781884|FG006|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
147168561|NCT02528357|530781885|FG007|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
147447789|NCT03246958|531803962|FG004|Overall Study|Physician Decision|0|||
147447790|NCT03246958|531803963|FG005|Overall Study|Physician Decision|0|||
147447791|NCT03246958|531803964|FG006|Overall Study|Physician Decision|0|||
147447792|NCT03246958|531803958|FG000|Overall Study|Never start treatment|1|||
147447793|NCT03246958|531803959|FG001|Overall Study|Never start treatment|0|||
147447794|NCT03246958|531803960|FG002|Overall Study|Never start treatment|0|||
147447795|NCT03246958|531803961|FG003|Overall Study|Never start treatment|0|||
147447796|NCT03246958|531803962|FG004|Overall Study|Never start treatment|0|||
147447797|NCT03246958|531803963|FG005|Overall Study|Never start treatment|0|||
147447798|NCT03246958|531803964|FG006|Overall Study|Never start treatment|0|||
147447799|NCT03246958|531803958|FG000|Overall Study|Over enrollment|0|||
147447800|NCT03246958|531803959|FG001|Overall Study|Over enrollment|2|||
147447801|NCT03246958|531803960|FG002|Overall Study|Over enrollment|0|||
147447802|NCT03246958|531803961|FG003|Overall Study|Over enrollment|0|||
147447803|NCT03246958|531803962|FG004|Overall Study|Over enrollment|0|||
147447804|NCT03246958|531803963|FG005|Overall Study|Over enrollment|0|||
147447805|NCT03246958|531803964|FG006|Overall Study|Over enrollment|0|||
147447806|NCT02311153|531803965|FG000|Overall Study|Lost to Follow-up|5|||
147447807|NCT02311153|531803966|FG001|Overall Study|Lost to Follow-up|7|||
147447808|NCT01650636|531803971|FG000|Washout up to 5 Months|Withdrawal by Subject|4|||
147447809|NCT01650636|531803972|FG001|Washout up to 5 Months|Withdrawal by Subject|8|||
147447810|NCT01650636|531803971|FG000|Washout up to 5 Months|Physician Decision|2|||
147447811|NCT01650636|531803972|FG001|Washout up to 5 Months|Physician Decision|2|||
147447812|NCT01650636|531803971|FG000|Washout up to 5 Months|Death|1|||
147447813|NCT01650636|531803972|FG001|Washout up to 5 Months|Death|0|||
147447814|NCT01650636|531803971|FG000|Washout up to 5 Months|Lost to Follow-up|2|||
147447815|NCT01650636|531803972|FG001|Washout up to 5 Months|Lost to Follow-up|8|||
147447816|NCT01650636|531803971|FG000|Washout up to 9 Months|Withdrawal by Subject|4|||
147447817|NCT01650636|531803972|FG001|Washout up to 9 Months|Withdrawal by Subject|2|||
147447818|NCT01650636|531803971|FG000|Washout up to 9 Months|Lost to Follow-up|2|||
147447819|NCT01650636|531803972|FG001|Washout up to 9 Months|Lost to Follow-up|1|||
147447820|NCT01560780|531803973|FG000|Overall Study|Death|2|||
147447821|NCT01560780|531803974|FG001|Overall Study|Death|1|||
147447822|NCT01560780|531803973|FG000|Overall Study|Patient Preference|11|||
147447823|NCT01560780|531803974|FG001|Overall Study|Patient Preference|11|||
147590612|NCT02010255|532319029|FG010|Overall Study|Adverse Event|0|||
147590613|NCT02010255|532319030|FG011|Overall Study|Adverse Event|0|||
147590614|NCT02010255|532319031|FG012|Overall Study|Adverse Event|0|||
147590615|NCT02010255|532319032|FG013|Overall Study|Adverse Event|0|||
147590616|NCT02010255|532319019|FG000|Overall Study|Lost to Follow-up|0|||
147590617|NCT02010255|532319020|FG001|Overall Study|Lost to Follow-up|0|||
147168562|NCT02528357|530781886|FG008|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
147168563|NCT02528357|530781887|FG009|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
147168564|NCT02528357|530781888|FG010|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
147168565|NCT02528357|530781889|FG011|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
147168566|NCT02528357|530781890|FG012|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
147168567|NCT02528357|530781891|FG013|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|1|||
147168568|NCT02528357|530781892|FG014|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
147168569|NCT02528357|530781893|FG015|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
147168570|NCT02528357|530781894|FG016|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
147447824|NCT01577186|531803975|FG000|Overall Study|Adverse Event|23|||
147447825|NCT01577186|531803975|FG000|Overall Study|Death|1|||
147447826|NCT01577186|531803975|FG000|Overall Study|Lost to Follow-up|28|||
147447827|NCT01577186|531803975|FG000|Overall Study|Withdrawal by Subject|35|||
147447828|NCT01577186|531803975|FG000|Overall Study|Insufficient Response|18|||
147447829|NCT01577186|531803975|FG000|Overall Study|Ineligible to Continue|15|||
147447830|NCT01577186|531803975|FG000|Overall Study|Non-Compliant|8|||
147447831|NCT01577186|531803975|FG000|Overall Study|Other|2|||
147447832|NCT02192827|531803985|FG000|Overall Study|Lost to Follow-up|25|||
147447833|NCT02192827|531803986|FG001|Overall Study|Lost to Follow-up|27|||
147590618|NCT02010255|532319021|FG002|Overall Study|Lost to Follow-up|1|||
147168571|NCT02528357|530781895|FG017|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
147168572|NCT02528357|530781896|FG018|Part2A:Comb. Th. (Up to Maximum 105wks)|Physician Decision|0|||
147168573|NCT02528357|530781878|FG000|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
147168574|NCT02528357|530781879|FG001|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
147168575|NCT02528357|530781880|FG002|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
147168576|NCT02528357|530781881|FG003|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
147168577|NCT02528357|530781882|FG004|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
147168578|NCT02528357|530781883|FG005|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
147168579|NCT02528357|530781884|FG006|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
147168580|NCT02528357|530781885|FG007|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
147168581|NCT02528357|530781886|FG008|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
147168582|NCT02528357|530781887|FG009|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
147168583|NCT02528357|530781888|FG010|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|3|||
147168584|NCT02528357|530781889|FG011|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
147168585|NCT02528357|530781890|FG012|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|1|||
147168586|NCT02528357|530781891|FG013|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|3|||
147168587|NCT02528357|530781892|FG014|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|1|||
147168588|NCT02528357|530781893|FG015|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
147168589|NCT02528357|530781894|FG016|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
147168590|NCT02528357|530781895|FG017|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
147168591|NCT02528357|530781896|FG018|Part2A:Comb. Th. (Up to Maximum 105wks)|Withdrawal by Subject|0|||
147168592|NCT02528357|530781878|FG000|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
147168593|NCT02528357|530781879|FG001|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
147168594|NCT02528357|530781880|FG002|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
147168595|NCT02528357|530781881|FG003|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
147168596|NCT02528357|530781882|FG004|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
147168597|NCT02528357|530781883|FG005|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
147168598|NCT02528357|530781884|FG006|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
147168599|NCT02528357|530781885|FG007|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
147168600|NCT02528357|530781886|FG008|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
147168601|NCT02528357|530781887|FG009|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
147168602|NCT02528357|530781888|FG010|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
147168603|NCT02528357|530781889|FG011|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|3|||
147168604|NCT02528357|530781890|FG012|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|4|||
147168605|NCT02528357|530781891|FG013|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
147168606|NCT02528357|530781892|FG014|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
147168607|NCT02528357|530781893|FG015|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
147168608|NCT02528357|530781894|FG016|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
147168609|NCT02528357|530781895|FG017|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
147168610|NCT02528357|530781896|FG018|Part2A:Comb. Th. (Up to Maximum 105wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
147168611|NCT02528357|530781878|FG000|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
147168612|NCT02528357|530781879|FG001|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
147168613|NCT02528357|530781880|FG002|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
147168614|NCT02528357|530781881|FG003|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
147168615|NCT02528357|530781882|FG004|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
147168616|NCT02528357|530781883|FG005|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
147168617|NCT02528357|530781884|FG006|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
147168618|NCT02528357|530781885|FG007|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
147168619|NCT02528357|530781886|FG008|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
147168620|NCT02528357|530781887|FG009|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
147168621|NCT02528357|530781888|FG010|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
147168622|NCT02528357|530781889|FG011|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
147168623|NCT02528357|530781890|FG012|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
147168624|NCT02528357|530781891|FG013|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
147168625|NCT02528357|530781892|FG014|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
147654695|NCT00547248|532559100|FG003|Overall Study|Protocol Violation|1|||
147654696|NCT00547248|532559097|FG000|Overall Study|Migrated/moved from study area|0|||
147168626|NCT02528357|530781893|FG015|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
147168627|NCT02528357|530781894|FG016|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|2|||
147168628|NCT02528357|530781895|FG017|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
147168629|NCT02528357|530781896|FG018|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Withdrawal by Subject|0|||
147168630|NCT02528357|530781878|FG000|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
147168631|NCT02528357|530781879|FG001|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
147168632|NCT02528357|530781880|FG002|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
147168633|NCT02528357|530781881|FG003|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
147168634|NCT02528357|530781882|FG004|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
147323591|NCT03283553|531349960|FG001|Patient Participant Flow|Lost to Follow-up|1|||
147323592|NCT03283553|531349959|FG000|Care Partner Participant Flow|Withdrawal by Subject|4|||
147323593|NCT03283553|531349960|FG001|Care Partner Participant Flow|Withdrawal by Subject|3|||
147323594|NCT03283553|531349959|FG000|Care Partner Participant Flow|Lost to Follow-up|1|||
147323595|NCT03283553|531349960|FG001|Care Partner Participant Flow|Lost to Follow-up|1|||
147323596|NCT03283553|531349959|FG000|Care Partner Participant Flow|Discontinued because patient death|5|||
147323597|NCT03283553|531349960|FG001|Care Partner Participant Flow|Discontinued because patient death|11|||
147323598|NCT03686683|531349961|FG000|Overall Study|Withdrawal by Subject|52|||
147323599|NCT03686683|531349962|FG001|Overall Study|Withdrawal by Subject|32|||
147323600|NCT03686683|531349961|FG000|Overall Study|Lost to Follow-up|23|||
147323601|NCT03686683|531349962|FG001|Overall Study|Lost to Follow-up|19|||
147323602|NCT03686683|531349961|FG000|Overall Study|Adverse Event|1|||
147323603|NCT03686683|531349962|FG001|Overall Study|Adverse Event|0|||
147323604|NCT03686683|531349961|FG000|Overall Study|Death|10|||
147323605|NCT03686683|531349962|FG001|Overall Study|Death|5|||
147323606|NCT03686683|531349961|FG000|Overall Study|Progressive Disease|1|||
147323607|NCT03686683|531349962|FG001|Overall Study|Progressive Disease|1|||
147323608|NCT03686683|531349961|FG000|Overall Study|Noncompliance|1|||
147323609|NCT03686683|531349962|FG001|Overall Study|Noncompliance|0|||
147323610|NCT03686683|531349961|FG000|Overall Study|Physician Decision|1|||
147323611|NCT03686683|531349962|FG001|Overall Study|Physician Decision|1|||
147323612|NCT03686683|531349961|FG000|Overall Study|Screen fail post-randomization|1|||
147168635|NCT02528357|530781883|FG005|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
147168636|NCT02528357|530781884|FG006|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
147168637|NCT02528357|530781885|FG007|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
147168638|NCT02528357|530781886|FG008|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
147168639|NCT02528357|530781887|FG009|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
147168640|NCT02528357|530781888|FG010|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
147168641|NCT02528357|530781889|FG011|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
147168642|NCT02528357|530781890|FG012|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
147168643|NCT02528357|530781891|FG013|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
147168644|NCT02528357|530781892|FG014|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
147168645|NCT02528357|530781893|FG015|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|0|||
147168646|NCT02528357|530781894|FG016|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|1|||
147168647|NCT02528357|530781895|FG017|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|4|||
147168648|NCT02528357|530781896|FG018|Part2B:Expan. Coh.(Up to Maximum 33 Wks)|Follow-up assessments removed (Protocol Amendment 4)|3|||
147168649|NCT01927055|530781901|FG000|Open-label|Adverse Event|6|||
147168650|NCT01927055|530781902|FG001|Open-label|Adverse Event|0|||
147168651|NCT01927055|530781903|FG002|Open-label|Adverse Event|0|||
147168652|NCT01927055|530781901|FG000|Open-label|Withdrawal by Subject|1|||
147168653|NCT01927055|530781902|FG001|Open-label|Withdrawal by Subject|0|||
147168654|NCT01927055|530781903|FG002|Open-label|Withdrawal by Subject|0|||
147168655|NCT01927055|530781901|FG000|Open-label|Study Stopped|4|||
147168656|NCT01927055|530781902|FG001|Open-label|Study Stopped|0|||
147168657|NCT01927055|530781903|FG002|Open-label|Study Stopped|0|||
147168658|NCT01927055|530781901|FG000|Open-label|Supine Hypertension|4|||
147168659|NCT01927055|530781902|FG001|Open-label|Supine Hypertension|0|||
147168660|NCT01927055|530781903|FG002|Open-label|Supine Hypertension|0|||
147168661|NCT01927055|530781901|FG000|Open-label|Difficulty attending study visits|1|||
147168662|NCT01927055|530781902|FG001|Open-label|Difficulty attending study visits|0|||
147168663|NCT01927055|530781903|FG002|Open-label|Difficulty attending study visits|0|||
147323613|NCT03686683|531349962|FG001|Overall Study|Screen fail post-randomization|0|||
147323614|NCT03686683|531349961|FG000|Overall Study|Protocol Violation|3|||
147323615|NCT03686683|531349962|FG001|Overall Study|Protocol Violation|0|||
147447834|NCT02192827|531803985|FG000|Overall Study|Given additional steroids with admission|13|||
147447835|NCT02192827|531803986|FG001|Overall Study|Given additional steroids with admission|11|||
147168664|NCT01927055|530781901|FG000|Double-Blind|Adverse Event|0|||
147168665|NCT01927055|530781902|FG001|Double-Blind|Adverse Event|1|||
147168666|NCT01927055|530781903|FG002|Double-Blind|Adverse Event|1|||
147168667|NCT01927055|530781901|FG000|Double-Blind|Protocol Violation|0|||
147168668|NCT01927055|530781902|FG001|Double-Blind|Protocol Violation|0|||
147447836|NCT00414453|531803988|FG000|Overall Study|Abnormal lab work|16|||
147447837|NCT01265797|531803993|FG000|Run-in Month|Withdrawal by Subject|0|||
147447838|NCT01265797|531803994|FG001|Run-in Month|Withdrawal by Subject|4|||
147447839|NCT01265797|531803993|FG000|Run-in Month|1st seizure during run-in month|0|||
147447840|NCT01265797|531803994|FG001|Run-in Month|1st seizure during run-in month|1|||
147447841|NCT01265797|531803993|FG000|Blinded Month|Lack of Efficacy|5|||
147447842|NCT01265797|531803994|FG001|Blinded Month|Lack of Efficacy|0|||
147447843|NCT01265797|531803993|FG000|Blinded Month|Lost to Follow-up|1|||
147447844|NCT01265797|531803994|FG001|Blinded Month|Lost to Follow-up|0|||
147447845|NCT01265797|531803993|FG000|Blinded Month|Protocol Violation|2|||
147447846|NCT01265797|531803994|FG001|Blinded Month|Protocol Violation|1|||
147447847|NCT01265797|531803993|FG000|Blinded Month|Adverse Event|2|||
147447848|NCT01265797|531803994|FG001|Blinded Month|Adverse Event|0|||
147447849|NCT01265797|531803993|FG000|Blinded Month|Diary data incomplete|0|||
147447850|NCT01265797|531803994|FG001|Blinded Month|Diary data incomplete|1|||
147447851|NCT01265797|531803993|FG000|Open Label Month|Lost to Follow-up|0|||
147447852|NCT01265797|531803994|FG001|Open Label Month|Lost to Follow-up|1|||
147447853|NCT01422915|531803995|FG000|Overall Study|Adverse Event|1|||
147447854|NCT02980224|531803996|FG000|Overall Study|Adverse Event|4|||
147168669|NCT01927055|530781903|FG002|Double-Blind|Protocol Violation|1|||
147168670|NCT01927055|530781901|FG000|Double-Blind|Withdrawal by Subject|0|||
147447855|NCT02980224|531803997|FG001|Overall Study|Adverse Event|1|||
147447856|NCT02980224|531803996|FG000|Overall Study|Withdrawal by Subject|0|||
147447857|NCT02980224|531803997|FG001|Overall Study|Withdrawal by Subject|2|||
147447858|NCT01979536|531803998|FG000|Overall Study|Physician Decision|2|||
147447859|NCT01979536|531803999|FG001|Overall Study|Physician Decision|3|||
147447860|NCT01979536|531803998|FG000|Overall Study|Withdrawal by Subject|0|||
147447861|NCT01979536|531803999|FG001|Overall Study|Withdrawal by Subject|1|||
147447862|NCT01979536|531803998|FG000|Overall Study|Refusal|0|||
147447863|NCT01979536|531803999|FG001|Overall Study|Refusal|1|||
147447864|NCT01979536|531803998|FG000|Overall Study|Relapse|0|||
147447865|NCT01979536|531803999|FG001|Overall Study|Relapse|1|||
147447866|NCT01979536|531803998|FG000|Overall Study|Study terminated by Sponsor|0|||
147447867|NCT01979536|531803999|FG001|Overall Study|Study terminated by Sponsor|1|||
147447868|NCT01979536|531803998|FG000|Overall Study|Did not start treatment|0|||
147447869|NCT01979536|531803999|FG001|Overall Study|Did not start treatment|1|||
147447870|NCT03077685|531804000|FG000|Overall Study|Lost to Follow-up|0|||
147447871|NCT03077685|531804001|FG001|Overall Study|Lost to Follow-up|0|||
147447872|NCT03077685|531804002|FG002|Overall Study|Lost to Follow-up|0|||
147447873|NCT03077685|531804003|FG003|Overall Study|Lost to Follow-up|0|||
147447874|NCT03077685|531804004|FG004|Overall Study|Lost to Follow-up|1|||
147447875|NCT03077685|531804000|FG000|Overall Study|Death|0|||
147447876|NCT03077685|531804001|FG001|Overall Study|Death|0|||
147447877|NCT03077685|531804002|FG002|Overall Study|Death|1|||
147447878|NCT03077685|531804003|FG003|Overall Study|Death|1|||
147447879|NCT03077685|531804004|FG004|Overall Study|Death|3|||
147447880|NCT03077685|531804000|FG000|Overall Study|Withdrawal by Subject|0|||
147447881|NCT03077685|531804001|FG001|Overall Study|Withdrawal by Subject|0|||
147447882|NCT03077685|531804002|FG002|Overall Study|Withdrawal by Subject|0|||
147447883|NCT03077685|531804003|FG003|Overall Study|Withdrawal by Subject|2|||
147447884|NCT03077685|531804004|FG004|Overall Study|Withdrawal by Subject|1|||
147447885|NCT03077685|531804000|FG000|Overall Study|Physician Decision|0|||
147447886|NCT03077685|531804001|FG001|Overall Study|Physician Decision|0|||
147447887|NCT03077685|531804002|FG002|Overall Study|Physician Decision|1|||
147168671|NCT01927055|530781902|FG001|Double-Blind|Withdrawal by Subject|2|||
147168672|NCT01927055|530781903|FG002|Double-Blind|Withdrawal by Subject|3|||
147168673|NCT01927055|530781901|FG000|Double-Blind|Study Stopped|0|||
147168674|NCT01927055|530781902|FG001|Double-Blind|Study Stopped|7|||
147168675|NCT01927055|530781903|FG002|Double-Blind|Study Stopped|7|||
147654697|NCT00547248|532559098|FG001|Overall Study|Migrated/moved from study area|0|||
147168676|NCT01927055|530781901|FG000|Double-Blind|Supine Hypertension|0|||
147447888|NCT03077685|531804003|FG003|Overall Study|Physician Decision|0|||
147447889|NCT03077685|531804004|FG004|Overall Study|Physician Decision|3|||
147447890|NCT03077685|531804000|FG000|Overall Study|Disease Progression|1|||
147447891|NCT03077685|531804001|FG001|Overall Study|Disease Progression|0|||
147447892|NCT03077685|531804002|FG002|Overall Study|Disease Progression|0|||
147447893|NCT03077685|531804003|FG003|Overall Study|Disease Progression|2|||
147447894|NCT03077685|531804004|FG004|Overall Study|Disease Progression|1|||
147447895|NCT03077685|531804000|FG000|Overall Study|Withdrawn to proceed to surgery|0|||
147447896|NCT03077685|531804001|FG001|Overall Study|Withdrawn to proceed to surgery|0|||
147447897|NCT03077685|531804002|FG002|Overall Study|Withdrawn to proceed to surgery|0|||
147168677|NCT01927055|530781902|FG001|Double-Blind|Supine Hypertension|0|||
147447898|NCT03077685|531804003|FG003|Overall Study|Withdrawn to proceed to surgery|1|||
147447899|NCT03077685|531804004|FG004|Overall Study|Withdrawn to proceed to surgery|1|||
147168678|NCT01927055|530781903|FG002|Double-Blind|Supine Hypertension|1|||
147168679|NCT01927055|530781901|FG000|Double-Blind|Extended Vacation|0|||
147168680|NCT01927055|530781902|FG001|Double-Blind|Extended Vacation|1|||
147168681|NCT01927055|530781903|FG002|Double-Blind|Extended Vacation|0|||
147168682|NCT02477553|530781905|FG000|Overall Study|Screening up-to-date|12|||
147168683|NCT02477553|530781906|FG001|Overall Study|Screening up-to-date|13|||
147168684|NCT02477553|530781905|FG000|Overall Study|No MD visit|1|||
147168685|NCT02477553|530781906|FG001|Overall Study|No MD visit|1|||
147168686|NCT02477553|530781905|FG000|Overall Study|Workup consistent w/CRC|1|||
147168687|NCT02477553|530781906|FG001|Overall Study|Workup consistent w/CRC|1|||
147168688|NCT02477553|530781905|FG000|Overall Study|Technical issues with intervention|2|||
147168689|NCT02477553|530781906|FG001|Overall Study|Technical issues with intervention|0|||
147168690|NCT02477553|530781905|FG000|Overall Study|Elevated risk for CRC|2|||
147168691|NCT02477553|530781906|FG001|Overall Study|Elevated risk for CRC|2|||
147168692|NCT02477553|530781905|FG000|Overall Study|MD advised against screening|1|||
147168693|NCT02477553|530781906|FG001|Overall Study|MD advised against screening|3|||
147168694|NCT02477553|530781905|FG000|Overall Study|patient deceased|1|||
147168695|NCT02477553|530781906|FG001|Overall Study|patient deceased|0|||
147168696|NCT02745535|530781912|FG000|Overall Study|Death|1|||
147168697|NCT02745535|530781912|FG000|Overall Study|Adverse Event|3|||
147168698|NCT02745535|530781912|FG000|Overall Study|Lost to Follow-up|2|||
147168699|NCT01291277|530781913|FG000|Overall Study|Death|2|||
147168700|NCT01291277|530781914|FG001|Overall Study|Death|2|||
147168701|NCT01291277|530781913|FG000|Overall Study|Lost to Follow-up|3|||
147168702|NCT01291277|530781914|FG001|Overall Study|Lost to Follow-up|1|||
147168703|NCT00849108|530781915|FG000|Cohort 1 Dose Ranging and Dose Interval|Withdrawal by Subject|1|||
147168704|NCT00849108|530781916|FG001|Cohort 1 Dose Ranging and Dose Interval|Withdrawal by Subject|0|||
147168705|NCT00849108|530781915|FG000|Cohort 2 Efficacy|Adverse Event|0|||
147168706|NCT00849108|530781916|FG001|Cohort 2 Efficacy|Adverse Event|1|||
147168707|NCT00849108|530781915|FG000|Cohort 2 Efficacy|Other|0|||
147168708|NCT00849108|530781916|FG001|Cohort 2 Efficacy|Other|9|||
147168709|NCT02963701|530781920|FG000|Period 1 (Including Washout) (2 Days)|Withdrawal by Subject|1|||
147168710|NCT02963701|530781921|FG001|Period 1 (Including Washout) (2 Days)|Withdrawal by Subject|0|||
147168711|NCT03480009|530781922|FG000|Overall Study|Lost to Follow-up|4|||
147168712|NCT03480009|530781923|FG001|Overall Study|Lost to Follow-up|5|||
147168713|NCT03480009|530781924|FG002|Overall Study|Lost to Follow-up|4|||
147168714|NCT03480009|530781925|FG003|Overall Study|Lost to Follow-up|0|||
147168715|NCT00637572|530781928|FG000|Overall Study|Adverse Event|1|||
147168716|NCT00637572|530781929|FG001|Overall Study|Adverse Event|2|||
147168717|NCT00637572|530781928|FG000|Overall Study|Death|0|||
147168718|NCT00637572|530781929|FG001|Overall Study|Death|1|||
147168719|NCT00637572|530781928|FG000|Overall Study|Lost to Follow-up|0|||
147168720|NCT00637572|530781929|FG001|Overall Study|Lost to Follow-up|1|||
147168721|NCT00637572|530781928|FG000|Overall Study|Physician Decision|1|||
147168722|NCT00637572|530781929|FG001|Overall Study|Physician Decision|1|||
147168723|NCT00637572|530781928|FG000|Overall Study|Withdrawal by Subject|0|||
147168724|NCT00637572|530781929|FG001|Overall Study|Withdrawal by Subject|2|||
147168725|NCT00637572|530781928|FG000|Overall Study|Illicit Drug Use|1|||
147168726|NCT00637572|530781929|FG001|Overall Study|Illicit Drug Use|0|||
147168727|NCT01345682|530781930|FG000|Overall Study|Progressive disease per RECIST|226|||
147447900|NCT03077685|531804000|FG000|Overall Study|Subject entered hospice care|0|||
147654698|NCT00547248|532559099|FG002|Overall Study|Migrated/moved from study area|2|||
147654699|NCT00547248|532559100|FG003|Overall Study|Migrated/moved from study area|0|||
147654700|NCT00547248|532559097|FG000|Overall Study|Withdrawal by Subject|0|||
147654701|NCT00547248|532559098|FG001|Overall Study|Withdrawal by Subject|0|||
147654702|NCT00547248|532559099|FG002|Overall Study|Withdrawal by Subject|7|||
147654703|NCT00547248|532559100|FG003|Overall Study|Withdrawal by Subject|1|||
147654704|NCT00534248|532559101|FG000|Overall Study|Adverse Event|19|||
147654705|NCT00534248|532559102|FG001|Overall Study|Adverse Event|29|||
147654706|NCT00534248|532559101|FG000|Overall Study|Lost to Follow-up|353|||
147654707|NCT00534248|532559102|FG001|Overall Study|Lost to Follow-up|375|||
147654708|NCT00534248|532559101|FG000|Overall Study|Other protocol specified criteria|13|||
147654709|NCT00534248|532559102|FG001|Overall Study|Other protocol specified criteria|3|||
147654710|NCT00534248|532559101|FG000|Overall Study|Physician Decision|10|||
147654711|NCT00534248|532559102|FG001|Overall Study|Physician Decision|7|||
147654712|NCT00534248|532559101|FG000|Overall Study|Protocol Violation|3|||
147654713|NCT00534248|532559102|FG001|Overall Study|Protocol Violation|4|||
147654714|NCT00534248|532559101|FG000|Overall Study|Withdrawal by Subject|263|||
147654715|NCT00534248|532559102|FG001|Overall Study|Withdrawal by Subject|255|||
147654716|NCT00697593|532559110|FG000|Overall Study|Adverse Event|3|||
147654717|NCT00697593|532559110|FG000|Overall Study|Protocol Violation|1|||
147168728|NCT01345682|530781931|FG001|Overall Study|Progressive disease per RECIST|93|||
147168729|NCT01345682|530781930|FG000|Overall Study|Worsening of underlying cancer disease|23|||
147168730|NCT01345682|530781931|FG001|Overall Study|Worsening of underlying cancer disease|12|||
147168731|NCT01345682|530781930|FG000|Overall Study|Adverse Event|51|||
147168732|NCT01345682|530781931|FG001|Overall Study|Adverse Event|41|||
147168733|NCT01345682|530781930|FG000|Overall Study|Non-compliance with protocol|0|||
147590619|NCT02010255|532319022|FG003|Overall Study|Lost to Follow-up|0|||
147590620|NCT02010255|532319023|FG004|Overall Study|Lost to Follow-up|1|||
147590621|NCT02010255|532319024|FG005|Overall Study|Lost to Follow-up|0|||
147590622|NCT02010255|532319025|FG006|Overall Study|Lost to Follow-up|0|||
147590623|NCT02010255|532319026|FG007|Overall Study|Lost to Follow-up|0|||
147590624|NCT02010255|532319027|FG008|Overall Study|Lost to Follow-up|0|||
147590625|NCT02010255|532319028|FG009|Overall Study|Lost to Follow-up|0|||
147590626|NCT02010255|532319029|FG010|Overall Study|Lost to Follow-up|0|||
147590627|NCT02010255|532319030|FG011|Overall Study|Lost to Follow-up|0|||
147590628|NCT02010255|532319031|FG012|Overall Study|Lost to Follow-up|0|||
147590629|NCT02010255|532319032|FG013|Overall Study|Lost to Follow-up|0|||
147590630|NCT02010255|532319019|FG000|Overall Study|Randomized but Not Treated|0|||
147590631|NCT02010255|532319020|FG001|Overall Study|Randomized but Not Treated|0|||
147590632|NCT02010255|532319021|FG002|Overall Study|Randomized but Not Treated|0|||
147590633|NCT02010255|532319022|FG003|Overall Study|Randomized but Not Treated|0|||
147590634|NCT02010255|532319023|FG004|Overall Study|Randomized but Not Treated|0|||
147590635|NCT02010255|532319024|FG005|Overall Study|Randomized but Not Treated|0|||
147590636|NCT02010255|532319025|FG006|Overall Study|Randomized but Not Treated|0|||
147590637|NCT02010255|532319026|FG007|Overall Study|Randomized but Not Treated|0|||
147590638|NCT02010255|532319027|FG008|Overall Study|Randomized but Not Treated|0|||
147590639|NCT02010255|532319028|FG009|Overall Study|Randomized but Not Treated|0|||
147590640|NCT02010255|532319029|FG010|Overall Study|Randomized but Not Treated|0|||
147244172|NCT02573311|531066940|FG000|Disposition for Part 1|Withdrawal by Subject|7|||
147244173|NCT02573311|531066941|FG001|Disposition for Part 1|Withdrawal by Subject|3|||
147244174|NCT02573311|531066940|FG000|Disposition for Part 2|Physician Decision|25|||
147244175|NCT02573311|531066941|FG001|Disposition for Part 2|Physician Decision|7|||
147244176|NCT02573311|531066940|FG000|Disposition for Part 2|Adverse Event|36|||
147244177|NCT02573311|531066941|FG001|Disposition for Part 2|Adverse Event|5|||
147244178|NCT02573311|531066940|FG000|Disposition for Part 2|Lost to Follow-up|76|||
147244179|NCT02573311|531066941|FG001|Disposition for Part 2|Lost to Follow-up|7|||
147244180|NCT02573311|531066940|FG000|Disposition for Part 2|Withdrawal by Subject|60|||
147244181|NCT02573311|531066941|FG001|Disposition for Part 2|Withdrawal by Subject|3|||
147244182|NCT02573311|531066940|FG000|Disposition for Part 2|Investigator decision|0|||
147244183|NCT02573311|531066941|FG001|Disposition for Part 2|Investigator decision|1|||
147244184|NCT02573311|531066940|FG000|Disposition for Part 2|Other than specified above|13|||
147244185|NCT02573311|531066941|FG001|Disposition for Part 2|Other than specified above|3|||
147244186|NCT05537883|531066943|FG000|Overall Study|revisional surgery|4|||
147244187|NCT05537883|531066944|FG001|Overall Study|revisional surgery|2|||
147244188|NCT05537883|531066943|FG000|Overall Study|surgeries were cancelled|0|||
147244189|NCT05537883|531066944|FG001|Overall Study|surgeries were cancelled|2|||
147244190|NCT05537883|531066943|FG000|Overall Study|not being compliant with the Seamless MD app|31|||
147244191|NCT05537883|531066944|FG001|Overall Study|not being compliant with the Seamless MD app|30|||
147244192|NCT02099708|531066945|FG000|Overall Study|Data Not Available|30|||
147244193|NCT02099708|531066945|FG000|Overall Study|Lost to Follow-up|141|||
147244194|NCT02099708|531066945|FG000|Overall Study|Other|29|||
147244195|NCT05229406|531066946|FG000|Overall Study|Withdrawal by Subject|1|||
147244196|NCT05229406|531066947|FG001|Overall Study|Withdrawal by Subject|2|||
147244197|NCT01370356|531066950|FG000|Overall Study|Death|1|||
147244198|NCT01370356|531066951|FG001|Overall Study|Death|0|||
147244199|NCT01370356|531066950|FG000|Overall Study|Lack of Efficacy|6|||
147244200|NCT01370356|531066951|FG001|Overall Study|Lack of Efficacy|28|||
147590641|NCT02010255|532319030|FG011|Overall Study|Randomized but Not Treated|0|||
147590642|NCT02010255|532319031|FG012|Overall Study|Randomized but Not Treated|0|||
147590643|NCT02010255|532319032|FG013|Overall Study|Randomized but Not Treated|1|||
147590644|NCT00351351|532319033|FG000|Overall Study|surgical access pbs; device issues|9|||
147590645|NCT00351351|532319034|FG001|Overall Study|surgical access pbs; device issues|4|||
147590646|NCT03176784|532319035|FG000|Overall Study|Lost to Follow-up|77|||
147590647|NCT03176784|532319036|FG001|Overall Study|Lost to Follow-up|79|||
147590648|NCT03176784|532319037|FG002|Overall Study|Lost to Follow-up|79|||
147590649|NCT03176784|532319038|FG003|Overall Study|Lost to Follow-up|49|||
147590650|NCT03176784|532319035|FG000|Overall Study|Withdrawal by Subject|28|||
147590651|NCT03176784|532319036|FG001|Overall Study|Withdrawal by Subject|34|||
147590652|NCT03176784|532319037|FG002|Overall Study|Withdrawal by Subject|34|||
147590653|NCT03176784|532319038|FG003|Overall Study|Withdrawal by Subject|21|||
147590654|NCT02990806|532319039|FG000|Stage 1 (22 Weeks)|Adverse Event|1|||
147590655|NCT02990806|532319040|FG001|Stage 1 (22 Weeks)|Adverse Event|15|||
147590656|NCT02990806|532319041|FG002|Stage 1 (22 Weeks)|Adverse Event|0|||
147590657|NCT02990806|532319042|FG003|Stage 1 (22 Weeks)|Adverse Event|0|||
147590658|NCT02990806|532319039|FG000|Stage 1 (22 Weeks)|Physician Decision|1|||
147244201|NCT01370356|531066950|FG000|Overall Study|Lost to Follow-up|76|||
147244202|NCT01370356|531066951|FG001|Overall Study|Lost to Follow-up|81|||
147244203|NCT01370356|531066950|FG000|Overall Study|Withdrawal by Subject|54|||
147244204|NCT01370356|531066951|FG001|Overall Study|Withdrawal by Subject|59|||
147244205|NCT01370356|531066950|FG000|Overall Study|Reason not specified|39|||
147244206|NCT01370356|531066951|FG001|Overall Study|Reason not specified|43|||
147590659|NCT02990806|532319040|FG001|Stage 1 (22 Weeks)|Physician Decision|1|||
147168734|NCT01345682|530781931|FG001|Overall Study|Non-compliance with protocol|1|||
147168735|NCT01345682|530781930|FG000|Overall Study|Lost to Follow-up|0|||
147168736|NCT01345682|530781931|FG001|Overall Study|Lost to Follow-up|1|||
147168737|NCT01345682|530781930|FG000|Overall Study|Refused to continue trial medication|16|||
147168738|NCT01345682|530781931|FG001|Overall Study|Refused to continue trial medication|9|||
147168739|NCT01345682|530781930|FG000|Overall Study|Not treated|2|||
147168740|NCT01345682|530781931|FG001|Overall Study|Not treated|1|||
147168741|NCT01345682|530781930|FG000|Overall Study|Reason other than those specified above|4|||
147168742|NCT01345682|530781931|FG001|Overall Study|Reason other than those specified above|3|||
147590660|NCT02990806|532319041|FG002|Stage 1 (22 Weeks)|Physician Decision|0|||
147590661|NCT02990806|532319042|FG003|Stage 1 (22 Weeks)|Physician Decision|0|||
147590662|NCT02990806|532319039|FG000|Stage 1 (22 Weeks)|Initiated protocol-prohibited medication|2|||
147590663|NCT02990806|532319040|FG001|Stage 1 (22 Weeks)|Initiated protocol-prohibited medication|2|||
147590664|NCT02990806|532319041|FG002|Stage 1 (22 Weeks)|Initiated protocol-prohibited medication|0|||
147168743|NCT00896649|530781932|FG000|Overall Study|Physician Decision|1|||
147168744|NCT00896649|530781932|FG000|Overall Study|Pregnancy|1|||
147168745|NCT00896649|530781932|FG000|Overall Study|missing documentation|1|||
147168746|NCT00896649|530781932|FG000|Overall Study|technical difficulties|2|||
147168747|NCT01075984|530781935|FG000|Treatment Phase|Adverse Event|0|||
147168748|NCT01075984|530781936|FG001|Treatment Phase|Adverse Event|1|||
147168749|NCT01075984|530781937|FG002|Treatment Phase|Adverse Event|3|||
147168750|NCT01075984|530781938|FG003|Treatment Phase|Adverse Event|7|||
147168751|NCT01075984|530781939|FG004|Treatment Phase|Adverse Event|35|||
147168752|NCT01075984|530781935|FG000|Treatment Phase|Protocol Violation|0|||
147168753|NCT01075984|530781936|FG001|Treatment Phase|Protocol Violation|0|||
147168754|NCT01075984|530781937|FG002|Treatment Phase|Protocol Violation|1|||
147168755|NCT01075984|530781938|FG003|Treatment Phase|Protocol Violation|0|||
147168756|NCT01075984|530781939|FG004|Treatment Phase|Protocol Violation|3|||
147168757|NCT01075984|530781935|FG000|Treatment Phase|Withdrawal by Subject|0|||
147168758|NCT01075984|530781936|FG001|Treatment Phase|Withdrawal by Subject|0|||
147168759|NCT01075984|530781937|FG002|Treatment Phase|Withdrawal by Subject|2|||
147168760|NCT01075984|530781938|FG003|Treatment Phase|Withdrawal by Subject|0|||
147244207|NCT01370356|531066950|FG000|Overall Study|Protocol Violation|3|||
147244208|NCT01370356|531066951|FG001|Overall Study|Protocol Violation|3|||
147244209|NCT01370356|531066950|FG000|Overall Study|Adverse event (AE) Related to Study Drug|12|||
147244210|NCT01370356|531066951|FG001|Overall Study|Adverse event (AE) Related to Study Drug|9|||
147244211|NCT01370356|531066950|FG000|Overall Study|AE Not Related to Study Drug|1|||
147244212|NCT01370356|531066951|FG001|Overall Study|AE Not Related to Study Drug|4|||
147244213|NCT01658072|531066952|FG000|Overall Study|Protocol Violation|4|||
147244214|NCT01658072|531066953|FG001|Overall Study|Protocol Violation|2|||
147244215|NCT00040664|531066954|FG000|Overall Study|Adverse Event|12|||
147244216|NCT00040664|531066955|FG001|Overall Study|Adverse Event|3|||
147590665|NCT02990806|532319042|FG003|Stage 1 (22 Weeks)|Initiated protocol-prohibited medication|0|||
147590666|NCT02990806|532319039|FG000|Stage 1 (22 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
147590667|NCT02990806|532319040|FG001|Stage 1 (22 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
147590668|NCT02990806|532319041|FG002|Stage 1 (22 Weeks)|Noncompliant with visit schedule and/or protocol|0|||
147590669|NCT02990806|532319042|FG003|Stage 1 (22 Weeks)|Noncompliant with visit schedule and/or protocol|0|||
147590670|NCT02990806|532319039|FG000|Stage 1 (22 Weeks)|Lost to Follow-up|2|||
147590671|NCT02990806|532319040|FG001|Stage 1 (22 Weeks)|Lost to Follow-up|2|||
147590672|NCT02990806|532319041|FG002|Stage 1 (22 Weeks)|Lost to Follow-up|0|||
147590673|NCT02990806|532319042|FG003|Stage 1 (22 Weeks)|Lost to Follow-up|0|||
147590674|NCT02990806|532319039|FG000|Stage 1 (22 Weeks)|Withdrawal by Subject|4|||
147590675|NCT02990806|532319040|FG001|Stage 1 (22 Weeks)|Withdrawal by Subject|26|||
147590676|NCT02990806|532319041|FG002|Stage 1 (22 Weeks)|Withdrawal by Subject|0|||
147590677|NCT02990806|532319042|FG003|Stage 1 (22 Weeks)|Withdrawal by Subject|0|||
147590678|NCT02990806|532319039|FG000|Stage 1 (22 Weeks)|Lack of Efficacy|1|||
147590679|NCT02990806|532319040|FG001|Stage 1 (22 Weeks)|Lack of Efficacy|2|||
147590680|NCT02990806|532319041|FG002|Stage 1 (22 Weeks)|Lack of Efficacy|0|||
147590681|NCT02990806|532319042|FG003|Stage 1 (22 Weeks)|Lack of Efficacy|0|||
147590682|NCT02990806|532319039|FG000|Stage 1 (22 Weeks)|Death|0|||
147590683|NCT02990806|532319040|FG001|Stage 1 (22 Weeks)|Death|1|||
147590684|NCT02990806|532319041|FG002|Stage 1 (22 Weeks)|Death|0|||
147590685|NCT02990806|532319042|FG003|Stage 1 (22 Weeks)|Death|0|||
147590686|NCT02990806|532319039|FG000|Stage 1 (22 Weeks)|Required antibiotics resulting in drug interruption >2 weeks|0|||
147590687|NCT02990806|532319040|FG001|Stage 1 (22 Weeks)|Required antibiotics resulting in drug interruption >2 weeks|1|||
147590688|NCT02990806|532319041|FG002|Stage 1 (22 Weeks)|Required antibiotics resulting in drug interruption >2 weeks|0|||
147168761|NCT01075984|530781939|FG004|Treatment Phase|Withdrawal by Subject|15|||
147168762|NCT01075984|530781935|FG000|Treatment Phase|Treatment Failure|0|||
147168763|NCT01075984|530781936|FG001|Treatment Phase|Treatment Failure|0|||
147168764|NCT01075984|530781937|FG002|Treatment Phase|Treatment Failure|1|||
147168765|NCT01075984|530781938|FG003|Treatment Phase|Treatment Failure|0|||
147244217|NCT00040664|531066956|FG002|Overall Study|Adverse Event|2|||
147244218|NCT00040664|531066957|FG003|Overall Study|Adverse Event|7|||
147590689|NCT02990806|532319042|FG003|Stage 1 (22 Weeks)|Required antibiotics resulting in drug interruption >2 weeks|0|||
147590690|NCT02990806|532319039|FG000|Stage 1 (22 Weeks)|Protocol deviation|0|||
147590691|NCT02990806|532319040|FG001|Stage 1 (22 Weeks)|Protocol deviation|1|||
147590692|NCT02990806|532319041|FG002|Stage 1 (22 Weeks)|Protocol deviation|0|||
147590693|NCT02990806|532319042|FG003|Stage 1 (22 Weeks)|Protocol deviation|0|||
147590694|NCT02990806|532319039|FG000|Stage 1 (22 Weeks)|Other|1|||
147590695|NCT02990806|532319040|FG001|Stage 1 (22 Weeks)|Other|3|||
147168766|NCT01075984|530781939|FG004|Treatment Phase|Treatment Failure|5|||
147168767|NCT01075984|530781935|FG000|Treatment Phase|Progression of disease|0|||
147168768|NCT01075984|530781936|FG001|Treatment Phase|Progression of disease|0|||
147168769|NCT01075984|530781937|FG002|Treatment Phase|Progression of disease|0|||
147168770|NCT01075984|530781938|FG003|Treatment Phase|Progression of disease|0|||
147168771|NCT01075984|530781939|FG004|Treatment Phase|Progression of disease|2|||
147590696|NCT02990806|532319041|FG002|Stage 1 (22 Weeks)|Other|0|||
147590697|NCT02990806|532319042|FG003|Stage 1 (22 Weeks)|Other|0|||
147590698|NCT02990806|532319039|FG000|Stage 2 (32 Weeks)|Adverse Event|9|||
147590699|NCT02990806|532319040|FG001|Stage 2 (32 Weeks)|Adverse Event|0|||
147590700|NCT02990806|532319041|FG002|Stage 2 (32 Weeks)|Adverse Event|7|||
147590701|NCT02990806|532319042|FG003|Stage 2 (32 Weeks)|Adverse Event|7|||
147590702|NCT02990806|532319039|FG000|Stage 2 (32 Weeks)|Death|1|||
147590703|NCT02990806|532319040|FG001|Stage 2 (32 Weeks)|Death|0|||
147590704|NCT02990806|532319041|FG002|Stage 2 (32 Weeks)|Death|0|||
147590705|NCT02990806|532319042|FG003|Stage 2 (32 Weeks)|Death|0|||
147590706|NCT02990806|532319039|FG000|Stage 2 (32 Weeks)|Physician Decision|3|||
147590707|NCT02990806|532319040|FG001|Stage 2 (32 Weeks)|Physician Decision|0|||
147168772|NCT01075984|530781935|FG000|Follow-up Phase|Protocol Violation|0|||
147168773|NCT01075984|530781936|FG001|Follow-up Phase|Protocol Violation|0|||
147168774|NCT01075984|530781937|FG002|Follow-up Phase|Protocol Violation|1|||
147168775|NCT01075984|530781938|FG003|Follow-up Phase|Protocol Violation|0|||
147168776|NCT01075984|530781939|FG004|Follow-up Phase|Protocol Violation|3|||
147168777|NCT01075984|530781935|FG000|Follow-up Phase|Adverse Event|0|||
147168778|NCT01075984|530781936|FG001|Follow-up Phase|Adverse Event|0|||
147168779|NCT01075984|530781937|FG002|Follow-up Phase|Adverse Event|0|||
147168780|NCT01075984|530781938|FG003|Follow-up Phase|Adverse Event|2|||
147590708|NCT02990806|532319041|FG002|Stage 2 (32 Weeks)|Physician Decision|1|||
147590709|NCT02990806|532319042|FG003|Stage 2 (32 Weeks)|Physician Decision|0|||
147590710|NCT02990806|532319039|FG000|Stage 2 (32 Weeks)|Diagnosed with malignancy|1|||
147590711|NCT02990806|532319040|FG001|Stage 2 (32 Weeks)|Diagnosed with malignancy|0|||
147590712|NCT02990806|532319041|FG002|Stage 2 (32 Weeks)|Diagnosed with malignancy|0|||
147590713|NCT02990806|532319042|FG003|Stage 2 (32 Weeks)|Diagnosed with malignancy|1|||
147168781|NCT01075984|530781939|FG004|Follow-up Phase|Adverse Event|27|||
147168782|NCT01075984|530781935|FG000|Follow-up Phase|Administrative|0|||
147168783|NCT01075984|530781936|FG001|Follow-up Phase|Administrative|0|||
147168784|NCT01075984|530781937|FG002|Follow-up Phase|Administrative|0|||
147168785|NCT01075984|530781938|FG003|Follow-up Phase|Administrative|0|||
147168786|NCT01075984|530781939|FG004|Follow-up Phase|Administrative|1|||
147168787|NCT01075984|530781935|FG000|Follow-up Phase|Withdrawal by Subject|0|||
147168788|NCT01075984|530781936|FG001|Follow-up Phase|Withdrawal by Subject|0|||
147168789|NCT01075984|530781937|FG002|Follow-up Phase|Withdrawal by Subject|0|||
147168790|NCT01075984|530781938|FG003|Follow-up Phase|Withdrawal by Subject|0|||
147168791|NCT01075984|530781939|FG004|Follow-up Phase|Withdrawal by Subject|10|||
147168792|NCT01075984|530781935|FG000|Follow-up Phase|Progression of disease|0|||
147168793|NCT01075984|530781936|FG001|Follow-up Phase|Progression of disease|0|||
147244219|NCT00040664|531066954|FG000|Overall Study|Lack of Efficacy|9|||
147244220|NCT00040664|531066955|FG001|Overall Study|Lack of Efficacy|2|||
147244221|NCT00040664|531066956|FG002|Overall Study|Lack of Efficacy|3|||
147244222|NCT00040664|531066957|FG003|Overall Study|Lack of Efficacy|4|||
147244223|NCT00040664|531066954|FG000|Overall Study|Insufficient CD4 response|1|||
147244224|NCT00040664|531066955|FG001|Overall Study|Insufficient CD4 response|0|||
147244225|NCT00040664|531066956|FG002|Overall Study|Insufficient CD4 response|1|||
147244226|NCT00040664|531066957|FG003|Overall Study|Insufficient CD4 response|0|||
147244227|NCT00040664|531066954|FG000|Overall Study|Lost to Follow-up|4|||
147244228|NCT00040664|531066955|FG001|Overall Study|Lost to Follow-up|2|||
147244229|NCT00040664|531066956|FG002|Overall Study|Lost to Follow-up|0|||
147244230|NCT00040664|531066957|FG003|Overall Study|Lost to Follow-up|2|||
147447901|NCT03077685|531804001|FG001|Overall Study|Subject entered hospice care|0|||
147168794|NCT01075984|530781937|FG002|Follow-up Phase|Progression of disease|0|||
147168795|NCT01075984|530781938|FG003|Follow-up Phase|Progression of disease|0|||
147168796|NCT01075984|530781939|FG004|Follow-up Phase|Progression of disease|2|||
147168797|NCT01075984|530781935|FG000|Follow-up Phase|Treatment failure|0|||
147654718|NCT00697593|532559110|FG000|Overall Study|Lack of Efficacy|3|||
147168798|NCT01075984|530781936|FG001|Follow-up Phase|Treatment failure|0|||
147168799|NCT01075984|530781937|FG002|Follow-up Phase|Treatment failure|0|||
147244231|NCT00040664|531066954|FG000|Overall Study|Protocol Violation|2|||
147590714|NCT02990806|532319039|FG000|Stage 2 (32 Weeks)|Required antibiotics resulting in drug interruption|1|||
147590715|NCT02990806|532319040|FG001|Stage 2 (32 Weeks)|Required antibiotics resulting in drug interruption|0|||
147590716|NCT02990806|532319041|FG002|Stage 2 (32 Weeks)|Required antibiotics resulting in drug interruption|1|||
147168800|NCT01075984|530781938|FG003|Follow-up Phase|Treatment failure|0|||
147168801|NCT01075984|530781939|FG004|Follow-up Phase|Treatment failure|4|||
147168802|NCT03652675|530781941|FG000|Overall Study|Lost to Follow-up|4|||
147168803|NCT03652675|530781942|FG001|Overall Study|Lost to Follow-up|4|||
147168804|NCT01638559|530781943|FG000|Overall Study|Lost to Follow-up|1|||
147168805|NCT01638559|530781943|FG000|Overall Study|Withdrawal by Subject|1|||
147168806|NCT01638559|530781943|FG000|Overall Study|Subject declined to travel for biopsy|1|||
147168807|NCT01274429|530781954|FG000|Overall Study|Study closed do to lack of funding|5|||
147168808|NCT04046250|530781964|FG000|Overall Study|Death|0|||
147168809|NCT04046250|530781965|FG001|Overall Study|Death|1|||
147168810|NCT04046250|530781964|FG000|Overall Study|Withdrawal by Subject|3|||
147168811|NCT04046250|530781965|FG001|Overall Study|Withdrawal by Subject|3|||
147168812|NCT03268941|530783773|FG000|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
147168813|NCT03268941|530783774|FG001|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
147168814|NCT03268941|530783775|FG002|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
147168815|NCT03268941|530783776|FG003|Part 1 (Days 1 to 9)|Withdrawal by Subject|1|||
147168816|NCT03268941|530783777|FG004|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
147168817|NCT03268941|530783778|FG005|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
147168818|NCT03268941|530783779|FG006|Part 1 (Days 1 to 9)|Withdrawal by Subject|0|||
147168819|NCT03268941|530783773|FG000|Part 1 (Days 1 to 9)|Adverse Event|0|||
147168820|NCT03268941|530783774|FG001|Part 1 (Days 1 to 9)|Adverse Event|0|||
147168821|NCT03268941|530783775|FG002|Part 1 (Days 1 to 9)|Adverse Event|0|||
147168822|NCT03268941|530783776|FG003|Part 1 (Days 1 to 9)|Adverse Event|1|||
147168823|NCT03268941|530783777|FG004|Part 1 (Days 1 to 9)|Adverse Event|0|||
147168824|NCT03268941|530783778|FG005|Part 1 (Days 1 to 9)|Adverse Event|0|||
147168825|NCT03268941|530783779|FG006|Part 1 (Days 1 to 9)|Adverse Event|0|||
147168826|NCT03268941|530783773|FG000|Part 1 (Days 1 to 9)|Protocol Deviation|1|||
147168827|NCT03268941|530783774|FG001|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
147168828|NCT03268941|530783775|FG002|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
147168829|NCT03268941|530783776|FG003|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
147168830|NCT03268941|530783777|FG004|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
147168831|NCT03268941|530783778|FG005|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
147168832|NCT03268941|530783779|FG006|Part 1 (Days 1 to 9)|Protocol Deviation|0|||
147168833|NCT03268941|530783773|FG000|Part 2: Days 17 to 25|Reason not specified|0|||
147168834|NCT03268941|530783774|FG001|Part 2: Days 17 to 25|Reason not specified|0|||
147168835|NCT03268941|530783775|FG002|Part 2: Days 17 to 25|Reason not specified|0|||
147168836|NCT03268941|530783776|FG003|Part 2: Days 17 to 25|Reason not specified|0|||
147168837|NCT03268941|530783777|FG004|Part 2: Days 17 to 25|Reason not specified|0|||
147168838|NCT03268941|530783778|FG005|Part 2: Days 17 to 25|Reason not specified|0|||
147168839|NCT03268941|530783779|FG006|Part 2: Days 17 to 25|Reason not specified|1|||
147590717|NCT02990806|532319042|FG003|Stage 2 (32 Weeks)|Required antibiotics resulting in drug interruption|1|||
147590718|NCT02990806|532319039|FG000|Stage 2 (32 Weeks)|Initiated protocol-prohibited medication|1|||
147168840|NCT03268941|530783773|FG000|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
147168841|NCT03268941|530783774|FG001|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
147168842|NCT03268941|530783775|FG002|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
147168843|NCT03268941|530783776|FG003|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
147168844|NCT03268941|530783777|FG004|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
147168845|NCT03268941|530783778|FG005|Part 2: Days 17 to 25|Withdrawal by Subject|0|||
147168846|NCT03268941|530783779|FG006|Part 2: Days 17 to 25|Withdrawal by Subject|1|||
147168847|NCT01216683|530783780|FG000|Induction|Never started treatment|0|||
147168848|NCT01216683|530783781|FG001|Induction|Never started treatment|6|||
147168849|NCT01216683|530783782|FG002|Induction|Never started treatment|3|||
147168850|NCT01216683|530783780|FG000|Induction|Lack of Efficacy|4|||
147168851|NCT01216683|530783781|FG001|Induction|Lack of Efficacy|3|||
147168852|NCT01216683|530783782|FG002|Induction|Lack of Efficacy|7|||
147168853|NCT01216683|530783780|FG000|Induction|Adverse Event|0|||
147168854|NCT01216683|530783781|FG001|Induction|Adverse Event|5|||
147168855|NCT01216683|530783782|FG002|Induction|Adverse Event|5|||
147168856|NCT01216683|530783780|FG000|Induction|Death|0|||
147168857|NCT01216683|530783781|FG001|Induction|Death|0|||
147168858|NCT01216683|530783782|FG002|Induction|Death|2|||
147168859|NCT01216683|530783780|FG000|Induction|Withdrawal by Subject|0|||
147168860|NCT01216683|530783781|FG001|Induction|Withdrawal by Subject|4|||
147168861|NCT01216683|530783782|FG002|Induction|Withdrawal by Subject|2|||
147168862|NCT01216683|530783780|FG000|Induction|Other disease|0|||
147168863|NCT01216683|530783781|FG001|Induction|Other disease|1|||
147168864|NCT01216683|530783782|FG002|Induction|Other disease|2|||
147168865|NCT01216683|530783780|FG000|Continuation|Lack of Efficacy|3|||
147168866|NCT01216683|530783781|FG001|Continuation|Lack of Efficacy|2|||
147168867|NCT01216683|530783782|FG002|Continuation|Lack of Efficacy|7|||
147168868|NCT01216683|530783780|FG000|Continuation|Adverse Event|5|||
147168869|NCT01216683|530783781|FG001|Continuation|Adverse Event|3|||
147168870|NCT01216683|530783782|FG002|Continuation|Adverse Event|16|||
147168871|NCT01216683|530783780|FG000|Continuation|Death|1|||
147168872|NCT01216683|530783781|FG001|Continuation|Death|0|||
147168873|NCT01216683|530783782|FG002|Continuation|Death|2|||
147168874|NCT01216683|530783780|FG000|Continuation|Withdrawal by Subject|4|||
147168875|NCT01216683|530783781|FG001|Continuation|Withdrawal by Subject|5|||
147168876|NCT01216683|530783782|FG002|Continuation|Withdrawal by Subject|9|||
147168877|NCT01216683|530783780|FG000|Continuation|Other diseases|0|||
147168878|NCT01216683|530783781|FG001|Continuation|Other diseases|2|||
147168879|NCT01216683|530783782|FG002|Continuation|Other diseases|1|||
147168880|NCT01216683|530783780|FG000|Continuation|Physician Decision|1|||
147168881|NCT01216683|530783781|FG001|Continuation|Physician Decision|0|||
147168882|NCT01216683|530783782|FG002|Continuation|Physician Decision|1|||
147168883|NCT01216683|530783780|FG000|Continuation|Non-compliance|1|||
147168884|NCT01216683|530783781|FG001|Continuation|Non-compliance|0|||
147168885|NCT01216683|530783782|FG002|Continuation|Non-compliance|1|||
147168886|NCT01216683|530783780|FG000|Continuation|Insurance change|0|||
147168887|NCT01216683|530783781|FG001|Continuation|Insurance change|1|||
147168888|NCT01216683|530783782|FG002|Continuation|Insurance change|0|||
147168889|NCT01216683|530783780|FG000|Continuation|Mistakenly stayed on treatment for longer than expected|0|||
147168890|NCT01216683|530783781|FG001|Continuation|Mistakenly stayed on treatment for longer than expected|1|||
147168891|NCT01216683|530783782|FG002|Continuation|Mistakenly stayed on treatment for longer than expected|0|||
147168892|NCT01216683|530783780|FG000|Continuation|Not reported|0|||
147168893|NCT01216683|530783781|FG001|Continuation|Not reported|0|||
147168894|NCT01216683|530783782|FG002|Continuation|Not reported|1|||
147168895|NCT01216683|530783780|FG000|Continuation|Never started treatment|0|||
147168896|NCT01216683|530783781|FG001|Continuation|Never started treatment|1|||
147168897|NCT01216683|530783782|FG002|Continuation|Never started treatment|5|||
147168898|NCT01629953|530783783|FG000|Overall Study|Death|3|||
147168899|NCT01629953|530783784|FG001|Overall Study|Death|1|||
147168900|NCT01629953|530783783|FG000|Overall Study|Lost to Follow-up|10|||
147168901|NCT01629953|530783784|FG001|Overall Study|Lost to Follow-up|14|||
147168902|NCT00344500|530783785|FG000|Overall Study|Adverse Event|6|||
147168903|NCT00344500|530783786|FG001|Overall Study|Adverse Event|2|||
147168904|NCT00344500|530783787|FG002|Overall Study|Adverse Event|0|||
147168905|NCT00344500|530783785|FG000|Overall Study|Lost to Follow-up|5|||
147168906|NCT00344500|530783786|FG001|Overall Study|Lost to Follow-up|13|||
147168907|NCT00344500|530783787|FG002|Overall Study|Lost to Follow-up|1|||
147168908|NCT00344500|530783785|FG000|Overall Study|Withdrawal by Subject|7|||
147168909|NCT00344500|530783786|FG001|Overall Study|Withdrawal by Subject|10|||
147168910|NCT00344500|530783787|FG002|Overall Study|Withdrawal by Subject|0|||
147168911|NCT00344500|530783785|FG000|Overall Study|Protocol Violation|4|||
147168912|NCT00344500|530783786|FG001|Overall Study|Protocol Violation|7|||
147168913|NCT00344500|530783787|FG002|Overall Study|Protocol Violation|1|||
147168914|NCT00344500|530783785|FG000|Overall Study|Not Noted|1|||
147168915|NCT00344500|530783786|FG001|Overall Study|Not Noted|3|||
147590719|NCT02990806|532319040|FG001|Stage 2 (32 Weeks)|Initiated protocol-prohibited medication|0|||
147590720|NCT02990806|532319041|FG002|Stage 2 (32 Weeks)|Initiated protocol-prohibited medication|0|||
147590721|NCT02990806|532319042|FG003|Stage 2 (32 Weeks)|Initiated protocol-prohibited medication|2|||
147590722|NCT02990806|532319039|FG000|Stage 2 (32 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
147590723|NCT02990806|532319040|FG001|Stage 2 (32 Weeks)|Noncompliant with visit schedule and/or protocol|0|||
147590724|NCT02990806|532319041|FG002|Stage 2 (32 Weeks)|Noncompliant with visit schedule and/or protocol|6|||
147590725|NCT02990806|532319042|FG003|Stage 2 (32 Weeks)|Noncompliant with visit schedule and/or protocol|5|||
147590726|NCT02990806|532319039|FG000|Stage 2 (32 Weeks)|Lost to Follow-up|1|||
147590727|NCT02990806|532319040|FG001|Stage 2 (32 Weeks)|Lost to Follow-up|0|||
147590728|NCT02990806|532319041|FG002|Stage 2 (32 Weeks)|Lost to Follow-up|1|||
147590729|NCT02990806|532319042|FG003|Stage 2 (32 Weeks)|Lost to Follow-up|2|||
147590730|NCT02990806|532319039|FG000|Stage 2 (32 Weeks)|Protocol deviation|2|||
147590731|NCT02990806|532319040|FG001|Stage 2 (32 Weeks)|Protocol deviation|0|||
147590732|NCT02990806|532319041|FG002|Stage 2 (32 Weeks)|Protocol deviation|2|||
147590733|NCT02990806|532319042|FG003|Stage 2 (32 Weeks)|Protocol deviation|3|||
147590734|NCT02990806|532319039|FG000|Stage 2 (32 Weeks)|Withdrawal by Subject|14|||
147590735|NCT02990806|532319040|FG001|Stage 2 (32 Weeks)|Withdrawal by Subject|0|||
147590736|NCT02990806|532319041|FG002|Stage 2 (32 Weeks)|Withdrawal by Subject|4|||
147590737|NCT02990806|532319042|FG003|Stage 2 (32 Weeks)|Withdrawal by Subject|8|||
147590738|NCT02990806|532319039|FG000|Stage 2 (32 Weeks)|Lack of Efficacy|4|||
147590739|NCT02990806|532319040|FG001|Stage 2 (32 Weeks)|Lack of Efficacy|0|||
147654719|NCT00697593|532559110|FG000|Overall Study|Suspension of the study by sponsor|12|||
147168916|NCT00344500|530783787|FG002|Overall Study|Not Noted|0|||
147168917|NCT02252965|530783789|FG000|Overall Study|Adverse Event|9|||
147168918|NCT02252965|530783790|FG001|Overall Study|Adverse Event|14|||
147168919|NCT02252965|530783789|FG000|Overall Study|Lost to Follow-up|16|||
147168920|NCT02252965|530783790|FG001|Overall Study|Lost to Follow-up|8|||
147168921|NCT02252965|530783789|FG000|Overall Study|Protocol Violation|4|||
147168922|NCT02252965|530783790|FG001|Overall Study|Protocol Violation|5|||
147168923|NCT02252965|530783789|FG000|Overall Study|Lack of Efficacy|0|||
147168924|NCT02252965|530783790|FG001|Overall Study|Lack of Efficacy|2|||
147168925|NCT02252965|530783789|FG000|Overall Study|Withdrawal by Subject|7|||
147590740|NCT02990806|532319041|FG002|Stage 2 (32 Weeks)|Lack of Efficacy|2|||
147590741|NCT02990806|532319042|FG003|Stage 2 (32 Weeks)|Lack of Efficacy|3|||
147590742|NCT02990806|532319039|FG000|Stage 2 (32 Weeks)|Other|3|||
147168926|NCT02252965|530783790|FG001|Overall Study|Withdrawal by Subject|9|||
147168927|NCT02252965|530783789|FG000|Overall Study|Other|4|||
147168928|NCT02252965|530783790|FG001|Overall Study|Other|5|||
147168929|NCT02615691|530783793|FG000|Part A: Main Study (5 Years)|Adverse Event|3|||
147168930|NCT02615691|530783793|FG000|Part A: Main Study (5 Years)|Physician Decision|2|||
147168931|NCT02615691|530783793|FG000|Part A: Main Study (5 Years)|Withdrawal by Subject|7|||
147168932|NCT02615691|530783793|FG000|Part A: Main Study (5 Years)|Reason Not Specified|2|||
147168933|NCT04279613|530783795|FG000|Cohort 1: Dose Level 1 mg|Protocol Violation|0|||
147168934|NCT04279613|530783796|FG001|Cohort 1: Dose Level 1 mg|Protocol Violation|0|||
147168935|NCT04279613|530783797|FG002|Cohort 1: Dose Level 1 mg|Protocol Violation|0|||
147168936|NCT04279613|530783798|FG003|Cohort 1: Dose Level 1 mg|Protocol Violation|0|||
147168937|NCT04279613|530783799|FG004|Cohort 1: Dose Level 1 mg|Protocol Violation|1|||
147168938|NCT04279613|530783795|FG000|Cohort 2: Dose Level 5 mg|Adverse Event|0|||
147168939|NCT04279613|530783796|FG001|Cohort 2: Dose Level 5 mg|Adverse Event|1|||
147168940|NCT04279613|530783797|FG002|Cohort 2: Dose Level 5 mg|Adverse Event|0|||
147168941|NCT04279613|530783798|FG003|Cohort 2: Dose Level 5 mg|Adverse Event|0|||
147168942|NCT04279613|530783799|FG004|Cohort 2: Dose Level 5 mg|Adverse Event|0|||
147168943|NCT04279613|530783795|FG000|Cohort 3: Dose Level 12.5 mg|Protocol Violation|0|||
147168944|NCT04279613|530783796|FG001|Cohort 3: Dose Level 12.5 mg|Protocol Violation|0|||
147168945|NCT04279613|530783797|FG002|Cohort 3: Dose Level 12.5 mg|Protocol Violation|1|||
147168946|NCT04279613|530783798|FG003|Cohort 3: Dose Level 12.5 mg|Protocol Violation|0|||
147168947|NCT04279613|530783799|FG004|Cohort 3: Dose Level 12.5 mg|Protocol Violation|0|||
147168948|NCT04279613|530783795|FG000|Cohort 4: Dose Level 25 mg|Adverse Event|0|||
147168949|NCT04279613|530783796|FG001|Cohort 4: Dose Level 25 mg|Adverse Event|0|||
147168950|NCT04279613|530783797|FG002|Cohort 4: Dose Level 25 mg|Adverse Event|0|||
147168951|NCT04279613|530783798|FG003|Cohort 4: Dose Level 25 mg|Adverse Event|0|||
147168952|NCT04279613|530783799|FG004|Cohort 4: Dose Level 25 mg|Adverse Event|1|||
147168953|NCT04279613|530783795|FG000|Cohort 4: Dose Level 25 mg|Withdrawal by Subject|0|||
147168954|NCT04279613|530783796|FG001|Cohort 4: Dose Level 25 mg|Withdrawal by Subject|0|||
147168955|NCT04279613|530783797|FG002|Cohort 4: Dose Level 25 mg|Withdrawal by Subject|0|||
147168956|NCT04279613|530783798|FG003|Cohort 4: Dose Level 25 mg|Withdrawal by Subject|1|||
147168957|NCT04279613|530783799|FG004|Cohort 4: Dose Level 25 mg|Withdrawal by Subject|0|||
147168958|NCT04051827|530783800|FG000|Overall Study|Death|1|||
147168959|NCT04051827|530783800|FG000|Overall Study|Withdrawal by Subject|4|||
147168960|NCT04051827|530783800|FG000|Overall Study|Progressive disease|16|||
147168961|NCT04051827|530783800|FG000|Overall Study|Physician Decision|1|||
147168962|NCT04051827|530783800|FG000|Overall Study|Other|4|||
147168963|NCT02888743|530783801|FG000|Overall Study|Withdrawal by Subject|1|||
147168964|NCT02888743|530783802|FG001|Overall Study|Withdrawal by Subject|2|||
147168965|NCT02888743|530783803|FG002|Overall Study|Withdrawal by Subject|2|||
147168966|NCT02888743|530783804|FG003|Overall Study|Withdrawal by Subject|0|||
147168967|NCT02888743|530783805|FG004|Overall Study|Withdrawal by Subject|1|||
147168968|NCT02888743|530783801|FG000|Overall Study|Disease progression before treatment|2|||
147168969|NCT02888743|530783802|FG001|Overall Study|Disease progression before treatment|0|||
147168970|NCT02888743|530783803|FG002|Overall Study|Disease progression before treatment|2|||
147168971|NCT02888743|530783804|FG003|Overall Study|Disease progression before treatment|0|||
147168972|NCT02888743|530783805|FG004|Overall Study|Disease progression before treatment|0|||
147168973|NCT02888743|530783801|FG000|Overall Study|Patient ineligible|1|||
147168974|NCT02888743|530783802|FG001|Overall Study|Patient ineligible|2|||
147168975|NCT02888743|530783803|FG002|Overall Study|Patient ineligible|0|||
147168976|NCT02888743|530783804|FG003|Overall Study|Patient ineligible|0|||
147168977|NCT02888743|530783805|FG004|Overall Study|Patient ineligible|0|||
147168978|NCT01424566|530783806|FG000|Single-blind Treatment|Adverse Event|71|||
147168979|NCT01424566|530783807|FG001|Single-blind Treatment|Adverse Event|0|||
147168980|NCT01424566|530783808|FG002|Single-blind Treatment|Adverse Event|0|||
147168981|NCT01424566|530783806|FG000|Single-blind Treatment|Withdrawal by Subject|16|||
147168982|NCT01424566|530783807|FG001|Single-blind Treatment|Withdrawal by Subject|0|||
147168983|NCT01424566|530783808|FG002|Single-blind Treatment|Withdrawal by Subject|0|||
147168984|NCT01424566|530783806|FG000|Single-blind Treatment|Withdrawal by Investigator|2|||
147168985|NCT01424566|530783807|FG001|Single-blind Treatment|Withdrawal by Investigator|0|||
147590743|NCT02990806|532319040|FG001|Stage 2 (32 Weeks)|Other|0|||
147590744|NCT02990806|532319041|FG002|Stage 2 (32 Weeks)|Other|4|||
147168986|NCT01424566|530783808|FG002|Single-blind Treatment|Withdrawal by Investigator|0|||
147168987|NCT01424566|530783806|FG000|Single-blind Treatment|Did Not Meet Inclusion Criteria|108|||
147168988|NCT01424566|530783807|FG001|Single-blind Treatment|Did Not Meet Inclusion Criteria|0|||
147590745|NCT02990806|532319042|FG003|Stage 2 (32 Weeks)|Other|1|||
147590746|NCT02990806|532319039|FG000|Stage 2 (32 Weeks)|Ineligible according to Tuberculosis (TB) criteria|0|||
147168989|NCT01424566|530783808|FG002|Single-blind Treatment|Did Not Meet Inclusion Criteria|0|||
147168990|NCT01424566|530783806|FG000|Single-blind Treatment|Met Exclusion Criteria|1|||
147168991|NCT01424566|530783807|FG001|Single-blind Treatment|Met Exclusion Criteria|0|||
147168992|NCT01424566|530783808|FG002|Single-blind Treatment|Met Exclusion Criteria|0|||
147168993|NCT01424566|530783806|FG000|Single-blind Treatment|Did Not Administer Any Study Drug|2|||
147447902|NCT03077685|531804002|FG002|Overall Study|Subject entered hospice care|0|||
147447903|NCT03077685|531804003|FG003|Overall Study|Subject entered hospice care|0|||
147447904|NCT03077685|531804004|FG004|Overall Study|Subject entered hospice care|1|||
147447905|NCT04194528|531804006|FG000|Overall Study|Adverse Event|1|||
147447906|NCT03921424|531804007|FG000|Overall Study|Lost to Follow-up|0|||
147447907|NCT03921424|531804008|FG001|Overall Study|Lost to Follow-up|1|||
147447908|NCT03921424|531804007|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
147447909|NCT03921424|531804008|FG001|Overall Study|Withdrawal By Parent/Guardian|2|||
147590747|NCT02990806|532319040|FG001|Stage 2 (32 Weeks)|Ineligible according to Tuberculosis (TB) criteria|0|||
147590748|NCT02990806|532319041|FG002|Stage 2 (32 Weeks)|Ineligible according to Tuberculosis (TB) criteria|0|||
147447910|NCT04294901|531804018|FG000|Overall Study|Death|86|||
147447911|NCT04294901|531804019|FG001|Overall Study|Death|110|||
147590749|NCT02990806|532319042|FG003|Stage 2 (32 Weeks)|Ineligible according to Tuberculosis (TB) criteria|1|||
147590750|NCT02990806|532319039|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Adverse Event|5|||
147590751|NCT02990806|532319040|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Adverse Event|0|||
147590752|NCT02990806|532319041|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Adverse Event|4|||
147590753|NCT02990806|532319042|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Adverse Event|3|||
147590754|NCT02990806|532319039|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Physician Decision|1|||
147590755|NCT02990806|532319040|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Physician Decision|0|||
147590756|NCT02990806|532319041|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Physician Decision|1|||
147590757|NCT02990806|532319042|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Physician Decision|1|||
147590758|NCT02990806|532319039|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
147590759|NCT02990806|532319040|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Noncompliant with visit schedule and/or protocol|0|||
147590760|NCT02990806|532319041|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
147590761|NCT02990806|532319042|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Noncompliant with visit schedule and/or protocol|2|||
147590762|NCT02990806|532319039|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Lost to Follow-up|1|||
147590763|NCT02990806|532319040|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Lost to Follow-up|0|||
147168994|NCT01424566|530783807|FG001|Single-blind Treatment|Did Not Administer Any Study Drug|0|||
147168995|NCT01424566|530783808|FG002|Single-blind Treatment|Did Not Administer Any Study Drug|0|||
147168996|NCT01424566|530783806|FG000|Double-blind Treatment|Adverse Event|0|||
147168997|NCT01424566|530783807|FG001|Double-blind Treatment|Adverse Event|21|||
147168998|NCT01424566|530783808|FG002|Double-blind Treatment|Adverse Event|13|||
147168999|NCT01424566|530783806|FG000|Double-blind Treatment|Withdrawal by Subject|0|||
147169000|NCT01424566|530783807|FG001|Double-blind Treatment|Withdrawal by Subject|2|||
147169001|NCT01424566|530783808|FG002|Double-blind Treatment|Withdrawal by Subject|0|||
147169002|NCT01424566|530783806|FG000|Double-blind Treatment|Withdrawal by Investigator|0|||
147169003|NCT01424566|530783807|FG001|Double-blind Treatment|Withdrawal by Investigator|1|||
147169004|NCT01424566|530783808|FG002|Double-blind Treatment|Withdrawal by Investigator|1|||
147169005|NCT01424566|530783806|FG000|Double-blind Treatment|Lack of Efficacy|0|||
147169006|NCT01424566|530783807|FG001|Double-blind Treatment|Lack of Efficacy|1|||
147169007|NCT01424566|530783808|FG002|Double-blind Treatment|Lack of Efficacy|1|||
147169008|NCT01079936|530783813|FG000|Phase I: MTD|First Remission Status|2|||
147169009|NCT01079936|530783814|FG001|Phase I: MTD|First Remission Status|0|||
147169010|NCT01079936|530783815|FG002|Phase I: MTD|First Remission Status|0|||
147169011|NCT01079936|530783816|FG003|Phase I: MTD|First Remission Status|0|||
147169012|NCT01079936|530783817|FG004|Phase I: MTD|First Remission Status|0|||
147169013|NCT01079936|530783813|FG000|Phase I: MTD|No Stem Cell Transplantation|2|||
147169014|NCT01079936|530783814|FG001|Phase I: MTD|No Stem Cell Transplantation|0|||
147169015|NCT01079936|530783815|FG002|Phase I: MTD|No Stem Cell Transplantation|0|||
147169016|NCT01079936|530783816|FG003|Phase I: MTD|No Stem Cell Transplantation|0|||
147169017|NCT01079936|530783817|FG004|Phase I: MTD|No Stem Cell Transplantation|0|||
147169018|NCT01079936|530783813|FG000|Phase II|Adverse Event|0|||
147169019|NCT01079936|530783814|FG001|Phase II|Adverse Event|0|||
147169020|NCT01079936|530783815|FG002|Phase II|Adverse Event|1|||
147169021|NCT01079936|530783816|FG003|Phase II|Adverse Event|0|||
147169022|NCT01079936|530783817|FG004|Phase II|Adverse Event|0|||
147169023|NCT01079936|530783813|FG000|Phase II|Insurance Issue|0|||
147169024|NCT01079936|530783814|FG001|Phase II|Insurance Issue|0|||
147590764|NCT02990806|532319041|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Lost to Follow-up|0|||
147590765|NCT02990806|532319042|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Lost to Follow-up|1|||
147590766|NCT02990806|532319039|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Withdrawal by Subject|0|||
147169025|NCT01079936|530783815|FG002|Phase II|Insurance Issue|0|||
147169026|NCT01079936|530783816|FG003|Phase II|Insurance Issue|0|||
147447912|NCT04294901|531804018|FG000|Overall Study|Provider did not have historical control patients|581|||
147447913|NCT04294901|531804019|FG001|Overall Study|Provider did not have historical control patients|0|||
147447914|NCT04294901|531804018|FG000|Overall Study|Provider did not have intervention patients|0|||
147169027|NCT01079936|530783817|FG004|Phase II|Insurance Issue|1|||
147169028|NCT02335424|530783818|FG000|Overall Study|Withdrawal by Subject|19|||
147169029|NCT02335424|530783818|FG000|Overall Study|Adverse Event|25|||
147169030|NCT02335424|530783818|FG000|Overall Study|Death|273|||
147590767|NCT02990806|532319040|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Withdrawal by Subject|0|||
147590768|NCT02990806|532319041|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Withdrawal by Subject|2|||
147590769|NCT02990806|532319042|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Withdrawal by Subject|1|||
147590770|NCT02990806|532319039|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Lack of Efficacy|0|||
147590771|NCT02990806|532319040|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Lack of Efficacy|0|||
147169031|NCT02335424|530783818|FG000|Overall Study|Lost to Follow-up|3|||
147169032|NCT02335424|530783818|FG000|Overall Study|Physician Decision|13|||
147169033|NCT02335424|530783818|FG000|Overall Study|Participation in study terminated by Sponsor|39|||
147169034|NCT02335424|530783818|FG000|Overall Study|Protocol Violation|1|||
147169035|NCT02335424|530783818|FG000|Overall Study|Screen failure|1|||
147169036|NCT02712424|530783819|FG000|Overall Study|Lost to Follow-up|34|||
147169037|NCT02712424|530783820|FG001|Overall Study|Lost to Follow-up|32|||
147169038|NCT02723175|530783821|FG000|Overall Study|Lost to 1 Month Follow Up|3|||
147169039|NCT02723175|530783822|FG001|Overall Study|Lost to 1 Month Follow Up|2|||
147169040|NCT02723175|530783821|FG000|Overall Study|Lost to 3 Month Follow Up|1|||
147169041|NCT02723175|530783822|FG001|Overall Study|Lost to 3 Month Follow Up|1|||
147169042|NCT04109976|530783823|FG000|Overall Study|Withdrawal by Subject|1|||
147169043|NCT04109976|530783824|FG001|Overall Study|Withdrawal by Subject|0|||
147169044|NCT02598128|530783829|FG000|Period A: Days -7 to -1|Adverse Event|1|||
147169045|NCT02598128|530783830|FG001|Period A: Days -7 to -1|Adverse Event|0|||
147169046|NCT02598128|530783831|FG002|Period A: Days -7 to -1|Adverse Event|0|||
147169047|NCT02598128|530783832|FG003|Period A: Days -7 to -1|Adverse Event|0|||
147169048|NCT03134183|530783833|FG000|Overall Study|Withdrawal by Subject|1|||
147169049|NCT03134183|530783834|FG001|Overall Study|Withdrawal by Subject|1|||
147169050|NCT00845065|530783837|FG000|Overall Study|Adverse Event|3|||
147169051|NCT00845065|530783838|FG001|Overall Study|Adverse Event|23|||
147169052|NCT00845065|530783837|FG000|Overall Study|Lack of Efficacy|43|||
147169053|NCT00845065|530783838|FG001|Overall Study|Lack of Efficacy|21|||
147169054|NCT00845065|530783837|FG000|Overall Study|Non-Medical Reasons|1|||
147169055|NCT00845065|530783838|FG001|Overall Study|Non-Medical Reasons|11|||
147169056|NCT02299076|530783839|FG000|Overall Study|Fraudulent Entries|20|||
147169057|NCT02299076|530783840|FG001|Overall Study|Fraudulent Entries|14|||
147169058|NCT01198509|530783841|FG000|Overall Study|Withdrawal by Subject|1|||
147169059|NCT01198509|530783842|FG001|Overall Study|Withdrawal by Subject|0|||
147169060|NCT01198509|530783843|FG002|Overall Study|Withdrawal by Subject|0|||
147169061|NCT01198509|530783844|FG003|Overall Study|Withdrawal by Subject|0|||
147169062|NCT01198509|530783845|FG004|Overall Study|Withdrawal by Subject|0|||
147169063|NCT01198509|530783846|FG005|Overall Study|Withdrawal by Subject|0|||
147169064|NCT02228096|530783855|FG000|Overall Study|Study terminated by Sponsor|24|||
147169065|NCT02228096|530783855|FG000|Overall Study|Lack of Efficacy|18|||
147169066|NCT02228096|530783855|FG000|Overall Study|Death|12|||
147169067|NCT02228096|530783855|FG000|Overall Study|Physician Decision|3|||
147169068|NCT02228096|530783855|FG000|Overall Study|Subject/guardian decision|2|||
147169069|NCT02228096|530783855|FG000|Overall Study|New therapy for study indication|1|||
147169070|NCT02228096|530783855|FG000|Overall Study|Enrolled, not infused|11|||
147169071|NCT00499746|530783856|FG000|Phase 1(6-9 One Day Sessions)|Failed to perform study task|7|||
147169072|NCT00499746|530783856|FG000|Phase 1(6-9 One Day Sessions)|Withdrawal by Subject|3|||
147169073|NCT00499746|530783856|FG000|Phase 1(6-9 One Day Sessions)|Investigator decision|1|||
147169074|NCT00499746|530783856|FG000|Phase 1(6-9 One Day Sessions)|Unable to determine|1|||
147169075|NCT01969721|530783857|FG000|Overall Study|Adverse Event|3|||
147169076|NCT01969721|530783858|FG001|Overall Study|Adverse Event|8|||
147169077|NCT01969721|530783859|FG002|Overall Study|Adverse Event|3|||
147169078|NCT01969721|530783860|FG003|Overall Study|Adverse Event|2|||
147169079|NCT01969721|530783857|FG000|Overall Study|Lack of Efficacy|0|||
147169080|NCT01969721|530783858|FG001|Overall Study|Lack of Efficacy|0|||
147169081|NCT01969721|530783859|FG002|Overall Study|Lack of Efficacy|1|||
147169082|NCT01969721|530783860|FG003|Overall Study|Lack of Efficacy|0|||
147169083|NCT01969721|530783857|FG000|Overall Study|Non compliant with protocol|1|||
147169084|NCT01969721|530783858|FG001|Overall Study|Non compliant with protocol|1|||
147169085|NCT01969721|530783859|FG002|Overall Study|Non compliant with protocol|0|||
147169086|NCT01969721|530783860|FG003|Overall Study|Non compliant with protocol|2|||
147169087|NCT01969721|530783857|FG000|Overall Study|Other not defined above|0|||
147169088|NCT01969721|530783858|FG001|Overall Study|Other not defined above|2|||
147590772|NCT02990806|532319041|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Lack of Efficacy|1|||
147590773|NCT02990806|532319042|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Lack of Efficacy|0|||
147590774|NCT02990806|532319039|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Other|0|||
147169089|NCT01969721|530783859|FG002|Overall Study|Other not defined above|0|||
147169090|NCT01969721|530783860|FG003|Overall Study|Other not defined above|0|||
147169091|NCT01969721|530783857|FG000|Overall Study|Discontinued during washout periods.|0|||
147169092|NCT01969721|530783858|FG001|Overall Study|Discontinued during washout periods.|1|||
147169093|NCT01969721|530783859|FG002|Overall Study|Discontinued during washout periods.|1|||
147169094|NCT01969721|530783860|FG003|Overall Study|Discontinued during washout periods.|2|||
147169095|NCT02383433|530783863|FG000|Overall Study|Disease progression|2|||
147169096|NCT04311463|530783866|FG000|Period 1 (Up to Day 3)|Participant met Protocol defined withdrawal criteria|1|||
147169097|NCT04311463|530783867|FG001|Period 1 (Up to Day 3)|Participant met Protocol defined withdrawal criteria|0|||
147169098|NCT04311463|530783866|FG000|Washout Period (Up to Day 7)|Withdrawal by Subject|1|||
147169099|NCT04311463|530783867|FG001|Washout Period (Up to Day 7)|Withdrawal by Subject|1|||
147169100|NCT04311463|530783866|FG000|Period 2 (Up to Day 3)|Participant met Protocol defined withdrawal criteria|2|||
147169101|NCT04311463|530783867|FG001|Period 2 (Up to Day 3)|Participant met Protocol defined withdrawal criteria|1|||
147590775|NCT02990806|532319040|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Other|0|||
147590776|NCT02990806|532319041|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Other|0|||
147169102|NCT00952614|530783868|FG000|Overall Study|Death|3|||
147169103|NCT00952614|530783868|FG000|Overall Study|Lost to Follow-up|3|||
147169104|NCT00952614|530783868|FG000|Overall Study|other reason|1|||
147169105|NCT04023682|530783870|FG000|Overall Study|Clinical schedules did not allow continued participation|6|||
147169106|NCT03180307|530783879|FG000|Overall Study|Lost to Follow-up|2|||
147169107|NCT03180307|530783880|FG001|Overall Study|Lost to Follow-up|0|||
147169108|NCT03180307|530783879|FG000|Overall Study|Death|1|||
147169109|NCT03180307|530783880|FG001|Overall Study|Death|0|||
147169110|NCT03180307|530783879|FG000|Overall Study|Majority of which were disease too extensive and camera not used|3|||
147169111|NCT03180307|530783880|FG001|Overall Study|Majority of which were disease too extensive and camera not used|0|||
147169112|NCT01563172|530783883|FG000|Overall Study|Adverse Event|5|||
147169113|NCT01563172|530783883|FG000|Overall Study|Lost to Follow-up|2|||
147169114|NCT01563172|530783883|FG000|Overall Study|Other (Protocol deviation)|5|||
147169115|NCT01563172|530783883|FG000|Overall Study|Other (Not specified)|1|||
147169116|NCT02986854|530783885|FG000|Overall Study|Withdrawal by Subject|0|||
147169117|NCT02986854|530783886|FG001|Overall Study|Withdrawal by Subject|1|||
147169118|NCT02986854|530783887|FG002|Overall Study|Withdrawal by Subject|1|||
147169119|NCT02986854|530783885|FG000|Overall Study|Lost to Follow-up|3|||
147169120|NCT02986854|530783886|FG001|Overall Study|Lost to Follow-up|11|||
147169121|NCT02986854|530783887|FG002|Overall Study|Lost to Follow-up|2|||
147169122|NCT00718770|530783890|FG000|Overall Study|Adverse Event|1|||
147169123|NCT00718770|530783890|FG000|Overall Study|Lack of Efficacy|1|||
147169124|NCT00718770|530783890|FG000|Overall Study|Lack of Efficacy|1|||
147169125|NCT00718770|530783890|FG000|Overall Study|Adverse Event|1|||
147169126|NCT00718770|530783890|FG000|Overall Study|Lack of Efficacy|1|||
147169127|NCT00718770|530783890|FG000|Overall Study|Adverse Event|1|||
147169128|NCT00718770|530783890|FG000|Overall Study|Lack of Efficacy|1|||
147169129|NCT00718770|530783890|FG000|Overall Study|Adverse Event|1|||
147169130|NCT01624090|530783894|FG000|Overall Study|DLT, taken off therapy|0|||
147169131|NCT01624090|530783895|FG001|Overall Study|DLT, taken off therapy|1|||
147169132|NCT01624090|530783896|FG002|Overall Study|DLT, taken off therapy|0|||
147169133|NCT01624090|530783897|FG003|Overall Study|DLT, taken off therapy|0|||
147169134|NCT01624090|530783894|FG000|Overall Study|Withdrew prior to treatment|0|||
147169135|NCT01624090|530783895|FG001|Overall Study|Withdrew prior to treatment|1|||
147169136|NCT01624090|530783896|FG002|Overall Study|Withdrew prior to treatment|0|||
147169137|NCT01624090|530783897|FG003|Overall Study|Withdrew prior to treatment|0|||
147169138|NCT01624090|530783894|FG000|Overall Study|Died on study|0|||
147323616|NCT03686683|531349961|FG000|Overall Study|No data available|1|||
147323617|NCT03686683|531349962|FG001|Overall Study|No data available|0|||
147323618|NCT03255941|531349963|FG000|Overall Study|Not eligible or refused injection|37|||
147323619|NCT03255941|531349964|FG001|Overall Study|Not eligible or refused injection|44|||
147323620|NCT03255941|531349965|FG002|Overall Study|Not eligible or refused injection|5|||
147323621|NCT03255941|531349966|FG003|Overall Study|Not eligible or refused injection|6|||
147323622|NCT03255941|531349963|FG000|Overall Study|Did not complete exit interview|1|||
147323623|NCT03255941|531349964|FG001|Overall Study|Did not complete exit interview|2|||
147323624|NCT03255941|531349965|FG002|Overall Study|Did not complete exit interview|0|||
147323625|NCT03255941|531349966|FG003|Overall Study|Did not complete exit interview|0|||
147323626|NCT00372060|531349967|FG000|Period I - Double-blind (Weeks 0-12)|Adverse Event|2|||
147323627|NCT00372060|531349968|FG001|Period I - Double-blind (Weeks 0-12)|Adverse Event|0|||
147323628|NCT00372060|531349967|FG000|Period I - Double-blind (Weeks 0-12)|Lack of Efficacy|0|||
147323629|NCT00372060|531349968|FG001|Period I - Double-blind (Weeks 0-12)|Lack of Efficacy|1|||
147323630|NCT00372060|531349967|FG000|Period I - Double-blind (Weeks 0-12)|No improvement in hyperglycemia|1|||
147323631|NCT00372060|531349968|FG001|Period I - Double-blind (Weeks 0-12)|No improvement in hyperglycemia|0|||
147323632|NCT00372060|531349967|FG000|Period II - Open-label (Weeks 12-52)|Adverse Event|3|||
147323633|NCT00372060|531349968|FG001|Period II - Open-label (Weeks 12-52)|Adverse Event|0|||
147590777|NCT02990806|532319042|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Other|2|||
147590778|NCT02990806|532319039|FG000|Stage 3 (Safety Follow-up) (8 Weeks)|Initiated protocol-prohibited medication|0|||
147169139|NCT01624090|530783895|FG001|Overall Study|Died on study|0|||
147169140|NCT01624090|530783896|FG002|Overall Study|Died on study|2|||
147169141|NCT01624090|530783897|FG003|Overall Study|Died on study|0|||
147169142|NCT01624090|530783894|FG000|Overall Study|Did not complete 1 crse of therapy|0|||
147169143|NCT01624090|530783895|FG001|Overall Study|Did not complete 1 crse of therapy|0|||
147169144|NCT01624090|530783896|FG002|Overall Study|Did not complete 1 crse of therapy|2|||
147323634|NCT00372060|531349967|FG000|Period II - Open-label (Weeks 12-52)|Lack of Efficacy|9|||
147596002|NCT00251641|532338767|FG000|Overall Study|Progression of Disease|0|||
147169145|NCT01624090|530783897|FG003|Overall Study|Did not complete 1 crse of therapy|0|||
147169146|NCT01624090|530783894|FG000|Overall Study|Dose escalated|0|||
147169147|NCT01624090|530783895|FG001|Overall Study|Dose escalated|0|||
147169148|NCT01624090|530783896|FG002|Overall Study|Dose escalated|3|||
147169149|NCT01624090|530783897|FG003|Overall Study|Dose escalated|0|||
147169150|NCT00772109|530783898|FG000|Overall Study|Serious adverse event|1|||
147169151|NCT00772109|530783899|FG001|Overall Study|Serious adverse event|0|||
147169152|NCT00772109|530783900|FG002|Overall Study|Serious adverse event|1|||
147169153|NCT00772109|530783901|FG003|Overall Study|Serious adverse event|0|||
147169154|NCT00772109|530783898|FG000|Overall Study|Protocol Violation|5|||
147169155|NCT00772109|530783899|FG001|Overall Study|Protocol Violation|8|||
147169156|NCT00772109|530783900|FG002|Overall Study|Protocol Violation|7|||
147169157|NCT00772109|530783901|FG003|Overall Study|Protocol Violation|6|||
147169158|NCT00772109|530783898|FG000|Overall Study|Lost to Follow-up|7|||
147169159|NCT00772109|530783899|FG001|Overall Study|Lost to Follow-up|3|||
147169160|NCT00772109|530783900|FG002|Overall Study|Lost to Follow-up|5|||
147169161|NCT00772109|530783901|FG003|Overall Study|Lost to Follow-up|9|||
147169162|NCT00772109|530783898|FG000|Overall Study|Withdrawal by Subject|8|||
147169163|NCT00772109|530783899|FG001|Overall Study|Withdrawal by Subject|8|||
147169164|NCT00772109|530783900|FG002|Overall Study|Withdrawal by Subject|6|||
147169165|NCT00772109|530783901|FG003|Overall Study|Withdrawal by Subject|16|||
147169166|NCT00752726|530783902|FG000|Overall Study|Lost to Follow-up|2|||
147169167|NCT00752726|530783903|FG001|Overall Study|Lost to Follow-up|1|||
147169168|NCT00752726|530783902|FG000|Overall Study|Adverse Event|3|||
147169169|NCT00752726|530783903|FG001|Overall Study|Adverse Event|0|||
147169170|NCT00752726|530783902|FG000|Overall Study|Withdrawal by Subject|5|||
147169171|NCT00752726|530783903|FG001|Overall Study|Withdrawal by Subject|10|||
147169172|NCT00752726|530783902|FG000|Overall Study|Other Reason|1|||
147169173|NCT00752726|530783903|FG001|Overall Study|Other Reason|2|||
147169174|NCT01403116|530783904|FG000|Overall Study|Adverse Event|7|||
147169175|NCT01403116|530783905|FG001|Overall Study|Adverse Event|4|||
147169176|NCT01403116|530783904|FG000|Overall Study|Lost to Follow-up|7|||
147169177|NCT01403116|530783905|FG001|Overall Study|Lost to Follow-up|5|||
147169178|NCT01403116|530783904|FG000|Overall Study|Withdrawal by Subject|12|||
147169179|NCT01403116|530783905|FG001|Overall Study|Withdrawal by Subject|15|||
147169180|NCT01403116|530783904|FG000|Overall Study|Non-compliance of study drug|3|||
147169181|NCT01403116|530783905|FG001|Overall Study|Non-compliance of study drug|0|||
147169182|NCT01403116|530783904|FG000|Overall Study|Protocol Violation|0|||
147169183|NCT01403116|530783905|FG001|Overall Study|Protocol Violation|1|||
147169184|NCT01403116|530783904|FG000|Overall Study|undisclosed Hx of Prostate Ca|1|||
147169185|NCT01403116|530783905|FG001|Overall Study|undisclosed Hx of Prostate Ca|0|||
147169186|NCT01403116|530783904|FG000|Overall Study|Hct >54%|2|||
147169187|NCT01403116|530783905|FG001|Overall Study|Hct >54%|0|||
147169188|NCT01403116|530783904|FG000|Overall Study|unable to keep appointments|0|||
147169189|NCT01403116|530783905|FG001|Overall Study|unable to keep appointments|2|||
147169190|NCT01895309|530783906|FG000|Overall Study|Adverse Event|13|||
147169191|NCT01895309|530783907|FG001|Overall Study|Adverse Event|17|||
147169192|NCT01895309|530783906|FG000|Overall Study|Protocol Violation|1|||
147169193|NCT01895309|530783907|FG001|Overall Study|Protocol Violation|0|||
147169194|NCT01895309|530783906|FG000|Overall Study|Lack of Efficacy|1|||
147169195|NCT01895309|530783907|FG001|Overall Study|Lack of Efficacy|3|||
147169196|NCT01895309|530783906|FG000|Overall Study|Lost to Follow-up|1|||
147169197|NCT01895309|530783907|FG001|Overall Study|Lost to Follow-up|3|||
147169198|NCT01895309|530783906|FG000|Overall Study|Physician Decision|15|||
147169199|NCT01895309|530783907|FG001|Overall Study|Physician Decision|10|||
147169200|NCT01895309|530783906|FG000|Overall Study|Withdrawal by Subject|9|||
147169201|NCT01895309|530783907|FG001|Overall Study|Withdrawal by Subject|18|||
147169202|NCT00042666|530783908|FG000|Overall Study|Adverse Event|2|||
147169203|NCT00042666|530783908|FG000|Overall Study|Death|4|||
147169204|NCT00042666|530783908|FG000|Overall Study|Protocol Violation|1|||
147169205|NCT00042666|530783908|FG000|Overall Study|Participant/Physician Perception|1|||
147169206|NCT00042666|530783908|FG000|Overall Study|Progressive Disease|41|||
147169207|NCT00042666|530783908|FG000|Overall Study|Other|1|||
147169208|NCT00042666|530783908|FG000|Overall Study|Other|4|||
147169209|NCT04232215|530783909|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|0|||
147169210|NCT04232215|530783910|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|2|||
147169211|NCT01555125|530783913|FG000|Induction Period|Lost to Follow-up|0|||
147169212|NCT01555125|530783914|FG001|Induction Period|Lost to Follow-up|2|||
147169213|NCT01555125|530783915|FG002|Induction Period|Lost to Follow-up|0|||
147169214|NCT01555125|530783916|FG003|Induction Period|Lost to Follow-up|0|||
147169215|NCT01555125|530783917|FG004|Induction Period|Lost to Follow-up|0|||
147169216|NCT01555125|530783913|FG000|Induction Period|Adverse Event|0|||
147169217|NCT01555125|530783914|FG001|Induction Period|Adverse Event|1|||
147169218|NCT01555125|530783915|FG002|Induction Period|Adverse Event|0|||
147169219|NCT01555125|530783916|FG003|Induction Period|Adverse Event|0|||
147169220|NCT01555125|530783917|FG004|Induction Period|Adverse Event|1|||
147169221|NCT01555125|530783913|FG000|Induction Period|Subject / guardian decision|0|||
147169222|NCT01555125|530783914|FG001|Induction Period|Subject / guardian decision|0|||
147169223|NCT01555125|530783915|FG002|Induction Period|Subject / guardian decision|0|||
147169224|NCT01555125|530783916|FG003|Induction Period|Subject / guardian decision|0|||
147169225|NCT01555125|530783917|FG004|Induction Period|Subject / guardian decision|2|||
147169226|NCT01555125|530783913|FG000|Induction Period|Death|1|||
147169227|NCT01555125|530783914|FG001|Induction Period|Death|0|||
147169228|NCT01555125|530783915|FG002|Induction Period|Death|0|||
147169229|NCT01555125|530783916|FG003|Induction Period|Death|0|||
147169230|NCT01555125|530783917|FG004|Induction Period|Death|0|||
147169231|NCT01555125|530783913|FG000|Maintenance Period|Adverse Event|1|||
147169232|NCT01555125|530783914|FG001|Maintenance Period|Adverse Event|1|||
147169233|NCT01555125|530783915|FG002|Maintenance Period|Adverse Event|0|||
147169234|NCT01555125|530783916|FG003|Maintenance Period|Adverse Event|0|||
147169235|NCT01555125|530783917|FG004|Maintenance Period|Adverse Event|0|||
147169236|NCT01555125|530783913|FG000|Maintenance Period|Subject / guardian decision|1|||
147169237|NCT01555125|530783914|FG001|Maintenance Period|Subject / guardian decision|2|||
147169238|NCT01555125|530783915|FG002|Maintenance Period|Subject / guardian decision|0|||
147169239|NCT01555125|530783916|FG003|Maintenance Period|Subject / guardian decision|0|||
147169240|NCT01555125|530783917|FG004|Maintenance Period|Subject / guardian decision|0|||
147169241|NCT01555125|530783913|FG000|Maintenance Period|Lost to Follow-up|2|||
147169242|NCT01555125|530783914|FG001|Maintenance Period|Lost to Follow-up|0|||
147169243|NCT01555125|530783915|FG002|Maintenance Period|Lost to Follow-up|0|||
147169244|NCT01555125|530783916|FG003|Maintenance Period|Lost to Follow-up|1|||
147169245|NCT01555125|530783917|FG004|Maintenance Period|Lost to Follow-up|0|||
147169246|NCT01555125|530783913|FG000|Maintenance Period|Lack of Efficacy|6|||
147169247|NCT01555125|530783914|FG001|Maintenance Period|Lack of Efficacy|1|||
147169248|NCT01555125|530783915|FG002|Maintenance Period|Lack of Efficacy|3|||
147169249|NCT01555125|530783916|FG003|Maintenance Period|Lack of Efficacy|0|||
147169250|NCT01555125|530783917|FG004|Maintenance Period|Lack of Efficacy|0|||
147169251|NCT01555125|530783913|FG000|Maintenance Period|Physician Decision|0|||
147169252|NCT01555125|530783914|FG001|Maintenance Period|Physician Decision|0|||
147169253|NCT01555125|530783915|FG002|Maintenance Period|Physician Decision|1|||
147169254|NCT01555125|530783916|FG003|Maintenance Period|Physician Decision|0|||
147169255|NCT01555125|530783917|FG004|Maintenance Period|Physician Decision|0|||
147169256|NCT01555125|530783913|FG000|Maintenance Period|Death|0|||
147169257|NCT01555125|530783914|FG001|Maintenance Period|Death|0|||
147169258|NCT01555125|530783915|FG002|Maintenance Period|Death|0|||
147169259|NCT01555125|530783916|FG003|Maintenance Period|Death|1|||
147169260|NCT01555125|530783917|FG004|Maintenance Period|Death|0|||
147169261|NCT01555125|530783913|FG000|Extension|Adverse Event|1|||
147169262|NCT01555125|530783914|FG001|Extension|Adverse Event|2|||
147169263|NCT01555125|530783915|FG002|Extension|Adverse Event|1|||
147169264|NCT01555125|530783916|FG003|Extension|Adverse Event|1|||
147169265|NCT01555125|530783917|FG004|Extension|Adverse Event|0|||
147169266|NCT01555125|530783913|FG000|Extension|Protocol deviation|1|||
147169267|NCT01555125|530783914|FG001|Extension|Protocol deviation|0|||
147169268|NCT01555125|530783915|FG002|Extension|Protocol deviation|0|||
147169269|NCT01555125|530783916|FG003|Extension|Protocol deviation|0|||
147169270|NCT01555125|530783917|FG004|Extension|Protocol deviation|0|||
147169271|NCT01555125|530783913|FG000|Extension|Lack of Efficacy|7|||
147169272|NCT01555125|530783914|FG001|Extension|Lack of Efficacy|6|||
147169273|NCT01555125|530783915|FG002|Extension|Lack of Efficacy|3|||
147169274|NCT01555125|530783916|FG003|Extension|Lack of Efficacy|0|||
147169275|NCT01555125|530783917|FG004|Extension|Lack of Efficacy|0|||
147169276|NCT01555125|530783913|FG000|Extension|Lost to Follow-up|2|||
147169277|NCT01555125|530783914|FG001|Extension|Lost to Follow-up|1|||
147169278|NCT01555125|530783915|FG002|Extension|Lost to Follow-up|2|||
147169279|NCT01555125|530783916|FG003|Extension|Lost to Follow-up|0|||
147169280|NCT01555125|530783917|FG004|Extension|Lost to Follow-up|0|||
147169281|NCT01555125|530783913|FG000|Extension|Study terminated by sponsor|32|||
147169282|NCT01555125|530783914|FG001|Extension|Study terminated by sponsor|33|||
147169283|NCT01555125|530783915|FG002|Extension|Study terminated by sponsor|16|||
147169284|NCT01555125|530783916|FG003|Extension|Study terminated by sponsor|20|||
147169285|NCT01555125|530783917|FG004|Extension|Study terminated by sponsor|0|||
147169286|NCT01555125|530783913|FG000|Extension|Subject/guardian decision|1|||
147169287|NCT01555125|530783914|FG001|Extension|Subject/guardian decision|9|||
147169288|NCT01555125|530783915|FG002|Extension|Subject/guardian decision|1|||
147169289|NCT01555125|530783916|FG003|Extension|Subject/guardian decision|0|||
147169290|NCT01555125|530783917|FG004|Extension|Subject/guardian decision|0|||
147169291|NCT01555125|530783913|FG000|Extension|Technical Problems|1|||
147169292|NCT01555125|530783914|FG001|Extension|Technical Problems|0|||
147169293|NCT01555125|530783915|FG002|Extension|Technical Problems|0|||
147169294|NCT01555125|530783916|FG003|Extension|Technical Problems|1|||
147169295|NCT01555125|530783917|FG004|Extension|Technical Problems|0|||
147169296|NCT01555125|530783913|FG000|Follow-Up Period|Lost to Follow-up|1|||
147169297|NCT01555125|530783914|FG001|Follow-Up Period|Lost to Follow-up|0|||
147169298|NCT01555125|530783915|FG002|Follow-Up Period|Lost to Follow-up|0|||
147169299|NCT01555125|530783916|FG003|Follow-Up Period|Lost to Follow-up|0|||
147169300|NCT01555125|530783917|FG004|Follow-Up Period|Lost to Follow-up|0|||
147169301|NCT01555125|530783913|FG000|Follow-Up Period|Subject / guardian decision|3|||
147169302|NCT01555125|530783914|FG001|Follow-Up Period|Subject / guardian decision|1|||
147169303|NCT01555125|530783915|FG002|Follow-Up Period|Subject / guardian decision|1|||
147169304|NCT01555125|530783916|FG003|Follow-Up Period|Subject / guardian decision|1|||
147169305|NCT01555125|530783917|FG004|Follow-Up Period|Subject / guardian decision|0|||
147169306|NCT02651220|530783918|FG000|Overall Study|Adverse Event|1|||
147169307|NCT02651220|530783919|FG001|Overall Study|Adverse Event|5|||
147169308|NCT02651220|530783920|FG002|Overall Study|Adverse Event|1|||
147169309|NCT02651220|530783918|FG000|Overall Study|Lost to Follow-up|8|||
147169310|NCT02651220|530783919|FG001|Overall Study|Lost to Follow-up|14|||
147169311|NCT02651220|530783920|FG002|Overall Study|Lost to Follow-up|14|||
147169312|NCT02651220|530783918|FG000|Overall Study|Non-Compliance with Study Drug|4|||
147169313|NCT02651220|530783919|FG001|Overall Study|Non-Compliance with Study Drug|0|||
147169314|NCT02651220|530783920|FG002|Overall Study|Non-Compliance with Study Drug|1|||
147169315|NCT02651220|530783918|FG000|Overall Study|Pregnancy|1|||
147169316|NCT02651220|530783919|FG001|Overall Study|Pregnancy|0|||
147169317|NCT02651220|530783920|FG002|Overall Study|Pregnancy|1|||
147169318|NCT02651220|530783918|FG000|Overall Study|Protocol Violation|0|||
147169319|NCT02651220|530783919|FG001|Overall Study|Protocol Violation|0|||
147169320|NCT02651220|530783920|FG002|Overall Study|Protocol Violation|1|||
147169321|NCT02651220|530783918|FG000|Overall Study|Withdrawal by Subject|5|||
147169322|NCT02651220|530783919|FG001|Overall Study|Withdrawal by Subject|6|||
147169323|NCT02651220|530783920|FG002|Overall Study|Withdrawal by Subject|8|||
147169324|NCT02651220|530783918|FG000|Overall Study|Miscellaneous|4|||
147169325|NCT02651220|530783919|FG001|Overall Study|Miscellaneous|1|||
147169326|NCT02651220|530783920|FG002|Overall Study|Miscellaneous|2|||
147169327|NCT02651220|530783918|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
147169328|NCT02651220|530783919|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
147169329|NCT02651220|530783920|FG002|Overall Study|Withdrawal by Parent/Guardian|1|||
147169330|NCT04268745|530783921|FG000|Overall Study|Lost to Follow-up|2|||
147169331|NCT04268745|530783922|FG001|Overall Study|Lost to Follow-up|3|||
147169332|NCT04268745|530783921|FG000|Overall Study|Withdrawal by Subject|4|||
147169333|NCT04268745|530783922|FG001|Overall Study|Withdrawal by Subject|2|||
147169334|NCT04268745|530783921|FG000|Overall Study|Death in the family|1|||
147169335|NCT04268745|530783922|FG001|Overall Study|Death in the family|0|||
147169336|NCT00447122|530783924|FG000|Overall Study|worsening medical condition -came off|0|||
147169337|NCT00447122|530783925|FG001|Overall Study|worsening medical condition -came off|1|||
147169338|NCT00447122|530783926|FG002|Overall Study|worsening medical condition -came off|0|||
147169339|NCT00447122|530783927|FG003|Overall Study|worsening medical condition -came off|0|||
147169340|NCT02409342|530783929|FG000|Overall Study|Death|211|||
147169341|NCT02409342|530783930|FG001|Overall Study|Death|201|||
147169342|NCT02409342|530783929|FG000|Overall Study|Withdrawal by Subject|24|||
147169343|NCT02409342|530783930|FG001|Overall Study|Withdrawal by Subject|17|||
147169344|NCT02409342|530783929|FG000|Overall Study|Study Terminated By Sponsor|48|||
147169345|NCT02409342|530783930|FG001|Overall Study|Study Terminated By Sponsor|59|||
147169346|NCT02409342|530783929|FG000|Overall Study|Lost to Follow-up|3|||
147323635|NCT00372060|531349968|FG001|Period II - Open-label (Weeks 12-52)|Lack of Efficacy|8|||
147323636|NCT00372060|531349967|FG000|Period II - Open-label (Weeks 12-52)|Withdrawal by Subject|2|||
147323637|NCT00372060|531349968|FG001|Period II - Open-label (Weeks 12-52)|Withdrawal by Subject|0|||
147323638|NCT01579578|531349980|FG000|Overall Study|Death|4|||
147323639|NCT01579578|531349981|FG001|Overall Study|Death|1|||
147323640|NCT01579578|531349980|FG000|Overall Study|Lost to Follow-up|1|||
147323641|NCT01579578|531349981|FG001|Overall Study|Lost to Follow-up|1|||
147323642|NCT01579578|531349980|FG000|Overall Study|Withdrawal by Subject|2|||
147323643|NCT01579578|531349981|FG001|Overall Study|Withdrawal by Subject|1|||
147323644|NCT01579578|531349980|FG000|Overall Study|Eligibility criteria|3|||
147323645|NCT01579578|531349981|FG001|Overall Study|Eligibility criteria|9|||
147323646|NCT01579578|531349980|FG000|Overall Study|Ongoing|3|||
147323647|NCT01579578|531349981|FG001|Overall Study|Ongoing|0|||
147323648|NCT01004263|531349982|FG000|Overall Study|Adverse Event|15|||
147323649|NCT01004263|531349982|FG000|Overall Study|Withdrawal by Subject|58|||
147323650|NCT01004263|531349982|FG000|Overall Study|Protocol Violation|10|||
147323651|NCT01004263|531349982|FG000|Overall Study|Lost to Follow-up|64|||
147169347|NCT02409342|530783930|FG001|Overall Study|Lost to Follow-up|5|||
147169348|NCT02409342|530783929|FG000|Overall Study|Local ethics requires subjects' data be removed from aug 2020 to currently.|0|||
147323652|NCT01004263|531349982|FG000|Overall Study|Lack of Efficacy|13|||
147323653|NCT01004263|531349982|FG000|Overall Study|Pregnancy|2|||
147323654|NCT01004263|531349982|FG000|Overall Study|Physician Decision|15|||
147169349|NCT02409342|530783930|FG001|Overall Study|Local ethics requires subjects' data be removed from aug 2020 to currently.|1|||
147169350|NCT02409342|530783929|FG000|Overall Study|Participant Moved Into Roll-Over Study|0|||
147169351|NCT02409342|530783930|FG001|Overall Study|Participant Moved Into Roll-Over Study|2|||
147169352|NCT02409342|530783929|FG000|Overall Study|Sponsor Decision|1|||
147169353|NCT02409342|530783930|FG001|Overall Study|Sponsor Decision|0|||
147169354|NCT00279812|530783940|FG000|Overall Study|Protocol Violation|1|||
147169355|NCT00279812|530783941|FG001|Overall Study|Protocol Violation|1|||
147169356|NCT00279812|530783942|FG002|Overall Study|Protocol Violation|0|||
147323655|NCT01004263|531349982|FG000|Overall Study|Lack of Qualifying Event|2|||
147169357|NCT00279812|530783943|FG003|Overall Study|Protocol Violation|0|||
147169358|NCT00279812|530783944|FG004|Overall Study|Protocol Violation|1|||
147169359|NCT00279812|530783945|FG005|Overall Study|Protocol Violation|0|||
147169360|NCT00279812|530783940|FG000|Overall Study|Withdrawal by Subject|0|||
147169361|NCT00279812|530783941|FG001|Overall Study|Withdrawal by Subject|4|||
147169362|NCT00279812|530783942|FG002|Overall Study|Withdrawal by Subject|2|||
147169363|NCT00279812|530783943|FG003|Overall Study|Withdrawal by Subject|0|||
147169364|NCT00279812|530783944|FG004|Overall Study|Withdrawal by Subject|0|||
147169365|NCT00279812|530783945|FG005|Overall Study|Withdrawal by Subject|0|||
147169366|NCT00279812|530783940|FG000|Overall Study|Adverse Event|0|||
147169367|NCT00279812|530783941|FG001|Overall Study|Adverse Event|1|||
147169368|NCT00279812|530783942|FG002|Overall Study|Adverse Event|1|||
147169369|NCT00279812|530783943|FG003|Overall Study|Adverse Event|0|||
147169370|NCT00279812|530783944|FG004|Overall Study|Adverse Event|2|||
147169371|NCT00279812|530783945|FG005|Overall Study|Adverse Event|1|||
147169372|NCT05327361|530783946|FG000|Overall Study|Lost to Follow-up|4|||
147169373|NCT01439373|530783947|FG000|Monotherapy (Day 1)|Participant Dropped-out at Day 1 visit|0|||
147169374|NCT01439373|530783948|FG001|Monotherapy (Day 1)|Participant Dropped-out at Day 1 visit|1|||
147169375|NCT01439373|530783947|FG000|Combined With PEG and RIBA (Day 2 to 28)|Adverse Event|2|||
147169376|NCT01439373|530783948|FG001|Combined With PEG and RIBA (Day 2 to 28)|Adverse Event|0|||
147169377|NCT04576897|530783949|FG000|Overall Study|37 scans were determined by the sponsor to be invalid.|37|||
147169378|NCT03834220|530783950|FG000|Overall Study|Adverse Event|1|||
147169379|NCT03834220|530783951|FG001|Overall Study|Adverse Event|0|||
147169380|NCT03834220|530783952|FG002|Overall Study|Adverse Event|0|||
147169381|NCT03834220|530783950|FG000|Overall Study|Death|8|||
147169382|NCT03834220|530783951|FG001|Overall Study|Death|1|||
147169383|NCT03834220|530783952|FG002|Overall Study|Death|17|||
147169384|NCT03834220|530783950|FG000|Overall Study|Reason not Specified|9|||
147169385|NCT03834220|530783951|FG001|Overall Study|Reason not Specified|0|||
147169386|NCT03834220|530783952|FG002|Overall Study|Reason not Specified|6|||
147169387|NCT03834220|530783950|FG000|Overall Study|Sponsor/EthicsCommittee Decided to Terminate Study|10|||
147169388|NCT03834220|530783951|FG001|Overall Study|Sponsor/EthicsCommittee Decided to Terminate Study|1|||
147169389|NCT03834220|530783952|FG002|Overall Study|Sponsor/EthicsCommittee Decided to Terminate Study|4|||
147169390|NCT03834220|530783950|FG000|Overall Study|Withdrawal of Consent|2|||
147169391|NCT03834220|530783951|FG001|Overall Study|Withdrawal of Consent|2|||
147169392|NCT03834220|530783952|FG002|Overall Study|Withdrawal of Consent|2|||
147169393|NCT02593318|530783955|FG000|Overall Study|Withdrawal by Subject|1|||
147169394|NCT02593318|530783956|FG001|Overall Study|Withdrawal by Subject|1|||
147169395|NCT01174173|530783958|FG000|Overall Study|drug-drug interaction|1|||
147169396|NCT00527332|530783962|FG000|Overall Study|Protocol Violation|4|||
147169397|NCT00527332|530783963|FG001|Overall Study|Protocol Violation|8|||
147169398|NCT00527332|530783962|FG000|Overall Study|Withdrew consent|5|||
147169399|NCT00527332|530783963|FG001|Overall Study|Withdrew consent|1|||
147169400|NCT02720692|530786113|FG000|Overall Study|Withdrawal by Subject|3|||
147169401|NCT02720692|530786114|FG001|Overall Study|Withdrawal by Subject|0|||
147169402|NCT02720692|530786113|FG000|Overall Study|Physician Decision|1|||
147169403|NCT02720692|530786114|FG001|Overall Study|Physician Decision|0|||
147169404|NCT02720692|530786113|FG000|Overall Study|Lost to Follow-up|8|||
147169405|NCT02720692|530786114|FG001|Overall Study|Lost to Follow-up|3|||
147169406|NCT02720692|530786113|FG000|Overall Study|Subject unable to return for visit|1|||
147169407|NCT02720692|530786114|FG001|Overall Study|Subject unable to return for visit|0|||
147169408|NCT02503501|530786115|FG000|Overall Study|Physician Decision|1|||
147169409|NCT02503501|530786116|FG001|Overall Study|Physician Decision|0|||
147169410|NCT02503501|530786115|FG000|Overall Study|Protocol Violation|0|||
147169411|NCT02503501|530786116|FG001|Overall Study|Protocol Violation|1|||
147169412|NCT02503501|530786115|FG000|Overall Study|Withdrawal by Subject|0|||
147169413|NCT02503501|530786116|FG001|Overall Study|Withdrawal by Subject|2|||
147169414|NCT01740401|530786117|FG000|Overall Study|Progression of disease|6|||
147169415|NCT01740401|530786117|FG000|Overall Study|Adverse Event|2|||
147169416|NCT01740401|530786117|FG000|Overall Study|Did not reach primary endpoint|2|||
147169417|NCT03878758|530786118|FG000|Overall Study|Withdrawal by Subject|1|||
147169418|NCT03878758|530786118|FG000|Overall Study|Protocol defined|2|||
147169419|NCT03878758|530786118|FG000|Overall Study|Improper consent documentation|1|||
147169420|NCT00765063|530786119|FG000|Overall Study|Lack of Efficacy|5|||
147169421|NCT00765063|530786119|FG000|Overall Study|Withdrawal by Subject|1|||
147169422|NCT00765063|530786119|FG000|Overall Study|Other|16|||
147169423|NCT00765063|530786119|FG000|Overall Study|Protocol Violation|6|||
147169424|NCT00765063|530786119|FG000|Overall Study|Adverse Event|4|||
147169425|NCT03614325|530786120|FG000|Overall Study|Withdrawal by Subject|0|||
147169426|NCT03614325|530786121|FG001|Overall Study|Withdrawal by Subject|2|||
147169427|NCT03614325|530786120|FG000|Overall Study|Surgery Cancelled|2|||
147169428|NCT03614325|530786121|FG001|Overall Study|Surgery Cancelled|1|||
147169429|NCT03614325|530786120|FG000|Overall Study|Lost to Follow-up|2|||
147169430|NCT03614325|530786121|FG001|Overall Study|Lost to Follow-up|1|||
147169431|NCT03614325|530786120|FG000|Overall Study|Surgery never scheduled|1|||
147169432|NCT03614325|530786121|FG001|Overall Study|Surgery never scheduled|0|||
147169433|NCT00321464|530786122|FG000|Overall Study|Death|169|||
147169434|NCT00321464|530786123|FG001|Overall Study|Death|174|||
147169435|NCT00321464|530786122|FG000|Overall Study|Disease progression|124|||
147169436|NCT00321464|530786123|FG001|Overall Study|Disease progression|124|||
147169437|NCT00321464|530786122|FG000|Overall Study|Withdrawal by Subject|117|||
147169438|NCT00321464|530786123|FG001|Overall Study|Withdrawal by Subject|118|||
147169439|NCT00321464|530786122|FG000|Overall Study|Participant request|57|||
147169440|NCT00321464|530786123|FG001|Overall Study|Participant request|61|||
147169441|NCT00321464|530786122|FG000|Overall Study|Adverse Event|43|||
147169442|NCT00321464|530786123|FG001|Overall Study|Adverse Event|28|||
147169443|NCT00321464|530786122|FG000|Overall Study|Physician Decision|15|||
147169444|NCT00321464|530786123|FG001|Overall Study|Physician Decision|14|||
147169445|NCT00321464|530786122|FG000|Overall Study|Noncompliance|4|||
147169446|NCT00321464|530786123|FG001|Overall Study|Noncompliance|10|||
147169447|NCT00321464|530786122|FG000|Overall Study|Lost to Follow-up|7|||
147169448|NCT00321464|530786123|FG001|Overall Study|Lost to Follow-up|8|||
147169449|NCT00321464|530786122|FG000|Overall Study|Protocol deviation|0|||
147169450|NCT00321464|530786123|FG001|Overall Study|Protocol deviation|2|||
147169451|NCT00321464|530786122|FG000|Overall Study|Ineligibility determined|2|||
147169452|NCT00321464|530786123|FG001|Overall Study|Ineligibility determined|1|||
147169453|NCT00321464|530786122|FG000|Overall Study|Other|21|||
147169454|NCT00321464|530786123|FG001|Overall Study|Other|18|||
147169455|NCT01673620|530786124|FG000|Overall Study|Adverse Event|1|||
147169456|NCT01673620|530786125|FG001|Overall Study|Adverse Event|0|||
147169457|NCT01206582|530786126|FG000|Overall Study|Withdrew prior to study|1|||
147169458|NCT01206582|530786127|FG001|Overall Study|Withdrew prior to study|0|||
147169459|NCT01206582|530786126|FG000|Overall Study|Discontinued intervention before week 8|1|||
147169460|NCT01206582|530786127|FG001|Overall Study|Discontinued intervention before week 8|2|||
147169461|NCT02522325|530786128|FG000|Overall Study|Adverse Event|0|||
147169462|NCT02522325|530786129|FG001|Overall Study|Adverse Event|1|||
147169463|NCT02081599|530786132|FG000|Period 1：Double-blind Period|Adverse Event|3|||
147169464|NCT02081599|530786133|FG001|Period 1：Double-blind Period|Adverse Event|0|||
147169465|NCT02081599|530786132|FG000|Period 1：Double-blind Period|Lack of Efficacy|2|||
147169466|NCT02081599|530786133|FG001|Period 1：Double-blind Period|Lack of Efficacy|1|||
147169467|NCT02081599|530786132|FG000|Period 1：Double-blind Period|Physician Decision|1|||
147169468|NCT02081599|530786133|FG001|Period 1：Double-blind Period|Physician Decision|0|||
147169469|NCT02081599|530786132|FG000|Period 1：Double-blind Period|Protocol Violation|0|||
147169470|NCT02081599|530786133|FG001|Period 1：Double-blind Period|Protocol Violation|1|||
147169471|NCT02081599|530786132|FG000|Period 1：Double-blind Period|Withdrawal by Subject|1|||
147169472|NCT02081599|530786133|FG001|Period 1：Double-blind Period|Withdrawal by Subject|0|||
147169473|NCT02081599|530786132|FG000|Period 1：Double-blind Period|stopping criteria|1|||
147169474|NCT02081599|530786133|FG001|Period 1：Double-blind Period|stopping criteria|0|||
147169475|NCT02081599|530786132|FG000|Period 2：Open-label Period|Adverse Event|1|||
147169476|NCT02081599|530786133|FG001|Period 2：Open-label Period|Adverse Event|0|||
147169477|NCT02081599|530786132|FG000|Period 2：Open-label Period|Lack of Efficacy|2|||
147169478|NCT02081599|530786133|FG001|Period 2：Open-label Period|Lack of Efficacy|4|||
147169479|NCT02081599|530786132|FG000|Period 2：Open-label Period|Physician Decision|1|||
147169480|NCT02081599|530786133|FG001|Period 2：Open-label Period|Physician Decision|0|||
147169481|NCT02081599|530786132|FG000|Period 2：Open-label Period|Withdrawal by Subject|2|||
147169482|NCT02081599|530786133|FG001|Period 2：Open-label Period|Withdrawal by Subject|0|||
147169483|NCT00306527|530786139|FG000|Overall Study|Lost to Follow-up|3|||
147169484|NCT00306527|530786140|FG001|Overall Study|Lost to Follow-up|4|||
147169485|NCT00306527|530786141|FG002|Overall Study|Lost to Follow-up|3|||
147169486|NCT00306527|530786142|FG003|Overall Study|Lost to Follow-up|0|||
147323656|NCT01770860|531349983|FG000|Overall Study|Withdrawal by Subject|4|||
147323657|NCT01770860|531349983|FG000|Overall Study|Lost to Follow-up|1|||
147169487|NCT00306527|530786139|FG000|Overall Study|Withdrawal by Subject|2|||
147169488|NCT00306527|530786140|FG001|Overall Study|Withdrawal by Subject|3|||
147169489|NCT00306527|530786141|FG002|Overall Study|Withdrawal by Subject|0|||
147169490|NCT00306527|530786142|FG003|Overall Study|Withdrawal by Subject|3|||
147169491|NCT00306527|530786139|FG000|Overall Study|Adverse Event|0|||
147169492|NCT00306527|530786140|FG001|Overall Study|Adverse Event|0|||
147169493|NCT00306527|530786141|FG002|Overall Study|Adverse Event|1|||
147169494|NCT00306527|530786142|FG003|Overall Study|Adverse Event|1|||
147169495|NCT00306527|530786139|FG000|Overall Study|Death|1|||
147169496|NCT00306527|530786140|FG001|Overall Study|Death|0|||
147169497|NCT00306527|530786141|FG002|Overall Study|Death|1|||
147323658|NCT01770860|531349983|FG000|Overall Study|Administrative decision made by the PI|1|||
147323659|NCT01528709|531349984|FG000|Overall Study|Death|2|||
147323660|NCT01528709|531349985|FG001|Overall Study|Death|0|||
147169498|NCT00306527|530786142|FG003|Overall Study|Death|2|||
147169499|NCT00785980|530786143|FG000|7 Day Washout Period|Protocol Violation|3|||
147169500|NCT00528801|530786144|FG000|Overall Study|Withdrawal by Subject|1|||
147169501|NCT00528801|530786145|FG001|Overall Study|Withdrawal by Subject|1|||
147169502|NCT00528801|530786144|FG000|Overall Study|Protocol Violation|11|||
147169503|NCT00528801|530786145|FG001|Overall Study|Protocol Violation|5|||
147169504|NCT00528801|530786144|FG000|Overall Study|Lost to Follow-up|15|||
147169505|NCT00528801|530786145|FG001|Overall Study|Lost to Follow-up|4|||
147169506|NCT00528801|530786144|FG000|Overall Study|Administrative Reasons|0|||
147169507|NCT00528801|530786145|FG001|Overall Study|Administrative Reasons|1|||
147169508|NCT02207491|530786146|FG000|Overall Study|Adverse Event|20|||
147169509|NCT02207491|530786147|FG001|Overall Study|Adverse Event|4|||
147169510|NCT02207491|530786146|FG000|Overall Study|Withdrawal by Subject|3|||
147169511|NCT02207491|530786147|FG001|Overall Study|Withdrawal by Subject|2|||
147169512|NCT02207491|530786146|FG000|Overall Study|Non-compliant|0|||
147169513|NCT02207491|530786147|FG001|Overall Study|Non-compliant|1|||
147169514|NCT02207491|530786146|FG000|Overall Study|Lost to Follow-up|0|||
147169515|NCT02207491|530786147|FG001|Overall Study|Lost to Follow-up|1|||
147169516|NCT02207491|530786146|FG000|Overall Study|Lack of Efficacy|3|||
147169517|NCT02207491|530786147|FG001|Overall Study|Lack of Efficacy|0|||
147169518|NCT02207491|530786146|FG000|Overall Study|Physician Decision|2|||
147169519|NCT02207491|530786147|FG001|Overall Study|Physician Decision|0|||
147169520|NCT02207491|530786146|FG000|Overall Study|Protocol Violation|3|||
147169521|NCT02207491|530786147|FG001|Overall Study|Protocol Violation|5|||
147169522|NCT00387725|530786148|FG000|Overall Study|Adverse Event|0|||
147169523|NCT00387725|530786149|FG001|Overall Study|Adverse Event|0|||
147169524|NCT00387725|530786150|FG002|Overall Study|Adverse Event|0|||
147169525|NCT00387725|530786151|FG003|Overall Study|Adverse Event|1|||
147169526|NCT00387725|530786148|FG000|Overall Study|Protocol Violation|0|||
147169527|NCT00387725|530786149|FG001|Overall Study|Protocol Violation|1|||
147169528|NCT00387725|530786150|FG002|Overall Study|Protocol Violation|0|||
147169529|NCT00387725|530786151|FG003|Overall Study|Protocol Violation|0|||
147169530|NCT00387725|530786148|FG000|Overall Study|Withdrawal by Subject|1|||
147169531|NCT00387725|530786149|FG001|Overall Study|Withdrawal by Subject|0|||
147169532|NCT00387725|530786150|FG002|Overall Study|Withdrawal by Subject|1|||
147169533|NCT00387725|530786151|FG003|Overall Study|Withdrawal by Subject|0|||
147169534|NCT00387725|530786148|FG000|Overall Study|Parent/legal guardian request|0|||
147169535|NCT00387725|530786149|FG001|Overall Study|Parent/legal guardian request|0|||
147169536|NCT00387725|530786150|FG002|Overall Study|Parent/legal guardian request|1|||
147169537|NCT00387725|530786151|FG003|Overall Study|Parent/legal guardian request|1|||
147169538|NCT02429791|530786153|FG000|Early Switch Phase (Up to Week 52)|Adverse Event|6|||
147169539|NCT02429791|530786154|FG001|Early Switch Phase (Up to Week 52)|Adverse Event|2|||
147169540|NCT02429791|530786153|FG000|Early Switch Phase (Up to Week 52)|Physician Decision|0|||
147169541|NCT02429791|530786154|FG001|Early Switch Phase (Up to Week 52)|Physician Decision|2|||
147169542|NCT02429791|530786153|FG000|Early Switch Phase (Up to Week 52)|Lack of Efficacy|2|||
147169543|NCT02429791|530786154|FG001|Early Switch Phase (Up to Week 52)|Lack of Efficacy|1|||
147169544|NCT02429791|530786153|FG000|Early Switch Phase (Up to Week 52)|Lost to Follow-up|1|||
147169545|NCT02429791|530786154|FG001|Early Switch Phase (Up to Week 52)|Lost to Follow-up|2|||
147169546|NCT02429791|530786153|FG000|Early Switch Phase (Up to Week 52)|Protocol Violation|1|||
147169547|NCT02429791|530786154|FG001|Early Switch Phase (Up to Week 52)|Protocol Violation|4|||
147169548|NCT02429791|530786153|FG000|Early Switch Phase (Up to Week 52)|Withdrawal by Subject|3|||
147169549|NCT02429791|530786154|FG001|Early Switch Phase (Up to Week 52)|Withdrawal by Subject|7|||
147169550|NCT02429791|530786153|FG000|Late Switch Phase (Week 52 to Week 148)|Adverse Event|11|||
147169551|NCT02429791|530786154|FG001|Late Switch Phase (Week 52 to Week 148)|Adverse Event|12|||
147169552|NCT02429791|530786153|FG000|Late Switch Phase (Week 52 to Week 148)|Physician Decision|0|||
147169553|NCT02429791|530786154|FG001|Late Switch Phase (Week 52 to Week 148)|Physician Decision|4|||
147169554|NCT02429791|530786153|FG000|Late Switch Phase (Week 52 to Week 148)|Lack of Efficacy|4|||
147169555|NCT02429791|530786154|FG001|Late Switch Phase (Week 52 to Week 148)|Lack of Efficacy|3|||
147169556|NCT02429791|530786153|FG000|Late Switch Phase (Week 52 to Week 148)|Lost to Follow-up|0|||
147169557|NCT02429791|530786154|FG001|Late Switch Phase (Week 52 to Week 148)|Lost to Follow-up|1|||
147169558|NCT02429791|530786153|FG000|Late Switch Phase (Week 52 to Week 148)|Protocol Violation|3|||
147169559|NCT02429791|530786154|FG001|Late Switch Phase (Week 52 to Week 148)|Protocol Violation|3|||
147169560|NCT02429791|530786153|FG000|Late Switch Phase (Week 52 to Week 148)|Withdrawal by Subject|7|||
147169561|NCT02429791|530786154|FG001|Late Switch Phase (Week 52 to Week 148)|Withdrawal by Subject|5|||
147244232|NCT00040664|531066955|FG001|Overall Study|Protocol Violation|1|||
147654720|NCT03498313|532559111|FG000|Experimental Period 1|Adverse Event|1|||
147654721|NCT03498313|532559112|FG001|Experimental Period 1|Adverse Event|0|||
147654722|NCT03498313|532559113|FG002|Experimental Period 1|Adverse Event|0|||
147654723|NCT03498313|532559114|FG003|Experimental Period 1|Adverse Event|1|||
147654724|NCT03498313|532559115|FG004|Experimental Period 1|Adverse Event|0|||
147169562|NCT02429791|530786153|FG000|Continuation Phase(Week 148 to Week 411)|Adverse Event|3|||
147169563|NCT02429791|530786154|FG001|Continuation Phase(Week 148 to Week 411)|Adverse Event|1|||
147169564|NCT02429791|530786153|FG000|Continuation Phase(Week 148 to Week 411)|Lack of Efficacy|1|||
147169565|NCT02429791|530786154|FG001|Continuation Phase(Week 148 to Week 411)|Lack of Efficacy|0|||
147169566|NCT02429791|530786153|FG000|Continuation Phase(Week 148 to Week 411)|Protocol Violation|1|||
147169567|NCT02429791|530786154|FG001|Continuation Phase(Week 148 to Week 411)|Protocol Violation|0|||
147169568|NCT02429791|530786153|FG000|Continuation Phase(Week 148 to Week 411)|Withdrawal by Subject|1|||
147169569|NCT02429791|530786154|FG001|Continuation Phase(Week 148 to Week 411)|Withdrawal by Subject|1|||
147590779|NCT02990806|532319040|FG001|Stage 3 (Safety Follow-up) (8 Weeks)|Initiated protocol-prohibited medication|0|||
147590780|NCT02990806|532319041|FG002|Stage 3 (Safety Follow-up) (8 Weeks)|Initiated protocol-prohibited medication|1|||
147169570|NCT02429791|530786153|FG000|Continuation Phase(Week 148 to Week 411)|Lost to Follow-up|1|||
147169571|NCT02429791|530786154|FG001|Continuation Phase(Week 148 to Week 411)|Lost to Follow-up|1|||
147169572|NCT02429791|530786153|FG000|Continuation Phase(Week 148 to Week 411)|Investigator discretion|0|||
147169573|NCT02429791|530786154|FG001|Continuation Phase(Week 148 to Week 411)|Investigator discretion|2|||
147169574|NCT04201093|530786155|FG000|Overall Study|Adverse Event|6|||
147169575|NCT04201093|530786156|FG001|Overall Study|Adverse Event|29|||
147169576|NCT04201093|530786157|FG002|Overall Study|Adverse Event|35|||
147169577|NCT04201093|530786155|FG000|Overall Study|Death|2|||
147169578|NCT04201093|530786156|FG001|Overall Study|Death|1|||
147169579|NCT04201093|530786157|FG002|Overall Study|Death|0|||
147169580|NCT04201093|530786155|FG000|Overall Study|Lack of Efficacy|5|||
147169581|NCT04201093|530786156|FG001|Overall Study|Lack of Efficacy|1|||
147169582|NCT04201093|530786157|FG002|Overall Study|Lack of Efficacy|2|||
147169583|NCT04201093|530786155|FG000|Overall Study|Lost to Follow-up|0|||
147169584|NCT04201093|530786156|FG001|Overall Study|Lost to Follow-up|0|||
147169585|NCT04201093|530786157|FG002|Overall Study|Lost to Follow-up|1|||
147169586|NCT04201093|530786155|FG000|Overall Study|Failure to Meet Continuation Criteria|0|||
147169587|NCT04201093|530786156|FG001|Overall Study|Failure to Meet Continuation Criteria|0|||
147169588|NCT04201093|530786157|FG002|Overall Study|Failure to Meet Continuation Criteria|1|||
147169589|NCT04201093|530786155|FG000|Overall Study|Treatment with Prohibited Concomitant Medications|0|||
147169590|NCT04201093|530786156|FG001|Overall Study|Treatment with Prohibited Concomitant Medications|0|||
147169591|NCT04201093|530786157|FG002|Overall Study|Treatment with Prohibited Concomitant Medications|1|||
147169592|NCT04201093|530786155|FG000|Overall Study|Non-Compliance with Study Schedule|0|||
147169593|NCT04201093|530786156|FG001|Overall Study|Non-Compliance with Study Schedule|0|||
147169594|NCT04201093|530786157|FG002|Overall Study|Non-Compliance with Study Schedule|1|||
147169595|NCT04201093|530786155|FG000|Overall Study|Physician Decision|1|||
147169596|NCT04201093|530786156|FG001|Overall Study|Physician Decision|0|||
147169597|NCT04201093|530786157|FG002|Overall Study|Physician Decision|0|||
147169598|NCT04201093|530786155|FG000|Overall Study|Protocol Deviation|1|||
147169599|NCT04201093|530786156|FG001|Overall Study|Protocol Deviation|0|||
147169600|NCT04201093|530786157|FG002|Overall Study|Protocol Deviation|0|||
147169601|NCT04201093|530786155|FG000|Overall Study|Site Terminated by Sponsor|5|||
147169602|NCT04201093|530786156|FG001|Overall Study|Site Terminated by Sponsor|3|||
147169603|NCT04201093|530786157|FG002|Overall Study|Site Terminated by Sponsor|1|||
147169604|NCT04201093|530786155|FG000|Overall Study|Withdrawal by Subject|7|||
147169605|NCT04201093|530786156|FG001|Overall Study|Withdrawal by Subject|8|||
147169606|NCT04201093|530786157|FG002|Overall Study|Withdrawal by Subject|15|||
147169607|NCT04201093|530786155|FG000|Overall Study|Other|0|||
147169608|NCT04201093|530786156|FG001|Overall Study|Other|1|||
147169609|NCT04201093|530786157|FG002|Overall Study|Other|2|||
147169610|NCT00007020|530786158|FG000|Overall Study|Death|16|||
147169611|NCT00007020|530786158|FG000|Overall Study|Lost to Follow-up|13|||
147169612|NCT00007020|530786158|FG000|Overall Study|Pt withdrawn (worsening cholestasis)|1|||
147169613|NCT00007020|530786158|FG000|Overall Study|Pt withdrawn (liver transplant)|4|||
147169614|NCT00007020|530786158|FG000|Overall Study|Pt cared for by outside physician|4|||
147169615|NCT00007020|530786158|FG000|Overall Study|No evidence of treatment|6|||
147169616|NCT00881504|530786159|FG000|Overall Study|Withdrawal by Subject|1|||
147169617|NCT01276223|530786160|FG000|Overall Study|Adverse Event|7|||
147169618|NCT01276223|530786161|FG001|Overall Study|Adverse Event|4|||
147169619|NCT01276223|530786162|FG002|Overall Study|Adverse Event|1|||
147169620|NCT01276223|530786160|FG000|Overall Study|Lost to Follow-up|0|||
147169621|NCT01276223|530786161|FG001|Overall Study|Lost to Follow-up|0|||
147169622|NCT01276223|530786162|FG002|Overall Study|Lost to Follow-up|1|||
147169623|NCT01276223|530786160|FG000|Overall Study|Other|0|||
147169624|NCT01276223|530786161|FG001|Overall Study|Other|0|||
147169625|NCT01276223|530786162|FG002|Overall Study|Other|1|||
147169626|NCT01276223|530786160|FG000|Overall Study|Pt Decision Unrelated to Adverse Event|3|||
147169627|NCT01276223|530786161|FG001|Overall Study|Pt Decision Unrelated to Adverse Event|0|||
147169628|NCT01276223|530786162|FG002|Overall Study|Pt Decision Unrelated to Adverse Event|0|||
147169629|NCT01276223|530786160|FG000|Overall Study|Protocol Violation|1|||
147590781|NCT02990806|532319042|FG003|Stage 3 (Safety Follow-up) (8 Weeks)|Initiated protocol-prohibited medication|0|||
147169630|NCT01276223|530786161|FG001|Overall Study|Protocol Violation|0|||
147169631|NCT01276223|530786162|FG002|Overall Study|Protocol Violation|0|||
147169632|NCT05011058|530786163|FG000|Overall Study|Sponsor Decision|2|||
147169633|NCT05011058|530786164|FG001|Overall Study|Sponsor Decision|0|||
147169634|NCT05011058|530786165|FG002|Overall Study|Sponsor Decision|14|||
147169635|NCT05011058|530786166|FG003|Overall Study|Sponsor Decision|0|||
147169636|NCT05011058|530786167|FG004|Overall Study|Sponsor Decision|0|||
147169637|NCT05011058|530786168|FG005|Overall Study|Sponsor Decision|1|||
147590782|NCT01010750|532319043|FG000|Second Intervention|Adverse Event|0|||
147169638|NCT05011058|530786169|FG006|Overall Study|Sponsor Decision|0|||
147169639|NCT05011058|530786170|FG007|Overall Study|Sponsor Decision|5|||
147169640|NCT02596230|530786171|FG000|Screening Period for Objective 2|Participants not participating in obj 2|3714|||
147169641|NCT02596230|530786172|FG001|Screening Period for Objective 2|Participants not participating in obj 2|228|||
147169642|NCT02596230|530786173|FG002|Screening Period for Objective 2|Participants not participating in obj 2|0|||
147169643|NCT02596230|530786174|FG003|Screening Period for Objective 2|Participants not participating in obj 2|846|||
147169644|NCT02596230|530786175|FG004|Screening Period for Objective 2|Participants not participating in obj 2|0|||
147169645|NCT02596230|530786171|FG000|Objective 2, One Year|Lost to Follow-up|0|||
147169646|NCT02596230|530786172|FG001|Objective 2, One Year|Lost to Follow-up|41|||
147169647|NCT02596230|530786173|FG002|Objective 2, One Year|Lost to Follow-up|41|||
147169648|NCT02596230|530786174|FG003|Objective 2, One Year|Lost to Follow-up|32|||
147169649|NCT02596230|530786175|FG004|Objective 2, One Year|Lost to Follow-up|46|||
147169650|NCT02596230|530786171|FG000|Objective 2, One Year|Withdrawal by Subject|0|||
147169651|NCT02596230|530786172|FG001|Objective 2, One Year|Withdrawal by Subject|11|||
147169652|NCT02596230|530786173|FG002|Objective 2, One Year|Withdrawal by Subject|14|||
147169653|NCT02596230|530786174|FG003|Objective 2, One Year|Withdrawal by Subject|5|||
147169654|NCT02596230|530786175|FG004|Objective 2, One Year|Withdrawal by Subject|2|||
147169655|NCT02596230|530786171|FG000|Objective 2, One Year|Adverse drug reaction|0|||
147169656|NCT02596230|530786172|FG001|Objective 2, One Year|Adverse drug reaction|1|||
147169657|NCT02596230|530786173|FG002|Objective 2, One Year|Adverse drug reaction|0|||
147169658|NCT02596230|530786174|FG003|Objective 2, One Year|Adverse drug reaction|0|||
147169659|NCT02596230|530786175|FG004|Objective 2, One Year|Adverse drug reaction|0|||
147169660|NCT02596230|530786171|FG000|Objective 2, One Year|Death|0|||
147169661|NCT02596230|530786172|FG001|Objective 2, One Year|Death|12|||
147169662|NCT02596230|530786173|FG002|Objective 2, One Year|Death|41|||
147169663|NCT02596230|530786174|FG003|Objective 2, One Year|Death|21|||
147169664|NCT02596230|530786175|FG004|Objective 2, One Year|Death|30|||
147169665|NCT02596230|530786171|FG000|Objective 2, One Year|Other|0|||
147169666|NCT02596230|530786172|FG001|Objective 2, One Year|Other|3|||
147169667|NCT02596230|530786173|FG002|Objective 2, One Year|Other|2|||
147169668|NCT02596230|530786174|FG003|Objective 2, One Year|Other|0|||
147169669|NCT02596230|530786175|FG004|Objective 2, One Year|Other|0|||
147169670|NCT01571232|530786176|FG000|Overall Study|Lost to Follow-up|0|||
147169671|NCT01571232|530786177|FG001|Overall Study|Lost to Follow-up|1|||
147169672|NCT01571232|530786176|FG000|Overall Study|Withdrawal by Subject|1|||
147169673|NCT01571232|530786177|FG001|Overall Study|Withdrawal by Subject|0|||
147169674|NCT02478164|530786178|FG000|Overall Study|Lack of Efficacy|13|||
147169675|NCT02478164|530786178|FG000|Overall Study|Adverse Event|1|||
147169676|NCT02478164|530786178|FG000|Overall Study|Withdrawal by Subject|1|||
147169677|NCT00802893|530786179|FG000|Overall Study|study terminated|3|||
147169678|NCT00320424|530786180|FG000|Overall Study|Adverse Event|3|||
147169679|NCT00320424|530786180|FG000|Overall Study|Other|3|||
147169680|NCT00231413|530786187|FG000|Overall Study|Non-serious AE|0|||
147169681|NCT00231413|530786188|FG001|Overall Study|Non-serious AE|0|||
147169682|NCT00231413|530786189|FG002|Overall Study|Non-serious AE|1|||
147169683|NCT00231413|530786190|FG003|Overall Study|Non-serious AE|0|||
147169684|NCT00231413|530786191|FG004|Overall Study|Non-serious AE|0|||
147169685|NCT00231413|530786192|FG005|Overall Study|Non-serious AE|0|||
147169686|NCT00231413|530786193|FG006|Overall Study|Non-serious AE|1|||
147169687|NCT00231413|530786187|FG000|Overall Study|Withdrawal by Subject|3|||
147169688|NCT00231413|530786188|FG001|Overall Study|Withdrawal by Subject|1|||
147169689|NCT00231413|530786189|FG002|Overall Study|Withdrawal by Subject|4|||
147169690|NCT00231413|530786190|FG003|Overall Study|Withdrawal by Subject|2|||
147169691|NCT00231413|530786191|FG004|Overall Study|Withdrawal by Subject|2|||
147169692|NCT00231413|530786192|FG005|Overall Study|Withdrawal by Subject|0|||
147169693|NCT00231413|530786193|FG006|Overall Study|Withdrawal by Subject|3|||
147169694|NCT00231413|530786187|FG000|Overall Study|Migrated/moved from study area|0|||
147169695|NCT00231413|530786188|FG001|Overall Study|Migrated/moved from study area|0|||
147169696|NCT00231413|530786189|FG002|Overall Study|Migrated/moved from study area|1|||
147169697|NCT00231413|530786190|FG003|Overall Study|Migrated/moved from study area|0|||
147169698|NCT00231413|530786191|FG004|Overall Study|Migrated/moved from study area|0|||
147169699|NCT00231413|530786192|FG005|Overall Study|Migrated/moved from study area|1|||
147654725|NCT03498313|532559116|FG005|Experimental Period 1|Adverse Event|0|||
147654726|NCT03498313|532559111|FG000|Experimental Period 1|Withdrawal by Subject|0|||
147654727|NCT03498313|532559112|FG001|Experimental Period 1|Withdrawal by Subject|1|||
147654728|NCT03498313|532559113|FG002|Experimental Period 1|Withdrawal by Subject|0|||
147654729|NCT03498313|532559114|FG003|Experimental Period 1|Withdrawal by Subject|0|||
147654730|NCT03498313|532559115|FG004|Experimental Period 1|Withdrawal by Subject|0|||
147169700|NCT00231413|530786193|FG006|Overall Study|Migrated/moved from study area|0|||
147169701|NCT00231413|530786187|FG000|Overall Study|Lost to Follow-up|4|||
147169702|NCT00231413|530786188|FG001|Overall Study|Lost to Follow-up|4|||
147169703|NCT00231413|530786189|FG002|Overall Study|Lost to Follow-up|1|||
147169704|NCT00231413|530786190|FG003|Overall Study|Lost to Follow-up|1|||
147169705|NCT00231413|530786191|FG004|Overall Study|Lost to Follow-up|1|||
147169706|NCT00231413|530786192|FG005|Overall Study|Lost to Follow-up|4|||
147169707|NCT00231413|530786193|FG006|Overall Study|Lost to Follow-up|0|||
147169708|NCT00231413|530786187|FG000|Overall Study|Pregnancy|1|||
147169709|NCT00231413|530786188|FG001|Overall Study|Pregnancy|0|||
147169710|NCT00231413|530786189|FG002|Overall Study|Pregnancy|0|||
147169711|NCT00231413|530786190|FG003|Overall Study|Pregnancy|0|||
147169712|NCT00231413|530786191|FG004|Overall Study|Pregnancy|0|||
147169713|NCT00231413|530786192|FG005|Overall Study|Pregnancy|0|||
147169714|NCT00231413|530786193|FG006|Overall Study|Pregnancy|0|||
147169715|NCT01659255|530786194|FG000|Overall Study|Adverse Event|0|||
147169716|NCT01659255|530786195|FG001|Overall Study|Adverse Event|0|||
147169717|NCT01659255|530786196|FG002|Overall Study|Adverse Event|0|||
147169718|NCT01659255|530786197|FG003|Overall Study|Adverse Event|0|||
147169719|NCT01659255|530786198|FG004|Overall Study|Adverse Event|0|||
147169720|NCT01659255|530786199|FG005|Overall Study|Adverse Event|1|||
147169721|NCT01659255|530786200|FG006|Overall Study|Adverse Event|1|||
147169722|NCT01659255|530786201|FG007|Overall Study|Adverse Event|0|||
147169723|NCT01659255|530786202|FG008|Overall Study|Adverse Event|0|||
147169724|NCT01659255|530786203|FG009|Overall Study|Adverse Event|1|||
147169725|NCT01659255|530786204|FG010|Overall Study|Adverse Event|0|||
147169726|NCT01659255|530786205|FG011|Overall Study|Adverse Event|1|||
147169727|NCT01659255|530786206|FG012|Overall Study|Adverse Event|0|||
147169728|NCT01659255|530786207|FG013|Overall Study|Adverse Event|2|||
147169729|NCT01659255|530786208|FG014|Overall Study|Adverse Event|0|||
147169730|NCT01659255|530786209|FG015|Overall Study|Adverse Event|1|||
147169731|NCT01659255|530786210|FG016|Overall Study|Adverse Event|0|||
147169732|NCT01659255|530786194|FG000|Overall Study|Death|0|||
147169733|NCT01659255|530786195|FG001|Overall Study|Death|1|||
147169734|NCT01659255|530786196|FG002|Overall Study|Death|0|||
147169735|NCT01659255|530786197|FG003|Overall Study|Death|0|||
147169736|NCT01659255|530786198|FG004|Overall Study|Death|0|||
147169737|NCT01659255|530786199|FG005|Overall Study|Death|0|||
147169738|NCT01659255|530786200|FG006|Overall Study|Death|0|||
147169739|NCT01659255|530786201|FG007|Overall Study|Death|1|||
147169740|NCT01659255|530786202|FG008|Overall Study|Death|1|||
147169741|NCT01659255|530786203|FG009|Overall Study|Death|0|||
147169742|NCT01659255|530786204|FG010|Overall Study|Death|0|||
147169743|NCT01659255|530786205|FG011|Overall Study|Death|0|||
147169744|NCT01659255|530786206|FG012|Overall Study|Death|1|||
147169745|NCT01659255|530786207|FG013|Overall Study|Death|1|||
147169746|NCT01659255|530786208|FG014|Overall Study|Death|2|||
147169747|NCT01659255|530786209|FG015|Overall Study|Death|1|||
147169748|NCT01659255|530786210|FG016|Overall Study|Death|0|||
147169749|NCT01659255|530786194|FG000|Overall Study|Progressive Disease|2|||
147169750|NCT01659255|530786195|FG001|Overall Study|Progressive Disease|0|||
147169751|NCT01659255|530786196|FG002|Overall Study|Progressive Disease|0|||
147169752|NCT01659255|530786197|FG003|Overall Study|Progressive Disease|0|||
147169753|NCT01659255|530786198|FG004|Overall Study|Progressive Disease|0|||
147169754|NCT01659255|530786199|FG005|Overall Study|Progressive Disease|0|||
147169755|NCT01659255|530786200|FG006|Overall Study|Progressive Disease|0|||
147169756|NCT01659255|530786201|FG007|Overall Study|Progressive Disease|1|||
147169757|NCT01659255|530786202|FG008|Overall Study|Progressive Disease|0|||
147169758|NCT01659255|530786203|FG009|Overall Study|Progressive Disease|2|||
147169759|NCT01659255|530786204|FG010|Overall Study|Progressive Disease|2|||
147169760|NCT01659255|530786205|FG011|Overall Study|Progressive Disease|3|||
147323661|NCT01528709|531349984|FG000|Overall Study|Withdrawal by Subject|10|||
147323662|NCT01528709|531349985|FG001|Overall Study|Withdrawal by Subject|15|||
147323663|NCT01528709|531349984|FG000|Overall Study|allergy|1|||
147323664|NCT01528709|531349985|FG001|Overall Study|allergy|0|||
147323665|NCT01237678|531349986|FG000|Phase I - IMGN901+Carboplatin+Etoposide|Adverse Event|5|||
147323666|NCT01237678|531349987|FG001|Phase I - IMGN901+Carboplatin+Etoposide|Adverse Event|0|||
147323667|NCT01237678|531349988|FG002|Phase I - IMGN901+Carboplatin+Etoposide|Adverse Event|0|||
147323668|NCT01237678|531349986|FG000|Phase I - IMGN901+Carboplatin+Etoposide|Lack of Efficacy|24|||
147323669|NCT01237678|531349987|FG001|Phase I - IMGN901+Carboplatin+Etoposide|Lack of Efficacy|0|||
147323670|NCT01237678|531349988|FG002|Phase I - IMGN901+Carboplatin+Etoposide|Lack of Efficacy|0|||
147323671|NCT01237678|531349986|FG000|Phase I - IMGN901+Carboplatin+Etoposide|Withdrawal by Subject|3|||
147323672|NCT01237678|531349987|FG001|Phase I - IMGN901+Carboplatin+Etoposide|Withdrawal by Subject|0|||
147323673|NCT01237678|531349988|FG002|Phase I - IMGN901+Carboplatin+Etoposide|Withdrawal by Subject|0|||
147169761|NCT01659255|530786206|FG012|Overall Study|Progressive Disease|5|||
147169762|NCT01659255|530786207|FG013|Overall Study|Progressive Disease|13|||
147169763|NCT01659255|530786208|FG014|Overall Study|Progressive Disease|6|||
147169764|NCT01659255|530786209|FG015|Overall Study|Progressive Disease|2|||
147169765|NCT01659255|530786210|FG016|Overall Study|Progressive Disease|3|||
147169766|NCT01659255|530786194|FG000|Overall Study|Withdrew Consent|0|||
147169767|NCT01659255|530786195|FG001|Overall Study|Withdrew Consent|0|||
147169768|NCT01659255|530786196|FG002|Overall Study|Withdrew Consent|0|||
147169769|NCT01659255|530786197|FG003|Overall Study|Withdrew Consent|0|||
147169770|NCT01659255|530786198|FG004|Overall Study|Withdrew Consent|0|||
147169771|NCT01659255|530786199|FG005|Overall Study|Withdrew Consent|0|||
147169772|NCT01659255|530786200|FG006|Overall Study|Withdrew Consent|0|||
147169773|NCT01659255|530786201|FG007|Overall Study|Withdrew Consent|0|||
147169774|NCT01659255|530786202|FG008|Overall Study|Withdrew Consent|0|||
147169775|NCT01659255|530786203|FG009|Overall Study|Withdrew Consent|0|||
147169776|NCT01659255|530786204|FG010|Overall Study|Withdrew Consent|1|||
147169777|NCT01659255|530786205|FG011|Overall Study|Withdrew Consent|0|||
147169778|NCT01659255|530786206|FG012|Overall Study|Withdrew Consent|0|||
147169779|NCT01659255|530786207|FG013|Overall Study|Withdrew Consent|1|||
147169780|NCT01659255|530786208|FG014|Overall Study|Withdrew Consent|0|||
147169781|NCT01659255|530786209|FG015|Overall Study|Withdrew Consent|0|||
147169782|NCT01659255|530786210|FG016|Overall Study|Withdrew Consent|0|||
147169783|NCT01659255|530786194|FG000|Overall Study|Investigator Decision|0|||
147169784|NCT01659255|530786195|FG001|Overall Study|Investigator Decision|0|||
147169785|NCT01659255|530786196|FG002|Overall Study|Investigator Decision|0|||
147169786|NCT01659255|530786197|FG003|Overall Study|Investigator Decision|0|||
147169787|NCT01659255|530786198|FG004|Overall Study|Investigator Decision|0|||
147169788|NCT01659255|530786199|FG005|Overall Study|Investigator Decision|0|||
147169789|NCT01659255|530786200|FG006|Overall Study|Investigator Decision|0|||
147169790|NCT01659255|530786201|FG007|Overall Study|Investigator Decision|0|||
147169791|NCT01659255|530786202|FG008|Overall Study|Investigator Decision|0|||
147169792|NCT01659255|530786203|FG009|Overall Study|Investigator Decision|0|||
147169793|NCT01659255|530786204|FG010|Overall Study|Investigator Decision|0|||
147169794|NCT01659255|530786205|FG011|Overall Study|Investigator Decision|0|||
147169795|NCT01659255|530786206|FG012|Overall Study|Investigator Decision|1|||
147169796|NCT01659255|530786207|FG013|Overall Study|Investigator Decision|1|||
147169797|NCT01659255|530786208|FG014|Overall Study|Investigator Decision|0|||
147169798|NCT01659255|530786209|FG015|Overall Study|Investigator Decision|0|||
147169799|NCT01659255|530786210|FG016|Overall Study|Investigator Decision|0|||
147169800|NCT01659255|530786194|FG000|Overall Study|Sponsor's Decision|0|||
147169801|NCT01659255|530786195|FG001|Overall Study|Sponsor's Decision|0|||
147169802|NCT01659255|530786196|FG002|Overall Study|Sponsor's Decision|0|||
147169803|NCT01659255|530786197|FG003|Overall Study|Sponsor's Decision|0|||
147169804|NCT01659255|530786198|FG004|Overall Study|Sponsor's Decision|0|||
147169805|NCT01659255|530786199|FG005|Overall Study|Sponsor's Decision|0|||
147169806|NCT01659255|530786200|FG006|Overall Study|Sponsor's Decision|1|||
147169807|NCT01659255|530786201|FG007|Overall Study|Sponsor's Decision|0|||
147169808|NCT01659255|530786202|FG008|Overall Study|Sponsor's Decision|0|||
147169809|NCT01659255|530786203|FG009|Overall Study|Sponsor's Decision|0|||
147169810|NCT01659255|530786204|FG010|Overall Study|Sponsor's Decision|0|||
147169811|NCT01659255|530786205|FG011|Overall Study|Sponsor's Decision|0|||
147169812|NCT01659255|530786206|FG012|Overall Study|Sponsor's Decision|0|||
147169813|NCT01659255|530786207|FG013|Overall Study|Sponsor's Decision|0|||
147169814|NCT01659255|530786208|FG014|Overall Study|Sponsor's Decision|0|||
147169815|NCT01659255|530786209|FG015|Overall Study|Sponsor's Decision|0|||
147169816|NCT01659255|530786210|FG016|Overall Study|Sponsor's Decision|0|||
147169817|NCT01659255|530786194|FG000|Overall Study|Completed Treatment Per Protocol at the Time|0|||
147169818|NCT01659255|530786195|FG001|Overall Study|Completed Treatment Per Protocol at the Time|0|||
147169819|NCT01659255|530786196|FG002|Overall Study|Completed Treatment Per Protocol at the Time|0|||
147169820|NCT01659255|530786197|FG003|Overall Study|Completed Treatment Per Protocol at the Time|0|||
147169821|NCT01659255|530786198|FG004|Overall Study|Completed Treatment Per Protocol at the Time|0|||
147169822|NCT01659255|530786199|FG005|Overall Study|Completed Treatment Per Protocol at the Time|0|||
147169823|NCT01659255|530786200|FG006|Overall Study|Completed Treatment Per Protocol at the Time|0|||
147169824|NCT01659255|530786201|FG007|Overall Study|Completed Treatment Per Protocol at the Time|0|||
147169825|NCT01659255|530786202|FG008|Overall Study|Completed Treatment Per Protocol at the Time|0|||
147169826|NCT01659255|530786203|FG009|Overall Study|Completed Treatment Per Protocol at the Time|0|||
147169827|NCT01659255|530786204|FG010|Overall Study|Completed Treatment Per Protocol at the Time|0|||
147169828|NCT01659255|530786205|FG011|Overall Study|Completed Treatment Per Protocol at the Time|0|||
147169829|NCT01659255|530786206|FG012|Overall Study|Completed Treatment Per Protocol at the Time|0|||
147169830|NCT01659255|530786207|FG013|Overall Study|Completed Treatment Per Protocol at the Time|0|||
147169831|NCT01659255|530786208|FG014|Overall Study|Completed Treatment Per Protocol at the Time|0|||
147169832|NCT01659255|530786209|FG015|Overall Study|Completed Treatment Per Protocol at the Time|1|||
147169833|NCT01659255|530786210|FG016|Overall Study|Completed Treatment Per Protocol at the Time|0|||
147169834|NCT01659255|530786194|FG000|Overall Study|Participant Went on to Have an Allograft|0|||
147169835|NCT01659255|530786195|FG001|Overall Study|Participant Went on to Have an Allograft|0|||
147169836|NCT01659255|530786196|FG002|Overall Study|Participant Went on to Have an Allograft|0|||
147169837|NCT01659255|530786197|FG003|Overall Study|Participant Went on to Have an Allograft|0|||
147169838|NCT01659255|530786198|FG004|Overall Study|Participant Went on to Have an Allograft|0|||
147169839|NCT01659255|530786199|FG005|Overall Study|Participant Went on to Have an Allograft|0|||
147169840|NCT01659255|530786200|FG006|Overall Study|Participant Went on to Have an Allograft|0|||
147169841|NCT01659255|530786201|FG007|Overall Study|Participant Went on to Have an Allograft|0|||
147169842|NCT01659255|530786202|FG008|Overall Study|Participant Went on to Have an Allograft|0|||
147169843|NCT01659255|530786203|FG009|Overall Study|Participant Went on to Have an Allograft|0|||
147169844|NCT01659255|530786204|FG010|Overall Study|Participant Went on to Have an Allograft|0|||
147169845|NCT01659255|530786205|FG011|Overall Study|Participant Went on to Have an Allograft|0|||
147169846|NCT01659255|530786206|FG012|Overall Study|Participant Went on to Have an Allograft|1|||
147169847|NCT01659255|530786207|FG013|Overall Study|Participant Went on to Have an Allograft|0|||
147447915|NCT04294901|531804019|FG001|Overall Study|Provider did not have intervention patients|98|||
147447916|NCT05038020|531804021|FG000|Overall Study|Early Termination|3|||
147447917|NCT05038020|531804022|FG001|Overall Study|Early Termination|0|||
147447918|NCT01394939|531805601|FG000|Overall Study|Adverse Event|1|||
147169848|NCT01659255|530786208|FG014|Overall Study|Participant Went on to Have an Allograft|0|||
147169849|NCT01659255|530786209|FG015|Overall Study|Participant Went on to Have an Allograft|0|||
147169850|NCT01659255|530786210|FG016|Overall Study|Participant Went on to Have an Allograft|0|||
147169851|NCT03316950|530786211|FG000|Initial Intervention (1 to 3 Months)|Withdrawal by Subject|1|||
147169852|NCT03316950|530786212|FG001|Initial Intervention (1 to 3 Months)|Withdrawal by Subject|2|||
147169853|NCT03316950|530786213|FG002|Initial Intervention (1 to 3 Months)|Withdrawal by Subject|3|||
147169854|NCT03316950|530786214|FG003|Initial Intervention (1 to 3 Months)|Withdrawal by Subject|0|||
147169855|NCT03316950|530786211|FG000|Initial Intervention (1 to 3 Months)|Physician Decision|2|||
147169856|NCT03316950|530786212|FG001|Initial Intervention (1 to 3 Months)|Physician Decision|0|||
147169857|NCT03316950|530786213|FG002|Initial Intervention (1 to 3 Months)|Physician Decision|1|||
147169858|NCT03316950|530786214|FG003|Initial Intervention (1 to 3 Months)|Physician Decision|0|||
147169859|NCT03316950|530786211|FG000|Initial Intervention (1 to 3 Months)|Lost to Follow-up|0|||
147169860|NCT03316950|530786212|FG001|Initial Intervention (1 to 3 Months)|Lost to Follow-up|2|||
147169861|NCT03316950|530786213|FG002|Initial Intervention (1 to 3 Months)|Lost to Follow-up|5|||
147169862|NCT03316950|530786214|FG003|Initial Intervention (1 to 3 Months)|Lost to Follow-up|0|||
147169863|NCT02809053|530786215|FG000|Overall Study|Death|0|||
147169864|NCT02809053|530786216|FG001|Overall Study|Death|1|||
147169865|NCT02809053|530786215|FG000|Overall Study|Lost to Follow-up|3|||
147244233|NCT00040664|531066956|FG002|Overall Study|Protocol Violation|0|||
147244234|NCT00040664|531066957|FG003|Overall Study|Protocol Violation|1|||
147654731|NCT03498313|532559116|FG005|Experimental Period 1|Withdrawal by Subject|0|||
147654732|NCT03498313|532559111|FG000|Washout Period 1|Anovulation|1|||
147654733|NCT03498313|532559112|FG001|Washout Period 1|Anovulation|0|||
147654734|NCT03498313|532559113|FG002|Washout Period 1|Anovulation|0|||
147654735|NCT03498313|532559114|FG003|Washout Period 1|Anovulation|0|||
147654736|NCT03498313|532559115|FG004|Washout Period 1|Anovulation|0|||
147654737|NCT03498313|532559116|FG005|Washout Period 1|Anovulation|0|||
147654738|NCT03498313|532559111|FG000|Washout Period 1|Withdrawal by Subject|0|||
147654739|NCT03498313|532559112|FG001|Washout Period 1|Withdrawal by Subject|3|||
147654740|NCT03498313|532559113|FG002|Washout Period 1|Withdrawal by Subject|0|||
147654741|NCT03498313|532559114|FG003|Washout Period 1|Withdrawal by Subject|1|||
147654742|NCT03498313|532559115|FG004|Washout Period 1|Withdrawal by Subject|0|||
147654743|NCT03498313|532559116|FG005|Washout Period 1|Withdrawal by Subject|1|||
147654744|NCT03498313|532559111|FG000|Experimental Period 2|Adverse Event|0|||
147654745|NCT03498313|532559112|FG001|Experimental Period 2|Adverse Event|0|||
147654746|NCT03498313|532559113|FG002|Experimental Period 2|Adverse Event|0|||
147654747|NCT03498313|532559114|FG003|Experimental Period 2|Adverse Event|0|||
147654748|NCT03498313|532559115|FG004|Experimental Period 2|Adverse Event|1|||
147654749|NCT03498313|532559116|FG005|Experimental Period 2|Adverse Event|2|||
147654750|NCT03498313|532559111|FG000|Washout Period 2|Physician Decision|1|||
147654751|NCT03498313|532559112|FG001|Washout Period 2|Physician Decision|0|||
147654752|NCT03498313|532559113|FG002|Washout Period 2|Physician Decision|0|||
147654753|NCT03498313|532559114|FG003|Washout Period 2|Physician Decision|1|||
147654754|NCT03498313|532559115|FG004|Washout Period 2|Physician Decision|0|||
147654755|NCT03498313|532559116|FG005|Washout Period 2|Physician Decision|1|||
147654756|NCT03498313|532559111|FG000|Washout Period 2|Withdrawal by Subject|3|||
147654757|NCT03498313|532559112|FG001|Washout Period 2|Withdrawal by Subject|2|||
147654758|NCT03498313|532559113|FG002|Washout Period 2|Withdrawal by Subject|0|||
147654759|NCT03498313|532559114|FG003|Washout Period 2|Withdrawal by Subject|0|||
147654760|NCT03498313|532559115|FG004|Washout Period 2|Withdrawal by Subject|2|||
147654761|NCT03498313|532559116|FG005|Washout Period 2|Withdrawal by Subject|0|||
147654762|NCT03498313|532559111|FG000|Washout Period 2|Anovulation|0|||
147654763|NCT03498313|532559112|FG001|Washout Period 2|Anovulation|0|||
147654764|NCT03498313|532559113|FG002|Washout Period 2|Anovulation|0|||
147244235|NCT00040664|531066954|FG000|Overall Study|Withdrawal by Subject|7|||
147244236|NCT00040664|531066955|FG001|Overall Study|Withdrawal by Subject|0|||
147447919|NCT01394939|531805602|FG001|Overall Study|Adverse Event|3|||
147654765|NCT03498313|532559114|FG003|Washout Period 2|Anovulation|0|||
147654766|NCT03498313|532559115|FG004|Washout Period 2|Anovulation|0|||
147654767|NCT03498313|532559116|FG005|Washout Period 2|Anovulation|1|||
147654768|NCT02630563|532559119|FG000|Overall Study|Administrative|1|||
147654769|NCT02239640|532559122|FG000|Overall Study|Withdrawal by Subject|3|||
147654770|NCT02239640|532559122|FG000|Overall Study|Lost to Follow-up|72|||
147654771|NCT02239640|532559122|FG000|Overall Study|Death|142|||
147654772|NCT00929994|532559123|FG000|Overall Study|Withdrawal by Subject|1|||
147169866|NCT02809053|530786216|FG001|Overall Study|Lost to Follow-up|1|||
147169867|NCT02809053|530786215|FG000|Overall Study|Withdrawal by Subject|2|||
147169868|NCT02809053|530786216|FG001|Overall Study|Withdrawal by Subject|3|||
147244237|NCT00040664|531066956|FG002|Overall Study|Withdrawal by Subject|3|||
147654773|NCT00929994|532559123|FG000|Overall Study|medical issue unrelated to intervention|4|||
147590783|NCT01010750|532319044|FG001|Second Intervention|Adverse Event|1|||
147590784|NCT01010750|532319045|FG002|Second Intervention|Adverse Event|0|||
147590785|NCT01010750|532319046|FG003|Second Intervention|Adverse Event|0|||
147590786|NCT01010750|532319047|FG004|Second Intervention|Adverse Event|0|||
147590787|NCT01010750|532319048|FG005|Second Intervention|Adverse Event|0|||
147590788|NCT01202877|532319056|FG000|Overall Study|Disease Progression|0|||
147590789|NCT01202877|532319057|FG001|Overall Study|Disease Progression|1|||
147590790|NCT01202877|532319058|FG002|Overall Study|Disease Progression|2|||
147590791|NCT01202877|532319056|FG000|Overall Study|Adverse Event|0|||
147590792|NCT01202877|532319057|FG001|Overall Study|Adverse Event|0|||
147590793|NCT01202877|532319058|FG002|Overall Study|Adverse Event|2|||
147590794|NCT01202877|532319056|FG000|Overall Study|Withdrawal by Subject|0|||
147590795|NCT01202877|532319057|FG001|Overall Study|Withdrawal by Subject|0|||
147590796|NCT01202877|532319058|FG002|Overall Study|Withdrawal by Subject|1|||
147590797|NCT01202877|532319056|FG000|Overall Study|Death|0|||
147590798|NCT01202877|532319057|FG001|Overall Study|Death|0|||
147590799|NCT01202877|532319058|FG002|Overall Study|Death|1|||
147590800|NCT00396331|532319059|FG000|Overall Study|Failed to mobilize - no transplant|8|||
147590801|NCT00396331|532319059|FG000|Overall Study|Did not go on to transplant|5|||
147590802|NCT00396331|532319059|FG000|Overall Study|Lost to Follow-up|3|||
147169869|NCT02809053|530786215|FG000|Overall Study|Disease Progression|2|||
147169870|NCT02809053|530786216|FG001|Overall Study|Disease Progression|1|||
147590803|NCT00396331|532319059|FG000|Overall Study|Death|16|||
147169871|NCT02565810|530786219|FG000|Overall Study|Withdrawal by Subject|1|||
147169872|NCT02049138|530786220|FG000|Overall Study|Adverse Event|46|||
147169873|NCT02049138|530786221|FG001|Overall Study|Adverse Event|25|||
147169874|NCT02049138|530786222|FG002|Overall Study|Adverse Event|1|||
147169875|NCT02049138|530786220|FG000|Overall Study|Withdrawal by Subject|57|||
147169876|NCT02049138|530786221|FG001|Overall Study|Withdrawal by Subject|21|||
147169877|NCT02049138|530786222|FG002|Overall Study|Withdrawal by Subject|5|||
147169878|NCT02049138|530786220|FG000|Overall Study|Lost to Follow-up|18|||
147169879|NCT02049138|530786221|FG001|Overall Study|Lost to Follow-up|5|||
147169880|NCT02049138|530786222|FG002|Overall Study|Lost to Follow-up|1|||
147169881|NCT02049138|530786220|FG000|Overall Study|Lack of Efficacy|10|||
147169882|NCT02049138|530786221|FG001|Overall Study|Lack of Efficacy|26|||
147590804|NCT00680186|532319060|FG000|Overall Study|Adverse Event|47|||
147169883|NCT02049138|530786222|FG002|Overall Study|Lack of Efficacy|1|||
147169884|NCT02049138|530786220|FG000|Overall Study|Non-Compliance|15|||
147169885|NCT02049138|530786221|FG001|Overall Study|Non-Compliance|6|||
147169886|NCT02049138|530786222|FG002|Overall Study|Non-Compliance|0|||
147169887|NCT02049138|530786220|FG000|Overall Study|Required Alternative / Prohibited Therapy|1|||
147169888|NCT02049138|530786221|FG001|Overall Study|Required Alternative / Prohibited Therapy|1|||
147169889|NCT02049138|530786222|FG002|Overall Study|Required Alternative / Prohibited Therapy|0|||
147169890|NCT02049138|530786220|FG000|Overall Study|Coronavirus Disease-2019 (COVID-19) Infection|1|||
147590805|NCT00680186|532319061|FG001|Overall Study|Adverse Event|44|||
147590806|NCT00680186|532319060|FG000|Overall Study|Protocol Violation|31|||
147590807|NCT00680186|532319061|FG001|Overall Study|Protocol Violation|26|||
147590808|NCT00680186|532319060|FG000|Overall Study|Lost to Follow-up|11|||
147590809|NCT00680186|532319061|FG001|Overall Study|Lost to Follow-up|6|||
147590810|NCT00680186|532319060|FG000|Overall Study|Withdrawal by Subject|32|||
147590811|NCT00680186|532319061|FG001|Overall Study|Withdrawal by Subject|39|||
147590812|NCT00680186|532319060|FG000|Overall Study|Other|4|||
147590813|NCT00680186|532319061|FG001|Overall Study|Other|1|||
147590814|NCT00873119|532319062|FG000|Overall Study|Patient request|4|||
147590815|NCT00873119|532319063|FG001|Overall Study|Patient request|2|||
147590816|NCT00873119|532319062|FG000|Overall Study|Adverse Event|8|||
147590817|NCT00873119|532319063|FG001|Overall Study|Adverse Event|0|||
147169891|NCT02049138|530786221|FG001|Overall Study|Coronavirus Disease-2019 (COVID-19) Infection|0|||
147169892|NCT02049138|530786222|FG002|Overall Study|Coronavirus Disease-2019 (COVID-19) Infection|0|||
147169893|NCT02049138|530786220|FG000|Overall Study|COVID-19 Logistical Restrictions|1|||
147169894|NCT02049138|530786221|FG001|Overall Study|COVID-19 Logistical Restrictions|0|||
147169895|NCT02049138|530786222|FG002|Overall Study|COVID-19 Logistical Restrictions|0|||
147590818|NCT00873119|532319062|FG000|Overall Study|Progressive disease|26|||
147590819|NCT00873119|532319063|FG001|Overall Study|Progressive disease|18|||
147590820|NCT00873119|532319062|FG000|Overall Study|Death|2|||
147590821|NCT00873119|532319063|FG001|Overall Study|Death|1|||
147169896|NCT02049138|530786220|FG000|Overall Study|Other|15|||
147169897|NCT02049138|530786221|FG001|Overall Study|Other|13|||
147590822|NCT00873119|532319062|FG000|Overall Study|Other|2|||
147590823|NCT00873119|532319063|FG001|Overall Study|Other|5|||
147590824|NCT00873119|532319062|FG000|Overall Study|Not treated|2|||
147590825|NCT00873119|532319063|FG001|Overall Study|Not treated|0|||
147590826|NCT03648879|532319064|FG000|Overall Study|Subject determined to have Cadherin-1 (CDH1) variant of uncertain significance.|1|||
147590827|NCT00466726|532319065|FG000|Overall Study|Not evaluable for response|14|||
147590828|NCT04403763|532319066|FG000|Stage 1|Participant did not dose due to Sponsor decision|1|||
147590829|NCT04403763|532319067|FG001|Stage 1|Participant did not dose due to Sponsor decision|1|||
147590830|NCT04403763|532319068|FG002|Stage 1|Participant did not dose due to Sponsor decision|0|||
147590831|NCT04403763|532319069|FG003|Stage 1|Participant did not dose due to Sponsor decision|0|||
147169898|NCT02049138|530786222|FG002|Overall Study|Other|0|||
147169899|NCT02049138|530786220|FG000|Overall Study|Missing|0|||
147169900|NCT02049138|530786221|FG001|Overall Study|Missing|1|||
147169901|NCT02049138|530786222|FG002|Overall Study|Missing|0|||
147169902|NCT00491608|530786223|FG000|Overall Study|Death|2|||
147169903|NCT00491608|530786223|FG000|Overall Study|Withdrawal by Subject|1|||
147169904|NCT00257660|530786224|FG000|Overall Study|Lack of Efficacy|5|||
147169905|NCT00257660|530786225|FG001|Overall Study|Lack of Efficacy|23|||
147169906|NCT00257660|530786224|FG000|Overall Study|Withdrawal by Subject|2|||
147169907|NCT00257660|530786225|FG001|Overall Study|Withdrawal by Subject|0|||
147169908|NCT00257660|530786224|FG000|Overall Study|Lost to Follow-up|1|||
147169909|NCT00257660|530786225|FG001|Overall Study|Lost to Follow-up|0|||
147169910|NCT00257660|530786224|FG000|Overall Study|PI & Subject Schedule Conflicts|1|||
147169911|NCT00257660|530786225|FG001|Overall Study|PI & Subject Schedule Conflicts|0|||
147169912|NCT00257660|530786224|FG000|Overall Study|No longer wanted to do blood draws|1|||
147169913|NCT00257660|530786225|FG001|Overall Study|No longer wanted to do blood draws|0|||
147169914|NCT00413374|530786230|FG000|Overall Study|Ineligible due to screening criteria.|3|||
147169915|NCT00413374|530786231|FG001|Overall Study|Ineligible due to screening criteria.|0|||
147169916|NCT00413374|530786230|FG000|Overall Study|Adverse Event|1|||
147169917|NCT00413374|530786231|FG001|Overall Study|Adverse Event|0|||
147169918|NCT00413374|530786230|FG000|Overall Study|Lost to Follow-up|1|||
147169919|NCT00413374|530786231|FG001|Overall Study|Lost to Follow-up|0|||
147169920|NCT00413374|530786230|FG000|Overall Study|Surgery|1|||
147169921|NCT00413374|530786231|FG001|Overall Study|Surgery|0|||
147169922|NCT00552760|530786232|FG000|Overall Study|Adverse Event|3|||
147169923|NCT00552760|530786233|FG001|Overall Study|Adverse Event|5|||
147169924|NCT00552760|530786232|FG000|Overall Study|Relapsed- Depressed Event|10|||
147169925|NCT00552760|530786233|FG001|Overall Study|Relapsed- Depressed Event|16|||
147169926|NCT00552760|530786232|FG000|Overall Study|Relapse- Manic Event|3|||
147169927|NCT00552760|530786233|FG001|Overall Study|Relapse- Manic Event|3|||
147169928|NCT00552760|530786232|FG000|Overall Study|Relapsed- Mixed Event|3|||
147169929|NCT00552760|530786233|FG001|Overall Study|Relapsed- Mixed Event|5|||
147169930|NCT00552760|530786232|FG000|Overall Study|Protocol Violation|0|||
147169931|NCT00552760|530786233|FG001|Overall Study|Protocol Violation|1|||
147169932|NCT00552760|530786232|FG000|Overall Study|Lost to Follow-up|1|||
147169933|NCT00552760|530786233|FG001|Overall Study|Lost to Follow-up|1|||
147169934|NCT00552760|530786232|FG000|Overall Study|Non-compliance|1|||
147169935|NCT00552760|530786233|FG001|Overall Study|Non-compliance|1|||
147169936|NCT00552760|530786232|FG000|Overall Study|Medical Condition|1|||
147169937|NCT00552760|530786233|FG001|Overall Study|Medical Condition|1|||
147169938|NCT00552760|530786232|FG000|Overall Study|Withdrawal by Subject|3|||
147169939|NCT00552760|530786233|FG001|Overall Study|Withdrawal by Subject|0|||
147169940|NCT00552760|530786232|FG000|Overall Study|Medication Change|1|||
147169941|NCT00552760|530786233|FG001|Overall Study|Medication Change|0|||
147169942|NCT03022981|530786234|FG000|Overall Study|Adverse Event|0|||
147169943|NCT03022981|530786235|FG001|Overall Study|Adverse Event|1|||
147169944|NCT03022981|530786236|FG002|Overall Study|Adverse Event|0|||
147169945|NCT03022981|530786234|FG000|Overall Study|Investigator's Discretion|0|||
147169946|NCT03022981|530786235|FG001|Overall Study|Investigator's Discretion|1|||
147169947|NCT03022981|530786236|FG002|Overall Study|Investigator's Discretion|2|||
147244238|NCT00040664|531066957|FG003|Overall Study|Withdrawal by Subject|4|||
147244239|NCT00040664|531066954|FG000|Overall Study|Pregnancy|3|||
147244240|NCT00040664|531066955|FG001|Overall Study|Pregnancy|0|||
147244241|NCT00040664|531066956|FG002|Overall Study|Pregnancy|0|||
147654774|NCT00929994|532559123|FG000|Overall Study|employment|1|||
147654775|NCT02061813|532559126|FG000|Overall Study|Withdrawal by Subject|1|||
147654776|NCT02061813|532559126|FG000|Overall Study|Protocol Violation|2|||
147654777|NCT01705080|532559127|FG000|Overall Study|Missed visit|10|||
147654778|NCT01705080|532559128|FG001|Overall Study|Missed visit|4|||
147654779|NCT01705080|532559129|FG002|Overall Study|Missed visit|1|||
147654780|NCT01705080|532559127|FG000|Overall Study|Death|4|||
147169948|NCT03022981|530786234|FG000|Overall Study|Lost to Follow-up|6|||
147169949|NCT03022981|530786235|FG001|Overall Study|Lost to Follow-up|2|||
147244242|NCT00040664|531066957|FG003|Overall Study|Pregnancy|3|||
147244243|NCT00040664|531066954|FG000|Overall Study|Medication adherence/compliance problems|8|||
147654781|NCT01705080|532559128|FG001|Overall Study|Death|4|||
147169950|NCT03022981|530786236|FG002|Overall Study|Lost to Follow-up|1|||
147169951|NCT03022981|530786234|FG000|Overall Study|Non-Compliance With Study Drug|0|||
147169952|NCT03022981|530786235|FG001|Overall Study|Non-Compliance With Study Drug|0|||
147169953|NCT03022981|530786236|FG002|Overall Study|Non-Compliance With Study Drug|2|||
147169954|NCT03022981|530786234|FG000|Overall Study|Withdrew Assent By Parent/Guardian|0|||
147169955|NCT03022981|530786235|FG001|Overall Study|Withdrew Assent By Parent/Guardian|0|||
147169956|NCT03022981|530786236|FG002|Overall Study|Withdrew Assent By Parent/Guardian|1|||
147169957|NCT03615066|530786237|FG000|Main Study|Withdrew Consent|0|||
147169958|NCT03615066|530786238|FG001|Main Study|Withdrew Consent|1|||
147169959|NCT03615066|530786239|FG002|Main Study|Withdrew Consent|1|||
147169960|NCT03615066|530786237|FG000|Main Study|Lost to Follow-up|0|||
147244244|NCT00040664|531066955|FG001|Overall Study|Medication adherence/compliance problems|2|||
147654782|NCT01705080|532559129|FG002|Overall Study|Death|6|||
147447920|NCT01394939|531805603|FG002|Overall Study|Adverse Event|0|||
147447921|NCT01394939|531805604|FG003|Overall Study|Adverse Event|2|||
147447922|NCT01394939|531805601|FG000|Overall Study|Death|0|||
147447923|NCT01394939|531805602|FG001|Overall Study|Death|2|||
147447924|NCT01394939|531805603|FG002|Overall Study|Death|0|||
147447925|NCT01394939|531805604|FG003|Overall Study|Death|0|||
147447926|NCT01394939|531805601|FG000|Overall Study|Physician Decision|0|||
147447927|NCT01394939|531805602|FG001|Overall Study|Physician Decision|1|||
147447928|NCT01394939|531805603|FG002|Overall Study|Physician Decision|0|||
147447929|NCT01394939|531805604|FG003|Overall Study|Physician Decision|0|||
147447930|NCT01394939|531805601|FG000|Overall Study|Withdrawal by Subject|0|||
147447931|NCT01394939|531805602|FG001|Overall Study|Withdrawal by Subject|2|||
147447932|NCT01394939|531805603|FG002|Overall Study|Withdrawal by Subject|0|||
147447933|NCT01394939|531805604|FG003|Overall Study|Withdrawal by Subject|2|||
147447934|NCT01394939|531805601|FG000|Overall Study|Others|0|||
147447935|NCT01394939|531805602|FG001|Overall Study|Others|2|||
147447936|NCT01394939|531805603|FG002|Overall Study|Others|0|||
147447937|NCT01394939|531805604|FG003|Overall Study|Others|3|||
147447938|NCT02831673|531805605|FG000|Double-blind (Day 1 to Week 96)|Adverse Event|10|||
147447939|NCT02831673|531805606|FG001|Double-blind (Day 1 to Week 96)|Adverse Event|7|||
147447940|NCT02831673|531805607|FG002|Double-blind (Day 1 to Week 96)|Adverse Event|0|||
147447941|NCT02831673|531805608|FG003|Double-blind (Day 1 to Week 96)|Adverse Event|0|||
147447942|NCT02831673|531805609|FG004|Double-blind (Day 1 to Week 96)|Adverse Event|0|||
147447943|NCT02831673|531805605|FG000|Double-blind (Day 1 to Week 96)|Lack of Efficacy|4|||
147169961|NCT03615066|530786238|FG001|Main Study|Lost to Follow-up|0|||
147169962|NCT03615066|530786239|FG002|Main Study|Lost to Follow-up|1|||
147169963|NCT03615066|530786237|FG000|Treatment-free Follow-up (TFFU) Phase|Adverse Event|1|||
147447944|NCT02831673|531805606|FG001|Double-blind (Day 1 to Week 96)|Lack of Efficacy|2|||
147447945|NCT02831673|531805607|FG002|Double-blind (Day 1 to Week 96)|Lack of Efficacy|0|||
147447946|NCT02831673|531805608|FG003|Double-blind (Day 1 to Week 96)|Lack of Efficacy|0|||
147447947|NCT02831673|531805609|FG004|Double-blind (Day 1 to Week 96)|Lack of Efficacy|0|||
147169964|NCT03615066|530786238|FG001|Treatment-free Follow-up (TFFU) Phase|Adverse Event|0|||
147169965|NCT03615066|530786239|FG002|Treatment-free Follow-up (TFFU) Phase|Adverse Event|0|||
147169966|NCT03615066|530786237|FG000|Treatment-free Follow-up (TFFU) Phase|Protocol Violation|1|||
147169967|NCT03615066|530786238|FG001|Treatment-free Follow-up (TFFU) Phase|Protocol Violation|0|||
147169968|NCT03615066|530786239|FG002|Treatment-free Follow-up (TFFU) Phase|Protocol Violation|0|||
147169969|NCT03615066|530786237|FG000|Treatment-free Follow-up (TFFU) Phase|Withdrew Consent|0|||
147169970|NCT03615066|530786238|FG001|Treatment-free Follow-up (TFFU) Phase|Withdrew Consent|1|||
147169971|NCT03615066|530786239|FG002|Treatment-free Follow-up (TFFU) Phase|Withdrew Consent|0|||
147169972|NCT00924404|530786240|FG000|Overall Study|Lost to Follow-up|6|||
147169973|NCT00924404|530786241|FG001|Overall Study|Lost to Follow-up|4|||
147169974|NCT02437084|530786242|FG000|Overall Study|Withdrawal by Subject|2|||
147169975|NCT02437084|530786242|FG000|Overall Study|Physician Decision|1|||
147169976|NCT01571453|530786243|FG000|Overall Study|Adverse Event|14|||
147169977|NCT01571453|530786244|FG001|Overall Study|Adverse Event|32|||
147169978|NCT01571453|530786243|FG000|Overall Study|Lack of Efficacy|8|||
147169979|NCT01571453|530786244|FG001|Overall Study|Lack of Efficacy|3|||
147169980|NCT01571453|530786243|FG000|Overall Study|Non-compliance|2|||
147169981|NCT01571453|530786244|FG001|Overall Study|Non-compliance|4|||
147169982|NCT01571453|530786243|FG000|Overall Study|Protocol Violation|1|||
147169983|NCT01571453|530786244|FG001|Overall Study|Protocol Violation|5|||
147169984|NCT01571453|530786243|FG000|Overall Study|Withdrawal of consent|5|||
147169985|NCT01571453|530786244|FG001|Overall Study|Withdrawal of consent|13|||
147169986|NCT01571453|530786243|FG000|Overall Study|Lost to Follow-up|4|||
147169987|NCT01571453|530786244|FG001|Overall Study|Lost to Follow-up|2|||
147169988|NCT01571453|530786243|FG000|Overall Study|Administrative or other reason(s)|4|||
147323674|NCT01237678|531349986|FG000|Phase I - IMGN901+Carboplatin+Etoposide|Incorrect Original Diagnosis|1|||
147447948|NCT02831673|531805605|FG000|Double-blind (Day 1 to Week 96)|Protocol Deviation|6|||
147447949|NCT02831673|531805606|FG001|Double-blind (Day 1 to Week 96)|Protocol Deviation|6|||
147447950|NCT02831673|531805607|FG002|Double-blind (Day 1 to Week 96)|Protocol Deviation|0|||
147447951|NCT02831673|531805608|FG003|Double-blind (Day 1 to Week 96)|Protocol Deviation|0|||
147447952|NCT02831673|531805609|FG004|Double-blind (Day 1 to Week 96)|Protocol Deviation|0|||
147447953|NCT02831673|531805605|FG000|Double-blind (Day 1 to Week 96)|Protocol Withdrawal Criterion Met|2|||
147447954|NCT02831673|531805606|FG001|Double-blind (Day 1 to Week 96)|Protocol Withdrawal Criterion Met|6|||
147447955|NCT02831673|531805607|FG002|Double-blind (Day 1 to Week 96)|Protocol Withdrawal Criterion Met|0|||
147447956|NCT02831673|531805608|FG003|Double-blind (Day 1 to Week 96)|Protocol Withdrawal Criterion Met|0|||
147169989|NCT01571453|530786244|FG001|Overall Study|Administrative or other reason(s)|3|||
147169990|NCT00129961|530786245|FG000|Overall Study|Adverse Event|1|||
147169991|NCT00129961|530786246|FG001|Overall Study|Adverse Event|0|||
147169992|NCT00129961|530786245|FG000|Overall Study|Death|1|||
147169993|NCT00129961|530786246|FG001|Overall Study|Death|1|||
147169994|NCT00129961|530786245|FG000|Overall Study|Withdrawal by Sponsor|14|||
147169995|NCT00129961|530786246|FG001|Overall Study|Withdrawal by Sponsor|20|||
147169996|NCT00129961|530786245|FG000|Overall Study|Physician Decision|1|||
147447957|NCT02831673|531805609|FG004|Double-blind (Day 1 to Week 96)|Protocol Withdrawal Criterion Met|0|||
147447958|NCT02831673|531805605|FG000|Double-blind (Day 1 to Week 96)|Lost to Follow-up|13|||
147447959|NCT02831673|531805606|FG001|Double-blind (Day 1 to Week 96)|Lost to Follow-up|7|||
147447960|NCT02831673|531805607|FG002|Double-blind (Day 1 to Week 96)|Lost to Follow-up|0|||
147590832|NCT04403763|532319070|FG004|Stage 1|Participant did not dose due to Sponsor decision|0|||
147590833|NCT04403763|532319071|FG005|Stage 1|Participant did not dose due to Sponsor decision|0|||
147590834|NCT04403763|532319072|FG006|Stage 1|Participant did not dose due to Sponsor decision|0|||
147590835|NCT04403763|532319066|FG000|Stage 1|Early termination due to PK tube failure|0|||
147590836|NCT04403763|532319067|FG001|Stage 1|Early termination due to PK tube failure|0|||
147590837|NCT04403763|532319068|FG002|Stage 1|Early termination due to PK tube failure|1|||
147590838|NCT04403763|532319069|FG003|Stage 1|Early termination due to PK tube failure|0|||
147590839|NCT04403763|532319070|FG004|Stage 1|Early termination due to PK tube failure|0|||
147590840|NCT04403763|532319071|FG005|Stage 1|Early termination due to PK tube failure|0|||
147169997|NCT00129961|530786246|FG001|Overall Study|Physician Decision|0|||
147169998|NCT00129961|530786245|FG000|Overall Study|Withdrawal by Subject|2|||
147169999|NCT00129961|530786246|FG001|Overall Study|Withdrawal by Subject|1|||
147170000|NCT00129961|530786245|FG000|Overall Study|Missing Record|0|||
147170001|NCT00129961|530786246|FG001|Overall Study|Missing Record|1|||
147170002|NCT01985360|530786247|FG000|Overall Study|Withdrawal by Subject|4|||
147170003|NCT01985360|530786248|FG001|Overall Study|Withdrawal by Subject|0|||
147170004|NCT01985360|530786247|FG000|Overall Study|Lost to Follow-up|5|||
147170005|NCT01985360|530786248|FG001|Overall Study|Lost to Follow-up|3|||
147170006|NCT03691779|530786253|FG000|Part B (24 Weeks)|Adverse Event|0|||
147170007|NCT03691779|530786254|FG001|Part B (24 Weeks)|Adverse Event|1|||
147170008|NCT03691779|530786253|FG000|Part B (24 Weeks)|Withdrawal of consent (not due to AE)|0|||
147170009|NCT03691779|530786254|FG001|Part B (24 Weeks)|Withdrawal of consent (not due to AE)|1|||
147170010|NCT03869333|530786259|FG000|Overall Study|Lost to Follow-up|1|||
147170011|NCT03869333|530786260|FG001|Overall Study|Lost to Follow-up|0|||
147170012|NCT03869333|530786261|FG002|Overall Study|Lost to Follow-up|0|||
147170013|NCT03869333|530786262|FG003|Overall Study|Lost to Follow-up|0|||
147170014|NCT03869333|530786259|FG000|Overall Study|Pregnancy|1|||
147170015|NCT03869333|530786260|FG001|Overall Study|Pregnancy|0|||
147170016|NCT03869333|530786261|FG002|Overall Study|Pregnancy|0|||
147170017|NCT03869333|530786262|FG003|Overall Study|Pregnancy|0|||
147170018|NCT03869333|530786259|FG000|Overall Study|Physician Decision|0|||
147170019|NCT03869333|530786260|FG001|Overall Study|Physician Decision|1|||
147170020|NCT03869333|530786261|FG002|Overall Study|Physician Decision|0|||
147170021|NCT03869333|530786262|FG003|Overall Study|Physician Decision|0|||
147170022|NCT01459913|530786263|FG000|Overall Study|Adverse Event|0|||
147170023|NCT01459913|530786264|FG001|Overall Study|Adverse Event|0|||
147170024|NCT01459913|530786265|FG002|Overall Study|Adverse Event|0|||
147170025|NCT01459913|530786266|FG003|Overall Study|Adverse Event|3|||
147170026|NCT01459913|530786263|FG000|Overall Study|Withdrawal by Subject|4|||
147170027|NCT01459913|530786264|FG001|Overall Study|Withdrawal by Subject|0|||
147170028|NCT01459913|530786265|FG002|Overall Study|Withdrawal by Subject|0|||
147170029|NCT01459913|530786266|FG003|Overall Study|Withdrawal by Subject|5|||
147170030|NCT01459913|530786263|FG000|Overall Study|Lost to Follow-up|7|||
147170031|NCT01459913|530786264|FG001|Overall Study|Lost to Follow-up|4|||
147170032|NCT01459913|530786265|FG002|Overall Study|Lost to Follow-up|1|||
147170033|NCT01459913|530786266|FG003|Overall Study|Lost to Follow-up|8|||
147170034|NCT01459913|530786263|FG000|Overall Study|Death|0|||
147170035|NCT01459913|530786264|FG001|Overall Study|Death|0|||
147170036|NCT01459913|530786265|FG002|Overall Study|Death|0|||
147170037|NCT01459913|530786266|FG003|Overall Study|Death|1|||
147170038|NCT01459913|530786263|FG000|Overall Study|Non- Compliance|0|||
147170039|NCT01459913|530786264|FG001|Overall Study|Non- Compliance|0|||
147170040|NCT01459913|530786265|FG002|Overall Study|Non- Compliance|0|||
147170041|NCT01459913|530786266|FG003|Overall Study|Non- Compliance|3|||
147590841|NCT04403763|532319072|FG006|Stage 1|Early termination due to PK tube failure|0|||
147590842|NCT04403763|532319066|FG000|Stage 2A|Adverse Event|0|||
147170042|NCT01459913|530786263|FG000|Overall Study|Physician Decision|0|||
147170043|NCT01459913|530786264|FG001|Overall Study|Physician Decision|1|||
147170044|NCT01459913|530786265|FG002|Overall Study|Physician Decision|0|||
147170045|NCT01459913|530786266|FG003|Overall Study|Physician Decision|0|||
147170046|NCT01459913|530786263|FG000|Overall Study|Study Terminated by Sponsor|30|||
147170047|NCT01459913|530786264|FG001|Overall Study|Study Terminated by Sponsor|15|||
147170048|NCT01459913|530786265|FG002|Overall Study|Study Terminated by Sponsor|9|||
147170049|NCT01459913|530786266|FG003|Overall Study|Study Terminated by Sponsor|11|||
147170050|NCT01459913|530786263|FG000|Overall Study|Other|0|||
147170051|NCT01459913|530786264|FG001|Overall Study|Other|0|||
147590843|NCT04403763|532319067|FG001|Stage 2A|Adverse Event|0|||
147170052|NCT01459913|530786265|FG002|Overall Study|Other|3|||
147170053|NCT01459913|530786266|FG003|Overall Study|Other|1|||
147170054|NCT01459913|530786263|FG000|Overall Study|Did Not Meet Inclusion Criteria|0|||
147170055|NCT01459913|530786264|FG001|Overall Study|Did Not Meet Inclusion Criteria|0|||
147170056|NCT01459913|530786265|FG002|Overall Study|Did Not Meet Inclusion Criteria|0|||
147170057|NCT01459913|530786266|FG003|Overall Study|Did Not Meet Inclusion Criteria|1|||
147170058|NCT01064687|530786269|FG000|Overall Study|Adverse Event|9|||
147170059|NCT01064687|530786270|FG001|Overall Study|Adverse Event|4|||
147170060|NCT01064687|530786271|FG002|Overall Study|Adverse Event|10|||
147170061|NCT01064687|530786272|FG003|Overall Study|Adverse Event|3|||
147170062|NCT01064687|530786269|FG000|Overall Study|Death|1|||
147170063|NCT01064687|530786270|FG001|Overall Study|Death|1|||
147170064|NCT01064687|530786271|FG002|Overall Study|Death|0|||
147170065|NCT01064687|530786272|FG003|Overall Study|Death|0|||
147170066|NCT01064687|530786269|FG000|Overall Study|Entry Criteria Not Met|3|||
147170067|NCT01064687|530786270|FG001|Overall Study|Entry Criteria Not Met|0|||
147170068|NCT01064687|530786271|FG002|Overall Study|Entry Criteria Not Met|0|||
147170069|NCT01064687|530786272|FG003|Overall Study|Entry Criteria Not Met|0|||
147170070|NCT01064687|530786269|FG000|Overall Study|Lack of Efficacy|1|||
147170071|NCT01064687|530786270|FG001|Overall Study|Lack of Efficacy|0|||
147170072|NCT01064687|530786271|FG002|Overall Study|Lack of Efficacy|2|||
147170073|NCT01064687|530786272|FG003|Overall Study|Lack of Efficacy|3|||
147170074|NCT01064687|530786269|FG000|Overall Study|Lost to Follow-up|7|||
147170075|NCT01064687|530786270|FG001|Overall Study|Lost to Follow-up|10|||
147170076|NCT01064687|530786271|FG002|Overall Study|Lost to Follow-up|13|||
147170077|NCT01064687|530786272|FG003|Overall Study|Lost to Follow-up|5|||
147170078|NCT01064687|530786269|FG000|Overall Study|Physician Decision|2|||
147170079|NCT01064687|530786270|FG001|Overall Study|Physician Decision|2|||
147170080|NCT01064687|530786271|FG002|Overall Study|Physician Decision|0|||
147170081|NCT01064687|530786272|FG003|Overall Study|Physician Decision|0|||
147170082|NCT01064687|530786269|FG000|Overall Study|Protocol Violation|1|||
147170083|NCT01064687|530786270|FG001|Overall Study|Protocol Violation|1|||
147170084|NCT01064687|530786271|FG002|Overall Study|Protocol Violation|0|||
147170085|NCT01064687|530786272|FG003|Overall Study|Protocol Violation|1|||
147170086|NCT01064687|530786269|FG000|Overall Study|Sponsor Decision|0|||
147170087|NCT01064687|530786270|FG001|Overall Study|Sponsor Decision|0|||
147170088|NCT01064687|530786271|FG002|Overall Study|Sponsor Decision|3|||
147170089|NCT01064687|530786272|FG003|Overall Study|Sponsor Decision|0|||
147170090|NCT01064687|530786269|FG000|Overall Study|Withdrawal by Subject|9|||
147170091|NCT01064687|530786270|FG001|Overall Study|Withdrawal by Subject|7|||
147170092|NCT01064687|530786271|FG002|Overall Study|Withdrawal by Subject|12|||
147170093|NCT01064687|530786272|FG003|Overall Study|Withdrawal by Subject|5|||
147170094|NCT01064687|530786269|FG000|Overall Study|Treatment Noncompliance|1|||
147170095|NCT01064687|530786270|FG001|Overall Study|Treatment Noncompliance|1|||
147170096|NCT01064687|530786271|FG002|Overall Study|Treatment Noncompliance|1|||
147170097|NCT01064687|530786272|FG003|Overall Study|Treatment Noncompliance|0|||
147170098|NCT02966015|530786273|FG000|Inclusion Visit|did not answer questionnaire|8|||
147170099|NCT02966015|530786274|FG001|Inclusion Visit|did not answer questionnaire|3|||
147170100|NCT02039856|530786277|FG000|Overall Study|Death|5|||
147170101|NCT02039856|530786278|FG001|Overall Study|Death|3|||
147170102|NCT02039856|530786277|FG000|Overall Study|Partial survey completion|61|||
147170103|NCT02039856|530786278|FG001|Overall Study|Partial survey completion|26|||
147170104|NCT02039856|530786277|FG000|Overall Study|Lost to Follow-up|388|||
147170105|NCT02039856|530786278|FG001|Overall Study|Lost to Follow-up|206|||
147170106|NCT02039856|530786277|FG000|Overall Study|Withdrawal by Subject|1573|||
147170107|NCT02039856|530786278|FG001|Overall Study|Withdrawal by Subject|618|||
147170108|NCT02540291|530786279|FG000|Overall Study|Death|7|||
147170109|NCT02540291|530786280|FG001|Overall Study|Death|7|||
147170110|NCT02540291|530786281|FG002|Overall Study|Death|5|||
147170111|NCT02540291|530786282|FG003|Overall Study|Death|7|||
147447961|NCT02831673|531805608|FG003|Double-blind (Day 1 to Week 96)|Lost to Follow-up|0|||
147170112|NCT02540291|530786279|FG000|Overall Study|Lost to Follow-up|0|||
147170113|NCT02540291|530786280|FG001|Overall Study|Lost to Follow-up|0|||
147170114|NCT02540291|530786281|FG002|Overall Study|Lost to Follow-up|1|||
147170115|NCT02540291|530786282|FG003|Overall Study|Lost to Follow-up|0|||
147170116|NCT02540291|530786279|FG000|Overall Study|Withdrawal Of Consent|0|||
147170117|NCT02540291|530786280|FG001|Overall Study|Withdrawal Of Consent|1|||
147170118|NCT02540291|530786281|FG002|Overall Study|Withdrawal Of Consent|0|||
147170119|NCT02540291|530786282|FG003|Overall Study|Withdrawal Of Consent|0|||
147170120|NCT02540291|530786279|FG000|Overall Study|Study Terminated By Sponsor|1|||
147170121|NCT02540291|530786280|FG001|Overall Study|Study Terminated By Sponsor|0|||
147170122|NCT02540291|530786281|FG002|Overall Study|Study Terminated By Sponsor|0|||
147170123|NCT02540291|530786282|FG003|Overall Study|Study Terminated By Sponsor|0|||
147170124|NCT02540291|530786279|FG000|Overall Study|Other|0|||
147170125|NCT02540291|530786280|FG001|Overall Study|Other|0|||
147170126|NCT02540291|530786281|FG002|Overall Study|Other|1|||
147170127|NCT02540291|530786282|FG003|Overall Study|Other|0|||
147170128|NCT02666105|530786292|FG000|Overall Study|Death|1|||
147170129|NCT02806960|530788259|FG000|Period 1|Study Terminated (withdrawn by sponsor)|3|||
147170130|NCT02806960|530788260|FG001|Period 1|Study Terminated (withdrawn by sponsor)|3|||
147170131|NCT02806960|530788261|FG002|Period 1|Study Terminated (withdrawn by sponsor)|3|||
147170132|NCT02806960|530788262|FG003|Period 1|Study Terminated (withdrawn by sponsor)|3|||
147170133|NCT01769196|530788263|FG000|Overall Study|Adverse Event|24|||
147170134|NCT01769196|530788264|FG001|Overall Study|Adverse Event|20|||
147170135|NCT01769196|530788263|FG000|Overall Study|Death|21|||
147170136|NCT01769196|530788264|FG001|Overall Study|Death|26|||
147170137|NCT01769196|530788263|FG000|Overall Study|Investigator Discretion|7|||
147170138|NCT01769196|530788264|FG001|Overall Study|Investigator Discretion|3|||
147170139|NCT01769196|530788263|FG000|Overall Study|Lack of Efficacy|3|||
147170140|NCT01769196|530788264|FG001|Overall Study|Lack of Efficacy|2|||
147170141|NCT01769196|530788263|FG000|Overall Study|Progressive disease|11|||
147170142|NCT01769196|530788264|FG001|Overall Study|Progressive disease|6|||
147170143|NCT01769196|530788263|FG000|Overall Study|Protocol defined criteria for withdrawal|9|||
147170144|NCT01769196|530788264|FG001|Overall Study|Protocol defined criteria for withdrawal|11|||
147170145|NCT01769196|530788263|FG000|Overall Study|Protocol Violation|0|||
147170146|NCT01769196|530788264|FG001|Overall Study|Protocol Violation|3|||
147170147|NCT01769196|530788263|FG000|Overall Study|Study terminated by sponsor|160|||
147170148|NCT01769196|530788264|FG001|Overall Study|Study terminated by sponsor|161|||
147170149|NCT01769196|530788263|FG000|Overall Study|Participant never dosed with study drug|1|||
147170150|NCT01769196|530788264|FG001|Overall Study|Participant never dosed with study drug|0|||
147170151|NCT01769196|530788263|FG000|Overall Study|Withdrew consent|36|||
147170152|NCT01769196|530788264|FG001|Overall Study|Withdrew consent|40|||
147170153|NCT00126776|530788265|FG000|Overall Study|follow up complete on all patients|0|||
147170154|NCT00126776|530788266|FG001|Overall Study|follow up complete on all patients|0|||
147170155|NCT01272869|530788278|FG000|Period 2 (14 Days)|Adverse Event|1|||
147170156|NCT01272869|530788279|FG001|Period 2 (14 Days)|Adverse Event|0|||
147170157|NCT00771615|530788280|FG000|Overall Study|Withdrawal by Subject|0|||
147170158|NCT00771615|530788281|FG001|Overall Study|Withdrawal by Subject|1|||
147170159|NCT00771615|530788282|FG002|Overall Study|Withdrawal by Subject|0|||
147170160|NCT00771615|530788283|FG003|Overall Study|Withdrawal by Subject|0|||
147170161|NCT00771615|530788284|FG004|Overall Study|Withdrawal by Subject|0|||
147170162|NCT00771615|530788285|FG005|Overall Study|Withdrawal by Subject|0|||
147170163|NCT00771615|530788286|FG006|Overall Study|Withdrawal by Subject|0|||
147170164|NCT00771615|530788287|FG007|Overall Study|Withdrawal by Subject|1|||
147170165|NCT00771615|530788288|FG008|Overall Study|Withdrawal by Subject|0|||
147170166|NCT00771615|530788280|FG000|Overall Study|Lost to Follow-up|1|||
147170167|NCT00771615|530788281|FG001|Overall Study|Lost to Follow-up|1|||
147170168|NCT00771615|530788282|FG002|Overall Study|Lost to Follow-up|1|||
147170169|NCT00771615|530788283|FG003|Overall Study|Lost to Follow-up|1|||
147170170|NCT00771615|530788284|FG004|Overall Study|Lost to Follow-up|0|||
147170171|NCT00771615|530788285|FG005|Overall Study|Lost to Follow-up|1|||
147170172|NCT00771615|530788286|FG006|Overall Study|Lost to Follow-up|1|||
147170173|NCT00771615|530788287|FG007|Overall Study|Lost to Follow-up|0|||
147170174|NCT00771615|530788288|FG008|Overall Study|Lost to Follow-up|0|||
147170175|NCT02455076|530788289|FG000|Inpatient|Withdrawal by Subject|1|||
147170176|NCT02455076|530788290|FG001|Inpatient|Withdrawal by Subject|0|||
147170177|NCT02455076|530788291|FG002|Inpatient|Withdrawal by Subject|0|||
147170178|NCT02455076|530788292|FG003|Inpatient|Withdrawal by Subject|0|||
147170179|NCT02455076|530788293|FG004|Inpatient|Withdrawal by Subject|0|||
147170180|NCT02455076|530788289|FG000|Inpatient|Discharged <24 h after admission|0|||
147170181|NCT02455076|530788290|FG001|Inpatient|Discharged <24 h after admission|1|||
147170182|NCT02455076|530788291|FG002|Inpatient|Discharged <24 h after admission|0|||
147170183|NCT02455076|530788292|FG003|Inpatient|Discharged <24 h after admission|0|||
147170184|NCT02455076|530788293|FG004|Inpatient|Discharged <24 h after admission|0|||
147170185|NCT02455076|530788289|FG000|Inpatient|Adverse Event|3|||
147170186|NCT02455076|530788290|FG001|Inpatient|Adverse Event|0|||
147170187|NCT02455076|530788291|FG002|Inpatient|Adverse Event|0|||
147170188|NCT02455076|530788292|FG003|Inpatient|Adverse Event|0|||
147170189|NCT02455076|530788293|FG004|Inpatient|Adverse Event|0|||
147170190|NCT02455076|530788289|FG000|Outpatient|Adverse Event|0|||
147170191|NCT02455076|530788290|FG001|Outpatient|Adverse Event|0|||
147170192|NCT02455076|530788291|FG002|Outpatient|Adverse Event|0|||
147170193|NCT02455076|530788292|FG003|Outpatient|Adverse Event|5|||
147170194|NCT02455076|530788293|FG004|Outpatient|Adverse Event|0|||
147170195|NCT02455076|530788289|FG000|Outpatient|Lost to Follow-up|0|||
147170196|NCT02455076|530788290|FG001|Outpatient|Lost to Follow-up|0|||
147170197|NCT02455076|530788291|FG002|Outpatient|Lost to Follow-up|0|||
147170198|NCT02455076|530788292|FG003|Outpatient|Lost to Follow-up|1|||
147170199|NCT02455076|530788293|FG004|Outpatient|Lost to Follow-up|12|||
147323675|NCT01237678|531349987|FG001|Phase I - IMGN901+Carboplatin+Etoposide|Incorrect Original Diagnosis|0|||
147323676|NCT01237678|531349988|FG002|Phase I - IMGN901+Carboplatin+Etoposide|Incorrect Original Diagnosis|0|||
147170200|NCT00859937|530788294|FG000|Overall Study|Protocol Violation|1|||
147170201|NCT00859937|530788295|FG001|Overall Study|Protocol Violation|0|||
147170202|NCT03908476|530788296|FG000|Overall Study|Death|3|||
147170203|NCT03908476|530788297|FG001|Overall Study|Death|0|||
147170204|NCT03908476|530788296|FG000|Overall Study|Lost to Follow-up|3|||
147170205|NCT03908476|530788297|FG001|Overall Study|Lost to Follow-up|1|||
147170206|NCT03908476|530788296|FG000|Overall Study|Withdrawal by Subject|7|||
147170207|NCT03908476|530788297|FG001|Overall Study|Withdrawal by Subject|1|||
147170208|NCT03908476|530788296|FG000|Overall Study|Physician Decision|2|||
147170209|NCT03908476|530788297|FG001|Overall Study|Physician Decision|0|||
147170210|NCT03908476|530788296|FG000|Overall Study|System Explanted and not Replaced|4|||
147170211|NCT03908476|530788297|FG001|Overall Study|System Explanted and not Replaced|0|||
147170212|NCT03908476|530788296|FG000|Overall Study|Intrathecal Pump|1|||
147447962|NCT02831673|531805609|FG004|Double-blind (Day 1 to Week 96)|Lost to Follow-up|0|||
147447963|NCT02831673|531805605|FG000|Double-blind (Day 1 to Week 96)|Physician Decision|9|||
147447964|NCT02831673|531805606|FG001|Double-blind (Day 1 to Week 96)|Physician Decision|4|||
147447965|NCT02831673|531805607|FG002|Double-blind (Day 1 to Week 96)|Physician Decision|0|||
147447966|NCT02831673|531805608|FG003|Double-blind (Day 1 to Week 96)|Physician Decision|0|||
147447967|NCT02831673|531805609|FG004|Double-blind (Day 1 to Week 96)|Physician Decision|0|||
147447968|NCT02831673|531805605|FG000|Double-blind (Day 1 to Week 96)|Withdrawal by Subject|11|||
147447969|NCT02831673|531805606|FG001|Double-blind (Day 1 to Week 96)|Withdrawal by Subject|6|||
147447970|NCT02831673|531805607|FG002|Double-blind (Day 1 to Week 96)|Withdrawal by Subject|0|||
147447971|NCT02831673|531805608|FG003|Double-blind (Day 1 to Week 96)|Withdrawal by Subject|0|||
147447972|NCT02831673|531805609|FG004|Double-blind (Day 1 to Week 96)|Withdrawal by Subject|0|||
147447973|NCT02831673|531805605|FG000|Double-blind (Day 1 to Week 96)|Randomized but not treated|3|||
147447974|NCT02831673|531805606|FG001|Double-blind (Day 1 to Week 96)|Randomized but not treated|2|||
147447975|NCT02831673|531805607|FG002|Double-blind (Day 1 to Week 96)|Randomized but not treated|0|||
147447976|NCT02831673|531805608|FG003|Double-blind (Day 1 to Week 96)|Randomized but not treated|0|||
147447977|NCT02831673|531805609|FG004|Double-blind (Day 1 to Week 96)|Randomized but not treated|0|||
147170213|NCT03908476|530788297|FG001|Overall Study|Intrathecal Pump|0|||
147170214|NCT03908476|530788296|FG000|Overall Study|Patient Has Requested an Explant of the Device|1|||
147170215|NCT03908476|530788297|FG001|Overall Study|Patient Has Requested an Explant of the Device|0|||
147170216|NCT05194267|530788298|FG000|Overall Study|Withdrawal by Subject|2|||
147170217|NCT02868229|530788299|FG000|Overall Study|Adverse Event|1|||
147170218|NCT02868229|530788300|FG001|Overall Study|Adverse Event|0|||
147170219|NCT02868229|530788301|FG002|Overall Study|Adverse Event|0|||
147170220|NCT02868229|530788302|FG003|Overall Study|Adverse Event|1|||
147170221|NCT02868229|530788299|FG000|Overall Study|Death|0|||
147170222|NCT02868229|530788300|FG001|Overall Study|Death|0|||
147170223|NCT02868229|530788301|FG002|Overall Study|Death|1|||
147170224|NCT02868229|530788302|FG003|Overall Study|Death|1|||
147170225|NCT02868229|530788299|FG000|Overall Study|Missed dose|0|||
147170226|NCT02868229|530788300|FG001|Overall Study|Missed dose|0|||
147170227|NCT02868229|530788301|FG002|Overall Study|Missed dose|0|||
147170228|NCT02868229|530788302|FG003|Overall Study|Missed dose|3|||
147170229|NCT02540668|530788305|FG000|Period 2 - LY3314814 and Warfarin|Physician Decision|0|||
147170230|NCT02540668|530788306|FG001|Period 2 - LY3314814 and Warfarin|Physician Decision|1|||
147170231|NCT03270891|530788307|FG000|Overall Study|Lost to Follow-up|3|||
147170232|NCT03270891|530788308|FG001|Overall Study|Lost to Follow-up|6|||
147170233|NCT03270891|530788309|FG002|Overall Study|Lost to Follow-up|0|||
147170234|NCT03270891|530788307|FG000|Overall Study|Withdrawal by Subject|1|||
147170235|NCT03270891|530788308|FG001|Overall Study|Withdrawal by Subject|0|||
147170236|NCT03270891|530788309|FG002|Overall Study|Withdrawal by Subject|0|||
147170237|NCT03270891|530788307|FG000|Overall Study|For Physician arm only; those physicians who did not have patients who participated|0|||
147170238|NCT03270891|530788308|FG001|Overall Study|For Physician arm only; those physicians who did not have patients who participated|0|||
147170239|NCT03270891|530788309|FG002|Overall Study|For Physician arm only; those physicians who did not have patients who participated|7|||
147170240|NCT05779007|530788310|FG000|Overall Study|not meeting eligibility criteria|3517|||
147170241|NCT05779007|530788311|FG001|Overall Study|not meeting eligibility criteria|2009|||
147170242|NCT05147662|530788314|FG000|Overall Study|Withdrawal by parent/guardian|3|||
147170243|NCT05147662|530788314|FG000|Overall Study|Assigned to treatment but never treated|1|||
147170244|NCT04676867|530788317|FG000|Overall Study|Screen failure|0|||
147170245|NCT04676867|530788318|FG001|Overall Study|Screen failure|0|||
147170246|NCT04676867|530788319|FG002|Overall Study|Screen failure|6|||
147170247|NCT04676867|530788320|FG003|Overall Study|Screen failure|2|||
147170248|NCT04676867|530788317|FG000|Overall Study|Death|0|||
147170249|NCT04676867|530788318|FG001|Overall Study|Death|0|||
147170250|NCT04676867|530788319|FG002|Overall Study|Death|1|||
147170251|NCT04676867|530788320|FG003|Overall Study|Death|0|||
147170252|NCT04676867|530788317|FG000|Overall Study|Withdrawal by Subject|2|||
147170253|NCT04676867|530788318|FG001|Overall Study|Withdrawal by Subject|2|||
147170254|NCT04676867|530788319|FG002|Overall Study|Withdrawal by Subject|4|||
147170255|NCT04676867|530788320|FG003|Overall Study|Withdrawal by Subject|4|||
147170256|NCT04676867|530788317|FG000|Overall Study|Lost to Follow-up|1|||
147170257|NCT04676867|530788318|FG001|Overall Study|Lost to Follow-up|0|||
147170258|NCT04676867|530788319|FG002|Overall Study|Lost to Follow-up|0|||
147170259|NCT04676867|530788320|FG003|Overall Study|Lost to Follow-up|0|||
147170260|NCT00549770|530788321|FG000|Overall Study|Protocol deviation|1|||
147170261|NCT00549770|530788322|FG001|Overall Study|Protocol deviation|1|||
147590844|NCT04403763|532319068|FG002|Stage 2A|Adverse Event|0|||
147170262|NCT00549770|530788323|FG002|Overall Study|Protocol deviation|1|||
147447978|NCT02831673|531805605|FG000|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
147590845|NCT04403763|532319069|FG003|Stage 2A|Adverse Event|0|||
147590846|NCT04403763|532319070|FG004|Stage 2A|Adverse Event|0|||
147170263|NCT00549770|530788324|FG003|Overall Study|Protocol deviation|2|||
147170264|NCT00549770|530788325|FG004|Overall Study|Protocol deviation|2|||
147170265|NCT00549770|530788326|FG005|Overall Study|Protocol deviation|2|||
147170266|NCT00549770|530788327|FG006|Overall Study|Protocol deviation|1|||
147170267|NCT00549770|530788328|FG007|Overall Study|Protocol deviation|2|||
147170268|NCT00549770|530788321|FG000|Overall Study|Administrative problems|0|||
147170269|NCT00549770|530788322|FG001|Overall Study|Administrative problems|1|||
147170270|NCT00549770|530788323|FG002|Overall Study|Administrative problems|0|||
147170271|NCT00549770|530788324|FG003|Overall Study|Administrative problems|0|||
147170272|NCT00549770|530788325|FG004|Overall Study|Administrative problems|0|||
147170273|NCT00549770|530788326|FG005|Overall Study|Administrative problems|0|||
147170274|NCT00549770|530788327|FG006|Overall Study|Administrative problems|0|||
147170275|NCT00549770|530788328|FG007|Overall Study|Administrative problems|1|||
147170276|NCT00549770|530788321|FG000|Overall Study|Lost to Follow-up|0|||
147170277|NCT00549770|530788322|FG001|Overall Study|Lost to Follow-up|0|||
147170278|NCT00549770|530788323|FG002|Overall Study|Lost to Follow-up|2|||
147170279|NCT00549770|530788324|FG003|Overall Study|Lost to Follow-up|2|||
147170280|NCT00549770|530788325|FG004|Overall Study|Lost to Follow-up|3|||
147170281|NCT00549770|530788326|FG005|Overall Study|Lost to Follow-up|2|||
147170282|NCT00549770|530788327|FG006|Overall Study|Lost to Follow-up|0|||
147170283|NCT00549770|530788328|FG007|Overall Study|Lost to Follow-up|0|||
147170284|NCT00549770|530788321|FG000|Overall Study|Withdrawal by Subject|4|||
147170285|NCT00549770|530788322|FG001|Overall Study|Withdrawal by Subject|6|||
147170286|NCT00549770|530788323|FG002|Overall Study|Withdrawal by Subject|4|||
147170287|NCT00549770|530788324|FG003|Overall Study|Withdrawal by Subject|5|||
147170288|NCT00549770|530788325|FG004|Overall Study|Withdrawal by Subject|6|||
147170289|NCT00549770|530788326|FG005|Overall Study|Withdrawal by Subject|6|||
147170290|NCT00549770|530788327|FG006|Overall Study|Withdrawal by Subject|4|||
147590847|NCT04403763|532319071|FG005|Stage 2A|Adverse Event|0|||
147590848|NCT04403763|532319072|FG006|Stage 2A|Adverse Event|1|||
147590849|NCT00350402|532319073|FG000|Overall Study|Lost to Follow-up|1|||
147590850|NCT00350402|532319074|FG001|Overall Study|Lost to Follow-up|1|||
147590851|NCT01376310|532319075|FG000|Overall Study|Study closed/terminated|1|||
147590852|NCT01376310|532319076|FG001|Overall Study|Study closed/terminated|2|||
147590853|NCT01376310|532319075|FG000|Overall Study|Withdrawal by Subject|8|||
147590854|NCT01376310|532319076|FG001|Overall Study|Withdrawal by Subject|2|||
147590855|NCT01376310|532319075|FG000|Overall Study|Physician Decision|26|||
147590856|NCT01376310|532319076|FG001|Overall Study|Physician Decision|7|||
147590857|NCT01376310|532319075|FG000|Overall Study|Lost to Follow-up|1|||
147590858|NCT01376310|532319076|FG001|Overall Study|Lost to Follow-up|0|||
147590859|NCT02339740|532319079|FG000|Overall Study|Death|1|||
147590860|NCT02339740|532319080|FG001|Overall Study|Death|0|||
147590861|NCT02339740|532319079|FG000|Overall Study|Physician Decision|0|||
147323677|NCT01237678|531349986|FG000|Phase II|Adverse Event|0|||
147323678|NCT01237678|531349987|FG001|Phase II|Adverse Event|39|||
147170291|NCT00549770|530788328|FG007|Overall Study|Withdrawal by Subject|9|||
147323679|NCT01237678|531349988|FG002|Phase II|Adverse Event|9|||
147323680|NCT01237678|531349986|FG000|Phase II|Death|0|||
147323681|NCT01237678|531349987|FG001|Phase II|Death|0|||
147323682|NCT01237678|531349988|FG002|Phase II|Death|2|||
147323683|NCT01237678|531349986|FG000|Phase II|Lack of Efficacy|0|||
147323684|NCT01237678|531349987|FG001|Phase II|Lack of Efficacy|25|||
147323685|NCT01237678|531349988|FG002|Phase II|Lack of Efficacy|3|||
147323686|NCT01237678|531349986|FG000|Phase II|Withdrawal by Subject|0|||
147323687|NCT01237678|531349987|FG001|Phase II|Withdrawal by Subject|1|||
147323688|NCT01237678|531349988|FG002|Phase II|Withdrawal by Subject|5|||
147323689|NCT01237678|531349986|FG000|Phase II|Completed Cycles 4-6|0|||
147323690|NCT01237678|531349987|FG001|Phase II|Completed Cycles 4-6|11|||
147323691|NCT01237678|531349988|FG002|Phase II|Completed Cycles 4-6|21|||
147323692|NCT01237678|531349986|FG000|Phase II|Sponsor Decision/Study Closed|0|||
147323693|NCT01237678|531349987|FG001|Phase II|Sponsor Decision/Study Closed|18|||
147323694|NCT01237678|531349988|FG002|Phase II|Sponsor Decision/Study Closed|7|||
147323695|NCT01237678|531349986|FG000|Phase II|Randomized but were not treated|0|||
147323696|NCT01237678|531349987|FG001|Phase II|Randomized but were not treated|4|||
147323697|NCT01237678|531349988|FG002|Phase II|Randomized but were not treated|3|||
147323698|NCT05124899|531349992|FG000|Overall Study|Lost to Follow-up|3|||
147323699|NCT03432533|531349994|FG000|Overall Study|Lost to Follow-up|1|||
147323700|NCT03432533|531349995|FG001|Overall Study|Lost to Follow-up|2|||
147323701|NCT03432533|531349994|FG000|Overall Study|Withdrawal by Subject|14|||
147323702|NCT03432533|531349995|FG001|Overall Study|Withdrawal by Subject|9|||
147323703|NCT01648283|531349996|FG000|Overall Study|Withdrawal by Subject|14|||
147590862|NCT02339740|532319080|FG001|Overall Study|Physician Decision|2|||
147590863|NCT02339740|532319079|FG000|Overall Study|Withdrawal by Subject|5|||
147170292|NCT00549770|530788321|FG000|Overall Study|Lack of Efficacy|1|||
147170293|NCT00549770|530788322|FG001|Overall Study|Lack of Efficacy|0|||
147170294|NCT00549770|530788323|FG002|Overall Study|Lack of Efficacy|2|||
147170295|NCT00549770|530788324|FG003|Overall Study|Lack of Efficacy|3|||
147170296|NCT00549770|530788325|FG004|Overall Study|Lack of Efficacy|5|||
147323704|NCT00578227|531350000|FG000|Overall Study|Lost to Follow-up|0|||
147323705|NCT00578227|531350001|FG001|Overall Study|Lost to Follow-up|1|||
147323706|NCT00578227|531350002|FG002|Overall Study|Lost to Follow-up|1|||
147590864|NCT02339740|532319080|FG001|Overall Study|Withdrawal by Subject|1|||
147590865|NCT02339740|532319079|FG000|Overall Study|Inevaluable-RQPCR positive not confirmed|3|||
147590866|NCT02339740|532319080|FG001|Overall Study|Inevaluable-RQPCR positive not confirmed|1|||
147590867|NCT00645944|532319081|FG000|Randomized|Withdrawal by Subject|1|||
147590868|NCT00645944|532319082|FG001|Randomized|Withdrawal by Subject|2|||
147590869|NCT00645944|532319081|FG000|Received Medication|Adverse Event|2|||
147590870|NCT00645944|532319082|FG001|Received Medication|Adverse Event|1|||
147590871|NCT00645944|532319081|FG000|Received Medication|Withdrawal by Subject|1|||
147590872|NCT00645944|532319082|FG001|Received Medication|Withdrawal by Subject|1|||
147590873|NCT00645944|532319081|FG000|Received Medication|Lost to Follow-up|1|||
147590874|NCT00645944|532319082|FG001|Received Medication|Lost to Follow-up|0|||
147590875|NCT00645944|532319081|FG000|Received Medication|Protocol Violation|2|||
147590876|NCT00645944|532319082|FG001|Received Medication|Protocol Violation|1|||
147590877|NCT01807117|532319084|FG000|Overall Study|Physician Decision|2|||
147590878|NCT01807117|532319084|FG000|Overall Study|Disease diagnosis not a study disease|1|||
147590879|NCT00834899|532319085|FG000|Overall Study|Withdrawal by Subject|1|||
147590880|NCT00834899|532319086|FG001|Overall Study|Withdrawal by Subject|1|||
147590881|NCT02709486|532319092|FG000|Overall Study|Adverse Event|2|||
147590882|NCT02709486|532319093|FG001|Overall Study|Adverse Event|5|||
147590883|NCT02709486|532319094|FG002|Overall Study|Adverse Event|3|||
147590884|NCT02709486|532319092|FG000|Overall Study|Death|0|||
147590885|NCT02709486|532319093|FG001|Overall Study|Death|0|||
147590886|NCT02709486|532319094|FG002|Overall Study|Death|2|||
147590887|NCT02709486|532319092|FG000|Overall Study|Insufficient clinical response|7|||
147590888|NCT02709486|532319093|FG001|Overall Study|Insufficient clinical response|3|||
147590889|NCT02709486|532319094|FG002|Overall Study|Insufficient clinical response|3|||
147590890|NCT02709486|532319092|FG000|Overall Study|Lost to Follow-up|3|||
147590891|NCT02709486|532319093|FG001|Overall Study|Lost to Follow-up|2|||
147590892|NCT02709486|532319094|FG002|Overall Study|Lost to Follow-up|2|||
147590893|NCT02709486|532319092|FG000|Overall Study|Other|0|||
147590894|NCT02709486|532319093|FG001|Overall Study|Other|2|||
147170297|NCT00549770|530788326|FG005|Overall Study|Lack of Efficacy|1|||
147170298|NCT00549770|530788327|FG006|Overall Study|Lack of Efficacy|3|||
147170299|NCT00549770|530788328|FG007|Overall Study|Lack of Efficacy|8|||
147170300|NCT00549770|530788321|FG000|Overall Study|Abnormal test procedure results|0|||
147170301|NCT00549770|530788322|FG001|Overall Study|Abnormal test procedure results|0|||
147170302|NCT00549770|530788323|FG002|Overall Study|Abnormal test procedure results|0|||
147170303|NCT00549770|530788324|FG003|Overall Study|Abnormal test procedure results|2|||
147170304|NCT00549770|530788325|FG004|Overall Study|Abnormal test procedure results|0|||
147170305|NCT00549770|530788326|FG005|Overall Study|Abnormal test procedure results|1|||
147170306|NCT00549770|530788327|FG006|Overall Study|Abnormal test procedure results|1|||
147170307|NCT00549770|530788328|FG007|Overall Study|Abnormal test procedure results|1|||
147170308|NCT00549770|530788321|FG000|Overall Study|Abnormal laboratory values|0|||
147170309|NCT00549770|530788322|FG001|Overall Study|Abnormal laboratory values|0|||
147170310|NCT00549770|530788323|FG002|Overall Study|Abnormal laboratory values|0|||
147170311|NCT00549770|530788324|FG003|Overall Study|Abnormal laboratory values|0|||
147170312|NCT00549770|530788325|FG004|Overall Study|Abnormal laboratory values|0|||
147170313|NCT00549770|530788326|FG005|Overall Study|Abnormal laboratory values|1|||
147170314|NCT00549770|530788327|FG006|Overall Study|Abnormal laboratory values|0|||
147170315|NCT00549770|530788328|FG007|Overall Study|Abnormal laboratory values|0|||
147170316|NCT00549770|530788321|FG000|Overall Study|Adverse Event|1|||
147170317|NCT00549770|530788322|FG001|Overall Study|Adverse Event|3|||
147170318|NCT00549770|530788323|FG002|Overall Study|Adverse Event|1|||
147170319|NCT00549770|530788324|FG003|Overall Study|Adverse Event|2|||
147170320|NCT00549770|530788325|FG004|Overall Study|Adverse Event|1|||
147170321|NCT00549770|530788326|FG005|Overall Study|Adverse Event|0|||
147170322|NCT00549770|530788327|FG006|Overall Study|Adverse Event|5|||
147170323|NCT00549770|530788328|FG007|Overall Study|Adverse Event|4|||
147170324|NCT02294734|530788329|FG000|Overall Study|Adverse Event|5|||
147170325|NCT02294734|530788330|FG001|Overall Study|Adverse Event|5|||
147170326|NCT02294734|530788329|FG000|Overall Study|Met Protocol Defined Stopping Criteria|1|||
147170327|NCT02294734|530788330|FG001|Overall Study|Met Protocol Defined Stopping Criteria|0|||
147244245|NCT00040664|531066956|FG002|Overall Study|Medication adherence/compliance problems|1|||
147244246|NCT00040664|531066957|FG003|Overall Study|Medication adherence/compliance problems|5|||
147244247|NCT00040664|531066954|FG000|Overall Study|Poor taste|2|||
147244248|NCT00040664|531066955|FG001|Overall Study|Poor taste|0|||
147244249|NCT00040664|531066956|FG002|Overall Study|Poor taste|2|||
147244250|NCT00040664|531066957|FG003|Overall Study|Poor taste|0|||
147244251|NCT00040664|531066954|FG000|Overall Study|Pharmacokinetic target not achieved|2|||
147244252|NCT00040664|531066955|FG001|Overall Study|Pharmacokinetic target not achieved|1|||
147244253|NCT00040664|531066956|FG002|Overall Study|Pharmacokinetic target not achieved|0|||
147590895|NCT02709486|532319094|FG002|Overall Study|Other|3|||
147244254|NCT00040664|531066957|FG003|Overall Study|Pharmacokinetic target not achieved|1|||
147244255|NCT00040664|531066954|FG000|Overall Study|Change of formulation|2|||
147590896|NCT02709486|532319092|FG000|Overall Study|Withdrawal by Subject|32|||
147590897|NCT02709486|532319093|FG001|Overall Study|Withdrawal by Subject|22|||
147590898|NCT02709486|532319094|FG002|Overall Study|Withdrawal by Subject|32|||
147590899|NCT00606502|532319099|FG000|Randomization|Randomized but not treated|3|||
147590900|NCT00606502|532319100|FG001|Randomization|Randomized but not treated|0|||
147170328|NCT02294734|530788329|FG000|Overall Study|Lost to Follow-up|2|||
147170329|NCT02294734|530788330|FG001|Overall Study|Lost to Follow-up|0|||
147170330|NCT02294734|530788329|FG000|Overall Study|Physician Decision|2|||
147170331|NCT02294734|530788330|FG001|Overall Study|Physician Decision|1|||
147170332|NCT02294734|530788329|FG000|Overall Study|Withdrawal by Subject|4|||
147170333|NCT02294734|530788330|FG001|Overall Study|Withdrawal by Subject|2|||
147170334|NCT00548717|530788331|FG000|Overall Study|Death|5|||
147170335|NCT00548717|530788332|FG001|Overall Study|Death|2|||
147170336|NCT00548717|530788331|FG000|Overall Study|Relapse|3|||
147170337|NCT00548717|530788332|FG001|Overall Study|Relapse|0|||
147170338|NCT00548717|530788331|FG000|Overall Study|Alternative treatment for GVHD|1|||
147170339|NCT00548717|530788332|FG001|Overall Study|Alternative treatment for GVHD|0|||
147170340|NCT00908037|530788334|FG000|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
147170341|NCT00908037|530788335|FG001|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
147170342|NCT00908037|530788336|FG002|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
147170343|NCT00908037|530788337|FG003|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
147170344|NCT00908037|530788338|FG004|Part 2 (7 Week Randomized Period)|Protocol Violation|1|||
147170345|NCT00908037|530788339|FG005|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
147170346|NCT00908037|530788340|FG006|Part 2 (7 Week Randomized Period)|Protocol Violation|3|||
147170347|NCT00908037|530788341|FG007|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
147170348|NCT00908037|530788342|FG008|Part 2 (7 Week Randomized Period)|Protocol Violation|1|||
147170349|NCT00908037|530788343|FG009|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
147170350|NCT00908037|530788344|FG010|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
147170351|NCT00908037|530788345|FG011|Part 2 (7 Week Randomized Period)|Protocol Violation|0|||
147170352|NCT00908037|530788334|FG000|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
147170353|NCT00908037|530788335|FG001|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
147170354|NCT00908037|530788336|FG002|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
147170355|NCT00908037|530788337|FG003|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
147170356|NCT00908037|530788338|FG004|Part 2 (7 Week Randomized Period)|Lost to Follow-up|2|||
147170357|NCT00908037|530788339|FG005|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
147170358|NCT00908037|530788340|FG006|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
147170359|NCT00908037|530788341|FG007|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
147170360|NCT00908037|530788342|FG008|Part 2 (7 Week Randomized Period)|Lost to Follow-up|4|||
147170361|NCT00908037|530788343|FG009|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
147170362|NCT00908037|530788344|FG010|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
147170363|NCT00908037|530788345|FG011|Part 2 (7 Week Randomized Period)|Lost to Follow-up|0|||
147170364|NCT00908037|530788334|FG000|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
147170365|NCT00908037|530788335|FG001|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
147170366|NCT00908037|530788336|FG002|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
147170367|NCT00908037|530788337|FG003|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|1|||
147170368|NCT00908037|530788338|FG004|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
147170369|NCT00908037|530788339|FG005|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
147170370|NCT00908037|530788340|FG006|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|1|||
147170371|NCT00908037|530788341|FG007|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
147170372|NCT00908037|530788342|FG008|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
147170373|NCT00908037|530788343|FG009|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
147170374|NCT00908037|530788344|FG010|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
147170375|NCT00908037|530788345|FG011|Part 2 (7 Week Randomized Period)|Withdrawal by parent/ guardian|0|||
147170376|NCT00908037|530788334|FG000|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
147170377|NCT00908037|530788335|FG001|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
147170378|NCT00908037|530788336|FG002|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
147170379|NCT00908037|530788337|FG003|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
147170380|NCT00908037|530788338|FG004|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
147170381|NCT00908037|530788339|FG005|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
147170382|NCT00908037|530788340|FG006|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
147170383|NCT00908037|530788341|FG007|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
147170384|NCT00908037|530788342|FG008|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
147654783|NCT01705080|532559127|FG000|Overall Study|Withdrawal by Subject|61|||
147170385|NCT00908037|530788343|FG009|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
147170386|NCT00908037|530788344|FG010|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|0|||
147170387|NCT00908037|530788345|FG011|Part 2/3(Eltrombopag Open-Label Period)|Lack of Efficacy|1|||
147170388|NCT00908037|530788334|FG000|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
147170389|NCT00908037|530788335|FG001|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
147170390|NCT00908037|530788336|FG002|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
147170391|NCT00908037|530788337|FG003|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
147170392|NCT00908037|530788338|FG004|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
147170393|NCT00908037|530788339|FG005|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
147170394|NCT00908037|530788340|FG006|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
147170395|NCT00908037|530788341|FG007|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
147170396|NCT00908037|530788342|FG008|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
147170397|NCT00908037|530788343|FG009|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|1|||
147170398|NCT00908037|530788344|FG010|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|0|||
147170399|NCT00908037|530788345|FG011|Part 2/3(Eltrombopag Open-Label Period)|Lost to Follow-up|2|||
147170400|NCT00908037|530788334|FG000|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
147170401|NCT00908037|530788335|FG001|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
147170402|NCT00908037|530788336|FG002|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
147170403|NCT00908037|530788337|FG003|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
147170404|NCT00908037|530788338|FG004|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
147170405|NCT00908037|530788339|FG005|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
147170406|NCT00908037|530788340|FG006|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
147170407|NCT00908037|530788341|FG007|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
147170408|NCT00908037|530788342|FG008|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
147170409|NCT00908037|530788343|FG009|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|1|||
147170410|NCT00908037|530788344|FG010|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
147170411|NCT00908037|530788345|FG011|Part 2/3(Eltrombopag Open-Label Period)|Withdrawal by parent/guardian|0|||
147170412|NCT00908037|530788334|FG000|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
147170413|NCT00908037|530788335|FG001|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
147170414|NCT00908037|530788336|FG002|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
147170415|NCT00908037|530788337|FG003|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
147170416|NCT00908037|530788338|FG004|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
147170417|NCT00908037|530788339|FG005|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
147170418|NCT00908037|530788340|FG006|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
147170419|NCT00908037|530788341|FG007|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
147170420|NCT00908037|530788342|FG008|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
147170421|NCT00908037|530788343|FG009|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
147170422|NCT00908037|530788344|FG010|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|2|||
147170423|NCT00908037|530788345|FG011|Part 2/3(Eltrombopag Open-Label Period)|Adverse Event|0|||
147170424|NCT00908037|530788334|FG000|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
147170425|NCT00908037|530788335|FG001|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
147170426|NCT00908037|530788336|FG002|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
147170427|NCT00908037|530788337|FG003|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
147170428|NCT00908037|530788338|FG004|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
147170429|NCT00908037|530788339|FG005|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
147170430|NCT00908037|530788340|FG006|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
147170431|NCT00908037|530788341|FG007|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
147170432|NCT00908037|530788342|FG008|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
147170433|NCT00908037|530788343|FG009|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|1|||
147170434|NCT00908037|530788344|FG010|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
147170435|NCT00908037|530788345|FG011|Part 2/3(Eltrombopag Open-Label Period)|Physician Decision|0|||
147170436|NCT00908037|530788334|FG000|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
147170437|NCT00908037|530788335|FG001|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
147170438|NCT00908037|530788336|FG002|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
147170439|NCT00908037|530788337|FG003|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
147170440|NCT00908037|530788338|FG004|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
147170441|NCT00908037|530788339|FG005|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
147170442|NCT00908037|530788340|FG006|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
147170443|NCT00908037|530788341|FG007|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
147170444|NCT00908037|530788342|FG008|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
147170445|NCT00908037|530788343|FG009|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
147170446|NCT00908037|530788344|FG010|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|2|||
147170447|NCT00908037|530788345|FG011|Part 2/3(Eltrombopag Open-Label Period)|Randomized but did not receive treatment|0|||
147170448|NCT00025155|530788348|FG000|Overall Study|Ineligible: Wrong primary cancer site|1|||
147170449|NCT00025155|530788348|FG000|Overall Study|Ineligible: Second primary cancer site|1|||
147170450|NCT05086510|530788349|FG000|Overall Study|Lost to Follow-up|0|||
147170451|NCT05086510|530788350|FG001|Overall Study|Lost to Follow-up|2|||
147170452|NCT05086510|530788349|FG000|Overall Study|Death|0|||
147170453|NCT05086510|530788350|FG001|Overall Study|Death|2|||
147170454|NCT00084487|530788360|FG000|Overall Study|Death|1|||
147244256|NCT00040664|531066955|FG001|Overall Study|Change of formulation|2|||
147170455|NCT01561963|530788361|FG000|Overall Study|Adverse Event|1|||
147170456|NCT04598269|530788362|FG000|Overall Study|Adverse Event|0|||
147170457|NCT04598269|530788363|FG001|Overall Study|Adverse Event|3|||
147170458|NCT04598269|530788362|FG000|Overall Study|Withdrawal by Subject|1|||
147170459|NCT04598269|530788363|FG001|Overall Study|Withdrawal by Subject|4|||
147170460|NCT04598269|530788362|FG000|Overall Study|Lost to Follow-up|1|||
147170461|NCT04598269|530788363|FG001|Overall Study|Lost to Follow-up|0|||
147170462|NCT04598269|530788362|FG000|Overall Study|Not Treated|2|||
147170463|NCT04598269|530788363|FG001|Overall Study|Not Treated|0|||
147170464|NCT03040986|530788364|FG000|Overall Study|Hospice|1|||
147170465|NCT03040986|530788365|FG001|Overall Study|Hospice|0|||
147170466|NCT03040986|530788364|FG000|Overall Study|Adverse Event|2|||
147170467|NCT03040986|530788365|FG001|Overall Study|Adverse Event|1|||
147170468|NCT03040986|530788364|FG000|Overall Study|Disease progression on study|3|||
147170469|NCT03040986|530788365|FG001|Overall Study|Disease progression on study|1|||
147170470|NCT02177838|530788366|FG000|Overall Study|Withdrawal by Subject|1|||
147170471|NCT02177838|530788366|FG000|Overall Study|Physician Decision|1|||
147170472|NCT02177838|530788366|FG000|Overall Study|Death|1|||
147170473|NCT00737633|530788371|FG000|Overall Study|Study terminated by sponsor|44|||
147170474|NCT00737633|530788372|FG001|Overall Study|Study terminated by sponsor|55|||
147170475|NCT00737633|530788371|FG000|Overall Study|Lost to Follow-up|0|||
147170476|NCT00737633|530788372|FG001|Overall Study|Lost to Follow-up|1|||
147170477|NCT00737633|530788371|FG000|Overall Study|protocol non-compliance|0|||
147170478|NCT00737633|530788372|FG001|Overall Study|protocol non-compliance|1|||
147170479|NCT00377364|530788373|FG000|Overall Study|Lost to Follow-up|1|||
147170480|NCT00377364|530788374|FG001|Overall Study|Lost to Follow-up|0|||
147170481|NCT00377364|530788373|FG000|Overall Study|Withdrawal by Subject|1|||
147170482|NCT00377364|530788374|FG001|Overall Study|Withdrawal by Subject|0|||
147170483|NCT02925728|530788375|FG000|Overall Study|Death|3|||
147170484|NCT02925728|530788376|FG001|Overall Study|Death|5|||
147170485|NCT02925728|530788375|FG000|Overall Study|Physician Decision|1|||
147170486|NCT02925728|530788376|FG001|Overall Study|Physician Decision|0|||
147170487|NCT02925728|530788375|FG000|Overall Study|Withdrawal by Subject|1|||
147170488|NCT02925728|530788376|FG001|Overall Study|Withdrawal by Subject|0|||
147170489|NCT03101085|530788377|FG000|Overall Study|Lost to Follow-up|0|||
147170490|NCT03101085|530788378|FG001|Overall Study|Lost to Follow-up|1|||
147170491|NCT00695864|530788382|FG000|Placebo|Withdrawal by Subject|1|||
147170492|NCT00695864|530788382|FG000|Placebo|Physician Decision|4|||
147170493|NCT01879072|530788383|FG000|Overall Study|Withdrawal by Subject|121|||
147170494|NCT01879072|530788383|FG000|Overall Study|Not Transplanted|30|||
147170495|NCT00626405|530788391|FG000|Overall Study|Deemed Ineligible|1|||
147170496|NCT00626405|530788392|FG001|Overall Study|Deemed Ineligible|0|||
147170497|NCT00626405|530788391|FG000|Overall Study|Withdrawal by Subject|0|||
147170498|NCT00626405|530788392|FG001|Overall Study|Withdrawal by Subject|1|||
147170499|NCT01264419|530788396|FG000|Overall Study|Lost to Follow-up|3|||
147170500|NCT02100475|530790350|FG000|Overall Study|Unclassified|1|||
147170501|NCT02100475|530790351|FG001|Overall Study|Unclassified|2|||
147170502|NCT02100475|530790350|FG000|Overall Study|Withdrawal criteria|1|||
147170503|NCT02100475|530790351|FG001|Overall Study|Withdrawal criteria|0|||
147170504|NCT00527982|530790358|FG000|Overall Study|Physician Decision|1|||
147170505|NCT00527982|530790359|FG001|Overall Study|Physician Decision|0|||
147170506|NCT01939366|530790360|FG000|Overall Study|Adverse Event|8|||
147170507|NCT01939366|530790361|FG001|Overall Study|Adverse Event|17|||
147170508|NCT01939366|530790362|FG002|Overall Study|Adverse Event|30|||
147170509|NCT01939366|530790363|FG003|Overall Study|Adverse Event|8|||
147170510|NCT01939366|530790364|FG004|Overall Study|Adverse Event|5|||
147170511|NCT01939366|530790360|FG000|Overall Study|Lack of Efficacy|2|||
147170512|NCT01939366|530790361|FG001|Overall Study|Lack of Efficacy|1|||
147170513|NCT01939366|530790362|FG002|Overall Study|Lack of Efficacy|1|||
147170514|NCT01939366|530790363|FG003|Overall Study|Lack of Efficacy|1|||
147170515|NCT01939366|530790364|FG004|Overall Study|Lack of Efficacy|3|||
147170516|NCT01939366|530790360|FG000|Overall Study|Lost to Follow-up|1|||
147170517|NCT01939366|530790361|FG001|Overall Study|Lost to Follow-up|1|||
147170518|NCT01939366|530790362|FG002|Overall Study|Lost to Follow-up|0|||
147170519|NCT01939366|530790363|FG003|Overall Study|Lost to Follow-up|0|||
147170520|NCT01939366|530790364|FG004|Overall Study|Lost to Follow-up|0|||
147170521|NCT01939366|530790360|FG000|Overall Study|Withdrawal by Subject|1|||
147170522|NCT01939366|530790361|FG001|Overall Study|Withdrawal by Subject|0|||
147170523|NCT01939366|530790362|FG002|Overall Study|Withdrawal by Subject|2|||
147170524|NCT01939366|530790363|FG003|Overall Study|Withdrawal by Subject|2|||
147170525|NCT01939366|530790364|FG004|Overall Study|Withdrawal by Subject|3|||
147170526|NCT01939366|530790360|FG000|Overall Study|Inclusion criteria not met|0|||
147170527|NCT01939366|530790361|FG001|Overall Study|Inclusion criteria not met|1|||
147170528|NCT01939366|530790362|FG002|Overall Study|Inclusion criteria not met|1|||
147170529|NCT01939366|530790363|FG003|Overall Study|Inclusion criteria not met|0|||
147170530|NCT01939366|530790364|FG004|Overall Study|Inclusion criteria not met|1|||
147170531|NCT01939366|530790360|FG000|Overall Study|Other|0|||
147170532|NCT01939366|530790361|FG001|Overall Study|Other|0|||
147170533|NCT01939366|530790362|FG002|Overall Study|Other|2|||
147170534|NCT01939366|530790363|FG003|Overall Study|Other|2|||
147170535|NCT01939366|530790364|FG004|Overall Study|Other|1|||
147170536|NCT01939366|530790360|FG000|Overall Study|Protocol Violation|0|||
147170537|NCT01939366|530790361|FG001|Overall Study|Protocol Violation|0|||
147170538|NCT01939366|530790362|FG002|Overall Study|Protocol Violation|0|||
147170539|NCT01939366|530790363|FG003|Overall Study|Protocol Violation|1|||
147170540|NCT01939366|530790364|FG004|Overall Study|Protocol Violation|0|||
147170541|NCT01939366|530790360|FG000|Overall Study|Sponsor decision|0|||
147170542|NCT01939366|530790361|FG001|Overall Study|Sponsor decision|0|||
147170543|NCT01939366|530790362|FG002|Overall Study|Sponsor decision|0|||
147170544|NCT01939366|530790363|FG003|Overall Study|Sponsor decision|0|||
147170545|NCT01939366|530790364|FG004|Overall Study|Sponsor decision|2|||
147170546|NCT01939366|530790360|FG000|Overall Study|GCP non-compliance at site|2|||
147170547|NCT01939366|530790361|FG001|Overall Study|GCP non-compliance at site|3|||
147170548|NCT01939366|530790362|FG002|Overall Study|GCP non-compliance at site|2|||
147170549|NCT01939366|530790363|FG003|Overall Study|GCP non-compliance at site|3|||
147170550|NCT01939366|530790364|FG004|Overall Study|GCP non-compliance at site|3|||
147170551|NCT04680975|530790369|FG000|Overall Study|Adverse Event|3|||
147170552|NCT04680975|530790369|FG000|Overall Study|Death|1|||
147170553|NCT04680975|530790369|FG000|Overall Study|Progressive Disease|1|||
147170554|NCT04680975|530790369|FG000|Overall Study|Withdrawal by Subject|1|||
147170555|NCT03909152|530790370|FG000|Overall Study|Adverse Event|14|||
147170556|NCT03909152|530790371|FG001|Overall Study|Adverse Event|5|||
147170557|NCT03909152|530790372|FG002|Overall Study|Adverse Event|1|||
147170558|NCT03909152|530790373|FG003|Overall Study|Adverse Event|14|||
147170559|NCT04541628|530790376|FG000|Overall Study|Study Terminated|1|||
147170560|NCT04541628|530790377|FG001|Overall Study|Study Terminated|1|||
147170561|NCT04541628|530790378|FG002|Overall Study|Study Terminated|1|||
147170562|NCT01192412|530790383|FG000|Overall Study|Lost to Follow-up|2|||
147170563|NCT01192412|530790384|FG001|Overall Study|Lost to Follow-up|1|||
147170564|NCT01192412|530790383|FG000|Overall Study|Withdrawal by Subject|2|||
147170565|NCT01192412|530790384|FG001|Overall Study|Withdrawal by Subject|1|||
147170566|NCT00151476|530790385|FG000|FAP Identified Subjects|Protocol Violation|0|||
147170567|NCT00151476|530790386|FG001|FAP Identified Subjects|Protocol Violation|1|||
147170568|NCT00151476|530790385|FG000|FAP Analyzed Subjects|Lost to Follow-up|0|||
147170569|NCT00151476|530790386|FG001|FAP Analyzed Subjects|Lost to Follow-up|2|||
147170570|NCT00151476|530790385|FG000|FAP Analyzed Subjects|Other study participation|0|||
147170571|NCT00151476|530790386|FG001|FAP Analyzed Subjects|Other study participation|1|||
147170572|NCT04099511|530790391|FG000|Overall Study|Lost to Follow-up|2|||
147170573|NCT04099511|530790392|FG001|Overall Study|Lost to Follow-up|2|||
147170574|NCT04099511|530790391|FG000|Overall Study|Withdrawal by Subject|8|||
147170575|NCT04099511|530790392|FG001|Overall Study|Withdrawal by Subject|4|||
147170576|NCT06151288|530790394|FG000|Overall Study|Lost to Follow-up|4|||
147170577|NCT06151288|530790395|FG001|Overall Study|Lost to Follow-up|2|||
147170578|NCT06151288|530790396|FG002|Overall Study|Lost to Follow-up|4|||
147170579|NCT06151288|530790397|FG003|Overall Study|Lost to Follow-up|3|||
147170580|NCT06151288|530790394|FG000|Overall Study|Withdrawal by Subject|4|||
147170581|NCT06151288|530790395|FG001|Overall Study|Withdrawal by Subject|5|||
147244257|NCT00040664|531066956|FG002|Overall Study|Change of formulation|0|||
147244258|NCT00040664|531066957|FG003|Overall Study|Change of formulation|0|||
147244259|NCT00040664|531066954|FG000|Overall Study|Non-viability of oral suspension|1|||
147244260|NCT00040664|531066955|FG001|Overall Study|Non-viability of oral suspension|0|||
147244261|NCT00040664|531066956|FG002|Overall Study|Non-viability of oral suspension|1|||
147244262|NCT00040664|531066957|FG003|Overall Study|Non-viability of oral suspension|0|||
147244263|NCT01233258|531066960|FG000|First Intervention (6 Months)|Withdrawal by Subject|0|||
147244264|NCT01233258|531066961|FG001|First Intervention (6 Months)|Withdrawal by Subject|0|||
147323707|NCT00578227|531350000|FG000|Overall Study|Withdrawal by Subject|5|||
147323708|NCT00578227|531350001|FG001|Overall Study|Withdrawal by Subject|1|||
147654784|NCT01705080|532559128|FG001|Overall Study|Withdrawal by Subject|44|||
147654785|NCT01705080|532559129|FG002|Overall Study|Withdrawal by Subject|9|||
147654786|NCT00206427|532559130|FG000|Overall Study|Adverse Event|2|||
147654787|NCT00281697|532559131|FG000|Overall Study|> 60 days since last dose of study drug|4|||
147654788|NCT00281697|532559132|FG001|Overall Study|> 60 days since last dose of study drug|4|||
147654789|NCT00281697|532559131|FG000|Overall Study|Adverse Event|54|||
147654790|NCT00281697|532559132|FG001|Overall Study|Adverse Event|15|||
147170582|NCT06151288|530790396|FG002|Overall Study|Withdrawal by Subject|1|||
147170583|NCT06151288|530790397|FG003|Overall Study|Withdrawal by Subject|1|||
147170584|NCT01240200|530790399|FG000|12-week Crossover Phase - Period 1|Withdrawal by Subject|2|||
147170585|NCT01240200|530790400|FG001|12-week Crossover Phase - Period 1|Withdrawal by Subject|1|||
147170586|NCT03194438|530790403|FG000|Overall Study|Withdrawal by Subject|2|||
147170587|NCT02708485|530790404|FG000|Overall Study|Withdrawal by Subject|3|||
147170588|NCT02708485|530790405|FG001|Overall Study|Withdrawal by Subject|2|||
147323709|NCT00578227|531350002|FG002|Overall Study|Withdrawal by Subject|3|||
147170589|NCT01554514|530790410|FG000|Overall Study|1 patient ineligible with congenital TTP|1|||
147170590|NCT01554514|530790410|FG000|Overall Study|Physician Decision|1|||
147654791|NCT00281697|532559131|FG000|Overall Study|Death|8|||
147654792|NCT00281697|532559132|FG001|Overall Study|Death|3|||
147654793|NCT00281697|532559131|FG000|Overall Study|Disease progression|279|||
147170591|NCT01423916|530790411|FG000|Overall Study|Adverse Event|5|||
147170592|NCT01423916|530790412|FG001|Overall Study|Adverse Event|9|||
147170593|NCT01423916|530790413|FG002|Overall Study|Adverse Event|2|||
147170594|NCT01423916|530790411|FG000|Overall Study|Met Withdrawal Criteria|1|||
147170595|NCT01423916|530790412|FG001|Overall Study|Met Withdrawal Criteria|1|||
147170596|NCT01423916|530790413|FG002|Overall Study|Met Withdrawal Criteria|1|||
147170597|NCT01423916|530790411|FG000|Overall Study|Physician Decision|1|||
147170598|NCT01423916|530790412|FG001|Overall Study|Physician Decision|0|||
147170599|NCT01423916|530790413|FG002|Overall Study|Physician Decision|1|||
147170600|NCT01423916|530790411|FG000|Overall Study|Withdrawal by Subject|3|||
147170601|NCT01423916|530790412|FG001|Overall Study|Withdrawal by Subject|10|||
147170602|NCT01423916|530790413|FG002|Overall Study|Withdrawal by Subject|3|||
147170603|NCT01423916|530790411|FG000|Overall Study|Protocol Deviation|1|||
147170604|NCT01423916|530790412|FG001|Overall Study|Protocol Deviation|0|||
147170605|NCT01423916|530790413|FG002|Overall Study|Protocol Deviation|0|||
147170606|NCT03157583|530790416|FG000|Overall Study|Other (did not meet study criteria)|1|||
147170607|NCT01581619|530790426|FG000|Overall Study|Withdrawal by Subject|1|||
147170608|NCT01581619|530790426|FG000|Overall Study|Lost to Follow-up|1|||
147170609|NCT00290498|530790427|FG000|Overall Study|Death|2|||
147170610|NCT00290498|530790428|FG001|Overall Study|Death|0|||
147170611|NCT00290498|530790427|FG000|Overall Study|Physician Decision|1|||
147170612|NCT00290498|530790428|FG001|Overall Study|Physician Decision|0|||
147170613|NCT00290498|530790427|FG000|Overall Study|Withdrawal by Subject|1|||
147170614|NCT00290498|530790428|FG001|Overall Study|Withdrawal by Subject|0|||
147654794|NCT00281697|532559132|FG001|Overall Study|Disease progression|149|||
147244265|NCT01233258|531066962|FG002|First Intervention (6 Months)|Withdrawal by Subject|0|||
147244266|NCT01233258|531066963|FG003|First Intervention (6 Months)|Withdrawal by Subject|1|||
147244267|NCT01233258|531066964|FG004|First Intervention (6 Months)|Withdrawal by Subject|0|||
147244268|NCT01233258|531066965|FG005|First Intervention (6 Months)|Withdrawal by Subject|1|||
147244269|NCT01233258|531066960|FG000|First Intervention (6 Months)|Protocol Violation|0|||
147244270|NCT01233258|531066961|FG001|First Intervention (6 Months)|Protocol Violation|0|||
147244271|NCT01233258|531066962|FG002|First Intervention (6 Months)|Protocol Violation|1|||
147244272|NCT01233258|531066963|FG003|First Intervention (6 Months)|Protocol Violation|0|||
147654795|NCT00281697|532559131|FG000|Overall Study|Other|5|||
147654796|NCT00281697|532559132|FG001|Overall Study|Other|6|||
147654797|NCT00281697|532559131|FG000|Overall Study|Physician's decision to withdraw|15|||
147654798|NCT00281697|532559132|FG001|Overall Study|Physician's decision to withdraw|12|||
147654799|NCT00281697|532559131|FG000|Overall Study|Subject/guardian's decision to withdraw|33|||
147654800|NCT00281697|532559132|FG001|Overall Study|Subject/guardian's decision to withdraw|6|||
147654801|NCT00281697|532559131|FG000|Overall Study|Did not receive study drug|3|||
147654802|NCT00281697|532559132|FG001|Overall Study|Did not receive study drug|2|||
147654803|NCT00632125|532559133|FG000|Overall Study|Death|82|||
147654804|NCT00632125|532559133|FG000|Overall Study|Withdrawal by Subject|44|||
147654805|NCT00632125|532559133|FG000|Overall Study|Adverse Event|36|||
147654806|NCT00632125|532559133|FG000|Overall Study|Renal transplantation|17|||
147654807|NCT00632125|532559133|FG000|Overall Study|Need for systemic immunosuppressive medi|8|||
147654808|NCT00632125|532559133|FG000|Overall Study|Non-compliance|8|||
147654809|NCT00632125|532559133|FG000|Overall Study|Development of uncontrolled hypertension|5|||
147654810|NCT00632125|532559133|FG000|Overall Study|Moved to other dialysis unit, etc.|102|||
147654811|NCT02075008|532559146|FG000|Overall Study|Technical problems|1|||
147654812|NCT02075008|532559146|FG000|Overall Study|Pregnancy|1|||
147654813|NCT02075008|532559146|FG000|Overall Study|Physician Decision|1|||
147654814|NCT02075008|532559146|FG000|Overall Study|Lost to Follow-up|1|||
147654815|NCT02075008|532559146|FG000|Overall Study|Lack of Efficacy|1|||
147654816|NCT02075008|532559146|FG000|Overall Study|Death|1|||
147654817|NCT02075008|532559146|FG000|Overall Study|Adverse Event|5|||
147654818|NCT02075008|532559146|FG000|Overall Study|Withdrawal by Subject|6|||
147654819|NCT02075008|532559146|FG000|Overall Study|Study terminated by Sponsor|159|||
147654820|NCT00572455|532559147|FG000|Stage I (14 Days)|Adverse Event|0|||
147654821|NCT00572455|532559148|FG001|Stage I (14 Days)|Adverse Event|0|||
147654822|NCT00572455|532559149|FG002|Stage I (14 Days)|Adverse Event|0|||
147654823|NCT00572455|532559150|FG003|Stage I (14 Days)|Adverse Event|0|||
147170615|NCT00290498|530790427|FG000|Overall Study|Ineligible|3|||
147244273|NCT01233258|531066964|FG004|First Intervention (6 Months)|Protocol Violation|0|||
147244274|NCT01233258|531066965|FG005|First Intervention (6 Months)|Protocol Violation|0|||
147244275|NCT01233258|531066960|FG000|First Intervention (6 Months)|Non-compliance with study medication|1|||
147244276|NCT01233258|531066961|FG001|First Intervention (6 Months)|Non-compliance with study medication|0|||
147244277|NCT01233258|531066962|FG002|First Intervention (6 Months)|Non-compliance with study medication|0|||
147654824|NCT00572455|532559151|FG004|Stage I (14 Days)|Adverse Event|0|||
147447979|NCT02831673|531805606|FG001|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
147654825|NCT00572455|532559152|FG005|Stage I (14 Days)|Adverse Event|3|||
147654826|NCT00572455|532559153|FG006|Stage I (14 Days)|Adverse Event|0|||
147654827|NCT00572455|532559154|FG007|Stage I (14 Days)|Adverse Event|0|||
147654828|NCT00572455|532559155|FG008|Stage I (14 Days)|Adverse Event|0|||
147654829|NCT00572455|532559156|FG009|Stage I (14 Days)|Adverse Event|0|||
147590901|NCT00606502|532319099|FG000|Treatment|Treatment ongoing at time of data cutoff|0|||
147170616|NCT00290498|530790428|FG001|Overall Study|Ineligible|0|||
147170617|NCT00290498|530790427|FG000|Overall Study|Non-Compliance|1|||
147170618|NCT00290498|530790428|FG001|Overall Study|Non-Compliance|0|||
147170619|NCT02250664|530790431|FG000|Overall Study|Lost to Follow-up|18|||
147170620|NCT02250664|530790432|FG001|Overall Study|Lost to Follow-up|28|||
147170621|NCT02250664|530790433|FG002|Overall Study|Lost to Follow-up|33|||
147170622|NCT02250664|530790431|FG000|Overall Study|Personal Reasons|7|||
147170623|NCT02250664|530790432|FG001|Overall Study|Personal Reasons|8|||
147170624|NCT02250664|530790433|FG002|Overall Study|Personal Reasons|14|||
147170625|NCT02250664|530790431|FG000|Overall Study|Adverse Event|6|||
147170626|NCT02250664|530790432|FG001|Overall Study|Adverse Event|3|||
147170627|NCT02250664|530790433|FG002|Overall Study|Adverse Event|8|||
147170628|NCT02250664|530790431|FG000|Overall Study|Incarcerated|2|||
147170629|NCT02250664|530790432|FG001|Overall Study|Incarcerated|1|||
147170630|NCT02250664|530790433|FG002|Overall Study|Incarcerated|2|||
147170631|NCT02250664|530790431|FG000|Overall Study|Withdrawal by Subject|0|||
147170632|NCT02250664|530790432|FG001|Overall Study|Withdrawal by Subject|1|||
147170633|NCT02250664|530790433|FG002|Overall Study|Withdrawal by Subject|2|||
147170634|NCT02250664|530790431|FG000|Overall Study|Death|0|||
147170635|NCT02250664|530790432|FG001|Overall Study|Death|1|||
147170636|NCT02250664|530790433|FG002|Overall Study|Death|1|||
147170637|NCT02250664|530790431|FG000|Overall Study|Physician Decision|1|||
147170638|NCT02250664|530790432|FG001|Overall Study|Physician Decision|3|||
147170639|NCT02250664|530790433|FG002|Overall Study|Physician Decision|1|||
147170640|NCT02250664|530790431|FG000|Overall Study|Protocol Violation|1|||
147170641|NCT02250664|530790432|FG001|Overall Study|Protocol Violation|0|||
147170642|NCT02250664|530790433|FG002|Overall Study|Protocol Violation|1|||
147170643|NCT02250664|530790431|FG000|Overall Study|Reason unknown|1|||
147170644|NCT02250664|530790432|FG001|Overall Study|Reason unknown|0|||
147170645|NCT02250664|530790433|FG002|Overall Study|Reason unknown|0|||
147170646|NCT03847909|530790435|FG000|Overall Study|Withdrawal by Subject|1|||
147170647|NCT03847909|530790436|FG001|Overall Study|Withdrawal by Subject|1|||
147170648|NCT04268173|530790437|FG000|Overall Study|Lost to Follow-up|75|||
147170649|NCT04268173|530790438|FG001|Overall Study|Lost to Follow-up|108|||
147170650|NCT00869401|530790439|FG000|Overall Study|Withdrawal by Subject|0|||
147170651|NCT00869401|530790440|FG001|Overall Study|Withdrawal by Subject|0|||
147170652|NCT00869401|530790441|FG002|Overall Study|Withdrawal by Subject|0|||
147170653|NCT00869401|530790442|FG003|Overall Study|Withdrawal by Subject|5|||
147170654|NCT00869401|530790443|FG004|Overall Study|Withdrawal by Subject|3|||
147170655|NCT01147900|530790444|FG000|At Year 10|Lost to Follow-up|0|||
147170656|NCT01147900|530790445|FG001|At Year 10|Lost to Follow-up|1|||
147170657|NCT01147900|530790446|FG002|At Year 10|Lost to Follow-up|0|||
147170658|NCT00975143|530790447|FG000|Overall Study|Adverse Event|19|||
147170659|NCT00975143|530790448|FG001|Overall Study|Adverse Event|15|||
147170660|NCT00975143|530790447|FG000|Overall Study|Withdrawal by Subject|15|||
147170661|NCT00975143|530790448|FG001|Overall Study|Withdrawal by Subject|15|||
147170662|NCT00975143|530790447|FG000|Overall Study|Lost to Follow-up|20|||
147170663|NCT00975143|530790448|FG001|Overall Study|Lost to Follow-up|16|||
147170664|NCT00975143|530790447|FG000|Overall Study|Non-compliance|5|||
147170665|NCT00975143|530790448|FG001|Overall Study|Non-compliance|8|||
147170666|NCT00975143|530790447|FG000|Overall Study|Physician Decision|1|||
147170667|NCT00975143|530790448|FG001|Overall Study|Physician Decision|2|||
147170668|NCT00975143|530790447|FG000|Overall Study|Details not available|10|||
147170669|NCT00975143|530790448|FG001|Overall Study|Details not available|4|||
147170670|NCT01375608|530790449|FG000|Overall Study|Withdrawal by Subject|2|||
147170671|NCT00581360|530790450|FG000|Overall Study|Withdrawal by Subject|1|||
147170672|NCT03129360|530790451|FG000|Overall Study|Did not meet entry criteria|0|||
147170673|NCT03129360|530790452|FG001|Overall Study|Did not meet entry criteria|2|||
147170674|NCT03129360|530790453|FG002|Overall Study|Did not meet entry criteria|1|||
147170675|NCT03129360|530790451|FG000|Overall Study|Excluded due to motion in scanner|1|||
147170676|NCT03129360|530790452|FG001|Overall Study|Excluded due to motion in scanner|0|||
147170677|NCT03129360|530790453|FG002|Overall Study|Excluded due to motion in scanner|0|||
147170678|NCT00545103|530790454|FG000|Overall Study|Lack of Efficacy|48|||
147170679|NCT00545103|530790455|FG001|Overall Study|Lack of Efficacy|45|||
147590902|NCT00606502|532319100|FG001|Treatment|Treatment ongoing at time of data cutoff|3|||
147590903|NCT02443545|532319107|FG000|Overall Study|Adverse Event|1|||
147590904|NCT02443545|532319108|FG001|Overall Study|Adverse Event|1|||
147170680|NCT00545103|530790456|FG002|Overall Study|Lack of Efficacy|31|||
147170681|NCT00545103|530790457|FG003|Overall Study|Lack of Efficacy|27|||
147590905|NCT02443545|532319107|FG000|Overall Study|Lost to Follow-up|0|||
147170682|NCT00545103|530790454|FG000|Overall Study|Withdrawal by Subject|6|||
147170683|NCT00545103|530790455|FG001|Overall Study|Withdrawal by Subject|10|||
147170684|NCT00545103|530790456|FG002|Overall Study|Withdrawal by Subject|18|||
147170685|NCT00545103|530790457|FG003|Overall Study|Withdrawal by Subject|22|||
147170686|NCT00545103|530790454|FG000|Overall Study|Adverse Event|11|||
147170687|NCT00545103|530790455|FG001|Overall Study|Adverse Event|12|||
147170688|NCT00545103|530790456|FG002|Overall Study|Adverse Event|17|||
147170689|NCT00545103|530790457|FG003|Overall Study|Adverse Event|10|||
147170690|NCT00545103|530790454|FG000|Overall Study|Lost to Follow-up|4|||
147590906|NCT02443545|532319108|FG001|Overall Study|Lost to Follow-up|2|||
147590907|NCT02443545|532319107|FG000|Overall Study|Physician Decision|3|||
147590908|NCT02443545|532319108|FG001|Overall Study|Physician Decision|0|||
147590909|NCT02443545|532319107|FG000|Overall Study|Protocol Violation|8|||
147590910|NCT02443545|532319108|FG001|Overall Study|Protocol Violation|1|||
147590911|NCT02443545|532319107|FG000|Overall Study|Pregnancy|1|||
147590912|NCT02443545|532319108|FG001|Overall Study|Pregnancy|1|||
147590913|NCT02443545|532319107|FG000|Overall Study|Withdrawal by Subject|6|||
147590914|NCT02443545|532319108|FG001|Overall Study|Withdrawal by Subject|3|||
147590915|NCT02443545|532319107|FG000|Overall Study|Termination of study|20|||
147590916|NCT02443545|532319108|FG001|Overall Study|Termination of study|11|||
147590917|NCT01855048|532319110|FG000|Overall Study|Withdrawal by Subject|0|||
147590918|NCT01855048|532319111|FG001|Overall Study|Withdrawal by Subject|1|||
147590919|NCT01855048|532319112|FG002|Overall Study|Withdrawal by Subject|0|||
147170691|NCT00545103|530790455|FG001|Overall Study|Lost to Follow-up|6|||
147170692|NCT00545103|530790456|FG002|Overall Study|Lost to Follow-up|3|||
147170693|NCT00545103|530790457|FG003|Overall Study|Lost to Follow-up|4|||
147170694|NCT00545103|530790454|FG000|Overall Study|Protocol Violation|1|||
147170695|NCT00545103|530790455|FG001|Overall Study|Protocol Violation|2|||
147170696|NCT00545103|530790456|FG002|Overall Study|Protocol Violation|3|||
147170697|NCT00545103|530790457|FG003|Overall Study|Protocol Violation|0|||
147170698|NCT00545103|530790454|FG000|Overall Study|Suspected recurrence of diverticulitis|1|||
147170699|NCT00545103|530790455|FG001|Overall Study|Suspected recurrence of diverticulitis|0|||
147170700|NCT00545103|530790456|FG002|Overall Study|Suspected recurrence of diverticulitis|0|||
147170701|NCT00545103|530790457|FG003|Overall Study|Suspected recurrence of diverticulitis|3|||
147170702|NCT00545103|530790454|FG000|Overall Study|Difficult to open package|0|||
147170703|NCT00545103|530790455|FG001|Overall Study|Difficult to open package|0|||
147170704|NCT00545103|530790456|FG002|Overall Study|Difficult to open package|0|||
147590920|NCT01855048|532319113|FG003|Overall Study|Withdrawal by Subject|0|||
147590921|NCT01855048|532319114|FG004|Overall Study|Withdrawal by Subject|1|||
147590922|NCT01855048|532319115|FG005|Overall Study|Withdrawal by Subject|0|||
147590923|NCT03465436|532319116|FG000|Period 1|Protocol Violation|0|||
147590924|NCT03465436|532319117|FG001|Period 1|Protocol Violation|0|||
147590925|NCT03465436|532319118|FG002|Period 1|Protocol Violation|1|||
147590926|NCT03465436|532319119|FG003|Period 1|Protocol Violation|0|||
147590927|NCT03465436|532319116|FG000|Period 2|Protocol Violation|0|||
147590928|NCT03465436|532319117|FG001|Period 2|Protocol Violation|1|||
147590929|NCT03465436|532319118|FG002|Period 2|Protocol Violation|0|||
147590930|NCT03465436|532319119|FG003|Period 2|Protocol Violation|0|||
147590931|NCT03465436|532319116|FG000|Period 3|Protocol Violation|1|||
147590932|NCT03465436|532319117|FG001|Period 3|Protocol Violation|1|||
147590933|NCT03465436|532319118|FG002|Period 3|Protocol Violation|0|||
147590934|NCT03465436|532319119|FG003|Period 3|Protocol Violation|0|||
147590935|NCT03465436|532319116|FG000|Period 4|Protocol Violation|0|||
147323710|NCT01511250|531350003|FG000|Overall Study|Withdrawal of Consent|1|||
147323711|NCT01511250|531350004|FG001|Overall Study|Withdrawal of Consent|0|||
147323712|NCT01511250|531350005|FG002|Overall Study|Withdrawal of Consent|0|||
147323713|NCT01511250|531350006|FG003|Overall Study|Withdrawal of Consent|0|||
147323714|NCT01511250|531350007|FG004|Overall Study|Withdrawal of Consent|0|||
147323715|NCT01511250|531350008|FG005|Overall Study|Withdrawal of Consent|0|||
147323716|NCT01511250|531350009|FG006|Overall Study|Withdrawal of Consent|0|||
147323717|NCT01511250|531350010|FG007|Overall Study|Withdrawal of Consent|1|||
147323718|NCT01511250|531350011|FG008|Overall Study|Withdrawal of Consent|1|||
147323719|NCT01511250|531350012|FG009|Overall Study|Withdrawal of Consent|0|||
147323720|NCT01511250|531350003|FG000|Overall Study|Sponsor/Investigator Decision|1|||
147323721|NCT01511250|531350004|FG001|Overall Study|Sponsor/Investigator Decision|0|||
147323722|NCT01511250|531350005|FG002|Overall Study|Sponsor/Investigator Decision|0|||
147323723|NCT01511250|531350006|FG003|Overall Study|Sponsor/Investigator Decision|0|||
147323724|NCT01511250|531350007|FG004|Overall Study|Sponsor/Investigator Decision|0|||
147323725|NCT01511250|531350008|FG005|Overall Study|Sponsor/Investigator Decision|0|||
147323726|NCT01511250|531350009|FG006|Overall Study|Sponsor/Investigator Decision|0|||
147323727|NCT01511250|531350010|FG007|Overall Study|Sponsor/Investigator Decision|0|||
147323728|NCT01511250|531350011|FG008|Overall Study|Sponsor/Investigator Decision|0|||
147323729|NCT01511250|531350012|FG009|Overall Study|Sponsor/Investigator Decision|0|||
147323730|NCT01511250|531350003|FG000|Overall Study|Lost to Follow-up|7|||
147590936|NCT03465436|532319117|FG001|Period 4|Protocol Violation|0|||
147590937|NCT03465436|532319118|FG002|Period 4|Protocol Violation|1|||
147590938|NCT03465436|532319119|FG003|Period 4|Protocol Violation|0|||
147590939|NCT01813071|532319120|FG000|Overall Study|Protocol Violation|0|||
147170705|NCT00545103|530790457|FG003|Overall Study|Difficult to open package|1|||
147170706|NCT00545103|530790454|FG000|Overall Study|Investigational product not taken|1|||
147170707|NCT00545103|530790455|FG001|Overall Study|Investigational product not taken|0|||
147590940|NCT01813071|532319121|FG001|Overall Study|Protocol Violation|0|||
147590941|NCT01813071|532319122|FG002|Overall Study|Protocol Violation|0|||
147170708|NCT00545103|530790456|FG002|Overall Study|Investigational product not taken|0|||
147447980|NCT02831673|531805607|FG002|Open-label Phase (Week 96 to Week 148)|Adverse Event|3|||
147447981|NCT02831673|531805608|FG003|Open-label Phase (Week 96 to Week 148)|Adverse Event|6|||
147447982|NCT02831673|531805609|FG004|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
147447983|NCT02831673|531805605|FG000|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
147447984|NCT02831673|531805606|FG001|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
147447985|NCT02831673|531805607|FG002|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|1|||
147590942|NCT01813071|532319123|FG003|Overall Study|Protocol Violation|0|||
147590943|NCT01813071|532319124|FG004|Overall Study|Protocol Violation|1|||
147170709|NCT00545103|530790457|FG003|Overall Study|Investigational product not taken|1|||
147170710|NCT00545103|530790454|FG000|Overall Study|Wish to start a family|0|||
147170711|NCT00545103|530790455|FG001|Overall Study|Wish to start a family|0|||
147170712|NCT00545103|530790456|FG002|Overall Study|Wish to start a family|0|||
147170713|NCT00545103|530790457|FG003|Overall Study|Wish to start a family|1|||
147170714|NCT00545103|530790454|FG000|Overall Study|Diverticulitis crisis|0|||
147170715|NCT00545103|530790455|FG001|Overall Study|Diverticulitis crisis|0|||
147170716|NCT00545103|530790456|FG002|Overall Study|Diverticulitis crisis|0|||
147170717|NCT00545103|530790457|FG003|Overall Study|Diverticulitis crisis|1|||
147170718|NCT00545103|530790454|FG000|Overall Study|Personal reasons|1|||
147170719|NCT00545103|530790455|FG001|Overall Study|Personal reasons|0|||
147170720|NCT00545103|530790456|FG002|Overall Study|Personal reasons|0|||
147170721|NCT00545103|530790457|FG003|Overall Study|Personal reasons|0|||
147170722|NCT00545103|530790454|FG000|Overall Study|Subject's decision|1|||
147170723|NCT00545103|530790455|FG001|Overall Study|Subject's decision|0|||
147170724|NCT00545103|530790456|FG002|Overall Study|Subject's decision|0|||
147170725|NCT00545103|530790457|FG003|Overall Study|Subject's decision|0|||
147170726|NCT00545103|530790454|FG000|Overall Study|Noncompliance|0|||
147170727|NCT00545103|530790455|FG001|Overall Study|Noncompliance|1|||
147170728|NCT00545103|530790456|FG002|Overall Study|Noncompliance|0|||
147170729|NCT00545103|530790457|FG003|Overall Study|Noncompliance|0|||
147170730|NCT00545103|530790454|FG000|Overall Study|Investigator decision|0|||
147170731|NCT00545103|530790455|FG001|Overall Study|Investigator decision|0|||
147170732|NCT00545103|530790456|FG002|Overall Study|Investigator decision|1|||
147170733|NCT00545103|530790457|FG003|Overall Study|Investigator decision|0|||
147170734|NCT00545103|530790454|FG000|Overall Study|Subject moved|0|||
147170735|NCT00545103|530790455|FG001|Overall Study|Subject moved|1|||
147170736|NCT00545103|530790456|FG002|Overall Study|Subject moved|0|||
147170737|NCT00545103|530790457|FG003|Overall Study|Subject moved|0|||
147170738|NCT00545103|530790454|FG000|Overall Study|Use of prohibited medication|0|||
147170739|NCT00545103|530790455|FG001|Overall Study|Use of prohibited medication|0|||
147447986|NCT02831673|531805608|FG003|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|2|||
147590944|NCT01813071|532319125|FG005|Overall Study|Protocol Violation|4|||
147590945|NCT01813071|532319126|FG006|Overall Study|Protocol Violation|2|||
147590946|NCT01813071|532319127|FG007|Overall Study|Protocol Violation|4|||
147590947|NCT01813071|532319128|FG008|Overall Study|Protocol Violation|2|||
147590948|NCT01813071|532319120|FG000|Overall Study|Withdrawal by Subject|0|||
147590949|NCT01813071|532319121|FG001|Overall Study|Withdrawal by Subject|0|||
147590950|NCT01813071|532319122|FG002|Overall Study|Withdrawal by Subject|0|||
147590951|NCT01813071|532319123|FG003|Overall Study|Withdrawal by Subject|0|||
147590952|NCT01813071|532319124|FG004|Overall Study|Withdrawal by Subject|0|||
147590953|NCT01813071|532319125|FG005|Overall Study|Withdrawal by Subject|1|||
147590954|NCT01813071|532319126|FG006|Overall Study|Withdrawal by Subject|0|||
147170740|NCT00545103|530790456|FG002|Overall Study|Use of prohibited medication|1|||
147170741|NCT00545103|530790457|FG003|Overall Study|Use of prohibited medication|0|||
147170742|NCT00545103|530790454|FG000|Overall Study|Does not want to take study drug anymore|1|||
147170743|NCT00545103|530790455|FG001|Overall Study|Does not want to take study drug anymore|0|||
147170744|NCT00545103|530790456|FG002|Overall Study|Does not want to take study drug anymore|1|||
147170745|NCT00545103|530790457|FG003|Overall Study|Does not want to take study drug anymore|0|||
147447987|NCT02831673|531805609|FG004|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
147590955|NCT01813071|532319127|FG007|Overall Study|Withdrawal by Subject|0|||
147170746|NCT00545103|530790454|FG000|Overall Study|Subject met endpoint under protocol v. 1|0|||
147170747|NCT00545103|530790455|FG001|Overall Study|Subject met endpoint under protocol v. 1|0|||
147170748|NCT00545103|530790456|FG002|Overall Study|Subject met endpoint under protocol v. 1|1|||
147170749|NCT00545103|530790457|FG003|Overall Study|Subject met endpoint under protocol v. 1|0|||
147170750|NCT00545103|530790454|FG000|Overall Study|Death|0|||
147170751|NCT00545103|530790455|FG001|Overall Study|Death|1|||
147590956|NCT01813071|532319128|FG008|Overall Study|Withdrawal by Subject|0|||
147170752|NCT00545103|530790456|FG002|Overall Study|Death|0|||
147170753|NCT00545103|530790457|FG003|Overall Study|Death|0|||
147170754|NCT01953913|530790458|FG000|Overall Study|Disease Progression|349|||
147170755|NCT01953913|530790458|FG000|Overall Study|Worsening of underlying cancer|22|||
147447988|NCT02831673|531805605|FG000|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
147170756|NCT01953913|530790458|FG000|Overall Study|Adverse Event|20|||
147170757|NCT01953913|530790458|FG000|Overall Study|Protocol Violation|6|||
147170758|NCT01953913|530790458|FG000|Overall Study|Lost to Follow-up|4|||
147170759|NCT01953913|530790458|FG000|Overall Study|Withdrawal by Subject|32|||
147590957|NCT01813071|532319120|FG000|Overall Study|Adverse Event|0|||
147170760|NCT01953913|530790458|FG000|Overall Study|Other than listed|108|||
147170761|NCT01953913|530790458|FG000|Overall Study|Not Treated|1|||
147170762|NCT01353911|530790459|FG000|Overall Study|Lost to Follow-up|2|||
147170763|NCT01353911|530790460|FG001|Overall Study|Lost to Follow-up|6|||
147323731|NCT01511250|531350004|FG001|Overall Study|Lost to Follow-up|3|||
147323732|NCT01511250|531350005|FG002|Overall Study|Lost to Follow-up|3|||
147323733|NCT01511250|531350006|FG003|Overall Study|Lost to Follow-up|3|||
147323734|NCT01511250|531350007|FG004|Overall Study|Lost to Follow-up|0|||
147590958|NCT01813071|532319121|FG001|Overall Study|Adverse Event|0|||
147590959|NCT01813071|532319122|FG002|Overall Study|Adverse Event|0|||
147590960|NCT01813071|532319123|FG003|Overall Study|Adverse Event|0|||
147590961|NCT01813071|532319124|FG004|Overall Study|Adverse Event|0|||
147590962|NCT01813071|532319125|FG005|Overall Study|Adverse Event|1|||
147590963|NCT01813071|532319126|FG006|Overall Study|Adverse Event|0|||
147590964|NCT01813071|532319127|FG007|Overall Study|Adverse Event|0|||
147590965|NCT01813071|532319128|FG008|Overall Study|Adverse Event|0|||
147590966|NCT01813071|532319120|FG000|Overall Study|Physician Decision|0|||
147590967|NCT01813071|532319121|FG001|Overall Study|Physician Decision|0|||
147590968|NCT01813071|532319122|FG002|Overall Study|Physician Decision|0|||
147590969|NCT01813071|532319123|FG003|Overall Study|Physician Decision|0|||
147590970|NCT01813071|532319124|FG004|Overall Study|Physician Decision|0|||
147590971|NCT01813071|532319125|FG005|Overall Study|Physician Decision|0|||
147590972|NCT01813071|532319126|FG006|Overall Study|Physician Decision|1|||
147590973|NCT01813071|532319127|FG007|Overall Study|Physician Decision|0|||
147590974|NCT01813071|532319128|FG008|Overall Study|Physician Decision|0|||
147590975|NCT01813071|532319120|FG000|Overall Study|Met inc/exc criteria|0|||
147590976|NCT01813071|532319121|FG001|Overall Study|Met inc/exc criteria|0|||
147590977|NCT01813071|532319122|FG002|Overall Study|Met inc/exc criteria|0|||
147590978|NCT01813071|532319123|FG003|Overall Study|Met inc/exc criteria|0|||
147590979|NCT01813071|532319124|FG004|Overall Study|Met inc/exc criteria|0|||
147590980|NCT01813071|532319125|FG005|Overall Study|Met inc/exc criteria|1|||
147590981|NCT01813071|532319126|FG006|Overall Study|Met inc/exc criteria|0|||
147590982|NCT01813071|532319127|FG007|Overall Study|Met inc/exc criteria|1|||
147590983|NCT01813071|532319128|FG008|Overall Study|Met inc/exc criteria|1|||
147590984|NCT01688726|532319132|FG000|Overall Study|Adverse Event|1|||
147590985|NCT01688726|532319133|FG001|Overall Study|Adverse Event|0|||
147590986|NCT01688726|532319132|FG000|Overall Study|Relocated abroad|0|||
147590987|NCT01688726|532319133|FG001|Overall Study|Relocated abroad|1|||
147590988|NCT04553913|532319134|FG000|Overall Study|patient's block resolved prior to PACU|1|||
147590989|NCT04553913|532319134|FG000|Overall Study|did not use the device properly|5|||
147590990|NCT01172821|532319135|FG000|Overall Study|Adverse Event|5|||
147590991|NCT01172821|532319136|FG001|Overall Study|Adverse Event|2|||
147590992|NCT01172821|532319137|FG002|Overall Study|Adverse Event|2|||
147590993|NCT01172821|532319138|FG003|Overall Study|Adverse Event|7|||
147590994|NCT01172821|532319135|FG000|Overall Study|Protocol Violation|0|||
147590995|NCT01172821|532319136|FG001|Overall Study|Protocol Violation|2|||
147590996|NCT01172821|532319137|FG002|Overall Study|Protocol Violation|1|||
147590997|NCT01172821|532319138|FG003|Overall Study|Protocol Violation|2|||
147590998|NCT01172821|532319135|FG000|Overall Study|Lost to Follow-up|4|||
147590999|NCT01172821|532319136|FG001|Overall Study|Lost to Follow-up|1|||
147591000|NCT01172821|532319137|FG002|Overall Study|Lost to Follow-up|2|||
147591001|NCT01172821|532319138|FG003|Overall Study|Lost to Follow-up|2|||
147591002|NCT01172821|532319135|FG000|Overall Study|Withdrawal by Subject|2|||
147591003|NCT01172821|532319136|FG001|Overall Study|Withdrawal by Subject|3|||
147591004|NCT01172821|532319137|FG002|Overall Study|Withdrawal by Subject|3|||
147591005|NCT01172821|532319138|FG003|Overall Study|Withdrawal by Subject|3|||
147591006|NCT01172821|532319135|FG000|Overall Study|Other|3|||
147591007|NCT01172821|532319136|FG001|Overall Study|Other|4|||
147591008|NCT01172821|532319137|FG002|Overall Study|Other|5|||
147591009|NCT01172821|532319138|FG003|Overall Study|Other|3|||
147591010|NCT00710749|532319140|FG000|First Intervention|Withdrawal by Subject|1|||
147591011|NCT00710749|532319141|FG001|First Intervention|Withdrawal by Subject|0|||
147591012|NCT02985879|532319144|FG000|Overall Study|Adverse Event|7|||
147591013|NCT02985879|532319145|FG001|Overall Study|Adverse Event|9|||
147591014|NCT02985879|532319146|FG002|Overall Study|Adverse Event|7|||
147591015|NCT02985879|532319144|FG000|Overall Study|Withdrew consent|6|||
147323735|NCT01511250|531350008|FG005|Overall Study|Lost to Follow-up|0|||
147591016|NCT02985879|532319145|FG001|Overall Study|Withdrew consent|8|||
147591017|NCT02985879|532319146|FG002|Overall Study|Withdrew consent|10|||
147591018|NCT02985879|532319144|FG000|Overall Study|Lost to Follow-up|1|||
147591019|NCT02985879|532319145|FG001|Overall Study|Lost to Follow-up|0|||
147591020|NCT02985879|532319146|FG002|Overall Study|Lost to Follow-up|2|||
147591021|NCT02985879|532319144|FG000|Overall Study|Other, not specified|62|||
147591022|NCT02985879|532319145|FG001|Overall Study|Other, not specified|58|||
147591023|NCT02985879|532319146|FG002|Overall Study|Other, not specified|58|||
147170764|NCT01353911|530790461|FG002|Overall Study|Lost to Follow-up|4|||
147591024|NCT04974619|532320926|FG000|Overall Study|Lost to Follow-up|0|||
147591025|NCT04974619|532320927|FG001|Overall Study|Lost to Follow-up|0|||
147591026|NCT04974619|532320928|FG002|Overall Study|Lost to Follow-up|1|||
147170765|NCT01353911|530790462|FG003|Overall Study|Lost to Follow-up|0|||
147170766|NCT01353911|530790463|FG004|Overall Study|Lost to Follow-up|4|||
147170767|NCT01353911|530790464|FG005|Overall Study|Lost to Follow-up|4|||
147170768|NCT01353911|530790465|FG006|Overall Study|Lost to Follow-up|3|||
147170769|NCT01353911|530790466|FG007|Overall Study|Lost to Follow-up|6|||
147170770|NCT01353911|530790459|FG000|Overall Study|Withdrawal by Subject|2|||
147170771|NCT01353911|530790460|FG001|Overall Study|Withdrawal by Subject|3|||
147170772|NCT01353911|530790461|FG002|Overall Study|Withdrawal by Subject|4|||
147170773|NCT01353911|530790462|FG003|Overall Study|Withdrawal by Subject|2|||
147447989|NCT02831673|531805606|FG001|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
147447990|NCT02831673|531805607|FG002|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
147447991|NCT02831673|531805608|FG003|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|1|||
147447992|NCT02831673|531805609|FG004|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
147447993|NCT02831673|531805605|FG000|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criterion Met|0|||
147447994|NCT02831673|531805606|FG001|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criterion Met|0|||
147447995|NCT02831673|531805607|FG002|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criterion Met|2|||
147447996|NCT02831673|531805608|FG003|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criterion Met|1|||
147447997|NCT02831673|531805609|FG004|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criterion Met|0|||
147447998|NCT02831673|531805605|FG000|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
147447999|NCT02831673|531805606|FG001|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
147448000|NCT02831673|531805607|FG002|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|7|||
147448001|NCT02831673|531805608|FG003|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|6|||
147448002|NCT02831673|531805609|FG004|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
147448003|NCT02831673|531805605|FG000|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
147448004|NCT02831673|531805606|FG001|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
147448005|NCT02831673|531805607|FG002|Open-label Phase (Week 96 to Week 148)|Physician Decision|1|||
147448006|NCT02831673|531805608|FG003|Open-label Phase (Week 96 to Week 148)|Physician Decision|4|||
147448007|NCT02831673|531805609|FG004|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
147448008|NCT02831673|531805605|FG000|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
147448009|NCT02831673|531805606|FG001|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
147448010|NCT02831673|531805607|FG002|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|6|||
147448011|NCT02831673|531805608|FG003|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|5|||
147448012|NCT02831673|531805609|FG004|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
147448013|NCT02831673|531805605|FG000|Continuation Phase(Week 148 to Week 280)|Adverse Event|0|||
147448014|NCT02831673|531805606|FG001|Continuation Phase(Week 148 to Week 280)|Adverse Event|0|||
147448015|NCT02831673|531805607|FG002|Continuation Phase(Week 148 to Week 280)|Adverse Event|0|||
147591027|NCT04974619|532320926|FG000|Overall Study|Withdrawal by Subject|0|||
147591028|NCT04974619|532320927|FG001|Overall Study|Withdrawal by Subject|0|||
147591029|NCT04974619|532320928|FG002|Overall Study|Withdrawal by Subject|1|||
147591030|NCT04974619|532320926|FG000|Overall Study|Protocol Violation|0|||
147591031|NCT04974619|532320927|FG001|Overall Study|Protocol Violation|1|||
147591032|NCT04974619|532320928|FG002|Overall Study|Protocol Violation|0|||
147591033|NCT03959527|532320935|FG000|Overall Study|Withdrawal by Subject|8|||
147591034|NCT03959527|532320936|FG001|Overall Study|Withdrawal by Subject|3|||
147591035|NCT03959527|532320935|FG000|Overall Study|Lost to Follow-up|31|||
147591036|NCT03959527|532320936|FG001|Overall Study|Lost to Follow-up|15|||
147591037|NCT03959527|532320935|FG000|Overall Study|Did not meet eligibility criteria|1|||
147591038|NCT03959527|532320936|FG001|Overall Study|Did not meet eligibility criteria|1|||
147591039|NCT03959527|532320935|FG000|Overall Study|Protocol Violation|10|||
147591040|NCT03959527|532320936|FG001|Overall Study|Protocol Violation|5|||
147591041|NCT01688466|532320937|FG000|Overall Study|Withdrawal by Subject|2|||
147591042|NCT01688466|532320938|FG001|Overall Study|Withdrawal by Subject|1|||
147591043|NCT01688466|532320937|FG000|Overall Study|Death|0|||
147591044|NCT01688466|532320938|FG001|Overall Study|Death|1|||
147591045|NCT01688466|532320937|FG000|Overall Study|Adverse Event|0|||
147591046|NCT01688466|532320938|FG001|Overall Study|Adverse Event|4|||
147591047|NCT01688466|532320937|FG000|Overall Study|Not evaluable|0|||
147591048|NCT01688466|532320938|FG001|Overall Study|Not evaluable|1|||
147591049|NCT02658487|532320947|FG000|Overall Study|Death|2|||
147591050|NCT02658487|532320947|FG000|Overall Study|Disease progression|10|||
147591051|NCT02658487|532320947|FG000|Overall Study|Alternative therapy|1|||
147591052|NCT02658487|532320947|FG000|Overall Study|Adverse Event|1|||
147170774|NCT01353911|530790463|FG004|Overall Study|Withdrawal by Subject|2|||
147591053|NCT02658487|532320947|FG000|Overall Study|Treatment Failure, circulating blasts|1|||
147591054|NCT02658487|532320947|FG000|Overall Study|Refractory acute myeloid leukemia (AML)|1|||
147591055|NCT01647958|532320948|FG000|Initial Study|Lost to Follow-up|2|||
147170775|NCT01353911|530790464|FG005|Overall Study|Withdrawal by Subject|3|||
147170776|NCT01353911|530790465|FG006|Overall Study|Withdrawal by Subject|3|||
147170777|NCT01353911|530790466|FG007|Overall Study|Withdrawal by Subject|9|||
147170778|NCT01353911|530790459|FG000|Overall Study|Status Not Recorded|4|||
147170779|NCT01353911|530790460|FG001|Overall Study|Status Not Recorded|0|||
147170780|NCT01353911|530790461|FG002|Overall Study|Status Not Recorded|1|||
147170781|NCT01353911|530790462|FG003|Overall Study|Status Not Recorded|0|||
147170782|NCT01353911|530790463|FG004|Overall Study|Status Not Recorded|0|||
147170783|NCT01353911|530790464|FG005|Overall Study|Status Not Recorded|0|||
147170784|NCT01353911|530790465|FG006|Overall Study|Status Not Recorded|0|||
147170785|NCT01353911|530790466|FG007|Overall Study|Status Not Recorded|0|||
147170786|NCT00082381|530790468|FG000|Overall Study|Adverse Event|27|||
147170787|NCT00082381|530790469|FG001|Overall Study|Adverse Event|2|||
147170788|NCT00082381|530790468|FG000|Overall Study|Lost to Follow-up|5|||
147170789|NCT00082381|530790469|FG001|Overall Study|Lost to Follow-up|7|||
147170790|NCT00082381|530790468|FG000|Overall Study|Patient Decision|8|||
147170791|NCT00082381|530790469|FG001|Overall Study|Patient Decision|4|||
147170792|NCT00082381|530790468|FG000|Overall Study|Physician Decision|1|||
147170793|NCT00082381|530790469|FG001|Overall Study|Physician Decision|2|||
147170794|NCT00082381|530790468|FG000|Overall Study|Protocol Violation|10|||
147170795|NCT00082381|530790469|FG001|Overall Study|Protocol Violation|11|||
147170796|NCT00082381|530790468|FG000|Overall Study|Loss of Glucose Control|4|||
147170797|NCT00082381|530790469|FG001|Overall Study|Loss of Glucose Control|0|||
147170798|NCT02925741|530790471|FG000|Overall Study|Withdrawal by Subject|11|||
147170799|NCT02925741|530790472|FG001|Overall Study|Withdrawal by Subject|0|||
147170800|NCT00494507|530790475|FG000|Double-Blind Phase|Adverse Event|2|||
147170801|NCT00494507|530790476|FG001|Double-Blind Phase|Adverse Event|0|||
147170802|NCT00494507|530790477|FG002|Double-Blind Phase|Adverse Event|1|||
147170803|NCT00494507|530790478|FG003|Double-Blind Phase|Adverse Event|0|||
147170804|NCT00494507|530790475|FG000|Double-Blind Phase|Withdrawal by Subject|1|||
147170805|NCT00494507|530790476|FG001|Double-Blind Phase|Withdrawal by Subject|0|||
147170806|NCT00494507|530790477|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
147170807|NCT00494507|530790478|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
147170808|NCT00494507|530790475|FG000|Double-Blind Phase|Subject Non-compliance|0|||
147170809|NCT00494507|530790476|FG001|Double-Blind Phase|Subject Non-compliance|0|||
147170810|NCT00494507|530790477|FG002|Double-Blind Phase|Subject Non-compliance|1|||
147170811|NCT00494507|530790478|FG003|Double-Blind Phase|Subject Non-compliance|0|||
147170812|NCT00494507|530790475|FG000|Double-Blind Phase|Negative DNA test|0|||
147170813|NCT00494507|530790476|FG001|Double-Blind Phase|Negative DNA test|0|||
147170814|NCT00494507|530790477|FG002|Double-Blind Phase|Negative DNA test|0|||
147170815|NCT00494507|530790478|FG003|Double-Blind Phase|Negative DNA test|1|||
147170816|NCT00494507|530790475|FG000|Open-Label Phase|Adverse Event|0|||
147170817|NCT00494507|530790476|FG001|Open-Label Phase|Adverse Event|1|||
147170818|NCT00494507|530790477|FG002|Open-Label Phase|Adverse Event|5|||
147170819|NCT00494507|530790478|FG003|Open-Label Phase|Adverse Event|3|||
147170820|NCT00494507|530790475|FG000|Open-Label Phase|Worsening Disease|0|||
147170821|NCT00494507|530790476|FG001|Open-Label Phase|Worsening Disease|0|||
147170822|NCT00494507|530790477|FG002|Open-Label Phase|Worsening Disease|0|||
147170823|NCT00494507|530790478|FG003|Open-Label Phase|Worsening Disease|2|||
147170824|NCT00295932|530790479|FG000|Overall Study|Not Treated|0|||
147170825|NCT00295932|530790480|FG001|Overall Study|Not Treated|0|||
147170826|NCT00295932|530790481|FG002|Overall Study|Not Treated|0|||
147170827|NCT00295932|530790482|FG003|Overall Study|Not Treated|0|||
147170828|NCT00295932|530790483|FG004|Overall Study|Not Treated|0|||
147170829|NCT00295932|530790484|FG005|Overall Study|Not Treated|0|||
147170830|NCT00295932|530790485|FG006|Overall Study|Not Treated|0|||
147170831|NCT00295932|530790486|FG007|Overall Study|Not Treated|0|||
147323736|NCT01511250|531350009|FG006|Overall Study|Lost to Follow-up|2|||
147323737|NCT01511250|531350010|FG007|Overall Study|Lost to Follow-up|3|||
147323738|NCT01511250|531350011|FG008|Overall Study|Lost to Follow-up|13|||
147323739|NCT01511250|531350012|FG009|Overall Study|Lost to Follow-up|5|||
147323740|NCT01511250|531350003|FG000|Overall Study|Protocol Violation|0|||
147323741|NCT01511250|531350004|FG001|Overall Study|Protocol Violation|2|||
147323742|NCT01511250|531350005|FG002|Overall Study|Protocol Violation|1|||
147323743|NCT01511250|531350006|FG003|Overall Study|Protocol Violation|0|||
147323744|NCT01511250|531350007|FG004|Overall Study|Protocol Violation|0|||
147170832|NCT00295932|530790487|FG008|Overall Study|Not Treated|0|||
147170833|NCT00295932|530790488|FG009|Overall Study|Not Treated|0|||
147170834|NCT00295932|530790489|FG010|Overall Study|Not Treated|1|||
147323745|NCT01511250|531350008|FG005|Overall Study|Protocol Violation|0|||
147170835|NCT00109577|530790490|FG000|Overall Study|Withdrawal by Subject|3|||
147170836|NCT00109577|530790491|FG001|Overall Study|Withdrawal by Subject|3|||
147170837|NCT00587847|530790492|FG000|Overall Study|Lack of Efficacy|5|||
147170838|NCT00587847|530790492|FG000|Overall Study|Adverse Event|2|||
147323746|NCT01511250|531350009|FG006|Overall Study|Protocol Violation|0|||
147323747|NCT01511250|531350010|FG007|Overall Study|Protocol Violation|0|||
147170839|NCT02613169|530790493|FG000|Overall Study|Withdrawal by Subject|4|||
147170840|NCT02613169|530790494|FG001|Overall Study|Withdrawal by Subject|1|||
147170841|NCT02613169|530790493|FG000|Overall Study|Lost to Follow-up|0|||
147170842|NCT02613169|530790494|FG001|Overall Study|Lost to Follow-up|5|||
147170843|NCT02613169|530790493|FG000|Overall Study|HIV|0|||
147323748|NCT01511250|531350011|FG008|Overall Study|Protocol Violation|0|||
147170844|NCT02613169|530790494|FG001|Overall Study|HIV|2|||
147170845|NCT02613169|530790493|FG000|Overall Study|No TB infection endpoint|14|||
147170846|NCT02613169|530790494|FG001|Overall Study|No TB infection endpoint|9|||
147170847|NCT00343382|530790495|FG000|Overall Study|Adverse Event|2|||
147170848|NCT00343382|530790496|FG001|Overall Study|Adverse Event|10|||
147170849|NCT00343382|530790497|FG002|Overall Study|Adverse Event|7|||
147170850|NCT00343382|530790495|FG000|Overall Study|Withdrawal by Subject|1|||
147170851|NCT00343382|530790496|FG001|Overall Study|Withdrawal by Subject|2|||
147170852|NCT00343382|530790497|FG002|Overall Study|Withdrawal by Subject|6|||
147170853|NCT00343382|530790495|FG000|Overall Study|Other Reason Not Specified|1|||
147170854|NCT00343382|530790496|FG001|Overall Study|Other Reason Not Specified|2|||
147170855|NCT00343382|530790497|FG002|Overall Study|Other Reason Not Specified|4|||
147170856|NCT03729245|530790498|FG000|Overall Study|Lost to Follow-up|5|||
147170857|NCT03729245|530790499|FG001|Overall Study|Lost to Follow-up|6|||
147170858|NCT03729245|530790498|FG000|Overall Study|Withdrawal by Subject|16|||
147170859|NCT03729245|530790499|FG001|Overall Study|Withdrawal by Subject|19|||
147170860|NCT03729245|530790498|FG000|Overall Study|Patient did not complete the end of study form but is not followed on the study anymore.|1|||
147170861|NCT03729245|530790499|FG001|Overall Study|Patient did not complete the end of study form but is not followed on the study anymore.|0|||
147170862|NCT04032080|530790500|FG000|Overall Study|Death|6|||
147170863|NCT00884832|530790501|FG000|Overall Study|Withdrawal by Subject|0|||
147170864|NCT00884832|530790502|FG001|Overall Study|Withdrawal by Subject|1|||
147170865|NCT02096263|530790503|FG000|Overall Study|Adverse Event|1|||
147170866|NCT02096263|530790504|FG001|Overall Study|Adverse Event|0|||
147170867|NCT02096263|530790505|FG002|Overall Study|Adverse Event|1|||
147170868|NCT02096263|530790503|FG000|Overall Study|Lost to Follow-up|14|||
147170869|NCT02096263|530790504|FG001|Overall Study|Lost to Follow-up|18|||
147170870|NCT02096263|530790505|FG002|Overall Study|Lost to Follow-up|15|||
147170871|NCT02096263|530790503|FG000|Overall Study|Other|7|||
147170872|NCT02096263|530790504|FG001|Overall Study|Other|9|||
147170873|NCT02096263|530790505|FG002|Overall Study|Other|6|||
147323749|NCT01511250|531350012|FG009|Overall Study|Protocol Violation|0|||
147323750|NCT01763047|531350017|FG000|Period 1|Test Article Not Available|4|||
147323751|NCT01763047|531350018|FG001|Period 1|Test Article Not Available|1|||
147170874|NCT02096263|530790503|FG000|Overall Study|Sponsor study termination|0|||
147170875|NCT02096263|530790504|FG001|Overall Study|Sponsor study termination|0|||
147170876|NCT02096263|530790505|FG002|Overall Study|Sponsor study termination|1|||
147170877|NCT02096263|530790503|FG000|Overall Study|Protocol Violation|7|||
147170878|NCT02096263|530790504|FG001|Overall Study|Protocol Violation|2|||
147170879|NCT02096263|530790505|FG002|Overall Study|Protocol Violation|8|||
147170880|NCT02096263|530790503|FG000|Overall Study|Withdrawal by Subject|5|||
147170881|NCT02096263|530790504|FG001|Overall Study|Withdrawal by Subject|7|||
147170882|NCT02096263|530790505|FG002|Overall Study|Withdrawal by Subject|8|||
147170883|NCT03322423|530790506|FG000|Period 1|Subject no longer eligible|0|||
147170884|NCT03322423|530790507|FG001|Period 1|Subject no longer eligible|1|||
147170885|NCT03322423|530790506|FG000|Period 1|Withdrawal by Subject|0|||
147170886|NCT03322423|530790507|FG001|Period 1|Withdrawal by Subject|1|||
147170887|NCT03322423|530790506|FG000|Period 1|Incorrect Lens Dispensed|1|||
147170888|NCT03322423|530790507|FG001|Period 1|Incorrect Lens Dispensed|0|||
147170889|NCT03322423|530790506|FG000|Period 1|Unsatisfactory Lens Fitting|1|||
147170890|NCT03322423|530790507|FG001|Period 1|Unsatisfactory Lens Fitting|0|||
147170891|NCT03322423|530790506|FG000|Period 2|Dispensed incorrect lens in left eye|0|||
147170892|NCT03322423|530790507|FG001|Period 2|Dispensed incorrect lens in left eye|1|||
147170893|NCT03322423|530790506|FG000|Period 2|Protocol Violation|1|||
147170894|NCT03322423|530790507|FG001|Period 2|Protocol Violation|0|||
147170895|NCT03322423|530790506|FG000|Period 2|Subject not eligible for Pytergiumectomy|0|||
147170896|NCT03322423|530790507|FG001|Period 2|Subject not eligible for Pytergiumectomy|1|||
147170897|NCT02337725|530790508|FG000|Overall Study|Pretreatment Event/AE before Treatment|0|||
147170898|NCT02337725|530790509|FG001|Overall Study|Pretreatment Event/AE before Treatment|1|||
147170899|NCT02337725|530790508|FG000|Overall Study|Pretreatment Event/AE in Treatment|8|||
147170900|NCT02337725|530790509|FG001|Overall Study|Pretreatment Event/AE in Treatment|3|||
147170901|NCT02337725|530790508|FG000|Overall Study|Major Protocol Deviation|0|||
147170902|NCT02337725|530790509|FG001|Overall Study|Major Protocol Deviation|1|||
147323752|NCT01763047|531350017|FG000|Period 1|Protocol Violation|4|||
147323753|NCT01763047|531350018|FG001|Period 1|Protocol Violation|4|||
147323754|NCT01763047|531350017|FG000|Period 1|No Longer Meets Eligibility criteria|1|||
147323755|NCT01763047|531350018|FG001|Period 1|No Longer Meets Eligibility criteria|0|||
147170903|NCT02337725|530790508|FG000|Overall Study|Voluntary Withdrawal|14|||
147170904|NCT02337725|530790509|FG001|Overall Study|Voluntary Withdrawal|3|||
147170905|NCT02337725|530790508|FG000|Overall Study|Lack of Efficacy|4|||
147170906|NCT02337725|530790509|FG001|Overall Study|Lack of Efficacy|0|||
147170907|NCT04891107|530790510|FG000|Overall Study|Physician Decision|1|||
147323756|NCT01763047|531350017|FG000|Period 1|Adverse Event|0|||
147323757|NCT01763047|531350018|FG001|Period 1|Adverse Event|1|||
147170908|NCT04891107|530790510|FG000|Overall Study|Withdrawal by Subject|1|||
147170909|NCT04891107|530790510|FG000|Overall Study|Screen failure after consent|1|||
147170910|NCT00500760|530790517|FG000|Overall Study|Death|32|||
147170911|NCT00500760|530790518|FG001|Overall Study|Death|15|||
147170912|NCT00500760|530790517|FG000|Overall Study|Withdrawal by Subject|5|||
147170913|NCT00500760|530790518|FG001|Overall Study|Withdrawal by Subject|7|||
147170914|NCT00500760|530790517|FG000|Overall Study|Administrative decision|2|||
147170915|NCT00500760|530790518|FG001|Overall Study|Administrative decision|0|||
147170916|NCT00500760|530790517|FG000|Overall Study|Lost to Follow-up|3|||
147170917|NCT00500760|530790518|FG001|Overall Study|Lost to Follow-up|0|||
147170918|NCT00500760|530790517|FG000|Overall Study|Other|1|||
147170919|NCT00500760|530790518|FG001|Overall Study|Other|2|||
147591056|NCT01647958|532320949|FG001|Initial Study|Lost to Follow-up|3|||
147591057|NCT01647958|532320948|FG000|Continuation Phase|treatment received during Overall Study|39|||
147591058|NCT01647958|532320949|FG001|Continuation Phase|treatment received during Overall Study|0|||
147591059|NCT01647958|532320948|FG000|Extended Follow-up Phase|Lost to Follow-up|8|||
147591060|NCT01647958|532320949|FG001|Extended Follow-up Phase|Lost to Follow-up|0|||
147170920|NCT03178669|530790519|FG000|Overall Study|Adverse Event|4|||
147170921|NCT03178669|530790520|FG001|Overall Study|Adverse Event|1|||
147170922|NCT03178669|530790521|FG002|Overall Study|Adverse Event|4|||
147170923|NCT03178669|530790522|FG003|Overall Study|Adverse Event|2|||
147170924|NCT03178669|530790523|FG004|Overall Study|Adverse Event|2|||
147170925|NCT03178669|530790519|FG000|Overall Study|Lack of Efficacy|0|||
147170926|NCT03178669|530790520|FG001|Overall Study|Lack of Efficacy|0|||
147170927|NCT03178669|530790521|FG002|Overall Study|Lack of Efficacy|2|||
147170928|NCT03178669|530790522|FG003|Overall Study|Lack of Efficacy|0|||
147170929|NCT03178669|530790523|FG004|Overall Study|Lack of Efficacy|1|||
147170930|NCT03178669|530790519|FG000|Overall Study|Physician Decision|0|||
147170931|NCT03178669|530790520|FG001|Overall Study|Physician Decision|0|||
147170932|NCT03178669|530790521|FG002|Overall Study|Physician Decision|0|||
147170933|NCT03178669|530790522|FG003|Overall Study|Physician Decision|0|||
147170934|NCT03178669|530790523|FG004|Overall Study|Physician Decision|1|||
147170935|NCT03178669|530790519|FG000|Overall Study|Withdrawal by Subject|1|||
147170936|NCT03178669|530790520|FG001|Overall Study|Withdrawal by Subject|0|||
147170937|NCT03178669|530790521|FG002|Overall Study|Withdrawal by Subject|1|||
147170938|NCT03178669|530790522|FG003|Overall Study|Withdrawal by Subject|1|||
147170939|NCT03178669|530790523|FG004|Overall Study|Withdrawal by Subject|0|||
147170940|NCT03178669|530790519|FG000|Overall Study|Lost to Follow-up|0|||
147170941|NCT03178669|530790520|FG001|Overall Study|Lost to Follow-up|0|||
147170942|NCT03178669|530790521|FG002|Overall Study|Lost to Follow-up|0|||
147170943|NCT03178669|530790522|FG003|Overall Study|Lost to Follow-up|1|||
147170944|NCT03178669|530790523|FG004|Overall Study|Lost to Follow-up|0|||
147170945|NCT01600092|530790524|FG000|Overall Study|Adverse Event|2|||
147170946|NCT01600092|530790525|FG001|Overall Study|Adverse Event|0|||
147170947|NCT01600092|530790524|FG000|Overall Study|Lost to Follow-up|4|||
147170948|NCT01600092|530790525|FG001|Overall Study|Lost to Follow-up|6|||
147170949|NCT01600092|530790524|FG000|Overall Study|Withdrawal by parent/guardian|8|||
147170950|NCT01600092|530790525|FG001|Overall Study|Withdrawal by parent/guardian|6|||
147170951|NCT01600092|530790524|FG000|Overall Study|Physician Decision|1|||
147170952|NCT01600092|530790525|FG001|Overall Study|Physician Decision|1|||
147170953|NCT01600092|530790524|FG000|Overall Study|Randomized but not vaccinated|3|||
147170954|NCT01600092|530790525|FG001|Overall Study|Randomized but not vaccinated|3|||
147170955|NCT02914561|530790526|FG000|Induction Study (Day 1 to Week 10)|Adverse Event|15|||
147170956|NCT02914561|530790527|FG001|Induction Study (Day 1 to Week 10)|Adverse Event|14|||
147170957|NCT02914561|530790528|FG002|Induction Study (Day 1 to Week 10)|Adverse Event|14|||
147170958|NCT02914561|530790529|FG003|Induction Study (Day 1 to Week 10)|Adverse Event|24|||
147170959|NCT02914561|530790530|FG004|Induction Study (Day 1 to Week 10)|Adverse Event|31|||
147170960|NCT02914561|530790531|FG005|Induction Study (Day 1 to Week 10)|Adverse Event|19|||
147170961|NCT02914561|530790532|FG006|Induction Study (Day 1 to Week 10)|Adverse Event|0|||
147170962|NCT02914561|530790533|FG007|Induction Study (Day 1 to Week 10)|Adverse Event|0|||
147170963|NCT02914561|530790534|FG008|Induction Study (Day 1 to Week 10)|Adverse Event|0|||
147170964|NCT02914561|530790535|FG009|Induction Study (Day 1 to Week 10)|Adverse Event|0|||
147170965|NCT02914561|530790536|FG010|Induction Study (Day 1 to Week 10)|Adverse Event|0|||
147170966|NCT02914561|530790526|FG000|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|1|||
147170967|NCT02914561|530790527|FG001|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|9|||
147170968|NCT02914561|530790528|FG002|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|6|||
147170969|NCT02914561|530790529|FG003|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|0|||
147170970|NCT02914561|530790530|FG004|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|7|||
147591061|NCT01885182|532320950|FG000|Overall Study|Adverse Event|11|||
147591062|NCT01885182|532320951|FG001|Overall Study|Adverse Event|13|||
147591063|NCT01885182|532320950|FG000|Overall Study|Withdrawal by Subject|13|||
147591064|NCT01885182|532320951|FG001|Overall Study|Withdrawal by Subject|6|||
147591065|NCT01885182|532320950|FG000|Overall Study|Lost to Follow-up|2|||
147591066|NCT01885182|532320951|FG001|Overall Study|Lost to Follow-up|2|||
147591067|NCT01885182|532320950|FG000|Overall Study|Lack of Efficacy|8|||
147170971|NCT02914561|530790531|FG005|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|12|||
147170972|NCT02914561|530790532|FG006|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|0|||
147170973|NCT02914561|530790533|FG007|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|0|||
147170974|NCT02914561|530790534|FG008|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|0|||
147170975|NCT02914561|530790535|FG009|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|0|||
147591068|NCT01885182|532320951|FG001|Overall Study|Lack of Efficacy|1|||
147244278|NCT01233258|531066963|FG003|First Intervention (6 Months)|Non-compliance with study medication|0|||
147244279|NCT01233258|531066964|FG004|First Intervention (6 Months)|Non-compliance with study medication|0|||
147244280|NCT01233258|531066965|FG005|First Intervention (6 Months)|Non-compliance with study medication|0|||
147244281|NCT01049308|531066966|FG000|Pill Counts|Withdrawal by Subject|83|||
147244282|NCT03845985|531066967|FG000|Overall Study|Lost to Follow-up|2|||
147244283|NCT03845985|531066968|FG001|Overall Study|Lost to Follow-up|1|||
147244284|NCT03845985|531066967|FG000|Overall Study|Physician Decision|1|||
147244285|NCT03845985|531066968|FG001|Overall Study|Physician Decision|0|||
147244286|NCT03845985|531066967|FG000|Overall Study|Withdrawal by Subject|4|||
147244287|NCT03845985|531066968|FG001|Overall Study|Withdrawal by Subject|1|||
147244288|NCT01318993|531066969|FG000|Overall Study|Adverse Event|53|||
147244289|NCT01318993|531066969|FG000|Overall Study|Lack of Efficacy|121|||
147244290|NCT01318993|531066969|FG000|Overall Study|Protocol Violation|3|||
147323758|NCT01763047|531350017|FG000|Period 1|Unsatisfactory Visual Response|0|||
147323759|NCT01763047|531350018|FG001|Period 1|Unsatisfactory Visual Response|3|||
147323760|NCT01763047|531350017|FG000|Period 1|Lens Power Not Available|0|||
147323761|NCT01763047|531350018|FG001|Period 1|Lens Power Not Available|1|||
147323762|NCT01763047|531350017|FG000|Period 1|Study Site office Closed|0|||
147323763|NCT01763047|531350018|FG001|Period 1|Study Site office Closed|1|||
147323764|NCT01763047|531350017|FG000|Period 2|Lens Discomfort|1|||
147323765|NCT01763047|531350018|FG001|Period 2|Lens Discomfort|0|||
147323766|NCT01763047|531350017|FG000|Period 2|No longer meets Eligibility Criteria|1|||
147323767|NCT01763047|531350018|FG001|Period 2|No longer meets Eligibility Criteria|0|||
147323768|NCT01763047|531350017|FG000|Period 2|Study Site office Closed|1|||
147323769|NCT01763047|531350018|FG001|Period 2|Study Site office Closed|1|||
147323770|NCT01763047|531350017|FG000|Period 2|Unsatisfactory Visual Response|1|||
147323771|NCT01763047|531350018|FG001|Period 2|Unsatisfactory Visual Response|1|||
147323772|NCT01763047|531350017|FG000|Period 2|Protocol Violation|0|||
147323773|NCT01763047|531350018|FG001|Period 2|Protocol Violation|2|||
147323774|NCT01763047|531350017|FG000|Period 2|Unsatisfactory lens Fitting|0|||
147323775|NCT01763047|531350018|FG001|Period 2|Unsatisfactory lens Fitting|1|||
147323776|NCT00916006|531350022|FG000|Overall Study|Adverse Event|1|||
147323777|NCT00916006|531350023|FG001|Overall Study|Adverse Event|1|||
147323778|NCT00916006|531350022|FG000|Overall Study|Withdrawal by Subject|2|||
147323779|NCT00916006|531350023|FG001|Overall Study|Withdrawal by Subject|5|||
147323780|NCT00916006|531350022|FG000|Overall Study|Protocol Violation|0|||
147323781|NCT00916006|531350023|FG001|Overall Study|Protocol Violation|1|||
147591069|NCT01432574|532320961|FG000|Overall Study|Moved|2|||
147591070|NCT01432574|532320961|FG000|Overall Study|Not interested|1|||
147591071|NCT02516410|532320962|FG000|Overall Study|Adverse Event|0|||
147591072|NCT02516410|532320963|FG001|Overall Study|Adverse Event|1|||
147591073|NCT02516410|532320962|FG000|Overall Study|Withdrawal by Subject|0|||
147591074|NCT02516410|532320963|FG001|Overall Study|Withdrawal by Subject|1|||
147591075|NCT01475253|532320968|FG000|Randomized, Blinded Study|Withdrawal by Subject|1|||
147591076|NCT01475253|532320969|FG001|Randomized, Blinded Study|Withdrawal by Subject|1|||
147244291|NCT01318993|531066969|FG000|Overall Study|Protocol based stopping criteria|6|||
147244292|NCT01318993|531066969|FG000|Overall Study|Study closed or terminated|174|||
147244293|NCT01318993|531066969|FG000|Overall Study|Lost to Follow-up|4|||
147244294|NCT01318993|531066969|FG000|Overall Study|Physician Decision|13|||
147591077|NCT01475253|532320970|FG002|Randomized, Blinded Study|Withdrawal by Subject|0|||
147591078|NCT01475253|532320971|FG003|Randomized, Blinded Study|Withdrawal by Subject|0|||
147591079|NCT01475253|532320968|FG000|Randomized, Blinded Study|Lost to Follow-up|1|||
147170976|NCT02914561|530790536|FG010|Induction Study (Day 1 to Week 10)|Withdrawal by Subject|0|||
147170977|NCT02914561|530790526|FG000|Induction Study (Day 1 to Week 10)|Protocol Violation|0|||
147170978|NCT02914561|530790527|FG001|Induction Study (Day 1 to Week 10)|Protocol Violation|4|||
147170979|NCT02914561|530790528|FG002|Induction Study (Day 1 to Week 10)|Protocol Violation|1|||
147170980|NCT02914561|530790529|FG003|Induction Study (Day 1 to Week 10)|Protocol Violation|1|||
147170981|NCT02914561|530790530|FG004|Induction Study (Day 1 to Week 10)|Protocol Violation|3|||
147170982|NCT02914561|530790531|FG005|Induction Study (Day 1 to Week 10)|Protocol Violation|1|||
147170983|NCT02914561|530790532|FG006|Induction Study (Day 1 to Week 10)|Protocol Violation|0|||
147170984|NCT02914561|530790533|FG007|Induction Study (Day 1 to Week 10)|Protocol Violation|0|||
147170985|NCT02914561|530790534|FG008|Induction Study (Day 1 to Week 10)|Protocol Violation|0|||
147170986|NCT02914561|530790535|FG009|Induction Study (Day 1 to Week 10)|Protocol Violation|0|||
147170987|NCT02914561|530790536|FG010|Induction Study (Day 1 to Week 10)|Protocol Violation|0|||
147170988|NCT02914561|530790526|FG000|Induction Study (Day 1 to Week 10)|Physician Decision|1|||
147170989|NCT02914561|530790527|FG001|Induction Study (Day 1 to Week 10)|Physician Decision|5|||
147170990|NCT02914561|530790528|FG002|Induction Study (Day 1 to Week 10)|Physician Decision|2|||
147170991|NCT02914561|530790529|FG003|Induction Study (Day 1 to Week 10)|Physician Decision|0|||
147170992|NCT02914561|530790530|FG004|Induction Study (Day 1 to Week 10)|Physician Decision|4|||
147244295|NCT01318993|531066969|FG000|Overall Study|Withdrawal by Subject|24|||
147244296|NCT01269463|531066970|FG000|First Intervention|Withdrawal by Subject|1|||
147323782|NCT02929108|531350028|FG000|Overall Study|Hospice patient death|100|||
147323783|NCT02929108|531350029|FG001|Overall Study|Hospice patient death|64|||
147654830|NCT00572455|532559157|FG010|Stage I (14 Days)|Adverse Event|0|||
147591080|NCT01475253|532320969|FG001|Randomized, Blinded Study|Lost to Follow-up|0|||
147591081|NCT01475253|532320970|FG002|Randomized, Blinded Study|Lost to Follow-up|0|||
147591082|NCT01475253|532320971|FG003|Randomized, Blinded Study|Lost to Follow-up|0|||
147591083|NCT03135899|532320972|FG000|Overall Study|Failed spirometry,unable to repeat visit|0|||
147591084|NCT03135899|532320973|FG001|Overall Study|Failed spirometry,unable to repeat visit|0|||
147591085|NCT03135899|532320974|FG002|Overall Study|Failed spirometry,unable to repeat visit|0|||
147591086|NCT03135899|532320975|FG003|Overall Study|Failed spirometry,unable to repeat visit|0|||
147170993|NCT02914561|530790531|FG005|Induction Study (Day 1 to Week 10)|Physician Decision|4|||
147170994|NCT02914561|530790532|FG006|Induction Study (Day 1 to Week 10)|Physician Decision|0|||
147170995|NCT02914561|530790533|FG007|Induction Study (Day 1 to Week 10)|Physician Decision|0|||
147170996|NCT02914561|530790534|FG008|Induction Study (Day 1 to Week 10)|Physician Decision|0|||
147170997|NCT02914561|530790535|FG009|Induction Study (Day 1 to Week 10)|Physician Decision|0|||
147170998|NCT02914561|530790536|FG010|Induction Study (Day 1 to Week 10)|Physician Decision|0|||
147170999|NCT02914561|530790526|FG000|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
147171000|NCT02914561|530790527|FG001|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
147171001|NCT02914561|530790528|FG002|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|1|||
147171002|NCT02914561|530790529|FG003|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
147171003|NCT02914561|530790530|FG004|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
147171004|NCT02914561|530790531|FG005|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|1|||
147171005|NCT02914561|530790532|FG006|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
147171006|NCT02914561|530790533|FG007|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
147171007|NCT02914561|530790534|FG008|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
147171008|NCT02914561|530790535|FG009|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
147171009|NCT02914561|530790536|FG010|Induction Study (Day 1 to Week 10)|Non-Compliance with Study Drug|0|||
147171010|NCT02914561|530790526|FG000|Induction Study (Day 1 to Week 10)|Pregnancy|1|||
147171011|NCT02914561|530790527|FG001|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
147171012|NCT02914561|530790528|FG002|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
147171013|NCT02914561|530790529|FG003|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
147171014|NCT02914561|530790530|FG004|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
147171015|NCT02914561|530790531|FG005|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
147591087|NCT03135899|532320976|FG004|Overall Study|Failed spirometry,unable to repeat visit|0|||
147591088|NCT03135899|532320977|FG005|Overall Study|Failed spirometry,unable to repeat visit|0|||
147591089|NCT03135899|532320978|FG006|Overall Study|Failed spirometry,unable to repeat visit|1|||
147591090|NCT03135899|532320979|FG007|Overall Study|Failed spirometry,unable to repeat visit|0|||
147591091|NCT03135899|532320972|FG000|Overall Study|Withdrawal by Subject|0|||
147591092|NCT03135899|532320973|FG001|Overall Study|Withdrawal by Subject|0|||
147591093|NCT03135899|532320974|FG002|Overall Study|Withdrawal by Subject|0|||
147591094|NCT03135899|532320975|FG003|Overall Study|Withdrawal by Subject|0|||
147591095|NCT03135899|532320976|FG004|Overall Study|Withdrawal by Subject|0|||
147591096|NCT03135899|532320977|FG005|Overall Study|Withdrawal by Subject|2|||
147591097|NCT03135899|532320978|FG006|Overall Study|Withdrawal by Subject|0|||
147591098|NCT03135899|532320979|FG007|Overall Study|Withdrawal by Subject|0|||
147591099|NCT04146363|532320980|FG000|Induction Period|Adverse Event|1|||
147591100|NCT04146363|532320981|FG001|Induction Period|Adverse Event|2|||
147591101|NCT04146363|532320982|FG002|Induction Period|Adverse Event|0|||
147591102|NCT04146363|532320983|FG003|Induction Period|Adverse Event|0|||
147591103|NCT04146363|532320984|FG004|Induction Period|Adverse Event|0|||
147591104|NCT04146363|532320985|FG005|Induction Period|Adverse Event|0|||
147591105|NCT04146363|532320986|FG006|Induction Period|Adverse Event|0|||
147591106|NCT04146363|532320987|FG007|Induction Period|Adverse Event|0|||
147591107|NCT04146363|532320988|FG008|Induction Period|Adverse Event|0|||
147591108|NCT04146363|532320989|FG009|Induction Period|Adverse Event|0|||
147171016|NCT02914561|530790532|FG006|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
147171017|NCT02914561|530790533|FG007|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
147171018|NCT02914561|530790534|FG008|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
147171019|NCT02914561|530790535|FG009|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
147171020|NCT02914561|530790536|FG010|Induction Study (Day 1 to Week 10)|Pregnancy|0|||
147171021|NCT02914561|530790526|FG000|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
147171022|NCT02914561|530790527|FG001|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
147171023|NCT02914561|530790528|FG002|Induction Study (Day 1 to Week 10)|Lost to Follow-up|1|||
147171024|NCT02914561|530790529|FG003|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
147171025|NCT02914561|530790530|FG004|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
147244297|NCT01269463|531066971|FG001|First Intervention|Withdrawal by Subject|0|||
147591109|NCT04146363|532320990|FG010|Induction Period|Adverse Event|0|||
147591110|NCT04146363|532320980|FG000|Induction Period|Due to Epidemic/Pandemic|1|||
147591111|NCT04146363|532320981|FG001|Induction Period|Due to Epidemic/Pandemic|2|||
147171026|NCT02914561|530790531|FG005|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
147244298|NCT01269463|531066970|FG000|First Intervention|Adverse Event|1|||
147591112|NCT04146363|532320982|FG002|Induction Period|Due to Epidemic/Pandemic|0|||
147591113|NCT04146363|532320983|FG003|Induction Period|Due to Epidemic/Pandemic|0|||
147171027|NCT02914561|530790532|FG006|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
147171028|NCT02914561|530790533|FG007|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
147591114|NCT04146363|532320984|FG004|Induction Period|Due to Epidemic/Pandemic|0|||
147591115|NCT04146363|532320985|FG005|Induction Period|Due to Epidemic/Pandemic|0|||
147591116|NCT04146363|532320986|FG006|Induction Period|Due to Epidemic/Pandemic|0|||
147591117|NCT04146363|532320987|FG007|Induction Period|Due to Epidemic/Pandemic|0|||
147591118|NCT04146363|532320988|FG008|Induction Period|Due to Epidemic/Pandemic|0|||
147591119|NCT04146363|532320989|FG009|Induction Period|Due to Epidemic/Pandemic|0|||
147591120|NCT04146363|532320990|FG010|Induction Period|Due to Epidemic/Pandemic|0|||
147591121|NCT04146363|532320980|FG000|Induction Period|Lack of Efficacy|7|||
147591122|NCT04146363|532320981|FG001|Induction Period|Lack of Efficacy|2|||
147591123|NCT04146363|532320982|FG002|Induction Period|Lack of Efficacy|0|||
147591124|NCT04146363|532320983|FG003|Induction Period|Lack of Efficacy|0|||
147591125|NCT04146363|532320984|FG004|Induction Period|Lack of Efficacy|0|||
147591126|NCT04146363|532320985|FG005|Induction Period|Lack of Efficacy|0|||
147591127|NCT04146363|532320986|FG006|Induction Period|Lack of Efficacy|0|||
147591128|NCT04146363|532320987|FG007|Induction Period|Lack of Efficacy|0|||
147591129|NCT04146363|532320988|FG008|Induction Period|Lack of Efficacy|0|||
147591130|NCT04146363|532320989|FG009|Induction Period|Lack of Efficacy|0|||
147591131|NCT04146363|532320990|FG010|Induction Period|Lack of Efficacy|0|||
147591132|NCT04146363|532320980|FG000|Induction Period|Lost to Follow-up|1|||
147591133|NCT04146363|532320981|FG001|Induction Period|Lost to Follow-up|4|||
147591134|NCT04146363|532320982|FG002|Induction Period|Lost to Follow-up|0|||
147591135|NCT04146363|532320983|FG003|Induction Period|Lost to Follow-up|0|||
147591136|NCT04146363|532320984|FG004|Induction Period|Lost to Follow-up|0|||
147591137|NCT04146363|532320985|FG005|Induction Period|Lost to Follow-up|0|||
147591138|NCT04146363|532320986|FG006|Induction Period|Lost to Follow-up|0|||
147591139|NCT04146363|532320987|FG007|Induction Period|Lost to Follow-up|0|||
147591140|NCT04146363|532320988|FG008|Induction Period|Lost to Follow-up|0|||
147591141|NCT04146363|532320989|FG009|Induction Period|Lost to Follow-up|0|||
147591142|NCT04146363|532320990|FG010|Induction Period|Lost to Follow-up|0|||
147591143|NCT04146363|532320980|FG000|Induction Period|Positive quantiferon test|0|||
147591144|NCT04146363|532320981|FG001|Induction Period|Positive quantiferon test|1|||
147591145|NCT04146363|532320982|FG002|Induction Period|Positive quantiferon test|0|||
147591146|NCT04146363|532320983|FG003|Induction Period|Positive quantiferon test|0|||
147591147|NCT04146363|532320984|FG004|Induction Period|Positive quantiferon test|0|||
147591148|NCT04146363|532320985|FG005|Induction Period|Positive quantiferon test|0|||
147591149|NCT04146363|532320986|FG006|Induction Period|Positive quantiferon test|0|||
147591150|NCT04146363|532320987|FG007|Induction Period|Positive quantiferon test|0|||
147591151|NCT04146363|532320988|FG008|Induction Period|Positive quantiferon test|0|||
147591152|NCT04146363|532320989|FG009|Induction Period|Positive quantiferon test|0|||
147591153|NCT04146363|532320990|FG010|Induction Period|Positive quantiferon test|0|||
147591154|NCT04146363|532320980|FG000|Induction Period|Protocol Deviation|5|||
147591155|NCT04146363|532320981|FG001|Induction Period|Protocol Deviation|6|||
147591156|NCT04146363|532320982|FG002|Induction Period|Protocol Deviation|0|||
147591157|NCT04146363|532320983|FG003|Induction Period|Protocol Deviation|0|||
147591158|NCT04146363|532320984|FG004|Induction Period|Protocol Deviation|0|||
147591159|NCT04146363|532320985|FG005|Induction Period|Protocol Deviation|0|||
147591160|NCT04146363|532320986|FG006|Induction Period|Protocol Deviation|0|||
147591161|NCT04146363|532320987|FG007|Induction Period|Protocol Deviation|0|||
147591162|NCT04146363|532320988|FG008|Induction Period|Protocol Deviation|0|||
147591163|NCT04146363|532320989|FG009|Induction Period|Protocol Deviation|0|||
147591164|NCT04146363|532320990|FG010|Induction Period|Protocol Deviation|0|||
147591165|NCT04146363|532320980|FG000|Induction Period|Withdrawal by Subject|6|||
147591166|NCT04146363|532320981|FG001|Induction Period|Withdrawal by Subject|3|||
147591167|NCT04146363|532320982|FG002|Induction Period|Withdrawal by Subject|0|||
147591168|NCT04146363|532320983|FG003|Induction Period|Withdrawal by Subject|0|||
147591169|NCT04146363|532320984|FG004|Induction Period|Withdrawal by Subject|0|||
147591170|NCT04146363|532320985|FG005|Induction Period|Withdrawal by Subject|0|||
147591171|NCT04146363|532320986|FG006|Induction Period|Withdrawal by Subject|0|||
147591172|NCT04146363|532320987|FG007|Induction Period|Withdrawal by Subject|0|||
147591173|NCT04146363|532320988|FG008|Induction Period|Withdrawal by Subject|0|||
147591174|NCT04146363|532320989|FG009|Induction Period|Withdrawal by Subject|0|||
147171029|NCT02914561|530790534|FG008|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
147171030|NCT02914561|530790535|FG009|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
147171031|NCT02914561|530790536|FG010|Induction Study (Day 1 to Week 10)|Lost to Follow-up|0|||
147171032|NCT02914561|530790526|FG000|Induction Study (Day 1 to Week 10)|Randomized but not treated|1|||
147171033|NCT02914561|530790527|FG001|Induction Study (Day 1 to Week 10)|Randomized but not treated|0|||
147171034|NCT02914561|530790528|FG002|Induction Study (Day 1 to Week 10)|Randomized but not treated|2|||
147591175|NCT04146363|532320990|FG010|Induction Period|Withdrawal by Subject|0|||
147591176|NCT04146363|532320980|FG000|Maintenance Blinded Treatment Period|Adverse Event|0|||
147591177|NCT04146363|532320981|FG001|Maintenance Blinded Treatment Period|Adverse Event|0|||
147591178|NCT04146363|532320982|FG002|Maintenance Blinded Treatment Period|Adverse Event|0|||
147591179|NCT04146363|532320983|FG003|Maintenance Blinded Treatment Period|Adverse Event|0|||
147171035|NCT02914561|530790529|FG003|Induction Study (Day 1 to Week 10)|Randomized but not treated|2|||
147171036|NCT02914561|530790530|FG004|Induction Study (Day 1 to Week 10)|Randomized but not treated|2|||
147171037|NCT02914561|530790531|FG005|Induction Study (Day 1 to Week 10)|Randomized but not treated|2|||
147171038|NCT02914561|530790532|FG006|Induction Study (Day 1 to Week 10)|Randomized but not treated|0|||
147171039|NCT02914561|530790533|FG007|Induction Study (Day 1 to Week 10)|Randomized but not treated|0|||
147171040|NCT02914561|530790534|FG008|Induction Study (Day 1 to Week 10)|Randomized but not treated|0|||
147171041|NCT02914561|530790535|FG009|Induction Study (Day 1 to Week 10)|Randomized but not treated|0|||
147591180|NCT04146363|532320984|FG004|Maintenance Blinded Treatment Period|Adverse Event|0|||
147591181|NCT04146363|532320985|FG005|Maintenance Blinded Treatment Period|Adverse Event|0|||
147591182|NCT04146363|532320986|FG006|Maintenance Blinded Treatment Period|Adverse Event|1|||
147591183|NCT04146363|532320987|FG007|Maintenance Blinded Treatment Period|Adverse Event|1|||
147591184|NCT04146363|532320988|FG008|Maintenance Blinded Treatment Period|Adverse Event|0|||
147591185|NCT04146363|532320989|FG009|Maintenance Blinded Treatment Period|Adverse Event|0|||
147591186|NCT04146363|532320990|FG010|Maintenance Blinded Treatment Period|Adverse Event|0|||
147591187|NCT04146363|532320980|FG000|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
147591188|NCT04146363|532320981|FG001|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
147591189|NCT04146363|532320982|FG002|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
147591190|NCT04146363|532320983|FG003|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
147591191|NCT04146363|532320984|FG004|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
147591192|NCT04146363|532320985|FG005|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
147591193|NCT04146363|532320986|FG006|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
147591194|NCT04146363|532320987|FG007|Maintenance Blinded Treatment Period|Lack of Efficacy|1|||
147591195|NCT04146363|532320988|FG008|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
147591196|NCT04146363|532320989|FG009|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
147591197|NCT04146363|532320990|FG010|Maintenance Blinded Treatment Period|Lack of Efficacy|0|||
147591198|NCT04146363|532320980|FG000|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
147591199|NCT04146363|532320981|FG001|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
147591200|NCT04146363|532320982|FG002|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
147591201|NCT04146363|532320983|FG003|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
147591202|NCT04146363|532320984|FG004|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
147591203|NCT04146363|532320985|FG005|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
147591204|NCT04146363|532320986|FG006|Maintenance Blinded Treatment Period|Lost to Follow-up|1|||
147591205|NCT04146363|532320987|FG007|Maintenance Blinded Treatment Period|Lost to Follow-up|1|||
147591206|NCT04146363|532320988|FG008|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
147591207|NCT04146363|532320989|FG009|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
147591208|NCT04146363|532320990|FG010|Maintenance Blinded Treatment Period|Lost to Follow-up|0|||
147591209|NCT04146363|532320980|FG000|Maintenance Blinded Treatment Period|Physician Decision|0|||
147591210|NCT04146363|532320981|FG001|Maintenance Blinded Treatment Period|Physician Decision|0|||
147591211|NCT04146363|532320982|FG002|Maintenance Blinded Treatment Period|Physician Decision|1|||
147591212|NCT04146363|532320983|FG003|Maintenance Blinded Treatment Period|Physician Decision|0|||
147591213|NCT04146363|532320984|FG004|Maintenance Blinded Treatment Period|Physician Decision|0|||
147591214|NCT04146363|532320985|FG005|Maintenance Blinded Treatment Period|Physician Decision|1|||
147591215|NCT04146363|532320986|FG006|Maintenance Blinded Treatment Period|Physician Decision|0|||
147591216|NCT04146363|532320987|FG007|Maintenance Blinded Treatment Period|Physician Decision|0|||
147591217|NCT04146363|532320988|FG008|Maintenance Blinded Treatment Period|Physician Decision|0|||
147591218|NCT04146363|532320989|FG009|Maintenance Blinded Treatment Period|Physician Decision|0|||
147591219|NCT04146363|532320990|FG010|Maintenance Blinded Treatment Period|Physician Decision|0|||
147591220|NCT04146363|532320980|FG000|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
147591221|NCT04146363|532320981|FG001|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
147591222|NCT04146363|532320982|FG002|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
147591223|NCT04146363|532320983|FG003|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
147591224|NCT04146363|532320984|FG004|Maintenance Blinded Treatment Period|Withdrawal by Subject|1|||
147591225|NCT04146363|532320985|FG005|Maintenance Blinded Treatment Period|Withdrawal by Subject|2|||
147654831|NCT00572455|532559158|FG011|Stage I (14 Days)|Adverse Event|0|||
147171042|NCT02914561|530790536|FG010|Induction Study (Day 1 to Week 10)|Randomized but not treated|0|||
147171043|NCT02914561|530790526|FG000|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|0|||
147171044|NCT02914561|530790527|FG001|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|0|||
147171045|NCT02914561|530790528|FG002|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|0|||
147171046|NCT02914561|530790529|FG003|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|0|||
147171047|NCT02914561|530790530|FG004|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|0|||
147171048|NCT02914561|530790531|FG005|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|0|||
147171049|NCT02914561|530790532|FG006|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|31|||
147171050|NCT02914561|530790533|FG007|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|32|||
147654832|NCT00572455|532559159|FG012|Stage I (14 Days)|Adverse Event|0|||
147654833|NCT00572455|532559160|FG013|Stage I (14 Days)|Adverse Event|0|||
147654834|NCT00572455|532559147|FG000|Stage I (14 Days)|Other|0|||
147654835|NCT00572455|532559148|FG001|Stage I (14 Days)|Other|0|||
147654836|NCT00572455|532559149|FG002|Stage I (14 Days)|Other|0|||
147654837|NCT00572455|532559150|FG003|Stage I (14 Days)|Other|0|||
147654838|NCT00572455|532559151|FG004|Stage I (14 Days)|Other|1|||
147654839|NCT00572455|532559152|FG005|Stage I (14 Days)|Other|0|||
147654840|NCT00572455|532559153|FG006|Stage I (14 Days)|Other|0|||
147654841|NCT00572455|532559154|FG007|Stage I (14 Days)|Other|0|||
147654842|NCT00572455|532559155|FG008|Stage I (14 Days)|Other|0|||
147654843|NCT00572455|532559156|FG009|Stage I (14 Days)|Other|0|||
147654844|NCT00572455|532559157|FG010|Stage I (14 Days)|Other|0|||
147654845|NCT00572455|532559158|FG011|Stage I (14 Days)|Other|0|||
147654846|NCT00572455|532559159|FG012|Stage I (14 Days)|Other|0|||
147654847|NCT00572455|532559160|FG013|Stage I (14 Days)|Other|0|||
147654848|NCT00572455|532559147|FG000|Stage II (28 Days)|Adverse Event|0|||
147654849|NCT00572455|532559148|FG001|Stage II (28 Days)|Adverse Event|0|||
147654850|NCT00572455|532559149|FG002|Stage II (28 Days)|Adverse Event|0|||
147654851|NCT00572455|532559150|FG003|Stage II (28 Days)|Adverse Event|0|||
147654852|NCT00572455|532559151|FG004|Stage II (28 Days)|Adverse Event|0|||
147654853|NCT00572455|532559152|FG005|Stage II (28 Days)|Adverse Event|0|||
147654854|NCT00572455|532559153|FG006|Stage II (28 Days)|Adverse Event|0|||
147654855|NCT00572455|532559154|FG007|Stage II (28 Days)|Adverse Event|0|||
147654856|NCT00572455|532559155|FG008|Stage II (28 Days)|Adverse Event|1|||
147654857|NCT00572455|532559156|FG009|Stage II (28 Days)|Adverse Event|3|||
147654858|NCT00572455|532559157|FG010|Stage II (28 Days)|Adverse Event|3|||
147654859|NCT00572455|532559158|FG011|Stage II (28 Days)|Adverse Event|4|||
147654860|NCT00572455|532559159|FG012|Stage II (28 Days)|Adverse Event|5|||
147654861|NCT00572455|532559160|FG013|Stage II (28 Days)|Adverse Event|1|||
147654862|NCT00572455|532559147|FG000|Stage II (28 Days)|Death|0|||
147654863|NCT00572455|532559148|FG001|Stage II (28 Days)|Death|0|||
147654864|NCT00572455|532559149|FG002|Stage II (28 Days)|Death|0|||
147654865|NCT00572455|532559150|FG003|Stage II (28 Days)|Death|0|||
147654866|NCT00572455|532559151|FG004|Stage II (28 Days)|Death|0|||
147654867|NCT00572455|532559152|FG005|Stage II (28 Days)|Death|0|||
147654868|NCT00572455|532559153|FG006|Stage II (28 Days)|Death|0|||
147654869|NCT00572455|532559154|FG007|Stage II (28 Days)|Death|0|||
147654870|NCT00572455|532559155|FG008|Stage II (28 Days)|Death|1|||
147654871|NCT00572455|532559156|FG009|Stage II (28 Days)|Death|0|||
147654872|NCT00572455|532559157|FG010|Stage II (28 Days)|Death|0|||
147654873|NCT00572455|532559158|FG011|Stage II (28 Days)|Death|0|||
147654874|NCT00572455|532559159|FG012|Stage II (28 Days)|Death|0|||
147654875|NCT00572455|532559160|FG013|Stage II (28 Days)|Death|0|||
147654876|NCT00572455|532559147|FG000|Stage II (28 Days)|Withdrawal by Subject|0|||
147654877|NCT00572455|532559148|FG001|Stage II (28 Days)|Withdrawal by Subject|0|||
147654878|NCT00572455|532559149|FG002|Stage II (28 Days)|Withdrawal by Subject|0|||
147448016|NCT02831673|531805608|FG003|Continuation Phase(Week 148 to Week 280)|Adverse Event|0|||
147448017|NCT02831673|531805609|FG004|Continuation Phase(Week 148 to Week 280)|Adverse Event|1|||
147654879|NCT00572455|532559150|FG003|Stage II (28 Days)|Withdrawal by Subject|0|||
147448018|NCT02831673|531805605|FG000|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
147654880|NCT00572455|532559151|FG004|Stage II (28 Days)|Withdrawal by Subject|0|||
147654881|NCT00572455|532559152|FG005|Stage II (28 Days)|Withdrawal by Subject|0|||
147654882|NCT00572455|532559153|FG006|Stage II (28 Days)|Withdrawal by Subject|0|||
147654883|NCT00572455|532559154|FG007|Stage II (28 Days)|Withdrawal by Subject|1|||
147654884|NCT00572455|532559155|FG008|Stage II (28 Days)|Withdrawal by Subject|0|||
147654885|NCT00572455|532559156|FG009|Stage II (28 Days)|Withdrawal by Subject|0|||
147654886|NCT00572455|532559157|FG010|Stage II (28 Days)|Withdrawal by Subject|2|||
147654887|NCT00572455|532559158|FG011|Stage II (28 Days)|Withdrawal by Subject|0|||
147654888|NCT00572455|532559159|FG012|Stage II (28 Days)|Withdrawal by Subject|0|||
147654889|NCT00572455|532559160|FG013|Stage II (28 Days)|Withdrawal by Subject|0|||
147654890|NCT00572455|532559147|FG000|Stage II (28 Days)|Other|0|||
147654891|NCT00572455|532559148|FG001|Stage II (28 Days)|Other|0|||
147654892|NCT00572455|532559149|FG002|Stage II (28 Days)|Other|0|||
147654893|NCT00572455|532559150|FG003|Stage II (28 Days)|Other|0|||
147654894|NCT00572455|532559151|FG004|Stage II (28 Days)|Other|0|||
147654895|NCT00572455|532559152|FG005|Stage II (28 Days)|Other|0|||
147654896|NCT00572455|532559153|FG006|Stage II (28 Days)|Other|0|||
147448019|NCT02831673|531805606|FG001|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
147654897|NCT00572455|532559154|FG007|Stage II (28 Days)|Other|0|||
147654898|NCT00572455|532559155|FG008|Stage II (28 Days)|Other|1|||
147654899|NCT00572455|532559156|FG009|Stage II (28 Days)|Other|0|||
147654900|NCT00572455|532559157|FG010|Stage II (28 Days)|Other|0|||
147654901|NCT00572455|532559158|FG011|Stage II (28 Days)|Other|0|||
147654902|NCT00572455|532559159|FG012|Stage II (28 Days)|Other|0|||
147654903|NCT00572455|532559160|FG013|Stage II (28 Days)|Other|0|||
147654904|NCT00572455|532559147|FG000|Stage II (28 Days)|Randomized, but not treated|0|||
147654905|NCT00572455|532559148|FG001|Stage II (28 Days)|Randomized, but not treated|0|||
147654906|NCT00572455|532559149|FG002|Stage II (28 Days)|Randomized, but not treated|0|||
147654907|NCT00572455|532559150|FG003|Stage II (28 Days)|Randomized, but not treated|0|||
147654908|NCT00572455|532559151|FG004|Stage II (28 Days)|Randomized, but not treated|0|||
147654909|NCT00572455|532559152|FG005|Stage II (28 Days)|Randomized, but not treated|0|||
147654910|NCT00572455|532559153|FG006|Stage II (28 Days)|Randomized, but not treated|0|||
147654911|NCT00572455|532559154|FG007|Stage II (28 Days)|Randomized, but not treated|0|||
147654912|NCT00572455|532559155|FG008|Stage II (28 Days)|Randomized, but not treated|0|||
147654913|NCT00572455|532559156|FG009|Stage II (28 Days)|Randomized, but not treated|0|||
147654914|NCT00572455|532559157|FG010|Stage II (28 Days)|Randomized, but not treated|0|||
147654915|NCT00572455|532559158|FG011|Stage II (28 Days)|Randomized, but not treated|0|||
147654916|NCT00572455|532559159|FG012|Stage II (28 Days)|Randomized, but not treated|0|||
147654917|NCT00572455|532559160|FG013|Stage II (28 Days)|Randomized, but not treated|1|||
147654918|NCT04446429|532559161|FG000|Overall Study|Lost to Follow-up|6|||
147654919|NCT04446429|532559162|FG001|Overall Study|Lost to Follow-up|0|||
147654920|NCT05205005|532559163|FG000|Overall Study|Withdrawal by Subject|1|||
147654921|NCT05205005|532559164|FG001|Overall Study|Withdrawal by Subject|0|||
147654922|NCT05205005|532559163|FG000|Overall Study|Adverse Event|1|||
147591226|NCT04146363|532320986|FG006|Maintenance Blinded Treatment Period|Withdrawal by Subject|3|||
147591227|NCT04146363|532320987|FG007|Maintenance Blinded Treatment Period|Withdrawal by Subject|5|||
147591228|NCT04146363|532320988|FG008|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
147591229|NCT04146363|532320989|FG009|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
147591230|NCT04146363|532320990|FG010|Maintenance Blinded Treatment Period|Withdrawal by Subject|0|||
147591231|NCT04146363|532320980|FG000|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
147591232|NCT04146363|532320981|FG001|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
147591233|NCT04146363|532320982|FG002|Maintenance Blinded Treatment Period|Entered Escape Arm|1|||
147591234|NCT04146363|532320983|FG003|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
147591235|NCT04146363|532320984|FG004|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
147591236|NCT04146363|532320985|FG005|Maintenance Blinded Treatment Period|Entered Escape Arm|7|||
147591237|NCT04146363|532320986|FG006|Maintenance Blinded Treatment Period|Entered Escape Arm|4|||
147591238|NCT04146363|532320987|FG007|Maintenance Blinded Treatment Period|Entered Escape Arm|6|||
147654923|NCT05205005|532559164|FG001|Overall Study|Adverse Event|0|||
147654924|NCT00694356|532559168|FG000|Overall Study|Adverse Event|1|||
147654925|NCT00694356|532559169|FG001|Overall Study|Adverse Event|0|||
147654926|NCT00694356|532559170|FG002|Overall Study|Adverse Event|0|||
147654927|NCT00694356|532559168|FG000|Overall Study|Progressive Disease|2|||
147654928|NCT00694356|532559169|FG001|Overall Study|Progressive Disease|6|||
147654929|NCT00694356|532559170|FG002|Overall Study|Progressive Disease|6|||
147654930|NCT01308463|532559174|FG000|Overall Study|Study Discontinued|23|||
147654931|NCT01308463|532559174|FG000|Overall Study|Death|4|||
147654932|NCT01308463|532559174|FG000|Overall Study|Revision|2|||
147654933|NCT01042392|532559175|FG000|Period II(Randomized,Double Blinded,8wk)|Adverse Event|6|||
147654934|NCT01042392|532559176|FG001|Period II(Randomized,Double Blinded,8wk)|Adverse Event|0|||
147654935|NCT01042392|532559177|FG002|Period II(Randomized,Double Blinded,8wk)|Adverse Event|5|||
147654936|NCT01042392|532559178|FG003|Period II(Randomized,Double Blinded,8wk)|Adverse Event|0|||
147654937|NCT01042392|532559175|FG000|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|1|||
147654938|NCT01042392|532559176|FG001|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|0|||
147654939|NCT01042392|532559177|FG002|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|0|||
147654940|NCT01042392|532559178|FG003|Period II(Randomized,Double Blinded,8wk)|Unsatisfactory therapeutic effect|0|||
147654941|NCT01042392|532559175|FG000|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|1|||
147654942|NCT01042392|532559176|FG001|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|0|||
147654943|NCT01042392|532559177|FG002|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|2|||
147654944|NCT01042392|532559178|FG003|Period II(Randomized,Double Blinded,8wk)|Withdrawal by Subject|0|||
147654945|NCT01042392|532559175|FG000|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|0|||
147654946|NCT01042392|532559176|FG001|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|0|||
147654947|NCT01042392|532559177|FG002|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|1|||
147654948|NCT01042392|532559178|FG003|Period II(Randomized,Double Blinded,8wk)|Lost to Follow-up|0|||
147654949|NCT01042392|532559175|FG000|Period II(Randomized,Double Blinded,8wk)|Administrative problems|2|||
147654950|NCT01042392|532559176|FG001|Period II(Randomized,Double Blinded,8wk)|Administrative problems|0|||
147654951|NCT01042392|532559177|FG002|Period II(Randomized,Double Blinded,8wk)|Administrative problems|0|||
147654952|NCT01042392|532559178|FG003|Period II(Randomized,Double Blinded,8wk)|Administrative problems|0|||
147654953|NCT01042392|532559175|FG000|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|0|||
147654954|NCT01042392|532559176|FG001|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|0|||
147654955|NCT01042392|532559177|FG002|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|1|||
147654956|NCT01042392|532559178|FG003|Period III (Unblinded,Controlled, 1 Day)|Adverse Event|0|||
147654957|NCT01042392|532559175|FG000|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|2|||
147654958|NCT01042392|532559176|FG001|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|0|||
147654959|NCT01042392|532559177|FG002|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|0|||
147654960|NCT01042392|532559178|FG003|Period III (Unblinded,Controlled, 1 Day)|Protocol Violation|0|||
147654961|NCT01042392|532559175|FG000|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|0|||
147654962|NCT01042392|532559176|FG001|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|0|||
147171051|NCT02914561|530790534|FG008|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|40|||
147171052|NCT02914561|530790535|FG009|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|25|||
147171053|NCT02914561|530790536|FG010|Maintenance Study (Weeks 11 to 58)|Protocol-Specified Disease Worsening|43|||
147171054|NCT02914561|530790526|FG000|Maintenance Study (Weeks 11 to 58)|Adverse Event|0|||
147171055|NCT02914561|530790527|FG001|Maintenance Study (Weeks 11 to 58)|Adverse Event|0|||
147171056|NCT02914561|530790528|FG002|Maintenance Study (Weeks 11 to 58)|Adverse Event|0|||
147171057|NCT02914561|530790529|FG003|Maintenance Study (Weeks 11 to 58)|Adverse Event|0|||
147171058|NCT02914561|530790530|FG004|Maintenance Study (Weeks 11 to 58)|Adverse Event|0|||
147171059|NCT02914561|530790531|FG005|Maintenance Study (Weeks 11 to 58)|Adverse Event|0|||
147171060|NCT02914561|530790532|FG006|Maintenance Study (Weeks 11 to 58)|Adverse Event|9|||
147171061|NCT02914561|530790533|FG007|Maintenance Study (Weeks 11 to 58)|Adverse Event|2|||
147448020|NCT02831673|531805607|FG002|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
147448021|NCT02831673|531805608|FG003|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
147591239|NCT04146363|532320988|FG008|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
147591240|NCT04146363|532320989|FG009|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
147591241|NCT04146363|532320990|FG010|Maintenance Blinded Treatment Period|Entered Escape Arm|0|||
147591242|NCT04146363|532320980|FG000|Maintenance Open Label Escape Arm|Adverse Event|0|||
147591243|NCT04146363|532320981|FG001|Maintenance Open Label Escape Arm|Adverse Event|0|||
147591244|NCT04146363|532320982|FG002|Maintenance Open Label Escape Arm|Adverse Event|0|||
147591245|NCT04146363|532320983|FG003|Maintenance Open Label Escape Arm|Adverse Event|0|||
147591246|NCT04146363|532320984|FG004|Maintenance Open Label Escape Arm|Adverse Event|0|||
147591247|NCT04146363|532320985|FG005|Maintenance Open Label Escape Arm|Adverse Event|0|||
147591248|NCT04146363|532320986|FG006|Maintenance Open Label Escape Arm|Adverse Event|0|||
147591249|NCT04146363|532320987|FG007|Maintenance Open Label Escape Arm|Adverse Event|0|||
147591250|NCT04146363|532320988|FG008|Maintenance Open Label Escape Arm|Adverse Event|1|||
147591251|NCT04146363|532320989|FG009|Maintenance Open Label Escape Arm|Adverse Event|4|||
147591252|NCT04146363|532320990|FG010|Maintenance Open Label Escape Arm|Adverse Event|0|||
147591253|NCT04146363|532320980|FG000|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
147591254|NCT04146363|532320981|FG001|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
147591255|NCT04146363|532320982|FG002|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
147591256|NCT04146363|532320983|FG003|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
147591257|NCT04146363|532320984|FG004|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
147591258|NCT04146363|532320985|FG005|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
147591259|NCT04146363|532320986|FG006|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
147591260|NCT04146363|532320987|FG007|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
147591261|NCT04146363|532320988|FG008|Maintenance Open Label Escape Arm|Lack of Efficacy|11|||
147591262|NCT04146363|532320989|FG009|Maintenance Open Label Escape Arm|Lack of Efficacy|17|||
147591263|NCT04146363|532320990|FG010|Maintenance Open Label Escape Arm|Lack of Efficacy|1|||
147591264|NCT04146363|532320980|FG000|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
147591265|NCT04146363|532320981|FG001|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
147591266|NCT04146363|532320982|FG002|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
147591267|NCT04146363|532320983|FG003|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
147591268|NCT04146363|532320984|FG004|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
147591269|NCT04146363|532320985|FG005|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
147591270|NCT04146363|532320986|FG006|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
147591271|NCT04146363|532320987|FG007|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
147591272|NCT04146363|532320988|FG008|Maintenance Open Label Escape Arm|Lost to Follow-up|1|||
147591273|NCT04146363|532320989|FG009|Maintenance Open Label Escape Arm|Lost to Follow-up|2|||
147591274|NCT04146363|532320990|FG010|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
147591275|NCT04146363|532320980|FG000|Maintenance Open Label Escape Arm|Physician Decision|0|||
147591276|NCT04146363|532320981|FG001|Maintenance Open Label Escape Arm|Physician Decision|0|||
147591277|NCT04146363|532320982|FG002|Maintenance Open Label Escape Arm|Physician Decision|0|||
147591278|NCT04146363|532320983|FG003|Maintenance Open Label Escape Arm|Physician Decision|0|||
147591279|NCT04146363|532320984|FG004|Maintenance Open Label Escape Arm|Physician Decision|0|||
147591280|NCT04146363|532320985|FG005|Maintenance Open Label Escape Arm|Physician Decision|0|||
147591281|NCT04146363|532320986|FG006|Maintenance Open Label Escape Arm|Physician Decision|0|||
147591282|NCT04146363|532320987|FG007|Maintenance Open Label Escape Arm|Physician Decision|0|||
147591283|NCT04146363|532320988|FG008|Maintenance Open Label Escape Arm|Physician Decision|1|||
147591284|NCT04146363|532320989|FG009|Maintenance Open Label Escape Arm|Physician Decision|1|||
147591285|NCT04146363|532320990|FG010|Maintenance Open Label Escape Arm|Physician Decision|0|||
147591286|NCT04146363|532320980|FG000|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
147591287|NCT04146363|532320981|FG001|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
147591288|NCT04146363|532320982|FG002|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
147591289|NCT04146363|532320983|FG003|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
147591290|NCT04146363|532320984|FG004|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
147591291|NCT04146363|532320985|FG005|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
147323784|NCT02929108|531350030|FG002|Overall Study|Hospice patient death|28|||
147591292|NCT04146363|532320986|FG006|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
147591293|NCT04146363|532320987|FG007|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
147591294|NCT04146363|532320988|FG008|Maintenance Open Label Escape Arm|Withdrawal by Subject|5|||
147591295|NCT04146363|532320989|FG009|Maintenance Open Label Escape Arm|Withdrawal by Subject|2|||
147591296|NCT04146363|532320990|FG010|Maintenance Open Label Escape Arm|Withdrawal by Subject|2|||
147591297|NCT04146363|532320980|FG000|Maintenance Open Label Escape Arm|Pregnancy|0|||
147591298|NCT04146363|532320981|FG001|Maintenance Open Label Escape Arm|Pregnancy|0|||
147591299|NCT04146363|532320982|FG002|Maintenance Open Label Escape Arm|Pregnancy|0|||
147591300|NCT04146363|532320983|FG003|Maintenance Open Label Escape Arm|Pregnancy|0|||
147591301|NCT04146363|532320984|FG004|Maintenance Open Label Escape Arm|Pregnancy|0|||
147591302|NCT04146363|532320985|FG005|Maintenance Open Label Escape Arm|Pregnancy|0|||
147591303|NCT04146363|532320986|FG006|Maintenance Open Label Escape Arm|Pregnancy|0|||
147591304|NCT04146363|532320987|FG007|Maintenance Open Label Escape Arm|Pregnancy|0|||
147591305|NCT04146363|532320988|FG008|Maintenance Open Label Escape Arm|Pregnancy|0|||
147591306|NCT04146363|532320989|FG009|Maintenance Open Label Escape Arm|Pregnancy|1|||
147171062|NCT02914561|530790534|FG008|Maintenance Study (Weeks 11 to 58)|Adverse Event|11|||
147171063|NCT02914561|530790535|FG009|Maintenance Study (Weeks 11 to 58)|Adverse Event|2|||
147171064|NCT02914561|530790536|FG010|Maintenance Study (Weeks 11 to 58)|Adverse Event|12|||
147171065|NCT02914561|530790526|FG000|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|0|||
147171066|NCT02914561|530790527|FG001|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|0|||
147171067|NCT02914561|530790528|FG002|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|0|||
147171068|NCT02914561|530790529|FG003|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|0|||
147171069|NCT02914561|530790530|FG004|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|0|||
147171070|NCT02914561|530790531|FG005|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|0|||
147171071|NCT02914561|530790532|FG006|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|5|||
147171072|NCT02914561|530790533|FG007|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|1|||
147171073|NCT02914561|530790534|FG008|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|2|||
147171074|NCT02914561|530790535|FG009|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|1|||
147171075|NCT02914561|530790536|FG010|Maintenance Study (Weeks 11 to 58)|Withdrawal by Subject|9|||
147171076|NCT02914561|530790526|FG000|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
147171077|NCT02914561|530790527|FG001|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
147171078|NCT02914561|530790528|FG002|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
147171079|NCT02914561|530790529|FG003|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
147171080|NCT02914561|530790530|FG004|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
147171081|NCT02914561|530790531|FG005|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
147171082|NCT02914561|530790532|FG006|Maintenance Study (Weeks 11 to 58)|Protocol Violation|4|||
147171083|NCT02914561|530790533|FG007|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
147171084|NCT02914561|530790534|FG008|Maintenance Study (Weeks 11 to 58)|Protocol Violation|2|||
147171085|NCT02914561|530790535|FG009|Maintenance Study (Weeks 11 to 58)|Protocol Violation|0|||
147171086|NCT02914561|530790536|FG010|Maintenance Study (Weeks 11 to 58)|Protocol Violation|4|||
147171087|NCT02914561|530790526|FG000|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
147171088|NCT02914561|530790527|FG001|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
147171089|NCT02914561|530790528|FG002|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
147171090|NCT02914561|530790529|FG003|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
147171091|NCT02914561|530790530|FG004|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
147171092|NCT02914561|530790531|FG005|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
147171093|NCT02914561|530790532|FG006|Maintenance Study (Weeks 11 to 58)|Physician Decision|1|||
147171094|NCT02914561|530790533|FG007|Maintenance Study (Weeks 11 to 58)|Physician Decision|0|||
147171095|NCT02914561|530790534|FG008|Maintenance Study (Weeks 11 to 58)|Physician Decision|2|||
147171096|NCT02914561|530790535|FG009|Maintenance Study (Weeks 11 to 58)|Physician Decision|1|||
147171097|NCT02914561|530790536|FG010|Maintenance Study (Weeks 11 to 58)|Physician Decision|3|||
147171098|NCT02914561|530790526|FG000|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
147171099|NCT02914561|530790527|FG001|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
147171100|NCT02914561|530790528|FG002|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
147171101|NCT02914561|530790529|FG003|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
147171102|NCT02914561|530790530|FG004|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
147171103|NCT02914561|530790531|FG005|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
147171104|NCT02914561|530790532|FG006|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|3|||
147171105|NCT02914561|530790533|FG007|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
147171106|NCT02914561|530790534|FG008|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|1|||
147171107|NCT02914561|530790535|FG009|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
147171108|NCT02914561|530790536|FG010|Maintenance Study (Weeks 11 to 58)|Lost to Follow-up|0|||
147171109|NCT02914561|530790526|FG000|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
147591307|NCT04146363|532320990|FG010|Maintenance Open Label Escape Arm|Pregnancy|0|||
147171110|NCT02914561|530790527|FG001|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
147591308|NCT04146363|532320980|FG000|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
147591309|NCT04146363|532320981|FG001|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
147591310|NCT04146363|532320982|FG002|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
147591311|NCT04146363|532320983|FG003|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
147591312|NCT04146363|532320984|FG004|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
147591313|NCT04146363|532320985|FG005|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
147591314|NCT04146363|532320986|FG006|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
147591315|NCT04146363|532320987|FG007|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
147591316|NCT04146363|532320988|FG008|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
147591317|NCT04146363|532320989|FG009|Maintenance Open Label Escape Arm|EASI Scoring Error|2|||
147591318|NCT04146363|532320990|FG010|Maintenance Open Label Escape Arm|EASI Scoring Error|0|||
147591319|NCT02914236|532320995|FG000|Overall Study|Lost to Follow-up|1|||
147591320|NCT02676284|532320996|FG000|Overall Study|Withdrawal by Subject|1|||
147591321|NCT00708708|532320998|FG000|Overall Study|Another therapy instead of Enbrel|141|||
147591322|NCT00708708|532320998|FG000|Overall Study|Lost to Follow-up|52|||
147591323|NCT00708708|532320998|FG000|Overall Study|Withdrawal by Subject|51|||
147591324|NCT00708708|532320998|FG000|Overall Study|Intolerance|42|||
147591325|NCT00708708|532320998|FG000|Overall Study|Another therapy along with Enbrel|15|||
147591326|NCT00708708|532320998|FG000|Overall Study|Other unspecified|11|||
147591327|NCT00708708|532320998|FG000|Overall Study|Good effectiveness|9|||
147591328|NCT00708708|532320998|FG000|Overall Study|Ineffectiveness (no systemic therapy)|9|||
147591329|NCT00708708|532320998|FG000|Overall Study|Administrative reasons|7|||
147591330|NCT00708708|532320998|FG000|Overall Study|Lack of effectiveness|4|||
147591331|NCT00708708|532320998|FG000|Overall Study|Lack of compliance|3|||
147591332|NCT00708708|532320998|FG000|Overall Study|Pregnancy|3|||
147591333|NCT00708708|532320998|FG000|Overall Study|Adverse Event|3|||
147591334|NCT00708708|532320998|FG000|Overall Study|Missing values|392|||
147591335|NCT00856830|532320999|FG000|Irinotecan & Bendamustine|Death|0|||
147591336|NCT00856830|532321000|FG001|Irinotecan & Bendamustine|Death|0|||
147591337|NCT00856830|532321001|FG002|Irinotecan & Bendamustine|Death|0|||
147591338|NCT00856830|532321002|FG003|Irinotecan & Bendamustine|Death|2|||
147591339|NCT00856830|532320999|FG000|Irinotecan & Bendamustine|Physician Decision|0|||
147591340|NCT00856830|532321000|FG001|Irinotecan & Bendamustine|Physician Decision|0|||
147591341|NCT00856830|532321001|FG002|Irinotecan & Bendamustine|Physician Decision|0|||
147591342|NCT00856830|532321002|FG003|Irinotecan & Bendamustine|Physician Decision|1|||
147654963|NCT01042392|532559177|FG002|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|2|||
147654964|NCT01042392|532559178|FG003|Period III (Unblinded,Controlled, 1 Day)|Withdrawal by Subject|0|||
147654965|NCT01042392|532559175|FG000|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|0|||
147654966|NCT01042392|532559176|FG001|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|1|||
147654967|NCT01042392|532559177|FG002|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|1|||
147654968|NCT01042392|532559178|FG003|Period III (Unblinded,Controlled, 1 Day)|Administrative problems|1|||
147654969|NCT03117361|532559179|FG000|Overall Study|Progressive disease|5|||
147654970|NCT03117361|532559179|FG000|Overall Study|Death|1|||
147654971|NCT03117361|532559179|FG000|Overall Study|Physician Decision|2|||
147654972|NCT03117361|532559179|FG000|Overall Study|On study treatment at the end of study|1|||
147654973|NCT03117361|532559179|FG000|Overall Study|Treatment-related adverse event|1|||
147654974|NCT00587795|532559180|FG000|Overall Study|Withdrawal by Subject|1|||
147654975|NCT00587795|532559181|FG001|Overall Study|Withdrawal by Subject|0|||
147654976|NCT00943592|532559182|FG000|Overall Study|Death|3|||
147654977|NCT02072941|532559183|FG000|Overall Study|Withdrawal by Subject|29|||
147654978|NCT02072941|532559184|FG001|Overall Study|Withdrawal by Subject|21|||
147654979|NCT02072941|532559183|FG000|Overall Study|Lost to Follow-up|4|||
147654980|NCT02072941|532559184|FG001|Overall Study|Lost to Follow-up|4|||
147654981|NCT02072941|532559183|FG000|Overall Study|Death|3|||
147654982|NCT02072941|532559184|FG001|Overall Study|Death|2|||
147654983|NCT02072941|532559183|FG000|Overall Study|Removed by Study Staff|2|||
147654984|NCT02072941|532559184|FG001|Overall Study|Removed by Study Staff|2|||
147654985|NCT01247350|532559185|FG000|Overall Study|Adverse Event|0|||
147654986|NCT01247350|532559186|FG001|Overall Study|Adverse Event|0|||
147654987|NCT01247350|532559187|FG002|Overall Study|Adverse Event|1|||
147654988|NCT01247350|532559188|FG003|Overall Study|Adverse Event|0|||
147654989|NCT01247350|532559189|FG004|Overall Study|Adverse Event|0|||
147323785|NCT02929108|531350031|FG003|Overall Study|Hospice patient death|46|||
147323786|NCT02929108|531350032|FG004|Overall Study|Hospice patient death|55|||
147591343|NCT03768726|532321005|FG000|Treatment Phase|Adverse Event|2|||
147591344|NCT03768726|532321006|FG001|Treatment Phase|Adverse Event|2|||
147591345|NCT03768726|532321005|FG000|Treatment Phase|Lost to Follow-up|1|||
147591346|NCT03768726|532321006|FG001|Treatment Phase|Lost to Follow-up|0|||
147591347|NCT03768726|532321005|FG000|Treatment Phase|Withdrawal By Parent/Guardian|2|||
147591348|NCT03768726|532321006|FG001|Treatment Phase|Withdrawal By Parent/Guardian|0|||
147591349|NCT03768726|532321005|FG000|Treatment Phase|Withdrawal by Subject|3|||
147323787|NCT02929108|531350033|FG005|Overall Study|Hospice patient death|28|||
147591350|NCT03768726|532321006|FG001|Treatment Phase|Withdrawal by Subject|1|||
147654990|NCT01247350|532559185|FG000|Overall Study|Withdrawal by Subject|0|||
147591351|NCT03768726|532321005|FG000|Follow-Up|Adverse Event|2|||
147591352|NCT03768726|532321006|FG001|Follow-Up|Adverse Event|2|||
147591353|NCT03768726|532321005|FG000|Follow-Up|Withdrawal By Parent/Guardian|1|||
147591354|NCT03768726|532321006|FG001|Follow-Up|Withdrawal By Parent/Guardian|1|||
147591355|NCT03768726|532321005|FG000|Follow-Up|Withdrawal by Subject|2|||
147591356|NCT03768726|532321006|FG001|Follow-Up|Withdrawal by Subject|0|||
147591357|NCT03768726|532321005|FG000|Follow-Up|Other|1|||
147591358|NCT03768726|532321006|FG001|Follow-Up|Other|0|||
147591359|NCT01286558|532321007|FG000|Overall Study|Adverse Event|1|||
147591360|NCT01286558|532321008|FG001|Overall Study|Adverse Event|1|||
147591361|NCT01286558|532321007|FG000|Overall Study|Withdrawal by Subject|0|||
147591362|NCT01286558|532321008|FG001|Overall Study|Withdrawal by Subject|1|||
147591363|NCT01787279|532321010|FG000|Overall Study|Lost to Follow-up|2|||
147591364|NCT01787279|532321010|FG000|Overall Study|Lack of Efficacy|1|||
147591365|NCT00140413|532321013|FG000|Overall Study|Lost to Follow-up|1|||
147591366|NCT00140413|532321014|FG001|Overall Study|Lost to Follow-up|0|||
147591367|NCT00140413|532321013|FG000|Overall Study|Withdrawal by Subject|2|||
147591368|NCT00140413|532321014|FG001|Overall Study|Withdrawal by Subject|0|||
147591369|NCT02694549|532321015|FG000|Overall Study|screen failures|2|||
147591370|NCT01567826|532321018|FG000|Overall Study|Lost to Follow-up|3|||
147591371|NCT01567826|532321019|FG001|Overall Study|Lost to Follow-up|2|||
147591372|NCT03575871|532321026|FG000|Overall Study|Adverse Event|5|||
147591373|NCT03575871|532321027|FG001|Overall Study|Adverse Event|5|||
147591374|NCT03575871|532321028|FG002|Overall Study|Adverse Event|8|||
147591375|NCT03575871|532321026|FG000|Overall Study|Death|1|||
147591376|NCT03575871|532321027|FG001|Overall Study|Death|0|||
147591377|NCT03575871|532321028|FG002|Overall Study|Death|0|||
147591378|NCT03575871|532321026|FG000|Overall Study|Lack of Efficacy|5|||
147591379|NCT03575871|532321027|FG001|Overall Study|Lack of Efficacy|4|||
147591380|NCT03575871|532321028|FG002|Overall Study|Lack of Efficacy|7|||
147591381|NCT03575871|532321026|FG000|Overall Study|Lost to Follow-up|1|||
147591382|NCT03575871|532321027|FG001|Overall Study|Lost to Follow-up|1|||
147591383|NCT03575871|532321028|FG002|Overall Study|Lost to Follow-up|1|||
147591384|NCT03575871|532321026|FG000|Overall Study|Protocol Deviation|1|||
147591385|NCT03575871|532321027|FG001|Overall Study|Protocol Deviation|1|||
147591386|NCT03575871|532321028|FG002|Overall Study|Protocol Deviation|1|||
147591387|NCT03575871|532321026|FG000|Overall Study|Withdrawal by Subject|6|||
147591388|NCT03575871|532321027|FG001|Overall Study|Withdrawal by Subject|1|||
147591389|NCT03575871|532321028|FG002|Overall Study|Withdrawal by Subject|9|||
147171111|NCT02914561|530790528|FG002|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
147171112|NCT02914561|530790529|FG003|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
147171113|NCT02914561|530790530|FG004|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
147171114|NCT02914561|530790531|FG005|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
147171115|NCT02914561|530790532|FG006|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
147171116|NCT02914561|530790533|FG007|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
147171117|NCT02914561|530790534|FG008|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|1|||
147171118|NCT02914561|530790535|FG009|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
147171119|NCT02914561|530790536|FG010|Maintenance Study (Weeks 11 to 58)|Non-Compliance with Study Drug|0|||
147171120|NCT02914561|530790526|FG000|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
147171121|NCT02914561|530790527|FG001|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
147171122|NCT02914561|530790528|FG002|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
147171123|NCT02914561|530790529|FG003|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
147171124|NCT02914561|530790530|FG004|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
147171125|NCT02914561|530790531|FG005|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
147171126|NCT02914561|530790532|FG006|Maintenance Study (Weeks 11 to 58)|Pregnancy|1|||
147171127|NCT02914561|530790533|FG007|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
147171128|NCT02914561|530790534|FG008|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
147171129|NCT02914561|530790535|FG009|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
147171130|NCT02914561|530790536|FG010|Maintenance Study (Weeks 11 to 58)|Pregnancy|0|||
147171131|NCT02914561|530790526|FG000|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
147171132|NCT02914561|530790527|FG001|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
147171133|NCT02914561|530790528|FG002|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
147171134|NCT02914561|530790529|FG003|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
147171135|NCT02914561|530790530|FG004|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
147171136|NCT02914561|530790531|FG005|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
147591390|NCT03575871|532321026|FG000|Overall Study|Other than specified|2|||
147591391|NCT03575871|532321027|FG001|Overall Study|Other than specified|2|||
147591392|NCT03575871|532321028|FG002|Overall Study|Other than specified|0|||
147591393|NCT02017860|532321029|FG000|Overall Study|Adverse Event|1|||
147591394|NCT02017860|532321029|FG000|Overall Study|Withdrawal by Subject|1|||
147591395|NCT06005597|532321030|FG000|Overall Study|Lost to Follow-up|1|||
147591396|NCT06005597|532321031|FG001|Overall Study|Lost to Follow-up|2|||
147591397|NCT06005597|532321032|FG002|Overall Study|Lost to Follow-up|1|||
147591398|NCT06005597|532321033|FG003|Overall Study|Lost to Follow-up|2|||
147654991|NCT01247350|532559186|FG001|Overall Study|Withdrawal by Subject|0|||
147654992|NCT01247350|532559187|FG002|Overall Study|Withdrawal by Subject|0|||
147654993|NCT01247350|532559188|FG003|Overall Study|Withdrawal by Subject|1|||
147654994|NCT01247350|532559189|FG004|Overall Study|Withdrawal by Subject|0|||
147654995|NCT01247350|532559185|FG000|Overall Study|Entry criteria not met|0|||
147654996|NCT01247350|532559186|FG001|Overall Study|Entry criteria not met|0|||
147654997|NCT01247350|532559187|FG002|Overall Study|Entry criteria not met|0|||
147654998|NCT01247350|532559188|FG003|Overall Study|Entry criteria not met|0|||
147654999|NCT01247350|532559189|FG004|Overall Study|Entry criteria not met|1|||
147655000|NCT02438280|532559192|FG000|Overall Study|Physician Decision|1|||
147655001|NCT02438280|532559193|FG001|Overall Study|Physician Decision|0|||
147655002|NCT02982863|532559194|FG000|Overall Study|Not eligible patients|809|||
147171137|NCT02914561|530790532|FG006|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
147171138|NCT02914561|530790533|FG007|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|0|||
147171139|NCT02914561|530790534|FG008|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|1|||
147171140|NCT02914561|530790535|FG009|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|1|||
147171141|NCT02914561|530790536|FG010|Maintenance Study (Weeks 11 to 58)|Randomized but not treated|1|||
147171142|NCT03332160|530790537|FG000|Overall Study|Withdrawal by Subject|1|||
147171143|NCT03332160|530790538|FG001|Overall Study|Withdrawal by Subject|1|||
147171144|NCT03332160|530790537|FG000|Overall Study|Adverse Event|0|||
147171145|NCT03332160|530790538|FG001|Overall Study|Adverse Event|1|||
147171146|NCT03332160|530790537|FG000|Overall Study|Developed Exclusion Criteria|0|||
147171147|NCT03332160|530790538|FG001|Overall Study|Developed Exclusion Criteria|1|||
147171148|NCT03332160|530790537|FG000|Overall Study|Non-adherence to treatment|0|||
147171149|NCT03332160|530790538|FG001|Overall Study|Non-adherence to treatment|2|||
147171150|NCT03517566|530790544|FG000|Overall Study|Adverse Event|5|||
147171151|NCT03517566|530790545|FG001|Overall Study|Adverse Event|2|||
147171152|NCT03517566|530790546|FG002|Overall Study|Adverse Event|2|||
147171153|NCT03517566|530790547|FG003|Overall Study|Adverse Event|8|||
147171154|NCT03517566|530790548|FG004|Overall Study|Adverse Event|7|||
147171155|NCT03517566|530790544|FG000|Overall Study|Lack of Efficacy|3|||
147171156|NCT03517566|530790545|FG001|Overall Study|Lack of Efficacy|2|||
147171157|NCT03517566|530790546|FG002|Overall Study|Lack of Efficacy|1|||
147171158|NCT03517566|530790547|FG003|Overall Study|Lack of Efficacy|1|||
147171159|NCT03517566|530790548|FG004|Overall Study|Lack of Efficacy|4|||
147171160|NCT03517566|530790544|FG000|Overall Study|Lost to Follow-up|3|||
147171161|NCT03517566|530790545|FG001|Overall Study|Lost to Follow-up|1|||
147171162|NCT03517566|530790546|FG002|Overall Study|Lost to Follow-up|1|||
147171163|NCT03517566|530790547|FG003|Overall Study|Lost to Follow-up|1|||
147171164|NCT03517566|530790548|FG004|Overall Study|Lost to Follow-up|0|||
147171165|NCT03517566|530790544|FG000|Overall Study|Physician Decision|1|||
147171166|NCT03517566|530790545|FG001|Overall Study|Physician Decision|1|||
147171167|NCT03517566|530790546|FG002|Overall Study|Physician Decision|0|||
147171168|NCT03517566|530790547|FG003|Overall Study|Physician Decision|1|||
147171169|NCT03517566|530790548|FG004|Overall Study|Physician Decision|0|||
147171170|NCT03517566|530790544|FG000|Overall Study|Pregnancy|0|||
147171171|NCT03517566|530790545|FG001|Overall Study|Pregnancy|1|||
147171172|NCT03517566|530790546|FG002|Overall Study|Pregnancy|0|||
147171173|NCT03517566|530790547|FG003|Overall Study|Pregnancy|0|||
147171174|NCT03517566|530790548|FG004|Overall Study|Pregnancy|0|||
147171175|NCT03517566|530790544|FG000|Overall Study|Protocol Deviation|0|||
147171176|NCT03517566|530790545|FG001|Overall Study|Protocol Deviation|1|||
147171177|NCT03517566|530790546|FG002|Overall Study|Protocol Deviation|0|||
147171178|NCT03517566|530790547|FG003|Overall Study|Protocol Deviation|1|||
147171179|NCT03517566|530790548|FG004|Overall Study|Protocol Deviation|1|||
147171180|NCT03517566|530790544|FG000|Overall Study|Study terminated by Sponsor|11|||
147171181|NCT03517566|530790545|FG001|Overall Study|Study terminated by Sponsor|5|||
147171182|NCT03517566|530790546|FG002|Overall Study|Study terminated by Sponsor|6|||
147171183|NCT03517566|530790547|FG003|Overall Study|Study terminated by Sponsor|14|||
147171184|NCT03517566|530790548|FG004|Overall Study|Study terminated by Sponsor|12|||
147171185|NCT03517566|530790544|FG000|Overall Study|Subject Decision /Guardian Decision|9|||
147171186|NCT03517566|530790545|FG001|Overall Study|Subject Decision /Guardian Decision|8|||
147171187|NCT03517566|530790546|FG002|Overall Study|Subject Decision /Guardian Decision|5|||
147171188|NCT03517566|530790547|FG003|Overall Study|Subject Decision /Guardian Decision|8|||
147323788|NCT02929108|531350034|FG006|Overall Study|Hospice patient death|78|||
147171189|NCT03517566|530790548|FG004|Overall Study|Subject Decision /Guardian Decision|8|||
147171190|NCT01183468|530790549|FG000|Overall Study|Lost to Follow-up|2|||
147171191|NCT01183468|530790550|FG001|Overall Study|Lost to Follow-up|1|||
147323789|NCT01008748|531350035|FG000|Overall Study|Lost to Follow-up|80|||
147323790|NCT01008748|531350035|FG000|Overall Study|Other|1|||
147655003|NCT02982863|532559195|FG001|Overall Study|Not eligible patients|4261|||
147171192|NCT01183468|530790551|FG002|Overall Study|Lost to Follow-up|0|||
147171193|NCT01183468|530790552|FG003|Overall Study|Lost to Follow-up|0|||
147655004|NCT02982863|532559196|FG002|Overall Study|Not eligible patients|1852|||
147171194|NCT01183468|530790549|FG000|Overall Study|Physician Decision|1|||
147171195|NCT01183468|530790550|FG001|Overall Study|Physician Decision|0|||
147171196|NCT01183468|530790551|FG002|Overall Study|Physician Decision|0|||
147591399|NCT06005597|532321030|FG000|Overall Study|Death|1|||
147591400|NCT06005597|532321031|FG001|Overall Study|Death|1|||
147591401|NCT06005597|532321032|FG002|Overall Study|Death|1|||
147591402|NCT06005597|532321033|FG003|Overall Study|Death|0|||
147591403|NCT02224573|532321040|FG000|Treatment Phase|Caregiver Asked to Stop Investigational Medicinal Product (IMP)|0|||
147591404|NCT02224573|532321041|FG001|Treatment Phase|Caregiver Asked to Stop Investigational Medicinal Product (IMP)|1|||
147591405|NCT02224573|532321040|FG000|Treatment Phase|Started on Other IMP|1|||
147591406|NCT02224573|532321041|FG001|Treatment Phase|Started on Other IMP|0|||
147591407|NCT02224573|532321040|FG000|Treatment Phase|Participant Discontinued IMP|0|||
147591408|NCT02224573|532321041|FG001|Treatment Phase|Participant Discontinued IMP|1|||
147591409|NCT02224573|532321040|FG000|Treatment Phase|Lack of Efficacy|15|||
147591410|NCT02224573|532321041|FG001|Treatment Phase|Lack of Efficacy|8|||
147591411|NCT02224573|532321040|FG000|Treatment Phase|Began Commercial Product|1|||
147591412|NCT02224573|532321041|FG001|Treatment Phase|Began Commercial Product|0|||
147591413|NCT02224573|532321040|FG000|Treatment Phase|Lack of Efficacy per Participant/Caregiver|3|||
147591414|NCT02224573|532321041|FG001|Treatment Phase|Lack of Efficacy per Participant/Caregiver|3|||
147591415|NCT02224573|532321040|FG000|Treatment Phase|Met Withdrawal Criteria|5|||
147591416|NCT02224573|532321041|FG001|Treatment Phase|Met Withdrawal Criteria|7|||
147591417|NCT02224573|532321040|FG000|Treatment Phase|Participant Did Not Return for Visits|0|||
147591418|NCT02224573|532321041|FG001|Treatment Phase|Participant Did Not Return for Visits|1|||
147591419|NCT02224573|532321040|FG000|Treatment Phase|Continued Compassionate Use|1|||
147591420|NCT02224573|532321041|FG001|Treatment Phase|Continued Compassionate Use|0|||
147591421|NCT02224573|532321040|FG000|Treatment Phase|Lack of Efficiency|2|||
147591422|NCT02224573|532321041|FG001|Treatment Phase|Lack of Efficiency|1|||
147591423|NCT02224573|532321040|FG000|Treatment Phase|Participant with Protocol-Excluded Treatment|0|||
147591424|NCT02224573|532321041|FG001|Treatment Phase|Participant with Protocol-Excluded Treatment|1|||
147591425|NCT02224573|532321040|FG000|Treatment Phase|Participant Moved|2|||
147591426|NCT02224573|532321041|FG001|Treatment Phase|Participant Moved|0|||
147591427|NCT02224573|532321040|FG000|Treatment Phase|Withdrawal by Participant or Parent/Guardian|62|||
147591428|NCT02224573|532321041|FG001|Treatment Phase|Withdrawal by Participant or Parent/Guardian|48|||
147591429|NCT02224573|532321040|FG000|Treatment Phase|Refused Medication|1|||
147591430|NCT02224573|532321041|FG001|Treatment Phase|Refused Medication|1|||
147591431|NCT02224573|532321040|FG000|Treatment Phase|Adverse Event|26|||
147591432|NCT02224573|532321041|FG001|Treatment Phase|Adverse Event|38|||
147591433|NCT02224573|532321040|FG000|Treatment Phase|Placed in Group Home|0|||
147591434|NCT02224573|532321041|FG001|Treatment Phase|Placed in Group Home|1|||
147591435|NCT02224573|532321040|FG000|Treatment Phase|Pursued Other Trials|1|||
147591436|NCT02224573|532321041|FG001|Treatment Phase|Pursued Other Trials|0|||
147591437|NCT02224573|532321040|FG000|Treatment Phase|Withdrawn by the Investigator|23|||
147591438|NCT02224573|532321041|FG001|Treatment Phase|Withdrawn by the Investigator|11|||
147591439|NCT02224573|532321040|FG000|Treatment Phase|Lost to Follow-up|2|||
147591440|NCT02224573|532321041|FG001|Treatment Phase|Lost to Follow-up|1|||
147591441|NCT02224573|532321040|FG000|Taper Phase|Completed Incorrect Number of Taper Days|1|||
147591442|NCT02224573|532321041|FG001|Taper Phase|Completed Incorrect Number of Taper Days|0|||
147591443|NCT02224573|532321040|FG000|Taper Phase|Hospitalization/Dose Reduction|1|||
147591444|NCT02224573|532321041|FG001|Taper Phase|Hospitalization/Dose Reduction|0|||
147591445|NCT02224573|532321040|FG000|Taper Phase|Withdrawn by participants or parent/guardian|0|||
147591446|NCT02224573|532321041|FG001|Taper Phase|Withdrawn by participants or parent/guardian|3|||
147591447|NCT02224573|532321040|FG000|Taper Phase|Adverse Event|1|||
147591448|NCT02224573|532321041|FG001|Taper Phase|Adverse Event|1|||
147591449|NCT00252174|532321042|FG000|Overall Study|Withdrawal by Subject|0|||
147591450|NCT00252174|532321043|FG001|Overall Study|Withdrawal by Subject|1|||
147591451|NCT00252174|532321044|FG002|Overall Study|Withdrawal by Subject|0|||
147591452|NCT02546362|532321045|FG000|4-week Treatment Period|Lost to Follow-up|1|||
147591453|NCT02546362|532321045|FG000|4-week Treatment Period|Change in medication|2|||
147591454|NCT02546362|532321045|FG000|12-week Treatment Period|Withdrawal by Subject|6|||
147591455|NCT02546362|532321045|FG000|12-week Treatment Period|Lost to Follow-up|2|||
147591456|NCT02546362|532321045|FG000|12-week Treatment Period|Change in medication|1|||
147591457|NCT01138826|532321046|FG000|Washout Period I (of 16 Days)|Lost to Follow-up|1|||
147591458|NCT01138826|532321047|FG001|Washout Period I (of 16 Days)|Lost to Follow-up|1|||
147591459|NCT01138826|532321048|FG002|Washout Period I (of 16 Days)|Lost to Follow-up|0|||
147591460|NCT01138826|532321049|FG003|Washout Period I (of 16 Days)|Lost to Follow-up|0|||
147591461|NCT01138826|532321050|FG004|Washout Period I (of 16 Days)|Lost to Follow-up|1|||
147591462|NCT01138826|532321051|FG005|Washout Period I (of 16 Days)|Lost to Follow-up|0|||
147591463|NCT05206448|532321052|FG000|Overall Study|Lost to Follow-up|2|||
147591464|NCT05206448|532321053|FG001|Overall Study|Lost to Follow-up|2|||
147591465|NCT05206448|532321052|FG000|Overall Study|Withdrawal by Subject|2|||
147591466|NCT05206448|532321053|FG001|Overall Study|Withdrawal by Subject|0|||
147591467|NCT05206448|532321052|FG000|Overall Study|found ineligible after randomization|1|||
147591468|NCT05206448|532321053|FG001|Overall Study|found ineligible after randomization|1|||
147591469|NCT05206448|532321052|FG000|Overall Study|unable to complete study due to personal constraints|1|||
147591470|NCT05206448|532321053|FG001|Overall Study|unable to complete study due to personal constraints|0|||
147655005|NCT02982863|532559197|FG003|Overall Study|Not eligible patients|1400|||
147655006|NCT02982863|532559198|FG004|Overall Study|Not eligible patients|492|||
147655007|NCT02457195|532559199|FG000|Overall Study|Adverse Event|3|||
147655008|NCT02457195|532559199|FG000|Overall Study|Protocol Violation|2|||
147655009|NCT02457195|532559199|FG000|Overall Study|Withdrawal by Subject|4|||
147655010|NCT05359952|532559200|FG000|Overall Study|Lost to Follow-up|1|||
147655011|NCT05359952|532559201|FG001|Overall Study|Lost to Follow-up|0|||
147655012|NCT05980013|532559202|FG000|Overall Study|Withdrawal by Subject|0|||
147655013|NCT05980013|532559203|FG001|Overall Study|Withdrawal by Subject|1|||
147655014|NCT05980013|532559202|FG000|Overall Study|Device Error|0|||
147655015|NCT05980013|532559203|FG001|Overall Study|Device Error|1|||
147655016|NCT03066778|532559204|FG000|Overall Study|Death|195|||
147655017|NCT03066778|532559205|FG001|Overall Study|Death|205|||
147655018|NCT03066778|532559204|FG000|Overall Study|Withdrawal by Subject|5|||
147655019|NCT03066778|532559205|FG001|Overall Study|Withdrawal by Subject|7|||
147655020|NCT02091414|532559206|FG000|Overall Study|Withdrawal by Subject|2|||
147655021|NCT02091414|532559206|FG000|Overall Study|Death|2|||
147655022|NCT03146741|532559207|FG000|Overall Study|Txp with non-HCV+ heart|4|||
147655023|NCT03146741|532559207|FG000|Overall Study|Listeted for MOT|2|||
147655024|NCT03146741|532559207|FG000|Overall Study|Physician Decision|2|||
147655025|NCT03146741|532559207|FG000|Overall Study|Awaiting txp|2|||
147591471|NCT05206448|532321052|FG000|Overall Study|Became pregnant during gap in treatment after pregnancy loss|0|||
147591472|NCT05206448|532321053|FG001|Overall Study|Became pregnant during gap in treatment after pregnancy loss|1|||
147591473|NCT00754442|532321057|FG000|Overall Study|Withdrawal by Subject|5|||
147591474|NCT00754442|532321058|FG001|Overall Study|Withdrawal by Subject|3|||
147591475|NCT01557842|532321059|FG000|Overall Study|Lost to Follow-up|0|||
147591476|NCT01557842|532321060|FG001|Overall Study|Lost to Follow-up|1|||
147591477|NCT01557842|532321059|FG000|Overall Study|Death|1|||
147591478|NCT01557842|532321060|FG001|Overall Study|Death|0|||
147591479|NCT01557842|532321059|FG000|Overall Study|Lack of Efficacy|0|||
147591480|NCT01557842|532321060|FG001|Overall Study|Lack of Efficacy|1|||
147591481|NCT01557842|532321059|FG000|Overall Study|Not Meet Inclusion/Exclusion Criteria|3|||
147591482|NCT01557842|532321060|FG001|Overall Study|Not Meet Inclusion/Exclusion Criteria|0|||
147591483|NCT01557842|532321059|FG000|Overall Study|Study Terminated by Sponsor|3|||
147591484|NCT01557842|532321060|FG001|Overall Study|Study Terminated by Sponsor|4|||
147591485|NCT01557842|532321059|FG000|Overall Study|Not Ablated|2|||
147591486|NCT01557842|532321060|FG001|Overall Study|Not Ablated|0|||
147591487|NCT05560763|532321061|FG000|Overall Study|Withdrawal by Subject|4|||
147591488|NCT06972251|532321064|FG000|Overall Study|Withdrawal by Subject|1|||
147591489|NCT06972251|532321065|FG001|Overall Study|Withdrawal by Subject|0|||
147591490|NCT06972251|532321064|FG000|Overall Study|Lost to Follow-up|10|||
147591491|NCT06972251|532321065|FG001|Overall Study|Lost to Follow-up|2|||
147591492|NCT00949988|532321066|FG000|Overall Study|Withdrawal by Subject|3|||
147591493|NCT01929395|532321068|FG000|Overall Study|Did not complete - non-related toxicity|1|||
147591494|NCT01929395|532321069|FG001|Overall Study|Did not complete - non-related toxicity|0|||
147591495|NCT01929395|532321070|FG002|Overall Study|Did not complete - non-related toxicity|0|||
147591496|NCT01929395|532321068|FG000|Overall Study|Withdrawal by Subject|0|||
147591497|NCT01929395|532321069|FG001|Overall Study|Withdrawal by Subject|1|||
147591498|NCT01929395|532321070|FG002|Overall Study|Withdrawal by Subject|0|||
147591499|NCT01929395|532321068|FG000|Overall Study|Screen Fail|0|||
147591500|NCT01929395|532321069|FG001|Overall Study|Screen Fail|0|||
147591501|NCT01929395|532321070|FG002|Overall Study|Screen Fail|1|||
147591502|NCT00484419|532321071|FG000|Overall Study|Adverse Event|3|||
147591503|NCT00484419|532321072|FG001|Overall Study|Adverse Event|0|||
147591504|NCT00484419|532321073|FG002|Overall Study|Adverse Event|0|||
147591505|NCT00484419|532321071|FG000|Overall Study|Lost to Follow-up|1|||
147591506|NCT00484419|532321072|FG001|Overall Study|Lost to Follow-up|0|||
147591507|NCT00484419|532321073|FG002|Overall Study|Lost to Follow-up|2|||
147591508|NCT00484419|532321071|FG000|Overall Study|Withdrawal by Subject|3|||
147591509|NCT00484419|532321072|FG001|Overall Study|Withdrawal by Subject|1|||
147591510|NCT00484419|532321073|FG002|Overall Study|Withdrawal by Subject|1|||
147591511|NCT00484419|532321071|FG000|Overall Study|subject met discontinuation criteria|2|||
147591512|NCT00484419|532321072|FG001|Overall Study|subject met discontinuation criteria|2|||
147655026|NCT00902746|532559210|FG000|Overall Study|Protocol Violation|7|||
147655027|NCT00902746|532559210|FG000|Overall Study|Withdrawal by Subject|16|||
147655028|NCT00902746|532559210|FG000|Overall Study|Adverse Event|8|||
147655029|NCT00902746|532559210|FG000|Overall Study|Lost to Follow-up|3|||
147655030|NCT00902746|532559210|FG000|Overall Study|Physician Decision|2|||
147591513|NCT00484419|532321073|FG002|Overall Study|subject met discontinuation criteria|4|||
147591514|NCT00484419|532321071|FG000|Overall Study|required restricted medication|1|||
147591515|NCT00484419|532321072|FG001|Overall Study|required restricted medication|0|||
147591516|NCT00484419|532321073|FG002|Overall Study|required restricted medication|1|||
147591517|NCT00484419|532321071|FG000|Overall Study|Physician Decision|1|||
147591518|NCT00484419|532321072|FG001|Overall Study|Physician Decision|1|||
147655031|NCT02081001|532559215|FG000|Overall Study|Adverse Event|0|||
147655032|NCT02081001|532559216|FG001|Overall Study|Adverse Event|0|||
147171197|NCT01183468|530790552|FG003|Overall Study|Physician Decision|0|||
147323791|NCT00052962|531350036|FG000|Overall Study|Not evaluable|0|||
147591519|NCT00484419|532321073|FG002|Overall Study|Physician Decision|1|||
147591520|NCT00484419|532321071|FG000|Overall Study|subject unable to receive medication|1|||
147591521|NCT00484419|532321072|FG001|Overall Study|subject unable to receive medication|0|||
147591522|NCT00484419|532321073|FG002|Overall Study|subject unable to receive medication|0|||
147591523|NCT00484419|532321071|FG000|Overall Study|subject relocated|0|||
147591524|NCT00484419|532321072|FG001|Overall Study|subject relocated|1|||
147591525|NCT00484419|532321073|FG002|Overall Study|subject relocated|0|||
147591526|NCT00484419|532321071|FG000|Overall Study|sponsor decision, randomized in error|0|||
147591527|NCT00484419|532321072|FG001|Overall Study|sponsor decision, randomized in error|0|||
147591528|NCT00484419|532321073|FG002|Overall Study|sponsor decision, randomized in error|2|||
147591529|NCT03604341|532321074|FG000|Overall Study|Withdrawal by Subject|1|||
147591530|NCT03604341|532321075|FG001|Overall Study|Withdrawal by Subject|1|||
147591531|NCT03604341|532321074|FG000|Overall Study|Adverse Event|1|||
147591532|NCT03604341|532321075|FG001|Overall Study|Adverse Event|0|||
147591533|NCT03604341|532321074|FG000|Overall Study|Protocol Violation|0|||
147591534|NCT03604341|532321075|FG001|Overall Study|Protocol Violation|1|||
147591535|NCT01829113|532321077|FG000|Overall Study|Disease Progression|37|||
147591536|NCT01829113|532321078|FG001|Overall Study|Disease Progression|48|||
147591537|NCT01829113|532321077|FG000|Overall Study|Adverse Event|14|||
147591538|NCT01829113|532321078|FG001|Overall Study|Adverse Event|10|||
147591539|NCT01829113|532321077|FG000|Overall Study|Withdrawal by Subject|17|||
147591540|NCT01829113|532321078|FG001|Overall Study|Withdrawal by Subject|10|||
147591541|NCT01829113|532321077|FG000|Overall Study|Death|4|||
147591542|NCT01829113|532321078|FG001|Overall Study|Death|6|||
147591543|NCT01829113|532321077|FG000|Overall Study|Sponsor Decision|1|||
147591544|NCT01829113|532321078|FG001|Overall Study|Sponsor Decision|1|||
147591545|NCT01829113|532321077|FG000|Overall Study|No Study Treatment Received|3|||
147591546|NCT01829113|532321078|FG001|Overall Study|No Study Treatment Received|2|||
147591547|NCT01829113|532321077|FG000|Overall Study|Physician Decision|1|||
147591548|NCT01829113|532321078|FG001|Overall Study|Physician Decision|1|||
147591549|NCT00355472|532321079|FG000|Overall Study|Physician Decision|1|||
147591550|NCT01341587|532321086|FG000|Overall Study|Lost to Follow-up|2|||
147591551|NCT01341587|532321087|FG001|Overall Study|Lost to Follow-up|0|||
147591552|NCT01341587|532321086|FG000|Overall Study|stopped using the meters|2|||
147591553|NCT01341587|532321087|FG001|Overall Study|stopped using the meters|10|||
147591554|NCT04740931|532321089|FG000|Part 1 (Baseline up to Week 24)|Withdrawal by Subject|0|||
147591555|NCT04740931|532321090|FG001|Part 1 (Baseline up to Week 24)|Withdrawal by Subject|4|||
147591556|NCT04740931|532321089|FG000|Part 1 (Baseline up to Week 24)|Death|1|||
147591557|NCT04740931|532321090|FG001|Part 1 (Baseline up to Week 24)|Death|2|||
147591558|NCT04740931|532321089|FG000|Part 1 (Baseline up to Week 24)|Non-compliance with study drug|2|||
147591559|NCT04740931|532321090|FG001|Part 1 (Baseline up to Week 24)|Non-compliance with study drug|0|||
147591560|NCT04740931|532321089|FG000|Part 1 (Baseline up to Week 24)|Reason Not Specified|2|||
147591561|NCT04740931|532321090|FG001|Part 1 (Baseline up to Week 24)|Reason Not Specified|0|||
147591562|NCT04740931|532321089|FG000|Part 1 (Baseline up to Week 24)|Adverse Event|1|||
147591563|NCT04740931|532321090|FG001|Part 1 (Baseline up to Week 24)|Adverse Event|1|||
147591564|NCT04740931|532321089|FG000|Part 1 (Baseline up to Week 24)|Protocol Violation|0|||
147591565|NCT04740931|532321090|FG001|Part 1 (Baseline up to Week 24)|Protocol Violation|1|||
147591566|NCT04740931|532321089|FG000|Part 1 (Baseline up to Week 24)|Physician Decision|0|||
147171198|NCT01183468|530790549|FG000|Overall Study|Withdrawal by Subject|0|||
147171199|NCT01183468|530790550|FG001|Overall Study|Withdrawal by Subject|1|||
147171200|NCT01183468|530790551|FG002|Overall Study|Withdrawal by Subject|0|||
147323792|NCT00052962|531350037|FG001|Overall Study|Not evaluable|2|||
147591567|NCT04740931|532321090|FG001|Part 1 (Baseline up to Week 24)|Physician Decision|1|||
147591568|NCT04740931|532321089|FG000|Part 1 (Baseline up to Week 24)|Lost to Follow-up|0|||
147591569|NCT04740931|532321090|FG001|Part 1 (Baseline up to Week 24)|Lost to Follow-up|1|||
147171201|NCT01183468|530790552|FG003|Overall Study|Withdrawal by Subject|0|||
147171202|NCT00454649|530790554|FG000|Overall Study|Lack of Efficacy|2|||
147171203|NCT00454649|530790555|FG001|Overall Study|Lack of Efficacy|2|||
147171204|NCT00454649|530790556|FG002|Overall Study|Lack of Efficacy|10|||
147171205|NCT00454649|530790557|FG003|Overall Study|Lack of Efficacy|3|||
147171206|NCT00454649|530790558|FG004|Overall Study|Lack of Efficacy|0|||
147171207|NCT00454649|530790559|FG005|Overall Study|Lack of Efficacy|4|||
147171208|NCT00454649|530790560|FG006|Overall Study|Lack of Efficacy|5|||
147171209|NCT00454649|530790561|FG007|Overall Study|Lack of Efficacy|13|||
147171210|NCT00454649|530790562|FG008|Overall Study|Lack of Efficacy|10|||
147171211|NCT00454649|530790563|FG009|Overall Study|Lack of Efficacy|2|||
147171212|NCT00454649|530790554|FG000|Overall Study|Adverse Event|0|||
147171213|NCT00454649|530790555|FG001|Overall Study|Adverse Event|1|||
147171214|NCT00454649|530790556|FG002|Overall Study|Adverse Event|3|||
147171215|NCT00454649|530790557|FG003|Overall Study|Adverse Event|0|||
147171216|NCT00454649|530790558|FG004|Overall Study|Adverse Event|1|||
147323793|NCT00052962|531350036|FG000|Overall Study|Not randomized/not evaluable|1|||
147591570|NCT04740931|532321089|FG000|Part 2 (Week 24 to Week 72)|Withdrawal by Subject|11|||
147591571|NCT04740931|532321090|FG001|Part 2 (Week 24 to Week 72)|Withdrawal by Subject|11|||
147591572|NCT04740931|532321089|FG000|Part 2 (Week 24 to Week 72)|Lost to Follow-up|3|||
147591573|NCT04740931|532321090|FG001|Part 2 (Week 24 to Week 72)|Lost to Follow-up|9|||
147591574|NCT04740931|532321089|FG000|Part 2 (Week 24 to Week 72)|Adverse Event|5|||
147591575|NCT04740931|532321090|FG001|Part 2 (Week 24 to Week 72)|Adverse Event|5|||
147591576|NCT04740931|532321089|FG000|Part 2 (Week 24 to Week 72)|Death|4|||
147591577|NCT04740931|532321090|FG001|Part 2 (Week 24 to Week 72)|Death|1|||
147591578|NCT04740931|532321089|FG000|Part 2 (Week 24 to Week 72)|Other|1|||
147591579|NCT04740931|532321090|FG001|Part 2 (Week 24 to Week 72)|Other|3|||
147591580|NCT04740931|532321089|FG000|Part 2 (Week 24 to Week 72)|Physician Decision|2|||
147591581|NCT04740931|532321090|FG001|Part 2 (Week 24 to Week 72)|Physician Decision|1|||
147591582|NCT04740931|532321089|FG000|Part 2 (Week 24 to Week 72)|Non-compliance with study drug|1|||
147591583|NCT04740931|532321090|FG001|Part 2 (Week 24 to Week 72)|Non-compliance with study drug|0|||
147591584|NCT01534637|532321091|FG000|Overall Study|Physician Decision|3|||
147591585|NCT01534637|532321091|FG000|Overall Study|Lack of Efficacy|3|||
147591586|NCT01534637|532321091|FG000|Overall Study|Withdrawal by Subject|1|||
147591587|NCT01534637|532321091|FG000|Overall Study|Adverse Event|1|||
147591588|NCT01534637|532321091|FG000|Overall Study|Liver Mets before treatment|1|||
147591589|NCT02377921|532321092|FG000|Overall Study|Subject non-compliance|1|||
147591590|NCT02377921|532321093|FG001|Overall Study|Subject non-compliance|1|||
147591591|NCT00706355|532321096|FG000|Period 1: PF-04217903 50 mg|Withdrawal by Subject|1|||
147591592|NCT00706355|532321097|FG001|Period 1: PF-04217903 50 mg|Withdrawal by Subject|0|||
147591593|NCT00706355|532321098|FG002|Period 1: PF-04217903 50 mg|Withdrawal by Subject|0|||
147591594|NCT00706355|532321099|FG003|Period 1: PF-04217903 50 mg|Withdrawal by Subject|0|||
147591595|NCT00706355|532321096|FG000|Period 1: PF-04217903 50 mg|Objective progression or relapse|2|||
147591596|NCT00706355|532321097|FG001|Period 1: PF-04217903 50 mg|Objective progression or relapse|0|||
147591597|NCT00706355|532321098|FG002|Period 1: PF-04217903 50 mg|Objective progression or relapse|0|||
147591598|NCT00706355|532321099|FG003|Period 1: PF-04217903 50 mg|Objective progression or relapse|0|||
147591599|NCT00706355|532321096|FG000|Period 2: PF-04217903 100 mg|Withdrawal by Subject|0|||
147591600|NCT00706355|532321097|FG001|Period 2: PF-04217903 100 mg|Withdrawal by Subject|1|||
147591601|NCT00706355|532321098|FG002|Period 2: PF-04217903 100 mg|Withdrawal by Subject|0|||
147591602|NCT00706355|532321099|FG003|Period 2: PF-04217903 100 mg|Withdrawal by Subject|0|||
147591603|NCT00706355|532321096|FG000|Period 2: PF-04217903 100 mg|Global deterioration of health status|0|||
147591604|NCT00706355|532321097|FG001|Period 2: PF-04217903 100 mg|Global deterioration of health status|1|||
147591605|NCT00706355|532321098|FG002|Period 2: PF-04217903 100 mg|Global deterioration of health status|0|||
147591606|NCT00706355|532321099|FG003|Period 2: PF-04217903 100 mg|Global deterioration of health status|0|||
147591607|NCT00706355|532321096|FG000|Period 2: PF-04217903 100 mg|Objective progression or relapse|0|||
147591608|NCT00706355|532321097|FG001|Period 2: PF-04217903 100 mg|Objective progression or relapse|5|||
147591609|NCT00706355|532321098|FG002|Period 2: PF-04217903 100 mg|Objective progression or relapse|0|||
147591610|NCT00706355|532321099|FG003|Period 2: PF-04217903 100 mg|Objective progression or relapse|0|||
147591611|NCT00706355|532321096|FG000|Period 3: PF-04217903 200 mg|Adverse Event|0|||
147591612|NCT00706355|532321097|FG001|Period 3: PF-04217903 200 mg|Adverse Event|0|||
147591613|NCT00706355|532321098|FG002|Period 3: PF-04217903 200 mg|Adverse Event|1|||
147591614|NCT00706355|532321099|FG003|Period 3: PF-04217903 200 mg|Adverse Event|0|||
147591615|NCT00706355|532321096|FG000|Period 3: PF-04217903 200 mg|Withdrawal by Subject|0|||
147591616|NCT00706355|532321097|FG001|Period 3: PF-04217903 200 mg|Withdrawal by Subject|0|||
147591617|NCT00706355|532321098|FG002|Period 3: PF-04217903 200 mg|Withdrawal by Subject|1|||
147591618|NCT00706355|532321099|FG003|Period 3: PF-04217903 200 mg|Withdrawal by Subject|0|||
147591619|NCT00706355|532321096|FG000|Period 4: PF-04217903 150 mg|Adverse Event|0|||
147591620|NCT00706355|532321097|FG001|Period 4: PF-04217903 150 mg|Adverse Event|0|||
147591621|NCT00706355|532321098|FG002|Period 4: PF-04217903 150 mg|Adverse Event|0|||
147591622|NCT00706355|532321099|FG003|Period 4: PF-04217903 150 mg|Adverse Event|2|||
147591623|NCT00706355|532321096|FG000|Period 4: PF-04217903 150 mg|Objective progression or relapse|0|||
147591624|NCT00706355|532321097|FG001|Period 4: PF-04217903 150 mg|Objective progression or relapse|0|||
147591625|NCT00706355|532321098|FG002|Period 4: PF-04217903 150 mg|Objective progression or relapse|0|||
147591626|NCT00706355|532321099|FG003|Period 4: PF-04217903 150 mg|Objective progression or relapse|2|||
147591627|NCT02510014|532321100|FG000|Run-In Period (Days -14 to Day -1)|Adverse Event|1|||
147591628|NCT02510014|532321101|FG001|Run-In Period (Days -14 to Day -1)|Adverse Event|1|||
147591629|NCT02510014|532321100|FG000|Run-In Period (Days -14 to Day -1)|Withdrawal symptoms|1|||
147591630|NCT02510014|532321101|FG001|Run-In Period (Days -14 to Day -1)|Withdrawal symptoms|0|||
147591631|NCT02510014|532321100|FG000|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|44|||
147591632|NCT02510014|532321101|FG001|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|3|||
147171217|NCT00454649|530790559|FG005|Overall Study|Adverse Event|2|||
147171218|NCT00454649|530790560|FG006|Overall Study|Adverse Event|3|||
147591633|NCT02510014|532321100|FG000|Run-In Period (Days -14 to Day -1)|Physician Decision|0|||
147591634|NCT02510014|532321101|FG001|Run-In Period (Days -14 to Day -1)|Physician Decision|1|||
147591635|NCT02510014|532321100|FG000|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|22|||
147591636|NCT02510014|532321101|FG001|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|3|||
147591637|NCT02510014|532321100|FG000|Run-In Period (Days -14 to Day -1)|Withdrawn by the investigator|7|||
147591638|NCT02510014|532321101|FG001|Run-In Period (Days -14 to Day -1)|Withdrawn by the investigator|1|||
147591639|NCT02510014|532321100|FG000|Run-In Period (Days -14 to Day -1)|Protocol Violation|2|||
147591640|NCT02510014|532321101|FG001|Run-In Period (Days -14 to Day -1)|Protocol Violation|0|||
147591641|NCT02510014|532321100|FG000|Run-In Period (Days -14 to Day -1)|Other|19|||
147591642|NCT02510014|532321101|FG001|Run-In Period (Days -14 to Day -1)|Other|1|||
147591643|NCT02510014|532321100|FG000|Treatment Period|Adverse Event|11|||
147591644|NCT02510014|532321101|FG001|Treatment Period|Adverse Event|4|||
147591645|NCT02510014|532321100|FG000|Treatment Period|Withdrawal symptoms|3|||
147591646|NCT02510014|532321101|FG001|Treatment Period|Withdrawal symptoms|0|||
147591647|NCT02510014|532321100|FG000|Treatment Period|Lost to Follow-up|80|||
147591648|NCT02510014|532321101|FG001|Treatment Period|Lost to Follow-up|19|||
147591649|NCT02510014|532321100|FG000|Treatment Period|Physician Decision|5|||
147591650|NCT02510014|532321101|FG001|Treatment Period|Physician Decision|0|||
147591651|NCT02510014|532321100|FG000|Treatment Period|Withdrawal by Subject|67|||
147591652|NCT02510014|532321101|FG001|Treatment Period|Withdrawal by Subject|24|||
147591653|NCT02510014|532321100|FG000|Treatment Period|Withdrawn by the investigator|7|||
147591654|NCT02510014|532321101|FG001|Treatment Period|Withdrawn by the investigator|1|||
147591655|NCT02510014|532321100|FG000|Treatment Period|Protocol Violation|4|||
147591656|NCT02510014|532321101|FG001|Treatment Period|Protocol Violation|4|||
147591657|NCT02510014|532321100|FG000|Treatment Period|Incarceration, pregnancy, misc|29|||
147591658|NCT02510014|532321101|FG001|Treatment Period|Incarceration, pregnancy, misc|5|||
147591659|NCT04179019|532321104|FG000|Overall Study|Lost to Follow-up|2|||
147591660|NCT04179019|532321104|FG000|Overall Study|Physician Decision|2|||
147591661|NCT04179019|532321104|FG000|Overall Study|Withdrawal by Subject|5|||
147171219|NCT00454649|530790561|FG007|Overall Study|Adverse Event|4|||
147171220|NCT00454649|530790562|FG008|Overall Study|Adverse Event|6|||
147171221|NCT00454649|530790563|FG009|Overall Study|Adverse Event|2|||
147171222|NCT00454649|530790554|FG000|Overall Study|Lost to Follow-up|0|||
147171223|NCT00454649|530790555|FG001|Overall Study|Lost to Follow-up|0|||
147171224|NCT00454649|530790556|FG002|Overall Study|Lost to Follow-up|1|||
147171225|NCT00454649|530790557|FG003|Overall Study|Lost to Follow-up|0|||
147171226|NCT00454649|530790558|FG004|Overall Study|Lost to Follow-up|0|||
147171227|NCT00454649|530790559|FG005|Overall Study|Lost to Follow-up|0|||
147171228|NCT00454649|530790560|FG006|Overall Study|Lost to Follow-up|1|||
147171229|NCT00454649|530790561|FG007|Overall Study|Lost to Follow-up|0|||
147171230|NCT00454649|530790562|FG008|Overall Study|Lost to Follow-up|0|||
147171231|NCT00454649|530790563|FG009|Overall Study|Lost to Follow-up|0|||
147244299|NCT01269463|531066971|FG001|First Intervention|Adverse Event|0|||
147244300|NCT01269463|531066970|FG000|First Intervention|Lack of Efficacy|0|||
147244301|NCT01269463|531066971|FG001|First Intervention|Lack of Efficacy|1|||
147244302|NCT01269463|531066970|FG000|First Intervention|Physician Decision|0|||
147244303|NCT01269463|531066971|FG001|First Intervention|Physician Decision|1|||
147244304|NCT00558558|531066972|FG000|Overall Study|Unable to swallow|1|||
147244305|NCT00558558|531066972|FG000|Overall Study|Withdrawal by Subject|1|||
147244306|NCT00558558|531066972|FG000|Overall Study|Lack of Efficacy|4|||
147244307|NCT02549937|531066974|FG000|Overall Study|Death|0|||
147244308|NCT02549937|531066975|FG001|Overall Study|Death|1|||
147244309|NCT02549937|531066976|FG002|Overall Study|Death|0|||
147244310|NCT02549937|531066977|FG003|Overall Study|Death|1|||
147244311|NCT02549937|531066978|FG004|Overall Study|Death|0|||
147244312|NCT02549937|531066979|FG005|Overall Study|Death|8|||
147244313|NCT02549937|531066980|FG006|Overall Study|Death|0|||
147244314|NCT02549937|531066981|FG007|Overall Study|Death|0|||
147244315|NCT02549937|531066982|FG008|Overall Study|Death|19|||
147244316|NCT02549937|531066974|FG000|Overall Study|No follow up required|3|||
147244317|NCT02549937|531066975|FG001|Overall Study|No follow up required|6|||
147244318|NCT02549937|531066976|FG002|Overall Study|No follow up required|3|||
147244319|NCT02549937|531066977|FG003|Overall Study|No follow up required|8|||
147244320|NCT02549937|531066978|FG004|Overall Study|No follow up required|12|||
147244321|NCT02549937|531066979|FG005|Overall Study|No follow up required|21|||
147244322|NCT02549937|531066980|FG006|Overall Study|No follow up required|9|||
147244323|NCT02549937|531066981|FG007|Overall Study|No follow up required|11|||
147244324|NCT02549937|531066982|FG008|Overall Study|No follow up required|0|||
147244325|NCT02549937|531066974|FG000|Overall Study|Other|0|||
147244326|NCT02549937|531066975|FG001|Overall Study|Other|0|||
147244327|NCT02549937|531066976|FG002|Overall Study|Other|0|||
147244328|NCT02549937|531066977|FG003|Overall Study|Other|0|||
147244329|NCT02549937|531066978|FG004|Overall Study|Other|1|||
147244330|NCT02549937|531066979|FG005|Overall Study|Other|0|||
147244331|NCT02549937|531066980|FG006|Overall Study|Other|3|||
147591662|NCT04179019|532321104|FG000|Overall Study|Adverse Event|4|||
147591663|NCT05626803|532322646|FG000|Overall Study|Lost to Follow-up|0|||
147171232|NCT00454649|530790554|FG000|Overall Study|Other|1|||
147244332|NCT02549937|531066981|FG007|Overall Study|Other|2|||
147244333|NCT02549937|531066982|FG008|Overall Study|Other|3|||
147171233|NCT00454649|530790555|FG001|Overall Study|Other|1|||
147244334|NCT02549937|531066974|FG000|Overall Study|Lost to Follow-up|0|||
147244335|NCT02549937|531066975|FG001|Overall Study|Lost to Follow-up|0|||
147244336|NCT02549937|531066976|FG002|Overall Study|Lost to Follow-up|0|||
147655033|NCT02081001|532559217|FG002|Overall Study|Adverse Event|0|||
147655034|NCT02081001|532559218|FG003|Overall Study|Adverse Event|0|||
147655035|NCT02081001|532559219|FG004|Overall Study|Adverse Event|1|||
147655036|NCT02081001|532559220|FG005|Overall Study|Adverse Event|0|||
147655037|NCT02081001|532559221|FG006|Overall Study|Adverse Event|0|||
147655038|NCT02081001|532559222|FG007|Overall Study|Adverse Event|0|||
147655039|NCT02081001|532559223|FG008|Overall Study|Adverse Event|0|||
147655040|NCT02081001|532559224|FG009|Overall Study|Adverse Event|0|||
147655041|NCT02081001|532559225|FG010|Overall Study|Adverse Event|0|||
147655042|NCT02081001|532559226|FG011|Overall Study|Adverse Event|0|||
147655043|NCT01765569|532559233|FG000|Period B|Withdrawal by Subject|1|||
147655044|NCT01765569|532559233|FG000|Period C|Death|1|||
147655045|NCT01030718|532559234|FG000|Studies CA180-031 and -036 Combined|Insufficient effect|1|||
147655046|NCT01030718|532559235|FG001|Studies CA180-031 and -036 Combined|Insufficient effect|1|||
147655047|NCT01030718|532559236|FG002|Studies CA180-031 and -036 Combined|Insufficient effect|11|||
147655048|NCT01030718|532559234|FG000|Studies CA180-031 and -036 Combined|Adverse Event|3|||
147655049|NCT01030718|532559235|FG001|Studies CA180-031 and -036 Combined|Adverse Event|5|||
147655050|NCT01030718|532559236|FG002|Studies CA180-031 and -036 Combined|Adverse Event|1|||
147655051|NCT01030718|532559234|FG000|Studies CA180-031 and -036 Combined|Death|0|||
147655052|NCT01030718|532559235|FG001|Studies CA180-031 and -036 Combined|Death|1|||
147655053|NCT01030718|532559236|FG002|Studies CA180-031 and -036 Combined|Death|0|||
147655054|NCT01030718|532559234|FG000|Studies CA180-031 and -036 Combined|other reasons|0|||
147655055|NCT01030718|532559235|FG001|Studies CA180-031 and -036 Combined|other reasons|2|||
147655056|NCT01030718|532559236|FG002|Studies CA180-031 and -036 Combined|other reasons|0|||
147655057|NCT01030718|532559234|FG000|Study CA180-036 Only|insufficient effect|1|||
147655058|NCT01030718|532559235|FG001|Study CA180-036 Only|insufficient effect|1|||
147655059|NCT01030718|532559236|FG002|Study CA180-036 Only|insufficient effect|5|||
147655060|NCT01030718|532559234|FG000|Study CA180-036 Only|Adverse Event|2|||
147655061|NCT01030718|532559235|FG001|Study CA180-036 Only|Adverse Event|3|||
147655062|NCT01030718|532559236|FG002|Study CA180-036 Only|Adverse Event|0|||
147655063|NCT01030718|532559234|FG000|Study CA180-036 Only|Death|0|||
147655064|NCT01030718|532559235|FG001|Study CA180-036 Only|Death|1|||
147655065|NCT01030718|532559236|FG002|Study CA180-036 Only|Death|0|||
147655066|NCT01030718|532559234|FG000|Study CA180-036 Only|Other Reasons|0|||
147655067|NCT01030718|532559235|FG001|Study CA180-036 Only|Other Reasons|2|||
147655068|NCT01030718|532559236|FG002|Study CA180-036 Only|Other Reasons|0|||
147655069|NCT00423813|532559237|FG000|Overall Study|Adverse Event|11|||
147655070|NCT00423813|532559238|FG001|Overall Study|Adverse Event|30|||
147655071|NCT00423813|532559239|FG002|Overall Study|Adverse Event|40|||
147655072|NCT00423813|532559237|FG000|Overall Study|Withdrawal by Subject|6|||
147655073|NCT00423813|532559238|FG001|Overall Study|Withdrawal by Subject|8|||
147655074|NCT00423813|532559239|FG002|Overall Study|Withdrawal by Subject|5|||
147171234|NCT00454649|530790556|FG002|Overall Study|Other|5|||
147171235|NCT00454649|530790557|FG003|Overall Study|Other|3|||
147171236|NCT00454649|530790558|FG004|Overall Study|Other|0|||
147171237|NCT00454649|530790559|FG005|Overall Study|Other|0|||
147171238|NCT00454649|530790560|FG006|Overall Study|Other|0|||
147171239|NCT00454649|530790561|FG007|Overall Study|Other|0|||
147171240|NCT00454649|530790562|FG008|Overall Study|Other|3|||
147171241|NCT00454649|530790563|FG009|Overall Study|Other|1|||
147171242|NCT00454649|530790554|FG000|Overall Study|Withdrawal by Subject|0|||
147171243|NCT00454649|530790555|FG001|Overall Study|Withdrawal by Subject|0|||
147171244|NCT00454649|530790556|FG002|Overall Study|Withdrawal by Subject|0|||
147171245|NCT00454649|530790557|FG003|Overall Study|Withdrawal by Subject|0|||
147171246|NCT00454649|530790558|FG004|Overall Study|Withdrawal by Subject|0|||
147171247|NCT00454649|530790559|FG005|Overall Study|Withdrawal by Subject|1|||
147171248|NCT00454649|530790560|FG006|Overall Study|Withdrawal by Subject|0|||
147171249|NCT00454649|530790561|FG007|Overall Study|Withdrawal by Subject|2|||
147171250|NCT00454649|530790562|FG008|Overall Study|Withdrawal by Subject|1|||
147171251|NCT00454649|530790563|FG009|Overall Study|Withdrawal by Subject|0|||
147171252|NCT00086411|530790566|FG000|Overall Study|Lost to Follow-up|11|||
147171253|NCT00086411|530790567|FG001|Overall Study|Lost to Follow-up|11|||
147171254|NCT00086411|530790568|FG002|Overall Study|Lost to Follow-up|13|||
147655075|NCT00423813|532559237|FG000|Overall Study|Lost to Follow-up|5|||
147171255|NCT00086411|530790569|FG003|Overall Study|Lost to Follow-up|12|||
147171256|NCT01078168|530790572|FG000|Overall Study|Physician Decision|0|||
147171257|NCT01078168|530790573|FG001|Overall Study|Physician Decision|1|||
147171258|NCT03109184|530792089|FG000|Overall Study|Lost to Follow-up|6|||
147171259|NCT03109184|530792090|FG001|Overall Study|Lost to Follow-up|6|||
147171260|NCT03109184|530792089|FG000|Overall Study|Withdrawal by Subject|1|||
147655076|NCT00423813|532559238|FG001|Overall Study|Lost to Follow-up|4|||
147171261|NCT03109184|530792090|FG001|Overall Study|Withdrawal by Subject|1|||
147655077|NCT00423813|532559239|FG002|Overall Study|Lost to Follow-up|4|||
147171262|NCT00602420|530792091|FG000|Overall Study|Death|1|||
147171263|NCT00602420|530792092|FG001|Overall Study|Death|4|||
147171264|NCT00602420|530792091|FG000|Overall Study|Chemotoxicity, Inc. Data,Ineligible|5|||
147171265|NCT00602420|530792092|FG001|Overall Study|Chemotoxicity, Inc. Data,Ineligible|3|||
147171266|NCT00602420|530792091|FG000|Overall Study|Withdrawal by Subject|18|||
147655078|NCT00423813|532559237|FG000|Overall Study|Lack of Efficacy|23|||
147655079|NCT00423813|532559238|FG001|Overall Study|Lack of Efficacy|18|||
147655080|NCT00423813|532559239|FG002|Overall Study|Lack of Efficacy|19|||
147655081|NCT00423813|532559237|FG000|Overall Study|Physician Decision|2|||
147655082|NCT00423813|532559238|FG001|Overall Study|Physician Decision|0|||
147655083|NCT00423813|532559239|FG002|Overall Study|Physician Decision|0|||
147655084|NCT00423813|532559237|FG000|Overall Study|Sponsor Decision|0|||
147655085|NCT00423813|532559238|FG001|Overall Study|Sponsor Decision|1|||
147655086|NCT00423813|532559239|FG002|Overall Study|Sponsor Decision|0|||
147655087|NCT00423813|532559237|FG000|Overall Study|Protocol Violation|9|||
147655088|NCT00423813|532559238|FG001|Overall Study|Protocol Violation|4|||
147171267|NCT00602420|530792092|FG001|Overall Study|Withdrawal by Subject|17|||
147171268|NCT00602420|530792091|FG000|Overall Study|Adverse Event|1|||
147171269|NCT00602420|530792092|FG001|Overall Study|Adverse Event|0|||
147171270|NCT02315560|530792096|FG000|Overall Study|noncompliance by subjects|3|||
147171271|NCT01041287|530792097|FG000|Treatment Period 2 (3 Months)|Lost to Follow-up|3|||
147171272|NCT01041287|530792098|FG001|Treatment Period 2 (3 Months)|Lost to Follow-up|3|||
147171273|NCT01041287|530792097|FG000|Treatment Period 2 (3 Months)|Adverse Event|0|||
147171274|NCT01041287|530792098|FG001|Treatment Period 2 (3 Months)|Adverse Event|2|||
147171275|NCT01209078|530792099|FG000|Overall Study|Adverse Event|5|||
147171276|NCT01209078|530792100|FG001|Overall Study|Adverse Event|0|||
147171277|NCT01209078|530792099|FG000|Overall Study|Lost to Follow-up|4|||
147171278|NCT01209078|530792100|FG001|Overall Study|Lost to Follow-up|0|||
147171279|NCT01209078|530792099|FG000|Overall Study|Physician Decision|5|||
147171280|NCT01209078|530792100|FG001|Overall Study|Physician Decision|2|||
147171281|NCT01209078|530792099|FG000|Overall Study|Withdrawal by Subject|2|||
147171282|NCT01209078|530792100|FG001|Overall Study|Withdrawal by Subject|1|||
147171283|NCT00924508|530792101|FG000|Overall Study|Withdrawal by Subject|3|||
147171284|NCT03464019|530792102|FG000|NODE-301 Part 1|Withdrawal by Subject|0|||
147171285|NCT03464019|530792103|FG001|NODE-301 Part 1|Withdrawal by Subject|0|||
147171286|NCT03464019|530792104|FG002|NODE-301 Part 1|Withdrawal by Subject|18|||
147171287|NCT03464019|530792102|FG000|NODE-301 Part 1|Ablation|0|||
147171288|NCT03464019|530792103|FG001|NODE-301 Part 1|Ablation|0|||
147171289|NCT03464019|530792104|FG002|NODE-301 Part 1|Ablation|16|||
147171290|NCT03464019|530792102|FG000|NODE-301 Part 1|Test Dose Failure|0|||
147171291|NCT03464019|530792103|FG001|NODE-301 Part 1|Test Dose Failure|0|||
147171292|NCT03464019|530792104|FG002|NODE-301 Part 1|Test Dose Failure|8|||
147171293|NCT03464019|530792102|FG000|NODE-301 Part 1|Adverse Event|0|||
147171294|NCT03464019|530792103|FG001|NODE-301 Part 1|Adverse Event|0|||
147171295|NCT03464019|530792104|FG002|NODE-301 Part 1|Adverse Event|5|||
147171296|NCT03464019|530792102|FG000|NODE-301 Part 1|Physician Decision|0|||
147171297|NCT03464019|530792103|FG001|NODE-301 Part 1|Physician Decision|0|||
147171298|NCT03464019|530792104|FG002|NODE-301 Part 1|Physician Decision|4|||
147171299|NCT03464019|530792102|FG000|NODE-301 Part 1|Lost to Follow-up|0|||
147655089|NCT00423813|532559239|FG002|Overall Study|Protocol Violation|4|||
147655090|NCT00423813|532559237|FG000|Overall Study|Pregnancy|0|||
147655091|NCT00423813|532559238|FG001|Overall Study|Pregnancy|0|||
147655092|NCT00423813|532559239|FG002|Overall Study|Pregnancy|1|||
147655093|NCT00423813|532559237|FG000|Overall Study|Subject started night shift work|1|||
147655094|NCT00423813|532559238|FG001|Overall Study|Subject started night shift work|0|||
147655095|NCT00423813|532559239|FG002|Overall Study|Subject started night shift work|0|||
147655096|NCT00423813|532559237|FG000|Overall Study|Will start exclusionary medications|0|||
147655097|NCT00423813|532559238|FG001|Overall Study|Will start exclusionary medications|1|||
147655098|NCT00423813|532559239|FG002|Overall Study|Will start exclusionary medications|0|||
147655099|NCT00423813|532559237|FG000|Overall Study|Undergoing tests for Cushings Syndrome|0|||
147655100|NCT00423813|532559238|FG001|Overall Study|Undergoing tests for Cushings Syndrome|0|||
147655101|NCT00423813|532559239|FG002|Overall Study|Undergoing tests for Cushings Syndrome|1|||
147655102|NCT01386944|532559240|FG000|Overall Study|Adverse Event|26|||
147171300|NCT03464019|530792103|FG001|NODE-301 Part 1|Lost to Follow-up|0|||
147171301|NCT03464019|530792104|FG002|NODE-301 Part 1|Lost to Follow-up|3|||
147171302|NCT03464019|530792102|FG000|NODE-301 Part 1|Protocol Violation|0|||
147448022|NCT02831673|531805609|FG004|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|1|||
147171303|NCT03464019|530792103|FG001|NODE-301 Part 1|Protocol Violation|0|||
147171304|NCT03464019|530792104|FG002|NODE-301 Part 1|Protocol Violation|2|||
147448023|NCT02831673|531805605|FG000|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
147171305|NCT03464019|530792102|FG000|NODE-301 Part 1|Reason was not provided by the participant|0|||
147171306|NCT03464019|530792103|FG001|NODE-301 Part 1|Reason was not provided by the participant|0|||
147171307|NCT03464019|530792104|FG002|NODE-301 Part 1|Reason was not provided by the participant|15|||
147171308|NCT03464019|530792102|FG000|NODE-301 Part 1|Transitioned to Part 2 (RAPID)|0|||
147171309|NCT03464019|530792103|FG001|NODE-301 Part 1|Transitioned to Part 2 (RAPID)|0|||
147171310|NCT03464019|530792104|FG002|NODE-301 Part 1|Transitioned to Part 2 (RAPID)|82|||
147244337|NCT02549937|531066977|FG003|Overall Study|Lost to Follow-up|0|||
147655103|NCT01386944|532559240|FG000|Overall Study|Lack of Efficacy|14|||
147655104|NCT01386944|532559240|FG000|Overall Study|Lost to Follow-up|8|||
147655105|NCT01386944|532559240|FG000|Overall Study|Unspecified reason|8|||
147655106|NCT01904032|532559242|FG000|Overall Study|Adverse Event|3|||
147171311|NCT03464019|530792102|FG000|NODE-301 Part 1|Participants did not experienced PSVT before cutoff and did not enroll in Part 2|0|||
147171312|NCT03464019|530792103|FG001|NODE-301 Part 1|Participants did not experienced PSVT before cutoff and did not enroll in Part 2|0|||
147171313|NCT03464019|530792104|FG002|NODE-301 Part 1|Participants did not experienced PSVT before cutoff and did not enroll in Part 2|80|||
147171314|NCT03464019|530792102|FG000|NODE-301 Part 2 and Part 3|Withdrawal by Subject|5|||
147171315|NCT03464019|530792103|FG001|NODE-301 Part 2 and Part 3|Withdrawal by Subject|1|||
147171316|NCT03464019|530792104|FG002|NODE-301 Part 2 and Part 3|Withdrawal by Subject|32|||
147323794|NCT00052962|531350037|FG001|Overall Study|Not randomized/not evaluable|0|||
147323795|NCT02820051|531350043|FG000|Overall Study|Lost to Follow-up|7|||
147323796|NCT02820051|531350044|FG001|Overall Study|Lost to Follow-up|4|||
147323797|NCT01222247|531350048|FG000|Overall Study|Lost to Follow-up|2|||
147323798|NCT01222247|531350049|FG001|Overall Study|Lost to Follow-up|2|||
147323799|NCT02084082|531350050|FG000|Washout Period 1 (35 Days)|Adverse Event|0|||
147323800|NCT02084082|531350051|FG001|Washout Period 1 (35 Days)|Adverse Event|0|||
147323801|NCT02084082|531350052|FG002|Washout Period 1 (35 Days)|Adverse Event|1|||
147323802|NCT02084082|531350053|FG003|Washout Period 1 (35 Days)|Adverse Event|1|||
147323803|NCT02084082|531350050|FG000|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
147323804|NCT02084082|531350051|FG001|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
147323805|NCT02084082|531350052|FG002|Washout Period 1 (35 Days)|Withdrawal by Subject|0|||
147591664|NCT05626803|532322647|FG001|Overall Study|Lost to Follow-up|1|||
147591665|NCT05626803|532322648|FG002|Overall Study|Lost to Follow-up|0|||
147591666|NCT05626803|532322649|FG003|Overall Study|Lost to Follow-up|0|||
147591667|NCT01000610|532322651|FG000|Overall Study|Adverse Event|1|||
147591668|NCT01000610|532322651|FG000|Overall Study|Lost to Follow-up|4|||
147591669|NCT01000610|532322651|FG000|Overall Study|Treatment failure|1|||
147591670|NCT00595335|532322656|FG000|Baseline to Six Months|Withdrawal by Subject|0|||
147591671|NCT00595335|532322657|FG001|Baseline to Six Months|Withdrawal by Subject|1|||
147591672|NCT00595335|532322656|FG000|Baseline to Six Months|Disease Progression|1|||
147591673|NCT00595335|532322657|FG001|Baseline to Six Months|Disease Progression|1|||
147591674|NCT00595335|532322656|FG000|Baseline to Six Months|Adverse Event|1|||
147591675|NCT00595335|532322657|FG001|Baseline to Six Months|Adverse Event|0|||
147591676|NCT00595335|532322656|FG000|Six Months to Twelve Months|Withdrawal by Subject|0|||
147591677|NCT00595335|532322657|FG001|Six Months to Twelve Months|Withdrawal by Subject|1|||
147591678|NCT00595335|532322656|FG000|Six Months to Twelve Months|Disease Progression|1|||
147591679|NCT00595335|532322657|FG001|Six Months to Twelve Months|Disease Progression|0|||
147591680|NCT00493779|532322669|FG000|Overall Study|Logistical issue at site|1|||
147591681|NCT01131299|532322670|FG000|Overall Study|Withdrawal by Subject|4|||
147591682|NCT01131299|532322671|FG001|Overall Study|Withdrawal by Subject|7|||
147591683|NCT02148913|532322681|FG000|Overall Study|Death|0|||
147591684|NCT02148913|532322682|FG001|Overall Study|Death|1|||
147591685|NCT02148913|532322683|FG002|Overall Study|Death|0|||
147591686|NCT02148913|532322684|FG003|Overall Study|Death|0|||
147591687|NCT01287039|532322685|FG000|Overall Study|Noncompliance with study procedures|0|||
147591688|NCT01287039|532322686|FG001|Overall Study|Noncompliance with study procedures|1|||
147591689|NCT01287039|532322685|FG000|Overall Study|Change of location/residence|0|||
147591690|NCT01287039|532322686|FG001|Overall Study|Change of location/residence|3|||
147591691|NCT01287039|532322685|FG000|Overall Study|Elective surgery|0|||
147591692|NCT01287039|532322686|FG001|Overall Study|Elective surgery|1|||
147591693|NCT01287039|532322685|FG000|Overall Study|Protocol Violation|2|||
147591694|NCT01287039|532322686|FG001|Overall Study|Protocol Violation|3|||
147591695|NCT01287039|532322685|FG000|Overall Study|Excluded medication taken|1|||
147591696|NCT01287039|532322686|FG001|Overall Study|Excluded medication taken|0|||
147591697|NCT01287039|532322685|FG000|Overall Study|Noncompliance with study medication|0|||
147591698|NCT01287039|532322686|FG001|Overall Study|Noncompliance with study medication|1|||
147591699|NCT01287039|532322685|FG000|Overall Study|Problem with travel|0|||
147591700|NCT01287039|532322686|FG001|Overall Study|Problem with travel|1|||
147591701|NCT01287039|532322685|FG000|Overall Study|Death|1|||
147591702|NCT01287039|532322686|FG001|Overall Study|Death|0|||
147591703|NCT01287039|532322685|FG000|Overall Study|Change of residence|1|||
147591704|NCT01287039|532322686|FG001|Overall Study|Change of residence|0|||
147591705|NCT01287039|532322685|FG000|Overall Study|Adverse Event|7|||
147591706|NCT01287039|532322686|FG001|Overall Study|Adverse Event|4|||
147171317|NCT03464019|530792102|FG000|NODE-301 Part 2 and Part 3|Ablation|8|||
147591707|NCT01287039|532322685|FG000|Overall Study|Withdrawal by Subject|14|||
147171318|NCT03464019|530792103|FG001|NODE-301 Part 2 and Part 3|Ablation|11|||
147171319|NCT03464019|530792104|FG002|NODE-301 Part 2 and Part 3|Ablation|46|||
147323806|NCT02084082|531350053|FG003|Washout Period 1 (35 Days)|Withdrawal by Subject|1|||
147323807|NCT00832780|531350054|FG000|Overall Study|Death|16|||
147323808|NCT00832780|531350054|FG000|Overall Study|Lost to Follow-up|4|||
147591708|NCT01287039|532322686|FG001|Overall Study|Withdrawal by Subject|11|||
147591709|NCT01287039|532322685|FG000|Overall Study|Lost to Follow-up|3|||
147591710|NCT01287039|532322686|FG001|Overall Study|Lost to Follow-up|2|||
147591711|NCT00262041|532322688|FG000|Overall Study|Withdrawal by Subject|0|||
147591712|NCT00262041|532322689|FG001|Overall Study|Withdrawal by Subject|3|||
147591713|NCT00262041|532322690|FG002|Overall Study|Withdrawal by Subject|1|||
147591714|NCT00262041|532322688|FG000|Overall Study|Lost to Follow-up|1|||
147591715|NCT00262041|532322689|FG001|Overall Study|Lost to Follow-up|1|||
147591716|NCT00262041|532322690|FG002|Overall Study|Lost to Follow-up|5|||
147171320|NCT03464019|530792102|FG000|NODE-301 Part 2 and Part 3|Test Dose failure|0|||
147171321|NCT03464019|530792103|FG001|NODE-301 Part 2 and Part 3|Test Dose failure|0|||
147171322|NCT03464019|530792104|FG002|NODE-301 Part 2 and Part 3|Test Dose failure|8|||
147171323|NCT03464019|530792102|FG000|NODE-301 Part 2 and Part 3|Adverse Event|1|||
147171324|NCT03464019|530792103|FG001|NODE-301 Part 2 and Part 3|Adverse Event|3|||
147171325|NCT03464019|530792104|FG002|NODE-301 Part 2 and Part 3|Adverse Event|14|||
147171326|NCT03464019|530792102|FG000|NODE-301 Part 2 and Part 3|Physician Decision|0|||
147171327|NCT03464019|530792103|FG001|NODE-301 Part 2 and Part 3|Physician Decision|0|||
147171328|NCT03464019|530792104|FG002|NODE-301 Part 2 and Part 3|Physician Decision|2|||
147171329|NCT03464019|530792102|FG000|NODE-301 Part 2 and Part 3|Lost to Follow-up|1|||
147171330|NCT03464019|530792103|FG001|NODE-301 Part 2 and Part 3|Lost to Follow-up|0|||
147591717|NCT00262041|532322688|FG000|Overall Study|Unable to classify|1|||
147591718|NCT00262041|532322689|FG001|Overall Study|Unable to classify|0|||
147591719|NCT00262041|532322690|FG002|Overall Study|Unable to classify|0|||
147591720|NCT01173471|532322693|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
147591721|NCT01173471|532322694|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
147591722|NCT01173471|532322695|FG002|Overall Study|Eligibility criteria not fulfilled|1|||
147591723|NCT01173471|532322696|FG003|Overall Study|Eligibility criteria not fulfilled|1|||
147591724|NCT01173471|532322693|FG000|Overall Study|Condition under investigation worsened|2|||
147591725|NCT01173471|532322694|FG001|Overall Study|Condition under investigation worsened|0|||
147591726|NCT01173471|532322695|FG002|Overall Study|Condition under investigation worsened|0|||
147591727|NCT01173471|532322696|FG003|Overall Study|Condition under investigation worsened|0|||
147591728|NCT01173471|532322693|FG000|Overall Study|Lost to Follow-up|0|||
147591729|NCT01173471|532322694|FG001|Overall Study|Lost to Follow-up|0|||
147591730|NCT01173471|532322695|FG002|Overall Study|Lost to Follow-up|1|||
147591731|NCT01173471|532322696|FG003|Overall Study|Lost to Follow-up|0|||
147591732|NCT01173471|532322693|FG000|Overall Study|Reason given as Other|0|||
147591733|NCT01173471|532322694|FG001|Overall Study|Reason given as Other|0|||
147591734|NCT01173471|532322695|FG002|Overall Study|Reason given as Other|1|||
147591735|NCT01173471|532322696|FG003|Overall Study|Reason given as Other|0|||
147591736|NCT04132336|532322697|FG000|Overall Study|Investigator Decision|0|||
147591737|NCT04132336|532322698|FG001|Overall Study|Investigator Decision|1|||
147591738|NCT04132336|532322699|FG002|Overall Study|Investigator Decision|0|||
147591739|NCT04132336|532322700|FG003|Overall Study|Investigator Decision|0|||
147171331|NCT03464019|530792104|FG002|NODE-301 Part 2 and Part 3|Lost to Follow-up|7|||
147171332|NCT03464019|530792102|FG000|NODE-301 Part 2 and Part 3|Protocol Violation|0|||
147171333|NCT03464019|530792103|FG001|NODE-301 Part 2 and Part 3|Protocol Violation|1|||
147171334|NCT03464019|530792104|FG002|NODE-301 Part 2 and Part 3|Protocol Violation|2|||
147171335|NCT03464019|530792102|FG000|NODE-301 Part 2 and Part 3|Pregnancy|0|||
147171336|NCT03464019|530792103|FG001|NODE-301 Part 2 and Part 3|Pregnancy|0|||
147171337|NCT03464019|530792104|FG002|NODE-301 Part 2 and Part 3|Pregnancy|1|||
147171338|NCT03464019|530792102|FG000|NODE-301 Part 2 and Part 3|Prohibited Medication|1|||
147171339|NCT03464019|530792103|FG001|NODE-301 Part 2 and Part 3|Prohibited Medication|1|||
147171340|NCT03464019|530792104|FG002|NODE-301 Part 2 and Part 3|Prohibited Medication|4|||
147171341|NCT03464019|530792102|FG000|NODE-301 Part 2 and Part 3|Study Terminated by Sponsor|46|||
147171342|NCT03464019|530792103|FG001|NODE-301 Part 2 and Part 3|Study Terminated by Sponsor|61|||
147171343|NCT03464019|530792104|FG002|NODE-301 Part 2 and Part 3|Study Terminated by Sponsor|314|||
147171344|NCT03464019|530792102|FG000|NODE-301 Part 2 and Part 3|Reason was not provided by the participant|5|||
147171345|NCT03464019|530792103|FG001|NODE-301 Part 2 and Part 3|Reason was not provided by the participant|1|||
147171346|NCT03464019|530792104|FG002|NODE-301 Part 2 and Part 3|Reason was not provided by the participant|15|||
147171347|NCT00767806|530792105|FG000|Overall Study|Adverse Event|30|||
147171348|NCT00767806|530792106|FG001|Overall Study|Adverse Event|11|||
147171349|NCT00767806|530792105|FG000|Overall Study|Withdrawal by Subject|8|||
147171350|NCT00767806|530792106|FG001|Overall Study|Withdrawal by Subject|13|||
147171351|NCT00767806|530792105|FG000|Overall Study|Protocol Violation|6|||
147171352|NCT00767806|530792106|FG001|Overall Study|Protocol Violation|5|||
147171353|NCT00767806|530792105|FG000|Overall Study|Lack of Efficacy|1|||
147171354|NCT00767806|530792106|FG001|Overall Study|Lack of Efficacy|9|||
147171355|NCT00767806|530792105|FG000|Overall Study|Physician Decision|4|||
147171356|NCT00767806|530792106|FG001|Overall Study|Physician Decision|3|||
147171357|NCT00767806|530792105|FG000|Overall Study|Lost to Follow-up|1|||
147171358|NCT00767806|530792106|FG001|Overall Study|Lost to Follow-up|4|||
147171359|NCT00767806|530792105|FG000|Overall Study|Entry Criteria Not Met|1|||
147171360|NCT00767806|530792106|FG001|Overall Study|Entry Criteria Not Met|1|||
147591740|NCT04132336|532322701|FG004|Overall Study|Investigator Decision|0|||
147655107|NCT01904032|532559243|FG001|Overall Study|Adverse Event|1|||
147171361|NCT00767806|530792105|FG000|Overall Study|Sponsor Decision|0|||
147171362|NCT00767806|530792106|FG001|Overall Study|Sponsor Decision|1|||
147591741|NCT04132336|532322702|FG005|Overall Study|Investigator Decision|0|||
147591742|NCT04132336|532322703|FG006|Overall Study|Investigator Decision|0|||
147591743|NCT04319159|532322708|FG000|Overall Study|Screening failure|13|||
147655108|NCT01904032|532559242|FG000|Overall Study|Lost to Follow-up|4|||
147171363|NCT00372697|530792107|FG000|Overall Study|Protocol Violation|1|||
147171364|NCT00372697|530792108|FG001|Overall Study|Protocol Violation|1|||
147171365|NCT01815840|530792109|FG000|Overall Study|Missing|1|||
147171366|NCT01815840|530792110|FG001|Overall Study|Missing|0|||
147171367|NCT01815840|530792109|FG000|Overall Study|Withdrew Consent|31|||
147171368|NCT01815840|530792110|FG001|Overall Study|Withdrew Consent|30|||
147171369|NCT01815840|530792109|FG000|Overall Study|Administrative/Other|1|||
147171370|NCT01815840|530792110|FG001|Overall Study|Administrative/Other|3|||
147171371|NCT01815840|530792109|FG000|Overall Study|Adverse Event|10|||
147171372|NCT01815840|530792110|FG001|Overall Study|Adverse Event|16|||
147171373|NCT01815840|530792109|FG000|Overall Study|Death|2|||
147171374|NCT01815840|530792110|FG001|Overall Study|Death|2|||
147171375|NCT01815840|530792109|FG000|Overall Study|Disease progression|3|||
147171376|NCT01815840|530792110|FG001|Overall Study|Disease progression|2|||
147171377|NCT01815840|530792109|FG000|Overall Study|Investigators Decision|2|||
147171378|NCT01815840|530792110|FG001|Overall Study|Investigators Decision|3|||
147171379|NCT01815840|530792109|FG000|Overall Study|Lost to Follow-up|3|||
147171380|NCT01815840|530792110|FG001|Overall Study|Lost to Follow-up|6|||
147171381|NCT01815840|530792109|FG000|Overall Study|Refused Treatment|5|||
147171382|NCT01815840|530792110|FG001|Overall Study|Refused Treatment|1|||
147591744|NCT04319159|532322708|FG000|Overall Study|Re-screening due to COVID-19 implications|2|||
147591745|NCT04319159|532322708|FG000|Overall Study|Withdrawal by Subject|1|||
147591746|NCT02100319|532322711|FG000|Overall Study|Case Report Forms Uncollected|11|||
147591747|NCT02100319|532322711|FG000|Overall Study|Protocol Deviation|5|||
147591748|NCT02370914|532322712|FG000|Overall Study|Protocol Violation|2|||
147591749|NCT01478828|532322714|FG000|Overall Study|Adverse Event|1|||
147591750|NCT05611996|532322715|FG000|Overall Study|Ineligible|1|||
147171383|NCT01815840|530792109|FG000|Overall Study|Sponsor Termination Treatment|1|||
147171384|NCT01815840|530792110|FG001|Overall Study|Sponsor Termination Treatment|0|||
147171385|NCT03221842|530792112|FG000|Period 1 (Open-label)|Adverse Event|4|||
147171386|NCT03221842|530792113|FG001|Period 1 (Open-label)|Adverse Event|0|||
147171387|NCT03221842|530792112|FG000|Period 1 (Open-label)|Physician Decision|2|||
147171388|NCT03221842|530792113|FG001|Period 1 (Open-label)|Physician Decision|0|||
147171389|NCT03221842|530792112|FG000|Period 1 (Open-label)|Lost to Follow-up|1|||
147171390|NCT03221842|530792113|FG001|Period 1 (Open-label)|Lost to Follow-up|0|||
147171391|NCT03221842|530792112|FG000|Period 1 (Open-label)|Terminated by sponsor|1|||
147171392|NCT03221842|530792113|FG001|Period 1 (Open-label)|Terminated by sponsor|0|||
147171393|NCT03221842|530792112|FG000|Period 1 (Open-label)|Other|2|||
147171394|NCT03221842|530792113|FG001|Period 1 (Open-label)|Other|0|||
147171395|NCT03221842|530792112|FG000|Period 2 (Randomized, Blinded)|Death|0|||
147171396|NCT03221842|530792113|FG001|Period 2 (Randomized, Blinded)|Death|1|||
147171397|NCT03221842|530792112|FG000|Period 2 (Randomized, Blinded)|Lack of Efficacy|1|||
147171398|NCT03221842|530792113|FG001|Period 2 (Randomized, Blinded)|Lack of Efficacy|0|||
147171399|NCT00704288|530792114|FG000|Overall Treatment Period|Adverse Event|11|||
147171400|NCT00704288|530792115|FG001|Overall Treatment Period|Adverse Event|8|||
147171401|NCT00704288|530792116|FG002|Overall Treatment Period|Adverse Event|22|||
147171402|NCT00704288|530792114|FG000|Overall Treatment Period|Death|0|||
147171403|NCT00704288|530792115|FG001|Overall Treatment Period|Death|0|||
147171404|NCT00704288|530792116|FG002|Overall Treatment Period|Death|1|||
147171405|NCT00704288|530792114|FG000|Overall Treatment Period|Physician Decision|0|||
147171406|NCT00704288|530792115|FG001|Overall Treatment Period|Physician Decision|2|||
147171407|NCT00704288|530792116|FG002|Overall Treatment Period|Physician Decision|0|||
147171408|NCT00704288|530792114|FG000|Overall Treatment Period|Withdrawal by Subject|0|||
147171409|NCT00704288|530792115|FG001|Overall Treatment Period|Withdrawal by Subject|1|||
147171410|NCT00704288|530792116|FG002|Overall Treatment Period|Withdrawal by Subject|3|||
147171411|NCT00704288|530792114|FG000|Overall Treatment Period|Disease progression--per Modified MacDonald Criteria (Group A)|30|||
147171412|NCT00704288|530792115|FG001|Overall Treatment Period|Disease progression--per Modified MacDonald Criteria (Group A)|0|||
147171413|NCT00704288|530792116|FG002|Overall Treatment Period|Disease progression--per Modified MacDonald Criteria (Group A)|0|||
147591751|NCT05611996|532322715|FG000|Overall Study|Withdrawal by Subject|9|||
147591752|NCT04479475|532322716|FG000|Overall Study|Withdrawal by Subject|7|||
147591753|NCT00296491|532322718|FG000|Overall Study|Low Pollen Counts|18|||
147591754|NCT00296491|532322719|FG001|Overall Study|Low Pollen Counts|26|||
147591755|NCT00296491|532322720|FG002|Overall Study|Low Pollen Counts|25|||
147591756|NCT00296491|532322721|FG003|Overall Study|Low Pollen Counts|16|||
147591757|NCT00296491|532322718|FG000|Overall Study|Protocol Violation|4|||
147591758|NCT00296491|532322719|FG001|Overall Study|Protocol Violation|6|||
147591759|NCT00296491|532322720|FG002|Overall Study|Protocol Violation|2|||
147171414|NCT00704288|530792114|FG000|Overall Treatment Period|Disease Progression--Radiologic Progression (Group B and C)|0|||
147171415|NCT00704288|530792115|FG001|Overall Treatment Period|Disease Progression--Radiologic Progression (Group B and C)|42|||
147171416|NCT00704288|530792116|FG002|Overall Treatment Period|Disease Progression--Radiologic Progression (Group B and C)|76|||
147171417|NCT00704288|530792114|FG000|Overall Treatment Period|Disease Progression--Clinical Deterioration|3|||
147171418|NCT00704288|530792115|FG001|Overall Treatment Period|Disease Progression--Clinical Deterioration|6|||
147244338|NCT02549937|531066978|FG004|Overall Study|Lost to Follow-up|0|||
147591760|NCT00296491|532322721|FG003|Overall Study|Protocol Violation|3|||
147655109|NCT01904032|532559243|FG001|Overall Study|Lost to Follow-up|2|||
147655110|NCT00531947|532559244|FG000|Overall Study|Adverse Event|5|||
147655111|NCT00531947|532559245|FG001|Overall Study|Adverse Event|10|||
147655112|NCT00531947|532559244|FG000|Overall Study|Lost to Follow-up|12|||
147655113|NCT00531947|532559245|FG001|Overall Study|Lost to Follow-up|9|||
147655114|NCT00531947|532559244|FG000|Overall Study|Withdrawal by Subject|14|||
147655115|NCT00531947|532559245|FG001|Overall Study|Withdrawal by Subject|19|||
147655116|NCT00531947|532559244|FG000|Overall Study|Protocol Violation|2|||
147655117|NCT00531947|532559245|FG001|Overall Study|Protocol Violation|1|||
147655118|NCT00531947|532559244|FG000|Overall Study|Non-Compliance|4|||
147655119|NCT00531947|532559245|FG001|Overall Study|Non-Compliance|7|||
147655120|NCT00531947|532559244|FG000|Overall Study|Other (e.g., Lack of Efficacy)|5|||
147655121|NCT00531947|532559245|FG001|Overall Study|Other (e.g., Lack of Efficacy)|5|||
147655122|NCT02383355|532559250|FG000|Overall Study|Adverse Event|2|||
147655123|NCT02383355|532559251|FG001|Overall Study|Adverse Event|0|||
147655124|NCT03681184|532559258|FG000|6-Month Double-Blind Period|Parent/Caregiver Withdrew Consent|0|||
147171419|NCT00704288|530792116|FG002|Overall Treatment Period|Disease Progression--Clinical Deterioration|11|||
147171420|NCT00704288|530792114|FG000|Overall Treatment Period|Roll-over to another study|1|||
147171421|NCT00704288|530792115|FG001|Overall Treatment Period|Roll-over to another study|0|||
147171422|NCT00704288|530792116|FG002|Overall Treatment Period|Roll-over to another study|4|||
147171423|NCT00704288|530792114|FG000|Overall Treatment Period|Other--Subject had intracranial hemorrhage|1|||
147171424|NCT00704288|530792115|FG001|Overall Treatment Period|Other--Subject had intracranial hemorrhage|0|||
147171425|NCT00704288|530792116|FG002|Overall Treatment Period|Other--Subject had intracranial hemorrhage|0|||
147171426|NCT00704288|530792114|FG000|Extended Post Treatment Follow Up Period|Death|41|||
147171427|NCT00704288|530792115|FG001|Extended Post Treatment Follow Up Period|Death|50|||
147171428|NCT00704288|530792116|FG002|Extended Post Treatment Follow Up Period|Death|93|||
147171429|NCT00704288|530792114|FG000|Extended Post Treatment Follow Up Period|Lost to Follow-up|0|||
147171430|NCT00704288|530792115|FG001|Extended Post Treatment Follow Up Period|Lost to Follow-up|2|||
147171431|NCT00704288|530792116|FG002|Extended Post Treatment Follow Up Period|Lost to Follow-up|1|||
147171432|NCT00704288|530792114|FG000|Extended Post Treatment Follow Up Period|Withdrawal by Subject|0|||
147171433|NCT00704288|530792115|FG001|Extended Post Treatment Follow Up Period|Withdrawal by Subject|2|||
147171434|NCT00704288|530792116|FG002|Extended Post Treatment Follow Up Period|Withdrawal by Subject|2|||
147171435|NCT00704288|530792114|FG000|Extended Post Treatment Follow Up Period|Various reasons|5|||
147171436|NCT00704288|530792115|FG001|Extended Post Treatment Follow Up Period|Various reasons|5|||
147171437|NCT00704288|530792116|FG002|Extended Post Treatment Follow Up Period|Various reasons|21|||
147171438|NCT01055314|530792117|FG000|Overall Study|Adverse Event|7|||
147171439|NCT01055314|530792118|FG001|Overall Study|Adverse Event|4|||
147448024|NCT02831673|531805606|FG001|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
147448025|NCT02831673|531805607|FG002|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
147591761|NCT00296491|532322718|FG000|Overall Study|Adverse Event|1|||
147171440|NCT01055314|530792117|FG000|Overall Study|Death|2|||
147171441|NCT01055314|530792118|FG001|Overall Study|Death|1|||
147171442|NCT01055314|530792117|FG000|Overall Study|Lack of Efficacy|11|||
147591762|NCT00296491|532322719|FG001|Overall Study|Adverse Event|3|||
147591763|NCT00296491|532322720|FG002|Overall Study|Adverse Event|1|||
147591764|NCT00296491|532322721|FG003|Overall Study|Adverse Event|4|||
147591765|NCT00296491|532322718|FG000|Overall Study|Withdrawn due to Asthma|0|||
147591766|NCT00296491|532322719|FG001|Overall Study|Withdrawn due to Asthma|0|||
147591767|NCT00296491|532322720|FG002|Overall Study|Withdrawn due to Asthma|0|||
147591768|NCT00296491|532322721|FG003|Overall Study|Withdrawn due to Asthma|4|||
147591769|NCT00296491|532322718|FG000|Overall Study|Withdrawal by Subject|7|||
147591770|NCT00296491|532322719|FG001|Overall Study|Withdrawal by Subject|3|||
147591771|NCT00296491|532322720|FG002|Overall Study|Withdrawal by Subject|3|||
147591772|NCT00296491|532322721|FG003|Overall Study|Withdrawal by Subject|2|||
147591773|NCT00296491|532322718|FG000|Overall Study|Non-Compliance|12|||
147591774|NCT00296491|532322719|FG001|Overall Study|Non-Compliance|13|||
147591775|NCT00296491|532322720|FG002|Overall Study|Non-Compliance|10|||
147591776|NCT00296491|532322721|FG003|Overall Study|Non-Compliance|14|||
147591777|NCT00296491|532322718|FG000|Overall Study|Lost to Follow-up|0|||
147591778|NCT00296491|532322719|FG001|Overall Study|Lost to Follow-up|2|||
147591779|NCT00296491|532322720|FG002|Overall Study|Lost to Follow-up|2|||
147591780|NCT00296491|532322721|FG003|Overall Study|Lost to Follow-up|0|||
147591781|NCT03451006|532322722|FG000|Overall Study|Withdrawal by Subject|2|||
147591782|NCT03451006|532322723|FG001|Overall Study|Withdrawal by Subject|2|||
147591783|NCT02547766|532322724|FG000|Overall Study|Withdrawal by Subject|1|||
147591784|NCT05444543|532322727|FG000|Overall Study|Withdrawal by Subject|1|||
147591785|NCT05444543|532322728|FG001|Overall Study|Withdrawal by Subject|0|||
147591786|NCT05444543|532322727|FG000|Overall Study|Failed to achieve initial remission on therapy|1|||
147591787|NCT05444543|532322728|FG001|Overall Study|Failed to achieve initial remission on therapy|0|||
147591788|NCT05444543|532322727|FG000|Overall Study|Adverse Event|0|||
147591789|NCT05444543|532322728|FG001|Overall Study|Adverse Event|1|||
147448026|NCT02831673|531805608|FG003|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
147448027|NCT02831673|531805609|FG004|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|10|||
147448028|NCT02831673|531805605|FG000|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
147448029|NCT02831673|531805606|FG001|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
147448030|NCT02831673|531805607|FG002|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
147448031|NCT02831673|531805608|FG003|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
147448032|NCT02831673|531805609|FG004|Continuation Phase(Week 148 to Week 280)|Physician Decision|2|||
147448033|NCT02831673|531805605|FG000|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
147448034|NCT02831673|531805606|FG001|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
147448035|NCT02831673|531805607|FG002|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
147448036|NCT02831673|531805608|FG003|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
147448037|NCT02831673|531805609|FG004|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|7|||
147448038|NCT00477165|531805610|FG000|Overall Study|Adverse Event|7|||
147448039|NCT00477165|531805611|FG001|Overall Study|Adverse Event|2|||
147448040|NCT01623271|531805618|FG000|Overall Study|Withdrawal by Subject|2|||
147448041|NCT00631371|531805625|FG000|Overall Study|Lost to Follow-up|24|||
147448042|NCT00631371|531805626|FG001|Overall Study|Lost to Follow-up|19|||
147448043|NCT00631371|531805625|FG000|Overall Study|Other reason|5|||
147448044|NCT00631371|531805626|FG001|Overall Study|Other reason|12|||
147448045|NCT00631371|531805625|FG000|Overall Study|subject request|38|||
147448046|NCT00631371|531805626|FG001|Overall Study|subject request|45|||
147448047|NCT00631371|531805625|FG000|Overall Study|Discontinuation of study by Sponsor|70|||
147448048|NCT00631371|531805626|FG001|Overall Study|Discontinuation of study by Sponsor|76|||
147448049|NCT00631371|531805625|FG000|Overall Study|Death|263|||
147448050|NCT00631371|531805626|FG001|Overall Study|Death|239|||
147448051|NCT01659320|531805629|FG000|Overall Study|Withdrawal by Subject|2|||
147448052|NCT01659320|531805629|FG000|Overall Study|Physician Decision|1|||
147448053|NCT00590590|531805630|FG000|Overall Study|Lack of Efficacy|1|||
147448054|NCT00590590|531805631|FG001|Overall Study|Lack of Efficacy|2|||
147448055|NCT00590590|531805632|FG002|Overall Study|Lack of Efficacy|0|||
147448056|NCT00590590|531805630|FG000|Overall Study|Adverse Event|1|||
147448057|NCT00590590|531805631|FG001|Overall Study|Adverse Event|0|||
147448058|NCT00590590|531805632|FG002|Overall Study|Adverse Event|0|||
147448059|NCT00590590|531805630|FG000|Overall Study|Protocol Violation|0|||
147448060|NCT00590590|531805631|FG001|Overall Study|Protocol Violation|0|||
147448061|NCT00590590|531805632|FG002|Overall Study|Protocol Violation|2|||
147448062|NCT00590590|531805630|FG000|Overall Study|Lost to Follow-up|4|||
147448063|NCT00590590|531805631|FG001|Overall Study|Lost to Follow-up|1|||
147448064|NCT00590590|531805632|FG002|Overall Study|Lost to Follow-up|2|||
147448065|NCT00590590|531805630|FG000|Overall Study|Withdrawal by Subject|0|||
147591790|NCT05444543|532322727|FG000|Overall Study|Family relocating at a distance from study site|0|||
147591791|NCT05444543|532322728|FG001|Overall Study|Family relocating at a distance from study site|1|||
147591792|NCT03847194|532322729|FG000|Overall Study|Lost to Follow-up|2|||
147591793|NCT03847194|532322730|FG001|Overall Study|Lost to Follow-up|5|||
147591794|NCT03847194|532322729|FG000|Overall Study|Withdrawal by Subject|1|||
147591795|NCT03847194|532322730|FG001|Overall Study|Withdrawal by Subject|2|||
147591796|NCT03847194|532322729|FG000|Overall Study|Death|0|||
147591797|NCT03847194|532322730|FG001|Overall Study|Death|1|||
147591798|NCT01144403|532322732|FG000|Overall Study|Lost to Follow-up|3|||
147591799|NCT01144403|532322732|FG000|Overall Study|Death|1|||
147591800|NCT01144403|532322732|FG000|Overall Study|Adverse Event|1|||
147591801|NCT03891329|532322733|FG000|Overall Study|Death|5|||
147591802|NCT03891329|532322733|FG000|Overall Study|Lost to Follow-up|4|||
147591803|NCT03891329|532322733|FG000|Overall Study|Physician Decision|4|||
147591804|NCT03891329|532322733|FG000|Overall Study|Device explanted|3|||
147591805|NCT03891329|532322733|FG000|Overall Study|No study device implanted|3|||
147591806|NCT02654587|532322734|FG000|Overall Study|patient alive at end of study|22|||
147591807|NCT02654587|532322735|FG001|Overall Study|patient alive at end of study|8|||
147591808|NCT02654587|532322734|FG000|Overall Study|Withdrawal by Subject|1|||
147591809|NCT02654587|532322735|FG001|Overall Study|Withdrawal by Subject|7|||
147591810|NCT01825837|532322736|FG000|PART I|Withdrawal by Subject|0|||
147591811|NCT01825837|532322737|FG001|PART I|Withdrawal by Subject|0|||
147591812|NCT01825837|532322738|FG002|PART I|Withdrawal by Subject|0|||
147591813|NCT01825837|532322739|FG003|PART I|Withdrawal by Subject|6|||
147591814|NCT01825837|532322736|FG000|PART I|Patient non-compliance|0|||
147591815|NCT01825837|532322737|FG001|PART I|Patient non-compliance|0|||
147591816|NCT01825837|532322738|FG002|PART I|Patient non-compliance|0|||
147448066|NCT00590590|531805631|FG001|Overall Study|Withdrawal by Subject|1|||
147448067|NCT00590590|531805632|FG002|Overall Study|Withdrawal by Subject|1|||
147448068|NCT00590590|531805630|FG000|Overall Study|Did not complete due to study closure|1|||
147591817|NCT01825837|532322739|FG003|PART I|Patient non-compliance|1|||
147591818|NCT01825837|532322736|FG000|PART I|Treatment failure|0|||
147591819|NCT01825837|532322737|FG001|PART I|Treatment failure|0|||
147591820|NCT01825837|532322738|FG002|PART I|Treatment failure|0|||
147591821|NCT01825837|532322739|FG003|PART I|Treatment failure|7|||
147591822|NCT01825837|532322736|FG000|PART I|reason unspecified|0|||
147655125|NCT03681184|532559259|FG001|6-Month Double-Blind Period|Parent/Caregiver Withdrew Consent|1|||
147655126|NCT02787083|532559260|FG000|Overall Study|Adverse Event|1|||
147655127|NCT02787083|532559261|FG001|Overall Study|Adverse Event|0|||
147655128|NCT02787083|532559260|FG000|Overall Study|Withdrawal by Subject|2|||
147655129|NCT02787083|532559261|FG001|Overall Study|Withdrawal by Subject|2|||
147655130|NCT03162328|532559262|FG000|Screening Period|Did not meet inclusion/exclusion|21|||
147655131|NCT03162328|532559263|FG001|Screening Period|Did not meet inclusion/exclusion|0|||
147655132|NCT03162328|532559264|FG002|Screening Period|Did not meet inclusion/exclusion|0|||
147655133|NCT03162328|532559262|FG000|Screening Period|Withdrawal by Subject|1|||
147655134|NCT03162328|532559263|FG001|Screening Period|Withdrawal by Subject|0|||
147655135|NCT03162328|532559264|FG002|Screening Period|Withdrawal by Subject|0|||
147655136|NCT03162328|532559262|FG000|Study Period|Withdrawal by Subject|0|||
147171443|NCT01055314|530792118|FG001|Overall Study|Lack of Efficacy|19|||
147171444|NCT01055314|530792117|FG000|Overall Study|Physician Decision|10|||
147171445|NCT01055314|530792118|FG001|Overall Study|Physician Decision|5|||
147171446|NCT01055314|530792117|FG000|Overall Study|Withdrawal by Subject|1|||
147171447|NCT01055314|530792118|FG001|Overall Study|Withdrawal by Subject|0|||
147171448|NCT01055314|530792117|FG000|Overall Study|Ineligible|3|||
147323809|NCT00832780|531350054|FG000|Overall Study|no reason given|2|||
147591823|NCT01825837|532322737|FG001|PART I|reason unspecified|0|||
147591824|NCT01825837|532322738|FG002|PART I|reason unspecified|0|||
147591825|NCT01825837|532322739|FG003|PART I|reason unspecified|3|||
147591826|NCT01825837|532322736|FG000|PART II|Withdrawal by Subject|3|||
147591827|NCT01825837|532322737|FG001|PART II|Withdrawal by Subject|3|||
147591828|NCT01825837|532322738|FG002|PART II|Withdrawal by Subject|7|||
147591829|NCT01825837|532322739|FG003|PART II|Withdrawal by Subject|0|||
147591830|NCT01825837|532322736|FG000|PART II|Patient non-compliance|5|||
147591831|NCT01825837|532322737|FG001|PART II|Patient non-compliance|2|||
147591832|NCT01825837|532322738|FG002|PART II|Patient non-compliance|4|||
147591833|NCT01825837|532322739|FG003|PART II|Patient non-compliance|0|||
147591834|NCT01825837|532322736|FG000|PART II|Adverse Event|3|||
147591835|NCT01825837|532322737|FG001|PART II|Adverse Event|3|||
147591836|NCT01825837|532322738|FG002|PART II|Adverse Event|1|||
147591837|NCT01825837|532322739|FG003|PART II|Adverse Event|0|||
147591838|NCT01825837|532322736|FG000|PART II|Treatment failure|6|||
147591839|NCT01825837|532322737|FG001|PART II|Treatment failure|4|||
147591840|NCT01825837|532322738|FG002|PART II|Treatment failure|5|||
147591841|NCT01825837|532322739|FG003|PART II|Treatment failure|0|||
147591842|NCT01825837|532322736|FG000|PART II|reason unspecified|2|||
147591843|NCT01825837|532322737|FG001|PART II|reason unspecified|2|||
147591844|NCT01825837|532322738|FG002|PART II|reason unspecified|2|||
147591845|NCT01825837|532322739|FG003|PART II|reason unspecified|0|||
147591846|NCT00904748|532322740|FG000|Overall Study|Withdrawal by Subject|1|||
147591847|NCT00904748|532322741|FG001|Overall Study|Withdrawal by Subject|1|||
147591848|NCT00904748|532322742|FG002|Overall Study|Withdrawal by Subject|1|||
147591849|NCT00904748|532322743|FG003|Overall Study|Withdrawal by Subject|2|||
147591850|NCT00904748|532322744|FG004|Overall Study|Withdrawal by Subject|0|||
147591851|NCT00904748|532322745|FG005|Overall Study|Withdrawal by Subject|0|||
147591852|NCT00904748|532322740|FG000|Overall Study|Adverse Event|0|||
147591853|NCT00904748|532322741|FG001|Overall Study|Adverse Event|0|||
147591854|NCT00904748|532322742|FG002|Overall Study|Adverse Event|0|||
147591855|NCT00904748|532322743|FG003|Overall Study|Adverse Event|0|||
147591856|NCT00904748|532322744|FG004|Overall Study|Adverse Event|1|||
147591857|NCT00904748|532322745|FG005|Overall Study|Adverse Event|0|||
147591858|NCT02096588|532322746|FG000|Overall Study|Lack of Efficacy|2|||
147591859|NCT02096588|532322747|FG001|Overall Study|Lack of Efficacy|0|||
147591860|NCT02096588|532322746|FG000|Overall Study|Withdrawal by Subject|0|||
147591861|NCT02096588|532322747|FG001|Overall Study|Withdrawal by Subject|1|||
147591862|NCT01020799|532322752|FG000|Overall Study|Adverse Event|4|||
147591863|NCT01020799|532322753|FG001|Overall Study|Adverse Event|3|||
147323810|NCT00832780|531350054|FG000|Overall Study|other complicating condition|2|||
147591864|NCT01020799|532322754|FG002|Overall Study|Adverse Event|2|||
147591865|NCT01020799|532322752|FG000|Overall Study|non-compliance; lack of efficacy; etc.|4|||
147655137|NCT03162328|532559263|FG001|Study Period|Withdrawal by Subject|0|||
147171449|NCT01055314|530792118|FG001|Overall Study|Ineligible|5|||
147171450|NCT01055314|530792117|FG000|Overall Study|Refusal of further protocol therapy|10|||
147591866|NCT01020799|532322753|FG001|Overall Study|non-compliance; lack of efficacy; etc.|3|||
147591867|NCT01020799|532322754|FG002|Overall Study|non-compliance; lack of efficacy; etc.|0|||
147591868|NCT01020799|532322752|FG000|Overall Study|Protocol Violation|3|||
147591869|NCT01020799|532322753|FG001|Overall Study|Protocol Violation|2|||
147591870|NCT01020799|532322754|FG002|Overall Study|Protocol Violation|0|||
147591871|NCT01020799|532322752|FG000|Overall Study|Withdrawal by Subject|2|||
147655138|NCT03162328|532559264|FG002|Study Period|Withdrawal by Subject|1|||
147655139|NCT00980655|532559266|FG000|Overall Study|Adverse Event|13|||
147655140|NCT00980655|532559267|FG001|Overall Study|Adverse Event|31|||
147171451|NCT01055314|530792118|FG001|Overall Study|Refusal of further protocol therapy|4|||
147591872|NCT01020799|532322753|FG001|Overall Study|Withdrawal by Subject|2|||
147591873|NCT01020799|532322754|FG002|Overall Study|Withdrawal by Subject|3|||
147655141|NCT00980655|532559266|FG000|Overall Study|Death|0|||
147655142|NCT00980655|532559267|FG001|Overall Study|Death|7|||
147655143|NCT00980655|532559266|FG000|Overall Study|Protocol Violation|2|||
147171452|NCT01055314|530792117|FG000|Overall Study|No treatment|1|||
147171453|NCT01055314|530792118|FG001|Overall Study|No treatment|0|||
147655144|NCT00980655|532559267|FG001|Overall Study|Protocol Violation|7|||
147655145|NCT00980655|532559266|FG000|Overall Study|Withdrawal by Subject|0|||
147171454|NCT00568126|530792119|FG000|Overall Study|Adverse Event|3|||
147171455|NCT00568126|530792120|FG001|Overall Study|Adverse Event|0|||
147171456|NCT00568126|530792119|FG000|Overall Study|Withdrawal by Subject|2|||
147171457|NCT00568126|530792120|FG001|Overall Study|Withdrawal by Subject|3|||
147171458|NCT00568126|530792119|FG000|Overall Study|Lost to Follow-up|4|||
147171459|NCT00568126|530792120|FG001|Overall Study|Lost to Follow-up|3|||
147655146|NCT00980655|532559267|FG001|Overall Study|Withdrawal by Subject|4|||
147655147|NCT00980655|532559266|FG000|Overall Study|Lost to Follow-up|0|||
147655148|NCT00980655|532559267|FG001|Overall Study|Lost to Follow-up|1|||
147655149|NCT00980655|532559266|FG000|Overall Study|Parent/legal guardian request|1|||
147655150|NCT00980655|532559267|FG001|Overall Study|Parent/legal guardian request|0|||
147655151|NCT00980655|532559266|FG000|Overall Study|Other|0|||
147655152|NCT00980655|532559267|FG001|Overall Study|Other|1|||
147655153|NCT02823470|532561453|FG000|Overall Study|Adverse Event|1|||
147655154|NCT02823470|532561454|FG001|Overall Study|Adverse Event|0|||
147655155|NCT02823470|532561453|FG000|Overall Study|Study terminated by sponsor|8|||
147655156|NCT02823470|532561454|FG001|Overall Study|Study terminated by sponsor|15|||
147171460|NCT00568126|530792119|FG000|Overall Study|Lack of Efficacy|0|||
147171461|NCT00568126|530792120|FG001|Overall Study|Lack of Efficacy|1|||
147655157|NCT01073163|532561456|FG000|Overall Study|Adverse Event|1|||
147655158|NCT01073163|532561456|FG000|Overall Study|Disease Progression|1|||
147655159|NCT01073163|532561456|FG000|Overall Study|Early termination|1|||
147655160|NCT00703677|532561457|FG000|Overall Study|Dropout-withdrawal not related to drug|3|||
147655161|NCT04441788|532561458|FG000|Overall Study|Voluntary Withdrawl|0|||
147655162|NCT04441788|532561459|FG001|Overall Study|Voluntary Withdrawl|1|||
147655163|NCT04441788|532561460|FG002|Overall Study|Voluntary Withdrawl|0|||
147655164|NCT04441788|532561458|FG000|Overall Study|Ineligibility|1|||
147655165|NCT04441788|532561459|FG001|Overall Study|Ineligibility|0|||
147655166|NCT04441788|532561460|FG002|Overall Study|Ineligibility|0|||
147655167|NCT04441788|532561458|FG000|Overall Study|Adverse Event|0|||
147655168|NCT04441788|532561459|FG001|Overall Study|Adverse Event|0|||
147171462|NCT00568126|530792119|FG000|Overall Study|Physician Decision|2|||
147171463|NCT00568126|530792120|FG001|Overall Study|Physician Decision|2|||
147171464|NCT04395690|530792121|FG000|Overall Study|Lost to Follow-up|1|||
147171465|NCT04395690|530792122|FG001|Overall Study|Lost to Follow-up|1|||
147171466|NCT04512976|530792123|FG000|Overall Study|Unable to complete the exercise protocols in the study.|0|||
147171467|NCT04512976|530792124|FG001|Overall Study|Unable to complete the exercise protocols in the study.|0|||
147171468|NCT04512976|530792125|FG002|Overall Study|Unable to complete the exercise protocols in the study.|0|||
147171469|NCT04512976|530792126|FG003|Overall Study|Unable to complete the exercise protocols in the study.|0|||
147171470|NCT04512976|530792127|FG004|Overall Study|Unable to complete the exercise protocols in the study.|0|||
147171471|NCT04512976|530792128|FG005|Overall Study|Unable to complete the exercise protocols in the study.|3|||
147171472|NCT02702414|530792129|FG000|Overall Study|Death|96|||
147171473|NCT02702414|530792130|FG001|Overall Study|Death|42|||
147171474|NCT02702414|530792129|FG000|Overall Study|Lost to Follow-up|0|||
147171475|NCT02702414|530792130|FG001|Overall Study|Lost to Follow-up|1|||
147171476|NCT02702414|530792129|FG000|Overall Study|Withdrawal by Subject|0|||
147171477|NCT02702414|530792130|FG001|Overall Study|Withdrawal by Subject|1|||
147171478|NCT02702414|530792129|FG000|Overall Study|Protocol Violation|1|||
147171479|NCT02702414|530792130|FG001|Overall Study|Protocol Violation|0|||
147171480|NCT02702414|530792129|FG000|Overall Study|Sponsor Decision|8|||
147171481|NCT02702414|530792130|FG001|Overall Study|Sponsor Decision|7|||
147171482|NCT03446456|530792132|FG000|Overall Study|Participant was in a previous social learning study (exclusion criteria)|1|||
147171483|NCT03446456|530792133|FG001|Overall Study|Participant was in a previous social learning study (exclusion criteria)|1|||
147171484|NCT03446456|530792132|FG000|Overall Study|Lost to Follow-up|1|||
147171485|NCT03446456|530792133|FG001|Overall Study|Lost to Follow-up|3|||
147171486|NCT03446456|530792132|FG000|Overall Study|Participant failed the toxicology test|1|||
147171487|NCT03446456|530792133|FG001|Overall Study|Participant failed the toxicology test|0|||
147171488|NCT03446456|530792132|FG000|Overall Study|Break down of the experimental equipment|1|||
147655169|NCT04441788|532561460|FG002|Overall Study|Adverse Event|4|||
147171489|NCT03446456|530792133|FG001|Overall Study|Break down of the experimental equipment|0|||
147655170|NCT04441788|532561458|FG000|Overall Study|Study Terminated by Sponsor|16|||
147655171|NCT04441788|532561459|FG001|Overall Study|Study Terminated by Sponsor|16|||
147655172|NCT04441788|532561460|FG002|Overall Study|Study Terminated by Sponsor|12|||
147655173|NCT03859648|532561463|FG000|Overall Study|Lost to Follow-up|1|||
147655174|NCT03859648|532561463|FG000|Overall Study|Adverse Event|1|||
147655175|NCT02315664|532561464|FG000|Overall Study|Lost to Follow-up|1|||
147655176|NCT02315664|532561465|FG001|Overall Study|Lost to Follow-up|1|||
147655177|NCT02315664|532561464|FG000|Overall Study|Withdrawal by Subject|0|||
147655178|NCT02315664|532561465|FG001|Overall Study|Withdrawal by Subject|3|||
147591874|NCT01020799|532322752|FG000|Overall Study|Lost to Follow-up|6|||
147591875|NCT01020799|532322753|FG001|Overall Study|Lost to Follow-up|4|||
147591876|NCT01020799|532322754|FG002|Overall Study|Lost to Follow-up|2|||
147171490|NCT04369950|530792134|FG000|Overall Study|Protocol Violation|2|||
147171491|NCT04369950|530792135|FG001|Overall Study|Protocol Violation|2|||
147171492|NCT00989963|530792136|FG000|Overall Study|Adverse Event|1|||
147171493|NCT00989963|530792137|FG001|Overall Study|Adverse Event|1|||
147171494|NCT00989963|530792138|FG002|Overall Study|Adverse Event|1|||
147171495|NCT01529034|530792147|FG000|Overall Study|Discontinued prior to study treatment|14|||
147171496|NCT01529034|530792147|FG000|Overall Study|Site closure|62|||
147171497|NCT01529034|530792147|FG000|Overall Study|Study termination|29|||
147171498|NCT01529034|530792147|FG000|Overall Study|Withdrawal by Subject|25|||
147171499|NCT01529034|530792147|FG000|Overall Study|No treated SCs within protocol window|13|||
147171500|NCT01529034|530792147|FG000|Overall Study|Noncompliance|8|||
147171501|NCT01529034|530792147|FG000|Overall Study|Caregiver no longer available|7|||
147171502|NCT01529034|530792147|FG000|Overall Study|Adverse Event|4|||
147171503|NCT01529034|530792147|FG000|Overall Study|Protocol Violation|4|||
147171504|NCT01529034|530792147|FG000|Overall Study|Lack of Efficacy|4|||
147171505|NCT01529034|530792147|FG000|Overall Study|Investigator no longer available|2|||
147171506|NCT01529034|530792147|FG000|Overall Study|Study drug not available|2|||
147171507|NCT04588389|530792148|FG000|Overall Study|Issues with anesthesia during surgery|2|||
147171508|NCT04588389|530792149|FG001|Overall Study|Issues with anesthesia during surgery|0|||
147171509|NCT04588389|530792150|FG002|Overall Study|Issues with anesthesia during surgery|0|||
147171510|NCT00658814|530792153|FG000|Remission Induction Chemotherapy|Adverse Event|1|||
147171511|NCT00658814|530792154|FG001|Remission Induction Chemotherapy|Adverse Event|3|||
147171512|NCT00658814|530792153|FG000|Remission Induction Chemotherapy|Withdrawal by Subject|3|||
147171513|NCT00658814|530792154|FG001|Remission Induction Chemotherapy|Withdrawal by Subject|4|||
147171514|NCT00658814|530792153|FG000|Remission Induction Chemotherapy|Progression/Relapse|0|||
147171515|NCT00658814|530792154|FG001|Remission Induction Chemotherapy|Progression/Relapse|1|||
147171516|NCT00658814|530792153|FG000|Remission Induction Chemotherapy|Death|1|||
147171517|NCT00658814|530792154|FG001|Remission Induction Chemotherapy|Death|4|||
147171518|NCT00658814|530792153|FG000|Remission Induction Chemotherapy|Not protocol specified|2|||
147171519|NCT00658814|530792154|FG001|Remission Induction Chemotherapy|Not protocol specified|4|||
147171520|NCT00658814|530792153|FG000|Remission Induction Chemotherapy|Not eligible|1|||
147171521|NCT00658814|530792154|FG001|Remission Induction Chemotherapy|Not eligible|2|||
147171522|NCT00658814|530792153|FG000|Consolidation Therapy|Not protocol specified|0|||
147171523|NCT00658814|530792154|FG001|Consolidation Therapy|Not protocol specified|1|||
147591877|NCT01560507|532322760|FG000|Overall Study|Lost to Follow-up|3|||
147591878|NCT01560507|532322761|FG001|Overall Study|Lost to Follow-up|1|||
147171524|NCT00658814|530792153|FG000|Consolidation Therapy|Not eligible|2|||
147323811|NCT00832780|531350054|FG000|Overall Study|Physician Decision|1|||
147323812|NCT00764868|531350069|FG000|Overall Study|Adverse Event|18|||
147323813|NCT00764868|531350069|FG000|Overall Study|Withdrawal by Subject|31|||
147591879|NCT01560507|532322762|FG002|Overall Study|Lost to Follow-up|2|||
147171525|NCT00658814|530792154|FG001|Consolidation Therapy|Not eligible|2|||
147171526|NCT00658814|530792153|FG000|Maintenance Therapy|Adverse Event|1|||
147171527|NCT00658814|530792154|FG001|Maintenance Therapy|Adverse Event|1|||
147171528|NCT00658814|530792153|FG000|Maintenance Therapy|Not protocol specified|1|||
147171529|NCT00658814|530792154|FG001|Maintenance Therapy|Not protocol specified|0|||
147171530|NCT00658814|530792153|FG000|Maintenance Therapy|Not eligible|1|||
147171531|NCT00658814|530792154|FG001|Maintenance Therapy|Not eligible|0|||
147171532|NCT01141478|530792155|FG000|Overall Study|Withdrawal by Subject|1|||
147171533|NCT01141478|530792156|FG001|Overall Study|Withdrawal by Subject|1|||
147171534|NCT05026853|530792161|FG000|Overall Study|Cancelled appointment|1|||
147171535|NCT05026853|530792162|FG001|Overall Study|Cancelled appointment|0|||
147171536|NCT05026853|530792161|FG000|Overall Study|Excluded due to technical difficulties with generating scorecard|8|||
147171537|NCT05026853|530792162|FG001|Overall Study|Excluded due to technical difficulties with generating scorecard|0|||
147171538|NCT05026853|530792161|FG000|Overall Study|Did not complete 12-week survey|16|||
147171539|NCT05026853|530792162|FG001|Overall Study|Did not complete 12-week survey|16|||
147171540|NCT03836677|530792163|FG000|Period 1|Adverse Event|0|||
147171541|NCT03836677|530792164|FG001|Period 1|Adverse Event|1|||
147171542|NCT03836677|530792163|FG000|Period 2|Severe non-compliance to protocol|1|||
147171543|NCT03836677|530792164|FG001|Period 2|Severe non-compliance to protocol|0|||
147171544|NCT01732913|530792165|FG000|Overall Study|Study Terminated by Sponsor|105|||
147171545|NCT01732913|530792166|FG001|Overall Study|Study Terminated by Sponsor|55|||
147171546|NCT01732913|530792165|FG000|Overall Study|Withdrawal by Subject|27|||
147171547|NCT01732913|530792166|FG001|Overall Study|Withdrawal by Subject|4|||
147171548|NCT01732913|530792165|FG000|Overall Study|Physician Decision|14|||
147323814|NCT00764868|531350069|FG000|Overall Study|Non-compliance|16|||
147591880|NCT01560507|532322760|FG000|Overall Study|Withdrawal by Subject|1|||
147171549|NCT01732913|530792166|FG001|Overall Study|Physician Decision|7|||
147171550|NCT01732913|530792165|FG000|Overall Study|Other|7|||
147323815|NCT00764868|531350069|FG000|Overall Study|Lost to Follow-up|25|||
147591881|NCT01560507|532322761|FG001|Overall Study|Withdrawal by Subject|1|||
147171551|NCT01732913|530792166|FG001|Overall Study|Other|1|||
147171552|NCT01732913|530792165|FG000|Overall Study|Initiation of Other Anti-Cancer Therapy|3|||
147171553|NCT01732913|530792166|FG001|Overall Study|Initiation of Other Anti-Cancer Therapy|2|||
147171554|NCT03233438|530792167|FG000|Overall Study|Lost to Follow-up|4|||
147171555|NCT03233438|530792168|FG001|Overall Study|Lost to Follow-up|9|||
147171556|NCT03233438|530792167|FG000|Overall Study|Withdrawal by Subject|2|||
147171557|NCT03233438|530792168|FG001|Overall Study|Withdrawal by Subject|1|||
147171558|NCT03233438|530792167|FG000|Overall Study|No recording of dalbavancin|0|||
147171559|NCT03233438|530792168|FG001|Overall Study|No recording of dalbavancin|1|||
147171560|NCT03831945|530792169|FG000|Overall Study|Received study agent, never started second Analytical Treatment Interruption (ATI) due to COVID-19|4|||
147171561|NCT03831945|530792170|FG001|Overall Study|Received study agent, never started second Analytical Treatment Interruption (ATI) due to COVID-19|4|||
147171562|NCT03831945|530792169|FG000|Overall Study|Received study agent, never started second analytical Treatment Interruption due to unprotected sex|1|||
147171563|NCT03831945|530792170|FG001|Overall Study|Received study agent, never started second analytical Treatment Interruption due to unprotected sex|1|||
147171564|NCT03831945|530792169|FG000|Overall Study|Received study agent, second analytical treatment interruption (ATI) ended early due to COVID-19|2|||
147171565|NCT03831945|530792170|FG001|Overall Study|Received study agent, second analytical treatment interruption (ATI) ended early due to COVID-19|1|||
147171566|NCT01300455|530792172|FG000|Washout|Withdrawal by Subject|1|||
147171567|NCT01300455|530792173|FG001|Washout|Withdrawal by Subject|0|||
147171568|NCT00694304|530792177|FG000|Overall Study|Adverse Event|42|||
147171569|NCT00694304|530792177|FG000|Overall Study|Lack of Efficacy|35|||
147171570|NCT00694304|530792177|FG000|Overall Study|Non-compliance With Study Product|16|||
147171571|NCT00694304|530792177|FG000|Overall Study|Protocol Violation|6|||
147171572|NCT00694304|530792177|FG000|Overall Study|Withdrawal of Consent|61|||
147171573|NCT00694304|530792177|FG000|Overall Study|Lost to Follow-up|15|||
147171574|NCT00694304|530792177|FG000|Overall Study|Administrative or Other Reasons|32|||
147171575|NCT02438813|530792178|FG000|Overall Study|Patient Decision|59|||
147171576|NCT02438813|530792178|FG000|Overall Study|Patient Lost to Follow-Up|137|||
147171577|NCT02438813|530792178|FG000|Overall Study|Study Ended by Sponsor|80|||
147171578|NCT02438813|530792178|FG000|Overall Study|Patients Not Treated/No EOT Visit|249|||
147171579|NCT00576576|530792179|FG000|Overall Study|Lost to Follow-up|6|||
147171580|NCT00576576|530792179|FG000|Overall Study|Protocol Violation|1|||
147171581|NCT03135210|530792180|FG000|Overall Study|Death|0|||
147171582|NCT03135210|530792181|FG001|Overall Study|Death|1|||
147171583|NCT01270256|530792189|FG000|Overall Study|Withdrawal by Subject|1|||
147171584|NCT01270256|530792190|FG001|Overall Study|Withdrawal by Subject|0|||
147171585|NCT02879578|530792191|FG000|Overall Study|Adverse Event|1|||
147171586|NCT02879578|530792192|FG001|Overall Study|Adverse Event|2|||
147171587|NCT02879578|530792193|FG002|Overall Study|Adverse Event|14|||
147171588|NCT02879578|530792191|FG000|Overall Study|Protocol Violation|0|||
147171589|NCT02879578|530792192|FG001|Overall Study|Protocol Violation|1|||
147171590|NCT02879578|530792193|FG002|Overall Study|Protocol Violation|1|||
147171591|NCT02879578|530792191|FG000|Overall Study|Withdrawal by Subject|8|||
147171592|NCT02879578|530792192|FG001|Overall Study|Withdrawal by Subject|6|||
147171593|NCT02879578|530792193|FG002|Overall Study|Withdrawal by Subject|9|||
147171594|NCT02879578|530792191|FG000|Overall Study|Lost to Follow-up|1|||
147171595|NCT02879578|530792192|FG001|Overall Study|Lost to Follow-up|0|||
147171596|NCT02879578|530792193|FG002|Overall Study|Lost to Follow-up|4|||
147171597|NCT02879578|530792191|FG000|Overall Study|Physician Decision|0|||
147171598|NCT02879578|530792192|FG001|Overall Study|Physician Decision|0|||
147171599|NCT02879578|530792193|FG002|Overall Study|Physician Decision|4|||
147171600|NCT04566692|530792194|FG000|Overall Study|Adverse Event|2|||
147171601|NCT04566692|530792195|FG001|Overall Study|Adverse Event|0|||
147171602|NCT04566692|530792194|FG000|Overall Study|Withdrawal by Subject|1|||
147171603|NCT04566692|530792195|FG001|Overall Study|Withdrawal by Subject|1|||
147171604|NCT00671437|530792196|FG000|Overall Study|Progressive disease before C1 week 8|8|||
147171605|NCT00671437|530792196|FG000|Overall Study|Cutaneous SCC of head and neck|3|||
147171606|NCT00671437|530792196|FG000|Overall Study|Adverse Event|3|||
147171607|NCT00671437|530792196|FG000|Overall Study|Ineligible post-hoc|1|||
147171608|NCT05098509|530792197|FG000|Overall Study|Withdrawal by Subject|0|||
147171609|NCT05098509|530792198|FG001|Overall Study|Withdrawal by Subject|0|||
147171610|NCT05098509|530792199|FG002|Overall Study|Withdrawal by Subject|1|||
147171611|NCT05098509|530792200|FG003|Overall Study|Withdrawal by Subject|0|||
147171612|NCT05098509|530792197|FG000|Overall Study|Early study termination|1|||
147171613|NCT05098509|530792198|FG001|Overall Study|Early study termination|1|||
147171614|NCT05098509|530792199|FG002|Overall Study|Early study termination|1|||
147171615|NCT05098509|530792200|FG003|Overall Study|Early study termination|0|||
147171616|NCT04033068|530792201|FG000|Overall Study|Withdrawal by Subject|0|||
147171617|NCT04033068|530792202|FG001|Overall Study|Withdrawal by Subject|0|||
147171618|NCT04033068|530792203|FG002|Overall Study|Withdrawal by Subject|1|||
147171619|NCT04033068|530792204|FG003|Overall Study|Withdrawal by Subject|0|||
147171620|NCT04033068|530792201|FG000|Overall Study|Lost to Follow-up|0|||
147171621|NCT04033068|530792202|FG001|Overall Study|Lost to Follow-up|1|||
147323816|NCT00764868|531350069|FG000|Overall Study|Lack of Efficacy|5|||
147171622|NCT04033068|530792203|FG002|Overall Study|Lost to Follow-up|0|||
147171623|NCT04033068|530792204|FG003|Overall Study|Lost to Follow-up|0|||
147171624|NCT04033068|530792201|FG000|Overall Study|Inclusion / exclusion criteria not fulfilled|0|||
147171625|NCT04033068|530792202|FG001|Overall Study|Inclusion / exclusion criteria not fulfilled|0|||
147171626|NCT04033068|530792203|FG002|Overall Study|Inclusion / exclusion criteria not fulfilled|0|||
147655179|NCT01677182|532561466|FG000|Overall Study|Adverse Event|2|||
147655180|NCT01677182|532561467|FG001|Overall Study|Adverse Event|1|||
147655181|NCT01677182|532561468|FG002|Overall Study|Adverse Event|8|||
147655182|NCT01677182|532561466|FG000|Overall Study|Protocol Violation|5|||
147655183|NCT01677182|532561467|FG001|Overall Study|Protocol Violation|1|||
147655184|NCT01677182|532561468|FG002|Overall Study|Protocol Violation|4|||
147655185|NCT01677182|532561466|FG000|Overall Study|Lost to Follow-up|4|||
147655186|NCT01677182|532561467|FG001|Overall Study|Lost to Follow-up|0|||
147655187|NCT01677182|532561468|FG002|Overall Study|Lost to Follow-up|3|||
147655188|NCT01677182|532561466|FG000|Overall Study|Withdrawal by Subject|7|||
147655189|NCT01677182|532561467|FG001|Overall Study|Withdrawal by Subject|12|||
147655190|NCT01677182|532561468|FG002|Overall Study|Withdrawal by Subject|10|||
147655191|NCT01677182|532561466|FG000|Overall Study|Study termination|12|||
147655192|NCT01677182|532561467|FG001|Overall Study|Study termination|9|||
147655193|NCT01677182|532561468|FG002|Overall Study|Study termination|11|||
147655194|NCT01677182|532561466|FG000|Overall Study|Lack of Efficacy|3|||
147655195|NCT01677182|532561467|FG001|Overall Study|Lack of Efficacy|0|||
147655196|NCT01677182|532561468|FG002|Overall Study|Lack of Efficacy|1|||
147655197|NCT01677182|532561466|FG000|Overall Study|Other reasons|1|||
147655198|NCT01677182|532561467|FG001|Overall Study|Other reasons|5|||
147655199|NCT01677182|532561468|FG002|Overall Study|Other reasons|2|||
147655200|NCT02501161|532561469|FG000|Overall Study|Adverse Event|2|||
147655201|NCT02501161|532561470|FG001|Overall Study|Adverse Event|6|||
147655202|NCT02501161|532561469|FG000|Overall Study|Lost to Follow-up|7|||
147655203|NCT02501161|532561470|FG001|Overall Study|Lost to Follow-up|4|||
147655204|NCT02501161|532561469|FG000|Overall Study|Withdrawal by Subject|10|||
147655205|NCT02501161|532561470|FG001|Overall Study|Withdrawal by Subject|15|||
147655206|NCT02501161|532561469|FG000|Overall Study|Other|3|||
147655207|NCT02501161|532561470|FG001|Overall Study|Other|0|||
147655208|NCT00667992|532561473|FG000|First Intervention 100 Mcg Twice Daily|Condition Under Investigation Worsened|2|||
147655209|NCT00667992|532561474|FG001|First Intervention 100 Mcg Twice Daily|Condition Under Investigation Worsened|3|||
147655210|NCT00667992|532561473|FG000|First Intervention 100 Mcg Twice Daily|Withdrawal by Subject|2|||
147655211|NCT00667992|532561474|FG001|First Intervention 100 Mcg Twice Daily|Withdrawal by Subject|0|||
147655212|NCT00667992|532561473|FG000|First Intervention 100 Mcg Twice Daily|Adverse Event|0|||
147655213|NCT00667992|532561474|FG001|First Intervention 100 Mcg Twice Daily|Adverse Event|1|||
147655214|NCT00667992|532561473|FG000|First Intervention 100 Mcg Twice Daily|Pregnancy|1|||
147655215|NCT00667992|532561474|FG001|First Intervention 100 Mcg Twice Daily|Pregnancy|0|||
147655216|NCT00667992|532561473|FG000|First Intervention 100 Mcg Twice Daily|Adverse Event|0|||
147655217|NCT00667992|532561474|FG001|First Intervention 100 Mcg Twice Daily|Adverse Event|1|||
147655218|NCT00667992|532561473|FG000|Second Intervention 400 Mcg Twice Daily|Withdrawal by Subject|1|||
147655219|NCT00667992|532561474|FG001|Second Intervention 400 Mcg Twice Daily|Withdrawal by Subject|0|||
147655220|NCT00667992|532561473|FG000|Second Intervention 400 Mcg Twice Daily|Condition Under Investigation Worsened|2|||
147655221|NCT00667992|532561474|FG001|Second Intervention 400 Mcg Twice Daily|Condition Under Investigation Worsened|3|||
147655222|NCT00667992|532561473|FG000|Second Intervention 400 Mcg Twice Daily|Medication not allowed taken|0|||
147655223|NCT00667992|532561474|FG001|Second Intervention 400 Mcg Twice Daily|Medication not allowed taken|1|||
147655224|NCT00667992|532561473|FG000|Wash-out|Not within one doubling dilution|4|||
147655225|NCT00667992|532561474|FG001|Wash-out|Not within one doubling dilution|3|||
147171627|NCT04033068|530792204|FG003|Overall Study|Inclusion / exclusion criteria not fulfilled|1|||
147171628|NCT02540265|530792208|FG000|Overall Study|Lost to Follow-up|0|||
147171629|NCT02540265|530792209|FG001|Overall Study|Lost to Follow-up|0|||
147171630|NCT02540265|530792210|FG002|Overall Study|Lost to Follow-up|1|||
147171631|NCT01972789|530792211|FG000|Overall Study|Adverse Event|11|||
147171632|NCT01972789|530792212|FG001|Overall Study|Adverse Event|4|||
147171633|NCT01972789|530792211|FG000|Overall Study|Subject withdrew consent|14|||
147171634|NCT01972789|530792212|FG001|Overall Study|Subject withdrew consent|12|||
147171635|NCT01972789|530792211|FG000|Overall Study|Lost to Follow-up|4|||
147171636|NCT01972789|530792212|FG001|Overall Study|Lost to Follow-up|7|||
147171637|NCT01972789|530792211|FG000|Overall Study|Death|7|||
147171638|NCT01972789|530792212|FG001|Overall Study|Death|5|||
147171639|NCT01972789|530792211|FG000|Overall Study|Protocol deviation|1|||
147171640|NCT01972789|530792212|FG001|Overall Study|Protocol deviation|0|||
147655226|NCT00667992|532561473|FG000|Wash-out|Failure to wash-out|2|||
147655227|NCT00667992|532561474|FG001|Wash-out|Failure to wash-out|2|||
147171641|NCT01972789|530792211|FG000|Overall Study|Physician Decision|3|||
147655228|NCT00667992|532561473|FG000|Wash-out|Withdrawal by Subject|1|||
147655229|NCT00667992|532561474|FG001|Wash-out|Withdrawal by Subject|0|||
147655230|NCT00667992|532561473|FG000|Third Intervention 100 Mcg Twice Daily|Withdrawal by Subject|1|||
147655231|NCT00667992|532561474|FG001|Third Intervention 100 Mcg Twice Daily|Withdrawal by Subject|0|||
147171642|NCT01972789|530792212|FG001|Overall Study|Physician Decision|2|||
147655232|NCT00667992|532561473|FG000|Third Intervention 100 Mcg Twice Daily|Adverse Event|0|||
147655233|NCT00667992|532561474|FG001|Third Intervention 100 Mcg Twice Daily|Adverse Event|1|||
147655234|NCT00762762|532561475|FG000|Overall Study|Did not return for appointments|6|||
147655235|NCT00762762|532561476|FG001|Overall Study|Did not return for appointments|8|||
147655236|NCT02748057|532561477|FG000|Overall Study|Adverse Event|1|||
147655237|NCT02748057|532561478|FG001|Overall Study|Adverse Event|0|||
147655238|NCT02748057|532561477|FG000|Overall Study|Physician Decision|0|||
147655239|NCT02748057|532561478|FG001|Overall Study|Physician Decision|1|||
147655240|NCT02748057|532561477|FG000|Overall Study|Protocol Violation|2|||
147655241|NCT02748057|532561478|FG001|Overall Study|Protocol Violation|1|||
147655242|NCT02748057|532561477|FG000|Overall Study|Participant Moved|1|||
147655243|NCT02748057|532561478|FG001|Overall Study|Participant Moved|0|||
147655244|NCT02748057|532561477|FG000|Overall Study|Withdrawal by Subject|1|||
147655245|NCT02748057|532561478|FG001|Overall Study|Withdrawal by Subject|0|||
147655246|NCT02793947|532561487|FG000|Overall Study|Death|1|||
147655247|NCT02793947|532561488|FG001|Overall Study|Death|0|||
147655248|NCT02793947|532561487|FG000|Overall Study|Physician Decision|1|||
147655249|NCT02793947|532561488|FG001|Overall Study|Physician Decision|5|||
147655250|NCT01310127|532561492|FG000|Overall Study|Protocol Violation|1|||
147655251|NCT01310127|532561493|FG001|Overall Study|Protocol Violation|1|||
147655252|NCT01310127|532561492|FG000|Overall Study|advanced psc cataract outlier|1|||
147655253|NCT01310127|532561493|FG001|Overall Study|advanced psc cataract outlier|0|||
147655254|NCT01465230|532561494|FG000|Overall Study|Withdrawal by Subject|2|||
147655255|NCT01738919|532561496|FG000|Overall Study|Lost to Follow-up|1|||
147655256|NCT01738919|532561497|FG001|Overall Study|Lost to Follow-up|0|||
147655257|NCT01738919|532561496|FG000|Overall Study|Immigrated|0|||
147655258|NCT01738919|532561497|FG001|Overall Study|Immigrated|1|||
147655259|NCT01738919|532561496|FG000|Overall Study|Withdrawal by Subject|0|||
147655260|NCT01738919|532561497|FG001|Overall Study|Withdrawal by Subject|1|||
147655261|NCT01738919|532561496|FG000|Overall Study|Not treated in accordance to guidelines|0|||
147655262|NCT01738919|532561497|FG001|Overall Study|Not treated in accordance to guidelines|1|||
147655263|NCT02532257|532561501|FG000|Overall Study|Adverse Event|2|||
147655264|NCT02532257|532561501|FG000|Overall Study|Physician Decision|4|||
147655265|NCT02532257|532561501|FG000|Overall Study|Withdrawal by Subject|3|||
147655266|NCT02532257|532561501|FG000|Overall Study|Progressive Disease|10|||
147655267|NCT02849171|532561502|FG000|Overall Study|Withdrawal by Subject|1|||
147655268|NCT02849171|532561502|FG000|Overall Study|Not treated|1|||
147655269|NCT02090283|532561503|FG000|Overall Study|Withdrawal by Subject|6|||
147323817|NCT00764868|531350069|FG000|Overall Study|Subject moved|7|||
147323818|NCT00764868|531350069|FG000|Overall Study|Pregnancy|3|||
147323819|NCT00764868|531350069|FG000|Overall Study|Prohibited medication|1|||
147323820|NCT00764868|531350069|FG000|Overall Study|Out of town|1|||
147323821|NCT00764868|531350069|FG000|Overall Study|Misuse and compliance of study drug|1|||
147323822|NCT00764868|531350069|FG000|Overall Study|Subject sent to boarding school|1|||
147323823|NCT00764868|531350069|FG000|Overall Study|Met an exclusion criteria|1|||
147323824|NCT00764868|531350069|FG000|Overall Study|Positive drug screen|2|||
147323825|NCT00764868|531350069|FG000|Overall Study|Sponsor requested withdrawal|1|||
147323826|NCT01221181|531350077|FG000|Overall Study|Lost to Follow-up|1|||
147323827|NCT00429793|531350078|FG000|Overall Study|Improper pre-protocol treatment|3|||
147323828|NCT00429793|531350078|FG000|Overall Study|Required test not done|1|||
147323829|NCT00429793|531350078|FG000|Overall Study|Never treated|1|||
147323830|NCT00429793|531350078|FG000|Overall Study|Non-measurable|1|||
147323831|NCT01394991|531350079|FG000|Overall Study|Adverse Event|0|||
147323832|NCT01394991|531350080|FG001|Overall Study|Adverse Event|4|||
147323833|NCT01394991|531350079|FG000|Overall Study|Lack of Efficacy|5|||
147323834|NCT01394991|531350080|FG001|Overall Study|Lack of Efficacy|7|||
147323835|NCT01394991|531350079|FG000|Overall Study|Lost to Follow-up|6|||
147323836|NCT01394991|531350080|FG001|Overall Study|Lost to Follow-up|8|||
147323837|NCT01394991|531350079|FG000|Overall Study|Physician Decision|1|||
147323838|NCT01394991|531350080|FG001|Overall Study|Physician Decision|3|||
147323839|NCT01394991|531350079|FG000|Overall Study|Protocol Violation|1|||
147323840|NCT01394991|531350080|FG001|Overall Study|Protocol Violation|1|||
147323841|NCT01394991|531350079|FG000|Overall Study|Withdrawal by Subject|20|||
147323842|NCT01394991|531350080|FG001|Overall Study|Withdrawal by Subject|17|||
147655270|NCT02090283|532561504|FG001|Overall Study|Withdrawal by Subject|6|||
147323843|NCT01394991|531350079|FG000|Overall Study|Chemotherapy Termination|10|||
147655271|NCT02090283|532561505|FG002|Overall Study|Withdrawal by Subject|6|||
147655272|NCT02090283|532561503|FG000|Overall Study|Sponsor Terminated Study|6|||
147655273|NCT02090283|532561504|FG001|Overall Study|Sponsor Terminated Study|6|||
147655274|NCT02090283|532561505|FG002|Overall Study|Sponsor Terminated Study|1|||
147655275|NCT02090283|532561503|FG000|Overall Study|Lost to Follow-up|2|||
147655276|NCT02090283|532561504|FG001|Overall Study|Lost to Follow-up|2|||
147655277|NCT02090283|532561505|FG002|Overall Study|Lost to Follow-up|3|||
147655278|NCT02090283|532561503|FG000|Overall Study|Adverse Event|1|||
147655279|NCT02090283|532561504|FG001|Overall Study|Adverse Event|1|||
147323844|NCT01394991|531350080|FG001|Overall Study|Chemotherapy Termination|15|||
147323845|NCT01394991|531350079|FG000|Overall Study|Disease Progression|7|||
147323846|NCT01394991|531350080|FG001|Overall Study|Disease Progression|7|||
147591882|NCT01560507|532322762|FG002|Overall Study|Withdrawal by Subject|0|||
147591883|NCT00560937|532322763|FG000|Overall Study|Withdrawal by Subject|0|||
147591884|NCT00560937|532322764|FG001|Overall Study|Withdrawal by Subject|1|||
147591885|NCT00560937|532322763|FG000|Overall Study|Physician Decision|1|||
147591886|NCT00560937|532322764|FG001|Overall Study|Physician Decision|1|||
147591887|NCT01138111|532322765|FG000|Overall Study|Withdrawal by Subject|5|||
147591888|NCT01138111|532322765|FG000|Overall Study|Adverse Event|1|||
147171643|NCT01887353|530792225|FG000|Overall Study|Study stopped early|4|||
147171644|NCT01887353|530792226|FG001|Overall Study|Study stopped early|3|||
147171645|NCT00649428|530794247|FG000|Overall Study|Adverse Event|2|||
147171646|NCT00649428|530794248|FG001|Overall Study|Adverse Event|2|||
147171647|NCT00649428|530794247|FG000|Overall Study|Withdrawal by Subject|6|||
147171648|NCT00649428|530794248|FG001|Overall Study|Withdrawal by Subject|6|||
147591889|NCT01138111|532322765|FG000|Overall Study|Death|1|||
147591890|NCT01138111|532322765|FG000|Overall Study|Lost to Follow-up|2|||
147591891|NCT01118117|532322766|FG000|Overall Study|Death|8|||
147591892|NCT01118117|532322767|FG001|Overall Study|Death|0|||
147591893|NCT01118117|532322766|FG000|Overall Study|Lost to Follow-up|6|||
147591894|NCT01118117|532322767|FG001|Overall Study|Lost to Follow-up|0|||
147591895|NCT01118117|532322766|FG000|Overall Study|Missed 12 Month Visit|7|||
147591896|NCT01118117|532322767|FG001|Overall Study|Missed 12 Month Visit|0|||
147591897|NCT01660022|532322768|FG000|First Sequence (7 Days)|Withdrawal by Subject|0|||
147591898|NCT01660022|532322769|FG001|First Sequence (7 Days)|Withdrawal by Subject|1|||
147591899|NCT01660022|532322770|FG002|First Sequence (7 Days)|Withdrawal by Subject|0|||
147591900|NCT01660022|532322771|FG003|First Sequence (7 Days)|Withdrawal by Subject|1|||
147591901|NCT01660022|532322772|FG004|First Sequence (7 Days)|Withdrawal by Subject|0|||
147591902|NCT01660022|532322773|FG005|First Sequence (7 Days)|Withdrawal by Subject|0|||
147591903|NCT01660022|532322768|FG000|First Sequence (7 Days)|Adverse Event|0|||
147591904|NCT01660022|532322769|FG001|First Sequence (7 Days)|Adverse Event|0|||
147591905|NCT01660022|532322770|FG002|First Sequence (7 Days)|Adverse Event|0|||
147591906|NCT01660022|532322771|FG003|First Sequence (7 Days)|Adverse Event|0|||
147591907|NCT01660022|532322772|FG004|First Sequence (7 Days)|Adverse Event|1|||
147591908|NCT01660022|532322773|FG005|First Sequence (7 Days)|Adverse Event|3|||
147591909|NCT01660022|532322768|FG000|First Sequence (7 Days)|Protocol Violation|0|||
147591910|NCT01660022|532322769|FG001|First Sequence (7 Days)|Protocol Violation|0|||
147591911|NCT01660022|532322770|FG002|First Sequence (7 Days)|Protocol Violation|0|||
147591912|NCT01660022|532322771|FG003|First Sequence (7 Days)|Protocol Violation|0|||
147591913|NCT01660022|532322772|FG004|First Sequence (7 Days)|Protocol Violation|0|||
147591914|NCT01660022|532322773|FG005|First Sequence (7 Days)|Protocol Violation|1|||
147591915|NCT02149121|532322779|FG000|Main Study Period|Lack of Efficacy|2|||
147591916|NCT02149121|532322780|FG001|Main Study Period|Lack of Efficacy|2|||
147591917|NCT02149121|532322781|FG002|Main Study Period|Lack of Efficacy|1|||
147591918|NCT02149121|532322782|FG003|Main Study Period|Lack of Efficacy|0|||
147591919|NCT02149121|532322783|FG004|Main Study Period|Lack of Efficacy|0|||
147591920|NCT02149121|532322784|FG005|Main Study Period|Lack of Efficacy|0|||
147591921|NCT02149121|532322785|FG006|Main Study Period|Lack of Efficacy|0|||
147591922|NCT02149121|532322779|FG000|Main Study Period|Withdrawal by Subject|9|||
147591923|NCT02149121|532322780|FG001|Main Study Period|Withdrawal by Subject|5|||
147591924|NCT02149121|532322781|FG002|Main Study Period|Withdrawal by Subject|1|||
147591925|NCT02149121|532322782|FG003|Main Study Period|Withdrawal by Subject|0|||
147591926|NCT02149121|532322783|FG004|Main Study Period|Withdrawal by Subject|0|||
147591927|NCT02149121|532322784|FG005|Main Study Period|Withdrawal by Subject|0|||
147591928|NCT02149121|532322785|FG006|Main Study Period|Withdrawal by Subject|0|||
147591929|NCT02149121|532322779|FG000|Main Study Period|Adverse Event|2|||
147591930|NCT02149121|532322780|FG001|Main Study Period|Adverse Event|5|||
147591931|NCT02149121|532322781|FG002|Main Study Period|Adverse Event|1|||
147591932|NCT02149121|532322782|FG003|Main Study Period|Adverse Event|0|||
147591933|NCT02149121|532322783|FG004|Main Study Period|Adverse Event|0|||
147591934|NCT02149121|532322784|FG005|Main Study Period|Adverse Event|0|||
147591935|NCT02149121|532322785|FG006|Main Study Period|Adverse Event|0|||
147591936|NCT02149121|532322779|FG000|Main Study Period|Protocol Violation|2|||
147591937|NCT02149121|532322780|FG001|Main Study Period|Protocol Violation|0|||
147591938|NCT02149121|532322781|FG002|Main Study Period|Protocol Violation|0|||
147171649|NCT00649428|530794247|FG000|Overall Study|Lost to Follow-up|1|||
147171650|NCT00649428|530794248|FG001|Overall Study|Lost to Follow-up|3|||
147171651|NCT00649428|530794247|FG000|Overall Study|Insufficient manufacturing yield|5|||
147171652|NCT00649428|530794248|FG001|Overall Study|Insufficient manufacturing yield|1|||
147171653|NCT00649428|530794247|FG000|Overall Study|Protocol Violation|6|||
147171654|NCT00649428|530794248|FG001|Overall Study|Protocol Violation|2|||
147171655|NCT00649428|530794247|FG000|Overall Study|Physician Decision|0|||
147591939|NCT02149121|532322782|FG003|Main Study Period|Protocol Violation|0|||
147591940|NCT02149121|532322783|FG004|Main Study Period|Protocol Violation|0|||
147591941|NCT02149121|532322784|FG005|Main Study Period|Protocol Violation|0|||
147591942|NCT02149121|532322785|FG006|Main Study Period|Protocol Violation|0|||
147591943|NCT02149121|532322779|FG000|Main Study Period|Lost to Follow-up|2|||
147591944|NCT02149121|532322780|FG001|Main Study Period|Lost to Follow-up|1|||
147591945|NCT02149121|532322781|FG002|Main Study Period|Lost to Follow-up|0|||
147171656|NCT00649428|530794248|FG001|Overall Study|Physician Decision|1|||
147171657|NCT04599465|530794249|FG000|Overall Study|Physician Decision|1|||
147171658|NCT04599465|530794249|FG000|Overall Study|Withdrawal of consent (not due to AE)|2|||
147171659|NCT00495625|530794252|FG000|Overall Study|Did not complete at least 1 42 day cycle|10|||
147171660|NCT02702180|530794254|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
147171661|NCT02702180|530794255|FG001|Double-blind Treatment Period|Withdrawal by Subject|1|||
147171662|NCT02702180|530794256|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
147171663|NCT02702180|530794254|FG000|Double-blind Treatment Period|Adverse Event|0|||
147171664|NCT02702180|530794255|FG001|Double-blind Treatment Period|Adverse Event|0|||
147171665|NCT02702180|530794256|FG002|Double-blind Treatment Period|Adverse Event|1|||
147171666|NCT02702180|530794254|FG000|Double-blind Treatment Period|Lack of Efficacy|0|||
147171667|NCT02702180|530794255|FG001|Double-blind Treatment Period|Lack of Efficacy|0|||
147171668|NCT02702180|530794256|FG002|Double-blind Treatment Period|Lack of Efficacy|1|||
147171669|NCT02702180|530794254|FG000|Double-blind Treatment Period|Protocol Violation|0|||
147171670|NCT02702180|530794255|FG001|Double-blind Treatment Period|Protocol Violation|0|||
147171671|NCT02702180|530794256|FG002|Double-blind Treatment Period|Protocol Violation|2|||
147171672|NCT02702180|530794254|FG000|Open-label Treatment Period|Withdrawal by Subject|0|||
147171673|NCT02702180|530794255|FG001|Open-label Treatment Period|Withdrawal by Subject|1|||
147171674|NCT02702180|530794256|FG002|Open-label Treatment Period|Withdrawal by Subject|1|||
147171675|NCT02702180|530794254|FG000|Open-label Treatment Period|Withdrawn in error|0|||
147171676|NCT02702180|530794255|FG001|Open-label Treatment Period|Withdrawn in error|0|||
147171677|NCT02702180|530794256|FG002|Open-label Treatment Period|Withdrawn in error|1|||
147171678|NCT00679172|530794260|FG000|Overall Study|Non-compliance|1|||
147655280|NCT02090283|532561505|FG002|Overall Study|Adverse Event|0|||
147171679|NCT00679172|530794261|FG001|Overall Study|Non-compliance|1|||
147171680|NCT00679172|530794262|FG002|Overall Study|Non-compliance|0|||
147171681|NCT00679172|530794263|FG003|Overall Study|Non-compliance|1|||
147171682|NCT00679172|530794264|FG004|Overall Study|Non-compliance|0|||
147591946|NCT02149121|532322782|FG003|Main Study Period|Lost to Follow-up|0|||
147591947|NCT02149121|532322783|FG004|Main Study Period|Lost to Follow-up|0|||
147591948|NCT02149121|532322784|FG005|Main Study Period|Lost to Follow-up|0|||
147591949|NCT02149121|532322785|FG006|Main Study Period|Lost to Follow-up|0|||
147591950|NCT02149121|532322779|FG000|Main Study Period|Death|1|||
147591951|NCT02149121|532322780|FG001|Main Study Period|Death|0|||
147591952|NCT02149121|532322781|FG002|Main Study Period|Death|0|||
147591953|NCT02149121|532322782|FG003|Main Study Period|Death|0|||
147591954|NCT02149121|532322783|FG004|Main Study Period|Death|0|||
147591955|NCT02149121|532322784|FG005|Main Study Period|Death|0|||
147591956|NCT02149121|532322785|FG006|Main Study Period|Death|0|||
147591957|NCT02149121|532322779|FG000|Main Study Period|Physician Decision|1|||
147591958|NCT02149121|532322780|FG001|Main Study Period|Physician Decision|0|||
147591959|NCT02149121|532322781|FG002|Main Study Period|Physician Decision|0|||
147591960|NCT02149121|532322782|FG003|Main Study Period|Physician Decision|0|||
147591961|NCT02149121|532322783|FG004|Main Study Period|Physician Decision|0|||
147591962|NCT02149121|532322784|FG005|Main Study Period|Physician Decision|0|||
147591963|NCT02149121|532322785|FG006|Main Study Period|Physician Decision|0|||
147591964|NCT02149121|532322779|FG000|Main Study Period|Developed any malignancy|0|||
147591965|NCT02149121|532322780|FG001|Main Study Period|Developed any malignancy|1|||
147591966|NCT02149121|532322781|FG002|Main Study Period|Developed any malignancy|1|||
147591967|NCT02149121|532322782|FG003|Main Study Period|Developed any malignancy|0|||
147591968|NCT02149121|532322783|FG004|Main Study Period|Developed any malignancy|0|||
147591969|NCT02149121|532322784|FG005|Main Study Period|Developed any malignancy|0|||
147591970|NCT02149121|532322785|FG006|Main Study Period|Developed any malignancy|0|||
147171683|NCT00679172|530794260|FG000|Overall Study|Other not specified|0|||
147171684|NCT00679172|530794261|FG001|Overall Study|Other not specified|0|||
147171685|NCT00679172|530794262|FG002|Overall Study|Other not specified|1|||
147171686|NCT00679172|530794263|FG003|Overall Study|Other not specified|0|||
147171687|NCT00679172|530794264|FG004|Overall Study|Other not specified|0|||
147171688|NCT02241343|530794268|FG000|Overall Study|Adverse Event|1|||
147171689|NCT00753454|530794269|FG000|Overall Study|Adverse Event|4|||
147171690|NCT00753454|530794269|FG000|Overall Study|Lack of Efficacy|1|||
147171691|NCT00753454|530794269|FG000|Overall Study|Lost to Follow-up|3|||
147171692|NCT00753454|530794269|FG000|Overall Study|Withdrawal by Subject|5|||
147171693|NCT00753454|530794269|FG000|Overall Study|Investigator Decision|1|||
147171694|NCT05249569|530794270|FG000|Overall Study|Sponsor pulled support for one of the study drugs.|1|||
147171695|NCT03927144|530794271|FG000|Core Phase|Adverse Event|9|||
147171696|NCT03927144|530794272|FG001|Core Phase|Adverse Event|5|||
147591971|NCT02149121|532322779|FG000|Main Study Period|Unmet predefined eligibility criteria|2|||
147171697|NCT03927144|530794271|FG000|Core Phase|Lost to Follow-up|3|||
147591972|NCT02149121|532322780|FG001|Main Study Period|Unmet predefined eligibility criteria|2|||
147591973|NCT02149121|532322781|FG002|Main Study Period|Unmet predefined eligibility criteria|0|||
147591974|NCT02149121|532322782|FG003|Main Study Period|Unmet predefined eligibility criteria|0|||
147591975|NCT02149121|532322783|FG004|Main Study Period|Unmet predefined eligibility criteria|0|||
147655281|NCT02090283|532561503|FG000|Overall Study|Protocol Violation|2|||
147655282|NCT02090283|532561504|FG001|Overall Study|Protocol Violation|0|||
147655283|NCT02090283|532561505|FG002|Overall Study|Protocol Violation|0|||
147655284|NCT02964338|532561508|FG000|Overall Study|Sponsor terminated study for futility|12|||
147655285|NCT02964338|532561509|FG001|Overall Study|Sponsor terminated study for futility|15|||
147655286|NCT02964338|532561510|FG002|Overall Study|Sponsor terminated study for futility|14|||
147655287|NCT02964338|532561508|FG000|Overall Study|Lack of Efficacy|0|||
147655288|NCT02964338|532561509|FG001|Overall Study|Lack of Efficacy|3|||
147655289|NCT02964338|532561510|FG002|Overall Study|Lack of Efficacy|0|||
147655290|NCT02964338|532561508|FG000|Overall Study|Lost to Follow-up|1|||
147655291|NCT02964338|532561509|FG001|Overall Study|Lost to Follow-up|0|||
147655292|NCT02964338|532561510|FG002|Overall Study|Lost to Follow-up|3|||
147655293|NCT02964338|532561508|FG000|Overall Study|Protocol Violation|0|||
147655294|NCT02964338|532561509|FG001|Overall Study|Protocol Violation|1|||
147655295|NCT02964338|532561510|FG002|Overall Study|Protocol Violation|0|||
147655296|NCT02964338|532561508|FG000|Overall Study|Withdrawal by Subject|1|||
147655297|NCT02964338|532561509|FG001|Overall Study|Withdrawal by Subject|3|||
147655298|NCT02964338|532561510|FG002|Overall Study|Withdrawal by Subject|1|||
147655299|NCT02964338|532561508|FG000|Overall Study|Adverse Event|2|||
147655300|NCT02964338|532561509|FG001|Overall Study|Adverse Event|1|||
147655301|NCT02964338|532561510|FG002|Overall Study|Adverse Event|1|||
147655302|NCT02964338|532561508|FG000|Overall Study|Non-compliant with e-diary|0|||
147655303|NCT02964338|532561509|FG001|Overall Study|Non-compliant with e-diary|1|||
147655304|NCT02964338|532561510|FG002|Overall Study|Non-compliant with e-diary|0|||
147655305|NCT02964338|532561508|FG000|Overall Study|Did not meet criteria|1|||
147171698|NCT03927144|530794272|FG001|Core Phase|Lost to Follow-up|2|||
147171699|NCT03927144|530794271|FG000|Core Phase|New Therapy for Study Indication|0|||
147171700|NCT03927144|530794272|FG001|Core Phase|New Therapy for Study Indication|1|||
147171701|NCT03927144|530794271|FG000|Core Phase|No Longer Clinically Benefiting|4|||
147171702|NCT03927144|530794272|FG001|Core Phase|No Longer Clinically Benefiting|4|||
147171703|NCT03927144|530794271|FG000|Core Phase|Physician Decision|2|||
147171704|NCT03927144|530794272|FG001|Core Phase|Physician Decision|8|||
147171705|NCT03927144|530794271|FG000|Core Phase|Protocol Violation|2|||
147171706|NCT03927144|530794272|FG001|Core Phase|Protocol Violation|2|||
147171707|NCT03927144|530794271|FG000|Core Phase|Withdrawal by Subject|16|||
147171708|NCT03927144|530794272|FG001|Core Phase|Withdrawal by Subject|40|||
147171709|NCT03927144|530794271|FG000|Extension Phase|Adverse Event|2|||
147171710|NCT03927144|530794272|FG001|Extension Phase|Adverse Event|1|||
147171711|NCT03927144|530794271|FG000|Extension Phase|No longer clinically benefiting|4|||
147655306|NCT02964338|532561509|FG001|Overall Study|Did not meet criteria|0|||
147655307|NCT02964338|532561510|FG002|Overall Study|Did not meet criteria|0|||
147655308|NCT00621257|532561511|FG000|Overall Study|Lost to Follow-up|4|||
147655309|NCT00621257|532561512|FG001|Overall Study|Lost to Follow-up|0|||
147655310|NCT00621257|532561513|FG002|Overall Study|Lost to Follow-up|2|||
147655311|NCT00621257|532561514|FG003|Overall Study|Lost to Follow-up|4|||
147655312|NCT00621257|532561515|FG004|Overall Study|Lost to Follow-up|7|||
147655313|NCT00621257|532561511|FG000|Overall Study|Adverse Event|0|||
147655314|NCT00621257|532561512|FG001|Overall Study|Adverse Event|1|||
147655315|NCT00621257|532561513|FG002|Overall Study|Adverse Event|1|||
147655316|NCT00621257|532561514|FG003|Overall Study|Adverse Event|0|||
147655317|NCT00621257|532561515|FG004|Overall Study|Adverse Event|0|||
147655318|NCT00621257|532561511|FG000|Overall Study|Physician Decision|0|||
147655319|NCT00621257|532561512|FG001|Overall Study|Physician Decision|2|||
147171712|NCT03927144|530794272|FG001|Extension Phase|No longer clinically benefiting|5|||
147171713|NCT03927144|530794271|FG000|Extension Phase|Pregnancy|1|||
147171714|NCT03927144|530794272|FG001|Extension Phase|Pregnancy|0|||
147171715|NCT03927144|530794271|FG000|Extension Phase|Protocol Violation|0|||
147171716|NCT03927144|530794272|FG001|Extension Phase|Protocol Violation|1|||
147171717|NCT03927144|530794271|FG000|Extension Phase|Withdrawal by Subject|8|||
147323847|NCT01394991|531350079|FG000|Overall Study|Prematurely Termination of Trial|9|||
147323848|NCT01394991|531350080|FG001|Overall Study|Prematurely Termination of Trial|10|||
147323849|NCT03073005|531350081|FG000|Overall Study|Death|6|||
147323850|NCT03073005|531350082|FG001|Overall Study|Death|0|||
147323851|NCT03073005|531350083|FG002|Overall Study|Death|7|||
147323852|NCT03073005|531350084|FG003|Overall Study|Death|0|||
147655320|NCT00621257|532561513|FG002|Overall Study|Physician Decision|0|||
147655321|NCT00621257|532561514|FG003|Overall Study|Physician Decision|1|||
147171718|NCT03927144|530794272|FG001|Extension Phase|Withdrawal by Subject|3|||
147171719|NCT02271945|530794275|FG000|Overall Study|Death|3|||
147171720|NCT02271945|530794276|FG001|Overall Study|Death|3|||
147323853|NCT03073005|531350081|FG000|Overall Study|caregiver withdrew bc of pt death|0|||
147655322|NCT00621257|532561515|FG004|Overall Study|Physician Decision|1|||
147171721|NCT02271945|530794275|FG000|Overall Study|Withdrawal by Subject|1|||
147171722|NCT02271945|530794276|FG001|Overall Study|Withdrawal by Subject|1|||
147171723|NCT02271945|530794275|FG000|Overall Study|Other|1|||
147323854|NCT03073005|531350082|FG001|Overall Study|caregiver withdrew bc of pt death|6|||
147323855|NCT03073005|531350083|FG002|Overall Study|caregiver withdrew bc of pt death|0|||
147655323|NCT00621257|532561511|FG000|Overall Study|Withdrawal by Subject|0|||
147171724|NCT02271945|530794276|FG001|Overall Study|Other|1|||
147655324|NCT00621257|532561512|FG001|Overall Study|Withdrawal by Subject|0|||
147591976|NCT02149121|532322784|FG005|Main Study Period|Unmet predefined eligibility criteria|0|||
147591977|NCT02149121|532322785|FG006|Main Study Period|Unmet predefined eligibility criteria|0|||
147591978|NCT02149121|532322779|FG000|Main Study Period|Disease progression|0|||
147591979|NCT02149121|532322780|FG001|Main Study Period|Disease progression|1|||
147591980|NCT02149121|532322781|FG002|Main Study Period|Disease progression|0|||
147591981|NCT02149121|532322782|FG003|Main Study Period|Disease progression|0|||
147591982|NCT02149121|532322783|FG004|Main Study Period|Disease progression|0|||
147171725|NCT01452919|530794277|FG000|Open-Label Treatment|Adverse Event|5|||
147171726|NCT01452919|530794278|FG001|Open-Label Treatment|Adverse Event|0|||
147171727|NCT01452919|530794279|FG002|Open-Label Treatment|Adverse Event|0|||
147171728|NCT01452919|530794277|FG000|Open-Label Treatment|Lost to Follow-up|4|||
147171729|NCT01452919|530794278|FG001|Open-Label Treatment|Lost to Follow-up|0|||
147171730|NCT01452919|530794279|FG002|Open-Label Treatment|Lost to Follow-up|0|||
147171731|NCT01452919|530794277|FG000|Open-Label Treatment|Perceived lack of efficacy|3|||
147171732|NCT01452919|530794278|FG001|Open-Label Treatment|Perceived lack of efficacy|0|||
147171733|NCT01452919|530794279|FG002|Open-Label Treatment|Perceived lack of efficacy|0|||
147171734|NCT01452919|530794277|FG000|Open-Label Treatment|Protocol Violation|4|||
147171735|NCT01452919|530794278|FG001|Open-Label Treatment|Protocol Violation|0|||
147171736|NCT01452919|530794279|FG002|Open-Label Treatment|Protocol Violation|0|||
147171737|NCT01452919|530794277|FG000|Open-Label Treatment|Sponsor Decision|1|||
147171738|NCT01452919|530794278|FG001|Open-Label Treatment|Sponsor Decision|0|||
147171739|NCT01452919|530794279|FG002|Open-Label Treatment|Sponsor Decision|0|||
147171740|NCT01452919|530794277|FG000|Open-Label Treatment|Withdrawal by Subject|2|||
147171741|NCT01452919|530794278|FG001|Open-Label Treatment|Withdrawal by Subject|0|||
147171742|NCT01452919|530794279|FG002|Open-Label Treatment|Withdrawal by Subject|0|||
147171743|NCT01452919|530794277|FG000|Open-Label Treatment|Subject is moving or has moved|1|||
147171744|NCT01452919|530794278|FG001|Open-Label Treatment|Subject is moving or has moved|0|||
147171745|NCT01452919|530794279|FG002|Open-Label Treatment|Subject is moving or has moved|0|||
147171746|NCT01452919|530794277|FG000|Randomization Treatment|Adverse Event|0|||
147171747|NCT01452919|530794278|FG001|Randomization Treatment|Adverse Event|0|||
147171748|NCT01452919|530794279|FG002|Randomization Treatment|Adverse Event|2|||
147171749|NCT01452919|530794277|FG000|Randomization Treatment|Sponsor Decision|0|||
147171750|NCT01452919|530794278|FG001|Randomization Treatment|Sponsor Decision|1|||
147171751|NCT01452919|530794279|FG002|Randomization Treatment|Sponsor Decision|0|||
147171752|NCT01452919|530794277|FG000|Randomization Treatment|Withdrawal by Subject|0|||
147171753|NCT01452919|530794278|FG001|Randomization Treatment|Withdrawal by Subject|1|||
147171754|NCT01452919|530794279|FG002|Randomization Treatment|Withdrawal by Subject|0|||
147171755|NCT01452919|530794277|FG000|Randomization Treatment|Subject is moving or has moved|0|||
147171756|NCT01452919|530794278|FG001|Randomization Treatment|Subject is moving or has moved|1|||
147171757|NCT01452919|530794279|FG002|Randomization Treatment|Subject is moving or has moved|0|||
147171758|NCT00615030|530794280|FG000|Period I|Administrative problem|0|||
147171759|NCT00615030|530794281|FG001|Period I|Administrative problem|0|||
147171760|NCT00615030|530794282|FG002|Period I|Administrative problem|0|||
147171761|NCT00615030|530794283|FG003|Period I|Administrative problem|0|||
147171762|NCT00615030|530794284|FG004|Period I|Administrative problem|1|||
147171763|NCT00615030|530794285|FG005|Period I|Administrative problem|0|||
147171764|NCT00615030|530794286|FG006|Period I|Administrative problem|0|||
147171765|NCT00615030|530794287|FG007|Period I|Administrative problem|0|||
147591983|NCT02149121|532322784|FG005|Main Study Period|Disease progression|0|||
147591984|NCT02149121|532322785|FG006|Main Study Period|Disease progression|0|||
147591985|NCT02149121|532322779|FG000|Extension Study Period|Withdrawal by Subject|0|||
147591986|NCT02149121|532322780|FG001|Extension Study Period|Withdrawal by Subject|0|||
147591987|NCT02149121|532322781|FG002|Extension Study Period|Withdrawal by Subject|0|||
147591988|NCT02149121|532322782|FG003|Extension Study Period|Withdrawal by Subject|1|||
147591989|NCT02149121|532322783|FG004|Extension Study Period|Withdrawal by Subject|0|||
147591990|NCT02149121|532322784|FG005|Extension Study Period|Withdrawal by Subject|2|||
147591991|NCT02149121|532322785|FG006|Extension Study Period|Withdrawal by Subject|0|||
147591992|NCT03166124|532322786|FG000|Treatment Period 1|Adverse Event|0|||
147591993|NCT03166124|532322787|FG001|Treatment Period 1|Adverse Event|0|||
147591994|NCT03166124|532322788|FG002|Treatment Period 1|Adverse Event|1|||
147591995|NCT03166124|532322789|FG003|Treatment Period 1|Adverse Event|0|||
147591996|NCT03166124|532322786|FG000|Wash-out Period|Withdrawal by Subject|0|||
147591997|NCT03166124|532322787|FG001|Wash-out Period|Withdrawal by Subject|1|||
147591998|NCT03166124|532322788|FG002|Wash-out Period|Withdrawal by Subject|0|||
147591999|NCT03166124|532322789|FG003|Wash-out Period|Withdrawal by Subject|1|||
147592000|NCT03166124|532322786|FG000|Wash-out Period|Adverse Event|0|||
147592001|NCT03166124|532322787|FG001|Wash-out Period|Adverse Event|1|||
147592002|NCT03166124|532322788|FG002|Wash-out Period|Adverse Event|1|||
147592003|NCT03166124|532322789|FG003|Wash-out Period|Adverse Event|0|||
147592004|NCT00788593|532322792|FG000|Placebo Run-in Phase|Adverse Event|2|||
147592005|NCT00788593|532322793|FG001|Placebo Run-in Phase|Adverse Event|0|||
147592006|NCT00788593|532322794|FG002|Placebo Run-in Phase|Adverse Event|0|||
147323856|NCT03073005|531350084|FG003|Overall Study|caregiver withdrew bc of pt death|7|||
147323857|NCT03073005|531350081|FG000|Overall Study|Lost to Follow-up|2|||
147323858|NCT03073005|531350082|FG001|Overall Study|Lost to Follow-up|2|||
147323859|NCT03073005|531350083|FG002|Overall Study|Lost to Follow-up|1|||
147323860|NCT03073005|531350084|FG003|Overall Study|Lost to Follow-up|2|||
147323861|NCT03073005|531350081|FG000|Overall Study|Withdrawal by Subject|0|||
147655325|NCT00621257|532561513|FG002|Overall Study|Withdrawal by Subject|0|||
147655326|NCT00621257|532561514|FG003|Overall Study|Withdrawal by Subject|1|||
147323862|NCT03073005|531350082|FG001|Overall Study|Withdrawal by Subject|4|||
147323863|NCT03073005|531350083|FG002|Overall Study|Withdrawal by Subject|4|||
147323864|NCT03073005|531350084|FG003|Overall Study|Withdrawal by Subject|4|||
147323865|NCT02427646|531350085|FG000|Overall Study|Lack of Efficacy|2|||
147323866|NCT02427646|531350086|FG001|Overall Study|Lack of Efficacy|3|||
147323867|NCT02427646|531350085|FG000|Overall Study|Physician Decision|1|||
147655327|NCT00621257|532561515|FG004|Overall Study|Withdrawal by Subject|1|||
147655328|NCT01255904|532561519|FG000|Overall Study|Physician Decision|1|||
147171766|NCT00615030|530794288|FG008|Period I|Administrative problem|0|||
147171767|NCT00615030|530794289|FG009|Period I|Administrative problem|0|||
147171768|NCT00615030|530794290|FG010|Period I|Administrative problem|0|||
147171769|NCT00615030|530794291|FG011|Period I|Administrative problem|0|||
147171770|NCT00615030|530794280|FG000|Period I|Protocol deviation|1|||
147171771|NCT00615030|530794281|FG001|Period I|Protocol deviation|0|||
147171772|NCT00615030|530794282|FG002|Period I|Protocol deviation|0|||
147171773|NCT00615030|530794283|FG003|Period I|Protocol deviation|0|||
147323868|NCT02427646|531350086|FG001|Overall Study|Physician Decision|4|||
147323869|NCT02427646|531350085|FG000|Overall Study|Protocol Violation|3|||
147323870|NCT02427646|531350086|FG001|Overall Study|Protocol Violation|3|||
147323871|NCT02427646|531350085|FG000|Overall Study|Bothersome hand weakness|2|||
147323872|NCT02427646|531350086|FG001|Overall Study|Bothersome hand weakness|4|||
147323873|NCT03824236|531350087|FG000|Overall Study|Lost to Follow-up|0|||
147171774|NCT00615030|530794284|FG004|Period I|Protocol deviation|0|||
147171775|NCT00615030|530794285|FG005|Period I|Protocol deviation|0|||
147171776|NCT00615030|530794286|FG006|Period I|Protocol deviation|0|||
147171777|NCT00615030|530794287|FG007|Period I|Protocol deviation|0|||
147171778|NCT00615030|530794288|FG008|Period I|Protocol deviation|0|||
147448069|NCT00590590|531805631|FG001|Overall Study|Did not complete due to study closure|1|||
147448070|NCT00590590|531805632|FG002|Overall Study|Did not complete due to study closure|1|||
147448071|NCT00590590|531805630|FG000|Overall Study|Did not complete study|0|||
147592007|NCT00788593|532322792|FG000|Placebo Run-in Phase|Withdrawal by Subject|2|||
147592008|NCT00788593|532322793|FG001|Placebo Run-in Phase|Withdrawal by Subject|0|||
147171779|NCT00615030|530794289|FG009|Period I|Protocol deviation|0|||
147171780|NCT00615030|530794290|FG010|Period I|Protocol deviation|0|||
147171781|NCT00615030|530794291|FG011|Period I|Protocol deviation|0|||
147171782|NCT00615030|530794280|FG000|Period I|Subject withdrew consent|0|||
147171783|NCT00615030|530794281|FG001|Period I|Subject withdrew consent|0|||
147171784|NCT00615030|530794282|FG002|Period I|Subject withdrew consent|0|||
147171785|NCT00615030|530794283|FG003|Period I|Subject withdrew consent|0|||
147171786|NCT00615030|530794284|FG004|Period I|Subject withdrew consent|0|||
147171787|NCT00615030|530794285|FG005|Period I|Subject withdrew consent|0|||
147171788|NCT00615030|530794286|FG006|Period I|Subject withdrew consent|0|||
147171789|NCT00615030|530794287|FG007|Period I|Subject withdrew consent|0|||
147448072|NCT00590590|531805631|FG001|Overall Study|Did not complete study|1|||
147592009|NCT00788593|532322794|FG002|Placebo Run-in Phase|Withdrawal by Subject|0|||
147592010|NCT00788593|532322792|FG000|Placebo Run-in Phase|Protocol Violation|2|||
147592011|NCT00788593|532322793|FG001|Placebo Run-in Phase|Protocol Violation|0|||
147592012|NCT00788593|532322794|FG002|Placebo Run-in Phase|Protocol Violation|0|||
147592013|NCT00788593|532322792|FG000|First Intervention Period|Adverse Event|0|||
147592014|NCT00788593|532322793|FG001|First Intervention Period|Adverse Event|1|||
147592015|NCT00788593|532322794|FG002|First Intervention Period|Adverse Event|0|||
147655329|NCT01255904|532561520|FG001|Overall Study|Physician Decision|4|||
147655330|NCT00184002|532561522|FG000|Overall Study|Adverse Event|9|||
147655331|NCT00184002|532561522|FG000|Overall Study|Death|3|||
147655332|NCT00184002|532561522|FG000|Overall Study|Physician Decision|1|||
147655333|NCT00184002|532561522|FG000|Overall Study|Withdrawal by Subject|4|||
147171790|NCT00615030|530794288|FG008|Period I|Subject withdrew consent|1|||
147171791|NCT00615030|530794289|FG009|Period I|Subject withdrew consent|0|||
147171792|NCT00615030|530794290|FG010|Period I|Subject withdrew consent|1|||
147323874|NCT03824236|531350088|FG001|Overall Study|Lost to Follow-up|0|||
147592016|NCT00788593|532322792|FG000|Second Intervention Period|Lost to Follow-up|0|||
147171793|NCT00615030|530794291|FG011|Period I|Subject withdrew consent|1|||
147171794|NCT00615030|530794280|FG000|Period I|Abnormal laboratory value(s)|0|||
147171795|NCT00615030|530794281|FG001|Period I|Abnormal laboratory value(s)|0|||
147323875|NCT03824236|531350089|FG002|Overall Study|Lost to Follow-up|1|||
147323876|NCT04091672|531352347|FG000|Overall Study|Death|6|||
147171796|NCT00615030|530794282|FG002|Period I|Abnormal laboratory value(s)|0|||
147171797|NCT00615030|530794283|FG003|Period I|Abnormal laboratory value(s)|0|||
147323877|NCT04091672|531352348|FG001|Overall Study|Death|6|||
147171798|NCT00615030|530794284|FG004|Period I|Abnormal laboratory value(s)|0|||
147592017|NCT00788593|532322793|FG001|Second Intervention Period|Lost to Follow-up|1|||
147592018|NCT00788593|532322794|FG002|Second Intervention Period|Lost to Follow-up|0|||
147592019|NCT00788593|532322792|FG000|Second Intervention Period|Other|0|||
147592020|NCT00788593|532322793|FG001|Second Intervention Period|Other|0|||
147592021|NCT00788593|532322794|FG002|Second Intervention Period|Other|1|||
147592022|NCT00515034|532322795|FG000|Overall Study|Adverse Event|2|||
147592023|NCT00515034|532322796|FG001|Overall Study|Adverse Event|0|||
147655334|NCT02171429|532561523|FG000|Overall Study|Other|0|||
147655335|NCT02171429|532561524|FG001|Overall Study|Other|1|||
147655336|NCT02171429|532561525|FG002|Overall Study|Other|1|||
147655337|NCT02171429|532561523|FG000|Overall Study|Non-Compliance|0|||
147655338|NCT02171429|532561524|FG001|Overall Study|Non-Compliance|0|||
147655339|NCT02171429|532561525|FG002|Overall Study|Non-Compliance|1|||
147655340|NCT02171429|532561523|FG000|Overall Study|Physician Decision|0|||
147655341|NCT02171429|532561524|FG001|Overall Study|Physician Decision|0|||
147655342|NCT02171429|532561525|FG002|Overall Study|Physician Decision|1|||
147655343|NCT02171429|532561523|FG000|Overall Study|Withdrawal by Subject|1|||
147171799|NCT00615030|530794285|FG005|Period I|Abnormal laboratory value(s)|1|||
147171800|NCT00615030|530794286|FG006|Period I|Abnormal laboratory value(s)|0|||
147171801|NCT00615030|530794287|FG007|Period I|Abnormal laboratory value(s)|0|||
147171802|NCT00615030|530794288|FG008|Period I|Abnormal laboratory value(s)|0|||
147171803|NCT00615030|530794289|FG009|Period I|Abnormal laboratory value(s)|0|||
147171804|NCT00615030|530794290|FG010|Period I|Abnormal laboratory value(s)|0|||
147171805|NCT00615030|530794291|FG011|Period I|Abnormal laboratory value(s)|0|||
147171806|NCT00615030|530794280|FG000|Period II|Adverse Event|0|||
147171807|NCT00615030|530794281|FG001|Period II|Adverse Event|0|||
147171808|NCT00615030|530794282|FG002|Period II|Adverse Event|1|||
147171809|NCT00615030|530794283|FG003|Period II|Adverse Event|0|||
147323878|NCT04091672|531352347|FG000|Overall Study|Lost to Follow-up|7|||
147323879|NCT04091672|531352348|FG001|Overall Study|Lost to Follow-up|7|||
147323880|NCT04091672|531352347|FG000|Overall Study|Withdrawal by Subject|3|||
147323881|NCT04091672|531352348|FG001|Overall Study|Withdrawal by Subject|3|||
147323882|NCT04091672|531352347|FG000|Overall Study|Non-Compliance With Study Schedule|2|||
147323883|NCT04091672|531352348|FG001|Overall Study|Non-Compliance With Study Schedule|2|||
147323884|NCT05296629|531352349|FG000|Overall Study|Withdrawal by Subject|3|||
147323885|NCT05296629|531352350|FG001|Overall Study|Withdrawal by Subject|10|||
147323886|NCT05296629|531352351|FG002|Overall Study|Withdrawal by Subject|4|||
147323887|NCT05296629|531352349|FG000|Overall Study|Lost to Follow-up|2|||
147323888|NCT05296629|531352350|FG001|Overall Study|Lost to Follow-up|7|||
147323889|NCT05296629|531352351|FG002|Overall Study|Lost to Follow-up|1|||
147323890|NCT05296629|531352349|FG000|Overall Study|Adverse Event|0|||
147323891|NCT05296629|531352350|FG001|Overall Study|Adverse Event|4|||
147323892|NCT05296629|531352351|FG002|Overall Study|Adverse Event|2|||
147323893|NCT05296629|531352349|FG000|Overall Study|Protocol Violation|0|||
147323894|NCT05296629|531352350|FG001|Overall Study|Protocol Violation|2|||
147592024|NCT00515034|532322797|FG002|Overall Study|Adverse Event|1|||
147592025|NCT00515034|532322798|FG003|Overall Study|Adverse Event|0|||
147592026|NCT00515034|532322795|FG000|Overall Study|Death|4|||
147592027|NCT00515034|532322796|FG001|Overall Study|Death|2|||
147592028|NCT00515034|532322797|FG002|Overall Study|Death|1|||
147655344|NCT02171429|532561524|FG001|Overall Study|Withdrawal by Subject|1|||
147171810|NCT00615030|530794284|FG004|Period II|Adverse Event|0|||
147171811|NCT00615030|530794285|FG005|Period II|Adverse Event|0|||
147171812|NCT00615030|530794286|FG006|Period II|Adverse Event|0|||
147171813|NCT00615030|530794287|FG007|Period II|Adverse Event|0|||
147171814|NCT00615030|530794288|FG008|Period II|Adverse Event|1|||
147323895|NCT05296629|531352351|FG002|Overall Study|Protocol Violation|0|||
147592029|NCT00515034|532322798|FG003|Overall Study|Death|3|||
147592030|NCT00515034|532322795|FG000|Overall Study|Withdrawal by Subject|1|||
147171815|NCT00615030|530794289|FG009|Period II|Adverse Event|0|||
147171816|NCT00615030|530794290|FG010|Period II|Adverse Event|0|||
147171817|NCT00615030|530794291|FG011|Period II|Adverse Event|0|||
147171818|NCT00615030|530794280|FG000|Period II|Subject withdrew consent|0|||
147171819|NCT00615030|530794281|FG001|Period II|Subject withdrew consent|0|||
147171820|NCT00615030|530794282|FG002|Period II|Subject withdrew consent|0|||
147171821|NCT00615030|530794283|FG003|Period II|Subject withdrew consent|1|||
147171822|NCT00615030|530794284|FG004|Period II|Subject withdrew consent|0|||
147171823|NCT00615030|530794285|FG005|Period II|Subject withdrew consent|0|||
147171824|NCT00615030|530794286|FG006|Period II|Subject withdrew consent|1|||
147171825|NCT00615030|530794287|FG007|Period II|Subject withdrew consent|0|||
147171826|NCT00615030|530794288|FG008|Period II|Subject withdrew consent|0|||
147171827|NCT00615030|530794289|FG009|Period II|Subject withdrew consent|0|||
147171828|NCT00615030|530794290|FG010|Period II|Subject withdrew consent|0|||
147171829|NCT00615030|530794291|FG011|Period II|Subject withdrew consent|0|||
147171830|NCT00615030|530794280|FG000|Period III|Administrative problems|1|||
147171831|NCT00615030|530794281|FG001|Period III|Administrative problems|0|||
147323896|NCT02268396|531352352|FG000|Overall Study|Adverse Event|3|||
147323897|NCT02268396|531352352|FG000|Overall Study|Administrative|2|||
147655345|NCT02171429|532561525|FG002|Overall Study|Withdrawal by Subject|1|||
147655346|NCT02171429|532561523|FG000|Overall Study|Lost to Follow-up|0|||
147244339|NCT02549937|531066979|FG005|Overall Study|Lost to Follow-up|0|||
147244340|NCT02549937|531066980|FG006|Overall Study|Lost to Follow-up|0|||
147244341|NCT02549937|531066981|FG007|Overall Study|Lost to Follow-up|0|||
147244342|NCT02549937|531066982|FG008|Overall Study|Lost to Follow-up|3|||
147244343|NCT02549937|531066974|FG000|Overall Study|Withdrawal by Subject|0|||
147244344|NCT02549937|531066975|FG001|Overall Study|Withdrawal by Subject|0|||
147244345|NCT02549937|531066976|FG002|Overall Study|Withdrawal by Subject|0|||
147244346|NCT02549937|531066977|FG003|Overall Study|Withdrawal by Subject|0|||
147244347|NCT02549937|531066978|FG004|Overall Study|Withdrawal by Subject|0|||
147244348|NCT02549937|531066979|FG005|Overall Study|Withdrawal by Subject|1|||
147244349|NCT02549937|531066980|FG006|Overall Study|Withdrawal by Subject|4|||
147244350|NCT02549937|531066981|FG007|Overall Study|Withdrawal by Subject|3|||
147244351|NCT02549937|531066982|FG008|Overall Study|Withdrawal by Subject|2|||
147244352|NCT02549937|531066974|FG000|Overall Study|Sponsor Decision|0|||
147244353|NCT02549937|531066975|FG001|Overall Study|Sponsor Decision|0|||
147244354|NCT02549937|531066976|FG002|Overall Study|Sponsor Decision|0|||
147244355|NCT02549937|531066977|FG003|Overall Study|Sponsor Decision|0|||
147244356|NCT02549937|531066978|FG004|Overall Study|Sponsor Decision|0|||
147244357|NCT02549937|531066979|FG005|Overall Study|Sponsor Decision|0|||
147244358|NCT02549937|531066980|FG006|Overall Study|Sponsor Decision|0|||
147244359|NCT02549937|531066981|FG007|Overall Study|Sponsor Decision|0|||
147244360|NCT02549937|531066982|FG008|Overall Study|Sponsor Decision|6|||
147592031|NCT00515034|532322796|FG001|Overall Study|Withdrawal by Subject|0|||
147592032|NCT00515034|532322797|FG002|Overall Study|Withdrawal by Subject|3|||
147592033|NCT00515034|532322798|FG003|Overall Study|Withdrawal by Subject|0|||
147592034|NCT00515034|532322795|FG000|Overall Study|Physician Decision|0|||
147592035|NCT00515034|532322796|FG001|Overall Study|Physician Decision|0|||
147592036|NCT00515034|532322797|FG002|Overall Study|Physician Decision|1|||
147592037|NCT00515034|532322798|FG003|Overall Study|Physician Decision|1|||
147592038|NCT00515034|532322795|FG000|Overall Study|Other|1|||
147592039|NCT00515034|532322796|FG001|Overall Study|Other|0|||
147592040|NCT00515034|532322797|FG002|Overall Study|Other|2|||
147592041|NCT00515034|532322798|FG003|Overall Study|Other|1|||
147592042|NCT02858726|532322799|FG000|Overall Study|Adverse Event|4|||
147592043|NCT02858726|532322800|FG001|Overall Study|Adverse Event|4|||
147592044|NCT02858726|532322801|FG002|Overall Study|Adverse Event|9|||
147592045|NCT02858726|532322802|FG003|Overall Study|Adverse Event|1|||
147592046|NCT02858726|532322799|FG000|Overall Study|Physician Decision|0|||
147592047|NCT02858726|532322800|FG001|Overall Study|Physician Decision|0|||
147592048|NCT02858726|532322801|FG002|Overall Study|Physician Decision|1|||
147592049|NCT02858726|532322802|FG003|Overall Study|Physician Decision|0|||
147592050|NCT02858726|532322799|FG000|Overall Study|Protocol Violation|0|||
147592051|NCT02858726|532322800|FG001|Overall Study|Protocol Violation|0|||
147592052|NCT02858726|532322801|FG002|Overall Study|Protocol Violation|0|||
147592053|NCT02858726|532322802|FG003|Overall Study|Protocol Violation|1|||
147592054|NCT02858726|532322799|FG000|Overall Study|Study Terminated by Sponsor|0|||
147592055|NCT02858726|532322800|FG001|Overall Study|Study Terminated by Sponsor|0|||
147592056|NCT02858726|532322801|FG002|Overall Study|Study Terminated by Sponsor|0|||
147592057|NCT02858726|532322802|FG003|Overall Study|Study Terminated by Sponsor|1|||
147592058|NCT02858726|532322799|FG000|Overall Study|Withdrawal by Subject|1|||
147592059|NCT02858726|532322800|FG001|Overall Study|Withdrawal by Subject|2|||
147592060|NCT02858726|532322801|FG002|Overall Study|Withdrawal by Subject|1|||
147592061|NCT02858726|532322802|FG003|Overall Study|Withdrawal by Subject|0|||
147592062|NCT02858726|532322799|FG000|Overall Study|Noncompliance|0|||
147592063|NCT02858726|532322800|FG001|Overall Study|Noncompliance|1|||
147592064|NCT02858726|532322801|FG002|Overall Study|Noncompliance|0|||
147592065|NCT02858726|532322802|FG003|Overall Study|Noncompliance|0|||
147592066|NCT00233987|532322809|FG000|Overall Study|Withdrawal by Subject|1|||
147592067|NCT00233987|532322809|FG000|Overall Study|Lack of Efficacy|2|||
147592068|NCT00233987|532322809|FG000|Overall Study|Reason Under Review|1|||
147592069|NCT00233987|532322809|FG000|Overall Study|Other - Not Protocol Specified|5|||
147592070|NCT00233987|532322809|FG000|Overall Study|Eligible but No Treatment Received|2|||
147592071|NCT00233987|532322809|FG000|Overall Study|Ineligible|4|||
147592072|NCT01481324|532322813|FG000|Overall Study|Missing Data|0|||
147592073|NCT01481324|532322814|FG001|Overall Study|Missing Data|2|||
147592074|NCT01481324|532322815|FG002|Overall Study|Missing Data|2|||
147592075|NCT00952276|532322821|FG000|Overall Study|Withdrawal by Subject|1|||
147592076|NCT00952276|532322822|FG001|Overall Study|Withdrawal by Subject|0|||
147592077|NCT00952276|532322823|FG002|Overall Study|Withdrawal by Subject|0|||
147592078|NCT00952276|532322824|FG003|Overall Study|Withdrawal by Subject|1|||
147592079|NCT00952276|532322825|FG004|Overall Study|Withdrawal by Subject|0|||
147244361|NCT00317356|531066983|FG000|Overall Study|Adverse Event|0|||
147244362|NCT00317356|531066984|FG001|Overall Study|Adverse Event|0|||
147592080|NCT02427984|532322826|FG000|Overall Study|Lost to Follow-up|13|||
147244363|NCT00317356|531066985|FG002|Overall Study|Adverse Event|1|||
147592081|NCT02427984|532322827|FG001|Overall Study|Lost to Follow-up|5|||
147244364|NCT00317356|531066986|FG003|Overall Study|Adverse Event|0|||
147244365|NCT00317356|531066983|FG000|Overall Study|Lack of Efficacy|1|||
147592082|NCT02427984|532322828|FG002|Overall Study|Lost to Follow-up|18|||
147592083|NCT03821272|532324978|FG000|Overall Study|Death|1|||
147592084|NCT03821272|532324979|FG001|Overall Study|Death|0|||
147592085|NCT03821272|532324978|FG000|Overall Study|Physician Decision|1|||
147592086|NCT03821272|532324979|FG001|Overall Study|Physician Decision|0|||
147592087|NCT03821272|532324978|FG000|Overall Study|Withdrawal by Subject|1|||
147592088|NCT03821272|532324979|FG001|Overall Study|Withdrawal by Subject|0|||
147592089|NCT05904769|532324980|FG000|Overall Study|Physician Decision|0|||
147592090|NCT05904769|532324981|FG001|Overall Study|Physician Decision|6|||
147592091|NCT01010126|532324985|FG000|Overall Study|Withdrawal by Subject|1|||
147592092|NCT01010126|532324986|FG001|Overall Study|Withdrawal by Subject|0|||
147592093|NCT01010126|532324987|FG002|Overall Study|Withdrawal by Subject|1|||
147592094|NCT01010126|532324988|FG003|Overall Study|Withdrawal by Subject|0|||
147592095|NCT01010126|532324989|FG004|Overall Study|Withdrawal by Subject|3|||
147592096|NCT01010126|532324990|FG005|Overall Study|Withdrawal by Subject|0|||
147592097|NCT00493246|532324993|FG000|Overall Study|Withdrawal by Subject|0|||
147323898|NCT02268396|531352352|FG000|Overall Study|Withdrawal by Subject|1|||
147323899|NCT02268396|531352352|FG000|Overall Study|Lost to Follow-up|2|||
147323900|NCT02268396|531352352|FG000|Overall Study|Protocol-Specified Criteria|2|||
147323901|NCT02268396|531352352|FG000|Overall Study|2 Subjects no Day 29 Assessment|2|||
147323902|NCT01304706|531352353|FG000|Overall Study|Adverse Event|2|||
147323903|NCT01304706|531352353|FG000|Overall Study|Lack of Efficacy|1|||
147323904|NCT01304706|531352353|FG000|Overall Study|Death|3|||
147323905|NCT01304706|531352353|FG000|Overall Study|Withdrawal by Subject|3|||
147323906|NCT01304706|531352353|FG000|Overall Study|Lost to Follow-up|7|||
147323907|NCT01304706|531352353|FG000|Overall Study|Discontinued due to failed drug admin.|1|||
147323908|NCT04978363|531352359|FG000|Overall Study|Other medical issues unrelated to the study|0|||
147323909|NCT04978363|531352360|FG001|Overall Study|Other medical issues unrelated to the study|0|||
147323910|NCT04978363|531352361|FG002|Overall Study|Other medical issues unrelated to the study|0|||
147323911|NCT04978363|531352362|FG003|Overall Study|Other medical issues unrelated to the study|0|||
147323912|NCT04978363|531352363|FG004|Overall Study|Other medical issues unrelated to the study|1|||
147323913|NCT04978363|531352364|FG005|Overall Study|Other medical issues unrelated to the study|0|||
147323914|NCT04978363|531352365|FG006|Overall Study|Other medical issues unrelated to the study|0|||
147323915|NCT04978363|531352366|FG007|Overall Study|Other medical issues unrelated to the study|0|||
147323916|NCT04978363|531352367|FG008|Overall Study|Other medical issues unrelated to the study|0|||
147323917|NCT04978363|531352368|FG009|Overall Study|Other medical issues unrelated to the study|0|||
147323918|NCT04978363|531352369|FG010|Overall Study|Other medical issues unrelated to the study|0|||
147592098|NCT00493246|532324994|FG001|Overall Study|Withdrawal by Subject|0|||
147592099|NCT00493246|532324995|FG002|Overall Study|Withdrawal by Subject|0|||
147592100|NCT00493246|532324996|FG003|Overall Study|Withdrawal by Subject|0|||
147323919|NCT04978363|531352359|FG000|Overall Study|Unable to meet the necessary time commitment|0|||
147592101|NCT00493246|532324997|FG004|Overall Study|Withdrawal by Subject|1|||
147592102|NCT00493246|532324998|FG005|Overall Study|Withdrawal by Subject|0|||
147592103|NCT00493246|532324999|FG006|Overall Study|Withdrawal by Subject|0|||
147592104|NCT00493246|532325000|FG007|Overall Study|Withdrawal by Subject|0|||
147592105|NCT00493246|532324993|FG000|Overall Study|No access to draw blood|0|||
147592106|NCT00493246|532324994|FG001|Overall Study|No access to draw blood|0|||
147592107|NCT00493246|532324995|FG002|Overall Study|No access to draw blood|0|||
147592108|NCT00493246|532324996|FG003|Overall Study|No access to draw blood|0|||
147592109|NCT00493246|532324997|FG004|Overall Study|No access to draw blood|0|||
147592110|NCT00493246|532324998|FG005|Overall Study|No access to draw blood|1|||
147592111|NCT00493246|532324999|FG006|Overall Study|No access to draw blood|0|||
147592112|NCT00493246|532325000|FG007|Overall Study|No access to draw blood|0|||
147592113|NCT00493246|532324993|FG000|Overall Study|Lost to Follow-up|0|||
147592114|NCT00493246|532324994|FG001|Overall Study|Lost to Follow-up|0|||
147592115|NCT00493246|532324995|FG002|Overall Study|Lost to Follow-up|0|||
147592116|NCT00493246|532324996|FG003|Overall Study|Lost to Follow-up|0|||
147592117|NCT00493246|532324997|FG004|Overall Study|Lost to Follow-up|0|||
147592118|NCT00493246|532324998|FG005|Overall Study|Lost to Follow-up|0|||
147592119|NCT00493246|532324999|FG006|Overall Study|Lost to Follow-up|1|||
147171832|NCT00615030|530794282|FG002|Period III|Administrative problems|0|||
147171833|NCT00615030|530794283|FG003|Period III|Administrative problems|1|||
147171834|NCT00615030|530794284|FG004|Period III|Administrative problems|0|||
147171835|NCT00615030|530794285|FG005|Period III|Administrative problems|0|||
147171836|NCT00615030|530794286|FG006|Period III|Administrative problems|0|||
147171837|NCT00615030|530794287|FG007|Period III|Administrative problems|0|||
147323920|NCT04978363|531352360|FG001|Overall Study|Unable to meet the necessary time commitment|0|||
147448073|NCT00590590|531805632|FG002|Overall Study|Did not complete study|0|||
147592120|NCT00493246|532325000|FG007|Overall Study|Lost to Follow-up|0|||
147592121|NCT01207440|532325003|FG000|Overall Study|Adverse Event|46|||
147592122|NCT01207440|532325004|FG001|Overall Study|Adverse Event|11|||
147592123|NCT01207440|532325005|FG002|Overall Study|Adverse Event|7|||
147592124|NCT01207440|532325006|FG003|Overall Study|Adverse Event|2|||
147592125|NCT01207440|532325007|FG004|Overall Study|Adverse Event|6|||
147592126|NCT01207440|532325008|FG005|Overall Study|Adverse Event|6|||
147592127|NCT01207440|532325009|FG006|Overall Study|Adverse Event|2|||
147592128|NCT01207440|532325003|FG000|Overall Study|Death|6|||
147592129|NCT01207440|532325004|FG001|Overall Study|Death|3|||
147592130|NCT01207440|532325005|FG002|Overall Study|Death|2|||
147592131|NCT01207440|532325006|FG003|Overall Study|Death|2|||
147592132|NCT01207440|532325007|FG004|Overall Study|Death|7|||
147592133|NCT01207440|532325008|FG005|Overall Study|Death|5|||
147592134|NCT01207440|532325009|FG006|Overall Study|Death|1|||
147592135|NCT01207440|532325003|FG000|Overall Study|Lack of Efficacy|13|||
147592136|NCT01207440|532325004|FG001|Overall Study|Lack of Efficacy|2|||
147592137|NCT01207440|532325005|FG002|Overall Study|Lack of Efficacy|5|||
147592138|NCT01207440|532325006|FG003|Overall Study|Lack of Efficacy|1|||
147592139|NCT01207440|532325007|FG004|Overall Study|Lack of Efficacy|2|||
147592140|NCT01207440|532325008|FG005|Overall Study|Lack of Efficacy|3|||
147592141|NCT01207440|532325009|FG006|Overall Study|Lack of Efficacy|0|||
147171838|NCT00615030|530794288|FG008|Period III|Administrative problems|0|||
147171839|NCT00615030|530794289|FG009|Period III|Administrative problems|0|||
147171840|NCT00615030|530794290|FG010|Period III|Administrative problems|0|||
147171841|NCT00615030|530794291|FG011|Period III|Administrative problems|0|||
147171842|NCT01359943|530794292|FG000|Double-blind (Weeks 0 - 16)|Abnormal laboratory values|1|||
147171843|NCT01359943|530794293|FG001|Double-blind (Weeks 0 - 16)|Abnormal laboratory values|0|||
147171844|NCT01359943|530794294|FG002|Double-blind (Weeks 0 - 16)|Abnormal laboratory values|0|||
147171845|NCT01359943|530794292|FG000|Double-blind (Weeks 0 - 16)|Adverse Event|1|||
147171846|NCT01359943|530794293|FG001|Double-blind (Weeks 0 - 16)|Adverse Event|2|||
147171847|NCT01359943|530794294|FG002|Double-blind (Weeks 0 - 16)|Adverse Event|0|||
147171848|NCT01359943|530794292|FG000|Double-blind (Weeks 0 - 16)|Withdrawal by Subject|0|||
147171849|NCT01359943|530794293|FG001|Double-blind (Weeks 0 - 16)|Withdrawal by Subject|2|||
147171850|NCT01359943|530794294|FG002|Double-blind (Weeks 0 - 16)|Withdrawal by Subject|0|||
147171851|NCT01359943|530794292|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Administrative problems|1|||
147448074|NCT01870401|531805633|FG000|Overall Study|Death|48|||
147592142|NCT01207440|532325003|FG000|Overall Study|Lost to Follow-up|0|||
147592143|NCT01207440|532325004|FG001|Overall Study|Lost to Follow-up|0|||
147592144|NCT01207440|532325005|FG002|Overall Study|Lost to Follow-up|2|||
147592145|NCT01207440|532325006|FG003|Overall Study|Lost to Follow-up|1|||
147592146|NCT01207440|532325007|FG004|Overall Study|Lost to Follow-up|0|||
147592147|NCT01207440|532325008|FG005|Overall Study|Lost to Follow-up|0|||
147592148|NCT01207440|532325009|FG006|Overall Study|Lost to Follow-up|0|||
147592149|NCT01207440|532325003|FG000|Overall Study|Non-compliance with Study Drug|3|||
147592150|NCT01207440|532325004|FG001|Overall Study|Non-compliance with Study Drug|0|||
147592151|NCT01207440|532325005|FG002|Overall Study|Non-compliance with Study Drug|1|||
147592152|NCT01207440|532325006|FG003|Overall Study|Non-compliance with Study Drug|0|||
147592153|NCT01207440|532325007|FG004|Overall Study|Non-compliance with Study Drug|0|||
147592154|NCT01207440|532325008|FG005|Overall Study|Non-compliance with Study Drug|0|||
147592155|NCT01207440|532325009|FG006|Overall Study|Non-compliance with Study Drug|0|||
147592156|NCT01207440|532325003|FG000|Overall Study|Physician Decision|6|||
147592157|NCT01207440|532325004|FG001|Overall Study|Physician Decision|5|||
147592158|NCT01207440|532325005|FG002|Overall Study|Physician Decision|5|||
147592159|NCT01207440|532325006|FG003|Overall Study|Physician Decision|0|||
147592160|NCT01207440|532325007|FG004|Overall Study|Physician Decision|1|||
147592161|NCT01207440|532325008|FG005|Overall Study|Physician Decision|0|||
147592162|NCT01207440|532325009|FG006|Overall Study|Physician Decision|0|||
147592163|NCT01207440|532325003|FG000|Overall Study|Progressive Disease|19|||
147592164|NCT01207440|532325004|FG001|Overall Study|Progressive Disease|10|||
147592165|NCT01207440|532325005|FG002|Overall Study|Progressive Disease|19|||
147592166|NCT01207440|532325006|FG003|Overall Study|Progressive Disease|7|||
147592167|NCT01207440|532325007|FG004|Overall Study|Progressive Disease|23|||
147592168|NCT01207440|532325008|FG005|Overall Study|Progressive Disease|27|||
147592169|NCT01207440|532325009|FG006|Overall Study|Progressive Disease|0|||
147592170|NCT01207440|532325003|FG000|Overall Study|Protocol Violation|2|||
147592171|NCT01207440|532325004|FG001|Overall Study|Protocol Violation|0|||
147592172|NCT01207440|532325005|FG002|Overall Study|Protocol Violation|0|||
147592173|NCT01207440|532325006|FG003|Overall Study|Protocol Violation|0|||
147592174|NCT01207440|532325007|FG004|Overall Study|Protocol Violation|0|||
147592175|NCT01207440|532325008|FG005|Overall Study|Protocol Violation|0|||
147592176|NCT01207440|532325009|FG006|Overall Study|Protocol Violation|0|||
147592177|NCT01207440|532325003|FG000|Overall Study|Site Terminated by Sponsor|69|||
147592178|NCT01207440|532325004|FG001|Overall Study|Site Terminated by Sponsor|19|||
147592179|NCT01207440|532325005|FG002|Overall Study|Site Terminated by Sponsor|12|||
147592180|NCT01207440|532325006|FG003|Overall Study|Site Terminated by Sponsor|2|||
147655347|NCT02171429|532561524|FG001|Overall Study|Lost to Follow-up|1|||
147171852|NCT01359943|530794293|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Administrative problems|0|||
147244366|NCT00317356|531066984|FG001|Overall Study|Lack of Efficacy|1|||
147171853|NCT01359943|530794294|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Administrative problems|0|||
147592181|NCT01207440|532325007|FG004|Overall Study|Site Terminated by Sponsor|3|||
147592182|NCT01207440|532325008|FG005|Overall Study|Site Terminated by Sponsor|0|||
147592183|NCT01207440|532325009|FG006|Overall Study|Site Terminated by Sponsor|2|||
147592184|NCT01207440|532325003|FG000|Overall Study|Withdrawal by Subject|29|||
147592185|NCT01207440|532325004|FG001|Overall Study|Withdrawal by Subject|4|||
147448075|NCT01870401|531805634|FG001|Overall Study|Death|24|||
147448076|NCT01870401|531805633|FG000|Overall Study|Withdrawal by Subject|39|||
147448077|NCT01870401|531805634|FG001|Overall Study|Withdrawal by Subject|26|||
147448078|NCT01870401|531805633|FG000|Overall Study|Lost to Follow-up|19|||
147448079|NCT01870401|531805634|FG001|Overall Study|Lost to Follow-up|14|||
147592186|NCT01207440|532325005|FG002|Overall Study|Withdrawal by Subject|5|||
147592187|NCT01207440|532325006|FG003|Overall Study|Withdrawal by Subject|3|||
147592188|NCT01207440|532325007|FG004|Overall Study|Withdrawal by Subject|2|||
147592189|NCT01207440|532325008|FG005|Overall Study|Withdrawal by Subject|2|||
147592190|NCT01207440|532325009|FG006|Overall Study|Withdrawal by Subject|0|||
147592191|NCT01207440|532325003|FG000|Overall Study|Reason Not Specified|10|||
147592192|NCT01207440|532325004|FG001|Overall Study|Reason Not Specified|10|||
147171854|NCT01359943|530794292|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Withdrawal by Subject|1|||
147171855|NCT01359943|530794293|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Withdrawal by Subject|3|||
147171856|NCT01359943|530794294|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Withdrawal by Subject|4|||
147171857|NCT01359943|530794292|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Protocol deviation|0|||
147171858|NCT01359943|530794293|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Protocol deviation|1|||
147592193|NCT01207440|532325005|FG002|Overall Study|Reason Not Specified|7|||
147592194|NCT01207440|532325006|FG003|Overall Study|Reason Not Specified|0|||
147592195|NCT01207440|532325007|FG004|Overall Study|Reason Not Specified|4|||
147592196|NCT01207440|532325008|FG005|Overall Study|Reason Not Specified|3|||
147592197|NCT01207440|532325009|FG006|Overall Study|Reason Not Specified|0|||
147592198|NCT03341000|532325010|FG000|Overall Study|Adverse Event|1|||
147592199|NCT01592721|532325011|FG000|Long-term Follow-up|Death|1|||
147592200|NCT00380692|532325015|FG000|Study Period II - Double Blind|Adverse Event|1|||
147592201|NCT00380692|532325016|FG001|Study Period II - Double Blind|Adverse Event|0|||
147592202|NCT00380692|532325015|FG000|Study Period II - Double Blind|Protocol Violation|2|||
147592203|NCT00380692|532325016|FG001|Study Period II - Double Blind|Protocol Violation|2|||
147592204|NCT00380692|532325015|FG000|Study Period II - Double Blind|Withdrawal by Subject|0|||
147592205|NCT00380692|532325016|FG001|Study Period II - Double Blind|Withdrawal by Subject|0|||
147592206|NCT00380692|532325015|FG000|Study Period II - Double Blind|Physician Decision|0|||
147592207|NCT00380692|532325016|FG001|Study Period II - Double Blind|Physician Decision|1|||
147592208|NCT00380692|532325015|FG000|Study Period II - Double Blind|Lack of Efficacy|1|||
147592209|NCT00380692|532325016|FG001|Study Period II - Double Blind|Lack of Efficacy|0|||
147592210|NCT00380692|532325015|FG000|Study Period II - Double Blind|Parent/Caregiver Decision|1|||
147592211|NCT00380692|532325016|FG001|Study Period II - Double Blind|Parent/Caregiver Decision|0|||
147592212|NCT00380692|532325015|FG000|Study Period III - Open Label|Adverse Event|5|||
147592213|NCT00380692|532325016|FG001|Study Period III - Open Label|Adverse Event|3|||
147592214|NCT00380692|532325015|FG000|Study Period III - Open Label|Protocol Violation|0|||
147592215|NCT00380692|532325016|FG001|Study Period III - Open Label|Protocol Violation|0|||
147592216|NCT00380692|532325015|FG000|Study Period III - Open Label|Withdrawal by Subject|0|||
147592217|NCT00380692|532325016|FG001|Study Period III - Open Label|Withdrawal by Subject|1|||
147592218|NCT00380692|532325015|FG000|Study Period III - Open Label|Physician Decision|0|||
147592219|NCT00380692|532325016|FG001|Study Period III - Open Label|Physician Decision|3|||
147655348|NCT02171429|532561525|FG002|Overall Study|Lost to Follow-up|0|||
147244367|NCT00317356|531066985|FG002|Overall Study|Lack of Efficacy|0|||
147244368|NCT00317356|531066986|FG003|Overall Study|Lack of Efficacy|3|||
147244369|NCT00317356|531066983|FG000|Overall Study|Physician Decision|0|||
147244370|NCT00317356|531066984|FG001|Overall Study|Physician Decision|1|||
147244371|NCT00317356|531066985|FG002|Overall Study|Physician Decision|0|||
147244372|NCT00317356|531066986|FG003|Overall Study|Physician Decision|0|||
147244373|NCT03199274|531066987|FG000|Overall Study|Withdrawal by Subject|4|||
147244374|NCT03199274|531066988|FG001|Overall Study|Withdrawal by Subject|0|||
147244375|NCT03199274|531066987|FG000|Overall Study|Lost to Follow-up|0|||
147244376|NCT03199274|531066988|FG001|Overall Study|Lost to Follow-up|1|||
147244377|NCT03199274|531066987|FG000|Overall Study|Deemed screen fail because he had no arteries to access during flow study|0|||
147244378|NCT03199274|531066988|FG001|Overall Study|Deemed screen fail because he had no arteries to access during flow study|1|||
147244379|NCT05980182|531066989|FG000|Overall Study|Lost to Follow-up|10|||
147244380|NCT00638378|531068888|FG000|Overall Study|Death|2|||
147244381|NCT00638378|531068888|FG000|Overall Study|Adverse Event|1|||
147244382|NCT00638378|531068888|FG000|Overall Study|Disease progression|15|||
147244383|NCT00638378|531068888|FG000|Overall Study|Physician Decision|4|||
147244384|NCT03761277|531068896|FG000|Enrollment to Implant|Screen Failure|17|||
147244385|NCT03761277|531068896|FG000|Enrollment to Implant|Withdrawal by Subject|17|||
147244386|NCT03761277|531068896|FG000|Enrollment to Implant|Physician Decision|2|||
147244387|NCT03761277|531068896|FG000|Enrollment to Implant|Site Closure|3|||
147244388|NCT03761277|531068896|FG000|Enrollment to Implant|Sponsor Request|2|||
147244389|NCT03761277|531068896|FG000|Post-Implant to 6 Months|Adverse Event|2|||
147244390|NCT03761277|531068896|FG000|Post-Implant to 6 Months|Death|1|||
147244391|NCT03761277|531068896|FG000|Post-Implant to 6 Months|Site Closure|2|||
147244392|NCT03761277|531068896|FG000|6 Months to 12 Months|Completed Study under Protocol v3|25|||
147244393|NCT03761277|531068896|FG000|6 Months to 12 Months|Physician Decision|2|||
147592220|NCT00380692|532325015|FG000|Study Period III - Open Label|Lack of Efficacy|0|||
147592221|NCT00380692|532325016|FG001|Study Period III - Open Label|Lack of Efficacy|4|||
147592222|NCT00380692|532325015|FG000|Study Period III - Open Label|Parent/Caregiver Decision|1|||
147592223|NCT00380692|532325016|FG001|Study Period III - Open Label|Parent/Caregiver Decision|1|||
147592224|NCT02698865|532325019|FG000|Overall Study|Other|11|||
147592225|NCT02698865|532325020|FG001|Overall Study|Other|11|||
147592226|NCT02698865|532325019|FG000|Overall Study|Withdrawal by Subject|20|||
147592227|NCT02698865|532325020|FG001|Overall Study|Withdrawal by Subject|16|||
147592228|NCT02698865|532325019|FG000|Overall Study|Physician Decision|0|||
147592229|NCT02698865|532325020|FG001|Overall Study|Physician Decision|4|||
147592230|NCT02698865|532325019|FG000|Overall Study|Lost to Follow-up|4|||
147592231|NCT02698865|532325020|FG001|Overall Study|Lost to Follow-up|2|||
147592232|NCT03861481|532325021|FG000|Overall Study|COVID-19 pandemic circumstances|0|||
147592233|NCT03861481|532325022|FG001|Overall Study|COVID-19 pandemic circumstances|1|||
147592234|NCT03861481|532325021|FG000|Overall Study|Participant not plan to participate in the study CIDP04|1|||
147592235|NCT03861481|532325022|FG001|Overall Study|Participant not plan to participate in the study CIDP04|0|||
147592236|NCT03861481|532325021|FG000|Overall Study|Relapse|1|||
147592237|NCT03861481|532325022|FG001|Overall Study|Relapse|0|||
147592238|NCT03861481|532325021|FG000|Overall Study|Withdrawal by Subject|0|||
147592239|NCT03861481|532325022|FG001|Overall Study|Withdrawal by Subject|1|||
147592240|NCT03861481|532325021|FG000|Overall Study|Lack of Efficacy|4|||
147592241|NCT03861481|532325022|FG001|Overall Study|Lack of Efficacy|5|||
147592242|NCT00773734|532325023|FG000|Core: Placebo Controlled Phase Week 0-16|Adverse Event|5|||
147592243|NCT00773734|532325024|FG001|Core: Placebo Controlled Phase Week 0-16|Adverse Event|1|||
147592244|NCT00773734|532325025|FG002|Core: Placebo Controlled Phase Week 0-16|Adverse Event|8|||
147592245|NCT00773734|532325026|FG003|Core: Placebo Controlled Phase Week 0-16|Adverse Event|10|||
147592246|NCT00773734|532325027|FG004|Core: Placebo Controlled Phase Week 0-16|Adverse Event|0|||
147592247|NCT00773734|532325028|FG005|Core: Placebo Controlled Phase Week 0-16|Adverse Event|0|||
147592248|NCT00773734|532325023|FG000|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|4|||
147592249|NCT00773734|532325024|FG001|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|3|||
147592250|NCT00773734|532325025|FG002|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|2|||
147592251|NCT00773734|532325026|FG003|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|2|||
147592252|NCT00773734|532325027|FG004|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|0|||
147592253|NCT00773734|532325028|FG005|Core: Placebo Controlled Phase Week 0-16|Lack of Efficacy|0|||
147592254|NCT00773734|532325023|FG000|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|2|||
147592255|NCT00773734|532325024|FG001|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|2|||
147592256|NCT00773734|532325025|FG002|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|6|||
147592257|NCT00773734|532325026|FG003|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|4|||
147592258|NCT00773734|532325027|FG004|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|0|||
147592259|NCT00773734|532325028|FG005|Core: Placebo Controlled Phase Week 0-16|Withdrawal by Subject|0|||
147592260|NCT00773734|532325023|FG000|Core: Placebo Controlled Phase Week 0-16|Death|1|||
147592261|NCT00773734|532325024|FG001|Core: Placebo Controlled Phase Week 0-16|Death|0|||
147592262|NCT00773734|532325025|FG002|Core: Placebo Controlled Phase Week 0-16|Death|0|||
147592263|NCT00773734|532325026|FG003|Core: Placebo Controlled Phase Week 0-16|Death|0|||
147592264|NCT00773734|532325027|FG004|Core: Placebo Controlled Phase Week 0-16|Death|0|||
147592265|NCT00773734|532325028|FG005|Core: Placebo Controlled Phase Week 0-16|Death|0|||
147592266|NCT00773734|532325023|FG000|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|2|||
147592267|NCT00773734|532325024|FG001|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0|||
147592268|NCT00773734|532325025|FG002|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0|||
147592269|NCT00773734|532325026|FG003|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|1|||
147592270|NCT00773734|532325027|FG004|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0|||
147592271|NCT00773734|532325028|FG005|Core: Placebo Controlled Phase Week 0-16|Lost to Follow-up|0|||
147592272|NCT00773734|532325023|FG000|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|1|||
147592273|NCT00773734|532325024|FG001|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|3|||
147592274|NCT00773734|532325025|FG002|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|4|||
147592275|NCT00773734|532325026|FG003|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|0|||
147592276|NCT00773734|532325027|FG004|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|0|||
147592277|NCT00773734|532325028|FG005|Core: Placebo Controlled Phase Week 0-16|Protocol Violation|0|||
147592278|NCT00773734|532325023|FG000|Core: Placebo Controlled Phase Week 0-16|Other|1|||
147592279|NCT00773734|532325024|FG001|Core: Placebo Controlled Phase Week 0-16|Other|1|||
147592280|NCT00773734|532325025|FG002|Core: Placebo Controlled Phase Week 0-16|Other|1|||
147655349|NCT02171429|532561523|FG000|Overall Study|Death|0|||
147171859|NCT01359943|530794294|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Protocol deviation|0|||
147171860|NCT01359943|530794292|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Lack of Efficacy|3|||
147171861|NCT01359943|530794293|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Lack of Efficacy|3|||
147171862|NCT01359943|530794294|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Lack of Efficacy|3|||
147171863|NCT01359943|530794292|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Abnormal laboratory values|0|||
147448080|NCT01870401|531805633|FG000|Overall Study|Other|9|||
147171864|NCT01359943|530794293|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Abnormal laboratory values|1|||
147171865|NCT01359943|530794294|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Abnormal laboratory values|0|||
147171866|NCT01359943|530794292|FG000|Open Label 150 mg s.c. (Weeks 16 - 52)|Adverse Event|3|||
147171867|NCT01359943|530794293|FG001|Open Label 150 mg s.c. (Weeks 16 - 52)|Adverse Event|5|||
147171868|NCT01359943|530794294|FG002|Open Label 150 mg s.c. (Weeks 16 - 52)|Adverse Event|1|||
147171869|NCT01359943|530794292|FG000|Follow-up (Weeks 52 - 60)|Withdrawal by Subject|1|||
147171870|NCT01359943|530794293|FG001|Follow-up (Weeks 52 - 60)|Withdrawal by Subject|5|||
147171871|NCT01359943|530794294|FG002|Follow-up (Weeks 52 - 60)|Withdrawal by Subject|4|||
147171872|NCT01359943|530794292|FG000|Follow-up (Weeks 52 - 60)|Administrative problems|1|||
147171873|NCT01359943|530794293|FG001|Follow-up (Weeks 52 - 60)|Administrative problems|0|||
147171874|NCT01359943|530794294|FG002|Follow-up (Weeks 52 - 60)|Administrative problems|0|||
147171875|NCT01359943|530794292|FG000|Follow-up (Weeks 52 - 60)|Protocol deviation|0|||
147171876|NCT01359943|530794293|FG001|Follow-up (Weeks 52 - 60)|Protocol deviation|1|||
147171877|NCT01359943|530794294|FG002|Follow-up (Weeks 52 - 60)|Protocol deviation|0|||
147171878|NCT01359943|530794292|FG000|Follow-up (Weeks 52 - 60)|Lack of Efficacy|3|||
147171879|NCT01359943|530794293|FG001|Follow-up (Weeks 52 - 60)|Lack of Efficacy|3|||
147171880|NCT01359943|530794294|FG002|Follow-up (Weeks 52 - 60)|Lack of Efficacy|3|||
147171881|NCT01359943|530794292|FG000|Follow-up (Weeks 52 - 60)|Abnormal laboratory value|0|||
147171882|NCT01359943|530794293|FG001|Follow-up (Weeks 52 - 60)|Abnormal laboratory value|1|||
147171883|NCT01359943|530794294|FG002|Follow-up (Weeks 52 - 60)|Abnormal laboratory value|0|||
147655350|NCT02171429|532561524|FG001|Overall Study|Death|0|||
147655351|NCT02171429|532561525|FG002|Overall Study|Death|1|||
147655352|NCT01724177|532561530|FG000|Overall Study|Adverse Event|8|||
147655353|NCT01724177|532561530|FG000|Overall Study|Progressive disease or Relapsed Disease|16|||
147655354|NCT01724177|532561530|FG000|Overall Study|Nervous participant|1|||
147655355|NCT01724177|532561530|FG000|Overall Study|Serious Adverse Event Related|1|||
147655356|NCT02821416|532561535|FG000|Overall Study|Adverse Event|0|||
147655357|NCT02821416|532561536|FG001|Overall Study|Adverse Event|1|||
147655358|NCT02821416|532561535|FG000|Overall Study|Withdrawal by Subject|2|||
147655359|NCT02821416|532561536|FG001|Overall Study|Withdrawal by Subject|0|||
147655360|NCT02821416|532561535|FG000|Overall Study|Lost to Follow-up|1|||
147655361|NCT02821416|532561536|FG001|Overall Study|Lost to Follow-up|0|||
147655362|NCT02256917|532561537|FG000|Prophylactic Treatment Phase I|Lost to Follow-up|1|||
147655363|NCT02256917|532561537|FG000|Prophylactic Treatment Phase II|Lost to Follow-up|1|||
147655364|NCT02256917|532561537|FG000|Prophylactic Treatment Phase II|Withdrawn Consent|1|||
147592281|NCT00773734|532325026|FG003|Core: Placebo Controlled Phase Week 0-16|Other|1|||
147592282|NCT00773734|532325027|FG004|Core: Placebo Controlled Phase Week 0-16|Other|0|||
147592283|NCT00773734|532325028|FG005|Core: Placebo Controlled Phase Week 0-16|Other|0|||
147592284|NCT00773734|532325023|FG000|Core: Active Treatment Phase Week 16-24|Adverse Event|0|||
147592285|NCT00773734|532325024|FG001|Core: Active Treatment Phase Week 16-24|Adverse Event|4|||
147592286|NCT00773734|532325025|FG002|Core: Active Treatment Phase Week 16-24|Adverse Event|0|||
147592287|NCT00773734|532325026|FG003|Core: Active Treatment Phase Week 16-24|Adverse Event|0|||
147592288|NCT00773734|532325027|FG004|Core: Active Treatment Phase Week 16-24|Adverse Event|1|||
147592289|NCT00773734|532325028|FG005|Core: Active Treatment Phase Week 16-24|Adverse Event|2|||
147592290|NCT00773734|532325023|FG000|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|0|||
147592291|NCT00773734|532325024|FG001|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|4|||
147592292|NCT00773734|532325025|FG002|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|4|||
147592293|NCT00773734|532325026|FG003|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|1|||
147592294|NCT00773734|532325027|FG004|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|0|||
147592295|NCT00773734|532325028|FG005|Core: Active Treatment Phase Week 16-24|Lack of Efficacy|0|||
147592296|NCT00773734|532325023|FG000|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|0|||
147592297|NCT00773734|532325024|FG001|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|1|||
147592298|NCT00773734|532325025|FG002|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|1|||
147592299|NCT00773734|532325026|FG003|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|0|||
147592300|NCT00773734|532325027|FG004|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|0|||
147655365|NCT02256917|532561537|FG000|Prophylactic Treatment Phase II|Did not attend completion visit|1|||
147655366|NCT02256917|532561537|FG000|Prophylactic Treatment Phase II|Discontinued medication|1|||
147655367|NCT00540644|532561538|FG000|Overall Study|Adverse Event|3|||
147655368|NCT00540644|532561539|FG001|Overall Study|Adverse Event|1|||
147171884|NCT01359943|530794292|FG000|Follow-up (Weeks 52 - 60)|Adverse Event|3|||
147171885|NCT01359943|530794293|FG001|Follow-up (Weeks 52 - 60)|Adverse Event|5|||
147171886|NCT01359943|530794294|FG002|Follow-up (Weeks 52 - 60)|Adverse Event|1|||
147171887|NCT03002311|530794299|FG000|Overall Study|Lost to Follow-up|13|||
147655369|NCT00540644|532561538|FG000|Overall Study|Disease Progression|3|||
147323921|NCT04978363|531352361|FG002|Overall Study|Unable to meet the necessary time commitment|1|||
147655370|NCT00540644|532561539|FG001|Overall Study|Disease Progression|1|||
147655371|NCT00540644|532561538|FG000|Overall Study|Physician Decision|0|||
147171888|NCT03002311|530794300|FG001|Overall Study|Lost to Follow-up|26|||
147171889|NCT03002311|530794299|FG000|Overall Study|Referral provider called to schedule app|3|||
147655372|NCT00540644|532561539|FG001|Overall Study|Physician Decision|5|||
147171890|NCT03002311|530794300|FG001|Overall Study|Referral provider called to schedule app|3|||
147171891|NCT03002311|530794299|FG000|Overall Study|Physician Decision|3|||
147171892|NCT03002311|530794300|FG001|Overall Study|Physician Decision|1|||
147171893|NCT00308074|530794301|FG000|Overall Study|Withdrawal by Subject|1|||
147171894|NCT03722524|530794305|FG000|Overall Study|Protocol Violation|86|||
147171895|NCT03722524|530794305|FG000|Overall Study|Adverse Event|7|||
147171896|NCT03722524|530794305|FG000|Overall Study|Lost to Follow-up|1|||
147171897|NCT03722524|530794305|FG000|Overall Study|Reason is not stated|1|||
147171898|NCT03722524|530794305|FG000|Overall Study|Physician Decision|1|||
147171899|NCT03722524|530794305|FG000|Overall Study|Patient's decision (refusal to continue participation)|3|||
147171900|NCT02649894|530794307|FG000|Overall Study|Adverse Event|1|||
147171901|NCT02649894|530794308|FG001|Overall Study|Adverse Event|0|||
147171902|NCT02649894|530794307|FG000|Overall Study|Physician Decision|0|||
147171903|NCT02649894|530794308|FG001|Overall Study|Physician Decision|1|||
147171904|NCT02649894|530794307|FG000|Overall Study|Withdrawal by Subject|5|||
147171905|NCT02649894|530794308|FG001|Overall Study|Withdrawal by Subject|2|||
147171906|NCT02649894|530794307|FG000|Overall Study|Lost to Follow-up|2|||
147171907|NCT02649894|530794308|FG001|Overall Study|Lost to Follow-up|1|||
147171908|NCT02649894|530794307|FG000|Overall Study|Death|30|||
147171909|NCT02649894|530794308|FG001|Overall Study|Death|7|||
147171910|NCT02649894|530794307|FG000|Overall Study|Other, not specified|6|||
147171911|NCT02649894|530794308|FG001|Overall Study|Other, not specified|0|||
147171912|NCT00719680|530794309|FG000|Overall Study|Adverse Event|1|||
147171913|NCT00719680|530794309|FG000|Overall Study|Lost to Follow-up|1|||
147171914|NCT00719680|530794309|FG000|Overall Study|Withdrawal by Subject|3|||
147171915|NCT02911142|530794310|FG000|Phase I - Safety & Tolerability|Did not complete last cycle of EPOCH-R2 due to progressive disease.|1|||
147171916|NCT02911142|530794310|FG000|Phase II - Recommended Phase 2 Dose|Refused further treatment|1|||
147171917|NCT02911142|530794310|FG000|Phase II - Recommended Phase 2 Dose|Physician Decision|2|||
147171918|NCT02911142|530794310|FG000|Phase II - Recommended Phase 2 Dose|Death|1|||
147171919|NCT01286740|530794311|FG000|Overall Study|Enrolled but not treated|1|||
147171920|NCT01286740|530794311|FG000|Overall Study|Protocol Violation|1|||
147592301|NCT00773734|532325028|FG005|Core: Active Treatment Phase Week 16-24|Withdrawal by Subject|2|||
147592302|NCT00773734|532325023|FG000|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0|||
147592303|NCT00773734|532325024|FG001|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|1|||
147592304|NCT00773734|532325025|FG002|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|1|||
147592305|NCT00773734|532325026|FG003|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0|||
147592306|NCT00773734|532325027|FG004|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0|||
147592307|NCT00773734|532325028|FG005|Core: Active Treatment Phase Week 16-24|Lost to Follow-up|0|||
147592308|NCT00773734|532325023|FG000|Core: Active Treatment Phase Week 16-24|Protocol Violation|0|||
147592309|NCT00773734|532325024|FG001|Core: Active Treatment Phase Week 16-24|Protocol Violation|1|||
147592310|NCT00773734|532325025|FG002|Core: Active Treatment Phase Week 16-24|Protocol Violation|1|||
147592311|NCT00773734|532325026|FG003|Core: Active Treatment Phase Week 16-24|Protocol Violation|1|||
147592312|NCT00773734|532325027|FG004|Core: Active Treatment Phase Week 16-24|Protocol Violation|0|||
147592313|NCT00773734|532325028|FG005|Core: Active Treatment Phase Week 16-24|Protocol Violation|1|||
147592314|NCT00773734|532325023|FG000|Core: Active Treatment Phase Week 16-24|Other|0|||
147592315|NCT00773734|532325024|FG001|Core: Active Treatment Phase Week 16-24|Other|1|||
147592316|NCT00773734|532325025|FG002|Core: Active Treatment Phase Week 16-24|Other|0|||
147592317|NCT00773734|532325026|FG003|Core: Active Treatment Phase Week 16-24|Other|0|||
147592318|NCT00773734|532325027|FG004|Core: Active Treatment Phase Week 16-24|Other|0|||
147592319|NCT00773734|532325028|FG005|Core: Active Treatment Phase Week 16-24|Other|0|||
147592320|NCT00773734|532325023|FG000|Extension: Active Treatment Week 24-52|Adverse Event|0|||
147592321|NCT00773734|532325024|FG001|Extension: Active Treatment Week 24-52|Adverse Event|0|||
147592322|NCT00773734|532325025|FG002|Extension: Active Treatment Week 24-52|Adverse Event|0|||
147592323|NCT00773734|532325026|FG003|Extension: Active Treatment Week 24-52|Adverse Event|0|||
147592324|NCT00773734|532325027|FG004|Extension: Active Treatment Week 24-52|Adverse Event|2|||
147592325|NCT00773734|532325028|FG005|Extension: Active Treatment Week 24-52|Adverse Event|1|||
147592326|NCT00773734|532325023|FG000|Extension: Active Treatment Week 24-52|Lack of Efficacy|0|||
147592327|NCT00773734|532325024|FG001|Extension: Active Treatment Week 24-52|Lack of Efficacy|8|||
147592328|NCT00773734|532325025|FG002|Extension: Active Treatment Week 24-52|Lack of Efficacy|10|||
147171921|NCT03266172|530794312|FG000|Part A: Period 1(2 Days)|Withdrawal by Subject|1|||
147171922|NCT03266172|530794313|FG001|Part A: Period 1(2 Days)|Withdrawal by Subject|0|||
147592329|NCT00773734|532325026|FG003|Extension: Active Treatment Week 24-52|Lack of Efficacy|3|||
147171923|NCT03266172|530794314|FG002|Part A: Period 1(2 Days)|Withdrawal by Subject|0|||
147171924|NCT03266172|530794312|FG000|Part A: Washout Period (7 Days)|Adverse Event|1|||
147171925|NCT03266172|530794313|FG001|Part A: Washout Period (7 Days)|Adverse Event|0|||
147171926|NCT03266172|530794314|FG002|Part A: Washout Period (7 Days)|Adverse Event|0|||
147171927|NCT03266172|530794312|FG000|Part A: Washout Period (7 Days)|Withdrawal by Subject|1|||
147171928|NCT03266172|530794313|FG001|Part A: Washout Period (7 Days)|Withdrawal by Subject|0|||
147171929|NCT03266172|530794314|FG002|Part A: Washout Period (7 Days)|Withdrawal by Subject|0|||
147171930|NCT03266172|530794312|FG000|Part B: Washout (7 Days)|Withdrawal by Subject|0|||
147171931|NCT03266172|530794313|FG001|Part B: Washout (7 Days)|Withdrawal by Subject|2|||
147171932|NCT03266172|530794314|FG002|Part B: Washout (7 Days)|Withdrawal by Subject|0|||
147171933|NCT03266172|530794312|FG000|Part C Washout Period (7 Days)|Withdrawal by Subject|0|||
147171934|NCT03266172|530794313|FG001|Part C Washout Period (7 Days)|Withdrawal by Subject|0|||
147171935|NCT03266172|530794314|FG002|Part C Washout Period (7 Days)|Withdrawal by Subject|1|||
147171936|NCT03266172|530794312|FG000|Part C Washout Period (7 Days)|Withdrawal by Subject|0|||
147171937|NCT03266172|530794313|FG001|Part C Washout Period (7 Days)|Withdrawal by Subject|0|||
147171938|NCT03266172|530794314|FG002|Part C Washout Period (7 Days)|Withdrawal by Subject|1|||
147171939|NCT04856904|530794318|FG000|Overall Study|Physician Decision|1|||
147171940|NCT04856904|530794319|FG001|Overall Study|Physician Decision|1|||
147171941|NCT04856904|530794318|FG000|Overall Study|Withdrawal by Subject|13|||
147171942|NCT04856904|530794319|FG001|Overall Study|Withdrawal by Subject|13|||
147171943|NCT04856904|530794318|FG000|Overall Study|Adverse Event|1|||
147171944|NCT04856904|530794319|FG001|Overall Study|Adverse Event|1|||
147171945|NCT04856904|530794318|FG000|Overall Study|Non-compliance with study drug|1|||
147171946|NCT04856904|530794319|FG001|Overall Study|Non-compliance with study drug|1|||
147171947|NCT04856904|530794318|FG000|Overall Study|Lost to Follow-up|4|||
147171948|NCT04856904|530794319|FG001|Overall Study|Lost to Follow-up|4|||
147171949|NCT04856904|530794318|FG000|Overall Study|Withdrawal by Subject|1|||
147171950|NCT04856904|530794319|FG001|Overall Study|Withdrawal by Subject|1|||
147592330|NCT00773734|532325027|FG004|Extension: Active Treatment Week 24-52|Lack of Efficacy|1|||
147592331|NCT00773734|532325028|FG005|Extension: Active Treatment Week 24-52|Lack of Efficacy|2|||
147592332|NCT00773734|532325023|FG000|Extension: Active Treatment Week 24-52|Withdrawal by Subject|0|||
147592333|NCT00773734|532325024|FG001|Extension: Active Treatment Week 24-52|Withdrawal by Subject|3|||
147592334|NCT00773734|532325025|FG002|Extension: Active Treatment Week 24-52|Withdrawal by Subject|1|||
147592335|NCT00773734|532325026|FG003|Extension: Active Treatment Week 24-52|Withdrawal by Subject|2|||
147592336|NCT00773734|532325027|FG004|Extension: Active Treatment Week 24-52|Withdrawal by Subject|2|||
147592337|NCT00773734|532325028|FG005|Extension: Active Treatment Week 24-52|Withdrawal by Subject|3|||
147592338|NCT00773734|532325023|FG000|Extension: Active Treatment Week 24-52|Lost to Follow-up|0|||
147171951|NCT04856904|530794318|FG000|Overall Study|Protocol Violation|1|||
147323922|NCT04978363|531352362|FG003|Overall Study|Unable to meet the necessary time commitment|0|||
147592339|NCT00773734|532325024|FG001|Extension: Active Treatment Week 24-52|Lost to Follow-up|2|||
147592340|NCT00773734|532325025|FG002|Extension: Active Treatment Week 24-52|Lost to Follow-up|5|||
147592341|NCT00773734|532325026|FG003|Extension: Active Treatment Week 24-52|Lost to Follow-up|3|||
147592342|NCT00773734|532325027|FG004|Extension: Active Treatment Week 24-52|Lost to Follow-up|0|||
147592343|NCT00773734|532325028|FG005|Extension: Active Treatment Week 24-52|Lost to Follow-up|1|||
147592344|NCT00773734|532325023|FG000|Extension: Active Treatment Week 24-52|Other|0|||
147592345|NCT00773734|532325024|FG001|Extension: Active Treatment Week 24-52|Other|0|||
147592346|NCT00773734|532325025|FG002|Extension: Active Treatment Week 24-52|Other|1|||
147592347|NCT00773734|532325026|FG003|Extension: Active Treatment Week 24-52|Other|2|||
147592348|NCT00773734|532325027|FG004|Extension: Active Treatment Week 24-52|Other|0|||
147592349|NCT00773734|532325028|FG005|Extension: Active Treatment Week 24-52|Other|1|||
147592350|NCT00773734|532325023|FG000|LTE Period: Week 52 to 6 Years|Adverse Event|0|||
147592351|NCT00773734|532325024|FG001|LTE Period: Week 52 to 6 Years|Adverse Event|0|||
147592352|NCT00773734|532325025|FG002|LTE Period: Week 52 to 6 Years|Adverse Event|0|||
147592353|NCT00773734|532325026|FG003|LTE Period: Week 52 to 6 Years|Adverse Event|1|||
147592354|NCT00773734|532325027|FG004|LTE Period: Week 52 to 6 Years|Adverse Event|0|||
147592355|NCT00773734|532325028|FG005|LTE Period: Week 52 to 6 Years|Adverse Event|0|||
147592356|NCT00773734|532325023|FG000|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0|||
147592357|NCT00773734|532325024|FG001|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0|||
147592358|NCT00773734|532325025|FG002|LTE Period: Week 52 to 6 Years|Lack of Efficacy|2|||
147592359|NCT00773734|532325026|FG003|LTE Period: Week 52 to 6 Years|Lack of Efficacy|4|||
147592360|NCT00773734|532325027|FG004|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0|||
147655373|NCT00540644|532561538|FG000|Overall Study|Withdrawal by Subject|2|||
147655374|NCT00540644|532561539|FG001|Overall Study|Withdrawal by Subject|2|||
147655375|NCT00540644|532561538|FG000|Overall Study|Noncomplilance|1|||
147323923|NCT04978363|531352363|FG004|Overall Study|Unable to meet the necessary time commitment|0|||
147323924|NCT04978363|531352364|FG005|Overall Study|Unable to meet the necessary time commitment|0|||
147323925|NCT04978363|531352365|FG006|Overall Study|Unable to meet the necessary time commitment|0|||
147323926|NCT04978363|531352366|FG007|Overall Study|Unable to meet the necessary time commitment|0|||
147323927|NCT04978363|531352367|FG008|Overall Study|Unable to meet the necessary time commitment|0|||
147323928|NCT04978363|531352368|FG009|Overall Study|Unable to meet the necessary time commitment|0|||
147655376|NCT00540644|532561539|FG001|Overall Study|Noncomplilance|0|||
147655377|NCT01869777|532561540|FG000|Overall Study|Excluded from the analysis, ineligible|1|||
147655378|NCT04819438|532561542|FG000|Overall Study|Withdrawal by Subject|1|||
147655379|NCT04819438|532561543|FG001|Overall Study|Withdrawal by Subject|0|||
147171952|NCT04856904|530794319|FG001|Overall Study|Protocol Violation|1|||
147171953|NCT00847015|530794320|FG000|Overall Study|Withdrawal by Subject|1|||
147171954|NCT00847015|530794320|FG000|Overall Study|declined any surgery|1|||
147592361|NCT00773734|532325028|FG005|LTE Period: Week 52 to 6 Years|Lack of Efficacy|0|||
147592362|NCT00773734|532325023|FG000|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0|||
147171955|NCT00847015|530794320|FG000|Overall Study|partial cystectomy vs radical cystectomy|1|||
147171956|NCT00902174|530794321|FG000|Overall Study|Adverse Event|27|||
147171957|NCT00902174|530794322|FG001|Overall Study|Adverse Event|7|||
147171958|NCT00902174|530794321|FG000|Overall Study|Lack of Efficacy|1|||
147171959|NCT00902174|530794322|FG001|Overall Study|Lack of Efficacy|5|||
147171960|NCT00902174|530794321|FG000|Overall Study|Death|2|||
147171961|NCT00902174|530794322|FG001|Overall Study|Death|2|||
147592363|NCT00773734|532325024|FG001|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0|||
147592364|NCT00773734|532325025|FG002|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|6|||
147592365|NCT00773734|532325026|FG003|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|3|||
147592366|NCT00773734|532325027|FG004|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0|||
147592367|NCT00773734|532325028|FG005|LTE Period: Week 52 to 6 Years|Withdrawal by Subject|0|||
147592368|NCT00773734|532325023|FG000|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0|||
147592369|NCT00773734|532325024|FG001|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0|||
147592370|NCT00773734|532325025|FG002|LTE Period: Week 52 to 6 Years|Lost to Follow-up|4|||
147592371|NCT00773734|532325026|FG003|LTE Period: Week 52 to 6 Years|Lost to Follow-up|4|||
147592372|NCT00773734|532325027|FG004|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0|||
147592373|NCT00773734|532325028|FG005|LTE Period: Week 52 to 6 Years|Lost to Follow-up|0|||
147592374|NCT01220297|532325035|FG000|Overall Study|Death|2|||
147592375|NCT01220297|532325035|FG000|Overall Study|Lost to Follow-up|1|||
147592376|NCT02119286|532325037|FG000|Overall Study|Adverse Event|9|||
147592377|NCT02119286|532325038|FG001|Overall Study|Adverse Event|7|||
147592378|NCT02119286|532325039|FG002|Overall Study|Adverse Event|2|||
147592379|NCT02119286|532325037|FG000|Overall Study|Lack of Efficacy|11|||
147592380|NCT02119286|532325038|FG001|Overall Study|Lack of Efficacy|3|||
147592381|NCT02119286|532325039|FG002|Overall Study|Lack of Efficacy|4|||
147592382|NCT02119286|532325037|FG000|Overall Study|Lost to Follow-up|2|||
147592383|NCT02119286|532325038|FG001|Overall Study|Lost to Follow-up|0|||
147592384|NCT02119286|532325039|FG002|Overall Study|Lost to Follow-up|1|||
147592385|NCT02119286|532325037|FG000|Overall Study|Withdrawal by Subject|4|||
147592386|NCT02119286|532325038|FG001|Overall Study|Withdrawal by Subject|1|||
147592387|NCT02119286|532325039|FG002|Overall Study|Withdrawal by Subject|0|||
147592388|NCT04109313|532325040|FG000|Overall Study|Pregnancy|1|||
147592389|NCT04109313|532325040|FG000|Overall Study|Adverse Event|11|||
147592390|NCT04109313|532325040|FG000|Overall Study|Lack of Efficacy|11|||
147592391|NCT04109313|532325040|FG000|Overall Study|Lost to Follow-up|1|||
147592392|NCT04109313|532325040|FG000|Overall Study|Physician Decision|2|||
147592393|NCT04109313|532325040|FG000|Overall Study|Subject Decision|13|||
147592394|NCT04109313|532325040|FG000|Overall Study|Covid-19 situation|2|||
147592395|NCT01272921|532325041|FG000|Overall Study|Protocol Violation|2|||
147592396|NCT01272921|532325042|FG001|Overall Study|Protocol Violation|1|||
147592397|NCT01132664|532325043|FG000|Phase lb|Adverse Event|0|||
147592398|NCT01132664|532325044|FG001|Phase lb|Adverse Event|1|||
147592399|NCT01132664|532325045|FG002|Phase lb|Adverse Event|0|||
147655380|NCT04819438|532561542|FG000|Overall Study|Adverse Event|0|||
147655381|NCT04819438|532561543|FG001|Overall Study|Adverse Event|1|||
147171962|NCT00902174|530794321|FG000|Overall Study|Withdrawal by Subject|2|||
147171963|NCT00902174|530794322|FG001|Overall Study|Withdrawal by Subject|1|||
147171964|NCT00902174|530794321|FG000|Overall Study|Abnormal labs|1|||
147171965|NCT00902174|530794322|FG001|Overall Study|Abnormal labs|1|||
147171966|NCT00902174|530794321|FG000|Overall Study|Protocol Violation|1|||
147171967|NCT00902174|530794322|FG001|Overall Study|Protocol Violation|1|||
147171968|NCT00902174|530794321|FG000|Overall Study|Administration problem|0|||
147171969|NCT00902174|530794322|FG001|Overall Study|Administration problem|1|||
147171970|NCT00454584|530794323|FG000|Controlled Period|Adverse Event|5|||
147171971|NCT00454584|530794324|FG001|Controlled Period|Adverse Event|2|||
147171972|NCT00454584|530794325|FG002|Controlled Period|Adverse Event|1|||
147171973|NCT00454584|530794326|FG003|Controlled Period|Adverse Event|0|||
147171974|NCT00454584|530794327|FG004|Controlled Period|Adverse Event|0|||
147171975|NCT00454584|530794328|FG005|Controlled Period|Adverse Event|0|||
147171976|NCT00454584|530794323|FG000|Controlled Period|Lost to Follow-up|1|||
147171977|NCT00454584|530794324|FG001|Controlled Period|Lost to Follow-up|2|||
147171978|NCT00454584|530794325|FG002|Controlled Period|Lost to Follow-up|2|||
147592400|NCT01132664|532325046|FG003|Phase lb|Adverse Event|0|||
147592401|NCT01132664|532325047|FG004|Phase lb|Adverse Event|0|||
147592402|NCT01132664|532325043|FG000|Phase lb|Withdrawal by Subject|1|||
147592403|NCT01132664|532325044|FG001|Phase lb|Withdrawal by Subject|2|||
147171979|NCT00454584|530794326|FG003|Controlled Period|Lost to Follow-up|0|||
147592404|NCT01132664|532325045|FG002|Phase lb|Withdrawal by Subject|0|||
147171980|NCT00454584|530794327|FG004|Controlled Period|Lost to Follow-up|0|||
147171981|NCT00454584|530794328|FG005|Controlled Period|Lost to Follow-up|0|||
147171982|NCT00454584|530794323|FG000|Controlled Period|Other|5|||
147171983|NCT00454584|530794324|FG001|Controlled Period|Other|4|||
147171984|NCT00454584|530794325|FG002|Controlled Period|Other|2|||
147592405|NCT01132664|532325046|FG003|Phase lb|Withdrawal by Subject|0|||
147592406|NCT01132664|532325047|FG004|Phase lb|Withdrawal by Subject|0|||
147171985|NCT00454584|530794326|FG003|Controlled Period|Other|0|||
147171986|NCT00454584|530794327|FG004|Controlled Period|Other|0|||
147171987|NCT00454584|530794328|FG005|Controlled Period|Other|0|||
147171988|NCT00454584|530794323|FG000|After Controlled Period|Adverse Event|0|||
147171989|NCT00454584|530794324|FG001|After Controlled Period|Adverse Event|0|||
147171990|NCT00454584|530794325|FG002|After Controlled Period|Adverse Event|0|||
147171991|NCT00454584|530794326|FG003|After Controlled Period|Adverse Event|9|||
147171992|NCT00454584|530794327|FG004|After Controlled Period|Adverse Event|3|||
147592407|NCT01132664|532325043|FG000|Phase lb|Disease Progression|4|||
147592408|NCT01132664|532325044|FG001|Phase lb|Disease Progression|9|||
147592409|NCT01132664|532325045|FG002|Phase lb|Disease Progression|0|||
147592410|NCT01132664|532325046|FG003|Phase lb|Disease Progression|0|||
147592411|NCT01132664|532325047|FG004|Phase lb|Disease Progression|0|||
147592412|NCT01132664|532325043|FG000|Phase ll|Death|0|||
147592413|NCT01132664|532325044|FG001|Phase ll|Death|0|||
147592414|NCT01132664|532325045|FG002|Phase ll|Death|2|||
147592415|NCT01132664|532325046|FG003|Phase ll|Death|0|||
147592416|NCT01132664|532325047|FG004|Phase ll|Death|0|||
147592417|NCT01132664|532325043|FG000|Phase ll|Adverse Event|0|||
147592418|NCT01132664|532325044|FG001|Phase ll|Adverse Event|0|||
147592419|NCT01132664|532325045|FG002|Phase ll|Adverse Event|10|||
147592420|NCT01132664|532325046|FG003|Phase ll|Adverse Event|0|||
147592421|NCT01132664|532325047|FG004|Phase ll|Adverse Event|0|||
147592422|NCT01132664|532325043|FG000|Phase ll|Withdrawal by Subject|0|||
147592423|NCT01132664|532325044|FG001|Phase ll|Withdrawal by Subject|0|||
147592424|NCT01132664|532325045|FG002|Phase ll|Withdrawal by Subject|3|||
147592425|NCT01132664|532325046|FG003|Phase ll|Withdrawal by Subject|0|||
147592426|NCT01132664|532325047|FG004|Phase ll|Withdrawal by Subject|0|||
147592427|NCT01132664|532325043|FG000|Phase ll|Disease progression|0|||
147592428|NCT01132664|532325044|FG001|Phase ll|Disease progression|0|||
147592429|NCT01132664|532325045|FG002|Phase ll|Disease progression|35|||
147592430|NCT01132664|532325046|FG003|Phase ll|Disease progression|0|||
147592431|NCT01132664|532325047|FG004|Phase ll|Disease progression|0|||
147592432|NCT01132664|532325043|FG000|BM Cohort|Disease progression|0|||
147592433|NCT01132664|532325044|FG001|BM Cohort|Disease progression|0|||
147592434|NCT01132664|532325045|FG002|BM Cohort|Disease progression|0|||
147592435|NCT01132664|532325046|FG003|BM Cohort|Disease progression|3|||
147592436|NCT01132664|532325047|FG004|BM Cohort|Disease progression|4|||
147592437|NCT01132664|532325043|FG000|BM Cohort|Adverse Event|0|||
147592438|NCT01132664|532325044|FG001|BM Cohort|Adverse Event|0|||
147592439|NCT01132664|532325045|FG002|BM Cohort|Adverse Event|0|||
147592440|NCT01132664|532325046|FG003|BM Cohort|Adverse Event|0|||
147592441|NCT01132664|532325047|FG004|BM Cohort|Adverse Event|1|||
147592442|NCT01132664|532325043|FG000|BM Cohort|Withdrawal by Subject|0|||
147592443|NCT01132664|532325044|FG001|BM Cohort|Withdrawal by Subject|0|||
147592444|NCT01132664|532325045|FG002|BM Cohort|Withdrawal by Subject|0|||
147592445|NCT01132664|532325046|FG003|BM Cohort|Withdrawal by Subject|0|||
147171993|NCT00454584|530794328|FG005|After Controlled Period|Adverse Event|9|||
147171994|NCT00454584|530794323|FG000|After Controlled Period|Lack of Efficacy|0|||
147171995|NCT00454584|530794324|FG001|After Controlled Period|Lack of Efficacy|0|||
147171996|NCT00454584|530794325|FG002|After Controlled Period|Lack of Efficacy|0|||
147171997|NCT00454584|530794326|FG003|After Controlled Period|Lack of Efficacy|1|||
147171998|NCT00454584|530794327|FG004|After Controlled Period|Lack of Efficacy|0|||
147171999|NCT00454584|530794328|FG005|After Controlled Period|Lack of Efficacy|0|||
147172000|NCT00454584|530794323|FG000|After Controlled Period|Lost to Follow-up|0|||
147172001|NCT00454584|530794324|FG001|After Controlled Period|Lost to Follow-up|0|||
147172002|NCT00454584|530794325|FG002|After Controlled Period|Lost to Follow-up|0|||
147172003|NCT00454584|530794326|FG003|After Controlled Period|Lost to Follow-up|2|||
147172004|NCT00454584|530794327|FG004|After Controlled Period|Lost to Follow-up|4|||
147172005|NCT00454584|530794328|FG005|After Controlled Period|Lost to Follow-up|6|||
147172006|NCT00454584|530794323|FG000|After Controlled Period|Other|0|||
147172007|NCT00454584|530794324|FG001|After Controlled Period|Other|0|||
147172008|NCT00454584|530794325|FG002|After Controlled Period|Other|0|||
147592446|NCT01132664|532325047|FG004|BM Cohort|Withdrawal by Subject|1|||
147655382|NCT04819438|532561542|FG000|Overall Study|Protocol Violation|0|||
147655383|NCT04819438|532561543|FG001|Overall Study|Protocol Violation|1|||
147592447|NCT01996332|532325049|FG000|Overall Study|Adverse Event|117|||
147655384|NCT02869893|532561544|FG000|Overall Study|participant aversion to IV|5|||
147655385|NCT02869893|532561544|FG000|Overall Study|participant fear of MRI scanner|2|||
147655386|NCT00705341|532561545|FG000|Phase 2: Trial|Withdrawal by Subject|0|||
147172009|NCT00454584|530794326|FG003|After Controlled Period|Other|1|||
147592448|NCT01996332|532325049|FG000|Overall Study|Lack of Efficacy|1245|||
147172010|NCT00454584|530794327|FG004|After Controlled Period|Other|0|||
147172011|NCT00454584|530794328|FG005|After Controlled Period|Other|0|||
147172012|NCT00454584|530794323|FG000|After Controlled Period|Other|0|||
147172013|NCT00454584|530794324|FG001|After Controlled Period|Other|0|||
147592449|NCT01996332|532325049|FG000|Overall Study|Death|264|||
147592450|NCT01996332|532325049|FG000|Overall Study|Protocol Violation|9|||
147592451|NCT01996332|532325049|FG000|Overall Study|Withdrawal by Subject|71|||
147172014|NCT00454584|530794325|FG002|After Controlled Period|Other|0|||
147592452|NCT01996332|532325049|FG000|Overall Study|Other|20|||
147172015|NCT00454584|530794326|FG003|After Controlled Period|Other|13|||
147172016|NCT00454584|530794327|FG004|After Controlled Period|Other|5|||
147172017|NCT00454584|530794328|FG005|After Controlled Period|Other|17|||
147172018|NCT01716104|530794329|FG000|Overall Study|Do not meet inclusion criteria|6|||
147172019|NCT01716104|530794330|FG001|Overall Study|Do not meet inclusion criteria|7|||
147172020|NCT02895945|530794331|FG000|Overall Study|Physician Decision|2|||
147172021|NCT02895945|530794332|FG001|Overall Study|Physician Decision|1|||
147172022|NCT03429543|530794337|FG000|Overall Study|Adverse Event|1|||
147172023|NCT03429543|530794338|FG001|Overall Study|Adverse Event|1|||
147172024|NCT03429543|530794339|FG002|Overall Study|Adverse Event|0|||
147172025|NCT03429543|530794340|FG003|Overall Study|Adverse Event|0|||
147172026|NCT03429543|530794341|FG004|Overall Study|Adverse Event|0|||
147172027|NCT03429543|530794342|FG005|Overall Study|Adverse Event|2|||
147172028|NCT03429543|530794343|FG006|Overall Study|Adverse Event|0|||
147172029|NCT03429543|530794337|FG000|Overall Study|Lost to Follow-up|1|||
147172030|NCT03429543|530794338|FG001|Overall Study|Lost to Follow-up|0|||
147172031|NCT03429543|530794339|FG002|Overall Study|Lost to Follow-up|0|||
147172032|NCT03429543|530794340|FG003|Overall Study|Lost to Follow-up|0|||
147172033|NCT03429543|530794341|FG004|Overall Study|Lost to Follow-up|1|||
147172034|NCT03429543|530794342|FG005|Overall Study|Lost to Follow-up|0|||
147172035|NCT03429543|530794343|FG006|Overall Study|Lost to Follow-up|0|||
147172036|NCT03429543|530794337|FG000|Overall Study|Withdrawal by Subject|5|||
147172037|NCT03429543|530794338|FG001|Overall Study|Withdrawal by Subject|0|||
147172038|NCT03429543|530794339|FG002|Overall Study|Withdrawal by Subject|1|||
147172039|NCT03429543|530794340|FG003|Overall Study|Withdrawal by Subject|2|||
147172040|NCT03429543|530794341|FG004|Overall Study|Withdrawal by Subject|6|||
147172041|NCT03429543|530794342|FG005|Overall Study|Withdrawal by Subject|3|||
147172042|NCT03429543|530794343|FG006|Overall Study|Withdrawal by Subject|1|||
147172043|NCT03429543|530794337|FG000|Overall Study|Other reason than listed|0|||
147172044|NCT03429543|530794338|FG001|Overall Study|Other reason than listed|1|||
147172045|NCT03429543|530794339|FG002|Overall Study|Other reason than listed|0|||
147172046|NCT03429543|530794340|FG003|Overall Study|Other reason than listed|0|||
147172047|NCT03429543|530794341|FG004|Overall Study|Other reason than listed|4|||
147172048|NCT03429543|530794342|FG005|Overall Study|Other reason than listed|4|||
147172049|NCT03429543|530794343|FG006|Overall Study|Other reason than listed|0|||
147172050|NCT03429543|530794337|FG000|Overall Study|Not treated|0|||
147172051|NCT03429543|530794338|FG001|Overall Study|Not treated|0|||
147172052|NCT03429543|530794339|FG002|Overall Study|Not treated|0|||
147172053|NCT03429543|530794340|FG003|Overall Study|Not treated|0|||
147172054|NCT03429543|530794341|FG004|Overall Study|Not treated|1|||
147172055|NCT03429543|530794342|FG005|Overall Study|Not treated|0|||
147172056|NCT03429543|530794343|FG006|Overall Study|Not treated|0|||
147172057|NCT01818492|530794344|FG000|Overall Study|Adverse Event|2|||
147172058|NCT01818492|530794344|FG000|Overall Study|Death|3|||
147172059|NCT01818492|530794344|FG000|Overall Study|Withdrawal by Subject|1|||
147172060|NCT01818492|530794344|FG000|Overall Study|Additional therapy when not allowed PP|4|||
147172061|NCT02345330|530794347|FG000|Overall Study|Death|1|||
147172062|NCT02345330|530794347|FG000|Overall Study|Progressive Disease|2|||
147172063|NCT00454181|530794349|FG000|Overall Study|Adverse Event|1|||
147172064|NCT00454181|530794350|FG001|Overall Study|Adverse Event|1|||
147172065|NCT00454181|530794349|FG000|Overall Study|Lost to Follow-up|11|||
147172066|NCT00454181|530794350|FG001|Overall Study|Lost to Follow-up|1|||
147172067|NCT00454181|530794349|FG000|Overall Study|Protocol Violation|1|||
147172068|NCT00454181|530794350|FG001|Overall Study|Protocol Violation|1|||
147172069|NCT00454181|530794349|FG000|Overall Study|Withdrawal by Subject|2|||
147172070|NCT00454181|530794350|FG001|Overall Study|Withdrawal by Subject|0|||
147172071|NCT02976103|530794354|FG000|Overall Study|Withdrawal by Subject|1|||
147172072|NCT02976103|530794355|FG001|Overall Study|Withdrawal by Subject|0|||
147172073|NCT02976103|530794354|FG000|Overall Study|Lost to Follow-up|12|||
147172074|NCT02976103|530794355|FG001|Overall Study|Lost to Follow-up|8|||
147172075|NCT00079677|530794356|FG000|Overall Study|Adverse Event|5|||
147172076|NCT00079677|530794357|FG001|Overall Study|Adverse Event|6|||
147172077|NCT00079677|530794356|FG000|Overall Study|Lack of Efficacy|1|||
147172078|NCT00079677|530794357|FG001|Overall Study|Lack of Efficacy|0|||
147172079|NCT00079677|530794356|FG000|Overall Study|Lost to Follow-up|2|||
147172080|NCT00079677|530794357|FG001|Overall Study|Lost to Follow-up|2|||
147172081|NCT00079677|530794356|FG000|Overall Study|Physician Decision|3|||
147172082|NCT00079677|530794357|FG001|Overall Study|Physician Decision|0|||
147172083|NCT00079677|530794356|FG000|Overall Study|Protocol Violation|2|||
147172084|NCT00079677|530794357|FG001|Overall Study|Protocol Violation|3|||
147172085|NCT00079677|530794356|FG000|Overall Study|Withdrawal by Subject|5|||
147172086|NCT00079677|530794357|FG001|Overall Study|Withdrawal by Subject|3|||
147172087|NCT00079677|530794356|FG000|Overall Study|Miscellaneous|2|||
147172088|NCT00079677|530794357|FG001|Overall Study|Miscellaneous|0|||
147172089|NCT00565136|530794358|FG000|Overall Study|Lost to Follow-up|1|||
147172090|NCT00565136|530794358|FG000|Overall Study|Withdrawal by Subject|1|||
147172091|NCT00565136|530794358|FG000|Overall Study|Protocol Violation|1|||
147172092|NCT00989781|530794364|FG000|Ovarian Response to hCG|Lost to Follow-up|3|||
147448081|NCT01870401|531805634|FG001|Overall Study|Other|7|||
147172093|NCT00989781|530794365|FG001|Ovarian Response to hCG|Lost to Follow-up|2|||
147172094|NCT00409344|530794370|FG000|Overall Study|no enrollment|0|||
147172095|NCT00409344|530794371|FG001|Overall Study|no enrollment|0|||
147172096|NCT05096312|530794372|FG000|Overall Study|Lost to Follow-up|2|||
147172097|NCT05096312|530794373|FG001|Overall Study|Lost to Follow-up|4|||
147172098|NCT05096312|530794372|FG000|Overall Study|Adverse Event|1|||
147172099|NCT05096312|530794373|FG001|Overall Study|Adverse Event|0|||
147172100|NCT01805037|530794374|FG000|1st Cycle of Maintenance (3 Weeks)|Lack of Efficacy|0|||
147172101|NCT01805037|530794375|FG001|1st Cycle of Maintenance (3 Weeks)|Lack of Efficacy|2|||
147172102|NCT01805037|530794374|FG000|1st Cycle of Maintenance (3 Weeks)|Withdrawal by Subject|0|||
147172103|NCT01805037|530794375|FG001|1st Cycle of Maintenance (3 Weeks)|Withdrawal by Subject|2|||
147172104|NCT01805037|530794374|FG000|1st Cycle of Maintenance (3 Weeks)|Adverse Event|0|||
147172105|NCT01805037|530794375|FG001|1st Cycle of Maintenance (3 Weeks)|Adverse Event|1|||
147172106|NCT01805037|530794374|FG000|1st Cycle of Maintenance (3 Weeks)|Death|0|||
147172107|NCT01805037|530794375|FG001|1st Cycle of Maintenance (3 Weeks)|Death|1|||
147172108|NCT01805037|530794374|FG000|2nd Cycle of Maintenance and Beyond|Adverse Event|0|||
147172109|NCT01805037|530794375|FG001|2nd Cycle of Maintenance and Beyond|Adverse Event|10|||
147172110|NCT01805037|530794374|FG000|2nd Cycle of Maintenance and Beyond|Progressive Disease|0|||
147172111|NCT01805037|530794375|FG001|2nd Cycle of Maintenance and Beyond|Progressive Disease|1|||
147172112|NCT01805037|530794374|FG000|2nd Cycle of Maintenance and Beyond|Withdrawal by Subject|0|||
147172113|NCT01805037|530794375|FG001|2nd Cycle of Maintenance and Beyond|Withdrawal by Subject|1|||
147172114|NCT01805037|530794374|FG000|Follow Up (up to 3 Years)|Death|0|||
147172115|NCT01805037|530794375|FG001|Follow Up (up to 3 Years)|Death|2|||
147172116|NCT01805037|530794374|FG000|Follow Up (up to 3 Years)|Withdrawal by Subject|0|||
147172117|NCT01805037|530794375|FG001|Follow Up (up to 3 Years)|Withdrawal by Subject|3|||
147172118|NCT01805037|530794374|FG000|Follow Up (up to 3 Years)|Lost to Follow-up|0|||
147172119|NCT01805037|530794375|FG001|Follow Up (up to 3 Years)|Lost to Follow-up|1|||
147172120|NCT03927404|530794376|FG000|Overall Study|Withdrawal by Subject|1|||
147172121|NCT01229449|530794377|FG000|Overall Study|Withdrawal by Subject|0|||
147172122|NCT01229449|530794378|FG001|Overall Study|Withdrawal by Subject|3|||
147172123|NCT01229449|530794379|FG002|Overall Study|Withdrawal by Subject|0|||
147172124|NCT01229449|530794380|FG003|Overall Study|Withdrawal by Subject|1|||
147172125|NCT01229449|530794381|FG004|Overall Study|Withdrawal by Subject|1|||
147172126|NCT01229449|530794377|FG000|Overall Study|Lost to Follow-up|1|||
147172127|NCT01229449|530794378|FG001|Overall Study|Lost to Follow-up|1|||
147172128|NCT01229449|530794379|FG002|Overall Study|Lost to Follow-up|1|||
147172129|NCT01229449|530794380|FG003|Overall Study|Lost to Follow-up|0|||
147172130|NCT01229449|530794381|FG004|Overall Study|Lost to Follow-up|0|||
147172131|NCT01229449|530794377|FG000|Overall Study|Physician Decision|0|||
147172132|NCT01229449|530794378|FG001|Overall Study|Physician Decision|0|||
147172133|NCT01229449|530794379|FG002|Overall Study|Physician Decision|1|||
147172134|NCT01229449|530794380|FG003|Overall Study|Physician Decision|0|||
147172135|NCT01229449|530794381|FG004|Overall Study|Physician Decision|0|||
147172136|NCT03203291|530794384|FG000|Overall Study|Withdrawal by Subject|1|||
147172137|NCT03157037|530794385|FG000|Overall Study|Death|1|||
147172138|NCT02102399|530794386|FG000|Overall Study|Withdrawal by Subject|6|||
147172139|NCT02102399|530794387|FG001|Overall Study|Withdrawal by Subject|4|||
147172140|NCT04349033|530794388|FG000|Overall Study|Lost to Follow-up|3|||
147172141|NCT04349033|530794389|FG001|Overall Study|Lost to Follow-up|1|||
147172142|NCT04349033|530794390|FG002|Overall Study|Lost to Follow-up|1|||
147172143|NCT00324233|530794393|FG000|First Period|unable to insert catheter|1|||
147172144|NCT00324233|530794394|FG001|First Period|unable to insert catheter|0|||
147172145|NCT00324233|530794393|FG000|Second Period|unable to insert catheter|1|||
147172146|NCT00324233|530794394|FG001|Second Period|unable to insert catheter|1|||
147172147|NCT00324233|530794393|FG000|Second Period|Protocol Violation|4|||
147172148|NCT00324233|530794394|FG001|Second Period|Protocol Violation|6|||
147172149|NCT01704456|530794397|FG000|Overall Study|Lost to Follow-up|8|||
147172150|NCT01704456|530794398|FG001|Overall Study|Lost to Follow-up|14|||
147172151|NCT00498355|530794399|FG000|Overall Study|Lost to Follow-up|1|||
147172152|NCT00410605|530794400|FG000|Overall Study|Adverse Event|12|||
147172153|NCT00410605|530794400|FG000|Overall Study|Physician Decision|3|||
147172154|NCT00410605|530794400|FG000|Overall Study|Withdrawal by Subject|5|||
147172155|NCT00410605|530794400|FG000|Overall Study|Started Non-Protocol Therapy|3|||
147172156|NCT00410605|530794400|FG000|Overall Study|Stopped treatmen to collect stem cells|1|||
147172157|NCT00410605|530794400|FG000|Overall Study|Transferred to another Institution|1|||
147172158|NCT04583956|530794401|FG000|Overall Study|Death|9|||
147172159|NCT04583956|530794402|FG001|Overall Study|Death|11|||
147172160|NCT04583956|530794401|FG000|Overall Study|Lost to Follow-up|7|||
147172161|NCT04583956|530794402|FG001|Overall Study|Lost to Follow-up|9|||
147172162|NCT04583956|530794401|FG000|Overall Study|Protocol Violation|2|||
147172163|NCT04583956|530794402|FG001|Overall Study|Protocol Violation|0|||
147172164|NCT04583956|530794401|FG000|Overall Study|Withdrawal by Subject|0|||
147172165|NCT04583956|530794402|FG001|Overall Study|Withdrawal by Subject|2|||
147172166|NCT04583956|530794401|FG000|Overall Study|Randomized but not dosed|2|||
147172167|NCT04583956|530794402|FG001|Overall Study|Randomized but not dosed|3|||
147172168|NCT04583956|530794401|FG000|Overall Study|Withdrawal of consent before product administration|1|||
147172169|NCT04583956|530794402|FG001|Overall Study|Withdrawal of consent before product administration|0|||
147172170|NCT03908970|530794403|FG000|Overall Study|Adverse Event|7|||
147172171|NCT03908970|530794404|FG001|Overall Study|Adverse Event|21|||
147172172|NCT03908970|530794403|FG000|Overall Study|Physician Decision|1|||
147172173|NCT03908970|530794404|FG001|Overall Study|Physician Decision|4|||
147172174|NCT03908970|530794403|FG000|Overall Study|Withdrawal by Subject|9|||
147172175|NCT03908970|530794404|FG001|Overall Study|Withdrawal by Subject|22|||
147172176|NCT04407234|530794405|FG000|Overall Study|Adverse Event|3|||
147172177|NCT04407234|530794406|FG001|Overall Study|Adverse Event|3|||
147172178|NCT02008227|530795874|FG000|Overall Study|Lost to Follow-up|7|||
147172179|NCT02008227|530795875|FG001|Overall Study|Lost to Follow-up|9|||
147172180|NCT02008227|530795874|FG000|Overall Study|Death|494|||
147172181|NCT02008227|530795875|FG001|Overall Study|Death|485|||
147172182|NCT02008227|530795874|FG000|Overall Study|Withdrawal by Subject|67|||
147172183|NCT02008227|530795875|FG001|Overall Study|Withdrawal by Subject|36|||
147172184|NCT02008227|530795874|FG000|Overall Study|Study Terminated By Sponsor|44|||
147172185|NCT02008227|530795875|FG001|Overall Study|Study Terminated By Sponsor|83|||
147172186|NCT00742417|530795876|FG000|Randomized|Withdrawal by legal representative|0|||
147172187|NCT00742417|530795877|FG001|Randomized|Withdrawal by legal representative|1|||
147172188|NCT00742417|530795876|FG000|Randomized|Withdrawal by Subject|1|||
147172189|NCT00742417|530795877|FG001|Randomized|Withdrawal by Subject|0|||
147172190|NCT00742417|530795876|FG000|Randomized|Physician Decision|1|||
147172191|NCT00742417|530795877|FG001|Randomized|Physician Decision|0|||
147172192|NCT00742417|530795876|FG000|Intensive Period|Withdrawal by Subject|1|||
147172193|NCT00742417|530795877|FG001|Intensive Period|Withdrawal by Subject|1|||
147172194|NCT00742417|530795876|FG000|Intensive Period|Adverse Event|2|||
147172195|NCT00742417|530795877|FG001|Intensive Period|Adverse Event|0|||
147172196|NCT00965575|530795880|FG000|Overall Study|subject unwillingness to swallow study c|1|||
147172197|NCT00965575|530795881|FG001|Overall Study|subject unwillingness to swallow study c|0|||
147172198|NCT02814175|530795884|FG000|Part 1|Adverse Event|2|||
147172199|NCT02814175|530795885|FG001|Part 1|Adverse Event|3|||
147172200|NCT02814175|530795886|FG002|Part 1|Adverse Event|0|||
147172201|NCT02814175|530795887|FG003|Part 1|Adverse Event|0|||
147172202|NCT02814175|530795888|FG004|Part 1|Adverse Event|0|||
147172203|NCT02814175|530795889|FG005|Part 1|Adverse Event|0|||
147172204|NCT02814175|530795884|FG000|Part 1|Withdrawal Consent|8|||
147172205|NCT02814175|530795885|FG001|Part 1|Withdrawal Consent|1|||
147172206|NCT02814175|530795886|FG002|Part 1|Withdrawal Consent|0|||
147172207|NCT02814175|530795887|FG003|Part 1|Withdrawal Consent|0|||
147172208|NCT02814175|530795888|FG004|Part 1|Withdrawal Consent|0|||
147172209|NCT02814175|530795889|FG005|Part 1|Withdrawal Consent|0|||
147172210|NCT02814175|530795884|FG000|Part 1|Lost to Follow-up|1|||
147172211|NCT02814175|530795885|FG001|Part 1|Lost to Follow-up|0|||
147172212|NCT02814175|530795886|FG002|Part 1|Lost to Follow-up|0|||
147172213|NCT02814175|530795887|FG003|Part 1|Lost to Follow-up|0|||
147244394|NCT03761277|531068896|FG000|6 Months to 12 Months|Withdrawal by Subject|1|||
147244395|NCT00684307|531068897|FG000|Overall Study|Adverse Event|11|||
147244396|NCT00684307|531068898|FG001|Overall Study|Adverse Event|6|||
147244397|NCT00684307|531068899|FG002|Overall Study|Adverse Event|15|||
147244398|NCT00684307|531068900|FG003|Overall Study|Adverse Event|16|||
147244399|NCT00684307|531068901|FG004|Overall Study|Adverse Event|8|||
147655387|NCT00705341|532561546|FG001|Phase 2: Trial|Withdrawal by Subject|0|||
147655388|NCT00705341|532561547|FG002|Phase 2: Trial|Withdrawal by Subject|6|||
147655389|NCT00705341|532561548|FG003|Phase 2: Trial|Withdrawal by Subject|4|||
147244400|NCT00684307|531068897|FG000|Overall Study|Development of increasing Liver Function|0|||
147244401|NCT00684307|531068898|FG001|Overall Study|Development of increasing Liver Function|2|||
147244402|NCT00684307|531068899|FG002|Overall Study|Development of increasing Liver Function|0|||
147244403|NCT00684307|531068900|FG003|Overall Study|Development of increasing Liver Function|1|||
147244404|NCT00684307|531068901|FG004|Overall Study|Development of increasing Liver Function|0|||
147655390|NCT00705341|532561545|FG000|Phase 2: Trial|Did not meet post-diluent threshold|0|||
147172214|NCT02814175|530795888|FG004|Part 1|Lost to Follow-up|0|||
147172215|NCT02814175|530795889|FG005|Part 1|Lost to Follow-up|0|||
147172216|NCT02814175|530795884|FG000|Part 1|Lack of Efficacy|1|||
147172217|NCT02814175|530795885|FG001|Part 1|Lack of Efficacy|2|||
147172218|NCT02814175|530795886|FG002|Part 1|Lack of Efficacy|0|||
147172219|NCT02814175|530795887|FG003|Part 1|Lack of Efficacy|0|||
147172220|NCT02814175|530795888|FG004|Part 1|Lack of Efficacy|0|||
147172221|NCT02814175|530795889|FG005|Part 1|Lack of Efficacy|0|||
147172222|NCT02814175|530795884|FG000|Part 2|Adverse Event|0|||
147172223|NCT02814175|530795885|FG001|Part 2|Adverse Event|0|||
147172224|NCT02814175|530795886|FG002|Part 2|Adverse Event|0|||
147172225|NCT02814175|530795887|FG003|Part 2|Adverse Event|1|||
147172226|NCT02814175|530795888|FG004|Part 2|Adverse Event|1|||
147244405|NCT00684307|531068897|FG000|Overall Study|Fullfillment of exclusion criteria|1|||
147244406|NCT00684307|531068898|FG001|Overall Study|Fullfillment of exclusion criteria|0|||
147172227|NCT02814175|530795889|FG005|Part 2|Adverse Event|2|||
147172228|NCT02814175|530795884|FG000|Part 2|Withdrawal Consent|0|||
147172229|NCT02814175|530795885|FG001|Part 2|Withdrawal Consent|0|||
147172230|NCT02814175|530795886|FG002|Part 2|Withdrawal Consent|0|||
147172231|NCT02814175|530795887|FG003|Part 2|Withdrawal Consent|2|||
147172232|NCT02814175|530795888|FG004|Part 2|Withdrawal Consent|1|||
147172233|NCT02814175|530795889|FG005|Part 2|Withdrawal Consent|1|||
147172234|NCT02814175|530795884|FG000|Part 2|Lost to Follow-up|0|||
147172235|NCT02814175|530795885|FG001|Part 2|Lost to Follow-up|0|||
147448082|NCT01870401|531805633|FG000|Overall Study|On-going in the Study|35|||
147448083|NCT01870401|531805634|FG001|Overall Study|On-going in the Study|25|||
147448084|NCT00713700|531805635|FG000|Overall Study|Lost to Follow-up|3|||
147172236|NCT02814175|530795886|FG002|Part 2|Lost to Follow-up|0|||
147172237|NCT02814175|530795887|FG003|Part 2|Lost to Follow-up|1|||
147172238|NCT02814175|530795888|FG004|Part 2|Lost to Follow-up|0|||
147172239|NCT02814175|530795889|FG005|Part 2|Lost to Follow-up|0|||
147172240|NCT02814175|530795884|FG000|Part 2|Lack of Efficacy|0|||
147172241|NCT02814175|530795885|FG001|Part 2|Lack of Efficacy|0|||
147172242|NCT02814175|530795886|FG002|Part 2|Lack of Efficacy|0|||
147172243|NCT02814175|530795887|FG003|Part 2|Lack of Efficacy|0|||
147172244|NCT02814175|530795888|FG004|Part 2|Lack of Efficacy|0|||
147172245|NCT02814175|530795889|FG005|Part 2|Lack of Efficacy|3|||
147172246|NCT01912339|530795890|FG000|Blinded (0 to 3 Months)|Declined to participate|1|||
147172247|NCT01912339|530795891|FG001|Blinded (0 to 3 Months)|Declined to participate|0|||
147172248|NCT01912339|530795892|FG002|Blinded (0 to 3 Months)|Declined to participate|0|||
147172249|NCT01912339|530795890|FG000|Blinded (0 to 3 Months)|Open Prostatectomy|1|||
147172250|NCT01912339|530795891|FG001|Blinded (0 to 3 Months)|Open Prostatectomy|0|||
147172251|NCT01912339|530795892|FG002|Blinded (0 to 3 Months)|Open Prostatectomy|0|||
147172252|NCT01912339|530795890|FG000|Unblinded (3 to 6 Months/Crossover)|Withdrawal by Subject|1|||
147172253|NCT01912339|530795891|FG001|Unblinded (3 to 6 Months/Crossover)|Withdrawal by Subject|0|||
147172254|NCT01912339|530795892|FG002|Unblinded (3 to 6 Months/Crossover)|Withdrawal by Subject|0|||
147172255|NCT01912339|530795890|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Lost to Follow-up|5|||
147172256|NCT01912339|530795891|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Lost to Follow-up|0|||
147172257|NCT01912339|530795892|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Lost to Follow-up|0|||
147172258|NCT01912339|530795890|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Missed Visit|5|||
147172259|NCT01912339|530795891|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Missed Visit|0|||
147172260|NCT01912339|530795892|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Missed Visit|0|||
147172261|NCT01912339|530795890|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Withdrawal by Subject|1|||
147172262|NCT01912339|530795891|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Withdrawal by Subject|0|||
147172263|NCT01912339|530795892|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Withdrawal by Subject|3|||
147172264|NCT01912339|530795890|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|BPH Medication|1|||
147172265|NCT01912339|530795891|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|BPH Medication|0|||
147172266|NCT01912339|530795892|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|BPH Medication|0|||
147172267|NCT01912339|530795890|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|TURP/Laser|1|||
147172268|NCT01912339|530795891|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|TURP/Laser|0|||
147172269|NCT01912339|530795892|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|TURP/Laser|0|||
147172270|NCT01912339|530795890|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Physician Decision|0|||
147172271|NCT01912339|530795891|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Physician Decision|0|||
147172272|NCT01912339|530795892|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Physician Decision|1|||
147172273|NCT01912339|530795890|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Death|0|||
147172274|NCT01912339|530795891|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Death|0|||
147172275|NCT01912339|530795892|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Death|1|||
147172276|NCT01912339|530795890|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Subject started on Cialis|0|||
147172277|NCT01912339|530795891|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Subject started on Cialis|0|||
147448085|NCT00713700|531805635|FG000|Overall Study|Withdrawal by Subject|1|||
147448086|NCT00781456|531805636|FG000|Overall Study|Adverse Event|3|||
147448087|NCT00781456|531805637|FG001|Overall Study|Adverse Event|3|||
147448088|NCT00781456|531805636|FG000|Overall Study|Withdrawal by Subject|3|||
147448089|NCT00781456|531805637|FG001|Overall Study|Withdrawal by Subject|5|||
147448090|NCT00781456|531805636|FG000|Overall Study|Protocol Violation|4|||
147448091|NCT00781456|531805637|FG001|Overall Study|Protocol Violation|1|||
147448092|NCT00781456|531805636|FG000|Overall Study|Noncompliance With Protocol|1|||
147448093|NCT00781456|531805637|FG001|Overall Study|Noncompliance With Protocol|1|||
147448094|NCT00781456|531805636|FG000|Overall Study|Lost to Follow-up|10|||
147172278|NCT01912339|530795892|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Subject started on Cialis|1|||
147448095|NCT00781456|531805637|FG001|Overall Study|Lost to Follow-up|5|||
147448096|NCT00781456|531805636|FG000|Overall Study|Other Reason, Unknown|0|||
147448097|NCT00781456|531805637|FG001|Overall Study|Other Reason, Unknown|1|||
147172279|NCT01912339|530795890|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Had PVP - Prostate laser surgery|0|||
147172280|NCT01912339|530795891|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Had PVP - Prostate laser surgery|0|||
147172281|NCT01912339|530795892|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Had PVP - Prostate laser surgery|1|||
147448098|NCT03776175|531805640|FG000|Treatment Period (42 Days)|Adverse Event|0|||
147448099|NCT03776175|531805641|FG001|Treatment Period (42 Days)|Adverse Event|1|||
147172282|NCT01912339|530795890|FG000|Unblinded (6 Months/Crossover to 5 Yrs)|Still in Study|120|||
147172283|NCT01912339|530795891|FG001|Unblinded (6 Months/Crossover to 5 Yrs)|Still in Study|0|||
147172284|NCT01912339|530795892|FG002|Unblinded (6 Months/Crossover to 5 Yrs)|Still in Study|46|||
147172285|NCT01754493|530795893|FG000|Overall Study|Adverse Event|1|||
147172286|NCT01754493|530795893|FG000|Overall Study|Lost to Follow-up|3|||
147172287|NCT01754493|530795893|FG000|Overall Study|Withdrawal by Subject|1|||
147172288|NCT01754493|530795893|FG000|Overall Study|Moved out of town|1|||
147172289|NCT01754493|530795893|FG000|Overall Study|Scheduling conflict|1|||
147172290|NCT02489942|530795894|FG000|Overall Study|Request by patient|602|||
147172291|NCT02489942|530795894|FG000|Overall Study|Improvement/remission|157|||
147172292|NCT02489942|530795894|FG000|Overall Study|No change/Progressive disease|263|||
147172293|NCT02489942|530795894|FG000|Overall Study|Adverse Event|522|||
147172294|NCT02489942|530795894|FG000|Overall Study|Other personal reasons|1218|||
147172295|NCT02489942|530795894|FG000|Overall Study|Lost to Follow-up|456|||
147172296|NCT02489942|530795894|FG000|Overall Study|Not continuously investigated|7|||
147172297|NCT02489942|530795894|FG000|Overall Study|Patient started jardiance treatment out of registration period|1|||
147172298|NCT02489942|530795894|FG000|Overall Study|Multiple registration|1|||
147172299|NCT02489942|530795894|FG000|Overall Study|No patient visit after entry|100|||
147172300|NCT02489942|530795894|FG000|Overall Study|No treatment with Jardiance|2|||
147172301|NCT02489942|530795894|FG000|Overall Study|Patient received Jardiance before registration|1|||
147172302|NCT02489942|530795894|FG000|Overall Study|No CRF collected|86|||
147172303|NCT01272635|530795895|FG000|Overall Study|Lost to Follow-up|31|||
147172304|NCT01272635|530795896|FG001|Overall Study|Lost to Follow-up|20|||
147172305|NCT01272635|530795897|FG002|Overall Study|Lost to Follow-up|31|||
147172306|NCT01272635|530795898|FG003|Overall Study|Lost to Follow-up|23|||
147172307|NCT01543776|530795901|FG000|Overall Study|Withdrawal by Subject|2|||
147172308|NCT01543776|530795902|FG001|Overall Study|Withdrawal by Subject|2|||
147172309|NCT03626545|530795903|FG000|Overall Study|Progressive disease|3|||
147172310|NCT03626545|530795904|FG001|Overall Study|Progressive disease|82|||
147172311|NCT03626545|530795905|FG002|Overall Study|Progressive disease|85|||
147172312|NCT03626545|530795903|FG000|Overall Study|Adverse Event|3|||
147172313|NCT03626545|530795904|FG001|Overall Study|Adverse Event|13|||
147172314|NCT03626545|530795905|FG002|Overall Study|Adverse Event|10|||
147172315|NCT03626545|530795903|FG000|Overall Study|Physician Decision|1|||
147172316|NCT03626545|530795904|FG001|Overall Study|Physician Decision|18|||
147172317|NCT03626545|530795905|FG002|Overall Study|Physician Decision|14|||
147172318|NCT03626545|530795903|FG000|Overall Study|Subject Decision|0|||
147172319|NCT03626545|530795904|FG001|Overall Study|Subject Decision|5|||
147172320|NCT03626545|530795905|FG002|Overall Study|Subject Decision|5|||
147172321|NCT03626545|530795903|FG000|Overall Study|Death|1|||
147172322|NCT03626545|530795904|FG001|Overall Study|Death|1|||
147172323|NCT03626545|530795905|FG002|Overall Study|Death|1|||
147172324|NCT03626545|530795903|FG000|Overall Study|Protocol Deviation|0|||
147172325|NCT03626545|530795904|FG001|Overall Study|Protocol Deviation|1|||
147172326|NCT03626545|530795905|FG002|Overall Study|Protocol Deviation|1|||
147172327|NCT03626545|530795903|FG000|Overall Study|Guardian Decision|0|||
147172328|NCT03626545|530795904|FG001|Overall Study|Guardian Decision|0|||
147172329|NCT03626545|530795905|FG002|Overall Study|Guardian Decision|1|||
147172330|NCT03387020|530795907|FG000|Overall Study|Adverse Event|0|||
147172331|NCT03387020|530795908|FG001|Overall Study|Adverse Event|2|||
147172332|NCT03387020|530795909|FG002|Overall Study|Adverse Event|0|||
147172333|NCT03387020|530795907|FG000|Overall Study|Withdrawal by Subject|2|||
147172334|NCT03387020|530795908|FG001|Overall Study|Withdrawal by Subject|0|||
147172335|NCT03387020|530795909|FG002|Overall Study|Withdrawal by Subject|0|||
147172336|NCT00434642|530795910|FG000|Blinded Treatment Phase|Adverse Event|12|||
147172337|NCT00434642|530795911|FG001|Blinded Treatment Phase|Adverse Event|58|||
147172338|NCT00434642|530795910|FG000|Blinded Treatment Phase|Clinical Disease Progression|4|||
147172339|NCT00434642|530795911|FG001|Blinded Treatment Phase|Clinical Disease Progression|5|||
147172340|NCT00434642|530795910|FG000|Blinded Treatment Phase|Disease Progression Per RECIST|168|||
147172341|NCT00434642|530795911|FG001|Blinded Treatment Phase|Disease Progression Per RECIST|109|||
147172342|NCT00434642|530795910|FG000|Blinded Treatment Phase|Physician Decision|19|||
147172343|NCT00434642|530795911|FG001|Blinded Treatment Phase|Physician Decision|27|||
147172344|NCT00434642|530795910|FG000|Blinded Treatment Phase|Sponsor's Decision To Terminate Study|3|||
147172345|NCT00434642|530795911|FG001|Blinded Treatment Phase|Sponsor's Decision To Terminate Study|0|||
147172346|NCT00434642|530795910|FG000|Blinded Treatment Phase|Subject's Decision-Discontinue Treatment|32|||
147172347|NCT00434642|530795911|FG001|Blinded Treatment Phase|Subject's Decision-Discontinue Treatment|29|||
147172348|NCT00434642|530795910|FG000|Blinded Treatment Phase|Did not Receive Treatment|4|||
147172349|NCT00434642|530795911|FG001|Blinded Treatment Phase|Did not Receive Treatment|1|||
147172350|NCT00434642|530795910|FG000|Open-label Treatment Phase|Adverse Event|0|||
147172351|NCT00434642|530795911|FG001|Open-label Treatment Phase|Adverse Event|5|||
147172352|NCT00434642|530795910|FG000|Open-label Treatment Phase|Disease Progression Per RECIST|0|||
147172353|NCT00434642|530795911|FG001|Open-label Treatment Phase|Disease Progression Per RECIST|6|||
147172354|NCT02421588|530795912|FG000|Overall Study|Non-treatment-related AE|8|||
147172355|NCT02421588|530795913|FG001|Overall Study|Non-treatment-related AE|8|||
147172356|NCT02421588|530795912|FG000|Overall Study|Progressive disease|152|||
147172357|NCT02421588|530795913|FG001|Overall Study|Progressive disease|135|||
147172358|NCT02421588|530795912|FG000|Overall Study|Death|11|||
147172359|NCT02421588|530795913|FG001|Overall Study|Death|3|||
147172360|NCT02421588|530795912|FG000|Overall Study|Physician Decision|8|||
147172361|NCT02421588|530795913|FG001|Overall Study|Physician Decision|17|||
147172362|NCT02421588|530795912|FG000|Overall Study|Other reason not specified|3|||
147172363|NCT02421588|530795913|FG001|Overall Study|Other reason not specified|1|||
147172364|NCT02421588|530795912|FG000|Overall Study|Symptomatic deterioration|13|||
147172365|NCT02421588|530795913|FG001|Overall Study|Symptomatic deterioration|19|||
147172366|NCT02421588|530795912|FG000|Overall Study|Treatment-related AE|10|||
147172367|NCT02421588|530795913|FG001|Overall Study|Treatment-related AE|14|||
147172368|NCT02421588|530795912|FG000|Overall Study|Withdrawal by Subject|14|||
147172369|NCT02421588|530795913|FG001|Overall Study|Withdrawal by Subject|16|||
147172370|NCT02421588|530795912|FG000|Overall Study|Not treated|2|||
147172371|NCT02421588|530795913|FG001|Overall Study|Not treated|8|||
147172372|NCT04071158|530795919|FG000|Overall Study|Lost to Follow-up|1|||
147172373|NCT04071158|530795920|FG001|Overall Study|Lost to Follow-up|2|||
147172374|NCT04071158|530795921|FG002|Overall Study|Lost to Follow-up|3|||
147172375|NCT04071158|530795922|FG003|Overall Study|Lost to Follow-up|3|||
147172376|NCT04071158|530795923|FG004|Overall Study|Lost to Follow-up|5|||
147172377|NCT04071158|530795919|FG000|Overall Study|Randomized but not treated|2|||
147172378|NCT04071158|530795920|FG001|Overall Study|Randomized but not treated|2|||
147172379|NCT04071158|530795921|FG002|Overall Study|Randomized but not treated|0|||
147172380|NCT04071158|530795922|FG003|Overall Study|Randomized but not treated|0|||
147172381|NCT04071158|530795923|FG004|Overall Study|Randomized but not treated|0|||
147655391|NCT00705341|532561546|FG001|Phase 2: Trial|Did not meet post-diluent threshold|0|||
147655392|NCT00705341|532561547|FG002|Phase 2: Trial|Did not meet post-diluent threshold|1|||
147655393|NCT00705341|532561548|FG003|Phase 2: Trial|Did not meet post-diluent threshold|0|||
147655394|NCT03665077|532561551|FG000|Overall Study|Lost to Follow-up|2|||
147655395|NCT03665077|532561551|FG000|Overall Study|Physician Decision|2|||
147655396|NCT00435461|532561552|FG000|Overall Study|Visit changed to EarlyWithdrawn Visit|1|||
147172382|NCT01178099|530795924|FG000|Overall Study|Physician Decision|0|||
147172383|NCT01178099|530795925|FG001|Overall Study|Physician Decision|1|||
147172384|NCT02473367|530795928|FG000|Wait 1|Withdrawal by Subject|1|||
147172385|NCT02473367|530795928|FG000|Period 4|Lost to Follow-up|1|||
147172386|NCT04816721|530795929|FG000|Overall Study|Withdrawal by Subject|0|||
147172387|NCT04816721|530795930|FG001|Overall Study|Withdrawal by Subject|2|||
147172388|NCT04816721|530795931|FG002|Overall Study|Withdrawal by Subject|0|||
147172389|NCT04816721|530795932|FG003|Overall Study|Withdrawal by Subject|1|||
147172390|NCT04816721|530795933|FG004|Overall Study|Withdrawal by Subject|1|||
147172391|NCT04816721|530795934|FG005|Overall Study|Withdrawal by Subject|0|||
147172392|NCT04816721|530795935|FG006|Overall Study|Withdrawal by Subject|0|||
147172393|NCT04816721|530795936|FG007|Overall Study|Withdrawal by Subject|0|||
147172394|NCT04816721|530795929|FG000|Overall Study|Miscellaneous|0|||
147172395|NCT04816721|530795930|FG001|Overall Study|Miscellaneous|0|||
147172396|NCT04816721|530795931|FG002|Overall Study|Miscellaneous|0|||
147172397|NCT04816721|530795932|FG003|Overall Study|Miscellaneous|0|||
147172398|NCT04816721|530795933|FG004|Overall Study|Miscellaneous|0|||
147172399|NCT04816721|530795934|FG005|Overall Study|Miscellaneous|1|||
147172400|NCT04816721|530795935|FG006|Overall Study|Miscellaneous|0|||
147172401|NCT04816721|530795936|FG007|Overall Study|Miscellaneous|0|||
147172402|NCT04816721|530795929|FG000|Overall Study|Lost to Follow-up|0|||
147172403|NCT04816721|530795930|FG001|Overall Study|Lost to Follow-up|0|||
147172404|NCT04816721|530795931|FG002|Overall Study|Lost to Follow-up|0|||
147172405|NCT04816721|530795932|FG003|Overall Study|Lost to Follow-up|1|||
147172406|NCT04816721|530795933|FG004|Overall Study|Lost to Follow-up|0|||
147172407|NCT04816721|530795934|FG005|Overall Study|Lost to Follow-up|0|||
147172408|NCT04816721|530795935|FG006|Overall Study|Lost to Follow-up|0|||
147172409|NCT04816721|530795936|FG007|Overall Study|Lost to Follow-up|0|||
147172410|NCT02678923|530795951|FG000|Overall Study|Protocol Deviation (Not Dosed)|1|||
147172411|NCT02678923|530795952|FG001|Overall Study|Protocol Deviation (Not Dosed)|3|||
147172412|NCT02678923|530795951|FG000|Overall Study|Withdrawal by Subject|3|||
147172413|NCT02678923|530795952|FG001|Overall Study|Withdrawal by Subject|2|||
147172414|NCT02678923|530795951|FG000|Overall Study|Lost to Follow-up|1|||
147172415|NCT02678923|530795952|FG001|Overall Study|Lost to Follow-up|0|||
147172416|NCT02678923|530795951|FG000|Overall Study|Did Not Return for Study Visits|1|||
147172417|NCT02678923|530795952|FG001|Overall Study|Did Not Return for Study Visits|0|||
147448100|NCT03776175|531805642|FG002|Treatment Period (42 Days)|Adverse Event|1|||
147655397|NCT00435461|532561553|FG001|Overall Study|Visit changed to EarlyWithdrawn Visit|0|||
147172418|NCT00455143|530795953|FG000|Overall Study|Physician Decision|1|||
147172419|NCT00455143|530795953|FG000|Overall Study|Withdrawal by Subject|1|||
147172420|NCT00455143|530795953|FG000|Overall Study|Staff was not avail to follow patient|2|||
147172421|NCT00455143|530795953|FG000|Overall Study|No longer met Inclusion Criteria|1|||
147172422|NCT00455143|530795953|FG000|Overall Study|Surgical time, staff not available|1|||
147655398|NCT00435461|532561554|FG002|Overall Study|Visit changed to EarlyWithdrawn Visit|0|||
147655399|NCT00435461|532561552|FG000|Overall Study|Protocol Violation|6|||
147172423|NCT05222555|530795956|FG000|Overall Study|Ongoing|2|||
147172424|NCT05222555|530795957|FG001|Overall Study|Ongoing|18|||
147172425|NCT05222555|530795956|FG000|Overall Study|Adverse Event|1|||
147172426|NCT05222555|530795957|FG001|Overall Study|Adverse Event|1|||
147172427|NCT05222555|530795956|FG000|Overall Study|Death|0|||
147448101|NCT03776175|531805643|FG003|Treatment Period (42 Days)|Adverse Event|0|||
147172428|NCT05222555|530795957|FG001|Overall Study|Death|6|||
147172429|NCT05222555|530795956|FG000|Overall Study|Withdrawal by Subject|0|||
147172430|NCT05222555|530795957|FG001|Overall Study|Withdrawal by Subject|11|||
147172431|NCT00300365|530795958|FG000|Overall Study|Lost to Follow-up|1|||
147172432|NCT00300365|530795959|FG001|Overall Study|Lost to Follow-up|0|||
147172433|NCT00300365|530795958|FG000|Overall Study|Physician Decision|2|||
147172434|NCT00300365|530795959|FG001|Overall Study|Physician Decision|0|||
147172435|NCT00300365|530795958|FG000|Overall Study|Withdrawal by Subject|1|||
147172436|NCT00300365|530795959|FG001|Overall Study|Withdrawal by Subject|0|||
147172437|NCT00300365|530795958|FG000|Overall Study|Adverse Event|0|||
147172438|NCT00300365|530795959|FG001|Overall Study|Adverse Event|2|||
147172439|NCT01374178|530795962|FG000|Washout Period of at Least 7 Days|Withdrawal by Subject|1|||
147172440|NCT01374178|530795963|FG001|Washout Period of at Least 7 Days|Withdrawal by Subject|0|||
147172441|NCT01374178|530795962|FG000|Period 2 (up to 24 Hours After Dosing)|Adverse Event|2|||
147172442|NCT01374178|530795963|FG001|Period 2 (up to 24 Hours After Dosing)|Adverse Event|0|||
147172443|NCT01422824|530795964|FG000|Overall Study|Case record form not evaluated|1|||
147172444|NCT01422824|530795964|FG000|Overall Study|Lost to Follow-up|37|||
147172445|NCT01641822|530795965|FG000|Run-in Phase|Noncompliance with study drug|1|||
147172446|NCT01641822|530795966|FG001|Run-in Phase|Noncompliance with study drug|0|||
147172447|NCT01641822|530795967|FG002|Run-in Phase|Noncompliance with study drug|0|||
147172448|NCT01641822|530795965|FG000|Run-in Phase|Adverse Event|3|||
147172449|NCT01641822|530795966|FG001|Run-in Phase|Adverse Event|0|||
147172450|NCT01641822|530795967|FG002|Run-in Phase|Adverse Event|0|||
147172451|NCT01641822|530795965|FG000|Run-in Phase|Withdrew consent|1|||
147172452|NCT01641822|530795966|FG001|Run-in Phase|Withdrew consent|0|||
147172453|NCT01641822|530795967|FG002|Run-in Phase|Withdrew consent|0|||
147172454|NCT01641822|530795965|FG000|Run-in Phase|Protocol-specified criteria for withdraw|9|||
147172455|NCT01641822|530795966|FG001|Run-in Phase|Protocol-specified criteria for withdraw|0|||
147172456|NCT01641822|530795967|FG002|Run-in Phase|Protocol-specified criteria for withdraw|0|||
147172457|NCT01641822|530795965|FG000|Comparative Phase|Noncompliance with study drug|0|||
147172458|NCT01641822|530795966|FG001|Comparative Phase|Noncompliance with study drug|1|||
147172459|NCT01641822|530795967|FG002|Comparative Phase|Noncompliance with study drug|0|||
147172460|NCT01641822|530795965|FG000|Comparative Phase|Investigator's discretion|0|||
147172461|NCT01641822|530795966|FG001|Comparative Phase|Investigator's discretion|0|||
147172462|NCT01641822|530795967|FG002|Comparative Phase|Investigator's discretion|1|||
147172463|NCT01641822|530795965|FG000|Comparative Phase|Pregnancy|0|||
147172464|NCT01641822|530795966|FG001|Comparative Phase|Pregnancy|0|||
147172465|NCT01641822|530795967|FG002|Comparative Phase|Pregnancy|1|||
147172466|NCT01641822|530795965|FG000|Comparative Phase|Adverse event, serious fatal|0|||
147172467|NCT01641822|530795966|FG001|Comparative Phase|Adverse event, serious fatal|1|||
147172468|NCT01641822|530795967|FG002|Comparative Phase|Adverse event, serious fatal|0|||
147172469|NCT01641822|530795965|FG000|Comparative Phase|Withdrew consent|0|||
147172470|NCT01641822|530795966|FG001|Comparative Phase|Withdrew consent|3|||
147172471|NCT01641822|530795967|FG002|Comparative Phase|Withdrew consent|7|||
147172472|NCT01641822|530795965|FG000|Comparative Phase|Protocol-specified criteria for withdraw|0|||
147172473|NCT01641822|530795966|FG001|Comparative Phase|Protocol-specified criteria for withdraw|1|||
147172474|NCT01641822|530795967|FG002|Comparative Phase|Protocol-specified criteria for withdraw|1|||
147172475|NCT02760810|530795968|FG000|Overall Study|Protocol Violation|1|||
147172476|NCT02421601|530795969|FG000|Overall Study|Adverse Event|4|||
147172477|NCT02421601|530795969|FG000|Overall Study|Lack of Efficacy|5|||
147172478|NCT02421601|530795969|FG000|Overall Study|Physician Decision|1|||
147172479|NCT02421601|530795969|FG000|Overall Study|Withdrawal by Subject|31|||
147172480|NCT02421601|530795969|FG000|Overall Study|Others|41|||
147172481|NCT00470418|530795974|FG000|Overall Study|Withdrawal by Subject|1|||
147172482|NCT00470418|530795975|FG001|Overall Study|Withdrawal by Subject|0|||
147172483|NCT00599638|530795976|FG000|First Intervention Period (2 Weeks)|Adverse Event|1|||
147172484|NCT00599638|530795977|FG001|First Intervention Period (2 Weeks)|Adverse Event|0|||
147172485|NCT00599638|530795978|FG002|First Intervention Period (2 Weeks)|Adverse Event|3|||
147172486|NCT00599638|530795979|FG003|First Intervention Period (2 Weeks)|Adverse Event|2|||
147172487|NCT00599638|530795976|FG000|First Intervention Period (2 Weeks)|Withdrawal by Subject|1|||
147172488|NCT00599638|530795977|FG001|First Intervention Period (2 Weeks)|Withdrawal by Subject|0|||
147172489|NCT00599638|530795978|FG002|First Intervention Period (2 Weeks)|Withdrawal by Subject|0|||
147172490|NCT00599638|530795979|FG003|First Intervention Period (2 Weeks)|Withdrawal by Subject|1|||
147172491|NCT00599638|530795976|FG000|First Intervention Period (2 Weeks)|Protocol Violation|0|||
147172492|NCT00599638|530795977|FG001|First Intervention Period (2 Weeks)|Protocol Violation|1|||
147172493|NCT00599638|530795978|FG002|First Intervention Period (2 Weeks)|Protocol Violation|0|||
147172494|NCT00599638|530795979|FG003|First Intervention Period (2 Weeks)|Protocol Violation|1|||
147172495|NCT00599638|530795976|FG000|First Intervention Period (2 Weeks)|Randomized but not Treated|0|||
147172496|NCT00599638|530795977|FG001|First Intervention Period (2 Weeks)|Randomized but not Treated|1|||
147172497|NCT00599638|530795978|FG002|First Intervention Period (2 Weeks)|Randomized but not Treated|0|||
147172498|NCT00599638|530795979|FG003|First Intervention Period (2 Weeks)|Randomized but not Treated|1|||
147172499|NCT00599638|530795976|FG000|Washout Period (2 Weeks)|Withdrawal by Subject|1|||
147172500|NCT00599638|530795977|FG001|Washout Period (2 Weeks)|Withdrawal by Subject|0|||
147172501|NCT00599638|530795978|FG002|Washout Period (2 Weeks)|Withdrawal by Subject|0|||
147172502|NCT00599638|530795979|FG003|Washout Period (2 Weeks)|Withdrawal by Subject|1|||
147172503|NCT00599638|530795976|FG000|Washout Period (2 Weeks)|Adverse Event|0|||
147172504|NCT00599638|530795977|FG001|Washout Period (2 Weeks)|Adverse Event|0|||
147172505|NCT00599638|530795978|FG002|Washout Period (2 Weeks)|Adverse Event|0|||
147172506|NCT00599638|530795979|FG003|Washout Period (2 Weeks)|Adverse Event|1|||
147172507|NCT00599638|530795976|FG000|Washout Period (2 Weeks)|Lost to Follow-up|0|||
147172508|NCT00599638|530795977|FG001|Washout Period (2 Weeks)|Lost to Follow-up|0|||
147172509|NCT00599638|530795978|FG002|Washout Period (2 Weeks)|Lost to Follow-up|0|||
147172510|NCT00599638|530795979|FG003|Washout Period (2 Weeks)|Lost to Follow-up|1|||
147172511|NCT00599638|530795976|FG000|Washout Period (2 Weeks)|Protocol Violation|0|||
147172512|NCT00599638|530795977|FG001|Washout Period (2 Weeks)|Protocol Violation|1|||
147172513|NCT00599638|530795978|FG002|Washout Period (2 Weeks)|Protocol Violation|0|||
147172514|NCT00599638|530795979|FG003|Washout Period (2 Weeks)|Protocol Violation|0|||
147172515|NCT00599638|530795976|FG000|Second Intervention Period (2 Weeks)|Protocol Violation|1|||
147172516|NCT00599638|530795977|FG001|Second Intervention Period (2 Weeks)|Protocol Violation|0|||
147172517|NCT00599638|530795978|FG002|Second Intervention Period (2 Weeks)|Protocol Violation|0|||
147172518|NCT00599638|530795979|FG003|Second Intervention Period (2 Weeks)|Protocol Violation|0|||
147172519|NCT03006887|530795980|FG000|Overall Study|Adverse Event|1|||
147172520|NCT00462748|530795981|FG000|Overall Study|Adverse Event|7|||
147172521|NCT00462748|530795982|FG001|Overall Study|Adverse Event|5|||
147172522|NCT00462748|530795983|FG002|Overall Study|Adverse Event|9|||
147172523|NCT00462748|530795981|FG000|Overall Study|Protocol Violation|0|||
147172524|NCT00462748|530795982|FG001|Overall Study|Protocol Violation|2|||
147172525|NCT00462748|530795983|FG002|Overall Study|Protocol Violation|1|||
147172526|NCT00462748|530795981|FG000|Overall Study|Withdrew consent|3|||
147172527|NCT00462748|530795982|FG001|Overall Study|Withdrew consent|3|||
147172528|NCT00462748|530795983|FG002|Overall Study|Withdrew consent|0|||
147172529|NCT00462748|530795981|FG000|Overall Study|Lost to Follow-up|1|||
147172530|NCT00462748|530795982|FG001|Overall Study|Lost to Follow-up|1|||
147172531|NCT00462748|530795983|FG002|Overall Study|Lost to Follow-up|1|||
147172532|NCT00462748|530795981|FG000|Overall Study|Discontinued after 41 days Rx|1|||
147172533|NCT00462748|530795982|FG001|Overall Study|Discontinued after 41 days Rx|0|||
147172534|NCT00462748|530795983|FG002|Overall Study|Discontinued after 41 days Rx|0|||
147172535|NCT01729208|530795984|FG000|Baseline|Physician Decision|5|||
147172536|NCT01729208|530795985|FG001|Baseline|Physician Decision|4|||
147172537|NCT01729208|530795984|FG000|12 Months Follow-up|Withdrawal by Subject|4|||
147172538|NCT01729208|530795985|FG001|12 Months Follow-up|Withdrawal by Subject|7|||
147172539|NCT01729208|530795984|FG000|12 Months Follow-up|Lost to Follow-up|3|||
147172540|NCT01729208|530795985|FG001|12 Months Follow-up|Lost to Follow-up|3|||
147172541|NCT01729208|530795984|FG000|24 Months Follow-up|Lost to Follow-up|3|||
147172542|NCT01729208|530795985|FG001|24 Months Follow-up|Lost to Follow-up|0|||
147323929|NCT04978363|531352369|FG010|Overall Study|Unable to meet the necessary time commitment|0|||
147323930|NCT04978363|531352359|FG000|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
147323931|NCT04978363|531352360|FG001|Overall Study|Didn't feel safe and had pain with hands-free crutch|1|||
147323932|NCT04978363|531352361|FG002|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
147172543|NCT01729208|530795984|FG000|36 Months Follow-up|Physician Decision|1|||
147172544|NCT01729208|530795985|FG001|36 Months Follow-up|Physician Decision|0|||
147172545|NCT01729208|530795984|FG000|36 Months Follow-up|Withdrawal by Subject|2|||
147172546|NCT01729208|530795985|FG001|36 Months Follow-up|Withdrawal by Subject|4|||
147172547|NCT02428413|530795986|FG000|Overall Study|Device to measure WAG malfunctioned|3|||
147172548|NCT02428413|530795987|FG001|Overall Study|Device to measure WAG malfunctioned|5|||
147172549|NCT02428413|530795986|FG000|Overall Study|Protocol Violation|1|||
147172550|NCT02428413|530795987|FG001|Overall Study|Protocol Violation|2|||
147172551|NCT02428413|530795986|FG000|Overall Study|Case Cancelled|2|||
147172552|NCT02428413|530795987|FG001|Overall Study|Case Cancelled|0|||
147172553|NCT02428413|530795986|FG000|Overall Study|Missed Cases|1|||
147172554|NCT02428413|530795987|FG001|Overall Study|Missed Cases|2|||
147172555|NCT02428413|530795986|FG000|Overall Study|Nurse Refusal|1|||
147172556|NCT02428413|530795987|FG001|Overall Study|Nurse Refusal|0|||
147655400|NCT00435461|532561553|FG001|Overall Study|Protocol Violation|9|||
147655401|NCT00435461|532561554|FG002|Overall Study|Protocol Violation|10|||
147172557|NCT03689855|530795990|FG000|Overall Study|Adverse Event|3|||
147172558|NCT03689855|530795990|FG000|Overall Study|Withdrawal by Subject|1|||
147172559|NCT01438177|530795991|FG000|Overall Study|Withdrawal by Subject|1|||
147172560|NCT01438177|530795991|FG000|Overall Study|Initiation of new therapy|1|||
147172561|NCT02772978|530795992|FG000|Overall Study|Withdrawal by Subject|1|||
147172562|NCT02772978|530795993|FG001|Overall Study|Withdrawal by Subject|1|||
147172563|NCT00428844|530796003|FG000|Completed Study Drug Treatment|Adverse Event|2|||
147172564|NCT00428844|530796004|FG001|Completed Study Drug Treatment|Adverse Event|4|||
147172565|NCT00428844|530796005|FG002|Completed Study Drug Treatment|Adverse Event|4|||
147172566|NCT00428844|530796003|FG000|Completed Study Drug Treatment|Protocol Violation|0|||
147172567|NCT00428844|530796004|FG001|Completed Study Drug Treatment|Protocol Violation|1|||
147172568|NCT00428844|530796005|FG002|Completed Study Drug Treatment|Protocol Violation|1|||
147172569|NCT00428844|530796003|FG000|Completed Study Drug Treatment|Withdrawal by Subject|0|||
147172570|NCT00428844|530796004|FG001|Completed Study Drug Treatment|Withdrawal by Subject|1|||
147172571|NCT00428844|530796005|FG002|Completed Study Drug Treatment|Withdrawal by Subject|1|||
147172572|NCT00428844|530796003|FG000|Completed Study Drug Treatment|Randomized Not Treated|0|||
147172573|NCT00428844|530796004|FG001|Completed Study Drug Treatment|Randomized Not Treated|0|||
147172574|NCT00428844|530796005|FG002|Completed Study Drug Treatment|Randomized Not Treated|1|||
147172575|NCT00428844|530796003|FG000|Completed Test of Cure (TOC) Visit|Adverse Event|0|||
147172576|NCT00428844|530796004|FG001|Completed Test of Cure (TOC) Visit|Adverse Event|1|||
147172577|NCT00428844|530796005|FG002|Completed Test of Cure (TOC) Visit|Adverse Event|1|||
147172578|NCT00428844|530796003|FG000|Completed Test of Cure (TOC) Visit|Protocol Violation|0|||
147172579|NCT00428844|530796004|FG001|Completed Test of Cure (TOC) Visit|Protocol Violation|0|||
147172580|NCT00428844|530796005|FG002|Completed Test of Cure (TOC) Visit|Protocol Violation|1|||
147172581|NCT00428844|530796003|FG000|Completed Test of Cure (TOC) Visit|Withdrawal by Subject|1|||
147172582|NCT00428844|530796004|FG001|Completed Test of Cure (TOC) Visit|Withdrawal by Subject|0|||
147172583|NCT00428844|530796005|FG002|Completed Test of Cure (TOC) Visit|Withdrawal by Subject|0|||
147172584|NCT00428844|530796003|FG000|Completed Test of Cure (TOC) Visit|Lack of Efficacy|2|||
147172585|NCT00428844|530796004|FG001|Completed Test of Cure (TOC) Visit|Lack of Efficacy|0|||
147172586|NCT00428844|530796005|FG002|Completed Test of Cure (TOC) Visit|Lack of Efficacy|0|||
147172587|NCT00428844|530796003|FG000|Completed Test of Cure (TOC) Visit|Microbiologic failure|0|||
147172588|NCT00428844|530796004|FG001|Completed Test of Cure (TOC) Visit|Microbiologic failure|1|||
147172589|NCT00428844|530796005|FG002|Completed Test of Cure (TOC) Visit|Microbiologic failure|0|||
147172590|NCT00488826|530796006|FG000|Overall Study|Withdrawal by Subject|40|||
147172591|NCT00488826|530796007|FG001|Overall Study|Withdrawal by Subject|35|||
147172592|NCT00488826|530796008|FG002|Overall Study|Withdrawal by Subject|19|||
147172593|NCT00488826|530796006|FG000|Overall Study|Protocol Violation|0|||
147172594|NCT00488826|530796007|FG001|Overall Study|Protocol Violation|0|||
147172595|NCT00488826|530796008|FG002|Overall Study|Protocol Violation|2|||
147172596|NCT00488826|530796006|FG000|Overall Study|Adverse Event|9|||
147172597|NCT00488826|530796007|FG001|Overall Study|Adverse Event|15|||
147172598|NCT00488826|530796008|FG002|Overall Study|Adverse Event|4|||
147172599|NCT00488826|530796006|FG000|Overall Study|Lost to Follow-up|5|||
147172600|NCT00488826|530796007|FG001|Overall Study|Lost to Follow-up|1|||
147172601|NCT00488826|530796008|FG002|Overall Study|Lost to Follow-up|0|||
147172602|NCT00488826|530796006|FG000|Overall Study|Protocol Deviations|2|||
147172603|NCT00488826|530796007|FG001|Overall Study|Protocol Deviations|1|||
147172604|NCT00488826|530796008|FG002|Overall Study|Protocol Deviations|1|||
147172605|NCT04667104|530796015|FG000|FU:Week 24 to FU Week 48 (i.e.Week 72.4)|Other|0|||
147172606|NCT04667104|530796016|FG001|FU:Week 24 to FU Week 48 (i.e.Week 72.4)|Other|0|||
147172607|NCT04667104|530796017|FG002|FU:Week 24 to FU Week 48 (i.e.Week 72.4)|Other|1|||
147172608|NCT03208088|530796019|FG000|Period 2|Withdrawal by Subject|0|||
147172609|NCT03208088|530796020|FG001|Period 2|Withdrawal by Subject|0|||
147323933|NCT04978363|531352362|FG003|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
147323934|NCT04978363|531352363|FG004|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
147323935|NCT04978363|531352364|FG005|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
147323936|NCT04978363|531352365|FG006|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
147323937|NCT04978363|531352366|FG007|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
147323938|NCT04978363|531352367|FG008|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
147323939|NCT04978363|531352368|FG009|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
147323940|NCT04978363|531352369|FG010|Overall Study|Didn't feel safe and had pain with hands-free crutch|0|||
147323941|NCT00940017|531352370|FG000|Overall Study|did not meet entrance criteria|3|||
147323942|NCT00940017|531352370|FG000|Overall Study|Adverse Event|1|||
147323943|NCT01684046|531352371|FG000|Period 1, First 30 Days|Adverse Event|0|||
147323944|NCT01684046|531352372|FG001|Period 1, First 30 Days|Adverse Event|2|||
147323945|NCT05328973|531352381|FG000|Overall Study|Withdrawal by Subject|0|||
147323946|NCT05328973|531352382|FG001|Overall Study|Withdrawal by Subject|1|||
147323947|NCT02680756|531352389|FG000|Overall Study|Adverse Event|10|||
147323948|NCT02680756|531352390|FG001|Overall Study|Adverse Event|2|||
147323949|NCT02680756|531352389|FG000|Overall Study|Lost to Follow-up|7|||
147323950|NCT02680756|531352390|FG001|Overall Study|Lost to Follow-up|6|||
147323951|NCT02680756|531352389|FG000|Overall Study|Withdrawal by Subject|5|||
147323952|NCT02680756|531352390|FG001|Overall Study|Withdrawal by Subject|5|||
147323953|NCT02680756|531352389|FG000|Overall Study|Physician Decision|4|||
147323954|NCT02680756|531352390|FG001|Overall Study|Physician Decision|1|||
147323955|NCT02680756|531352389|FG000|Overall Study|Hb ≤7.5 g/dL|0|||
147323956|NCT02680756|531352390|FG001|Overall Study|Hb ≤7.5 g/dL|2|||
147172610|NCT03208088|530796021|FG002|Period 2|Withdrawal by Subject|0|||
147172611|NCT03208088|530796022|FG003|Period 2|Withdrawal by Subject|0|||
147172612|NCT03208088|530796023|FG004|Period 2|Withdrawal by Subject|0|||
147323957|NCT02680756|531352389|FG000|Overall Study|Blood transfusion for any reason|0|||
147323958|NCT02680756|531352390|FG001|Overall Study|Blood transfusion for any reason|1|||
147172613|NCT03208088|530796024|FG005|Period 2|Withdrawal by Subject|0|||
147172614|NCT03208088|530796025|FG006|Period 2|Withdrawal by Subject|0|||
147172615|NCT03208088|530796026|FG007|Period 2|Withdrawal by Subject|0|||
147172616|NCT03208088|530796027|FG008|Period 2|Withdrawal by Subject|1|||
147172617|NCT03208088|530796028|FG009|Period 2|Withdrawal by Subject|0|||
147172618|NCT03208088|530796019|FG000|Period 3|Unsatisfactory Test Article|0|||
147172619|NCT03208088|530796020|FG001|Period 3|Unsatisfactory Test Article|0|||
147172620|NCT03208088|530796021|FG002|Period 3|Unsatisfactory Test Article|0|||
147172621|NCT03208088|530796022|FG003|Period 3|Unsatisfactory Test Article|1|||
147172622|NCT03208088|530796023|FG004|Period 3|Unsatisfactory Test Article|0|||
147172623|NCT03208088|530796024|FG005|Period 3|Unsatisfactory Test Article|0|||
147172624|NCT03208088|530796025|FG006|Period 3|Unsatisfactory Test Article|0|||
147172625|NCT03208088|530796026|FG007|Period 3|Unsatisfactory Test Article|0|||
147172626|NCT03208088|530796027|FG008|Period 3|Unsatisfactory Test Article|0|||
147172627|NCT03208088|530796028|FG009|Period 3|Unsatisfactory Test Article|0|||
147172628|NCT03208088|530796019|FG000|Period 4|Unsatisfactory Test Article|0|||
147172629|NCT03208088|530796020|FG001|Period 4|Unsatisfactory Test Article|0|||
147172630|NCT03208088|530796021|FG002|Period 4|Unsatisfactory Test Article|0|||
147172631|NCT03208088|530796022|FG003|Period 4|Unsatisfactory Test Article|1|||
147172632|NCT03208088|530796023|FG004|Period 4|Unsatisfactory Test Article|0|||
147172633|NCT03208088|530796024|FG005|Period 4|Unsatisfactory Test Article|0|||
147172634|NCT03208088|530796025|FG006|Period 4|Unsatisfactory Test Article|0|||
147172635|NCT03208088|530796026|FG007|Period 4|Unsatisfactory Test Article|0|||
147172636|NCT03208088|530796027|FG008|Period 4|Unsatisfactory Test Article|0|||
147172637|NCT03208088|530796028|FG009|Period 4|Unsatisfactory Test Article|0|||
147172638|NCT00605345|530796029|FG000|Overall Study|Withdrawal by Subject|1|||
147172639|NCT00605345|530796030|FG001|Overall Study|Withdrawal by Subject|0|||
147172640|NCT00605345|530796029|FG000|Overall Study|Adverse Event|0|||
147172641|NCT00605345|530796030|FG001|Overall Study|Adverse Event|1|||
147172642|NCT00605345|530796029|FG000|Overall Study|Protocol Violation|0|||
147172643|NCT00605345|530796030|FG001|Overall Study|Protocol Violation|2|||
147172644|NCT02126839|530796031|FG000|Overall Study|Adverse Event|0|||
147172645|NCT02126839|530796032|FG001|Overall Study|Adverse Event|1|||
147172646|NCT02126839|530796031|FG000|Overall Study|Withdrawal by Subject|1|||
147172647|NCT02126839|530796032|FG001|Overall Study|Withdrawal by Subject|0|||
147172648|NCT02126839|530796031|FG000|Overall Study|Withdrawal by parent/guardian|1|||
147172649|NCT02126839|530796032|FG001|Overall Study|Withdrawal by parent/guardian|0|||
147172650|NCT02126839|530796031|FG000|Overall Study|Protocol Violation|2|||
147172651|NCT02126839|530796032|FG001|Overall Study|Protocol Violation|3|||
147172652|NCT02126839|530796031|FG000|Overall Study|Sponsor request|0|||
147172653|NCT02126839|530796032|FG001|Overall Study|Sponsor request|1|||
147172654|NCT02126839|530796031|FG000|Overall Study|Lost to Follow-up|1|||
147172655|NCT02126839|530796032|FG001|Overall Study|Lost to Follow-up|4|||
147172656|NCT02126839|530796031|FG000|Overall Study|Other|5|||
147172657|NCT02126839|530796032|FG001|Overall Study|Other|5|||
147172658|NCT00422383|530796033|FG000|Overall Study|Adverse Event|5|||
147172659|NCT00422383|530796034|FG001|Overall Study|Adverse Event|3|||
147172660|NCT00422383|530796035|FG002|Overall Study|Adverse Event|1|||
147172661|NCT00422383|530796036|FG003|Overall Study|Adverse Event|1|||
147172662|NCT00422383|530796037|FG004|Overall Study|Adverse Event|0|||
147172663|NCT00422383|530796033|FG000|Overall Study|Lack of Efficacy|4|||
147172664|NCT00422383|530796034|FG001|Overall Study|Lack of Efficacy|4|||
147172665|NCT00422383|530796035|FG002|Overall Study|Lack of Efficacy|2|||
147172666|NCT00422383|530796036|FG003|Overall Study|Lack of Efficacy|1|||
147172667|NCT00422383|530796037|FG004|Overall Study|Lack of Efficacy|1|||
147172668|NCT00422383|530796033|FG000|Overall Study|Lost to Follow-up|0|||
147172669|NCT00422383|530796034|FG001|Overall Study|Lost to Follow-up|1|||
147172670|NCT00422383|530796035|FG002|Overall Study|Lost to Follow-up|0|||
147172671|NCT00422383|530796036|FG003|Overall Study|Lost to Follow-up|0|||
147172672|NCT00422383|530796037|FG004|Overall Study|Lost to Follow-up|1|||
147172673|NCT00422383|530796033|FG000|Overall Study|Protocol Violation|1|||
147244407|NCT00684307|531068899|FG002|Overall Study|Fullfillment of exclusion criteria|0|||
147172674|NCT00422383|530796034|FG001|Overall Study|Protocol Violation|1|||
147172675|NCT00422383|530796035|FG002|Overall Study|Protocol Violation|1|||
147172676|NCT00422383|530796036|FG003|Overall Study|Protocol Violation|0|||
147172677|NCT00422383|530796037|FG004|Overall Study|Protocol Violation|0|||
147172678|NCT00422383|530796033|FG000|Overall Study|Withdrawal by Subject|5|||
147172679|NCT00422383|530796034|FG001|Overall Study|Withdrawal by Subject|5|||
147172680|NCT00422383|530796035|FG002|Overall Study|Withdrawal by Subject|0|||
147172681|NCT00422383|530796036|FG003|Overall Study|Withdrawal by Subject|0|||
147172682|NCT00422383|530796037|FG004|Overall Study|Withdrawal by Subject|1|||
147172683|NCT00411632|530796038|FG000|Overall Study|Death|1|||
147172684|NCT01108523|530796039|FG000|Overall Study|Protocol Violation|4|||
147172685|NCT00761527|530796042|FG000|Overall Study|Adverse Event|3|||
147172686|NCT00761527|530796042|FG000|Overall Study|Poor Compliance|8|||
147172687|NCT00761527|530796042|FG000|Overall Study|Lost to Follow-up|9|||
147172688|NCT00761527|530796042|FG000|Overall Study|Unknown reason|2|||
147172689|NCT03831100|530798178|FG000|Overall Study|Patients who developed a recurrent or new primary cancer went off study per protocol|6|||
147592453|NCT01996332|532325049|FG000|Overall Study|Clinical Deterioration|28|||
147592454|NCT01996332|532325049|FG000|Overall Study|Physician Decision|17|||
147592455|NCT01996332|532325049|FG000|Overall Study|Lost to Follow-up|34|||
147592456|NCT02113189|532325050|FG000|Overall Study|Lost to follow up|2|||
147592457|NCT02113189|532325051|FG001|Overall Study|Lost to follow up|1|||
147172690|NCT03831100|530798179|FG001|Overall Study|Patients who developed a recurrent or new primary cancer went off study per protocol|4|||
147172691|NCT04566601|530798180|FG000|Overall Study|Other than listed|13|||
147172692|NCT04566601|530798181|FG001|Overall Study|Other than listed|4|||
147172693|NCT04566601|530798182|FG002|Overall Study|Other than listed|2|||
147172694|NCT04566601|530798183|FG003|Overall Study|Other than listed|1|||
147172695|NCT04566601|530798184|FG004|Overall Study|Other than listed|4|||
147172696|NCT04566601|530798180|FG000|Overall Study|Protocol deviation|3|||
147172697|NCT04566601|530798181|FG001|Overall Study|Protocol deviation|0|||
147172698|NCT04566601|530798182|FG002|Overall Study|Protocol deviation|1|||
147172699|NCT04566601|530798183|FG003|Overall Study|Protocol deviation|1|||
147172700|NCT04566601|530798184|FG004|Overall Study|Protocol deviation|1|||
147172701|NCT04566601|530798180|FG000|Overall Study|Technical problems|0|||
147172702|NCT04566601|530798181|FG001|Overall Study|Technical problems|0|||
147172703|NCT04566601|530798182|FG002|Overall Study|Technical problems|1|||
147172704|NCT04566601|530798183|FG003|Overall Study|Technical problems|0|||
147172705|NCT04566601|530798184|FG004|Overall Study|Technical problems|0|||
147172706|NCT04566601|530798180|FG000|Overall Study|No reason available|3|||
147172707|NCT04566601|530798181|FG001|Overall Study|No reason available|2|||
147172708|NCT04566601|530798182|FG002|Overall Study|No reason available|7|||
147172709|NCT04566601|530798183|FG003|Overall Study|No reason available|1|||
147172710|NCT04566601|530798184|FG004|Overall Study|No reason available|5|||
147323959|NCT02680756|531352389|FG000|Overall Study|Death|1|||
147323960|NCT02680756|531352390|FG001|Overall Study|Death|0|||
147323961|NCT02680756|531352389|FG000|Overall Study|Protocol Violation|1|||
147323962|NCT02680756|531352390|FG001|Overall Study|Protocol Violation|0|||
147323963|NCT02680756|531352389|FG000|Overall Study|TSAT above 60% or a ferritin above 800 m|1|||
147323964|NCT02680756|531352390|FG001|Overall Study|TSAT above 60% or a ferritin above 800 m|0|||
147323965|NCT02680756|531352389|FG000|Overall Study|None of above or not recorded|3|||
147323966|NCT02680756|531352390|FG001|Overall Study|None of above or not recorded|2|||
147323967|NCT00480441|531352391|FG000|Screening|Not Eligible|37|||
147323968|NCT00480441|531352392|FG001|Screening|Not Eligible|0|||
147323969|NCT00480441|531352393|FG002|Screening|Not Eligible|0|||
147323970|NCT00480441|531352391|FG000|Baseline Functional MRI|Functional MRI data not usable|4|||
147323971|NCT00480441|531352392|FG001|Baseline Functional MRI|Functional MRI data not usable|0|||
147323972|NCT00480441|531352393|FG002|Baseline Functional MRI|Functional MRI data not usable|0|||
147323973|NCT00480441|531352391|FG000|Baseline Functional MRI|Lost to Follow-up|4|||
147323974|NCT00480441|531352392|FG001|Baseline Functional MRI|Lost to Follow-up|0|||
147323975|NCT00480441|531352393|FG002|Baseline Functional MRI|Lost to Follow-up|0|||
147323976|NCT00480441|531352391|FG000|Baseline Functional MRI|physical contraindication|4|||
147323977|NCT00480441|531352392|FG001|Baseline Functional MRI|physical contraindication|0|||
147323978|NCT00480441|531352393|FG002|Baseline Functional MRI|physical contraindication|0|||
147323979|NCT00480441|531352391|FG000|Randomization|Lost to Follow-up|0|||
147323980|NCT00480441|531352392|FG001|Randomization|Lost to Follow-up|7|||
147323981|NCT00480441|531352393|FG002|Randomization|Lost to Follow-up|2|||
147323982|NCT03681691|531352394|FG000|Overall Study|COVID|1|||
147323983|NCT03681691|531352395|FG001|Overall Study|COVID|0|||
147323984|NCT03681691|531352394|FG000|Overall Study|prolonged bleeding|1|||
147323985|NCT03681691|531352395|FG001|Overall Study|prolonged bleeding|0|||
147323986|NCT03681691|531352394|FG000|Overall Study|veins would not stay open during the PET scan.|0|||
147323987|NCT03681691|531352395|FG001|Overall Study|veins would not stay open during the PET scan.|1|||
147323988|NCT00748969|531352396|FG000|Overall Study|Withdrawal by Subject|1|||
147323989|NCT00748969|531352397|FG001|Overall Study|Withdrawal by Subject|0|||
147323990|NCT00748969|531352396|FG000|Overall Study|Withdrawal by Subject|0|||
147323991|NCT00748969|531352397|FG001|Overall Study|Withdrawal by Subject|1|||
147323992|NCT02334306|531352398|FG000|Double-blind Period|Adverse Event|0|||
147323993|NCT02334306|531352399|FG001|Double-blind Period|Adverse Event|1|||
147323994|NCT02334306|531352398|FG000|Double-blind Period|Withdrawal by Subject|1|||
147323995|NCT02334306|531352399|FG001|Double-blind Period|Withdrawal by Subject|1|||
147592458|NCT02113189|532325052|FG002|Overall Study|Lost to follow up|3|||
147323996|NCT00465985|531352400|FG000|Part I - Open-label Treatment Period|Unsatisfactory therapeutic effect|4|||
147323997|NCT00465985|531352401|FG001|Part I - Open-label Treatment Period|Unsatisfactory therapeutic effect|0|||
147592459|NCT05016622|532325053|FG000|1st Booster: 4-6 Month Follow up Visit|Lost to Follow-up|59|||
147592460|NCT05016622|532325053|FG000|2nd Booster: 4 Week Follow up Visit|Declined to Participate|2|||
147592461|NCT01304693|532325054|FG000|Overall Study|Adverse Event|0|||
147172711|NCT04566601|530798180|FG000|Overall Study|Burden of study procedures|3|||
147172712|NCT04566601|530798181|FG001|Overall Study|Burden of study procedures|0|||
147172713|NCT04566601|530798182|FG002|Overall Study|Burden of study procedures|0|||
147172714|NCT04566601|530798183|FG003|Overall Study|Burden of study procedures|3|||
147172715|NCT04566601|530798184|FG004|Overall Study|Burden of study procedures|1|||
147172716|NCT04566601|530798180|FG000|Overall Study|Change of residence|2|||
147172717|NCT04566601|530798181|FG001|Overall Study|Change of residence|2|||
147172718|NCT04566601|530798182|FG002|Overall Study|Change of residence|0|||
147172719|NCT04566601|530798183|FG003|Overall Study|Change of residence|1|||
147172720|NCT04566601|530798184|FG004|Overall Study|Change of residence|2|||
147172721|NCT04566601|530798180|FG000|Overall Study|Perceived lack of efficacy|2|||
147172722|NCT04566601|530798181|FG001|Overall Study|Perceived lack of efficacy|0|||
147172723|NCT04566601|530798182|FG002|Overall Study|Perceived lack of efficacy|1|||
147172724|NCT04566601|530798183|FG003|Overall Study|Perceived lack of efficacy|1|||
147172725|NCT04566601|530798184|FG004|Overall Study|Perceived lack of efficacy|2|||
147172726|NCT04566601|530798180|FG000|Overall Study|Adverse Event|7|||
147172727|NCT04566601|530798181|FG001|Overall Study|Adverse Event|4|||
147172728|NCT04566601|530798182|FG002|Overall Study|Adverse Event|6|||
147172729|NCT04566601|530798183|FG003|Overall Study|Adverse Event|5|||
147172730|NCT04566601|530798184|FG004|Overall Study|Adverse Event|12|||
147172731|NCT03047031|530798186|FG000|Overall Study|Other than listed|1|||
147172732|NCT03047031|530798187|FG001|Overall Study|Other than listed|0|||
147172733|NCT03047031|530798188|FG002|Overall Study|Other than listed|0|||
147172734|NCT03047031|530798186|FG000|Overall Study|Lost to Follow-up|4|||
147172735|NCT03047031|530798187|FG001|Overall Study|Lost to Follow-up|0|||
147172736|NCT03047031|530798188|FG002|Overall Study|Lost to Follow-up|0|||
147172737|NCT03047031|530798186|FG000|Overall Study|Patient refusal to continue taking trial medication|2|||
147172738|NCT03047031|530798187|FG001|Overall Study|Patient refusal to continue taking trial medication|0|||
147172739|NCT03047031|530798188|FG002|Overall Study|Patient refusal to continue taking trial medication|0|||
147172740|NCT03047031|530798186|FG000|Overall Study|Adverse Event|1|||
147172741|NCT03047031|530798187|FG001|Overall Study|Adverse Event|0|||
147172742|NCT03047031|530798188|FG002|Overall Study|Adverse Event|0|||
147172743|NCT03047031|530798186|FG000|Overall Study|Withdrawal by Subject|2|||
147172744|NCT03047031|530798187|FG001|Overall Study|Withdrawal by Subject|0|||
147172745|NCT03047031|530798188|FG002|Overall Study|Withdrawal by Subject|0|||
147172746|NCT03047031|530798186|FG000|Overall Study|Change to other medication|2|||
147172747|NCT03047031|530798187|FG001|Overall Study|Change to other medication|0|||
147172748|NCT03047031|530798188|FG002|Overall Study|Change to other medication|0|||
147172749|NCT03047031|530798186|FG000|Overall Study|Patients were not followed as planned in the protocol|0|||
147172750|NCT03047031|530798187|FG001|Overall Study|Patients were not followed as planned in the protocol|4|||
147172751|NCT03047031|530798188|FG002|Overall Study|Patients were not followed as planned in the protocol|3|||
147172752|NCT01450098|530798189|FG000|Period 3|Protocol Violation|0|||
147172753|NCT01450098|530798190|FG001|Period 3|Protocol Violation|1|||
147172754|NCT01450098|530798189|FG000|Period 3|Withdrawal by Subject|0|||
147172755|NCT01450098|530798190|FG001|Period 3|Withdrawal by Subject|2|||
147172756|NCT03229109|530798192|FG000|Overall Study|Withdrawal by Subject|0|||
147172757|NCT03229109|530798193|FG001|Overall Study|Withdrawal by Subject|0|||
147172758|NCT03229109|530798194|FG002|Overall Study|Withdrawal by Subject|0|||
147172759|NCT03229109|530798195|FG003|Overall Study|Withdrawal by Subject|1|||
147172760|NCT04207749|530798196|FG000|Overall Study|Lost to Follow-up|0|||
147172761|NCT04207749|530798197|FG001|Overall Study|Lost to Follow-up|2|||
147172762|NCT04207749|530798196|FG000|Overall Study|Protocol Violation|0|||
147172763|NCT04207749|530798197|FG001|Overall Study|Protocol Violation|1|||
147172764|NCT04207749|530798196|FG000|Overall Study|Withdrawal by Subject|3|||
147172765|NCT04207749|530798197|FG001|Overall Study|Withdrawal by Subject|0|||
147172766|NCT04207749|530798196|FG000|Overall Study|Unable to attend study visits due to COVID-19 pandemic|1|||
147172767|NCT04207749|530798197|FG001|Overall Study|Unable to attend study visits due to COVID-19 pandemic|4|||
147172768|NCT03416127|530798200|FG000|Overall Study|Withdrawal by Subject|0|||
147172769|NCT03416127|530798201|FG001|Overall Study|Withdrawal by Subject|1|||
147172770|NCT03416127|530798202|FG002|Overall Study|Withdrawal by Subject|1|||
147172771|NCT00567359|530798203|FG000|Overall Study|Withdrawal by Subject|1|||
147172772|NCT02397057|530798204|FG000|Overall Study|Withdrawal by Subject|6|||
147172773|NCT02397057|530798205|FG001|Overall Study|Withdrawal by Subject|7|||
147172774|NCT02397057|530798204|FG000|Overall Study|Lost to Follow-up|4|||
147172775|NCT02397057|530798205|FG001|Overall Study|Lost to Follow-up|3|||
147172776|NCT02397057|530798204|FG000|Overall Study|Death|1|||
147172777|NCT02397057|530798205|FG001|Overall Study|Death|0|||
147172778|NCT02397057|530798204|FG000|Overall Study|Adverse Event|0|||
147172779|NCT02397057|530798205|FG001|Overall Study|Adverse Event|1|||
147448102|NCT03776175|531805640|FG000|Treatment Period (42 Days)|Lost to Follow-up|0|||
147172780|NCT02397057|530798204|FG000|Overall Study|Physician Decision|0|||
147172781|NCT02397057|530798205|FG001|Overall Study|Physician Decision|1|||
147172782|NCT02397057|530798204|FG000|Overall Study|Subject did not receive study drug|0|||
147172783|NCT02397057|530798205|FG001|Overall Study|Subject did not receive study drug|1|||
147172784|NCT00793325|530798207|FG000|Overall Study|Protocol Violation|18|||
147172785|NCT00793325|530798207|FG000|Overall Study|Lost to Follow-up|1|||
147172786|NCT01329939|530798212|FG000|Overall Study|Lost to Follow-up|3|||
147172787|NCT01329939|530798213|FG001|Overall Study|Lost to Follow-up|0|||
147172788|NCT01329939|530798214|FG002|Overall Study|Lost to Follow-up|1|||
147172789|NCT01329939|530798215|FG003|Overall Study|Lost to Follow-up|2|||
147172790|NCT01329939|530798212|FG000|Overall Study|Withdrawal by Subject|0|||
147172791|NCT01329939|530798213|FG001|Overall Study|Withdrawal by Subject|1|||
147172792|NCT01329939|530798214|FG002|Overall Study|Withdrawal by Subject|0|||
147244408|NCT00684307|531068900|FG003|Overall Study|Fullfillment of exclusion criteria|3|||
147244409|NCT00684307|531068901|FG004|Overall Study|Fullfillment of exclusion criteria|1|||
147244410|NCT00684307|531068897|FG000|Overall Study|Incorrect enrolment or randomization|4|||
147244411|NCT00684307|531068898|FG001|Overall Study|Incorrect enrolment or randomization|0|||
147244412|NCT00684307|531068899|FG002|Overall Study|Incorrect enrolment or randomization|0|||
147172793|NCT01329939|530798215|FG003|Overall Study|Withdrawal by Subject|0|||
147244413|NCT00684307|531068900|FG003|Overall Study|Incorrect enrolment or randomization|0|||
147244414|NCT00684307|531068901|FG004|Overall Study|Incorrect enrolment or randomization|0|||
147244415|NCT00684307|531068897|FG000|Overall Study|Interupted IP for more than 7 days|0|||
147244416|NCT00684307|531068898|FG001|Overall Study|Interupted IP for more than 7 days|4|||
147244417|NCT00684307|531068899|FG002|Overall Study|Interupted IP for more than 7 days|1|||
147323998|NCT00465985|531352400|FG000|Part II - 1:1 ACZ885:Placebo|Unsatisfactory therapeutic effect|0|||
147323999|NCT00465985|531352401|FG001|Part II - 1:1 ACZ885:Placebo|Unsatisfactory therapeutic effect|12|||
147172794|NCT01329939|530798212|FG000|Overall Study|Adverse Event|0|||
147172795|NCT01329939|530798213|FG001|Overall Study|Adverse Event|0|||
147172796|NCT01329939|530798214|FG002|Overall Study|Adverse Event|0|||
147172797|NCT01329939|530798215|FG003|Overall Study|Adverse Event|3|||
147172798|NCT01966445|530798216|FG000|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0|||
147172799|NCT01966445|530798217|FG001|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0|||
147172800|NCT01966445|530798218|FG002|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0|||
147172801|NCT01966445|530798219|FG003|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|2|||
147172802|NCT01966445|530798220|FG004|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0|||
147172803|NCT01966445|530798221|FG005|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|1|||
147172804|NCT01966445|530798222|FG006|Part1 (Median Exposure of 6.143 Weeks)|Lost to Follow-up|0|||
147324000|NCT00465985|531352400|FG000|Part III - Open-label Treatment Period|Unsatisfactory therapeutic effect|1|||
147324001|NCT00465985|531352401|FG001|Part III - Open-label Treatment Period|Unsatisfactory therapeutic effect|0|||
147592462|NCT01304693|532325055|FG001|Overall Study|Adverse Event|0|||
147592463|NCT01304693|532325056|FG002|Overall Study|Adverse Event|0|||
147592464|NCT01304693|532325057|FG003|Overall Study|Adverse Event|0|||
147592465|NCT01304693|532325058|FG004|Overall Study|Adverse Event|1|||
147592466|NCT01304693|532325054|FG000|Overall Study|Decision Unrelated to an Adverse Event|0|||
147592467|NCT01304693|532325055|FG001|Overall Study|Decision Unrelated to an Adverse Event|0|||
147592468|NCT01304693|532325056|FG002|Overall Study|Decision Unrelated to an Adverse Event|1|||
147592469|NCT01304693|532325057|FG003|Overall Study|Decision Unrelated to an Adverse Event|1|||
147592470|NCT01304693|532325058|FG004|Overall Study|Decision Unrelated to an Adverse Event|0|||
147592471|NCT02954159|532325059|FG000|Overall Study|Study ended prematurely due to low enrol|1|||
147592472|NCT02954159|532325060|FG001|Overall Study|Study ended prematurely due to low enrol|0|||
147592473|NCT02954159|532325059|FG000|Overall Study|Withdrawal by Subject|0|||
147592474|NCT02954159|532325060|FG001|Overall Study|Withdrawal by Subject|1|||
147592475|NCT02581163|532325062|FG000|Overall Study|Failure to return|15|||
147592476|NCT02581163|532325062|FG000|Overall Study|Insufficient virological response|3|||
147592477|NCT02581163|532325062|FG000|Overall Study|Withdrew consent|1|||
147592478|NCT02581163|532325062|FG000|Overall Study|Death|1|||
147592479|NCT02581163|532325062|FG000|Overall Study|Other, not specified|9|||
147592480|NCT03438396|532325063|FG000|Overall Study|Reason Not Specified|9|||
147592481|NCT03438396|532325063|FG000|Overall Study|Withdrawal by Subject|5|||
147592482|NCT03438396|532325063|FG000|Overall Study|Lost to Follow-up|2|||
147592483|NCT03438396|532325063|FG000|Overall Study|Death|85|||
147592484|NCT03438396|532325063|FG000|Overall Study|Not treated|1|||
147592485|NCT03578237|532325067|FG000|Postoperative Day 0 - Month 12|Timepoints past 21 days were only for amputee and mastectomy subjects and not others|14|||
147592486|NCT03578237|532325068|FG001|Postoperative Day 0 - Month 12|Timepoints past 21 days were only for amputee and mastectomy subjects and not others|16|||
147592487|NCT02488330|532325069|FG000|Overall Study|Adverse Event|1|||
147592488|NCT02488330|532325069|FG000|Overall Study|Physician Decision|2|||
147592489|NCT02488330|532325069|FG000|Overall Study|Death|2|||
147592490|NCT02488330|532325069|FG000|Overall Study|Disease Progression|3|||
147592491|NCT02488330|532325069|FG000|Overall Study|Study Termination by Sponsor|4|||
147592492|NCT00584844|532325070|FG000|Overall Study|Withdrawal by Subject|59|||
147592493|NCT00584844|532325070|FG000|Overall Study|Screen Failure|20|||
147592494|NCT01206816|532325071|FG000|Overall Study|Protocol Violation|0|||
147592495|NCT01206816|532325072|FG001|Overall Study|Protocol Violation|0|||
147592496|NCT01206816|532325073|FG002|Overall Study|Protocol Violation|1|||
147592497|NCT01206816|532325074|FG003|Overall Study|Protocol Violation|0|||
147592498|NCT01206816|532325075|FG004|Overall Study|Protocol Violation|0|||
147592499|NCT01206816|532325076|FG005|Overall Study|Protocol Violation|0|||
147592500|NCT01206816|532325077|FG006|Overall Study|Protocol Violation|0|||
147592501|NCT01206816|532325071|FG000|Overall Study|Withdrawal by Subject|0|||
147592502|NCT01206816|532325072|FG001|Overall Study|Withdrawal by Subject|0|||
147592503|NCT01206816|532325073|FG002|Overall Study|Withdrawal by Subject|1|||
147592504|NCT01206816|532325074|FG003|Overall Study|Withdrawal by Subject|0|||
147592505|NCT01206816|532325075|FG004|Overall Study|Withdrawal by Subject|0|||
147172805|NCT01966445|530798216|FG000|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|0|||
147448103|NCT03776175|531805641|FG001|Treatment Period (42 Days)|Lost to Follow-up|0|||
147448104|NCT03776175|531805642|FG002|Treatment Period (42 Days)|Lost to Follow-up|0|||
147448105|NCT03776175|531805643|FG003|Treatment Period (42 Days)|Lost to Follow-up|2|||
147448106|NCT03776175|531805640|FG000|Treatment Period (42 Days)|Participants screened at other site|0|||
147448107|NCT03776175|531805641|FG001|Treatment Period (42 Days)|Participants screened at other site|2|||
147448108|NCT03776175|531805642|FG002|Treatment Period (42 Days)|Participants screened at other site|0|||
147448109|NCT03776175|531805643|FG003|Treatment Period (42 Days)|Participants screened at other site|0|||
147448110|NCT03776175|531805640|FG000|Treatment Period (42 Days)|Withdrawal by Subject|1|||
147448111|NCT03776175|531805641|FG001|Treatment Period (42 Days)|Withdrawal by Subject|2|||
147448112|NCT03776175|531805642|FG002|Treatment Period (42 Days)|Withdrawal by Subject|3|||
147448113|NCT03776175|531805643|FG003|Treatment Period (42 Days)|Withdrawal by Subject|0|||
147448114|NCT03776175|531805640|FG000|Treatment Period (42 Days)|Unable to attend study visits|0|||
147448115|NCT03776175|531805641|FG001|Treatment Period (42 Days)|Unable to attend study visits|2|||
147448116|NCT03776175|531805642|FG002|Treatment Period (42 Days)|Unable to attend study visits|0|||
147448117|NCT03776175|531805643|FG003|Treatment Period (42 Days)|Unable to attend study visits|0|||
147448118|NCT03776175|531805640|FG000|Follow-Up Period (35 Days)|Lost to Follow-up|0|||
147448119|NCT03776175|531805641|FG001|Follow-Up Period (35 Days)|Lost to Follow-up|0|||
147448120|NCT03776175|531805642|FG002|Follow-Up Period (35 Days)|Lost to Follow-up|0|||
147448121|NCT03776175|531805643|FG003|Follow-Up Period (35 Days)|Lost to Follow-up|2|||
147448122|NCT00960661|531805644|FG000|Basal Insulin Optimization Phase (BIO)|Adverse Event|6|||
147448123|NCT00960661|531805645|FG001|Basal Insulin Optimization Phase (BIO)|Adverse Event|0|||
147448124|NCT00960661|531805646|FG002|Basal Insulin Optimization Phase (BIO)|Adverse Event|0|||
147448125|NCT00960661|531805644|FG000|Basal Insulin Optimization Phase (BIO)|Lost to Follow-up|4|||
147448126|NCT00960661|531805645|FG001|Basal Insulin Optimization Phase (BIO)|Lost to Follow-up|0|||
147448127|NCT00960661|531805646|FG002|Basal Insulin Optimization Phase (BIO)|Lost to Follow-up|0|||
147448128|NCT00960661|531805644|FG000|Basal Insulin Optimization Phase (BIO)|Entry criteria not met|331|||
147448129|NCT00960661|531805645|FG001|Basal Insulin Optimization Phase (BIO)|Entry criteria not met|0|||
147448130|NCT00960661|531805646|FG002|Basal Insulin Optimization Phase (BIO)|Entry criteria not met|0|||
147448131|NCT00960661|531805644|FG000|Basal Insulin Optimization Phase (BIO)|Withdrawal by Subject|47|||
147172806|NCT01966445|530798217|FG001|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|1|||
147172807|NCT01966445|530798218|FG002|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|0|||
147172808|NCT01966445|530798219|FG003|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|1|||
147172809|NCT01966445|530798220|FG004|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|1|||
147172810|NCT01966445|530798221|FG005|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|0|||
147172811|NCT01966445|530798222|FG006|Part1 (Median Exposure of 6.143 Weeks)|Physician Decision|0|||
147172812|NCT01966445|530798216|FG000|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|0|||
147172813|NCT01966445|530798217|FG001|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|1|||
147172814|NCT01966445|530798218|FG002|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|1|||
147172815|NCT01966445|530798219|FG003|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|0|||
147172816|NCT01966445|530798220|FG004|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|2|||
147172817|NCT01966445|530798221|FG005|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|0|||
147172818|NCT01966445|530798222|FG006|Part1 (Median Exposure of 6.143 Weeks)|Withdrawal by Subject|0|||
147172819|NCT01966445|530798216|FG000|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
147172820|NCT01966445|530798217|FG001|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
147172821|NCT01966445|530798218|FG002|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
147172822|NCT01966445|530798219|FG003|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
147172823|NCT01966445|530798220|FG004|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
147172824|NCT01966445|530798221|FG005|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|0|||
147172825|NCT01966445|530798222|FG006|Part2 (Median Exposure of 7.143 Weeks)|Physician Decision|3|||
147172826|NCT01966445|530798216|FG000|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
147172827|NCT01966445|530798217|FG001|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
147172828|NCT01966445|530798218|FG002|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
147172829|NCT01966445|530798219|FG003|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
147172830|NCT01966445|530798220|FG004|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
147172831|NCT01966445|530798221|FG005|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|0|||
147172832|NCT01966445|530798222|FG006|Part2 (Median Exposure of 7.143 Weeks)|Withdrawal by Subject|2|||
147448132|NCT00960661|531805645|FG001|Basal Insulin Optimization Phase (BIO)|Withdrawal by Subject|0|||
147448133|NCT00960661|531805646|FG002|Basal Insulin Optimization Phase (BIO)|Withdrawal by Subject|0|||
147592506|NCT01206816|532325076|FG005|Overall Study|Withdrawal by Subject|0|||
147592507|NCT01206816|532325077|FG006|Overall Study|Withdrawal by Subject|0|||
147592508|NCT01206816|532325071|FG000|Overall Study|Progressive disease|3|||
147592509|NCT01206816|532325072|FG001|Overall Study|Progressive disease|3|||
147592510|NCT01206816|532325073|FG002|Overall Study|Progressive disease|13|||
147592511|NCT01206816|532325074|FG003|Overall Study|Progressive disease|3|||
147592512|NCT01206816|532325075|FG004|Overall Study|Progressive disease|3|||
147172833|NCT00117793|530798225|FG000|Overall Study|Withdrawal by Subject|12|||
147592513|NCT01206816|532325076|FG005|Overall Study|Progressive disease|16|||
147592514|NCT01206816|532325077|FG006|Overall Study|Progressive disease|3|||
147592515|NCT01206816|532325071|FG000|Overall Study|Other AE|0|||
147592516|NCT01206816|532325072|FG001|Overall Study|Other AE|0|||
147592517|NCT01206816|532325073|FG002|Overall Study|Other AE|4|||
147592518|NCT01206816|532325074|FG003|Overall Study|Other AE|0|||
147592519|NCT01206816|532325075|FG004|Overall Study|Other AE|0|||
147592520|NCT01206816|532325076|FG005|Overall Study|Other AE|3|||
147172834|NCT01753401|530798226|FG000|Double-blind Period (8 Weeks)|Adverse Event|0|||
147172835|NCT01753401|530798227|FG001|Double-blind Period (8 Weeks)|Adverse Event|2|||
147172836|NCT01753401|530798228|FG002|Double-blind Period (8 Weeks)|Adverse Event|0|||
147172837|NCT01753401|530798229|FG003|Double-blind Period (8 Weeks)|Adverse Event|0|||
147172838|NCT01753401|530798226|FG000|Double-blind Period (8 Weeks)|Withdrawal by Subject|1|||
147172839|NCT01753401|530798227|FG001|Double-blind Period (8 Weeks)|Withdrawal by Subject|1|||
147172840|NCT01753401|530798228|FG002|Double-blind Period (8 Weeks)|Withdrawal by Subject|0|||
147172841|NCT01753401|530798229|FG003|Double-blind Period (8 Weeks)|Withdrawal by Subject|0|||
147172842|NCT01753401|530798226|FG000|Double-blind Period (8 Weeks)|Protocol Violation|0|||
147172843|NCT01753401|530798227|FG001|Double-blind Period (8 Weeks)|Protocol Violation|1|||
147172844|NCT01753401|530798228|FG002|Double-blind Period (8 Weeks)|Protocol Violation|0|||
147172845|NCT01753401|530798229|FG003|Double-blind Period (8 Weeks)|Protocol Violation|0|||
147172846|NCT01753401|530798226|FG000|Open Label Period (44 Weeks)|Adverse Event|0|||
147172847|NCT01753401|530798227|FG001|Open Label Period (44 Weeks)|Adverse Event|0|||
147172848|NCT01753401|530798228|FG002|Open Label Period (44 Weeks)|Adverse Event|3|||
147172849|NCT01753401|530798229|FG003|Open Label Period (44 Weeks)|Adverse Event|4|||
147172850|NCT01753401|530798226|FG000|Open Label Period (44 Weeks)|Withdrawal by Subject|0|||
147172851|NCT01753401|530798227|FG001|Open Label Period (44 Weeks)|Withdrawal by Subject|0|||
147172852|NCT01753401|530798228|FG002|Open Label Period (44 Weeks)|Withdrawal by Subject|0|||
147172853|NCT01753401|530798229|FG003|Open Label Period (44 Weeks)|Withdrawal by Subject|2|||
147172854|NCT01753401|530798226|FG000|Open Label Period (44 Weeks)|Lack of Efficacy|0|||
147172855|NCT01753401|530798227|FG001|Open Label Period (44 Weeks)|Lack of Efficacy|0|||
147172856|NCT01753401|530798228|FG002|Open Label Period (44 Weeks)|Lack of Efficacy|1|||
147172857|NCT01753401|530798229|FG003|Open Label Period (44 Weeks)|Lack of Efficacy|1|||
147172858|NCT01753401|530798226|FG000|Open Label Period (44 Weeks)|Reason not provided|0|||
147172859|NCT01753401|530798227|FG001|Open Label Period (44 Weeks)|Reason not provided|0|||
147172860|NCT01753401|530798228|FG002|Open Label Period (44 Weeks)|Reason not provided|0|||
147172861|NCT01753401|530798229|FG003|Open Label Period (44 Weeks)|Reason not provided|2|||
147172862|NCT03688100|530798234|FG000|Overall Study|Lost to Follow-up|21|||
147172863|NCT03688100|530798235|FG001|Overall Study|Lost to Follow-up|15|||
147172864|NCT03688100|530798236|FG002|Overall Study|Lost to Follow-up|15|||
147592521|NCT01206816|532325077|FG006|Overall Study|Other AE|2|||
147592522|NCT01206816|532325071|FG000|Overall Study|other than stated above|0|||
147592523|NCT01206816|532325072|FG001|Overall Study|other than stated above|0|||
147592524|NCT01206816|532325073|FG002|Overall Study|other than stated above|1|||
147655402|NCT00435461|532561552|FG000|Overall Study|Participant randomized(inadequate score)|1|||
147655403|NCT00435461|532561553|FG001|Overall Study|Participant randomized(inadequate score)|0|||
147172865|NCT03688100|530798237|FG003|Overall Study|Lost to Follow-up|18|||
147172866|NCT03688100|530798234|FG000|Overall Study|Withdrawal by Subject|19|||
147172867|NCT03688100|530798235|FG001|Overall Study|Withdrawal by Subject|16|||
147172868|NCT03688100|530798236|FG002|Overall Study|Withdrawal by Subject|0|||
147172869|NCT03688100|530798237|FG003|Overall Study|Withdrawal by Subject|0|||
147172870|NCT03688100|530798234|FG000|Overall Study|Death|36|||
147172871|NCT03688100|530798235|FG001|Overall Study|Death|27|||
147172872|NCT03688100|530798236|FG002|Overall Study|Death|0|||
147324002|NCT00465985|531352400|FG000|Part III - Open-label Treatment Period|Adverse Event|1|||
147324003|NCT00465985|531352401|FG001|Part III - Open-label Treatment Period|Adverse Event|0|||
147324004|NCT01687270|531352402|FG000|Overall Study|Lack of Efficacy|11|||
147324005|NCT01687270|531352402|FG000|Overall Study|Lost to Follow-up|1|||
147324006|NCT03302156|531352403|FG000|Overall Study|no visible evidence of tumor on MRI|0|||
147324007|NCT03302156|531352404|FG001|Overall Study|no visible evidence of tumor on MRI|1|||
147324008|NCT03302156|531352405|FG002|Overall Study|no visible evidence of tumor on MRI|0|||
147324009|NCT03532178|531352406|FG000|First Period|Withdrawal by Subject|1|||
147324010|NCT03532178|531352407|FG001|First Period|Withdrawal by Subject|3|||
147324011|NCT03532178|531352406|FG000|First Period|technical issues in data collection Technical issues|0|||
147324012|NCT03532178|531352407|FG001|First Period|technical issues in data collection Technical issues|1|||
147592525|NCT01206816|532325074|FG003|Overall Study|other than stated above|0|||
147172873|NCT03688100|530798237|FG003|Overall Study|Death|0|||
147592526|NCT01206816|532325075|FG004|Overall Study|other than stated above|0|||
147655404|NCT00435461|532561554|FG002|Overall Study|Participant randomized(inadequate score)|0|||
147172874|NCT02453555|530798245|FG000|24-week Double-blind Treatment Period|Adverse Event|2|||
147172875|NCT02453555|530798246|FG001|24-week Double-blind Treatment Period|Adverse Event|0|||
147172876|NCT02453555|530798247|FG002|24-week Double-blind Treatment Period|Adverse Event|0|||
147172877|NCT02453555|530798248|FG003|24-week Double-blind Treatment Period|Adverse Event|0|||
147592527|NCT01206816|532325076|FG005|Overall Study|other than stated above|0|||
147172878|NCT02453555|530798249|FG004|24-week Double-blind Treatment Period|Adverse Event|0|||
147172879|NCT02453555|530798250|FG005|24-week Double-blind Treatment Period|Adverse Event|0|||
147172880|NCT02453555|530798245|FG000|24-week Double-blind Treatment Period|Lost to Follow-up|1|||
147172881|NCT02453555|530798246|FG001|24-week Double-blind Treatment Period|Lost to Follow-up|0|||
147172882|NCT02453555|530798247|FG002|24-week Double-blind Treatment Period|Lost to Follow-up|0|||
147172883|NCT02453555|530798248|FG003|24-week Double-blind Treatment Period|Lost to Follow-up|0|||
147172884|NCT02453555|530798249|FG004|24-week Double-blind Treatment Period|Lost to Follow-up|0|||
147172885|NCT02453555|530798250|FG005|24-week Double-blind Treatment Period|Lost to Follow-up|0|||
147172886|NCT02453555|530798245|FG000|24-week Double-blind Treatment Period|Withdrawal by Subject|2|||
147655405|NCT00435461|532561552|FG000|Overall Study|Compliance less than 80 percent|1|||
147655406|NCT00435461|532561553|FG001|Overall Study|Compliance less than 80 percent|0|||
147655407|NCT00435461|532561554|FG002|Overall Study|Compliance less than 80 percent|0|||
147655408|NCT00435461|532561552|FG000|Overall Study|In error, two study medications switched|1|||
147655409|NCT00435461|532561553|FG001|Overall Study|In error, two study medications switched|0|||
147655410|NCT00435461|532561554|FG002|Overall Study|In error, two study medications switched|0|||
147655411|NCT00435461|532561552|FG000|Overall Study|Lack of Efficacy|2|||
147655412|NCT00435461|532561553|FG001|Overall Study|Lack of Efficacy|1|||
147655413|NCT00435461|532561554|FG002|Overall Study|Lack of Efficacy|0|||
147655414|NCT00435461|532561552|FG000|Overall Study|Withdrawal by Subject|1|||
147655415|NCT00435461|532561553|FG001|Overall Study|Withdrawal by Subject|0|||
147655416|NCT00435461|532561554|FG002|Overall Study|Withdrawal by Subject|2|||
147655417|NCT00435461|532561552|FG000|Overall Study|Randomized in error|1|||
147655418|NCT00435461|532561553|FG001|Overall Study|Randomized in error|0|||
147655419|NCT00435461|532561554|FG002|Overall Study|Randomized in error|0|||
147655420|NCT00435461|532561552|FG000|Overall Study|Participant could not tolerate symptoms|0|||
147655421|NCT00435461|532561553|FG001|Overall Study|Participant could not tolerate symptoms|0|||
147655422|NCT00435461|532561554|FG002|Overall Study|Participant could not tolerate symptoms|1|||
147172887|NCT02453555|530798246|FG001|24-week Double-blind Treatment Period|Withdrawal by Subject|4|||
147172888|NCT02453555|530798247|FG002|24-week Double-blind Treatment Period|Withdrawal by Subject|0|||
147172889|NCT02453555|530798248|FG003|24-week Double-blind Treatment Period|Withdrawal by Subject|0|||
147172890|NCT02453555|530798249|FG004|24-week Double-blind Treatment Period|Withdrawal by Subject|0|||
147172891|NCT02453555|530798250|FG005|24-week Double-blind Treatment Period|Withdrawal by Subject|0|||
147172892|NCT02453555|530798245|FG000|24-week Double-blind Treatment Period|Other than specified above|0|||
147172893|NCT02453555|530798246|FG001|24-week Double-blind Treatment Period|Other than specified above|3|||
147172894|NCT02453555|530798247|FG002|24-week Double-blind Treatment Period|Other than specified above|0|||
147172895|NCT02453555|530798248|FG003|24-week Double-blind Treatment Period|Other than specified above|0|||
147172896|NCT02453555|530798249|FG004|24-week Double-blind Treatment Period|Other than specified above|0|||
147172897|NCT02453555|530798250|FG005|24-week Double-blind Treatment Period|Other than specified above|0|||
147172898|NCT02453555|530798245|FG000|Extension Period|Adverse Event|0|||
147172899|NCT02453555|530798246|FG001|Extension Period|Adverse Event|0|||
147172900|NCT02453555|530798247|FG002|Extension Period|Adverse Event|1|||
147172901|NCT02453555|530798248|FG003|Extension Period|Adverse Event|2|||
147172902|NCT02453555|530798249|FG004|Extension Period|Adverse Event|1|||
147172903|NCT02453555|530798250|FG005|Extension Period|Adverse Event|1|||
147172904|NCT02453555|530798245|FG000|Extension Period|Protocol Violation|0|||
147172905|NCT02453555|530798246|FG001|Extension Period|Protocol Violation|0|||
147172906|NCT02453555|530798247|FG002|Extension Period|Protocol Violation|1|||
147172907|NCT02453555|530798248|FG003|Extension Period|Protocol Violation|0|||
147172908|NCT02453555|530798249|FG004|Extension Period|Protocol Violation|0|||
147172909|NCT02453555|530798250|FG005|Extension Period|Protocol Violation|0|||
147172910|NCT02453555|530798245|FG000|Extension Period|Withdrawal by Subject|0|||
147172911|NCT02453555|530798246|FG001|Extension Period|Withdrawal by Subject|0|||
147172912|NCT02453555|530798247|FG002|Extension Period|Withdrawal by Subject|1|||
147172913|NCT02453555|530798248|FG003|Extension Period|Withdrawal by Subject|0|||
147172914|NCT02453555|530798249|FG004|Extension Period|Withdrawal by Subject|0|||
147172915|NCT02453555|530798250|FG005|Extension Period|Withdrawal by Subject|0|||
147172916|NCT02409719|530798255|FG000|Overall Study|Lost to Follow-up|3|||
147172917|NCT02409719|530798256|FG001|Overall Study|Lost to Follow-up|3|||
147172918|NCT02479139|530798257|FG000|Overall Study|Lost to Follow-up|2|||
147172919|NCT02479139|530798258|FG001|Overall Study|Lost to Follow-up|4|||
147172920|NCT02479139|530798259|FG002|Overall Study|Lost to Follow-up|4|||
147172921|NCT02479139|530798260|FG003|Overall Study|Lost to Follow-up|2|||
147655423|NCT00435461|532561552|FG000|Overall Study|Participant could not swallow capsule|0|||
147655424|NCT00435461|532561553|FG001|Overall Study|Participant could not swallow capsule|0|||
147172922|NCT02479139|530798261|FG004|Overall Study|Lost to Follow-up|3|||
147172923|NCT02479139|530798262|FG005|Overall Study|Lost to Follow-up|5|||
147172924|NCT02479139|530798257|FG000|Overall Study|Withdrew Consent|5|||
147172925|NCT02479139|530798258|FG001|Overall Study|Withdrew Consent|6|||
147172926|NCT02479139|530798259|FG002|Overall Study|Withdrew Consent|1|||
147172927|NCT02479139|530798260|FG003|Overall Study|Withdrew Consent|4|||
147172928|NCT02479139|530798261|FG004|Overall Study|Withdrew Consent|1|||
147172929|NCT02479139|530798262|FG005|Overall Study|Withdrew Consent|1|||
147172930|NCT02479139|530798257|FG000|Overall Study|Treatment Failure/Lack of Efficacy|0|||
147172931|NCT02479139|530798258|FG001|Overall Study|Treatment Failure/Lack of Efficacy|0|||
147172932|NCT02479139|530798259|FG002|Overall Study|Treatment Failure/Lack of Efficacy|1|||
147172933|NCT02479139|530798260|FG003|Overall Study|Treatment Failure/Lack of Efficacy|0|||
147172934|NCT02479139|530798261|FG004|Overall Study|Treatment Failure/Lack of Efficacy|0|||
147172935|NCT02479139|530798262|FG005|Overall Study|Treatment Failure/Lack of Efficacy|0|||
147172936|NCT02479139|530798257|FG000|Overall Study|Other Miscellaneous Reasons|1|||
147172937|NCT02479139|530798258|FG001|Overall Study|Other Miscellaneous Reasons|0|||
147172938|NCT02479139|530798259|FG002|Overall Study|Other Miscellaneous Reasons|1|||
147172939|NCT02479139|530798260|FG003|Overall Study|Other Miscellaneous Reasons|1|||
147172940|NCT02479139|530798261|FG004|Overall Study|Other Miscellaneous Reasons|1|||
147172941|NCT02479139|530798262|FG005|Overall Study|Other Miscellaneous Reasons|0|||
147172942|NCT00764673|530798263|FG000|Overall Study|Death|1|||
147172943|NCT00764673|530798263|FG000|Overall Study|Lost to Follow-up|3|||
147172944|NCT00764673|530798263|FG000|Overall Study|Withdrawal by Subject|6|||
147172945|NCT00764673|530798263|FG000|Overall Study|Revision of Device|2|||
147172946|NCT01727336|530798266|FG000|Part 1 Dalantercept Dose Escalation|Adverse Event|0|||
147172947|NCT01727336|530798267|FG001|Part 1 Dalantercept Dose Escalation|Adverse Event|1|||
147172948|NCT01727336|530798268|FG002|Part 1 Dalantercept Dose Escalation|Adverse Event|5|||
147172949|NCT01727336|530798269|FG003|Part 1 Dalantercept Dose Escalation|Adverse Event|0|||
147172950|NCT01727336|530798270|FG004|Part 1 Dalantercept Dose Escalation|Adverse Event|0|||
147172951|NCT01727336|530798271|FG005|Part 1 Dalantercept Dose Escalation|Adverse Event|0|||
147172952|NCT01727336|530798266|FG000|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|3|||
147172953|NCT01727336|530798267|FG001|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|1|||
147172954|NCT01727336|530798268|FG002|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|3|||
147172955|NCT01727336|530798269|FG003|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|0|||
147172956|NCT01727336|530798270|FG004|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|0|||
147172957|NCT01727336|530798271|FG005|Part 1 Dalantercept Dose Escalation|Lack of Efficacy|0|||
147172958|NCT01727336|530798266|FG000|Part 2 Blinded|Death|0|||
147172959|NCT01727336|530798267|FG001|Part 2 Blinded|Death|0|||
147172960|NCT01727336|530798268|FG002|Part 2 Blinded|Death|0|||
147172961|NCT01727336|530798269|FG003|Part 2 Blinded|Death|0|||
147172962|NCT01727336|530798270|FG004|Part 2 Blinded|Death|20|||
147172963|NCT01727336|530798271|FG005|Part 2 Blinded|Death|16|||
147172964|NCT01727336|530798266|FG000|Part 2 Blinded|Lack of Efficacy|0|||
147172965|NCT01727336|530798267|FG001|Part 2 Blinded|Lack of Efficacy|0|||
147172966|NCT01727336|530798268|FG002|Part 2 Blinded|Lack of Efficacy|0|||
147172967|NCT01727336|530798269|FG003|Part 2 Blinded|Lack of Efficacy|0|||
147172968|NCT01727336|530798270|FG004|Part 2 Blinded|Lack of Efficacy|42|||
147172969|NCT01727336|530798271|FG005|Part 2 Blinded|Lack of Efficacy|44|||
147172970|NCT01727336|530798266|FG000|Part 2 Blinded|Lost to Follow-up|0|||
147172971|NCT01727336|530798267|FG001|Part 2 Blinded|Lost to Follow-up|0|||
147172972|NCT01727336|530798268|FG002|Part 2 Blinded|Lost to Follow-up|0|||
147172973|NCT01727336|530798269|FG003|Part 2 Blinded|Lost to Follow-up|0|||
147172974|NCT01727336|530798270|FG004|Part 2 Blinded|Lost to Follow-up|0|||
147172975|NCT01727336|530798271|FG005|Part 2 Blinded|Lost to Follow-up|1|||
147172976|NCT01727336|530798266|FG000|Part 2 Blinded|Withdrawal by Subject|0|||
147172977|NCT01727336|530798267|FG001|Part 2 Blinded|Withdrawal by Subject|0|||
147172978|NCT01727336|530798268|FG002|Part 2 Blinded|Withdrawal by Subject|0|||
147592528|NCT01206816|532325077|FG006|Overall Study|other than stated above|1|||
147592529|NCT01939496|532325078|FG000|Overall Study|Adverse Event|2|||
147592530|NCT01939496|532325079|FG001|Overall Study|Adverse Event|0|||
147592531|NCT01939496|532325080|FG002|Overall Study|Adverse Event|0|||
147172979|NCT01727336|530798269|FG003|Part 2 Blinded|Withdrawal by Subject|0|||
147172980|NCT01727336|530798270|FG004|Part 2 Blinded|Withdrawal by Subject|0|||
147172981|NCT01727336|530798271|FG005|Part 2 Blinded|Withdrawal by Subject|4|||
147172982|NCT01727336|530798266|FG000|Part 2 Blinded|use of prohibited medications|0|||
147244418|NCT00684307|531068900|FG003|Overall Study|Interupted IP for more than 7 days|3|||
147244419|NCT00684307|531068901|FG004|Overall Study|Interupted IP for more than 7 days|3|||
147244420|NCT00684307|531068897|FG000|Overall Study|Severe non compliance to protocol|1|||
147244421|NCT00684307|531068898|FG001|Overall Study|Severe non compliance to protocol|0|||
147244422|NCT00684307|531068899|FG002|Overall Study|Severe non compliance to protocol|0|||
147244423|NCT00684307|531068900|FG003|Overall Study|Severe non compliance to protocol|1|||
147244424|NCT00684307|531068901|FG004|Overall Study|Severe non compliance to protocol|2|||
147244425|NCT00684307|531068897|FG000|Overall Study|Participant not willing to continue|7|||
147172983|NCT01727336|530798267|FG001|Part 2 Blinded|use of prohibited medications|0|||
147172984|NCT01727336|530798268|FG002|Part 2 Blinded|use of prohibited medications|0|||
147172985|NCT01727336|530798269|FG003|Part 2 Blinded|use of prohibited medications|0|||
147172986|NCT01727336|530798270|FG004|Part 2 Blinded|use of prohibited medications|1|||
147172987|NCT01727336|530798271|FG005|Part 2 Blinded|use of prohibited medications|3|||
147172988|NCT00619099|530798272|FG000|Overall Study|Progressive Disease|7|||
147172989|NCT00619099|530798273|FG001|Overall Study|Progressive Disease|5|||
147592532|NCT01939496|532325078|FG000|Overall Study|Lost to Follow-up|1|||
147592533|NCT01939496|532325079|FG001|Overall Study|Lost to Follow-up|1|||
147172990|NCT00619099|530798272|FG000|Overall Study|Allogeneic Bone Marrow Transplantation|2|||
147172991|NCT00619099|530798273|FG001|Overall Study|Allogeneic Bone Marrow Transplantation|1|||
147172992|NCT00619099|530798272|FG000|Overall Study|Adverse Event|4|||
147172993|NCT00619099|530798273|FG001|Overall Study|Adverse Event|3|||
147172994|NCT00619099|530798272|FG000|Overall Study|Emergence of Clinically Significant Lab|1|||
147172995|NCT00619099|530798273|FG001|Overall Study|Emergence of Clinically Significant Lab|2|||
147172996|NCT00619099|530798272|FG000|Overall Study|Withdrawal by Subject|10|||
147172997|NCT00619099|530798273|FG001|Overall Study|Withdrawal by Subject|2|||
147172998|NCT00619099|530798272|FG000|Overall Study|Physician Decision|9|||
147172999|NCT00619099|530798273|FG001|Overall Study|Physician Decision|6|||
147173000|NCT00885482|530798274|FG000|Overall Study|Pregnancy|1|||
147592534|NCT01939496|532325080|FG002|Overall Study|Lost to Follow-up|0|||
147592535|NCT01939496|532325078|FG000|Overall Study|Physician Decision|1|||
147173001|NCT00885482|530798274|FG000|Overall Study|Lack of Efficacy|1|||
147173002|NCT00885482|530798274|FG000|Overall Study|Death|1|||
147173003|NCT00885482|530798274|FG000|Overall Study|low Therapeutic drug monitoring (TDM)|1|||
147173004|NCT00084656|530798275|FG000|Overall Study|Other reasons|0|||
147173005|NCT00084656|530798276|FG001|Overall Study|Other reasons|12|||
147173006|NCT00084656|530798277|FG002|Overall Study|Other reasons|11|||
147173007|NCT00084656|530798275|FG000|Overall Study|Withdrawal by Subject|15|||
147173008|NCT00084656|530798276|FG001|Overall Study|Withdrawal by Subject|4|||
147173009|NCT00084656|530798277|FG002|Overall Study|Withdrawal by Subject|4|||
147173010|NCT00084656|530798275|FG000|Overall Study|Disease relapse|0|||
147173011|NCT00084656|530798276|FG001|Overall Study|Disease relapse|9|||
147173012|NCT00084656|530798277|FG002|Overall Study|Disease relapse|10|||
147173013|NCT00084656|530798275|FG000|Overall Study|Disease progression|9|||
147173014|NCT00084656|530798276|FG001|Overall Study|Disease progression|0|||
147173015|NCT00084656|530798277|FG002|Overall Study|Disease progression|0|||
147173016|NCT00084656|530798275|FG000|Overall Study|Lost to Follow-up|1|||
147173017|NCT00084656|530798276|FG001|Overall Study|Lost to Follow-up|0|||
147173018|NCT00084656|530798277|FG002|Overall Study|Lost to Follow-up|1|||
147173019|NCT01532869|530798278|FG000|Blinded-Treatment Period (Up to Week 24)|Death|0|||
147173020|NCT01532869|530798279|FG001|Blinded-Treatment Period (Up to Week 24)|Death|1|||
147173021|NCT01532869|530798278|FG000|Blinded-Treatment Period (Up to Week 24)|Adverse Event|2|||
147173022|NCT01532869|530798279|FG001|Blinded-Treatment Period (Up to Week 24)|Adverse Event|3|||
147173023|NCT01532869|530798278|FG000|Blinded-Treatment Period (Up to Week 24)|Lost to Follow-up|0|||
147173024|NCT01532869|530798279|FG001|Blinded-Treatment Period (Up to Week 24)|Lost to Follow-up|1|||
147173025|NCT01532869|530798278|FG000|Blinded-Treatment Period (Up to Week 24)|Non-compliance|1|||
147173026|NCT01532869|530798279|FG001|Blinded-Treatment Period (Up to Week 24)|Non-compliance|0|||
147173027|NCT01532869|530798278|FG000|Blinded-Treatment Period (Up to Week 24)|Lack of Efficacy|1|||
147173028|NCT01532869|530798279|FG001|Blinded-Treatment Period (Up to Week 24)|Lack of Efficacy|1|||
147173029|NCT01532869|530798278|FG000|Blinded-Treatment Period (Up to Week 24)|Withdrawal by Subject|4|||
147173030|NCT01532869|530798279|FG001|Blinded-Treatment Period (Up to Week 24)|Withdrawal by Subject|2|||
147173031|NCT01532869|530798278|FG000|Blinded-Treatment Period (Up to Week 48)|Death|0|||
147173032|NCT01532869|530798279|FG001|Blinded-Treatment Period (Up to Week 48)|Death|3|||
147173033|NCT01532869|530798278|FG000|Blinded-Treatment Period (Up to Week 48)|Adverse Event|4|||
147173034|NCT01532869|530798279|FG001|Blinded-Treatment Period (Up to Week 48)|Adverse Event|5|||
147324013|NCT03532178|531352406|FG000|Second Period|Withdrawal by Subject|1|||
147324014|NCT03532178|531352407|FG001|Second Period|Withdrawal by Subject|1|||
147324015|NCT03532178|531352406|FG000|Second Period|Technical issues|0|||
147324016|NCT03532178|531352407|FG001|Second Period|Technical issues|1|||
147324017|NCT03278028|531352410|FG000|Overall Study|Lost to Follow-up|1|||
147324018|NCT03278028|531352411|FG001|Overall Study|Lost to Follow-up|0|||
147324019|NCT03278028|531352410|FG000|Overall Study|Withdrawal by Subject|3|||
147324020|NCT03278028|531352411|FG001|Overall Study|Withdrawal by Subject|1|||
147324021|NCT03278028|531352410|FG000|Overall Study|Pregnancy|0|||
147324022|NCT03278028|531352411|FG001|Overall Study|Pregnancy|1|||
147324023|NCT03635112|531352412|FG000|Overall Study|Adverse Event|5|||
147324024|NCT03635112|531352413|FG001|Overall Study|Adverse Event|9|||
147448134|NCT00960661|531805644|FG000|Basal Insulin Optimization Phase (BIO)|Physician Decision|8|||
147448135|NCT00960661|531805645|FG001|Basal Insulin Optimization Phase (BIO)|Physician Decision|0|||
147448136|NCT00960661|531805646|FG002|Basal Insulin Optimization Phase (BIO)|Physician Decision|0|||
147592536|NCT01939496|532325079|FG001|Overall Study|Physician Decision|0|||
147592537|NCT01939496|532325080|FG002|Overall Study|Physician Decision|0|||
147592538|NCT01939496|532325078|FG000|Overall Study|Protocol Violation|3|||
147173035|NCT01532869|530798278|FG000|Blinded-Treatment Period (Up to Week 48)|Lost to Follow-up|0|||
147173036|NCT01532869|530798279|FG001|Blinded-Treatment Period (Up to Week 48)|Lost to Follow-up|1|||
147173037|NCT01532869|530798278|FG000|Blinded-Treatment Period (Up to Week 48)|Non-Compliance|1|||
147173038|NCT01532869|530798279|FG001|Blinded-Treatment Period (Up to Week 48)|Non-Compliance|0|||
147324025|NCT03635112|531352414|FG002|Overall Study|Adverse Event|14|||
147324026|NCT03635112|531352412|FG000|Overall Study|Lost to Follow-up|1|||
147324027|NCT03635112|531352413|FG001|Overall Study|Lost to Follow-up|0|||
147324028|NCT03635112|531352414|FG002|Overall Study|Lost to Follow-up|1|||
147592539|NCT01939496|532325079|FG001|Overall Study|Protocol Violation|0|||
147592540|NCT01939496|532325080|FG002|Overall Study|Protocol Violation|0|||
147173039|NCT01532869|530798278|FG000|Blinded-Treatment Period (Up to Week 48)|Lack of Efficacy|0|||
147173040|NCT01532869|530798279|FG001|Blinded-Treatment Period (Up to Week 48)|Lack of Efficacy|1|||
147173041|NCT01532869|530798278|FG000|Blinded-Treatment Period (Up to Week 48)|Withdrawal by Subject|5|||
147173042|NCT01532869|530798279|FG001|Blinded-Treatment Period (Up to Week 48)|Withdrawal by Subject|3|||
147173043|NCT01532869|530798278|FG000|Blinded-Treatment Period (Up to Week 48)|Physician Decision|1|||
147173044|NCT01532869|530798279|FG001|Blinded-Treatment Period (Up to Week 48)|Physician Decision|0|||
147173045|NCT01532869|530798278|FG000|Open-label Period (Week 48 to Week 96)|Adverse Event|4|||
147173046|NCT01532869|530798279|FG001|Open-label Period (Week 48 to Week 96)|Adverse Event|1|||
147173047|NCT01532869|530798278|FG000|Open-label Period (Week 48 to Week 96)|Non-compliance|1|||
147173048|NCT01532869|530798279|FG001|Open-label Period (Week 48 to Week 96)|Non-compliance|0|||
147173049|NCT01532869|530798278|FG000|Open-label Period (Week 48 to Week 96)|Lack of Efficacy|1|||
147173050|NCT01532869|530798279|FG001|Open-label Period (Week 48 to Week 96)|Lack of Efficacy|1|||
147173051|NCT01532869|530798278|FG000|Open-label Period (Week 48 to Week 96)|Withdrawal by Subject|1|||
147173052|NCT01532869|530798279|FG001|Open-label Period (Week 48 to Week 96)|Withdrawal by Subject|1|||
147173053|NCT01026220|530798280|FG000|Induction|Death|1|||
147173054|NCT01026220|530798281|FG001|Induction|Death|0|||
147173055|NCT01026220|530798282|FG002|Induction|Death|0|||
147173056|NCT01026220|530798280|FG000|Induction|Lack of Efficacy|2|||
147173057|NCT01026220|530798281|FG001|Induction|Lack of Efficacy|0|||
147173058|NCT01026220|530798282|FG002|Induction|Lack of Efficacy|0|||
147173059|NCT01026220|530798280|FG000|Induction|Physician Decision|12|||
147173060|NCT01026220|530798281|FG001|Induction|Physician Decision|0|||
147173061|NCT01026220|530798282|FG002|Induction|Physician Decision|0|||
147173062|NCT01026220|530798280|FG000|Induction|Withdrawal by Subject|9|||
147173063|NCT01026220|530798281|FG001|Induction|Withdrawal by Subject|0|||
147173064|NCT01026220|530798282|FG002|Induction|Withdrawal by Subject|0|||
147173065|NCT01026220|530798280|FG000|Induction|Ineligible|1|||
147173066|NCT01026220|530798281|FG001|Induction|Ineligible|0|||
147173067|NCT01026220|530798282|FG002|Induction|Ineligible|0|||
147173068|NCT01026220|530798280|FG000|Consolidation Maintenance|Death|0|||
147173069|NCT01026220|530798281|FG001|Consolidation Maintenance|Death|1|||
147173070|NCT01026220|530798282|FG002|Consolidation Maintenance|Death|0|||
147173071|NCT01026220|530798280|FG000|Consolidation Maintenance|Lack of Efficacy|0|||
147173072|NCT01026220|530798281|FG001|Consolidation Maintenance|Lack of Efficacy|1|||
147173073|NCT01026220|530798282|FG002|Consolidation Maintenance|Lack of Efficacy|1|||
147173074|NCT01026220|530798280|FG000|Consolidation Maintenance|Physician Decision|0|||
147173075|NCT01026220|530798281|FG001|Consolidation Maintenance|Physician Decision|2|||
147173076|NCT01026220|530798282|FG002|Consolidation Maintenance|Physician Decision|7|||
147173077|NCT01026220|530798280|FG000|Consolidation Maintenance|Withdrawal by Subject|0|||
147173078|NCT01026220|530798281|FG001|Consolidation Maintenance|Withdrawal by Subject|2|||
147173079|NCT01026220|530798282|FG002|Consolidation Maintenance|Withdrawal by Subject|6|||
147173080|NCT00778895|530798283|FG000|Active Phase|Adverse Event|3|||
147173081|NCT00778895|530798284|FG001|Active Phase|Adverse Event|1|||
147173082|NCT00778895|530798285|FG002|Active Phase|Adverse Event|0|||
147173083|NCT00778895|530798283|FG000|Active Phase|Withdrawal by Subject|1|||
147173084|NCT00778895|530798284|FG001|Active Phase|Withdrawal by Subject|4|||
147173085|NCT00778895|530798285|FG002|Active Phase|Withdrawal by Subject|0|||
147173086|NCT00778895|530798283|FG000|Active Phase|Lost to Follow-up|1|||
147173087|NCT00778895|530798284|FG001|Active Phase|Lost to Follow-up|1|||
147173088|NCT00778895|530798285|FG002|Active Phase|Lost to Follow-up|0|||
147173089|NCT00778895|530798283|FG000|Active Phase|Other|2|||
147173090|NCT00778895|530798284|FG001|Active Phase|Other|0|||
147173091|NCT00778895|530798285|FG002|Active Phase|Other|0|||
147173092|NCT00778895|530798283|FG000|ESFU Phase|Adverse Event|2|||
147173093|NCT00778895|530798284|FG001|ESFU Phase|Adverse Event|1|||
147324029|NCT03635112|531352412|FG000|Overall Study|Physician Decision|5|||
147324030|NCT03635112|531352413|FG001|Overall Study|Physician Decision|7|||
147324031|NCT03635112|531352414|FG002|Overall Study|Physician Decision|5|||
147324032|NCT03635112|531352412|FG000|Overall Study|Protocol Violation|0|||
147324033|NCT03635112|531352413|FG001|Overall Study|Protocol Violation|0|||
147324034|NCT03635112|531352414|FG002|Overall Study|Protocol Violation|1|||
147324035|NCT03635112|531352412|FG000|Overall Study|Study Terminated by Sponsor|11|||
147324036|NCT03635112|531352413|FG001|Overall Study|Study Terminated by Sponsor|17|||
147324037|NCT03635112|531352414|FG002|Overall Study|Study Terminated by Sponsor|21|||
147324038|NCT03635112|531352412|FG000|Overall Study|Withdrawal by Subject|4|||
147324039|NCT03635112|531352413|FG001|Overall Study|Withdrawal by Subject|9|||
147592541|NCT01939496|532325078|FG000|Overall Study|Withdrawal by Subject|0|||
147592542|NCT01939496|532325079|FG001|Overall Study|Withdrawal by Subject|1|||
147173094|NCT00778895|530798285|FG002|ESFU Phase|Adverse Event|0|||
147173095|NCT00778895|530798283|FG000|ESFU Phase|Withdrawal by Subject|1|||
147173096|NCT00778895|530798284|FG001|ESFU Phase|Withdrawal by Subject|4|||
147173097|NCT00778895|530798285|FG002|ESFU Phase|Withdrawal by Subject|0|||
147173098|NCT00778895|530798283|FG000|ESFU Phase|Lost to Follow-up|6|||
147324040|NCT03635112|531352414|FG002|Overall Study|Withdrawal by Subject|7|||
147173099|NCT00778895|530798284|FG001|ESFU Phase|Lost to Follow-up|7|||
147592543|NCT01939496|532325080|FG002|Overall Study|Withdrawal by Subject|1|||
147592544|NCT01939496|532325078|FG000|Overall Study|Blood Pressure Withdrawal Criteria|0|||
147592545|NCT01939496|532325079|FG001|Overall Study|Blood Pressure Withdrawal Criteria|1|||
147592546|NCT01939496|532325080|FG002|Overall Study|Blood Pressure Withdrawal Criteria|0|||
147173100|NCT00778895|530798285|FG002|ESFU Phase|Lost to Follow-up|2|||
147173101|NCT00778895|530798283|FG000|ESFU Phase|Other|2|||
147173102|NCT00778895|530798284|FG001|ESFU Phase|Other|0|||
147173103|NCT00778895|530798285|FG002|ESFU Phase|Other|0|||
147173104|NCT01009086|530798293|FG000|Overall Study|Lack of Efficacy|16|||
147173105|NCT01009086|530798294|FG001|Overall Study|Lack of Efficacy|15|||
147173106|NCT01009086|530798295|FG002|Overall Study|Lack of Efficacy|9|||
147173107|NCT01009086|530798293|FG000|Overall Study|Lost to Follow-up|4|||
147173108|NCT01009086|530798294|FG001|Overall Study|Lost to Follow-up|5|||
147173109|NCT01009086|530798295|FG002|Overall Study|Lost to Follow-up|3|||
147655425|NCT00435461|532561554|FG002|Overall Study|Participant could not swallow capsule|1|||
147592547|NCT01939496|532325078|FG000|Overall Study|Other|2|||
147592548|NCT01939496|532325079|FG001|Overall Study|Other|0|||
147655426|NCT00435461|532561552|FG000|Overall Study|Pregnancy|2|||
147173110|NCT01009086|530798293|FG000|Overall Study|Adverse Event|12|||
147592549|NCT01939496|532325080|FG002|Overall Study|Other|1|||
147655427|NCT00435461|532561553|FG001|Overall Study|Pregnancy|0|||
147655428|NCT00435461|532561554|FG002|Overall Study|Pregnancy|0|||
147655429|NCT00435461|532561552|FG000|Overall Study|Participant moved eDiary,studymedication|1|||
147655430|NCT00435461|532561553|FG001|Overall Study|Participant moved eDiary,studymedication|0|||
147655431|NCT00435461|532561554|FG002|Overall Study|Participant moved eDiary,studymedication|0|||
147655432|NCT00435461|532561552|FG000|Overall Study|Participant ended study one day early|1|||
147655433|NCT00435461|532561553|FG001|Overall Study|Participant ended study one day early|0|||
147655434|NCT00435461|532561554|FG002|Overall Study|Participant ended study one day early|0|||
147655435|NCT00435461|532561552|FG000|Overall Study|Noncompliance with study requirements|1|||
147655436|NCT00435461|532561553|FG001|Overall Study|Noncompliance with study requirements|1|||
147655437|NCT00435461|532561554|FG002|Overall Study|Noncompliance with study requirements|1|||
147655438|NCT00435461|532561552|FG000|Overall Study|Adverse Event|1|||
147655439|NCT00435461|532561553|FG001|Overall Study|Adverse Event|2|||
147655440|NCT00435461|532561554|FG002|Overall Study|Adverse Event|6|||
147655441|NCT00435461|532561552|FG000|Overall Study|Non-Compliance of diary|2|||
147655442|NCT00435461|532561553|FG001|Overall Study|Non-Compliance of diary|0|||
147655443|NCT00435461|532561554|FG002|Overall Study|Non-Compliance of diary|1|||
147655444|NCT00435461|532561552|FG000|Overall Study|Lost to Follow-up|1|||
147655445|NCT00435461|532561553|FG001|Overall Study|Lost to Follow-up|1|||
147655446|NCT00435461|532561554|FG002|Overall Study|Lost to Follow-up|2|||
147655447|NCT01768559|532561559|FG000|Overall Study|Randomized but not treated|0|||
147655448|NCT01768559|532561560|FG001|Overall Study|Randomized but not treated|0|||
147655449|NCT01768559|532561561|FG002|Overall Study|Randomized but not treated|1|||
147655450|NCT01768559|532561559|FG000|Overall Study|Adverse Event|15|||
147655451|NCT01768559|532561560|FG001|Overall Study|Adverse Event|2|||
147655452|NCT01768559|532561561|FG002|Overall Study|Adverse Event|5|||
147655453|NCT01768559|532561559|FG000|Overall Study|Lack of Efficacy|6|||
147655454|NCT01768559|532561560|FG001|Overall Study|Lack of Efficacy|4|||
147655455|NCT01768559|532561561|FG002|Overall Study|Lack of Efficacy|0|||
147655456|NCT01768559|532561559|FG000|Overall Study|Poor compliance to protocol|0|||
147655457|NCT01768559|532561560|FG001|Overall Study|Poor compliance to protocol|3|||
147655458|NCT01768559|532561561|FG002|Overall Study|Poor compliance to protocol|2|||
147655459|NCT01768559|532561559|FG000|Overall Study|Other than specified|9|||
147655460|NCT01768559|532561560|FG001|Overall Study|Other than specified|8|||
147655461|NCT01768559|532561561|FG002|Overall Study|Other than specified|5|||
147655462|NCT00837967|532561562|FG000|Washout Period of 7 - 14 Days|Adverse Event|2|||
147655463|NCT00837967|532561563|FG001|Washout Period of 7 - 14 Days|Adverse Event|0|||
147655464|NCT02504320|532561566|FG000|Treatment Period 1|Positive Drug Screen|0|||
147655465|NCT02504320|532561567|FG001|Treatment Period 1|Positive Drug Screen|0|||
147655466|NCT02504320|532561568|FG002|Treatment Period 1|Positive Drug Screen|1|||
147655467|NCT02504320|532561569|FG003|Treatment Period 1|Positive Drug Screen|0|||
147592550|NCT01642914|532325081|FG000|Overall Study|Adverse Event|11|||
147592551|NCT01642914|532325082|FG001|Overall Study|Adverse Event|7|||
147592552|NCT01642914|532325083|FG002|Overall Study|Adverse Event|15|||
147592553|NCT01642914|532325081|FG000|Overall Study|Lack of Efficacy|9|||
147592554|NCT01642914|532325082|FG001|Overall Study|Lack of Efficacy|4|||
147592555|NCT01642914|532325083|FG002|Overall Study|Lack of Efficacy|2|||
147592556|NCT01642914|532325081|FG000|Overall Study|Protocol Violation|15|||
147592557|NCT01642914|532325082|FG001|Overall Study|Protocol Violation|13|||
147592558|NCT01642914|532325083|FG002|Overall Study|Protocol Violation|6|||
147655468|NCT02504320|532561566|FG000|Treatment Period 2|Positive Drug Screen|0|||
147173111|NCT01009086|530798294|FG001|Overall Study|Adverse Event|11|||
147173112|NCT01009086|530798295|FG002|Overall Study|Adverse Event|8|||
147592559|NCT01642914|532325081|FG000|Overall Study|Withdrawal by Subject|5|||
147592560|NCT01642914|532325082|FG001|Overall Study|Withdrawal by Subject|5|||
147592561|NCT01642914|532325083|FG002|Overall Study|Withdrawal by Subject|10|||
147592562|NCT01642914|532325081|FG000|Overall Study|Lost to Follow-up|5|||
147173113|NCT01009086|530798293|FG000|Overall Study|Withdrawal by Subject|9|||
147173114|NCT01009086|530798294|FG001|Overall Study|Withdrawal by Subject|11|||
147173115|NCT01009086|530798295|FG002|Overall Study|Withdrawal by Subject|13|||
147173116|NCT01009086|530798293|FG000|Overall Study|Other|3|||
147173117|NCT01009086|530798294|FG001|Overall Study|Other|5|||
147173118|NCT01009086|530798295|FG002|Overall Study|Other|1|||
147173119|NCT01389323|530798296|FG000|Treatment Period (up to 48 Weeks)|Lack of Efficacy|41|||
147173120|NCT01389323|530798296|FG000|Treatment Period (up to 48 Weeks)|Adverse Event|24|||
147173121|NCT01389323|530798296|FG000|Treatment Period (up to 48 Weeks)|Participant's request to discontinue|6|||
147173122|NCT01389323|530798296|FG000|Treatment Period (up to 48 Weeks)|Withdrawal by Subject|7|||
147173123|NCT01389323|530798296|FG000|Treatment Period (up to 48 Weeks)|Lost to Follow-up|10|||
147173124|NCT01389323|530798296|FG000|Treatment Period (up to 48 Weeks)|Poor/non-compliance|5|||
147173125|NCT01389323|530798296|FG000|Treatment Period (up to 48 Weeks)|Did not meet study criteria|2|||
147173126|NCT01389323|530798296|FG000|Follow-up Period (up to 48 Weeks)|Withdrawal by Subject|10|||
147173127|NCT01389323|530798296|FG000|Follow-up Period (up to 48 Weeks)|Lost to Follow-up|22|||
147173128|NCT01389323|530798296|FG000|Follow-up Period (up to 48 Weeks)|Follow-up no longer needed per protocol|2|||
147173129|NCT01389323|530798296|FG000|Follow-up Period (up to 48 Weeks)|Other|3|||
147173130|NCT01147848|530798302|FG000|Run-in Period|Screen Failure|623|||
147173131|NCT01147848|530798303|FG001|Run-in Period|Screen Failure|0|||
147173132|NCT01147848|530798304|FG002|Run-in Period|Screen Failure|0|||
147173133|NCT01147848|530798302|FG000|Run-in Period|Run-in Failure|135|||
147173134|NCT01147848|530798303|FG001|Run-in Period|Run-in Failure|0|||
147173135|NCT01147848|530798304|FG002|Run-in Period|Run-in Failure|0|||
147173136|NCT01147848|530798302|FG000|Randomized Phase|Adverse Event|0|||
147173137|NCT01147848|530798303|FG001|Randomized Phase|Adverse Event|6|||
147173138|NCT01147848|530798304|FG002|Randomized Phase|Adverse Event|8|||
147324041|NCT03635112|531352412|FG000|Overall Study|Miscellaneous|0|||
147324042|NCT03635112|531352413|FG001|Overall Study|Miscellaneous|0|||
147324043|NCT03635112|531352414|FG002|Overall Study|Miscellaneous|1|||
147324044|NCT00463151|531352415|FG000|Overall Study|Adverse Event|0|||
147324045|NCT00463151|531352416|FG001|Overall Study|Adverse Event|0|||
147324046|NCT00463151|531352417|FG002|Overall Study|Adverse Event|1|||
147324047|NCT00463151|531352418|FG003|Overall Study|Adverse Event|0|||
147324048|NCT00463151|531352415|FG000|Overall Study|Lack of Efficacy|2|||
147324049|NCT00463151|531352416|FG001|Overall Study|Lack of Efficacy|5|||
147324050|NCT00463151|531352417|FG002|Overall Study|Lack of Efficacy|2|||
147324051|NCT00463151|531352418|FG003|Overall Study|Lack of Efficacy|5|||
147324052|NCT00463151|531352415|FG000|Overall Study|Protocol Violation|0|||
147324053|NCT00463151|531352416|FG001|Overall Study|Protocol Violation|0|||
147324054|NCT00463151|531352417|FG002|Overall Study|Protocol Violation|0|||
147324055|NCT00463151|531352418|FG003|Overall Study|Protocol Violation|1|||
147324056|NCT00463151|531352415|FG000|Overall Study|Withdrawal by Subject|0|||
147324057|NCT00463151|531352416|FG001|Overall Study|Withdrawal by Subject|0|||
147324058|NCT00463151|531352417|FG002|Overall Study|Withdrawal by Subject|0|||
147448137|NCT00960661|531805644|FG000|Basal Insulin Optimization Phase (BIO)|Sponsor decision|3|||
147448138|NCT00960661|531805645|FG001|Basal Insulin Optimization Phase (BIO)|Sponsor decision|0|||
147173139|NCT01147848|530798302|FG000|Randomized Phase|Lack of Efficacy|0|||
147173140|NCT01147848|530798303|FG001|Randomized Phase|Lack of Efficacy|20|||
147655469|NCT02504320|532561567|FG001|Treatment Period 2|Positive Drug Screen|1|||
147655470|NCT02504320|532561568|FG002|Treatment Period 2|Positive Drug Screen|0|||
147655471|NCT02504320|532561569|FG003|Treatment Period 2|Positive Drug Screen|0|||
147655472|NCT02504320|532561566|FG000|Treatment Period 3|Positive Drug Screen|0|||
147655473|NCT02504320|532561567|FG001|Treatment Period 3|Positive Drug Screen|0|||
147655474|NCT02504320|532561568|FG002|Treatment Period 3|Positive Drug Screen|0|||
147655475|NCT02504320|532561569|FG003|Treatment Period 3|Positive Drug Screen|1|||
147655476|NCT02504320|532561566|FG000|Treatment Period 3|Adverse Event|0|||
147655477|NCT02504320|532561567|FG001|Treatment Period 3|Adverse Event|0|||
147655478|NCT02504320|532561568|FG002|Treatment Period 3|Adverse Event|1|||
147655479|NCT02504320|532561569|FG003|Treatment Period 3|Adverse Event|0|||
147655480|NCT01737879|532561570|FG000|Overall Study|Death|1|||
147173141|NCT01147848|530798304|FG002|Randomized Phase|Lack of Efficacy|11|||
147173142|NCT01147848|530798302|FG000|Randomized Phase|Protocol Violation|0|||
147324059|NCT00463151|531352418|FG003|Overall Study|Withdrawal by Subject|1|||
147448139|NCT00960661|531805646|FG002|Basal Insulin Optimization Phase (BIO)|Sponsor decision|0|||
147173143|NCT01147848|530798303|FG001|Randomized Phase|Protocol Violation|7|||
147655481|NCT01737879|532561570|FG000|Overall Study|Sponsor decision|40|||
147173144|NCT01147848|530798304|FG002|Randomized Phase|Protocol Violation|10|||
147173145|NCT01147848|530798302|FG000|Randomized Phase|Lost to Follow-up|0|||
147324060|NCT05349084|531352419|FG000|Overall Study|Radiotracer production failed. Patient received an intervention so did not qualify to come back.|1|||
147324061|NCT00972543|531352420|FG000|Overall Study|Adverse Event|1|||
147324062|NCT00972543|531352421|FG001|Overall Study|Adverse Event|0|||
147655482|NCT00685360|532561571|FG000|Overall Study|Lost to Follow-up|0|||
147655483|NCT00685360|532561572|FG001|Overall Study|Lost to Follow-up|1|||
147655484|NCT00685360|532561573|FG002|Overall Study|Lost to Follow-up|2|||
147655485|NCT00685360|532561571|FG000|Overall Study|Adverse Event|4|||
147655486|NCT00685360|532561572|FG001|Overall Study|Adverse Event|6|||
147173146|NCT01147848|530798303|FG001|Randomized Phase|Lost to Follow-up|5|||
147173147|NCT01147848|530798304|FG002|Randomized Phase|Lost to Follow-up|7|||
147173148|NCT01147848|530798302|FG000|Randomized Phase|Physician Decision|0|||
147173149|NCT01147848|530798303|FG001|Randomized Phase|Physician Decision|0|||
147173150|NCT01147848|530798304|FG002|Randomized Phase|Physician Decision|1|||
147173151|NCT01147848|530798302|FG000|Randomized Phase|Withdrawal by Subject|0|||
147173152|NCT01147848|530798303|FG001|Randomized Phase|Withdrawal by Subject|7|||
147173153|NCT01147848|530798304|FG002|Randomized Phase|Withdrawal by Subject|9|||
147173154|NCT03596450|530798317|FG000|Overall Study|Death|9|||
147173155|NCT03596450|530798318|FG001|Overall Study|Death|9|||
147173156|NCT03596450|530798317|FG000|Overall Study|Protocol Violation|18|||
147173157|NCT03596450|530798318|FG001|Overall Study|Protocol Violation|26|||
147173158|NCT03596450|530798317|FG000|Overall Study|Lost to Follow-up|50|||
147448140|NCT00960661|531805644|FG000|Interventional Phase|Adverse Event|0|||
147655487|NCT00685360|532561573|FG002|Overall Study|Adverse Event|4|||
147655488|NCT00685360|532561571|FG000|Overall Study|Subject Met (Protocol Specified) Withdrawal Criteria|1|||
147655489|NCT00685360|532561572|FG001|Overall Study|Subject Met (Protocol Specified) Withdrawal Criteria|0|||
147655490|NCT00685360|532561573|FG002|Overall Study|Subject Met (Protocol Specified) Withdrawal Criteria|2|||
147655491|NCT00685360|532561571|FG000|Overall Study|Subject was Withdrawn From Participation by the Investigator|0|||
147655492|NCT00685360|532561572|FG001|Overall Study|Subject was Withdrawn From Participation by the Investigator|4|||
147655493|NCT00685360|532561573|FG002|Overall Study|Subject was Withdrawn From Participation by the Investigator|1|||
147655494|NCT00685360|532561571|FG000|Overall Study|Subject Withdrew Consent to Participate|13|||
147655495|NCT00685360|532561572|FG001|Overall Study|Subject Withdrew Consent to Participate|2|||
147655496|NCT00685360|532561573|FG002|Overall Study|Subject Withdrew Consent to Participate|5|||
147655497|NCT00685360|532561571|FG000|Overall Study|Protocol Deviation|0|||
147655498|NCT00685360|532561572|FG001|Overall Study|Protocol Deviation|1|||
147655499|NCT00685360|532561573|FG002|Overall Study|Protocol Deviation|1|||
147655500|NCT04978337|532561576|FG000|Overall Study|Withdrawal by Subject|0|||
147655501|NCT04978337|532561577|FG001|Overall Study|Withdrawal by Subject|1|||
147655502|NCT02497404|532561578|FG000|Overall Study|Adverse Event|1|||
147655503|NCT01408901|532561579|FG000|6-Week Follow-Up|Lost to Follow-up|2|||
147655504|NCT01408901|532561580|FG001|6-Week Follow-Up|Lost to Follow-up|1|||
147655505|NCT01408901|532561581|FG002|6-Week Follow-Up|Lost to Follow-up|3|||
147655506|NCT01408901|532561582|FG003|6-Week Follow-Up|Lost to Follow-up|2|||
147655507|NCT01408901|532561579|FG000|6-Week Follow-Up|Death|1|||
147655508|NCT01408901|532561580|FG001|6-Week Follow-Up|Death|0|||
147655509|NCT01408901|532561581|FG002|6-Week Follow-Up|Death|0|||
147655510|NCT01408901|532561582|FG003|6-Week Follow-Up|Death|0|||
147655511|NCT01408901|532561579|FG000|6-Week Follow-Up|Cancelled visit|0|||
147655512|NCT01408901|532561580|FG001|6-Week Follow-Up|Cancelled visit|1|||
147655513|NCT01408901|532561581|FG002|6-Week Follow-Up|Cancelled visit|0|||
147655514|NCT01408901|532561582|FG003|6-Week Follow-Up|Cancelled visit|2|||
147655515|NCT01408901|532561579|FG000|12-Week Follow-Up (Primary Endpoint)|Lost to Follow-up|0|||
147655516|NCT01408901|532561580|FG001|12-Week Follow-Up (Primary Endpoint)|Lost to Follow-up|0|||
147655517|NCT01408901|532561581|FG002|12-Week Follow-Up (Primary Endpoint)|Lost to Follow-up|0|||
147655518|NCT01408901|532561582|FG003|12-Week Follow-Up (Primary Endpoint)|Lost to Follow-up|2|||
147655519|NCT01408901|532561579|FG000|12-Week Follow-Up (Primary Endpoint)|Death|1|||
147655520|NCT01408901|532561580|FG001|12-Week Follow-Up (Primary Endpoint)|Death|0|||
147655521|NCT01408901|532561581|FG002|12-Week Follow-Up (Primary Endpoint)|Death|0|||
147655522|NCT01408901|532561582|FG003|12-Week Follow-Up (Primary Endpoint)|Death|0|||
147655523|NCT01408901|532561579|FG000|12-Week Follow-Up (Primary Endpoint)|Cancelled visit|0|||
147655524|NCT01408901|532561580|FG001|12-Week Follow-Up (Primary Endpoint)|Cancelled visit|2|||
147655525|NCT01408901|532561581|FG002|12-Week Follow-Up (Primary Endpoint)|Cancelled visit|0|||
147655526|NCT01408901|532561582|FG003|12-Week Follow-Up (Primary Endpoint)|Cancelled visit|1|||
147655527|NCT01408901|532561579|FG000|26-Week Follow-Up|Lost to Follow-up|1|||
147655528|NCT01408901|532561580|FG001|26-Week Follow-Up|Lost to Follow-up|1|||
147655529|NCT01408901|532561581|FG002|26-Week Follow-Up|Lost to Follow-up|0|||
147655530|NCT01408901|532561582|FG003|26-Week Follow-Up|Lost to Follow-up|1|||
147655531|NCT01408901|532561579|FG000|26-Week Follow-Up|Death|0|||
147655532|NCT01408901|532561580|FG001|26-Week Follow-Up|Death|1|||
147655533|NCT01408901|532561581|FG002|26-Week Follow-Up|Death|0|||
147655534|NCT01408901|532561582|FG003|26-Week Follow-Up|Death|0|||
147655535|NCT00845676|532561583|FG000|Overall Study|Virologic breakthrough at week 20|1|||
147173159|NCT03596450|530798318|FG001|Overall Study|Lost to Follow-up|56|||
147173160|NCT03596450|530798317|FG000|Overall Study|Adverse Event|14|||
147173161|NCT03596450|530798318|FG001|Overall Study|Adverse Event|7|||
147655536|NCT00845676|532561583|FG000|Overall Study|Adverse Event|1|||
147655537|NCT03275389|532561585|FG000|Overall Study|Lost to Follow-up|10|||
147655538|NCT03275389|532561586|FG001|Overall Study|Lost to Follow-up|10|||
147655539|NCT03275389|532561587|FG002|Overall Study|Lost to Follow-up|19|||
147655540|NCT03275389|532561588|FG003|Overall Study|Lost to Follow-up|12|||
147655541|NCT03275389|532561589|FG004|Overall Study|Lost to Follow-up|11|||
147655542|NCT03275389|532561590|FG005|Overall Study|Lost to Follow-up|12|||
147655543|NCT03275389|532561591|FG006|Overall Study|Lost to Follow-up|21|||
147173162|NCT03596450|530798317|FG000|Overall Study|Withdrawal by Subject|38|||
147173163|NCT03596450|530798318|FG001|Overall Study|Withdrawal by Subject|36|||
147173164|NCT03596450|530798317|FG000|Overall Study|Accidentally Randomized|2|||
147173165|NCT03596450|530798318|FG001|Overall Study|Accidentally Randomized|0|||
147173166|NCT03596450|530798317|FG000|Overall Study|Other reasons|48|||
147173167|NCT03596450|530798318|FG001|Overall Study|Other reasons|53|||
147173168|NCT03596450|530798317|FG000|Overall Study|Pregnancy|2|||
147173169|NCT03596450|530798318|FG001|Overall Study|Pregnancy|0|||
147173170|NCT04058886|530798319|FG000|Overall Study|Withdrawal by Subject|4|||
147173171|NCT04058886|530798319|FG000|Overall Study|Inadequate deafness interpreter service|1|||
147173172|NCT01069705|530798320|FG000|Overall Study|Adverse Event|1|||
147173173|NCT01069705|530798320|FG000|Overall Study|Withdrawal by Subject|2|||
147173174|NCT03624127|530798321|FG000|Pre-treatment|Participant discontinued from study prior to treatment due to incorrect randomization|0|||
147173175|NCT03624127|530798322|FG001|Pre-treatment|Participant discontinued from study prior to treatment due to incorrect randomization|1|||
147173176|NCT03624127|530798323|FG002|Pre-treatment|Participant discontinued from study prior to treatment due to incorrect randomization|0|||
147173177|NCT03624127|530798321|FG000|Treatment Week 0 - Week 16|Adverse Event|5|||
147173178|NCT03624127|530798322|FG001|Treatment Week 0 - Week 16|Adverse Event|7|||
147173179|NCT03624127|530798323|FG002|Treatment Week 0 - Week 16|Adverse Event|10|||
147173180|NCT03624127|530798321|FG000|Treatment Week 0 - Week 16|Death|0|||
147173181|NCT03624127|530798322|FG001|Treatment Week 0 - Week 16|Death|1|||
147173182|NCT03624127|530798323|FG002|Treatment Week 0 - Week 16|Death|0|||
147173183|NCT03624127|530798321|FG000|Treatment Week 0 - Week 16|Lack of Efficacy|0|||
147173184|NCT03624127|530798322|FG001|Treatment Week 0 - Week 16|Lack of Efficacy|1|||
147173185|NCT03624127|530798323|FG002|Treatment Week 0 - Week 16|Lack of Efficacy|1|||
147173186|NCT03624127|530798321|FG000|Treatment Week 0 - Week 16|Lost to Follow-up|7|||
147173187|NCT03624127|530798322|FG001|Treatment Week 0 - Week 16|Lost to Follow-up|2|||
147173188|NCT03624127|530798323|FG002|Treatment Week 0 - Week 16|Lost to Follow-up|4|||
147173189|NCT03624127|530798321|FG000|Treatment Week 0 - Week 16|Protocol Violation|1|||
147173190|NCT03624127|530798322|FG001|Treatment Week 0 - Week 16|Protocol Violation|1|||
147173191|NCT03624127|530798323|FG002|Treatment Week 0 - Week 16|Protocol Violation|2|||
147173192|NCT03624127|530798321|FG000|Treatment Week 0 - Week 16|Withdrawal by Subject|4|||
147324063|NCT00972543|531352420|FG000|Overall Study|Early study termination by sponsor|4|||
147324064|NCT00972543|531352421|FG001|Overall Study|Early study termination by sponsor|1|||
147592563|NCT01642914|532325082|FG001|Overall Study|Lost to Follow-up|3|||
147592564|NCT01642914|532325083|FG002|Overall Study|Lost to Follow-up|7|||
147592565|NCT01642914|532325081|FG000|Overall Study|Other Reason|1|||
147592566|NCT01642914|532325082|FG001|Overall Study|Other Reason|0|||
147592567|NCT01642914|532325083|FG002|Overall Study|Other Reason|0|||
147592568|NCT01705236|532325084|FG000|Overall Study|Lost to Follow-up|1|||
147592569|NCT01705236|532325084|FG000|Overall Study|Administrative problems|2|||
147592570|NCT01705236|532325084|FG000|Overall Study|Unsatisfactory therapeutic effect|3|||
147592571|NCT01705236|532325084|FG000|Overall Study|Protocol Violation|3|||
147592572|NCT01705236|532325084|FG000|Overall Study|Abnormal test procedure result(s)|4|||
147592573|NCT01705236|532325084|FG000|Overall Study|Abnormal laboratory value(s)|4|||
147592574|NCT01705236|532325084|FG000|Overall Study|Withdrawal by Subject|5|||
147592575|NCT01705236|532325084|FG000|Overall Study|Adverse Event|5|||
147592576|NCT03028740|532325085|FG000|Overall Study|Did not Receive Study Drug|4|||
147592577|NCT03028740|532325086|FG001|Overall Study|Did not Receive Study Drug|5|||
147592578|NCT03028740|532325085|FG000|Overall Study|Adverse Event|8|||
147592579|NCT03028740|532325086|FG001|Overall Study|Adverse Event|26|||
147592580|NCT03028740|532325085|FG000|Overall Study|Lack of Efficacy|0|||
147592581|NCT03028740|532325086|FG001|Overall Study|Lack of Efficacy|1|||
147592582|NCT03028740|532325085|FG000|Overall Study|Withdrawal by Subject|48|||
147592583|NCT03028740|532325086|FG001|Overall Study|Withdrawal by Subject|101|||
147592584|NCT03028740|532325085|FG000|Overall Study|Lost to Follow-up|30|||
147592585|NCT03028740|532325086|FG001|Overall Study|Lost to Follow-up|54|||
147324065|NCT00293462|531352422|FG000|Overall Study|Withdrawal by Subject|4|||
147324066|NCT00293462|531352423|FG001|Overall Study|Withdrawal by Subject|3|||
147324067|NCT00293462|531352424|FG002|Overall Study|Withdrawal by Subject|8|||
147324068|NCT00293462|531352422|FG000|Overall Study|Death|1|||
147324069|NCT00293462|531352423|FG001|Overall Study|Death|0|||
147324070|NCT00293462|531352424|FG002|Overall Study|Death|0|||
147324071|NCT00293462|531352422|FG000|Overall Study|Lost to Follow-up|0|||
147592586|NCT03028740|532325085|FG000|Overall Study|Physician Decision|4|||
147592587|NCT03028740|532325086|FG001|Overall Study|Physician Decision|11|||
147173193|NCT03624127|530798322|FG001|Treatment Week 0 - Week 16|Withdrawal by Subject|3|||
147173194|NCT03624127|530798323|FG002|Treatment Week 0 - Week 16|Withdrawal by Subject|3|||
147173195|NCT03624127|530798321|FG000|Treatment Week 0 - Week 16|Other reasons|8|||
147173196|NCT03624127|530798322|FG001|Treatment Week 0 - Week 16|Other reasons|5|||
147324072|NCT00293462|531352423|FG001|Overall Study|Lost to Follow-up|1|||
147324073|NCT00293462|531352424|FG002|Overall Study|Lost to Follow-up|0|||
147592588|NCT03028740|532325085|FG000|Overall Study|Protocol Violation|4|||
147592589|NCT03028740|532325086|FG001|Overall Study|Protocol Violation|8|||
147592590|NCT03028740|532325085|FG000|Overall Study|Non-compliance with Study Drug|0|||
147592591|NCT03028740|532325086|FG001|Overall Study|Non-compliance with Study Drug|2|||
147173197|NCT03624127|530798323|FG002|Treatment Week 0 - Week 16|Other reasons|3|||
147173198|NCT03624127|530798321|FG000|Treatment Week 16 - Week 24|Adverse Event|1|||
147173199|NCT03624127|530798322|FG001|Treatment Week 16 - Week 24|Adverse Event|0|||
147173200|NCT03624127|530798323|FG002|Treatment Week 16 - Week 24|Adverse Event|1|||
147173201|NCT03624127|530798321|FG000|Treatment Week 16 - Week 24|Lack of Efficacy|3|||
147173202|NCT03624127|530798322|FG001|Treatment Week 16 - Week 24|Lack of Efficacy|0|||
147173203|NCT03624127|530798323|FG002|Treatment Week 16 - Week 24|Lack of Efficacy|0|||
147173204|NCT03624127|530798321|FG000|Treatment Week 16 - Week 24|Lost to Follow-up|0|||
147173205|NCT03624127|530798322|FG001|Treatment Week 16 - Week 24|Lost to Follow-up|0|||
147592592|NCT03028740|532325085|FG000|Overall Study|Study Terminated by Sponsor|467|||
147592593|NCT03028740|532325086|FG001|Overall Study|Study Terminated by Sponsor|917|||
147655544|NCT03275389|532561592|FG007|Overall Study|Lost to Follow-up|15|||
147655545|NCT03275389|532561593|FG008|Overall Study|Lost to Follow-up|12|||
147655546|NCT03275389|532561594|FG009|Overall Study|Lost to Follow-up|14|||
147655547|NCT03275389|532561585|FG000|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
147655548|NCT03275389|532561586|FG001|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
147655549|NCT03275389|532561587|FG002|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
147655550|NCT03275389|532561588|FG003|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
147592594|NCT03028740|532325085|FG000|Overall Study|Protocol-specified Withdrawal Criteria Met|27|||
147592595|NCT03028740|532325086|FG001|Overall Study|Protocol-specified Withdrawal Criteria Met|55|||
147592596|NCT03028740|532325085|FG000|Overall Study|Reason not Specified|1|||
147592597|NCT03028740|532325086|FG001|Overall Study|Reason not Specified|5|||
147592598|NCT00171301|532325087|FG000|Overall Study|Death|1|||
147592599|NCT00171301|532325088|FG001|Overall Study|Death|2|||
147592600|NCT00171301|532325087|FG000|Overall Study|Adverse Event|1|||
147592601|NCT00171301|532325088|FG001|Overall Study|Adverse Event|2|||
147592602|NCT00171301|532325087|FG000|Overall Study|Lost to Follow-up|6|||
147592603|NCT00171301|532325088|FG001|Overall Study|Lost to Follow-up|2|||
147592604|NCT00171301|532325087|FG000|Overall Study|Protocol Violation|0|||
147592605|NCT00171301|532325088|FG001|Overall Study|Protocol Violation|2|||
147592606|NCT00171301|532325087|FG000|Overall Study|Withdrawal by Subject|0|||
147592607|NCT00171301|532325088|FG001|Overall Study|Withdrawal by Subject|1|||
147592608|NCT02589522|532325090|FG000|Overall Study|Physician Decision|1|||
147592609|NCT02589522|532325091|FG001|Overall Study|Physician Decision|2|||
147592610|NCT02589522|532325092|FG002|Overall Study|Physician Decision|0|||
147592611|NCT02589522|532325090|FG000|Overall Study|Did not start treatment|1|||
147592612|NCT02589522|532325091|FG001|Overall Study|Did not start treatment|0|||
147592613|NCT02589522|532325092|FG002|Overall Study|Did not start treatment|0|||
147592614|NCT02025010|532325093|FG000|Overall Study|Symptomatic or radiographic progression|36|||
147592615|NCT02025010|532325093|FG000|Overall Study|Adverse Event|6|||
147592616|NCT02025010|532325093|FG000|Overall Study|Physician Decision|7|||
147592617|NCT02025010|532325093|FG000|Overall Study|Withdrawal by Subject|3|||
147592618|NCT02025010|532325093|FG000|Overall Study|Intercurrent illness|3|||
147592619|NCT02025010|532325093|FG000|Overall Study|Patients still on treatment|3|||
147592620|NCT02025010|532325093|FG000|Overall Study|Never initiate the treatment|2|||
147592621|NCT01300052|532325094|FG000|Overall Study|Adverse Event|3|||
147592622|NCT01300052|532325095|FG001|Overall Study|Adverse Event|0|||
147592623|NCT01300052|532325094|FG000|Overall Study|Withdrawal by Subject|2|||
147592624|NCT01300052|532325095|FG001|Overall Study|Withdrawal by Subject|2|||
147592625|NCT01300052|532325094|FG000|Overall Study|Protocol Violation|1|||
147592626|NCT01300052|532325095|FG001|Overall Study|Protocol Violation|1|||
147592627|NCT01661881|532325096|FG000|Overall Study|Disease Progression|1|||
147592628|NCT01231373|532325097|FG000|Overall Study|Withdrew consent prior to randomization|2|||
147592629|NCT01231373|532325098|FG001|Overall Study|Withdrew consent prior to randomization|1|||
147592630|NCT01231373|532325099|FG002|Overall Study|Withdrew consent prior to randomization|0|||
147592631|NCT01231373|532325100|FG003|Overall Study|Withdrew consent prior to randomization|0|||
147592632|NCT01231373|532325097|FG000|Overall Study|Lost to Follow-up|0|||
147592633|NCT01231373|532325098|FG001|Overall Study|Lost to Follow-up|0|||
147592634|NCT01231373|532325099|FG002|Overall Study|Lost to Follow-up|0|||
147592635|NCT01231373|532325100|FG003|Overall Study|Lost to Follow-up|1|||
147592636|NCT01231373|532325097|FG000|Overall Study|Withdrew Consent|1|||
147592637|NCT01231373|532325098|FG001|Overall Study|Withdrew Consent|0|||
147592638|NCT01231373|532325099|FG002|Overall Study|Withdrew Consent|0|||
147592639|NCT01231373|532325100|FG003|Overall Study|Withdrew Consent|0|||
147592640|NCT00102687|532325105|FG000|Initial Period|Withdrawal by Subject|6|||
147592641|NCT00102687|532325106|FG001|Initial Period|Withdrawal by Subject|3|||
147592642|NCT00102687|532325107|FG002|Initial Period|Withdrawal by Subject|5|||
147592643|NCT00102687|532325108|FG003|Initial Period|Withdrawal by Subject|0|||
147592644|NCT00102687|532325109|FG004|Initial Period|Withdrawal by Subject|0|||
147592645|NCT00102687|532325105|FG000|Initial Period|Adverse Event|4|||
147592646|NCT00102687|532325106|FG001|Initial Period|Adverse Event|7|||
147592647|NCT00102687|532325107|FG002|Initial Period|Adverse Event|9|||
147173206|NCT03624127|530798323|FG002|Treatment Week 16 - Week 24|Lost to Follow-up|2|||
147592648|NCT00102687|532325108|FG003|Initial Period|Adverse Event|0|||
147655551|NCT03275389|532561589|FG004|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
147655552|NCT03275389|532561590|FG005|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|1|||
147173207|NCT03624127|530798321|FG000|Treatment Week 16 - Week 24|Protocol Violation|1|||
147173208|NCT03624127|530798322|FG001|Treatment Week 16 - Week 24|Protocol Violation|0|||
147173209|NCT03624127|530798323|FG002|Treatment Week 16 - Week 24|Protocol Violation|0|||
147173210|NCT03624127|530798321|FG000|Treatment Week 16 - Week 24|Withdrawal by Subject|2|||
147173211|NCT03624127|530798322|FG001|Treatment Week 16 - Week 24|Withdrawal by Subject|0|||
147173212|NCT03624127|530798323|FG002|Treatment Week 16 - Week 24|Withdrawal by Subject|1|||
147173213|NCT03624127|530798321|FG000|Treatment Week 16 - Week 24|Other reasons|3|||
147173214|NCT03624127|530798322|FG001|Treatment Week 16 - Week 24|Other reasons|0|||
147173215|NCT03624127|530798323|FG002|Treatment Week 16 - Week 24|Other reasons|0|||
147173216|NCT03624127|530798321|FG000|Treatment Week 24 - Week 52|Adverse Event|8|||
147173217|NCT03624127|530798322|FG001|Treatment Week 24 - Week 52|Adverse Event|0|||
147173218|NCT03624127|530798323|FG002|Treatment Week 24 - Week 52|Adverse Event|1|||
147173219|NCT03624127|530798321|FG000|Treatment Week 24 - Week 52|Lack of Efficacy|6|||
147173220|NCT03624127|530798322|FG001|Treatment Week 24 - Week 52|Lack of Efficacy|0|||
147173221|NCT03624127|530798323|FG002|Treatment Week 24 - Week 52|Lack of Efficacy|0|||
147173222|NCT03624127|530798321|FG000|Treatment Week 24 - Week 52|Lost to Follow-up|5|||
147173223|NCT03624127|530798322|FG001|Treatment Week 24 - Week 52|Lost to Follow-up|0|||
147173224|NCT03624127|530798323|FG002|Treatment Week 24 - Week 52|Lost to Follow-up|1|||
147173225|NCT03624127|530798321|FG000|Treatment Week 24 - Week 52|Protocol Violation|2|||
147173226|NCT03624127|530798322|FG001|Treatment Week 24 - Week 52|Protocol Violation|0|||
147173227|NCT03624127|530798323|FG002|Treatment Week 24 - Week 52|Protocol Violation|0|||
147173228|NCT03624127|530798321|FG000|Treatment Week 24 - Week 52|Site terminated by sponsor|2|||
147173229|NCT03624127|530798322|FG001|Treatment Week 24 - Week 52|Site terminated by sponsor|0|||
147173230|NCT03624127|530798323|FG002|Treatment Week 24 - Week 52|Site terminated by sponsor|0|||
147173231|NCT03624127|530798321|FG000|Treatment Week 24 - Week 52|Withdrawal by Subject|10|||
147173232|NCT03624127|530798322|FG001|Treatment Week 24 - Week 52|Withdrawal by Subject|0|||
147173233|NCT03624127|530798323|FG002|Treatment Week 24 - Week 52|Withdrawal by Subject|0|||
147173234|NCT03624127|530798321|FG000|Treatment Week 24 - Week 52|Other reasons|19|||
147173235|NCT03624127|530798322|FG001|Treatment Week 24 - Week 52|Other reasons|0|||
147173236|NCT03624127|530798323|FG002|Treatment Week 24 - Week 52|Other reasons|2|||
147173237|NCT00915551|530798324|FG000|Overall Study|Withdrawal by Subject|0|||
147173238|NCT00915551|530798325|FG001|Overall Study|Withdrawal by Subject|1|||
147173239|NCT04390841|530798326|FG000|Overall Study|Withdrawal by Subject|2|||
147173240|NCT02999633|530798327|FG000|Overall Study|Adverse Event|2|||
147173241|NCT02999633|530798327|FG000|Overall Study|Progressive disease|12|||
147173242|NCT03262441|530798328|FG000|Overall Study|Withdrawal by Subject|1|||
147173243|NCT01545050|530798329|FG000|Overall Study|Lack of Efficacy|0|||
147173244|NCT01545050|530798330|FG001|Overall Study|Lack of Efficacy|0|||
147173245|NCT01545050|530798331|FG002|Overall Study|Lack of Efficacy|0|||
147173246|NCT01545050|530798332|FG003|Overall Study|Lack of Efficacy|3|||
147173247|NCT01545050|530798333|FG004|Overall Study|Lack of Efficacy|2|||
147173248|NCT01545050|530798329|FG000|Overall Study|Adverse Event|1|||
147173249|NCT01545050|530798330|FG001|Overall Study|Adverse Event|1|||
147173250|NCT01545050|530798331|FG002|Overall Study|Adverse Event|2|||
147173251|NCT01545050|530798332|FG003|Overall Study|Adverse Event|2|||
147173252|NCT01545050|530798333|FG004|Overall Study|Adverse Event|0|||
147173253|NCT01545050|530798329|FG000|Overall Study|Discontinued study treatment|1|||
147448141|NCT00960661|531805645|FG001|Interventional Phase|Adverse Event|17|||
147448142|NCT00960661|531805646|FG002|Interventional Phase|Adverse Event|8|||
147448143|NCT00960661|531805644|FG000|Interventional Phase|Death|0|||
147448144|NCT00960661|531805645|FG001|Interventional Phase|Death|1|||
147448145|NCT00960661|531805646|FG002|Interventional Phase|Death|0|||
147448146|NCT00960661|531805644|FG000|Interventional Phase|Lost to Follow-up|0|||
147592649|NCT00102687|532325109|FG004|Initial Period|Adverse Event|0|||
147173254|NCT01545050|530798330|FG001|Overall Study|Discontinued study treatment|0|||
147173255|NCT01545050|530798331|FG002|Overall Study|Discontinued study treatment|0|||
147173256|NCT01545050|530798332|FG003|Overall Study|Discontinued study treatment|0|||
147173257|NCT01545050|530798333|FG004|Overall Study|Discontinued study treatment|0|||
147173258|NCT01545050|530798329|FG000|Overall Study|Withdrawal by Subject|1|||
147173259|NCT01545050|530798330|FG001|Overall Study|Withdrawal by Subject|0|||
147173260|NCT01545050|530798331|FG002|Overall Study|Withdrawal by Subject|0|||
147448147|NCT00960661|531805645|FG001|Interventional Phase|Lost to Follow-up|0|||
147173261|NCT01545050|530798332|FG003|Overall Study|Withdrawal by Subject|2|||
147173262|NCT01545050|530798333|FG004|Overall Study|Withdrawal by Subject|1|||
147173263|NCT01545050|530798329|FG000|Overall Study|Participant no longer meets study criteria|0|||
147173264|NCT01545050|530798330|FG001|Overall Study|Participant no longer meets study criteria|2|||
147173265|NCT01545050|530798331|FG002|Overall Study|Participant no longer meets study criteria|0|||
147173266|NCT01545050|530798332|FG003|Overall Study|Participant no longer meets study criteria|0|||
147173267|NCT01545050|530798333|FG004|Overall Study|Participant no longer meets study criteria|1|||
147173268|NCT01545050|530798329|FG000|Overall Study|Administrative reason by sponsor|4|||
147173269|NCT01545050|530798330|FG001|Overall Study|Administrative reason by sponsor|2|||
147324074|NCT00293462|531352422|FG000|Overall Study|Change Treatment Regimen (ineligible)|1|||
147324075|NCT00293462|531352423|FG001|Overall Study|Change Treatment Regimen (ineligible)|0|||
147173270|NCT01545050|530798331|FG002|Overall Study|Administrative reason by sponsor|3|||
147173271|NCT01545050|530798332|FG003|Overall Study|Administrative reason by sponsor|5|||
147173272|NCT01545050|530798333|FG004|Overall Study|Administrative reason by sponsor|5|||
147173273|NCT02607228|530798334|FG000|Overall Study|Progressive Disease|4|||
147173274|NCT02607228|530798335|FG001|Overall Study|Progressive Disease|3|||
147173275|NCT02607228|530798336|FG002|Overall Study|Progressive Disease|1|||
147173276|NCT02607228|530798337|FG003|Overall Study|Progressive Disease|5|||
147173277|NCT02607228|530798338|FG004|Overall Study|Progressive Disease|4|||
147592650|NCT00102687|532325105|FG000|Initial Period|Transformation to AML (blast > 30%)|1|||
147592651|NCT00102687|532325106|FG001|Initial Period|Transformation to AML (blast > 30%)|3|||
147592652|NCT00102687|532325107|FG002|Initial Period|Transformation to AML (blast > 30%)|0|||
147592653|NCT00102687|532325108|FG003|Initial Period|Transformation to AML (blast > 30%)|0|||
147592654|NCT00102687|532325109|FG004|Initial Period|Transformation to AML (blast > 30%)|0|||
147592655|NCT00102687|532325105|FG000|Initial Period|Protocol Violation|0|||
147592656|NCT00102687|532325106|FG001|Initial Period|Protocol Violation|0|||
147592657|NCT00102687|532325107|FG002|Initial Period|Protocol Violation|2|||
147592658|NCT00102687|532325108|FG003|Initial Period|Protocol Violation|0|||
147592659|NCT00102687|532325109|FG004|Initial Period|Protocol Violation|0|||
147592660|NCT00102687|532325105|FG000|Initial Period|Physician Decision|2|||
147592661|NCT00102687|532325106|FG001|Initial Period|Physician Decision|9|||
147592662|NCT00102687|532325107|FG002|Initial Period|Physician Decision|6|||
147592663|NCT00102687|532325108|FG003|Initial Period|Physician Decision|0|||
147592664|NCT00102687|532325109|FG004|Initial Period|Physician Decision|0|||
147592665|NCT00102687|532325105|FG000|Initial Period|Sponsor's decision|0|||
147592666|NCT00102687|532325106|FG001|Initial Period|Sponsor's decision|1|||
147592667|NCT00102687|532325107|FG002|Initial Period|Sponsor's decision|1|||
147592668|NCT00102687|532325108|FG003|Initial Period|Sponsor's decision|0|||
147592669|NCT00102687|532325109|FG004|Initial Period|Sponsor's decision|0|||
147592670|NCT00102687|532325105|FG000|Initial Period|Failed Treatments (relapse,disease prog)|4|||
147592671|NCT00102687|532325106|FG001|Initial Period|Failed Treatments (relapse,disease prog)|4|||
147592672|NCT00102687|532325107|FG002|Initial Period|Failed Treatments (relapse,disease prog)|2|||
147592673|NCT00102687|532325108|FG003|Initial Period|Failed Treatments (relapse,disease prog)|0|||
147592674|NCT00102687|532325109|FG004|Initial Period|Failed Treatments (relapse,disease prog)|0|||
147592675|NCT00102687|532325105|FG000|Initial Period|Death|1|||
147592676|NCT00102687|532325106|FG001|Initial Period|Death|1|||
147173278|NCT02607228|530798339|FG005|Overall Study|Progressive Disease|3|||
147173279|NCT02607228|530798340|FG006|Overall Study|Progressive Disease|1|||
147173280|NCT02607228|530798334|FG000|Overall Study|Adverse Event|1|||
147173281|NCT02607228|530798335|FG001|Overall Study|Adverse Event|0|||
147173282|NCT02607228|530798336|FG002|Overall Study|Adverse Event|1|||
147173283|NCT02607228|530798337|FG003|Overall Study|Adverse Event|0|||
147173284|NCT02607228|530798338|FG004|Overall Study|Adverse Event|1|||
147173285|NCT02607228|530798339|FG005|Overall Study|Adverse Event|1|||
147173286|NCT02607228|530798340|FG006|Overall Study|Adverse Event|1|||
147173287|NCT02607228|530798334|FG000|Overall Study|Investigator's Discretion|0|||
147173288|NCT02607228|530798335|FG001|Overall Study|Investigator's Discretion|0|||
147173289|NCT02607228|530798336|FG002|Overall Study|Investigator's Discretion|1|||
147173290|NCT02607228|530798337|FG003|Overall Study|Investigator's Discretion|0|||
147173291|NCT02607228|530798338|FG004|Overall Study|Investigator's Discretion|0|||
147173292|NCT02607228|530798339|FG005|Overall Study|Investigator's Discretion|1|||
147173293|NCT02607228|530798340|FG006|Overall Study|Investigator's Discretion|0|||
147173294|NCT02607228|530798334|FG000|Overall Study|Withdrew Consent|0|||
147173295|NCT02607228|530798335|FG001|Overall Study|Withdrew Consent|1|||
147173296|NCT02607228|530798336|FG002|Overall Study|Withdrew Consent|0|||
147173297|NCT02607228|530798337|FG003|Overall Study|Withdrew Consent|0|||
147173298|NCT02607228|530798338|FG004|Overall Study|Withdrew Consent|0|||
147173299|NCT02607228|530798339|FG005|Overall Study|Withdrew Consent|1|||
147173300|NCT02607228|530798340|FG006|Overall Study|Withdrew Consent|0|||
147173301|NCT02607228|530798334|FG000|Overall Study|Study Terminated by Sponsor|0|||
147173302|NCT02607228|530798335|FG001|Overall Study|Study Terminated by Sponsor|0|||
147173303|NCT02607228|530798336|FG002|Overall Study|Study Terminated by Sponsor|0|||
147173304|NCT02607228|530798337|FG003|Overall Study|Study Terminated by Sponsor|1|||
147173305|NCT02607228|530798338|FG004|Overall Study|Study Terminated by Sponsor|0|||
147173306|NCT02607228|530798339|FG005|Overall Study|Study Terminated by Sponsor|0|||
147173307|NCT02607228|530798340|FG006|Overall Study|Study Terminated by Sponsor|0|||
147592677|NCT00102687|532325107|FG002|Initial Period|Death|1|||
147592678|NCT00102687|532325108|FG003|Initial Period|Death|0|||
147592679|NCT00102687|532325109|FG004|Initial Period|Death|0|||
147173308|NCT03235089|530798341|FG000|Overall Study|Lost to Follow-up|1|||
147173309|NCT03235089|530798342|FG001|Overall Study|Lost to Follow-up|1|||
147173310|NCT03235089|530798341|FG000|Overall Study|Physician Decision|2|||
147173311|NCT03235089|530798342|FG001|Overall Study|Physician Decision|2|||
147173312|NCT01196416|530798354|FG000|Overall Study|Withdrawal by Subject|2|||
147173313|NCT00727558|530798360|FG000|Overall Study|Lens issue|0|||
147173314|NCT00727558|530798361|FG001|Overall Study|Lens issue|1|||
147173315|NCT00727558|530798360|FG000|Overall Study|Adverse Event|0|||
147592680|NCT00102687|532325105|FG000|Maintenance Period|Withdrawal by Subject|4|||
147173316|NCT00727558|530798361|FG001|Overall Study|Adverse Event|1|||
147173317|NCT00727558|530798360|FG000|Overall Study|Subject unable to return for follow-up|1|||
147173318|NCT00727558|530798361|FG001|Overall Study|Subject unable to return for follow-up|1|||
147173319|NCT00727558|530798360|FG000|Overall Study|Lost to Follow-up|1|||
147173320|NCT00727558|530798361|FG001|Overall Study|Lost to Follow-up|0|||
147173321|NCT01717326|530798362|FG000|Overall Study|Death|0|||
147173322|NCT01717326|530798363|FG001|Overall Study|Death|0|||
147173323|NCT01717326|530798364|FG002|Overall Study|Death|0|||
147173324|NCT01717326|530798365|FG003|Overall Study|Death|0|||
147173325|NCT01717326|530798366|FG004|Overall Study|Death|0|||
147173326|NCT01717326|530798367|FG005|Overall Study|Death|0|||
147173327|NCT01717326|530798368|FG006|Overall Study|Death|0|||
147173328|NCT01717326|530798369|FG007|Overall Study|Death|0|||
147173329|NCT01717326|530798370|FG008|Overall Study|Death|0|||
147173330|NCT01717326|530798371|FG009|Overall Study|Death|0|||
147173331|NCT01717326|530798372|FG010|Overall Study|Death|1|||
147173332|NCT01717326|530798373|FG011|Overall Study|Death|0|||
147173333|NCT01717326|530798374|FG012|Overall Study|Death|0|||
147173334|NCT01717326|530798375|FG013|Overall Study|Death|0|||
147173335|NCT01717326|530798376|FG014|Overall Study|Death|0|||
147173336|NCT01717326|530798377|FG015|Overall Study|Death|0|||
147173337|NCT01717326|530798378|FG016|Overall Study|Death|0|||
147173338|NCT01717326|530798379|FG017|Overall Study|Death|0|||
147173339|NCT01717326|530798380|FG018|Overall Study|Death|0|||
147173340|NCT01717326|530798381|FG019|Overall Study|Death|0|||
147173341|NCT01717326|530798362|FG000|Overall Study|Lost to Follow-up|3|||
147173342|NCT01717326|530798363|FG001|Overall Study|Lost to Follow-up|0|||
147173343|NCT01717326|530798364|FG002|Overall Study|Lost to Follow-up|0|||
147173344|NCT01717326|530798365|FG003|Overall Study|Lost to Follow-up|2|||
147173345|NCT01717326|530798366|FG004|Overall Study|Lost to Follow-up|1|||
147173346|NCT01717326|530798367|FG005|Overall Study|Lost to Follow-up|0|||
147173347|NCT01717326|530798368|FG006|Overall Study|Lost to Follow-up|1|||
147173348|NCT01717326|530798369|FG007|Overall Study|Lost to Follow-up|0|||
147173349|NCT01717326|530798370|FG008|Overall Study|Lost to Follow-up|0|||
147173350|NCT01717326|530798371|FG009|Overall Study|Lost to Follow-up|0|||
147173351|NCT01717326|530798372|FG010|Overall Study|Lost to Follow-up|1|||
147173352|NCT01717326|530798373|FG011|Overall Study|Lost to Follow-up|0|||
147173353|NCT01717326|530798374|FG012|Overall Study|Lost to Follow-up|0|||
147173354|NCT01717326|530798375|FG013|Overall Study|Lost to Follow-up|0|||
147173355|NCT01717326|530798376|FG014|Overall Study|Lost to Follow-up|0|||
147173356|NCT01717326|530798377|FG015|Overall Study|Lost to Follow-up|2|||
147173357|NCT01717326|530798378|FG016|Overall Study|Lost to Follow-up|1|||
147173358|NCT01717326|530798379|FG017|Overall Study|Lost to Follow-up|0|||
147173359|NCT01717326|530798380|FG018|Overall Study|Lost to Follow-up|2|||
147173360|NCT01717326|530798381|FG019|Overall Study|Lost to Follow-up|3|||
147173361|NCT01717326|530798362|FG000|Overall Study|Physician Decision|0|||
147173362|NCT01717326|530798363|FG001|Overall Study|Physician Decision|0|||
147173363|NCT01717326|530798364|FG002|Overall Study|Physician Decision|0|||
147173364|NCT01717326|530798365|FG003|Overall Study|Physician Decision|0|||
147173365|NCT01717326|530798366|FG004|Overall Study|Physician Decision|0|||
147173366|NCT01717326|530798367|FG005|Overall Study|Physician Decision|0|||
147173367|NCT01717326|530798368|FG006|Overall Study|Physician Decision|0|||
147173368|NCT01717326|530798369|FG007|Overall Study|Physician Decision|0|||
147173369|NCT01717326|530798370|FG008|Overall Study|Physician Decision|0|||
147173370|NCT01717326|530798371|FG009|Overall Study|Physician Decision|1|||
147173371|NCT01717326|530798372|FG010|Overall Study|Physician Decision|0|||
147173372|NCT01717326|530798373|FG011|Overall Study|Physician Decision|0|||
147173373|NCT01717326|530798374|FG012|Overall Study|Physician Decision|0|||
147173374|NCT01717326|530798375|FG013|Overall Study|Physician Decision|0|||
147173375|NCT01717326|530798376|FG014|Overall Study|Physician Decision|0|||
147173376|NCT01717326|530798377|FG015|Overall Study|Physician Decision|0|||
147592681|NCT00102687|532325106|FG001|Maintenance Period|Withdrawal by Subject|0|||
147173377|NCT01717326|530798378|FG016|Overall Study|Physician Decision|0|||
147173378|NCT01717326|530798379|FG017|Overall Study|Physician Decision|0|||
147592682|NCT00102687|532325107|FG002|Maintenance Period|Withdrawal by Subject|2|||
147592683|NCT00102687|532325108|FG003|Maintenance Period|Withdrawal by Subject|3|||
147592684|NCT00102687|532325109|FG004|Maintenance Period|Withdrawal by Subject|1|||
147173379|NCT01717326|530798380|FG018|Overall Study|Physician Decision|0|||
147173380|NCT01717326|530798381|FG019|Overall Study|Physician Decision|0|||
147173381|NCT01717326|530798362|FG000|Overall Study|Protocol Violation|0|||
147173382|NCT01717326|530798363|FG001|Overall Study|Protocol Violation|0|||
147173383|NCT01717326|530798364|FG002|Overall Study|Protocol Violation|0|||
147173384|NCT01717326|530798365|FG003|Overall Study|Protocol Violation|0|||
147173385|NCT01717326|530798366|FG004|Overall Study|Protocol Violation|1|||
147173386|NCT01717326|530798367|FG005|Overall Study|Protocol Violation|0|||
147173387|NCT01717326|530798368|FG006|Overall Study|Protocol Violation|0|||
147173388|NCT01717326|530798369|FG007|Overall Study|Protocol Violation|0|||
147173389|NCT01717326|530798370|FG008|Overall Study|Protocol Violation|0|||
147173390|NCT01717326|530798371|FG009|Overall Study|Protocol Violation|0|||
147173391|NCT01717326|530798372|FG010|Overall Study|Protocol Violation|0|||
147173392|NCT01717326|530798373|FG011|Overall Study|Protocol Violation|0|||
147173393|NCT01717326|530798374|FG012|Overall Study|Protocol Violation|0|||
147173394|NCT01717326|530798375|FG013|Overall Study|Protocol Violation|0|||
147173395|NCT01717326|530798376|FG014|Overall Study|Protocol Violation|0|||
147173396|NCT01717326|530798377|FG015|Overall Study|Protocol Violation|0|||
147173397|NCT01717326|530798378|FG016|Overall Study|Protocol Violation|0|||
147173398|NCT01717326|530798379|FG017|Overall Study|Protocol Violation|0|||
147173399|NCT01717326|530798380|FG018|Overall Study|Protocol Violation|0|||
147173400|NCT01717326|530798381|FG019|Overall Study|Protocol Violation|0|||
147173401|NCT01717326|530798362|FG000|Overall Study|Withdrawal by Subject|0|||
147173402|NCT01717326|530798363|FG001|Overall Study|Withdrawal by Subject|1|||
147173403|NCT01717326|530798364|FG002|Overall Study|Withdrawal by Subject|0|||
147173404|NCT01717326|530798365|FG003|Overall Study|Withdrawal by Subject|0|||
147173405|NCT01717326|530798366|FG004|Overall Study|Withdrawal by Subject|0|||
147173406|NCT01717326|530798367|FG005|Overall Study|Withdrawal by Subject|0|||
147173407|NCT01717326|530798368|FG006|Overall Study|Withdrawal by Subject|0|||
147173408|NCT01717326|530798369|FG007|Overall Study|Withdrawal by Subject|0|||
147173409|NCT01717326|530798370|FG008|Overall Study|Withdrawal by Subject|0|||
147173410|NCT01717326|530798371|FG009|Overall Study|Withdrawal by Subject|1|||
147173411|NCT01717326|530798372|FG010|Overall Study|Withdrawal by Subject|0|||
147173412|NCT01717326|530798373|FG011|Overall Study|Withdrawal by Subject|0|||
147173413|NCT01717326|530798374|FG012|Overall Study|Withdrawal by Subject|1|||
147173414|NCT01717326|530798375|FG013|Overall Study|Withdrawal by Subject|0|||
147173415|NCT01717326|530798376|FG014|Overall Study|Withdrawal by Subject|0|||
147173416|NCT01717326|530798377|FG015|Overall Study|Withdrawal by Subject|1|||
147173417|NCT01717326|530798378|FG016|Overall Study|Withdrawal by Subject|0|||
147173418|NCT01717326|530798379|FG017|Overall Study|Withdrawal by Subject|0|||
147173419|NCT01717326|530798380|FG018|Overall Study|Withdrawal by Subject|2|||
147173420|NCT01717326|530798381|FG019|Overall Study|Withdrawal by Subject|3|||
147173421|NCT01123707|530798382|FG000|Overall Study|Lost to Follow-up|3|||
147173422|NCT01123707|530798383|FG001|Overall Study|Lost to Follow-up|1|||
147173423|NCT01123707|530798384|FG002|Overall Study|Lost to Follow-up|3|||
147173424|NCT01123707|530798385|FG003|Overall Study|Lost to Follow-up|2|||
147173425|NCT01123707|530798382|FG000|Overall Study|Adverse Event|5|||
147173426|NCT01123707|530798383|FG001|Overall Study|Adverse Event|7|||
147173427|NCT01123707|530798384|FG002|Overall Study|Adverse Event|5|||
147173428|NCT01123707|530798385|FG003|Overall Study|Adverse Event|3|||
147173429|NCT01123707|530798382|FG000|Overall Study|Sponsor Discontinued Study|30|||
147173430|NCT01123707|530798383|FG001|Overall Study|Sponsor Discontinued Study|24|||
147173431|NCT01123707|530798384|FG002|Overall Study|Sponsor Discontinued Study|25|||
147173432|NCT01123707|530798385|FG003|Overall Study|Sponsor Discontinued Study|40|||
147173433|NCT01123707|530798382|FG000|Overall Study|Participant Met Withdrawal Criteria|1|||
147173434|NCT01123707|530798383|FG001|Overall Study|Participant Met Withdrawal Criteria|1|||
147173435|NCT01123707|530798384|FG002|Overall Study|Participant Met Withdrawal Criteria|0|||
147173436|NCT01123707|530798385|FG003|Overall Study|Participant Met Withdrawal Criteria|1|||
147173437|NCT01123707|530798382|FG000|Overall Study|Investigator Withdrew Participant|0|||
147173438|NCT01123707|530798383|FG001|Overall Study|Investigator Withdrew Participant|1|||
147173439|NCT01123707|530798384|FG002|Overall Study|Investigator Withdrew Participant|1|||
147173440|NCT01123707|530798385|FG003|Overall Study|Investigator Withdrew Participant|1|||
147173441|NCT01123707|530798382|FG000|Overall Study|Subject Withdrew Consent|4|||
147173442|NCT01123707|530798383|FG001|Overall Study|Subject Withdrew Consent|5|||
147173443|NCT01123707|530798384|FG002|Overall Study|Subject Withdrew Consent|1|||
147173444|NCT01123707|530798385|FG003|Overall Study|Subject Withdrew Consent|2|||
147173445|NCT01123707|530798382|FG000|Overall Study|Lack of Efficacy|1|||
147173446|NCT01123707|530798383|FG001|Overall Study|Lack of Efficacy|2|||
147173447|NCT01123707|530798384|FG002|Overall Study|Lack of Efficacy|1|||
147173448|NCT01123707|530798385|FG003|Overall Study|Lack of Efficacy|0|||
147173449|NCT01123707|530798382|FG000|Overall Study|Subject Met Exclusion Criteria|0|||
147173450|NCT01123707|530798383|FG001|Overall Study|Subject Met Exclusion Criteria|0|||
147173451|NCT01123707|530798384|FG002|Overall Study|Subject Met Exclusion Criteria|2|||
147173452|NCT01123707|530798385|FG003|Overall Study|Subject Met Exclusion Criteria|1|||
147173453|NCT03281304|530798386|FG000|Treatment Phase (up to 42 Months)|Adverse Event|10|||
147173454|NCT03281304|530798387|FG001|Treatment Phase (up to 42 Months)|Adverse Event|10|||
147173455|NCT03281304|530798386|FG000|Treatment Phase (up to 42 Months)|Lack of Efficacy|3|||
147173456|NCT03281304|530798387|FG001|Treatment Phase (up to 42 Months)|Lack of Efficacy|2|||
147173457|NCT03281304|530798386|FG000|Treatment Phase (up to 42 Months)|Pregnancy|1|||
147173458|NCT03281304|530798387|FG001|Treatment Phase (up to 42 Months)|Pregnancy|0|||
147173459|NCT03281304|530798386|FG000|Treatment Phase (up to 42 Months)|Withdrawal by Subject|5|||
147173460|NCT03281304|530798387|FG001|Treatment Phase (up to 42 Months)|Withdrawal by Subject|12|||
147173461|NCT03281304|530798386|FG000|Treatment Phase (up to 42 Months)|Death|0|||
147655553|NCT03275389|532561591|FG006|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
147655554|NCT03275389|532561592|FG007|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
147173462|NCT03281304|530798387|FG001|Treatment Phase (up to 42 Months)|Death|1|||
147173463|NCT03281304|530798386|FG000|Treatment Phase (up to 42 Months)|Study terminated by sponsor|15|||
147173464|NCT03281304|530798387|FG001|Treatment Phase (up to 42 Months)|Study terminated by sponsor|16|||
147173465|NCT03281304|530798386|FG000|Treatment Phase (up to 42 Months)|Other|0|||
147173466|NCT03281304|530798387|FG001|Treatment Phase (up to 42 Months)|Other|2|||
147173467|NCT03281304|530798386|FG000|Follow-up Phase (up to 4 Weeks)|Other|2|||
147173468|NCT03281304|530798387|FG001|Follow-up Phase (up to 4 Weeks)|Other|1|||
147173469|NCT01114438|530798388|FG000|Overall Study|Adverse Event|10|||
147173470|NCT01114438|530798388|FG000|Overall Study|concomitant medication|1|||
147173471|NCT01114438|530798388|FG000|Overall Study|Physician Decision|1|||
147173472|NCT01114438|530798388|FG000|Overall Study|Withdrawal by Subject|2|||
147173473|NCT02577016|530798393|FG000|Overall Study|Adverse Event|2|||
147173474|NCT02577016|530798394|FG001|Overall Study|Adverse Event|1|||
147173475|NCT02577016|530798393|FG000|Overall Study|Physician Decision|0|||
147173476|NCT02577016|530798394|FG001|Overall Study|Physician Decision|1|||
147173477|NCT00566254|530798395|FG000|Overall Study|Adverse Event|3|||
147173478|NCT00566254|530798396|FG001|Overall Study|Adverse Event|1|||
147173479|NCT00566254|530798395|FG000|Overall Study|Protocol Violation|1|||
147173480|NCT00566254|530798396|FG001|Overall Study|Protocol Violation|3|||
147173481|NCT00566254|530798395|FG000|Overall Study|Withdrawal by Subject|1|||
147173482|NCT00566254|530798396|FG001|Overall Study|Withdrawal by Subject|2|||
147173483|NCT00566254|530798395|FG000|Overall Study|Lack of Efficacy|5|||
147173484|NCT00566254|530798396|FG001|Overall Study|Lack of Efficacy|6|||
147173485|NCT00566254|530798395|FG000|Overall Study|Other|0|||
147173486|NCT00566254|530798396|FG001|Overall Study|Other|2|||
147173487|NCT00687531|530798397|FG000|Overall Study|Did not meet protocol eligibility|104|||
147173488|NCT00687531|530798397|FG000|Overall Study|Adverse Event|5|||
147173489|NCT00687531|530798397|FG000|Overall Study|Lost to Follow-up|26|||
147173490|NCT02301624|530798398|FG000|Blind Induction Phase|Withdrawal by Subject|1|||
147173491|NCT02301624|530798399|FG001|Blind Induction Phase|Withdrawal by Subject|0|||
147173492|NCT02301624|530798398|FG000|Open-label Maintenance Phase|Withdrawal by Subject|4|||
147173493|NCT02301624|530798399|FG001|Open-label Maintenance Phase|Withdrawal by Subject|8|||
147173494|NCT02301624|530798398|FG000|Open-label Maintenance Phase|Adverse Event|2|||
147173495|NCT02301624|530798399|FG001|Open-label Maintenance Phase|Adverse Event|5|||
147173496|NCT02301624|530798398|FG000|Open-label Maintenance Phase|Physician Decision|3|||
147173497|NCT02301624|530798399|FG001|Open-label Maintenance Phase|Physician Decision|3|||
147173498|NCT02301624|530798398|FG000|Open-label Maintenance Phase|Death|2|||
147173499|NCT02301624|530798399|FG001|Open-label Maintenance Phase|Death|1|||
147173500|NCT02301624|530798398|FG000|Open-label Maintenance Phase|Participant felt no change in condition|1|||
147173501|NCT02301624|530798399|FG001|Open-label Maintenance Phase|Participant felt no change in condition|0|||
147173502|NCT03210961|530800279|FG000|Overall Study|Adverse Event|0|||
147173503|NCT03210961|530800280|FG001|Overall Study|Adverse Event|0|||
147173504|NCT03210961|530800281|FG002|Overall Study|Adverse Event|0|||
147173505|NCT03210961|530800282|FG003|Overall Study|Adverse Event|0|||
147173506|NCT03210961|530800283|FG004|Overall Study|Adverse Event|0|||
147173507|NCT03210961|530800284|FG005|Overall Study|Adverse Event|0|||
147173508|NCT03210961|530800285|FG006|Overall Study|Adverse Event|0|||
147173509|NCT03210961|530800286|FG007|Overall Study|Adverse Event|0|||
147173510|NCT03210961|530800287|FG008|Overall Study|Adverse Event|0|||
147173511|NCT03210961|530800288|FG009|Overall Study|Adverse Event|0|||
147173512|NCT03210961|530800289|FG010|Overall Study|Adverse Event|0|||
147173513|NCT03210961|530800290|FG011|Overall Study|Adverse Event|0|||
147173514|NCT03210961|530800291|FG012|Overall Study|Adverse Event|0|||
147173515|NCT03210961|530800292|FG013|Overall Study|Adverse Event|1|||
147173516|NCT03210961|530800293|FG014|Overall Study|Adverse Event|0|||
147173517|NCT03210961|530800279|FG000|Overall Study|Lost to Follow-up|0|||
147173518|NCT03210961|530800280|FG001|Overall Study|Lost to Follow-up|0|||
147173519|NCT03210961|530800281|FG002|Overall Study|Lost to Follow-up|0|||
147173520|NCT03210961|530800282|FG003|Overall Study|Lost to Follow-up|0|||
147173521|NCT03210961|530800283|FG004|Overall Study|Lost to Follow-up|0|||
147173522|NCT03210961|530800284|FG005|Overall Study|Lost to Follow-up|0|||
147173523|NCT03210961|530800285|FG006|Overall Study|Lost to Follow-up|0|||
147173524|NCT03210961|530800286|FG007|Overall Study|Lost to Follow-up|0|||
147173525|NCT03210961|530800287|FG008|Overall Study|Lost to Follow-up|0|||
147655555|NCT03275389|532561593|FG008|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|0|||
147655556|NCT03275389|532561594|FG009|Overall Study|SERIOUS ADVERSE EVENT AND/OR PIMD|1|||
147655557|NCT03275389|532561585|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|1|||
147655558|NCT03275389|532561586|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
147173526|NCT03210961|530800288|FG009|Overall Study|Lost to Follow-up|0|||
147173527|NCT03210961|530800289|FG010|Overall Study|Lost to Follow-up|0|||
147173528|NCT03210961|530800290|FG011|Overall Study|Lost to Follow-up|0|||
147173529|NCT03210961|530800291|FG012|Overall Study|Lost to Follow-up|0|||
147173530|NCT03210961|530800292|FG013|Overall Study|Lost to Follow-up|0|||
147324076|NCT00293462|531352424|FG002|Overall Study|Change Treatment Regimen (ineligible)|0|||
147324077|NCT00293462|531352422|FG000|Overall Study|Hypersensitive Reaction (to Salt & Soda)|0|||
147173531|NCT03210961|530800293|FG014|Overall Study|Lost to Follow-up|1|||
147324078|NCT00293462|531352423|FG001|Overall Study|Hypersensitive Reaction (to Salt & Soda)|1|||
147173532|NCT03210961|530800279|FG000|Overall Study|Withdrawal by Subject|0|||
147173533|NCT03210961|530800280|FG001|Overall Study|Withdrawal by Subject|0|||
147173534|NCT03210961|530800281|FG002|Overall Study|Withdrawal by Subject|0|||
147324079|NCT00293462|531352424|FG002|Overall Study|Hypersensitive Reaction (to Salt & Soda)|0|||
147655559|NCT03275389|532561587|FG002|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
147655560|NCT03275389|532561588|FG003|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|5|||
147655561|NCT03275389|532561589|FG004|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|3|||
147655562|NCT03275389|532561590|FG005|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|3|||
147655563|NCT03275389|532561591|FG006|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|3|||
147655564|NCT03275389|532561592|FG007|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|3|||
147655565|NCT03275389|532561593|FG008|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|2|||
147655566|NCT03275389|532561594|FG009|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|2|||
147655567|NCT03275389|532561585|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
147655568|NCT03275389|532561586|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
147655569|NCT03275389|532561587|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
147655570|NCT03275389|532561588|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|3|||
147655571|NCT03275389|532561589|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
147655572|NCT03275389|532561590|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
147655573|NCT03275389|532561591|FG006|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
147655574|NCT03275389|532561592|FG007|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
147655575|NCT03275389|532561593|FG008|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
147655576|NCT03275389|532561594|FG009|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
147173535|NCT03210961|530800282|FG003|Overall Study|Withdrawal by Subject|0|||
147173536|NCT03210961|530800283|FG004|Overall Study|Withdrawal by Subject|0|||
147173537|NCT03210961|530800284|FG005|Overall Study|Withdrawal by Subject|0|||
147173538|NCT03210961|530800285|FG006|Overall Study|Withdrawal by Subject|0|||
147173539|NCT03210961|530800286|FG007|Overall Study|Withdrawal by Subject|0|||
147173540|NCT03210961|530800287|FG008|Overall Study|Withdrawal by Subject|0|||
147173541|NCT03210961|530800288|FG009|Overall Study|Withdrawal by Subject|0|||
147173542|NCT03210961|530800289|FG010|Overall Study|Withdrawal by Subject|0|||
147173543|NCT03210961|530800290|FG011|Overall Study|Withdrawal by Subject|0|||
147173544|NCT03210961|530800291|FG012|Overall Study|Withdrawal by Subject|0|||
147173545|NCT03210961|530800292|FG013|Overall Study|Withdrawal by Subject|0|||
147173546|NCT03210961|530800293|FG014|Overall Study|Withdrawal by Subject|1|||
147173547|NCT03210961|530800279|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
147173548|NCT03210961|530800280|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
147173549|NCT03210961|530800281|FG002|Overall Study|No Longer Meets Eligibility Criteria|0|||
147173550|NCT03210961|530800282|FG003|Overall Study|No Longer Meets Eligibility Criteria|0|||
147173551|NCT03210961|530800283|FG004|Overall Study|No Longer Meets Eligibility Criteria|0|||
147173552|NCT03210961|530800284|FG005|Overall Study|No Longer Meets Eligibility Criteria|0|||
147173553|NCT03210961|530800285|FG006|Overall Study|No Longer Meets Eligibility Criteria|0|||
147173554|NCT03210961|530800286|FG007|Overall Study|No Longer Meets Eligibility Criteria|0|||
147173555|NCT03210961|530800287|FG008|Overall Study|No Longer Meets Eligibility Criteria|0|||
147173556|NCT03210961|530800288|FG009|Overall Study|No Longer Meets Eligibility Criteria|0|||
147173557|NCT03210961|530800289|FG010|Overall Study|No Longer Meets Eligibility Criteria|0|||
147173558|NCT03210961|530800290|FG011|Overall Study|No Longer Meets Eligibility Criteria|0|||
147173559|NCT03210961|530800291|FG012|Overall Study|No Longer Meets Eligibility Criteria|0|||
147173560|NCT03210961|530800292|FG013|Overall Study|No Longer Meets Eligibility Criteria|1|||
147173561|NCT03210961|530800293|FG014|Overall Study|No Longer Meets Eligibility Criteria|0|||
147173562|NCT03210961|530800279|FG000|Overall Study|Other|0|||
147173563|NCT03210961|530800280|FG001|Overall Study|Other|0|||
147173564|NCT03210961|530800281|FG002|Overall Study|Other|0|||
147173565|NCT03210961|530800282|FG003|Overall Study|Other|1|||
147173566|NCT03210961|530800283|FG004|Overall Study|Other|0|||
147173567|NCT03210961|530800284|FG005|Overall Study|Other|0|||
147173568|NCT03210961|530800285|FG006|Overall Study|Other|1|||
147173569|NCT03210961|530800286|FG007|Overall Study|Other|0|||
147173570|NCT03210961|530800287|FG008|Overall Study|Other|0|||
147173571|NCT03210961|530800288|FG009|Overall Study|Other|0|||
147173572|NCT03210961|530800289|FG010|Overall Study|Other|1|||
147173573|NCT03210961|530800290|FG011|Overall Study|Other|0|||
147173574|NCT03210961|530800291|FG012|Overall Study|Other|2|||
147173575|NCT03210961|530800292|FG013|Overall Study|Other|2|||
147173576|NCT03210961|530800293|FG014|Overall Study|Other|0|||
147173577|NCT02467582|530800294|FG000|Allocation|Withdrawal by Subject|1|||
147655577|NCT03275389|532561585|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
147655578|NCT03275389|532561586|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
147173578|NCT02467582|530800295|FG001|Allocation|Withdrawal by Subject|0|||
147173579|NCT02467582|530800294|FG000|Follow-up|Death|5|||
147244426|NCT00684307|531068898|FG001|Overall Study|Participant not willing to continue|10|||
147244427|NCT00684307|531068899|FG002|Overall Study|Participant not willing to continue|11|||
147244428|NCT00684307|531068900|FG003|Overall Study|Participant not willing to continue|5|||
147244429|NCT00684307|531068901|FG004|Overall Study|Participant not willing to continue|8|||
147244430|NCT00684307|531068897|FG000|Overall Study|Criteria from the CSR|0|||
147244431|NCT00684307|531068898|FG001|Overall Study|Criteria from the CSR|0|||
147173580|NCT02467582|530800295|FG001|Follow-up|Death|4|||
147173581|NCT02467582|530800294|FG000|Follow-up|Lost to Follow-up|6|||
147173582|NCT02467582|530800295|FG001|Follow-up|Lost to Follow-up|5|||
147173583|NCT00703924|530800296|FG000|Overall Study|Withdrawal by Subject|1|||
147173584|NCT00703924|530800297|FG001|Overall Study|Withdrawal by Subject|1|||
147173585|NCT01031979|530800300|FG000|Overall Study|Lost to Follow-up|5|||
147173586|NCT01031979|530800301|FG001|Overall Study|Lost to Follow-up|4|||
147173587|NCT03592368|530800303|FG000|Overall Study|Per protocol, randomized but not exposed to intervention due to COVID policy|0|||
147173588|NCT03592368|530800304|FG001|Overall Study|Per protocol, randomized but not exposed to intervention due to COVID policy|1|||
147173589|NCT03592368|530800305|FG002|Overall Study|Per protocol, randomized but not exposed to intervention due to COVID policy|0|||
147173590|NCT03592368|530800306|FG003|Overall Study|Per protocol, randomized but not exposed to intervention due to COVID policy|0|||
147173591|NCT03592368|530800303|FG000|Overall Study|Adverse Event|0|||
147173592|NCT03592368|530800304|FG001|Overall Study|Adverse Event|0|||
147173593|NCT03592368|530800305|FG002|Overall Study|Adverse Event|0|||
147173594|NCT03592368|530800306|FG003|Overall Study|Adverse Event|1|||
147173595|NCT03592368|530800303|FG000|Overall Study|Per protocol, received intervention but with inadequate engagement for arm inclusion|1|||
147173596|NCT03592368|530800304|FG001|Overall Study|Per protocol, received intervention but with inadequate engagement for arm inclusion|1|||
147173597|NCT03592368|530800305|FG002|Overall Study|Per protocol, received intervention but with inadequate engagement for arm inclusion|0|||
147173598|NCT03592368|530800306|FG003|Overall Study|Per protocol, received intervention but with inadequate engagement for arm inclusion|0|||
147173599|NCT03354273|530800314|FG000|Overall Study|Adverse Event|5|||
147173600|NCT03354273|530800314|FG000|Overall Study|Screen Failure|21|||
147173601|NCT03354273|530800314|FG000|Overall Study|Withdrawal by Subject|34|||
147173602|NCT03354273|530800314|FG000|Overall Study|Technical Problems|30|||
147173603|NCT03354273|530800314|FG000|Overall Study|Lost to Follow-up|4|||
147173604|NCT03354273|530800314|FG000|Overall Study|Investigator Decision|3|||
147173605|NCT03354273|530800314|FG000|Overall Study|Investigational Medicinal Product (IMP) Supply Issues|21|||
147173606|NCT03354273|530800314|FG000|Overall Study|Issues With Performing Invasive Coronary Angiography (ICA)|20|||
147173607|NCT03354273|530800314|FG000|Overall Study|COVID-19 Restrictions|9|||
147173608|NCT03354273|530800314|FG000|Overall Study|Other|5|||
147173609|NCT01971008|530800315|FG000|Overall Study|Protocol Violation|2|||
147173610|NCT01971008|530800316|FG001|Overall Study|Protocol Violation|1|||
147173611|NCT03775512|530800317|FG000|Overall Study|Death|1|||
147173612|NCT03775512|530800318|FG001|Overall Study|Death|1|||
147173613|NCT03775512|530800317|FG000|Overall Study|Withdrawal by Subject|7|||
147173614|NCT03775512|530800318|FG001|Overall Study|Withdrawal by Subject|4|||
147173615|NCT03775512|530800317|FG000|Overall Study|Lost to Follow-up|5|||
147173616|NCT03775512|530800318|FG001|Overall Study|Lost to Follow-up|5|||
147173617|NCT03775512|530800317|FG000|Overall Study|Excluded before Catheter insertion|14|||
147173618|NCT03775512|530800318|FG001|Overall Study|Excluded before Catheter insertion|5|||
147173619|NCT03775512|530800317|FG000|Overall Study|Discontinued before RF energy applied on inserted catheter|2|||
147173620|NCT03775512|530800318|FG001|Overall Study|Discontinued before RF energy applied on inserted catheter|1|||
147173621|NCT03775512|530800317|FG000|Overall Study|Due to a late entrance criteria deviation|0|||
147173622|NCT03775512|530800318|FG001|Overall Study|Due to a late entrance criteria deviation|1|||
147173623|NCT00705367|530800321|FG000|Long-term Extension Period|Adverse Event|2|||
147173624|NCT00705367|530800322|FG001|Long-term Extension Period|Adverse Event|0|||
147173625|NCT00705367|530800321|FG000|Long-term Extension Period|Withdrawal by Subject|2|||
147173626|NCT00705367|530800322|FG001|Long-term Extension Period|Withdrawal by Subject|0|||
147173627|NCT00705367|530800321|FG000|Long-term Extension Period|Lack of Efficacy|1|||
147173628|NCT00705367|530800322|FG001|Long-term Extension Period|Lack of Efficacy|0|||
147173629|NCT00705367|530800321|FG000|Long-term Extension Period|No longer met study criteria|1|||
147173630|NCT00705367|530800322|FG001|Long-term Extension Period|No longer met study criteria|0|||
147173631|NCT00705367|530800321|FG000|Long-term Extension Period|Administrative reason by sponsor|3|||
147173632|NCT00705367|530800322|FG001|Long-term Extension Period|Administrative reason by sponsor|0|||
147173633|NCT01959139|530800326|FG000|Phase II|Disease progression|0|||
147173634|NCT01959139|530800327|FG001|Phase II|Disease progression|0|||
147173635|NCT01959139|530800328|FG002|Phase II|Disease progression|26|||
147173636|NCT01959139|530800329|FG003|Phase II|Disease progression|34|||
147173637|NCT01959139|530800326|FG000|Phase II|Adverse Event|0|||
147173638|NCT01959139|530800327|FG001|Phase II|Adverse Event|0|||
147173639|NCT01959139|530800328|FG002|Phase II|Adverse Event|10|||
147173640|NCT01959139|530800329|FG003|Phase II|Adverse Event|11|||
147173641|NCT01959139|530800326|FG000|Phase II|Patient Refusal|0|||
147173642|NCT01959139|530800327|FG001|Phase II|Patient Refusal|0|||
147173643|NCT01959139|530800328|FG002|Phase II|Patient Refusal|5|||
147173644|NCT01959139|530800329|FG003|Phase II|Patient Refusal|4|||
147173645|NCT01959139|530800326|FG000|Phase II|Death|0|||
147173646|NCT01959139|530800327|FG001|Phase II|Death|0|||
147173647|NCT01959139|530800328|FG002|Phase II|Death|3|||
147173648|NCT01959139|530800329|FG003|Phase II|Death|1|||
147592685|NCT00102687|532325105|FG000|Maintenance Period|Adverse Event|1|||
147592686|NCT00102687|532325106|FG001|Maintenance Period|Adverse Event|0|||
147592687|NCT00102687|532325107|FG002|Maintenance Period|Adverse Event|0|||
147592688|NCT00102687|532325108|FG003|Maintenance Period|Adverse Event|1|||
147173649|NCT01959139|530800326|FG000|Phase II|Other/Unknown|0|||
147173650|NCT01959139|530800327|FG001|Phase II|Other/Unknown|0|||
147173651|NCT01959139|530800328|FG002|Phase II|Other/Unknown|8|||
147173652|NCT01959139|530800329|FG003|Phase II|Other/Unknown|5|||
147173653|NCT01959139|530800326|FG000|Phase II|On treatment|0|||
147448148|NCT00960661|531805646|FG002|Interventional Phase|Lost to Follow-up|2|||
147448149|NCT00960661|531805644|FG000|Interventional Phase|entry criteria not met|0|||
147448150|NCT00960661|531805645|FG001|Interventional Phase|entry criteria not met|3|||
147448151|NCT00960661|531805646|FG002|Interventional Phase|entry criteria not met|0|||
147448152|NCT00960661|531805644|FG000|Interventional Phase|Protocol Violation|0|||
147448153|NCT00960661|531805645|FG001|Interventional Phase|Protocol Violation|7|||
147448154|NCT00960661|531805646|FG002|Interventional Phase|Protocol Violation|2|||
147592689|NCT00102687|532325109|FG004|Maintenance Period|Adverse Event|3|||
147592690|NCT00102687|532325105|FG000|Maintenance Period|Transformation to AML (blast > 30%)|0|||
147592691|NCT00102687|532325106|FG001|Maintenance Period|Transformation to AML (blast > 30%)|1|||
147592692|NCT00102687|532325107|FG002|Maintenance Period|Transformation to AML (blast > 30%)|0|||
147173654|NCT01959139|530800327|FG001|Phase II|On treatment|0|||
147173655|NCT01959139|530800328|FG002|Phase II|On treatment|4|||
147173656|NCT01959139|530800329|FG003|Phase II|On treatment|0|||
147173657|NCT02629822|530800330|FG000|Base Study|Lost to Follow-up|2|||
147173658|NCT02629822|530800330|FG000|Base Study|Non-Compliance With Study Drug|1|||
147173659|NCT02629822|530800330|FG000|Extension Study|Adverse Event|1|||
147173660|NCT02629822|530800330|FG000|Extension Study|Lost to Follow-up|1|||
147173661|NCT03679624|530800331|FG000|Overall Study|Adverse Event|1|||
147173662|NCT03679624|530800332|FG001|Overall Study|Adverse Event|0|||
147173663|NCT00741013|530800333|FG000|Overall Study|Adverse Event|1|||
147173664|NCT00741013|530800334|FG001|Overall Study|Adverse Event|0|||
147173665|NCT00741013|530800335|FG002|Overall Study|Adverse Event|0|||
147173666|NCT00741013|530800333|FG000|Overall Study|Withdrawal by Subject|0|||
147173667|NCT00741013|530800334|FG001|Overall Study|Withdrawal by Subject|0|||
147173668|NCT00741013|530800335|FG002|Overall Study|Withdrawal by Subject|1|||
147173669|NCT00741013|530800333|FG000|Overall Study|Discovered failed screen after enrolled|0|||
147173670|NCT00741013|530800334|FG001|Overall Study|Discovered failed screen after enrolled|2|||
147173671|NCT00741013|530800335|FG002|Overall Study|Discovered failed screen after enrolled|0|||
147173672|NCT00082407|530800336|FG000|Overall Study|Adverse Event|20|||
147173673|NCT00082407|530800337|FG001|Overall Study|Adverse Event|0|||
147173674|NCT00082407|530800336|FG000|Overall Study|Protocol Violation|14|||
147173675|NCT00082407|530800337|FG001|Overall Study|Protocol Violation|12|||
147173676|NCT00082407|530800336|FG000|Overall Study|Patient Decision|13|||
147173677|NCT00082407|530800337|FG001|Overall Study|Patient Decision|6|||
147173678|NCT00082407|530800336|FG000|Overall Study|Physician Decision|5|||
147173679|NCT00082407|530800337|FG001|Overall Study|Physician Decision|3|||
147324080|NCT00293462|531352422|FG000|Overall Study|Refuse Radiation Treatment|1|||
147592693|NCT00102687|532325108|FG003|Maintenance Period|Transformation to AML (blast > 30%)|2|||
147592694|NCT00102687|532325109|FG004|Maintenance Period|Transformation to AML (blast > 30%)|0|||
147592695|NCT00102687|532325105|FG000|Maintenance Period|Failed Treatment (relapse,disease prog)|1|||
147592696|NCT00102687|532325106|FG001|Maintenance Period|Failed Treatment (relapse,disease prog)|1|||
147173680|NCT00082407|530800336|FG000|Overall Study|Loss of Glucose Control|2|||
147173681|NCT00082407|530800337|FG001|Overall Study|Loss of Glucose Control|2|||
147173682|NCT00082407|530800336|FG000|Overall Study|Death|2|||
147173683|NCT00082407|530800337|FG001|Overall Study|Death|1|||
147173684|NCT00082407|530800336|FG000|Overall Study|Lost to Follow-up|0|||
147324081|NCT00293462|531352423|FG001|Overall Study|Refuse Radiation Treatment|0|||
147324082|NCT00293462|531352424|FG002|Overall Study|Refuse Radiation Treatment|0|||
147324083|NCT00293462|531352422|FG000|Overall Study|No Show|0|||
147324084|NCT00293462|531352423|FG001|Overall Study|No Show|0|||
147173685|NCT00082407|530800337|FG001|Overall Study|Lost to Follow-up|3|||
147324085|NCT00293462|531352424|FG002|Overall Study|No Show|1|||
147324086|NCT00293462|531352422|FG000|Overall Study|Went back to his home country|0|||
147324087|NCT00293462|531352423|FG001|Overall Study|Went back to his home country|0|||
147324088|NCT00293462|531352424|FG002|Overall Study|Went back to his home country|1|||
147324089|NCT00293462|531352422|FG000|Overall Study|Blood clot after chemotherapy|0|||
147592697|NCT00102687|532325107|FG002|Maintenance Period|Failed Treatment (relapse,disease prog)|1|||
147173686|NCT00858208|530800338|FG000|Overall Study|Adverse Event|3|||
147173687|NCT00858208|530800338|FG000|Overall Study|Lost to Follow-up|26|||
147173688|NCT00858208|530800338|FG000|Overall Study|Participant refused|40|||
147173689|NCT00858208|530800338|FG000|Overall Study|Other|10|||
147173690|NCT02352753|530800339|FG000|6-Month Dosing Period|Decision by sponsor|2|||
147592698|NCT00102687|532325108|FG003|Maintenance Period|Failed Treatment (relapse,disease prog)|3|||
147173691|NCT02352753|530800339|FG000|6-Month Dosing Period|Withdrawal by Subject|34|||
147173692|NCT02352753|530800339|FG000|6-Month Dosing Period|Lost to Follow-up|2|||
147448155|NCT00960661|531805644|FG000|Interventional Phase|Withdrawal by Subject|0|||
147592699|NCT00102687|532325109|FG004|Maintenance Period|Failed Treatment (relapse,disease prog)|4|||
147592700|NCT00102687|532325105|FG000|Maintenance Period|Death|0|||
147448156|NCT00960661|531805645|FG001|Interventional Phase|Withdrawal by Subject|18|||
147173693|NCT02352753|530800339|FG000|6-Month Dosing Period|Transitioning to Q3M|60|||
147173694|NCT02352753|530800339|FG000|3-Month Dosing Period|Decision by sponsor|14|||
147173695|NCT02352753|530800339|FG000|3-Month Dosing Period|Withdrawal by Subject|6|||
147173696|NCT00539305|530800340|FG000|Overall Study|Adverse Event|1|||
147173697|NCT00539305|530800341|FG001|Overall Study|Adverse Event|0|||
147173698|NCT00539305|530800340|FG000|Overall Study|Substance Use|0|||
147173699|NCT00539305|530800341|FG001|Overall Study|Substance Use|1|||
147173700|NCT00539305|530800340|FG000|Overall Study|Withdrawal by Subject|0|||
147173701|NCT00539305|530800341|FG001|Overall Study|Withdrawal by Subject|1|||
147173702|NCT01440816|530800344|FG000|Overall Study|Disease Progression|0|||
147173703|NCT01440816|530800345|FG001|Overall Study|Disease Progression|9|||
147173704|NCT01440816|530800344|FG000|Overall Study|To Be Seen By Local Oncologist|1|||
147173705|NCT01440816|530800345|FG001|Overall Study|To Be Seen By Local Oncologist|2|||
147173706|NCT04302545|530800348|FG000|Overall Study|Lost to Follow-up|3|||
147173707|NCT04302545|530800349|FG001|Overall Study|Lost to Follow-up|4|||
147173708|NCT02516592|530800350|FG000|Overall Study|Patient withdrew consent|5|||
147173709|NCT02516592|530800351|FG001|Overall Study|Patient withdrew consent|2|||
147173710|NCT02516592|530800350|FG000|Overall Study|Protocol deviation|4|||
147173711|NCT02516592|530800351|FG001|Overall Study|Protocol deviation|4|||
147173712|NCT02516592|530800350|FG000|Overall Study|Lost to Follow-up|2|||
147173713|NCT02516592|530800351|FG001|Overall Study|Lost to Follow-up|3|||
147324090|NCT00293462|531352423|FG001|Overall Study|Blood clot after chemotherapy|0|||
147173714|NCT02516592|530800350|FG000|Overall Study|Patient/guardian decision|2|||
147173715|NCT02516592|530800351|FG001|Overall Study|Patient/guardian decision|1|||
147324091|NCT00293462|531352424|FG002|Overall Study|Blood clot after chemotherapy|1|||
147324092|NCT00293462|531352422|FG000|Overall Study|Ischemic stroke after chemotherapy|0|||
147324093|NCT00293462|531352423|FG001|Overall Study|Ischemic stroke after chemotherapy|0|||
147324094|NCT00293462|531352424|FG002|Overall Study|Ischemic stroke after chemotherapy|1|||
147324095|NCT00293462|531352422|FG000|Overall Study|Possible Tracheostomy leakage|0|||
147324096|NCT00293462|531352423|FG001|Overall Study|Possible Tracheostomy leakage|1|||
147324097|NCT00293462|531352424|FG002|Overall Study|Possible Tracheostomy leakage|0|||
147324098|NCT00293462|531352422|FG000|Overall Study|Low radiation dose in oral cavity|0|||
147324099|NCT00293462|531352423|FG001|Overall Study|Low radiation dose in oral cavity|1|||
147324100|NCT00293462|531352424|FG002|Overall Study|Low radiation dose in oral cavity|0|||
147324101|NCT00293462|531352422|FG000|Overall Study|Physician Decision|0|||
147324102|NCT00293462|531352423|FG001|Overall Study|Physician Decision|1|||
147324103|NCT00293462|531352424|FG002|Overall Study|Physician Decision|0|||
147324104|NCT00688688|531352425|FG000|Overall Study|Eligibility criterion not met|7|||
147324105|NCT00688688|531352426|FG001|Overall Study|Eligibility criterion not met|7|||
147324106|NCT00688688|531352427|FG002|Overall Study|Eligibility criterion not met|10|||
147324107|NCT00688688|531352425|FG000|Overall Study|Adverse Event|52|||
147324108|NCT00688688|531352426|FG001|Overall Study|Adverse Event|51|||
147324109|NCT00688688|531352427|FG002|Overall Study|Adverse Event|50|||
147324110|NCT00688688|531352425|FG000|Overall Study|Lack of Efficacy|34|||
147324111|NCT00688688|531352426|FG001|Overall Study|Lack of Efficacy|25|||
147324112|NCT00688688|531352427|FG002|Overall Study|Lack of Efficacy|45|||
147324113|NCT00688688|531352425|FG000|Overall Study|Withdrawal by Subject|66|||
147324114|NCT00688688|531352426|FG001|Overall Study|Withdrawal by Subject|75|||
147324115|NCT00688688|531352427|FG002|Overall Study|Withdrawal by Subject|65|||
147324116|NCT00688688|531352425|FG000|Overall Study|Lost to Follow-up|14|||
147324117|NCT00688688|531352426|FG001|Overall Study|Lost to Follow-up|7|||
147324118|NCT00688688|531352427|FG002|Overall Study|Lost to Follow-up|7|||
147324119|NCT00688688|531352425|FG000|Overall Study|Protocol Violation|6|||
147324120|NCT00688688|531352426|FG001|Overall Study|Protocol Violation|9|||
147324121|NCT00688688|531352427|FG002|Overall Study|Protocol Violation|11|||
147324122|NCT00688688|531352425|FG000|Overall Study|Randomized but never received study drug|1|||
147324123|NCT00688688|531352426|FG001|Overall Study|Randomized but never received study drug|0|||
147173716|NCT02516592|530800350|FG000|Overall Study|Adverse Event|1|||
147173717|NCT02516592|530800351|FG001|Overall Study|Adverse Event|2|||
147173718|NCT02516592|530800350|FG000|Overall Study|Abnormal test procedure result|1|||
147173719|NCT02516592|530800351|FG001|Overall Study|Abnormal test procedure result|0|||
147173720|NCT02516592|530800350|FG000|Overall Study|Death|1|||
147324124|NCT00688688|531352427|FG002|Overall Study|Randomized but never received study drug|0|||
147324125|NCT00688688|531352425|FG000|Overall Study|Non-compliance with study procedures|5|||
147324126|NCT00688688|531352426|FG001|Overall Study|Non-compliance with study procedures|3|||
147324127|NCT00688688|531352427|FG002|Overall Study|Non-compliance with study procedures|4|||
147324128|NCT00688688|531352425|FG000|Overall Study|Taking exclusionary medications|1|||
147448157|NCT00960661|531805646|FG002|Interventional Phase|Withdrawal by Subject|29|||
147448158|NCT00960661|531805644|FG000|Interventional Phase|Physician Decision|0|||
147324129|NCT00688688|531352426|FG001|Overall Study|Taking exclusionary medications|0|||
147173721|NCT02516592|530800351|FG001|Overall Study|Death|1|||
147173722|NCT03068754|530800352|FG000|Randomized Treatment Period (RTP)|Adverse Event|1|||
147173723|NCT03068754|530800353|FG001|Randomized Treatment Period (RTP)|Adverse Event|3|||
147173724|NCT03068754|530800354|FG002|Randomized Treatment Period (RTP)|Adverse Event|0|||
147173725|NCT03068754|530800355|FG003|Randomized Treatment Period (RTP)|Adverse Event|0|||
147324130|NCT00688688|531352427|FG002|Overall Study|Taking exclusionary medications|0|||
147448159|NCT00960661|531805645|FG001|Interventional Phase|Physician Decision|3|||
147448160|NCT00960661|531805646|FG002|Interventional Phase|Physician Decision|5|||
147448161|NCT00960661|531805644|FG000|Interventional Phase|sponsor decision|0|||
147448162|NCT00960661|531805645|FG001|Interventional Phase|sponsor decision|1|||
147448163|NCT00960661|531805646|FG002|Interventional Phase|sponsor decision|0|||
147448164|NCT00960661|531805644|FG000|Interventional Phase|Lack of Efficacy|0|||
147448165|NCT00960661|531805645|FG001|Interventional Phase|Lack of Efficacy|2|||
147448166|NCT00960661|531805646|FG002|Interventional Phase|Lack of Efficacy|0|||
147448167|NCT03363321|531805649|FG000|Overall Study|Withdrawal by Subject|0|||
147448168|NCT03363321|531805650|FG001|Overall Study|Withdrawal by Subject|1|||
147655579|NCT03275389|532561587|FG002|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|1|||
147173726|NCT03068754|530800352|FG000|Randomized Treatment Period (RTP)|Death|2|||
147448169|NCT03363321|531805651|FG002|Overall Study|Withdrawal by Subject|0|||
147448170|NCT03363321|531805652|FG003|Overall Study|Withdrawal by Subject|1|||
147448171|NCT03363321|531805653|FG004|Overall Study|Withdrawal by Subject|0|||
147448172|NCT01032915|531805654|FG000|Overall Study|Adverse Event|2|||
147448173|NCT01032915|531805655|FG001|Overall Study|Adverse Event|2|||
147448174|NCT01032915|531805656|FG002|Overall Study|Adverse Event|1|||
147655580|NCT03275389|532561588|FG003|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
147655581|NCT03275389|532561589|FG004|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
147655582|NCT03275389|532561590|FG005|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
147173727|NCT03068754|530800353|FG001|Randomized Treatment Period (RTP)|Death|2|||
147173728|NCT03068754|530800354|FG002|Randomized Treatment Period (RTP)|Death|0|||
147173729|NCT03068754|530800355|FG003|Randomized Treatment Period (RTP)|Death|0|||
147173730|NCT03068754|530800352|FG000|Randomized Treatment Period (RTP)|Disease progression|1|||
147173731|NCT03068754|530800353|FG001|Randomized Treatment Period (RTP)|Disease progression|2|||
147173732|NCT03068754|530800354|FG002|Randomized Treatment Period (RTP)|Disease progression|0|||
147173733|NCT03068754|530800355|FG003|Randomized Treatment Period (RTP)|Disease progression|0|||
147173734|NCT03068754|530800352|FG000|Randomized Treatment Period (RTP)|Lost to Follow-up|1|||
147173735|NCT03068754|530800353|FG001|Randomized Treatment Period (RTP)|Lost to Follow-up|0|||
147173736|NCT03068754|530800354|FG002|Randomized Treatment Period (RTP)|Lost to Follow-up|0|||
147173737|NCT03068754|530800355|FG003|Randomized Treatment Period (RTP)|Lost to Follow-up|0|||
147173738|NCT03068754|530800352|FG000|Randomized Treatment Period (RTP)|Withdrawal by Subject|6|||
147173739|NCT03068754|530800353|FG001|Randomized Treatment Period (RTP)|Withdrawal by Subject|2|||
147173740|NCT03068754|530800354|FG002|Randomized Treatment Period (RTP)|Withdrawal by Subject|0|||
147173741|NCT03068754|530800355|FG003|Randomized Treatment Period (RTP)|Withdrawal by Subject|0|||
147173742|NCT03068754|530800352|FG000|Randomized Treatment Period (RTP)|Discontinued by Physician|1|||
147173743|NCT03068754|530800353|FG001|Randomized Treatment Period (RTP)|Discontinued by Physician|0|||
147173744|NCT03068754|530800354|FG002|Randomized Treatment Period (RTP)|Discontinued by Physician|0|||
147173745|NCT03068754|530800355|FG003|Randomized Treatment Period (RTP)|Discontinued by Physician|0|||
147173746|NCT03068754|530800352|FG000|Randomized Treatment Period (RTP)|Subject Decision based on Compensation|0|||
147173747|NCT03068754|530800353|FG001|Randomized Treatment Period (RTP)|Subject Decision based on Compensation|1|||
147173748|NCT03068754|530800354|FG002|Randomized Treatment Period (RTP)|Subject Decision based on Compensation|0|||
147173749|NCT03068754|530800355|FG003|Randomized Treatment Period (RTP)|Subject Decision based on Compensation|0|||
147173750|NCT03068754|530800352|FG000|Randomized Treatment Period (RTP)|Trial Terminated by Sponsor|55|||
147173751|NCT03068754|530800353|FG001|Randomized Treatment Period (RTP)|Trial Terminated by Sponsor|29|||
147173752|NCT03068754|530800354|FG002|Randomized Treatment Period (RTP)|Trial Terminated by Sponsor|0|||
147173753|NCT03068754|530800355|FG003|Randomized Treatment Period (RTP)|Trial Terminated by Sponsor|0|||
147173754|NCT03068754|530800352|FG000|Open Label Extension Period (OLE)|Adverse Event|0|||
147173755|NCT03068754|530800353|FG001|Open Label Extension Period (OLE)|Adverse Event|0|||
147173756|NCT03068754|530800354|FG002|Open Label Extension Period (OLE)|Adverse Event|0|||
147173757|NCT03068754|530800355|FG003|Open Label Extension Period (OLE)|Adverse Event|1|||
147173758|NCT03068754|530800352|FG000|Open Label Extension Period (OLE)|Death|0|||
147173759|NCT03068754|530800353|FG001|Open Label Extension Period (OLE)|Death|0|||
147173760|NCT03068754|530800354|FG002|Open Label Extension Period (OLE)|Death|0|||
147173761|NCT03068754|530800355|FG003|Open Label Extension Period (OLE)|Death|1|||
147173762|NCT03068754|530800352|FG000|Open Label Extension Period (OLE)|Disease progression|0|||
147173763|NCT03068754|530800353|FG001|Open Label Extension Period (OLE)|Disease progression|0|||
147173764|NCT03068754|530800354|FG002|Open Label Extension Period (OLE)|Disease progression|3|||
147173765|NCT03068754|530800355|FG003|Open Label Extension Period (OLE)|Disease progression|1|||
147173766|NCT03068754|530800352|FG000|Open Label Extension Period (OLE)|Withdrawal by Subject|0|||
147324131|NCT00688688|531352425|FG000|Overall Study|Site closure|0|||
147324132|NCT00688688|531352426|FG001|Overall Study|Site closure|1|||
147448175|NCT01032915|531805657|FG003|Overall Study|Adverse Event|1|||
147448176|NCT01032915|531805654|FG000|Overall Study|Abnormal test procedure result|0|||
147448177|NCT01032915|531805655|FG001|Overall Study|Abnormal test procedure result|0|||
147655583|NCT03275389|532561591|FG006|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
147655584|NCT03275389|532561592|FG007|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
147655585|NCT03275389|532561593|FG008|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
147448178|NCT01032915|531805656|FG002|Overall Study|Abnormal test procedure result|1|||
147448179|NCT01032915|531805657|FG003|Overall Study|Abnormal test procedure result|0|||
147448180|NCT01032915|531805654|FG000|Overall Study|Withdrawal by Subject|0|||
147448181|NCT01032915|531805655|FG001|Overall Study|Withdrawal by Subject|3|||
147448182|NCT01032915|531805656|FG002|Overall Study|Withdrawal by Subject|1|||
147448183|NCT01032915|531805657|FG003|Overall Study|Withdrawal by Subject|1|||
147448184|NCT01032915|531805654|FG000|Overall Study|Administrative reasons|5|||
147448185|NCT01032915|531805655|FG001|Overall Study|Administrative reasons|6|||
147448186|NCT01032915|531805656|FG002|Overall Study|Administrative reasons|4|||
147448187|NCT01032915|531805657|FG003|Overall Study|Administrative reasons|4|||
147448188|NCT01032915|531805654|FG000|Overall Study|Protocol Violation|1|||
147448189|NCT01032915|531805655|FG001|Overall Study|Protocol Violation|0|||
147448190|NCT01032915|531805656|FG002|Overall Study|Protocol Violation|0|||
147448191|NCT01032915|531805657|FG003|Overall Study|Protocol Violation|1|||
147448192|NCT02915523|531805658|FG000|Dose Determination Phase (Phase 1B)|Death|5|||
147448193|NCT02915523|531805659|FG001|Dose Determination Phase (Phase 1B)|Death|4|||
147448194|NCT02915523|531805660|FG002|Dose Determination Phase (Phase 1B)|Death|0|||
147448195|NCT02915523|531805661|FG003|Dose Determination Phase (Phase 1B)|Death|0|||
147448196|NCT02915523|531805658|FG000|Dose Determination Phase (Phase 1B)|Sponsor Decision|1|||
147448197|NCT02915523|531805659|FG001|Dose Determination Phase (Phase 1B)|Sponsor Decision|3|||
147448198|NCT02915523|531805660|FG002|Dose Determination Phase (Phase 1B)|Sponsor Decision|0|||
147448199|NCT02915523|531805661|FG003|Dose Determination Phase (Phase 1B)|Sponsor Decision|0|||
147448200|NCT02915523|531805658|FG000|Dose Determination Phase (Phase 1B)|Withdrawal by Subject|0|||
147448201|NCT02915523|531805659|FG001|Dose Determination Phase (Phase 1B)|Withdrawal by Subject|1|||
147448202|NCT02915523|531805660|FG002|Dose Determination Phase (Phase 1B)|Withdrawal by Subject|0|||
147448203|NCT02915523|531805661|FG003|Dose Determination Phase (Phase 1B)|Withdrawal by Subject|0|||
147448204|NCT02915523|531805658|FG000|Expansion Phase (Phase 2)|Death|0|||
147173767|NCT03068754|530800353|FG001|Open Label Extension Period (OLE)|Withdrawal by Subject|0|||
147173768|NCT03068754|530800354|FG002|Open Label Extension Period (OLE)|Withdrawal by Subject|5|||
147173769|NCT03068754|530800355|FG003|Open Label Extension Period (OLE)|Withdrawal by Subject|0|||
147173770|NCT03068754|530800352|FG000|Open Label Extension Period (OLE)|Subject Discontinued for Non-efficacy|0|||
147173771|NCT03068754|530800353|FG001|Open Label Extension Period (OLE)|Subject Discontinued for Non-efficacy|0|||
147173772|NCT03068754|530800354|FG002|Open Label Extension Period (OLE)|Subject Discontinued for Non-efficacy|1|||
147173773|NCT03068754|530800355|FG003|Open Label Extension Period (OLE)|Subject Discontinued for Non-efficacy|0|||
147173774|NCT03068754|530800352|FG000|Open Label Extension Period (OLE)|Trial Terminated by Sponsor|0|||
147173775|NCT03068754|530800353|FG001|Open Label Extension Period (OLE)|Trial Terminated by Sponsor|0|||
147173776|NCT03068754|530800354|FG002|Open Label Extension Period (OLE)|Trial Terminated by Sponsor|12|||
147173777|NCT03068754|530800355|FG003|Open Label Extension Period (OLE)|Trial Terminated by Sponsor|3|||
147173778|NCT01110382|530800356|FG000|Overall Study|Withdrawal by Subject|0|||
147173779|NCT01110382|530800357|FG001|Overall Study|Withdrawal by Subject|1|||
147173780|NCT01110382|530800356|FG000|Overall Study|Protocol Violation|0|||
147173781|NCT01110382|530800357|FG001|Overall Study|Protocol Violation|1|||
147173782|NCT00077649|530800358|FG000|Overall Study|Adverse Event|5|||
147173783|NCT00077649|530800359|FG001|Overall Study|Adverse Event|1|||
147173784|NCT00077649|530800360|FG002|Overall Study|Adverse Event|7|||
147173785|NCT00077649|530800361|FG003|Overall Study|Adverse Event|9|||
147173786|NCT00077649|530800358|FG000|Overall Study|Lack of Efficacy|5|||
147173787|NCT00077649|530800359|FG001|Overall Study|Lack of Efficacy|3|||
147173788|NCT00077649|530800360|FG002|Overall Study|Lack of Efficacy|3|||
147173789|NCT00077649|530800361|FG003|Overall Study|Lack of Efficacy|2|||
147173790|NCT00077649|530800358|FG000|Overall Study|Withdrawal by Subject|0|||
147173791|NCT00077649|530800359|FG001|Overall Study|Withdrawal by Subject|1|||
147173792|NCT00077649|530800360|FG002|Overall Study|Withdrawal by Subject|1|||
147173793|NCT00077649|530800361|FG003|Overall Study|Withdrawal by Subject|2|||
147173794|NCT00077649|530800358|FG000|Overall Study|Lost to Follow-up|2|||
147173795|NCT00077649|530800359|FG001|Overall Study|Lost to Follow-up|2|||
147173796|NCT00077649|530800360|FG002|Overall Study|Lost to Follow-up|3|||
147173797|NCT00077649|530800361|FG003|Overall Study|Lost to Follow-up|2|||
147173798|NCT00077649|530800358|FG000|Overall Study|Abnormality of Laboratory Test|1|||
147173799|NCT00077649|530800359|FG001|Overall Study|Abnormality of Laboratory Test|2|||
147173800|NCT00077649|530800360|FG002|Overall Study|Abnormality of Laboratory Test|1|||
147173801|NCT00077649|530800361|FG003|Overall Study|Abnormality of Laboratory Test|2|||
147448205|NCT02915523|531805659|FG001|Expansion Phase (Phase 2)|Death|0|||
147448206|NCT02915523|531805660|FG002|Expansion Phase (Phase 2)|Death|26|||
147448207|NCT02915523|531805661|FG003|Expansion Phase (Phase 2)|Death|53|||
147448208|NCT02915523|531805658|FG000|Expansion Phase (Phase 2)|Sponsor Decision|0|||
147448209|NCT02915523|531805659|FG001|Expansion Phase (Phase 2)|Sponsor Decision|0|||
147173802|NCT00077649|530800358|FG000|Overall Study|Randomized but never dosed|1|||
147173803|NCT00077649|530800359|FG001|Overall Study|Randomized but never dosed|0|||
147173804|NCT00077649|530800360|FG002|Overall Study|Randomized but never dosed|0|||
147448210|NCT02915523|531805660|FG002|Expansion Phase (Phase 2)|Sponsor Decision|4|||
147448211|NCT02915523|531805661|FG003|Expansion Phase (Phase 2)|Sponsor Decision|22|||
147173805|NCT00077649|530800361|FG003|Overall Study|Randomized but never dosed|0|||
147173806|NCT00590577|530800364|FG000|Overall Study|Lack of Efficacy|31|||
147173807|NCT00590577|530800365|FG001|Overall Study|Lack of Efficacy|28|||
147173808|NCT00590577|530800366|FG002|Overall Study|Lack of Efficacy|23|||
147173809|NCT00590577|530800367|FG003|Overall Study|Lack of Efficacy|45|||
147173810|NCT00590577|530800364|FG000|Overall Study|Withdrawal by Subject|23|||
147173811|NCT00590577|530800365|FG001|Overall Study|Withdrawal by Subject|28|||
147173812|NCT00590577|530800366|FG002|Overall Study|Withdrawal by Subject|30|||
147173813|NCT00590577|530800367|FG003|Overall Study|Withdrawal by Subject|26|||
147173814|NCT00590577|530800364|FG000|Overall Study|Adverse Event|10|||
147173815|NCT00590577|530800365|FG001|Overall Study|Adverse Event|10|||
147173816|NCT00590577|530800366|FG002|Overall Study|Adverse Event|13|||
147173817|NCT00590577|530800367|FG003|Overall Study|Adverse Event|11|||
147173818|NCT00590577|530800364|FG000|Overall Study|Lost to Follow-up|12|||
147173819|NCT00590577|530800365|FG001|Overall Study|Lost to Follow-up|6|||
147173820|NCT00590577|530800366|FG002|Overall Study|Lost to Follow-up|6|||
147173821|NCT00590577|530800367|FG003|Overall Study|Lost to Follow-up|9|||
147655586|NCT03275389|532561594|FG009|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|1|||
147655587|NCT03275389|532561585|FG000|Overall Study|Other|0|||
147655588|NCT03275389|532561586|FG001|Overall Study|Other|4|||
147655589|NCT03275389|532561587|FG002|Overall Study|Other|3|||
147655590|NCT03275389|532561588|FG003|Overall Study|Other|2|||
147655591|NCT03275389|532561589|FG004|Overall Study|Other|2|||
147655592|NCT03275389|532561590|FG005|Overall Study|Other|2|||
147655593|NCT03275389|532561591|FG006|Overall Study|Other|0|||
147655594|NCT03275389|532561592|FG007|Overall Study|Other|0|||
147655595|NCT03275389|532561593|FG008|Overall Study|Other|1|||
147655596|NCT03275389|532561594|FG009|Overall Study|Other|0|||
147655597|NCT01790516|532561595|FG000|Overall Study|Physician Decision|1|||
147324133|NCT00688688|531352427|FG002|Overall Study|Site closure|0|||
147324134|NCT00688688|531352425|FG000|Overall Study|Violation of exclusion criterion|0|||
147655598|NCT01790516|532561596|FG001|Overall Study|Physician Decision|0|||
147173822|NCT00590577|530800364|FG000|Overall Study|Pregnancy|0|||
147173823|NCT00590577|530800365|FG001|Overall Study|Pregnancy|1|||
147173824|NCT00590577|530800366|FG002|Overall Study|Pregnancy|0|||
147173825|NCT00590577|530800367|FG003|Overall Study|Pregnancy|0|||
147173826|NCT00590577|530800364|FG000|Overall Study|Various reasons|1|||
147173827|NCT00590577|530800365|FG001|Overall Study|Various reasons|3|||
147173828|NCT00590577|530800366|FG002|Overall Study|Various reasons|1|||
147173829|NCT00590577|530800367|FG003|Overall Study|Various reasons|2|||
147173830|NCT01300260|530800368|FG000|Period 1 of Study: First Intervention|Adverse Event|0|||
147173831|NCT01300260|530800369|FG001|Period 1 of Study: First Intervention|Adverse Event|1|||
147173832|NCT01300260|530800368|FG000|Period 1 of Study: First Intervention|Withdrawal by Subject|1|||
147173833|NCT01300260|530800369|FG001|Period 1 of Study: First Intervention|Withdrawal by Subject|0|||
147173834|NCT01300260|530800368|FG000|Period 2 of Study: Second Intervention|Adverse Event|0|||
147173835|NCT01300260|530800369|FG001|Period 2 of Study: Second Intervention|Adverse Event|1|||
147173836|NCT00235716|530800379|FG000|Overall Study|Death|26|||
147173837|NCT00235716|530800380|FG001|Overall Study|Death|39|||
147173838|NCT00235716|530800381|FG002|Overall Study|Death|32|||
147173839|NCT00235716|530800382|FG003|Overall Study|Death|31|||
147173840|NCT00235716|530800379|FG000|Overall Study|Withdrawal by Subject|23|||
147173841|NCT00235716|530800380|FG001|Overall Study|Withdrawal by Subject|19|||
147173842|NCT00235716|530800381|FG002|Overall Study|Withdrawal by Subject|17|||
147173843|NCT00235716|530800382|FG003|Overall Study|Withdrawal by Subject|18|||
147173844|NCT00235716|530800379|FG000|Overall Study|Lost to Follow-up|12|||
147173845|NCT00235716|530800380|FG001|Overall Study|Lost to Follow-up|7|||
147173846|NCT00235716|530800381|FG002|Overall Study|Lost to Follow-up|14|||
147173847|NCT00235716|530800382|FG003|Overall Study|Lost to Follow-up|10|||
147173848|NCT00235716|530800379|FG000|Overall Study|Adverse Event|1|||
147173849|NCT00235716|530800380|FG001|Overall Study|Adverse Event|1|||
147173850|NCT00235716|530800381|FG002|Overall Study|Adverse Event|1|||
147173851|NCT00235716|530800382|FG003|Overall Study|Adverse Event|0|||
147324135|NCT00688688|531352426|FG001|Overall Study|Violation of exclusion criterion|1|||
147324136|NCT00688688|531352427|FG002|Overall Study|Violation of exclusion criterion|0|||
147324137|NCT04296942|531352428|FG000|Overall Study|Study closure by sponsor|1|||
147655599|NCT03749109|532561597|FG000|Overall Study|Adverse Event|2|||
147655600|NCT03749109|532561598|FG001|Overall Study|Adverse Event|0|||
147173852|NCT00235716|530800379|FG000|Overall Study|Physician Decision|0|||
147173853|NCT00235716|530800380|FG001|Overall Study|Physician Decision|1|||
147173854|NCT00235716|530800381|FG002|Overall Study|Physician Decision|1|||
147173855|NCT00235716|530800382|FG003|Overall Study|Physician Decision|3|||
147173856|NCT03238924|530800383|FG000|Overall Study|Withdrawal by Subject|2|||
147173857|NCT03238924|530800384|FG001|Overall Study|Withdrawal by Subject|2|||
147173858|NCT03576716|530800385|FG000|Overall Study|Withdrawal by Subject|0|||
147173859|NCT03576716|530800386|FG001|Overall Study|Withdrawal by Subject|1|||
147655601|NCT03034135|532561599|FG000|Overall Study|Withdrawal by Subject|2|||
147655602|NCT02576977|532562932|FG000|Overall Study|Adverse Event|13|||
147655603|NCT02576977|532562933|FG001|Overall Study|Adverse Event|2|||
147655604|NCT02576977|532562932|FG000|Overall Study|Death|73|||
147173860|NCT00559988|530800387|FG000|Overall Study|Death|147|||
147173861|NCT00559988|530800388|FG001|Overall Study|Death|140|||
147173862|NCT00559988|530800387|FG000|Overall Study|Withdrawal by Subject|152|||
147173863|NCT00559988|530800388|FG001|Overall Study|Withdrawal by Subject|139|||
147173864|NCT00559988|530800387|FG000|Overall Study|Lost to Follow-up|42|||
147173865|NCT00559988|530800388|FG001|Overall Study|Lost to Follow-up|56|||
147173866|NCT00559988|530800387|FG000|Overall Study|ICD device explanted|10|||
147173867|NCT00559988|530800388|FG001|Overall Study|ICD device explanted|17|||
147173868|NCT01455194|530800389|FG000|Overall Study|Screen Failure|20|||
147173869|NCT01455194|530800390|FG001|Overall Study|Screen Failure|0|||
147173870|NCT01455194|530800391|FG002|Overall Study|Screen Failure|0|||
147173871|NCT01455194|530800392|FG003|Overall Study|Screen Failure|0|||
147173872|NCT01455194|530800389|FG000|Overall Study|Randomisation Failure|90|||
147173873|NCT01455194|530800390|FG001|Overall Study|Randomisation Failure|0|||
147173874|NCT01455194|530800391|FG002|Overall Study|Randomisation Failure|0|||
147173875|NCT01455194|530800392|FG003|Overall Study|Randomisation Failure|0|||
147173876|NCT01455194|530800389|FG000|Overall Study|Deterioration in asthma|12|||
147173877|NCT01455194|530800390|FG001|Overall Study|Deterioration in asthma|6|||
147173878|NCT01455194|530800391|FG002|Overall Study|Deterioration in asthma|14|||
147173879|NCT01455194|530800392|FG003|Overall Study|Deterioration in asthma|9|||
147173880|NCT01455194|530800389|FG000|Overall Study|Adverse Event|1|||
147173881|NCT01455194|530800390|FG001|Overall Study|Adverse Event|1|||
147173882|NCT01455194|530800391|FG002|Overall Study|Adverse Event|1|||
147173883|NCT01455194|530800392|FG003|Overall Study|Adverse Event|3|||
147173884|NCT01455194|530800389|FG000|Overall Study|Withdrawal by Subject|21|||
147173885|NCT01455194|530800390|FG001|Overall Study|Withdrawal by Subject|16|||
147173886|NCT01455194|530800391|FG002|Overall Study|Withdrawal by Subject|12|||
147173887|NCT01455194|530800392|FG003|Overall Study|Withdrawal by Subject|9|||
147173888|NCT01455194|530800389|FG000|Overall Study|Lost to Follow-up|2|||
147173889|NCT01455194|530800390|FG001|Overall Study|Lost to Follow-up|0|||
147173890|NCT01455194|530800391|FG002|Overall Study|Lost to Follow-up|1|||
147173891|NCT01455194|530800392|FG003|Overall Study|Lost to Follow-up|1|||
147173892|NCT01455194|530800389|FG000|Overall Study|Pregnancy|0|||
147173893|NCT01455194|530800390|FG001|Overall Study|Pregnancy|1|||
147324138|NCT04296942|531352429|FG001|Overall Study|Study closure by sponsor|0|||
147324139|NCT04296942|531352430|FG002|Overall Study|Study closure by sponsor|0|||
147324140|NCT00530777|531352438|FG000|Overall Study|Lost to Follow-up|0|||
147324141|NCT00530777|531352439|FG001|Overall Study|Lost to Follow-up|1|||
147324142|NCT00530777|531352438|FG000|Overall Study|Death|1|||
147324143|NCT00530777|531352439|FG001|Overall Study|Death|2|||
147324144|NCT00530777|531352438|FG000|Overall Study|Physician Decision|1|||
147324145|NCT00530777|531352439|FG001|Overall Study|Physician Decision|0|||
147324146|NCT00530777|531352438|FG000|Overall Study|Withdrawal by Subject|0|||
147324147|NCT00530777|531352439|FG001|Overall Study|Withdrawal by Subject|1|||
147324148|NCT00530777|531352438|FG000|Overall Study|Unable to adhere to visit schedule|5|||
147324149|NCT00530777|531352439|FG001|Overall Study|Unable to adhere to visit schedule|1|||
147324150|NCT01582243|531352444|FG000|Overall Study|Withdrawal by Subject|1|||
147324151|NCT01582243|531352444|FG000|Overall Study|Adverse Event|1|||
147324152|NCT01582243|531352444|FG000|Overall Study|Lost to Follow-up|1|||
147324153|NCT03382821|531352445|FG000|Overall Study|Did not receive allocated intervention.|0|||
147324154|NCT03382821|531352446|FG001|Overall Study|Did not receive allocated intervention.|3|||
147324155|NCT00797225|531352448|FG000|Weeks 1 to 12|Adverse Event|0|||
147324156|NCT00797225|531352449|FG001|Weeks 1 to 12|Adverse Event|0|||
147324157|NCT00797225|531352450|FG002|Weeks 1 to 12|Adverse Event|1|||
147324158|NCT00797225|531352451|FG003|Weeks 1 to 12|Adverse Event|0|||
147324159|NCT00797225|531352452|FG004|Weeks 1 to 12|Adverse Event|0|||
147324160|NCT00797225|531352453|FG005|Weeks 1 to 12|Adverse Event|0|||
147324161|NCT00797225|531352454|FG006|Weeks 1 to 12|Adverse Event|0|||
147324162|NCT00797225|531352455|FG007|Weeks 1 to 12|Adverse Event|0|||
147324163|NCT00797225|531352448|FG000|Weeks 1 to 12|Non-compliance|0|||
147324164|NCT00797225|531352449|FG001|Weeks 1 to 12|Non-compliance|1|||
147324165|NCT00797225|531352450|FG002|Weeks 1 to 12|Non-compliance|0|||
147324166|NCT00797225|531352451|FG003|Weeks 1 to 12|Non-compliance|0|||
147324167|NCT00797225|531352452|FG004|Weeks 1 to 12|Non-compliance|0|||
147324168|NCT00797225|531352453|FG005|Weeks 1 to 12|Non-compliance|0|||
147324169|NCT00797225|531352454|FG006|Weeks 1 to 12|Non-compliance|0|||
147324170|NCT00797225|531352455|FG007|Weeks 1 to 12|Non-compliance|0|||
147324171|NCT00797225|531352448|FG000|Weeks 1 to 12|Lack of Efficacy|1|||
147324172|NCT00797225|531352449|FG001|Weeks 1 to 12|Lack of Efficacy|0|||
147173894|NCT01455194|530800391|FG002|Overall Study|Pregnancy|1|||
147173895|NCT01455194|530800392|FG003|Overall Study|Pregnancy|0|||
147173896|NCT01455194|530800389|FG000|Overall Study|Discontinuation criterion fulfilled|3|||
147173897|NCT01455194|530800390|FG001|Overall Study|Discontinuation criterion fulfilled|2|||
147173898|NCT01455194|530800391|FG002|Overall Study|Discontinuation criterion fulfilled|0|||
147173899|NCT01455194|530800392|FG003|Overall Study|Discontinuation criterion fulfilled|2|||
147324173|NCT00797225|531352450|FG002|Weeks 1 to 12|Lack of Efficacy|0|||
147324174|NCT00797225|531352451|FG003|Weeks 1 to 12|Lack of Efficacy|0|||
147324175|NCT00797225|531352452|FG004|Weeks 1 to 12|Lack of Efficacy|0|||
147324176|NCT00797225|531352453|FG005|Weeks 1 to 12|Lack of Efficacy|0|||
147592701|NCT00102687|532325106|FG001|Maintenance Period|Death|0|||
147592702|NCT00102687|532325107|FG002|Maintenance Period|Death|0|||
147592703|NCT00102687|532325108|FG003|Maintenance Period|Death|1|||
147592704|NCT00102687|532325109|FG004|Maintenance Period|Death|1|||
147592705|NCT00102687|532325105|FG000|Maintenance Period|Physician Decision|1|||
147592706|NCT00102687|532325106|FG001|Maintenance Period|Physician Decision|2|||
147592707|NCT00102687|532325107|FG002|Maintenance Period|Physician Decision|3|||
147592708|NCT00102687|532325108|FG003|Maintenance Period|Physician Decision|0|||
147655605|NCT02576977|532562933|FG001|Overall Study|Death|60|||
147655606|NCT02576977|532562932|FG000|Overall Study|Screen failure|1|||
147655607|NCT02576977|532562933|FG001|Overall Study|Screen failure|0|||
147655608|NCT02576977|532562932|FG000|Overall Study|Study Terminated at Selected Sites|27|||
147655609|NCT02576977|532562933|FG001|Overall Study|Study Terminated at Selected Sites|50|||
147655610|NCT02576977|532562932|FG000|Overall Study|Withdrawal by Subject|11|||
147655611|NCT02576977|532562933|FG001|Overall Study|Withdrawal by Subject|11|||
147655612|NCT02576977|532562932|FG000|Overall Study|Final Disposition Unknown|0|||
147655613|NCT02576977|532562933|FG001|Overall Study|Final Disposition Unknown|1|||
147655614|NCT02576977|532562932|FG000|Overall Study|Lost to Follow-up|1|||
147655615|NCT02576977|532562933|FG001|Overall Study|Lost to Follow-up|0|||
147655616|NCT02576977|532562932|FG000|Overall Study|Progressive Disease|0|||
147655617|NCT02576977|532562933|FG001|Overall Study|Progressive Disease|1|||
147655618|NCT02489448|532562942|FG000|Overall Study|Death|3|||
147655619|NCT02489448|532562942|FG000|Overall Study|Withdrawal by Subject|2|||
147655620|NCT04152083|532562943|FG000|Overall Study|Lost to Follow-up|2|||
147655621|NCT04152083|532562944|FG001|Overall Study|Lost to Follow-up|1|||
147655622|NCT04152083|532562943|FG000|Overall Study|Adverse Event|1|||
147655623|NCT04152083|532562944|FG001|Overall Study|Adverse Event|0|||
147655624|NCT04152083|532562943|FG000|Overall Study|Randomized but not treated|3|||
147655625|NCT04152083|532562944|FG001|Overall Study|Randomized but not treated|2|||
147655626|NCT03280056|532562945|FG000|Overall Study|Withdrawal by Subject|12|||
147655627|NCT03280056|532562946|FG001|Overall Study|Withdrawal by Subject|14|||
147655628|NCT03280056|532562945|FG000|Overall Study|Death|9|||
147655629|NCT03280056|532562946|FG001|Overall Study|Death|2|||
147655630|NCT03280056|532562945|FG000|Overall Study|Adverse Event|1|||
147655631|NCT03280056|532562946|FG001|Overall Study|Adverse Event|3|||
147655632|NCT03280056|532562945|FG000|Overall Study|Lost to Follow-up|1|||
147655633|NCT03280056|532562946|FG001|Overall Study|Lost to Follow-up|1|||
147655634|NCT03280056|532562945|FG000|Overall Study|Physician Decision|0|||
147655635|NCT03280056|532562946|FG001|Overall Study|Physician Decision|1|||
147655636|NCT03280056|532562945|FG000|Overall Study|Early Discontinuation|1|||
147655637|NCT03280056|532562946|FG001|Overall Study|Early Discontinuation|0|||
147655638|NCT01135524|532562949|FG000|Overall Study|Withdrawal by Subject|14|||
147655639|NCT01135524|532562949|FG000|Overall Study|Adverse Event|20|||
147655640|NCT01135524|532562949|FG000|Overall Study|Lost to Follow-up|3|||
147655641|NCT01135524|532562949|FG000|Overall Study|Administrative|151|||
147655642|NCT01135524|532562949|FG000|Overall Study|Lack of Efficacy|8|||
147655643|NCT00807612|532562952|FG000|Overall Study|Death|8|||
147655644|NCT00807612|532562952|FG000|Overall Study|Study early termination|5|||
147655645|NCT00807612|532562952|FG000|Overall Study|Withdrawal by Subject|1|||
147655646|NCT04607135|532562953|FG000|Overall Study|Physician Decision|1|||
147655647|NCT04607135|532562953|FG000|Overall Study|Withdrawal by Subject|1|||
147655648|NCT04607135|532562953|FG000|Overall Study|Equipment not working|3|||
147655649|NCT03465709|532562954|FG000|Overall Study|Study/Site Terminated by Sponsor|14|||
147655650|NCT03465709|532562954|FG000|Overall Study|Withdrawal by Subject|3|||
147655651|NCT04892446|532562955|FG000|Overall Study|Death|4|||
147655652|NCT04892446|532562956|FG001|Overall Study|Death|4|||
147655653|NCT04892446|532562957|FG002|Overall Study|Death|0|||
147655654|NCT04892446|532562955|FG000|Overall Study|Withdrew consent|3|||
147655655|NCT04892446|532562956|FG001|Overall Study|Withdrew consent|0|||
147655656|NCT04892446|532562957|FG002|Overall Study|Withdrew consent|1|||
147655657|NCT04892446|532562955|FG000|Overall Study|Investigator's discretion|1|||
147655658|NCT04892446|532562956|FG001|Overall Study|Investigator's discretion|1|||
147655659|NCT04892446|532562957|FG002|Overall Study|Investigator's discretion|0|||
147655660|NCT04892446|532562955|FG000|Overall Study|Study terminated by sponsor|0|||
147655661|NCT04892446|532562956|FG001|Overall Study|Study terminated by sponsor|0|||
147655662|NCT04892446|532562957|FG002|Overall Study|Study terminated by sponsor|2|||
147655663|NCT03193047|532562959|FG000|Overall Study|Physician Decision|1|||
147655664|NCT03193047|532562960|FG001|Overall Study|Physician Decision|0|||
147655665|NCT03193047|532562959|FG000|Overall Study|Participant Left State|1|||
147173900|NCT01455194|530800389|FG000|Overall Study|Miscellaneous|4|||
147592709|NCT00102687|532325109|FG004|Maintenance Period|Physician Decision|4|||
147592710|NCT01258101|532325110|FG000|Overall Study|Adverse Event|5|||
147592711|NCT01258101|532325111|FG001|Overall Study|Adverse Event|6|||
147655666|NCT03193047|532562960|FG001|Overall Study|Participant Left State|0|||
147655667|NCT02328937|532562961|FG000|Period 1|Lost to Follow-up|0|||
147655668|NCT02328937|532562962|FG001|Period 1|Lost to Follow-up|0|||
147655669|NCT02328937|532562963|FG002|Period 1|Lost to Follow-up|0|||
147655670|NCT02328937|532562964|FG003|Period 1|Lost to Follow-up|1|||
147655671|NCT02328937|532562965|FG004|Period 1|Lost to Follow-up|0|||
147324177|NCT00797225|531352454|FG006|Weeks 1 to 12|Lack of Efficacy|0|||
147324178|NCT00797225|531352455|FG007|Weeks 1 to 12|Lack of Efficacy|0|||
147324179|NCT00797225|531352448|FG000|Weeks 1 to 12|Sponsor Decision|1|||
147324180|NCT00797225|531352449|FG001|Weeks 1 to 12|Sponsor Decision|0|||
147324181|NCT00797225|531352450|FG002|Weeks 1 to 12|Sponsor Decision|0|||
147324182|NCT00797225|531352451|FG003|Weeks 1 to 12|Sponsor Decision|0|||
147324183|NCT00797225|531352452|FG004|Weeks 1 to 12|Sponsor Decision|0|||
147324184|NCT00797225|531352453|FG005|Weeks 1 to 12|Sponsor Decision|0|||
147324185|NCT00797225|531352454|FG006|Weeks 1 to 12|Sponsor Decision|0|||
147173901|NCT01455194|530800390|FG001|Overall Study|Miscellaneous|5|||
147173902|NCT01455194|530800391|FG002|Overall Study|Miscellaneous|1|||
147173903|NCT01455194|530800392|FG003|Overall Study|Miscellaneous|4|||
147173904|NCT02891382|530800393|FG000|Overall Study|Lost to Follow-up|3|||
147173905|NCT02891382|530800394|FG001|Overall Study|Lost to Follow-up|4|||
147173906|NCT02891382|530800395|FG002|Overall Study|Lost to Follow-up|5|||
147173907|NCT02891382|530800396|FG003|Overall Study|Lost to Follow-up|3|||
147173908|NCT02891382|530800397|FG004|Overall Study|Lost to Follow-up|4|||
147173909|NCT02516228|530800398|FG000|Overall Study|Lost to Follow-up|1|||
147173910|NCT02516228|530800398|FG000|Overall Study|Withdrawal by Subject|1|||
147173911|NCT02516228|530800398|FG000|Overall Study|Physician Decision|1|||
147173912|NCT03916484|530800399|FG000|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
147173913|NCT03916484|530800400|FG001|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|1|||
147173914|NCT03916484|530800401|FG002|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
147173915|NCT03916484|530800402|FG003|Stage 1 Intervention (Months 1-3)|Lost to Follow-up|0|||
147173916|NCT03916484|530800399|FG000|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|2|||
147173917|NCT03916484|530800400|FG001|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|11|||
147173918|NCT03916484|530800401|FG002|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|4|||
147173919|NCT03916484|530800402|FG003|Stage 2 Intervention (Months 4-6)|Lost to Follow-up|1|||
147173920|NCT00788710|530800403|FG000|Overall Study|Adverse Event|1|||
147173921|NCT00788710|530800404|FG001|Overall Study|Adverse Event|3|||
147324186|NCT00797225|531352455|FG007|Weeks 1 to 12|Sponsor Decision|0|||
147324187|NCT00797225|531352448|FG000|Weeks 13 to 24|Non-compliance|0|||
147324188|NCT00797225|531352449|FG001|Weeks 13 to 24|Non-compliance|2|||
147324189|NCT00797225|531352450|FG002|Weeks 13 to 24|Non-compliance|0|||
147448212|NCT02915523|531805658|FG000|Expansion Phase (Phase 2)|Withdrawal by Subject|0|||
147448213|NCT02915523|531805659|FG001|Expansion Phase (Phase 2)|Withdrawal by Subject|0|||
147592712|NCT01258101|532325112|FG002|Overall Study|Adverse Event|0|||
147592713|NCT01258101|532325113|FG003|Overall Study|Adverse Event|0|||
147592714|NCT01258101|532325110|FG000|Overall Study|Extra exclusion criterion amended|2|||
147592715|NCT01258101|532325111|FG001|Overall Study|Extra exclusion criterion amended|1|||
147592716|NCT01258101|532325112|FG002|Overall Study|Extra exclusion criterion amended|1|||
147592717|NCT01258101|532325113|FG003|Overall Study|Extra exclusion criterion amended|1|||
147592718|NCT01258101|532325110|FG000|Overall Study|Informed consent has been withdrawn|2|||
147592719|NCT01258101|532325111|FG001|Overall Study|Informed consent has been withdrawn|2|||
147592720|NCT01258101|532325112|FG002|Overall Study|Informed consent has been withdrawn|1|||
147592721|NCT01258101|532325113|FG003|Overall Study|Informed consent has been withdrawn|1|||
147592722|NCT01258101|532325110|FG000|Overall Study|Patient is not able to attend visits|8|||
147592723|NCT01258101|532325111|FG001|Overall Study|Patient is not able to attend visits|9|||
147592724|NCT01258101|532325112|FG002|Overall Study|Patient is not able to attend visits|7|||
147592725|NCT01258101|532325113|FG003|Overall Study|Patient is not able to attend visits|6|||
147592726|NCT01258101|532325110|FG000|Overall Study|Patient´s compliance|4|||
147592727|NCT01258101|532325111|FG001|Overall Study|Patient´s compliance|3|||
147592728|NCT01258101|532325112|FG002|Overall Study|Patient´s compliance|1|||
147592729|NCT01258101|532325113|FG003|Overall Study|Patient´s compliance|2|||
147592730|NCT01258101|532325110|FG000|Overall Study|Lost to Follow-up|5|||
147592731|NCT01258101|532325111|FG001|Overall Study|Lost to Follow-up|5|||
147592732|NCT01258101|532325112|FG002|Overall Study|Lost to Follow-up|0|||
147592733|NCT01258101|532325113|FG003|Overall Study|Lost to Follow-up|6|||
147592734|NCT01258101|532325110|FG000|Overall Study|PCR positive at week 24|0|||
147592735|NCT01258101|532325111|FG001|Overall Study|PCR positive at week 24|0|||
147592736|NCT01258101|532325112|FG002|Overall Study|PCR positive at week 24|0|||
147592737|NCT01258101|532325113|FG003|Overall Study|PCR positive at week 24|1|||
147592738|NCT01258101|532325110|FG000|Overall Study|Other reason|7|||
147592739|NCT01258101|532325111|FG001|Overall Study|Other reason|8|||
147592740|NCT01258101|532325112|FG002|Overall Study|Other reason|1|||
147592741|NCT01258101|532325113|FG003|Overall Study|Other reason|8|||
147592742|NCT00063882|532325114|FG000|Overall Study|Protocol Violation|3|||
147173922|NCT00788710|530800405|FG002|Overall Study|Adverse Event|4|||
147173923|NCT00788710|530800403|FG000|Overall Study|Lack of Efficacy|0|||
147173924|NCT00788710|530800404|FG001|Overall Study|Lack of Efficacy|0|||
147173925|NCT00788710|530800405|FG002|Overall Study|Lack of Efficacy|1|||
147592743|NCT00063882|532325115|FG001|Overall Study|Protocol Violation|3|||
147592744|NCT00063882|532325114|FG000|Overall Study|Withdrawal by Subject|2|||
147592745|NCT00063882|532325115|FG001|Overall Study|Withdrawal by Subject|1|||
147592746|NCT01949116|532325124|FG000|Overall Study|Death|2|||
147592747|NCT01949116|532325125|FG001|Overall Study|Death|0|||
147324190|NCT00797225|531352451|FG003|Weeks 13 to 24|Non-compliance|0|||
147324191|NCT00797225|531352452|FG004|Weeks 13 to 24|Non-compliance|0|||
147324192|NCT00797225|531352453|FG005|Weeks 13 to 24|Non-compliance|0|||
147173926|NCT00788710|530800403|FG000|Overall Study|Lost to Follow-up|0|||
147173927|NCT00788710|530800404|FG001|Overall Study|Lost to Follow-up|1|||
147173928|NCT00788710|530800405|FG002|Overall Study|Lost to Follow-up|0|||
147173929|NCT00788710|530800403|FG000|Overall Study|Physician Decision|2|||
147173930|NCT00788710|530800404|FG001|Overall Study|Physician Decision|1|||
147173931|NCT00788710|530800405|FG002|Overall Study|Physician Decision|0|||
147173932|NCT00788710|530800403|FG000|Overall Study|Protocol Violation|0|||
147173933|NCT00788710|530800404|FG001|Overall Study|Protocol Violation|1|||
147173934|NCT00788710|530800405|FG002|Overall Study|Protocol Violation|1|||
147173935|NCT00788710|530800403|FG000|Overall Study|Withdrawal by Subject|2|||
147173936|NCT00788710|530800404|FG001|Overall Study|Withdrawal by Subject|2|||
147173937|NCT00788710|530800405|FG002|Overall Study|Withdrawal by Subject|0|||
147173938|NCT01990859|530800408|FG000|Treatment (4 Doses Over 12 Weeks)|Progressive Disease|5|||
147173939|NCT01990859|530800408|FG000|Week 12 to Week 24 Post Dosing Follow Up|Disease Progression|17|||
147173940|NCT02262754|530800409|FG000|Overall Study|Adverse Event|3|||
147173941|NCT02262754|530800410|FG001|Overall Study|Adverse Event|4|||
147173942|NCT02262754|530800411|FG002|Overall Study|Adverse Event|0|||
147173943|NCT02262754|530800409|FG000|Overall Study|Lack of Efficacy|2|||
147173944|NCT02262754|530800410|FG001|Overall Study|Lack of Efficacy|0|||
147173945|NCT02262754|530800411|FG002|Overall Study|Lack of Efficacy|1|||
147173946|NCT02262754|530800409|FG000|Overall Study|Lost to Follow-up|0|||
147173947|NCT02262754|530800410|FG001|Overall Study|Lost to Follow-up|0|||
147173948|NCT02262754|530800411|FG002|Overall Study|Lost to Follow-up|1|||
147173949|NCT02262754|530800409|FG000|Overall Study|No longer meets eligibility criteria|0|||
147173950|NCT02262754|530800410|FG001|Overall Study|No longer meets eligibility criteria|1|||
147173951|NCT02262754|530800411|FG002|Overall Study|No longer meets eligibility criteria|0|||
147173952|NCT02262754|530800409|FG000|Overall Study|Study terminated by sponsor|5|||
147173953|NCT02262754|530800410|FG001|Overall Study|Study terminated by sponsor|4|||
147173954|NCT02262754|530800411|FG002|Overall Study|Study terminated by sponsor|4|||
147173955|NCT02262754|530800409|FG000|Overall Study|Protocol Violation|1|||
147173956|NCT02262754|530800410|FG001|Overall Study|Protocol Violation|0|||
147173957|NCT02262754|530800411|FG002|Overall Study|Protocol Violation|0|||
147173958|NCT02262754|530800409|FG000|Overall Study|Withdrawal by Subject|1|||
147173959|NCT02262754|530800410|FG001|Overall Study|Withdrawal by Subject|0|||
147173960|NCT02262754|530800411|FG002|Overall Study|Withdrawal by Subject|1|||
147173961|NCT02262754|530800409|FG000|Overall Study|Other|4|||
147173962|NCT02262754|530800410|FG001|Overall Study|Other|0|||
147173963|NCT02262754|530800411|FG002|Overall Study|Other|2|||
147173964|NCT04079114|530800414|FG000|Overall Study|Study prematuely terminated.|166|||
147324193|NCT00797225|531352454|FG006|Weeks 13 to 24|Non-compliance|0|||
147324194|NCT00797225|531352455|FG007|Weeks 13 to 24|Non-compliance|0|||
147324195|NCT00797225|531352448|FG000|Weeks 13 to 24|Withdrawal by Subject|0|||
147324196|NCT00797225|531352449|FG001|Weeks 13 to 24|Withdrawal by Subject|1|||
147324197|NCT00797225|531352450|FG002|Weeks 13 to 24|Withdrawal by Subject|1|||
147324198|NCT00797225|531352451|FG003|Weeks 13 to 24|Withdrawal by Subject|0|||
147324199|NCT00797225|531352452|FG004|Weeks 13 to 24|Withdrawal by Subject|0|||
147324200|NCT00797225|531352453|FG005|Weeks 13 to 24|Withdrawal by Subject|0|||
147324201|NCT00797225|531352454|FG006|Weeks 13 to 24|Withdrawal by Subject|0|||
147324202|NCT00797225|531352455|FG007|Weeks 13 to 24|Withdrawal by Subject|0|||
147324203|NCT00797225|531352448|FG000|Weeks 13 to 24|Lost to Follow-up|0|||
147324204|NCT00797225|531352449|FG001|Weeks 13 to 24|Lost to Follow-up|0|||
147324205|NCT00797225|531352450|FG002|Weeks 13 to 24|Lost to Follow-up|1|||
147324206|NCT00797225|531352451|FG003|Weeks 13 to 24|Lost to Follow-up|0|||
147324207|NCT00797225|531352452|FG004|Weeks 13 to 24|Lost to Follow-up|1|||
147324208|NCT00797225|531352453|FG005|Weeks 13 to 24|Lost to Follow-up|0|||
147324209|NCT00797225|531352454|FG006|Weeks 13 to 24|Lost to Follow-up|0|||
147324210|NCT00797225|531352455|FG007|Weeks 13 to 24|Lost to Follow-up|0|||
147324211|NCT00797225|531352448|FG000|Weeks 13 to 24|Adverse Event|0|||
147324212|NCT00797225|531352449|FG001|Weeks 13 to 24|Adverse Event|1|||
147324213|NCT00797225|531352450|FG002|Weeks 13 to 24|Adverse Event|0|||
147324214|NCT00797225|531352451|FG003|Weeks 13 to 24|Adverse Event|0|||
147324215|NCT00797225|531352452|FG004|Weeks 13 to 24|Adverse Event|0|||
147324216|NCT00797225|531352453|FG005|Weeks 13 to 24|Adverse Event|0|||
147173965|NCT00629798|530800419|FG000|Overall Study|Not Treated|4|||
147173966|NCT02554981|530800420|FG000|Overall Study|Adverse Event|1|||
147324217|NCT00797225|531352454|FG006|Weeks 13 to 24|Adverse Event|1|||
147173967|NCT02554981|530800420|FG000|Overall Study|Administrative Reasons|1|||
147173968|NCT02554981|530800420|FG000|Overall Study|Other Miscellaneous Reasons|3|||
147324218|NCT00797225|531352455|FG007|Weeks 13 to 24|Adverse Event|0|||
147324219|NCT00797225|531352448|FG000|Weeks 13 to 24|Sponsor Decision|0|||
147324220|NCT00797225|531352449|FG001|Weeks 13 to 24|Sponsor Decision|0|||
147173969|NCT02292706|530800423|FG000|Overall Study|Lost to Follow-up|20|||
147173970|NCT02292706|530800424|FG001|Overall Study|Lost to Follow-up|44|||
147173971|NCT02292706|530800425|FG002|Overall Study|Lost to Follow-up|24|||
147173972|NCT02292706|530800426|FG003|Overall Study|Lost to Follow-up|61|||
147324221|NCT00797225|531352450|FG002|Weeks 13 to 24|Sponsor Decision|0|||
147173973|NCT02292706|530800427|FG004|Overall Study|Lost to Follow-up|21|||
147173974|NCT02292706|530800428|FG005|Overall Study|Lost to Follow-up|52|||
147173975|NCT02292706|530800429|FG006|Overall Study|Lost to Follow-up|25|||
147173976|NCT02292706|530800430|FG007|Overall Study|Lost to Follow-up|0|||
147173977|NCT02292706|530800423|FG000|Overall Study|Withdrew consent|15|||
147173978|NCT02292706|530800424|FG001|Overall Study|Withdrew consent|56|||
147173979|NCT02292706|530800425|FG002|Overall Study|Withdrew consent|43|||
147173980|NCT02292706|530800426|FG003|Overall Study|Withdrew consent|36|||
147173981|NCT02292706|530800427|FG004|Overall Study|Withdrew consent|13|||
147173982|NCT02292706|530800428|FG005|Overall Study|Withdrew consent|51|||
147173983|NCT02292706|530800429|FG006|Overall Study|Withdrew consent|20|||
147173984|NCT02292706|530800430|FG007|Overall Study|Withdrew consent|0|||
147448214|NCT02915523|531805660|FG002|Expansion Phase (Phase 2)|Withdrawal by Subject|6|||
147448215|NCT02915523|531805661|FG003|Expansion Phase (Phase 2)|Withdrawal by Subject|8|||
147448216|NCT02915523|531805658|FG000|Expansion Phase (Phase 2)|Lost to Follow-up|0|||
147448217|NCT02915523|531805659|FG001|Expansion Phase (Phase 2)|Lost to Follow-up|0|||
147448218|NCT02915523|531805660|FG002|Expansion Phase (Phase 2)|Lost to Follow-up|0|||
147448219|NCT02915523|531805661|FG003|Expansion Phase (Phase 2)|Lost to Follow-up|2|||
147448220|NCT01780831|531805662|FG000|Overall Study|Withdrawal by Subject|0|||
147448221|NCT01780831|531805663|FG001|Overall Study|Withdrawal by Subject|0|||
147448222|NCT01780831|531805664|FG002|Overall Study|Withdrawal by Subject|4|||
147448223|NCT01780831|531805665|FG003|Overall Study|Withdrawal by Subject|0|||
147448224|NCT01780831|531805662|FG000|Overall Study|Lost to Follow-up|0|||
147173985|NCT02292706|530800423|FG000|Overall Study|Death|3|||
147173986|NCT02292706|530800424|FG001|Overall Study|Death|11|||
147173987|NCT02292706|530800425|FG002|Overall Study|Death|16|||
147173988|NCT02292706|530800426|FG003|Overall Study|Death|22|||
147173989|NCT02292706|530800427|FG004|Overall Study|Death|8|||
147173990|NCT02292706|530800428|FG005|Overall Study|Death|17|||
147173991|NCT02292706|530800429|FG006|Overall Study|Death|3|||
147173992|NCT02292706|530800430|FG007|Overall Study|Death|0|||
147173993|NCT02292706|530800423|FG000|Overall Study|Study terminated by sponsor|0|||
147173994|NCT02292706|530800424|FG001|Overall Study|Study terminated by sponsor|9|||
147173995|NCT02292706|530800425|FG002|Overall Study|Study terminated by sponsor|4|||
147173996|NCT02292706|530800426|FG003|Overall Study|Study terminated by sponsor|21|||
147173997|NCT02292706|530800427|FG004|Overall Study|Study terminated by sponsor|11|||
147173998|NCT02292706|530800428|FG005|Overall Study|Study terminated by sponsor|13|||
147173999|NCT02292706|530800429|FG006|Overall Study|Study terminated by sponsor|3|||
147174000|NCT02292706|530800430|FG007|Overall Study|Study terminated by sponsor|0|||
147448225|NCT01780831|531805663|FG001|Overall Study|Lost to Follow-up|0|||
147448226|NCT01780831|531805664|FG002|Overall Study|Lost to Follow-up|0|||
147448227|NCT01780831|531805665|FG003|Overall Study|Lost to Follow-up|1|||
147448228|NCT00183274|531805666|FG000|Phase 1: Open-Label|Adverse Event|31|||
147448229|NCT00183274|531805667|FG001|Phase 1: Open-Label|Adverse Event|0|||
147448230|NCT00183274|531805668|FG002|Phase 1: Open-Label|Adverse Event|0|||
147448231|NCT00183274|531805669|FG003|Phase 1: Open-Label|Adverse Event|0|||
147448232|NCT00183274|531805670|FG004|Phase 1: Open-Label|Adverse Event|0|||
147448233|NCT00183274|531805671|FG005|Phase 1: Open-Label|Adverse Event|0|||
147592748|NCT01949116|532325124|FG000|Overall Study|Lost to Follow-up|1|||
147592749|NCT01949116|532325125|FG001|Overall Study|Lost to Follow-up|3|||
147592750|NCT01949116|532325124|FG000|Overall Study|Withdrawal by Subject|5|||
147592751|NCT01949116|532325125|FG001|Overall Study|Withdrawal by Subject|3|||
147592752|NCT02556307|532325128|FG000|Overall Study|Premature treatment interruption|11|||
147592753|NCT02556307|532325128|FG000|Overall Study|Lost to Follow-up|36|||
147592754|NCT02556307|532325128|FG000|Overall Study|Change to triple therapy|4|||
147592755|NCT02556307|532325128|FG000|Overall Study|Enrolled but not treated|2|||
147174001|NCT02292706|530800423|FG000|Overall Study|Investigator's discretion|4|||
147174002|NCT02292706|530800424|FG001|Overall Study|Investigator's discretion|9|||
147174003|NCT02292706|530800425|FG002|Overall Study|Investigator's discretion|7|||
147174004|NCT02292706|530800426|FG003|Overall Study|Investigator's discretion|11|||
147448234|NCT00183274|531805666|FG000|Phase 1: Open-Label|Lack of Efficacy|13|||
147448235|NCT00183274|531805667|FG001|Phase 1: Open-Label|Lack of Efficacy|0|||
147448236|NCT00183274|531805668|FG002|Phase 1: Open-Label|Lack of Efficacy|0|||
147448237|NCT00183274|531805669|FG003|Phase 1: Open-Label|Lack of Efficacy|0|||
147174005|NCT02292706|530800427|FG004|Overall Study|Investigator's discretion|4|||
147174006|NCT02292706|530800428|FG005|Overall Study|Investigator's discretion|10|||
147174007|NCT02292706|530800429|FG006|Overall Study|Investigator's discretion|1|||
147174008|NCT02292706|530800430|FG007|Overall Study|Investigator's discretion|0|||
147174009|NCT02292706|530800423|FG000|Overall Study|Liver transplant|1|||
147448238|NCT00183274|531805670|FG004|Phase 1: Open-Label|Lack of Efficacy|0|||
147448239|NCT00183274|531805671|FG005|Phase 1: Open-Label|Lack of Efficacy|0|||
147655672|NCT02328937|532562966|FG005|Period 1|Lost to Follow-up|0|||
147448240|NCT00183274|531805666|FG000|Phase 1: Open-Label|Protocol Violation|11|||
147448241|NCT00183274|531805667|FG001|Phase 1: Open-Label|Protocol Violation|0|||
147448242|NCT00183274|531805668|FG002|Phase 1: Open-Label|Protocol Violation|0|||
147592756|NCT03438227|532325129|FG000|Overall Study|Withdrawal by Subject|10|||
147592757|NCT03438227|532325130|FG001|Overall Study|Withdrawal by Subject|5|||
147592758|NCT00293202|532325133|FG000|Overall Study|Withdrawal by Subject|1|||
147592759|NCT00293202|532325134|FG001|Overall Study|Withdrawal by Subject|2|||
147592760|NCT00293202|532325133|FG000|Overall Study|positive ANA (antinuclear antibody)|1|||
147592761|NCT00293202|532325134|FG001|Overall Study|positive ANA (antinuclear antibody)|0|||
147174010|NCT02292706|530800424|FG001|Overall Study|Liver transplant|1|||
147174011|NCT02292706|530800425|FG002|Overall Study|Liver transplant|11|||
147174012|NCT02292706|530800426|FG003|Overall Study|Liver transplant|16|||
147174013|NCT02292706|530800427|FG004|Overall Study|Liver transplant|5|||
147174014|NCT02292706|530800428|FG005|Overall Study|Liver transplant|6|||
147174015|NCT02292706|530800429|FG006|Overall Study|Liver transplant|5|||
147174016|NCT02292706|530800430|FG007|Overall Study|Liver transplant|0|||
147174017|NCT02292706|530800423|FG000|Overall Study|Enrolled but not met eligibility criteria|1|||
147174018|NCT02292706|530800424|FG001|Overall Study|Enrolled but not met eligibility criteria|2|||
147174019|NCT02292706|530800425|FG002|Overall Study|Enrolled but not met eligibility criteria|2|||
147174020|NCT02292706|530800426|FG003|Overall Study|Enrolled but not met eligibility criteria|2|||
147174021|NCT02292706|530800427|FG004|Overall Study|Enrolled but not met eligibility criteria|2|||
147174022|NCT02292706|530800428|FG005|Overall Study|Enrolled but not met eligibility criteria|6|||
147174023|NCT02292706|530800429|FG006|Overall Study|Enrolled but not met eligibility criteria|2|||
147174024|NCT02292706|530800430|FG007|Overall Study|Enrolled but not met eligibility criteria|19|||
147174025|NCT02292706|530800423|FG000|Overall Study|Subject terminated by sponsor|1|||
147174026|NCT02292706|530800424|FG001|Overall Study|Subject terminated by sponsor|0|||
147174027|NCT02292706|530800425|FG002|Overall Study|Subject terminated by sponsor|0|||
147174028|NCT02292706|530800426|FG003|Overall Study|Subject terminated by sponsor|2|||
147174029|NCT02292706|530800427|FG004|Overall Study|Subject terminated by sponsor|1|||
147174030|NCT02292706|530800428|FG005|Overall Study|Subject terminated by sponsor|0|||
147174031|NCT02292706|530800429|FG006|Overall Study|Subject terminated by sponsor|0|||
147174032|NCT02292706|530800430|FG007|Overall Study|Subject terminated by sponsor|0|||
147174033|NCT02292706|530800423|FG000|Overall Study|Missing|0|||
147174034|NCT02292706|530800424|FG001|Overall Study|Missing|0|||
147174035|NCT02292706|530800425|FG002|Overall Study|Missing|1|||
147174036|NCT02292706|530800426|FG003|Overall Study|Missing|1|||
147174037|NCT02292706|530800427|FG004|Overall Study|Missing|0|||
147174038|NCT02292706|530800428|FG005|Overall Study|Missing|1|||
147174039|NCT02292706|530800429|FG006|Overall Study|Missing|0|||
147174040|NCT02292706|530800430|FG007|Overall Study|Missing|0|||
147174041|NCT02292706|530800423|FG000|Overall Study|Virologic relapse or reinfection|1|||
147174042|NCT02292706|530800424|FG001|Overall Study|Virologic relapse or reinfection|0|||
147174043|NCT02292706|530800425|FG002|Overall Study|Virologic relapse or reinfection|0|||
147174044|NCT02292706|530800426|FG003|Overall Study|Virologic relapse or reinfection|1|||
147174045|NCT02292706|530800427|FG004|Overall Study|Virologic relapse or reinfection|0|||
147174046|NCT02292706|530800428|FG005|Overall Study|Virologic relapse or reinfection|1|||
147174047|NCT02292706|530800429|FG006|Overall Study|Virologic relapse or reinfection|0|||
147174048|NCT02292706|530800430|FG007|Overall Study|Virologic relapse or reinfection|0|||
147174049|NCT01990612|530800433|FG000|Overall Study|Lost to Follow-up|2|||
147174050|NCT01990612|530800434|FG001|Overall Study|Lost to Follow-up|1|||
147174051|NCT01990612|530800433|FG000|Overall Study|Withdrawal by Subject|5|||
147174052|NCT01990612|530800434|FG001|Overall Study|Withdrawal by Subject|2|||
147324222|NCT00797225|531352451|FG003|Weeks 13 to 24|Sponsor Decision|0|||
147324223|NCT00797225|531352452|FG004|Weeks 13 to 24|Sponsor Decision|0|||
147324224|NCT00797225|531352453|FG005|Weeks 13 to 24|Sponsor Decision|0|||
147324225|NCT00797225|531352454|FG006|Weeks 13 to 24|Sponsor Decision|1|||
147324226|NCT00797225|531352455|FG007|Weeks 13 to 24|Sponsor Decision|0|||
147324227|NCT02096003|531352458|FG000|Overall Study|Protocol Violation|0|||
147324228|NCT02096003|531352459|FG001|Overall Study|Protocol Violation|2|||
147324229|NCT02096003|531352458|FG000|Overall Study|additional surgery|2|||
147324230|NCT02096003|531352459|FG001|Overall Study|additional surgery|1|||
147324231|NCT03178201|531352460|FG000|Overall Study|Off study|5|||
147324232|NCT01767909|531352463|FG000|Overall Study|Withdrawal by Subject|4|||
147324233|NCT01767909|531352464|FG001|Overall Study|Withdrawal by Subject|7|||
147324234|NCT01767909|531352463|FG000|Overall Study|Adverse Event|3|||
147324235|NCT01767909|531352464|FG001|Overall Study|Adverse Event|1|||
147324236|NCT01767909|531352463|FG000|Overall Study|Withdrawal by Study Partner|3|||
147174053|NCT02725866|530800435|FG000|Overall Study|Failure to return|6|||
147324237|NCT01767909|531352464|FG001|Overall Study|Withdrawal by Study Partner|1|||
147324238|NCT01767909|531352463|FG000|Overall Study|Non-Compliance|2|||
147592762|NCT00293202|532325133|FG000|Overall Study|on-hold due to fistula maturation time|1|||
147592763|NCT00293202|532325134|FG001|Overall Study|on-hold due to fistula maturation time|0|||
147174054|NCT02725866|530800435|FG000|Overall Study|Withdrew consent|3|||
147174055|NCT02725866|530800435|FG000|Overall Study|Insufficient virological response|1|||
147174056|NCT02725866|530800435|FG000|Overall Study|Other, not specified|4|||
147174057|NCT02188849|530800438|FG000|Overall Study|Lost to Follow-up|3|||
147174058|NCT02188849|530800439|FG001|Overall Study|Lost to Follow-up|8|||
147324239|NCT01767909|531352464|FG001|Overall Study|Non-Compliance|0|||
147324240|NCT01767909|531352463|FG000|Overall Study|Perceived Lack of Efficacy|1|||
147592764|NCT00706992|532325137|FG000|Overall Study|Study termination|5|||
147592765|NCT00706992|532325138|FG001|Overall Study|Study termination|5|||
147592766|NCT00706992|532325139|FG002|Overall Study|Study termination|6|||
147244432|NCT00684307|531068899|FG002|Overall Study|Criteria from the CSR|1|||
147244433|NCT00684307|531068900|FG003|Overall Study|Criteria from the CSR|3|||
147244434|NCT00684307|531068901|FG004|Overall Study|Criteria from the CSR|3|||
147448243|NCT00183274|531805669|FG003|Phase 1: Open-Label|Protocol Violation|0|||
147448244|NCT00183274|531805670|FG004|Phase 1: Open-Label|Protocol Violation|0|||
147448245|NCT00183274|531805671|FG005|Phase 1: Open-Label|Protocol Violation|0|||
147448246|NCT00183274|531805666|FG000|Phase 1: Open-Label|Withdrawal by Subject|13|||
147448247|NCT00183274|531805667|FG001|Phase 1: Open-Label|Withdrawal by Subject|0|||
147448248|NCT00183274|531805668|FG002|Phase 1: Open-Label|Withdrawal by Subject|0|||
147448249|NCT00183274|531805669|FG003|Phase 1: Open-Label|Withdrawal by Subject|0|||
147448250|NCT00183274|531805670|FG004|Phase 1: Open-Label|Withdrawal by Subject|0|||
147448251|NCT00183274|531805671|FG005|Phase 1: Open-Label|Withdrawal by Subject|0|||
147592767|NCT00706992|532325140|FG003|Overall Study|Study termination|2|||
147592768|NCT00706992|532325141|FG004|Overall Study|Study termination|3|||
147592769|NCT00706992|532325142|FG005|Overall Study|Study termination|2|||
147592770|NCT00706992|532325143|FG006|Overall Study|Study termination|3|||
147592771|NCT00706992|532325137|FG000|Overall Study|Disease progression before treatment|0|||
147592772|NCT00706992|532325138|FG001|Overall Study|Disease progression before treatment|0|||
147592773|NCT00706992|532325139|FG002|Overall Study|Disease progression before treatment|0|||
147592774|NCT00706992|532325140|FG003|Overall Study|Disease progression before treatment|0|||
147592775|NCT00706992|532325141|FG004|Overall Study|Disease progression before treatment|1|||
147592776|NCT00706992|532325142|FG005|Overall Study|Disease progression before treatment|0|||
147592777|NCT00706992|532325143|FG006|Overall Study|Disease progression before treatment|0|||
147592778|NCT01277718|532325144|FG000|Period 2 - Second Intervention|Protocol Violation|0|||
147592779|NCT01277718|532325145|FG001|Period 2 - Second Intervention|Protocol Violation|1|||
147592780|NCT01277718|532325144|FG000|Period 2 - Second Intervention|Physician Decision|0|||
147592781|NCT01277718|532325145|FG001|Period 2 - Second Intervention|Physician Decision|2|||
147592782|NCT02746627|532325147|FG000|Overall Study|Withdrawal by Subject|1|||
147592783|NCT02746627|532325148|FG001|Overall Study|Withdrawal by Subject|1|||
147592784|NCT02746627|532325149|FG002|Overall Study|Withdrawal by Subject|1|||
147592785|NCT01744093|532326816|FG000|Overall Study|Withdrawal by Subject|6|||
147592786|NCT01744093|532326817|FG001|Overall Study|Withdrawal by Subject|1|||
147592787|NCT02006628|532326818|FG000|Overall Study|Adverse Event|1|||
147592788|NCT02006628|532326819|FG001|Overall Study|Adverse Event|1|||
147592789|NCT02006628|532326818|FG000|Overall Study|Withdrawal by Subject|2|||
147592790|NCT02006628|532326819|FG001|Overall Study|Withdrawal by Subject|1|||
147592791|NCT02384941|532326822|FG000|Overall Study|Adverse Event|11|||
147592792|NCT02384941|532326823|FG001|Overall Study|Adverse Event|13|||
147592793|NCT02384941|532326824|FG002|Overall Study|Adverse Event|17|||
147592794|NCT02384941|532326822|FG000|Overall Study|Lost to Follow-up|3|||
147592795|NCT02384941|532326823|FG001|Overall Study|Lost to Follow-up|2|||
147592796|NCT02384941|532326824|FG002|Overall Study|Lost to Follow-up|1|||
147592797|NCT02384941|532326822|FG000|Overall Study|Non-Compliance With Study Drug|2|||
147592798|NCT02384941|532326823|FG001|Overall Study|Non-Compliance With Study Drug|0|||
147592799|NCT02384941|532326824|FG002|Overall Study|Non-Compliance With Study Drug|1|||
147592800|NCT02384941|532326822|FG000|Overall Study|Physician Decision|1|||
147592801|NCT02384941|532326823|FG001|Overall Study|Physician Decision|1|||
147592802|NCT02384941|532326824|FG002|Overall Study|Physician Decision|0|||
147592803|NCT02384941|532326822|FG000|Overall Study|Protocol Violation|3|||
147592804|NCT02384941|532326823|FG001|Overall Study|Protocol Violation|0|||
147592805|NCT02384941|532326824|FG002|Overall Study|Protocol Violation|0|||
147592806|NCT02384941|532326822|FG000|Overall Study|Withdrawal by Subject|26|||
147592807|NCT02384941|532326823|FG001|Overall Study|Withdrawal by Subject|19|||
147592808|NCT02384941|532326824|FG002|Overall Study|Withdrawal by Subject|20|||
147592809|NCT02384941|532326822|FG000|Overall Study|Pregnancy|0|||
147592810|NCT02384941|532326823|FG001|Overall Study|Pregnancy|0|||
147592811|NCT02384941|532326824|FG002|Overall Study|Pregnancy|1|||
147592812|NCT02384941|532326822|FG000|Overall Study|Other than specified above|4|||
147592813|NCT02384941|532326823|FG001|Overall Study|Other than specified above|0|||
147592814|NCT02384941|532326824|FG002|Overall Study|Other than specified above|1|||
147592815|NCT02493777|532326825|FG000|Overall Study|Lost to Follow-up|0|||
147592816|NCT02493777|532326826|FG001|Overall Study|Lost to Follow-up|1|||
147592817|NCT00468728|532326827|FG000|Treatment|criteria for mITT population|4|||
147592818|NCT00468728|532326828|FG001|Treatment|criteria for mITT population|11|||
147592819|NCT00468728|532326827|FG000|Follow-up|mITT failure|34|||
147592820|NCT00468728|532326828|FG001|Follow-up|mITT failure|31|||
147244435|NCT00543140|531068902|FG000|Overall Study|Lost to Follow-up|33|||
147592821|NCT04572243|532326829|FG000|Core Study: 14 Weeks|Adverse Event|1|||
147592822|NCT04572243|532326830|FG001|Core Study: 14 Weeks|Adverse Event|2|||
147592823|NCT04572243|532326831|FG002|Core Study: 14 Weeks|Adverse Event|0|||
147592824|NCT04572243|532326832|FG003|Core Study: 14 Weeks|Adverse Event|0|||
147448252|NCT00183274|531805666|FG000|Phase 1: Open-Label|Lost to Follow-up|33|||
147592825|NCT04572243|532326829|FG000|Core Study: 14 Weeks|Subject choice|0|||
147592826|NCT04572243|532326830|FG001|Core Study: 14 Weeks|Subject choice|2|||
147592827|NCT04572243|532326831|FG002|Core Study: 14 Weeks|Subject choice|0|||
147592828|NCT04572243|532326832|FG003|Core Study: 14 Weeks|Subject choice|0|||
147324241|NCT01767909|531352464|FG001|Overall Study|Perceived Lack of Efficacy|0|||
147324242|NCT01767909|531352463|FG000|Overall Study|Investigator Recommendation|0|||
147324243|NCT01767909|531352464|FG001|Overall Study|Investigator Recommendation|1|||
147324244|NCT01767909|531352463|FG000|Overall Study|Lost to Follow-up|0|||
147324245|NCT01767909|531352464|FG001|Overall Study|Lost to Follow-up|1|||
147324246|NCT01767909|531352463|FG000|Overall Study|LP uncessessful|0|||
147324247|NCT01767909|531352464|FG001|Overall Study|LP uncessessful|1|||
147324248|NCT01723774|531352465|FG000|Neoadjuvant|Ki67 > 10%|4|||
147174059|NCT00812565|530800441|FG000|Overall Study|Did Not Receive Study Medication|1|||
147174060|NCT00812565|530800442|FG001|Overall Study|Did Not Receive Study Medication|1|||
147174061|NCT00812565|530800443|FG002|Overall Study|Did Not Receive Study Medication|0|||
147174062|NCT00812565|530800444|FG003|Overall Study|Did Not Receive Study Medication|0|||
147174063|NCT00812565|530800445|FG004|Overall Study|Did Not Receive Study Medication|0|||
147174064|NCT00812565|530800446|FG005|Overall Study|Did Not Receive Study Medication|0|||
147174065|NCT00812565|530800447|FG006|Overall Study|Did Not Receive Study Medication|0|||
147174066|NCT00812565|530800448|FG007|Overall Study|Did Not Receive Study Medication|0|||
147174067|NCT00812565|530800441|FG000|Overall Study|Adverse Event|0|||
147174068|NCT00812565|530800442|FG001|Overall Study|Adverse Event|0|||
147174069|NCT00812565|530800443|FG002|Overall Study|Adverse Event|0|||
147174070|NCT00812565|530800444|FG003|Overall Study|Adverse Event|2|||
147174071|NCT00812565|530800445|FG004|Overall Study|Adverse Event|0|||
147174072|NCT00812565|530800446|FG005|Overall Study|Adverse Event|0|||
147174073|NCT00812565|530800447|FG006|Overall Study|Adverse Event|0|||
147174074|NCT00812565|530800448|FG007|Overall Study|Adverse Event|1|||
147174075|NCT00812565|530800441|FG000|Overall Study|Did Not Come to Study Visit|1|||
147174076|NCT00812565|530800442|FG001|Overall Study|Did Not Come to Study Visit|0|||
147174077|NCT00812565|530800443|FG002|Overall Study|Did Not Come to Study Visit|0|||
147174078|NCT00812565|530800444|FG003|Overall Study|Did Not Come to Study Visit|0|||
147174079|NCT00812565|530800445|FG004|Overall Study|Did Not Come to Study Visit|0|||
147174080|NCT00812565|530800446|FG005|Overall Study|Did Not Come to Study Visit|0|||
147174081|NCT00812565|530800447|FG006|Overall Study|Did Not Come to Study Visit|0|||
147174082|NCT00812565|530800448|FG007|Overall Study|Did Not Come to Study Visit|0|||
147324249|NCT01723774|531352466|FG001|Neoadjuvant|Ki67 > 10%|0|||
147324250|NCT01723774|531352467|FG002|Neoadjuvant|Ki67 > 10%|10|||
147324251|NCT01723774|531352468|FG003|Neoadjuvant|Ki67 > 10%|0|||
147324252|NCT01723774|531352465|FG000|Neoadjuvant|Withdrawal by Subject|3|||
147324253|NCT01723774|531352466|FG001|Neoadjuvant|Withdrawal by Subject|1|||
147324254|NCT01723774|531352467|FG002|Neoadjuvant|Withdrawal by Subject|0|||
147324255|NCT01723774|531352468|FG003|Neoadjuvant|Withdrawal by Subject|0|||
147324256|NCT01723774|531352465|FG000|Neoadjuvant|Disease progression|0|||
147324257|NCT01723774|531352466|FG001|Neoadjuvant|Disease progression|1|||
147324258|NCT01723774|531352467|FG002|Neoadjuvant|Disease progression|1|||
147324259|NCT01723774|531352468|FG003|Neoadjuvant|Disease progression|0|||
147324260|NCT01723774|531352465|FG000|Neoadjuvant|Adverse Event|0|||
147324261|NCT01723774|531352466|FG001|Neoadjuvant|Adverse Event|1|||
147324262|NCT01723774|531352467|FG002|Neoadjuvant|Adverse Event|2|||
147324263|NCT01723774|531352468|FG003|Neoadjuvant|Adverse Event|0|||
147324264|NCT01723774|531352465|FG000|Neoadjuvant|High estradiol|0|||
147324265|NCT01723774|531352466|FG001|Neoadjuvant|High estradiol|1|||
147324266|NCT01723774|531352467|FG002|Neoadjuvant|High estradiol|0|||
147324267|NCT01723774|531352468|FG003|Neoadjuvant|High estradiol|0|||
147324268|NCT04956692|531352475|FG000|Overall Study|Death|115|||
147324269|NCT04956692|531352476|FG001|Overall Study|Death|47|||
147592829|NCT04572243|532326829|FG000|Core Study: 14 Weeks|Withdrawal of consent|1|||
147174083|NCT00812565|530800441|FG000|Overall Study|Withdrawal of Consent|1|||
147174084|NCT00812565|530800442|FG001|Overall Study|Withdrawal of Consent|0|||
147174085|NCT00812565|530800443|FG002|Overall Study|Withdrawal of Consent|0|||
147174086|NCT00812565|530800444|FG003|Overall Study|Withdrawal of Consent|0|||
147174087|NCT00812565|530800445|FG004|Overall Study|Withdrawal of Consent|1|||
147174088|NCT00812565|530800446|FG005|Overall Study|Withdrawal of Consent|0|||
147592830|NCT04572243|532326830|FG001|Core Study: 14 Weeks|Withdrawal of consent|0|||
147592831|NCT04572243|532326831|FG002|Core Study: 14 Weeks|Withdrawal of consent|0|||
147592832|NCT04572243|532326832|FG003|Core Study: 14 Weeks|Withdrawal of consent|0|||
147324270|NCT04956692|531352475|FG000|Overall Study|Lost to Follow-up|0|||
147324271|NCT04956692|531352476|FG001|Overall Study|Lost to Follow-up|1|||
147324272|NCT04956692|531352475|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
147324273|NCT04956692|531352476|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
147324274|NCT04956692|531352475|FG000|Overall Study|Withdrawal by Subject|5|||
147324275|NCT04956692|531352476|FG001|Overall Study|Withdrawal by Subject|2|||
147324276|NCT04956692|531352475|FG000|Overall Study|Ongoing in Study|236|||
147592833|NCT04572243|532326829|FG000|Core Study: 14 Weeks|Randomized but not treated|1|||
147174089|NCT00812565|530800447|FG006|Overall Study|Withdrawal of Consent|0|||
147174090|NCT00812565|530800448|FG007|Overall Study|Withdrawal of Consent|0|||
147174091|NCT00812565|530800441|FG000|Overall Study|Reason Not Specified|0|||
147174092|NCT00812565|530800442|FG001|Overall Study|Reason Not Specified|0|||
147324277|NCT04956692|531352476|FG001|Overall Study|Ongoing in Study|123|||
147324278|NCT04863898|531352482|FG000|Overall Study|Away from study clinic during intervention training period|2|||
147331199|NCT04436120|531377600|FG001|Overall Study|neither a de novo biopsy nor a research blood draw|0|||
147592834|NCT04572243|532326830|FG001|Core Study: 14 Weeks|Randomized but not treated|0|||
147592835|NCT04572243|532326831|FG002|Core Study: 14 Weeks|Randomized but not treated|0|||
147592836|NCT04572243|532326832|FG003|Core Study: 14 Weeks|Randomized but not treated|0|||
147592837|NCT00775606|532326833|FG000|Overall Study|Study sponsor terminated funding|3|||
147655673|NCT02328937|532562961|FG000|Period 2|Adverse Event|0|||
147174093|NCT00812565|530800443|FG002|Overall Study|Reason Not Specified|0|||
147174094|NCT00812565|530800444|FG003|Overall Study|Reason Not Specified|0|||
147174095|NCT00812565|530800445|FG004|Overall Study|Reason Not Specified|0|||
147174096|NCT00812565|530800446|FG005|Overall Study|Reason Not Specified|1|||
147174097|NCT00812565|530800447|FG006|Overall Study|Reason Not Specified|0|||
147174098|NCT00812565|530800448|FG007|Overall Study|Reason Not Specified|0|||
147174099|NCT01793883|530800451|FG000|Overall Study|Withdrawal by Subject|3|||
147174100|NCT01793883|530800452|FG001|Overall Study|Withdrawal by Subject|7|||
147174101|NCT01793883|530800453|FG002|Overall Study|Withdrawal by Subject|3|||
147174102|NCT01793883|530800451|FG000|Overall Study|Subject noncompliance|0|||
147174103|NCT01793883|530800452|FG001|Overall Study|Subject noncompliance|1|||
147174104|NCT01793883|530800453|FG002|Overall Study|Subject noncompliance|1|||
147174105|NCT01793883|530800451|FG000|Overall Study|Lost to Follow-up|5|||
147174106|NCT01793883|530800452|FG001|Overall Study|Lost to Follow-up|1|||
147174107|NCT01793883|530800453|FG002|Overall Study|Lost to Follow-up|3|||
147174108|NCT01793883|530800451|FG000|Overall Study|Randomized in error|1|||
147174109|NCT01793883|530800452|FG001|Overall Study|Randomized in error|0|||
147174110|NCT01793883|530800453|FG002|Overall Study|Randomized in error|0|||
147174111|NCT01793883|530800451|FG000|Overall Study|Unable to complete spriometry|1|||
147174112|NCT01793883|530800452|FG001|Overall Study|Unable to complete spriometry|0|||
147174113|NCT01793883|530800453|FG002|Overall Study|Unable to complete spriometry|0|||
147174114|NCT01793883|530800451|FG000|Overall Study|Unable to complete measurements|1|||
147174115|NCT01793883|530800452|FG001|Overall Study|Unable to complete measurements|0|||
147174116|NCT01793883|530800453|FG002|Overall Study|Unable to complete measurements|0|||
147174117|NCT01793883|530800451|FG000|Overall Study|Met exclusion criteria|1|||
147174118|NCT01793883|530800452|FG001|Overall Study|Met exclusion criteria|0|||
147174119|NCT01793883|530800453|FG002|Overall Study|Met exclusion criteria|0|||
147174120|NCT01793883|530800451|FG000|Overall Study|Dosing error|0|||
147174121|NCT01793883|530800452|FG001|Overall Study|Dosing error|1|||
147174122|NCT01793883|530800453|FG002|Overall Study|Dosing error|0|||
147174123|NCT01793883|530800451|FG000|Overall Study|Respiratory distress during spirometry|0|||
147174124|NCT01793883|530800452|FG001|Overall Study|Respiratory distress during spirometry|0|||
147174125|NCT01793883|530800453|FG002|Overall Study|Respiratory distress during spirometry|1|||
147174126|NCT02353728|530800454|FG000|Overall Study|Subject non-compliance|1|||
147174127|NCT00895310|530800455|FG000|Overall Study|Withdrawal by Subject|1|||
147174128|NCT00659230|530800456|FG000|Overall Study|Lost to Follow-up|2|||
147174129|NCT00659230|530800457|FG001|Overall Study|Lost to Follow-up|5|||
147174130|NCT00659230|530800456|FG000|Overall Study|Lost source documentation|5|||
147174131|NCT00659230|530800457|FG001|Overall Study|Lost source documentation|4|||
147174132|NCT00659230|530800456|FG000|Overall Study|Did not return post-randomization|2|||
147174133|NCT00659230|530800457|FG001|Overall Study|Did not return post-randomization|3|||
147174134|NCT00547521|530800458|FG000|Short Term Study (4 Months)|Adverse Event|1|||
147174135|NCT00547521|530800459|FG001|Short Term Study (4 Months)|Adverse Event|0|||
147174136|NCT00547521|530800458|FG000|Short Term Study (4 Months)|Lack of Efficacy|0|||
147174137|NCT00547521|530800459|FG001|Short Term Study (4 Months)|Lack of Efficacy|2|||
147174138|NCT00547521|530800458|FG000|Short Term Study (4 Months)|Withdrawal of consent|0|||
147174139|NCT00547521|530800459|FG001|Short Term Study (4 Months)|Withdrawal of consent|1|||
147174140|NCT00547521|530800458|FG000|Short Term Study (4 Months)|primary endpoint evaluation not complete|0|||
147174141|NCT00547521|530800459|FG001|Short Term Study (4 Months)|primary endpoint evaluation not complete|1|||
147174142|NCT00547521|530800458|FG000|Long Term Extension (LTE) Study|Lack of Efficacy|0|||
147174143|NCT00547521|530800459|FG001|Long Term Extension (LTE) Study|Lack of Efficacy|14|||
147174144|NCT00547521|530800458|FG000|Long Term Extension (LTE) Study|Adverse Event|0|||
147174145|NCT00547521|530800459|FG001|Long Term Extension (LTE) Study|Adverse Event|9|||
147174146|NCT00547521|530800458|FG000|Long Term Extension (LTE) Study|Lost to Follow-up|0|||
147174147|NCT00547521|530800459|FG001|Long Term Extension (LTE) Study|Lost to Follow-up|3|||
147174148|NCT00547521|530800458|FG000|Long Term Extension (LTE) Study|Withdrawal by Subject|0|||
147174149|NCT00547521|530800459|FG001|Long Term Extension (LTE) Study|Withdrawal by Subject|2|||
147174150|NCT00547521|530800458|FG000|Long Term Extension (LTE) Study|Other|0|||
147174151|NCT00547521|530800459|FG001|Long Term Extension (LTE) Study|Other|2|||
147174152|NCT00547521|530800458|FG000|Long Term Extension (LTE) Study|Poor/Non-Compliance|0|||
147174153|NCT00547521|530800459|FG001|Long Term Extension (LTE) Study|Poor/Non-Compliance|1|||
147174154|NCT05066165|530802613|FG000|C1:DoseLevel1 Assignment|Pivoting to an allogeneic version of this program|0|||
147174155|NCT05066165|530802614|FG001|C1:DoseLevel1 Assignment|Pivoting to an allogeneic version of this program|4|||
147174156|NCT05066165|530802613|FG000|C1:DoseLevel1 Dosed Participants (W1-16)|Death|1|||
147174157|NCT05066165|530802614|FG001|C1:DoseLevel1 Dosed Participants (W1-16)|Death|1|||
147174158|NCT02454478|530802618|FG000|Overall Study|Incomplete DLT Evaluation|1|||
147174159|NCT01959841|530802625|FG000|Overall Study|Adverse Event|1|||
147174160|NCT01959841|530802626|FG001|Overall Study|Adverse Event|3|||
147174161|NCT01959841|530802627|FG002|Overall Study|Adverse Event|2|||
147174162|NCT01959841|530802625|FG000|Overall Study|Lack of Efficacy|5|||
147174163|NCT01959841|530802626|FG001|Overall Study|Lack of Efficacy|0|||
147174164|NCT01959841|530802627|FG002|Overall Study|Lack of Efficacy|0|||
147174165|NCT01959841|530802625|FG000|Overall Study|Lost to Follow-up|1|||
147174166|NCT01959841|530802626|FG001|Overall Study|Lost to Follow-up|1|||
147174167|NCT01959841|530802627|FG002|Overall Study|Lost to Follow-up|0|||
147174168|NCT01959841|530802625|FG000|Overall Study|Physician Decision|0|||
147174169|NCT01959841|530802626|FG001|Overall Study|Physician Decision|2|||
147174170|NCT01959841|530802627|FG002|Overall Study|Physician Decision|3|||
147174171|NCT01959841|530802625|FG000|Overall Study|Protocol Violation|16|||
147174172|NCT01959841|530802626|FG001|Overall Study|Protocol Violation|23|||
147174173|NCT01959841|530802627|FG002|Overall Study|Protocol Violation|16|||
147174174|NCT01959841|530802625|FG000|Overall Study|Withdrawal by Subject|7|||
147174175|NCT01959841|530802626|FG001|Overall Study|Withdrawal by Subject|7|||
147174176|NCT01959841|530802627|FG002|Overall Study|Withdrawal by Subject|5|||
147174177|NCT01959841|530802625|FG000|Overall Study|Clinical laboratory value|2|||
147174178|NCT01959841|530802626|FG001|Overall Study|Clinical laboratory value|6|||
147174179|NCT01959841|530802627|FG002|Overall Study|Clinical laboratory value|6|||
147174180|NCT01959841|530802625|FG000|Overall Study|Platelet count below on day1 or 4|11|||
147174181|NCT01959841|530802626|FG001|Overall Study|Platelet count below on day1 or 4|15|||
147174182|NCT01959841|530802627|FG002|Overall Study|Platelet count below on day1 or 4|11|||
147174183|NCT00780416|530802629|FG000|Overall Study|Physician Decision|3|||
147174184|NCT00780416|530802630|FG001|Overall Study|Physician Decision|3|||
147174185|NCT00780416|530802629|FG000|Overall Study|Protocol Violation|1|||
147174186|NCT00780416|530802630|FG001|Overall Study|Protocol Violation|0|||
147174187|NCT00780416|530802629|FG000|Overall Study|Withdrawal by Subject|8|||
147174188|NCT00780416|530802630|FG001|Overall Study|Withdrawal by Subject|6|||
147174189|NCT00666224|530802633|FG000|Double-Blind|Adverse Event|15|||
147174190|NCT00666224|530802634|FG001|Double-Blind|Adverse Event|5|||
147174191|NCT00666224|530802633|FG000|Double-Blind|Lost to Follow-up|2|||
147174192|NCT00666224|530802634|FG001|Double-Blind|Lost to Follow-up|2|||
147174193|NCT00666224|530802633|FG000|Double-Blind|Withdrawal by Subject|18|||
147174194|NCT00666224|530802634|FG001|Double-Blind|Withdrawal by Subject|14|||
147174195|NCT00666224|530802633|FG000|Double-Blind|Physician Decision|0|||
147174196|NCT00666224|530802634|FG001|Double-Blind|Physician Decision|3|||
147174197|NCT00666224|530802633|FG000|Double-Blind|Sponsor decision|1|||
147174198|NCT00666224|530802634|FG001|Double-Blind|Sponsor decision|0|||
147174199|NCT00666224|530802633|FG000|Double-Blind|Pregnancy|3|||
147174200|NCT00666224|530802634|FG001|Double-Blind|Pregnancy|2|||
147174201|NCT00666224|530802633|FG000|Double-Blind|Noncompliance|1|||
147244436|NCT00543140|531068902|FG000|Overall Study|Withdrawal by Subject|13|||
147244437|NCT00543140|531068902|FG000|Overall Study|Protocol Violation|10|||
147244438|NCT00543140|531068902|FG000|Overall Study|Insufficient weight loss|10|||
147244439|NCT00543140|531068902|FG000|Overall Study|SAE leading to explant of SAGB|3|||
147244440|NCT00543140|531068902|FG000|Overall Study|Death|1|||
147244441|NCT00543140|531068902|FG000|Overall Study|Subject moved|1|||
147244442|NCT00543140|531068902|FG000|Overall Study|Conversion to different procedure|1|||
147244443|NCT00578812|531068903|FG000|Overall Study|Not treated|6|||
147244444|NCT00578812|531068904|FG001|Overall Study|Not treated|7|||
147244445|NCT04532164|531068905|FG000|Overall Study|Adverse Event|1|||
147244446|NCT04532164|531068905|FG000|Overall Study|Protocol Violation|5|||
147244447|NCT04532164|531068905|FG000|Overall Study|Lost to Follow-up|1|||
147244448|NCT04532164|531068905|FG000|Overall Study|Found to be Ineligible|3|||
147244449|NCT04532164|531068905|FG000|Overall Study|Withdrawal by Subject|14|||
147244450|NCT02483520|531068906|FG000|Overall Study|Lost to Follow-up|3|||
147244451|NCT02483520|531068907|FG001|Overall Study|Lost to Follow-up|4|||
147244452|NCT02483520|531068906|FG000|Overall Study|Withdrawal by Subject|4|||
147244453|NCT02483520|531068907|FG001|Overall Study|Withdrawal by Subject|14|||
147244454|NCT02483520|531068906|FG000|Overall Study|Hospitalized|2|||
147244455|NCT02483520|531068907|FG001|Overall Study|Hospitalized|3|||
147244456|NCT02483520|531068906|FG000|Overall Study|Moved to LTC|2|||
147244457|NCT02483520|531068907|FG001|Overall Study|Moved to LTC|3|||
147244458|NCT01104493|531068908|FG000|Overall Study|Lost to Follow-up|0|||
147244459|NCT01104493|531068909|FG001|Overall Study|Lost to Follow-up|2|||
147244460|NCT02269241|531068911|FG000|Overall Study|Lost to Follow-up|269|||
147244461|NCT02269241|531068911|FG000|Overall Study|Withdrawal by Subject|155|||
147244462|NCT02269241|531068911|FG000|Overall Study|Protocol Violation|1|||
147244463|NCT02269241|531068911|FG000|Overall Study|Physician Decision|7|||
147244464|NCT02269241|531068911|FG000|Overall Study|Pregnancy|15|||
147244465|NCT02269241|531068911|FG000|Overall Study|Wish for pregnancy|5|||
147244466|NCT02269241|531068911|FG000|Overall Study|Development of an exclusion criteria|16|||
147244467|NCT02269241|531068911|FG000|Overall Study|Adverse Event|113|||
147244468|NCT02269241|531068911|FG000|Overall Study|At the specific request of the sponsor|20|||
147244469|NCT02269241|531068911|FG000|Overall Study|Several reasons not classified|53|||
147174202|NCT00666224|530802634|FG001|Double-Blind|Noncompliance|0|||
147174203|NCT00666224|530802633|FG000|Double-Blind|Death|1|||
147174204|NCT00666224|530802634|FG001|Double-Blind|Death|0|||
147174205|NCT00666224|530802633|FG000|Double-Blind|Undefined/Unknown|4|||
147174206|NCT00666224|530802634|FG001|Double-Blind|Undefined/Unknown|1|||
147174207|NCT00666224|530802633|FG000|Open-Label|Adverse Event|8|||
147174208|NCT00666224|530802634|FG001|Open-Label|Adverse Event|43|||
147174209|NCT00666224|530802633|FG000|Open-Label|Lost to Follow-up|4|||
147174210|NCT00666224|530802634|FG001|Open-Label|Lost to Follow-up|5|||
147174211|NCT00666224|530802633|FG000|Open-Label|Withdrawal by Subject|12|||
147174212|NCT00666224|530802634|FG001|Open-Label|Withdrawal by Subject|25|||
147174213|NCT00666224|530802633|FG000|Open-Label|Physician Decision|7|||
147174214|NCT00666224|530802634|FG001|Open-Label|Physician Decision|5|||
147174215|NCT00666224|530802633|FG000|Open-Label|Pregnancy|1|||
147174216|NCT00666224|530802634|FG001|Open-Label|Pregnancy|5|||
147174217|NCT00666224|530802633|FG000|Open-Label|Noncompliance|2|||
147174218|NCT00666224|530802634|FG001|Open-Label|Noncompliance|1|||
147174219|NCT00666224|530802633|FG000|Open-Label|Undefined/Unknown|1|||
147174220|NCT00666224|530802634|FG001|Open-Label|Undefined/Unknown|1|||
147174221|NCT03521141|530802644|FG000|Overall Study|Death|1|||
147174222|NCT03521141|530802645|FG001|Overall Study|Death|0|||
147174223|NCT03521141|530802646|FG002|Overall Study|Death|1|||
147174224|NCT00655629|530802654|FG000|Overall Study|Adverse Event|4|||
147174225|NCT00655629|530802655|FG001|Overall Study|Adverse Event|1|||
147174226|NCT00655629|530802654|FG000|Overall Study|Lack of Efficacy|2|||
147174227|NCT00655629|530802655|FG001|Overall Study|Lack of Efficacy|12|||
147174228|NCT00655629|530802654|FG000|Overall Study|Lost to Follow-up|4|||
147174229|NCT00655629|530802655|FG001|Overall Study|Lost to Follow-up|3|||
147174230|NCT00655629|530802654|FG000|Overall Study|Protocol Violation|5|||
147174231|NCT00655629|530802655|FG001|Overall Study|Protocol Violation|3|||
147174232|NCT00655629|530802654|FG000|Overall Study|consent withdrawn|6|||
147174233|NCT00655629|530802655|FG001|Overall Study|consent withdrawn|4|||
147174234|NCT01610336|530802656|FG000|Overall Study|Progressive Disease|4|||
147174235|NCT01610336|530802657|FG001|Overall Study|Progressive Disease|6|||
147174236|NCT01610336|530802658|FG002|Overall Study|Progressive Disease|6|||
147174237|NCT01610336|530802659|FG003|Overall Study|Progressive Disease|5|||
147174238|NCT01610336|530802660|FG004|Overall Study|Progressive Disease|3|||
147655674|NCT02328937|532562962|FG001|Period 2|Adverse Event|0|||
147655675|NCT02328937|532562963|FG002|Period 2|Adverse Event|1|||
147655676|NCT02328937|532562964|FG003|Period 2|Adverse Event|0|||
147655677|NCT02328937|532562965|FG004|Period 2|Adverse Event|0|||
147655678|NCT02328937|532562966|FG005|Period 2|Adverse Event|0|||
147655679|NCT01210222|532562967|FG000|Overall Study|Ineligible|2|||
147655680|NCT01210222|532562967|FG000|Overall Study|Never treated|1|||
147655681|NCT04865419|532562972|FG000|Overall Study|Other|1|||
147655682|NCT04865419|532562973|FG001|Overall Study|Other|2|||
147655683|NCT04865419|532562974|FG002|Overall Study|Other|2|||
147655684|NCT04865419|532562975|FG003|Overall Study|Other|1|||
147655685|NCT04865419|532562976|FG004|Overall Study|Other|3|||
147655686|NCT04865419|532562977|FG005|Overall Study|Other|0|||
147655687|NCT04865419|532562978|FG006|Overall Study|Other|0|||
147655688|NCT04865419|532562979|FG007|Overall Study|Other|1|||
147655689|NCT04865419|532562980|FG008|Overall Study|Other|0|||
147655690|NCT04865419|532562981|FG009|Overall Study|Other|0|||
147655691|NCT04865419|532562982|FG010|Overall Study|Other|0|||
147655692|NCT04865419|532562972|FG000|Overall Study|Withdrawal by Subject|0|||
147655693|NCT04865419|532562973|FG001|Overall Study|Withdrawal by Subject|1|||
147655694|NCT04865419|532562974|FG002|Overall Study|Withdrawal by Subject|1|||
147655695|NCT04865419|532562975|FG003|Overall Study|Withdrawal by Subject|0|||
147655696|NCT04865419|532562976|FG004|Overall Study|Withdrawal by Subject|0|||
147655697|NCT04865419|532562977|FG005|Overall Study|Withdrawal by Subject|0|||
147655698|NCT04865419|532562978|FG006|Overall Study|Withdrawal by Subject|0|||
147655699|NCT04865419|532562979|FG007|Overall Study|Withdrawal by Subject|1|||
147655700|NCT04865419|532562980|FG008|Overall Study|Withdrawal by Subject|2|||
147655701|NCT04865419|532562981|FG009|Overall Study|Withdrawal by Subject|1|||
147655702|NCT04865419|532562982|FG010|Overall Study|Withdrawal by Subject|0|||
147655703|NCT04865419|532562972|FG000|Overall Study|Study terminated by Sponsor|0|||
147655704|NCT04865419|532562973|FG001|Overall Study|Study terminated by Sponsor|0|||
147655705|NCT04865419|532562974|FG002|Overall Study|Study terminated by Sponsor|0|||
147655706|NCT04865419|532562975|FG003|Overall Study|Study terminated by Sponsor|2|||
147655707|NCT04865419|532562976|FG004|Overall Study|Study terminated by Sponsor|2|||
147655708|NCT04865419|532562977|FG005|Overall Study|Study terminated by Sponsor|0|||
147174239|NCT01610336|530802661|FG005|Overall Study|Progressive Disease|10|||
147174240|NCT01610336|530802662|FG006|Overall Study|Progressive Disease|1|||
147655709|NCT04865419|532562978|FG006|Overall Study|Study terminated by Sponsor|0|||
147655710|NCT04865419|532562979|FG007|Overall Study|Study terminated by Sponsor|0|||
147655711|NCT04865419|532562980|FG008|Overall Study|Study terminated by Sponsor|0|||
147655712|NCT04865419|532562981|FG009|Overall Study|Study terminated by Sponsor|0|||
147655713|NCT04865419|532562982|FG010|Overall Study|Study terminated by Sponsor|1|||
147655714|NCT04865419|532562972|FG000|Overall Study|Death|3|||
147655715|NCT04865419|532562973|FG001|Overall Study|Death|1|||
147174241|NCT01610336|530802663|FG007|Overall Study|Progressive Disease|6|||
147174242|NCT01610336|530802664|FG008|Overall Study|Progressive Disease|6|||
147174243|NCT01610336|530802665|FG009|Overall Study|Progressive Disease|40|||
147592838|NCT00775606|532326834|FG001|Overall Study|Study sponsor terminated funding|0|||
147592839|NCT03253744|532326839|FG000|Completion of Follow-Up|Continuing follow-up.|2|||
147592840|NCT03253744|532326840|FG001|Completion of Follow-Up|Continuing follow-up.|0|||
147174244|NCT01610336|530802666|FG010|Overall Study|Progressive Disease|36|||
147174245|NCT01610336|530802656|FG000|Overall Study|Adverse Event|0|||
147174246|NCT01610336|530802657|FG001|Overall Study|Adverse Event|0|||
147174247|NCT01610336|530802658|FG002|Overall Study|Adverse Event|0|||
147174248|NCT01610336|530802659|FG003|Overall Study|Adverse Event|1|||
147174249|NCT01610336|530802660|FG004|Overall Study|Adverse Event|1|||
147174250|NCT01610336|530802661|FG005|Overall Study|Adverse Event|1|||
147174251|NCT01610336|530802662|FG006|Overall Study|Adverse Event|0|||
147174252|NCT01610336|530802663|FG007|Overall Study|Adverse Event|0|||
147174253|NCT01610336|530802664|FG008|Overall Study|Adverse Event|2|||
147174254|NCT01610336|530802665|FG009|Overall Study|Adverse Event|8|||
147174255|NCT01610336|530802666|FG010|Overall Study|Adverse Event|6|||
147174256|NCT01610336|530802656|FG000|Overall Study|Subject/Guardian decision|1|||
147174257|NCT01610336|530802657|FG001|Overall Study|Subject/Guardian decision|1|||
147174258|NCT01610336|530802658|FG002|Overall Study|Subject/Guardian decision|0|||
147174259|NCT01610336|530802659|FG003|Overall Study|Subject/Guardian decision|1|||
147174260|NCT01610336|530802660|FG004|Overall Study|Subject/Guardian decision|0|||
147174261|NCT01610336|530802661|FG005|Overall Study|Subject/Guardian decision|0|||
147174262|NCT01610336|530802662|FG006|Overall Study|Subject/Guardian decision|0|||
147174263|NCT01610336|530802663|FG007|Overall Study|Subject/Guardian decision|1|||
147174264|NCT01610336|530802664|FG008|Overall Study|Subject/Guardian decision|0|||
147592841|NCT03253744|532326841|FG002|Completion of Follow-Up|Continuing follow-up.|0|||
147174265|NCT01610336|530802665|FG009|Overall Study|Subject/Guardian decision|2|||
147174266|NCT01610336|530802666|FG010|Overall Study|Subject/Guardian decision|2|||
147174267|NCT01610336|530802656|FG000|Overall Study|Death|0|||
147174268|NCT01610336|530802657|FG001|Overall Study|Death|0|||
147592842|NCT03253744|532326842|FG003|Completion of Follow-Up|Continuing follow-up.|4|||
147174269|NCT01610336|530802658|FG002|Overall Study|Death|0|||
147174270|NCT01610336|530802659|FG003|Overall Study|Death|0|||
147174271|NCT01610336|530802660|FG004|Overall Study|Death|0|||
147174272|NCT01610336|530802661|FG005|Overall Study|Death|1|||
147174273|NCT01610336|530802662|FG006|Overall Study|Death|3|||
147174274|NCT01610336|530802663|FG007|Overall Study|Death|0|||
147174275|NCT01610336|530802664|FG008|Overall Study|Death|0|||
147174276|NCT01610336|530802665|FG009|Overall Study|Death|1|||
147174277|NCT01610336|530802666|FG010|Overall Study|Death|2|||
147174278|NCT01610336|530802656|FG000|Overall Study|Non-Compliance with study treatment|0|||
147174279|NCT01610336|530802657|FG001|Overall Study|Non-Compliance with study treatment|0|||
147592843|NCT02408120|532326843|FG000|Overall Study|Withdrawal by Subject|0|||
147174280|NCT01610336|530802658|FG002|Overall Study|Non-Compliance with study treatment|0|||
147174281|NCT01610336|530802659|FG003|Overall Study|Non-Compliance with study treatment|0|||
147244470|NCT02269241|531068911|FG000|Overall Study|Screening failures|546|||
147244471|NCT03020160|531068912|FG000|Overall Study|Withdrawal by Subject|1|||
147244472|NCT03020160|531068913|FG001|Overall Study|Withdrawal by Subject|0|||
147244473|NCT02270957|531068914|FG000|Overall Study|Lack of Efficacy|2|||
147244474|NCT02270957|531068915|FG001|Overall Study|Lack of Efficacy|4|||
147244475|NCT02270957|531068914|FG000|Overall Study|Adverse Event|2|||
147244476|NCT02270957|531068915|FG001|Overall Study|Adverse Event|0|||
147244477|NCT01513473|531068916|FG000|Main Trial (26 Weeks)|Adverse Event|0|||
147244478|NCT01513473|531068917|FG001|Main Trial (26 Weeks)|Adverse Event|2|||
147244479|NCT01513473|531068916|FG000|Main Trial (26 Weeks)|Withdrawal by Subject|4|||
147244480|NCT01513473|531068917|FG001|Main Trial (26 Weeks)|Withdrawal by Subject|7|||
147244481|NCT01513473|531068916|FG000|Main Trial (26 Weeks)|Unclassified|0|||
147244482|NCT01513473|531068917|FG001|Main Trial (26 Weeks)|Unclassified|2|||
147244483|NCT01513473|531068916|FG000|Extension Trial (26 Weeks)|Adverse Event|0|||
147244484|NCT01513473|531068917|FG001|Extension Trial (26 Weeks)|Adverse Event|1|||
147244485|NCT01513473|531068916|FG000|Extension Trial (26 Weeks)|Withdrawal by Subject|1|||
147244486|NCT01513473|531068917|FG001|Extension Trial (26 Weeks)|Withdrawal by Subject|5|||
147244487|NCT04166435|531068919|FG000|Overall Study|2 patients ineligible for response|2|||
147244488|NCT01218204|531068920|FG000|Part B Washout|Adverse Event|0|||
147244489|NCT01218204|531068921|FG001|Part B Washout|Adverse Event|1|||
147592844|NCT02408120|532326844|FG001|Overall Study|Withdrawal by Subject|1|||
147592845|NCT02408120|532326843|FG000|Overall Study|Treatment Refusal|1|||
147592846|NCT02408120|532326844|FG001|Overall Study|Treatment Refusal|0|||
147655716|NCT04865419|532562974|FG002|Overall Study|Death|4|||
147244490|NCT01218204|531068922|FG002|Part B Washout|Adverse Event|0|||
147655717|NCT04865419|532562975|FG003|Overall Study|Death|2|||
147655718|NCT04865419|532562976|FG004|Overall Study|Death|5|||
147244491|NCT01218204|531068923|FG003|Part B Washout|Adverse Event|0|||
147174282|NCT01610336|530802660|FG004|Overall Study|Non-Compliance with study treatment|0|||
147174283|NCT01610336|530802661|FG005|Overall Study|Non-Compliance with study treatment|0|||
147174284|NCT01610336|530802662|FG006|Overall Study|Non-Compliance with study treatment|0|||
147174285|NCT01610336|530802663|FG007|Overall Study|Non-Compliance with study treatment|0|||
147174286|NCT01610336|530802664|FG008|Overall Study|Non-Compliance with study treatment|0|||
147655719|NCT04865419|532562977|FG005|Overall Study|Death|2|||
147174287|NCT01610336|530802665|FG009|Overall Study|Non-Compliance with study treatment|1|||
147174288|NCT01610336|530802666|FG010|Overall Study|Non-Compliance with study treatment|0|||
147174289|NCT01610336|530802656|FG000|Overall Study|Physician Decision|0|||
147174290|NCT01610336|530802657|FG001|Overall Study|Physician Decision|0|||
147174291|NCT01610336|530802658|FG002|Overall Study|Physician Decision|0|||
147174292|NCT01610336|530802659|FG003|Overall Study|Physician Decision|0|||
147174293|NCT01610336|530802660|FG004|Overall Study|Physician Decision|0|||
147174294|NCT01610336|530802661|FG005|Overall Study|Physician Decision|0|||
147174295|NCT01610336|530802662|FG006|Overall Study|Physician Decision|1|||
147174296|NCT01610336|530802663|FG007|Overall Study|Physician Decision|0|||
147174297|NCT01610336|530802664|FG008|Overall Study|Physician Decision|0|||
147174298|NCT01610336|530802665|FG009|Overall Study|Physician Decision|0|||
147174299|NCT01610336|530802666|FG010|Overall Study|Physician Decision|0|||
147174300|NCT01610336|530802656|FG000|Overall Study|Protocol Deviation|0|||
147174301|NCT01610336|530802657|FG001|Overall Study|Protocol Deviation|0|||
147174302|NCT01610336|530802658|FG002|Overall Study|Protocol Deviation|0|||
147174303|NCT01610336|530802659|FG003|Overall Study|Protocol Deviation|0|||
147174304|NCT01610336|530802660|FG004|Overall Study|Protocol Deviation|0|||
147174305|NCT01610336|530802661|FG005|Overall Study|Protocol Deviation|0|||
147174306|NCT01610336|530802662|FG006|Overall Study|Protocol Deviation|0|||
147174307|NCT01610336|530802663|FG007|Overall Study|Protocol Deviation|0|||
147174308|NCT01610336|530802664|FG008|Overall Study|Protocol Deviation|0|||
147174309|NCT01610336|530802665|FG009|Overall Study|Protocol Deviation|1|||
147174310|NCT01610336|530802666|FG010|Overall Study|Protocol Deviation|0|||
147174311|NCT01610336|530802656|FG000|Overall Study|Transfer to another trial|0|||
147174312|NCT01610336|530802657|FG001|Overall Study|Transfer to another trial|0|||
147174313|NCT01610336|530802658|FG002|Overall Study|Transfer to another trial|0|||
147174314|NCT01610336|530802659|FG003|Overall Study|Transfer to another trial|0|||
147174315|NCT01610336|530802660|FG004|Overall Study|Transfer to another trial|0|||
147174316|NCT01610336|530802661|FG005|Overall Study|Transfer to another trial|0|||
147174317|NCT01610336|530802662|FG006|Overall Study|Transfer to another trial|0|||
147174318|NCT01610336|530802663|FG007|Overall Study|Transfer to another trial|0|||
147174319|NCT01610336|530802664|FG008|Overall Study|Transfer to another trial|0|||
147174320|NCT01610336|530802665|FG009|Overall Study|Transfer to another trial|0|||
147174321|NCT01610336|530802666|FG010|Overall Study|Transfer to another trial|1|||
147174322|NCT01559675|530802669|FG000|Overall Study|Protocol Violation|1|||
147174323|NCT01559675|530802670|FG001|Overall Study|Protocol Violation|2|||
147174324|NCT01559675|530802669|FG000|Overall Study|2nd operation on same patient excluded|14|||
147174325|NCT01559675|530802670|FG001|Overall Study|2nd operation on same patient excluded|12|||
147174326|NCT00193180|530802673|FG000|Overall Study|Lack of Efficacy|1|||
147174327|NCT00193180|530802673|FG000|Overall Study|Adverse Event|8|||
147174328|NCT00193180|530802673|FG000|Overall Study|Protocol Violation|1|||
147174329|NCT01393639|530802674|FG000|Overall Study|Protocol Violation|0|||
147174330|NCT01393639|530802675|FG001|Overall Study|Protocol Violation|0|||
147174331|NCT01393639|530802676|FG002|Overall Study|Protocol Violation|0|||
147174332|NCT01393639|530802677|FG003|Overall Study|Protocol Violation|1|||
147174333|NCT01393639|530802678|FG004|Overall Study|Protocol Violation|0|||
147174334|NCT01393639|530802679|FG005|Overall Study|Protocol Violation|0|||
147174335|NCT01393639|530802680|FG006|Overall Study|Protocol Violation|0|||
147174336|NCT01393639|530802674|FG000|Overall Study|Other|0|||
147174337|NCT01393639|530802675|FG001|Overall Study|Other|2|||
147174338|NCT01393639|530802676|FG002|Overall Study|Other|0|||
147174339|NCT01393639|530802677|FG003|Overall Study|Other|2|||
147174340|NCT01393639|530802678|FG004|Overall Study|Other|1|||
147174341|NCT01393639|530802679|FG005|Overall Study|Other|0|||
147174342|NCT01393639|530802680|FG006|Overall Study|Other|1|||
147174343|NCT01393639|530802674|FG000|Overall Study|Withdrawal by Subject|1|||
147174344|NCT01393639|530802675|FG001|Overall Study|Withdrawal by Subject|1|||
147174345|NCT01393639|530802676|FG002|Overall Study|Withdrawal by Subject|0|||
147174346|NCT01393639|530802677|FG003|Overall Study|Withdrawal by Subject|0|||
147174347|NCT01393639|530802678|FG004|Overall Study|Withdrawal by Subject|0|||
147174348|NCT01393639|530802679|FG005|Overall Study|Withdrawal by Subject|0|||
147174349|NCT01393639|530802680|FG006|Overall Study|Withdrawal by Subject|1|||
147174350|NCT01393639|530802674|FG000|Overall Study|Medication error without associated AE|0|||
147174351|NCT01393639|530802675|FG001|Overall Study|Medication error without associated AE|0|||
147174352|NCT01393639|530802676|FG002|Overall Study|Medication error without associated AE|0|||
147174353|NCT01393639|530802677|FG003|Overall Study|Medication error without associated AE|0|||
147174354|NCT01393639|530802678|FG004|Overall Study|Medication error without associated AE|0|||
147174355|NCT01393639|530802679|FG005|Overall Study|Medication error without associated AE|0|||
147174356|NCT01393639|530802680|FG006|Overall Study|Medication error without associated AE|1|||
147174357|NCT01393639|530802674|FG000|Overall Study|Lost to Follow-up|0|||
147174358|NCT01393639|530802675|FG001|Overall Study|Lost to Follow-up|1|||
147174359|NCT01393639|530802676|FG002|Overall Study|Lost to Follow-up|0|||
147174360|NCT01393639|530802677|FG003|Overall Study|Lost to Follow-up|0|||
147174361|NCT01393639|530802678|FG004|Overall Study|Lost to Follow-up|0|||
147174362|NCT01393639|530802679|FG005|Overall Study|Lost to Follow-up|0|||
147174363|NCT01393639|530802680|FG006|Overall Study|Lost to Follow-up|1|||
147174364|NCT01393639|530802674|FG000|Overall Study|Lack of Efficacy|0|||
147174365|NCT01393639|530802675|FG001|Overall Study|Lack of Efficacy|0|||
147174366|NCT01393639|530802676|FG002|Overall Study|Lack of Efficacy|0|||
147174367|NCT01393639|530802677|FG003|Overall Study|Lack of Efficacy|0|||
147174368|NCT01393639|530802678|FG004|Overall Study|Lack of Efficacy|0|||
147174369|NCT01393639|530802679|FG005|Overall Study|Lack of Efficacy|0|||
147174370|NCT01393639|530802680|FG006|Overall Study|Lack of Efficacy|1|||
147174371|NCT01393639|530802674|FG000|Overall Study|Adverse Event|2|||
147174372|NCT01393639|530802675|FG001|Overall Study|Adverse Event|3|||
147174373|NCT01393639|530802676|FG002|Overall Study|Adverse Event|1|||
147174374|NCT01393639|530802677|FG003|Overall Study|Adverse Event|2|||
147174375|NCT01393639|530802678|FG004|Overall Study|Adverse Event|0|||
147174376|NCT01393639|530802679|FG005|Overall Study|Adverse Event|2|||
147174377|NCT01393639|530802680|FG006|Overall Study|Adverse Event|3|||
147174378|NCT01832155|530802681|FG000|Beginning of Study: Baseline at 0 Week|Withdrawal by Subject|1|||
147174379|NCT01832155|530802682|FG001|Beginning of Study: Baseline at 0 Week|Withdrawal by Subject|0|||
147174380|NCT01832155|530802681|FG000|Mid-point of Study: 0 - 4 Weeks|Protocol Violation|1|||
147174381|NCT01832155|530802682|FG001|Mid-point of Study: 0 - 4 Weeks|Protocol Violation|0|||
147174382|NCT01369641|530802683|FG000|Overall Study|Withdrawal by Subject|1|||
147174383|NCT00842543|530802684|FG000|Overall Study|Withdrawal by Subject|2|||
147174384|NCT00842543|530802685|FG001|Overall Study|Withdrawal by Subject|0|||
147174385|NCT00842543|530802686|FG002|Overall Study|Withdrawal by Subject|3|||
147174386|NCT00842543|530802687|FG003|Overall Study|Withdrawal by Subject|4|||
147174387|NCT03100058|530802693|FG000|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
147174388|NCT03100058|530802694|FG001|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
147174389|NCT03100058|530802695|FG002|Epoch 3 (24 Weeks of Treatment)|Adverse Event|4|||
147174390|NCT03100058|530802696|FG003|Epoch 3 (24 Weeks of Treatment)|Adverse Event|8|||
147174391|NCT03100058|530802697|FG004|Epoch 3 (24 Weeks of Treatment)|Adverse Event|1|||
147174392|NCT03100058|530802698|FG005|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
147174393|NCT03100058|530802699|FG006|Epoch 3 (24 Weeks of Treatment)|Adverse Event|3|||
147174394|NCT03100058|530802700|FG007|Epoch 3 (24 Weeks of Treatment)|Adverse Event|11|||
147174395|NCT03100058|530802701|FG008|Epoch 3 (24 Weeks of Treatment)|Adverse Event|2|||
147174396|NCT03100058|530802702|FG009|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
147174397|NCT03100058|530802703|FG010|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
147174398|NCT03100058|530802704|FG011|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
147174399|NCT03100058|530802705|FG012|Epoch 3 (24 Weeks of Treatment)|Adverse Event|0|||
147174400|NCT03100058|530802693|FG000|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|2|||
147174401|NCT03100058|530802694|FG001|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|4|||
147174402|NCT03100058|530802695|FG002|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|3|||
147174403|NCT03100058|530802696|FG003|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|4|||
147174404|NCT03100058|530802697|FG004|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|1|||
147174405|NCT03100058|530802698|FG005|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|1|||
147174406|NCT03100058|530802699|FG006|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|1|||
147174407|NCT03100058|530802700|FG007|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|4|||
147174408|NCT03100058|530802701|FG008|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|2|||
147174409|NCT03100058|530802702|FG009|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|0|||
147174410|NCT03100058|530802703|FG010|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|0|||
147174411|NCT03100058|530802704|FG011|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|0|||
147174412|NCT03100058|530802705|FG012|Epoch 3 (24 Weeks of Treatment)|Withdrawal by Subject|0|||
147174413|NCT03100058|530802693|FG000|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
147174414|NCT03100058|530802694|FG001|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|1|||
147174415|NCT03100058|530802695|FG002|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|1|||
147174416|NCT03100058|530802696|FG003|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
147174417|NCT03100058|530802697|FG004|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
147174418|NCT03100058|530802698|FG005|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|1|||
147174419|NCT03100058|530802699|FG006|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|1|||
147174420|NCT03100058|530802700|FG007|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
147174421|NCT03100058|530802701|FG008|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
147174422|NCT03100058|530802702|FG009|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
147174423|NCT03100058|530802703|FG010|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
147174424|NCT03100058|530802704|FG011|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
147174425|NCT03100058|530802705|FG012|Epoch 3 (24 Weeks of Treatment)|Non-compliance with study treatment|0|||
147174426|NCT03100058|530802693|FG000|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
147174427|NCT03100058|530802694|FG001|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|1|||
147174428|NCT03100058|530802695|FG002|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|1|||
147174429|NCT03100058|530802696|FG003|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
147174430|NCT03100058|530802697|FG004|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
147174431|NCT03100058|530802698|FG005|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
147174432|NCT03100058|530802699|FG006|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|1|||
147174433|NCT03100058|530802700|FG007|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
147174434|NCT03100058|530802701|FG008|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|1|||
147174435|NCT03100058|530802702|FG009|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
147174436|NCT03100058|530802703|FG010|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
147174437|NCT03100058|530802704|FG011|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
147174438|NCT03100058|530802705|FG012|Epoch 3 (24 Weeks of Treatment)|Lost to Follow-up|0|||
147174439|NCT03100058|530802693|FG000|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
147174440|NCT03100058|530802694|FG001|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
147174441|NCT03100058|530802695|FG002|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
147174442|NCT03100058|530802696|FG003|Epoch 3 (24 Weeks of Treatment)|Physician Decision|1|||
147174443|NCT03100058|530802697|FG004|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
147174444|NCT03100058|530802698|FG005|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
147174445|NCT03100058|530802699|FG006|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
147174446|NCT03100058|530802700|FG007|Epoch 3 (24 Weeks of Treatment)|Physician Decision|1|||
147174447|NCT03100058|530802701|FG008|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
147174448|NCT03100058|530802702|FG009|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
147174449|NCT03100058|530802703|FG010|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
147174450|NCT03100058|530802704|FG011|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
147174451|NCT03100058|530802705|FG012|Epoch 3 (24 Weeks of Treatment)|Physician Decision|0|||
147174452|NCT03100058|530802693|FG000|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
147174453|NCT03100058|530802694|FG001|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
147174454|NCT03100058|530802695|FG002|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
147174455|NCT03100058|530802696|FG003|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|1|||
147174456|NCT03100058|530802697|FG004|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
147174457|NCT03100058|530802698|FG005|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
147174458|NCT03100058|530802699|FG006|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|1|||
147174459|NCT03100058|530802700|FG007|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
147174460|NCT03100058|530802701|FG008|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
147174461|NCT03100058|530802702|FG009|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
147174462|NCT03100058|530802703|FG010|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
147174463|NCT03100058|530802704|FG011|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
147174464|NCT03100058|530802705|FG012|Epoch 3 (24 Weeks of Treatment)|Protocol Violation|0|||
147174465|NCT03100058|530802693|FG000|Epoch 3 (24 Weeks of Treatment)|Death|0|||
147174466|NCT03100058|530802694|FG001|Epoch 3 (24 Weeks of Treatment)|Death|1|||
147174467|NCT03100058|530802695|FG002|Epoch 3 (24 Weeks of Treatment)|Death|0|||
147174468|NCT03100058|530802696|FG003|Epoch 3 (24 Weeks of Treatment)|Death|0|||
147174469|NCT03100058|530802697|FG004|Epoch 3 (24 Weeks of Treatment)|Death|0|||
147174470|NCT03100058|530802698|FG005|Epoch 3 (24 Weeks of Treatment)|Death|0|||
147174471|NCT03100058|530802699|FG006|Epoch 3 (24 Weeks of Treatment)|Death|0|||
147174472|NCT03100058|530802700|FG007|Epoch 3 (24 Weeks of Treatment)|Death|0|||
147174473|NCT03100058|530802701|FG008|Epoch 3 (24 Weeks of Treatment)|Death|0|||
147174474|NCT03100058|530802702|FG009|Epoch 3 (24 Weeks of Treatment)|Death|0|||
147174475|NCT03100058|530802703|FG010|Epoch 3 (24 Weeks of Treatment)|Death|0|||
147655720|NCT04865419|532562978|FG006|Overall Study|Death|1|||
147655721|NCT04865419|532562979|FG007|Overall Study|Death|1|||
147655722|NCT04865419|532562980|FG008|Overall Study|Death|2|||
147655723|NCT04865419|532562981|FG009|Overall Study|Death|2|||
147655724|NCT04865419|532562982|FG010|Overall Study|Death|1|||
147655725|NCT04865419|532562972|FG000|Overall Study|Lost to Follow-up|0|||
147655726|NCT04865419|532562973|FG001|Overall Study|Lost to Follow-up|0|||
147655727|NCT04865419|532562974|FG002|Overall Study|Lost to Follow-up|0|||
147655728|NCT04865419|532562975|FG003|Overall Study|Lost to Follow-up|0|||
147655729|NCT04865419|532562976|FG004|Overall Study|Lost to Follow-up|0|||
147655730|NCT04865419|532562977|FG005|Overall Study|Lost to Follow-up|0|||
147655731|NCT04865419|532562978|FG006|Overall Study|Lost to Follow-up|0|||
147655732|NCT04865419|532562979|FG007|Overall Study|Lost to Follow-up|0|||
147655733|NCT04865419|532562980|FG008|Overall Study|Lost to Follow-up|0|||
147655734|NCT04865419|532562981|FG009|Overall Study|Lost to Follow-up|1|||
147655735|NCT04865419|532562982|FG010|Overall Study|Lost to Follow-up|0|||
147655736|NCT00547157|532562983|FG000|Overall Study|Other|1|||
147655737|NCT00547157|532562984|FG001|Overall Study|Other|0|||
147655738|NCT00547157|532562983|FG000|Overall Study|Death|38|||
147655739|NCT00547157|532562984|FG001|Overall Study|Death|18|||
147655740|NCT00547157|532562983|FG000|Overall Study|Withdrawal by Subject|3|||
147655741|NCT00547157|532562984|FG001|Overall Study|Withdrawal by Subject|1|||
147655742|NCT00547157|532562983|FG000|Overall Study|Administrative decision|3|||
147655743|NCT00547157|532562984|FG001|Overall Study|Administrative decision|2|||
147655744|NCT00547157|532562983|FG000|Overall Study|Lost to Follow-up|4|||
147655745|NCT00547157|532562984|FG001|Overall Study|Lost to Follow-up|2|||
147655746|NCT04186221|532562985|FG000|Overall Study|Death|1|||
147655747|NCT00972283|532562992|FG000|Main: Week 0 to 52 (NN1250-3582)|Adverse Event|31|||
147655748|NCT00972283|532562993|FG001|Main: Week 0 to 52 (NN1250-3582)|Adverse Event|9|||
147655749|NCT00972283|532562992|FG000|Main: Week 0 to 52 (NN1250-3582)|Lack of Efficacy|3|||
147448253|NCT00183274|531805667|FG001|Phase 1: Open-Label|Lost to Follow-up|0|||
147448254|NCT00183274|531805668|FG002|Phase 1: Open-Label|Lost to Follow-up|0|||
147448255|NCT00183274|531805669|FG003|Phase 1: Open-Label|Lost to Follow-up|0|||
147448256|NCT00183274|531805670|FG004|Phase 1: Open-Label|Lost to Follow-up|0|||
147448257|NCT00183274|531805671|FG005|Phase 1: Open-Label|Lost to Follow-up|0|||
147448258|NCT00183274|531805666|FG000|Phase 1: Open-Label|Other|9|||
147448259|NCT00183274|531805667|FG001|Phase 1: Open-Label|Other|0|||
147448260|NCT00183274|531805668|FG002|Phase 1: Open-Label|Other|0|||
147448261|NCT00183274|531805669|FG003|Phase 1: Open-Label|Other|0|||
147448262|NCT00183274|531805670|FG004|Phase 1: Open-Label|Other|0|||
147448263|NCT00183274|531805671|FG005|Phase 1: Open-Label|Other|0|||
147592847|NCT02408120|532326843|FG000|Overall Study|Received Steroids|1|||
147592848|NCT02408120|532326844|FG001|Overall Study|Received Steroids|1|||
147592849|NCT02408120|532326843|FG000|Overall Study|Discharged same day|1|||
147592850|NCT02408120|532326844|FG001|Overall Study|Discharged same day|1|||
147592851|NCT02408120|532326843|FG000|Overall Study|Did not receive insulin|1|||
147592852|NCT02408120|532326844|FG001|Overall Study|Did not receive insulin|2|||
147592853|NCT01134627|532326845|FG000|Overall Study|Adverse Event|47|||
147592854|NCT01134627|532326846|FG001|Overall Study|Adverse Event|31|||
147592855|NCT01134627|532326845|FG000|Overall Study|Lost to Follow-up|1|||
147592856|NCT01134627|532326846|FG001|Overall Study|Lost to Follow-up|2|||
147592857|NCT01134627|532326845|FG000|Overall Study|Protocol Violation|3|||
147592858|NCT01134627|532326846|FG001|Overall Study|Protocol Violation|5|||
147592859|NCT01134627|532326845|FG000|Overall Study|Lack of Efficacy|2|||
147592860|NCT01134627|532326846|FG001|Overall Study|Lack of Efficacy|12|||
147592861|NCT01134627|532326845|FG000|Overall Study|Withdrawal by Subject|4|||
147592862|NCT01134627|532326846|FG001|Overall Study|Withdrawal by Subject|3|||
147592863|NCT01134627|532326845|FG000|Overall Study|Planning to become pregnant/pregnancy|1|||
147592864|NCT01134627|532326846|FG001|Overall Study|Planning to become pregnant/pregnancy|0|||
147592865|NCT01134627|532326845|FG000|Overall Study|Other|11|||
147592866|NCT01134627|532326846|FG001|Overall Study|Other|14|||
147592867|NCT03739138|532326858|FG000|Overall Study|Death|0|||
147592868|NCT03739138|532326859|FG001|Overall Study|Death|7|||
147592869|NCT03739138|532326860|FG002|Overall Study|Death|4|||
147592870|NCT03739138|532326861|FG003|Overall Study|Death|13|||
147174476|NCT03100058|530802704|FG011|Epoch 3 (24 Weeks of Treatment)|Death|0|||
147174477|NCT03100058|530802705|FG012|Epoch 3 (24 Weeks of Treatment)|Death|0|||
147174478|NCT03100058|530802693|FG000|Epoch 3 (24 Weeks of Treatment)|Pregnancy|1|||
147174479|NCT03100058|530802694|FG001|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
147174480|NCT03100058|530802695|FG002|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
147174481|NCT03100058|530802696|FG003|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
147174482|NCT03100058|530802697|FG004|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
147174483|NCT03100058|530802698|FG005|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
147174484|NCT03100058|530802699|FG006|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
147174485|NCT03100058|530802700|FG007|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
147174486|NCT03100058|530802701|FG008|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
147174487|NCT03100058|530802702|FG009|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
147174488|NCT03100058|530802703|FG010|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
147174489|NCT03100058|530802704|FG011|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
147174490|NCT03100058|530802705|FG012|Epoch 3 (24 Weeks of Treatment)|Pregnancy|0|||
147174491|NCT03100058|530802693|FG000|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
147174492|NCT03100058|530802694|FG001|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
147174493|NCT03100058|530802695|FG002|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
147174494|NCT03100058|530802696|FG003|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
147174495|NCT03100058|530802697|FG004|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
147174496|NCT03100058|530802698|FG005|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
147174497|NCT03100058|530802699|FG006|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|1|||
147174498|NCT03100058|530802700|FG007|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
147174499|NCT03100058|530802701|FG008|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
147174500|NCT03100058|530802702|FG009|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
147174501|NCT03100058|530802703|FG010|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
147174502|NCT03100058|530802704|FG011|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
147448264|NCT00183274|531805666|FG000|Phase 2: Double-Blind|Relapsed|0|||
147448265|NCT00183274|531805667|FG001|Phase 2: Double-Blind|Relapsed|8|||
147592871|NCT03739138|532326862|FG004|Overall Study|Death|0|||
147592872|NCT03739138|532326858|FG000|Overall Study|Lost to Follow-up|0|||
147174503|NCT03100058|530802705|FG012|Epoch 3 (24 Weeks of Treatment)|Lack of Efficacy|0|||
147592873|NCT03739138|532326859|FG001|Overall Study|Lost to Follow-up|0|||
147592874|NCT03739138|532326860|FG002|Overall Study|Lost to Follow-up|1|||
147592875|NCT03739138|532326861|FG003|Overall Study|Lost to Follow-up|0|||
147592876|NCT03739138|532326862|FG004|Overall Study|Lost to Follow-up|0|||
147174504|NCT03100058|530802693|FG000|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
147174505|NCT03100058|530802694|FG001|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
147244492|NCT01218204|531068920|FG000|Part B Washout|Lost to Follow-up|0|||
147448266|NCT00183274|531805668|FG002|Phase 2: Double-Blind|Relapsed|29|||
147448267|NCT00183274|531805669|FG003|Phase 2: Double-Blind|Relapsed|0|||
147448268|NCT00183274|531805670|FG004|Phase 2: Double-Blind|Relapsed|0|||
147592877|NCT03739138|532326858|FG000|Overall Study|Study Terminated By Sponsor|0|||
147174506|NCT03100058|530802695|FG002|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
147174507|NCT03100058|530802696|FG003|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
147174508|NCT03100058|530802697|FG004|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
147174509|NCT03100058|530802698|FG005|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
147174510|NCT03100058|530802699|FG006|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
147174511|NCT03100058|530802700|FG007|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
147174512|NCT03100058|530802701|FG008|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
147174513|NCT03100058|530802702|FG009|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|0|||
147174514|NCT03100058|530802703|FG010|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|4|||
147174515|NCT03100058|530802704|FG011|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|2|||
147174516|NCT03100058|530802705|FG012|Epoch 4 (Last 24 Weeks of the Study)|Withdrawal by Subject|1|||
147174517|NCT03100058|530802693|FG000|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
147174518|NCT03100058|530802694|FG001|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
147174519|NCT03100058|530802695|FG002|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
147174520|NCT03100058|530802696|FG003|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
147174521|NCT03100058|530802697|FG004|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
147174522|NCT03100058|530802698|FG005|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
147174523|NCT03100058|530802699|FG006|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
147174524|NCT03100058|530802700|FG007|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
147174525|NCT03100058|530802701|FG008|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
147174526|NCT03100058|530802702|FG009|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
147174527|NCT03100058|530802703|FG010|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|3|||
147174528|NCT03100058|530802704|FG011|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|1|||
147174529|NCT03100058|530802705|FG012|Epoch 4 (Last 24 Weeks of the Study)|Lost to Follow-up|0|||
147174530|NCT03100058|530802693|FG000|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
147174531|NCT03100058|530802694|FG001|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
147174532|NCT03100058|530802695|FG002|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
147174533|NCT03100058|530802696|FG003|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
147174534|NCT03100058|530802697|FG004|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
147174535|NCT03100058|530802698|FG005|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
147174536|NCT03100058|530802699|FG006|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
147174537|NCT03100058|530802700|FG007|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
147174538|NCT03100058|530802701|FG008|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
147174539|NCT03100058|530802702|FG009|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|4|||
147174540|NCT03100058|530802703|FG010|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|7|||
147174541|NCT03100058|530802704|FG011|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|0|||
147174542|NCT03100058|530802705|FG012|Epoch 4 (Last 24 Weeks of the Study)|Adverse Event|2|||
147174543|NCT03100058|530802693|FG000|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
147174544|NCT03100058|530802694|FG001|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
147174545|NCT03100058|530802695|FG002|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
147174546|NCT03100058|530802696|FG003|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
147174547|NCT03100058|530802697|FG004|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
147174548|NCT03100058|530802698|FG005|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
147174549|NCT03100058|530802699|FG006|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
147174550|NCT03100058|530802700|FG007|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
147174551|NCT03100058|530802701|FG008|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
147174552|NCT03100058|530802702|FG009|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
147174553|NCT03100058|530802703|FG010|Epoch 4 (Last 24 Weeks of the Study)|Death|1|||
147174554|NCT03100058|530802704|FG011|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
147174555|NCT03100058|530802705|FG012|Epoch 4 (Last 24 Weeks of the Study)|Death|0|||
147174556|NCT03100058|530802693|FG000|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
147174557|NCT03100058|530802694|FG001|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
147174558|NCT03100058|530802695|FG002|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
147174559|NCT03100058|530802696|FG003|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
147244493|NCT01218204|531068921|FG001|Part B Washout|Lost to Follow-up|2|||
147244494|NCT01218204|531068922|FG002|Part B Washout|Lost to Follow-up|0|||
147244495|NCT01218204|531068923|FG003|Part B Washout|Lost to Follow-up|0|||
147592878|NCT03739138|532326859|FG001|Overall Study|Study Terminated By Sponsor|0|||
147592879|NCT03739138|532326860|FG002|Overall Study|Study Terminated By Sponsor|0|||
147592880|NCT03739138|532326861|FG003|Overall Study|Study Terminated By Sponsor|4|||
147592881|NCT03739138|532326862|FG004|Overall Study|Study Terminated By Sponsor|0|||
147592882|NCT03739138|532326858|FG000|Overall Study|Withdrawal by Subject|0|||
147592883|NCT03739138|532326859|FG001|Overall Study|Withdrawal by Subject|0|||
147592884|NCT03739138|532326860|FG002|Overall Study|Withdrawal by Subject|0|||
147592885|NCT03739138|532326861|FG003|Overall Study|Withdrawal by Subject|1|||
147592886|NCT03739138|532326862|FG004|Overall Study|Withdrawal by Subject|0|||
147592887|NCT00767520|532326863|FG000|Overall Study|Participants still on treatment|11|||
147174560|NCT03100058|530802697|FG004|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
147174561|NCT03100058|530802698|FG005|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
147174562|NCT03100058|530802699|FG006|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
147174563|NCT03100058|530802700|FG007|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
147174564|NCT03100058|530802701|FG008|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
147174565|NCT03100058|530802702|FG009|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
147174566|NCT03100058|530802703|FG010|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
147174567|NCT03100058|530802704|FG011|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|0|||
147174568|NCT03100058|530802705|FG012|Epoch 4 (Last 24 Weeks of the Study)|Pregnancy|1|||
147174569|NCT03100058|530802693|FG000|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
147174570|NCT03100058|530802694|FG001|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
147174571|NCT03100058|530802695|FG002|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
147655750|NCT00972283|532562993|FG001|Main: Week 0 to 52 (NN1250-3582)|Lack of Efficacy|0|||
147655751|NCT00972283|532562992|FG000|Main: Week 0 to 52 (NN1250-3582)|Protocol Violation|23|||
147655752|NCT00972283|532562993|FG001|Main: Week 0 to 52 (NN1250-3582)|Protocol Violation|12|||
147655753|NCT00972283|532562992|FG000|Main: Week 0 to 52 (NN1250-3582)|Withdrawal criteria|8|||
147655754|NCT00972283|532562993|FG001|Main: Week 0 to 52 (NN1250-3582)|Withdrawal criteria|2|||
147655755|NCT00972283|532562992|FG000|Main: Week 0 to 52 (NN1250-3582)|Unclassified|72|||
147655756|NCT00972283|532562993|FG001|Main: Week 0 to 52 (NN1250-3582)|Unclassified|17|||
147655757|NCT00972283|532562992|FG000|Extension: Week 53 to 78 (NN1250-3667)|Adverse Event|4|||
147655758|NCT00972283|532562993|FG001|Extension: Week 53 to 78 (NN1250-3667)|Adverse Event|0|||
147655759|NCT00972283|532562992|FG000|Extension: Week 53 to 78 (NN1250-3667)|Lack of Efficacy|1|||
147655760|NCT00972283|532562993|FG001|Extension: Week 53 to 78 (NN1250-3667)|Lack of Efficacy|1|||
147655761|NCT00972283|532562992|FG000|Extension: Week 53 to 78 (NN1250-3667)|Protocol Violation|5|||
147655762|NCT00972283|532562993|FG001|Extension: Week 53 to 78 (NN1250-3667)|Protocol Violation|0|||
147655763|NCT00972283|532562992|FG000|Extension: Week 53 to 78 (NN1250-3667)|Withdrawal criteria|6|||
147655764|NCT00972283|532562993|FG001|Extension: Week 53 to 78 (NN1250-3667)|Withdrawal criteria|2|||
147655765|NCT00972283|532562992|FG000|Extension: Week 53 to 78 (NN1250-3667)|Unclassified|11|||
147655766|NCT00972283|532562993|FG001|Extension: Week 53 to 78 (NN1250-3667)|Unclassified|5|||
147655767|NCT00282152|532562994|FG000|Overall Study|Withdrawal by Subject|1|||
147655768|NCT00282152|532562995|FG001|Overall Study|Withdrawal by Subject|0|||
147655769|NCT00585325|532562996|FG000|Overall Study|Withdrawal by Subject|1|||
147655770|NCT00585325|532562997|FG001|Overall Study|Withdrawal by Subject|1|||
147655771|NCT03092791|532562998|FG000|Overall Study|Lost to Follow-up|0|||
147655772|NCT03092791|532562999|FG001|Overall Study|Lost to Follow-up|0|||
147655773|NCT03092791|532563000|FG002|Overall Study|Lost to Follow-up|0|||
147655774|NCT03092791|532563001|FG003|Overall Study|Lost to Follow-up|0|||
147655775|NCT03092791|532563002|FG004|Overall Study|Lost to Follow-up|0|||
147655776|NCT03092791|532563003|FG005|Overall Study|Lost to Follow-up|0|||
147655777|NCT03092791|532563004|FG006|Overall Study|Lost to Follow-up|1|||
147655778|NCT03092791|532563005|FG007|Overall Study|Lost to Follow-up|0|||
147655779|NCT03092791|532562998|FG000|Overall Study|Withdrawal of Consent|0|||
147655780|NCT03092791|532562999|FG001|Overall Study|Withdrawal of Consent|0|||
147655781|NCT03092791|532563000|FG002|Overall Study|Withdrawal of Consent|0|||
147655782|NCT03092791|532563001|FG003|Overall Study|Withdrawal of Consent|0|||
147655783|NCT03092791|532563002|FG004|Overall Study|Withdrawal of Consent|4|||
147655784|NCT03092791|532563003|FG005|Overall Study|Withdrawal of Consent|12|||
147655785|NCT03092791|532563004|FG006|Overall Study|Withdrawal of Consent|6|||
147655786|NCT03092791|532563005|FG007|Overall Study|Withdrawal of Consent|4|||
147655787|NCT03092791|532562998|FG000|Overall Study|Study Termination|0|||
147655788|NCT03092791|532562999|FG001|Overall Study|Study Termination|0|||
147655789|NCT03092791|532563000|FG002|Overall Study|Study Termination|0|||
147655790|NCT03092791|532563001|FG003|Overall Study|Study Termination|0|||
147655791|NCT03092791|532563002|FG004|Overall Study|Study Termination|55|||
147655792|NCT03092791|532563003|FG005|Overall Study|Study Termination|46|||
147655793|NCT03092791|532563004|FG006|Overall Study|Study Termination|53|||
147655794|NCT03092791|532563005|FG007|Overall Study|Study Termination|55|||
147655795|NCT03092791|532562998|FG000|Overall Study|Death|0|||
147655796|NCT03092791|532562999|FG001|Overall Study|Death|0|||
147655797|NCT03092791|532563000|FG002|Overall Study|Death|0|||
147655798|NCT03092791|532563001|FG003|Overall Study|Death|0|||
147655799|NCT03092791|532563002|FG004|Overall Study|Death|0|||
147174572|NCT03100058|530802696|FG003|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
147174573|NCT03100058|530802697|FG004|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
147174574|NCT03100058|530802698|FG005|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
147655800|NCT03092791|532563003|FG005|Overall Study|Death|1|||
147655801|NCT03092791|532563004|FG006|Overall Study|Death|0|||
147655802|NCT03092791|532563005|FG007|Overall Study|Death|1|||
147655803|NCT03092791|532562998|FG000|Overall Study|Reason Not Specified|0|||
147655804|NCT03092791|532562999|FG001|Overall Study|Reason Not Specified|0|||
147655805|NCT03092791|532563000|FG002|Overall Study|Reason Not Specified|0|||
147655806|NCT03092791|532563001|FG003|Overall Study|Reason Not Specified|0|||
147655807|NCT03092791|532563002|FG004|Overall Study|Reason Not Specified|1|||
147174575|NCT03100058|530802699|FG006|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
147174576|NCT03100058|530802700|FG007|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
147174577|NCT03100058|530802701|FG008|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
147174578|NCT03100058|530802702|FG009|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|1|||
147174579|NCT03100058|530802703|FG010|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
147174580|NCT03100058|530802704|FG011|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
147174581|NCT03100058|530802705|FG012|Epoch 4 (Last 24 Weeks of the Study)|non-compliance with study treatment|0|||
147174582|NCT02718716|530802706|FG000|Overall Study|Lack of Efficacy|1|||
147174583|NCT02718716|530802707|FG001|Overall Study|Lack of Efficacy|0|||
147174584|NCT02718716|530802708|FG002|Overall Study|Lack of Efficacy|0|||
147174585|NCT02718716|530802709|FG003|Overall Study|Lack of Efficacy|0|||
147174586|NCT02718716|530802710|FG004|Overall Study|Lack of Efficacy|0|||
147174587|NCT02942485|530802711|FG000|Overall Study|Lost to Follow-up|1|||
147174588|NCT02942485|530802712|FG001|Overall Study|Lost to Follow-up|0|||
147174589|NCT03194646|530802717|FG000|Overall Study|Adverse Event|24|||
147174590|NCT03194646|530802718|FG001|Overall Study|Adverse Event|25|||
147174591|NCT03194646|530802719|FG002|Overall Study|Adverse Event|14|||
147174592|NCT03194646|530802720|FG003|Overall Study|Adverse Event|17|||
147174593|NCT03194646|530802717|FG000|Overall Study|Lack of Efficacy|4|||
147174594|NCT03194646|530802718|FG001|Overall Study|Lack of Efficacy|2|||
147174595|NCT03194646|530802719|FG002|Overall Study|Lack of Efficacy|2|||
147174596|NCT03194646|530802720|FG003|Overall Study|Lack of Efficacy|12|||
147174597|NCT03194646|530802717|FG000|Overall Study|Lost to Follow-up|30|||
147244496|NCT01218204|531068920|FG000|Part B Washout|Physician Decision|0|||
147244497|NCT01218204|531068921|FG001|Part B Washout|Physician Decision|14|||
147655808|NCT03092791|532563003|FG005|Overall Study|Reason Not Specified|1|||
147655809|NCT03092791|532563004|FG006|Overall Study|Reason Not Specified|0|||
147174598|NCT03194646|530802718|FG001|Overall Study|Lost to Follow-up|22|||
147244498|NCT01218204|531068922|FG002|Part B Washout|Physician Decision|0|||
147244499|NCT01218204|531068923|FG003|Part B Washout|Physician Decision|0|||
147244500|NCT01218204|531068920|FG000|Part B Washout|Withdrawal by Subject|0|||
147244501|NCT01218204|531068921|FG001|Part B Washout|Withdrawal by Subject|14|||
147244502|NCT01218204|531068922|FG002|Part B Washout|Withdrawal by Subject|0|||
147244503|NCT01218204|531068923|FG003|Part B Washout|Withdrawal by Subject|0|||
147244504|NCT01218204|531068920|FG000|Part B Washout|Reached defined stopping criteria|0|||
147244505|NCT01218204|531068921|FG001|Part B Washout|Reached defined stopping criteria|2|||
147244506|NCT01218204|531068922|FG002|Part B Washout|Reached defined stopping criteria|0|||
147244507|NCT01218204|531068923|FG003|Part B Washout|Reached defined stopping criteria|0|||
147244508|NCT01218204|531068920|FG000|Part B Washout|Did not meet continuation criteria|0|||
147244509|NCT01218204|531068921|FG001|Part B Washout|Did not meet continuation criteria|112|||
147244510|NCT01218204|531068922|FG002|Part B Washout|Did not meet continuation criteria|0|||
147244511|NCT01218204|531068923|FG003|Part B Washout|Did not meet continuation criteria|0|||
147244512|NCT01218204|531068920|FG000|Part B Run-in|Adverse Event|0|||
147244513|NCT01218204|531068921|FG001|Part B Run-in|Adverse Event|0|||
147244514|NCT01218204|531068922|FG002|Part B Run-in|Adverse Event|1|||
147244515|NCT01218204|531068923|FG003|Part B Run-in|Adverse Event|0|||
147244516|NCT01218204|531068920|FG000|Part B Run-in|Protocol Violation|0|||
147244517|NCT01218204|531068921|FG001|Part B Run-in|Protocol Violation|0|||
147244518|NCT01218204|531068922|FG002|Part B Run-in|Protocol Violation|2|||
147244519|NCT01218204|531068923|FG003|Part B Run-in|Protocol Violation|0|||
147244520|NCT01218204|531068920|FG000|Part B Run-in|Withdrawal by Subject|0|||
147244521|NCT01218204|531068921|FG001|Part B Run-in|Withdrawal by Subject|0|||
147244522|NCT01218204|531068922|FG002|Part B Run-in|Withdrawal by Subject|3|||
147244523|NCT01218204|531068923|FG003|Part B Run-in|Withdrawal by Subject|0|||
147244524|NCT01218204|531068920|FG000|Part B Pooled Treatment Arm|Adverse Event|0|||
147244525|NCT01218204|531068921|FG001|Part B Pooled Treatment Arm|Adverse Event|0|||
147244526|NCT01218204|531068922|FG002|Part B Pooled Treatment Arm|Adverse Event|0|||
147244527|NCT01218204|531068923|FG003|Part B Pooled Treatment Arm|Adverse Event|2|||
147244528|NCT01218204|531068920|FG000|Part B Pooled Treatment Arm|Protocol Violation|0|||
147244529|NCT01218204|531068921|FG001|Part B Pooled Treatment Arm|Protocol Violation|0|||
147244530|NCT01218204|531068922|FG002|Part B Pooled Treatment Arm|Protocol Violation|0|||
147244531|NCT01218204|531068923|FG003|Part B Pooled Treatment Arm|Protocol Violation|1|||
147244532|NCT00743340|531068924|FG000|Overall Study|Study medication non-compliance|1|||
147244533|NCT00743340|531068924|FG000|Overall Study|Lost to Follow-up|1|||
147244534|NCT00743340|531068924|FG000|Overall Study|Withdrawal from the Study|5|||
147244535|NCT00743340|531068924|FG000|Overall Study|Protocol Violation|1|||
147244536|NCT00743340|531068924|FG000|Overall Study|Virologic failure|8|||
147244537|NCT00743340|531068924|FG000|Overall Study|Pregnancy|1|||
147244538|NCT00743340|531068924|FG000|Overall Study|Rolled over to other Gilead Study|23|||
147174599|NCT03194646|530802719|FG002|Overall Study|Lost to Follow-up|12|||
147174600|NCT03194646|530802720|FG003|Overall Study|Lost to Follow-up|35|||
147174601|NCT03194646|530802717|FG000|Overall Study|Non-compliance with study drug|4|||
147174602|NCT03194646|530802718|FG001|Overall Study|Non-compliance with study drug|0|||
147174603|NCT03194646|530802719|FG002|Overall Study|Non-compliance with study drug|1|||
147174604|NCT03194646|530802720|FG003|Overall Study|Non-compliance with study drug|1|||
147174605|NCT03194646|530802717|FG000|Overall Study|Other|89|||
147174606|NCT03194646|530802718|FG001|Overall Study|Other|68|||
147174607|NCT03194646|530802719|FG002|Overall Study|Other|34|||
147174608|NCT03194646|530802720|FG003|Overall Study|Other|31|||
147174609|NCT03194646|530802717|FG000|Overall Study|Physician Decision|7|||
147174610|NCT03194646|530802718|FG001|Overall Study|Physician Decision|9|||
147174611|NCT03194646|530802719|FG002|Overall Study|Physician Decision|5|||
147174612|NCT03194646|530802720|FG003|Overall Study|Physician Decision|4|||
147174613|NCT03194646|530802717|FG000|Overall Study|Pregnancy|4|||
147174614|NCT03194646|530802718|FG001|Overall Study|Pregnancy|5|||
147174615|NCT03194646|530802719|FG002|Overall Study|Pregnancy|1|||
147174616|NCT03194646|530802720|FG003|Overall Study|Pregnancy|2|||
147174617|NCT03194646|530802717|FG000|Overall Study|Protocol Violation|4|||
147174618|NCT03194646|530802718|FG001|Overall Study|Protocol Violation|2|||
147174619|NCT03194646|530802719|FG002|Overall Study|Protocol Violation|1|||
147174620|NCT03194646|530802720|FG003|Overall Study|Protocol Violation|1|||
147174621|NCT03194646|530802717|FG000|Overall Study|Site terminated by sponsor|0|||
147174622|NCT03194646|530802718|FG001|Overall Study|Site terminated by sponsor|0|||
147174623|NCT03194646|530802719|FG002|Overall Study|Site terminated by sponsor|2|||
147174624|NCT03194646|530802720|FG003|Overall Study|Site terminated by sponsor|0|||
147174625|NCT03194646|530802717|FG000|Overall Study|Study terminated by sponsor|62|||
147174626|NCT03194646|530802718|FG001|Overall Study|Study terminated by sponsor|61|||
147174627|NCT03194646|530802719|FG002|Overall Study|Study terminated by sponsor|30|||
147174628|NCT03194646|530802720|FG003|Overall Study|Study terminated by sponsor|34|||
147174629|NCT03194646|530802717|FG000|Overall Study|Withdrawal by Subject|75|||
147174630|NCT03194646|530802718|FG001|Overall Study|Withdrawal by Subject|74|||
147174631|NCT03194646|530802719|FG002|Overall Study|Withdrawal by Subject|36|||
147174632|NCT03194646|530802720|FG003|Overall Study|Withdrawal by Subject|131|||
147174633|NCT03194646|530802717|FG000|Overall Study|Missing|1|||
147174634|NCT03194646|530802718|FG001|Overall Study|Missing|0|||
147174635|NCT03194646|530802719|FG002|Overall Study|Missing|1|||
147174636|NCT03194646|530802720|FG003|Overall Study|Missing|12|||
147174637|NCT02141360|530802721|FG000|Overall Study|Withdrawal by Subject|6|||
147174638|NCT02141360|530802722|FG001|Overall Study|Withdrawal by Subject|0|||
147174639|NCT02141360|530802723|FG002|Overall Study|Withdrawal by Subject|0|||
147174640|NCT02141360|530802721|FG000|Overall Study|Study Terminated before Visit|1|||
147174641|NCT02141360|530802722|FG001|Overall Study|Study Terminated before Visit|0|||
147174642|NCT02141360|530802723|FG002|Overall Study|Study Terminated before Visit|0|||
147174643|NCT00098306|530802725|FG000|Double Blind|Randomized, not treated|9|||
147174644|NCT00098306|530802726|FG001|Double Blind|Randomized, not treated|5|||
147174645|NCT00098306|530802727|FG002|Double Blind|Randomized, not treated|2|||
147324279|NCT04863898|531352482|FG000|Overall Study|Preferred not to answer on endline survey why they did not participate in the training|1|||
147324280|NCT04863898|531352482|FG000|Overall Study|Lost to Follow-up|3|||
147324281|NCT04863898|531352482|FG000|Overall Study|Self reported at endline that they had not received information about the training|1|||
147324282|NCT04863898|531352482|FG000|Overall Study|No longer employed at clinic|3|||
147324283|NCT03285711|531352483|FG000|Blinded Phase (Up to Week 16)|Adverse Event|2|||
147324284|NCT03285711|531352484|FG001|Blinded Phase (Up to Week 16)|Adverse Event|1|||
147324285|NCT03285711|531352485|FG002|Blinded Phase (Up to Week 16)|Adverse Event|0|||
147324286|NCT03285711|531352486|FG003|Blinded Phase (Up to Week 16)|Adverse Event|0|||
147324287|NCT03285711|531352483|FG000|Blinded Phase (Up to Week 16)|Protocol Violation|1|||
147324288|NCT03285711|531352484|FG001|Blinded Phase (Up to Week 16)|Protocol Violation|0|||
147324289|NCT03285711|531352485|FG002|Blinded Phase (Up to Week 16)|Protocol Violation|0|||
147324290|NCT03285711|531352486|FG003|Blinded Phase (Up to Week 16)|Protocol Violation|0|||
147324291|NCT03285711|531352483|FG000|Blinded Phase (Week 16 to 32)|Lack of Efficacy|0|||
147592888|NCT00767520|532326864|FG001|Overall Study|Participants still on treatment|15|||
147592889|NCT00767520|532326863|FG000|Overall Study|Randomized in error and Never treated|0|||
147592890|NCT00767520|532326864|FG001|Overall Study|Randomized in error and Never treated|2|||
147592891|NCT02777918|532326867|FG000|Overall Study|Medical reasons|1|||
147174646|NCT00098306|530802728|FG003|Double Blind|Randomized, not treated|0|||
147174647|NCT00098306|530802729|FG004|Double Blind|Randomized, not treated|0|||
147174648|NCT00098306|530802730|FG005|Double Blind|Randomized, not treated|0|||
147174649|NCT00098306|530802731|FG006|Double Blind|Randomized, not treated|0|||
147324292|NCT03285711|531352484|FG001|Blinded Phase (Week 16 to 32)|Lack of Efficacy|0|||
147174650|NCT00098306|530802725|FG000|Double Blind|Ongoing at cut-off date|151|||
147324293|NCT03285711|531352485|FG002|Blinded Phase (Week 16 to 32)|Lack of Efficacy|1|||
147324294|NCT03285711|531352486|FG003|Blinded Phase (Week 16 to 32)|Lack of Efficacy|0|||
147448269|NCT00183274|531805671|FG005|Phase 2: Double-Blind|Relapsed|0|||
147174651|NCT00098306|530802726|FG001|Double Blind|Ongoing at cut-off date|166|||
147174652|NCT00098306|530802727|FG002|Double Blind|Ongoing at cut-off date|72|||
147174653|NCT00098306|530802728|FG003|Double Blind|Ongoing at cut-off date|0|||
147174654|NCT00098306|530802729|FG004|Double Blind|Ongoing at cut-off date|0|||
147174655|NCT00098306|530802730|FG005|Double Blind|Ongoing at cut-off date|0|||
147174656|NCT00098306|530802731|FG006|Double Blind|Ongoing at cut-off date|0|||
147174657|NCT00098306|530802725|FG000|Double Blind|Adverse Event|11|||
147174658|NCT00098306|530802726|FG001|Double Blind|Adverse Event|10|||
147174659|NCT00098306|530802727|FG002|Double Blind|Adverse Event|6|||
147174660|NCT00098306|530802728|FG003|Double Blind|Adverse Event|0|||
147174661|NCT00098306|530802729|FG004|Double Blind|Adverse Event|0|||
147174662|NCT00098306|530802730|FG005|Double Blind|Adverse Event|0|||
147174663|NCT00098306|530802731|FG006|Double Blind|Adverse Event|0|||
147174664|NCT00098306|530802725|FG000|Double Blind|Lack of Efficacy|43|||
147174665|NCT00098306|530802726|FG001|Double Blind|Lack of Efficacy|34|||
147174666|NCT00098306|530802727|FG002|Double Blind|Lack of Efficacy|17|||
147174667|NCT00098306|530802728|FG003|Double Blind|Lack of Efficacy|0|||
147174668|NCT00098306|530802729|FG004|Double Blind|Lack of Efficacy|0|||
147174669|NCT00098306|530802730|FG005|Double Blind|Lack of Efficacy|0|||
147174670|NCT00098306|530802731|FG006|Double Blind|Lack of Efficacy|0|||
147174671|NCT00098306|530802725|FG000|Double Blind|Death|1|||
147174672|NCT00098306|530802726|FG001|Double Blind|Death|4|||
147174673|NCT00098306|530802727|FG002|Double Blind|Death|1|||
147174674|NCT00098306|530802728|FG003|Double Blind|Death|0|||
147174675|NCT00098306|530802729|FG004|Double Blind|Death|0|||
147174676|NCT00098306|530802730|FG005|Double Blind|Death|0|||
147174677|NCT00098306|530802731|FG006|Double Blind|Death|0|||
147174678|NCT00098306|530802725|FG000|Double Blind|Participant defaulted|19|||
147174679|NCT00098306|530802726|FG001|Double Blind|Participant defaulted|18|||
147174680|NCT00098306|530802727|FG002|Double Blind|Participant defaulted|11|||
147174681|NCT00098306|530802728|FG003|Double Blind|Participant defaulted|0|||
147174682|NCT00098306|530802729|FG004|Double Blind|Participant defaulted|0|||
147174683|NCT00098306|530802730|FG005|Double Blind|Participant defaulted|0|||
147174684|NCT00098306|530802731|FG006|Double Blind|Participant defaulted|0|||
147174685|NCT00098306|530802725|FG000|Double Blind|Un-specified|7|||
147174686|NCT00098306|530802726|FG001|Double Blind|Un-specified|3|||
147174687|NCT00098306|530802727|FG002|Double Blind|Un-specified|11|||
147324295|NCT03285711|531352483|FG000|Extended Blinded Phase (Week 32 to 52)|Lack of Efficacy|0|||
147324296|NCT03285711|531352484|FG001|Extended Blinded Phase (Week 32 to 52)|Lack of Efficacy|1|||
147324297|NCT03285711|531352485|FG002|Extended Blinded Phase (Week 32 to 52)|Lack of Efficacy|0|||
147324298|NCT03285711|531352486|FG003|Extended Blinded Phase (Week 32 to 52)|Lack of Efficacy|0|||
147324299|NCT02431533|531352487|FG000|Overall Study|Withdrawal by Subject|1|||
147324300|NCT02431533|531352488|FG001|Overall Study|Withdrawal by Subject|3|||
147324301|NCT02431533|531352487|FG000|Overall Study|Developed Exclusionary criteria|1|||
147324302|NCT02431533|531352488|FG001|Overall Study|Developed Exclusionary criteria|0|||
147324303|NCT02234310|531352491|FG000|Overall Study|Physician Decision|1|||
147324304|NCT02234310|531352491|FG000|Overall Study|Adverse Event|1|||
147324305|NCT02234310|531352491|FG000|Overall Study|Eligibility Criteria not fulfilled|2|||
147324306|NCT02234310|531352491|FG000|Overall Study|Withdrawal by Subject|2|||
147324307|NCT00235495|531352492|FG000|Overall Study|Death|52|||
147324308|NCT00235495|531352493|FG001|Overall Study|Death|42|||
147324309|NCT00235495|531352492|FG000|Overall Study|Withdrawal by Subject|5|||
147324310|NCT00235495|531352493|FG001|Overall Study|Withdrawal by Subject|3|||
147324311|NCT00235495|531352492|FG000|Overall Study|Lost to Follow-up|11|||
147324312|NCT00235495|531352493|FG001|Overall Study|Lost to Follow-up|13|||
147324313|NCT00235495|531352492|FG000|Overall Study|Visit/assessmen outside window/missing|0|||
147324314|NCT00235495|531352493|FG001|Overall Study|Visit/assessmen outside window/missing|10|||
147324315|NCT03251378|531352494|FG000|Overall Study|Death|3|||
147324316|NCT03251378|531352495|FG001|Overall Study|Death|2|||
147324317|NCT03251378|531352496|FG002|Overall Study|Death|3|||
147324318|NCT03251378|531352497|FG003|Overall Study|Death|30|||
147324319|NCT03251378|531352498|FG004|Overall Study|Death|24|||
147324320|NCT03251378|531352499|FG005|Overall Study|Death|12|||
147324321|NCT03251378|531352500|FG006|Overall Study|Death|12|||
147324322|NCT03251378|531352494|FG000|Overall Study|Lost to Follow-up|0|||
147174688|NCT00098306|530802728|FG003|Double Blind|Un-specified|0|||
147174689|NCT00098306|530802729|FG004|Double Blind|Un-specified|0|||
147174690|NCT00098306|530802730|FG005|Double Blind|Un-specified|0|||
147174691|NCT00098306|530802731|FG006|Double Blind|Un-specified|0|||
147174692|NCT00098306|530802725|FG000|Open Label|Lack of Efficacy|0|||
147324323|NCT03251378|531352495|FG001|Overall Study|Lost to Follow-up|0|||
147324324|NCT03251378|531352496|FG002|Overall Study|Lost to Follow-up|1|||
147174693|NCT00098306|530802726|FG001|Open Label|Lack of Efficacy|0|||
147174694|NCT00098306|530802727|FG002|Open Label|Lack of Efficacy|0|||
147174695|NCT00098306|530802728|FG003|Open Label|Lack of Efficacy|13|||
147174696|NCT00098306|530802729|FG004|Open Label|Lack of Efficacy|0|||
147174697|NCT00098306|530802730|FG005|Open Label|Lack of Efficacy|0|||
147174698|NCT00098306|530802731|FG006|Open Label|Lack of Efficacy|0|||
147324325|NCT03251378|531352497|FG003|Overall Study|Lost to Follow-up|3|||
147324326|NCT03251378|531352498|FG004|Overall Study|Lost to Follow-up|0|||
147174699|NCT00098306|530802725|FG000|Open Label|Adverse Event|0|||
147174700|NCT00098306|530802726|FG001|Open Label|Adverse Event|0|||
147174701|NCT00098306|530802727|FG002|Open Label|Adverse Event|0|||
147324327|NCT03251378|531352499|FG005|Overall Study|Lost to Follow-up|0|||
147324328|NCT03251378|531352500|FG006|Overall Study|Lost to Follow-up|0|||
147174702|NCT00098306|530802728|FG003|Open Label|Adverse Event|2|||
147174703|NCT00098306|530802729|FG004|Open Label|Adverse Event|0|||
147448270|NCT00183274|531805666|FG000|Phase 2: Double-Blind|Withdrawal by Subject|0|||
147448271|NCT00183274|531805667|FG001|Phase 2: Double-Blind|Withdrawal by Subject|18|||
147448272|NCT00183274|531805668|FG002|Phase 2: Double-Blind|Withdrawal by Subject|14|||
147448273|NCT00183274|531805669|FG003|Phase 2: Double-Blind|Withdrawal by Subject|0|||
147448274|NCT00183274|531805670|FG004|Phase 2: Double-Blind|Withdrawal by Subject|0|||
147448275|NCT00183274|531805671|FG005|Phase 2: Double-Blind|Withdrawal by Subject|0|||
147448276|NCT00183274|531805666|FG000|Phase 3: Double-Blind|Withdrawal by Subject|0|||
147448277|NCT00183274|531805667|FG001|Phase 3: Double-Blind|Withdrawal by Subject|0|||
147448278|NCT00183274|531805668|FG002|Phase 3: Double-Blind|Withdrawal by Subject|0|||
147448279|NCT00183274|531805669|FG003|Phase 3: Double-Blind|Withdrawal by Subject|1|||
147448280|NCT00183274|531805670|FG004|Phase 3: Double-Blind|Withdrawal by Subject|9|||
147448281|NCT00183274|531805671|FG005|Phase 3: Double-Blind|Withdrawal by Subject|2|||
147448282|NCT00183274|531805666|FG000|Phase 3: Double-Blind|Relapsed|0|||
147592892|NCT02777918|532326868|FG001|Overall Study|Medical reasons|2|||
147592893|NCT02777918|532326867|FG000|Overall Study|Too busy / stressed|1|||
147592894|NCT02777918|532326868|FG001|Overall Study|Too busy / stressed|1|||
147592895|NCT02777918|532326867|FG000|Overall Study|Withdrawal by Subject|1|||
147592896|NCT02777918|532326868|FG001|Overall Study|Withdrawal by Subject|1|||
147592897|NCT00757848|532326869|FG000|Overall Study|Voluntary discontinuation|1|||
147592898|NCT00757848|532326870|FG001|Overall Study|Voluntary discontinuation|0|||
147592899|NCT00757848|532326869|FG000|Overall Study|Adverse Event|1|||
147592900|NCT00757848|532326870|FG001|Overall Study|Adverse Event|2|||
147592901|NCT00757848|532326869|FG000|Overall Study|Incorrect enrolment|1|||
147592902|NCT00757848|532326870|FG001|Overall Study|Incorrect enrolment|0|||
147592903|NCT01338987|532326871|FG000|Overall Study|enrolled on new protocol|0|||
147592904|NCT01338987|532326872|FG001|Overall Study|enrolled on new protocol|0|||
147592905|NCT01338987|532326873|FG002|Overall Study|enrolled on new protocol|1|||
147592906|NCT01338987|532326874|FG003|Overall Study|enrolled on new protocol|0|||
147592907|NCT01338987|532326875|FG004|Overall Study|enrolled on new protocol|0|||
147592908|NCT01338987|532326871|FG000|Overall Study|Disease progression on study|2|||
147592909|NCT01338987|532326872|FG001|Overall Study|Disease progression on study|1|||
147592910|NCT01338987|532326873|FG002|Overall Study|Disease progression on study|1|||
147592911|NCT01338987|532326874|FG003|Overall Study|Disease progression on study|0|||
147174704|NCT00098306|530802730|FG005|Open Label|Adverse Event|0|||
147174705|NCT00098306|530802731|FG006|Open Label|Adverse Event|0|||
147174706|NCT00098306|530802725|FG000|Open Label|Death|0|||
147174707|NCT00098306|530802726|FG001|Open Label|Death|0|||
147174708|NCT00098306|530802727|FG002|Open Label|Death|0|||
147174709|NCT00098306|530802728|FG003|Open Label|Death|4|||
147174710|NCT00098306|530802729|FG004|Open Label|Death|0|||
147174711|NCT00098306|530802730|FG005|Open Label|Death|0|||
147174712|NCT00098306|530802731|FG006|Open Label|Death|0|||
147174713|NCT00098306|530802725|FG000|Open Label|Participant defaulted|0|||
147174714|NCT00098306|530802726|FG001|Open Label|Participant defaulted|0|||
147174715|NCT00098306|530802727|FG002|Open Label|Participant defaulted|0|||
147174716|NCT00098306|530802728|FG003|Open Label|Participant defaulted|24|||
147174717|NCT00098306|530802729|FG004|Open Label|Participant defaulted|0|||
147174718|NCT00098306|530802730|FG005|Open Label|Participant defaulted|0|||
147174719|NCT00098306|530802731|FG006|Open Label|Participant defaulted|0|||
147174720|NCT00098306|530802725|FG000|Open Label|Un-specified|0|||
147174721|NCT00098306|530802726|FG001|Open Label|Un-specified|0|||
147174722|NCT00098306|530802727|FG002|Open Label|Un-specified|0|||
147174723|NCT00098306|530802728|FG003|Open Label|Un-specified|15|||
147174724|NCT00098306|530802729|FG004|Open Label|Un-specified|0|||
147174725|NCT00098306|530802730|FG005|Open Label|Un-specified|0|||
147174726|NCT00098306|530802731|FG006|Open Label|Un-specified|0|||
147174727|NCT00098306|530802725|FG000|Open Label|Ongoing at cut-off date|0|||
147174728|NCT00098306|530802726|FG001|Open Label|Ongoing at cut-off date|0|||
147244539|NCT00743340|531068924|FG000|Overall Study|Participant Relocated|1|||
147448283|NCT00183274|531805667|FG001|Phase 3: Double-Blind|Relapsed|0|||
147448284|NCT00183274|531805668|FG002|Phase 3: Double-Blind|Relapsed|0|||
147448285|NCT00183274|531805669|FG003|Phase 3: Double-Blind|Relapsed|1|||
147592912|NCT01338987|532326875|FG004|Overall Study|Disease progression on study|0|||
147592913|NCT00720226|532326885|FG000|Overall Study|Withdrawal by Subject|7|||
147592914|NCT00720226|532326886|FG001|Overall Study|Withdrawal by Subject|4|||
147592915|NCT00958126|532326887|FG000|Overall Study|Serious Adverse Event|0|||
147592916|NCT00958126|532326888|FG001|Overall Study|Serious Adverse Event|2|||
147174729|NCT00098306|530802727|FG002|Open Label|Ongoing at cut-off date|0|||
147174730|NCT00098306|530802728|FG003|Open Label|Ongoing at cut-off date|269|||
147174731|NCT00098306|530802729|FG004|Open Label|Ongoing at cut-off date|62|||
147174732|NCT00098306|530802730|FG005|Open Label|Ongoing at cut-off date|0|||
147174733|NCT00098306|530802731|FG006|Open Label|Ongoing at cut-off date|0|||
147174734|NCT00098306|530802725|FG000|Observational Phase|Death|0|||
147174735|NCT00098306|530802726|FG001|Observational Phase|Death|0|||
147448286|NCT00183274|531805670|FG004|Phase 3: Double-Blind|Relapsed|11|||
147174736|NCT00098306|530802727|FG002|Observational Phase|Death|0|||
147174737|NCT00098306|530802728|FG003|Observational Phase|Death|0|||
147174738|NCT00098306|530802729|FG004|Observational Phase|Death|0|||
147448287|NCT00183274|531805671|FG005|Phase 3: Double-Blind|Relapsed|2|||
147174739|NCT00098306|530802730|FG005|Observational Phase|Death|5|||
147174740|NCT00098306|530802731|FG006|Observational Phase|Death|4|||
147174741|NCT00098306|530802725|FG000|Observational Phase|Participant defaulted|0|||
147174742|NCT00098306|530802726|FG001|Observational Phase|Participant defaulted|0|||
147174743|NCT00098306|530802727|FG002|Observational Phase|Participant defaulted|0|||
147174744|NCT00098306|530802728|FG003|Observational Phase|Participant defaulted|0|||
147174745|NCT00098306|530802729|FG004|Observational Phase|Participant defaulted|0|||
147174746|NCT00098306|530802730|FG005|Observational Phase|Participant defaulted|34|||
147174747|NCT00098306|530802731|FG006|Observational Phase|Participant defaulted|18|||
147174748|NCT00098306|530802725|FG000|Observational Phase|Un-specified|0|||
147174749|NCT00098306|530802726|FG001|Observational Phase|Un-specified|0|||
147174750|NCT00098306|530802727|FG002|Observational Phase|Un-specified|0|||
147174751|NCT00098306|530802728|FG003|Observational Phase|Un-specified|0|||
147174752|NCT00098306|530802729|FG004|Observational Phase|Un-specified|0|||
147174753|NCT00098306|530802730|FG005|Observational Phase|Un-specified|7|||
147174754|NCT00098306|530802731|FG006|Observational Phase|Un-specified|4|||
147174755|NCT00129467|530802732|FG000|Received Intervention|Death|1|||
147174756|NCT00129467|530802733|FG001|Received Intervention|Death|1|||
147174757|NCT00129467|530802732|FG000|Received Intervention|Cardiac SAE (hypertension)|1|||
147174758|NCT00129467|530802733|FG001|Received Intervention|Cardiac SAE (hypertension)|1|||
147174759|NCT00129467|530802732|FG000|Received Intervention|Delirium|2|||
147174760|NCT00129467|530802733|FG001|Received Intervention|Delirium|0|||
147174761|NCT00129467|530802732|FG000|Received Intervention|Withdrawal by Subject|1|||
147174762|NCT00129467|530802733|FG001|Received Intervention|Withdrawal by Subject|0|||
147174763|NCT00129467|530802732|FG000|Received Intervention|Nausea|1|||
147174764|NCT00129467|530802733|FG001|Received Intervention|Nausea|0|||
147174765|NCT00129467|530802732|FG000|Received Intervention|Intolerance to citalopram|0|||
147174766|NCT00129467|530802733|FG001|Received Intervention|Intolerance to citalopram|1|||
147174767|NCT00129467|530802732|FG000|Received Intervention|Dizzyness, fatigue|0|||
147174768|NCT00129467|530802733|FG001|Received Intervention|Dizzyness, fatigue|1|||
147174769|NCT00129467|530802732|FG000|Open Label for SSRI+Methylphenidate Arm|Death|1|||
147174770|NCT00129467|530802733|FG001|Open Label for SSRI+Methylphenidate Arm|Death|0|||
147174771|NCT00129467|530802732|FG000|Open Label for SSRI+Methylphenidate Arm|Delirium|1|||
147174772|NCT00129467|530802733|FG001|Open Label for SSRI+Methylphenidate Arm|Delirium|0|||
147174773|NCT01331291|530802734|FG000|Overall Study|Lack of Efficacy|2|||
147174774|NCT01331291|530802735|FG001|Overall Study|Lack of Efficacy|8|||
147174775|NCT01331291|530802734|FG000|Overall Study|Death|0|||
147174776|NCT01331291|530802735|FG001|Overall Study|Death|1|||
147174777|NCT01424228|530802736|FG000|Overall Study|Withdrawal by Subject|27|||
147174778|NCT01424228|530802737|FG001|Overall Study|Withdrawal by Subject|11|||
147174779|NCT01424228|530802736|FG000|Overall Study|Adverse Event|10|||
147174780|NCT01424228|530802737|FG001|Overall Study|Adverse Event|14|||
147174781|NCT01424228|530802736|FG000|Overall Study|Sponsor's decision|9|||
147174782|NCT01424228|530802737|FG001|Overall Study|Sponsor's decision|12|||
147174783|NCT01424228|530802736|FG000|Overall Study|Lack of Efficacy|5|||
147174784|NCT01424228|530802737|FG001|Overall Study|Lack of Efficacy|7|||
147174785|NCT01424228|530802736|FG000|Overall Study|inclusion/exclusion criteria not met|2|||
147174786|NCT01424228|530802737|FG001|Overall Study|inclusion/exclusion criteria not met|2|||
147174787|NCT01424228|530802736|FG000|Overall Study|Non-compliance|2|||
147174788|NCT01424228|530802737|FG001|Overall Study|Non-compliance|0|||
147174789|NCT01424228|530802736|FG000|Overall Study|Worsening of symptoms|1|||
147448288|NCT00879645|531805672|FG000|Overall Study|Adverse Event|1|||
147174790|NCT01424228|530802737|FG001|Overall Study|Worsening of symptoms|0|||
147244540|NCT00489541|531068925|FG000|12-Month Clinical Follow-up|Withdrawal by Subject|2|||
147244541|NCT00489541|531068926|FG001|12-Month Clinical Follow-up|Withdrawal by Subject|3|||
147244542|NCT00489541|531068925|FG000|12-Month Clinical Follow-up|Lost to Follow-up|2|||
147244543|NCT00489541|531068926|FG001|12-Month Clinical Follow-up|Lost to Follow-up|0|||
147244544|NCT00489541|531068925|FG000|12-Month Clinical Follow-up|Missed 12-Month Visit|2|||
147244545|NCT00489541|531068926|FG001|12-Month Clinical Follow-up|Missed 12-Month Visit|0|||
147244546|NCT00489541|531068925|FG000|12-Month Clinical Follow-up|Death|3|||
147244547|NCT00489541|531068926|FG001|12-Month Clinical Follow-up|Death|2|||
147244548|NCT00489541|531068925|FG000|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|23|||
147244549|NCT00489541|531068926|FG001|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|12|||
147244550|NCT00489541|531068925|FG000|9-Month Angiographic Follow-up|Not Evaluable for 9-Month Angiography|4|||
147244551|NCT00489541|531068926|FG001|9-Month Angiographic Follow-up|Not Evaluable for 9-Month Angiography|5|||
147174791|NCT01424228|530802736|FG000|Overall Study|Unplanned journey|0|||
147174792|NCT01424228|530802737|FG001|Overall Study|Unplanned journey|1|||
147174793|NCT00932165|530802738|FG000|Overall Study|Lost to Follow-up|1|||
147244552|NCT05131646|531068927|FG000|Overall Study|Withdrawal by Subject|1|||
147174794|NCT00293020|530802741|FG000|Overall Study|Withdrawal by Subject|34|||
147174795|NCT00293020|530802741|FG000|Overall Study|Adverse Event|30|||
147174796|NCT00293020|530802741|FG000|Overall Study|Death|32|||
147174797|NCT00293020|530802741|FG000|Overall Study|Lack of Efficacy|12|||
147174798|NCT00293020|530802741|FG000|Overall Study|Lost to Follow-up|4|||
147174799|NCT00293020|530802741|FG000|Overall Study|Protocol Violation|6|||
147174800|NCT00293020|530802741|FG000|Overall Study|Physician Decision|21|||
147174801|NCT00293020|530802741|FG000|Overall Study|Other Reason|22|||
147174802|NCT00293020|530802741|FG000|Overall Study|No dose taken|1|||
147174803|NCT00666965|530802742|FG000|Overall Study|Adverse Event|0|||
147174804|NCT00666965|530802743|FG001|Overall Study|Adverse Event|2|||
147174805|NCT00666965|530802744|FG002|Overall Study|Adverse Event|1|||
147174806|NCT00666965|530802745|FG003|Overall Study|Adverse Event|9|||
147174807|NCT00666965|530802742|FG000|Overall Study|Lack of Efficacy|1|||
147174808|NCT00666965|530802743|FG001|Overall Study|Lack of Efficacy|1|||
147174809|NCT00666965|530802744|FG002|Overall Study|Lack of Efficacy|0|||
147174810|NCT00666965|530802745|FG003|Overall Study|Lack of Efficacy|0|||
147174811|NCT00666965|530802742|FG000|Overall Study|Protocol Violation|0|||
147174812|NCT00666965|530802743|FG001|Overall Study|Protocol Violation|0|||
147174813|NCT00666965|530802744|FG002|Overall Study|Protocol Violation|0|||
147174814|NCT00666965|530802745|FG003|Overall Study|Protocol Violation|2|||
147174815|NCT00666965|530802742|FG000|Overall Study|Discontinuation criteria|2|||
147174816|NCT00666965|530802743|FG001|Overall Study|Discontinuation criteria|1|||
147174817|NCT00666965|530802744|FG002|Overall Study|Discontinuation criteria|1|||
147174818|NCT00666965|530802745|FG003|Overall Study|Discontinuation criteria|2|||
147174819|NCT00666965|530802742|FG000|Overall Study|Withdrawal by Subject|0|||
147174820|NCT00666965|530802743|FG001|Overall Study|Withdrawal by Subject|0|||
147174821|NCT00666965|530802744|FG002|Overall Study|Withdrawal by Subject|0|||
147174822|NCT00666965|530802745|FG003|Overall Study|Withdrawal by Subject|2|||
147174823|NCT01894022|530802751|FG000|Overall Study|Death|1|||
147174824|NCT01894022|530802752|FG001|Overall Study|Death|0|||
147174825|NCT01894022|530802751|FG000|Overall Study|Adverse Event, non-fatal|1|||
147174826|NCT01894022|530802752|FG001|Overall Study|Adverse Event, non-fatal|0|||
147174827|NCT01894022|530802751|FG000|Overall Study|Study Closed/terminated|7|||
147174828|NCT01894022|530802752|FG001|Overall Study|Study Closed/terminated|10|||
147174829|NCT02249182|530802756|FG000|Treatment Phase|Lost to Follow-up|4|||
147174830|NCT02249182|530802757|FG001|Treatment Phase|Lost to Follow-up|0|||
147174831|NCT02249182|530802758|FG002|Treatment Phase|Lost to Follow-up|0|||
147174832|NCT02249182|530802759|FG003|Treatment Phase|Lost to Follow-up|0|||
147174833|NCT02249182|530802760|FG004|Treatment Phase|Lost to Follow-up|0|||
147174834|NCT05090852|530802765|FG000|Overall Study|Physician Decision|5|||
147174835|NCT00504894|530802766|FG000|Overall Study|fMRI technical problems|1|||
147174836|NCT00504894|530802767|FG001|Overall Study|fMRI technical problems|1|||
147174837|NCT00504894|530802768|FG002|Overall Study|fMRI technical problems|0|||
147174838|NCT00504894|530802766|FG000|Overall Study|Withdrawal by Subject|0|||
147174839|NCT00504894|530802767|FG001|Overall Study|Withdrawal by Subject|1|||
147174840|NCT00504894|530802768|FG002|Overall Study|Withdrawal by Subject|0|||
147174841|NCT00504894|530802766|FG000|Overall Study|Infusion technical problems|0|||
147174842|NCT00504894|530802767|FG001|Overall Study|Infusion technical problems|1|||
147174843|NCT00504894|530802768|FG002|Overall Study|Infusion technical problems|0|||
147174844|NCT00504894|530802766|FG000|Overall Study|poor subject data|2|||
147174845|NCT00504894|530802767|FG001|Overall Study|poor subject data|0|||
147174846|NCT00504894|530802768|FG002|Overall Study|poor subject data|0|||
147174847|NCT00148941|530802769|FG000|Overall Study|Lost to Follow-up|17|||
147174848|NCT00148941|530802770|FG001|Overall Study|Lost to Follow-up|24|||
147174849|NCT00148941|530802771|FG002|Overall Study|Lost to Follow-up|18|||
147174850|NCT00148941|530802772|FG003|Overall Study|Lost to Follow-up|22|||
147174851|NCT00148941|530802769|FG000|Overall Study|Withdrawal by Subject|1|||
147174852|NCT00148941|530802770|FG001|Overall Study|Withdrawal by Subject|0|||
147174853|NCT00148941|530802771|FG002|Overall Study|Withdrawal by Subject|1|||
147174854|NCT00148941|530802772|FG003|Overall Study|Withdrawal by Subject|0|||
147174855|NCT00148941|530802769|FG000|Overall Study|Other|0|||
147174856|NCT00148941|530802770|FG001|Overall Study|Other|0|||
147174857|NCT00148941|530802771|FG002|Overall Study|Other|1|||
147174858|NCT00148941|530802772|FG003|Overall Study|Other|2|||
147174859|NCT03244826|530802773|FG000|Overall Study|Withdrawal by Subject|2|||
147174860|NCT03244826|530802774|FG001|Overall Study|Withdrawal by Subject|0|||
147174861|NCT03244826|530802773|FG000|Overall Study|Transplant delayed or withdrawn|12|||
147174862|NCT03244826|530802774|FG001|Overall Study|Transplant delayed or withdrawn|10|||
147174863|NCT02673684|530802777|FG000|Overall Study|Study not completed d/t loss of funding|9|||
147174864|NCT02673684|530802778|FG001|Overall Study|Study not completed d/t loss of funding|8|||
147174865|NCT04356040|530802779|FG000|Overall Study|Death|2|||
147174866|NCT04356040|530802780|FG001|Overall Study|Death|0|||
147174867|NCT04356040|530802779|FG000|Overall Study|Lost to Follow-up|1|||
147174868|NCT04356040|530802780|FG001|Overall Study|Lost to Follow-up|0|||
147174869|NCT04356040|530802779|FG000|Overall Study|Physician Decision|0|||
147174870|NCT04356040|530802780|FG001|Overall Study|Physician Decision|1|||
147174871|NCT04356040|530802779|FG000|Overall Study|Withdrawal by Subject|13|||
147174872|NCT04356040|530802780|FG001|Overall Study|Withdrawal by Subject|1|||
147174873|NCT04356040|530802779|FG000|Overall Study|Enrollment Pause|10|||
147174874|NCT04356040|530802780|FG001|Overall Study|Enrollment Pause|0|||
147174875|NCT04356040|530802779|FG000|Overall Study|Did not meet Inclusion/Exclusion criteria|7|||
147174876|NCT04356040|530802780|FG001|Overall Study|Did not meet Inclusion/Exclusion criteria|0|||
147174877|NCT04356040|530802779|FG000|Overall Study|Procedure aborted prior to device insertion into the vasculature|1|||
147174878|NCT04356040|530802780|FG001|Overall Study|Procedure aborted prior to device insertion into the vasculature|0|||
147174879|NCT04356040|530802779|FG000|Overall Study|PI left institution|3|||
147174880|NCT04356040|530802780|FG001|Overall Study|PI left institution|0|||
147174881|NCT01092663|530802781|FG000|Overall Study|Withdrawal by Subject|3|||
147174882|NCT01092663|530802782|FG001|Overall Study|Withdrawal by Subject|2|||
147174883|NCT01092663|530802781|FG000|Overall Study|Glucose >300mg/dL|1|||
147174884|NCT01092663|530802782|FG001|Overall Study|Glucose >300mg/dL|0|||
147174885|NCT01092663|530802781|FG000|Overall Study|High fasting triglyceride|2|||
147174886|NCT01092663|530802782|FG001|Overall Study|High fasting triglyceride|0|||
147174887|NCT01092663|530802781|FG000|Overall Study|Adverse Event|1|||
147174888|NCT01092663|530802782|FG001|Overall Study|Adverse Event|1|||
147174889|NCT01092663|530802781|FG000|Overall Study|Protocol Violation|0|||
147174890|NCT01092663|530802782|FG001|Overall Study|Protocol Violation|1|||
147174891|NCT01008904|530802783|FG000|Overall Study|Lost to Follow-up|1|||
147174892|NCT01008904|530802783|FG000|Overall Study|Adverse Event|2|||
147174893|NCT01008904|530802783|FG000|Overall Study|unexpected unrelated surgery|1|||
147174894|NCT00360568|530802784|FG000|Overall Study|Adverse Event|1|||
147174895|NCT00360568|530802785|FG001|Overall Study|Adverse Event|2|||
147174896|NCT00360568|530802784|FG000|Overall Study|Lack of Efficacy|1|||
147174897|NCT00360568|530802785|FG001|Overall Study|Lack of Efficacy|0|||
147174898|NCT00360568|530802784|FG000|Overall Study|Withdrawal by Subject|0|||
147174899|NCT00360568|530802785|FG001|Overall Study|Withdrawal by Subject|3|||
147174900|NCT01008449|530802786|FG000|Overall Study|Lost to Follow-up|29|||
147174901|NCT01008449|530802787|FG001|Overall Study|Lost to Follow-up|19|||
147174902|NCT01220180|530802788|FG000|Overall Study|Lost to Follow-up|76|||
147174903|NCT01220180|530802788|FG000|Overall Study|Other|72|||
147174904|NCT01220180|530802788|FG000|Overall Study|Adverse Event|35|||
147174905|NCT01220180|530802788|FG000|Overall Study|Lack of Efficacy|22|||
147174906|NCT01220180|530802788|FG000|Overall Study|Death|1|||
147174907|NCT01220180|530802788|FG000|Overall Study|Randomized but not treated|1|||
147174908|NCT01067469|530802789|FG000|Overall Study|Withdrawal by Subject|0|||
147174909|NCT01067469|530802790|FG001|Overall Study|Withdrawal by Subject|1|||
147174910|NCT01067469|530802789|FG000|Overall Study|Disease Progression|0|||
147174911|NCT01067469|530802790|FG001|Overall Study|Disease Progression|1|||
147174912|NCT01364389|530802793|FG000|Overall Study|Withdrawal by Subject|0|||
147174913|NCT01364389|530802794|FG001|Overall Study|Withdrawal by Subject|1|||
147174914|NCT01364389|530802795|FG002|Overall Study|Withdrawal by Subject|0|||
147174915|NCT01364389|530802793|FG000|Overall Study|Protocol deviation|0|||
147174916|NCT01364389|530802794|FG001|Overall Study|Protocol deviation|0|||
147174917|NCT01364389|530802795|FG002|Overall Study|Protocol deviation|1|||
147174918|NCT01364389|530802793|FG000|Overall Study|Administrative problems|1|||
147174919|NCT01364389|530802794|FG001|Overall Study|Administrative problems|0|||
147174920|NCT01364389|530802795|FG002|Overall Study|Administrative problems|0|||
147174921|NCT01364389|530802793|FG000|Overall Study|Adverse Event|1|||
147174922|NCT01364389|530802794|FG001|Overall Study|Adverse Event|0|||
147174923|NCT01364389|530802795|FG002|Overall Study|Adverse Event|0|||
147174924|NCT01534195|530802796|FG000|Overall Study|Withdrawal by Subject|1|||
147174925|NCT01534195|530802797|FG001|Overall Study|Withdrawal by Subject|1|||
147174926|NCT01959243|530802804|FG000|Overall Study|Investigator Decision|3|||
147174927|NCT01959243|530802805|FG001|Overall Study|Investigator Decision|0|||
147174928|NCT01959243|530802804|FG000|Overall Study|Adverse Event|5|||
147244553|NCT05131646|531068928|FG001|Overall Study|Withdrawal by Subject|0|||
147244554|NCT05131646|531068929|FG002|Overall Study|Withdrawal by Subject|0|||
147244555|NCT00003479|531068930|FG000|Overall Study|Not evaluable|3|||
147244556|NCT02042183|531068933|FG000|Overall Study|Physician Decision|7|||
147244557|NCT02042183|531068934|FG001|Overall Study|Physician Decision|2|||
147244558|NCT02042183|531068933|FG000|Overall Study|Lack of Efficacy|4|||
147244559|NCT02042183|531068934|FG001|Overall Study|Lack of Efficacy|3|||
147244560|NCT02042183|531068933|FG000|Overall Study|Non-compliance with Study Drug|2|||
147244561|NCT02042183|531068934|FG001|Overall Study|Non-compliance with Study Drug|3|||
147244562|NCT02042183|531068933|FG000|Overall Study|Adverse Event|17|||
147244563|NCT02042183|531068934|FG001|Overall Study|Adverse Event|6|||
147324329|NCT03251378|531352494|FG000|Overall Study|Patient withdrew consent and refused to provide follow-up information|0|||
147174929|NCT01959243|530802805|FG001|Overall Study|Adverse Event|2|||
147174930|NCT01959243|530802804|FG000|Overall Study|Administrative reasons|2|||
147174931|NCT01959243|530802805|FG001|Overall Study|Administrative reasons|1|||
147174932|NCT01959243|530802804|FG000|Overall Study|Lost to Follow-up|3|||
147244564|NCT02042183|531068933|FG000|Overall Study|Other|3|||
147174933|NCT01959243|530802805|FG001|Overall Study|Lost to Follow-up|1|||
147174934|NCT01345669|530802806|FG000|Overall Study|Primary tumour recurrence|53|||
147174935|NCT01345669|530802807|FG001|Overall Study|Primary tumour recurrence|32|||
147244565|NCT02042183|531068934|FG001|Overall Study|Other|3|||
147448289|NCT00879645|531805673|FG001|Overall Study|Adverse Event|0|||
147174936|NCT01345669|530802806|FG000|Overall Study|Second primary tumour|4|||
147174937|NCT01345669|530802807|FG001|Overall Study|Second primary tumour|3|||
147174938|NCT01345669|530802806|FG000|Overall Study|Adverse Event|63|||
147174939|NCT01345669|530802807|FG001|Overall Study|Adverse Event|9|||
147174940|NCT01345669|530802806|FG000|Overall Study|Protocol Violation|3|||
147324330|NCT03251378|531352495|FG001|Overall Study|Patient withdrew consent and refused to provide follow-up information|0|||
147324331|NCT03251378|531352496|FG002|Overall Study|Patient withdrew consent and refused to provide follow-up information|0|||
147174941|NCT01345669|530802807|FG001|Overall Study|Protocol Violation|1|||
147174942|NCT01345669|530802806|FG000|Overall Study|Lost to Follow-up|1|||
147174943|NCT01345669|530802807|FG001|Overall Study|Lost to Follow-up|1|||
147174944|NCT01345669|530802806|FG000|Overall Study|Withdrawal by Subject|52|||
147174945|NCT01345669|530802807|FG001|Overall Study|Withdrawal by Subject|13|||
147174946|NCT01345669|530802806|FG000|Overall Study|Other Reasons|111|||
147174947|NCT01345669|530802807|FG001|Overall Study|Other Reasons|60|||
147174948|NCT03343626|530804290|FG000|Overall Study|Lost to Follow-up|4|||
147174949|NCT03343626|530804291|FG001|Overall Study|Lost to Follow-up|3|||
147174950|NCT03343626|530804292|FG002|Overall Study|Lost to Follow-up|2|||
147174951|NCT03343626|530804293|FG003|Overall Study|Lost to Follow-up|5|||
147174952|NCT03343626|530804294|FG004|Overall Study|Lost to Follow-up|4|||
147174953|NCT03343626|530804295|FG005|Overall Study|Lost to Follow-up|4|||
147174954|NCT03343626|530804296|FG006|Overall Study|Lost to Follow-up|4|||
147174955|NCT03343626|530804297|FG007|Overall Study|Lost to Follow-up|7|||
147174956|NCT03343626|530804290|FG000|Overall Study|Withdrawal of Consent|2|||
147174957|NCT03343626|530804291|FG001|Overall Study|Withdrawal of Consent|1|||
147174958|NCT03343626|530804292|FG002|Overall Study|Withdrawal of Consent|0|||
147174959|NCT03343626|530804293|FG003|Overall Study|Withdrawal of Consent|3|||
147174960|NCT03343626|530804294|FG004|Overall Study|Withdrawal of Consent|3|||
147174961|NCT03343626|530804295|FG005|Overall Study|Withdrawal of Consent|1|||
147174962|NCT03343626|530804296|FG006|Overall Study|Withdrawal of Consent|1|||
147174963|NCT03343626|530804297|FG007|Overall Study|Withdrawal of Consent|2|||
147174964|NCT03343626|530804290|FG000|Overall Study|Reason not Specified|0|||
147174965|NCT03343626|530804291|FG001|Overall Study|Reason not Specified|1|||
147174966|NCT03343626|530804292|FG002|Overall Study|Reason not Specified|0|||
147174967|NCT03343626|530804293|FG003|Overall Study|Reason not Specified|0|||
147174968|NCT03343626|530804294|FG004|Overall Study|Reason not Specified|0|||
147174969|NCT03343626|530804295|FG005|Overall Study|Reason not Specified|0|||
147174970|NCT03343626|530804296|FG006|Overall Study|Reason not Specified|0|||
147174971|NCT03343626|530804297|FG007|Overall Study|Reason not Specified|1|||
147174972|NCT03343626|530804290|FG000|Overall Study|Data Entry Error|0|||
147174973|NCT03343626|530804291|FG001|Overall Study|Data Entry Error|0|||
147174974|NCT03343626|530804292|FG002|Overall Study|Data Entry Error|0|||
147174975|NCT03343626|530804293|FG003|Overall Study|Data Entry Error|0|||
147174976|NCT03343626|530804294|FG004|Overall Study|Data Entry Error|0|||
147174977|NCT03343626|530804295|FG005|Overall Study|Data Entry Error|0|||
147174978|NCT03343626|530804296|FG006|Overall Study|Data Entry Error|0|||
147244566|NCT02042183|531068933|FG000|Overall Study|Withdrawal by Subject|21|||
147244567|NCT02042183|531068934|FG001|Overall Study|Withdrawal by Subject|16|||
147244568|NCT02042183|531068933|FG000|Overall Study|Site Terminated by Sponsor|2|||
147244569|NCT02042183|531068934|FG001|Overall Study|Site Terminated by Sponsor|1|||
147244570|NCT02042183|531068933|FG000|Overall Study|Lost to Follow-up|9|||
147244571|NCT02042183|531068934|FG001|Overall Study|Lost to Follow-up|2|||
147244572|NCT01192516|531068937|FG000|Overall Study|Lost to Follow-up|7|||
147244573|NCT01192516|531068938|FG001|Overall Study|Lost to Follow-up|10|||
147324332|NCT03251378|531352497|FG003|Overall Study|Patient withdrew consent and refused to provide follow-up information|3|||
147324333|NCT03251378|531352498|FG004|Overall Study|Patient withdrew consent and refused to provide follow-up information|2|||
147324334|NCT03251378|531352499|FG005|Overall Study|Patient withdrew consent and refused to provide follow-up information|1|||
147324335|NCT03251378|531352500|FG006|Overall Study|Patient withdrew consent and refused to provide follow-up information|1|||
147324336|NCT03251378|531352494|FG000|Overall Study|Progressive disease|2|||
147324337|NCT03251378|531352495|FG001|Overall Study|Progressive disease|0|||
147324338|NCT03251378|531352496|FG002|Overall Study|Progressive disease|0|||
147324339|NCT03251378|531352497|FG003|Overall Study|Progressive disease|1|||
147324340|NCT03251378|531352498|FG004|Overall Study|Progressive disease|0|||
147324341|NCT03251378|531352499|FG005|Overall Study|Progressive disease|0|||
147324342|NCT03251378|531352500|FG006|Overall Study|Progressive disease|0|||
147448290|NCT00879645|531805674|FG002|Overall Study|Adverse Event|0|||
147174979|NCT03343626|530804297|FG007|Overall Study|Data Entry Error|1|||
147174980|NCT01487265|530804301|FG000|Overall Study|Adverse Event|8|||
147174981|NCT01487265|530804301|FG000|Overall Study|Withdrawal by Subject|5|||
147174982|NCT01487265|530804301|FG000|Overall Study|Disease Progression|21|||
147174983|NCT01487265|530804301|FG000|Overall Study|Death|2|||
147174984|NCT01487265|530804301|FG000|Overall Study|Still on Treatment|1|||
147244574|NCT01192516|531068939|FG002|Overall Study|Lost to Follow-up|7|||
147324343|NCT03251378|531352494|FG000|Overall Study|Physician Decision|0|||
147324344|NCT03251378|531352495|FG001|Overall Study|Physician Decision|2|||
147324345|NCT03251378|531352496|FG002|Overall Study|Physician Decision|0|||
147174985|NCT01618695|530804302|FG000|Core Phase|Adverse Event|4|||
147174986|NCT01618695|530804303|FG001|Core Phase|Adverse Event|5|||
147174987|NCT01618695|530804304|FG002|Core Phase|Adverse Event|15|||
147174988|NCT01618695|530804305|FG003|Core Phase|Adverse Event|20|||
147174989|NCT01618695|530804302|FG000|Core Phase|Lost to Follow-up|0|||
147244575|NCT01192516|531068937|FG000|Overall Study|Withdrawal by Subject|4|||
147592917|NCT00958126|532326889|FG002|Overall Study|Serious Adverse Event|0|||
147592918|NCT00958126|532326890|FG003|Overall Study|Serious Adverse Event|0|||
147174990|NCT01618695|530804303|FG001|Core Phase|Lost to Follow-up|0|||
147174991|NCT01618695|530804304|FG002|Core Phase|Lost to Follow-up|1|||
147174992|NCT01618695|530804305|FG003|Core Phase|Lost to Follow-up|0|||
147174993|NCT01618695|530804302|FG000|Core Phase|Withdrawal by Subject|16|||
147174994|NCT01618695|530804303|FG001|Core Phase|Withdrawal by Subject|11|||
147174995|NCT01618695|530804304|FG002|Core Phase|Withdrawal by Subject|9|||
147174996|NCT01618695|530804305|FG003|Core Phase|Withdrawal by Subject|13|||
147174997|NCT01618695|530804302|FG000|Core Phase|Pregnancy|2|||
147174998|NCT01618695|530804303|FG001|Core Phase|Pregnancy|0|||
147174999|NCT01618695|530804304|FG002|Core Phase|Pregnancy|0|||
147175000|NCT01618695|530804305|FG003|Core Phase|Pregnancy|0|||
147175001|NCT01618695|530804302|FG000|Core Phase|Lack of Efficacy|1|||
147175002|NCT01618695|530804303|FG001|Core Phase|Lack of Efficacy|2|||
147175003|NCT01618695|530804304|FG002|Core Phase|Lack of Efficacy|1|||
147175004|NCT01618695|530804305|FG003|Core Phase|Lack of Efficacy|1|||
147175005|NCT01618695|530804302|FG000|Core Phase|Other than specified|1|||
147175006|NCT01618695|530804303|FG001|Core Phase|Other than specified|2|||
147175007|NCT01618695|530804304|FG002|Core Phase|Other than specified|2|||
147175008|NCT01618695|530804305|FG003|Core Phase|Other than specified|2|||
147175009|NCT01618695|530804302|FG000|Core Phase|Not treated|1|||
147175010|NCT01618695|530804303|FG001|Core Phase|Not treated|0|||
147175011|NCT01618695|530804304|FG002|Core Phase|Not treated|2|||
147175012|NCT01618695|530804305|FG003|Core Phase|Not treated|0|||
147175013|NCT01618695|530804302|FG000|Extension Phase|Lack of Efficacy|17|||
147175014|NCT01618695|530804303|FG001|Extension Phase|Lack of Efficacy|33|||
147175015|NCT01618695|530804304|FG002|Extension Phase|Lack of Efficacy|26|||
147175016|NCT01618695|530804305|FG003|Extension Phase|Lack of Efficacy|24|||
147175017|NCT01618695|530804302|FG000|Extension Phase|Pregnancy|2|||
147175018|NCT01618695|530804303|FG001|Extension Phase|Pregnancy|0|||
147175019|NCT01618695|530804304|FG002|Extension Phase|Pregnancy|1|||
147175020|NCT01618695|530804305|FG003|Extension Phase|Pregnancy|1|||
147175021|NCT01618695|530804302|FG000|Extension Phase|Withdrawal by Subject|43|||
147175022|NCT01618695|530804303|FG001|Extension Phase|Withdrawal by Subject|48|||
147175023|NCT01618695|530804304|FG002|Extension Phase|Withdrawal by Subject|42|||
147175024|NCT01618695|530804305|FG003|Extension Phase|Withdrawal by Subject|33|||
147175025|NCT01618695|530804302|FG000|Extension Phase|Adverse Event|18|||
147175026|NCT01618695|530804303|FG001|Extension Phase|Adverse Event|16|||
147175027|NCT01618695|530804304|FG002|Extension Phase|Adverse Event|9|||
147175028|NCT01618695|530804305|FG003|Extension Phase|Adverse Event|20|||
147175029|NCT01618695|530804302|FG000|Extension Phase|Lost to Follow-up|2|||
147175030|NCT01618695|530804303|FG001|Extension Phase|Lost to Follow-up|1|||
147175031|NCT01618695|530804304|FG002|Extension Phase|Lost to Follow-up|1|||
147175032|NCT01618695|530804305|FG003|Extension Phase|Lost to Follow-up|1|||
147175033|NCT01618695|530804302|FG000|Extension Phase|Other than specified|13|||
147175034|NCT01618695|530804303|FG001|Extension Phase|Other than specified|18|||
147175035|NCT01618695|530804304|FG002|Extension Phase|Other than specified|13|||
147175036|NCT01618695|530804305|FG003|Extension Phase|Other than specified|18|||
147175037|NCT02291419|530804306|FG000|Overall Study|Early study termination|1|||
147175038|NCT02291419|530804307|FG001|Overall Study|Early study termination|5|||
147175039|NCT01732770|530804312|FG000|Overall Study|Lost to Follow-up|2|||
147175040|NCT01732770|530804313|FG001|Overall Study|Lost to Follow-up|3|||
147175041|NCT01732770|530804312|FG000|Overall Study|Withdrawal by Subject|5|||
147175042|NCT01732770|530804313|FG001|Overall Study|Withdrawal by Subject|3|||
147244576|NCT01192516|531068938|FG001|Overall Study|Withdrawal by Subject|4|||
147244577|NCT01192516|531068939|FG002|Overall Study|Withdrawal by Subject|1|||
147244578|NCT01192516|531068937|FG000|Overall Study|started new treatment|5|||
147244579|NCT01192516|531068938|FG001|Overall Study|started new treatment|1|||
147244580|NCT01192516|531068939|FG002|Overall Study|started new treatment|0|||
147244581|NCT01192516|531068937|FG000|Overall Study|Unable to follow Actiwatch instructions|4|||
147244582|NCT01192516|531068938|FG001|Overall Study|Unable to follow Actiwatch instructions|2|||
147244583|NCT01192516|531068939|FG002|Overall Study|Unable to follow Actiwatch instructions|0|||
147592919|NCT00958126|532326891|FG004|Overall Study|Serious Adverse Event|0|||
147592920|NCT00958126|532326892|FG005|Overall Study|Serious Adverse Event|0|||
147175043|NCT01732770|530804312|FG000|Overall Study|Decision by Sponsor|2|||
147175044|NCT01732770|530804313|FG001|Overall Study|Decision by Sponsor|2|||
147175045|NCT01732770|530804312|FG000|Overall Study|Death|1|||
147175046|NCT01732770|530804313|FG001|Overall Study|Death|0|||
147175047|NCT03828617|530804319|FG000|Overall Study|Lost to Follow-up|22|||
147175048|NCT03828617|530804320|FG001|Overall Study|Lost to Follow-up|12|||
147175049|NCT03828617|530804321|FG002|Overall Study|Lost to Follow-up|23|||
147175050|NCT03828617|530804322|FG003|Overall Study|Lost to Follow-up|7|||
147175051|NCT03828617|530804319|FG000|Overall Study|No longer met eligibility criteria|0|||
147175052|NCT03828617|530804320|FG001|Overall Study|No longer met eligibility criteria|1|||
147175053|NCT03828617|530804321|FG002|Overall Study|No longer met eligibility criteria|1|||
147175054|NCT03828617|530804322|FG003|Overall Study|No longer met eligibility criteria|3|||
147175055|NCT03828617|530804319|FG000|Overall Study|Protocol Violation|0|||
147244584|NCT02321800|531068940|FG000|Overall Study|Withdrawal by Subject|3|||
147244585|NCT02321800|531068941|FG001|Overall Study|Withdrawal by Subject|3|||
147244586|NCT02321800|531068940|FG000|Overall Study|Death|1|||
147244587|NCT02321800|531068941|FG001|Overall Study|Death|0|||
147244588|NCT02321800|531068940|FG000|Overall Study|Protocol Violation|1|||
147244589|NCT02321800|531068941|FG001|Overall Study|Protocol Violation|0|||
147244590|NCT02321800|531068940|FG000|Overall Study|Lost to Follow-up|10|||
147244591|NCT02321800|531068941|FG001|Overall Study|Lost to Follow-up|4|||
147244592|NCT02321800|531068940|FG000|Overall Study|Adverse Event|2|||
147244593|NCT02321800|531068941|FG001|Overall Study|Adverse Event|3|||
147244594|NCT02321800|531068940|FG000|Overall Study|Other, Miscellaneous|3|||
147244595|NCT02321800|531068941|FG001|Overall Study|Other, Miscellaneous|1|||
147244596|NCT01051323|531068942|FG000|Overall Study|Discontinuation of treatment|103|||
147244597|NCT01051323|531068942|FG000|Overall Study|Transplantation|28|||
147244598|NCT01051323|531068942|FG000|Overall Study|Dialysis dependency|22|||
147244599|NCT01051323|531068942|FG000|Overall Study|Withdrawal by Subject|13|||
147244600|NCT01051323|531068942|FG000|Overall Study|Lost to Follow-up|31|||
147244601|NCT01051323|531068942|FG000|Overall Study|Death|129|||
147244602|NCT01051323|531068942|FG000|Overall Study|Hospitalization|28|||
147244603|NCT01051323|531068942|FG000|Overall Study|Other|148|||
147244604|NCT01051323|531068942|FG000|Overall Study|Missing|37|||
147244605|NCT04605484|531068944|FG000|Overall Study|Lost to Follow-up|0|||
147244606|NCT04605484|531068945|FG001|Overall Study|Lost to Follow-up|1|||
147244607|NCT04605484|531068946|FG002|Overall Study|Lost to Follow-up|1|||
147244608|NCT04605484|531068944|FG000|Overall Study|Other|0|||
147244609|NCT04605484|531068945|FG001|Overall Study|Other|1|||
147244610|NCT04605484|531068946|FG002|Overall Study|Other|0|||
147244611|NCT04171531|531068949|FG000|Overall Study|Lost to Follow-up|4|||
147244612|NCT04171531|531068950|FG001|Overall Study|Lost to Follow-up|5|||
147244613|NCT04171531|531068949|FG000|Overall Study|Consent only through 6 months|1|||
147244614|NCT04171531|531068950|FG001|Overall Study|Consent only through 6 months|1|||
147244615|NCT04171531|531068949|FG000|Overall Study|Insurance did not cover procedure|0|||
147244616|NCT04171531|531068950|FG001|Overall Study|Insurance did not cover procedure|1|||
147244617|NCT04171531|531068949|FG000|Overall Study|Physician Decision|0|||
147244618|NCT04171531|531068950|FG001|Overall Study|Physician Decision|3|||
147244619|NCT04171531|531068949|FG000|Overall Study|Withdrawal by Subject|1|||
147244620|NCT04171531|531068950|FG001|Overall Study|Withdrawal by Subject|5|||
147244621|NCT04862585|531068954|FG000|Overall Study|two subjects withdrew due to perceived side effects of premedications|2|||
147244622|NCT04862585|531068955|FG001|Overall Study|two subjects withdrew due to perceived side effects of premedications|0|||
147244623|NCT04862585|531068954|FG000|Overall Study|five subjects withdrew due to what they considered to be an unfavorable randomization assignment|2|||
147244624|NCT04862585|531068955|FG001|Overall Study|five subjects withdrew due to what they considered to be an unfavorable randomization assignment|3|||
147244625|NCT04862585|531068954|FG000|Overall Study|one subject discontinued paclitaxel due to toxicity|0|||
147244626|NCT04862585|531068955|FG001|Overall Study|one subject discontinued paclitaxel due to toxicity|1|||
147244627|NCT04862585|531068954|FG000|Overall Study|one withdrew without providing a reason|0|||
147244628|NCT04862585|531068955|FG001|Overall Study|one withdrew without providing a reason|1|||
147244629|NCT03366337|531068958|FG000|Overall Study|Lost to Follow-up|1|||
147244630|NCT03366337|531068959|FG001|Overall Study|Lost to Follow-up|0|||
147244631|NCT03366337|531068960|FG002|Overall Study|Lost to Follow-up|1|||
147244632|NCT03366337|531068961|FG003|Overall Study|Lost to Follow-up|0|||
147244633|NCT03366337|531068958|FG000|Overall Study|Withdrawal by Subject|2|||
147244634|NCT03366337|531068959|FG001|Overall Study|Withdrawal by Subject|0|||
147244635|NCT03366337|531068960|FG002|Overall Study|Withdrawal by Subject|1|||
147244636|NCT03366337|531068961|FG003|Overall Study|Withdrawal by Subject|1|||
147244637|NCT05288062|531068962|FG000|Overall Study|Ineligible|0|||
147244638|NCT05288062|531068963|FG001|Overall Study|Ineligible|0|||
147244639|NCT05288062|531068964|FG002|Overall Study|Ineligible|1|||
147244640|NCT05288062|531068965|FG003|Overall Study|Ineligible|0|||
147244641|NCT05288062|531068962|FG000|Overall Study|Withdrawal by Subject|0|||
147244642|NCT05288062|531068963|FG001|Overall Study|Withdrawal by Subject|0|||
147244643|NCT05288062|531068964|FG002|Overall Study|Withdrawal by Subject|1|||
147244644|NCT05288062|531068965|FG003|Overall Study|Withdrawal by Subject|0|||
147244645|NCT01025752|531068969|FG000|Overall Study|Lost to Follow-up|7|||
147244646|NCT01025752|531068970|FG001|Overall Study|Lost to Follow-up|10|||
147244647|NCT01025752|531068969|FG000|Overall Study|Physician Decision|1|||
147244648|NCT01025752|531068970|FG001|Overall Study|Physician Decision|3|||
147244649|NCT01537393|531068973|FG000|Overall Study|Exclude prior to study|32|||
147244650|NCT01537393|531068974|FG001|Overall Study|Exclude prior to study|44|||
147244651|NCT01537393|531068973|FG000|Overall Study|Death|20|||
147244652|NCT01537393|531068974|FG001|Overall Study|Death|32|||
147244653|NCT01537393|531068973|FG000|Overall Study|Withdrawal by Subject|18|||
147244654|NCT01537393|531068974|FG001|Overall Study|Withdrawal by Subject|17|||
147244655|NCT01537393|531068973|FG000|Overall Study|Lost to Follow-up|53|||
147244656|NCT01537393|531068974|FG001|Overall Study|Lost to Follow-up|48|||
147244657|NCT01537393|531068973|FG000|Overall Study|Failure - Regrafted|28|||
147244658|NCT01537393|531068974|FG001|Overall Study|Failure - Regrafted|43|||
147244659|NCT01537393|531068973|FG000|Overall Study|Failure - Not regrafted|2|||
147244660|NCT01537393|531068974|FG001|Overall Study|Failure - Not regrafted|6|||
147175056|NCT03828617|530804320|FG001|Overall Study|Protocol Violation|2|||
147175057|NCT03828617|530804321|FG002|Overall Study|Protocol Violation|0|||
147175058|NCT03828617|530804322|FG003|Overall Study|Protocol Violation|0|||
147175059|NCT03828617|530804319|FG000|Overall Study|Withdrawal by Subject|2|||
147175060|NCT03828617|530804320|FG001|Overall Study|Withdrawal by Subject|0|||
147175061|NCT03828617|530804321|FG002|Overall Study|Withdrawal by Subject|2|||
147175062|NCT03828617|530804322|FG003|Overall Study|Withdrawal by Subject|0|||
147175063|NCT01271725|530804323|FG000|Part A|Progressive disease according to RECIST|8|||
147592921|NCT00958126|532326893|FG006|Overall Study|Serious Adverse Event|1|||
147592922|NCT00958126|532326894|FG007|Overall Study|Serious Adverse Event|0|||
147592923|NCT00958126|532326887|FG000|Overall Study|Withdrawal by Subject|0|||
147592924|NCT00958126|532326888|FG001|Overall Study|Withdrawal by Subject|2|||
147175064|NCT01271725|530804324|FG001|Part A|Progressive disease according to RECIST|0|||
147175065|NCT01271725|530804323|FG000|Part A|Clinical signs/symptoms of progression|2|||
147175066|NCT01271725|530804324|FG001|Part A|Clinical signs/symptoms of progression|0|||
147175067|NCT01271725|530804323|FG000|Part A|Other Adverse Event|8|||
147175068|NCT01271725|530804324|FG001|Part A|Other Adverse Event|0|||
147175069|NCT01271725|530804323|FG000|Part A|Lost to Follow-up|1|||
147175070|NCT01271725|530804324|FG001|Part A|Lost to Follow-up|0|||
147175071|NCT01271725|530804323|FG000|Part A|Withdrawal by Subject|12|||
147175072|NCT01271725|530804324|FG001|Part A|Withdrawal by Subject|0|||
147592925|NCT00958126|532326889|FG002|Overall Study|Withdrawal by Subject|0|||
147592926|NCT00958126|532326890|FG003|Overall Study|Withdrawal by Subject|0|||
147592927|NCT00958126|532326891|FG004|Overall Study|Withdrawal by Subject|0|||
147592928|NCT00958126|532326892|FG005|Overall Study|Withdrawal by Subject|0|||
147175073|NCT01271725|530804323|FG000|Part A|Other than specified|3|||
147175074|NCT01271725|530804324|FG001|Part A|Other than specified|0|||
147175075|NCT01271725|530804323|FG000|Part A|Protocol Violation|1|||
147175076|NCT01271725|530804324|FG001|Part A|Protocol Violation|0|||
147175077|NCT01271725|530804323|FG000|Part B|Other than specified|0|||
147175078|NCT01271725|530804324|FG001|Part B|Other than specified|2|||
147175079|NCT01271725|530804323|FG000|Part B|Clinical signs/symptoms of progression|0|||
147175080|NCT01271725|530804324|FG001|Part B|Clinical signs/symptoms of progression|2|||
147175081|NCT01271725|530804323|FG000|Part B|Other Adverse Event|0|||
147175082|NCT01271725|530804324|FG001|Part B|Other Adverse Event|1|||
147175083|NCT01271725|530804323|FG000|Part B|Protocol Violation|0|||
147175084|NCT01271725|530804324|FG001|Part B|Protocol Violation|1|||
147175085|NCT01271725|530804323|FG000|Part B|Withdrawal by Subject|0|||
147175086|NCT01271725|530804324|FG001|Part B|Withdrawal by Subject|6|||
147175087|NCT02950480|530804327|FG000|Overall Study|Withdrawal by Subject|1|||
147175088|NCT02950480|530804328|FG001|Overall Study|Withdrawal by Subject|0|||
147175089|NCT01835223|530804335|FG000|Overall Study|Adverse Event|1|||
147175090|NCT01835223|530804336|FG001|Overall Study|Adverse Event|0|||
147175091|NCT01835223|530804335|FG000|Overall Study|Withdrawal by Subject|2|||
147175092|NCT01835223|530804336|FG001|Overall Study|Withdrawal by Subject|0|||
147175093|NCT01835223|530804335|FG000|Overall Study|Disease progression|2|||
147175094|NCT01835223|530804336|FG001|Overall Study|Disease progression|1|||
147175095|NCT01835223|530804335|FG000|Overall Study|Became Inelligible|4|||
147175096|NCT01835223|530804336|FG001|Overall Study|Became Inelligible|0|||
147175097|NCT03149055|530804337|FG000|Overall Study|Not treated|4|||
147175098|NCT02630472|530804338|FG000|Overall Study|Physician Decision|10|||
147175099|NCT02630472|530804339|FG001|Overall Study|Physician Decision|0|||
147175100|NCT01279616|530804340|FG000|Overall Study|donor could not be located|5|||
147175101|NCT01279616|530804340|FG000|Overall Study|no signs of sickle cell disease|2|||
147175102|NCT00413036|530804341|FG000|Overall Study|Adverse Event|44|||
147175103|NCT00413036|530804341|FG000|Overall Study|Lack of Efficacy|129|||
147175104|NCT00413036|530804341|FG000|Overall Study|Withdrawal by Subject|7|||
147175105|NCT00413036|530804341|FG000|Overall Study|Death|9|||
147175106|NCT00413036|530804341|FG000|Overall Study|Other|26|||
147175107|NCT00413036|530804341|FG000|Overall Study|Missing|2|||
147244661|NCT01537393|531068973|FG000|Overall Study|Censored (severe event unrelated to PT)|1|||
147592929|NCT00958126|532326893|FG006|Overall Study|Withdrawal by Subject|0|||
147175108|NCT00183625|530804342|FG000|Overall Study|Withdrawal by Subject|18|||
147175109|NCT00183625|530804343|FG001|Overall Study|Withdrawal by Subject|18|||
147175110|NCT00183625|530804344|FG002|Overall Study|Withdrawal by Subject|19|||
147175111|NCT00183625|530804345|FG003|Overall Study|Withdrawal by Subject|14|||
147175112|NCT01483183|530804350|FG000|Overall Study|Physician Decision|0|||
147175113|NCT01483183|530804351|FG001|Overall Study|Physician Decision|0|||
147175114|NCT01483183|530804352|FG002|Overall Study|Physician Decision|0|||
147175115|NCT01483183|530804353|FG003|Overall Study|Physician Decision|0|||
147175116|NCT01483183|530804354|FG004|Overall Study|Physician Decision|0|||
147175117|NCT01483183|530804355|FG005|Overall Study|Physician Decision|0|||
147175118|NCT01483183|530804356|FG006|Overall Study|Physician Decision|2|||
147175119|NCT01483183|530804357|FG007|Overall Study|Physician Decision|0|||
147324346|NCT03251378|531352497|FG003|Overall Study|Physician Decision|0|||
147175120|NCT01483183|530804358|FG008|Overall Study|Physician Decision|0|||
147175121|NCT01483183|530804359|FG009|Overall Study|Physician Decision|0|||
147175122|NCT01483183|530804350|FG000|Overall Study|Withdrawal by Subject|0|||
147592930|NCT00958126|532326894|FG007|Overall Study|Withdrawal by Subject|0|||
147592931|NCT00958126|532326887|FG000|Overall Study|Moved away from study area|0|||
147592932|NCT00958126|532326888|FG001|Overall Study|Moved away from study area|0|||
147592933|NCT00958126|532326889|FG002|Overall Study|Moved away from study area|1|||
147592934|NCT00958126|532326890|FG003|Overall Study|Moved away from study area|1|||
147592935|NCT00958126|532326891|FG004|Overall Study|Moved away from study area|0|||
147592936|NCT00958126|532326892|FG005|Overall Study|Moved away from study area|0|||
147592937|NCT00958126|532326893|FG006|Overall Study|Moved away from study area|0|||
147592938|NCT00958126|532326894|FG007|Overall Study|Moved away from study area|0|||
147592939|NCT00958126|532326887|FG000|Overall Study|Lost to Follow-up|1|||
147592940|NCT00958126|532326888|FG001|Overall Study|Lost to Follow-up|5|||
147592941|NCT00958126|532326889|FG002|Overall Study|Lost to Follow-up|9|||
147592942|NCT00958126|532326890|FG003|Overall Study|Lost to Follow-up|8|||
147592943|NCT00958126|532326891|FG004|Overall Study|Lost to Follow-up|0|||
147175123|NCT01483183|530804351|FG001|Overall Study|Withdrawal by Subject|0|||
147175124|NCT01483183|530804352|FG002|Overall Study|Withdrawal by Subject|0|||
147175125|NCT01483183|530804353|FG003|Overall Study|Withdrawal by Subject|0|||
147175126|NCT01483183|530804354|FG004|Overall Study|Withdrawal by Subject|0|||
147175127|NCT01483183|530804355|FG005|Overall Study|Withdrawal by Subject|0|||
147175128|NCT01483183|530804356|FG006|Overall Study|Withdrawal by Subject|0|||
147175129|NCT01483183|530804357|FG007|Overall Study|Withdrawal by Subject|0|||
147175130|NCT01483183|530804358|FG008|Overall Study|Withdrawal by Subject|0|||
147175131|NCT01483183|530804359|FG009|Overall Study|Withdrawal by Subject|1|||
147175132|NCT00239928|530804360|FG000|Overall Study|Lack of Efficacy|1|||
147175133|NCT00239928|530804360|FG000|Overall Study|Adverse Event|4|||
147175134|NCT00239928|530804360|FG000|Overall Study|Not need to continue study|3|||
147175135|NCT00239928|530804360|FG000|Overall Study|Withdrawal by Subject|2|||
147175136|NCT04869358|530804366|FG000|Overall Study|Wish to have children.|1|||
147175137|NCT04869358|530804367|FG001|Overall Study|Wish to have children.|0|||
147175138|NCT04869358|530804368|FG002|Overall Study|Wish to have children.|0|||
147175139|NCT04869358|530804369|FG003|Overall Study|Wish to have children.|0|||
147175140|NCT03550404|530804375|FG000|Phase 2|Unable to complete due to other duties during COVID-19 pandemic|3|||
147175141|NCT03550404|530804376|FG001|Phase 2|Unable to complete due to other duties during COVID-19 pandemic|0|||
147175142|NCT03550404|530804377|FG002|Phase 2|Unable to complete due to other duties during COVID-19 pandemic|0|||
147175143|NCT03550404|530804375|FG000|Phase 2|Vacated position|1|||
147175144|NCT03550404|530804376|FG001|Phase 2|Vacated position|0|||
147175145|NCT03550404|530804377|FG002|Phase 2|Vacated position|0|||
147175146|NCT00820222|530804378|FG000|Overall Study|Lost to Follow-up|10|||
147175147|NCT00820222|530804379|FG001|Overall Study|Lost to Follow-up|9|||
147175148|NCT00820222|530804378|FG000|Overall Study|Withdrawal by Subject|19|||
147175149|NCT00820222|530804379|FG001|Overall Study|Withdrawal by Subject|21|||
147175150|NCT00820222|530804378|FG000|Overall Study|Physician Decision|93|||
147175151|NCT00820222|530804379|FG001|Overall Study|Physician Decision|88|||
147175152|NCT00820222|530804378|FG000|Overall Study|Sponsor Terminated Study|43|||
147175153|NCT00820222|530804379|FG001|Overall Study|Sponsor Terminated Study|65|||
147175154|NCT00820222|530804378|FG000|Overall Study|Unkown|11|||
147175155|NCT00820222|530804379|FG001|Overall Study|Unkown|7|||
147175156|NCT02690714|530804380|FG000|Post-Wk 48: Safety Week 48 to EoS Visit|Physician Decision|1|||
147175157|NCT02690714|530804380|FG000|Post-Wk 48: Safety Week 48 to EoS Visit|Withdrawal by Subject|1|||
147175158|NCT01361178|530804381|FG000|Overall Study|Death|13|||
147175159|NCT01361178|530804382|FG001|Overall Study|Death|0|||
147175160|NCT05392803|530804389|FG000|Overall Study|Lost to Follow-up|0|||
147175161|NCT05392803|530804390|FG001|Overall Study|Lost to Follow-up|2|||
147175162|NCT01630889|530804400|FG000|Overall Study|Death|2|||
147175163|NCT01630889|530804400|FG000|Overall Study|Withdrawal by Subject|1|||
147175164|NCT01630889|530804400|FG000|Overall Study|Other than Specified|2|||
147175165|NCT01630889|530804400|FG000|Overall Study|Lost to Follow-up|4|||
147175166|NCT01630889|530804400|FG000|Overall Study|Other|1|||
147244662|NCT01537393|531068974|FG001|Overall Study|Censored (severe event unrelated to PT)|1|||
147244663|NCT01697566|531068975|FG000|Overall Study|Withdrawal by Subject|0|||
147244664|NCT01697566|531068976|FG001|Overall Study|Withdrawal by Subject|0|||
147244665|NCT01697566|531068977|FG002|Overall Study|Withdrawal by Subject|1|||
147244666|NCT01697566|531068978|FG003|Overall Study|Withdrawal by Subject|1|||
147592944|NCT00958126|532326892|FG005|Overall Study|Lost to Follow-up|0|||
147175167|NCT02974842|530804401|FG000|Overall Study|Withdrawal by Subject|4|||
147175168|NCT02974842|530804401|FG000|Overall Study|Screen failures|4|||
147175169|NCT01068158|530804407|FG000|Overall Study|Withdrawal by Subject|1|||
147592945|NCT00958126|532326893|FG006|Overall Study|Lost to Follow-up|0|||
147175170|NCT01068158|530804408|FG001|Overall Study|Withdrawal by Subject|2|||
147175171|NCT01068158|530804407|FG000|Overall Study|Lost to Follow-up|7|||
147175172|NCT01068158|530804408|FG001|Overall Study|Lost to Follow-up|0|||
147175173|NCT01068158|530804407|FG000|Overall Study|Protocol Violation|0|||
147175174|NCT01068158|530804408|FG001|Overall Study|Protocol Violation|2|||
147175175|NCT01368081|530804415|FG000|Overall Study|Adverse Event|4|||
147175176|NCT01368081|530804416|FG001|Overall Study|Adverse Event|4|||
147244667|NCT01697566|531068975|FG000|Overall Study|Final biopsy not obtained|0|||
147592946|NCT00958126|532326894|FG007|Overall Study|Lost to Follow-up|0|||
147592947|NCT00958126|532326887|FG000|Overall Study|Sponsor/Investigator decision|0|||
147175177|NCT01368081|530804417|FG002|Overall Study|Adverse Event|3|||
147175178|NCT01368081|530804418|FG003|Overall Study|Adverse Event|2|||
147175179|NCT01368081|530804419|FG004|Overall Study|Adverse Event|2|||
147175180|NCT01368081|530804420|FG005|Overall Study|Adverse Event|5|||
147175181|NCT01368081|530804421|FG006|Overall Study|Adverse Event|6|||
147175182|NCT01368081|530804422|FG007|Overall Study|Adverse Event|2|||
147175183|NCT01368081|530804423|FG008|Overall Study|Adverse Event|3|||
147175184|NCT01368081|530804424|FG009|Overall Study|Adverse Event|5|||
147175185|NCT01368081|530804425|FG010|Overall Study|Adverse Event|6|||
147175186|NCT01368081|530804426|FG011|Overall Study|Adverse Event|1|||
147175187|NCT01368081|530804427|FG012|Overall Study|Adverse Event|3|||
147175188|NCT01368081|530804415|FG000|Overall Study|Lack of Efficacy|0|||
147175189|NCT01368081|530804416|FG001|Overall Study|Lack of Efficacy|1|||
147175190|NCT01368081|530804417|FG002|Overall Study|Lack of Efficacy|0|||
147592948|NCT00958126|532326888|FG001|Overall Study|Sponsor/Investigator decision|0|||
147592949|NCT00958126|532326889|FG002|Overall Study|Sponsor/Investigator decision|0|||
147175191|NCT01368081|530804418|FG003|Overall Study|Lack of Efficacy|1|||
147175192|NCT01368081|530804419|FG004|Overall Study|Lack of Efficacy|0|||
147175193|NCT01368081|530804420|FG005|Overall Study|Lack of Efficacy|0|||
147175194|NCT01368081|530804421|FG006|Overall Study|Lack of Efficacy|0|||
147175195|NCT01368081|530804422|FG007|Overall Study|Lack of Efficacy|2|||
147175196|NCT01368081|530804423|FG008|Overall Study|Lack of Efficacy|0|||
147175197|NCT01368081|530804424|FG009|Overall Study|Lack of Efficacy|0|||
147175198|NCT01368081|530804425|FG010|Overall Study|Lack of Efficacy|0|||
147175199|NCT01368081|530804426|FG011|Overall Study|Lack of Efficacy|0|||
147175200|NCT01368081|530804427|FG012|Overall Study|Lack of Efficacy|0|||
147175201|NCT01368081|530804415|FG000|Overall Study|Protocol Violation|0|||
147175202|NCT01368081|530804416|FG001|Overall Study|Protocol Violation|0|||
147175203|NCT01368081|530804417|FG002|Overall Study|Protocol Violation|0|||
147175204|NCT01368081|530804418|FG003|Overall Study|Protocol Violation|0|||
147175205|NCT01368081|530804419|FG004|Overall Study|Protocol Violation|0|||
147175206|NCT01368081|530804420|FG005|Overall Study|Protocol Violation|1|||
147175207|NCT01368081|530804421|FG006|Overall Study|Protocol Violation|0|||
147175208|NCT01368081|530804422|FG007|Overall Study|Protocol Violation|1|||
147175209|NCT01368081|530804423|FG008|Overall Study|Protocol Violation|0|||
147175210|NCT01368081|530804424|FG009|Overall Study|Protocol Violation|0|||
147175211|NCT01368081|530804425|FG010|Overall Study|Protocol Violation|0|||
147175212|NCT01368081|530804426|FG011|Overall Study|Protocol Violation|0|||
147175213|NCT01368081|530804427|FG012|Overall Study|Protocol Violation|0|||
147175214|NCT01368081|530804415|FG000|Overall Study|Lost to Follow-up|0|||
147175215|NCT01368081|530804416|FG001|Overall Study|Lost to Follow-up|0|||
147175216|NCT01368081|530804417|FG002|Overall Study|Lost to Follow-up|0|||
147592950|NCT00958126|532326890|FG003|Overall Study|Sponsor/Investigator decision|1|||
147592951|NCT00958126|532326891|FG004|Overall Study|Sponsor/Investigator decision|0|||
147592952|NCT00958126|532326892|FG005|Overall Study|Sponsor/Investigator decision|0|||
147592953|NCT00958126|532326893|FG006|Overall Study|Sponsor/Investigator decision|0|||
147592954|NCT00958126|532326894|FG007|Overall Study|Sponsor/Investigator decision|0|||
147592955|NCT00958126|532326887|FG000|Overall Study|Other Reason|0|||
147592956|NCT00958126|532326888|FG001|Overall Study|Other Reason|0|||
147592957|NCT00958126|532326889|FG002|Overall Study|Other Reason|0|||
147592958|NCT00958126|532326890|FG003|Overall Study|Other Reason|1|||
147592959|NCT00958126|532326891|FG004|Overall Study|Other Reason|0|||
147592960|NCT00958126|532326892|FG005|Overall Study|Other Reason|1|||
147592961|NCT00958126|532326893|FG006|Overall Study|Other Reason|0|||
147592962|NCT00958126|532326894|FG007|Overall Study|Other Reason|0|||
147175217|NCT01368081|530804418|FG003|Overall Study|Lost to Follow-up|0|||
147175218|NCT01368081|530804419|FG004|Overall Study|Lost to Follow-up|0|||
147175219|NCT01368081|530804420|FG005|Overall Study|Lost to Follow-up|0|||
147175220|NCT01368081|530804421|FG006|Overall Study|Lost to Follow-up|0|||
147175221|NCT01368081|530804422|FG007|Overall Study|Lost to Follow-up|0|||
147175222|NCT01368081|530804423|FG008|Overall Study|Lost to Follow-up|0|||
147175223|NCT01368081|530804424|FG009|Overall Study|Lost to Follow-up|0|||
147592963|NCT03401073|532326895|FG000|Overall Study|Lost to Follow-up|1|||
147592964|NCT03401073|532326896|FG001|Overall Study|Lost to Follow-up|2|||
147175224|NCT01368081|530804425|FG010|Overall Study|Lost to Follow-up|0|||
147175225|NCT01368081|530804426|FG011|Overall Study|Lost to Follow-up|0|||
147592965|NCT00733369|532326897|FG000|Overall Study|Lost to Follow-up|2|||
147592966|NCT00733369|532326898|FG001|Overall Study|Lost to Follow-up|1|||
147175226|NCT01368081|530804427|FG012|Overall Study|Lost to Follow-up|1|||
147175227|NCT01368081|530804415|FG000|Overall Study|Withdrawal by Subject|4|||
147175228|NCT01368081|530804416|FG001|Overall Study|Withdrawal by Subject|4|||
147175229|NCT01368081|530804417|FG002|Overall Study|Withdrawal by Subject|1|||
147175230|NCT01368081|530804418|FG003|Overall Study|Withdrawal by Subject|1|||
147175231|NCT01368081|530804419|FG004|Overall Study|Withdrawal by Subject|0|||
147175232|NCT01368081|530804420|FG005|Overall Study|Withdrawal by Subject|3|||
147175233|NCT01368081|530804421|FG006|Overall Study|Withdrawal by Subject|4|||
147592967|NCT00733369|532326897|FG000|Overall Study|Adverse Event|4|||
147592968|NCT00733369|532326898|FG001|Overall Study|Adverse Event|4|||
147592969|NCT00733369|532326897|FG000|Overall Study|Protocol Violation|4|||
147592970|NCT00733369|532326898|FG001|Overall Study|Protocol Violation|4|||
147175234|NCT01368081|530804422|FG007|Overall Study|Withdrawal by Subject|2|||
147175235|NCT01368081|530804423|FG008|Overall Study|Withdrawal by Subject|5|||
147175236|NCT01368081|530804424|FG009|Overall Study|Withdrawal by Subject|4|||
147175237|NCT01368081|530804425|FG010|Overall Study|Withdrawal by Subject|3|||
147175238|NCT01368081|530804426|FG011|Overall Study|Withdrawal by Subject|2|||
147175239|NCT01368081|530804427|FG012|Overall Study|Withdrawal by Subject|0|||
147175240|NCT01368081|530804415|FG000|Overall Study|Other reason not defined above|2|||
147175241|NCT01368081|530804416|FG001|Overall Study|Other reason not defined above|0|||
147175242|NCT01368081|530804417|FG002|Overall Study|Other reason not defined above|0|||
147175243|NCT01368081|530804418|FG003|Overall Study|Other reason not defined above|1|||
147175244|NCT01368081|530804419|FG004|Overall Study|Other reason not defined above|0|||
147175245|NCT01368081|530804420|FG005|Overall Study|Other reason not defined above|1|||
147175246|NCT01368081|530804421|FG006|Overall Study|Other reason not defined above|2|||
147175247|NCT01368081|530804422|FG007|Overall Study|Other reason not defined above|0|||
147175248|NCT01368081|530804423|FG008|Overall Study|Other reason not defined above|0|||
147175249|NCT01368081|530804424|FG009|Overall Study|Other reason not defined above|1|||
147175250|NCT01368081|530804425|FG010|Overall Study|Other reason not defined above|0|||
147175251|NCT01368081|530804426|FG011|Overall Study|Other reason not defined above|0|||
147175252|NCT01368081|530804427|FG012|Overall Study|Other reason not defined above|3|||
147175253|NCT00238238|530804433|FG000|Overall Study|Withdrawal by Subject|0|||
147175254|NCT00238238|530804434|FG001|Overall Study|Withdrawal by Subject|3|||
147244668|NCT01697566|531068976|FG001|Overall Study|Final biopsy not obtained|0|||
147244669|NCT01697566|531068977|FG002|Overall Study|Final biopsy not obtained|1|||
147244670|NCT01697566|531068978|FG003|Overall Study|Final biopsy not obtained|0|||
147244671|NCT00459953|531068979|FG000|Overall Study|not analyzed-household member in study|1|||
147244672|NCT00459953|531068980|FG001|Overall Study|not analyzed-household member in study|1|||
147244673|NCT01447433|531068981|FG000|Overall Study|Lost to Follow-up|0|||
147244674|NCT01447433|531068982|FG001|Overall Study|Lost to Follow-up|2|||
147244675|NCT01447433|531068981|FG000|Overall Study|Withdrawal by Subject|3|||
147244676|NCT01447433|531068982|FG001|Overall Study|Withdrawal by Subject|3|||
147244677|NCT01447433|531068981|FG000|Overall Study|Protocol Violation|1|||
147244678|NCT01447433|531068982|FG001|Overall Study|Protocol Violation|1|||
147244679|NCT00036270|531068983|FG000|Randomized to Study Treatment|Withdrawal by Subject|6|||
147244680|NCT00036270|531068984|FG001|Randomized to Study Treatment|Withdrawal by Subject|7|||
147244681|NCT00036270|531068983|FG000|Study Treatment to 5 Year Report|Ongoing|1081|||
147244682|NCT00036270|531068984|FG001|Study Treatment to 5 Year Report|Ongoing|736|||
147244683|NCT00036270|531068983|FG000|Study Treatment to 5 Year Report|Disease- Free Survival (DFS) event|507|||
147244684|NCT00036270|531068984|FG001|Study Treatment to 5 Year Report|Disease- Free Survival (DFS) event|447|||
147244685|NCT00036270|531068983|FG000|Study Treatment to 5 Year Report|Adverse Event|501|||
147244686|NCT00036270|531068984|FG001|Study Treatment to 5 Year Report|Adverse Event|782|||
147244687|NCT00036270|531068983|FG000|Study Treatment to 5 Year Report|Other|277|||
147244688|NCT00036270|531068984|FG001|Study Treatment to 5 Year Report|Other|288|||
147244689|NCT00036270|531068983|FG000|Study Treatment to 5 Year Report|Treatment refusal|113|||
147244690|NCT00036270|531068984|FG001|Study Treatment to 5 Year Report|Treatment refusal|208|||
147244691|NCT00036270|531068983|FG000|Study Treatment to 5 Year Report|Randomized but not treated|46|||
147244692|NCT00036270|531068984|FG001|Study Treatment to 5 Year Report|Randomized but not treated|54|||
147244693|NCT00036270|531068983|FG000|Study Treatment to 5 Year Report|Protocol Violation|23|||
147244694|NCT00036270|531068984|FG001|Study Treatment to 5 Year Report|Protocol Violation|91|||
147244695|NCT00036270|531068983|FG000|Study Treatment to 5 Year Report|Intercurrent illness|17|||
147244696|NCT00036270|531068984|FG001|Study Treatment to 5 Year Report|Intercurrent illness|29|||
147244697|NCT00036270|531068983|FG000|Study Treatment to 5 Year Report|Too early switch|0|||
147244698|NCT00036270|531068984|FG001|Study Treatment to 5 Year Report|Too early switch|103|||
147244699|NCT00036270|531068983|FG000|Study Treatment to 5 Year Report|No/too late switch/refusal to switch|0|||
147244700|NCT00036270|531068984|FG001|Study Treatment to 5 Year Report|No/too late switch/refusal to switch|750|||
147244701|NCT01578187|531068985|FG000|Usability Phase|Withdrawal by Subject|1|||
147244702|NCT02516163|531068990|FG000|Overall Study|Withdrawal by Subject|1|||
147244703|NCT02516163|531068990|FG000|Overall Study|Failed MRI/incorrect MRI protocol|11|||
147244704|NCT02516163|531068990|FG000|Overall Study|Unfit/delay in surgery|3|||
147244705|NCT02516163|531068990|FG000|Overall Study|Use of incorrect measurement technique|5|||
147244706|NCT02516163|531068990|FG000|Overall Study|Data not recorded|2|||
147244707|NCT02516163|531068990|FG000|Overall Study|MRI contraindication exclusion|6|||
147244708|NCT01709162|531068993|FG000|Overall Study|Disease progression|3|||
147244709|NCT01709162|531068994|FG001|Overall Study|Disease progression|3|||
147244710|NCT01709162|531068993|FG000|Overall Study|Study drug toxicity|2|||
147244711|NCT01709162|531068994|FG001|Overall Study|Study drug toxicity|0|||
147175255|NCT00238238|530804435|FG002|Overall Study|Withdrawal by Subject|0|||
147175256|NCT01007838|530804439|FG000|Overall Study|Withdrawal by Subject|1|||
147244712|NCT01709162|531068993|FG000|Overall Study|Administrative reason by sponsor|0|||
147244713|NCT01709162|531068994|FG001|Overall Study|Administrative reason by sponsor|1|||
147244714|NCT01709162|531068993|FG000|Overall Study|Other|1|||
147244715|NCT01709162|531068994|FG001|Overall Study|Other|0|||
147592971|NCT01470612|532326899|FG000|Overall Study|Adverse Event|20|||
147592972|NCT01470612|532326900|FG001|Overall Study|Adverse Event|80|||
147592973|NCT01470612|532326899|FG000|Overall Study|Death|0|||
147175257|NCT01007838|530804440|FG001|Overall Study|Withdrawal by Subject|0|||
147175258|NCT01007838|530804441|FG002|Overall Study|Withdrawal by Subject|0|||
147175259|NCT01007838|530804442|FG003|Overall Study|Withdrawal by Subject|0|||
147175260|NCT01007838|530804439|FG000|Overall Study|Physician Decision|1|||
147175261|NCT01007838|530804440|FG001|Overall Study|Physician Decision|0|||
147175262|NCT01007838|530804441|FG002|Overall Study|Physician Decision|0|||
147175263|NCT01007838|530804442|FG003|Overall Study|Physician Decision|0|||
147175264|NCT01007838|530804439|FG000|Overall Study|Started home haemodialysis|1|||
147175265|NCT01007838|530804440|FG001|Overall Study|Started home haemodialysis|0|||
147175266|NCT01007838|530804441|FG002|Overall Study|Started home haemodialysis|0|||
147175267|NCT01007838|530804442|FG003|Overall Study|Started home haemodialysis|0|||
147175268|NCT02277119|530804443|FG000|Overall Study|Lack of Efficacy|1|||
147175269|NCT02277119|530804444|FG001|Overall Study|Lack of Efficacy|1|||
147175270|NCT02277119|530804445|FG002|Overall Study|Lack of Efficacy|1|||
147175271|NCT02277119|530804443|FG000|Overall Study|Protocol Violation|2|||
147175272|NCT02277119|530804444|FG001|Overall Study|Protocol Violation|3|||
147175273|NCT02277119|530804445|FG002|Overall Study|Protocol Violation|7|||
147175274|NCT04699461|530804446|FG000|Overall Study|Withdrawal by Subject|1|||
147175275|NCT04699461|530804447|FG001|Overall Study|Withdrawal by Subject|0|||
147175276|NCT04699461|530804446|FG000|Overall Study|Study termination by sponsor|2|||
147175277|NCT04699461|530804447|FG001|Overall Study|Study termination by sponsor|1|||
147175278|NCT04699461|530804446|FG000|Overall Study|Death|1|||
147175279|NCT04699461|530804447|FG001|Overall Study|Death|0|||
147175280|NCT04699461|530804446|FG000|Overall Study|Radiographic progression|0|||
147175281|NCT04699461|530804447|FG001|Overall Study|Radiographic progression|1|||
147175282|NCT02478255|530804448|FG000|Overall Study|Physician Decision|6|||
147175283|NCT02478255|530804449|FG001|Overall Study|Physician Decision|0|||
147175284|NCT02478255|530804448|FG000|Overall Study|Withdrawal by Subject|2|||
147175285|NCT02478255|530804449|FG001|Overall Study|Withdrawal by Subject|0|||
147175286|NCT03068767|530804455|FG000|Overall Study|Lost to Follow-up|7|||
147175287|NCT03068767|530804456|FG001|Overall Study|Lost to Follow-up|3|||
147175288|NCT03068767|530804455|FG000|Overall Study|Protocol Violation|3|||
147175289|NCT03068767|530804456|FG001|Overall Study|Protocol Violation|0|||
147175290|NCT01730586|530804457|FG000|Overall Study|Progressive Disease|2|||
147175291|NCT01730586|530804457|FG000|Overall Study|Inadequate Trial|8|||
147175292|NCT01730586|530804457|FG000|Overall Study|Adverse Event|2|||
147175293|NCT01730586|530804457|FG000|Overall Study|Hospice|1|||
147175294|NCT00061633|530804458|FG000|Overall Study|Adverse Event|1|||
147175295|NCT00061633|530804459|FG001|Overall Study|Adverse Event|2|||
147175296|NCT00061633|530804458|FG000|Overall Study|Withdrawal by Subject|2|||
147175297|NCT00061633|530804459|FG001|Overall Study|Withdrawal by Subject|2|||
147175298|NCT00061633|530804458|FG000|Overall Study|Lost to Follow-up|1|||
147175299|NCT00061633|530804459|FG001|Overall Study|Lost to Follow-up|4|||
147175300|NCT00061633|530804458|FG000|Overall Study|Other|1|||
147175301|NCT00061633|530804459|FG001|Overall Study|Other|1|||
147175302|NCT00061633|530804458|FG000|Overall Study|Never received study treatment|0|||
147175303|NCT00061633|530804459|FG001|Overall Study|Never received study treatment|2|||
147175304|NCT01431963|530804460|FG000|Overall Study|Adverse Event|18|||
147175305|NCT01431963|530804460|FG000|Overall Study|Lack of Efficacy|7|||
147175306|NCT01431963|530804460|FG000|Overall Study|Protocol Violation|1|||
147175307|NCT01431963|530804460|FG000|Overall Study|Protocol-defined Stopping Criteria|2|||
147175308|NCT01431963|530804460|FG000|Overall Study|Physician Decision|4|||
147175309|NCT01431963|530804460|FG000|Overall Study|Withdrawal by Subject|3|||
147175310|NCT01370265|530806232|FG000|First Intervention|Adverse Event|1|||
147175311|NCT01370265|530806233|FG001|First Intervention|Adverse Event|1|||
147175312|NCT02611817|530806234|FG000|Open-label Induction Phase|Reason not Specified|9|||
147175313|NCT02611817|530806235|FG001|Open-label Induction Phase|Reason not Specified|0|||
147175314|NCT02611817|530806236|FG002|Open-label Induction Phase|Reason not Specified|0|||
147175315|NCT02611817|530806234|FG000|Open-label Induction Phase|Lack of Efficacy|8|||
147244716|NCT01709162|531068993|FG000|Overall Study|Withdrawal by Subject|0|||
147244717|NCT01709162|531068994|FG001|Overall Study|Withdrawal by Subject|1|||
147244718|NCT01874054|531068995|FG000|Overall Study|Withdrawal by Subject|3|||
147244719|NCT01874054|531068995|FG000|Overall Study|Study Termination by Sponsor|42|||
147244720|NCT01874054|531068995|FG000|Overall Study|Lost to Follow-up|5|||
147244721|NCT01874054|531068995|FG000|Overall Study|Death|5|||
147244722|NCT00799422|531068999|FG000|First Week of Wear|Lost to Follow-up|0|||
147175316|NCT02611817|530806235|FG001|Open-label Induction Phase|Lack of Efficacy|0|||
147244723|NCT00799422|531069000|FG001|First Week of Wear|Lost to Follow-up|0|||
147175317|NCT02611817|530806236|FG002|Open-label Induction Phase|Lack of Efficacy|0|||
147175318|NCT02611817|530806234|FG000|Open-label Induction Phase|Pregnancy|1|||
147175319|NCT02611817|530806235|FG001|Open-label Induction Phase|Pregnancy|0|||
147175320|NCT02611817|530806236|FG002|Open-label Induction Phase|Pregnancy|0|||
147175321|NCT02611817|530806234|FG000|Open-label Induction Phase|Withdrawal by Subject|9|||
147175322|NCT02611817|530806235|FG001|Open-label Induction Phase|Withdrawal by Subject|0|||
147592974|NCT01470612|532326900|FG001|Overall Study|Death|1|||
147592975|NCT01470612|532326899|FG000|Overall Study|Lack of Efficacy|20|||
147175323|NCT02611817|530806236|FG002|Open-label Induction Phase|Withdrawal by Subject|0|||
147175324|NCT02611817|530806234|FG000|Open-label Induction Phase|Lost to Follow-up|2|||
147175325|NCT02611817|530806235|FG001|Open-label Induction Phase|Lost to Follow-up|0|||
147175326|NCT02611817|530806236|FG002|Open-label Induction Phase|Lost to Follow-up|0|||
147175327|NCT02611817|530806234|FG000|Open-label Induction Phase|Protocol Violation|5|||
147175328|NCT02611817|530806235|FG001|Open-label Induction Phase|Protocol Violation|0|||
147175329|NCT02611817|530806236|FG002|Open-label Induction Phase|Protocol Violation|0|||
147175330|NCT02611817|530806234|FG000|Open-label Induction Phase|Adverse Event|16|||
147175331|NCT02611817|530806235|FG001|Open-label Induction Phase|Adverse Event|0|||
147175332|NCT02611817|530806236|FG002|Open-label Induction Phase|Adverse Event|0|||
147175333|NCT02611817|530806234|FG000|Double-blind Maintenance Phase|Adverse Event|0|||
147175334|NCT02611817|530806235|FG001|Double-blind Maintenance Phase|Adverse Event|12|||
147175335|NCT02611817|530806236|FG002|Double-blind Maintenance Phase|Adverse Event|11|||
147175336|NCT02611817|530806234|FG000|Double-blind Maintenance Phase|Randomized but not Treated|0|||
147175337|NCT02611817|530806235|FG001|Double-blind Maintenance Phase|Randomized but not Treated|1|||
147175338|NCT02611817|530806236|FG002|Double-blind Maintenance Phase|Randomized but not Treated|0|||
147175339|NCT02611817|530806234|FG000|Double-blind Maintenance Phase|Reason not Specified|0|||
147175340|NCT02611817|530806235|FG001|Double-blind Maintenance Phase|Reason not Specified|1|||
147175341|NCT02611817|530806236|FG002|Double-blind Maintenance Phase|Reason not Specified|2|||
147175342|NCT02611817|530806234|FG000|Double-blind Maintenance Phase|Lack of Efficacy|0|||
147175343|NCT02611817|530806235|FG001|Double-blind Maintenance Phase|Lack of Efficacy|43|||
147175344|NCT02611817|530806236|FG002|Double-blind Maintenance Phase|Lack of Efficacy|78|||
147175345|NCT02611817|530806234|FG000|Double-blind Maintenance Phase|Pregnancy|0|||
147175346|NCT02611817|530806235|FG001|Double-blind Maintenance Phase|Pregnancy|0|||
147175347|NCT02611817|530806236|FG002|Double-blind Maintenance Phase|Pregnancy|1|||
147175348|NCT02611817|530806234|FG000|Double-blind Maintenance Phase|Withdrawal by Subject|0|||
147175349|NCT02611817|530806235|FG001|Double-blind Maintenance Phase|Withdrawal by Subject|5|||
147175350|NCT02611817|530806236|FG002|Double-blind Maintenance Phase|Withdrawal by Subject|14|||
147175351|NCT02611817|530806234|FG000|Double-blind Maintenance Phase|Lost to Follow-up|0|||
147175352|NCT02611817|530806235|FG001|Double-blind Maintenance Phase|Lost to Follow-up|0|||
147175353|NCT02611817|530806236|FG002|Double-blind Maintenance Phase|Lost to Follow-up|1|||
147175354|NCT03077919|530806237|FG000|Overall Study|Lost to Follow-up|4|||
147175355|NCT03077919|530806238|FG001|Overall Study|Lost to Follow-up|1|||
147175356|NCT00826618|530806239|FG000|Overall Study|Withdrawal by Subject|1|||
147175357|NCT01363661|530806246|FG000|Overall Study|Adverse Event|9|||
147175358|NCT01363661|530806247|FG001|Overall Study|Adverse Event|2|||
147175359|NCT01363661|530806246|FG000|Overall Study|Withdrawal by Subject|1|||
147175360|NCT01363661|530806247|FG001|Overall Study|Withdrawal by Subject|1|||
147175361|NCT01363661|530806246|FG000|Overall Study|Protocol Violation|1|||
147175362|NCT01363661|530806247|FG001|Overall Study|Protocol Violation|0|||
147175363|NCT01363661|530806246|FG000|Overall Study|Lost to Follow-up|3|||
147175364|NCT01363661|530806247|FG001|Overall Study|Lost to Follow-up|1|||
147175365|NCT00303485|530806254|FG000|Overall Study|Adverse Event/Intercurrent Illness|0|||
147175366|NCT00303485|530806255|FG001|Overall Study|Adverse Event/Intercurrent Illness|1|||
147175367|NCT00303485|530806254|FG000|Overall Study|Failure to return|0|||
147175368|NCT00303485|530806255|FG001|Overall Study|Failure to return|1|||
147175369|NCT00303485|530806254|FG000|Overall Study|Withdrawal by Subject|1|||
147175370|NCT00303485|530806255|FG001|Overall Study|Withdrawal by Subject|0|||
147175371|NCT01378325|530806263|FG000|Overall Study|Protocol Violation|0|||
147175372|NCT01378325|530806264|FG001|Overall Study|Protocol Violation|1|||
147175373|NCT01496469|530806267|FG000|Overall Study|Adverse Event|1|||
147175374|NCT01496469|530806268|FG001|Overall Study|Adverse Event|0|||
147175375|NCT01496469|530806267|FG000|Overall Study|Protocol Violation|2|||
147175376|NCT01496469|530806268|FG001|Overall Study|Protocol Violation|0|||
147175377|NCT01496469|530806267|FG000|Overall Study|Lost to Follow-up|1|||
147175378|NCT01496469|530806268|FG001|Overall Study|Lost to Follow-up|1|||
147175379|NCT01496469|530806267|FG000|Overall Study|Withdrawal by Subject|4|||
147175380|NCT01496469|530806268|FG001|Overall Study|Withdrawal by Subject|4|||
147175381|NCT01496469|530806267|FG000|Overall Study|BP exceeds protocol limits|1|||
147175382|NCT01496469|530806268|FG001|Overall Study|BP exceeds protocol limits|2|||
147175383|NCT01496469|530806267|FG000|Overall Study|Other|1|||
147175384|NCT01496469|530806268|FG001|Overall Study|Other|1|||
147175385|NCT00630344|530806270|FG000|Overall Study|Adverse Event|5|||
147175386|NCT00630344|530806270|FG000|Overall Study|Progressive Disease|19|||
147175387|NCT00630344|530806270|FG000|Overall Study|Physician Decision|9|||
147175388|NCT00630344|530806270|FG000|Overall Study|Withdrawal by Subject|1|||
147175389|NCT00630344|530806270|FG000|Overall Study|Intercurrent Illness|1|||
147175390|NCT00630344|530806270|FG000|Overall Study|Other|1|||
147175391|NCT01357551|530806271|FG000|Overall Study|Withdrawal by Subject|6|||
147175392|NCT01357551|530806272|FG001|Overall Study|Withdrawal by Subject|4|||
147175393|NCT01357551|530806271|FG000|Overall Study|Death|0|||
147175394|NCT01357551|530806272|FG001|Overall Study|Death|1|||
147175395|NCT01357551|530806271|FG000|Overall Study|Lost to Follow-up|16|||
147175396|NCT01357551|530806272|FG001|Overall Study|Lost to Follow-up|6|||
147175397|NCT00891228|530806275|FG000|Overall Study|Adverse Event|0|||
147175398|NCT00891228|530806276|FG001|Overall Study|Adverse Event|2|||
147175399|NCT00891228|530806277|FG002|Overall Study|Adverse Event|3|||
147175400|NCT00891228|530806275|FG000|Overall Study|Withdrawal by Subject|2|||
147175401|NCT00891228|530806276|FG001|Overall Study|Withdrawal by Subject|4|||
147175402|NCT00891228|530806277|FG002|Overall Study|Withdrawal by Subject|5|||
147175403|NCT00891228|530806275|FG000|Overall Study|Protocol Violation|3|||
147175404|NCT00891228|530806276|FG001|Overall Study|Protocol Violation|1|||
147175405|NCT00891228|530806277|FG002|Overall Study|Protocol Violation|2|||
147175406|NCT00891228|530806275|FG000|Overall Study|Physician Decision|2|||
147175407|NCT00891228|530806276|FG001|Overall Study|Physician Decision|1|||
147175408|NCT00891228|530806277|FG002|Overall Study|Physician Decision|0|||
147175409|NCT00891228|530806275|FG000|Overall Study|Lost to Follow-up|4|||
147175410|NCT00891228|530806276|FG001|Overall Study|Lost to Follow-up|4|||
147175411|NCT00891228|530806277|FG002|Overall Study|Lost to Follow-up|5|||
147175412|NCT00891228|530806275|FG000|Overall Study|Pregnancy|0|||
147175413|NCT00891228|530806276|FG001|Overall Study|Pregnancy|1|||
147175414|NCT00891228|530806277|FG002|Overall Study|Pregnancy|0|||
147175415|NCT02688985|530806286|FG000|Overall Study|Adverse Event|1|||
147175416|NCT02688985|530806287|FG001|Overall Study|Adverse Event|2|||
147175417|NCT02688985|530806288|FG002|Overall Study|Adverse Event|2|||
147175418|NCT02688985|530806289|FG003|Overall Study|Adverse Event|0|||
147175419|NCT02688985|530806290|FG004|Overall Study|Adverse Event|0|||
147175420|NCT02688985|530806286|FG000|Overall Study|Continued Onto Commercially Available Ocrelizumab|12|||
147175421|NCT02688985|530806287|FG001|Overall Study|Continued Onto Commercially Available Ocrelizumab|12|||
147175422|NCT02688985|530806288|FG002|Overall Study|Continued Onto Commercially Available Ocrelizumab|14|||
147175423|NCT02688985|530806289|FG003|Overall Study|Continued Onto Commercially Available Ocrelizumab|14|||
147175424|NCT02688985|530806290|FG004|Overall Study|Continued Onto Commercially Available Ocrelizumab|21|||
147175425|NCT02688985|530806286|FG000|Overall Study|Death|0|||
147175426|NCT02688985|530806287|FG001|Overall Study|Death|0|||
147175427|NCT02688985|530806288|FG002|Overall Study|Death|0|||
147175428|NCT02688985|530806289|FG003|Overall Study|Death|0|||
147175429|NCT02688985|530806290|FG004|Overall Study|Death|1|||
147175430|NCT02688985|530806286|FG000|Overall Study|Lack of Efficacy|0|||
147175431|NCT02688985|530806287|FG001|Overall Study|Lack of Efficacy|0|||
147175432|NCT02688985|530806288|FG002|Overall Study|Lack of Efficacy|0|||
147175433|NCT02688985|530806289|FG003|Overall Study|Lack of Efficacy|0|||
147175434|NCT02688985|530806290|FG004|Overall Study|Lack of Efficacy|1|||
147175435|NCT02688985|530806286|FG000|Overall Study|Lost to Follow-up|2|||
147175436|NCT02688985|530806287|FG001|Overall Study|Lost to Follow-up|0|||
147175437|NCT02688985|530806288|FG002|Overall Study|Lost to Follow-up|1|||
147175438|NCT02688985|530806289|FG003|Overall Study|Lost to Follow-up|1|||
147175439|NCT02688985|530806290|FG004|Overall Study|Lost to Follow-up|1|||
147175440|NCT02688985|530806286|FG000|Overall Study|Non-Compliance With Study Drug|1|||
147175441|NCT02688985|530806287|FG001|Overall Study|Non-Compliance With Study Drug|3|||
147175442|NCT02688985|530806288|FG002|Overall Study|Non-Compliance With Study Drug|1|||
147175443|NCT02688985|530806289|FG003|Overall Study|Non-Compliance With Study Drug|0|||
147175444|NCT02688985|530806290|FG004|Overall Study|Non-Compliance With Study Drug|1|||
147175445|NCT02688985|530806286|FG000|Overall Study|Other|3|||
147175446|NCT02688985|530806287|FG001|Overall Study|Other|4|||
147175447|NCT02688985|530806288|FG002|Overall Study|Other|1|||
147175448|NCT02688985|530806289|FG003|Overall Study|Other|0|||
147175449|NCT02688985|530806290|FG004|Overall Study|Other|0|||
147175450|NCT02688985|530806286|FG000|Overall Study|Physician Decision|2|||
147175451|NCT02688985|530806287|FG001|Overall Study|Physician Decision|2|||
147175452|NCT02688985|530806288|FG002|Overall Study|Physician Decision|0|||
147175453|NCT02688985|530806289|FG003|Overall Study|Physician Decision|0|||
147175454|NCT02688985|530806290|FG004|Overall Study|Physician Decision|1|||
147175455|NCT02688985|530806286|FG000|Overall Study|Pregnancy|0|||
147175456|NCT02688985|530806287|FG001|Overall Study|Pregnancy|0|||
147175457|NCT02688985|530806288|FG002|Overall Study|Pregnancy|2|||
147175458|NCT02688985|530806289|FG003|Overall Study|Pregnancy|1|||
147592976|NCT01470612|532326900|FG001|Overall Study|Lack of Efficacy|326|||
147175459|NCT02688985|530806290|FG004|Overall Study|Pregnancy|0|||
147175460|NCT02688985|530806286|FG000|Overall Study|Study Terminated By Sponsor|0|||
147175461|NCT02688985|530806287|FG001|Overall Study|Study Terminated By Sponsor|0|||
147175462|NCT02688985|530806288|FG002|Overall Study|Study Terminated By Sponsor|0|||
147175463|NCT02688985|530806289|FG003|Overall Study|Study Terminated By Sponsor|1|||
147175464|NCT02688985|530806290|FG004|Overall Study|Study Terminated By Sponsor|0|||
147175465|NCT02688985|530806286|FG000|Overall Study|Withdrawal by Subject|2|||
147175466|NCT02688985|530806287|FG001|Overall Study|Withdrawal by Subject|8|||
147175467|NCT02688985|530806288|FG002|Overall Study|Withdrawal by Subject|7|||
147175468|NCT02688985|530806289|FG003|Overall Study|Withdrawal by Subject|1|||
147175469|NCT02688985|530806290|FG004|Overall Study|Withdrawal by Subject|4|||
147175470|NCT01964963|530806293|FG000|Overall Study|Case Report Forms Uncollected|888|||
147175471|NCT01964963|530806293|FG000|Overall Study|Protocol Deviation|50|||
147175472|NCT01964963|530806293|FG000|Overall Study|Data Reliability was not Assured|5|||
147175473|NCT00930553|530806294|FG000|Overall Study|Adverse Event|1|||
147592977|NCT01470612|532326899|FG000|Overall Study|Lost to Follow-up|2|||
147175474|NCT00930553|530806294|FG000|Overall Study|Lack of Efficacy|7|||
147175475|NCT00930553|530806294|FG000|Overall Study|Physician Decision|39|||
147175476|NCT00930553|530806294|FG000|Overall Study|Protocol Violation|1|||
147175477|NCT00930553|530806294|FG000|Overall Study|Pregnancy|1|||
147175478|NCT00930553|530806294|FG000|Overall Study|Withdrawal by Subject|88|||
147175479|NCT00930553|530806294|FG000|Overall Study|Lost to Follow-up|25|||
147175480|NCT00930553|530806294|FG000|Overall Study|Death|9|||
147175481|NCT00930553|530806294|FG000|Overall Study|Study terminated by sponsor|24|||
147175482|NCT00930553|530806294|FG000|Overall Study|Other than specified above|28|||
147175483|NCT01726582|530806295|FG000|Overall Study|Physician Decision|99|||
147175484|NCT01726582|530806295|FG000|Overall Study|Death|85|||
147175485|NCT01235234|530806296|FG000|Overall Study|Adverse Event|2|||
147175486|NCT01235234|530806297|FG001|Overall Study|Adverse Event|2|||
147175487|NCT01235234|530806298|FG002|Overall Study|Adverse Event|1|||
147175488|NCT03704688|530806303|FG000|Overall Study|Adverse Event|0|||
147175489|NCT03704688|530806304|FG001|Overall Study|Adverse Event|0|||
147175490|NCT03704688|530806305|FG002|Overall Study|Adverse Event|0|||
147175491|NCT03704688|530806306|FG003|Overall Study|Adverse Event|4|||
147175492|NCT03704688|530806307|FG004|Overall Study|Adverse Event|1|||
147175493|NCT03704688|530806308|FG005|Overall Study|Adverse Event|0|||
147175494|NCT03704688|530806303|FG000|Overall Study|Disease Progression|0|||
147175495|NCT03704688|530806304|FG001|Overall Study|Disease Progression|0|||
147175496|NCT03704688|530806305|FG002|Overall Study|Disease Progression|0|||
147175497|NCT03704688|530806306|FG003|Overall Study|Disease Progression|3|||
147175498|NCT03704688|530806307|FG004|Overall Study|Disease Progression|1|||
147175499|NCT03704688|530806308|FG005|Overall Study|Disease Progression|0|||
147175500|NCT03704688|530806303|FG000|Overall Study|Death|0|||
147175501|NCT03704688|530806304|FG001|Overall Study|Death|0|||
147175502|NCT03704688|530806305|FG002|Overall Study|Death|0|||
147175503|NCT03704688|530806306|FG003|Overall Study|Death|0|||
147448291|NCT00879645|531805675|FG003|Overall Study|Adverse Event|0|||
147175504|NCT03704688|530806307|FG004|Overall Study|Death|3|||
147175505|NCT03704688|530806308|FG005|Overall Study|Death|0|||
147175506|NCT00787189|530806309|FG000|Overall Study|Lost to Follow-up|2|||
147175507|NCT00787189|530806310|FG001|Overall Study|Lost to Follow-up|2|||
147175508|NCT00847886|530806311|FG000|Overall Study|Adverse Event|0|||
147175509|NCT00847886|530806312|FG001|Overall Study|Adverse Event|1|||
147175510|NCT02462720|530806313|FG000|Part 2|Withdrawal by Subject|1|||
147175511|NCT02462720|530806314|FG001|Part 2|Withdrawal by Subject|0|||
147175512|NCT02462720|530806313|FG000|Part 2|Protocol Violation|0|||
147175513|NCT02462720|530806314|FG001|Part 2|Protocol Violation|1|||
147175514|NCT03250182|530806319|FG000|Overall Study|Withdrawal by Subject|1|||
147175515|NCT01068769|530806320|FG000|Overall Study|Ineligible|1|||
147175516|NCT03671304|530806325|FG000|Overall Study|study terminated|7|||
147175517|NCT00596830|530806326|FG000|Overall Study|Death|258|||
147175518|NCT00596830|530806327|FG001|Overall Study|Death|247|||
147175519|NCT00596830|530806326|FG000|Overall Study|Lost to Follow-up|7|||
147175520|NCT00596830|530806327|FG001|Overall Study|Lost to Follow-up|11|||
147175521|NCT00596830|530806326|FG000|Overall Study|Withdrawal by Subject|22|||
147175522|NCT00596830|530806327|FG001|Overall Study|Withdrawal by Subject|12|||
147175523|NCT00596830|530806326|FG000|Overall Study|Study terminated by sponsor|51|||
147175524|NCT00596830|530806327|FG001|Overall Study|Study terminated by sponsor|62|||
147175525|NCT00596830|530806326|FG000|Overall Study|Follow-up was discontinued|1|||
147175526|NCT00596830|530806327|FG001|Overall Study|Follow-up was discontinued|0|||
147175527|NCT00596830|530806326|FG000|Overall Study|Randomized but not treated|3|||
147175528|NCT00596830|530806327|FG001|Overall Study|Randomized but not treated|7|||
147175529|NCT00887926|530806328|FG000|Overall Study|Withdrawal by Subject|0|||
147175530|NCT00887926|530806329|FG001|Overall Study|Withdrawal by Subject|1|||
147175531|NCT00887926|530806330|FG002|Overall Study|Withdrawal by Subject|0|||
147175532|NCT00887926|530806331|FG003|Overall Study|Withdrawal by Subject|0|||
147175533|NCT02097030|530806332|FG000|First Intervention (3 Days)|Lost to Follow-up|1|||
147175534|NCT02097030|530806333|FG001|First Intervention (3 Days)|Lost to Follow-up|0|||
147175535|NCT02097030|530806332|FG000|First Intervention (3 Days)|Visual Acuity|0|||
147175536|NCT02097030|530806333|FG001|First Intervention (3 Days)|Visual Acuity|1|||
147175537|NCT00774800|530806334|FG000|Intervention 4|Withdrawal by Subject|1|||
147175538|NCT01336023|530806341|FG000|Week 0 to Week 26|Adverse Event|8|||
147175539|NCT01336023|530806342|FG001|Week 0 to Week 26|Adverse Event|10|||
147175540|NCT01336023|530806343|FG002|Week 0 to Week 26|Adverse Event|24|||
147175541|NCT01336023|530806341|FG000|Week 0 to Week 26|Lack of Efficacy|0|||
147175542|NCT01336023|530806342|FG001|Week 0 to Week 26|Lack of Efficacy|1|||
147175543|NCT01336023|530806343|FG002|Week 0 to Week 26|Lack of Efficacy|0|||
147175544|NCT01336023|530806341|FG000|Week 0 to Week 26|Protocol Violation|1|||
147592978|NCT01470612|532326900|FG001|Overall Study|Lost to Follow-up|5|||
147175545|NCT01336023|530806342|FG001|Week 0 to Week 26|Protocol Violation|2|||
147175546|NCT01336023|530806343|FG002|Week 0 to Week 26|Protocol Violation|0|||
147175547|NCT01336023|530806341|FG000|Week 0 to Week 26|Withdrawal Criteria|34|||
147175548|NCT01336023|530806342|FG001|Week 0 to Week 26|Withdrawal Criteria|69|||
147175549|NCT01336023|530806343|FG002|Week 0 to Week 26|Withdrawal Criteria|40|||
147175550|NCT01336023|530806341|FG000|Week 0 to Week 26|Unclassified|5|||
147448292|NCT00542269|531805680|FG000|Overall Study|Adverse Event|10|||
147324347|NCT03251378|531352498|FG004|Overall Study|Physician Decision|0|||
147324348|NCT03251378|531352499|FG005|Overall Study|Physician Decision|0|||
147324349|NCT03251378|531352500|FG006|Overall Study|Physician Decision|0|||
147324350|NCT03251378|531352494|FG000|Overall Study|Other|2|||
147324351|NCT03251378|531352495|FG001|Overall Study|Other|3|||
147324352|NCT03251378|531352496|FG002|Overall Study|Other|2|||
147324353|NCT03251378|531352497|FG003|Overall Study|Other|0|||
147324354|NCT03251378|531352498|FG004|Overall Study|Other|1|||
147324355|NCT03251378|531352499|FG005|Overall Study|Other|1|||
147324356|NCT03251378|531352500|FG006|Overall Study|Other|1|||
147324357|NCT03251378|531352494|FG000|Overall Study|Other|0|||
147324358|NCT03251378|531352495|FG001|Overall Study|Other|0|||
147448293|NCT00542269|531805681|FG001|Overall Study|Adverse Event|4|||
147448294|NCT00542269|531805682|FG002|Overall Study|Adverse Event|5|||
147175551|NCT01336023|530806342|FG001|Week 0 to Week 26|Unclassified|16|||
147175552|NCT01336023|530806343|FG002|Week 0 to Week 26|Unclassified|9|||
147175553|NCT01336023|530806341|FG000|Week 27 to 52|Adverse Event|1|||
147175554|NCT01336023|530806342|FG001|Week 27 to 52|Adverse Event|5|||
147175555|NCT01336023|530806343|FG002|Week 27 to 52|Adverse Event|2|||
147175556|NCT01336023|530806341|FG000|Week 27 to 52|Protocol Violation|0|||
147175557|NCT01336023|530806342|FG001|Week 27 to 52|Protocol Violation|2|||
147175558|NCT01336023|530806343|FG002|Week 27 to 52|Protocol Violation|1|||
147175559|NCT01336023|530806341|FG000|Week 27 to 52|Withdrawal Criteria|14|||
147175560|NCT01336023|530806342|FG001|Week 27 to 52|Withdrawal Criteria|19|||
147175561|NCT01336023|530806343|FG002|Week 27 to 52|Withdrawal Criteria|16|||
147175562|NCT01336023|530806341|FG000|Week 27 to 52|Unclassified|13|||
147175563|NCT01336023|530806342|FG001|Week 27 to 52|Unclassified|18|||
147175564|NCT01336023|530806343|FG002|Week 27 to 52|Unclassified|9|||
147175565|NCT04496453|530806344|FG000|Overall Study|Lost to Follow-up|6|||
147175566|NCT04294147|530806345|FG000|Overall Study|Protocol Violation|2|||
147175567|NCT04294147|530806346|FG001|Overall Study|Protocol Violation|0|||
147175568|NCT02332291|530806347|FG000|Phase 1: Blinded Escitalopram or Placebo|Adverse Event|3|||
147175569|NCT02332291|530806348|FG001|Phase 1: Blinded Escitalopram or Placebo|Adverse Event|5|||
147175570|NCT02332291|530806347|FG000|Phase 1: Blinded Escitalopram or Placebo|Worsening Depression|0|||
147175571|NCT02332291|530806348|FG001|Phase 1: Blinded Escitalopram or Placebo|Worsening Depression|4|||
147175572|NCT02332291|530806347|FG000|Phase 1: Blinded Escitalopram or Placebo|Withdrawal by Subject|1|||
147175573|NCT02332291|530806348|FG001|Phase 1: Blinded Escitalopram or Placebo|Withdrawal by Subject|0|||
147175574|NCT02332291|530806347|FG000|Phase 2: Open-Label Bupropion|Adverse Event|2|||
147175575|NCT02332291|530806348|FG001|Phase 2: Open-Label Bupropion|Adverse Event|7|||
147175576|NCT02332291|530806347|FG000|Phase 2: Open-Label Bupropion|Worsening Depression|0|||
147175577|NCT02332291|530806348|FG001|Phase 2: Open-Label Bupropion|Worsening Depression|1|||
147175578|NCT02332291|530806347|FG000|Phase 2: Open-Label Bupropion|Lost to Follow-up|1|||
147175579|NCT02332291|530806348|FG001|Phase 2: Open-Label Bupropion|Lost to Follow-up|0|||
147175580|NCT03916081|530806351|FG000|Overall Study|Adverse Event|1|||
147175581|NCT03916081|530806352|FG001|Overall Study|Adverse Event|0|||
147175582|NCT03916081|530806353|FG002|Overall Study|Adverse Event|0|||
147175583|NCT03916081|530806351|FG000|Overall Study|Physician Decision|0|||
147175584|NCT03916081|530806352|FG001|Overall Study|Physician Decision|0|||
147175585|NCT03916081|530806353|FG002|Overall Study|Physician Decision|1|||
147175586|NCT03916081|530806351|FG000|Overall Study|Lost to Follow-up|0|||
147175587|NCT03916081|530806352|FG001|Overall Study|Lost to Follow-up|1|||
147175588|NCT03916081|530806353|FG002|Overall Study|Lost to Follow-up|0|||
147175589|NCT03916081|530806351|FG000|Overall Study|Withdrawal by Subject|3|||
147175590|NCT03916081|530806352|FG001|Overall Study|Withdrawal by Subject|0|||
147175591|NCT03916081|530806353|FG002|Overall Study|Withdrawal by Subject|1|||
147175592|NCT03916081|530806351|FG000|Overall Study|Worsening of AD|0|||
147175593|NCT03916081|530806352|FG001|Overall Study|Worsening of AD|0|||
147175594|NCT03916081|530806353|FG002|Overall Study|Worsening of AD|1|||
147175595|NCT01240135|530806354|FG000|Period Two, 14 Days of Wear|Withdrawal by Subject|1|||
147175596|NCT01240135|530806355|FG001|Period Two, 14 Days of Wear|Withdrawal by Subject|1|||
147175597|NCT01240135|530806354|FG000|Period Two, 14 Days of Wear|Adverse Event|0|||
147175598|NCT01240135|530806355|FG001|Period Two, 14 Days of Wear|Adverse Event|1|||
147175599|NCT00699335|530806356|FG000|Overall Study|Combination of multiple reasons|176|||
147175600|NCT00699335|530806356|FG000|Overall Study|Missing data|52|||
147175601|NCT02726022|530806357|FG000|Overall Study|Adverse Event|14|||
147175602|NCT02726022|530806357|FG000|Overall Study|Treatment Failure|8|||
147175603|NCT02726022|530806357|FG000|Overall Study|Poor Compliance|13|||
147175604|NCT02726022|530806357|FG000|Overall Study|Treatment Failure and Poor Compliance|1|||
147175605|NCT02828020|530806359|FG000|Treatment Period|Adverse Event|3|||
147175606|NCT02828020|530806360|FG001|Treatment Period|Adverse Event|1|||
147175607|NCT02828020|530806361|FG002|Treatment Period|Adverse Event|1|||
147324359|NCT03251378|531352496|FG002|Overall Study|Other|0|||
147324360|NCT03251378|531352497|FG003|Overall Study|Other|4|||
147324361|NCT03251378|531352498|FG004|Overall Study|Other|13|||
147592979|NCT01470612|532326899|FG000|Overall Study|Did not meet entrance criteria|0|||
147175608|NCT02828020|530806359|FG000|Treatment Period|Withdrawal of Consent|10|||
147324362|NCT03251378|531352499|FG005|Overall Study|Other|0|||
147324363|NCT03251378|531352500|FG006|Overall Study|Other|0|||
147175609|NCT02828020|530806360|FG001|Treatment Period|Withdrawal of Consent|14|||
147175610|NCT02828020|530806361|FG002|Treatment Period|Withdrawal of Consent|9|||
147175611|NCT02828020|530806359|FG000|Treatment Period|Lost to Follow-up|21|||
147175612|NCT02828020|530806360|FG001|Treatment Period|Lost to Follow-up|24|||
147175613|NCT02828020|530806361|FG002|Treatment Period|Lost to Follow-up|18|||
147175614|NCT02828020|530806359|FG000|Treatment Period|Lack of Qualifying Event|44|||
147175615|NCT02828020|530806360|FG001|Treatment Period|Lack of Qualifying Event|53|||
147175616|NCT02828020|530806361|FG002|Treatment Period|Lack of Qualifying Event|43|||
147175617|NCT02828020|530806359|FG000|Treatment Period|Pregnancy|0|||
147175618|NCT02828020|530806360|FG001|Treatment Period|Pregnancy|2|||
147175619|NCT02828020|530806361|FG002|Treatment Period|Pregnancy|0|||
147175620|NCT02828020|530806359|FG000|Treatment Period|Protocol Violation|2|||
147175621|NCT02828020|530806360|FG001|Treatment Period|Protocol Violation|4|||
147175622|NCT02828020|530806361|FG002|Treatment Period|Protocol Violation|7|||
147175623|NCT02828020|530806359|FG000|Treatment Period|Other Miscellaneous Reasons|0|||
147175624|NCT02828020|530806360|FG001|Treatment Period|Other Miscellaneous Reasons|1|||
147175625|NCT02828020|530806361|FG002|Treatment Period|Other Miscellaneous Reasons|0|||
147175626|NCT02828020|530806359|FG000|Safety Follow-up Period|Withdrawal of Consent|10|||
147175627|NCT02828020|530806360|FG001|Safety Follow-up Period|Withdrawal of Consent|8|||
147175628|NCT02828020|530806361|FG002|Safety Follow-up Period|Withdrawal of Consent|7|||
147175629|NCT02828020|530806359|FG000|Safety Follow-up Period|Lost to Follow-up|9|||
147175630|NCT02828020|530806360|FG001|Safety Follow-up Period|Lost to Follow-up|8|||
147175631|NCT02828020|530806361|FG002|Safety Follow-up Period|Lost to Follow-up|11|||
147175632|NCT02828020|530806359|FG000|Safety Follow-up Period|Protocol Violation|0|||
147175633|NCT02828020|530806360|FG001|Safety Follow-up Period|Protocol Violation|2|||
147175634|NCT02828020|530806361|FG002|Safety Follow-up Period|Protocol Violation|1|||
147175635|NCT02828020|530806359|FG000|Safety Follow-up Period|Other Miscellaneous Reasons|1|||
147175636|NCT02828020|530806360|FG001|Safety Follow-up Period|Other Miscellaneous Reasons|0|||
147175637|NCT02828020|530806361|FG002|Safety Follow-up Period|Other Miscellaneous Reasons|0|||
147175638|NCT03688620|530806362|FG000|Overall Study|Other|0|||
147175639|NCT03688620|530806363|FG001|Overall Study|Other|0|||
147175640|NCT03688620|530806364|FG002|Overall Study|Other|1|||
147175641|NCT03688620|530806362|FG000|Overall Study|Unwilling to attend the scheduled visit|0|||
147175642|NCT03688620|530806363|FG001|Overall Study|Unwilling to attend the scheduled visit|1|||
147175643|NCT03688620|530806364|FG002|Overall Study|Unwilling to attend the scheduled visit|0|||
147175644|NCT03688620|530806362|FG000|Overall Study|Lost to Follow-up|16|||
147175645|NCT03688620|530806363|FG001|Overall Study|Lost to Follow-up|0|||
147175646|NCT03688620|530806364|FG002|Overall Study|Lost to Follow-up|1|||
147175647|NCT03688620|530806362|FG000|Overall Study|Withdrawal by Subject|0|||
147175648|NCT03688620|530806363|FG001|Overall Study|Withdrawal by Subject|0|||
147175649|NCT03688620|530806364|FG002|Overall Study|Withdrawal by Subject|6|||
147175650|NCT01183065|530806366|FG000|Overall Study|Patient no longer fits eligibility crite|1|||
147175651|NCT00416455|530806367|FG000|Overall Study|PET / CT not done|3|||
147175652|NCT00416455|530806368|FG001|Overall Study|PET / CT not done|5|||
147175653|NCT00416455|530806367|FG000|Overall Study|PET / CT poor quality|2|||
147175654|NCT00416455|530806368|FG001|Overall Study|PET / CT poor quality|1|||
147175655|NCT00416455|530806367|FG000|Overall Study|Inadequate pathology|11|||
147175656|NCT00416455|530806368|FG001|Overall Study|Inadequate pathology|2|||
147175657|NCT02456857|530806369|FG000|Overall Study|Disease Progression|4|||
147175658|NCT01983774|530806373|FG000|Overall Study|Lung Transplant|0|||
147175659|NCT01983774|530806374|FG001|Overall Study|Lung Transplant|1|||
147175660|NCT01983774|530806373|FG000|Overall Study|Lost to Follow-up|1|||
147175661|NCT01983774|530806374|FG001|Overall Study|Lost to Follow-up|0|||
147175662|NCT01339897|530806375|FG000|Overall Study|Adverse Event|1|||
147175663|NCT01339897|530806376|FG001|Overall Study|Adverse Event|0|||
147175664|NCT01339897|530806377|FG002|Overall Study|Adverse Event|0|||
147175665|NCT01339897|530806378|FG003|Overall Study|Adverse Event|1|||
147175666|NCT03657095|530806381|FG000|Overall Study|Withdrawal by Subject|1|||
147175667|NCT03657095|530806382|FG001|Overall Study|Withdrawal by Subject|1|||
147175668|NCT03657095|530806381|FG000|Overall Study|Adverse Event|0|||
147175669|NCT03657095|530806382|FG001|Overall Study|Adverse Event|3|||
147175670|NCT03657095|530806381|FG000|Overall Study|Study Terminated by Sponsor|58|||
147175671|NCT03657095|530806382|FG001|Overall Study|Study Terminated by Sponsor|49|||
147175672|NCT03043651|530806387|FG000|Overall Study|Death|1|||
147175673|NCT03043651|530806387|FG000|Overall Study|Progressive Disease|2|||
147175674|NCT03043651|530806387|FG000|Overall Study|Adverse Event|2|||
147175675|NCT03043651|530806387|FG000|Overall Study|Withdrawal by Subject|4|||
147175676|NCT03043651|530806387|FG000|Overall Study|Study Terminated by Sponsor|39|||
147175677|NCT02980133|530806388|FG000|Overall Study|Other than specified|1|||
147175678|NCT02980133|530806389|FG001|Overall Study|Other than specified|1|||
147175679|NCT02980133|530806390|FG002|Overall Study|Other than specified|2|||
147175680|NCT02980133|530806391|FG003|Overall Study|Other than specified|2|||
147175681|NCT02980133|530806388|FG000|Overall Study|Lost to Follow-up|0|||
147175682|NCT02980133|530806389|FG001|Overall Study|Lost to Follow-up|0|||
147175683|NCT02980133|530806390|FG002|Overall Study|Lost to Follow-up|1|||
147175684|NCT02980133|530806391|FG003|Overall Study|Lost to Follow-up|3|||
147175685|NCT02980133|530806388|FG000|Overall Study|Protocol Violation|0|||
147175686|NCT02980133|530806389|FG001|Overall Study|Protocol Violation|1|||
147175687|NCT02980133|530806390|FG002|Overall Study|Protocol Violation|0|||
147175688|NCT02980133|530806391|FG003|Overall Study|Protocol Violation|0|||
147175689|NCT02980133|530806388|FG000|Overall Study|Withdrawal by parent/guardian|6|||
147175690|NCT02980133|530806389|FG001|Overall Study|Withdrawal by parent/guardian|3|||
147175691|NCT02980133|530806390|FG002|Overall Study|Withdrawal by parent/guardian|3|||
147175692|NCT02980133|530806391|FG003|Overall Study|Withdrawal by parent/guardian|1|||
147175693|NCT02980133|530806388|FG000|Overall Study|Withdrawal by Subject|0|||
147175694|NCT02980133|530806389|FG001|Overall Study|Withdrawal by Subject|0|||
147175695|NCT02980133|530806390|FG002|Overall Study|Withdrawal by Subject|1|||
147175696|NCT02980133|530806391|FG003|Overall Study|Withdrawal by Subject|0|||
147175697|NCT02596945|530806392|FG000|Overall Study|No documentation of study drug dosing|3|||
147175698|NCT02596945|530806392|FG000|Overall Study|Other|32|||
147175699|NCT02596945|530806392|FG000|Overall Study|Change to hemodialysis|15|||
147175700|NCT02596945|530806392|FG000|Overall Study|Other Erythropoietin stimulating agent|4|||
147175701|NCT02596945|530806392|FG000|Overall Study|Withdrawal by Subject|1|||
147175702|NCT02596945|530806392|FG000|Overall Study|Missing|1|||
147175703|NCT03738618|530808368|FG000|Overall Study|Protocol deviation|23|||
147175704|NCT03738618|530808369|FG001|Overall Study|Protocol deviation|0|||
147175705|NCT03738618|530808368|FG000|Overall Study|Adverse Event|4|||
147175706|NCT03738618|530808369|FG001|Overall Study|Adverse Event|0|||
147175707|NCT03738618|530808368|FG000|Overall Study|Lost to Follow-up|2|||
147244724|NCT00799422|531069001|FG002|First Week of Wear|Lost to Follow-up|1|||
147244725|NCT00799422|531069002|FG003|First Week of Wear|Lost to Follow-up|0|||
147244726|NCT00799422|531069003|FG004|First Week of Wear|Lost to Follow-up|0|||
147244727|NCT00799422|531069004|FG005|First Week of Wear|Lost to Follow-up|0|||
147244728|NCT00799422|531068999|FG000|First Week of Wear|Adverse Event|0|||
147244729|NCT00799422|531069000|FG001|First Week of Wear|Adverse Event|0|||
147244730|NCT00799422|531069001|FG002|First Week of Wear|Adverse Event|0|||
147244731|NCT00799422|531069002|FG003|First Week of Wear|Adverse Event|1|||
147244732|NCT00799422|531069003|FG004|First Week of Wear|Adverse Event|0|||
147244733|NCT00799422|531069004|FG005|First Week of Wear|Adverse Event|0|||
147244734|NCT00880009|531069005|FG000|Overall Study|Study terminated by sponsor|14|||
147244735|NCT00880009|531069005|FG000|Overall Study|Withdrawal by Subject|1|||
147244736|NCT00880009|531069005|FG000|Overall Study|Protocol Violation|1|||
147244737|NCT01217801|531069006|FG000|Period 1|Protocol Violation|1|||
147244738|NCT01217801|531069007|FG001|Period 1|Protocol Violation|1|||
147244739|NCT01217801|531069006|FG000|Period 1|Withdrawal by Subject|0|||
147244740|NCT01217801|531069007|FG001|Period 1|Withdrawal by Subject|1|||
147244741|NCT04584645|531069008|FG000|Overall Study|"Those participants who did not complete the 3 or 6 month surveys are considered not completed."|18995|||
147244742|NCT04584645|531069009|FG001|Overall Study|"Those participants who did not complete the 3 or 6 month surveys are considered not completed."|18906|||
147244743|NCT00390468|531069010|FG000|Overall Study|Protocol Violation|2|||
147244744|NCT00390468|531069010|FG000|Overall Study|Lack of Efficacy|1|||
147244745|NCT04112784|531069016|FG000|Overall Study|Did Not Proceed Due to Time Constraints|9|||
147244746|NCT04112784|531069016|FG000|Overall Study|Screen Failures|4|||
147244747|NCT02010775|531069018|FG000|Overall Study|Adverse Event|0|||
147244748|NCT02010775|531069019|FG001|Overall Study|Adverse Event|0|||
147244749|NCT02010775|531069020|FG002|Overall Study|Adverse Event|0|||
147244750|NCT02010775|531069021|FG003|Overall Study|Adverse Event|0|||
147244751|NCT02010775|531069022|FG004|Overall Study|Adverse Event|1|||
147244752|NCT02010775|531069018|FG000|Overall Study|Pregnancy|0|||
147244753|NCT02010775|531069019|FG001|Overall Study|Pregnancy|0|||
147244754|NCT02010775|531069020|FG002|Overall Study|Pregnancy|2|||
147244755|NCT02010775|531069021|FG003|Overall Study|Pregnancy|0|||
147244756|NCT02010775|531069022|FG004|Overall Study|Pregnancy|0|||
147244757|NCT02010775|531069018|FG000|Overall Study|Lost to Follow-up|2|||
147244758|NCT02010775|531069019|FG001|Overall Study|Lost to Follow-up|0|||
147244759|NCT02010775|531069020|FG002|Overall Study|Lost to Follow-up|0|||
147244760|NCT02010775|531069021|FG003|Overall Study|Lost to Follow-up|1|||
147244761|NCT02010775|531069022|FG004|Overall Study|Lost to Follow-up|1|||
147244762|NCT02010775|531069018|FG000|Overall Study|Personal Reasons|3|||
147244763|NCT02010775|531069019|FG001|Overall Study|Personal Reasons|3|||
147244764|NCT02010775|531069020|FG002|Overall Study|Personal Reasons|1|||
147244765|NCT02010775|531069021|FG003|Overall Study|Personal Reasons|2|||
147244766|NCT02010775|531069022|FG004|Overall Study|Personal Reasons|4|||
147244767|NCT00256750|531069023|FG000|Transplanted Pre-Treatment|Withdrawal by Subject|3|||
147175708|NCT03738618|530808369|FG001|Overall Study|Lost to Follow-up|0|||
147175709|NCT03738618|530808368|FG000|Overall Study|Randomization failure|1|||
147175710|NCT03738618|530808369|FG001|Overall Study|Randomization failure|0|||
147175711|NCT03738618|530808368|FG000|Overall Study|Participant relocated, unable to continue in trial|1|||
147175712|NCT03738618|530808369|FG001|Overall Study|Participant relocated, unable to continue in trial|0|||
147175713|NCT03738618|530808368|FG000|Overall Study|Participant did not show to visit (stimulation day 12)|1|||
147244768|NCT00256750|531069024|FG001|Transplanted Pre-Treatment|Withdrawal by Subject|0|||
147244769|NCT00256750|531069025|FG002|Transplanted Pre-Treatment|Withdrawal by Subject|0|||
147244770|NCT00256750|531069023|FG000|Transplanted Pre-Treatment|Other|2|||
147175714|NCT03738618|530808369|FG001|Overall Study|Participant did not show to visit (stimulation day 12)|0|||
147175715|NCT03499314|530808372|FG000|Overall Study|Time Commitment|1|||
147175716|NCT03499314|530808373|FG001|Overall Study|Time Commitment|2|||
147175717|NCT03499314|530808372|FG000|Overall Study|Medical issue unrelated to research study|1|||
147175718|NCT03499314|530808373|FG001|Overall Study|Medical issue unrelated to research study|1|||
147175719|NCT00872599|530808374|FG000|Second Washout Period|Adverse Event|1|||
147175720|NCT00872599|530808375|FG001|Second Washout Period|Adverse Event|1|||
147175721|NCT04794270|530808376|FG000|Period 1|Non Compliance|1|||
147175722|NCT04794270|530808377|FG001|Period 1|Non Compliance|0|||
147175723|NCT04794270|530808376|FG000|Period 1|Adverse Event|1|||
147175724|NCT04794270|530808377|FG001|Period 1|Adverse Event|0|||
147175725|NCT04794270|530808376|FG000|Period 2|Unsatisfactory Lens Fitting due to Test Article|1|||
147175726|NCT04794270|530808377|FG001|Period 2|Unsatisfactory Lens Fitting due to Test Article|0|||
147175727|NCT02510001|530808378|FG000|Overall Study|Early disease progression|0|||
147175728|NCT02510001|530808379|FG001|Overall Study|Early disease progression|0|||
147175729|NCT02510001|530808380|FG002|Overall Study|Early disease progression|0|||
147175730|NCT02510001|530808381|FG003|Overall Study|Early disease progression|1|||
147175731|NCT02510001|530808382|FG004|Overall Study|Early disease progression|1|||
147175732|NCT02510001|530808383|FG005|Overall Study|Early disease progression|1|||
147175733|NCT02510001|530808384|FG006|Overall Study|Early disease progression|0|||
147175734|NCT02510001|530808385|FG007|Overall Study|Early disease progression|0|||
147175735|NCT02510001|530808378|FG000|Overall Study|Adverse Event|0|||
147175736|NCT02510001|530808379|FG001|Overall Study|Adverse Event|0|||
147175737|NCT02510001|530808380|FG002|Overall Study|Adverse Event|0|||
147175738|NCT02510001|530808381|FG003|Overall Study|Adverse Event|1|||
147175739|NCT02510001|530808382|FG004|Overall Study|Adverse Event|2|||
147175740|NCT02510001|530808383|FG005|Overall Study|Adverse Event|1|||
147175741|NCT02510001|530808384|FG006|Overall Study|Adverse Event|2|||
147175742|NCT02510001|530808385|FG007|Overall Study|Adverse Event|5|||
147175743|NCT02510001|530808378|FG000|Overall Study|Physician Decision|0|||
147175744|NCT02510001|530808379|FG001|Overall Study|Physician Decision|0|||
147175745|NCT02510001|530808380|FG002|Overall Study|Physician Decision|0|||
147244771|NCT00256750|531069024|FG001|Transplanted Pre-Treatment|Other|0|||
147244772|NCT00256750|531069025|FG002|Transplanted Pre-Treatment|Other|0|||
147244773|NCT00256750|531069023|FG000|Transplanted Pre-Treatment|Death|1|||
147244774|NCT00256750|531069024|FG001|Transplanted Pre-Treatment|Death|0|||
147244775|NCT00256750|531069025|FG002|Transplanted Pre-Treatment|Death|0|||
147244776|NCT00256750|531069023|FG000|Post-Transplant Treated (12 Months)|Adverse Event|20|||
147244777|NCT00256750|531069024|FG001|Post-Transplant Treated (12 Months)|Adverse Event|12|||
147244778|NCT00256750|531069025|FG002|Post-Transplant Treated (12 Months)|Adverse Event|8|||
147244779|NCT00256750|531069023|FG000|Post-Transplant Treated (12 Months)|Death|3|||
147244780|NCT00256750|531069024|FG001|Post-Transplant Treated (12 Months)|Death|2|||
147244781|NCT00256750|531069025|FG002|Post-Transplant Treated (12 Months)|Death|4|||
147244782|NCT00256750|531069023|FG000|Post-Transplant Treated (12 Months)|Lack of Efficacy|10|||
147244783|NCT00256750|531069024|FG001|Post-Transplant Treated (12 Months)|Lack of Efficacy|22|||
147244784|NCT00256750|531069025|FG002|Post-Transplant Treated (12 Months)|Lack of Efficacy|27|||
147244785|NCT00256750|531069023|FG000|Post-Transplant Treated (12 Months)|Lost to Follow-up|1|||
147244786|NCT00256750|531069024|FG001|Post-Transplant Treated (12 Months)|Lost to Follow-up|0|||
147244787|NCT00256750|531069025|FG002|Post-Transplant Treated (12 Months)|Lost to Follow-up|0|||
147244788|NCT00256750|531069023|FG000|Post-Transplant Treated (12 Months)|Other|5|||
147244789|NCT00256750|531069024|FG001|Post-Transplant Treated (12 Months)|Other|4|||
147244790|NCT00256750|531069025|FG002|Post-Transplant Treated (12 Months)|Other|2|||
147244791|NCT00256750|531069023|FG000|Post-Transplant Treated (12 Months)|Withdrawal by Subject|0|||
147244792|NCT00256750|531069024|FG001|Post-Transplant Treated (12 Months)|Withdrawal by Subject|3|||
147244793|NCT00256750|531069025|FG002|Post-Transplant Treated (12 Months)|Withdrawal by Subject|5|||
147244794|NCT00256750|531069023|FG000|Post-Transplant Treated (12 Months)|Protocol Violation|2|||
147244795|NCT00256750|531069024|FG001|Post-Transplant Treated (12 Months)|Protocol Violation|0|||
147244796|NCT00256750|531069025|FG002|Post-Transplant Treated (12 Months)|Protocol Violation|0|||
147175746|NCT02510001|530808381|FG003|Overall Study|Physician Decision|0|||
147175747|NCT02510001|530808382|FG004|Overall Study|Physician Decision|1|||
147175748|NCT02510001|530808383|FG005|Overall Study|Physician Decision|0|||
147175749|NCT02510001|530808384|FG006|Overall Study|Physician Decision|0|||
147175750|NCT02510001|530808385|FG007|Overall Study|Physician Decision|0|||
147175751|NCT02510001|530808378|FG000|Overall Study|Withdrawal by Subject|0|||
147592980|NCT01470612|532326900|FG001|Overall Study|Did not meet entrance criteria|1|||
147175752|NCT02510001|530808379|FG001|Overall Study|Withdrawal by Subject|0|||
147175753|NCT02510001|530808380|FG002|Overall Study|Withdrawal by Subject|0|||
147175754|NCT02510001|530808381|FG003|Overall Study|Withdrawal by Subject|0|||
147175755|NCT02510001|530808382|FG004|Overall Study|Withdrawal by Subject|0|||
147175756|NCT02510001|530808383|FG005|Overall Study|Withdrawal by Subject|0|||
147175757|NCT02510001|530808384|FG006|Overall Study|Withdrawal by Subject|0|||
147175758|NCT02510001|530808385|FG007|Overall Study|Withdrawal by Subject|2|||
147244797|NCT00256750|531069023|FG000|Post-Transplant Treated (24 Months)|Adverse Event|7|||
147244798|NCT00256750|531069024|FG001|Post-Transplant Treated (24 Months)|Adverse Event|3|||
147324364|NCT04739423|531352507|FG000|Overall Study|Protocol Violation|0|||
147324365|NCT04739423|531352508|FG001|Overall Study|Protocol Violation|1|||
147324366|NCT04739423|531352509|FG002|Overall Study|Protocol Violation|0|||
147324367|NCT04739423|531352510|FG003|Overall Study|Protocol Violation|0|||
147324368|NCT04739423|531352511|FG004|Overall Study|Protocol Violation|0|||
147324369|NCT04739423|531352512|FG005|Overall Study|Protocol Violation|0|||
147324370|NCT04739423|531352507|FG000|Overall Study|Adverse Event|0|||
147324371|NCT04739423|531352508|FG001|Overall Study|Adverse Event|0|||
147324372|NCT04739423|531352509|FG002|Overall Study|Adverse Event|1|||
147324373|NCT04739423|531352510|FG003|Overall Study|Adverse Event|0|||
147324374|NCT04739423|531352511|FG004|Overall Study|Adverse Event|1|||
147324375|NCT04739423|531352512|FG005|Overall Study|Adverse Event|0|||
147324376|NCT04739423|531352507|FG000|Overall Study|Withdrawal by Subject|0|||
147324377|NCT04739423|531352508|FG001|Overall Study|Withdrawal by Subject|0|||
147324378|NCT04739423|531352509|FG002|Overall Study|Withdrawal by Subject|0|||
147324379|NCT04739423|531352510|FG003|Overall Study|Withdrawal by Subject|0|||
147324380|NCT04739423|531352511|FG004|Overall Study|Withdrawal by Subject|0|||
147324381|NCT04739423|531352512|FG005|Overall Study|Withdrawal by Subject|1|||
147324382|NCT00783692|531352522|FG000|Induction Phase|Adverse Event|7|||
147324383|NCT00783692|531352523|FG001|Induction Phase|Adverse Event|9|||
147324384|NCT00783692|531352524|FG002|Induction Phase|Adverse Event|24|||
147324385|NCT00783692|531352525|FG003|Induction Phase|Adverse Event|0|||
147324386|NCT00783692|531352526|FG004|Induction Phase|Adverse Event|0|||
147324387|NCT00783692|531352527|FG005|Induction Phase|Adverse Event|0|||
147324388|NCT00783692|531352528|FG006|Induction Phase|Adverse Event|0|||
147324389|NCT00783692|531352522|FG000|Induction Phase|Protocol Violation|0|||
147324390|NCT00783692|531352523|FG001|Induction Phase|Protocol Violation|0|||
147324391|NCT00783692|531352524|FG002|Induction Phase|Protocol Violation|1|||
147324392|NCT00783692|531352525|FG003|Induction Phase|Protocol Violation|0|||
147324393|NCT00783692|531352526|FG004|Induction Phase|Protocol Violation|0|||
147324394|NCT00783692|531352527|FG005|Induction Phase|Protocol Violation|0|||
147324395|NCT00783692|531352528|FG006|Induction Phase|Protocol Violation|0|||
147324396|NCT00783692|531352522|FG000|Induction Phase|Lack of Efficacy|1|||
147324397|NCT00783692|531352523|FG001|Induction Phase|Lack of Efficacy|3|||
147324398|NCT00783692|531352524|FG002|Induction Phase|Lack of Efficacy|28|||
147324399|NCT00783692|531352525|FG003|Induction Phase|Lack of Efficacy|0|||
147324400|NCT00783692|531352526|FG004|Induction Phase|Lack of Efficacy|0|||
147324401|NCT00783692|531352527|FG005|Induction Phase|Lack of Efficacy|0|||
147324402|NCT00783692|531352528|FG006|Induction Phase|Lack of Efficacy|0|||
147324403|NCT00783692|531352522|FG000|Induction Phase|Withdrawal by Subject|3|||
147324404|NCT00783692|531352523|FG001|Induction Phase|Withdrawal by Subject|9|||
147324405|NCT00783692|531352524|FG002|Induction Phase|Withdrawal by Subject|16|||
147324406|NCT00783692|531352525|FG003|Induction Phase|Withdrawal by Subject|0|||
147324407|NCT00783692|531352526|FG004|Induction Phase|Withdrawal by Subject|0|||
147324408|NCT00783692|531352527|FG005|Induction Phase|Withdrawal by Subject|0|||
147324409|NCT00783692|531352528|FG006|Induction Phase|Withdrawal by Subject|0|||
147324410|NCT00783692|531352522|FG000|Induction Phase|Lost to Follow-up|0|||
147324411|NCT00783692|531352523|FG001|Induction Phase|Lost to Follow-up|0|||
147324412|NCT00783692|531352524|FG002|Induction Phase|Lost to Follow-up|3|||
147592981|NCT01470612|532326899|FG000|Overall Study|Pregnancy|2|||
147592982|NCT01470612|532326900|FG001|Overall Study|Pregnancy|10|||
147592983|NCT01470612|532326899|FG000|Overall Study|Protocol Violation|2|||
147175759|NCT01504841|530808389|FG000|Overall Study|Withdrawal by Subject|1|||
147175760|NCT01504841|530808390|FG001|Overall Study|Withdrawal by Subject|1|||
147175761|NCT01504841|530808391|FG002|Overall Study|Withdrawal by Subject|0|||
147175762|NCT04440813|530808394|FG000|Overall Study|Lost to Follow-up|5|||
147175763|NCT04440813|530808395|FG001|Overall Study|Lost to Follow-up|5|||
147175764|NCT00291018|530808400|FG000|Overall Study|Not Consented or Declined PAS|12|||
147175765|NCT00291018|530808401|FG001|Overall Study|Not Consented or Declined PAS|15|||
147175766|NCT00291018|530808402|FG002|Overall Study|Not Consented or Declined PAS|15|||
147175767|NCT00291018|530808400|FG000|Overall Study|Death|3|||
147175768|NCT00291018|530808401|FG001|Overall Study|Death|3|||
147175769|NCT00291018|530808402|FG002|Overall Study|Death|4|||
147175770|NCT00291018|530808400|FG000|Overall Study|Withdrawal by Subject|2|||
147175771|NCT00291018|530808401|FG001|Overall Study|Withdrawal by Subject|8|||
147324413|NCT00783692|531352525|FG003|Induction Phase|Lost to Follow-up|0|||
147324414|NCT00783692|531352526|FG004|Induction Phase|Lost to Follow-up|0|||
147324415|NCT00783692|531352527|FG005|Induction Phase|Lost to Follow-up|0|||
147324416|NCT00783692|531352528|FG006|Induction Phase|Lost to Follow-up|0|||
147324417|NCT00783692|531352522|FG000|Induction Phase|Other|0|||
147324418|NCT00783692|531352523|FG001|Induction Phase|Other|0|||
147324419|NCT00783692|531352524|FG002|Induction Phase|Other|2|||
147324420|NCT00783692|531352525|FG003|Induction Phase|Other|0|||
147175772|NCT00291018|530808402|FG002|Overall Study|Withdrawal by Subject|1|||
147324421|NCT00783692|531352526|FG004|Induction Phase|Other|0|||
147324422|NCT00783692|531352527|FG005|Induction Phase|Other|0|||
147324423|NCT00783692|531352528|FG006|Induction Phase|Other|0|||
147324424|NCT00783692|531352522|FG000|Maintenance Phase|Adverse Event|7|||
147592984|NCT01470612|532326900|FG001|Overall Study|Protocol Violation|7|||
147592985|NCT01470612|532326899|FG000|Overall Study|Withdrawal by Subject|24|||
147324425|NCT00783692|531352523|FG001|Maintenance Phase|Adverse Event|0|||
147324426|NCT00783692|531352524|FG002|Maintenance Phase|Adverse Event|0|||
147324427|NCT00783692|531352525|FG003|Maintenance Phase|Adverse Event|15|||
147324428|NCT00783692|531352526|FG004|Maintenance Phase|Adverse Event|12|||
147324429|NCT00783692|531352527|FG005|Maintenance Phase|Adverse Event|9|||
147324430|NCT00783692|531352528|FG006|Maintenance Phase|Adverse Event|38|||
147324431|NCT00783692|531352522|FG000|Maintenance Phase|Protocol Violation|0|||
147324432|NCT00783692|531352523|FG001|Maintenance Phase|Protocol Violation|0|||
147324433|NCT00783692|531352524|FG002|Maintenance Phase|Protocol Violation|0|||
147324434|NCT00783692|531352525|FG003|Maintenance Phase|Protocol Violation|1|||
147324435|NCT00783692|531352526|FG004|Maintenance Phase|Protocol Violation|2|||
147324436|NCT00783692|531352527|FG005|Maintenance Phase|Protocol Violation|3|||
147324437|NCT00783692|531352528|FG006|Maintenance Phase|Protocol Violation|4|||
147324438|NCT00783692|531352522|FG000|Maintenance Phase|Lack of Efficacy|79|||
147324439|NCT00783692|531352523|FG001|Maintenance Phase|Lack of Efficacy|0|||
147324440|NCT00783692|531352524|FG002|Maintenance Phase|Lack of Efficacy|0|||
147324441|NCT00783692|531352525|FG003|Maintenance Phase|Lack of Efficacy|64|||
147324442|NCT00783692|531352526|FG004|Maintenance Phase|Lack of Efficacy|58|||
147324443|NCT00783692|531352527|FG005|Maintenance Phase|Lack of Efficacy|48|||
147324444|NCT00783692|531352528|FG006|Maintenance Phase|Lack of Efficacy|177|||
147324445|NCT00783692|531352522|FG000|Maintenance Phase|Withdrawal by Subject|7|||
147324446|NCT00783692|531352523|FG001|Maintenance Phase|Withdrawal by Subject|0|||
147324447|NCT00783692|531352524|FG002|Maintenance Phase|Withdrawal by Subject|0|||
147324448|NCT00783692|531352525|FG003|Maintenance Phase|Withdrawal by Subject|7|||
147324449|NCT00783692|531352526|FG004|Maintenance Phase|Withdrawal by Subject|6|||
147324450|NCT00783692|531352527|FG005|Maintenance Phase|Withdrawal by Subject|9|||
147324451|NCT00783692|531352528|FG006|Maintenance Phase|Withdrawal by Subject|24|||
147324452|NCT00783692|531352522|FG000|Maintenance Phase|Lost to Follow-up|2|||
147324453|NCT00783692|531352523|FG001|Maintenance Phase|Lost to Follow-up|0|||
147324454|NCT00783692|531352524|FG002|Maintenance Phase|Lost to Follow-up|0|||
147324455|NCT00783692|531352525|FG003|Maintenance Phase|Lost to Follow-up|1|||
147324456|NCT00783692|531352526|FG004|Maintenance Phase|Lost to Follow-up|3|||
147324457|NCT00783692|531352527|FG005|Maintenance Phase|Lost to Follow-up|2|||
147324458|NCT00783692|531352528|FG006|Maintenance Phase|Lost to Follow-up|5|||
147324459|NCT00783692|531352522|FG000|Maintenance Phase|Other|0|||
147324460|NCT00783692|531352523|FG001|Maintenance Phase|Other|0|||
147324461|NCT00783692|531352524|FG002|Maintenance Phase|Other|0|||
147324462|NCT00783692|531352525|FG003|Maintenance Phase|Other|1|||
147324463|NCT00783692|531352526|FG004|Maintenance Phase|Other|0|||
147324464|NCT00783692|531352527|FG005|Maintenance Phase|Other|1|||
147324465|NCT00783692|531352528|FG006|Maintenance Phase|Other|1|||
147324466|NCT03005288|531352531|FG000|Overall Study|Withdrawal by Subject|7|||
147324467|NCT03005288|531352532|FG001|Overall Study|Withdrawal by Subject|5|||
147324468|NCT03005288|531352531|FG000|Overall Study|Lost to Follow-up|0|||
147324469|NCT03005288|531352532|FG001|Overall Study|Lost to Follow-up|1|||
147324470|NCT03005288|531352531|FG000|Overall Study|Adverse Event|5|||
147324471|NCT03005288|531352532|FG001|Overall Study|Adverse Event|0|||
147324472|NCT03005288|531352531|FG000|Overall Study|Protocol deviation|0|||
147324473|NCT03005288|531352532|FG001|Overall Study|Protocol deviation|1|||
147592986|NCT01470612|532326900|FG001|Overall Study|Withdrawal by Subject|79|||
147592987|NCT01470612|532326899|FG000|Overall Study|Other|14|||
147592988|NCT01470612|532326900|FG001|Overall Study|Other|156|||
147592989|NCT03856593|532326903|FG000|Overall Study|Prescriber had no opioid prescriptions or was missing prescription information during study period|15|||
147175773|NCT00291018|530808400|FG000|Overall Study|Failures|5|||
147324474|NCT03005288|531352531|FG000|Overall Study|Physician Decision|0|||
147324475|NCT03005288|531352532|FG001|Overall Study|Physician Decision|1|||
147324476|NCT00209274|531352533|FG000|Overall Study|Missed visit|3|||
147324477|NCT00209274|531352534|FG001|Overall Study|Missed visit|2|||
147324478|NCT00209274|531352533|FG000|Overall Study|Death|32|||
147324479|NCT00209274|531352534|FG001|Overall Study|Death|15|||
147324480|NCT00209274|531352533|FG000|Overall Study|Withdrawal by Subject|30|||
147324481|NCT00209274|531352534|FG001|Overall Study|Withdrawal by Subject|15|||
147324482|NCT00209274|531352533|FG000|Overall Study|Randomized not treated (RNT)|6|||
147324483|NCT00209274|531352534|FG001|Overall Study|Randomized not treated (RNT)|15|||
147324484|NCT02753530|531352535|FG000|Overall Study|Adverse Event|7|||
147324485|NCT02753530|531352536|FG001|Overall Study|Adverse Event|1|||
147324486|NCT02753530|531352535|FG000|Overall Study|Death|0|||
147324487|NCT02753530|531352536|FG001|Overall Study|Death|1|||
147324488|NCT02753530|531352535|FG000|Overall Study|Physician Decision|0|||
147324489|NCT02753530|531352536|FG001|Overall Study|Physician Decision|1|||
147324490|NCT02753530|531352535|FG000|Overall Study|Protocol Violation|1|||
147324491|NCT02753530|531352536|FG001|Overall Study|Protocol Violation|0|||
147324492|NCT02753530|531352535|FG000|Overall Study|Withdrawal by Subject|4|||
147324493|NCT02753530|531352536|FG001|Overall Study|Withdrawal by Subject|3|||
147324494|NCT01734811|531352542|FG000|Overall Study|Lost to Follow-up|2|||
147175774|NCT00291018|530808401|FG001|Overall Study|Failures|12|||
147324495|NCT01734811|531352543|FG001|Overall Study|Lost to Follow-up|3|||
147324496|NCT01734811|531352542|FG000|Overall Study|Withdrawal by Subject|2|||
147592990|NCT03856593|532326904|FG001|Overall Study|Prescriber had no opioid prescriptions or was missing prescription information during study period|16|||
147592991|NCT03078582|532326910|FG000|Overall Study|Adverse Event|0|||
147592992|NCT03078582|532326911|FG001|Overall Study|Adverse Event|8|||
147592993|NCT02039414|532326922|FG000|Overall Study|Delivered|1|||
147592994|NCT02039414|532326923|FG001|Overall Study|Delivered|1|||
147592995|NCT02039414|532326922|FG000|Overall Study|Lost to Follow-up|2|||
147592996|NCT02039414|532326923|FG001|Overall Study|Lost to Follow-up|0|||
147592997|NCT02039414|532326922|FG000|Overall Study|Protocol Violation|3|||
147592998|NCT02039414|532326923|FG001|Overall Study|Protocol Violation|1|||
147592999|NCT02972502|532326928|FG000|Overall Study|Lost to Follow-up|3|||
147175775|NCT00291018|530808402|FG002|Overall Study|Failures|5|||
147175776|NCT00291018|530808400|FG000|Overall Study|Lost to Follow-up|3|||
147175777|NCT00291018|530808401|FG001|Overall Study|Lost to Follow-up|4|||
147175778|NCT00291018|530808402|FG002|Overall Study|Lost to Follow-up|18|||
147175779|NCT02219334|530808404|FG000|Overall Study|Withdrawal by Subject|1|||
147175780|NCT02219334|530808405|FG001|Overall Study|Withdrawal by Subject|0|||
147175781|NCT02219334|530808404|FG000|Overall Study|Protocol Violation|7|||
147175782|NCT02219334|530808405|FG001|Overall Study|Protocol Violation|3|||
147175783|NCT05362058|530808406|FG000|Treatment Period|Adverse Event|3|||
147175784|NCT05362058|530808407|FG001|Treatment Period|Adverse Event|3|||
147175785|NCT05362058|530808406|FG000|Treatment Period|Assigned treatment by mistake|3|||
147175786|NCT05362058|530808407|FG001|Treatment Period|Assigned treatment by mistake|4|||
147175787|NCT05362058|530808406|FG000|Treatment Period|Death|1|||
147175788|NCT05362058|530808407|FG001|Treatment Period|Death|1|||
147175789|NCT05362058|530808406|FG000|Treatment Period|Lost to Follow-up|6|||
147175790|NCT05362058|530808407|FG001|Treatment Period|Lost to Follow-up|3|||
147175791|NCT05362058|530808406|FG000|Treatment Period|Non-compliance with study drug|0|||
147175792|NCT05362058|530808407|FG001|Treatment Period|Non-compliance with study drug|1|||
147175793|NCT05362058|530808406|FG000|Treatment Period|Physician Decision|1|||
147175794|NCT05362058|530808407|FG001|Treatment Period|Physician Decision|0|||
147175795|NCT05362058|530808406|FG000|Treatment Period|Protocol deviation|1|||
147175796|NCT05362058|530808407|FG001|Treatment Period|Protocol deviation|0|||
147175797|NCT05362058|530808406|FG000|Treatment Period|Withdrawal by Subject|10|||
147175798|NCT05362058|530808407|FG001|Treatment Period|Withdrawal by Subject|11|||
147175799|NCT05362058|530808406|FG000|Follow-Up Period|Death|1|||
147175800|NCT05362058|530808407|FG001|Follow-Up Period|Death|0|||
147175801|NCT05362058|530808406|FG000|Follow-Up Period|Lost to Follow-up|2|||
147175802|NCT05362058|530808407|FG001|Follow-Up Period|Lost to Follow-up|1|||
147175803|NCT05362058|530808406|FG000|Follow-Up Period|Protocol deviation|1|||
147175804|NCT05362058|530808407|FG001|Follow-Up Period|Protocol deviation|1|||
147175805|NCT05362058|530808406|FG000|Follow-Up Period|Withdrawal by Subject|0|||
147175806|NCT05362058|530808407|FG001|Follow-Up Period|Withdrawal by Subject|3|||
147175807|NCT00711971|530808408|FG000|Overall Study|Lost to Follow-up|3|||
147175808|NCT00711971|530808409|FG001|Overall Study|Lost to Follow-up|4|||
147175809|NCT00711971|530808410|FG002|Overall Study|Lost to Follow-up|1|||
147175810|NCT04774926|530808414|FG000|Overall Study|Adverse Event|15|||
147175811|NCT04774926|530808414|FG000|Overall Study|Lost to Follow-up|3|||
147175812|NCT04774926|530808414|FG000|Overall Study|Physician Decision|6|||
147175813|NCT04774926|530808414|FG000|Overall Study|Withdrawal by Subject|3|||
147175814|NCT04774926|530808414|FG000|Overall Study|The original PI resigned and a new one could not be appointed|4|||
147175815|NCT02524158|530808415|FG000|12-weeks Assessment|Withdrawal by Subject|1|||
147593000|NCT02972502|532326929|FG001|Overall Study|Lost to Follow-up|1|||
147593001|NCT02972502|532326928|FG000|Overall Study|Withdrawal by Subject|1|||
147593002|NCT02972502|532326929|FG001|Overall Study|Withdrawal by Subject|1|||
147593003|NCT03832738|532326930|FG000|Overall Study|Withdrawal by Subject|6|||
147175816|NCT02524158|530808416|FG001|12-weeks Assessment|Withdrawal by Subject|1|||
147175817|NCT02524158|530808415|FG000|12-weeks Assessment|Lost to Follow-up|18|||
147175818|NCT02524158|530808416|FG001|12-weeks Assessment|Lost to Follow-up|12|||
147175819|NCT02524158|530808415|FG000|6-month Assessment|Withdrawal by Subject|1|||
147175820|NCT02524158|530808416|FG001|6-month Assessment|Withdrawal by Subject|1|||
147175821|NCT02524158|530808415|FG000|6-month Assessment|Lost to Follow-up|21|||
147175822|NCT02524158|530808416|FG001|6-month Assessment|Lost to Follow-up|20|||
147175823|NCT01973998|530808420|FG000|Overall Study|Death|2|||
147175824|NCT01973998|530808421|FG001|Overall Study|Death|2|||
147175825|NCT00646399|530808422|FG000|Overall Study|Death|63|||
147175826|NCT00646399|530808423|FG001|Overall Study|Death|53|||
147175827|NCT00646399|530808422|FG000|Overall Study|Withdrawal by Subject|9|||
147175828|NCT00646399|530808423|FG001|Overall Study|Withdrawal by Subject|10|||
147175829|NCT00646399|530808422|FG000|Overall Study|Other Reason|11|||
147244799|NCT00256750|531069025|FG002|Post-Transplant Treated (24 Months)|Adverse Event|6|||
147244800|NCT00256750|531069023|FG000|Post-Transplant Treated (24 Months)|Withdrawal by Subject|5|||
147244801|NCT00256750|531069024|FG001|Post-Transplant Treated (24 Months)|Withdrawal by Subject|1|||
147244802|NCT00256750|531069025|FG002|Post-Transplant Treated (24 Months)|Withdrawal by Subject|0|||
147244803|NCT00256750|531069023|FG000|Post-Transplant Treated (24 Months)|Death|3|||
147244804|NCT00256750|531069024|FG001|Post-Transplant Treated (24 Months)|Death|0|||
147593004|NCT03832738|532326931|FG001|Overall Study|Withdrawal by Subject|7|||
147593005|NCT03832738|532326932|FG002|Overall Study|Withdrawal by Subject|16|||
147175830|NCT00646399|530808423|FG001|Overall Study|Other Reason|11|||
147175831|NCT02540993|530808424|FG000|Overall Study|Lost to Follow-up|5|||
147175832|NCT02540993|530808425|FG001|Overall Study|Lost to Follow-up|3|||
147175833|NCT02540993|530808424|FG000|Overall Study|Withdrawal by Subject|4|||
147175834|NCT02540993|530808425|FG001|Overall Study|Withdrawal by Subject|6|||
147175835|NCT02540993|530808424|FG000|Overall Study|GCP violations|33|||
147175836|NCT02540993|530808425|FG001|Overall Study|GCP violations|27|||
147175837|NCT00844558|530808426|FG000|Overall Study|Withdrawal by Subject|9|||
147175838|NCT00844558|530808427|FG001|Overall Study|Withdrawal by Subject|2|||
147175839|NCT00844558|530808426|FG000|Overall Study|Death|1|||
147175840|NCT00844558|530808427|FG001|Overall Study|Death|0|||
147175841|NCT00844558|530808426|FG000|Overall Study|Protocol Violation|1|||
147175842|NCT00844558|530808427|FG001|Overall Study|Protocol Violation|1|||
147175843|NCT00844558|530808426|FG000|Overall Study|Lost to Follow-up|0|||
147175844|NCT00844558|530808427|FG001|Overall Study|Lost to Follow-up|1|||
147175845|NCT00844558|530808426|FG000|Overall Study|Physician Decision|1|||
147175846|NCT00844558|530808427|FG001|Overall Study|Physician Decision|0|||
147175847|NCT00588094|530808428|FG000|Overall Study|Adverse Event|3|||
147175848|NCT00588094|530808428|FG000|Overall Study|Progression of Disease|2|||
147175849|NCT02202538|530808436|FG000|Overall Study|Withdrawal by Subject|5|||
147175850|NCT02202538|530808436|FG000|Overall Study|Did not meet all inclusion criteria|2|||
147175851|NCT02202538|530808436|FG000|Overall Study|Investigator Decision|1|||
147175852|NCT01457846|530808437|FG000|Overall Study|Death before treatment|1|||
147175853|NCT01457846|530808438|FG001|Overall Study|Death before treatment|2|||
147175854|NCT01457846|530808437|FG000|Overall Study|Did not receive treatment|0|||
147175855|NCT01457846|530808438|FG001|Overall Study|Did not receive treatment|1|||
147175856|NCT01457846|530808437|FG000|Overall Study|Death|27|||
147175857|NCT01457846|530808438|FG001|Overall Study|Death|16|||
147175858|NCT01457846|530808437|FG000|Overall Study|Unclassified reason for not completed|11|||
147175859|NCT01457846|530808438|FG001|Overall Study|Unclassified reason for not completed|10|||
147175860|NCT01457846|530808437|FG000|Overall Study|Withdrawal by Subject|1|||
147175861|NCT01457846|530808438|FG001|Overall Study|Withdrawal by Subject|1|||
147175862|NCT01457846|530808437|FG000|Overall Study|Lost to Follow-up|1|||
147175863|NCT01457846|530808438|FG001|Overall Study|Lost to Follow-up|0|||
147175864|NCT01846741|530808439|FG000|Baseline Visit|Subject did not meet entry criteria|2|||
147175865|NCT01853878|530808440|FG000|Overall Study|Recurrence|2|||
147175866|NCT01853878|530808441|FG001|Overall Study|Recurrence|0|||
147175867|NCT01853878|530808440|FG000|Overall Study|Adverse Event|2|||
147175868|NCT01853878|530808441|FG001|Overall Study|Adverse Event|0|||
147175869|NCT01853878|530808440|FG000|Overall Study|Withdrawal by Subject|3|||
147175870|NCT01853878|530808441|FG001|Overall Study|Withdrawal by Subject|1|||
147175871|NCT01853878|530808440|FG000|Overall Study|Migrated/moved from the study area|1|||
147175872|NCT01853878|530808441|FG001|Overall Study|Migrated/moved from the study area|0|||
147175873|NCT01853878|530808440|FG000|Overall Study|Other|55|||
147175874|NCT01853878|530808441|FG001|Overall Study|Other|43|||
147175875|NCT03997825|530808442|FG000|Overall Study|Death|3|||
147175876|NCT03997825|530808442|FG000|Overall Study|Lost to Follow-up|10|||
147244805|NCT00256750|531069025|FG002|Post-Transplant Treated (24 Months)|Death|0|||
147244806|NCT00256750|531069023|FG000|Post-Transplant Treated (24 Months)|Lack of Efficacy|4|||
147244807|NCT00256750|531069024|FG001|Post-Transplant Treated (24 Months)|Lack of Efficacy|3|||
147244808|NCT00256750|531069025|FG002|Post-Transplant Treated (24 Months)|Lack of Efficacy|2|||
147244809|NCT00256750|531069023|FG000|Post-Transplant Treated (24 Months)|Other|2|||
147244810|NCT00256750|531069024|FG001|Post-Transplant Treated (24 Months)|Other|0|||
147244811|NCT00256750|531069025|FG002|Post-Transplant Treated (24 Months)|Other|1|||
147244812|NCT00256750|531069023|FG000|Post-Transplant Treated (36 Months)|Adverse Event|5|||
147244813|NCT00256750|531069024|FG001|Post-Transplant Treated (36 Months)|Adverse Event|1|||
147244814|NCT00256750|531069025|FG002|Post-Transplant Treated (36 Months)|Adverse Event|2|||
147244815|NCT00256750|531069023|FG000|Post-Transplant Treated (36 Months)|Withdrawal by Subject|1|||
147244816|NCT00256750|531069024|FG001|Post-Transplant Treated (36 Months)|Withdrawal by Subject|0|||
147244817|NCT00256750|531069025|FG002|Post-Transplant Treated (36 Months)|Withdrawal by Subject|1|||
147244818|NCT00256750|531069023|FG000|Post-Transplant Treated (36 Months)|Death|0|||
147244819|NCT00256750|531069024|FG001|Post-Transplant Treated (36 Months)|Death|2|||
147244820|NCT00256750|531069025|FG002|Post-Transplant Treated (36 Months)|Death|1|||
147244821|NCT00256750|531069023|FG000|Post-Transplant Treated (36 Months)|Subject no longer meets study criteria|0|||
147175877|NCT03997825|530808442|FG000|Overall Study|Withdrawal by Subject|3|||
147175878|NCT03997825|530808442|FG000|Overall Study|Refused participation|1|||
147175879|NCT00383162|530808443|FG000|Migraine Attack 1 (Period 1)|No opportunity to treat migraine|3|||
147175880|NCT00383162|530808444|FG001|Migraine Attack 1 (Period 1)|No opportunity to treat migraine|4|||
147244822|NCT00256750|531069024|FG001|Post-Transplant Treated (36 Months)|Subject no longer meets study criteria|0|||
147244823|NCT00256750|531069025|FG002|Post-Transplant Treated (36 Months)|Subject no longer meets study criteria|1|||
147244824|NCT00256750|531069023|FG000|Post-Transplant Treated (36 Months)|Lack of Efficacy|4|||
147244825|NCT00256750|531069024|FG001|Post-Transplant Treated (36 Months)|Lack of Efficacy|1|||
147593006|NCT03832738|532326930|FG000|Overall Study|Physician Decision|0|||
147175881|NCT00383162|530808443|FG000|Migraine Attack 1 (Period 1)|Lost to Follow-up|8|||
147175882|NCT00383162|530808444|FG001|Migraine Attack 1 (Period 1)|Lost to Follow-up|7|||
147175883|NCT00383162|530808443|FG000|Migraine Attack 1 (Period 1)|Did not meet eligibility criteria|4|||
147175884|NCT00383162|530808444|FG001|Migraine Attack 1 (Period 1)|Did not meet eligibility criteria|2|||
147175885|NCT00383162|530808443|FG000|Migraine Attack 1 (Period 1)|Withdrawal by Subject|2|||
147175886|NCT00383162|530808444|FG001|Migraine Attack 1 (Period 1)|Withdrawal by Subject|0|||
147175887|NCT00383162|530808443|FG000|Migraine Attack 1 (Period 1)|Non-compliant|3|||
147175888|NCT00383162|530808444|FG001|Migraine Attack 1 (Period 1)|Non-compliant|0|||
147175889|NCT00383162|530808443|FG000|Migraine Attack 2 (Period 2)|No opportunity to treat migraine 2|1|||
147175890|NCT00383162|530808444|FG001|Migraine Attack 2 (Period 2)|No opportunity to treat migraine 2|3|||
147175891|NCT00383162|530808443|FG000|Migraine Attack 2 (Period 2)|Lost to Follow-up|0|||
147175892|NCT00383162|530808444|FG001|Migraine Attack 2 (Period 2)|Lost to Follow-up|1|||
147175893|NCT00383162|530808443|FG000|Migraine Attack 2 (Period 2)|Adverse Event|1|||
147175894|NCT00383162|530808444|FG001|Migraine Attack 2 (Period 2)|Adverse Event|0|||
147175895|NCT00383162|530808443|FG000|Migraine Attack 2 (Period 2)|Unknown reason|0|||
147175896|NCT00383162|530808444|FG001|Migraine Attack 2 (Period 2)|Unknown reason|3|||
147175897|NCT00767819|530808445|FG000|Overall Study|Unsatisfactory therapeutic effect|18|||
147175898|NCT00767819|530808446|FG001|Overall Study|Unsatisfactory therapeutic effect|14|||
147175899|NCT00767819|530808447|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
147175900|NCT00767819|530808445|FG000|Overall Study|Withdrawal by Subject|1|||
147175901|NCT00767819|530808446|FG001|Overall Study|Withdrawal by Subject|1|||
147175902|NCT00767819|530808447|FG002|Overall Study|Withdrawal by Subject|0|||
147175903|NCT00767819|530808445|FG000|Overall Study|Administrative problems|0|||
147175904|NCT00767819|530808446|FG001|Overall Study|Administrative problems|1|||
147175905|NCT00767819|530808447|FG002|Overall Study|Administrative problems|0|||
147175906|NCT00767819|530808445|FG000|Overall Study|Death|2|||
147175907|NCT00767819|530808446|FG001|Overall Study|Death|3|||
147175908|NCT00767819|530808447|FG002|Overall Study|Death|0|||
147175909|NCT00767819|530808445|FG000|Overall Study|Adverse Event|2|||
147175910|NCT00767819|530808446|FG001|Overall Study|Adverse Event|0|||
147175911|NCT00767819|530808447|FG002|Overall Study|Adverse Event|0|||
147175912|NCT00767819|530808445|FG000|Overall Study|Abnormal lab values|1|||
147175913|NCT00767819|530808446|FG001|Overall Study|Abnormal lab values|0|||
147175914|NCT00767819|530808447|FG002|Overall Study|Abnormal lab values|0|||
147175915|NCT00767819|530808445|FG000|Overall Study|Lost to Follow-up|1|||
147175916|NCT00767819|530808446|FG001|Overall Study|Lost to Follow-up|0|||
147175917|NCT00767819|530808447|FG002|Overall Study|Lost to Follow-up|0|||
147175918|NCT01153698|530808448|FG000|Overall Study|Adverse Event|12|||
147175919|NCT01153698|530808448|FG000|Overall Study|Lost to Follow-up|4|||
147175920|NCT01153698|530808448|FG000|Overall Study|Withdrawal by Subject|2|||
147175921|NCT01153698|530808448|FG000|Overall Study|Switch to other anticoagulants|4|||
147175922|NCT01153698|530808448|FG000|Overall Study|Other|2|||
147175923|NCT01153698|530808448|FG000|Overall Study|Not treated with Pradaxa|5|||
147175924|NCT00465647|530808454|FG000|Overall Study|Administrative|2|||
147175925|NCT00465647|530808455|FG001|Overall Study|Administrative|2|||
147175926|NCT00465647|530808456|FG002|Overall Study|Administrative|3|||
147175927|NCT00465647|530808457|FG003|Overall Study|Administrative|2|||
147175928|NCT00465647|530808454|FG000|Overall Study|Adverse Event|2|||
147175929|NCT00465647|530808455|FG001|Overall Study|Adverse Event|0|||
147175930|NCT00465647|530808456|FG002|Overall Study|Adverse Event|3|||
147175931|NCT00465647|530808457|FG003|Overall Study|Adverse Event|2|||
147175932|NCT00465647|530808454|FG000|Overall Study|Withdrawal by Subject|1|||
147175933|NCT00465647|530808455|FG001|Overall Study|Withdrawal by Subject|2|||
147175934|NCT00465647|530808456|FG002|Overall Study|Withdrawal by Subject|2|||
147175935|NCT00465647|530808457|FG003|Overall Study|Withdrawal by Subject|7|||
147175936|NCT00465647|530808454|FG000|Overall Study|"The other reasons included loss of IV"|8|||
147175937|NCT00465647|530808455|FG001|Overall Study|"The other reasons included loss of IV"|4|||
147175938|NCT00465647|530808456|FG002|Overall Study|"The other reasons included loss of IV"|3|||
147175939|NCT00465647|530808457|FG003|Overall Study|"The other reasons included loss of IV"|2|||
147175940|NCT01371305|530808462|FG000|Overall Study|Adverse Event|0|||
147175941|NCT01371305|530808463|FG001|Overall Study|Adverse Event|0|||
147175942|NCT01371305|530808464|FG002|Overall Study|Adverse Event|0|||
147175943|NCT01371305|530808465|FG003|Overall Study|Adverse Event|2|||
147175944|NCT01371305|530808466|FG004|Overall Study|Adverse Event|1|||
147175945|NCT01371305|530808467|FG005|Overall Study|Adverse Event|0|||
147175946|NCT01371305|530808462|FG000|Overall Study|Study terminated by sponsor|0|||
147175947|NCT01371305|530808463|FG001|Overall Study|Study terminated by sponsor|0|||
147448295|NCT00542269|531805680|FG000|Overall Study|Protocol Violation|1|||
147175948|NCT01371305|530808464|FG002|Overall Study|Study terminated by sponsor|0|||
147175949|NCT01371305|530808465|FG003|Overall Study|Study terminated by sponsor|0|||
147175950|NCT01371305|530808466|FG004|Overall Study|Study terminated by sponsor|3|||
147175951|NCT01371305|530808467|FG005|Overall Study|Study terminated by sponsor|1|||
147175952|NCT01371305|530808462|FG000|Overall Study|Subject request|0|||
147175953|NCT01371305|530808463|FG001|Overall Study|Subject request|0|||
147175954|NCT01371305|530808464|FG002|Overall Study|Subject request|0|||
147175955|NCT01371305|530808465|FG003|Overall Study|Subject request|0|||
147593007|NCT03832738|532326931|FG001|Overall Study|Physician Decision|1|||
147593008|NCT03832738|532326932|FG002|Overall Study|Physician Decision|2|||
147593009|NCT03832738|532326930|FG000|Overall Study|Adverse Event|2|||
147593010|NCT03832738|532326931|FG001|Overall Study|Adverse Event|3|||
147593011|NCT03832738|532326932|FG002|Overall Study|Adverse Event|1|||
147593012|NCT03832738|532326930|FG000|Overall Study|Pregnancy|0|||
147593013|NCT03832738|532326931|FG001|Overall Study|Pregnancy|1|||
147593014|NCT03832738|532326932|FG002|Overall Study|Pregnancy|0|||
147593015|NCT03852459|532326933|FG000|Overall Study|Adverse Event|2|||
147593016|NCT03852459|532326934|FG001|Overall Study|Adverse Event|2|||
147593017|NCT03852459|532326933|FG000|Overall Study|Withdrawal by Subject|1|||
147593018|NCT03852459|532326934|FG001|Overall Study|Withdrawal by Subject|1|||
147593019|NCT00430950|532326935|FG000|Overall Study|Adverse Event|7|||
147593020|NCT00430950|532326936|FG001|Overall Study|Adverse Event|6|||
147593021|NCT00430950|532326935|FG000|Overall Study|Withdrawal by Subject|1|||
147175956|NCT01371305|530808466|FG004|Overall Study|Subject request|0|||
147175957|NCT01371305|530808467|FG005|Overall Study|Subject request|1|||
147175958|NCT04038567|530808468|FG000|Overall Study|Lost to Follow-up|6|||
147175959|NCT04038567|530808469|FG001|Overall Study|Lost to Follow-up|4|||
147175960|NCT04038567|530808470|FG002|Overall Study|Lost to Follow-up|5|||
147175961|NCT04038567|530808471|FG003|Overall Study|Lost to Follow-up|4|||
147175962|NCT04038567|530808472|FG004|Overall Study|Lost to Follow-up|6|||
147175963|NCT04038567|530808473|FG005|Overall Study|Lost to Follow-up|4|||
147175964|NCT04038567|530808474|FG006|Overall Study|Lost to Follow-up|4|||
147175965|NCT04038567|530808475|FG007|Overall Study|Lost to Follow-up|1|||
147175966|NCT04038567|530808468|FG000|Overall Study|Withdrawal by Subject|2|||
147175967|NCT04038567|530808469|FG001|Overall Study|Withdrawal by Subject|1|||
147175968|NCT04038567|530808470|FG002|Overall Study|Withdrawal by Subject|1|||
147175969|NCT04038567|530808471|FG003|Overall Study|Withdrawal by Subject|1|||
147175970|NCT04038567|530808472|FG004|Overall Study|Withdrawal by Subject|4|||
147175971|NCT04038567|530808473|FG005|Overall Study|Withdrawal by Subject|1|||
147175972|NCT04038567|530808474|FG006|Overall Study|Withdrawal by Subject|1|||
147175973|NCT04038567|530808475|FG007|Overall Study|Withdrawal by Subject|1|||
147175974|NCT04038567|530808468|FG000|Overall Study|missed survey window|1|||
147175975|NCT04038567|530808469|FG001|Overall Study|missed survey window|2|||
147175976|NCT04038567|530808470|FG002|Overall Study|missed survey window|0|||
147175977|NCT04038567|530808471|FG003|Overall Study|missed survey window|0|||
147175978|NCT04038567|530808472|FG004|Overall Study|missed survey window|1|||
147175979|NCT04038567|530808473|FG005|Overall Study|missed survey window|1|||
147175980|NCT04038567|530808474|FG006|Overall Study|missed survey window|2|||
147175981|NCT04038567|530808475|FG007|Overall Study|missed survey window|2|||
147175982|NCT04038567|530808468|FG000|Overall Study|technical issues|0|||
147175983|NCT04038567|530808469|FG001|Overall Study|technical issues|0|||
147175984|NCT04038567|530808470|FG002|Overall Study|technical issues|0|||
147175985|NCT04038567|530808471|FG003|Overall Study|technical issues|0|||
147175986|NCT04038567|530808472|FG004|Overall Study|technical issues|0|||
147175987|NCT04038567|530808473|FG005|Overall Study|technical issues|0|||
147175988|NCT04038567|530808474|FG006|Overall Study|technical issues|1|||
147175989|NCT04038567|530808475|FG007|Overall Study|technical issues|0|||
147175990|NCT04038567|530808468|FG000|Overall Study|Medical issues (i.e., illness)|0|||
147175991|NCT04038567|530808469|FG001|Overall Study|Medical issues (i.e., illness)|1|||
147175992|NCT04038567|530808470|FG002|Overall Study|Medical issues (i.e., illness)|2|||
147175993|NCT04038567|530808471|FG003|Overall Study|Medical issues (i.e., illness)|1|||
147175994|NCT04038567|530808472|FG004|Overall Study|Medical issues (i.e., illness)|1|||
147175995|NCT04038567|530808473|FG005|Overall Study|Medical issues (i.e., illness)|1|||
147175996|NCT04038567|530808474|FG006|Overall Study|Medical issues (i.e., illness)|0|||
147175997|NCT04038567|530808475|FG007|Overall Study|Medical issues (i.e., illness)|0|||
147175998|NCT04038567|530808468|FG000|Overall Study|Death|0|||
147175999|NCT04038567|530808469|FG001|Overall Study|Death|0|||
147176000|NCT04038567|530808470|FG002|Overall Study|Death|0|||
147324497|NCT01734811|531352543|FG001|Overall Study|Withdrawal by Subject|0|||
147324498|NCT01290094|531352544|FG000|Overall Study|Withdrawal by Subject|1|||
147324499|NCT01290094|531352544|FG000|Overall Study|Lost to Follow-up|5|||
147324500|NCT01712685|531352549|FG000|Overall Study|pt declined to participate before trmt|1|||
147324501|NCT01871285|531352550|FG000|First Intervention (1 Day)|Adverse Event|1|||
147176001|NCT04038567|530808471|FG003|Overall Study|Death|1|||
147176002|NCT04038567|530808472|FG004|Overall Study|Death|1|||
147176003|NCT04038567|530808473|FG005|Overall Study|Death|0|||
147324502|NCT01871285|531352551|FG001|First Intervention (1 Day)|Adverse Event|0|||
147324503|NCT01871285|531352552|FG002|First Intervention (1 Day)|Adverse Event|0|||
147324504|NCT01871285|531352553|FG003|First Intervention (1 Day)|Adverse Event|0|||
147448296|NCT00542269|531805681|FG001|Overall Study|Protocol Violation|1|||
147176004|NCT04038567|530808474|FG006|Overall Study|Death|0|||
147176005|NCT04038567|530808475|FG007|Overall Study|Death|1|||
147176006|NCT02220712|530808476|FG000|Overall Study|Adverse Event|1|||
147593022|NCT00430950|532326936|FG001|Overall Study|Withdrawal by Subject|0|||
147593023|NCT00430950|532326935|FG000|Overall Study|concomitant medication,etc.|5|||
147593024|NCT00430950|532326936|FG001|Overall Study|concomitant medication,etc.|7|||
147593025|NCT02442271|532326937|FG000|Overall Study|Adverse Event|1|||
147593026|NCT02442271|532326937|FG000|Overall Study|Withdrew Consent|1|||
147593027|NCT02442271|532326937|FG000|Overall Study|Lost to Follow-up|1|||
147176007|NCT02220712|530808476|FG000|Overall Study|Withdrawal by Subject|2|||
147176008|NCT02220712|530808476|FG000|Overall Study|Exacerbation of symptoms of an underlying disease|1|||
147176009|NCT00760838|530808480|FG000|Overall Study|Adverse Event|1|||
147176010|NCT00760838|530808481|FG001|Overall Study|Adverse Event|1|||
147176011|NCT00760838|530808480|FG000|Overall Study|Lack of Efficacy|1|||
147176012|NCT00760838|530808481|FG001|Overall Study|Lack of Efficacy|0|||
147176013|NCT00760838|530808480|FG000|Overall Study|Lost to Follow-up|2|||
147176014|NCT00760838|530808481|FG001|Overall Study|Lost to Follow-up|0|||
147176015|NCT00760838|530808480|FG000|Overall Study|Withdrawal by Subject|1|||
147176016|NCT00760838|530808481|FG001|Overall Study|Withdrawal by Subject|1|||
147176017|NCT01817959|530808482|FG000|Overall Study|Graft loss|1|||
147176018|NCT01817959|530808483|FG001|Overall Study|Graft loss|1|||
147176019|NCT01817959|530808482|FG000|Overall Study|forbidden medication|1|||
147176020|NCT01817959|530808483|FG001|Overall Study|forbidden medication|1|||
147176021|NCT01817959|530808482|FG000|Overall Study|Adverse Event|1|||
147176022|NCT01817959|530808483|FG001|Overall Study|Adverse Event|0|||
147176023|NCT01817959|530808482|FG000|Overall Study|Patient didn't proceed to 1st Islet Inf|1|||
147176024|NCT01817959|530808483|FG001|Overall Study|Patient didn't proceed to 1st Islet Inf|1|||
147176025|NCT04356352|530808497|FG000|Overall Study|PIV in location that was excluded, surgery cancelled|2|||
147176026|NCT04356352|530808498|FG001|Overall Study|PIV in location that was excluded, surgery cancelled|0|||
147176027|NCT04356352|530808499|FG002|Overall Study|PIV in location that was excluded, surgery cancelled|0|||
147176028|NCT04356352|530808497|FG000|Overall Study|Protocol Violation|0|||
147176029|NCT04356352|530808498|FG001|Overall Study|Protocol Violation|3|||
147176030|NCT04356352|530808499|FG002|Overall Study|Protocol Violation|1|||
147176031|NCT00781859|530808500|FG000|Overall Study|Adverse Event|2|||
147176032|NCT00781859|530808501|FG001|Overall Study|Adverse Event|2|||
147176033|NCT00781859|530808500|FG000|Overall Study|Withdrawal by Subject|8|||
147176034|NCT00781859|530808501|FG001|Overall Study|Withdrawal by Subject|4|||
147176035|NCT00781859|530808500|FG000|Overall Study|Lost to Follow-up|6|||
147176036|NCT00781859|530808501|FG001|Overall Study|Lost to Follow-up|3|||
147176037|NCT00781859|530808500|FG000|Overall Study|Death|3|||
147176038|NCT00781859|530808501|FG001|Overall Study|Death|0|||
147176039|NCT01138501|530808502|FG000|Overall Study|Protocol Violation|2|||
147176040|NCT01138501|530808502|FG000|Overall Study|Withdrawal by Subject|3|||
147176041|NCT00622388|530808503|FG000|Overall Study|Disease Progression|47|||
147176042|NCT00622388|530808503|FG000|Overall Study|Adverse Event|6|||
147176043|NCT00622388|530808503|FG000|Overall Study|Protocol Violation|3|||
147176044|NCT00622388|530808503|FG000|Overall Study|Participant Refusal|1|||
147176045|NCT00622388|530808503|FG000|Overall Study|Death|3|||
147176046|NCT00622388|530808503|FG000|Overall Study|Received Alternate Anticancer Therapy|8|||
147176047|NCT00622388|530808503|FG000|Overall Study|Took Prohibited Medication|2|||
147176048|NCT00622388|530808503|FG000|Overall Study|Withdrew Consent|1|||
147176049|NCT00622388|530808503|FG000|Overall Study|Insurance Expired|1|||
147176050|NCT00348309|530808504|FG000|Overall Study|Adverse Event|56|||
147176051|NCT00348309|530808505|FG001|Overall Study|Adverse Event|28|||
147176052|NCT00348309|530808506|FG002|Overall Study|Adverse Event|63|||
147176053|NCT00348309|530808504|FG000|Overall Study|Lost to Follow-up|6|||
147176054|NCT00348309|530808505|FG001|Overall Study|Lost to Follow-up|7|||
147593028|NCT02442271|532326937|FG000|Overall Study|Other|1|||
147593029|NCT00831623|532326943|FG000|Overall Study|Withdrawal by Subject|9|||
147593030|NCT00831623|532326943|FG000|Overall Study|Lost to Follow-up|1|||
147593031|NCT00831623|532326943|FG000|Overall Study|Not 2 years post-treatment|12|||
147176055|NCT00348309|530808506|FG002|Overall Study|Lost to Follow-up|4|||
147176056|NCT00348309|530808504|FG000|Overall Study|Protocol Violation|7|||
147176057|NCT00348309|530808505|FG001|Overall Study|Protocol Violation|12|||
147176058|NCT00348309|530808506|FG002|Overall Study|Protocol Violation|7|||
147176059|NCT00348309|530808504|FG000|Overall Study|Withdrawal by Subject|33|||
147176060|NCT00348309|530808505|FG001|Overall Study|Withdrawal by Subject|37|||
147176061|NCT00348309|530808506|FG002|Overall Study|Withdrawal by Subject|40|||
147176062|NCT00348309|530808504|FG000|Overall Study|Non-compliance|8|||
147176063|NCT00348309|530808505|FG001|Overall Study|Non-compliance|6|||
147176064|NCT00348309|530808506|FG002|Overall Study|Non-compliance|8|||
147176065|NCT00348309|530808504|FG000|Overall Study|Death of caregiver|1|||
147176066|NCT00348309|530808505|FG001|Overall Study|Death of caregiver|0|||
147593032|NCT01564459|532326946|FG000|Run-In|Adverse Event|7|||
147176067|NCT00348309|530808506|FG002|Overall Study|Death of caregiver|1|||
147176068|NCT00348309|530808504|FG000|Overall Study|Lack of insight, dementia|1|||
147176069|NCT00348309|530808505|FG001|Overall Study|Lack of insight, dementia|0|||
147176070|NCT00348309|530808506|FG002|Overall Study|Lack of insight, dementia|0|||
147176071|NCT00348309|530808504|FG000|Overall Study|Wrong bottle allocated|1|||
147176072|NCT00348309|530808505|FG001|Overall Study|Wrong bottle allocated|0|||
147176073|NCT00348309|530808506|FG002|Overall Study|Wrong bottle allocated|0|||
147176074|NCT00348309|530808504|FG000|Overall Study|Caregiver sick|1|||
147593033|NCT01564459|532326947|FG001|Run-In|Adverse Event|0|||
147593034|NCT01564459|532326948|FG002|Run-In|Adverse Event|0|||
147176075|NCT00348309|530808505|FG001|Overall Study|Caregiver sick|0|||
147176076|NCT00348309|530808506|FG002|Overall Study|Caregiver sick|0|||
147176077|NCT00348309|530808504|FG000|Overall Study|Use of prohibited medication|5|||
147176078|NCT00348309|530808505|FG001|Overall Study|Use of prohibited medication|2|||
147176079|NCT00348309|530808506|FG002|Overall Study|Use of prohibited medication|2|||
147176080|NCT00348309|530808504|FG000|Overall Study|Caregiver withdrawal|3|||
147176081|NCT00348309|530808505|FG001|Overall Study|Caregiver withdrawal|0|||
147176082|NCT00348309|530808506|FG002|Overall Study|Caregiver withdrawal|7|||
147176083|NCT00348309|530808504|FG000|Overall Study|Unable to complete ET visit|1|||
147176084|NCT00348309|530808505|FG001|Overall Study|Unable to complete ET visit|0|||
147176085|NCT00348309|530808506|FG002|Overall Study|Unable to complete ET visit|0|||
147176086|NCT00348309|530808504|FG000|Overall Study|PI closing medical practice|1|||
147176087|NCT00348309|530808505|FG001|Overall Study|PI closing medical practice|0|||
147176088|NCT00348309|530808506|FG002|Overall Study|PI closing medical practice|0|||
147176089|NCT00348309|530808504|FG000|Overall Study|Principal investigator's decision|1|||
147176090|NCT00348309|530808505|FG001|Overall Study|Principal investigator's decision|0|||
147176091|NCT00348309|530808506|FG002|Overall Study|Principal investigator's decision|0|||
147176092|NCT00348309|530808504|FG000|Overall Study|No disponibility of medication|1|||
147176093|NCT00348309|530808505|FG001|Overall Study|No disponibility of medication|0|||
147176094|NCT00348309|530808506|FG002|Overall Study|No disponibility of medication|0|||
147176095|NCT00348309|530808504|FG000|Overall Study|Worsened neurodegenerative disease|1|||
147176096|NCT00348309|530808505|FG001|Overall Study|Worsened neurodegenerative disease|0|||
147176097|NCT00348309|530808506|FG002|Overall Study|Worsened neurodegenerative disease|0|||
147176098|NCT00348309|530808504|FG000|Overall Study|Cognitive and behaviour worsening|2|||
147176099|NCT00348309|530808505|FG001|Overall Study|Cognitive and behaviour worsening|0|||
147176100|NCT00348309|530808506|FG002|Overall Study|Cognitive and behaviour worsening|0|||
147176101|NCT00348309|530808504|FG000|Overall Study|Worsening of alzheimer|1|||
147176102|NCT00348309|530808505|FG001|Overall Study|Worsening of alzheimer|0|||
147176103|NCT00348309|530808506|FG002|Overall Study|Worsening of alzheimer|1|||
147176104|NCT00348309|530808504|FG000|Overall Study|Did not appear in time for Visit 3|1|||
147176105|NCT00348309|530808505|FG001|Overall Study|Did not appear in time for Visit 3|0|||
147176106|NCT00348309|530808506|FG002|Overall Study|Did not appear in time for Visit 3|0|||
147176107|NCT00348309|530808504|FG000|Overall Study|Participant died|2|||
147176108|NCT00348309|530808505|FG001|Overall Study|Participant died|1|||
147176109|NCT00348309|530808506|FG002|Overall Study|Participant died|1|||
147176110|NCT00348309|530808504|FG000|Overall Study|Decision of sponsor|1|||
147176111|NCT00348309|530808505|FG001|Overall Study|Decision of sponsor|0|||
147176112|NCT00348309|530808506|FG002|Overall Study|Decision of sponsor|0|||
147176113|NCT00348309|530808504|FG000|Overall Study|Ineffectiveness of treatment|0|||
147176114|NCT00348309|530808505|FG001|Overall Study|Ineffectiveness of treatment|1|||
147176115|NCT00348309|530808506|FG002|Overall Study|Ineffectiveness of treatment|0|||
147593035|NCT01564459|532326946|FG000|Run-In|Lost to Follow-up|1|||
147593036|NCT01564459|532326947|FG001|Run-In|Lost to Follow-up|0|||
147593037|NCT01564459|532326948|FG002|Run-In|Lost to Follow-up|0|||
147176116|NCT00348309|530808504|FG000|Overall Study|A foul of exclusion criteria|0|||
147176117|NCT00348309|530808505|FG001|Overall Study|A foul of exclusion criteria|1|||
147176118|NCT00348309|530808506|FG002|Overall Study|A foul of exclusion criteria|0|||
147176119|NCT00348309|530808504|FG000|Overall Study|Participant was hospitalized|0|||
147324505|NCT01871285|531352550|FG000|First Intervention (1 Day)|Lost to Follow-up|0|||
147324506|NCT01871285|531352551|FG001|First Intervention (1 Day)|Lost to Follow-up|1|||
147324507|NCT01871285|531352552|FG002|First Intervention (1 Day)|Lost to Follow-up|1|||
147324508|NCT01871285|531352553|FG003|First Intervention (1 Day)|Lost to Follow-up|0|||
147324509|NCT00359619|531354306|FG000|Overall Study|Adverse Event|0|||
147324510|NCT00359619|531354307|FG001|Overall Study|Adverse Event|0|||
147593038|NCT01564459|532326946|FG000|Run-In|Non-compliance with study drug|2|||
147593039|NCT01564459|532326947|FG001|Run-In|Non-compliance with study drug|0|||
147176120|NCT00348309|530808505|FG001|Overall Study|Participant was hospitalized|1|||
147176121|NCT00348309|530808506|FG002|Overall Study|Participant was hospitalized|0|||
147176122|NCT00348309|530808504|FG000|Overall Study|Sponsor refuseal|0|||
147176123|NCT00348309|530808505|FG001|Overall Study|Sponsor refuseal|1|||
147176124|NCT00348309|530808506|FG002|Overall Study|Sponsor refuseal|1|||
147176125|NCT00348309|530808504|FG000|Overall Study|Forgot often medication|0|||
147176126|NCT00348309|530808505|FG001|Overall Study|Forgot often medication|1|||
147324511|NCT00359619|531354308|FG002|Overall Study|Adverse Event|1|||
147324512|NCT00359619|531354309|FG003|Overall Study|Adverse Event|0|||
147324513|NCT00359619|531354310|FG004|Overall Study|Adverse Event|0|||
147324514|NCT00359619|531354311|FG005|Overall Study|Adverse Event|0|||
147593040|NCT01564459|532326948|FG002|Run-In|Non-compliance with study drug|0|||
147593041|NCT01564459|532326946|FG000|Run-In|Protocol Violation|1|||
147176127|NCT00348309|530808506|FG002|Overall Study|Forgot often medication|0|||
147176128|NCT00348309|530808504|FG000|Overall Study|Medical Monitor decision|0|||
147324515|NCT00359619|531354312|FG006|Overall Study|Adverse Event|1|||
147593042|NCT01564459|532326947|FG001|Run-In|Protocol Violation|0|||
147593043|NCT01564459|532326948|FG002|Run-In|Protocol Violation|0|||
147593044|NCT01564459|532326946|FG000|Run-In|Withdrawal by Subject|1|||
147593045|NCT01564459|532326947|FG001|Run-In|Withdrawal by Subject|0|||
147593046|NCT01564459|532326948|FG002|Run-In|Withdrawal by Subject|0|||
147593047|NCT01564459|532326946|FG000|Double-blind Treatment|Adverse Event|0|||
147176129|NCT00348309|530808505|FG001|Overall Study|Medical Monitor decision|0|||
147176130|NCT00348309|530808506|FG002|Overall Study|Medical Monitor decision|1|||
147176131|NCT00348309|530808504|FG000|Overall Study|Increased dose of Aricept|0|||
147176132|NCT00348309|530808505|FG001|Overall Study|Increased dose of Aricept|0|||
147176133|NCT00348309|530808506|FG002|Overall Study|Increased dose of Aricept|1|||
147176134|NCT00348309|530808504|FG000|Overall Study|Site closure|0|||
147176135|NCT00348309|530808505|FG001|Overall Study|Site closure|0|||
147176136|NCT00348309|530808506|FG002|Overall Study|Site closure|1|||
147176137|NCT00348309|530808504|FG000|Overall Study|Adverse event not attended|0|||
147176138|NCT00348309|530808505|FG001|Overall Study|Adverse event not attended|0|||
147176139|NCT00348309|530808506|FG002|Overall Study|Adverse event not attended|1|||
147176140|NCT00348309|530808504|FG000|Overall Study|ECG abnormal|0|||
147176141|NCT00348309|530808505|FG001|Overall Study|ECG abnormal|0|||
147176142|NCT00348309|530808506|FG002|Overall Study|ECG abnormal|2|||
147176143|NCT00348309|530808504|FG000|Overall Study|Cardiologist recommendations|0|||
147176144|NCT00348309|530808505|FG001|Overall Study|Cardiologist recommendations|0|||
147176145|NCT00348309|530808506|FG002|Overall Study|Cardiologist recommendations|1|||
147176146|NCT00348309|530808504|FG000|Overall Study|HCV career|0|||
147176147|NCT00348309|530808505|FG001|Overall Study|HCV career|0|||
147176148|NCT00348309|530808506|FG002|Overall Study|HCV career|1|||
147176149|NCT01743040|530808507|FG000|Overall Study|Death|1|||
147176150|NCT01743040|530808507|FG000|Overall Study|Lost to Follow-up|66|||
147176151|NCT01743040|530808507|FG000|Overall Study|Physician Decision|40|||
147176152|NCT01743040|530808507|FG000|Overall Study|Protocol Violation|1|||
147176153|NCT01743040|530808507|FG000|Overall Study|Withdrawal by Subject|121|||
147176154|NCT01894243|530808508|FG000|Overall Study|Adverse Event|0|||
147176155|NCT01894243|530808509|FG001|Overall Study|Adverse Event|1|||
147176156|NCT01894243|530808510|FG002|Overall Study|Adverse Event|2|||
147176157|NCT01894243|530808508|FG000|Overall Study|Death|0|||
147176158|NCT01894243|530808509|FG001|Overall Study|Death|0|||
147176159|NCT01894243|530808510|FG002|Overall Study|Death|3|||
147176160|NCT01894243|530808508|FG000|Overall Study|Lack of Efficacy|3|||
147176161|NCT01894243|530808509|FG001|Overall Study|Lack of Efficacy|3|||
147176162|NCT01894243|530808510|FG002|Overall Study|Lack of Efficacy|1|||
147176163|NCT01894243|530808508|FG000|Overall Study|Condition under investigation worsened|8|||
147176164|NCT01894243|530808509|FG001|Overall Study|Condition under investigation worsened|6|||
147176165|NCT01894243|530808510|FG002|Overall Study|Condition under investigation worsened|2|||
147176166|NCT01894243|530808508|FG000|Overall Study|Subject decision|1|||
147176167|NCT01894243|530808509|FG001|Overall Study|Subject decision|0|||
147176168|NCT01894243|530808510|FG002|Overall Study|Subject decision|0|||
147176169|NCT01894243|530808508|FG000|Overall Study|Other|1|||
147176170|NCT01894243|530808509|FG001|Overall Study|Other|0|||
147176171|NCT01894243|530808510|FG002|Overall Study|Other|0|||
147176172|NCT00828750|530808511|FG000|Overall Study|Lack of Efficacy|3|||
147176173|NCT00828750|530808511|FG000|Overall Study|Normal PC Remained While No Treatment|1|||
147176174|NCT04006392|530808512|FG000|Overall Study|Lost to Follow-up|0|||
147176175|NCT04006392|530808513|FG001|Overall Study|Lost to Follow-up|1|||
147176176|NCT01299116|530808514|FG000|Overall Study|Lost to Follow-up|65|||
147176177|NCT01299116|530808515|FG001|Overall Study|Lost to Follow-up|9|||
147244826|NCT00256750|531069025|FG002|Post-Transplant Treated (36 Months)|Lack of Efficacy|0|||
147244827|NCT00256750|531069023|FG000|Post-Transplant Treated (36 Months)|Protocol Violation|0|||
147244828|NCT00256750|531069024|FG001|Post-Transplant Treated (36 Months)|Protocol Violation|1|||
147244829|NCT00256750|531069025|FG002|Post-Transplant Treated (36 Months)|Protocol Violation|0|||
147244830|NCT00256750|531069023|FG000|Post-Transplant Treated (36 Months)|Other|0|||
147593048|NCT01564459|532326947|FG001|Double-blind Treatment|Adverse Event|0|||
147593049|NCT01564459|532326948|FG002|Double-blind Treatment|Adverse Event|1|||
147593050|NCT02080832|532326958|FG000|Overall Study|Excluded from analysis by MRI|9|||
147176178|NCT01299116|530808516|FG002|Overall Study|Lost to Follow-up|11|||
147176179|NCT01620944|530808517|FG000|Overall Study|Early termination of Study|2|||
147176180|NCT01620944|530808518|FG001|Overall Study|Early termination of Study|1|||
147176181|NCT04378114|530808519|FG000|Overall Study|Withdrawal by Subject|5|||
147176182|NCT00830180|530808520|FG000|Overall Study|Adverse Event|6|||
147176183|NCT00830180|530808520|FG000|Overall Study|Death|11|||
147176184|NCT00830180|530808520|FG000|Overall Study|Insufficient clinical response|1|||
147176185|NCT00830180|530808520|FG000|Overall Study|Withdrawal by Subject|5|||
147176186|NCT00830180|530808520|FG000|Overall Study|Progressive disease|2|||
147176187|NCT00830180|530808520|FG000|Overall Study|Other - Unspecified|1|||
147176188|NCT01832532|530808521|FG000|Overall Study|Withdrawal by Subject|5|||
147176189|NCT01832532|530808522|FG001|Overall Study|Withdrawal by Subject|2|||
147176190|NCT00392990|530808523|FG000|Treatment on Study|Adverse Event|3|||
147176191|NCT00392990|530808524|FG001|Treatment on Study|Adverse Event|1|||
147176192|NCT00392990|530808523|FG000|Follow up for 2 Years|Death|4|||
147244831|NCT00256750|531069024|FG001|Post-Transplant Treated (36 Months)|Other|1|||
147593051|NCT02080832|532326959|FG001|Overall Study|Excluded from analysis by MRI|10|||
147324516|NCT00359619|531354306|FG000|Overall Study|Withdrawal by Subject|3|||
147324517|NCT00359619|531354307|FG001|Overall Study|Withdrawal by Subject|1|||
147324518|NCT00359619|531354308|FG002|Overall Study|Withdrawal by Subject|4|||
147244832|NCT00256750|531069025|FG002|Post-Transplant Treated (36 Months)|Other|1|||
147244833|NCT00256750|531069023|FG000|Long Term Extension (LTE; 84 Months)|Adverse Event|13|||
147244834|NCT00256750|531069024|FG001|Long Term Extension (LTE; 84 Months)|Adverse Event|11|||
147244835|NCT00256750|531069025|FG002|Long Term Extension (LTE; 84 Months)|Adverse Event|14|||
147244836|NCT00256750|531069023|FG000|Long Term Extension (LTE; 84 Months)|Withdrawal by Subject|5|||
147244837|NCT00256750|531069024|FG001|Long Term Extension (LTE; 84 Months)|Withdrawal by Subject|4|||
147244838|NCT00256750|531069025|FG002|Long Term Extension (LTE; 84 Months)|Withdrawal by Subject|1|||
147244839|NCT00256750|531069023|FG000|Long Term Extension (LTE; 84 Months)|Lost to Follow-up|4|||
147244840|NCT00256750|531069024|FG001|Long Term Extension (LTE; 84 Months)|Lost to Follow-up|1|||
147244841|NCT00256750|531069025|FG002|Long Term Extension (LTE; 84 Months)|Lost to Follow-up|1|||
147244842|NCT00256750|531069023|FG000|Long Term Extension (LTE; 84 Months)|Death|9|||
147244843|NCT00256750|531069024|FG001|Long Term Extension (LTE; 84 Months)|Death|4|||
147244844|NCT00256750|531069025|FG002|Long Term Extension (LTE; 84 Months)|Death|4|||
147244845|NCT00256750|531069023|FG000|Long Term Extension (LTE; 84 Months)|Lack of Efficacy|6|||
147244846|NCT00256750|531069024|FG001|Long Term Extension (LTE; 84 Months)|Lack of Efficacy|3|||
147244847|NCT00256750|531069025|FG002|Long Term Extension (LTE; 84 Months)|Lack of Efficacy|0|||
147244848|NCT00256750|531069023|FG000|Long Term Extension (LTE; 84 Months)|Poor/Non-compliance|4|||
147244849|NCT00256750|531069024|FG001|Long Term Extension (LTE; 84 Months)|Poor/Non-compliance|1|||
147244850|NCT00256750|531069025|FG002|Long Term Extension (LTE; 84 Months)|Poor/Non-compliance|1|||
147324519|NCT00359619|531354309|FG003|Overall Study|Withdrawal by Subject|2|||
147324520|NCT00359619|531354310|FG004|Overall Study|Withdrawal by Subject|2|||
147324521|NCT00359619|531354311|FG005|Overall Study|Withdrawal by Subject|0|||
147324522|NCT00359619|531354312|FG006|Overall Study|Withdrawal by Subject|3|||
147324523|NCT00359619|531354306|FG000|Overall Study|Other|1|||
147324524|NCT00359619|531354307|FG001|Overall Study|Other|0|||
147324525|NCT00359619|531354308|FG002|Overall Study|Other|0|||
147324526|NCT00359619|531354309|FG003|Overall Study|Other|0|||
147176193|NCT00392990|530808524|FG001|Follow up for 2 Years|Death|0|||
147176194|NCT00991406|530808528|FG000|Overall Study|One participant did not respond to FES.|1|||
147176195|NCT03824587|530808529|FG000|Run-in Period|Screen Failure|0|||
147176196|NCT03824587|530808530|FG001|Run-in Period|Screen Failure|275|||
147176197|NCT03824587|530808529|FG000|Treatment Period|Adverse Event|4|||
147176198|NCT03824587|530808530|FG001|Treatment Period|Adverse Event|1|||
147176199|NCT03824587|530808529|FG000|Treatment Period|Withdrawal by Subject|0|||
147176200|NCT03824587|530808530|FG001|Treatment Period|Withdrawal by Subject|1|||
147176201|NCT03824587|530808529|FG000|Treatment Period|Kidney Transplant|1|||
147176202|NCT03824587|530808530|FG001|Treatment Period|Kidney Transplant|1|||
147176203|NCT00986362|530808531|FG000|Overall Study|Death|2|||
147176204|NCT00986362|530808532|FG001|Overall Study|Death|0|||
147176205|NCT00986362|530808531|FG000|Overall Study|Lost to Follow-up|0|||
147176206|NCT00986362|530808532|FG001|Overall Study|Lost to Follow-up|1|||
147176207|NCT01300572|530808533|FG000|Overall Study|HAMA + post dosimetry|1|||
147176208|NCT02160145|530808534|FG000|Prerandomization Single-blind Period|Placebo run-in failure|23|||
147176209|NCT02160145|530808535|FG001|Prerandomization Single-blind Period|Placebo run-in failure|0|||
147176210|NCT02160145|530808536|FG002|Prerandomization Single-blind Period|Placebo run-in failure|0|||
147176211|NCT02160145|530808534|FG000|Prerandomization Single-blind Period|Tolvaptan titration/run-in failure|126|||
147176212|NCT02160145|530808535|FG001|Prerandomization Single-blind Period|Tolvaptan titration/run-in failure|0|||
147176213|NCT02160145|530808536|FG002|Prerandomization Single-blind Period|Tolvaptan titration/run-in failure|0|||
147176214|NCT02160145|530808534|FG000|Randomized Double-blind Period|Subject decision|0|||
147176215|NCT02160145|530808535|FG001|Randomized Double-blind Period|Subject decision|21|||
147176216|NCT02160145|530808536|FG002|Randomized Double-blind Period|Subject decision|20|||
147176217|NCT02160145|530808534|FG000|Randomized Double-blind Period|Lost to Follow-up|0|||
147176218|NCT02160145|530808535|FG001|Randomized Double-blind Period|Lost to Follow-up|1|||
147176219|NCT02160145|530808536|FG002|Randomized Double-blind Period|Lost to Follow-up|3|||
147244851|NCT00256750|531069023|FG000|Long Term Extension (LTE; 84 Months)|Pregnancy|0|||
147244852|NCT00256750|531069024|FG001|Long Term Extension (LTE; 84 Months)|Pregnancy|1|||
147244853|NCT00256750|531069025|FG002|Long Term Extension (LTE; 84 Months)|Pregnancy|2|||
147324527|NCT00359619|531354310|FG004|Overall Study|Other|0|||
147244854|NCT00256750|531069023|FG000|Long Term Extension (LTE; 84 Months)|Administrative Reason By Sponsor|1|||
147176220|NCT02160145|530808534|FG000|Randomized Double-blind Period|Physician Decision|0|||
147324528|NCT00359619|531354311|FG005|Overall Study|Other|0|||
147324529|NCT00359619|531354312|FG006|Overall Study|Other|0|||
147324530|NCT00359619|531354306|FG000|Overall Study|Lost to Follow-up|4|||
147176221|NCT02160145|530808535|FG001|Randomized Double-blind Period|Physician Decision|7|||
147176222|NCT02160145|530808536|FG002|Randomized Double-blind Period|Physician Decision|5|||
147176223|NCT02006979|530808537|FG000|Overall Study|Withdrawal by Subject|1|||
147244855|NCT00256750|531069024|FG001|Long Term Extension (LTE; 84 Months)|Administrative Reason By Sponsor|1|||
147324531|NCT00359619|531354307|FG001|Overall Study|Lost to Follow-up|4|||
147593052|NCT02080832|532326960|FG002|Overall Study|Excluded from analysis by MRI|14|||
147593053|NCT02080832|532326958|FG000|Overall Study|Lost to Follow-up|0|||
147593054|NCT02080832|532326959|FG001|Overall Study|Lost to Follow-up|2|||
147176224|NCT02006979|530808538|FG001|Overall Study|Withdrawal by Subject|1|||
147176225|NCT02006979|530808537|FG000|Overall Study|Protocol Violation|0|||
147176226|NCT02006979|530808538|FG001|Overall Study|Protocol Violation|1|||
147176227|NCT00375518|530808539|FG000|Overall Study|Withdrawal by Subject|2|||
147176228|NCT00375518|530808540|FG001|Overall Study|Withdrawal by Subject|10|||
147176229|NCT00375518|530808539|FG000|Overall Study|Patient Not Treated|6|||
147176230|NCT00375518|530808540|FG001|Overall Study|Patient Not Treated|6|||
147176231|NCT00375518|530808539|FG000|Overall Study|Death|0|||
147176232|NCT00375518|530808540|FG001|Overall Study|Death|1|||
147176233|NCT03170193|530808541|FG000|Overall Study|Withdrawal by Subject|0|||
147176234|NCT03170193|530808542|FG001|Overall Study|Withdrawal by Subject|0|||
147176235|NCT03170193|530808543|FG002|Overall Study|Withdrawal by Subject|0|||
147176236|NCT03170193|530808544|FG003|Overall Study|Withdrawal by Subject|1|||
147176237|NCT03170193|530808545|FG004|Overall Study|Withdrawal by Subject|0|||
147176238|NCT03170193|530808546|FG005|Overall Study|Withdrawal by Subject|0|||
147176239|NCT03170193|530808547|FG006|Overall Study|Withdrawal by Subject|0|||
147176240|NCT03170193|530808541|FG000|Overall Study|Lost to Follow-up|1|||
147176241|NCT03170193|530808542|FG001|Overall Study|Lost to Follow-up|1|||
147176242|NCT03170193|530808543|FG002|Overall Study|Lost to Follow-up|0|||
147176243|NCT03170193|530808544|FG003|Overall Study|Lost to Follow-up|0|||
147176244|NCT03170193|530808545|FG004|Overall Study|Lost to Follow-up|0|||
147176245|NCT03170193|530808546|FG005|Overall Study|Lost to Follow-up|0|||
147176246|NCT03170193|530808547|FG006|Overall Study|Lost to Follow-up|0|||
147176247|NCT03052816|530808550|FG000|Overall Study|Withdrawal by Subject|1|||
147176248|NCT03052816|530808551|FG001|Overall Study|Withdrawal by Subject|0|||
147176249|NCT03052816|530808550|FG000|Overall Study|Desired opioids|2|||
147176250|NCT03052816|530808551|FG001|Overall Study|Desired opioids|0|||
147176251|NCT03755661|530808554|FG000|Overall Study|Lost to Follow-up|1|||
147176252|NCT03755661|530808555|FG001|Overall Study|Lost to Follow-up|0|||
147176253|NCT01016600|530811488|FG000|Overall Study|Did not start treatment|1|||
147176254|NCT01016600|530811489|FG001|Overall Study|Did not start treatment|0|||
147176255|NCT01016600|530811490|FG002|Overall Study|Did not start treatment|0|||
147176256|NCT01016600|530811491|FG003|Overall Study|Did not start treatment|0|||
147176257|NCT00265317|530811497|FG000|Lead-In|Objective progression or relapse|6|||
147176258|NCT00265317|530811498|FG001|Lead-In|Objective progression or relapse|11|||
147176259|NCT00265317|530811499|FG002|Lead-In|Objective progression or relapse|0|||
147176260|NCT00265317|530811500|FG003|Lead-In|Objective progression or relapse|0|||
147176261|NCT00265317|530811497|FG000|Lead-In|Adverse Event|2|||
147176262|NCT00265317|530811498|FG001|Lead-In|Adverse Event|1|||
147176263|NCT00265317|530811499|FG002|Lead-In|Adverse Event|0|||
147176264|NCT00265317|530811500|FG003|Lead-In|Adverse Event|0|||
147176265|NCT00265317|530811497|FG000|Lead-In|Death|3|||
147176266|NCT00265317|530811498|FG001|Lead-In|Death|5|||
147176267|NCT00265317|530811499|FG002|Lead-In|Death|0|||
147176268|NCT00265317|530811500|FG003|Lead-In|Death|0|||
147176269|NCT00265317|530811497|FG000|Lead-In|Withdrawal/other than adverse event|1|||
147176270|NCT00265317|530811498|FG001|Lead-In|Withdrawal/other than adverse event|0|||
147176271|NCT00265317|530811499|FG002|Lead-In|Withdrawal/other than adverse event|0|||
147176272|NCT00265317|530811500|FG003|Lead-In|Withdrawal/other than adverse event|0|||
147176273|NCT00265317|530811497|FG000|Phase 2|Objective progression or relapse|0|||
147176274|NCT00265317|530811498|FG001|Phase 2|Objective progression or relapse|0|||
147176275|NCT00265317|530811499|FG002|Phase 2|Objective progression or relapse|37|||
147176276|NCT00265317|530811500|FG003|Phase 2|Objective progression or relapse|38|||
147176277|NCT00265317|530811497|FG000|Phase 2|Global deterioration of health status|0|||
147176278|NCT00265317|530811498|FG001|Phase 2|Global deterioration of health status|0|||
147176279|NCT00265317|530811499|FG002|Phase 2|Global deterioration of health status|3|||
147176280|NCT00265317|530811500|FG003|Phase 2|Global deterioration of health status|0|||
147593055|NCT02080832|532326960|FG002|Overall Study|Lost to Follow-up|2|||
147593056|NCT03545191|532326962|FG000|Overall Study|Death|1|||
147593057|NCT03545191|532326963|FG001|Overall Study|Death|0|||
147593058|NCT03545191|532326964|FG002|Overall Study|Death|0|||
147324532|NCT00359619|531354308|FG002|Overall Study|Lost to Follow-up|2|||
147593059|NCT03545191|532326962|FG000|Overall Study|Adverse Event|4|||
147176281|NCT00265317|530811497|FG000|Phase 2|Adverse Event|0|||
147176282|NCT00265317|530811498|FG001|Phase 2|Adverse Event|0|||
147176283|NCT00265317|530811499|FG002|Phase 2|Adverse Event|7|||
147176284|NCT00265317|530811500|FG003|Phase 2|Adverse Event|5|||
147176285|NCT00265317|530811497|FG000|Phase 2|Death|0|||
147176286|NCT00265317|530811498|FG001|Phase 2|Death|0|||
147176287|NCT00265317|530811499|FG002|Phase 2|Death|12|||
147176288|NCT00265317|530811500|FG003|Phase 2|Death|15|||
147176289|NCT00265317|530811497|FG000|Phase 2|Protocol Violation|0|||
147176290|NCT00265317|530811498|FG001|Phase 2|Protocol Violation|0|||
147176291|NCT00265317|530811499|FG002|Phase 2|Protocol Violation|1|||
147176292|NCT00265317|530811500|FG003|Phase 2|Protocol Violation|4|||
147176293|NCT00265317|530811497|FG000|Phase 2|Lost to Follow-up|0|||
147593060|NCT03545191|532326963|FG001|Overall Study|Adverse Event|2|||
147655810|NCT03092791|532563005|FG007|Overall Study|Reason Not Specified|0|||
147176294|NCT00265317|530811498|FG001|Phase 2|Lost to Follow-up|0|||
147176295|NCT00265317|530811499|FG002|Phase 2|Lost to Follow-up|0|||
147176296|NCT00265317|530811500|FG003|Phase 2|Lost to Follow-up|1|||
147176297|NCT00265317|530811497|FG000|Phase 2|Withdrawal/other than adverse event|0|||
147176298|NCT00265317|530811498|FG001|Phase 2|Withdrawal/other than adverse event|0|||
147176299|NCT00265317|530811499|FG002|Phase 2|Withdrawal/other than adverse event|2|||
147176300|NCT00265317|530811500|FG003|Phase 2|Withdrawal/other than adverse event|1|||
147176301|NCT00265317|530811497|FG000|Phase 2|Study terminated by sponsor|0|||
147176302|NCT00265317|530811498|FG001|Phase 2|Study terminated by sponsor|0|||
147176303|NCT00265317|530811499|FG002|Phase 2|Study terminated by sponsor|1|||
147176304|NCT00265317|530811500|FG003|Phase 2|Study terminated by sponsor|0|||
147176305|NCT00265317|530811497|FG000|Phase 2|Other|0|||
147176306|NCT00265317|530811498|FG001|Phase 2|Other|0|||
147176307|NCT00265317|530811499|FG002|Phase 2|Other|1|||
147176308|NCT00265317|530811500|FG003|Phase 2|Other|1|||
147176309|NCT00801229|530811501|FG000|Signed Consent|Withdrawal by Subject|2|||
147176310|NCT00801229|530811502|FG001|Signed Consent|Withdrawal by Subject|2|||
147176311|NCT00801229|530811501|FG000|Signed Consent|Found Ineligible|1|||
147176312|NCT00801229|530811502|FG001|Signed Consent|Found Ineligible|1|||
147176313|NCT00801229|530811501|FG000|Received Study Drug/Placebo|Elevated SGOT level|1|||
147176314|NCT00801229|530811502|FG001|Received Study Drug/Placebo|Elevated SGOT level|0|||
147176315|NCT00801229|530811501|FG000|Received Study Drug/Placebo|Sub-threshold ADHD|0|||
147176316|NCT00801229|530811502|FG001|Received Study Drug/Placebo|Sub-threshold ADHD|1|||
147176317|NCT00801229|530811501|FG000|Received Study Drug/Placebo|Simulator sickness|1|||
147176318|NCT00801229|530811502|FG001|Received Study Drug/Placebo|Simulator sickness|1|||
147176319|NCT00801229|530811501|FG000|Received Study Drug/Placebo|Withdrawal by Subject|1|||
147176320|NCT00801229|530811502|FG001|Received Study Drug/Placebo|Withdrawal by Subject|0|||
147176321|NCT00801229|530811501|FG000|Received Study Drug/Placebo|Lost to Follow-up|0|||
147176322|NCT00801229|530811502|FG001|Received Study Drug/Placebo|Lost to Follow-up|1|||
147176323|NCT00801229|530811501|FG000|Received Study Drug/Placebo|Adverse Event|1|||
147176324|NCT00801229|530811502|FG001|Received Study Drug/Placebo|Adverse Event|1|||
147176325|NCT03826186|530811503|FG000|Overall Study|Protocol Violation|2|||
147176326|NCT03826186|530811504|FG001|Overall Study|Protocol Violation|0|||
147176327|NCT03826186|530811503|FG000|Overall Study|Withdrawal by Subject|1|||
147176328|NCT03826186|530811504|FG001|Overall Study|Withdrawal by Subject|0|||
147176329|NCT02300259|530811505|FG000|Period 1|Adverse Event|0|||
147176330|NCT02300259|530811506|FG001|Period 1|Adverse Event|0|||
147176331|NCT02300259|530811507|FG002|Period 1|Adverse Event|1|||
147176332|NCT02300259|530811505|FG000|Period 1|Withdrawal by Subject|0|||
147176333|NCT02300259|530811506|FG001|Period 1|Withdrawal by Subject|0|||
147176334|NCT02300259|530811507|FG002|Period 1|Withdrawal by Subject|1|||
147176335|NCT02300259|530811505|FG000|Period 2|Adverse Event|1|||
147176336|NCT02300259|530811506|FG001|Period 2|Adverse Event|0|||
147176337|NCT02300259|530811507|FG002|Period 2|Adverse Event|0|||
147176338|NCT02300259|530811505|FG000|Period 2|Withdrawal by Subject|0|||
147176339|NCT02300259|530811506|FG001|Period 2|Withdrawal by Subject|0|||
147176340|NCT02300259|530811507|FG002|Period 2|Withdrawal by Subject|1|||
147176341|NCT02737475|530811508|FG000|Overall Study|Other reasons|0|||
147176342|NCT02737475|530811509|FG001|Overall Study|Other reasons|0|||
147176343|NCT02737475|530811510|FG002|Overall Study|Other reasons|0|||
147176344|NCT02737475|530811511|FG003|Overall Study|Other reasons|0|||
147176345|NCT02737475|530811512|FG004|Overall Study|Other reasons|1|||
147176346|NCT02737475|530811513|FG005|Overall Study|Other reasons|1|||
147176347|NCT02737475|530811514|FG006|Overall Study|Other reasons|0|||
147176348|NCT02737475|530811515|FG007|Overall Study|Other reasons|0|||
147176349|NCT02737475|530811516|FG008|Overall Study|Other reasons|1|||
147176350|NCT02737475|530811517|FG009|Overall Study|Other reasons|0|||
147176351|NCT02737475|530811518|FG010|Overall Study|Other reasons|1|||
147176352|NCT02737475|530811519|FG011|Overall Study|Other reasons|0|||
147176353|NCT02737475|530811520|FG012|Overall Study|Other reasons|0|||
147176354|NCT02737475|530811521|FG013|Overall Study|Other reasons|0|||
147176355|NCT02737475|530811522|FG014|Overall Study|Other reasons|0|||
147176356|NCT02737475|530811523|FG015|Overall Study|Other reasons|0|||
147176357|NCT02737475|530811524|FG016|Overall Study|Other reasons|0|||
147176358|NCT02737475|530811525|FG017|Overall Study|Other reasons|0|||
147176359|NCT02737475|530811526|FG018|Overall Study|Other reasons|0|||
147176360|NCT02737475|530811527|FG019|Overall Study|Other reasons|0|||
147176361|NCT02737475|530811528|FG020|Overall Study|Other reasons|0|||
147176362|NCT02737475|530811529|FG021|Overall Study|Other reasons|1|||
147176363|NCT02737475|530811530|FG022|Overall Study|Other reasons|0|||
147176364|NCT02737475|530811531|FG023|Overall Study|Other reasons|1|||
147176365|NCT02737475|530811532|FG024|Overall Study|Other reasons|1|||
147176366|NCT02737475|530811533|FG025|Overall Study|Other reasons|1|||
147176367|NCT02737475|530811534|FG026|Overall Study|Other reasons|0|||
147176368|NCT02737475|530811508|FG000|Overall Study|Death|1|||
147176369|NCT02737475|530811509|FG001|Overall Study|Death|0|||
147176370|NCT02737475|530811510|FG002|Overall Study|Death|0|||
147176371|NCT02737475|530811511|FG003|Overall Study|Death|1|||
147176372|NCT02737475|530811512|FG004|Overall Study|Death|0|||
147244856|NCT00256750|531069025|FG002|Long Term Extension (LTE; 84 Months)|Administrative Reason By Sponsor|0|||
147244857|NCT00256750|531069023|FG000|Long Term Extension (LTE; 84 Months)|Other|5|||
147244858|NCT00256750|531069024|FG001|Long Term Extension (LTE; 84 Months)|Other|4|||
147244859|NCT00256750|531069025|FG002|Long Term Extension (LTE; 84 Months)|Other|5|||
147244860|NCT04659161|531069026|FG000|Overall Study|Adverse Event|10|||
147244861|NCT04659161|531069027|FG001|Overall Study|Adverse Event|6|||
147244862|NCT04659161|531069026|FG000|Overall Study|Withdrawal by Subject|13|||
147244863|NCT04659161|531069027|FG001|Overall Study|Withdrawal by Subject|12|||
147244864|NCT04659161|531069026|FG000|Overall Study|Other|9|||
147244865|NCT04659161|531069027|FG001|Overall Study|Other|8|||
147244866|NCT02197130|531069031|FG000|Overall Study|Adverse Event|13|||
147244867|NCT02197130|531069032|FG001|Overall Study|Adverse Event|4|||
147244868|NCT02197130|531069033|FG002|Overall Study|Adverse Event|23|||
147244869|NCT02197130|531069031|FG000|Overall Study|Death|0|||
147244870|NCT02197130|531069032|FG001|Overall Study|Death|1|||
147244871|NCT02197130|531069033|FG002|Overall Study|Death|0|||
147244872|NCT02197130|531069031|FG000|Overall Study|Lost to Follow-up|2|||
147244873|NCT02197130|531069032|FG001|Overall Study|Lost to Follow-up|0|||
147244874|NCT02197130|531069033|FG002|Overall Study|Lost to Follow-up|1|||
147244875|NCT02197130|531069031|FG000|Overall Study|Does not meet entrance criteria|0|||
147244876|NCT02197130|531069032|FG001|Overall Study|Does not meet entrance criteria|0|||
147244877|NCT02197130|531069033|FG002|Overall Study|Does not meet entrance criteria|1|||
147244878|NCT02197130|531069031|FG000|Overall Study|Withdrawal by Subject|0|||
147244879|NCT02197130|531069032|FG001|Overall Study|Withdrawal by Subject|3|||
147244880|NCT02197130|531069033|FG002|Overall Study|Withdrawal by Subject|4|||
147244881|NCT02197130|531069031|FG000|Overall Study|Other|1|||
147244882|NCT02197130|531069032|FG001|Overall Study|Other|0|||
147244883|NCT02197130|531069033|FG002|Overall Study|Other|3|||
147244884|NCT02615145|531069034|FG000|Overall Study|Did Not Start Treatment|0|||
147244885|NCT02615145|531069035|FG001|Overall Study|Did Not Start Treatment|0|||
147244886|NCT02615145|531069036|FG002|Overall Study|Did Not Start Treatment|1|||
147244887|NCT02615145|531069037|FG003|Overall Study|Did Not Start Treatment|1|||
147244888|NCT02615145|531069034|FG000|Overall Study|Failure to Return|20|||
147244889|NCT02615145|531069035|FG001|Overall Study|Failure to Return|10|||
147244890|NCT02615145|531069036|FG002|Overall Study|Failure to Return|7|||
147244891|NCT02615145|531069037|FG003|Overall Study|Failure to Return|0|||
147244892|NCT02615145|531069034|FG000|Overall Study|Death|2|||
147244893|NCT02615145|531069035|FG001|Overall Study|Death|3|||
147244894|NCT02615145|531069036|FG002|Overall Study|Death|0|||
147244895|NCT02615145|531069037|FG003|Overall Study|Death|0|||
147244896|NCT02615145|531069034|FG000|Overall Study|Other, Not Specified|5|||
147244897|NCT02615145|531069035|FG001|Overall Study|Other, Not Specified|2|||
147244898|NCT02615145|531069036|FG002|Overall Study|Other, Not Specified|0|||
147244899|NCT02615145|531069037|FG003|Overall Study|Other, Not Specified|0|||
147244900|NCT03648983|531069044|FG000|Overall Study|Study was terminated due to PI departure|95|||
147244901|NCT04404361|531069048|FG000|Overall Study|Death|12|||
147244902|NCT04404361|531069049|FG001|Overall Study|Death|12|||
147244903|NCT04404361|531069048|FG000|Overall Study|Withdrawal by Subject|13|||
147244904|NCT04404361|531069049|FG001|Overall Study|Withdrawal by Subject|5|||
147244905|NCT04404361|531069048|FG000|Overall Study|Lost to Follow-up|6|||
147244906|NCT04404361|531069049|FG001|Overall Study|Lost to Follow-up|3|||
147244907|NCT04404361|531069048|FG000|Overall Study|patient hospitalized and was nonverbal at the end of the study|0|||
147244908|NCT04404361|531069049|FG001|Overall Study|patient hospitalized and was nonverbal at the end of the study|1|||
147244909|NCT00903695|531070699|FG000|Overall Study|medical exclusion after 1st testing|1|||
147244910|NCT00903695|531070700|FG001|Overall Study|medical exclusion after 1st testing|0|||
147244911|NCT00903695|531070699|FG000|Overall Study|lung cancer|1|||
147244912|NCT00903695|531070700|FG001|Overall Study|lung cancer|0|||
147244913|NCT01342796|531070703|FG000|Overall Study|Withdrawal by Subject|2|||
147244914|NCT01342796|531070704|FG001|Overall Study|Withdrawal by Subject|0|||
147244915|NCT01342796|531070703|FG000|Overall Study|Lost to Follow-up|0|||
147244916|NCT01342796|531070704|FG001|Overall Study|Lost to Follow-up|3|||
147244917|NCT01342796|531070703|FG000|Overall Study|Inappropriate enrollment|1|||
147244918|NCT01342796|531070704|FG001|Overall Study|Inappropriate enrollment|0|||
147244919|NCT03489720|531070707|FG000|Overall Study|Withdrawal by Subject|2|||
147244920|NCT03489720|531070708|FG001|Overall Study|Withdrawal by Subject|0|||
147244921|NCT03521934|531070717|FG000|Overall Study|Death|65|||
147244922|NCT03521934|531070718|FG001|Overall Study|Death|73|||
147244923|NCT03521934|531070717|FG000|Overall Study|Withdrawal by Subject|18|||
147244924|NCT03521934|531070718|FG001|Overall Study|Withdrawal by Subject|23|||
147244925|NCT03521934|531070717|FG000|Overall Study|Site Terminated by Sponsor|39|||
147448297|NCT00542269|531805682|FG002|Overall Study|Protocol Violation|0|||
147448298|NCT00542269|531805680|FG000|Overall Study|Withdrawal by Subject|1|||
147244926|NCT03521934|531070718|FG001|Overall Study|Site Terminated by Sponsor|35|||
147244927|NCT03521934|531070717|FG000|Overall Study|Study Terminated by Sponsor|483|||
147244928|NCT03521934|531070718|FG001|Overall Study|Study Terminated by Sponsor|477|||
147244929|NCT03521934|531070717|FG000|Overall Study|Reason not Specified|3|||
147244930|NCT03521934|531070718|FG001|Overall Study|Reason not Specified|6|||
147176373|NCT02737475|530811513|FG005|Overall Study|Death|0|||
147176374|NCT02737475|530811514|FG006|Overall Study|Death|0|||
147176375|NCT02737475|530811515|FG007|Overall Study|Death|2|||
147176376|NCT02737475|530811516|FG008|Overall Study|Death|0|||
147176377|NCT02737475|530811517|FG009|Overall Study|Death|0|||
147176378|NCT02737475|530811518|FG010|Overall Study|Death|0|||
147176379|NCT02737475|530811519|FG011|Overall Study|Death|4|||
147176380|NCT02737475|530811520|FG012|Overall Study|Death|2|||
147176381|NCT02737475|530811521|FG013|Overall Study|Death|2|||
147176382|NCT02737475|530811522|FG014|Overall Study|Death|0|||
147176383|NCT02737475|530811523|FG015|Overall Study|Death|2|||
147176384|NCT02737475|530811524|FG016|Overall Study|Death|2|||
147176385|NCT02737475|530811525|FG017|Overall Study|Death|2|||
147176386|NCT02737475|530811526|FG018|Overall Study|Death|1|||
147176387|NCT02737475|530811527|FG019|Overall Study|Death|0|||
147176388|NCT02737475|530811528|FG020|Overall Study|Death|0|||
147176389|NCT02737475|530811529|FG021|Overall Study|Death|0|||
147176390|NCT02737475|530811530|FG022|Overall Study|Death|0|||
147176391|NCT02737475|530811531|FG023|Overall Study|Death|0|||
147176392|NCT02737475|530811532|FG024|Overall Study|Death|0|||
147176393|NCT02737475|530811533|FG025|Overall Study|Death|0|||
147176394|NCT02737475|530811534|FG026|Overall Study|Death|0|||
147176395|NCT02737475|530811508|FG000|Overall Study|Participant withdrew consent|0|||
147176396|NCT02737475|530811509|FG001|Overall Study|Participant withdrew consent|0|||
147176397|NCT02737475|530811510|FG002|Overall Study|Participant withdrew consent|0|||
147176398|NCT02737475|530811511|FG003|Overall Study|Participant withdrew consent|0|||
147176399|NCT02737475|530811512|FG004|Overall Study|Participant withdrew consent|0|||
147176400|NCT02737475|530811513|FG005|Overall Study|Participant withdrew consent|2|||
147176401|NCT02737475|530811514|FG006|Overall Study|Participant withdrew consent|0|||
147176402|NCT02737475|530811515|FG007|Overall Study|Participant withdrew consent|0|||
147176403|NCT02737475|530811516|FG008|Overall Study|Participant withdrew consent|0|||
147176404|NCT02737475|530811517|FG009|Overall Study|Participant withdrew consent|0|||
147176405|NCT02737475|530811518|FG010|Overall Study|Participant withdrew consent|0|||
147176406|NCT02737475|530811519|FG011|Overall Study|Participant withdrew consent|0|||
147176407|NCT02737475|530811520|FG012|Overall Study|Participant withdrew consent|0|||
147176408|NCT02737475|530811521|FG013|Overall Study|Participant withdrew consent|0|||
147176409|NCT02737475|530811522|FG014|Overall Study|Participant withdrew consent|1|||
147176410|NCT02737475|530811523|FG015|Overall Study|Participant withdrew consent|0|||
147176411|NCT02737475|530811524|FG016|Overall Study|Participant withdrew consent|0|||
147176412|NCT02737475|530811525|FG017|Overall Study|Participant withdrew consent|2|||
147176413|NCT02737475|530811526|FG018|Overall Study|Participant withdrew consent|1|||
147176414|NCT02737475|530811527|FG019|Overall Study|Participant withdrew consent|0|||
147176415|NCT02737475|530811528|FG020|Overall Study|Participant withdrew consent|2|||
147176416|NCT02737475|530811529|FG021|Overall Study|Participant withdrew consent|0|||
147176417|NCT02737475|530811530|FG022|Overall Study|Participant withdrew consent|0|||
147176418|NCT02737475|530811531|FG023|Overall Study|Participant withdrew consent|0|||
147176419|NCT02737475|530811532|FG024|Overall Study|Participant withdrew consent|0|||
147176420|NCT02737475|530811533|FG025|Overall Study|Participant withdrew consent|0|||
147176421|NCT02737475|530811534|FG026|Overall Study|Participant withdrew consent|0|||
147176422|NCT02737475|530811508|FG000|Overall Study|Lost to Follow-up|0|||
147176423|NCT02737475|530811509|FG001|Overall Study|Lost to Follow-up|0|||
147176424|NCT02737475|530811510|FG002|Overall Study|Lost to Follow-up|0|||
147176425|NCT02737475|530811511|FG003|Overall Study|Lost to Follow-up|0|||
147176426|NCT02737475|530811512|FG004|Overall Study|Lost to Follow-up|0|||
147176427|NCT02737475|530811513|FG005|Overall Study|Lost to Follow-up|0|||
147176428|NCT02737475|530811514|FG006|Overall Study|Lost to Follow-up|0|||
147176429|NCT02737475|530811515|FG007|Overall Study|Lost to Follow-up|0|||
147176430|NCT02737475|530811516|FG008|Overall Study|Lost to Follow-up|0|||
147176431|NCT02737475|530811517|FG009|Overall Study|Lost to Follow-up|0|||
147176432|NCT02737475|530811518|FG010|Overall Study|Lost to Follow-up|0|||
147176433|NCT02737475|530811519|FG011|Overall Study|Lost to Follow-up|0|||
147176434|NCT02737475|530811520|FG012|Overall Study|Lost to Follow-up|0|||
147176435|NCT02737475|530811521|FG013|Overall Study|Lost to Follow-up|0|||
147176436|NCT02737475|530811522|FG014|Overall Study|Lost to Follow-up|0|||
147176437|NCT02737475|530811523|FG015|Overall Study|Lost to Follow-up|1|||
147176438|NCT02737475|530811524|FG016|Overall Study|Lost to Follow-up|0|||
147176439|NCT02737475|530811525|FG017|Overall Study|Lost to Follow-up|0|||
147176440|NCT02737475|530811526|FG018|Overall Study|Lost to Follow-up|0|||
147176441|NCT02737475|530811527|FG019|Overall Study|Lost to Follow-up|0|||
147176442|NCT02737475|530811528|FG020|Overall Study|Lost to Follow-up|0|||
147176443|NCT02737475|530811529|FG021|Overall Study|Lost to Follow-up|0|||
147176444|NCT02737475|530811530|FG022|Overall Study|Lost to Follow-up|0|||
147176445|NCT02737475|530811531|FG023|Overall Study|Lost to Follow-up|0|||
147176446|NCT02737475|530811532|FG024|Overall Study|Lost to Follow-up|0|||
147176447|NCT02737475|530811533|FG025|Overall Study|Lost to Follow-up|0|||
147176448|NCT02737475|530811534|FG026|Overall Study|Lost to Follow-up|0|||
147176449|NCT02737475|530811508|FG000|Overall Study|Disease Progression|0|||
147176450|NCT02737475|530811509|FG001|Overall Study|Disease Progression|0|||
147176451|NCT02737475|530811510|FG002|Overall Study|Disease Progression|0|||
147176452|NCT02737475|530811511|FG003|Overall Study|Disease Progression|0|||
147176453|NCT02737475|530811512|FG004|Overall Study|Disease Progression|0|||
147176454|NCT02737475|530811513|FG005|Overall Study|Disease Progression|0|||
147176455|NCT02737475|530811514|FG006|Overall Study|Disease Progression|0|||
147176456|NCT02737475|530811515|FG007|Overall Study|Disease Progression|0|||
147176457|NCT02737475|530811516|FG008|Overall Study|Disease Progression|0|||
147176458|NCT02737475|530811517|FG009|Overall Study|Disease Progression|0|||
147176459|NCT02737475|530811518|FG010|Overall Study|Disease Progression|0|||
147176460|NCT02737475|530811519|FG011|Overall Study|Disease Progression|0|||
147176461|NCT02737475|530811520|FG012|Overall Study|Disease Progression|0|||
147176462|NCT02737475|530811521|FG013|Overall Study|Disease Progression|0|||
147176463|NCT02737475|530811522|FG014|Overall Study|Disease Progression|0|||
147176464|NCT02737475|530811523|FG015|Overall Study|Disease Progression|0|||
147176465|NCT02737475|530811524|FG016|Overall Study|Disease Progression|0|||
147176466|NCT02737475|530811525|FG017|Overall Study|Disease Progression|0|||
147176467|NCT02737475|530811526|FG018|Overall Study|Disease Progression|0|||
147176468|NCT02737475|530811527|FG019|Overall Study|Disease Progression|0|||
147176469|NCT02737475|530811528|FG020|Overall Study|Disease Progression|0|||
147176470|NCT02737475|530811529|FG021|Overall Study|Disease Progression|0|||
147176471|NCT02737475|530811530|FG022|Overall Study|Disease Progression|0|||
147176472|NCT02737475|530811531|FG023|Overall Study|Disease Progression|0|||
147176473|NCT02737475|530811532|FG024|Overall Study|Disease Progression|0|||
147176474|NCT02737475|530811533|FG025|Overall Study|Disease Progression|0|||
147176475|NCT02737475|530811534|FG026|Overall Study|Disease Progression|1|||
147176476|NCT02255461|530811539|FG000|Overall Study|Adverse Event|0|||
147176477|NCT02255461|530811540|FG001|Overall Study|Adverse Event|1|||
147176478|NCT02255461|530811541|FG002|Overall Study|Adverse Event|0|||
147176479|NCT02255461|530811542|FG003|Overall Study|Adverse Event|0|||
147176480|NCT02255461|530811543|FG004|Overall Study|Adverse Event|1|||
147176481|NCT02255461|530811539|FG000|Overall Study|Withdrawal by Subject|0|||
147176482|NCT02255461|530811540|FG001|Overall Study|Withdrawal by Subject|0|||
147176483|NCT02255461|530811541|FG002|Overall Study|Withdrawal by Subject|1|||
147176484|NCT02255461|530811542|FG003|Overall Study|Withdrawal by Subject|0|||
147176485|NCT02255461|530811543|FG004|Overall Study|Withdrawal by Subject|1|||
147176486|NCT02255461|530811539|FG000|Overall Study|Not meet dose reduction BSA requirement|0|||
147176487|NCT02255461|530811540|FG001|Overall Study|Not meet dose reduction BSA requirement|1|||
147176488|NCT02255461|530811541|FG002|Overall Study|Not meet dose reduction BSA requirement|0|||
147176489|NCT02255461|530811542|FG003|Overall Study|Not meet dose reduction BSA requirement|0|||
147176490|NCT02255461|530811543|FG004|Overall Study|Not meet dose reduction BSA requirement|0|||
147176491|NCT01858740|530811547|FG000|Overall Study|Death|4|||
147176492|NCT03386487|530811548|FG000|Overall Study|Lost to Follow-up|5|||
147176493|NCT03386487|530811549|FG001|Overall Study|Lost to Follow-up|6|||
147176494|NCT03386487|530811548|FG000|Overall Study|Withdrawal by Subject|11|||
147176495|NCT03386487|530811549|FG001|Overall Study|Withdrawal by Subject|7|||
147176496|NCT03386487|530811548|FG000|Overall Study|Physician Decision|11|||
147176497|NCT03386487|530811549|FG001|Overall Study|Physician Decision|8|||
147176498|NCT04207060|530811552|FG000|Overall Study|Lost to Follow-up|2|||
147176499|NCT04207060|530811553|FG001|Overall Study|Lost to Follow-up|0|||
147176500|NCT01067144|530811554|FG000|Treatment|Did not receive allocated intervention|4|||
147176501|NCT01067144|530811555|FG001|Treatment|Did not receive allocated intervention|7|||
147244931|NCT00727025|531070719|FG000|Overall Study|Physician Decision|23|||
147244932|NCT02101060|531070720|FG000|Overall Study|Adverse Event|1|||
147244933|NCT02101060|531070721|FG001|Overall Study|Adverse Event|0|||
147244934|NCT02101060|531070720|FG000|Overall Study|Withdrawal by Subject|1|||
147244935|NCT02101060|531070721|FG001|Overall Study|Withdrawal by Subject|1|||
147244936|NCT02101060|531070720|FG000|Overall Study|Lost to Follow-up|3|||
147244937|NCT02101060|531070721|FG001|Overall Study|Lost to Follow-up|3|||
147244938|NCT00127660|531070726|FG000|Overall Study|Protocol Violation|3|||
147244939|NCT00127660|531070727|FG001|Overall Study|Protocol Violation|3|||
147244940|NCT00127660|531070728|FG002|Overall Study|Protocol Violation|5|||
147324533|NCT00359619|531354309|FG003|Overall Study|Lost to Follow-up|1|||
147448299|NCT00542269|531805681|FG001|Overall Study|Withdrawal by Subject|0|||
147176502|NCT01067144|530811554|FG000|Follow-up|Lost to Follow-up|22|||
147176503|NCT01067144|530811555|FG001|Follow-up|Lost to Follow-up|12|||
147176504|NCT01067144|530811554|FG000|Follow-up|Censored owing to second surgery|19|||
147176505|NCT01067144|530811555|FG001|Follow-up|Censored owing to second surgery|28|||
147176506|NCT01067144|530811554|FG000|Follow-up|Withdrawal by Subject|18|||
147244941|NCT00127660|531070729|FG003|Overall Study|Protocol Violation|0|||
147448300|NCT00542269|531805682|FG002|Overall Study|Withdrawal by Subject|0|||
147176507|NCT01067144|530811555|FG001|Follow-up|Withdrawal by Subject|14|||
147176508|NCT01067144|530811554|FG000|Follow-up|Surgery cancelled|0|||
147176509|NCT01067144|530811555|FG001|Follow-up|Surgery cancelled|1|||
147176510|NCT01067144|530811554|FG000|Follow-up|Death|0|||
147176511|NCT01067144|530811555|FG001|Follow-up|Death|1|||
147176512|NCT01835158|530811558|FG000|Overall Study|Withdrawal by Subject|1|||
147176513|NCT01835158|530811559|FG001|Overall Study|Withdrawal by Subject|6|||
147244942|NCT01833520|531070730|FG000|Overall Study|Lack of Efficacy|3|||
147244943|NCT01833520|531070731|FG001|Overall Study|Lack of Efficacy|3|||
147324534|NCT00359619|531354310|FG004|Overall Study|Lost to Follow-up|1|||
147176514|NCT00296140|530811560|FG000|Overall Study|Lost to Follow-up|1|||
147176515|NCT00296140|530811561|FG001|Overall Study|Lost to Follow-up|0|||
147176516|NCT00296140|530811560|FG000|Overall Study|Withdrawal by Subject|1|||
147176517|NCT00296140|530811561|FG001|Overall Study|Withdrawal by Subject|0|||
147176518|NCT00296140|530811560|FG000|Overall Study|Discharge to Nursing Home|1|||
147176519|NCT00296140|530811561|FG001|Overall Study|Discharge to Nursing Home|0|||
147176520|NCT01856582|530811562|FG000|Overall Study|Died prior to Boost infusion|1|||
147176521|NCT00880191|530811566|FG000|Overall Study|Refused further treatment|4|||
147176522|NCT00880191|530811567|FG001|Overall Study|Refused further treatment|1|||
147176523|NCT00880191|530811566|FG000|Overall Study|Adverse Event|8|||
147176524|NCT00880191|530811567|FG001|Overall Study|Adverse Event|6|||
147176525|NCT00880191|530811566|FG000|Overall Study|Hospitalization/efficacy|1|||
147176526|NCT00880191|530811567|FG001|Overall Study|Hospitalization/efficacy|1|||
147176527|NCT01919801|530811570|FG000|Overall Study|Withdrawal by Subject|1|||
147176528|NCT01919801|530811571|FG001|Overall Study|Withdrawal by Subject|0|||
147176529|NCT01919801|530811570|FG000|Overall Study|Physician Decision|0|||
147176530|NCT01919801|530811571|FG001|Overall Study|Physician Decision|1|||
147176531|NCT01919801|530811570|FG000|Overall Study|Lost to Follow-up|0|||
147176532|NCT01919801|530811571|FG001|Overall Study|Lost to Follow-up|1|||
147176533|NCT01919801|530811570|FG000|Overall Study|Other|0|||
147176534|NCT01919801|530811571|FG001|Overall Study|Other|1|||
147176535|NCT01843062|530811572|FG000|Overall Study|Protocol Violation|1|||
147176536|NCT01843062|530811573|FG001|Overall Study|Protocol Violation|0|||
147176537|NCT01843062|530811572|FG000|Overall Study|New treatment following progression|2|||
147176538|NCT01843062|530811573|FG001|Overall Study|New treatment following progression|0|||
147176539|NCT01843062|530811572|FG000|Overall Study|Pregnancy|1|||
147176540|NCT01843062|530811573|FG001|Overall Study|Pregnancy|0|||
147176541|NCT01843062|530811572|FG000|Overall Study|Adverse Event|2|||
147176542|NCT01843062|530811573|FG001|Overall Study|Adverse Event|0|||
147176543|NCT01843062|530811572|FG000|Overall Study|Incorrect randomisation|1|||
147176544|NCT01843062|530811573|FG001|Overall Study|Incorrect randomisation|0|||
147176545|NCT01843062|530811572|FG000|Overall Study|Withdrawal by Subject|12|||
147176546|NCT01843062|530811573|FG001|Overall Study|Withdrawal by Subject|3|||
147176547|NCT01843062|530811572|FG000|Overall Study|Death|1|||
147176548|NCT01843062|530811573|FG001|Overall Study|Death|2|||
147176549|NCT01843062|530811572|FG000|Overall Study|Lost to Follow-up|2|||
147176550|NCT01843062|530811573|FG001|Overall Study|Lost to Follow-up|4|||
147176551|NCT01677858|530811574|FG000|Overall Study|Adverse Event|0|||
147176552|NCT01677858|530811575|FG001|Overall Study|Adverse Event|0|||
147176553|NCT01677858|530811576|FG002|Overall Study|Adverse Event|2|||
147176554|NCT01677858|530811577|FG003|Overall Study|Adverse Event|3|||
147176555|NCT01677858|530811578|FG004|Overall Study|Adverse Event|13|||
147176556|NCT01677858|530811574|FG000|Overall Study|Death|0|||
147176557|NCT01677858|530811575|FG001|Overall Study|Death|0|||
147176558|NCT01677858|530811576|FG002|Overall Study|Death|0|||
147176559|NCT01677858|530811577|FG003|Overall Study|Death|0|||
147176560|NCT01677858|530811578|FG004|Overall Study|Death|1|||
147593061|NCT03545191|532326964|FG002|Overall Study|Adverse Event|7|||
147593062|NCT03545191|532326962|FG000|Overall Study|Other reasons|3|||
147593063|NCT03545191|532326963|FG001|Overall Study|Other reasons|11|||
147593064|NCT03545191|532326964|FG002|Overall Study|Other reasons|8|||
147593065|NCT03545191|532326962|FG000|Overall Study|Withdrawal by Subject|13|||
147593066|NCT03545191|532326963|FG001|Overall Study|Withdrawal by Subject|10|||
147593067|NCT03545191|532326964|FG002|Overall Study|Withdrawal by Subject|12|||
147593068|NCT03545191|532326962|FG000|Overall Study|Lost to Follow-up|1|||
147593069|NCT03545191|532326963|FG001|Overall Study|Lost to Follow-up|2|||
147593070|NCT03545191|532326964|FG002|Overall Study|Lost to Follow-up|3|||
147176561|NCT01677858|530811574|FG000|Overall Study|Physician Decision|1|||
147176562|NCT01677858|530811575|FG001|Overall Study|Physician Decision|0|||
147176563|NCT01677858|530811576|FG002|Overall Study|Physician Decision|2|||
147176564|NCT01677858|530811577|FG003|Overall Study|Physician Decision|0|||
147176565|NCT01677858|530811578|FG004|Overall Study|Physician Decision|12|||
147176566|NCT01677858|530811574|FG000|Overall Study|Progressive Disease|2|||
147176567|NCT01677858|530811575|FG001|Overall Study|Progressive Disease|1|||
147176568|NCT01677858|530811576|FG002|Overall Study|Progressive Disease|9|||
147176569|NCT01677858|530811577|FG003|Overall Study|Progressive Disease|3|||
147176570|NCT01677858|530811578|FG004|Overall Study|Progressive Disease|43|||
147176571|NCT01677858|530811574|FG000|Overall Study|Withdrawal by Subject|0|||
147176572|NCT01677858|530811575|FG001|Overall Study|Withdrawal by Subject|1|||
147176573|NCT01677858|530811576|FG002|Overall Study|Withdrawal by Subject|1|||
147176574|NCT01677858|530811577|FG003|Overall Study|Withdrawal by Subject|0|||
147176575|NCT01677858|530811578|FG004|Overall Study|Withdrawal by Subject|15|||
147176576|NCT01677858|530811574|FG000|Overall Study|Lost to Follow-up|0|||
147176577|NCT01677858|530811575|FG001|Overall Study|Lost to Follow-up|0|||
147176578|NCT01677858|530811576|FG002|Overall Study|Lost to Follow-up|0|||
147176579|NCT01677858|530811577|FG003|Overall Study|Lost to Follow-up|0|||
147176580|NCT01677858|530811578|FG004|Overall Study|Lost to Follow-up|1|||
147176581|NCT01331109|530811579|FG000|Overall Study|Adverse Event|6|||
147593071|NCT00766831|532326965|FG000|Overall Study|Withdrawal by Subject|4|||
147593072|NCT00766831|532326965|FG000|Overall Study|Lost to Follow-up|3|||
147176582|NCT01331109|530811579|FG000|Overall Study|Lack of Efficacy|2|||
147176583|NCT01331109|530811579|FG000|Overall Study|Protocol Violation|3|||
147176584|NCT01331109|530811579|FG000|Overall Study|Withdrawal by Subject|7|||
147176585|NCT01331109|530811579|FG000|Overall Study|Lost to Follow-up|1|||
147176586|NCT01331109|530811579|FG000|Overall Study|Study Terminated by Sponsor|38|||
147176587|NCT00988091|530811583|FG000|Double-blind Period|Withdrawal by Subject|15|||
147176588|NCT00988091|530811584|FG001|Double-blind Period|Withdrawal by Subject|13|||
147176589|NCT00988091|530811583|FG000|Double-blind Period|Lost to Follow-up|12|||
147176590|NCT00988091|530811584|FG001|Double-blind Period|Lost to Follow-up|14|||
147176591|NCT00988091|530811583|FG000|Double-blind Period|Other|8|||
147176592|NCT00988091|530811584|FG001|Double-blind Period|Other|8|||
147176593|NCT00988091|530811583|FG000|Double-blind Period|Adverse Event|6|||
147176594|NCT00988091|530811584|FG001|Double-blind Period|Adverse Event|9|||
147176595|NCT00988091|530811583|FG000|Double-blind Period|Use of exclusionary medication|2|||
147176596|NCT00988091|530811584|FG001|Double-blind Period|Use of exclusionary medication|3|||
147176597|NCT00988091|530811583|FG000|Open-label Period|Adverse Event|4|||
147176598|NCT00988091|530811584|FG001|Open-label Period|Adverse Event|7|||
147176599|NCT00988091|530811583|FG000|Open-label Period|Use of exclusionary medication|1|||
147176600|NCT00988091|530811584|FG001|Open-label Period|Use of exclusionary medication|1|||
147176601|NCT00988091|530811583|FG000|Open-label Period|Protocol Violation|1|||
147176602|NCT00988091|530811584|FG001|Open-label Period|Protocol Violation|1|||
147176603|NCT00988091|530811583|FG000|Open-label Period|Withdrawal by Subject|10|||
147176604|NCT00988091|530811584|FG001|Open-label Period|Withdrawal by Subject|16|||
147176605|NCT00988091|530811583|FG000|Open-label Period|Lost to Follow-up|3|||
147176606|NCT00988091|530811584|FG001|Open-label Period|Lost to Follow-up|5|||
147176607|NCT00988091|530811583|FG000|Open-label Period|Other|2|||
147176608|NCT00988091|530811584|FG001|Open-label Period|Other|3|||
147176609|NCT00773747|530811585|FG000|Overall Study|Lack of Efficacy|112|||
147176610|NCT00773747|530811586|FG001|Overall Study|Lack of Efficacy|144|||
147176611|NCT00773747|530811585|FG000|Overall Study|Physician Decision|26|||
147176612|NCT00773747|530811586|FG001|Overall Study|Physician Decision|18|||
147176613|NCT00773747|530811585|FG000|Overall Study|Lost to Follow-up|0|||
147176614|NCT00773747|530811586|FG001|Overall Study|Lost to Follow-up|1|||
147176615|NCT00773747|530811585|FG000|Overall Study|Protocol Violation|2|||
147176616|NCT00773747|530811586|FG001|Overall Study|Protocol Violation|2|||
147176617|NCT00773747|530811585|FG000|Overall Study|Withdrawal by Subject|89|||
147176618|NCT00773747|530811586|FG001|Overall Study|Withdrawal by Subject|61|||
147176619|NCT00773747|530811585|FG000|Overall Study|Adverse Event|61|||
147176620|NCT00773747|530811586|FG001|Overall Study|Adverse Event|62|||
147176621|NCT00773747|530811585|FG000|Overall Study|Death|5|||
147176622|NCT00773747|530811586|FG001|Overall Study|Death|8|||
147176623|NCT00773747|530811585|FG000|Overall Study|Not Treated|2|||
147176624|NCT00773747|530811586|FG001|Overall Study|Not Treated|0|||
147176625|NCT02669212|530811589|FG000|Overall Study|Lost to Follow-up|1|||
147176626|NCT02669212|530811590|FG001|Overall Study|Lost to Follow-up|0|||
147176627|NCT02669212|530811589|FG000|Overall Study|Medical Condition|3|||
147176628|NCT02669212|530811590|FG001|Overall Study|Medical Condition|4|||
147176629|NCT02669212|530811589|FG000|Overall Study|Withdrawal by Subject|0|||
147176630|NCT02669212|530811590|FG001|Overall Study|Withdrawal by Subject|2|||
147176631|NCT02669212|530811589|FG000|Overall Study|Excluded - determined NOT post-infectious|0|||
147176632|NCT02669212|530811590|FG001|Overall Study|Excluded - determined NOT post-infectious|4|||
147593073|NCT00766831|532326965|FG000|Overall Study|Adverse Event|20|||
147593074|NCT00766831|532326965|FG000|Overall Study|Protocol Violation|15|||
147176633|NCT03549104|530811591|FG000|Overall Study|Withdrawal by Subject|5|||
147176634|NCT03549104|530811592|FG001|Overall Study|Withdrawal by Subject|2|||
147176635|NCT03549104|530811591|FG000|Overall Study|Covid shelter in place|1|||
147176636|NCT03549104|530811592|FG001|Overall Study|Covid shelter in place|2|||
147176637|NCT03078855|530811596|FG000|Overall Study|Lack of Efficacy|62|||
147176638|NCT03078855|530811597|FG001|Overall Study|Lack of Efficacy|31|||
147176639|NCT03078855|530811596|FG000|Overall Study|Death|1|||
147176640|NCT03078855|530811597|FG001|Overall Study|Death|0|||
147176641|NCT03078855|530811596|FG000|Overall Study|Withdrawal by Subject|12|||
147176642|NCT03078855|530811597|FG001|Overall Study|Withdrawal by Subject|6|||
147176643|NCT03078855|530811596|FG000|Overall Study|Physician Decision|3|||
147176644|NCT03078855|530811597|FG001|Overall Study|Physician Decision|2|||
147176645|NCT03078855|530811596|FG000|Overall Study|Second Malignancy|4|||
147593075|NCT00766831|532326965|FG000|Overall Study|Physician Decision|5|||
147593076|NCT00766831|532326965|FG000|Overall Study|Withdrawal of consent|26|||
147176646|NCT03078855|530811597|FG001|Overall Study|Second Malignancy|0|||
147176647|NCT03078855|530811596|FG000|Overall Study|Ineligible|2|||
147176648|NCT03078855|530811597|FG001|Overall Study|Ineligible|0|||
147176649|NCT03078855|530811596|FG000|Overall Study|Withdrew before day 1 treatment|2|||
147176650|NCT03078855|530811597|FG001|Overall Study|Withdrew before day 1 treatment|1|||
147176651|NCT00391027|530811598|FG000|Overall Study|Adverse Event|8|||
147176652|NCT00391027|530811599|FG001|Overall Study|Adverse Event|8|||
147176653|NCT00391027|530811598|FG000|Overall Study|Lack of Efficacy|3|||
147176654|NCT00391027|530811599|FG001|Overall Study|Lack of Efficacy|0|||
147176655|NCT00391027|530811598|FG000|Overall Study|Withdrawal by Subject|10|||
147655811|NCT02182830|532563006|FG000|Overall Study|Not Treated|1|||
147176656|NCT00391027|530811599|FG001|Overall Study|Withdrawal by Subject|1|||
147176657|NCT00391027|530811598|FG000|Overall Study|Other|4|||
147176658|NCT00391027|530811599|FG001|Overall Study|Other|3|||
147176659|NCT03422536|530811600|FG000|Randomized|Physician Decision|1|||
147176660|NCT03422536|530811601|FG001|Randomized|Physician Decision|1|||
147176661|NCT03422536|530811600|FG000|Allocation - Received Intervention|Disease progression|19|||
147176662|NCT03422536|530811601|FG001|Allocation - Received Intervention|Disease progression|25|||
147176663|NCT03422536|530811600|FG000|Allocation - Received Intervention|Death|1|||
147176664|NCT03422536|530811601|FG001|Allocation - Received Intervention|Death|3|||
147176665|NCT03422536|530811600|FG000|Allocation - Received Intervention|Adverse Event|1|||
147176666|NCT03422536|530811601|FG001|Allocation - Received Intervention|Adverse Event|0|||
147176667|NCT03422536|530811600|FG000|Allocation - Received Intervention|Physician Decision|1|||
147176668|NCT03422536|530811601|FG001|Allocation - Received Intervention|Physician Decision|1|||
147176669|NCT03422536|530811600|FG000|Allocation - Received Intervention|Withdrawal by Subject|3|||
147176670|NCT03422536|530811601|FG001|Allocation - Received Intervention|Withdrawal by Subject|2|||
147176671|NCT03422536|530811600|FG000|Allocation - Received Intervention|Lost to Follow-up|1|||
147176672|NCT03422536|530811601|FG001|Allocation - Received Intervention|Lost to Follow-up|0|||
147176673|NCT00532298|530811602|FG000|Overall Study|Adverse Event|1|||
147176674|NCT00532298|530811603|FG001|Overall Study|Adverse Event|0|||
147176675|NCT00532298|530811604|FG002|Overall Study|Adverse Event|0|||
147176676|NCT00532298|530811605|FG003|Overall Study|Adverse Event|0|||
147176677|NCT00532298|530811606|FG004|Overall Study|Adverse Event|1|||
147176678|NCT00532298|530811607|FG005|Overall Study|Adverse Event|1|||
147176679|NCT00532298|530811602|FG000|Overall Study|Lost to Follow-up|1|||
147176680|NCT00532298|530811603|FG001|Overall Study|Lost to Follow-up|1|||
147176681|NCT00532298|530811604|FG002|Overall Study|Lost to Follow-up|1|||
147176682|NCT00532298|530811605|FG003|Overall Study|Lost to Follow-up|0|||
147176683|NCT00532298|530811606|FG004|Overall Study|Lost to Follow-up|0|||
147176684|NCT00532298|530811607|FG005|Overall Study|Lost to Follow-up|1|||
147176685|NCT00479856|530811608|FG000|Overall Study|Adverse Event|1|||
147176686|NCT00479856|530811608|FG000|Overall Study|Withdrawal by Subject|1|||
147176687|NCT00479856|530811608|FG000|Overall Study|Physician Decision|1|||
147176688|NCT04164732|530811615|FG000|Treatment run-in Period|Adverse Event|4|||
147176689|NCT04164732|530811616|FG001|Treatment run-in Period|Adverse Event|0|||
147176690|NCT04164732|530811617|FG002|Treatment run-in Period|Adverse Event|0|||
147176691|NCT04164732|530811615|FG000|Treatment run-in Period|Physician Decision|1|||
147176692|NCT04164732|530811616|FG001|Treatment run-in Period|Physician Decision|0|||
147176693|NCT04164732|530811617|FG002|Treatment run-in Period|Physician Decision|0|||
147176694|NCT04164732|530811615|FG000|Treatment run-in Period|Screen Failure|1|||
147324535|NCT00359619|531354311|FG005|Overall Study|Lost to Follow-up|5|||
147324536|NCT00359619|531354312|FG006|Overall Study|Lost to Follow-up|0|||
147324537|NCT01251614|531354313|FG000|Overall Study|Adverse Event|1|||
147324538|NCT01251614|531354314|FG001|Overall Study|Adverse Event|0|||
147324539|NCT01251614|531354315|FG002|Overall Study|Adverse Event|1|||
147324540|NCT01251614|531354313|FG000|Overall Study|Lack of Efficacy|1|||
147324541|NCT01251614|531354314|FG001|Overall Study|Lack of Efficacy|9|||
147324542|NCT01251614|531354315|FG002|Overall Study|Lack of Efficacy|4|||
147324543|NCT01251614|531354313|FG000|Overall Study|Clearing of Psoriatic Lesions|1|||
147324544|NCT01251614|531354314|FG001|Overall Study|Clearing of Psoriatic Lesions|0|||
147324545|NCT01251614|531354315|FG002|Overall Study|Clearing of Psoriatic Lesions|0|||
147324546|NCT01251614|531354313|FG000|Overall Study|Pregnancy|0|||
147324547|NCT01251614|531354314|FG001|Overall Study|Pregnancy|0|||
147324548|NCT01251614|531354315|FG002|Overall Study|Pregnancy|2|||
147324549|NCT01251614|531354313|FG000|Overall Study|Loss of Disease Control|0|||
147176695|NCT04164732|530811616|FG001|Treatment run-in Period|Screen Failure|0|||
147176696|NCT04164732|530811617|FG002|Treatment run-in Period|Screen Failure|0|||
147176697|NCT04164732|530811615|FG000|Randomized Treatment Period|Adverse Event|0|||
147176698|NCT04164732|530811616|FG001|Randomized Treatment Period|Adverse Event|1|||
147176699|NCT04164732|530811617|FG002|Randomized Treatment Period|Adverse Event|0|||
147176700|NCT04164732|530811615|FG000|Randomized Treatment Period|Protocol Deviation|0|||
147176701|NCT04164732|530811616|FG001|Randomized Treatment Period|Protocol Deviation|1|||
147324550|NCT01251614|531354314|FG001|Overall Study|Loss of Disease Control|1|||
147324551|NCT01251614|531354315|FG002|Overall Study|Loss of Disease Control|0|||
147324552|NCT01251614|531354313|FG000|Overall Study|Withdrawal by Subject|0|||
147448301|NCT00542269|531805680|FG000|Overall Study|Administrative problems|1|||
147448302|NCT00542269|531805681|FG001|Overall Study|Administrative problems|1|||
147176702|NCT04164732|530811617|FG002|Randomized Treatment Period|Protocol Deviation|1|||
147176703|NCT04164732|530811615|FG000|Randomized Treatment Period|Withdrawal by Subject|0|||
147176704|NCT04164732|530811616|FG001|Randomized Treatment Period|Withdrawal by Subject|1|||
147176705|NCT04164732|530811617|FG002|Randomized Treatment Period|Withdrawal by Subject|0|||
147176706|NCT00661622|530811618|FG000|Overall Study|Protocol Violation|1|||
147176707|NCT00661622|530811619|FG001|Overall Study|Protocol Violation|0|||
147324553|NCT01251614|531354314|FG001|Overall Study|Withdrawal by Subject|2|||
147324554|NCT01251614|531354315|FG002|Overall Study|Withdrawal by Subject|1|||
147324555|NCT01251614|531354313|FG000|Overall Study|Lost to Follow-up|0|||
147324556|NCT01251614|531354314|FG001|Overall Study|Lost to Follow-up|1|||
147176708|NCT04765202|530811624|FG000|Overall Study|Lost to Follow-up|1|||
147176709|NCT04765202|530811625|FG001|Overall Study|Lost to Follow-up|1|||
147176710|NCT04765202|530811626|FG002|Overall Study|Lost to Follow-up|2|||
147176711|NCT04765202|530811627|FG003|Overall Study|Lost to Follow-up|2|||
147176712|NCT04765202|530811624|FG000|Overall Study|Physician Decision|0|||
147176713|NCT04765202|530811625|FG001|Overall Study|Physician Decision|0|||
147176714|NCT04765202|530811626|FG002|Overall Study|Physician Decision|1|||
147176715|NCT04765202|530811627|FG003|Overall Study|Physician Decision|1|||
147176716|NCT04929249|530811628|FG000|Overall Study|Adverse Event|2|||
147176717|NCT04929249|530811629|FG001|Overall Study|Adverse Event|1|||
147176718|NCT04929249|530811628|FG000|Overall Study|Death|2|||
147176719|NCT04929249|530811629|FG001|Overall Study|Death|1|||
147176720|NCT04929249|530811628|FG000|Overall Study|Lost to Follow-up|3|||
147176721|NCT04929249|530811629|FG001|Overall Study|Lost to Follow-up|11|||
147176722|NCT04929249|530811628|FG000|Overall Study|Technical problems|0|||
147176723|NCT04929249|530811629|FG001|Overall Study|Technical problems|1|||
147176724|NCT04929249|530811628|FG000|Overall Study|Subject decision|6|||
147176725|NCT04929249|530811629|FG001|Overall Study|Subject decision|8|||
147176726|NCT04929249|530811628|FG000|Overall Study|Withdrew consent|0|||
147176727|NCT04929249|530811629|FG001|Overall Study|Withdrew consent|8|||
147176728|NCT01620762|530811630|FG000|Overall Study|Protocol Violation|1|||
147176729|NCT01620762|530811631|FG001|Overall Study|Protocol Violation|1|||
147176730|NCT01620762|530811632|FG002|Overall Study|Protocol Violation|1|||
147176731|NCT01620762|530811630|FG000|Overall Study|Adverse Event|9|||
147176732|NCT01620762|530811631|FG001|Overall Study|Adverse Event|5|||
147176733|NCT01620762|530811632|FG002|Overall Study|Adverse Event|2|||
147176734|NCT01620762|530811630|FG000|Overall Study|Withdrawal by Subject|23|||
147176735|NCT01620762|530811631|FG001|Overall Study|Withdrawal by Subject|26|||
147176736|NCT01620762|530811632|FG002|Overall Study|Withdrawal by Subject|27|||
147176737|NCT01620762|530811630|FG000|Overall Study|Lost to Follow-up|11|||
147176738|NCT01620762|530811631|FG001|Overall Study|Lost to Follow-up|17|||
147176739|NCT01620762|530811632|FG002|Overall Study|Lost to Follow-up|10|||
147176740|NCT01620762|530811630|FG000|Overall Study|Protocol deviation|1|||
147176741|NCT01620762|530811631|FG001|Overall Study|Protocol deviation|1|||
147176742|NCT01620762|530811632|FG002|Overall Study|Protocol deviation|6|||
147176743|NCT01620762|530811630|FG000|Overall Study|Subject deterioration|0|||
147176744|NCT01620762|530811631|FG001|Overall Study|Subject deterioration|1|||
147176745|NCT01620762|530811632|FG002|Overall Study|Subject deterioration|1|||
147176746|NCT01620762|530811630|FG000|Overall Study|Non-specified|3|||
147176747|NCT01620762|530811631|FG001|Overall Study|Non-specified|6|||
147176748|NCT01620762|530811632|FG002|Overall Study|Non-specified|5|||
147176749|NCT01620762|530811630|FG000|Overall Study|Use of prohibted therapies|0|||
147176750|NCT01620762|530811631|FG001|Overall Study|Use of prohibted therapies|1|||
147176751|NCT01620762|530811632|FG002|Overall Study|Use of prohibted therapies|1|||
147176752|NCT00705146|530811633|FG000|Overall Study|Lost to Follow-up|1|||
147176753|NCT00705146|530811634|FG001|Overall Study|Lost to Follow-up|1|||
147176754|NCT00095173|530811635|FG000|Open-Label Lead-In Phase (Period A)|Adverse Event|1|||
147176755|NCT00095173|530811636|FG001|Open-Label Lead-In Phase (Period A)|Adverse Event|0|||
147176756|NCT00095173|530811637|FG002|Open-Label Lead-In Phase (Period A)|Adverse Event|0|||
147176757|NCT00095173|530811638|FG003|Open-Label Lead-In Phase (Period A)|Adverse Event|0|||
147176758|NCT00095173|530811639|FG004|Open-Label Lead-In Phase (Period A)|Adverse Event|0|||
147176759|NCT00095173|530811640|FG005|Open-Label Lead-In Phase (Period A)|Adverse Event|0|||
147176760|NCT00095173|530811635|FG000|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|17|||
147176761|NCT00095173|530811636|FG001|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0|||
147176762|NCT00095173|530811637|FG002|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0|||
147176763|NCT00095173|530811638|FG003|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0|||
147176764|NCT00095173|530811639|FG004|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0|||
147244944|NCT01833520|531070732|FG002|Overall Study|Lack of Efficacy|8|||
147244945|NCT01833520|531070733|FG003|Overall Study|Lack of Efficacy|3|||
147244946|NCT03266107|531070734|FG000|Enrollment to Procedure|Failure to Access Due to Hardened Bone|1|||
147324557|NCT01251614|531354315|FG002|Overall Study|Lost to Follow-up|0|||
147176765|NCT00095173|530811640|FG005|Open-Label Lead-In Phase (Period A)|Lack of Efficacy|0|||
147176766|NCT00095173|530811635|FG000|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|1|||
147176767|NCT00095173|530811636|FG001|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0|||
147176768|NCT00095173|530811637|FG002|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0|||
147176769|NCT00095173|530811638|FG003|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0|||
147176770|NCT00095173|530811639|FG004|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0|||
147176771|NCT00095173|530811640|FG005|Open-Label Lead-In Phase (Period A)|Withdrawal by Subject|0|||
147176772|NCT00095173|530811635|FG000|Open-Label Lead-In Phase (Period A)|Other|1|||
147176773|NCT00095173|530811636|FG001|Open-Label Lead-In Phase (Period A)|Other|0|||
147176774|NCT00095173|530811637|FG002|Open-Label Lead-In Phase (Period A)|Other|0|||
147176775|NCT00095173|530811638|FG003|Open-Label Lead-In Phase (Period A)|Other|0|||
147176776|NCT00095173|530811639|FG004|Open-Label Lead-In Phase (Period A)|Other|0|||
147176777|NCT00095173|530811640|FG005|Open-Label Lead-In Phase (Period A)|Other|0|||
147176778|NCT00095173|530811635|FG000|Double-Blind Phase (Period B)|Lack of Efficacy|0|||
147244947|NCT03266107|531070734|FG000|Enrollment to Procedure|Study stopped prior to Procedure|2|||
147176779|NCT00095173|530811636|FG001|Double-Blind Phase (Period B)|Lack of Efficacy|10|||
147176780|NCT00095173|530811637|FG002|Double-Blind Phase (Period B)|Lack of Efficacy|31|||
147176781|NCT00095173|530811638|FG003|Double-Blind Phase (Period B)|Lack of Efficacy|0|||
147176782|NCT00095173|530811639|FG004|Double-Blind Phase (Period B)|Lack of Efficacy|0|||
147176783|NCT00095173|530811640|FG005|Double-Blind Phase (Period B)|Lack of Efficacy|0|||
147176784|NCT00095173|530811635|FG000|Double-Blind Phase (Period B)|Withdrawal by Subject|0|||
147176785|NCT00095173|530811636|FG001|Double-Blind Phase (Period B)|Withdrawal by Subject|1|||
147176786|NCT00095173|530811637|FG002|Double-Blind Phase (Period B)|Withdrawal by Subject|0|||
147176787|NCT00095173|530811638|FG003|Double-Blind Phase (Period B)|Withdrawal by Subject|0|||
147176788|NCT00095173|530811639|FG004|Double-Blind Phase (Period B)|Withdrawal by Subject|0|||
147176789|NCT00095173|530811640|FG005|Double-Blind Phase (Period B)|Withdrawal by Subject|0|||
147176790|NCT00095173|530811635|FG000|Open-Label Extension Phase (Period C)|Death|0|||
147176791|NCT00095173|530811636|FG001|Open-Label Extension Phase (Period C)|Death|0|||
147176792|NCT00095173|530811637|FG002|Open-Label Extension Phase (Period C)|Death|0|||
147176793|NCT00095173|530811638|FG003|Open-Label Extension Phase (Period C)|Death|0|||
147176794|NCT00095173|530811639|FG004|Open-Label Extension Phase (Period C)|Death|0|||
147244948|NCT03266107|531070734|FG000|3-Month Follow-up Visit|Lost to Follow-up|1|||
147244949|NCT03266107|531070734|FG000|12-Month Follow-up Visit|Lost to Follow-up|1|||
147244950|NCT03454997|531070735|FG000|Overall Study|Staff Coach - Left Oranization|1|||
147593077|NCT00766831|532326965|FG000|Overall Study|Non cooperation by participants|14|||
147593078|NCT00766831|532326965|FG000|Overall Study|Other|28|||
147593079|NCT01392326|532326966|FG000|Overall Study|Death|2|||
147593080|NCT01392326|532326967|FG001|Overall Study|Death|0|||
147593081|NCT01392326|532326968|FG002|Overall Study|Death|0|||
147593082|NCT01392326|532326966|FG000|Overall Study|Withdrawal by Subject|12|||
147593083|NCT01392326|532326967|FG001|Overall Study|Withdrawal by Subject|11|||
147593084|NCT01392326|532326968|FG002|Overall Study|Withdrawal by Subject|15|||
147593085|NCT01392326|532326966|FG000|Overall Study|Protocol Violation|2|||
147593086|NCT01392326|532326967|FG001|Overall Study|Protocol Violation|0|||
147593087|NCT01392326|532326968|FG002|Overall Study|Protocol Violation|0|||
147593088|NCT01392326|532326966|FG000|Overall Study|Pregnancy|0|||
147593089|NCT01392326|532326967|FG001|Overall Study|Pregnancy|0|||
147593090|NCT01392326|532326968|FG002|Overall Study|Pregnancy|1|||
147593091|NCT01392326|532326966|FG000|Overall Study|Physician Decision|7|||
147593092|NCT01392326|532326967|FG001|Overall Study|Physician Decision|5|||
147593093|NCT01392326|532326968|FG002|Overall Study|Physician Decision|2|||
147593094|NCT01392326|532326966|FG000|Overall Study|Lost to Follow-up|1|||
147593095|NCT01392326|532326967|FG001|Overall Study|Lost to Follow-up|3|||
147244951|NCT03454997|531070736|FG001|Overall Study|Staff Coach - Left Oranization|1|||
147244952|NCT03454997|531070735|FG000|Overall Study|Staff Coach - Withdrawal by Site|0|||
147244953|NCT03454997|531070736|FG001|Overall Study|Staff Coach - Withdrawal by Site|2|||
147244954|NCT03454997|531070735|FG000|Overall Study|Staff Coach - Withdrawal by subject|0|||
147244955|NCT03454997|531070736|FG001|Overall Study|Staff Coach - Withdrawal by subject|1|||
147244956|NCT03454997|531070735|FG000|Overall Study|Staff Coach - Lost to follow-up|0|||
147244957|NCT03454997|531070736|FG001|Overall Study|Staff Coach - Lost to follow-up|1|||
147244958|NCT03454997|531070735|FG000|Overall Study|Client with SMI - Lost to follow-up|2|||
147244959|NCT03454997|531070736|FG001|Overall Study|Client with SMI - Lost to follow-up|1|||
147244960|NCT03454997|531070735|FG000|Overall Study|Client with SMI - Left organization|0|||
147244961|NCT03454997|531070736|FG001|Overall Study|Client with SMI - Left organization|1|||
147244962|NCT03454997|531070735|FG000|Overall Study|Client with SMI - Withdrawal by site|0|||
147244963|NCT03454997|531070736|FG001|Overall Study|Client with SMI - Withdrawal by site|11|||
147244964|NCT01191801|531070739|FG000|Overall Study|Death|36|||
147244965|NCT01191801|531070740|FG001|Overall Study|Death|12|||
147244966|NCT01191801|531070739|FG000|Overall Study|Lack of Efficacy|176|||
147244967|NCT01191801|531070740|FG001|Overall Study|Lack of Efficacy|258|||
147244968|NCT01191801|531070739|FG000|Overall Study|Adverse Event|9|||
147244969|NCT01191801|531070740|FG001|Overall Study|Adverse Event|8|||
147244970|NCT01191801|531070739|FG000|Overall Study|Protocol Violation|2|||
147244971|NCT01191801|531070740|FG001|Overall Study|Protocol Violation|4|||
147244972|NCT01191801|531070739|FG000|Overall Study|Physician Decision|47|||
147244973|NCT01191801|531070740|FG001|Overall Study|Physician Decision|24|||
147593096|NCT01392326|532326968|FG002|Overall Study|Lost to Follow-up|4|||
147593097|NCT01392326|532326966|FG000|Overall Study|Lack of Efficacy|14|||
147593098|NCT01392326|532326967|FG001|Overall Study|Lack of Efficacy|10|||
147593099|NCT01392326|532326968|FG002|Overall Study|Lack of Efficacy|15|||
147593100|NCT01392326|532326966|FG000|Overall Study|Adverse Event|9|||
147593101|NCT01392326|532326967|FG001|Overall Study|Adverse Event|6|||
147593102|NCT01392326|532326968|FG002|Overall Study|Adverse Event|11|||
147593103|NCT00094094|532326971|FG000|Overall Study|Death|2|||
147244974|NCT01191801|531070739|FG000|Overall Study|Withdrawal by Subject|1|||
147244975|NCT01191801|531070740|FG001|Overall Study|Withdrawal by Subject|4|||
147244976|NCT01191801|531070739|FG000|Overall Study|Not Provided|45|||
147244977|NCT01191801|531070740|FG001|Overall Study|Not Provided|27|||
147593104|NCT00094094|532326971|FG000|Overall Study|Lack of Efficacy|23|||
147593105|NCT00094094|532326971|FG000|Overall Study|Adverse Event|7|||
147593106|NCT02655016|532326972|FG000|Overall Study|Disease progression|6|||
147593107|NCT02655016|532326973|FG001|Overall Study|Disease progression|4|||
147593108|NCT02655016|532326972|FG000|Overall Study|Site closed|0|||
147593109|NCT02655016|532326973|FG001|Overall Study|Site closed|1|||
147593110|NCT02655016|532326972|FG000|Overall Study|Death|30|||
147593111|NCT02655016|532326973|FG001|Overall Study|Death|48|||
147593112|NCT02655016|532326972|FG000|Overall Study|Lost to Follow-up|1|||
147593113|NCT02655016|532326973|FG001|Overall Study|Lost to Follow-up|1|||
147593114|NCT02655016|532326972|FG000|Overall Study|Withdrawal by Subject|18|||
147593115|NCT02655016|532326973|FG001|Overall Study|Withdrawal by Subject|36|||
147593116|NCT04459715|532326974|FG000|Overall Study|Adverse Event|3|||
147593117|NCT04459715|532326975|FG001|Overall Study|Adverse Event|3|||
147593118|NCT04459715|532326974|FG000|Overall Study|Death|111|||
147593119|NCT04459715|532326975|FG001|Overall Study|Death|93|||
147593120|NCT04459715|532326974|FG000|Overall Study|Lost to Follow-up|10|||
147593121|NCT04459715|532326975|FG001|Overall Study|Lost to Follow-up|9|||
147593122|NCT04459715|532326974|FG000|Overall Study|Other Reasons|4|||
147593123|NCT04459715|532326975|FG001|Overall Study|Other Reasons|5|||
147593124|NCT04459715|532326974|FG000|Overall Study|PROTOCOL DEVIATION|0|||
147593125|NCT04459715|532326975|FG001|Overall Study|PROTOCOL DEVIATION|1|||
147593126|NCT04459715|532326974|FG000|Overall Study|RANDOMIZED BY MISTAKE|0|||
147593127|NCT04459715|532326975|FG001|Overall Study|RANDOMIZED BY MISTAKE|1|||
147593128|NCT04459715|532326974|FG000|Overall Study|STUDY TERMINATED BY SPONSOR|214|||
147593129|NCT04459715|532326975|FG001|Overall Study|STUDY TERMINATED BY SPONSOR|232|||
147593130|NCT04459715|532326974|FG000|Overall Study|Withdrawal by Subject|22|||
147593131|NCT04459715|532326975|FG001|Overall Study|Withdrawal by Subject|22|||
147593132|NCT06029959|532328924|FG000|Overall Study|Physician Decision|6|||
147593133|NCT00003138|532328925|FG000|Step 1|Reasons off treatment not documented|60|||
147593134|NCT00003138|532328926|FG001|Step 1|Reasons off treatment not documented|57|||
147593135|NCT00003138|532328925|FG000|Step 1|Never started treatment|1|||
147593136|NCT00003138|532328926|FG001|Step 1|Never started treatment|0|||
147593137|NCT00003138|532328925|FG000|Step 2 (Cross Over)|Reasons off treatment not documented|26|||
147593138|NCT00003138|532328926|FG001|Step 2 (Cross Over)|Reasons off treatment not documented|0|||
147593139|NCT00003138|532328925|FG000|Step 3 (EPO 150 Units/kg and G-CSF)|Off treatment reasons not documented|12|||
147593140|NCT00003138|532328926|FG001|Step 3 (EPO 150 Units/kg and G-CSF)|Off treatment reasons not documented|19|||
147593141|NCT00003138|532328925|FG000|Step 3 (EPO 150 Units/kg and G-CSF)|Never started treatment|0|||
147593142|NCT00003138|532328926|FG001|Step 3 (EPO 150 Units/kg and G-CSF)|Never started treatment|1|||
147593143|NCT00003138|532328925|FG000|Step 4 (EPO 300 Units/kg and G-CSF)|Off treatment reasons not documented|6|||
147176795|NCT00095173|530811640|FG005|Open-Label Extension Phase (Period C)|Death|1|||
147176796|NCT00095173|530811635|FG000|Open-Label Extension Phase (Period C)|Adverse Event|0|||
147176797|NCT00095173|530811636|FG001|Open-Label Extension Phase (Period C)|Adverse Event|0|||
147176798|NCT00095173|530811637|FG002|Open-Label Extension Phase (Period C)|Adverse Event|0|||
147176799|NCT00095173|530811638|FG003|Open-Label Extension Phase (Period C)|Adverse Event|1|||
147176800|NCT00095173|530811639|FG004|Open-Label Extension Phase (Period C)|Adverse Event|2|||
147176801|NCT00095173|530811640|FG005|Open-Label Extension Phase (Period C)|Adverse Event|3|||
147176802|NCT00095173|530811635|FG000|Open-Label Extension Phase (Period C)|Lack of Efficacy|0|||
147176803|NCT00095173|530811636|FG001|Open-Label Extension Phase (Period C)|Lack of Efficacy|0|||
147176804|NCT00095173|530811637|FG002|Open-Label Extension Phase (Period C)|Lack of Efficacy|0|||
147176805|NCT00095173|530811638|FG003|Open-Label Extension Phase (Period C)|Lack of Efficacy|11|||
147176806|NCT00095173|530811639|FG004|Open-Label Extension Phase (Period C)|Lack of Efficacy|5|||
147176807|NCT00095173|530811640|FG005|Open-Label Extension Phase (Period C)|Lack of Efficacy|8|||
147176808|NCT00095173|530811635|FG000|Open-Label Extension Phase (Period C)|Lost to Follow-up|0|||
147176809|NCT00095173|530811636|FG001|Open-Label Extension Phase (Period C)|Lost to Follow-up|0|||
147176810|NCT00095173|530811637|FG002|Open-Label Extension Phase (Period C)|Lost to Follow-up|0|||
147176811|NCT00095173|530811638|FG003|Open-Label Extension Phase (Period C)|Lost to Follow-up|2|||
147176812|NCT00095173|530811639|FG004|Open-Label Extension Phase (Period C)|Lost to Follow-up|5|||
147176813|NCT00095173|530811640|FG005|Open-Label Extension Phase (Period C)|Lost to Follow-up|6|||
147176814|NCT00095173|530811635|FG000|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0|||
147176815|NCT00095173|530811636|FG001|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0|||
147176816|NCT00095173|530811637|FG002|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0|||
147176817|NCT00095173|530811638|FG003|Open-Label Extension Phase (Period C)|Withdrawal by Subject|4|||
147176818|NCT00095173|530811639|FG004|Open-Label Extension Phase (Period C)|Withdrawal by Subject|6|||
147176819|NCT00095173|530811640|FG005|Open-Label Extension Phase (Period C)|Withdrawal by Subject|0|||
147176820|NCT00095173|530811635|FG000|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0|||
147176821|NCT00095173|530811636|FG001|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0|||
147176822|NCT00095173|530811637|FG002|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0|||
147324558|NCT00049517|531354316|FG000|Induction|Disease progression|0|||
147324559|NCT00049517|531354317|FG001|Induction|Disease progression|0|||
147176823|NCT00095173|530811638|FG003|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|0|||
147324560|NCT00049517|531354318|FG002|Induction|Disease progression|0|||
147593144|NCT00003138|532328926|FG001|Step 4 (EPO 300 Units/kg and G-CSF)|Off treatment reasons not documented|7|||
147176824|NCT00095173|530811639|FG004|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|1|||
147176825|NCT00095173|530811640|FG005|Open-Label Extension Phase (Period C)|No Longer Meets Study Criteria|1|||
147176826|NCT00095173|530811635|FG000|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0|||
147176827|NCT00095173|530811636|FG001|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0|||
147176828|NCT00095173|530811637|FG002|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0|||
147176829|NCT00095173|530811638|FG003|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|0|||
147176830|NCT00095173|530811639|FG004|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|2|||
147176831|NCT00095173|530811640|FG005|Open-Label Extension Phase (Period C)|Poor/Non-Compliance|2|||
147176832|NCT00095173|530811635|FG000|Open-Label Extension Phase (Period C)|Pregnancy|0|||
147176833|NCT00095173|530811636|FG001|Open-Label Extension Phase (Period C)|Pregnancy|0|||
147176834|NCT00095173|530811637|FG002|Open-Label Extension Phase (Period C)|Pregnancy|0|||
147176835|NCT00095173|530811638|FG003|Open-Label Extension Phase (Period C)|Pregnancy|1|||
147176836|NCT00095173|530811639|FG004|Open-Label Extension Phase (Period C)|Pregnancy|2|||
147176837|NCT00095173|530811640|FG005|Open-Label Extension Phase (Period C)|Pregnancy|3|||
147176838|NCT00095173|530811635|FG000|Open-Label Extension Phase (Period C)|Other|0|||
147176839|NCT00095173|530811636|FG001|Open-Label Extension Phase (Period C)|Other|0|||
147176840|NCT00095173|530811637|FG002|Open-Label Extension Phase (Period C)|Other|0|||
147176841|NCT00095173|530811638|FG003|Open-Label Extension Phase (Period C)|Other|4|||
147176842|NCT00095173|530811639|FG004|Open-Label Extension Phase (Period C)|Other|6|||
147176843|NCT00095173|530811640|FG005|Open-Label Extension Phase (Period C)|Other|8|||
147176844|NCT02951429|530811648|FG000|Overall Study|Adverse Event|3|||
147176845|NCT02951429|530811649|FG001|Overall Study|Adverse Event|7|||
147176846|NCT02951429|530811648|FG000|Overall Study|Death|28|||
147176847|NCT02951429|530811649|FG001|Overall Study|Death|36|||
147176848|NCT02951429|530811648|FG000|Overall Study|Lack of Efficacy|0|||
147176849|NCT02951429|530811649|FG001|Overall Study|Lack of Efficacy|1|||
147176850|NCT02951429|530811648|FG000|Overall Study|Lost to Follow-up|0|||
147176851|NCT02951429|530811649|FG001|Overall Study|Lost to Follow-up|1|||
147176852|NCT02951429|530811648|FG000|Overall Study|Lung Transplantation|9|||
147176853|NCT02951429|530811649|FG001|Overall Study|Lung Transplantation|6|||
147176854|NCT02951429|530811648|FG000|Overall Study|Other|1|||
147176855|NCT02951429|530811649|FG001|Overall Study|Other|3|||
147176856|NCT02951429|530811648|FG000|Overall Study|Progressive Disease|1|||
147176857|NCT02951429|530811649|FG001|Overall Study|Progressive Disease|1|||
147176858|NCT02951429|530811648|FG000|Overall Study|Withdrawal by Subject|7|||
147176859|NCT02951429|530811649|FG001|Overall Study|Withdrawal by Subject|11|||
147176860|NCT02951429|530811648|FG000|Overall Study|Participant ongoing in the study|23|||
147176861|NCT02951429|530811649|FG001|Overall Study|Participant ongoing in the study|17|||
147176862|NCT01620528|530811650|FG000|Treatment Period|Did Not Receive Study Drug|0|||
147176863|NCT01620528|530811651|FG001|Treatment Period|Did Not Receive Study Drug|0|||
147176864|NCT01620528|530811652|FG002|Treatment Period|Did Not Receive Study Drug|1|||
147176865|NCT01620528|530811650|FG000|Treatment Period|Withdrawal by Subject|35|||
147176866|NCT01620528|530811651|FG001|Treatment Period|Withdrawal by Subject|21|||
147176867|NCT01620528|530811652|FG002|Treatment Period|Withdrawal by Subject|16|||
147176868|NCT01620528|530811650|FG000|Treatment Period|Adverse Event|17|||
147176869|NCT01620528|530811651|FG001|Treatment Period|Adverse Event|13|||
147176870|NCT01620528|530811652|FG002|Treatment Period|Adverse Event|21|||
147176871|NCT01620528|530811650|FG000|Treatment Period|Lost to Follow-up|16|||
147176872|NCT01620528|530811651|FG001|Treatment Period|Lost to Follow-up|8|||
147176873|NCT01620528|530811652|FG002|Treatment Period|Lost to Follow-up|14|||
147176874|NCT01620528|530811650|FG000|Treatment Period|Other|9|||
147176875|NCT01620528|530811651|FG001|Treatment Period|Other|5|||
147176876|NCT01620528|530811652|FG002|Treatment Period|Other|7|||
147176877|NCT01620528|530811650|FG000|Treatment Period|Subject Noncompliant|11|||
147176878|NCT01620528|530811651|FG001|Treatment Period|Subject Noncompliant|2|||
147176879|NCT01620528|530811652|FG002|Treatment Period|Subject Noncompliant|2|||
147176880|NCT01620528|530811650|FG000|Treatment Period|Pregnancy|7|||
147176881|NCT01620528|530811651|FG001|Treatment Period|Pregnancy|2|||
147176882|NCT01620528|530811652|FG002|Treatment Period|Pregnancy|2|||
147176883|NCT01620528|530811650|FG000|Treatment Period|Surgery/Invasive Intervention|5|||
147244978|NCT03926169|531070747|FG000|Period A|Adverse Event|2|||
147176884|NCT01620528|530811651|FG001|Treatment Period|Surgery/Invasive Intervention|1|||
147244979|NCT03926169|531070748|FG001|Period A|Adverse Event|2|||
147244980|NCT03926169|531070749|FG002|Period A|Adverse Event|1|||
147176885|NCT01620528|530811652|FG002|Treatment Period|Surgery/Invasive Intervention|3|||
147176886|NCT01620528|530811650|FG000|Treatment Period|Exclusionary Medication Received|0|||
147176887|NCT01620528|530811651|FG001|Treatment Period|Exclusionary Medication Received|1|||
147176888|NCT01620528|530811652|FG002|Treatment Period|Exclusionary Medication Received|0|||
147176889|NCT01620528|530811650|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|3|||
147244981|NCT03926169|531070747|FG000|Period A|Withdrawal by Subject|2|||
147176890|NCT01620528|530811651|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|7|||
147176891|NCT01620528|530811652|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|3|||
147244982|NCT03926169|531070748|FG001|Period A|Withdrawal by Subject|2|||
147244983|NCT03926169|531070749|FG002|Period A|Withdrawal by Subject|2|||
147176892|NCT01620528|530811650|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|3|||
147176893|NCT01620528|530811651|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|2|||
147176894|NCT01620528|530811652|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|4|||
147176895|NCT01620528|530811650|FG000|Post-Treatment Follow-Up Period|Exclusionary Medication Received|0|||
147176896|NCT01620528|530811651|FG001|Post-Treatment Follow-Up Period|Exclusionary Medication Received|1|||
147176897|NCT01620528|530811652|FG002|Post-Treatment Follow-Up Period|Exclusionary Medication Received|1|||
147176898|NCT01620528|530811650|FG000|Post-Treatment Follow-Up Period|Surgery/Invasive Intervention|8|||
147176899|NCT01620528|530811651|FG001|Post-Treatment Follow-Up Period|Surgery/Invasive Intervention|3|||
147176900|NCT01620528|530811652|FG002|Post-Treatment Follow-Up Period|Surgery/Invasive Intervention|4|||
147176901|NCT01620528|530811650|FG000|Post-Treatment Follow-Up Period|Other|6|||
147176902|NCT01620528|530811651|FG001|Post-Treatment Follow-Up Period|Other|4|||
147176903|NCT01620528|530811652|FG002|Post-Treatment Follow-Up Period|Other|2|||
147176904|NCT02161757|530811654|FG000|Randomised Through Start Treatment|Did not receive treatment|3|||
147176905|NCT02161757|530811655|FG001|Randomised Through Start Treatment|Did not receive treatment|2|||
147176906|NCT02161757|530811656|FG002|Randomised Through Start Treatment|Did not receive treatment|0|||
147176907|NCT02161757|530811654|FG000|Treatment Through Study Completion|Adverse Event|1|||
147176908|NCT02161757|530811655|FG001|Treatment Through Study Completion|Adverse Event|1|||
147176909|NCT02161757|530811656|FG002|Treatment Through Study Completion|Adverse Event|0|||
147176910|NCT02161757|530811654|FG000|Treatment Through Study Completion|Protocol Violation|0|||
147176911|NCT02161757|530811655|FG001|Treatment Through Study Completion|Protocol Violation|1|||
147176912|NCT02161757|530811656|FG002|Treatment Through Study Completion|Protocol Violation|2|||
147176913|NCT02161757|530811654|FG000|Treatment Through Study Completion|Withdrawal by Subject|27|||
147176914|NCT02161757|530811655|FG001|Treatment Through Study Completion|Withdrawal by Subject|19|||
147176915|NCT02161757|530811656|FG002|Treatment Through Study Completion|Withdrawal by Subject|20|||
147176916|NCT02161757|530811654|FG000|Treatment Through Study Completion|Lost to Follow-up|7|||
147176917|NCT02161757|530811655|FG001|Treatment Through Study Completion|Lost to Follow-up|2|||
147176918|NCT02161757|530811656|FG002|Treatment Through Study Completion|Lost to Follow-up|4|||
147176919|NCT02161757|530811654|FG000|Treatment Through Study Completion|Other|20|||
147176920|NCT02161757|530811655|FG001|Treatment Through Study Completion|Other|19|||
147176921|NCT02161757|530811656|FG002|Treatment Through Study Completion|Other|12|||
147176922|NCT02161757|530811654|FG000|Treatment Through Study Completion|Death|2|||
147176923|NCT02161757|530811655|FG001|Treatment Through Study Completion|Death|1|||
147176924|NCT02161757|530811656|FG002|Treatment Through Study Completion|Death|1|||
147176925|NCT00391625|530811657|FG000|Month 14|Withdrawal by Subject|1|||
147176926|NCT00391625|530811657|FG000|Month 50|Physician Decision|1|||
147176927|NCT03664765|530811658|FG000|Overall Study|Withdrawal by Subject|4|||
147176928|NCT03664765|530811659|FG001|Overall Study|Withdrawal by Subject|1|||
147176929|NCT03664765|530811658|FG000|Overall Study|Lost to Follow-up|0|||
147176930|NCT03664765|530811659|FG001|Overall Study|Lost to Follow-up|1|||
147176931|NCT01628965|530811668|FG000|Overall Study|Adverse Event|30|||
147176932|NCT01628965|530811668|FG000|Overall Study|Lack of Efficacy|7|||
147176933|NCT01628965|530811668|FG000|Overall Study|Withdrawal by Subject|3|||
147176934|NCT01628965|530811668|FG000|Overall Study|Lost to Follow-up|1|||
147176935|NCT01628965|530811668|FG000|Overall Study|Discontinuation criteria|8|||
147176936|NCT00330681|530811669|FG000|Overall Study|Adverse Event|3|||
147176937|NCT00330681|530811670|FG001|Overall Study|Adverse Event|6|||
147176938|NCT00330681|530811669|FG000|Overall Study|Protocol Violation|0|||
147176939|NCT00330681|530811670|FG001|Overall Study|Protocol Violation|1|||
147176940|NCT00330681|530811669|FG000|Overall Study|Withdrawal by Subject|5|||
147176941|NCT00330681|530811670|FG001|Overall Study|Withdrawal by Subject|5|||
147176942|NCT00330681|530811669|FG000|Overall Study|Tracheotomy due to worsening of ALS|1|||
147176943|NCT00330681|530811670|FG001|Overall Study|Tracheotomy due to worsening of ALS|2|||
147176944|NCT00847197|530811671|FG000|Overall Study|Adverse Event|21|||
147176945|NCT00847197|530811672|FG001|Overall Study|Adverse Event|3|||
147448303|NCT00542269|531805682|FG002|Overall Study|Administrative problems|1|||
147448304|NCT03873714|531805683|FG000|Overall Study|Six (6) were withdrawn, and one (1) was a Screen Failure|7|||
147448305|NCT00708123|531805686|FG000|Period 1|Protocol Violation|0|||
147176946|NCT00847197|530811671|FG000|Overall Study|Protocol Violation|0|||
147176947|NCT00847197|530811672|FG001|Overall Study|Protocol Violation|1|||
147176948|NCT00847197|530811671|FG000|Overall Study|Withdrawal by Subject|3|||
147176949|NCT00847197|530811672|FG001|Overall Study|Withdrawal by Subject|1|||
147176950|NCT00825812|530811675|FG000|Overall Study|Never entered follow up|0|||
147176951|NCT00825812|530811676|FG001|Overall Study|Never entered follow up|0|||
147176952|NCT00825812|530811677|FG002|Overall Study|Never entered follow up|0|||
147176953|NCT00825812|530811678|FG003|Overall Study|Never entered follow up|1|||
147176954|NCT00825812|530811675|FG000|Overall Study|Adverse Event|0|||
147176955|NCT00825812|530811676|FG001|Overall Study|Adverse Event|0|||
147176956|NCT00825812|530811677|FG002|Overall Study|Adverse Event|0|||
147176957|NCT00825812|530811678|FG003|Overall Study|Adverse Event|1|||
147176958|NCT00825812|530811675|FG000|Overall Study|Subject withdrew consent|0|||
147176959|NCT00825812|530811676|FG001|Overall Study|Subject withdrew consent|0|||
147176960|NCT00825812|530811677|FG002|Overall Study|Subject withdrew consent|3|||
147176961|NCT00825812|530811678|FG003|Overall Study|Subject withdrew consent|2|||
147176962|NCT00825812|530811675|FG000|Overall Study|Non-compliance with protocol|0|||
147176963|NCT00825812|530811676|FG001|Overall Study|Non-compliance with protocol|0|||
147176964|NCT00825812|530811677|FG002|Overall Study|Non-compliance with protocol|0|||
147176965|NCT00825812|530811678|FG003|Overall Study|Non-compliance with protocol|1|||
147176966|NCT00825812|530811675|FG000|Overall Study|Administrative|0|||
147176967|NCT00825812|530811676|FG001|Overall Study|Administrative|1|||
147176968|NCT00825812|530811677|FG002|Overall Study|Administrative|3|||
147176969|NCT00825812|530811678|FG003|Overall Study|Administrative|5|||
147176970|NCT03597061|530811679|FG000|Overall Study|Lost to Follow-up|1|||
147176971|NCT03597061|530811680|FG001|Overall Study|Lost to Follow-up|0|||
147176972|NCT03597061|530811679|FG000|Overall Study|Protocol Violation|0|||
147176973|NCT03597061|530811680|FG001|Overall Study|Protocol Violation|1|||
147176974|NCT00895453|530811681|FG000|Overall Study|Lost to Follow-up|25|||
147176975|NCT00895453|530811682|FG001|Overall Study|Lost to Follow-up|25|||
147176976|NCT00895453|530811683|FG002|Overall Study|Lost to Follow-up|23|||
147176977|NCT04167137|530811684|FG000|Overall Study|Disease progression|1|||
147176978|NCT04167137|530811685|FG001|Overall Study|Disease progression|1|||
147176979|NCT04167137|530811686|FG002|Overall Study|Disease progression|3|||
147176980|NCT04167137|530811687|FG003|Overall Study|Disease progression|3|||
147176981|NCT04167137|530811688|FG004|Overall Study|Disease progression|2|||
147176982|NCT04167137|530811689|FG005|Overall Study|Disease progression|3|||
147176983|NCT04167137|530811690|FG006|Overall Study|Disease progression|2|||
147176984|NCT04167137|530811691|FG007|Overall Study|Disease progression|2|||
147176985|NCT04167137|530811684|FG000|Overall Study|Withdrawal by Subject|1|||
147176986|NCT04167137|530811685|FG001|Overall Study|Withdrawal by Subject|0|||
147176987|NCT04167137|530811686|FG002|Overall Study|Withdrawal by Subject|0|||
147176988|NCT04167137|530811687|FG003|Overall Study|Withdrawal by Subject|1|||
147176989|NCT04167137|530811688|FG004|Overall Study|Withdrawal by Subject|0|||
147176990|NCT04167137|530811689|FG005|Overall Study|Withdrawal by Subject|2|||
147176991|NCT04167137|530811690|FG006|Overall Study|Withdrawal by Subject|1|||
147176992|NCT04167137|530811691|FG007|Overall Study|Withdrawal by Subject|0|||
147176993|NCT04167137|530811684|FG000|Overall Study|Adverse Event|0|||
147176994|NCT04167137|530811685|FG001|Overall Study|Adverse Event|0|||
147176995|NCT04167137|530811686|FG002|Overall Study|Adverse Event|0|||
147176996|NCT04167137|530811687|FG003|Overall Study|Adverse Event|0|||
147176997|NCT04167137|530811688|FG004|Overall Study|Adverse Event|0|||
147176998|NCT04167137|530811689|FG005|Overall Study|Adverse Event|1|||
147176999|NCT04167137|530811690|FG006|Overall Study|Adverse Event|0|||
147177000|NCT04167137|530811691|FG007|Overall Study|Adverse Event|1|||
147177001|NCT04167137|530811684|FG000|Overall Study|Physician Decision|0|||
147177002|NCT04167137|530811685|FG001|Overall Study|Physician Decision|0|||
147177003|NCT04167137|530811686|FG002|Overall Study|Physician Decision|0|||
147177004|NCT04167137|530811687|FG003|Overall Study|Physician Decision|1|||
147177005|NCT04167137|530811688|FG004|Overall Study|Physician Decision|0|||
147177006|NCT04167137|530811689|FG005|Overall Study|Physician Decision|0|||
147177007|NCT04167137|530811690|FG006|Overall Study|Physician Decision|1|||
147177008|NCT04167137|530811691|FG007|Overall Study|Physician Decision|0|||
147177009|NCT04167137|530811684|FG000|Overall Study|Death|0|||
147177010|NCT04167137|530811685|FG001|Overall Study|Death|1|||
147177011|NCT04167137|530811686|FG002|Overall Study|Death|0|||
147177012|NCT04167137|530811687|FG003|Overall Study|Death|0|||
147177013|NCT04167137|530811688|FG004|Overall Study|Death|0|||
147177014|NCT04167137|530811689|FG005|Overall Study|Death|0|||
147177015|NCT04167137|530811690|FG006|Overall Study|Death|0|||
147177016|NCT04167137|530811691|FG007|Overall Study|Death|0|||
147177017|NCT04167137|530811684|FG000|Overall Study|Study terminated by Sponsor|0|||
147177018|NCT04167137|530811685|FG001|Overall Study|Study terminated by Sponsor|0|||
147244984|NCT03926169|531070747|FG000|Period A|Lost to Follow-up|3|||
147244985|NCT03926169|531070748|FG001|Period A|Lost to Follow-up|1|||
147244986|NCT03926169|531070749|FG002|Period A|Lost to Follow-up|0|||
147244987|NCT03926169|531070747|FG000|Period A|Lack of Efficacy|0|||
147244988|NCT03926169|531070748|FG001|Period A|Lack of Efficacy|2|||
147177019|NCT04167137|530811686|FG002|Overall Study|Study terminated by Sponsor|0|||
147177020|NCT04167137|530811687|FG003|Overall Study|Study terminated by Sponsor|0|||
147177021|NCT04167137|530811688|FG004|Overall Study|Study terminated by Sponsor|0|||
147177022|NCT04167137|530811689|FG005|Overall Study|Study terminated by Sponsor|0|||
147177023|NCT04167137|530811690|FG006|Overall Study|Study terminated by Sponsor|0|||
147177024|NCT04167137|530811691|FG007|Overall Study|Study terminated by Sponsor|1|||
147244989|NCT03926169|531070749|FG002|Period A|Lack of Efficacy|2|||
147244990|NCT03926169|531070747|FG000|Period A|COVID-19 Infection|0|||
147244991|NCT03926169|531070748|FG001|Period A|COVID-19 Infection|1|||
147244992|NCT03926169|531070749|FG002|Period A|COVID-19 Infection|0|||
147177025|NCT00400569|530811693|FG000|Overall Study|Death|1|||
147177026|NCT02461745|530811697|FG000|Overall Study|Lack of Efficacy|9|||
147244993|NCT03926169|531070747|FG000|Period A|COVID-19 Logistical Restrictions|0|||
147244994|NCT03926169|531070748|FG001|Period A|COVID-19 Logistical Restrictions|2|||
147177027|NCT02461745|530811698|FG001|Overall Study|Lack of Efficacy|1|||
147177028|NCT02461745|530811697|FG000|Overall Study|Lost to Follow-up|2|||
147177029|NCT02461745|530811698|FG001|Overall Study|Lost to Follow-up|2|||
147177030|NCT02461745|530811697|FG000|Overall Study|Withdrawal by Subject|3|||
147177031|NCT02461745|530811698|FG001|Overall Study|Withdrawal by Subject|1|||
147177032|NCT03848949|530811699|FG000|Overall Study|Lost to Follow-up|5|||
147177033|NCT03848949|530811700|FG001|Overall Study|Lost to Follow-up|7|||
147177034|NCT03712787|530814081|FG000|Overall Study|Adverse Event|2|||
147177035|NCT03712787|530814082|FG001|Overall Study|Adverse Event|3|||
147177036|NCT03712787|530814083|FG002|Overall Study|Adverse Event|0|||
147177037|NCT03712787|530814084|FG003|Overall Study|Adverse Event|4|||
147177038|NCT03712787|530814081|FG000|Overall Study|Withdrawal by Subject|4|||
147177039|NCT03712787|530814082|FG001|Overall Study|Withdrawal by Subject|14|||
147177040|NCT03712787|530814083|FG002|Overall Study|Withdrawal by Subject|12|||
147177041|NCT03712787|530814084|FG003|Overall Study|Withdrawal by Subject|8|||
147177042|NCT03712787|530814081|FG000|Overall Study|Lost to Follow-up|1|||
147177043|NCT03712787|530814082|FG001|Overall Study|Lost to Follow-up|1|||
147177044|NCT03712787|530814083|FG002|Overall Study|Lost to Follow-up|2|||
147177045|NCT03712787|530814084|FG003|Overall Study|Lost to Follow-up|1|||
147177046|NCT03712787|530814081|FG000|Overall Study|COVID-19 Logistical Restrictions|1|||
147177047|NCT03712787|530814082|FG001|Overall Study|COVID-19 Logistical Restrictions|1|||
147177048|NCT03712787|530814083|FG002|Overall Study|COVID-19 Logistical Restrictions|0|||
147177049|NCT03712787|530814084|FG003|Overall Study|COVID-19 Logistical Restrictions|0|||
147177050|NCT03712787|530814081|FG000|Overall Study|COVID-19 Infection|0|||
147177051|NCT03712787|530814082|FG001|Overall Study|COVID-19 Infection|1|||
147177052|NCT03712787|530814083|FG002|Overall Study|COVID-19 Infection|0|||
147177053|NCT03712787|530814084|FG003|Overall Study|COVID-19 Infection|0|||
147177054|NCT03712787|530814081|FG000|Overall Study|Other, Not Specified|79|||
147177055|NCT03712787|530814082|FG001|Overall Study|Other, Not Specified|77|||
147177056|NCT03712787|530814083|FG002|Overall Study|Other, Not Specified|74|||
147177057|NCT03712787|530814084|FG003|Overall Study|Other, Not Specified|78|||
147177058|NCT01865448|530814085|FG000|Overall Study|Adverse Event|1|||
147177059|NCT01865448|530814086|FG001|Overall Study|Adverse Event|1|||
147177060|NCT01865448|530814085|FG000|Overall Study|Pregnancy|0|||
147177061|NCT01865448|530814086|FG001|Overall Study|Pregnancy|1|||
147177062|NCT01865448|530814085|FG000|Overall Study|dropout unrelated to study|1|||
147177063|NCT01865448|530814086|FG001|Overall Study|dropout unrelated to study|1|||
147177064|NCT00931606|530814090|FG000|Overall Study|Death|1|||
147177065|NCT00931606|530814091|FG001|Overall Study|Death|3|||
147177066|NCT00931606|530814092|FG002|Overall Study|Death|2|||
147177067|NCT00931606|530814093|FG003|Overall Study|Death|0|||
147177068|NCT00931606|530814090|FG000|Overall Study|Lost to Follow-up|0|||
147177069|NCT00931606|530814091|FG001|Overall Study|Lost to Follow-up|1|||
147177070|NCT00931606|530814092|FG002|Overall Study|Lost to Follow-up|0|||
147177071|NCT00931606|530814093|FG003|Overall Study|Lost to Follow-up|0|||
147177072|NCT00931606|530814090|FG000|Overall Study|Physician Decision|0|||
147177073|NCT00931606|530814091|FG001|Overall Study|Physician Decision|0|||
147177074|NCT00931606|530814092|FG002|Overall Study|Physician Decision|3|||
147177075|NCT00931606|530814093|FG003|Overall Study|Physician Decision|0|||
147177076|NCT00931606|530814090|FG000|Overall Study|Sponsor Decision|1|||
147177077|NCT00931606|530814091|FG001|Overall Study|Sponsor Decision|4|||
147177078|NCT00931606|530814092|FG002|Overall Study|Sponsor Decision|0|||
147177079|NCT00931606|530814093|FG003|Overall Study|Sponsor Decision|2|||
147177080|NCT00931606|530814090|FG000|Overall Study|Withdrawal by Subject|3|||
147177081|NCT00931606|530814091|FG001|Overall Study|Withdrawal by Subject|1|||
147177082|NCT00931606|530814092|FG002|Overall Study|Withdrawal by Subject|1|||
147177083|NCT00931606|530814093|FG003|Overall Study|Withdrawal by Subject|1|||
147177084|NCT05111249|530814098|FG000|Overall Study|Lost to Follow-up|0|||
147177085|NCT05111249|530814099|FG001|Overall Study|Lost to Follow-up|2|||
147177086|NCT05111249|530814098|FG000|Overall Study|Physician Decision|0|||
147177087|NCT05111249|530814099|FG001|Overall Study|Physician Decision|1|||
147177088|NCT05111249|530814098|FG000|Overall Study|Participant decision|1|||
147177089|NCT05111249|530814099|FG001|Overall Study|Participant decision|5|||
147177090|NCT05128578|530814100|FG000|Overall Study|Withdrawal by Subject|9|||
147177091|NCT05128578|530814100|FG000|Overall Study|Lost to Follow-up|5|||
147177092|NCT00871338|530814101|FG000|Prior to Booster|Withdrawal by Subject|1|||
147177093|NCT00871338|530814102|FG001|Prior to Booster|Withdrawal by Subject|3|||
147177094|NCT00871338|530814101|FG000|Prior to Booster|Lost to Follow-up|1|||
147177095|NCT00871338|530814102|FG001|Prior to Booster|Lost to Follow-up|0|||
147177096|NCT02391363|530814103|FG000|Overall Study|Lost to Follow-up|5|||
147177097|NCT02391363|530814104|FG001|Overall Study|Lost to Follow-up|5|||
147177098|NCT02391363|530814103|FG000|Overall Study|Withdrawal by Subject|6|||
147177099|NCT02391363|530814104|FG001|Overall Study|Withdrawal by Subject|3|||
147177100|NCT00799266|530814107|FG000|Overall Study|Adverse Event|0|||
147177101|NCT00799266|530814108|FG001|Overall Study|Adverse Event|1|||
147177102|NCT00799266|530814107|FG000|Overall Study|Subject withdrew consent|3|||
147177103|NCT00799266|530814108|FG001|Overall Study|Subject withdrew consent|0|||
147244995|NCT03926169|531070749|FG002|Period A|COVID-19 Logistical Restrictions|1|||
147244996|NCT03926169|531070747|FG000|Period A|Other, Not Specified|1|||
147244997|NCT03926169|531070748|FG001|Period A|Other, Not Specified|0|||
147244998|NCT03926169|531070749|FG002|Period A|Other, Not Specified|0|||
147244999|NCT03926169|531070747|FG000|Period B|Adverse Event|3|||
147177104|NCT01702025|530814109|FG000|Overall Study|Equipment failure|1|||
147177105|NCT01702025|530814110|FG001|Overall Study|Equipment failure|0|||
147177106|NCT01702025|530814111|FG002|Overall Study|Equipment failure|0|||
147177107|NCT01702025|530814112|FG003|Overall Study|Equipment failure|0|||
147177108|NCT01702025|530814109|FG000|Overall Study|Adverse Event|1|||
147177109|NCT01702025|530814110|FG001|Overall Study|Adverse Event|1|||
147177110|NCT01702025|530814111|FG002|Overall Study|Adverse Event|1|||
147177111|NCT01702025|530814112|FG003|Overall Study|Adverse Event|0|||
147177112|NCT02679755|530814113|FG000|Overall Study|Death|0|||
147177113|NCT02679755|530814114|FG001|Overall Study|Death|3|||
147177114|NCT02679755|530814113|FG000|Overall Study|Global deterioration of health status|1|||
147177115|NCT02679755|530814114|FG001|Overall Study|Global deterioration of health status|8|||
147177116|NCT02679755|530814113|FG000|Overall Study|Lost to Follow-up|1|||
147177117|NCT02679755|530814114|FG001|Overall Study|Lost to Follow-up|0|||
147177118|NCT02679755|530814113|FG000|Overall Study|Objective progression or relapse|24|||
147177119|NCT02679755|530814114|FG001|Overall Study|Objective progression or relapse|83|||
147177120|NCT02679755|530814113|FG000|Overall Study|Not defined|0|||
147177121|NCT02679755|530814114|FG001|Overall Study|Not defined|2|||
147177122|NCT02679755|530814113|FG000|Overall Study|Withdrawal by participant|6|||
147177123|NCT02679755|530814114|FG001|Overall Study|Withdrawal by participant|3|||
147177124|NCT02679755|530814113|FG000|Overall Study|Adverse Event|1|||
147177125|NCT02679755|530814114|FG001|Overall Study|Adverse Event|4|||
147177126|NCT02679755|530814113|FG000|Overall Study|Adverse events not related to study drug|1|||
147177127|NCT02679755|530814114|FG001|Overall Study|Adverse events not related to study drug|2|||
147177128|NCT01061359|530814115|FG000|Overall Study|Death|32|||
147177129|NCT01061359|530814115|FG000|Overall Study|Lost to Follow-up|1072|||
147177130|NCT01061359|530814115|FG000|Overall Study|Relapse|187|||
147177131|NCT01061359|530814115|FG000|Overall Study|Secondary neoplasm|11|||
147177132|NCT02610777|530814118|FG000|Overall Study|Lost to Follow-up|1|||
147177133|NCT02610777|530814119|FG001|Overall Study|Lost to Follow-up|0|||
147177134|NCT02610777|530814118|FG000|Overall Study|Site Terminated by Sponsor|9|||
147177135|NCT02610777|530814119|FG001|Overall Study|Site Terminated by Sponsor|8|||
147177136|NCT02610777|530814118|FG000|Overall Study|Withdrawal by Subject|2|||
147177137|NCT02610777|530814119|FG001|Overall Study|Withdrawal by Subject|2|||
147177138|NCT02610777|530814118|FG000|Overall Study|Reason not Specified|0|||
147177139|NCT02610777|530814119|FG001|Overall Study|Reason not Specified|1|||
147177140|NCT02610777|530814118|FG000|Overall Study|Death|50|||
147177141|NCT02610777|530814119|FG001|Overall Study|Death|47|||
147177142|NCT00732875|530814120|FG000|Overall Study|Adverse Event|16|||
147177143|NCT00732875|530814120|FG000|Overall Study|Withdrawal by Subject|6|||
147177144|NCT00732875|530814120|FG000|Overall Study|Lack of Efficacy|13|||
147177145|NCT00660179|530814123|FG000|Overall Study|Death|44|||
147177146|NCT00660179|530814124|FG001|Overall Study|Death|47|||
147177147|NCT00660179|530814125|FG002|Overall Study|Death|34|||
147177148|NCT00660179|530814123|FG000|Overall Study|Withdrawal of consent|4|||
147177149|NCT00660179|530814124|FG001|Overall Study|Withdrawal of consent|6|||
147177150|NCT00660179|530814125|FG002|Overall Study|Withdrawal of consent|4|||
147177151|NCT00660179|530814123|FG000|Overall Study|Lost to Follow-up|7|||
147177152|NCT00660179|530814124|FG001|Overall Study|Lost to Follow-up|5|||
147177153|NCT00660179|530814125|FG002|Overall Study|Lost to Follow-up|2|||
147177154|NCT00660179|530814123|FG000|Overall Study|Administrative reason|0|||
147177155|NCT00660179|530814124|FG001|Overall Study|Administrative reason|0|||
147177156|NCT00660179|530814125|FG002|Overall Study|Administrative reason|1|||
147593145|NCT04495283|532328927|FG000|Overall Study|Physician Decision|0|||
147593146|NCT04495283|532328928|FG001|Overall Study|Physician Decision|0|||
147593147|NCT04495283|532328929|FG002|Overall Study|Physician Decision|1|||
147593148|NCT04495283|532328927|FG000|Overall Study|Withdrawal by Subject|0|||
147593149|NCT04495283|532328928|FG001|Overall Study|Withdrawal by Subject|1|||
147593150|NCT04495283|532328929|FG002|Overall Study|Withdrawal by Subject|1|||
147593151|NCT04495283|532328927|FG000|Overall Study|Other|1|||
147593152|NCT04495283|532328928|FG001|Overall Study|Other|0|||
147593153|NCT04495283|532328929|FG002|Overall Study|Other|1|||
147593154|NCT02631876|532328932|FG000|Overall Study|Death|96|||
147177157|NCT00660179|530814123|FG000|Overall Study|Incorrect randomization|1|||
147177158|NCT00660179|530814124|FG001|Overall Study|Incorrect randomization|0|||
147177159|NCT00660179|530814125|FG002|Overall Study|Incorrect randomization|0|||
147177160|NCT04171219|530814130|FG000|Overall Study|Adverse Event|1|||
147177161|NCT04171219|530814131|FG001|Overall Study|Adverse Event|0|||
147177162|NCT04171219|530814130|FG000|Overall Study|Death|0|||
147177163|NCT04171219|530814131|FG001|Overall Study|Death|1|||
147177164|NCT04171219|530814130|FG000|Overall Study|Lack of Efficacy|9|||
147177165|NCT04171219|530814131|FG001|Overall Study|Lack of Efficacy|13|||
147177166|NCT04171219|530814130|FG000|Overall Study|Withdrawal by Subject|1|||
147177167|NCT04171219|530814131|FG001|Overall Study|Withdrawal by Subject|2|||
147177168|NCT04171219|530814130|FG000|Overall Study|Clinical PD and extended treatment holding/ Patient choice/withdrew consent|1|||
147177169|NCT04171219|530814131|FG001|Overall Study|Clinical PD and extended treatment holding/ Patient choice/withdrew consent|1|||
147593155|NCT02631876|532328933|FG001|Overall Study|Death|50|||
147593156|NCT02631876|532328932|FG000|Overall Study|Investigator's discretion|1|||
147177170|NCT04171219|530814130|FG000|Overall Study|Clinical PD/Patient choice|1|||
147177171|NCT04171219|530814131|FG001|Overall Study|Clinical PD/Patient choice|0|||
147177172|NCT04171219|530814130|FG000|Overall Study|Toxicity/ Patient choice|1|||
147177173|NCT04171219|530814131|FG001|Overall Study|Toxicity/ Patient choice|0|||
147177174|NCT02974257|530814134|FG000|Overall Study|Transitioned to comfort-measures only prior to meeting fraction of inspired oxygen (FiO2) criteria|1|||
147177175|NCT02974257|530814135|FG001|Overall Study|Transitioned to comfort-measures only prior to meeting fraction of inspired oxygen (FiO2) criteria|0|||
147177176|NCT02974257|530814134|FG000|Overall Study|Clinical indication for thiamine|1|||
147177177|NCT02974257|530814135|FG001|Overall Study|Clinical indication for thiamine|0|||
147177178|NCT02974257|530814134|FG000|Overall Study|Already on thiamine|1|||
147177179|NCT02974257|530814135|FG001|Overall Study|Already on thiamine|0|||
147177180|NCT02974257|530814134|FG000|Overall Study|Extubated prior to study drug|0|||
147177181|NCT02974257|530814135|FG001|Overall Study|Extubated prior to study drug|1|||
147177182|NCT02974257|530814134|FG000|Overall Study|Death|0|||
147177183|NCT02974257|530814135|FG001|Overall Study|Death|1|||
147177184|NCT00398567|530814138|FG000|Overall Study|Disease Progression|3|||
147177185|NCT00398567|530814139|FG001|Overall Study|Disease Progression|4|||
147177186|NCT00398567|530814140|FG002|Overall Study|Disease Progression|27|||
147177187|NCT00398567|530814138|FG000|Overall Study|Withdrawal by Subject|1|||
147177188|NCT00398567|530814139|FG001|Overall Study|Withdrawal by Subject|0|||
147177189|NCT00398567|530814140|FG002|Overall Study|Withdrawal by Subject|4|||
147177190|NCT00398567|530814138|FG000|Overall Study|Adverse Event|0|||
147177191|NCT00398567|530814139|FG001|Overall Study|Adverse Event|0|||
147177192|NCT00398567|530814140|FG002|Overall Study|Adverse Event|2|||
147177193|NCT00398567|530814138|FG000|Overall Study|Protocol Violation|0|||
147177194|NCT00398567|530814139|FG001|Overall Study|Protocol Violation|0|||
147177195|NCT00398567|530814140|FG002|Overall Study|Protocol Violation|1|||
147177196|NCT04878211|530814147|FG000|Overall Study|Lost to Follow-up|0|||
147177197|NCT04878211|530814148|FG001|Overall Study|Lost to Follow-up|0|||
147177198|NCT04878211|530814149|FG002|Overall Study|Lost to Follow-up|0|||
147177199|NCT04878211|530814150|FG003|Overall Study|Lost to Follow-up|1|||
147177200|NCT04878211|530814151|FG004|Overall Study|Lost to Follow-up|0|||
147177201|NCT04878211|530814152|FG005|Overall Study|Lost to Follow-up|1|||
147177202|NCT04878211|530814147|FG000|Overall Study|Protocol deviation|1|||
147177203|NCT04878211|530814148|FG001|Overall Study|Protocol deviation|0|||
147177204|NCT04878211|530814149|FG002|Overall Study|Protocol deviation|0|||
147177205|NCT04878211|530814150|FG003|Overall Study|Protocol deviation|0|||
147177206|NCT04878211|530814151|FG004|Overall Study|Protocol deviation|0|||
147177207|NCT04878211|530814152|FG005|Overall Study|Protocol deviation|0|||
147177208|NCT04878211|530814147|FG000|Overall Study|Study terminated by sponsor|0|||
147177209|NCT04878211|530814148|FG001|Overall Study|Study terminated by sponsor|0|||
147177210|NCT04878211|530814149|FG002|Overall Study|Study terminated by sponsor|0|||
147177211|NCT04878211|530814150|FG003|Overall Study|Study terminated by sponsor|0|||
147177212|NCT04878211|530814151|FG004|Overall Study|Study terminated by sponsor|9|||
147177213|NCT04878211|530814152|FG005|Overall Study|Study terminated by sponsor|4|||
147177214|NCT04878211|530814147|FG000|Overall Study|Subject decision|0|||
147177215|NCT04878211|530814148|FG001|Overall Study|Subject decision|0|||
147177216|NCT04878211|530814149|FG002|Overall Study|Subject decision|0|||
147177217|NCT04878211|530814150|FG003|Overall Study|Subject decision|0|||
147177218|NCT04878211|530814151|FG004|Overall Study|Subject decision|1|||
147177219|NCT04878211|530814152|FG005|Overall Study|Subject decision|0|||
147177220|NCT01687101|530814159|FG000|Overall Study|Lost to Follow-up|7|||
147177221|NCT05274269|530814160|FG000|Overall Study|Adverse Event|0|||
147177222|NCT05274269|530814161|FG001|Overall Study|Adverse Event|3|||
147177223|NCT05274269|530814160|FG000|Overall Study|Death|0|||
147177224|NCT05274269|530814161|FG001|Overall Study|Death|1|||
147177225|NCT05274269|530814160|FG000|Overall Study|Other|0|||
147177226|NCT05274269|530814161|FG001|Overall Study|Other|2|||
147177227|NCT05274269|530814160|FG000|Overall Study|Withdrawal of consent (not due to AE)|0|||
147177228|NCT05274269|530814161|FG001|Overall Study|Withdrawal of consent (not due to AE)|2|||
147177229|NCT02206035|530814162|FG000|Overall Study|Physician Decision|10|||
147177230|NCT02206035|530814163|FG001|Overall Study|Physician Decision|0|||
147177231|NCT02206035|530814164|FG002|Overall Study|Physician Decision|175|||
147177232|NCT02936843|530814165|FG000|Overall Study|Lost to Follow-up|3|||
147177233|NCT02936843|530814166|FG001|Overall Study|Lost to Follow-up|1|||
147177234|NCT02936843|530814165|FG000|Overall Study|Withdrawal by Subject|1|||
147177235|NCT02936843|530814166|FG001|Overall Study|Withdrawal by Subject|1|||
147177236|NCT03668613|530814167|FG000|Overall Study|Adverse Event|1|||
147177237|NCT03668613|530814168|FG001|Overall Study|Adverse Event|2|||
147177238|NCT03668613|530814167|FG000|Overall Study|Lack of Efficacy|5|||
147177239|NCT03668613|530814168|FG001|Overall Study|Lack of Efficacy|1|||
147177240|NCT03668613|530814167|FG000|Overall Study|Pregnancy|0|||
147177241|NCT03668613|530814168|FG001|Overall Study|Pregnancy|2|||
147177242|NCT03668613|530814167|FG000|Overall Study|Protocol Violation|1|||
147177243|NCT03668613|530814168|FG001|Overall Study|Protocol Violation|0|||
147177244|NCT03668613|530814167|FG000|Overall Study|Physician Decision|1|||
147177245|NCT03668613|530814168|FG001|Overall Study|Physician Decision|0|||
147177246|NCT03668613|530814167|FG000|Overall Study|Withdrawal by Subject|2|||
147177247|NCT03668613|530814168|FG001|Overall Study|Withdrawal by Subject|1|||
147177248|NCT03668613|530814167|FG000|Overall Study|Guardian decision|1|||
147177249|NCT03668613|530814168|FG001|Overall Study|Guardian decision|0|||
147177250|NCT00709618|530814171|FG000|Overall Study|Withdrawal by Subject|4|||
147177251|NCT00709618|530814171|FG000|Overall Study|Lost to Follow-up|1|||
147177252|NCT00709618|530814171|FG000|Overall Study|Study Closed/Terminated|25|||
147177253|NCT04042909|530814172|FG000|Overall Study|Withdrawal by Subject|1|||
147177254|NCT04042909|530814173|FG001|Overall Study|Withdrawal by Subject|0|||
147177255|NCT04042909|530814174|FG002|Overall Study|Withdrawal by Subject|0|||
147177256|NCT04042909|530814172|FG000|Overall Study|duplicate cases|2|||
147177257|NCT04042909|530814173|FG001|Overall Study|duplicate cases|0|||
147177258|NCT04042909|530814174|FG002|Overall Study|duplicate cases|0|||
147177259|NCT04042909|530814172|FG000|Overall Study|technical problem|0|||
147177260|NCT04042909|530814173|FG001|Overall Study|technical problem|1|||
147177261|NCT04042909|530814174|FG002|Overall Study|technical problem|0|||
147177262|NCT00894361|530814177|FG000|Overall Study|deaths and less than 2 years followup|24|||
147177263|NCT00894361|530814178|FG001|Overall Study|deaths and less than 2 years followup|64|||
147177264|NCT00286494|530814183|FG000|Overall Study|Hyperglycemic rescue|12|||
147177265|NCT00286494|530814184|FG001|Overall Study|Hyperglycemic rescue|19|||
147177266|NCT00286494|530814185|FG002|Overall Study|Hyperglycemic rescue|18|||
147177267|NCT00286494|530814183|FG000|Overall Study|Withdrawal by Subject|2|||
147177268|NCT00286494|530814184|FG001|Overall Study|Withdrawal by Subject|10|||
147177269|NCT00286494|530814185|FG002|Overall Study|Withdrawal by Subject|9|||
147177270|NCT00286494|530814183|FG000|Overall Study|Adverse Event|3|||
147177271|NCT00286494|530814184|FG001|Overall Study|Adverse Event|8|||
147177272|NCT00286494|530814185|FG002|Overall Study|Adverse Event|6|||
147177273|NCT00286494|530814183|FG000|Overall Study|Physician Decision|5|||
147177274|NCT00286494|530814184|FG001|Overall Study|Physician Decision|5|||
147177275|NCT00286494|530814185|FG002|Overall Study|Physician Decision|1|||
147177276|NCT00286494|530814183|FG000|Overall Study|Lost to Follow-up|3|||
147177277|NCT00286494|530814184|FG001|Overall Study|Lost to Follow-up|1|||
147177278|NCT00286494|530814185|FG002|Overall Study|Lost to Follow-up|3|||
147177279|NCT00286494|530814183|FG000|Overall Study|Protocol Violation|1|||
147177280|NCT00286494|530814184|FG001|Overall Study|Protocol Violation|1|||
147177281|NCT00286494|530814185|FG002|Overall Study|Protocol Violation|2|||
147177282|NCT04776317|530814186|FG000|Overall Study|Physician Decision|0|||
147177283|NCT04776317|530814187|FG001|Overall Study|Physician Decision|1|||
147177284|NCT04776317|530814188|FG002|Overall Study|Physician Decision|0|||
147177285|NCT04776317|530814189|FG003|Overall Study|Physician Decision|0|||
147177286|NCT04776317|530814190|FG004|Overall Study|Physician Decision|0|||
147177287|NCT04776317|530814191|FG005|Overall Study|Physician Decision|0|||
147177288|NCT04776317|530814192|FG006|Overall Study|Physician Decision|0|||
147177289|NCT04776317|530814193|FG007|Overall Study|Physician Decision|0|||
147177290|NCT04776317|530814194|FG008|Overall Study|Physician Decision|0|||
147177291|NCT04776317|530814195|FG009|Overall Study|Physician Decision|0|||
147177292|NCT04776317|530814196|FG010|Overall Study|Physician Decision|0|||
147177293|NCT04776317|530814197|FG011|Overall Study|Physician Decision|0|||
147177294|NCT04776317|530814198|FG012|Overall Study|Physician Decision|0|||
147177295|NCT04776317|530814199|FG013|Overall Study|Physician Decision|0|||
147177296|NCT04776317|530814200|FG014|Overall Study|Physician Decision|0|||
147177297|NCT04776317|530814186|FG000|Overall Study|Protocol Violation|0|||
147177298|NCT04776317|530814187|FG001|Overall Study|Protocol Violation|0|||
147177299|NCT04776317|530814188|FG002|Overall Study|Protocol Violation|1|||
147177300|NCT04776317|530814189|FG003|Overall Study|Protocol Violation|0|||
147177301|NCT04776317|530814190|FG004|Overall Study|Protocol Violation|0|||
147177302|NCT04776317|530814191|FG005|Overall Study|Protocol Violation|0|||
147177303|NCT04776317|530814192|FG006|Overall Study|Protocol Violation|0|||
147177304|NCT04776317|530814193|FG007|Overall Study|Protocol Violation|0|||
147177305|NCT04776317|530814194|FG008|Overall Study|Protocol Violation|0|||
147177306|NCT04776317|530814195|FG009|Overall Study|Protocol Violation|0|||
147177307|NCT04776317|530814196|FG010|Overall Study|Protocol Violation|0|||
147177308|NCT04776317|530814197|FG011|Overall Study|Protocol Violation|0|||
147177309|NCT04776317|530814198|FG012|Overall Study|Protocol Violation|0|||
147177310|NCT04776317|530814199|FG013|Overall Study|Protocol Violation|0|||
147177311|NCT04776317|530814200|FG014|Overall Study|Protocol Violation|0|||
147177312|NCT04776317|530814186|FG000|Overall Study|Withdrawal by Subject|0|||
147177313|NCT04776317|530814187|FG001|Overall Study|Withdrawal by Subject|0|||
147177314|NCT04776317|530814188|FG002|Overall Study|Withdrawal by Subject|0|||
147177315|NCT04776317|530814189|FG003|Overall Study|Withdrawal by Subject|0|||
147177316|NCT04776317|530814190|FG004|Overall Study|Withdrawal by Subject|1|||
147177317|NCT04776317|530814191|FG005|Overall Study|Withdrawal by Subject|0|||
147177318|NCT04776317|530814192|FG006|Overall Study|Withdrawal by Subject|0|||
147177319|NCT04776317|530814193|FG007|Overall Study|Withdrawal by Subject|0|||
147177320|NCT04776317|530814194|FG008|Overall Study|Withdrawal by Subject|0|||
147177321|NCT04776317|530814195|FG009|Overall Study|Withdrawal by Subject|0|||
147177322|NCT04776317|530814196|FG010|Overall Study|Withdrawal by Subject|0|||
147177323|NCT04776317|530814197|FG011|Overall Study|Withdrawal by Subject|0|||
147177324|NCT04776317|530814198|FG012|Overall Study|Withdrawal by Subject|0|||
147177325|NCT04776317|530814199|FG013|Overall Study|Withdrawal by Subject|0|||
147177326|NCT04776317|530814200|FG014|Overall Study|Withdrawal by Subject|0|||
147324561|NCT00049517|531354319|FG003|Induction|Disease progression|0|||
147324562|NCT00049517|531354320|FG004|Induction|Disease progression|18|||
147324563|NCT00049517|531354321|FG005|Induction|Disease progression|11|||
147324564|NCT00049517|531354316|FG000|Induction|Adverse Event|0|||
147324565|NCT00049517|531354317|FG001|Induction|Adverse Event|0|||
147324566|NCT00049517|531354318|FG002|Induction|Adverse Event|0|||
147324567|NCT00049517|531354319|FG003|Induction|Adverse Event|0|||
147655812|NCT02182830|532563007|FG001|Overall Study|Not Treated|1|||
147655813|NCT02182830|532563006|FG000|Overall Study|Trial stopped, reason missing|3|||
147655814|NCT02182830|532563007|FG001|Overall Study|Trial stopped, reason missing|3|||
147655815|NCT02182830|532563006|FG000|Overall Study|Consent withdrawn|8|||
147655816|NCT02182830|532563007|FG001|Overall Study|Consent withdrawn|8|||
147655817|NCT02182830|532563006|FG000|Overall Study|Lost to Follow-up|3|||
147655818|NCT02182830|532563007|FG001|Overall Study|Lost to Follow-up|3|||
147655819|NCT01990768|532563008|FG000|Intervention Started|Found to be ineligible|14|||
147655820|NCT01990768|532563009|FG001|Intervention Started|Found to be ineligible|13|||
147655821|NCT01990768|532563010|FG002|Intervention Started|Found to be ineligible|11|||
147655822|NCT01990768|532563008|FG000|Intervention Started|Study drug issue or kit malfunction|9|||
147655823|NCT01990768|532563009|FG001|Intervention Started|Study drug issue or kit malfunction|6|||
147655824|NCT01990768|532563010|FG002|Intervention Started|Study drug issue or kit malfunction|7|||
147655825|NCT01990768|532563008|FG000|Intervention Started|Patient became ineligible due to vitals|5|||
147655826|NCT01990768|532563009|FG001|Intervention Started|Patient became ineligible due to vitals|5|||
147655827|NCT01990768|532563010|FG002|Intervention Started|Patient became ineligible due to vitals|2|||
147655828|NCT01990768|532563008|FG000|Intervention Started|Not enough time for EMS to enroll|4|||
147655829|NCT01990768|532563009|FG001|Intervention Started|Not enough time for EMS to enroll|3|||
147655830|NCT01990768|532563010|FG002|Intervention Started|Not enough time for EMS to enroll|0|||
147655831|NCT01990768|532563008|FG000|Intervention Started|Patient care priority|1|||
147655832|NCT01990768|532563009|FG001|Intervention Started|Patient care priority|2|||
147655833|NCT01990768|532563010|FG002|Intervention Started|Patient care priority|3|||
147655834|NCT01990768|532563008|FG000|Intervention Started|IV lost|2|||
147655835|NCT01990768|532563009|FG001|Intervention Started|IV lost|2|||
147655836|NCT01990768|532563010|FG002|Intervention Started|IV lost|2|||
147655837|NCT01990768|532563008|FG000|Intervention Started|Required CPR|1|||
147655838|NCT01990768|532563009|FG001|Intervention Started|Required CPR|1|||
147655839|NCT01990768|532563010|FG002|Intervention Started|Required CPR|0|||
147655840|NCT01990768|532563008|FG000|Intervention Started|Seizure or hx of seizure|0|||
147655841|NCT01990768|532563009|FG001|Intervention Started|Seizure or hx of seizure|0|||
147655842|NCT01990768|532563010|FG002|Intervention Started|Seizure or hx of seizure|2|||
147655843|NCT01990768|532563008|FG000|Intervention Started|Discovered to be pregnant|0|||
147655844|NCT01990768|532563009|FG001|Intervention Started|Discovered to be pregnant|1|||
147655845|NCT01990768|532563010|FG002|Intervention Started|Discovered to be pregnant|0|||
147655846|NCT01990768|532563008|FG000|Prehospital Study Drug Infusion|Protocol non-compliance|4|||
147655847|NCT01990768|532563009|FG001|Prehospital Study Drug Infusion|Protocol non-compliance|11|||
147655848|NCT01990768|532563010|FG002|Prehospital Study Drug Infusion|Protocol non-compliance|10|||
147655849|NCT01990768|532563008|FG000|Prehospital Study Drug Infusion|Seizure or concern for seizure|4|||
147655850|NCT01990768|532563009|FG001|Prehospital Study Drug Infusion|Seizure or concern for seizure|3|||
147655851|NCT01990768|532563010|FG002|Prehospital Study Drug Infusion|Seizure or concern for seizure|4|||
147655852|NCT01990768|532563008|FG000|Prehospital Study Drug Infusion|Required CPR|2|||
147655853|NCT01990768|532563009|FG001|Prehospital Study Drug Infusion|Required CPR|6|||
147655854|NCT01990768|532563010|FG002|Prehospital Study Drug Infusion|Required CPR|0|||
147655855|NCT01990768|532563008|FG000|Prehospital Study Drug Infusion|Other safety concern|2|||
147655856|NCT01990768|532563009|FG001|Prehospital Study Drug Infusion|Other safety concern|1|||
147655857|NCT01990768|532563010|FG002|Prehospital Study Drug Infusion|Other safety concern|1|||
147655858|NCT01990768|532563008|FG000|Prehospital Study Drug Infusion|Death|3|||
147655859|NCT01990768|532563009|FG001|Prehospital Study Drug Infusion|Death|1|||
147655860|NCT01990768|532563010|FG002|Prehospital Study Drug Infusion|Death|1|||
147655861|NCT01990768|532563008|FG000|Prehospital Study Drug Infusion|Discharged|2|||
147655862|NCT01990768|532563009|FG001|Prehospital Study Drug Infusion|Discharged|1|||
147655863|NCT01990768|532563010|FG002|Prehospital Study Drug Infusion|Discharged|0|||
147655864|NCT01990768|532563008|FG000|Prehospital Study Drug Infusion|Withdrawal by Subject|1|||
147655865|NCT01990768|532563009|FG001|Prehospital Study Drug Infusion|Withdrawal by Subject|0|||
147655866|NCT01990768|532563010|FG002|Prehospital Study Drug Infusion|Withdrawal by Subject|0|||
147655867|NCT01990768|532563008|FG000|Prehospital Study Drug Infusion|Emergency unblinding|0|||
147655868|NCT01990768|532563009|FG001|Prehospital Study Drug Infusion|Emergency unblinding|0|||
147655869|NCT01990768|532563010|FG002|Prehospital Study Drug Infusion|Emergency unblinding|1|||
147655870|NCT01990768|532563008|FG000|Prehospital Study Drug Infusion|Unknown if completed|1|||
147655871|NCT01990768|532563009|FG001|Prehospital Study Drug Infusion|Unknown if completed|4|||
147655872|NCT01990768|532563010|FG002|Prehospital Study Drug Infusion|Unknown if completed|2|||
147324568|NCT00049517|531354320|FG004|Induction|Adverse Event|5|||
147324569|NCT00049517|531354321|FG005|Induction|Adverse Event|7|||
147324570|NCT00049517|531354316|FG000|Induction|Death|0|||
147177327|NCT05438576|530814201|FG000|Overall Study|Death|1|||
147177328|NCT05438576|530814202|FG001|Overall Study|Death|1|||
147177329|NCT05438576|530814201|FG000|Overall Study|Withdrawal by Subject|4|||
147177330|NCT05438576|530814202|FG001|Overall Study|Withdrawal by Subject|2|||
147177331|NCT05438576|530814201|FG000|Overall Study|Not Eligible|2|||
147177332|NCT05438576|530814202|FG001|Overall Study|Not Eligible|1|||
147177333|NCT05438576|530814201|FG000|Overall Study|Did not complete baseline testing|22|||
147177334|NCT05438576|530814202|FG001|Overall Study|Did not complete baseline testing|4|||
147177335|NCT02881762|530814203|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|0|||
147177336|NCT02881762|530814204|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
147177337|NCT01415401|530814211|FG000|Overall Study|Adverse Event|5|||
147177338|NCT01415401|530814211|FG000|Overall Study|DId not meet inclusion/exclusion criteri|1|||
147177339|NCT01415401|530814211|FG000|Overall Study|Terminated by Sponsor|1|||
147177340|NCT00994422|530814212|FG000|Overall Study|Lost to Follow-up|7|||
147177341|NCT00994422|530814213|FG001|Overall Study|Lost to Follow-up|1|||
147177342|NCT04124705|530814214|FG000|Titration Period|Adverse Event|9|||
147177343|NCT04124705|530814215|FG001|Titration Period|Adverse Event|5|||
147177344|NCT04124705|530814214|FG000|Titration Period|Withdrawal by Subject|6|||
147177345|NCT04124705|530814215|FG001|Titration Period|Withdrawal by Subject|3|||
147177346|NCT04124705|530814214|FG000|Titration Period|Lost to Follow-up|0|||
147177347|NCT04124705|530814215|FG001|Titration Period|Lost to Follow-up|1|||
147177348|NCT04124705|530814214|FG000|Titration Period|Death|1|||
147177349|NCT04124705|530814215|FG001|Titration Period|Death|1|||
147177350|NCT04124705|530814214|FG000|Titration Period|Lack of Efficacy|2|||
147177351|NCT04124705|530814215|FG001|Titration Period|Lack of Efficacy|0|||
147177352|NCT04124705|530814214|FG000|Titration Period|Physician Decision|2|||
147177353|NCT04124705|530814215|FG001|Titration Period|Physician Decision|0|||
147177354|NCT04124705|530814214|FG000|Titration Period|Non-compliance with Study Drug|2|||
147177355|NCT04124705|530814215|FG001|Titration Period|Non-compliance with Study Drug|0|||
147177356|NCT04124705|530814214|FG000|Titration Period|Other|4|||
147177357|NCT04124705|530814215|FG001|Titration Period|Other|9|||
147177358|NCT04124705|530814214|FG000|Stabilization Period|Adverse Event|4|||
147177359|NCT04124705|530814215|FG001|Stabilization Period|Adverse Event|2|||
147655873|NCT01990768|532563008|FG000|In-Hospital Study Drug Infusion|Discharged|19|||
147655874|NCT01990768|532563009|FG001|In-Hospital Study Drug Infusion|Discharged|18|||
147655875|NCT01990768|532563010|FG002|In-Hospital Study Drug Infusion|Discharged|13|||
147655876|NCT01990768|532563008|FG000|In-Hospital Study Drug Infusion|Protocol non-compliance|14|||
147655877|NCT01990768|532563009|FG001|In-Hospital Study Drug Infusion|Protocol non-compliance|17|||
147655878|NCT01990768|532563010|FG002|In-Hospital Study Drug Infusion|Protocol non-compliance|10|||
147655879|NCT01990768|532563008|FG000|In-Hospital Study Drug Infusion|Withdrawal by Subject|13|||
147655880|NCT01990768|532563009|FG001|In-Hospital Study Drug Infusion|Withdrawal by Subject|7|||
147655881|NCT01990768|532563010|FG002|In-Hospital Study Drug Infusion|Withdrawal by Subject|12|||
147655882|NCT01990768|532563008|FG000|In-Hospital Study Drug Infusion|Death or comfort care|12|||
147655883|NCT01990768|532563009|FG001|In-Hospital Study Drug Infusion|Death or comfort care|11|||
147655884|NCT01990768|532563010|FG002|In-Hospital Study Drug Infusion|Death or comfort care|6|||
147655885|NCT01990768|532563008|FG000|In-Hospital Study Drug Infusion|Emergency unblinding|11|||
147655886|NCT01990768|532563009|FG001|In-Hospital Study Drug Infusion|Emergency unblinding|4|||
147655887|NCT01990768|532563010|FG002|In-Hospital Study Drug Infusion|Emergency unblinding|7|||
147655888|NCT01990768|532563008|FG000|In-Hospital Study Drug Infusion|Seizure or concern for seizure|8|||
147655889|NCT01990768|532563009|FG001|In-Hospital Study Drug Infusion|Seizure or concern for seizure|9|||
147245000|NCT03926169|531070748|FG001|Period B|Adverse Event|1|||
147245001|NCT03926169|531070749|FG002|Period B|Adverse Event|1|||
147245002|NCT03926169|531070747|FG000|Period B|Withdrawal by Subject|1|||
147245003|NCT03926169|531070748|FG001|Period B|Withdrawal by Subject|3|||
147245004|NCT03926169|531070749|FG002|Period B|Withdrawal by Subject|0|||
147245005|NCT03926169|531070747|FG000|Period B|Lack of Efficacy|3|||
147177360|NCT04124705|530814214|FG000|Stabilization Period|Withdrawal by Subject|1|||
147177361|NCT04124705|530814215|FG001|Stabilization Period|Withdrawal by Subject|1|||
147177362|NCT04124705|530814214|FG000|Stabilization Period|Lost to Follow-up|0|||
147177363|NCT04124705|530814215|FG001|Stabilization Period|Lost to Follow-up|1|||
147177364|NCT04124705|530814214|FG000|Stabilization Period|Lack of Efficacy|4|||
147177365|NCT04124705|530814215|FG001|Stabilization Period|Lack of Efficacy|2|||
147177366|NCT04124705|530814214|FG000|Stabilization Period|Protocol Deviation|0|||
147177367|NCT04124705|530814215|FG001|Stabilization Period|Protocol Deviation|2|||
147177368|NCT04124705|530814214|FG000|Stabilization Period|Other|2|||
147245006|NCT03926169|531070748|FG001|Period B|Lack of Efficacy|1|||
147245007|NCT03926169|531070749|FG002|Period B|Lack of Efficacy|1|||
147245008|NCT03926169|531070747|FG000|Period B|Lost to Follow-up|1|||
147245009|NCT03926169|531070748|FG001|Period B|Lost to Follow-up|1|||
147245010|NCT03926169|531070749|FG002|Period B|Lost to Follow-up|4|||
147655890|NCT01990768|532563010|FG002|In-Hospital Study Drug Infusion|Seizure or concern for seizure|17|||
147177369|NCT04124705|530814215|FG001|Stabilization Period|Other|2|||
147177370|NCT01636986|530814220|FG000|Overall Study|Withdrawal by Subject|0|||
147245011|NCT03926169|531070747|FG000|Period B|Other, Not Specified|62|||
147177371|NCT01636986|530814221|FG001|Overall Study|Withdrawal by Subject|1|||
147177372|NCT01636986|530814220|FG000|Overall Study|Corneal Staining|0|||
147177373|NCT01636986|530814221|FG001|Overall Study|Corneal Staining|1|||
147177374|NCT00395850|530814229|FG000|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|6|||
147177375|NCT00395850|530814230|FG001|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|0|||
147177376|NCT00395850|530814231|FG002|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|0|||
147177377|NCT00395850|530814232|FG003|Pre-randomization Baseline/Induction|noncompliance (missed med/urine)|0|||
147177378|NCT00395850|530814229|FG000|Pre-randomization Baseline/Induction|Withdrawal by Subject|4|||
147177379|NCT00395850|530814230|FG001|Pre-randomization Baseline/Induction|Withdrawal by Subject|0|||
147177380|NCT00395850|530814231|FG002|Pre-randomization Baseline/Induction|Withdrawal by Subject|0|||
147177381|NCT00395850|530814232|FG003|Pre-randomization Baseline/Induction|Withdrawal by Subject|0|||
147177382|NCT00395850|530814229|FG000|Pre-randomization Baseline/Induction|Inconsistent attendance|1|||
147177383|NCT00395850|530814230|FG001|Pre-randomization Baseline/Induction|Inconsistent attendance|0|||
147177384|NCT00395850|530814231|FG002|Pre-randomization Baseline/Induction|Inconsistent attendance|0|||
147177385|NCT00395850|530814232|FG003|Pre-randomization Baseline/Induction|Inconsistent attendance|0|||
147177386|NCT00395850|530814229|FG000|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|2|||
147177387|NCT00395850|530814230|FG001|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|2|||
147177388|NCT00395850|530814231|FG002|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|6|||
147177389|NCT00395850|530814232|FG003|Randomization to Disulfiram/ Pre-admin|noncompliance - missed med/urines|4|||
147177390|NCT00395850|530814229|FG000|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|1|||
147177391|NCT00395850|530814230|FG001|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|0|||
147177392|NCT00395850|530814231|FG002|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|0|||
147177393|NCT00395850|530814232|FG003|Randomization to Disulfiram/ Pre-admin|noncompliance with alcohol use|0|||
147177394|NCT00395850|530814229|FG000|Randomization to Disulfiram/ Pre-admin|suicidal ideation|1|||
147177395|NCT00395850|530814230|FG001|Randomization to Disulfiram/ Pre-admin|suicidal ideation|0|||
147177396|NCT00395850|530814231|FG002|Randomization to Disulfiram/ Pre-admin|suicidal ideation|0|||
147177397|NCT00395850|530814232|FG003|Randomization to Disulfiram/ Pre-admin|suicidal ideation|0|||
147177398|NCT00395850|530814229|FG000|Randomization to Disulfiram/ Pre-admin|work schedule conflict|1|||
147177399|NCT00395850|530814230|FG001|Randomization to Disulfiram/ Pre-admin|work schedule conflict|0|||
147177400|NCT00395850|530814231|FG002|Randomization to Disulfiram/ Pre-admin|work schedule conflict|0|||
147177401|NCT00395850|530814232|FG003|Randomization to Disulfiram/ Pre-admin|work schedule conflict|0|||
147177402|NCT01844778|530814239|FG000|Overall Study|Protocol deviation|0|||
147177403|NCT01844778|530814240|FG001|Overall Study|Protocol deviation|1|||
147177404|NCT01844778|530814241|FG002|Overall Study|Protocol deviation|2|||
147177405|NCT01844778|530814239|FG000|Overall Study|Withdrawal by Subject|2|||
147177406|NCT01844778|530814240|FG001|Overall Study|Withdrawal by Subject|0|||
147177407|NCT01844778|530814241|FG002|Overall Study|Withdrawal by Subject|0|||
147177408|NCT01844778|530814239|FG000|Overall Study|Adverse Event|0|||
147177409|NCT01844778|530814240|FG001|Overall Study|Adverse Event|2|||
147177410|NCT01844778|530814241|FG002|Overall Study|Adverse Event|2|||
147177411|NCT01736618|530814244|FG000|Overall Study|Death|294|||
147177412|NCT01736618|530814244|FG000|Overall Study|Lost to Follow-up|193|||
147177413|NCT01736618|530814244|FG000|Overall Study|Withdrawal by Subject|54|||
147177414|NCT01736618|530814244|FG000|Overall Study|Subject unable to be followed at study location|223|||
147177415|NCT01736618|530814244|FG000|Overall Study|Physician Decision|33|||
147177416|NCT01736618|530814244|FG000|Overall Study|Transplant or removal of target organ|19|||
147177417|NCT01736618|530814244|FG000|Overall Study|Change in indication or condition|78|||
147177418|NCT01736618|530814244|FG000|Overall Study|Study device explant|103|||
147177419|NCT01736618|530814244|FG000|Overall Study|Unable to complete implant|2|||
147177420|NCT00211887|530814247|FG000|Overall Study|Adverse Event|8|||
147177421|NCT00211887|530814248|FG001|Overall Study|Adverse Event|4|||
147177422|NCT00211887|530814249|FG002|Overall Study|Adverse Event|6|||
147177423|NCT00211887|530814247|FG000|Overall Study|Death|1|||
147177424|NCT00211887|530814248|FG001|Overall Study|Death|1|||
147177425|NCT00211887|530814249|FG002|Overall Study|Death|1|||
147177426|NCT00211887|530814247|FG000|Overall Study|Lost to Follow-up|28|||
147177427|NCT00211887|530814248|FG001|Overall Study|Lost to Follow-up|13|||
147177428|NCT00211887|530814249|FG002|Overall Study|Lost to Follow-up|9|||
147177429|NCT00211887|530814247|FG000|Overall Study|Non-medical reason|31|||
147177430|NCT00211887|530814248|FG001|Overall Study|Non-medical reason|14|||
147177431|NCT00211887|530814249|FG002|Overall Study|Non-medical reason|8|||
147177432|NCT00211887|530814247|FG000|Overall Study|Other medical reason|15|||
147177433|NCT00211887|530814248|FG001|Overall Study|Other medical reason|11|||
147177434|NCT00211887|530814249|FG002|Overall Study|Other medical reason|7|||
147177435|NCT00211887|530814247|FG000|Overall Study|Side effects|19|||
147177436|NCT00211887|530814248|FG001|Overall Study|Side effects|13|||
147177437|NCT00211887|530814249|FG002|Overall Study|Side effects|5|||
147177438|NCT00965419|530814250|FG000|Open Label Treatment for Responders|Adverse Event|33|||
147177439|NCT00965419|530814250|FG000|Open Label Treatment for Responders|Entry Criteria Not Met|1|||
147177440|NCT00965419|530814250|FG000|Open Label Treatment for Responders|Protocol Violation|21|||
147177441|NCT00965419|530814250|FG000|Open Label Treatment for Responders|Withdrawal by Subject|27|||
147177442|NCT00965419|530814250|FG000|Open Label Treatment for Responders|Physician Decision|6|||
147177443|NCT00965419|530814250|FG000|Open Label Treatment for Responders|Sponsor Decision|5|||
147177444|NCT00965419|530814250|FG000|Open Label Treatment for Responders|Parent/Caregiver Decision|41|||
147655891|NCT01990768|532563008|FG000|In-Hospital Study Drug Infusion|CVA/thrombotic event or concern for one|5|||
147655892|NCT01990768|532563009|FG001|In-Hospital Study Drug Infusion|CVA/thrombotic event or concern for one|5|||
147655893|NCT01990768|532563010|FG002|In-Hospital Study Drug Infusion|CVA/thrombotic event or concern for one|4|||
147655894|NCT01990768|532563008|FG000|In-Hospital Study Drug Infusion|Required CPR|3|||
147655895|NCT01990768|532563009|FG001|In-Hospital Study Drug Infusion|Required CPR|7|||
147655896|NCT01990768|532563010|FG002|In-Hospital Study Drug Infusion|Required CPR|1|||
147655897|NCT01990768|532563008|FG000|In-Hospital Study Drug Infusion|Other safety concern|4|||
147655898|NCT01990768|532563009|FG001|In-Hospital Study Drug Infusion|Other safety concern|2|||
147655899|NCT01990768|532563010|FG002|In-Hospital Study Drug Infusion|Other safety concern|3|||
147177445|NCT00965419|530814250|FG000|Open Label Treatment for Responders|Lack of Efficacy|67|||
147177446|NCT00965419|530814250|FG000|Open Label Treatment for Responders|Lost to Follow-up|46|||
147177447|NCT00965419|530814250|FG000|Follow-up Phase|Adverse Event|9|||
147177448|NCT00965419|530814250|FG000|Follow-up Phase|Protocol Violation|4|||
147177449|NCT00965419|530814250|FG000|Follow-up Phase|Withdrawal by Subject|8|||
147177450|NCT00965419|530814250|FG000|Follow-up Phase|Physician Decision|4|||
147177451|NCT00965419|530814250|FG000|Follow-up Phase|Parent/Caregiver Decision|9|||
147177452|NCT00965419|530814250|FG000|Follow-up Phase|Lack of Efficacy|28|||
147177453|NCT02475278|530816018|FG000|Overall Study|Lost to Follow-up|1|||
147177454|NCT02475278|530816018|FG000|Overall Study|Reason Not Specified|1|||
147177455|NCT01946152|530816019|FG000|Overall Study|Adverse Event|1|||
147177456|NCT01946152|530816020|FG001|Overall Study|Adverse Event|0|||
147655900|NCT01990768|532563008|FG000|In-Hospital Study Drug Infusion|Taken into police custody|4|||
147655901|NCT01990768|532563009|FG001|In-Hospital Study Drug Infusion|Taken into police custody|0|||
147655902|NCT01990768|532563010|FG002|In-Hospital Study Drug Infusion|Taken into police custody|3|||
147655903|NCT01990768|532563008|FG000|In-Hospital Study Drug Infusion|Found not to be injured|1|||
147655904|NCT01990768|532563009|FG001|In-Hospital Study Drug Infusion|Found not to be injured|1|||
147655905|NCT01990768|532563010|FG002|In-Hospital Study Drug Infusion|Found not to be injured|1|||
147655906|NCT01990768|532563008|FG000|In-Hospital Study Drug Infusion|Transfer to non-participating facility|1|||
147655907|NCT01990768|532563009|FG001|In-Hospital Study Drug Infusion|Transfer to non-participating facility|1|||
147655908|NCT01990768|532563010|FG002|In-Hospital Study Drug Infusion|Transfer to non-participating facility|0|||
147655909|NCT01990768|532563008|FG000|In-Hospital Study Drug Infusion|Other procoagulant administered|0|||
147655910|NCT01990768|532563009|FG001|In-Hospital Study Drug Infusion|Other procoagulant administered|1|||
147655911|NCT01990768|532563010|FG002|In-Hospital Study Drug Infusion|Other procoagulant administered|2|||
147655912|NCT01990768|532563008|FG000|In-Hospital Study Drug Infusion|Unknown if completed|0|||
147655913|NCT01990768|532563009|FG001|In-Hospital Study Drug Infusion|Unknown if completed|0|||
147655914|NCT01990768|532563010|FG002|In-Hospital Study Drug Infusion|Unknown if completed|1|||
147655915|NCT01990768|532563008|FG000|6-Month Follow-up|Withdrawal by Subject|25|||
147655916|NCT01990768|532563009|FG001|6-Month Follow-up|Withdrawal by Subject|25|||
147655917|NCT01990768|532563010|FG002|6-Month Follow-up|Withdrawal by Subject|26|||
147655918|NCT01990768|532563008|FG000|6-Month Follow-up|Calls unreturned or refused contact|4|||
147655919|NCT01990768|532563009|FG001|6-Month Follow-up|Calls unreturned or refused contact|15|||
147655920|NCT01990768|532563010|FG002|6-Month Follow-up|Calls unreturned or refused contact|20|||
147177457|NCT01946152|530816021|FG002|Overall Study|Adverse Event|0|||
147177458|NCT01946152|530816022|FG003|Overall Study|Adverse Event|0|||
147177459|NCT01946152|530816019|FG000|Overall Study|Withdrawal by Subject|0|||
147655921|NCT01990768|532563008|FG000|6-Month Follow-up|No contact information|5|||
147655922|NCT01990768|532563009|FG001|6-Month Follow-up|No contact information|6|||
147655923|NCT01990768|532563010|FG002|6-Month Follow-up|No contact information|5|||
147655924|NCT01990768|532563008|FG000|6-Month Follow-up|Homeless|4|||
147655925|NCT01990768|532563009|FG001|6-Month Follow-up|Homeless|3|||
147177460|NCT01946152|530816020|FG001|Overall Study|Withdrawal by Subject|2|||
147177461|NCT01946152|530816021|FG002|Overall Study|Withdrawal by Subject|0|||
147177462|NCT01946152|530816022|FG003|Overall Study|Withdrawal by Subject|0|||
147177463|NCT01946152|530816019|FG000|Overall Study|Progression|0|||
147177464|NCT01946152|530816020|FG001|Overall Study|Progression|1|||
147177465|NCT01946152|530816021|FG002|Overall Study|Progression|4|||
147177466|NCT01946152|530816022|FG003|Overall Study|Progression|7|||
147177467|NCT01946152|530816019|FG000|Overall Study|Physician Decision|0|||
147177468|NCT01946152|530816020|FG001|Overall Study|Physician Decision|0|||
147177469|NCT01946152|530816021|FG002|Overall Study|Physician Decision|1|||
147177470|NCT01946152|530816022|FG003|Overall Study|Physician Decision|0|||
147177471|NCT01946152|530816019|FG000|Overall Study|Second malignancy|0|||
147177472|NCT01946152|530816020|FG001|Overall Study|Second malignancy|0|||
147177473|NCT01946152|530816021|FG002|Overall Study|Second malignancy|1|||
147177474|NCT01946152|530816022|FG003|Overall Study|Second malignancy|0|||
147177475|NCT01946152|530816019|FG000|Overall Study|Adverse Event|0|||
147177476|NCT01946152|530816020|FG001|Overall Study|Adverse Event|0|||
147177477|NCT01946152|530816021|FG002|Overall Study|Adverse Event|0|||
147177478|NCT01946152|530816022|FG003|Overall Study|Adverse Event|1|||
147177479|NCT03688074|530816025|FG000|Overall Study|Adverse Event|0|||
147177480|NCT03688074|530816026|FG001|Overall Study|Adverse Event|1|||
147177481|NCT03688074|530816025|FG000|Overall Study|Other|1|||
147177482|NCT03688074|530816026|FG001|Overall Study|Other|0|||
147177483|NCT03056339|530816027|FG000|Overall Study|Failed Requirements|0|||
147177484|NCT03056339|530816028|FG001|Overall Study|Failed Requirements|2|||
147177485|NCT03056339|530816029|FG002|Overall Study|Failed Requirements|7|||
147177486|NCT03056339|530816030|FG003|Overall Study|Failed Requirements|1|||
147177487|NCT01363908|530816031|FG000|Chronic Dosing (CD) Phase|Adverse Event|1|||
147177488|NCT01363908|530816032|FG001|Chronic Dosing (CD) Phase|Adverse Event|1|||
147177489|NCT01363908|530816031|FG000|Chronic Dosing (CD) Phase|Patient decision|0|||
147177490|NCT01363908|530816032|FG001|Chronic Dosing (CD) Phase|Patient decision|1|||
147177491|NCT01363908|530816031|FG000|Chronic Dosing (CD) Phase|Physician Decision|0|||
147177492|NCT01363908|530816032|FG001|Chronic Dosing (CD) Phase|Physician Decision|1|||
147177493|NCT01363908|530816031|FG000|Chronic Dosing (CD) Phase|Early study termination|9|||
147177494|NCT01363908|530816032|FG001|Chronic Dosing (CD) Phase|Early study termination|3|||
147177495|NCT02644343|530816033|FG000|Overall Study|Withdrawal by Subject|1|||
147177496|NCT03437577|530816034|FG000|Pre-Randomization|Withdrawal by Subject|0|||
147177497|NCT03437577|530816035|FG001|Pre-Randomization|Withdrawal by Subject|0|||
147177498|NCT03437577|530816036|FG002|Pre-Randomization|Withdrawal by Subject|10|||
147177499|NCT03437577|530816034|FG000|Post-Randomization|Physician Decision|0|||
147177500|NCT03437577|530816035|FG001|Post-Randomization|Physician Decision|2|||
147177501|NCT03437577|530816036|FG002|Post-Randomization|Physician Decision|0|||
147177502|NCT00536471|530816037|FG000|Overall Study|Lost to Follow-up|48|||
147177503|NCT00536471|530816038|FG001|Overall Study|Lost to Follow-up|23|||
147177504|NCT00536471|530816039|FG002|Overall Study|Lost to Follow-up|48|||
147177505|NCT00536471|530816040|FG003|Overall Study|Lost to Follow-up|22|||
147177506|NCT00536471|530816037|FG000|Overall Study|Adverse Event|32|||
147177507|NCT00536471|530816038|FG001|Overall Study|Adverse Event|16|||
147177508|NCT00536471|530816039|FG002|Overall Study|Adverse Event|28|||
147177509|NCT00536471|530816040|FG003|Overall Study|Adverse Event|13|||
147177510|NCT00536471|530816037|FG000|Overall Study|Withdrawal by Subject|40|||
147177511|NCT00536471|530816038|FG001|Overall Study|Withdrawal by Subject|24|||
147177512|NCT00536471|530816039|FG002|Overall Study|Withdrawal by Subject|43|||
147177513|NCT00536471|530816040|FG003|Overall Study|Withdrawal by Subject|21|||
147177514|NCT00536471|530816037|FG000|Overall Study|Lack of Efficacy|17|||
147177515|NCT00536471|530816038|FG001|Overall Study|Lack of Efficacy|18|||
147177516|NCT00536471|530816039|FG002|Overall Study|Lack of Efficacy|11|||
147177517|NCT00536471|530816040|FG003|Overall Study|Lack of Efficacy|9|||
147177518|NCT00536471|530816037|FG000|Overall Study|Protocol Violation|8|||
147177519|NCT00536471|530816038|FG001|Overall Study|Protocol Violation|1|||
147177520|NCT00536471|530816039|FG002|Overall Study|Protocol Violation|2|||
147177521|NCT00536471|530816040|FG003|Overall Study|Protocol Violation|3|||
147177522|NCT00536471|530816037|FG000|Overall Study|Physician Decision|11|||
147177523|NCT00536471|530816038|FG001|Overall Study|Physician Decision|1|||
147177524|NCT00536471|530816039|FG002|Overall Study|Physician Decision|3|||
147177525|NCT00536471|530816040|FG003|Overall Study|Physician Decision|2|||
147177526|NCT00536471|530816037|FG000|Overall Study|Death|0|||
147177527|NCT00536471|530816038|FG001|Overall Study|Death|0|||
147177528|NCT00536471|530816039|FG002|Overall Study|Death|1|||
147177529|NCT00536471|530816040|FG003|Overall Study|Death|2|||
147177530|NCT00536471|530816037|FG000|Overall Study|Sponsor Decision|0|||
147177531|NCT00536471|530816038|FG001|Overall Study|Sponsor Decision|1|||
147177532|NCT00536471|530816039|FG002|Overall Study|Sponsor Decision|3|||
147177533|NCT00536471|530816040|FG003|Overall Study|Sponsor Decision|2|||
147177534|NCT04273893|530816043|FG000|Overall Study|Withdrawal by Subject|0|||
147177535|NCT04273893|530816044|FG001|Overall Study|Withdrawal by Subject|2|||
147177536|NCT04273893|530816043|FG000|Overall Study|Treatment of Disease Progression|0|||
147177537|NCT04273893|530816044|FG001|Overall Study|Treatment of Disease Progression|2|||
147245012|NCT03926169|531070748|FG001|Period B|Other, Not Specified|57|||
147245013|NCT03926169|531070749|FG002|Period B|Other, Not Specified|65|||
147245014|NCT03708328|531070752|FG000|Overall Study|Death|3|||
147177538|NCT04273893|530816043|FG000|Overall Study|Death|1|||
147177539|NCT04273893|530816044|FG001|Overall Study|Death|2|||
147177540|NCT04273893|530816043|FG000|Overall Study|Lost to Follow-up|0|||
147177541|NCT04273893|530816044|FG001|Overall Study|Lost to Follow-up|2|||
147177542|NCT04273893|530816043|FG000|Overall Study|Physician Decision|1|||
147448306|NCT00708123|531805687|FG001|Period 1|Protocol Violation|1|||
147177543|NCT04273893|530816044|FG001|Overall Study|Physician Decision|0|||
147177544|NCT02783599|530816049|FG000|Overall Study|Progressive disease|23|||
147177545|NCT02783599|530816049|FG000|Overall Study|Surgical Resection|10|||
147177546|NCT02783599|530816049|FG000|Overall Study|Adverse Event|4|||
147177547|NCT02783599|530816049|FG000|Overall Study|Physician Decision|2|||
147177548|NCT02783599|530816049|FG000|Overall Study|Death|1|||
147177549|NCT00856544|530816052|FG000|Overall Study|Randomized but not treated|3|||
147177550|NCT00856544|530816053|FG001|Overall Study|Randomized but not treated|0|||
147177551|NCT00856544|530816054|FG002|Overall Study|Randomized but not treated|0|||
147655926|NCT01990768|532563010|FG002|6-Month Follow-up|Homeless|6|||
147177552|NCT00856544|530816055|FG003|Overall Study|Randomized but not treated|0|||
147177553|NCT00856544|530816052|FG000|Overall Study|Death|0|||
147177554|NCT00856544|530816053|FG001|Overall Study|Death|2|||
147177555|NCT00856544|530816054|FG002|Overall Study|Death|0|||
147177556|NCT00856544|530816055|FG003|Overall Study|Death|0|||
147177557|NCT00856544|530816052|FG000|Overall Study|Adverse Event|20|||
147177558|NCT00856544|530816053|FG001|Overall Study|Adverse Event|29|||
147177559|NCT00856544|530816054|FG002|Overall Study|Adverse Event|2|||
147177560|NCT00856544|530816055|FG003|Overall Study|Adverse Event|3|||
147177561|NCT00856544|530816052|FG000|Overall Study|Lack of Efficacy|16|||
147177562|NCT00856544|530816053|FG001|Overall Study|Lack of Efficacy|12|||
147177563|NCT00856544|530816054|FG002|Overall Study|Lack of Efficacy|3|||
147177564|NCT00856544|530816055|FG003|Overall Study|Lack of Efficacy|3|||
147177565|NCT00856544|530816052|FG000|Overall Study|Other|9|||
147177566|NCT00856544|530816053|FG001|Overall Study|Other|16|||
147177567|NCT00856544|530816054|FG002|Overall Study|Other|1|||
147177568|NCT00856544|530816055|FG003|Overall Study|Other|6|||
147177569|NCT00856544|530816052|FG000|Overall Study|Lost to Follow-up|1|||
147177570|NCT00856544|530816053|FG001|Overall Study|Lost to Follow-up|2|||
147177571|NCT00856544|530816054|FG002|Overall Study|Lost to Follow-up|2|||
147177572|NCT00856544|530816055|FG003|Overall Study|Lost to Follow-up|0|||
147177573|NCT00856544|530816052|FG000|Overall Study|Withdrawal by Subject|8|||
147177574|NCT00856544|530816053|FG001|Overall Study|Withdrawal by Subject|5|||
147177575|NCT00856544|530816054|FG002|Overall Study|Withdrawal by Subject|0|||
147177576|NCT00856544|530816055|FG003|Overall Study|Withdrawal by Subject|1|||
147177577|NCT01564732|530816056|FG000|Overall Study|Early termination by the study sponsor|6|||
147177578|NCT01564732|530816057|FG001|Overall Study|Early termination by the study sponsor|5|||
147177579|NCT01036321|530816058|FG000|Overall Study|Ineligible after randomization|0|||
147177580|NCT01036321|530816059|FG001|Overall Study|Ineligible after randomization|1|||
147177581|NCT01036321|530816058|FG000|Overall Study|Withdrawal by Subject|3|||
147177582|NCT01036321|530816059|FG001|Overall Study|Withdrawal by Subject|2|||
147177583|NCT01036321|530816058|FG000|Overall Study|Adverse Event|2|||
147177584|NCT01036321|530816059|FG001|Overall Study|Adverse Event|1|||
147177585|NCT00381693|530816060|FG000|Overall Study|Death|1|||
147177586|NCT00381693|530816060|FG000|Overall Study|Adverse Event|4|||
147177587|NCT00381693|530816060|FG000|Overall Study|Patient Choice|1|||
147177588|NCT00381693|530816060|FG000|Overall Study|Progression|2|||
147177589|NCT02003534|530816063|FG000|Overall Study|Lost to Follow-up|47|||
147177590|NCT03920254|530816065|FG000|Overall Study|Adverse Event|1|||
147177591|NCT03920254|530816066|FG001|Overall Study|Adverse Event|0|||
147177592|NCT03920254|530816067|FG002|Overall Study|Adverse Event|0|||
147177593|NCT03920254|530816065|FG000|Overall Study|Physician Decision|0|||
147177594|NCT03920254|530816066|FG001|Overall Study|Physician Decision|1|||
147177595|NCT03920254|530816067|FG002|Overall Study|Physician Decision|2|||
147177596|NCT03920254|530816065|FG000|Overall Study|Study Terminated By Sponsor|12|||
147177597|NCT03920254|530816066|FG001|Overall Study|Study Terminated By Sponsor|17|||
147177598|NCT03920254|530816067|FG002|Overall Study|Study Terminated By Sponsor|12|||
147177599|NCT03920254|530816065|FG000|Overall Study|Withdrawal by Subject|0|||
147177600|NCT03920254|530816066|FG001|Overall Study|Withdrawal by Subject|0|||
147177601|NCT03920254|530816067|FG002|Overall Study|Withdrawal by Subject|1|||
147177602|NCT03040674|530816068|FG000|Overall Study|Lost to Follow-up|225|||
147177603|NCT03040674|530816068|FG000|Overall Study|Death|23|||
147177604|NCT05173012|530816069|FG000|Overall Study|Adverse Event|2|||
147177605|NCT05173012|530816070|FG001|Overall Study|Adverse Event|3|||
147177606|NCT05173012|530816071|FG002|Overall Study|Adverse Event|4|||
147177607|NCT05173012|530816072|FG003|Overall Study|Adverse Event|13|||
147177608|NCT05173012|530816073|FG004|Overall Study|Adverse Event|0|||
147177609|NCT05173012|530816074|FG005|Overall Study|Adverse Event|0|||
147177610|NCT05173012|530816075|FG006|Overall Study|Adverse Event|2|||
147177611|NCT05173012|530816076|FG007|Overall Study|Adverse Event|4|||
147177612|NCT05173012|530816069|FG000|Overall Study|Lost to Follow-up|0|||
147177613|NCT05173012|530816070|FG001|Overall Study|Lost to Follow-up|0|||
147177614|NCT05173012|530816071|FG002|Overall Study|Lost to Follow-up|0|||
147177615|NCT05173012|530816072|FG003|Overall Study|Lost to Follow-up|1|||
147177616|NCT05173012|530816073|FG004|Overall Study|Lost to Follow-up|0|||
147177617|NCT05173012|530816074|FG005|Overall Study|Lost to Follow-up|0|||
147177618|NCT05173012|530816075|FG006|Overall Study|Lost to Follow-up|0|||
147177619|NCT05173012|530816076|FG007|Overall Study|Lost to Follow-up|0|||
147177620|NCT05173012|530816069|FG000|Overall Study|Withdrawal by Subject|1|||
147177621|NCT05173012|530816070|FG001|Overall Study|Withdrawal by Subject|0|||
147177622|NCT05173012|530816071|FG002|Overall Study|Withdrawal by Subject|1|||
147245015|NCT03708328|531070753|FG001|Overall Study|Death|3|||
147245016|NCT03708328|531070754|FG002|Overall Study|Death|4|||
147245017|NCT03708328|531070755|FG003|Overall Study|Death|2|||
147245018|NCT03708328|531070756|FG004|Overall Study|Death|2|||
147245019|NCT03708328|531070757|FG005|Overall Study|Death|13|||
147245020|NCT03708328|531070758|FG006|Overall Study|Death|26|||
147245021|NCT03708328|531070759|FG007|Overall Study|Death|18|||
147245022|NCT03708328|531070760|FG008|Overall Study|Death|13|||
147324571|NCT00049517|531354317|FG001|Induction|Death|0|||
147324572|NCT00049517|531354318|FG002|Induction|Death|0|||
147324573|NCT00049517|531354319|FG003|Induction|Death|0|||
147324574|NCT00049517|531354320|FG004|Induction|Death|9|||
147324575|NCT00049517|531354321|FG005|Induction|Death|6|||
147324576|NCT00049517|531354316|FG000|Induction|Withdrawal by Subject|0|||
147177623|NCT05173012|530816072|FG003|Overall Study|Withdrawal by Subject|3|||
147177624|NCT05173012|530816073|FG004|Overall Study|Withdrawal by Subject|1|||
147177625|NCT05173012|530816074|FG005|Overall Study|Withdrawal by Subject|0|||
147177626|NCT05173012|530816075|FG006|Overall Study|Withdrawal by Subject|1|||
147177627|NCT05173012|530816076|FG007|Overall Study|Withdrawal by Subject|0|||
147177628|NCT05173012|530816069|FG000|Overall Study|Protocol Deviation|0|||
147177629|NCT05173012|530816070|FG001|Overall Study|Protocol Deviation|0|||
147177630|NCT05173012|530816071|FG002|Overall Study|Protocol Deviation|0|||
147177631|NCT05173012|530816072|FG003|Overall Study|Protocol Deviation|1|||
147177632|NCT05173012|530816073|FG004|Overall Study|Protocol Deviation|0|||
147177633|NCT05173012|530816074|FG005|Overall Study|Protocol Deviation|0|||
147177634|NCT05173012|530816075|FG006|Overall Study|Protocol Deviation|0|||
147177635|NCT05173012|530816076|FG007|Overall Study|Protocol Deviation|0|||
147177636|NCT05173012|530816069|FG000|Overall Study|Other|0|||
147177637|NCT05173012|530816070|FG001|Overall Study|Other|0|||
147177638|NCT05173012|530816071|FG002|Overall Study|Other|0|||
147177639|NCT05173012|530816072|FG003|Overall Study|Other|2|||
147177640|NCT05173012|530816073|FG004|Overall Study|Other|0|||
147177641|NCT05173012|530816074|FG005|Overall Study|Other|0|||
147177642|NCT05173012|530816075|FG006|Overall Study|Other|0|||
147177643|NCT05173012|530816076|FG007|Overall Study|Other|0|||
147177644|NCT00517361|530816077|FG000|Overall Study|Death|6|||
147177645|NCT00517361|530816077|FG000|Overall Study|The study was terminated|5|||
147177646|NCT03517228|530816081|FG000|Overall Study|Withdrawal by Subject|2|||
147177647|NCT03517228|530816081|FG000|Overall Study|Hard drive issues, abandoned prior to surgery|2|||
147177648|NCT03517228|530816081|FG000|Overall Study|Anatomy issue - abandoned prior to surgery|1|||
147177649|NCT03517228|530816081|FG000|Overall Study|Surgery was at MAIN, could not change location to JOSIE|1|||
147177650|NCT03517228|530816081|FG000|Overall Study|Canceled due to device being updated|1|||
147177651|NCT03517228|530816081|FG000|Overall Study|No V Cares in stock|1|||
147177652|NCT03517228|530816081|FG000|Overall Study|Service issue, use of device cancelled prior to surgery|2|||
147177653|NCT03781414|530816086|FG000|Overall Study|Study terminated by sponsor|39|||
147177654|NCT03781414|530816087|FG001|Overall Study|Study terminated by sponsor|34|||
147177655|NCT03781414|530816088|FG002|Overall Study|Study terminated by sponsor|25|||
147177656|NCT03781414|530816086|FG000|Overall Study|Adverse Event|3|||
147177657|NCT03781414|530816087|FG001|Overall Study|Adverse Event|6|||
147177658|NCT03781414|530816088|FG002|Overall Study|Adverse Event|3|||
147177659|NCT03781414|530816086|FG000|Overall Study|Physician Decision|2|||
147177660|NCT03781414|530816087|FG001|Overall Study|Physician Decision|0|||
147177661|NCT03781414|530816088|FG002|Overall Study|Physician Decision|1|||
147177662|NCT03781414|530816086|FG000|Overall Study|Withdrawal by Subject|2|||
147177663|NCT03781414|530816087|FG001|Overall Study|Withdrawal by Subject|3|||
147177664|NCT03781414|530816088|FG002|Overall Study|Withdrawal by Subject|3|||
147177665|NCT03781414|530816086|FG000|Overall Study|Death|1|||
147177666|NCT03781414|530816087|FG001|Overall Study|Death|4|||
147177667|NCT03781414|530816088|FG002|Overall Study|Death|0|||
147177668|NCT03781414|530816086|FG000|Overall Study|Lost to Follow-up|1|||
147177669|NCT03781414|530816087|FG001|Overall Study|Lost to Follow-up|1|||
147177670|NCT03781414|530816088|FG002|Overall Study|Lost to Follow-up|0|||
147177671|NCT04752358|530816091|FG000|Overall Study|Death|2|||
147177672|NCT04752358|530816092|FG001|Overall Study|Death|1|||
147177673|NCT00719355|530816093|FG000|Overall Study|Death|0|||
147177674|NCT00719355|530816094|FG001|Overall Study|Death|1|||
147177675|NCT00719355|530816093|FG000|Overall Study|Medical|14|||
147177676|NCT00719355|530816094|FG001|Overall Study|Medical|5|||
147324577|NCT00049517|531354317|FG001|Induction|Withdrawal by Subject|0|||
147324578|NCT00049517|531354318|FG002|Induction|Withdrawal by Subject|0|||
147177677|NCT00719355|530816093|FG000|Overall Study|Compliance|4|||
147177678|NCT00719355|530816094|FG001|Overall Study|Compliance|6|||
147177679|NCT00719355|530816093|FG000|Overall Study|Moved|0|||
147177680|NCT00719355|530816094|FG001|Overall Study|Moved|1|||
147177681|NCT01824355|530816095|FG000|Overall Study|Adverse Event|2|||
147177682|NCT01824355|530816095|FG000|Overall Study|unevaluable reference method results per|1|||
147324579|NCT00049517|531354319|FG003|Induction|Withdrawal by Subject|0|||
147324580|NCT00049517|531354320|FG004|Induction|Withdrawal by Subject|1|||
147177683|NCT00836186|530816099|FG000|Overall Study|Blood could not be drawn|1|||
147177684|NCT05232864|530816105|FG000|Overall Study|Adverse Event|0|||
147324581|NCT00049517|531354321|FG005|Induction|Withdrawal by Subject|3|||
147177685|NCT05232864|530816106|FG001|Overall Study|Adverse Event|1|||
147177686|NCT05232864|530816105|FG000|Overall Study|Study terminated by sponsor|16|||
147177687|NCT05232864|530816106|FG001|Overall Study|Study terminated by sponsor|14|||
147324582|NCT00049517|531354316|FG000|Induction|Alternative therapy|0|||
147324583|NCT00049517|531354317|FG001|Induction|Alternative therapy|0|||
147324584|NCT00049517|531354318|FG002|Induction|Alternative therapy|0|||
147324585|NCT00049517|531354319|FG003|Induction|Alternative therapy|0|||
147177688|NCT02023996|530816107|FG000|Overall Study|Protocol Violation|6|||
147177689|NCT01496846|530816115|FG000|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|1|||
147177690|NCT01496846|530816116|FG001|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|1|||
147177691|NCT01496846|530816117|FG002|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0|||
147177692|NCT01496846|530816118|FG003|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0|||
147177693|NCT01496846|530816119|FG004|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0|||
147177694|NCT01496846|530816120|FG005|IANB Articaine (All Participants)|"Inadequate lip numbness: missed block"|0|||
147177695|NCT01772576|530816121|FG000|Overall Study|Death|15|||
147177696|NCT01772576|530816121|FG000|Overall Study|Protocol Violation|1|||
147177697|NCT01772576|530816121|FG000|Overall Study|Lost to Follow-up|3|||
147177698|NCT01772576|530816121|FG000|Overall Study|Study device not used|3|||
147177699|NCT01772576|530816121|FG000|Overall Study|Adverse Event|6|||
147177700|NCT01772576|530816121|FG000|Overall Study|Withdrawal by Subject|6|||
147177701|NCT00923845|530816122|FG000|Induction Therapy|Poor performance status|0|||
147177702|NCT00923845|530816123|FG001|Induction Therapy|Poor performance status|2|||
147177703|NCT00379912|530816125|FG000|Overall Study|Lack of Efficacy|1|||
147177704|NCT00379912|530816126|FG001|Overall Study|Lack of Efficacy|0|||
147177705|NCT02578186|530816127|FG000|Period 1 (First of Crossover)|Did not meet Phase 2 eligibility|4|||
147177706|NCT02578186|530816128|FG001|Period 1 (First of Crossover)|Did not meet Phase 2 eligibility|4|||
147177707|NCT02578186|530816127|FG000|Period 1 (First of Crossover)|Withdrawal by Subject|1|||
147177708|NCT02578186|530816128|FG001|Period 1 (First of Crossover)|Withdrawal by Subject|1|||
147177709|NCT02873338|530816129|FG000|Overall Study|Adverse Event|0|||
147177710|NCT02873338|530816130|FG001|Overall Study|Adverse Event|2|||
147177711|NCT02873338|530816131|FG002|Overall Study|Adverse Event|1|||
147177712|NCT02873338|530816129|FG000|Overall Study|Death|2|||
147177713|NCT02873338|530816130|FG001|Overall Study|Death|1|||
147177714|NCT02873338|530816131|FG002|Overall Study|Death|1|||
147177715|NCT02873338|530816129|FG000|Overall Study|Withdrawal by Subject|2|||
147177716|NCT02873338|530816130|FG001|Overall Study|Withdrawal by Subject|1|||
147177717|NCT02873338|530816131|FG002|Overall Study|Withdrawal by Subject|3|||
147177718|NCT02873338|530816129|FG000|Overall Study|Lack of Efficacy|0|||
147177719|NCT02873338|530816130|FG001|Overall Study|Lack of Efficacy|2|||
147177720|NCT02873338|530816131|FG002|Overall Study|Lack of Efficacy|0|||
147177721|NCT02873338|530816129|FG000|Overall Study|Other or Missing|14|||
147177722|NCT02873338|530816130|FG001|Overall Study|Other or Missing|15|||
147177723|NCT02873338|530816131|FG002|Overall Study|Other or Missing|13|||
147177724|NCT02038075|530816132|FG000|Overall Study|Withdrawal by Subject|3|||
147177725|NCT02038075|530816133|FG001|Overall Study|Withdrawal by Subject|0|||
147177726|NCT04000581|530816134|FG000|Overall Study|Withdrawal by Subject|0|||
147177727|NCT04000581|530816135|FG001|Overall Study|Withdrawal by Subject|1|||
147177728|NCT03477838|530816136|FG000|Overall Study|Lost to Follow-up|14|||
147177729|NCT02519595|530816138|FG000|Overall Study|Protocol Violation|8|||
147177730|NCT02519595|530816139|FG001|Overall Study|Protocol Violation|22|||
147177731|NCT02519595|530816140|FG002|Overall Study|Protocol Violation|16|||
147177732|NCT00850538|530816143|FG000|Overall Study|unable/unwilling to complete MRI|13|||
147177733|NCT00850538|530816143|FG000|Overall Study|specimen missed due to scheduling error|14|||
147177734|NCT00850538|530816143|FG000|Overall Study|specimen unusable|7|||
147177735|NCT00850538|530816143|FG000|Overall Study|Withdrawal by Subject|3|||
147177736|NCT00850538|530816143|FG000|Overall Study|radiology error|2|||
147177737|NCT00850538|530816143|FG000|Overall Study|Protocol Violation|2|||
147177738|NCT03188510|530816149|FG000|Overall Study|Inappropriate behavior with site staff|0|||
147177739|NCT03188510|530816150|FG001|Overall Study|Inappropriate behavior with site staff|1|||
147177740|NCT03188510|530816151|FG002|Overall Study|Inappropriate behavior with site staff|0|||
147177741|NCT01088399|530816153|FG000|Overall Study|Adverse Event|211|||
147177742|NCT01088399|530816154|FG001|Overall Study|Adverse Event|16|||
147177743|NCT01088399|530816155|FG002|Overall Study|Adverse Event|0|||
147177744|NCT01088399|530816153|FG000|Overall Study|Death|204|||
147177745|NCT01088399|530816154|FG001|Overall Study|Death|45|||
147177746|NCT01088399|530816155|FG002|Overall Study|Death|0|||
147177747|NCT01088399|530816153|FG000|Overall Study|Lack of Efficacy|298|||
147177748|NCT01088399|530816154|FG001|Overall Study|Lack of Efficacy|7|||
147177749|NCT01088399|530816155|FG002|Overall Study|Lack of Efficacy|5|||
147177750|NCT01088399|530816153|FG000|Overall Study|Lost to Follow-up|1070|||
147177751|NCT01088399|530816154|FG001|Overall Study|Lost to Follow-up|278|||
147177752|NCT01088399|530816155|FG002|Overall Study|Lost to Follow-up|58|||
147177753|NCT01088399|530816153|FG000|Overall Study|Physician Decision|531|||
147177754|NCT01088399|530816154|FG001|Overall Study|Physician Decision|88|||
147177755|NCT01088399|530816155|FG002|Overall Study|Physician Decision|16|||
147324586|NCT00049517|531354320|FG004|Induction|Alternative therapy|2|||
147177756|NCT01088399|530816153|FG000|Overall Study|Withdrawal by Subject|544|||
147177757|NCT01088399|530816154|FG001|Overall Study|Withdrawal by Subject|195|||
147177758|NCT01088399|530816155|FG002|Overall Study|Withdrawal by Subject|33|||
147177759|NCT01088399|530816153|FG000|Overall Study|Change to or start of somatropin therapy|234|||
147177760|NCT01088399|530816154|FG001|Overall Study|Change to or start of somatropin therapy|17|||
147177761|NCT01088399|530816155|FG002|Overall Study|Change to or start of somatropin therapy|12|||
147177762|NCT01088399|530816153|FG000|Overall Study|Sponsor decision|1573|||
147177763|NCT01088399|530816154|FG001|Overall Study|Sponsor decision|298|||
147177764|NCT01088399|530816155|FG002|Overall Study|Sponsor decision|7|||
147177765|NCT01088399|530816153|FG000|Overall Study|Protocol Violation|10|||
147177766|NCT01088399|530816154|FG001|Overall Study|Protocol Violation|1|||
147177767|NCT01088399|530816155|FG002|Overall Study|Protocol Violation|0|||
147177768|NCT01088399|530816153|FG000|Overall Study|Enrollment criteria not met|48|||
147177769|NCT01088399|530816154|FG001|Overall Study|Enrollment criteria not met|119|||
147177770|NCT01088399|530816155|FG002|Overall Study|Enrollment criteria not met|70|||
147177771|NCT01088399|530816153|FG000|Overall Study|Study summary visit not completed|2398|||
147177772|NCT01088399|530816154|FG001|Overall Study|Study summary visit not completed|283|||
147177773|NCT01088399|530816155|FG002|Overall Study|Study summary visit not completed|80|||
147177774|NCT01748825|530816159|FG000|Dose Escalation|Refused further treatment|2|||
147177775|NCT01748825|530816160|FG001|Dose Escalation|Refused further treatment|2|||
147177776|NCT01748825|530816161|FG002|Dose Escalation|Refused further treatment|0|||
147177777|NCT01748825|530816162|FG003|Dose Escalation|Refused further treatment|0|||
147177778|NCT01748825|530816163|FG004|Dose Escalation|Refused further treatment|1|||
147177779|NCT01748825|530816164|FG005|Dose Escalation|Refused further treatment|2|||
147177780|NCT01748825|530816165|FG006|Dose Escalation|Refused further treatment|0|||
147177781|NCT01748825|530816166|FG007|Dose Escalation|Refused further treatment|0|||
147177782|NCT01748825|530816167|FG008|Dose Escalation|Refused further treatment|0|||
147177783|NCT01748825|530816168|FG009|Dose Escalation|Refused further treatment|0|||
147177784|NCT01748825|530816159|FG000|Dose Escalation|Switched to alternative treatment|0|||
147177785|NCT01748825|530816160|FG001|Dose Escalation|Switched to alternative treatment|0|||
147177786|NCT01748825|530816161|FG002|Dose Escalation|Switched to alternative treatment|0|||
147177787|NCT01748825|530816162|FG003|Dose Escalation|Switched to alternative treatment|1|||
147177788|NCT01748825|530816163|FG004|Dose Escalation|Switched to alternative treatment|0|||
147177789|NCT01748825|530816164|FG005|Dose Escalation|Switched to alternative treatment|0|||
147177790|NCT01748825|530816165|FG006|Dose Escalation|Switched to alternative treatment|0|||
147177791|NCT01748825|530816166|FG007|Dose Escalation|Switched to alternative treatment|0|||
147177792|NCT01748825|530816167|FG008|Dose Escalation|Switched to alternative treatment|0|||
147177793|NCT01748825|530816168|FG009|Dose Escalation|Switched to alternative treatment|0|||
147177794|NCT01748825|530816159|FG000|Dose Escalation|Adverse Event|0|||
147177795|NCT01748825|530816160|FG001|Dose Escalation|Adverse Event|0|||
147177796|NCT01748825|530816161|FG002|Dose Escalation|Adverse Event|0|||
147177797|NCT01748825|530816162|FG003|Dose Escalation|Adverse Event|0|||
147177798|NCT01748825|530816163|FG004|Dose Escalation|Adverse Event|0|||
147177799|NCT01748825|530816164|FG005|Dose Escalation|Adverse Event|0|||
147177800|NCT01748825|530816165|FG006|Dose Escalation|Adverse Event|1|||
147177801|NCT01748825|530816166|FG007|Dose Escalation|Adverse Event|0|||
147177802|NCT01748825|530816167|FG008|Dose Escalation|Adverse Event|0|||
147245023|NCT03708328|531070761|FG009|Overall Study|Death|8|||
147245024|NCT03708328|531070752|FG000|Overall Study|Lost to Follow-up|0|||
147245025|NCT03708328|531070753|FG001|Overall Study|Lost to Follow-up|1|||
147245026|NCT03708328|531070754|FG002|Overall Study|Lost to Follow-up|0|||
147245027|NCT03708328|531070755|FG003|Overall Study|Lost to Follow-up|1|||
147245028|NCT03708328|531070756|FG004|Overall Study|Lost to Follow-up|0|||
147245029|NCT03708328|531070757|FG005|Overall Study|Lost to Follow-up|3|||
147245030|NCT03708328|531070758|FG006|Overall Study|Lost to Follow-up|3|||
147245031|NCT03708328|531070759|FG007|Overall Study|Lost to Follow-up|0|||
147655927|NCT01990768|532563008|FG000|6-Month Follow-up|Prisoner at time of enrollment|0|||
147655928|NCT01990768|532563009|FG001|6-Month Follow-up|Prisoner at time of enrollment|0|||
147655929|NCT01990768|532563010|FG002|6-Month Follow-up|Prisoner at time of enrollment|1|||
147655930|NCT01990768|532563008|FG000|6-Month Follow-up|Prisoner at time of follow-up|0|||
147655931|NCT01990768|532563009|FG001|6-Month Follow-up|Prisoner at time of follow-up|2|||
147655932|NCT01990768|532563010|FG002|6-Month Follow-up|Prisoner at time of follow-up|0|||
147655933|NCT01990768|532563008|FG000|6-Month Follow-up|Patient at psychiatric hospital|1|||
147655934|NCT01990768|532563009|FG001|6-Month Follow-up|Patient at psychiatric hospital|0|||
147655935|NCT01990768|532563010|FG002|6-Month Follow-up|Patient at psychiatric hospital|0|||
147655936|NCT00154375|532563011|FG000|Overall Study|Unsatisfactory therapeutic effect|25|||
147655937|NCT00154375|532563012|FG001|Overall Study|Unsatisfactory therapeutic effect|26|||
147655938|NCT00154375|532563011|FG000|Overall Study|Adverse Event|18|||
147655939|NCT00154375|532563012|FG001|Overall Study|Adverse Event|20|||
147655940|NCT00154375|532563011|FG000|Overall Study|Withdrawal by Subject|14|||
147655941|NCT00154375|532563012|FG001|Overall Study|Withdrawal by Subject|10|||
147655942|NCT00154375|532563011|FG000|Overall Study|Death|5|||
147655943|NCT00154375|532563012|FG001|Overall Study|Death|13|||
147177803|NCT01748825|530816168|FG009|Dose Escalation|Adverse Event|0|||
147655944|NCT00154375|532563011|FG000|Overall Study|Study drug no longer required|5|||
147655945|NCT00154375|532563012|FG001|Overall Study|Study drug no longer required|3|||
147655946|NCT00154375|532563011|FG000|Overall Study|Lost to Follow-up|2|||
147655947|NCT00154375|532563012|FG001|Overall Study|Lost to Follow-up|1|||
147177804|NCT01748825|530816159|FG000|Dose Expansion|Refused further treatment|0|||
147177805|NCT01748825|530816160|FG001|Dose Expansion|Refused further treatment|0|||
147245032|NCT03708328|531070760|FG008|Overall Study|Lost to Follow-up|0|||
147655948|NCT00154375|532563011|FG000|Overall Study|Abnormal laboratory value(s)|0|||
147177806|NCT01748825|530816161|FG002|Dose Expansion|Refused further treatment|0|||
147177807|NCT01748825|530816162|FG003|Dose Expansion|Refused further treatment|0|||
147177808|NCT01748825|530816163|FG004|Dose Expansion|Refused further treatment|0|||
147177809|NCT01748825|530816164|FG005|Dose Expansion|Refused further treatment|0|||
147177810|NCT01748825|530816165|FG006|Dose Expansion|Refused further treatment|0|||
147177811|NCT01748825|530816166|FG007|Dose Expansion|Refused further treatment|0|||
147177812|NCT01748825|530816167|FG008|Dose Expansion|Refused further treatment|1|||
147177813|NCT01748825|530816168|FG009|Dose Expansion|Refused further treatment|1|||
147177814|NCT01748825|530816159|FG000|Dose Expansion|Switched to alternative treatment|0|||
147177815|NCT01748825|530816160|FG001|Dose Expansion|Switched to alternative treatment|0|||
147177816|NCT01748825|530816161|FG002|Dose Expansion|Switched to alternative treatment|0|||
147177817|NCT01748825|530816162|FG003|Dose Expansion|Switched to alternative treatment|0|||
147177818|NCT01748825|530816163|FG004|Dose Expansion|Switched to alternative treatment|0|||
147177819|NCT01748825|530816164|FG005|Dose Expansion|Switched to alternative treatment|0|||
147177820|NCT01748825|530816165|FG006|Dose Expansion|Switched to alternative treatment|0|||
147177821|NCT01748825|530816166|FG007|Dose Expansion|Switched to alternative treatment|0|||
147177822|NCT01748825|530816167|FG008|Dose Expansion|Switched to alternative treatment|0|||
147177823|NCT01748825|530816168|FG009|Dose Expansion|Switched to alternative treatment|1|||
147177824|NCT01748825|530816159|FG000|Dose Expansion|Adverse Event|0|||
147177825|NCT01748825|530816160|FG001|Dose Expansion|Adverse Event|0|||
147177826|NCT01748825|530816161|FG002|Dose Expansion|Adverse Event|0|||
147177827|NCT01748825|530816162|FG003|Dose Expansion|Adverse Event|0|||
147177828|NCT01748825|530816163|FG004|Dose Expansion|Adverse Event|0|||
147177829|NCT01748825|530816164|FG005|Dose Expansion|Adverse Event|0|||
147177830|NCT01748825|530816165|FG006|Dose Expansion|Adverse Event|0|||
147177831|NCT01748825|530816166|FG007|Dose Expansion|Adverse Event|0|||
147177832|NCT01748825|530816167|FG008|Dose Expansion|Adverse Event|0|||
147177833|NCT01748825|530816168|FG009|Dose Expansion|Adverse Event|3|||
147177834|NCT01748825|530816159|FG000|Dose Expansion|Physician Decision|0|||
147177835|NCT01748825|530816160|FG001|Dose Expansion|Physician Decision|0|||
147177836|NCT01748825|530816161|FG002|Dose Expansion|Physician Decision|0|||
147177837|NCT01748825|530816162|FG003|Dose Expansion|Physician Decision|0|||
147177838|NCT01748825|530816163|FG004|Dose Expansion|Physician Decision|0|||
147177839|NCT01748825|530816164|FG005|Dose Expansion|Physician Decision|0|||
147177840|NCT01748825|530816165|FG006|Dose Expansion|Physician Decision|0|||
147177841|NCT01748825|530816166|FG007|Dose Expansion|Physician Decision|0|||
147177842|NCT01748825|530816167|FG008|Dose Expansion|Physician Decision|1|||
147177843|NCT01748825|530816168|FG009|Dose Expansion|Physician Decision|0|||
147177844|NCT02921087|530816169|FG000|Overall Study|Withdrawal by Subject|0|||
147177845|NCT02921087|530816170|FG001|Overall Study|Withdrawal by Subject|1|||
147177846|NCT00852241|530816171|FG000|Overall Study|Physician Decision|18|||
147177847|NCT00619307|530816173|FG000|Overall Study|Adverse Event|0|||
147177848|NCT00619307|530816174|FG001|Overall Study|Adverse Event|1|||
147177849|NCT00619307|530816173|FG000|Overall Study|Lost to Follow-up|0|||
147177850|NCT00619307|530816174|FG001|Overall Study|Lost to Follow-up|1|||
147177851|NCT00619307|530816173|FG000|Overall Study|Protocol Violation|3|||
147177852|NCT00619307|530816174|FG001|Overall Study|Protocol Violation|0|||
147177853|NCT00619307|530816173|FG000|Overall Study|Withdrew consent|1|||
147177854|NCT00619307|530816174|FG001|Overall Study|Withdrew consent|0|||
147177855|NCT00619307|530816173|FG000|Overall Study|Severe migraine|0|||
147177856|NCT00619307|530816174|FG001|Overall Study|Severe migraine|1|||
147177857|NCT00619307|530816173|FG000|Overall Study|MS attack plus steroids|0|||
147177858|NCT00619307|530816174|FG001|Overall Study|MS attack plus steroids|1|||
147177859|NCT00118430|530816177|FG000|Overall Study|Withdrawal by Subject|6|||
147177860|NCT00118430|530816178|FG001|Overall Study|Withdrawal by Subject|2|||
147177861|NCT00118430|530816179|FG002|Overall Study|Withdrawal by Subject|0|||
147177862|NCT00118430|530816177|FG000|Overall Study|Lost to Follow-up|15|||
147177863|NCT00118430|530816178|FG001|Overall Study|Lost to Follow-up|22|||
147324587|NCT00049517|531354321|FG005|Induction|Alternative therapy|2|||
147324588|NCT00049517|531354316|FG000|Induction|Other complicating disease|0|||
147324589|NCT00049517|531354317|FG001|Induction|Other complicating disease|0|||
147324590|NCT00049517|531354318|FG002|Induction|Other complicating disease|0|||
147324591|NCT00049517|531354319|FG003|Induction|Other complicating disease|0|||
147324592|NCT00049517|531354320|FG004|Induction|Other complicating disease|3|||
147177864|NCT00118430|530816179|FG002|Overall Study|Lost to Follow-up|28|||
147177865|NCT02147288|530816180|FG000|Overall Study|post-operative hematoma|1|||
147177866|NCT02147288|530816181|FG001|Overall Study|post-operative hematoma|1|||
147324593|NCT00049517|531354321|FG005|Induction|Other complicating disease|0|||
147177867|NCT02147288|530816182|FG002|Overall Study|post-operative hematoma|0|||
147324594|NCT00049517|531354316|FG000|Induction|Reasons not reported|0|||
147177868|NCT02147288|530816183|FG003|Overall Study|post-operative hematoma|0|||
147177869|NCT02147288|530816184|FG004|Overall Study|post-operative hematoma|0|||
147177870|NCT02147288|530816185|FG005|Overall Study|post-operative hematoma|0|||
147324595|NCT00049517|531354317|FG001|Induction|Reasons not reported|0|||
147177871|NCT02147288|530816186|FG006|Overall Study|post-operative hematoma|0|||
147177872|NCT02147288|530816187|FG007|Overall Study|post-operative hematoma|0|||
147177873|NCT02147288|530816188|FG008|Overall Study|post-operative hematoma|0|||
147177874|NCT02147288|530816189|FG009|Overall Study|post-operative hematoma|0|||
147177875|NCT02147288|530816180|FG000|Overall Study|complications from concurrent hernia rep|0|||
147177876|NCT02147288|530816181|FG001|Overall Study|complications from concurrent hernia rep|1|||
147177877|NCT02147288|530816182|FG002|Overall Study|complications from concurrent hernia rep|0|||
147177878|NCT02147288|530816183|FG003|Overall Study|complications from concurrent hernia rep|0|||
147177879|NCT02147288|530816184|FG004|Overall Study|complications from concurrent hernia rep|0|||
147177880|NCT02147288|530816185|FG005|Overall Study|complications from concurrent hernia rep|0|||
147177881|NCT02147288|530816186|FG006|Overall Study|complications from concurrent hernia rep|0|||
147177882|NCT02147288|530816187|FG007|Overall Study|complications from concurrent hernia rep|0|||
147177883|NCT02147288|530816188|FG008|Overall Study|complications from concurrent hernia rep|0|||
147177884|NCT02147288|530816189|FG009|Overall Study|complications from concurrent hernia rep|0|||
147177885|NCT02069392|530816192|FG000|Overall Study|Withdrawal by Subject|4|||
147177886|NCT02069392|530816193|FG001|Overall Study|Withdrawal by Subject|2|||
147177887|NCT00269633|530816194|FG000|Overall Study|Withdrawal by Subject|1|||
147177888|NCT00269633|530816195|FG001|Overall Study|Withdrawal by Subject|0|||
147177889|NCT04412707|530816196|FG000|Cycle 1|Death|0|||
147177890|NCT04412707|530816197|FG001|Cycle 1|Death|3|||
147177891|NCT04412707|530816196|FG000|Cycle 1|Disease progression|1|||
147177892|NCT04412707|530816197|FG001|Cycle 1|Disease progression|2|||
147177893|NCT04412707|530816196|FG000|Cycle 2|Death|0|||
147177894|NCT04412707|530816197|FG001|Cycle 2|Death|1|||
147177895|NCT04412707|530816196|FG000|Cycle 2|Disease progression|3|||
147177896|NCT04412707|530816197|FG001|Cycle 2|Disease progression|0|||
147177897|NCT04412707|530816196|FG000|Cycle 3 to End of Study (EOS)|Death|1|||
147177898|NCT04412707|530816197|FG001|Cycle 3 to End of Study (EOS)|Death|3|||
147177899|NCT04412707|530816196|FG000|Cycle 3 to End of Study (EOS)|Disease progression|4|||
147177900|NCT04412707|530816197|FG001|Cycle 3 to End of Study (EOS)|Disease progression|2|||
147177901|NCT04412707|530816196|FG000|Cycle 3 to End of Study (EOS)|Study terminated by Sponsor|4|||
147177902|NCT04412707|530816197|FG001|Cycle 3 to End of Study (EOS)|Study terminated by Sponsor|2|||
147177903|NCT04412707|530816196|FG000|Cycle 3 to End of Study (EOS)|Withdrawal by Subject|1|||
147177904|NCT04412707|530816197|FG001|Cycle 3 to End of Study (EOS)|Withdrawal by Subject|0|||
147177905|NCT02927938|530816198|FG000|Overall Study|Death|0|||
147177906|NCT02927938|530816199|FG001|Overall Study|Death|1|||
147177907|NCT02927938|530816200|FG002|Overall Study|Death|0|||
147177908|NCT02927938|530816201|FG003|Overall Study|Death|4|||
147177909|NCT02927938|530816198|FG000|Overall Study|Early Study Termination|1|||
147177910|NCT02927938|530816199|FG001|Overall Study|Early Study Termination|5|||
147177911|NCT02927938|530816200|FG002|Overall Study|Early Study Termination|4|||
147177912|NCT02927938|530816201|FG003|Overall Study|Early Study Termination|3|||
147177913|NCT01504412|530817738|FG000|Overall Study|Adverse Event|1|||
147177914|NCT01504412|530817739|FG001|Overall Study|Adverse Event|8|||
147177915|NCT01504412|530817740|FG002|Overall Study|Adverse Event|1|||
147177916|NCT01504412|530817741|FG003|Overall Study|Adverse Event|7|||
147177917|NCT01504412|530817742|FG004|Overall Study|Adverse Event|10|||
147177918|NCT01504412|530817738|FG000|Overall Study|Withdrawal by Subject|2|||
147177919|NCT01504412|530817739|FG001|Overall Study|Withdrawal by Subject|1|||
147177920|NCT01504412|530817740|FG002|Overall Study|Withdrawal by Subject|1|||
147177921|NCT01504412|530817741|FG003|Overall Study|Withdrawal by Subject|5|||
147177922|NCT01504412|530817742|FG004|Overall Study|Withdrawal by Subject|1|||
147177923|NCT01504412|530817738|FG000|Overall Study|Other|2|||
147177924|NCT01504412|530817739|FG001|Overall Study|Other|1|||
147177925|NCT01504412|530817740|FG002|Overall Study|Other|1|||
147177926|NCT01504412|530817741|FG003|Overall Study|Other|6|||
147177927|NCT01504412|530817742|FG004|Overall Study|Other|1|||
147177928|NCT01504412|530817738|FG000|Overall Study|Lost to Follow-up|0|||
147177929|NCT01504412|530817739|FG001|Overall Study|Lost to Follow-up|2|||
147177930|NCT01504412|530817740|FG002|Overall Study|Lost to Follow-up|0|||
147177931|NCT01504412|530817741|FG003|Overall Study|Lost to Follow-up|0|||
147177932|NCT01504412|530817742|FG004|Overall Study|Lost to Follow-up|0|||
147177933|NCT01504412|530817738|FG000|Overall Study|Lack of Efficacy|0|||
147177934|NCT01504412|530817739|FG001|Overall Study|Lack of Efficacy|0|||
147177935|NCT01504412|530817740|FG002|Overall Study|Lack of Efficacy|1|||
147177936|NCT01504412|530817741|FG003|Overall Study|Lack of Efficacy|0|||
147177937|NCT01504412|530817742|FG004|Overall Study|Lack of Efficacy|1|||
147177938|NCT01504412|530817738|FG000|Overall Study|Death|0|||
147177939|NCT01504412|530817739|FG001|Overall Study|Death|0|||
147177940|NCT01504412|530817740|FG002|Overall Study|Death|0|||
147177941|NCT01504412|530817741|FG003|Overall Study|Death|1|||
147177942|NCT01504412|530817742|FG004|Overall Study|Death|0|||
147177943|NCT02598297|530817760|FG000|Overall Study|Study terminated by Sponsor|21|||
147177944|NCT02598297|530817761|FG001|Overall Study|Study terminated by Sponsor|23|||
147177945|NCT02598297|530817760|FG000|Overall Study|Adverse Event|1|||
147177946|NCT02598297|530817761|FG001|Overall Study|Adverse Event|1|||
147177947|NCT02598297|530817760|FG000|Overall Study|Physician Decision|1|||
147177948|NCT02598297|530817761|FG001|Overall Study|Physician Decision|0|||
147324596|NCT00049517|531354318|FG002|Induction|Reasons not reported|0|||
147177949|NCT02598297|530817760|FG000|Overall Study|Subject/guardian decision|1|||
147177950|NCT02598297|530817761|FG001|Overall Study|Subject/guardian decision|0|||
147177951|NCT02598297|530817760|FG000|Overall Study|Followed for survival|1|||
147177952|NCT02598297|530817761|FG001|Overall Study|Followed for survival|0|||
147177953|NCT01934010|530817771|FG000|Overall Study|Adverse Event|1|||
147177954|NCT01934010|530817772|FG001|Overall Study|Adverse Event|1|||
147177955|NCT01934010|530817773|FG002|Overall Study|Adverse Event|0|||
147177956|NCT01934010|530817771|FG000|Overall Study|Withdrawal by Subject|15|||
147177957|NCT01934010|530817772|FG001|Overall Study|Withdrawal by Subject|6|||
147177958|NCT01934010|530817773|FG002|Overall Study|Withdrawal by Subject|2|||
147177959|NCT01934010|530817771|FG000|Overall Study|Lost to Follow-up|7|||
147177960|NCT01934010|530817772|FG001|Overall Study|Lost to Follow-up|4|||
147177961|NCT01934010|530817773|FG002|Overall Study|Lost to Follow-up|0|||
147177962|NCT01393821|530817774|FG000|Overall Study|Cancel|1|||
147177963|NCT01393821|530817775|FG001|Overall Study|Cancel|1|||
147177964|NCT01393821|530817774|FG000|Overall Study|not evaluable for primary endpoint|4|||
147177965|NCT01393821|530817775|FG001|Overall Study|not evaluable for primary endpoint|2|||
147177966|NCT00377858|530817786|FG000|Overall Study|Withdrawal by Subject|12|||
147177967|NCT00377858|530817787|FG001|Overall Study|Withdrawal by Subject|11|||
147177968|NCT00377858|530817786|FG000|Overall Study|Lost to Follow-up|6|||
147177969|NCT00377858|530817787|FG001|Overall Study|Lost to Follow-up|1|||
147177970|NCT00377858|530817786|FG000|Overall Study|Physician Decision|5|||
147177971|NCT00377858|530817787|FG001|Overall Study|Physician Decision|5|||
147177972|NCT00377858|530817786|FG000|Overall Study|Protocol Violation|3|||
147177973|NCT00377858|530817787|FG001|Overall Study|Protocol Violation|4|||
147177974|NCT00377858|530817786|FG000|Overall Study|Adverse Event|2|||
147177975|NCT00377858|530817787|FG001|Overall Study|Adverse Event|1|||
147177976|NCT00377858|530817786|FG000|Overall Study|Entry Criteria Not Met|2|||
147177977|NCT00377858|530817787|FG001|Overall Study|Entry Criteria Not Met|0|||
147177978|NCT00377858|530817786|FG000|Overall Study|Sponsor Decision|1|||
147177979|NCT00377858|530817787|FG001|Overall Study|Sponsor Decision|2|||
147177980|NCT00377858|530817786|FG000|Overall Study|Death|0|||
147177981|NCT00377858|530817787|FG001|Overall Study|Death|3|||
147177982|NCT03534141|530817788|FG000|Overall Study|Enrolled in other clinical trial|1|||
147177983|NCT03534141|530817789|FG001|Overall Study|Enrolled in other clinical trial|0|||
147177984|NCT03534141|530817788|FG000|Overall Study|Liver transplant aborted after randomization|0|||
147177985|NCT03534141|530817789|FG001|Overall Study|Liver transplant aborted after randomization|2|||
147177986|NCT03534141|530817788|FG000|Overall Study|Liver graft explanted due to surgical issue|0|||
147177987|NCT03534141|530817789|FG001|Overall Study|Liver graft explanted due to surgical issue|1|||
147177988|NCT04303572|530817790|FG000|Overall Study|Study closed due to poor enrollment|1|||
147177989|NCT06312592|530817791|FG000|Overall Study|Lost to Follow-up|29|||
147177990|NCT06312592|530817792|FG001|Overall Study|Lost to Follow-up|13|||
147177991|NCT03785405|530817795|FG000|Overall Study|Adverse Event|16|||
147177992|NCT03785405|530817796|FG001|Overall Study|Adverse Event|1|||
147177993|NCT03785405|530817795|FG000|Overall Study|Death|6|||
147177994|NCT03785405|530817796|FG001|Overall Study|Death|4|||
147177995|NCT03785405|530817795|FG000|Overall Study|Guardian decision|4|||
147177996|NCT03785405|530817796|FG001|Overall Study|Guardian decision|1|||
147177997|NCT03785405|530817795|FG000|Overall Study|Lost to Follow-up|1|||
147245033|NCT03708328|531070761|FG009|Overall Study|Lost to Follow-up|1|||
147655949|NCT00154375|532563012|FG001|Overall Study|Abnormal laboratory value(s)|2|||
147655950|NCT00154375|532563011|FG000|Overall Study|Protocol Violation|0|||
147655951|NCT00154375|532563012|FG001|Overall Study|Protocol Violation|1|||
147655952|NCT00154375|532563011|FG000|Overall Study|Suspected progression of disease|44|||
147655953|NCT00154375|532563012|FG001|Overall Study|Suspected progression of disease|30|||
147655954|NCT00334295|532563015|FG000|Overall Study|Patients received fewer than 3 injection|5|||
147655955|NCT01588405|532563016|FG000|Overall Study|Adverse Event|1|||
147655956|NCT01588405|532563016|FG000|Overall Study|Clinical Worsening|1|||
147655957|NCT00792116|532563019|FG000|Overall Study|Lost to Follow-up|0|||
147655958|NCT00792116|532563020|FG001|Overall Study|Lost to Follow-up|1|||
147655959|NCT00792116|532563019|FG000|Overall Study|Discontnued intervention|1|||
147655960|NCT00792116|532563020|FG001|Overall Study|Discontnued intervention|0|||
147655961|NCT02453256|532563021|FG000|Double Blind Period|Death|1|||
147655962|NCT02453256|532563022|FG001|Double Blind Period|Death|1|||
147177998|NCT03785405|530817796|FG001|Overall Study|Lost to Follow-up|0|||
147177999|NCT03785405|530817795|FG000|Overall Study|Physician Decision|8|||
147178000|NCT03785405|530817796|FG001|Overall Study|Physician Decision|5|||
147178001|NCT03785405|530817795|FG000|Overall Study|Participant decision|2|||
147178002|NCT03785405|530817796|FG001|Overall Study|Participant decision|0|||
147178003|NCT03785405|530817795|FG000|Overall Study|Other|1|||
147178004|NCT03785405|530817796|FG001|Overall Study|Other|0|||
147178005|NCT03785405|530817795|FG000|Overall Study|No treatment was received|0|||
147178006|NCT03785405|530817796|FG001|Overall Study|No treatment was received|1|||
147178007|NCT01948063|530817797|FG000|Overall Study|Boston MCI halted research protocol|0|||
147178008|NCT01948063|530817798|FG001|Overall Study|Boston MCI halted research protocol|1|||
147178009|NCT01948063|530817797|FG000|Overall Study|Discovered an enrollment in other study|0|||
147178010|NCT01948063|530817798|FG001|Overall Study|Discovered an enrollment in other study|1|||
147178011|NCT01948063|530817797|FG000|Overall Study|Blood samples were accidentally thawed|1|||
147178012|NCT01948063|530817798|FG001|Overall Study|Blood samples were accidentally thawed|0|||
147178013|NCT00245037|530817801|FG000|Overall Study|Death|17|||
147178014|NCT00203424|530817803|FG000|Treatment Period|Withdrawal by Subject|4|||
147178015|NCT00203424|530817803|FG000|Treatment Period|Adverse Event|5|||
147178016|NCT00203424|530817803|FG000|Treatment Period|progressive disease|2|||
147178017|NCT00203424|530817803|FG000|Follow-up Period|Withdrawal by Subject|1|||
147178018|NCT00203424|530817803|FG000|Follow-up Period|progressive disease|4|||
147178019|NCT00203424|530817803|FG000|Follow-up Period|Lost to Follow-up|1|||
147178020|NCT00555672|530817804|FG000|Overall Study|Death|0|||
147178021|NCT00555672|530817805|FG001|Overall Study|Death|2|||
147178022|NCT00555672|530817804|FG000|Overall Study|Adverse Event|8|||
147178023|NCT00555672|530817805|FG001|Overall Study|Adverse Event|2|||
147178024|NCT00555672|530817804|FG000|Overall Study|Objective progression or relapse|11|||
147178025|NCT00555672|530817805|FG001|Overall Study|Objective progression or relapse|5|||
147178026|NCT00555672|530817804|FG000|Overall Study|Other|3|||
147178027|NCT00555672|530817805|FG001|Overall Study|Other|1|||
147178028|NCT00555672|530817804|FG000|Overall Study|Participant refused|2|||
147178029|NCT00555672|530817805|FG001|Overall Study|Participant refused|0|||
147178030|NCT01053988|530817806|FG000|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|220|||
147178031|NCT01053988|530817807|FG001|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
147178032|NCT01053988|530817808|FG002|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
147178033|NCT01053988|530817809|FG003|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
147178034|NCT01053988|530817810|FG004|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
147178035|NCT01053988|530817811|FG005|2-week, Single-blind Run-In Period|Did Not Meet Continuation Criteria|0|||
147178036|NCT01053988|530817806|FG000|2-week, Single-blind Run-In Period|Study Closed/Terminated|98|||
147178037|NCT01053988|530817807|FG001|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
147178038|NCT01053988|530817808|FG002|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
147178039|NCT01053988|530817809|FG003|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
147178040|NCT01053988|530817810|FG004|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
147178041|NCT01053988|530817811|FG005|2-week, Single-blind Run-In Period|Study Closed/Terminated|0|||
147178042|NCT01053988|530817806|FG000|2-week, Single-blind Run-In Period|Withdrawal by Subject|30|||
147178043|NCT01053988|530817807|FG001|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
147178044|NCT01053988|530817808|FG002|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
147178045|NCT01053988|530817809|FG003|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
147178046|NCT01053988|530817810|FG004|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
147324597|NCT00049517|531354319|FG003|Induction|Reasons not reported|0|||
147178047|NCT01053988|530817811|FG005|2-week, Single-blind Run-In Period|Withdrawal by Subject|0|||
147178048|NCT01053988|530817806|FG000|2-week, Single-blind Run-In Period|Adverse Event|6|||
147178049|NCT01053988|530817807|FG001|2-week, Single-blind Run-In Period|Adverse Event|0|||
147178050|NCT01053988|530817808|FG002|2-week, Single-blind Run-In Period|Adverse Event|0|||
147178051|NCT01053988|530817809|FG003|2-week, Single-blind Run-In Period|Adverse Event|0|||
147178052|NCT01053988|530817810|FG004|2-week, Single-blind Run-In Period|Adverse Event|0|||
147178053|NCT01053988|530817811|FG005|2-week, Single-blind Run-In Period|Adverse Event|0|||
147178054|NCT01053988|530817806|FG000|2-week, Single-blind Run-In Period|Physician Decision|5|||
147178055|NCT01053988|530817807|FG001|2-week, Single-blind Run-In Period|Physician Decision|0|||
147178056|NCT01053988|530817808|FG002|2-week, Single-blind Run-In Period|Physician Decision|0|||
147178057|NCT01053988|530817809|FG003|2-week, Single-blind Run-In Period|Physician Decision|0|||
147178058|NCT01053988|530817810|FG004|2-week, Single-blind Run-In Period|Physician Decision|0|||
147178059|NCT01053988|530817811|FG005|2-week, Single-blind Run-In Period|Physician Decision|0|||
147178060|NCT01053988|530817806|FG000|2-week, Single-blind Run-In Period|Lost to Follow-up|1|||
147178061|NCT01053988|530817807|FG001|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
147178062|NCT01053988|530817808|FG002|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
147178063|NCT01053988|530817809|FG003|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
147178064|NCT01053988|530817810|FG004|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
147178065|NCT01053988|530817811|FG005|2-week, Single-blind Run-In Period|Lost to Follow-up|0|||
147178066|NCT01053988|530817806|FG000|24-week, Double-blind Treatment Period|Adverse Event|0|||
147178067|NCT01053988|530817807|FG001|24-week, Double-blind Treatment Period|Adverse Event|15|||
147178068|NCT01053988|530817808|FG002|24-week, Double-blind Treatment Period|Adverse Event|23|||
147178069|NCT01053988|530817809|FG003|24-week, Double-blind Treatment Period|Adverse Event|24|||
147178070|NCT01053988|530817810|FG004|24-week, Double-blind Treatment Period|Adverse Event|17|||
147178071|NCT01053988|530817811|FG005|24-week, Double-blind Treatment Period|Adverse Event|14|||
147655963|NCT02453256|532563021|FG000|Double Blind Period|Adverse Event|3|||
147655964|NCT02453256|532563022|FG001|Double Blind Period|Adverse Event|2|||
147655965|NCT02453256|532563021|FG000|Double Blind Period|Withdrawal by Subject|9|||
147655966|NCT02453256|532563022|FG001|Double Blind Period|Withdrawal by Subject|5|||
147178072|NCT01053988|530817806|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
147178073|NCT01053988|530817807|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|3|||
147178074|NCT01053988|530817808|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|2|||
147178075|NCT01053988|530817809|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|2|||
147178076|NCT01053988|530817810|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|3|||
147178077|NCT01053988|530817811|FG005|24-week, Double-blind Treatment Period|Lack of Efficacy-No Sub-Reason|0|||
147178078|NCT01053988|530817806|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|0|||
147178079|NCT01053988|530817807|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|17|||
147178080|NCT01053988|530817808|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|16|||
147178081|NCT01053988|530817809|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|13|||
147178082|NCT01053988|530817810|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|9|||
147178083|NCT01053988|530817811|FG005|24-week, Double-blind Treatment Period|Lack of Efficacy-Sub-Reason Exacerbation|12|||
147178084|NCT01053988|530817806|FG000|24-week, Double-blind Treatment Period|Protocol Violation|0|||
147178085|NCT01053988|530817807|FG001|24-week, Double-blind Treatment Period|Protocol Violation|3|||
147178086|NCT01053988|530817808|FG002|24-week, Double-blind Treatment Period|Protocol Violation|4|||
147178087|NCT01053988|530817809|FG003|24-week, Double-blind Treatment Period|Protocol Violation|2|||
147178088|NCT01053988|530817810|FG004|24-week, Double-blind Treatment Period|Protocol Violation|1|||
147178089|NCT01053988|530817811|FG005|24-week, Double-blind Treatment Period|Protocol Violation|4|||
147178090|NCT01053988|530817806|FG000|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0|||
147178091|NCT01053988|530817807|FG001|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|11|||
147178092|NCT01053988|530817808|FG002|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|5|||
147178093|NCT01053988|530817809|FG003|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|8|||
147178094|NCT01053988|530817810|FG004|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|13|||
147178095|NCT01053988|530817811|FG005|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|9|||
147178096|NCT01053988|530817806|FG000|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
147178097|NCT01053988|530817807|FG001|24-week, Double-blind Treatment Period|Lost to Follow-up|4|||
147178098|NCT01053988|530817808|FG002|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
147178099|NCT01053988|530817809|FG003|24-week, Double-blind Treatment Period|Lost to Follow-up|2|||
147178100|NCT01053988|530817810|FG004|24-week, Double-blind Treatment Period|Lost to Follow-up|1|||
147178101|NCT01053988|530817811|FG005|24-week, Double-blind Treatment Period|Lost to Follow-up|3|||
147178102|NCT01053988|530817806|FG000|24-week, Double-blind Treatment Period|Physician Decision|0|||
147178103|NCT01053988|530817807|FG001|24-week, Double-blind Treatment Period|Physician Decision|5|||
147178104|NCT01053988|530817808|FG002|24-week, Double-blind Treatment Period|Physician Decision|2|||
147178105|NCT01053988|530817809|FG003|24-week, Double-blind Treatment Period|Physician Decision|5|||
147178106|NCT01053988|530817810|FG004|24-week, Double-blind Treatment Period|Physician Decision|5|||
147178107|NCT01053988|530817811|FG005|24-week, Double-blind Treatment Period|Physician Decision|4|||
147178108|NCT01053988|530817806|FG000|24-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
147178109|NCT01053988|530817807|FG001|24-week, Double-blind Treatment Period|Withdrawal by Subject|11|||
147178110|NCT01053988|530817808|FG002|24-week, Double-blind Treatment Period|Withdrawal by Subject|9|||
147178111|NCT01053988|530817809|FG003|24-week, Double-blind Treatment Period|Withdrawal by Subject|7|||
147178112|NCT01053988|530817810|FG004|24-week, Double-blind Treatment Period|Withdrawal by Subject|10|||
147178113|NCT01053988|530817811|FG005|24-week, Double-blind Treatment Period|Withdrawal by Subject|9|||
147178114|NCT01922271|530817812|FG000|WASHOUT Period|Withdrawal by Subject|1|||
147178115|NCT01922271|530817813|FG001|WASHOUT Period|Withdrawal by Subject|0|||
147178116|NCT02123823|530817814|FG000|Overall Study|Lack of Efficacy|0|||
147178117|NCT02123823|530817815|FG001|Overall Study|Lack of Efficacy|2|||
147178118|NCT02123823|530817816|FG002|Overall Study|Lack of Efficacy|8|||
147178119|NCT02123823|530817817|FG003|Overall Study|Lack of Efficacy|10|||
147178120|NCT02123823|530817814|FG000|Overall Study|Progressive disease|3|||
147178121|NCT02123823|530817815|FG001|Overall Study|Progressive disease|19|||
147178122|NCT02123823|530817816|FG002|Overall Study|Progressive disease|52|||
147178123|NCT02123823|530817817|FG003|Overall Study|Progressive disease|53|||
147178124|NCT02123823|530817814|FG000|Overall Study|Withdrawal by Subject|0|||
147178125|NCT02123823|530817815|FG001|Overall Study|Withdrawal by Subject|0|||
147178126|NCT02123823|530817816|FG002|Overall Study|Withdrawal by Subject|7|||
147178127|NCT02123823|530817817|FG003|Overall Study|Withdrawal by Subject|2|||
147178128|NCT02123823|530817814|FG000|Overall Study|Adverse Event|0|||
147178129|NCT02123823|530817815|FG001|Overall Study|Adverse Event|0|||
147178130|NCT02123823|530817816|FG002|Overall Study|Adverse Event|3|||
147178131|NCT02123823|530817817|FG003|Overall Study|Adverse Event|5|||
147178132|NCT02106403|530817831|FG000|Follow-Up Visit 3|Other Reason|0|||
147178133|NCT02106403|530817832|FG001|Follow-Up Visit 3|Other Reason|0|||
147178134|NCT02106403|530817833|FG002|Follow-Up Visit 3|Other Reason|0|||
147178135|NCT02106403|530817834|FG003|Follow-Up Visit 3|Other Reason|0|||
147178136|NCT02106403|530817835|FG004|Follow-Up Visit 3|Other Reason|0|||
147178137|NCT02106403|530817836|FG005|Follow-Up Visit 3|Other Reason|1|||
147178138|NCT01128946|530817841|FG000|Period I|Protocol Violation|0|||
147178139|NCT01128946|530817842|FG001|Period I|Protocol Violation|1|||
147178140|NCT01128946|530817843|FG002|Period I|Protocol Violation|0|||
147178141|NCT01128946|530817844|FG003|Period I|Protocol Violation|0|||
147178142|NCT01128946|530817841|FG000|Period I|Withdrawal by Subject|0|||
147178143|NCT01128946|530817842|FG001|Period I|Withdrawal by Subject|0|||
147178144|NCT01128946|530817843|FG002|Period I|Withdrawal by Subject|1|||
147178145|NCT01128946|530817844|FG003|Period I|Withdrawal by Subject|1|||
147178146|NCT01128946|530817841|FG000|Period II|Protocol Violation|0|||
147178147|NCT01128946|530817842|FG001|Period II|Protocol Violation|1|||
147178148|NCT01128946|530817843|FG002|Period II|Protocol Violation|0|||
147178149|NCT01128946|530817844|FG003|Period II|Protocol Violation|0|||
147178150|NCT01128946|530817841|FG000|Period II|Withdrawal by Subject|0|||
147178151|NCT01128946|530817842|FG001|Period II|Withdrawal by Subject|0|||
147178152|NCT01128946|530817843|FG002|Period II|Withdrawal by Subject|0|||
147178153|NCT01128946|530817844|FG003|Period II|Withdrawal by Subject|1|||
147178154|NCT01128946|530817841|FG000|Period III|Protocol Violation|1|||
147178155|NCT01128946|530817842|FG001|Period III|Protocol Violation|0|||
147178156|NCT01128946|530817843|FG002|Period III|Protocol Violation|0|||
147178157|NCT01128946|530817844|FG003|Period III|Protocol Violation|0|||
147178158|NCT04698993|530817845|FG000|Overall Study|PCR results not accessible|2|||
147178159|NCT04698993|530817846|FG001|Overall Study|PCR results not accessible|7|||
147178160|NCT04698993|530817845|FG000|Overall Study|incomplete documentation of kit assessment prior to testing|1|||
147178161|NCT04698993|530817846|FG001|Overall Study|incomplete documentation of kit assessment prior to testing|0|||
147178162|NCT00621140|530817847|FG000|Overall Study|Adverse Event|4|||
147178163|NCT00621140|530817848|FG001|Overall Study|Adverse Event|5|||
147178164|NCT00621140|530817847|FG000|Overall Study|Lost to Follow-up|1|||
147178165|NCT00621140|530817848|FG001|Overall Study|Lost to Follow-up|2|||
147178166|NCT00621140|530817847|FG000|Overall Study|Withdrawal by Subject|4|||
147324598|NCT00049517|531354320|FG004|Induction|Reasons not reported|22|||
147324599|NCT00049517|531354321|FG005|Induction|Reasons not reported|25|||
147324600|NCT00049517|531354316|FG000|Conditioning/Transplant|Disease progression|14|||
147178167|NCT00621140|530817848|FG001|Overall Study|Withdrawal by Subject|6|||
147178168|NCT00621140|530817847|FG000|Overall Study|Other incl. lack of efficacy|6|||
147178169|NCT00621140|530817848|FG001|Overall Study|Other incl. lack of efficacy|5|||
147178170|NCT00145574|530817849|FG000|Double Blind|Adverse Event|0|||
147178171|NCT00145574|530817850|FG001|Double Blind|Adverse Event|3|||
147178172|NCT00145574|530817851|FG002|Double Blind|Adverse Event|1|||
147178173|NCT00145574|530817849|FG000|Double Blind|Withdrawal by Subject|1|||
147178174|NCT00145574|530817850|FG001|Double Blind|Withdrawal by Subject|1|||
147178175|NCT00145574|530817851|FG002|Double Blind|Withdrawal by Subject|1|||
147178176|NCT00145574|530817849|FG000|Double Blind|required restricted medicine|0|||
147178177|NCT00145574|530817850|FG001|Double Blind|required restricted medicine|1|||
147178178|NCT00145574|530817851|FG002|Double Blind|required restricted medicine|0|||
147178179|NCT00145574|530817849|FG000|Open Label Long-term Extension|Adverse Event|0|||
147178180|NCT00145574|530817850|FG001|Open Label Long-term Extension|Adverse Event|0|||
147178181|NCT00145574|530817851|FG002|Open Label Long-term Extension|Adverse Event|5|||
147178182|NCT00145574|530817849|FG000|Open Label Long-term Extension|Lost to Follow-up|0|||
147178183|NCT00145574|530817850|FG001|Open Label Long-term Extension|Lost to Follow-up|0|||
147178184|NCT00145574|530817851|FG002|Open Label Long-term Extension|Lost to Follow-up|1|||
147178185|NCT00145574|530817849|FG000|Open Label Long-term Extension|Withdrawal by Subject|0|||
147178186|NCT00145574|530817850|FG001|Open Label Long-term Extension|Withdrawal by Subject|0|||
147178187|NCT00145574|530817851|FG002|Open Label Long-term Extension|Withdrawal by Subject|4|||
147178188|NCT00145574|530817849|FG000|Open Label Long-term Extension|required restricted medicine|0|||
147178189|NCT00145574|530817850|FG001|Open Label Long-term Extension|required restricted medicine|0|||
147178190|NCT00145574|530817851|FG002|Open Label Long-term Extension|required restricted medicine|1|||
147178191|NCT00527904|530817852|FG000|Overall Study|Adverse Event|45|||
147178192|NCT00527904|530817852|FG000|Overall Study|Withdrawal by Subject|21|||
147178193|NCT00527904|530817852|FG000|Overall Study|Lost to Follow-up|8|||
147178194|NCT00527904|530817852|FG000|Overall Study|misc|22|||
147178195|NCT02669121|530817854|FG000|Overall Study|Adverse Event|4|||
147178196|NCT02669121|530817855|FG001|Overall Study|Adverse Event|5|||
147178197|NCT02669121|530817854|FG000|Overall Study|Lost to Follow-up|15|||
147178198|NCT02669121|530817855|FG001|Overall Study|Lost to Follow-up|27|||
147178199|NCT02669121|530817854|FG000|Overall Study|Withdrawal by Subject|132|||
147178200|NCT02669121|530817855|FG001|Overall Study|Withdrawal by Subject|140|||
147178201|NCT02669121|530817854|FG000|Overall Study|Pregnancy|0|||
147178202|NCT02669121|530817855|FG001|Overall Study|Pregnancy|1|||
147178203|NCT02669121|530817854|FG000|Overall Study|Discharged from US Military Active Service|117|||
147178204|NCT02669121|530817855|FG001|Overall Study|Discharged from US Military Active Service|91|||
147178205|NCT02669121|530817854|FG000|Overall Study|Reason not Specified|22|||
147178206|NCT02669121|530817855|FG001|Overall Study|Reason not Specified|18|||
147178207|NCT02687581|530817856|FG000|Overall Study|Withdrawal by Subject|1|||
147178208|NCT02687581|530817857|FG001|Overall Study|Withdrawal by Subject|0|||
147178209|NCT02687581|530817858|FG002|Overall Study|Withdrawal by Subject|0|||
147178210|NCT02687581|530817859|FG003|Overall Study|Withdrawal by Subject|1|||
147178211|NCT02687581|530817856|FG000|Overall Study|Lost to Follow-up|2|||
147178212|NCT02687581|530817857|FG001|Overall Study|Lost to Follow-up|2|||
147178213|NCT02687581|530817858|FG002|Overall Study|Lost to Follow-up|0|||
147448307|NCT00708123|531805688|FG002|Period 1|Protocol Violation|0|||
147448308|NCT00708123|531805689|FG003|Period 1|Protocol Violation|1|||
147178214|NCT02687581|530817859|FG003|Overall Study|Lost to Follow-up|0|||
147178215|NCT02687581|530817856|FG000|Overall Study|the device is too small for the patient.|1|||
147178216|NCT02687581|530817857|FG001|Overall Study|the device is too small for the patient.|0|||
147178217|NCT02687581|530817858|FG002|Overall Study|the device is too small for the patient.|0|||
147178218|NCT02687581|530817859|FG003|Overall Study|the device is too small for the patient.|0|||
147178219|NCT00835341|530817860|FG000|Overall Study|Lost to Follow-up|3|||
147178220|NCT00835341|530817861|FG001|Overall Study|Lost to Follow-up|12|||
147178221|NCT04405076|530817863|FG000|Part A (Blinded Phase)|Lost to Follow-up|6|||
147178222|NCT04405076|530817864|FG001|Part A (Blinded Phase)|Lost to Follow-up|6|||
147178223|NCT04405076|530817865|FG002|Part A (Blinded Phase)|Lost to Follow-up|7|||
147178224|NCT04405076|530817866|FG003|Part A (Blinded Phase)|Lost to Follow-up|0|||
147178225|NCT04405076|530817867|FG004|Part A (Blinded Phase)|Lost to Follow-up|0|||
147178226|NCT04405076|530817868|FG005|Part A (Blinded Phase)|Lost to Follow-up|0|||
147178227|NCT04405076|530817869|FG006|Part A (Blinded Phase)|Lost to Follow-up|0|||
147178228|NCT04405076|530817870|FG007|Part A (Blinded Phase)|Lost to Follow-up|0|||
147178229|NCT04405076|530817871|FG008|Part A (Blinded Phase)|Lost to Follow-up|0|||
147178230|NCT04405076|530817863|FG000|Part A (Blinded Phase)|Physician Decision|1|||
147178231|NCT04405076|530817864|FG001|Part A (Blinded Phase)|Physician Decision|2|||
147178232|NCT04405076|530817865|FG002|Part A (Blinded Phase)|Physician Decision|0|||
147178233|NCT04405076|530817866|FG003|Part A (Blinded Phase)|Physician Decision|0|||
147178234|NCT04405076|530817867|FG004|Part A (Blinded Phase)|Physician Decision|0|||
147178235|NCT04405076|530817868|FG005|Part A (Blinded Phase)|Physician Decision|0|||
147178236|NCT04405076|530817869|FG006|Part A (Blinded Phase)|Physician Decision|0|||
147178237|NCT04405076|530817870|FG007|Part A (Blinded Phase)|Physician Decision|0|||
147178238|NCT04405076|530817871|FG008|Part A (Blinded Phase)|Physician Decision|0|||
147178239|NCT04405076|530817863|FG000|Part A (Blinded Phase)|Protocol Violation|3|||
147178240|NCT04405076|530817864|FG001|Part A (Blinded Phase)|Protocol Violation|3|||
147178241|NCT04405076|530817865|FG002|Part A (Blinded Phase)|Protocol Violation|8|||
147178242|NCT04405076|530817866|FG003|Part A (Blinded Phase)|Protocol Violation|0|||
147178243|NCT04405076|530817867|FG004|Part A (Blinded Phase)|Protocol Violation|0|||
147178244|NCT04405076|530817868|FG005|Part A (Blinded Phase)|Protocol Violation|0|||
147178245|NCT04405076|530817869|FG006|Part A (Blinded Phase)|Protocol Violation|0|||
147178246|NCT04405076|530817870|FG007|Part A (Blinded Phase)|Protocol Violation|0|||
147178247|NCT04405076|530817871|FG008|Part A (Blinded Phase)|Protocol Violation|0|||
147178248|NCT04405076|530817863|FG000|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|1|||
147178249|NCT04405076|530817864|FG001|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
147178250|NCT04405076|530817865|FG002|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
147178251|NCT04405076|530817866|FG003|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
147178252|NCT04405076|530817867|FG004|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
147178253|NCT04405076|530817868|FG005|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
147178254|NCT04405076|530817869|FG006|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
147178255|NCT04405076|530817870|FG007|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
147178256|NCT04405076|530817871|FG008|Part A (Blinded Phase)|Withdrawal of consent (COVID-19 non-infection related)|0|||
147178257|NCT04405076|530817863|FG000|Part A (Blinded Phase)|Withdrawal of consent (other)|1|||
147178258|NCT04405076|530817864|FG001|Part A (Blinded Phase)|Withdrawal of consent (other)|4|||
147178259|NCT04405076|530817865|FG002|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
147178260|NCT04405076|530817866|FG003|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
147178261|NCT04405076|530817867|FG004|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
147178262|NCT04405076|530817868|FG005|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
147178263|NCT04405076|530817869|FG006|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
147178264|NCT04405076|530817870|FG007|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
147655967|NCT02453256|532563021|FG000|Double Blind Period|Other|0|||
147655968|NCT02453256|532563022|FG001|Double Blind Period|Other|1|||
147655969|NCT02453256|532563021|FG000|Open Label Period|Adverse Event|1|||
147655970|NCT02453256|532563022|FG001|Open Label Period|Adverse Event|3|||
147655971|NCT02453256|532563021|FG000|Open Label Period|Death|0|||
147655972|NCT02453256|532563022|FG001|Open Label Period|Death|1|||
147655973|NCT02453256|532563021|FG000|Open Label Period|Lost to Follow-up|1|||
147655974|NCT02453256|532563022|FG001|Open Label Period|Lost to Follow-up|0|||
147655975|NCT02453256|532563021|FG000|Open Label Period|Other|0|||
147178265|NCT04405076|530817871|FG008|Part A (Blinded Phase)|Withdrawal of consent (other)|0|||
147178266|NCT04405076|530817863|FG000|Part A (Blinded Phase)|Other than Specified|0|||
147178267|NCT04405076|530817864|FG001|Part A (Blinded Phase)|Other than Specified|0|||
147178268|NCT04405076|530817865|FG002|Part A (Blinded Phase)|Other than Specified|3|||
147655976|NCT02453256|532563022|FG001|Open Label Period|Other|2|||
147655977|NCT02453256|532563021|FG000|Open Label Period|Withdrawal by Subject|5|||
147448309|NCT00708123|531805690|FG004|Period 1|Protocol Violation|0|||
147655978|NCT02453256|532563022|FG001|Open Label Period|Withdrawal by Subject|1|||
147655979|NCT01216332|532563023|FG000|Overall Study|Withdrawal by Subject|4|||
147178269|NCT04405076|530817866|FG003|Part A (Blinded Phase)|Other than Specified|0|||
147178270|NCT04405076|530817867|FG004|Part A (Blinded Phase)|Other than Specified|0|||
147178271|NCT04405076|530817868|FG005|Part A (Blinded Phase)|Other than Specified|0|||
147178272|NCT04405076|530817869|FG006|Part A (Blinded Phase)|Other than Specified|0|||
147178273|NCT04405076|530817870|FG007|Part A (Blinded Phase)|Other than Specified|0|||
147178274|NCT04405076|530817871|FG008|Part A (Blinded Phase)|Other than Specified|0|||
147178275|NCT04405076|530817863|FG000|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
147178276|NCT04405076|530817864|FG001|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
147178277|NCT04405076|530817865|FG002|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
147178278|NCT04405076|530817866|FG003|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|6|||
147178279|NCT04405076|530817867|FG004|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|1|||
147178280|NCT04405076|530817868|FG005|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|4|||
147178281|NCT04405076|530817869|FG006|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
147178282|NCT04405076|530817870|FG007|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
147178283|NCT04405076|530817871|FG008|Part B (Open-Label Interventional Phase)|Withdrawal by Subject|0|||
147178284|NCT04405076|530817863|FG000|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
147178285|NCT04405076|530817864|FG001|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
147178286|NCT04405076|530817865|FG002|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
147178287|NCT04405076|530817866|FG003|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
147178288|NCT04405076|530817867|FG004|Part B (Open-Label Interventional Phase)|Physician Decision|1|||
147178289|NCT04405076|530817868|FG005|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
147178290|NCT04405076|530817869|FG006|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
147178291|NCT04405076|530817870|FG007|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
147178292|NCT04405076|530817871|FG008|Part B (Open-Label Interventional Phase)|Physician Decision|0|||
147178293|NCT04405076|530817863|FG000|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
147178294|NCT04405076|530817864|FG001|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
147178295|NCT04405076|530817865|FG002|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
147178296|NCT04405076|530817866|FG003|Part B (Open-Label Interventional Phase)|Lost to Follow-up|6|||
147178297|NCT04405076|530817867|FG004|Part B (Open-Label Interventional Phase)|Lost to Follow-up|3|||
147178298|NCT04405076|530817868|FG005|Part B (Open-Label Interventional Phase)|Lost to Follow-up|2|||
147178299|NCT04405076|530817869|FG006|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
147178300|NCT04405076|530817870|FG007|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
147178301|NCT04405076|530817871|FG008|Part B (Open-Label Interventional Phase)|Lost to Follow-up|0|||
147178302|NCT04405076|530817863|FG000|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
147178303|NCT04405076|530817864|FG001|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
147178304|NCT04405076|530817865|FG002|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
147178305|NCT04405076|530817866|FG003|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
147178306|NCT04405076|530817867|FG004|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
147178307|NCT04405076|530817868|FG005|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
147178308|NCT04405076|530817869|FG006|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|0|||
147178309|NCT04405076|530817870|FG007|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|2|||
147178310|NCT04405076|530817871|FG008|Part C (Rollover Proof of Concept)|Withdrawal of consent (other)|1|||
147245034|NCT03708328|531070752|FG000|Overall Study|Physician Decision|0|||
147245035|NCT03708328|531070753|FG001|Overall Study|Physician Decision|0|||
147245036|NCT03708328|531070754|FG002|Overall Study|Physician Decision|0|||
147655980|NCT01216332|532563024|FG001|Overall Study|Withdrawal by Subject|0|||
147655981|NCT01066871|532563028|FG000|Overall Study|Lost to Follow-up|0|||
147655982|NCT01066871|532563029|FG001|Overall Study|Lost to Follow-up|2|||
147655983|NCT01066871|532563030|FG002|Overall Study|Lost to Follow-up|2|||
147655984|NCT01066871|532563031|FG003|Overall Study|Lost to Follow-up|0|||
147655985|NCT01066871|532563028|FG000|Overall Study|Protocol Violation|1|||
147655986|NCT01066871|532563029|FG001|Overall Study|Protocol Violation|0|||
147655987|NCT01066871|532563030|FG002|Overall Study|Protocol Violation|3|||
147655988|NCT01066871|532563031|FG003|Overall Study|Protocol Violation|2|||
147655989|NCT01066871|532563028|FG000|Overall Study|Lack of Efficacy|0|||
147655990|NCT01066871|532563029|FG001|Overall Study|Lack of Efficacy|0|||
147655991|NCT01066871|532563030|FG002|Overall Study|Lack of Efficacy|0|||
147655992|NCT01066871|532563031|FG003|Overall Study|Lack of Efficacy|1|||
147655993|NCT01066871|532563028|FG000|Overall Study|Withdrawal by Subject|3|||
147655994|NCT01066871|532563029|FG001|Overall Study|Withdrawal by Subject|1|||
147655995|NCT01066871|532563030|FG002|Overall Study|Withdrawal by Subject|0|||
147655996|NCT01066871|532563031|FG003|Overall Study|Withdrawal by Subject|0|||
147245037|NCT03708328|531070755|FG003|Overall Study|Physician Decision|0|||
147655997|NCT01066871|532563028|FG000|Overall Study|Other|0|||
147655998|NCT01066871|532563029|FG001|Overall Study|Other|2|||
147655999|NCT01066871|532563030|FG002|Overall Study|Other|1|||
147656000|NCT01066871|532563031|FG003|Overall Study|Other|2|||
147656001|NCT04162795|532563032|FG000|Overall Study|Other|16|||
147656002|NCT04162795|532563032|FG000|Overall Study|Screen failures|10|||
147178311|NCT04405076|530817863|FG000|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
147178312|NCT04405076|530817864|FG001|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
147178313|NCT04405076|530817865|FG002|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
147178314|NCT04405076|530817866|FG003|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
147178315|NCT04405076|530817867|FG004|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
147178316|NCT04405076|530817868|FG005|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
147178317|NCT04405076|530817869|FG006|Part C (Rollover Proof of Concept)|Lost to Follow-up|2|||
147178318|NCT04405076|530817870|FG007|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
147178319|NCT04405076|530817871|FG008|Part C (Rollover Proof of Concept)|Lost to Follow-up|0|||
147178320|NCT04310566|530817872|FG000|Period 1|Study Termination due to COVID-19|15|||
147178321|NCT04310566|530817873|FG001|Period 1|Study Termination due to COVID-19|17|||
147178322|NCT04310566|530817872|FG000|Period 1|Protocol Violation|0|||
147178323|NCT04310566|530817873|FG001|Period 1|Protocol Violation|1|||
147178324|NCT04310566|530817872|FG000|Period 1|Subject no longer meets eligbility criteria|0|||
147178325|NCT04310566|530817873|FG001|Period 1|Subject no longer meets eligbility criteria|1|||
147178326|NCT04310566|530817872|FG000|Period 1|Lost to Follow-up|1|||
147178327|NCT04310566|530817873|FG001|Period 1|Lost to Follow-up|0|||
147178328|NCT04310566|530817872|FG000|Period 1|Withdrawal by Subject|0|||
147178329|NCT04310566|530817873|FG001|Period 1|Withdrawal by Subject|1|||
147178330|NCT04310566|530817872|FG000|Period 2|Study Termination|7|||
147178331|NCT04310566|530817873|FG001|Period 2|Study Termination|5|||
147178332|NCT00384332|530817883|FG000|Overall Study|Lost to Follow-up|4|||
147178333|NCT00384332|530817884|FG001|Overall Study|Lost to Follow-up|0|||
147178334|NCT02560012|530817885|FG000|Overall Study|Study Terminated|2|||
147178335|NCT02218008|530817888|FG000|Stage 1 (S1)|Adverse Event|6|||
147178336|NCT02218008|530817889|FG001|Stage 1 (S1)|Adverse Event|5|||
147178337|NCT02218008|530817890|FG002|Stage 1 (S1)|Adverse Event|11|||
147178338|NCT02218008|530817891|FG003|Stage 1 (S1)|Adverse Event|0|||
147178339|NCT02218008|530817892|FG004|Stage 1 (S1)|Adverse Event|0|||
147178340|NCT02218008|530817893|FG005|Stage 1 (S1)|Adverse Event|0|||
147178341|NCT02218008|530817888|FG000|Stage 1 (S1)|Withdrawal by Subject|6|||
147178342|NCT02218008|530817889|FG001|Stage 1 (S1)|Withdrawal by Subject|1|||
147178343|NCT02218008|530817890|FG002|Stage 1 (S1)|Withdrawal by Subject|1|||
147178344|NCT02218008|530817891|FG003|Stage 1 (S1)|Withdrawal by Subject|0|||
147178345|NCT02218008|530817892|FG004|Stage 1 (S1)|Withdrawal by Subject|0|||
147178346|NCT02218008|530817893|FG005|Stage 1 (S1)|Withdrawal by Subject|0|||
147178347|NCT02218008|530817888|FG000|Stage 1 (S1)|Lack of Efficacy|3|||
147178348|NCT02218008|530817889|FG001|Stage 1 (S1)|Lack of Efficacy|0|||
147178349|NCT02218008|530817890|FG002|Stage 1 (S1)|Lack of Efficacy|0|||
147178350|NCT02218008|530817891|FG003|Stage 1 (S1)|Lack of Efficacy|0|||
147178351|NCT02218008|530817892|FG004|Stage 1 (S1)|Lack of Efficacy|0|||
147178352|NCT02218008|530817893|FG005|Stage 1 (S1)|Lack of Efficacy|0|||
147178353|NCT02218008|530817888|FG000|Stage 1 (S1)|Lost to Follow-up|3|||
147178354|NCT02218008|530817889|FG001|Stage 1 (S1)|Lost to Follow-up|0|||
147178355|NCT02218008|530817890|FG002|Stage 1 (S1)|Lost to Follow-up|1|||
147178356|NCT02218008|530817891|FG003|Stage 1 (S1)|Lost to Follow-up|0|||
147178357|NCT02218008|530817892|FG004|Stage 1 (S1)|Lost to Follow-up|0|||
147178358|NCT02218008|530817893|FG005|Stage 1 (S1)|Lost to Follow-up|0|||
147178359|NCT02218008|530817888|FG000|Stage 1 (S1)|Non-compliance with Study Drug|2|||
147178360|NCT02218008|530817889|FG001|Stage 1 (S1)|Non-compliance with Study Drug|1|||
147178361|NCT02218008|530817890|FG002|Stage 1 (S1)|Non-compliance with Study Drug|0|||
147178362|NCT02218008|530817891|FG003|Stage 1 (S1)|Non-compliance with Study Drug|0|||
147178363|NCT02218008|530817892|FG004|Stage 1 (S1)|Non-compliance with Study Drug|0|||
147178364|NCT02218008|530817893|FG005|Stage 1 (S1)|Non-compliance with Study Drug|0|||
147178365|NCT02218008|530817888|FG000|Stage 1 (S1)|Non-compliance; drug use|1|||
147178366|NCT02218008|530817889|FG001|Stage 1 (S1)|Non-compliance; drug use|0|||
147178367|NCT02218008|530817890|FG002|Stage 1 (S1)|Non-compliance; drug use|0|||
147178368|NCT02218008|530817891|FG003|Stage 1 (S1)|Non-compliance; drug use|0|||
147178369|NCT02218008|530817892|FG004|Stage 1 (S1)|Non-compliance; drug use|0|||
147178370|NCT02218008|530817893|FG005|Stage 1 (S1)|Non-compliance; drug use|0|||
147178371|NCT02218008|530817888|FG000|Stage 1 (S1)|Pregnancy|0|||
147178372|NCT02218008|530817889|FG001|Stage 1 (S1)|Pregnancy|0|||
147178373|NCT02218008|530817890|FG002|Stage 1 (S1)|Pregnancy|1|||
147178374|NCT02218008|530817891|FG003|Stage 1 (S1)|Pregnancy|0|||
147178375|NCT02218008|530817892|FG004|Stage 1 (S1)|Pregnancy|0|||
147178376|NCT02218008|530817893|FG005|Stage 1 (S1)|Pregnancy|0|||
147178377|NCT02218008|530817888|FG000|Stage 1 (S1)|Protocol Violation|0|||
147178378|NCT02218008|530817889|FG001|Stage 1 (S1)|Protocol Violation|0|||
147178379|NCT02218008|530817890|FG002|Stage 1 (S1)|Protocol Violation|1|||
147178380|NCT02218008|530817891|FG003|Stage 1 (S1)|Protocol Violation|0|||
147178381|NCT02218008|530817892|FG004|Stage 1 (S1)|Protocol Violation|0|||
147178382|NCT02218008|530817893|FG005|Stage 1 (S1)|Protocol Violation|0|||
147178383|NCT02218008|530817888|FG000|Stage 1 (S1)|Failure to Meet Eligibility Criteria|1|||
147178384|NCT02218008|530817889|FG001|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0|||
147178385|NCT02218008|530817890|FG002|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0|||
147178386|NCT02218008|530817891|FG003|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0|||
147178387|NCT02218008|530817892|FG004|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0|||
147178388|NCT02218008|530817893|FG005|Stage 1 (S1)|Failure to Meet Eligibility Criteria|0|||
147178389|NCT02218008|530817888|FG000|Stage 2 (S2)|Adverse Event|0|||
147178390|NCT02218008|530817889|FG001|Stage 2 (S2)|Adverse Event|0|||
147178391|NCT02218008|530817890|FG002|Stage 2 (S2)|Adverse Event|0|||
147178392|NCT02218008|530817891|FG003|Stage 2 (S2)|Adverse Event|2|||
147178393|NCT02218008|530817892|FG004|Stage 2 (S2)|Adverse Event|3|||
147178394|NCT02218008|530817893|FG005|Stage 2 (S2)|Adverse Event|3|||
147178395|NCT02218008|530817888|FG000|Stage 2 (S2)|Withdrawal by Subject|0|||
147178396|NCT02218008|530817889|FG001|Stage 2 (S2)|Withdrawal by Subject|0|||
147178397|NCT02218008|530817890|FG002|Stage 2 (S2)|Withdrawal by Subject|0|||
147178398|NCT02218008|530817891|FG003|Stage 2 (S2)|Withdrawal by Subject|1|||
147178399|NCT02218008|530817892|FG004|Stage 2 (S2)|Withdrawal by Subject|1|||
147178400|NCT02218008|530817893|FG005|Stage 2 (S2)|Withdrawal by Subject|0|||
147178401|NCT02218008|530817888|FG000|Stage 2 (S2)|Lack of Efficacy|0|||
147178402|NCT02218008|530817889|FG001|Stage 2 (S2)|Lack of Efficacy|0|||
147178403|NCT02218008|530817890|FG002|Stage 2 (S2)|Lack of Efficacy|0|||
147178404|NCT02218008|530817891|FG003|Stage 2 (S2)|Lack of Efficacy|0|||
147178405|NCT02218008|530817892|FG004|Stage 2 (S2)|Lack of Efficacy|0|||
147178406|NCT02218008|530817893|FG005|Stage 2 (S2)|Lack of Efficacy|2|||
147178407|NCT02218008|530817888|FG000|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0|||
147178408|NCT02218008|530817889|FG001|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0|||
147178409|NCT02218008|530817890|FG002|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0|||
147178410|NCT02218008|530817891|FG003|Stage 2 (S2)|Failure to Meet Eligibility Criteria|1|||
147178411|NCT02218008|530817892|FG004|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0|||
147178412|NCT02218008|530817893|FG005|Stage 2 (S2)|Failure to Meet Eligibility Criteria|0|||
147178413|NCT02218008|530817888|FG000|Stage 2 (S2)|Lost to Follow-up|0|||
147178414|NCT02218008|530817889|FG001|Stage 2 (S2)|Lost to Follow-up|0|||
147178415|NCT02218008|530817890|FG002|Stage 2 (S2)|Lost to Follow-up|0|||
147178416|NCT02218008|530817891|FG003|Stage 2 (S2)|Lost to Follow-up|0|||
147178417|NCT02218008|530817892|FG004|Stage 2 (S2)|Lost to Follow-up|0|||
147178418|NCT02218008|530817893|FG005|Stage 2 (S2)|Lost to Follow-up|1|||
147178419|NCT01278797|530817894|FG000|Period 1|Adverse Event|0|||
147178420|NCT01278797|530817895|FG001|Period 1|Adverse Event|1|||
147178421|NCT01278797|530817894|FG000|Period 1|Protocol Violation|1|||
147178422|NCT01278797|530817895|FG001|Period 1|Protocol Violation|0|||
147178423|NCT00620113|530817899|FG000|Overall Study|Adverse Event|3|||
147178424|NCT00620113|530817900|FG001|Overall Study|Adverse Event|2|||
147178425|NCT00620113|530817901|FG002|Overall Study|Adverse Event|2|||
147178426|NCT00620113|530817902|FG003|Overall Study|Adverse Event|1|||
147178427|NCT00620113|530817899|FG000|Overall Study|Lack of Efficacy|2|||
147178428|NCT00620113|530817900|FG001|Overall Study|Lack of Efficacy|3|||
147178429|NCT00620113|530817901|FG002|Overall Study|Lack of Efficacy|0|||
147178430|NCT00620113|530817902|FG003|Overall Study|Lack of Efficacy|2|||
147178431|NCT00620113|530817899|FG000|Overall Study|Physician Decision|1|||
147178432|NCT00620113|530817900|FG001|Overall Study|Physician Decision|0|||
147178433|NCT00620113|530817901|FG002|Overall Study|Physician Decision|0|||
147178434|NCT00620113|530817902|FG003|Overall Study|Physician Decision|2|||
147178435|NCT00620113|530817899|FG000|Overall Study|Protocol Violation|2|||
147178436|NCT00620113|530817900|FG001|Overall Study|Protocol Violation|1|||
147178437|NCT00620113|530817901|FG002|Overall Study|Protocol Violation|0|||
147178438|NCT00620113|530817902|FG003|Overall Study|Protocol Violation|0|||
147178439|NCT00620113|530817899|FG000|Overall Study|Withdrawal by Subject|5|||
147178440|NCT00620113|530817900|FG001|Overall Study|Withdrawal by Subject|1|||
147178441|NCT00620113|530817901|FG002|Overall Study|Withdrawal by Subject|3|||
147178442|NCT00620113|530817902|FG003|Overall Study|Withdrawal by Subject|5|||
147178443|NCT02476006|530817928|FG000|Overall Study|Death|4|||
147178444|NCT02476006|530817928|FG000|Overall Study|Lack of treatment efficacy|2|||
147178445|NCT02476006|530817928|FG000|Overall Study|Pregnancy|1|||
147178446|NCT02476006|530817928|FG000|Overall Study|Participant did not wish to continue|39|||
147178447|NCT02476006|530817928|FG000|Overall Study|Adverse Event|41|||
147178448|NCT02476006|530817928|FG000|Overall Study|Poor compliance to study protocol|3|||
147178449|NCT02476006|530817928|FG000|Overall Study|Sponsor decision|6|||
147178450|NCT02476006|530817928|FG000|Overall Study|Lost to Follow-up|5|||
147178451|NCT02476006|530817928|FG000|Overall Study|Physician Decision|5|||
147178452|NCT02476006|530817928|FG000|Overall Study|Study ended treatment not available|4|||
147178453|NCT02476006|530817928|FG000|Overall Study|Switched to commercial drug|4|||
147178454|NCT02476006|530817928|FG000|Overall Study|Excluded from study|1|||
147178455|NCT02476006|530817928|FG000|Overall Study|Protocol Violation|1|||
147178456|NCT02476006|530817928|FG000|Overall Study|Enrolled but not treated|4|||
147178457|NCT02813889|530819741|FG000|Overall Study|Excluded 7 due to protocol adjustments. Specific exclusions listed under each outcome measure.|7|||
147178458|NCT02813889|530819742|FG001|Overall Study|Excluded 7 due to protocol adjustments. Specific exclusions listed under each outcome measure.|0|||
147178459|NCT04014062|530819746|FG000|Period I: Dosing|Medical Grounds|4|||
147178460|NCT04014062|530819747|FG001|Period I: Dosing|Medical Grounds|5|||
147178461|NCT04014062|530819746|FG000|Period I: Dosing|Withdrawal by Subject|3|||
147178462|NCT04014062|530819747|FG001|Period I: Dosing|Withdrawal by Subject|1|||
147178463|NCT03038126|530819748|FG000|Overall Study|Death|1|||
147178464|NCT03038126|530819749|FG001|Overall Study|Death|1|||
147178465|NCT03038126|530819748|FG000|Overall Study|Withdrawal by Subject|5|||
147178466|NCT03038126|530819749|FG001|Overall Study|Withdrawal by Subject|0|||
147178467|NCT03038126|530819748|FG000|Overall Study|Lost to Follow-up|0|||
147178468|NCT03038126|530819749|FG001|Overall Study|Lost to Follow-up|1|||
147178469|NCT03038126|530819748|FG000|Overall Study|Long Term Hospitalization|2|||
147178470|NCT03038126|530819749|FG001|Overall Study|Long Term Hospitalization|0|||
147178471|NCT03038126|530819748|FG000|Overall Study|Too Ill to Participate|1|||
147178472|NCT03038126|530819749|FG001|Overall Study|Too Ill to Participate|2|||
147178473|NCT02451917|530819750|FG000|First Intervention (24 Weeks)|Lost to Follow-up|2|||
147178474|NCT02451917|530819751|FG001|First Intervention (24 Weeks)|Lost to Follow-up|0|||
147178475|NCT02451917|530819750|FG000|First Intervention (24 Weeks)|Death|0|||
147178476|NCT02451917|530819751|FG001|First Intervention (24 Weeks)|Death|1|||
147178477|NCT02451917|530819750|FG000|First Intervention (24 Weeks)|Adverse Event|0|||
147178478|NCT02451917|530819751|FG001|First Intervention (24 Weeks)|Adverse Event|2|||
147178479|NCT01724866|530819752|FG000|Overall Study|Adverse Event|0|||
147178480|NCT01724866|530819753|FG001|Overall Study|Adverse Event|0|||
147178481|NCT01724866|530819754|FG002|Overall Study|Adverse Event|1|||
147178482|NCT01724866|530819755|FG003|Overall Study|Adverse Event|1|||
147178483|NCT01724866|530819752|FG000|Overall Study|Initiation of Non-Protocol Therapy Either for Progressive Disease or Intolerance of TC Regimen|0|||
147178484|NCT01724866|530819753|FG001|Overall Study|Initiation of Non-Protocol Therapy Either for Progressive Disease or Intolerance of TC Regimen|2|||
147178485|NCT01724866|530819754|FG002|Overall Study|Initiation of Non-Protocol Therapy Either for Progressive Disease or Intolerance of TC Regimen|0|||
147178486|NCT01724866|530819755|FG003|Overall Study|Initiation of Non-Protocol Therapy Either for Progressive Disease or Intolerance of TC Regimen|0|||
147178487|NCT01724866|530819752|FG000|Overall Study|Investigator's Discretion|0|||
147178488|NCT01724866|530819753|FG001|Overall Study|Investigator's Discretion|1|||
147178489|NCT01724866|530819754|FG002|Overall Study|Investigator's Discretion|1|||
147178490|NCT01724866|530819755|FG003|Overall Study|Investigator's Discretion|0|||
147178491|NCT01724866|530819752|FG000|Overall Study|Need for Chemotherapy or Chemotherapy Regimen was Changed due to Amended HER2 Status|1|||
147178492|NCT01724866|530819753|FG001|Overall Study|Need for Chemotherapy or Chemotherapy Regimen was Changed due to Amended HER2 Status|0|||
147178493|NCT01724866|530819754|FG002|Overall Study|Need for Chemotherapy or Chemotherapy Regimen was Changed due to Amended HER2 Status|0|||
147178494|NCT01724866|530819755|FG003|Overall Study|Need for Chemotherapy or Chemotherapy Regimen was Changed due to Amended HER2 Status|0|||
147178495|NCT01724866|530819752|FG000|Overall Study|Participant Refused Further Treatment or Withdrew Consent|0|||
147178496|NCT01724866|530819753|FG001|Overall Study|Participant Refused Further Treatment or Withdrew Consent|2|||
147178497|NCT01724866|530819754|FG002|Overall Study|Participant Refused Further Treatment or Withdrew Consent|1|||
147178498|NCT01724866|530819755|FG003|Overall Study|Participant Refused Further Treatment or Withdrew Consent|0|||
147178499|NCT00411671|530819758|FG000|Overall Study|Adverse Event|15|||
147178500|NCT00411671|530819758|FG000|Overall Study|Death|2|||
147178501|NCT00411671|530819758|FG000|Overall Study|Lost to Follow-up|3|||
147178502|NCT01424501|530819759|FG000|Overall Study|Withdrawal by Subject|1|||
147178503|NCT01424501|530819760|FG001|Overall Study|Withdrawal by Subject|0|||
147178504|NCT01424501|530819761|FG002|Overall Study|Withdrawal by Subject|1|||
147656003|NCT02029274|532563035|FG000|Overall Study|Adverse Event|1|||
147656004|NCT02029274|532563036|FG001|Overall Study|Adverse Event|0|||
147656005|NCT02029274|532563037|FG002|Overall Study|Adverse Event|2|||
147656006|NCT02029274|532563038|FG003|Overall Study|Adverse Event|2|||
147656007|NCT01124292|532563039|FG000|Overall Study|Lost to Follow-up|2|||
147656008|NCT01124292|532563040|FG001|Overall Study|Lost to Follow-up|4|||
147656009|NCT01124292|532563041|FG002|Overall Study|Lost to Follow-up|3|||
147656010|NCT01124292|532563039|FG000|Overall Study|Physician Decision|0|||
147656011|NCT01124292|532563040|FG001|Overall Study|Physician Decision|3|||
147656012|NCT01124292|532563041|FG002|Overall Study|Physician Decision|2|||
147656013|NCT01124292|532563039|FG000|Overall Study|Withdrawal by Subject|0|||
147656014|NCT01124292|532563040|FG001|Overall Study|Withdrawal by Subject|6|||
147656015|NCT01124292|532563041|FG002|Overall Study|Withdrawal by Subject|2|||
147656016|NCT01124292|532563039|FG000|Overall Study|medical issue unrelated to the study|0|||
147656017|NCT01124292|532563040|FG001|Overall Study|medical issue unrelated to the study|0|||
147656018|NCT01124292|532563041|FG002|Overall Study|medical issue unrelated to the study|2|||
147656019|NCT01124292|532563039|FG000|Overall Study|piercing track closed|0|||
147656020|NCT01124292|532563040|FG001|Overall Study|piercing track closed|2|||
147656021|NCT01124292|532563041|FG002|Overall Study|piercing track closed|1|||
147656022|NCT03373461|532563043|FG000|Part 2|Adverse Event|0|||
147178505|NCT01424501|530819762|FG003|Overall Study|Withdrawal by Subject|0|||
147178506|NCT01424501|530819763|FG004|Overall Study|Withdrawal by Subject|0|||
147178507|NCT01424501|530819764|FG005|Overall Study|Withdrawal by Subject|0|||
147178508|NCT01424501|530819759|FG000|Overall Study|Lost to Follow-up|0|||
147178509|NCT01424501|530819760|FG001|Overall Study|Lost to Follow-up|1|||
147178510|NCT01424501|530819761|FG002|Overall Study|Lost to Follow-up|1|||
147656023|NCT03373461|532563044|FG001|Part 2|Adverse Event|1|||
147656024|NCT03373461|532563045|FG002|Part 2|Adverse Event|0|||
147656025|NCT03373461|532563046|FG003|Part 2|Adverse Event|0|||
147656026|NCT03373461|532563047|FG004|Part 2|Adverse Event|1|||
147324601|NCT00049517|531354317|FG001|Conditioning/Transplant|Disease progression|6|||
147324602|NCT00049517|531354318|FG002|Conditioning/Transplant|Disease progression|10|||
147324603|NCT00049517|531354319|FG003|Conditioning/Transplant|Disease progression|6|||
147324604|NCT00049517|531354320|FG004|Conditioning/Transplant|Disease progression|0|||
147324605|NCT00049517|531354321|FG005|Conditioning/Transplant|Disease progression|0|||
147324606|NCT00049517|531354316|FG000|Conditioning/Transplant|Adverse Event|2|||
147324607|NCT00049517|531354317|FG001|Conditioning/Transplant|Adverse Event|1|||
147324608|NCT00049517|531354318|FG002|Conditioning/Transplant|Adverse Event|4|||
147178511|NCT01424501|530819762|FG003|Overall Study|Lost to Follow-up|0|||
147178512|NCT01424501|530819763|FG004|Overall Study|Lost to Follow-up|0|||
147178513|NCT01424501|530819764|FG005|Overall Study|Lost to Follow-up|0|||
147178514|NCT01980095|530819765|FG000|Overall Study|Lost to Follow-up|6|||
147324609|NCT00049517|531354319|FG003|Conditioning/Transplant|Adverse Event|8|||
147324610|NCT00049517|531354320|FG004|Conditioning/Transplant|Adverse Event|0|||
147324611|NCT00049517|531354321|FG005|Conditioning/Transplant|Adverse Event|0|||
147324612|NCT00049517|531354316|FG000|Conditioning/Transplant|Death|1|||
147178515|NCT01980095|530819766|FG001|Overall Study|Lost to Follow-up|7|||
147178516|NCT01980095|530819765|FG000|Overall Study|Withdrawal by Subject|2|||
147178517|NCT01980095|530819766|FG001|Overall Study|Withdrawal by Subject|3|||
147178518|NCT01980095|530819765|FG000|Overall Study|Poor compliance|5|||
147178519|NCT01980095|530819766|FG001|Overall Study|Poor compliance|0|||
147178520|NCT01980095|530819765|FG000|Overall Study|Safety issue|0|||
147178521|NCT01980095|530819766|FG001|Overall Study|Safety issue|1|||
147178522|NCT01980095|530819765|FG000|Overall Study|Study drug discontinued|1|||
147178523|NCT01980095|530819766|FG001|Overall Study|Study drug discontinued|0|||
147178524|NCT01980095|530819765|FG000|Overall Study|Randomized by mistake|1|||
147178525|NCT01980095|530819766|FG001|Overall Study|Randomized by mistake|0|||
147324613|NCT00049517|531354317|FG001|Conditioning/Transplant|Death|0|||
147178526|NCT00546000|530819771|FG000|Overall Study|Adverse Event|1|||
147178527|NCT00546000|530819771|FG000|Overall Study|Lost to Follow-up|1|||
147178528|NCT00546000|530819771|FG000|Overall Study|Baseline HPA Axis Supression|2|||
147178529|NCT01362608|530819776|FG000|Overall Study|Protocol Violation|0|||
147178530|NCT01362608|530819777|FG001|Overall Study|Protocol Violation|1|||
147178531|NCT01362608|530819776|FG000|Overall Study|Lost to Follow-up|3|||
147178532|NCT01362608|530819777|FG001|Overall Study|Lost to Follow-up|1|||
147178533|NCT01362608|530819776|FG000|Overall Study|Withdrawal by Subject|1|||
147178534|NCT01362608|530819777|FG001|Overall Study|Withdrawal by Subject|2|||
147178535|NCT01362608|530819776|FG000|Overall Study|Lack of Efficacy|0|||
147178536|NCT01362608|530819777|FG001|Overall Study|Lack of Efficacy|2|||
147178537|NCT01362608|530819776|FG000|Overall Study|Adverse Event|0|||
147178538|NCT01362608|530819777|FG001|Overall Study|Adverse Event|2|||
147178539|NCT04809285|530819788|FG000|Phase 1|Lost to Follow-up|6|||
147178540|NCT04809285|530819788|FG000|Phase 1|Protocol Violation|2|||
147324614|NCT00049517|531354318|FG002|Conditioning/Transplant|Death|0|||
147324615|NCT00049517|531354319|FG003|Conditioning/Transplant|Death|2|||
147324616|NCT00049517|531354320|FG004|Conditioning/Transplant|Death|0|||
147324617|NCT00049517|531354321|FG005|Conditioning/Transplant|Death|0|||
147178541|NCT04809285|530819788|FG000|Phase 1|Physician Decision|3|||
147178542|NCT04809285|530819788|FG000|Phase 1|Withdrawal by Subject|29|||
147178543|NCT04809285|530819788|FG000|Phase 2|Protocol Violation|3|||
147178544|NCT04809285|530819788|FG000|Phase 2|Withdrawal by Subject|4|||
147178545|NCT02837029|530819791|FG000|Screening|Failed to meet screening requirements.|7|||
147178546|NCT02837029|530819792|FG001|Screening|Failed to meet screening requirements.|3|||
147178547|NCT02837029|530819793|FG002|Screening|Failed to meet screening requirements.|0|||
147178548|NCT02837029|530819791|FG000|Cycle 1 (DLT Monitoring Period)|Progressive Disease|2|||
147178549|NCT02837029|530819792|FG001|Cycle 1 (DLT Monitoring Period)|Progressive Disease|0|||
147178550|NCT02837029|530819793|FG002|Cycle 1 (DLT Monitoring Period)|Progressive Disease|0|||
147178551|NCT02837029|530819791|FG000|Cycle 1 (DLT Monitoring Period)|Adverse Event|0|||
147178552|NCT02837029|530819792|FG001|Cycle 1 (DLT Monitoring Period)|Adverse Event|2|||
147178553|NCT02837029|530819793|FG002|Cycle 1 (DLT Monitoring Period)|Adverse Event|0|||
147178554|NCT02837029|530819791|FG000|Cycle 1 (DLT Monitoring Period)|Withdrawal by Subject|0|||
147178555|NCT02837029|530819792|FG001|Cycle 1 (DLT Monitoring Period)|Withdrawal by Subject|1|||
147324618|NCT00049517|531354316|FG000|Conditioning/Transplant|Withdrawal by Subject|4|||
147324619|NCT00049517|531354317|FG001|Conditioning/Transplant|Withdrawal by Subject|8|||
147324620|NCT00049517|531354318|FG002|Conditioning/Transplant|Withdrawal by Subject|4|||
147178556|NCT02837029|530819793|FG002|Cycle 1 (DLT Monitoring Period)|Withdrawal by Subject|0|||
147178557|NCT02837029|530819791|FG000|Cycle 2 and Beyond|Adverse Event|1|||
147178558|NCT02837029|530819792|FG001|Cycle 2 and Beyond|Adverse Event|0|||
147178559|NCT02837029|530819793|FG002|Cycle 2 and Beyond|Adverse Event|0|||
147178560|NCT02837029|530819791|FG000|2 Year Follow-up|Death|6|||
147178561|NCT02837029|530819792|FG001|2 Year Follow-up|Death|7|||
147178562|NCT02837029|530819793|FG002|2 Year Follow-up|Death|0|||
147324621|NCT00049517|531354319|FG003|Conditioning/Transplant|Withdrawal by Subject|7|||
147324622|NCT00049517|531354320|FG004|Conditioning/Transplant|Withdrawal by Subject|0|||
147324623|NCT00049517|531354321|FG005|Conditioning/Transplant|Withdrawal by Subject|0|||
147324624|NCT00049517|531354316|FG000|Conditioning/Transplant|Alternative therapy|4|||
147656027|NCT01972464|532563050|FG000|Treatment Period (Week 1 Through Week 8)|Lost to Follow-up|2|||
147656028|NCT01972464|532563051|FG001|Treatment Period (Week 1 Through Week 8)|Lost to Follow-up|3|||
147656029|NCT01972464|532563050|FG000|Treatment Period (Week 1 Through Week 8)|Patient Relocated|1|||
147656030|NCT01972464|532563051|FG001|Treatment Period (Week 1 Through Week 8)|Patient Relocated|0|||
147656031|NCT01972464|532563050|FG000|Treatment Period (Week 1 Through Week 8)|Withdrawal by Subject|0|||
147656032|NCT01972464|532563051|FG001|Treatment Period (Week 1 Through Week 8)|Withdrawal by Subject|1|||
147656033|NCT01972464|532563050|FG000|3-Month Follow-Up (Week 20)|Lost to Follow-up|1|||
147178563|NCT02034877|530819796|FG000|Overall Study|Lost to Follow-up|0|||
147178564|NCT02034877|530819797|FG001|Overall Study|Lost to Follow-up|3|||
147178565|NCT02034877|530819796|FG000|Overall Study|No Longer Willing to Participate|0|||
147178566|NCT02034877|530819797|FG001|Overall Study|No Longer Willing to Participate|3|||
147178567|NCT00394706|530819803|FG000|Overall Study|Withdrawal by Subject|2|||
147178568|NCT00394706|530819804|FG001|Overall Study|Withdrawal by Subject|0|||
147178569|NCT00394706|530819805|FG002|Overall Study|Withdrawal by Subject|1|||
147178570|NCT00394706|530819806|FG003|Overall Study|Withdrawal by Subject|0|||
147178571|NCT00394706|530819807|FG004|Overall Study|Withdrawal by Subject|0|||
147178572|NCT00394706|530819808|FG005|Overall Study|Withdrawal by Subject|2|||
147178573|NCT00394706|530819809|FG006|Overall Study|Withdrawal by Subject|1|||
147178574|NCT00394706|530819810|FG007|Overall Study|Withdrawal by Subject|0|||
147178575|NCT00394706|530819803|FG000|Overall Study|Lost to Follow-up|2|||
147178576|NCT00394706|530819804|FG001|Overall Study|Lost to Follow-up|2|||
147178577|NCT00394706|530819805|FG002|Overall Study|Lost to Follow-up|8|||
147178578|NCT00394706|530819806|FG003|Overall Study|Lost to Follow-up|1|||
147178579|NCT00394706|530819807|FG004|Overall Study|Lost to Follow-up|2|||
147178580|NCT00394706|530819808|FG005|Overall Study|Lost to Follow-up|5|||
147178581|NCT00394706|530819809|FG006|Overall Study|Lost to Follow-up|2|||
147178582|NCT00394706|530819810|FG007|Overall Study|Lost to Follow-up|0|||
147178583|NCT00887549|530819813|FG000|Induction Therapy|Adverse Event|8|||
147178584|NCT00887549|530819813|FG000|Induction Therapy|Physician Decision|1|||
147178585|NCT00887549|530819813|FG000|Induction Therapy|Progressive Disease|13|||
147178586|NCT00887549|530819813|FG000|Induction Therapy|Death due to Study Disease|4|||
147178587|NCT00887549|530819813|FG000|Induction Therapy|Death due to Study Drug Toxicity|1|||
147178588|NCT00887549|530819813|FG000|Maintenance Therapy|Adverse Event|16|||
147656034|NCT01972464|532563051|FG001|3-Month Follow-Up (Week 20)|Lost to Follow-up|1|||
147656035|NCT04530838|532564906|FG000|Overall Study|Other|2|||
147656036|NCT04530838|532564907|FG001|Overall Study|Other|1|||
147656037|NCT04530838|532564908|FG002|Overall Study|Other|0|||
147656038|NCT04530838|532564906|FG000|Overall Study|Physician Decision|0|||
147656039|NCT04530838|532564907|FG001|Overall Study|Physician Decision|0|||
147656040|NCT04530838|532564908|FG002|Overall Study|Physician Decision|1|||
147656041|NCT04530838|532564906|FG000|Overall Study|Death|0|||
147656042|NCT04530838|532564907|FG001|Overall Study|Death|0|||
147656043|NCT04530838|532564908|FG002|Overall Study|Death|1|||
147656044|NCT04530838|532564906|FG000|Overall Study|Adverse Event|0|||
147656045|NCT04530838|532564907|FG001|Overall Study|Adverse Event|1|||
147656046|NCT04530838|532564908|FG002|Overall Study|Adverse Event|0|||
147656047|NCT04530838|532564906|FG000|Overall Study|No longer meets eligibility criteria|1|||
147656048|NCT04530838|532564907|FG001|Overall Study|No longer meets eligibility criteria|0|||
147656049|NCT04530838|532564908|FG002|Overall Study|No longer meets eligibility criteria|2|||
147656050|NCT04530838|532564906|FG000|Overall Study|Withdrawal by parent/guardian|5|||
147656051|NCT04530838|532564907|FG001|Overall Study|Withdrawal by parent/guardian|2|||
147656052|NCT04530838|532564908|FG002|Overall Study|Withdrawal by parent/guardian|2|||
147656053|NCT00803712|532564909|FG000|Overall Study|Noncompliance|3|||
147656054|NCT00803712|532564910|FG001|Overall Study|Noncompliance|0|||
147656055|NCT00803712|532564909|FG000|Overall Study|Adverse Event|5|||
147656056|NCT00803712|532564910|FG001|Overall Study|Adverse Event|0|||
147656057|NCT00803712|532564909|FG000|Overall Study|Death|8|||
147245038|NCT03708328|531070756|FG004|Overall Study|Physician Decision|0|||
147245039|NCT03708328|531070757|FG005|Overall Study|Physician Decision|1|||
147245040|NCT03708328|531070758|FG006|Overall Study|Physician Decision|0|||
147656058|NCT00803712|532564910|FG001|Overall Study|Death|7|||
147656059|NCT00803712|532564909|FG000|Overall Study|Lost to Follow-up|3|||
147656060|NCT00803712|532564910|FG001|Overall Study|Lost to Follow-up|1|||
147656061|NCT00803712|532564909|FG000|Overall Study|Withdrawal by Subject|2|||
147656062|NCT00803712|532564910|FG001|Overall Study|Withdrawal by Subject|4|||
147178589|NCT00887549|530819813|FG000|Maintenance Therapy|Physician Decision|1|||
147178590|NCT00887549|530819813|FG000|Maintenance Therapy|Progressive Disease|25|||
147178591|NCT00887549|530819813|FG000|Maintenance Therapy|Death due to adverse event|1|||
147245041|NCT03708328|531070759|FG007|Overall Study|Physician Decision|0|||
147656063|NCT00803712|532564909|FG000|Overall Study|"Other in electronic Case Report Form"|0|||
147656064|NCT00803712|532564910|FG001|Overall Study|"Other in electronic Case Report Form"|1|||
147656065|NCT00803712|532564909|FG000|Overall Study|Protocol criteria (other)|0|||
147656066|NCT00803712|532564910|FG001|Overall Study|Protocol criteria (other)|2|||
147178592|NCT04112303|530819814|FG000|Overall Study|Death|1|||
147245042|NCT03708328|531070760|FG008|Overall Study|Physician Decision|0|||
147656067|NCT00803712|532564909|FG000|Overall Study|Protocol criteria (renal transplant)|12|||
147178593|NCT00100789|530819815|FG000|Overall Study|Adverse Event|10|||
147178594|NCT00100789|530819815|FG000|Overall Study|Withdrawal by Subject|1|||
147178595|NCT00100789|530819815|FG000|Overall Study|Progression/relapse|42|||
147178596|NCT00100789|530819815|FG000|Overall Study|Death|2|||
147178597|NCT00100789|530819815|FG000|Overall Study|Not protocol specified|5|||
147178598|NCT00100789|530819815|FG000|Overall Study|Ineligible|3|||
147178599|NCT00100789|530819815|FG000|Overall Study|Never received treatment|1|||
147178600|NCT03472950|530819816|FG000|Overall Study|Lost to Follow-up|0|||
147178601|NCT03472950|530819817|FG001|Overall Study|Lost to Follow-up|1|||
147178602|NCT03472950|530819816|FG000|Overall Study|Adverse Event|0|||
147178603|NCT03472950|530819817|FG001|Overall Study|Adverse Event|3|||
147178604|NCT02506192|530819819|FG000|Overall Study|Withdrawal by Subject|1|||
147178605|NCT02506192|530819820|FG001|Overall Study|Withdrawal by Subject|1|||
147178606|NCT01685697|530819821|FG000|Overall Study|Protocol Violation|3|||
147178607|NCT01685697|530819822|FG001|Overall Study|Protocol Violation|3|||
147178608|NCT02703324|530819823|FG000|Period Two|Withdrawal by Subject|0|||
147178609|NCT02703324|530819824|FG001|Period Two|Withdrawal by Subject|0|||
147178610|NCT02703324|530819825|FG002|Period Two|Withdrawal by Subject|1|||
147178611|NCT02703324|530819826|FG003|Period Two|Withdrawal by Subject|0|||
147178612|NCT02703324|530819827|FG004|Period Two|Withdrawal by Subject|0|||
147178613|NCT02703324|530819828|FG005|Period Two|Withdrawal by Subject|0|||
147448310|NCT00708123|531805686|FG000|Period 1|Adverse Event|0|||
147448311|NCT00708123|531805687|FG001|Period 1|Adverse Event|0|||
147448312|NCT00708123|531805688|FG002|Period 1|Adverse Event|1|||
147448313|NCT00708123|531805689|FG003|Period 1|Adverse Event|0|||
147448314|NCT00708123|531805690|FG004|Period 1|Adverse Event|0|||
147448315|NCT00708123|531805686|FG000|Period 2|Protocol Violation|0|||
147448316|NCT00708123|531805687|FG001|Period 2|Protocol Violation|0|||
147448317|NCT00708123|531805688|FG002|Period 2|Protocol Violation|0|||
147448318|NCT00708123|531805689|FG003|Period 2|Protocol Violation|1|||
147178623|NCT01858766|530819830|FG000|Overall Study|Randomized but Never Treated|0|||
147178624|NCT01858766|530819831|FG001|Overall Study|Randomized but Never Treated|0|||
147178625|NCT01858766|530819832|FG002|Overall Study|Randomized but Never Treated|0|||
147178626|NCT01858766|530819833|FG003|Overall Study|Randomized but Never Treated|0|||
147178627|NCT01858766|530819834|FG004|Overall Study|Randomized but Never Treated|0|||
147178628|NCT01858766|530819835|FG005|Overall Study|Randomized but Never Treated|1|||
147178629|NCT01858766|530819836|FG006|Overall Study|Randomized but Never Treated|0|||
147178630|NCT01858766|530819837|FG007|Overall Study|Randomized but Never Treated|0|||
147178631|NCT01858766|530819838|FG008|Overall Study|Randomized but Never Treated|0|||
147178632|NCT01858766|530819839|FG009|Overall Study|Randomized but Never Treated|0|||
147178633|NCT01858766|530819840|FG010|Overall Study|Randomized but Never Treated|0|||
147178634|NCT01858766|530819841|FG011|Overall Study|Randomized but Never Treated|0|||
147178635|NCT01858766|530819842|FG012|Overall Study|Randomized but Never Treated|0|||
147178636|NCT01858766|530819843|FG013|Overall Study|Randomized but Never Treated|0|||
147178637|NCT01858766|530819844|FG014|Overall Study|Randomized but Never Treated|0|||
147178638|NCT01858766|530819845|FG015|Overall Study|Randomized but Never Treated|0|||
147178639|NCT01858766|530819846|FG016|Overall Study|Randomized but Never Treated|0|||
147178640|NCT01858766|530819847|FG017|Overall Study|Randomized but Never Treated|1|||
147178641|NCT01858766|530819848|FG018|Overall Study|Randomized but Never Treated|0|||
147178642|NCT01858766|530819830|FG000|Overall Study|Death|0|||
147178643|NCT01858766|530819831|FG001|Overall Study|Death|0|||
147178644|NCT01858766|530819832|FG002|Overall Study|Death|1|||
147178645|NCT01858766|530819833|FG003|Overall Study|Death|0|||
147178646|NCT01858766|530819834|FG004|Overall Study|Death|0|||
147448319|NCT00708123|531805690|FG004|Period 2|Protocol Violation|0|||
147656068|NCT00803712|532564910|FG001|Overall Study|Protocol criteria (renal transplant)|8|||
147178647|NCT01858766|530819835|FG005|Overall Study|Death|0|||
147178648|NCT01858766|530819836|FG006|Overall Study|Death|0|||
147178649|NCT01858766|530819837|FG007|Overall Study|Death|0|||
147245043|NCT03708328|531070761|FG009|Overall Study|Physician Decision|0|||
147245044|NCT03708328|531070752|FG000|Overall Study|Withdrawal by Subject|0|||
147245045|NCT03708328|531070753|FG001|Overall Study|Withdrawal by Subject|0|||
147245046|NCT03708328|531070754|FG002|Overall Study|Withdrawal by Subject|0|||
147245047|NCT03708328|531070755|FG003|Overall Study|Withdrawal by Subject|0|||
147245048|NCT03708328|531070756|FG004|Overall Study|Withdrawal by Subject|1|||
147245049|NCT03708328|531070757|FG005|Overall Study|Withdrawal by Subject|0|||
147245050|NCT03708328|531070758|FG006|Overall Study|Withdrawal by Subject|2|||
147245051|NCT03708328|531070759|FG007|Overall Study|Withdrawal by Subject|4|||
147656069|NCT00803712|532564909|FG000|Overall Study|Administrative decision|2|||
147656070|NCT00803712|532564910|FG001|Overall Study|Administrative decision|3|||
147178650|NCT01858766|530819838|FG008|Overall Study|Death|0|||
147178651|NCT01858766|530819839|FG009|Overall Study|Death|0|||
147178652|NCT01858766|530819840|FG010|Overall Study|Death|0|||
147178653|NCT01858766|530819841|FG011|Overall Study|Death|0|||
147178654|NCT01858766|530819842|FG012|Overall Study|Death|0|||
147178655|NCT01858766|530819843|FG013|Overall Study|Death|0|||
147178656|NCT01858766|530819844|FG014|Overall Study|Death|0|||
147178657|NCT01858766|530819845|FG015|Overall Study|Death|0|||
147448320|NCT00708123|531805686|FG000|Period 2|Other Reason|1|||
147178658|NCT01858766|530819846|FG016|Overall Study|Death|0|||
147178659|NCT01858766|530819847|FG017|Overall Study|Death|0|||
147178660|NCT01858766|530819848|FG018|Overall Study|Death|0|||
147178661|NCT01858766|530819830|FG000|Overall Study|Lack of Efficacy|1|||
147178662|NCT01858766|530819831|FG001|Overall Study|Lack of Efficacy|0|||
147178663|NCT01858766|530819832|FG002|Overall Study|Lack of Efficacy|0|||
147178664|NCT01858766|530819833|FG003|Overall Study|Lack of Efficacy|0|||
147178665|NCT01858766|530819834|FG004|Overall Study|Lack of Efficacy|1|||
147178666|NCT01858766|530819835|FG005|Overall Study|Lack of Efficacy|2|||
147178667|NCT01858766|530819836|FG006|Overall Study|Lack of Efficacy|0|||
147178668|NCT01858766|530819837|FG007|Overall Study|Lack of Efficacy|0|||
147178669|NCT01858766|530819838|FG008|Overall Study|Lack of Efficacy|0|||
147656071|NCT00803712|532564909|FG000|Overall Study|Protocol criteria (parathyroidectomy)|1|||
147656072|NCT00803712|532564910|FG001|Overall Study|Protocol criteria (parathyroidectomy)|1|||
147656073|NCT02861664|532564913|FG000|Overall Study|Withdrawal of Consent|0|||
147178670|NCT01858766|530819839|FG009|Overall Study|Lack of Efficacy|0|||
147178671|NCT01858766|530819840|FG010|Overall Study|Lack of Efficacy|0|||
147178672|NCT01858766|530819841|FG011|Overall Study|Lack of Efficacy|3|||
147178673|NCT01858766|530819842|FG012|Overall Study|Lack of Efficacy|5|||
147178674|NCT01858766|530819843|FG013|Overall Study|Lack of Efficacy|3|||
147178675|NCT01858766|530819844|FG014|Overall Study|Lack of Efficacy|5|||
147178676|NCT01858766|530819845|FG015|Overall Study|Lack of Efficacy|5|||
147178677|NCT01858766|530819846|FG016|Overall Study|Lack of Efficacy|2|||
147178678|NCT01858766|530819847|FG017|Overall Study|Lack of Efficacy|3|||
147178679|NCT01858766|530819848|FG018|Overall Study|Lack of Efficacy|3|||
147178680|NCT01858766|530819830|FG000|Overall Study|Lost to Follow-up|0|||
147178681|NCT01858766|530819831|FG001|Overall Study|Lost to Follow-up|0|||
147178682|NCT01858766|530819832|FG002|Overall Study|Lost to Follow-up|0|||
147178683|NCT01858766|530819833|FG003|Overall Study|Lost to Follow-up|0|||
147178684|NCT01858766|530819834|FG004|Overall Study|Lost to Follow-up|0|||
147178685|NCT01858766|530819835|FG005|Overall Study|Lost to Follow-up|1|||
147178686|NCT01858766|530819836|FG006|Overall Study|Lost to Follow-up|0|||
147178687|NCT01858766|530819837|FG007|Overall Study|Lost to Follow-up|2|||
147178688|NCT01858766|530819838|FG008|Overall Study|Lost to Follow-up|0|||
147178689|NCT01858766|530819839|FG009|Overall Study|Lost to Follow-up|0|||
147178690|NCT01858766|530819840|FG010|Overall Study|Lost to Follow-up|0|||
147178691|NCT01858766|530819841|FG011|Overall Study|Lost to Follow-up|1|||
147178692|NCT01858766|530819842|FG012|Overall Study|Lost to Follow-up|0|||
147178693|NCT01858766|530819843|FG013|Overall Study|Lost to Follow-up|0|||
147178694|NCT01858766|530819844|FG014|Overall Study|Lost to Follow-up|3|||
147178695|NCT01858766|530819845|FG015|Overall Study|Lost to Follow-up|1|||
147178696|NCT01858766|530819846|FG016|Overall Study|Lost to Follow-up|1|||
147178697|NCT01858766|530819847|FG017|Overall Study|Lost to Follow-up|0|||
147656074|NCT02861664|532564914|FG001|Overall Study|Withdrawal of Consent|1|||
147656075|NCT00905632|532564915|FG000|Overall Study|Adverse Event|0|||
147656076|NCT00905632|532564916|FG001|Overall Study|Adverse Event|0|||
147656077|NCT00905632|532564917|FG002|Overall Study|Adverse Event|0|||
147178698|NCT01858766|530819848|FG018|Overall Study|Lost to Follow-up|1|||
147178699|NCT01858766|530819830|FG000|Overall Study|Withdrew Consent|0|||
147178700|NCT01858766|530819831|FG001|Overall Study|Withdrew Consent|0|||
147178701|NCT01858766|530819832|FG002|Overall Study|Withdrew Consent|0|||
147178702|NCT01858766|530819833|FG003|Overall Study|Withdrew Consent|0|||
147178703|NCT01858766|530819834|FG004|Overall Study|Withdrew Consent|0|||
147245052|NCT03708328|531070760|FG008|Overall Study|Withdrawal by Subject|1|||
147245053|NCT03708328|531070761|FG009|Overall Study|Withdrawal by Subject|5|||
147245054|NCT03708328|531070752|FG000|Overall Study|Study Closed Locally|0|||
147245055|NCT03708328|531070753|FG001|Overall Study|Study Closed Locally|0|||
147245056|NCT03708328|531070754|FG002|Overall Study|Study Closed Locally|0|||
147245057|NCT03708328|531070755|FG003|Overall Study|Study Closed Locally|0|||
147245058|NCT03708328|531070756|FG004|Overall Study|Study Closed Locally|0|||
147245059|NCT03708328|531070757|FG005|Overall Study|Study Closed Locally|0|||
147245060|NCT03708328|531070758|FG006|Overall Study|Study Closed Locally|0|||
147245061|NCT03708328|531070759|FG007|Overall Study|Study Closed Locally|1|||
147245062|NCT03708328|531070760|FG008|Overall Study|Study Closed Locally|0|||
147245063|NCT03708328|531070761|FG009|Overall Study|Study Closed Locally|0|||
147245064|NCT03708328|531070752|FG000|Overall Study|Study Ended By Sponsor|0|||
147245065|NCT03708328|531070753|FG001|Overall Study|Study Ended By Sponsor|0|||
147245066|NCT03708328|531070754|FG002|Overall Study|Study Ended By Sponsor|0|||
147245067|NCT03708328|531070755|FG003|Overall Study|Study Ended By Sponsor|0|||
147245068|NCT03708328|531070756|FG004|Overall Study|Study Ended By Sponsor|0|||
147245069|NCT03708328|531070757|FG005|Overall Study|Study Ended By Sponsor|1|||
147245070|NCT03708328|531070758|FG006|Overall Study|Study Ended By Sponsor|0|||
147178704|NCT01858766|530819835|FG005|Overall Study|Withdrew Consent|0|||
147178705|NCT01858766|530819836|FG006|Overall Study|Withdrew Consent|0|||
147178706|NCT01858766|530819837|FG007|Overall Study|Withdrew Consent|0|||
147245071|NCT03708328|531070759|FG007|Overall Study|Study Ended By Sponsor|1|||
147656078|NCT00905632|532564918|FG003|Overall Study|Adverse Event|0|||
147178707|NCT01858766|530819838|FG008|Overall Study|Withdrew Consent|0|||
147178708|NCT01858766|530819839|FG009|Overall Study|Withdrew Consent|0|||
147178709|NCT01858766|530819840|FG010|Overall Study|Withdrew Consent|0|||
147178710|NCT01858766|530819841|FG011|Overall Study|Withdrew Consent|1|||
147178711|NCT01858766|530819842|FG012|Overall Study|Withdrew Consent|0|||
147178712|NCT01858766|530819843|FG013|Overall Study|Withdrew Consent|0|||
147324625|NCT00049517|531354317|FG001|Conditioning/Transplant|Alternative therapy|4|||
147324626|NCT00049517|531354318|FG002|Conditioning/Transplant|Alternative therapy|2|||
147324627|NCT00049517|531354319|FG003|Conditioning/Transplant|Alternative therapy|1|||
147324628|NCT00049517|531354320|FG004|Conditioning/Transplant|Alternative therapy|1|||
147324629|NCT00049517|531354321|FG005|Conditioning/Transplant|Alternative therapy|0|||
147656079|NCT00905632|532564919|FG004|Overall Study|Adverse Event|0|||
147178713|NCT01858766|530819844|FG014|Overall Study|Withdrew Consent|0|||
147178714|NCT01858766|530819845|FG015|Overall Study|Withdrew Consent|0|||
147178715|NCT01858766|530819846|FG016|Overall Study|Withdrew Consent|0|||
147178716|NCT01858766|530819847|FG017|Overall Study|Withdrew Consent|0|||
147178717|NCT01858766|530819848|FG018|Overall Study|Withdrew Consent|0|||
147178718|NCT00475709|530819855|FG000|Overall Study|Did not meet eligibility criteria|8|||
147178719|NCT00475709|530819855|FG000|Overall Study|Death|41|||
147178720|NCT00475709|530819855|FG000|Overall Study|Device Explant|6|||
147178721|NCT00475709|530819855|FG000|Overall Study|Lost to Follow-up|21|||
147178722|NCT04427072|530819861|FG000|Randomized Treatment Phase|Progressive disease|9|||
147178723|NCT04427072|530819862|FG001|Randomized Treatment Phase|Progressive disease|4|||
147178724|NCT04427072|530819861|FG000|Randomized Treatment Phase|Adverse Event|3|||
147178725|NCT04427072|530819862|FG001|Randomized Treatment Phase|Adverse Event|1|||
147178726|NCT04427072|530819861|FG000|Randomized Treatment Phase|Study terminated by sponsor|3|||
147178727|NCT04427072|530819862|FG001|Randomized Treatment Phase|Study terminated by sponsor|0|||
147178728|NCT04427072|530819861|FG000|Randomized Treatment Phase|Death|0|||
147178729|NCT04427072|530819862|FG001|Randomized Treatment Phase|Death|1|||
147178730|NCT04427072|530819861|FG000|Randomized Treatment Phase|Not treated (participant decision)|0|||
147178731|NCT04427072|530819862|FG001|Randomized Treatment Phase|Not treated (participant decision)|1|||
147178732|NCT04427072|530819861|FG000|Extension Treatment Phase|Progressive disease|0|||
147178733|NCT04427072|530819862|FG001|Extension Treatment Phase|Progressive disease|5|||
147178734|NCT03400176|530819863|FG000|Dose Escalation|Progressive disease|1|||
147178735|NCT03400176|530819864|FG001|Dose Escalation|Progressive disease|1|||
147178736|NCT03400176|530819865|FG002|Dose Escalation|Progressive disease|0|||
147178737|NCT03400176|530819866|FG003|Dose Escalation|Progressive disease|0|||
147178738|NCT03400176|530819867|FG004|Dose Escalation|Progressive disease|1|||
147178739|NCT03400176|530819863|FG000|Dose Escalation|Patient decision|0|||
147178740|NCT03400176|530819864|FG001|Dose Escalation|Patient decision|0|||
147178741|NCT03400176|530819865|FG002|Dose Escalation|Patient decision|0|||
147178742|NCT03400176|530819866|FG003|Dose Escalation|Patient decision|0|||
147178743|NCT03400176|530819867|FG004|Dose Escalation|Patient decision|1|||
147178744|NCT03400176|530819863|FG000|Dose Expansion|Patient decision|0|||
147178745|NCT03400176|530819864|FG001|Dose Expansion|Patient decision|0|||
147178746|NCT03400176|530819865|FG002|Dose Expansion|Patient decision|0|||
147178747|NCT03400176|530819866|FG003|Dose Expansion|Patient decision|1|||
147178748|NCT03400176|530819867|FG004|Dose Expansion|Patient decision|0|||
147178749|NCT03400176|530819863|FG000|Dose Expansion|Adverse Event|0|||
147178750|NCT03400176|530819864|FG001|Dose Expansion|Adverse Event|0|||
147178751|NCT03400176|530819865|FG002|Dose Expansion|Adverse Event|0|||
147178752|NCT03400176|530819866|FG003|Dose Expansion|Adverse Event|1|||
147178753|NCT03400176|530819867|FG004|Dose Expansion|Adverse Event|0|||
147178754|NCT03400176|530819863|FG000|Dose Expansion|Physician Decision|0|||
147178755|NCT03400176|530819864|FG001|Dose Expansion|Physician Decision|0|||
147178756|NCT03400176|530819865|FG002|Dose Expansion|Physician Decision|0|||
147178757|NCT03400176|530819866|FG003|Dose Expansion|Physician Decision|1|||
147178758|NCT03400176|530819867|FG004|Dose Expansion|Physician Decision|0|||
147178759|NCT03400176|530819863|FG000|Dose Expansion|Progressive disease|0|||
147178760|NCT03400176|530819864|FG001|Dose Expansion|Progressive disease|0|||
147178761|NCT03400176|530819865|FG002|Dose Expansion|Progressive disease|1|||
147178762|NCT03400176|530819866|FG003|Dose Expansion|Progressive disease|1|||
147178763|NCT03400176|530819867|FG004|Dose Expansion|Progressive disease|0|||
147178764|NCT02104947|530819872|FG000|Overall Study|Withdrawal by Subject|10|||
147656080|NCT00905632|532564920|FG005|Overall Study|Adverse Event|1|||
147656081|NCT00905632|532564921|FG006|Overall Study|Adverse Event|4|||
147656082|NCT02609386|532564922|FG000|Overall Study|Withdrawal by Subject|6|||
147656083|NCT02609386|532564923|FG001|Overall Study|Withdrawal by Subject|1|||
147656084|NCT02609386|532564922|FG000|Overall Study|Lost to Follow-up|3|||
147178765|NCT02104947|530819873|FG001|Overall Study|Withdrawal by Subject|3|||
147178766|NCT02104947|530819872|FG000|Overall Study|Lost to Follow-up|4|||
147178767|NCT02104947|530819873|FG001|Overall Study|Lost to Follow-up|4|||
147656085|NCT02609386|532564923|FG001|Overall Study|Lost to Follow-up|5|||
147178768|NCT02104947|530819872|FG000|Overall Study|Protocol Violation|6|||
147656086|NCT02609386|532564922|FG000|Overall Study|Death|19|||
147656087|NCT02609386|532564923|FG001|Overall Study|Death|9|||
147178769|NCT02104947|530819873|FG001|Overall Study|Protocol Violation|8|||
147178770|NCT02104947|530819872|FG000|Overall Study|Adverse Event|57|||
147178771|NCT02104947|530819873|FG001|Overall Study|Adverse Event|38|||
147656088|NCT02609386|532564922|FG000|Overall Study|Physician Decision|0|||
147656089|NCT02609386|532564923|FG001|Overall Study|Physician Decision|2|||
147656090|NCT00610168|532564924|FG000|Overall Study|Withdrawal by Subject|2|||
147656091|NCT00610168|532564925|FG001|Overall Study|Withdrawal by Subject|0|||
147656092|NCT00878800|532564930|FG000|Overall Study|Adverse Event|0|||
147656093|NCT00878800|532564931|FG001|Overall Study|Adverse Event|0|||
147656094|NCT00878800|532564932|FG002|Overall Study|Adverse Event|2|||
147656095|NCT00878800|532564933|FG003|Overall Study|Adverse Event|0|||
147656096|NCT00878800|532564934|FG004|Overall Study|Adverse Event|1|||
147656097|NCT00878800|532564930|FG000|Overall Study|Progressive disease|1|||
147656098|NCT00878800|532564931|FG001|Overall Study|Progressive disease|5|||
147656099|NCT00878800|532564932|FG002|Overall Study|Progressive disease|6|||
147656100|NCT00878800|532564933|FG003|Overall Study|Progressive disease|5|||
147656101|NCT00878800|532564934|FG004|Overall Study|Progressive disease|13|||
147656102|NCT00878800|532564930|FG000|Overall Study|Withdrew consent|1|||
147656103|NCT00878800|532564931|FG001|Overall Study|Withdrew consent|1|||
147656104|NCT00878800|532564932|FG002|Overall Study|Withdrew consent|0|||
147656105|NCT00878800|532564933|FG003|Overall Study|Withdrew consent|1|||
147656106|NCT00878800|532564934|FG004|Overall Study|Withdrew consent|1|||
147656107|NCT00878800|532564930|FG000|Overall Study|Death|0|||
147656108|NCT00878800|532564931|FG001|Overall Study|Death|0|||
147656109|NCT00878800|532564932|FG002|Overall Study|Death|1|||
147656110|NCT00878800|532564933|FG003|Overall Study|Death|0|||
147656111|NCT00878800|532564934|FG004|Overall Study|Death|0|||
147656112|NCT00878800|532564930|FG000|Overall Study|Other|1|||
147656113|NCT00878800|532564931|FG001|Overall Study|Other|1|||
147656114|NCT00878800|532564932|FG002|Overall Study|Other|0|||
147656115|NCT00878800|532564933|FG003|Overall Study|Other|0|||
147656116|NCT00878800|532564934|FG004|Overall Study|Other|1|||
147656117|NCT03318003|532564935|FG000|Overall Study|Withdrawal by Subject|1|||
147656118|NCT03318003|532564936|FG001|Overall Study|Withdrawal by Subject|1|||
147656119|NCT03318003|532564935|FG000|Overall Study|fetal loss|0|||
147656120|NCT03318003|532564936|FG001|Overall Study|fetal loss|1|||
147656121|NCT01266824|532564937|FG000|Overall Study|Study terminated prior to completion|2|||
147656122|NCT01266824|532564938|FG001|Overall Study|Study terminated prior to completion|3|||
147656123|NCT01029262|532564942|FG000|Overall Study|Adverse Event|9|||
147656124|NCT01029262|532564943|FG001|Overall Study|Adverse Event|52|||
147656125|NCT01029262|532564942|FG000|Overall Study|Lack of therapeutic effect|57|||
147656126|NCT01029262|532564943|FG001|Overall Study|Lack of therapeutic effect|76|||
147656127|NCT01029262|532564942|FG000|Overall Study|Withdrawal by Subject|10|||
147656128|NCT01029262|532564943|FG001|Overall Study|Withdrawal by Subject|17|||
147656129|NCT01029262|532564942|FG000|Overall Study|Protocol Violation|2|||
147656130|NCT01029262|532564943|FG001|Overall Study|Protocol Violation|3|||
147656131|NCT01029262|532564942|FG000|Overall Study|Miscellaneous|1|||
147656132|NCT01029262|532564943|FG001|Overall Study|Miscellaneous|9|||
147656133|NCT01029262|532564942|FG000|Overall Study|Death|0|||
147656134|NCT01029262|532564943|FG001|Overall Study|Death|3|||
147656135|NCT02620787|532564946|FG000|Overall Study|Adverse Event|1|||
147656136|NCT02620787|532564947|FG001|Overall Study|Adverse Event|0|||
147656137|NCT02620787|532564946|FG000|Overall Study|Eligibility Criteria Not Met|1|||
147656138|NCT02620787|532564947|FG001|Overall Study|Eligibility Criteria Not Met|0|||
147656139|NCT01896193|532564948|FG000|Overall Study|Lack of Efficacy|20|||
147656140|NCT01896193|532564949|FG001|Overall Study|Lack of Efficacy|11|||
147656141|NCT01896193|532564948|FG000|Overall Study|Protocol Violation|0|||
147656142|NCT01896193|532564949|FG001|Overall Study|Protocol Violation|1|||
147178772|NCT02104947|530819872|FG000|Overall Study|Other than stated above|2|||
147178773|NCT02104947|530819873|FG001|Overall Study|Other than stated above|3|||
147178774|NCT01090063|530819874|FG000|Screen|Screen Failed|4|||
147178775|NCT01090063|530819874|FG000|Treatment|Withdrawal by Subject|4|||
147178776|NCT00206440|530819882|FG000|Overall Study|Protocol Violation|1|||
147178777|NCT00206440|530819883|FG001|Overall Study|Protocol Violation|2|||
147178778|NCT00206440|530819882|FG000|Overall Study|Adverse Event|4|||
147178779|NCT00206440|530819883|FG001|Overall Study|Adverse Event|2|||
147178780|NCT01371734|530819884|FG000|Overall Study|Other|2|||
147178781|NCT01371734|530819885|FG001|Overall Study|Other|1|||
147656143|NCT01896193|532564948|FG000|Overall Study|Withdrew Consent|1|||
147656144|NCT01896193|532564949|FG001|Overall Study|Withdrew Consent|0|||
147656145|NCT02959918|532564951|FG000|Overall Study|Adverse Event|1|||
147656146|NCT02959918|532564952|FG001|Overall Study|Adverse Event|1|||
147656147|NCT02959918|532564953|FG002|Overall Study|Adverse Event|2|||
147656148|NCT02959918|532564954|FG003|Overall Study|Adverse Event|0|||
147656149|NCT02959918|532564955|FG004|Overall Study|Adverse Event|0|||
147178782|NCT01371734|530819886|FG002|Overall Study|Other|2|||
147178783|NCT01371734|530819884|FG000|Overall Study|Withdrawal by Subject|3|||
147178784|NCT01371734|530819885|FG001|Overall Study|Withdrawal by Subject|4|||
147656150|NCT02959918|532564956|FG005|Overall Study|Adverse Event|2|||
147656151|NCT02959918|532564957|FG006|Overall Study|Adverse Event|2|||
147656152|NCT02959918|532564958|FG007|Overall Study|Adverse Event|1|||
147656153|NCT02959918|532564959|FG008|Overall Study|Adverse Event|2|||
147656154|NCT02959918|532564960|FG009|Overall Study|Adverse Event|1|||
147656155|NCT02959918|532564961|FG010|Overall Study|Adverse Event|1|||
147448321|NCT00708123|531805687|FG001|Period 2|Other Reason|0|||
147245072|NCT03708328|531070760|FG008|Overall Study|Study Ended By Sponsor|0|||
147245073|NCT03708328|531070761|FG009|Overall Study|Study Ended By Sponsor|0|||
147245074|NCT03708328|531070752|FG000|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
147245075|NCT03708328|531070753|FG001|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
147245076|NCT03708328|531070754|FG002|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
147245077|NCT03708328|531070755|FG003|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
147245078|NCT03708328|531070756|FG004|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
147245079|NCT03708328|531070757|FG005|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
147245080|NCT03708328|531070758|FG006|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
147245081|NCT03708328|531070759|FG007|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
147245082|NCT03708328|531070760|FG008|Overall Study|Participant Was Alive, Did Not Return to Hospital|1|||
147245083|NCT03708328|531070761|FG009|Overall Study|Participant Was Alive, Did Not Return to Hospital|0|||
147245084|NCT04523220|531070762|FG000|Main Treatment Period|Physician Decision|1|||
147245085|NCT04523220|531070763|FG001|Main Treatment Period|Physician Decision|1|||
147245086|NCT04523220|531070764|FG002|Main Treatment Period|Physician Decision|0|||
147245087|NCT04523220|531070762|FG000|Main Treatment Period|Other|5|||
147245088|NCT04523220|531070763|FG001|Main Treatment Period|Other|2|||
147245089|NCT04523220|531070764|FG002|Main Treatment Period|Other|4|||
147245090|NCT04523220|531070762|FG000|Main Treatment Period|Subject Decision|5|||
147245091|NCT04523220|531070763|FG001|Main Treatment Period|Subject Decision|7|||
147245092|NCT04523220|531070764|FG002|Main Treatment Period|Subject Decision|3|||
147245093|NCT04523220|531070762|FG000|Main Treatment Period|Death|5|||
147245094|NCT04523220|531070763|FG001|Main Treatment Period|Death|11|||
147245095|NCT04523220|531070764|FG002|Main Treatment Period|Death|4|||
147245096|NCT04523220|531070762|FG000|Main Treatment Period|Adverse Event|11|||
147245097|NCT04523220|531070763|FG001|Main Treatment Period|Adverse Event|9|||
147245098|NCT04523220|531070764|FG002|Main Treatment Period|Adverse Event|9|||
147245099|NCT04523220|531070762|FG000|Main Treatment Period|Withdrawal by Subject|3|||
147245100|NCT04523220|531070763|FG001|Main Treatment Period|Withdrawal by Subject|3|||
147245101|NCT04523220|531070764|FG002|Main Treatment Period|Withdrawal by Subject|4|||
147245102|NCT04523220|531070762|FG000|Main Treatment Period|Study drug never adminstered|10|||
147245103|NCT04523220|531070763|FG001|Main Treatment Period|Study drug never adminstered|3|||
147245104|NCT04523220|531070764|FG002|Main Treatment Period|Study drug never adminstered|5|||
147245105|NCT04523220|531070762|FG000|Extension Treatment Period|Physician Decision|1|||
147245106|NCT04523220|531070763|FG001|Extension Treatment Period|Physician Decision|0|||
147245107|NCT04523220|531070764|FG002|Extension Treatment Period|Physician Decision|3|||
147245108|NCT04523220|531070762|FG000|Extension Treatment Period|Other|2|||
147245109|NCT04523220|531070763|FG001|Extension Treatment Period|Other|6|||
147245110|NCT04523220|531070764|FG002|Extension Treatment Period|Other|6|||
147245111|NCT04523220|531070762|FG000|Extension Treatment Period|Subject Decision|5|||
147448322|NCT00708123|531805688|FG002|Period 2|Other Reason|0|||
147448323|NCT00708123|531805689|FG003|Period 2|Other Reason|0|||
147593157|NCT02631876|532328933|FG001|Overall Study|Investigator's discretion|0|||
147593158|NCT02631876|532328932|FG000|Overall Study|Lost to Follow-up|2|||
147593159|NCT02631876|532328933|FG001|Overall Study|Lost to Follow-up|0|||
147593160|NCT02631876|532328932|FG000|Overall Study|Withdrawal by Subject|16|||
147593161|NCT02631876|532328933|FG001|Overall Study|Withdrawal by Subject|9|||
147593162|NCT02631876|532328932|FG000|Overall Study|Other than specified|4|||
147593163|NCT02631876|532328933|FG001|Overall Study|Other than specified|4|||
147593164|NCT01013649|532328936|FG000|First Step|Withdrawal by Subject|36|||
147593165|NCT01013649|532328937|FG001|First Step|Withdrawal by Subject|19|||
147593166|NCT01013649|532328938|FG002|First Step|Withdrawal by Subject|0|||
147593167|NCT01013649|532328939|FG003|First Step|Withdrawal by Subject|0|||
147593168|NCT01013649|532328936|FG000|First Step|Progression|58|||
147593169|NCT01013649|532328937|FG001|First Step|Progression|23|||
147593170|NCT01013649|532328938|FG002|First Step|Progression|0|||
147593171|NCT01013649|532328939|FG003|First Step|Progression|0|||
147593172|NCT01013649|532328936|FG000|First Step|Did not start 5th cycle of first step treatment|15|||
147593173|NCT01013649|532328937|FG001|First Step|Did not start 5th cycle of first step treatment|10|||
147593174|NCT01013649|532328938|FG002|First Step|Did not start 5th cycle of first step treatment|0|||
147593175|NCT01013649|532328939|FG003|First Step|Did not start 5th cycle of first step treatment|0|||
147593176|NCT01013649|532328936|FG000|First Step|Death|3|||
147593177|NCT01013649|532328937|FG001|First Step|Death|4|||
147593178|NCT01013649|532328938|FG002|First Step|Death|0|||
147593179|NCT01013649|532328939|FG003|First Step|Death|0|||
147593180|NCT01013649|532328936|FG000|First Step|Adverse Event|9|||
147593181|NCT01013649|532328937|FG001|First Step|Adverse Event|5|||
147593182|NCT01013649|532328938|FG002|First Step|Adverse Event|0|||
147593183|NCT01013649|532328939|FG003|First Step|Adverse Event|0|||
147593184|NCT01013649|532328936|FG000|First Step|Other|4|||
147593185|NCT01013649|532328937|FG001|First Step|Other|6|||
147593186|NCT01013649|532328938|FG002|First Step|Other|0|||
147593187|NCT01013649|532328939|FG003|First Step|Other|0|||
147593188|NCT04285567|532328940|FG000|Overall Study|Death|3|||
147593189|NCT04285567|532328941|FG001|Overall Study|Death|3|||
147448324|NCT00708123|531805690|FG004|Period 2|Other Reason|0|||
147448325|NCT00708123|531805686|FG000|Period 3|Lost to Follow-up|0|||
147656156|NCT02959918|532564962|FG011|Overall Study|Adverse Event|3|||
147656157|NCT02959918|532564963|FG012|Overall Study|Adverse Event|2|||
147656158|NCT02959918|532564964|FG013|Overall Study|Adverse Event|4|||
147656159|NCT02959918|532564951|FG000|Overall Study|Lost to Follow-up|0|||
147656160|NCT02959918|532564952|FG001|Overall Study|Lost to Follow-up|0|||
147656161|NCT02959918|532564953|FG002|Overall Study|Lost to Follow-up|0|||
147656162|NCT02959918|532564954|FG003|Overall Study|Lost to Follow-up|0|||
147656163|NCT02959918|532564955|FG004|Overall Study|Lost to Follow-up|0|||
147656164|NCT02959918|532564956|FG005|Overall Study|Lost to Follow-up|0|||
147656165|NCT02959918|532564957|FG006|Overall Study|Lost to Follow-up|0|||
147656166|NCT02959918|532564958|FG007|Overall Study|Lost to Follow-up|0|||
147656167|NCT02959918|532564959|FG008|Overall Study|Lost to Follow-up|0|||
147178785|NCT01371734|530819886|FG002|Overall Study|Withdrawal by Subject|9|||
147178786|NCT01371734|530819884|FG000|Overall Study|Lost to Follow-up|5|||
147178787|NCT01371734|530819885|FG001|Overall Study|Lost to Follow-up|3|||
147178788|NCT01371734|530819886|FG002|Overall Study|Lost to Follow-up|1|||
147178789|NCT01371734|530819884|FG000|Overall Study|Protocol Violation|3|||
147178790|NCT01371734|530819885|FG001|Overall Study|Protocol Violation|1|||
147178791|NCT01371734|530819886|FG002|Overall Study|Protocol Violation|2|||
147178792|NCT01371734|530819884|FG000|Overall Study|Adverse Event|8|||
147178793|NCT01371734|530819885|FG001|Overall Study|Adverse Event|8|||
147178794|NCT01371734|530819886|FG002|Overall Study|Adverse Event|3|||
147178795|NCT01371734|530819884|FG000|Overall Study|Lack of Efficacy|2|||
147178796|NCT01371734|530819885|FG001|Overall Study|Lack of Efficacy|2|||
147178797|NCT01371734|530819886|FG002|Overall Study|Lack of Efficacy|0|||
147178798|NCT00958165|530819887|FG000|Overall Study|Lost to Follow-up|5|||
147178799|NCT00958165|530819887|FG000|Overall Study|Not eligible|9|||
147178800|NCT01298765|530819888|FG000|Titration Period|Adverse Event|26|||
147178801|NCT01298765|530819888|FG000|Titration Period|Death|1|||
147178802|NCT01298765|530819888|FG000|Titration Period|Lack of Efficacy|21|||
147178803|NCT01298765|530819888|FG000|Titration Period|Lost to Follow-up|9|||
147178804|NCT01298765|530819888|FG000|Titration Period|Physician Decision|1|||
147178805|NCT01298765|530819888|FG000|Titration Period|Withdrawal by Subject|10|||
147178806|NCT01298765|530819888|FG000|Titration Period|Other: Not Lack of Analgesic Effect|8|||
147178807|NCT01298765|530819888|FG000|Long-Term Treatment Period|Adverse Event|19|||
147178808|NCT01298765|530819888|FG000|Long-Term Treatment Period|Lack of Efficacy|6|||
147178809|NCT01298765|530819888|FG000|Long-Term Treatment Period|Lost to Follow-up|8|||
147178810|NCT01298765|530819888|FG000|Long-Term Treatment Period|Withdrawal by Subject|19|||
147178811|NCT01298765|530819888|FG000|Long-Term Treatment Period|Physician Decision|1|||
147178812|NCT01298765|530819888|FG000|Long-Term Treatment Period|Other: Not Lack of Analgesic Effect|46|||
147245112|NCT04523220|531070763|FG001|Extension Treatment Period|Subject Decision|2|||
147245113|NCT04523220|531070764|FG002|Extension Treatment Period|Subject Decision|4|||
147245114|NCT04523220|531070762|FG000|Extension Treatment Period|Death|6|||
147245115|NCT04523220|531070763|FG001|Extension Treatment Period|Death|4|||
147245116|NCT04523220|531070764|FG002|Extension Treatment Period|Death|7|||
147245117|NCT04523220|531070762|FG000|Extension Treatment Period|Adverse Event|6|||
147245118|NCT04523220|531070763|FG001|Extension Treatment Period|Adverse Event|7|||
147245119|NCT04523220|531070764|FG002|Extension Treatment Period|Adverse Event|9|||
147245120|NCT04523220|531070762|FG000|Extension Treatment Period|Withdrawal by Subject|0|||
147245121|NCT04523220|531070763|FG001|Extension Treatment Period|Withdrawal by Subject|1|||
147245122|NCT04523220|531070764|FG002|Extension Treatment Period|Withdrawal by Subject|1|||
147245123|NCT04523220|531070762|FG000|Extension Treatment Period|Study drug never administered|0|||
147245124|NCT04523220|531070763|FG001|Extension Treatment Period|Study drug never administered|1|||
147245125|NCT04523220|531070764|FG002|Extension Treatment Period|Study drug never administered|0|||
147245126|NCT00571948|531070765|FG000|Overall Study|Lost to Follow-up|2|||
147245127|NCT00571948|531070766|FG001|Overall Study|Lost to Follow-up|0|||
147245128|NCT00571948|531070765|FG000|Overall Study|Withdrawal by Subject|1|||
147245129|NCT00571948|531070766|FG001|Overall Study|Withdrawal by Subject|2|||
147656168|NCT02959918|532564960|FG009|Overall Study|Lost to Follow-up|1|||
147656169|NCT02959918|532564961|FG010|Overall Study|Lost to Follow-up|0|||
147656170|NCT02959918|532564962|FG011|Overall Study|Lost to Follow-up|0|||
147245130|NCT00571948|531070765|FG000|Overall Study|Protocol Violation|3|||
147448326|NCT00708123|531805687|FG001|Period 3|Lost to Follow-up|0|||
147656171|NCT02959918|532564963|FG012|Overall Study|Lost to Follow-up|1|||
147656172|NCT02959918|532564964|FG013|Overall Study|Lost to Follow-up|0|||
147656173|NCT02959918|532564951|FG000|Overall Study|Withdrawal by Subject|0|||
147178813|NCT03565237|530819892|FG000|Overall Study|Non-compliance of Investigational Product|1|||
147178814|NCT03565237|530819892|FG000|Overall Study|Physician Decision|1|||
147178815|NCT01140061|530819895|FG000|Part I|Adverse Event|1|||
147178816|NCT01140061|530819896|FG001|Part I|Adverse Event|0|||
147178817|NCT01140061|530819897|FG002|Part I|Adverse Event|0|||
147245131|NCT00571948|531070766|FG001|Overall Study|Protocol Violation|3|||
147245132|NCT00571948|531070765|FG000|Overall Study|infant refused study meal|3|||
147245133|NCT00571948|531070766|FG001|Overall Study|infant refused study meal|4|||
147448327|NCT00708123|531805688|FG002|Period 3|Lost to Follow-up|1|||
147656174|NCT02959918|532564952|FG001|Overall Study|Withdrawal by Subject|0|||
147324630|NCT00049517|531354316|FG000|Conditioning/Transplant|Other complicating disease|2|||
147324631|NCT00049517|531354317|FG001|Conditioning/Transplant|Other complicating disease|0|||
147324632|NCT00049517|531354318|FG002|Conditioning/Transplant|Other complicating disease|0|||
147324633|NCT00049517|531354319|FG003|Conditioning/Transplant|Other complicating disease|4|||
147324634|NCT00049517|531354320|FG004|Conditioning/Transplant|Other complicating disease|0|||
147324635|NCT00049517|531354321|FG005|Conditioning/Transplant|Other complicating disease|1|||
147324636|NCT00049517|531354316|FG000|Conditioning/Transplant|Reasons not reported|25|||
147324637|NCT00049517|531354317|FG001|Conditioning/Transplant|Reasons not reported|31|||
147324638|NCT00049517|531354318|FG002|Conditioning/Transplant|Reasons not reported|18|||
147324639|NCT00049517|531354319|FG003|Conditioning/Transplant|Reasons not reported|15|||
147324640|NCT00049517|531354320|FG004|Conditioning/Transplant|Reasons not reported|5|||
147324641|NCT00049517|531354321|FG005|Conditioning/Transplant|Reasons not reported|5|||
147324642|NCT01419717|531354322|FG000|Overall Study|Protocol-specified Criteria|62|||
147324643|NCT01419717|531354322|FG000|Overall Study|Adverse Event|19|||
147324644|NCT01419717|531354322|FG000|Overall Study|Death|17|||
147178818|NCT01140061|530819898|FG003|Part I|Adverse Event|0|||
147178819|NCT01140061|530819899|FG004|Part I|Adverse Event|0|||
147178820|NCT01140061|530819900|FG005|Part I|Adverse Event|0|||
147178821|NCT01140061|530819901|FG006|Part I|Adverse Event|0|||
147178822|NCT01140061|530819902|FG007|Part I|Adverse Event|0|||
147178823|NCT01140061|530819903|FG008|Part I|Adverse Event|0|||
147178824|NCT01140061|530819904|FG009|Part I|Adverse Event|0|||
147178825|NCT01140061|530819895|FG000|Extension|Laboratory Adverse Event|0|||
147178826|NCT01140061|530819896|FG001|Extension|Laboratory Adverse Event|0|||
147178827|NCT01140061|530819897|FG002|Extension|Laboratory Adverse Event|0|||
147178828|NCT01140061|530819898|FG003|Extension|Laboratory Adverse Event|0|||
147178829|NCT01140061|530819899|FG004|Extension|Laboratory Adverse Event|0|||
147178830|NCT01140061|530819900|FG005|Extension|Laboratory Adverse Event|0|||
147178831|NCT01140061|530819901|FG006|Extension|Laboratory Adverse Event|0|||
147178832|NCT01140061|530819902|FG007|Extension|Laboratory Adverse Event|0|||
147178833|NCT01140061|530819903|FG008|Extension|Laboratory Adverse Event|0|||
147178834|NCT01140061|530819904|FG009|Extension|Laboratory Adverse Event|1|||
147178835|NCT00428389|530819906|FG000|Core Phase|Adverse Event|6|||
147178836|NCT00428389|530819907|FG001|Core Phase|Adverse Event|4|||
147178837|NCT00428389|530819906|FG000|Core Phase|Lack of Efficacy|2|||
147178838|NCT00428389|530819907|FG001|Core Phase|Lack of Efficacy|0|||
147178839|NCT00428389|530819906|FG000|Core Phase|Abnormal test procedure result(s)|0|||
147178840|NCT00428389|530819907|FG001|Core Phase|Abnormal test procedure result(s)|1|||
147324645|NCT01419717|531354322|FG000|Overall Study|Withdrawal by Subject|10|||
147324646|NCT01419717|531354322|FG000|Overall Study|Disease Progression|9|||
147324647|NCT01419717|531354322|FG000|Overall Study|Other|4|||
147324648|NCT01419717|531354322|FG000|Overall Study|Lost to Follow-up|2|||
147324649|NCT01419717|531354322|FG000|Overall Study|Administrative Decision|1|||
147324650|NCT01419717|531354322|FG000|Overall Study|Noncompliance|1|||
147324651|NCT02857283|531354323|FG000|First Exposure|Withdrawal by Subject|1|||
147324652|NCT02857283|531354324|FG001|First Exposure|Withdrawal by Subject|0|||
147324653|NCT00093795|531354325|FG000|Overall Study|No follow up data|20|||
147324654|NCT00093795|531354326|FG001|Overall Study|No follow up data|16|||
147324655|NCT00093795|531354327|FG002|Overall Study|No follow up data|17|||
147324656|NCT00613301|531354328|FG000|Overall Study|Adverse Event|49|||
147324657|NCT00613301|531354328|FG000|Overall Study|Lost to Follow-up|88|||
147324658|NCT00613301|531354328|FG000|Overall Study|Withdrawal by Subject|5|||
147324659|NCT00613301|531354328|FG000|Overall Study|Death|6|||
147324660|NCT00613301|531354328|FG000|Overall Study|Lack of Efficacy|13|||
147324661|NCT00613301|531354328|FG000|Overall Study|Physician Decision|2|||
147324662|NCT00613301|531354328|FG000|Overall Study|No data was collected|53|||
147324663|NCT00613301|531354328|FG000|Overall Study|Irregularly enrolled patients|12|||
147324664|NCT02790606|531354334|FG000|Overall Study|Death|27|||
147324665|NCT02790606|531354334|FG000|Overall Study|Lost to Follow-up|4|||
147324666|NCT02790606|531354334|FG000|Overall Study|Physician Decision|3|||
147324667|NCT02790606|531354334|FG000|Overall Study|Withdrawal by Subject|1|||
147324668|NCT02735915|531354335|FG000|Overall Study|Not vaccinated but subject ID assigned|8|||
147324669|NCT02735915|531354335|FG000|Overall Study|Withdrawal following SAE|2|||
147324670|NCT02735915|531354335|FG000|Overall Study|Withdrawal by Subject|1|||
147178841|NCT00428389|530819906|FG000|Core Phase|Withdrawal by Subject|3|||
147178842|NCT00428389|530819907|FG001|Core Phase|Withdrawal by Subject|4|||
147178843|NCT00428389|530819906|FG000|Core Phase|Protocol deviation|0|||
147178844|NCT00428389|530819907|FG001|Core Phase|Protocol deviation|2|||
147324671|NCT00946114|531354336|FG000|Overall Study|Death|5|||
147324672|NCT00946114|531354337|FG001|Overall Study|Death|2|||
147324673|NCT00946114|531354336|FG000|Overall Study|Other|1|||
147324674|NCT00946114|531354337|FG001|Overall Study|Other|0|||
147324675|NCT00946114|531354336|FG000|Overall Study|Withdrawal by Subject|2|||
147178845|NCT00428389|530819906|FG000|Extension Phase|Adverse Event|17|||
147178846|NCT00428389|530819907|FG001|Extension Phase|Adverse Event|11|||
147178847|NCT00428389|530819906|FG000|Extension Phase|Lack of Efficacy|4|||
147324676|NCT00946114|531354337|FG001|Overall Study|Withdrawal by Subject|0|||
147178848|NCT00428389|530819907|FG001|Extension Phase|Lack of Efficacy|3|||
147656175|NCT02959918|532564953|FG002|Overall Study|Withdrawal by Subject|1|||
147178849|NCT00428389|530819906|FG000|Extension Phase|Withdrawal by Subject|6|||
147178850|NCT00428389|530819907|FG001|Extension Phase|Withdrawal by Subject|6|||
147178851|NCT00428389|530819906|FG000|Extension Phase|Lost to Follow-up|0|||
147178852|NCT00428389|530819907|FG001|Extension Phase|Lost to Follow-up|3|||
147178853|NCT00428389|530819906|FG000|Extension Phase|Death|1|||
147178854|NCT00428389|530819907|FG001|Extension Phase|Death|0|||
147178855|NCT00428389|530819906|FG000|Extension Phase|Protocol Violation|3|||
147178856|NCT00428389|530819907|FG001|Extension Phase|Protocol Violation|2|||
147178857|NCT00428389|530819906|FG000|Extension Phase|Administrative problems|1|||
147178858|NCT00428389|530819907|FG001|Extension Phase|Administrative problems|1|||
147178859|NCT00766051|530819908|FG000|Overall Study|Withdrawal by Subject|2|||
147178860|NCT00766051|530819909|FG001|Overall Study|Withdrawal by Subject|0|||
147178861|NCT03216746|530819910|FG000|Overall Study|Lost to Follow-up|6|||
147178862|NCT03216746|530819911|FG001|Overall Study|Lost to Follow-up|8|||
147178863|NCT03216746|530819912|FG002|Overall Study|Lost to Follow-up|5|||
147178864|NCT03216746|530819913|FG003|Overall Study|Lost to Follow-up|6|||
147178865|NCT04384523|530819914|FG000|Overall Study|Lost to Follow-up|0|||
147178866|NCT04384523|530819915|FG001|Overall Study|Lost to Follow-up|0|||
147178867|NCT04384523|530819916|FG002|Overall Study|Lost to Follow-up|0|||
147178868|NCT04384523|530819917|FG003|Overall Study|Lost to Follow-up|0|||
147178869|NCT04384523|530819918|FG004|Overall Study|Lost to Follow-up|0|||
147178870|NCT04384523|530819919|FG005|Overall Study|Lost to Follow-up|1|||
147178871|NCT04384523|530819914|FG000|Overall Study|Protocol Violation|0|||
147178872|NCT04384523|530819915|FG001|Overall Study|Protocol Violation|1|||
147178873|NCT04384523|530819916|FG002|Overall Study|Protocol Violation|0|||
147178874|NCT04384523|530819917|FG003|Overall Study|Protocol Violation|0|||
147178875|NCT04384523|530819918|FG004|Overall Study|Protocol Violation|0|||
147178876|NCT04384523|530819919|FG005|Overall Study|Protocol Violation|0|||
147178877|NCT04384523|530819914|FG000|Overall Study|Withdrawal by Subject|1|||
147178878|NCT04384523|530819915|FG001|Overall Study|Withdrawal by Subject|0|||
147178879|NCT04384523|530819916|FG002|Overall Study|Withdrawal by Subject|0|||
147178880|NCT04384523|530819917|FG003|Overall Study|Withdrawal by Subject|0|||
147178881|NCT04384523|530819918|FG004|Overall Study|Withdrawal by Subject|0|||
147178882|NCT04384523|530819919|FG005|Overall Study|Withdrawal by Subject|0|||
147178883|NCT00635882|530819920|FG000|Overall Study|Protocol Violation|1|||
147178884|NCT00635882|530819921|FG001|Overall Study|Protocol Violation|0|||
147178885|NCT00635882|530819922|FG002|Overall Study|Protocol Violation|0|||
147178886|NCT00635882|530819923|FG003|Overall Study|Protocol Violation|0|||
147178887|NCT00635882|530819924|FG004|Overall Study|Protocol Violation|0|||
147178888|NCT00635882|530819925|FG005|Overall Study|Protocol Violation|0|||
147245134|NCT00571948|531070765|FG000|Overall Study|Parent were afraid of blood colection|2|||
147245135|NCT00571948|531070766|FG001|Overall Study|Parent were afraid of blood colection|5|||
147245136|NCT02030041|531070768|FG000|Overall Study|Withdrawal by Subject|2|||
147245137|NCT02030041|531070769|FG001|Overall Study|Withdrawal by Subject|2|||
147245138|NCT02030041|531070770|FG002|Overall Study|Withdrawal by Subject|1|||
147245139|NCT01032837|531070771|FG000|Overall Study|Adverse event/internal illness|0|||
147245140|NCT01032837|531070772|FG001|Overall Study|Adverse event/internal illness|1|||
147245141|NCT01032837|531070773|FG002|Overall Study|Adverse event/internal illness|0|||
147245142|NCT01032837|531070774|FG003|Overall Study|Adverse event/internal illness|1|||
147245143|NCT01032837|531070771|FG000|Overall Study|Withdrew consent|0|||
147245144|NCT01032837|531070772|FG001|Overall Study|Withdrew consent|2|||
147245145|NCT01032837|531070773|FG002|Overall Study|Withdrew consent|0|||
147245146|NCT01032837|531070774|FG003|Overall Study|Withdrew consent|1|||
147245147|NCT01032837|531070771|FG000|Overall Study|Failed to return|0|||
147245148|NCT01032837|531070772|FG001|Overall Study|Failed to return|0|||
147245149|NCT01032837|531070773|FG002|Overall Study|Failed to return|1|||
147245150|NCT01032837|531070774|FG003|Overall Study|Failed to return|0|||
147245151|NCT01032837|531070771|FG000|Overall Study|Refused treatment|0|||
147245152|NCT01032837|531070772|FG001|Overall Study|Refused treatment|0|||
147245153|NCT01032837|531070773|FG002|Overall Study|Refused treatment|0|||
147245154|NCT01032837|531070774|FG003|Overall Study|Refused treatment|1|||
147324677|NCT00723294|531354338|FG000|Overall Study|Lobular histology|2|||
147178889|NCT02305238|530819926|FG000|Overall Study|Death|2|||
147178890|NCT02305238|530819927|FG001|Overall Study|Death|1|||
147178891|NCT02305238|530819928|FG002|Overall Study|Death|0|||
147178892|NCT02305238|530819926|FG000|Overall Study|Progressive disease|4|||
147178893|NCT02305238|530819927|FG001|Overall Study|Progressive disease|4|||
147178894|NCT02305238|530819928|FG002|Overall Study|Progressive disease|0|||
147178895|NCT02305238|530819926|FG000|Overall Study|Logistical difficulties|1|||
147178896|NCT02305238|530819927|FG001|Overall Study|Logistical difficulties|3|||
147178897|NCT02305238|530819928|FG002|Overall Study|Logistical difficulties|0|||
147245155|NCT00843024|531070775|FG000|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|79|||
147245156|NCT00843024|531070776|FG001|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|74|||
147245157|NCT00843024|531070777|FG002|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0|||
147245158|NCT00843024|531070778|FG003|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0|||
147245159|NCT00843024|531070779|FG004|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0|||
147178898|NCT02305238|530819926|FG000|Overall Study|Protocol Violation|0|||
147178899|NCT02305238|530819927|FG001|Overall Study|Protocol Violation|3|||
147178900|NCT02305238|530819928|FG002|Overall Study|Protocol Violation|0|||
147178901|NCT02305238|530819926|FG000|Overall Study|Physician Decision|2|||
147178902|NCT02305238|530819927|FG001|Overall Study|Physician Decision|1|||
147178903|NCT02305238|530819928|FG002|Overall Study|Physician Decision|0|||
147178904|NCT02305238|530819926|FG000|Overall Study|Adverse Event|4|||
147178905|NCT02305238|530819927|FG001|Overall Study|Adverse Event|2|||
147178906|NCT02305238|530819928|FG002|Overall Study|Adverse Event|0|||
147178907|NCT02305238|530819926|FG000|Overall Study|Withdrawal by Subject|3|||
147178908|NCT02305238|530819927|FG001|Overall Study|Withdrawal by Subject|4|||
147178909|NCT02305238|530819928|FG002|Overall Study|Withdrawal by Subject|0|||
147178910|NCT02305238|530819926|FG000|Overall Study|Randomized failure|0|||
147178911|NCT02305238|530819927|FG001|Overall Study|Randomized failure|0|||
147178912|NCT02305238|530819928|FG002|Overall Study|Randomized failure|8|||
147178913|NCT02305238|530819926|FG000|Overall Study|Required procedure failed|0|||
147178914|NCT02305238|530819927|FG001|Overall Study|Required procedure failed|1|||
147178915|NCT02305238|530819928|FG002|Overall Study|Required procedure failed|0|||
147178916|NCT01711645|530819929|FG000|Overall Study|Withdrawal by Subject|8|||
147178917|NCT01711645|530819929|FG000|Overall Study|Lost to Follow-up|6|||
147178918|NCT01711645|530819929|FG000|Overall Study|Physician Decision|5|||
147178919|NCT00408434|530819930|FG000|Overall Study|Adverse Event|0|||
147178920|NCT00408434|530819931|FG001|Overall Study|Adverse Event|0|||
147178921|NCT00408434|530819932|FG002|Overall Study|Adverse Event|1|||
147178922|NCT00408434|530819933|FG003|Overall Study|Adverse Event|0|||
147178923|NCT00408434|530819934|FG004|Overall Study|Adverse Event|0|||
147178924|NCT00408434|530819935|FG005|Overall Study|Adverse Event|0|||
147178925|NCT00408434|530819936|FG006|Overall Study|Adverse Event|0|||
147178926|NCT00408434|530819930|FG000|Overall Study|Progressive disease|6|||
147178927|NCT00408434|530819931|FG001|Overall Study|Progressive disease|3|||
147178928|NCT00408434|530819932|FG002|Overall Study|Progressive disease|4|||
147178929|NCT00408434|530819933|FG003|Overall Study|Progressive disease|3|||
147178930|NCT00408434|530819934|FG004|Overall Study|Progressive disease|3|||
147178931|NCT00408434|530819935|FG005|Overall Study|Progressive disease|1|||
147178932|NCT00408434|530819936|FG006|Overall Study|Progressive disease|4|||
147178933|NCT00408434|530819930|FG000|Overall Study|Other|0|||
147178934|NCT00408434|530819931|FG001|Overall Study|Other|0|||
147178935|NCT00408434|530819932|FG002|Overall Study|Other|1|||
147178936|NCT00408434|530819933|FG003|Overall Study|Other|0|||
147178937|NCT00408434|530819934|FG004|Overall Study|Other|2|||
147178938|NCT00408434|530819935|FG005|Overall Study|Other|1|||
147178939|NCT00408434|530819936|FG006|Overall Study|Other|0|||
147178940|NCT00408434|530819930|FG000|Overall Study|Terminated by Investigator|0|||
147178941|NCT00408434|530819931|FG001|Overall Study|Terminated by Investigator|0|||
147178942|NCT00408434|530819932|FG002|Overall Study|Terminated by Investigator|0|||
147178943|NCT00408434|530819933|FG003|Overall Study|Terminated by Investigator|0|||
147178944|NCT00408434|530819934|FG004|Overall Study|Terminated by Investigator|1|||
147178945|NCT00408434|530819935|FG005|Overall Study|Terminated by Investigator|1|||
147178946|NCT00408434|530819936|FG006|Overall Study|Terminated by Investigator|0|||
147178947|NCT00588354|530819937|FG000|Baseline to 2 Weeks|Adverse Event|1|||
147178948|NCT00588354|530819938|FG001|Baseline to 2 Weeks|Adverse Event|0|||
147178949|NCT00588354|530819937|FG000|Baseline to 2 Weeks|Lack of Efficacy|1|||
147178950|NCT00588354|530819938|FG001|Baseline to 2 Weeks|Lack of Efficacy|0|||
147178951|NCT00588354|530819937|FG000|Baseline to 4 Weeks|Lost to Follow-up|0|||
147178952|NCT00588354|530819938|FG001|Baseline to 4 Weeks|Lost to Follow-up|1|||
147178953|NCT04230213|530819939|FG000|TP1: Week 0 (Day 1) to Week 10|Other|8|||
147178954|NCT04230213|530819940|FG001|TP1: Week 0 (Day 1) to Week 10|Other|0|||
147178955|NCT04230213|530819941|FG002|TP1: Week 0 (Day 1) to Week 10|Other|0|||
147178956|NCT04230213|530819939|FG000|TP1: Week 0 (Day 1) to Week 10|Withdrawal by Subject|7|||
147178957|NCT04230213|530819940|FG001|TP1: Week 0 (Day 1) to Week 10|Withdrawal by Subject|0|||
147178958|NCT04230213|530819941|FG002|TP1: Week 0 (Day 1) to Week 10|Withdrawal by Subject|0|||
147178959|NCT04230213|530819939|FG000|TP1: Week 0 (Day 1) to Week 10|Physician Decision|3|||
147178960|NCT04230213|530819940|FG001|TP1: Week 0 (Day 1) to Week 10|Physician Decision|0|||
147178961|NCT04230213|530819941|FG002|TP1: Week 0 (Day 1) to Week 10|Physician Decision|0|||
147178962|NCT04230213|530819939|FG000|TP2: Week 10 to Week 16|Other|0|||
147178963|NCT04230213|530819940|FG001|TP2: Week 10 to Week 16|Other|2|||
147178964|NCT04230213|530819941|FG002|TP2: Week 10 to Week 16|Other|1|||
147178965|NCT04230213|530819939|FG000|TP2: Week 10 to Week 16|Withdrawal by Subject|0|||
147178966|NCT04230213|530819940|FG001|TP2: Week 10 to Week 16|Withdrawal by Subject|0|||
147178967|NCT04230213|530819941|FG002|TP2: Week 10 to Week 16|Withdrawal by Subject|2|||
147178968|NCT04230213|530819939|FG000|TP3: Week 16 to Week 22|Lost to Follow-up|0|||
147178969|NCT04230213|530819940|FG001|TP3: Week 16 to Week 22|Lost to Follow-up|0|||
147178970|NCT04230213|530819941|FG002|TP3: Week 16 to Week 22|Lost to Follow-up|1|||
147178971|NCT04230213|530819939|FG000|TP3: Week 16 to Week 22|Withdrawal by Subject|0|||
147178972|NCT04230213|530819940|FG001|TP3: Week 16 to Week 22|Withdrawal by Subject|0|||
147178973|NCT04230213|530819941|FG002|TP3: Week 16 to Week 22|Withdrawal by Subject|2|||
147178974|NCT04230213|530819939|FG000|TP3: Week 16 to Week 22|Physician Decision|0|||
147448328|NCT00708123|531805689|FG003|Period 3|Lost to Follow-up|1|||
147324678|NCT00723294|531354338|FG000|Overall Study|>25% intraductal component|1|||
147324679|NCT00723294|531354338|FG000|Overall Study|No MRI tumor enhancement|1|||
147324680|NCT00723294|531354338|FG000|Overall Study|1.0-Tesla MRI|1|||
147324681|NCT00723294|531354338|FG000|Overall Study|No cryoabalation|2|||
147324682|NCT00723294|531354338|FG000|Overall Study|Did not undergo surgery|1|||
147324683|NCT00723294|531354338|FG000|Overall Study|Treated prior to registration|1|||
147324684|NCT00723294|531354338|FG000|Overall Study|Treated by non-credentialed surgeon|1|||
147324685|NCT00723294|531354338|FG000|Overall Study|Benign lesion|1|||
147324686|NCT00723294|531354338|FG000|Overall Study|Withdrawal by Subject|1|||
147324687|NCT00723294|531354338|FG000|Overall Study|No treatment due to probe failure|1|||
147324688|NCT01211665|531354339|FG000|Overall Study|Withdrawal by Subject|1|||
147324689|NCT01211665|531354340|FG001|Overall Study|Withdrawal by Subject|0|||
147324690|NCT01211665|531354339|FG000|Overall Study|Death|1|||
147324691|NCT01211665|531354340|FG001|Overall Study|Death|0|||
147324692|NCT02333630|531354341|FG000|Overall Study|Lost to Follow-up|5|||
147324693|NCT02333630|531354342|FG001|Overall Study|Lost to Follow-up|2|||
147324694|NCT05349864|531354343|FG000|Period 2 (5 Days)|Withdrawal by Subject|1|||
147324695|NCT05349864|531354344|FG001|Period 2 (5 Days)|Withdrawal by Subject|1|||
147324696|NCT00984282|531354345|FG000|Double Blind Treatment|Adverse Event|40|||
147324697|NCT00984282|531354346|FG001|Double Blind Treatment|Adverse Event|6|||
147324698|NCT00984282|531354345|FG000|Double Blind Treatment|Progression, recurrence or relapse|25|||
147593190|NCT04285567|532328940|FG000|Overall Study|Lost to Follow-up|1|||
147593191|NCT04285567|532328941|FG001|Overall Study|Lost to Follow-up|1|||
147593192|NCT04285567|532328940|FG000|Overall Study|Reason Not Specified|1|||
147593193|NCT04285567|532328941|FG001|Overall Study|Reason Not Specified|1|||
147593194|NCT04285567|532328940|FG000|Overall Study|Physician Decision|2|||
147593195|NCT04285567|532328941|FG001|Overall Study|Physician Decision|1|||
147178975|NCT04230213|530819940|FG001|TP3: Week 16 to Week 22|Physician Decision|0|||
147593196|NCT04285567|532328940|FG000|Overall Study|Withdrawal by Subject|2|||
147178976|NCT04230213|530819941|FG002|TP3: Week 16 to Week 22|Physician Decision|1|||
147178977|NCT04230213|530819939|FG000|TP3: Week 16 to Week 22|Other|0|||
147178978|NCT04230213|530819940|FG001|TP3: Week 16 to Week 22|Other|1|||
147178979|NCT04230213|530819941|FG002|TP3: Week 16 to Week 22|Other|3|||
147178980|NCT04230213|530819939|FG000|TP4: Week 22 to Week 32|Other|0|||
147178981|NCT04230213|530819940|FG001|TP4: Week 22 to Week 32|Other|5|||
147178982|NCT04230213|530819941|FG002|TP4: Week 22 to Week 32|Other|5|||
147178983|NCT04230213|530819939|FG000|TP4: Week 22 to Week 32|Withdrawal by Subject|0|||
147178984|NCT04230213|530819940|FG001|TP4: Week 22 to Week 32|Withdrawal by Subject|1|||
147178985|NCT04230213|530819941|FG002|TP4: Week 22 to Week 32|Withdrawal by Subject|2|||
147178986|NCT04230213|530819939|FG000|TP4: Week 22 to Week 32|Physician Decision|0|||
147178987|NCT04230213|530819940|FG001|TP4: Week 22 to Week 32|Physician Decision|2|||
147178988|NCT04230213|530819941|FG002|TP4: Week 22 to Week 32|Physician Decision|1|||
147324699|NCT00984282|531354346|FG001|Double Blind Treatment|Progression, recurrence or relapse|3|||
147324700|NCT00984282|531354345|FG000|Double Blind Treatment|Physician Decision|1|||
147593197|NCT04285567|532328941|FG001|Overall Study|Withdrawal by Subject|6|||
147593198|NCT04285567|532328940|FG000|Overall Study|Adverse Event|1|||
147593199|NCT04285567|532328941|FG001|Overall Study|Adverse Event|0|||
147593200|NCT04285567|532328940|FG000|Overall Study|Participants Ongoing in Follow-up|70|||
147593201|NCT04285567|532328941|FG001|Overall Study|Participants Ongoing in Follow-up|74|||
147593202|NCT02091141|532328942|FG000|Overall Study|Death|280|||
147593203|NCT02091141|532328943|FG001|Overall Study|Death|118|||
147593204|NCT02091141|532328944|FG002|Overall Study|Death|46|||
147593205|NCT02091141|532328945|FG003|Overall Study|Death|13|||
147593206|NCT02091141|532328946|FG004|Overall Study|Death|31|||
147593207|NCT02091141|532328947|FG005|Overall Study|Death|16|||
147593208|NCT02091141|532328948|FG006|Overall Study|Death|12|||
147593209|NCT02091141|532328942|FG000|Overall Study|Withdrawal by Subject|21|||
147593210|NCT02091141|532328943|FG001|Overall Study|Withdrawal by Subject|13|||
147593211|NCT02091141|532328944|FG002|Overall Study|Withdrawal by Subject|3|||
147593212|NCT02091141|532328945|FG003|Overall Study|Withdrawal by Subject|2|||
147593213|NCT02091141|532328946|FG004|Overall Study|Withdrawal by Subject|2|||
147593214|NCT02091141|532328947|FG005|Overall Study|Withdrawal by Subject|3|||
147593215|NCT02091141|532328948|FG006|Overall Study|Withdrawal by Subject|0|||
147593216|NCT02091141|532328942|FG000|Overall Study|Lost to Follow-up|21|||
147593217|NCT02091141|532328943|FG001|Overall Study|Lost to Follow-up|5|||
147593218|NCT02091141|532328944|FG002|Overall Study|Lost to Follow-up|1|||
147593219|NCT02091141|532328945|FG003|Overall Study|Lost to Follow-up|0|||
147593220|NCT02091141|532328946|FG004|Overall Study|Lost to Follow-up|1|||
147593221|NCT02091141|532328947|FG005|Overall Study|Lost to Follow-up|2|||
147324701|NCT00984282|531354346|FG001|Double Blind Treatment|Physician Decision|2|||
147324702|NCT00984282|531354345|FG000|Double Blind Treatment|Noncompliance with study medication|3|||
147593222|NCT02091141|532328948|FG006|Overall Study|Lost to Follow-up|0|||
147593223|NCT02091141|532328942|FG000|Overall Study|Reason Not Specified|6|||
147593224|NCT02091141|532328943|FG001|Overall Study|Reason Not Specified|5|||
147593225|NCT02091141|532328944|FG002|Overall Study|Reason Not Specified|2|||
147656176|NCT02959918|532564954|FG003|Overall Study|Withdrawal by Subject|2|||
147593226|NCT02091141|532328945|FG003|Overall Study|Reason Not Specified|0|||
147448329|NCT00708123|531805690|FG004|Period 3|Lost to Follow-up|0|||
147448330|NCT00708123|531805686|FG000|Period 4|Protocol Violation|0|||
147448331|NCT00708123|531805687|FG001|Period 4|Protocol Violation|1|||
147448332|NCT00708123|531805688|FG002|Period 4|Protocol Violation|0|||
147448333|NCT00708123|531805689|FG003|Period 4|Protocol Violation|0|||
147448334|NCT00708123|531805690|FG004|Period 4|Protocol Violation|0|||
147448335|NCT00401375|531805693|FG000|Overall Study|Protocol Violation|2|||
147448336|NCT00401375|531805694|FG001|Overall Study|Protocol Violation|2|||
147448337|NCT00401375|531805695|FG002|Overall Study|Protocol Violation|1|||
147448338|NCT00401375|531805693|FG000|Overall Study|Adverse Event|6|||
147178989|NCT04230213|530819939|FG000|Follow up: Week 32 to Week 36|Withdrawal by Subject|0|||
147178990|NCT04230213|530819940|FG001|Follow up: Week 32 to Week 36|Withdrawal by Subject|0|||
147178991|NCT04230213|530819941|FG002|Follow up: Week 32 to Week 36|Withdrawal by Subject|1|||
147178992|NCT04230213|530819939|FG000|Follow up: Week 32 to Week 36|Other|0|||
147178993|NCT04230213|530819940|FG001|Follow up: Week 32 to Week 36|Other|1|||
147178994|NCT04230213|530819941|FG002|Follow up: Week 32 to Week 36|Other|1|||
147178995|NCT03058692|530821520|FG000|Overall Study|Lost to Follow-up|2|||
147178996|NCT03058692|530821521|FG001|Overall Study|Lost to Follow-up|1|||
147178997|NCT03058692|530821520|FG000|Overall Study|Withdrawal by Subject|1|||
147178998|NCT03058692|530821521|FG001|Overall Study|Withdrawal by Subject|1|||
147178999|NCT00806988|530821522|FG000|Overall Study|Death|15|||
147179000|NCT00806988|530821523|FG001|Overall Study|Death|16|||
147179001|NCT00806988|530821522|FG000|Overall Study|Withdrawal by Subject|8|||
147179002|NCT00806988|530821523|FG001|Overall Study|Withdrawal by Subject|8|||
147179003|NCT00806988|530821522|FG000|Overall Study|Lost to Follow-up|4|||
147179004|NCT00806988|530821523|FG001|Overall Study|Lost to Follow-up|19|||
147179005|NCT04775953|530821525|FG000|Overall Study|Lost to Follow-up|6|||
147179006|NCT04775953|530821526|FG001|Overall Study|Lost to Follow-up|11|||
147179007|NCT04775953|530821525|FG000|Overall Study|Death|5|||
147179008|NCT04775953|530821526|FG001|Overall Study|Death|4|||
147245160|NCT00843024|531070780|FG005|Single-blind Placebo Run-In Phase|Did not meet continuation criteria|0|||
147245161|NCT00843024|531070775|FG000|Single-blind Placebo Run-In Phase|Lost to Follow-up|36|||
147245162|NCT00843024|531070776|FG001|Single-blind Placebo Run-In Phase|Lost to Follow-up|31|||
147245163|NCT00843024|531070777|FG002|Single-blind Placebo Run-In Phase|Lost to Follow-up|0|||
147245164|NCT00843024|531070778|FG003|Single-blind Placebo Run-In Phase|Lost to Follow-up|0|||
147245165|NCT00843024|531070779|FG004|Single-blind Placebo Run-In Phase|Lost to Follow-up|0|||
147245166|NCT00843024|531070780|FG005|Single-blind Placebo Run-In Phase|Lost to Follow-up|0|||
147245167|NCT00843024|531070775|FG000|Single-blind Placebo Run-In Phase|Withdrawal by Subject|19|||
147245168|NCT00843024|531070776|FG001|Single-blind Placebo Run-In Phase|Withdrawal by Subject|18|||
147245169|NCT00843024|531070777|FG002|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0|||
147245170|NCT00843024|531070778|FG003|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0|||
147245171|NCT00843024|531070779|FG004|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0|||
147245172|NCT00843024|531070780|FG005|Single-blind Placebo Run-In Phase|Withdrawal by Subject|0|||
147245173|NCT00843024|531070775|FG000|Single-blind Placebo Run-In Phase|Protocol Violation|4|||
147245174|NCT00843024|531070776|FG001|Single-blind Placebo Run-In Phase|Protocol Violation|5|||
147245175|NCT00843024|531070777|FG002|Single-blind Placebo Run-In Phase|Protocol Violation|0|||
147245176|NCT00843024|531070778|FG003|Single-blind Placebo Run-In Phase|Protocol Violation|0|||
147245177|NCT00843024|531070779|FG004|Single-blind Placebo Run-In Phase|Protocol Violation|0|||
147245178|NCT00843024|531070780|FG005|Single-blind Placebo Run-In Phase|Protocol Violation|0|||
147245179|NCT00843024|531070775|FG000|Single-blind Placebo Run-In Phase|Physician Decision|2|||
147245180|NCT00843024|531070776|FG001|Single-blind Placebo Run-In Phase|Physician Decision|6|||
147245181|NCT00843024|531070777|FG002|Single-blind Placebo Run-In Phase|Physician Decision|0|||
147245182|NCT00843024|531070778|FG003|Single-blind Placebo Run-In Phase|Physician Decision|0|||
147245183|NCT00843024|531070779|FG004|Single-blind Placebo Run-In Phase|Physician Decision|0|||
147245184|NCT00843024|531070780|FG005|Single-blind Placebo Run-In Phase|Physician Decision|0|||
147245185|NCT00843024|531070775|FG000|Single-blind Placebo Run-In Phase|Adverse Event|0|||
147245186|NCT00843024|531070776|FG001|Single-blind Placebo Run-In Phase|Adverse Event|1|||
147245187|NCT00843024|531070777|FG002|Single-blind Placebo Run-In Phase|Adverse Event|0|||
147245188|NCT00843024|531070778|FG003|Single-blind Placebo Run-In Phase|Adverse Event|0|||
147245189|NCT00843024|531070779|FG004|Single-blind Placebo Run-In Phase|Adverse Event|0|||
147245190|NCT00843024|531070780|FG005|Single-blind Placebo Run-In Phase|Adverse Event|0|||
147245191|NCT00843024|531070775|FG000|Single-blind Placebo Run-In Phase|Other|0|||
147245192|NCT00843024|531070776|FG001|Single-blind Placebo Run-In Phase|Other|1|||
147245193|NCT00843024|531070777|FG002|Single-blind Placebo Run-In Phase|Other|0|||
147245194|NCT00843024|531070778|FG003|Single-blind Placebo Run-In Phase|Other|0|||
147245195|NCT00843024|531070779|FG004|Single-blind Placebo Run-In Phase|Other|0|||
147448339|NCT00401375|531805694|FG001|Overall Study|Adverse Event|11|||
147448340|NCT00401375|531805695|FG002|Overall Study|Adverse Event|10|||
147448341|NCT00401375|531805693|FG000|Overall Study|Withdrawal by Subject|9|||
147448342|NCT00401375|531805694|FG001|Overall Study|Withdrawal by Subject|7|||
147179009|NCT04775953|530821525|FG000|Overall Study|Withdrawal by Subject|3|||
147179010|NCT04775953|530821526|FG001|Overall Study|Withdrawal by Subject|3|||
147324703|NCT00984282|531354346|FG001|Double Blind Treatment|Noncompliance with study medication|0|||
147324704|NCT00984282|531354345|FG000|Double Blind Treatment|Progression by clinical judgment|2|||
147324705|NCT00984282|531354346|FG001|Double Blind Treatment|Progression by clinical judgment|0|||
147324706|NCT00984282|531354345|FG000|Double Blind Treatment|Withdrawal by Subject|13|||
147324707|NCT00984282|531354346|FG001|Double Blind Treatment|Withdrawal by Subject|18|||
147324708|NCT00984282|531354345|FG000|Double Blind Treatment|Lost to Follow-up|3|||
147324709|NCT00984282|531354346|FG001|Double Blind Treatment|Lost to Follow-up|0|||
147324710|NCT00984282|531354345|FG000|Double Blind Treatment|Death|8|||
147324711|NCT00984282|531354346|FG001|Double Blind Treatment|Death|4|||
147324712|NCT00984282|531354345|FG000|Double Blind Treatment|Not treated|0|||
147324713|NCT00984282|531354346|FG001|Double Blind Treatment|Not treated|1|||
147324714|NCT00984282|531354345|FG000|Double Blind Treatment|Switched to commercial drug|6|||
147324715|NCT00984282|531354346|FG001|Double Blind Treatment|Switched to commercial drug|1|||
147324716|NCT00984282|531354345|FG000|Double Blind Treatment|protocol driven decision point|1|||
147324717|NCT00984282|531354346|FG001|Double Blind Treatment|protocol driven decision point|1|||
147324718|NCT00984282|531354345|FG000|Double Blind Treatment|Radiological and clinical progression|0|||
147324719|NCT00984282|531354346|FG001|Double Blind Treatment|Radiological and clinical progression|1|||
147324720|NCT00984282|531354345|FG000|Double Blind Treatment|Transferred to treat. continuation study|2|||
147324721|NCT00984282|531354346|FG001|Double Blind Treatment|Transferred to treat. continuation study|1|||
147324722|NCT00984282|531354345|FG000|Open-label Treatment|Adverse Event|20|||
147324723|NCT00984282|531354346|FG001|Open-label Treatment|Adverse Event|30|||
147324724|NCT00984282|531354345|FG000|Open-label Treatment|Withdrawal by Subject|6|||
147324725|NCT00984282|531354346|FG001|Open-label Treatment|Withdrawal by Subject|21|||
147324726|NCT00984282|531354345|FG000|Open-label Treatment|Death|7|||
147324727|NCT00984282|531354346|FG001|Open-label Treatment|Death|15|||
147324728|NCT00984282|531354345|FG000|Open-label Treatment|Progression, recurrence or relapse|40|||
147324729|NCT00984282|531354346|FG001|Open-label Treatment|Progression, recurrence or relapse|82|||
147324730|NCT00984282|531354345|FG000|Open-label Treatment|Lost to Follow-up|1|||
147324731|NCT00984282|531354346|FG001|Open-label Treatment|Lost to Follow-up|1|||
147324732|NCT00984282|531354345|FG000|Open-label Treatment|Patient convenience|1|||
147324733|NCT00984282|531354346|FG001|Open-label Treatment|Patient convenience|0|||
147324734|NCT00984282|531354345|FG000|Open-label Treatment|Non-compliant with study medication|1|||
147324735|NCT00984282|531354346|FG001|Open-label Treatment|Non-compliant with study medication|0|||
147324736|NCT00984282|531354345|FG000|Open-label Treatment|Target lesion removed|0|||
147324737|NCT00984282|531354346|FG001|Open-label Treatment|Target lesion removed|1|||
147324738|NCT00984282|531354345|FG000|Open-label Treatment|Protocol driven decision point|1|||
147324739|NCT00984282|531354346|FG001|Open-label Treatment|Protocol driven decision point|1|||
147324740|NCT00984282|531354345|FG000|Open-label Treatment|Transferred to treat. continuation study|2|||
147324741|NCT00984282|531354346|FG001|Open-label Treatment|Transferred to treat. continuation study|3|||
147324742|NCT00984282|531354345|FG000|Open-label Treatment|Switched to commercial drug|6|||
147324743|NCT00984282|531354346|FG001|Open-label Treatment|Switched to commercial drug|7|||
147324744|NCT00984282|531354345|FG000|Open-label Treatment|Physician Decision|1|||
147324745|NCT00984282|531354346|FG001|Open-label Treatment|Physician Decision|0|||
147324746|NCT00984282|531354345|FG000|Long Term Follow-up|Withdrawal by Subject|8|||
147324747|NCT00984282|531354346|FG001|Long Term Follow-up|Withdrawal by Subject|14|||
147324748|NCT00984282|531354345|FG000|Long Term Follow-up|Death|27|||
147324749|NCT00984282|531354346|FG001|Long Term Follow-up|Death|68|||
147324750|NCT00984282|531354345|FG000|Long Term Follow-up|Lost to Follow-up|3|||
147324751|NCT00984282|531354346|FG001|Long Term Follow-up|Lost to Follow-up|6|||
147324752|NCT00984282|531354345|FG000|Long Term Follow-up|Protocol driven decision point|25|||
147324753|NCT00984282|531354346|FG001|Long Term Follow-up|Protocol driven decision point|26|||
147324754|NCT00984282|531354345|FG000|Long Term Follow-up|Transferred to treat. continuation study|2|||
147324755|NCT00984282|531354346|FG001|Long Term Follow-up|Transferred to treat. continuation study|3|||
147324756|NCT00984282|531354345|FG000|Long Term Follow-up|Switched to commercial drug|4|||
147324757|NCT00984282|531354346|FG001|Long Term Follow-up|Switched to commercial drug|2|||
147324758|NCT00984282|531354345|FG000|Long Term Follow-up|Disease prog., recurrence or relapse|0|||
147656177|NCT02959918|532564955|FG004|Overall Study|Withdrawal by Subject|0|||
147656178|NCT02959918|532564956|FG005|Overall Study|Withdrawal by Subject|0|||
147656179|NCT02959918|532564957|FG006|Overall Study|Withdrawal by Subject|1|||
147656180|NCT02959918|532564958|FG007|Overall Study|Withdrawal by Subject|0|||
147656181|NCT02959918|532564959|FG008|Overall Study|Withdrawal by Subject|1|||
147656182|NCT02959918|532564960|FG009|Overall Study|Withdrawal by Subject|1|||
147656183|NCT02959918|532564961|FG010|Overall Study|Withdrawal by Subject|2|||
147656184|NCT02959918|532564962|FG011|Overall Study|Withdrawal by Subject|3|||
147656185|NCT02959918|532564963|FG012|Overall Study|Withdrawal by Subject|1|||
147656186|NCT02959918|532564964|FG013|Overall Study|Withdrawal by Subject|1|||
147656187|NCT02959918|532564951|FG000|Overall Study|Protocol Violation|0|||
147656188|NCT02959918|532564952|FG001|Overall Study|Protocol Violation|0|||
147656189|NCT02959918|532564953|FG002|Overall Study|Protocol Violation|1|||
147656190|NCT02959918|532564954|FG003|Overall Study|Protocol Violation|0|||
147656191|NCT02959918|532564955|FG004|Overall Study|Protocol Violation|0|||
147179011|NCT04775953|530821525|FG000|Overall Study|Protocol Violation|2|||
147179012|NCT04775953|530821526|FG001|Overall Study|Protocol Violation|0|||
147179013|NCT04775953|530821525|FG000|Overall Study|Participant non-compliance|0|||
147179014|NCT04775953|530821526|FG001|Overall Study|Participant non-compliance|1|||
147179015|NCT01698814|530821527|FG000|Overall Study|Adverse Event|0|||
147179016|NCT01698814|530821528|FG001|Overall Study|Adverse Event|2|||
147179017|NCT01698814|530821527|FG000|Overall Study|Lost to Follow-up|0|||
147179018|NCT01698814|530821528|FG001|Overall Study|Lost to Follow-up|1|||
147179019|NCT01698814|530821527|FG000|Overall Study|Pregnancy|1|||
147179020|NCT01698814|530821528|FG001|Overall Study|Pregnancy|0|||
147179021|NCT01698814|530821527|FG000|Overall Study|Randomized in error|1|||
147179022|NCT01698814|530821528|FG001|Overall Study|Randomized in error|0|||
147179023|NCT00855959|530821529|FG000|Overall Study|Adverse Event|2|||
147179024|NCT00855959|530821529|FG000|Overall Study|Lost to Follow-up|2|||
147179025|NCT00855959|530821529|FG000|Overall Study|Withdrawal by Subject|3|||
147179026|NCT00855959|530821529|FG000|Overall Study|Pregnancy|1|||
147179027|NCT00855959|530821529|FG000|Overall Study|Incorrect enrolment|1|||
147179028|NCT00368641|530821533|FG000|Overall Study|Adverse Event|2|||
147179029|NCT00368641|530821534|FG001|Overall Study|Adverse Event|1|||
147179030|NCT00368641|530821533|FG000|Overall Study|Death|1|||
147179031|NCT00368641|530821534|FG001|Overall Study|Death|0|||
147179032|NCT00368641|530821533|FG000|Overall Study|Withdrawal by Subject|1|||
147179033|NCT00368641|530821534|FG001|Overall Study|Withdrawal by Subject|0|||
147179034|NCT00368641|530821533|FG000|Overall Study|Sponsor decision to terminate study|2|||
147179035|NCT00368641|530821534|FG001|Overall Study|Sponsor decision to terminate study|5|||
147179036|NCT04737278|530821535|FG000|Overall Study|Lost to Follow-up|1|||
147179037|NCT04737278|530821536|FG001|Overall Study|Lost to Follow-up|1|||
147179038|NCT04737278|530821535|FG000|Overall Study|Withdrawal by Subject|1|||
147179039|NCT04737278|530821536|FG001|Overall Study|Withdrawal by Subject|0|||
147179040|NCT04737278|530821535|FG000|Overall Study|Protocol Violation|1|||
147179041|NCT04737278|530821536|FG001|Overall Study|Protocol Violation|1|||
147179042|NCT04737278|530821535|FG000|Overall Study|failure to complete questionnaire|1|||
147179043|NCT04737278|530821536|FG001|Overall Study|failure to complete questionnaire|1|||
147179044|NCT01128244|530821539|FG000|Overall Study|Adverse Event|1|||
147179045|NCT01128244|530821539|FG000|Overall Study|Scheduling conflict|2|||
147179046|NCT04506502|530821543|FG000|Overall Study|Withdrawal by Subject|1|||
147179047|NCT04506502|530821543|FG000|Overall Study|Illness and subsequent quarantine requirements related to SARS-CoV-2 local guidelines|1|||
147179048|NCT01449006|530821544|FG000|Overall Study|Lost to Follow-up|1|||
147179049|NCT01449006|530821545|FG001|Overall Study|Lost to Follow-up|0|||
147179050|NCT01449006|530821544|FG000|Overall Study|Withdrawal by Subject|1|||
147179051|NCT01449006|530821545|FG001|Overall Study|Withdrawal by Subject|0|||
147179052|NCT01449006|530821544|FG000|Overall Study|Protocol Violation|1|||
147179053|NCT01449006|530821545|FG001|Overall Study|Protocol Violation|0|||
147179054|NCT03526146|530821546|FG000|Overall Study|Lost to Follow-up|5|||
147179055|NCT03526146|530821546|FG000|Overall Study|Withdrawal by Subject|6|||
147179056|NCT03526146|530821546|FG000|Overall Study|class canceled due to COVID-19|4|||
147179057|NCT02588261|530821547|FG000|Overall Study|Study Terminated by Sponsor|157|||
147179058|NCT02588261|530821548|FG001|Overall Study|Study Terminated by Sponsor|142|||
147179059|NCT02588261|530821547|FG000|Overall Study|Protocol Deviation|1|||
147179060|NCT02588261|530821548|FG001|Overall Study|Protocol Deviation|0|||
147179061|NCT02588261|530821547|FG000|Overall Study|Death|1|||
147179062|NCT02588261|530821548|FG001|Overall Study|Death|2|||
147179063|NCT02588261|530821547|FG000|Overall Study|Withdrawal by Subject|12|||
147179064|NCT02588261|530821548|FG001|Overall Study|Withdrawal by Subject|8|||
147179065|NCT02588261|530821547|FG000|Overall Study|Noncompliance with Study Drug|0|||
147179066|NCT02588261|530821548|FG001|Overall Study|Noncompliance with Study Drug|1|||
147179067|NCT02588261|530821547|FG000|Overall Study|Miscellaneous|5|||
147179068|NCT02588261|530821548|FG001|Overall Study|Miscellaneous|4|||
147179069|NCT02588261|530821547|FG000|Overall Study|Progressive Disease|61|||
147179070|NCT02588261|530821548|FG001|Overall Study|Progressive Disease|82|||
147179071|NCT02588261|530821547|FG000|Overall Study|Adverse Event|29|||
147179072|NCT02588261|530821548|FG001|Overall Study|Adverse Event|24|||
147179073|NCT02588261|530821547|FG000|Overall Study|Lost to Follow-up|1|||
147179074|NCT02588261|530821548|FG001|Overall Study|Lost to Follow-up|0|||
147245196|NCT00843024|531070780|FG005|Single-blind Placebo Run-In Phase|Other|0|||
147245197|NCT00843024|531070775|FG000|Double-blind Treatment Phase|No opportunity to treat migraine|0|||
147593227|NCT02091141|532328946|FG004|Overall Study|Reason Not Specified|0|||
147593228|NCT02091141|532328947|FG005|Overall Study|Reason Not Specified|0|||
147179075|NCT01746368|530821553|FG000|Overall Study|Lost to Follow-up|2|||
147179076|NCT01746368|530821554|FG001|Overall Study|Lost to Follow-up|0|||
147179077|NCT01746368|530821553|FG000|Overall Study|Withdrawal by Subject|0|||
147179078|NCT01746368|530821554|FG001|Overall Study|Withdrawal by Subject|1|||
147179079|NCT05636852|530821555|FG000|Overall Study|Withdrawal by Subject|1|||
147179080|NCT05636852|530821555|FG000|Overall Study|Other than specified|1|||
147179081|NCT03705559|530821559|FG000|Overall Study|COVID Shut down|1|||
147179082|NCT00195091|530821560|FG000|Overall Study|Study terminated and PI has left MSKCC|16|||
147179083|NCT01979952|530821570|FG000|Overall Study|Adverse Event|4|||
147179084|NCT01979952|530821571|FG001|Overall Study|Adverse Event|5|||
147179085|NCT01979952|530821570|FG000|Overall Study|Protocol Violation|1|||
147179086|NCT01979952|530821571|FG001|Overall Study|Protocol Violation|0|||
147179087|NCT01979952|530821570|FG000|Overall Study|Withdrawal by Subject|2|||
147179088|NCT01979952|530821571|FG001|Overall Study|Withdrawal by Subject|1|||
147179089|NCT01979952|530821570|FG000|Overall Study|Other than specified above|1|||
147179090|NCT01979952|530821571|FG001|Overall Study|Other than specified above|0|||
147179091|NCT03364738|530821578|FG000|Overall Study|Early termination due to Food and Drug Administration recall of rhPTH(1-84) (Natpara)|6|||
147179092|NCT03364738|530821578|FG000|Overall Study|Withdrawal by Subject|1|||
147245198|NCT00843024|531070776|FG001|Double-blind Treatment Phase|No opportunity to treat migraine|0|||
147245199|NCT00843024|531070777|FG002|Double-blind Treatment Phase|No opportunity to treat migraine|20|||
147245200|NCT00843024|531070778|FG003|Double-blind Treatment Phase|No opportunity to treat migraine|10|||
147245201|NCT00843024|531070779|FG004|Double-blind Treatment Phase|No opportunity to treat migraine|13|||
147245202|NCT00843024|531070780|FG005|Double-blind Treatment Phase|No opportunity to treat migraine|14|||
147245203|NCT00843024|531070775|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
147245204|NCT00843024|531070776|FG001|Double-blind Treatment Phase|Lost to Follow-up|0|||
147245205|NCT00843024|531070777|FG002|Double-blind Treatment Phase|Lost to Follow-up|8|||
147245206|NCT00843024|531070778|FG003|Double-blind Treatment Phase|Lost to Follow-up|4|||
147245207|NCT00843024|531070779|FG004|Double-blind Treatment Phase|Lost to Follow-up|4|||
147245208|NCT00843024|531070780|FG005|Double-blind Treatment Phase|Lost to Follow-up|4|||
147245209|NCT00843024|531070775|FG000|Double-blind Treatment Phase|Withdrawal by Subject|0|||
147245210|NCT00843024|531070776|FG001|Double-blind Treatment Phase|Withdrawal by Subject|0|||
147245211|NCT00843024|531070777|FG002|Double-blind Treatment Phase|Withdrawal by Subject|0|||
147245212|NCT00843024|531070778|FG003|Double-blind Treatment Phase|Withdrawal by Subject|6|||
147245213|NCT00843024|531070779|FG004|Double-blind Treatment Phase|Withdrawal by Subject|0|||
147245214|NCT00843024|531070780|FG005|Double-blind Treatment Phase|Withdrawal by Subject|2|||
147245215|NCT00843024|531070775|FG000|Double-blind Treatment Phase|Protocol Violation|0|||
147245216|NCT00843024|531070776|FG001|Double-blind Treatment Phase|Protocol Violation|0|||
147245217|NCT00843024|531070777|FG002|Double-blind Treatment Phase|Protocol Violation|3|||
147245218|NCT00843024|531070778|FG003|Double-blind Treatment Phase|Protocol Violation|0|||
147245219|NCT00843024|531070779|FG004|Double-blind Treatment Phase|Protocol Violation|0|||
147245220|NCT00843024|531070780|FG005|Double-blind Treatment Phase|Protocol Violation|3|||
147245221|NCT00843024|531070775|FG000|Double-blind Treatment Phase|Physician Decision|0|||
147245222|NCT00843024|531070776|FG001|Double-blind Treatment Phase|Physician Decision|0|||
147245223|NCT00843024|531070777|FG002|Double-blind Treatment Phase|Physician Decision|0|||
147245224|NCT00843024|531070778|FG003|Double-blind Treatment Phase|Physician Decision|3|||
147245225|NCT00843024|531070779|FG004|Double-blind Treatment Phase|Physician Decision|1|||
147324759|NCT00984282|531354346|FG001|Long Term Follow-up|Disease prog., recurrence or relapse|1|||
147324760|NCT02223793|531354347|FG000|Overall Study|Lost to Follow-up|10|||
147324761|NCT02223793|531354348|FG001|Overall Study|Lost to Follow-up|1|||
147324762|NCT02223793|531354349|FG002|Overall Study|Lost to Follow-up|2|||
147324763|NCT02223793|531354347|FG000|Overall Study|Withdrawal by Subject|3|||
147324764|NCT02223793|531354348|FG001|Overall Study|Withdrawal by Subject|2|||
147324765|NCT02223793|531354349|FG002|Overall Study|Withdrawal by Subject|3|||
147324766|NCT02223793|531354347|FG000|Overall Study|Moved/studycenter unable to participate|4|||
147324767|NCT02223793|531354348|FG001|Overall Study|Moved/studycenter unable to participate|6|||
147324768|NCT02223793|531354349|FG002|Overall Study|Moved/studycenter unable to participate|8|||
147324769|NCT00315055|531354350|FG000|Overall Study|Protocol Violation|2|||
147324770|NCT00315055|531354351|FG001|Overall Study|Protocol Violation|4|||
147324771|NCT00315055|531354350|FG000|Overall Study|Lost to Follow-up|1|||
147324772|NCT00315055|531354351|FG001|Overall Study|Lost to Follow-up|1|||
147324773|NCT02359435|531354352|FG000|Overall Study|Lost to Follow-up|4|||
147324774|NCT02359435|531354353|FG001|Overall Study|Lost to Follow-up|4|||
147324775|NCT01289119|531354357|FG000|Overall Study|Adverse Event|2|||
147324776|NCT01289119|531354358|FG001|Overall Study|Adverse Event|1|||
147324777|NCT01289119|531354359|FG002|Overall Study|Adverse Event|0|||
147324778|NCT01289119|531354360|FG003|Overall Study|Adverse Event|2|||
147324779|NCT01289119|531354361|FG004|Overall Study|Adverse Event|1|||
147324780|NCT01289119|531354362|FG005|Overall Study|Adverse Event|0|||
147324781|NCT01289119|531354357|FG000|Overall Study|Major Protocol Deviation|2|||
147324782|NCT01289119|531354358|FG001|Overall Study|Major Protocol Deviation|1|||
147324783|NCT01289119|531354359|FG002|Overall Study|Major Protocol Deviation|3|||
147324784|NCT01289119|531354360|FG003|Overall Study|Major Protocol Deviation|0|||
147324785|NCT01289119|531354361|FG004|Overall Study|Major Protocol Deviation|2|||
147324786|NCT01289119|531354362|FG005|Overall Study|Major Protocol Deviation|1|||
147324787|NCT01289119|531354357|FG000|Overall Study|Lost to Follow-up|0|||
147324788|NCT01289119|531354358|FG001|Overall Study|Lost to Follow-up|3|||
147324789|NCT01289119|531354359|FG002|Overall Study|Lost to Follow-up|0|||
147324790|NCT01289119|531354360|FG003|Overall Study|Lost to Follow-up|0|||
147324791|NCT01289119|531354361|FG004|Overall Study|Lost to Follow-up|0|||
147179093|NCT03364738|530821578|FG000|Overall Study|Adverse Event|1|||
147179094|NCT03245398|530821579|FG000|Overall Study|Travelled to another island|1|||
147179095|NCT03245398|530821580|FG001|Overall Study|Travelled to another island|0|||
147179096|NCT04079816|530821581|FG000|Overall Study|Request of Subject|2|||
147179097|NCT04079816|530821581|FG000|Overall Study|Unable to draw samples|1|||
147179098|NCT04531241|530821582|FG000|Period 1|Withdrawal by Subject|2|||
147179099|NCT04531241|530821583|FG001|Period 1|Withdrawal by Subject|0|||
147179100|NCT04531241|530821582|FG000|Period 1|Dispesed incorrect lens power|1|||
147179101|NCT04531241|530821583|FG001|Period 1|Dispesed incorrect lens power|0|||
147179102|NCT04531241|530821582|FG000|Period 1|Protocol Violation|1|||
147179103|NCT04531241|530821583|FG001|Period 1|Protocol Violation|0|||
147179104|NCT04531241|530821582|FG000|Period 1|No longer eligible|0|||
147179105|NCT04531241|530821583|FG001|Period 1|No longer eligible|1|||
147179106|NCT04531241|530821582|FG000|Period 1|Lens Discomfort|0|||
147179107|NCT04531241|530821583|FG001|Period 1|Lens Discomfort|1|||
147179108|NCT04531241|530821582|FG000|Period 2|Covid-19 Related|1|||
147179109|NCT04531241|530821583|FG001|Period 2|Covid-19 Related|1|||
147179110|NCT02576795|530821584|FG000|Overall Study|Lost to Follow-up|0|||
147179111|NCT02576795|530821585|FG001|Overall Study|Lost to Follow-up|0|||
147179112|NCT02576795|530821586|FG002|Overall Study|Lost to Follow-up|1|||
147179113|NCT02576795|530821587|FG003|Overall Study|Lost to Follow-up|0|||
147179114|NCT01702246|530821588|FG000|Overall Study|Lost to Follow-up|2|||
147179115|NCT01702246|530821588|FG000|Overall Study|Withdrawal by Subject|2|||
147179116|NCT01702246|530821588|FG000|Overall Study|Physician Decision|1|||
147179117|NCT03724890|530821589|FG000|Overall Study|Death|2|||
147179118|NCT03724890|530821590|FG001|Overall Study|Death|6|||
147179119|NCT03724890|530821591|FG002|Overall Study|Death|3|||
147179120|NCT03724890|530821592|FG003|Overall Study|Death|5|||
147179121|NCT03724890|530821593|FG004|Overall Study|Death|2|||
147179122|NCT03724890|530821594|FG005|Overall Study|Death|0|||
147179123|NCT03724890|530821595|FG006|Overall Study|Death|2|||
147179124|NCT03724890|530821596|FG007|Overall Study|Death|3|||
147179125|NCT03724890|530821597|FG008|Overall Study|Death|4|||
147179126|NCT03724890|530821598|FG009|Overall Study|Death|2|||
147179127|NCT03724890|530821599|FG010|Overall Study|Death|2|||
147179128|NCT03724890|530821589|FG000|Overall Study|Lost to Follow-up|0|||
147179129|NCT03724890|530821590|FG001|Overall Study|Lost to Follow-up|3|||
147179130|NCT03724890|530821591|FG002|Overall Study|Lost to Follow-up|0|||
147179131|NCT03724890|530821592|FG003|Overall Study|Lost to Follow-up|1|||
147179132|NCT03724890|530821593|FG004|Overall Study|Lost to Follow-up|2|||
147179133|NCT03724890|530821594|FG005|Overall Study|Lost to Follow-up|2|||
147179134|NCT03724890|530821595|FG006|Overall Study|Lost to Follow-up|1|||
147179135|NCT03724890|530821596|FG007|Overall Study|Lost to Follow-up|0|||
147179136|NCT03724890|530821597|FG008|Overall Study|Lost to Follow-up|2|||
147179137|NCT03724890|530821598|FG009|Overall Study|Lost to Follow-up|0|||
147179138|NCT03724890|530821599|FG010|Overall Study|Lost to Follow-up|0|||
147179139|NCT03724890|530821589|FG000|Overall Study|Withdrawal by Subject|1|||
147245226|NCT00843024|531070780|FG005|Double-blind Treatment Phase|Physician Decision|1|||
147245227|NCT00843024|531070775|FG000|Double-blind Treatment Phase|Adverse Event|0|||
147245228|NCT00843024|531070776|FG001|Double-blind Treatment Phase|Adverse Event|0|||
147245229|NCT00843024|531070777|FG002|Double-blind Treatment Phase|Adverse Event|0|||
147245230|NCT00843024|531070778|FG003|Double-blind Treatment Phase|Adverse Event|0|||
147245231|NCT00843024|531070779|FG004|Double-blind Treatment Phase|Adverse Event|1|||
147245232|NCT00843024|531070780|FG005|Double-blind Treatment Phase|Adverse Event|1|||
147245233|NCT00843024|531070775|FG000|Double-blind Treatment Phase|Lack of Efficacy|0|||
147245234|NCT00843024|531070776|FG001|Double-blind Treatment Phase|Lack of Efficacy|0|||
147245235|NCT00843024|531070777|FG002|Double-blind Treatment Phase|Lack of Efficacy|0|||
147245236|NCT00843024|531070778|FG003|Double-blind Treatment Phase|Lack of Efficacy|0|||
147245237|NCT00843024|531070779|FG004|Double-blind Treatment Phase|Lack of Efficacy|1|||
147245238|NCT00843024|531070780|FG005|Double-blind Treatment Phase|Lack of Efficacy|0|||
147245239|NCT05201703|531070781|FG000|Overall Study|Did not understand how to boost medication despite counseling; did not boost|0|||
147245240|NCT05201703|531070782|FG001|Overall Study|Did not understand how to boost medication despite counseling; did not boost|1|||
147245241|NCT05201703|531070781|FG000|Overall Study|Subject did not tolerate the treatment (perampanel) due to mild side effects so exited the study.|0|||
147245242|NCT05201703|531070782|FG001|Overall Study|Subject did not tolerate the treatment (perampanel) due to mild side effects so exited the study.|1|||
147245243|NCT02006719|531070783|FG000|Overall Study|Withdrawal by Subject|10|||
147245244|NCT02006719|531070784|FG001|Overall Study|Withdrawal by Subject|2|||
147245245|NCT02006719|531070783|FG000|Overall Study|Lost to Follow-up|5|||
147245246|NCT02006719|531070784|FG001|Overall Study|Lost to Follow-up|1|||
147179140|NCT03724890|530821590|FG001|Overall Study|Withdrawal by Subject|2|||
147179141|NCT03724890|530821591|FG002|Overall Study|Withdrawal by Subject|1|||
147179142|NCT03724890|530821592|FG003|Overall Study|Withdrawal by Subject|0|||
147179143|NCT03724890|530821593|FG004|Overall Study|Withdrawal by Subject|0|||
147179144|NCT03724890|530821594|FG005|Overall Study|Withdrawal by Subject|1|||
147179145|NCT03724890|530821595|FG006|Overall Study|Withdrawal by Subject|0|||
147179146|NCT03724890|530821596|FG007|Overall Study|Withdrawal by Subject|0|||
147179147|NCT03724890|530821597|FG008|Overall Study|Withdrawal by Subject|2|||
147179148|NCT03724890|530821598|FG009|Overall Study|Withdrawal by Subject|2|||
147179149|NCT03724890|530821599|FG010|Overall Study|Withdrawal by Subject|1|||
147179150|NCT03724890|530821589|FG000|Overall Study|Other|1|||
147324792|NCT01289119|531354362|FG005|Overall Study|Lost to Follow-up|1|||
147593229|NCT02091141|532328948|FG006|Overall Study|Reason Not Specified|1|||
147593230|NCT02091141|532328942|FG000|Overall Study|Study Ended by Sponsor|1|||
147593231|NCT02091141|532328943|FG001|Overall Study|Study Ended by Sponsor|9|||
147593232|NCT02091141|532328944|FG002|Overall Study|Study Ended by Sponsor|0|||
147593233|NCT02091141|532328945|FG003|Overall Study|Study Ended by Sponsor|0|||
147593234|NCT02091141|532328946|FG004|Overall Study|Study Ended by Sponsor|0|||
147324793|NCT01289119|531354357|FG000|Overall Study|Withdrawal by Subject|4|||
147324794|NCT01289119|531354358|FG001|Overall Study|Withdrawal by Subject|2|||
147324795|NCT01289119|531354359|FG002|Overall Study|Withdrawal by Subject|4|||
147324796|NCT01289119|531354360|FG003|Overall Study|Withdrawal by Subject|3|||
147324797|NCT01289119|531354361|FG004|Overall Study|Withdrawal by Subject|1|||
147324798|NCT01289119|531354362|FG005|Overall Study|Withdrawal by Subject|1|||
147324799|NCT01289119|531354357|FG000|Overall Study|Pregnancy|0|||
147324800|NCT01289119|531354358|FG001|Overall Study|Pregnancy|1|||
147324801|NCT01289119|531354359|FG002|Overall Study|Pregnancy|0|||
147324802|NCT01289119|531354360|FG003|Overall Study|Pregnancy|0|||
147324803|NCT01289119|531354361|FG004|Overall Study|Pregnancy|0|||
147324804|NCT01289119|531354362|FG005|Overall Study|Pregnancy|0|||
147324805|NCT01289119|531354357|FG000|Overall Study|Lack of Efficacy|0|||
147324806|NCT01289119|531354358|FG001|Overall Study|Lack of Efficacy|1|||
147324807|NCT01289119|531354359|FG002|Overall Study|Lack of Efficacy|1|||
147324808|NCT01289119|531354360|FG003|Overall Study|Lack of Efficacy|1|||
147324809|NCT01289119|531354361|FG004|Overall Study|Lack of Efficacy|1|||
147324810|NCT01289119|531354362|FG005|Overall Study|Lack of Efficacy|1|||
147324811|NCT01289119|531354357|FG000|Overall Study|Other|1|||
147324812|NCT01289119|531354358|FG001|Overall Study|Other|0|||
147324813|NCT01289119|531354359|FG002|Overall Study|Other|1|||
147324814|NCT01289119|531354360|FG003|Overall Study|Other|0|||
147324815|NCT01289119|531354361|FG004|Overall Study|Other|0|||
147179151|NCT03724890|530821590|FG001|Overall Study|Other|0|||
147179152|NCT03724890|530821591|FG002|Overall Study|Other|0|||
147179153|NCT03724890|530821592|FG003|Overall Study|Other|0|||
147179154|NCT03724890|530821593|FG004|Overall Study|Other|0|||
147179155|NCT03724890|530821594|FG005|Overall Study|Other|0|||
147179156|NCT03724890|530821595|FG006|Overall Study|Other|0|||
147179157|NCT03724890|530821596|FG007|Overall Study|Other|1|||
147179158|NCT03724890|530821597|FG008|Overall Study|Other|1|||
147179159|NCT03724890|530821598|FG009|Overall Study|Other|0|||
147179160|NCT03724890|530821599|FG010|Overall Study|Other|2|||
147179161|NCT01635855|530821610|FG000|Overall Study|Withdrawal by Subject|4|||
147179162|NCT02708355|530821614|FG000|Overall Study|Adverse Event|1|||
147179163|NCT02708355|530821615|FG001|Overall Study|Adverse Event|0|||
147179164|NCT02708355|530821616|FG002|Overall Study|Adverse Event|0|||
147448343|NCT00401375|531805695|FG002|Overall Study|Withdrawal by Subject|7|||
147448344|NCT00401375|531805693|FG000|Overall Study|Lost to Follow-up|0|||
147448345|NCT00401375|531805694|FG001|Overall Study|Lost to Follow-up|1|||
147448346|NCT00401375|531805695|FG002|Overall Study|Lost to Follow-up|1|||
147448347|NCT00401375|531805693|FG000|Overall Study|Other than specified|2|||
147448348|NCT00401375|531805694|FG001|Overall Study|Other than specified|1|||
147448349|NCT00401375|531805695|FG002|Overall Study|Other than specified|3|||
147448350|NCT00401375|531805693|FG000|Overall Study|Randomized but not treated|3|||
147448351|NCT00401375|531805694|FG001|Overall Study|Randomized but not treated|3|||
147448352|NCT00401375|531805695|FG002|Overall Study|Randomized but not treated|3|||
147448353|NCT02821715|531805696|FG000|Overall Study|Protocol Violation|1|||
147448354|NCT02821715|531805697|FG001|Overall Study|Protocol Violation|0|||
147448355|NCT02821715|531805698|FG002|Overall Study|Protocol Violation|0|||
147448356|NCT02821715|531805699|FG003|Overall Study|Protocol Violation|0|||
147448357|NCT02821715|531805700|FG004|Overall Study|Protocol Violation|0|||
147448358|NCT02821715|531805701|FG005|Overall Study|Protocol Violation|0|||
147448359|NCT00677014|531805702|FG000|Overall Study|Lost to Follow-up|20|||
147448360|NCT00677014|531805703|FG001|Overall Study|Lost to Follow-up|12|||
147448361|NCT00677014|531805704|FG002|Overall Study|Lost to Follow-up|24|||
147593235|NCT02091141|532328947|FG005|Overall Study|Study Ended by Sponsor|0|||
147593236|NCT02091141|532328948|FG006|Overall Study|Study Ended by Sponsor|0|||
147179165|NCT01320202|530821617|FG000|Overall Study|Adverse Event|5|||
147179166|NCT01320202|530821618|FG001|Overall Study|Adverse Event|5|||
147179167|NCT01320202|530821617|FG000|Overall Study|Death|5|||
147179168|NCT01320202|530821618|FG001|Overall Study|Death|3|||
147179169|NCT01320202|530821617|FG000|Overall Study|Lost to Follow-up|1|||
147179170|NCT01320202|530821618|FG001|Overall Study|Lost to Follow-up|0|||
147324816|NCT01289119|531354362|FG005|Overall Study|Other|0|||
147448362|NCT00677014|531805702|FG000|Overall Study|Death|6|||
147448363|NCT00677014|531805703|FG001|Overall Study|Death|15|||
147448364|NCT00677014|531805704|FG002|Overall Study|Death|7|||
147324817|NCT01704846|531354363|FG000|Treatment Period 2|Withdrawal by Subject|0|||
147324818|NCT01704846|531354364|FG001|Treatment Period 2|Withdrawal by Subject|1|||
147448365|NCT00677014|531805702|FG000|Overall Study|Unavailable or unreadable 6 month LVESV|18|||
147448366|NCT00677014|531805703|FG001|Overall Study|Unavailable or unreadable 6 month LVESV|14|||
147593237|NCT02091141|532328942|FG000|Overall Study|Withdrew informed consent before receiving study drug|0|||
147656192|NCT02959918|532564956|FG005|Overall Study|Protocol Violation|1|||
147324819|NCT00530335|531354368|FG000|Overall Study|Adverse Event|3|||
147324820|NCT00530335|531354368|FG000|Overall Study|Protocol Violation|1|||
147324821|NCT00530335|531354368|FG000|Overall Study|Withdrawal by Subject|1|||
147324822|NCT00530335|531354368|FG000|Overall Study|Physician Decision|1|||
147324823|NCT01244984|531354369|FG000|Overall Study|Adverse Event|2|||
147324824|NCT01244984|531354370|FG001|Overall Study|Adverse Event|11|||
147324825|NCT01244984|531354371|FG002|Overall Study|Adverse Event|2|||
147324826|NCT01244984|531354369|FG000|Overall Study|Protocol Violation|1|||
147324827|NCT01244984|531354370|FG001|Overall Study|Protocol Violation|0|||
147324828|NCT01244984|531354371|FG002|Overall Study|Protocol Violation|0|||
147324829|NCT01244984|531354369|FG000|Overall Study|Protocol Defined Stopping Criteria|1|||
147324830|NCT01244984|531354370|FG001|Overall Study|Protocol Defined Stopping Criteria|1|||
147324831|NCT01244984|531354371|FG002|Overall Study|Protocol Defined Stopping Criteria|0|||
147324832|NCT01244984|531354369|FG000|Overall Study|Withdrawal by Subject|1|||
147324833|NCT01244984|531354370|FG001|Overall Study|Withdrawal by Subject|2|||
147324834|NCT01244984|531354371|FG002|Overall Study|Withdrawal by Subject|2|||
147324835|NCT01360840|531354372|FG000|Overall Study|Ongoing at data cut-off|10|||
147324836|NCT01360840|531354373|FG001|Overall Study|Ongoing at data cut-off|10|||
147324837|NCT01360840|531354374|FG002|Overall Study|Ongoing at data cut-off|9|||
147324838|NCT04668144|531354375|FG000|Overall Study|Protocol Violation|0|||
147324839|NCT04668144|531354376|FG001|Overall Study|Protocol Violation|1|||
147324840|NCT04668144|531354377|FG002|Overall Study|Protocol Violation|2|||
147324841|NCT02282527|531354380|FG000|Overall Study|Lost to Follow-up|0|||
147324842|NCT02282527|531354381|FG001|Overall Study|Lost to Follow-up|1|||
147324843|NCT02282527|531354380|FG000|Overall Study|Lack of home health aid|1|||
147324844|NCT02282527|531354381|FG001|Overall Study|Lack of home health aid|0|||
147324845|NCT01872611|531354382|FG000|Overall Study|Adverse Event|3|||
147324846|NCT01872611|531354383|FG001|Overall Study|Adverse Event|1|||
147324847|NCT01872611|531354382|FG000|Overall Study|Adverse Event, prior to treatment|0|||
147324848|NCT01872611|531354383|FG001|Overall Study|Adverse Event, prior to treatment|1|||
147324849|NCT01872611|531354382|FG000|Overall Study|Death|0|||
147324850|NCT01872611|531354383|FG001|Overall Study|Death|1|||
147324851|NCT01872611|531354382|FG000|Overall Study|Death, prior to treatment|0|||
147324852|NCT01872611|531354383|FG001|Overall Study|Death, prior to treatment|1|||
147324853|NCT01872611|531354382|FG000|Overall Study|Lost to Follow-up|8|||
147324854|NCT01872611|531354383|FG001|Overall Study|Lost to Follow-up|1|||
147324855|NCT01872611|531354382|FG000|Overall Study|Physician Decision|1|||
147324856|NCT01872611|531354383|FG001|Overall Study|Physician Decision|0|||
147324857|NCT01872611|531354382|FG000|Overall Study|Withdrawal by Subject|6|||
147324858|NCT01872611|531354383|FG001|Overall Study|Withdrawal by Subject|1|||
147324859|NCT01872611|531354382|FG000|Overall Study|Reason not provided|6|||
147324860|NCT01872611|531354383|FG001|Overall Study|Reason not provided|6|||
147324861|NCT03537651|531354384|FG000|Part A (Up to 96 Weeks)|Adverse Event|2|||
147324862|NCT03537651|531354384|FG000|Part A (Up to 96 Weeks)|Withdrawal of Consent (not due to AE)|2|||
147324863|NCT03537651|531354384|FG000|Part A (Up to 96 Weeks)|Commercial Drug is Available for Participant|56|||
147324864|NCT03537651|531354384|FG000|Part A (Up to 96 Weeks)|Other|1|||
147324865|NCT03537651|531354384|FG000|Part B (Up to 192 Weeks)|Adverse Event|1|||
147324866|NCT03537651|531354384|FG000|Part B (Up to 192 Weeks)|Withdrawal of Consent (not due to AE)|1|||
147324867|NCT03537651|531354384|FG000|Part B (Up to 192 Weeks)|Commercial Drug is available for Participant|56|||
147324868|NCT03537651|531354384|FG000|Part B (Up to 192 Weeks)|Other|1|||
147324869|NCT04639947|531354390|FG000|Overall Study|Screen fail|1|||
147324870|NCT02696785|531354395|FG000|Blinded Treatment Period|Adverse Event|0|||
147179171|NCT01320202|530821617|FG000|Overall Study|Physician Decision|3|||
147179172|NCT01320202|530821618|FG001|Overall Study|Physician Decision|1|||
147179173|NCT01320202|530821617|FG000|Overall Study|Protocol Violation|2|||
147179174|NCT01320202|530821618|FG001|Overall Study|Protocol Violation|1|||
147179175|NCT01320202|530821617|FG000|Overall Study|Withdrawal by Subject|10|||
147179176|NCT01320202|530821618|FG001|Overall Study|Withdrawal by Subject|3|||
147179177|NCT01320202|530821617|FG000|Overall Study|non-protocol change to ESA or IV iron|17|||
147179178|NCT01320202|530821618|FG001|Overall Study|non-protocol change to ESA or IV iron|20|||
147324871|NCT02696785|531354396|FG001|Blinded Treatment Period|Adverse Event|1|||
147324872|NCT02696785|531354397|FG002|Blinded Treatment Period|Adverse Event|3|||
147324873|NCT02696785|531354398|FG003|Blinded Treatment Period|Adverse Event|0|||
147324874|NCT02696785|531354395|FG000|Blinded Treatment Period|Withdrawal by Subject|0|||
147324875|NCT02696785|531354396|FG001|Blinded Treatment Period|Withdrawal by Subject|1|||
147324876|NCT02696785|531354397|FG002|Blinded Treatment Period|Withdrawal by Subject|1|||
147324877|NCT02696785|531354398|FG003|Blinded Treatment Period|Withdrawal by Subject|2|||
147324878|NCT02696785|531354395|FG000|Blinded Treatment Period|Lack of Efficacy|0|||
147179179|NCT01320202|530821617|FG000|Overall Study|kidney transplant|1|||
147324879|NCT02696785|531354396|FG001|Blinded Treatment Period|Lack of Efficacy|0|||
147324880|NCT02696785|531354397|FG002|Blinded Treatment Period|Lack of Efficacy|0|||
147324881|NCT02696785|531354398|FG003|Blinded Treatment Period|Lack of Efficacy|1|||
147324882|NCT02696785|531354395|FG000|Blinded Treatment Period|Screen Failure|1|||
147324883|NCT02696785|531354396|FG001|Blinded Treatment Period|Screen Failure|0|||
147324884|NCT02696785|531354397|FG002|Blinded Treatment Period|Screen Failure|0|||
147324885|NCT02696785|531354398|FG003|Blinded Treatment Period|Screen Failure|0|||
147656193|NCT02959918|532564957|FG006|Overall Study|Protocol Violation|0|||
147656194|NCT02959918|532564958|FG007|Overall Study|Protocol Violation|0|||
147656195|NCT02959918|532564959|FG008|Overall Study|Protocol Violation|2|||
147656196|NCT02959918|532564960|FG009|Overall Study|Protocol Violation|1|||
147656197|NCT02959918|532564961|FG010|Overall Study|Protocol Violation|0|||
147656198|NCT02959918|532564962|FG011|Overall Study|Protocol Violation|1|||
147656199|NCT02959918|532564963|FG012|Overall Study|Protocol Violation|1|||
147656200|NCT02959918|532564964|FG013|Overall Study|Protocol Violation|0|||
147656201|NCT02959918|532564951|FG000|Overall Study|Stopping Rule Met|1|||
147656202|NCT02959918|532564952|FG001|Overall Study|Stopping Rule Met|0|||
147656203|NCT02959918|532564953|FG002|Overall Study|Stopping Rule Met|3|||
147656204|NCT02959918|532564954|FG003|Overall Study|Stopping Rule Met|4|||
147656205|NCT02959918|532564955|FG004|Overall Study|Stopping Rule Met|5|||
147656206|NCT02959918|532564956|FG005|Overall Study|Stopping Rule Met|3|||
147656207|NCT02959918|532564957|FG006|Overall Study|Stopping Rule Met|2|||
147656208|NCT02959918|532564958|FG007|Overall Study|Stopping Rule Met|4|||
147656209|NCT02959918|532564959|FG008|Overall Study|Stopping Rule Met|1|||
147656210|NCT02959918|532564960|FG009|Overall Study|Stopping Rule Met|1|||
147656211|NCT02959918|532564961|FG010|Overall Study|Stopping Rule Met|3|||
147656212|NCT02959918|532564962|FG011|Overall Study|Stopping Rule Met|5|||
147656213|NCT02959918|532564963|FG012|Overall Study|Stopping Rule Met|2|||
147656214|NCT02959918|532564964|FG013|Overall Study|Stopping Rule Met|1|||
147656215|NCT02959918|532564951|FG000|Overall Study|Sponsor Decision, Pause in Clinical Trial|1|||
147656216|NCT02959918|532564952|FG001|Overall Study|Sponsor Decision, Pause in Clinical Trial|2|||
147179180|NCT01320202|530821618|FG001|Overall Study|kidney transplant|2|||
147179181|NCT01320202|530821617|FG000|Overall Study|blood transfusion|1|||
147179182|NCT01320202|530821618|FG001|Overall Study|blood transfusion|7|||
147179183|NCT01320202|530821617|FG000|Overall Study|moved/changed dialysis|5|||
147179184|NCT01320202|530821618|FG001|Overall Study|moved/changed dialysis|2|||
147179185|NCT01320202|530821617|FG000|Overall Study|sponsor request|2|||
147179186|NCT01320202|530821618|FG001|Overall Study|sponsor request|0|||
147179187|NCT01320202|530821617|FG000|Overall Study|ineligible|3|||
147179188|NCT01320202|530821618|FG001|Overall Study|ineligible|0|||
147179189|NCT01320202|530821617|FG000|Overall Study|regained renal function|1|||
147179190|NCT01320202|530821618|FG001|Overall Study|regained renal function|0|||
147245247|NCT02006719|531070783|FG000|Overall Study|Protocol Violation|2|||
147245248|NCT02006719|531070784|FG001|Overall Study|Protocol Violation|0|||
147245249|NCT02006719|531070783|FG000|Overall Study|Adverse Event|1|||
147245250|NCT02006719|531070784|FG001|Overall Study|Adverse Event|1|||
147245251|NCT02006719|531070783|FG000|Overall Study|Other/Unknown|0|||
147245252|NCT02006719|531070784|FG001|Overall Study|Other/Unknown|1|||
147245253|NCT02439138|531070790|FG000|Overall Study|Adverse Event|1|||
147245254|NCT02439138|531070790|FG000|Overall Study|PI decision to terminate the study|2|||
147245255|NCT03727347|531070791|FG000|Overall Study|Withdrawal by Subject|2|||
147245256|NCT03727347|531070791|FG000|Overall Study|Lost to Follow-up|1|||
147245257|NCT00006237|531070792|FG000|Overall Study|Adverse Event|39|||
147245258|NCT00006237|531070793|FG001|Overall Study|Adverse Event|29|||
147245259|NCT00006237|531070792|FG000|Overall Study|Death|1|||
147245260|NCT00006237|531070793|FG001|Overall Study|Death|0|||
147245261|NCT00006237|531070792|FG000|Overall Study|Refusal unrelated to adverse effects|8|||
147245262|NCT00006237|531070793|FG001|Overall Study|Refusal unrelated to adverse effects|4|||
147245263|NCT00006237|531070792|FG000|Overall Study|Progression/relapse|54|||
147245264|NCT00006237|531070793|FG001|Overall Study|Progression/relapse|2|||
147245265|NCT00006237|531070792|FG000|Overall Study|Not eligible|9|||
147245266|NCT00006237|531070793|FG001|Overall Study|Not eligible|20|||
147245267|NCT00006237|531070792|FG000|Overall Study|Withdrawal by Subject|0|||
147245268|NCT00006237|531070793|FG001|Overall Study|Withdrawal by Subject|1|||
147245269|NCT00006237|531070792|FG000|Overall Study|Not protocol specified|14|||
147245270|NCT00006237|531070793|FG001|Overall Study|Not protocol specified|5|||
147179191|NCT04090242|530821619|FG000|Overall Study|Withdrawal by Subject|1|||
147179192|NCT04090242|530821620|FG001|Overall Study|Withdrawal by Subject|0|||
147179193|NCT02513472|530821621|FG000|Overall Study|Radiological Disease Progression|45|||
147179194|NCT02513472|530821622|FG001|Overall Study|Radiological Disease Progression|57|||
147179195|NCT02513472|530821621|FG000|Overall Study|Clinical Disease Progression|5|||
147179196|NCT02513472|530821622|FG001|Overall Study|Clinical Disease Progression|13|||
147179197|NCT02513472|530821621|FG000|Overall Study|Adverse Event|8|||
147179198|NCT02513472|530821622|FG001|Overall Study|Adverse Event|11|||
147179199|NCT02513472|530821621|FG000|Overall Study|Withdrawal by Subject|0|||
147179200|NCT02513472|530821622|FG001|Overall Study|Withdrawal by Subject|4|||
147656217|NCT02959918|532564953|FG002|Overall Study|Sponsor Decision, Pause in Clinical Trial|1|||
147656218|NCT02959918|532564954|FG003|Overall Study|Sponsor Decision, Pause in Clinical Trial|3|||
147656219|NCT02959918|532564955|FG004|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
147656220|NCT02959918|532564956|FG005|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
147179201|NCT02513472|530821621|FG000|Overall Study|Subject Choice|2|||
147179202|NCT02513472|530821622|FG001|Overall Study|Subject Choice|7|||
147179203|NCT02513472|530821621|FG000|Overall Study|Treatment Completed as per Protocol|3|||
147179204|NCT02513472|530821622|FG001|Overall Study|Treatment Completed as per Protocol|3|||
147324886|NCT02696785|531354395|FG000|Washout Period|Withdrawal by Subject|0|||
147324887|NCT02696785|531354396|FG001|Washout Period|Withdrawal by Subject|1|||
147324888|NCT02696785|531354397|FG002|Washout Period|Withdrawal by Subject|0|||
147324889|NCT02696785|531354398|FG003|Washout Period|Withdrawal by Subject|0|||
147324890|NCT02696785|531354395|FG000|Washout Period|Lack of Efficacy|0|||
147324891|NCT02696785|531354396|FG001|Washout Period|Lack of Efficacy|1|||
147324892|NCT02696785|531354397|FG002|Washout Period|Lack of Efficacy|0|||
147324893|NCT02696785|531354398|FG003|Washout Period|Lack of Efficacy|0|||
147179205|NCT02513472|530821621|FG000|Overall Study|Other|3|||
147179206|NCT02513472|530821622|FG001|Overall Study|Other|6|||
147179207|NCT01019369|530821623|FG000|Overall Study|Lost to Follow-up|10|||
147179208|NCT01019369|530821624|FG001|Overall Study|Lost to Follow-up|6|||
147179209|NCT01019369|530821623|FG000|Overall Study|Withdrawal by Subject|0|||
147179210|NCT01019369|530821624|FG001|Overall Study|Withdrawal by Subject|1|||
147179211|NCT00604695|530821625|FG000|Overall Study|Did not receive first bolus.|0|||
147179212|NCT00604695|530821626|FG001|Overall Study|Did not receive first bolus.|4|||
147179213|NCT03214406|530821627|FG000|Overall Study|did not meet enrollment criteria|9|||
147179214|NCT03214406|530821628|FG001|Overall Study|did not meet enrollment criteria|13|||
147179215|NCT03214406|530821627|FG000|Overall Study|Withdrawal by Subject|1|||
147179216|NCT03214406|530821628|FG001|Overall Study|Withdrawal by Subject|0|||
147179217|NCT03214406|530821627|FG000|Overall Study|Lost to Follow-up|0|||
147179218|NCT03214406|530821628|FG001|Overall Study|Lost to Follow-up|2|||
147179219|NCT01098305|530821634|FG000|Overall Study|Lost to Follow-up|31|||
147324894|NCT02696785|531354395|FG000|Extended Treatment Period|Adverse Event|2|||
147593238|NCT02091141|532328943|FG001|Overall Study|Withdrew informed consent before receiving study drug|1|||
147593239|NCT02091141|532328944|FG002|Overall Study|Withdrew informed consent before receiving study drug|0|||
147593240|NCT02091141|532328945|FG003|Overall Study|Withdrew informed consent before receiving study drug|0|||
147593241|NCT02091141|532328946|FG004|Overall Study|Withdrew informed consent before receiving study drug|0|||
147593242|NCT02091141|532328947|FG005|Overall Study|Withdrew informed consent before receiving study drug|0|||
147593243|NCT02091141|532328948|FG006|Overall Study|Withdrew informed consent before receiving study drug|0|||
147593244|NCT04271735|532328949|FG000|Overall Study|Physician Decision|2|||
147593245|NCT04271735|532328950|FG001|Overall Study|Physician Decision|0|||
147593246|NCT02072148|532328952|FG000|Overall Study|withdrew prior to surgery|23|||
147593247|NCT02072148|532328953|FG001|Overall Study|withdrew prior to surgery|0|||
147593248|NCT02072148|532328954|FG002|Overall Study|withdrew prior to surgery|0|||
147593249|NCT02072148|532328952|FG000|Overall Study|Death|0|||
147593250|NCT02072148|532328953|FG001|Overall Study|Death|0|||
147593251|NCT02072148|532328954|FG002|Overall Study|Death|1|||
147179220|NCT01098305|530821635|FG001|Overall Study|Lost to Follow-up|33|||
147179221|NCT04565951|530821639|FG000|Overall Study|Lost to Follow-up|66|||
147179222|NCT04565951|530821640|FG001|Overall Study|Lost to Follow-up|38|||
147179223|NCT04565951|530821639|FG000|Overall Study|Withdrawal by Subject|14|||
147324895|NCT02696785|531354396|FG001|Extended Treatment Period|Adverse Event|3|||
147324896|NCT02696785|531354397|FG002|Extended Treatment Period|Adverse Event|2|||
147179224|NCT04565951|530821640|FG001|Overall Study|Withdrawal by Subject|7|||
147179225|NCT04565951|530821639|FG000|Overall Study|Death|0|||
147179226|NCT04565951|530821640|FG001|Overall Study|Death|1|||
147179227|NCT00429169|530821642|FG000|Overall Study|Lost to Follow-up|0|||
147179228|NCT00429169|530821643|FG001|Overall Study|Lost to Follow-up|1|||
147179229|NCT00429169|530821642|FG000|Overall Study|Ineligibility discovered after entry|2|||
147179230|NCT00429169|530821643|FG001|Overall Study|Ineligibility discovered after entry|1|||
147179231|NCT01746173|530821648|FG000|Overall Study|Disease Progression|2|||
147179232|NCT04371666|530821653|FG000|DB Treatment Period (52 Weeks)|Adverse Event|3|||
147179233|NCT04371666|530821654|FG001|DB Treatment Period (52 Weeks)|Adverse Event|1|||
147179234|NCT04371666|530821653|FG000|DB Treatment Period (52 Weeks)|Participant/Legal Guardian Decision|1|||
147179235|NCT04371666|530821654|FG001|DB Treatment Period (52 Weeks)|Participant/Legal Guardian Decision|2|||
147179236|NCT04371666|530821653|FG000|DB Treatment Period (52 Weeks)|Other than specified|1|||
147179237|NCT04371666|530821654|FG001|DB Treatment Period (52 Weeks)|Other than specified|0|||
147179238|NCT04371666|530821653|FG000|OLE (Maximum Exposure: 93.4 Weeks)|Participant/Legal Guardian Decision|2|||
147179239|NCT04371666|530821654|FG001|OLE (Maximum Exposure: 93.4 Weeks)|Participant/Legal Guardian Decision|2|||
147179240|NCT04371666|530821653|FG000|OLE (Maximum Exposure: 93.4 Weeks)|Sponsor Decision to Terminate Study|40|||
147245271|NCT01846416|531070798|FG000|Treatment Phase|Death|2|||
147245272|NCT01846416|531070799|FG001|Treatment Phase|Death|9|||
147245273|NCT01846416|531070800|FG002|Treatment Phase|Death|1|||
147245274|NCT01846416|531070798|FG000|Treatment Phase|Withdrawal by Subject|2|||
147245275|NCT01846416|531070799|FG001|Treatment Phase|Withdrawal by Subject|4|||
147245276|NCT01846416|531070800|FG002|Treatment Phase|Withdrawal by Subject|2|||
147245277|NCT01846416|531070798|FG000|Treatment Phase|Other|1|||
147245278|NCT01846416|531070799|FG001|Treatment Phase|Other|5|||
147324897|NCT02696785|531354398|FG003|Extended Treatment Period|Adverse Event|1|||
147324898|NCT02696785|531354395|FG000|Extended Treatment Period|Lack of Efficacy|0|||
147324899|NCT02696785|531354396|FG001|Extended Treatment Period|Lack of Efficacy|1|||
147324900|NCT02696785|531354397|FG002|Extended Treatment Period|Lack of Efficacy|0|||
147593252|NCT02072148|532328952|FG000|Overall Study|Withdrawal by Subject|0|||
147324901|NCT02696785|531354398|FG003|Extended Treatment Period|Lack of Efficacy|0|||
147324902|NCT02696785|531354395|FG000|Extended Treatment Period|Withdrawal by Subject|1|||
147324903|NCT02696785|531354396|FG001|Extended Treatment Period|Withdrawal by Subject|2|||
147324904|NCT02696785|531354397|FG002|Extended Treatment Period|Withdrawal by Subject|3|||
147324905|NCT02696785|531354398|FG003|Extended Treatment Period|Withdrawal by Subject|5|||
147324906|NCT02696785|531354395|FG000|Follow-up Period|Adverse Event|0|||
147324907|NCT02696785|531354396|FG001|Follow-up Period|Adverse Event|0|||
147324908|NCT02696785|531354397|FG002|Follow-up Period|Adverse Event|8|||
147324909|NCT02696785|531354398|FG003|Follow-up Period|Adverse Event|2|||
147324910|NCT02696785|531354395|FG000|Follow-up Period|Lost to Follow-up|0|||
147324911|NCT02696785|531354396|FG001|Follow-up Period|Lost to Follow-up|0|||
147324912|NCT02696785|531354397|FG002|Follow-up Period|Lost to Follow-up|0|||
147324913|NCT02696785|531354398|FG003|Follow-up Period|Lost to Follow-up|1|||
147324914|NCT02696785|531354395|FG000|Follow-up Period|Lack of Efficacy|0|||
147324915|NCT02696785|531354396|FG001|Follow-up Period|Lack of Efficacy|0|||
147324916|NCT02696785|531354397|FG002|Follow-up Period|Lack of Efficacy|0|||
147324917|NCT02696785|531354398|FG003|Follow-up Period|Lack of Efficacy|1|||
147324918|NCT02696785|531354395|FG000|Follow-up Period|Withdrawal by Subject|1|||
147324919|NCT02696785|531354396|FG001|Follow-up Period|Withdrawal by Subject|0|||
147324920|NCT02696785|531354397|FG002|Follow-up Period|Withdrawal by Subject|5|||
147324921|NCT02696785|531354398|FG003|Follow-up Period|Withdrawal by Subject|4|||
147324922|NCT02487446|531354406|FG000|Period 1|Physician Decision|0|||
147324923|NCT02487446|531354407|FG001|Period 1|Physician Decision|1|||
147324924|NCT02487446|531354406|FG000|Period 1|Lack of Efficacy|1|||
147324925|NCT02487446|531354407|FG001|Period 1|Lack of Efficacy|0|||
147324926|NCT02487446|531354406|FG000|Period 1|Protocol deviation|3|||
147324927|NCT02487446|531354407|FG001|Period 1|Protocol deviation|2|||
147324928|NCT02487446|531354406|FG000|Period 1|Lost to Follow-up|2|||
147324929|NCT02487446|531354407|FG001|Period 1|Lost to Follow-up|0|||
147324930|NCT02487446|531354406|FG000|Period 1|Withdrawal by Subject|2|||
147324931|NCT02487446|531354407|FG001|Period 1|Withdrawal by Subject|0|||
147324932|NCT02487446|531354406|FG000|Period 1|Adverse Event|5|||
147324933|NCT02487446|531354407|FG001|Period 1|Adverse Event|5|||
147324934|NCT02487446|531354406|FG000|Washout|Lost to Follow-up|0|||
147324935|NCT02487446|531354407|FG001|Washout|Lost to Follow-up|2|||
147324936|NCT02487446|531354406|FG000|Washout|Withdrawal by Subject|1|||
147324937|NCT02487446|531354407|FG001|Washout|Withdrawal by Subject|4|||
147324938|NCT02487446|531354406|FG000|Washout|Adverse Event|2|||
147324939|NCT02487446|531354407|FG001|Washout|Adverse Event|2|||
147324940|NCT02487446|531354406|FG000|Period 2|Protocol deviation|0|||
147324941|NCT02487446|531354407|FG001|Period 2|Protocol deviation|1|||
147324942|NCT02487446|531354406|FG000|Period 2|Lost to Follow-up|1|||
147324943|NCT02487446|531354407|FG001|Period 2|Lost to Follow-up|1|||
147324944|NCT02487446|531354406|FG000|Period 2|Withdrawal by Subject|1|||
147324945|NCT02487446|531354407|FG001|Period 2|Withdrawal by Subject|1|||
147324946|NCT02487446|531354406|FG000|Period 2|Adverse Event|6|||
147324947|NCT02487446|531354407|FG001|Period 2|Adverse Event|2|||
147448367|NCT00677014|531805704|FG002|Overall Study|Unavailable or unreadable 6 month LVESV|18|||
147448368|NCT00640328|531805705|FG000|First Treatment Period (Weeks 0-24)|Adverse Event|0|||
147324948|NCT01822821|531354408|FG000|Overall Study|Eligible surgery cancelled|1|||
147324949|NCT01822821|531354409|FG001|Overall Study|Eligible surgery cancelled|1|||
147324950|NCT01822821|531354408|FG000|Overall Study|Other reasons|1|||
147324951|NCT01822821|531354409|FG001|Overall Study|Other reasons|0|||
147324952|NCT02320253|531354410|FG000|Overall Study|Withdrawal by Subject|3|||
147593253|NCT02072148|532328953|FG001|Overall Study|Withdrawal by Subject|13|||
147593254|NCT02072148|532328954|FG002|Overall Study|Withdrawal by Subject|12|||
147324953|NCT02320253|531354411|FG001|Overall Study|Withdrawal by Subject|0|||
147324954|NCT02320253|531354412|FG002|Overall Study|Withdrawal by Subject|0|||
147324955|NCT02320253|531354410|FG000|Overall Study|Lost to Follow-up|2|||
147324956|NCT02320253|531354411|FG001|Overall Study|Lost to Follow-up|2|||
147324957|NCT02320253|531354412|FG002|Overall Study|Lost to Follow-up|1|||
147324958|NCT02320253|531354410|FG000|Overall Study|Death|1|||
147324959|NCT02320253|531354411|FG001|Overall Study|Death|0|||
147324960|NCT02320253|531354412|FG002|Overall Study|Death|1|||
147324961|NCT05750745|531354413|FG000|Overall Study|Adverse Event|1|||
147324962|NCT05750745|531354414|FG001|Overall Study|Adverse Event|0|||
147324963|NCT05750745|531354415|FG002|Overall Study|Adverse Event|0|||
147324964|NCT05750745|531354413|FG000|Overall Study|Protocol Violation|1|||
147324965|NCT05750745|531354414|FG001|Overall Study|Protocol Violation|0|||
147324966|NCT05750745|531354415|FG002|Overall Study|Protocol Violation|0|||
147593255|NCT00430495|532328955|FG000|Overall Study|Adverse Event|2|||
147324967|NCT05750745|531354413|FG000|Overall Study|Withdrawal by Subject|0|||
147593256|NCT00430495|532328956|FG001|Overall Study|Adverse Event|3|||
147593257|NCT00430495|532328957|FG002|Overall Study|Adverse Event|2|||
147324968|NCT05750745|531354414|FG001|Overall Study|Withdrawal by Subject|1|||
147324969|NCT05750745|531354415|FG002|Overall Study|Withdrawal by Subject|0|||
147324970|NCT05780047|531354417|FG000|Overall Study|Did not submit baseline urine test kit|226|||
147324971|NCT05780047|531354417|FG000|Overall Study|Lost to Follow-up|34|||
147593258|NCT00430495|532328958|FG003|Overall Study|Adverse Event|0|||
147324972|NCT05780047|531354417|FG000|Overall Study|Did not submit second urine test kit|124|||
147324973|NCT03590743|531354420|FG000|Overall Study|Withdrawal by Subject|0|||
147324974|NCT03590743|531354421|FG001|Overall Study|Withdrawal by Subject|1|||
147324975|NCT02696226|531354422|FG000|Overall Study|Study terminated - lack of enrollment|1|||
147324976|NCT02696226|531354423|FG001|Overall Study|Study terminated - lack of enrollment|0|||
147324977|NCT02696226|531354424|FG002|Overall Study|Study terminated - lack of enrollment|2|||
147324978|NCT02696226|531354425|FG003|Overall Study|Study terminated - lack of enrollment|0|||
147324979|NCT02698436|531354426|FG000|Overall Study|Adverse Event|1|||
147324980|NCT02698436|531354427|FG001|Overall Study|Adverse Event|0|||
147324981|NCT02698436|531354426|FG000|Overall Study|Withdrawal by Subject|3|||
147324982|NCT02698436|531354427|FG001|Overall Study|Withdrawal by Subject|3|||
147324983|NCT02698436|531354426|FG000|Overall Study|Lost to Follow-up|2|||
147324984|NCT02698436|531354427|FG001|Overall Study|Lost to Follow-up|4|||
147179241|NCT04371666|530821654|FG001|OLE (Maximum Exposure: 93.4 Weeks)|Sponsor Decision to Terminate Study|41|||
147179242|NCT04371666|530821653|FG000|OLE (Maximum Exposure: 93.4 Weeks)|Other than specified|1|||
147179243|NCT04371666|530821654|FG001|OLE (Maximum Exposure: 93.4 Weeks)|Other than specified|0|||
147179244|NCT00615017|530823491|FG000|Overall Study|Adverse Event|0|||
147179245|NCT00615017|530823492|FG001|Overall Study|Adverse Event|1|||
147179246|NCT00615017|530823493|FG002|Overall Study|Adverse Event|2|||
147324985|NCT02698436|531354426|FG000|Overall Study|Non-compliance with study regimen|1|||
147324986|NCT02698436|531354427|FG001|Overall Study|Non-compliance with study regimen|0|||
147324987|NCT00097370|531354428|FG000|Stage 1|Adverse Event|3|||
147324988|NCT00097370|531354428|FG000|Stage 1|Withdrawal by Subject|1|||
147324989|NCT00097370|531354428|FG000|Stage 1|Lack of Efficacy|2|||
147324990|NCT00097370|531354428|FG000|Stage 2|Adverse Event|5|||
147324991|NCT00097370|531354428|FG000|Stage 2|Withdrawal by Subject|1|||
147324992|NCT00097370|531354428|FG000|Stage 2|Lack of Efficacy|3|||
147324993|NCT00097370|531354428|FG000|Stage 2|Pregnancy|1|||
147324994|NCT00097370|531354428|FG000|Stage 2|Sponsor Terminated Study|2|||
147324995|NCT00097370|531354428|FG000|Stage 2|Lost to Follow-up|1|||
147324996|NCT00097370|531354428|FG000|Stage 3|Adverse Event|2|||
147324997|NCT00097370|531354428|FG000|Stage 3|Withdrawal by Subject|3|||
147324998|NCT00097370|531354428|FG000|Stage 3|Lack of Efficacy|1|||
147324999|NCT00097370|531354428|FG000|Stage 3|Sponsor Terminated Study|52|||
147325000|NCT00097370|531354428|FG000|Stage 3|Lost to Follow-up|1|||
147325001|NCT00062868|531354438|FG000|Dose Level 1|Death|2|||
147325002|NCT00062868|531354439|FG001|Dose Level 1|Death|0|||
147325003|NCT00062868|531354440|FG002|Dose Level 1|Death|0|||
147325004|NCT00062868|531354441|FG003|Dose Level 1|Death|2|||
147325005|NCT00062868|531354442|FG004|Dose Level 1|Death|0|||
147325006|NCT00062868|531354443|FG005|Dose Level 1|Death|0|||
147325007|NCT00062868|531354444|FG006|Dose Level 1|Death|3|||
147325008|NCT00062868|531354445|FG007|Dose Level 1|Death|0|||
147325009|NCT00062868|531354446|FG008|Dose Level 1|Death|0|||
147325010|NCT00062868|531354447|FG009|Dose Level 1|Death|0|||
147325011|NCT00062868|531354448|FG010|Dose Level 1|Death|0|||
147325012|NCT00062868|531354449|FG011|Dose Level 1|Death|0|||
147325013|NCT00062868|531354450|FG012|Dose Level 1|Death|0|||
147325014|NCT00062868|531354451|FG013|Dose Level 1|Death|0|||
147325015|NCT00062868|531354452|FG014|Dose Level 1|Death|0|||
147325016|NCT00062868|531354453|FG015|Dose Level 1|Death|0|||
147325017|NCT00062868|531354454|FG016|Dose Level 1|Death|0|||
147325018|NCT00062868|531354455|FG017|Dose Level 1|Death|0|||
147325019|NCT00062868|531354456|FG018|Dose Level 1|Death|7|||
147325020|NCT00062868|531354457|FG019|Dose Level 1|Death|0|||
147325021|NCT00062868|531354458|FG020|Dose Level 1|Death|1|||
147325022|NCT00062868|531354438|FG000|Dose Level 1|Lost to Follow-up|0|||
147325023|NCT00062868|531354439|FG001|Dose Level 1|Lost to Follow-up|0|||
147325024|NCT00062868|531354440|FG002|Dose Level 1|Lost to Follow-up|0|||
147325025|NCT00062868|531354441|FG003|Dose Level 1|Lost to Follow-up|0|||
147325026|NCT00062868|531354442|FG004|Dose Level 1|Lost to Follow-up|0|||
147325027|NCT00062868|531354443|FG005|Dose Level 1|Lost to Follow-up|0|||
147325028|NCT00062868|531354444|FG006|Dose Level 1|Lost to Follow-up|0|||
147325029|NCT00062868|531354445|FG007|Dose Level 1|Lost to Follow-up|0|||
147325030|NCT00062868|531354446|FG008|Dose Level 1|Lost to Follow-up|0|||
147325031|NCT00062868|531354447|FG009|Dose Level 1|Lost to Follow-up|0|||
147325032|NCT00062868|531354448|FG010|Dose Level 1|Lost to Follow-up|0|||
147325033|NCT00062868|531354449|FG011|Dose Level 1|Lost to Follow-up|0|||
147325034|NCT00062868|531354450|FG012|Dose Level 1|Lost to Follow-up|1|||
147325035|NCT00062868|531354451|FG013|Dose Level 1|Lost to Follow-up|0|||
147325036|NCT00062868|531354452|FG014|Dose Level 1|Lost to Follow-up|0|||
147325037|NCT00062868|531354453|FG015|Dose Level 1|Lost to Follow-up|0|||
147325038|NCT00062868|531354454|FG016|Dose Level 1|Lost to Follow-up|0|||
147325039|NCT00062868|531354455|FG017|Dose Level 1|Lost to Follow-up|0|||
147325040|NCT00062868|531354456|FG018|Dose Level 1|Lost to Follow-up|2|||
147325041|NCT00062868|531354457|FG019|Dose Level 1|Lost to Follow-up|0|||
147325042|NCT00062868|531354458|FG020|Dose Level 1|Lost to Follow-up|1|||
147325043|NCT00062868|531354438|FG000|Dose Level 2|Death|0|||
147325044|NCT00062868|531354439|FG001|Dose Level 2|Death|3|||
147325045|NCT00062868|531354440|FG002|Dose Level 2|Death|0|||
147325046|NCT00062868|531354441|FG003|Dose Level 2|Death|0|||
147325047|NCT00062868|531354442|FG004|Dose Level 2|Death|2|||
147325048|NCT00062868|531354443|FG005|Dose Level 2|Death|0|||
147325049|NCT00062868|531354444|FG006|Dose Level 2|Death|0|||
147325050|NCT00062868|531354445|FG007|Dose Level 2|Death|0|||
147325051|NCT00062868|531354446|FG008|Dose Level 2|Death|0|||
147325052|NCT00062868|531354447|FG009|Dose Level 2|Death|0|||
147325053|NCT00062868|531354448|FG010|Dose Level 2|Death|1|||
147325054|NCT00062868|531354449|FG011|Dose Level 2|Death|0|||
147325055|NCT00062868|531354450|FG012|Dose Level 2|Death|0|||
147325056|NCT00062868|531354451|FG013|Dose Level 2|Death|0|||
147325057|NCT00062868|531354452|FG014|Dose Level 2|Death|0|||
147325058|NCT00062868|531354453|FG015|Dose Level 2|Death|0|||
147325059|NCT00062868|531354454|FG016|Dose Level 2|Death|2|||
147325060|NCT00062868|531354455|FG017|Dose Level 2|Death|0|||
147325061|NCT00062868|531354456|FG018|Dose Level 2|Death|0|||
147325062|NCT00062868|531354457|FG019|Dose Level 2|Death|0|||
147325063|NCT00062868|531354458|FG020|Dose Level 2|Death|0|||
147325064|NCT00062868|531354438|FG000|Dose Level 2|Lost to Follow-up|0|||
147325065|NCT00062868|531354439|FG001|Dose Level 2|Lost to Follow-up|0|||
147325066|NCT00062868|531354440|FG002|Dose Level 2|Lost to Follow-up|0|||
147325067|NCT00062868|531354441|FG003|Dose Level 2|Lost to Follow-up|0|||
147325068|NCT00062868|531354442|FG004|Dose Level 2|Lost to Follow-up|0|||
147325069|NCT00062868|531354443|FG005|Dose Level 2|Lost to Follow-up|0|||
147325070|NCT00062868|531354444|FG006|Dose Level 2|Lost to Follow-up|0|||
147325071|NCT00062868|531354445|FG007|Dose Level 2|Lost to Follow-up|0|||
147325072|NCT00062868|531354446|FG008|Dose Level 2|Lost to Follow-up|0|||
147325073|NCT00062868|531354447|FG009|Dose Level 2|Lost to Follow-up|0|||
147325074|NCT00062868|531354448|FG010|Dose Level 2|Lost to Follow-up|0|||
147325075|NCT00062868|531354449|FG011|Dose Level 2|Lost to Follow-up|0|||
147325076|NCT00062868|531354450|FG012|Dose Level 2|Lost to Follow-up|0|||
147325077|NCT00062868|531354451|FG013|Dose Level 2|Lost to Follow-up|1|||
147325078|NCT00062868|531354452|FG014|Dose Level 2|Lost to Follow-up|0|||
147325079|NCT00062868|531354453|FG015|Dose Level 2|Lost to Follow-up|0|||
147325080|NCT00062868|531354454|FG016|Dose Level 2|Lost to Follow-up|1|||
147325081|NCT00062868|531354455|FG017|Dose Level 2|Lost to Follow-up|0|||
147325082|NCT00062868|531354456|FG018|Dose Level 2|Lost to Follow-up|0|||
147325083|NCT00062868|531354457|FG019|Dose Level 2|Lost to Follow-up|0|||
147325084|NCT00062868|531354458|FG020|Dose Level 2|Lost to Follow-up|0|||
147325085|NCT00062868|531354438|FG000|Dose Level 3|Death|0|||
147325086|NCT00062868|531354439|FG001|Dose Level 3|Death|0|||
147325087|NCT00062868|531354440|FG002|Dose Level 3|Death|0|||
147325088|NCT00062868|531354441|FG003|Dose Level 3|Death|0|||
147325089|NCT00062868|531354442|FG004|Dose Level 3|Death|0|||
147325090|NCT00062868|531354443|FG005|Dose Level 3|Death|0|||
147325091|NCT00062868|531354444|FG006|Dose Level 3|Death|0|||
147325092|NCT00062868|531354445|FG007|Dose Level 3|Death|0|||
147325093|NCT00062868|531354446|FG008|Dose Level 3|Death|0|||
147325094|NCT00062868|531354447|FG009|Dose Level 3|Death|0|||
147325095|NCT00062868|531354448|FG010|Dose Level 3|Death|0|||
147325096|NCT00062868|531354449|FG011|Dose Level 3|Death|1|||
147325097|NCT00062868|531354450|FG012|Dose Level 3|Death|0|||
147325098|NCT00062868|531354451|FG013|Dose Level 3|Death|0|||
147325099|NCT00062868|531354452|FG014|Dose Level 3|Death|0|||
147325100|NCT00062868|531354453|FG015|Dose Level 3|Death|0|||
147325101|NCT00062868|531354454|FG016|Dose Level 3|Death|0|||
147325102|NCT00062868|531354455|FG017|Dose Level 3|Death|1|||
147325103|NCT00062868|531354456|FG018|Dose Level 3|Death|0|||
147325104|NCT00062868|531354457|FG019|Dose Level 3|Death|0|||
147325105|NCT00062868|531354458|FG020|Dose Level 3|Death|0|||
147325106|NCT00062868|531354438|FG000|Dose Level 3|Lost to Follow-up|0|||
147448369|NCT00640328|531805706|FG001|First Treatment Period (Weeks 0-24)|Adverse Event|1|||
147179247|NCT00615017|530823494|FG003|Overall Study|Adverse Event|0|||
147179248|NCT00615017|530823495|FG004|Overall Study|Adverse Event|0|||
147179249|NCT00615017|530823496|FG005|Overall Study|Adverse Event|1|||
147179250|NCT00615017|530823491|FG000|Overall Study|Death|0|||
147179251|NCT00615017|530823492|FG001|Overall Study|Death|0|||
147179252|NCT00615017|530823493|FG002|Overall Study|Death|2|||
147325107|NCT00062868|531354439|FG001|Dose Level 3|Lost to Follow-up|0|||
147325108|NCT00062868|531354440|FG002|Dose Level 3|Lost to Follow-up|0|||
147325109|NCT00062868|531354441|FG003|Dose Level 3|Lost to Follow-up|0|||
147325110|NCT00062868|531354442|FG004|Dose Level 3|Lost to Follow-up|0|||
147325111|NCT00062868|531354443|FG005|Dose Level 3|Lost to Follow-up|0|||
147325112|NCT00062868|531354444|FG006|Dose Level 3|Lost to Follow-up|0|||
147325113|NCT00062868|531354445|FG007|Dose Level 3|Lost to Follow-up|0|||
147325114|NCT00062868|531354446|FG008|Dose Level 3|Lost to Follow-up|0|||
147325115|NCT00062868|531354447|FG009|Dose Level 3|Lost to Follow-up|0|||
147325116|NCT00062868|531354448|FG010|Dose Level 3|Lost to Follow-up|0|||
147325117|NCT00062868|531354449|FG011|Dose Level 3|Lost to Follow-up|0|||
147325118|NCT00062868|531354450|FG012|Dose Level 3|Lost to Follow-up|0|||
147325119|NCT00062868|531354451|FG013|Dose Level 3|Lost to Follow-up|0|||
147325120|NCT00062868|531354452|FG014|Dose Level 3|Lost to Follow-up|1|||
147325121|NCT00062868|531354453|FG015|Dose Level 3|Lost to Follow-up|0|||
147325122|NCT00062868|531354454|FG016|Dose Level 3|Lost to Follow-up|0|||
147179253|NCT00615017|530823494|FG003|Overall Study|Death|0|||
147179254|NCT00615017|530823495|FG004|Overall Study|Death|1|||
147179255|NCT00615017|530823496|FG005|Overall Study|Death|1|||
147179256|NCT00615017|530823491|FG000|Overall Study|Sepsis resolved|0|||
147179257|NCT00615017|530823492|FG001|Overall Study|Sepsis resolved|0|||
147179258|NCT00615017|530823493|FG002|Overall Study|Sepsis resolved|1|||
147179259|NCT00615017|530823494|FG003|Overall Study|Sepsis resolved|0|||
147179260|NCT00615017|530823495|FG004|Overall Study|Sepsis resolved|0|||
147179261|NCT00615017|530823496|FG005|Overall Study|Sepsis resolved|0|||
147179262|NCT00615017|530823491|FG000|Overall Study|Transferred out of Intensive Care Unit|0|||
147179263|NCT00615017|530823492|FG001|Overall Study|Transferred out of Intensive Care Unit|0|||
147179264|NCT00615017|530823493|FG002|Overall Study|Transferred out of Intensive Care Unit|0|||
147179265|NCT00615017|530823494|FG003|Overall Study|Transferred out of Intensive Care Unit|1|||
147179266|NCT00615017|530823495|FG004|Overall Study|Transferred out of Intensive Care Unit|0|||
147179267|NCT00615017|530823496|FG005|Overall Study|Transferred out of Intensive Care Unit|0|||
147179268|NCT00615017|530823491|FG000|Overall Study|Physician discontinued drug|0|||
147245279|NCT01846416|531070800|FG002|Treatment Phase|Other|1|||
147245280|NCT01846416|531070798|FG000|Treatment Phase|Physician Decision|1|||
147245281|NCT01846416|531070799|FG001|Treatment Phase|Physician Decision|2|||
147245282|NCT01846416|531070800|FG002|Treatment Phase|Physician Decision|0|||
147245283|NCT01846416|531070798|FG000|Treatment Phase|Adverse Event|3|||
147245284|NCT01846416|531070799|FG001|Treatment Phase|Adverse Event|4|||
147245285|NCT01846416|531070800|FG002|Treatment Phase|Adverse Event|0|||
147245286|NCT01846416|531070798|FG000|Treatment Phase|Non-compliance|0|||
147245287|NCT01846416|531070799|FG001|Treatment Phase|Non-compliance|2|||
147245288|NCT01846416|531070800|FG002|Treatment Phase|Non-compliance|0|||
147245289|NCT01846416|531070798|FG000|Treatment Phase|Study Terminated by Sponsor|1|||
147245290|NCT01846416|531070799|FG001|Treatment Phase|Study Terminated by Sponsor|4|||
147245291|NCT01846416|531070800|FG002|Treatment Phase|Study Terminated by Sponsor|0|||
147245292|NCT01846416|531070798|FG000|Treatment Phase|Progressive Disease|21|||
147245293|NCT01846416|531070799|FG001|Treatment Phase|Progressive Disease|63|||
147245294|NCT01846416|531070800|FG002|Treatment Phase|Progressive Disease|9|||
147245295|NCT01846416|531070798|FG000|Survival Follow-up|Death|21|||
147245296|NCT01846416|531070799|FG001|Survival Follow-up|Death|62|||
147245297|NCT01846416|531070800|FG002|Survival Follow-up|Death|9|||
147245298|NCT01846416|531070798|FG000|Survival Follow-up|Lost to Follow-up|0|||
147245299|NCT01846416|531070799|FG001|Survival Follow-up|Lost to Follow-up|2|||
147245300|NCT01846416|531070800|FG002|Survival Follow-up|Lost to Follow-up|2|||
147245301|NCT01846416|531070798|FG000|Survival Follow-up|Withdrawal by Subject|2|||
147245302|NCT01846416|531070799|FG001|Survival Follow-up|Withdrawal by Subject|7|||
147245303|NCT01846416|531070800|FG002|Survival Follow-up|Withdrawal by Subject|0|||
147245304|NCT01846416|531070798|FG000|Survival Follow-up|Study Terminated by Sponsor|2|||
147245305|NCT01846416|531070799|FG001|Survival Follow-up|Study Terminated by Sponsor|8|||
147245306|NCT01846416|531070800|FG002|Survival Follow-up|Study Terminated by Sponsor|0|||
147245307|NCT01846416|531070798|FG000|Survival Follow-up|Other|3|||
147245308|NCT01846416|531070799|FG001|Survival Follow-up|Other|1|||
147245309|NCT01846416|531070800|FG002|Survival Follow-up|Other|1|||
147245310|NCT01737697|531070803|FG000|Acute Phase-Initial 48 Hours|Adverse Event|0|||
147245311|NCT01737697|531070804|FG001|Acute Phase-Initial 48 Hours|Adverse Event|1|||
147245312|NCT01737697|531070805|FG002|Acute Phase-Initial 48 Hours|Adverse Event|0|||
147245313|NCT01737697|531070806|FG003|Acute Phase-Initial 48 Hours|Adverse Event|1|||
147245314|NCT01737697|531070807|FG004|Acute Phase-Initial 48 Hours|Adverse Event|1|||
147245315|NCT01737697|531070808|FG005|Acute Phase-Initial 48 Hours|Adverse Event|0|||
147245316|NCT01737697|531070809|FG006|Acute Phase-Initial 48 Hours|Adverse Event|0|||
147245317|NCT01737697|531070810|FG007|Acute Phase-Initial 48 Hours|Adverse Event|0|||
147245318|NCT01737697|531070811|FG008|Acute Phase-Initial 48 Hours|Adverse Event|0|||
147245319|NCT01737697|531070812|FG009|Acute Phase-Initial 48 Hours|Adverse Event|0|||
147245320|NCT01737697|531070813|FG010|Acute Phase-Initial 48 Hours|Adverse Event|0|||
147245321|NCT01737697|531070814|FG011|Acute Phase-Initial 48 Hours|Adverse Event|0|||
147245322|NCT01737697|531070815|FG012|Acute Phase-Initial 48 Hours|Adverse Event|0|||
147245323|NCT01737697|531070816|FG013|Acute Phase-Initial 48 Hours|Adverse Event|0|||
147245324|NCT01737697|531070817|FG014|Acute Phase-Initial 48 Hours|Adverse Event|0|||
147245325|NCT01737697|531070803|FG000|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|1|||
147245326|NCT01737697|531070804|FG001|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|1|||
147245327|NCT01737697|531070805|FG002|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|3|||
147245328|NCT01737697|531070806|FG003|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
147245329|NCT01737697|531070807|FG004|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
147245330|NCT01737697|531070808|FG005|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
147245331|NCT01737697|531070809|FG006|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
147245332|NCT01737697|531070810|FG007|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
147245333|NCT01737697|531070811|FG008|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
147179269|NCT00615017|530823492|FG001|Overall Study|Physician discontinued drug|0|||
147245334|NCT01737697|531070812|FG009|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
147245335|NCT01737697|531070813|FG010|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
147245336|NCT01737697|531070814|FG011|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
147325123|NCT00062868|531354455|FG017|Dose Level 3|Lost to Follow-up|0|||
147325124|NCT00062868|531354456|FG018|Dose Level 3|Lost to Follow-up|0|||
147325125|NCT00062868|531354457|FG019|Dose Level 3|Lost to Follow-up|0|||
147325126|NCT00062868|531354458|FG020|Dose Level 3|Lost to Follow-up|0|||
147325127|NCT00062868|531354438|FG000|Dose Level 3|Withdrew|0|||
147325128|NCT00062868|531354439|FG001|Dose Level 3|Withdrew|0|||
147325129|NCT00062868|531354440|FG002|Dose Level 3|Withdrew|2|||
147325130|NCT00062868|531354441|FG003|Dose Level 3|Withdrew|0|||
147325131|NCT00062868|531354442|FG004|Dose Level 3|Withdrew|0|||
147325132|NCT00062868|531354443|FG005|Dose Level 3|Withdrew|0|||
147325133|NCT00062868|531354444|FG006|Dose Level 3|Withdrew|0|||
147325134|NCT00062868|531354445|FG007|Dose Level 3|Withdrew|0|||
147325135|NCT00062868|531354446|FG008|Dose Level 3|Withdrew|0|||
147325136|NCT00062868|531354447|FG009|Dose Level 3|Withdrew|0|||
147325137|NCT00062868|531354448|FG010|Dose Level 3|Withdrew|0|||
147325138|NCT00062868|531354449|FG011|Dose Level 3|Withdrew|0|||
147325139|NCT00062868|531354450|FG012|Dose Level 3|Withdrew|0|||
147325140|NCT00062868|531354451|FG013|Dose Level 3|Withdrew|0|||
147325141|NCT00062868|531354452|FG014|Dose Level 3|Withdrew|0|||
147325142|NCT00062868|531354453|FG015|Dose Level 3|Withdrew|0|||
147325143|NCT00062868|531354454|FG016|Dose Level 3|Withdrew|0|||
147325144|NCT00062868|531354455|FG017|Dose Level 3|Withdrew|0|||
147325145|NCT00062868|531354456|FG018|Dose Level 3|Withdrew|0|||
147325146|NCT00062868|531354457|FG019|Dose Level 3|Withdrew|0|||
147325147|NCT00062868|531354458|FG020|Dose Level 3|Withdrew|0|||
147325148|NCT04949399|531354461|FG000|Overall Study|Lost to Follow-up|11|||
147325149|NCT04949399|531354462|FG001|Overall Study|Lost to Follow-up|6|||
147325150|NCT04949399|531354461|FG000|Overall Study|Withdrawal by Subject|2|||
147325151|NCT04949399|531354462|FG001|Overall Study|Withdrawal by Subject|3|||
147325152|NCT00670540|531354463|FG000|Overall Study|ineligible|17|||
147325153|NCT00670540|531354463|FG000|Overall Study|not living in France|348|||
147325154|NCT00670540|531354463|FG000|Overall Study|refused to participate|189|||
147325155|NCT00670540|531354463|FG000|Overall Study|controls randomised for no follow up|2770|||
147325156|NCT00670540|531354463|FG000|Overall Study|missing information inclusion criteria|1|||
147325157|NCT01866917|531354464|FG000|Overall Study|Pharmacist stopped dispensing treatment|4|||
147325158|NCT01866917|531354465|FG001|Overall Study|Pharmacist stopped dispensing treatment|6|||
147325159|NCT01140347|531354472|FG000|Overall Study|Lost to Follow-up|5|||
147325160|NCT01140347|531354473|FG001|Overall Study|Lost to Follow-up|6|||
147325161|NCT01140347|531354472|FG000|Overall Study|Withdrawal by Subject|13|||
147325162|NCT01140347|531354473|FG001|Overall Study|Withdrawal by Subject|8|||
147325163|NCT00901485|531354474|FG000|Overall Study|Lack of Efficacy|0|||
147325164|NCT00901485|531354475|FG001|Overall Study|Lack of Efficacy|2|||
147325165|NCT00901485|531354474|FG000|Overall Study|Withdrawal by Subject|1|||
147325166|NCT00901485|531354475|FG001|Overall Study|Withdrawal by Subject|2|||
147325167|NCT01959880|531354476|FG000|Overall Study|Withdrawal by Subject|11|||
147325168|NCT01959880|531354477|FG001|Overall Study|Withdrawal by Subject|13|||
147325169|NCT01959880|531354478|FG002|Overall Study|Withdrawal by Subject|8|||
147325170|NCT01959880|531354479|FG003|Overall Study|Withdrawal by Subject|7|||
147325171|NCT01959880|531354476|FG000|Overall Study|Death|1|||
147325172|NCT01959880|531354477|FG001|Overall Study|Death|10|||
147325173|NCT01959880|531354478|FG002|Overall Study|Death|1|||
147325174|NCT01959880|531354479|FG003|Overall Study|Death|2|||
147325175|NCT01959880|531354476|FG000|Overall Study|Lost to Follow-up|95|||
147325176|NCT01959880|531354477|FG001|Overall Study|Lost to Follow-up|18|||
147325177|NCT01959880|531354478|FG002|Overall Study|Lost to Follow-up|15|||
147325178|NCT01959880|531354479|FG003|Overall Study|Lost to Follow-up|8|||
147325179|NCT01959880|531354476|FG000|Overall Study|Explantation w/o study device reimplant.|22|||
147325180|NCT01959880|531354477|FG001|Overall Study|Explantation w/o study device reimplant.|17|||
147325181|NCT01959880|531354478|FG002|Overall Study|Explantation w/o study device reimplant.|5|||
147325182|NCT01959880|531354479|FG003|Overall Study|Explantation w/o study device reimplant.|12|||
147325183|NCT01959880|531354476|FG000|Overall Study|Study completed early-FDA approved|1003|||
147325184|NCT01959880|531354477|FG001|Overall Study|Study completed early-FDA approved|311|||
147325185|NCT01959880|531354478|FG002|Overall Study|Study completed early-FDA approved|179|||
147325186|NCT01959880|531354479|FG003|Overall Study|Study completed early-FDA approved|152|||
147325187|NCT01919619|531354480|FG000|Overall Study|Physician Decision|1|||
147325188|NCT01919619|531354481|FG001|Overall Study|Physician Decision|1|||
147325189|NCT00587288|531355655|FG000|Overall Study|Adverse Event|0|||
147325190|NCT00587288|531355656|FG001|Overall Study|Adverse Event|1|||
147325191|NCT00587288|531355655|FG000|Overall Study|Lack of Efficacy|2|||
147325192|NCT00587288|531355656|FG001|Overall Study|Lack of Efficacy|8|||
147325193|NCT00587288|531355655|FG000|Overall Study|Protocol Violation|1|||
147325194|NCT00587288|531355656|FG001|Overall Study|Protocol Violation|0|||
147325195|NCT01306331|531355657|FG000|Overall Study|Adverse Event|28|||
147325196|NCT01306331|531355658|FG001|Overall Study|Adverse Event|25|||
147325197|NCT01306331|531355657|FG000|Overall Study|Lost to Follow-up|321|||
147325198|NCT01306331|531355658|FG001|Overall Study|Lost to Follow-up|323|||
147325199|NCT01306331|531355657|FG000|Overall Study|Physician Decision|26|||
147325200|NCT01306331|531355658|FG001|Overall Study|Physician Decision|22|||
147325201|NCT01306331|531355657|FG000|Overall Study|Pregnancy|136|||
147325202|NCT01306331|531355658|FG001|Overall Study|Pregnancy|151|||
147245337|NCT01737697|531070815|FG012|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
147245338|NCT01737697|531070816|FG013|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
147245339|NCT01737697|531070817|FG014|Acute Phase-Initial 48 Hours|hypo-or hyperkalemia|0|||
147245340|NCT01737697|531070803|FG000|Acute Phase-Initial 48 Hours|Family emergency|0|||
147245341|NCT01737697|531070804|FG001|Acute Phase-Initial 48 Hours|Family emergency|0|||
147245342|NCT01737697|531070805|FG002|Acute Phase-Initial 48 Hours|Family emergency|0|||
147179270|NCT00615017|530823493|FG002|Overall Study|Physician discontinued drug|0|||
147179271|NCT00615017|530823494|FG003|Overall Study|Physician discontinued drug|0|||
147179272|NCT00615017|530823495|FG004|Overall Study|Physician discontinued drug|0|||
147179273|NCT00615017|530823496|FG005|Overall Study|Physician discontinued drug|1|||
147179274|NCT03777059|530823497|FG000|DB Treatment Period (Up to Week 12)|Adverse Event|6|||
147179275|NCT03777059|530823498|FG001|DB Treatment Period (Up to Week 12)|Adverse Event|9|||
147179276|NCT03777059|530823499|FG002|DB Treatment Period (Up to Week 12)|Adverse Event|4|||
147179277|NCT03777059|530823500|FG003|DB Treatment Period (Up to Week 12)|Adverse Event|6|||
147179278|NCT03777059|530823497|FG000|DB Treatment Period (Up to Week 12)|Lack of Efficacy|1|||
147179279|NCT03777059|530823498|FG001|DB Treatment Period (Up to Week 12)|Lack of Efficacy|0|||
147179280|NCT03777059|530823499|FG002|DB Treatment Period (Up to Week 12)|Lack of Efficacy|0|||
147179281|NCT03777059|530823500|FG003|DB Treatment Period (Up to Week 12)|Lack of Efficacy|1|||
147179282|NCT03777059|530823497|FG000|DB Treatment Period (Up to Week 12)|Withdrawal by Subject|8|||
147179283|NCT03777059|530823498|FG001|DB Treatment Period (Up to Week 12)|Withdrawal by Subject|9|||
147179284|NCT03777059|530823499|FG002|DB Treatment Period (Up to Week 12)|Withdrawal by Subject|8|||
147179285|NCT03777059|530823500|FG003|DB Treatment Period (Up to Week 12)|Withdrawal by Subject|10|||
147179286|NCT03777059|530823497|FG000|DB Treatment Period (Up to Week 12)|Lost to Follow-up|3|||
147179287|NCT03777059|530823498|FG001|DB Treatment Period (Up to Week 12)|Lost to Follow-up|3|||
147179288|NCT03777059|530823499|FG002|DB Treatment Period (Up to Week 12)|Lost to Follow-up|4|||
147179289|NCT03777059|530823500|FG003|DB Treatment Period (Up to Week 12)|Lost to Follow-up|5|||
147179290|NCT03777059|530823497|FG000|DB Treatment Period (Up to Week 12)|Pregnancy|0|||
147179291|NCT03777059|530823498|FG001|DB Treatment Period (Up to Week 12)|Pregnancy|1|||
147179292|NCT03777059|530823499|FG002|DB Treatment Period (Up to Week 12)|Pregnancy|0|||
147179293|NCT03777059|530823500|FG003|DB Treatment Period (Up to Week 12)|Pregnancy|0|||
147179294|NCT03777059|530823497|FG000|DB Treatment Period (Up to Week 12)|Protocol Deviation|4|||
147179295|NCT03777059|530823498|FG001|DB Treatment Period (Up to Week 12)|Protocol Deviation|5|||
147179296|NCT03777059|530823499|FG002|DB Treatment Period (Up to Week 12)|Protocol Deviation|7|||
147179297|NCT03777059|530823500|FG003|DB Treatment Period (Up to Week 12)|Protocol Deviation|8|||
147179298|NCT03777059|530823497|FG000|DB Treatment Period (Up to Week 12)|Reason Not Specified|0|||
147179299|NCT03777059|530823498|FG001|DB Treatment Period (Up to Week 12)|Reason Not Specified|2|||
147179300|NCT03777059|530823499|FG002|DB Treatment Period (Up to Week 12)|Reason Not Specified|0|||
147179301|NCT03777059|530823500|FG003|DB Treatment Period (Up to Week 12)|Reason Not Specified|1|||
147179302|NCT03777059|530823497|FG000|Follow-Up Period (Weeks 12 to 16)|Withdrawal by Subject|5|||
147179303|NCT03777059|530823498|FG001|Follow-Up Period (Weeks 12 to 16)|Withdrawal by Subject|3|||
147179304|NCT03777059|530823499|FG002|Follow-Up Period (Weeks 12 to 16)|Withdrawal by Subject|4|||
147179305|NCT03777059|530823500|FG003|Follow-Up Period (Weeks 12 to 16)|Withdrawal by Subject|5|||
147179306|NCT03777059|530823497|FG000|Follow-Up Period (Weeks 12 to 16)|Lost to Follow-up|0|||
147179307|NCT03777059|530823498|FG001|Follow-Up Period (Weeks 12 to 16)|Lost to Follow-up|1|||
147179308|NCT03777059|530823499|FG002|Follow-Up Period (Weeks 12 to 16)|Lost to Follow-up|0|||
147179309|NCT03777059|530823500|FG003|Follow-Up Period (Weeks 12 to 16)|Lost to Follow-up|3|||
147179310|NCT03777059|530823497|FG000|Follow-Up Period (Weeks 12 to 16)|Protocol Deviation|0|||
147179311|NCT03777059|530823498|FG001|Follow-Up Period (Weeks 12 to 16)|Protocol Deviation|1|||
147179312|NCT03777059|530823499|FG002|Follow-Up Period (Weeks 12 to 16)|Protocol Deviation|1|||
147179313|NCT03777059|530823500|FG003|Follow-Up Period (Weeks 12 to 16)|Protocol Deviation|0|||
147179314|NCT03777059|530823497|FG000|Follow-Up Period (Weeks 12 to 16)|Reason Not Specified|0|||
147179315|NCT03777059|530823498|FG001|Follow-Up Period (Weeks 12 to 16)|Reason Not Specified|0|||
147179316|NCT03777059|530823499|FG002|Follow-Up Period (Weeks 12 to 16)|Reason Not Specified|1|||
147179317|NCT03777059|530823500|FG003|Follow-Up Period (Weeks 12 to 16)|Reason Not Specified|1|||
147179318|NCT03350815|530823503|FG000|Period 1|Adverse Event|10|||
147179319|NCT03350815|530823504|FG001|Period 1|Adverse Event|0|||
147179320|NCT03350815|530823505|FG002|Period 1|Adverse Event|0|||
147179321|NCT03350815|530823506|FG003|Period 1|Adverse Event|0|||
147179322|NCT03350815|530823503|FG000|Period 1|Technical problems|1|||
147179323|NCT03350815|530823504|FG001|Period 1|Technical problems|0|||
147179324|NCT03350815|530823505|FG002|Period 1|Technical problems|0|||
147179325|NCT03350815|530823506|FG003|Period 1|Technical problems|0|||
147179326|NCT03350815|530823503|FG000|Period 1|Lost to Follow-up|3|||
147179327|NCT03350815|530823504|FG001|Period 1|Lost to Follow-up|0|||
147179328|NCT03350815|530823505|FG002|Period 1|Lost to Follow-up|0|||
147179329|NCT03350815|530823506|FG003|Period 1|Lost to Follow-up|0|||
147179330|NCT03350815|530823503|FG000|Period 1|Physician Decision|1|||
147245343|NCT01737697|531070806|FG003|Acute Phase-Initial 48 Hours|Family emergency|1|||
147245344|NCT01737697|531070807|FG004|Acute Phase-Initial 48 Hours|Family emergency|0|||
147245345|NCT01737697|531070808|FG005|Acute Phase-Initial 48 Hours|Family emergency|0|||
147325203|NCT01306331|531355657|FG000|Overall Study|Protocol Violation|154|||
147325204|NCT01306331|531355658|FG001|Overall Study|Protocol Violation|124|||
147325205|NCT01306331|531355657|FG000|Overall Study|Withdrawal by Subject|163|||
147325206|NCT01306331|531355658|FG001|Overall Study|Withdrawal by Subject|152|||
147325207|NCT01306331|531355657|FG000|Overall Study|Not sexually active|29|||
147325208|NCT01306331|531355658|FG001|Overall Study|Not sexually active|28|||
147325209|NCT01306331|531355657|FG000|Overall Study|Meth. no longer prim. meth. birth cntrl|10|||
147325210|NCT01306331|531355658|FG001|Overall Study|Meth. no longer prim. meth. birth cntrl|20|||
147179331|NCT03350815|530823504|FG001|Period 1|Physician Decision|0|||
147179332|NCT03350815|530823505|FG002|Period 1|Physician Decision|0|||
147179333|NCT03350815|530823506|FG003|Period 1|Physician Decision|0|||
147179334|NCT03350815|530823503|FG000|Period 1|Withdrawal by Subject|8|||
147179335|NCT03350815|530823504|FG001|Period 1|Withdrawal by Subject|0|||
147179336|NCT03350815|530823505|FG002|Period 1|Withdrawal by Subject|0|||
147179337|NCT03350815|530823506|FG003|Period 1|Withdrawal by Subject|0|||
147179338|NCT03350815|530823503|FG000|Period 1|Lack of Efficacy|15|||
147179339|NCT03350815|530823504|FG001|Period 1|Lack of Efficacy|0|||
147179340|NCT03350815|530823505|FG002|Period 1|Lack of Efficacy|0|||
147179341|NCT03350815|530823506|FG003|Period 1|Lack of Efficacy|0|||
147179342|NCT03350815|530823503|FG000|Period 1|Non-compliance with study treatment|2|||
147179343|NCT03350815|530823504|FG001|Period 1|Non-compliance with study treatment|0|||
147179344|NCT03350815|530823505|FG002|Period 1|Non-compliance with study treatment|0|||
147179345|NCT03350815|530823506|FG003|Period 1|Non-compliance with study treatment|0|||
147179346|NCT03350815|530823503|FG000|Period 1|Protocol Violation|3|||
147179347|NCT03350815|530823504|FG001|Period 1|Protocol Violation|0|||
147179348|NCT03350815|530823505|FG002|Period 1|Protocol Violation|0|||
147179349|NCT03350815|530823506|FG003|Period 1|Protocol Violation|0|||
147179350|NCT03350815|530823503|FG000|Period 2|Adverse Event|0|||
147179351|NCT03350815|530823504|FG001|Period 2|Adverse Event|3|||
147179352|NCT03350815|530823505|FG002|Period 2|Adverse Event|5|||
147179353|NCT03350815|530823506|FG003|Period 2|Adverse Event|0|||
147179354|NCT03350815|530823503|FG000|Period 2|Technical problem|0|||
147325211|NCT01306331|531355657|FG000|Overall Study|Other|34|||
147325212|NCT01306331|531355658|FG001|Overall Study|Other|32|||
147325213|NCT00409708|531355665|FG000|Treatment|Abnormal test procedure result(s)|1|||
147325214|NCT00409708|531355666|FG001|Treatment|Abnormal test procedure result(s)|0|||
147325215|NCT00409708|531355665|FG000|Treatment|Lack of Efficacy|0|||
147325216|NCT00409708|531355666|FG001|Treatment|Lack of Efficacy|1|||
147325217|NCT00409708|531355665|FG000|Treatment|Protocol Violation|6|||
147325218|NCT00409708|531355666|FG001|Treatment|Protocol Violation|2|||
147325219|NCT00409708|531355665|FG000|Treatment|Withdrawal by Subject|3|||
147325220|NCT00409708|531355666|FG001|Treatment|Withdrawal by Subject|8|||
147325221|NCT00409708|531355665|FG000|Treatment|Lost to Follow-up|0|||
147325222|NCT00409708|531355666|FG001|Treatment|Lost to Follow-up|6|||
147325223|NCT00409708|531355665|FG000|Treatment|Administrative problems|5|||
147325224|NCT00409708|531355666|FG001|Treatment|Administrative problems|0|||
147325225|NCT00409708|531355665|FG000|Washout|Lack of Efficacy|9|||
147325226|NCT00409708|531355666|FG001|Washout|Lack of Efficacy|1|||
147325227|NCT00409708|531355665|FG000|Washout|Protocol Violation|0|||
147325228|NCT00409708|531355666|FG001|Washout|Protocol Violation|1|||
147325229|NCT00409708|531355665|FG000|Washout|Withdrawal by Subject|11|||
147325230|NCT00409708|531355666|FG001|Washout|Withdrawal by Subject|5|||
147325231|NCT00409708|531355665|FG000|Washout|Lost to Follow-up|1|||
147325232|NCT00409708|531355666|FG001|Washout|Lost to Follow-up|3|||
147325233|NCT00088465|531355671|FG000|Overall Study|Withdrawal by Subject|290|||
147325234|NCT00088465|531355671|FG000|Overall Study|Adverse Event|77|||
147325235|NCT00088465|531355671|FG000|Overall Study|Lost to Follow-up|57|||
147179355|NCT03350815|530823504|FG001|Period 2|Technical problem|1|||
147179356|NCT03350815|530823505|FG002|Period 2|Technical problem|0|||
147179357|NCT03350815|530823506|FG003|Period 2|Technical problem|0|||
147179358|NCT03350815|530823503|FG000|Period 2|Lost to Follow-up|0|||
147325236|NCT00088465|531355671|FG000|Overall Study|Physician Decision|45|||
147325237|NCT00088465|531355671|FG000|Overall Study|Sponsor Decision|37|||
147325238|NCT00088465|531355671|FG000|Overall Study|Lack of Efficacy|27|||
147325239|NCT00088465|531355671|FG000|Overall Study|Protocol Violation|17|||
147325240|NCT00088465|531355671|FG000|Overall Study|Death|11|||
147325241|NCT00448864|531355672|FG000|Overall Study|Death|1|||
147325242|NCT00448864|531355673|FG001|Overall Study|Death|0|||
147325243|NCT00448864|531355674|FG002|Overall Study|Death|0|||
147179359|NCT03350815|530823504|FG001|Period 2|Lost to Follow-up|3|||
147179360|NCT03350815|530823505|FG002|Period 2|Lost to Follow-up|3|||
147179361|NCT03350815|530823506|FG003|Period 2|Lost to Follow-up|0|||
147179362|NCT03350815|530823503|FG000|Period 2|Physician Decision|0|||
147179363|NCT03350815|530823504|FG001|Period 2|Physician Decision|0|||
147179364|NCT03350815|530823505|FG002|Period 2|Physician Decision|1|||
147325244|NCT00448864|531355672|FG000|Overall Study|Lost to Follow-up|3|||
147325245|NCT00448864|531355673|FG001|Overall Study|Lost to Follow-up|1|||
147325246|NCT00448864|531355674|FG002|Overall Study|Lost to Follow-up|0|||
147325247|NCT00448864|531355672|FG000|Overall Study|Physician Decision|1|||
147179365|NCT03350815|530823506|FG003|Period 2|Physician Decision|0|||
147179366|NCT03350815|530823503|FG000|Period 2|Withdrawal by Subject|0|||
147325248|NCT00448864|531355673|FG001|Overall Study|Physician Decision|0|||
147325249|NCT00448864|531355674|FG002|Overall Study|Physician Decision|1|||
147325250|NCT00448864|531355672|FG000|Overall Study|Withdrawal by Subject|0|||
147325251|NCT00448864|531355673|FG001|Overall Study|Withdrawal by Subject|2|||
147325252|NCT00448864|531355674|FG002|Overall Study|Withdrawal by Subject|0|||
147325253|NCT00448864|531355672|FG000|Overall Study|Protocol Violation|0|||
147325254|NCT00448864|531355673|FG001|Overall Study|Protocol Violation|2|||
147325255|NCT00448864|531355674|FG002|Overall Study|Protocol Violation|0|||
147325256|NCT01390857|531355675|FG000|Overall Study|Protocol Violation|2|||
147325257|NCT01390857|531355675|FG000|Overall Study|Lost to Follow-up|1|||
147325258|NCT01390857|531355675|FG000|Overall Study|No Visit after the First Visit|7|||
147325259|NCT02757885|531355676|FG000|Overall Study|Screen Failures|4|||
147325260|NCT01474538|531355678|FG000|Treatment Period 1|Death|1|||
147325261|NCT01474538|531355679|FG001|Treatment Period 1|Death|0|||
147325262|NCT01474538|531355678|FG000|Treatment Period 1|Physician Decision|1|||
147325263|NCT01474538|531355679|FG001|Treatment Period 1|Physician Decision|0|||
147325264|NCT01474538|531355678|FG000|Treatment Period 1|Withdrawal by Subject|1|||
147325265|NCT01474538|531355679|FG001|Treatment Period 1|Withdrawal by Subject|3|||
147325266|NCT01474538|531355678|FG000|Treatment Period 1|Protocol Violation|0|||
147325267|NCT01474538|531355679|FG001|Treatment Period 1|Protocol Violation|1|||
147325268|NCT01474538|531355678|FG000|Treatment Period 2|Death|1|||
147325269|NCT01474538|531355679|FG001|Treatment Period 2|Death|0|||
147325270|NCT01474538|531355678|FG000|Treatment Period 2|Adverse Event|1|||
147325271|NCT01474538|531355679|FG001|Treatment Period 2|Adverse Event|1|||
147325272|NCT01474538|531355678|FG000|Treatment Period 2|Withdrawal by Subject|2|||
147325273|NCT01474538|531355679|FG001|Treatment Period 2|Withdrawal by Subject|0|||
147325274|NCT01474538|531355678|FG000|Treatment Period 2|Sponsor decision|1|||
147325275|NCT01474538|531355679|FG001|Treatment Period 2|Sponsor decision|0|||
147325276|NCT01474538|531355678|FG000|Treatment Period 2|Physician Decision|0|||
147325277|NCT01474538|531355679|FG001|Treatment Period 2|Physician Decision|1|||
147325278|NCT01474538|531355678|FG000|Treatment Period 2|Protocol Violation|1|||
147325279|NCT01474538|531355679|FG001|Treatment Period 2|Protocol Violation|0|||
147325280|NCT01456780|531355680|FG000|Overall Study|Lost to Follow-up|3|||
147325281|NCT01456780|531355681|FG001|Overall Study|Lost to Follow-up|3|||
147325282|NCT01456780|531355682|FG002|Overall Study|Lost to Follow-up|0|||
147325283|NCT02688621|531355685|FG000|Overall Study|Pregnancy|1|||
147325284|NCT02688621|531355686|FG001|Overall Study|Pregnancy|3|||
147325285|NCT02688621|531355685|FG000|Overall Study|Lost to Follow-up|38|||
147325286|NCT02688621|531355686|FG001|Overall Study|Lost to Follow-up|15|||
147325287|NCT02688621|531355685|FG000|Overall Study|Withdrawal by Subject|1|||
147325288|NCT02688621|531355686|FG001|Overall Study|Withdrawal by Subject|0|||
147325289|NCT04565249|531355689|FG000|Overall Study|Death|0|||
147179367|NCT03350815|530823504|FG001|Period 2|Withdrawal by Subject|3|||
147179368|NCT03350815|530823505|FG002|Period 2|Withdrawal by Subject|4|||
147179369|NCT03350815|530823506|FG003|Period 2|Withdrawal by Subject|0|||
147179370|NCT03350815|530823503|FG000|Period 2|Lack of Efficacy|0|||
147179371|NCT03350815|530823504|FG001|Period 2|Lack of Efficacy|6|||
147179372|NCT03350815|530823505|FG002|Period 2|Lack of Efficacy|2|||
147179373|NCT03350815|530823506|FG003|Period 2|Lack of Efficacy|0|||
147179374|NCT03350815|530823503|FG000|Period 2|Protocol Violation|0|||
147179375|NCT03350815|530823504|FG001|Period 2|Protocol Violation|0|||
147179376|NCT03350815|530823505|FG002|Period 2|Protocol Violation|1|||
147179377|NCT03350815|530823506|FG003|Period 2|Protocol Violation|0|||
147179378|NCT03350815|530823503|FG000|Period 2|New therapy for study indication|0|||
147179379|NCT03350815|530823504|FG001|Period 2|New therapy for study indication|0|||
147179380|NCT03350815|530823505|FG002|Period 2|New therapy for study indication|1|||
147179381|NCT03350815|530823506|FG003|Period 2|New therapy for study indication|0|||
147179382|NCT02517541|530823511|FG000|Baseline Period (Own Product)|Protocol Violation|1|||
147179383|NCT02517541|530823511|FG000|Test Period (SenSura Mio Convex Soft)|Adverse Event|3|||
147179384|NCT02517541|530823511|FG000|Test Period (SenSura Mio Convex Soft)|Lack of Efficacy|2|||
147179385|NCT02517541|530823511|FG000|Test Period (SenSura Mio Convex Soft)|Protocol Violation|1|||
147179386|NCT02517541|530823511|FG000|Test Period (SenSura Mio Convex Soft)|Withdrawal by Subject|4|||
147179387|NCT02517541|530823511|FG000|Test Period (SenSura Mio Convex Soft)|One subjects was not suited for the tes|2|||
147179388|NCT00699608|530823512|FG000|First Intervention|Withdrawal by Subject|0|||
147179389|NCT00699608|530823513|FG001|First Intervention|Withdrawal by Subject|0|||
147179390|NCT00699608|530823514|FG002|First Intervention|Withdrawal by Subject|1|||
147325290|NCT04565249|531355690|FG001|Overall Study|Death|0|||
147325291|NCT04565249|531355691|FG002|Overall Study|Death|0|||
147325292|NCT04565249|531355692|FG003|Overall Study|Death|1|||
147325293|NCT00886613|531355693|FG000|Overall Study|Protocol deviation (Part B)|1|||
147325294|NCT00886613|531355694|FG001|Overall Study|Protocol deviation (Part B)|0|||
147179391|NCT00699608|530823515|FG003|First Intervention|Withdrawal by Subject|0|||
147179392|NCT00699608|530823516|FG004|First Intervention|Withdrawal by Subject|0|||
147325295|NCT00886613|531355695|FG002|Overall Study|Protocol deviation (Part B)|0|||
147325296|NCT00886613|531355693|FG000|Overall Study|Lost to follow-up (Part B)|1|||
147325297|NCT00886613|531355694|FG001|Overall Study|Lost to follow-up (Part B)|0|||
147325298|NCT00886613|531355695|FG002|Overall Study|Lost to follow-up (Part B)|1|||
147325299|NCT00886613|531355693|FG000|Overall Study|Subject withdrew consent (Part A)|0|||
147325300|NCT00886613|531355694|FG001|Overall Study|Subject withdrew consent (Part A)|0|||
147325301|NCT00886613|531355695|FG002|Overall Study|Subject withdrew consent (Part A)|2|||
147325302|NCT01982760|531355698|FG000|Overall Study|Physician Decision|1|||
147325303|NCT01982760|531355699|FG001|Overall Study|Physician Decision|0|||
147325304|NCT00821236|531355700|FG000|Overall Study|Lost to Follow-up|3|||
147325305|NCT00282438|531355704|FG000|Overall Study|Lack of Efficacy|1|||
147325306|NCT00282438|531355705|FG001|Overall Study|Lack of Efficacy|0|||
147325307|NCT00282438|531355704|FG000|Overall Study|Death|0|||
147325308|NCT00282438|531355705|FG001|Overall Study|Death|1|||
147325309|NCT02397889|531355706|FG000|Overall Study|Physician Decision|1|||
147325310|NCT02397889|531355707|FG001|Overall Study|Physician Decision|0|||
147325311|NCT01928940|531355717|FG000|Overall Study|Adverse Event|0|||
147325312|NCT01928940|531355718|FG001|Overall Study|Adverse Event|1|||
147325313|NCT02954055|531355719|FG000|Overall Study|Did not initiate therapy|6|||
147325314|NCT02954055|531355720|FG001|Overall Study|Did not initiate therapy|1|||
147325315|NCT01352507|531355727|FG000|Treatment Period 1|Adverse Event|3|||
147325316|NCT01352507|531355728|FG001|Treatment Period 1|Adverse Event|0|||
147325317|NCT01352507|531355727|FG000|Treatment Period 1|Lost to Follow-up|3|||
147325318|NCT01352507|531355728|FG001|Treatment Period 1|Lost to Follow-up|4|||
147325319|NCT01352507|531355727|FG000|Treatment Period 1|Withdrawal by Subject|7|||
147325320|NCT01352507|531355728|FG001|Treatment Period 1|Withdrawal by Subject|5|||
147325321|NCT01352507|531355727|FG000|Treatment Period 1|Physician Decision|1|||
147325322|NCT01352507|531355728|FG001|Treatment Period 1|Physician Decision|0|||
147325323|NCT01352507|531355727|FG000|Washout Period|Withdrawal by Subject|0|||
147325324|NCT01352507|531355728|FG001|Washout Period|Withdrawal by Subject|1|||
147325325|NCT01352507|531355727|FG000|Treatment Period 2|Entry Criteria Not Met|1|||
147325326|NCT01352507|531355728|FG001|Treatment Period 2|Entry Criteria Not Met|0|||
147325327|NCT01352507|531355727|FG000|Treatment Period 2|Withdrawal by Subject|4|||
147325328|NCT01352507|531355728|FG001|Treatment Period 2|Withdrawal by Subject|3|||
147325329|NCT01352507|531355727|FG000|Treatment Period 2|Lack of Efficacy|1|||
147325330|NCT01352507|531355728|FG001|Treatment Period 2|Lack of Efficacy|0|||
147325331|NCT01119703|531355729|FG000|Overall Study|Adverse Event|0|||
147325332|NCT01119703|531355730|FG001|Overall Study|Adverse Event|1|||
147325333|NCT02095158|531355734|FG000|Overall Study|Adverse Event|14|||
147325334|NCT02095158|531355734|FG000|Overall Study|Lack of Efficacy|3|||
147325335|NCT02095158|531355734|FG000|Overall Study|Pregnancy|1|||
147325336|NCT02095158|531355734|FG000|Overall Study|Lost to Follow-up|20|||
147325337|NCT02095158|531355734|FG000|Overall Study|Personal Reasons|35|||
147325338|NCT02095158|531355734|FG000|Overall Study|Protocol Violation|1|||
147325339|NCT02095158|531355734|FG000|Overall Study|Other Miscellaneous Reasons|1|||
147325340|NCT00941031|531355735|FG000|Induction Period|Lack of Efficacy|2|||
147325341|NCT00941031|531355736|FG001|Induction Period|Lack of Efficacy|1|||
147325342|NCT00941031|531355737|FG002|Induction Period|Lack of Efficacy|0|||
147325343|NCT00941031|531355738|FG003|Induction Period|Lack of Efficacy|5|||
147325344|NCT00941031|531355739|FG004|Induction Period|Lack of Efficacy|0|||
147325345|NCT00941031|531355740|FG005|Induction Period|Lack of Efficacy|0|||
147325346|NCT00941031|531355741|FG006|Induction Period|Lack of Efficacy|0|||
147325347|NCT00941031|531355735|FG000|Induction Period|Withdrawal by Subject|1|||
147325348|NCT00941031|531355736|FG001|Induction Period|Withdrawal by Subject|2|||
147325349|NCT00941031|531355737|FG002|Induction Period|Withdrawal by Subject|2|||
147325350|NCT00941031|531355738|FG003|Induction Period|Withdrawal by Subject|2|||
147325351|NCT00941031|531355739|FG004|Induction Period|Withdrawal by Subject|0|||
147325352|NCT00941031|531355740|FG005|Induction Period|Withdrawal by Subject|0|||
147325353|NCT00941031|531355741|FG006|Induction Period|Withdrawal by Subject|0|||
147325354|NCT00941031|531355735|FG000|Induction Period|Adminstative Problems|1|||
147325355|NCT00941031|531355736|FG001|Induction Period|Adminstative Problems|1|||
147325356|NCT00941031|531355737|FG002|Induction Period|Adminstative Problems|1|||
147325357|NCT00941031|531355738|FG003|Induction Period|Adminstative Problems|0|||
147325358|NCT00941031|531355739|FG004|Induction Period|Adminstative Problems|0|||
147325359|NCT00941031|531355740|FG005|Induction Period|Adminstative Problems|0|||
147325360|NCT00941031|531355741|FG006|Induction Period|Adminstative Problems|0|||
147325361|NCT00941031|531355735|FG000|Induction Period|Adverse Event|1|||
147325362|NCT00941031|531355736|FG001|Induction Period|Adverse Event|0|||
147325363|NCT00941031|531355737|FG002|Induction Period|Adverse Event|3|||
147325364|NCT00941031|531355738|FG003|Induction Period|Adverse Event|2|||
147325365|NCT00941031|531355739|FG004|Induction Period|Adverse Event|0|||
147325366|NCT00941031|531355740|FG005|Induction Period|Adverse Event|0|||
147325367|NCT00941031|531355741|FG006|Induction Period|Adverse Event|0|||
147656221|NCT02959918|532564957|FG006|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
147325368|NCT00941031|531355735|FG000|Maintenance Period|Withdrawal by Subject|0|||
147325369|NCT00941031|531355736|FG001|Maintenance Period|Withdrawal by Subject|0|||
147325370|NCT00941031|531355737|FG002|Maintenance Period|Withdrawal by Subject|0|||
147325371|NCT00941031|531355738|FG003|Maintenance Period|Withdrawal by Subject|0|||
147325372|NCT00941031|531355739|FG004|Maintenance Period|Withdrawal by Subject|6|||
147325373|NCT00941031|531355740|FG005|Maintenance Period|Withdrawal by Subject|2|||
147656222|NCT02959918|532564958|FG007|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
147325374|NCT00941031|531355741|FG006|Maintenance Period|Withdrawal by Subject|13|||
147325375|NCT00941031|531355735|FG000|Maintenance Period|Administrative Problems|0|||
147593259|NCT00430495|532328955|FG000|Overall Study|Death|0|||
147593260|NCT00430495|532328956|FG001|Overall Study|Death|0|||
147593261|NCT00430495|532328957|FG002|Overall Study|Death|1|||
147593262|NCT00430495|532328958|FG003|Overall Study|Death|0|||
147593263|NCT00430495|532328955|FG000|Overall Study|Lost to Follow-up|0|||
147179393|NCT00699608|530823517|FG005|First Intervention|Withdrawal by Subject|0|||
147179394|NCT00699608|530823512|FG000|First Intervention|Protocol Violation|0|||
147179395|NCT00699608|530823513|FG001|First Intervention|Protocol Violation|0|||
147179396|NCT00699608|530823514|FG002|First Intervention|Protocol Violation|0|||
147179397|NCT00699608|530823515|FG003|First Intervention|Protocol Violation|0|||
147179398|NCT00699608|530823516|FG004|First Intervention|Protocol Violation|1|||
147179399|NCT00699608|530823517|FG005|First Intervention|Protocol Violation|0|||
147179400|NCT00699608|530823512|FG000|Second Intervention|Adverse Event|0|||
147179401|NCT00699608|530823513|FG001|Second Intervention|Adverse Event|0|||
147179402|NCT00699608|530823514|FG002|Second Intervention|Adverse Event|1|||
147179403|NCT00699608|530823515|FG003|Second Intervention|Adverse Event|0|||
147179404|NCT00699608|530823516|FG004|Second Intervention|Adverse Event|0|||
147179405|NCT00699608|530823517|FG005|Second Intervention|Adverse Event|0|||
147179406|NCT00699608|530823512|FG000|Second Intervention|Withdrawal by Subject|0|||
147179407|NCT00699608|530823513|FG001|Second Intervention|Withdrawal by Subject|0|||
147179408|NCT00699608|530823514|FG002|Second Intervention|Withdrawal by Subject|0|||
147179409|NCT00699608|530823515|FG003|Second Intervention|Withdrawal by Subject|1|||
147179410|NCT00699608|530823516|FG004|Second Intervention|Withdrawal by Subject|0|||
147179411|NCT00699608|530823517|FG005|Second Intervention|Withdrawal by Subject|0|||
147179412|NCT01136408|530823518|FG000|Overall Study|Adverse Event|4|||
147179413|NCT01136408|530823519|FG001|Overall Study|Adverse Event|8|||
147179414|NCT01136408|530823520|FG002|Overall Study|Adverse Event|4|||
147179415|NCT01136408|530823518|FG000|Overall Study|Protocol Violation|1|||
147179416|NCT01136408|530823519|FG001|Overall Study|Protocol Violation|1|||
147179417|NCT01136408|530823520|FG002|Overall Study|Protocol Violation|1|||
147179418|NCT02828436|530823521|FG000|Period 1|Did Not Meet Inclusion Criteria|0|||
147179419|NCT02828436|530823522|FG001|Period 1|Did Not Meet Inclusion Criteria|3|||
147179420|NCT02828436|530823521|FG000|Period 1|Lost to Follow-up|0|||
147179421|NCT02828436|530823522|FG001|Period 1|Lost to Follow-up|1|||
147179422|NCT02828436|530823521|FG000|Period 2|Withdrawal by Subject|4|||
147179423|NCT02828436|530823522|FG001|Period 2|Withdrawal by Subject|0|||
147179424|NCT02828436|530823521|FG000|Period 2|Did Not Meet Inclusion Criteria|3|||
147179425|NCT02828436|530823522|FG001|Period 2|Did Not Meet Inclusion Criteria|0|||
147179426|NCT02828436|530823521|FG000|Period 2|Lost to Follow-up|1|||
147179427|NCT02828436|530823522|FG001|Period 2|Lost to Follow-up|0|||
147179428|NCT03078556|530823525|FG000|Treatment Period 1 (4 Days)|Adverse Event|0|||
147179429|NCT03078556|530823526|FG001|Treatment Period 1 (4 Days)|Adverse Event|1|||
147179430|NCT03078556|530823527|FG002|Treatment Period 1 (4 Days)|Adverse Event|0|||
147179431|NCT03078556|530823528|FG003|Treatment Period 1 (4 Days)|Adverse Event|0|||
147179432|NCT03078556|530823525|FG000|Washout Period 1 (7 Days)|Lost to Follow-up|2|||
147179433|NCT03078556|530823526|FG001|Washout Period 1 (7 Days)|Lost to Follow-up|0|||
147179434|NCT03078556|530823527|FG002|Washout Period 1 (7 Days)|Lost to Follow-up|1|||
147179435|NCT03078556|530823528|FG003|Washout Period 1 (7 Days)|Lost to Follow-up|0|||
147179436|NCT03078556|530823525|FG000|Washout Period 1 (7 Days)|Adverse Event|0|||
147179437|NCT03078556|530823526|FG001|Washout Period 1 (7 Days)|Adverse Event|1|||
147179438|NCT03078556|530823527|FG002|Washout Period 1 (7 Days)|Adverse Event|0|||
147179439|NCT03078556|530823528|FG003|Washout Period 1 (7 Days)|Adverse Event|1|||
147179440|NCT03078556|530823525|FG000|Washout Period 1 (7 Days)|Physician Decision|0|||
147179441|NCT03078556|530823526|FG001|Washout Period 1 (7 Days)|Physician Decision|1|||
147179442|NCT03078556|530823527|FG002|Washout Period 1 (7 Days)|Physician Decision|0|||
147179443|NCT03078556|530823528|FG003|Washout Period 1 (7 Days)|Physician Decision|0|||
147179444|NCT04421482|530823530|FG000|Overall Study|Physician Decision|1|||
147179445|NCT03010319|530823531|FG000|Overall Study|Adverse Event|15|||
147179446|NCT03010319|530823532|FG001|Overall Study|Adverse Event|9|||
147179447|NCT03010319|530823531|FG000|Overall Study|Withdrawal by Subject|1|||
147179448|NCT03010319|530823532|FG001|Overall Study|Withdrawal by Subject|6|||
147179449|NCT03010319|530823531|FG000|Overall Study|Physician Decision|2|||
147179450|NCT03010319|530823532|FG001|Overall Study|Physician Decision|4|||
147179451|NCT03010319|530823531|FG000|Overall Study|Sponsor requested withdrawal|2|||
147179452|NCT03010319|530823532|FG001|Overall Study|Sponsor requested withdrawal|2|||
147179453|NCT03010319|530823531|FG000|Overall Study|Death|1|||
147179454|NCT03010319|530823532|FG001|Overall Study|Death|0|||
147179455|NCT03010319|530823531|FG000|Overall Study|Lost to Follow-up|0|||
147179456|NCT03010319|530823532|FG001|Overall Study|Lost to Follow-up|1|||
147179457|NCT03010319|530823531|FG000|Overall Study|Other Reason|5|||
147179458|NCT03010319|530823532|FG001|Overall Study|Other Reason|7|||
147179459|NCT02128724|530823533|FG000|Overall Study|Death|1|||
147179460|NCT02128724|530823534|FG001|Overall Study|Death|0|||
147179461|NCT02128724|530823535|FG002|Overall Study|Death|0|||
147179462|NCT02128724|530823536|FG003|Overall Study|Death|0|||
147593264|NCT00430495|532328956|FG001|Overall Study|Lost to Follow-up|1|||
147593265|NCT00430495|532328957|FG002|Overall Study|Lost to Follow-up|4|||
147325376|NCT00941031|531355736|FG001|Maintenance Period|Administrative Problems|0|||
147325377|NCT00941031|531355737|FG002|Maintenance Period|Administrative Problems|0|||
147325378|NCT00941031|531355738|FG003|Maintenance Period|Administrative Problems|0|||
147325379|NCT00941031|531355739|FG004|Maintenance Period|Administrative Problems|1|||
147325380|NCT00941031|531355740|FG005|Maintenance Period|Administrative Problems|0|||
147325381|NCT00941031|531355741|FG006|Maintenance Period|Administrative Problems|1|||
147325382|NCT00941031|531355735|FG000|Maintenance Period|Protocol Violation|0|||
147325383|NCT00941031|531355736|FG001|Maintenance Period|Protocol Violation|0|||
147325384|NCT00941031|531355737|FG002|Maintenance Period|Protocol Violation|0|||
147325385|NCT00941031|531355738|FG003|Maintenance Period|Protocol Violation|0|||
147325386|NCT00941031|531355739|FG004|Maintenance Period|Protocol Violation|0|||
147325387|NCT00941031|531355740|FG005|Maintenance Period|Protocol Violation|0|||
147325388|NCT00941031|531355741|FG006|Maintenance Period|Protocol Violation|1|||
147325389|NCT00941031|531355735|FG000|Maintenance Period|Adverse Event|0|||
147325390|NCT00941031|531355736|FG001|Maintenance Period|Adverse Event|0|||
147325391|NCT00941031|531355737|FG002|Maintenance Period|Adverse Event|0|||
147325392|NCT00941031|531355738|FG003|Maintenance Period|Adverse Event|0|||
147325393|NCT00941031|531355739|FG004|Maintenance Period|Adverse Event|0|||
147325394|NCT00941031|531355740|FG005|Maintenance Period|Adverse Event|2|||
147325395|NCT00941031|531355741|FG006|Maintenance Period|Adverse Event|8|||
147325396|NCT00941031|531355735|FG000|Maintenance Period|Lost to Follow-up|0|||
147325397|NCT00941031|531355736|FG001|Maintenance Period|Lost to Follow-up|0|||
147325398|NCT00941031|531355737|FG002|Maintenance Period|Lost to Follow-up|0|||
147325399|NCT00941031|531355738|FG003|Maintenance Period|Lost to Follow-up|0|||
147325400|NCT00941031|531355739|FG004|Maintenance Period|Lost to Follow-up|2|||
147325401|NCT00941031|531355740|FG005|Maintenance Period|Lost to Follow-up|2|||
147325402|NCT00941031|531355741|FG006|Maintenance Period|Lost to Follow-up|7|||
147325403|NCT00941031|531355735|FG000|Maintenance Period|Lack of Efficacy|0|||
147325404|NCT00941031|531355736|FG001|Maintenance Period|Lack of Efficacy|0|||
147325405|NCT00941031|531355737|FG002|Maintenance Period|Lack of Efficacy|0|||
147325406|NCT00941031|531355738|FG003|Maintenance Period|Lack of Efficacy|0|||
147325407|NCT00941031|531355739|FG004|Maintenance Period|Lack of Efficacy|0|||
147325408|NCT00941031|531355740|FG005|Maintenance Period|Lack of Efficacy|0|||
147325409|NCT00941031|531355741|FG006|Maintenance Period|Lack of Efficacy|13|||
147325410|NCT00631917|531355742|FG000|Overall Study|Adverse Event|34|||
147325411|NCT00631917|531355743|FG001|Overall Study|Adverse Event|45|||
147325412|NCT00631917|531355742|FG000|Overall Study|Abnormal laboratory value(s)|2|||
147325413|NCT00631917|531355743|FG001|Overall Study|Abnormal laboratory value(s)|1|||
147325414|NCT00631917|531355742|FG000|Overall Study|Abnormal test procedure result(s)|3|||
147325415|NCT00631917|531355743|FG001|Overall Study|Abnormal test procedure result(s)|2|||
147325416|NCT00631917|531355742|FG000|Overall Study|Unsatisfactory therapeutic effect|8|||
147325417|NCT00631917|531355743|FG001|Overall Study|Unsatisfactory therapeutic effect|14|||
147325418|NCT00631917|531355742|FG000|Overall Study|No longer required study drug|0|||
147325419|NCT00631917|531355743|FG001|Overall Study|No longer required study drug|1|||
147325420|NCT00631917|531355742|FG000|Overall Study|Protocol deviation|6|||
147325421|NCT00631917|531355743|FG001|Overall Study|Protocol deviation|5|||
147325422|NCT00631917|531355742|FG000|Overall Study|Subject withdrew consent|25|||
147325423|NCT00631917|531355743|FG001|Overall Study|Subject withdrew consent|33|||
147325424|NCT00631917|531355742|FG000|Overall Study|Lost to Follow-up|7|||
147325425|NCT00631917|531355743|FG001|Overall Study|Lost to Follow-up|7|||
147325426|NCT00631917|531355742|FG000|Overall Study|Administrative problems|2|||
147325427|NCT00631917|531355743|FG001|Overall Study|Administrative problems|0|||
147325428|NCT00631917|531355742|FG000|Overall Study|Death|1|||
147325429|NCT00631917|531355743|FG001|Overall Study|Death|0|||
147325430|NCT01076335|531355746|FG000|Overall Study|Withdrawal by Subject|3|||
147325431|NCT01076335|531355746|FG000|Overall Study|Withdrawal without treatment|1|||
147325432|NCT02939183|531355747|FG000|Overall Study|Death|0|||
147325433|NCT02939183|531355748|FG001|Overall Study|Death|0|||
147325434|NCT02939183|531355749|FG002|Overall Study|Death|1|||
147325435|NCT02939183|531355750|FG003|Overall Study|Death|0|||
147325436|NCT02939183|531355751|FG004|Overall Study|Death|0|||
147325437|NCT02939183|531355752|FG005|Overall Study|Death|2|||
147325438|NCT02939183|531355753|FG006|Overall Study|Death|1|||
147325439|NCT02939183|531355754|FG007|Overall Study|Death|0|||
147325440|NCT02939183|531355755|FG008|Overall Study|Death|0|||
147325441|NCT02939183|531355747|FG000|Overall Study|Sponsor decision|0|||
147325442|NCT02939183|531355748|FG001|Overall Study|Sponsor decision|1|||
147325443|NCT02939183|531355749|FG002|Overall Study|Sponsor decision|0|||
147325444|NCT02939183|531355750|FG003|Overall Study|Sponsor decision|1|||
147325445|NCT02939183|531355751|FG004|Overall Study|Sponsor decision|2|||
147179463|NCT02128724|530823533|FG000|Overall Study|Adverse Event|0|||
147325446|NCT02939183|531355752|FG005|Overall Study|Sponsor decision|0|||
147325447|NCT02939183|531355753|FG006|Overall Study|Sponsor decision|3|||
147325448|NCT02939183|531355754|FG007|Overall Study|Sponsor decision|1|||
147325449|NCT02939183|531355755|FG008|Overall Study|Sponsor decision|4|||
147325450|NCT02939183|531355747|FG000|Overall Study|Withdrawal by Subject|0|||
147325451|NCT02939183|531355748|FG001|Overall Study|Withdrawal by Subject|2|||
147325452|NCT02939183|531355749|FG002|Overall Study|Withdrawal by Subject|0|||
147325453|NCT02939183|531355750|FG003|Overall Study|Withdrawal by Subject|1|||
147325454|NCT02939183|531355751|FG004|Overall Study|Withdrawal by Subject|0|||
147325455|NCT02939183|531355752|FG005|Overall Study|Withdrawal by Subject|0|||
147325456|NCT02939183|531355753|FG006|Overall Study|Withdrawal by Subject|2|||
147325457|NCT02939183|531355754|FG007|Overall Study|Withdrawal by Subject|2|||
147325458|NCT02939183|531355755|FG008|Overall Study|Withdrawal by Subject|2|||
147325459|NCT02939183|531355747|FG000|Overall Study|Not treated due to adverse event|0|||
147325460|NCT02939183|531355748|FG001|Overall Study|Not treated due to adverse event|0|||
147325461|NCT02939183|531355749|FG002|Overall Study|Not treated due to adverse event|0|||
147325462|NCT02939183|531355750|FG003|Overall Study|Not treated due to adverse event|1|||
147325463|NCT02939183|531355751|FG004|Overall Study|Not treated due to adverse event|0|||
147325464|NCT02939183|531355752|FG005|Overall Study|Not treated due to adverse event|0|||
147325465|NCT02939183|531355753|FG006|Overall Study|Not treated due to adverse event|1|||
147325466|NCT02939183|531355754|FG007|Overall Study|Not treated due to adverse event|0|||
147325467|NCT02939183|531355755|FG008|Overall Study|Not treated due to adverse event|0|||
147325468|NCT01740557|531355756|FG000|Overall Study|Ineligible|1|||
147325469|NCT01740557|531355756|FG000|Overall Study|Screen failure|1|||
147325470|NCT00490555|531355757|FG000|Overall Study|noncompliant with drug administration|0|||
147325471|NCT00490555|531355758|FG001|Overall Study|noncompliant with drug administration|0|||
147325472|NCT00490555|531355759|FG002|Overall Study|noncompliant with drug administration|2|||
147325473|NCT00490555|531355760|FG003|Overall Study|noncompliant with drug administration|0|||
147325474|NCT00603538|531355761|FG000|Overall Study|Adverse Event|0|||
147325475|NCT00603538|531355762|FG001|Overall Study|Adverse Event|4|||
147325476|NCT00603538|531355763|FG002|Overall Study|Adverse Event|2|||
147325477|NCT00603538|531355761|FG000|Overall Study|Objective progression or relapse|3|||
147325478|NCT00603538|531355762|FG001|Overall Study|Objective progression or relapse|0|||
147325479|NCT00603538|531355763|FG002|Overall Study|Objective progression or relapse|0|||
147325480|NCT04794179|531355764|FG000|Overall Study|This participant didn't meet criteria after screening|1|||
147325481|NCT04794179|531355765|FG001|Overall Study|This participant didn't meet criteria after screening|0|||
147325482|NCT01096056|531355768|FG000|Overall Study|Lost to Follow-up|0|||
147325483|NCT01096056|531355769|FG001|Overall Study|Lost to Follow-up|1|||
147325484|NCT01737268|531355773|FG000|Overall Study|Adverse Event|6|||
147325485|NCT01737268|531355773|FG000|Overall Study|Worsening of Target Disease|2|||
147325486|NCT01737268|531355773|FG000|Overall Study|In consideration of the patient's safety|1|||
147593266|NCT00430495|532328958|FG003|Overall Study|Lost to Follow-up|0|||
147593267|NCT00430495|532328955|FG000|Overall Study|Protocol Violation|1|||
147325487|NCT01190176|531355776|FG000|Overall Study|Withdrawal by Subject|1|||
147325488|NCT01190176|531355776|FG000|Overall Study|Lost to Follow-up|1|||
147325489|NCT02909101|531355777|FG000|Overall Study|Lost to Follow-up|1|||
147325490|NCT02909101|531355778|FG001|Overall Study|Lost to Follow-up|1|||
147325491|NCT02189863|531355779|FG000|First 2 Weeks|Motion Sickness|4|||
147325492|NCT02189863|531355780|FG001|First 2 Weeks|Motion Sickness|2|||
147325493|NCT03697460|531355781|FG000|Overall Study|Withdrawal by Subject|3|||
147325494|NCT03369951|531355782|FG000|Overall Study|Withdrawal by Subject|3|||
147325495|NCT03369951|531355782|FG000|Overall Study|Death|1|||
147325496|NCT03369951|531355782|FG000|Overall Study|Lost to Follow-up|1|||
147325497|NCT03369951|531355782|FG000|Overall Study|Protocol Violation|1|||
147325498|NCT00725010|531355789|FG000|Overall Study|Toxicity|9|||
147325499|NCT00725010|531355789|FG000|Overall Study|Tumor Progression|7|||
147325500|NCT00725010|531355789|FG000|Overall Study|Withdrawal by Subject|2|||
147325501|NCT00725010|531355789|FG000|Overall Study|Death|1|||
147325502|NCT00725010|531355789|FG000|Overall Study|Lost to Follow-up|1|||
147325503|NCT00725010|531355789|FG000|Overall Study|Hepatopathy probably not Temodal-related|1|||
147325504|NCT00725010|531355789|FG000|Overall Study|Suspect lymph nodes neck thorax abdomen|1|||
147325505|NCT00725010|531355789|FG000|Overall Study|No further documentation|1|||
147325506|NCT00725010|531355789|FG000|Overall Study|Intensified treatment scheme: 3 on 1 off|2|||
147325507|NCT03499600|531355790|FG000|Overall Study|Caregiver/child dyad dropped out before completing a full course of treatment|21|||
147325508|NCT03499600|531355791|FG001|Overall Study|Caregiver/child dyad dropped out before completing a full course of treatment|30|||
147325509|NCT00569946|531357287|FG000|Overall Study|Adverse Event|16|||
147593268|NCT00430495|532328956|FG001|Overall Study|Protocol Violation|0|||
147179464|NCT02128724|530823534|FG001|Overall Study|Adverse Event|1|||
147325510|NCT00569946|531357287|FG000|Overall Study|Objective Progression or Relapse|42|||
147325511|NCT00569946|531357287|FG000|Overall Study|Global Deterioration of Health Status|1|||
147325512|NCT00797862|531357288|FG000|Overall Study|Adverse Event|86|||
147325513|NCT00797862|531357289|FG001|Overall Study|Adverse Event|44|||
147325514|NCT00797862|531357290|FG002|Overall Study|Adverse Event|58|||
147325515|NCT00797862|531357288|FG000|Overall Study|Abnormal Test Procedure Result|0|||
147325516|NCT00797862|531357289|FG001|Overall Study|Abnormal Test Procedure Result|1|||
147325517|NCT00797862|531357290|FG002|Overall Study|Abnormal Test Procedure Result|1|||
147325518|NCT00797862|531357288|FG000|Overall Study|Lack of Efficacy|1|||
147325519|NCT00797862|531357289|FG001|Overall Study|Lack of Efficacy|7|||
147325520|NCT00797862|531357290|FG002|Overall Study|Lack of Efficacy|6|||
147593269|NCT00430495|532328957|FG002|Overall Study|Protocol Violation|1|||
147325521|NCT00797862|531357288|FG000|Overall Study|No longer required study medication|1|||
147325522|NCT00797862|531357289|FG001|Overall Study|No longer required study medication|0|||
147325523|NCT00797862|531357290|FG002|Overall Study|No longer required study medication|0|||
147325524|NCT00797862|531357288|FG000|Overall Study|Withdrawal by Subject|14|||
147325525|NCT00797862|531357289|FG001|Overall Study|Withdrawal by Subject|7|||
147325526|NCT00797862|531357290|FG002|Overall Study|Withdrawal by Subject|7|||
147325527|NCT00797862|531357288|FG000|Overall Study|Lost to Follow-up|11|||
147325528|NCT00797862|531357289|FG001|Overall Study|Lost to Follow-up|0|||
147325529|NCT00797862|531357290|FG002|Overall Study|Lost to Follow-up|5|||
147325530|NCT00797862|531357288|FG000|Overall Study|Administrative Problem|4|||
147325531|NCT00797862|531357289|FG001|Overall Study|Administrative Problem|0|||
147325532|NCT00797862|531357290|FG002|Overall Study|Administrative Problem|0|||
147325533|NCT00797862|531357288|FG000|Overall Study|Protocol Violation|4|||
147325534|NCT00797862|531357289|FG001|Overall Study|Protocol Violation|6|||
147325535|NCT00797862|531357290|FG002|Overall Study|Protocol Violation|8|||
147325536|NCT00797862|531357288|FG000|Overall Study|Mis-randomized|3|||
147325537|NCT00797862|531357289|FG001|Overall Study|Mis-randomized|3|||
147325538|NCT00797862|531357290|FG002|Overall Study|Mis-randomized|1|||
147325539|NCT05074498|531357293|FG000|Part 1 (Upto Day 104)|Lost to Follow-up|0|||
147325540|NCT05074498|531357294|FG001|Part 1 (Upto Day 104)|Lost to Follow-up|0|||
147325541|NCT05074498|531357295|FG002|Part 1 (Upto Day 104)|Lost to Follow-up|0|||
147325542|NCT05074498|531357296|FG003|Part 1 (Upto Day 104)|Lost to Follow-up|1|||
147325543|NCT05074498|531357297|FG004|Part 1 (Upto Day 104)|Lost to Follow-up|0|||
147325544|NCT05074498|531357298|FG005|Part 1 (Upto Day 104)|Lost to Follow-up|0|||
147325545|NCT05074498|531357293|FG000|Part 1 (Upto Day 104)|Other|1|||
147325546|NCT05074498|531357294|FG001|Part 1 (Upto Day 104)|Other|0|||
147325547|NCT05074498|531357295|FG002|Part 1 (Upto Day 104)|Other|0|||
147325548|NCT05074498|531357296|FG003|Part 1 (Upto Day 104)|Other|0|||
147325549|NCT05074498|531357297|FG004|Part 1 (Upto Day 104)|Other|0|||
147325550|NCT05074498|531357298|FG005|Part 1 (Upto Day 104)|Other|0|||
147325551|NCT05074498|531357293|FG000|Part 2 (Upto Day 104)|Withdrawal by Subject|0|||
147325552|NCT05074498|531357294|FG001|Part 2 (Upto Day 104)|Withdrawal by Subject|0|||
147325553|NCT05074498|531357295|FG002|Part 2 (Upto Day 104)|Withdrawal by Subject|0|||
147325554|NCT05074498|531357296|FG003|Part 2 (Upto Day 104)|Withdrawal by Subject|0|||
147325555|NCT05074498|531357297|FG004|Part 2 (Upto Day 104)|Withdrawal by Subject|2|||
147325556|NCT05074498|531357298|FG005|Part 2 (Upto Day 104)|Withdrawal by Subject|0|||
147325557|NCT05074498|531357293|FG000|Part 2 (Upto Day 104)|Death|0|||
147325558|NCT05074498|531357294|FG001|Part 2 (Upto Day 104)|Death|0|||
147325559|NCT05074498|531357295|FG002|Part 2 (Upto Day 104)|Death|0|||
147179465|NCT02128724|530823535|FG002|Overall Study|Adverse Event|0|||
147179466|NCT02128724|530823536|FG003|Overall Study|Adverse Event|0|||
147179467|NCT02128724|530823533|FG000|Overall Study|Physician Decision|0|||
147325560|NCT05074498|531357296|FG003|Part 2 (Upto Day 104)|Death|0|||
147325561|NCT05074498|531357297|FG004|Part 2 (Upto Day 104)|Death|1|||
147325562|NCT05074498|531357298|FG005|Part 2 (Upto Day 104)|Death|0|||
147325563|NCT05074498|531357293|FG000|Part 2 (Upto Day 104)|Lost to Follow-up|0|||
147325564|NCT05074498|531357294|FG001|Part 2 (Upto Day 104)|Lost to Follow-up|0|||
147325565|NCT05074498|531357295|FG002|Part 2 (Upto Day 104)|Lost to Follow-up|0|||
147325566|NCT05074498|531357296|FG003|Part 2 (Upto Day 104)|Lost to Follow-up|0|||
147325567|NCT05074498|531357297|FG004|Part 2 (Upto Day 104)|Lost to Follow-up|1|||
147325568|NCT05074498|531357298|FG005|Part 2 (Upto Day 104)|Lost to Follow-up|2|||
147325569|NCT05074498|531357293|FG000|Part 2 (Upto Day 104)|Other|0|||
147325570|NCT05074498|531357294|FG001|Part 2 (Upto Day 104)|Other|0|||
147325571|NCT05074498|531357295|FG002|Part 2 (Upto Day 104)|Other|0|||
147325572|NCT05074498|531357296|FG003|Part 2 (Upto Day 104)|Other|0|||
147325573|NCT05074498|531357297|FG004|Part 2 (Upto Day 104)|Other|1|||
147325574|NCT05074498|531357298|FG005|Part 2 (Upto Day 104)|Other|0|||
147325575|NCT01240356|531357299|FG000|Overall Study|Withdrawal by Subject|2|||
147325576|NCT01240356|531357300|FG001|Overall Study|Withdrawal by Subject|0|||
147325577|NCT01240356|531357299|FG000|Overall Study|MRI contraindication|1|||
147325578|NCT01240356|531357300|FG001|Overall Study|MRI contraindication|0|||
147325579|NCT00172185|531357304|FG000|Overall Study|Adverse Event|0|||
147325580|NCT00172185|531357305|FG001|Overall Study|Adverse Event|1|||
147325581|NCT00172185|531357306|FG002|Overall Study|Adverse Event|3|||
147448370|NCT00640328|531805707|FG002|First Treatment Period (Weeks 0-24)|Adverse Event|0|||
147179468|NCT02128724|530823534|FG001|Overall Study|Physician Decision|0|||
147179469|NCT02128724|530823535|FG002|Overall Study|Physician Decision|0|||
147179470|NCT02128724|530823536|FG003|Overall Study|Physician Decision|2|||
147325582|NCT00172185|531357307|FG003|Overall Study|Adverse Event|4|||
147325583|NCT00172185|531357304|FG000|Overall Study|Physician Decision|0|||
147325584|NCT00172185|531357305|FG001|Overall Study|Physician Decision|0|||
147325585|NCT00172185|531357306|FG002|Overall Study|Physician Decision|1|||
147325586|NCT00172185|531357307|FG003|Overall Study|Physician Decision|0|||
147325587|NCT00172185|531357304|FG000|Overall Study|SPONSOR Decision|0|||
147325588|NCT00172185|531357305|FG001|Overall Study|SPONSOR Decision|1|||
147325589|NCT00172185|531357306|FG002|Overall Study|SPONSOR Decision|0|||
147325590|NCT00172185|531357307|FG003|Overall Study|SPONSOR Decision|0|||
147325591|NCT00172185|531357304|FG000|Overall Study|Withdrawal by Subject|0|||
147448371|NCT00640328|531805708|FG003|First Treatment Period (Weeks 0-24)|Adverse Event|0|||
147448372|NCT00640328|531805709|FG004|First Treatment Period (Weeks 0-24)|Adverse Event|0|||
147448373|NCT00640328|531805710|FG005|First Treatment Period (Weeks 0-24)|Adverse Event|0|||
147448374|NCT00640328|531805705|FG000|Second Treatment Period (Weeks 24-48)|Adverse Event|0|||
147448375|NCT00640328|531805706|FG001|Second Treatment Period (Weeks 24-48)|Adverse Event|0|||
147448376|NCT00640328|531805707|FG002|Second Treatment Period (Weeks 24-48)|Adverse Event|0|||
147448377|NCT00640328|531805708|FG003|Second Treatment Period (Weeks 24-48)|Adverse Event|0|||
147448378|NCT00640328|531805709|FG004|Second Treatment Period (Weeks 24-48)|Adverse Event|1|||
147448379|NCT00640328|531805710|FG005|Second Treatment Period (Weeks 24-48)|Adverse Event|0|||
147245346|NCT01737697|531070809|FG006|Acute Phase-Initial 48 Hours|Family emergency|0|||
147245347|NCT01737697|531070810|FG007|Acute Phase-Initial 48 Hours|Family emergency|0|||
147245348|NCT01737697|531070811|FG008|Acute Phase-Initial 48 Hours|Family emergency|0|||
147245349|NCT01737697|531070812|FG009|Acute Phase-Initial 48 Hours|Family emergency|0|||
147448380|NCT00640328|531805705|FG000|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0|||
147448381|NCT00640328|531805706|FG001|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0|||
147448382|NCT00640328|531805707|FG002|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|1|||
147448383|NCT00640328|531805708|FG003|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0|||
147448384|NCT00640328|531805709|FG004|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0|||
147593270|NCT00430495|532328958|FG003|Overall Study|Protocol Violation|0|||
147593271|NCT00430495|532328955|FG000|Overall Study|Disease Progression|1|||
147593272|NCT00430495|532328956|FG001|Overall Study|Disease Progression|1|||
147593273|NCT00430495|532328957|FG002|Overall Study|Disease Progression|0|||
147593274|NCT00430495|532328958|FG003|Overall Study|Disease Progression|0|||
147593275|NCT00430495|532328955|FG000|Overall Study|Other|8|||
147593276|NCT00430495|532328956|FG001|Overall Study|Other|2|||
147245350|NCT01737697|531070813|FG010|Acute Phase-Initial 48 Hours|Family emergency|0|||
147245351|NCT01737697|531070814|FG011|Acute Phase-Initial 48 Hours|Family emergency|0|||
147245352|NCT01737697|531070815|FG012|Acute Phase-Initial 48 Hours|Family emergency|0|||
147245353|NCT01737697|531070816|FG013|Acute Phase-Initial 48 Hours|Family emergency|0|||
147245354|NCT01737697|531070817|FG014|Acute Phase-Initial 48 Hours|Family emergency|0|||
147245355|NCT01737697|531070803|FG000|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
147245356|NCT01737697|531070804|FG001|Acute Phase-Initial 48 Hours|Sponsor's decision|1|||
147245357|NCT01737697|531070805|FG002|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
147245358|NCT01737697|531070806|FG003|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
147245359|NCT01737697|531070807|FG004|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
147245360|NCT01737697|531070808|FG005|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
147245361|NCT01737697|531070809|FG006|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
147325592|NCT00172185|531357305|FG001|Overall Study|Withdrawal by Subject|0|||
147325593|NCT00172185|531357306|FG002|Overall Study|Withdrawal by Subject|1|||
147325594|NCT00172185|531357307|FG003|Overall Study|Withdrawal by Subject|0|||
147325595|NCT04048135|531357308|FG000|Overall Study|Withdrawal by Subject|1|||
147325596|NCT04048135|531357309|FG001|Overall Study|Withdrawal by Subject|1|||
147325597|NCT04048135|531357310|FG002|Overall Study|Withdrawal by Subject|1|||
147325598|NCT04048135|531357311|FG003|Overall Study|Withdrawal by Subject|2|||
147325599|NCT04048135|531357312|FG004|Overall Study|Withdrawal by Subject|0|||
147325600|NCT04048135|531357313|FG005|Overall Study|Withdrawal by Subject|0|||
147325601|NCT04048135|531357314|FG006|Overall Study|Withdrawal by Subject|1|||
147325602|NCT04048135|531357315|FG007|Overall Study|Withdrawal by Subject|1|||
147325603|NCT04048135|531357308|FG000|Overall Study|Adverse Event|0|||
147325604|NCT04048135|531357309|FG001|Overall Study|Adverse Event|0|||
147325605|NCT04048135|531357310|FG002|Overall Study|Adverse Event|0|||
147325606|NCT04048135|531357311|FG003|Overall Study|Adverse Event|1|||
147325607|NCT04048135|531357312|FG004|Overall Study|Adverse Event|1|||
147325608|NCT04048135|531357313|FG005|Overall Study|Adverse Event|0|||
147325609|NCT04048135|531357314|FG006|Overall Study|Adverse Event|0|||
147325610|NCT04048135|531357315|FG007|Overall Study|Adverse Event|0|||
147325611|NCT04048135|531357308|FG000|Overall Study|Protocol Violation|0|||
147325612|NCT04048135|531357309|FG001|Overall Study|Protocol Violation|0|||
147325613|NCT04048135|531357310|FG002|Overall Study|Protocol Violation|0|||
147325614|NCT04048135|531357311|FG003|Overall Study|Protocol Violation|0|||
147325615|NCT04048135|531357312|FG004|Overall Study|Protocol Violation|0|||
147593277|NCT00430495|532328957|FG002|Overall Study|Other|5|||
147245362|NCT01737697|531070810|FG007|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
147325616|NCT04048135|531357313|FG005|Overall Study|Protocol Violation|1|||
147325617|NCT04048135|531357314|FG006|Overall Study|Protocol Violation|0|||
147325618|NCT04048135|531357315|FG007|Overall Study|Protocol Violation|0|||
147325619|NCT01677936|531357316|FG000|Overall Study|Lost to Follow-up|4|||
147325620|NCT01677936|531357317|FG001|Overall Study|Lost to Follow-up|1|||
147325621|NCT01677936|531357316|FG000|Overall Study|Protocol Violation|3|||
147325622|NCT01677936|531357317|FG001|Overall Study|Protocol Violation|0|||
147325623|NCT01677936|531357316|FG000|Overall Study|Adverse Event|1|||
147325624|NCT01677936|531357317|FG001|Overall Study|Adverse Event|0|||
147325625|NCT01677936|531357316|FG000|Overall Study|Lost to Follow-up|1|||
147593278|NCT00430495|532328958|FG003|Overall Study|Other|4|||
147325626|NCT01677936|531357317|FG001|Overall Study|Lost to Follow-up|0|||
147325627|NCT01677936|531357316|FG000|Overall Study|Protocol Violation|0|||
147325628|NCT01677936|531357317|FG001|Overall Study|Protocol Violation|4|||
147325629|NCT03837028|531357318|FG000|Overall Study|Lost to Follow-up|4|||
147325630|NCT03837028|531357319|FG001|Overall Study|Lost to Follow-up|0|||
147325631|NCT03837028|531357320|FG002|Overall Study|Lost to Follow-up|2|||
147325632|NCT03837028|531357321|FG003|Overall Study|Lost to Follow-up|0|||
147325633|NCT03837028|531357318|FG000|Overall Study|Withdrawal by Subject|12|||
147325634|NCT03837028|531357319|FG001|Overall Study|Withdrawal by Subject|11|||
147325635|NCT03837028|531357320|FG002|Overall Study|Withdrawal by Subject|11|||
147325636|NCT03837028|531357321|FG003|Overall Study|Withdrawal by Subject|7|||
147325637|NCT00157014|531357322|FG000|Overall Study|Death|4|||
147325638|NCT00157014|531357323|FG001|Overall Study|Death|2|||
147325639|NCT00157014|531357324|FG002|Overall Study|Death|1|||
147325640|NCT00157014|531357325|FG003|Overall Study|Death|1|||
147325641|NCT00157014|531357322|FG000|Overall Study|Physician Decision|0|||
147325642|NCT00157014|531357323|FG001|Overall Study|Physician Decision|1|||
147325643|NCT00157014|531357324|FG002|Overall Study|Physician Decision|0|||
147325644|NCT00157014|531357325|FG003|Overall Study|Physician Decision|0|||
147325645|NCT00157014|531357322|FG000|Overall Study|Medications withdrawn on family request|0|||
147325646|NCT00157014|531357323|FG001|Overall Study|Medications withdrawn on family request|1|||
147325647|NCT00157014|531357324|FG002|Overall Study|Medications withdrawn on family request|0|||
147325648|NCT00157014|531357325|FG003|Overall Study|Medications withdrawn on family request|0|||
147325649|NCT00157014|531357322|FG000|Overall Study|Patient withdrawn by investigator|1|||
147325650|NCT00157014|531357323|FG001|Overall Study|Patient withdrawn by investigator|0|||
147325651|NCT00157014|531357324|FG002|Overall Study|Patient withdrawn by investigator|0|||
147325652|NCT00157014|531357325|FG003|Overall Study|Patient withdrawn by investigator|0|||
147325653|NCT00157014|531357322|FG000|Overall Study|Patient unable to return in nursing home|1|||
147325654|NCT00157014|531357323|FG001|Overall Study|Patient unable to return in nursing home|0|||
147325655|NCT00157014|531357324|FG002|Overall Study|Patient unable to return in nursing home|0|||
147325656|NCT00157014|531357325|FG003|Overall Study|Patient unable to return in nursing home|0|||
147325657|NCT00157014|531357322|FG000|Overall Study|Patient would not receive transplant|0|||
147593279|NCT00430495|532328955|FG000|Overall Study|Randomized but not Treated|2|||
147593280|NCT00430495|532328956|FG001|Overall Study|Randomized but not Treated|0|||
147325658|NCT00157014|531357323|FG001|Overall Study|Patient would not receive transplant|1|||
147325659|NCT00157014|531357324|FG002|Overall Study|Patient would not receive transplant|0|||
147325660|NCT00157014|531357325|FG003|Overall Study|Patient would not receive transplant|0|||
147325661|NCT00157014|531357322|FG000|Overall Study|Withdrawal by Subject|1|||
147325662|NCT00157014|531357323|FG001|Overall Study|Withdrawal by Subject|0|||
147325663|NCT00157014|531357324|FG002|Overall Study|Withdrawal by Subject|0|||
147325664|NCT00157014|531357325|FG003|Overall Study|Withdrawal by Subject|0|||
147325665|NCT01362491|531357326|FG000|Overall Study|Ineligible|1|||
147325666|NCT01362491|531357327|FG001|Overall Study|Ineligible|0|||
147325667|NCT01362491|531357328|FG002|Overall Study|Ineligible|0|||
147325668|NCT01257503|531357329|FG000|Overall Study|Lost to Follow-up|7|||
147325669|NCT01257503|531357330|FG001|Overall Study|Lost to Follow-up|10|||
147325670|NCT01257503|531357329|FG000|Overall Study|Over 5 years old at enrollment|0|||
147325671|NCT01257503|531357330|FG001|Overall Study|Over 5 years old at enrollment|1|||
147325672|NCT01257503|531357329|FG000|Overall Study|strep culture positive at enrollment|1|||
147593281|NCT00430495|532328957|FG002|Overall Study|Randomized but not Treated|0|||
147593282|NCT00430495|532328958|FG003|Overall Study|Randomized but not Treated|0|||
147593283|NCT00158756|532328959|FG000|Overall Study|Withdrawal by Subject|5|||
147593284|NCT00158756|532328960|FG001|Overall Study|Withdrawal by Subject|0|||
147593285|NCT00158756|532328961|FG002|Overall Study|Withdrawal by Subject|6|||
147656223|NCT02959918|532564959|FG008|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
147656224|NCT02959918|532564960|FG009|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
147325673|NCT01257503|531357330|FG001|Overall Study|strep culture positive at enrollment|0|||
147325674|NCT04577183|531357338|FG000|Overall Study|Death|1|||
147325675|NCT04577183|531357338|FG000|Overall Study|Withdrawal by Subject|3|||
147325676|NCT04577183|531357338|FG000|Overall Study|Early termination|2|||
147325677|NCT02072226|531357346|FG000|Overall Study|Lost to Follow-up|11|||
147325678|NCT02072226|531357347|FG001|Overall Study|Lost to Follow-up|7|||
147325679|NCT02072226|531357346|FG000|Overall Study|Patient Non-compliance|2|||
147325680|NCT02072226|531357347|FG001|Overall Study|Patient Non-compliance|3|||
147325681|NCT02072226|531357346|FG000|Overall Study|Death|1|||
147325682|NCT02072226|531357347|FG001|Overall Study|Death|0|||
147325683|NCT02072226|531357346|FG000|Overall Study|Patient Withdrawal of Consent|1|||
147325684|NCT02072226|531357347|FG001|Overall Study|Patient Withdrawal of Consent|0|||
147325685|NCT03255018|531357350|FG000|Overall Study|Death on study|0|||
147325686|NCT03255018|531357351|FG001|Overall Study|Death on study|5|||
147325687|NCT03255018|531357350|FG000|Overall Study|Withdrawal by Subject|0|||
147325688|NCT03255018|531357351|FG001|Overall Study|Withdrawal by Subject|2|||
147325689|NCT04381494|531357353|FG000|Overall Study|Early termination of trial|19|||
147593286|NCT00158756|532328962|FG003|Overall Study|Withdrawal by Subject|1|||
147593287|NCT00158756|532328963|FG004|Overall Study|Withdrawal by Subject|3|||
147325690|NCT04381494|531357353|FG000|Overall Study|Investigator's discretion|1|||
147325691|NCT04381494|531357353|FG000|Overall Study|Withdrawal by Subject|9|||
147325692|NCT04381494|531357353|FG000|Overall Study|NSCLC disease progression|4|||
147325693|NCT04381494|531357353|FG000|Overall Study|Device-Related Adverse Event|2|||
147325694|NCT02950545|531357362|FG000|Session 1 (70 Minutes)|Withdrawal by Subject|0|||
147325695|NCT02950545|531357363|FG001|Session 1 (70 Minutes)|Withdrawal by Subject|0|||
147325696|NCT02950545|531357364|FG002|Session 1 (70 Minutes)|Withdrawal by Subject|0|||
147325697|NCT02950545|531357365|FG003|Session 1 (70 Minutes)|Withdrawal by Subject|0|||
147325698|NCT02950545|531357366|FG004|Session 1 (70 Minutes)|Withdrawal by Subject|0|||
147325699|NCT02950545|531357367|FG005|Session 1 (70 Minutes)|Withdrawal by Subject|1|||
147325700|NCT02950545|531357362|FG000|Washout 1 (5 Minutes)|Withdrawal by Subject|1|||
147325701|NCT02950545|531357363|FG001|Washout 1 (5 Minutes)|Withdrawal by Subject|0|||
147325702|NCT02950545|531357364|FG002|Washout 1 (5 Minutes)|Withdrawal by Subject|0|||
147325703|NCT02950545|531357365|FG003|Washout 1 (5 Minutes)|Withdrawal by Subject|1|||
147325704|NCT02950545|531357366|FG004|Washout 1 (5 Minutes)|Withdrawal by Subject|0|||
147325705|NCT02950545|531357367|FG005|Washout 1 (5 Minutes)|Withdrawal by Subject|1|||
147325706|NCT02950545|531357362|FG000|Session 2 (70 Minutes)|Withdrawal by Subject|0|||
147325707|NCT02950545|531357363|FG001|Session 2 (70 Minutes)|Withdrawal by Subject|0|||
147325708|NCT02950545|531357364|FG002|Session 2 (70 Minutes)|Withdrawal by Subject|0|||
147325709|NCT02950545|531357365|FG003|Session 2 (70 Minutes)|Withdrawal by Subject|0|||
147325710|NCT02950545|531357366|FG004|Session 2 (70 Minutes)|Withdrawal by Subject|1|||
147325711|NCT02950545|531357367|FG005|Session 2 (70 Minutes)|Withdrawal by Subject|0|||
147325712|NCT02950545|531357362|FG000|Washout 2 (5 Minutes)|Withdrawal by Subject|1|||
147325713|NCT02950545|531357363|FG001|Washout 2 (5 Minutes)|Withdrawal by Subject|0|||
147325714|NCT02950545|531357364|FG002|Washout 2 (5 Minutes)|Withdrawal by Subject|0|||
147325715|NCT02950545|531357365|FG003|Washout 2 (5 Minutes)|Withdrawal by Subject|0|||
147325716|NCT02950545|531357366|FG004|Washout 2 (5 Minutes)|Withdrawal by Subject|0|||
147325717|NCT02950545|531357367|FG005|Washout 2 (5 Minutes)|Withdrawal by Subject|0|||
147325718|NCT02950545|531357362|FG000|Session 3 (70 Minutes)|Withdrawal by Subject|0|||
147325719|NCT02950545|531357363|FG001|Session 3 (70 Minutes)|Withdrawal by Subject|0|||
147325720|NCT02950545|531357364|FG002|Session 3 (70 Minutes)|Withdrawal by Subject|0|||
147325721|NCT02950545|531357365|FG003|Session 3 (70 Minutes)|Withdrawal by Subject|0|||
147325722|NCT02950545|531357366|FG004|Session 3 (70 Minutes)|Withdrawal by Subject|0|||
147325723|NCT02950545|531357367|FG005|Session 3 (70 Minutes)|Withdrawal by Subject|1|||
147325724|NCT03101592|531357368|FG000|Overall Study|participant files could not be located|111|||
147325725|NCT03101592|531357369|FG001|Overall Study|participant files could not be located|170|||
147325726|NCT03101592|531357370|FG002|Overall Study|participant files could not be located|118|||
147325727|NCT03398356|531357371|FG000|Before Treatment|Lost to Follow-up|1|||
147325728|NCT03398356|531357372|FG001|Before Treatment|Lost to Follow-up|2|||
147325729|NCT03398356|531357373|FG002|Before Treatment|Lost to Follow-up|0|||
147325730|NCT03398356|531357371|FG000|Before Treatment|drug intolerance|2|||
147325731|NCT03398356|531357372|FG001|Before Treatment|drug intolerance|1|||
147325732|NCT03398356|531357373|FG002|Before Treatment|drug intolerance|0|||
147325733|NCT03398356|531357371|FG000|Before Treatment|Withdrawal by Subject|0|||
147325734|NCT03398356|531357372|FG001|Before Treatment|Withdrawal by Subject|5|||
147325735|NCT03398356|531357373|FG002|Before Treatment|Withdrawal by Subject|0|||
147325736|NCT03398356|531357371|FG000|Before Treatment|Physician Decision|0|||
147325737|NCT03398356|531357372|FG001|Before Treatment|Physician Decision|0|||
147325738|NCT03398356|531357373|FG002|Before Treatment|Physician Decision|11|||
147325739|NCT03398356|531357371|FG000|After 6 Weeks of Treatment|Physician Decision|0|||
147325740|NCT03398356|531357372|FG001|After 6 Weeks of Treatment|Physician Decision|2|||
147325741|NCT03398356|531357373|FG002|After 6 Weeks of Treatment|Physician Decision|0|||
147325742|NCT00647348|531357375|FG000|Overall Study|Lost to Follow-up|3|||
147325743|NCT00647348|531357376|FG001|Overall Study|Lost to Follow-up|6|||
147593288|NCT00158756|532328959|FG000|Overall Study|Adverse Event|0|||
147593289|NCT00158756|532328960|FG001|Overall Study|Adverse Event|0|||
147325744|NCT00619151|531357377|FG000|Overall Study|Study terminated prior to followup|1|||
147325745|NCT00619151|531357378|FG001|Overall Study|Study terminated prior to followup|0|||
147448385|NCT00640328|531805710|FG005|IFUP (Week 48 to Individual Termination)|Withdrawal by Subject|0|||
147448386|NCT00640328|531805705|FG000|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0|||
147448387|NCT00640328|531805706|FG001|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|1|||
147325750|NCT01941316|531357384|FG000|Overall Study|Adverse Event|0|||
147325751|NCT01941316|531357385|FG001|Overall Study|Adverse Event|1|||
147325752|NCT01941316|531357386|FG002|Overall Study|Adverse Event|0|||
147325753|NCT01941316|531357387|FG003|Overall Study|Adverse Event|7|||
147325754|NCT01941316|531357384|FG000|Overall Study|Progressive Disease|3|||
147325755|NCT01941316|531357385|FG001|Overall Study|Progressive Disease|6|||
147325756|NCT01941316|531357386|FG002|Overall Study|Progressive Disease|2|||
147325757|NCT01941316|531357387|FG003|Overall Study|Progressive Disease|29|||
147325758|NCT01941316|531357384|FG000|Overall Study|Withdrawal by Subject|0|||
147325759|NCT01941316|531357385|FG001|Overall Study|Withdrawal by Subject|2|||
147325760|NCT01941316|531357386|FG002|Overall Study|Withdrawal by Subject|1|||
147179471|NCT02128724|530823533|FG000|Overall Study|Withdrawal by Subject|0|||
147179472|NCT02128724|530823534|FG001|Overall Study|Withdrawal by Subject|0|||
147179473|NCT02128724|530823535|FG002|Overall Study|Withdrawal by Subject|0|||
147179474|NCT02128724|530823536|FG003|Overall Study|Withdrawal by Subject|1|||
147179475|NCT01442714|530823537|FG000|Overall Study|Death|11|||
147179476|NCT01442714|530823537|FG000|Overall Study|Withdrawal by Subject|1|||
147179477|NCT04306510|530823538|FG000|Overall Study|Voluntarily withdrawal|1|||
147179478|NCT04306510|530823538|FG000|Overall Study|Enrolled but Not Treated|1|||
147179479|NCT04720417|530823541|FG000|Overall Study|one subject did not initiate treatment due to rapid disease progression|1|||
147179480|NCT03329092|530823542|FG000|Overall Study|Other|2|||
147179481|NCT03329092|530823543|FG001|Overall Study|Other|2|||
147179482|NCT03329092|530823542|FG000|Overall Study|Withdrawal by Subject|16|||
147179483|NCT03329092|530823543|FG001|Overall Study|Withdrawal by Subject|3|||
147179484|NCT03329092|530823542|FG000|Overall Study|Physician Decision|1|||
147179485|NCT03329092|530823543|FG001|Overall Study|Physician Decision|0|||
147179486|NCT03329092|530823542|FG000|Overall Study|Death|17|||
147179487|NCT03329092|530823543|FG001|Overall Study|Death|11|||
147179488|NCT03329092|530823542|FG000|Overall Study|Adverse Event|3|||
147179489|NCT03329092|530823543|FG001|Overall Study|Adverse Event|1|||
147179490|NCT03329092|530823542|FG000|Overall Study|Lost to Follow-up|1|||
147179491|NCT03329092|530823543|FG001|Overall Study|Lost to Follow-up|1|||
147179492|NCT03314987|530823544|FG000|Overall Study|Lost to Follow-up|13|||
147179493|NCT03314987|530823545|FG001|Overall Study|Lost to Follow-up|13|||
147179494|NCT03574779|530823546|FG000|Overall Study|Screening failure|13|||
147179495|NCT03574779|530823547|FG001|Overall Study|Screening failure|83|||
147179496|NCT02751580|530823548|FG000|Overall Study|Lost to Follow-up|4|||
147179497|NCT02751580|530823548|FG000|Overall Study|Death|2|||
147325761|NCT01941316|531357387|FG003|Overall Study|Withdrawal by Subject|8|||
147179498|NCT01076036|530823551|FG000|Overall Study|Didn't meet inclusion/exclusion criteria|2|||
147179499|NCT02221674|530823552|FG000|Overall Study|Lost to Follow-up|1|||
147179500|NCT02221674|530823553|FG001|Overall Study|Lost to Follow-up|0|||
147179501|NCT02221674|530823554|FG002|Overall Study|Lost to Follow-up|0|||
147179502|NCT05292131|530823555|FG000|Overall Study|Lost to Follow-up|1|||
147179503|NCT05292131|530823556|FG001|Overall Study|Lost to Follow-up|1|||
147179504|NCT05292131|530823555|FG000|Overall Study|Withdrawal by Subject|0|||
147179505|NCT05292131|530823556|FG001|Overall Study|Withdrawal by Subject|1|||
147179506|NCT04390880|530823558|FG000|Overall Study|Withdrawal by Subject|1|||
147179507|NCT02557542|530823559|FG000|Overall Study|Poor recruitment|3|||
147179508|NCT02557542|530823560|FG001|Overall Study|Poor recruitment|0|||
147179509|NCT00465452|530823561|FG000|Overall Study|Adverse Event|1|||
147179510|NCT00172042|530823594|FG000|Overall Study|Adverse Event|27|||
147179511|NCT00172042|530823595|FG001|Overall Study|Adverse Event|13|||
147179512|NCT00172042|530823594|FG000|Overall Study|Abnormal laboratory value(s)|5|||
147179513|NCT00172042|530823595|FG001|Overall Study|Abnormal laboratory value(s)|1|||
147179514|NCT00172042|530823594|FG000|Overall Study|Abnormal test procedure(s)|0|||
147179515|NCT00172042|530823595|FG001|Overall Study|Abnormal test procedure(s)|3|||
147179516|NCT00172042|530823594|FG000|Overall Study|Unsatisfactory therapeutic effect|13|||
147179517|NCT00172042|530823595|FG001|Overall Study|Unsatisfactory therapeutic effect|11|||
147179518|NCT00172042|530823594|FG000|Overall Study|Patient no longer requires study drug|10|||
147179519|NCT00172042|530823595|FG001|Overall Study|Patient no longer requires study drug|8|||
147179520|NCT00172042|530823594|FG000|Overall Study|Protocol Violation|8|||
147179521|NCT00172042|530823595|FG001|Overall Study|Protocol Violation|7|||
147179522|NCT00172042|530823594|FG000|Overall Study|Withdrawal by Subject|37|||
147179523|NCT00172042|530823595|FG001|Overall Study|Withdrawal by Subject|25|||
147179524|NCT00172042|530823594|FG000|Overall Study|Lost to Follow-up|3|||
147179525|NCT00172042|530823595|FG001|Overall Study|Lost to Follow-up|5|||
147179526|NCT00172042|530823594|FG000|Overall Study|Administrative problems|13|||
147179527|NCT00172042|530823595|FG001|Overall Study|Administrative problems|10|||
147179528|NCT00172042|530823594|FG000|Overall Study|Death|42|||
147179529|NCT00172042|530823595|FG001|Overall Study|Death|42|||
147179530|NCT01771250|530823596|FG000|Period 1|Met exclusion criteria|1|||
147179531|NCT01771250|530823597|FG001|Period 1|Met exclusion criteria|0|||
147179532|NCT01180296|530823598|FG000|Overall Study|Protocol Violation|1|||
147179533|NCT01180296|530823599|FG001|Overall Study|Protocol Violation|2|||
147179534|NCT00483938|530823600|FG000|Overall Study|Protocol Violation|0|||
147179535|NCT00483938|530823601|FG001|Overall Study|Protocol Violation|0|||
147179536|NCT00483938|530823602|FG002|Overall Study|Protocol Violation|0|||
147179537|NCT00483938|530823603|FG003|Overall Study|Protocol Violation|0|||
147179538|NCT00483938|530823604|FG004|Overall Study|Protocol Violation|0|||
147179539|NCT00483938|530823605|FG005|Overall Study|Protocol Violation|0|||
147179540|NCT00483938|530823606|FG006|Overall Study|Protocol Violation|3|||
147179541|NCT00483938|530823600|FG000|Overall Study|Withdrawal by Subject|1|||
147325762|NCT01941316|531357384|FG000|Overall Study|Death|0|||
147179542|NCT00483938|530823601|FG001|Overall Study|Withdrawal by Subject|6|||
147179543|NCT00483938|530823602|FG002|Overall Study|Withdrawal by Subject|0|||
147179544|NCT00483938|530823603|FG003|Overall Study|Withdrawal by Subject|0|||
147179545|NCT00483938|530823604|FG004|Overall Study|Withdrawal by Subject|1|||
147179546|NCT00483938|530823605|FG005|Overall Study|Withdrawal by Subject|3|||
147325763|NCT01941316|531357385|FG001|Overall Study|Death|0|||
147325764|NCT01941316|531357386|FG002|Overall Study|Death|0|||
147325765|NCT01941316|531357387|FG003|Overall Study|Death|3|||
147325766|NCT01941316|531357384|FG000|Overall Study|Physician Decision|0|||
147325767|NCT01941316|531357385|FG001|Overall Study|Physician Decision|0|||
147325768|NCT01941316|531357386|FG002|Overall Study|Physician Decision|0|||
147325769|NCT01941316|531357387|FG003|Overall Study|Physician Decision|3|||
147325770|NCT01941316|531357384|FG000|Overall Study|Protocol Violation|0|||
147325771|NCT01941316|531357385|FG001|Overall Study|Protocol Violation|0|||
147325772|NCT01941316|531357386|FG002|Overall Study|Protocol Violation|0|||
147325773|NCT01941316|531357387|FG003|Overall Study|Protocol Violation|3|||
147325774|NCT01941316|531357384|FG000|Overall Study|Intercurrent illness|0|||
147325775|NCT01941316|531357385|FG001|Overall Study|Intercurrent illness|0|||
147325776|NCT01941316|531357386|FG002|Overall Study|Intercurrent illness|0|||
147325777|NCT01941316|531357387|FG003|Overall Study|Intercurrent illness|1|||
147325778|NCT01941316|531357384|FG000|Overall Study|Other, not specified|0|||
147325779|NCT01941316|531357385|FG001|Overall Study|Other, not specified|0|||
147325780|NCT01941316|531357386|FG002|Overall Study|Other, not specified|0|||
147325781|NCT01941316|531357387|FG003|Overall Study|Other, not specified|1|||
147325782|NCT02775435|531357388|FG000|Overall Study|Adverse Event|32|||
147325783|NCT02775435|531357389|FG001|Overall Study|Adverse Event|27|||
147325784|NCT02775435|531357388|FG000|Overall Study|Lost to Follow-up|2|||
147325785|NCT02775435|531357389|FG001|Overall Study|Lost to Follow-up|2|||
147325786|NCT02775435|531357388|FG000|Overall Study|Sponsor decision|44|||
147325787|NCT02775435|531357389|FG001|Overall Study|Sponsor decision|19|||
147325788|NCT02775435|531357388|FG000|Overall Study|Withdrawal by Subject|4|||
147179547|NCT00483938|530823606|FG006|Overall Study|Withdrawal by Subject|2|||
147179548|NCT00483938|530823600|FG000|Overall Study|Lost to Follow-up|1|||
147179549|NCT00483938|530823601|FG001|Overall Study|Lost to Follow-up|2|||
147179550|NCT00483938|530823602|FG002|Overall Study|Lost to Follow-up|0|||
147179551|NCT00483938|530823603|FG003|Overall Study|Lost to Follow-up|2|||
147179552|NCT00483938|530823604|FG004|Overall Study|Lost to Follow-up|1|||
147179553|NCT00483938|530823605|FG005|Overall Study|Lost to Follow-up|1|||
147179554|NCT00483938|530823606|FG006|Overall Study|Lost to Follow-up|3|||
147179555|NCT00483938|530823600|FG000|Overall Study|Death|0|||
147179556|NCT00483938|530823601|FG001|Overall Study|Death|2|||
147179557|NCT00483938|530823602|FG002|Overall Study|Death|0|||
147179558|NCT00483938|530823603|FG003|Overall Study|Death|0|||
147179559|NCT00483938|530823604|FG004|Overall Study|Death|0|||
147179560|NCT00483938|530823605|FG005|Overall Study|Death|0|||
147179561|NCT00483938|530823606|FG006|Overall Study|Death|0|||
147179562|NCT00483938|530823600|FG000|Overall Study|Other|3|||
147179563|NCT00483938|530823601|FG001|Overall Study|Other|9|||
147179564|NCT00483938|530823602|FG002|Overall Study|Other|0|||
147179565|NCT00483938|530823603|FG003|Overall Study|Other|4|||
147325789|NCT02775435|531357389|FG001|Overall Study|Withdrawal by Subject|9|||
147325790|NCT02775435|531357388|FG000|Overall Study|Death|196|||
147325791|NCT02775435|531357389|FG001|Overall Study|Death|224|||
147325792|NCT04555044|531357392|FG000|Overall Study|Adverse Event|0|||
147325793|NCT04555044|531357393|FG001|Overall Study|Adverse Event|1|||
147325794|NCT05487703|531357395|FG000|Overall Study|Other|19|||
147325795|NCT05487703|531357395|FG000|Overall Study|Participant not well|5|||
147179566|NCT00483938|530823604|FG004|Overall Study|Other|0|||
147179567|NCT00483938|530823605|FG005|Overall Study|Other|4|||
147325796|NCT05487703|531357395|FG000|Overall Study|Insurance Reasons|6|||
147325797|NCT05487703|531357395|FG000|Overall Study|Physician Decision|19|||
147325798|NCT05487703|531357395|FG000|Overall Study|Lack of Efficacy|60|||
147325799|NCT02403323|531357396|FG000|Part 1: Open Label Extension Period|Adverse Event|26|||
147325800|NCT02403323|531357397|FG001|Part 1: Open Label Extension Period|Adverse Event|0|||
147325801|NCT02403323|531357398|FG002|Part 1: Open Label Extension Period|Adverse Event|0|||
147179568|NCT00483938|530823606|FG006|Overall Study|Other|32|||
147179569|NCT03364309|530823609|FG000|Induction Period|Adverse Event|4|||
147179570|NCT03364309|530823610|FG001|Induction Period|Adverse Event|0|||
147179571|NCT03364309|530823611|FG002|Induction Period|Adverse Event|1|||
147179572|NCT03364309|530823612|FG003|Induction Period|Adverse Event|0|||
147179573|NCT03364309|530823613|FG004|Induction Period|Adverse Event|0|||
147325802|NCT02403323|531357396|FG000|Part 1: Open Label Extension Period|Death|3|||
147325803|NCT02403323|531357397|FG001|Part 1: Open Label Extension Period|Death|0|||
147325804|NCT02403323|531357398|FG002|Part 1: Open Label Extension Period|Death|0|||
147325805|NCT02403323|531357396|FG000|Part 1: Open Label Extension Period|Lost to Follow-up|23|||
147325806|NCT02403323|531357397|FG001|Part 1: Open Label Extension Period|Lost to Follow-up|0|||
147325807|NCT02403323|531357398|FG002|Part 1: Open Label Extension Period|Lost to Follow-up|0|||
147325808|NCT02403323|531357396|FG000|Part 1: Open Label Extension Period|Non-Compliance|2|||
147593290|NCT00158756|532328961|FG002|Overall Study|Adverse Event|1|||
147179574|NCT03364309|530823614|FG005|Induction Period|Adverse Event|0|||
147179575|NCT03364309|530823615|FG006|Induction Period|Adverse Event|0|||
147179576|NCT03364309|530823616|FG007|Induction Period|Adverse Event|0|||
147179577|NCT03364309|530823617|FG008|Induction Period|Adverse Event|0|||
147179578|NCT03364309|530823618|FG009|Induction Period|Adverse Event|0|||
147325809|NCT02403323|531357397|FG001|Part 1: Open Label Extension Period|Non-Compliance|0|||
147179579|NCT03364309|530823619|FG010|Induction Period|Adverse Event|0|||
147325810|NCT02403323|531357398|FG002|Part 1: Open Label Extension Period|Non-Compliance|0|||
147325811|NCT02403323|531357396|FG000|Part 1: Open Label Extension Period|Reason Not Specified|59|||
147325812|NCT02403323|531357397|FG001|Part 1: Open Label Extension Period|Reason Not Specified|0|||
147325813|NCT02403323|531357398|FG002|Part 1: Open Label Extension Period|Reason Not Specified|0|||
147325814|NCT02403323|531357396|FG000|Part 1: Open Label Extension Period|Physician Decision|61|||
147325815|NCT02403323|531357397|FG001|Part 1: Open Label Extension Period|Physician Decision|0|||
147325816|NCT02403323|531357398|FG002|Part 1: Open Label Extension Period|Physician Decision|0|||
147325817|NCT02403323|531357396|FG000|Part 1: Open Label Extension Period|Study Terminated By Sponsor|19|||
147325818|NCT02403323|531357397|FG001|Part 1: Open Label Extension Period|Study Terminated By Sponsor|0|||
147325819|NCT02403323|531357398|FG002|Part 1: Open Label Extension Period|Study Terminated By Sponsor|0|||
147325820|NCT02403323|531357396|FG000|Part 1: Open Label Extension Period|Other|1|||
147325821|NCT02403323|531357397|FG001|Part 1: Open Label Extension Period|Other|0|||
147325822|NCT02403323|531357398|FG002|Part 1: Open Label Extension Period|Other|0|||
147325823|NCT02403323|531357396|FG000|Part 1: Open Label Extension Period|Withdrawal by Subject|232|||
147325824|NCT02403323|531357397|FG001|Part 1: Open Label Extension Period|Withdrawal by Subject|0|||
147325825|NCT02403323|531357398|FG002|Part 1: Open Label Extension Period|Withdrawal by Subject|0|||
147325826|NCT02403323|531357396|FG000|Part 2: PML Safety Monitoring Period|Adverse Event|0|||
147325827|NCT02403323|531357397|FG001|Part 2: PML Safety Monitoring Period|Adverse Event|4|||
147325828|NCT02403323|531357398|FG002|Part 2: PML Safety Monitoring Period|Adverse Event|0|||
147325829|NCT02403323|531357396|FG000|Part 2: PML Safety Monitoring Period|Death|0|||
147325830|NCT02403323|531357397|FG001|Part 2: PML Safety Monitoring Period|Death|1|||
147325831|NCT02403323|531357398|FG002|Part 2: PML Safety Monitoring Period|Death|0|||
147325832|NCT02403323|531357396|FG000|Part 2: PML Safety Monitoring Period|Lost to Follow-up|0|||
147325833|NCT02403323|531357397|FG001|Part 2: PML Safety Monitoring Period|Lost to Follow-up|9|||
147325834|NCT02403323|531357398|FG002|Part 2: PML Safety Monitoring Period|Lost to Follow-up|3|||
147325835|NCT02403323|531357396|FG000|Part 2: PML Safety Monitoring Period|Non-Compliance|0|||
147179580|NCT03364309|530823620|FG011|Induction Period|Adverse Event|0|||
147325836|NCT02403323|531357397|FG001|Part 2: PML Safety Monitoring Period|Non-Compliance|1|||
147325837|NCT02403323|531357398|FG002|Part 2: PML Safety Monitoring Period|Non-Compliance|0|||
147325838|NCT02403323|531357396|FG000|Part 2: PML Safety Monitoring Period|Reason Not Specified|0|||
147325839|NCT02403323|531357397|FG001|Part 2: PML Safety Monitoring Period|Reason Not Specified|6|||
147325840|NCT02403323|531357398|FG002|Part 2: PML Safety Monitoring Period|Reason Not Specified|1|||
147325841|NCT02403323|531357396|FG000|Part 2: PML Safety Monitoring Period|Physician Decision|0|||
147325842|NCT02403323|531357397|FG001|Part 2: PML Safety Monitoring Period|Physician Decision|7|||
147325843|NCT02403323|531357398|FG002|Part 2: PML Safety Monitoring Period|Physician Decision|0|||
147325844|NCT02403323|531357396|FG000|Part 2: PML Safety Monitoring Period|Study Terminated By Sponsor|0|||
147325845|NCT02403323|531357397|FG001|Part 2: PML Safety Monitoring Period|Study Terminated By Sponsor|167|||
147325846|NCT02403323|531357398|FG002|Part 2: PML Safety Monitoring Period|Study Terminated By Sponsor|0|||
147325847|NCT02403323|531357396|FG000|Part 2: PML Safety Monitoring Period|Other|0|||
147325848|NCT02403323|531357397|FG001|Part 2: PML Safety Monitoring Period|Other|1|||
147325849|NCT02403323|531357398|FG002|Part 2: PML Safety Monitoring Period|Other|0|||
147325850|NCT02403323|531357396|FG000|Part 2: PML Safety Monitoring Period|Withdrawal by Subject|0|||
147325851|NCT02403323|531357397|FG001|Part 2: PML Safety Monitoring Period|Withdrawal by Subject|12|||
147325852|NCT02403323|531357398|FG002|Part 2: PML Safety Monitoring Period|Withdrawal by Subject|2|||
147325853|NCT00197236|531357402|FG000|Overall Study|Adverse Event|1|||
147325854|NCT00197236|531357403|FG001|Overall Study|Adverse Event|0|||
147325855|NCT00197236|531357404|FG002|Overall Study|Adverse Event|1|||
147325856|NCT00197236|531357402|FG000|Overall Study|Lost to Follow-up|5|||
147325857|NCT00197236|531357403|FG001|Overall Study|Lost to Follow-up|14|||
147325858|NCT00197236|531357404|FG002|Overall Study|Lost to Follow-up|6|||
147325859|NCT00197236|531357402|FG000|Overall Study|Protocol Violation|0|||
147325860|NCT00197236|531357403|FG001|Overall Study|Protocol Violation|0|||
147325861|NCT00197236|531357404|FG002|Overall Study|Protocol Violation|1|||
147325862|NCT00197236|531357402|FG000|Overall Study|Withdrawal by Subject|7|||
147325863|NCT00197236|531357403|FG001|Overall Study|Withdrawal by Subject|3|||
147325864|NCT00197236|531357404|FG002|Overall Study|Withdrawal by Subject|11|||
147325865|NCT00197236|531357402|FG000|Overall Study|Study drug/medication expiration|1|||
147325866|NCT00197236|531357403|FG001|Overall Study|Study drug/medication expiration|0|||
147325867|NCT00197236|531357404|FG002|Overall Study|Study drug/medication expiration|3|||
147325868|NCT00197236|531357402|FG000|Overall Study|Returned out of specified time window|0|||
147325869|NCT00197236|531357403|FG001|Overall Study|Returned out of specified time window|0|||
147325870|NCT00197236|531357404|FG002|Overall Study|Returned out of specified time window|1|||
147325871|NCT03885596|531357405|FG000|Overall Study|Withdrawal by Subject|2|||
147325872|NCT03885596|531357406|FG001|Overall Study|Withdrawal by Subject|1|||
147325873|NCT03885596|531357407|FG002|Overall Study|Withdrawal by Subject|0|||
147325874|NCT03885596|531357408|FG003|Overall Study|Withdrawal by Subject|0|||
147325875|NCT01835899|531357410|FG000|Overall Study|Adverse Event|0|||
147179581|NCT03364309|530823621|FG012|Induction Period|Adverse Event|0|||
147179582|NCT03364309|530823622|FG013|Induction Period|Adverse Event|0|||
147179583|NCT03364309|530823623|FG014|Induction Period|Adverse Event|0|||
147179584|NCT03364309|530823624|FG015|Induction Period|Adverse Event|0|||
147179585|NCT03364309|530823625|FG016|Induction Period|Adverse Event|0|||
147179586|NCT03364309|530823626|FG017|Induction Period|Adverse Event|0|||
147179587|NCT03364309|530823627|FG018|Induction Period|Adverse Event|0|||
147179588|NCT03364309|530823609|FG000|Induction Period|Withdrawal by Subject|1|||
147179589|NCT03364309|530823610|FG001|Induction Period|Withdrawal by Subject|3|||
147179590|NCT03364309|530823611|FG002|Induction Period|Withdrawal by Subject|0|||
147179591|NCT03364309|530823612|FG003|Induction Period|Withdrawal by Subject|0|||
147179592|NCT03364309|530823613|FG004|Induction Period|Withdrawal by Subject|0|||
147179593|NCT03364309|530823614|FG005|Induction Period|Withdrawal by Subject|0|||
147179594|NCT03364309|530823615|FG006|Induction Period|Withdrawal by Subject|0|||
147179595|NCT03364309|530823616|FG007|Induction Period|Withdrawal by Subject|0|||
147179596|NCT03364309|530823617|FG008|Induction Period|Withdrawal by Subject|0|||
147179597|NCT03364309|530823618|FG009|Induction Period|Withdrawal by Subject|0|||
147179598|NCT03364309|530823619|FG010|Induction Period|Withdrawal by Subject|0|||
147179599|NCT03364309|530823620|FG011|Induction Period|Withdrawal by Subject|0|||
147179600|NCT03364309|530823621|FG012|Induction Period|Withdrawal by Subject|0|||
147179601|NCT03364309|530823622|FG013|Induction Period|Withdrawal by Subject|0|||
147179602|NCT03364309|530823623|FG014|Induction Period|Withdrawal by Subject|0|||
147179603|NCT03364309|530823624|FG015|Induction Period|Withdrawal by Subject|0|||
147179604|NCT03364309|530823625|FG016|Induction Period|Withdrawal by Subject|0|||
147179605|NCT03364309|530823626|FG017|Induction Period|Withdrawal by Subject|0|||
147179606|NCT03364309|530823627|FG018|Induction Period|Withdrawal by Subject|0|||
147179607|NCT03364309|530823609|FG000|Induction Period|Lost to Follow-up|1|||
147179608|NCT03364309|530823610|FG001|Induction Period|Lost to Follow-up|0|||
147179609|NCT03364309|530823611|FG002|Induction Period|Lost to Follow-up|0|||
147179610|NCT03364309|530823612|FG003|Induction Period|Lost to Follow-up|0|||
147179611|NCT03364309|530823613|FG004|Induction Period|Lost to Follow-up|0|||
147179612|NCT03364309|530823614|FG005|Induction Period|Lost to Follow-up|0|||
147179613|NCT03364309|530823615|FG006|Induction Period|Lost to Follow-up|0|||
147179614|NCT03364309|530823616|FG007|Induction Period|Lost to Follow-up|0|||
147179615|NCT03364309|530823617|FG008|Induction Period|Lost to Follow-up|0|||
147179616|NCT03364309|530823618|FG009|Induction Period|Lost to Follow-up|0|||
147179617|NCT03364309|530823619|FG010|Induction Period|Lost to Follow-up|0|||
147179618|NCT03364309|530823620|FG011|Induction Period|Lost to Follow-up|0|||
147179619|NCT03364309|530823621|FG012|Induction Period|Lost to Follow-up|0|||
147179620|NCT03364309|530823622|FG013|Induction Period|Lost to Follow-up|0|||
147179621|NCT03364309|530823623|FG014|Induction Period|Lost to Follow-up|0|||
147179622|NCT03364309|530823624|FG015|Induction Period|Lost to Follow-up|0|||
147179623|NCT03364309|530823625|FG016|Induction Period|Lost to Follow-up|0|||
147179624|NCT03364309|530823626|FG017|Induction Period|Lost to Follow-up|0|||
147179625|NCT03364309|530823627|FG018|Induction Period|Lost to Follow-up|0|||
147179626|NCT03364309|530823609|FG000|Induction Period|Physician Decision|0|||
147179627|NCT03364309|530823610|FG001|Induction Period|Physician Decision|1|||
147179628|NCT03364309|530823611|FG002|Induction Period|Physician Decision|0|||
147179629|NCT03364309|530823612|FG003|Induction Period|Physician Decision|0|||
147179630|NCT03364309|530823613|FG004|Induction Period|Physician Decision|0|||
147179631|NCT03364309|530823614|FG005|Induction Period|Physician Decision|0|||
147179632|NCT03364309|530823615|FG006|Induction Period|Physician Decision|0|||
147179633|NCT03364309|530823616|FG007|Induction Period|Physician Decision|0|||
147179634|NCT03364309|530823617|FG008|Induction Period|Physician Decision|0|||
147179635|NCT03364309|530823618|FG009|Induction Period|Physician Decision|0|||
147179636|NCT03364309|530823619|FG010|Induction Period|Physician Decision|0|||
147179637|NCT03364309|530823620|FG011|Induction Period|Physician Decision|0|||
147179638|NCT03364309|530823621|FG012|Induction Period|Physician Decision|0|||
147179639|NCT03364309|530823622|FG013|Induction Period|Physician Decision|0|||
147179640|NCT03364309|530823623|FG014|Induction Period|Physician Decision|0|||
147179641|NCT03364309|530823624|FG015|Induction Period|Physician Decision|0|||
147179642|NCT03364309|530823625|FG016|Induction Period|Physician Decision|0|||
147179643|NCT03364309|530823626|FG017|Induction Period|Physician Decision|0|||
147179644|NCT03364309|530823627|FG018|Induction Period|Physician Decision|0|||
147179645|NCT03364309|530823609|FG000|Maintenance Period|Withdrawal by Subject|0|||
147245363|NCT01737697|531070811|FG008|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
147245364|NCT01737697|531070812|FG009|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
147245365|NCT01737697|531070813|FG010|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
147245366|NCT01737697|531070814|FG011|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
147245367|NCT01737697|531070815|FG012|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
147245368|NCT01737697|531070816|FG013|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
147179646|NCT03364309|530823610|FG001|Maintenance Period|Withdrawal by Subject|0|||
147179647|NCT03364309|530823611|FG002|Maintenance Period|Withdrawal by Subject|0|||
147179648|NCT03364309|530823612|FG003|Maintenance Period|Withdrawal by Subject|1|||
147179649|NCT03364309|530823613|FG004|Maintenance Period|Withdrawal by Subject|3|||
147179650|NCT03364309|530823614|FG005|Maintenance Period|Withdrawal by Subject|1|||
147325876|NCT01835899|531357411|FG001|Overall Study|Adverse Event|0|||
147325877|NCT01835899|531357412|FG002|Overall Study|Adverse Event|1|||
147325878|NCT01835899|531357410|FG000|Overall Study|Other than stated above|0|||
147325879|NCT01835899|531357411|FG001|Overall Study|Other than stated above|1|||
147325880|NCT01835899|531357412|FG002|Overall Study|Other than stated above|0|||
147325881|NCT02616263|531357413|FG000|Baseline to 6 Month (Intervention Phase)|Withdrawal by Subject|0|||
147325882|NCT02616263|531357414|FG001|Baseline to 6 Month (Intervention Phase)|Withdrawal by Subject|3|||
147325883|NCT02616263|531357413|FG000|Baseline to 6 Month (Intervention Phase)|Lost to Follow-up|1|||
147325884|NCT02616263|531357414|FG001|Baseline to 6 Month (Intervention Phase)|Lost to Follow-up|0|||
147325885|NCT02616263|531357413|FG000|6 Month to 1.5 Year|Death|1|||
147179651|NCT03364309|530823615|FG006|Maintenance Period|Withdrawal by Subject|3|||
147179652|NCT03364309|530823616|FG007|Maintenance Period|Withdrawal by Subject|0|||
147179653|NCT03364309|530823617|FG008|Maintenance Period|Withdrawal by Subject|1|||
147179654|NCT03364309|530823618|FG009|Maintenance Period|Withdrawal by Subject|1|||
147179655|NCT03364309|530823619|FG010|Maintenance Period|Withdrawal by Subject|2|||
147325886|NCT02616263|531357414|FG001|6 Month to 1.5 Year|Death|0|||
147325887|NCT02616263|531357413|FG000|6 Month to 1.5 Year|Lost to Follow-up|0|||
147325888|NCT02616263|531357414|FG001|6 Month to 1.5 Year|Lost to Follow-up|2|||
147179656|NCT03364309|530823620|FG011|Maintenance Period|Withdrawal by Subject|0|||
147179657|NCT03364309|530823621|FG012|Maintenance Period|Withdrawal by Subject|0|||
147179658|NCT03364309|530823622|FG013|Maintenance Period|Withdrawal by Subject|0|||
147179659|NCT03364309|530823623|FG014|Maintenance Period|Withdrawal by Subject|0|||
147179660|NCT03364309|530823624|FG015|Maintenance Period|Withdrawal by Subject|0|||
147179661|NCT03364309|530823625|FG016|Maintenance Period|Withdrawal by Subject|0|||
147179662|NCT03364309|530823626|FG017|Maintenance Period|Withdrawal by Subject|0|||
147179663|NCT03364309|530823627|FG018|Maintenance Period|Withdrawal by Subject|0|||
147179664|NCT03364309|530823609|FG000|Maintenance Period|Adverse Event|0|||
147179665|NCT03364309|530823610|FG001|Maintenance Period|Adverse Event|0|||
147179666|NCT03364309|530823611|FG002|Maintenance Period|Adverse Event|0|||
147179667|NCT03364309|530823612|FG003|Maintenance Period|Adverse Event|0|||
147179668|NCT03364309|530823613|FG004|Maintenance Period|Adverse Event|2|||
147179669|NCT03364309|530823614|FG005|Maintenance Period|Adverse Event|0|||
147179670|NCT03364309|530823615|FG006|Maintenance Period|Adverse Event|3|||
147179671|NCT03364309|530823616|FG007|Maintenance Period|Adverse Event|0|||
147179672|NCT03364309|530823617|FG008|Maintenance Period|Adverse Event|1|||
147245369|NCT01737697|531070817|FG014|Acute Phase-Initial 48 Hours|Sponsor's decision|0|||
147245370|NCT01737697|531070803|FG000|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
147245371|NCT01737697|531070804|FG001|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
147325889|NCT02616263|531357413|FG000|6 Month to 1.5 Year|Withdrawal by Subject|1|||
147325890|NCT02616263|531357414|FG001|6 Month to 1.5 Year|Withdrawal by Subject|1|||
147325891|NCT02616263|531357413|FG000|1.5 Year to 3+ Year Follow up|Withdrawal by Subject|4|||
147325892|NCT02616263|531357414|FG001|1.5 Year to 3+ Year Follow up|Withdrawal by Subject|2|||
147325893|NCT05015478|531357417|FG000|Second Experimental Condition|Withdrawal by Subject|0|||
147325894|NCT05015478|531357418|FG001|Second Experimental Condition|Withdrawal by Subject|0|||
147325895|NCT05015478|531357419|FG002|Second Experimental Condition|Withdrawal by Subject|0|||
147325896|NCT05015478|531357420|FG003|Second Experimental Condition|Withdrawal by Subject|1|||
147325897|NCT04319094|531357421|FG000|Baseline|Lost to Follow-up|4|||
147325898|NCT04319094|531357422|FG001|Baseline|Lost to Follow-up|5|||
147325899|NCT04319094|531357421|FG000|Baseline|Protocol Violation|0|||
147325900|NCT04319094|531357422|FG001|Baseline|Protocol Violation|3|||
147325901|NCT04319094|531357421|FG000|Baseline|Withdrawal by Subject|2|||
147325902|NCT04319094|531357422|FG001|Baseline|Withdrawal by Subject|1|||
147325903|NCT04319094|531357421|FG000|Post-Intervention|Death|0|||
147325904|NCT04319094|531357422|FG001|Post-Intervention|Death|1|||
147325905|NCT04319094|531357421|FG000|Post-Intervention|Lost to Follow-up|4|||
147325906|NCT04319094|531357422|FG001|Post-Intervention|Lost to Follow-up|4|||
147245372|NCT01737697|531070805|FG002|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
147245373|NCT01737697|531070806|FG003|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
147245374|NCT01737697|531070807|FG004|Acute Phase-Initial 48 Hours|Lost to Follow-up|1|||
147245375|NCT01737697|531070808|FG005|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
147245376|NCT01737697|531070809|FG006|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
147245377|NCT01737697|531070810|FG007|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
147325907|NCT04319094|531357421|FG000|Post-Intervention|Withdrawal by Subject|8|||
147325908|NCT04319094|531357422|FG001|Post-Intervention|Withdrawal by Subject|5|||
147325909|NCT04319094|531357421|FG000|Post-Intervention|Incomplete Data Collection|1|||
147325910|NCT04319094|531357422|FG001|Post-Intervention|Incomplete Data Collection|3|||
147325911|NCT04319094|531357421|FG000|3-month|Death|1|||
147325912|NCT04319094|531357422|FG001|3-month|Death|0|||
147325913|NCT04319094|531357421|FG000|3-month|Lost to Follow-up|2|||
147179673|NCT03364309|530823618|FG009|Maintenance Period|Adverse Event|0|||
147179674|NCT03364309|530823619|FG010|Maintenance Period|Adverse Event|2|||
147179675|NCT03364309|530823620|FG011|Maintenance Period|Adverse Event|0|||
147245378|NCT01737697|531070811|FG008|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
147245379|NCT01737697|531070812|FG009|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
147245380|NCT01737697|531070813|FG010|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
147179676|NCT03364309|530823621|FG012|Maintenance Period|Adverse Event|0|||
147179677|NCT03364309|530823622|FG013|Maintenance Period|Adverse Event|0|||
147179678|NCT03364309|530823623|FG014|Maintenance Period|Adverse Event|0|||
147179679|NCT03364309|530823624|FG015|Maintenance Period|Adverse Event|0|||
147179680|NCT03364309|530823625|FG016|Maintenance Period|Adverse Event|0|||
147179681|NCT03364309|530823626|FG017|Maintenance Period|Adverse Event|0|||
147179682|NCT03364309|530823627|FG018|Maintenance Period|Adverse Event|0|||
147179683|NCT03364309|530823609|FG000|Maintenance Period|Relapsed|0|||
147179684|NCT03364309|530823610|FG001|Maintenance Period|Relapsed|0|||
147179685|NCT03364309|530823611|FG002|Maintenance Period|Relapsed|0|||
147179686|NCT03364309|530823612|FG003|Maintenance Period|Relapsed|43|||
147179687|NCT03364309|530823613|FG004|Maintenance Period|Relapsed|7|||
147179688|NCT03364309|530823614|FG005|Maintenance Period|Relapsed|45|||
147179689|NCT03364309|530823615|FG006|Maintenance Period|Relapsed|10|||
147179690|NCT03364309|530823616|FG007|Maintenance Period|Relapsed|2|||
147179691|NCT03364309|530823617|FG008|Maintenance Period|Relapsed|0|||
147179692|NCT03364309|530823618|FG009|Maintenance Period|Relapsed|0|||
147179693|NCT03364309|530823619|FG010|Maintenance Period|Relapsed|0|||
147179694|NCT03364309|530823620|FG011|Maintenance Period|Relapsed|0|||
147179695|NCT03364309|530823621|FG012|Maintenance Period|Relapsed|0|||
147179696|NCT03364309|530823622|FG013|Maintenance Period|Relapsed|0|||
147179697|NCT03364309|530823623|FG014|Maintenance Period|Relapsed|0|||
147179698|NCT03364309|530823624|FG015|Maintenance Period|Relapsed|0|||
147179699|NCT03364309|530823625|FG016|Maintenance Period|Relapsed|0|||
147179700|NCT03364309|530823626|FG017|Maintenance Period|Relapsed|0|||
147179701|NCT03364309|530823627|FG018|Maintenance Period|Relapsed|0|||
147179702|NCT03364309|530823609|FG000|Maintenance Period|Lack of Efficacy|0|||
147179703|NCT03364309|530823610|FG001|Maintenance Period|Lack of Efficacy|0|||
147179704|NCT03364309|530823611|FG002|Maintenance Period|Lack of Efficacy|0|||
147179705|NCT03364309|530823612|FG003|Maintenance Period|Lack of Efficacy|0|||
147179706|NCT03364309|530823613|FG004|Maintenance Period|Lack of Efficacy|0|||
147179707|NCT03364309|530823614|FG005|Maintenance Period|Lack of Efficacy|0|||
147179708|NCT03364309|530823615|FG006|Maintenance Period|Lack of Efficacy|0|||
147179709|NCT03364309|530823616|FG007|Maintenance Period|Lack of Efficacy|0|||
147179710|NCT03364309|530823617|FG008|Maintenance Period|Lack of Efficacy|1|||
147179711|NCT03364309|530823618|FG009|Maintenance Period|Lack of Efficacy|3|||
147179712|NCT03364309|530823619|FG010|Maintenance Period|Lack of Efficacy|2|||
147179713|NCT03364309|530823620|FG011|Maintenance Period|Lack of Efficacy|0|||
147179714|NCT03364309|530823621|FG012|Maintenance Period|Lack of Efficacy|0|||
147179715|NCT03364309|530823622|FG013|Maintenance Period|Lack of Efficacy|0|||
147179716|NCT03364309|530823623|FG014|Maintenance Period|Lack of Efficacy|0|||
147179717|NCT03364309|530823624|FG015|Maintenance Period|Lack of Efficacy|0|||
147179718|NCT03364309|530823625|FG016|Maintenance Period|Lack of Efficacy|0|||
147179719|NCT03364309|530823626|FG017|Maintenance Period|Lack of Efficacy|0|||
147179720|NCT03364309|530823627|FG018|Maintenance Period|Lack of Efficacy|0|||
147179721|NCT03364309|530823609|FG000|Maintenance Period|Death|0|||
147179722|NCT03364309|530823610|FG001|Maintenance Period|Death|0|||
147179723|NCT03364309|530823611|FG002|Maintenance Period|Death|0|||
147179724|NCT03364309|530823612|FG003|Maintenance Period|Death|0|||
147179725|NCT03364309|530823613|FG004|Maintenance Period|Death|0|||
147179726|NCT03364309|530823614|FG005|Maintenance Period|Death|0|||
147179727|NCT03364309|530823615|FG006|Maintenance Period|Death|0|||
147179728|NCT03364309|530823616|FG007|Maintenance Period|Death|0|||
147179729|NCT03364309|530823617|FG008|Maintenance Period|Death|1|||
147179730|NCT03364309|530823618|FG009|Maintenance Period|Death|0|||
147179731|NCT03364309|530823619|FG010|Maintenance Period|Death|0|||
147179732|NCT03364309|530823620|FG011|Maintenance Period|Death|0|||
147179733|NCT03364309|530823621|FG012|Maintenance Period|Death|0|||
147179734|NCT03364309|530823622|FG013|Maintenance Period|Death|0|||
147179735|NCT03364309|530823623|FG014|Maintenance Period|Death|0|||
147179736|NCT03364309|530823624|FG015|Maintenance Period|Death|0|||
147179737|NCT03364309|530823625|FG016|Maintenance Period|Death|0|||
147179738|NCT03364309|530823626|FG017|Maintenance Period|Death|0|||
147179739|NCT03364309|530823627|FG018|Maintenance Period|Death|0|||
147179740|NCT03364309|530823609|FG000|Maintenance Period|Lost to Follow-up|0|||
147245381|NCT01737697|531070814|FG011|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
147179741|NCT03364309|530823610|FG001|Maintenance Period|Lost to Follow-up|0|||
147179742|NCT03364309|530823611|FG002|Maintenance Period|Lost to Follow-up|0|||
147179743|NCT03364309|530823612|FG003|Maintenance Period|Lost to Follow-up|0|||
147179744|NCT03364309|530823613|FG004|Maintenance Period|Lost to Follow-up|0|||
147179745|NCT03364309|530823614|FG005|Maintenance Period|Lost to Follow-up|0|||
147179746|NCT03364309|530823615|FG006|Maintenance Period|Lost to Follow-up|0|||
147179747|NCT03364309|530823616|FG007|Maintenance Period|Lost to Follow-up|0|||
147179748|NCT03364309|530823617|FG008|Maintenance Period|Lost to Follow-up|1|||
147179749|NCT03364309|530823618|FG009|Maintenance Period|Lost to Follow-up|0|||
147179750|NCT03364309|530823619|FG010|Maintenance Period|Lost to Follow-up|0|||
147179751|NCT03364309|530823620|FG011|Maintenance Period|Lost to Follow-up|0|||
147179752|NCT03364309|530823621|FG012|Maintenance Period|Lost to Follow-up|0|||
147179753|NCT03364309|530823622|FG013|Maintenance Period|Lost to Follow-up|0|||
147179754|NCT03364309|530823623|FG014|Maintenance Period|Lost to Follow-up|0|||
147179755|NCT03364309|530823624|FG015|Maintenance Period|Lost to Follow-up|0|||
147179756|NCT03364309|530823625|FG016|Maintenance Period|Lost to Follow-up|0|||
147179757|NCT03364309|530823626|FG017|Maintenance Period|Lost to Follow-up|0|||
147179758|NCT03364309|530823627|FG018|Maintenance Period|Lost to Follow-up|0|||
147179759|NCT03364309|530823609|FG000|Maintenance Period|Miscellaneous|0|||
147179760|NCT03364309|530823610|FG001|Maintenance Period|Miscellaneous|0|||
147179761|NCT03364309|530823611|FG002|Maintenance Period|Miscellaneous|0|||
147179762|NCT03364309|530823612|FG003|Maintenance Period|Miscellaneous|0|||
147179763|NCT03364309|530823613|FG004|Maintenance Period|Miscellaneous|0|||
147179764|NCT03364309|530823614|FG005|Maintenance Period|Miscellaneous|0|||
147179765|NCT03364309|530823615|FG006|Maintenance Period|Miscellaneous|0|||
147179766|NCT03364309|530823616|FG007|Maintenance Period|Miscellaneous|0|||
147179767|NCT03364309|530823617|FG008|Maintenance Period|Miscellaneous|1|||
147179768|NCT03364309|530823618|FG009|Maintenance Period|Miscellaneous|0|||
147179769|NCT03364309|530823619|FG010|Maintenance Period|Miscellaneous|0|||
147179770|NCT03364309|530823620|FG011|Maintenance Period|Miscellaneous|0|||
147179771|NCT03364309|530823621|FG012|Maintenance Period|Miscellaneous|0|||
147179772|NCT03364309|530823622|FG013|Maintenance Period|Miscellaneous|0|||
147245382|NCT01737697|531070815|FG012|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
147245383|NCT01737697|531070816|FG013|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
147245384|NCT01737697|531070817|FG014|Acute Phase-Initial 48 Hours|Lost to Follow-up|0|||
147245385|NCT01737697|531070803|FG000|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
147245386|NCT01737697|531070804|FG001|Acute Phase-Initial 48 Hours|Withdrawal by Subject|1|||
147245387|NCT01737697|531070805|FG002|Acute Phase-Initial 48 Hours|Withdrawal by Subject|1|||
147245388|NCT01737697|531070806|FG003|Acute Phase-Initial 48 Hours|Withdrawal by Subject|4|||
147245389|NCT01737697|531070807|FG004|Acute Phase-Initial 48 Hours|Withdrawal by Subject|1|||
147245390|NCT01737697|531070808|FG005|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
147245391|NCT01737697|531070809|FG006|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
147245392|NCT01737697|531070810|FG007|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
147245393|NCT01737697|531070811|FG008|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
147245394|NCT01737697|531070812|FG009|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
147245395|NCT01737697|531070813|FG010|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
147245396|NCT01737697|531070814|FG011|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
147245397|NCT01737697|531070815|FG012|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
147245398|NCT01737697|531070816|FG013|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
147245399|NCT01737697|531070817|FG014|Acute Phase-Initial 48 Hours|Withdrawal by Subject|0|||
147245400|NCT01737697|531070803|FG000|Subacute Phase|Adverse Event|0|||
147245401|NCT01737697|531070804|FG001|Subacute Phase|Adverse Event|0|||
147245402|NCT01737697|531070805|FG002|Subacute Phase|Adverse Event|0|||
147245403|NCT01737697|531070806|FG003|Subacute Phase|Adverse Event|0|||
147245404|NCT01737697|531070807|FG004|Subacute Phase|Adverse Event|0|||
147245405|NCT01737697|531070808|FG005|Subacute Phase|Adverse Event|1|||
147245406|NCT01737697|531070809|FG006|Subacute Phase|Adverse Event|1|||
147245407|NCT01737697|531070810|FG007|Subacute Phase|Adverse Event|1|||
147245408|NCT01737697|531070811|FG008|Subacute Phase|Adverse Event|1|||
147245409|NCT01737697|531070812|FG009|Subacute Phase|Adverse Event|1|||
147245410|NCT01737697|531070813|FG010|Subacute Phase|Adverse Event|4|||
147245411|NCT01737697|531070814|FG011|Subacute Phase|Adverse Event|1|||
147245412|NCT01737697|531070815|FG012|Subacute Phase|Adverse Event|1|||
147245413|NCT01737697|531070816|FG013|Subacute Phase|Adverse Event|0|||
147245414|NCT01737697|531070817|FG014|Subacute Phase|Adverse Event|0|||
147245415|NCT01737697|531070803|FG000|Subacute Phase|Withdrawal by Subject|0|||
147245416|NCT01737697|531070804|FG001|Subacute Phase|Withdrawal by Subject|0|||
147245417|NCT01737697|531070805|FG002|Subacute Phase|Withdrawal by Subject|0|||
147245418|NCT01737697|531070806|FG003|Subacute Phase|Withdrawal by Subject|0|||
147245419|NCT01737697|531070807|FG004|Subacute Phase|Withdrawal by Subject|0|||
147245420|NCT01737697|531070808|FG005|Subacute Phase|Withdrawal by Subject|1|||
147245421|NCT01737697|531070809|FG006|Subacute Phase|Withdrawal by Subject|0|||
147245422|NCT01737697|531070810|FG007|Subacute Phase|Withdrawal by Subject|2|||
147179773|NCT03364309|530823623|FG014|Maintenance Period|Miscellaneous|0|||
147179774|NCT03364309|530823624|FG015|Maintenance Period|Miscellaneous|0|||
147179775|NCT03364309|530823625|FG016|Maintenance Period|Miscellaneous|0|||
147245423|NCT01737697|531070811|FG008|Subacute Phase|Withdrawal by Subject|0|||
147245424|NCT01737697|531070812|FG009|Subacute Phase|Withdrawal by Subject|1|||
147245425|NCT01737697|531070813|FG010|Subacute Phase|Withdrawal by Subject|0|||
147179776|NCT03364309|530823626|FG017|Maintenance Period|Miscellaneous|0|||
147245426|NCT01737697|531070814|FG011|Subacute Phase|Withdrawal by Subject|1|||
147245427|NCT01737697|531070815|FG012|Subacute Phase|Withdrawal by Subject|1|||
147245428|NCT01737697|531070816|FG013|Subacute Phase|Withdrawal by Subject|1|||
147325914|NCT04319094|531357422|FG001|3-month|Lost to Follow-up|2|||
147179777|NCT03364309|530823627|FG018|Maintenance Period|Miscellaneous|0|||
147179778|NCT03364309|530823609|FG000|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
147179779|NCT03364309|530823610|FG001|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
147179780|NCT03364309|530823611|FG002|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
147179781|NCT03364309|530823612|FG003|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
147179782|NCT03364309|530823613|FG004|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
147179783|NCT03364309|530823614|FG005|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
147179784|NCT03364309|530823615|FG006|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
147179785|NCT03364309|530823616|FG007|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
147179786|NCT03364309|530823617|FG008|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
147179787|NCT03364309|530823618|FG009|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
147179788|NCT03364309|530823619|FG010|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
147179789|NCT03364309|530823620|FG011|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
147179790|NCT03364309|530823621|FG012|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
147179791|NCT03364309|530823622|FG013|Re-treatment (Maintenance) Period|Withdrawal by Subject|1|||
147179792|NCT03364309|530823623|FG014|Re-treatment (Maintenance) Period|Withdrawal by Subject|1|||
147179793|NCT03364309|530823624|FG015|Re-treatment (Maintenance) Period|Withdrawal by Subject|1|||
147179794|NCT03364309|530823625|FG016|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
147179795|NCT03364309|530823626|FG017|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
147179796|NCT03364309|530823627|FG018|Re-treatment (Maintenance) Period|Withdrawal by Subject|0|||
147179797|NCT03364309|530823609|FG000|Re-treatment (Maintenance) Period|Adverse Event|0|||
147179798|NCT03364309|530823610|FG001|Re-treatment (Maintenance) Period|Adverse Event|0|||
147179799|NCT03364309|530823611|FG002|Re-treatment (Maintenance) Period|Adverse Event|0|||
147179800|NCT03364309|530823612|FG003|Re-treatment (Maintenance) Period|Adverse Event|0|||
147245429|NCT01737697|531070817|FG014|Subacute Phase|Withdrawal by Subject|0|||
147245430|NCT01737697|531070803|FG000|Subacute Phase|Lost to Follow-up|0|||
147245431|NCT01737697|531070804|FG001|Subacute Phase|Lost to Follow-up|0|||
147245432|NCT01737697|531070805|FG002|Subacute Phase|Lost to Follow-up|0|||
147245433|NCT01737697|531070806|FG003|Subacute Phase|Lost to Follow-up|0|||
147245434|NCT01737697|531070807|FG004|Subacute Phase|Lost to Follow-up|0|||
147245435|NCT01737697|531070808|FG005|Subacute Phase|Lost to Follow-up|0|||
147245436|NCT01737697|531070809|FG006|Subacute Phase|Lost to Follow-up|0|||
147245437|NCT01737697|531070810|FG007|Subacute Phase|Lost to Follow-up|0|||
147245438|NCT01737697|531070811|FG008|Subacute Phase|Lost to Follow-up|0|||
147245439|NCT01737697|531070812|FG009|Subacute Phase|Lost to Follow-up|0|||
147245440|NCT01737697|531070813|FG010|Subacute Phase|Lost to Follow-up|0|||
147245441|NCT01737697|531070814|FG011|Subacute Phase|Lost to Follow-up|0|||
147245442|NCT01737697|531070815|FG012|Subacute Phase|Lost to Follow-up|0|||
147245443|NCT01737697|531070816|FG013|Subacute Phase|Lost to Follow-up|0|||
147245444|NCT01737697|531070817|FG014|Subacute Phase|Lost to Follow-up|1|||
147245445|NCT01737697|531070803|FG000|Subacute Phase|Hypo-or hyperkalemia|0|||
147245446|NCT01737697|531070804|FG001|Subacute Phase|Hypo-or hyperkalemia|0|||
147245447|NCT01737697|531070805|FG002|Subacute Phase|Hypo-or hyperkalemia|0|||
147245448|NCT01737697|531070806|FG003|Subacute Phase|Hypo-or hyperkalemia|0|||
147245449|NCT01737697|531070807|FG004|Subacute Phase|Hypo-or hyperkalemia|0|||
147245450|NCT01737697|531070808|FG005|Subacute Phase|Hypo-or hyperkalemia|0|||
147245451|NCT01737697|531070809|FG006|Subacute Phase|Hypo-or hyperkalemia|0|||
147245452|NCT01737697|531070810|FG007|Subacute Phase|Hypo-or hyperkalemia|0|||
147245453|NCT01737697|531070811|FG008|Subacute Phase|Hypo-or hyperkalemia|0|||
147245454|NCT01737697|531070812|FG009|Subacute Phase|Hypo-or hyperkalemia|0|||
147245455|NCT01737697|531070813|FG010|Subacute Phase|Hypo-or hyperkalemia|0|||
147245456|NCT01737697|531070814|FG011|Subacute Phase|Hypo-or hyperkalemia|1|||
147245457|NCT01737697|531070815|FG012|Subacute Phase|Hypo-or hyperkalemia|0|||
147245458|NCT01737697|531070816|FG013|Subacute Phase|Hypo-or hyperkalemia|1|||
147245459|NCT01737697|531070817|FG014|Subacute Phase|Hypo-or hyperkalemia|0|||
147245460|NCT01737697|531070803|FG000|Subacute Phase|Protocol Violation|0|||
147245461|NCT01737697|531070804|FG001|Subacute Phase|Protocol Violation|0|||
147245462|NCT01737697|531070805|FG002|Subacute Phase|Protocol Violation|0|||
147245463|NCT01737697|531070806|FG003|Subacute Phase|Protocol Violation|0|||
147245464|NCT01737697|531070807|FG004|Subacute Phase|Protocol Violation|0|||
147245465|NCT01737697|531070808|FG005|Subacute Phase|Protocol Violation|1|||
147245466|NCT01737697|531070809|FG006|Subacute Phase|Protocol Violation|0|||
147245467|NCT01737697|531070810|FG007|Subacute Phase|Protocol Violation|0|||
147245468|NCT01737697|531070811|FG008|Subacute Phase|Protocol Violation|0|||
147245469|NCT01737697|531070812|FG009|Subacute Phase|Protocol Violation|0|||
147245470|NCT01737697|531070813|FG010|Subacute Phase|Protocol Violation|1|||
147245471|NCT01737697|531070814|FG011|Subacute Phase|Protocol Violation|0|||
147245472|NCT01737697|531070815|FG012|Subacute Phase|Protocol Violation|0|||
147245473|NCT01737697|531070816|FG013|Subacute Phase|Protocol Violation|0|||
147245474|NCT01737697|531070817|FG014|Subacute Phase|Protocol Violation|0|||
147245475|NCT01737697|531070803|FG000|Subacute Phase|Physician Decision|0|||
147245476|NCT01737697|531070804|FG001|Subacute Phase|Physician Decision|0|||
147245477|NCT01737697|531070805|FG002|Subacute Phase|Physician Decision|0|||
147245478|NCT01737697|531070806|FG003|Subacute Phase|Physician Decision|0|||
147245479|NCT01737697|531070807|FG004|Subacute Phase|Physician Decision|0|||
147245480|NCT01737697|531070808|FG005|Subacute Phase|Physician Decision|0|||
147245481|NCT01737697|531070809|FG006|Subacute Phase|Physician Decision|0|||
147245482|NCT01737697|531070810|FG007|Subacute Phase|Physician Decision|0|||
147245483|NCT01737697|531070811|FG008|Subacute Phase|Physician Decision|1|||
147245484|NCT01737697|531070812|FG009|Subacute Phase|Physician Decision|0|||
147245485|NCT01737697|531070813|FG010|Subacute Phase|Physician Decision|0|||
147325915|NCT04319094|531357421|FG000|3-month|Withdrawal by Subject|0|||
147325916|NCT04319094|531357422|FG001|3-month|Withdrawal by Subject|3|||
147325917|NCT04319094|531357421|FG000|3-month|Incomplete data collection|9|||
147325918|NCT04319094|531357422|FG001|3-month|Incomplete data collection|7|||
147325919|NCT04319094|531357421|FG000|6-month|Lost to Follow-up|1|||
147325920|NCT04319094|531357422|FG001|6-month|Lost to Follow-up|1|||
147325921|NCT04319094|531357421|FG000|6-month|Withdrawal by Subject|0|||
147325922|NCT04319094|531357422|FG001|6-month|Withdrawal by Subject|3|||
147325923|NCT04319094|531357421|FG000|6-month|Incomplete data collection|14|||
147325924|NCT04319094|531357422|FG001|6-month|Incomplete data collection|9|||
147325925|NCT04319094|531357421|FG000|9-month|Lost to Follow-up|8|||
147325926|NCT04319094|531357422|FG001|9-month|Lost to Follow-up|4|||
147325927|NCT04319094|531357421|FG000|9-month|Withdrawal by Subject|0|||
147325928|NCT04319094|531357422|FG001|9-month|Withdrawal by Subject|1|||
147325929|NCT04319094|531357421|FG000|9-month|Incomplete data collection|8|||
147325930|NCT04319094|531357422|FG001|9-month|Incomplete data collection|5|||
147325931|NCT04319094|531357421|FG000|12-month|Lost to Follow-up|11|||
147325932|NCT04319094|531357422|FG001|12-month|Lost to Follow-up|8|||
147448388|NCT00640328|531805707|FG002|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0|||
147179801|NCT03364309|530823613|FG004|Re-treatment (Maintenance) Period|Adverse Event|0|||
147179802|NCT03364309|530823614|FG005|Re-treatment (Maintenance) Period|Adverse Event|0|||
147179803|NCT03364309|530823615|FG006|Re-treatment (Maintenance) Period|Adverse Event|0|||
147179804|NCT03364309|530823616|FG007|Re-treatment (Maintenance) Period|Adverse Event|0|||
147179805|NCT03364309|530823617|FG008|Re-treatment (Maintenance) Period|Adverse Event|0|||
147179806|NCT03364309|530823618|FG009|Re-treatment (Maintenance) Period|Adverse Event|0|||
147179807|NCT03364309|530823619|FG010|Re-treatment (Maintenance) Period|Adverse Event|0|||
147179808|NCT03364309|530823620|FG011|Re-treatment (Maintenance) Period|Adverse Event|0|||
147179809|NCT03364309|530823621|FG012|Re-treatment (Maintenance) Period|Adverse Event|0|||
147179810|NCT03364309|530823622|FG013|Re-treatment (Maintenance) Period|Adverse Event|0|||
147179811|NCT03364309|530823623|FG014|Re-treatment (Maintenance) Period|Adverse Event|1|||
147179812|NCT03364309|530823624|FG015|Re-treatment (Maintenance) Period|Adverse Event|0|||
147179813|NCT03364309|530823625|FG016|Re-treatment (Maintenance) Period|Adverse Event|0|||
147179814|NCT03364309|530823626|FG017|Re-treatment (Maintenance) Period|Adverse Event|0|||
147179815|NCT03364309|530823627|FG018|Re-treatment (Maintenance) Period|Adverse Event|0|||
147179816|NCT03364309|530823609|FG000|Re-treatment (Maintenance) Period|Relapse|0|||
147179817|NCT03364309|530823610|FG001|Re-treatment (Maintenance) Period|Relapse|0|||
147179818|NCT03364309|530823611|FG002|Re-treatment (Maintenance) Period|Relapse|0|||
147179819|NCT03364309|530823612|FG003|Re-treatment (Maintenance) Period|Relapse|0|||
147179820|NCT03364309|530823613|FG004|Re-treatment (Maintenance) Period|Relapse|0|||
147179821|NCT03364309|530823614|FG005|Re-treatment (Maintenance) Period|Relapse|0|||
147179822|NCT03364309|530823615|FG006|Re-treatment (Maintenance) Period|Relapse|0|||
147179823|NCT03364309|530823616|FG007|Re-treatment (Maintenance) Period|Relapse|0|||
147179824|NCT03364309|530823617|FG008|Re-treatment (Maintenance) Period|Relapse|0|||
147179825|NCT03364309|530823618|FG009|Re-treatment (Maintenance) Period|Relapse|0|||
147179826|NCT03364309|530823619|FG010|Re-treatment (Maintenance) Period|Relapse|0|||
147179827|NCT03364309|530823620|FG011|Re-treatment (Maintenance) Period|Relapse|0|||
147179828|NCT03364309|530823621|FG012|Re-treatment (Maintenance) Period|Relapse|1|||
147179829|NCT03364309|530823622|FG013|Re-treatment (Maintenance) Period|Relapse|0|||
147179830|NCT03364309|530823623|FG014|Re-treatment (Maintenance) Period|Relapse|0|||
147179831|NCT03364309|530823624|FG015|Re-treatment (Maintenance) Period|Relapse|1|||
147179832|NCT03364309|530823625|FG016|Re-treatment (Maintenance) Period|Relapse|0|||
147179833|NCT03364309|530823626|FG017|Re-treatment (Maintenance) Period|Relapse|0|||
147179834|NCT03364309|530823627|FG018|Re-treatment (Maintenance) Period|Relapse|0|||
147179835|NCT03364309|530823609|FG000|Post-Treatment Followup Period|Withdrawal by Subject|0|||
147179836|NCT03364309|530823610|FG001|Post-Treatment Followup Period|Withdrawal by Subject|0|||
147179837|NCT03364309|530823611|FG002|Post-Treatment Followup Period|Withdrawal by Subject|0|||
147179838|NCT03364309|530823612|FG003|Post-Treatment Followup Period|Withdrawal by Subject|0|||
147179839|NCT03364309|530823613|FG004|Post-Treatment Followup Period|Withdrawal by Subject|0|||
147179840|NCT03364309|530823614|FG005|Post-Treatment Followup Period|Withdrawal by Subject|0|||
147179841|NCT03364309|530823615|FG006|Post-Treatment Followup Period|Withdrawal by Subject|0|||
147179842|NCT03364309|530823616|FG007|Post-Treatment Followup Period|Withdrawal by Subject|0|||
147179843|NCT03364309|530823617|FG008|Post-Treatment Followup Period|Withdrawal by Subject|0|||
147179844|NCT03364309|530823618|FG009|Post-Treatment Followup Period|Withdrawal by Subject|0|||
147179845|NCT03364309|530823619|FG010|Post-Treatment Followup Period|Withdrawal by Subject|0|||
147179846|NCT03364309|530823620|FG011|Post-Treatment Followup Period|Withdrawal by Subject|0|||
147325933|NCT00654238|531357425|FG000|Overall Study|Screen Failures|4|||
147448389|NCT00640328|531805708|FG003|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|1|||
147448390|NCT00640328|531805709|FG004|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0|||
147325934|NCT00614744|531357426|FG000|Overall Study|Lost to Follow-up|5|||
147325935|NCT00614744|531357427|FG001|Overall Study|Lost to Follow-up|4|||
147325936|NCT00614744|531357426|FG000|Overall Study|Incomplete for Behavior Issues|0|||
147325937|NCT00614744|531357427|FG001|Overall Study|Incomplete for Behavior Issues|2|||
147179847|NCT03364309|530823621|FG012|Post-Treatment Followup Period|Withdrawal by Subject|0|||
147179848|NCT03364309|530823622|FG013|Post-Treatment Followup Period|Withdrawal by Subject|0|||
147179849|NCT03364309|530823623|FG014|Post-Treatment Followup Period|Withdrawal by Subject|0|||
147179850|NCT03364309|530823624|FG015|Post-Treatment Followup Period|Withdrawal by Subject|0|||
147448391|NCT00640328|531805710|FG005|IFUP (Week 48 to Individual Termination)|Not Recommended - Informed Consent Form|0|||
147448392|NCT02374099|531805713|FG000|Overall Study|Adverse Event|1|||
147179851|NCT03364309|530823625|FG016|Post-Treatment Followup Period|Withdrawal by Subject|3|||
147179852|NCT03364309|530823626|FG017|Post-Treatment Followup Period|Withdrawal by Subject|19|||
147179853|NCT03364309|530823627|FG018|Post-Treatment Followup Period|Withdrawal by Subject|1|||
147179854|NCT03364309|530823609|FG000|Post-Treatment Followup Period|Adverse Event|0|||
147179855|NCT03364309|530823610|FG001|Post-Treatment Followup Period|Adverse Event|0|||
147179856|NCT03364309|530823611|FG002|Post-Treatment Followup Period|Adverse Event|0|||
147179857|NCT03364309|530823612|FG003|Post-Treatment Followup Period|Adverse Event|0|||
147179858|NCT03364309|530823613|FG004|Post-Treatment Followup Period|Adverse Event|0|||
147179859|NCT03364309|530823614|FG005|Post-Treatment Followup Period|Adverse Event|0|||
147179860|NCT03364309|530823615|FG006|Post-Treatment Followup Period|Adverse Event|0|||
147179861|NCT03364309|530823616|FG007|Post-Treatment Followup Period|Adverse Event|0|||
147245486|NCT01737697|531070814|FG011|Subacute Phase|Physician Decision|0|||
147245487|NCT01737697|531070815|FG012|Subacute Phase|Physician Decision|0|||
147245488|NCT01737697|531070816|FG013|Subacute Phase|Physician Decision|0|||
147245489|NCT01737697|531070817|FG014|Subacute Phase|Physician Decision|0|||
147245490|NCT01737697|531070803|FG000|Subacute Phase|Death|0|||
147245491|NCT01737697|531070804|FG001|Subacute Phase|Death|0|||
147245492|NCT01737697|531070805|FG002|Subacute Phase|Death|0|||
147245493|NCT01737697|531070806|FG003|Subacute Phase|Death|0|||
147245494|NCT01737697|531070807|FG004|Subacute Phase|Death|0|||
147245495|NCT01737697|531070808|FG005|Subacute Phase|Death|0|||
147245496|NCT01737697|531070809|FG006|Subacute Phase|Death|0|||
147245497|NCT01737697|531070810|FG007|Subacute Phase|Death|0|||
147245498|NCT01737697|531070811|FG008|Subacute Phase|Death|0|||
147245499|NCT01737697|531070812|FG009|Subacute Phase|Death|0|||
147245500|NCT01737697|531070813|FG010|Subacute Phase|Death|1|||
147245501|NCT01737697|531070814|FG011|Subacute Phase|Death|0|||
147245502|NCT01737697|531070815|FG012|Subacute Phase|Death|0|||
147245503|NCT01737697|531070816|FG013|Subacute Phase|Death|0|||
147245504|NCT01737697|531070817|FG014|Subacute Phase|Death|0|||
147245505|NCT02207244|531070820|FG000|Placebo Controlled Period: Week 0-16|Adverse Event|2|||
147245506|NCT02207244|531070821|FG001|Placebo Controlled Period: Week 0-16|Adverse Event|9|||
147245507|NCT02207244|531070822|FG002|Placebo Controlled Period: Week 0-16|Adverse Event|4|||
147245508|NCT02207244|531070823|FG003|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
147245509|NCT02207244|531070824|FG004|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
147245510|NCT02207244|531070825|FG005|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
147245511|NCT02207244|531070826|FG006|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
147245512|NCT02207244|531070827|FG007|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
147245513|NCT02207244|531070828|FG008|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
147245514|NCT02207244|531070829|FG009|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
147245515|NCT02207244|531070830|FG010|Placebo Controlled Period: Week 0-16|Adverse Event|0|||
147245516|NCT02207244|531070820|FG000|Placebo Controlled Period: Week 0-16|Lack of Efficacy|4|||
147245517|NCT02207244|531070821|FG001|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
147245518|NCT02207244|531070822|FG002|Placebo Controlled Period: Week 0-16|Lack of Efficacy|2|||
147245519|NCT02207244|531070823|FG003|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
147245520|NCT02207244|531070824|FG004|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
147245521|NCT02207244|531070825|FG005|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
147245522|NCT02207244|531070826|FG006|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
147245523|NCT02207244|531070827|FG007|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
147245524|NCT02207244|531070828|FG008|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
147245525|NCT02207244|531070829|FG009|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
147245526|NCT02207244|531070830|FG010|Placebo Controlled Period: Week 0-16|Lack of Efficacy|0|||
147245527|NCT02207244|531070820|FG000|Placebo Controlled Period: Week 0-16|Lost to Follow-up|1|||
147245528|NCT02207244|531070821|FG001|Placebo Controlled Period: Week 0-16|Lost to Follow-up|3|||
147245529|NCT02207244|531070822|FG002|Placebo Controlled Period: Week 0-16|Lost to Follow-up|2|||
147245530|NCT02207244|531070823|FG003|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
147245531|NCT02207244|531070824|FG004|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
147245532|NCT02207244|531070825|FG005|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
147245533|NCT02207244|531070826|FG006|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
147245534|NCT02207244|531070827|FG007|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
147245535|NCT02207244|531070828|FG008|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
147245536|NCT02207244|531070829|FG009|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
147245537|NCT02207244|531070830|FG010|Placebo Controlled Period: Week 0-16|Lost to Follow-up|0|||
147245538|NCT02207244|531070820|FG000|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|7|||
147325938|NCT02414828|531357431|FG000|Overall Study|Lost to Follow-up|0|||
147245539|NCT02207244|531070821|FG001|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|1|||
147245540|NCT02207244|531070822|FG002|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
147245541|NCT02207244|531070823|FG003|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
147245542|NCT02207244|531070824|FG004|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
147245543|NCT02207244|531070825|FG005|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
147245544|NCT02207244|531070826|FG006|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
147245545|NCT02207244|531070827|FG007|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
147245546|NCT02207244|531070828|FG008|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
147245547|NCT02207244|531070829|FG009|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
147245548|NCT02207244|531070830|FG010|Placebo Controlled Period: Week 0-16|Withdrawal by Subject|0|||
147245549|NCT02207244|531070820|FG000|Placebo Controlled Period: Week 0-16|Protocol Violation|1|||
147245550|NCT02207244|531070821|FG001|Placebo Controlled Period: Week 0-16|Protocol Violation|3|||
147245551|NCT02207244|531070822|FG002|Placebo Controlled Period: Week 0-16|Protocol Violation|1|||
147245552|NCT02207244|531070823|FG003|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
147245553|NCT02207244|531070824|FG004|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
147245554|NCT02207244|531070825|FG005|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
147245555|NCT02207244|531070826|FG006|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
147245556|NCT02207244|531070827|FG007|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
147245557|NCT02207244|531070828|FG008|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
147245558|NCT02207244|531070829|FG009|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
147245559|NCT02207244|531070830|FG010|Placebo Controlled Period: Week 0-16|Protocol Violation|0|||
147245560|NCT02207244|531070820|FG000|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
147245561|NCT02207244|531070821|FG001|Placebo Controlled Period: Week 0-16|Noncompliance|1|||
147245562|NCT02207244|531070822|FG002|Placebo Controlled Period: Week 0-16|Noncompliance|2|||
147245563|NCT02207244|531070823|FG003|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
147245564|NCT02207244|531070824|FG004|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
147245565|NCT02207244|531070825|FG005|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
147245566|NCT02207244|531070826|FG006|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
147245567|NCT02207244|531070827|FG007|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
147245568|NCT02207244|531070828|FG008|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
147245569|NCT02207244|531070829|FG009|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
147245570|NCT02207244|531070830|FG010|Placebo Controlled Period: Week 0-16|Noncompliance|0|||
147245571|NCT02207244|531070820|FG000|Placebo Controlled Period: Week 0-16|OTHER|0|||
147245572|NCT02207244|531070821|FG001|Placebo Controlled Period: Week 0-16|OTHER|1|||
147245573|NCT02207244|531070822|FG002|Placebo Controlled Period: Week 0-16|OTHER|0|||
147245574|NCT02207244|531070823|FG003|Placebo Controlled Period: Week 0-16|OTHER|0|||
147245575|NCT02207244|531070824|FG004|Placebo Controlled Period: Week 0-16|OTHER|0|||
147245576|NCT02207244|531070825|FG005|Placebo Controlled Period: Week 0-16|OTHER|0|||
147245577|NCT02207244|531070826|FG006|Placebo Controlled Period: Week 0-16|OTHER|0|||
147245578|NCT02207244|531070827|FG007|Placebo Controlled Period: Week 0-16|OTHER|0|||
147245579|NCT02207244|531070828|FG008|Placebo Controlled Period: Week 0-16|OTHER|0|||
147245580|NCT02207244|531070829|FG009|Placebo Controlled Period: Week 0-16|OTHER|0|||
147245581|NCT02207244|531070830|FG010|Placebo Controlled Period: Week 0-16|OTHER|0|||
147245582|NCT02207244|531070820|FG000|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
147245583|NCT02207244|531070821|FG001|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
147245584|NCT02207244|531070822|FG002|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
147245585|NCT02207244|531070823|FG003|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
147245586|NCT02207244|531070824|FG004|Placebo Crossover and ACP: Week 16-28|Adverse Event|3|||
147245587|NCT02207244|531070825|FG005|Placebo Crossover and ACP: Week 16-28|Adverse Event|2|||
147245588|NCT02207244|531070826|FG006|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
147245589|NCT02207244|531070827|FG007|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
147245590|NCT02207244|531070828|FG008|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
147245591|NCT02207244|531070829|FG009|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
147245592|NCT02207244|531070830|FG010|Placebo Crossover and ACP: Week 16-28|Adverse Event|0|||
147245593|NCT02207244|531070820|FG000|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
147245594|NCT02207244|531070821|FG001|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
147245595|NCT02207244|531070822|FG002|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
147245596|NCT02207244|531070823|FG003|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
147245597|NCT02207244|531070824|FG004|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
147245598|NCT02207244|531070825|FG005|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|2|||
147245599|NCT02207244|531070826|FG006|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
147245600|NCT02207244|531070827|FG007|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
147245601|NCT02207244|531070828|FG008|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
147245602|NCT02207244|531070829|FG009|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
147325939|NCT02414828|531357432|FG001|Overall Study|Lost to Follow-up|1|||
147448393|NCT02374099|531805714|FG001|Overall Study|Adverse Event|0|||
147179862|NCT03364309|530823617|FG008|Post-Treatment Followup Period|Adverse Event|0|||
147179863|NCT03364309|530823618|FG009|Post-Treatment Followup Period|Adverse Event|0|||
147179864|NCT03364309|530823619|FG010|Post-Treatment Followup Period|Adverse Event|0|||
147179865|NCT03364309|530823620|FG011|Post-Treatment Followup Period|Adverse Event|0|||
147179866|NCT03364309|530823621|FG012|Post-Treatment Followup Period|Adverse Event|0|||
147179867|NCT03364309|530823622|FG013|Post-Treatment Followup Period|Adverse Event|0|||
147179868|NCT03364309|530823623|FG014|Post-Treatment Followup Period|Adverse Event|0|||
147179869|NCT03364309|530823624|FG015|Post-Treatment Followup Period|Adverse Event|0|||
147179870|NCT03364309|530823625|FG016|Post-Treatment Followup Period|Adverse Event|2|||
147179871|NCT03364309|530823626|FG017|Post-Treatment Followup Period|Adverse Event|6|||
147179872|NCT03364309|530823627|FG018|Post-Treatment Followup Period|Adverse Event|1|||
147179873|NCT03364309|530823609|FG000|Post-Treatment Followup Period|Lost to Follow-up|0|||
147179874|NCT03364309|530823610|FG001|Post-Treatment Followup Period|Lost to Follow-up|0|||
147179875|NCT03364309|530823611|FG002|Post-Treatment Followup Period|Lost to Follow-up|0|||
147179876|NCT03364309|530823612|FG003|Post-Treatment Followup Period|Lost to Follow-up|0|||
147179877|NCT03364309|530823613|FG004|Post-Treatment Followup Period|Lost to Follow-up|0|||
147179878|NCT03364309|530823614|FG005|Post-Treatment Followup Period|Lost to Follow-up|0|||
147179879|NCT03364309|530823615|FG006|Post-Treatment Followup Period|Lost to Follow-up|0|||
147179880|NCT03364309|530823616|FG007|Post-Treatment Followup Period|Lost to Follow-up|0|||
147179881|NCT03364309|530823617|FG008|Post-Treatment Followup Period|Lost to Follow-up|0|||
147179882|NCT03364309|530823618|FG009|Post-Treatment Followup Period|Lost to Follow-up|0|||
147179883|NCT03364309|530823619|FG010|Post-Treatment Followup Period|Lost to Follow-up|0|||
147179884|NCT03364309|530823620|FG011|Post-Treatment Followup Period|Lost to Follow-up|0|||
147179885|NCT03364309|530823621|FG012|Post-Treatment Followup Period|Lost to Follow-up|0|||
147179886|NCT03364309|530823622|FG013|Post-Treatment Followup Period|Lost to Follow-up|0|||
147179887|NCT03364309|530823623|FG014|Post-Treatment Followup Period|Lost to Follow-up|0|||
147179888|NCT03364309|530823624|FG015|Post-Treatment Followup Period|Lost to Follow-up|0|||
147179889|NCT03364309|530823625|FG016|Post-Treatment Followup Period|Lost to Follow-up|0|||
147179890|NCT03364309|530823626|FG017|Post-Treatment Followup Period|Lost to Follow-up|2|||
147179891|NCT03364309|530823627|FG018|Post-Treatment Followup Period|Lost to Follow-up|0|||
147179892|NCT03364309|530823609|FG000|Post-Treatment Followup Period|Miscellaneous|0|||
147179893|NCT03364309|530823610|FG001|Post-Treatment Followup Period|Miscellaneous|0|||
147179894|NCT03364309|530823611|FG002|Post-Treatment Followup Period|Miscellaneous|0|||
147179895|NCT03364309|530823612|FG003|Post-Treatment Followup Period|Miscellaneous|0|||
147179896|NCT03364309|530823613|FG004|Post-Treatment Followup Period|Miscellaneous|0|||
147179897|NCT03364309|530823614|FG005|Post-Treatment Followup Period|Miscellaneous|0|||
147179898|NCT03364309|530823615|FG006|Post-Treatment Followup Period|Miscellaneous|0|||
147179899|NCT03364309|530823616|FG007|Post-Treatment Followup Period|Miscellaneous|0|||
147179900|NCT03364309|530823617|FG008|Post-Treatment Followup Period|Miscellaneous|0|||
147179901|NCT03364309|530823618|FG009|Post-Treatment Followup Period|Miscellaneous|0|||
147179902|NCT03364309|530823619|FG010|Post-Treatment Followup Period|Miscellaneous|0|||
147179903|NCT03364309|530823620|FG011|Post-Treatment Followup Period|Miscellaneous|0|||
147179904|NCT03364309|530823621|FG012|Post-Treatment Followup Period|Miscellaneous|0|||
147179905|NCT03364309|530823622|FG013|Post-Treatment Followup Period|Miscellaneous|0|||
147179906|NCT03364309|530823623|FG014|Post-Treatment Followup Period|Miscellaneous|0|||
147179907|NCT03364309|530823624|FG015|Post-Treatment Followup Period|Miscellaneous|0|||
147179908|NCT03364309|530823625|FG016|Post-Treatment Followup Period|Miscellaneous|0|||
147179909|NCT03364309|530823626|FG017|Post-Treatment Followup Period|Miscellaneous|4|||
147179910|NCT03364309|530823627|FG018|Post-Treatment Followup Period|Miscellaneous|0|||
147179911|NCT01371552|530823628|FG000|Part 1, First 3 Days|Inconvenience|0|||
147179912|NCT01371552|530823629|FG001|Part 1, First 3 Days|Inconvenience|0|||
147179913|NCT01371552|530823630|FG002|Part 1, First 3 Days|Inconvenience|1|||
147179914|NCT01371552|530823631|FG003|Part 1, First 3 Days|Inconvenience|0|||
147179915|NCT01371552|530823632|FG004|Part 1, First 3 Days|Inconvenience|0|||
147179916|NCT01371552|530823633|FG005|Part 1, First 3 Days|Inconvenience|0|||
147179917|NCT00615992|530823634|FG000|Overall Study|Protocol Violation|67|||
147179918|NCT02328027|530823635|FG000|Overall Study|Withdrawal by Subject|0|||
147179919|NCT02328027|530823636|FG001|Overall Study|Withdrawal by Subject|1|||
147179920|NCT03319212|530823637|FG000|Overall Study|Discontinued as moving out of local area|0|||
147179921|NCT03319212|530823638|FG001|Overall Study|Discontinued as moving out of local area|1|||
147179922|NCT03319212|530823637|FG000|Overall Study|Adverse Event|2|||
147179923|NCT03319212|530823638|FG001|Overall Study|Adverse Event|2|||
147179924|NCT03319212|530823637|FG000|Overall Study|Withdrawal by Subject|0|||
147179925|NCT03319212|530823638|FG001|Overall Study|Withdrawal by Subject|1|||
147179926|NCT03319212|530823637|FG000|Overall Study|Lost to Follow-up|0|||
147179927|NCT03319212|530823638|FG001|Overall Study|Lost to Follow-up|1|||
147179928|NCT03319212|530823637|FG000|Overall Study|Physician Decision|1|||
147179929|NCT03319212|530823638|FG001|Overall Study|Physician Decision|0|||
147179930|NCT01811186|530823640|FG000|Overall Study|Adverse Event|54|||
147245603|NCT02207244|531070830|FG010|Placebo Crossover and ACP: Week 16-28|Lack of Efficacy|0|||
147245604|NCT02207244|531070820|FG000|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
147325940|NCT02414828|531357433|FG002|Overall Study|Lost to Follow-up|1|||
147325941|NCT02414828|531357434|FG003|Overall Study|Lost to Follow-up|2|||
147325942|NCT02738840|531359561|FG000|Overall Study|MRI Scan not Performed|5|||
147325943|NCT02738840|531359561|FG000|Overall Study|Lost to Follow-up|1|||
147325944|NCT02738840|531359561|FG000|Overall Study|Subject Participation Terminated by Investigator|1|||
147325945|NCT02738840|531359561|FG000|Overall Study|Subject Did not Meet Screening Inclusion/Exclusion Criteria|1|||
147325946|NCT00256308|531359565|FG000|Overall Study|Death|2|||
147325947|NCT00762463|531359567|FG000|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|2|||
147325948|NCT00762463|531359568|FG001|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|2|||
147325949|NCT00762463|531359569|FG002|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|0|||
147325950|NCT00762463|531359570|FG003|Double-blind Phase (Baseline to Week 6)|Insufficient clinical response|0|||
147325951|NCT00762463|531359567|FG000|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|3|||
147325952|NCT00762463|531359568|FG001|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|4|||
147325953|NCT00762463|531359569|FG002|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|0|||
147325954|NCT00762463|531359570|FG003|Double-blind Phase (Baseline to Week 6)|No longer willing to participate|0|||
147325955|NCT00762463|531359567|FG000|Double-blind Phase (Baseline to Week 6)|Adverse Event|2|||
147325956|NCT00762463|531359568|FG001|Double-blind Phase (Baseline to Week 6)|Adverse Event|4|||
147325957|NCT00762463|531359569|FG002|Double-blind Phase (Baseline to Week 6)|Adverse Event|0|||
147325958|NCT00762463|531359570|FG003|Double-blind Phase (Baseline to Week 6)|Adverse Event|0|||
147325959|NCT00762463|531359567|FG000|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|4|||
147325960|NCT00762463|531359568|FG001|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|1|||
147325961|NCT00762463|531359569|FG002|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|0|||
147325962|NCT00762463|531359570|FG003|Enrollment in Extension Phase (Week 6)|Did not sign 2nd informed consent form|0|||
147325963|NCT00762463|531359567|FG000|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|1|||
147325964|NCT00762463|531359568|FG001|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|0|||
147325965|NCT00762463|531359569|FG002|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|1|||
147448394|NCT02374099|531805713|FG000|Overall Study|Progressive Disease|35|||
147448395|NCT02374099|531805714|FG001|Overall Study|Progressive Disease|40|||
147448396|NCT02374099|531805713|FG000|Overall Study|Withdrawal by Subject|5|||
147448397|NCT02374099|531805714|FG001|Overall Study|Withdrawal by Subject|1|||
147448398|NCT02374099|531805713|FG000|Overall Study|Miscellaneous|2|||
147448399|NCT02374099|531805714|FG001|Overall Study|Miscellaneous|3|||
147448400|NCT02374099|531805713|FG000|Overall Study|Randomized, but not treated|2|||
147448401|NCT02374099|531805714|FG001|Overall Study|Randomized, but not treated|1|||
147448402|NCT02374099|531805713|FG000|Overall Study|Study Terminated by Sponsor|3|||
147448403|NCT02374099|531805714|FG001|Overall Study|Study Terminated by Sponsor|4|||
147448404|NCT01033825|531805715|FG000|Overall Study|Withdrawal by Subject|2|||
147448405|NCT01033825|531805716|FG001|Overall Study|Withdrawal by Subject|3|||
147448406|NCT01033825|531805717|FG002|Overall Study|Withdrawal by Subject|2|||
147448407|NCT01033825|531805718|FG003|Overall Study|Withdrawal by Subject|1|||
147448408|NCT01033825|531805719|FG004|Overall Study|Withdrawal by Subject|1|||
147448409|NCT01033825|531805720|FG005|Overall Study|Withdrawal by Subject|0|||
147448410|NCT01033825|531805721|FG006|Overall Study|Withdrawal by Subject|0|||
147448411|NCT01033825|531805715|FG000|Overall Study|Adverse Event|0|||
147448412|NCT01033825|531805716|FG001|Overall Study|Adverse Event|0|||
147448413|NCT01033825|531805717|FG002|Overall Study|Adverse Event|0|||
147448414|NCT01033825|531805718|FG003|Overall Study|Adverse Event|1|||
147448415|NCT01033825|531805719|FG004|Overall Study|Adverse Event|0|||
147448416|NCT01033825|531805720|FG005|Overall Study|Adverse Event|0|||
147448417|NCT01033825|531805721|FG006|Overall Study|Adverse Event|0|||
147448418|NCT01033825|531805715|FG000|Overall Study|Protocol Violation|1|||
147448419|NCT01033825|531805716|FG001|Overall Study|Protocol Violation|0|||
147448420|NCT01033825|531805717|FG002|Overall Study|Protocol Violation|0|||
147448421|NCT01033825|531805718|FG003|Overall Study|Protocol Violation|0|||
147448422|NCT01033825|531805719|FG004|Overall Study|Protocol Violation|0|||
147448423|NCT01033825|531805720|FG005|Overall Study|Protocol Violation|0|||
147448424|NCT01033825|531805721|FG006|Overall Study|Protocol Violation|0|||
147448425|NCT01033825|531805715|FG000|Overall Study|Other|0|||
147656225|NCT02959918|532564961|FG010|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
147325966|NCT00762463|531359570|FG003|Extension Phase (Week 6 to Week 12)|Lost to Follow-up|0|||
147325967|NCT00762463|531359567|FG000|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|1|||
147325968|NCT00762463|531359568|FG001|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|1|||
147325969|NCT00762463|531359569|FG002|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|0|||
147325970|NCT00762463|531359570|FG003|Extension Phase (Week 6 to Week 12)|Insufficient clinical response|1|||
147448426|NCT01033825|531805716|FG001|Overall Study|Other|0|||
147448427|NCT01033825|531805717|FG002|Overall Study|Other|0|||
147448428|NCT01033825|531805718|FG003|Overall Study|Other|0|||
147448429|NCT01033825|531805719|FG004|Overall Study|Other|1|||
147448430|NCT01033825|531805720|FG005|Overall Study|Other|0|||
147448431|NCT01033825|531805721|FG006|Overall Study|Other|0|||
147448432|NCT04294719|531805722|FG000|Overall Study|Withdrawal by Subject|1|||
147448433|NCT00081159|531805724|FG000|Overall Study|Withdrawal by Subject|0|||
147325971|NCT00762463|531359567|FG000|Extension Phase (Week 6 to Week 12)|No longer willing to participate|1|||
147325972|NCT00762463|531359568|FG001|Extension Phase (Week 6 to Week 12)|No longer willing to participate|0|||
147325973|NCT00762463|531359569|FG002|Extension Phase (Week 6 to Week 12)|No longer willing to participate|3|||
147325974|NCT00762463|531359570|FG003|Extension Phase (Week 6 to Week 12)|No longer willing to participate|0|||
147325975|NCT00762463|531359567|FG000|Extension Phase (Week 6 to Week 12)|Other|0|||
147245605|NCT02207244|531070821|FG001|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
147245606|NCT02207244|531070822|FG002|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
147245607|NCT02207244|531070823|FG003|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|1|||
147245608|NCT02207244|531070824|FG004|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|2|||
147245609|NCT02207244|531070825|FG005|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|2|||
147245610|NCT02207244|531070826|FG006|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
147245611|NCT02207244|531070827|FG007|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
147245612|NCT02207244|531070828|FG008|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
147245613|NCT02207244|531070829|FG009|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
147245614|NCT02207244|531070830|FG010|Placebo Crossover and ACP: Week 16-28|Lost to Follow-up|0|||
147245615|NCT02207244|531070820|FG000|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
147245616|NCT02207244|531070821|FG001|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
147245617|NCT02207244|531070822|FG002|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
147245618|NCT02207244|531070823|FG003|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|3|||
147245619|NCT02207244|531070824|FG004|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|3|||
147245620|NCT02207244|531070825|FG005|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|2|||
147245621|NCT02207244|531070826|FG006|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
147245622|NCT02207244|531070827|FG007|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
147245623|NCT02207244|531070828|FG008|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
147245624|NCT02207244|531070829|FG009|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
147245625|NCT02207244|531070830|FG010|Placebo Crossover and ACP: Week 16-28|Withdrawal by Subject|0|||
147245626|NCT02207244|531070820|FG000|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
147245627|NCT02207244|531070821|FG001|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
147245628|NCT02207244|531070822|FG002|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
147245629|NCT02207244|531070823|FG003|Placebo Crossover and ACP: Week 16-28|Protocol Violation|1|||
147245630|NCT02207244|531070824|FG004|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
147245631|NCT02207244|531070825|FG005|Placebo Crossover and ACP: Week 16-28|Protocol Violation|1|||
147245632|NCT02207244|531070826|FG006|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
147245633|NCT02207244|531070827|FG007|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
147245634|NCT02207244|531070828|FG008|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
147245635|NCT02207244|531070829|FG009|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
147245636|NCT02207244|531070830|FG010|Placebo Crossover and ACP: Week 16-28|Protocol Violation|0|||
147245637|NCT02207244|531070820|FG000|Placebo Crossover and ACP: Week 16-28|Other|0|||
147245638|NCT02207244|531070821|FG001|Placebo Crossover and ACP: Week 16-28|Other|0|||
147245639|NCT02207244|531070822|FG002|Placebo Crossover and ACP: Week 16-28|Other|0|||
147245640|NCT02207244|531070823|FG003|Placebo Crossover and ACP: Week 16-28|Other|1|||
147245641|NCT02207244|531070824|FG004|Placebo Crossover and ACP: Week 16-28|Other|0|||
147245642|NCT02207244|531070825|FG005|Placebo Crossover and ACP: Week 16-28|Other|0|||
147245643|NCT02207244|531070826|FG006|Placebo Crossover and ACP: Week 16-28|Other|0|||
147245644|NCT02207244|531070827|FG007|Placebo Crossover and ACP: Week 16-28|Other|0|||
147245645|NCT02207244|531070828|FG008|Placebo Crossover and ACP: Week 16-28|Other|0|||
147245646|NCT02207244|531070829|FG009|Placebo Crossover and ACP: Week 16-28|Other|0|||
147245647|NCT02207244|531070830|FG010|Placebo Crossover and ACP: Week 16-28|Other|0|||
147245648|NCT02207244|531070820|FG000|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
147245649|NCT02207244|531070821|FG001|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
147245650|NCT02207244|531070822|FG002|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
147245651|NCT02207244|531070823|FG003|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
147245652|NCT02207244|531070824|FG004|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
147245653|NCT02207244|531070825|FG005|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
147245654|NCT02207244|531070826|FG006|Withdrawal and Re-treatment: Week 28-72|Adverse Event|1|||
147245655|NCT02207244|531070827|FG007|Withdrawal and Re-treatment: Week 28-72|Adverse Event|5|||
147245656|NCT02207244|531070828|FG008|Withdrawal and Re-treatment: Week 28-72|Adverse Event|3|||
147245657|NCT02207244|531070829|FG009|Withdrawal and Re-treatment: Week 28-72|Adverse Event|2|||
147245658|NCT02207244|531070830|FG010|Withdrawal and Re-treatment: Week 28-72|Adverse Event|0|||
147245659|NCT02207244|531070820|FG000|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
147245660|NCT02207244|531070821|FG001|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
147245661|NCT02207244|531070822|FG002|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
147245662|NCT02207244|531070823|FG003|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
147245663|NCT02207244|531070824|FG004|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
147325976|NCT00762463|531359568|FG001|Extension Phase (Week 6 to Week 12)|Other|0|||
147325977|NCT00762463|531359569|FG002|Extension Phase (Week 6 to Week 12)|Other|0|||
147325978|NCT00762463|531359570|FG003|Extension Phase (Week 6 to Week 12)|Other|1|||
147325979|NCT00531479|531359571|FG000|Overall Study|Death|68|||
147325980|NCT00531479|531359572|FG001|Overall Study|Death|71|||
147325981|NCT00531479|531359571|FG000|Overall Study|Lost to Follow-up|0|||
147325982|NCT00531479|531359572|FG001|Overall Study|Lost to Follow-up|2|||
147325983|NCT00531479|531359571|FG000|Overall Study|Other|0|||
147325984|NCT00531479|531359572|FG001|Overall Study|Other|1|||
147325985|NCT00531479|531359571|FG000|Overall Study|Withdrawal by Subject|6|||
147325986|NCT00531479|531359572|FG001|Overall Study|Withdrawal by Subject|6|||
147325987|NCT00531479|531359571|FG000|Overall Study|Did not receive treatment|2|||
147325988|NCT00531479|531359572|FG001|Overall Study|Did not receive treatment|3|||
147325989|NCT04358549|531359575|FG000|Overall Study|Adverse Event|0|||
147325990|NCT04358549|531359576|FG001|Overall Study|Adverse Event|1|||
147325991|NCT04358549|531359575|FG000|Overall Study|Death|1|||
147325992|NCT04358549|531359576|FG001|Overall Study|Death|0|||
147325993|NCT04358549|531359575|FG000|Overall Study|Lost to Follow-up|2|||
147325994|NCT04358549|531359576|FG001|Overall Study|Lost to Follow-up|1|||
147325995|NCT04358549|531359575|FG000|Overall Study|Withdrawal by Subject|6|||
147325996|NCT04358549|531359576|FG001|Overall Study|Withdrawal by Subject|6|||
147325997|NCT04358549|531359575|FG000|Overall Study|Start remdesivir|1|||
147325998|NCT04358549|531359576|FG001|Overall Study|Start remdesivir|0|||
147325999|NCT04867902|531359580|FG000|Overall Study|Lost to Follow-up|1|||
147326000|NCT04867902|531359580|FG000|Overall Study|Withdrawal by Subject|2|||
147326001|NCT04867902|531359580|FG000|Overall Study|Protocol Violation|1|||
147326002|NCT05355116|531359581|FG000|Overall Study|Withdrawal by Subject|2|||
147326003|NCT02501629|531359582|FG000|Overall Study|Death|0|||
147326004|NCT02501629|531359583|FG001|Overall Study|Death|1|||
147326005|NCT02501629|531359582|FG000|Overall Study|Withdrawn from study by sponsor|1|||
147326006|NCT02501629|531359583|FG001|Overall Study|Withdrawn from study by sponsor|0|||
147326007|NCT02501629|531359582|FG000|Overall Study|Early termination by sponsor|1|||
147326008|NCT02501629|531359583|FG001|Overall Study|Early termination by sponsor|0|||
147326009|NCT02501629|531359582|FG000|Overall Study|Withdrawal by Subject|3|||
147326010|NCT02501629|531359583|FG001|Overall Study|Withdrawal by Subject|5|||
147326011|NCT02501629|531359582|FG000|Overall Study|Subject did not return to site|0|||
147326012|NCT02501629|531359583|FG001|Overall Study|Subject did not return to site|1|||
147326013|NCT00868231|531359586|FG000|Treatment Period 1|Adverse Event|0|||
147326014|NCT00868231|531359587|FG001|Treatment Period 1|Adverse Event|0|||
147326015|NCT00868231|531359588|FG002|Treatment Period 1|Adverse Event|0|||
147326016|NCT00868231|531359589|FG003|Treatment Period 1|Adverse Event|0|||
147326017|NCT00868231|531359590|FG004|Treatment Period 1|Adverse Event|1|||
147326018|NCT00868231|531359591|FG005|Treatment Period 1|Adverse Event|0|||
147326019|NCT00868231|531359586|FG000|Treatment Period 2|Adverse Event|1|||
147326020|NCT00868231|531359587|FG001|Treatment Period 2|Adverse Event|0|||
147326021|NCT00868231|531359588|FG002|Treatment Period 2|Adverse Event|0|||
147326022|NCT00868231|531359589|FG003|Treatment Period 2|Adverse Event|0|||
147326023|NCT00868231|531359590|FG004|Treatment Period 2|Adverse Event|0|||
147326024|NCT00868231|531359591|FG005|Treatment Period 2|Adverse Event|0|||
147326025|NCT00868231|531359586|FG000|Treatment Period 3|Adverse Event|0|||
147326026|NCT00868231|531359587|FG001|Treatment Period 3|Adverse Event|0|||
147326027|NCT00868231|531359588|FG002|Treatment Period 3|Adverse Event|1|||
147326028|NCT00868231|531359589|FG003|Treatment Period 3|Adverse Event|0|||
147326029|NCT00868231|531359590|FG004|Treatment Period 3|Adverse Event|0|||
147179931|NCT01811186|530823641|FG001|Overall Study|Adverse Event|38|||
147179932|NCT01811186|530823640|FG000|Overall Study|Protocol Violation|5|||
147179933|NCT01811186|530823641|FG001|Overall Study|Protocol Violation|6|||
147179934|NCT01811186|530823640|FG000|Overall Study|Withdrawal by Subject|5|||
147179935|NCT01811186|530823641|FG001|Overall Study|Withdrawal by Subject|10|||
147179936|NCT01811186|530823640|FG000|Overall Study|Lack of Efficacy|3|||
147179937|NCT01811186|530823641|FG001|Overall Study|Lack of Efficacy|6|||
147179938|NCT01811186|530823640|FG000|Overall Study|Lost to Follow-up|4|||
147179939|NCT01811186|530823641|FG001|Overall Study|Lost to Follow-up|2|||
147179940|NCT02465203|530823642|FG000|Overall Study|Protocol Violation|1|||
147179941|NCT02465203|530823643|FG001|Overall Study|Protocol Violation|1|||
147179942|NCT02465203|530823644|FG002|Overall Study|Protocol Violation|1|||
147179943|NCT02465203|530823642|FG000|Overall Study|Study terminated by sponsor|50|||
147179944|NCT02465203|530823643|FG001|Overall Study|Study terminated by sponsor|34|||
147179945|NCT02465203|530823644|FG002|Overall Study|Study terminated by sponsor|11|||
147179946|NCT02465203|530823642|FG000|Overall Study|New therapy for study indication|4|||
147179947|NCT02465203|530823643|FG001|Overall Study|New therapy for study indication|0|||
147179948|NCT02465203|530823644|FG002|Overall Study|New therapy for study indication|0|||
147326030|NCT00868231|531359591|FG005|Treatment Period 3|Adverse Event|0|||
147326031|NCT03120676|531359592|FG000|Overall Study|Not treated|1|||
147326032|NCT01168401|531359593|FG000|Overall Study|Lost to Follow-up|1|||
147179949|NCT02465203|530823642|FG000|Overall Study|Patient/guardian decision|1|||
147179950|NCT02465203|530823643|FG001|Overall Study|Patient/guardian decision|1|||
147179951|NCT02465203|530823644|FG002|Overall Study|Patient/guardian decision|1|||
147179952|NCT04072887|530823649|FG000|Overall Study|Withdrawal by Subject|3|||
147326033|NCT01168401|531359594|FG001|Overall Study|Lost to Follow-up|1|||
147326034|NCT01168401|531359595|FG002|Overall Study|Lost to Follow-up|2|||
147179953|NCT04072887|530823650|FG001|Overall Study|Withdrawal by Subject|8|||
147179954|NCT04072887|530823651|FG002|Overall Study|Withdrawal by Subject|1|||
147179955|NCT04072887|530823652|FG003|Overall Study|Withdrawal by Subject|3|||
147326035|NCT01168401|531359596|FG003|Overall Study|Lost to Follow-up|1|||
147179956|NCT04072887|530823653|FG004|Overall Study|Withdrawal by Subject|3|||
147179957|NCT04072887|530823654|FG005|Overall Study|Withdrawal by Subject|13|||
147179958|NCT04072887|530823649|FG000|Overall Study|Adverse Event|2|||
147179959|NCT04072887|530823650|FG001|Overall Study|Adverse Event|4|||
147179960|NCT04072887|530823651|FG002|Overall Study|Adverse Event|1|||
147179961|NCT04072887|530823652|FG003|Overall Study|Adverse Event|4|||
147179962|NCT04072887|530823653|FG004|Overall Study|Adverse Event|0|||
147179963|NCT04072887|530823654|FG005|Overall Study|Adverse Event|1|||
147179964|NCT04072887|530823649|FG000|Overall Study|Physician Decision|2|||
147179965|NCT04072887|530823650|FG001|Overall Study|Physician Decision|0|||
147179966|NCT04072887|530823651|FG002|Overall Study|Physician Decision|0|||
147179967|NCT04072887|530823652|FG003|Overall Study|Physician Decision|0|||
147179968|NCT04072887|530823653|FG004|Overall Study|Physician Decision|0|||
147326036|NCT01168401|531359597|FG004|Overall Study|Lost to Follow-up|0|||
147326037|NCT01168401|531359598|FG005|Overall Study|Lost to Follow-up|0|||
147326038|NCT01168401|531359599|FG006|Overall Study|Lost to Follow-up|0|||
147326039|NCT01168401|531359600|FG007|Overall Study|Lost to Follow-up|0|||
147326040|NCT01168401|531359601|FG008|Overall Study|Lost to Follow-up|0|||
147326041|NCT01168401|531359602|FG009|Overall Study|Lost to Follow-up|0|||
147326042|NCT01168401|531359603|FG010|Overall Study|Lost to Follow-up|0|||
147326043|NCT01168401|531359593|FG000|Overall Study|Withdrawal by Subject|0|||
147326044|NCT01168401|531359594|FG001|Overall Study|Withdrawal by Subject|0|||
147326045|NCT01168401|531359595|FG002|Overall Study|Withdrawal by Subject|0|||
147326046|NCT01168401|531359596|FG003|Overall Study|Withdrawal by Subject|1|||
147326047|NCT01168401|531359597|FG004|Overall Study|Withdrawal by Subject|0|||
147326048|NCT01168401|531359598|FG005|Overall Study|Withdrawal by Subject|0|||
147326049|NCT01168401|531359599|FG006|Overall Study|Withdrawal by Subject|0|||
147326050|NCT01168401|531359600|FG007|Overall Study|Withdrawal by Subject|0|||
147326051|NCT01168401|531359601|FG008|Overall Study|Withdrawal by Subject|0|||
147326052|NCT01168401|531359602|FG009|Overall Study|Withdrawal by Subject|0|||
147326053|NCT01168401|531359603|FG010|Overall Study|Withdrawal by Subject|0|||
147326054|NCT00672256|531359604|FG000|Overall Study|PI dropped, bad data|44|||
147326055|NCT01801930|531359605|FG000|Overall Study|Clear progression of the primary disease is observed|6|||
147326056|NCT01801930|531359606|FG001|Overall Study|Clear progression of the primary disease is observed|5|||
147326057|NCT01801930|531359607|FG002|Overall Study|Clear progression of the primary disease is observed|6|||
147326058|NCT01801930|531359608|FG003|Overall Study|Clear progression of the primary disease is observed|6|||
147326059|NCT01801930|531359605|FG000|Overall Study|DLT occurs|0|||
147326060|NCT01801930|531359606|FG001|Overall Study|DLT occurs|1|||
147326061|NCT01801930|531359607|FG002|Overall Study|DLT occurs|0|||
147326062|NCT01801930|531359608|FG003|Overall Study|DLT occurs|0|||
147326063|NCT01720043|531359614|FG000|Overall Study|Withdrawal by Subject|1|||
147326064|NCT01516892|531359615|FG000|Overall Study|Adverse Event|25|||
147326065|NCT01516892|531359615|FG000|Overall Study|Lack of Efficacy|35|||
147326066|NCT01516892|531359615|FG000|Overall Study|Pregnancy|5|||
147326067|NCT01516892|531359615|FG000|Overall Study|Lost to Follow-up|82|||
147326068|NCT01516892|531359615|FG000|Overall Study|Subject Withdrew Consent|92|||
147326069|NCT01516892|531359615|FG000|Overall Study|Protocol Violation|60|||
147326070|NCT01516892|531359615|FG000|Overall Study|Other Miscellaneous Reasons|43|||
147326071|NCT01516892|531359615|FG000|Overall Study|Missing|1|||
147326072|NCT03613129|531359616|FG000|Pre-treatment Assessment|Protocol Violation|2|||
147326073|NCT03613129|531359617|FG001|Pre-treatment Assessment|Protocol Violation|0|||
147326074|NCT03613129|531359618|FG002|Pre-treatment Assessment|Protocol Violation|0|||
147326075|NCT03613129|531359619|FG003|Pre-treatment Assessment|Protocol Violation|0|||
147326076|NCT03613129|531359620|FG004|Pre-treatment Assessment|Protocol Violation|0|||
147179969|NCT04072887|530823654|FG005|Overall Study|Physician Decision|1|||
147179970|NCT04072887|530823649|FG000|Overall Study|Lost to Follow-up|1|||
147326077|NCT03613129|531359616|FG000|Pre-treatment Assessment|Withdrawal by Subject|1|||
147326078|NCT03613129|531359617|FG001|Pre-treatment Assessment|Withdrawal by Subject|0|||
147326079|NCT03613129|531359618|FG002|Pre-treatment Assessment|Withdrawal by Subject|0|||
147326080|NCT03613129|531359619|FG003|Pre-treatment Assessment|Withdrawal by Subject|0|||
147326081|NCT03613129|531359620|FG004|Pre-treatment Assessment|Withdrawal by Subject|0|||
147326082|NCT00938340|531359621|FG000|Overall Study|Withdrawal by Subject|3|||
147326083|NCT00938340|531359621|FG000|Overall Study|Protocol Violation|1|||
147326084|NCT00938340|531359621|FG000|Overall Study|Adverse Event|1|||
147326085|NCT00711646|531359622|FG000|Overall Study|Adverse Event|6|||
147326086|NCT00711646|531359623|FG001|Overall Study|Adverse Event|1|||
147179971|NCT04072887|530823650|FG001|Overall Study|Lost to Follow-up|3|||
147179972|NCT04072887|530823651|FG002|Overall Study|Lost to Follow-up|0|||
147593291|NCT00158756|532328962|FG003|Overall Study|Adverse Event|0|||
147179973|NCT04072887|530823652|FG003|Overall Study|Lost to Follow-up|0|||
147179974|NCT04072887|530823653|FG004|Overall Study|Lost to Follow-up|0|||
147326087|NCT00711646|531359622|FG000|Overall Study|Withdrawal by Subject|4|||
147326088|NCT00711646|531359623|FG001|Overall Study|Withdrawal by Subject|0|||
147179975|NCT04072887|530823654|FG005|Overall Study|Lost to Follow-up|0|||
147179976|NCT04072887|530823649|FG000|Overall Study|Death|0|||
147593292|NCT00158756|532328963|FG004|Overall Study|Adverse Event|0|||
147593293|NCT00158756|532328959|FG000|Overall Study|Serious adverse event|0|||
147593294|NCT00158756|532328960|FG001|Overall Study|Serious adverse event|0|||
147593295|NCT00158756|532328961|FG002|Overall Study|Serious adverse event|1|||
147593296|NCT00158756|532328962|FG003|Overall Study|Serious adverse event|0|||
147593297|NCT00158756|532328963|FG004|Overall Study|Serious adverse event|0|||
147593298|NCT02400671|532328964|FG000|Overall Study|Death|5|||
147593299|NCT02400671|532328965|FG001|Overall Study|Death|3|||
147593300|NCT02400671|532328966|FG002|Overall Study|Death|4|||
147593301|NCT02400671|532328964|FG000|Overall Study|Lost to Follow-up|20|||
147593302|NCT02400671|532328965|FG001|Overall Study|Lost to Follow-up|27|||
147593303|NCT02400671|532328966|FG002|Overall Study|Lost to Follow-up|24|||
147593304|NCT02400671|532328964|FG000|Overall Study|Withdrawal by Subject|2|||
147593305|NCT02400671|532328965|FG001|Overall Study|Withdrawal by Subject|2|||
147593306|NCT02400671|532328966|FG002|Overall Study|Withdrawal by Subject|0|||
147593307|NCT01421342|532328967|FG000|Acute Treatment Phase (12 Weeks)|Lack of Efficacy|49|||
147593308|NCT01421342|532328968|FG001|Acute Treatment Phase (12 Weeks)|Lack of Efficacy|28|||
147593309|NCT01421342|532328969|FG002|Acute Treatment Phase (12 Weeks)|Lack of Efficacy|13|||
147593310|NCT01421342|532328967|FG000|Acute Treatment Phase (12 Weeks)|Adverse Event|53|||
147593311|NCT01421342|532328968|FG001|Acute Treatment Phase (12 Weeks)|Adverse Event|38|||
147593312|NCT01421342|532328969|FG002|Acute Treatment Phase (12 Weeks)|Adverse Event|27|||
147593313|NCT01421342|532328967|FG000|Acute Treatment Phase (12 Weeks)|Withdrawal by Subject|23|||
147593314|NCT01421342|532328968|FG001|Acute Treatment Phase (12 Weeks)|Withdrawal by Subject|20|||
147179977|NCT04072887|530823650|FG001|Overall Study|Death|2|||
147179978|NCT04072887|530823651|FG002|Overall Study|Death|0|||
147179979|NCT04072887|530823652|FG003|Overall Study|Death|2|||
147179980|NCT04072887|530823653|FG004|Overall Study|Death|3|||
147179981|NCT04072887|530823654|FG005|Overall Study|Death|0|||
147179982|NCT00856297|530823655|FG000|Overall Study|Unable to classify|2|||
147179983|NCT00856297|530823656|FG001|Overall Study|Unable to classify|0|||
147179984|NCT00856297|530823657|FG002|Overall Study|Unable to classify|0|||
147179985|NCT00856297|530823658|FG003|Overall Study|Unable to classify|0|||
147179986|NCT00856297|530823659|FG004|Overall Study|Unable to classify|0|||
147179987|NCT02508428|530823666|FG000|Overall Study|Death|32|||
147179988|NCT02508428|530823667|FG001|Overall Study|Death|33|||
147179989|NCT02508428|530823666|FG000|Overall Study|Liner revised|3|||
147179990|NCT02508428|530823667|FG001|Overall Study|Liner revised|19|||
147179991|NCT02508428|530823666|FG000|Overall Study|Incomplete follow-up|17|||
147179992|NCT02508428|530823667|FG001|Overall Study|Incomplete follow-up|15|||
147179993|NCT00534976|530823675|FG000|Period 2: Treatment Montelukast/ Placebo|Protocol Violation|0|||
147179994|NCT00534976|530823676|FG001|Period 2: Treatment Montelukast/ Placebo|Protocol Violation|1|||
147179995|NCT00534976|530823675|FG000|Period 3: Crossover Placebo/ Montelukast|Physician Decision|1|||
147179996|NCT00534976|530823676|FG001|Period 3: Crossover Placebo/ Montelukast|Physician Decision|0|||
147179997|NCT00534976|530823675|FG000|Period 3: Crossover Placebo/ Montelukast|Withdrawal by Subject|1|||
147179998|NCT00534976|530823676|FG001|Period 3: Crossover Placebo/ Montelukast|Withdrawal by Subject|0|||
147179999|NCT00861471|530823677|FG000|Overall Study|Withdrawal by Subject|1|||
147180000|NCT00861471|530823677|FG000|Overall Study|Adverse Event|2|||
147180001|NCT00861471|530823677|FG000|Overall Study|Lack of Efficacy|3|||
147180002|NCT00861471|530823677|FG000|Overall Study|treatment for lumbar laminectomy|1|||
147180003|NCT00861471|530823677|FG000|Overall Study|Physician Decision|2|||
147180004|NCT02092025|530823678|FG000|Overall Study|Case Report Forms Uncollected|44|||
147180005|NCT02092025|530823678|FG000|Overall Study|Protocol Deviation|24|||
147180006|NCT00264537|530823679|FG000|Overall Study|Death|0|||
147180007|NCT00264537|530823680|FG001|Overall Study|Death|3|||
147180008|NCT00264537|530823681|FG002|Overall Study|Death|3|||
147180009|NCT00264537|530823682|FG003|Overall Study|Death|2|||
147180010|NCT00264537|530823679|FG000|Overall Study|Lost to Follow-up|3|||
147180011|NCT00264537|530823680|FG001|Overall Study|Lost to Follow-up|4|||
147180012|NCT00264537|530823681|FG002|Overall Study|Lost to Follow-up|7|||
147180013|NCT00264537|530823682|FG003|Overall Study|Lost to Follow-up|6|||
147593315|NCT01421342|532328969|FG002|Acute Treatment Phase (12 Weeks)|Withdrawal by Subject|13|||
147180014|NCT00264537|530823679|FG000|Overall Study|Adverse Event|21|||
147180015|NCT00264537|530823680|FG001|Overall Study|Adverse Event|32|||
147180016|NCT00264537|530823681|FG002|Overall Study|Adverse Event|24|||
147180017|NCT00264537|530823682|FG003|Overall Study|Adverse Event|34|||
147180018|NCT00264537|530823679|FG000|Overall Study|Unsatisfactory therapeutic effect|5|||
147180019|NCT00264537|530823680|FG001|Overall Study|Unsatisfactory therapeutic effect|6|||
147180020|NCT00264537|530823681|FG002|Overall Study|Unsatisfactory therapeutic effect|5|||
147180021|NCT00264537|530823682|FG003|Overall Study|Unsatisfactory therapeutic effect|7|||
147180022|NCT00264537|530823679|FG000|Overall Study|Other|21|||
147180023|NCT00264537|530823680|FG001|Overall Study|Other|11|||
147180024|NCT00264537|530823681|FG002|Overall Study|Other|10|||
147180025|NCT00264537|530823682|FG003|Overall Study|Other|11|||
147180026|NCT00264537|530823679|FG000|Overall Study|Not treated|0|||
147180027|NCT00264537|530823680|FG001|Overall Study|Not treated|2|||
147326089|NCT00711646|531359622|FG000|Overall Study|Protocol Violation|0|||
147326090|NCT00711646|531359623|FG001|Overall Study|Protocol Violation|1|||
147326091|NCT00711646|531359622|FG000|Overall Study|Lost to Follow-up|1|||
147326092|NCT00711646|531359623|FG001|Overall Study|Lost to Follow-up|0|||
147326093|NCT00711646|531359622|FG000|Overall Study|administrative decision|0|||
147326094|NCT00711646|531359623|FG001|Overall Study|administrative decision|1|||
147326095|NCT00711646|531359622|FG000|Overall Study|patient non-compliance|1|||
147326096|NCT00711646|531359623|FG001|Overall Study|patient non-compliance|0|||
147326097|NCT00269399|531359624|FG000|Overall Study|Lack of Efficacy|27|||
147326098|NCT00269399|531359625|FG001|Overall Study|Lack of Efficacy|10|||
147326099|NCT00269399|531359624|FG000|Overall Study|Adverse Event|10|||
147326100|NCT00269399|531359625|FG001|Overall Study|Adverse Event|4|||
147326101|NCT00269399|531359624|FG000|Overall Study|Withdrawal by Subject|2|||
147326102|NCT00269399|531359625|FG001|Overall Study|Withdrawal by Subject|5|||
147326103|NCT00269399|531359624|FG000|Overall Study|Negative Lab Result for C. difficile|2|||
147326104|NCT00269399|531359625|FG001|Overall Study|Negative Lab Result for C. difficile|3|||
147326105|NCT00269399|531359624|FG000|Overall Study|Other|0|||
147326106|NCT00269399|531359625|FG001|Overall Study|Other|4|||
147326107|NCT00269399|531359624|FG000|Overall Study|Development of exclusion criteria|0|||
147326108|NCT00269399|531359625|FG001|Overall Study|Development of exclusion criteria|1|||
147326109|NCT03441360|531359626|FG000|Overall Study|Radiological disease progression|5|||
147326110|NCT03441360|531359627|FG001|Overall Study|Radiological disease progression|6|||
147326111|NCT03441360|531359628|FG002|Overall Study|Radiological disease progression|4|||
147326112|NCT03441360|531359626|FG000|Overall Study|Clinical disease progression|2|||
147326113|NCT03441360|531359627|FG001|Overall Study|Clinical disease progression|2|||
147326114|NCT03441360|531359628|FG002|Overall Study|Clinical disease progression|0|||
147326115|NCT03441360|531359626|FG000|Overall Study|Adverse Event|1|||
147326116|NCT03441360|531359627|FG001|Overall Study|Adverse Event|0|||
147326117|NCT03441360|531359628|FG002|Overall Study|Adverse Event|1|||
147326118|NCT03396835|531359629|FG000|Overall Study|Withdrawn prior to completion|1|||
147326119|NCT03396835|531359629|FG000|Overall Study|Did not meet criteria for data analysis|1|||
147326120|NCT01451814|531359630|FG000|Overall Study|Withdrawal by Subject|1|||
147326121|NCT01451814|531359631|FG001|Overall Study|Withdrawal by Subject|1|||
147326122|NCT01451814|531359630|FG000|Overall Study|Lost to Follow-up|5|||
147326123|NCT01451814|531359631|FG001|Overall Study|Lost to Follow-up|4|||
147326124|NCT03439124|531359632|FG000|Overall Study|Adverse Event|2|||
147326125|NCT03439124|531359633|FG001|Overall Study|Adverse Event|0|||
147326126|NCT03439124|531359632|FG000|Overall Study|Lost to Follow-up|1|||
147326127|NCT03439124|531359633|FG001|Overall Study|Lost to Follow-up|0|||
147326128|NCT03439124|531359632|FG000|Overall Study|Other reasons|1|||
147326129|NCT03439124|531359633|FG001|Overall Study|Other reasons|0|||
147326130|NCT04353037|531359635|FG000|Overall Study|Lost to Follow-up|0|||
147326131|NCT04353037|531359636|FG001|Overall Study|Lost to Follow-up|1|||
147326132|NCT04353037|531359637|FG002|Overall Study|Lost to Follow-up|2|||
147326133|NCT04353037|531359638|FG003|Overall Study|Lost to Follow-up|3|||
147326134|NCT04353037|531359635|FG000|Overall Study|Withdrawal by Subject|0|||
147326135|NCT04353037|531359636|FG001|Overall Study|Withdrawal by Subject|2|||
147326136|NCT04353037|531359637|FG002|Overall Study|Withdrawal by Subject|3|||
147326137|NCT04353037|531359638|FG003|Overall Study|Withdrawal by Subject|5|||
147326138|NCT04353037|531359635|FG000|Overall Study|Adverse Event|0|||
147326139|NCT04353037|531359636|FG001|Overall Study|Adverse Event|0|||
147326140|NCT04353037|531359637|FG002|Overall Study|Adverse Event|2|||
147326141|NCT04353037|531359638|FG003|Overall Study|Adverse Event|0|||
147326142|NCT04353037|531359635|FG000|Overall Study|Exposure Change|0|||
147326143|NCT04353037|531359636|FG001|Overall Study|Exposure Change|0|||
147326144|NCT04353037|531359637|FG002|Overall Study|Exposure Change|0|||
147180028|NCT00264537|530823681|FG002|Overall Study|Not treated|1|||
147180029|NCT00264537|530823682|FG003|Overall Study|Not treated|0|||
147180030|NCT02123576|530823683|FG000|Overall Study|Adverse Event|1|||
147180031|NCT02123576|530823684|FG001|Overall Study|Adverse Event|0|||
147180032|NCT00934128|530823685|FG000|First Intervention (2 Hours)|Withdrawal by Subject|0|||
147180033|NCT00934128|530823686|FG001|First Intervention (2 Hours)|Withdrawal by Subject|1|||
147326145|NCT04353037|531359638|FG003|Overall Study|Exposure Change|2|||
147326146|NCT03710564|531359639|FG000|Overall Study|Study Terminated by Sponsor|104|||
147326147|NCT03710564|531359640|FG001|Overall Study|Study Terminated by Sponsor|55|||
147326148|NCT03710564|531359639|FG000|Overall Study|Withdrawal by Subject|57|||
147326149|NCT03710564|531359640|FG001|Overall Study|Withdrawal by Subject|25|||
147326150|NCT03710564|531359639|FG000|Overall Study|Death|10|||
147326151|NCT03710564|531359640|FG001|Overall Study|Death|4|||
147326152|NCT03710564|531359639|FG000|Overall Study|Lost to Follow-up|5|||
147326153|NCT03710564|531359640|FG001|Overall Study|Lost to Follow-up|4|||
147326154|NCT03710564|531359639|FG000|Overall Study|Protocol Violation|3|||
147326155|NCT03710564|531359640|FG001|Overall Study|Protocol Violation|2|||
147326156|NCT03710564|531359639|FG000|Overall Study|Adverse Event|3|||
147326157|NCT03710564|531359640|FG001|Overall Study|Adverse Event|0|||
147326158|NCT03710564|531359639|FG000|Overall Study|Physician Decision|2|||
147326159|NCT03710564|531359640|FG001|Overall Study|Physician Decision|3|||
147326160|NCT02993471|531359641|FG000|Period 2 (Drug Cocktail + Ixekizumab)|Protocol Violation|1|||
147326161|NCT02993471|531359641|FG000|Period 2 (Drug Cocktail + Ixekizumab)|Withdrawal by Subject|1|||
147326162|NCT04939428|531359642|FG000|Overall Study|Death|0|||
147326163|NCT04939428|531359643|FG001|Overall Study|Death|1|||
147326164|NCT04939428|531359644|FG002|Overall Study|Death|0|||
147326165|NCT04939428|531359642|FG000|Overall Study|Lost to Follow-up|0|||
147326166|NCT04939428|531359643|FG001|Overall Study|Lost to Follow-up|5|||
147326167|NCT04939428|531359644|FG002|Overall Study|Lost to Follow-up|0|||
147326168|NCT04939428|531359642|FG000|Overall Study|Physician Decision|1|||
147326169|NCT04939428|531359643|FG001|Overall Study|Physician Decision|0|||
147326170|NCT04939428|531359644|FG002|Overall Study|Physician Decision|0|||
147326171|NCT04939428|531359642|FG000|Overall Study|Randomized By Mistake Without Study Treatment|1|||
147326172|NCT04939428|531359643|FG001|Overall Study|Randomized By Mistake Without Study Treatment|0|||
147326173|NCT04939428|531359644|FG002|Overall Study|Randomized By Mistake Without Study Treatment|0|||
147326174|NCT04939428|531359642|FG000|Overall Study|Withdrawal by Subject|10|||
147326175|NCT04939428|531359643|FG001|Overall Study|Withdrawal by Subject|11|||
147326176|NCT04939428|531359644|FG002|Overall Study|Withdrawal by Subject|0|||
147326177|NCT04939428|531359642|FG000|Overall Study|Unkown|6|||
147180034|NCT00934128|530823685|FG000|First Intervention (2 Hours)|Adverse Event|4|||
147180035|NCT00934128|530823686|FG001|First Intervention (2 Hours)|Adverse Event|1|||
147180036|NCT00934128|530823685|FG000|First Intervention (2 Hours)|Treatment Delivery Order Switched|1|||
147180037|NCT00934128|530823686|FG001|First Intervention (2 Hours)|Treatment Delivery Order Switched|0|||
147326178|NCT04939428|531359643|FG001|Overall Study|Unkown|3|||
147326179|NCT04939428|531359644|FG002|Overall Study|Unkown|0|||
147326180|NCT04939428|531359642|FG000|Overall Study|Discotinued per protocol|0|||
147326181|NCT04939428|531359643|FG001|Overall Study|Discotinued per protocol|0|||
147326182|NCT04939428|531359644|FG002|Overall Study|Discotinued per protocol|902|||
147326183|NCT00877851|531359647|FG000|Overall Study|Lost to Follow-up|5|||
147326184|NCT00877851|531359648|FG001|Overall Study|Lost to Follow-up|5|||
147326185|NCT00877851|531359647|FG000|Overall Study|computer problem|3|||
147326186|NCT00877851|531359648|FG001|Overall Study|computer problem|0|||
147326187|NCT00877851|531359647|FG000|Overall Study|no longer interested in participating|1|||
147326188|NCT00877851|531359648|FG001|Overall Study|no longer interested in participating|0|||
147326189|NCT03424239|531359649|FG000|Overall Study|Withdrawal by Subject|2|||
147326190|NCT00770211|531359650|FG000|Overall Study|Lost to Follow-up|1|||
147326191|NCT00770211|531359651|FG001|Overall Study|Lost to Follow-up|0|||
147326192|NCT00770211|531359650|FG000|Overall Study|Withdrawal by Subject|0|||
147326193|NCT00770211|531359651|FG001|Overall Study|Withdrawal by Subject|2|||
147326194|NCT00318656|531359653|FG000|Overall Study|Took Avandamet instead of Glim/Met|0|||
147326195|NCT00318656|531359654|FG001|Overall Study|Took Avandamet instead of Glim/Met|1|||
147326196|NCT00318656|531359653|FG000|Overall Study|Did not receive any treatment|0|||
147326197|NCT00318656|531359654|FG001|Overall Study|Did not receive any treatment|1|||
147326198|NCT01446003|531359655|FG000|Period 1|Protocol Violation|2|||
147326199|NCT01446003|531359656|FG001|Period 1|Protocol Violation|0|||
147326200|NCT01446003|531359655|FG000|Period 2|Adverse Event|1|||
147326201|NCT01446003|531359656|FG001|Period 2|Adverse Event|0|||
147326202|NCT03905135|531359657|FG000|Dose Escalation|Adverse Event|1|||
147448434|NCT00081159|531805725|FG001|Overall Study|Withdrawal by Subject|3|||
147593316|NCT01421342|532328967|FG000|Acute Treatment Phase (12 Weeks)|Death|0|||
147593317|NCT01421342|532328968|FG001|Acute Treatment Phase (12 Weeks)|Death|0|||
147593318|NCT01421342|532328969|FG002|Acute Treatment Phase (12 Weeks)|Death|3|||
147593319|NCT01421342|532328967|FG000|Acute Treatment Phase (12 Weeks)|Lost to Follow-up|6|||
147593320|NCT01421342|532328968|FG001|Acute Treatment Phase (12 Weeks)|Lost to Follow-up|18|||
147593321|NCT01421342|532328969|FG002|Acute Treatment Phase (12 Weeks)|Lost to Follow-up|21|||
147593322|NCT01421342|532328967|FG000|Acute Treatment Phase (12 Weeks)|Non-adherence|15|||
147593323|NCT01421342|532328968|FG001|Acute Treatment Phase (12 Weeks)|Non-adherence|7|||
147593324|NCT01421342|532328969|FG002|Acute Treatment Phase (12 Weeks)|Non-adherence|13|||
147593325|NCT01421342|532328967|FG000|Acute Treatment Phase (12 Weeks)|Dure to other illness|3|||
147593326|NCT01421342|532328968|FG001|Acute Treatment Phase (12 Weeks)|Dure to other illness|2|||
147593327|NCT01421342|532328969|FG002|Acute Treatment Phase (12 Weeks)|Dure to other illness|4|||
147593328|NCT01421342|532328967|FG000|Acute Treatment Phase (12 Weeks)|Participant moved away|1|||
147593329|NCT01421342|532328968|FG001|Acute Treatment Phase (12 Weeks)|Participant moved away|6|||
147593330|NCT01421342|532328969|FG002|Acute Treatment Phase (12 Weeks)|Participant moved away|1|||
147593331|NCT01421342|532328967|FG000|Acute Treatment Phase (12 Weeks)|Other reason for withdrawal|8|||
147656226|NCT02959918|532564962|FG011|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
147326203|NCT03905135|531359658|FG001|Dose Escalation|Adverse Event|1|||
147326204|NCT03905135|531359657|FG000|Dose Escalation|Progressive disease|3|||
147326205|NCT03905135|531359658|FG001|Dose Escalation|Progressive disease|1|||
147326206|NCT03905135|531359657|FG000|Dose Escalation|Intercurrent illness|1|||
147326207|NCT03905135|531359658|FG001|Dose Escalation|Intercurrent illness|0|||
147326208|NCT02042443|531359661|FG000|Overall Study|Adverse Event|2|||
147326209|NCT02042443|531359662|FG001|Overall Study|Adverse Event|1|||
147326210|NCT02042443|531359661|FG000|Overall Study|Withdrawal by Subject|0|||
147326211|NCT02042443|531359662|FG001|Overall Study|Withdrawal by Subject|1|||
147326212|NCT02042443|531359661|FG000|Overall Study|Progression|21|||
147593332|NCT01421342|532328968|FG001|Acute Treatment Phase (12 Weeks)|Other reason for withdrawal|9|||
147593333|NCT01421342|532328969|FG002|Acute Treatment Phase (12 Weeks)|Other reason for withdrawal|4|||
147593334|NCT01421342|532328967|FG000|Completed to Week 12 But Then Withdrawn|Lack of Efficacy|111|||
147593335|NCT01421342|532328968|FG001|Completed to Week 12 But Then Withdrawn|Lack of Efficacy|93|||
147180038|NCT00934128|530823685|FG000|Washout Period (1 Hour)|Patient preference|1|||
147180039|NCT00934128|530823686|FG001|Washout Period (1 Hour)|Patient preference|3|||
147180040|NCT00934128|530823685|FG000|Washout Period (1 Hour)|Pain|1|||
147180041|NCT00934128|530823686|FG001|Washout Period (1 Hour)|Pain|0|||
147180042|NCT00934128|530823685|FG000|Washout Period (1 Hour)|Too tired|1|||
147180043|NCT00934128|530823686|FG001|Washout Period (1 Hour)|Too tired|0|||
147180044|NCT00934128|530823685|FG000|Washout Period (1 Hour)|Dyspnea too low to continue|4|||
147593336|NCT01421342|532328969|FG002|Completed to Week 12 But Then Withdrawn|Lack of Efficacy|88|||
147180045|NCT00934128|530823686|FG001|Washout Period (1 Hour)|Dyspnea too low to continue|2|||
147180046|NCT00934128|530823685|FG000|Second Intervention (2 Hours)|Claustrophobia/anxiety|0|||
147180047|NCT00934128|530823686|FG001|Second Intervention (2 Hours)|Claustrophobia/anxiety|3|||
147180048|NCT03228212|530823687|FG000|Period 1|Adverse Event|1|||
147180049|NCT03228212|530823688|FG001|Period 1|Adverse Event|0|||
147180050|NCT03228212|530823687|FG000|Period 1|no longer meets eligibility criteria|0|||
147180051|NCT03228212|530823688|FG001|Period 1|no longer meets eligibility criteria|1|||
147180052|NCT03228212|530823687|FG000|Period 2|Lost to Follow-up|1|||
147180053|NCT03228212|530823688|FG001|Period 2|Lost to Follow-up|0|||
147180054|NCT02834247|530823689|FG000|Dose Escalation Phase|Study Terminated by Sponsor|1|||
147180055|NCT02834247|530823690|FG001|Dose Escalation Phase|Study Terminated by Sponsor|2|||
147180056|NCT02834247|530823691|FG002|Dose Escalation Phase|Study Terminated by Sponsor|0|||
147180057|NCT02834247|530823692|FG003|Dose Escalation Phase|Study Terminated by Sponsor|0|||
147180058|NCT02834247|530823689|FG000|Dose Escalation Phase|Death|5|||
147180059|NCT02834247|530823690|FG001|Dose Escalation Phase|Death|6|||
147180060|NCT02834247|530823691|FG002|Dose Escalation Phase|Death|5|||
147180061|NCT02834247|530823692|FG003|Dose Escalation Phase|Death|0|||
147180062|NCT02834247|530823689|FG000|Dose Escalation Phase|Lost to Follow-up|0|||
147180063|NCT02834247|530823690|FG001|Dose Escalation Phase|Lost to Follow-up|1|||
147180064|NCT02834247|530823691|FG002|Dose Escalation Phase|Lost to Follow-up|0|||
147180065|NCT02834247|530823692|FG003|Dose Escalation Phase|Lost to Follow-up|0|||
147180066|NCT02834247|530823689|FG000|Dose Escalation Phase|Withdrawal by Subject|2|||
147180067|NCT02834247|530823690|FG001|Dose Escalation Phase|Withdrawal by Subject|2|||
147180068|NCT02834247|530823691|FG002|Dose Escalation Phase|Withdrawal by Subject|0|||
147180069|NCT02834247|530823692|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
147180070|NCT02834247|530823689|FG000|Dose Expansion Phase|Study Terminated by Sponsor|0|||
147180071|NCT02834247|530823690|FG001|Dose Expansion Phase|Study Terminated by Sponsor|0|||
147180072|NCT02834247|530823691|FG002|Dose Expansion Phase|Study Terminated by Sponsor|0|||
147180073|NCT02834247|530823692|FG003|Dose Expansion Phase|Study Terminated by Sponsor|7|||
147180074|NCT02834247|530823689|FG000|Dose Expansion Phase|Death|0|||
147180075|NCT02834247|530823690|FG001|Dose Expansion Phase|Death|0|||
147180076|NCT02834247|530823691|FG002|Dose Expansion Phase|Death|0|||
147180077|NCT02834247|530823692|FG003|Dose Expansion Phase|Death|8|||
147180078|NCT02834247|530823689|FG000|Dose Expansion Phase|Lost to Follow-up|0|||
147180079|NCT02834247|530823690|FG001|Dose Expansion Phase|Lost to Follow-up|0|||
147180080|NCT02834247|530823691|FG002|Dose Expansion Phase|Lost to Follow-up|0|||
147180081|NCT02834247|530823692|FG003|Dose Expansion Phase|Lost to Follow-up|1|||
147180082|NCT02834247|530823689|FG000|Dose Expansion Phase|Withdrawal by Subject|0|||
147180083|NCT02834247|530823690|FG001|Dose Expansion Phase|Withdrawal by Subject|0|||
147180084|NCT02834247|530823691|FG002|Dose Expansion Phase|Withdrawal by Subject|0|||
147180085|NCT02834247|530823692|FG003|Dose Expansion Phase|Withdrawal by Subject|1|||
147180086|NCT01807299|530823693|FG000|Overall Study|Protocol Violation|3|||
147180087|NCT01807299|530823694|FG001|Overall Study|Protocol Violation|1|||
147180088|NCT01807299|530823695|FG002|Overall Study|Protocol Violation|0|||
147180089|NCT01807299|530823696|FG003|Overall Study|Protocol Violation|2|||
147180090|NCT04829916|530825165|FG000|Overall Study|Withdrawal by Subject|1|||
147180091|NCT04829916|530825166|FG001|Overall Study|Withdrawal by Subject|0|||
147180092|NCT02287467|530825168|FG000|Overall Study|Protocol Violation|12|||
147180093|NCT02287467|530825169|FG001|Overall Study|Protocol Violation|9|||
147180094|NCT03781778|530825170|FG000|Overall Study|Withdrawal by Subject|2|||
147180095|NCT03781778|530825171|FG001|Overall Study|Withdrawal by Subject|2|||
147180096|NCT04343755|530825179|FG000|Overall Study|Death|11|||
147180097|NCT04343755|530825179|FG000|Overall Study|Screen Failure|1|||
147180098|NCT03755882|530825180|FG000|Period 1|Protocol Violation|1|||
147245664|NCT02207244|531070825|FG005|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
147180099|NCT03755882|530825181|FG001|Period 1|Protocol Violation|0|||
147180100|NCT03755882|530825180|FG000|Period 1|Unsatisfactory Lens Fitting Test Article|3|||
147180101|NCT03755882|530825181|FG001|Period 1|Unsatisfactory Lens Fitting Test Article|0|||
147180102|NCT02292446|530825182|FG000|Overall Study|Adverse Event|12|||
147180103|NCT02292446|530825182|FG000|Overall Study|Death|1|||
147180104|NCT02292446|530825182|FG000|Overall Study|Disease progression|2|||
147180105|NCT02292446|530825182|FG000|Overall Study|Subject/guardian decision|2|||
147180106|NCT02292446|530825182|FG000|Overall Study|Withdrawal by Subject|3|||
147593337|NCT01421342|532328967|FG000|Completed to Week 12 But Then Withdrawn|QIDS Score >=11|7|||
147593338|NCT01421342|532328968|FG001|Completed to Week 12 But Then Withdrawn|QIDS Score >=11|10|||
147593339|NCT01421342|532328969|FG002|Completed to Week 12 But Then Withdrawn|QIDS Score >=11|12|||
147593340|NCT01421342|532328967|FG000|Completed to Week 12 But Then Withdrawn|Adverse Event|4|||
147593341|NCT01421342|532328968|FG001|Completed to Week 12 But Then Withdrawn|Adverse Event|3|||
147593342|NCT01421342|532328969|FG002|Completed to Week 12 But Then Withdrawn|Adverse Event|6|||
147593343|NCT01421342|532328967|FG000|Completed to Week 12 But Then Withdrawn|Withdrawal by Subject|13|||
147593344|NCT01421342|532328968|FG001|Completed to Week 12 But Then Withdrawn|Withdrawal by Subject|4|||
147593345|NCT01421342|532328969|FG002|Completed to Week 12 But Then Withdrawn|Withdrawal by Subject|11|||
147593346|NCT01421342|532328967|FG000|Completed to Week 12 But Then Withdrawn|Lost to Follow-up|4|||
147180107|NCT01290757|530825187|FG000|Overall Study|Adverse Event|1|||
147180108|NCT01290757|530825188|FG001|Overall Study|Adverse Event|0|||
147180109|NCT01290757|530825187|FG000|Overall Study|Protocol Violation|1|||
147180110|NCT01290757|530825188|FG001|Overall Study|Protocol Violation|1|||
147180111|NCT01290757|530825187|FG000|Overall Study|Other|0|||
147180112|NCT01290757|530825188|FG001|Overall Study|Other|1|||
147180113|NCT00570310|530825189|FG000|Overall Study|Adverse Event|1|||
147180114|NCT00570310|530825190|FG001|Overall Study|Adverse Event|2|||
147180115|NCT00570310|530825189|FG000|Overall Study|Lack of Efficacy|1|||
147180116|NCT00570310|530825190|FG001|Overall Study|Lack of Efficacy|4|||
147180117|NCT03329846|530825193|FG000|Overall Study|Disease progression|4|||
147180118|NCT03329846|530825194|FG001|Overall Study|Disease progression|6|||
147180119|NCT03329846|530825193|FG000|Overall Study|Study drug toxicity|1|||
147180120|NCT03329846|530825194|FG001|Overall Study|Study drug toxicity|0|||
147180121|NCT03329846|530825193|FG000|Overall Study|Participant request to discontinue treatment|0|||
147180122|NCT03329846|530825194|FG001|Overall Study|Participant request to discontinue treatment|1|||
147180123|NCT03329846|530825193|FG000|Overall Study|Participant withdrew consent|1|||
147180124|NCT03329846|530825194|FG001|Overall Study|Participant withdrew consent|0|||
147180125|NCT03329846|530825193|FG000|Overall Study|Other reasons|2|||
147180126|NCT03329846|530825194|FG001|Overall Study|Other reasons|2|||
147180127|NCT00108862|530825195|FG000|Overall Study|Death|31|||
147180128|NCT00108862|530825196|FG001|Overall Study|Death|37|||
147180129|NCT00108862|530825195|FG000|Overall Study|Withdrawal by Subject|10|||
147180130|NCT00108862|530825196|FG001|Overall Study|Withdrawal by Subject|6|||
147180131|NCT00108862|530825195|FG000|Overall Study|Lost to Follow-up|27|||
147180132|NCT00108862|530825196|FG001|Overall Study|Lost to Follow-up|19|||
147180133|NCT02021643|530825197|FG000|Overall Study|Enrolled but Never Treated|1|||
147180134|NCT02021643|530825198|FG001|Overall Study|Enrolled but Never Treated|0|||
147180135|NCT02021643|530825199|FG002|Overall Study|Enrolled but Never Treated|0|||
147180136|NCT02021643|530825200|FG003|Overall Study|Enrolled but Never Treated|0|||
147180137|NCT02021643|530825197|FG000|Overall Study|Adverse Event|0|||
147180138|NCT02021643|530825198|FG001|Overall Study|Adverse Event|1|||
147180139|NCT02021643|530825199|FG002|Overall Study|Adverse Event|0|||
147180140|NCT02021643|530825200|FG003|Overall Study|Adverse Event|0|||
147180141|NCT02021643|530825197|FG000|Overall Study|Death|0|||
147180142|NCT02021643|530825198|FG001|Overall Study|Death|1|||
147180143|NCT02021643|530825199|FG002|Overall Study|Death|0|||
147180144|NCT02021643|530825200|FG003|Overall Study|Death|0|||
147180145|NCT02021643|530825197|FG000|Overall Study|Investigator's Discretion|1|||
147180146|NCT02021643|530825198|FG001|Overall Study|Investigator's Discretion|0|||
147180147|NCT02021643|530825199|FG002|Overall Study|Investigator's Discretion|0|||
147180148|NCT02021643|530825200|FG003|Overall Study|Investigator's Discretion|0|||
147180149|NCT02021643|530825197|FG000|Overall Study|Lack of Efficacy|7|||
147180150|NCT02021643|530825198|FG001|Overall Study|Lack of Efficacy|6|||
147180151|NCT02021643|530825199|FG002|Overall Study|Lack of Efficacy|0|||
147180152|NCT02021643|530825200|FG003|Overall Study|Lack of Efficacy|12|||
147180153|NCT02021643|530825197|FG000|Overall Study|Lost to Follow-up|0|||
147180154|NCT02021643|530825198|FG001|Overall Study|Lost to Follow-up|1|||
147180155|NCT02021643|530825199|FG002|Overall Study|Lost to Follow-up|0|||
147180156|NCT02021643|530825200|FG003|Overall Study|Lost to Follow-up|0|||
147180157|NCT02021643|530825197|FG000|Overall Study|Withdrew Consent|0|||
147180158|NCT02021643|530825198|FG001|Overall Study|Withdrew Consent|1|||
147180159|NCT02021643|530825199|FG002|Overall Study|Withdrew Consent|0|||
147180160|NCT02021643|530825200|FG003|Overall Study|Withdrew Consent|0|||
147180161|NCT01345188|530825203|FG000|Randomization Ranolazine/Placebo 6 Weeks|Withdrawal by Subject|2|||
147180162|NCT01345188|530825203|FG000|Crossover Ranolazine/Placebo 6 Weeks|Lost to Follow-up|1|||
147593347|NCT01421342|532328968|FG001|Completed to Week 12 But Then Withdrawn|Lost to Follow-up|3|||
147593348|NCT01421342|532328969|FG002|Completed to Week 12 But Then Withdrawn|Lost to Follow-up|3|||
147180163|NCT06041919|530825206|FG000|Overall Study|Lost to Follow-up|1|||
147180164|NCT06041919|530825207|FG001|Overall Study|Lost to Follow-up|0|||
147180165|NCT06041919|530825208|FG002|Overall Study|Lost to Follow-up|0|||
147180166|NCT06041919|530825209|FG003|Overall Study|Lost to Follow-up|0|||
147180167|NCT06041919|530825210|FG004|Overall Study|Lost to Follow-up|0|||
147180168|NCT06041919|530825206|FG000|Overall Study|At the request of the investigator or the sponsor|0|||
147180169|NCT06041919|530825207|FG001|Overall Study|At the request of the investigator or the sponsor|1|||
147448435|NCT00081159|531805724|FG000|Overall Study|Myelosuppression prior to treatment|0|||
147448436|NCT00081159|531805725|FG001|Overall Study|Myelosuppression prior to treatment|1|||
147448437|NCT00081159|531805724|FG000|Overall Study|Lost to Follow-up|2|||
147593349|NCT01421342|532328967|FG000|Completed to Week 12 But Then Withdrawn|Non-adherence|5|||
147593350|NCT01421342|532328968|FG001|Completed to Week 12 But Then Withdrawn|Non-adherence|4|||
147593351|NCT01421342|532328969|FG002|Completed to Week 12 But Then Withdrawn|Non-adherence|5|||
147593352|NCT01421342|532328967|FG000|Completed to Week 12 But Then Withdrawn|Due to Other Illness|1|||
147593353|NCT01421342|532328968|FG001|Completed to Week 12 But Then Withdrawn|Due to Other Illness|0|||
147593354|NCT01421342|532328969|FG002|Completed to Week 12 But Then Withdrawn|Due to Other Illness|2|||
147593355|NCT01421342|532328967|FG000|Completed to Week 12 But Then Withdrawn|Participant Moved Away|1|||
147593356|NCT01421342|532328968|FG001|Completed to Week 12 But Then Withdrawn|Participant Moved Away|5|||
147593357|NCT01421342|532328969|FG002|Completed to Week 12 But Then Withdrawn|Participant Moved Away|5|||
147593358|NCT01421342|532328967|FG000|Completed to Week 12 But Then Withdrawn|Oher reason for withdrawal|3|||
147593359|NCT01421342|532328968|FG001|Completed to Week 12 But Then Withdrawn|Oher reason for withdrawal|3|||
147593360|NCT01421342|532328969|FG002|Completed to Week 12 But Then Withdrawn|Oher reason for withdrawal|4|||
147180170|NCT06041919|530825208|FG002|Overall Study|At the request of the investigator or the sponsor|0|||
147180171|NCT06041919|530825209|FG003|Overall Study|At the request of the investigator or the sponsor|0|||
147180172|NCT06041919|530825210|FG004|Overall Study|At the request of the investigator or the sponsor|0|||
147180173|NCT04526145|530825211|FG000|Overall Study|Withdrawal by Subject|5|||
147180174|NCT01625000|530825215|FG000|Overall Study|Physician Decision|15|||
147180175|NCT01625000|530825216|FG001|Overall Study|Physician Decision|7|||
147180176|NCT01625000|530825217|FG002|Overall Study|Physician Decision|7|||
147180177|NCT01625000|530825218|FG003|Overall Study|Physician Decision|2|||
147180178|NCT01625000|530825219|FG004|Overall Study|Physician Decision|15|||
147180179|NCT01625000|530825215|FG000|Overall Study|Protocol Violation|3|||
147180180|NCT01625000|530825216|FG001|Overall Study|Protocol Violation|10|||
147180181|NCT01625000|530825217|FG002|Overall Study|Protocol Violation|4|||
147180182|NCT01625000|530825218|FG003|Overall Study|Protocol Violation|1|||
147180183|NCT01625000|530825219|FG004|Overall Study|Protocol Violation|2|||
147180184|NCT01625000|530825215|FG000|Overall Study|Withdrawal by Subject|19|||
147180185|NCT01625000|530825216|FG001|Overall Study|Withdrawal by Subject|16|||
147180186|NCT01625000|530825217|FG002|Overall Study|Withdrawal by Subject|11|||
147180187|NCT01625000|530825218|FG003|Overall Study|Withdrawal by Subject|9|||
147180188|NCT01625000|530825219|FG004|Overall Study|Withdrawal by Subject|17|||
147180189|NCT01625000|530825215|FG000|Overall Study|Adverse Event (including Death)|15|||
147180190|NCT01625000|530825216|FG001|Overall Study|Adverse Event (including Death)|19|||
147180191|NCT01625000|530825217|FG002|Overall Study|Adverse Event (including Death)|11|||
147180192|NCT01625000|530825218|FG003|Overall Study|Adverse Event (including Death)|7|||
147180193|NCT01625000|530825219|FG004|Overall Study|Adverse Event (including Death)|21|||
147180194|NCT00566852|530825220|FG000|Overall Study|Protocol Violation|22|||
147180195|NCT00566852|530825221|FG001|Overall Study|Protocol Violation|24|||
147180196|NCT00566852|530825220|FG000|Overall Study|Death|95|||
147180197|NCT00566852|530825221|FG001|Overall Study|Death|78|||
147180198|NCT00566852|530825220|FG000|Overall Study|Withdrawal by Subject|30|||
147180199|NCT00566852|530825221|FG001|Overall Study|Withdrawal by Subject|25|||
147180200|NCT00566852|530825220|FG000|Overall Study|Patient refusal|37|||
147180201|NCT00566852|530825221|FG001|Overall Study|Patient refusal|37|||
147180202|NCT00566852|530825220|FG000|Overall Study|Not tested due to disability|6|||
147180203|NCT00566852|530825221|FG001|Overall Study|Not tested due to disability|12|||
147180204|NCT00566852|530825220|FG000|Overall Study|Missing reason not specified|1|||
147180205|NCT00566852|530825221|FG001|Overall Study|Missing reason not specified|2|||
147180206|NCT00566852|530825220|FG000|Overall Study|Missing reason not reported|16|||
147180207|NCT00566852|530825221|FG001|Overall Study|Missing reason not reported|20|||
147180208|NCT01147055|530825222|FG000|First Intervention Period|Lost to Follow-up|1|||
147180209|NCT01147055|530825223|FG001|First Intervention Period|Lost to Follow-up|0|||
147180210|NCT00577824|530825224|FG000|Overall Study|Adverse Event|6|||
147180211|NCT00577824|530825225|FG001|Overall Study|Adverse Event|18|||
147180212|NCT00577824|530825226|FG002|Overall Study|Adverse Event|1|||
147180213|NCT00577824|530825224|FG000|Overall Study|Patient decision|0|||
147180214|NCT00577824|530825225|FG001|Overall Study|Patient decision|1|||
147180215|NCT00577824|530825226|FG002|Overall Study|Patient decision|1|||
147180216|NCT00577824|530825224|FG000|Overall Study|Protocol Violation|1|||
147180217|NCT00577824|530825225|FG001|Overall Study|Protocol Violation|1|||
147180218|NCT00577824|530825226|FG002|Overall Study|Protocol Violation|0|||
147180219|NCT01518374|530825227|FG000|Overall Study|Withdrawal by Subject|2|||
147180220|NCT01518374|530825227|FG000|Overall Study|Protocol Violation|3|||
147180221|NCT01518374|530825227|FG000|Overall Study|Lost to Follow-up|2|||
147448438|NCT00081159|531805725|FG001|Overall Study|Lost to Follow-up|1|||
147448439|NCT03693625|531805726|FG000|Overall Study|Adverse Event|2|||
147180222|NCT04607837|530825233|FG000|Overall Study|Adverse Event|8|||
147180223|NCT04607837|530825234|FG001|Overall Study|Adverse Event|2|||
147180224|NCT04607837|530825233|FG000|Overall Study|Withdrawal by Subject|8|||
147180225|NCT04607837|530825234|FG001|Overall Study|Withdrawal by Subject|7|||
147180226|NCT04607837|530825233|FG000|Overall Study|Physician Decision|2|||
147180227|NCT04607837|530825234|FG001|Overall Study|Physician Decision|0|||
147180228|NCT04607837|530825233|FG000|Overall Study|Lack of Efficacy|2|||
147180229|NCT04607837|530825234|FG001|Overall Study|Lack of Efficacy|0|||
147180230|NCT04607837|530825233|FG000|Overall Study|Participant terminated by sponsor|1|||
147180231|NCT04607837|530825234|FG001|Overall Study|Participant terminated by sponsor|0|||
147180232|NCT04607837|530825233|FG000|Overall Study|Disease worsening|36|||
147180233|NCT04607837|530825234|FG001|Overall Study|Disease worsening|36|||
147180234|NCT04607837|530825233|FG000|Overall Study|Other|1|||
147180235|NCT04607837|530825234|FG001|Overall Study|Other|0|||
147180236|NCT02362464|530825235|FG000|Overall Study|Switched to alternative therapy|1|||
147180237|NCT02362464|530825235|FG000|Overall Study|Refused further treatment|1|||
147180238|NCT02362464|530825235|FG000|Overall Study|Physician Decision|4|||
147180239|NCT04209205|530825240|FG000|Overall Study|Adverse Event|2|||
147180240|NCT04209205|530825241|FG001|Overall Study|Adverse Event|3|||
147180241|NCT04209205|530825240|FG000|Overall Study|Lost to Follow-up|3|||
147180242|NCT04209205|530825241|FG001|Overall Study|Lost to Follow-up|1|||
147180243|NCT04209205|530825240|FG000|Overall Study|Physician Decision|1|||
147180244|NCT04209205|530825241|FG001|Overall Study|Physician Decision|1|||
147180245|NCT04209205|530825240|FG000|Overall Study|Subject decision|10|||
147180246|NCT04209205|530825241|FG001|Overall Study|Subject decision|10|||
147180247|NCT04209205|530825240|FG000|Overall Study|Progressive disease|1|||
147180248|NCT04209205|530825241|FG001|Overall Study|Progressive disease|0|||
147180249|NCT04209205|530825240|FG000|Overall Study|Protocol deviation|0|||
147180250|NCT04209205|530825241|FG001|Overall Study|Protocol deviation|1|||
147180251|NCT04209205|530825240|FG000|Overall Study|New therapy for study indication|1|||
147180252|NCT04209205|530825241|FG001|Overall Study|New therapy for study indication|0|||
147180253|NCT04209205|530825240|FG000|Overall Study|Adverse event - placebo not switched|0|||
147180254|NCT04209205|530825241|FG001|Overall Study|Adverse event - placebo not switched|1|||
147180255|NCT04209205|530825240|FG000|Overall Study|Subject decision - placebo not switched|0|||
147180256|NCT04209205|530825241|FG001|Overall Study|Subject decision - placebo not switched|5|||
147180257|NCT04209205|530825240|FG000|Overall Study|Death - placebo not switched|0|||
147180258|NCT04209205|530825241|FG001|Overall Study|Death - placebo not switched|1|||
147180259|NCT05870865|530825242|FG000|Randomized|Did not receive study treatment|2|||
147180260|NCT05870865|530825243|FG001|Randomized|Did not receive study treatment|4|||
147245665|NCT02207244|531070826|FG006|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
147593361|NCT01421342|532328967|FG000|Completed to Week 12 But Then Withdrawn|End of Study Time|0|||
147593362|NCT01421342|532328968|FG001|Completed to Week 12 But Then Withdrawn|End of Study Time|0|||
147593363|NCT01421342|532328969|FG002|Completed to Week 12 But Then Withdrawn|End of Study Time|2|||
147593364|NCT01421342|532328967|FG000|Continuation of Treatment (Week 12 - 36)|Lack of Efficacy|11|||
147593365|NCT01421342|532328968|FG001|Continuation of Treatment (Week 12 - 36)|Lack of Efficacy|5|||
147245666|NCT02207244|531070827|FG007|Withdrawal and Re-treatment: Week 28-72|Pregnancy|2|||
147245667|NCT02207244|531070828|FG008|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
147245668|NCT02207244|531070829|FG009|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
147245669|NCT02207244|531070830|FG010|Withdrawal and Re-treatment: Week 28-72|Pregnancy|0|||
147245670|NCT02207244|531070820|FG000|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
147245671|NCT02207244|531070821|FG001|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
147245672|NCT02207244|531070822|FG002|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
147245673|NCT02207244|531070823|FG003|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
147245674|NCT02207244|531070824|FG004|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
147245675|NCT02207244|531070825|FG005|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
147245676|NCT02207244|531070826|FG006|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|1|||
147245677|NCT02207244|531070827|FG007|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|3|||
147245678|NCT02207244|531070828|FG008|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|2|||
147245679|NCT02207244|531070829|FG009|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|2|||
147245680|NCT02207244|531070830|FG010|Withdrawal and Re-treatment: Week 28-72|Lack of Efficacy|0|||
147245681|NCT02207244|531070820|FG000|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
147245682|NCT02207244|531070821|FG001|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
147245683|NCT02207244|531070822|FG002|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
147245684|NCT02207244|531070823|FG003|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
147245685|NCT02207244|531070824|FG004|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
147245686|NCT02207244|531070825|FG005|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
147245687|NCT02207244|531070826|FG006|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|2|||
147245688|NCT02207244|531070827|FG007|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|7|||
147593366|NCT01421342|532328969|FG002|Continuation of Treatment (Week 12 - 36)|Lack of Efficacy|11|||
147593367|NCT01421342|532328967|FG000|Continuation of Treatment (Week 12 - 36)|Adverse Event|0|||
147656227|NCT02959918|532564963|FG012|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
147180261|NCT05870865|530825244|FG002|Randomized|Did not receive study treatment|4|||
147180262|NCT05870865|530825245|FG003|Randomized|Did not receive study treatment|3|||
147180263|NCT05870865|530825242|FG000|Treatment Period|Adverse Event|1|||
147180264|NCT05870865|530825243|FG001|Treatment Period|Adverse Event|1|||
147180265|NCT05870865|530825244|FG002|Treatment Period|Adverse Event|1|||
147180266|NCT05870865|530825245|FG003|Treatment Period|Adverse Event|1|||
147180267|NCT05870865|530825242|FG000|Treatment Period|Lost to Follow-up|0|||
147180268|NCT05870865|530825243|FG001|Treatment Period|Lost to Follow-up|1|||
147180269|NCT05870865|530825244|FG002|Treatment Period|Lost to Follow-up|2|||
147180270|NCT05870865|530825245|FG003|Treatment Period|Lost to Follow-up|0|||
147180271|NCT05870865|530825242|FG000|Treatment Period|Protocol Violation|0|||
147180272|NCT05870865|530825243|FG001|Treatment Period|Protocol Violation|0|||
147180273|NCT05870865|530825244|FG002|Treatment Period|Protocol Violation|0|||
147180274|NCT05870865|530825245|FG003|Treatment Period|Protocol Violation|1|||
147180275|NCT05870865|530825242|FG000|Treatment Period|Withdrawal by Subject|0|||
147180276|NCT05870865|530825243|FG001|Treatment Period|Withdrawal by Subject|1|||
147180277|NCT05870865|530825244|FG002|Treatment Period|Withdrawal by Subject|1|||
147180278|NCT05870865|530825245|FG003|Treatment Period|Withdrawal by Subject|1|||
147180279|NCT03828019|530825250|FG000|Overall Study|Withdrawal by Subject|3|||
147180280|NCT03828019|530825251|FG001|Overall Study|Withdrawal by Subject|8|||
147180281|NCT03828019|530825250|FG000|Overall Study|Lost to Follow-up|1|||
147180282|NCT03828019|530825251|FG001|Overall Study|Lost to Follow-up|6|||
147180283|NCT03828019|530825250|FG000|Overall Study|Incarcerated|1|||
147180284|NCT03828019|530825251|FG001|Overall Study|Incarcerated|0|||
147180285|NCT03828019|530825250|FG000|Overall Study|Adverse Event|0|||
147180286|NCT03828019|530825251|FG001|Overall Study|Adverse Event|1|||
147180287|NCT05715242|530825252|FG000|Overall Study|Lost to Follow-up|0|||
147180288|NCT05715242|530825253|FG001|Overall Study|Lost to Follow-up|0|||
147180289|NCT05715242|530825254|FG002|Overall Study|Lost to Follow-up|1|||
147180290|NCT05715242|530825255|FG003|Overall Study|Lost to Follow-up|0|||
147180291|NCT05715242|530825256|FG004|Overall Study|Lost to Follow-up|0|||
147180292|NCT05715242|530825257|FG005|Overall Study|Lost to Follow-up|1|||
147180293|NCT05715242|530825258|FG006|Overall Study|Lost to Follow-up|0|||
147180294|NCT05715242|530825259|FG007|Overall Study|Lost to Follow-up|0|||
147180295|NCT05715242|530825260|FG008|Overall Study|Lost to Follow-up|0|||
147180296|NCT05715242|530825261|FG009|Overall Study|Lost to Follow-up|0|||
147180297|NCT05715242|530825262|FG010|Overall Study|Lost to Follow-up|0|||
147180298|NCT05715242|530825263|FG011|Overall Study|Lost to Follow-up|0|||
147180299|NCT05715242|530825264|FG012|Overall Study|Lost to Follow-up|0|||
147180300|NCT05715242|530825265|FG013|Overall Study|Lost to Follow-up|0|||
147180301|NCT05715242|530825266|FG014|Overall Study|Lost to Follow-up|0|||
147180302|NCT05715242|530825267|FG015|Overall Study|Lost to Follow-up|0|||
147180303|NCT00048347|530825270|FG000|Overall Study|Screen failure|2|||
147180304|NCT00195663|530825271|FG000|2-year Double-blind Treatment Period|Adverse Event|21|||
147180305|NCT00195663|530825272|FG001|2-year Double-blind Treatment Period|Adverse Event|27|||
147180306|NCT00195663|530825273|FG002|2-year Double-blind Treatment Period|Adverse Event|32|||
147180307|NCT00195663|530825271|FG000|2-year Double-blind Treatment Period|Death|0|||
147180308|NCT00195663|530825272|FG001|2-year Double-blind Treatment Period|Death|2|||
147180309|NCT00195663|530825273|FG002|2-year Double-blind Treatment Period|Death|0|||
147180310|NCT00195663|530825271|FG000|2-year Double-blind Treatment Period|Lost to Follow-up|0|||
147180311|NCT00195663|530825272|FG001|2-year Double-blind Treatment Period|Lost to Follow-up|0|||
147180312|NCT00195663|530825273|FG002|2-year Double-blind Treatment Period|Lost to Follow-up|1|||
147180313|NCT00195663|530825271|FG000|2-year Double-blind Treatment Period|Withdrawal by Subject|15|||
147180314|NCT00195663|530825272|FG001|2-year Double-blind Treatment Period|Withdrawal by Subject|18|||
147180315|NCT00195663|530825273|FG002|2-year Double-blind Treatment Period|Withdrawal by Subject|12|||
147180316|NCT00195663|530825271|FG000|2-year Double-blind Treatment Period|Lack of Efficacy|47|||
147180317|NCT00195663|530825272|FG001|2-year Double-blind Treatment Period|Lack of Efficacy|52|||
147180318|NCT00195663|530825273|FG002|2-year Double-blind Treatment Period|Lack of Efficacy|13|||
147180319|NCT00195663|530825271|FG000|2-year Double-blind Treatment Period|Protocol Violation|6|||
147180320|NCT00195663|530825272|FG001|2-year Double-blind Treatment Period|Protocol Violation|6|||
147180321|NCT00195663|530825273|FG002|2-year Double-blind Treatment Period|Protocol Violation|4|||
147180322|NCT00195663|530825271|FG000|2-year Double-blind Treatment Period|Planned selection criteria|0|||
147180323|NCT00195663|530825272|FG001|2-year Double-blind Treatment Period|Planned selection criteria|1|||
147180324|NCT00195663|530825273|FG002|2-year Double-blind Treatment Period|Planned selection criteria|0|||
147180325|NCT00195663|530825271|FG000|2-year Double-blind Treatment Period|Recovery|1|||
147180326|NCT00195663|530825272|FG001|2-year Double-blind Treatment Period|Recovery|0|||
147180327|NCT00195663|530825273|FG002|2-year Double-blind Treatment Period|Recovery|1|||
147180328|NCT00195663|530825271|FG000|2-year Double-blind Treatment Period|Administrative reasons|3|||
147180329|NCT00195663|530825272|FG001|2-year Double-blind Treatment Period|Administrative reasons|2|||
147180330|NCT00195663|530825273|FG002|2-year Double-blind Treatment Period|Administrative reasons|9|||
147180331|NCT00195663|530825271|FG000|Open-Label Extension Period|Adverse Event|21|||
147245689|NCT02207244|531070828|FG008|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
147245690|NCT02207244|531070829|FG009|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|2|||
147245691|NCT02207244|531070830|FG010|Withdrawal and Re-treatment: Week 28-72|Lost to Follow-up|0|||
147656228|NCT02959918|532564964|FG013|Overall Study|Sponsor Decision, Pause in Clinical Trial|0|||
147180332|NCT00195663|530825272|FG001|Open-Label Extension Period|Adverse Event|32|||
147326213|NCT02042443|531359662|FG001|Overall Study|Progression|17|||
147326214|NCT02042443|531359661|FG000|Overall Study|not protocol specified|1|||
147326215|NCT02042443|531359662|FG001|Overall Study|not protocol specified|1|||
147326216|NCT02042443|531359661|FG000|Overall Study|Not eligible/not analyzable|3|||
147180333|NCT00195663|530825273|FG002|Open-Label Extension Period|Adverse Event|36|||
147180334|NCT00195663|530825271|FG000|Open-Label Extension Period|Lost to Follow-up|9|||
147180335|NCT00195663|530825272|FG001|Open-Label Extension Period|Lost to Follow-up|2|||
147180336|NCT00195663|530825273|FG002|Open-Label Extension Period|Lost to Follow-up|6|||
147180337|NCT00195663|530825271|FG000|Open-Label Extension Period|Recovery|0|||
147180338|NCT00195663|530825272|FG001|Open-Label Extension Period|Recovery|2|||
147180339|NCT00195663|530825273|FG002|Open-Label Extension Period|Recovery|2|||
147180340|NCT00195663|530825271|FG000|Open-Label Extension Period|Protocol Violation|3|||
147180341|NCT00195663|530825272|FG001|Open-Label Extension Period|Protocol Violation|4|||
147180342|NCT00195663|530825273|FG002|Open-Label Extension Period|Protocol Violation|4|||
147180343|NCT00195663|530825271|FG000|Open-Label Extension Period|Death|2|||
147180344|NCT00195663|530825272|FG001|Open-Label Extension Period|Death|2|||
147180345|NCT00195663|530825273|FG002|Open-Label Extension Period|Death|2|||
147180346|NCT00195663|530825271|FG000|Open-Label Extension Period|Withdrawal by Subject|16|||
147180347|NCT00195663|530825272|FG001|Open-Label Extension Period|Withdrawal by Subject|15|||
147180348|NCT00195663|530825273|FG002|Open-Label Extension Period|Withdrawal by Subject|22|||
147180349|NCT00195663|530825271|FG000|Open-Label Extension Period|Lack of Efficacy|14|||
147180350|NCT00195663|530825272|FG001|Open-Label Extension Period|Lack of Efficacy|6|||
147180351|NCT00195663|530825273|FG002|Open-Label Extension Period|Lack of Efficacy|12|||
147180352|NCT00195663|530825271|FG000|Open-Label Extension Period|Administrative reasons|11|||
147180353|NCT00195663|530825272|FG001|Open-Label Extension Period|Administrative reasons|11|||
147180354|NCT00195663|530825273|FG002|Open-Label Extension Period|Administrative reasons|13|||
147180355|NCT03182907|530825276|FG000|Overall Study|Death|3|||
147180356|NCT03182907|530825277|FG001|Overall Study|Death|0|||
147245692|NCT02207244|531070820|FG000|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
147245693|NCT02207244|531070821|FG001|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
147245694|NCT02207244|531070822|FG002|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
147245695|NCT02207244|531070823|FG003|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
147245696|NCT02207244|531070824|FG004|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
147245697|NCT02207244|531070825|FG005|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
147245698|NCT02207244|531070826|FG006|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|2|||
147245699|NCT02207244|531070827|FG007|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|7|||
147245700|NCT02207244|531070828|FG008|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|2|||
147245701|NCT02207244|531070829|FG009|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|2|||
147245702|NCT02207244|531070830|FG010|Withdrawal and Re-treatment: Week 28-72|Withdrawal by Subject|0|||
147245703|NCT02207244|531070820|FG000|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
147245704|NCT02207244|531070821|FG001|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
147245705|NCT02207244|531070822|FG002|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
147245706|NCT02207244|531070823|FG003|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
147245707|NCT02207244|531070824|FG004|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
147245708|NCT02207244|531070825|FG005|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
147245709|NCT02207244|531070826|FG006|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
147245710|NCT02207244|531070827|FG007|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|1|||
147245711|NCT02207244|531070828|FG008|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|1|||
147245712|NCT02207244|531070829|FG009|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
147245713|NCT02207244|531070830|FG010|Withdrawal and Re-treatment: Week 28-72|Protocol Violation|0|||
147245714|NCT02207244|531070820|FG000|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
147245715|NCT02207244|531070821|FG001|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
147245716|NCT02207244|531070822|FG002|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
147245717|NCT02207244|531070823|FG003|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
147245718|NCT02207244|531070824|FG004|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
147245719|NCT02207244|531070825|FG005|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
147245720|NCT02207244|531070826|FG006|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
147245721|NCT02207244|531070827|FG007|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
147245722|NCT02207244|531070828|FG008|Withdrawal and Re-treatment: Week 28-72|Noncompliance|1|||
147245723|NCT02207244|531070829|FG009|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
147245724|NCT02207244|531070830|FG010|Withdrawal and Re-treatment: Week 28-72|Noncompliance|0|||
147326217|NCT02042443|531359662|FG001|Overall Study|Not eligible/not analyzable|6|||
147326218|NCT01007149|531359665|FG000|Overall Study|Administrative problems|0|||
147659420|NCT01064414|532576181|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|4|||
147326219|NCT01007149|531359666|FG001|Overall Study|Administrative problems|1|||
147180357|NCT03182907|530825276|FG000|Overall Study|Protocol Violation|4|||
147180358|NCT03182907|530825277|FG001|Overall Study|Protocol Violation|0|||
147180359|NCT03182907|530825276|FG000|Overall Study|Lost to Follow-up|1|||
147326220|NCT02784704|531359667|FG000|Overall Study|Adverse Event|4|||
147326221|NCT02784704|531359668|FG001|Overall Study|Adverse Event|2|||
147326222|NCT02784704|531359667|FG000|Overall Study|Lost to Follow-up|6|||
147326223|NCT02784704|531359668|FG001|Overall Study|Lost to Follow-up|4|||
147326224|NCT02784704|531359667|FG000|Overall Study|Withdrawal by Subject|1|||
147326225|NCT02784704|531359668|FG001|Overall Study|Withdrawal by Subject|3|||
147326226|NCT02784704|531359667|FG000|Overall Study|Subject Non Compliance|2|||
147326227|NCT02784704|531359668|FG001|Overall Study|Subject Non Compliance|0|||
147326228|NCT01913340|531359669|FG000|Overall Study|Death|2|||
147326229|NCT01913340|531359670|FG001|Overall Study|Death|5|||
147326230|NCT01913340|531359669|FG000|Overall Study|Lost to Follow-up|1|||
147326231|NCT01913340|531359670|FG001|Overall Study|Lost to Follow-up|1|||
147326232|NCT03568162|531359672|FG000|Overall Study|Adverse Event|0|||
147326233|NCT03568162|531359673|FG001|Overall Study|Adverse Event|1|||
147326234|NCT03568162|531359674|FG002|Overall Study|Adverse Event|2|||
147326235|NCT03568162|531359675|FG003|Overall Study|Adverse Event|0|||
147326236|NCT03568162|531359676|FG004|Overall Study|Adverse Event|0|||
147326237|NCT03568162|531359677|FG005|Overall Study|Adverse Event|1|||
147326238|NCT03568162|531359672|FG000|Overall Study|Death|0|||
147326239|NCT03568162|531359673|FG001|Overall Study|Death|0|||
147326240|NCT03568162|531359674|FG002|Overall Study|Death|0|||
147326241|NCT03568162|531359675|FG003|Overall Study|Death|0|||
147326242|NCT03568162|531359676|FG004|Overall Study|Death|1|||
147326243|NCT03568162|531359677|FG005|Overall Study|Death|0|||
147326244|NCT03568162|531359672|FG000|Overall Study|Lost to Follow-up|3|||
147326245|NCT03568162|531359673|FG001|Overall Study|Lost to Follow-up|2|||
147326246|NCT03568162|531359674|FG002|Overall Study|Lost to Follow-up|4|||
147326247|NCT03568162|531359675|FG003|Overall Study|Lost to Follow-up|2|||
147326248|NCT03568162|531359676|FG004|Overall Study|Lost to Follow-up|3|||
147326249|NCT03568162|531359677|FG005|Overall Study|Lost to Follow-up|2|||
147326250|NCT03568162|531359672|FG000|Overall Study|Physician Decision|0|||
147326251|NCT03568162|531359673|FG001|Overall Study|Physician Decision|1|||
147326252|NCT03568162|531359674|FG002|Overall Study|Physician Decision|1|||
147326253|NCT03568162|531359675|FG003|Overall Study|Physician Decision|0|||
147326254|NCT03568162|531359676|FG004|Overall Study|Physician Decision|1|||
147326255|NCT03568162|531359677|FG005|Overall Study|Physician Decision|0|||
147326256|NCT03568162|531359672|FG000|Overall Study|Pregnancy|0|||
147326257|NCT03568162|531359673|FG001|Overall Study|Pregnancy|0|||
147326258|NCT03568162|531359674|FG002|Overall Study|Pregnancy|0|||
147326259|NCT03568162|531359675|FG003|Overall Study|Pregnancy|1|||
147326260|NCT03568162|531359676|FG004|Overall Study|Pregnancy|0|||
147326261|NCT03568162|531359677|FG005|Overall Study|Pregnancy|0|||
147656229|NCT02959918|532564951|FG000|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
147656230|NCT02959918|532564952|FG001|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
147180360|NCT03182907|530825277|FG001|Overall Study|Lost to Follow-up|0|||
147326262|NCT03568162|531359672|FG000|Overall Study|Protocol Violation|1|||
147326263|NCT03568162|531359673|FG001|Overall Study|Protocol Violation|0|||
147326264|NCT03568162|531359674|FG002|Overall Study|Protocol Violation|1|||
147656231|NCT02959918|532564953|FG002|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
147656232|NCT02959918|532564954|FG003|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
147180361|NCT03182907|530825276|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
147180362|NCT03182907|530825277|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
147180363|NCT00166439|530825279|FG000|Overall Study|Ineligible|5|||
147180364|NCT00106353|530825282|FG000|Part 1|Disease progression|3|||
147180365|NCT00106353|530825283|FG001|Part 1|Disease progression|4|||
147180366|NCT00106353|530825284|FG002|Part 1|Disease progression|1|||
147180367|NCT00106353|530825285|FG003|Part 1|Disease progression|3|||
147180368|NCT00106353|530825286|FG004|Part 1|Disease progression|0|||
147180369|NCT00106353|530825287|FG005|Part 1|Disease progression|0|||
147180370|NCT00106353|530825288|FG006|Part 1|Disease progression|0|||
147180371|NCT00106353|530825282|FG000|Part 1|Withdrawal by Subject|0|||
147326265|NCT03568162|531359675|FG003|Overall Study|Protocol Violation|1|||
147326266|NCT03568162|531359676|FG004|Overall Study|Protocol Violation|1|||
147326267|NCT03568162|531359677|FG005|Overall Study|Protocol Violation|1|||
147326268|NCT03568162|531359672|FG000|Overall Study|Withdrawal by Subject|15|||
147326269|NCT03568162|531359673|FG001|Overall Study|Withdrawal by Subject|15|||
147326270|NCT03568162|531359674|FG002|Overall Study|Withdrawal by Subject|26|||
147326271|NCT03568162|531359675|FG003|Overall Study|Withdrawal by Subject|22|||
147656233|NCT02959918|532564955|FG004|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
147180372|NCT00106353|530825283|FG001|Part 1|Withdrawal by Subject|0|||
147180373|NCT00106353|530825284|FG002|Part 1|Withdrawal by Subject|1|||
147180374|NCT00106353|530825285|FG003|Part 1|Withdrawal by Subject|2|||
147326272|NCT03568162|531359676|FG004|Overall Study|Withdrawal by Subject|6|||
147326273|NCT03568162|531359677|FG005|Overall Study|Withdrawal by Subject|9|||
147326274|NCT03568162|531359672|FG000|Overall Study|Others|3|||
147326275|NCT03568162|531359673|FG001|Overall Study|Others|4|||
147326276|NCT03568162|531359674|FG002|Overall Study|Others|1|||
147326277|NCT03568162|531359675|FG003|Overall Study|Others|4|||
147326278|NCT03568162|531359676|FG004|Overall Study|Others|2|||
147326279|NCT03568162|531359677|FG005|Overall Study|Others|1|||
147180375|NCT00106353|530825286|FG004|Part 1|Withdrawal by Subject|0|||
147180376|NCT00106353|530825287|FG005|Part 1|Withdrawal by Subject|0|||
147180377|NCT00106353|530825288|FG006|Part 1|Withdrawal by Subject|0|||
147180378|NCT00106353|530825282|FG000|Part 1|Symptomatic deterioration|0|||
147180379|NCT00106353|530825283|FG001|Part 1|Symptomatic deterioration|0|||
147180380|NCT00106353|530825284|FG002|Part 1|Symptomatic deterioration|1|||
147180381|NCT00106353|530825285|FG003|Part 1|Symptomatic deterioration|0|||
147180382|NCT00106353|530825286|FG004|Part 1|Symptomatic deterioration|0|||
147180383|NCT00106353|530825287|FG005|Part 1|Symptomatic deterioration|0|||
147180384|NCT00106353|530825288|FG006|Part 1|Symptomatic deterioration|0|||
147180385|NCT00106353|530825282|FG000|Part 1|Entered follow-up phase|1|||
147180386|NCT00106353|530825283|FG001|Part 1|Entered follow-up phase|1|||
147180387|NCT00106353|530825284|FG002|Part 1|Entered follow-up phase|0|||
147180388|NCT00106353|530825285|FG003|Part 1|Entered follow-up phase|1|||
147180389|NCT00106353|530825286|FG004|Part 1|Entered follow-up phase|0|||
147180390|NCT00106353|530825287|FG005|Part 1|Entered follow-up phase|0|||
147180391|NCT00106353|530825288|FG006|Part 1|Entered follow-up phase|0|||
147180392|NCT00106353|530825282|FG000|Part 1|Adverse Event|0|||
147180393|NCT00106353|530825283|FG001|Part 1|Adverse Event|0|||
147180394|NCT00106353|530825284|FG002|Part 1|Adverse Event|0|||
147180395|NCT00106353|530825285|FG003|Part 1|Adverse Event|1|||
147180396|NCT00106353|530825286|FG004|Part 1|Adverse Event|0|||
147180397|NCT00106353|530825287|FG005|Part 1|Adverse Event|0|||
147180398|NCT00106353|530825288|FG006|Part 1|Adverse Event|0|||
147180399|NCT00106353|530825282|FG000|Part 2|Disease progression|0|||
147180400|NCT00106353|530825283|FG001|Part 2|Disease progression|0|||
147180401|NCT00106353|530825284|FG002|Part 2|Disease progression|0|||
147180402|NCT00106353|530825285|FG003|Part 2|Disease progression|0|||
147245725|NCT02207244|531070820|FG000|Withdrawal and Re-treatment: Week 28-72|Other|0|||
147245726|NCT02207244|531070821|FG001|Withdrawal and Re-treatment: Week 28-72|Other|0|||
147245727|NCT02207244|531070822|FG002|Withdrawal and Re-treatment: Week 28-72|Other|0|||
147245728|NCT02207244|531070823|FG003|Withdrawal and Re-treatment: Week 28-72|Other|0|||
147245729|NCT02207244|531070824|FG004|Withdrawal and Re-treatment: Week 28-72|Other|0|||
147245730|NCT02207244|531070825|FG005|Withdrawal and Re-treatment: Week 28-72|Other|0|||
147245731|NCT02207244|531070826|FG006|Withdrawal and Re-treatment: Week 28-72|Other|0|||
147245732|NCT02207244|531070827|FG007|Withdrawal and Re-treatment: Week 28-72|Other|2|||
147245733|NCT02207244|531070828|FG008|Withdrawal and Re-treatment: Week 28-72|Other|0|||
147245734|NCT02207244|531070829|FG009|Withdrawal and Re-treatment: Week 28-72|Other|0|||
147245735|NCT02207244|531070830|FG010|Withdrawal and Re-treatment: Week 28-72|Other|0|||
147245736|NCT02207244|531070820|FG000|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
147245737|NCT02207244|531070821|FG001|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
147245738|NCT02207244|531070822|FG002|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
147245739|NCT02207244|531070823|FG003|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
147245740|NCT02207244|531070824|FG004|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
147245741|NCT02207244|531070825|FG005|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
147245742|NCT02207244|531070826|FG006|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|8|||
147245743|NCT02207244|531070827|FG007|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
147245744|NCT02207244|531070828|FG008|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
147245745|NCT02207244|531070829|FG009|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
147245746|NCT02207244|531070830|FG010|Withdrawal and Re-treatment: Week 28-72|Participants not retreated with guselkumab|0|||
147245747|NCT02207244|531070820|FG000|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
147245748|NCT02207244|531070821|FG001|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
147245749|NCT02207244|531070822|FG002|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
147245750|NCT02207244|531070823|FG003|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
147245751|NCT02207244|531070824|FG004|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
147245752|NCT02207244|531070825|FG005|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
147245753|NCT02207244|531070826|FG006|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
147245754|NCT02207244|531070827|FG007|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
147245755|NCT02207244|531070828|FG008|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|10|||
147245756|NCT02207244|531070829|FG009|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|0|||
147245757|NCT02207244|531070830|FG010|Open-label Guselkumab: Week 72-264|Withdrawal by Subject|30|||
147448440|NCT03693625|531805727|FG001|Overall Study|Adverse Event|0|||
147180403|NCT00106353|530825286|FG004|Part 2|Disease progression|8|||
147180404|NCT00106353|530825287|FG005|Part 2|Disease progression|14|||
147180405|NCT00106353|530825288|FG006|Part 2|Disease progression|13|||
147180406|NCT00106353|530825282|FG000|Part 2|Death|0|||
147180407|NCT00106353|530825283|FG001|Part 2|Death|0|||
147180408|NCT00106353|530825284|FG002|Part 2|Death|0|||
147180409|NCT00106353|530825285|FG003|Part 2|Death|0|||
147180410|NCT00106353|530825286|FG004|Part 2|Death|3|||
147180411|NCT00106353|530825287|FG005|Part 2|Death|0|||
147180412|NCT00106353|530825288|FG006|Part 2|Death|1|||
147180413|NCT00106353|530825282|FG000|Part 2|Symptomatic deterioration|0|||
147180414|NCT00106353|530825283|FG001|Part 2|Symptomatic deterioration|0|||
147180415|NCT00106353|530825284|FG002|Part 2|Symptomatic deterioration|0|||
147180416|NCT00106353|530825285|FG003|Part 2|Symptomatic deterioration|0|||
147180417|NCT00106353|530825286|FG004|Part 2|Symptomatic deterioration|3|||
147180418|NCT00106353|530825287|FG005|Part 2|Symptomatic deterioration|0|||
147180419|NCT00106353|530825288|FG006|Part 2|Symptomatic deterioration|0|||
147180420|NCT00106353|530825282|FG000|Part 2|Adverse Event|0|||
147180421|NCT00106353|530825283|FG001|Part 2|Adverse Event|0|||
147180422|NCT00106353|530825284|FG002|Part 2|Adverse Event|0|||
147180423|NCT00106353|530825285|FG003|Part 2|Adverse Event|0|||
147180424|NCT00106353|530825286|FG004|Part 2|Adverse Event|0|||
147180425|NCT00106353|530825287|FG005|Part 2|Adverse Event|2|||
147180426|NCT00106353|530825288|FG006|Part 2|Adverse Event|1|||
147180427|NCT00106353|530825282|FG000|Part 2|Other|0|||
147180428|NCT00106353|530825283|FG001|Part 2|Other|0|||
147180429|NCT00106353|530825284|FG002|Part 2|Other|0|||
147180430|NCT00106353|530825285|FG003|Part 2|Other|0|||
147180431|NCT00106353|530825286|FG004|Part 2|Other|1|||
147180432|NCT00106353|530825287|FG005|Part 2|Other|1|||
147180433|NCT00106353|530825288|FG006|Part 2|Other|1|||
147180434|NCT00106353|530825282|FG000|Part 2|Withdrawal by Subject|0|||
147180435|NCT00106353|530825283|FG001|Part 2|Withdrawal by Subject|0|||
147180436|NCT00106353|530825284|FG002|Part 2|Withdrawal by Subject|0|||
147180437|NCT00106353|530825285|FG003|Part 2|Withdrawal by Subject|0|||
147180438|NCT00106353|530825286|FG004|Part 2|Withdrawal by Subject|1|||
147180439|NCT00106353|530825287|FG005|Part 2|Withdrawal by Subject|0|||
147245758|NCT02207244|531070820|FG000|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
147245759|NCT02207244|531070821|FG001|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
147245760|NCT02207244|531070822|FG002|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
147245761|NCT02207244|531070823|FG003|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
147245762|NCT02207244|531070824|FG004|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
147245763|NCT02207244|531070825|FG005|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
147245764|NCT02207244|531070826|FG006|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
147245765|NCT02207244|531070827|FG007|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
147245766|NCT02207244|531070828|FG008|Open-label Guselkumab: Week 72-264|Lack of Efficacy|2|||
147245767|NCT02207244|531070829|FG009|Open-label Guselkumab: Week 72-264|Lack of Efficacy|0|||
147245768|NCT02207244|531070830|FG010|Open-label Guselkumab: Week 72-264|Lack of Efficacy|3|||
147245769|NCT02207244|531070820|FG000|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
147245770|NCT02207244|531070821|FG001|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
147245771|NCT02207244|531070822|FG002|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
147245772|NCT02207244|531070823|FG003|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
147245773|NCT02207244|531070824|FG004|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
147245774|NCT02207244|531070825|FG005|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
147245775|NCT02207244|531070826|FG006|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
147245776|NCT02207244|531070827|FG007|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
147245777|NCT02207244|531070828|FG008|Open-label Guselkumab: Week 72-264|Lost to Follow-up|5|||
147245778|NCT02207244|531070829|FG009|Open-label Guselkumab: Week 72-264|Lost to Follow-up|0|||
147245779|NCT02207244|531070830|FG010|Open-label Guselkumab: Week 72-264|Lost to Follow-up|26|||
147245780|NCT02207244|531070820|FG000|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
147245781|NCT02207244|531070821|FG001|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
147245782|NCT02207244|531070822|FG002|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
147245783|NCT02207244|531070823|FG003|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
147245784|NCT02207244|531070824|FG004|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
147245785|NCT02207244|531070825|FG005|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
147245786|NCT02207244|531070826|FG006|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
147245787|NCT02207244|531070827|FG007|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
147245788|NCT02207244|531070828|FG008|Open-label Guselkumab: Week 72-264|Adverse Event|12|||
147245789|NCT02207244|531070829|FG009|Open-label Guselkumab: Week 72-264|Adverse Event|0|||
147245790|NCT02207244|531070830|FG010|Open-label Guselkumab: Week 72-264|Adverse Event|21|||
147245791|NCT02207244|531070820|FG000|Open-label Guselkumab: Week 72-264|Death|0|||
147245792|NCT02207244|531070821|FG001|Open-label Guselkumab: Week 72-264|Death|0|||
147245793|NCT02207244|531070822|FG002|Open-label Guselkumab: Week 72-264|Death|0|||
147245794|NCT02207244|531070823|FG003|Open-label Guselkumab: Week 72-264|Death|0|||
147245795|NCT02207244|531070824|FG004|Open-label Guselkumab: Week 72-264|Death|0|||
147326280|NCT00768066|531359678|FG000|Overall Study|Did not receive study product injection.|3|||
147180440|NCT00106353|530825288|FG006|Part 2|Withdrawal by Subject|0|||
147180441|NCT00106353|530825282|FG000|Part 2|Physician Decision|0|||
147180442|NCT00106353|530825283|FG001|Part 2|Physician Decision|0|||
147180443|NCT00106353|530825284|FG002|Part 2|Physician Decision|0|||
147180444|NCT00106353|530825285|FG003|Part 2|Physician Decision|0|||
147180445|NCT00106353|530825286|FG004|Part 2|Physician Decision|0|||
147180446|NCT00106353|530825287|FG005|Part 2|Physician Decision|1|||
147180447|NCT00106353|530825288|FG006|Part 2|Physician Decision|0|||
147180448|NCT03193736|530825289|FG000|Overall Study|Death|2|||
147180449|NCT03193736|530825289|FG000|Overall Study|Withdrawal by Subject|1|||
147326281|NCT00768066|531359679|FG001|Overall Study|Did not receive study product injection.|3|||
147326282|NCT00768066|531359680|FG002|Overall Study|Did not receive study product injection.|0|||
147180450|NCT03193736|530825289|FG000|Overall Study|Lost to Follow-up|1|||
147180451|NCT03193736|530825289|FG000|Overall Study|implant not received|1|||
147180452|NCT03369236|530825290|FG000|Double-blind Treatment Period|Accidental unblinding|0|||
147180453|NCT03369236|530825291|FG001|Double-blind Treatment Period|Accidental unblinding|1|||
147180454|NCT03369236|530825290|FG000|Open-label Extension Period|Lack of Efficacy|2|||
147180455|NCT03369236|530825291|FG001|Open-label Extension Period|Lack of Efficacy|1|||
147180456|NCT03369236|530825290|FG000|Open-label Extension Period|Adverse Event|0|||
147180457|NCT03369236|530825291|FG001|Open-label Extension Period|Adverse Event|1|||
147180458|NCT03369236|530825290|FG000|Open-label Extension Period|Sponsor decision to close study|3|||
147180459|NCT03369236|530825291|FG001|Open-label Extension Period|Sponsor decision to close study|4|||
147180460|NCT00423449|530825292|FG000|Overall Study|Clinical Adverse Event|1|||
147180461|NCT00423449|530825293|FG001|Overall Study|Clinical Adverse Event|0|||
147180462|NCT00423449|530825294|FG002|Overall Study|Clinical Adverse Event|1|||
147180463|NCT00423449|530825295|FG003|Overall Study|Clinical Adverse Event|8|||
147180464|NCT00423449|530825296|FG004|Overall Study|Clinical Adverse Event|2|||
147180465|NCT00423449|530825292|FG000|Overall Study|Death|1|||
147180466|NCT00423449|530825293|FG001|Overall Study|Death|0|||
147180467|NCT00423449|530825294|FG002|Overall Study|Death|2|||
147180468|NCT00423449|530825295|FG003|Overall Study|Death|1|||
147180469|NCT00423449|530825296|FG004|Overall Study|Death|1|||
147180470|NCT00423449|530825292|FG000|Overall Study|Progressive Disease|1|||
147180471|NCT00423449|530825293|FG001|Overall Study|Progressive Disease|3|||
147180472|NCT00423449|530825294|FG002|Overall Study|Progressive Disease|8|||
147180473|NCT00423449|530825295|FG003|Overall Study|Progressive Disease|11|||
147180474|NCT00423449|530825296|FG004|Overall Study|Progressive Disease|4|||
147180475|NCT00423449|530825292|FG000|Overall Study|Laboratory Adverse Event|0|||
147180476|NCT00423449|530825293|FG001|Overall Study|Laboratory Adverse Event|1|||
147180477|NCT00423449|530825294|FG002|Overall Study|Laboratory Adverse Event|2|||
147180478|NCT00423449|530825295|FG003|Overall Study|Laboratory Adverse Event|0|||
147180479|NCT00423449|530825296|FG004|Overall Study|Laboratory Adverse Event|0|||
147180480|NCT00423449|530825292|FG000|Overall Study|Other|0|||
147180481|NCT00423449|530825293|FG001|Overall Study|Other|0|||
147180482|NCT00423449|530825294|FG002|Overall Study|Other|0|||
147180483|NCT00423449|530825295|FG003|Overall Study|Other|1|||
147180484|NCT00423449|530825296|FG004|Overall Study|Other|0|||
147180485|NCT00423449|530825292|FG000|Overall Study|Protocol Violation|0|||
147180486|NCT00423449|530825293|FG001|Overall Study|Protocol Violation|0|||
147180487|NCT00423449|530825294|FG002|Overall Study|Protocol Violation|2|||
147180488|NCT00423449|530825295|FG003|Overall Study|Protocol Violation|1|||
147180489|NCT00423449|530825296|FG004|Overall Study|Protocol Violation|0|||
147180490|NCT01153724|530825297|FG000|Treatment Period 1|Withdrawal by Subject|1|||
147180491|NCT01153724|530825297|FG000|Treatment Period 2|Adverse Event|1|||
147180492|NCT01153724|530825297|FG000|Treatment Period 2|Other reason not defined above|1|||
147180493|NCT02697435|530825302|FG000|Overall Study|Withdrawal by Subject|1|||
147180494|NCT02697435|530825303|FG001|Overall Study|Withdrawal by Subject|0|||
147180495|NCT02697435|530825302|FG000|Overall Study|Physician Decision|0|||
147180496|NCT02697435|530825303|FG001|Overall Study|Physician Decision|4|||
147180497|NCT00367835|530825304|FG000|Overall Study|Adverse Event|14|||
147180498|NCT00367835|530825305|FG001|Overall Study|Adverse Event|1|||
147180499|NCT00367835|530825304|FG000|Overall Study|Protocol Violation|1|||
147245796|NCT02207244|531070825|FG005|Open-label Guselkumab: Week 72-264|Death|0|||
147245797|NCT02207244|531070826|FG006|Open-label Guselkumab: Week 72-264|Death|0|||
147245798|NCT02207244|531070827|FG007|Open-label Guselkumab: Week 72-264|Death|0|||
147245799|NCT02207244|531070828|FG008|Open-label Guselkumab: Week 72-264|Death|1|||
147245800|NCT02207244|531070829|FG009|Open-label Guselkumab: Week 72-264|Death|0|||
147245801|NCT02207244|531070830|FG010|Open-label Guselkumab: Week 72-264|Death|1|||
147245802|NCT02207244|531070820|FG000|Open-label Guselkumab: Week 72-264|Other|0|||
147245803|NCT02207244|531070821|FG001|Open-label Guselkumab: Week 72-264|Other|0|||
147245804|NCT02207244|531070822|FG002|Open-label Guselkumab: Week 72-264|Other|0|||
147245805|NCT02207244|531070823|FG003|Open-label Guselkumab: Week 72-264|Other|0|||
147245806|NCT02207244|531070824|FG004|Open-label Guselkumab: Week 72-264|Other|0|||
147245807|NCT02207244|531070825|FG005|Open-label Guselkumab: Week 72-264|Other|0|||
147180500|NCT00367835|530825305|FG001|Overall Study|Protocol Violation|7|||
147180501|NCT00367835|530825304|FG000|Overall Study|Withdrawal by Subject|7|||
147180502|NCT00367835|530825305|FG001|Overall Study|Withdrawal by Subject|6|||
147180503|NCT00367835|530825304|FG000|Overall Study|Lost to Follow-up|1|||
147180504|NCT00367835|530825305|FG001|Overall Study|Lost to Follow-up|4|||
147180505|NCT00367835|530825304|FG000|Overall Study|Lack of Efficacy|3|||
147180506|NCT00367835|530825305|FG001|Overall Study|Lack of Efficacy|12|||
147245808|NCT02207244|531070826|FG006|Open-label Guselkumab: Week 72-264|Other|0|||
147326283|NCT04831775|531359681|FG000|Overall Study|Lost to Follow-up|11|||
147180507|NCT00367835|530825304|FG000|Overall Study|Subject in juvenile detention center|1|||
147180508|NCT00367835|530825305|FG001|Overall Study|Subject in juvenile detention center|0|||
147245809|NCT02207244|531070827|FG007|Open-label Guselkumab: Week 72-264|Other|0|||
147326284|NCT04831775|531359682|FG001|Overall Study|Lost to Follow-up|13|||
147326285|NCT00337818|531359683|FG000|Overall Study|Lost to Follow-up|289|||
147326286|NCT00337818|531359684|FG001|Overall Study|Lost to Follow-up|91|||
147326287|NCT00337818|531359685|FG002|Overall Study|Lost to Follow-up|107|||
147326288|NCT03115346|531359688|FG000|Overall Study|Did not have AAA surgery|28|||
147326289|NCT03115346|531359689|FG001|Overall Study|Did not have AAA surgery|15|||
147326290|NCT03115346|531359688|FG000|Overall Study|Death|3|||
147326291|NCT03115346|531359689|FG001|Overall Study|Death|1|||
147326292|NCT03115346|531359688|FG000|Overall Study|Withdrawal by Subject|0|||
147326293|NCT03115346|531359689|FG001|Overall Study|Withdrawal by Subject|3|||
147326294|NCT03115346|531359688|FG000|Overall Study|Lost to Follow-up|0|||
147326295|NCT03115346|531359689|FG001|Overall Study|Lost to Follow-up|3|||
147326296|NCT00389519|531359692|FG000|Placebo Run-In|Did not meet blood pressure criteria|119|||
147326297|NCT00389519|531359693|FG001|Placebo Run-In|Did not meet blood pressure criteria|0|||
147326298|NCT00389519|531359694|FG002|Placebo Run-In|Did not meet blood pressure criteria|0|||
147326299|NCT00389519|531359695|FG003|Placebo Run-In|Did not meet blood pressure criteria|0|||
147326300|NCT00389519|531359692|FG000|Placebo Run-In|Withdrawal by Subject|19|||
147326301|NCT00389519|531359693|FG001|Placebo Run-In|Withdrawal by Subject|0|||
147326302|NCT00389519|531359694|FG002|Placebo Run-In|Withdrawal by Subject|0|||
147326303|NCT00389519|531359695|FG003|Placebo Run-In|Withdrawal by Subject|0|||
147326304|NCT00389519|531359692|FG000|Placebo Run-In|Reason not specified|40|||
147656234|NCT02959918|532564956|FG005|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
147656235|NCT02959918|532564957|FG006|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
147656236|NCT02959918|532564958|FG007|Overall Study|Subject Hospitalized, out of window for next dosing period|1|||
147656237|NCT02959918|532564959|FG008|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
147656238|NCT02959918|532564960|FG009|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
147326305|NCT00389519|531359693|FG001|Placebo Run-In|Reason not specified|0|||
147326306|NCT00389519|531359694|FG002|Placebo Run-In|Reason not specified|0|||
147326307|NCT00389519|531359695|FG003|Placebo Run-In|Reason not specified|0|||
147326308|NCT00389519|531359692|FG000|Randomized|Did not receive study drug|2|||
147326309|NCT00389519|531359693|FG001|Randomized|Did not receive study drug|0|||
147326310|NCT00389519|531359694|FG002|Randomized|Did not receive study drug|0|||
147326311|NCT00389519|531359695|FG003|Randomized|Did not receive study drug|0|||
147326312|NCT00389519|531359692|FG000|Treated|Adverse Event|1|||
147326313|NCT00389519|531359693|FG001|Treated|Adverse Event|0|||
147326314|NCT00389519|531359694|FG002|Treated|Adverse Event|0|||
147326315|NCT00389519|531359695|FG003|Treated|Adverse Event|2|||
147326316|NCT00389519|531359692|FG000|Treated|Reason not specified|1|||
147326317|NCT00389519|531359693|FG001|Treated|Reason not specified|1|||
147326318|NCT00389519|531359694|FG002|Treated|Reason not specified|0|||
147326319|NCT00389519|531359695|FG003|Treated|Reason not specified|2|||
147326320|NCT03425539|531359696|FG000|Overall Study|Randomized but not treated|0|||
147326321|NCT03425539|531359697|FG001|Overall Study|Randomized but not treated|1|||
147326322|NCT03425539|531359696|FG000|Overall Study|Adverse Event|2|||
147326323|NCT03425539|531359697|FG001|Overall Study|Adverse Event|2|||
147326324|NCT03425539|531359696|FG000|Overall Study|Withdrawal by Subject|3|||
147326325|NCT03425539|531359697|FG001|Overall Study|Withdrawal by Subject|0|||
147326326|NCT03425539|531359696|FG000|Overall Study|Lost to Follow-up|0|||
147326327|NCT03425539|531359697|FG001|Overall Study|Lost to Follow-up|1|||
147326328|NCT01080131|531359698|FG000|Core Study (0- 12 Weeks)|Abnormal laboratory value(s)|1|||
147326329|NCT01080131|531359699|FG001|Core Study (0- 12 Weeks)|Abnormal laboratory value(s)|1|||
147326330|NCT01080131|531359698|FG000|Core Study (0- 12 Weeks)|Patient withdrew consent|6|||
147326331|NCT01080131|531359699|FG001|Core Study (0- 12 Weeks)|Patient withdrew consent|4|||
147326332|NCT01080131|531359698|FG000|Core Study (0- 12 Weeks)|Lost to Follow-up|5|||
147326333|NCT01080131|531359699|FG001|Core Study (0- 12 Weeks)|Lost to Follow-up|3|||
147326334|NCT01080131|531359698|FG000|Core Study (0- 12 Weeks)|Administrative problems|0|||
147326335|NCT01080131|531359699|FG001|Core Study (0- 12 Weeks)|Administrative problems|1|||
147326336|NCT01080131|531359698|FG000|Core Study (0- 12 Weeks)|Death|1|||
147326337|NCT01080131|531359699|FG001|Core Study (0- 12 Weeks)|Death|0|||
147326338|NCT01080131|531359698|FG000|Core Study (0- 12 Weeks)|Protocol deviation|0|||
147326339|NCT01080131|531359699|FG001|Core Study (0- 12 Weeks)|Protocol deviation|2|||
147326340|NCT01080131|531359698|FG000|Extension Study 1 (12 -24 Weeks)|Adverse Event|1|||
147326341|NCT01080131|531359699|FG001|Extension Study 1 (12 -24 Weeks)|Adverse Event|0|||
147326342|NCT01080131|531359698|FG000|Extension Study 1 (12 -24 Weeks)|Unsatisfactory Therapeutic Effect|0|||
147326343|NCT01080131|531359699|FG001|Extension Study 1 (12 -24 Weeks)|Unsatisfactory Therapeutic Effect|1|||
147326344|NCT01080131|531359698|FG000|Extension Study 1 (12 -24 Weeks)|Withdrawal by Subject|4|||
147326345|NCT01080131|531359699|FG001|Extension Study 1 (12 -24 Weeks)|Withdrawal by Subject|3|||
147326346|NCT01080131|531359698|FG000|Extension Study 1 (12 -24 Weeks)|Lost to Follow-up|1|||
147326347|NCT01080131|531359699|FG001|Extension Study 1 (12 -24 Weeks)|Lost to Follow-up|0|||
147326348|NCT01080131|531359698|FG000|Extension Study 2 (25-72 Weeks)|Adverse Event|1|||
147326349|NCT01080131|531359699|FG001|Extension Study 2 (25-72 Weeks)|Adverse Event|2|||
147326350|NCT01080131|531359698|FG000|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|3|||
147180509|NCT00367835|530825304|FG000|Overall Study|refused blood collection|1|||
147180510|NCT00367835|530825305|FG001|Overall Study|refused blood collection|0|||
147180511|NCT00367835|530825304|FG000|Overall Study|Did not respond to calls|1|||
147180512|NCT00367835|530825305|FG001|Overall Study|Did not respond to calls|0|||
147180513|NCT00367835|530825304|FG000|Overall Study|History of lead poisoning|0|||
147180514|NCT00367835|530825305|FG001|Overall Study|History of lead poisoning|1|||
147180515|NCT00445770|530825310|FG000|Overall Study|Adverse Event|9|||
147180516|NCT00445770|530825311|FG001|Overall Study|Adverse Event|15|||
147180517|NCT00445770|530825312|FG002|Overall Study|Adverse Event|19|||
147180518|NCT00445770|530825310|FG000|Overall Study|Lack of Efficacy|38|||
147180519|NCT00445770|530825311|FG001|Overall Study|Lack of Efficacy|13|||
147180520|NCT00445770|530825312|FG002|Overall Study|Lack of Efficacy|6|||
147180521|NCT00445770|530825310|FG000|Overall Study|Lost to Follow-up|0|||
147180522|NCT00445770|530825311|FG001|Overall Study|Lost to Follow-up|2|||
147180523|NCT00445770|530825312|FG002|Overall Study|Lost to Follow-up|0|||
147180524|NCT00445770|530825310|FG000|Overall Study|Other|6|||
147180525|NCT00445770|530825311|FG001|Overall Study|Other|5|||
147180526|NCT00445770|530825312|FG002|Overall Study|Other|6|||
147180527|NCT00811174|530825314|FG000|Overall Study|Protocol Violation|2|||
147180528|NCT00811174|530825314|FG000|Overall Study|Sponsors Decision|1|||
147180529|NCT00999544|530826819|FG000|Overall Study|Withdrawal by Subject|1|||
147180530|NCT01392547|530826820|FG000|Overall Study|Adverse Event|2|||
147180531|NCT01392547|530826820|FG000|Overall Study|Non-compliance|2|||
147180532|NCT01392547|530826820|FG000|Overall Study|Withdrawal criteria|3|||
147180533|NCT01392547|530826820|FG000|Overall Study|Unclassified|1|||
147180534|NCT02936635|530826822|FG000|Overall Study|Adverse Event|43|||
147180535|NCT02936635|530826823|FG001|Overall Study|Adverse Event|25|||
147180536|NCT02936635|530826822|FG000|Overall Study|Progressive Disease|10|||
147180537|NCT02936635|530826823|FG001|Overall Study|Progressive Disease|18|||
147180538|NCT02936635|530826822|FG000|Overall Study|Sponsor Discretion|10|||
147180539|NCT02936635|530826823|FG001|Overall Study|Sponsor Discretion|16|||
147180540|NCT02936635|530826822|FG000|Overall Study|Death|9|||
147180541|NCT02936635|530826823|FG001|Overall Study|Death|15|||
147180542|NCT02936635|530826822|FG000|Overall Study|Withdrawal by Subject|8|||
147180543|NCT02936635|530826823|FG001|Overall Study|Withdrawal by Subject|15|||
147180544|NCT02936635|530826822|FG000|Overall Study|Physician Decision|2|||
147180545|NCT02936635|530826823|FG001|Overall Study|Physician Decision|9|||
147180546|NCT02936635|530826822|FG000|Overall Study|Lost to Follow-up|1|||
147180547|NCT02936635|530826823|FG001|Overall Study|Lost to Follow-up|2|||
147180548|NCT02936635|530826822|FG000|Overall Study|Protocol Violation|1|||
147180549|NCT02936635|530826823|FG001|Overall Study|Protocol Violation|0|||
147180550|NCT02936635|530826822|FG000|Overall Study|Lack of effect/Entry into other study|31|||
147180551|NCT02936635|530826823|FG001|Overall Study|Lack of effect/Entry into other study|65|||
147180552|NCT02407223|530826824|FG000|Overall Study|Adverse Event|1|||
147180553|NCT02407223|530826825|FG001|Overall Study|Adverse Event|0|||
147180554|NCT02407223|530826826|FG002|Overall Study|Adverse Event|1|||
147180555|NCT02407223|530826824|FG000|Overall Study|Lack of Efficacy|6|||
147180556|NCT02407223|530826825|FG001|Overall Study|Lack of Efficacy|6|||
147180557|NCT02407223|530826826|FG002|Overall Study|Lack of Efficacy|4|||
147180558|NCT02407223|530826824|FG000|Overall Study|Lost to Follow-up|1|||
147180559|NCT02407223|530826825|FG001|Overall Study|Lost to Follow-up|0|||
147180560|NCT02407223|530826826|FG002|Overall Study|Lost to Follow-up|2|||
147245810|NCT02207244|531070828|FG008|Open-label Guselkumab: Week 72-264|Other|8|||
147180561|NCT02407223|530826824|FG000|Overall Study|Withdrawal by Subject|2|||
147180562|NCT02407223|530826825|FG001|Overall Study|Withdrawal by Subject|4|||
147180563|NCT02407223|530826826|FG002|Overall Study|Withdrawal by Subject|4|||
147180564|NCT02407223|530826824|FG000|Overall Study|Study Terminated by Sponsor|77|||
147180565|NCT02407223|530826825|FG001|Overall Study|Study Terminated by Sponsor|80|||
147180566|NCT02407223|530826826|FG002|Overall Study|Study Terminated by Sponsor|86|||
147180567|NCT02407223|530826824|FG000|Overall Study|Subject Refused Further Study Treatment|0|||
147180568|NCT02407223|530826825|FG001|Overall Study|Subject Refused Further Study Treatment|1|||
147180569|NCT02407223|530826826|FG002|Overall Study|Subject Refused Further Study Treatment|0|||
147180570|NCT02407223|530826824|FG000|Overall Study|Other|29|||
147180571|NCT02407223|530826825|FG001|Overall Study|Other|27|||
147180572|NCT02407223|530826826|FG002|Overall Study|Other|25|||
147180573|NCT00447226|530826827|FG000|12-Week Open-label Phase|Adverse Event|0|||
147180574|NCT00447226|530826828|FG001|12-Week Open-label Phase|Adverse Event|3|||
147180575|NCT00447226|530826827|FG000|12-Week Open-label Phase|Protocol Violation|0|||
147180576|NCT00447226|530826828|FG001|12-Week Open-label Phase|Protocol Violation|1|||
147180577|NCT00447226|530826827|FG000|12-Week Open-label Phase|Disease Progression|0|||
147180578|NCT00447226|530826828|FG001|12-Week Open-label Phase|Disease Progression|20|||
147180579|NCT00447226|530826827|FG000|12-Week Open-label Phase|Physician Decision|0|||
147180580|NCT00447226|530826828|FG001|12-Week Open-label Phase|Physician Decision|1|||
147180581|NCT00447226|530826827|FG000|Double-blind Phase|Disease Progression|4|||
147180582|NCT00447226|530826828|FG001|Double-blind Phase|Disease Progression|3|||
147245811|NCT02207244|531070829|FG009|Open-label Guselkumab: Week 72-264|Other|0|||
147245812|NCT02207244|531070830|FG010|Open-label Guselkumab: Week 72-264|Other|19|||
147245813|NCT02207244|531070820|FG000|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
147180583|NCT00584012|530826836|FG000|Overall Study|Withdrawal by Subject|1|||
147180584|NCT04404556|530826837|FG000|Intervention|Withdrawal by Subject|15|||
147180585|NCT04404556|530826838|FG001|Intervention|Withdrawal by Subject|3|||
147180586|NCT04404556|530826837|FG000|Intervention|Did not complete all intervention sessions|2|||
147180587|NCT04404556|530826838|FG001|Intervention|Did not complete all intervention sessions|1|||
147180588|NCT04404556|530826837|FG000|Post-Intervention|Missing Data|1|||
147326351|NCT01080131|531359699|FG001|Extension Study 2 (25-72 Weeks)|Withdrawal by Subject|4|||
147326352|NCT01080131|531359698|FG000|Extension Study 2 (25-72 Weeks)|Lost to Follow-up|4|||
147326353|NCT01080131|531359699|FG001|Extension Study 2 (25-72 Weeks)|Lost to Follow-up|5|||
147326354|NCT02014558|531359700|FG000|Overall Study|Never Received Study Drug|0|||
147326355|NCT02014558|531359701|FG001|Overall Study|Never Received Study Drug|0|||
147326356|NCT02014558|531359702|FG002|Overall Study|Never Received Study Drug|0|||
147326357|NCT02014558|531359703|FG003|Overall Study|Never Received Study Drug|0|||
147326358|NCT02014558|531359704|FG004|Overall Study|Never Received Study Drug|1|||
147326359|NCT02014558|531359705|FG005|Overall Study|Never Received Study Drug|0|||
147326360|NCT02014558|531359706|FG006|Overall Study|Never Received Study Drug|1|||
147326361|NCT02014558|531359707|FG007|Overall Study|Never Received Study Drug|0|||
147326362|NCT02014558|531359708|FG008|Overall Study|Never Received Study Drug|2|||
147326363|NCT02014558|531359709|FG009|Overall Study|Never Received Study Drug|0|||
147326364|NCT02014558|531359710|FG010|Overall Study|Never Received Study Drug|2|||
147326365|NCT02014558|531359711|FG011|Overall Study|Never Received Study Drug|2|||
147326366|NCT02014558|531359712|FG012|Overall Study|Never Received Study Drug|0|||
147326367|NCT02014558|531359700|FG000|Overall Study|Adverse Event|0|||
147326368|NCT02014558|531359701|FG001|Overall Study|Adverse Event|0|||
147326369|NCT02014558|531359702|FG002|Overall Study|Adverse Event|0|||
147326370|NCT02014558|531359703|FG003|Overall Study|Adverse Event|0|||
147326371|NCT02014558|531359704|FG004|Overall Study|Adverse Event|1|||
147326372|NCT02014558|531359705|FG005|Overall Study|Adverse Event|0|||
147326373|NCT02014558|531359706|FG006|Overall Study|Adverse Event|0|||
147326374|NCT02014558|531359707|FG007|Overall Study|Adverse Event|0|||
147326375|NCT02014558|531359708|FG008|Overall Study|Adverse Event|2|||
147326376|NCT02014558|531359709|FG009|Overall Study|Adverse Event|2|||
147326377|NCT02014558|531359710|FG010|Overall Study|Adverse Event|5|||
147326378|NCT02014558|531359711|FG011|Overall Study|Adverse Event|21|||
147326379|NCT02014558|531359712|FG012|Overall Study|Adverse Event|3|||
147326380|NCT02014558|531359700|FG000|Overall Study|Death|1|||
147326381|NCT02014558|531359701|FG001|Overall Study|Death|0|||
147326382|NCT02014558|531359702|FG002|Overall Study|Death|0|||
147326383|NCT02014558|531359703|FG003|Overall Study|Death|0|||
147326384|NCT02014558|531359704|FG004|Overall Study|Death|0|||
147326385|NCT02014558|531359705|FG005|Overall Study|Death|0|||
147326386|NCT02014558|531359706|FG006|Overall Study|Death|1|||
147326387|NCT02014558|531359707|FG007|Overall Study|Death|1|||
147326388|NCT02014558|531359708|FG008|Overall Study|Death|2|||
147326389|NCT02014558|531359709|FG009|Overall Study|Death|5|||
147180589|NCT04404556|530826838|FG001|Post-Intervention|Missing Data|2|||
147180590|NCT04404556|530826837|FG000|Follow-up 1|Withdrawal by Subject|5|||
147180591|NCT04404556|530826838|FG001|Follow-up 1|Withdrawal by Subject|1|||
147180592|NCT04404556|530826837|FG000|Follow-up 1|Missing Data|4|||
147180593|NCT04404556|530826838|FG001|Follow-up 1|Missing Data|7|||
147180594|NCT04404556|530826837|FG000|Follow-up 2|Withdrawal by Subject|1|||
147180595|NCT04404556|530826838|FG001|Follow-up 2|Withdrawal by Subject|1|||
147180596|NCT04404556|530826837|FG000|Follow-up 2|Missing Data|6|||
147180597|NCT04404556|530826838|FG001|Follow-up 2|Missing Data|5|||
147180598|NCT00763386|530826840|FG000|Overall Study|Adverse Event|43|||
147180599|NCT00763386|530826841|FG001|Overall Study|Adverse Event|33|||
147180600|NCT00763386|530826840|FG000|Overall Study|Death|1|||
147180601|NCT00763386|530826841|FG001|Overall Study|Death|2|||
147180602|NCT00763386|530826840|FG000|Overall Study|Lost to Follow-up|3|||
147180603|NCT00763386|530826841|FG001|Overall Study|Lost to Follow-up|3|||
147180604|NCT00763386|530826840|FG000|Overall Study|Withdrawal by Subject|0|||
147180605|NCT00763386|530826841|FG001|Overall Study|Withdrawal by Subject|1|||
147180606|NCT00763386|530826840|FG000|Overall Study|CRF missing|0|||
147180607|NCT00763386|530826841|FG001|Overall Study|CRF missing|1|||
147326390|NCT02014558|531359710|FG010|Overall Study|Death|5|||
147326391|NCT02014558|531359711|FG011|Overall Study|Death|19|||
147326392|NCT02014558|531359712|FG012|Overall Study|Death|2|||
147326393|NCT02014558|531359700|FG000|Overall Study|Lack of Efficacy|1|||
147326394|NCT02014558|531359701|FG001|Overall Study|Lack of Efficacy|2|||
147326395|NCT02014558|531359702|FG002|Overall Study|Lack of Efficacy|1|||
147326396|NCT02014558|531359703|FG003|Overall Study|Lack of Efficacy|1|||
147326397|NCT02014558|531359704|FG004|Overall Study|Lack of Efficacy|0|||
147326398|NCT02014558|531359705|FG005|Overall Study|Lack of Efficacy|0|||
147326399|NCT02014558|531359706|FG006|Overall Study|Lack of Efficacy|1|||
147180608|NCT00763386|530826840|FG000|Overall Study|Study Prosthesis Removed|1|||
147180609|NCT00763386|530826841|FG001|Overall Study|Study Prosthesis Removed|0|||
147180610|NCT00502671|530826842|FG000|Overall Study|Disease Progression|13|||
147326400|NCT02014558|531359707|FG007|Overall Study|Lack of Efficacy|3|||
147180611|NCT00502671|530826842|FG000|Overall Study|Personal Reasons|22|||
147326401|NCT02014558|531359708|FG008|Overall Study|Lack of Efficacy|3|||
147180612|NCT00502671|530826842|FG000|Overall Study|Lost to Follow-up|7|||
147180613|NCT00502671|530826842|FG000|Overall Study|Protocol Violation|16|||
147180614|NCT00502671|530826842|FG000|Overall Study|Adverse Event|19|||
147180615|NCT01402817|530826843|FG000|Overall Study|Withdrawal by Subject|3|||
147180616|NCT01402817|530826843|FG000|Overall Study|Study Suspended by FDA|8|||
147180617|NCT00681629|530826844|FG000|Overall Study|Study termination|4|||
147180618|NCT00681629|530826845|FG001|Overall Study|Study termination|2|||
147180619|NCT00681629|530826844|FG000|Overall Study|Adverse Event|1|||
147180620|NCT00681629|530826845|FG001|Overall Study|Adverse Event|0|||
147180621|NCT01173601|530826847|FG000|Confirmation (CF) Phase, 3 Weeks|Adverse Event|23|||
147180622|NCT01173601|530826848|FG001|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
147180623|NCT01173601|530826849|FG002|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
147180624|NCT01173601|530826850|FG003|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
147180625|NCT01173601|530826851|FG004|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
147180626|NCT01173601|530826847|FG000|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|9|||
147180627|NCT01173601|530826848|FG001|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
147180628|NCT01173601|530826849|FG002|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
147180629|NCT01173601|530826850|FG003|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
147180630|NCT01173601|530826851|FG004|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
147180631|NCT01173601|530826847|FG000|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|7|||
147180632|NCT01173601|530826848|FG001|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
147180633|NCT01173601|530826849|FG002|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
147180634|NCT01173601|530826850|FG003|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
147180635|NCT01173601|530826851|FG004|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
147180636|NCT01173601|530826847|FG000|Confirmation (CF) Phase, 3 Weeks|Physician Decision|3|||
147180637|NCT01173601|530826848|FG001|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
147180638|NCT01173601|530826849|FG002|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
147180639|NCT01173601|530826850|FG003|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
147180640|NCT01173601|530826851|FG004|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
147180641|NCT01173601|530826847|FG000|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|15|||
147180642|NCT01173601|530826848|FG001|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
147180643|NCT01173601|530826849|FG002|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
147180644|NCT01173601|530826850|FG003|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
147180645|NCT01173601|530826851|FG004|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
147180646|NCT01173601|530826847|FG000|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|25|||
147180647|NCT01173601|530826848|FG001|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
147180648|NCT01173601|530826849|FG002|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
147180649|NCT01173601|530826850|FG003|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
147180650|NCT01173601|530826851|FG004|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
147180651|NCT01173601|530826847|FG000|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|6|||
147180652|NCT01173601|530826848|FG001|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
147180653|NCT01173601|530826849|FG002|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
147180654|NCT01173601|530826850|FG003|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
147180655|NCT01173601|530826851|FG004|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
147180656|NCT01173601|530826847|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|0|||
147180657|NCT01173601|530826848|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|10|||
147180658|NCT01173601|530826849|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|15|||
147180659|NCT01173601|530826850|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|7|||
147180660|NCT01173601|530826851|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|14|||
147180661|NCT01173601|530826847|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|0|||
147180662|NCT01173601|530826848|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|10|||
147180663|NCT01173601|530826849|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|6|||
147180664|NCT01173601|530826850|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|8|||
147180665|NCT01173601|530826851|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|9|||
147180666|NCT01173601|530826847|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0|||
147180667|NCT01173601|530826848|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|3|||
147180668|NCT01173601|530826849|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0|||
147180669|NCT01173601|530826850|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|2|||
147180670|NCT01173601|530826851|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|9|||
147180671|NCT01173601|530826847|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
147180672|NCT01173601|530826848|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|2|||
147180673|NCT01173601|530826849|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
147180674|NCT01173601|530826850|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|2|||
147180675|NCT01173601|530826851|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1|||
147180676|NCT01173601|530826847|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|0|||
147180677|NCT01173601|530826848|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|1|||
147656239|NCT02959918|532564961|FG010|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
147180678|NCT01173601|530826849|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5|||
147180679|NCT01173601|530826850|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|4|||
147180680|NCT01173601|530826851|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5|||
147180681|NCT01173601|530826847|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|0|||
147180682|NCT01173601|530826848|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|9|||
147180683|NCT01173601|530826849|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|7|||
147180684|NCT01173601|530826850|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|5|||
147180685|NCT01173601|530826851|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|24|||
147180686|NCT01173601|530826847|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
147180687|NCT01173601|530826848|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
147180688|NCT01173601|530826849|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
147180689|NCT01173601|530826850|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2|||
147180690|NCT01173601|530826851|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|6|||
147180691|NCT02274792|530826852|FG000|Overall Study|Withdrawal by Subject|13|||
147180692|NCT02274792|530826852|FG000|Overall Study|Lost to Follow-up|8|||
147180693|NCT02274792|530826852|FG000|Overall Study|Protocol Specified Criteria|2|||
147180694|NCT02274792|530826852|FG000|Overall Study|Sponsor Decision|2|||
147180695|NCT01510158|530826853|FG000|Overall Study|Adverse Event|7|||
147180696|NCT01510158|530826854|FG001|Overall Study|Adverse Event|8|||
147180697|NCT01510158|530826855|FG002|Overall Study|Adverse Event|5|||
147180698|NCT01510158|530826853|FG000|Overall Study|Gout flare|1|||
147180699|NCT01510158|530826854|FG001|Overall Study|Gout flare|0|||
147180700|NCT01510158|530826855|FG002|Overall Study|Gout flare|0|||
147180701|NCT01510158|530826853|FG000|Overall Study|Protocol Violation|17|||
147180702|NCT01510158|530826854|FG001|Overall Study|Protocol Violation|16|||
147180703|NCT01510158|530826855|FG002|Overall Study|Protocol Violation|24|||
147180704|NCT01510158|530826853|FG000|Overall Study|Sponsor terminated study.|2|||
147180705|NCT01510158|530826854|FG001|Overall Study|Sponsor terminated study.|0|||
147180706|NCT01510158|530826855|FG002|Overall Study|Sponsor terminated study.|2|||
147180707|NCT01510158|530826853|FG000|Overall Study|Lost to Follow-up|13|||
147180708|NCT01510158|530826854|FG001|Overall Study|Lost to Follow-up|16|||
147180709|NCT01510158|530826855|FG002|Overall Study|Lost to Follow-up|9|||
147180710|NCT01510158|530826853|FG000|Overall Study|Withdrawal by Subject|10|||
147180711|NCT01510158|530826854|FG001|Overall Study|Withdrawal by Subject|13|||
147180712|NCT01510158|530826855|FG002|Overall Study|Withdrawal by Subject|10|||
147180713|NCT01510158|530826853|FG000|Overall Study|Death|1|||
147180714|NCT01510158|530826854|FG001|Overall Study|Death|0|||
147180715|NCT01510158|530826855|FG002|Overall Study|Death|0|||
147180716|NCT05258149|530826856|FG000|Period 1|Protocol Deviation|1|||
147180717|NCT05258149|530826857|FG001|Period 1|Protocol Deviation|0|||
147180718|NCT05258149|530826856|FG000|Period 1|Adverse Event|0|||
147180719|NCT05258149|530826857|FG001|Period 1|Adverse Event|1|||
147180720|NCT05258149|530826856|FG000|Period 2|Unsatisfactory Visual Response due to Test Article|1|||
147180721|NCT05258149|530826857|FG001|Period 2|Unsatisfactory Visual Response due to Test Article|0|||
147180722|NCT05258149|530826856|FG000|Period 2|Subject No Longer Meets Eligibility Criteria|0|||
147180723|NCT05258149|530826857|FG001|Period 2|Subject No Longer Meets Eligibility Criteria|1|||
147180724|NCT05258149|530826856|FG000|Period 3|Subject Was Not Returning for More Than A Week|0|||
147180725|NCT05258149|530826857|FG001|Period 3|Subject Was Not Returning for More Than A Week|1|||
147180726|NCT00832416|530826864|FG000|Overall Study|Lack of Efficacy|17|||
147180727|NCT00832416|530826865|FG001|Overall Study|Lack of Efficacy|15|||
147180728|NCT00832416|530826866|FG002|Overall Study|Lack of Efficacy|13|||
147180729|NCT00832416|530826867|FG003|Overall Study|Lack of Efficacy|52|||
147180730|NCT00832416|530826864|FG000|Overall Study|Withdrawal by Subject|5|||
147180731|NCT00832416|530826865|FG001|Overall Study|Withdrawal by Subject|7|||
147180732|NCT00832416|530826866|FG002|Overall Study|Withdrawal by Subject|2|||
147180733|NCT00832416|530826867|FG003|Overall Study|Withdrawal by Subject|10|||
147180734|NCT00832416|530826864|FG000|Overall Study|Physician Decision|2|||
147180735|NCT00832416|530826865|FG001|Overall Study|Physician Decision|12|||
147180736|NCT00832416|530826866|FG002|Overall Study|Physician Decision|5|||
147180737|NCT00832416|530826867|FG003|Overall Study|Physician Decision|10|||
147180738|NCT00832416|530826864|FG000|Overall Study|Administrative|0|||
147180739|NCT00832416|530826865|FG001|Overall Study|Administrative|0|||
147448441|NCT03693625|531805726|FG000|Overall Study|Study Terminated By Sponsor|20|||
147448442|NCT03693625|531805727|FG001|Overall Study|Study Terminated By Sponsor|7|||
147448443|NCT03693625|531805726|FG000|Overall Study|Withdrawal by Subject|1|||
147180740|NCT00832416|530826866|FG002|Overall Study|Administrative|0|||
147448444|NCT03693625|531805727|FG001|Overall Study|Withdrawal by Subject|1|||
147448445|NCT01883635|531805729|FG000|Overall Study|Withdrawal by Subject|4|||
147448446|NCT01883635|531805730|FG001|Overall Study|Withdrawal by Subject|0|||
147180741|NCT00832416|530826867|FG003|Overall Study|Administrative|1|||
147180742|NCT00832416|530826864|FG000|Overall Study|Adverse Event|21|||
147180743|NCT00832416|530826865|FG001|Overall Study|Adverse Event|19|||
147180744|NCT00832416|530826866|FG002|Overall Study|Adverse Event|41|||
147180745|NCT00832416|530826867|FG003|Overall Study|Adverse Event|10|||
147180746|NCT00832416|530826864|FG000|Overall Study|Death|1|||
147180747|NCT00832416|530826865|FG001|Overall Study|Death|0|||
147180748|NCT00832416|530826866|FG002|Overall Study|Death|0|||
147180749|NCT00832416|530826867|FG003|Overall Study|Death|0|||
147180750|NCT02114606|530826868|FG000|Overall Study|Unable to swallow Cytosponge|6|||
147180751|NCT05786508|530826878|FG000|Overall Study|Withdrawal by Subject|2|||
147180752|NCT05786508|530826879|FG001|Overall Study|Withdrawal by Subject|0|||
147180753|NCT04426318|530826880|FG000|Overall Study|failed attention checks and had their data removed from analyses|2|||
147180754|NCT04426318|530826881|FG001|Overall Study|failed attention checks and had their data removed from analyses|2|||
147180755|NCT02152761|530826884|FG000|Epoch: Treatment Epoch|Technical problems|0|||
147180756|NCT02152761|530826885|FG001|Epoch: Treatment Epoch|Technical problems|0|||
147180757|NCT02152761|530826886|FG002|Epoch: Treatment Epoch|Technical problems|0|||
147180758|NCT02152761|530826887|FG003|Epoch: Treatment Epoch|Technical problems|1|||
147180759|NCT02152761|530826884|FG000|Epoch: Treatment Epoch|Lost to Follow-up|0|||
147180760|NCT02152761|530826885|FG001|Epoch: Treatment Epoch|Lost to Follow-up|2|||
147180761|NCT02152761|530826886|FG002|Epoch: Treatment Epoch|Lost to Follow-up|0|||
147180762|NCT02152761|530826887|FG003|Epoch: Treatment Epoch|Lost to Follow-up|0|||
147180763|NCT02152761|530826884|FG000|Epoch: Treatment Epoch|Withdrawal by Subject|7|||
147180764|NCT02152761|530826885|FG001|Epoch: Treatment Epoch|Withdrawal by Subject|8|||
147180765|NCT02152761|530826886|FG002|Epoch: Treatment Epoch|Withdrawal by Subject|3|||
147180766|NCT02152761|530826887|FG003|Epoch: Treatment Epoch|Withdrawal by Subject|5|||
147180767|NCT02152761|530826884|FG000|Epoch: Treatment Epoch|Adverse Event|3|||
147180768|NCT02152761|530826885|FG001|Epoch: Treatment Epoch|Adverse Event|6|||
147180769|NCT02152761|530826886|FG002|Epoch: Treatment Epoch|Adverse Event|1|||
147180770|NCT02152761|530826887|FG003|Epoch: Treatment Epoch|Adverse Event|2|||
147180771|NCT02152761|530826884|FG000|Epoch: Treatment Epoch|Death|0|||
147180772|NCT02152761|530826885|FG001|Epoch: Treatment Epoch|Death|3|||
147180773|NCT02152761|530826886|FG002|Epoch: Treatment Epoch|Death|1|||
147180774|NCT02152761|530826887|FG003|Epoch: Treatment Epoch|Death|0|||
147180775|NCT02152761|530826884|FG000|Epoch: Treatment Epoch|Non-compliance with treatment|1|||
147180776|NCT02152761|530826885|FG001|Epoch: Treatment Epoch|Non-compliance with treatment|1|||
147180777|NCT02152761|530826886|FG002|Epoch: Treatment Epoch|Non-compliance with treatment|0|||
147180778|NCT02152761|530826887|FG003|Epoch: Treatment Epoch|Non-compliance with treatment|0|||
147180779|NCT02152761|530826884|FG000|Epoch: Post-treatment Follow-up Epoch|Withdrawal by Subject|1|||
147180780|NCT02152761|530826885|FG001|Epoch: Post-treatment Follow-up Epoch|Withdrawal by Subject|3|||
147180781|NCT02152761|530826886|FG002|Epoch: Post-treatment Follow-up Epoch|Withdrawal by Subject|0|||
147180782|NCT02152761|530826887|FG003|Epoch: Post-treatment Follow-up Epoch|Withdrawal by Subject|1|||
147180783|NCT02152761|530826884|FG000|Epoch: Post-treatment Follow-up Epoch|Lost to Follow-up|1|||
147180784|NCT02152761|530826885|FG001|Epoch: Post-treatment Follow-up Epoch|Lost to Follow-up|4|||
147180785|NCT02152761|530826886|FG002|Epoch: Post-treatment Follow-up Epoch|Lost to Follow-up|0|||
147180786|NCT02152761|530826887|FG003|Epoch: Post-treatment Follow-up Epoch|Lost to Follow-up|0|||
147180787|NCT02152761|530826884|FG000|Epoch: Post-treatment Follow-up Epoch|Adverse Event|1|||
147180788|NCT02152761|530826885|FG001|Epoch: Post-treatment Follow-up Epoch|Adverse Event|0|||
147180789|NCT02152761|530826886|FG002|Epoch: Post-treatment Follow-up Epoch|Adverse Event|0|||
147180790|NCT02152761|530826887|FG003|Epoch: Post-treatment Follow-up Epoch|Adverse Event|0|||
147180791|NCT02152761|530826884|FG000|Epoch: Post-treatment Follow-up Epoch|Death|1|||
147180792|NCT02152761|530826885|FG001|Epoch: Post-treatment Follow-up Epoch|Death|0|||
147180793|NCT02152761|530826886|FG002|Epoch: Post-treatment Follow-up Epoch|Death|0|||
147180794|NCT02152761|530826887|FG003|Epoch: Post-treatment Follow-up Epoch|Death|1|||
147180795|NCT01957202|530826888|FG000|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
147180796|NCT01957202|530826889|FG001|Treatment Period 2 (8 Days)|Withdrawal by Subject|1|||
147180797|NCT01957202|530826890|FG002|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
147180798|NCT01957202|530826891|FG003|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
147180799|NCT01957202|530826892|FG004|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
147180800|NCT01957202|530826893|FG005|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
147180801|NCT01957202|530826894|FG006|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
147180802|NCT01957202|530826895|FG007|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
147180803|NCT01957202|530826896|FG008|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
147180804|NCT01957202|530826897|FG009|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
147180805|NCT01957202|530826898|FG010|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
147180806|NCT01957202|530826899|FG011|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
147180807|NCT01957202|530826900|FG012|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
147180808|NCT01957202|530826901|FG013|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
147180809|NCT01957202|530826902|FG014|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
147180810|NCT01957202|530826903|FG015|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
147180811|NCT01957202|530826904|FG016|Treatment Period 2 (8 Days)|Withdrawal by Subject|1|||
147245814|NCT02207244|531070821|FG001|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
147245815|NCT02207244|531070822|FG002|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
147245816|NCT02207244|531070823|FG003|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
147245817|NCT02207244|531070824|FG004|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
147245818|NCT02207244|531070825|FG005|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
147180812|NCT01957202|530826905|FG017|Treatment Period 2 (8 Days)|Withdrawal by Subject|0|||
147180813|NCT01957202|530826888|FG000|Treatment Period 3 (8 Days)|Adverse Event|0|||
147180814|NCT01957202|530826889|FG001|Treatment Period 3 (8 Days)|Adverse Event|0|||
147180815|NCT01957202|530826890|FG002|Treatment Period 3 (8 Days)|Adverse Event|0|||
147180816|NCT01957202|530826891|FG003|Treatment Period 3 (8 Days)|Adverse Event|0|||
147180817|NCT01957202|530826892|FG004|Treatment Period 3 (8 Days)|Adverse Event|0|||
147180818|NCT01957202|530826893|FG005|Treatment Period 3 (8 Days)|Adverse Event|0|||
147180819|NCT01957202|530826894|FG006|Treatment Period 3 (8 Days)|Adverse Event|0|||
147180820|NCT01957202|530826895|FG007|Treatment Period 3 (8 Days)|Adverse Event|0|||
147180821|NCT01957202|530826896|FG008|Treatment Period 3 (8 Days)|Adverse Event|0|||
147180822|NCT01957202|530826897|FG009|Treatment Period 3 (8 Days)|Adverse Event|0|||
147180823|NCT01957202|530826898|FG010|Treatment Period 3 (8 Days)|Adverse Event|0|||
147180824|NCT01957202|530826899|FG011|Treatment Period 3 (8 Days)|Adverse Event|0|||
147180825|NCT01957202|530826900|FG012|Treatment Period 3 (8 Days)|Adverse Event|0|||
147180826|NCT01957202|530826901|FG013|Treatment Period 3 (8 Days)|Adverse Event|0|||
147180827|NCT01957202|530826902|FG014|Treatment Period 3 (8 Days)|Adverse Event|0|||
147180828|NCT01957202|530826903|FG015|Treatment Period 3 (8 Days)|Adverse Event|0|||
147180829|NCT01957202|530826904|FG016|Treatment Period 3 (8 Days)|Adverse Event|1|||
147180830|NCT01957202|530826905|FG017|Treatment Period 3 (8 Days)|Adverse Event|0|||
147180831|NCT01456169|530826906|FG000|Overall Study|Adverse Event|1|||
147180832|NCT01456169|530826907|FG001|Overall Study|Adverse Event|2|||
147180833|NCT01456169|530826908|FG002|Overall Study|Adverse Event|7|||
147180834|NCT01456169|530826906|FG000|Overall Study|Major Protocol Deviation|3|||
147180835|NCT01456169|530826907|FG001|Overall Study|Major Protocol Deviation|2|||
147180836|NCT01456169|530826908|FG002|Overall Study|Major Protocol Deviation|3|||
147180837|NCT01456169|530826906|FG000|Overall Study|Voluntary Withdrawal|3|||
147180838|NCT01456169|530826907|FG001|Overall Study|Voluntary Withdrawal|0|||
147180839|NCT01456169|530826908|FG002|Overall Study|Voluntary Withdrawal|2|||
147180840|NCT01456169|530826906|FG000|Overall Study|Lack of Efficacy|2|||
147180841|NCT01456169|530826907|FG001|Overall Study|Lack of Efficacy|0|||
147180842|NCT01456169|530826908|FG002|Overall Study|Lack of Efficacy|0|||
147180843|NCT01456169|530826906|FG000|Overall Study|Other|1|||
147180844|NCT01456169|530826907|FG001|Overall Study|Other|1|||
147180845|NCT01456169|530826908|FG002|Overall Study|Other|0|||
147180846|NCT02652156|530826909|FG000|Overall Study|Physician Decision|1|||
147180847|NCT02652156|530826910|FG001|Overall Study|Physician Decision|0|||
147180848|NCT02652156|530826911|FG002|Overall Study|Physician Decision|0|||
147180849|NCT00496080|530826912|FG000|Overall Study|Lost to Follow-up|9|||
147180850|NCT00496080|530826912|FG000|Overall Study|Surgical re-intervention|7|||
147180851|NCT00496080|530826912|FG000|Overall Study|Withdrawal by Subject|5|||
147180852|NCT00496080|530826912|FG000|Overall Study|Physician Decision|6|||
147180853|NCT00479336|530826917|FG000|Overall Study|Adverse Event|1|||
147180854|NCT00479336|530826918|FG001|Overall Study|Adverse Event|1|||
147180855|NCT00479336|530826919|FG002|Overall Study|Adverse Event|1|||
147180856|NCT00479336|530826920|FG003|Overall Study|Adverse Event|3|||
147180857|NCT00479336|530826917|FG000|Overall Study|Lack of Efficacy|1|||
147180858|NCT00479336|530826918|FG001|Overall Study|Lack of Efficacy|0|||
147180859|NCT00479336|530826919|FG002|Overall Study|Lack of Efficacy|0|||
147180860|NCT00479336|530826920|FG003|Overall Study|Lack of Efficacy|0|||
147180861|NCT00479336|530826917|FG000|Overall Study|Protocol Violation|0|||
147180862|NCT00479336|530826918|FG001|Overall Study|Protocol Violation|1|||
147180863|NCT00479336|530826919|FG002|Overall Study|Protocol Violation|0|||
147180864|NCT00479336|530826920|FG003|Overall Study|Protocol Violation|0|||
147180865|NCT00479336|530826917|FG000|Overall Study|Withdrawal by Subject|1|||
147180866|NCT00479336|530826918|FG001|Overall Study|Withdrawal by Subject|2|||
147180867|NCT00479336|530826919|FG002|Overall Study|Withdrawal by Subject|0|||
147180868|NCT00479336|530826920|FG003|Overall Study|Withdrawal by Subject|0|||
147180869|NCT00479336|530826917|FG000|Overall Study|Physician Decision|0|||
147180870|NCT00479336|530826918|FG001|Overall Study|Physician Decision|1|||
147180871|NCT00479336|530826919|FG002|Overall Study|Physician Decision|0|||
147180872|NCT00479336|530826920|FG003|Overall Study|Physician Decision|2|||
147180873|NCT00479336|530826917|FG000|Overall Study|Resolution of all hepatic edema findings|1|||
147180874|NCT00479336|530826918|FG001|Overall Study|Resolution of all hepatic edema findings|1|||
147180875|NCT00479336|530826919|FG002|Overall Study|Resolution of all hepatic edema findings|0|||
147180876|NCT00479336|530826920|FG003|Overall Study|Resolution of all hepatic edema findings|0|||
147180877|NCT03066193|530826921|FG000|Overall Study|Withdrawal by Subject|1|||
147180878|NCT02859246|530826922|FG000|Overall Study|Screen fails|3|||
147180879|NCT02859246|530826922|FG000|Overall Study|Adverse Event|1|||
147180880|NCT02859246|530826922|FG000|Overall Study|Withdrawal by Subject|1|||
147180881|NCT05280717|530826923|FG000|Part A (Up to Week 35)|Withdrawal by Subject|1|||
147180882|NCT05280717|530826924|FG001|Part A (Up to Week 35)|Withdrawal by Subject|3|||
147180883|NCT05280717|530826925|FG002|Part A (Up to Week 35)|Withdrawal by Subject|2|||
147180884|NCT05280717|530826926|FG003|Part A (Up to Week 35)|Withdrawal by Subject|0|||
147180885|NCT05280717|530826927|FG004|Part A (Up to Week 35)|Withdrawal by Subject|0|||
147180886|NCT05280717|530826928|FG005|Part A (Up to Week 35)|Withdrawal by Subject|0|||
147180887|NCT05280717|530826929|FG006|Part A (Up to Week 35)|Withdrawal by Subject|0|||
147326402|NCT02014558|531359709|FG009|Overall Study|Lack of Efficacy|3|||
147180888|NCT05280717|530826923|FG000|Part A (Up to Week 35)|Randomized but not received treatment|1|||
147180889|NCT05280717|530826924|FG001|Part A (Up to Week 35)|Randomized but not received treatment|0|||
147180890|NCT05280717|530826925|FG002|Part A (Up to Week 35)|Randomized but not received treatment|0|||
147180891|NCT05280717|530826926|FG003|Part A (Up to Week 35)|Randomized but not received treatment|0|||
147180892|NCT05280717|530826927|FG004|Part A (Up to Week 35)|Randomized but not received treatment|0|||
147180893|NCT05280717|530826928|FG005|Part A (Up to Week 35)|Randomized but not received treatment|0|||
147180894|NCT05280717|530826929|FG006|Part A (Up to Week 35)|Randomized but not received treatment|0|||
147180895|NCT05280717|530826923|FG000|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|0|||
147656240|NCT02959918|532564962|FG011|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
147656241|NCT02959918|532564963|FG012|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
147656242|NCT02959918|532564964|FG013|Overall Study|Subject Hospitalized, out of window for next dosing period|0|||
147656243|NCT02959918|532564951|FG000|Overall Study|PI Discretion due to abnormal Hgb results|0|||
147656244|NCT02959918|532564952|FG001|Overall Study|PI Discretion due to abnormal Hgb results|0|||
147656245|NCT02959918|532564953|FG002|Overall Study|PI Discretion due to abnormal Hgb results|0|||
147656246|NCT02959918|532564954|FG003|Overall Study|PI Discretion due to abnormal Hgb results|0|||
147656247|NCT02959918|532564955|FG004|Overall Study|PI Discretion due to abnormal Hgb results|0|||
147180896|NCT05280717|530826924|FG001|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|1|||
147180897|NCT05280717|530826925|FG002|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|0|||
147180898|NCT05280717|530826926|FG003|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|0|||
147180899|NCT05280717|530826927|FG004|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|0|||
147180900|NCT05280717|530826928|FG005|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|0|||
147180901|NCT05280717|530826929|FG006|Part A (Up to Week 35)|Participant was randomized for treatment arm 2 but dosed in treatment arm 4|0|||
147656248|NCT02959918|532564956|FG005|Overall Study|PI Discretion due to abnormal Hgb results|0|||
147656249|NCT02959918|532564957|FG006|Overall Study|PI Discretion due to abnormal Hgb results|0|||
147656250|NCT02959918|532564958|FG007|Overall Study|PI Discretion due to abnormal Hgb results|0|||
147656251|NCT02959918|532564959|FG008|Overall Study|PI Discretion due to abnormal Hgb results|1|||
147656252|NCT02959918|532564960|FG009|Overall Study|PI Discretion due to abnormal Hgb results|0|||
147180902|NCT05280717|530826923|FG000|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|0|||
147180903|NCT05280717|530826924|FG001|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|0|||
147180904|NCT05280717|530826925|FG002|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|1|||
147180905|NCT05280717|530826926|FG003|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|0|||
147180906|NCT05280717|530826927|FG004|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|0|||
147180907|NCT05280717|530826928|FG005|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|0|||
147180908|NCT05280717|530826929|FG006|Part A (Up to Week 35)|Participant was randomized for treatment arm 3 but dosed in treatment arm 4|0|||
147180909|NCT05280717|530826923|FG000|Part C (Up to Week 35)|Withdrawal by Subject|0|||
147180910|NCT05280717|530826924|FG001|Part C (Up to Week 35)|Withdrawal by Subject|0|||
147180911|NCT05280717|530826925|FG002|Part C (Up to Week 35)|Withdrawal by Subject|0|||
147180912|NCT05280717|530826926|FG003|Part C (Up to Week 35)|Withdrawal by Subject|0|||
147180913|NCT05280717|530826927|FG004|Part C (Up to Week 35)|Withdrawal by Subject|0|||
147180914|NCT05280717|530826928|FG005|Part C (Up to Week 35)|Withdrawal by Subject|2|||
147180915|NCT05280717|530826929|FG006|Part C (Up to Week 35)|Withdrawal by Subject|0|||
147180916|NCT05280717|530826923|FG000|Part C (Up to Week 35)|Enrolled but not received treatment|0|||
147180917|NCT05280717|530826924|FG001|Part C (Up to Week 35)|Enrolled but not received treatment|0|||
147180918|NCT05280717|530826925|FG002|Part C (Up to Week 35)|Enrolled but not received treatment|0|||
147180919|NCT05280717|530826926|FG003|Part C (Up to Week 35)|Enrolled but not received treatment|0|||
147180920|NCT05280717|530826927|FG004|Part C (Up to Week 35)|Enrolled but not received treatment|0|||
147180921|NCT05280717|530826928|FG005|Part C (Up to Week 35)|Enrolled but not received treatment|2|||
147180922|NCT05280717|530826929|FG006|Part C (Up to Week 35)|Enrolled but not received treatment|0|||
147180923|NCT00080301|530826930|FG000|Overall Study|Randomized but Never Treated|5|||
147180924|NCT00080301|530826931|FG001|Overall Study|Randomized but Never Treated|10|||
147180925|NCT00080301|530826930|FG000|Overall Study|Still on Treatment as of CSR date|0|||
147180926|NCT00080301|530826931|FG001|Overall Study|Still on Treatment as of CSR date|1|||
147180927|NCT01397461|530826932|FG000|Overall Study|Withdrawal by Subject|2|||
147180928|NCT01397461|530826933|FG001|Overall Study|Withdrawal by Subject|1|||
147245819|NCT02207244|531070826|FG006|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
147245820|NCT02207244|531070827|FG007|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
147245821|NCT02207244|531070828|FG008|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
147326403|NCT02014558|531359710|FG010|Overall Study|Lack of Efficacy|16|||
147656253|NCT02959918|532564961|FG010|Overall Study|PI Discretion due to abnormal Hgb results|0|||
147656254|NCT02959918|532564962|FG011|Overall Study|PI Discretion due to abnormal Hgb results|0|||
147180929|NCT01397461|530826934|FG002|Overall Study|Withdrawal by Subject|0|||
147180930|NCT01397461|530826932|FG000|Overall Study|Lost to Follow-up|0|||
147180931|NCT01397461|530826933|FG001|Overall Study|Lost to Follow-up|2|||
147180932|NCT01397461|530826934|FG002|Overall Study|Lost to Follow-up|1|||
147180933|NCT01397461|530826932|FG000|Overall Study|Lack of Efficacy|0|||
147180934|NCT01397461|530826933|FG001|Overall Study|Lack of Efficacy|3|||
147180935|NCT01397461|530826934|FG002|Overall Study|Lack of Efficacy|0|||
147180936|NCT01397461|530826932|FG000|Overall Study|Not treated|0|||
147180937|NCT01397461|530826933|FG001|Overall Study|Not treated|0|||
147180938|NCT01397461|530826934|FG002|Overall Study|Not treated|1|||
147180939|NCT05729568|530826935|FG000|Overall Study|Still on Study|52|||
147180940|NCT05729568|530826936|FG001|Overall Study|Still on Study|26|||
147180941|NCT05729568|530826935|FG000|Overall Study|Randomized but Never Treated|3|||
147180942|NCT05729568|530826936|FG001|Overall Study|Randomized but Never Treated|0|||
147180943|NCT05729568|530826935|FG000|Overall Study|Adverse Event|0|||
147180944|NCT05729568|530826936|FG001|Overall Study|Adverse Event|1|||
147180945|NCT05729568|530826935|FG000|Overall Study|Investigator's Discretion|1|||
147180946|NCT05729568|530826936|FG001|Overall Study|Investigator's Discretion|0|||
147180947|NCT04181762|530826937|FG000|Overall Study|Adverse Event|1|||
147180948|NCT04181762|530826938|FG001|Overall Study|Adverse Event|3|||
147180949|NCT04181762|530826937|FG000|Overall Study|Lost to Follow-up|1|||
147180950|NCT04181762|530826938|FG001|Overall Study|Lost to Follow-up|1|||
147180951|NCT04181762|530826937|FG000|Overall Study|Physician Decision|1|||
147180952|NCT04181762|530826938|FG001|Overall Study|Physician Decision|3|||
147180953|NCT04181762|530826937|FG000|Overall Study|Pregnancy|0|||
147180954|NCT04181762|530826938|FG001|Overall Study|Pregnancy|1|||
147180955|NCT04181762|530826937|FG000|Overall Study|Lack of Efficacy|2|||
147180956|NCT04181762|530826938|FG001|Overall Study|Lack of Efficacy|2|||
147180957|NCT04181762|530826937|FG000|Overall Study|Study terminated by sponsor|95|||
147180958|NCT04181762|530826938|FG001|Overall Study|Study terminated by sponsor|97|||
147180959|NCT04181762|530826937|FG000|Overall Study|Subject decision|11|||
147180960|NCT04181762|530826938|FG001|Overall Study|Subject decision|4|||
147180961|NCT04181762|530826937|FG000|Overall Study|Death|1|||
147180962|NCT04181762|530826938|FG001|Overall Study|Death|1|||
147180963|NCT04181762|530826937|FG000|Overall Study|Protocol deviation|1|||
147180964|NCT04181762|530826938|FG001|Overall Study|Protocol deviation|0|||
147180965|NCT04181762|530826937|FG000|Overall Study|Withdrawal of informed consent|1|||
147180966|NCT04181762|530826938|FG001|Overall Study|Withdrawal of informed consent|3|||
147180967|NCT01514201|530826948|FG000|PHASE I: Veliparib + Radiation Therapy|Lack of Efficacy|1|||
147180968|NCT01514201|530826949|FG001|PHASE I: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
147180969|NCT01514201|530826950|FG002|PHASE I: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
147180970|NCT01514201|530826951|FG003|PHASE I: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
147180971|NCT01514201|530826948|FG000|PHASE I: Maintenance With Veliparib/TMZ|Adverse Event|0|||
147180972|NCT01514201|530826949|FG001|PHASE I: Maintenance With Veliparib/TMZ|Adverse Event|1|||
147180973|NCT01514201|530826950|FG002|PHASE I: Maintenance With Veliparib/TMZ|Adverse Event|1|||
147180974|NCT01514201|530826951|FG003|PHASE I: Maintenance With Veliparib/TMZ|Adverse Event|0|||
147180975|NCT01514201|530826948|FG000|PHASE I: Maintenance With Veliparib/TMZ|Lack of Efficacy|4|||
147180976|NCT01514201|530826949|FG001|PHASE I: Maintenance With Veliparib/TMZ|Lack of Efficacy|4|||
147180977|NCT01514201|530826950|FG002|PHASE I: Maintenance With Veliparib/TMZ|Lack of Efficacy|5|||
147180978|NCT01514201|530826951|FG003|PHASE I: Maintenance With Veliparib/TMZ|Lack of Efficacy|0|||
147180979|NCT01514201|530826948|FG000|PHASE I: Maintenance With Veliparib/TMZ|Withdrawal by Subject|1|||
147180980|NCT01514201|530826949|FG001|PHASE I: Maintenance With Veliparib/TMZ|Withdrawal by Subject|1|||
147180981|NCT01514201|530826950|FG002|PHASE I: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0|||
147180982|NCT01514201|530826951|FG003|PHASE I: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0|||
147180983|NCT01514201|530826948|FG000|PHASE II: Veliparib + Radiation Therapy|Ineligible|0|||
147180984|NCT01514201|530826949|FG001|PHASE II: Veliparib + Radiation Therapy|Ineligible|0|||
147180985|NCT01514201|530826950|FG002|PHASE II: Veliparib + Radiation Therapy|Ineligible|0|||
147180986|NCT01514201|530826951|FG003|PHASE II: Veliparib + Radiation Therapy|Ineligible|1|||
147245822|NCT02207244|531070829|FG009|Open-label Guselkumab: Week 72-264|Pregnancy|0|||
147245823|NCT02207244|531070830|FG010|Open-label Guselkumab: Week 72-264|Pregnancy|2|||
147245824|NCT01866930|531070832|FG000|Treatment Period|Other|1|||
147180987|NCT01514201|530826948|FG000|PHASE II: Veliparib + Radiation Therapy|Adverse Event|0|||
147180988|NCT01514201|530826949|FG001|PHASE II: Veliparib + Radiation Therapy|Adverse Event|0|||
147180989|NCT01514201|530826950|FG002|PHASE II: Veliparib + Radiation Therapy|Adverse Event|0|||
147245825|NCT01866930|531070833|FG001|Treatment Period|Other|0|||
147245826|NCT01866930|531070832|FG000|Treatment Period|Death|0|||
147245827|NCT01866930|531070833|FG001|Treatment Period|Death|2|||
147245828|NCT01866930|531070832|FG000|Treatment Period|Poor/non compliance|0|||
147180990|NCT01514201|530826951|FG003|PHASE II: Veliparib + Radiation Therapy|Adverse Event|2|||
147180991|NCT01514201|530826948|FG000|PHASE II: Veliparib + Radiation Therapy|Death|0|||
147245829|NCT01866930|531070833|FG001|Treatment Period|Poor/non compliance|2|||
147245830|NCT01866930|531070832|FG000|Treatment Period|No longer meets study criteria|0|||
147245831|NCT01866930|531070833|FG001|Treatment Period|No longer meets study criteria|1|||
147245832|NCT01866930|531070832|FG000|Treatment Period|Withdrawal by Subject|2|||
147656255|NCT02959918|532564963|FG012|Overall Study|PI Discretion due to abnormal Hgb results|0|||
147656256|NCT02959918|532564964|FG013|Overall Study|PI Discretion due to abnormal Hgb results|0|||
147656257|NCT02959918|532564951|FG000|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
147656258|NCT02959918|532564952|FG001|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
147656259|NCT02959918|532564953|FG002|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
147656260|NCT02959918|532564954|FG003|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
147180992|NCT01514201|530826949|FG001|PHASE II: Veliparib + Radiation Therapy|Death|0|||
147180993|NCT01514201|530826950|FG002|PHASE II: Veliparib + Radiation Therapy|Death|0|||
147180994|NCT01514201|530826951|FG003|PHASE II: Veliparib + Radiation Therapy|Death|1|||
147180995|NCT01514201|530826948|FG000|PHASE II: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
147180996|NCT01514201|530826949|FG001|PHASE II: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
147180997|NCT01514201|530826950|FG002|PHASE II: Veliparib + Radiation Therapy|Lack of Efficacy|0|||
147180998|NCT01514201|530826951|FG003|PHASE II: Veliparib + Radiation Therapy|Lack of Efficacy|2|||
147180999|NCT01514201|530826948|FG000|PHASE II: Veliparib + Radiation Therapy|Withdrawal by Subject|0|||
147181000|NCT01514201|530826949|FG001|PHASE II: Veliparib + Radiation Therapy|Withdrawal by Subject|0|||
147181001|NCT01514201|530826950|FG002|PHASE II: Veliparib + Radiation Therapy|Withdrawal by Subject|0|||
147181002|NCT01514201|530826951|FG003|PHASE II: Veliparib + Radiation Therapy|Withdrawal by Subject|6|||
147181003|NCT01514201|530826948|FG000|PHASE II: Maintenance With Veliparib/TMZ|Adverse Event|0|||
147181004|NCT01514201|530826949|FG001|PHASE II: Maintenance With Veliparib/TMZ|Adverse Event|0|||
147181005|NCT01514201|530826950|FG002|PHASE II: Maintenance With Veliparib/TMZ|Adverse Event|0|||
147181006|NCT01514201|530826951|FG003|PHASE II: Maintenance With Veliparib/TMZ|Adverse Event|4|||
147181007|NCT01514201|530826948|FG000|PHASE II: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0|||
147181008|NCT01514201|530826949|FG001|PHASE II: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0|||
147181009|NCT01514201|530826950|FG002|PHASE II: Maintenance With Veliparib/TMZ|Withdrawal by Subject|0|||
147181010|NCT01514201|530826951|FG003|PHASE II: Maintenance With Veliparib/TMZ|Withdrawal by Subject|7|||
147181011|NCT01514201|530826948|FG000|PHASE II: Maintenance With Veliparib/TMZ|Lack of Efficacy|0|||
147181012|NCT01514201|530826949|FG001|PHASE II: Maintenance With Veliparib/TMZ|Lack of Efficacy|0|||
147181013|NCT01514201|530826950|FG002|PHASE II: Maintenance With Veliparib/TMZ|Lack of Efficacy|0|||
147181014|NCT01514201|530826951|FG003|PHASE II: Maintenance With Veliparib/TMZ|Lack of Efficacy|22|||
147181015|NCT05888181|530826953|FG000|Overall Study|Lost to Follow-up|1|||
147181016|NCT05888181|530826954|FG001|Overall Study|Lost to Follow-up|1|||
147181017|NCT05888181|530826955|FG002|Overall Study|Lost to Follow-up|0|||
147181018|NCT00637416|530826957|FG000|Overall Study|Lost to Follow-up|1|||
147181019|NCT00637416|530826958|FG001|Overall Study|Lost to Follow-up|1|||
147181020|NCT00637416|530826957|FG000|Overall Study|Unable to take study drug|0|||
147181021|NCT00637416|530826958|FG001|Overall Study|Unable to take study drug|1|||
147181022|NCT02534909|530826969|FG000|Treatment Period 1 to 3 (up to Week 312)|Withdrawal by Subject|1|||
147181023|NCT00132808|530826970|FG000|Stratum I|Adverse Event|2|||
147181024|NCT00132808|530826971|FG001|Stratum I|Adverse Event|1|||
147181025|NCT00132808|530826972|FG002|Stratum I|Adverse Event|0|||
147181026|NCT00132808|530826970|FG000|Stratum I|Lost to Follow-up|3|||
147181027|NCT00132808|530826971|FG001|Stratum I|Lost to Follow-up|4|||
147181028|NCT00132808|530826972|FG002|Stratum I|Lost to Follow-up|1|||
147181029|NCT00132808|530826970|FG000|Stratum I|Withdrawal by Subject|4|||
147181030|NCT00132808|530826971|FG001|Stratum I|Withdrawal by Subject|7|||
147181031|NCT00132808|530826972|FG002|Stratum I|Withdrawal by Subject|3|||
147245833|NCT01866930|531070833|FG001|Treatment Period|Withdrawal by Subject|8|||
147245834|NCT01866930|531070832|FG000|Treatment Period|Lack of Efficacy|1|||
147245835|NCT01866930|531070833|FG001|Treatment Period|Lack of Efficacy|9|||
147245836|NCT01866930|531070832|FG000|Treatment Period|Adverse Event|4|||
147245837|NCT01866930|531070833|FG001|Treatment Period|Adverse Event|12|||
147245838|NCT01866930|531070832|FG000|Treatment Period|Lost to Follow-up|1|||
147245839|NCT01866930|531070833|FG001|Treatment Period|Lost to Follow-up|1|||
147245840|NCT01866930|531070832|FG000|Follow-up Period|Lost to Follow-up|1|||
147245841|NCT01866930|531070833|FG001|Follow-up Period|Lost to Follow-up|1|||
147245842|NCT01866930|531070832|FG000|Follow-up Period|Other|1|||
147245843|NCT01866930|531070833|FG001|Follow-up Period|Other|5|||
147245844|NCT01866930|531070832|FG000|Follow-up Period|No longer required per protocol|1|||
147245845|NCT01866930|531070833|FG001|Follow-up Period|No longer required per protocol|0|||
147245846|NCT01866930|531070832|FG000|Follow-up Period|Withdrawal by Subject|3|||
147245847|NCT01866930|531070833|FG001|Follow-up Period|Withdrawal by Subject|3|||
147245848|NCT02521870|531070840|FG000|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
147245849|NCT02521870|531070841|FG001|Phase 1: Dose Escalation|Withdrawal by Subject|1|||
147245850|NCT02521870|531070842|FG002|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
147245851|NCT02521870|531070843|FG003|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
147245852|NCT02521870|531070844|FG004|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
147181032|NCT00132808|530826970|FG000|Stratum I|Abnormal test procedure result (s)|0|||
147181033|NCT00132808|530826971|FG001|Stratum I|Abnormal test procedure result (s)|0|||
147181034|NCT00132808|530826972|FG002|Stratum I|Abnormal test procedure result (s)|1|||
147181035|NCT00132808|530826970|FG000|Stratum II|Adverse Event|1|||
147326404|NCT02014558|531359711|FG011|Overall Study|Lack of Efficacy|8|||
147245853|NCT02521870|531070845|FG005|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
147245854|NCT02521870|531070846|FG006|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
147245855|NCT02521870|531070847|FG007|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
147245856|NCT02521870|531070848|FG008|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
147245857|NCT02521870|531070849|FG009|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
147245858|NCT02521870|531070850|FG010|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
147245859|NCT02521870|531070851|FG011|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
147245860|NCT02521870|531070840|FG000|Phase 1: Dose Escalation|Adverse Event|2|||
147245861|NCT02521870|531070841|FG001|Phase 1: Dose Escalation|Adverse Event|1|||
147245862|NCT02521870|531070842|FG002|Phase 1: Dose Escalation|Adverse Event|0|||
147245863|NCT02521870|531070843|FG003|Phase 1: Dose Escalation|Adverse Event|0|||
147245864|NCT02521870|531070844|FG004|Phase 1: Dose Escalation|Adverse Event|0|||
147245865|NCT02521870|531070845|FG005|Phase 1: Dose Escalation|Adverse Event|0|||
147245866|NCT02521870|531070846|FG006|Phase 1: Dose Escalation|Adverse Event|0|||
147245867|NCT02521870|531070847|FG007|Phase 1: Dose Escalation|Adverse Event|0|||
147245868|NCT02521870|531070848|FG008|Phase 1: Dose Escalation|Adverse Event|0|||
147245869|NCT02521870|531070849|FG009|Phase 1: Dose Escalation|Adverse Event|0|||
147245870|NCT02521870|531070850|FG010|Phase 1: Dose Escalation|Adverse Event|0|||
147245871|NCT02521870|531070851|FG011|Phase 1: Dose Escalation|Adverse Event|0|||
147245872|NCT02521870|531070840|FG000|Phase 1: Dose Escalation|Progressive Disease|3|||
147245873|NCT02521870|531070841|FG001|Phase 1: Dose Escalation|Progressive Disease|2|||
147245874|NCT02521870|531070842|FG002|Phase 1: Dose Escalation|Progressive Disease|4|||
147245875|NCT02521870|531070843|FG003|Phase 1: Dose Escalation|Progressive Disease|6|||
147245876|NCT02521870|531070844|FG004|Phase 1: Dose Escalation|Progressive Disease|0|||
147245877|NCT02521870|531070845|FG005|Phase 1: Dose Escalation|Progressive Disease|0|||
147245878|NCT02521870|531070846|FG006|Phase 1: Dose Escalation|Progressive Disease|0|||
147245879|NCT02521870|531070847|FG007|Phase 1: Dose Escalation|Progressive Disease|0|||
147245880|NCT02521870|531070848|FG008|Phase 1: Dose Escalation|Progressive Disease|0|||
147245881|NCT02521870|531070849|FG009|Phase 1: Dose Escalation|Progressive Disease|0|||
147245882|NCT02521870|531070850|FG010|Phase 1: Dose Escalation|Progressive Disease|0|||
147245883|NCT02521870|531070851|FG011|Phase 1: Dose Escalation|Progressive Disease|0|||
147245884|NCT02521870|531070840|FG000|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
147245885|NCT02521870|531070841|FG001|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
147245886|NCT02521870|531070842|FG002|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
147245887|NCT02521870|531070843|FG003|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
147245888|NCT02521870|531070844|FG004|Phase 2: Dose Expansion|Withdrawal by Subject|5|||
147245889|NCT02521870|531070845|FG005|Phase 2: Dose Expansion|Withdrawal by Subject|1|||
147245890|NCT02521870|531070846|FG006|Phase 2: Dose Expansion|Withdrawal by Subject|1|||
147245891|NCT02521870|531070847|FG007|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
147245892|NCT02521870|531070848|FG008|Phase 2: Dose Expansion|Withdrawal by Subject|1|||
147245893|NCT02521870|531070849|FG009|Phase 2: Dose Expansion|Withdrawal by Subject|1|||
147245894|NCT02521870|531070850|FG010|Phase 2: Dose Expansion|Withdrawal by Subject|2|||
147326405|NCT02014558|531359712|FG012|Overall Study|Lack of Efficacy|5|||
147326406|NCT02014558|531359700|FG000|Overall Study|Lost to Follow-up|0|||
147326407|NCT02014558|531359701|FG001|Overall Study|Lost to Follow-up|0|||
147181036|NCT00132808|530826971|FG001|Stratum II|Adverse Event|2|||
147181037|NCT00132808|530826972|FG002|Stratum II|Adverse Event|1|||
147181038|NCT00132808|530826970|FG000|Stratum II|Death|1|||
147181039|NCT00132808|530826971|FG001|Stratum II|Death|0|||
147181040|NCT00132808|530826972|FG002|Stratum II|Death|0|||
147181041|NCT00132808|530826970|FG000|Stratum II|Lost to Follow-up|2|||
147181042|NCT00132808|530826971|FG001|Stratum II|Lost to Follow-up|2|||
147181043|NCT00132808|530826972|FG002|Stratum II|Lost to Follow-up|1|||
147181044|NCT00132808|530826970|FG000|Stratum II|Protocol Violation|0|||
147181045|NCT00132808|530826971|FG001|Stratum II|Protocol Violation|2|||
147181046|NCT00132808|530826972|FG002|Stratum II|Protocol Violation|1|||
147181047|NCT00132808|530826970|FG000|Stratum II|Withdrawal by Subject|4|||
147181048|NCT00132808|530826971|FG001|Stratum II|Withdrawal by Subject|9|||
147181049|NCT00132808|530826972|FG002|Stratum II|Withdrawal by Subject|6|||
147181050|NCT04137731|530826975|FG000|Overall Study|Surgery Cancellation|1|||
147181051|NCT04137731|530826976|FG001|Overall Study|Surgery Cancellation|2|||
147245895|NCT02521870|531070851|FG011|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
147326408|NCT02014558|531359702|FG002|Overall Study|Lost to Follow-up|0|||
147181052|NCT04137731|530826975|FG000|Overall Study|Withdrawal by Subject|2|||
147245896|NCT02521870|531070840|FG000|Phase 2: Dose Expansion|Adverse Event|0|||
147245897|NCT02521870|531070841|FG001|Phase 2: Dose Expansion|Adverse Event|0|||
147245898|NCT02521870|531070842|FG002|Phase 2: Dose Expansion|Adverse Event|0|||
147245899|NCT02521870|531070843|FG003|Phase 2: Dose Expansion|Adverse Event|0|||
147326409|NCT02014558|531359703|FG003|Overall Study|Lost to Follow-up|0|||
147448447|NCT01187953|531805731|FG000|Overall Study|Death|11|||
147181053|NCT04137731|530826976|FG001|Overall Study|Withdrawal by Subject|0|||
147181054|NCT04137731|530826975|FG000|Overall Study|Protocol Violation|0|||
147181055|NCT04137731|530826976|FG001|Overall Study|Protocol Violation|1|||
147181056|NCT00362648|530826977|FG000|Overall Study|Adverse Event|12|||
147181057|NCT00362648|530826978|FG001|Overall Study|Adverse Event|21|||
147181058|NCT00362648|530826979|FG002|Overall Study|Adverse Event|1|||
147181059|NCT00362648|530826980|FG003|Overall Study|Adverse Event|0|||
147181060|NCT00362648|530826977|FG000|Overall Study|Lost to Follow-up|62|||
147181061|NCT00362648|530826978|FG001|Overall Study|Lost to Follow-up|69|||
147181062|NCT00362648|530826979|FG002|Overall Study|Lost to Follow-up|4|||
147181063|NCT00362648|530826980|FG003|Overall Study|Lost to Follow-up|3|||
147181064|NCT00362648|530826977|FG000|Overall Study|Protocol Violation|4|||
147181065|NCT00362648|530826978|FG001|Overall Study|Protocol Violation|2|||
147181066|NCT00362648|530826979|FG002|Overall Study|Protocol Violation|2|||
147181067|NCT00362648|530826980|FG003|Overall Study|Protocol Violation|2|||
147181068|NCT00362648|530826977|FG000|Overall Study|Withdrawal by Subject|48|||
147181069|NCT00362648|530826978|FG001|Overall Study|Withdrawal by Subject|42|||
147181070|NCT00362648|530826979|FG002|Overall Study|Withdrawal by Subject|2|||
147181071|NCT00362648|530826980|FG003|Overall Study|Withdrawal by Subject|6|||
147181072|NCT02204072|530826981|FG000|Overall Study|Discontinued Enzalutamide due to withdrawal by subject|1|||
147181073|NCT02204072|530826982|FG001|Overall Study|Discontinued Enzalutamide due to withdrawal by subject|0|||
147181074|NCT02204072|530826983|FG002|Overall Study|Discontinued Enzalutamide due to withdrawal by subject|2|||
147326410|NCT02014558|531359704|FG004|Overall Study|Lost to Follow-up|0|||
147326411|NCT02014558|531359705|FG005|Overall Study|Lost to Follow-up|0|||
147181075|NCT02204072|530826984|FG003|Overall Study|Discontinued Enzalutamide due to withdrawal by subject|9|||
147181076|NCT02204072|530826985|FG004|Overall Study|Discontinued Enzalutamide due to withdrawal by subject|6|||
147181077|NCT02204072|530826981|FG000|Overall Study|Discontinued Enzalutamide due to adverse events|0|||
147181078|NCT02204072|530826982|FG001|Overall Study|Discontinued Enzalutamide due to adverse events|3|||
147181079|NCT02204072|530826983|FG002|Overall Study|Discontinued Enzalutamide due to adverse events|1|||
147181080|NCT02204072|530826984|FG003|Overall Study|Discontinued Enzalutamide due to adverse events|6|||
147181081|NCT02204072|530826985|FG004|Overall Study|Discontinued Enzalutamide due to adverse events|6|||
147181082|NCT02204072|530826981|FG000|Overall Study|Discontinued Enzalutamide due to progressive disease|2|||
147181083|NCT02204072|530826982|FG001|Overall Study|Discontinued Enzalutamide due to progressive disease|4|||
147181084|NCT02204072|530826983|FG002|Overall Study|Discontinued Enzalutamide due to progressive disease|19|||
147181085|NCT02204072|530826984|FG003|Overall Study|Discontinued Enzalutamide due to progressive disease|26|||
147181086|NCT02204072|530826985|FG004|Overall Study|Discontinued Enzalutamide due to progressive disease|31|||
147181087|NCT02204072|530826981|FG000|Overall Study|Discontinued Enzalutamide due to other reason|0|||
147181088|NCT02204072|530826982|FG001|Overall Study|Discontinued Enzalutamide due to other reason|0|||
147181089|NCT02204072|530826983|FG002|Overall Study|Discontinued Enzalutamide due to other reason|2|||
147181090|NCT02204072|530826984|FG003|Overall Study|Discontinued Enzalutamide due to other reason|0|||
147181091|NCT02204072|530826985|FG004|Overall Study|Discontinued Enzalutamide due to other reason|0|||
147181092|NCT03983304|530826986|FG000|Overall Study|Withdrawal by Subject|5|||
147181093|NCT03983304|530826986|FG000|Overall Study|Lost to Follow-up|2|||
147181094|NCT01587040|530826992|FG000|Overall Study|Protocol Violation|0|||
147181095|NCT01587040|530826993|FG001|Overall Study|Protocol Violation|0|||
147181096|NCT01587040|530826994|FG002|Overall Study|Protocol Violation|1|||
147181097|NCT01587040|530826995|FG003|Overall Study|Protocol Violation|0|||
147181098|NCT01587040|530826992|FG000|Overall Study|Adverse Event|0|||
147181099|NCT01587040|530826993|FG001|Overall Study|Adverse Event|1|||
147181100|NCT01587040|530826994|FG002|Overall Study|Adverse Event|10|||
147181101|NCT01587040|530826995|FG003|Overall Study|Adverse Event|0|||
147181102|NCT01587040|530826992|FG000|Overall Study|Disease progression|12|||
147181103|NCT01587040|530826993|FG001|Overall Study|Disease progression|1|||
147181104|NCT01587040|530826994|FG002|Overall Study|Disease progression|15|||
147181105|NCT01587040|530826995|FG003|Overall Study|Disease progression|3|||
147181106|NCT01587040|530826992|FG000|Overall Study|Other than specified|5|||
147181107|NCT01587040|530826993|FG001|Overall Study|Other than specified|1|||
147181108|NCT01587040|530826994|FG002|Overall Study|Other than specified|11|||
147181109|NCT01587040|530826995|FG003|Overall Study|Other than specified|1|||
147181110|NCT04300309|530826998|FG000|Overall Study|Lost to Follow-up|1|||
147181111|NCT04300309|530826999|FG001|Overall Study|Lost to Follow-up|0|||
147181112|NCT04346654|530827001|FG000|Overall Study|Adverse Event|2|||
147181113|NCT04346654|530827002|FG001|Overall Study|Adverse Event|0|||
147181114|NCT04346654|530827001|FG000|Overall Study|Non-response|1|||
147181115|NCT04346654|530827002|FG001|Overall Study|Non-response|1|||
147181116|NCT04346654|530827001|FG000|Overall Study|Withdrawal by Subject|2|||
147181117|NCT04346654|530827002|FG001|Overall Study|Withdrawal by Subject|0|||
147181118|NCT04346654|530827001|FG000|Overall Study|Lost to Follow-up|0|||
147326412|NCT02014558|531359706|FG006|Overall Study|Lost to Follow-up|0|||
147326413|NCT02014558|531359707|FG007|Overall Study|Lost to Follow-up|0|||
147326414|NCT02014558|531359708|FG008|Overall Study|Lost to Follow-up|0|||
147326415|NCT02014558|531359709|FG009|Overall Study|Lost to Follow-up|0|||
147326416|NCT02014558|531359710|FG010|Overall Study|Lost to Follow-up|1|||
147326417|NCT02014558|531359711|FG011|Overall Study|Lost to Follow-up|0|||
147326418|NCT02014558|531359712|FG012|Overall Study|Lost to Follow-up|0|||
147181119|NCT04346654|530827002|FG001|Overall Study|Lost to Follow-up|1|||
147181120|NCT04346654|530827001|FG000|Overall Study|Pregnancy|0|||
147326419|NCT02014558|531359700|FG000|Overall Study|Progressive Disease|1|||
147181121|NCT04346654|530827002|FG001|Overall Study|Pregnancy|1|||
147181122|NCT02343406|530827005|FG000|Overall Study|Progressive disease|72|||
147181123|NCT02343406|530827006|FG001|Overall Study|Progressive disease|70|||
147181124|NCT02343406|530827007|FG002|Overall Study|Progressive disease|43|||
147181125|NCT02343406|530827008|FG003|Overall Study|Progressive disease|15|||
147181126|NCT02343406|530827009|FG004|Overall Study|Progressive disease|5|||
147181127|NCT02343406|530827005|FG000|Overall Study|Adverse Event|6|||
147181128|NCT02343406|530827006|FG001|Overall Study|Adverse Event|8|||
147181129|NCT02343406|530827007|FG002|Overall Study|Adverse Event|6|||
147181130|NCT02343406|530827008|FG003|Overall Study|Adverse Event|3|||
147181131|NCT02343406|530827009|FG004|Overall Study|Adverse Event|0|||
147181132|NCT02343406|530827005|FG000|Overall Study|Withdrawal by Subject|6|||
147181133|NCT02343406|530827006|FG001|Overall Study|Withdrawal by Subject|4|||
147181134|NCT02343406|530827007|FG002|Overall Study|Withdrawal by Subject|8|||
147181135|NCT02343406|530827008|FG003|Overall Study|Withdrawal by Subject|3|||
147181136|NCT02343406|530827009|FG004|Overall Study|Withdrawal by Subject|0|||
147181137|NCT02343406|530827005|FG000|Overall Study|Death|2|||
147181138|NCT02343406|530827006|FG001|Overall Study|Death|1|||
147181139|NCT02343406|530827007|FG002|Overall Study|Death|0|||
147181140|NCT02343406|530827008|FG003|Overall Study|Death|0|||
147181141|NCT02343406|530827009|FG004|Overall Study|Death|0|||
147181142|NCT02343406|530827005|FG000|Overall Study|Start of a new anti-cancer treatment|0|||
147181143|NCT02343406|530827006|FG001|Overall Study|Start of a new anti-cancer treatment|1|||
147181144|NCT02343406|530827007|FG002|Overall Study|Start of a new anti-cancer treatment|0|||
147181145|NCT02343406|530827008|FG003|Overall Study|Start of a new anti-cancer treatment|1|||
147181146|NCT02343406|530827009|FG004|Overall Study|Start of a new anti-cancer treatment|0|||
147181147|NCT02343406|530827005|FG000|Overall Study|Other primary malignancy|0|||
147181148|NCT02343406|530827006|FG001|Overall Study|Other primary malignancy|1|||
147181149|NCT02343406|530827007|FG002|Overall Study|Other primary malignancy|0|||
147181150|NCT02343406|530827008|FG003|Overall Study|Other primary malignancy|0|||
147181151|NCT02343406|530827009|FG004|Overall Study|Other primary malignancy|0|||
147181152|NCT02343406|530827005|FG000|Overall Study|Other, not specified|2|||
147181153|NCT02343406|530827006|FG001|Overall Study|Other, not specified|1|||
147181154|NCT02343406|530827007|FG002|Overall Study|Other, not specified|1|||
147181155|NCT02343406|530827008|FG003|Overall Study|Other, not specified|4|||
147181156|NCT02343406|530827009|FG004|Overall Study|Other, not specified|0|||
147181157|NCT00858637|530827010|FG000|Active Comparison Phase|Adverse Event|14|||
147181158|NCT00858637|530827011|FG001|Active Comparison Phase|Adverse Event|0|||
147181159|NCT00858637|530827012|FG002|Active Comparison Phase|Adverse Event|0|||
147181160|NCT00858637|530827013|FG003|Active Comparison Phase|Adverse Event|9|||
147181161|NCT00858637|530827014|FG004|Active Comparison Phase|Adverse Event|0|||
147181162|NCT00858637|530827015|FG005|Active Comparison Phase|Adverse Event|0|||
147181163|NCT00858637|530827010|FG000|Active Comparison Phase|Death|1|||
147181164|NCT00858637|530827011|FG001|Active Comparison Phase|Death|0|||
147181165|NCT00858637|530827012|FG002|Active Comparison Phase|Death|0|||
147181166|NCT00858637|530827013|FG003|Active Comparison Phase|Death|1|||
147181167|NCT00858637|530827014|FG004|Active Comparison Phase|Death|0|||
147181168|NCT00858637|530827015|FG005|Active Comparison Phase|Death|0|||
147181169|NCT00858637|530827010|FG000|Active Comparison Phase|Physician Decision|1|||
147181170|NCT00858637|530827011|FG001|Active Comparison Phase|Physician Decision|0|||
147326420|NCT02014558|531359701|FG001|Overall Study|Progressive Disease|0|||
147326421|NCT02014558|531359702|FG002|Overall Study|Progressive Disease|1|||
147326422|NCT02014558|531359703|FG003|Overall Study|Progressive Disease|1|||
147326423|NCT02014558|531359704|FG004|Overall Study|Progressive Disease|1|||
147326424|NCT02014558|531359705|FG005|Overall Study|Progressive Disease|2|||
147326425|NCT02014558|531359706|FG006|Overall Study|Progressive Disease|1|||
147181171|NCT00858637|530827012|FG002|Active Comparison Phase|Physician Decision|0|||
147181172|NCT00858637|530827013|FG003|Active Comparison Phase|Physician Decision|1|||
147181173|NCT00858637|530827014|FG004|Active Comparison Phase|Physician Decision|0|||
147181174|NCT00858637|530827015|FG005|Active Comparison Phase|Physician Decision|0|||
147181175|NCT00858637|530827010|FG000|Active Comparison Phase|Withdrawal by Subject|7|||
147181176|NCT00858637|530827011|FG001|Active Comparison Phase|Withdrawal by Subject|0|||
147593368|NCT01421342|532328968|FG001|Continuation of Treatment (Week 12 - 36)|Adverse Event|6|||
147593369|NCT01421342|532328969|FG002|Continuation of Treatment (Week 12 - 36)|Adverse Event|11|||
147593370|NCT01421342|532328967|FG000|Continuation of Treatment (Week 12 - 36)|Withdrawal by Subject|7|||
147593371|NCT01421342|532328968|FG001|Continuation of Treatment (Week 12 - 36)|Withdrawal by Subject|6|||
147593372|NCT01421342|532328969|FG002|Continuation of Treatment (Week 12 - 36)|Withdrawal by Subject|4|||
147181177|NCT00858637|530827012|FG002|Active Comparison Phase|Withdrawal by Subject|0|||
147181178|NCT00858637|530827013|FG003|Active Comparison Phase|Withdrawal by Subject|6|||
147181179|NCT00858637|530827014|FG004|Active Comparison Phase|Withdrawal by Subject|0|||
147181180|NCT00858637|530827015|FG005|Active Comparison Phase|Withdrawal by Subject|0|||
147181181|NCT00858637|530827010|FG000|Active Comparison Phase|Other Reasons|1|||
147181182|NCT00858637|530827011|FG001|Active Comparison Phase|Other Reasons|0|||
147181183|NCT00858637|530827012|FG002|Active Comparison Phase|Other Reasons|0|||
147181184|NCT00858637|530827013|FG003|Active Comparison Phase|Other Reasons|1|||
147181185|NCT00858637|530827014|FG004|Active Comparison Phase|Other Reasons|0|||
147181186|NCT00858637|530827015|FG005|Active Comparison Phase|Other Reasons|0|||
147181187|NCT00858637|530827010|FG000|Placebo-controlled Withdrawal Phase|Death|0|||
147181188|NCT00858637|530827011|FG001|Placebo-controlled Withdrawal Phase|Death|0|||
147181189|NCT00858637|530827012|FG002|Placebo-controlled Withdrawal Phase|Death|1|||
147181190|NCT00858637|530827013|FG003|Placebo-controlled Withdrawal Phase|Death|0|||
147181191|NCT00858637|530827014|FG004|Placebo-controlled Withdrawal Phase|Death|1|||
147181192|NCT00858637|530827015|FG005|Placebo-controlled Withdrawal Phase|Death|0|||
147181193|NCT00858637|530827010|FG000|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0|||
147181194|NCT00858637|530827011|FG001|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0|||
147181195|NCT00858637|530827012|FG002|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0|||
147181196|NCT00858637|530827013|FG003|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0|||
147181197|NCT00858637|530827014|FG004|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|0|||
147181198|NCT00858637|530827015|FG005|Placebo-controlled Withdrawal Phase|Withdrawal by Subject|1|||
147181199|NCT01380834|530827016|FG000|Overall Study|Physician Decision|1|||
147181200|NCT01380834|530827017|FG001|Overall Study|Physician Decision|0|||
147181201|NCT04677504|530827018|FG000|Overall Study|Death|51|||
147181202|NCT04677504|530827019|FG001|Overall Study|Death|49|||
147181203|NCT04677504|530827018|FG000|Overall Study|Progressive Disease|1|||
147181204|NCT04677504|530827019|FG001|Overall Study|Progressive Disease|0|||
147181205|NCT04677504|530827018|FG000|Overall Study|Symptomatic Deterioration|1|||
147181206|NCT04677504|530827019|FG001|Overall Study|Symptomatic Deterioration|0|||
147181207|NCT04677504|530827018|FG000|Overall Study|Withdrawal by Subject|2|||
147181208|NCT04677504|530827019|FG001|Overall Study|Withdrawal by Subject|5|||
147181209|NCT04677504|530827018|FG000|Overall Study|Study Terminated By Sponsor|28|||
147181210|NCT04677504|530827019|FG001|Overall Study|Study Terminated By Sponsor|24|||
147181211|NCT04677504|530827018|FG000|Overall Study|Adverse Event|0|||
147181212|NCT04677504|530827019|FG001|Overall Study|Adverse Event|1|||
147181213|NCT02058563|530827022|FG000|Overall Study|Lost to Follow-up|26|||
147181214|NCT02058563|530827023|FG001|Overall Study|Lost to Follow-up|22|||
147181215|NCT02058563|530827022|FG000|Overall Study|Other (vaccinated later as new subject)|1|||
147181216|NCT02058563|530827023|FG001|Overall Study|Other (vaccinated later as new subject)|0|||
147181217|NCT02058563|530827022|FG000|Overall Study|Consent Withdrawal|1|||
147181218|NCT02058563|530827023|FG001|Overall Study|Consent Withdrawal|1|||
147181219|NCT02058563|530827022|FG000|Overall Study|Other (patient incarcerated)|0|||
147181220|NCT02058563|530827023|FG001|Overall Study|Other (patient incarcerated)|1|||
147181221|NCT04039217|530827024|FG000|Overall Study|Lost to Follow-up|1|||
147181222|NCT00167310|530827025|FG000|Overall Study|Protocol Violation|5|||
147181223|NCT00167310|530827026|FG001|Overall Study|Protocol Violation|3|||
147181224|NCT00167310|530827025|FG000|Overall Study|Withdrawal by Subject|3|||
147181225|NCT00167310|530827026|FG001|Overall Study|Withdrawal by Subject|7|||
147181226|NCT03304873|530827027|FG000|Overall Study|Lost to Follow-up|1|||
147181227|NCT03304873|530827028|FG001|Overall Study|Lost to Follow-up|8|||
147181228|NCT01868477|530827030|FG000|Overall Study|Adverse Event|2|||
147181229|NCT01868477|530827031|FG001|Overall Study|Adverse Event|4|||
147181230|NCT01868477|530827030|FG000|Overall Study|Disease progression|1|||
147181231|NCT01868477|530827031|FG001|Overall Study|Disease progression|1|||
147181232|NCT01868477|530827030|FG000|Overall Study|Withdrawal by Subject|1|||
147181233|NCT01868477|530827031|FG001|Overall Study|Withdrawal by Subject|0|||
147181234|NCT00042991|530827032|FG000|Overall Study|Adverse Event|1|||
147181235|NCT00042991|530827033|FG001|Overall Study|Adverse Event|4|||
147181236|NCT00042991|530827034|FG002|Overall Study|Adverse Event|2|||
147181237|NCT00042991|530827035|FG003|Overall Study|Adverse Event|0|||
147181238|NCT00042991|530827036|FG004|Overall Study|Adverse Event|0|||
147181239|NCT00042991|530827037|FG005|Overall Study|Adverse Event|1|||
147181240|NCT00042991|530827038|FG006|Overall Study|Adverse Event|0|||
147181241|NCT00042991|530827032|FG000|Overall Study|Withdrawal by Subject|0|||
147181242|NCT00042991|530827033|FG001|Overall Study|Withdrawal by Subject|7|||
147181243|NCT00042991|530827034|FG002|Overall Study|Withdrawal by Subject|2|||
147181244|NCT00042991|530827035|FG003|Overall Study|Withdrawal by Subject|0|||
147181245|NCT00042991|530827036|FG004|Overall Study|Withdrawal by Subject|1|||
147181246|NCT00042991|530827037|FG005|Overall Study|Withdrawal by Subject|0|||
147181247|NCT00042991|530827038|FG006|Overall Study|Withdrawal by Subject|0|||
147181248|NCT00042991|530827032|FG000|Overall Study|Disease Progression|5|||
147181249|NCT00042991|530827033|FG001|Overall Study|Disease Progression|29|||
147181250|NCT00042991|530827034|FG002|Overall Study|Disease Progression|2|||
147181251|NCT00042991|530827035|FG003|Overall Study|Disease Progression|2|||
147181252|NCT00042991|530827036|FG004|Overall Study|Disease Progression|1|||
147181253|NCT00042991|530827037|FG005|Overall Study|Disease Progression|4|||
147181254|NCT00042991|530827038|FG006|Overall Study|Disease Progression|2|||
147181255|NCT00042991|530827032|FG000|Overall Study|Alternative Therapy|0|||
147181256|NCT00042991|530827033|FG001|Overall Study|Alternative Therapy|0|||
147181257|NCT00042991|530827034|FG002|Overall Study|Alternative Therapy|0|||
147181258|NCT00042991|530827035|FG003|Overall Study|Alternative Therapy|0|||
147181259|NCT00042991|530827036|FG004|Overall Study|Alternative Therapy|1|||
147181260|NCT00042991|530827037|FG005|Overall Study|Alternative Therapy|0|||
147181261|NCT00042991|530827038|FG006|Overall Study|Alternative Therapy|0|||
147181262|NCT01574651|530827039|FG000|Overall Study|Lost to Follow-up|2|||
147181263|NCT01574651|530827040|FG001|Overall Study|Lost to Follow-up|4|||
147181264|NCT01574651|530827039|FG000|Overall Study|Administrative problems|0|||
147181265|NCT01574651|530827040|FG001|Overall Study|Administrative problems|1|||
147181266|NCT01574651|530827039|FG000|Overall Study|Death|3|||
147181267|NCT01574651|530827040|FG001|Overall Study|Death|3|||
147181268|NCT01574651|530827039|FG000|Overall Study|Patient's inability to use the device|0|||
147181269|NCT01574651|530827040|FG001|Overall Study|Patient's inability to use the device|1|||
147181270|NCT01574651|530827039|FG000|Overall Study|Adverse Event|36|||
147181271|NCT01574651|530827040|FG001|Overall Study|Adverse Event|27|||
147181272|NCT01574651|530827039|FG000|Overall Study|Abnormal laboratory value(s)|1|||
147181273|NCT01574651|530827040|FG001|Overall Study|Abnormal laboratory value(s)|0|||
147181274|NCT01574651|530827039|FG000|Overall Study|Abnormal test procedure result(s)|1|||
147181275|NCT01574651|530827040|FG001|Overall Study|Abnormal test procedure result(s)|1|||
147181276|NCT01574651|530827039|FG000|Overall Study|Unsatisfactory therapeutic effect|6|||
147181277|NCT01574651|530827040|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
147181278|NCT01574651|530827039|FG000|Overall Study|Protocol Violation|3|||
147181279|NCT01574651|530827040|FG001|Overall Study|Protocol Violation|5|||
147181280|NCT01574651|530827039|FG000|Overall Study|Withdrawal by Subject|9|||
147181281|NCT01574651|530827040|FG001|Overall Study|Withdrawal by Subject|10|||
147181282|NCT01101035|530829035|FG000|Overall Study|Adverse Event|191|||
147181283|NCT01101035|530829036|FG001|Overall Study|Adverse Event|172|||
147181284|NCT01101035|530829035|FG000|Overall Study|Major Protocol Deviation|52|||
147181285|NCT01101035|530829036|FG001|Overall Study|Major Protocol Deviation|46|||
147181286|NCT01101035|530829035|FG000|Overall Study|Lost to Follow-up|226|||
147181287|NCT01101035|530829036|FG001|Overall Study|Lost to Follow-up|223|||
147181288|NCT01101035|530829035|FG000|Overall Study|Voluntary Withdrawal|595|||
147181289|NCT01101035|530829036|FG001|Overall Study|Voluntary Withdrawal|587|||
147181290|NCT01101035|530829035|FG000|Overall Study|Reason not Specified|333|||
147181291|NCT01101035|530829036|FG001|Overall Study|Reason not Specified|363|||
147181292|NCT02871635|530829037|FG000|Overall Study|Primary lack of efficacy|4|||
147181293|NCT02871635|530829038|FG001|Overall Study|Primary lack of efficacy|4|||
147181294|NCT02871635|530829037|FG000|Overall Study|Protocol Violation|3|||
147181295|NCT02871635|530829038|FG001|Overall Study|Protocol Violation|1|||
147181296|NCT02871635|530829037|FG000|Overall Study|Lost to Follow-up|1|||
147181297|NCT02871635|530829038|FG001|Overall Study|Lost to Follow-up|2|||
147181298|NCT02871635|530829037|FG000|Overall Study|Pregnancy|0|||
147181299|NCT02871635|530829038|FG001|Overall Study|Pregnancy|2|||
147181300|NCT02871635|530829037|FG000|Overall Study|Physician Decision|1|||
147181301|NCT02871635|530829038|FG001|Overall Study|Physician Decision|1|||
147181302|NCT02871635|530829037|FG000|Overall Study|Withdrawal by Subject|3|||
147181303|NCT02871635|530829038|FG001|Overall Study|Withdrawal by Subject|4|||
147181304|NCT02871635|530829037|FG000|Overall Study|Adverse Event|4|||
147181305|NCT02871635|530829038|FG001|Overall Study|Adverse Event|4|||
147181306|NCT02871635|530829037|FG000|Overall Study|Secondary lack of efficacy|2|||
147181307|NCT02871635|530829038|FG001|Overall Study|Secondary lack of efficacy|1|||
147181308|NCT00412893|530829041|FG000|Overall Study|Adverse Event|31|||
147181309|NCT00412893|530829042|FG001|Overall Study|Adverse Event|53|||
147181310|NCT00412893|530829041|FG000|Overall Study|Death|17|||
147181311|NCT00412893|530829042|FG001|Overall Study|Death|21|||
147181312|NCT00412893|530829041|FG000|Overall Study|Insufficient Therapeutic Response|39|||
147181313|NCT00412893|530829042|FG001|Overall Study|Insufficient Therapeutic Response|23|||
147181314|NCT00412893|530829041|FG000|Overall Study|Lost to Follow-up|2|||
147181315|NCT00412893|530829042|FG001|Overall Study|Lost to Follow-up|1|||
147181316|NCT00412893|530829041|FG000|Overall Study|Violation of Selection at Entry|17|||
147181317|NCT00412893|530829042|FG001|Overall Study|Violation of Selection at Entry|10|||
147181318|NCT00412893|530829041|FG000|Overall Study|Other Protocol Violation|10|||
147181319|NCT00412893|530829042|FG001|Overall Study|Other Protocol Violation|6|||
147181320|NCT00412893|530829041|FG000|Overall Study|Did Not Cooperate|12|||
147181321|NCT00412893|530829042|FG001|Overall Study|Did Not Cooperate|9|||
147181322|NCT00412893|530829041|FG000|Overall Study|Administrative Reason|12|||
147181323|NCT00412893|530829042|FG001|Overall Study|Administrative Reason|15|||
147181324|NCT00412893|530829041|FG000|Overall Study|Randomized but Never Received Study Drug|5|||
147181325|NCT00412893|530829042|FG001|Overall Study|Randomized but Never Received Study Drug|6|||
147181326|NCT00853151|530829043|FG000|Overall Study|Adverse Event|1|||
147181327|NCT00853151|530829044|FG001|Overall Study|Adverse Event|4|||
147181328|NCT00853151|530829045|FG002|Overall Study|Adverse Event|2|||
147181329|NCT00853151|530829046|FG003|Overall Study|Adverse Event|0|||
147181330|NCT00853151|530829043|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|1|||
147181331|NCT00853151|530829044|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
147181332|NCT00853151|530829045|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
147181333|NCT00853151|530829046|FG003|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
147181334|NCT00853151|530829043|FG000|Overall Study|Lost to Follow-up|2|||
147181335|NCT00853151|530829044|FG001|Overall Study|Lost to Follow-up|0|||
147181336|NCT00853151|530829045|FG002|Overall Study|Lost to Follow-up|3|||
147181337|NCT00853151|530829046|FG003|Overall Study|Lost to Follow-up|0|||
147181338|NCT00853151|530829043|FG000|Overall Study|Death|1|||
147181339|NCT00853151|530829044|FG001|Overall Study|Death|0|||
147181340|NCT00853151|530829045|FG002|Overall Study|Death|0|||
147181341|NCT00853151|530829046|FG003|Overall Study|Death|1|||
147181342|NCT00853151|530829043|FG000|Overall Study|Protocol Violation|0|||
147181343|NCT00853151|530829044|FG001|Overall Study|Protocol Violation|0|||
147181344|NCT00853151|530829045|FG002|Overall Study|Protocol Violation|0|||
147181345|NCT00853151|530829046|FG003|Overall Study|Protocol Violation|1|||
147181346|NCT00853151|530829043|FG000|Overall Study|Withdrawal by Subject|5|||
147181347|NCT00853151|530829044|FG001|Overall Study|Withdrawal by Subject|4|||
147181348|NCT00853151|530829045|FG002|Overall Study|Withdrawal by Subject|2|||
147181349|NCT00853151|530829046|FG003|Overall Study|Withdrawal by Subject|1|||
147181350|NCT00853151|530829043|FG000|Overall Study|Physician Decision|0|||
147181351|NCT00853151|530829044|FG001|Overall Study|Physician Decision|2|||
147181352|NCT00853151|530829045|FG002|Overall Study|Physician Decision|1|||
147181353|NCT00853151|530829046|FG003|Overall Study|Physician Decision|0|||
147181354|NCT00853151|530829043|FG000|Overall Study|Sponsor Decision|0|||
147181355|NCT00853151|530829044|FG001|Overall Study|Sponsor Decision|3|||
147181356|NCT00853151|530829045|FG002|Overall Study|Sponsor Decision|0|||
147181357|NCT00853151|530829046|FG003|Overall Study|Sponsor Decision|0|||
147181358|NCT01751984|530829047|FG000|Overall Study|Adverse Event|5|||
147181359|NCT01751984|530829048|FG001|Overall Study|Adverse Event|3|||
147181360|NCT01751984|530829047|FG000|Overall Study|Withdrawal by Subject|0|||
147181361|NCT01751984|530829048|FG001|Overall Study|Withdrawal by Subject|1|||
147181362|NCT01751984|530829047|FG000|Overall Study|Per Investigator/Sponsor/Regulatory Body|1|||
147181363|NCT01751984|530829048|FG001|Overall Study|Per Investigator/Sponsor/Regulatory Body|0|||
147181364|NCT01797263|530829052|FG000|Overall Study|Withdrawal by Subject|21|||
147181365|NCT01797263|530829053|FG001|Overall Study|Withdrawal by Subject|25|||
147181366|NCT01797263|530829052|FG000|Overall Study|Death|1|||
147181367|NCT01797263|530829053|FG001|Overall Study|Death|0|||
147181368|NCT01797263|530829052|FG000|Overall Study|Lost to Follow-up|15|||
147181369|NCT01797263|530829053|FG001|Overall Study|Lost to Follow-up|15|||
147181370|NCT02342223|530829054|FG000|Overall Study|Lost to Follow-up|1|||
147181371|NCT04098809|530829057|FG000|Overall Study|Withdrawal by Subject|1|||
147181372|NCT04098809|530829058|FG001|Overall Study|Withdrawal by Subject|3|||
147181373|NCT04098809|530829057|FG000|Overall Study|Physician Decision|2|||
147181374|NCT04098809|530829058|FG001|Overall Study|Physician Decision|1|||
147181375|NCT01200368|530829059|FG000|Infant Series|Adverse Event|2|||
147181376|NCT01200368|530829060|FG001|Infant Series|Adverse Event|2|||
147181377|NCT01200368|530829061|FG002|Infant Series|Adverse Event|3|||
147181378|NCT01200368|530829059|FG000|Infant Series|Withdrawal by Subject|0|||
147181379|NCT01200368|530829060|FG001|Infant Series|Withdrawal by Subject|2|||
147181380|NCT01200368|530829061|FG002|Infant Series|Withdrawal by Subject|2|||
147181381|NCT01200368|530829059|FG000|Infant Series|Did not meet entrance criteria|0|||
147181382|NCT01200368|530829060|FG001|Infant Series|Did not meet entrance criteria|1|||
147181383|NCT01200368|530829061|FG002|Infant Series|Did not meet entrance criteria|0|||
147181384|NCT01200368|530829059|FG000|Infant Series|Randomized, not vaccinated|0|||
147181385|NCT01200368|530829060|FG001|Infant Series|Randomized, not vaccinated|1|||
147181386|NCT01200368|530829061|FG002|Infant Series|Randomized, not vaccinated|1|||
147181387|NCT01200368|530829059|FG000|Infant Series|Other|1|||
147181388|NCT01200368|530829060|FG001|Infant Series|Other|0|||
147181389|NCT01200368|530829061|FG002|Infant Series|Other|0|||
147181390|NCT01200368|530829059|FG000|After Infant Series|Adverse Event|6|||
147245900|NCT02521870|531070844|FG004|Phase 2: Dose Expansion|Adverse Event|11|||
147245901|NCT02521870|531070845|FG005|Phase 2: Dose Expansion|Adverse Event|2|||
147245902|NCT02521870|531070846|FG006|Phase 2: Dose Expansion|Adverse Event|0|||
147245903|NCT02521870|531070847|FG007|Phase 2: Dose Expansion|Adverse Event|1|||
147181391|NCT01200368|530829060|FG001|After Infant Series|Adverse Event|6|||
147181392|NCT01200368|530829061|FG002|After Infant Series|Adverse Event|3|||
147181393|NCT01200368|530829059|FG000|After Infant Series|Withdrawal by Subject|10|||
147245904|NCT02521870|531070848|FG008|Phase 2: Dose Expansion|Adverse Event|5|||
147245905|NCT02521870|531070849|FG009|Phase 2: Dose Expansion|Adverse Event|0|||
147245906|NCT02521870|531070850|FG010|Phase 2: Dose Expansion|Adverse Event|1|||
147245907|NCT02521870|531070851|FG011|Phase 2: Dose Expansion|Adverse Event|0|||
147245908|NCT02521870|531070840|FG000|Phase 2: Dose Expansion|Progressive Disease|0|||
147245909|NCT02521870|531070841|FG001|Phase 2: Dose Expansion|Progressive Disease|0|||
147181394|NCT01200368|530829060|FG001|After Infant Series|Withdrawal by Subject|8|||
147181395|NCT01200368|530829061|FG002|After Infant Series|Withdrawal by Subject|4|||
147181396|NCT01200368|530829059|FG000|After Infant Series|Lost to Follow-up|1|||
147181397|NCT01200368|530829060|FG001|After Infant Series|Lost to Follow-up|0|||
147181398|NCT01200368|530829061|FG002|After Infant Series|Lost to Follow-up|0|||
147181399|NCT01200368|530829059|FG000|After Infant Series|Other|1|||
147245910|NCT02521870|531070842|FG002|Phase 2: Dose Expansion|Progressive Disease|0|||
147245911|NCT02521870|531070843|FG003|Phase 2: Dose Expansion|Progressive Disease|0|||
147181400|NCT01200368|530829060|FG001|After Infant Series|Other|2|||
147181401|NCT01200368|530829061|FG002|After Infant Series|Other|2|||
147181402|NCT01200368|530829059|FG000|Toddler Dose|Adverse Event|0|||
147181403|NCT01200368|530829060|FG001|Toddler Dose|Adverse Event|3|||
147181404|NCT01200368|530829061|FG002|Toddler Dose|Adverse Event|1|||
147181405|NCT02741596|530829062|FG000|Overall Study|Adverse Event|1|||
147181406|NCT02741596|530829063|FG001|Overall Study|Adverse Event|5|||
147181407|NCT02741596|530829062|FG000|Overall Study|Lost to Follow-up|1|||
147181408|NCT02741596|530829063|FG001|Overall Study|Lost to Follow-up|1|||
147181409|NCT02741596|530829062|FG000|Overall Study|Physician Decision|2|||
147181410|NCT02741596|530829063|FG001|Overall Study|Physician Decision|1|||
147181411|NCT02741596|530829062|FG000|Overall Study|Pregnancy|3|||
147181412|NCT02741596|530829063|FG001|Overall Study|Pregnancy|1|||
147181413|NCT02741596|530829062|FG000|Overall Study|Other (Unspecified)|0|||
147181414|NCT02741596|530829063|FG001|Overall Study|Other (Unspecified)|3|||
147181415|NCT02741596|530829062|FG000|Overall Study|Subject withdrawn-Other|17|||
147181416|NCT02741596|530829063|FG001|Overall Study|Subject withdrawn-Other|4|||
147181417|NCT02741596|530829062|FG000|Overall Study|Subject withdrawn-to commercial product|54|||
147181418|NCT02741596|530829063|FG001|Overall Study|Subject withdrawn-to commercial product|63|||
147181419|NCT04854551|530829066|FG000|Overall Study|Withdrawal by Subject|1|||
147181420|NCT04854551|530829067|FG001|Overall Study|Withdrawal by Subject|1|||
147181421|NCT00181766|530829068|FG000|Overall Study|Lost to Follow-up|6|||
147181422|NCT00181766|530829068|FG000|Overall Study|Adverse Event|4|||
147181423|NCT00181766|530829068|FG000|Overall Study|non-compliance|2|||
147181424|NCT00687804|530829069|FG000|Core Study|Adverse Event|5|||
147181425|NCT00687804|530829070|FG001|Core Study|Adverse Event|3|||
147181426|NCT00687804|530829071|FG002|Core Study|Adverse Event|3|||
147181427|NCT00687804|530829069|FG000|Core Study|Abnormal laboratory value(s)|1|||
147181428|NCT00687804|530829070|FG001|Core Study|Abnormal laboratory value(s)|0|||
147181429|NCT00687804|530829071|FG002|Core Study|Abnormal laboratory value(s)|0|||
147181430|NCT00687804|530829069|FG000|Core Study|Lack of Efficacy|1|||
147181431|NCT00687804|530829070|FG001|Core Study|Lack of Efficacy|1|||
147181432|NCT00687804|530829071|FG002|Core Study|Lack of Efficacy|1|||
147181433|NCT00687804|530829069|FG000|Core Study|Withdrawal by Subject|4|||
147181434|NCT00687804|530829070|FG001|Core Study|Withdrawal by Subject|7|||
147181435|NCT00687804|530829071|FG002|Core Study|Withdrawal by Subject|7|||
147181436|NCT00687804|530829069|FG000|Core Study|Lost to Follow-up|0|||
147181437|NCT00687804|530829070|FG001|Core Study|Lost to Follow-up|1|||
147181438|NCT00687804|530829071|FG002|Core Study|Lost to Follow-up|0|||
147181439|NCT00687804|530829069|FG000|Core Study|Death|2|||
147181440|NCT00687804|530829070|FG001|Core Study|Death|2|||
147181441|NCT00687804|530829071|FG002|Core Study|Death|2|||
147181442|NCT00687804|530829069|FG000|Core Study|Protocol Violation|1|||
147181443|NCT00687804|530829070|FG001|Core Study|Protocol Violation|1|||
147181444|NCT00687804|530829071|FG002|Core Study|Protocol Violation|0|||
147181445|NCT00687804|530829069|FG000|Open-Label Extension Study|Adverse Event|2|||
147181446|NCT00687804|530829070|FG001|Open-Label Extension Study|Adverse Event|2|||
147181447|NCT00687804|530829071|FG002|Open-Label Extension Study|Adverse Event|2|||
147181448|NCT00687804|530829069|FG000|Open-Label Extension Study|Subject withdrew consent|3|||
147181449|NCT00687804|530829070|FG001|Open-Label Extension Study|Subject withdrew consent|4|||
147181450|NCT00687804|530829071|FG002|Open-Label Extension Study|Subject withdrew consent|4|||
147181451|NCT00687804|530829069|FG000|Open-Label Extension Study|Lost to Follow-up|2|||
147181452|NCT00687804|530829070|FG001|Open-Label Extension Study|Lost to Follow-up|1|||
147181453|NCT00687804|530829071|FG002|Open-Label Extension Study|Lost to Follow-up|2|||
147181454|NCT00687804|530829069|FG000|Open-Label Extension Study|Administrative problems|1|||
147181455|NCT00687804|530829070|FG001|Open-Label Extension Study|Administrative problems|1|||
147181456|NCT00687804|530829071|FG002|Open-Label Extension Study|Administrative problems|0|||
147181457|NCT00687804|530829069|FG000|Open-Label Extension Study|Death|2|||
147181458|NCT00687804|530829070|FG001|Open-Label Extension Study|Death|3|||
147181459|NCT00687804|530829071|FG002|Open-Label Extension Study|Death|3|||
147181460|NCT00413218|530829072|FG000|Overall Study|Randomized but didn't receive study drug|2|||
147181461|NCT00413218|530829073|FG001|Overall Study|Randomized but didn't receive study drug|8|||
147181462|NCT00413218|530829072|FG000|Overall Study|Death|57|||
147181463|NCT00413218|530829073|FG001|Overall Study|Death|56|||
147181464|NCT00413218|530829072|FG000|Overall Study|Lost to Follow-up|14|||
147181465|NCT00413218|530829073|FG001|Overall Study|Lost to Follow-up|17|||
147181466|NCT00413218|530829072|FG000|Overall Study|Admin|20|||
147181467|NCT00413218|530829073|FG001|Overall Study|Admin|14|||
147181468|NCT00413218|530829072|FG000|Overall Study|Missing|1|||
147181469|NCT00413218|530829073|FG001|Overall Study|Missing|0|||
147181470|NCT00413218|530829072|FG000|Overall Study|Withdrawal by Subject|9|||
147181471|NCT00413218|530829073|FG001|Overall Study|Withdrawal by Subject|1|||
147181472|NCT04034004|530829075|FG000|Overall Study|Withdrawal by Subject|1|||
147245912|NCT02521870|531070844|FG004|Phase 2: Dose Expansion|Progressive Disease|22|||
147593373|NCT01421342|532328967|FG000|Continuation of Treatment (Week 12 - 36)|Lost to Follow-up|4|||
147181473|NCT04034004|530829076|FG001|Overall Study|Withdrawal by Subject|2|||
147181474|NCT04034004|530829077|FG002|Overall Study|Withdrawal by Subject|2|||
147181475|NCT04034004|530829078|FG003|Overall Study|Withdrawal by Subject|3|||
147181476|NCT04034004|530829075|FG000|Overall Study|could not find vein to administer IV|2|||
147181477|NCT04034004|530829076|FG001|Overall Study|could not find vein to administer IV|1|||
147181478|NCT04034004|530829077|FG002|Overall Study|could not find vein to administer IV|0|||
147181479|NCT04034004|530829078|FG003|Overall Study|could not find vein to administer IV|0|||
147245913|NCT02521870|531070845|FG005|Phase 2: Dose Expansion|Progressive Disease|18|||
147245914|NCT02521870|531070846|FG006|Phase 2: Dose Expansion|Progressive Disease|17|||
147245915|NCT02521870|531070847|FG007|Phase 2: Dose Expansion|Progressive Disease|7|||
147245916|NCT02521870|531070848|FG008|Phase 2: Dose Expansion|Progressive Disease|5|||
147245917|NCT02521870|531070849|FG009|Phase 2: Dose Expansion|Progressive Disease|17|||
147245918|NCT02521870|531070850|FG010|Phase 2: Dose Expansion|Progressive Disease|17|||
147245919|NCT02521870|531070851|FG011|Phase 2: Dose Expansion|Progressive Disease|21|||
147245920|NCT02521870|531070840|FG000|Phase 2: Dose Expansion|Death|0|||
147181480|NCT04034004|530829075|FG000|Overall Study|nurse accidentally unblinded subject|0|||
147181481|NCT04034004|530829076|FG001|Overall Study|nurse accidentally unblinded subject|0|||
147181482|NCT04034004|530829077|FG002|Overall Study|nurse accidentally unblinded subject|0|||
147181483|NCT04034004|530829078|FG003|Overall Study|nurse accidentally unblinded subject|1|||
147181484|NCT04317040|530829079|FG000|Overall Study|Lost to Follow-up|2|||
147181485|NCT04317040|530829080|FG001|Overall Study|Lost to Follow-up|0|||
147181486|NCT04317040|530829079|FG000|Overall Study|Death|16|||
147181487|NCT04317040|530829080|FG001|Overall Study|Death|18|||
147181488|NCT04317040|530829079|FG000|Overall Study|Withdrawal by Subject|0|||
147181489|NCT04317040|530829080|FG001|Overall Study|Withdrawal by Subject|1|||
147181490|NCT04317040|530829079|FG000|Overall Study|Incomplete assessments|0|||
147245921|NCT02521870|531070841|FG001|Phase 2: Dose Expansion|Death|0|||
147181491|NCT04317040|530829080|FG001|Overall Study|Incomplete assessments|1|||
147181492|NCT03672292|530829081|FG000|Overall Study|Adverse Event|3|||
147181493|NCT03672292|530829082|FG001|Overall Study|Adverse Event|1|||
147181494|NCT03672292|530829081|FG000|Overall Study|Physician Decision|0|||
147181495|NCT03672292|530829082|FG001|Overall Study|Physician Decision|1|||
147181496|NCT03672292|530829081|FG000|Overall Study|Withdrawal by Subject|1|||
147181497|NCT03672292|530829082|FG001|Overall Study|Withdrawal by Subject|2|||
147181498|NCT02518971|530829083|FG000|Overall Study|Lost to Follow-up|0|||
147181499|NCT02518971|530829084|FG001|Overall Study|Lost to Follow-up|1|||
147181500|NCT02518971|530829083|FG000|Overall Study|Physician Decision|6|||
147181501|NCT02518971|530829084|FG001|Overall Study|Physician Decision|6|||
147181502|NCT02518971|530829083|FG000|Overall Study|Protocol Violation|6|||
147181503|NCT02518971|530829084|FG001|Overall Study|Protocol Violation|4|||
147245922|NCT02521870|531070842|FG002|Phase 2: Dose Expansion|Death|0|||
147245923|NCT02521870|531070843|FG003|Phase 2: Dose Expansion|Death|0|||
147245924|NCT02521870|531070844|FG004|Phase 2: Dose Expansion|Death|1|||
147245925|NCT02521870|531070845|FG005|Phase 2: Dose Expansion|Death|1|||
147245926|NCT02521870|531070846|FG006|Phase 2: Dose Expansion|Death|3|||
147245927|NCT02521870|531070847|FG007|Phase 2: Dose Expansion|Death|1|||
147245928|NCT02521870|531070848|FG008|Phase 2: Dose Expansion|Death|1|||
147245929|NCT02521870|531070849|FG009|Phase 2: Dose Expansion|Death|5|||
147245930|NCT02521870|531070850|FG010|Phase 2: Dose Expansion|Death|2|||
147448448|NCT01187953|531805732|FG001|Overall Study|Death|13|||
147448449|NCT01187953|531805731|FG000|Overall Study|Adverse Event|1|||
147448450|NCT01187953|531805732|FG001|Overall Study|Adverse Event|2|||
147593374|NCT01421342|532328968|FG001|Continuation of Treatment (Week 12 - 36)|Lost to Follow-up|11|||
147593375|NCT01421342|532328969|FG002|Continuation of Treatment (Week 12 - 36)|Lost to Follow-up|9|||
147181504|NCT02518971|530829083|FG000|Overall Study|Withdrawal by Subject|4|||
147181505|NCT02518971|530829084|FG001|Overall Study|Withdrawal by Subject|5|||
147181506|NCT02518971|530829083|FG000|Overall Study|Side effects|1|||
147181507|NCT02518971|530829084|FG001|Overall Study|Side effects|0|||
147181508|NCT02518971|530829083|FG000|Overall Study|medication lost in mail|0|||
147181509|NCT02518971|530829084|FG001|Overall Study|medication lost in mail|1|||
147181510|NCT02518971|530829083|FG000|Overall Study|eligibility criteria no longer met|6|||
147181511|NCT02518971|530829084|FG001|Overall Study|eligibility criteria no longer met|3|||
147181512|NCT03088917|530829085|FG000|Overall Study|In care/cured elsewhere|15|||
147181513|NCT03088917|530829085|FG000|Overall Study|Refuse re-evaluation|13|||
147181514|NCT03088917|530829085|FG000|Overall Study|Contact not established|13|||
147245931|NCT02521870|531070851|FG011|Phase 2: Dose Expansion|Death|2|||
147593376|NCT01421342|532328967|FG000|Continuation of Treatment (Week 12 - 36)|Non-adherence|3|||
147181515|NCT03088917|530829085|FG000|Overall Study|Severe comorbidity/short life expectancy|5|||
147181516|NCT03088917|530829085|FG000|Overall Study|Moved outside study region|50|||
147245932|NCT02521870|531070840|FG000|Phase 2: Dose Expansion|Other|0|||
147245933|NCT02521870|531070841|FG001|Phase 2: Dose Expansion|Other|0|||
147448451|NCT01187953|531805731|FG000|Overall Study|Lost to Follow-up|0|||
147593377|NCT01421342|532328968|FG001|Continuation of Treatment (Week 12 - 36)|Non-adherence|8|||
147181517|NCT00757237|530829086|FG000|Overall Study|Lost to Follow-up|0|||
147181518|NCT00757237|530829087|FG001|Overall Study|Lost to Follow-up|1|||
147181519|NCT00757237|530829086|FG000|Overall Study|Protocol Violation|0|||
147181520|NCT00757237|530829087|FG001|Overall Study|Protocol Violation|2|||
147181521|NCT00757237|530829086|FG000|Overall Study|Physician Decision|2|||
147181522|NCT00757237|530829087|FG001|Overall Study|Physician Decision|3|||
147181523|NCT00757237|530829086|FG000|Overall Study|Withdrawal by Subject|8|||
147245934|NCT02521870|531070842|FG002|Phase 2: Dose Expansion|Other|0|||
147245935|NCT02521870|531070843|FG003|Phase 2: Dose Expansion|Other|0|||
147326426|NCT02014558|531359707|FG007|Overall Study|Progressive Disease|6|||
147181524|NCT00757237|530829087|FG001|Overall Study|Withdrawal by Subject|12|||
147181525|NCT00757237|530829086|FG000|Overall Study|Safety or Tolerability|3|||
147181526|NCT00757237|530829087|FG001|Overall Study|Safety or Tolerability|5|||
147181527|NCT00757237|530829086|FG000|Overall Study|Other|0|||
147181528|NCT00757237|530829087|FG001|Overall Study|Other|2|||
147181529|NCT05150990|530829094|FG000|Overall Study|Decline in health of older adult (unrelated to the intervention)|5|||
147181530|NCT05150990|530829095|FG001|Overall Study|Decline in health of older adult (unrelated to the intervention)|2|||
147181531|NCT05150990|530829094|FG000|Overall Study|Dissatisfaction with surveys (length, time commitment, too personal) or other study procedures|6|||
147181532|NCT05150990|530829095|FG001|Overall Study|Dissatisfaction with surveys (length, time commitment, too personal) or other study procedures|2|||
147181533|NCT05150990|530829094|FG000|Overall Study|Adverse response to the intervention - social strain|0|||
147181534|NCT05150990|530829095|FG001|Overall Study|Adverse response to the intervention - social strain|2|||
147181535|NCT05150990|530829094|FG000|Overall Study|Adverse response to the intervention - discomfort using technology|0|||
147181536|NCT05150990|530829095|FG001|Overall Study|Adverse response to the intervention - discomfort using technology|1|||
147181537|NCT05150990|530829094|FG000|Overall Study|External circumstances (family emergency, loss of Wifi)|0|||
147181538|NCT05150990|530829095|FG001|Overall Study|External circumstances (family emergency, loss of Wifi)|2|||
147181539|NCT05150990|530829094|FG000|Overall Study|Participant no longer eligible due to history of seizures not previously reported|0|||
147181540|NCT05150990|530829095|FG001|Overall Study|Participant no longer eligible due to history of seizures not previously reported|1|||
147181541|NCT05150990|530829094|FG000|Overall Study|Death (unrelated to the intervention)|1|||
147181542|NCT05150990|530829095|FG001|Overall Study|Death (unrelated to the intervention)|2|||
147181543|NCT00779025|530829096|FG000|Overall Study|Withdrawal by Subject|1|||
147181544|NCT02735343|530829119|FG000|Overall Study|screen fail|0|||
147181545|NCT02735343|530829120|FG001|Overall Study|screen fail|2|||
147181546|NCT00310817|530829127|FG000|Overall Study|AE or Death|3|||
147181547|NCT00310817|530829128|FG001|Overall Study|AE or Death|1|||
147181548|NCT00310817|530829129|FG002|Overall Study|AE or Death|0|||
147181549|NCT00310817|530829130|FG003|Overall Study|AE or Death|0|||
147181550|NCT00310817|530829127|FG000|Overall Study|Withdrawal by Subject|1|||
147181551|NCT00310817|530829128|FG001|Overall Study|Withdrawal by Subject|4|||
147181552|NCT00310817|530829129|FG002|Overall Study|Withdrawal by Subject|6|||
147181553|NCT00310817|530829130|FG003|Overall Study|Withdrawal by Subject|7|||
147181554|NCT00310817|530829127|FG000|Overall Study|Lost to Follow-up|2|||
147181555|NCT00310817|530829128|FG001|Overall Study|Lost to Follow-up|1|||
147181556|NCT00310817|530829129|FG002|Overall Study|Lost to Follow-up|0|||
147181557|NCT00310817|530829130|FG003|Overall Study|Lost to Follow-up|0|||
147181558|NCT00310817|530829127|FG000|Overall Study|Inappropriate Enrollment|1|||
147181559|NCT00310817|530829128|FG001|Overall Study|Inappropriate Enrollment|0|||
147181560|NCT00310817|530829129|FG002|Overall Study|Inappropriate Enrollment|1|||
147181561|NCT00310817|530829130|FG003|Overall Study|Inappropriate Enrollment|0|||
147181562|NCT00310817|530829127|FG000|Overall Study|Protocol Violation|1|||
147656261|NCT02959918|532564955|FG004|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
147656262|NCT02959918|532564956|FG005|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
147656263|NCT02959918|532564957|FG006|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
147656264|NCT02959918|532564958|FG007|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
147448452|NCT01187953|531805732|FG001|Overall Study|Lost to Follow-up|3|||
147448453|NCT01187953|531805731|FG000|Overall Study|Withdrawal by Subject|3|||
147448454|NCT01187953|531805732|FG001|Overall Study|Withdrawal by Subject|3|||
147448455|NCT01464307|531805733|FG000|Main Period|Death|0|||
147448456|NCT01464307|531805734|FG001|Main Period|Death|1|||
147448457|NCT01464307|531805733|FG000|Main Period|Adverse Event|6|||
147448458|NCT01464307|531805734|FG001|Main Period|Adverse Event|1|||
147448459|NCT01464307|531805733|FG000|Main Period|Lack of Efficacy|2|||
147448460|NCT01464307|531805734|FG001|Main Period|Lack of Efficacy|0|||
147448461|NCT01464307|531805733|FG000|Main Period|Withdrawal by Subject|5|||
147448462|NCT01464307|531805734|FG001|Main Period|Withdrawal by Subject|2|||
147448463|NCT01464307|531805733|FG000|Main Period|Predefined discontinuation criteria|2|||
147448464|NCT01464307|531805734|FG001|Main Period|Predefined discontinuation criteria|1|||
147448465|NCT01464307|531805733|FG000|Open-Label Extension Period|Adverse Event|15|||
147448466|NCT01464307|531805734|FG001|Open-Label Extension Period|Adverse Event|0|||
147448467|NCT01464307|531805733|FG000|Open-Label Extension Period|Withdrawal by Subject|14|||
147656265|NCT02959918|532564959|FG008|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
147656266|NCT02959918|532564960|FG009|Overall Study|Subject under-dosed with study drug and removed by Sponsor|1|||
147656267|NCT02959918|532564961|FG010|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
147656268|NCT02959918|532564962|FG011|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
147656269|NCT02959918|532564963|FG012|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
147656270|NCT02959918|532564964|FG013|Overall Study|Subject under-dosed with study drug and removed by Sponsor|0|||
147181563|NCT00310817|530829128|FG001|Overall Study|Protocol Violation|1|||
147181564|NCT00310817|530829129|FG002|Overall Study|Protocol Violation|1|||
147181565|NCT00310817|530829130|FG003|Overall Study|Protocol Violation|1|||
147181566|NCT00310817|530829127|FG000|Overall Study|Unable to classify|3|||
147181567|NCT00310817|530829128|FG001|Overall Study|Unable to classify|1|||
147656271|NCT02585713|532564966|FG000|Overall Study|Withdrew prior to treatment|2|||
147656272|NCT02585713|532564967|FG001|Overall Study|Withdrew prior to treatment|7|||
147656273|NCT02585713|532564966|FG000|Overall Study|Other|3|||
147656274|NCT02585713|532564967|FG001|Overall Study|Other|1|||
147656275|NCT03173456|532564970|FG000|Baseline|Medication dispensing system malfunction'|0|||
147656276|NCT03173456|532564971|FG001|Baseline|Medication dispensing system malfunction'|1|||
147656277|NCT03173456|532564972|FG002|Baseline|Medication dispensing system malfunction'|0|||
147656278|NCT03173456|532564973|FG003|Baseline|Medication dispensing system malfunction'|0|||
147656279|NCT03173456|532564974|FG004|Baseline|Medication dispensing system malfunction'|2|||
147656280|NCT03173456|532564970|FG000|2 Hour Follow-up|Withdrawal by Subject|0|||
147656281|NCT03173456|532564971|FG001|2 Hour Follow-up|Withdrawal by Subject|1|||
147656282|NCT03173456|532564972|FG002|2 Hour Follow-up|Withdrawal by Subject|1|||
147656283|NCT03173456|532564973|FG003|2 Hour Follow-up|Withdrawal by Subject|1|||
147656284|NCT03173456|532564974|FG004|2 Hour Follow-up|Withdrawal by Subject|2|||
147656285|NCT01733121|532564975|FG000|Double-Blind Period (Week 0 to 6)|Adverse Event|2|||
147656286|NCT01733121|532564976|FG001|Double-Blind Period (Week 0 to 6)|Adverse Event|0|||
147656287|NCT01733121|532564975|FG000|Double-Blind Period (Week 0 to 6)|Non-compliance|3|||
147656288|NCT01733121|532564976|FG001|Double-Blind Period (Week 0 to 6)|Non-compliance|2|||
147656289|NCT01733121|532564975|FG000|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|1|||
147656290|NCT01733121|532564976|FG001|Double-Blind Period (Week 0 to 6)|Withdrawal by Subject|3|||
147656291|NCT01733121|532564975|FG000|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|1|||
147656292|NCT01733121|532564976|FG001|Double-Blind Period (Week 0 to 6)|Lost to Follow-up|0|||
147656293|NCT03061188|532564979|FG000|Went on to Cycle 2 and Beyond|Adverse Event|0|||
147656294|NCT03061188|532564980|FG001|Went on to Cycle 2 and Beyond|Adverse Event|0|||
147656295|NCT03061188|532564981|FG002|Went on to Cycle 2 and Beyond|Adverse Event|1|||
147656296|NCT03061188|532564982|FG003|Went on to Cycle 2 and Beyond|Adverse Event|1|||
147656297|NCT03061188|532564979|FG000|On Follow-up for 3 Years|Death|0|||
147656298|NCT03061188|532564980|FG001|On Follow-up for 3 Years|Death|3|||
147656299|NCT03061188|532564981|FG002|On Follow-up for 3 Years|Death|5|||
147656300|NCT03061188|532564982|FG003|On Follow-up for 3 Years|Death|4|||
147656301|NCT03061188|532564979|FG000|On Follow-up for 3 Years|Withdrawal by Subject|0|||
147656302|NCT03061188|532564980|FG001|On Follow-up for 3 Years|Withdrawal by Subject|0|||
147656303|NCT03061188|532564981|FG002|On Follow-up for 3 Years|Withdrawal by Subject|0|||
147656304|NCT03061188|532564982|FG003|On Follow-up for 3 Years|Withdrawal by Subject|1|||
147656305|NCT02609984|532564984|FG000|Overall Study|Death|29|||
147656306|NCT02609984|532564985|FG001|Overall Study|Death|26|||
147656307|NCT02609984|532564984|FG000|Overall Study|Participation Discontinued by Sponsor|12|||
147656308|NCT02609984|532564985|FG001|Overall Study|Participation Discontinued by Sponsor|10|||
147656309|NCT02609984|532564984|FG000|Overall Study|Lost to Follow-up|1|||
147656310|NCT02609984|532564985|FG001|Overall Study|Lost to Follow-up|2|||
147656311|NCT02609984|532564984|FG000|Overall Study|Withdrawal by Subject|0|||
147656312|NCT02609984|532564985|FG001|Overall Study|Withdrawal by Subject|1|||
147656313|NCT02609984|532564984|FG000|Overall Study|Disease Progression|2|||
147656314|NCT02609984|532564985|FG001|Overall Study|Disease Progression|0|||
147656315|NCT02306850|532564991|FG000|Overall Study|Lack of Efficacy|2|||
147656316|NCT02420262|532564992|FG000|Overall Study|Adverse Event|1|||
147656317|NCT02420262|532564993|FG001|Overall Study|Adverse Event|0|||
147656318|NCT02420262|532564992|FG000|Overall Study|Withdrawal by Subject|1|||
147656319|NCT02420262|532564993|FG001|Overall Study|Withdrawal by Subject|4|||
147656320|NCT02420262|532564992|FG000|Overall Study|Unclassified|0|||
147656321|NCT02420262|532564993|FG001|Overall Study|Unclassified|1|||
147656322|NCT00941304|532564994|FG000|Overall Study|Lost to Follow-up|1|||
147656323|NCT00941304|532564995|FG001|Overall Study|Lost to Follow-up|0|||
147656324|NCT00941304|532564996|FG002|Overall Study|Lost to Follow-up|0|||
147656325|NCT00941304|532564997|FG003|Overall Study|Lost to Follow-up|0|||
147656326|NCT00941304|532564998|FG004|Overall Study|Lost to Follow-up|0|||
147656327|NCT03293394|532564999|FG000|Follow-up (6 Months)|Adverse Event|4|||
147656328|NCT03293394|532565000|FG001|Follow-up (6 Months)|Adverse Event|2|||
147656329|NCT00784719|532565003|FG000|Overall Study|Adverse Event|0|||
147656330|NCT00784719|532565004|FG001|Overall Study|Adverse Event|2|||
147656331|NCT00784719|532565005|FG002|Overall Study|Adverse Event|0|||
147656332|NCT00784719|532565006|FG003|Overall Study|Adverse Event|0|||
147656333|NCT00784719|532565007|FG004|Overall Study|Adverse Event|1|||
147656334|NCT00784719|532565008|FG005|Overall Study|Adverse Event|1|||
147656335|NCT00784719|532565009|FG006|Overall Study|Adverse Event|1|||
147656336|NCT00784719|532565003|FG000|Overall Study|Lost to Follow-up|0|||
147656337|NCT00784719|532565004|FG001|Overall Study|Lost to Follow-up|0|||
147656338|NCT00784719|532565005|FG002|Overall Study|Lost to Follow-up|0|||
147656339|NCT00784719|532565006|FG003|Overall Study|Lost to Follow-up|0|||
147656340|NCT00784719|532565007|FG004|Overall Study|Lost to Follow-up|1|||
147656341|NCT00784719|532565008|FG005|Overall Study|Lost to Follow-up|1|||
147656342|NCT00784719|532565009|FG006|Overall Study|Lost to Follow-up|0|||
147656343|NCT00784719|532565003|FG000|Overall Study|Other|2|||
147656344|NCT00784719|532565004|FG001|Overall Study|Other|1|||
147656345|NCT00784719|532565005|FG002|Overall Study|Other|1|||
147656346|NCT00784719|532565006|FG003|Overall Study|Other|0|||
147656347|NCT00784719|532565007|FG004|Overall Study|Other|2|||
147656348|NCT00784719|532565008|FG005|Overall Study|Other|1|||
147656349|NCT00784719|532565009|FG006|Overall Study|Other|3|||
147656350|NCT00784719|532565003|FG000|Overall Study|Withdrawal by Subject|1|||
147656351|NCT00784719|532565004|FG001|Overall Study|Withdrawal by Subject|0|||
147656352|NCT00784719|532565005|FG002|Overall Study|Withdrawal by Subject|0|||
147656353|NCT00784719|532565006|FG003|Overall Study|Withdrawal by Subject|0|||
147656354|NCT00784719|532565007|FG004|Overall Study|Withdrawal by Subject|2|||
147656355|NCT00784719|532565008|FG005|Overall Study|Withdrawal by Subject|0|||
147656356|NCT00784719|532565009|FG006|Overall Study|Withdrawal by Subject|1|||
147656357|NCT01436227|532565013|FG000|Overall Study|Adverse Event|7|||
147656358|NCT01436227|532565013|FG000|Overall Study|Death|1|||
147656359|NCT01436227|532565013|FG000|Overall Study|Lack of Efficacy|1|||
147656360|NCT01436227|532565013|FG000|Overall Study|Lost to Follow-up|3|||
147656361|NCT01436227|532565013|FG000|Overall Study|Physician Decision|1|||
147656362|NCT01436227|532565013|FG000|Overall Study|Withdrawal by Subject|7|||
147656363|NCT01436227|532565013|FG000|Overall Study|Disease progression, relapse|6|||
147656364|NCT05446142|532565014|FG000|Period 2|Adverse Event|1|||
147656365|NCT05446142|532565015|FG001|Period 2|Adverse Event|0|||
147656366|NCT05446142|532565016|FG002|Period 2|Adverse Event|0|||
147656367|NCT05446142|532565017|FG003|Period 2|Adverse Event|0|||
147656368|NCT05446142|532565018|FG004|Period 2|Adverse Event|0|||
147656369|NCT05446142|532565019|FG005|Period 2|Adverse Event|0|||
147656370|NCT02098395|532565024|FG000|Overall Study|Protocol Violation|2|||
147656371|NCT02098395|532565025|FG001|Overall Study|Protocol Violation|2|||
147656372|NCT02098395|532565026|FG002|Overall Study|Protocol Violation|0|||
147656373|NCT02098395|532565027|FG003|Overall Study|Protocol Violation|7|||
147656374|NCT02098395|532565024|FG000|Overall Study|Withdrawal by Subject|10|||
147656375|NCT02098395|532565025|FG001|Overall Study|Withdrawal by Subject|10|||
147656376|NCT02098395|532565026|FG002|Overall Study|Withdrawal by Subject|5|||
147656377|NCT02098395|532565027|FG003|Overall Study|Withdrawal by Subject|13|||
147656378|NCT02098395|532565024|FG000|Overall Study|Adverse Event|12|||
147656379|NCT02098395|532565025|FG001|Overall Study|Adverse Event|19|||
147656380|NCT02098395|532565026|FG002|Overall Study|Adverse Event|34|||
147656381|NCT02098395|532565027|FG003|Overall Study|Adverse Event|2|||
147656382|NCT02098395|532565024|FG000|Overall Study|Lost to Follow-up|2|||
147656383|NCT02098395|532565025|FG001|Overall Study|Lost to Follow-up|1|||
147656384|NCT02098395|532565026|FG002|Overall Study|Lost to Follow-up|0|||
147656385|NCT02098395|532565027|FG003|Overall Study|Lost to Follow-up|3|||
147656386|NCT02098395|532565024|FG000|Overall Study|Unclassified|0|||
147656387|NCT02098395|532565025|FG001|Overall Study|Unclassified|0|||
147656388|NCT02098395|532565026|FG002|Overall Study|Unclassified|3|||
147656389|NCT02098395|532565027|FG003|Overall Study|Unclassified|2|||
147656390|NCT04633226|532565036|FG000|Overall Study|Withdrawal by parent/guardian|4|||
147656391|NCT04633226|532565036|FG000|Overall Study|Randomized by mistake without study treatment|1|||
147656392|NCT05415462|532565043|FG000|Overall Study|Death|18|||
147656393|NCT05415462|532565044|FG001|Overall Study|Death|10|||
147656394|NCT05415462|532565043|FG000|Overall Study|Lost to Follow-up|72|||
147656395|NCT05415462|532565044|FG001|Overall Study|Lost to Follow-up|64|||
147656396|NCT05415462|532565043|FG000|Overall Study|Physician Decision|5|||
147656397|NCT05415462|532565044|FG001|Overall Study|Physician Decision|5|||
147656398|NCT05415462|532565043|FG000|Overall Study|Protocol Deviation|1|||
147656399|NCT05415462|532565044|FG001|Overall Study|Protocol Deviation|0|||
147656400|NCT05415462|532565043|FG000|Overall Study|Withdrawal by Subject|129|||
147656401|NCT05415462|532565044|FG001|Overall Study|Withdrawal by Subject|101|||
147656402|NCT05415462|532565043|FG000|Overall Study|Other Than Specified|8|||
147656403|NCT05415462|532565044|FG001|Overall Study|Other Than Specified|8|||
147656404|NCT02137226|532565068|FG000|Period 1 (Initial Randomization)|Adverse Event|3|||
147656405|NCT02137226|532565069|FG001|Period 1 (Initial Randomization)|Adverse Event|3|||
147656406|NCT02137226|532565070|FG002|Period 1 (Initial Randomization)|Adverse Event|0|||
147656407|NCT02137226|532565071|FG003|Period 1 (Initial Randomization)|Adverse Event|0|||
147656408|NCT02137226|532565072|FG004|Period 1 (Initial Randomization)|Adverse Event|0|||
147656409|NCT02137226|532565068|FG000|Period 1 (Initial Randomization)|Withdrawal by Subject|11|||
147656410|NCT02137226|532565069|FG001|Period 1 (Initial Randomization)|Withdrawal by Subject|5|||
147656411|NCT02137226|532565070|FG002|Period 1 (Initial Randomization)|Withdrawal by Subject|0|||
147656412|NCT02137226|532565071|FG003|Period 1 (Initial Randomization)|Withdrawal by Subject|0|||
147656413|NCT02137226|532565072|FG004|Period 1 (Initial Randomization)|Withdrawal by Subject|0|||
147656414|NCT02137226|532565068|FG000|Period 1 (Initial Randomization)|Physician Decision|1|||
147656415|NCT02137226|532565069|FG001|Period 1 (Initial Randomization)|Physician Decision|3|||
147656416|NCT02137226|532565070|FG002|Period 1 (Initial Randomization)|Physician Decision|0|||
147656417|NCT02137226|532565071|FG003|Period 1 (Initial Randomization)|Physician Decision|0|||
147656418|NCT02137226|532565072|FG004|Period 1 (Initial Randomization)|Physician Decision|0|||
147656419|NCT02137226|532565068|FG000|Period 1 (Initial Randomization)|Lost to Follow-up|3|||
147656420|NCT02137226|532565069|FG001|Period 1 (Initial Randomization)|Lost to Follow-up|2|||
147656421|NCT02137226|532565070|FG002|Period 1 (Initial Randomization)|Lost to Follow-up|0|||
147656422|NCT02137226|532565071|FG003|Period 1 (Initial Randomization)|Lost to Follow-up|0|||
147181568|NCT00310817|530829129|FG002|Overall Study|Unable to classify|0|||
147181569|NCT00310817|530829130|FG003|Overall Study|Unable to classify|0|||
147181570|NCT02915978|530829131|FG000|Overall Study|Adverse Event|2|||
147181571|NCT02915978|530829132|FG001|Overall Study|Adverse Event|1|||
147181572|NCT02915978|530829133|FG002|Overall Study|Adverse Event|0|||
147181573|NCT00548145|530829137|FG000|Overall Study|Death|0|||
147181574|NCT00548145|530829138|FG001|Overall Study|Death|1|||
147181575|NCT00548145|530829137|FG000|Overall Study|Withdrawal by Subject|0|||
147181576|NCT00548145|530829138|FG001|Overall Study|Withdrawal by Subject|2|||
147181577|NCT00548145|530829137|FG000|Overall Study|Physician Decision|1|||
147181578|NCT00548145|530829138|FG001|Overall Study|Physician Decision|1|||
147181579|NCT00874848|530829139|FG000|Overall Study|Adverse Event|13|||
147181580|NCT00874848|530829140|FG001|Overall Study|Adverse Event|2|||
147181581|NCT00874848|530829139|FG000|Overall Study|Progressive neoplastic disease|38|||
147181582|NCT00874848|530829140|FG001|Overall Study|Progressive neoplastic disease|18|||
147181583|NCT00874848|530829139|FG000|Overall Study|Withdrawal by Subject|7|||
147181584|NCT00874848|530829140|FG001|Overall Study|Withdrawal by Subject|4|||
147181585|NCT00874848|530829139|FG000|Overall Study|Noncompliance|1|||
147181586|NCT00874848|530829140|FG001|Overall Study|Noncompliance|1|||
147181587|NCT00874848|530829139|FG000|Overall Study|Failure to comply with protocol|0|||
147181588|NCT00874848|530829140|FG001|Overall Study|Failure to comply with protocol|1|||
147181589|NCT00874848|530829139|FG000|Overall Study|Physician Decision|0|||
147181590|NCT00874848|530829140|FG001|Overall Study|Physician Decision|2|||
147181591|NCT04522141|530829145|FG000|Overall Study|Withdrawal by Subject|1|||
147181592|NCT04522141|530829146|FG001|Overall Study|Withdrawal by Subject|0|||
147593378|NCT01421342|532328969|FG002|Continuation of Treatment (Week 12 - 36)|Non-adherence|4|||
147593379|NCT01421342|532328967|FG000|Continuation of Treatment (Week 12 - 36)|End of Study Time|15|||
147181593|NCT03052049|530829147|FG000|Overall Study|Withdrawal by Subject|2|||
147245936|NCT02521870|531070844|FG004|Phase 2: Dose Expansion|Other|10|||
147245937|NCT02521870|531070845|FG005|Phase 2: Dose Expansion|Other|3|||
147245938|NCT02521870|531070846|FG006|Phase 2: Dose Expansion|Other|2|||
147245939|NCT02521870|531070847|FG007|Phase 2: Dose Expansion|Other|0|||
147245940|NCT02521870|531070848|FG008|Phase 2: Dose Expansion|Other|10|||
147245941|NCT02521870|531070849|FG009|Phase 2: Dose Expansion|Other|5|||
147245942|NCT02521870|531070850|FG010|Phase 2: Dose Expansion|Other|1|||
147245943|NCT02521870|531070851|FG011|Phase 2: Dose Expansion|Other|7|||
147245944|NCT02521870|531070840|FG000|Phase 2: Dose Expansion|Lost to Follow-up|0|||
147245945|NCT02521870|531070841|FG001|Phase 2: Dose Expansion|Lost to Follow-up|0|||
147245946|NCT02521870|531070842|FG002|Phase 2: Dose Expansion|Lost to Follow-up|0|||
147245947|NCT02521870|531070843|FG003|Phase 2: Dose Expansion|Lost to Follow-up|0|||
147245948|NCT02521870|531070844|FG004|Phase 2: Dose Expansion|Lost to Follow-up|1|||
147245949|NCT02521870|531070845|FG005|Phase 2: Dose Expansion|Lost to Follow-up|0|||
147245950|NCT02521870|531070846|FG006|Phase 2: Dose Expansion|Lost to Follow-up|0|||
147245951|NCT02521870|531070847|FG007|Phase 2: Dose Expansion|Lost to Follow-up|0|||
147245952|NCT02521870|531070848|FG008|Phase 2: Dose Expansion|Lost to Follow-up|0|||
147245953|NCT02521870|531070849|FG009|Phase 2: Dose Expansion|Lost to Follow-up|0|||
147245954|NCT02521870|531070850|FG010|Phase 2: Dose Expansion|Lost to Follow-up|0|||
147245955|NCT02521870|531070851|FG011|Phase 2: Dose Expansion|Lost to Follow-up|0|||
147245956|NCT02521870|531070840|FG000|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
147245957|NCT02521870|531070841|FG001|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
147245958|NCT02521870|531070842|FG002|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
147245959|NCT02521870|531070843|FG003|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
147245960|NCT02521870|531070844|FG004|Phase 2: Dose Expansion|Non-Compliance with Study Drug|2|||
147245961|NCT02521870|531070845|FG005|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
147245962|NCT02521870|531070846|FG006|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
147245963|NCT02521870|531070847|FG007|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
147245964|NCT02521870|531070848|FG008|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
147245965|NCT02521870|531070849|FG009|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
147245966|NCT02521870|531070850|FG010|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
147245967|NCT02521870|531070851|FG011|Phase 2: Dose Expansion|Non-Compliance with Study Drug|0|||
147245968|NCT00279305|531070852|FG000|Overall Study|Pregnancy|1|||
147245969|NCT00279305|531070853|FG001|Overall Study|Pregnancy|0|||
147245970|NCT00279305|531070852|FG000|Overall Study|Withdrawal by Subject|2|||
147245971|NCT00279305|531070853|FG001|Overall Study|Withdrawal by Subject|0|||
147245972|NCT00279305|531070852|FG000|Overall Study|Dificulting establishing IV|1|||
147245973|NCT00279305|531070853|FG001|Overall Study|Dificulting establishing IV|0|||
147245974|NCT00279305|531070852|FG000|Overall Study|FDA Safety Alert|4|||
147181594|NCT03508609|530829148|FG000|Overall Study|Withdrawal by Subject|1|||
147181595|NCT00999518|530829152|FG000|Overall Study|Adverse Event|1|||
147181596|NCT00999518|530829153|FG001|Overall Study|Adverse Event|6|||
147181597|NCT00999518|530829154|FG002|Overall Study|Adverse Event|3|||
147181598|NCT00999518|530829155|FG003|Overall Study|Adverse Event|1|||
147181599|NCT00999518|530829156|FG004|Overall Study|Adverse Event|2|||
147181600|NCT00999518|530829152|FG000|Overall Study|Lack of Efficacy|2|||
147181601|NCT00999518|530829153|FG001|Overall Study|Lack of Efficacy|0|||
147181602|NCT00999518|530829154|FG002|Overall Study|Lack of Efficacy|0|||
147181603|NCT00999518|530829155|FG003|Overall Study|Lack of Efficacy|2|||
147181604|NCT00999518|530829156|FG004|Overall Study|Lack of Efficacy|2|||
147448468|NCT01464307|531805734|FG001|Open-Label Extension Period|Withdrawal by Subject|0|||
147448469|NCT01464307|531805733|FG000|Open-Label Extension Period|Lack of Efficacy|5|||
147448470|NCT01464307|531805734|FG001|Open-Label Extension Period|Lack of Efficacy|0|||
147448471|NCT01464307|531805733|FG000|Open-Label Extension Period|Death|1|||
147593380|NCT01421342|532328968|FG001|Continuation of Treatment (Week 12 - 36)|End of Study Time|20|||
147593381|NCT01421342|532328969|FG002|Continuation of Treatment (Week 12 - 36)|End of Study Time|14|||
147593382|NCT01421342|532328967|FG000|Continuation of Treatment (Week 12 - 36)|Participant moved away|4|||
147593383|NCT01421342|532328968|FG001|Continuation of Treatment (Week 12 - 36)|Participant moved away|1|||
147593384|NCT01421342|532328969|FG002|Continuation of Treatment (Week 12 - 36)|Participant moved away|3|||
147593385|NCT01421342|532328967|FG000|Continuation of Treatment (Week 12 - 36)|Due to Other Illness|2|||
147593386|NCT01421342|532328968|FG001|Continuation of Treatment (Week 12 - 36)|Due to Other Illness|2|||
147593387|NCT01421342|532328969|FG002|Continuation of Treatment (Week 12 - 36)|Due to Other Illness|2|||
147593388|NCT01421342|532328967|FG000|Continuation of Treatment (Week 12 - 36)|Other reason for withdrawal|6|||
147593389|NCT01421342|532328968|FG001|Continuation of Treatment (Week 12 - 36)|Other reason for withdrawal|0|||
147593390|NCT01421342|532328969|FG002|Continuation of Treatment (Week 12 - 36)|Other reason for withdrawal|7|||
147593391|NCT03656874|532328972|FG000|Overall Study|Lost to Follow-up|3|||
147593392|NCT03656874|532328973|FG001|Overall Study|Lost to Follow-up|17|||
147593393|NCT02712333|532328979|FG000|First Period|Withdrawal by Subject|3|||
147593394|NCT02712333|532328980|FG001|First Period|Withdrawal by Subject|2|||
147593395|NCT03463993|532328981|FG000|Overall Study|Lost to Follow-up|7|||
147593396|NCT03463993|532328982|FG001|Overall Study|Lost to Follow-up|8|||
147593397|NCT03463993|532328981|FG000|Overall Study|Withdrawal by Subject|2|||
147593398|NCT03463993|532328982|FG001|Overall Study|Withdrawal by Subject|0|||
147593399|NCT03463993|532328981|FG000|Overall Study|Protocol Violation|4|||
147593400|NCT03463993|532328982|FG001|Overall Study|Protocol Violation|1|||
147593401|NCT03463993|532328981|FG000|Overall Study|Had a vaginal delivery prior to caesarean delivery|9|||
147593402|NCT03463993|532328982|FG001|Overall Study|Had a vaginal delivery prior to caesarean delivery|11|||
147593403|NCT03463993|532328981|FG000|Overall Study|Had emergency caesarean delivery prior to elective caesarean delivery|7|||
147593404|NCT03463993|532328982|FG001|Overall Study|Had emergency caesarean delivery prior to elective caesarean delivery|6|||
147593405|NCT02566993|532328983|FG000|Overall Study|Randomized but not treated|5|||
147593406|NCT02566993|532328984|FG001|Overall Study|Randomized but not treated|16|||
147593407|NCT02566993|532328983|FG000|Overall Study|Progressive disease|213|||
147593408|NCT02566993|532328984|FG001|Overall Study|Progressive disease|152|||
147593409|NCT02566993|532328983|FG000|Overall Study|Withdrawal by Subject|12|||
147593410|NCT02566993|532328984|FG001|Overall Study|Withdrawal by Subject|28|||
147593411|NCT02566993|532328983|FG000|Overall Study|Death|17|||
147593412|NCT02566993|532328984|FG001|Overall Study|Death|23|||
147593413|NCT02566993|532328983|FG000|Overall Study|Physician Decision|10|||
147593414|NCT02566993|532328984|FG001|Overall Study|Physician Decision|17|||
147593415|NCT02566993|532328983|FG000|Overall Study|Study drug-related adverse event|20|||
147181605|NCT00999518|530829152|FG000|Overall Study|Lost to Follow-up|0|||
147181606|NCT00999518|530829153|FG001|Overall Study|Lost to Follow-up|0|||
147181607|NCT00999518|530829154|FG002|Overall Study|Lost to Follow-up|0|||
147181608|NCT00999518|530829155|FG003|Overall Study|Lost to Follow-up|4|||
147181609|NCT00999518|530829156|FG004|Overall Study|Lost to Follow-up|1|||
147181610|NCT00999518|530829152|FG000|Overall Study|Did not meet entrance criteria|0|||
147181611|NCT00999518|530829153|FG001|Overall Study|Did not meet entrance criteria|0|||
147181612|NCT00999518|530829154|FG002|Overall Study|Did not meet entrance criteria|0|||
147181613|NCT00999518|530829155|FG003|Overall Study|Did not meet entrance criteria|0|||
147245975|NCT00279305|531070853|FG001|Overall Study|FDA Safety Alert|1|||
147245976|NCT02862171|531070854|FG000|Overall Study|Death|1|||
147245977|NCT02862171|531070854|FG000|Overall Study|Lost to Follow-up|13|||
147245978|NCT02862171|531070854|FG000|Overall Study|Withdrawal by Subject|57|||
147245979|NCT02862171|531070854|FG000|Overall Study|Non-compliance|4|||
147245980|NCT02862171|531070854|FG000|Overall Study|HIV-1 seroconversion|18|||
147245981|NCT03930797|531070855|FG000|Overall Study|Lost to Follow-up|3|||
147245982|NCT03930797|531070856|FG001|Overall Study|Lost to Follow-up|10|||
147245983|NCT00662012|531070857|FG000|Overall Study|Lost to Follow-up|85|||
147245984|NCT00662012|531070857|FG000|Overall Study|Death|1|||
147245985|NCT00662012|531070857|FG000|Overall Study|Withdrawal by Subject|1|||
147245986|NCT02144012|531070860|FG000|Overall Study|Adverse Event|1|||
147245987|NCT02144012|531070861|FG001|Overall Study|Adverse Event|0|||
147245988|NCT02144012|531070860|FG000|Overall Study|Death|1|||
147245989|NCT02144012|531070861|FG001|Overall Study|Death|0|||
147245990|NCT02144012|531070860|FG000|Overall Study|Withdrawal by Subject|11|||
147245991|NCT02144012|531070861|FG001|Overall Study|Withdrawal by Subject|3|||
147245992|NCT02144012|531070860|FG000|Overall Study|Study Terminated by Sponsor|18|||
147245993|NCT02144012|531070861|FG001|Overall Study|Study Terminated by Sponsor|12|||
147245994|NCT02144012|531070860|FG000|Overall Study|Other|3|||
147245995|NCT02144012|531070861|FG001|Overall Study|Other|0|||
147593416|NCT02566993|532328984|FG001|Overall Study|Study drug-related adverse event|41|||
147181614|NCT00999518|530829156|FG004|Overall Study|Did not meet entrance criteria|1|||
147181615|NCT00999518|530829152|FG000|Overall Study|Study terminated by sponsor|10|||
147181616|NCT00999518|530829153|FG001|Overall Study|Study terminated by sponsor|6|||
147181617|NCT00999518|530829154|FG002|Overall Study|Study terminated by sponsor|5|||
147181618|NCT00999518|530829155|FG003|Overall Study|Study terminated by sponsor|5|||
147181619|NCT00999518|530829156|FG004|Overall Study|Study terminated by sponsor|9|||
147181620|NCT00999518|530829152|FG000|Overall Study|Pregnancy|0|||
147181621|NCT00999518|530829153|FG001|Overall Study|Pregnancy|0|||
147181622|NCT00999518|530829154|FG002|Overall Study|Pregnancy|1|||
147181623|NCT00999518|530829155|FG003|Overall Study|Pregnancy|0|||
147181624|NCT00999518|530829156|FG004|Overall Study|Pregnancy|0|||
147181625|NCT00999518|530829152|FG000|Overall Study|Protocol Violation|0|||
147181626|NCT00999518|530829153|FG001|Overall Study|Protocol Violation|1|||
147181627|NCT00999518|530829154|FG002|Overall Study|Protocol Violation|0|||
147181628|NCT00999518|530829155|FG003|Overall Study|Protocol Violation|0|||
147181629|NCT00999518|530829156|FG004|Overall Study|Protocol Violation|2|||
147181630|NCT00999518|530829152|FG000|Overall Study|Withdrawal by Subject|5|||
147181631|NCT00999518|530829153|FG001|Overall Study|Withdrawal by Subject|4|||
147181632|NCT00999518|530829154|FG002|Overall Study|Withdrawal by Subject|10|||
147181633|NCT00999518|530829155|FG003|Overall Study|Withdrawal by Subject|6|||
147181634|NCT00999518|530829156|FG004|Overall Study|Withdrawal by Subject|1|||
147181635|NCT00999518|530829152|FG000|Overall Study|Other|5|||
147181636|NCT00999518|530829153|FG001|Overall Study|Other|7|||
147181637|NCT00999518|530829154|FG002|Overall Study|Other|1|||
147181638|NCT00999518|530829155|FG003|Overall Study|Other|4|||
147181639|NCT00999518|530829156|FG004|Overall Study|Other|5|||
147181640|NCT00999518|530829152|FG000|Overall Study|Randomized but not Treated|1|||
147181641|NCT00999518|530829153|FG001|Overall Study|Randomized but not Treated|1|||
147181642|NCT00999518|530829154|FG002|Overall Study|Randomized but not Treated|2|||
147656423|NCT02137226|532565072|FG004|Period 1 (Initial Randomization)|Lost to Follow-up|0|||
147656424|NCT02137226|532565068|FG000|Period 1 (Initial Randomization)|Lack of Efficacy|1|||
147181643|NCT00999518|530829155|FG003|Overall Study|Randomized but not Treated|0|||
147181644|NCT00999518|530829156|FG004|Overall Study|Randomized but not Treated|1|||
147181645|NCT00250276|530829157|FG000|Overall Study|Serious Adverse Event|0|||
147181646|NCT00250276|530829158|FG001|Overall Study|Serious Adverse Event|0|||
147181647|NCT00250276|530829159|FG002|Overall Study|Serious Adverse Event|1|||
147181648|NCT00250276|530829160|FG003|Overall Study|Serious Adverse Event|0|||
147181649|NCT00250276|530829157|FG000|Overall Study|Non-serious Adverse Event|2|||
147181650|NCT00250276|530829158|FG001|Overall Study|Non-serious Adverse Event|0|||
147181651|NCT00250276|530829159|FG002|Overall Study|Non-serious Adverse Event|0|||
147181652|NCT00250276|530829160|FG003|Overall Study|Non-serious Adverse Event|2|||
147181653|NCT00250276|530829157|FG000|Overall Study|Protocol Violation|0|||
147181654|NCT00250276|530829158|FG001|Overall Study|Protocol Violation|1|||
147181655|NCT00250276|530829159|FG002|Overall Study|Protocol Violation|0|||
147181656|NCT00250276|530829160|FG003|Overall Study|Protocol Violation|0|||
147181657|NCT00250276|530829157|FG000|Overall Study|Withdrawal by Subject|1|||
147181658|NCT00250276|530829158|FG001|Overall Study|Withdrawal by Subject|2|||
147181659|NCT00250276|530829159|FG002|Overall Study|Withdrawal by Subject|3|||
147181660|NCT00250276|530829160|FG003|Overall Study|Withdrawal by Subject|2|||
147181661|NCT00250276|530829157|FG000|Overall Study|Migrated/moved from study area|3|||
147181662|NCT00250276|530829158|FG001|Overall Study|Migrated/moved from study area|0|||
147181663|NCT00250276|530829159|FG002|Overall Study|Migrated/moved from study area|2|||
147181664|NCT00250276|530829160|FG003|Overall Study|Migrated/moved from study area|7|||
147181665|NCT00250276|530829157|FG000|Overall Study|Lost to Follow-up|11|||
147181666|NCT00250276|530829158|FG001|Overall Study|Lost to Follow-up|18|||
147181667|NCT00250276|530829159|FG002|Overall Study|Lost to Follow-up|13|||
147181668|NCT00250276|530829160|FG003|Overall Study|Lost to Follow-up|8|||
147181669|NCT01546688|530829161|FG000|Overall Study|Adverse Event|0|||
147181670|NCT01546688|530829162|FG001|Overall Study|Adverse Event|4|||
147181671|NCT01546688|530829161|FG000|Overall Study|Withdrawal by Subject|2|||
147181672|NCT01546688|530829162|FG001|Overall Study|Withdrawal by Subject|1|||
147245996|NCT04656691|531070862|FG000|Overall Study|Adverse Event|1|||
147245997|NCT02846779|531070865|FG000|Overall Study|Lost Enrollment|83|||
147245998|NCT02846779|531070866|FG001|Overall Study|Lost Enrollment|82|||
147245999|NCT02846779|531070867|FG002|Overall Study|Lost Enrollment|86|||
147181673|NCT01546688|530829161|FG000|Overall Study|Lack of Efficacy|1|||
147181674|NCT01546688|530829162|FG001|Overall Study|Lack of Efficacy|0|||
147181675|NCT00782483|530829165|FG000|Overall Study|Early Termination of Protocol - PI Reloc|6|||
147181676|NCT03543137|530829166|FG000|Study Period 2: Up to Day 8|Withdrawal by Subject|1|||
147181677|NCT03543137|530829167|FG001|Study Period 2: Up to Day 8|Withdrawal by Subject|0|||
147181678|NCT03543137|530829166|FG000|Study Period 2: Up to Day 8|Protocol Violation|1|||
147246000|NCT02846779|531070865|FG000|Overall Study|Less than 31 days of follow-up|56|||
147181679|NCT03543137|530829167|FG001|Study Period 2: Up to Day 8|Protocol Violation|0|||
147181680|NCT03543137|530829166|FG000|Study Period 2: Up to Day 8|Adverse Event|0|||
147181681|NCT03543137|530829167|FG001|Study Period 2: Up to Day 8|Adverse Event|1|||
147181682|NCT01052077|530829169|FG000|Phase A|Lost to Follow-up|22|||
147181683|NCT01052077|530829170|FG001|Phase A|Lost to Follow-up|0|||
147181684|NCT01052077|530829171|FG002|Phase A|Lost to Follow-up|0|||
147181685|NCT01052077|530829172|FG003|Phase A|Lost to Follow-up|0|||
147181686|NCT01052077|530829169|FG000|Phase A|Adverse Event|32|||
147181687|NCT01052077|530829170|FG001|Phase A|Adverse Event|0|||
147181688|NCT01052077|530829171|FG002|Phase A|Adverse Event|0|||
147181689|NCT01052077|530829172|FG003|Phase A|Adverse Event|0|||
147181690|NCT01052077|530829169|FG000|Phase A|Met Withdrawal Criteria|26|||
147181691|NCT01052077|530829170|FG001|Phase A|Met Withdrawal Criteria|0|||
147181692|NCT01052077|530829171|FG002|Phase A|Met Withdrawal Criteria|0|||
147181693|NCT01052077|530829172|FG003|Phase A|Met Withdrawal Criteria|0|||
147181694|NCT01052077|530829169|FG000|Phase A|Physician Decision|10|||
147181695|NCT01052077|530829170|FG001|Phase A|Physician Decision|0|||
147181696|NCT01052077|530829171|FG002|Phase A|Physician Decision|0|||
147181697|NCT01052077|530829172|FG003|Phase A|Physician Decision|0|||
147181698|NCT01052077|530829169|FG000|Phase A|Withdrawal by Subject|29|||
147181699|NCT01052077|530829170|FG001|Phase A|Withdrawal by Subject|0|||
147246001|NCT02846779|531070866|FG001|Overall Study|Less than 31 days of follow-up|45|||
147246002|NCT02846779|531070867|FG002|Overall Study|Less than 31 days of follow-up|52|||
147246003|NCT00887978|531070870|FG000|Overall Study|Adverse Event|18|||
147246004|NCT00887978|531070871|FG001|Overall Study|Adverse Event|5|||
147246005|NCT00887978|531070870|FG000|Overall Study|Clinical Worsening|4|||
147246006|NCT00887978|531070871|FG001|Overall Study|Clinical Worsening|4|||
147246007|NCT00887978|531070870|FG000|Overall Study|Death|2|||
147246008|NCT00887978|531070871|FG001|Overall Study|Death|3|||
147246009|NCT00887978|531070870|FG000|Overall Study|Withdrawal by Subject|1|||
147246010|NCT00887978|531070871|FG001|Overall Study|Withdrawal by Subject|2|||
147246011|NCT00887978|531070870|FG000|Overall Study|Lost to Follow-up|0|||
147246012|NCT00887978|531070871|FG001|Overall Study|Lost to Follow-up|1|||
147246013|NCT04023526|531072656|FG000|Overall Study|Ongoing treatment at data cutoff|5|||
147246014|NCT04023526|531072657|FG001|Overall Study|Ongoing treatment at data cutoff|9|||
147593417|NCT02566993|532328983|FG000|Overall Study|Non study drug-related adverse event|9|||
147593418|NCT02566993|532328984|FG001|Overall Study|Non study drug-related adverse event|9|||
147593419|NCT02566993|532328983|FG000|Overall Study|Symptomatic deterioration|9|||
147593420|NCT02566993|532328984|FG001|Overall Study|Symptomatic deterioration|16|||
147593421|NCT02566993|532328983|FG000|Overall Study|End of study due to events required for OS analysis according to study protocol had been reached|9|||
147593422|NCT02566993|532328984|FG001|Overall Study|End of study due to events required for OS analysis according to study protocol had been reached|1|||
147246015|NCT04023526|531072656|FG000|Overall Study|Randomized but did not receive assigned treatment|0|||
147246016|NCT04023526|531072657|FG001|Overall Study|Randomized but did not receive assigned treatment|1|||
147246017|NCT02324569|531072662|FG000|Overall Study|Pretreatment Event/Adverse Event|9|||
147246018|NCT02324569|531072663|FG001|Overall Study|Pretreatment Event/Adverse Event|10|||
147246019|NCT02324569|531072662|FG000|Overall Study|Voluntary Withdrawal|3|||
147246020|NCT02324569|531072663|FG001|Overall Study|Voluntary Withdrawal|6|||
147246021|NCT02324569|531072662|FG000|Overall Study|Lack of Efficacy|2|||
147246022|NCT02324569|531072663|FG001|Overall Study|Lack of Efficacy|3|||
147246023|NCT02324569|531072662|FG000|Overall Study|Change Insulin Dosage Exceeding Criteria|0|||
147246024|NCT02324569|531072663|FG001|Overall Study|Change Insulin Dosage Exceeding Criteria|2|||
147246025|NCT02324569|531072662|FG000|Overall Study|Inconvenient Schedule|2|||
147246026|NCT02324569|531072663|FG001|Overall Study|Inconvenient Schedule|0|||
147246027|NCT01943292|531072664|FG000|Overall Study|Withdrawal by Subject|1|||
147246028|NCT01943292|531072665|FG001|Overall Study|Withdrawal by Subject|0|||
147246029|NCT01943292|531072666|FG002|Overall Study|Withdrawal by Subject|0|||
147246030|NCT00996216|531072667|FG000|Part 1 (Pre-Antiviral Treatment Phase)|Withdrawal by Subject|1|||
147246031|NCT00996216|531072667|FG000|Part 2 (Antiviral Treatment Phase)|Lost to Follow-up|3|||
147246032|NCT00996216|531072667|FG000|Part 2 (Antiviral Treatment Phase)|Withdrawal by Subject|1|||
147246033|NCT00759031|531072676|FG000|First Intervention (1 Day)|Physician Decision|1|||
147246034|NCT00759031|531072677|FG001|First Intervention (1 Day)|Physician Decision|0|||
147246035|NCT00759031|531072676|FG000|First Intervention (1 Day)|Withdrawal by Subject|0|||
147246036|NCT00759031|531072677|FG001|First Intervention (1 Day)|Withdrawal by Subject|1|||
147246037|NCT00759031|531072676|FG000|First Intervention (1 Day)|Screening failure|1|||
147246038|NCT00759031|531072677|FG001|First Intervention (1 Day)|Screening failure|0|||
147246039|NCT00309387|531072678|FG000|Overall Study|Death|72|||
147246040|NCT00309387|531072679|FG001|Overall Study|Death|73|||
147246041|NCT00309387|531072678|FG000|Overall Study|Lost to Follow-up|70|||
147246042|NCT00309387|531072679|FG001|Overall Study|Lost to Follow-up|86|||
147246043|NCT01599234|531072692|FG000|Overall Study|Adverse Event|9|||
147246044|NCT01599234|531072693|FG001|Overall Study|Adverse Event|5|||
147246045|NCT01599234|531072692|FG000|Overall Study|Withdrawal by Subject|2|||
147246046|NCT01599234|531072693|FG001|Overall Study|Withdrawal by Subject|1|||
147246047|NCT01599234|531072692|FG000|Overall Study|Lost to Follow-up|1|||
147246048|NCT01599234|531072693|FG001|Overall Study|Lost to Follow-up|2|||
147596003|NCT00251641|532338768|FG001|Overall Study|Progression of Disease|2|||
147181700|NCT01052077|530829171|FG002|Phase A|Withdrawal by Subject|0|||
147181701|NCT01052077|530829172|FG003|Phase A|Withdrawal by Subject|0|||
147181702|NCT01052077|530829169|FG000|Phase A|Protocol Deviation|27|||
147181703|NCT01052077|530829170|FG001|Phase A|Protocol Deviation|0|||
147656425|NCT02137226|532565069|FG001|Period 1 (Initial Randomization)|Lack of Efficacy|0|||
147656426|NCT02137226|532565070|FG002|Period 1 (Initial Randomization)|Lack of Efficacy|0|||
147656427|NCT02137226|532565071|FG003|Period 1 (Initial Randomization)|Lack of Efficacy|0|||
147656428|NCT02137226|532565072|FG004|Period 1 (Initial Randomization)|Lack of Efficacy|0|||
147656429|NCT02137226|532565068|FG000|Period 1 (Initial Randomization)|Other Reason|1|||
147656430|NCT02137226|532565069|FG001|Period 1 (Initial Randomization)|Other Reason|3|||
147656431|NCT02137226|532565070|FG002|Period 1 (Initial Randomization)|Other Reason|0|||
147656432|NCT02137226|532565071|FG003|Period 1 (Initial Randomization)|Other Reason|0|||
147656433|NCT02137226|532565072|FG004|Period 1 (Initial Randomization)|Other Reason|0|||
147656434|NCT02137226|532565068|FG000|Period 2 (Re - Randomization)|Adverse Event|0|||
147656435|NCT02137226|532565069|FG001|Period 2 (Re - Randomization)|Adverse Event|0|||
147656436|NCT02137226|532565070|FG002|Period 2 (Re - Randomization)|Adverse Event|3|||
147656437|NCT02137226|532565071|FG003|Period 2 (Re - Randomization)|Adverse Event|1|||
147656438|NCT02137226|532565072|FG004|Period 2 (Re - Randomization)|Adverse Event|4|||
147656439|NCT02137226|532565068|FG000|Period 2 (Re - Randomization)|Withdrawal by Subject|0|||
147656440|NCT02137226|532565069|FG001|Period 2 (Re - Randomization)|Withdrawal by Subject|0|||
147656441|NCT02137226|532565070|FG002|Period 2 (Re - Randomization)|Withdrawal by Subject|8|||
147656442|NCT02137226|532565071|FG003|Period 2 (Re - Randomization)|Withdrawal by Subject|5|||
147656443|NCT02137226|532565072|FG004|Period 2 (Re - Randomization)|Withdrawal by Subject|4|||
147656444|NCT02137226|532565068|FG000|Period 2 (Re - Randomization)|Physician Decision|0|||
147656445|NCT02137226|532565069|FG001|Period 2 (Re - Randomization)|Physician Decision|0|||
147656446|NCT02137226|532565070|FG002|Period 2 (Re - Randomization)|Physician Decision|0|||
147656447|NCT02137226|532565071|FG003|Period 2 (Re - Randomization)|Physician Decision|1|||
147656448|NCT02137226|532565072|FG004|Period 2 (Re - Randomization)|Physician Decision|0|||
147656449|NCT02137226|532565068|FG000|Period 2 (Re - Randomization)|Lost to Follow-up|0|||
147656450|NCT02137226|532565069|FG001|Period 2 (Re - Randomization)|Lost to Follow-up|0|||
147656451|NCT02137226|532565070|FG002|Period 2 (Re - Randomization)|Lost to Follow-up|3|||
147656452|NCT02137226|532565071|FG003|Period 2 (Re - Randomization)|Lost to Follow-up|0|||
147656453|NCT02137226|532565072|FG004|Period 2 (Re - Randomization)|Lost to Follow-up|0|||
147656454|NCT02137226|532565068|FG000|Period 2 (Re - Randomization)|Lack of Efficacy|0|||
147656455|NCT02137226|532565069|FG001|Period 2 (Re - Randomization)|Lack of Efficacy|0|||
147656456|NCT02137226|532565070|FG002|Period 2 (Re - Randomization)|Lack of Efficacy|2|||
147656457|NCT02137226|532565071|FG003|Period 2 (Re - Randomization)|Lack of Efficacy|0|||
147656458|NCT02137226|532565072|FG004|Period 2 (Re - Randomization)|Lack of Efficacy|0|||
147656459|NCT02137226|532565068|FG000|Period 2 (Re - Randomization)|Other Reason|0|||
147656460|NCT02137226|532565069|FG001|Period 2 (Re - Randomization)|Other Reason|0|||
147656461|NCT02137226|532565070|FG002|Period 2 (Re - Randomization)|Other Reason|1|||
147656462|NCT02137226|532565071|FG003|Period 2 (Re - Randomization)|Other Reason|1|||
147656463|NCT02137226|532565072|FG004|Period 2 (Re - Randomization)|Other Reason|1|||
147656464|NCT02998996|532565073|FG000|Overall Study|Lost to Follow-up|0|||
147656465|NCT02998996|532565074|FG001|Overall Study|Lost to Follow-up|0|||
147656466|NCT02998996|532565075|FG002|Overall Study|Lost to Follow-up|1|||
147656467|NCT02998996|532565076|FG003|Overall Study|Lost to Follow-up|0|||
147656468|NCT02998996|532565077|FG004|Overall Study|Lost to Follow-up|0|||
147656469|NCT02998996|532565078|FG005|Overall Study|Lost to Follow-up|0|||
147656470|NCT02998996|532565073|FG000|Overall Study|Pregnancy|0|||
147656471|NCT02998996|532565074|FG001|Overall Study|Pregnancy|1|||
147656472|NCT02998996|532565075|FG002|Overall Study|Pregnancy|0|||
147656473|NCT02998996|532565076|FG003|Overall Study|Pregnancy|0|||
147656474|NCT02998996|532565077|FG004|Overall Study|Pregnancy|0|||
147656475|NCT02998996|532565078|FG005|Overall Study|Pregnancy|0|||
147656476|NCT02998996|532565073|FG000|Overall Study|Family reasons|0|||
147656477|NCT02998996|532565074|FG001|Overall Study|Family reasons|0|||
147656478|NCT02998996|532565075|FG002|Overall Study|Family reasons|0|||
147656479|NCT02998996|532565076|FG003|Overall Study|Family reasons|0|||
147656480|NCT02998996|532565077|FG004|Overall Study|Family reasons|1|||
147656481|NCT02998996|532565078|FG005|Overall Study|Family reasons|0|||
147656482|NCT00003896|532565083|FG000|Overall Study|Adverse Event|16|||
147656483|NCT00003896|532565083|FG000|Overall Study|Withdrawal by Subject|1|||
147656484|NCT00003896|532565083|FG000|Overall Study|Lack of Efficacy|1|||
147181704|NCT01052077|530829171|FG002|Phase A|Protocol Deviation|0|||
147181705|NCT01052077|530829172|FG003|Phase A|Protocol Deviation|0|||
147181706|NCT01052077|530829169|FG000|Phase B|Lost to Follow-up|0|||
147181707|NCT01052077|530829170|FG001|Phase B|Lost to Follow-up|2|||
147181708|NCT01052077|530829171|FG002|Phase B|Lost to Follow-up|3|||
147181709|NCT01052077|530829172|FG003|Phase B|Lost to Follow-up|0|||
147181710|NCT01052077|530829169|FG000|Phase B|Adverse Event|0|||
147181711|NCT01052077|530829170|FG001|Phase B|Adverse Event|9|||
147181712|NCT01052077|530829171|FG002|Phase B|Adverse Event|2|||
147656485|NCT00003896|532565083|FG000|Overall Study|Death|3|||
147656486|NCT00003896|532565083|FG000|Overall Study|not protocol specified|3|||
147656487|NCT00003896|532565083|FG000|Overall Study|ineligible|5|||
147656488|NCT01398358|532565086|FG000|Overall Study|Lost to Follow-up|11|||
147181713|NCT01052077|530829172|FG003|Phase B|Adverse Event|0|||
147181714|NCT01052077|530829169|FG000|Phase B|Met Withdrawal Criteria|0|||
147326427|NCT02014558|531359708|FG008|Overall Study|Progressive Disease|5|||
147326428|NCT02014558|531359709|FG009|Overall Study|Progressive Disease|6|||
147326429|NCT02014558|531359710|FG010|Overall Study|Progressive Disease|22|||
147326430|NCT02014558|531359711|FG011|Overall Study|Progressive Disease|31|||
147326431|NCT02014558|531359712|FG012|Overall Study|Progressive Disease|6|||
147326432|NCT02014558|531359700|FG000|Overall Study|Withdrawal by Subject|0|||
147326433|NCT02014558|531359701|FG001|Overall Study|Withdrawal by Subject|0|||
147326434|NCT02014558|531359702|FG002|Overall Study|Withdrawal by Subject|0|||
147326435|NCT02014558|531359703|FG003|Overall Study|Withdrawal by Subject|0|||
147326436|NCT02014558|531359704|FG004|Overall Study|Withdrawal by Subject|1|||
147326437|NCT02014558|531359705|FG005|Overall Study|Withdrawal by Subject|0|||
147326438|NCT02014558|531359706|FG006|Overall Study|Withdrawal by Subject|0|||
147326439|NCT02014558|531359707|FG007|Overall Study|Withdrawal by Subject|0|||
147326440|NCT02014558|531359708|FG008|Overall Study|Withdrawal by Subject|0|||
147326441|NCT02014558|531359709|FG009|Overall Study|Withdrawal by Subject|2|||
147326442|NCT02014558|531359710|FG010|Overall Study|Withdrawal by Subject|6|||
147326443|NCT02014558|531359711|FG011|Overall Study|Withdrawal by Subject|10|||
147326444|NCT02014558|531359712|FG012|Overall Study|Withdrawal by Subject|0|||
147326445|NCT02014558|531359700|FG000|Overall Study|Miscellaneous|2|||
147326446|NCT02014558|531359701|FG001|Overall Study|Miscellaneous|1|||
147326447|NCT02014558|531359702|FG002|Overall Study|Miscellaneous|1|||
147326448|NCT02014558|531359703|FG003|Overall Study|Miscellaneous|1|||
147326449|NCT02014558|531359704|FG004|Overall Study|Miscellaneous|0|||
147326450|NCT02014558|531359705|FG005|Overall Study|Miscellaneous|1|||
147326451|NCT02014558|531359706|FG006|Overall Study|Miscellaneous|0|||
147326452|NCT02014558|531359707|FG007|Overall Study|Miscellaneous|1|||
147326453|NCT02014558|531359708|FG008|Overall Study|Miscellaneous|1|||
147326454|NCT02014558|531359709|FG009|Overall Study|Miscellaneous|3|||
147326455|NCT02014558|531359710|FG010|Overall Study|Miscellaneous|12|||
147326456|NCT02014558|531359711|FG011|Overall Study|Miscellaneous|11|||
147326457|NCT02014558|531359712|FG012|Overall Study|Miscellaneous|1|||
147326458|NCT00299702|531359715|FG000|Overall Study|Death|1|||
147326459|NCT00299702|531359716|FG001|Overall Study|Death|0|||
147326460|NCT00299702|531359715|FG000|Overall Study|Adverse Event|0|||
147326461|NCT00299702|531359716|FG001|Overall Study|Adverse Event|4|||
147326462|NCT00299702|531359715|FG000|Overall Study|Lost to Follow-up|18|||
147326463|NCT00299702|531359716|FG001|Overall Study|Lost to Follow-up|10|||
147326464|NCT00299702|531359715|FG000|Overall Study|Withdrawal by Subject|25|||
147326465|NCT00299702|531359716|FG001|Overall Study|Withdrawal by Subject|23|||
147326466|NCT00299702|531359715|FG000|Overall Study|Pregnancy|0|||
147326467|NCT00299702|531359716|FG001|Overall Study|Pregnancy|1|||
147326468|NCT00299702|531359715|FG000|Overall Study|Insufficient Response|4|||
147326469|NCT00299702|531359716|FG001|Overall Study|Insufficient Response|3|||
147326470|NCT00299702|531359715|FG000|Overall Study|Admin issues, sponsor decision, etc.|5|||
147326471|NCT00299702|531359716|FG001|Overall Study|Admin issues, sponsor decision, etc.|9|||
147326472|NCT01560949|531359717|FG000|Systemic Phase: mFOLFIRINOX|Adverse Event|6|||
147326473|NCT01560949|531359717|FG000|Surgery Phase|Physician Decision|3|||
147326474|NCT00751036|531359718|FG000|Overall Study|Disease Progression|28|||
147326475|NCT00751036|531359719|FG001|Overall Study|Disease Progression|29|||
147326476|NCT00751036|531359718|FG000|Overall Study|Adverse Event|6|||
147326477|NCT00751036|531359719|FG001|Overall Study|Adverse Event|4|||
147326478|NCT00751036|531359718|FG000|Overall Study|Administrative Problems|3|||
147326479|NCT00751036|531359719|FG001|Overall Study|Administrative Problems|4|||
147326480|NCT00751036|531359718|FG000|Overall Study|Withdrawal by Subject|5|||
147326481|NCT00751036|531359719|FG001|Overall Study|Withdrawal by Subject|2|||
147326482|NCT00751036|531359718|FG000|Overall Study|Death|3|||
147326483|NCT00751036|531359719|FG001|Overall Study|Death|3|||
147326484|NCT00751036|531359718|FG000|Overall Study|Lost to Follow-up|0|||
147326485|NCT00751036|531359719|FG001|Overall Study|Lost to Follow-up|1|||
147326486|NCT00751036|531359718|FG000|Overall Study|Protocol Violation|1|||
147326487|NCT00751036|531359719|FG001|Overall Study|Protocol Violation|0|||
147326488|NCT00751036|531359718|FG000|Overall Study|Missing end of Treatment Page|2|||
147326489|NCT00751036|531359719|FG001|Overall Study|Missing end of Treatment Page|3|||
147326490|NCT04580407|531359720|FG000|Overall Study|Judged to be Required to Receive Prophylactic Treatment with Emicizumab|1|||
147448472|NCT01464307|531805734|FG001|Open-Label Extension Period|Death|0|||
147326491|NCT01562743|531359728|FG000|Overall Study|Adverse Event|29|||
147326492|NCT01562743|531359728|FG000|Overall Study|Lack of Efficacy|3|||
147326493|NCT01562743|531359728|FG000|Overall Study|Withdrawal by Subject|13|||
147326494|NCT01562743|531359728|FG000|Overall Study|Protocol Violation|1|||
147326495|NCT01562743|531359728|FG000|Overall Study|Discontinuation criteria|2|||
147326496|NCT01562743|531359728|FG000|Overall Study|Lost to Follow-up|2|||
147326497|NCT01562743|531359728|FG000|Overall Study|Physician Decision|2|||
147326498|NCT04155424|531359730|FG000|Overall Study|Other than specified|3|||
147326499|NCT04155424|531359730|FG000|Overall Study|Withdrawal by Subject|1|||
147326500|NCT04155424|531359730|FG000|Overall Study|Adverse Event|1|||
147326501|NCT02449044|531359731|FG000|Overall Study|Lost to Follow-up|2|||
147326502|NCT02449044|531359731|FG000|Overall Study|Withdrawal by Subject|13|||
147326503|NCT02449044|531359731|FG000|Overall Study|Adverse Event|30|||
147181715|NCT01052077|530829170|FG001|Phase B|Met Withdrawal Criteria|2|||
147181716|NCT01052077|530829171|FG002|Phase B|Met Withdrawal Criteria|1|||
147181717|NCT01052077|530829172|FG003|Phase B|Met Withdrawal Criteria|0|||
147181718|NCT01052077|530829169|FG000|Phase B|Physician Decision|0|||
147181719|NCT01052077|530829170|FG001|Phase B|Physician Decision|1|||
147181720|NCT01052077|530829171|FG002|Phase B|Physician Decision|1|||
147181721|NCT01052077|530829172|FG003|Phase B|Physician Decision|0|||
147181722|NCT01052077|530829169|FG000|Phase B|Withdrawal by Subject|0|||
147246049|NCT01599234|531072692|FG000|Overall Study|Lack of Efficacy|2|||
147246050|NCT01599234|531072693|FG001|Overall Study|Lack of Efficacy|4|||
147246051|NCT01599234|531072692|FG000|Overall Study|Unable to operate spray|1|||
147246052|NCT01599234|531072693|FG001|Overall Study|Unable to operate spray|0|||
147246053|NCT01599234|531072692|FG000|Overall Study|Sponsor request as creatinine levels <50|0|||
147593423|NCT02566993|532328983|FG000|Overall Study|Sponsor's decision after incorrect treatment at site|1|||
147593424|NCT02566993|532328984|FG001|Overall Study|Sponsor's decision after incorrect treatment at site|1|||
147593425|NCT02566993|532328983|FG000|Overall Study|Screening failure|2|||
147593426|NCT02566993|532328984|FG001|Overall Study|Screening failure|0|||
147593427|NCT02566993|532328983|FG000|Overall Study|Lost to Follow-up|0|||
147593428|NCT02566993|532328984|FG001|Overall Study|Lost to Follow-up|1|||
147593429|NCT02566993|532328983|FG000|Overall Study|Symptomatic deterioration, progression disease, and a decision by the Investigator|0|||
147593430|NCT02566993|532328984|FG001|Overall Study|Symptomatic deterioration, progression disease, and a decision by the Investigator|1|||
147593431|NCT02278718|532328985|FG000|Overall Study|Adverse Event|1|||
147593432|NCT02278718|532328986|FG001|Overall Study|Adverse Event|0|||
147593433|NCT02278718|532328985|FG000|Overall Study|Lost to Follow-up|2|||
147593434|NCT02278718|532328986|FG001|Overall Study|Lost to Follow-up|4|||
147593435|NCT02278718|532328985|FG000|Overall Study|Withdrawal by Subject|1|||
147593436|NCT02278718|532328986|FG001|Overall Study|Withdrawal by Subject|4|||
147593437|NCT02278718|532328985|FG000|Overall Study|The patient was randomised but did not receive study drug treatment|2|||
147593438|NCT02278718|532328986|FG001|Overall Study|The patient was randomised but did not receive study drug treatment|1|||
147593439|NCT02278718|532328985|FG000|Overall Study|Missing|0|||
147593440|NCT02278718|532328986|FG001|Overall Study|Missing|1|||
147593441|NCT04440449|532328987|FG000|Overall Study|Lost to Follow-up|2|||
147593442|NCT04440449|532328988|FG001|Overall Study|Lost to Follow-up|0|||
147593443|NCT03212794|532328989|FG000|Overall Study|Participation terminated due to prolonged inpatient stay (never able to receive intervention).|1|||
147593444|NCT03212794|532328990|FG001|Overall Study|Participation terminated due to prolonged inpatient stay (never able to receive intervention).|0|||
147593445|NCT03212794|532328989|FG000|Overall Study|Lost to Follow-up|5|||
147593446|NCT03212794|532328990|FG001|Overall Study|Lost to Follow-up|6|||
147593447|NCT03212794|532328989|FG000|Overall Study|Incarcerated; unable to participate|2|||
147593448|NCT03212794|532328990|FG001|Overall Study|Incarcerated; unable to participate|0|||
147593449|NCT03212794|532328989|FG000|Overall Study|Withdrawal by Subject|1|||
147593450|NCT03212794|532328990|FG001|Overall Study|Withdrawal by Subject|0|||
147593451|NCT03212794|532328989|FG000|Overall Study|Death|0|||
147593452|NCT03212794|532328990|FG001|Overall Study|Death|1|||
147593453|NCT03212794|532328989|FG000|Overall Study|Found to be ineligible after allocation|0|||
147593454|NCT03212794|532328990|FG001|Overall Study|Found to be ineligible after allocation|1|||
147593455|NCT03212794|532328989|FG000|Overall Study|Relocated out of area|2|||
147593456|NCT03212794|532328990|FG001|Overall Study|Relocated out of area|0|||
147593457|NCT00897949|532328991|FG000|Overall Study|Adverse Event|1|||
147593458|NCT00897949|532328992|FG001|Overall Study|Adverse Event|1|||
147593459|NCT00897949|532328993|FG002|Overall Study|Adverse Event|0|||
147593460|NCT00897949|532328991|FG000|Overall Study|Lost to Follow-up|0|||
147593461|NCT00897949|532328992|FG001|Overall Study|Lost to Follow-up|2|||
147593462|NCT00897949|532328993|FG002|Overall Study|Lost to Follow-up|1|||
147593463|NCT00897949|532328991|FG000|Overall Study|Protocol Violation|6|||
147593464|NCT00897949|532328992|FG001|Overall Study|Protocol Violation|3|||
147593465|NCT00897949|532328993|FG002|Overall Study|Protocol Violation|1|||
147593466|NCT00897949|532328991|FG000|Overall Study|Withdrawal by Subject|1|||
147593467|NCT00897949|532328992|FG001|Overall Study|Withdrawal by Subject|2|||
147593468|NCT00897949|532328993|FG002|Overall Study|Withdrawal by Subject|0|||
147593469|NCT00897949|532328991|FG000|Overall Study|Patient Uncoorperative|0|||
147593470|NCT00897949|532328992|FG001|Overall Study|Patient Uncoorperative|2|||
147593471|NCT00897949|532328993|FG002|Overall Study|Patient Uncoorperative|1|||
147593472|NCT00897949|532328991|FG000|Overall Study|Lost to Follow-up|30|||
147593473|NCT00897949|532328992|FG001|Overall Study|Lost to Follow-up|23|||
147593474|NCT00897949|532328993|FG002|Overall Study|Lost to Follow-up|17|||
147593475|NCT00897949|532328991|FG000|Overall Study|Withdrawal by Subject|24|||
147593476|NCT00897949|532328992|FG001|Overall Study|Withdrawal by Subject|31|||
147593477|NCT00897949|532328993|FG002|Overall Study|Withdrawal by Subject|17|||
147593478|NCT00897949|532328991|FG000|Overall Study|Abnormal Prestudy Labs|2|||
147593479|NCT00897949|532328992|FG001|Overall Study|Abnormal Prestudy Labs|3|||
147593480|NCT00897949|532328993|FG002|Overall Study|Abnormal Prestudy Labs|4|||
147593481|NCT00897949|532328991|FG000|Overall Study|Abnormal Baseline ECG|2|||
147593482|NCT00897949|532328992|FG001|Overall Study|Abnormal Baseline ECG|2|||
147593483|NCT00897949|532328993|FG002|Overall Study|Abnormal Baseline ECG|4|||
147326504|NCT02449044|531359731|FG000|Overall Study|Met Withdrawal Criteria|7|||
147326505|NCT02449044|531359731|FG000|Overall Study|Physician Decision|9|||
147326506|NCT02449044|531359731|FG000|Overall Study|Sponsor Discontinued Trial|3|||
147326507|NCT05526911|531361761|FG000|Overall Study|Adverse Event|2|||
147326508|NCT05025449|531361762|FG000|Overall Study|Withdrawal by Subject|1|||
147326509|NCT05025449|531361762|FG000|Overall Study|Patient emergently taken to operating room|1|||
147326510|NCT01537133|531361763|FG000|Overall Study|Withdrawal by Subject|2|||
147326511|NCT01537133|531361764|FG001|Overall Study|Withdrawal by Subject|0|||
147326512|NCT01537133|531361765|FG002|Overall Study|Withdrawal by Subject|0|||
147326513|NCT01537133|531361766|FG003|Overall Study|Withdrawal by Subject|0|||
147326514|NCT01537133|531361763|FG000|Overall Study|Lost to Follow-up|1|||
147326515|NCT01537133|531361764|FG001|Overall Study|Lost to Follow-up|0|||
147326516|NCT01537133|531361765|FG002|Overall Study|Lost to Follow-up|0|||
147326517|NCT01537133|531361766|FG003|Overall Study|Lost to Follow-up|0|||
147326518|NCT00991276|531361777|FG000|First Intervention Period|Adverse Event|0|||
147326519|NCT00991276|531361778|FG001|First Intervention Period|Adverse Event|1|||
147326520|NCT00991276|531361779|FG002|First Intervention Period|Adverse Event|0|||
147326521|NCT00991276|531361780|FG003|First Intervention Period|Adverse Event|1|||
147326522|NCT00991276|531361781|FG004|First Intervention Period|Adverse Event|0|||
147326523|NCT00991276|531361782|FG005|First Intervention Period|Adverse Event|0|||
147326524|NCT00991276|531361777|FG000|First Intervention Period|Protocol Violation|0|||
147326525|NCT00991276|531361778|FG001|First Intervention Period|Protocol Violation|0|||
147326526|NCT00991276|531361779|FG002|First Intervention Period|Protocol Violation|0|||
147326527|NCT00991276|531361780|FG003|First Intervention Period|Protocol Violation|0|||
147326528|NCT00991276|531361781|FG004|First Intervention Period|Protocol Violation|2|||
147326529|NCT00991276|531361782|FG005|First Intervention Period|Protocol Violation|0|||
147326530|NCT00991276|531361777|FG000|First Intervention Period|Insufficient clinical response|0|||
147326531|NCT00991276|531361778|FG001|First Intervention Period|Insufficient clinical response|0|||
147326532|NCT00991276|531361779|FG002|First Intervention Period|Insufficient clinical response|0|||
147326533|NCT00991276|531361780|FG003|First Intervention Period|Insufficient clinical response|0|||
147326534|NCT00991276|531361781|FG004|First Intervention Period|Insufficient clinical response|1|||
147326535|NCT00991276|531361782|FG005|First Intervention Period|Insufficient clinical response|0|||
147326536|NCT00991276|531361777|FG000|First Intervention Period|Other|0|||
147326537|NCT00991276|531361778|FG001|First Intervention Period|Other|0|||
147326538|NCT00991276|531361779|FG002|First Intervention Period|Other|0|||
147326539|NCT00991276|531361780|FG003|First Intervention Period|Other|1|||
147326540|NCT00991276|531361781|FG004|First Intervention Period|Other|1|||
147326541|NCT00991276|531361782|FG005|First Intervention Period|Other|0|||
147326542|NCT00991276|531361777|FG000|First Intervention Period|Withdrawal by Subject|0|||
147326543|NCT00991276|531361778|FG001|First Intervention Period|Withdrawal by Subject|1|||
147326544|NCT00991276|531361779|FG002|First Intervention Period|Withdrawal by Subject|0|||
147326545|NCT00991276|531361780|FG003|First Intervention Period|Withdrawal by Subject|1|||
147326546|NCT00991276|531361781|FG004|First Intervention Period|Withdrawal by Subject|0|||
147326547|NCT00991276|531361782|FG005|First Intervention Period|Withdrawal by Subject|1|||
147326548|NCT00991276|531361777|FG000|First Intervention Period|Lost to Follow-up|0|||
147326549|NCT00991276|531361778|FG001|First Intervention Period|Lost to Follow-up|1|||
147326550|NCT00991276|531361779|FG002|First Intervention Period|Lost to Follow-up|0|||
147326551|NCT00991276|531361780|FG003|First Intervention Period|Lost to Follow-up|1|||
147326552|NCT00991276|531361781|FG004|First Intervention Period|Lost to Follow-up|0|||
147326553|NCT00991276|531361782|FG005|First Intervention Period|Lost to Follow-up|0|||
147326554|NCT00991276|531361777|FG000|Second Intervention Period|Adverse Event|0|||
147326555|NCT00991276|531361778|FG001|Second Intervention Period|Adverse Event|2|||
147326556|NCT00991276|531361779|FG002|Second Intervention Period|Adverse Event|0|||
147326557|NCT00991276|531361780|FG003|Second Intervention Period|Adverse Event|1|||
147326558|NCT00991276|531361781|FG004|Second Intervention Period|Adverse Event|1|||
147326559|NCT00991276|531361782|FG005|Second Intervention Period|Adverse Event|0|||
147326560|NCT00991276|531361777|FG000|Second Intervention Period|Protocol Violation|1|||
147326561|NCT00991276|531361778|FG001|Second Intervention Period|Protocol Violation|0|||
147326562|NCT00991276|531361779|FG002|Second Intervention Period|Protocol Violation|0|||
147326563|NCT00991276|531361780|FG003|Second Intervention Period|Protocol Violation|0|||
147326564|NCT00991276|531361781|FG004|Second Intervention Period|Protocol Violation|0|||
147326565|NCT00991276|531361782|FG005|Second Intervention Period|Protocol Violation|0|||
147326566|NCT00991276|531361777|FG000|Second Intervention Period|Other|0|||
147326567|NCT00991276|531361778|FG001|Second Intervention Period|Other|0|||
147326568|NCT00991276|531361779|FG002|Second Intervention Period|Other|0|||
147326569|NCT00991276|531361780|FG003|Second Intervention Period|Other|1|||
147326570|NCT00991276|531361781|FG004|Second Intervention Period|Other|0|||
147326571|NCT00991276|531361782|FG005|Second Intervention Period|Other|1|||
147326572|NCT00991276|531361777|FG000|Third Intervention Period|Protocol Violation|1|||
147326573|NCT00991276|531361778|FG001|Third Intervention Period|Protocol Violation|0|||
147326574|NCT00991276|531361779|FG002|Third Intervention Period|Protocol Violation|0|||
147326575|NCT00991276|531361780|FG003|Third Intervention Period|Protocol Violation|0|||
147326576|NCT00991276|531361781|FG004|Third Intervention Period|Protocol Violation|0|||
147656489|NCT01398358|532565087|FG001|Overall Study|Lost to Follow-up|21|||
147656490|NCT01398358|532565088|FG002|Overall Study|Lost to Follow-up|18|||
147656491|NCT01398358|532565086|FG000|Overall Study|Withdrawal by Subject|3|||
147656492|NCT01398358|532565087|FG001|Overall Study|Withdrawal by Subject|2|||
147656493|NCT01398358|532565088|FG002|Overall Study|Withdrawal by Subject|2|||
147656494|NCT01398358|532565086|FG000|Overall Study|no longer eligible|1|||
147181723|NCT01052077|530829170|FG001|Phase B|Withdrawal by Subject|0|||
147181724|NCT01052077|530829171|FG002|Phase B|Withdrawal by Subject|5|||
147181725|NCT01052077|530829172|FG003|Phase B|Withdrawal by Subject|0|||
147181726|NCT01052077|530829169|FG000|Phase B|Protocol Deviation|0|||
147181727|NCT01052077|530829170|FG001|Phase B|Protocol Deviation|3|||
147656495|NCT01398358|532565087|FG001|Overall Study|no longer eligible|0|||
147656496|NCT01398358|532565088|FG002|Overall Study|no longer eligible|1|||
147656497|NCT00985686|532565090|FG000|Overall Study|Lost to Follow-up|1|||
147656498|NCT00985686|532565091|FG001|Overall Study|Lost to Follow-up|1|||
147656499|NCT00985686|532565092|FG002|Overall Study|Lost to Follow-up|0|||
147656500|NCT00985686|532565093|FG003|Overall Study|Lost to Follow-up|2|||
147181728|NCT01052077|530829171|FG002|Phase B|Protocol Deviation|4|||
147326577|NCT00991276|531361782|FG005|Third Intervention Period|Protocol Violation|0|||
147656501|NCT03134911|532565094|FG000|Overall Study|Screen failure|31|||
147656502|NCT03134911|532565094|FG000|Overall Study|Not meeting inclusion/exclusion criteria|3|||
147656503|NCT01087203|532565095|FG000|Overall Study|Lost to Follow-up|2|||
147656504|NCT01087203|532565096|FG001|Overall Study|Lost to Follow-up|0|||
147181729|NCT01052077|530829172|FG003|Phase B|Protocol Deviation|0|||
147326578|NCT00991276|531361777|FG000|Third Intervention Period|Other|0|||
147326579|NCT00991276|531361778|FG001|Third Intervention Period|Other|0|||
147326580|NCT00991276|531361779|FG002|Third Intervention Period|Other|0|||
147326581|NCT00991276|531361780|FG003|Third Intervention Period|Other|0|||
147326582|NCT00991276|531361781|FG004|Third Intervention Period|Other|0|||
147326583|NCT00991276|531361782|FG005|Third Intervention Period|Other|1|||
147326584|NCT00991276|531361777|FG000|Third Intervention Period|Adverse Event|0|||
147326585|NCT00991276|531361778|FG001|Third Intervention Period|Adverse Event|0|||
147326586|NCT00991276|531361779|FG002|Third Intervention Period|Adverse Event|1|||
147326587|NCT00991276|531361780|FG003|Third Intervention Period|Adverse Event|0|||
147326588|NCT00991276|531361781|FG004|Third Intervention Period|Adverse Event|0|||
147326589|NCT00991276|531361782|FG005|Third Intervention Period|Adverse Event|0|||
147326590|NCT00991276|531361777|FG000|Third Intervention Period|Withdrawal by Subject|0|||
147326591|NCT00991276|531361778|FG001|Third Intervention Period|Withdrawal by Subject|0|||
147326592|NCT00991276|531361779|FG002|Third Intervention Period|Withdrawal by Subject|0|||
147326593|NCT00991276|531361780|FG003|Third Intervention Period|Withdrawal by Subject|1|||
147326594|NCT00991276|531361781|FG004|Third Intervention Period|Withdrawal by Subject|0|||
147326595|NCT00991276|531361782|FG005|Third Intervention Period|Withdrawal by Subject|0|||
147326596|NCT01268891|531361783|FG000|Overall Study|Adverse Event|3|||
147326597|NCT01268891|531361784|FG001|Overall Study|Adverse Event|7|||
147326598|NCT01268891|531361783|FG000|Overall Study|Lack of Efficacy|1|||
147326599|NCT01268891|531361784|FG001|Overall Study|Lack of Efficacy|0|||
147326600|NCT01268891|531361783|FG000|Overall Study|Withdrawal of Consent|3|||
147326601|NCT01268891|531361784|FG001|Overall Study|Withdrawal of Consent|1|||
147326602|NCT01268891|531361783|FG000|Overall Study|Administrative or other reason(s)|1|||
147326603|NCT01268891|531361784|FG001|Overall Study|Administrative or other reason(s)|0|||
147326604|NCT01688973|531361786|FG000|Overall Study|Ineligible|2|||
147326605|NCT01688973|531361787|FG001|Overall Study|Ineligible|3|||
147326606|NCT01124162|531361788|FG000|First Intervention|Adverse Event|2|||
147326607|NCT01124162|531361789|FG001|First Intervention|Adverse Event|0|||
147326608|NCT01124162|531361788|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
147326609|NCT01124162|531361789|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
147326610|NCT02534896|531361798|FG000|Overall Study|Adverse Event|2|||
147326611|NCT02534896|531361799|FG001|Overall Study|Adverse Event|1|||
147326612|NCT02534896|531361800|FG002|Overall Study|Adverse Event|1|||
147326613|NCT02534896|531361798|FG000|Overall Study|Insufficient therapeutic response|2|||
147326614|NCT02534896|531361799|FG001|Overall Study|Insufficient therapeutic response|0|||
147326615|NCT02534896|531361800|FG002|Overall Study|Insufficient therapeutic response|0|||
147326616|NCT00920686|531361804|FG000|Overall Study|Lost to Follow-up|2|||
147326617|NCT00920686|531361805|FG001|Overall Study|Lost to Follow-up|3|||
147326618|NCT00920686|531361806|FG002|Overall Study|Lost to Follow-up|1|||
147326619|NCT00920686|531361804|FG000|Overall Study|Study drug dosing criteria not met|17|||
147326620|NCT00920686|531361805|FG001|Overall Study|Study drug dosing criteria not met|19|||
147326621|NCT00920686|531361806|FG002|Overall Study|Study drug dosing criteria not met|12|||
147326622|NCT03006341|531361807|FG000|Overall Study|Not linked in the EMR|25069|||
147326623|NCT03006341|531361808|FG001|Overall Study|Not linked in the EMR|67505|||
147326624|NCT03006341|531361809|FG002|Overall Study|Not linked in the EMR|30993|||
147326625|NCT03006341|531361810|FG003|Overall Study|Not linked in the EMR|10685|||
147326626|NCT00742274|531361811|FG000|Overall Study|Death|1|||
147326627|NCT00742274|531361812|FG001|Overall Study|Death|0|||
147181730|NCT01052077|530829169|FG000|Phase B|Lack of Efficacy|0|||
147656505|NCT01087203|532565095|FG000|Overall Study|Withdrawal by Subject|2|||
147656506|NCT01087203|532565096|FG001|Overall Study|Withdrawal by Subject|6|||
147656507|NCT01087203|532565095|FG000|Overall Study|Lack of Efficacy|1|||
147656508|NCT01087203|532565096|FG001|Overall Study|Lack of Efficacy|2|||
147656509|NCT01087203|532565095|FG000|Overall Study|Study terminated by sponsor|27|||
147656510|NCT01087203|532565096|FG001|Overall Study|Study terminated by sponsor|27|||
147656511|NCT02559570|532565098|FG000|Overall Study|Adverse Event|0|||
147181731|NCT01052077|530829170|FG001|Phase B|Lack of Efficacy|1|||
147181732|NCT01052077|530829171|FG002|Phase B|Lack of Efficacy|0|||
147181733|NCT01052077|530829172|FG003|Phase B|Lack of Efficacy|0|||
147181734|NCT01052077|530829169|FG000|Phase A+|Lost to Follow-up|0|||
147181735|NCT01052077|530829170|FG001|Phase A+|Lost to Follow-up|0|||
147181736|NCT01052077|530829171|FG002|Phase A+|Lost to Follow-up|0|||
147181737|NCT01052077|530829172|FG003|Phase A+|Lost to Follow-up|8|||
147181738|NCT01052077|530829169|FG000|Phase A+|Adverse Event|0|||
147181739|NCT01052077|530829170|FG001|Phase A+|Adverse Event|0|||
147181740|NCT01052077|530829171|FG002|Phase A+|Adverse Event|0|||
147656512|NCT02559570|532565099|FG001|Overall Study|Adverse Event|2|||
147656513|NCT02559570|532565100|FG002|Overall Study|Adverse Event|0|||
147656514|NCT02559570|532565101|FG003|Overall Study|Adverse Event|1|||
147656515|NCT02559570|532565102|FG004|Overall Study|Adverse Event|0|||
147181741|NCT01052077|530829172|FG003|Phase A+|Adverse Event|4|||
147181742|NCT01052077|530829169|FG000|Phase A+|Met Withdrawal Criteria|0|||
147246054|NCT01599234|531072693|FG001|Overall Study|Sponsor request as creatinine levels <50|1|||
147656516|NCT02559570|532565098|FG000|Overall Study|Withdrawal of Consent|0|||
147656517|NCT02559570|532565099|FG001|Overall Study|Withdrawal of Consent|0|||
147656518|NCT02559570|532565100|FG002|Overall Study|Withdrawal of Consent|1|||
147656519|NCT02559570|532565101|FG003|Overall Study|Withdrawal of Consent|2|||
147656520|NCT02559570|532565102|FG004|Overall Study|Withdrawal of Consent|1|||
147656521|NCT02559570|532565098|FG000|Overall Study|Lost to Follow-up|1|||
147656522|NCT02559570|532565099|FG001|Overall Study|Lost to Follow-up|0|||
147656523|NCT02559570|532565100|FG002|Overall Study|Lost to Follow-up|0|||
147656524|NCT02559570|532565101|FG003|Overall Study|Lost to Follow-up|0|||
147656525|NCT02559570|532565102|FG004|Overall Study|Lost to Follow-up|0|||
147656526|NCT02559570|532565098|FG000|Overall Study|Protocol Violation|1|||
147656527|NCT02559570|532565099|FG001|Overall Study|Protocol Violation|0|||
147656528|NCT02559570|532565100|FG002|Overall Study|Protocol Violation|0|||
147656529|NCT02559570|532565101|FG003|Overall Study|Protocol Violation|0|||
147656530|NCT02559570|532565102|FG004|Overall Study|Protocol Violation|1|||
147656531|NCT02559570|532565098|FG000|Overall Study|Other Miscellaneous Reasons|0|||
147656532|NCT02559570|532565099|FG001|Overall Study|Other Miscellaneous Reasons|0|||
147246055|NCT01599234|531072692|FG000|Overall Study|Death|1|||
147246056|NCT01599234|531072693|FG001|Overall Study|Death|0|||
147246057|NCT01599234|531072692|FG000|Overall Study|Patient would not stop driving|1|||
147246058|NCT01599234|531072693|FG001|Overall Study|Patient would not stop driving|0|||
147246059|NCT01599234|531072692|FG000|Overall Study|Contra-indication discovered|0|||
147246060|NCT01599234|531072693|FG001|Overall Study|Contra-indication discovered|1|||
147246061|NCT01599234|531072692|FG000|Overall Study|Pregnancy|0|||
147246062|NCT01599234|531072693|FG001|Overall Study|Pregnancy|1|||
147246063|NCT04492618|531072694|FG000|Overall Study|Withdrawal by Subject|1|||
147246064|NCT02495168|531072698|FG000|Overall Study|Other than Specified|18|||
147246065|NCT02495168|531072699|FG001|Overall Study|Other than Specified|22|||
147246066|NCT02495168|531072700|FG002|Overall Study|Other than Specified|5|||
147246067|NCT02495168|531072698|FG000|Overall Study|Did not Complete Final Visit On Time|4|||
147246068|NCT02495168|531072699|FG001|Overall Study|Did not Complete Final Visit On Time|3|||
147246069|NCT02495168|531072700|FG002|Overall Study|Did not Complete Final Visit On Time|2|||
147246070|NCT02495168|531072698|FG000|Overall Study|Physician Decision|1|||
147246071|NCT02495168|531072699|FG001|Overall Study|Physician Decision|1|||
147246072|NCT02495168|531072700|FG002|Overall Study|Physician Decision|0|||
147246073|NCT02495168|531072698|FG000|Overall Study|Lost to Follow-up|10|||
147246074|NCT02495168|531072699|FG001|Overall Study|Lost to Follow-up|6|||
147246075|NCT02495168|531072700|FG002|Overall Study|Lost to Follow-up|1|||
147246076|NCT02495168|531072698|FG000|Overall Study|Withdrawal by Subject|1|||
147246077|NCT02495168|531072699|FG001|Overall Study|Withdrawal by Subject|4|||
147246078|NCT02495168|531072700|FG002|Overall Study|Withdrawal by Subject|2|||
147246079|NCT02495168|531072698|FG000|Overall Study|Protocol Violation|0|||
147246080|NCT02495168|531072699|FG001|Overall Study|Protocol Violation|10|||
147246081|NCT02495168|531072700|FG002|Overall Study|Protocol Violation|1|||
147246082|NCT02495168|531072698|FG000|Overall Study|Adverse Event|4|||
147656533|NCT02559570|532565100|FG002|Overall Study|Other Miscellaneous Reasons|1|||
147656534|NCT02559570|532565101|FG003|Overall Study|Other Miscellaneous Reasons|0|||
147181743|NCT01052077|530829170|FG001|Phase A+|Met Withdrawal Criteria|0|||
147181744|NCT01052077|530829171|FG002|Phase A+|Met Withdrawal Criteria|0|||
147246083|NCT02495168|531072699|FG001|Overall Study|Adverse Event|8|||
147246084|NCT02495168|531072700|FG002|Overall Study|Adverse Event|3|||
147246085|NCT02495168|531072698|FG000|Overall Study|Lack of Efficacy|0|||
147246086|NCT02495168|531072699|FG001|Overall Study|Lack of Efficacy|0|||
147656535|NCT02559570|532565102|FG004|Overall Study|Other Miscellaneous Reasons|0|||
147656536|NCT00184093|532565111|FG000|Overall Study|Adverse Event|3|||
147181745|NCT01052077|530829172|FG003|Phase A+|Met Withdrawal Criteria|2|||
147181746|NCT01052077|530829169|FG000|Phase A+|Withdrawal by Subject|0|||
147656537|NCT00184093|532565111|FG000|Overall Study|Lost to Follow-up|3|||
147656538|NCT00184093|532565111|FG000|Overall Study|Physician Decision|1|||
147656539|NCT00184093|532565111|FG000|Overall Study|Withdrawal by Subject|2|||
147656540|NCT05095311|532565112|FG000|Overall Study|Lost to Follow-up|7|||
147656541|NCT05095311|532565113|FG001|Overall Study|Lost to Follow-up|0|||
147656542|NCT05095311|532565114|FG002|Overall Study|Lost to Follow-up|0|||
147656543|NCT02588664|532565115|FG000|Overall Study|Death|56|||
147656544|NCT02588664|532565116|FG001|Overall Study|Death|55|||
147656545|NCT02588664|532565115|FG000|Overall Study|Lost to Follow-up|1305|||
147656546|NCT02588664|532565116|FG001|Overall Study|Lost to Follow-up|990|||
147656547|NCT00534638|532565119|FG000|Overall Study|Withdrawal by Subject|3|||
147656548|NCT00534638|532565120|FG001|Overall Study|Withdrawal by Subject|4|||
147326628|NCT00742274|531361811|FG000|Overall Study|Withdrawal by Subject|1|||
147326629|NCT00742274|531361812|FG001|Overall Study|Withdrawal by Subject|2|||
147326630|NCT00742274|531361811|FG000|Overall Study|Removed for medical reasons|1|||
147326631|NCT00742274|531361812|FG001|Overall Study|Removed for medical reasons|1|||
147326632|NCT02219490|531361814|FG000|Overall Study|Adverse Event|24|||
147326633|NCT02219490|531361814|FG000|Overall Study|Withdrew consent|96|||
147326634|NCT02219490|531361814|FG000|Overall Study|Lost to Follow-up|126|||
147326635|NCT02219490|531361814|FG000|Overall Study|COVID-19 infection|2|||
147326636|NCT02219490|531361814|FG000|Overall Study|COVID-19 logistical restrictions|33|||
147326637|NCT02219490|531361814|FG000|Overall Study|Other, not specified|57|||
147326638|NCT02974010|531361817|FG000|Overall Study|Lost to Follow-up|3|||
147326639|NCT02974010|531361818|FG001|Overall Study|Lost to Follow-up|1|||
147326640|NCT02974010|531361819|FG002|Overall Study|Lost to Follow-up|0|||
147326641|NCT02974010|531361820|FG003|Overall Study|Lost to Follow-up|0|||
147326642|NCT02974010|531361817|FG000|Overall Study|Withdrawal by Subject|2|||
147326643|NCT02974010|531361818|FG001|Overall Study|Withdrawal by Subject|1|||
147326644|NCT02974010|531361819|FG002|Overall Study|Withdrawal by Subject|0|||
147326645|NCT02974010|531361820|FG003|Overall Study|Withdrawal by Subject|0|||
147326646|NCT02974010|531361817|FG000|Overall Study|Adverse Event|0|||
147326647|NCT02974010|531361818|FG001|Overall Study|Adverse Event|1|||
147326648|NCT02974010|531361819|FG002|Overall Study|Adverse Event|0|||
147326649|NCT02974010|531361820|FG003|Overall Study|Adverse Event|0|||
147326650|NCT02974010|531361817|FG000|Overall Study|Completed day 42 but did not return for day 70|1|||
147326651|NCT02974010|531361818|FG001|Overall Study|Completed day 42 but did not return for day 70|0|||
147326652|NCT02974010|531361819|FG002|Overall Study|Completed day 42 but did not return for day 70|1|||
147326653|NCT02974010|531361820|FG003|Overall Study|Completed day 42 but did not return for day 70|0|||
147326654|NCT02974010|531361817|FG000|Overall Study|Lack of Efficacy|0|||
147326655|NCT02974010|531361818|FG001|Overall Study|Lack of Efficacy|0|||
147326656|NCT02974010|531361819|FG002|Overall Study|Lack of Efficacy|1|||
147326657|NCT02974010|531361820|FG003|Overall Study|Lack of Efficacy|0|||
147326658|NCT04088188|531361823|FG000|Overall Study|Withdrawal by Subject|2|||
147326659|NCT04088188|531361824|FG001|Overall Study|Withdrawal by Subject|0|||
147326660|NCT04088188|531361823|FG000|Overall Study|Adverse Event|2|||
147326661|NCT04088188|531361824|FG001|Overall Study|Adverse Event|0|||
147326662|NCT03124108|531361825|FG000|Overall Study|Adverse Event|0|||
147326663|NCT03124108|531361826|FG001|Overall Study|Adverse Event|1|||
147326664|NCT03124108|531361827|FG002|Overall Study|Adverse Event|0|||
147326665|NCT01670019|531361837|FG000|Overall Study|Adverse Event|3|||
147326666|NCT01670019|531361838|FG001|Overall Study|Adverse Event|0|||
147326667|NCT01670019|531361837|FG000|Overall Study|Withdrawal by Subject|6|||
147326668|NCT01670019|531361838|FG001|Overall Study|Withdrawal by Subject|0|||
147326669|NCT05650333|531361839|FG000|Treatment Period (7 Days)|Adverse Event|1|||
147326670|NCT02524288|531361841|FG000|Overall Study|Adverse Event|115|||
147326671|NCT02524288|531361841|FG000|Overall Study|Lost to Follow-up|216|||
147326672|NCT02524288|531361841|FG000|Overall Study|Non-Compliance With Protocol|32|||
147326673|NCT02524288|531361841|FG000|Overall Study|Non-Compliance With Study Drug|14|||
147656549|NCT00534638|532565119|FG000|Overall Study|Migrated/moved from study area|13|||
147656550|NCT00534638|532565120|FG001|Overall Study|Migrated/moved from study area|11|||
147656551|NCT00534638|532565119|FG000|Overall Study|Lost to follow-up,incomplete vaccination|83|||
147326674|NCT02524288|531361841|FG000|Overall Study|Pregnancy Wish|6|||
147656552|NCT00534638|532565120|FG001|Overall Study|Lost to follow-up,incomplete vaccination|117|||
147326675|NCT02524288|531361841|FG000|Overall Study|Protocol Violation|6|||
147326676|NCT02524288|531361841|FG000|Overall Study|Screen Failure|2|||
147326677|NCT02524288|531361841|FG000|Overall Study|Site Discontinued Study Participation|1|||
147326678|NCT02524288|531361841|FG000|Overall Study|Study Terminated By Sponsor|1417|||
147326679|NCT02524288|531361841|FG000|Overall Study|Subject Moved|32|||
147656553|NCT00534638|532565119|FG000|Overall Study|Lost to follow-up, complete vaccination|4707|||
147656554|NCT00534638|532565120|FG001|Overall Study|Lost to follow-up, complete vaccination|10757|||
147326680|NCT02524288|531361841|FG000|Overall Study|Withdrawal by Subject|76|||
147326681|NCT02524288|531361841|FG000|Overall Study|Pregnancy|22|||
147656555|NCT00534638|532565119|FG000|Overall Study|Other|1685|||
147448473|NCT01464307|531805733|FG000|Open-Label Extension Period|Lost to Follow-up|1|||
147656556|NCT00534638|532565120|FG001|Overall Study|Other|902|||
147656557|NCT02903420|532565123|FG000|Overall Study|Death|3|||
147656558|NCT02500719|532565126|FG000|Overall Study|Lost to Follow-up|2|||
147656559|NCT02500719|532565127|FG001|Overall Study|Lost to Follow-up|3|||
147656560|NCT02500719|532565126|FG000|Overall Study|Trauma history|1|||
147656561|NCT02500719|532565127|FG001|Overall Study|Trauma history|0|||
147656562|NCT02500719|532565126|FG000|Overall Study|MRI data found to be unusable during analysis|0|||
147656563|NCT02500719|532565127|FG001|Overall Study|MRI data found to be unusable during analysis|1|||
147656564|NCT02500719|532565126|FG000|Overall Study|Did not meet criteria for PTSD|0|||
147656565|NCT02500719|532565127|FG001|Overall Study|Did not meet criteria for PTSD|1|||
147656566|NCT02500719|532565126|FG000|Overall Study|Claustrophobia|0|||
147656567|NCT02500719|532565127|FG001|Overall Study|Claustrophobia|1|||
147656568|NCT02500719|532565126|FG000|Overall Study|History of head trauma|0|||
147656569|NCT02500719|532565127|FG001|Overall Study|History of head trauma|1|||
147656570|NCT02710084|532565130|FG000|First Phase - 12 Weeks|Withdrawal by Subject|3|||
147656571|NCT02710084|532565131|FG001|First Phase - 12 Weeks|Withdrawal by Subject|1|||
147326682|NCT02524288|531361841|FG000|Overall Study|Physician Decision|2|||
147326683|NCT00517933|531361842|FG000|Period 1|Death|2|||
147326684|NCT00517933|531361843|FG001|Period 1|Death|1|||
147326685|NCT00517933|531361842|FG000|Period 1|Adverse Event|4|||
147326686|NCT00517933|531361843|FG001|Period 1|Adverse Event|4|||
147326687|NCT00517933|531361842|FG000|Period 1|Lost to Follow-up|2|||
147326688|NCT00517933|531361843|FG001|Period 1|Lost to Follow-up|0|||
147326689|NCT00517933|531361842|FG000|Period 1|Underwent lung transplant|0|||
147326690|NCT00517933|531361843|FG001|Period 1|Underwent lung transplant|1|||
147326691|NCT00517933|531361842|FG000|Period 2|Death|2|||
147326692|NCT00517933|531361843|FG001|Period 2|Death|4|||
147326693|NCT00517933|531361842|FG000|Period 2|Adverse Event|2|||
147326694|NCT00517933|531361843|FG001|Period 2|Adverse Event|4|||
147326695|NCT00517933|531361842|FG000|Period 2|Physician Decision|1|||
147326696|NCT00517933|531361843|FG001|Period 2|Physician Decision|0|||
147326697|NCT00517933|531361842|FG000|Period 2|Withdrawal by Subject|1|||
147326698|NCT00517933|531361843|FG001|Period 2|Withdrawal by Subject|3|||
147326699|NCT00517933|531361842|FG000|Period 2|Underwent lung transplant|0|||
147326700|NCT00517933|531361843|FG001|Period 2|Underwent lung transplant|2|||
147326701|NCT05096884|531361845|FG000|Overall Study|Excluded based on negative tilt table test|4|||
147326702|NCT03781804|531361846|FG000|Overall Study|Adverse Event|2|||
147326703|NCT03781804|531361847|FG001|Overall Study|Adverse Event|2|||
147326704|NCT03781804|531361848|FG002|Overall Study|Adverse Event|3|||
147326705|NCT03781804|531361846|FG000|Overall Study|Lost to Follow-up|1|||
147326706|NCT03781804|531361847|FG001|Overall Study|Lost to Follow-up|1|||
147326707|NCT03781804|531361848|FG002|Overall Study|Lost to Follow-up|2|||
147326708|NCT03781804|531361846|FG000|Overall Study|Lack of Efficacy|4|||
147326709|NCT03781804|531361847|FG001|Overall Study|Lack of Efficacy|2|||
147326710|NCT03781804|531361848|FG002|Overall Study|Lack of Efficacy|9|||
147326711|NCT03781804|531361846|FG000|Overall Study|Protocol Violation|0|||
147326712|NCT03781804|531361847|FG001|Overall Study|Protocol Violation|0|||
147326713|NCT03781804|531361848|FG002|Overall Study|Protocol Violation|1|||
147326714|NCT03781804|531361846|FG000|Overall Study|Withdrawal by Subject|0|||
147326715|NCT03781804|531361847|FG001|Overall Study|Withdrawal by Subject|1|||
147326716|NCT03781804|531361848|FG002|Overall Study|Withdrawal by Subject|1|||
147326717|NCT03781804|531361846|FG000|Overall Study|Reason not provided|2|||
147326718|NCT03781804|531361847|FG001|Overall Study|Reason not provided|2|||
147326719|NCT03781804|531361848|FG002|Overall Study|Reason not provided|0|||
147326720|NCT03717194|531361849|FG000|Overall Study|Withdrawal by Subject|2|||
147326721|NCT03717194|531361850|FG001|Overall Study|Withdrawal by Subject|4|||
147326722|NCT03717194|531361849|FG000|Overall Study|Adverse Event|1|||
147326723|NCT03717194|531361850|FG001|Overall Study|Adverse Event|1|||
147326724|NCT04678830|531361851|FG000|Overall Study|Lack of Efficacy|2|||
147656572|NCT00181883|532565132|FG000|Overall Study|Lack of Efficacy|2|||
147656573|NCT00181883|532565132|FG000|Overall Study|Treatment Limiting AEs|3|||
147181747|NCT01052077|530829170|FG001|Phase A+|Withdrawal by Subject|0|||
147181748|NCT01052077|530829171|FG002|Phase A+|Withdrawal by Subject|0|||
147181749|NCT01052077|530829172|FG003|Phase A+|Withdrawal by Subject|7|||
147181750|NCT01445080|530829173|FG000|Overall Study|Adverse Event|5|||
147181751|NCT01445080|530829174|FG001|Overall Study|Adverse Event|3|||
147181752|NCT01445080|530829175|FG002|Overall Study|Adverse Event|11|||
147181753|NCT01445080|530829176|FG003|Overall Study|Adverse Event|6|||
147326725|NCT04678830|531361852|FG001|Overall Study|Lack of Efficacy|0|||
147326726|NCT04678830|531361851|FG000|Overall Study|Withdrawal by Subject|0|||
147326727|NCT04678830|531361852|FG001|Overall Study|Withdrawal by Subject|1|||
147326728|NCT05550337|531361853|FG000|Overall Study|Lack of Efficacy|0|||
147326729|NCT05550337|531361854|FG001|Overall Study|Lack of Efficacy|0|||
147656574|NCT00181883|532565132|FG000|Overall Study|Withdrawal by Subject|4|||
147181754|NCT01445080|530829177|FG004|Overall Study|Adverse Event|2|||
147326730|NCT05550337|531361855|FG002|Overall Study|Lack of Efficacy|1|||
147326731|NCT05550337|531361853|FG000|Overall Study|Adverse Event|1|||
147326732|NCT05550337|531361854|FG001|Overall Study|Adverse Event|5|||
147326733|NCT05550337|531361855|FG002|Overall Study|Adverse Event|0|||
147326734|NCT05550337|531361853|FG000|Overall Study|Withdrawal by Subject|8|||
147326735|NCT05550337|531361854|FG001|Overall Study|Withdrawal by Subject|14|||
147326736|NCT05550337|531361855|FG002|Overall Study|Withdrawal by Subject|10|||
147181755|NCT01445080|530829178|FG005|Overall Study|Adverse Event|3|||
147181756|NCT01445080|530829179|FG006|Overall Study|Adverse Event|0|||
147181757|NCT01445080|530829180|FG007|Overall Study|Adverse Event|3|||
147181758|NCT01445080|530829181|FG008|Overall Study|Adverse Event|10|||
147181759|NCT01445080|530829173|FG000|Overall Study|Physician Decision|0|||
147593484|NCT00897949|532328991|FG000|Overall Study|Need for Concom. Med.|0|||
147593485|NCT00897949|532328992|FG001|Overall Study|Need for Concom. Med.|1|||
147593486|NCT00897949|532328993|FG002|Overall Study|Need for Concom. Med.|1|||
147593487|NCT00897949|532328991|FG000|Overall Study|Lack of Migraine Attack|29|||
147593488|NCT00897949|532328992|FG001|Overall Study|Lack of Migraine Attack|30|||
147593489|NCT00897949|532328993|FG002|Overall Study|Lack of Migraine Attack|19|||
147593490|NCT00897949|532328991|FG000|Overall Study|Did not take study drug|9|||
147593491|NCT00897949|532328992|FG001|Overall Study|Did not take study drug|3|||
147593492|NCT00897949|532328993|FG002|Overall Study|Did not take study drug|4|||
147593493|NCT01763918|532328994|FG000|Overall Study|Withdrawal by Subject|2|||
147593494|NCT01763918|532328995|FG001|Overall Study|Withdrawal by Subject|1|||
147593495|NCT01763918|532328996|FG002|Overall Study|Withdrawal by Subject|1|||
147593496|NCT01763918|532328997|FG003|Overall Study|Withdrawal by Subject|2|||
147593497|NCT01763918|532328994|FG000|Overall Study|Sponsor Decision|4|||
147593498|NCT01763918|532328995|FG001|Overall Study|Sponsor Decision|0|||
147593499|NCT01763918|532328996|FG002|Overall Study|Sponsor Decision|9|||
147593500|NCT01763918|532328997|FG003|Overall Study|Sponsor Decision|0|||
147593501|NCT01553747|532328998|FG000|Overall Study|Protocol Violation|0|||
147593502|NCT01553747|532328999|FG001|Overall Study|Protocol Violation|2|||
147593503|NCT01553747|532329000|FG002|Overall Study|Protocol Violation|0|||
147593504|NCT01553747|532328998|FG000|Overall Study|Voluntarily withdrew|70|||
147593505|NCT01553747|532328999|FG001|Overall Study|Voluntarily withdrew|66|||
147593506|NCT01553747|532329000|FG002|Overall Study|Voluntarily withdrew|74|||
147593507|NCT01553747|532328998|FG000|Overall Study|Adverse event or SAE|32|||
147593508|NCT01553747|532328999|FG001|Overall Study|Adverse event or SAE|28|||
147593509|NCT01553747|532329000|FG002|Overall Study|Adverse event or SAE|19|||
147593510|NCT01553747|532328998|FG000|Overall Study|Physician decision: other|10|||
147593511|NCT01553747|532328999|FG001|Overall Study|Physician decision: other|8|||
147593512|NCT01553747|532329000|FG002|Overall Study|Physician decision: other|7|||
147593513|NCT01553747|532328998|FG000|Overall Study|Lost to Follow-up|11|||
147593514|NCT01553747|532328999|FG001|Overall Study|Lost to Follow-up|5|||
147593515|NCT01553747|532329000|FG002|Overall Study|Lost to Follow-up|6|||
147593516|NCT01553747|532328998|FG000|Overall Study|Sponsor decision, specify|7|||
147593517|NCT01553747|532328999|FG001|Overall Study|Sponsor decision, specify|5|||
147593518|NCT01553747|532329000|FG002|Overall Study|Sponsor decision, specify|0|||
147593519|NCT01553747|532328998|FG000|Overall Study|Physician decision: lack of efficacy|1|||
147593520|NCT01553747|532328999|FG001|Overall Study|Physician decision: lack of efficacy|5|||
147593521|NCT01553747|532329000|FG002|Overall Study|Physician decision: lack of efficacy|3|||
147593522|NCT00977431|532329002|FG000|Overall Study|Other than listed|1|||
147593523|NCT00977431|532329003|FG001|Overall Study|Other than listed|0|||
147593524|NCT00977431|532329004|FG002|Overall Study|Other than listed|0|||
147593525|NCT00977431|532329005|FG003|Overall Study|Other than listed|0|||
147593526|NCT00977431|532329006|FG004|Overall Study|Other than listed|2|||
147593527|NCT00977431|532329002|FG000|Overall Study|Protocol Violation|0|||
147593528|NCT00977431|532329003|FG001|Overall Study|Protocol Violation|0|||
147593529|NCT00977431|532329004|FG002|Overall Study|Protocol Violation|1|||
147593530|NCT00977431|532329005|FG003|Overall Study|Protocol Violation|0|||
147593531|NCT00977431|532329006|FG004|Overall Study|Protocol Violation|0|||
147593532|NCT00977431|532329002|FG000|Overall Study|Adverse Event|3|||
147656575|NCT00181883|532565132|FG000|Overall Study|Lost to Follow-up|1|||
147656576|NCT05305989|532565133|FG000|Overall Study|Other|3|||
147656577|NCT05305989|532565134|FG001|Overall Study|Other|2|||
147181760|NCT01445080|530829174|FG001|Overall Study|Physician Decision|0|||
147181761|NCT01445080|530829175|FG002|Overall Study|Physician Decision|1|||
147181762|NCT01445080|530829176|FG003|Overall Study|Physician Decision|0|||
147181763|NCT01445080|530829177|FG004|Overall Study|Physician Decision|0|||
147181764|NCT01445080|530829178|FG005|Overall Study|Physician Decision|3|||
147181765|NCT01445080|530829179|FG006|Overall Study|Physician Decision|2|||
147181766|NCT01445080|530829180|FG007|Overall Study|Physician Decision|2|||
147181767|NCT01445080|530829181|FG008|Overall Study|Physician Decision|0|||
147181768|NCT01445080|530829173|FG000|Overall Study|Withdrawal by Subject|1|||
147181769|NCT01445080|530829174|FG001|Overall Study|Withdrawal by Subject|0|||
147181770|NCT01445080|530829175|FG002|Overall Study|Withdrawal by Subject|0|||
147181771|NCT01445080|530829176|FG003|Overall Study|Withdrawal by Subject|1|||
147181772|NCT01445080|530829177|FG004|Overall Study|Withdrawal by Subject|0|||
147181773|NCT01445080|530829178|FG005|Overall Study|Withdrawal by Subject|0|||
147181774|NCT01445080|530829179|FG006|Overall Study|Withdrawal by Subject|0|||
147593533|NCT00977431|532329003|FG001|Overall Study|Adverse Event|0|||
147593534|NCT00977431|532329004|FG002|Overall Study|Adverse Event|4|||
147593535|NCT00977431|532329005|FG003|Overall Study|Adverse Event|0|||
147593536|NCT00977431|532329006|FG004|Overall Study|Adverse Event|6|||
147593537|NCT00977431|532329002|FG000|Overall Study|Dose-limiting toxicity (DLT)|1|||
147593538|NCT00977431|532329003|FG001|Overall Study|Dose-limiting toxicity (DLT)|0|||
147656578|NCT05305989|532565135|FG002|Overall Study|Other|0|||
147656579|NCT05305989|532565133|FG000|Overall Study|Sponsor decision|2|||
147656580|NCT05305989|532565134|FG001|Overall Study|Sponsor decision|1|||
147656581|NCT05305989|532565135|FG002|Overall Study|Sponsor decision|0|||
147656582|NCT05305989|532565133|FG000|Overall Study|Protocol Violation|0|||
147656583|NCT05305989|532565134|FG001|Overall Study|Protocol Violation|1|||
147656584|NCT05305989|532565135|FG002|Overall Study|Protocol Violation|0|||
147656585|NCT05305989|532565133|FG000|Overall Study|Investigator decision|1|||
147656586|NCT05305989|532565134|FG001|Overall Study|Investigator decision|2|||
147656587|NCT05305989|532565135|FG002|Overall Study|Investigator decision|0|||
147656588|NCT05305989|532565133|FG000|Overall Study|Progression of cGVHD (progression requiring addition of new systemic therapy for cGVHD)|3|||
147656589|NCT05305989|532565134|FG001|Overall Study|Progression of cGVHD (progression requiring addition of new systemic therapy for cGVHD)|0|||
147656590|NCT05305989|532565135|FG002|Overall Study|Progression of cGVHD (progression requiring addition of new systemic therapy for cGVHD)|0|||
147656591|NCT05305989|532565133|FG000|Overall Study|Adverse Event|1|||
147656592|NCT05305989|532565134|FG001|Overall Study|Adverse Event|1|||
147656593|NCT05305989|532565135|FG002|Overall Study|Adverse Event|0|||
147656594|NCT05305989|532565133|FG000|Overall Study|Enrolled but never dosed|3|||
147656595|NCT05305989|532565134|FG001|Overall Study|Enrolled but never dosed|2|||
147656596|NCT05305989|532565135|FG002|Overall Study|Enrolled but never dosed|1|||
147656597|NCT03335813|532566543|FG000|Overall Study|Withdrawal by Subject|1|||
147656598|NCT01639144|532566546|FG000|Overall Study|Withdrawal by Subject|4|||
147656599|NCT01639144|532566547|FG001|Overall Study|Withdrawal by Subject|2|||
147656600|NCT01639144|532566546|FG000|Overall Study|Physician Decision|2|||
147656601|NCT01639144|532566547|FG001|Overall Study|Physician Decision|0|||
147656602|NCT01639144|532566546|FG000|Overall Study|Met postoperative exclusion criteria|4|||
147656603|NCT01639144|532566547|FG001|Overall Study|Met postoperative exclusion criteria|3|||
147656604|NCT00305227|532566552|FG000|Overall Study|Lost to Follow-up|7|||
147656605|NCT00305227|532566553|FG001|Overall Study|Lost to Follow-up|6|||
147656606|NCT03492437|532566555|FG000|Treatment Period 2|Withdrawal by Subject|0|||
147656607|NCT03492437|532566556|FG001|Treatment Period 2|Withdrawal by Subject|1|||
147656608|NCT03872843|532566557|FG000|Overall Study|Lost to Follow-up|5|||
147656609|NCT03872843|532566558|FG001|Overall Study|Lost to Follow-up|7|||
147656610|NCT05133323|532566559|FG000|Overall Study|Lack of Efficacy|0|||
147656611|NCT05133323|532566560|FG001|Overall Study|Lack of Efficacy|0|||
147656612|NCT05133323|532566561|FG002|Overall Study|Lack of Efficacy|1|||
147656613|NCT05133323|532566559|FG000|Overall Study|Withdrawal by Subject|2|||
147656614|NCT05133323|532566560|FG001|Overall Study|Withdrawal by Subject|1|||
147656615|NCT05133323|532566561|FG002|Overall Study|Withdrawal by Subject|0|||
147656616|NCT00577772|532566570|FG000|Overall Study|Lost to Follow-up|0|||
147656617|NCT00577772|532566571|FG001|Overall Study|Lost to Follow-up|1|||
147656618|NCT00856999|532566574|FG000|Overall Study|Withdrawal by Subject|5|||
147656619|NCT02465437|532566575|FG000|Overall Study|Physician Decision|0|||
147656620|NCT02465437|532566576|FG001|Overall Study|Physician Decision|0|||
147656621|NCT02465437|532566577|FG002|Overall Study|Physician Decision|1|||
147656622|NCT02465437|532566578|FG003|Overall Study|Physician Decision|0|||
147656623|NCT02465437|532566575|FG000|Overall Study|Withdrawal by Subject|1|||
147656624|NCT02465437|532566576|FG001|Overall Study|Withdrawal by Subject|0|||
147656625|NCT02465437|532566577|FG002|Overall Study|Withdrawal by Subject|0|||
147656626|NCT02465437|532566578|FG003|Overall Study|Withdrawal by Subject|1|||
147656627|NCT02465437|532566575|FG000|Overall Study|Adverse Event|0|||
147656628|NCT02465437|532566576|FG001|Overall Study|Adverse Event|1|||
147656629|NCT02465437|532566577|FG002|Overall Study|Adverse Event|0|||
147656630|NCT02465437|532566578|FG003|Overall Study|Adverse Event|0|||
147656631|NCT00003483|532566579|FG000|Overall Study|Not evaluable|1|||
147656632|NCT00103662|532566580|FG000|Overall Study|Entered Rescue Procedure|0|||
147656633|NCT00103662|532566581|FG001|Overall Study|Entered Rescue Procedure|7|||
147656634|NCT00103662|532566580|FG000|Overall Study|Death|7|||
147656635|NCT00103662|532566581|FG001|Overall Study|Death|7|||
147656636|NCT00103662|532566580|FG000|Overall Study|Elective Withdrawal|5|||
147656637|NCT00103662|532566581|FG001|Overall Study|Elective Withdrawal|5|||
147656638|NCT00103662|532566580|FG000|Overall Study|Lost to Follow-up|0|||
147246087|NCT02495168|531072700|FG002|Overall Study|Lack of Efficacy|3|||
147246088|NCT01425281|531072704|FG000|At 30-day Clinical Follow-up|Withdrawal by Subject|1|||
147656639|NCT00103662|532566581|FG001|Overall Study|Lost to Follow-up|1|||
147656640|NCT00103662|532566580|FG000|Overall Study|Other|6|||
147656641|NCT00103662|532566581|FG001|Overall Study|Other|9|||
147656642|NCT00103662|532566580|FG000|Overall Study|Failed mobilization|0|||
147246089|NCT01425281|531072705|FG001|At 30-day Clinical Follow-up|Withdrawal by Subject|0|||
147656643|NCT00103662|532566581|FG001|Overall Study|Failed mobilization|4|||
147656644|NCT00103662|532566580|FG000|Overall Study|Intercurrent illness|1|||
147656645|NCT00103662|532566581|FG001|Overall Study|Intercurrent illness|0|||
147656646|NCT00105989|532566583|FG000|Acute - Open Label: Week 0-10|Adverse Event|33|||
147656647|NCT00105989|532566584|FG001|Acute - Open Label: Week 0-10|Adverse Event|0|||
147656648|NCT00105989|532566583|FG000|Acute - Open Label: Week 0-10|Withdrawal by Subject|24|||
147656649|NCT00105989|532566584|FG001|Acute - Open Label: Week 0-10|Withdrawal by Subject|0|||
147656650|NCT00105989|532566583|FG000|Acute - Open Label: Week 0-10|Lack of Efficacy|17|||
147656651|NCT00105989|532566584|FG001|Acute - Open Label: Week 0-10|Lack of Efficacy|0|||
147656652|NCT00105989|532566583|FG000|Acute - Open Label: Week 0-10|Protocol Response Criteria Not Met|14|||
147656653|NCT00105989|532566584|FG001|Acute - Open Label: Week 0-10|Protocol Response Criteria Not Met|0|||
147656654|NCT00105989|532566583|FG000|Acute - Open Label: Week 0-10|Protocol Violation|8|||
147656655|NCT00105989|532566584|FG001|Acute - Open Label: Week 0-10|Protocol Violation|0|||
147656656|NCT00105989|532566583|FG000|Acute - Open Label: Week 0-10|Lost to Follow-up|4|||
147656657|NCT00105989|532566584|FG001|Acute - Open Label: Week 0-10|Lost to Follow-up|0|||
147656658|NCT00105989|532566583|FG000|Acute - Open Label: Week 0-10|Physician Decision|0|||
147656659|NCT00105989|532566584|FG001|Acute - Open Label: Week 0-10|Physician Decision|0|||
147656660|NCT00105989|532566583|FG000|Acute - Open Label: Week 0-10|Death|1|||
147656661|NCT00105989|532566584|FG001|Acute - Open Label: Week 0-10|Death|0|||
147656662|NCT00105989|532566583|FG000|Acute - Open Label: Week 0-10|Recurrence Criteria Met|0|||
147656663|NCT00105989|532566584|FG001|Acute - Open Label: Week 0-10|Recurrence Criteria Met|0|||
147656664|NCT00105989|532566583|FG000|Acute - Open Label: Week 0-10|Unspecified - no reason reported|0|||
147656665|NCT00105989|532566584|FG001|Acute - Open Label: Week 0-10|Unspecified - no reason reported|0|||
147656666|NCT00105989|532566583|FG000|Continuation - Open Label:Week 10-34|Adverse Event|25|||
147656667|NCT00105989|532566584|FG001|Continuation - Open Label:Week 10-34|Adverse Event|0|||
147656668|NCT00105989|532566583|FG000|Continuation - Open Label:Week 10-34|Withdrawal by Subject|50|||
147656669|NCT00105989|532566584|FG001|Continuation - Open Label:Week 10-34|Withdrawal by Subject|0|||
147656670|NCT00105989|532566583|FG000|Continuation - Open Label:Week 10-34|Lack of Efficacy|15|||
147656671|NCT00105989|532566584|FG001|Continuation - Open Label:Week 10-34|Lack of Efficacy|0|||
147656672|NCT00105989|532566583|FG000|Continuation - Open Label:Week 10-34|Protocol Response Criteria Not Met|16|||
147656673|NCT00105989|532566584|FG001|Continuation - Open Label:Week 10-34|Protocol Response Criteria Not Met|0|||
147656674|NCT00105989|532566583|FG000|Continuation - Open Label:Week 10-34|Protocol Violation|5|||
147656675|NCT00105989|532566584|FG001|Continuation - Open Label:Week 10-34|Protocol Violation|0|||
147656676|NCT00105989|532566583|FG000|Continuation - Open Label:Week 10-34|Lost to Follow-up|9|||
147656677|NCT00105989|532566584|FG001|Continuation - Open Label:Week 10-34|Lost to Follow-up|0|||
147656678|NCT00105989|532566583|FG000|Continuation - Open Label:Week 10-34|Physician Decision|3|||
147656679|NCT00105989|532566584|FG001|Continuation - Open Label:Week 10-34|Physician Decision|0|||
147656680|NCT00105989|532566583|FG000|Continuation - Open Label:Week 10-34|Death|0|||
147656681|NCT00105989|532566584|FG001|Continuation - Open Label:Week 10-34|Death|0|||
147656682|NCT00105989|532566583|FG000|Continuation - Open Label:Week 10-34|Recurrence Criteria Met|2|||
147656683|NCT00105989|532566584|FG001|Continuation - Open Label:Week 10-34|Recurrence Criteria Met|0|||
147656684|NCT00105989|532566583|FG000|Continuation - Open Label:Week 10-34|Unspecified - no reason reported|0|||
147656685|NCT00105989|532566584|FG001|Continuation - Open Label:Week 10-34|Unspecified - no reason reported|0|||
147656686|NCT00105989|532566583|FG000|Maintenance - Double-Blind:Week 34-86|Adverse Event|6|||
147656687|NCT00105989|532566584|FG001|Maintenance - Double-Blind:Week 34-86|Adverse Event|3|||
147656688|NCT00105989|532566583|FG000|Maintenance - Double-Blind:Week 34-86|Withdrawal by Subject|17|||
147656689|NCT00105989|532566584|FG001|Maintenance - Double-Blind:Week 34-86|Withdrawal by Subject|18|||
147656690|NCT00105989|532566583|FG000|Maintenance - Double-Blind:Week 34-86|Lack of Efficacy|0|||
147656691|NCT00105989|532566584|FG001|Maintenance - Double-Blind:Week 34-86|Lack of Efficacy|0|||
147656692|NCT00105989|532566583|FG000|Maintenance - Double-Blind:Week 34-86|Protocol Response Criteria Not Met|0|||
147656693|NCT00105989|532566584|FG001|Maintenance - Double-Blind:Week 34-86|Protocol Response Criteria Not Met|0|||
147656694|NCT00105989|532566583|FG000|Maintenance - Double-Blind:Week 34-86|Protocol Violation|5|||
147656695|NCT00105989|532566584|FG001|Maintenance - Double-Blind:Week 34-86|Protocol Violation|4|||
147656696|NCT00105989|532566583|FG000|Maintenance - Double-Blind:Week 34-86|Lost to Follow-up|4|||
147656697|NCT00105989|532566584|FG001|Maintenance - Double-Blind:Week 34-86|Lost to Follow-up|0|||
147656698|NCT00105989|532566583|FG000|Maintenance - Double-Blind:Week 34-86|Physician Decision|4|||
147656699|NCT00105989|532566584|FG001|Maintenance - Double-Blind:Week 34-86|Physician Decision|1|||
147656700|NCT00105989|532566583|FG000|Maintenance - Double-Blind:Week 34-86|Death|0|||
147656701|NCT00105989|532566584|FG001|Maintenance - Double-Blind:Week 34-86|Death|0|||
147656702|NCT00105989|532566583|FG000|Maintenance - Double-Blind:Week 34-86|Recurrence Criteria Met|14|||
147656703|NCT00105989|532566584|FG001|Maintenance - Double-Blind:Week 34-86|Recurrence Criteria Met|43|||
147656704|NCT00105989|532566583|FG000|Maintenance - Double-Blind:Week 34-86|Unspecified - no reason reported|0|||
147656705|NCT00105989|532566584|FG001|Maintenance - Double-Blind:Week 34-86|Unspecified - no reason reported|0|||
147656706|NCT00613821|532566591|FG000|Overall Study|Withdrawal by Subject|1|||
147656707|NCT00613821|532566592|FG001|Overall Study|Withdrawal by Subject|0|||
147656708|NCT00613821|532566591|FG000|Overall Study|Physician Decision|1|||
147656709|NCT00613821|532566592|FG001|Overall Study|Physician Decision|1|||
147656710|NCT02302846|532566594|FG000|Overall Study|Withdrawal by Subject|1|||
147656711|NCT00411450|532566595|FG000|Overall Study|Ongoing at time of data cut-off.|3|||
147656712|NCT00397189|532566596|FG000|3 Weeks Period|Lost to Follow-up|5|||
147656713|NCT00397189|532566597|FG001|3 Weeks Period|Lost to Follow-up|4|||
147656714|NCT00397189|532566596|FG000|3 Weeks Period|Adverse Event|3|||
147656715|NCT00397189|532566597|FG001|3 Weeks Period|Adverse Event|2|||
147181775|NCT01445080|530829180|FG007|Overall Study|Withdrawal by Subject|0|||
147656716|NCT00397189|532566596|FG000|3 Weeks Period|Withdrawal by Subject|13|||
147656717|NCT00397189|532566597|FG001|3 Weeks Period|Withdrawal by Subject|9|||
147656718|NCT00397189|532566596|FG000|3 Weeks Period|Physician Decision|0|||
147656719|NCT00397189|532566597|FG001|3 Weeks Period|Physician Decision|2|||
147656720|NCT00397189|532566596|FG000|3 Weeks Period|Protocol Violation|0|||
147656721|NCT00397189|532566597|FG001|3 Weeks Period|Protocol Violation|3|||
147656722|NCT00397189|532566596|FG000|3 Weeks Period|Other|0|||
147656723|NCT00397189|532566597|FG001|3 Weeks Period|Other|2|||
147656724|NCT01059773|532566598|FG000|Overall Study|Adverse Event|2|||
147656725|NCT01059773|532566599|FG001|Overall Study|Adverse Event|2|||
147656726|NCT01059773|532566598|FG000|Overall Study|Withdrawal by Subject|1|||
147656727|NCT01059773|532566599|FG001|Overall Study|Withdrawal by Subject|5|||
147656728|NCT01059773|532566598|FG000|Overall Study|Lost to Follow-up|1|||
147656729|NCT01059773|532566599|FG001|Overall Study|Lost to Follow-up|1|||
147656730|NCT01059773|532566598|FG000|Overall Study|Pregnancy|1|||
147656731|NCT01059773|532566599|FG001|Overall Study|Pregnancy|1|||
147656732|NCT01059773|532566598|FG000|Overall Study|Protocol Violation|6|||
147656733|NCT01059773|532566599|FG001|Overall Study|Protocol Violation|2|||
147656734|NCT01059773|532566598|FG000|Overall Study|Physician Decision|5|||
147656735|NCT01059773|532566599|FG001|Overall Study|Physician Decision|4|||
147656736|NCT01059773|532566598|FG000|Overall Study|Lack of Efficacy|3|||
147656737|NCT01059773|532566599|FG001|Overall Study|Lack of Efficacy|3|||
147656738|NCT01059773|532566598|FG000|Overall Study|Death|0|||
147656739|NCT01059773|532566599|FG001|Overall Study|Death|1|||
147656740|NCT01059773|532566598|FG000|Overall Study|Malignancy including squamous cell skin|0|||
147656741|NCT01059773|532566599|FG001|Overall Study|Malignancy including squamous cell skin|1|||
147656742|NCT01059773|532566598|FG000|Overall Study|Ineligible follow TB screening criteria|0|||
147656743|NCT01059773|532566599|FG001|Overall Study|Ineligible follow TB screening criteria|1|||
147656744|NCT01059773|532566598|FG000|Overall Study|Other|1|||
147656745|NCT01059773|532566599|FG001|Overall Study|Other|3|||
147656746|NCT00141518|532566602|FG000|Overall Study|Withdrew Consent Prior to Treatment|1|||
147656747|NCT00141518|532566603|FG001|Overall Study|Withdrew Consent Prior to Treatment|0|||
147656748|NCT00141518|532566604|FG002|Overall Study|Withdrew Consent Prior to Treatment|0|||
147656749|NCT00141518|532566602|FG000|Overall Study|Adverse Event|7|||
147656750|NCT00141518|532566603|FG001|Overall Study|Adverse Event|5|||
147656751|NCT00141518|532566604|FG002|Overall Study|Adverse Event|2|||
147656752|NCT00141518|532566602|FG000|Overall Study|Withdrawal by Subject|2|||
147656753|NCT00141518|532566603|FG001|Overall Study|Withdrawal by Subject|0|||
147656754|NCT00141518|532566604|FG002|Overall Study|Withdrawal by Subject|2|||
147656755|NCT00141518|532566602|FG000|Overall Study|Protocol Violation|1|||
147656756|NCT00141518|532566603|FG001|Overall Study|Protocol Violation|1|||
147656757|NCT00141518|532566604|FG002|Overall Study|Protocol Violation|2|||
147656758|NCT00141518|532566602|FG000|Overall Study|Lack of Efficacy|5|||
147656759|NCT00141518|532566603|FG001|Overall Study|Lack of Efficacy|0|||
147656760|NCT00141518|532566604|FG002|Overall Study|Lack of Efficacy|0|||
147656761|NCT01806168|532566605|FG000|Overall Study|Adverse Event|1|||
147656762|NCT01806168|532566606|FG001|Overall Study|Adverse Event|0|||
147656763|NCT01806168|532566607|FG002|Overall Study|Adverse Event|0|||
147656764|NCT01806168|532566605|FG000|Overall Study|Withdrawal by Subject|0|||
147656765|NCT01806168|532566606|FG001|Overall Study|Withdrawal by Subject|1|||
147656766|NCT01806168|532566607|FG002|Overall Study|Withdrawal by Subject|2|||
147656767|NCT01806168|532566605|FG000|Overall Study|Protocol Violation|0|||
147656768|NCT01806168|532566606|FG001|Overall Study|Protocol Violation|0|||
147656769|NCT01806168|532566607|FG002|Overall Study|Protocol Violation|1|||
147656770|NCT03410992|532566608|FG000|Initial Treatment Period: up to Wk16|Adverse Event|0|||
147656771|NCT03410992|532566609|FG001|Initial Treatment Period: up to Wk16|Adverse Event|5|||
147656772|NCT03410992|532566610|FG002|Initial Treatment Period: up to Wk16|Adverse Event|0|||
147656773|NCT03410992|532566611|FG003|Initial Treatment Period: up to Wk16|Adverse Event|0|||
147656774|NCT03410992|532566612|FG004|Initial Treatment Period: up to Wk16|Adverse Event|0|||
147656775|NCT03410992|532566613|FG005|Initial Treatment Period: up to Wk16|Adverse Event|0|||
147246090|NCT01425281|531072704|FG000|At 180-day Clinical Follow-up|Withdrawal by Subject|3|||
147656776|NCT03410992|532566614|FG006|Initial Treatment Period: up to Wk16|Adverse Event|0|||
147656777|NCT03410992|532566615|FG007|Initial Treatment Period: up to Wk16|Adverse Event|0|||
147246091|NCT01425281|531072705|FG001|At 180-day Clinical Follow-up|Withdrawal by Subject|0|||
147246092|NCT01425281|531072704|FG000|At 180-day Clinical Follow-up|Death|0|||
147656778|NCT03410992|532566616|FG008|Initial Treatment Period: up to Wk16|Adverse Event|0|||
147656779|NCT03410992|532566617|FG009|Initial Treatment Period: up to Wk16|Adverse Event|0|||
147656780|NCT03410992|532566618|FG010|Initial Treatment Period: up to Wk16|Adverse Event|0|||
147656781|NCT03410992|532566608|FG000|Initial Treatment Period: up to Wk16|Lack of Efficacy|2|||
147656782|NCT03410992|532566609|FG001|Initial Treatment Period: up to Wk16|Lack of Efficacy|1|||
147656783|NCT03410992|532566610|FG002|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
147656784|NCT03410992|532566611|FG003|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
147656785|NCT03410992|532566612|FG004|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
147656786|NCT03410992|532566613|FG005|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
147656787|NCT03410992|532566614|FG006|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
147656788|NCT03410992|532566615|FG007|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
147246093|NCT01425281|531072705|FG001|At 180-day Clinical Follow-up|Death|1|||
147246094|NCT01425281|531072704|FG000|At 1-year Clinical Follow-up|Withdrawal by Subject|1|||
147246095|NCT01425281|531072705|FG001|At 1-year Clinical Follow-up|Withdrawal by Subject|1|||
147246096|NCT01425281|531072704|FG000|At 1-year Clinical Follow-up|Withdrawal by Physician/Site|1|||
147246097|NCT01425281|531072705|FG001|At 1-year Clinical Follow-up|Withdrawal by Physician/Site|0|||
147246098|NCT01425281|531072704|FG000|At 2-year Clinical Follow-up|Withdrawal by Subject|2|||
147246099|NCT01425281|531072705|FG001|At 2-year Clinical Follow-up|Withdrawal by Subject|1|||
147246100|NCT01425281|531072704|FG000|At 2-year Clinical Follow-up|Death|2|||
147246101|NCT01425281|531072705|FG001|At 2-year Clinical Follow-up|Death|0|||
147246102|NCT01425281|531072704|FG000|At 2-year Clinical Follow-up|Lost to Follow-up|1|||
147246103|NCT01425281|531072705|FG001|At 2-year Clinical Follow-up|Lost to Follow-up|0|||
147246104|NCT01425281|531072704|FG000|At 2-year Clinical Follow-up|Patient did not want to participate in t|1|||
147246105|NCT01425281|531072705|FG001|At 2-year Clinical Follow-up|Patient did not want to participate in t|0|||
147246106|NCT01425281|531072704|FG000|At 3-year Clinical Follow-up|Withdrawal by Subject|3|||
147246107|NCT01425281|531072705|FG001|At 3-year Clinical Follow-up|Withdrawal by Subject|3|||
147246108|NCT01425281|531072704|FG000|At 3-year Clinical Follow-up|Death|2|||
147246109|NCT01425281|531072705|FG001|At 3-year Clinical Follow-up|Death|3|||
147246110|NCT01425281|531072704|FG000|At 4-year Clinical Follow-up|Death|7|||
147246111|NCT01425281|531072705|FG001|At 4-year Clinical Follow-up|Death|3|||
147246112|NCT01425281|531072704|FG000|At 4-year Clinical Follow-up|Withdrawal by Subject|3|||
147246113|NCT01425281|531072705|FG001|At 4-year Clinical Follow-up|Withdrawal by Subject|2|||
147246114|NCT01425281|531072704|FG000|At 4-year Clinical Follow-up|Did not consent for follow-up after 3 ye|10|||
147246115|NCT01425281|531072705|FG001|At 4-year Clinical Follow-up|Did not consent for follow-up after 3 ye|10|||
147246116|NCT01425281|531072704|FG000|At 4-year Clinical Follow-up|Terminated by Polish Ethics Committee|6|||
147246117|NCT01425281|531072705|FG001|At 4-year Clinical Follow-up|Terminated by Polish Ethics Committee|5|||
147246118|NCT01425281|531072704|FG000|At 4-year Clinical Follow-up|Lost to Follow-up|4|||
147246119|NCT01425281|531072705|FG001|At 4-year Clinical Follow-up|Lost to Follow-up|1|||
147246120|NCT01425281|531072704|FG000|At 5-year Clinical Follow-up|Death|2|||
147246121|NCT01425281|531072705|FG001|At 5-year Clinical Follow-up|Death|0|||
147246122|NCT01425281|531072704|FG000|At 5-year Clinical Follow-up|Lost to Follow-up|2|||
147246123|NCT01425281|531072705|FG001|At 5-year Clinical Follow-up|Lost to Follow-up|1|||
147246124|NCT01425281|531072704|FG000|At 5-year Clinical Follow-up|Terminated by Polish Ethics Committee|19|||
147246125|NCT01425281|531072705|FG001|At 5-year Clinical Follow-up|Terminated by Polish Ethics Committee|7|||
147246126|NCT01425281|531072704|FG000|At 5-year Clinical Follow-up|Refused/terminated|9|||
147246127|NCT01425281|531072705|FG001|At 5-year Clinical Follow-up|Refused/terminated|3|||
147246128|NCT01987505|531072706|FG000|Overall Study|Other|9|||
147246129|NCT01987505|531072706|FG000|Overall Study|Withdrawal by Subject|2|||
147246130|NCT01987505|531072706|FG000|Overall Study|Other Reason|2|||
147246131|NCT01987505|531072706|FG000|Overall Study|Lost to Follow-up|15|||
147246132|NCT01987505|531072706|FG000|Overall Study|Investigator Decision|2|||
147246133|NCT01987505|531072706|FG000|Overall Study|Death|4|||
147246134|NCT04202965|531072712|FG000|Overall Study|Adverse Event|3|||
147246135|NCT04202965|531072712|FG000|Overall Study|Did not meet inclusion criteria|1|||
147246136|NCT02794883|531072713|FG000|Pre-Surgical Treatment|Withdrawal by Subject|0|||
147246137|NCT02794883|531072714|FG001|Pre-Surgical Treatment|Withdrawal by Subject|0|||
147246138|NCT02794883|531072715|FG002|Pre-Surgical Treatment|Withdrawal by Subject|1|||
147246139|NCT02794883|531072713|FG000|Pre-Surgical Treatment|Progressive Disease|0|||
147246140|NCT02794883|531072714|FG001|Pre-Surgical Treatment|Progressive Disease|1|||
147246141|NCT02794883|531072715|FG002|Pre-Surgical Treatment|Progressive Disease|0|||
147246142|NCT02794883|531072713|FG000|Post-Surgery Treatment (Adjuvant)|Withdrawal by Subject|1|||
147246143|NCT02794883|531072714|FG001|Post-Surgery Treatment (Adjuvant)|Withdrawal by Subject|4|||
147246144|NCT02794883|531072715|FG002|Post-Surgery Treatment (Adjuvant)|Withdrawal by Subject|0|||
147246145|NCT02794883|531072713|FG000|Post-Surgery Treatment (Adjuvant)|Protocol Violation|1|||
147246146|NCT02794883|531072714|FG001|Post-Surgery Treatment (Adjuvant)|Protocol Violation|0|||
147246147|NCT02794883|531072715|FG002|Post-Surgery Treatment (Adjuvant)|Protocol Violation|0|||
147246148|NCT02794883|531072713|FG000|Post-Surgery Treatment (Adjuvant)|Progressive Disease|10|||
147246149|NCT02794883|531072714|FG001|Post-Surgery Treatment (Adjuvant)|Progressive Disease|6|||
147246150|NCT02794883|531072715|FG002|Post-Surgery Treatment (Adjuvant)|Progressive Disease|10|||
147246151|NCT02794883|531072713|FG000|Post-Surgery Treatment (Adjuvant)|Adverse Event|0|||
147246152|NCT02794883|531072714|FG001|Post-Surgery Treatment (Adjuvant)|Adverse Event|1|||
147246153|NCT02794883|531072715|FG002|Post-Surgery Treatment (Adjuvant)|Adverse Event|1|||
147246154|NCT02794883|531072713|FG000|Follow-up Period (up to 2 Years)|Death|12|||
147246155|NCT02794883|531072714|FG001|Follow-up Period (up to 2 Years)|Death|10|||
147246156|NCT02794883|531072715|FG002|Follow-up Period (up to 2 Years)|Death|10|||
147246157|NCT01727297|531072720|FG000|Overall Study|Death|13|||
147246158|NCT01727297|531072721|FG001|Overall Study|Death|0|||
147246159|NCT01727297|531072720|FG000|Overall Study|Protocol Violation|1|||
147246160|NCT01727297|531072721|FG001|Overall Study|Protocol Violation|10|||
147326737|NCT05550337|531361853|FG000|Overall Study|Pregnancy|0|||
147326738|NCT05550337|531361854|FG001|Overall Study|Pregnancy|0|||
147326739|NCT05550337|531361855|FG002|Overall Study|Pregnancy|1|||
147326740|NCT05550337|531361853|FG000|Overall Study|Protocol Violation|1|||
147326741|NCT05550337|531361854|FG001|Overall Study|Protocol Violation|3|||
147326742|NCT05550337|531361855|FG002|Overall Study|Protocol Violation|4|||
147326743|NCT05550337|531361853|FG000|Overall Study|Physician Decision|2|||
147326744|NCT05550337|531361854|FG001|Overall Study|Physician Decision|1|||
147326745|NCT05550337|531361855|FG002|Overall Study|Physician Decision|1|||
147326746|NCT05550337|531361853|FG000|Overall Study|Lost to Follow-up|16|||
147326747|NCT05550337|531361854|FG001|Overall Study|Lost to Follow-up|11|||
147326748|NCT05550337|531361855|FG002|Overall Study|Lost to Follow-up|11|||
147326749|NCT01836458|531361856|FG000|Overall Study|Unsatisfactory therapeutic effect|3|||
147326750|NCT01836458|531361857|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
147326751|NCT01836458|531361858|FG002|Overall Study|Unsatisfactory therapeutic effect|5|||
147326752|NCT01836458|531361859|FG003|Overall Study|Unsatisfactory therapeutic effect|6|||
147326753|NCT00561574|531361861|FG000|Overall Study|Adverse Event|21|||
147326754|NCT00561574|531361862|FG001|Overall Study|Adverse Event|24|||
147326755|NCT00561574|531361861|FG000|Overall Study|Lack of Efficacy|11|||
147326756|NCT00561574|531361862|FG001|Overall Study|Lack of Efficacy|21|||
147326757|NCT00561574|531361861|FG000|Overall Study|Withdrawal by Subject|4|||
147326758|NCT00561574|531361862|FG001|Overall Study|Withdrawal by Subject|4|||
147326759|NCT00561574|531361861|FG000|Overall Study|Reason Unrelated to Trial|6|||
147326760|NCT00561574|531361862|FG001|Overall Study|Reason Unrelated to Trial|2|||
147326761|NCT00561574|531361861|FG000|Overall Study|Lost to Follow-up|1|||
147326762|NCT00561574|531361862|FG001|Overall Study|Lost to Follow-up|0|||
147326763|NCT00561574|531361861|FG000|Overall Study|Other|5|||
147326764|NCT00561574|531361862|FG001|Overall Study|Other|7|||
147326765|NCT00445692|531361863|FG000|Overall Study|Adverse Event|11|||
147326766|NCT00445692|531361863|FG000|Overall Study|Lack of Efficacy|5|||
147326767|NCT00430677|531361869|FG000|Short-term Period|Death|1|||
147326768|NCT00430677|531361870|FG001|Short-term Period|Death|1|||
147326769|NCT00430677|531361871|FG002|Short-term Period|Death|5|||
147326770|NCT00430677|531361869|FG000|Short-term Period|Adverse Event|15|||
147326771|NCT00430677|531361870|FG001|Short-term Period|Adverse Event|13|||
147326772|NCT00430677|531361871|FG002|Short-term Period|Adverse Event|9|||
147326773|NCT00430677|531361869|FG000|Short-term Period|Lack of Efficacy|5|||
147326774|NCT00430677|531361870|FG001|Short-term Period|Lack of Efficacy|6|||
147326775|NCT00430677|531361871|FG002|Short-term Period|Lack of Efficacy|4|||
147326776|NCT00430677|531361869|FG000|Short-term Period|Withdrawal by Subject|1|||
147326777|NCT00430677|531361870|FG001|Short-term Period|Withdrawal by Subject|1|||
147326778|NCT00430677|531361871|FG002|Short-term Period|Withdrawal by Subject|2|||
147326779|NCT00430677|531361869|FG000|Short-term Period|Participant no longer met study criteria|1|||
147326780|NCT00430677|531361870|FG001|Short-term Period|Participant no longer met study criteria|1|||
147326781|NCT00430677|531361871|FG002|Short-term Period|Participant no longer met study criteria|2|||
147326782|NCT00430677|531361869|FG000|Short-term Period|Poor compliance/ noncompliance|0|||
147326783|NCT00430677|531361870|FG001|Short-term Period|Poor compliance/ noncompliance|1|||
147326784|NCT00430677|531361871|FG002|Short-term Period|Poor compliance/ noncompliance|0|||
147326785|NCT00430677|531361869|FG000|Short-term Period|Pregnancy|0|||
147326786|NCT00430677|531361870|FG001|Short-term Period|Pregnancy|2|||
147326787|NCT00430677|531361871|FG002|Short-term Period|Pregnancy|0|||
147326788|NCT00430677|531361869|FG000|Long-term Extension Period|Death|1|||
147326789|NCT00430677|531361870|FG001|Long-term Extension Period|Death|0|||
147326790|NCT00430677|531361871|FG002|Long-term Extension Period|Death|0|||
147326791|NCT00430677|531361869|FG000|Long-term Extension Period|Adverse Event|3|||
147326792|NCT00430677|531361870|FG001|Long-term Extension Period|Adverse Event|2|||
147326793|NCT00430677|531361871|FG002|Long-term Extension Period|Adverse Event|5|||
147326794|NCT00430677|531361869|FG000|Long-term Extension Period|Lack of Efficacy|5|||
147326795|NCT00430677|531361870|FG001|Long-term Extension Period|Lack of Efficacy|3|||
147326796|NCT00430677|531361871|FG002|Long-term Extension Period|Lack of Efficacy|8|||
147326797|NCT00430677|531361869|FG000|Long-term Extension Period|Lost to Follow-up|1|||
147326798|NCT00430677|531361870|FG001|Long-term Extension Period|Lost to Follow-up|1|||
147326799|NCT00430677|531361871|FG002|Long-term Extension Period|Lost to Follow-up|1|||
147326800|NCT00430677|531361869|FG000|Long-term Extension Period|Withdrawal by Subject|5|||
147326801|NCT00430677|531361870|FG001|Long-term Extension Period|Withdrawal by Subject|1|||
147326802|NCT00430677|531361871|FG002|Long-term Extension Period|Withdrawal by Subject|2|||
147326803|NCT00430677|531361869|FG000|Long-term Extension Period|Pregnancy|1|||
147326804|NCT00430677|531361870|FG001|Long-term Extension Period|Pregnancy|1|||
147326805|NCT00430677|531361871|FG002|Long-term Extension Period|Pregnancy|0|||
147326806|NCT00430677|531361869|FG000|Long-term Extension Period|Administrative reason by sponsor|41|||
147326807|NCT00430677|531361870|FG001|Long-term Extension Period|Administrative reason by sponsor|49|||
147326808|NCT00430677|531361871|FG002|Long-term Extension Period|Administrative reason by sponsor|46|||
147326809|NCT00430677|531361869|FG000|Long-term Extension Period|Other|2|||
147326810|NCT00430677|531361870|FG001|Long-term Extension Period|Other|1|||
147326811|NCT00430677|531361871|FG002|Long-term Extension Period|Other|1|||
147326812|NCT00430677|531361869|FG000|Long-term Extension Period|Poor compliance/noncompliance|1|||
147656789|NCT03410992|532566616|FG008|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
147656790|NCT03410992|532566617|FG009|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
147656791|NCT03410992|532566618|FG010|Initial Treatment Period: up to Wk16|Lack of Efficacy|0|||
147656792|NCT03410992|532566608|FG000|Initial Treatment Period: up to Wk16|Lost to Follow-up|1|||
147656793|NCT03410992|532566609|FG001|Initial Treatment Period: up to Wk16|Lost to Follow-up|3|||
147656794|NCT03410992|532566610|FG002|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
147656795|NCT03410992|532566611|FG003|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
147656796|NCT03410992|532566612|FG004|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
147656797|NCT03410992|532566613|FG005|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
147656798|NCT03410992|532566614|FG006|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
147656799|NCT03410992|532566615|FG007|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
147656800|NCT03410992|532566616|FG008|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
147656801|NCT03410992|532566617|FG009|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
147656802|NCT03410992|532566618|FG010|Initial Treatment Period: up to Wk16|Lost to Follow-up|0|||
147656803|NCT03410992|532566608|FG000|Initial Treatment Period: up to Wk16|Withdrawal by Subject|1|||
147656804|NCT03410992|532566609|FG001|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
147656805|NCT03410992|532566610|FG002|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
147656806|NCT03410992|532566611|FG003|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
147656807|NCT03410992|532566612|FG004|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
147656808|NCT03410992|532566613|FG005|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
147656809|NCT03410992|532566614|FG006|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
147656810|NCT03410992|532566615|FG007|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
147656811|NCT03410992|532566616|FG008|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
147656812|NCT03410992|532566617|FG009|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
147656813|NCT03410992|532566618|FG010|Initial Treatment Period: up to Wk16|Withdrawal by Subject|0|||
147656814|NCT03410992|532566608|FG000|Week 16 Assessment|PASI90 Non-Response at Week 16|81|||
147656815|NCT03410992|532566609|FG001|Week 16 Assessment|PASI90 Non-Response at Week 16|23|||
147656816|NCT03410992|532566610|FG002|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
147656817|NCT03410992|532566611|FG003|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
147656818|NCT03410992|532566612|FG004|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
147656819|NCT03410992|532566613|FG005|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
147656820|NCT03410992|532566614|FG006|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
147656821|NCT03410992|532566615|FG007|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
147656822|NCT03410992|532566616|FG008|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
147656823|NCT03410992|532566617|FG009|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
147656824|NCT03410992|532566618|FG010|Week 16 Assessment|PASI90 Non-Response at Week 16|0|||
147656825|NCT03410992|532566608|FG000|Week 16 Assessment|Incorrect escapers|0|||
147656826|NCT03410992|532566609|FG001|Week 16 Assessment|Incorrect escapers|6|||
147656827|NCT03410992|532566610|FG002|Week 16 Assessment|Incorrect escapers|0|||
147656828|NCT03410992|532566611|FG003|Week 16 Assessment|Incorrect escapers|0|||
147656829|NCT03410992|532566612|FG004|Week 16 Assessment|Incorrect escapers|0|||
147656830|NCT03410992|532566613|FG005|Week 16 Assessment|Incorrect escapers|0|||
147656831|NCT03410992|532566614|FG006|Week 16 Assessment|Incorrect escapers|0|||
147656832|NCT03410992|532566615|FG007|Week 16 Assessment|Incorrect escapers|0|||
147656833|NCT03410992|532566616|FG008|Week 16 Assessment|Incorrect escapers|0|||
147656834|NCT03410992|532566617|FG009|Week 16 Assessment|Incorrect escapers|0|||
147656835|NCT03410992|532566618|FG010|Week 16 Assessment|Incorrect escapers|0|||
147656836|NCT03410992|532566608|FG000|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
147656837|NCT03410992|532566609|FG001|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
147656838|NCT03410992|532566610|FG002|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
147656839|NCT03410992|532566611|FG003|Randomized-Withdrawal Period: up to Wk56|Adverse Event|3|||
147656840|NCT03410992|532566612|FG004|Randomized-Withdrawal Period: up to Wk56|Adverse Event|2|||
147656841|NCT03410992|532566613|FG005|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
147656842|NCT03410992|532566614|FG006|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
147656843|NCT03410992|532566615|FG007|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
147656844|NCT03410992|532566616|FG008|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
147656845|NCT03410992|532566617|FG009|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
147656846|NCT03410992|532566618|FG010|Randomized-Withdrawal Period: up to Wk56|Adverse Event|0|||
147656847|NCT03410992|532566608|FG000|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
147656848|NCT03410992|532566609|FG001|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
147656849|NCT03410992|532566610|FG002|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
147656850|NCT03410992|532566611|FG003|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|2|||
147656851|NCT03410992|532566612|FG004|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|1|||
147656852|NCT03410992|532566613|FG005|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|2|||
147656853|NCT03410992|532566614|FG006|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
147656854|NCT03410992|532566615|FG007|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
147246161|NCT01727297|531072720|FG000|Overall Study|Adverse Event|3|||
147246162|NCT01727297|531072721|FG001|Overall Study|Adverse Event|1|||
147246163|NCT01727297|531072720|FG000|Overall Study|Lost to Follow-up|11|||
147246164|NCT01727297|531072721|FG001|Overall Study|Lost to Follow-up|0|||
147246165|NCT01727297|531072720|FG000|Overall Study|Withdrawal by Subject|26|||
147246166|NCT01727297|531072721|FG001|Overall Study|Withdrawal by Subject|27|||
147246167|NCT01727297|531072720|FG000|Overall Study|Physician Decision|19|||
147246168|NCT01727297|531072721|FG001|Overall Study|Physician Decision|5|||
147246169|NCT01727297|531072720|FG000|Overall Study|Other (e.g. AF detection pre-implant)|29|||
147246170|NCT01727297|531072721|FG001|Overall Study|Other (e.g. AF detection pre-implant)|8|||
147246171|NCT00420927|531072734|FG000|Period 1|Adverse Event|19|||
147246172|NCT00420927|531072735|FG001|Period 1|Adverse Event|15|||
147246173|NCT00420927|531072736|FG002|Period 1|Adverse Event|0|||
147246174|NCT00420927|531072737|FG003|Period 1|Adverse Event|0|||
147246175|NCT00420927|531072738|FG004|Period 1|Adverse Event|0|||
147246176|NCT00420927|531072739|FG005|Period 1|Adverse Event|0|||
147246177|NCT00420927|531072740|FG006|Period 1|Adverse Event|0|||
147246178|NCT00420927|531072734|FG000|Period 1|Withdrawal by Subject|7|||
147246179|NCT00420927|531072735|FG001|Period 1|Withdrawal by Subject|12|||
147246180|NCT00420927|531072736|FG002|Period 1|Withdrawal by Subject|0|||
147246181|NCT00420927|531072737|FG003|Period 1|Withdrawal by Subject|0|||
147246182|NCT00420927|531072738|FG004|Period 1|Withdrawal by Subject|0|||
147246183|NCT00420927|531072739|FG005|Period 1|Withdrawal by Subject|0|||
147246184|NCT00420927|531072740|FG006|Period 1|Withdrawal by Subject|0|||
147246185|NCT00420927|531072734|FG000|Period 1|Lost to Follow-up|8|||
147246186|NCT00420927|531072735|FG001|Period 1|Lost to Follow-up|6|||
147246187|NCT00420927|531072736|FG002|Period 1|Lost to Follow-up|0|||
147246188|NCT00420927|531072737|FG003|Period 1|Lost to Follow-up|0|||
147246189|NCT00420927|531072738|FG004|Period 1|Lost to Follow-up|0|||
147246190|NCT00420927|531072739|FG005|Period 1|Lost to Follow-up|0|||
147246191|NCT00420927|531072740|FG006|Period 1|Lost to Follow-up|0|||
147246192|NCT00420927|531072734|FG000|Period 1|Lack of efficacy/Loss of efficacy|1|||
147246193|NCT00420927|531072735|FG001|Period 1|Lack of efficacy/Loss of efficacy|6|||
147246194|NCT00420927|531072736|FG002|Period 1|Lack of efficacy/Loss of efficacy|0|||
147246195|NCT00420927|531072737|FG003|Period 1|Lack of efficacy/Loss of efficacy|0|||
147246196|NCT00420927|531072738|FG004|Period 1|Lack of efficacy/Loss of efficacy|0|||
147246197|NCT00420927|531072739|FG005|Period 1|Lack of efficacy/Loss of efficacy|0|||
147246198|NCT00420927|531072740|FG006|Period 1|Lack of efficacy/Loss of efficacy|0|||
147246199|NCT00420927|531072734|FG000|Period 1|Death|2|||
147246200|NCT00420927|531072735|FG001|Period 1|Death|0|||
147246201|NCT00420927|531072736|FG002|Period 1|Death|0|||
147246202|NCT00420927|531072737|FG003|Period 1|Death|0|||
147246203|NCT00420927|531072738|FG004|Period 1|Death|0|||
147246204|NCT00420927|531072739|FG005|Period 1|Death|0|||
147246205|NCT00420927|531072740|FG006|Period 1|Death|0|||
147246206|NCT00420927|531072734|FG000|Period 1|Subject moved/relocated|0|||
147246207|NCT00420927|531072735|FG001|Period 1|Subject moved/relocated|2|||
147246208|NCT00420927|531072736|FG002|Period 1|Subject moved/relocated|0|||
147246209|NCT00420927|531072737|FG003|Period 1|Subject moved/relocated|0|||
147246210|NCT00420927|531072738|FG004|Period 1|Subject moved/relocated|0|||
147246211|NCT00420927|531072739|FG005|Period 1|Subject moved/relocated|0|||
147246212|NCT00420927|531072740|FG006|Period 1|Subject moved/relocated|0|||
147246213|NCT00420927|531072734|FG000|Period 1|Noncompliant with study drug|1|||
147246214|NCT00420927|531072735|FG001|Period 1|Noncompliant with study drug|1|||
147246215|NCT00420927|531072736|FG002|Period 1|Noncompliant with study drug|0|||
147246216|NCT00420927|531072737|FG003|Period 1|Noncompliant with study drug|0|||
147246217|NCT00420927|531072738|FG004|Period 1|Noncompliant with study drug|0|||
147246218|NCT00420927|531072739|FG005|Period 1|Noncompliant with study drug|0|||
147246219|NCT00420927|531072740|FG006|Period 1|Noncompliant with study drug|0|||
147246220|NCT00420927|531072734|FG000|Period 1|Randomization error|1|||
147246221|NCT00420927|531072735|FG001|Period 1|Randomization error|0|||
147246222|NCT00420927|531072736|FG002|Period 1|Randomization error|0|||
147246223|NCT00420927|531072737|FG003|Period 1|Randomization error|0|||
147246224|NCT00420927|531072738|FG004|Period 1|Randomization error|0|||
147246225|NCT00420927|531072739|FG005|Period 1|Randomization error|0|||
147246226|NCT00420927|531072740|FG006|Period 1|Randomization error|0|||
147246227|NCT00420927|531072734|FG000|Period 1|Suspected tuberculosis/positive test|1|||
147246228|NCT00420927|531072735|FG001|Period 1|Suspected tuberculosis/positive test|1|||
147246229|NCT00420927|531072736|FG002|Period 1|Suspected tuberculosis/positive test|0|||
147246230|NCT00420927|531072737|FG003|Period 1|Suspected tuberculosis/positive test|0|||
147246231|NCT00420927|531072738|FG004|Period 1|Suspected tuberculosis/positive test|0|||
147246232|NCT00420927|531072739|FG005|Period 1|Suspected tuberculosis/positive test|0|||
147246233|NCT00420927|531072740|FG006|Period 1|Suspected tuberculosis/positive test|0|||
147246234|NCT00420927|531072734|FG000|Period 1|Study site closure|0|||
147246235|NCT00420927|531072735|FG001|Period 1|Study site closure|1|||
147246236|NCT00420927|531072736|FG002|Period 1|Study site closure|0|||
147246237|NCT00420927|531072737|FG003|Period 1|Study site closure|0|||
147656855|NCT03410992|532566616|FG008|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
147656856|NCT03410992|532566617|FG009|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
147656857|NCT03410992|532566618|FG010|Randomized-Withdrawal Period: up to Wk56|Lost to Follow-up|0|||
147656858|NCT03410992|532566608|FG000|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
147656859|NCT03410992|532566609|FG001|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
147656860|NCT03410992|532566610|FG002|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
147656861|NCT03410992|532566611|FG003|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
147656862|NCT03410992|532566612|FG004|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
147656863|NCT03410992|532566613|FG005|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|3|||
147656864|NCT03410992|532566614|FG006|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
147656865|NCT03410992|532566615|FG007|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
147656866|NCT03410992|532566616|FG008|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
147656867|NCT03410992|532566617|FG009|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
147656868|NCT03410992|532566618|FG010|Randomized-Withdrawal Period: up to Wk56|Withdrawal by Subject|0|||
147656869|NCT03410992|532566608|FG000|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
147656870|NCT03410992|532566609|FG001|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
147656871|NCT03410992|532566610|FG002|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
147656872|NCT03410992|532566611|FG003|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|67|||
147656873|NCT03410992|532566612|FG004|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|4|||
147656874|NCT03410992|532566613|FG005|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|7|||
147656875|NCT03410992|532566614|FG006|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
147656876|NCT03410992|532566615|FG007|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
147656877|NCT03410992|532566616|FG008|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
147656878|NCT03410992|532566617|FG009|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
147656879|NCT03410992|532566618|FG010|Randomized-Withdrawal Period: up to Wk56|Relapse at Week 20 or later|0|||
147656880|NCT03410992|532566608|FG000|Escape Treatment: 12 Weeks|Adverse Event|0|||
147656881|NCT03410992|532566609|FG001|Escape Treatment: 12 Weeks|Adverse Event|0|||
147326813|NCT00430677|531361870|FG001|Long-term Extension Period|Poor compliance/noncompliance|0|||
147326814|NCT00430677|531361871|FG002|Long-term Extension Period|Poor compliance/noncompliance|0|||
147326815|NCT02040844|531361874|FG000|Overall Study|Adverse Event|0|||
147326816|NCT02040844|531361875|FG001|Overall Study|Adverse Event|0|||
147326817|NCT02040844|531361876|FG002|Overall Study|Adverse Event|1|||
147326818|NCT02040844|531361874|FG000|Overall Study|Withdrawal by Subject|16|||
147326819|NCT02040844|531361875|FG001|Overall Study|Withdrawal by Subject|22|||
147326820|NCT02040844|531361876|FG002|Overall Study|Withdrawal by Subject|25|||
147326821|NCT02040844|531361874|FG000|Overall Study|Lost to Follow-up|12|||
147326822|NCT02040844|531361875|FG001|Overall Study|Lost to Follow-up|9|||
147326823|NCT02040844|531361876|FG002|Overall Study|Lost to Follow-up|13|||
147326824|NCT02040844|531361874|FG000|Overall Study|Missing|13|||
147326825|NCT02040844|531361875|FG001|Overall Study|Missing|3|||
147326826|NCT02040844|531361876|FG002|Overall Study|Missing|2|||
147326827|NCT02040844|531361874|FG000|Overall Study|Non-specified|8|||
147326828|NCT02040844|531361875|FG001|Overall Study|Non-specified|2|||
147326829|NCT02040844|531361876|FG002|Overall Study|Non-specified|5|||
147326830|NCT02040844|531361874|FG000|Overall Study|Concomitant medication|1|||
147326831|NCT02040844|531361875|FG001|Overall Study|Concomitant medication|3|||
147326832|NCT02040844|531361876|FG002|Overall Study|Concomitant medication|1|||
147326833|NCT00946192|531361877|FG000|Overall Study|Lost to Follow-up|6|||
147326834|NCT00946192|531361878|FG001|Overall Study|Lost to Follow-up|11|||
147326835|NCT00946192|531361879|FG002|Overall Study|Lost to Follow-up|9|||
147326836|NCT00946192|531361877|FG000|Overall Study|Withdrawal by Subject|10|||
147326837|NCT00946192|531361878|FG001|Overall Study|Withdrawal by Subject|7|||
147326838|NCT00946192|531361879|FG002|Overall Study|Withdrawal by Subject|3|||
147326839|NCT00946192|531361877|FG000|Overall Study|Did not start medication|2|||
147326840|NCT00946192|531361878|FG001|Overall Study|Did not start medication|0|||
147326841|NCT00946192|531361879|FG002|Overall Study|Did not start medication|0|||
147326842|NCT00681811|531361884|FG000|Overall Study|Adverse Event|1|||
147326843|NCT00681811|531361885|FG001|Overall Study|Adverse Event|1|||
147326844|NCT00681811|531361884|FG000|Overall Study|Withdrawal by Subject|2|||
147326845|NCT00681811|531361885|FG001|Overall Study|Withdrawal by Subject|2|||
147326846|NCT00681811|531361884|FG000|Overall Study|Non-compliance|0|||
147448474|NCT01464307|531805734|FG001|Open-Label Extension Period|Lost to Follow-up|0|||
147448475|NCT01464307|531805733|FG000|Open-Label Extension Period|Non-compliance|9|||
147448476|NCT01464307|531805734|FG001|Open-Label Extension Period|Non-compliance|0|||
147326847|NCT00681811|531361885|FG001|Overall Study|Non-compliance|1|||
147326848|NCT02068885|531361886|FG000|Overall Study|Withdrew|3|||
147326849|NCT02068885|531361887|FG001|Overall Study|Withdrew|5|||
147326850|NCT02068885|531361888|FG002|Overall Study|Withdrew|8|||
147326851|NCT00828919|531361889|FG000|Overall Study|Death|0|||
147326852|NCT00828919|531361890|FG001|Overall Study|Death|1|||
147656882|NCT03410992|532566610|FG002|Escape Treatment: 12 Weeks|Adverse Event|0|||
147656883|NCT03410992|532566611|FG003|Escape Treatment: 12 Weeks|Adverse Event|0|||
147656884|NCT03410992|532566612|FG004|Escape Treatment: 12 Weeks|Adverse Event|0|||
147656885|NCT03410992|532566613|FG005|Escape Treatment: 12 Weeks|Adverse Event|0|||
147656886|NCT03410992|532566614|FG006|Escape Treatment: 12 Weeks|Adverse Event|0|||
147656887|NCT03410992|532566615|FG007|Escape Treatment: 12 Weeks|Adverse Event|1|||
147656888|NCT03410992|532566616|FG008|Escape Treatment: 12 Weeks|Adverse Event|0|||
147656889|NCT03410992|532566617|FG009|Escape Treatment: 12 Weeks|Adverse Event|0|||
147656890|NCT03410992|532566618|FG010|Escape Treatment: 12 Weeks|Adverse Event|0|||
147656891|NCT03410992|532566608|FG000|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
147656892|NCT03410992|532566609|FG001|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
147656893|NCT03410992|532566610|FG002|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
147656894|NCT03410992|532566611|FG003|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
147656895|NCT03410992|532566612|FG004|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
147656896|NCT03410992|532566613|FG005|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
147656897|NCT03410992|532566614|FG006|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
147656898|NCT03410992|532566615|FG007|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
147656899|NCT03410992|532566616|FG008|Escape Treatment: 12 Weeks|Withdrawal by Subject|1|||
147656900|NCT03410992|532566617|FG009|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
147656901|NCT03410992|532566618|FG010|Escape Treatment: 12 Weeks|Withdrawal by Subject|0|||
147656902|NCT01001910|532566619|FG000|Overall Study|Did not meet protocol defined eligibility s7.1.1 for primary outcome|6|||
147656903|NCT00614874|532566620|FG000|Overall Study|Protocol Violation|1|||
147656904|NCT00614874|532566620|FG000|Overall Study|Withdrawal by Subject|1|||
147656905|NCT03904420|532566621|FG000|Overall Study|Study terminated|2|||
147656906|NCT03904420|532566622|FG001|Overall Study|Study terminated|2|||
147656907|NCT01468454|532566623|FG000|Overall Study|Did not have surgery after PET|9|||
147656908|NCT01462630|532566626|FG000|Overall Study|Did not initiate therapy|3|||
147656909|NCT01462630|532566626|FG000|Overall Study|Death|1|||
147656910|NCT01462630|532566626|FG000|Overall Study|Protocol Violation|2|||
147656911|NCT01462630|532566626|FG000|Overall Study|Adverse Event|1|||
147656912|NCT01048541|532566630|FG000|Overall Study|Withdrawal by Subject|1|||
147656913|NCT01048541|532566631|FG001|Overall Study|Withdrawal by Subject|0|||
147656914|NCT00396383|532566638|FG000|Overall Study|Death|2|||
147656915|NCT00396383|532566638|FG000|Overall Study|Lost to Follow-up|1|||
147656916|NCT03538691|532566639|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Lost to Follow-up|24|||
147656917|NCT03538691|532566640|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Lost to Follow-up|0|||
147656918|NCT03538691|532566641|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Lost to Follow-up|0|||
147656919|NCT03538691|532566642|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Lost to Follow-up|0|||
147656920|NCT03538691|532566639|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Adverse Event|82|||
147656921|NCT03538691|532566640|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Adverse Event|0|||
147656922|NCT03538691|532566641|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Adverse Event|0|||
147656923|NCT03538691|532566642|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Adverse Event|0|||
147656924|NCT03538691|532566639|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Subject Withdrew Consent|54|||
147656925|NCT03538691|532566640|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Subject Withdrew Consent|0|||
147656926|NCT03538691|532566641|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Subject Withdrew Consent|0|||
147656927|NCT03538691|532566642|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Subject Withdrew Consent|0|||
147656928|NCT03538691|532566639|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Death|1|||
147656929|NCT03538691|532566640|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Death|0|||
147656930|NCT03538691|532566641|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Death|0|||
147656931|NCT03538691|532566642|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Death|0|||
147656932|NCT03538691|532566639|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Non-Compliance With Study Drug|9|||
147656933|NCT03538691|532566640|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Non-Compliance With Study Drug|0|||
147656934|NCT03538691|532566641|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Non-Compliance With Study Drug|0|||
147656935|NCT03538691|532566642|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Non-Compliance With Study Drug|0|||
147656936|NCT03538691|532566639|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Lack of Efficacy|185|||
147656937|NCT03538691|532566640|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Lack of Efficacy|0|||
147656938|NCT03538691|532566641|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Lack of Efficacy|0|||
147656939|NCT03538691|532566642|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Lack of Efficacy|0|||
147656940|NCT03538691|532566639|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Protocol Deviation|12|||
147656941|NCT03538691|532566640|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Protocol Deviation|0|||
147656942|NCT03538691|532566641|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Protocol Deviation|0|||
147656943|NCT03538691|532566642|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Protocol Deviation|0|||
147656944|NCT03538691|532566639|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Physician Decision|1|||
147656945|NCT03538691|532566640|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Physician Decision|0|||
147656946|NCT03538691|532566641|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Physician Decision|0|||
147656947|NCT03538691|532566642|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Physician Decision|0|||
147659421|NCT01064414|532576182|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|2|||
147448477|NCT01464307|531805733|FG000|Open-Label Extension Period|Predefined discontinuation criteria|6|||
147656948|NCT03538691|532566639|FG000|Phase A: Acute Treatment (up to 8 Weeks)|Reason not Specified (not due to Coronavirus Disease 2019 [COVID-19] Restriction)|15|||
147656949|NCT03538691|532566640|FG001|Phase A: Acute Treatment (up to 8 Weeks)|Reason not Specified (not due to Coronavirus Disease 2019 [COVID-19] Restriction)|0|||
147656950|NCT03538691|532566641|FG002|Phase A: Acute Treatment (up to 8 Weeks)|Reason not Specified (not due to Coronavirus Disease 2019 [COVID-19] Restriction)|0|||
147656951|NCT03538691|532566642|FG003|Phase A: Acute Treatment (up to 8 Weeks)|Reason not Specified (not due to Coronavirus Disease 2019 [COVID-19] Restriction)|0|||
147656952|NCT03538691|532566639|FG000|Phase B: Stabilization (12 Weeks)|Lost to Follow-up|0|||
147656953|NCT03538691|532566640|FG001|Phase B: Stabilization (12 Weeks)|Lost to Follow-up|5|||
147656954|NCT03538691|532566641|FG002|Phase B: Stabilization (12 Weeks)|Lost to Follow-up|0|||
147656955|NCT03538691|532566642|FG003|Phase B: Stabilization (12 Weeks)|Lost to Follow-up|0|||
147656956|NCT03538691|532566639|FG000|Phase B: Stabilization (12 Weeks)|Adverse Event|0|||
147656957|NCT03538691|532566640|FG001|Phase B: Stabilization (12 Weeks)|Adverse Event|52|||
147656958|NCT03538691|532566641|FG002|Phase B: Stabilization (12 Weeks)|Adverse Event|0|||
147656959|NCT03538691|532566642|FG003|Phase B: Stabilization (12 Weeks)|Adverse Event|0|||
147656960|NCT03538691|532566639|FG000|Phase B: Stabilization (12 Weeks)|Subject Withdrew Consent|0|||
147656961|NCT03538691|532566640|FG001|Phase B: Stabilization (12 Weeks)|Subject Withdrew Consent|47|||
147656962|NCT03538691|532566641|FG002|Phase B: Stabilization (12 Weeks)|Subject Withdrew Consent|0|||
147656963|NCT03538691|532566642|FG003|Phase B: Stabilization (12 Weeks)|Subject Withdrew Consent|0|||
147656964|NCT03538691|532566639|FG000|Phase B: Stabilization (12 Weeks)|Non-Compliance With Study Drug|0|||
147656965|NCT03538691|532566640|FG001|Phase B: Stabilization (12 Weeks)|Non-Compliance With Study Drug|9|||
147656966|NCT03538691|532566641|FG002|Phase B: Stabilization (12 Weeks)|Non-Compliance With Study Drug|0|||
147656967|NCT03538691|532566642|FG003|Phase B: Stabilization (12 Weeks)|Non-Compliance With Study Drug|0|||
147656968|NCT03538691|532566639|FG000|Phase B: Stabilization (12 Weeks)|Lack of Efficacy|0|||
147656969|NCT03538691|532566640|FG001|Phase B: Stabilization (12 Weeks)|Lack of Efficacy|136|||
147656970|NCT03538691|532566641|FG002|Phase B: Stabilization (12 Weeks)|Lack of Efficacy|0|||
147656971|NCT03538691|532566642|FG003|Phase B: Stabilization (12 Weeks)|Lack of Efficacy|0|||
147656972|NCT03538691|532566639|FG000|Phase B: Stabilization (12 Weeks)|Pregnancy|0|||
147656973|NCT03538691|532566640|FG001|Phase B: Stabilization (12 Weeks)|Pregnancy|1|||
147656974|NCT03538691|532566641|FG002|Phase B: Stabilization (12 Weeks)|Pregnancy|0|||
147656975|NCT03538691|532566642|FG003|Phase B: Stabilization (12 Weeks)|Pregnancy|0|||
147656976|NCT03538691|532566639|FG000|Phase B: Stabilization (12 Weeks)|Protocol Deviation|0|||
147656977|NCT03538691|532566640|FG001|Phase B: Stabilization (12 Weeks)|Protocol Deviation|9|||
147656978|NCT03538691|532566641|FG002|Phase B: Stabilization (12 Weeks)|Protocol Deviation|0|||
147656979|NCT03538691|532566642|FG003|Phase B: Stabilization (12 Weeks)|Protocol Deviation|0|||
147656980|NCT03538691|532566639|FG000|Phase B: Stabilization (12 Weeks)|Physician Decision|0|||
147656981|NCT03538691|532566640|FG001|Phase B: Stabilization (12 Weeks)|Physician Decision|6|||
147656982|NCT03538691|532566641|FG002|Phase B: Stabilization (12 Weeks)|Physician Decision|0|||
147656983|NCT03538691|532566642|FG003|Phase B: Stabilization (12 Weeks)|Physician Decision|0|||
147656984|NCT03538691|532566639|FG000|Phase B: Stabilization (12 Weeks)|Due to COVID-19 Restriction|0|||
147656985|NCT03538691|532566640|FG001|Phase B: Stabilization (12 Weeks)|Due to COVID-19 Restriction|1|||
147656986|NCT03538691|532566641|FG002|Phase B: Stabilization (12 Weeks)|Due to COVID-19 Restriction|0|||
147656987|NCT03538691|532566642|FG003|Phase B: Stabilization (12 Weeks)|Due to COVID-19 Restriction|0|||
147656988|NCT03538691|532566639|FG000|Phase B: Stabilization (12 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|0|||
147656989|NCT03538691|532566640|FG001|Phase B: Stabilization (12 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|11|||
147656990|NCT03538691|532566641|FG002|Phase B: Stabilization (12 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|0|||
147656991|NCT03538691|532566642|FG003|Phase B: Stabilization (12 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|0|||
147656992|NCT03538691|532566639|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Lost to Follow-up|0|||
147656993|NCT03538691|532566640|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Lost to Follow-up|0|||
147656994|NCT03538691|532566641|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Lost to Follow-up|16|||
147656995|NCT03538691|532566642|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Lost to Follow-up|4|||
147656996|NCT03538691|532566639|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Adverse Event|0|||
147656997|NCT03538691|532566640|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Adverse Event|0|||
147656998|NCT03538691|532566641|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Adverse Event|6|||
147656999|NCT03538691|532566642|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Adverse Event|6|||
147657000|NCT03538691|532566639|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Subject Withdrew Consent|0|||
147657001|NCT03538691|532566640|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Subject Withdrew Consent|0|||
147657002|NCT03538691|532566641|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Subject Withdrew Consent|6|||
147657003|NCT03538691|532566642|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Subject Withdrew Consent|19|||
147657004|NCT03538691|532566639|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Non-Compliance With Study Drug|0|||
147326853|NCT00828919|531361891|FG002|Overall Study|Death|2|||
147326854|NCT00828919|531361892|FG003|Overall Study|Death|0|||
147448478|NCT01464307|531805734|FG001|Open-Label Extension Period|Predefined discontinuation criteria|0|||
147326855|NCT00828919|531361893|FG004|Overall Study|Death|0|||
147657005|NCT03538691|532566640|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Non-Compliance With Study Drug|0|||
147657006|NCT03538691|532566641|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Non-Compliance With Study Drug|1|||
147657007|NCT03538691|532566642|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Non-Compliance With Study Drug|2|||
147657008|NCT03538691|532566639|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Non-compliant Participants|0|||
147657009|NCT03538691|532566640|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Non-compliant Participants|0|||
147657010|NCT03538691|532566641|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Non-compliant Participants|32|||
147657011|NCT03538691|532566642|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Non-compliant Participants|28|||
147657012|NCT03538691|532566639|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Pregnancy|0|||
147657013|NCT03538691|532566640|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Pregnancy|0|||
147657014|NCT03538691|532566641|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Pregnancy|1|||
147657015|NCT03538691|532566642|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Pregnancy|0|||
147657016|NCT03538691|532566639|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Lack of Efficacy (Phase C MDD Relapse)|0|||
147657017|NCT03538691|532566640|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Lack of Efficacy (Phase C MDD Relapse)|0|||
147657018|NCT03538691|532566641|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Lack of Efficacy (Phase C MDD Relapse)|54|||
147657019|NCT03538691|532566642|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Lack of Efficacy (Phase C MDD Relapse)|52|||
147657020|NCT03538691|532566639|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Physician Decision|0|||
147657021|NCT03538691|532566640|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Physician Decision|0|||
147657022|NCT03538691|532566641|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Physician Decision|0|||
147657023|NCT03538691|532566642|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Physician Decision|1|||
147657024|NCT03538691|532566639|FG000|Phase C:Randomized Withdrawal (26 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|0|||
147657025|NCT03538691|532566640|FG001|Phase C:Randomized Withdrawal (26 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|0|||
147657026|NCT03538691|532566641|FG002|Phase C:Randomized Withdrawal (26 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|4|||
147657027|NCT03538691|532566642|FG003|Phase C:Randomized Withdrawal (26 Weeks)|Reason not Specified (not due to COVID-19 Restriction)|6|||
147657028|NCT00481767|532566645|FG000|Overall Study|Withdrawal by Subject|16|||
147657029|NCT00481767|532566646|FG001|Overall Study|Withdrawal by Subject|11|||
147657030|NCT00481767|532566645|FG000|Overall Study|Lost to Follow-up|16|||
147657031|NCT00481767|532566646|FG001|Overall Study|Lost to Follow-up|10|||
147657032|NCT01366638|532566647|FG000|Overall Study|Withdrawal by Subject|0|||
147657033|NCT01366638|532566648|FG001|Overall Study|Withdrawal by Subject|0|||
147657034|NCT01366638|532566649|FG002|Overall Study|Withdrawal by Subject|6|||
147657035|NCT01366638|532566647|FG000|Overall Study|Other|1|||
147657036|NCT01366638|532566648|FG001|Overall Study|Other|0|||
147657037|NCT01366638|532566649|FG002|Overall Study|Other|0|||
147657038|NCT00636636|532566650|FG000|Overall Study|Other reason|4|||
147657039|NCT00636636|532566651|FG001|Overall Study|Other reason|6|||
147657040|NCT00636636|532566650|FG000|Overall Study|Adverse Event|19|||
147657041|NCT00636636|532566651|FG001|Overall Study|Adverse Event|8|||
147657042|NCT00636636|532566650|FG000|Overall Study|Lack of Efficacy|7|||
147657043|NCT00636636|532566651|FG001|Overall Study|Lack of Efficacy|12|||
147657044|NCT00636636|532566650|FG000|Overall Study|Protocol Violation|2|||
147657045|NCT00636636|532566651|FG001|Overall Study|Protocol Violation|2|||
147657046|NCT00636636|532566650|FG000|Overall Study|Lost to Follow-up|0|||
147657047|NCT00636636|532566651|FG001|Overall Study|Lost to Follow-up|1|||
147657048|NCT00636636|532566650|FG000|Overall Study|Death|0|||
147657049|NCT00636636|532566651|FG001|Overall Study|Death|1|||
147657050|NCT00636636|532566650|FG000|Overall Study|Withdrawal by Subject|4|||
147657051|NCT00636636|532566651|FG001|Overall Study|Withdrawal by Subject|9|||
147657052|NCT00524173|532566652|FG000|Overall Study|Lost to Follow-up|0|||
147657053|NCT00524173|532566653|FG001|Overall Study|Lost to Follow-up|1|||
147657054|NCT00524173|532566652|FG000|Overall Study|Death|1|||
147657055|NCT00524173|532566653|FG001|Overall Study|Death|0|||
147657056|NCT00524173|532566652|FG000|Overall Study|Had not reached endpoint at study close|4|||
147657057|NCT00524173|532566653|FG001|Overall Study|Had not reached endpoint at study close|1|||
147657058|NCT01237327|532566654|FG000|Overall Study|Protocol Violation: Core Study|1|||
147657059|NCT01237327|532566655|FG001|Overall Study|Protocol Violation: Core Study|0|||
147657060|NCT01237327|532566654|FG000|Overall Study|Completed 26 weeks treatment:Core Study|3|||
147657061|NCT01237327|532566655|FG001|Overall Study|Completed 26 weeks treatment:Core Study|2|||
147657062|NCT01237327|532566654|FG000|Overall Study|Progression of Disease: Core Study|18|||
147657063|NCT01237327|532566655|FG001|Overall Study|Progression of Disease: Core Study|22|||
147657064|NCT01237327|532566654|FG000|Overall Study|Progression of Disease: Extension Study|15|||
147657065|NCT01237327|532566655|FG001|Overall Study|Progression of Disease: Extension Study|13|||
147657066|NCT01237327|532566654|FG000|Overall Study|Protocol Specific Withdrawal Criteria|1|||
147657067|NCT01237327|532566655|FG001|Overall Study|Protocol Specific Withdrawal Criteria|0|||
147246238|NCT00420927|531072738|FG004|Period 1|Study site closure|0|||
147657068|NCT01237327|532566654|FG000|Overall Study|Withdrawal by Subject|1|||
147657069|NCT01237327|532566655|FG001|Overall Study|Withdrawal by Subject|3|||
147657070|NCT01237327|532566654|FG000|Overall Study|Lost to Follow-up|3|||
147657071|NCT01237327|532566655|FG001|Overall Study|Lost to Follow-up|0|||
147657072|NCT03300180|532566656|FG000|Baseline|Withdrawal by Subject|4|||
147657073|NCT03300180|532566657|FG001|Baseline|Withdrawal by Subject|6|||
147657074|NCT03300180|532566658|FG002|Baseline|Withdrawal by Subject|4|||
147657075|NCT03300180|532566656|FG000|6 Month Outcome|Withdrawal by Subject|12|||
147657076|NCT03300180|532566657|FG001|6 Month Outcome|Withdrawal by Subject|12|||
147657077|NCT03300180|532566658|FG002|6 Month Outcome|Withdrawal by Subject|19|||
147657078|NCT03300180|532566656|FG000|6 Month Outcome|Death|2|||
147657079|NCT03300180|532566657|FG001|6 Month Outcome|Death|4|||
147657080|NCT03300180|532566658|FG002|6 Month Outcome|Death|3|||
147657081|NCT03300180|532566656|FG000|6 Month Outcome|Missed Assessment|43|||
147657082|NCT03300180|532566657|FG001|6 Month Outcome|Missed Assessment|52|||
147657083|NCT03300180|532566658|FG002|6 Month Outcome|Missed Assessment|46|||
147657084|NCT03300180|532566656|FG000|12 Month Outcome|Withdrawal by Subject|3|||
147657085|NCT03300180|532566657|FG001|12 Month Outcome|Withdrawal by Subject|6|||
147657086|NCT03300180|532566658|FG002|12 Month Outcome|Withdrawal by Subject|6|||
147657087|NCT03300180|532566656|FG000|12 Month Outcome|Death|9|||
147657088|NCT03300180|532566657|FG001|12 Month Outcome|Death|6|||
147657089|NCT03300180|532566658|FG002|12 Month Outcome|Death|6|||
147657090|NCT03300180|532566656|FG000|12 Month Outcome|Missed Assessment|62|||
147657091|NCT03300180|532566657|FG001|12 Month Outcome|Missed Assessment|59|||
147657092|NCT03300180|532566658|FG002|12 Month Outcome|Missed Assessment|58|||
147657093|NCT03300180|532566656|FG000|18 Month Outcome Assessment|Withdrawal by Subject|14|||
147657094|NCT03300180|532566657|FG001|18 Month Outcome Assessment|Withdrawal by Subject|4|||
147657095|NCT03300180|532566658|FG002|18 Month Outcome Assessment|Withdrawal by Subject|13|||
147657096|NCT03300180|532566656|FG000|18 Month Outcome Assessment|Death|8|||
147657097|NCT03300180|532566657|FG001|18 Month Outcome Assessment|Death|5|||
147657098|NCT03300180|532566658|FG002|18 Month Outcome Assessment|Death|5|||
147657099|NCT03300180|532566656|FG000|18 Month Outcome Assessment|Missed Assessment|49|||
147657100|NCT03300180|532566657|FG001|18 Month Outcome Assessment|Missed Assessment|61|||
147657101|NCT03300180|532566658|FG002|18 Month Outcome Assessment|Missed Assessment|44|||
147657102|NCT03300180|532566656|FG000|24 Month Outcome Assessment|Withdrawal by Subject|6|||
147657103|NCT03300180|532566657|FG001|24 Month Outcome Assessment|Withdrawal by Subject|10|||
147657104|NCT03300180|532566658|FG002|24 Month Outcome Assessment|Withdrawal by Subject|4|||
147657105|NCT03300180|532566656|FG000|24 Month Outcome Assessment|Death|13|||
147657106|NCT03300180|532566657|FG001|24 Month Outcome Assessment|Death|13|||
147657107|NCT03300180|532566658|FG002|24 Month Outcome Assessment|Death|3|||
147657108|NCT03300180|532566656|FG000|24 Month Outcome Assessment|Missed Assessment|17|||
147657109|NCT03300180|532566657|FG001|24 Month Outcome Assessment|Missed Assessment|21|||
147657110|NCT03300180|532566658|FG002|24 Month Outcome Assessment|Missed Assessment|38|||
147657111|NCT01554163|532566663|FG000|Overall Study|Adverse Event|3|||
147657112|NCT01554163|532566664|FG001|Overall Study|Adverse Event|0|||
147657113|NCT01554163|532566663|FG000|Overall Study|Lack of Efficacy|1|||
147657114|NCT01554163|532566664|FG001|Overall Study|Lack of Efficacy|0|||
147657115|NCT01554163|532566663|FG000|Overall Study|Lost to Follow-up|1|||
147657116|NCT01554163|532566664|FG001|Overall Study|Lost to Follow-up|0|||
147657117|NCT01554163|532566663|FG000|Overall Study|Non-Compliance With Study Drug|1|||
147657118|NCT01554163|532566664|FG001|Overall Study|Non-Compliance With Study Drug|1|||
147657119|NCT01554163|532566663|FG000|Overall Study|Protocol Violation|0|||
147657120|NCT01554163|532566664|FG001|Overall Study|Protocol Violation|4|||
147657121|NCT01554163|532566663|FG000|Overall Study|Withdrawal by Subject|1|||
147657122|NCT01554163|532566664|FG001|Overall Study|Withdrawal by Subject|5|||
147657123|NCT01554163|532566663|FG000|Overall Study|Not Treated|1|||
147657124|NCT01554163|532566664|FG001|Overall Study|Not Treated|0|||
147657125|NCT01941537|532566665|FG000|Overall Study|Lack of Efficacy|1|||
147657126|NCT01941537|532566666|FG001|Overall Study|Lack of Efficacy|2|||
147657127|NCT01941537|532566665|FG000|Overall Study|Lost to Follow-up|1|||
147657128|NCT01941537|532566666|FG001|Overall Study|Lost to Follow-up|0|||
147657129|NCT01941537|532566665|FG000|Overall Study|Pregnancy|1|||
147657130|NCT01941537|532566666|FG001|Overall Study|Pregnancy|0|||
147657131|NCT01941537|532566665|FG000|Overall Study|Adverse Event|1|||
147657132|NCT01941537|532566666|FG001|Overall Study|Adverse Event|0|||
147657133|NCT01941537|532566665|FG000|Overall Study|Withdrawal by Subject|0|||
147657134|NCT01941537|532566666|FG001|Overall Study|Withdrawal by Subject|1|||
147657135|NCT02557516|532566668|FG000|Overall Study|Adverse Event|1|||
147181776|NCT01445080|530829181|FG008|Overall Study|Withdrawal by Subject|2|||
147181777|NCT01445080|530829173|FG000|Overall Study|Ineligible/Inevaluable|1|||
147657136|NCT02557516|532566669|FG001|Overall Study|Adverse Event|0|||
147657137|NCT02557516|532566670|FG002|Overall Study|Adverse Event|2|||
147657138|NCT02557516|532566671|FG003|Overall Study|Adverse Event|1|||
147657139|NCT02557516|532566668|FG000|Overall Study|Disease progression|0|||
147657140|NCT02557516|532566669|FG001|Overall Study|Disease progression|2|||
147657141|NCT02557516|532566670|FG002|Overall Study|Disease progression|0|||
147657142|NCT02557516|532566671|FG003|Overall Study|Disease progression|0|||
147657143|NCT02557516|532566668|FG000|Overall Study|Physician Decision|0|||
147657144|NCT02557516|532566669|FG001|Overall Study|Physician Decision|2|||
147657145|NCT02557516|532566670|FG002|Overall Study|Physician Decision|0|||
147657146|NCT02557516|532566671|FG003|Overall Study|Physician Decision|0|||
147657147|NCT02557516|532566668|FG000|Overall Study|Sponsor decision|0|||
147657148|NCT02557516|532566669|FG001|Overall Study|Sponsor decision|1|||
147657149|NCT02557516|532566670|FG002|Overall Study|Sponsor decision|2|||
147593539|NCT00977431|532329004|FG002|Overall Study|Dose-limiting toxicity (DLT)|1|||
147593540|NCT00977431|532329005|FG003|Overall Study|Dose-limiting toxicity (DLT)|0|||
147593541|NCT00977431|532329006|FG004|Overall Study|Dose-limiting toxicity (DLT)|0|||
147593542|NCT00977431|532329002|FG000|Overall Study|Progressive disease|2|||
147593543|NCT00977431|532329003|FG001|Overall Study|Progressive disease|6|||
147593544|NCT00977431|532329004|FG002|Overall Study|Progressive disease|1|||
147593545|NCT00977431|532329005|FG003|Overall Study|Progressive disease|3|||
147593546|NCT00977431|532329006|FG004|Overall Study|Progressive disease|5|||
147593547|NCT00518882|532329009|FG000|Double-Blind, Week 0-26|Adverse Event|23|||
147593548|NCT00518882|532329010|FG001|Double-Blind, Week 0-26|Adverse Event|31|||
147593549|NCT00518882|532329009|FG000|Double-Blind, Week 0-26|Lack of Efficacy|1|||
147593550|NCT00518882|532329010|FG001|Double-Blind, Week 0-26|Lack of Efficacy|0|||
147593551|NCT00518882|532329009|FG000|Double-Blind, Week 0-26|Protocol Violation|4|||
147593552|NCT00518882|532329010|FG001|Double-Blind, Week 0-26|Protocol Violation|3|||
147593553|NCT00518882|532329009|FG000|Double-Blind, Week 0-26|Withdrawal criteria|1|||
147593554|NCT00518882|532329010|FG001|Double-Blind, Week 0-26|Withdrawal criteria|1|||
147593555|NCT00518882|532329009|FG000|Double-Blind, Week 0-26|Lost to follow up|2|||
147593556|NCT00518882|532329010|FG001|Double-Blind, Week 0-26|Lost to follow up|1|||
147593557|NCT00518882|532329009|FG000|Double-Blind, Week 0-26|Subject decision|1|||
147593558|NCT00518882|532329010|FG001|Double-Blind, Week 0-26|Subject decision|1|||
147593559|NCT00518882|532329009|FG000|Double-Blind, Week 0-26|Withdrawal of consent|1|||
147593560|NCT00518882|532329010|FG001|Double-Blind, Week 0-26|Withdrawal of consent|3|||
147593561|NCT00518882|532329009|FG000|Double-Blind, Week 0-26|Loss of trust|0|||
147593562|NCT00518882|532329010|FG001|Double-Blind, Week 0-26|Loss of trust|1|||
147593563|NCT00518882|532329009|FG000|Double-Blind, Week 0-26|Fear of hypoglycaemia|0|||
147593564|NCT00518882|532329010|FG001|Double-Blind, Week 0-26|Fear of hypoglycaemia|1|||
147593565|NCT00518882|532329009|FG000|Double-Blind, Week 0-26|Hypoglycaemia|0|||
147593566|NCT00518882|532329010|FG001|Double-Blind, Week 0-26|Hypoglycaemia|2|||
147593567|NCT00518882|532329009|FG000|Double-Blind, Week 0-26|Mutual consent|0|||
147593568|NCT00518882|532329010|FG001|Double-Blind, Week 0-26|Mutual consent|1|||
147593569|NCT00518882|532329009|FG000|Open-Label Extension, Week 26-78|Adverse Event|3|||
147593570|NCT00518882|532329010|FG001|Open-Label Extension, Week 26-78|Adverse Event|9|||
147593571|NCT00518882|532329009|FG000|Open-Label Extension, Week 26-78|Lack of Efficacy|6|||
147593572|NCT00518882|532329010|FG001|Open-Label Extension, Week 26-78|Lack of Efficacy|5|||
147593573|NCT00518882|532329009|FG000|Open-Label Extension, Week 26-78|Protocol Violation|3|||
147593574|NCT00518882|532329010|FG001|Open-Label Extension, Week 26-78|Protocol Violation|4|||
147593575|NCT00518882|532329009|FG000|Open-Label Extension, Week 26-78|Withdrawel criteria|1|||
147593576|NCT00518882|532329010|FG001|Open-Label Extension, Week 26-78|Withdrawel criteria|2|||
147593577|NCT00518882|532329009|FG000|Open-Label Extension, Week 26-78|Hypoglycaemia|0|||
147593578|NCT00518882|532329010|FG001|Open-Label Extension, Week 26-78|Hypoglycaemia|1|||
147593579|NCT00518882|532329009|FG000|Open-Label Extension, Week 26-78|Lost to follow up|1|||
147593580|NCT00518882|532329010|FG001|Open-Label Extension, Week 26-78|Lost to follow up|1|||
147593581|NCT00518882|532329009|FG000|Open-Label Extension, Week 26-78|Consent withdrawn|2|||
147593582|NCT00518882|532329010|FG001|Open-Label Extension, Week 26-78|Consent withdrawn|1|||
147593583|NCT00518882|532329009|FG000|Open-Label Extension, Week 26-78|Change in treatment|1|||
147593584|NCT00518882|532329010|FG001|Open-Label Extension, Week 26-78|Change in treatment|1|||
147593585|NCT00518882|532329009|FG000|Open-Label Extension, Week 26-78|Creatine increased|1|||
147593586|NCT00518882|532329010|FG001|Open-Label Extension, Week 26-78|Creatine increased|0|||
147593587|NCT00518882|532329009|FG000|Open-Label Extension, Week 26-78|Decreased kidney function|1|||
147593588|NCT00518882|532329010|FG001|Open-Label Extension, Week 26-78|Decreased kidney function|0|||
147593589|NCT00518882|532329009|FG000|Open-Label Extension, Week 26-78|Exclusion criteria|2|||
147593590|NCT00518882|532329010|FG001|Open-Label Extension, Week 26-78|Exclusion criteria|0|||
147593591|NCT00518882|532329009|FG000|Open-Label Extension, Week 26-78|Subject decision|2|||
147593592|NCT00518882|532329010|FG001|Open-Label Extension, Week 26-78|Subject decision|0|||
147593593|NCT00518882|532329009|FG000|Open-Label Extension, Week 26-78|Completed extension 1 (weeks 26-40)|18|||
147593594|NCT00518882|532329010|FG001|Open-Label Extension, Week 26-78|Completed extension 1 (weeks 26-40)|25|||
147593595|NCT02696031|532329012|FG000|Up to Week 24|Adverse Event|2|||
147593596|NCT02696031|532329013|FG001|Up to Week 24|Adverse Event|4|||
147593597|NCT02696031|532329014|FG002|Up to Week 24|Adverse Event|2|||
147593598|NCT02696031|532329015|FG003|Up to Week 24|Adverse Event|0|||
147593599|NCT02696031|532329016|FG004|Up to Week 24|Adverse Event|0|||
147593600|NCT02696031|532329017|FG005|Up to Week 24|Adverse Event|0|||
147593601|NCT02696031|532329012|FG000|Up to Week 24|Lack of Efficacy|2|||
147593602|NCT02696031|532329013|FG001|Up to Week 24|Lack of Efficacy|1|||
147593603|NCT02696031|532329014|FG002|Up to Week 24|Lack of Efficacy|2|||
147593604|NCT02696031|532329015|FG003|Up to Week 24|Lack of Efficacy|0|||
147593605|NCT02696031|532329016|FG004|Up to Week 24|Lack of Efficacy|0|||
147593606|NCT02696031|532329017|FG005|Up to Week 24|Lack of Efficacy|0|||
147593607|NCT02696031|532329012|FG000|Up to Week 24|Lost to Follow-up|0|||
147593608|NCT02696031|532329013|FG001|Up to Week 24|Lost to Follow-up|1|||
147593609|NCT02696031|532329014|FG002|Up to Week 24|Lost to Follow-up|1|||
147593610|NCT02696031|532329015|FG003|Up to Week 24|Lost to Follow-up|0|||
147326856|NCT00828919|531361889|FG000|Overall Study|Adverse Event|2|||
147326857|NCT00828919|531361890|FG001|Overall Study|Adverse Event|2|||
147326858|NCT00828919|531361891|FG002|Overall Study|Adverse Event|2|||
147326859|NCT00828919|531361892|FG003|Overall Study|Adverse Event|1|||
147326860|NCT00828919|531361893|FG004|Overall Study|Adverse Event|3|||
147326861|NCT00828919|531361889|FG000|Overall Study|Objective progression or relapse|4|||
147326862|NCT00828919|531361890|FG001|Overall Study|Objective progression or relapse|4|||
147326863|NCT00828919|531361891|FG002|Overall Study|Objective progression or relapse|11|||
147326864|NCT00828919|531361892|FG003|Overall Study|Objective progression or relapse|0|||
147326865|NCT00828919|531361893|FG004|Overall Study|Objective progression or relapse|5|||
147326866|NCT00828919|531361889|FG000|Overall Study|No longer willing to participate in study|0|||
147326867|NCT00828919|531361890|FG001|Overall Study|No longer willing to participate in study|0|||
147326868|NCT00828919|531361891|FG002|Overall Study|No longer willing to participate in study|2|||
147326869|NCT00828919|531361892|FG003|Overall Study|No longer willing to participate in study|0|||
147326870|NCT00828919|531361893|FG004|Overall Study|No longer willing to participate in study|0|||
147326871|NCT00828919|531361889|FG000|Overall Study|Insufficient Clinical Response|0|||
147326872|NCT00828919|531361890|FG001|Overall Study|Insufficient Clinical Response|1|||
147326873|NCT00828919|531361891|FG002|Overall Study|Insufficient Clinical Response|2|||
147326874|NCT00828919|531361892|FG003|Overall Study|Insufficient Clinical Response|0|||
147326875|NCT00828919|531361893|FG004|Overall Study|Insufficient Clinical Response|0|||
147326876|NCT00828919|531361889|FG000|Overall Study|Subject refused continued treatment for reason other than adverse event|0|||
147326877|NCT00828919|531361890|FG001|Overall Study|Subject refused continued treatment for reason other than adverse event|0|||
147326878|NCT00828919|531361891|FG002|Overall Study|Subject refused continued treatment for reason other than adverse event|0|||
147326879|NCT00828919|531361892|FG003|Overall Study|Subject refused continued treatment for reason other than adverse event|0|||
147326880|NCT00828919|531361893|FG004|Overall Study|Subject refused continued treatment for reason other than adverse event|3|||
147326881|NCT00828919|531361889|FG000|Overall Study|Other|1|||
147326882|NCT00828919|531361890|FG001|Overall Study|Other|0|||
147326883|NCT00828919|531361891|FG002|Overall Study|Other|1|||
147326884|NCT00828919|531361892|FG003|Overall Study|Other|1|||
147326885|NCT00828919|531361893|FG004|Overall Study|Other|0|||
147326886|NCT00828919|531361889|FG000|Overall Study|Lost to Follow-up|0|||
147326887|NCT00828919|531361890|FG001|Overall Study|Lost to Follow-up|1|||
147326888|NCT00828919|531361891|FG002|Overall Study|Lost to Follow-up|0|||
147326889|NCT00828919|531361892|FG003|Overall Study|Lost to Follow-up|0|||
147326890|NCT00828919|531361893|FG004|Overall Study|Lost to Follow-up|0|||
147326891|NCT05567159|531361894|FG000|Overall Study|Adverse Event|4|||
147326892|NCT05567159|531361894|FG000|Overall Study|Physician Decision|3|||
147326893|NCT05567159|531361894|FG000|Overall Study|Protocol deviation|1|||
147326894|NCT04159506|531361895|FG000|Overall Study|Lost to Follow-up|2|||
147326895|NCT04159506|531361896|FG001|Overall Study|Lost to Follow-up|5|||
147326896|NCT02501811|531361897|FG000|Overall Study|Death|1|||
147326897|NCT02501811|531361898|FG001|Overall Study|Death|3|||
147593611|NCT02696031|532329016|FG004|Up to Week 24|Lost to Follow-up|0|||
147593612|NCT02696031|532329017|FG005|Up to Week 24|Lost to Follow-up|0|||
147593613|NCT02696031|532329012|FG000|Up to Week 24|Physician Decision|1|||
147593614|NCT02696031|532329013|FG001|Up to Week 24|Physician Decision|0|||
147593615|NCT02696031|532329014|FG002|Up to Week 24|Physician Decision|1|||
147593616|NCT02696031|532329015|FG003|Up to Week 24|Physician Decision|0|||
147593617|NCT02696031|532329016|FG004|Up to Week 24|Physician Decision|0|||
147593618|NCT02696031|532329017|FG005|Up to Week 24|Physician Decision|0|||
147593619|NCT02696031|532329012|FG000|Up to Week 24|Protocol Violation|1|||
147593620|NCT02696031|532329013|FG001|Up to Week 24|Protocol Violation|0|||
147593621|NCT02696031|532329014|FG002|Up to Week 24|Protocol Violation|0|||
147593622|NCT02696031|532329015|FG003|Up to Week 24|Protocol Violation|0|||
147593623|NCT02696031|532329016|FG004|Up to Week 24|Protocol Violation|0|||
147593624|NCT02696031|532329017|FG005|Up to Week 24|Protocol Violation|0|||
147593625|NCT02696031|532329012|FG000|Up to Week 24|Withdrawal by Subject|4|||
147593626|NCT02696031|532329013|FG001|Up to Week 24|Withdrawal by Subject|1|||
147593627|NCT02696031|532329014|FG002|Up to Week 24|Withdrawal by Subject|5|||
147593628|NCT02696031|532329015|FG003|Up to Week 24|Withdrawal by Subject|0|||
147593629|NCT02696031|532329016|FG004|Up to Week 24|Withdrawal by Subject|0|||
147593630|NCT02696031|532329017|FG005|Up to Week 24|Withdrawal by Subject|0|||
147593631|NCT02696031|532329012|FG000|Up to Week 52|Adverse Event|4|||
147593632|NCT02696031|532329013|FG001|Up to Week 52|Adverse Event|5|||
147593633|NCT02696031|532329014|FG002|Up to Week 52|Adverse Event|3|||
147326898|NCT02501811|531361899|FG002|Overall Study|Death|2|||
147326899|NCT02501811|531361900|FG003|Overall Study|Death|3|||
147326900|NCT02501811|531361897|FG000|Overall Study|Withdrawal by Subject|3|||
147326901|NCT02501811|531361898|FG001|Overall Study|Withdrawal by Subject|3|||
147593634|NCT02696031|532329015|FG003|Up to Week 52|Adverse Event|0|||
147593635|NCT02696031|532329016|FG004|Up to Week 52|Adverse Event|0|||
147593636|NCT02696031|532329017|FG005|Up to Week 52|Adverse Event|0|||
147326902|NCT02501811|531361899|FG002|Overall Study|Withdrawal by Subject|2|||
147326903|NCT02501811|531361900|FG003|Overall Study|Withdrawal by Subject|3|||
147326904|NCT02501811|531361897|FG000|Overall Study|Lost to Follow-up|0|||
147593637|NCT02696031|532329012|FG000|Up to Week 52|Lack of Efficacy|10|||
147657150|NCT02557516|532566671|FG003|Overall Study|Sponsor decision|8|||
147657151|NCT01243177|532566672|FG000|Overall Study|Lack of Efficacy|47|||
147657152|NCT01243177|532566673|FG001|Overall Study|Lack of Efficacy|31|||
147657153|NCT01243177|532566672|FG000|Overall Study|Protocol Violation|11|||
147657154|NCT01243177|532566673|FG001|Overall Study|Protocol Violation|10|||
147657155|NCT01243177|532566672|FG000|Overall Study|Lost to Follow-up|15|||
147657156|NCT01243177|532566673|FG001|Overall Study|Lost to Follow-up|18|||
147657157|NCT01243177|532566672|FG000|Overall Study|Withdrawal by Subject|46|||
147657158|NCT01243177|532566673|FG001|Overall Study|Withdrawal by Subject|38|||
147657159|NCT01243177|532566672|FG000|Overall Study|AE, serious fatal|0|||
147657160|NCT01243177|532566673|FG001|Overall Study|AE, serious fatal|1|||
147657161|NCT01243177|532566672|FG000|Overall Study|SAE, non-fatal|7|||
147657162|NCT01243177|532566673|FG001|Overall Study|SAE, non-fatal|9|||
147657163|NCT01243177|532566672|FG000|Overall Study|AE, non-serious non-fatal|40|||
147657164|NCT01243177|532566673|FG001|Overall Study|AE, non-serious non-fatal|58|||
147657165|NCT01243177|532566672|FG000|Overall Study|SAE, fatal + SAE, non-fatal|1|||
147657166|NCT01243177|532566673|FG001|Overall Study|SAE, fatal + SAE, non-fatal|0|||
147657167|NCT01243177|532566672|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
147657168|NCT01243177|532566673|FG001|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|1|||
147657169|NCT01243177|532566672|FG000|Overall Study|Other Reason|11|||
147657170|NCT01243177|532566673|FG001|Overall Study|Other Reason|12|||
147657171|NCT00669318|532568509|FG000|Overall Study|Withdrawal by Subject|2|||
147657172|NCT01239394|532568515|FG000|Overall Study|Adverse Event|1|||
147657173|NCT00524771|532568517|FG000|Overall Study|Protocol Violation|220|||
147657174|NCT00524771|532568518|FG001|Overall Study|Protocol Violation|585|||
147657175|NCT03743025|532568521|FG000|Overall Study|Surgery was cancelled|2|||
147657176|NCT03743025|532568522|FG001|Overall Study|Surgery was cancelled|1|||
147657177|NCT00791700|532568525|FG000|Overall Study|Insufficient clinical response|1|||
147657178|NCT00791700|532568526|FG001|Overall Study|Insufficient clinical response|4|||
147657179|NCT00791700|532568527|FG002|Overall Study|Insufficient clinical response|1|||
147657180|NCT00791700|532568528|FG003|Overall Study|Insufficient clinical response|8|||
147657181|NCT00791700|532568525|FG000|Overall Study|No longer willing to participate|1|||
147657182|NCT00791700|532568526|FG001|Overall Study|No longer willing to participate|1|||
147657183|NCT00791700|532568527|FG002|Overall Study|No longer willing to participate|0|||
147657184|NCT00791700|532568528|FG003|Overall Study|No longer willing to participate|8|||
147657185|NCT00791700|532568525|FG000|Overall Study|Non-compliance with study treatment|0|||
147657186|NCT00791700|532568526|FG001|Overall Study|Non-compliance with study treatment|2|||
147657187|NCT00791700|532568527|FG002|Overall Study|Non-compliance with study treatment|0|||
147657188|NCT00791700|532568528|FG003|Overall Study|Non-compliance with study treatment|4|||
147657189|NCT00791700|532568525|FG000|Overall Study|Withdrawn due to pregnancy|0|||
147657190|NCT00791700|532568526|FG001|Overall Study|Withdrawn due to pregnancy|0|||
147657191|NCT00791700|532568527|FG002|Overall Study|Withdrawn due to pregnancy|0|||
147657192|NCT00791700|532568528|FG003|Overall Study|Withdrawn due to pregnancy|1|||
147657193|NCT00791700|532568525|FG000|Overall Study|Other|0|||
147657194|NCT00791700|532568526|FG001|Overall Study|Other|1|||
147657195|NCT00791700|532568527|FG002|Overall Study|Other|0|||
147657196|NCT00791700|532568528|FG003|Overall Study|Other|1|||
147657197|NCT00791700|532568525|FG000|Overall Study|Death|0|||
147657198|NCT00791700|532568526|FG001|Overall Study|Death|0|||
147657199|NCT00791700|532568527|FG002|Overall Study|Death|0|||
147657200|NCT00791700|532568528|FG003|Overall Study|Death|1|||
147657201|NCT00791700|532568525|FG000|Overall Study|Lost to Follow-up|4|||
147657202|NCT00791700|532568526|FG001|Overall Study|Lost to Follow-up|3|||
147657203|NCT00791700|532568527|FG002|Overall Study|Lost to Follow-up|4|||
147657204|NCT00791700|532568528|FG003|Overall Study|Lost to Follow-up|6|||
147657205|NCT00791700|532568525|FG000|Overall Study|Adverse Event|0|||
147657206|NCT00791700|532568526|FG001|Overall Study|Adverse Event|0|||
147657207|NCT00791700|532568527|FG002|Overall Study|Adverse Event|1|||
147657208|NCT00791700|532568528|FG003|Overall Study|Adverse Event|1|||
147657209|NCT00996034|532568531|FG000|Overall Study|Lost to Follow-up|2|||
147326905|NCT02501811|531361898|FG001|Overall Study|Lost to Follow-up|0|||
147657210|NCT00996034|532568531|FG000|Overall Study|withdrawn by PI|1|||
147657211|NCT01720524|532568532|FG000|Part A|Insufficient Clinical Response|2|||
147657212|NCT01720524|532568533|FG001|Part A|Insufficient Clinical Response|4|||
147657213|NCT01720524|532568532|FG000|Part A|Adverse Event|2|||
147657214|NCT01720524|532568533|FG001|Part A|Adverse Event|2|||
147326906|NCT02501811|531361899|FG002|Overall Study|Lost to Follow-up|2|||
147657215|NCT01720524|532568532|FG000|Part A|Death|2|||
147657216|NCT01720524|532568533|FG001|Part A|Death|1|||
147657217|NCT01720524|532568532|FG000|Part A|Lost to Follow-up|0|||
147657218|NCT01720524|532568533|FG001|Part A|Lost to Follow-up|1|||
147657219|NCT01720524|532568532|FG000|Part A|Missed 28 day follow-up visit|1|||
147657220|NCT01720524|532568533|FG001|Part A|Missed 28 day follow-up visit|1|||
147657221|NCT01720524|532568532|FG000|Part A|Withdrawal by Subject|0|||
147657222|NCT01720524|532568533|FG001|Part A|Withdrawal by Subject|1|||
147657223|NCT01720524|532568532|FG000|Part A|Other|0|||
147657224|NCT01720524|532568533|FG001|Part A|Other|1|||
147326907|NCT02501811|531361900|FG003|Overall Study|Lost to Follow-up|1|||
147657225|NCT01720524|532568532|FG000|Part A|Lost to Follow-up|0|||
147657226|NCT01720524|532568533|FG001|Part A|Lost to Follow-up|1|||
147657227|NCT01720524|532568532|FG000|Part B|No longer willing to participate in study|1|||
147657228|NCT01720524|532568533|FG001|Part B|No longer willing to participate in study|4|||
147657229|NCT01720524|532568532|FG000|Part B|Other|2|||
147657230|NCT01720524|532568533|FG001|Part B|Other|0|||
147657231|NCT01720524|532568532|FG000|Part B|Lost to Follow-up|2|||
147657232|NCT01720524|532568533|FG001|Part B|Lost to Follow-up|3|||
147326908|NCT00662909|531361901|FG000|Overall Study|Adverse Event|17|||
147326909|NCT00662909|531361902|FG001|Overall Study|Adverse Event|18|||
147326910|NCT00662909|531361903|FG002|Overall Study|Adverse Event|19|||
147326911|NCT00662909|531361901|FG000|Overall Study|Lack of Efficacy|9|||
147326912|NCT00662909|531361902|FG001|Overall Study|Lack of Efficacy|1|||
147326913|NCT00662909|531361903|FG002|Overall Study|Lack of Efficacy|5|||
147326914|NCT00662909|531361901|FG000|Overall Study|Withdrawal by Subject|29|||
147326915|NCT00662909|531361902|FG001|Overall Study|Withdrawal by Subject|22|||
147326916|NCT00662909|531361903|FG002|Overall Study|Withdrawal by Subject|16|||
147326917|NCT00662909|531361901|FG000|Overall Study|Lost to Follow-up|2|||
147326918|NCT00662909|531361902|FG001|Overall Study|Lost to Follow-up|9|||
147326919|NCT00662909|531361903|FG002|Overall Study|Lost to Follow-up|3|||
147326920|NCT00662909|531361901|FG000|Overall Study|Protocol Violation|7|||
147326921|NCT00662909|531361902|FG001|Overall Study|Protocol Violation|4|||
147326922|NCT00662909|531361903|FG002|Overall Study|Protocol Violation|5|||
147326923|NCT00662909|531361901|FG000|Overall Study|Randomized- never received study drug|1|||
147326924|NCT00662909|531361902|FG001|Overall Study|Randomized- never received study drug|0|||
147326925|NCT00662909|531361903|FG002|Overall Study|Randomized- never received study drug|0|||
147326926|NCT00662909|531361901|FG000|Overall Study|Non-compliance with study procedures|3|||
147326927|NCT00662909|531361902|FG001|Overall Study|Non-compliance with study procedures|3|||
147326928|NCT00662909|531361903|FG002|Overall Study|Non-compliance with study procedures|2|||
147326929|NCT00662909|531361901|FG000|Overall Study|Physician Decision|1|||
147326930|NCT00662909|531361902|FG001|Overall Study|Physician Decision|1|||
147326931|NCT00662909|531361903|FG002|Overall Study|Physician Decision|2|||
147326932|NCT00662909|531361901|FG000|Overall Study|Eligibility criterion not met|0|||
147326933|NCT00662909|531361902|FG001|Overall Study|Eligibility criterion not met|1|||
147326934|NCT00662909|531361903|FG002|Overall Study|Eligibility criterion not met|1|||
147326935|NCT01311648|531363812|FG000|Main Study|Protocol Violation|0|||
147326936|NCT01311648|531363813|FG001|Main Study|Protocol Violation|1|||
147326937|NCT01311648|531363812|FG000|Main Study|Adverse Event|0|||
147326938|NCT01311648|531363813|FG001|Main Study|Adverse Event|1|||
147326939|NCT01311648|531363812|FG000|Main Study|Inhibitor management|0|||
147326940|NCT01311648|531363813|FG001|Main Study|Inhibitor management|17|||
147326941|NCT01311648|531363812|FG000|Main Study|Withdrawal by Subject|0|||
147326942|NCT01311648|531363813|FG001|Main Study|Withdrawal by Subject|2|||
147326943|NCT01311648|531363812|FG000|Extension Study|Physician Decision|0|||
147326944|NCT01311648|531363813|FG001|Extension Study|Physician Decision|1|||
147326945|NCT01311648|531363812|FG000|Extension Study|ITI therapy with marketed product|0|||
147326946|NCT01311648|531363813|FG001|Extension Study|ITI therapy with marketed product|1|||
147326947|NCT01311648|531363812|FG000|Extension Study|Incorrect visit planning|0|||
147326948|NCT01311648|531363813|FG001|Extension Study|Incorrect visit planning|1|||
147326949|NCT01311648|531363812|FG000|Extension Study|Family's decision|0|||
147326950|NCT01311648|531363813|FG001|Extension Study|Family's decision|1|||
147326951|NCT01311648|531363812|FG000|Extension Study|Failure of ITI therapy|0|||
147326952|NCT01311648|531363813|FG001|Extension Study|Failure of ITI therapy|3|||
147326953|NCT01311648|531363812|FG000|Extension Study|Long travel|0|||
147326954|NCT01311648|531363813|FG001|Extension Study|Long travel|1|||
147326955|NCT01311648|531363812|FG000|Extension Study|Diagnosed with von Willebrand disease|1|||
147326956|NCT01311648|531363813|FG001|Extension Study|Diagnosed with von Willebrand disease|0|||
147326957|NCT01311648|531363812|FG000|Extension Study|Withdrawal by Subject|0|||
147326958|NCT01311648|531363813|FG001|Extension Study|Withdrawal by Subject|1|||
147657233|NCT01720524|532568532|FG000|Part B|Death|0|||
147657234|NCT01720524|532568533|FG001|Part B|Death|2|||
147181778|NCT01445080|530829174|FG001|Overall Study|Ineligible/Inevaluable|2|||
147181779|NCT01445080|530829175|FG002|Overall Study|Ineligible/Inevaluable|0|||
147181780|NCT01445080|530829176|FG003|Overall Study|Ineligible/Inevaluable|1|||
147181781|NCT01445080|530829177|FG004|Overall Study|Ineligible/Inevaluable|2|||
147181782|NCT01445080|530829178|FG005|Overall Study|Ineligible/Inevaluable|3|||
147181783|NCT01445080|530829179|FG006|Overall Study|Ineligible/Inevaluable|0|||
147181784|NCT01445080|530829180|FG007|Overall Study|Ineligible/Inevaluable|0|||
147181785|NCT01445080|530829181|FG008|Overall Study|Ineligible/Inevaluable|6|||
147181786|NCT03887221|530829182|FG000|Overall Study|Protocol Violation|1|||
147181787|NCT03887221|530829183|FG001|Overall Study|Protocol Violation|0|||
147326959|NCT01311648|531363812|FG000|Extension Study|Inhibitor management|0|||
147326960|NCT01311648|531363813|FG001|Extension Study|Inhibitor management|2|||
147326961|NCT01107626|531363816|FG000|Step 1: Induction Therapy|Lack of Efficacy|167|||
147326962|NCT01107626|531363817|FG001|Step 1: Induction Therapy|Lack of Efficacy|0|||
147326963|NCT01107626|531363818|FG002|Step 1: Induction Therapy|Lack of Efficacy|0|||
147326964|NCT01107626|531363819|FG003|Step 1: Induction Therapy|Lack of Efficacy|0|||
147657235|NCT00158262|532568537|FG000|Overall Study|Lost to Follow-up|1|||
147657236|NCT00158262|532568538|FG001|Overall Study|Lost to Follow-up|1|||
147657237|NCT00527826|532568539|FG000|Overall Study|Adverse Event|10|||
147657238|NCT00527826|532568540|FG001|Overall Study|Adverse Event|10|||
147657239|NCT00527826|532568539|FG000|Overall Study|Lost to Follow-up|3|||
147657240|NCT00527826|532568540|FG001|Overall Study|Lost to Follow-up|2|||
147657241|NCT00527826|532568539|FG000|Overall Study|Withdrawal by Subject|5|||
147657242|NCT00527826|532568540|FG001|Overall Study|Withdrawal by Subject|8|||
147657243|NCT00527826|532568539|FG000|Overall Study|Inclusion Criteria Not Met|3|||
147657244|NCT00527826|532568540|FG001|Overall Study|Inclusion Criteria Not Met|3|||
147657245|NCT00527826|532568539|FG000|Overall Study|Alpha-1 Antitrypsin Deficiency|0|||
147657246|NCT00527826|532568540|FG001|Overall Study|Alpha-1 Antitrypsin Deficiency|1|||
147657247|NCT00527826|532568539|FG000|Overall Study|Additional Intake of Viani forte|0|||
147657248|NCT00527826|532568540|FG001|Overall Study|Additional Intake of Viani forte|1|||
147657249|NCT00527826|532568539|FG000|Overall Study|Participant moved away|0|||
147657250|NCT00527826|532568540|FG001|Overall Study|Participant moved away|1|||
147657251|NCT02105285|532568543|FG000|Overall Study|Adverse Event|1|||
147657252|NCT02105285|532568544|FG001|Overall Study|Adverse Event|1|||
147657253|NCT02105285|532568545|FG002|Overall Study|Adverse Event|0|||
147657254|NCT02105285|532568543|FG000|Overall Study|Protocol Violation|0|||
147657255|NCT02105285|532568544|FG001|Overall Study|Protocol Violation|1|||
147657256|NCT02105285|532568545|FG002|Overall Study|Protocol Violation|0|||
147657257|NCT02105285|532568543|FG000|Overall Study|Withdrawal by Subject|1|||
147657258|NCT02105285|532568544|FG001|Overall Study|Withdrawal by Subject|0|||
147657259|NCT02105285|532568545|FG002|Overall Study|Withdrawal by Subject|0|||
147657260|NCT01421641|532568546|FG000|Overall Study|Protocol Violation|2|||
147657261|NCT01421641|532568547|FG001|Overall Study|Protocol Violation|2|||
147657262|NCT02420119|532568549|FG000|Overall Study|insufficient laboratory data|5|||
147657263|NCT02364388|532568550|FG000|Overall Study|Protocol Violation|1|||
147657264|NCT02364388|532568550|FG000|Overall Study|Technical Failure|3|||
147657265|NCT02364388|532568550|FG000|Overall Study|No OA/US data|2|||
147657266|NCT02364388|532568550|FG000|Overall Study|No Biopsy|2|||
147657267|NCT03231306|532568551|FG000|Overall Study|<15% reduction in target tumor volume from baseline after Course 8 of therapy|3|||
147657268|NCT03231306|532568551|FG000|Overall Study|<20% reduction in target tumor volume from baseline after Course 12 of therapy|4|||
147657269|NCT03231306|532568551|FG000|Overall Study|Treatment delay > 21 days|2|||
147657270|NCT03231306|532568551|FG000|Overall Study|Refusal of further protocol therapy by subject/parent/guardian|6|||
147657271|NCT03231306|532568551|FG000|Overall Study|Non-compliance that in the opinion of the investigator does not allow for ongoing participation|5|||
147657272|NCT03231306|532568551|FG000|Overall Study|Binimetinib-related toxicity requiring removal from protocol therapy|3|||
147657273|NCT03231306|532568551|FG000|Overall Study|Subject Relocation Due to Covid Restrictions|1|||
147657274|NCT03231306|532568551|FG000|Overall Study|More than 1 Reason|2|||
147657275|NCT01808261|532568552|FG000|Overall Study|Physician Decision|0|||
147657276|NCT01808261|532568553|FG001|Overall Study|Physician Decision|2|||
147657277|NCT01808261|532568552|FG000|Overall Study|Study Closed/Terminated|25|||
147657278|NCT01808261|532568553|FG001|Overall Study|Study Closed/Terminated|23|||
147657279|NCT01808261|532568552|FG000|Overall Study|Adverse event, non-fatal|2|||
147657280|NCT01808261|532568553|FG001|Overall Study|Adverse event, non-fatal|0|||
147657281|NCT01808261|532568552|FG000|Overall Study|Consent withdrawn by subject|6|||
147657282|NCT01808261|532568553|FG001|Overall Study|Consent withdrawn by subject|7|||
147657283|NCT01808261|532568552|FG000|Overall Study|Lost to Follow-up|3|||
147657284|NCT01808261|532568553|FG001|Overall Study|Lost to Follow-up|1|||
147657285|NCT04501952|532568556|FG000|Overall Study|Adverse Event|0|||
147657286|NCT04501952|532568557|FG001|Overall Study|Adverse Event|3|||
147657287|NCT04501952|532568556|FG000|Overall Study|Investigator's Discretion|0|||
147657288|NCT04501952|532568557|FG001|Overall Study|Investigator's Discretion|1|||
147657289|NCT04501952|532568556|FG000|Overall Study|Protocol Violation|1|||
147657290|NCT04501952|532568557|FG001|Overall Study|Protocol Violation|1|||
147657291|NCT04501952|532568556|FG000|Overall Study|Withdrew Consent|5|||
147657292|NCT04501952|532568557|FG001|Overall Study|Withdrew Consent|4|||
147246239|NCT00420927|531072739|FG005|Period 1|Study site closure|0|||
147246240|NCT00420927|531072740|FG006|Period 1|Study site closure|0|||
147246241|NCT00420927|531072734|FG000|Period 1|Subject received new diagnosis|0|||
147246242|NCT00420927|531072735|FG001|Period 1|Subject received new diagnosis|2|||
147246243|NCT00420927|531072736|FG002|Period 1|Subject received new diagnosis|0|||
147246244|NCT00420927|531072737|FG003|Period 1|Subject received new diagnosis|0|||
147246245|NCT00420927|531072738|FG004|Period 1|Subject received new diagnosis|0|||
147246246|NCT00420927|531072739|FG005|Period 1|Subject received new diagnosis|0|||
147246247|NCT00420927|531072740|FG006|Period 1|Subject received new diagnosis|0|||
147246248|NCT00420927|531072734|FG000|Period 1|Received wrong treatment/incorrect dose|0|||
147246249|NCT00420927|531072735|FG001|Period 1|Received wrong treatment/incorrect dose|1|||
147246250|NCT00420927|531072736|FG002|Period 1|Received wrong treatment/incorrect dose|0|||
147246251|NCT00420927|531072737|FG003|Period 1|Received wrong treatment/incorrect dose|0|||
147246252|NCT00420927|531072738|FG004|Period 1|Received wrong treatment/incorrect dose|0|||
147657293|NCT04501952|532568556|FG000|Overall Study|Lost to Follow-up|7|||
147657294|NCT04501952|532568557|FG001|Overall Study|Lost to Follow-up|2|||
147657295|NCT04501952|532568556|FG000|Overall Study|Randomized and Never Treated|13|||
147246253|NCT00420927|531072739|FG005|Period 1|Received wrong treatment/incorrect dose|0|||
147246254|NCT00420927|531072740|FG006|Period 1|Received wrong treatment/incorrect dose|0|||
147246255|NCT00420927|531072734|FG000|Period 1|Failed to meet entry criteria|8|||
147246256|NCT00420927|531072735|FG001|Period 1|Failed to meet entry criteria|7|||
147246257|NCT00420927|531072736|FG002|Period 1|Failed to meet entry criteria|0|||
147246258|NCT00420927|531072737|FG003|Period 1|Failed to meet entry criteria|0|||
147246259|NCT00420927|531072738|FG004|Period 1|Failed to meet entry criteria|0|||
147246260|NCT00420927|531072739|FG005|Period 1|Failed to meet entry criteria|0|||
147246261|NCT00420927|531072740|FG006|Period 1|Failed to meet entry criteria|0|||
147246262|NCT00420927|531072734|FG000|Period 1|Took prohibited medication|1|||
147246263|NCT00420927|531072735|FG001|Period 1|Took prohibited medication|3|||
147246264|NCT00420927|531072736|FG002|Period 1|Took prohibited medication|0|||
147246265|NCT00420927|531072737|FG003|Period 1|Took prohibited medication|0|||
147246266|NCT00420927|531072738|FG004|Period 1|Took prohibited medication|0|||
147246267|NCT00420927|531072739|FG005|Period 1|Took prohibited medication|0|||
147246268|NCT00420927|531072740|FG006|Period 1|Took prohibited medication|0|||
147246269|NCT00420927|531072734|FG000|Period 2|Adverse Event|0|||
147246270|NCT00420927|531072735|FG001|Period 2|Adverse Event|0|||
147246271|NCT00420927|531072736|FG002|Period 2|Adverse Event|7|||
147246272|NCT00420927|531072737|FG003|Period 2|Adverse Event|3|||
147246273|NCT00420927|531072738|FG004|Period 2|Adverse Event|17|||
147246274|NCT00420927|531072739|FG005|Period 2|Adverse Event|6|||
147246275|NCT00420927|531072740|FG006|Period 2|Adverse Event|20|||
147246276|NCT00420927|531072734|FG000|Period 2|Withdrawal by Subject|0|||
147246277|NCT00420927|531072735|FG001|Period 2|Withdrawal by Subject|0|||
147246278|NCT00420927|531072736|FG002|Period 2|Withdrawal by Subject|1|||
147246279|NCT00420927|531072737|FG003|Period 2|Withdrawal by Subject|3|||
147246280|NCT00420927|531072738|FG004|Period 2|Withdrawal by Subject|11|||
147246281|NCT00420927|531072739|FG005|Period 2|Withdrawal by Subject|2|||
147246282|NCT00420927|531072740|FG006|Period 2|Withdrawal by Subject|12|||
147246283|NCT00420927|531072734|FG000|Period 2|Lost to Follow-up|0|||
147246284|NCT00420927|531072735|FG001|Period 2|Lost to Follow-up|0|||
147246285|NCT00420927|531072736|FG002|Period 2|Lost to Follow-up|2|||
147246286|NCT00420927|531072737|FG003|Period 2|Lost to Follow-up|2|||
147246287|NCT00420927|531072738|FG004|Period 2|Lost to Follow-up|6|||
147246288|NCT00420927|531072739|FG005|Period 2|Lost to Follow-up|3|||
147246289|NCT00420927|531072740|FG006|Period 2|Lost to Follow-up|9|||
147246290|NCT00420927|531072734|FG000|Period 2|Lack of efficacy/Loss of efficacy|0|||
147246291|NCT00420927|531072735|FG001|Period 2|Lack of efficacy/Loss of efficacy|0|||
147246292|NCT00420927|531072736|FG002|Period 2|Lack of efficacy/Loss of efficacy|2|||
147246293|NCT00420927|531072737|FG003|Period 2|Lack of efficacy/Loss of efficacy|1|||
147246294|NCT00420927|531072738|FG004|Period 2|Lack of efficacy/Loss of efficacy|6|||
147246295|NCT00420927|531072739|FG005|Period 2|Lack of efficacy/Loss of efficacy|2|||
147246296|NCT00420927|531072740|FG006|Period 2|Lack of efficacy/Loss of efficacy|6|||
147246297|NCT00420927|531072734|FG000|Period 2|Received wrong treatment/incorrect dose|0|||
147246298|NCT00420927|531072735|FG001|Period 2|Received wrong treatment/incorrect dose|0|||
147246299|NCT00420927|531072736|FG002|Period 2|Received wrong treatment/incorrect dose|0|||
147246300|NCT00420927|531072737|FG003|Period 2|Received wrong treatment/incorrect dose|0|||
147246301|NCT00420927|531072738|FG004|Period 2|Received wrong treatment/incorrect dose|0|||
147181788|NCT00947115|530829184|FG000|Overall Study|Missed reporting interval|3|||
147181789|NCT00947115|530829185|FG001|Overall Study|Missed reporting interval|4|||
147181790|NCT00947115|530829186|FG002|Overall Study|Missed reporting interval|2|||
147181791|NCT00947115|530829184|FG000|Overall Study|Physician Decision|0|||
147181792|NCT00947115|530829185|FG001|Overall Study|Physician Decision|2|||
147181793|NCT00947115|530829186|FG002|Overall Study|Physician Decision|0|||
147246302|NCT00420927|531072739|FG005|Period 2|Received wrong treatment/incorrect dose|0|||
147246303|NCT00420927|531072740|FG006|Period 2|Received wrong treatment/incorrect dose|1|||
147246304|NCT00420927|531072734|FG000|Period 2|Subject unable to find transportation|0|||
147181794|NCT00947115|530829184|FG000|Overall Study|Death|0|||
147181795|NCT00947115|530829185|FG001|Overall Study|Death|1|||
147181796|NCT00947115|530829186|FG002|Overall Study|Death|1|||
147181797|NCT00947115|530829184|FG000|Overall Study|Migrated from study area|2|||
147181798|NCT00947115|530829185|FG001|Overall Study|Migrated from study area|0|||
147181799|NCT00947115|530829186|FG002|Overall Study|Migrated from study area|0|||
147181800|NCT00947115|530829184|FG000|Overall Study|Withdrawal by Subject|1|||
147181801|NCT00947115|530829185|FG001|Overall Study|Withdrawal by Subject|3|||
147181802|NCT00947115|530829186|FG002|Overall Study|Withdrawal by Subject|4|||
147181803|NCT00947115|530829184|FG000|Overall Study|Lost to Follow-up|11|||
147181804|NCT00947115|530829185|FG001|Overall Study|Lost to Follow-up|12|||
147326965|NCT01107626|531363816|FG000|Step 1: Induction Therapy|Adverse Event|198|||
147246305|NCT00420927|531072735|FG001|Period 2|Subject unable to find transportation|0|||
147246306|NCT00420927|531072736|FG002|Period 2|Subject unable to find transportation|0|||
147246307|NCT00420927|531072737|FG003|Period 2|Subject unable to find transportation|0|||
147246308|NCT00420927|531072738|FG004|Period 2|Subject unable to find transportation|0|||
147326966|NCT01107626|531363817|FG001|Step 1: Induction Therapy|Adverse Event|0|||
147181805|NCT00947115|530829186|FG002|Overall Study|Lost to Follow-up|8|||
147181806|NCT02487030|530829187|FG000|Overall Study|Lack of Efficacy|2|||
147246309|NCT00420927|531072739|FG005|Period 2|Subject unable to find transportation|0|||
147246310|NCT00420927|531072740|FG006|Period 2|Subject unable to find transportation|1|||
147181807|NCT02487030|530829188|FG001|Overall Study|Lack of Efficacy|4|||
147181808|NCT02487030|530829189|FG002|Overall Study|Lack of Efficacy|1|||
147181809|NCT02487030|530829190|FG003|Overall Study|Lack of Efficacy|0|||
147181810|NCT02487030|530829191|FG004|Overall Study|Lack of Efficacy|1|||
147181811|NCT02487030|530829192|FG005|Overall Study|Lack of Efficacy|0|||
147181812|NCT02487030|530829193|FG006|Overall Study|Lack of Efficacy|0|||
147181813|NCT02487030|530829187|FG000|Overall Study|Lost to Follow-up|0|||
147181814|NCT02487030|530829188|FG001|Overall Study|Lost to Follow-up|0|||
147181815|NCT02487030|530829189|FG002|Overall Study|Lost to Follow-up|1|||
147181816|NCT02487030|530829190|FG003|Overall Study|Lost to Follow-up|1|||
147181817|NCT02487030|530829191|FG004|Overall Study|Lost to Follow-up|0|||
147181818|NCT02487030|530829192|FG005|Overall Study|Lost to Follow-up|1|||
147181819|NCT02487030|530829193|FG006|Overall Study|Lost to Follow-up|0|||
147181820|NCT02487030|530829187|FG000|Overall Study|Adverse Event|0|||
147181821|NCT02487030|530829188|FG001|Overall Study|Adverse Event|0|||
147181822|NCT02487030|530829189|FG002|Overall Study|Adverse Event|0|||
147246311|NCT00420927|531072734|FG000|Period 2|Physician Decision|0|||
147246312|NCT00420927|531072735|FG001|Period 2|Physician Decision|0|||
147246313|NCT00420927|531072736|FG002|Period 2|Physician Decision|0|||
147246314|NCT00420927|531072737|FG003|Period 2|Physician Decision|0|||
147246315|NCT00420927|531072738|FG004|Period 2|Physician Decision|1|||
147246316|NCT00420927|531072739|FG005|Period 2|Physician Decision|1|||
147246317|NCT00420927|531072740|FG006|Period 2|Physician Decision|0|||
147246318|NCT00420927|531072734|FG000|Period 2|Sponsor decision|0|||
147246319|NCT00420927|531072735|FG001|Period 2|Sponsor decision|0|||
147246320|NCT00420927|531072736|FG002|Period 2|Sponsor decision|1|||
147246321|NCT00420927|531072737|FG003|Period 2|Sponsor decision|0|||
147246322|NCT00420927|531072738|FG004|Period 2|Sponsor decision|0|||
147246323|NCT00420927|531072739|FG005|Period 2|Sponsor decision|0|||
147246324|NCT00420927|531072740|FG006|Period 2|Sponsor decision|1|||
147181823|NCT02487030|530829190|FG003|Overall Study|Adverse Event|1|||
147181824|NCT02487030|530829191|FG004|Overall Study|Adverse Event|0|||
147181825|NCT02487030|530829192|FG005|Overall Study|Adverse Event|0|||
147181826|NCT02487030|530829193|FG006|Overall Study|Adverse Event|0|||
147181827|NCT02487030|530829187|FG000|Overall Study|Death|0|||
147181828|NCT02487030|530829188|FG001|Overall Study|Death|0|||
147181829|NCT02487030|530829189|FG002|Overall Study|Death|0|||
147181830|NCT02487030|530829190|FG003|Overall Study|Death|0|||
147181831|NCT02487030|530829191|FG004|Overall Study|Death|1|||
147181832|NCT02487030|530829192|FG005|Overall Study|Death|0|||
147181833|NCT02487030|530829193|FG006|Overall Study|Death|0|||
147181834|NCT03857542|530829194|FG000|Overall Study|Adverse Event|1|||
147181835|NCT03857542|530829195|FG001|Overall Study|Adverse Event|3|||
147181836|NCT03857542|530829194|FG000|Overall Study|Withdrawal by Subject|2|||
147181837|NCT03857542|530829195|FG001|Overall Study|Withdrawal by Subject|1|||
147181838|NCT03857542|530829194|FG000|Overall Study|Lost to Follow-up|2|||
147181839|NCT03857542|530829195|FG001|Overall Study|Lost to Follow-up|1|||
147181840|NCT03857542|530829194|FG000|Overall Study|Reason not Specified|1|||
147181841|NCT03857542|530829195|FG001|Overall Study|Reason not Specified|0|||
147181842|NCT01594931|530831116|FG000|Overall Study|Adverse Event|3|||
147181843|NCT01594931|530831117|FG001|Overall Study|Adverse Event|1|||
147181844|NCT01594931|530831118|FG002|Overall Study|Adverse Event|1|||
147181845|NCT01594931|530831116|FG000|Overall Study|Withdrawal by Subject|2|||
147181846|NCT01594931|530831117|FG001|Overall Study|Withdrawal by Subject|1|||
147181847|NCT01594931|530831118|FG002|Overall Study|Withdrawal by Subject|1|||
147181848|NCT01594931|530831116|FG000|Overall Study|Lack of Efficacy|7|||
147181849|NCT01594931|530831117|FG001|Overall Study|Lack of Efficacy|2|||
147181850|NCT01594931|530831118|FG002|Overall Study|Lack of Efficacy|2|||
147246325|NCT00420927|531072734|FG000|Period 2|Randomization error|0|||
147246326|NCT00420927|531072735|FG001|Period 2|Randomization error|0|||
147246327|NCT00420927|531072736|FG002|Period 2|Randomization error|0|||
147246328|NCT00420927|531072737|FG003|Period 2|Randomization error|0|||
147181851|NCT01594931|530831116|FG000|Overall Study|Lost to Follow-up|4|||
147181852|NCT01594931|530831117|FG001|Overall Study|Lost to Follow-up|3|||
147181853|NCT01594931|530831118|FG002|Overall Study|Lost to Follow-up|3|||
147181854|NCT01594931|530831116|FG000|Overall Study|Protocol Violation|2|||
147181855|NCT01594931|530831117|FG001|Overall Study|Protocol Violation|1|||
147181856|NCT01594931|530831118|FG002|Overall Study|Protocol Violation|0|||
147181857|NCT01594931|530831116|FG000|Overall Study|No defiined|11|||
147246329|NCT00420927|531072738|FG004|Period 2|Randomization error|1|||
147246330|NCT00420927|531072739|FG005|Period 2|Randomization error|1|||
147246331|NCT00420927|531072740|FG006|Period 2|Randomization error|0|||
147246332|NCT00420927|531072734|FG000|Period 2|Noncompliant with study drug|0|||
147246333|NCT00420927|531072735|FG001|Period 2|Noncompliant with study drug|0|||
147448479|NCT00761514|531805737|FG000|Overall Study|Adverse Event|1|||
147181858|NCT01594931|530831117|FG001|Overall Study|No defiined|4|||
147181859|NCT01594931|530831118|FG002|Overall Study|No defiined|7|||
147181860|NCT04864639|530831120|FG000|Overall Study|Death|1|||
147246334|NCT00420927|531072736|FG002|Period 2|Noncompliant with study drug|0|||
147593638|NCT02696031|532329013|FG001|Up to Week 52|Lack of Efficacy|7|||
147181861|NCT04864639|530831120|FG000|Overall Study|Lost to Follow-up|1|||
147181862|NCT01478971|530831127|FG000|Standard of Care Period|Adverse Event|1|||
147181863|NCT01478971|530831127|FG000|Standard of Care Period|Withdrawal by Subject|3|||
147181864|NCT01478971|530831127|FG000|Standard of Care Period|Death|8|||
147181865|NCT01478971|530831127|FG000|Standard of Care Period|Lost to Follow-up|9|||
147181866|NCT01478971|530831127|FG000|Standard of Care Period|Other|4|||
147181867|NCT01478971|530831127|FG000|Peginesatide Treatment Period|Adverse Event|1|||
147181868|NCT01478971|530831127|FG000|Peginesatide Treatment Period|Withdrawal by Subject|1|||
147181869|NCT01478971|530831127|FG000|Peginesatide Treatment Period|Death|4|||
147181870|NCT01478971|530831127|FG000|Peginesatide Treatment Period|Lost to Follow-up|4|||
147181871|NCT01478971|530831127|FG000|Peginesatide Treatment Period|Other|4|||
147181872|NCT01525615|530831128|FG000|Overall Study|Adverse Event|11|||
147181873|NCT01525615|530831129|FG001|Overall Study|Adverse Event|7|||
147181874|NCT01525615|530831130|FG002|Overall Study|Adverse Event|5|||
147181875|NCT01525615|530831128|FG000|Overall Study|Lost to Follow-up|1|||
147181876|NCT01525615|530831129|FG001|Overall Study|Lost to Follow-up|0|||
147181877|NCT01525615|530831130|FG002|Overall Study|Lost to Follow-up|0|||
147181878|NCT01525615|530831128|FG000|Overall Study|Withdrawal by Subject|1|||
147181879|NCT01525615|530831129|FG001|Overall Study|Withdrawal by Subject|0|||
147181880|NCT01525615|530831130|FG002|Overall Study|Withdrawal by Subject|0|||
147181881|NCT01525615|530831128|FG000|Overall Study|Other reason not described above|1|||
147181882|NCT01525615|530831129|FG001|Overall Study|Other reason not described above|0|||
147181883|NCT01525615|530831130|FG002|Overall Study|Other reason not described above|1|||
147181884|NCT04050618|530831131|FG000|First Intervention|Withdrawal by Subject|2|||
147181885|NCT04050618|530831132|FG001|First Intervention|Withdrawal by Subject|0|||
147181886|NCT04050618|530831131|FG000|Second Intervention|Withdrawal by Subject|1|||
147181887|NCT04050618|530831132|FG001|Second Intervention|Withdrawal by Subject|0|||
147181888|NCT02451943|530831142|FG000|Overall Study|Withdrawal by Subject|13|||
147181889|NCT02451943|530831143|FG001|Overall Study|Withdrawal by Subject|16|||
147181890|NCT02451943|530831142|FG000|Overall Study|Lost to Follow-up|3|||
147181891|NCT02451943|530831143|FG001|Overall Study|Lost to Follow-up|4|||
147181892|NCT02451943|530831142|FG000|Overall Study|Sponsor Decision|0|||
147181893|NCT02451943|530831143|FG001|Overall Study|Sponsor Decision|4|||
147181894|NCT00217425|530831146|FG000|Overall Study|Never started treatment|2|||
147181895|NCT00217425|530831146|FG000|Overall Study|Patient ineligible|5|||
147181896|NCT00217425|530831146|FG000|Overall Study|Lack of Efficacy|13|||
147181897|NCT00217425|530831146|FG000|Overall Study|Adverse Event|8|||
147181898|NCT00217425|530831146|FG000|Overall Study|Withdrawal by Subject|4|||
147181899|NCT00217425|530831146|FG000|Overall Study|Other complicating disease|1|||
147181900|NCT00217425|530831146|FG000|Overall Study|Other|4|||
147181901|NCT03951077|530831147|FG000|Overall Study|Adverse Event|1|||
147181902|NCT03951077|530831148|FG001|Overall Study|Adverse Event|0|||
147181903|NCT03951077|530831149|FG002|Overall Study|Adverse Event|0|||
147181904|NCT03951077|530831150|FG003|Overall Study|Adverse Event|0|||
147181905|NCT03951077|530831151|FG004|Overall Study|Adverse Event|0|||
147181906|NCT03951077|530831152|FG005|Overall Study|Adverse Event|0|||
147181907|NCT03951077|530831147|FG000|Overall Study|Withdrawal by Subject|3|||
147181908|NCT03951077|530831148|FG001|Overall Study|Withdrawal by Subject|3|||
147181909|NCT03951077|530831149|FG002|Overall Study|Withdrawal by Subject|0|||
147181910|NCT03951077|530831150|FG003|Overall Study|Withdrawal by Subject|3|||
147181911|NCT03951077|530831151|FG004|Overall Study|Withdrawal by Subject|3|||
147181912|NCT03951077|530831152|FG005|Overall Study|Withdrawal by Subject|2|||
147181913|NCT03951077|530831147|FG000|Overall Study|Lost to Follow-up|1|||
147181914|NCT03951077|530831148|FG001|Overall Study|Lost to Follow-up|1|||
147181915|NCT03951077|530831149|FG002|Overall Study|Lost to Follow-up|2|||
147181916|NCT03951077|530831150|FG003|Overall Study|Lost to Follow-up|3|||
147181917|NCT03951077|530831151|FG004|Overall Study|Lost to Follow-up|2|||
147181918|NCT03951077|530831152|FG005|Overall Study|Lost to Follow-up|3|||
147181919|NCT03951077|530831147|FG000|Overall Study|Non-Compliance With Study Procedures|0|||
147181920|NCT03951077|530831148|FG001|Overall Study|Non-Compliance With Study Procedures|0|||
147181921|NCT03951077|530831149|FG002|Overall Study|Non-Compliance With Study Procedures|0|||
147181922|NCT03951077|530831150|FG003|Overall Study|Non-Compliance With Study Procedures|0|||
147181923|NCT03951077|530831151|FG004|Overall Study|Non-Compliance With Study Procedures|1|||
147181924|NCT03951077|530831152|FG005|Overall Study|Non-Compliance With Study Procedures|0|||
147181925|NCT03951077|530831147|FG000|Overall Study|Other, Not Specified|12|||
147181926|NCT03951077|530831148|FG001|Overall Study|Other, Not Specified|10|||
147181927|NCT03951077|530831149|FG002|Overall Study|Other, Not Specified|10|||
147181928|NCT03951077|530831150|FG003|Overall Study|Other, Not Specified|5|||
147181929|NCT03951077|530831151|FG004|Overall Study|Other, Not Specified|9|||
147181930|NCT03951077|530831152|FG005|Overall Study|Other, Not Specified|6|||
147181931|NCT03951077|530831147|FG000|Overall Study|Did Not Receive Any Study Drug|1|||
147181932|NCT03951077|530831148|FG001|Overall Study|Did Not Receive Any Study Drug|0|||
147181933|NCT03951077|530831149|FG002|Overall Study|Did Not Receive Any Study Drug|1|||
147181934|NCT03951077|530831150|FG003|Overall Study|Did Not Receive Any Study Drug|1|||
147181935|NCT03951077|530831151|FG004|Overall Study|Did Not Receive Any Study Drug|1|||
147593639|NCT02696031|532329014|FG002|Up to Week 52|Lack of Efficacy|11|||
147246335|NCT00420927|531072737|FG003|Period 2|Noncompliant with study drug|1|||
147246336|NCT00420927|531072738|FG004|Period 2|Noncompliant with study drug|0|||
147246337|NCT00420927|531072739|FG005|Period 2|Noncompliant with study drug|0|||
147246338|NCT00420927|531072740|FG006|Period 2|Noncompliant with study drug|2|||
147246339|NCT00420927|531072734|FG000|Period 2|Methotrexate intolerance|0|||
147246340|NCT00420927|531072735|FG001|Period 2|Methotrexate intolerance|0|||
147181936|NCT03951077|530831152|FG005|Overall Study|Did Not Receive Any Study Drug|0|||
147181937|NCT01473732|530831154|FG000|Overall Study|Adverse Event|1|||
147246341|NCT00420927|531072736|FG002|Period 2|Methotrexate intolerance|0|||
147246342|NCT00420927|531072737|FG003|Period 2|Methotrexate intolerance|0|||
147246343|NCT00420927|531072738|FG004|Period 2|Methotrexate intolerance|0|||
147246344|NCT00420927|531072739|FG005|Period 2|Methotrexate intolerance|0|||
147246345|NCT00420927|531072740|FG006|Period 2|Methotrexate intolerance|1|||
147657296|NCT04501952|532568557|FG001|Overall Study|Randomized and Never Treated|9|||
147181938|NCT01473732|530831155|FG001|Overall Study|Adverse Event|0|||
147181939|NCT01473732|530831154|FG000|Overall Study|Death|1|||
147181940|NCT01473732|530831155|FG001|Overall Study|Death|0|||
147181941|NCT01395901|530831156|FG000|Overall Study|Lost to Follow-up|4|||
147181942|NCT01395901|530831157|FG001|Overall Study|Lost to Follow-up|0|||
147181943|NCT01395901|530831156|FG000|Overall Study|Randomized but not received study drug|5|||
147181944|NCT01395901|530831157|FG001|Overall Study|Randomized but not received study drug|4|||
147181945|NCT01395901|530831156|FG000|Overall Study|Adverse Event|0|||
147181946|NCT01395901|530831157|FG001|Overall Study|Adverse Event|1|||
147181947|NCT01395901|530831156|FG000|Overall Study|Withdrawal of consent|1|||
147181948|NCT01395901|530831157|FG001|Overall Study|Withdrawal of consent|0|||
147181949|NCT01217944|530831161|FG000|Overall Study|Protocol Violation|1|||
147181950|NCT01217944|530831162|FG001|Overall Study|Protocol Violation|1|||
147181951|NCT01217944|530831163|FG002|Overall Study|Protocol Violation|0|||
147181952|NCT01217944|530831161|FG000|Overall Study|Lost to Follow-up|3|||
147181953|NCT01217944|530831162|FG001|Overall Study|Lost to Follow-up|1|||
147181954|NCT01217944|530831163|FG002|Overall Study|Lost to Follow-up|0|||
147181955|NCT01217944|530831161|FG000|Overall Study|Withdrawal by Subject|1|||
147181956|NCT01217944|530831162|FG001|Overall Study|Withdrawal by Subject|2|||
147181957|NCT01217944|530831163|FG002|Overall Study|Withdrawal by Subject|0|||
147181958|NCT01217944|530831161|FG000|Overall Study|Lack of Efficacy|1|||
147181959|NCT01217944|530831162|FG001|Overall Study|Lack of Efficacy|0|||
147181960|NCT01217944|530831163|FG002|Overall Study|Lack of Efficacy|0|||
147181961|NCT03579940|530831164|FG000|Period 2|Withdrawal by Subject|0|||
147181962|NCT03579940|530831165|FG001|Period 2|Withdrawal by Subject|0|||
147181963|NCT03579940|530831166|FG002|Period 2|Withdrawal by Subject|1|||
147181964|NCT03579940|530831167|FG003|Period 2|Withdrawal by Subject|0|||
147181965|NCT03579940|530831168|FG004|Period 2|Withdrawal by Subject|0|||
147181966|NCT03579940|530831169|FG005|Period 2|Withdrawal by Subject|0|||
147181967|NCT03579940|530831170|FG006|Period 2|Withdrawal by Subject|0|||
147181968|NCT03579940|530831171|FG007|Period 2|Withdrawal by Subject|0|||
147181969|NCT03579940|530831172|FG008|Period 2|Withdrawal by Subject|0|||
147181970|NCT03579940|530831173|FG009|Period 2|Withdrawal by Subject|0|||
147181971|NCT03579940|530831174|FG010|Period 2|Withdrawal by Subject|0|||
147181972|NCT00671034|530831175|FG000|Overall Study|Adverse Event|5|||
147181973|NCT00671034|530831176|FG001|Overall Study|Adverse Event|7|||
147181974|NCT00671034|530831177|FG002|Overall Study|Adverse Event|1|||
147181975|NCT00671034|530831175|FG000|Overall Study|Death|3|||
147181976|NCT00671034|530831176|FG001|Overall Study|Death|2|||
147181977|NCT00671034|530831177|FG002|Overall Study|Death|1|||
147181978|NCT00671034|530831175|FG000|Overall Study|Physician Decision|12|||
147181979|NCT00671034|530831176|FG001|Overall Study|Physician Decision|4|||
147181980|NCT00671034|530831177|FG002|Overall Study|Physician Decision|5|||
147181981|NCT00671034|530831175|FG000|Overall Study|VHR ALL feature|8|||
147181982|NCT00671034|530831176|FG001|Overall Study|VHR ALL feature|3|||
147181983|NCT00671034|530831177|FG002|Overall Study|VHR ALL feature|5|||
147657297|NCT02080364|532568558|FG000|Baseline Period|Protocol Violation|2|||
147657298|NCT02080364|532568559|FG001|Baseline Period|Protocol Violation|1|||
147657299|NCT02080364|532568560|FG002|Baseline Period|Protocol Violation|0|||
147657300|NCT02080364|532568561|FG003|Baseline Period|Protocol Violation|0|||
147181984|NCT00671034|530831175|FG000|Overall Study|Refusal|5|||
147181985|NCT00671034|530831176|FG001|Overall Study|Refusal|3|||
147181986|NCT00671034|530831177|FG002|Overall Study|Refusal|5|||
147657301|NCT02080364|532568558|FG000|Baseline Period|Other|0|||
147657302|NCT02080364|532568559|FG001|Baseline Period|Other|1|||
147657303|NCT02080364|532568560|FG002|Baseline Period|Other|1|||
147657304|NCT02080364|532568561|FG003|Baseline Period|Other|0|||
147181987|NCT00671034|530831175|FG000|Overall Study|includes Alternative therapy, etc.|6|||
147181988|NCT00671034|530831176|FG001|Overall Study|includes Alternative therapy, etc.|1|||
147181989|NCT00671034|530831177|FG002|Overall Study|includes Alternative therapy, etc.|7|||
147181990|NCT00713544|530831178|FG000|Overall Study|Adverse Event|5|||
147181991|NCT00713544|530831179|FG001|Overall Study|Adverse Event|3|||
147181992|NCT00713544|530831180|FG002|Overall Study|Adverse Event|7|||
147181993|NCT00713544|530831181|FG003|Overall Study|Adverse Event|7|||
147246346|NCT00420927|531072734|FG000|Period 2|Took prohibited medication|0|||
147657305|NCT02080364|532568558|FG000|Treatment Period|Adverse Event|10|||
147657306|NCT02080364|532568559|FG001|Treatment Period|Adverse Event|15|||
147657307|NCT02080364|532568560|FG002|Treatment Period|Adverse Event|11|||
147181994|NCT00713544|530831182|FG004|Overall Study|Adverse Event|3|||
147181995|NCT00713544|530831183|FG005|Overall Study|Adverse Event|5|||
147181996|NCT00713544|530831178|FG000|Overall Study|Withdrawal by Subject|2|||
147181997|NCT00713544|530831179|FG001|Overall Study|Withdrawal by Subject|0|||
147181998|NCT00713544|530831180|FG002|Overall Study|Withdrawal by Subject|3|||
147181999|NCT00713544|530831181|FG003|Overall Study|Withdrawal by Subject|2|||
147182000|NCT00713544|530831182|FG004|Overall Study|Withdrawal by Subject|3|||
147657308|NCT02080364|532568561|FG003|Treatment Period|Adverse Event|14|||
147657309|NCT02080364|532568558|FG000|Treatment Period|Lost to Follow-up|2|||
147657310|NCT02080364|532568559|FG001|Treatment Period|Lost to Follow-up|3|||
147657311|NCT02080364|532568560|FG002|Treatment Period|Lost to Follow-up|5|||
147657312|NCT02080364|532568561|FG003|Treatment Period|Lost to Follow-up|0|||
147657313|NCT02080364|532568558|FG000|Treatment Period|Protocol Violation|5|||
147657314|NCT02080364|532568559|FG001|Treatment Period|Protocol Violation|3|||
147657315|NCT02080364|532568560|FG002|Treatment Period|Protocol Violation|5|||
147657316|NCT02080364|532568561|FG003|Treatment Period|Protocol Violation|1|||
147657317|NCT02080364|532568558|FG000|Treatment Period|Withdrawal by Subject|16|||
147657318|NCT02080364|532568559|FG001|Treatment Period|Withdrawal by Subject|16|||
147657319|NCT02080364|532568560|FG002|Treatment Period|Withdrawal by Subject|15|||
147657320|NCT02080364|532568561|FG003|Treatment Period|Withdrawal by Subject|10|||
147657321|NCT02080364|532568558|FG000|Treatment Period|Study Terminated by Sponsor|0|||
147657322|NCT02080364|532568559|FG001|Treatment Period|Study Terminated by Sponsor|0|||
147657323|NCT02080364|532568560|FG002|Treatment Period|Study Terminated by Sponsor|180|||
147657324|NCT02080364|532568561|FG003|Treatment Period|Study Terminated by Sponsor|183|||
147657325|NCT02080364|532568558|FG000|Treatment Period|Other|14|||
147657326|NCT02080364|532568559|FG001|Treatment Period|Other|12|||
147182001|NCT00713544|530831183|FG005|Overall Study|Withdrawal by Subject|1|||
147182002|NCT00713544|530831178|FG000|Overall Study|Protocol Violation|0|||
147182003|NCT00713544|530831179|FG001|Overall Study|Protocol Violation|0|||
147182004|NCT00713544|530831180|FG002|Overall Study|Protocol Violation|0|||
147182005|NCT00713544|530831181|FG003|Overall Study|Protocol Violation|0|||
147182006|NCT00713544|530831182|FG004|Overall Study|Protocol Violation|0|||
147182007|NCT00713544|530831183|FG005|Overall Study|Protocol Violation|1|||
147246347|NCT00420927|531072735|FG001|Period 2|Took prohibited medication|0|||
147246348|NCT00420927|531072736|FG002|Period 2|Took prohibited medication|0|||
147246349|NCT00420927|531072737|FG003|Period 2|Took prohibited medication|0|||
147246350|NCT00420927|531072738|FG004|Period 2|Took prohibited medication|1|||
147246351|NCT00420927|531072739|FG005|Period 2|Took prohibited medication|0|||
147246352|NCT00420927|531072740|FG006|Period 2|Took prohibited medication|0|||
147246353|NCT03018704|531072741|FG000|Overall Study|Lost to Follow-up|1|||
147246354|NCT03018704|531072742|FG001|Overall Study|Lost to Follow-up|1|||
147246355|NCT00320411|531072743|FG000|Overall Study|No investigational product admin.|4|||
147246356|NCT04448171|531072746|FG000|Overall Study|Procedure Cancelled|1|||
147246357|NCT04448171|531072747|FG001|Overall Study|Procedure Cancelled|0|||
147246358|NCT04448171|531072746|FG000|Overall Study|Protocol Violation|1|||
147246359|NCT04448171|531072747|FG001|Overall Study|Protocol Violation|0|||
147246360|NCT00211809|531072752|FG000|Overall Study|Lack of Efficacy|1|||
147246361|NCT00211809|531072752|FG000|Overall Study|Lost to Follow-up|2|||
147246362|NCT00211809|531072752|FG000|Overall Study|Pregnancy|1|||
147246363|NCT00211809|531072752|FG000|Overall Study|side effects|2|||
147246364|NCT01417234|531072753|FG000|Overall Study|Subject non-compliant|3|||
147246365|NCT00023764|531072754|FG000|Overall Study|Other|1|||
147246366|NCT00023764|531072754|FG000|Overall Study|Adverse Event|4|||
147246367|NCT00023764|531072754|FG000|Overall Study|Withdrawal by Subject|1|||
147246368|NCT00023764|531072754|FG000|Overall Study|Progression of disease|6|||
147246369|NCT00023764|531072754|FG000|Overall Study|patient received other treatment|1|||
147246370|NCT00023764|531072754|FG000|Overall Study|delay in obtaining staging images|1|||
147246371|NCT01844518|531072757|FG000|Overall Study|Adverse Event|7|||
147246372|NCT01844518|531072758|FG001|Overall Study|Adverse Event|1|||
147246373|NCT01844518|531072757|FG000|Overall Study|Lack of Efficacy|17|||
147246374|NCT01844518|531072758|FG001|Overall Study|Lack of Efficacy|5|||
147246375|NCT01844518|531072757|FG000|Overall Study|Participant's request to discontinue|4|||
147246376|NCT01844518|531072758|FG001|Overall Study|Participant's request to discontinue|1|||
147246377|NCT01844518|531072757|FG000|Overall Study|Poor/Non-compliance|1|||
147246378|NCT01844518|531072758|FG001|Overall Study|Poor/Non-compliance|0|||
147246379|NCT01844518|531072757|FG000|Overall Study|No Longer Met Study Criteria|2|||
147246380|NCT01844518|531072758|FG001|Overall Study|No Longer Met Study Criteria|0|||
147246381|NCT01844518|531072757|FG000|Overall Study|Withdrawal by Subject|9|||
147326967|NCT01107626|531363818|FG002|Step 1: Induction Therapy|Adverse Event|0|||
147657327|NCT02080364|532568560|FG002|Treatment Period|Other|21|||
147182008|NCT00713544|530831178|FG000|Overall Study|Physician Decision|0|||
147182009|NCT00713544|530831179|FG001|Overall Study|Physician Decision|0|||
147657328|NCT02080364|532568561|FG003|Treatment Period|Other|16|||
147657329|NCT00991289|532568562|FG000|Overall Study|Adverse Event|1|||
147657330|NCT00991289|532568562|FG000|Overall Study|Physician Decision|2|||
147593640|NCT02696031|532329015|FG003|Up to Week 52|Lack of Efficacy|0|||
147593641|NCT02696031|532329016|FG004|Up to Week 52|Lack of Efficacy|0|||
147326968|NCT01107626|531363819|FG003|Step 1: Induction Therapy|Adverse Event|0|||
147326969|NCT01107626|531363816|FG000|Step 1: Induction Therapy|Death|62|||
147326970|NCT01107626|531363817|FG001|Step 1: Induction Therapy|Death|0|||
147326971|NCT01107626|531363818|FG002|Step 1: Induction Therapy|Death|0|||
147326972|NCT01107626|531363819|FG003|Step 1: Induction Therapy|Death|0|||
147326973|NCT01107626|531363816|FG000|Step 1: Induction Therapy|Withdrawal by Subject|54|||
147326974|NCT01107626|531363817|FG001|Step 1: Induction Therapy|Withdrawal by Subject|0|||
147326975|NCT01107626|531363818|FG002|Step 1: Induction Therapy|Withdrawal by Subject|0|||
147326976|NCT01107626|531363819|FG003|Step 1: Induction Therapy|Withdrawal by Subject|0|||
147326977|NCT01107626|531363816|FG000|Step 1: Induction Therapy|Complicating disease|13|||
147326978|NCT01107626|531363817|FG001|Step 1: Induction Therapy|Complicating disease|0|||
147326979|NCT01107626|531363818|FG002|Step 1: Induction Therapy|Complicating disease|0|||
147326980|NCT01107626|531363819|FG003|Step 1: Induction Therapy|Complicating disease|0|||
147326981|NCT01107626|531363816|FG000|Step 1: Induction Therapy|Alternative therapy|12|||
147326982|NCT01107626|531363817|FG001|Step 1: Induction Therapy|Alternative therapy|0|||
147326983|NCT01107626|531363818|FG002|Step 1: Induction Therapy|Alternative therapy|0|||
147326984|NCT01107626|531363819|FG003|Step 1: Induction Therapy|Alternative therapy|0|||
147326985|NCT01107626|531363816|FG000|Step 1: Induction Therapy|Symptomatic deterioration|10|||
147326986|NCT01107626|531363817|FG001|Step 1: Induction Therapy|Symptomatic deterioration|0|||
147326987|NCT01107626|531363818|FG002|Step 1: Induction Therapy|Symptomatic deterioration|0|||
147326988|NCT01107626|531363819|FG003|Step 1: Induction Therapy|Symptomatic deterioration|0|||
147326989|NCT01107626|531363816|FG000|Step 1: Induction Therapy|Non-compliance|4|||
147326990|NCT01107626|531363817|FG001|Step 1: Induction Therapy|Non-compliance|0|||
147326991|NCT01107626|531363818|FG002|Step 1: Induction Therapy|Non-compliance|0|||
147326992|NCT01107626|531363819|FG003|Step 1: Induction Therapy|Non-compliance|0|||
147326993|NCT01107626|531363816|FG000|Step 1: Induction Therapy|Pain|4|||
147326994|NCT01107626|531363817|FG001|Step 1: Induction Therapy|Pain|0|||
147326995|NCT01107626|531363818|FG002|Step 1: Induction Therapy|Pain|0|||
147326996|NCT01107626|531363819|FG003|Step 1: Induction Therapy|Pain|0|||
147326997|NCT01107626|531363816|FG000|Step 1: Induction Therapy|Protocol Violation|1|||
147326998|NCT01107626|531363817|FG001|Step 1: Induction Therapy|Protocol Violation|0|||
147326999|NCT01107626|531363818|FG002|Step 1: Induction Therapy|Protocol Violation|0|||
147327000|NCT01107626|531363819|FG003|Step 1: Induction Therapy|Protocol Violation|0|||
147327001|NCT01107626|531363816|FG000|Step 1: Induction Therapy|Hospice care|1|||
147327002|NCT01107626|531363817|FG001|Step 1: Induction Therapy|Hospice care|0|||
147327003|NCT01107626|531363818|FG002|Step 1: Induction Therapy|Hospice care|0|||
147327004|NCT01107626|531363819|FG003|Step 1: Induction Therapy|Hospice care|0|||
147327005|NCT01107626|531363816|FG000|Step 1: Induction Therapy|Physician Decision|1|||
147327006|NCT01107626|531363817|FG001|Step 1: Induction Therapy|Physician Decision|0|||
147327007|NCT01107626|531363818|FG002|Step 1: Induction Therapy|Physician Decision|0|||
147327008|NCT01107626|531363819|FG003|Step 1: Induction Therapy|Physician Decision|0|||
147327009|NCT01107626|531363816|FG000|Step 1: Induction Therapy|Off treatment reason not reported|50|||
147327010|NCT01107626|531363817|FG001|Step 1: Induction Therapy|Off treatment reason not reported|0|||
147327011|NCT01107626|531363818|FG002|Step 1: Induction Therapy|Off treatment reason not reported|0|||
147327012|NCT01107626|531363819|FG003|Step 1: Induction Therapy|Off treatment reason not reported|0|||
147327013|NCT01107626|531363816|FG000|Step 2: Maintenance Therapy|Lack of Efficacy|0|||
147327014|NCT01107626|531363817|FG001|Step 2: Maintenance Therapy|Lack of Efficacy|217|||
147327015|NCT01107626|531363818|FG002|Step 2: Maintenance Therapy|Lack of Efficacy|217|||
147327016|NCT01107626|531363819|FG003|Step 2: Maintenance Therapy|Lack of Efficacy|170|||
147327017|NCT01107626|531363816|FG000|Step 2: Maintenance Therapy|Adverse Event|0|||
147327018|NCT01107626|531363817|FG001|Step 2: Maintenance Therapy|Adverse Event|32|||
147327019|NCT01107626|531363818|FG002|Step 2: Maintenance Therapy|Adverse Event|29|||
147327020|NCT01107626|531363819|FG003|Step 2: Maintenance Therapy|Adverse Event|46|||
147327021|NCT01107626|531363816|FG000|Step 2: Maintenance Therapy|Death|0|||
147327022|NCT01107626|531363817|FG001|Step 2: Maintenance Therapy|Death|8|||
147327023|NCT01107626|531363818|FG002|Step 2: Maintenance Therapy|Death|2|||
147327024|NCT01107626|531363819|FG003|Step 2: Maintenance Therapy|Death|13|||
147327025|NCT01107626|531363816|FG000|Step 2: Maintenance Therapy|Withdrawal by Subject|0|||
147327026|NCT01107626|531363817|FG001|Step 2: Maintenance Therapy|Withdrawal by Subject|11|||
147327027|NCT01107626|531363818|FG002|Step 2: Maintenance Therapy|Withdrawal by Subject|21|||
147327028|NCT01107626|531363819|FG003|Step 2: Maintenance Therapy|Withdrawal by Subject|27|||
147327029|NCT01107626|531363816|FG000|Step 2: Maintenance Therapy|Alternative therapy|0|||
147327030|NCT01107626|531363817|FG001|Step 2: Maintenance Therapy|Alternative therapy|2|||
147327031|NCT01107626|531363818|FG002|Step 2: Maintenance Therapy|Alternative therapy|4|||
147327032|NCT01107626|531363819|FG003|Step 2: Maintenance Therapy|Alternative therapy|5|||
147327033|NCT01107626|531363816|FG000|Step 2: Maintenance Therapy|Other complicating disease|0|||
147327034|NCT01107626|531363817|FG001|Step 2: Maintenance Therapy|Other complicating disease|2|||
147327035|NCT01107626|531363818|FG002|Step 2: Maintenance Therapy|Other complicating disease|5|||
147327036|NCT01107626|531363819|FG003|Step 2: Maintenance Therapy|Other complicating disease|9|||
147327037|NCT01107626|531363816|FG000|Step 2: Maintenance Therapy|Symptomatic deterioration|0|||
147657331|NCT00991289|532568562|FG000|Overall Study|Withdrawal by Subject|3|||
147657332|NCT00991289|532568562|FG000|Overall Study|Lost to Follow-up|4|||
147657333|NCT00991289|532568562|FG000|Overall Study|Protocol Violation|2|||
147657334|NCT00436826|532568567|FG000|Double Blind Period (DBP)|Adverse Event|2|||
147657335|NCT00436826|532568568|FG001|Double Blind Period (DBP)|Adverse Event|0|||
147657336|NCT00436826|532568569|FG002|Double Blind Period (DBP)|Adverse Event|0|||
147657337|NCT00436826|532568570|FG003|Double Blind Period (DBP)|Adverse Event|0|||
147657338|NCT00436826|532568571|FG004|Double Blind Period (DBP)|Adverse Event|0|||
147657339|NCT00436826|532568572|FG005|Double Blind Period (DBP)|Adverse Event|0|||
147657340|NCT00436826|532568567|FG000|Double Blind Period (DBP)|Protocol Violation|1|||
147657341|NCT00436826|532568568|FG001|Double Blind Period (DBP)|Protocol Violation|0|||
147657342|NCT00436826|532568569|FG002|Double Blind Period (DBP)|Protocol Violation|0|||
147657343|NCT00436826|532568570|FG003|Double Blind Period (DBP)|Protocol Violation|0|||
147657344|NCT00436826|532568571|FG004|Double Blind Period (DBP)|Protocol Violation|0|||
147327038|NCT01107626|531363817|FG001|Step 2: Maintenance Therapy|Symptomatic deterioration|2|||
147327039|NCT01107626|531363818|FG002|Step 2: Maintenance Therapy|Symptomatic deterioration|4|||
147327040|NCT01107626|531363819|FG003|Step 2: Maintenance Therapy|Symptomatic deterioration|3|||
147327041|NCT01107626|531363816|FG000|Step 2: Maintenance Therapy|Exceeded maximum delay in treatment|0|||
147327042|NCT01107626|531363817|FG001|Step 2: Maintenance Therapy|Exceeded maximum delay in treatment|2|||
147327043|NCT01107626|531363818|FG002|Step 2: Maintenance Therapy|Exceeded maximum delay in treatment|2|||
147327044|NCT01107626|531363819|FG003|Step 2: Maintenance Therapy|Exceeded maximum delay in treatment|3|||
147327045|NCT01107626|531363816|FG000|Step 2: Maintenance Therapy|Diagnosis of progressive disease error|0|||
147327046|NCT01107626|531363817|FG001|Step 2: Maintenance Therapy|Diagnosis of progressive disease error|1|||
147327047|NCT01107626|531363818|FG002|Step 2: Maintenance Therapy|Diagnosis of progressive disease error|1|||
147327048|NCT01107626|531363819|FG003|Step 2: Maintenance Therapy|Diagnosis of progressive disease error|0|||
147327049|NCT01107626|531363816|FG000|Step 2: Maintenance Therapy|Financial reason|0|||
147327050|NCT01107626|531363817|FG001|Step 2: Maintenance Therapy|Financial reason|2|||
147327051|NCT01107626|531363818|FG002|Step 2: Maintenance Therapy|Financial reason|0|||
147327052|NCT01107626|531363819|FG003|Step 2: Maintenance Therapy|Financial reason|0|||
147327053|NCT01107626|531363816|FG000|Step 2: Maintenance Therapy|Physician Decision|0|||
147327054|NCT01107626|531363817|FG001|Step 2: Maintenance Therapy|Physician Decision|2|||
147327055|NCT01107626|531363818|FG002|Step 2: Maintenance Therapy|Physician Decision|3|||
147327056|NCT01107626|531363819|FG003|Step 2: Maintenance Therapy|Physician Decision|3|||
147327057|NCT01107626|531363816|FG000|Step 2: Maintenance Therapy|Hospice care|0|||
147327058|NCT01107626|531363817|FG001|Step 2: Maintenance Therapy|Hospice care|1|||
147327059|NCT01107626|531363818|FG002|Step 2: Maintenance Therapy|Hospice care|2|||
147327060|NCT01107626|531363819|FG003|Step 2: Maintenance Therapy|Hospice care|0|||
147327061|NCT01107626|531363816|FG000|Step 2: Maintenance Therapy|Non-compliance|0|||
147327062|NCT01107626|531363817|FG001|Step 2: Maintenance Therapy|Non-compliance|0|||
147327063|NCT01107626|531363818|FG002|Step 2: Maintenance Therapy|Non-compliance|0|||
147327064|NCT01107626|531363819|FG003|Step 2: Maintenance Therapy|Non-compliance|2|||
147327065|NCT01107626|531363816|FG000|Step 2: Maintenance Therapy|Pain|0|||
147327066|NCT01107626|531363817|FG001|Step 2: Maintenance Therapy|Pain|0|||
147327067|NCT01107626|531363818|FG002|Step 2: Maintenance Therapy|Pain|0|||
147327068|NCT01107626|531363819|FG003|Step 2: Maintenance Therapy|Pain|1|||
147327069|NCT01107626|531363816|FG000|Step 2: Maintenance Therapy|Off treatment reason not reported|0|||
147327070|NCT01107626|531363817|FG001|Step 2: Maintenance Therapy|Off treatment reason not reported|4|||
147327071|NCT01107626|531363818|FG002|Step 2: Maintenance Therapy|Off treatment reason not reported|4|||
147327072|NCT01107626|531363819|FG003|Step 2: Maintenance Therapy|Off treatment reason not reported|10|||
147327073|NCT03467724|531363821|FG000|Overall Study|Lost to Follow-up|5|||
147327074|NCT03467724|531363821|FG000|Overall Study|Withdrawal by Subject|1|||
147327075|NCT03467724|531363821|FG000|Overall Study|Protocol Violation|1|||
147327076|NCT03467724|531363821|FG000|Overall Study|Adverse Event|1|||
147327077|NCT04310579|531363822|FG000|Overall Study|Adverse Event|0|||
147327078|NCT04310579|531363823|FG001|Overall Study|Adverse Event|0|||
147327079|NCT04310579|531363824|FG002|Overall Study|Adverse Event|0|||
147657345|NCT00436826|532568572|FG005|Double Blind Period (DBP)|Protocol Violation|0|||
147657346|NCT00436826|532568567|FG000|Double Blind Period (DBP)|Other|10|||
147657347|NCT00436826|532568568|FG001|Double Blind Period (DBP)|Other|11|||
147182010|NCT00713544|530831180|FG002|Overall Study|Physician Decision|0|||
147182011|NCT00713544|530831181|FG003|Overall Study|Physician Decision|0|||
147182012|NCT00713544|530831182|FG004|Overall Study|Physician Decision|0|||
147182013|NCT00713544|530831183|FG005|Overall Study|Physician Decision|2|||
147327080|NCT04310579|531363825|FG003|Overall Study|Adverse Event|0|||
147327081|NCT04310579|531363826|FG004|Overall Study|Adverse Event|0|||
147327082|NCT04310579|531363827|FG005|Overall Study|Adverse Event|0|||
147327083|NCT04310579|531363828|FG006|Overall Study|Adverse Event|2|||
147327084|NCT04310579|531363829|FG007|Overall Study|Adverse Event|0|||
147327085|NCT04310579|531363830|FG008|Overall Study|Adverse Event|1|||
147657348|NCT00436826|532568569|FG002|Double Blind Period (DBP)|Other|0|||
147657349|NCT00436826|532568570|FG003|Double Blind Period (DBP)|Other|0|||
147657350|NCT00436826|532568571|FG004|Double Blind Period (DBP)|Other|0|||
147327086|NCT04310579|531363831|FG009|Overall Study|Adverse Event|1|||
147327087|NCT04310579|531363832|FG010|Overall Study|Adverse Event|0|||
147327088|NCT04310579|531363822|FG000|Overall Study|Withdrawal by Subject|0|||
147327089|NCT04310579|531363823|FG001|Overall Study|Withdrawal by Subject|0|||
147327090|NCT04310579|531363824|FG002|Overall Study|Withdrawal by Subject|0|||
147327091|NCT04310579|531363825|FG003|Overall Study|Withdrawal by Subject|0|||
147327092|NCT04310579|531363826|FG004|Overall Study|Withdrawal by Subject|0|||
147327093|NCT04310579|531363827|FG005|Overall Study|Withdrawal by Subject|1|||
147327094|NCT04310579|531363828|FG006|Overall Study|Withdrawal by Subject|0|||
147327095|NCT04310579|531363829|FG007|Overall Study|Withdrawal by Subject|0|||
147327096|NCT04310579|531363830|FG008|Overall Study|Withdrawal by Subject|0|||
147327097|NCT04310579|531363831|FG009|Overall Study|Withdrawal by Subject|0|||
147327098|NCT04310579|531363832|FG010|Overall Study|Withdrawal by Subject|0|||
147327099|NCT04310579|531363822|FG000|Overall Study|Positive COVID-19 test|0|||
147327100|NCT04310579|531363823|FG001|Overall Study|Positive COVID-19 test|0|||
147327101|NCT04310579|531363824|FG002|Overall Study|Positive COVID-19 test|0|||
147327102|NCT04310579|531363825|FG003|Overall Study|Positive COVID-19 test|0|||
147327103|NCT04310579|531363826|FG004|Overall Study|Positive COVID-19 test|0|||
147327104|NCT04310579|531363827|FG005|Overall Study|Positive COVID-19 test|0|||
147327105|NCT04310579|531363828|FG006|Overall Study|Positive COVID-19 test|0|||
147327106|NCT04310579|531363829|FG007|Overall Study|Positive COVID-19 test|0|||
147327107|NCT04310579|531363830|FG008|Overall Study|Positive COVID-19 test|0|||
147327108|NCT04310579|531363831|FG009|Overall Study|Positive COVID-19 test|0|||
147327109|NCT04310579|531363832|FG010|Overall Study|Positive COVID-19 test|1|||
147327110|NCT02236559|531363842|FG000|Overall Study|Met Exclusion|3|||
147327111|NCT02236559|531363843|FG001|Overall Study|Met Exclusion|6|||
147327112|NCT02236559|531363842|FG000|Overall Study|Did not Meet Inclusion|3|||
147327113|NCT02236559|531363843|FG001|Overall Study|Did not Meet Inclusion|3|||
147327114|NCT02236559|531363842|FG000|Overall Study|Subject Did Not Consent|4|||
147327115|NCT02236559|531363843|FG001|Overall Study|Subject Did Not Consent|2|||
147327116|NCT02236559|531363842|FG000|Overall Study|Physician Decision|1|||
147327117|NCT02236559|531363843|FG001|Overall Study|Physician Decision|1|||
147327118|NCT02236559|531363842|FG000|Overall Study|Withdrawal by Subject|1|||
147327119|NCT02236559|531363843|FG001|Overall Study|Withdrawal by Subject|0|||
147327120|NCT02049866|531363844|FG000|Overall Study|Withdrawal by Subject|1|||
147327121|NCT01117480|531363845|FG000|Overall Study|Protocol Violation|8|||
147327122|NCT01117480|531363845|FG000|Overall Study|Did Not Start Adalimumab Therapy|20|||
147327123|NCT03721016|531363846|FG000|Overall Study|Adverse Event|0|||
147327124|NCT03721016|531363847|FG001|Overall Study|Adverse Event|1|||
147327125|NCT03721016|531363848|FG002|Overall Study|Adverse Event|1|||
147327126|NCT03721016|531363846|FG000|Overall Study|Withdrawal by Subject|8|||
147327127|NCT03721016|531363847|FG001|Overall Study|Withdrawal by Subject|16|||
147327128|NCT03721016|531363848|FG002|Overall Study|Withdrawal by Subject|13|||
147327129|NCT03721016|531363846|FG000|Overall Study|Lost to Follow-up|4|||
147327130|NCT03721016|531363847|FG001|Overall Study|Lost to Follow-up|6|||
147327131|NCT03721016|531363848|FG002|Overall Study|Lost to Follow-up|5|||
147327132|NCT03721016|531363846|FG000|Overall Study|Physician Decision|0|||
147327133|NCT03721016|531363847|FG001|Overall Study|Physician Decision|1|||
147327134|NCT03721016|531363848|FG002|Overall Study|Physician Decision|2|||
147327135|NCT03721016|531363846|FG000|Overall Study|Protocol Violation|0|||
147327136|NCT03721016|531363847|FG001|Overall Study|Protocol Violation|1|||
147327137|NCT03721016|531363848|FG002|Overall Study|Protocol Violation|0|||
147327138|NCT03721016|531363846|FG000|Overall Study|Site terminated by sponsor|3|||
147327139|NCT03721016|531363847|FG001|Overall Study|Site terminated by sponsor|7|||
147327140|NCT03721016|531363848|FG002|Overall Study|Site terminated by sponsor|6|||
147327141|NCT03721016|531363846|FG000|Overall Study|Subject exited early due to COVID-19|1|||
147327142|NCT03721016|531363847|FG001|Overall Study|Subject exited early due to COVID-19|0|||
147327143|NCT03721016|531363848|FG002|Overall Study|Subject exited early due to COVID-19|0|||
147327144|NCT00817635|531363852|FG000|Overall Study|Adverse Event|1|||
147327145|NCT00817635|531363853|FG001|Overall Study|Adverse Event|0|||
147327146|NCT00817635|531363854|FG002|Overall Study|Adverse Event|0|||
147327147|NCT00817635|531363855|FG003|Overall Study|Adverse Event|1|||
147327148|NCT00817635|531363856|FG004|Overall Study|Adverse Event|1|||
147327149|NCT00817635|531363852|FG000|Overall Study|Abnormal Laboratory Value(s)|1|||
147327150|NCT00817635|531363853|FG001|Overall Study|Abnormal Laboratory Value(s)|1|||
147327151|NCT00817635|531363854|FG002|Overall Study|Abnormal Laboratory Value(s)|0|||
147327152|NCT00817635|531363855|FG003|Overall Study|Abnormal Laboratory Value(s)|0|||
147327153|NCT00817635|531363856|FG004|Overall Study|Abnormal Laboratory Value(s)|1|||
147448480|NCT00761514|531805737|FG000|Overall Study|Withdrawal by Subject|2|||
147182014|NCT00713544|530831178|FG000|Overall Study|Lack of Efficacy|0|||
147327154|NCT00817635|531363852|FG000|Overall Study|Withdrawal by Subject|2|||
147327155|NCT00817635|531363853|FG001|Overall Study|Withdrawal by Subject|1|||
147327156|NCT00817635|531363854|FG002|Overall Study|Withdrawal by Subject|0|||
147327157|NCT00817635|531363855|FG003|Overall Study|Withdrawal by Subject|1|||
147327158|NCT00817635|531363856|FG004|Overall Study|Withdrawal by Subject|2|||
147327159|NCT00817635|531363852|FG000|Overall Study|Lost to Follow-up|0|||
147182015|NCT00713544|530831179|FG001|Overall Study|Lack of Efficacy|1|||
147182016|NCT00713544|530831180|FG002|Overall Study|Lack of Efficacy|0|||
147182017|NCT00713544|530831181|FG003|Overall Study|Lack of Efficacy|1|||
147182018|NCT00713544|530831182|FG004|Overall Study|Lack of Efficacy|1|||
147182019|NCT00713544|530831183|FG005|Overall Study|Lack of Efficacy|0|||
147182020|NCT00713544|530831178|FG000|Overall Study|Lost to Follow-up|0|||
147182021|NCT00713544|530831179|FG001|Overall Study|Lost to Follow-up|0|||
147182022|NCT00713544|530831180|FG002|Overall Study|Lost to Follow-up|1|||
147182023|NCT00713544|530831181|FG003|Overall Study|Lost to Follow-up|0|||
147182024|NCT00713544|530831182|FG004|Overall Study|Lost to Follow-up|0|||
147182025|NCT00713544|530831183|FG005|Overall Study|Lost to Follow-up|0|||
147182026|NCT00713544|530831178|FG000|Overall Study|AZ decision - Hepatitis C ab reactive|0|||
147182027|NCT00713544|530831179|FG001|Overall Study|AZ decision - Hepatitis C ab reactive|1|||
147182028|NCT00713544|530831180|FG002|Overall Study|AZ decision - Hepatitis C ab reactive|0|||
147182029|NCT00713544|530831181|FG003|Overall Study|AZ decision - Hepatitis C ab reactive|0|||
147182030|NCT00713544|530831182|FG004|Overall Study|AZ decision - Hepatitis C ab reactive|0|||
147182031|NCT00713544|530831183|FG005|Overall Study|AZ decision - Hepatitis C ab reactive|0|||
147182032|NCT00713544|530831178|FG000|Overall Study|Incorrect enrollment|0|||
147182033|NCT00713544|530831179|FG001|Overall Study|Incorrect enrollment|1|||
147182034|NCT00713544|530831180|FG002|Overall Study|Incorrect enrollment|0|||
147182035|NCT00713544|530831181|FG003|Overall Study|Incorrect enrollment|0|||
147182036|NCT00713544|530831182|FG004|Overall Study|Incorrect enrollment|0|||
147182037|NCT00713544|530831183|FG005|Overall Study|Incorrect enrollment|0|||
147182038|NCT00713544|530831178|FG000|Overall Study|Hepatotoxicity - not an AE|0|||
147182039|NCT00713544|530831179|FG001|Overall Study|Hepatotoxicity - not an AE|0|||
147182040|NCT00713544|530831180|FG002|Overall Study|Hepatotoxicity - not an AE|0|||
147182041|NCT00713544|530831181|FG003|Overall Study|Hepatotoxicity - not an AE|0|||
147182042|NCT00713544|530831182|FG004|Overall Study|Hepatotoxicity - not an AE|1|||
147182043|NCT00713544|530831183|FG005|Overall Study|Hepatotoxicity - not an AE|0|||
147182044|NCT02471014|530831186|FG000|Overall Study|Lost to Follow-up|2|||
147182045|NCT02471014|530831187|FG001|Overall Study|Lost to Follow-up|2|||
147182046|NCT02380287|530831188|FG000|Overall Study|Adverse Event|0|||
147182047|NCT02380287|530831189|FG001|Overall Study|Adverse Event|0|||
147182048|NCT02380287|530831190|FG002|Overall Study|Adverse Event|1|||
147182049|NCT02380287|530831191|FG003|Overall Study|Adverse Event|0|||
147182050|NCT02380287|530831192|FG004|Overall Study|Adverse Event|0|||
147182051|NCT02380287|530831193|FG005|Overall Study|Adverse Event|0|||
147182052|NCT02380287|530831194|FG006|Overall Study|Adverse Event|0|||
147182053|NCT02380287|530831195|FG007|Overall Study|Adverse Event|0|||
147182054|NCT04473963|530831196|FG000|Overall Study|Withdrawal by Subject|1|||
147182055|NCT04473963|530831197|FG001|Overall Study|Withdrawal by Subject|1|||
147182056|NCT04473963|530831198|FG002|Overall Study|Withdrawal by Subject|0|||
147182057|NCT04473963|530831196|FG000|Overall Study|Not inducible in AF|0|||
147182058|NCT04473963|530831197|FG001|Overall Study|Not inducible in AF|0|||
147182059|NCT04473963|530831198|FG002|Overall Study|Not inducible in AF|2|||
147182060|NCT01641601|530831199|FG000|Overall Study|Study discontinued.|3|||
147182061|NCT01641601|530831200|FG001|Overall Study|Study discontinued.|5|||
147182062|NCT00587158|530831201|FG000|Overall Study|Did not want to do 24 hr urine collect.|4|||
147182063|NCT00587158|530831202|FG001|Overall Study|Did not want to do 24 hr urine collect.|3|||
147327160|NCT00817635|531363853|FG001|Overall Study|Lost to Follow-up|1|||
147448481|NCT00761514|531805737|FG000|Overall Study|Lost to Follow-up|1|||
147327161|NCT00817635|531363854|FG002|Overall Study|Lost to Follow-up|0|||
147327162|NCT00817635|531363855|FG003|Overall Study|Lost to Follow-up|1|||
147327163|NCT00817635|531363856|FG004|Overall Study|Lost to Follow-up|0|||
147327164|NCT00817635|531363852|FG000|Overall Study|Administrative Problems|0|||
147327165|NCT00817635|531363853|FG001|Overall Study|Administrative Problems|0|||
147327166|NCT00817635|531363854|FG002|Overall Study|Administrative Problems|0|||
147327167|NCT00817635|531363855|FG003|Overall Study|Administrative Problems|0|||
147327168|NCT00817635|531363856|FG004|Overall Study|Administrative Problems|1|||
147327169|NCT00817635|531363852|FG000|Overall Study|Protocol Violation|5|||
147327170|NCT00817635|531363853|FG001|Overall Study|Protocol Violation|1|||
147327171|NCT00817635|531363854|FG002|Overall Study|Protocol Violation|3|||
147182064|NCT00587158|530831201|FG000|Overall Study|Physician Decision|0|||
147182065|NCT00587158|530831202|FG001|Overall Study|Physician Decision|1|||
147182066|NCT00587158|530831201|FG000|Overall Study|Lost to Follow-up|1|||
147182067|NCT00587158|530831202|FG001|Overall Study|Lost to Follow-up|2|||
147182068|NCT00587158|530831201|FG000|Overall Study|Death|0|||
147182069|NCT00587158|530831202|FG001|Overall Study|Death|1|||
147182070|NCT00587158|530831201|FG000|Overall Study|Subject did not want to take study med|0|||
147182071|NCT00587158|530831202|FG001|Overall Study|Subject did not want to take study med|1|||
147182072|NCT04390243|530831206|FG000|Overall Study|Death|1|||
147182073|NCT04390243|530831206|FG000|Overall Study|Disease Progression|4|||
147182074|NCT04390243|530831206|FG000|Overall Study|Patient was on treatment when study was terminated|1|||
147182075|NCT01196026|530831213|FG000|Overall Study|Withdrawal by Subject|1|||
147182076|NCT01196026|530831214|FG001|Overall Study|Withdrawal by Subject|4|||
147182077|NCT01196026|530831215|FG002|Overall Study|Withdrawal by Subject|0|||
147327172|NCT00817635|531363855|FG003|Overall Study|Protocol Violation|2|||
147246382|NCT01844518|531072758|FG001|Overall Study|Withdrawal by Subject|0|||
147246383|NCT01844518|531072757|FG000|Overall Study|Pregnancy|1|||
147448482|NCT00761514|531805737|FG000|Overall Study|Health insurance didn't cover study drug|1|||
147448483|NCT00761514|531805737|FG000|Overall Study|Problem complying with study visit|1|||
147448484|NCT00761514|531805737|FG000|Overall Study|Unable to pay for medications|1|||
147182078|NCT01196026|530831216|FG003|Overall Study|Withdrawal by Subject|0|||
147182079|NCT01196026|530831217|FG004|Overall Study|Withdrawal by Subject|0|||
147182080|NCT01196026|530831218|FG005|Overall Study|Withdrawal by Subject|0|||
147182081|NCT01196026|530831213|FG000|Overall Study|Lost to Follow-up|0|||
147182082|NCT01196026|530831214|FG001|Overall Study|Lost to Follow-up|3|||
147182083|NCT01196026|530831215|FG002|Overall Study|Lost to Follow-up|0|||
147182084|NCT01196026|530831216|FG003|Overall Study|Lost to Follow-up|0|||
147182085|NCT01196026|530831217|FG004|Overall Study|Lost to Follow-up|1|||
147182086|NCT01196026|530831218|FG005|Overall Study|Lost to Follow-up|0|||
147182087|NCT01196026|530831213|FG000|Overall Study|Other|0|||
147182088|NCT01196026|530831214|FG001|Overall Study|Other|1|||
147448485|NCT02457637|531805740|FG000|Clinic or Telephone Follow-up|Lost to Follow-up|71|||
147448486|NCT00159861|531805741|FG000|Core Study - 16 Weeks|Death|3|||
147448487|NCT00159861|531805742|FG001|Core Study - 16 Weeks|Death|0|||
147448488|NCT00159861|531805741|FG000|Core Study - 16 Weeks|Adverse Event|12|||
147448489|NCT00159861|531805742|FG001|Core Study - 16 Weeks|Adverse Event|6|||
147448490|NCT00159861|531805741|FG000|Core Study - 16 Weeks|Lack of Efficacy|2|||
147448491|NCT00159861|531805742|FG001|Core Study - 16 Weeks|Lack of Efficacy|3|||
147448492|NCT00159861|531805741|FG000|Core Study - 16 Weeks|Reason Unspecified|5|||
147448493|NCT00159861|531805742|FG001|Core Study - 16 Weeks|Reason Unspecified|3|||
147448494|NCT00159861|531805741|FG000|Core Study - 16 Weeks|Subject Defaulted|1|||
147448495|NCT00159861|531805742|FG001|Core Study - 16 Weeks|Subject Defaulted|0|||
147448496|NCT00159861|531805741|FG000|Core Study - 16 Weeks|Randomized but not Treated|2|||
147448497|NCT00159861|531805742|FG001|Core Study - 16 Weeks|Randomized but not Treated|0|||
147448498|NCT00159861|531805741|FG000|Extension Study - up to 3 Years|Death|24|||
147448499|NCT00159861|531805742|FG001|Extension Study - up to 3 Years|Death|28|||
147448500|NCT00159861|531805741|FG000|Extension Study - up to 3 Years|Adverse Event|14|||
147448501|NCT00159861|531805742|FG001|Extension Study - up to 3 Years|Adverse Event|14|||
147448502|NCT00159861|531805741|FG000|Extension Study - up to 3 Years|Lack of Efficacy|5|||
147448503|NCT00159861|531805742|FG001|Extension Study - up to 3 Years|Lack of Efficacy|1|||
147448504|NCT00159861|531805741|FG000|Extension Study - up to 3 Years|Reason Unspecified|12|||
147448505|NCT00159861|531805742|FG001|Extension Study - up to 3 Years|Reason Unspecified|19|||
147448506|NCT00159861|531805741|FG000|Extension Study - up to 3 Years|Withdrawal by Subject|7|||
147448507|NCT00159861|531805742|FG001|Extension Study - up to 3 Years|Withdrawal by Subject|9|||
147448508|NCT01553136|531805744|FG000|Overall Study|Adverse Event|3|||
147448509|NCT01553136|531805745|FG001|Overall Study|Adverse Event|2|||
147448510|NCT01553136|531805744|FG000|Overall Study|Withdrawal by Subject|2|||
147448511|NCT01553136|531805745|FG001|Overall Study|Withdrawal by Subject|3|||
147448512|NCT01553136|531805744|FG000|Overall Study|Lost to Follow-up|4|||
147448513|NCT01553136|531805745|FG001|Overall Study|Lost to Follow-up|10|||
147448514|NCT01553136|531805744|FG000|Overall Study|Physician Decision|2|||
147448515|NCT01553136|531805745|FG001|Overall Study|Physician Decision|3|||
147448516|NCT01553136|531805744|FG000|Overall Study|Scheduling Difficulties|5|||
147448517|NCT01553136|531805745|FG001|Overall Study|Scheduling Difficulties|4|||
147448518|NCT03885089|531805746|FG000|Overall Study|No informed consent for publication of study results|2|||
147448519|NCT03349099|531805749|FG000|Overall Study|Physician Decision|3|||
147327173|NCT00817635|531363856|FG004|Overall Study|Protocol Violation|3|||
147327174|NCT00003656|531363859|FG000|Overall Study|Adverse Event|0|||
147327175|NCT00003656|531363860|FG001|Overall Study|Adverse Event|1|||
147327176|NCT00763282|531363863|FG000|Overall Study|Withdrawal by Subject|6|||
147448520|NCT03349099|531805750|FG001|Overall Study|Physician Decision|4|||
147448521|NCT03349099|531805749|FG000|Overall Study|Stone migrated from the kidney|1|||
147182089|NCT01196026|530831215|FG002|Overall Study|Other|0|||
147182090|NCT01196026|530831216|FG003|Overall Study|Other|0|||
147182091|NCT01196026|530831217|FG004|Overall Study|Other|0|||
147182092|NCT01196026|530831218|FG005|Overall Study|Other|0|||
147182093|NCT00799903|530831220|FG000|Overall Study|Investigator Site Closed|25|||
147182094|NCT00799903|530831221|FG001|Overall Study|Investigator Site Closed|23|||
147182095|NCT00799903|530831220|FG000|Overall Study|Withdrawal by Subject|179|||
147246384|NCT01844518|531072758|FG001|Overall Study|Pregnancy|0|||
147246385|NCT03129100|531072759|FG000|Lead-In Period (Period 1)|Adverse Event|2|||
147246386|NCT03129100|531072760|FG001|Lead-In Period (Period 1)|Adverse Event|6|||
147246387|NCT03129100|531072761|FG002|Lead-In Period (Period 1)|Adverse Event|0|||
147246388|NCT03129100|531072762|FG003|Lead-In Period (Period 1)|Adverse Event|0|||
147246389|NCT03129100|531072763|FG004|Lead-In Period (Period 1)|Adverse Event|0|||
147246390|NCT03129100|531072764|FG005|Lead-In Period (Period 1)|Adverse Event|0|||
147246391|NCT03129100|531072765|FG006|Lead-In Period (Period 1)|Adverse Event|0|||
147246392|NCT03129100|531072766|FG007|Lead-In Period (Period 1)|Adverse Event|0|||
147246393|NCT03129100|531072767|FG008|Lead-In Period (Period 1)|Adverse Event|0|||
147246394|NCT03129100|531072768|FG009|Lead-In Period (Period 1)|Adverse Event|0|||
147246395|NCT03129100|531072769|FG010|Lead-In Period (Period 1)|Adverse Event|0|||
147182096|NCT00799903|530831221|FG001|Overall Study|Withdrawal by Subject|175|||
147182097|NCT00799903|530831220|FG000|Overall Study|Lost to Follow-up|69|||
147182098|NCT00799903|530831221|FG001|Overall Study|Lost to Follow-up|80|||
147182099|NCT01221350|530831224|FG000|Overall Study|Discontinued intervention (GERD)|1|||
147182100|NCT01221350|530831225|FG001|Overall Study|Discontinued intervention (GERD)|0|||
147182101|NCT01221350|530831224|FG000|Overall Study|Exclusion criteria, asthma exacerbation|0|||
147182102|NCT01221350|530831225|FG001|Overall Study|Exclusion criteria, asthma exacerbation|1|||
147182103|NCT01221350|530831224|FG000|Overall Study|Withdrawal by Subject|4|||
147182104|NCT01221350|530831225|FG001|Overall Study|Withdrawal by Subject|2|||
147182105|NCT02715609|530831229|FG000|Overall Study|Patient only completed pre-operative treatment|1|||
147182106|NCT02715609|530831230|FG001|Overall Study|Patient only completed pre-operative treatment|0|||
147182107|NCT02715609|530831231|FG002|Overall Study|Patient only completed pre-operative treatment|0|||
147182108|NCT02715609|530831229|FG000|Overall Study|Withdrawal by Subject|0|||
147182109|NCT02715609|530831230|FG001|Overall Study|Withdrawal by Subject|0|||
147182110|NCT02715609|530831231|FG002|Overall Study|Withdrawal by Subject|1|||
147182111|NCT05236257|530831234|FG000|Overall Study|Ongoing with study treatment|29|||
147182112|NCT05236257|530831235|FG001|Overall Study|Ongoing with study treatment|1|||
147182113|NCT05236257|530831234|FG000|Overall Study|Discontinued study treatment|22|||
147182114|NCT05236257|530831235|FG001|Overall Study|Discontinued study treatment|41|||
147182115|NCT04752332|530831236|FG000|Overall Study|Adverse Event|3|||
147182116|NCT04752332|530831237|FG001|Overall Study|Adverse Event|1|||
147593642|NCT02696031|532329017|FG005|Up to Week 52|Lack of Efficacy|0|||
147593643|NCT02696031|532329012|FG000|Up to Week 52|Lost to Follow-up|1|||
147593644|NCT02696031|532329013|FG001|Up to Week 52|Lost to Follow-up|1|||
147593645|NCT02696031|532329014|FG002|Up to Week 52|Lost to Follow-up|1|||
147593646|NCT02696031|532329015|FG003|Up to Week 52|Lost to Follow-up|0|||
147593647|NCT02696031|532329016|FG004|Up to Week 52|Lost to Follow-up|0|||
147593648|NCT02696031|532329017|FG005|Up to Week 52|Lost to Follow-up|0|||
147593649|NCT02696031|532329012|FG000|Up to Week 52|Physician Decision|1|||
147593650|NCT02696031|532329013|FG001|Up to Week 52|Physician Decision|1|||
147593651|NCT02696031|532329014|FG002|Up to Week 52|Physician Decision|2|||
147593652|NCT02696031|532329015|FG003|Up to Week 52|Physician Decision|0|||
147593653|NCT02696031|532329016|FG004|Up to Week 52|Physician Decision|0|||
147593654|NCT02696031|532329017|FG005|Up to Week 52|Physician Decision|0|||
147593655|NCT02696031|532329012|FG000|Up to Week 52|Pregnancy|0|||
147593656|NCT02696031|532329013|FG001|Up to Week 52|Pregnancy|2|||
147593657|NCT02696031|532329014|FG002|Up to Week 52|Pregnancy|0|||
147593658|NCT02696031|532329015|FG003|Up to Week 52|Pregnancy|0|||
147593659|NCT02696031|532329016|FG004|Up to Week 52|Pregnancy|0|||
147593660|NCT02696031|532329017|FG005|Up to Week 52|Pregnancy|0|||
147593661|NCT02696031|532329012|FG000|Up to Week 52|Protocol Violation|1|||
147593662|NCT02696031|532329013|FG001|Up to Week 52|Protocol Violation|0|||
147593663|NCT02696031|532329014|FG002|Up to Week 52|Protocol Violation|0|||
147593664|NCT02696031|532329015|FG003|Up to Week 52|Protocol Violation|0|||
147593665|NCT02696031|532329016|FG004|Up to Week 52|Protocol Violation|0|||
147593666|NCT02696031|532329017|FG005|Up to Week 52|Protocol Violation|0|||
147593667|NCT02696031|532329012|FG000|Up to Week 52|Withdrawal by Subject|12|||
147593668|NCT02696031|532329013|FG001|Up to Week 52|Withdrawal by Subject|3|||
147593669|NCT02696031|532329014|FG002|Up to Week 52|Withdrawal by Subject|9|||
147593670|NCT02696031|532329015|FG003|Up to Week 52|Withdrawal by Subject|0|||
147593671|NCT02696031|532329016|FG004|Up to Week 52|Withdrawal by Subject|0|||
147593672|NCT02696031|532329017|FG005|Up to Week 52|Withdrawal by Subject|0|||
147593673|NCT02696031|532329012|FG000|Up to Week 104|Pregnancy|0|||
147593674|NCT02696031|532329013|FG001|Up to Week 104|Pregnancy|2|||
147593675|NCT02696031|532329014|FG002|Up to Week 104|Pregnancy|1|||
147593676|NCT02696031|532329015|FG003|Up to Week 104|Pregnancy|0|||
147593677|NCT02696031|532329016|FG004|Up to Week 104|Pregnancy|0|||
147593678|NCT02696031|532329017|FG005|Up to Week 104|Pregnancy|0|||
147593679|NCT02696031|532329012|FG000|Up to Week 104|Withdrawal by Subject|15|||
147593680|NCT02696031|532329013|FG001|Up to Week 104|Withdrawal by Subject|10|||
147593681|NCT02696031|532329014|FG002|Up to Week 104|Withdrawal by Subject|16|||
147593682|NCT02696031|532329015|FG003|Up to Week 104|Withdrawal by Subject|0|||
147593683|NCT02696031|532329016|FG004|Up to Week 104|Withdrawal by Subject|0|||
147593684|NCT02696031|532329017|FG005|Up to Week 104|Withdrawal by Subject|0|||
147593685|NCT02696031|532329012|FG000|Up to Week 104|Protocol Violation|1|||
147593686|NCT02696031|532329013|FG001|Up to Week 104|Protocol Violation|0|||
147593687|NCT02696031|532329014|FG002|Up to Week 104|Protocol Violation|0|||
147593688|NCT02696031|532329015|FG003|Up to Week 104|Protocol Violation|0|||
147593689|NCT02696031|532329016|FG004|Up to Week 104|Protocol Violation|0|||
147593690|NCT02696031|532329017|FG005|Up to Week 104|Protocol Violation|0|||
147593691|NCT02696031|532329012|FG000|Up to Week 104|Physician Decision|1|||
147593692|NCT02696031|532329013|FG001|Up to Week 104|Physician Decision|2|||
147593693|NCT02696031|532329014|FG002|Up to Week 104|Physician Decision|3|||
147593694|NCT02696031|532329015|FG003|Up to Week 104|Physician Decision|0|||
147593695|NCT02696031|532329016|FG004|Up to Week 104|Physician Decision|0|||
147593696|NCT02696031|532329017|FG005|Up to Week 104|Physician Decision|0|||
147657351|NCT00436826|532568572|FG005|Double Blind Period (DBP)|Other|0|||
147182117|NCT04752332|530831236|FG000|Overall Study|Disease Relapse|1|||
147182118|NCT04752332|530831237|FG001|Overall Study|Disease Relapse|0|||
147182119|NCT04752332|530831236|FG000|Overall Study|Non-compliance With Study Drug|2|||
147182120|NCT04752332|530831237|FG001|Overall Study|Non-compliance With Study Drug|0|||
147182121|NCT04752332|530831236|FG000|Overall Study|Physician Decision|2|||
147657352|NCT00436826|532568567|FG000|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0|||
147657353|NCT00436826|532568568|FG001|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0|||
147657354|NCT00436826|532568569|FG002|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0|||
147657355|NCT00436826|532568570|FG003|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|1|||
147657356|NCT00436826|532568571|FG004|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0|||
147657357|NCT00436826|532568572|FG005|Ext. Period (With Cladribine Treatment)|Lost to Follow-up|0|||
147657358|NCT00436826|532568567|FG000|Ext. Period (With Cladribine Treatment)|Other un-specified|0|||
147657359|NCT00436826|532568568|FG001|Ext. Period (With Cladribine Treatment)|Other un-specified|0|||
147657360|NCT00436826|532568569|FG002|Ext. Period (With Cladribine Treatment)|Other un-specified|46|||
147657361|NCT00436826|532568570|FG003|Ext. Period (With Cladribine Treatment)|Other un-specified|25|||
147657362|NCT00436826|532568571|FG004|Ext. Period (With Cladribine Treatment)|Other un-specified|0|||
147657363|NCT00436826|532568572|FG005|Ext. Period (With Cladribine Treatment)|Other un-specified|0|||
147657364|NCT00436826|532568567|FG000|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0|||
147657365|NCT00436826|532568568|FG001|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0|||
147657366|NCT00436826|532568569|FG002|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0|||
147657367|NCT00436826|532568570|FG003|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|0|||
147657368|NCT00436826|532568571|FG004|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|51|||
147657369|NCT00436826|532568572|FG005|Ext. Period (No Cladribine Treatment)|Sponsor's decision to terminate study|7|||
147657370|NCT00110357|532568578|FG000|Overall Study|Deterioration without progression|2|||
147657371|NCT00110357|532568579|FG001|Overall Study|Deterioration without progression|0|||
147657372|NCT00110357|532568578|FG000|Overall Study|Disease progression/relapse|20|||
147657373|NCT00110357|532568579|FG001|Overall Study|Disease progression/relapse|15|||
147657374|NCT00110357|532568578|FG000|Overall Study|Study Closure|1|||
147657375|NCT00110357|532568579|FG001|Overall Study|Study Closure|0|||
147182122|NCT04752332|530831237|FG001|Overall Study|Physician Decision|1|||
147182123|NCT04752332|530831236|FG000|Overall Study|Protocol Violation|1|||
147182124|NCT04752332|530831237|FG001|Overall Study|Protocol Violation|1|||
147182125|NCT04752332|530831236|FG000|Overall Study|Study Terminated by IRB/ERB|0|||
147182126|NCT04752332|530831237|FG001|Overall Study|Study Terminated by IRB/ERB|2|||
147182127|NCT04752332|530831236|FG000|Overall Study|Study Terminated by Sponsor|10|||
147182128|NCT04752332|530831237|FG001|Overall Study|Study Terminated by Sponsor|48|||
147182129|NCT04752332|530831236|FG000|Overall Study|Withdrawal by Subject|11|||
147327177|NCT00763282|531363864|FG001|Overall Study|Withdrawal by Subject|5|||
147327178|NCT00763282|531363863|FG000|Overall Study|Death|4|||
147327179|NCT00763282|531363864|FG001|Overall Study|Death|3|||
147327180|NCT00763282|531363863|FG000|Overall Study|Lost to Follow-up|22|||
147327181|NCT00763282|531363864|FG001|Overall Study|Lost to Follow-up|26|||
147327182|NCT00335556|531363867|FG000|Overall Study|Death|0|||
147327183|NCT00335556|531363868|FG001|Overall Study|Death|5|||
147327184|NCT00335556|531363869|FG002|Overall Study|Death|0|||
147327185|NCT00335556|531363870|FG003|Overall Study|Death|0|||
147327186|NCT00335556|531363871|FG004|Overall Study|Death|1|||
147327187|NCT00335556|531363872|FG005|Overall Study|Death|0|||
147327188|NCT00335556|531363867|FG000|Overall Study|Lack of Efficacy|0|||
147327189|NCT00335556|531363868|FG001|Overall Study|Lack of Efficacy|19|||
147327190|NCT00335556|531363869|FG002|Overall Study|Lack of Efficacy|3|||
147327191|NCT00335556|531363870|FG003|Overall Study|Lack of Efficacy|3|||
147327192|NCT00335556|531363871|FG004|Overall Study|Lack of Efficacy|0|||
147327193|NCT00335556|531363872|FG005|Overall Study|Lack of Efficacy|1|||
147182130|NCT04752332|530831237|FG001|Overall Study|Withdrawal by Subject|3|||
147182131|NCT00924443|530831240|FG000|Overall Study|Physician Decision|2|||
147182132|NCT00924443|530831240|FG000|Overall Study|Protocol Violation|1|||
147327194|NCT00335556|531363867|FG000|Overall Study|Physician Decision|0|||
147657376|NCT00110357|532568578|FG000|Overall Study|Study Drug Toxicity|1|||
147657377|NCT00110357|532568579|FG001|Overall Study|Study Drug Toxicity|3|||
147657378|NCT00110357|532568578|FG000|Overall Study|Withdrawal by Subject|3|||
147657379|NCT00110357|532568579|FG001|Overall Study|Withdrawal by Subject|1|||
147657380|NCT04004260|532568580|FG000|Overall Study|Withdrawal by Subject|7|||
147657381|NCT04004260|532568581|FG001|Overall Study|Withdrawal by Subject|3|||
147327195|NCT00335556|531363868|FG001|Overall Study|Physician Decision|6|||
147657382|NCT04004260|532568580|FG000|Overall Study|Lost to Follow-up|22|||
147327196|NCT00335556|531363869|FG002|Overall Study|Physician Decision|2|||
147182133|NCT02451124|530831242|FG000|Overall Study|Withdrawal by Subject|1|||
147327197|NCT00335556|531363870|FG003|Overall Study|Physician Decision|1|||
147327198|NCT00335556|531363871|FG004|Overall Study|Physician Decision|0|||
147327199|NCT00335556|531363872|FG005|Overall Study|Physician Decision|0|||
147327200|NCT00335556|531363867|FG000|Overall Study|Ineligible|2|||
147327201|NCT00335556|531363868|FG001|Overall Study|Ineligible|0|||
147657383|NCT04004260|532568581|FG001|Overall Study|Lost to Follow-up|12|||
147657384|NCT04004260|532568580|FG000|Overall Study|Did not engage in intervention|13|||
147657385|NCT04004260|532568581|FG001|Overall Study|Did not engage in intervention|17|||
147657386|NCT03382418|532568582|FG000|Overall Study|Withdrawal by Subject|1|||
147657387|NCT03382418|532568583|FG001|Overall Study|Withdrawal by Subject|0|||
147657388|NCT03382418|532568584|FG002|Overall Study|Withdrawal by Subject|0|||
147657389|NCT03382418|532568582|FG000|Overall Study|Lost to Follow-up|2|||
147657390|NCT03382418|532568583|FG001|Overall Study|Lost to Follow-up|3|||
147657391|NCT03382418|532568584|FG002|Overall Study|Lost to Follow-up|0|||
147657392|NCT02360280|532568585|FG000|Overall Study|Withdrawal by Subject|2|||
147657393|NCT02360280|532568586|FG001|Overall Study|Withdrawal by Subject|0|||
147657394|NCT02360280|532568585|FG000|Overall Study|Adverse Event|0|||
147657395|NCT02360280|532568586|FG001|Overall Study|Adverse Event|1|||
147657396|NCT02360280|532568585|FG000|Overall Study|Lost to Follow-up|1|||
147657397|NCT02360280|532568586|FG001|Overall Study|Lost to Follow-up|0|||
147657398|NCT05464420|532568587|FG000|Overall Study|Death|0|||
147657399|NCT05464420|532568588|FG001|Overall Study|Death|0|||
147657400|NCT05464420|532568589|FG002|Overall Study|Death|0|||
147657401|NCT05464420|532568590|FG003|Overall Study|Death|1|||
147657402|NCT05464420|532568587|FG000|Overall Study|Lost to Follow-up|16|||
147657403|NCT05464420|532568588|FG001|Overall Study|Lost to Follow-up|11|||
147657404|NCT05464420|532568589|FG002|Overall Study|Lost to Follow-up|11|||
147657405|NCT05464420|532568590|FG003|Overall Study|Lost to Follow-up|11|||
147657406|NCT05464420|532568587|FG000|Overall Study|Randomized in Error Without Study Treatment|0|||
147657407|NCT05464420|532568588|FG001|Overall Study|Randomized in Error Without Study Treatment|1|||
147657408|NCT05464420|532568589|FG002|Overall Study|Randomized in Error Without Study Treatment|0|||
147657409|NCT05464420|532568590|FG003|Overall Study|Randomized in Error Without Study Treatment|0|||
147657410|NCT05464420|532568587|FG000|Overall Study|Withdrawal by Subject|4|||
147657411|NCT05464420|532568588|FG001|Overall Study|Withdrawal by Subject|8|||
147657412|NCT05464420|532568589|FG002|Overall Study|Withdrawal by Subject|3|||
147448522|NCT03349099|531805750|FG001|Overall Study|Stone migrated from the kidney|0|||
147448523|NCT00278993|531805751|FG000|Overall Study|Adverse Event|24|||
147657413|NCT05464420|532568590|FG003|Overall Study|Withdrawal by Subject|1|||
147657414|NCT05464420|532568587|FG000|Overall Study|Protocol Violation|0|||
147657415|NCT05464420|532568588|FG001|Overall Study|Protocol Violation|0|||
147657416|NCT05464420|532568589|FG002|Overall Study|Protocol Violation|1|||
147657417|NCT05464420|532568590|FG003|Overall Study|Protocol Violation|1|||
147657418|NCT05464420|532568587|FG000|Overall Study|Unable to Adhere to Study Schedule|0|||
147657419|NCT05464420|532568588|FG001|Overall Study|Unable to Adhere to Study Schedule|0|||
147657420|NCT05464420|532568589|FG002|Overall Study|Unable to Adhere to Study Schedule|1|||
147657421|NCT05464420|532568590|FG003|Overall Study|Unable to Adhere to Study Schedule|0|||
147657422|NCT01383018|532568591|FG000|Overall Study|Adverse Event|14|||
147657423|NCT01383018|532568591|FG000|Overall Study|Death|10|||
147657424|NCT01383018|532568591|FG000|Overall Study|Lost to Follow-up|5|||
147657425|NCT01383018|532568591|FG000|Overall Study|Physician Decision|5|||
147657426|NCT01383018|532568591|FG000|Overall Study|Withdrawal by Subject|9|||
147657427|NCT01383018|532568591|FG000|Overall Study|Subject not implanted|76|||
147657428|NCT01383018|532568591|FG000|Overall Study|Missed Visit|247|||
147657429|NCT01383018|532568591|FG000|Overall Study|Site closed early-not compliance related|7|||
147657430|NCT01383018|532568591|FG000|Overall Study|Patient moved away from site|1|||
147657431|NCT01383018|532568591|FG000|Overall Study|Subject Incarcerated|1|||
147657432|NCT02472886|532568593|FG000|Overall Study|Lack of Efficacy|0|||
147657433|NCT02472886|532568594|FG001|Overall Study|Lack of Efficacy|2|||
147657434|NCT02472886|532568595|FG002|Overall Study|Lack of Efficacy|1|||
147657435|NCT00320788|532568596|FG000|Overall Study|Adverse Event|0|||
147657436|NCT00320788|532568597|FG001|Overall Study|Adverse Event|0|||
147657437|NCT00320788|532568598|FG002|Overall Study|Adverse Event|0|||
147657438|NCT00320788|532568599|FG003|Overall Study|Adverse Event|1|||
147657439|NCT00320788|532568600|FG004|Overall Study|Adverse Event|0|||
147657440|NCT00320788|532568596|FG000|Overall Study|Death|0|||
147448524|NCT00278993|531805751|FG000|Overall Study|Withdrawal by Subject|5|||
147657441|NCT00320788|532568597|FG001|Overall Study|Death|0|||
147657442|NCT00320788|532568598|FG002|Overall Study|Death|1|||
147182134|NCT03301350|530831243|FG000|Overall Study|Withdrawal by Subject|4|||
147182135|NCT03301350|530831243|FG000|Overall Study|Adverse Event|1|||
147182136|NCT03301350|530831243|FG000|Overall Study|Pt withdrawn per DSMC request|1|||
147182137|NCT03301350|530831243|FG000|Overall Study|completed all chemo cycles, however died prior to definitive surgery|1|||
147448525|NCT00278993|531805751|FG000|Overall Study|Progressive Disease|65|||
147448526|NCT00278993|531805751|FG000|Overall Study|Physician Decision|9|||
147657443|NCT00320788|532568599|FG003|Overall Study|Death|0|||
147657444|NCT00320788|532568600|FG004|Overall Study|Death|1|||
147657445|NCT00320788|532568596|FG000|Overall Study|Lost to Follow-up|0|||
147657446|NCT00320788|532568597|FG001|Overall Study|Lost to Follow-up|2|||
147657447|NCT00320788|532568598|FG002|Overall Study|Lost to Follow-up|1|||
147657448|NCT00320788|532568599|FG003|Overall Study|Lost to Follow-up|0|||
147657449|NCT00320788|532568600|FG004|Overall Study|Lost to Follow-up|0|||
147657450|NCT00320788|532568596|FG000|Overall Study|Decision by the Sponsor|1|||
147657451|NCT00320788|532568597|FG001|Overall Study|Decision by the Sponsor|1|||
147657452|NCT00320788|532568598|FG002|Overall Study|Decision by the Sponsor|0|||
147657453|NCT00320788|532568599|FG003|Overall Study|Decision by the Sponsor|0|||
147657454|NCT00320788|532568600|FG004|Overall Study|Decision by the Sponsor|1|||
147657455|NCT00320788|532568596|FG000|Overall Study|Other|1|||
147657456|NCT00320788|532568597|FG001|Overall Study|Other|2|||
147657457|NCT00320788|532568598|FG002|Overall Study|Other|1|||
147657458|NCT00320788|532568599|FG003|Overall Study|Other|1|||
147182138|NCT03301350|530831243|FG000|Overall Study|no detail provided|1|||
147182139|NCT01248949|530831244|FG000|Overall Study|Lost to Follow-up|2|||
147182140|NCT01248949|530831245|FG001|Overall Study|Lost to Follow-up|2|||
147182141|NCT01248949|530831246|FG002|Overall Study|Lost to Follow-up|2|||
147657459|NCT00320788|532568600|FG004|Overall Study|Other|1|||
147657460|NCT00320788|532568596|FG000|Overall Study|Physician Decision|1|||
147657461|NCT00320788|532568597|FG001|Overall Study|Physician Decision|1|||
147657462|NCT00320788|532568598|FG002|Overall Study|Physician Decision|0|||
147657463|NCT00320788|532568599|FG003|Overall Study|Physician Decision|0|||
147657464|NCT00320788|532568600|FG004|Overall Study|Physician Decision|0|||
147182142|NCT01248949|530831247|FG003|Overall Study|Lost to Follow-up|1|||
147182143|NCT01248949|530831248|FG004|Overall Study|Lost to Follow-up|0|||
147182144|NCT01248949|530831244|FG000|Overall Study|Withdrawal by Subject|5|||
147182145|NCT01248949|530831245|FG001|Overall Study|Withdrawal by Subject|3|||
147182146|NCT01248949|530831246|FG002|Overall Study|Withdrawal by Subject|11|||
147182147|NCT01248949|530831247|FG003|Overall Study|Withdrawal by Subject|3|||
147182148|NCT01248949|530831248|FG004|Overall Study|Withdrawal by Subject|1|||
147182149|NCT01248949|530831244|FG000|Overall Study|Death|22|||
147182150|NCT01248949|530831245|FG001|Overall Study|Death|7|||
147182151|NCT01248949|530831246|FG002|Overall Study|Death|21|||
147182152|NCT01248949|530831247|FG003|Overall Study|Death|6|||
147182153|NCT01248949|530831248|FG004|Overall Study|Death|2|||
147182154|NCT01248949|530831244|FG000|Overall Study|Alternative Therapy|1|||
147182155|NCT01248949|530831245|FG001|Overall Study|Alternative Therapy|0|||
147182156|NCT01248949|530831246|FG002|Overall Study|Alternative Therapy|0|||
147182157|NCT01248949|530831247|FG003|Overall Study|Alternative Therapy|0|||
147182158|NCT01248949|530831248|FG004|Overall Study|Alternative Therapy|0|||
147657465|NCT00320788|532568596|FG000|Overall Study|Protocol Violation|0|||
147657466|NCT00320788|532568597|FG001|Overall Study|Protocol Violation|0|||
147657467|NCT00320788|532568598|FG002|Overall Study|Protocol Violation|0|||
147657468|NCT00320788|532568599|FG003|Overall Study|Protocol Violation|0|||
147657469|NCT00320788|532568600|FG004|Overall Study|Protocol Violation|1|||
147657470|NCT00320788|532568596|FG000|Overall Study|Withdrawal by Subject|3|||
147657471|NCT00320788|532568597|FG001|Overall Study|Withdrawal by Subject|0|||
147657472|NCT00320788|532568598|FG002|Overall Study|Withdrawal by Subject|0|||
147657473|NCT00320788|532568599|FG003|Overall Study|Withdrawal by Subject|3|||
147657474|NCT00320788|532568600|FG004|Overall Study|Withdrawal by Subject|1|||
147657475|NCT03414229|532568601|FG000|Overall Study|Adverse Event|1|||
147657476|NCT03414229|532568602|FG001|Overall Study|Adverse Event|0|||
147182159|NCT01248949|530831244|FG000|Overall Study|Alternative Therapy.|1|||
147182160|NCT01248949|530831245|FG001|Overall Study|Alternative Therapy.|0|||
147182161|NCT01248949|530831246|FG002|Overall Study|Alternative Therapy.|0|||
147182162|NCT01248949|530831247|FG003|Overall Study|Alternative Therapy.|0|||
147182163|NCT01248949|530831248|FG004|Overall Study|Alternative Therapy.|0|||
147182164|NCT01248949|530831244|FG000|Overall Study|Palliative Radiation To Brain Metastases|1|||
147182165|NCT01248949|530831245|FG001|Overall Study|Palliative Radiation To Brain Metastases|0|||
147182166|NCT01248949|530831246|FG002|Overall Study|Palliative Radiation To Brain Metastases|0|||
147327202|NCT00335556|531363869|FG002|Overall Study|Ineligible|0|||
147327203|NCT00335556|531363870|FG003|Overall Study|Ineligible|0|||
147327204|NCT00335556|531363871|FG004|Overall Study|Ineligible|0|||
147327205|NCT00335556|531363872|FG005|Overall Study|Ineligible|0|||
147327206|NCT00335556|531363867|FG000|Overall Study|Refusal of further protocol therapy|0|||
147327207|NCT00335556|531363868|FG001|Overall Study|Refusal of further protocol therapy|4|||
147327208|NCT00335556|531363869|FG002|Overall Study|Refusal of further protocol therapy|0|||
147327209|NCT00335556|531363870|FG003|Overall Study|Refusal of further protocol therapy|1|||
147182167|NCT01248949|530831247|FG003|Overall Study|Palliative Radiation To Brain Metastases|0|||
147182168|NCT01248949|530831248|FG004|Overall Study|Palliative Radiation To Brain Metastases|0|||
147182169|NCT01248949|530831244|FG000|Overall Study|Entered Hospice And Refused Follow Up|0|||
147327210|NCT00335556|531363871|FG004|Overall Study|Refusal of further protocol therapy|0|||
147327211|NCT00335556|531363872|FG005|Overall Study|Refusal of further protocol therapy|0|||
147327212|NCT02365298|531363873|FG000|Period 2|incorrect Rx dispensed|1|||
147657477|NCT03414229|532568603|FG002|Overall Study|Adverse Event|2|||
147657478|NCT03414229|532568604|FG003|Overall Study|Adverse Event|1|||
147657479|NCT03414229|532568601|FG000|Overall Study|Lack of Efficacy|7|||
147657480|NCT03414229|532568602|FG001|Overall Study|Lack of Efficacy|4|||
147657481|NCT03414229|532568603|FG002|Overall Study|Lack of Efficacy|1|||
147182170|NCT01248949|530831245|FG001|Overall Study|Entered Hospice And Refused Follow Up|0|||
147182171|NCT01248949|530831246|FG002|Overall Study|Entered Hospice And Refused Follow Up|0|||
147182172|NCT01248949|530831247|FG003|Overall Study|Entered Hospice And Refused Follow Up|0|||
147327213|NCT02365298|531363874|FG001|Period 2|incorrect Rx dispensed|0|||
147327214|NCT02365298|531363873|FG000|Period 2|Discontinued at request of Sponsor|1|||
147182173|NCT01248949|530831248|FG004|Overall Study|Entered Hospice And Refused Follow Up|1|||
147182174|NCT01248949|530831244|FG000|Overall Study|Participant Went To Hospice|0|||
147182175|NCT01248949|530831245|FG001|Overall Study|Participant Went To Hospice|0|||
147182176|NCT01248949|530831246|FG002|Overall Study|Participant Went To Hospice|1|||
147182177|NCT01248949|530831247|FG003|Overall Study|Participant Went To Hospice|0|||
147182178|NCT01248949|530831248|FG004|Overall Study|Participant Went To Hospice|0|||
147327215|NCT02365298|531363874|FG001|Period 2|Discontinued at request of Sponsor|0|||
147327216|NCT02365298|531363873|FG000|Period 2|Test Article longer available|0|||
147327217|NCT02365298|531363874|FG001|Period 2|Test Article longer available|1|||
147327218|NCT02365298|531363873|FG000|Period 2|Protocol Violation|0|||
147327219|NCT02365298|531363874|FG001|Period 2|Protocol Violation|1|||
147327220|NCT03736785|531363875|FG000|Overall Study|Adverse Event|1|||
147327221|NCT03736785|531363876|FG001|Overall Study|Adverse Event|1|||
147327222|NCT03736785|531363877|FG002|Overall Study|Adverse Event|1|||
147327223|NCT03736785|531363875|FG000|Overall Study|Death|1|||
147327224|NCT03736785|531363876|FG001|Overall Study|Death|0|||
147327225|NCT03736785|531363877|FG002|Overall Study|Death|1|||
147327226|NCT03736785|531363875|FG000|Overall Study|Lost to Follow-up|0|||
147327227|NCT03736785|531363876|FG001|Overall Study|Lost to Follow-up|2|||
147327228|NCT03736785|531363877|FG002|Overall Study|Lost to Follow-up|3|||
147327229|NCT03736785|531363875|FG000|Overall Study|Non compliance with study drug|1|||
147327230|NCT03736785|531363876|FG001|Overall Study|Non compliance with study drug|1|||
147327231|NCT03736785|531363877|FG002|Overall Study|Non compliance with study drug|0|||
147327232|NCT03736785|531363875|FG000|Overall Study|Physician Decision|0|||
147327233|NCT03736785|531363876|FG001|Overall Study|Physician Decision|1|||
147327234|NCT03736785|531363877|FG002|Overall Study|Physician Decision|1|||
147327235|NCT03736785|531363875|FG000|Overall Study|Protocol Violation|1|||
147327236|NCT03736785|531363876|FG001|Overall Study|Protocol Violation|4|||
147327237|NCT03736785|531363877|FG002|Overall Study|Protocol Violation|3|||
147327238|NCT03736785|531363875|FG000|Overall Study|Sponsor Decision|1|||
147327239|NCT03736785|531363876|FG001|Overall Study|Sponsor Decision|0|||
147327240|NCT03736785|531363877|FG002|Overall Study|Sponsor Decision|0|||
147327241|NCT03736785|531363875|FG000|Overall Study|Unknown/Missing data|3|||
147327242|NCT03736785|531363876|FG001|Overall Study|Unknown/Missing data|2|||
147327243|NCT03736785|531363877|FG002|Overall Study|Unknown/Missing data|1|||
147327244|NCT03736785|531363875|FG000|Overall Study|Withdrawal by Subject|9|||
147327245|NCT03736785|531363876|FG001|Overall Study|Withdrawal by Subject|6|||
147327246|NCT03736785|531363877|FG002|Overall Study|Withdrawal by Subject|4|||
147327247|NCT00320489|531363880|FG000|Overall Study|Adverse Event|26|||
147327248|NCT00320489|531363881|FG001|Overall Study|Adverse Event|25|||
147327249|NCT00320489|531363880|FG000|Overall Study|Clinical Relapse|26|||
147327250|NCT00320489|531363881|FG001|Overall Study|Clinical Relapse|20|||
147327251|NCT00320489|531363880|FG000|Overall Study|Death|0|||
147327252|NCT00320489|531363881|FG001|Overall Study|Death|2|||
147327253|NCT00320489|531363880|FG000|Overall Study|Entry Criteria Exclusion|2|||
147327254|NCT00320489|531363881|FG001|Overall Study|Entry Criteria Exclusion|4|||
147327255|NCT00320489|531363880|FG000|Overall Study|Lack of Efficacy|16|||
147327256|NCT00320489|531363881|FG001|Overall Study|Lack of Efficacy|7|||
147327257|NCT00320489|531363880|FG000|Overall Study|Lost to Follow-up|21|||
147327258|NCT00320489|531363881|FG001|Overall Study|Lost to Follow-up|22|||
147327259|NCT00320489|531363880|FG000|Overall Study|Physician Decision|8|||
147327260|NCT00320489|531363881|FG001|Overall Study|Physician Decision|8|||
147327261|NCT00320489|531363880|FG000|Overall Study|Protocol Violation|4|||
147327262|NCT00320489|531363881|FG001|Overall Study|Protocol Violation|4|||
147327263|NCT00320489|531363880|FG000|Overall Study|Sponsor Decision|3|||
147327264|NCT00320489|531363881|FG001|Overall Study|Sponsor Decision|3|||
147327265|NCT00320489|531363880|FG000|Overall Study|Withdrawal by Subject|39|||
147327266|NCT00320489|531363881|FG001|Overall Study|Withdrawal by Subject|41|||
147327267|NCT03441984|531363882|FG000|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
147327268|NCT03441984|531363883|FG001|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
147327269|NCT03441984|531363884|FG002|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|1|||
147327270|NCT03441984|531363885|FG003|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
147182179|NCT01248949|530831244|FG000|Overall Study|Per Sponsor Request o Discontinue Drug|1|||
147182180|NCT01248949|530831245|FG001|Overall Study|Per Sponsor Request o Discontinue Drug|0|||
147327271|NCT03441984|531363886|FG004|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
147327272|NCT03441984|531363887|FG005|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
147327273|NCT03441984|531363888|FG006|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
147327274|NCT03441984|531363889|FG007|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
147327275|NCT03441984|531363890|FG008|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
147327276|NCT03441984|531363891|FG009|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
147327277|NCT03441984|531363892|FG010|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
147327278|NCT03441984|531363893|FG011|Part 1: Period 2 (Up to Day 4 )|Positive urine drug screen lab value|0|||
147327279|NCT02107014|531363897|FG000|Overall Study|Withdrew before drug: moving interstate|1|||
147327280|NCT03852433|531363901|FG000|Overall Study|Withdrawal of consent|5|||
147182181|NCT01248949|530831246|FG002|Overall Study|Per Sponsor Request o Discontinue Drug|0|||
147182182|NCT01248949|530831247|FG003|Overall Study|Per Sponsor Request o Discontinue Drug|0|||
147182183|NCT01248949|530831248|FG004|Overall Study|Per Sponsor Request o Discontinue Drug|0|||
147182184|NCT01248949|530831244|FG000|Overall Study|Pi Decision Due To Declining Status|0|||
147182185|NCT01248949|530831245|FG001|Overall Study|Pi Decision Due To Declining Status|0|||
147182186|NCT01248949|530831246|FG002|Overall Study|Pi Decision Due To Declining Status|1|||
147182187|NCT01248949|530831247|FG003|Overall Study|Pi Decision Due To Declining Status|0|||
147182188|NCT01248949|530831248|FG004|Overall Study|Pi Decision Due To Declining Status|0|||
147182189|NCT01248949|530831244|FG000|Overall Study|Pi Discretion Due To Hospitalisation|0|||
147182190|NCT01248949|530831245|FG001|Overall Study|Pi Discretion Due To Hospitalisation|1|||
147182191|NCT01248949|530831246|FG002|Overall Study|Pi Discretion Due To Hospitalisation|0|||
147657482|NCT03414229|532568604|FG003|Overall Study|Lack of Efficacy|9|||
147182192|NCT01248949|530831247|FG003|Overall Study|Pi Discretion Due To Hospitalisation|0|||
147246396|NCT03129100|531072770|FG011|Lead-In Period (Period 1)|Adverse Event|0|||
147246397|NCT03129100|531072771|FG012|Lead-In Period (Period 1)|Adverse Event|0|||
147246398|NCT03129100|531072772|FG013|Lead-In Period (Period 1)|Adverse Event|0|||
147246399|NCT03129100|531072773|FG014|Lead-In Period (Period 1)|Adverse Event|0|||
147246400|NCT03129100|531072774|FG015|Lead-In Period (Period 1)|Adverse Event|0|||
147246401|NCT03129100|531072775|FG016|Lead-In Period (Period 1)|Adverse Event|0|||
147246402|NCT03129100|531072776|FG017|Lead-In Period (Period 1)|Adverse Event|0|||
147246403|NCT03129100|531072777|FG018|Lead-In Period (Period 1)|Adverse Event|0|||
147246404|NCT03129100|531072778|FG019|Lead-In Period (Period 1)|Adverse Event|0|||
147246405|NCT03129100|531072779|FG020|Lead-In Period (Period 1)|Adverse Event|0|||
147246406|NCT03129100|531072780|FG021|Lead-In Period (Period 1)|Adverse Event|0|||
147246407|NCT03129100|531072781|FG022|Lead-In Period (Period 1)|Adverse Event|0|||
147246408|NCT03129100|531072782|FG023|Lead-In Period (Period 1)|Adverse Event|0|||
147246409|NCT03129100|531072783|FG024|Lead-In Period (Period 1)|Adverse Event|0|||
147246410|NCT03129100|531072784|FG025|Lead-In Period (Period 1)|Adverse Event|0|||
147246411|NCT03129100|531072759|FG000|Lead-In Period (Period 1)|Lost to Follow-up|2|||
147246412|NCT03129100|531072760|FG001|Lead-In Period (Period 1)|Lost to Follow-up|0|||
147246413|NCT03129100|531072761|FG002|Lead-In Period (Period 1)|Lost to Follow-up|0|||
147246414|NCT03129100|531072762|FG003|Lead-In Period (Period 1)|Lost to Follow-up|0|||
147246415|NCT03129100|531072763|FG004|Lead-In Period (Period 1)|Lost to Follow-up|0|||
147246416|NCT03129100|531072764|FG005|Lead-In Period (Period 1)|Lost to Follow-up|0|||
147246417|NCT03129100|531072765|FG006|Lead-In Period (Period 1)|Lost to Follow-up|0|||
147246418|NCT03129100|531072766|FG007|Lead-In Period (Period 1)|Lost to Follow-up|0|||
147246419|NCT03129100|531072767|FG008|Lead-In Period (Period 1)|Lost to Follow-up|0|||
147246420|NCT03129100|531072768|FG009|Lead-In Period (Period 1)|Lost to Follow-up|0|||
147246421|NCT03129100|531072769|FG010|Lead-In Period (Period 1)|Lost to Follow-up|0|||
147246422|NCT03129100|531072770|FG011|Lead-In Period (Period 1)|Lost to Follow-up|0|||
147246423|NCT03129100|531072771|FG012|Lead-In Period (Period 1)|Lost to Follow-up|0|||
147246424|NCT03129100|531072772|FG013|Lead-In Period (Period 1)|Lost to Follow-up|0|||
147246425|NCT03129100|531072773|FG014|Lead-In Period (Period 1)|Lost to Follow-up|0|||
147246426|NCT03129100|531072774|FG015|Lead-In Period (Period 1)|Lost to Follow-up|0|||
147246427|NCT03129100|531072775|FG016|Lead-In Period (Period 1)|Lost to Follow-up|0|||
147246428|NCT03129100|531072776|FG017|Lead-In Period (Period 1)|Lost to Follow-up|0|||
147246429|NCT03129100|531072777|FG018|Lead-In Period (Period 1)|Lost to Follow-up|0|||
147246430|NCT03129100|531072778|FG019|Lead-In Period (Period 1)|Lost to Follow-up|0|||
147246431|NCT03129100|531072779|FG020|Lead-In Period (Period 1)|Lost to Follow-up|0|||
147246432|NCT03129100|531072780|FG021|Lead-In Period (Period 1)|Lost to Follow-up|0|||
147246433|NCT03129100|531072781|FG022|Lead-In Period (Period 1)|Lost to Follow-up|0|||
147246434|NCT03129100|531072782|FG023|Lead-In Period (Period 1)|Lost to Follow-up|0|||
147246435|NCT03129100|531072783|FG024|Lead-In Period (Period 1)|Lost to Follow-up|0|||
147246436|NCT03129100|531072784|FG025|Lead-In Period (Period 1)|Lost to Follow-up|0|||
147246437|NCT03129100|531072759|FG000|Lead-In Period (Period 1)|Withdrawal by Subject|8|||
147246438|NCT03129100|531072760|FG001|Lead-In Period (Period 1)|Withdrawal by Subject|8|||
147246439|NCT03129100|531072761|FG002|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
147246440|NCT03129100|531072762|FG003|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
147246441|NCT03129100|531072763|FG004|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
147246442|NCT03129100|531072764|FG005|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
147246443|NCT03129100|531072765|FG006|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
147246444|NCT03129100|531072766|FG007|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
147246445|NCT03129100|531072767|FG008|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
147246446|NCT03129100|531072768|FG009|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
147246447|NCT03129100|531072769|FG010|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
147246448|NCT03129100|531072770|FG011|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
147246449|NCT03129100|531072771|FG012|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
147246450|NCT03129100|531072772|FG013|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
147246451|NCT03129100|531072773|FG014|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
147246452|NCT03129100|531072774|FG015|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
147246453|NCT03129100|531072775|FG016|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
147448527|NCT00278993|531805751|FG000|Overall Study|Not Otherwise Specified|4|||
147448528|NCT03451773|531807888|FG000|Overall Study|Death on study|1|||
147448529|NCT03451773|531807889|FG001|Overall Study|Death on study|5|||
147448530|NCT03451773|531807888|FG000|Overall Study|Death during follow-up period|0|||
147448531|NCT03451773|531807889|FG001|Overall Study|Death during follow-up period|1|||
147448532|NCT01964352|531807890|FG000|Overall Study|Adverse Event|13|||
147448533|NCT01964352|531807891|FG001|Overall Study|Adverse Event|3|||
147182193|NCT01248949|530831248|FG004|Overall Study|Pi Discretion Due To Hospitalisation|0|||
147327281|NCT03852433|531363902|FG001|Overall Study|Withdrawal of consent|8|||
147327282|NCT03852433|531363903|FG002|Overall Study|Withdrawal of consent|1|||
147327283|NCT03852433|531363904|FG003|Overall Study|Withdrawal of consent|1|||
147327284|NCT03852433|531363901|FG000|Overall Study|Adverse Event|1|||
147327285|NCT03852433|531363902|FG001|Overall Study|Adverse Event|1|||
147327286|NCT03852433|531363903|FG002|Overall Study|Adverse Event|1|||
147327287|NCT03852433|531363904|FG003|Overall Study|Adverse Event|1|||
147327288|NCT03852433|531363901|FG000|Overall Study|Lost to Follow-up|0|||
147327289|NCT03852433|531363902|FG001|Overall Study|Lost to Follow-up|1|||
147327290|NCT03852433|531363903|FG002|Overall Study|Lost to Follow-up|0|||
147327291|NCT03852433|531363904|FG003|Overall Study|Lost to Follow-up|1|||
147327292|NCT03852433|531363901|FG000|Overall Study|Pregnancy|0|||
147327293|NCT03852433|531363902|FG001|Overall Study|Pregnancy|1|||
147327294|NCT03852433|531363903|FG002|Overall Study|Pregnancy|1|||
147327295|NCT03852433|531363904|FG003|Overall Study|Pregnancy|0|||
147327296|NCT03852433|531363901|FG000|Overall Study|Protocol Violation|0|||
147327297|NCT03852433|531363902|FG001|Overall Study|Protocol Violation|0|||
147327298|NCT03852433|531363903|FG002|Overall Study|Protocol Violation|1|||
147327299|NCT03852433|531363904|FG003|Overall Study|Protocol Violation|1|||
147327300|NCT03852433|531363901|FG000|Overall Study|Death|0|||
147327301|NCT03852433|531363902|FG001|Overall Study|Death|0|||
147327302|NCT03852433|531363903|FG002|Overall Study|Death|1|||
147327303|NCT03852433|531363904|FG003|Overall Study|Death|0|||
147327304|NCT03852433|531363901|FG000|Overall Study|Lack of Efficacy|0|||
147327305|NCT03852433|531363902|FG001|Overall Study|Lack of Efficacy|1|||
147327306|NCT03852433|531363903|FG002|Overall Study|Lack of Efficacy|0|||
147327307|NCT03852433|531363904|FG003|Overall Study|Lack of Efficacy|0|||
147327308|NCT03852433|531363901|FG000|Overall Study|Non-compliance with study drug|0|||
147327309|NCT03852433|531363902|FG001|Overall Study|Non-compliance with study drug|0|||
147327310|NCT03852433|531363903|FG002|Overall Study|Non-compliance with study drug|0|||
147327311|NCT03852433|531363904|FG003|Overall Study|Non-compliance with study drug|1|||
147327312|NCT03852433|531363901|FG000|Overall Study|Physician Decision|1|||
147327313|NCT03852433|531363902|FG001|Overall Study|Physician Decision|0|||
147327314|NCT03852433|531363903|FG002|Overall Study|Physician Decision|0|||
147327315|NCT03852433|531363904|FG003|Overall Study|Physician Decision|0|||
147327316|NCT03852433|531363901|FG000|Overall Study|Randomized but never treated|1|||
147327317|NCT03852433|531363902|FG001|Overall Study|Randomized but never treated|0|||
147327318|NCT03852433|531363903|FG002|Overall Study|Randomized but never treated|0|||
147327319|NCT03852433|531363904|FG003|Overall Study|Randomized but never treated|0|||
147327320|NCT00746330|531363905|FG000|Period 1|Abnormal test procedure result|0|||
147327321|NCT00746330|531363906|FG001|Period 1|Abnormal test procedure result|0|||
147327322|NCT00746330|531363907|FG002|Period 1|Abnormal test procedure result|1|||
147327323|NCT00746330|531363908|FG003|Period 1|Abnormal test procedure result|0|||
147327324|NCT01981850|531363909|FG000|Main Phase Stage 1|Death|2|||
147327325|NCT01981850|531363910|FG001|Main Phase Stage 1|Death|0|||
147327326|NCT01981850|531363911|FG002|Main Phase Stage 1|Death|0|||
147327327|NCT01981850|531363912|FG003|Main Phase Stage 1|Death|0|||
147327328|NCT01981850|531363913|FG004|Main Phase Stage 1|Death|0|||
147327329|NCT01981850|531363914|FG005|Main Phase Stage 1|Death|0|||
147327330|NCT01981850|531363915|FG006|Main Phase Stage 1|Death|0|||
147327331|NCT01981850|531363916|FG007|Main Phase Stage 1|Death|0|||
147327332|NCT01981850|531363917|FG008|Main Phase Stage 1|Death|0|||
147327333|NCT01981850|531363918|FG009|Main Phase Stage 1|Death|0|||
147327334|NCT01981850|531363909|FG000|Main Phase Stage 1|Informed Consent Withdrawn|1|||
147327335|NCT01981850|531363910|FG001|Main Phase Stage 1|Informed Consent Withdrawn|0|||
147327336|NCT01981850|531363911|FG002|Main Phase Stage 1|Informed Consent Withdrawn|0|||
147327337|NCT01981850|531363912|FG003|Main Phase Stage 1|Informed Consent Withdrawn|0|||
147327338|NCT01981850|531363913|FG004|Main Phase Stage 1|Informed Consent Withdrawn|0|||
147327339|NCT01981850|531363914|FG005|Main Phase Stage 1|Informed Consent Withdrawn|0|||
147327340|NCT01981850|531363915|FG006|Main Phase Stage 1|Informed Consent Withdrawn|0|||
147327341|NCT01981850|531363916|FG007|Main Phase Stage 1|Informed Consent Withdrawn|0|||
147327342|NCT01981850|531363917|FG008|Main Phase Stage 1|Informed Consent Withdrawn|0|||
147327343|NCT01981850|531363918|FG009|Main Phase Stage 1|Informed Consent Withdrawn|0|||
147327344|NCT01981850|531363909|FG000|Main Phase Stage 1|Lack of Efficacy|0|||
147448534|NCT01964352|531807892|FG002|Overall Study|Adverse Event|4|||
147327345|NCT01981850|531363910|FG001|Main Phase Stage 1|Lack of Efficacy|2|||
147327346|NCT01981850|531363911|FG002|Main Phase Stage 1|Lack of Efficacy|0|||
147327347|NCT01981850|531363912|FG003|Main Phase Stage 1|Lack of Efficacy|0|||
147327348|NCT01981850|531363913|FG004|Main Phase Stage 1|Lack of Efficacy|0|||
147327349|NCT01981850|531363914|FG005|Main Phase Stage 1|Lack of Efficacy|0|||
147657483|NCT03414229|532568601|FG000|Overall Study|Change in therapy|1|||
147657484|NCT03414229|532568602|FG001|Overall Study|Change in therapy|0|||
147182194|NCT01248949|530831244|FG000|Overall Study|Lesion In ThoracicSpine Requires Therapy|0|||
147182195|NCT01248949|530831245|FG001|Overall Study|Lesion In ThoracicSpine Requires Therapy|0|||
147182196|NCT01248949|530831246|FG002|Overall Study|Lesion In ThoracicSpine Requires Therapy|1|||
147182197|NCT01248949|530831247|FG003|Overall Study|Lesion In ThoracicSpine Requires Therapy|0|||
147182198|NCT01248949|530831248|FG004|Overall Study|Lesion In ThoracicSpine Requires Therapy|0|||
147182199|NCT00286429|530831249|FG000|Overall Study|Adverse Event|4|||
147182200|NCT00286429|530831250|FG001|Overall Study|Adverse Event|1|||
147182201|NCT00286429|530831251|FG002|Overall Study|Adverse Event|6|||
147182202|NCT00286429|530831249|FG000|Overall Study|Lack of Efficacy|52|||
147182203|NCT00286429|530831250|FG001|Overall Study|Lack of Efficacy|27|||
147182204|NCT00286429|530831251|FG002|Overall Study|Lack of Efficacy|25|||
147182205|NCT00286429|530831249|FG000|Overall Study|Lost to Follow-up|2|||
147182206|NCT00286429|530831250|FG001|Overall Study|Lost to Follow-up|4|||
147182207|NCT00286429|530831251|FG002|Overall Study|Lost to Follow-up|3|||
147182208|NCT00286429|530831249|FG000|Overall Study|Physician Decision|10|||
147182209|NCT00286429|530831250|FG001|Overall Study|Physician Decision|7|||
147182210|NCT00286429|530831251|FG002|Overall Study|Physician Decision|7|||
147182211|NCT00286429|530831249|FG000|Overall Study|Protocol Violation|3|||
147182212|NCT00286429|530831250|FG001|Overall Study|Protocol Violation|5|||
147182213|NCT00286429|530831251|FG002|Overall Study|Protocol Violation|4|||
147182214|NCT00286429|530831249|FG000|Overall Study|Withdrawal by Subject|3|||
147182215|NCT00286429|530831250|FG001|Overall Study|Withdrawal by Subject|2|||
147182216|NCT00286429|530831251|FG002|Overall Study|Withdrawal by Subject|6|||
147182217|NCT00286429|530831249|FG000|Overall Study|Administrative Error|1|||
147182218|NCT00286429|530831250|FG001|Overall Study|Administrative Error|1|||
147182219|NCT00286429|530831251|FG002|Overall Study|Administrative Error|1|||
147182220|NCT00286429|530831249|FG000|Overall Study|Administrative Decision|0|||
147182221|NCT00286429|530831250|FG001|Overall Study|Administrative Decision|1|||
147182222|NCT00286429|530831251|FG002|Overall Study|Administrative Decision|0|||
147182223|NCT01746225|530831254|FG000|Overall Study|Death|1|||
147182224|NCT01746225|530831255|FG001|Overall Study|Death|0|||
147182225|NCT01746225|530831256|FG002|Overall Study|Death|1|||
147182226|NCT01746225|530831254|FG000|Overall Study|Withdrawal by Subject|5|||
147246454|NCT03129100|531072776|FG017|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
147246455|NCT03129100|531072777|FG018|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
147246456|NCT03129100|531072778|FG019|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
147246457|NCT03129100|531072779|FG020|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
147657485|NCT03414229|532568603|FG002|Overall Study|Change in therapy|0|||
147657486|NCT03414229|532568604|FG003|Overall Study|Change in therapy|0|||
147657487|NCT03414229|532568601|FG000|Overall Study|Pregnancy|0|||
147657488|NCT03414229|532568602|FG001|Overall Study|Pregnancy|0|||
147657489|NCT03414229|532568603|FG002|Overall Study|Pregnancy|1|||
147657490|NCT03414229|532568604|FG003|Overall Study|Pregnancy|0|||
147657491|NCT03414229|532568601|FG000|Overall Study|Withdrawal by Subject|0|||
147657492|NCT03414229|532568602|FG001|Overall Study|Withdrawal by Subject|1|||
147657493|NCT03414229|532568603|FG002|Overall Study|Withdrawal by Subject|1|||
147657494|NCT03414229|532568604|FG003|Overall Study|Withdrawal by Subject|0|||
147657495|NCT04533438|532568608|FG000|Crossover Period|Did not meet Eligibility to Crossover|0|||
147657496|NCT04533438|532568609|FG001|Crossover Period|Did not meet Eligibility to Crossover|11|||
147657497|NCT05568797|532568612|FG000|Overall Study|Adverse Event|0|||
147657498|NCT05568797|532568613|FG001|Overall Study|Adverse Event|8|||
147657499|NCT05568797|532568612|FG000|Overall Study|Lost to Follow-up|2|||
147657500|NCT05568797|532568613|FG001|Overall Study|Lost to Follow-up|3|||
147657501|NCT05568797|532568612|FG000|Overall Study|Withdrawal by Subject|1|||
147657502|NCT05568797|532568613|FG001|Overall Study|Withdrawal by Subject|10|||
147657503|NCT05568797|532568612|FG000|Overall Study|Other|2|||
147657504|NCT05568797|532568613|FG001|Overall Study|Other|2|||
147657505|NCT00099632|532568614|FG000|Overall Study|Lost to Follow-up|1|||
147657506|NCT00099632|532568615|FG001|Overall Study|Lost to Follow-up|0|||
147657507|NCT00099632|532568616|FG002|Overall Study|Lost to Follow-up|3|||
147657508|NCT00099632|532568617|FG003|Overall Study|Lost to Follow-up|1|||
147182227|NCT01746225|530831255|FG001|Overall Study|Withdrawal by Subject|15|||
147182228|NCT01746225|530831256|FG002|Overall Study|Withdrawal by Subject|19|||
147182229|NCT01746225|530831254|FG000|Overall Study|Physician Decision|14|||
147182230|NCT01746225|530831255|FG001|Overall Study|Physician Decision|11|||
147182231|NCT01746225|530831256|FG002|Overall Study|Physician Decision|3|||
147182232|NCT01746225|530831254|FG000|Overall Study|Adverse Event|15|||
147182233|NCT01746225|530831255|FG001|Overall Study|Adverse Event|12|||
147246458|NCT03129100|531072780|FG021|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
147657509|NCT00099632|532568618|FG004|Overall Study|Lost to Follow-up|1|||
147657510|NCT00099632|532568619|FG005|Overall Study|Lost to Follow-up|0|||
147657511|NCT00099632|532568614|FG000|Overall Study|Withdrawal by Subject|0|||
147657512|NCT00099632|532568615|FG001|Overall Study|Withdrawal by Subject|1|||
147657513|NCT00099632|532568616|FG002|Overall Study|Withdrawal by Subject|0|||
147657514|NCT00099632|532568617|FG003|Overall Study|Withdrawal by Subject|0|||
147657515|NCT00099632|532568618|FG004|Overall Study|Withdrawal by Subject|0|||
147657516|NCT00099632|532568619|FG005|Overall Study|Withdrawal by Subject|1|||
147657517|NCT00099632|532568614|FG000|Overall Study|Protocol Violation|0|||
147657518|NCT00099632|532568615|FG001|Overall Study|Protocol Violation|0|||
147657519|NCT00099632|532568616|FG002|Overall Study|Protocol Violation|0|||
147657520|NCT00099632|532568617|FG003|Overall Study|Protocol Violation|0|||
147657521|NCT00099632|532568618|FG004|Overall Study|Protocol Violation|0|||
147657522|NCT00099632|532568619|FG005|Overall Study|Protocol Violation|1|||
147657523|NCT03131687|532568620|FG000|Overall Study|Adverse Event|0|||
147657524|NCT03131687|532568621|FG001|Overall Study|Adverse Event|1|||
147657525|NCT03131687|532568622|FG002|Overall Study|Adverse Event|0|||
147657526|NCT03131687|532568623|FG003|Overall Study|Adverse Event|1|||
147657527|NCT03131687|532568624|FG004|Overall Study|Adverse Event|2|||
147657528|NCT03131687|532568625|FG005|Overall Study|Adverse Event|2|||
147657529|NCT03131687|532568620|FG000|Overall Study|Death|1|||
147657530|NCT03131687|532568621|FG001|Overall Study|Death|0|||
147657531|NCT03131687|532568622|FG002|Overall Study|Death|0|||
147657532|NCT03131687|532568623|FG003|Overall Study|Death|0|||
147657533|NCT03131687|532568624|FG004|Overall Study|Death|0|||
147657534|NCT03131687|532568625|FG005|Overall Study|Death|0|||
147657535|NCT03131687|532568620|FG000|Overall Study|Withdrawal by Subject|3|||
147657536|NCT03131687|532568621|FG001|Overall Study|Withdrawal by Subject|3|||
147657537|NCT03131687|532568622|FG002|Overall Study|Withdrawal by Subject|3|||
147657538|NCT03131687|532568623|FG003|Overall Study|Withdrawal by Subject|1|||
147657539|NCT03131687|532568624|FG004|Overall Study|Withdrawal by Subject|2|||
147657540|NCT03131687|532568625|FG005|Overall Study|Withdrawal by Subject|1|||
147657541|NCT03131687|532568620|FG000|Overall Study|Lost to Follow-up|1|||
147657542|NCT03131687|532568621|FG001|Overall Study|Lost to Follow-up|4|||
147657543|NCT03131687|532568622|FG002|Overall Study|Lost to Follow-up|0|||
147657544|NCT03131687|532568623|FG003|Overall Study|Lost to Follow-up|1|||
147657545|NCT03131687|532568624|FG004|Overall Study|Lost to Follow-up|4|||
147657546|NCT03131687|532568625|FG005|Overall Study|Lost to Follow-up|2|||
147657547|NCT03131687|532568620|FG000|Overall Study|Participant Started New Diabetic Drug|1|||
147657548|NCT03131687|532568621|FG001|Overall Study|Participant Started New Diabetic Drug|0|||
147657549|NCT03131687|532568622|FG002|Overall Study|Participant Started New Diabetic Drug|0|||
147657550|NCT03131687|532568623|FG003|Overall Study|Participant Started New Diabetic Drug|0|||
147657551|NCT03131687|532568624|FG004|Overall Study|Participant Started New Diabetic Drug|0|||
147657552|NCT03131687|532568625|FG005|Overall Study|Participant Started New Diabetic Drug|0|||
147657553|NCT03131687|532568620|FG000|Overall Study|Principle Investigator Decision|0|||
147657554|NCT03131687|532568621|FG001|Overall Study|Principle Investigator Decision|1|||
147657555|NCT03131687|532568622|FG002|Overall Study|Principle Investigator Decision|0|||
147657556|NCT03131687|532568623|FG003|Overall Study|Principle Investigator Decision|0|||
147657557|NCT03131687|532568624|FG004|Overall Study|Principle Investigator Decision|0|||
147657558|NCT03131687|532568625|FG005|Overall Study|Principle Investigator Decision|0|||
147657559|NCT03131687|532568620|FG000|Overall Study|Inadvertent Enrollment|0|||
147657560|NCT03131687|532568621|FG001|Overall Study|Inadvertent Enrollment|0|||
147657561|NCT03131687|532568622|FG002|Overall Study|Inadvertent Enrollment|0|||
147657562|NCT03131687|532568623|FG003|Overall Study|Inadvertent Enrollment|1|||
147657563|NCT03131687|532568624|FG004|Overall Study|Inadvertent Enrollment|0|||
147657564|NCT03131687|532568625|FG005|Overall Study|Inadvertent Enrollment|0|||
147657565|NCT02797678|532568626|FG000|Screening Phase|Meeting Inclusion/Exclusion criteria|25|||
147657566|NCT02797678|532568627|FG001|Screening Phase|Meeting Inclusion/Exclusion criteria|0|||
147657567|NCT02797678|532568628|FG002|Screening Phase|Meeting Inclusion/Exclusion criteria|0|||
147657568|NCT02797678|532568629|FG003|Screening Phase|Meeting Inclusion/Exclusion criteria|0|||
147657569|NCT02797678|532568626|FG000|First Intervention (5 Nights)|study/device use non-compliance|0|||
147657570|NCT02797678|532568627|FG001|First Intervention (5 Nights)|study/device use non-compliance|1|||
147657571|NCT02797678|532568628|FG002|First Intervention (5 Nights)|study/device use non-compliance|0|||
147657572|NCT02797678|532568629|FG003|First Intervention (5 Nights)|study/device use non-compliance|0|||
147657573|NCT02797678|532568626|FG000|Second Intervention (5 Nights)|study/device use non-compliance|0|||
147246459|NCT03129100|531072781|FG022|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
147246460|NCT03129100|531072782|FG023|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
147246461|NCT03129100|531072783|FG024|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
147657574|NCT02797678|532568627|FG001|Second Intervention (5 Nights)|study/device use non-compliance|0|||
147657575|NCT02797678|532568628|FG002|Second Intervention (5 Nights)|study/device use non-compliance|1|||
147657576|NCT02797678|532568629|FG003|Second Intervention (5 Nights)|study/device use non-compliance|0|||
147657577|NCT01670045|532568635|FG000|Overall Study|Withdrawal by Subject|3|||
147657578|NCT01670045|532568635|FG000|Overall Study|Adverse Event|1|||
147657579|NCT01670045|532568635|FG000|Overall Study|Death|1|||
147657580|NCT01670045|532568635|FG000|Overall Study|Lost to Follow-up|11|||
147657581|NCT03046953|532568642|FG000|Overall Study|Relapse/progressive disease|21|||
147657582|NCT03046953|532568642|FG000|Overall Study|Death|2|||
147657583|NCT03046953|532568642|FG000|Overall Study|Withdrawal by Subject|3|||
147657584|NCT02716584|532568645|FG000|Overall Study|Lost to Follow-up|8|||
147657585|NCT02716584|532568646|FG001|Overall Study|Lost to Follow-up|5|||
147657586|NCT00420628|532568647|FG000|Overall Study|Withdrawn by parent or gaurdian|5|||
147246462|NCT03129100|531072784|FG025|Lead-In Period (Period 1)|Withdrawal by Subject|0|||
147246463|NCT03129100|531072759|FG000|Lead-In Period (Period 1)|Lack of Efficacy|3|||
147246464|NCT03129100|531072760|FG001|Lead-In Period (Period 1)|Lack of Efficacy|2|||
147246465|NCT03129100|531072761|FG002|Lead-In Period (Period 1)|Lack of Efficacy|0|||
147246466|NCT03129100|531072762|FG003|Lead-In Period (Period 1)|Lack of Efficacy|0|||
147246467|NCT03129100|531072763|FG004|Lead-In Period (Period 1)|Lack of Efficacy|0|||
147246468|NCT03129100|531072764|FG005|Lead-In Period (Period 1)|Lack of Efficacy|0|||
147246469|NCT03129100|531072765|FG006|Lead-In Period (Period 1)|Lack of Efficacy|0|||
147246470|NCT03129100|531072766|FG007|Lead-In Period (Period 1)|Lack of Efficacy|0|||
147246471|NCT03129100|531072767|FG008|Lead-In Period (Period 1)|Lack of Efficacy|0|||
147246472|NCT03129100|531072768|FG009|Lead-In Period (Period 1)|Lack of Efficacy|0|||
147246473|NCT03129100|531072769|FG010|Lead-In Period (Period 1)|Lack of Efficacy|0|||
147246474|NCT03129100|531072770|FG011|Lead-In Period (Period 1)|Lack of Efficacy|0|||
147246475|NCT03129100|531072771|FG012|Lead-In Period (Period 1)|Lack of Efficacy|0|||
147246476|NCT03129100|531072772|FG013|Lead-In Period (Period 1)|Lack of Efficacy|0|||
147246477|NCT03129100|531072773|FG014|Lead-In Period (Period 1)|Lack of Efficacy|0|||
147246478|NCT03129100|531072774|FG015|Lead-In Period (Period 1)|Lack of Efficacy|0|||
147246479|NCT03129100|531072775|FG016|Lead-In Period (Period 1)|Lack of Efficacy|0|||
147246480|NCT03129100|531072776|FG017|Lead-In Period (Period 1)|Lack of Efficacy|0|||
147246481|NCT03129100|531072777|FG018|Lead-In Period (Period 1)|Lack of Efficacy|0|||
147246482|NCT03129100|531072778|FG019|Lead-In Period (Period 1)|Lack of Efficacy|0|||
147246483|NCT03129100|531072779|FG020|Lead-In Period (Period 1)|Lack of Efficacy|0|||
147246484|NCT03129100|531072780|FG021|Lead-In Period (Period 1)|Lack of Efficacy|0|||
147246485|NCT03129100|531072781|FG022|Lead-In Period (Period 1)|Lack of Efficacy|0|||
147246486|NCT03129100|531072782|FG023|Lead-In Period (Period 1)|Lack of Efficacy|0|||
147246487|NCT03129100|531072783|FG024|Lead-In Period (Period 1)|Lack of Efficacy|0|||
147246488|NCT03129100|531072784|FG025|Lead-In Period (Period 1)|Lack of Efficacy|0|||
147246489|NCT03129100|531072759|FG000|Lead-In Period (Period 1)|Surgery Programmed|0|||
147246490|NCT03129100|531072760|FG001|Lead-In Period (Period 1)|Surgery Programmed|1|||
147246491|NCT03129100|531072761|FG002|Lead-In Period (Period 1)|Surgery Programmed|0|||
147246492|NCT03129100|531072762|FG003|Lead-In Period (Period 1)|Surgery Programmed|0|||
147246493|NCT03129100|531072763|FG004|Lead-In Period (Period 1)|Surgery Programmed|0|||
147246494|NCT03129100|531072764|FG005|Lead-In Period (Period 1)|Surgery Programmed|0|||
147246495|NCT03129100|531072765|FG006|Lead-In Period (Period 1)|Surgery Programmed|0|||
147246496|NCT03129100|531072766|FG007|Lead-In Period (Period 1)|Surgery Programmed|0|||
147246497|NCT03129100|531072767|FG008|Lead-In Period (Period 1)|Surgery Programmed|0|||
147246498|NCT03129100|531072768|FG009|Lead-In Period (Period 1)|Surgery Programmed|0|||
147246499|NCT03129100|531072769|FG010|Lead-In Period (Period 1)|Surgery Programmed|0|||
147246500|NCT03129100|531072770|FG011|Lead-In Period (Period 1)|Surgery Programmed|0|||
147246501|NCT03129100|531072771|FG012|Lead-In Period (Period 1)|Surgery Programmed|0|||
147246502|NCT03129100|531072772|FG013|Lead-In Period (Period 1)|Surgery Programmed|0|||
147246503|NCT03129100|531072773|FG014|Lead-In Period (Period 1)|Surgery Programmed|0|||
147246504|NCT03129100|531072774|FG015|Lead-In Period (Period 1)|Surgery Programmed|0|||
147246505|NCT03129100|531072775|FG016|Lead-In Period (Period 1)|Surgery Programmed|0|||
147246506|NCT03129100|531072776|FG017|Lead-In Period (Period 1)|Surgery Programmed|0|||
147246507|NCT03129100|531072777|FG018|Lead-In Period (Period 1)|Surgery Programmed|0|||
147246508|NCT03129100|531072778|FG019|Lead-In Period (Period 1)|Surgery Programmed|0|||
147246509|NCT03129100|531072779|FG020|Lead-In Period (Period 1)|Surgery Programmed|0|||
147246510|NCT03129100|531072780|FG021|Lead-In Period (Period 1)|Surgery Programmed|0|||
147246511|NCT03129100|531072781|FG022|Lead-In Period (Period 1)|Surgery Programmed|0|||
147246512|NCT03129100|531072782|FG023|Lead-In Period (Period 1)|Surgery Programmed|0|||
147246513|NCT03129100|531072783|FG024|Lead-In Period (Period 1)|Surgery Programmed|0|||
147246514|NCT03129100|531072784|FG025|Lead-In Period (Period 1)|Surgery Programmed|0|||
147246515|NCT03129100|531072759|FG000|Period2 Extension Period (Group A and B)|Adverse Event|0|||
147246516|NCT03129100|531072760|FG001|Period2 Extension Period (Group A and B)|Adverse Event|0|||
147246517|NCT03129100|531072761|FG002|Period2 Extension Period (Group A and B)|Adverse Event|2|||
147246518|NCT03129100|531072762|FG003|Period2 Extension Period (Group A and B)|Adverse Event|1|||
147246519|NCT03129100|531072763|FG004|Period2 Extension Period (Group A and B)|Adverse Event|0|||
147246520|NCT03129100|531072764|FG005|Period2 Extension Period (Group A and B)|Adverse Event|2|||
147246521|NCT03129100|531072765|FG006|Period2 Extension Period (Group A and B)|Adverse Event|0|||
147246522|NCT03129100|531072766|FG007|Period2 Extension Period (Group A and B)|Adverse Event|0|||
147246523|NCT03129100|531072767|FG008|Period2 Extension Period (Group A and B)|Adverse Event|0|||
147246524|NCT03129100|531072768|FG009|Period2 Extension Period (Group A and B)|Adverse Event|0|||
147246525|NCT03129100|531072769|FG010|Period2 Extension Period (Group A and B)|Adverse Event|0|||
147593697|NCT02696031|532329012|FG000|Up to Week 104|Lost to Follow-up|2|||
147246526|NCT03129100|531072770|FG011|Period2 Extension Period (Group A and B)|Adverse Event|0|||
147246527|NCT03129100|531072771|FG012|Period2 Extension Period (Group A and B)|Adverse Event|0|||
147246528|NCT03129100|531072772|FG013|Period2 Extension Period (Group A and B)|Adverse Event|0|||
147246529|NCT03129100|531072773|FG014|Period2 Extension Period (Group A and B)|Adverse Event|0|||
147593698|NCT02696031|532329013|FG001|Up to Week 104|Lost to Follow-up|3|||
147593699|NCT02696031|532329014|FG002|Up to Week 104|Lost to Follow-up|1|||
147593700|NCT02696031|532329015|FG003|Up to Week 104|Lost to Follow-up|0|||
147593701|NCT02696031|532329016|FG004|Up to Week 104|Lost to Follow-up|0|||
147593702|NCT02696031|532329017|FG005|Up to Week 104|Lost to Follow-up|0|||
147593703|NCT02696031|532329012|FG000|Up to Week 104|Lack of Efficacy|13|||
147593704|NCT02696031|532329013|FG001|Up to Week 104|Lack of Efficacy|12|||
147593705|NCT02696031|532329014|FG002|Up to Week 104|Lack of Efficacy|11|||
147593706|NCT02696031|532329015|FG003|Up to Week 104|Lack of Efficacy|0|||
147593707|NCT02696031|532329016|FG004|Up to Week 104|Lack of Efficacy|0|||
147593708|NCT02696031|532329017|FG005|Up to Week 104|Lack of Efficacy|0|||
147593709|NCT02696031|532329012|FG000|Up to Week 104|Adverse Event|7|||
147593710|NCT02696031|532329013|FG001|Up to Week 104|Adverse Event|11|||
147593711|NCT02696031|532329014|FG002|Up to Week 104|Adverse Event|5|||
147593712|NCT02696031|532329015|FG003|Up to Week 104|Adverse Event|0|||
147593713|NCT02696031|532329016|FG004|Up to Week 104|Adverse Event|0|||
147593714|NCT02696031|532329017|FG005|Up to Week 104|Adverse Event|0|||
147593715|NCT02696031|532329012|FG000|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0|||
147593716|NCT02696031|532329013|FG001|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|1|||
147593717|NCT02696031|532329014|FG002|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0|||
147593718|NCT02696031|532329015|FG003|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0|||
147593719|NCT02696031|532329016|FG004|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0|||
147593720|NCT02696031|532329017|FG005|Up to Week 104|Pt completed wk 52. Withdrawal by subject at wk 52.|0|||
147593721|NCT02696031|532329012|FG000|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|0|||
147593722|NCT02696031|532329013|FG001|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|0|||
147593723|NCT02696031|532329014|FG002|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|0|||
147593724|NCT02696031|532329015|FG003|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|6|||
147593725|NCT02696031|532329016|FG004|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|8|||
147593726|NCT02696031|532329017|FG005|Extension Phase From wk 104 to wk 208|Withdrawal by Subject|2|||
147593727|NCT02696031|532329012|FG000|Extension Phase From wk 104 to wk 208|Physician Decision|0|||
147593728|NCT02696031|532329013|FG001|Extension Phase From wk 104 to wk 208|Physician Decision|0|||
147593729|NCT02696031|532329014|FG002|Extension Phase From wk 104 to wk 208|Physician Decision|0|||
147593730|NCT02696031|532329015|FG003|Extension Phase From wk 104 to wk 208|Physician Decision|1|||
147593731|NCT02696031|532329016|FG004|Extension Phase From wk 104 to wk 208|Physician Decision|1|||
147593732|NCT02696031|532329017|FG005|Extension Phase From wk 104 to wk 208|Physician Decision|0|||
147593733|NCT02696031|532329012|FG000|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0|||
147593734|NCT02696031|532329013|FG001|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0|||
147596004|NCT00251641|532338767|FG000|Overall Study|Lost to Follow-up|3|||
147246530|NCT03129100|531072774|FG015|Period2 Extension Period (Group A and B)|Adverse Event|0|||
147246531|NCT03129100|531072775|FG016|Period2 Extension Period (Group A and B)|Adverse Event|0|||
147246532|NCT03129100|531072776|FG017|Period2 Extension Period (Group A and B)|Adverse Event|0|||
147246533|NCT03129100|531072777|FG018|Period2 Extension Period (Group A and B)|Adverse Event|0|||
147246534|NCT03129100|531072778|FG019|Period2 Extension Period (Group A and B)|Adverse Event|0|||
147246535|NCT03129100|531072779|FG020|Period2 Extension Period (Group A and B)|Adverse Event|0|||
147246536|NCT03129100|531072780|FG021|Period2 Extension Period (Group A and B)|Adverse Event|0|||
147246537|NCT03129100|531072781|FG022|Period2 Extension Period (Group A and B)|Adverse Event|0|||
147246538|NCT03129100|531072782|FG023|Period2 Extension Period (Group A and B)|Adverse Event|0|||
147246539|NCT03129100|531072783|FG024|Period2 Extension Period (Group A and B)|Adverse Event|0|||
147246540|NCT03129100|531072784|FG025|Period2 Extension Period (Group A and B)|Adverse Event|0|||
147246541|NCT03129100|531072759|FG000|Period2 Extension Period (Group A and B)|Death|0|||
147246542|NCT03129100|531072760|FG001|Period2 Extension Period (Group A and B)|Death|0|||
147246543|NCT03129100|531072761|FG002|Period2 Extension Period (Group A and B)|Death|1|||
147246544|NCT03129100|531072762|FG003|Period2 Extension Period (Group A and B)|Death|0|||
147246545|NCT03129100|531072763|FG004|Period2 Extension Period (Group A and B)|Death|0|||
147246546|NCT03129100|531072764|FG005|Period2 Extension Period (Group A and B)|Death|0|||
147246547|NCT03129100|531072765|FG006|Period2 Extension Period (Group A and B)|Death|0|||
147246548|NCT03129100|531072766|FG007|Period2 Extension Period (Group A and B)|Death|0|||
147246549|NCT03129100|531072767|FG008|Period2 Extension Period (Group A and B)|Death|0|||
147246550|NCT03129100|531072768|FG009|Period2 Extension Period (Group A and B)|Death|0|||
147246551|NCT03129100|531072769|FG010|Period2 Extension Period (Group A and B)|Death|0|||
147246552|NCT03129100|531072770|FG011|Period2 Extension Period (Group A and B)|Death|0|||
147246553|NCT03129100|531072771|FG012|Period2 Extension Period (Group A and B)|Death|0|||
147246554|NCT03129100|531072772|FG013|Period2 Extension Period (Group A and B)|Death|0|||
147246555|NCT03129100|531072773|FG014|Period2 Extension Period (Group A and B)|Death|0|||
147246556|NCT03129100|531072774|FG015|Period2 Extension Period (Group A and B)|Death|0|||
147246557|NCT03129100|531072775|FG016|Period2 Extension Period (Group A and B)|Death|0|||
147246558|NCT03129100|531072776|FG017|Period2 Extension Period (Group A and B)|Death|0|||
147246559|NCT03129100|531072777|FG018|Period2 Extension Period (Group A and B)|Death|0|||
147246560|NCT03129100|531072778|FG019|Period2 Extension Period (Group A and B)|Death|0|||
147657587|NCT00420628|532568648|FG001|Overall Study|Withdrawn by parent or gaurdian|2|||
147657588|NCT00420628|532568647|FG000|Overall Study|Lost to Follow-up|3|||
147657589|NCT00420628|532568648|FG001|Overall Study|Lost to Follow-up|2|||
147657590|NCT00420628|532568647|FG000|Overall Study|Adverse Event|1|||
147657591|NCT00420628|532568648|FG001|Overall Study|Adverse Event|0|||
147657592|NCT00656175|532568651|FG000|Overall Study|Adverse Event|1|||
147657593|NCT00656175|532568652|FG001|Overall Study|Adverse Event|0|||
147657594|NCT00656175|532568651|FG000|Overall Study|Transportation issues|0|||
147657595|NCT00656175|532568652|FG001|Overall Study|Transportation issues|1|||
147657596|NCT01903993|532568656|FG000|Overall Study|Death|118|||
147657597|NCT01903993|532568657|FG001|Overall Study|Death|121|||
147657598|NCT01903993|532568656|FG000|Overall Study|Withdrawal by Subject|15|||
147657599|NCT01903993|532568657|FG001|Overall Study|Withdrawal by Subject|4|||
147657600|NCT01903993|532568656|FG000|Overall Study|Lost to Follow-up|2|||
147657601|NCT01903993|532568657|FG001|Overall Study|Lost to Follow-up|3|||
147657602|NCT01903993|532568656|FG000|Overall Study|Study Terminated by Sponsor|8|||
147657603|NCT01903993|532568657|FG001|Overall Study|Study Terminated by Sponsor|14|||
147657604|NCT01903993|532568656|FG000|Overall Study|Terminated by Sponsor After 31 Aug 2018|0|||
147657605|NCT01903993|532568657|FG001|Overall Study|Terminated by Sponsor After 31 Aug 2018|2|||
147657606|NCT03283930|532568667|FG000|Overall Study|Scheduling conflict|8|||
147657607|NCT03283930|532568668|FG001|Overall Study|Scheduling conflict|10|||
147657608|NCT03283930|532568667|FG000|Overall Study|Due to coronavirus disease 2019 (COVID-19) pandemic|1|||
147657609|NCT03283930|532568668|FG001|Overall Study|Due to coronavirus disease 2019 (COVID-19) pandemic|1|||
147657610|NCT03283930|532568667|FG000|Overall Study|Technical software issue|2|||
147657611|NCT03283930|532568668|FG001|Overall Study|Technical software issue|2|||
147657612|NCT00805129|532568669|FG000|Overall Study|Not treated|1|||
147657613|NCT01868165|532568670|FG000|Overall Study|Withdrawal by Subject|36|||
147657614|NCT01868165|532568670|FG000|Overall Study|Physician Decision|2|||
147657615|NCT01868165|532568670|FG000|Overall Study|Lost to Follow-up|3|||
147657616|NCT01868165|532568670|FG000|Overall Study|Death|4|||
147657617|NCT00571662|532568671|FG000|Overall Study|Withdrawal by Subject|2|||
147657618|NCT00571662|532568671|FG000|Overall Study|psychiatric instability|1|||
147657619|NCT00571662|532568671|FG000|Overall Study|Adverse Event|5|||
147657620|NCT01429298|532568672|FG000|Overall Study|Protocol Violation|4|||
147657621|NCT01429298|532568673|FG001|Overall Study|Protocol Violation|6|||
147657622|NCT01839916|532568674|FG000|Overall Study|Death|9|||
147657623|NCT01839916|532568674|FG000|Overall Study|Physician Decision|17|||
147657624|NCT01839916|532568674|FG000|Overall Study|Relapse|12|||
147657625|NCT01839916|532568674|FG000|Overall Study|GVHD|2|||
147657626|NCT01839916|532568674|FG000|Overall Study|Graft Failure|1|||
147657627|NCT02385110|532568677|FG000|Overall Study|Early Death|1|||
147657628|NCT02385110|532568678|FG001|Overall Study|Early Death|0|||
147657629|NCT01971567|532570042|FG000|Overall Study|Withdrawal by Subject|3|||
147657630|NCT01971567|532570043|FG001|Overall Study|Withdrawal by Subject|2|||
147657631|NCT01971567|532570042|FG000|Overall Study|Lost to Follow-up|1|||
147657632|NCT01971567|532570043|FG001|Overall Study|Lost to Follow-up|0|||
147657633|NCT01223404|532570044|FG000|First Intervention (1 Day)|Adverse Event|0|||
147657634|NCT01223404|532570045|FG001|First Intervention (1 Day)|Adverse Event|0|||
147657635|NCT01223404|532570046|FG002|First Intervention (1 Day)|Adverse Event|0|||
147657636|NCT01223404|532570047|FG003|First Intervention (1 Day)|Adverse Event|1|||
147657637|NCT01223404|532570048|FG004|First Intervention (1 Day)|Adverse Event|0|||
147657638|NCT01223404|532570049|FG005|First Intervention (1 Day)|Adverse Event|0|||
147657639|NCT01223404|532570044|FG000|Second Intervention (1 Day)|Adverse Event|1|||
147657640|NCT01223404|532570045|FG001|Second Intervention (1 Day)|Adverse Event|0|||
147657641|NCT01223404|532570046|FG002|Second Intervention (1 Day)|Adverse Event|0|||
147657642|NCT01223404|532570047|FG003|Second Intervention (1 Day)|Adverse Event|0|||
147657643|NCT01223404|532570048|FG004|Second Intervention (1 Day)|Adverse Event|0|||
147657644|NCT01223404|532570049|FG005|Second Intervention (1 Day)|Adverse Event|0|||
147657645|NCT01223404|532570044|FG000|Third Intervention (1 Day)|Non-compliance (slept)|0|||
147657646|NCT01223404|532570045|FG001|Third Intervention (1 Day)|Non-compliance (slept)|0|||
147657647|NCT01223404|532570046|FG002|Third Intervention (1 Day)|Non-compliance (slept)|0|||
147657648|NCT01223404|532570047|FG003|Third Intervention (1 Day)|Non-compliance (slept)|1|||
147182234|NCT01746225|530831256|FG002|Overall Study|Adverse Event|17|||
147327350|NCT01981850|531363915|FG006|Main Phase Stage 1|Lack of Efficacy|0|||
147327351|NCT01981850|531363916|FG007|Main Phase Stage 1|Lack of Efficacy|0|||
147657649|NCT01223404|532570048|FG004|Third Intervention (1 Day)|Non-compliance (slept)|0|||
147657650|NCT01223404|532570049|FG005|Third Intervention (1 Day)|Non-compliance (slept)|0|||
147657651|NCT00707057|532570050|FG000|Overall Study|Withdrawal by Subject|8|||
147657652|NCT00707057|532570051|FG001|Overall Study|Withdrawal by Subject|3|||
147657653|NCT00707057|532570050|FG000|Overall Study|Dosed incorrectly|0|||
147657654|NCT00707057|532570051|FG001|Overall Study|Dosed incorrectly|1|||
147657655|NCT02492165|532570052|FG000|Overall Study|Withdrawal by Subject|0|||
147657656|NCT02492165|532570053|FG001|Overall Study|Withdrawal by Subject|1|||
147657657|NCT02492165|532570054|FG002|Overall Study|Withdrawal by Subject|0|||
147657658|NCT02492165|532570055|FG003|Overall Study|Withdrawal by Subject|0|||
147657659|NCT02750332|532570056|FG000|Treatment Period 1|Withdrawal by Subject|0|||
147657660|NCT02750332|532570057|FG001|Treatment Period 1|Withdrawal by Subject|1|||
147657661|NCT02937740|532570058|FG000|BID for 90 Days, 22 mg/Day|Withdrawal by Subject|3|||
147657662|NCT02937740|532570059|FG001|BID for 90 Days, 22 mg/Day|Withdrawal by Subject|14|||
147657663|NCT02937740|532570058|FG000|BID for 90 Days, 22 mg/Day|Adverse Event|0|||
147657664|NCT02937740|532570059|FG001|BID for 90 Days, 22 mg/Day|Adverse Event|10|||
147657665|NCT02937740|532570058|FG000|BID for 90 Days, 22 mg/Day|Lost to Follow-up|2|||
147657666|NCT02937740|532570059|FG001|BID for 90 Days, 22 mg/Day|Lost to Follow-up|7|||
147657667|NCT02937740|532570058|FG000|Uptitrated to TID on Day 90 for 30 Days|Withdrawal by Subject|1|||
147657668|NCT02937740|532570059|FG001|Uptitrated to TID on Day 90 for 30 Days|Withdrawal by Subject|0|||
147657669|NCT02937740|532570058|FG000|Uptitrated to TID on Day 90 for 30 Days|Lost to Follow-up|0|||
147657670|NCT02937740|532570059|FG001|Uptitrated to TID on Day 90 for 30 Days|Lost to Follow-up|1|||
147657671|NCT02937740|532570058|FG000|Uptitrated to TID on Day 90 for 30 Days|Missed visits|0|||
147657672|NCT02937740|532570059|FG001|Uptitrated to TID on Day 90 for 30 Days|Missed visits|1|||
147657673|NCT04194489|532570060|FG000|Overall Study|Withdrawal by Subject|5|||
147657674|NCT04194489|532570060|FG000|Overall Study|Lost to Follow-up|48|||
147657675|NCT04147247|532570066|FG000|Overall Study|Progressive disease|3|||
147657676|NCT04147247|532570067|FG001|Overall Study|Progressive disease|3|||
147657677|NCT04147247|532570068|FG002|Overall Study|Progressive disease|4|||
147657678|NCT04147247|532570069|FG003|Overall Study|Progressive disease|4|||
147657679|NCT04147247|532570070|FG004|Overall Study|Progressive disease|3|||
147657680|NCT04147247|532570066|FG000|Overall Study|Physician Decision|0|||
147657681|NCT04147247|532570067|FG001|Overall Study|Physician Decision|1|||
147657682|NCT04147247|532570068|FG002|Overall Study|Physician Decision|0|||
147657683|NCT04147247|532570069|FG003|Overall Study|Physician Decision|0|||
147657684|NCT04147247|532570070|FG004|Overall Study|Physician Decision|0|||
147657685|NCT04147247|532570066|FG000|Overall Study|Clinical Disease Progression|0|||
147657686|NCT04147247|532570067|FG001|Overall Study|Clinical Disease Progression|0|||
147657687|NCT04147247|532570068|FG002|Overall Study|Clinical Disease Progression|0|||
147657688|NCT04147247|532570069|FG003|Overall Study|Clinical Disease Progression|0|||
147657689|NCT04147247|532570070|FG004|Overall Study|Clinical Disease Progression|1|||
147657690|NCT04147247|532570066|FG000|Overall Study|Adverse Event|0|||
147657691|NCT04147247|532570067|FG001|Overall Study|Adverse Event|0|||
147657692|NCT04147247|532570068|FG002|Overall Study|Adverse Event|1|||
147657693|NCT04147247|532570069|FG003|Overall Study|Adverse Event|0|||
147657694|NCT04147247|532570070|FG004|Overall Study|Adverse Event|1|||
147657695|NCT00327340|532570073|FG000|Overall Study|Withdrawal by Subject|1|||
147657696|NCT00327340|532570074|FG001|Overall Study|Withdrawal by Subject|5|||
147657697|NCT00327340|532570073|FG000|Overall Study|Physician Decision|1|||
147657698|NCT00327340|532570074|FG001|Overall Study|Physician Decision|1|||
147657699|NCT00327340|532570073|FG000|Overall Study|Disease Progression|10|||
147657700|NCT00327340|532570074|FG001|Overall Study|Disease Progression|19|||
147657701|NCT00327340|532570073|FG000|Overall Study|Symptomatic Disease|0|||
147657702|NCT00327340|532570074|FG001|Overall Study|Symptomatic Disease|2|||
147657703|NCT00327340|532570073|FG000|Overall Study|Adverse Event|3|||
147657704|NCT00327340|532570074|FG001|Overall Study|Adverse Event|3|||
147657705|NCT02915159|532570076|FG000|Overall Study|Participant no longer meets criteria|2|||
147657706|NCT02915159|532570077|FG001|Overall Study|Participant no longer meets criteria|0|||
147657707|NCT02915159|532570076|FG000|Overall Study|poor/non-compliance|1|||
147657708|NCT02915159|532570077|FG001|Overall Study|poor/non-compliance|0|||
147657709|NCT02915159|532570076|FG000|Overall Study|Participant withdrew consent|5|||
147657710|NCT02915159|532570077|FG001|Overall Study|Participant withdrew consent|1|||
147657711|NCT02915159|532570076|FG000|Overall Study|Request to discontinue treatment|1|||
147657712|NCT02915159|532570077|FG001|Overall Study|Request to discontinue treatment|2|||
147657713|NCT02915159|532570076|FG000|Overall Study|Adverse Event|2|||
147657714|NCT02915159|532570077|FG001|Overall Study|Adverse Event|2|||
147657715|NCT02915159|532570076|FG000|Overall Study|Lack of Efficacy|0|||
147657716|NCT02915159|532570077|FG001|Overall Study|Lack of Efficacy|3|||
147657717|NCT04534517|532570078|FG000|Overall Study|Adverse Event|1|||
147657718|NCT04534517|532570078|FG000|Overall Study|Withdrawal by Subject|1|||
147657719|NCT04534517|532570078|FG000|Overall Study|Unsatisfactory Visual Response due to Test Article|1|||
147657720|NCT04534517|532570078|FG000|Overall Study|COVID-19 Related|1|||
147657721|NCT00823264|532570079|FG000|Overall Study|Protocol Violation|2|||
147657722|NCT00823264|532570080|FG001|Overall Study|Protocol Violation|0|||
147657723|NCT01714544|532570081|FG000|Overall Study|Lost to Follow-up|1|||
147657724|NCT01714544|532570081|FG000|Overall Study|Physician Decision|1|||
147657725|NCT01714544|532570081|FG000|Overall Study|Withdrawal by Subject|1|||
147657726|NCT03373760|532570088|FG000|Overall Study|Adverse Event|8|||
147657727|NCT03373760|532570088|FG000|Overall Study|Disease Progression|46|||
147657728|NCT03373760|532570088|FG000|Overall Study|Death|4|||
147657729|NCT01093586|532570089|FG000|Overall Study|Failed to engraft|3|||
147657730|NCT00613366|532570090|FG000|Overall Study|Withdrawal by Subject|3|||
147657731|NCT00613366|532570091|FG001|Overall Study|Withdrawal by Subject|2|||
147657732|NCT01968811|532570092|FG000|Overall Study|Protocol Violation|4|||
147657733|NCT01968811|532570092|FG000|Overall Study|post op.ref. of subject to other hospita|1|||
147657734|NCT01716663|532570094|FG000|Overall Study|Withdrawn prior to procedure|4|||
147657735|NCT01716663|532570094|FG000|Overall Study|Treated with non-study catheter|2|||
147657736|NCT00872521|532570095|FG000|Completed PAD Induction|Patient choice|0|||
147657737|NCT00872521|532570096|FG001|Completed PAD Induction|Patient choice|1|||
147657738|NCT00872521|532570097|FG002|Completed PAD Induction|Patient choice|0|||
147657739|NCT00872521|532570095|FG000|Completed PAD Induction|Disease progression|0|||
147657740|NCT00872521|532570096|FG001|Completed PAD Induction|Disease progression|2|||
147657741|NCT00872521|532570097|FG002|Completed PAD Induction|Disease progression|0|||
147657742|NCT00872521|532570095|FG000|Completed PAD Induction|Adverse Event|4|||
147657743|NCT00872521|532570096|FG001|Completed PAD Induction|Adverse Event|0|||
147657744|NCT00872521|532570097|FG002|Completed PAD Induction|Adverse Event|0|||
147657745|NCT00872521|532570095|FG000|Completed PAD Induction|Death|1|||
147657746|NCT00872521|532570096|FG001|Completed PAD Induction|Death|1|||
147657747|NCT00872521|532570097|FG002|Completed PAD Induction|Death|0|||
147657748|NCT00872521|532570095|FG000|Primary Endpoint Analysis|Other|1|||
147657749|NCT00872521|532570096|FG001|Primary Endpoint Analysis|Other|2|||
147657750|NCT00872521|532570097|FG002|Primary Endpoint Analysis|Other|0|||
147657751|NCT00872521|532570095|FG000|Primary Endpoint Analysis|Patient choice|0|||
147657752|NCT00872521|532570096|FG001|Primary Endpoint Analysis|Patient choice|1|||
147657753|NCT00872521|532570097|FG002|Primary Endpoint Analysis|Patient choice|0|||
147657754|NCT00872521|532570095|FG000|Primary Endpoint Analysis|Efficacy data unavailable|0|||
147657755|NCT00872521|532570096|FG001|Primary Endpoint Analysis|Efficacy data unavailable|2|||
147657756|NCT00872521|532570097|FG002|Primary Endpoint Analysis|Efficacy data unavailable|0|||
147657757|NCT00872521|532570095|FG000|Primary Endpoint Analysis|Patient response missing|0|||
147657758|NCT00872521|532570096|FG001|Primary Endpoint Analysis|Patient response missing|0|||
147657759|NCT00872521|532570097|FG002|Primary Endpoint Analysis|Patient response missing|1|||
147657760|NCT00872521|532570095|FG000|Completed 3-month Follow up|Other|0|||
147657761|NCT00872521|532570096|FG001|Completed 3-month Follow up|Other|2|||
147657762|NCT00872521|532570097|FG002|Completed 3-month Follow up|Other|0|||
147657763|NCT00872521|532570095|FG000|Completed 3-month Follow up|Physician Decision|0|||
147657764|NCT00872521|532570096|FG001|Completed 3-month Follow up|Physician Decision|1|||
147657765|NCT00872521|532570097|FG002|Completed 3-month Follow up|Physician Decision|0|||
147657766|NCT00872521|532570095|FG000|Secondary Endpoint Analysis|Efficacy data unavailable|0|||
147657767|NCT00872521|532570096|FG001|Secondary Endpoint Analysis|Efficacy data unavailable|2|||
147657768|NCT00872521|532570097|FG002|Secondary Endpoint Analysis|Efficacy data unavailable|1|||
147657769|NCT03006562|532570098|FG000|Overall Study|Lost to Follow-up|0|||
147657770|NCT03006562|532570099|FG001|Overall Study|Lost to Follow-up|1|||
147657771|NCT01089127|532570104|FG000|Overall Study|Adverse Event|5|||
147657772|NCT01089127|532570105|FG001|Overall Study|Adverse Event|1|||
147657773|NCT01089127|532570106|FG002|Overall Study|Adverse Event|1|||
147657774|NCT01089127|532570107|FG003|Overall Study|Adverse Event|0|||
147657775|NCT01089127|532570108|FG004|Overall Study|Adverse Event|0|||
147657776|NCT01089127|532570109|FG005|Overall Study|Adverse Event|1|||
147657777|NCT01089127|532570104|FG000|Overall Study|Subject withdrew consent|0|||
147657778|NCT01089127|532570105|FG001|Overall Study|Subject withdrew consent|1|||
147657779|NCT01089127|532570106|FG002|Overall Study|Subject withdrew consent|1|||
147657780|NCT01089127|532570107|FG003|Overall Study|Subject withdrew consent|1|||
147657781|NCT01089127|532570108|FG004|Overall Study|Subject withdrew consent|0|||
147657782|NCT01089127|532570109|FG005|Overall Study|Subject withdrew consent|2|||
147657783|NCT01089127|532570104|FG000|Overall Study|Abnormal test procedure result(s)|2|||
147657784|NCT01089127|532570105|FG001|Overall Study|Abnormal test procedure result(s)|1|||
147657785|NCT01089127|532570106|FG002|Overall Study|Abnormal test procedure result(s)|0|||
147657786|NCT01089127|532570107|FG003|Overall Study|Abnormal test procedure result(s)|0|||
147657787|NCT01089127|532570108|FG004|Overall Study|Abnormal test procedure result(s)|0|||
147657788|NCT01089127|532570109|FG005|Overall Study|Abnormal test procedure result(s)|0|||
147657789|NCT01089127|532570104|FG000|Overall Study|Lost to Follow-up|1|||
147657790|NCT01089127|532570105|FG001|Overall Study|Lost to Follow-up|1|||
147657791|NCT01089127|532570106|FG002|Overall Study|Lost to Follow-up|0|||
147657792|NCT01089127|532570107|FG003|Overall Study|Lost to Follow-up|0|||
147657793|NCT01089127|532570108|FG004|Overall Study|Lost to Follow-up|1|||
147657794|NCT01089127|532570109|FG005|Overall Study|Lost to Follow-up|0|||
147657795|NCT01089127|532570104|FG000|Overall Study|Protocol deviation|0|||
147657796|NCT01089127|532570105|FG001|Overall Study|Protocol deviation|1|||
147657797|NCT01089127|532570106|FG002|Overall Study|Protocol deviation|0|||
147657798|NCT01089127|532570107|FG003|Overall Study|Protocol deviation|0|||
147448535|NCT01964352|531807893|FG003|Overall Study|Adverse Event|3|||
147657799|NCT01089127|532570108|FG004|Overall Study|Protocol deviation|1|||
147657800|NCT01089127|532570109|FG005|Overall Study|Protocol deviation|0|||
147657801|NCT00511810|532570113|FG000|Overall Study|Lost to Follow-up|1|||
147657802|NCT00511810|532570114|FG001|Overall Study|Lost to Follow-up|2|||
147657803|NCT00511810|532570113|FG000|Overall Study|Lack of Efficacy|0|||
147657804|NCT00511810|532570114|FG001|Overall Study|Lack of Efficacy|2|||
147657805|NCT00511810|532570113|FG000|Overall Study|Refused second scn|0|||
147657806|NCT00511810|532570114|FG001|Overall Study|Refused second scn|1|||
147657807|NCT02427841|532570115|FG000|Overall Study|Lack of Efficacy|5|||
147657808|NCT02427841|532570115|FG000|Overall Study|Physician Decision|2|||
147657809|NCT02427841|532570115|FG000|Overall Study|Withdrawal by Subject|1|||
147657810|NCT02592447|532570118|FG000|Overall Study|Lost to Follow-up|1|||
147327352|NCT01981850|531363917|FG008|Main Phase Stage 1|Lack of Efficacy|0|||
147327353|NCT01981850|531363918|FG009|Main Phase Stage 1|Lack of Efficacy|0|||
147327354|NCT01981850|531363909|FG000|Main Phase Stage 1|Various reasons|0|||
147327355|NCT01981850|531363910|FG001|Main Phase Stage 1|Various reasons|0|||
147327356|NCT01981850|531363911|FG002|Main Phase Stage 1|Various reasons|2|||
147327357|NCT01981850|531363912|FG003|Main Phase Stage 1|Various reasons|0|||
147327358|NCT01981850|531363913|FG004|Main Phase Stage 1|Various reasons|0|||
147327359|NCT01981850|531363914|FG005|Main Phase Stage 1|Various reasons|0|||
147327360|NCT01981850|531363915|FG006|Main Phase Stage 1|Various reasons|0|||
147327361|NCT01981850|531363916|FG007|Main Phase Stage 1|Various reasons|0|||
147327362|NCT01981850|531363917|FG008|Main Phase Stage 1|Various reasons|0|||
147327363|NCT01981850|531363918|FG009|Main Phase Stage 1|Various reasons|0|||
147327364|NCT01981850|531363909|FG000|Main Phase Stage 2|Adverse Event|0|||
147327365|NCT01981850|531363910|FG001|Main Phase Stage 2|Adverse Event|0|||
147327366|NCT01981850|531363911|FG002|Main Phase Stage 2|Adverse Event|0|||
147327367|NCT01981850|531363912|FG003|Main Phase Stage 2|Adverse Event|0|||
147327368|NCT01981850|531363913|FG004|Main Phase Stage 2|Adverse Event|6|||
147327369|NCT01981850|531363914|FG005|Main Phase Stage 2|Adverse Event|5|||
147327370|NCT01981850|531363915|FG006|Main Phase Stage 2|Adverse Event|7|||
147327371|NCT01981850|531363916|FG007|Main Phase Stage 2|Adverse Event|0|||
147327372|NCT01981850|531363917|FG008|Main Phase Stage 2|Adverse Event|0|||
147327373|NCT01981850|531363918|FG009|Main Phase Stage 2|Adverse Event|0|||
147327374|NCT01981850|531363909|FG000|Main Phase Stage 2|Informed Consent Withdrawn|0|||
147327375|NCT01981850|531363910|FG001|Main Phase Stage 2|Informed Consent Withdrawn|0|||
147327376|NCT01981850|531363911|FG002|Main Phase Stage 2|Informed Consent Withdrawn|0|||
147327377|NCT01981850|531363912|FG003|Main Phase Stage 2|Informed Consent Withdrawn|0|||
147327378|NCT01981850|531363913|FG004|Main Phase Stage 2|Informed Consent Withdrawn|4|||
147327379|NCT01981850|531363914|FG005|Main Phase Stage 2|Informed Consent Withdrawn|3|||
147327380|NCT01981850|531363915|FG006|Main Phase Stage 2|Informed Consent Withdrawn|3|||
147327381|NCT01981850|531363916|FG007|Main Phase Stage 2|Informed Consent Withdrawn|0|||
147327382|NCT01981850|531363917|FG008|Main Phase Stage 2|Informed Consent Withdrawn|0|||
147327383|NCT01981850|531363918|FG009|Main Phase Stage 2|Informed Consent Withdrawn|0|||
147327384|NCT01981850|531363909|FG000|Main Phase Stage 2|Lack of Efficacy|0|||
147327385|NCT01981850|531363910|FG001|Main Phase Stage 2|Lack of Efficacy|0|||
147327386|NCT01981850|531363911|FG002|Main Phase Stage 2|Lack of Efficacy|0|||
147327387|NCT01981850|531363912|FG003|Main Phase Stage 2|Lack of Efficacy|0|||
147327388|NCT01981850|531363913|FG004|Main Phase Stage 2|Lack of Efficacy|1|||
147327389|NCT01981850|531363914|FG005|Main Phase Stage 2|Lack of Efficacy|2|||
147327390|NCT01981850|531363915|FG006|Main Phase Stage 2|Lack of Efficacy|0|||
147327391|NCT01981850|531363916|FG007|Main Phase Stage 2|Lack of Efficacy|0|||
147327392|NCT01981850|531363917|FG008|Main Phase Stage 2|Lack of Efficacy|0|||
147327393|NCT01981850|531363918|FG009|Main Phase Stage 2|Lack of Efficacy|0|||
147327394|NCT01981850|531363909|FG000|Main Phase Stage 2|Various reasons|0|||
147327395|NCT01981850|531363910|FG001|Main Phase Stage 2|Various reasons|0|||
147327396|NCT01981850|531363911|FG002|Main Phase Stage 2|Various reasons|0|||
147327397|NCT01981850|531363912|FG003|Main Phase Stage 2|Various reasons|0|||
147327398|NCT01981850|531363913|FG004|Main Phase Stage 2|Various reasons|2|||
147327399|NCT01981850|531363914|FG005|Main Phase Stage 2|Various reasons|0|||
147327400|NCT01981850|531363915|FG006|Main Phase Stage 2|Various reasons|1|||
147327401|NCT01981850|531363916|FG007|Main Phase Stage 2|Various reasons|0|||
147327402|NCT01981850|531363917|FG008|Main Phase Stage 2|Various reasons|0|||
147327403|NCT01981850|531363918|FG009|Main Phase Stage 2|Various reasons|0|||
147327404|NCT01981850|531363909|FG000|Main Phase Stage 2|Progressive Disease|0|||
147327405|NCT01981850|531363910|FG001|Main Phase Stage 2|Progressive Disease|0|||
147327406|NCT01981850|531363911|FG002|Main Phase Stage 2|Progressive Disease|0|||
147327407|NCT01981850|531363912|FG003|Main Phase Stage 2|Progressive Disease|0|||
147327408|NCT01981850|531363913|FG004|Main Phase Stage 2|Progressive Disease|0|||
147327409|NCT01981850|531363914|FG005|Main Phase Stage 2|Progressive Disease|6|||
147327410|NCT01981850|531363915|FG006|Main Phase Stage 2|Progressive Disease|6|||
147327411|NCT01981850|531363916|FG007|Main Phase Stage 2|Progressive Disease|0|||
147327412|NCT01981850|531363917|FG008|Main Phase Stage 2|Progressive Disease|0|||
147327413|NCT01981850|531363918|FG009|Main Phase Stage 2|Progressive Disease|0|||
147327414|NCT01981850|531363909|FG000|Open Label Extension (OLE)|Adverse Event|0|||
147327415|NCT01981850|531363910|FG001|Open Label Extension (OLE)|Adverse Event|0|||
147327416|NCT01981850|531363911|FG002|Open Label Extension (OLE)|Adverse Event|0|||
147327417|NCT01981850|531363912|FG003|Open Label Extension (OLE)|Adverse Event|0|||
147327418|NCT01981850|531363913|FG004|Open Label Extension (OLE)|Adverse Event|0|||
147327419|NCT01981850|531363914|FG005|Open Label Extension (OLE)|Adverse Event|0|||
147327420|NCT01981850|531363915|FG006|Open Label Extension (OLE)|Adverse Event|0|||
147327421|NCT01981850|531363916|FG007|Open Label Extension (OLE)|Adverse Event|2|||
147327422|NCT01981850|531363917|FG008|Open Label Extension (OLE)|Adverse Event|1|||
147327423|NCT01981850|531363918|FG009|Open Label Extension (OLE)|Adverse Event|8|||
147327424|NCT01981850|531363909|FG000|Open Label Extension (OLE)|Lack of Efficacy|0|||
147327425|NCT01981850|531363910|FG001|Open Label Extension (OLE)|Lack of Efficacy|0|||
147182235|NCT01746225|530831254|FG000|Overall Study|Continuing Treatment|5|||
147657811|NCT02592447|532570119|FG001|Overall Study|Lost to Follow-up|0|||
147657812|NCT02592447|532570118|FG000|Overall Study|Ineligible after randomization|1|||
147657813|NCT02592447|532570119|FG001|Overall Study|Ineligible after randomization|0|||
147657814|NCT02592447|532570118|FG000|Overall Study|Withdrawal by Subject|0|||
147657815|NCT02592447|532570119|FG001|Overall Study|Withdrawal by Subject|1|||
147657816|NCT01096160|532570124|FG000|Overall Study|Adverse Event|0|||
147657817|NCT01096160|532570125|FG001|Overall Study|Adverse Event|0|||
147657818|NCT01096160|532570126|FG002|Overall Study|Adverse Event|1|||
147657819|NCT01096160|532570127|FG003|Overall Study|Adverse Event|0|||
147657820|NCT01096160|532570128|FG004|Overall Study|Adverse Event|0|||
147657821|NCT01096160|532570129|FG005|Overall Study|Adverse Event|0|||
147657822|NCT01096160|532570130|FG006|Overall Study|Adverse Event|0|||
147657823|NCT01096160|532570131|FG007|Overall Study|Adverse Event|0|||
147657824|NCT01096160|532570132|FG008|Overall Study|Adverse Event|0|||
147657825|NCT01096160|532570133|FG009|Overall Study|Adverse Event|1|||
147657826|NCT01096160|532570124|FG000|Overall Study|Met stopping criteria per protocol|0|||
147657827|NCT01096160|532570125|FG001|Overall Study|Met stopping criteria per protocol|0|||
147657828|NCT01096160|532570126|FG002|Overall Study|Met stopping criteria per protocol|0|||
147657829|NCT01096160|532570127|FG003|Overall Study|Met stopping criteria per protocol|0|||
147657830|NCT01096160|532570128|FG004|Overall Study|Met stopping criteria per protocol|1|||
147657831|NCT01096160|532570129|FG005|Overall Study|Met stopping criteria per protocol|0|||
147657832|NCT01096160|532570130|FG006|Overall Study|Met stopping criteria per protocol|2|||
147657833|NCT01096160|532570131|FG007|Overall Study|Met stopping criteria per protocol|0|||
147657834|NCT01096160|532570132|FG008|Overall Study|Met stopping criteria per protocol|2|||
147657835|NCT01096160|532570133|FG009|Overall Study|Met stopping criteria per protocol|0|||
147657836|NCT00627497|532570135|FG000|Overall Study|Lost to Follow-up|1|||
147657837|NCT00627497|532570136|FG001|Overall Study|Lost to Follow-up|1|||
147657838|NCT00627497|532570137|FG002|Overall Study|Lost to Follow-up|0|||
147657839|NCT00627497|532570138|FG003|Overall Study|Lost to Follow-up|0|||
147657840|NCT01300247|532570139|FG000|Overall Study|Death|1|||
147657841|NCT01300247|532570140|FG001|Overall Study|Death|1|||
147657842|NCT01300247|532570139|FG000|Overall Study|Lost to Follow-up|2|||
147657843|NCT01300247|532570140|FG001|Overall Study|Lost to Follow-up|0|||
147657844|NCT01300247|532570139|FG000|Overall Study|Withdrawal by Subject|1|||
147657845|NCT01300247|532570140|FG001|Overall Study|Withdrawal by Subject|0|||
147657846|NCT01300247|532570139|FG000|Overall Study|Non-Compliance|0|||
147657847|NCT01300247|532570140|FG001|Overall Study|Non-Compliance|1|||
147657848|NCT00922116|532570141|FG000|Overall Study|Adverse Event|4|||
147657849|NCT00922116|532570141|FG000|Overall Study|Death|1|||
147657850|NCT00922116|532570141|FG000|Overall Study|Lost to Follow-up|1|||
147657851|NCT00922116|532570141|FG000|Overall Study|Withdrawal by Subject|4|||
147657852|NCT00922116|532570141|FG000|Overall Study|Other|5|||
147657853|NCT06060496|532570142|FG000|Overall Study|Withdrawal by Subject|2|||
147657854|NCT06060496|532570142|FG000|Overall Study|Lost to Follow-up|2|||
147657855|NCT02028507|532570143|FG000|Overall Study|Progressive Disease|122|||
147657856|NCT02028507|532570144|FG001|Overall Study|Progressive Disease|90|||
147657857|NCT02028507|532570145|FG002|Overall Study|Progressive Disease|102|||
147657858|NCT02028507|532570146|FG003|Overall Study|Progressive Disease|89|||
147657859|NCT02028507|532570143|FG000|Overall Study|Adverse Event|8|||
147657860|NCT02028507|532570144|FG001|Overall Study|Adverse Event|25|||
147657861|NCT02028507|532570145|FG002|Overall Study|Adverse Event|3|||
147657862|NCT02028507|532570146|FG003|Overall Study|Adverse Event|16|||
147657863|NCT02028507|532570143|FG000|Overall Study|Withdrawal by Subject|6|||
147657864|NCT02028507|532570144|FG001|Overall Study|Withdrawal by Subject|8|||
147657865|NCT02028507|532570145|FG002|Overall Study|Withdrawal by Subject|5|||
147657866|NCT02028507|532570146|FG003|Overall Study|Withdrawal by Subject|9|||
147657867|NCT02028507|532570143|FG000|Overall Study|Protocol Violation|2|||
147657868|NCT02028507|532570144|FG001|Overall Study|Protocol Violation|4|||
147657869|NCT02028507|532570145|FG002|Overall Study|Protocol Violation|1|||
147657870|NCT02028507|532570146|FG003|Overall Study|Protocol Violation|3|||
147657871|NCT02028507|532570143|FG000|Overall Study|Physician Decision|0|||
147657872|NCT02028507|532570144|FG001|Overall Study|Physician Decision|4|||
147657873|NCT02028507|532570145|FG002|Overall Study|Physician Decision|0|||
147657874|NCT02028507|532570146|FG003|Overall Study|Physician Decision|0|||
147657875|NCT02028507|532570143|FG000|Overall Study|Death|1|||
147657876|NCT02028507|532570144|FG001|Overall Study|Death|0|||
147657877|NCT02028507|532570145|FG002|Overall Study|Death|1|||
147657878|NCT02028507|532570146|FG003|Overall Study|Death|3|||
147657879|NCT02028507|532570143|FG000|Overall Study|Patient Required Therapy/Procedure Not Permitted|0|||
147657880|NCT02028507|532570144|FG001|Overall Study|Patient Required Therapy/Procedure Not Permitted|1|||
147657881|NCT02028507|532570145|FG002|Overall Study|Patient Required Therapy/Procedure Not Permitted|0|||
147657882|NCT02028507|532570146|FG003|Overall Study|Patient Required Therapy/Procedure Not Permitted|1|||
147657883|NCT02028507|532570143|FG000|Overall Study|Second Invasive Primary Malignancy|1|||
147657884|NCT02028507|532570144|FG001|Overall Study|Second Invasive Primary Malignancy|0|||
147657885|NCT02028507|532570145|FG002|Overall Study|Second Invasive Primary Malignancy|0|||
147657886|NCT02028507|532570146|FG003|Overall Study|Second Invasive Primary Malignancy|1|||
147657887|NCT02028507|532570143|FG000|Overall Study|Randomized But Not Treated|3|||
147657888|NCT02028507|532570144|FG001|Overall Study|Randomized But Not Treated|6|||
147657889|NCT02028507|532570145|FG002|Overall Study|Randomized But Not Treated|0|||
147657890|NCT02028507|532570146|FG003|Overall Study|Randomized But Not Treated|4|||
147657891|NCT02028507|532570143|FG000|Overall Study|Enzyme defect|0|||
147657892|NCT02028507|532570144|FG001|Overall Study|Enzyme defect|0|||
147657893|NCT02028507|532570145|FG002|Overall Study|Enzyme defect|0|||
147657894|NCT02028507|532570146|FG003|Overall Study|Enzyme defect|1|||
147657895|NCT02028507|532570143|FG000|Overall Study|Patient was not able to take whole dose of capecitabine|0|||
147657896|NCT02028507|532570144|FG001|Overall Study|Patient was not able to take whole dose of capecitabine|0|||
147657897|NCT02028507|532570145|FG002|Overall Study|Patient was not able to take whole dose of capecitabine|0|||
147657898|NCT02028507|532570146|FG003|Overall Study|Patient was not able to take whole dose of capecitabine|1|||
147657899|NCT02028507|532570143|FG000|Overall Study|Ongoing at date of cut-off 30-May-2019|10|||
147657900|NCT02028507|532570144|FG001|Overall Study|Ongoing at date of cut-off 30-May-2019|5|||
147657901|NCT02028507|532570145|FG002|Overall Study|Ongoing at date of cut-off 30-May-2019|37|||
147657902|NCT02028507|532570146|FG003|Overall Study|Ongoing at date of cut-off 30-May-2019|28|||
147657903|NCT02258659|532570147|FG000|Overall Study|Withdrawal by Subject|1|||
147657904|NCT03990051|532570148|FG000|Masked Period|Lost to Follow-up|1|||
147657905|NCT03990051|532570149|FG001|Masked Period|Lost to Follow-up|0|||
147657906|NCT03990051|532570148|FG000|Long Term Period|Death|1|||
147657907|NCT03990051|532570149|FG001|Long Term Period|Death|1|||
147657908|NCT03990051|532570148|FG000|Long Term Period|Lost to Follow-up|7|||
147657909|NCT03990051|532570149|FG001|Long Term Period|Lost to Follow-up|2|||
147657910|NCT00272844|532570150|FG000|Overall Study|Withdrawal by Subject|5|||
147657911|NCT03060291|532570151|FG000|3-month Follow-up|Declined to respond|8|||
147657912|NCT03060291|532570152|FG001|3-month Follow-up|Declined to respond|10|||
147657913|NCT03060291|532570153|FG002|3-month Follow-up|Declined to respond|2|||
147657914|NCT03060291|532570151|FG000|6-month Follow-up|Declined to respond|7|||
147657915|NCT03060291|532570152|FG001|6-month Follow-up|Declined to respond|13|||
147657916|NCT03060291|532570153|FG002|6-month Follow-up|Declined to respond|4|||
147657917|NCT03060291|532570151|FG000|12-month Follow-up|Declined to respond|7|||
147657918|NCT03060291|532570152|FG001|12-month Follow-up|Declined to respond|16|||
147657919|NCT03060291|532570153|FG002|12-month Follow-up|Declined to respond|6|||
147657920|NCT00618826|532570154|FG000|Overall Study|Adverse Event|1|||
147657921|NCT01509664|532570156|FG000|Overall Study|Lost to Follow-up|15|||
147657922|NCT01509664|532570157|FG001|Overall Study|Lost to Follow-up|21|||
147657923|NCT01556932|532570160|FG000|Time Point 60 Minutes|Withdrawal by Subject|1|||
147657924|NCT01556932|532570161|FG001|Time Point 60 Minutes|Withdrawal by Subject|1|||
147657925|NCT02256839|532570164|FG000|Overall Study|Did not meet Eligibility Criteria|2|||
147657926|NCT02256839|532570165|FG001|Overall Study|Did not meet Eligibility Criteria|3|||
147657927|NCT01843803|532570166|FG000|Overall Study|not a Veteran, did not see provider|1|||
147657928|NCT01843803|532570167|FG001|Overall Study|not a Veteran, did not see provider|3|||
147657929|NCT05285787|532570169|FG000|Overall Study|Withdrawal by Subject|1|||
147657930|NCT01051817|532570177|FG000|Overall Study|Adverse Event|0|||
147657931|NCT01051817|532570178|FG001|Overall Study|Adverse Event|2|||
147657932|NCT01051817|532570177|FG000|Overall Study|Abnormal Test Proceedure reults|0|||
147657933|NCT01051817|532570178|FG001|Overall Study|Abnormal Test Proceedure reults|1|||
147657934|NCT01051817|532570177|FG000|Overall Study|Withdrawal by Subject|3|||
147657935|NCT01051817|532570178|FG001|Overall Study|Withdrawal by Subject|5|||
147657936|NCT01051817|532570177|FG000|Overall Study|Protocol Violation|0|||
147657937|NCT01051817|532570178|FG001|Overall Study|Protocol Violation|1|||
147657938|NCT04346199|532570179|FG000|Overall Study|Death|8|||
147657939|NCT04346199|532570180|FG001|Overall Study|Death|9|||
147657940|NCT04346199|532570179|FG000|Overall Study|Lost to Follow-up|0|||
147657941|NCT04346199|532570180|FG001|Overall Study|Lost to Follow-up|1|||
147657942|NCT04346199|532570179|FG000|Overall Study|Study terminated by sponsor incorrectly entered in database - participants completed the study|2|||
147657943|NCT04346199|532570180|FG001|Overall Study|Study terminated by sponsor incorrectly entered in database - participants completed the study|0|||
147657944|NCT04346199|532570179|FG000|Overall Study|Withdrawal by Subject|5|||
147657945|NCT04346199|532570180|FG001|Overall Study|Withdrawal by Subject|1|||
147657946|NCT00627926|532570181|FG000|Overall Study|Adverse Event|26|||
147657947|NCT00627926|532570182|FG001|Overall Study|Adverse Event|37|||
147657948|NCT00627926|532570183|FG002|Overall Study|Adverse Event|36|||
147657949|NCT00627926|532570181|FG000|Overall Study|Death|1|||
147657950|NCT00627926|532570182|FG001|Overall Study|Death|0|||
147657951|NCT00627926|532570183|FG002|Overall Study|Death|0|||
147246561|NCT03129100|531072779|FG020|Period2 Extension Period (Group A and B)|Death|0|||
147657952|NCT00627926|532570181|FG000|Overall Study|Lost to Follow-up|4|||
147657953|NCT00627926|532570182|FG001|Overall Study|Lost to Follow-up|3|||
147657954|NCT00627926|532570183|FG002|Overall Study|Lost to Follow-up|4|||
147657955|NCT00627926|532570181|FG000|Overall Study|Withdrawal by Subject|2|||
147657956|NCT00627926|532570182|FG001|Overall Study|Withdrawal by Subject|1|||
147657957|NCT00627926|532570183|FG002|Overall Study|Withdrawal by Subject|0|||
147657958|NCT00627926|532570181|FG000|Overall Study|Lack of Efficacy|118|||
147657959|NCT00627926|532570182|FG001|Overall Study|Lack of Efficacy|40|||
147246562|NCT03129100|531072780|FG021|Period2 Extension Period (Group A and B)|Death|0|||
147657960|NCT00627926|532570183|FG002|Overall Study|Lack of Efficacy|38|||
147657961|NCT00627926|532570181|FG000|Overall Study|Noncompliance/unspecified|8|||
147657962|NCT00627926|532570182|FG001|Overall Study|Noncompliance/unspecified|23|||
147657963|NCT00627926|532570183|FG002|Overall Study|Noncompliance/unspecified|17|||
147657964|NCT02401035|532570184|FG000|Overall Study|Withdrawal by Subject|1|||
147657965|NCT02401035|532570185|FG001|Overall Study|Withdrawal by Subject|0|||
147657966|NCT00869128|532570186|FG000|Overall Study|lack of Compliance|6|||
147657967|NCT00869128|532570187|FG001|Overall Study|lack of Compliance|6|||
147657968|NCT05259163|532572161|FG000|Initial Testing - 1st Intervention|Investigator needed to continue adding cylinder beyond testing limit for the device.|1|||
147657969|NCT05259163|532572162|FG001|Initial Testing - 1st Intervention|Investigator needed to continue adding cylinder beyond testing limit for the device.|0|||
147657970|NCT05251233|532572163|FG000|Overall Study|Disease progression - did not start treatment|0|||
147657971|NCT05251233|532572164|FG001|Overall Study|Disease progression - did not start treatment|0|||
147657972|NCT05251233|532572165|FG002|Overall Study|Disease progression - did not start treatment|5|||
147657973|NCT05251233|532572163|FG000|Overall Study|Determined to be ineligible - did not start treatment|0|||
147657974|NCT05251233|532572164|FG001|Overall Study|Determined to be ineligible - did not start treatment|0|||
147657975|NCT05251233|532572165|FG002|Overall Study|Determined to be ineligible - did not start treatment|7|||
147246563|NCT03129100|531072781|FG022|Period2 Extension Period (Group A and B)|Death|0|||
147246564|NCT03129100|531072782|FG023|Period2 Extension Period (Group A and B)|Death|0|||
147246565|NCT03129100|531072783|FG024|Period2 Extension Period (Group A and B)|Death|0|||
147246566|NCT03129100|531072784|FG025|Period2 Extension Period (Group A and B)|Death|0|||
147246567|NCT03129100|531072759|FG000|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
147246568|NCT03129100|531072760|FG001|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
147657976|NCT05251233|532572163|FG000|Overall Study|Patient was NPO with NGT, could not receive oral medication - did not start treatment|0|||
147657977|NCT05251233|532572164|FG001|Overall Study|Patient was NPO with NGT, could not receive oral medication - did not start treatment|0|||
147657978|NCT05251233|532572165|FG002|Overall Study|Patient was NPO with NGT, could not receive oral medication - did not start treatment|1|||
147657979|NCT05251233|532572163|FG000|Overall Study|Had a total gastrectomy - did not start treatment|0|||
147657980|NCT05251233|532572164|FG001|Overall Study|Had a total gastrectomy - did not start treatment|0|||
147657981|NCT05251233|532572165|FG002|Overall Study|Had a total gastrectomy - did not start treatment|1|||
147657982|NCT05251233|532572163|FG000|Overall Study|Death - did not start treatment|3|||
147657983|NCT05251233|532572164|FG001|Overall Study|Death - did not start treatment|0|||
147657984|NCT05251233|532572165|FG002|Overall Study|Death - did not start treatment|0|||
147657985|NCT05251233|532572163|FG000|Overall Study|Withdrawal by Subject|2|||
147657986|NCT05251233|532572164|FG001|Overall Study|Withdrawal by Subject|2|||
147657987|NCT05251233|532572165|FG002|Overall Study|Withdrawal by Subject|0|||
147657988|NCT05251233|532572163|FG000|Overall Study|Other complicating disease|2|||
147657989|NCT05251233|532572164|FG001|Overall Study|Other complicating disease|1|||
147657990|NCT05251233|532572165|FG002|Overall Study|Other complicating disease|0|||
147246569|NCT03129100|531072761|FG002|Period2 Extension Period (Group A and B)|Withdrawal by Subject|13|||
147246570|NCT03129100|531072762|FG003|Period2 Extension Period (Group A and B)|Withdrawal by Subject|5|||
147246571|NCT03129100|531072763|FG004|Period2 Extension Period (Group A and B)|Withdrawal by Subject|1|||
147246572|NCT03129100|531072764|FG005|Period2 Extension Period (Group A and B)|Withdrawal by Subject|1|||
147246573|NCT03129100|531072765|FG006|Period2 Extension Period (Group A and B)|Withdrawal by Subject|2|||
147246574|NCT03129100|531072766|FG007|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
147246575|NCT03129100|531072767|FG008|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
147246576|NCT03129100|531072768|FG009|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
147246577|NCT03129100|531072769|FG010|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
147246578|NCT03129100|531072770|FG011|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
147246579|NCT03129100|531072771|FG012|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
147246580|NCT03129100|531072772|FG013|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
147246581|NCT03129100|531072773|FG014|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
147246582|NCT03129100|531072774|FG015|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
147246583|NCT03129100|531072775|FG016|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
147246584|NCT03129100|531072776|FG017|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
147246585|NCT03129100|531072777|FG018|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
147246586|NCT03129100|531072778|FG019|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
147246587|NCT03129100|531072779|FG020|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
147246588|NCT03129100|531072780|FG021|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
147246589|NCT03129100|531072781|FG022|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
147246590|NCT03129100|531072782|FG023|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
147246591|NCT03129100|531072783|FG024|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
147246592|NCT03129100|531072784|FG025|Period2 Extension Period (Group A and B)|Withdrawal by Subject|0|||
147246593|NCT03129100|531072759|FG000|Period2 Extension Period (Group A and B)|Physician Decision|0|||
147448536|NCT01964352|531807890|FG000|Overall Study|Lack of Efficacy|6|||
147657991|NCT05251233|532572163|FG000|Overall Study|Attending physician did not order medication for patient - did not start treatment|0|||
147657992|NCT05251233|532572164|FG001|Overall Study|Attending physician did not order medication for patient - did not start treatment|0|||
147657993|NCT05251233|532572165|FG002|Overall Study|Attending physician did not order medication for patient - did not start treatment|1|||
147657994|NCT05251233|532572163|FG000|Overall Study|Patient was ordered NPO and had NGT placed.|0|||
147657995|NCT05251233|532572164|FG001|Overall Study|Patient was ordered NPO and had NGT placed.|1|||
147657996|NCT05251233|532572165|FG002|Overall Study|Patient was ordered NPO and had NGT placed.|0|||
147657997|NCT00103285|532572166|FG000|Induction|Adverse Event|14|||
147657998|NCT00103285|532572167|FG001|Induction|Adverse Event|0|||
147657999|NCT00103285|532572168|FG002|Induction|Adverse Event|0|||
147658000|NCT00103285|532572169|FG003|Induction|Adverse Event|0|||
147658001|NCT00103285|532572170|FG004|Induction|Adverse Event|0|||
147658002|NCT00103285|532572171|FG005|Induction|Adverse Event|0|||
147327426|NCT01981850|531363911|FG002|Open Label Extension (OLE)|Lack of Efficacy|0|||
147327427|NCT01981850|531363912|FG003|Open Label Extension (OLE)|Lack of Efficacy|0|||
147327428|NCT01981850|531363913|FG004|Open Label Extension (OLE)|Lack of Efficacy|0|||
147327429|NCT01981850|531363914|FG005|Open Label Extension (OLE)|Lack of Efficacy|0|||
147327430|NCT01981850|531363915|FG006|Open Label Extension (OLE)|Lack of Efficacy|0|||
147327431|NCT01981850|531363916|FG007|Open Label Extension (OLE)|Lack of Efficacy|4|||
147327432|NCT01981850|531363917|FG008|Open Label Extension (OLE)|Lack of Efficacy|1|||
147327433|NCT01981850|531363918|FG009|Open Label Extension (OLE)|Lack of Efficacy|19|||
147327434|NCT01981850|531363909|FG000|Open Label Extension (OLE)|Various reasons|0|||
147327435|NCT01981850|531363910|FG001|Open Label Extension (OLE)|Various reasons|0|||
147327436|NCT01981850|531363911|FG002|Open Label Extension (OLE)|Various reasons|0|||
147327437|NCT01981850|531363912|FG003|Open Label Extension (OLE)|Various reasons|0|||
147327438|NCT01981850|531363913|FG004|Open Label Extension (OLE)|Various reasons|0|||
147327439|NCT01981850|531363914|FG005|Open Label Extension (OLE)|Various reasons|0|||
147327440|NCT01981850|531363915|FG006|Open Label Extension (OLE)|Various reasons|0|||
147327441|NCT01981850|531363916|FG007|Open Label Extension (OLE)|Various reasons|3|||
147327442|NCT01981850|531363917|FG008|Open Label Extension (OLE)|Various reasons|1|||
147327443|NCT01981850|531363918|FG009|Open Label Extension (OLE)|Various reasons|3|||
147327444|NCT01981850|531363909|FG000|Open Label Extension (OLE)|Progressive Disease|0|||
147327445|NCT01981850|531363910|FG001|Open Label Extension (OLE)|Progressive Disease|0|||
147327446|NCT01981850|531363911|FG002|Open Label Extension (OLE)|Progressive Disease|0|||
147327447|NCT01981850|531363912|FG003|Open Label Extension (OLE)|Progressive Disease|0|||
147327448|NCT01981850|531363913|FG004|Open Label Extension (OLE)|Progressive Disease|0|||
147327449|NCT01981850|531363914|FG005|Open Label Extension (OLE)|Progressive Disease|0|||
147327450|NCT01981850|531363915|FG006|Open Label Extension (OLE)|Progressive Disease|0|||
147327451|NCT01981850|531363916|FG007|Open Label Extension (OLE)|Progressive Disease|3|||
147327452|NCT01981850|531363917|FG008|Open Label Extension (OLE)|Progressive Disease|2|||
147327453|NCT01981850|531363918|FG009|Open Label Extension (OLE)|Progressive Disease|9|||
147327454|NCT01981850|531363909|FG000|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
147327455|NCT01981850|531363910|FG001|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
147327456|NCT01981850|531363911|FG002|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
147327457|NCT01981850|531363912|FG003|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
147327458|NCT01981850|531363913|FG004|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
147327459|NCT01981850|531363914|FG005|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
147327460|NCT01981850|531363915|FG006|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
147327461|NCT01981850|531363916|FG007|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
147327462|NCT01981850|531363917|FG008|Open Label Extension (OLE)|Informed Consent Withdrawn|0|||
147327463|NCT01981850|531363918|FG009|Open Label Extension (OLE)|Informed Consent Withdrawn|8|||
147327464|NCT01981850|531363909|FG000|Open Label Extension (OLE)|Lost to Follow-up|0|||
147327465|NCT01981850|531363910|FG001|Open Label Extension (OLE)|Lost to Follow-up|0|||
147327466|NCT01981850|531363911|FG002|Open Label Extension (OLE)|Lost to Follow-up|0|||
147327467|NCT01981850|531363912|FG003|Open Label Extension (OLE)|Lost to Follow-up|0|||
147327468|NCT01981850|531363913|FG004|Open Label Extension (OLE)|Lost to Follow-up|0|||
147327469|NCT01981850|531363914|FG005|Open Label Extension (OLE)|Lost to Follow-up|0|||
147327470|NCT01981850|531363915|FG006|Open Label Extension (OLE)|Lost to Follow-up|0|||
147327471|NCT01981850|531363916|FG007|Open Label Extension (OLE)|Lost to Follow-up|0|||
147327472|NCT01981850|531363917|FG008|Open Label Extension (OLE)|Lost to Follow-up|0|||
147327473|NCT01981850|531363918|FG009|Open Label Extension (OLE)|Lost to Follow-up|1|||
147327474|NCT01467700|531363919|FG000|Overall Study|Pretreatment Event or Adverse Event|6|||
147327475|NCT01467700|531363920|FG001|Overall Study|Pretreatment Event or Adverse Event|4|||
147327476|NCT01467700|531363921|FG002|Overall Study|Pretreatment Event or Adverse Event|2|||
147658003|NCT00103285|532572172|FG006|Induction|Adverse Event|0|||
147658004|NCT00103285|532572173|FG007|Induction|Adverse Event|0|||
147658005|NCT00103285|532572166|FG000|Induction|Death|24|||
147327477|NCT01467700|531363922|FG003|Overall Study|Pretreatment Event or Adverse Event|3|||
147327478|NCT01467700|531363919|FG000|Overall Study|Major Protocol Deviation|3|||
147658006|NCT00103285|532572167|FG001|Induction|Death|0|||
147658007|NCT00103285|532572168|FG002|Induction|Death|0|||
147658008|NCT00103285|532572169|FG003|Induction|Death|0|||
147327479|NCT01467700|531363920|FG001|Overall Study|Major Protocol Deviation|3|||
147327480|NCT01467700|531363921|FG002|Overall Study|Major Protocol Deviation|2|||
147327481|NCT01467700|531363922|FG003|Overall Study|Major Protocol Deviation|3|||
147327482|NCT01467700|531363919|FG000|Overall Study|Lost to Follow-up|6|||
147327483|NCT01467700|531363920|FG001|Overall Study|Lost to Follow-up|5|||
147327484|NCT01467700|531363921|FG002|Overall Study|Lost to Follow-up|2|||
147327485|NCT01467700|531363922|FG003|Overall Study|Lost to Follow-up|3|||
147327486|NCT01467700|531363919|FG000|Overall Study|Voluntary Withdrawal|5|||
147327487|NCT01467700|531363920|FG001|Overall Study|Voluntary Withdrawal|7|||
147327488|NCT01467700|531363921|FG002|Overall Study|Voluntary Withdrawal|6|||
147327489|NCT01467700|531363922|FG003|Overall Study|Voluntary Withdrawal|2|||
147327490|NCT01467700|531363919|FG000|Overall Study|Study Termination|6|||
147327491|NCT01467700|531363920|FG001|Overall Study|Study Termination|5|||
147327492|NCT01467700|531363921|FG002|Overall Study|Study Termination|10|||
147327493|NCT01467700|531363922|FG003|Overall Study|Study Termination|7|||
147327494|NCT01467700|531363919|FG000|Overall Study|Pregnancy|0|||
147327495|NCT01467700|531363920|FG001|Overall Study|Pregnancy|1|||
147327496|NCT01467700|531363921|FG002|Overall Study|Pregnancy|1|||
147327497|NCT01467700|531363922|FG003|Overall Study|Pregnancy|0|||
147327498|NCT01467700|531363919|FG000|Overall Study|Lack of Efficacy|2|||
147327499|NCT01467700|531363920|FG001|Overall Study|Lack of Efficacy|0|||
147327500|NCT01467700|531363921|FG002|Overall Study|Lack of Efficacy|2|||
147327501|NCT01467700|531363922|FG003|Overall Study|Lack of Efficacy|1|||
147327502|NCT01467700|531363919|FG000|Overall Study|Reason not Specified|1|||
147327503|NCT01467700|531363920|FG001|Overall Study|Reason not Specified|3|||
147593735|NCT02696031|532329014|FG002|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0|||
147327504|NCT01467700|531363921|FG002|Overall Study|Reason not Specified|2|||
147327505|NCT01467700|531363922|FG003|Overall Study|Reason not Specified|8|||
147327506|NCT03523962|531363923|FG000|Closed Fractures|Death|86|||
147327507|NCT03523962|531363924|FG001|Closed Fractures|Death|71|||
147327508|NCT03523962|531363925|FG002|Closed Fractures|Death|0|||
147327509|NCT03523962|531363926|FG003|Closed Fractures|Death|0|||
147327510|NCT03523962|531363923|FG000|Closed Fractures|Lost to Follow-up|62|||
147327511|NCT03523962|531363924|FG001|Closed Fractures|Lost to Follow-up|36|||
147327512|NCT03523962|531363925|FG002|Closed Fractures|Lost to Follow-up|0|||
147327513|NCT03523962|531363926|FG003|Closed Fractures|Lost to Follow-up|0|||
147327514|NCT03523962|531363923|FG000|Closed Fractures|Withdrawal by Subject|19|||
147327515|NCT03523962|531363924|FG001|Closed Fractures|Withdrawal by Subject|29|||
147327516|NCT03523962|531363925|FG002|Closed Fractures|Withdrawal by Subject|0|||
147327517|NCT03523962|531363926|FG003|Closed Fractures|Withdrawal by Subject|0|||
147327518|NCT03523962|531363923|FG000|Closed Fractures|Incarceration|1|||
147593736|NCT02696031|532329015|FG003|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|1|||
147593737|NCT02696031|532329016|FG004|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0|||
147593738|NCT02696031|532329017|FG005|Extension Phase From wk 104 to wk 208|Non-compliance with study treatment|0|||
147593739|NCT02696031|532329012|FG000|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0|||
147593740|NCT02696031|532329013|FG001|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0|||
147593741|NCT02696031|532329014|FG002|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0|||
147593742|NCT02696031|532329015|FG003|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0|||
147593743|NCT02696031|532329016|FG004|Extension Phase From wk 104 to wk 208|Lost to Follow-up|1|||
147593744|NCT02696031|532329017|FG005|Extension Phase From wk 104 to wk 208|Lost to Follow-up|0|||
147593745|NCT02696031|532329012|FG000|Extension Phase From wk 104 to wk 208|Lack of Efficacy|0|||
147593746|NCT02696031|532329013|FG001|Extension Phase From wk 104 to wk 208|Lack of Efficacy|0|||
147593747|NCT02696031|532329014|FG002|Extension Phase From wk 104 to wk 208|Lack of Efficacy|0|||
147593748|NCT02696031|532329015|FG003|Extension Phase From wk 104 to wk 208|Lack of Efficacy|1|||
147593749|NCT02696031|532329016|FG004|Extension Phase From wk 104 to wk 208|Lack of Efficacy|1|||
147593750|NCT02696031|532329017|FG005|Extension Phase From wk 104 to wk 208|Lack of Efficacy|3|||
147593751|NCT02696031|532329012|FG000|Extension Phase From wk 104 to wk 208|Adverse Event|0|||
147593752|NCT02696031|532329013|FG001|Extension Phase From wk 104 to wk 208|Adverse Event|0|||
147593753|NCT02696031|532329014|FG002|Extension Phase From wk 104 to wk 208|Adverse Event|0|||
147593754|NCT02696031|532329015|FG003|Extension Phase From wk 104 to wk 208|Adverse Event|1|||
147593755|NCT02696031|532329016|FG004|Extension Phase From wk 104 to wk 208|Adverse Event|4|||
147593756|NCT02696031|532329017|FG005|Extension Phase From wk 104 to wk 208|Adverse Event|1|||
147593757|NCT00597116|532329018|FG000|Overall Study|Adverse Event|2|||
147593758|NCT00597116|532329019|FG001|Overall Study|Adverse Event|1|||
147593759|NCT00597116|532329018|FG000|Overall Study|Withdrawal by Subject|0|||
147593760|NCT00597116|532329019|FG001|Overall Study|Withdrawal by Subject|2|||
147593761|NCT00597116|532329018|FG000|Overall Study|Physician Decision|0|||
147327519|NCT03523962|531363924|FG001|Closed Fractures|Incarceration|4|||
147327520|NCT03523962|531363925|FG002|Closed Fractures|Incarceration|0|||
147327521|NCT03523962|531363926|FG003|Closed Fractures|Incarceration|0|||
147327522|NCT03523962|531363923|FG000|Open Fractures|Death|0|||
147327523|NCT03523962|531363924|FG001|Open Fractures|Death|0|||
147327524|NCT03523962|531363925|FG002|Open Fractures|Death|11|||
147327525|NCT03523962|531363926|FG003|Open Fractures|Death|6|||
147658009|NCT00103285|532572170|FG004|Induction|Death|0|||
147658010|NCT00103285|532572171|FG005|Induction|Death|0|||
147658011|NCT00103285|532572172|FG006|Induction|Death|0|||
147327526|NCT03523962|531363923|FG000|Open Fractures|Lost to Follow-up|0|||
147327527|NCT03523962|531363924|FG001|Open Fractures|Lost to Follow-up|0|||
147327528|NCT03523962|531363925|FG002|Open Fractures|Lost to Follow-up|15|||
147327529|NCT03523962|531363926|FG003|Open Fractures|Lost to Follow-up|8|||
147327530|NCT03523962|531363923|FG000|Open Fractures|Withdrawal by Subject|0|||
147327531|NCT03523962|531363924|FG001|Open Fractures|Withdrawal by Subject|0|||
147327532|NCT03523962|531363925|FG002|Open Fractures|Withdrawal by Subject|6|||
147327533|NCT03523962|531363926|FG003|Open Fractures|Withdrawal by Subject|2|||
147327534|NCT03523962|531363923|FG000|Open Fractures|Incarceration|0|||
147327535|NCT03523962|531363924|FG001|Open Fractures|Incarceration|0|||
147327536|NCT03523962|531363925|FG002|Open Fractures|Incarceration|1|||
147327537|NCT03523962|531363926|FG003|Open Fractures|Incarceration|0|||
147327538|NCT00121199|531363937|FG000|Overall Study|Adverse Event|11|||
147327539|NCT00121199|531363937|FG000|Overall Study|Refusal Unrelated to Adverse Event|1|||
147327540|NCT00121199|531363937|FG000|Overall Study|Progression/Relapse|1|||
147327541|NCT00121199|531363937|FG000|Overall Study|Death|3|||
147327542|NCT00121199|531363937|FG000|Overall Study|Other - Not Protocol Specified|3|||
147327543|NCT00121199|531363937|FG000|Overall Study|Ineligible|9|||
147327544|NCT03168438|531363938|FG000|Overall Study|Long term follow-up declined, study terminated by sponsor|0|||
147327545|NCT03168438|531363939|FG001|Overall Study|Long term follow-up declined, study terminated by sponsor|1|||
147327546|NCT01018511|531363942|FG000|Overall Study|Not fulfilling eligibility criteria|6|||
147327547|NCT01018511|531363943|FG001|Overall Study|Not fulfilling eligibility criteria|7|||
147327548|NCT01018511|531363944|FG002|Overall Study|Not fulfilling eligibility criteria|7|||
147327549|NCT01018511|531363945|FG003|Overall Study|Not fulfilling eligibility criteria|3|||
147448537|NCT01964352|531807891|FG001|Overall Study|Lack of Efficacy|0|||
147658012|NCT00103285|532572173|FG007|Induction|Death|0|||
147658013|NCT00103285|532572166|FG000|Induction|Physician Decision|103|||
147658014|NCT00103285|532572167|FG001|Induction|Physician Decision|0|||
147246594|NCT03129100|531072760|FG001|Period2 Extension Period (Group A and B)|Physician Decision|0|||
147246595|NCT03129100|531072761|FG002|Period2 Extension Period (Group A and B)|Physician Decision|1|||
147246596|NCT03129100|531072762|FG003|Period2 Extension Period (Group A and B)|Physician Decision|0|||
147246597|NCT03129100|531072763|FG004|Period2 Extension Period (Group A and B)|Physician Decision|0|||
147246598|NCT03129100|531072764|FG005|Period2 Extension Period (Group A and B)|Physician Decision|0|||
147246599|NCT03129100|531072765|FG006|Period2 Extension Period (Group A and B)|Physician Decision|0|||
147246600|NCT03129100|531072766|FG007|Period2 Extension Period (Group A and B)|Physician Decision|0|||
147246601|NCT03129100|531072767|FG008|Period2 Extension Period (Group A and B)|Physician Decision|0|||
147246602|NCT03129100|531072768|FG009|Period2 Extension Period (Group A and B)|Physician Decision|0|||
147246603|NCT03129100|531072769|FG010|Period2 Extension Period (Group A and B)|Physician Decision|0|||
147246604|NCT03129100|531072770|FG011|Period2 Extension Period (Group A and B)|Physician Decision|0|||
147246605|NCT03129100|531072771|FG012|Period2 Extension Period (Group A and B)|Physician Decision|0|||
147246606|NCT03129100|531072772|FG013|Period2 Extension Period (Group A and B)|Physician Decision|0|||
147246607|NCT03129100|531072773|FG014|Period2 Extension Period (Group A and B)|Physician Decision|0|||
147246608|NCT03129100|531072774|FG015|Period2 Extension Period (Group A and B)|Physician Decision|0|||
147246609|NCT03129100|531072775|FG016|Period2 Extension Period (Group A and B)|Physician Decision|0|||
147246610|NCT03129100|531072776|FG017|Period2 Extension Period (Group A and B)|Physician Decision|0|||
147246611|NCT03129100|531072777|FG018|Period2 Extension Period (Group A and B)|Physician Decision|0|||
147246612|NCT03129100|531072778|FG019|Period2 Extension Period (Group A and B)|Physician Decision|0|||
147246613|NCT03129100|531072779|FG020|Period2 Extension Period (Group A and B)|Physician Decision|0|||
147246614|NCT03129100|531072780|FG021|Period2 Extension Period (Group A and B)|Physician Decision|0|||
147246615|NCT03129100|531072781|FG022|Period2 Extension Period (Group A and B)|Physician Decision|0|||
147246616|NCT03129100|531072782|FG023|Period2 Extension Period (Group A and B)|Physician Decision|0|||
147246617|NCT03129100|531072783|FG024|Period2 Extension Period (Group A and B)|Physician Decision|0|||
147246618|NCT03129100|531072784|FG025|Period2 Extension Period (Group A and B)|Physician Decision|0|||
147246619|NCT03129100|531072759|FG000|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
147246620|NCT03129100|531072760|FG001|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
147246621|NCT03129100|531072761|FG002|Period2 Extension Period (Group A and B)|Lack of Efficacy|2|||
147246622|NCT03129100|531072762|FG003|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
147246623|NCT03129100|531072763|FG004|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
147246624|NCT03129100|531072764|FG005|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
147246625|NCT03129100|531072765|FG006|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
147246626|NCT03129100|531072766|FG007|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
147246627|NCT03129100|531072767|FG008|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
147246628|NCT03129100|531072768|FG009|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
147246629|NCT03129100|531072769|FG010|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
147658015|NCT00103285|532572168|FG002|Induction|Physician Decision|0|||
147658016|NCT00103285|532572169|FG003|Induction|Physician Decision|0|||
147658017|NCT00103285|532572170|FG004|Induction|Physician Decision|0|||
147658018|NCT00103285|532572171|FG005|Induction|Physician Decision|0|||
147658019|NCT00103285|532572172|FG006|Induction|Physician Decision|0|||
147658020|NCT00103285|532572173|FG007|Induction|Physician Decision|0|||
147658021|NCT00103285|532572166|FG000|Induction|Withdrawal by Subject|1|||
147658022|NCT00103285|532572167|FG001|Induction|Withdrawal by Subject|0|||
147658023|NCT00103285|532572168|FG002|Induction|Withdrawal by Subject|0|||
147658024|NCT00103285|532572169|FG003|Induction|Withdrawal by Subject|0|||
147658025|NCT00103285|532572170|FG004|Induction|Withdrawal by Subject|0|||
147658026|NCT00103285|532572171|FG005|Induction|Withdrawal by Subject|0|||
147658027|NCT00103285|532572172|FG006|Induction|Withdrawal by Subject|0|||
147658028|NCT00103285|532572173|FG007|Induction|Withdrawal by Subject|0|||
147658029|NCT00103285|532572166|FG000|Induction|Ineligible|43|||
147658030|NCT00103285|532572167|FG001|Induction|Ineligible|0|||
147658031|NCT00103285|532572168|FG002|Induction|Ineligible|0|||
147182236|NCT01746225|530831255|FG001|Overall Study|Continuing Treatment|8|||
147182237|NCT01746225|530831256|FG002|Overall Study|Continuing Treatment|3|||
147182238|NCT03245775|530831259|FG000|Overall Study|Lost to Follow-up|25|||
147182239|NCT03245775|530831260|FG001|Overall Study|Lost to Follow-up|26|||
147182240|NCT03245775|530831261|FG002|Overall Study|Lost to Follow-up|16|||
147182241|NCT03245775|530831262|FG003|Overall Study|Lost to Follow-up|16|||
147182242|NCT02713828|530831265|FG000|Overall Study|Death|2|||
147182243|NCT02713828|530831266|FG001|Overall Study|Death|0|||
147182244|NCT02713828|530831265|FG000|Overall Study|Withdrawal by Subject|1|||
147182245|NCT02713828|530831266|FG001|Overall Study|Withdrawal by Subject|0|||
147182246|NCT02713828|530831265|FG000|Overall Study|study terminated but patient allowed to|2|||
147182247|NCT02713828|530831266|FG001|Overall Study|study terminated but patient allowed to|0|||
147182248|NCT03302247|530831270|FG000|Overall Study|the study has closed prematurely|2|||
147182249|NCT03302247|530831270|FG000|Overall Study|Death|1|||
147182250|NCT03197376|530831271|FG000|Primary and Booster Phase|Adverse Event|0|||
147182251|NCT03197376|530831272|FG001|Primary and Booster Phase|Adverse Event|0|||
147182252|NCT03197376|530831273|FG002|Primary and Booster Phase|Adverse Event|0|||
147182253|NCT03197376|530831274|FG003|Primary and Booster Phase|Adverse Event|1|||
147182254|NCT03197376|530831271|FG000|Primary and Booster Phase|Death|1|||
147182255|NCT03197376|530831272|FG001|Primary and Booster Phase|Death|0|||
147182256|NCT03197376|530831273|FG002|Primary and Booster Phase|Death|0|||
147182257|NCT03197376|530831274|FG003|Primary and Booster Phase|Death|2|||
147182258|NCT03197376|530831271|FG000|Primary and Booster Phase|Lost to Follow-up|0|||
147182259|NCT03197376|530831272|FG001|Primary and Booster Phase|Lost to Follow-up|0|||
147182260|NCT03197376|530831273|FG002|Primary and Booster Phase|Lost to Follow-up|1|||
147182261|NCT03197376|530831274|FG003|Primary and Booster Phase|Lost to Follow-up|0|||
147182262|NCT03197376|530831271|FG000|Primary and Booster Phase|Physician Decision|1|||
147658032|NCT00103285|532572169|FG003|Induction|Ineligible|0|||
147658033|NCT00103285|532572170|FG004|Induction|Ineligible|0|||
147658034|NCT00103285|532572171|FG005|Induction|Ineligible|0|||
147658035|NCT00103285|532572172|FG006|Induction|Ineligible|0|||
147658036|NCT00103285|532572173|FG007|Induction|Ineligible|0|||
147658037|NCT00103285|532572166|FG000|Induction|Refusal|906|||
147658038|NCT00103285|532572167|FG001|Induction|Refusal|0|||
147658039|NCT00103285|532572168|FG002|Induction|Refusal|0|||
147658040|NCT00103285|532572169|FG003|Induction|Refusal|0|||
147658041|NCT00103285|532572170|FG004|Induction|Refusal|0|||
147658042|NCT00103285|532572171|FG005|Induction|Refusal|0|||
147658043|NCT00103285|532572172|FG006|Induction|Refusal|0|||
147658044|NCT00103285|532572173|FG007|Induction|Refusal|0|||
147658045|NCT00103285|532572166|FG000|Induction|Other|258|||
147658046|NCT00103285|532572167|FG001|Induction|Other|0|||
147658047|NCT00103285|532572168|FG002|Induction|Other|0|||
147658048|NCT00103285|532572169|FG003|Induction|Other|0|||
147658049|NCT00103285|532572170|FG004|Induction|Other|0|||
147182263|NCT03197376|530831272|FG001|Primary and Booster Phase|Physician Decision|0|||
147182264|NCT03197376|530831273|FG002|Primary and Booster Phase|Physician Decision|1|||
147182265|NCT03197376|530831274|FG003|Primary and Booster Phase|Physician Decision|3|||
147182266|NCT03197376|530831271|FG000|Primary and Booster Phase|Withdrawal by subject's parents|11|||
147182267|NCT03197376|530831272|FG001|Primary and Booster Phase|Withdrawal by subject's parents|10|||
147327550|NCT01018511|531363942|FG000|Overall Study|Adverse Event|5|||
147327551|NCT01018511|531363943|FG001|Overall Study|Adverse Event|9|||
147327552|NCT01018511|531363944|FG002|Overall Study|Adverse Event|13|||
147327553|NCT01018511|531363945|FG003|Overall Study|Adverse Event|10|||
147182268|NCT03197376|530831273|FG002|Primary and Booster Phase|Withdrawal by subject's parents|14|||
147327554|NCT01018511|531363942|FG000|Overall Study|Lack of Efficacy|4|||
147327555|NCT01018511|531363943|FG001|Overall Study|Lack of Efficacy|1|||
147658050|NCT00103285|532572171|FG005|Induction|Other|0|||
147658051|NCT00103285|532572172|FG006|Induction|Other|0|||
147658052|NCT00103285|532572173|FG007|Induction|Other|0|||
147658053|NCT00103285|532572166|FG000|Response Assignment|Adverse Event|0|||
147658054|NCT00103285|532572167|FG001|Response Assignment|Adverse Event|8|||
147658055|NCT00103285|532572168|FG002|Response Assignment|Adverse Event|3|||
147658056|NCT00103285|532572169|FG003|Response Assignment|Adverse Event|2|||
147658057|NCT00103285|532572170|FG004|Response Assignment|Adverse Event|3|||
147658058|NCT00103285|532572171|FG005|Response Assignment|Adverse Event|1|||
147182269|NCT03197376|530831274|FG003|Primary and Booster Phase|Withdrawal by subject's parents|11|||
147182270|NCT03197376|530831271|FG000|Primary and Booster Phase|Ineligibility criteria|1|||
147182271|NCT03197376|530831272|FG001|Primary and Booster Phase|Ineligibility criteria|1|||
147182272|NCT03197376|530831273|FG002|Primary and Booster Phase|Ineligibility criteria|4|||
147182273|NCT03197376|530831274|FG003|Primary and Booster Phase|Ineligibility criteria|2|||
147182274|NCT03197376|530831271|FG000|Primary and Booster Phase|Not vaccine related|1|||
147327556|NCT01018511|531363944|FG002|Overall Study|Lack of Efficacy|1|||
147327557|NCT01018511|531363945|FG003|Overall Study|Lack of Efficacy|2|||
147327558|NCT01018511|531363942|FG000|Overall Study|Withdrawal by Subject|6|||
147327559|NCT01018511|531363943|FG001|Overall Study|Withdrawal by Subject|5|||
147327560|NCT01018511|531363944|FG002|Overall Study|Withdrawal by Subject|11|||
147327561|NCT01018511|531363945|FG003|Overall Study|Withdrawal by Subject|9|||
147327562|NCT01018511|531363942|FG000|Overall Study|Lost to Follow-up|0|||
147327563|NCT01018511|531363943|FG001|Overall Study|Lost to Follow-up|0|||
147327564|NCT01018511|531363944|FG002|Overall Study|Lost to Follow-up|1|||
147327565|NCT01018511|531363945|FG003|Overall Study|Lost to Follow-up|0|||
147327566|NCT01018511|531363942|FG000|Overall Study|Protocol Violation|5|||
147327567|NCT01018511|531363943|FG001|Overall Study|Protocol Violation|8|||
147327568|NCT01018511|531363944|FG002|Overall Study|Protocol Violation|7|||
147327569|NCT01018511|531363945|FG003|Overall Study|Protocol Violation|9|||
147327570|NCT01018511|531363942|FG000|Overall Study|Miscellaneous|0|||
147327571|NCT01018511|531363943|FG001|Overall Study|Miscellaneous|2|||
147327572|NCT01018511|531363944|FG002|Overall Study|Miscellaneous|0|||
147327573|NCT01018511|531363945|FG003|Overall Study|Miscellaneous|0|||
147327574|NCT04523181|531363946|FG000|Overall Study|Withdrawal by Subject|4|||
147327575|NCT04523181|531363947|FG001|Overall Study|Withdrawal by Subject|5|||
147327576|NCT04523181|531363946|FG000|Overall Study|Lost to Follow-up|2|||
147327577|NCT04523181|531363947|FG001|Overall Study|Lost to Follow-up|3|||
147327578|NCT04523181|531363946|FG000|Overall Study|Physician Decision|1|||
147327579|NCT04523181|531363947|FG001|Overall Study|Physician Decision|0|||
147327580|NCT04523181|531363946|FG000|Overall Study|Transferred to external facility.|1|||
147327581|NCT04523181|531363947|FG001|Overall Study|Transferred to external facility.|1|||
147327582|NCT01649427|531363948|FG000|Overall Study|Adverse Event|1|||
147327583|NCT01649427|531363949|FG001|Overall Study|Adverse Event|1|||
147327584|NCT01649427|531363948|FG000|Overall Study|Withdrawal by Subject|8|||
147327585|NCT01649427|531363949|FG001|Overall Study|Withdrawal by Subject|7|||
147327586|NCT01649427|531363948|FG000|Overall Study|Lost to Follow-up|0|||
147327587|NCT01649427|531363949|FG001|Overall Study|Lost to Follow-up|1|||
147327588|NCT01649427|531363948|FG000|Overall Study|Graft loss|0|||
147327589|NCT01649427|531363949|FG001|Overall Study|Graft loss|1|||
147327590|NCT01649427|531363948|FG000|Overall Study|Surgical problems during nephrectomy|2|||
147327591|NCT01649427|531363949|FG001|Overall Study|Surgical problems during nephrectomy|2|||
147327592|NCT02482233|531363959|FG000|Overall Study|Lost to Follow-up|1|||
147327593|NCT02482233|531363960|FG001|Overall Study|Lost to Follow-up|1|||
147327594|NCT04888585|531363961|FG000|Placebo-Controlled (Baseline-Week 12)|Other|4|||
147327595|NCT04888585|531363962|FG001|Placebo-Controlled (Baseline-Week 12)|Other|4|||
147327596|NCT04888585|531363963|FG002|Placebo-Controlled (Baseline-Week 12)|Other|4|||
147327597|NCT04888585|531363964|FG003|Placebo-Controlled (Baseline-Week 12)|Other|2|||
147327598|NCT04888585|531363965|FG004|Placebo-Controlled (Baseline-Week 12)|Other|1|||
147327599|NCT04888585|531363966|FG005|Placebo-Controlled (Baseline-Week 12)|Other|0|||
147327600|NCT04888585|531363967|FG006|Placebo-Controlled (Baseline-Week 12)|Other|0|||
147327601|NCT04888585|531363968|FG007|Placebo-Controlled (Baseline-Week 12)|Other|0|||
147327602|NCT04888585|531363969|FG008|Placebo-Controlled (Baseline-Week 12)|Other|0|||
147327603|NCT04888585|531363970|FG009|Placebo-Controlled (Baseline-Week 12)|Other|0|||
147327604|NCT04888585|531363971|FG010|Placebo-Controlled (Baseline-Week 12)|Other|0|||
147327605|NCT04888585|531363961|FG000|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
147327606|NCT04888585|531363962|FG001|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|1|||
147327607|NCT04888585|531363963|FG002|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|4|||
147327608|NCT04888585|531363964|FG003|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|3|||
147327609|NCT04888585|531363965|FG004|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|3|||
147182275|NCT03197376|530831272|FG001|Primary and Booster Phase|Not vaccine related|2|||
147327610|NCT04888585|531363966|FG005|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
147327611|NCT04888585|531363967|FG006|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
147327612|NCT04888585|531363968|FG007|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
147327613|NCT04888585|531363969|FG008|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
147327614|NCT04888585|531363970|FG009|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
147327615|NCT04888585|531363971|FG010|Placebo-Controlled (Baseline-Week 12)|Withdrawal by Subject|0|||
147327616|NCT04888585|531363961|FG000|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
147327617|NCT04888585|531363962|FG001|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
147327618|NCT04888585|531363963|FG002|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|1|||
147327619|NCT04888585|531363964|FG003|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
147327620|NCT04888585|531363965|FG004|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|1|||
147658059|NCT00103285|532572172|FG006|Response Assignment|Adverse Event|1|||
147658060|NCT00103285|532572173|FG007|Response Assignment|Adverse Event|2|||
147658061|NCT00103285|532572166|FG000|Response Assignment|Death|0|||
147658062|NCT00103285|532572167|FG001|Response Assignment|Death|5|||
147658063|NCT00103285|532572168|FG002|Response Assignment|Death|2|||
147658064|NCT00103285|532572169|FG003|Response Assignment|Death|2|||
147658065|NCT00103285|532572170|FG004|Response Assignment|Death|3|||
147658066|NCT00103285|532572171|FG005|Response Assignment|Death|1|||
147658067|NCT00103285|532572172|FG006|Response Assignment|Death|0|||
147658068|NCT00103285|532572173|FG007|Response Assignment|Death|8|||
147658069|NCT00103285|532572166|FG000|Response Assignment|Lost to Follow-up|0|||
147658070|NCT00103285|532572167|FG001|Response Assignment|Lost to Follow-up|9|||
147658071|NCT00103285|532572168|FG002|Response Assignment|Lost to Follow-up|5|||
147658072|NCT00103285|532572169|FG003|Response Assignment|Lost to Follow-up|5|||
147658073|NCT00103285|532572170|FG004|Response Assignment|Lost to Follow-up|1|||
147658074|NCT00103285|532572171|FG005|Response Assignment|Lost to Follow-up|2|||
147658075|NCT00103285|532572172|FG006|Response Assignment|Lost to Follow-up|2|||
147658076|NCT00103285|532572173|FG007|Response Assignment|Lost to Follow-up|5|||
147658077|NCT00103285|532572166|FG000|Response Assignment|Physician Decision|0|||
147658078|NCT00103285|532572167|FG001|Response Assignment|Physician Decision|13|||
147658079|NCT00103285|532572168|FG002|Response Assignment|Physician Decision|14|||
147658080|NCT00103285|532572169|FG003|Response Assignment|Physician Decision|9|||
147658081|NCT00103285|532572170|FG004|Response Assignment|Physician Decision|13|||
147658082|NCT00103285|532572171|FG005|Response Assignment|Physician Decision|7|||
147658083|NCT00103285|532572172|FG006|Response Assignment|Physician Decision|4|||
147658084|NCT00103285|532572173|FG007|Response Assignment|Physician Decision|35|||
147658085|NCT00103285|532572166|FG000|Response Assignment|Protocol Violation|0|||
147658086|NCT00103285|532572167|FG001|Response Assignment|Protocol Violation|2|||
147658087|NCT00103285|532572168|FG002|Response Assignment|Protocol Violation|0|||
147658088|NCT00103285|532572169|FG003|Response Assignment|Protocol Violation|0|||
147658089|NCT00103285|532572170|FG004|Response Assignment|Protocol Violation|0|||
147658090|NCT00103285|532572171|FG005|Response Assignment|Protocol Violation|0|||
147658091|NCT00103285|532572172|FG006|Response Assignment|Protocol Violation|0|||
147658092|NCT00103285|532572173|FG007|Response Assignment|Protocol Violation|0|||
147182276|NCT03197376|530831273|FG002|Primary and Booster Phase|Not vaccine related|0|||
147182277|NCT03197376|530831274|FG003|Primary and Booster Phase|Not vaccine related|6|||
147182278|NCT03197376|530831271|FG000|Immune Persistence Phase|Lost to Follow-up|0|||
147182279|NCT03197376|530831272|FG001|Immune Persistence Phase|Lost to Follow-up|0|||
147182280|NCT03197376|530831273|FG002|Immune Persistence Phase|Lost to Follow-up|2|||
147182281|NCT03197376|530831274|FG003|Immune Persistence Phase|Lost to Follow-up|1|||
147182282|NCT03197376|530831271|FG000|Immune Persistence Phase|Withdrawal by subject's parents|4|||
147182283|NCT03197376|530831272|FG001|Immune Persistence Phase|Withdrawal by subject's parents|4|||
147182284|NCT03197376|530831273|FG002|Immune Persistence Phase|Withdrawal by subject's parents|2|||
147182285|NCT03197376|530831274|FG003|Immune Persistence Phase|Withdrawal by subject's parents|3|||
147182286|NCT03197376|530831271|FG000|Immune Persistence Phase|Not vaccine related|1|||
147182287|NCT03197376|530831272|FG001|Immune Persistence Phase|Not vaccine related|0|||
147182288|NCT03197376|530831273|FG002|Immune Persistence Phase|Not vaccine related|1|||
147182289|NCT03197376|530831274|FG003|Immune Persistence Phase|Not vaccine related|1|||
147182290|NCT02978833|530831278|FG000|Overall Study|Study terminated|1|||
147182291|NCT02978833|530831279|FG001|Overall Study|Study terminated|1|||
147182292|NCT01123395|530831280|FG000|Washout Period of 14 Days|Withdrawal by Subject|0|||
147182293|NCT01123395|530831281|FG001|Washout Period of 14 Days|Withdrawal by Subject|1|||
147182294|NCT03691571|530831282|FG000|Overall Study|Withdrawal by Subject|9|||
147182295|NCT03691571|530831283|FG001|Overall Study|Withdrawal by Subject|2|||
147182296|NCT03937713|530832712|FG000|Overall Study|Withdrawal by Subject|3|||
147182297|NCT03937713|530832713|FG001|Overall Study|Withdrawal by Subject|6|||
147182298|NCT03937713|530832712|FG000|Overall Study|Lost to Follow-up|1|||
147182299|NCT03937713|530832713|FG001|Overall Study|Lost to Follow-up|0|||
147182300|NCT00922623|530832719|FG000|Overall Study|Other|4|||
147182301|NCT00922623|530832719|FG000|Overall Study|Lost to Follow-up|1|||
147182302|NCT02420379|530832720|FG000|Overall Study|Withdrawal by Subject|0|||
147182303|NCT02420379|530832721|FG001|Overall Study|Withdrawal by Subject|3|||
147182304|NCT02420379|530832720|FG000|Overall Study|Unable to complete due to schooling|0|||
147182305|NCT02420379|530832721|FG001|Overall Study|Unable to complete due to schooling|1|||
147246630|NCT03129100|531072770|FG011|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
147246631|NCT03129100|531072771|FG012|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
147246632|NCT03129100|531072772|FG013|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
147246633|NCT03129100|531072773|FG014|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
147246634|NCT03129100|531072774|FG015|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
147658093|NCT00103285|532572166|FG000|Response Assignment|Withdrawal by Subject|0|||
147658094|NCT00103285|532572167|FG001|Response Assignment|Withdrawal by Subject|4|||
147658095|NCT00103285|532572168|FG002|Response Assignment|Withdrawal by Subject|1|||
147658096|NCT00103285|532572169|FG003|Response Assignment|Withdrawal by Subject|1|||
147658097|NCT00103285|532572170|FG004|Response Assignment|Withdrawal by Subject|2|||
147658098|NCT00103285|532572171|FG005|Response Assignment|Withdrawal by Subject|2|||
147182306|NCT02420379|530832720|FG000|Overall Study|Transitioned to commercial drug|1|||
147182307|NCT02420379|530832721|FG001|Overall Study|Transitioned to commercial drug|0|||
147182308|NCT00086047|530832722|FG000|Overall Study|Lost to Follow-up|7|||
147182309|NCT00086047|530832723|FG001|Overall Study|Lost to Follow-up|6|||
147182310|NCT00086047|530832722|FG000|Overall Study|Physician Decision|0|||
147182311|NCT00086047|530832723|FG001|Overall Study|Physician Decision|1|||
147182312|NCT00269919|530832729|FG000|Overall Study|Other|26|||
147182313|NCT00269919|530832729|FG000|Overall Study|Started but not treated|1|||
147182314|NCT00786799|530832730|FG000|Overall Study|Lost to Follow-up|1|||
147182315|NCT00786799|530832731|FG001|Overall Study|Lost to Follow-up|1|||
147182316|NCT00950846|530832734|FG000|Overall Study|Death|6|||
147182317|NCT00950846|530832734|FG000|Overall Study|Lost to Follow-up|3|||
147182318|NCT00950846|530832734|FG000|Overall Study|Possible undiagnosed AML at study entry|1|||
147182319|NCT01799226|530832737|FG000|Overall Study|Withdrawal by Subject|1|||
147182320|NCT01799226|530832738|FG001|Overall Study|Withdrawal by Subject|0|||
147182321|NCT01799226|530832737|FG000|Overall Study|Disqualified at Day 14|1|||
147182322|NCT01799226|530832738|FG001|Overall Study|Disqualified at Day 14|0|||
147182323|NCT02178995|530832739|FG000|Double Blind|Adverse Event|0|||
147182324|NCT02178995|530832740|FG001|Double Blind|Adverse Event|0|||
147182325|NCT02178995|530832741|FG002|Double Blind|Adverse Event|0|||
147658099|NCT00103285|532572172|FG006|Response Assignment|Withdrawal by Subject|0|||
147182326|NCT02178995|530832742|FG003|Double Blind|Adverse Event|0|||
147182327|NCT02178995|530832743|FG004|Double Blind|Adverse Event|0|||
147182328|NCT02178995|530832744|FG005|Double Blind|Adverse Event|1|||
147182329|NCT02178995|530832745|FG006|Double Blind|Adverse Event|0|||
147182330|NCT02178995|530832746|FG007|Double Blind|Adverse Event|1|||
147182331|NCT02178995|530832747|FG008|Double Blind|Adverse Event|1|||
147182332|NCT02178995|530832739|FG000|Double Blind|Lost to Follow-up|0|||
147182333|NCT02178995|530832740|FG001|Double Blind|Lost to Follow-up|1|||
147182334|NCT02178995|530832741|FG002|Double Blind|Lost to Follow-up|0|||
147182335|NCT02178995|530832742|FG003|Double Blind|Lost to Follow-up|0|||
147182336|NCT02178995|530832743|FG004|Double Blind|Lost to Follow-up|0|||
147182337|NCT02178995|530832744|FG005|Double Blind|Lost to Follow-up|0|||
147182338|NCT02178995|530832745|FG006|Double Blind|Lost to Follow-up|0|||
147182339|NCT02178995|530832746|FG007|Double Blind|Lost to Follow-up|1|||
147182340|NCT02178995|530832747|FG008|Double Blind|Lost to Follow-up|0|||
147182341|NCT02178995|530832739|FG000|Open Label|Adverse Event|2|||
147182342|NCT02178995|530832740|FG001|Open Label|Adverse Event|0|||
147182343|NCT02178995|530832741|FG002|Open Label|Adverse Event|0|||
147182344|NCT02178995|530832742|FG003|Open Label|Adverse Event|0|||
147182345|NCT02178995|530832743|FG004|Open Label|Adverse Event|0|||
147182346|NCT02178995|530832744|FG005|Open Label|Adverse Event|0|||
147182347|NCT02178995|530832745|FG006|Open Label|Adverse Event|0|||
147182348|NCT02178995|530832746|FG007|Open Label|Adverse Event|0|||
147182349|NCT02178995|530832747|FG008|Open Label|Adverse Event|0|||
147182350|NCT00981461|530832748|FG000|Overall Study|Lost to Follow-up|5|||
147182351|NCT00981461|530832749|FG001|Overall Study|Lost to Follow-up|2|||
147182352|NCT03361293|530832752|FG000|Overall Study|Lost to Follow-up|0|||
147182353|NCT03361293|530832753|FG001|Overall Study|Lost to Follow-up|2|||
147182354|NCT03361293|530832752|FG000|Overall Study|Withdrawal by Subject|1|||
147182355|NCT03361293|530832753|FG001|Overall Study|Withdrawal by Subject|3|||
147658100|NCT00103285|532572173|FG007|Response Assignment|Withdrawal by Subject|2|||
147658101|NCT00103285|532572166|FG000|Response Assignment|Ineligible|0|||
147182356|NCT00483405|530832754|FG000|Overall Study|Adverse Event|8|||
147182357|NCT00483405|530832754|FG000|Overall Study|Lack of Efficacy|14|||
147182358|NCT00483405|530832754|FG000|Overall Study|Death|3|||
147182359|NCT00483405|530832754|FG000|Overall Study|Withdrawal by Subject|2|||
147182360|NCT00483405|530832754|FG000|Overall Study|Other complicating disease|1|||
147182361|NCT00571038|530832755|FG000|Overall Study|Lost to Follow-up|1|||
147182362|NCT00571038|530832756|FG001|Overall Study|Lost to Follow-up|4|||
147182363|NCT00571038|530832755|FG000|Overall Study|Death|7|||
147182364|NCT00571038|530832756|FG001|Overall Study|Death|5|||
147182365|NCT00571038|530832755|FG000|Overall Study|Withdrawal by Subject|1|||
147182366|NCT00571038|530832756|FG001|Overall Study|Withdrawal by Subject|3|||
147182367|NCT00571038|530832755|FG000|Overall Study|Moved out of state|2|||
147182368|NCT00571038|530832756|FG001|Overall Study|Moved out of state|2|||
147182369|NCT01426958|530832757|FG000|Overall Study|Adverse Event|2|||
147182370|NCT02631551|530832758|FG000|Overall Study|Adverse Event|1|||
147182371|NCT02631551|530832759|FG001|Overall Study|Adverse Event|2|||
147182372|NCT02631551|530832760|FG002|Overall Study|Adverse Event|4|||
147182373|NCT02631551|530832761|FG003|Overall Study|Adverse Event|0|||
147182374|NCT02631551|530832758|FG000|Overall Study|Lack of Efficacy|0|||
147182375|NCT02631551|530832759|FG001|Overall Study|Lack of Efficacy|0|||
147658102|NCT00103285|532572167|FG001|Response Assignment|Ineligible|8|||
147182376|NCT02631551|530832760|FG002|Overall Study|Lack of Efficacy|1|||
147182377|NCT02631551|530832761|FG003|Overall Study|Lack of Efficacy|0|||
147182378|NCT02631551|530832758|FG000|Overall Study|Lost to Follow-up|1|||
147182379|NCT02631551|530832759|FG001|Overall Study|Lost to Follow-up|2|||
147182380|NCT02631551|530832760|FG002|Overall Study|Lost to Follow-up|0|||
147182381|NCT02631551|530832761|FG003|Overall Study|Lost to Follow-up|3|||
147658103|NCT00103285|532572168|FG002|Response Assignment|Ineligible|6|||
147182382|NCT02631551|530832758|FG000|Overall Study|Withdrawal by Subject|2|||
147182383|NCT02631551|530832759|FG001|Overall Study|Withdrawal by Subject|2|||
147182384|NCT02631551|530832760|FG002|Overall Study|Withdrawal by Subject|0|||
147182385|NCT02631551|530832761|FG003|Overall Study|Withdrawal by Subject|5|||
147182386|NCT02631551|530832758|FG000|Overall Study|Protocol deviation|3|||
147182387|NCT02631551|530832759|FG001|Overall Study|Protocol deviation|6|||
147182388|NCT02631551|530832760|FG002|Overall Study|Protocol deviation|3|||
147182389|NCT02631551|530832761|FG003|Overall Study|Protocol deviation|0|||
147182390|NCT02631551|530832758|FG000|Overall Study|Non-compliance with study procedures|0|||
147182391|NCT02631551|530832759|FG001|Overall Study|Non-compliance with study procedures|0|||
147182392|NCT02631551|530832760|FG002|Overall Study|Non-compliance with study procedures|1|||
147182393|NCT02631551|530832761|FG003|Overall Study|Non-compliance with study procedures|1|||
147182394|NCT02631551|530832758|FG000|Overall Study|Non-compliance with study drug|1|||
147182395|NCT02631551|530832759|FG001|Overall Study|Non-compliance with study drug|0|||
147182396|NCT02631551|530832760|FG002|Overall Study|Non-compliance with study drug|0|||
147182397|NCT02631551|530832761|FG003|Overall Study|Non-compliance with study drug|0|||
147182398|NCT02631551|530832758|FG000|Overall Study|Other, specific reasons not collected|5|||
147182399|NCT02631551|530832759|FG001|Overall Study|Other, specific reasons not collected|7|||
147182400|NCT02631551|530832760|FG002|Overall Study|Other, specific reasons not collected|2|||
147182401|NCT02631551|530832761|FG003|Overall Study|Other, specific reasons not collected|2|||
147182402|NCT02073682|530832766|FG000|Overall Study|Low Creatinine Clearance|1|||
147182403|NCT02073682|530832767|FG001|Overall Study|Low Creatinine Clearance|2|||
147182404|NCT02073682|530832766|FG000|Overall Study|Death|86|||
147182405|NCT02073682|530832767|FG001|Overall Study|Death|100|||
147182406|NCT02073682|530832766|FG000|Overall Study|Cancer Cured|10|||
147182407|NCT02073682|530832767|FG001|Overall Study|Cancer Cured|15|||
147182408|NCT02073682|530832766|FG000|Overall Study|ID: Patient Noncompliance|1|||
147182409|NCT02073682|530832767|FG001|Overall Study|ID: Patient Noncompliance|2|||
147182410|NCT02073682|530832766|FG000|Overall Study|ID: Palliative Treatment Only|10|||
147182411|NCT02073682|530832767|FG001|Overall Study|ID: Palliative Treatment Only|7|||
147182412|NCT02073682|530832766|FG000|Overall Study|Prohibited Concomitant Medication Use|0|||
147182413|NCT02073682|530832767|FG001|Overall Study|Prohibited Concomitant Medication Use|1|||
147593762|NCT00597116|532329019|FG001|Overall Study|Physician Decision|1|||
147593763|NCT00597116|532329018|FG000|Overall Study|Death|0|||
147593764|NCT00597116|532329019|FG001|Overall Study|Death|1|||
147593765|NCT00597116|532329018|FG000|Overall Study|Lost to Follow-up|1|||
147593766|NCT00597116|532329019|FG001|Overall Study|Lost to Follow-up|0|||
147593767|NCT00597116|532329018|FG000|Overall Study|Progressive disease|11|||
147593768|NCT00597116|532329019|FG001|Overall Study|Progressive disease|6|||
147593769|NCT02903238|532329023|FG000|Overall Study|Lost to Follow-up|4|||
147593770|NCT00700817|532329028|FG000|Week 0-26 (Main Period)|Adverse Event|14|||
147593771|NCT00700817|532329029|FG001|Week 0-26 (Main Period)|Adverse Event|15|||
147593772|NCT00700817|532329030|FG002|Week 0-26 (Main Period)|Adverse Event|4|||
147593773|NCT00700817|532329031|FG003|Week 0-26 (Main Period)|Adverse Event|0|||
147593774|NCT00700817|532329032|FG004|Week 0-26 (Main Period)|Adverse Event|0|||
147593775|NCT00700817|532329028|FG000|Week 0-26 (Main Period)|Lack of Efficacy|4|||
147593776|NCT00700817|532329029|FG001|Week 0-26 (Main Period)|Lack of Efficacy|0|||
147593777|NCT00700817|532329030|FG002|Week 0-26 (Main Period)|Lack of Efficacy|4|||
147593778|NCT00700817|532329031|FG003|Week 0-26 (Main Period)|Lack of Efficacy|0|||
147593779|NCT00700817|532329032|FG004|Week 0-26 (Main Period)|Lack of Efficacy|0|||
147593780|NCT00700817|532329028|FG000|Week 0-26 (Main Period)|Protocol Violation|14|||
147593781|NCT00700817|532329029|FG001|Week 0-26 (Main Period)|Protocol Violation|4|||
147593782|NCT00700817|532329030|FG002|Week 0-26 (Main Period)|Protocol Violation|4|||
147593783|NCT00700817|532329031|FG003|Week 0-26 (Main Period)|Protocol Violation|0|||
147593784|NCT00700817|532329032|FG004|Week 0-26 (Main Period)|Protocol Violation|0|||
147593785|NCT00700817|532329028|FG000|Week 0-26 (Main Period)|Withdrawal criteria|10|||
147593786|NCT00700817|532329029|FG001|Week 0-26 (Main Period)|Withdrawal criteria|7|||
147593787|NCT00700817|532329030|FG002|Week 0-26 (Main Period)|Withdrawal criteria|5|||
147593788|NCT00700817|532329031|FG003|Week 0-26 (Main Period)|Withdrawal criteria|0|||
147593789|NCT00700817|532329032|FG004|Week 0-26 (Main Period)|Withdrawal criteria|0|||
147593790|NCT00700817|532329028|FG000|Week 0-26 (Main Period)|Unclassified|14|||
147593791|NCT00700817|532329029|FG001|Week 0-26 (Main Period)|Unclassified|4|||
147593792|NCT00700817|532329030|FG002|Week 0-26 (Main Period)|Unclassified|8|||
147593793|NCT00700817|532329031|FG003|Week 0-26 (Main Period)|Unclassified|0|||
147593794|NCT00700817|532329032|FG004|Week 0-26 (Main Period)|Unclassified|0|||
147593795|NCT00700817|532329028|FG000|Week 26-52 (Extension Period 1)|Adverse Event|5|||
147593796|NCT00700817|532329029|FG001|Week 26-52 (Extension Period 1)|Adverse Event|10|||
147593797|NCT00700817|532329030|FG002|Week 26-52 (Extension Period 1)|Adverse Event|3|||
147593798|NCT00700817|532329031|FG003|Week 26-52 (Extension Period 1)|Adverse Event|0|||
147182414|NCT02073682|530832766|FG000|Overall Study|Platelet Count <50,000/mL|1|||
147182415|NCT02073682|530832767|FG001|Overall Study|Platelet Count <50,000/mL|2|||
147182416|NCT02073682|530832766|FG000|Overall Study|Surgery/Medical Procedure|3|||
147182417|NCT02073682|530832767|FG001|Overall Study|Surgery/Medical Procedure|1|||
147182418|NCT02073682|530832766|FG000|Overall Study|Withdrawal by Subject|6|||
147182419|NCT02073682|530832767|FG001|Overall Study|Withdrawal by Subject|8|||
147182420|NCT02073682|530832766|FG000|Overall Study|Start of New Chemotherapy Regimen|6|||
147182421|NCT02073682|530832767|FG001|Overall Study|Start of New Chemotherapy Regimen|3|||
147182422|NCT02073682|530832766|FG000|Overall Study|Cancer Progression|53|||
147182423|NCT02073682|530832767|FG001|Overall Study|Cancer Progression|33|||
147182424|NCT02073682|530832766|FG000|Overall Study|Protocol Violation|1|||
147182425|NCT02073682|530832767|FG001|Overall Study|Protocol Violation|0|||
147182426|NCT02073682|530832766|FG000|Overall Study|Adverse Event|79|||
147182427|NCT02073682|530832767|FG001|Overall Study|Adverse Event|62|||
147182428|NCT02073682|530832766|FG000|Overall Study|No reason provided|11|||
147182429|NCT02073682|530832767|FG001|Overall Study|No reason provided|9|||
147182430|NCT02073682|530832766|FG000|Overall Study|PD: Inconvenience of Dosing|21|||
147182431|NCT02073682|530832767|FG001|Overall Study|PD: Inconvenience of Dosing|78|||
147182432|NCT02073682|530832766|FG000|Overall Study|Lost to Follow-up|1|||
147182433|NCT02073682|530832767|FG001|Overall Study|Lost to Follow-up|1|||
147182434|NCT02073682|530832766|FG000|Overall Study|ID: Benefit/Risk Judgment|32|||
147182435|NCT02073682|530832767|FG001|Overall Study|ID: Benefit/Risk Judgment|46|||
147182436|NCT01965704|530832768|FG000|Overall Study|Withdrawal by Subject|2|||
147182437|NCT01965704|530832769|FG001|Overall Study|Withdrawal by Subject|2|||
147182438|NCT01965704|530832770|FG002|Overall Study|Withdrawal by Subject|1|||
147182439|NCT01965704|530832771|FG003|Overall Study|Withdrawal by Subject|1|||
147182440|NCT01965704|530832768|FG000|Overall Study|Delivered at home|1|||
147182441|NCT01965704|530832769|FG001|Overall Study|Delivered at home|1|||
147182442|NCT01965704|530832770|FG002|Overall Study|Delivered at home|0|||
147182443|NCT01965704|530832771|FG003|Overall Study|Delivered at home|0|||
147182444|NCT01965704|530832768|FG000|Overall Study|Experienced complications|0|||
147182445|NCT01965704|530832769|FG001|Overall Study|Experienced complications|0|||
147182446|NCT01965704|530832770|FG002|Overall Study|Experienced complications|2|||
147182447|NCT01965704|530832771|FG003|Overall Study|Experienced complications|2|||
147182448|NCT01965704|530832768|FG000|Overall Study|Adverse Event|0|||
147182449|NCT01965704|530832769|FG001|Overall Study|Adverse Event|0|||
147182450|NCT01965704|530832770|FG002|Overall Study|Adverse Event|1|||
147182451|NCT01965704|530832771|FG003|Overall Study|Adverse Event|1|||
147182452|NCT01965704|530832768|FG000|Overall Study|Did not meet inclusion criteria|0|||
147182453|NCT01965704|530832769|FG001|Overall Study|Did not meet inclusion criteria|0|||
147182454|NCT01965704|530832770|FG002|Overall Study|Did not meet inclusion criteria|1|||
147182455|NCT01965704|530832771|FG003|Overall Study|Did not meet inclusion criteria|1|||
147182456|NCT01843023|530832783|FG000|Overall Study|Death|1|||
147182457|NCT01843023|530832784|FG001|Overall Study|Death|0|||
147182458|NCT01843023|530832783|FG000|Overall Study|Lost to Follow-up|24|||
147182459|NCT01843023|530832784|FG001|Overall Study|Lost to Follow-up|29|||
147182460|NCT01843023|530832783|FG000|Overall Study|Withdrawal by Subject|8|||
147182461|NCT01843023|530832784|FG001|Overall Study|Withdrawal by Subject|6|||
147182462|NCT00466921|530832785|FG000|First 3 Cycles of Treatment|Adverse Event|2|||
147182463|NCT00466921|530832785|FG000|First 3 Cycles of Treatment|Withdrawal by Subject|5|||
147182464|NCT00466921|530832785|FG000|Completed 4 Cycles/Reached 1st Response|Withdrawal by Subject|2|||
147182465|NCT00466921|530832785|FG000|Completed 4 Cycles/Reached 1st Response|Progressive Disease|2|||
147182466|NCT00466921|530832785|FG000|Completed 4 Cycles/Reached 1st Response|Other|1|||
147182467|NCT00466921|530832785|FG000|Follow up for a Minimum of 1 Year|Death|6|||
147182468|NCT02741635|530832791|FG000|Overall Study|Withdrawal by Subject|1|||
147182469|NCT01427933|530832795|FG000|Overall Study|Withdrawal by Subject|5|||
147182470|NCT01427933|530832796|FG001|Overall Study|Withdrawal by Subject|8|||
147182471|NCT01427933|530832795|FG000|Overall Study|Lost to Follow-up|1|||
147182472|NCT01427933|530832796|FG001|Overall Study|Lost to Follow-up|5|||
147182473|NCT01427933|530832795|FG000|Overall Study|Other|1|||
147182474|NCT01427933|530832796|FG001|Overall Study|Other|0|||
147182475|NCT01427933|530832795|FG000|Overall Study|Investigator's Decision|1|||
147182476|NCT01427933|530832796|FG001|Overall Study|Investigator's Decision|0|||
147182477|NCT01633541|530832799|FG000|Overall Study|Death|1|||
147182478|NCT01633541|530832800|FG001|Overall Study|Death|0|||
147182479|NCT03472326|530832801|FG000|Part 2: Combination Therapy|Study Terminated by Sponsor|0|||
147182480|NCT03472326|530832802|FG001|Part 2: Combination Therapy|Study Terminated by Sponsor|0|||
147182481|NCT03472326|530832803|FG002|Part 2: Combination Therapy|Study Terminated by Sponsor|1|||
147182482|NCT03472326|530832804|FG003|Part 2: Combination Therapy|Study Terminated by Sponsor|2|||
147182483|NCT03472326|530832801|FG000|Part 2: Combination Therapy|Pregnancy|0|||
147182484|NCT03472326|530832802|FG001|Part 2: Combination Therapy|Pregnancy|0|||
147182485|NCT03472326|530832803|FG002|Part 2: Combination Therapy|Pregnancy|0|||
147182486|NCT03472326|530832804|FG003|Part 2: Combination Therapy|Pregnancy|1|||
147182487|NCT05447663|530832805|FG000|Overall Study|Study terminated by Sponsor|5|||
147182488|NCT05447663|530832805|FG000|Overall Study|Death|2|||
147182489|NCT05447663|530832805|FG000|Overall Study|Withdrawal by Subject|1|||
147182490|NCT01100320|530832808|FG000|Period 1|Withdrawal by Subject|2|||
147182491|NCT01100320|530832809|FG001|Period 1|Withdrawal by Subject|4|||
147182492|NCT01100320|530832808|FG000|Period 1|Positive Drug Screen|1|||
147182493|NCT01100320|530832809|FG001|Period 1|Positive Drug Screen|1|||
147182494|NCT01100320|530832808|FG000|Period 1|Adverse Event|2|||
147182495|NCT01100320|530832809|FG001|Period 1|Adverse Event|2|||
147182496|NCT01100320|530832808|FG000|Period 2|Withdrawal by Subject|1|||
147182497|NCT01100320|530832809|FG001|Period 2|Withdrawal by Subject|1|||
147182498|NCT04669301|530832810|FG000|Overall Study|Lost to Follow-up|0|||
147182499|NCT04669301|530832811|FG001|Overall Study|Lost to Follow-up|1|||
147182500|NCT04669301|530832812|FG002|Overall Study|Lost to Follow-up|0|||
147182501|NCT04669301|530832810|FG000|Overall Study|Withdrawal by Subject|3|||
147182502|NCT04669301|530832811|FG001|Overall Study|Withdrawal by Subject|2|||
147182503|NCT04669301|530832812|FG002|Overall Study|Withdrawal by Subject|0|||
147182504|NCT02863328|530832814|FG000|Overall Study|Lost to Follow-up|4|||
147182505|NCT02863328|530832815|FG001|Overall Study|Lost to Follow-up|10|||
147182506|NCT02863328|530832814|FG000|Overall Study|Withdrawal by Subject|7|||
147182507|NCT02863328|530832815|FG001|Overall Study|Withdrawal by Subject|12|||
147182508|NCT02863328|530832814|FG000|Overall Study|Died|0|||
147182509|NCT02863328|530832815|FG001|Overall Study|Died|1|||
147182510|NCT01870726|530832816|FG000|Overall Study|Withdrawal of informed consent|0|||
147182511|NCT01870726|530832817|FG001|Overall Study|Withdrawal of informed consent|0|||
147182512|NCT01870726|530832818|FG002|Overall Study|Withdrawal of informed consent|0|||
147182513|NCT01870726|530832819|FG003|Overall Study|Withdrawal of informed consent|1|||
147182514|NCT01870726|530832820|FG004|Overall Study|Withdrawal of informed consent|0|||
147182515|NCT01870726|530832821|FG005|Overall Study|Withdrawal of informed consent|0|||
147182516|NCT01870726|530832822|FG006|Overall Study|Withdrawal of informed consent|0|||
147182517|NCT01870726|530832816|FG000|Overall Study|Withdrawal by Subject|0|||
147182518|NCT01870726|530832817|FG001|Overall Study|Withdrawal by Subject|1|||
147182519|NCT01870726|530832818|FG002|Overall Study|Withdrawal by Subject|0|||
147182520|NCT01870726|530832819|FG003|Overall Study|Withdrawal by Subject|0|||
147182521|NCT01870726|530832820|FG004|Overall Study|Withdrawal by Subject|0|||
147182522|NCT01870726|530832821|FG005|Overall Study|Withdrawal by Subject|0|||
147182523|NCT01870726|530832822|FG006|Overall Study|Withdrawal by Subject|0|||
147182524|NCT01870726|530832816|FG000|Overall Study|Adverse Event|0|||
147182525|NCT01870726|530832817|FG001|Overall Study|Adverse Event|0|||
147182526|NCT01870726|530832818|FG002|Overall Study|Adverse Event|0|||
147182527|NCT01870726|530832819|FG003|Overall Study|Adverse Event|0|||
147182528|NCT01870726|530832820|FG004|Overall Study|Adverse Event|1|||
147182529|NCT01870726|530832821|FG005|Overall Study|Adverse Event|1|||
147182530|NCT01870726|530832822|FG006|Overall Study|Adverse Event|0|||
147182531|NCT01870726|530832816|FG000|Overall Study|Progressive disease|5|||
147182532|NCT01870726|530832817|FG001|Overall Study|Progressive disease|5|||
147182533|NCT01870726|530832818|FG002|Overall Study|Progressive disease|4|||
147182534|NCT01870726|530832819|FG003|Overall Study|Progressive disease|5|||
147182535|NCT01870726|530832820|FG004|Overall Study|Progressive disease|6|||
147182536|NCT01870726|530832821|FG005|Overall Study|Progressive disease|4|||
147182537|NCT01870726|530832822|FG006|Overall Study|Progressive disease|10|||
147658104|NCT00103285|532572169|FG003|Response Assignment|Ineligible|2|||
147658105|NCT00103285|532572170|FG004|Response Assignment|Ineligible|0|||
147658106|NCT00103285|532572171|FG005|Response Assignment|Ineligible|3|||
147658107|NCT00103285|532572172|FG006|Response Assignment|Ineligible|1|||
147658108|NCT00103285|532572173|FG007|Response Assignment|Ineligible|5|||
147658109|NCT00103285|532572166|FG000|Response Assignment|Refusal|0|||
147658110|NCT00103285|532572167|FG001|Response Assignment|Refusal|53|||
147658111|NCT00103285|532572168|FG002|Response Assignment|Refusal|5|||
147658112|NCT00103285|532572169|FG003|Response Assignment|Refusal|3|||
147658113|NCT00103285|532572170|FG004|Response Assignment|Refusal|25|||
147658114|NCT00103285|532572171|FG005|Response Assignment|Refusal|15|||
147658115|NCT00103285|532572172|FG006|Response Assignment|Refusal|30|||
147182538|NCT00595478|530832823|FG000|36-week Follow-up Period|Lost to Follow-up|5|||
147182539|NCT00595478|530832824|FG001|36-week Follow-up Period|Lost to Follow-up|4|||
147182540|NCT00595478|530832823|FG000|36-week Follow-up Period|Withdrawal by Subject|4|||
147182541|NCT00595478|530832824|FG001|36-week Follow-up Period|Withdrawal by Subject|4|||
147182542|NCT00186901|530832826|FG000|Overall Study|Pregnancy|6|||
147182543|NCT00186901|530832827|FG001|Overall Study|Pregnancy|3|||
147182544|NCT00186901|530832828|FG002|Overall Study|Pregnancy|0|||
147182545|NCT00186901|530832826|FG000|Overall Study|Lost to Follow-up|6|||
147182546|NCT00186901|530832827|FG001|Overall Study|Lost to Follow-up|3|||
147182547|NCT00186901|530832828|FG002|Overall Study|Lost to Follow-up|0|||
147182548|NCT00186901|530832826|FG000|Overall Study|Bone Mineral Density dropped > 5%|9|||
147182549|NCT00186901|530832827|FG001|Overall Study|Bone Mineral Density dropped > 5%|7|||
147182550|NCT00186901|530832828|FG002|Overall Study|Bone Mineral Density dropped > 5%|0|||
147246635|NCT03129100|531072775|FG016|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
147658116|NCT00103285|532572173|FG007|Response Assignment|Refusal|10|||
147658117|NCT00103285|532572166|FG000|Response Assignment|Other|0|||
147658118|NCT00103285|532572167|FG001|Response Assignment|Other|30|||
147658119|NCT00103285|532572168|FG002|Response Assignment|Other|48|||
147182551|NCT00186901|530832826|FG000|Overall Study|ALL relapse or second malignancy|1|||
147182552|NCT00186901|530832827|FG001|Overall Study|ALL relapse or second malignancy|2|||
147182553|NCT00186901|530832828|FG002|Overall Study|ALL relapse or second malignancy|0|||
147182554|NCT00186901|530832826|FG000|Overall Study|Withdrawal by Subject|4|||
147182555|NCT00186901|530832827|FG001|Overall Study|Withdrawal by Subject|5|||
147182556|NCT00186901|530832828|FG002|Overall Study|Withdrawal by Subject|0|||
147658120|NCT00103285|532572169|FG003|Response Assignment|Other|38|||
147658121|NCT00103285|532572170|FG004|Response Assignment|Other|37|||
147658122|NCT00103285|532572171|FG005|Response Assignment|Other|17|||
147658123|NCT00103285|532572172|FG006|Response Assignment|Other|11|||
147658124|NCT00103285|532572173|FG007|Response Assignment|Other|53|||
147658125|NCT00452439|532572174|FG000|Overall Study|Lost to Follow-up|1|||
147658126|NCT00452439|532572175|FG001|Overall Study|Lost to Follow-up|1|||
147658127|NCT00452439|532572174|FG000|Overall Study|Refused Treatment|4|||
147658128|NCT00452439|532572175|FG001|Overall Study|Refused Treatment|3|||
147658129|NCT00452439|532572174|FG000|Overall Study|Death|3|||
147182557|NCT00186901|530832826|FG000|Overall Study|Open label|3|||
147182558|NCT00186901|530832827|FG001|Overall Study|Open label|2|||
147182559|NCT00186901|530832828|FG002|Overall Study|Open label|0|||
147182560|NCT00186901|530832826|FG000|Overall Study|Limited adherence to study requirements|20|||
147182561|NCT00186901|530832827|FG001|Overall Study|Limited adherence to study requirements|23|||
147182562|NCT00186901|530832828|FG002|Overall Study|Limited adherence to study requirements|0|||
147182563|NCT00186901|530832826|FG000|Overall Study|Bone Mineral Density > 0|0|||
147182564|NCT00186901|530832827|FG001|Overall Study|Bone Mineral Density > 0|0|||
147182565|NCT00186901|530832828|FG002|Overall Study|Bone Mineral Density > 0|149|||
147246636|NCT03129100|531072776|FG017|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
147658130|NCT00452439|532572175|FG001|Overall Study|Death|1|||
147658131|NCT00452439|532572174|FG000|Overall Study|Bone Marrow Transplant|0|||
147658132|NCT00452439|532572175|FG001|Overall Study|Bone Marrow Transplant|1|||
147658133|NCT00452439|532572174|FG000|Overall Study|Too Ill to Continue|0|||
147658134|NCT00452439|532572175|FG001|Overall Study|Too Ill to Continue|1|||
147658135|NCT00452439|532572174|FG000|Overall Study|Failed to achieve complete response|2|||
147658136|NCT00452439|532572175|FG001|Overall Study|Failed to achieve complete response|0|||
147658137|NCT00452439|532572174|FG000|Overall Study|Relapse|3|||
147658138|NCT00452439|532572175|FG001|Overall Study|Relapse|0|||
147658139|NCT00452439|532572174|FG000|Overall Study|Fracture|1|||
147658140|NCT00452439|532572175|FG001|Overall Study|Fracture|0|||
147658141|NCT01381926|532572176|FG000|Low/High Dose of 1st Treatment (2months)|Adverse Event|2|||
147658142|NCT01381926|532572177|FG001|Low/High Dose of 1st Treatment (2months)|Adverse Event|0|||
147658143|NCT01381926|532572176|FG000|Low/High Dose of 1st Treatment (2months)|Withdrawal by Subject|0|||
147658144|NCT01381926|532572177|FG001|Low/High Dose of 1st Treatment (2months)|Withdrawal by Subject|1|||
147658145|NCT02624947|532572179|FG000|Maternal Participants|Adverse Event|5|||
147658146|NCT02624947|532572180|FG001|Maternal Participants|Adverse Event|0|||
147658147|NCT02624947|532572179|FG000|Maternal Participants|Investigator Decision|5|||
147658148|NCT02624947|532572180|FG001|Maternal Participants|Investigator Decision|3|||
147658149|NCT02624947|532572179|FG000|Maternal Participants|Lost to Follow-up|54|||
147658150|NCT02624947|532572180|FG001|Maternal Participants|Lost to Follow-up|24|||
147658151|NCT02624947|532572179|FG000|Maternal Participants|Non Compliance|8|||
147658152|NCT02624947|532572180|FG001|Maternal Participants|Non Compliance|5|||
147658153|NCT02624947|532572179|FG000|Maternal Participants|Sponsor Request|1|||
147658154|NCT02624947|532572180|FG001|Maternal Participants|Sponsor Request|1|||
147658155|NCT02624947|532572179|FG000|Maternal Participants|Voluntary withdrawal unrelated to AE|48|||
147658156|NCT02624947|532572180|FG001|Maternal Participants|Voluntary withdrawal unrelated to AE|27|||
147658157|NCT02624947|532572179|FG000|Maternal Participants|Miscellaneous|23|||
147658158|NCT02624947|532572180|FG001|Maternal Participants|Miscellaneous|15|||
147658159|NCT02624947|532572179|FG000|Infant Participants|Adverse Event|18|||
147658160|NCT02624947|532572180|FG001|Infant Participants|Adverse Event|11|||
147658161|NCT02624947|532572179|FG000|Infant Participants|Investigator Decision|5|||
147658162|NCT02624947|532572180|FG001|Infant Participants|Investigator Decision|4|||
147658163|NCT02624947|532572179|FG000|Infant Participants|Lost to Follow-up|93|||
147658164|NCT02624947|532572180|FG001|Infant Participants|Lost to Follow-up|58|||
147658165|NCT02624947|532572179|FG000|Infant Participants|Non Compliance|17|||
147658166|NCT02624947|532572180|FG001|Infant Participants|Non Compliance|7|||
147658167|NCT02624947|532572179|FG000|Infant Participants|Sponsor Request|0|||
147658168|NCT02624947|532572180|FG001|Infant Participants|Sponsor Request|1|||
147182566|NCT00555217|530832829|FG000|Overall Study|Withdrawal by Subject|35|||
147182567|NCT00555217|530832830|FG001|Overall Study|Withdrawal by Subject|31|||
147182568|NCT00555217|530832829|FG000|Overall Study|Lost to Follow-up|19|||
147246637|NCT03129100|531072777|FG018|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
147246638|NCT03129100|531072778|FG019|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
147246639|NCT03129100|531072779|FG020|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
147658169|NCT02624947|532572179|FG000|Infant Participants|Voluntary Withdrawal unrelated to AE|48|||
147658170|NCT02624947|532572180|FG001|Infant Participants|Voluntary Withdrawal unrelated to AE|25|||
147658171|NCT02624947|532572179|FG000|Infant Participants|Miscellaneous|50|||
147658172|NCT02624947|532572180|FG001|Infant Participants|Miscellaneous|26|||
147658173|NCT03654729|532572191|FG000|Overall Study|Death|9|||
147658174|NCT03654729|532572192|FG001|Overall Study|Death|9|||
147658175|NCT03654729|532572193|FG002|Overall Study|Death|16|||
147658176|NCT03654729|532572191|FG000|Overall Study|Withdrawal by Subject|8|||
147658177|NCT03654729|532572192|FG001|Overall Study|Withdrawal by Subject|6|||
147658178|NCT03654729|532572193|FG002|Overall Study|Withdrawal by Subject|4|||
147182569|NCT00555217|530832830|FG001|Overall Study|Lost to Follow-up|20|||
147182570|NCT00555217|530832829|FG000|Overall Study|close out sites|21|||
147182571|NCT00555217|530832830|FG001|Overall Study|close out sites|17|||
147182572|NCT02363959|530832836|FG000|Overall Study|Medical instability|1|||
147182573|NCT02363959|530832837|FG001|Overall Study|Medical instability|0|||
147182574|NCT00950248|530832838|FG000|Year 1: Baseline|Withdrawal by Subject|6|||
147182575|NCT00950248|530832839|FG001|Year 1: Baseline|Withdrawal by Subject|0|||
147182576|NCT00950248|530832840|FG002|Year 1: Baseline|Withdrawal by Subject|0|||
147182577|NCT00950248|530832838|FG000|Year 1: Baseline|worsening of symptoms|2|||
147182578|NCT00950248|530832839|FG001|Year 1: Baseline|worsening of symptoms|0|||
147182579|NCT00950248|530832840|FG002|Year 1: Baseline|worsening of symptoms|0|||
147182580|NCT00950248|530832838|FG000|Year 2&3 Treatment Randomization|worsening of symptoms|0|||
147182581|NCT00950248|530832839|FG001|Year 2&3 Treatment Randomization|worsening of symptoms|2|||
147182582|NCT00950248|530832840|FG002|Year 2&3 Treatment Randomization|worsening of symptoms|4|||
147182583|NCT00950248|530832838|FG000|Year 2&3 Treatment Randomization|Withdrawal by Subject|0|||
147182584|NCT00950248|530832839|FG001|Year 2&3 Treatment Randomization|Withdrawal by Subject|3|||
147182585|NCT00950248|530832840|FG002|Year 2&3 Treatment Randomization|Withdrawal by Subject|0|||
147182586|NCT00950248|530832838|FG000|Year 2&3 Treatment Randomization|Death|0|||
147182587|NCT00950248|530832839|FG001|Year 2&3 Treatment Randomization|Death|0|||
147658179|NCT03654729|532572191|FG000|Overall Study|Study terminated by Sponsor|3|||
147182588|NCT00950248|530832840|FG002|Year 2&3 Treatment Randomization|Death|1|||
147182589|NCT00950248|530832838|FG000|Year 2&3 Treatment Randomization|MRI contraindication|0|||
147182590|NCT00950248|530832839|FG001|Year 2&3 Treatment Randomization|MRI contraindication|1|||
147182591|NCT00950248|530832840|FG002|Year 2&3 Treatment Randomization|MRI contraindication|0|||
147182592|NCT02663622|530832841|FG000|Overall Study|Death|3|||
147182593|NCT02663622|530832842|FG001|Overall Study|Death|1|||
147658180|NCT03654729|532572192|FG001|Overall Study|Study terminated by Sponsor|5|||
147658181|NCT03654729|532572193|FG002|Overall Study|Study terminated by Sponsor|4|||
147658182|NCT03654729|532572191|FG000|Overall Study|Not reported|2|||
147182594|NCT02663622|530832843|FG002|Overall Study|Death|1|||
147182595|NCT02663622|530832844|FG003|Overall Study|Death|8|||
147182596|NCT02663622|530832841|FG000|Overall Study|Protocol Violation|0|||
147182597|NCT02663622|530832842|FG001|Overall Study|Protocol Violation|0|||
147182598|NCT02663622|530832843|FG002|Overall Study|Protocol Violation|0|||
147182599|NCT02663622|530832844|FG003|Overall Study|Protocol Violation|1|||
147182600|NCT00930930|530832847|FG000|Overall Study|Death|1|||
147182601|NCT00930930|530832848|FG001|Overall Study|Death|0|||
147182602|NCT00930930|530832847|FG000|Overall Study|Physician Decision|1|||
147182603|NCT00930930|530832848|FG001|Overall Study|Physician Decision|0|||
147182604|NCT00930930|530832847|FG000|Overall Study|Adverse Event|13|||
147182605|NCT00930930|530832848|FG001|Overall Study|Adverse Event|3|||
147182606|NCT00930930|530832847|FG000|Overall Study|Withdrawal by Subject|3|||
147182607|NCT00930930|530832848|FG001|Overall Study|Withdrawal by Subject|1|||
147182608|NCT00930930|530832847|FG000|Overall Study|Disease progression|2|||
147182609|NCT00930930|530832848|FG001|Overall Study|Disease progression|3|||
147182610|NCT00930930|530832847|FG000|Overall Study|excessive lapse btw txs, not eligible|0|||
147182611|NCT00930930|530832848|FG001|Overall Study|excessive lapse btw txs, not eligible|1|||
147182612|NCT00930930|530832847|FG000|Overall Study|patients not compliant|1|||
147182613|NCT00930930|530832848|FG001|Overall Study|patients not compliant|1|||
147182614|NCT04618744|530832849|FG000|Overall Study|Adverse Event|0|||
147246640|NCT03129100|531072780|FG021|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
147246641|NCT03129100|531072781|FG022|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
147246642|NCT03129100|531072782|FG023|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
147246643|NCT03129100|531072783|FG024|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
147246644|NCT03129100|531072784|FG025|Period2 Extension Period (Group A and B)|Lack of Efficacy|0|||
147246645|NCT03129100|531072759|FG000|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
147658183|NCT03654729|532572192|FG001|Overall Study|Not reported|4|||
147658184|NCT03654729|532572193|FG002|Overall Study|Not reported|5|||
147182615|NCT04618744|530832850|FG001|Overall Study|Adverse Event|1|||
147182616|NCT04618744|530832849|FG000|Overall Study|Withdrawal by Subject|0|||
147182617|NCT04618744|530832850|FG001|Overall Study|Withdrawal by Subject|1|||
147182618|NCT00900029|530832851|FG000|Overall Study|Lost to Follow-up|0|||
147182619|NCT00900029|530832852|FG001|Overall Study|Lost to Follow-up|2|||
147182620|NCT00900029|530832853|FG002|Overall Study|Lost to Follow-up|1|||
147182621|NCT00900029|530832854|FG003|Overall Study|Lost to Follow-up|4|||
147246646|NCT03129100|531072760|FG001|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
147658185|NCT03654729|532572191|FG000|Overall Study|Progressive disease|3|||
147182622|NCT00900029|530832855|FG004|Overall Study|Lost to Follow-up|4|||
147182623|NCT00900029|530832851|FG000|Overall Study|Withdrawal by Subject|2|||
147182624|NCT00900029|530832852|FG001|Overall Study|Withdrawal by Subject|2|||
147182625|NCT00900029|530832853|FG002|Overall Study|Withdrawal by Subject|1|||
147182626|NCT00900029|530832854|FG003|Overall Study|Withdrawal by Subject|1|||
147182627|NCT00900029|530832855|FG004|Overall Study|Withdrawal by Subject|1|||
147182628|NCT00900029|530832851|FG000|Overall Study|Adverse Event|0|||
147182629|NCT00900029|530832852|FG001|Overall Study|Adverse Event|0|||
147182630|NCT00900029|530832853|FG002|Overall Study|Adverse Event|1|||
147182631|NCT00900029|530832854|FG003|Overall Study|Adverse Event|1|||
147182632|NCT00900029|530832855|FG004|Overall Study|Adverse Event|1|||
147182633|NCT00900029|530832851|FG000|Overall Study|Death|1|||
147182634|NCT00900029|530832852|FG001|Overall Study|Death|0|||
147182635|NCT00900029|530832853|FG002|Overall Study|Death|0|||
147182636|NCT00900029|530832854|FG003|Overall Study|Death|1|||
147182637|NCT00900029|530832855|FG004|Overall Study|Death|0|||
147182638|NCT02709330|530832856|FG000|Overall Study|Death|5|||
147182639|NCT02709330|530832857|FG001|Overall Study|Death|0|||
147182640|NCT02709330|530832856|FG000|Overall Study|Lost to Follow-up|2|||
147182641|NCT02709330|530832857|FG001|Overall Study|Lost to Follow-up|0|||
147182642|NCT02709330|530832856|FG000|Overall Study|Physician Decision|2|||
147182643|NCT02709330|530832857|FG001|Overall Study|Physician Decision|0|||
147182644|NCT02709330|530832856|FG000|Overall Study|Withdrawal by Subject|4|||
147182645|NCT02709330|530832857|FG001|Overall Study|Withdrawal by Subject|0|||
147182646|NCT02587819|530832860|FG000|Overall Study|Adverse Event|1|||
147182647|NCT02587819|530832860|FG000|Overall Study|Lost to Follow-up|1|||
147182648|NCT00511238|530832861|FG000|Overall Study|Adverse Event|13|||
147182649|NCT00511238|530832862|FG001|Overall Study|Adverse Event|33|||
147182650|NCT00511238|530832861|FG000|Overall Study|Withdrawal by Subject|2|||
147182651|NCT00511238|530832862|FG001|Overall Study|Withdrawal by Subject|22|||
147182652|NCT00511238|530832861|FG000|Overall Study|Progressive Disease|23|||
147182653|NCT00511238|530832862|FG001|Overall Study|Progressive Disease|157|||
147182654|NCT00511238|530832861|FG000|Overall Study|various reasons|4|||
147182655|NCT00511238|530832862|FG001|Overall Study|various reasons|14|||
147182656|NCT03449758|530834577|FG000|Overall Study|Major protocol deviation|1|||
147182657|NCT03449758|530834577|FG000|Overall Study|Treatment inefficacy|5|||
147182658|NCT03449758|530834577|FG000|Overall Study|Adverse Event|9|||
147182659|NCT03449758|530834577|FG000|Overall Study|Consent withdrawal|1|||
147182660|NCT03449758|530834577|FG000|Overall Study|Other unspecified reason|3|||
147182661|NCT00859547|530834584|FG000|Overall Study|Lost to Follow-up|1|||
147182662|NCT00859547|530834584|FG000|Overall Study|Parent withdrew consent|1|||
147182663|NCT01410890|530834586|FG000|Overall Study|Withdrawal by Subject|0|||
147182664|NCT01410890|530834587|FG001|Overall Study|Withdrawal by Subject|1|||
147182665|NCT00997035|530834591|FG000|3-week Followup Visit|Lost to Follow-up|9|||
147182666|NCT00997035|530834592|FG001|3-week Followup Visit|Lost to Follow-up|6|||
147182667|NCT00997035|530834591|FG000|3-month Follow-up Visit|Lost to Follow-up|12|||
147182668|NCT00997035|530834592|FG001|3-month Follow-up Visit|Lost to Follow-up|6|||
147182669|NCT02544503|530834598|FG000|Overall Study|Screen fail; these participants did not take part in the 1 month assessment|24|||
147182670|NCT02544503|530834599|FG001|Overall Study|Screen fail; these participants did not take part in the 1 month assessment|3|||
147182671|NCT02544503|530834598|FG000|Overall Study|Lost to Follow-up|9|||
147182672|NCT02544503|530834599|FG001|Overall Study|Lost to Follow-up|0|||
147182673|NCT02544503|530834598|FG000|Overall Study|Withdrawal by Subject|1|||
147182674|NCT02544503|530834599|FG001|Overall Study|Withdrawal by Subject|0|||
147182675|NCT00991939|530834602|FG000|Overall Study|Lost to Follow-up|0|||
147182676|NCT00991939|530834603|FG001|Overall Study|Lost to Follow-up|1|||
147182677|NCT00991939|530834602|FG000|Overall Study|Withdrawal by Subject|1|||
147182678|NCT00991939|530834603|FG001|Overall Study|Withdrawal by Subject|0|||
147182679|NCT00991939|530834602|FG000|Overall Study|Entire study terminated|4|||
147182680|NCT00991939|530834603|FG001|Overall Study|Entire study terminated|1|||
147182681|NCT00714415|530834604|FG000|Overall Study|Lack of Efficacy|1|||
147182682|NCT00714415|530834605|FG001|Overall Study|Lack of Efficacy|0|||
147182683|NCT00714415|530834604|FG000|Overall Study|Death|1|||
147182684|NCT00714415|530834605|FG001|Overall Study|Death|0|||
147182685|NCT01461707|530834608|FG000|Overall Study|Withdrawal by Subject|1|||
147182686|NCT01461707|530834609|FG001|Overall Study|Withdrawal by Subject|0|||
147182687|NCT01450761|530834610|FG000|Randomization|Subject no longer meets study criteria|1|||
147182688|NCT01450761|530834611|FG001|Randomization|Subject no longer meets study criteria|2|||
147182689|NCT01450761|530834610|FG000|Randomization|Withdrawal by Subject|2|||
147182690|NCT01450761|530834611|FG001|Randomization|Withdrawal by Subject|0|||
147182691|NCT01450761|530834610|FG000|Randomization|Disease progression|0|||
147182692|NCT01450761|530834611|FG001|Randomization|Disease progression|2|||
147182693|NCT01450761|530834610|FG000|Randomization|Adverse Event unrelated to study drug|1|||
147182694|NCT01450761|530834611|FG001|Randomization|Adverse Event unrelated to study drug|0|||
147182695|NCT01450761|530834610|FG000|Randomization|Other|0|||
147182696|NCT01450761|530834611|FG001|Randomization|Other|1|||
147182697|NCT01450761|530834610|FG000|Lead-in Chemotherapy|Disease progression|33|||
147182698|NCT01450761|530834611|FG001|Lead-in Chemotherapy|Disease progression|32|||
147182699|NCT01450761|530834610|FG000|Lead-in Chemotherapy|Adverse event unrelated to study drug|21|||
147182700|NCT01450761|530834611|FG001|Lead-in Chemotherapy|Adverse event unrelated to study drug|19|||
147182701|NCT01450761|530834610|FG000|Lead-in Chemotherapy|Withdrawal by Subject|14|||
147182702|NCT01450761|530834611|FG001|Lead-in Chemotherapy|Withdrawal by Subject|12|||
147182703|NCT01450761|530834610|FG000|Lead-in Chemotherapy|Study drug toxicity|6|||
147182704|NCT01450761|530834611|FG001|Lead-in Chemotherapy|Study drug toxicity|10|||
147182705|NCT01450761|530834610|FG000|Lead-in Chemotherapy|No longer meets study criteria|3|||
147182706|NCT01450761|530834611|FG001|Lead-in Chemotherapy|No longer meets study criteria|7|||
147182707|NCT01450761|530834610|FG000|Lead-in Chemotherapy|Death|3|||
147182708|NCT01450761|530834611|FG001|Lead-in Chemotherapy|Death|3|||
147182709|NCT01450761|530834610|FG000|Lead-in Chemotherapy|Other|2|||
147182710|NCT01450761|530834611|FG001|Lead-in Chemotherapy|Other|2|||
147182711|NCT01450761|530834610|FG000|Lead-in Chemotherapy|Lost to Follow-up|2|||
147182712|NCT01450761|530834611|FG001|Lead-in Chemotherapy|Lost to Follow-up|0|||
147182713|NCT01450761|530834610|FG000|Treatment With Blinded Study Therapy|Disease progression|318|||
147182714|NCT01450761|530834611|FG001|Treatment With Blinded Study Therapy|Disease progression|415|||
147182715|NCT01450761|530834610|FG000|Treatment With Blinded Study Therapy|Study drug toxicity|87|||
147182716|NCT01450761|530834611|FG001|Treatment With Blinded Study Therapy|Study drug toxicity|9|||
147182717|NCT01450761|530834610|FG000|Treatment With Blinded Study Therapy|Adverse event unrelated to study drug|27|||
147182718|NCT01450761|530834611|FG001|Treatment With Blinded Study Therapy|Adverse event unrelated to study drug|19|||
147182719|NCT01450761|530834610|FG000|Treatment With Blinded Study Therapy|Subject request to discontinue treatment|15|||
147182720|NCT01450761|530834611|FG001|Treatment With Blinded Study Therapy|Subject request to discontinue treatment|8|||
147182721|NCT01450761|530834610|FG000|Treatment With Blinded Study Therapy|Withdrawal by Subject|12|||
147182722|NCT01450761|530834611|FG001|Treatment With Blinded Study Therapy|Withdrawal by Subject|5|||
147182723|NCT01450761|530834610|FG000|Treatment With Blinded Study Therapy|Death|5|||
147182724|NCT01450761|530834611|FG001|Treatment With Blinded Study Therapy|Death|6|||
147182725|NCT01450761|530834610|FG000|Treatment With Blinded Study Therapy|Other/Unspecified|5|||
147182726|NCT01450761|530834611|FG001|Treatment With Blinded Study Therapy|Other/Unspecified|4|||
147182727|NCT01450761|530834610|FG000|Treatment With Blinded Study Therapy|Lost to Follow-up|2|||
147182728|NCT01450761|530834611|FG001|Treatment With Blinded Study Therapy|Lost to Follow-up|1|||
147182729|NCT01450761|530834610|FG000|Treatment With Blinded Study Therapy|Maximum clinical benefit|1|||
147182730|NCT01450761|530834611|FG001|Treatment With Blinded Study Therapy|Maximum clinical benefit|2|||
147182731|NCT01450761|530834610|FG000|Treatment With Blinded Study Therapy|No longer meets study criteria|1|||
147182732|NCT01450761|530834611|FG001|Treatment With Blinded Study Therapy|No longer meets study criteria|2|||
147182733|NCT01450761|530834610|FG000|Treatment With Blinded Study Therapy|Not reported|2|||
147182734|NCT01450761|530834611|FG001|Treatment With Blinded Study Therapy|Not reported|2|||
147182735|NCT01450761|530834610|FG000|Treatment With Blinded Study Therapy|Poor/non-compliance|1|||
147182736|NCT01450761|530834611|FG001|Treatment With Blinded Study Therapy|Poor/non-compliance|0|||
147182737|NCT01450761|530834610|FG000|Treatment With Blinded Study Therapy|Administrative reason by sponsor|2|||
147182738|NCT01450761|530834611|FG001|Treatment With Blinded Study Therapy|Administrative reason by sponsor|3|||
147182739|NCT03801174|530834633|FG000|Overall Study|Withdrawal by Subject|14|||
147246647|NCT03129100|531072761|FG002|Period2 Extension Period (Group A and B)|Lost to Follow-up|2|||
147246648|NCT03129100|531072762|FG003|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
147246649|NCT03129100|531072763|FG004|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
147246650|NCT03129100|531072764|FG005|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
147246651|NCT03129100|531072765|FG006|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
147246652|NCT03129100|531072766|FG007|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
147246653|NCT03129100|531072767|FG008|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
147246654|NCT03129100|531072768|FG009|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
147246655|NCT03129100|531072769|FG010|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
147246656|NCT03129100|531072770|FG011|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
147246657|NCT03129100|531072771|FG012|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
147246658|NCT03129100|531072772|FG013|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
147246659|NCT03129100|531072773|FG014|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
147246660|NCT03129100|531072774|FG015|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
147246661|NCT03129100|531072775|FG016|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
147246662|NCT03129100|531072776|FG017|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
147246663|NCT03129100|531072777|FG018|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
147246664|NCT03129100|531072778|FG019|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
147246665|NCT03129100|531072779|FG020|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
147246666|NCT03129100|531072780|FG021|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
147246667|NCT03129100|531072781|FG022|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
147246668|NCT03129100|531072782|FG023|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
147246669|NCT03129100|531072783|FG024|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
147246670|NCT03129100|531072784|FG025|Period2 Extension Period (Group A and B)|Lost to Follow-up|0|||
147246671|NCT03129100|531072759|FG000|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
147246672|NCT03129100|531072760|FG001|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
147246673|NCT03129100|531072761|FG002|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
147246674|NCT03129100|531072762|FG003|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
147246675|NCT03129100|531072763|FG004|Period2 Extension Period (Group A and B)|Experienced Flare|5|||
147246676|NCT03129100|531072764|FG005|Period2 Extension Period (Group A and B)|Experienced Flare|6|||
147182740|NCT03801174|530834634|FG001|Overall Study|Withdrawal by Subject|15|||
147182741|NCT03801174|530834633|FG000|Overall Study|Death|1|||
147182742|NCT03801174|530834634|FG001|Overall Study|Death|0|||
147182743|NCT03801174|530834633|FG000|Overall Study|Pregnancy|2|||
147182744|NCT03801174|530834634|FG001|Overall Study|Pregnancy|2|||
147182745|NCT03801174|530834633|FG000|Overall Study|Lost to Follow-up|19|||
147182746|NCT03801174|530834634|FG001|Overall Study|Lost to Follow-up|10|||
147182747|NCT03801174|530834633|FG000|Overall Study|Other|4|||
147182748|NCT03801174|530834634|FG001|Overall Study|Other|3|||
147182749|NCT03801174|530834633|FG000|Overall Study|Lack of Efficacy|4|||
147182750|NCT03801174|530834634|FG001|Overall Study|Lack of Efficacy|0|||
147182751|NCT03801174|530834633|FG000|Overall Study|Unwilling to complete activities|5|||
147182752|NCT03801174|530834634|FG001|Overall Study|Unwilling to complete activities|6|||
147182753|NCT03801174|530834633|FG000|Overall Study|Moved out of area|3|||
147182754|NCT03801174|530834634|FG001|Overall Study|Moved out of area|0|||
147182755|NCT00855816|530834635|FG000|Overall Study|Withdrawal by Subject|22|||
147327621|NCT04888585|531363966|FG005|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
147327622|NCT04888585|531363967|FG006|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
147327623|NCT04888585|531363968|FG007|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
147327624|NCT04888585|531363969|FG008|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
147327625|NCT04888585|531363970|FG009|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
147327626|NCT04888585|531363971|FG010|Placebo-Controlled (Baseline-Week 12)|Lost to Follow-up|0|||
147327627|NCT04888585|531363961|FG000|Long Term Extension (Wk 13-End of Study)|Death|0|||
147327628|NCT04888585|531363962|FG001|Long Term Extension (Wk 13-End of Study)|Death|0|||
147327629|NCT04888585|531363963|FG002|Long Term Extension (Wk 13-End of Study)|Death|0|||
147327630|NCT04888585|531363964|FG003|Long Term Extension (Wk 13-End of Study)|Death|0|||
147327631|NCT04888585|531363965|FG004|Long Term Extension (Wk 13-End of Study)|Death|0|||
147327632|NCT04888585|531363966|FG005|Long Term Extension (Wk 13-End of Study)|Death|0|||
147327633|NCT04888585|531363967|FG006|Long Term Extension (Wk 13-End of Study)|Death|0|||
147327634|NCT04888585|531363968|FG007|Long Term Extension (Wk 13-End of Study)|Death|1|||
147327635|NCT04888585|531363969|FG008|Long Term Extension (Wk 13-End of Study)|Death|0|||
147327636|NCT04888585|531363970|FG009|Long Term Extension (Wk 13-End of Study)|Death|0|||
147327637|NCT04888585|531363971|FG010|Long Term Extension (Wk 13-End of Study)|Death|3|||
147327638|NCT04888585|531363961|FG000|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|0|||
147327639|NCT04888585|531363962|FG001|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|0|||
147327640|NCT04888585|531363963|FG002|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|0|||
147327641|NCT04888585|531363964|FG003|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|0|||
147327642|NCT04888585|531363965|FG004|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|0|||
147327643|NCT04888585|531363966|FG005|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|5|||
147327644|NCT04888585|531363967|FG006|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|5|||
147327645|NCT04888585|531363968|FG007|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|8|||
147327646|NCT04888585|531363969|FG008|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|8|||
147327647|NCT04888585|531363970|FG009|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|8|||
147327648|NCT04888585|531363971|FG010|Long Term Extension (Wk 13-End of Study)|Withdrawal by Subject|11|||
147327649|NCT04888585|531363961|FG000|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|0|||
147327650|NCT04888585|531363962|FG001|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|0|||
147327651|NCT04888585|531363963|FG002|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|0|||
147327652|NCT04888585|531363964|FG003|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|0|||
147327653|NCT04888585|531363965|FG004|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|0|||
147327654|NCT04888585|531363966|FG005|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|37|||
147327655|NCT04888585|531363967|FG006|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|36|||
147327656|NCT04888585|531363968|FG007|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|78|||
147327657|NCT04888585|531363969|FG008|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|71|||
147327658|NCT04888585|531363970|FG009|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|71|||
147327659|NCT04888585|531363971|FG010|Long Term Extension (Wk 13-End of Study)|Study terminated by sponsor|72|||
147327660|NCT04888585|531363961|FG000|Long Term Extension (Wk 13-End of Study)|Other|0|||
147327661|NCT04888585|531363962|FG001|Long Term Extension (Wk 13-End of Study)|Other|0|||
147327662|NCT04888585|531363963|FG002|Long Term Extension (Wk 13-End of Study)|Other|0|||
147327663|NCT04888585|531363964|FG003|Long Term Extension (Wk 13-End of Study)|Other|0|||
147327664|NCT04888585|531363965|FG004|Long Term Extension (Wk 13-End of Study)|Other|0|||
147327665|NCT04888585|531363966|FG005|Long Term Extension (Wk 13-End of Study)|Other|3|||
147327666|NCT04888585|531363967|FG006|Long Term Extension (Wk 13-End of Study)|Other|1|||
147448538|NCT01964352|531807892|FG002|Overall Study|Lack of Efficacy|0|||
147448539|NCT01964352|531807893|FG003|Overall Study|Lack of Efficacy|0|||
147448540|NCT01964352|531807890|FG000|Overall Study|Protocol Violation|2|||
147596005|NCT00251641|532338768|FG001|Overall Study|Lost to Follow-up|3|||
147182756|NCT00855816|530834636|FG001|Overall Study|Withdrawal by Subject|15|||
147182757|NCT00855816|530834635|FG000|Overall Study|Lost to Follow-up|3|||
147182758|NCT00855816|530834636|FG001|Overall Study|Lost to Follow-up|5|||
147182759|NCT00855816|530834635|FG000|Overall Study|Death|1|||
147182760|NCT00855816|530834636|FG001|Overall Study|Death|0|||
147182761|NCT00855816|530834635|FG000|Overall Study|Became ineligible|0|||
147182762|NCT00855816|530834636|FG001|Overall Study|Became ineligible|1|||
147182763|NCT00337207|530834640|FG000|Overall Study|Withdrawal by Subject|3|||
147182764|NCT01521507|530834641|FG000|Stage 1: Randomized Design|Device did not fit, No Treatment|2|||
147182765|NCT01521507|530834642|FG001|Stage 1: Randomized Design|Device did not fit, No Treatment|0|||
147182766|NCT01521507|530834641|FG000|Stage 1: Randomized Design|Withdrawal by Subject|1|||
147182767|NCT01521507|530834642|FG001|Stage 1: Randomized Design|Withdrawal by Subject|3|||
147182768|NCT01521507|530834641|FG000|Stage 1: Randomized Design|Lost to Follow-up|0|||
147182769|NCT01521507|530834642|FG001|Stage 1: Randomized Design|Lost to Follow-up|2|||
147182770|NCT01521507|530834641|FG000|Stage 2: Observational Design|Device did not fit, No Treatment|0|||
147182771|NCT01521507|530834642|FG001|Stage 2: Observational Design|Device did not fit, No Treatment|1|||
147182772|NCT01521507|530834641|FG000|Stage 2: Observational Design|Withdrawal by Subject|3|||
147182773|NCT01521507|530834642|FG001|Stage 2: Observational Design|Withdrawal by Subject|1|||
147182774|NCT01521507|530834641|FG000|Stage 2: Observational Design|Physician Decision|1|||
147182775|NCT01521507|530834642|FG001|Stage 2: Observational Design|Physician Decision|0|||
147182776|NCT03573323|530834643|FG000|Blinded Treatment Period (Weeks 0-24)|Screen Failure|1|||
147182777|NCT03573323|530834644|FG001|Blinded Treatment Period (Weeks 0-24)|Screen Failure|1|||
147182778|NCT03573323|530834643|FG000|Blinded Treatment Period (Weeks 0-24)|Adverse Event|15|||
147182779|NCT03573323|530834644|FG001|Blinded Treatment Period (Weeks 0-24)|Adverse Event|8|||
147182780|NCT03573323|530834643|FG000|Blinded Treatment Period (Weeks 0-24)|Protocol Violation|3|||
147182781|NCT03573323|530834644|FG001|Blinded Treatment Period (Weeks 0-24)|Protocol Violation|8|||
147182782|NCT03573323|530834643|FG000|Blinded Treatment Period (Weeks 0-24)|Withdrawal by Subject|17|||
147182783|NCT03573323|530834644|FG001|Blinded Treatment Period (Weeks 0-24)|Withdrawal by Subject|9|||
147182784|NCT03573323|530834643|FG000|Blinded Treatment Period (Weeks 0-24)|Lack of Efficacy|2|||
147182785|NCT03573323|530834644|FG001|Blinded Treatment Period (Weeks 0-24)|Lack of Efficacy|3|||
147658186|NCT03654729|532572192|FG001|Overall Study|Progressive disease|0|||
147658187|NCT03654729|532572193|FG002|Overall Study|Progressive disease|0|||
147658188|NCT03654729|532572191|FG000|Overall Study|Lost to Follow-up|2|||
147658189|NCT03654729|532572192|FG001|Overall Study|Lost to Follow-up|0|||
147658190|NCT03654729|532572193|FG002|Overall Study|Lost to Follow-up|0|||
147658191|NCT03654729|532572191|FG000|Overall Study|Physician Decision|2|||
147658192|NCT03654729|532572192|FG001|Overall Study|Physician Decision|0|||
147658193|NCT03654729|532572193|FG002|Overall Study|Physician Decision|0|||
147182786|NCT03573323|530834643|FG000|Blinded Treatment Period (Weeks 0-24)|Pregnancy|1|||
147182787|NCT03573323|530834644|FG001|Blinded Treatment Period (Weeks 0-24)|Pregnancy|2|||
147182788|NCT03573323|530834643|FG000|Blinded Treatment Period (Weeks 0-24)|Physician Decision|1|||
147182789|NCT03573323|530834644|FG001|Blinded Treatment Period (Weeks 0-24)|Physician Decision|0|||
147182790|NCT03573323|530834643|FG000|Blinded Treatment Period (Weeks 0-24)|Lost to Follow-up|14|||
147182791|NCT03573323|530834644|FG001|Blinded Treatment Period (Weeks 0-24)|Lost to Follow-up|13|||
147182792|NCT03573323|530834643|FG000|Blinded Treatment Period (Weeks 0-24)|Sponsor Decision|0|||
147182793|NCT03573323|530834644|FG001|Blinded Treatment Period (Weeks 0-24)|Sponsor Decision|1|||
147182794|NCT03573323|530834643|FG000|Blinded Treatment Period (Weeks 0-24)|Alkaline Phosphatase (ALP) level reached|0|||
147182795|NCT03573323|530834644|FG001|Blinded Treatment Period (Weeks 0-24)|Alkaline Phosphatase (ALP) level reached|1|||
147182796|NCT03573323|530834643|FG000|Blinded Treatment Period (Weeks 0-24)|Noncompliant to protocol procedures|1|||
147182797|NCT03573323|530834644|FG001|Blinded Treatment Period (Weeks 0-24)|Noncompliant to protocol procedures|2|||
147182798|NCT03573323|530834643|FG000|Post-Treatment Follow Up (Weeks 25-36)|Withdrawal by Subject|22|||
147182799|NCT03573323|530834644|FG001|Post-Treatment Follow Up (Weeks 25-36)|Withdrawal by Subject|12|||
147182800|NCT03573323|530834643|FG000|Post-Treatment Follow Up (Weeks 25-36)|Lack of Efficacy|8|||
147182801|NCT03573323|530834644|FG001|Post-Treatment Follow Up (Weeks 25-36)|Lack of Efficacy|19|||
147182802|NCT03573323|530834643|FG000|Post-Treatment Follow Up (Weeks 25-36)|Physician Decision|4|||
147182803|NCT03573323|530834644|FG001|Post-Treatment Follow Up (Weeks 25-36)|Physician Decision|3|||
147182804|NCT03573323|530834643|FG000|Post-Treatment Follow Up (Weeks 25-36)|Did not wish to return to study|3|||
147182805|NCT03573323|530834644|FG001|Post-Treatment Follow Up (Weeks 25-36)|Did not wish to return to study|2|||
147182806|NCT03573323|530834643|FG000|Post-Treatment Follow Up (Weeks 25-36)|Discontinued Trt and Completed Follow Up|14|||
147182807|NCT03573323|530834644|FG001|Post-Treatment Follow Up (Weeks 25-36)|Discontinued Trt and Completed Follow Up|8|||
147182808|NCT03573323|530834643|FG000|Post-Treatment Follow Up (Weeks 25-36)|Not Compliant to Protocol Procedures|8|||
147182809|NCT03573323|530834644|FG001|Post-Treatment Follow Up (Weeks 25-36)|Not Compliant to Protocol Procedures|11|||
147182810|NCT03573323|530834643|FG000|Post-Treatment Follow Up (Weeks 25-36)|Sponsor Decision|0|||
147246677|NCT03129100|531072765|FG006|Period2 Extension Period (Group A and B)|Experienced Flare|19|||
147246678|NCT03129100|531072766|FG007|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
147246679|NCT03129100|531072767|FG008|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
147246680|NCT03129100|531072768|FG009|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
147658194|NCT03654729|532572191|FG000|Overall Study|Protocol Violation|1|||
147658195|NCT03654729|532572192|FG001|Overall Study|Protocol Violation|1|||
147658196|NCT03654729|532572193|FG002|Overall Study|Protocol Violation|0|||
147182811|NCT03573323|530834644|FG001|Post-Treatment Follow Up (Weeks 25-36)|Sponsor Decision|1|||
147182812|NCT03573323|530834643|FG000|Post-Treatment Follow Up (Weeks 25-36)|Repeat Infections|0|||
147182813|NCT03573323|530834644|FG001|Post-Treatment Follow Up (Weeks 25-36)|Repeat Infections|1|||
147182814|NCT03188432|530834645|FG000|Overall Study|Death|3|||
147182815|NCT03188432|530834645|FG000|Overall Study|Withdrawal by Subject|15|||
147182816|NCT03188432|530834645|FG000|Overall Study|Did not complete protocol treatment|9|||
147182817|NCT01687296|530834648|FG000|Overall Study|Lack of Efficacy|1|||
147182818|NCT01687296|530834649|FG001|Overall Study|Lack of Efficacy|1|||
147182819|NCT01687296|530834648|FG000|Overall Study|Protocol Violation|0|||
147182820|NCT01687296|530834649|FG001|Overall Study|Protocol Violation|1|||
147182821|NCT01687296|530834648|FG000|Overall Study|Withdrawal by Subject|6|||
147182822|NCT01687296|530834649|FG001|Overall Study|Withdrawal by Subject|3|||
147182823|NCT02336230|530834652|FG000|Overall Study|Adverse Event|1|||
147182824|NCT02336230|530834652|FG000|Overall Study|Withdrawal of consent|1|||
147182825|NCT02336230|530834652|FG000|Overall Study|Death|9|||
147182826|NCT02336230|530834652|FG000|Overall Study|Dose not received due to shipping delay|1|||
147182827|NCT02336230|530834652|FG000|Overall Study|Discontinuation of MSC infusion|1|||
147182828|NCT02524171|530834653|FG000|6-month Follow-up|Lost to Follow-up|53|||
147182829|NCT02524171|530834654|FG001|6-month Follow-up|Lost to Follow-up|45|||
147182830|NCT02524171|530834653|FG000|12-month Follow-up Interview|Lost to Follow-up|45|||
147182831|NCT02524171|530834654|FG001|12-month Follow-up Interview|Lost to Follow-up|41|||
147182832|NCT01695135|530834655|FG000|Double-blind Treatment Phase|Progressive disease|50|||
147182833|NCT01695135|530834656|FG001|Double-blind Treatment Phase|Progressive disease|110|||
147182834|NCT01695135|530834657|FG002|Double-blind Treatment Phase|Progressive disease|0|||
147182835|NCT01695135|530834658|FG003|Double-blind Treatment Phase|Progressive disease|0|||
147182836|NCT01695135|530834655|FG000|Double-blind Treatment Phase|Withdrawal by Subject|6|||
147182837|NCT01695135|530834656|FG001|Double-blind Treatment Phase|Withdrawal by Subject|14|||
147182838|NCT01695135|530834657|FG002|Double-blind Treatment Phase|Withdrawal by Subject|0|||
147182839|NCT01695135|530834658|FG003|Double-blind Treatment Phase|Withdrawal by Subject|0|||
147182840|NCT01695135|530834655|FG000|Double-blind Treatment Phase|Adverse Event|7|||
147182841|NCT01695135|530834656|FG001|Double-blind Treatment Phase|Adverse Event|7|||
147182842|NCT01695135|530834657|FG002|Double-blind Treatment Phase|Adverse Event|0|||
147182843|NCT01695135|530834658|FG003|Double-blind Treatment Phase|Adverse Event|0|||
147182844|NCT01695135|530834655|FG000|Double-blind Treatment Phase|Other|1|||
147182845|NCT01695135|530834656|FG001|Double-blind Treatment Phase|Other|3|||
147182846|NCT01695135|530834657|FG002|Double-blind Treatment Phase|Other|0|||
147182847|NCT01695135|530834658|FG003|Double-blind Treatment Phase|Other|0|||
147182848|NCT01695135|530834655|FG000|Double-blind Treatment Phase|Physician Decision|6|||
147182849|NCT01695135|530834656|FG001|Double-blind Treatment Phase|Physician Decision|3|||
147182850|NCT01695135|530834657|FG002|Double-blind Treatment Phase|Physician Decision|0|||
147182851|NCT01695135|530834658|FG003|Double-blind Treatment Phase|Physician Decision|0|||
147182852|NCT01695135|530834655|FG000|Double-blind Treatment Phase|Death|1|||
147182853|NCT01695135|530834656|FG001|Double-blind Treatment Phase|Death|1|||
147182854|NCT01695135|530834657|FG002|Double-blind Treatment Phase|Death|0|||
147182855|NCT01695135|530834658|FG003|Double-blind Treatment Phase|Death|0|||
147182856|NCT01695135|530834655|FG000|Double-blind Treatment Phase|Noncompliance with study drug|0|||
147182857|NCT01695135|530834656|FG001|Double-blind Treatment Phase|Noncompliance with study drug|1|||
147182858|NCT01695135|530834657|FG002|Double-blind Treatment Phase|Noncompliance with study drug|0|||
147182859|NCT01695135|530834658|FG003|Double-blind Treatment Phase|Noncompliance with study drug|0|||
147182860|NCT01695135|530834655|FG000|Open Label Extension Treatment Phase|Progressive disease|0|||
147182861|NCT01695135|530834656|FG001|Open Label Extension Treatment Phase|Progressive disease|0|||
147182862|NCT01695135|530834657|FG002|Open Label Extension Treatment Phase|Progressive disease|13|||
147182863|NCT01695135|530834658|FG003|Open Label Extension Treatment Phase|Progressive disease|22|||
147182864|NCT01695135|530834655|FG000|Open Label Extension Treatment Phase|Withdrawal by Subject|0|||
147182865|NCT01695135|530834656|FG001|Open Label Extension Treatment Phase|Withdrawal by Subject|0|||
147182866|NCT01695135|530834657|FG002|Open Label Extension Treatment Phase|Withdrawal by Subject|6|||
147182867|NCT01695135|530834658|FG003|Open Label Extension Treatment Phase|Withdrawal by Subject|16|||
147182868|NCT01695135|530834655|FG000|Open Label Extension Treatment Phase|Adverse Event|0|||
147182869|NCT01695135|530834656|FG001|Open Label Extension Treatment Phase|Adverse Event|0|||
147182870|NCT01695135|530834657|FG002|Open Label Extension Treatment Phase|Adverse Event|11|||
147182871|NCT01695135|530834658|FG003|Open Label Extension Treatment Phase|Adverse Event|16|||
147182872|NCT01695135|530834655|FG000|Open Label Extension Treatment Phase|Other|0|||
147182873|NCT01695135|530834656|FG001|Open Label Extension Treatment Phase|Other|0|||
147327667|NCT04888585|531363968|FG007|Long Term Extension (Wk 13-End of Study)|Other|4|||
147182874|NCT01695135|530834657|FG002|Open Label Extension Treatment Phase|Other|4|||
147327668|NCT04888585|531363969|FG008|Long Term Extension (Wk 13-End of Study)|Other|5|||
147593799|NCT00700817|532329032|FG004|Week 26-52 (Extension Period 1)|Adverse Event|0|||
147593800|NCT00700817|532329028|FG000|Week 26-52 (Extension Period 1)|Protocol Violation|3|||
147182875|NCT01695135|530834658|FG003|Open Label Extension Treatment Phase|Other|7|||
147593801|NCT00700817|532329029|FG001|Week 26-52 (Extension Period 1)|Protocol Violation|2|||
147182876|NCT01695135|530834655|FG000|Open Label Extension Treatment Phase|Physician Decision|0|||
147182877|NCT01695135|530834656|FG001|Open Label Extension Treatment Phase|Physician Decision|0|||
147182878|NCT01695135|530834657|FG002|Open Label Extension Treatment Phase|Physician Decision|4|||
147182879|NCT01695135|530834658|FG003|Open Label Extension Treatment Phase|Physician Decision|1|||
147182880|NCT01695135|530834655|FG000|Open Label Extension Treatment Phase|Death|0|||
147182881|NCT01695135|530834656|FG001|Open Label Extension Treatment Phase|Death|0|||
147182882|NCT01695135|530834657|FG002|Open Label Extension Treatment Phase|Death|2|||
147182883|NCT01695135|530834658|FG003|Open Label Extension Treatment Phase|Death|7|||
147182884|NCT01695135|530834655|FG000|Open Label Extension Treatment Phase|Noncompliance with study drug|0|||
147182885|NCT01695135|530834656|FG001|Open Label Extension Treatment Phase|Noncompliance with study drug|0|||
147182886|NCT01695135|530834657|FG002|Open Label Extension Treatment Phase|Noncompliance with study drug|0|||
147182887|NCT01695135|530834658|FG003|Open Label Extension Treatment Phase|Noncompliance with study drug|1|||
147182888|NCT00216671|530834661|FG000|Overall Study|Adverse Event|4|||
147182889|NCT00216671|530834662|FG001|Overall Study|Adverse Event|9|||
147182890|NCT00216671|530834661|FG000|Overall Study|Pregnancy|0|||
147182891|NCT00216671|530834662|FG001|Overall Study|Pregnancy|1|||
147182892|NCT00216671|530834661|FG000|Overall Study|Withdrawal by Subject|4|||
147182893|NCT00216671|530834662|FG001|Overall Study|Withdrawal by Subject|2|||
147182894|NCT00216671|530834661|FG000|Overall Study|Refused Injections|3|||
147182895|NCT00216671|530834662|FG001|Overall Study|Refused Injections|13|||
147182896|NCT00216671|530834661|FG000|Overall Study|No Need to Continue Medication|1|||
147182897|NCT00216671|530834662|FG001|Overall Study|No Need to Continue Medication|1|||
147182898|NCT00216671|530834661|FG000|Overall Study|Insufficient Response|9|||
147182899|NCT00216671|530834662|FG001|Overall Study|Insufficient Response|4|||
147182900|NCT00216671|530834661|FG000|Overall Study|Lost to Follow-up|3|||
147182901|NCT00216671|530834662|FG001|Overall Study|Lost to Follow-up|5|||
147182902|NCT00216671|530834661|FG000|Overall Study|Non compliant|2|||
147182903|NCT00216671|530834662|FG001|Overall Study|Non compliant|2|||
147182904|NCT00216671|530834661|FG000|Overall Study|Ineligible|0|||
147182905|NCT00216671|530834662|FG001|Overall Study|Ineligible|2|||
147182906|NCT00216671|530834661|FG000|Overall Study|Physician Decision|1|||
147182907|NCT00216671|530834662|FG001|Overall Study|Physician Decision|1|||
147182908|NCT00216671|530834661|FG000|Overall Study|Protocol Violation|3|||
147182909|NCT00216671|530834662|FG001|Overall Study|Protocol Violation|5|||
147182910|NCT00216671|530834661|FG000|Overall Study|Relapse|1|||
147182911|NCT00216671|530834662|FG001|Overall Study|Relapse|0|||
147182912|NCT00216671|530834661|FG000|Overall Study|Investigator Illness|0|||
147182913|NCT00216671|530834662|FG001|Overall Study|Investigator Illness|1|||
147182914|NCT00216671|530834661|FG000|Overall Study|Patient Moved|0|||
147182915|NCT00216671|530834662|FG001|Overall Study|Patient Moved|1|||
147182916|NCT00216671|530834661|FG000|Overall Study|Ineligible, no efficacy data|2|||
147182917|NCT00216671|530834662|FG001|Overall Study|Ineligible, no efficacy data|2|||
147182918|NCT00216671|530834661|FG000|Overall Study|Insufficient Response Adverse Event|2|||
147182919|NCT00216671|530834662|FG001|Overall Study|Insufficient Response Adverse Event|1|||
147182920|NCT02714569|530834663|FG000|Part A Second Intervention|Withdrawal by Subject|0|||
147182921|NCT02714569|530834664|FG001|Part A Second Intervention|Withdrawal by Subject|1|||
147182922|NCT02714569|530834665|FG002|Part A Second Intervention|Withdrawal by Subject|0|||
147182923|NCT02714569|530834666|FG003|Part A Second Intervention|Withdrawal by Subject|0|||
147182924|NCT02714569|530834667|FG004|Part A Second Intervention|Withdrawal by Subject|0|||
147182925|NCT02714569|530834668|FG005|Part A Second Intervention|Withdrawal by Subject|0|||
147182926|NCT02714569|530834669|FG006|Part A Second Intervention|Withdrawal by Subject|0|||
147182927|NCT02714569|530834670|FG007|Part A Second Intervention|Withdrawal by Subject|0|||
147182928|NCT02714569|530834671|FG008|Part A Second Intervention|Withdrawal by Subject|0|||
147327669|NCT04888585|531363970|FG009|Long Term Extension (Wk 13-End of Study)|Other|5|||
147327670|NCT04888585|531363971|FG010|Long Term Extension (Wk 13-End of Study)|Other|3|||
147327671|NCT04888585|531363961|FG000|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
147327672|NCT04888585|531363962|FG001|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
147593802|NCT00700817|532329030|FG002|Week 26-52 (Extension Period 1)|Protocol Violation|2|||
147593803|NCT00700817|532329031|FG003|Week 26-52 (Extension Period 1)|Protocol Violation|0|||
147593804|NCT00700817|532329032|FG004|Week 26-52 (Extension Period 1)|Protocol Violation|0|||
147593805|NCT00700817|532329028|FG000|Week 26-52 (Extension Period 1)|Lack of Efficacy|2|||
147593806|NCT00700817|532329029|FG001|Week 26-52 (Extension Period 1)|Lack of Efficacy|3|||
147593807|NCT00700817|532329030|FG002|Week 26-52 (Extension Period 1)|Lack of Efficacy|7|||
147593808|NCT00700817|532329031|FG003|Week 26-52 (Extension Period 1)|Lack of Efficacy|0|||
147593809|NCT00700817|532329032|FG004|Week 26-52 (Extension Period 1)|Lack of Efficacy|0|||
147593810|NCT00700817|532329028|FG000|Week 26-52 (Extension Period 1)|Withdrawal criteria|6|||
147593811|NCT00700817|532329029|FG001|Week 26-52 (Extension Period 1)|Withdrawal criteria|8|||
147593812|NCT00700817|532329030|FG002|Week 26-52 (Extension Period 1)|Withdrawal criteria|2|||
147182929|NCT02714569|530834672|FG009|Part A Second Intervention|Withdrawal by Subject|0|||
147182930|NCT02714569|530834673|FG010|Part A Second Intervention|Withdrawal by Subject|0|||
147182931|NCT02714569|530834663|FG000|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
147182932|NCT02714569|530834664|FG001|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
147182933|NCT02714569|530834665|FG002|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
147182934|NCT02714569|530834666|FG003|Part A Third Intervention|Positive Urine Drug Screen (UDS)|1|||
147182935|NCT02714569|530834667|FG004|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
147182936|NCT02714569|530834668|FG005|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
147182937|NCT02714569|530834669|FG006|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
147327673|NCT04888585|531363963|FG002|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
147327674|NCT04888585|531363964|FG003|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
147182938|NCT02714569|530834670|FG007|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
147182939|NCT02714569|530834671|FG008|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
147182940|NCT02714569|530834672|FG009|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
147182941|NCT02714569|530834673|FG010|Part A Third Intervention|Positive Urine Drug Screen (UDS)|0|||
147182942|NCT02714569|530834663|FG000|Part A Third Intervention|Adverse Event|0|||
147182943|NCT02714569|530834664|FG001|Part A Third Intervention|Adverse Event|0|||
147182944|NCT02714569|530834665|FG002|Part A Third Intervention|Adverse Event|1|||
147182945|NCT02714569|530834666|FG003|Part A Third Intervention|Adverse Event|0|||
147182946|NCT02714569|530834667|FG004|Part A Third Intervention|Adverse Event|0|||
147182947|NCT02714569|530834668|FG005|Part A Third Intervention|Adverse Event|0|||
147182948|NCT02714569|530834669|FG006|Part A Third Intervention|Adverse Event|0|||
147182949|NCT02714569|530834670|FG007|Part A Third Intervention|Adverse Event|0|||
147182950|NCT02714569|530834671|FG008|Part A Third Intervention|Adverse Event|0|||
147182951|NCT02714569|530834672|FG009|Part A Third Intervention|Adverse Event|0|||
147182952|NCT02714569|530834673|FG010|Part A Third Intervention|Adverse Event|0|||
147182953|NCT02714569|530834663|FG000|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|1|||
147182954|NCT02714569|530834664|FG001|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
147182955|NCT02714569|530834665|FG002|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
147182956|NCT02714569|530834666|FG003|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
147182957|NCT02714569|530834667|FG004|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
147182958|NCT02714569|530834668|FG005|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|1|||
147182959|NCT02714569|530834669|FG006|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
147182960|NCT02714569|530834670|FG007|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
147182961|NCT02714569|530834671|FG008|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
147182962|NCT02714569|530834672|FG009|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
147182963|NCT02714569|530834673|FG010|Part A Fourth Intervention|Positive Urinary Drug Screen (UDS)|0|||
147182964|NCT02714569|530834663|FG000|Part B (Overall)|Lost to Follow-up|0|||
147182965|NCT02714569|530834664|FG001|Part B (Overall)|Lost to Follow-up|0|||
147182966|NCT02714569|530834665|FG002|Part B (Overall)|Lost to Follow-up|0|||
147182967|NCT02714569|530834666|FG003|Part B (Overall)|Lost to Follow-up|0|||
147182968|NCT02714569|530834667|FG004|Part B (Overall)|Lost to Follow-up|0|||
147182969|NCT02714569|530834668|FG005|Part B (Overall)|Lost to Follow-up|0|||
147182970|NCT02714569|530834669|FG006|Part B (Overall)|Lost to Follow-up|1|||
147182971|NCT02714569|530834670|FG007|Part B (Overall)|Lost to Follow-up|0|||
147182972|NCT02714569|530834671|FG008|Part B (Overall)|Lost to Follow-up|0|||
147246681|NCT03129100|531072769|FG010|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
147246682|NCT03129100|531072770|FG011|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
147246683|NCT03129100|531072771|FG012|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
147246684|NCT03129100|531072772|FG013|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
147246685|NCT03129100|531072773|FG014|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
147246686|NCT03129100|531072774|FG015|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
147246687|NCT03129100|531072775|FG016|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
147246688|NCT03129100|531072776|FG017|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
147246689|NCT03129100|531072777|FG018|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
147246690|NCT03129100|531072778|FG019|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
147246691|NCT03129100|531072779|FG020|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
147246692|NCT03129100|531072780|FG021|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
147246693|NCT03129100|531072781|FG022|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
147246694|NCT03129100|531072782|FG023|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
147246695|NCT03129100|531072783|FG024|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
147246696|NCT03129100|531072784|FG025|Period2 Extension Period (Group A and B)|Experienced Flare|0|||
147246697|NCT03129100|531072759|FG000|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
147246698|NCT03129100|531072760|FG001|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
147182973|NCT02714569|530834672|FG009|Part B (Overall)|Lost to Follow-up|0|||
147182974|NCT02714569|530834673|FG010|Part B (Overall)|Lost to Follow-up|0|||
147182975|NCT02714569|530834663|FG000|Part B (Overall)|Withdrawal by Subject|0|||
147182976|NCT02714569|530834664|FG001|Part B (Overall)|Withdrawal by Subject|0|||
147327675|NCT04888585|531363965|FG004|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
147182977|NCT02714569|530834665|FG002|Part B (Overall)|Withdrawal by Subject|0|||
147182978|NCT02714569|530834666|FG003|Part B (Overall)|Withdrawal by Subject|0|||
147182979|NCT02714569|530834667|FG004|Part B (Overall)|Withdrawal by Subject|0|||
147182980|NCT02714569|530834668|FG005|Part B (Overall)|Withdrawal by Subject|0|||
147182981|NCT02714569|530834669|FG006|Part B (Overall)|Withdrawal by Subject|0|||
147182982|NCT02714569|530834670|FG007|Part B (Overall)|Withdrawal by Subject|1|||
147182983|NCT02714569|530834671|FG008|Part B (Overall)|Withdrawal by Subject|0|||
147182984|NCT02714569|530834672|FG009|Part B (Overall)|Withdrawal by Subject|1|||
147246699|NCT03129100|531072761|FG002|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
147246700|NCT03129100|531072762|FG003|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
147246701|NCT03129100|531072763|FG004|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
147246702|NCT03129100|531072764|FG005|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
147246703|NCT03129100|531072765|FG006|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
147246704|NCT03129100|531072766|FG007|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
147246705|NCT03129100|531072767|FG008|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
147246706|NCT03129100|531072768|FG009|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|1|||
147246707|NCT03129100|531072769|FG010|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
147246708|NCT03129100|531072770|FG011|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
147448541|NCT01964352|531807891|FG001|Overall Study|Protocol Violation|4|||
147593813|NCT00700817|532329031|FG003|Week 26-52 (Extension Period 1)|Withdrawal criteria|0|||
147593814|NCT00700817|532329032|FG004|Week 26-52 (Extension Period 1)|Withdrawal criteria|0|||
147593815|NCT00700817|532329028|FG000|Week 26-52 (Extension Period 1)|Unclassified|4|||
147593816|NCT00700817|532329029|FG001|Week 26-52 (Extension Period 1)|Unclassified|3|||
147593817|NCT00700817|532329030|FG002|Week 26-52 (Extension Period 1)|Unclassified|1|||
147593818|NCT00700817|532329031|FG003|Week 26-52 (Extension Period 1)|Unclassified|0|||
147593819|NCT00700817|532329032|FG004|Week 26-52 (Extension Period 1)|Unclassified|0|||
147593820|NCT00700817|532329028|FG000|Week 52-78 (Extension Period 2)|Adverse Event|0|||
147593821|NCT00700817|532329029|FG001|Week 52-78 (Extension Period 2)|Adverse Event|3|||
147593822|NCT00700817|532329030|FG002|Week 52-78 (Extension Period 2)|Adverse Event|0|||
147593823|NCT00700817|532329031|FG003|Week 52-78 (Extension Period 2)|Adverse Event|6|||
147593824|NCT00700817|532329032|FG004|Week 52-78 (Extension Period 2)|Adverse Event|0|||
147593825|NCT00700817|532329028|FG000|Week 52-78 (Extension Period 2)|Protocol Violation|1|||
147593826|NCT00700817|532329029|FG001|Week 52-78 (Extension Period 2)|Protocol Violation|2|||
147593827|NCT00700817|532329030|FG002|Week 52-78 (Extension Period 2)|Protocol Violation|0|||
147593828|NCT00700817|532329031|FG003|Week 52-78 (Extension Period 2)|Protocol Violation|1|||
147593829|NCT00700817|532329032|FG004|Week 52-78 (Extension Period 2)|Protocol Violation|1|||
147593830|NCT00700817|532329028|FG000|Week 52-78 (Extension Period 2)|Lack of Efficacy|3|||
147593831|NCT00700817|532329029|FG001|Week 52-78 (Extension Period 2)|Lack of Efficacy|3|||
147593832|NCT00700817|532329030|FG002|Week 52-78 (Extension Period 2)|Lack of Efficacy|0|||
147593833|NCT00700817|532329031|FG003|Week 52-78 (Extension Period 2)|Lack of Efficacy|0|||
147593834|NCT00700817|532329032|FG004|Week 52-78 (Extension Period 2)|Lack of Efficacy|0|||
147593835|NCT00700817|532329028|FG000|Week 52-78 (Extension Period 2)|Withdrawal criteria|4|||
147593836|NCT00700817|532329029|FG001|Week 52-78 (Extension Period 2)|Withdrawal criteria|3|||
147593837|NCT00700817|532329030|FG002|Week 52-78 (Extension Period 2)|Withdrawal criteria|0|||
147593838|NCT00700817|532329031|FG003|Week 52-78 (Extension Period 2)|Withdrawal criteria|1|||
147593839|NCT00700817|532329032|FG004|Week 52-78 (Extension Period 2)|Withdrawal criteria|3|||
147593840|NCT00700817|532329028|FG000|Week 52-78 (Extension Period 2)|Unclassified|2|||
147593841|NCT00700817|532329029|FG001|Week 52-78 (Extension Period 2)|Unclassified|4|||
147593842|NCT00700817|532329030|FG002|Week 52-78 (Extension Period 2)|Unclassified|0|||
147593843|NCT00700817|532329031|FG003|Week 52-78 (Extension Period 2)|Unclassified|0|||
147593844|NCT00700817|532329032|FG004|Week 52-78 (Extension Period 2)|Unclassified|1|||
147593845|NCT00058214|532329033|FG000|Overall Study|Adverse Event|1|||
147593846|NCT00049842|532329034|FG000|Treatment Phase|Adverse Event|47|||
147593847|NCT00049842|532329035|FG001|Treatment Phase|Adverse Event|12|||
147593848|NCT00049842|532329034|FG000|Treatment Phase|Withdrawal by Subject|35|||
147593849|NCT00049842|532329035|FG001|Treatment Phase|Withdrawal by Subject|46|||
147593850|NCT00049842|532329034|FG000|Treatment Phase|Non-compliance with protocol|7|||
147593851|NCT00049842|532329035|FG001|Treatment Phase|Non-compliance with protocol|8|||
147593852|NCT00049842|532329034|FG000|Treatment Phase|Lost to Follow-up|4|||
147593853|NCT00049842|532329035|FG001|Treatment Phase|Lost to Follow-up|8|||
147593854|NCT00049842|532329034|FG000|Treatment Phase|Administrative|0|||
147593855|NCT00049842|532329035|FG001|Treatment Phase|Administrative|3|||
147593856|NCT00049842|532329034|FG000|Treatment Phase|Did not meet protocol eligibility|0|||
147593857|NCT00049842|532329035|FG001|Treatment Phase|Did not meet protocol eligibility|1|||
147593858|NCT00049842|532329034|FG000|Follow-up Phase|Adverse Event|6|||
147593859|NCT00049842|532329035|FG001|Follow-up Phase|Adverse Event|1|||
147593860|NCT00049842|532329034|FG000|Follow-up Phase|Other|1|||
147593861|NCT00049842|532329035|FG001|Follow-up Phase|Other|4|||
147593862|NCT03977701|532329036|FG000|Overall Study|COVID-19 pandemic|0|||
147182985|NCT02714569|530834673|FG010|Part B (Overall)|Withdrawal by Subject|0|||
147327676|NCT04888585|531363966|FG005|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
147327677|NCT04888585|531363967|FG006|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|4|||
147182986|NCT02714569|530834663|FG000|Part B (Overall)|Adverse Event|0|||
147182987|NCT02714569|530834664|FG001|Part B (Overall)|Adverse Event|0|||
147182988|NCT02714569|530834665|FG002|Part B (Overall)|Adverse Event|0|||
147182989|NCT02714569|530834666|FG003|Part B (Overall)|Adverse Event|0|||
147182990|NCT02714569|530834667|FG004|Part B (Overall)|Adverse Event|0|||
147182991|NCT02714569|530834668|FG005|Part B (Overall)|Adverse Event|0|||
147182992|NCT02714569|530834669|FG006|Part B (Overall)|Adverse Event|0|||
147182993|NCT02714569|530834670|FG007|Part B (Overall)|Adverse Event|0|||
147182994|NCT02714569|530834671|FG008|Part B (Overall)|Adverse Event|0|||
147182995|NCT02714569|530834672|FG009|Part B (Overall)|Adverse Event|1|||
147182996|NCT02714569|530834673|FG010|Part B (Overall)|Adverse Event|0|||
147182997|NCT01684202|530834674|FG000|Dose-escalation Period|Adverse Event|0|||
147182998|NCT01684202|530834675|FG001|Dose-escalation Period|Adverse Event|1|||
147182999|NCT01684202|530834676|FG002|Dose-escalation Period|Adverse Event|0|||
147183000|NCT01684202|530834677|FG003|Dose-escalation Period|Adverse Event|0|||
147183001|NCT01684202|530834674|FG000|Dose-escalation Period|Withdrawal by Subject|1|||
147183002|NCT01684202|530834675|FG001|Dose-escalation Period|Withdrawal by Subject|0|||
147183003|NCT01684202|530834676|FG002|Dose-escalation Period|Withdrawal by Subject|0|||
147183004|NCT01684202|530834677|FG003|Dose-escalation Period|Withdrawal by Subject|0|||
147183005|NCT01684202|530834674|FG000|Maintenance Period|Adverse Event|1|||
147183006|NCT01684202|530834675|FG001|Maintenance Period|Adverse Event|1|||
147183007|NCT01684202|530834676|FG002|Maintenance Period|Adverse Event|1|||
147183008|NCT01684202|530834677|FG003|Maintenance Period|Adverse Event|1|||
147183009|NCT01684202|530834674|FG000|Maintenance Period|Physician Decision|0|||
147183010|NCT01684202|530834675|FG001|Maintenance Period|Physician Decision|1|||
147183011|NCT01684202|530834676|FG002|Maintenance Period|Physician Decision|0|||
147183012|NCT01684202|530834677|FG003|Maintenance Period|Physician Decision|0|||
147183013|NCT01684202|530834674|FG000|Maintenance Period|Withdrawal by Subject|0|||
147183014|NCT01684202|530834675|FG001|Maintenance Period|Withdrawal by Subject|1|||
147183015|NCT01684202|530834676|FG002|Maintenance Period|Withdrawal by Subject|0|||
147183016|NCT01684202|530834677|FG003|Maintenance Period|Withdrawal by Subject|0|||
147183017|NCT03305770|530834678|FG000|Overall Study|Physician Decision - prior to dispense|0|||
147183018|NCT03305770|530834679|FG001|Overall Study|Physician Decision - prior to dispense|1|||
147183019|NCT03305770|530834678|FG000|Overall Study|Subject moved|1|||
147183020|NCT03305770|530834679|FG001|Overall Study|Subject moved|0|||
147183021|NCT03539601|530834680|FG000|Overall Study|Withdraw by parent/guardian|1|||
147183022|NCT03539601|530834681|FG001|Overall Study|Withdraw by parent/guardian|0|||
147183023|NCT03539601|530834682|FG002|Overall Study|Withdraw by parent/guardian|1|||
147183024|NCT03539601|530834683|FG003|Overall Study|Withdraw by parent/guardian|0|||
147183025|NCT03539601|530834680|FG000|Overall Study|Adverse Event|0|||
147183026|NCT03539601|530834681|FG001|Overall Study|Adverse Event|2|||
147183027|NCT03539601|530834682|FG002|Overall Study|Adverse Event|0|||
147183028|NCT03539601|530834683|FG003|Overall Study|Adverse Event|0|||
147183029|NCT03539601|530834680|FG000|Overall Study|Lost to Follow-up|2|||
147183030|NCT03539601|530834681|FG001|Overall Study|Lost to Follow-up|4|||
147183031|NCT03539601|530834682|FG002|Overall Study|Lost to Follow-up|5|||
147183032|NCT03539601|530834683|FG003|Overall Study|Lost to Follow-up|0|||
147183033|NCT03539601|530834680|FG000|Overall Study|Withdrawal by Subject|2|||
147183034|NCT03539601|530834681|FG001|Overall Study|Withdrawal by Subject|0|||
147327678|NCT04888585|531363968|FG007|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|2|||
147183035|NCT03539601|530834682|FG002|Overall Study|Withdrawal by Subject|0|||
147183036|NCT03539601|530834683|FG003|Overall Study|Withdrawal by Subject|1|||
147183037|NCT03539601|530834680|FG000|Overall Study|Randomized but not treated|1|||
147183038|NCT03539601|530834681|FG001|Overall Study|Randomized but not treated|1|||
147183039|NCT03539601|530834682|FG002|Overall Study|Randomized but not treated|0|||
147183040|NCT03539601|530834683|FG003|Overall Study|Randomized but not treated|0|||
147183041|NCT00226811|530834684|FG000|Overall Study|Death|8|||
147183042|NCT00226811|530834684|FG000|Overall Study|Adverse Event|11|||
147183043|NCT00226811|530834684|FG000|Overall Study|Lack of Efficacy|55|||
147183044|NCT00226811|530834684|FG000|Overall Study|Withdrawal by Subject|2|||
147183045|NCT01010971|530834685|FG000|Overall Study|Adverse Event|2|||
147183046|NCT01010971|530834686|FG001|Overall Study|Adverse Event|4|||
147183047|NCT01010971|530834687|FG002|Overall Study|Adverse Event|3|||
147183048|NCT01010971|530834685|FG000|Overall Study|Withdrawal by Subject|0|||
147183049|NCT01010971|530834686|FG001|Overall Study|Withdrawal by Subject|2|||
147183050|NCT01010971|530834687|FG002|Overall Study|Withdrawal by Subject|5|||
147183051|NCT01010971|530834685|FG000|Overall Study|Lost to Follow-up|0|||
147183052|NCT01010971|530834686|FG001|Overall Study|Lost to Follow-up|2|||
147183053|NCT01010971|530834687|FG002|Overall Study|Lost to Follow-up|3|||
147593863|NCT03977701|532329037|FG001|Overall Study|COVID-19 pandemic|0|||
147183054|NCT01010971|530834685|FG000|Overall Study|Other|1|||
147183055|NCT01010971|530834686|FG001|Overall Study|Other|0|||
147183056|NCT01010971|530834687|FG002|Overall Study|Other|2|||
147183057|NCT03386721|530834688|FG000|Overall Study|Death|12|||
147183058|NCT03386721|530834689|FG001|Overall Study|Death|21|||
147327679|NCT04888585|531363969|FG008|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|2|||
147327680|NCT04888585|531363970|FG009|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|1|||
147327681|NCT04888585|531363971|FG010|Long Term Extension (Wk 13-End of Study)|Lost to Follow-up|0|||
147327682|NCT04927975|531363972|FG000|Period 1 (Baseline-Week 24)|Withdrawal by Subject|2|||
147327683|NCT04927975|531363973|FG001|Period 1 (Baseline-Week 24)|Withdrawal by Subject|0|||
147327684|NCT04927975|531363974|FG002|Period 1 (Baseline-Week 24)|Withdrawal by Subject|0|||
147327685|NCT04927975|531363975|FG003|Period 1 (Baseline-Week 24)|Withdrawal by Subject|1|||
147327686|NCT04927975|531363976|FG004|Period 1 (Baseline-Week 24)|Withdrawal by Subject|1|||
147327687|NCT04927975|531363977|FG005|Period 1 (Baseline-Week 24)|Withdrawal by Subject|4|||
147327688|NCT04927975|531363972|FG000|Period 1 (Baseline-Week 24)|Lost to Follow-up|0|||
147327689|NCT04927975|531363973|FG001|Period 1 (Baseline-Week 24)|Lost to Follow-up|0|||
147327690|NCT04927975|531363974|FG002|Period 1 (Baseline-Week 24)|Lost to Follow-up|0|||
147327691|NCT04927975|531363975|FG003|Period 1 (Baseline-Week 24)|Lost to Follow-up|2|||
147327692|NCT04927975|531363976|FG004|Period 1 (Baseline-Week 24)|Lost to Follow-up|1|||
147327693|NCT04927975|531363977|FG005|Period 1 (Baseline-Week 24)|Lost to Follow-up|0|||
147327694|NCT04927975|531363972|FG000|Period 1 (Baseline-Week 24)|Death|0|||
147327695|NCT04927975|531363973|FG001|Period 1 (Baseline-Week 24)|Death|0|||
147327696|NCT04927975|531363974|FG002|Period 1 (Baseline-Week 24)|Death|0|||
147327697|NCT04927975|531363975|FG003|Period 1 (Baseline-Week 24)|Death|0|||
147327698|NCT04927975|531363976|FG004|Period 1 (Baseline-Week 24)|Death|0|||
147327699|NCT04927975|531363977|FG005|Period 1 (Baseline-Week 24)|Death|1|||
147327700|NCT04927975|531363972|FG000|Period 2 (Week 24-52)|Lost to Follow-up|0|||
147327701|NCT04927975|531363973|FG001|Period 2 (Week 24-52)|Lost to Follow-up|1|||
147327702|NCT04927975|531363974|FG002|Period 2 (Week 24-52)|Lost to Follow-up|0|||
147327703|NCT04927975|531363975|FG003|Period 2 (Week 24-52)|Lost to Follow-up|2|||
147327704|NCT04927975|531363976|FG004|Period 2 (Week 24-52)|Lost to Follow-up|6|||
147327705|NCT04927975|531363977|FG005|Period 2 (Week 24-52)|Lost to Follow-up|2|||
147327706|NCT04927975|531363972|FG000|Period 2 (Week 24-52)|Withdrawal by Subject|0|||
147327707|NCT04927975|531363973|FG001|Period 2 (Week 24-52)|Withdrawal by Subject|1|||
147327708|NCT04927975|531363974|FG002|Period 2 (Week 24-52)|Withdrawal by Subject|1|||
147327709|NCT04927975|531363975|FG003|Period 2 (Week 24-52)|Withdrawal by Subject|4|||
147327710|NCT04927975|531363976|FG004|Period 2 (Week 24-52)|Withdrawal by Subject|1|||
147327711|NCT04927975|531363977|FG005|Period 2 (Week 24-52)|Withdrawal by Subject|1|||
147327712|NCT00630864|531363978|FG000|Part 1 (up to Week 6)|Adverse Event|1|||
147183059|NCT03386721|530834690|FG002|Overall Study|Death|2|||
147183060|NCT03386721|530834691|FG003|Overall Study|Death|5|||
147183061|NCT03386721|530834692|FG004|Overall Study|Death|1|||
147183062|NCT03386721|530834693|FG005|Overall Study|Death|12|||
147183063|NCT03386721|530834694|FG006|Overall Study|Death|1|||
147183064|NCT03386721|530834695|FG007|Overall Study|Death|1|||
147183065|NCT03386721|530834696|FG008|Overall Study|Death|12|||
147183066|NCT03386721|530834697|FG009|Overall Study|Death|20|||
147183067|NCT03386721|530834698|FG010|Overall Study|Death|21|||
147183068|NCT03386721|530834699|FG011|Overall Study|Death|21|||
147183069|NCT03386721|530834700|FG012|Overall Study|Death|14|||
147183070|NCT03386721|530834701|FG013|Overall Study|Death|2|||
147183071|NCT03386721|530834702|FG014|Overall Study|Death|1|||
147183072|NCT03386721|530834688|FG000|Overall Study|Lost to Follow-up|1|||
147183073|NCT03386721|530834689|FG001|Overall Study|Lost to Follow-up|3|||
147183074|NCT03386721|530834690|FG002|Overall Study|Lost to Follow-up|0|||
147183075|NCT03386721|530834691|FG003|Overall Study|Lost to Follow-up|0|||
147183076|NCT03386721|530834692|FG004|Overall Study|Lost to Follow-up|0|||
147183077|NCT03386721|530834693|FG005|Overall Study|Lost to Follow-up|2|||
147327713|NCT00630864|531363978|FG000|Part 2 (After Week 6 up to Month 12)|Liver transplant|2|||
147327714|NCT01645111|531365462|FG000|Overall Study|Did not require Clevidipine|15|||
147327715|NCT04057196|531365463|FG000|Overall Study|Withdrawal by Subject|3|||
147327716|NCT04057196|531365463|FG000|Overall Study|Death|3|||
147327717|NCT01118377|531365464|FG000|Overall Study|Did Not Receive Study Medication|1|||
147327718|NCT01118377|531365464|FG000|Overall Study|Death|38|||
147327719|NCT01118377|531365464|FG000|Overall Study|Failure to Return|3|||
147327720|NCT00739102|531365469|FG000|Overall Study|Death|5|||
147327721|NCT00739102|531365469|FG000|Overall Study|Withdrawal by Subject|10|||
147327722|NCT01062126|531365470|FG000|Overall Study|Death|209|||
147327723|NCT01062126|531365470|FG000|Overall Study|All Withdrawals|324|||
147327724|NCT00646451|531365471|FG000|Overall Study|Adverse Event|3|||
147593864|NCT03977701|532329038|FG002|Overall Study|COVID-19 pandemic|0|||
147183078|NCT03386721|530834694|FG006|Overall Study|Lost to Follow-up|1|||
147183079|NCT03386721|530834695|FG007|Overall Study|Lost to Follow-up|0|||
147183080|NCT03386721|530834696|FG008|Overall Study|Lost to Follow-up|1|||
147183081|NCT03386721|530834697|FG009|Overall Study|Lost to Follow-up|2|||
147183082|NCT03386721|530834698|FG010|Overall Study|Lost to Follow-up|1|||
147327725|NCT00646451|531365472|FG001|Overall Study|Adverse Event|0|||
147327726|NCT00646451|531365471|FG000|Overall Study|Exacerbation of pre-existing condition|1|||
147183083|NCT03386721|530834699|FG011|Overall Study|Lost to Follow-up|0|||
147327727|NCT00646451|531365472|FG001|Overall Study|Exacerbation of pre-existing condition|0|||
147327728|NCT02232178|531365473|FG000|Overall Study|Lost to Follow-up|0|||
147183084|NCT03386721|530834700|FG012|Overall Study|Lost to Follow-up|0|||
147183085|NCT03386721|530834701|FG013|Overall Study|Lost to Follow-up|0|||
147183086|NCT03386721|530834702|FG014|Overall Study|Lost to Follow-up|0|||
147183087|NCT03386721|530834688|FG000|Overall Study|Reason not specified|3|||
147183088|NCT03386721|530834689|FG001|Overall Study|Reason not specified|0|||
147183089|NCT03386721|530834690|FG002|Overall Study|Reason not specified|0|||
147183090|NCT03386721|530834691|FG003|Overall Study|Reason not specified|0|||
147183091|NCT03386721|530834692|FG004|Overall Study|Reason not specified|0|||
147183092|NCT03386721|530834693|FG005|Overall Study|Reason not specified|3|||
147183093|NCT03386721|530834694|FG006|Overall Study|Reason not specified|1|||
147183094|NCT03386721|530834695|FG007|Overall Study|Reason not specified|0|||
147183095|NCT03386721|530834696|FG008|Overall Study|Reason not specified|0|||
147183096|NCT03386721|530834697|FG009|Overall Study|Reason not specified|1|||
147183097|NCT03386721|530834698|FG010|Overall Study|Reason not specified|2|||
147183098|NCT03386721|530834699|FG011|Overall Study|Reason not specified|6|||
147183099|NCT03386721|530834700|FG012|Overall Study|Reason not specified|1|||
147183100|NCT03386721|530834701|FG013|Overall Study|Reason not specified|0|||
147183101|NCT03386721|530834702|FG014|Overall Study|Reason not specified|0|||
147183102|NCT03386721|530834688|FG000|Overall Study|Progressive Disease|0|||
147183103|NCT03386721|530834689|FG001|Overall Study|Progressive Disease|0|||
147183104|NCT03386721|530834690|FG002|Overall Study|Progressive Disease|1|||
147183105|NCT03386721|530834691|FG003|Overall Study|Progressive Disease|0|||
147183106|NCT03386721|530834692|FG004|Overall Study|Progressive Disease|0|||
147183107|NCT03386721|530834693|FG005|Overall Study|Progressive Disease|1|||
147183108|NCT03386721|530834694|FG006|Overall Study|Progressive Disease|0|||
147183109|NCT03386721|530834695|FG007|Overall Study|Progressive Disease|0|||
147183110|NCT03386721|530834696|FG008|Overall Study|Progressive Disease|2|||
147183111|NCT03386721|530834697|FG009|Overall Study|Progressive Disease|1|||
147183112|NCT03386721|530834698|FG010|Overall Study|Progressive Disease|1|||
147183113|NCT03386721|530834699|FG011|Overall Study|Progressive Disease|0|||
147183114|NCT03386721|530834700|FG012|Overall Study|Progressive Disease|1|||
147183115|NCT03386721|530834701|FG013|Overall Study|Progressive Disease|0|||
147183116|NCT03386721|530834702|FG014|Overall Study|Progressive Disease|0|||
147183117|NCT03386721|530834688|FG000|Overall Study|Site Terminated by Sponsor|5|||
147183118|NCT03386721|530834689|FG001|Overall Study|Site Terminated by Sponsor|5|||
147183119|NCT03386721|530834690|FG002|Overall Study|Site Terminated by Sponsor|0|||
147183120|NCT03386721|530834691|FG003|Overall Study|Site Terminated by Sponsor|0|||
147183121|NCT03386721|530834692|FG004|Overall Study|Site Terminated by Sponsor|1|||
147183122|NCT03386721|530834693|FG005|Overall Study|Site Terminated by Sponsor|3|||
147183123|NCT03386721|530834694|FG006|Overall Study|Site Terminated by Sponsor|0|||
147183124|NCT03386721|530834695|FG007|Overall Study|Site Terminated by Sponsor|1|||
147183125|NCT03386721|530834696|FG008|Overall Study|Site Terminated by Sponsor|4|||
147183126|NCT03386721|530834697|FG009|Overall Study|Site Terminated by Sponsor|5|||
147183127|NCT03386721|530834698|FG010|Overall Study|Site Terminated by Sponsor|3|||
147183128|NCT03386721|530834699|FG011|Overall Study|Site Terminated by Sponsor|11|||
147183129|NCT03386721|530834700|FG012|Overall Study|Site Terminated by Sponsor|6|||
147183130|NCT03386721|530834701|FG013|Overall Study|Site Terminated by Sponsor|0|||
147183131|NCT03386721|530834702|FG014|Overall Study|Site Terminated by Sponsor|0|||
147183132|NCT03386721|530834688|FG000|Overall Study|Symptomatic Deterioration|0|||
147183133|NCT03386721|530834689|FG001|Overall Study|Symptomatic Deterioration|0|||
147183134|NCT03386721|530834690|FG002|Overall Study|Symptomatic Deterioration|0|||
147183135|NCT03386721|530834691|FG003|Overall Study|Symptomatic Deterioration|0|||
147183136|NCT03386721|530834692|FG004|Overall Study|Symptomatic Deterioration|0|||
147183137|NCT03386721|530834693|FG005|Overall Study|Symptomatic Deterioration|0|||
147183138|NCT03386721|530834694|FG006|Overall Study|Symptomatic Deterioration|0|||
147183139|NCT03386721|530834695|FG007|Overall Study|Symptomatic Deterioration|0|||
147183140|NCT03386721|530834696|FG008|Overall Study|Symptomatic Deterioration|1|||
147183141|NCT03386721|530834697|FG009|Overall Study|Symptomatic Deterioration|0|||
147327729|NCT02232178|531365474|FG001|Overall Study|Lost to Follow-up|1|||
147327730|NCT02232178|531365475|FG002|Overall Study|Lost to Follow-up|0|||
147327731|NCT02232178|531365473|FG000|Overall Study|ineligibility|0|||
147183142|NCT03386721|530834698|FG010|Overall Study|Symptomatic Deterioration|0|||
147183143|NCT03386721|530834699|FG011|Overall Study|Symptomatic Deterioration|1|||
147183144|NCT03386721|530834700|FG012|Overall Study|Symptomatic Deterioration|0|||
147183145|NCT03386721|530834701|FG013|Overall Study|Symptomatic Deterioration|0|||
147183146|NCT03386721|530834702|FG014|Overall Study|Symptomatic Deterioration|0|||
147183147|NCT03386721|530834688|FG000|Overall Study|Withdrawal by Subject|1|||
147183148|NCT03386721|530834689|FG001|Overall Study|Withdrawal by Subject|2|||
147327732|NCT02232178|531365474|FG001|Overall Study|ineligibility|0|||
147183149|NCT03386721|530834690|FG002|Overall Study|Withdrawal by Subject|0|||
147327733|NCT02232178|531365475|FG002|Overall Study|ineligibility|1|||
147183150|NCT03386721|530834691|FG003|Overall Study|Withdrawal by Subject|0|||
147183151|NCT03386721|530834692|FG004|Overall Study|Withdrawal by Subject|0|||
147183152|NCT03386721|530834693|FG005|Overall Study|Withdrawal by Subject|0|||
147183153|NCT03386721|530834694|FG006|Overall Study|Withdrawal by Subject|0|||
147183154|NCT03386721|530834695|FG007|Overall Study|Withdrawal by Subject|0|||
147183155|NCT03386721|530834696|FG008|Overall Study|Withdrawal by Subject|2|||
147327734|NCT02232178|531365473|FG000|Overall Study|surgical complication|1|||
147448542|NCT01964352|531807892|FG002|Overall Study|Protocol Violation|0|||
147448543|NCT01964352|531807893|FG003|Overall Study|Protocol Violation|2|||
147448544|NCT01964352|531807890|FG000|Overall Study|Lost to Follow-up|1|||
147658197|NCT03654729|532572191|FG000|Overall Study|Non-compliance with study drug|0|||
147658198|NCT03654729|532572192|FG001|Overall Study|Non-compliance with study drug|1|||
147183156|NCT03386721|530834697|FG009|Overall Study|Withdrawal by Subject|1|||
147183157|NCT03386721|530834698|FG010|Overall Study|Withdrawal by Subject|3|||
147183158|NCT03386721|530834699|FG011|Overall Study|Withdrawal by Subject|2|||
147183159|NCT03386721|530834700|FG012|Overall Study|Withdrawal by Subject|3|||
147183160|NCT03386721|530834701|FG013|Overall Study|Withdrawal by Subject|0|||
147183161|NCT03386721|530834702|FG014|Overall Study|Withdrawal by Subject|0|||
147183162|NCT00700713|530834704|FG000|Overall Study|Protocol Violation|1|||
147183163|NCT00700713|530834705|FG001|Overall Study|Protocol Violation|0|||
147183164|NCT00700713|530834706|FG002|Overall Study|Protocol Violation|1|||
147183165|NCT00700713|530834704|FG000|Overall Study|Withdrawal by Subject|0|||
147183166|NCT00700713|530834705|FG001|Overall Study|Withdrawal by Subject|0|||
147183167|NCT00700713|530834706|FG002|Overall Study|Withdrawal by Subject|1|||
147183168|NCT00550953|530834707|FG000|Overall Study|Adverse Event|4|||
147183169|NCT00550953|530834708|FG001|Overall Study|Adverse Event|3|||
147183170|NCT00550953|530834707|FG000|Overall Study|Not able to visit the site|2|||
147183171|NCT00550953|530834708|FG001|Overall Study|Not able to visit the site|3|||
147183172|NCT03797586|530834709|FG000|Overall Study|Lost to Follow-up|3|||
147183173|NCT03797586|530834710|FG001|Overall Study|Lost to Follow-up|6|||
147183174|NCT03797586|530834709|FG000|Overall Study|Death|1|||
147183175|NCT03797586|530834710|FG001|Overall Study|Death|1|||
147183176|NCT03797586|530834709|FG000|Overall Study|Adverse Event|0|||
147183177|NCT03797586|530834710|FG001|Overall Study|Adverse Event|2|||
147183178|NCT04980612|530834711|FG000|Overall Study|Withdrawal by Subject|7|||
147183179|NCT04980612|530834712|FG001|Overall Study|Withdrawal by Subject|5|||
147183180|NCT01502228|530834715|FG000|Overall Study|Death|1|||
147183181|NCT05730387|530834716|FG000|Overall Study|Stillbirth|0|||
147183182|NCT05730387|530834717|FG001|Overall Study|Stillbirth|262|||
147183183|NCT05730387|530834716|FG000|Overall Study|Died during or after delivery|2|||
147183184|NCT05730387|530834717|FG001|Overall Study|Died during or after delivery|85|||
147183185|NCT05730387|530834716|FG000|Overall Study|Died after being admitted|0|||
147183186|NCT05730387|530834717|FG001|Overall Study|Died after being admitted|44|||
147183187|NCT05730387|530834716|FG000|Overall Study|Lost to Follow-up|69|||
147183188|NCT05730387|530834717|FG001|Overall Study|Lost to Follow-up|77|||
147183189|NCT02728089|530834718|FG000|Overall Study|Physician Decision|2|||
147183190|NCT02728089|530834718|FG000|Overall Study|Withdrawal by Subject|1|||
147183191|NCT01219985|530834719|FG000|Overall Study|Physician Decision|20|||
147183192|NCT00596752|530834720|FG000|Overall Study|Other Reason|44|||
147183193|NCT00596752|530834721|FG001|Overall Study|Other Reason|49|||
147183194|NCT00596752|530834720|FG000|Overall Study|Adverse Event|34|||
147183195|NCT00596752|530834721|FG001|Overall Study|Adverse Event|34|||
147183196|NCT00596752|530834720|FG000|Overall Study|Lost to Follow-up|22|||
147183197|NCT00596752|530834721|FG001|Overall Study|Lost to Follow-up|38|||
147183198|NCT00596752|530834720|FG000|Overall Study|Withdrawal by Subject|12|||
147183199|NCT00596752|530834721|FG001|Overall Study|Withdrawal by Subject|9|||
147183200|NCT00596752|530834720|FG000|Overall Study|Unsatisfactory Compliance|9|||
147183201|NCT00596752|530834721|FG001|Overall Study|Unsatisfactory Compliance|6|||
147183202|NCT00596752|530834720|FG000|Overall Study|Lack of Efficacy|4|||
147183203|NCT00596752|530834721|FG001|Overall Study|Lack of Efficacy|7|||
147183204|NCT00596752|530834720|FG000|Overall Study|Protocol Violation|1|||
147183205|NCT00596752|530834721|FG001|Overall Study|Protocol Violation|0|||
147183206|NCT04797780|530834722|FG000|Overall Study|Lost to Follow-up|1|||
147183207|NCT04797780|530834723|FG001|Overall Study|Lost to Follow-up|1|||
147183208|NCT04797780|530834722|FG000|Overall Study|Withdrawal by Subject|14|||
147183209|NCT04797780|530834723|FG001|Overall Study|Withdrawal by Subject|9|||
147183210|NCT04797780|530834722|FG000|Overall Study|Death|49|||
147183211|NCT04797780|530834723|FG001|Overall Study|Death|20|||
147183212|NCT02940496|530834724|FG000|Overall Study|Adverse Event|1|||
147183213|NCT02940496|530834725|FG001|Overall Study|Adverse Event|0|||
147183214|NCT02940496|530834724|FG000|Overall Study|Death|2|||
147183215|NCT02940496|530834725|FG001|Overall Study|Death|0|||
147183216|NCT02940496|530834724|FG000|Overall Study|Hospice Care|1|||
147183217|NCT02940496|530834725|FG001|Overall Study|Hospice Care|0|||
147183218|NCT02940496|530834724|FG000|Overall Study|No MRE Done|1|||
147183219|NCT02940496|530834725|FG001|Overall Study|No MRE Done|0|||
147183220|NCT02940496|530834724|FG000|Overall Study|MRE Failure|1|||
147183221|NCT02940496|530834725|FG001|Overall Study|MRE Failure|0|||
147183222|NCT02586727|530834726|FG000|Overall Study|Lost to Follow-up|1|||
147183223|NCT02586727|530834727|FG001|Overall Study|Lost to Follow-up|0|||
147183224|NCT04089761|530834732|FG000|"Run In Phase"|Not eligible to proceed to the treatment phase|14|||
147183225|NCT04089761|530834732|FG000|"Run In Phase"|Lost to Follow-up|1|||
147183226|NCT04089761|530834732|FG000|"Treatment Phase"|No evaluable data|5|||
147183227|NCT04089761|530834732|FG000|"Treatment Phase"|Lost to Follow-up|1|||
147183228|NCT02119663|530834733|FG000|Overall Study|Disease progression|26|||
147183229|NCT02119663|530834734|FG001|Overall Study|Disease progression|27|||
147327735|NCT02232178|531365474|FG001|Overall Study|surgical complication|0|||
147327736|NCT02232178|531365475|FG002|Overall Study|surgical complication|0|||
147327737|NCT01149681|531365476|FG000|Overall Study|Withdrawal by Subject|7|||
147327738|NCT01149681|531365476|FG000|Overall Study|Progressive disease|1|||
147327739|NCT01149681|531365476|FG000|Overall Study|Physician Decision|2|||
147327740|NCT01149681|531365476|FG000|Overall Study|adverse events nonrelated study drug|2|||
147183230|NCT02119663|530834733|FG000|Overall Study|Adverse Event|5|||
147183231|NCT02119663|530834734|FG001|Overall Study|Adverse Event|5|||
147183232|NCT02119663|530834733|FG000|Overall Study|Death|3|||
147183233|NCT02119663|530834734|FG001|Overall Study|Death|2|||
147183234|NCT02119663|530834733|FG000|Overall Study|Physician Decision|1|||
147183235|NCT02119663|530834734|FG001|Overall Study|Physician Decision|2|||
147183236|NCT02119663|530834733|FG000|Overall Study|Other unspecified|2|||
147183237|NCT02119663|530834734|FG001|Overall Study|Other unspecified|0|||
147183238|NCT02119663|530834733|FG000|Overall Study|Subject decision|0|||
147183239|NCT02119663|530834734|FG001|Overall Study|Subject decision|1|||
147183240|NCT02119663|530834733|FG000|Overall Study|Study Terminated by the Sponsor|3|||
147183241|NCT02119663|530834734|FG001|Overall Study|Study Terminated by the Sponsor|4|||
147183242|NCT00699660|530834735|FG000|Overall Study|Lost to Follow-up|4|||
147183243|NCT00699660|530834736|FG001|Overall Study|Lost to Follow-up|2|||
147183244|NCT00699660|530834735|FG000|Overall Study|missing reports and recording failures|10|||
147183245|NCT00699660|530834736|FG001|Overall Study|missing reports and recording failures|6|||
147183246|NCT00103740|530834741|FG000|Period 1 - Core|Adverse Event|1|||
147183247|NCT00103740|530834742|FG001|Period 1 - Core|Adverse Event|0|||
147183248|NCT00103740|530834741|FG000|Period 1 - Core|Protocol Violation|3|||
147183249|NCT00103740|530834742|FG001|Period 1 - Core|Protocol Violation|2|||
147183250|NCT00103740|530834741|FG000|Period 1 - Core|Patient withdrew consent|3|||
147183251|NCT00103740|530834742|FG001|Period 1 - Core|Patient withdrew consent|2|||
147183252|NCT00103740|530834741|FG000|Period 2 - Extended Observation Period|Lost to Follow-up|7|||
147183253|NCT00103740|530834742|FG001|Period 2 - Extended Observation Period|Lost to Follow-up|6|||
147183254|NCT00103740|530834741|FG000|Period 2 - Extended Observation Period|Withdrew for nonclinical reason|21|||
147183255|NCT00103740|530834742|FG001|Period 2 - Extended Observation Period|Withdrew for nonclinical reason|13|||
147183256|NCT00103740|530834741|FG000|Period 2 - Extended Observation Period|Clinical reason other than Paget's|5|||
147183257|NCT00103740|530834742|FG001|Period 2 - Extended Observation Period|Clinical reason other than Paget's|6|||
147183258|NCT00103740|530834741|FG000|Period 2 - Extended Observation Period|Death|6|||
147183259|NCT00103740|530834742|FG001|Period 2 - Extended Observation Period|Death|2|||
147183260|NCT00103740|530834741|FG000|Period 2 - Extended Observation Period|Amendment 6 informed consent not signed|30|||
147183261|NCT00103740|530834742|FG001|Period 2 - Extended Observation Period|Amendment 6 informed consent not signed|9|||
147183262|NCT03310723|530836588|FG000|Overall Study|Withdrawal by Subject|0|||
147183263|NCT03310723|530836589|FG001|Overall Study|Withdrawal by Subject|1|||
147183264|NCT03310723|530836588|FG000|Overall Study|Protocol Violation|0|||
147183265|NCT03310723|530836589|FG001|Overall Study|Protocol Violation|2|||
147183266|NCT02098746|530836590|FG000|Overall Study|Changes of Investigator|2|||
147183267|NCT02098746|530836590|FG000|Overall Study|Other Miscellaneous Reasons|1|||
147183268|NCT02098746|530836590|FG000|Overall Study|Enrolled 15 Days After the First Dose|1|||
147183269|NCT02098746|530836590|FG000|Overall Study|Data Not Available After Treatment|1|||
147183270|NCT00330759|530836591|FG000|Overall Study|Death|316|||
147183271|NCT00330759|530836592|FG001|Overall Study|Death|310|||
147183272|NCT00330759|530836591|FG000|Overall Study|Disease progression|104|||
147183273|NCT00330759|530836592|FG001|Overall Study|Disease progression|126|||
147183274|NCT00330759|530836591|FG000|Overall Study|Withdrawal by Subject|143|||
147183275|NCT00330759|530836592|FG001|Overall Study|Withdrawal by Subject|124|||
147183276|NCT00330759|530836591|FG000|Overall Study|Adverse Event|48|||
147183277|NCT00330759|530836592|FG001|Overall Study|Adverse Event|36|||
147183278|NCT00330759|530836591|FG000|Overall Study|Participant request|31|||
147183279|NCT00330759|530836592|FG001|Overall Study|Participant request|22|||
147183280|NCT00330759|530836591|FG000|Overall Study|Lost to Follow-up|16|||
147183281|NCT00330759|530836592|FG001|Overall Study|Lost to Follow-up|22|||
147183282|NCT00330759|530836591|FG000|Overall Study|Noncompliance|15|||
147183283|NCT00330759|530836592|FG001|Overall Study|Noncompliance|17|||
147183284|NCT00330759|530836591|FG000|Overall Study|Physician Decision|1|||
147183285|NCT00330759|530836592|FG001|Overall Study|Physician Decision|2|||
147183286|NCT00330759|530836591|FG000|Overall Study|Protocol deviation|0|||
147327741|NCT01167426|531365477|FG000|Overall Study|Lost to Follow-up|6|||
147593865|NCT03977701|532329039|FG003|Overall Study|COVID-19 pandemic|0|||
147593866|NCT03977701|532329040|FG004|Overall Study|COVID-19 pandemic|0|||
147593867|NCT03977701|532329041|FG005|Overall Study|COVID-19 pandemic|1|||
147183287|NCT00330759|530836592|FG001|Overall Study|Protocol deviation|2|||
147183288|NCT00330759|530836591|FG000|Overall Study|Ineligibility determined|2|||
147183289|NCT00330759|530836592|FG001|Overall Study|Ineligibility determined|1|||
147183290|NCT00330759|530836591|FG000|Overall Study|Other|36|||
147183291|NCT00330759|530836592|FG001|Overall Study|Other|44|||
147183292|NCT04070989|530836593|FG000|Overall Study|Death|1|||
147327742|NCT01167426|531365477|FG000|Overall Study|Protocol Violation|1|||
147327743|NCT01167426|531365477|FG000|Overall Study|Withdrawal by Subject|2|||
147327744|NCT01167426|531365477|FG000|Overall Study|Sponsor Decision|1|||
147658199|NCT03654729|532572193|FG002|Overall Study|Non-compliance with study drug|0|||
147658200|NCT03654729|532572191|FG000|Overall Study|Site terminated by Sponsor|1|||
147658201|NCT03654729|532572192|FG001|Overall Study|Site terminated by Sponsor|0|||
147658202|NCT03654729|532572193|FG002|Overall Study|Site terminated by Sponsor|0|||
147658203|NCT01919164|532572208|FG000|Overall Study|Adverse Event|6|||
147658204|NCT01919164|532572209|FG001|Overall Study|Adverse Event|4|||
147327745|NCT04176458|531365479|FG000|Overall Study|Covid 19|4|||
147658205|NCT01919164|532572210|FG002|Overall Study|Adverse Event|9|||
147658206|NCT01919164|532572211|FG003|Overall Study|Adverse Event|3|||
147658207|NCT01919164|532572212|FG004|Overall Study|Adverse Event|2|||
147658208|NCT01919164|532572208|FG000|Overall Study|Lost to Follow-up|2|||
147658209|NCT01919164|532572209|FG001|Overall Study|Lost to Follow-up|2|||
147658210|NCT01919164|532572210|FG002|Overall Study|Lost to Follow-up|2|||
147658211|NCT01919164|532572211|FG003|Overall Study|Lost to Follow-up|0|||
147658212|NCT01919164|532572212|FG004|Overall Study|Lost to Follow-up|4|||
147658213|NCT01919164|532572208|FG000|Overall Study|Death|1|||
147658214|NCT01919164|532572209|FG001|Overall Study|Death|0|||
147658215|NCT01919164|532572210|FG002|Overall Study|Death|0|||
147658216|NCT01919164|532572211|FG003|Overall Study|Death|0|||
147658217|NCT01919164|532572212|FG004|Overall Study|Death|0|||
147658218|NCT01919164|532572208|FG000|Overall Study|Protocol Violation|6|||
147658219|NCT01919164|532572209|FG001|Overall Study|Protocol Violation|0|||
147658220|NCT01919164|532572210|FG002|Overall Study|Protocol Violation|3|||
147658221|NCT01919164|532572211|FG003|Overall Study|Protocol Violation|2|||
147658222|NCT01919164|532572212|FG004|Overall Study|Protocol Violation|2|||
147658223|NCT01919164|532572208|FG000|Overall Study|Disease progression|2|||
147658224|NCT01919164|532572209|FG001|Overall Study|Disease progression|2|||
147658225|NCT01919164|532572210|FG002|Overall Study|Disease progression|1|||
147658226|NCT01919164|532572211|FG003|Overall Study|Disease progression|2|||
147658227|NCT01919164|532572212|FG004|Overall Study|Disease progression|1|||
147658228|NCT01919164|532572208|FG000|Overall Study|Withdrew consent|13|||
147658229|NCT01919164|532572209|FG001|Overall Study|Withdrew consent|13|||
147658230|NCT01919164|532572210|FG002|Overall Study|Withdrew consent|14|||
147658231|NCT01919164|532572211|FG003|Overall Study|Withdrew consent|14|||
147658232|NCT01919164|532572212|FG004|Overall Study|Withdrew consent|9|||
147658233|NCT01919164|532572208|FG000|Overall Study|Other Un-specified|13|||
147658234|NCT01919164|532572209|FG001|Overall Study|Other Un-specified|9|||
147327746|NCT02131324|531365480|FG000|Overall Study|Withdrawal by Subject|1|||
147327747|NCT02131324|531365481|FG001|Overall Study|Withdrawal by Subject|2|||
147327748|NCT02131324|531365480|FG000|Overall Study|Lost to Follow-up|1|||
147327749|NCT02131324|531365481|FG001|Overall Study|Lost to Follow-up|1|||
147327750|NCT00891618|531365482|FG000|Overall Study|Withdrawal by Subject|1|||
147327751|NCT04582877|531365483|FG000|Overall Study|Did not use device measurement|5|||
147327752|NCT04582877|531365483|FG000|Overall Study|No fractional flow reserve test results|2|||
147327753|NCT04582877|531365483|FG000|Overall Study|Protocol Violation|1|||
147327754|NCT02595398|531365486|FG000|Overall Study|Non-compliance|1|||
147327755|NCT02595398|531365487|FG001|Overall Study|Non-compliance|0|||
147327756|NCT02595398|531365486|FG000|Overall Study|Withdrawal by Subject|2|||
147327757|NCT02595398|531365487|FG001|Overall Study|Withdrawal by Subject|1|||
147327758|NCT02595398|531365486|FG000|Overall Study|Lost to Follow-up|1|||
147327759|NCT02595398|531365487|FG001|Overall Study|Lost to Follow-up|0|||
147327760|NCT03601507|531365488|FG000|Overall Study|Adverse Event|1|||
147327761|NCT01664104|531365489|FG000|Overall Study|Adverse Event|6|||
147327762|NCT01664104|531365489|FG000|Overall Study|Lack of Efficacy|2|||
147327763|NCT01664104|531365489|FG000|Overall Study|Withdrawal by Subject|1|||
147327764|NCT01664104|531365489|FG000|Overall Study|Lost to Follow-up|4|||
147327765|NCT01664104|531365489|FG000|Overall Study|Other|1|||
147327766|NCT01664104|531365489|FG000|Overall Study|Unknown: Reason Unrelated to TCZ|2|||
147327767|NCT03761784|531365493|FG000|Overall Study|Adverse Event|4|||
147327768|NCT03761784|531365494|FG001|Overall Study|Adverse Event|0|||
147658235|NCT01919164|532572210|FG002|Overall Study|Other Un-specified|8|||
147327769|NCT03761784|531365493|FG000|Overall Study|Lost to Follow-up|10|||
147327770|NCT03761784|531365494|FG001|Overall Study|Lost to Follow-up|7|||
147448545|NCT01964352|531807891|FG001|Overall Study|Lost to Follow-up|0|||
147658236|NCT01919164|532572211|FG003|Overall Study|Other Un-specified|7|||
147658237|NCT01919164|532572212|FG004|Overall Study|Other Un-specified|15|||
147327771|NCT03761784|531365493|FG000|Overall Study|Pregnancy|1|||
147327772|NCT03761784|531365494|FG001|Overall Study|Pregnancy|0|||
147327773|NCT03761784|531365493|FG000|Overall Study|Protocol Violation|2|||
147327774|NCT03761784|531365494|FG001|Overall Study|Protocol Violation|0|||
147327775|NCT03761784|531365493|FG000|Overall Study|Withdrawal by Parent or Guardian|4|||
147658238|NCT00588146|532572214|FG000|First Intervention (Baseline to 6 mo)|Adverse Event|4|||
147658239|NCT00588146|532572215|FG001|First Intervention (Baseline to 6 mo)|Adverse Event|3|||
147658240|NCT02100839|532572216|FG000|Multiple Ascending Dose|Adverse Event|2|||
147658241|NCT02100839|532572217|FG001|Multiple Ascending Dose|Adverse Event|0|||
147658242|NCT02100839|532572216|FG000|Multiple Ascending Dose|Withdrawal by Subject|2|||
147658243|NCT02100839|532572217|FG001|Multiple Ascending Dose|Withdrawal by Subject|0|||
147327776|NCT03761784|531365494|FG001|Overall Study|Withdrawal by Parent or Guardian|1|||
147448546|NCT01964352|531807892|FG002|Overall Study|Lost to Follow-up|0|||
147327777|NCT03761784|531365493|FG000|Overall Study|Withdrawal by Subject|9|||
147327778|NCT03761784|531365494|FG001|Overall Study|Withdrawal by Subject|4|||
147327779|NCT03761784|531365493|FG000|Overall Study|Physician Decision|1|||
147327780|NCT03761784|531365494|FG001|Overall Study|Physician Decision|0|||
147327781|NCT03761784|531365493|FG000|Overall Study|Other Than Specified|1|||
147327782|NCT03761784|531365494|FG001|Overall Study|Other Than Specified|0|||
147327783|NCT00586339|531365495|FG000|Overall Study|Withdrawal by Subject|1|||
147327784|NCT00586339|531365496|FG001|Overall Study|Withdrawal by Subject|3|||
147327785|NCT00586339|531365497|FG002|Overall Study|Withdrawal by Subject|1|||
147327786|NCT00586339|531365495|FG000|Overall Study|Migrated/moved from study area|3|||
147327787|NCT00586339|531365496|FG001|Overall Study|Migrated/moved from study area|2|||
147327788|NCT00586339|531365497|FG002|Overall Study|Migrated/moved from study area|4|||
147327789|NCT00586339|531365495|FG000|Overall Study|Lost to Follow-up|3|||
147327790|NCT00586339|531365496|FG001|Overall Study|Lost to Follow-up|2|||
147327791|NCT00586339|531365497|FG002|Overall Study|Lost to Follow-up|1|||
147327792|NCT01081145|531365498|FG000|Open-Label Phase|Lack of Efficacy|56|||
147327793|NCT01081145|531365499|FG001|Open-Label Phase|Lack of Efficacy|0|||
147327794|NCT01081145|531365498|FG000|Open-Label Phase|Response criteria not met|46|||
147327795|NCT01081145|531365499|FG001|Open-Label Phase|Response criteria not met|0|||
147327796|NCT01081145|531365498|FG000|Open-Label Phase|Adverse Event|42|||
147327797|NCT01081145|531365499|FG001|Open-Label Phase|Adverse Event|0|||
147327798|NCT01081145|531365498|FG000|Open-Label Phase|Withdrawal by Subject|41|||
147327799|NCT01081145|531365499|FG001|Open-Label Phase|Withdrawal by Subject|0|||
147327800|NCT01081145|531365498|FG000|Open-Label Phase|Other|12|||
147327801|NCT01081145|531365499|FG001|Open-Label Phase|Other|0|||
147327802|NCT01081145|531365498|FG000|Open-Label Phase|Lost to Follow-up|11|||
147327803|NCT01081145|531365499|FG001|Open-Label Phase|Lost to Follow-up|0|||
147327804|NCT01081145|531365498|FG000|Open-Label Phase|Protocol Violation|4|||
147327805|NCT01081145|531365499|FG001|Open-Label Phase|Protocol Violation|0|||
147327806|NCT01081145|531365498|FG000|Double-Blind Randomized-Withdrawal Phase|Adverse Event|3|||
147327807|NCT01081145|531365499|FG001|Double-Blind Randomized-Withdrawal Phase|Adverse Event|2|||
147327808|NCT01081145|531365498|FG000|Double-Blind Randomized-Withdrawal Phase|Protocol Violation|1|||
147327809|NCT01081145|531365499|FG001|Double-Blind Randomized-Withdrawal Phase|Protocol Violation|0|||
147327810|NCT01081145|531365498|FG000|Double-Blind Randomized-Withdrawal Phase|Withdrawal by Subject|10|||
147327811|NCT01081145|531365499|FG001|Double-Blind Randomized-Withdrawal Phase|Withdrawal by Subject|8|||
147327812|NCT01081145|531365498|FG000|Double-Blind Randomized-Withdrawal Phase|Lost to Follow-up|3|||
147327813|NCT01081145|531365499|FG001|Double-Blind Randomized-Withdrawal Phase|Lost to Follow-up|2|||
147327814|NCT01081145|531365498|FG000|Double-Blind Randomized-Withdrawal Phase|Lack of Efficacy|13|||
147327815|NCT01081145|531365499|FG001|Double-Blind Randomized-Withdrawal Phase|Lack of Efficacy|20|||
147327816|NCT01081145|531365498|FG000|Double-Blind Randomized-Withdrawal Phase|Treatment failure criteria met|47|||
147327817|NCT01081145|531365499|FG001|Double-Blind Randomized-Withdrawal Phase|Treatment failure criteria met|71|||
147327818|NCT01081145|531365498|FG000|Double-Blind Randomized-Withdrawal Phase|Other|4|||
147327819|NCT01081145|531365499|FG001|Double-Blind Randomized-Withdrawal Phase|Other|3|||
147327820|NCT03235349|531365504|FG000|Overall Study|Adverse Event|1|||
147327821|NCT03235349|531365504|FG000|Overall Study|Other|1|||
147327822|NCT03394027|531365505|FG000|Overall Study|Ineligible|3|||
147327823|NCT03394027|531365506|FG001|Overall Study|Ineligible|1|||
147327824|NCT03394027|531365507|FG002|Overall Study|Ineligible|3|||
147327825|NCT03394027|531365505|FG000|Overall Study|Participant declined to participate before treatment started|0|||
147327826|NCT03394027|531365506|FG001|Overall Study|Participant declined to participate before treatment started|0|||
147327827|NCT03394027|531365507|FG002|Overall Study|Participant declined to participate before treatment started|1|||
147327828|NCT04305912|531365517|FG000|First Intervention|COVID-19 Suspension|2|||
147183293|NCT04070989|530836594|FG001|Overall Study|Death|0|||
147183294|NCT04070989|530836595|FG002|Overall Study|Death|0|||
147183295|NCT04070989|530836593|FG000|Overall Study|Study Terminated by Sponsor|7|||
147183296|NCT04070989|530836594|FG001|Overall Study|Study Terminated by Sponsor|8|||
147183297|NCT04070989|530836595|FG002|Overall Study|Study Terminated by Sponsor|23|||
147183298|NCT04070989|530836593|FG000|Overall Study|Withdrawal by Subject|0|||
147183299|NCT04070989|530836594|FG001|Overall Study|Withdrawal by Subject|1|||
147183300|NCT04070989|530836595|FG002|Overall Study|Withdrawal by Subject|0|||
147183301|NCT04070989|530836593|FG000|Overall Study|Inclusion/Exclusion Criteria not met|2|||
147327829|NCT04305912|531365518|FG001|First Intervention|COVID-19 Suspension|0|||
147327830|NCT04305912|531365517|FG000|First Intervention|Withdrawal by Subject|0|||
147327831|NCT04305912|531365518|FG001|First Intervention|Withdrawal by Subject|1|||
147327832|NCT04305912|531365517|FG000|Second Intervention|Adverse Event|0|||
147327833|NCT04305912|531365518|FG001|Second Intervention|Adverse Event|1|||
147327834|NCT01268566|531365520|FG000|Overall Study|Lost to Follow-up|1|||
147327835|NCT01268566|531365520|FG000|Overall Study|Withdrawal by Subject|12|||
147327836|NCT01268566|531365520|FG000|Overall Study|Death|30|||
147327837|NCT02138916|531365525|FG000|Overall Study|eg., meds change, lack of efficacy, etc.|6|||
147327838|NCT02138916|531365526|FG001|Overall Study|eg., meds change, lack of efficacy, etc.|9|||
147327839|NCT02138916|531365527|FG002|Overall Study|eg., meds change, lack of efficacy, etc.|7|||
147658244|NCT00463801|532572222|FG000|Overall Study|Protocol Violation|1|||
147183302|NCT04070989|530836594|FG001|Overall Study|Inclusion/Exclusion Criteria not met|0|||
147183303|NCT04070989|530836595|FG002|Overall Study|Inclusion/Exclusion Criteria not met|1|||
147183304|NCT04070989|530836593|FG000|Overall Study|Other|1|||
147448547|NCT01964352|531807893|FG003|Overall Study|Lost to Follow-up|1|||
147448548|NCT01964352|531807890|FG000|Overall Study|Withdrawal by Subject|4|||
147183305|NCT04070989|530836594|FG001|Overall Study|Other|1|||
147327840|NCT02138916|531365525|FG000|Overall Study|Death|14|||
147327841|NCT02138916|531365526|FG001|Overall Study|Death|11|||
147327842|NCT02138916|531365527|FG002|Overall Study|Death|12|||
147327843|NCT02138916|531365525|FG000|Overall Study|Withdrawal by Subject|27|||
147327844|NCT02138916|531365526|FG001|Overall Study|Withdrawal by Subject|31|||
147327845|NCT02138916|531365527|FG002|Overall Study|Withdrawal by Subject|32|||
147327846|NCT02138916|531365525|FG000|Overall Study|Study specific withdrawal criteria|0|||
147327847|NCT02138916|531365526|FG001|Overall Study|Study specific withdrawal criteria|0|||
147327848|NCT02138916|531365527|FG002|Overall Study|Study specific withdrawal criteria|1|||
147327849|NCT02138916|531365525|FG000|Overall Study|incorrect enrolment|1|||
147327850|NCT02138916|531365526|FG001|Overall Study|incorrect enrolment|1|||
147327851|NCT02138916|531365527|FG002|Overall Study|incorrect enrolment|0|||
147327852|NCT02138916|531365525|FG000|Overall Study|Severe non-compliance|1|||
147327853|NCT02138916|531365526|FG001|Overall Study|Severe non-compliance|2|||
147327854|NCT02138916|531365527|FG002|Overall Study|Severe non-compliance|1|||
147327855|NCT02138916|531365525|FG000|Overall Study|Lost to Follow-up|4|||
147327856|NCT02138916|531365526|FG001|Overall Study|Lost to Follow-up|2|||
147327857|NCT02138916|531365527|FG002|Overall Study|Lost to Follow-up|3|||
147327858|NCT02138916|531365525|FG000|Overall Study|Adverse Event|4|||
147327859|NCT02138916|531365526|FG001|Overall Study|Adverse Event|4|||
147327860|NCT02138916|531365527|FG002|Overall Study|Adverse Event|3|||
147327861|NCT01348087|531365528|FG000|Overall Study|Unsatisfactory therapeutic effect|35|||
147183306|NCT04070989|530836595|FG002|Overall Study|Other|0|||
147183307|NCT04685798|530836614|FG000|Overall Study|Did not have standard of care FDG PET/CT|2|||
147183308|NCT04640311|530836615|FG000|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|1|||
147183309|NCT04640311|530836616|FG001|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
147183310|NCT04640311|530836617|FG002|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
147183311|NCT04640311|530836618|FG003|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
147183312|NCT04640311|530836619|FG004|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
147183313|NCT04640311|530836620|FG005|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
147183314|NCT04640311|530836621|FG006|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
147183315|NCT04640311|530836622|FG007|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
147183316|NCT04640311|530836623|FG008|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
147183317|NCT04640311|530836624|FG009|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
147183318|NCT04640311|530836625|FG010|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
147183319|NCT04640311|530836626|FG011|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
147183320|NCT04640311|530836627|FG012|Part A:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
147183321|NCT04640311|530836615|FG000|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
147183322|NCT04640311|530836616|FG001|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|1|||
147183323|NCT04640311|530836617|FG002|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
147183324|NCT04640311|530836618|FG003|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
147183325|NCT04640311|530836619|FG004|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
147183326|NCT04640311|530836620|FG005|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
147246709|NCT03129100|531072771|FG012|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
147246710|NCT03129100|531072772|FG013|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
147246711|NCT03129100|531072773|FG014|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
147246712|NCT03129100|531072774|FG015|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
147246713|NCT03129100|531072775|FG016|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
147246714|NCT03129100|531072776|FG017|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
147246715|NCT03129100|531072777|FG018|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
147246716|NCT03129100|531072778|FG019|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
147246717|NCT03129100|531072779|FG020|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
147246718|NCT03129100|531072780|FG021|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
147246719|NCT03129100|531072781|FG022|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
147246720|NCT03129100|531072782|FG023|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
147246721|NCT03129100|531072783|FG024|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
147327862|NCT01348087|531365528|FG000|Overall Study|Administrative problems|79|||
147327863|NCT01348087|531365528|FG000|Overall Study|protocol deviation|1|||
147327864|NCT01348087|531365528|FG000|Overall Study|Lost to Follow-up|1|||
147327865|NCT01348087|531365528|FG000|Overall Study|Subject withdrew consent|7|||
147327866|NCT01348087|531365528|FG000|Overall Study|Adverse Event|25|||
147448549|NCT01964352|531807891|FG001|Overall Study|Withdrawal by Subject|2|||
147448550|NCT01964352|531807892|FG002|Overall Study|Withdrawal by Subject|1|||
147246722|NCT03129100|531072784|FG025|Period 2 (Retreatment Extension Period)|Withdrawal by Subject|0|||
147246723|NCT03129100|531072759|FG000|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
147246724|NCT03129100|531072760|FG001|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
147246725|NCT03129100|531072761|FG002|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
147246726|NCT03129100|531072762|FG003|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
147246727|NCT03129100|531072763|FG004|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
147246728|NCT03129100|531072764|FG005|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
147246729|NCT03129100|531072765|FG006|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
147246730|NCT03129100|531072766|FG007|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
147246731|NCT03129100|531072767|FG008|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
147246732|NCT03129100|531072768|FG009|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
147246733|NCT03129100|531072769|FG010|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
147246734|NCT03129100|531072770|FG011|Period3-Long-Term Extension Period A & B|Adverse Event|6|||
147246735|NCT03129100|531072771|FG012|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
147246736|NCT03129100|531072772|FG013|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
147327867|NCT00117988|531365530|FG000|Overall Study|Death|3|||
147327868|NCT00117988|531365530|FG000|Overall Study|Adverse Event|1|||
147327869|NCT03822351|531365531|FG000|Overall Study|Death|27|||
147327870|NCT03822351|531365532|FG001|Overall Study|Death|23|||
147327871|NCT03822351|531365533|FG002|Overall Study|Death|24|||
147327872|NCT03822351|531365531|FG000|Overall Study|Lost to Follow-up|6|||
147327873|NCT03822351|531365532|FG001|Overall Study|Lost to Follow-up|2|||
147327874|NCT03822351|531365533|FG002|Overall Study|Lost to Follow-up|1|||
147327875|NCT03822351|531365531|FG000|Overall Study|Withdrawal by Subject|10|||
147327876|NCT03822351|531365532|FG001|Overall Study|Withdrawal by Subject|4|||
147327877|NCT03822351|531365533|FG002|Overall Study|Withdrawal by Subject|6|||
147327878|NCT03822351|531365531|FG000|Overall Study|Progressive Disease|2|||
147327879|NCT03822351|531365532|FG001|Overall Study|Progressive Disease|1|||
147327880|NCT03822351|531365533|FG002|Overall Study|Progressive Disease|0|||
147327881|NCT03822351|531365531|FG000|Overall Study|Not Treated|1|||
147327882|NCT03822351|531365532|FG001|Overall Study|Not Treated|1|||
147327883|NCT03822351|531365533|FG002|Overall Study|Not Treated|1|||
147327884|NCT02081391|531365542|FG000|12-hour Treatment|Withdrawal by Subject|3|||
147327885|NCT02081391|531365543|FG001|12-hour Treatment|Withdrawal by Subject|2|||
147327886|NCT02081391|531365544|FG002|12-hour Treatment|Withdrawal by Subject|0|||
147327887|NCT02081391|531365545|FG003|12-hour Treatment|Withdrawal by Subject|0|||
147327888|NCT02081391|531365542|FG000|12-hour Treatment|Physician Decision|4|||
147327889|NCT02081391|531365543|FG001|12-hour Treatment|Physician Decision|1|||
147327890|NCT02081391|531365544|FG002|12-hour Treatment|Physician Decision|0|||
147327891|NCT02081391|531365545|FG003|12-hour Treatment|Physician Decision|0|||
147327892|NCT02081391|531365542|FG000|12-hour Treatment|Lack of Efficacy|3|||
147327893|NCT02081391|531365543|FG001|12-hour Treatment|Lack of Efficacy|0|||
147327894|NCT02081391|531365544|FG002|12-hour Treatment|Lack of Efficacy|0|||
147327895|NCT02081391|531365545|FG003|12-hour Treatment|Lack of Efficacy|0|||
147327896|NCT02081391|531365542|FG000|12-hour Treatment|Adverse Event|4|||
147327897|NCT02081391|531365543|FG001|12-hour Treatment|Adverse Event|2|||
147327898|NCT02081391|531365544|FG002|12-hour Treatment|Adverse Event|0|||
147327899|NCT02081391|531365545|FG003|12-hour Treatment|Adverse Event|0|||
147327900|NCT02081391|531365542|FG000|12-hour Treatment|Recovery (opioid no longer needed)|2|||
147246737|NCT03129100|531072773|FG014|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
147246738|NCT03129100|531072774|FG015|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
147246739|NCT03129100|531072775|FG016|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
147246740|NCT03129100|531072776|FG017|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
147327901|NCT02081391|531365543|FG001|12-hour Treatment|Recovery (opioid no longer needed)|0|||
147327902|NCT02081391|531365544|FG002|12-hour Treatment|Recovery (opioid no longer needed)|1|||
147327903|NCT02081391|531365545|FG003|12-hour Treatment|Recovery (opioid no longer needed)|0|||
147327904|NCT02081391|531365542|FG000|12-hour Treatment|Further reasons|2|||
147327905|NCT02081391|531365543|FG001|12-hour Treatment|Further reasons|1|||
147327906|NCT02081391|531365544|FG002|12-hour Treatment|Further reasons|0|||
147327907|NCT02081391|531365545|FG003|12-hour Treatment|Further reasons|0|||
147327908|NCT02081391|531365542|FG000|24-hour Treatment and Trial Completion|Physician Decision|10|||
147327909|NCT02081391|531365543|FG001|24-hour Treatment and Trial Completion|Physician Decision|5|||
147327910|NCT02081391|531365544|FG002|24-hour Treatment and Trial Completion|Physician Decision|0|||
147327911|NCT02081391|531365545|FG003|24-hour Treatment and Trial Completion|Physician Decision|0|||
147327912|NCT02081391|531365542|FG000|24-hour Treatment and Trial Completion|Lack of Efficacy|1|||
147327913|NCT02081391|531365543|FG001|24-hour Treatment and Trial Completion|Lack of Efficacy|3|||
147327914|NCT02081391|531365544|FG002|24-hour Treatment and Trial Completion|Lack of Efficacy|0|||
147327915|NCT02081391|531365545|FG003|24-hour Treatment and Trial Completion|Lack of Efficacy|0|||
147327916|NCT02081391|531365542|FG000|24-hour Treatment and Trial Completion|Adverse Event|1|||
147327917|NCT02081391|531365543|FG001|24-hour Treatment and Trial Completion|Adverse Event|0|||
147327918|NCT02081391|531365544|FG002|24-hour Treatment and Trial Completion|Adverse Event|0|||
147327919|NCT02081391|531365545|FG003|24-hour Treatment and Trial Completion|Adverse Event|0|||
147327920|NCT02081391|531365542|FG000|24-hour Treatment and Trial Completion|Recovery (opioid no longer needed)|11|||
147327921|NCT02081391|531365543|FG001|24-hour Treatment and Trial Completion|Recovery (opioid no longer needed)|5|||
147327922|NCT02081391|531365544|FG002|24-hour Treatment and Trial Completion|Recovery (opioid no longer needed)|1|||
147327923|NCT02081391|531365545|FG003|24-hour Treatment and Trial Completion|Recovery (opioid no longer needed)|0|||
147327924|NCT02081391|531365542|FG000|24-hour Treatment and Trial Completion|Technical Problems|1|||
147327925|NCT02081391|531365543|FG001|24-hour Treatment and Trial Completion|Technical Problems|1|||
147246741|NCT03129100|531072777|FG018|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
147327926|NCT02081391|531365544|FG002|24-hour Treatment and Trial Completion|Technical Problems|0|||
147327927|NCT02081391|531365545|FG003|24-hour Treatment and Trial Completion|Technical Problems|0|||
147327928|NCT02081391|531365542|FG000|24-hour Treatment and Trial Completion|Further reasons|3|||
147327929|NCT02081391|531365543|FG001|24-hour Treatment and Trial Completion|Further reasons|4|||
147327930|NCT02081391|531365544|FG002|24-hour Treatment and Trial Completion|Further reasons|0|||
147327931|NCT02081391|531365545|FG003|24-hour Treatment and Trial Completion|Further reasons|0|||
147327932|NCT01458275|531365546|FG000|Overall Study|Adverse Event|3|||
147327933|NCT01458275|531365547|FG001|Overall Study|Adverse Event|4|||
147327934|NCT01458275|531365548|FG002|Overall Study|Adverse Event|1|||
147327935|NCT01458275|531365546|FG000|Overall Study|Lost to Follow-up|3|||
147327936|NCT01458275|531365547|FG001|Overall Study|Lost to Follow-up|2|||
147327937|NCT01458275|531365548|FG002|Overall Study|Lost to Follow-up|5|||
147327938|NCT01458275|531365546|FG000|Overall Study|Protocol Violation|5|||
147327939|NCT01458275|531365547|FG001|Overall Study|Protocol Violation|5|||
147327940|NCT01458275|531365548|FG002|Overall Study|Protocol Violation|2|||
147327941|NCT01458275|531365546|FG000|Overall Study|Withdrawal by Subject|3|||
147327942|NCT01458275|531365547|FG001|Overall Study|Withdrawal by Subject|2|||
147327943|NCT01458275|531365548|FG002|Overall Study|Withdrawal by Subject|1|||
147327944|NCT01729871|531365549|FG000|Overall Study|Adverse Event|7|||
147327945|NCT01729871|531365550|FG001|Overall Study|Adverse Event|7|||
147246742|NCT03129100|531072778|FG019|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
147246743|NCT03129100|531072779|FG020|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
147246744|NCT03129100|531072780|FG021|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
147246745|NCT03129100|531072781|FG022|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
147246746|NCT03129100|531072782|FG023|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
147246747|NCT03129100|531072783|FG024|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
147246748|NCT03129100|531072784|FG025|Period3-Long-Term Extension Period A & B|Adverse Event|0|||
147246749|NCT03129100|531072759|FG000|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
147246750|NCT03129100|531072760|FG001|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
147246751|NCT03129100|531072761|FG002|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
147246752|NCT03129100|531072762|FG003|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
147246753|NCT03129100|531072763|FG004|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
147246754|NCT03129100|531072764|FG005|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
147246755|NCT03129100|531072765|FG006|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
147246756|NCT03129100|531072766|FG007|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
147246757|NCT03129100|531072767|FG008|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
147246758|NCT03129100|531072768|FG009|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
147246759|NCT03129100|531072769|FG010|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
147246760|NCT03129100|531072770|FG011|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|12|||
147246761|NCT03129100|531072771|FG012|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|7|||
147246762|NCT03129100|531072772|FG013|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|4|||
147246763|NCT03129100|531072773|FG014|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|2|||
147246764|NCT03129100|531072774|FG015|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
147246765|NCT03129100|531072775|FG016|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
147246766|NCT03129100|531072776|FG017|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
147246767|NCT03129100|531072777|FG018|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
147246768|NCT03129100|531072778|FG019|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
147246769|NCT03129100|531072779|FG020|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
147246770|NCT03129100|531072780|FG021|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
147246771|NCT03129100|531072781|FG022|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
147246772|NCT03129100|531072782|FG023|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
147246773|NCT03129100|531072783|FG024|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
147246774|NCT03129100|531072784|FG025|Period3-Long-Term Extension Period A & B|Withdrawal by Subject|0|||
147246775|NCT03129100|531072759|FG000|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
147246776|NCT03129100|531072760|FG001|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
147327946|NCT01729871|531365549|FG000|Overall Study|Death|0|||
147327947|NCT01729871|531365550|FG001|Overall Study|Death|1|||
147327948|NCT01729871|531365549|FG000|Overall Study|Lack of Efficacy|0|||
147327949|NCT01729871|531365550|FG001|Overall Study|Lack of Efficacy|1|||
147327950|NCT01729871|531365549|FG000|Overall Study|Physician Decision|0|||
147183327|NCT04640311|530836621|FG006|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
147327951|NCT01729871|531365550|FG001|Overall Study|Physician Decision|2|||
147327952|NCT01729871|531365549|FG000|Overall Study|Protocol Violation|1|||
147327953|NCT01729871|531365550|FG001|Overall Study|Protocol Violation|0|||
147327954|NCT01729871|531365549|FG000|Overall Study|Withdrawal by Subject|0|||
147327955|NCT01729871|531365550|FG001|Overall Study|Withdrawal by Subject|3|||
147327956|NCT01729871|531365549|FG000|Overall Study|Other|4|||
147327957|NCT01729871|531365550|FG001|Overall Study|Other|9|||
147327958|NCT03971357|531365551|FG000|Overall Study|Lack of Efficacy|0|||
147327959|NCT03971357|531365552|FG001|Overall Study|Lack of Efficacy|1|||
147327960|NCT01555762|531365553|FG000|Overall Study|No information on Bevacizumab intake|11|||
147327961|NCT01555762|531365553|FG000|Overall Study|Missing start date of infusion|8|||
147327962|NCT01555762|531365553|FG000|Overall Study|75 years old or more ticked No|1|||
147327963|NCT01555762|531365553|FG000|Overall Study|Treatment with Bevacizumab ticked No|24|||
147327964|NCT01555762|531365553|FG000|Overall Study|Death linked to progression of disease|165|||
147327965|NCT01555762|531365553|FG000|Overall Study|Lost follow-up/moved house/changed team|35|||
147327966|NCT01555762|531365553|FG000|Overall Study|Investigator's decision|10|||
147327967|NCT01555762|531365553|FG000|Overall Study|Participant not wishing to continue|5|||
147327968|NCT01555762|531365553|FG000|Overall Study|Missing data|1|||
147327969|NCT01555762|531365553|FG000|Overall Study|Death linked to an adverse event|14|||
147327970|NCT01333514|531365554|FG000|Overall Study|Withdrawal by Subject|1|||
147327971|NCT01333514|531365555|FG001|Overall Study|Withdrawal by Subject|0|||
147327972|NCT00836810|531365558|FG000|Overall Study|New diagnosis|1|||
147327973|NCT00836810|531365559|FG001|Overall Study|New diagnosis|0|||
147327974|NCT00819910|531365560|FG000|Overall Study|Adverse Event|0|||
147327975|NCT00819910|531365561|FG001|Overall Study|Adverse Event|0|||
147327976|NCT00819910|531365562|FG002|Overall Study|Adverse Event|2|||
147327977|NCT00819910|531365563|FG003|Overall Study|Adverse Event|1|||
147327978|NCT00819910|531365560|FG000|Overall Study|Withdrawal by Subject|1|||
147327979|NCT00819910|531365561|FG001|Overall Study|Withdrawal by Subject|1|||
147327980|NCT00819910|531365562|FG002|Overall Study|Withdrawal by Subject|1|||
147327981|NCT00819910|531365563|FG003|Overall Study|Withdrawal by Subject|0|||
147327982|NCT00819910|531365560|FG000|Overall Study|Lost to Follow-up|1|||
147327983|NCT00819910|531365561|FG001|Overall Study|Lost to Follow-up|0|||
147327984|NCT00819910|531365562|FG002|Overall Study|Lost to Follow-up|0|||
147327985|NCT00819910|531365563|FG003|Overall Study|Lost to Follow-up|0|||
147327986|NCT00871429|531365565|FG000|Overall Study|Lost to Follow-up|6|||
147327987|NCT00871429|531365565|FG000|Overall Study|Withdrawal by Subject|17|||
147327988|NCT00871429|531365565|FG000|Overall Study|Questionnaire not completed|1|||
147327989|NCT03102242|531365566|FG000|Overall Study|Adverse Event|2|||
147327990|NCT01137292|531365567|FG000|Overall Study|Death|30|||
147327991|NCT01137292|531365567|FG000|Overall Study|Adverse Event|3|||
147327992|NCT01137292|531365567|FG000|Overall Study|Lack of Efficacy|13|||
147327993|NCT01137292|531365567|FG000|Overall Study|Lost to Follow-up|1|||
147327994|NCT01137292|531365567|FG000|Overall Study|Other|7|||
147327995|NCT01311713|531365572|FG000|Overall Study|Death|0|||
147327996|NCT01311713|531365573|FG001|Overall Study|Death|0|||
147327997|NCT01311713|531365574|FG002|Overall Study|Death|1|||
147327998|NCT01311713|531365575|FG003|Overall Study|Death|1|||
147327999|NCT01311713|531365576|FG004|Overall Study|Death|0|||
147328000|NCT01311713|531365577|FG005|Overall Study|Death|1|||
147328001|NCT01311713|531365578|FG006|Overall Study|Death|0|||
147328002|NCT01311713|531365572|FG000|Overall Study|Adverse Event|0|||
147328003|NCT01311713|531365573|FG001|Overall Study|Adverse Event|1|||
147328004|NCT01311713|531365574|FG002|Overall Study|Adverse Event|0|||
147328005|NCT01311713|531365575|FG003|Overall Study|Adverse Event|2|||
147328006|NCT01311713|531365576|FG004|Overall Study|Adverse Event|0|||
147328007|NCT01311713|531365577|FG005|Overall Study|Adverse Event|0|||
147328008|NCT01311713|531365578|FG006|Overall Study|Adverse Event|2|||
147328009|NCT01311713|531365572|FG000|Overall Study|Withdrawal by Subject|0|||
147328010|NCT01311713|531365573|FG001|Overall Study|Withdrawal by Subject|1|||
147328011|NCT01311713|531365574|FG002|Overall Study|Withdrawal by Subject|1|||
147328012|NCT01311713|531365575|FG003|Overall Study|Withdrawal by Subject|0|||
147328013|NCT01311713|531365576|FG004|Overall Study|Withdrawal by Subject|0|||
147328014|NCT01311713|531365577|FG005|Overall Study|Withdrawal by Subject|1|||
147328015|NCT01311713|531365578|FG006|Overall Study|Withdrawal by Subject|2|||
147183328|NCT04640311|530836622|FG007|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
147328016|NCT01311713|531365572|FG000|Overall Study|Disease progression|3|||
147328017|NCT01311713|531365573|FG001|Overall Study|Disease progression|4|||
147328018|NCT01311713|531365574|FG002|Overall Study|Disease progression|3|||
147328019|NCT01311713|531365575|FG003|Overall Study|Disease progression|2|||
147448551|NCT01964352|531807893|FG003|Overall Study|Withdrawal by Subject|0|||
147328020|NCT01311713|531365576|FG004|Overall Study|Disease progression|4|||
147328021|NCT01311713|531365577|FG005|Overall Study|Disease progression|4|||
147328022|NCT01311713|531365578|FG006|Overall Study|Disease progression|5|||
147328023|NCT01311713|531365572|FG000|Overall Study|Lost to Follow-up|0|||
147328024|NCT01311713|531365573|FG001|Overall Study|Lost to Follow-up|0|||
147593868|NCT03977701|532329042|FG006|Overall Study|COVID-19 pandemic|0|||
147328025|NCT01311713|531365574|FG002|Overall Study|Lost to Follow-up|1|||
147328026|NCT01311713|531365575|FG003|Overall Study|Lost to Follow-up|0|||
147328027|NCT01311713|531365576|FG004|Overall Study|Lost to Follow-up|0|||
147328028|NCT01311713|531365577|FG005|Overall Study|Lost to Follow-up|0|||
147328029|NCT01311713|531365578|FG006|Overall Study|Lost to Follow-up|0|||
147328030|NCT01311713|531365572|FG000|Overall Study|Stopped taking study medication|0|||
147328031|NCT01311713|531365573|FG001|Overall Study|Stopped taking study medication|0|||
147328032|NCT01311713|531365574|FG002|Overall Study|Stopped taking study medication|0|||
147328033|NCT01311713|531365575|FG003|Overall Study|Stopped taking study medication|1|||
147328034|NCT01311713|531365576|FG004|Overall Study|Stopped taking study medication|1|||
147328035|NCT01311713|531365577|FG005|Overall Study|Stopped taking study medication|0|||
147658245|NCT00463801|532572222|FG000|Overall Study|Lack of Efficacy|2|||
147658246|NCT00463801|532572222|FG000|Overall Study|Adverse Event|4|||
147658247|NCT00463801|532572222|FG000|Overall Study|Lost to Follow-up|5|||
147658248|NCT00463801|532572222|FG000|Overall Study|No longer require therapy|1|||
147658249|NCT03272347|532572223|FG000|Overall Study|Death|0|||
147658250|NCT03272347|532572224|FG001|Overall Study|Death|0|||
147328036|NCT01311713|531365578|FG006|Overall Study|Stopped taking study medication|0|||
147328037|NCT01311713|531365572|FG000|Overall Study|Enrolled but not treated|0|||
147328038|NCT01311713|531365573|FG001|Overall Study|Enrolled but not treated|0|||
147328039|NCT01311713|531365574|FG002|Overall Study|Enrolled but not treated|1|||
147658251|NCT03272347|532572225|FG002|Overall Study|Death|0|||
147183329|NCT04640311|530836623|FG008|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
147328040|NCT01311713|531365575|FG003|Overall Study|Enrolled but not treated|0|||
147328041|NCT01311713|531365576|FG004|Overall Study|Enrolled but not treated|0|||
147328042|NCT01311713|531365577|FG005|Overall Study|Enrolled but not treated|0|||
147328043|NCT01311713|531365578|FG006|Overall Study|Enrolled but not treated|0|||
147328044|NCT01311713|531365572|FG000|Overall Study|Other than specified|0|||
147328045|NCT01311713|531365573|FG001|Overall Study|Other than specified|1|||
147328046|NCT01311713|531365574|FG002|Overall Study|Other than specified|2|||
147328047|NCT01311713|531365575|FG003|Overall Study|Other than specified|0|||
147328048|NCT01311713|531365576|FG004|Overall Study|Other than specified|0|||
147328049|NCT01311713|531365577|FG005|Overall Study|Other than specified|0|||
147328050|NCT01311713|531365578|FG006|Overall Study|Other than specified|0|||
147328051|NCT01772719|531365581|FG000|Overall Study|Withdrawal by Subject|3|||
147328052|NCT01772719|531365581|FG000|Overall Study|Adverse Event|2|||
147328053|NCT01772719|531365581|FG000|Overall Study|Protocol Violation|1|||
147328054|NCT01772719|531365581|FG000|Overall Study|Lost to Follow-up|1|||
147328055|NCT00477412|531365582|FG000|Overall Study|Death|0|||
147658252|NCT03272347|532572226|FG003|Overall Study|Death|1|||
147183330|NCT04640311|530836624|FG009|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
147183331|NCT04640311|530836625|FG010|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
147183332|NCT04640311|530836626|FG011|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
147183333|NCT04640311|530836627|FG012|Part A:Treatment Period 1 (Up to 2 Days)|Protocol Violation|0|||
147183334|NCT04640311|530836615|FG000|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
147183335|NCT04640311|530836616|FG001|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|1|||
147183336|NCT04640311|530836617|FG002|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
147183337|NCT04640311|530836618|FG003|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
147183338|NCT04640311|530836619|FG004|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
147183339|NCT04640311|530836620|FG005|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
147183340|NCT04640311|530836621|FG006|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
147183341|NCT04640311|530836622|FG007|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
147183342|NCT04640311|530836623|FG008|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
147183343|NCT04640311|530836624|FG009|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
147183344|NCT04640311|530836625|FG010|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
147183345|NCT04640311|530836626|FG011|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
147183346|NCT04640311|530836627|FG012|Part A:Treatment Period 1 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
147328056|NCT00477412|531365583|FG001|Overall Study|Death|0|||
147328057|NCT00477412|531365584|FG002|Overall Study|Death|0|||
147328058|NCT00477412|531365585|FG003|Overall Study|Death|4|||
147328059|NCT00477412|531365582|FG000|Overall Study|Lost to Follow-up|0|||
147328060|NCT00477412|531365583|FG001|Overall Study|Lost to Follow-up|0|||
147328061|NCT00477412|531365584|FG002|Overall Study|Lost to Follow-up|0|||
147328062|NCT00477412|531365585|FG003|Overall Study|Lost to Follow-up|1|||
147328063|NCT00477412|531365582|FG000|Overall Study|Withdrawal by Subject|0|||
147658253|NCT03272347|532572223|FG000|Overall Study|Lost to Follow-up|1|||
147658254|NCT03272347|532572224|FG001|Overall Study|Lost to Follow-up|3|||
147328064|NCT00477412|531365583|FG001|Overall Study|Withdrawal by Subject|0|||
147328065|NCT00477412|531365584|FG002|Overall Study|Withdrawal by Subject|0|||
147328066|NCT00477412|531365585|FG003|Overall Study|Withdrawal by Subject|2|||
147328067|NCT00477412|531365582|FG000|Overall Study|Second Malignancy|0|||
147328068|NCT00477412|531365583|FG001|Overall Study|Second Malignancy|0|||
147328069|NCT00477412|531365584|FG002|Overall Study|Second Malignancy|0|||
147328070|NCT00477412|531365585|FG003|Overall Study|Second Malignancy|1|||
147328071|NCT00477412|531365582|FG000|Overall Study|Adverse Event|1|||
147328072|NCT00477412|531365583|FG001|Overall Study|Adverse Event|0|||
147328073|NCT00477412|531365584|FG002|Overall Study|Adverse Event|1|||
147328074|NCT00477412|531365585|FG003|Overall Study|Adverse Event|0|||
147328075|NCT02931396|531365587|FG000|Overall Study|Lost to Follow-up|3|||
147328076|NCT02931396|531365588|FG001|Overall Study|Lost to Follow-up|0|||
147328077|NCT02931396|531365587|FG000|Overall Study|Withdrawal by Subject|2|||
147328078|NCT02931396|531365588|FG001|Overall Study|Withdrawal by Subject|0|||
147328079|NCT05460663|531365589|FG000|Overall Study|Withdrawal by Subject|2|||
147183347|NCT04640311|530836615|FG000|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|3|||
147183348|NCT04640311|530836616|FG001|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|5|||
147183349|NCT04640311|530836617|FG002|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|6|||
147183350|NCT04640311|530836618|FG003|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
147183351|NCT04640311|530836619|FG004|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
147183352|NCT04640311|530836620|FG005|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
147183353|NCT04640311|530836621|FG006|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
147183354|NCT04640311|530836622|FG007|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
147183355|NCT04640311|530836623|FG008|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
147183356|NCT04640311|530836624|FG009|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
147183357|NCT04640311|530836625|FG010|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
147183358|NCT04640311|530836626|FG011|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
147183359|NCT04640311|530836627|FG012|Part A:Treatment Period 2 (Up to 2 Days)|Withdrawn by sponsor due to impact of inclement weather events|0|||
147183360|NCT04640311|530836615|FG000|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
147183361|NCT04640311|530836616|FG001|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
147183362|NCT04640311|530836617|FG002|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|2|||
147183363|NCT04640311|530836618|FG003|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
147183364|NCT04640311|530836619|FG004|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
147183365|NCT04640311|530836620|FG005|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
147183366|NCT04640311|530836621|FG006|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
147183367|NCT04640311|530836622|FG007|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
147183368|NCT04640311|530836623|FG008|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
147183369|NCT04640311|530836624|FG009|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
147183370|NCT04640311|530836625|FG010|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
147183371|NCT04640311|530836626|FG011|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
147246777|NCT03129100|531072761|FG002|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
147246778|NCT03129100|531072762|FG003|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
147246779|NCT03129100|531072763|FG004|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
147246780|NCT03129100|531072764|FG005|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
147246781|NCT03129100|531072765|FG006|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
147246782|NCT03129100|531072766|FG007|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
147246783|NCT03129100|531072767|FG008|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
147246784|NCT03129100|531072768|FG009|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
147246785|NCT03129100|531072769|FG010|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
147246786|NCT03129100|531072770|FG011|Period3-Long-Term Extension Period A & B|Lost to Follow-up|1|||
147246787|NCT03129100|531072771|FG012|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
147246788|NCT03129100|531072772|FG013|Period3-Long-Term Extension Period A & B|Lost to Follow-up|1|||
147246789|NCT03129100|531072773|FG014|Period3-Long-Term Extension Period A & B|Lost to Follow-up|1|||
147246790|NCT03129100|531072774|FG015|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
147246791|NCT03129100|531072775|FG016|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
147246792|NCT03129100|531072776|FG017|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
147246793|NCT03129100|531072777|FG018|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
147328080|NCT05460663|531365590|FG001|Overall Study|Withdrawal by Subject|5|||
147328081|NCT03068468|531367916|FG000|Placebo-Controlled Period|Randomized but not Treated|1|||
147328082|NCT03068468|531367917|FG001|Placebo-Controlled Period|Randomized but not Treated|3|||
147328083|NCT03068468|531367918|FG002|Placebo-Controlled Period|Randomized but not Treated|0|||
147328084|NCT03068468|531367919|FG003|Placebo-Controlled Period|Randomized but not Treated|0|||
147183372|NCT04640311|530836627|FG012|Part A:Treatment Period 2 (Up to 2 Days)|Adverse Event|0|||
147183373|NCT04640311|530836615|FG000|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
147183374|NCT04640311|530836616|FG001|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
147183375|NCT04640311|530836617|FG002|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
147183376|NCT04640311|530836618|FG003|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|1|||
147183377|NCT04640311|530836619|FG004|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
147183378|NCT04640311|530836620|FG005|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
147183379|NCT04640311|530836621|FG006|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|1|||
147183380|NCT04640311|530836622|FG007|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
147183381|NCT04640311|530836623|FG008|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
147183382|NCT04640311|530836624|FG009|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
147183383|NCT04640311|530836625|FG010|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
147183384|NCT04640311|530836626|FG011|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
147183385|NCT04640311|530836627|FG012|Part B:Treatment Period 1 (Up to 2 Days)|Withdrawal by Subject|0|||
147183386|NCT04640311|530836615|FG000|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
147183387|NCT04640311|530836616|FG001|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
147183388|NCT04640311|530836617|FG002|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
147183389|NCT04640311|530836618|FG003|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
147183390|NCT04640311|530836619|FG004|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
147183391|NCT04640311|530836620|FG005|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|1|||
147183392|NCT04640311|530836621|FG006|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
147183393|NCT04640311|530836622|FG007|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
147183394|NCT04640311|530836623|FG008|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|2|||
147183395|NCT04640311|530836624|FG009|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
147183396|NCT04640311|530836625|FG010|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
147183397|NCT04640311|530836626|FG011|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
147183398|NCT04640311|530836627|FG012|Part B:Treatment Period 1 (Up to 2 Days)|Physician Decision|0|||
147183399|NCT04640311|530836615|FG000|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
147183400|NCT04640311|530836616|FG001|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
147183401|NCT04640311|530836617|FG002|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
147183402|NCT04640311|530836618|FG003|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
147183403|NCT04640311|530836619|FG004|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
147183404|NCT04640311|530836620|FG005|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
147183405|NCT04640311|530836621|FG006|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|1|||
147183406|NCT04640311|530836622|FG007|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
147183407|NCT04640311|530836623|FG008|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
147183408|NCT04640311|530836624|FG009|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
147183409|NCT04640311|530836625|FG010|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|1|||
147183410|NCT04640311|530836626|FG011|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
147183411|NCT04640311|530836627|FG012|Part B:Treatment Period 1 (Up to 2 Days)|Adverse Event|0|||
147183412|NCT04640311|530836615|FG000|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
147183413|NCT04640311|530836616|FG001|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
147183414|NCT04640311|530836617|FG002|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
147183415|NCT04640311|530836618|FG003|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
147183416|NCT04640311|530836619|FG004|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
147183417|NCT04640311|530836620|FG005|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
147183418|NCT04640311|530836621|FG006|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
147183419|NCT04640311|530836622|FG007|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
147183420|NCT04640311|530836623|FG008|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
147183421|NCT04640311|530836624|FG009|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
147183422|NCT04640311|530836625|FG010|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
147183423|NCT04640311|530836626|FG011|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|1|||
147183424|NCT04640311|530836627|FG012|Part B: Treatment Period 2(Up to 2 Days)|Withdrawal by Subject|0|||
147183425|NCT01388907|530836631|FG000|Overall Study|Adverse Event|2|||
147183426|NCT01388907|530836632|FG001|Overall Study|Adverse Event|0|||
147183427|NCT01910402|530836633|FG000|Randomized Phase (Up to 48 Weeks)|Adverse Event|10|||
147183428|NCT01910402|530836634|FG001|Randomized Phase (Up to 48 Weeks)|Adverse Event|18|||
147183429|NCT01910402|530836635|FG002|Randomized Phase (Up to 48 Weeks)|Adverse Event|0|||
147183430|NCT01910402|530836633|FG000|Randomized Phase (Up to 48 Weeks)|Physician Decision|1|||
147183431|NCT01910402|530836634|FG001|Randomized Phase (Up to 48 Weeks)|Physician Decision|0|||
147328085|NCT03068468|531367916|FG000|Placebo-Controlled Period|Lack of Efficacy|0|||
147328086|NCT03068468|531367917|FG001|Placebo-Controlled Period|Lack of Efficacy|1|||
147328087|NCT03068468|531367918|FG002|Placebo-Controlled Period|Lack of Efficacy|0|||
147328088|NCT03068468|531367919|FG003|Placebo-Controlled Period|Lack of Efficacy|0|||
147328089|NCT03068468|531367916|FG000|Placebo-Controlled Period|Adverse Event|16|||
147183432|NCT01910402|530836635|FG002|Randomized Phase (Up to 48 Weeks)|Physician Decision|0|||
147183433|NCT01910402|530836633|FG000|Randomized Phase (Up to 48 Weeks)|Lack of Efficacy|5|||
147183434|NCT01910402|530836634|FG001|Randomized Phase (Up to 48 Weeks)|Lack of Efficacy|4|||
147183435|NCT01910402|530836635|FG002|Randomized Phase (Up to 48 Weeks)|Lack of Efficacy|0|||
147183436|NCT01910402|530836633|FG000|Randomized Phase (Up to 48 Weeks)|Lost to Follow-up|11|||
147183437|NCT01910402|530836634|FG001|Randomized Phase (Up to 48 Weeks)|Lost to Follow-up|13|||
147183438|NCT01910402|530836635|FG002|Randomized Phase (Up to 48 Weeks)|Lost to Follow-up|0|||
147183439|NCT01910402|530836633|FG000|Randomized Phase (Up to 48 Weeks)|Withdrawal by Subject|5|||
147183440|NCT01910402|530836634|FG001|Randomized Phase (Up to 48 Weeks)|Withdrawal by Subject|7|||
147183441|NCT01910402|530836635|FG002|Randomized Phase (Up to 48 Weeks)|Withdrawal by Subject|0|||
147183442|NCT01910402|530836633|FG000|Randomized Phase (Up to 48 Weeks)|Randomized, but did not receive treatment|2|||
147183443|NCT01910402|530836634|FG001|Randomized Phase (Up to 48 Weeks)|Randomized, but did not receive treatment|2|||
147183444|NCT01910402|530836635|FG002|Randomized Phase (Up to 48 Weeks)|Randomized, but did not receive treatment|0|||
147183445|NCT01910402|530836633|FG000|Randomized Phase (Up to 48 Weeks)|Protocol Deviation|10|||
147183446|NCT01910402|530836634|FG001|Randomized Phase (Up to 48 Weeks)|Protocol Deviation|13|||
147183447|NCT01910402|530836635|FG002|Randomized Phase (Up to 48 Weeks)|Protocol Deviation|0|||
147183448|NCT01910402|530836633|FG000|Continuation Phase(From Weeks 48 to 432)|Physician Decision|0|||
147183449|NCT01910402|530836634|FG001|Continuation Phase(From Weeks 48 to 432)|Physician Decision|0|||
147183450|NCT01910402|530836635|FG002|Continuation Phase(From Weeks 48 to 432)|Physician Decision|1|||
147183451|NCT01910402|530836633|FG000|Continuation Phase(From Weeks 48 to 432)|Adverse Event|0|||
147183452|NCT01910402|530836634|FG001|Continuation Phase(From Weeks 48 to 432)|Adverse Event|0|||
147183453|NCT01910402|530836635|FG002|Continuation Phase(From Weeks 48 to 432)|Adverse Event|4|||
147183454|NCT01910402|530836633|FG000|Continuation Phase(From Weeks 48 to 432)|Withdrawal by Subject|0|||
147183455|NCT01910402|530836634|FG001|Continuation Phase(From Weeks 48 to 432)|Withdrawal by Subject|0|||
147183456|NCT01910402|530836635|FG002|Continuation Phase(From Weeks 48 to 432)|Withdrawal by Subject|7|||
147183457|NCT01910402|530836633|FG000|Continuation Phase(From Weeks 48 to 432)|Lost to Follow-up|0|||
147183458|NCT01910402|530836634|FG001|Continuation Phase(From Weeks 48 to 432)|Lost to Follow-up|0|||
147183459|NCT01910402|530836635|FG002|Continuation Phase(From Weeks 48 to 432)|Lost to Follow-up|8|||
147246794|NCT03129100|531072778|FG019|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
147246795|NCT03129100|531072779|FG020|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
147246796|NCT03129100|531072780|FG021|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
147246797|NCT03129100|531072781|FG022|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
147246798|NCT03129100|531072782|FG023|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
147246799|NCT03129100|531072783|FG024|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
147246800|NCT03129100|531072784|FG025|Period3-Long-Term Extension Period A & B|Lost to Follow-up|0|||
147246801|NCT03129100|531072759|FG000|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
147246802|NCT03129100|531072760|FG001|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
147246803|NCT03129100|531072761|FG002|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
147246804|NCT03129100|531072762|FG003|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
147246805|NCT03129100|531072763|FG004|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
147246806|NCT03129100|531072764|FG005|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
147246807|NCT03129100|531072765|FG006|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
147246808|NCT03129100|531072766|FG007|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
147246809|NCT03129100|531072767|FG008|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
147246810|NCT03129100|531072768|FG009|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
147246811|NCT03129100|531072769|FG010|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
147246812|NCT03129100|531072770|FG011|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
147246813|NCT03129100|531072771|FG012|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
147246814|NCT03129100|531072772|FG013|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
147246815|NCT03129100|531072773|FG014|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
147246816|NCT03129100|531072774|FG015|Period3-Long-Term Extension Period A & B|Lack of Efficacy|1|||
147246817|NCT03129100|531072775|FG016|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
147246818|NCT03129100|531072776|FG017|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
147246819|NCT03129100|531072777|FG018|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
147246820|NCT03129100|531072778|FG019|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
147246821|NCT03129100|531072779|FG020|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
147246822|NCT03129100|531072780|FG021|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
147246823|NCT03129100|531072781|FG022|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
147246824|NCT03129100|531072782|FG023|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
147246825|NCT03129100|531072783|FG024|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
147246826|NCT03129100|531072784|FG025|Period3-Long-Term Extension Period A & B|Lack of Efficacy|0|||
147246827|NCT03129100|531072759|FG000|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
147246828|NCT03129100|531072760|FG001|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
147183460|NCT01910402|530836633|FG000|Continuation Phase(From Weeks 48 to 432)|Lack of Efficacy|0|||
147183461|NCT01910402|530836634|FG001|Continuation Phase(From Weeks 48 to 432)|Lack of Efficacy|0|||
147183462|NCT01910402|530836635|FG002|Continuation Phase(From Weeks 48 to 432)|Lack of Efficacy|1|||
147183463|NCT01910402|530836633|FG000|Continuation Phase(From Weeks 48 to 432)|Protocol Deviation|0|||
147183464|NCT01910402|530836634|FG001|Continuation Phase(From Weeks 48 to 432)|Protocol Deviation|0|||
147183465|NCT01910402|530836635|FG002|Continuation Phase(From Weeks 48 to 432)|Protocol Deviation|15|||
147183466|NCT00824473|530836636|FG000|Overall Study|Adverse Event|4|||
147183467|NCT00824473|530836637|FG001|Overall Study|Adverse Event|5|||
147183468|NCT00824473|530836636|FG000|Overall Study|Lack of Efficacy|2|||
147183469|NCT00824473|530836637|FG001|Overall Study|Lack of Efficacy|2|||
147183470|NCT00824473|530836636|FG000|Overall Study|Protocol Violation|2|||
147183471|NCT00824473|530836637|FG001|Overall Study|Protocol Violation|0|||
147183472|NCT00824473|530836636|FG000|Overall Study|Non-Compliance|4|||
147183473|NCT00824473|530836637|FG001|Overall Study|Non-Compliance|2|||
147183474|NCT00824473|530836636|FG000|Overall Study|Withdrawal by Subject|2|||
147183475|NCT00824473|530836637|FG001|Overall Study|Withdrawal by Subject|3|||
147183476|NCT00824473|530836636|FG000|Overall Study|Other|1|||
147183477|NCT00824473|530836637|FG001|Overall Study|Other|1|||
147183478|NCT01359904|530836638|FG000|Overall Study|Withdrawal by Subject|1|||
147183479|NCT01359904|530836639|FG001|Overall Study|Withdrawal by Subject|0|||
147183480|NCT03594773|530836641|FG000|Overall Study|Withdrawal by Subject|3|||
147183481|NCT03594773|530836642|FG001|Overall Study|Withdrawal by Subject|2|||
147183482|NCT03594773|530836641|FG000|Overall Study|Lost to Follow-up|3|||
147183483|NCT03594773|530836642|FG001|Overall Study|Lost to Follow-up|4|||
147183484|NCT01550757|530836643|FG000|Overall Study|Lost to Follow-up|21|||
147183485|NCT01550757|530836644|FG001|Overall Study|Lost to Follow-up|14|||
147183486|NCT01550757|530836645|FG002|Overall Study|Lost to Follow-up|42|||
147183487|NCT01550757|530836646|FG003|Overall Study|Lost to Follow-up|53|||
147183488|NCT01550757|530836643|FG000|Overall Study|Withdrawal by Subject|2|||
147183489|NCT01550757|530836644|FG001|Overall Study|Withdrawal by Subject|0|||
147183490|NCT01550757|530836645|FG002|Overall Study|Withdrawal by Subject|3|||
147183491|NCT01550757|530836646|FG003|Overall Study|Withdrawal by Subject|1|||
147183492|NCT03191630|530836647|FG000|Overall Study|Lost to Follow-up|7|||
147183493|NCT03191630|530836648|FG001|Overall Study|Lost to Follow-up|7|||
147183494|NCT00193206|530836651|FG000|Preoperative Therapy|Lack of Efficacy|2|||
147183495|NCT00193206|530836651|FG000|Preoperative Therapy|Adverse Event|2|||
147183496|NCT00193206|530836651|FG000|Preoperative Therapy|Withdrawal by Subject|2|||
147183497|NCT00193206|530836651|FG000|Preoperative Therapy|False Positive Pregnancy Test|1|||
147183498|NCT00193206|530836651|FG000|Postoperative Therapy|Withdrawal by Subject|7|||
147183499|NCT00193206|530836651|FG000|Postoperative Therapy|Physician Decision|3|||
147183500|NCT00193206|530836651|FG000|Postoperative Therapy|Intercurrent Illness|2|||
147183501|NCT00193206|530836651|FG000|Postoperative Therapy|Lack of Efficacy|1|||
147183502|NCT00193206|530836651|FG000|Postoperative Therapy|Protocol Violation|1|||
147183503|NCT00740584|530836658|FG000|Overall Study|Withdrawal by Subject|1|||
147183504|NCT03461146|530836661|FG000|Overall Study|Adverse Event|2|||
147183505|NCT03461146|530836661|FG000|Overall Study|Physician Decision|1|||
147183506|NCT02915263|530836666|FG000|Overall Study|Covid|3|||
147183507|NCT02915263|530836667|FG001|Overall Study|Covid|2|||
147183508|NCT02478463|530836668|FG000|Treatment Period 1 (Up to Day 29)|Physician Decision|1|||
147183509|NCT02478463|530836668|FG000|Washout Period (Up to 42 Days)|Lost to Follow-up|1|||
147183510|NCT02478463|530836668|FG000|Treatment Period 2 (Up to 52 Weeks)|Withdrawal by Subject|1|||
147183511|NCT01479868|530836672|FG000|Overall Study|Adverse Event|1|||
147183512|NCT01479868|530836672|FG000|Overall Study|Lost to Follow-up|4|||
147183513|NCT01479868|530836672|FG000|Overall Study|Protocol Violation|1|||
147183514|NCT01479868|530836672|FG000|Overall Study|Withdrawal by Subject|1|||
147183515|NCT01479868|530836672|FG000|Overall Study|Sponsor's Decision|1|||
147183516|NCT01479868|530836672|FG000|Overall Study|Initiation of new HCV Therapy|1|||
147183517|NCT01618669|530836673|FG000|Overall Study|Lost to Follow-up|1|||
147183518|NCT01618669|530836674|FG001|Overall Study|Lost to Follow-up|1|||
147183519|NCT01618669|530836673|FG000|Overall Study|Randomized but Never Received Study Drug|3|||
147183520|NCT01618669|530836674|FG001|Overall Study|Randomized but Never Received Study Drug|2|||
147183521|NCT01618669|530836673|FG000|Overall Study|Adverse Event|16|||
147183522|NCT01618669|530836674|FG001|Overall Study|Adverse Event|7|||
147183523|NCT01618669|530836673|FG000|Overall Study|Protocol Violation|5|||
147183524|NCT01618669|530836674|FG001|Overall Study|Protocol Violation|3|||
147183525|NCT01618669|530836673|FG000|Overall Study|Withdrawal by Subject|9|||
147183526|NCT01618669|530836674|FG001|Overall Study|Withdrawal by Subject|9|||
147183527|NCT01618669|530836673|FG000|Overall Study|Miscellaneous Reason|0|||
147183528|NCT01618669|530836674|FG001|Overall Study|Miscellaneous Reason|1|||
147183529|NCT01177007|530836675|FG000|Overall Study|Lost to Follow-up|2|||
147183530|NCT01177007|530836675|FG000|Overall Study|Death|4|||
147183531|NCT01177007|530836675|FG000|Overall Study|Entered hospice care|5|||
147183532|NCT01177007|530836675|FG000|Overall Study|Required additional Y90 treatment|6|||
147183533|NCT01177007|530836675|FG000|Overall Study|Change in treatment modality|21|||
147183534|NCT03259087|530836676|FG000|Part 1 and Period 1 of Part 2|Adverse Event|0|||
147183535|NCT03259087|530836677|FG001|Part 1 and Period 1 of Part 2|Adverse Event|0|||
147183536|NCT03259087|530836678|FG002|Part 1 and Period 1 of Part 2|Adverse Event|0|||
147183537|NCT03259087|530836679|FG003|Part 1 and Period 1 of Part 2|Adverse Event|0|||
147183538|NCT03259087|530836680|FG004|Part 1 and Period 1 of Part 2|Adverse Event|1|||
147183539|NCT03259087|530836676|FG000|Period 2 of Part 2|Adverse Event|0|||
147183540|NCT03259087|530836677|FG001|Period 2 of Part 2|Adverse Event|0|||
147183541|NCT03259087|530836678|FG002|Period 2 of Part 2|Adverse Event|0|||
147183542|NCT03259087|530836679|FG003|Period 2 of Part 2|Adverse Event|0|||
147183543|NCT03259087|530836680|FG004|Period 2 of Part 2|Adverse Event|1|||
147183544|NCT04950465|530836681|FG000|Overall Study|Lost to Follow-up|1|||
147183545|NCT04950465|530836682|FG001|Overall Study|Lost to Follow-up|0|||
147183546|NCT04950465|530836683|FG002|Overall Study|Lost to Follow-up|0|||
147183547|NCT02753946|530836699|FG000|Overall Study|Adverse Event|7|||
147183548|NCT02753946|530836700|FG001|Overall Study|Adverse Event|6|||
147183549|NCT02753946|530836699|FG000|Overall Study|Withdrawal by Subject|6|||
147183550|NCT02753946|530836700|FG001|Overall Study|Withdrawal by Subject|1|||
147183551|NCT02753946|530836699|FG000|Overall Study|Lack of Efficacy|1|||
147183552|NCT02753946|530836700|FG001|Overall Study|Lack of Efficacy|0|||
147183553|NCT02753946|530836699|FG000|Overall Study|Physician Decision|0|||
147183554|NCT02753946|530836700|FG001|Overall Study|Physician Decision|2|||
147183555|NCT01369784|530836701|FG000|Overall Study|Protocol Violation|12|||
147183556|NCT02680665|530836702|FG000|Overall Study|No visit after the first prescription|5|||
147183557|NCT02905266|530836703|FG000|Treatment Phase Part 1|Participant Withdrew Consent|1|||
147183558|NCT02905266|530836704|FG001|Treatment Phase Part 1|Participant Withdrew Consent|0|||
147183559|NCT02905266|530836703|FG000|Treatment Phase Part 1|Disease Progression|6|||
147183560|NCT02905266|530836704|FG001|Treatment Phase Part 1|Disease Progression|7|||
147183561|NCT02905266|530836703|FG000|Treatment Phase Part 1|Study Drug Toxicity|22|||
147183562|NCT02905266|530836704|FG001|Treatment Phase Part 1|Study Drug Toxicity|16|||
147183563|NCT02905266|530836703|FG000|Transition From Part 1 to Part 2|Adverse event unrelated to study drug|1|||
147183564|NCT02905266|530836704|FG001|Transition From Part 1 to Part 2|Adverse event unrelated to study drug|0|||
147183565|NCT02905266|530836703|FG000|Transition From Part 1 to Part 2|Disease progression|2|||
147183566|NCT02905266|530836704|FG001|Transition From Part 1 to Part 2|Disease progression|1|||
147183567|NCT02905266|530836703|FG000|Transition From Part 1 to Part 2|Study drug toxicity|0|||
147183568|NCT02905266|530836704|FG001|Transition From Part 1 to Part 2|Study drug toxicity|4|||
147183569|NCT02905266|530836703|FG000|Transition From Part 1 to Part 2|Death|0|||
147183570|NCT02905266|530836704|FG001|Transition From Part 1 to Part 2|Death|1|||
147183571|NCT02905266|530836703|FG000|Transition From Part 1 to Part 2|Participant withdrew consent|0|||
147183572|NCT02905266|530836704|FG001|Transition From Part 1 to Part 2|Participant withdrew consent|1|||
147183573|NCT02905266|530836703|FG000|Transition From Part 1 to Part 2|Adverse Event|1|||
147183574|NCT02905266|530836704|FG001|Transition From Part 1 to Part 2|Adverse Event|1|||
147183575|NCT02905266|530836703|FG000|Maintenance Phase Part 2|Disease Progression|9|||
147183576|NCT02905266|530836704|FG001|Maintenance Phase Part 2|Disease Progression|2|||
147183577|NCT02905266|530836703|FG000|Maintenance Phase Part 2|Study Drug Toxicity|3|||
147183578|NCT02905266|530836704|FG001|Maintenance Phase Part 2|Study Drug Toxicity|4|||
147183579|NCT02905266|530836703|FG000|Maintenance Phase Part 2|Maximum Clinical Benefit|0|||
147183580|NCT02905266|530836704|FG001|Maintenance Phase Part 2|Maximum Clinical Benefit|2|||
147183581|NCT02292719|530836710|FG000|Overall Study|Withdrawal by Subject|0|||
147183582|NCT02292719|530836711|FG001|Overall Study|Withdrawal by Subject|0|||
147183583|NCT02292719|530836712|FG002|Overall Study|Withdrawal by Subject|0|||
147183584|NCT02292719|530836713|FG003|Overall Study|Withdrawal by Subject|1|||
147183585|NCT02292719|530836714|FG004|Overall Study|Withdrawal by Subject|1|||
147183586|NCT02292719|530836715|FG005|Overall Study|Withdrawal by Subject|0|||
147183587|NCT02292719|530836710|FG000|Overall Study|Subject enrolled in new study.|0|||
147183588|NCT02292719|530836711|FG001|Overall Study|Subject enrolled in new study.|0|||
147183589|NCT02292719|530836712|FG002|Overall Study|Subject enrolled in new study.|1|||
147183590|NCT02292719|530836713|FG003|Overall Study|Subject enrolled in new study.|0|||
147183591|NCT02292719|530836714|FG004|Overall Study|Subject enrolled in new study.|0|||
147183592|NCT02292719|530836715|FG005|Overall Study|Subject enrolled in new study.|0|||
147183593|NCT05973006|530836716|FG000|Overall Study|Early termination|3|||
147183594|NCT05973006|530836717|FG001|Overall Study|Early termination|9|||
147183595|NCT02326597|530836722|FG000|Overall Study|Lost to Follow-up|42|||
147183596|NCT02326597|530836723|FG001|Overall Study|Lost to Follow-up|32|||
147183597|NCT00770601|530836726|FG000|Overall Study|Withdrawal by Subject|1|||
147183598|NCT00428948|530836727|FG000|Overall Study|Lost to Follow-up|15|||
147183599|NCT00428948|530836728|FG001|Overall Study|Lost to Follow-up|8|||
147183600|NCT00428948|530836727|FG000|Overall Study|Adverse Event|148|||
147183601|NCT00428948|530836728|FG001|Overall Study|Adverse Event|24|||
147183602|NCT00428948|530836727|FG000|Overall Study|Subject Met Withdrawal Criteria|4|||
147246829|NCT03129100|531072761|FG002|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
147246830|NCT03129100|531072762|FG003|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
147246831|NCT03129100|531072763|FG004|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
147246832|NCT03129100|531072764|FG005|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
147246833|NCT03129100|531072765|FG006|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
147183603|NCT00428948|530836728|FG001|Overall Study|Subject Met Withdrawal Criteria|0|||
147183604|NCT00428948|530836727|FG000|Overall Study|Investigator Withdrew Subject|3|||
147183605|NCT00428948|530836728|FG001|Overall Study|Investigator Withdrew Subject|4|||
147183606|NCT00428948|530836727|FG000|Overall Study|Subject Withdrew Consent|50|||
147183607|NCT00428948|530836728|FG001|Overall Study|Subject Withdrew Consent|30|||
147183608|NCT00428948|530836727|FG000|Overall Study|Protocol Deviation|1|||
147183609|NCT00428948|530836728|FG001|Overall Study|Protocol Deviation|1|||
147183610|NCT05907395|530836731|FG000|Period 1|No longer met eligibility criteria|0|||
147183611|NCT05907395|530836732|FG001|Period 1|No longer met eligibility criteria|1|||
147183612|NCT05907395|530836733|FG002|Period 1|No longer met eligibility criteria|0|||
147183613|NCT05907395|530836734|FG003|Period 1|No longer met eligibility criteria|0|||
147183614|NCT05907395|530836735|FG004|Period 1|No longer met eligibility criteria|0|||
147183615|NCT05907395|530836736|FG005|Period 1|No longer met eligibility criteria|1|||
147183616|NCT05907395|530836737|FG006|Period 1|No longer met eligibility criteria|1|||
147183617|NCT05907395|530836738|FG007|Period 1|No longer met eligibility criteria|0|||
147183618|NCT05907395|530836739|FG008|Period 1|No longer met eligibility criteria|0|||
147183619|NCT05907395|530836740|FG009|Period 1|No longer met eligibility criteria|0|||
147183620|NCT05907395|530836741|FG010|Period 1|No longer met eligibility criteria|0|||
147183621|NCT05907395|530836742|FG011|Period 1|No longer met eligibility criteria|0|||
147183622|NCT05907395|530836731|FG000|Period 2|Adverse Event|0|||
147183623|NCT05907395|530836732|FG001|Period 2|Adverse Event|0|||
147183624|NCT05907395|530836733|FG002|Period 2|Adverse Event|0|||
147183625|NCT05907395|530836734|FG003|Period 2|Adverse Event|1|||
147183626|NCT05907395|530836735|FG004|Period 2|Adverse Event|0|||
147183627|NCT05907395|530836736|FG005|Period 2|Adverse Event|0|||
147183628|NCT05907395|530836737|FG006|Period 2|Adverse Event|0|||
147183629|NCT05907395|530836738|FG007|Period 2|Adverse Event|1|||
147183630|NCT05907395|530836739|FG008|Period 2|Adverse Event|0|||
147183631|NCT05907395|530836740|FG009|Period 2|Adverse Event|0|||
147183632|NCT05907395|530836741|FG010|Period 2|Adverse Event|0|||
147183633|NCT05907395|530836742|FG011|Period 2|Adverse Event|0|||
147183634|NCT05907395|530836731|FG000|Period 2|Personal reason|0|||
147183635|NCT05907395|530836732|FG001|Period 2|Personal reason|0|||
147183636|NCT05907395|530836733|FG002|Period 2|Personal reason|0|||
147183637|NCT05907395|530836734|FG003|Period 2|Personal reason|0|||
147183638|NCT05907395|530836735|FG004|Period 2|Personal reason|0|||
147183639|NCT05907395|530836736|FG005|Period 2|Personal reason|0|||
147183640|NCT05907395|530836737|FG006|Period 2|Personal reason|0|||
147183641|NCT05907395|530836738|FG007|Period 2|Personal reason|0|||
147183642|NCT05907395|530836739|FG008|Period 2|Personal reason|0|||
147183643|NCT05907395|530836740|FG009|Period 2|Personal reason|1|||
147183644|NCT05907395|530836741|FG010|Period 2|Personal reason|0|||
147183645|NCT05907395|530836742|FG011|Period 2|Personal reason|0|||
147183646|NCT05907395|530836731|FG000|Period 3|Adverse Event|0|||
147183647|NCT05907395|530836732|FG001|Period 3|Adverse Event|0|||
147183648|NCT05907395|530836733|FG002|Period 3|Adverse Event|0|||
147183649|NCT05907395|530836734|FG003|Period 3|Adverse Event|0|||
147183650|NCT05907395|530836735|FG004|Period 3|Adverse Event|1|||
147183651|NCT05907395|530836736|FG005|Period 3|Adverse Event|0|||
147183652|NCT05907395|530836737|FG006|Period 3|Adverse Event|0|||
147183653|NCT05907395|530836738|FG007|Period 3|Adverse Event|0|||
147183654|NCT05907395|530836739|FG008|Period 3|Adverse Event|0|||
147183655|NCT05907395|530836740|FG009|Period 3|Adverse Event|0|||
147183656|NCT05907395|530836741|FG010|Period 3|Adverse Event|0|||
147183657|NCT05907395|530836742|FG011|Period 3|Adverse Event|0|||
147183658|NCT04544956|530836743|FG000|Overall Study|Withdrawal by Subject|1|||
147183659|NCT01099397|530836744|FG000|Overall Study|Lost to Follow-up|4|||
147183660|NCT01099397|530836744|FG000|Overall Study|Protocol Violation|4|||
147183661|NCT01099397|530836744|FG000|Overall Study|Withdrawal by Subject|5|||
147246834|NCT03129100|531072766|FG007|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
147246835|NCT03129100|531072767|FG008|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
147246836|NCT03129100|531072768|FG009|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
147246837|NCT03129100|531072769|FG010|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
147246838|NCT03129100|531072770|FG011|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
147246839|NCT03129100|531072771|FG012|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|24|||
147246840|NCT03129100|531072772|FG013|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
147246841|NCT03129100|531072773|FG014|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|2|||
147246842|NCT03129100|531072774|FG015|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|8|||
147246843|NCT03129100|531072775|FG016|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
147183662|NCT00003199|530836746|FG000|Overall Study|Refused Post-Transplant Immunotherapy|5|||
147183663|NCT00003199|530836746|FG000|Overall Study|Lack of insurance clearance|2|||
147183664|NCT00003199|530836746|FG000|Overall Study|Screen fail|15|||
147183665|NCT00940498|530836747|FG000|Overall Study|Death|2|||
147183666|NCT00940498|530836748|FG001|Overall Study|Death|0|||
147183667|NCT00940498|530836749|FG002|Overall Study|Death|0|||
147183668|NCT00940498|530836750|FG003|Overall Study|Death|1|||
147183669|NCT00940498|530836751|FG004|Overall Study|Death|5|||
147183670|NCT00940498|530836752|FG005|Overall Study|Death|0|||
147448552|NCT01964352|531807890|FG000|Overall Study|Other than stated above|0|||
147183671|NCT00940498|530836753|FG006|Overall Study|Death|1|||
147183672|NCT00940498|530836754|FG007|Overall Study|Death|0|||
147183673|NCT00940498|530836747|FG000|Overall Study|Lost to Follow-up|1|||
147183674|NCT00940498|530836748|FG001|Overall Study|Lost to Follow-up|1|||
147183675|NCT00940498|530836749|FG002|Overall Study|Lost to Follow-up|2|||
147183676|NCT00940498|530836750|FG003|Overall Study|Lost to Follow-up|0|||
147183677|NCT00940498|530836751|FG004|Overall Study|Lost to Follow-up|1|||
147183678|NCT00940498|530836752|FG005|Overall Study|Lost to Follow-up|0|||
147183679|NCT00940498|530836753|FG006|Overall Study|Lost to Follow-up|0|||
147183680|NCT00940498|530836754|FG007|Overall Study|Lost to Follow-up|1|||
147183681|NCT00940498|530836747|FG000|Overall Study|Disease Progression|0|||
147183682|NCT00940498|530836748|FG001|Overall Study|Disease Progression|0|||
147183683|NCT00940498|530836749|FG002|Overall Study|Disease Progression|1|||
147183684|NCT00940498|530836750|FG003|Overall Study|Disease Progression|1|||
147183685|NCT00940498|530836751|FG004|Overall Study|Disease Progression|0|||
147183686|NCT00940498|530836752|FG005|Overall Study|Disease Progression|1|||
147183687|NCT00940498|530836753|FG006|Overall Study|Disease Progression|0|||
147183688|NCT00940498|530836754|FG007|Overall Study|Disease Progression|0|||
147183689|NCT00940498|530836747|FG000|Overall Study|Physician Decision|0|||
147183690|NCT00940498|530836748|FG001|Overall Study|Physician Decision|0|||
147183691|NCT00940498|530836749|FG002|Overall Study|Physician Decision|0|||
147183692|NCT00940498|530836750|FG003|Overall Study|Physician Decision|0|||
147183693|NCT00940498|530836751|FG004|Overall Study|Physician Decision|2|||
147183694|NCT00940498|530836752|FG005|Overall Study|Physician Decision|0|||
147183695|NCT00940498|530836753|FG006|Overall Study|Physician Decision|0|||
147183696|NCT00940498|530836754|FG007|Overall Study|Physician Decision|0|||
147183697|NCT00940498|530836747|FG000|Overall Study|Not treated due to disease related pain|0|||
147183698|NCT00940498|530836748|FG001|Overall Study|Not treated due to disease related pain|0|||
147183699|NCT00940498|530836749|FG002|Overall Study|Not treated due to disease related pain|0|||
147183700|NCT00940498|530836750|FG003|Overall Study|Not treated due to disease related pain|0|||
147183701|NCT00940498|530836751|FG004|Overall Study|Not treated due to disease related pain|1|||
147183702|NCT00940498|530836752|FG005|Overall Study|Not treated due to disease related pain|0|||
147183703|NCT00940498|530836753|FG006|Overall Study|Not treated due to disease related pain|0|||
147183704|NCT00940498|530836754|FG007|Overall Study|Not treated due to disease related pain|0|||
147183705|NCT00650845|530836755|FG000|Overall Study|Withdrawal by Subject|5|||
147183706|NCT00650845|530836756|FG001|Overall Study|Withdrawal by Subject|0|||
147183707|NCT00650845|530836755|FG000|Overall Study|Protocol Violation|0|||
147183708|NCT00650845|530836756|FG001|Overall Study|Protocol Violation|13|||
147183709|NCT03761810|530836757|FG000|Overall Study|Adverse Event|12|||
147183710|NCT03761810|530836758|FG001|Overall Study|Adverse Event|0|||
147183711|NCT03761810|530836757|FG000|Overall Study|Lost to Follow-up|15|||
147183712|NCT03761810|530836758|FG001|Overall Study|Lost to Follow-up|7|||
147183713|NCT03761810|530836757|FG000|Overall Study|Pregnancy|1|||
147183714|NCT03761810|530836758|FG001|Overall Study|Pregnancy|0|||
147183715|NCT03761810|530836757|FG000|Overall Study|Withdrawal by Subject|14|||
147183716|NCT03761810|530836758|FG001|Overall Study|Withdrawal by Subject|5|||
147183717|NCT03761810|530836757|FG000|Overall Study|Physician Decision|1|||
147183718|NCT03761810|530836758|FG001|Overall Study|Physician Decision|0|||
147183719|NCT03761810|530836757|FG000|Overall Study|Withdrawal by Parent/Guardian|4|||
147183720|NCT03761810|530836758|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
147183721|NCT03761810|530836757|FG000|Overall Study|Other Than Specified|1|||
147183722|NCT03761810|530836758|FG001|Overall Study|Other Than Specified|0|||
147183723|NCT03932760|530836761|FG000|Overall Study|Became Ineligible|2|||
147183724|NCT03932760|530836762|FG001|Overall Study|Became Ineligible|5|||
147183725|NCT03932760|530836761|FG000|Overall Study|Withdrawal by Subject|6|||
147183726|NCT03932760|530836762|FG001|Overall Study|Withdrawal by Subject|6|||
147183727|NCT04178720|530836763|FG000|Overall Study|Withdrawal by Subject|2|||
147183728|NCT04178720|530836764|FG001|Overall Study|Withdrawal by Subject|0|||
147183729|NCT04178720|530836763|FG000|Overall Study|Relocation|0|||
147183730|NCT04178720|530836764|FG001|Overall Study|Relocation|1|||
147183731|NCT00869518|530836765|FG000|Overall Study|Lost to Follow-up|1|||
147183732|NCT00869518|530836766|FG001|Overall Study|Lost to Follow-up|1|||
147183733|NCT03922620|530836769|FG000|Overall Study|Data and outcome measures not tabulated due to discontinued enrollment.|1|||
147183734|NCT03922620|530836770|FG001|Overall Study|Data and outcome measures not tabulated due to discontinued enrollment.|0|||
147183735|NCT00983385|530836771|FG000|Observation Period|Not eligible to be dosed|20|||
147183736|NCT00983385|530836771|FG000|Observation Period|Not Evaluable due to Non Compliance|12|||
147183737|NCT01223183|530836773|FG000|Imaging Day 1|Physician Decision|0|||
147183738|NCT01223183|530836774|FG001|Imaging Day 1|Physician Decision|1|||
147183739|NCT01223183|530836773|FG000|Washout Period (5-24 Days)|Lost to Follow-up|1|||
147183740|NCT01223183|530836774|FG001|Washout Period (5-24 Days)|Lost to Follow-up|0|||
147183741|NCT01223183|530836773|FG000|Washout Period (5-24 Days)|Physician Decision|1|||
147183742|NCT01223183|530836774|FG001|Washout Period (5-24 Days)|Physician Decision|0|||
147183743|NCT00163020|530836775|FG000|Overall Study|Lost to Follow-up|0|||
147183744|NCT00163020|530836776|FG001|Overall Study|Lost to Follow-up|2|||
147183745|NCT03772665|530836777|FG000|Overall Study|Protocol Violation|1|||
147183746|NCT03772665|530836778|FG001|Overall Study|Protocol Violation|0|||
147183747|NCT01633788|530839794|FG000|Overall Study|Adverse Event|1|||
147183748|NCT01633788|530839795|FG001|Overall Study|Adverse Event|3|||
147183749|NCT01633788|530839796|FG002|Overall Study|Adverse Event|3|||
147183750|NCT01633788|530839797|FG003|Overall Study|Adverse Event|3|||
147183751|NCT01633788|530839794|FG000|Overall Study|Lost to Follow-up|2|||
147183752|NCT01633788|530839795|FG001|Overall Study|Lost to Follow-up|2|||
147183753|NCT01633788|530839796|FG002|Overall Study|Lost to Follow-up|2|||
147183754|NCT01633788|530839797|FG003|Overall Study|Lost to Follow-up|0|||
147183755|NCT01633788|530839794|FG000|Overall Study|Personal Reasons|3|||
147183756|NCT01633788|530839795|FG001|Overall Study|Personal Reasons|1|||
147183757|NCT01633788|530839796|FG002|Overall Study|Personal Reasons|1|||
147183758|NCT01633788|530839797|FG003|Overall Study|Personal Reasons|3|||
147183759|NCT01633788|530839794|FG000|Overall Study|Protocol Violation|1|||
147183760|NCT01633788|530839795|FG001|Overall Study|Protocol Violation|0|||
147183761|NCT01633788|530839796|FG002|Overall Study|Protocol Violation|1|||
147183762|NCT01633788|530839797|FG003|Overall Study|Protocol Violation|0|||
147183763|NCT01633788|530839794|FG000|Overall Study|Other Reasons|0|||
147183764|NCT01633788|530839795|FG001|Overall Study|Other Reasons|2|||
147183765|NCT01633788|530839796|FG002|Overall Study|Other Reasons|3|||
147183766|NCT01633788|530839797|FG003|Overall Study|Other Reasons|7|||
147183767|NCT01929226|530839798|FG000|Overall Study|Lost to Follow-up|4|||
147183768|NCT01929226|530839799|FG001|Overall Study|Lost to Follow-up|0|||
147183769|NCT01929226|530839798|FG000|Overall Study|Withdrawal by Subject|1|||
147183770|NCT01929226|530839799|FG001|Overall Study|Withdrawal by Subject|1|||
147183771|NCT03553758|530839800|FG000|Overall Study|Lost to Follow-up|1|||
147183772|NCT00592904|530839804|FG000|Overall Study|Adverse Event|15|||
147183773|NCT00592904|530839805|FG001|Overall Study|Adverse Event|25|||
147183774|NCT00592904|530839806|FG002|Overall Study|Adverse Event|13|||
147183775|NCT00592904|530839807|FG003|Overall Study|Adverse Event|5|||
147183776|NCT00592904|530839804|FG000|Overall Study|Protocol Violation|1|||
147183777|NCT00592904|530839805|FG001|Overall Study|Protocol Violation|1|||
147183778|NCT00592904|530839806|FG002|Overall Study|Protocol Violation|0|||
147183779|NCT00592904|530839807|FG003|Overall Study|Protocol Violation|1|||
147183780|NCT00592904|530839804|FG000|Overall Study|Withdrawal by Subject|4|||
147183781|NCT00592904|530839805|FG001|Overall Study|Withdrawal by Subject|16|||
147183782|NCT00592904|530839806|FG002|Overall Study|Withdrawal by Subject|1|||
147183783|NCT00592904|530839807|FG003|Overall Study|Withdrawal by Subject|2|||
147183784|NCT00592904|530839804|FG000|Overall Study|Lack of Efficacy|2|||
147183785|NCT00592904|530839805|FG001|Overall Study|Lack of Efficacy|7|||
147183786|NCT00592904|530839806|FG002|Overall Study|Lack of Efficacy|2|||
147183787|NCT00592904|530839807|FG003|Overall Study|Lack of Efficacy|3|||
147183788|NCT00592904|530839804|FG000|Overall Study|Physician Decision|0|||
147183789|NCT00592904|530839805|FG001|Overall Study|Physician Decision|3|||
147183790|NCT00592904|530839806|FG002|Overall Study|Physician Decision|1|||
147183791|NCT00592904|530839807|FG003|Overall Study|Physician Decision|0|||
147183792|NCT00592904|530839804|FG000|Overall Study|Other|3|||
147183793|NCT00592904|530839805|FG001|Overall Study|Other|3|||
147183794|NCT00592904|530839806|FG002|Overall Study|Other|0|||
147183795|NCT00592904|530839807|FG003|Overall Study|Other|0|||
147183796|NCT02640547|530839808|FG000|Overall Study|Failure to Return|1|||
147183797|NCT02640547|530839808|FG000|Overall Study|Withdrawal by Subject|1|||
147183798|NCT02640547|530839808|FG000|Overall Study|Death|6|||
147183799|NCT02640547|530839808|FG000|Overall Study|Miscellaneous|3|||
147183800|NCT02525588|530839809|FG000|Overall Study|Death|3|||
147183801|NCT02525588|530839810|FG001|Overall Study|Death|1|||
147183802|NCT02525588|530839809|FG000|Overall Study|Lost to Follow-up|2|||
147183803|NCT02525588|530839810|FG001|Overall Study|Lost to Follow-up|0|||
147328090|NCT03068468|531367917|FG001|Placebo-Controlled Period|Adverse Event|21|||
147328091|NCT03068468|531367918|FG002|Placebo-Controlled Period|Adverse Event|0|||
147328092|NCT03068468|531367919|FG003|Placebo-Controlled Period|Adverse Event|0|||
147183804|NCT02525588|530839809|FG000|Overall Study|Withdrawal by Subject|1|||
147183805|NCT02525588|530839810|FG001|Overall Study|Withdrawal by Subject|1|||
147183806|NCT02525588|530839809|FG000|Overall Study|Adverse Event|0|||
147593869|NCT03977701|532329043|FG007|Overall Study|COVID-19 pandemic|1|||
147183807|NCT02525588|530839810|FG001|Overall Study|Adverse Event|1|||
147183808|NCT03018691|530839811|FG000|Overall Study|Adverse Event|1|||
147183809|NCT03018691|530839812|FG001|Overall Study|Adverse Event|1|||
147183810|NCT03018691|530839813|FG002|Overall Study|Adverse Event|4|||
147183811|NCT03018691|530839811|FG000|Overall Study|Lack of Efficacy|0|||
147183812|NCT03018691|530839812|FG001|Overall Study|Lack of Efficacy|0|||
147183813|NCT03018691|530839813|FG002|Overall Study|Lack of Efficacy|1|||
147183814|NCT03018691|530839811|FG000|Overall Study|Withdrawal by Subject|0|||
147183815|NCT03018691|530839812|FG001|Overall Study|Withdrawal by Subject|0|||
147183816|NCT03018691|530839813|FG002|Overall Study|Withdrawal by Subject|1|||
147183817|NCT03018691|530839811|FG000|Overall Study|Withdrawal by parent/guardian|1|||
147183818|NCT03018691|530839812|FG001|Overall Study|Withdrawal by parent/guardian|0|||
147183819|NCT03018691|530839813|FG002|Overall Study|Withdrawal by parent/guardian|1|||
147183820|NCT03369418|530839815|FG000|Overall Study|Withdrawal by Subject|3|||
147328093|NCT03068468|531367916|FG000|Placebo-Controlled Period|Withdrawal by Subject|3|||
147183821|NCT03369418|530839816|FG001|Overall Study|Withdrawal by Subject|3|||
147183822|NCT01485094|530839817|FG000|Overall Study|Adverse Event|1|||
147183823|NCT01485094|530839818|FG001|Overall Study|Adverse Event|1|||
147183824|NCT01485094|530839819|FG002|Overall Study|Adverse Event|1|||
147183825|NCT01485094|530839817|FG000|Overall Study|Lost to Follow-up|1|||
147183826|NCT01485094|530839818|FG001|Overall Study|Lost to Follow-up|0|||
147183827|NCT01485094|530839819|FG002|Overall Study|Lost to Follow-up|0|||
147183828|NCT01485094|530839817|FG000|Overall Study|Withdrawal by Subject|1|||
147183829|NCT01485094|530839818|FG001|Overall Study|Withdrawal by Subject|1|||
147183830|NCT01485094|530839819|FG002|Overall Study|Withdrawal by Subject|0|||
147183831|NCT01172535|530839820|FG000|Overall Study|Death|3|||
147183832|NCT01172535|530839820|FG000|Overall Study|Withdrawal by Subject|2|||
147183833|NCT01172535|530839820|FG000|Overall Study|Lost to Follow-up|1|||
147183834|NCT01172535|530839820|FG000|Overall Study|Ineligible at study entry|1|||
147183835|NCT01172535|530839820|FG000|Overall Study|Unwilling to adhere to study requirement|1|||
147183836|NCT02698826|530839826|FG000|Overall Study|Death|13|||
147183837|NCT02698826|530839826|FG000|Overall Study|Adverse Event|1|||
147183838|NCT01879683|530839831|FG000|Overall Study|Did not Complete 4-week Follow-up Visit|1|||
147183839|NCT01508169|530839835|FG000|Overall Study|Adverse Event|1|||
147183840|NCT01508169|530839836|FG001|Overall Study|Adverse Event|0|||
147183841|NCT01508169|530839835|FG000|Overall Study|Withdrawal by Subject|1|||
147183842|NCT01508169|530839836|FG001|Overall Study|Withdrawal by Subject|0|||
147183843|NCT01508169|530839835|FG000|Overall Study|Lost to Follow-up|1|||
147183844|NCT01508169|530839836|FG001|Overall Study|Lost to Follow-up|2|||
147183845|NCT03600740|530839842|FG000|Overall Study|Surgical plan was altered-subject not eligible|1|||
147183846|NCT01702558|530839843|FG000|Overall Study|Withdrawal by Subject|0|||
147183847|NCT01702558|530839844|FG001|Overall Study|Withdrawal by Subject|0|||
147183848|NCT01702558|530839845|FG002|Overall Study|Withdrawal by Subject|0|||
147183849|NCT01702558|530839846|FG003|Overall Study|Withdrawal by Subject|12|||
147183850|NCT01702558|530839847|FG004|Overall Study|Withdrawal by Subject|4|||
147183851|NCT01702558|530839843|FG000|Overall Study|Lost to Follow-up|0|||
147183852|NCT01702558|530839844|FG001|Overall Study|Lost to Follow-up|0|||
147183853|NCT01702558|530839845|FG002|Overall Study|Lost to Follow-up|0|||
147183854|NCT01702558|530839846|FG003|Overall Study|Lost to Follow-up|3|||
147183855|NCT01702558|530839847|FG004|Overall Study|Lost to Follow-up|0|||
147183856|NCT01702558|530839843|FG000|Overall Study|Death|4|||
147183857|NCT01702558|530839844|FG001|Overall Study|Death|3|||
147183858|NCT01702558|530839845|FG002|Overall Study|Death|3|||
147183859|NCT01702558|530839846|FG003|Overall Study|Death|16|||
147183860|NCT01702558|530839847|FG004|Overall Study|Death|20|||
147183861|NCT01702558|530839843|FG000|Overall Study|Safety Follow-Up less than 3 Months|0|||
147183862|NCT01702558|530839844|FG001|Overall Study|Safety Follow-Up less than 3 Months|0|||
147183863|NCT01702558|530839845|FG002|Overall Study|Safety Follow-Up less than 3 Months|2|||
147183864|NCT01702558|530839846|FG003|Overall Study|Safety Follow-Up less than 3 Months|0|||
147183865|NCT01702558|530839847|FG004|Overall Study|Safety Follow-Up less than 3 Months|0|||
147183866|NCT01702558|530839843|FG000|Overall Study|Study Terminated by Sponsor|0|||
147183867|NCT01702558|530839844|FG001|Overall Study|Study Terminated by Sponsor|1|||
147183868|NCT01702558|530839845|FG002|Overall Study|Study Terminated by Sponsor|0|||
147246844|NCT03129100|531072776|FG017|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
147246845|NCT03129100|531072777|FG018|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
147246846|NCT03129100|531072778|FG019|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
147246847|NCT03129100|531072779|FG020|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
147246848|NCT03129100|531072780|FG021|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
147246849|NCT03129100|531072781|FG022|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
147246850|NCT03129100|531072782|FG023|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
147183869|NCT01702558|530839846|FG003|Overall Study|Study Terminated by Sponsor|0|||
147183870|NCT01702558|530839847|FG004|Overall Study|Study Terminated by Sponsor|1|||
147183871|NCT01702558|530839843|FG000|Overall Study|Other|0|||
147183872|NCT01702558|530839844|FG001|Overall Study|Other|0|||
147183873|NCT01702558|530839845|FG002|Overall Study|Other|0|||
147183874|NCT01702558|530839846|FG003|Overall Study|Other|16|||
147183875|NCT01702558|530839847|FG004|Overall Study|Other|17|||
147183876|NCT02396212|530839850|FG000|Overall Study|Adverse Event|1|||
147183877|NCT02396212|530839850|FG000|Overall Study|Lack of Efficacy|2|||
147183878|NCT01623115|530839851|FG000|Overall Study|Randomized but not treated|0|||
147183879|NCT01623115|530839852|FG001|Overall Study|Randomized but not treated|1|||
147183880|NCT01623115|530839851|FG000|Overall Study|Physician Decision|1|||
147183881|NCT01623115|530839852|FG001|Overall Study|Physician Decision|0|||
147183882|NCT01623115|530839851|FG000|Overall Study|Participants moved|1|||
147183883|NCT01623115|530839852|FG001|Overall Study|Participants moved|5|||
147183884|NCT01623115|530839851|FG000|Overall Study|Adverse Event|10|||
147183885|NCT01623115|530839852|FG001|Overall Study|Adverse Event|13|||
147183886|NCT01623115|530839851|FG000|Overall Study|Poor compliance to protocol|4|||
147183887|NCT01623115|530839852|FG001|Overall Study|Poor compliance to protocol|10|||
147183888|NCT01623115|530839851|FG000|Overall Study|Consent withdrawn by participant|2|||
147183889|NCT01623115|530839852|FG001|Overall Study|Consent withdrawn by participant|6|||
147183890|NCT01623115|530839851|FG000|Overall Study|Related to study drug administration|0|||
147183891|NCT01623115|530839852|FG001|Overall Study|Related to study drug administration|2|||
147183892|NCT01623115|530839851|FG000|Overall Study|Last visit outside protocol visit window|14|||
147183893|NCT01623115|530839852|FG001|Overall Study|Last visit outside protocol visit window|26|||
147183894|NCT01623115|530839851|FG000|Overall Study|Site closure|1|||
147183895|NCT01623115|530839852|FG001|Overall Study|Site closure|7|||
147183896|NCT01623115|530839851|FG000|Overall Study|Death|0|||
147183897|NCT01623115|530839852|FG001|Overall Study|Death|4|||
147183898|NCT01623115|530839851|FG000|Overall Study|Other than specified above|0|||
147183899|NCT01623115|530839852|FG001|Overall Study|Other than specified above|3|||
147183900|NCT01338818|530839856|FG000|Overall Study|Adverse Event|8|||
147183901|NCT01338818|530839856|FG000|Overall Study|Lack of Efficacy|5|||
147183902|NCT01338818|530839856|FG000|Overall Study|no longer require study drug|1|||
147183903|NCT01338818|530839856|FG000|Overall Study|Withdrawal by Subject|11|||
147183904|NCT01338818|530839856|FG000|Overall Study|Lost to Follow-up|4|||
147183905|NCT01338818|530839856|FG000|Overall Study|Administrative problems|3|||
147183906|NCT01338818|530839856|FG000|Overall Study|Protocol Deviation|4|||
147183907|NCT01620086|530839857|FG000|Overall Study|Withdrawal by Subject|3|||
147183908|NCT01620086|530839858|FG001|Overall Study|Withdrawal by Subject|3|||
147183909|NCT01620086|530839859|FG002|Overall Study|Withdrawal by Subject|0|||
147183910|NCT01620086|530839857|FG000|Overall Study|failed study criteria|1|||
147183911|NCT01620086|530839858|FG001|Overall Study|failed study criteria|4|||
147183912|NCT01620086|530839859|FG002|Overall Study|failed study criteria|0|||
147183913|NCT01620086|530839857|FG000|Overall Study|Physician Decision|1|||
147183914|NCT01620086|530839858|FG001|Overall Study|Physician Decision|0|||
147183915|NCT01620086|530839859|FG002|Overall Study|Physician Decision|0|||
147183916|NCT05202418|530839865|FG000|Overall Study|Withdrawal by Subject|2|||
147183917|NCT05202418|530839866|FG001|Overall Study|Withdrawal by Subject|1|||
147183918|NCT05202418|530839865|FG000|Overall Study|Lost to Follow-up|1|||
147183919|NCT05202418|530839866|FG001|Overall Study|Lost to Follow-up|1|||
147183920|NCT02562716|530839867|FG000|Overall Study|Adverse Event|7|||
147183921|NCT02562716|530839868|FG001|Overall Study|Adverse Event|14|||
147183922|NCT02562716|530839867|FG000|Overall Study|Withdrawal unrelated to AE|7|||
147183923|NCT02562716|530839868|FG001|Overall Study|Withdrawal unrelated to AE|1|||
147183924|NCT02562716|530839867|FG000|Overall Study|Progression|8|||
147183925|NCT02562716|530839868|FG001|Overall Study|Progression|10|||
147183926|NCT02562716|530839867|FG000|Overall Study|Death|2|||
147183927|NCT02562716|530839868|FG001|Overall Study|Death|1|||
147183928|NCT02562716|530839867|FG000|Overall Study|Not protocol specified|4|||
147183929|NCT02562716|530839868|FG001|Overall Study|Not protocol specified|2|||
147183930|NCT00684996|530839869|FG000|Overall Study|Adverse Event|1|||
147183931|NCT00684996|530839869|FG000|Overall Study|Refusal unrelated to adverse event|1|||
147183932|NCT00684996|530839869|FG000|Overall Study|Progression/relapse|2|||
147183933|NCT00684996|530839869|FG000|Overall Study|Other reasons not protocol specified|1|||
147183934|NCT02519439|530839872|FG000|Overall Study|Study Termination|19|||
147183935|NCT02519439|530839872|FG000|Overall Study|Withdrawal by Subject|1|||
147183936|NCT02519439|530839872|FG000|Overall Study|Adverse Event|1|||
147183937|NCT01078441|530839875|FG000|Overall Study|Withdrawal by Subject|1|||
147183938|NCT02868554|530839876|FG000|Overall Study|Lost to Follow-up|3|||
147183939|NCT02868554|530839877|FG001|Overall Study|Lost to Follow-up|0|||
147183940|NCT02868554|530839878|FG002|Overall Study|Lost to Follow-up|1|||
147183941|NCT04915729|530839879|FG000|Overall Study|Lost to Follow-up|20|||
147183942|NCT04915729|530839880|FG001|Overall Study|Lost to Follow-up|10|||
147183943|NCT04915729|530839879|FG000|Overall Study|Withdrawal by Subject|12|||
147183944|NCT04915729|530839880|FG001|Overall Study|Withdrawal by Subject|5|||
147183945|NCT04915729|530839879|FG000|Overall Study|Death|34|||
147246851|NCT03129100|531072783|FG024|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
147246852|NCT03129100|531072784|FG025|Period3-Long-Term Extension Period A & B|Escalated to IXE80Q2W|0|||
147246853|NCT03129100|531072759|FG000|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
147246854|NCT03129100|531072760|FG001|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
147246855|NCT03129100|531072761|FG002|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
147246856|NCT03129100|531072762|FG003|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
147246857|NCT03129100|531072763|FG004|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
147246858|NCT03129100|531072764|FG005|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
147183946|NCT04915729|530839880|FG001|Overall Study|Death|44|||
147183947|NCT04915729|530839879|FG000|Overall Study|not treated|3|||
147183948|NCT04915729|530839880|FG001|Overall Study|not treated|6|||
147246859|NCT03129100|531072765|FG006|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
147183949|NCT04915729|530839879|FG000|Overall Study|Investigator removed subject|1|||
147183950|NCT04915729|530839880|FG001|Overall Study|Investigator removed subject|2|||
147183951|NCT04915729|530839879|FG000|Overall Study|questionnaire result not evaluated|1|||
147246860|NCT03129100|531072766|FG007|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
147183952|NCT04915729|530839880|FG001|Overall Study|questionnaire result not evaluated|0|||
147183953|NCT04915729|530839879|FG000|Overall Study|refuse of hospital visit|1|||
147183954|NCT04915729|530839880|FG001|Overall Study|refuse of hospital visit|3|||
147183955|NCT04915729|530839879|FG000|Overall Study|Subject withdrew|1|||
147183956|NCT04915729|530839880|FG001|Overall Study|Subject withdrew|0|||
147183957|NCT04961541|530839881|FG000|Overall Study|Adverse Event|0|||
147183958|NCT04961541|530839882|FG001|Overall Study|Adverse Event|0|||
147183959|NCT04961541|530839883|FG002|Overall Study|Adverse Event|0|||
147183960|NCT04961541|530839884|FG003|Overall Study|Adverse Event|0|||
147183961|NCT04961541|530839885|FG004|Overall Study|Adverse Event|0|||
147183962|NCT04961541|530839886|FG005|Overall Study|Adverse Event|1|||
147183963|NCT04961541|530839887|FG006|Overall Study|Adverse Event|0|||
147183964|NCT04961541|530839888|FG007|Overall Study|Adverse Event|0|||
147183965|NCT04961541|530839889|FG008|Overall Study|Adverse Event|0|||
147183966|NCT04961541|530839890|FG009|Overall Study|Adverse Event|0|||
147183967|NCT04961541|530839891|FG010|Overall Study|Adverse Event|0|||
147183968|NCT04961541|530839892|FG011|Overall Study|Adverse Event|0|||
147183969|NCT04961541|530839893|FG012|Overall Study|Adverse Event|0|||
147183970|NCT04961541|530839894|FG013|Overall Study|Adverse Event|0|||
147183971|NCT04961541|530839881|FG000|Overall Study|Lost to Follow-up|0|||
147183972|NCT04961541|530839882|FG001|Overall Study|Lost to Follow-up|0|||
147183973|NCT04961541|530839883|FG002|Overall Study|Lost to Follow-up|3|||
147183974|NCT04961541|530839884|FG003|Overall Study|Lost to Follow-up|0|||
147183975|NCT04961541|530839885|FG004|Overall Study|Lost to Follow-up|0|||
147183976|NCT04961541|530839886|FG005|Overall Study|Lost to Follow-up|0|||
147183977|NCT04961541|530839887|FG006|Overall Study|Lost to Follow-up|1|||
147183978|NCT04961541|530839888|FG007|Overall Study|Lost to Follow-up|1|||
147183979|NCT04961541|530839889|FG008|Overall Study|Lost to Follow-up|0|||
147183980|NCT04961541|530839890|FG009|Overall Study|Lost to Follow-up|1|||
147183981|NCT04961541|530839891|FG010|Overall Study|Lost to Follow-up|0|||
147183982|NCT04961541|530839892|FG011|Overall Study|Lost to Follow-up|0|||
147183983|NCT04961541|530839893|FG012|Overall Study|Lost to Follow-up|1|||
147183984|NCT04961541|530839894|FG013|Overall Study|Lost to Follow-up|0|||
147183985|NCT04961541|530839881|FG000|Overall Study|Withdrawal by Subject|0|||
147183986|NCT04961541|530839882|FG001|Overall Study|Withdrawal by Subject|0|||
147183987|NCT04961541|530839883|FG002|Overall Study|Withdrawal by Subject|1|||
147183988|NCT04961541|530839884|FG003|Overall Study|Withdrawal by Subject|1|||
147183989|NCT04961541|530839885|FG004|Overall Study|Withdrawal by Subject|0|||
147183990|NCT04961541|530839886|FG005|Overall Study|Withdrawal by Subject|0|||
147183991|NCT04961541|530839887|FG006|Overall Study|Withdrawal by Subject|0|||
147183992|NCT04961541|530839888|FG007|Overall Study|Withdrawal by Subject|0|||
147183993|NCT04961541|530839889|FG008|Overall Study|Withdrawal by Subject|0|||
147183994|NCT04961541|530839890|FG009|Overall Study|Withdrawal by Subject|1|||
147183995|NCT04961541|530839891|FG010|Overall Study|Withdrawal by Subject|0|||
147183996|NCT04961541|530839892|FG011|Overall Study|Withdrawal by Subject|0|||
147183997|NCT04961541|530839893|FG012|Overall Study|Withdrawal by Subject|0|||
147183998|NCT04961541|530839894|FG013|Overall Study|Withdrawal by Subject|0|||
147183999|NCT00191308|530839895|FG000|Overall Study|Adverse Event|1|||
147184000|NCT03710642|530839897|FG000|Overall Study|Adverse Event|5|||
147184001|NCT03710642|530839898|FG001|Overall Study|Adverse Event|1|||
147184002|NCT03710642|530839897|FG000|Overall Study|non-site physician recommendation|1|||
147184003|NCT03710642|530839898|FG001|Overall Study|non-site physician recommendation|0|||
147184004|NCT03710642|530839897|FG000|Overall Study|Participant unwilling or unable to participate|1|||
147184005|NCT03710642|530839898|FG001|Overall Study|Participant unwilling or unable to participate|1|||
147184006|NCT03710642|530839897|FG000|Overall Study|"other is selected as the reason for study termination"|1|||
147184007|NCT03710642|530839898|FG001|Overall Study|"other is selected as the reason for study termination"|3|||
147184008|NCT03710642|530839897|FG000|Overall Study|NA-no code provided|1|||
147184009|NCT03710642|530839898|FG001|Overall Study|NA-no code provided|0|||
147184010|NCT03710642|530839897|FG000|Overall Study|Withdrawal by Subject|1|||
147184011|NCT03710642|530839898|FG001|Overall Study|Withdrawal by Subject|0|||
147184012|NCT01970306|530839899|FG000|Overall Study|Not eligible|3|||
147184013|NCT01970306|530839899|FG000|Overall Study|Not able to be treated|9|||
147184014|NCT03066596|530839900|FG000|Overall Study|Withdrawal by Subject|4|||
147184015|NCT03066596|530839901|FG001|Overall Study|Withdrawal by Subject|2|||
147184016|NCT03066596|530839900|FG000|Overall Study|Lost to Follow-up|14|||
147184017|NCT03066596|530839901|FG001|Overall Study|Lost to Follow-up|10|||
147184018|NCT02864901|530839902|FG000|Overall Study|Withdrawal by Subject|1|||
147184019|NCT02864901|530839903|FG001|Overall Study|Withdrawal by Subject|0|||
147246861|NCT03129100|531072767|FG008|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
147246862|NCT03129100|531072768|FG009|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
147246863|NCT03129100|531072769|FG010|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
147246864|NCT03129100|531072770|FG011|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
147246865|NCT03129100|531072771|FG012|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
147246866|NCT03129100|531072772|FG013|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
147246867|NCT03129100|531072773|FG014|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
147246868|NCT03129100|531072774|FG015|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
147184020|NCT00782717|530839904|FG000|Overall Study|Adverse Event|2|||
147184021|NCT00782717|530839905|FG001|Overall Study|Adverse Event|5|||
147184022|NCT00782717|530839904|FG000|Overall Study|Patient decision unrelated to AE|6|||
147184023|NCT00782717|530839905|FG001|Overall Study|Patient decision unrelated to AE|3|||
147184024|NCT00782717|530839904|FG000|Overall Study|Noncompliance|2|||
147184025|NCT00782717|530839905|FG001|Overall Study|Noncompliance|1|||
147246869|NCT03129100|531072775|FG016|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
147246870|NCT03129100|531072776|FG017|Period 3 (Flare)|Escalated to IXE80Q2W|2|||
147246871|NCT03129100|531072777|FG018|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
147246872|NCT03129100|531072778|FG019|Period 3 (Flare)|Escalated to IXE80Q2W|3|||
147246873|NCT03129100|531072779|FG020|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
147246874|NCT03129100|531072780|FG021|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
147246875|NCT03129100|531072781|FG022|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
147246876|NCT03129100|531072782|FG023|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
147246877|NCT03129100|531072783|FG024|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
147246878|NCT03129100|531072784|FG025|Period 3 (Flare)|Escalated to IXE80Q2W|0|||
147246879|NCT03129100|531072759|FG000|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
147246880|NCT03129100|531072760|FG001|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
147246881|NCT03129100|531072761|FG002|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
147246882|NCT03129100|531072762|FG003|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
147246883|NCT03129100|531072763|FG004|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
147246884|NCT03129100|531072764|FG005|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
147246885|NCT03129100|531072765|FG006|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
147246886|NCT03129100|531072766|FG007|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
147246887|NCT03129100|531072767|FG008|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
147246888|NCT03129100|531072768|FG009|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
147246889|NCT03129100|531072769|FG010|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
147246890|NCT03129100|531072770|FG011|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
147246891|NCT03129100|531072771|FG012|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
147246892|NCT03129100|531072772|FG013|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
147246893|NCT03129100|531072773|FG014|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
147246894|NCT03129100|531072774|FG015|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
147246895|NCT03129100|531072775|FG016|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
147246896|NCT03129100|531072776|FG017|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
147246897|NCT03129100|531072777|FG018|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
147246898|NCT03129100|531072778|FG019|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
147246899|NCT03129100|531072779|FG020|Period 3 (Dose Escalation)|Withdrawal by Subject|2|||
147246900|NCT03129100|531072780|FG021|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
147246901|NCT03129100|531072781|FG022|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
147246902|NCT03129100|531072782|FG023|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
147246903|NCT03129100|531072783|FG024|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
147246904|NCT03129100|531072784|FG025|Period 3 (Dose Escalation)|Withdrawal by Subject|0|||
147246905|NCT03129100|531072759|FG000|Period 3 (Dose Escalation)|Physician Decision|0|||
147246906|NCT03129100|531072760|FG001|Period 3 (Dose Escalation)|Physician Decision|0|||
147246907|NCT03129100|531072761|FG002|Period 3 (Dose Escalation)|Physician Decision|0|||
147246908|NCT03129100|531072762|FG003|Period 3 (Dose Escalation)|Physician Decision|0|||
147246909|NCT03129100|531072763|FG004|Period 3 (Dose Escalation)|Physician Decision|0|||
147246910|NCT03129100|531072764|FG005|Period 3 (Dose Escalation)|Physician Decision|0|||
147246911|NCT03129100|531072765|FG006|Period 3 (Dose Escalation)|Physician Decision|0|||
147246912|NCT03129100|531072766|FG007|Period 3 (Dose Escalation)|Physician Decision|0|||
147246913|NCT03129100|531072767|FG008|Period 3 (Dose Escalation)|Physician Decision|0|||
147246914|NCT03129100|531072768|FG009|Period 3 (Dose Escalation)|Physician Decision|0|||
147246915|NCT03129100|531072769|FG010|Period 3 (Dose Escalation)|Physician Decision|0|||
147246916|NCT03129100|531072770|FG011|Period 3 (Dose Escalation)|Physician Decision|0|||
147246917|NCT03129100|531072771|FG012|Period 3 (Dose Escalation)|Physician Decision|0|||
147246918|NCT03129100|531072772|FG013|Period 3 (Dose Escalation)|Physician Decision|0|||
147246919|NCT03129100|531072773|FG014|Period 3 (Dose Escalation)|Physician Decision|0|||
147246920|NCT03129100|531072774|FG015|Period 3 (Dose Escalation)|Physician Decision|0|||
147246921|NCT03129100|531072775|FG016|Period 3 (Dose Escalation)|Physician Decision|0|||
147246922|NCT03129100|531072776|FG017|Period 3 (Dose Escalation)|Physician Decision|0|||
147246923|NCT03129100|531072777|FG018|Period 3 (Dose Escalation)|Physician Decision|0|||
147246924|NCT03129100|531072778|FG019|Period 3 (Dose Escalation)|Physician Decision|0|||
147246925|NCT03129100|531072779|FG020|Period 3 (Dose Escalation)|Physician Decision|1|||
147246926|NCT03129100|531072780|FG021|Period 3 (Dose Escalation)|Physician Decision|0|||
147246927|NCT03129100|531072781|FG022|Period 3 (Dose Escalation)|Physician Decision|0|||
147246928|NCT03129100|531072782|FG023|Period 3 (Dose Escalation)|Physician Decision|0|||
147246929|NCT03129100|531072783|FG024|Period 3 (Dose Escalation)|Physician Decision|0|||
147246930|NCT03129100|531072784|FG025|Period 3 (Dose Escalation)|Physician Decision|0|||
147246931|NCT03129100|531072759|FG000|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
147328094|NCT03068468|531367917|FG001|Placebo-Controlled Period|Withdrawal by Subject|11|||
147246932|NCT03129100|531072760|FG001|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
147328095|NCT03068468|531367918|FG002|Placebo-Controlled Period|Withdrawal by Subject|0|||
147328096|NCT03068468|531367919|FG003|Placebo-Controlled Period|Withdrawal by Subject|0|||
147328097|NCT03068468|531367916|FG000|Placebo-Controlled Period|Withdrawal by Parent/Guardian|1|||
147328098|NCT03068468|531367917|FG001|Placebo-Controlled Period|Withdrawal by Parent/Guardian|2|||
147246933|NCT03129100|531072761|FG002|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
147593870|NCT03977701|532329044|FG008|Overall Study|COVID-19 pandemic|0|||
147328099|NCT03068468|531367918|FG002|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
147184026|NCT00782717|530839904|FG000|Overall Study|Treatment failure|3|||
147184027|NCT00782717|530839905|FG001|Overall Study|Treatment failure|14|||
147184028|NCT00782717|530839904|FG000|Overall Study|Enrollment close prior to surgery|1|||
147184029|NCT00782717|530839905|FG001|Overall Study|Enrollment close prior to surgery|0|||
147184030|NCT00782717|530839904|FG000|Overall Study|Did not meet entrance criteria|1|||
147184031|NCT00782717|530839905|FG001|Overall Study|Did not meet entrance criteria|3|||
147184032|NCT00782717|530839904|FG000|Overall Study|Exited in error|0|||
147184033|NCT00782717|530839905|FG001|Overall Study|Exited in error|2|||
147184034|NCT02446717|530839906|FG000|Overall Study|Adverse Event|0|||
147184035|NCT02446717|530839907|FG001|Overall Study|Adverse Event|0|||
147184036|NCT02446717|530839908|FG002|Overall Study|Adverse Event|1|||
147184037|NCT02446717|530839909|FG003|Overall Study|Adverse Event|0|||
147184038|NCT02446717|530839910|FG004|Overall Study|Adverse Event|0|||
147184039|NCT02446717|530839906|FG000|Overall Study|Lost to Follow-up|0|||
147184040|NCT02446717|530839907|FG001|Overall Study|Lost to Follow-up|1|||
147184041|NCT02446717|530839908|FG002|Overall Study|Lost to Follow-up|1|||
147184042|NCT02446717|530839909|FG003|Overall Study|Lost to Follow-up|0|||
147184043|NCT02446717|530839910|FG004|Overall Study|Lost to Follow-up|1|||
147184044|NCT02446717|530839906|FG000|Overall Study|Withdrew consent|0|||
147184045|NCT02446717|530839907|FG001|Overall Study|Withdrew consent|0|||
147184046|NCT02446717|530839908|FG002|Overall Study|Withdrew consent|0|||
147184047|NCT02446717|530839909|FG003|Overall Study|Withdrew consent|1|||
147184048|NCT02446717|530839910|FG004|Overall Study|Withdrew consent|0|||
147184049|NCT05167825|530839913|FG000|Overall Study|Ongoing|3|||
147184050|NCT04739436|530839916|FG000|Overall Study|Lost to Follow-up|21|||
147184051|NCT04739436|530839917|FG001|Overall Study|Lost to Follow-up|23|||
147184052|NCT04739436|530839916|FG000|Overall Study|Withdrawal by Subject|4|||
147184053|NCT04739436|530839917|FG001|Overall Study|Withdrawal by Subject|6|||
147184054|NCT04739436|530839916|FG000|Overall Study|not randomized properly|1|||
147184055|NCT04739436|530839917|FG001|Overall Study|not randomized properly|0|||
147184056|NCT03201419|530839919|FG000|Overall Study|Adverse Event|3|||
147184057|NCT03201419|530839920|FG001|Overall Study|Adverse Event|1|||
147184058|NCT03201419|530839921|FG002|Overall Study|Adverse Event|0|||
147184059|NCT03201419|530839922|FG003|Overall Study|Adverse Event|0|||
147184060|NCT03201419|530839923|FG004|Overall Study|Adverse Event|1|||
147184061|NCT03201419|530839924|FG005|Overall Study|Adverse Event|1|||
147184062|NCT03201419|530839925|FG006|Overall Study|Adverse Event|5|||
147184063|NCT03201419|530839926|FG007|Overall Study|Adverse Event|0|||
147184064|NCT03201419|530839927|FG008|Overall Study|Adverse Event|0|||
147184065|NCT03201419|530839919|FG000|Overall Study|Lost to Follow-up|1|||
147184066|NCT03201419|530839920|FG001|Overall Study|Lost to Follow-up|0|||
147184067|NCT03201419|530839921|FG002|Overall Study|Lost to Follow-up|0|||
147184068|NCT03201419|530839922|FG003|Overall Study|Lost to Follow-up|0|||
147184069|NCT03201419|530839923|FG004|Overall Study|Lost to Follow-up|0|||
147184070|NCT03201419|530839924|FG005|Overall Study|Lost to Follow-up|0|||
147184071|NCT03201419|530839925|FG006|Overall Study|Lost to Follow-up|0|||
147184072|NCT03201419|530839926|FG007|Overall Study|Lost to Follow-up|0|||
147184073|NCT03201419|530839927|FG008|Overall Study|Lost to Follow-up|0|||
147184074|NCT03201419|530839919|FG000|Overall Study|Protocol Deviation|0|||
147184075|NCT03201419|530839920|FG001|Overall Study|Protocol Deviation|0|||
147184076|NCT03201419|530839921|FG002|Overall Study|Protocol Deviation|0|||
147184077|NCT03201419|530839922|FG003|Overall Study|Protocol Deviation|0|||
147184078|NCT03201419|530839923|FG004|Overall Study|Protocol Deviation|0|||
147184079|NCT03201419|530839924|FG005|Overall Study|Protocol Deviation|0|||
147184080|NCT03201419|530839925|FG006|Overall Study|Protocol Deviation|1|||
147184081|NCT03201419|530839926|FG007|Overall Study|Protocol Deviation|0|||
147184082|NCT03201419|530839927|FG008|Overall Study|Protocol Deviation|0|||
147184083|NCT03201419|530839919|FG000|Overall Study|Withdrawal by Subject|4|||
147184084|NCT03201419|530839920|FG001|Overall Study|Withdrawal by Subject|2|||
147184085|NCT03201419|530839921|FG002|Overall Study|Withdrawal by Subject|1|||
147328100|NCT03068468|531367919|FG003|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
147328101|NCT03068468|531367916|FG000|Placebo-Controlled Period|Reason Not Specified|1|||
147184086|NCT03201419|530839922|FG003|Overall Study|Withdrawal by Subject|0|||
147184087|NCT03201419|530839923|FG004|Overall Study|Withdrawal by Subject|0|||
147184088|NCT03201419|530839924|FG005|Overall Study|Withdrawal by Subject|0|||
147184089|NCT03201419|530839925|FG006|Overall Study|Withdrawal by Subject|0|||
147328102|NCT03068468|531367917|FG001|Placebo-Controlled Period|Reason Not Specified|6|||
147184090|NCT03201419|530839926|FG007|Overall Study|Withdrawal by Subject|1|||
147184091|NCT03201419|530839927|FG008|Overall Study|Withdrawal by Subject|2|||
147184092|NCT03201419|530839919|FG000|Overall Study|Other|0|||
147184093|NCT03201419|530839920|FG001|Overall Study|Other|0|||
147184094|NCT03201419|530839921|FG002|Overall Study|Other|1|||
147184095|NCT03201419|530839922|FG003|Overall Study|Other|0|||
147184096|NCT03201419|530839923|FG004|Overall Study|Other|0|||
147184097|NCT03201419|530839924|FG005|Overall Study|Other|0|||
147184098|NCT03201419|530839925|FG006|Overall Study|Other|0|||
147184099|NCT03201419|530839926|FG007|Overall Study|Other|0|||
147184100|NCT03201419|530839927|FG008|Overall Study|Other|0|||
147593871|NCT03977701|532329045|FG009|Overall Study|COVID-19 pandemic|0|||
147328103|NCT03068468|531367918|FG002|Placebo-Controlled Period|Reason Not Specified|0|||
147328104|NCT03068468|531367919|FG003|Placebo-Controlled Period|Reason Not Specified|0|||
147328105|NCT03068468|531367916|FG000|Placebo-Controlled Period|Death|0|||
147448553|NCT01964352|531807891|FG001|Overall Study|Other than stated above|2|||
147184101|NCT02701283|530839928|FG000|Overall Study|Death|25|||
147184102|NCT02701283|530839929|FG001|Overall Study|Death|29|||
147184103|NCT02701283|530839930|FG002|Overall Study|Death|19|||
147184104|NCT02701283|530839928|FG000|Overall Study|Lost to Follow-up|3|||
147184105|NCT02701283|530839929|FG001|Overall Study|Lost to Follow-up|8|||
147184106|NCT02701283|530839930|FG002|Overall Study|Lost to Follow-up|1|||
147184107|NCT02701283|530839928|FG000|Overall Study|Withdrawal by Subject|12|||
147184108|NCT02701283|530839929|FG001|Overall Study|Withdrawal by Subject|41|||
147184109|NCT02701283|530839930|FG002|Overall Study|Withdrawal by Subject|1|||
147184110|NCT02701283|530839928|FG000|Overall Study|Missed 2-year visit|22|||
147184111|NCT02701283|530839929|FG001|Overall Study|Missed 2-year visit|27|||
147184112|NCT02701283|530839930|FG002|Overall Study|Missed 2-year visit|0|||
147184113|NCT02701283|530839928|FG000|Overall Study|Exited prior to procedure (3 subjects crossed over from SAVR to TAVR)|7|||
147184114|NCT02701283|530839929|FG001|Overall Study|Exited prior to procedure (3 subjects crossed over from SAVR to TAVR)|57|||
147184115|NCT02701283|530839930|FG002|Overall Study|Exited prior to procedure (3 subjects crossed over from SAVR to TAVR)|0|||
147184116|NCT00892775|530839931|FG000|Overall Study|Protocol Violation|1|||
147184117|NCT00892775|530839932|FG001|Overall Study|Protocol Violation|0|||
147184118|NCT00892775|530839931|FG000|Overall Study|Subject difficulties with blood drawing|1|||
147184119|NCT00892775|530839932|FG001|Overall Study|Subject difficulties with blood drawing|0|||
147184120|NCT00892775|530839931|FG000|Overall Study|Disclaimer/ Withdrawal caused by H1N1|1|||
147184121|NCT00892775|530839932|FG001|Overall Study|Disclaimer/ Withdrawal caused by H1N1|0|||
147184122|NCT00892775|530839931|FG000|Overall Study|Migrated/ moved from study area|1|||
147184123|NCT00892775|530839932|FG001|Overall Study|Migrated/ moved from study area|0|||
147184124|NCT00892775|530839931|FG000|Overall Study|Withdrawal by Subject|0|||
147184125|NCT00892775|530839932|FG001|Overall Study|Withdrawal by Subject|1|||
147184126|NCT00892775|530839931|FG000|Overall Study|Lost to Follow-up|1|||
147184127|NCT00892775|530839932|FG001|Overall Study|Lost to Follow-up|0|||
147184128|NCT00398320|530839933|FG000|Overall Study|Death|1|||
147184129|NCT00398320|530839933|FG000|Overall Study|Adverse Event|4|||
147184130|NCT00398320|530839933|FG000|Overall Study|Physician Decision|1|||
147184131|NCT00064792|530839934|FG000|Overall Study|Withdrawal by Subject|2|||
147184132|NCT00064792|530839935|FG001|Overall Study|Withdrawal by Subject|0|||
147184133|NCT00064792|530839934|FG000|Overall Study|Adverse Event|3|||
147184134|NCT00064792|530839935|FG001|Overall Study|Adverse Event|0|||
147184135|NCT03160898|530839936|FG000|Overall Study|Adverse Event|4|||
147184136|NCT03160898|530839937|FG001|Overall Study|Adverse Event|8|||
147184137|NCT03160898|530839938|FG002|Overall Study|Adverse Event|7|||
147184138|NCT03160898|530839939|FG003|Overall Study|Adverse Event|10|||
147184139|NCT03160898|530839936|FG000|Overall Study|Death|1|||
147184140|NCT03160898|530839937|FG001|Overall Study|Death|0|||
147184141|NCT03160898|530839938|FG002|Overall Study|Death|0|||
147184142|NCT03160898|530839939|FG003|Overall Study|Death|1|||
147184143|NCT03160898|530839936|FG000|Overall Study|Difficulty Traveling to Clinic Visits|3|||
147184144|NCT03160898|530839937|FG001|Overall Study|Difficulty Traveling to Clinic Visits|0|||
147184145|NCT03160898|530839938|FG002|Overall Study|Difficulty Traveling to Clinic Visits|0|||
147184146|NCT03160898|530839939|FG003|Overall Study|Difficulty Traveling to Clinic Visits|1|||
147184147|NCT03160898|530839936|FG000|Overall Study|Lost to Follow-up|1|||
147246934|NCT03129100|531072762|FG003|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
147246935|NCT03129100|531072763|FG004|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
147246936|NCT03129100|531072764|FG005|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
147246937|NCT03129100|531072765|FG006|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
147246938|NCT03129100|531072766|FG007|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
147246939|NCT03129100|531072767|FG008|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
147246940|NCT03129100|531072768|FG009|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
147246941|NCT03129100|531072769|FG010|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
147246942|NCT03129100|531072770|FG011|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
147246943|NCT03129100|531072771|FG012|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
147246944|NCT03129100|531072772|FG013|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
147246945|NCT03129100|531072773|FG014|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
147246946|NCT03129100|531072774|FG015|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
147246947|NCT03129100|531072775|FG016|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
147246948|NCT03129100|531072776|FG017|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
147448554|NCT01964352|531807892|FG002|Overall Study|Other than stated above|1|||
147184148|NCT03160898|530839937|FG001|Overall Study|Lost to Follow-up|1|||
147184149|NCT03160898|530839938|FG002|Overall Study|Lost to Follow-up|1|||
147184150|NCT03160898|530839939|FG003|Overall Study|Lost to Follow-up|2|||
147184151|NCT03160898|530839936|FG000|Overall Study|Physician Decision|1|||
147184152|NCT03160898|530839937|FG001|Overall Study|Physician Decision|0|||
147184153|NCT03160898|530839938|FG002|Overall Study|Physician Decision|0|||
147246949|NCT03129100|531072777|FG018|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
147246950|NCT03129100|531072778|FG019|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
147246951|NCT03129100|531072779|FG020|Period 3 (Dose Escalation)|Lack of Efficacy|1|||
147246952|NCT03129100|531072780|FG021|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
147246953|NCT03129100|531072781|FG022|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
147246954|NCT03129100|531072782|FG023|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
147246955|NCT03129100|531072783|FG024|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
147246956|NCT03129100|531072784|FG025|Period 3 (Dose Escalation)|Lack of Efficacy|0|||
147246957|NCT03129100|531072759|FG000|Period 4 (Post Treatment Follow-up)|Death|0|||
147246958|NCT03129100|531072760|FG001|Period 4 (Post Treatment Follow-up)|Death|0|||
147246959|NCT03129100|531072761|FG002|Period 4 (Post Treatment Follow-up)|Death|0|||
147246960|NCT03129100|531072762|FG003|Period 4 (Post Treatment Follow-up)|Death|0|||
147246961|NCT03129100|531072763|FG004|Period 4 (Post Treatment Follow-up)|Death|0|||
147246962|NCT03129100|531072764|FG005|Period 4 (Post Treatment Follow-up)|Death|0|||
147246963|NCT03129100|531072765|FG006|Period 4 (Post Treatment Follow-up)|Death|0|||
147246964|NCT03129100|531072766|FG007|Period 4 (Post Treatment Follow-up)|Death|0|||
147246965|NCT03129100|531072767|FG008|Period 4 (Post Treatment Follow-up)|Death|0|||
147246966|NCT03129100|531072768|FG009|Period 4 (Post Treatment Follow-up)|Death|0|||
147246967|NCT03129100|531072769|FG010|Period 4 (Post Treatment Follow-up)|Death|0|||
147246968|NCT03129100|531072770|FG011|Period 4 (Post Treatment Follow-up)|Death|0|||
147246969|NCT03129100|531072771|FG012|Period 4 (Post Treatment Follow-up)|Death|0|||
147246970|NCT03129100|531072772|FG013|Period 4 (Post Treatment Follow-up)|Death|0|||
147246971|NCT03129100|531072773|FG014|Period 4 (Post Treatment Follow-up)|Death|0|||
147246972|NCT03129100|531072774|FG015|Period 4 (Post Treatment Follow-up)|Death|0|||
147246973|NCT03129100|531072775|FG016|Period 4 (Post Treatment Follow-up)|Death|0|||
147246974|NCT03129100|531072776|FG017|Period 4 (Post Treatment Follow-up)|Death|0|||
147246975|NCT03129100|531072777|FG018|Period 4 (Post Treatment Follow-up)|Death|0|||
147246976|NCT03129100|531072778|FG019|Period 4 (Post Treatment Follow-up)|Death|0|||
147246977|NCT03129100|531072779|FG020|Period 4 (Post Treatment Follow-up)|Death|0|||
147328106|NCT03068468|531367917|FG001|Placebo-Controlled Period|Death|1|||
147328107|NCT03068468|531367918|FG002|Placebo-Controlled Period|Death|0|||
147328108|NCT03068468|531367919|FG003|Placebo-Controlled Period|Death|0|||
147328109|NCT03068468|531367916|FG000|Open-Label Extension Period|Lack of Efficacy|0|||
147328110|NCT03068468|531367917|FG001|Open-Label Extension Period|Lack of Efficacy|0|||
147328111|NCT03068468|531367918|FG002|Open-Label Extension Period|Lack of Efficacy|1|||
147328112|NCT03068468|531367919|FG003|Open-Label Extension Period|Lack of Efficacy|2|||
147328113|NCT03068468|531367916|FG000|Open-Label Extension Period|Adverse Event|0|||
147328114|NCT03068468|531367917|FG001|Open-Label Extension Period|Adverse Event|0|||
147328115|NCT03068468|531367918|FG002|Open-Label Extension Period|Adverse Event|13|||
147328116|NCT03068468|531367919|FG003|Open-Label Extension Period|Adverse Event|17|||
147328117|NCT03068468|531367916|FG000|Open-Label Extension Period|Withdrawal by Subject|0|||
147328118|NCT03068468|531367917|FG001|Open-Label Extension Period|Withdrawal by Subject|0|||
147328119|NCT03068468|531367918|FG002|Open-Label Extension Period|Withdrawal by Subject|7|||
147328120|NCT03068468|531367919|FG003|Open-Label Extension Period|Withdrawal by Subject|20|||
147328121|NCT03068468|531367916|FG000|Open-Label Extension Period|Death|0|||
147328122|NCT03068468|531367917|FG001|Open-Label Extension Period|Death|0|||
147328123|NCT03068468|531367918|FG002|Open-Label Extension Period|Death|0|||
147328124|NCT03068468|531367919|FG003|Open-Label Extension Period|Death|1|||
147328125|NCT03068468|531367916|FG000|Open-Label Extension Period|Lost to Follow-up|0|||
147328126|NCT03068468|531367917|FG001|Open-Label Extension Period|Lost to Follow-up|0|||
147328127|NCT03068468|531367918|FG002|Open-Label Extension Period|Lost to Follow-up|1|||
147328128|NCT03068468|531367919|FG003|Open-Label Extension Period|Lost to Follow-up|0|||
147328129|NCT03068468|531367916|FG000|Open-Label Extension Period|Failure to Meet Randomization Criteria|0|||
147328130|NCT03068468|531367917|FG001|Open-Label Extension Period|Failure to Meet Randomization Criteria|0|||
147328131|NCT03068468|531367918|FG002|Open-Label Extension Period|Failure to Meet Randomization Criteria|2|||
147328132|NCT03068468|531367919|FG003|Open-Label Extension Period|Failure to Meet Randomization Criteria|0|||
147328133|NCT03068468|531367916|FG000|Open-Label Extension Period|Withdrawal by Sponsor|0|||
147328134|NCT03068468|531367917|FG001|Open-Label Extension Period|Withdrawal by Sponsor|0|||
147328135|NCT03068468|531367918|FG002|Open-Label Extension Period|Withdrawal by Sponsor|115|||
147328136|NCT03068468|531367919|FG003|Open-Label Extension Period|Withdrawal by Sponsor|228|||
147328137|NCT03068468|531367916|FG000|Open-Label Extension Period|Withdrawal by Parent/Guardian|0|||
147328138|NCT03068468|531367917|FG001|Open-Label Extension Period|Withdrawal by Parent/Guardian|0|||
147328139|NCT03068468|531367918|FG002|Open-Label Extension Period|Withdrawal by Parent/Guardian|0|||
147328140|NCT03068468|531367919|FG003|Open-Label Extension Period|Withdrawal by Parent/Guardian|4|||
147328141|NCT03068468|531367916|FG000|Open-Label Extension Period|Reason not Specified|0|||
147246978|NCT03129100|531072780|FG021|Period 4 (Post Treatment Follow-up)|Death|0|||
147246979|NCT03129100|531072781|FG022|Period 4 (Post Treatment Follow-up)|Death|0|||
147246980|NCT03129100|531072782|FG023|Period 4 (Post Treatment Follow-up)|Death|0|||
147328142|NCT03068468|531367917|FG001|Open-Label Extension Period|Reason not Specified|0|||
147328143|NCT03068468|531367918|FG002|Open-Label Extension Period|Reason not Specified|1|||
147328144|NCT03068468|531367919|FG003|Open-Label Extension Period|Reason not Specified|4|||
147328145|NCT02466516|531367921|FG000|Overall Study|Adverse Event|1|||
147328146|NCT02466516|531367922|FG001|Overall Study|Adverse Event|1|||
147184154|NCT03160898|530839939|FG003|Overall Study|Physician Decision|1|||
147184155|NCT03160898|530839936|FG000|Overall Study|Progressive Disease|4|||
147184156|NCT03160898|530839937|FG001|Overall Study|Progressive Disease|1|||
147448555|NCT01964352|531807893|FG003|Overall Study|Other than stated above|2|||
147448556|NCT03468855|531807894|FG000|Overall Study|Adverse Event|2|||
147448557|NCT03468855|531807894|FG000|Overall Study|Lost to Follow-up|5|||
147448558|NCT03468855|531807894|FG000|Overall Study|Withdrawal by Subject|3|||
147448559|NCT03468855|531807894|FG000|Overall Study|Inclusion/Exclusion Enrollment Violator|1|||
147448560|NCT00879229|531807895|FG000|Overall Study|Study terminated by Sponsor|13|||
147328147|NCT02466516|531367923|FG002|Overall Study|Adverse Event|0|||
147328148|NCT02466516|531367924|FG003|Overall Study|Adverse Event|0|||
147328149|NCT02466516|531367925|FG004|Overall Study|Adverse Event|0|||
147328150|NCT02466516|531367921|FG000|Overall Study|Withdrew Consent|1|||
147184157|NCT03160898|530839938|FG002|Overall Study|Progressive Disease|2|||
147184158|NCT03160898|530839939|FG003|Overall Study|Progressive Disease|1|||
147184159|NCT03160898|530839936|FG000|Overall Study|Protocol Violation|1|||
147184160|NCT03160898|530839937|FG001|Overall Study|Protocol Violation|0|||
147184161|NCT03160898|530839938|FG002|Overall Study|Protocol Violation|2|||
147184162|NCT03160898|530839939|FG003|Overall Study|Protocol Violation|0|||
147184163|NCT03160898|530839936|FG000|Overall Study|Sponsor Discretion|2|||
147184164|NCT03160898|530839937|FG001|Overall Study|Sponsor Discretion|0|||
147184165|NCT03160898|530839938|FG002|Overall Study|Sponsor Discretion|0|||
147184166|NCT03160898|530839939|FG003|Overall Study|Sponsor Discretion|0|||
147184167|NCT03160898|530839936|FG000|Overall Study|Withdrawal by Subject|1|||
147184168|NCT03160898|530839937|FG001|Overall Study|Withdrawal by Subject|3|||
147184169|NCT03160898|530839938|FG002|Overall Study|Withdrawal by Subject|2|||
147184170|NCT03160898|530839939|FG003|Overall Study|Withdrawal by Subject|1|||
147184171|NCT03160898|530839936|FG000|Overall Study|Other|2|||
147184172|NCT03160898|530839937|FG001|Overall Study|Other|0|||
147328151|NCT02466516|531367922|FG001|Overall Study|Withdrew Consent|0|||
147328152|NCT02466516|531367923|FG002|Overall Study|Withdrew Consent|0|||
147328153|NCT02466516|531367924|FG003|Overall Study|Withdrew Consent|0|||
147328154|NCT02466516|531367925|FG004|Overall Study|Withdrew Consent|0|||
147328155|NCT02466516|531367921|FG000|Overall Study|Lost to Follow-up|2|||
147328156|NCT02466516|531367922|FG001|Overall Study|Lost to Follow-up|0|||
147328157|NCT02466516|531367923|FG002|Overall Study|Lost to Follow-up|1|||
147328158|NCT02466516|531367924|FG003|Overall Study|Lost to Follow-up|0|||
147328159|NCT02466516|531367925|FG004|Overall Study|Lost to Follow-up|0|||
147328160|NCT03712930|531367926|FG000|Overall Study|Death|7|||
147328161|NCT03712930|531367926|FG000|Overall Study|Physician Decision|1|||
147328162|NCT03712930|531367926|FG000|Overall Study|Study Terminated by Sponsor|3|||
147328163|NCT03712930|531367926|FG000|Overall Study|Progressive Disease|2|||
147328164|NCT03895034|531367927|FG000|Overall Study|Lost to Follow-up|2|||
147328165|NCT01510912|531367928|FG000|Overall Study|Adverse Event|99|||
147328166|NCT01510912|531367928|FG000|Overall Study|Lack of Efficacy|12|||
147328167|NCT01510912|531367928|FG000|Overall Study|Non-compliance with trial drug|23|||
147328168|NCT01510912|531367928|FG000|Overall Study|Withdrawal by Subject|49|||
147328169|NCT01510912|531367928|FG000|Overall Study|Physician Decision|1|||
147184173|NCT03160898|530839938|FG002|Overall Study|Other|2|||
147184174|NCT03160898|530839939|FG003|Overall Study|Other|2|||
147328170|NCT01510912|531367928|FG000|Overall Study|Protocol Violation|27|||
147328171|NCT01510912|531367928|FG000|Overall Study|Lost to Follow-up|26|||
147328172|NCT01510912|531367928|FG000|Overall Study|Other, including joint replacement|5|||
147328173|NCT03784963|531367929|FG000|Overall Study|Study terminated by PI for low/no enrollment. All efforts were taken to gather all possible data.|12|||
147448561|NCT00879229|531807896|FG001|Overall Study|Study terminated by Sponsor|12|||
147448562|NCT00879229|531807895|FG000|Overall Study|Death|4|||
147448563|NCT00879229|531807896|FG001|Overall Study|Death|2|||
147184175|NCT03405818|530839940|FG000|Overall Study|Withdrawal by Subject|4|||
147184176|NCT03405818|530839940|FG000|Overall Study|Lost to Follow-up|4|||
147184177|NCT00291486|530839943|FG000|Overall Study|Adverse Event|0|||
147184178|NCT00291486|530839944|FG001|Overall Study|Adverse Event|3|||
147184179|NCT00291486|530839945|FG002|Overall Study|Adverse Event|0|||
147184180|NCT00291486|530839946|FG003|Overall Study|Adverse Event|1|||
147184181|NCT00291486|530839947|FG004|Overall Study|Adverse Event|0|||
147184182|NCT00291486|530839943|FG000|Overall Study|Withdrawal by Subject|0|||
147184183|NCT00291486|530839944|FG001|Overall Study|Withdrawal by Subject|0|||
147184184|NCT00291486|530839945|FG002|Overall Study|Withdrawal by Subject|0|||
147184185|NCT00291486|530839946|FG003|Overall Study|Withdrawal by Subject|0|||
147184186|NCT00291486|530839947|FG004|Overall Study|Withdrawal by Subject|1|||
147184187|NCT00291486|530839943|FG000|Overall Study|Disease progression|1|||
147184188|NCT00291486|530839944|FG001|Overall Study|Disease progression|0|||
147184189|NCT00291486|530839945|FG002|Overall Study|Disease progression|1|||
147184190|NCT00291486|530839946|FG003|Overall Study|Disease progression|0|||
147184191|NCT00291486|530839947|FG004|Overall Study|Disease progression|0|||
147184192|NCT01045694|530839950|FG000|Overall Study|Withdrawal by Subject|2|||
147184193|NCT00992459|530839951|FG000|Overall Study|Withdrawal by Subject|0|||
147184194|NCT00992459|530839952|FG001|Overall Study|Withdrawal by Subject|1|||
147328174|NCT03784963|531367930|FG001|Overall Study|Study terminated by PI for low/no enrollment. All efforts were taken to gather all possible data.|10|||
147658255|NCT03272347|532572225|FG002|Overall Study|Lost to Follow-up|5|||
147658256|NCT03272347|532572226|FG003|Overall Study|Lost to Follow-up|1|||
147658257|NCT03272347|532572223|FG000|Overall Study|Physician Decision|4|||
147658258|NCT03272347|532572224|FG001|Overall Study|Physician Decision|2|||
147658259|NCT03272347|532572225|FG002|Overall Study|Physician Decision|5|||
147658260|NCT03272347|532572226|FG003|Overall Study|Physician Decision|4|||
147658261|NCT03272347|532572223|FG000|Overall Study|Screen Failure|1|||
147658262|NCT03272347|532572224|FG001|Overall Study|Screen Failure|0|||
147658263|NCT03272347|532572225|FG002|Overall Study|Screen Failure|0|||
147658264|NCT03272347|532572226|FG003|Overall Study|Screen Failure|0|||
147658265|NCT03272347|532572223|FG000|Overall Study|Withdrawal by Subject|5|||
147658266|NCT03272347|532572224|FG001|Overall Study|Withdrawal by Subject|1|||
147658267|NCT03272347|532572225|FG002|Overall Study|Withdrawal by Subject|2|||
147658268|NCT03272347|532572226|FG003|Overall Study|Withdrawal by Subject|1|||
147658269|NCT00940888|532572227|FG000|Overall Study|Unsuccessful Implant|4|||
147658270|NCT00940888|532572227|FG000|Overall Study|Death|461|||
147658271|NCT00940888|532572227|FG000|Overall Study|Withdrawn - Non-Death|364|||
147658272|NCT00940888|532572227|FG000|Overall Study|Lost to Follow-up|6|||
147658273|NCT02250300|532572230|FG000|Expansion Phase|Death|6|||
147658274|NCT02250300|532572231|FG001|Expansion Phase|Death|7|||
147658275|NCT02250300|532572232|FG002|Expansion Phase|Death|0|||
147658276|NCT02250300|532572233|FG003|Expansion Phase|Death|0|||
147658277|NCT03512353|532572234|FG000|Overall Study|Sponsor Decision|3|||
147658278|NCT03512353|532572234|FG000|Overall Study|Death|1|||
147328175|NCT03784963|531367931|FG002|Overall Study|Study terminated by PI for low/no enrollment. All efforts were taken to gather all possible data.|1|||
147328176|NCT03784963|531367932|FG003|Overall Study|Study terminated by PI for low/no enrollment. All efforts were taken to gather all possible data.|0|||
147658279|NCT03569098|532572235|FG000|Double-Blind Treatment Cycle 1|Withdrawal by Subject|5|||
147658280|NCT03569098|532572236|FG001|Double-Blind Treatment Cycle 1|Withdrawal by Subject|2|||
147184195|NCT00992459|530839951|FG000|Overall Study|Adverse Event|1|||
147328177|NCT03181958|531367933|FG000|Overall Study|Lost to Follow-up|17|||
147328178|NCT03181958|531367934|FG001|Overall Study|Lost to Follow-up|21|||
147328179|NCT03181958|531367935|FG002|Overall Study|Lost to Follow-up|15|||
147328180|NCT00349908|531367939|FG000|Overall Study|Withdrawal by Subject|0|||
147328181|NCT00349908|531367940|FG001|Overall Study|Withdrawal by Subject|4|||
147658281|NCT03569098|532572237|FG002|Double-Blind Treatment Cycle 1|Withdrawal by Subject|5|||
147658282|NCT03569098|532572235|FG000|Double-Blind Treatment Cycle 1|Study terminated by sponsor|0|||
147658283|NCT03569098|532572236|FG001|Double-Blind Treatment Cycle 1|Study terminated by sponsor|6|||
147658284|NCT03569098|532572237|FG002|Double-Blind Treatment Cycle 1|Study terminated by sponsor|3|||
147184196|NCT00992459|530839952|FG001|Overall Study|Adverse Event|0|||
147184197|NCT01408459|530839953|FG000|Overall Study|Withdrawal by Subject|1|||
147184198|NCT01408459|530839954|FG001|Overall Study|Withdrawal by Subject|1|||
147184199|NCT01657292|530839964|FG000|Overall Study|Adverse Event|6|||
147184200|NCT01657292|530839964|FG000|Overall Study|Withdrawal by Subject|2|||
147184201|NCT01657292|530839964|FG000|Overall Study|Violation of eligibility criteria|1|||
147184202|NCT01657292|530839964|FG000|Overall Study|Change of therapy|1|||
147184203|NCT04725500|530839966|FG000|Screening|Screen Failure|26|||
147184204|NCT04725500|530839966|FG000|Screening|Withdrawal by Subject|1|||
147184205|NCT04725500|530839966|FG000|2 Week Take Home|Screen Fail|5|||
147184206|NCT01467505|530841964|FG000|Overall Study|Adverse Event|1|||
147184207|NCT01467505|530841965|FG001|Overall Study|Adverse Event|0|||
147184208|NCT01467505|530841964|FG000|Overall Study|Withdrawal by Subject|4|||
147184209|NCT01467505|530841965|FG001|Overall Study|Withdrawal by Subject|0|||
147184210|NCT01467505|530841964|FG000|Overall Study|Study Terminated by Sponsor|28|||
147184211|NCT01467505|530841965|FG001|Overall Study|Study Terminated by Sponsor|3|||
147184212|NCT02807623|530841966|FG000|Overall Study|Lost to Follow-up|23|||
147184213|NCT02807623|530841967|FG001|Overall Study|Lost to Follow-up|18|||
147184214|NCT02807623|530841968|FG002|Overall Study|Lost to Follow-up|22|||
147184215|NCT02807623|530841966|FG000|Overall Study|Drug intolerance|0|||
147184216|NCT02807623|530841967|FG001|Overall Study|Drug intolerance|1|||
147184217|NCT02807623|530841968|FG002|Overall Study|Drug intolerance|0|||
147184218|NCT02807623|530841966|FG000|Overall Study|incomplete blood draw|0|||
147184219|NCT02807623|530841967|FG001|Overall Study|incomplete blood draw|2|||
147184220|NCT02807623|530841968|FG002|Overall Study|incomplete blood draw|1|||
147184221|NCT03811340|530841969|FG000|Overall Study|subjects did not complete the survey.|90|||
147184222|NCT05104450|530841970|FG000|Overall Study|Death|1|||
147184223|NCT05104450|530841971|FG001|Overall Study|Death|2|||
147184224|NCT05104450|530841970|FG000|Overall Study|Withdrawal by Subject|3|||
147184225|NCT05104450|530841971|FG001|Overall Study|Withdrawal by Subject|1|||
147184226|NCT01380769|530841972|FG000|Overall Study|Withdrawal by Subject|7|||
147184227|NCT01380769|530841973|FG001|Overall Study|Withdrawal by Subject|11|||
147184228|NCT01380769|530841972|FG000|Overall Study|Physician Decision|1|||
147184229|NCT01380769|530841973|FG001|Overall Study|Physician Decision|1|||
147184230|NCT01380769|530841972|FG000|Overall Study|Adverse Event|1|||
147184231|NCT01380769|530841973|FG001|Overall Study|Adverse Event|1|||
147184232|NCT01380769|530841972|FG000|Overall Study|Protocol Violation|0|||
147184233|NCT01380769|530841973|FG001|Overall Study|Protocol Violation|1|||
147328182|NCT00151996|531367943|FG000|Overall Study|Adverse Event|3|||
147328183|NCT00151996|531367944|FG001|Overall Study|Adverse Event|2|||
147328184|NCT00151996|531367943|FG000|Overall Study|Withdrawal by Subject|1|||
147184234|NCT01080807|530841975|FG000|Overall Study|Adverse Event|9|||
147184235|NCT01080807|530841976|FG001|Overall Study|Adverse Event|1|||
147184236|NCT01080807|530841975|FG000|Overall Study|Lack of Efficacy|0|||
147184237|NCT01080807|530841976|FG001|Overall Study|Lack of Efficacy|1|||
147184238|NCT01080807|530841975|FG000|Overall Study|Withdrawal by Subject|7|||
147184239|NCT01080807|530841976|FG001|Overall Study|Withdrawal by Subject|2|||
147184240|NCT01080807|530841975|FG000|Overall Study|Protocol Violation|7|||
147184241|NCT01080807|530841976|FG001|Overall Study|Protocol Violation|6|||
147184242|NCT01080807|530841975|FG000|Overall Study|Lost to Follow-up|6|||
147184243|NCT01080807|530841976|FG001|Overall Study|Lost to Follow-up|4|||
147184244|NCT01080807|530841975|FG000|Overall Study|Noncompliance with drug administration|1|||
147184245|NCT01080807|530841976|FG001|Overall Study|Noncompliance with drug administration|1|||
147184246|NCT01080807|530841975|FG000|Overall Study|Noncompliance to study procedures|1|||
147184247|NCT01080807|530841976|FG001|Overall Study|Noncompliance to study procedures|1|||
147184248|NCT01080807|530841975|FG000|Overall Study|Began working day shift|0|||
147184249|NCT01080807|530841976|FG001|Overall Study|Began working day shift|2|||
147184250|NCT01080807|530841975|FG000|Overall Study|Laid off or terminated from job|1|||
147246981|NCT03129100|531072783|FG024|Period 4 (Post Treatment Follow-up)|Death|1|||
147246982|NCT03129100|531072784|FG025|Period 4 (Post Treatment Follow-up)|Death|0|||
147246983|NCT03129100|531072759|FG000|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
147246984|NCT03129100|531072760|FG001|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
147246985|NCT03129100|531072761|FG002|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
147246986|NCT03129100|531072762|FG003|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
147246987|NCT03129100|531072763|FG004|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
147246988|NCT03129100|531072764|FG005|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
147246989|NCT03129100|531072765|FG006|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
147246990|NCT03129100|531072766|FG007|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
147246991|NCT03129100|531072767|FG008|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
147246992|NCT03129100|531072768|FG009|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
147246993|NCT03129100|531072769|FG010|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
147246994|NCT03129100|531072770|FG011|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
147246995|NCT03129100|531072771|FG012|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
147246996|NCT03129100|531072772|FG013|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
147246997|NCT03129100|531072773|FG014|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
147246998|NCT03129100|531072774|FG015|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
147246999|NCT03129100|531072775|FG016|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
147247000|NCT03129100|531072776|FG017|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
147247001|NCT03129100|531072777|FG018|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
147247002|NCT03129100|531072778|FG019|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
147247003|NCT03129100|531072779|FG020|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
147247004|NCT03129100|531072780|FG021|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
147247005|NCT03129100|531072781|FG022|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
147247006|NCT03129100|531072782|FG023|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|0|||
147247007|NCT03129100|531072783|FG024|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|2|||
147247008|NCT03129100|531072784|FG025|Period 4 (Post Treatment Follow-up)|Lost to Follow-up|2|||
147247009|NCT03129100|531072759|FG000|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
147247010|NCT03129100|531072760|FG001|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
147247011|NCT03129100|531072761|FG002|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
147247012|NCT03129100|531072762|FG003|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
147247013|NCT03129100|531072763|FG004|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
147247014|NCT03129100|531072764|FG005|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
147247015|NCT03129100|531072765|FG006|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
147247016|NCT03129100|531072766|FG007|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
147247017|NCT03129100|531072767|FG008|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
147247018|NCT03129100|531072768|FG009|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
147247019|NCT03129100|531072769|FG010|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
147247020|NCT03129100|531072770|FG011|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
147247021|NCT03129100|531072771|FG012|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
147247022|NCT03129100|531072772|FG013|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
147247023|NCT03129100|531072773|FG014|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
147247024|NCT03129100|531072774|FG015|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
147448564|NCT00879229|531807895|FG000|Overall Study|Adverse Event|2|||
147184251|NCT01080807|530841976|FG001|Overall Study|Laid off or terminated from job|2|||
147184252|NCT01080807|530841975|FG000|Overall Study|Stopped working consistent night shifts|0|||
147184253|NCT01080807|530841976|FG001|Overall Study|Stopped working consistent night shifts|1|||
147184254|NCT01080807|530841975|FG000|Overall Study|Work schedule changing|1|||
147184255|NCT01080807|530841976|FG001|Overall Study|Work schedule changing|1|||
147184256|NCT01080807|530841975|FG000|Overall Study|Work schedule and travel|0|||
147184257|NCT01080807|530841976|FG001|Overall Study|Work schedule and travel|1|||
147184258|NCT01080807|530841975|FG000|Overall Study|Switched to first shift|1|||
147184259|NCT01080807|530841976|FG001|Overall Study|Switched to first shift|0|||
147184260|NCT01080807|530841975|FG000|Overall Study|Moved away without notifying center|1|||
147184261|NCT01080807|530841976|FG001|Overall Study|Moved away without notifying center|0|||
147184262|NCT03456076|530841989|FG000|Overall Study|Withdrawal by Subject|5|||
147184263|NCT03456076|530841990|FG001|Overall Study|Withdrawal by Subject|9|||
147184264|NCT03456076|530841989|FG000|Overall Study|Protocol deviation|0|||
147184265|NCT03456076|530841990|FG001|Overall Study|Protocol deviation|1|||
147184266|NCT03456076|530841989|FG000|Overall Study|Lost to Follow-up|0|||
147184267|NCT03456076|530841990|FG001|Overall Study|Lost to Follow-up|1|||
147184268|NCT03456076|530841989|FG000|Overall Study|Death|2|||
147184269|NCT03456076|530841990|FG001|Overall Study|Death|5|||
147184270|NCT03456076|530841989|FG000|Overall Study|Study ongoing|123|||
147184271|NCT03456076|530841990|FG001|Overall Study|Study ongoing|111|||
147184272|NCT02045095|530841991|FG000|Overall Study|Other|0|||
147184273|NCT02045095|530841992|FG001|Overall Study|Other|0|||
147184274|NCT02045095|530841993|FG002|Overall Study|Other|1|||
147184275|NCT02045095|530841994|FG003|Overall Study|Other|0|||
147184276|NCT02045095|530841995|FG004|Overall Study|Other|0|||
147184277|NCT02045095|530841996|FG005|Overall Study|Other|2|||
147184278|NCT02045095|530841997|FG006|Overall Study|Other|0|||
147184279|NCT02045095|530841991|FG000|Overall Study|Progressive Disease|3|||
147184280|NCT02045095|530841992|FG001|Overall Study|Progressive Disease|3|||
147184281|NCT02045095|530841993|FG002|Overall Study|Progressive Disease|2|||
147184282|NCT02045095|530841994|FG003|Overall Study|Progressive Disease|4|||
147184283|NCT02045095|530841995|FG004|Overall Study|Progressive Disease|2|||
147184284|NCT02045095|530841996|FG005|Overall Study|Progressive Disease|4|||
147184285|NCT02045095|530841997|FG006|Overall Study|Progressive Disease|1|||
147184286|NCT02045095|530841991|FG000|Overall Study|Withdrawal by Subject|0|||
147184287|NCT02045095|530841992|FG001|Overall Study|Withdrawal by Subject|0|||
147184288|NCT02045095|530841993|FG002|Overall Study|Withdrawal by Subject|0|||
147184289|NCT02045095|530841994|FG003|Overall Study|Withdrawal by Subject|0|||
147184290|NCT02045095|530841995|FG004|Overall Study|Withdrawal by Subject|3|||
147184291|NCT02045095|530841996|FG005|Overall Study|Withdrawal by Subject|0|||
147184292|NCT02045095|530841997|FG006|Overall Study|Withdrawal by Subject|0|||
147184293|NCT02045095|530841991|FG000|Overall Study|Adverse Event|0|||
147184294|NCT02045095|530841992|FG001|Overall Study|Adverse Event|1|||
147184295|NCT02045095|530841993|FG002|Overall Study|Adverse Event|1|||
147184296|NCT02045095|530841994|FG003|Overall Study|Adverse Event|0|||
147184297|NCT02045095|530841995|FG004|Overall Study|Adverse Event|0|||
147184298|NCT02045095|530841996|FG005|Overall Study|Adverse Event|2|||
147184299|NCT02045095|530841997|FG006|Overall Study|Adverse Event|0|||
147184300|NCT01020786|530842001|FG000|Induction Period|Entry Criteria Not Met|2|||
147184301|NCT01020786|530842001|FG000|Induction Period|Adverse Event|10|||
147184302|NCT01020786|530842001|FG000|Induction Period|Progressive Disease|31|||
147184303|NCT01020786|530842001|FG000|Induction Period|Investigator Decision|3|||
147184304|NCT01020786|530842001|FG000|Induction Period|Withdrawal by Subject|3|||
147184305|NCT01020786|530842001|FG000|Maintenance Period|Adverse Event|8|||
147184306|NCT01020786|530842001|FG000|Maintenance Period|Progressive Disease|43|||
147184307|NCT01020786|530842001|FG000|Maintenance Period|Withdrawal by Subject|8|||
147184308|NCT01020786|530842001|FG000|Maintenance Period|Sponsor Decision|1|||
147184309|NCT01818596|530842002|FG000|Overall Study|Enrolled but Not Treated|4|||
147184310|NCT01818596|530842003|FG001|Overall Study|Enrolled but Not Treated|0|||
147184311|NCT01818596|530842002|FG000|Overall Study|Adverse Event|7|||
147184312|NCT01818596|530842003|FG001|Overall Study|Adverse Event|0|||
147184313|NCT01818596|530842002|FG000|Overall Study|Death|3|||
147184314|NCT01818596|530842003|FG001|Overall Study|Death|0|||
147184315|NCT01818596|530842002|FG000|Overall Study|Investigator's Discretion|4|||
147184316|NCT01818596|530842003|FG001|Overall Study|Investigator's Discretion|0|||
147184317|NCT01818596|530842002|FG000|Overall Study|Protocol Violation|1|||
147184318|NCT01818596|530842003|FG001|Overall Study|Protocol Violation|0|||
147184319|NCT01818596|530842002|FG000|Overall Study|Withdrew Consent|5|||
147247025|NCT03129100|531072775|FG016|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
147247026|NCT03129100|531072776|FG017|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
147247027|NCT03129100|531072777|FG018|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
147184320|NCT01818596|530842003|FG001|Overall Study|Withdrew Consent|0|||
147184321|NCT01818596|530842002|FG000|Overall Study|Lost to Follow-up|7|||
147184322|NCT01818596|530842003|FG001|Overall Study|Lost to Follow-up|0|||
147184323|NCT04435366|530842009|FG000|Year 1 (12 Months)|Adverse Event|3|||
147184324|NCT04435366|530842010|FG001|Year 1 (12 Months)|Adverse Event|0|||
147184325|NCT04435366|530842011|FG002|Year 1 (12 Months)|Adverse Event|2|||
147184326|NCT04435366|530842009|FG000|Year 1 (12 Months)|Death|2|||
147184327|NCT04435366|530842010|FG001|Year 1 (12 Months)|Death|0|||
147184328|NCT04435366|530842011|FG002|Year 1 (12 Months)|Death|1|||
147184329|NCT04435366|530842009|FG000|Year 1 (12 Months)|Lost to Follow-up|2|||
147184330|NCT04435366|530842010|FG001|Year 1 (12 Months)|Lost to Follow-up|0|||
147184331|NCT04435366|530842011|FG002|Year 1 (12 Months)|Lost to Follow-up|1|||
147184332|NCT04435366|530842009|FG000|Year 1 (12 Months)|Withdrawal by Subject|17|||
147184333|NCT04435366|530842010|FG001|Year 1 (12 Months)|Withdrawal by Subject|0|||
147184334|NCT04435366|530842011|FG002|Year 1 (12 Months)|Withdrawal by Subject|13|||
147184335|NCT04435366|530842009|FG000|Year 1 (12 Months)|Patient non-compliance|1|||
147184336|NCT04435366|530842010|FG001|Year 1 (12 Months)|Patient non-compliance|0|||
147184337|NCT04435366|530842011|FG002|Year 1 (12 Months)|Patient non-compliance|0|||
147184338|NCT04435366|530842009|FG000|Year 1 (12 Months)|Not treated|0|||
147184339|NCT04435366|530842010|FG001|Year 1 (12 Months)|Not treated|0|||
147184340|NCT04435366|530842011|FG002|Year 1 (12 Months)|Not treated|1|||
147184341|NCT04435366|530842009|FG000|Year 2 (12 Months)|Death|1|||
147184342|NCT04435366|530842010|FG001|Year 2 (12 Months)|Death|4|||
147184343|NCT04435366|530842011|FG002|Year 2 (12 Months)|Death|6|||
147184344|NCT04435366|530842009|FG000|Year 2 (12 Months)|Lost to Follow-up|0|||
147184345|NCT04435366|530842010|FG001|Year 2 (12 Months)|Lost to Follow-up|2|||
147184346|NCT04435366|530842011|FG002|Year 2 (12 Months)|Lost to Follow-up|0|||
147184347|NCT04435366|530842009|FG000|Year 2 (12 Months)|Withdrawal by Subject|4|||
147184348|NCT04435366|530842010|FG001|Year 2 (12 Months)|Withdrawal by Subject|3|||
147184349|NCT04435366|530842011|FG002|Year 2 (12 Months)|Withdrawal by Subject|7|||
147184350|NCT04435366|530842009|FG000|Year 2 (12 Months)|Adverse Event|2|||
147184351|NCT04435366|530842010|FG001|Year 2 (12 Months)|Adverse Event|1|||
147184352|NCT04435366|530842011|FG002|Year 2 (12 Months)|Adverse Event|6|||
147184353|NCT00837213|530842013|FG000|Overall Study|Lost to Follow-up|3|||
147184354|NCT00837213|530842014|FG001|Overall Study|Lost to Follow-up|2|||
147184355|NCT00837213|530842013|FG000|Overall Study|Withdrawal by Subject|2|||
147184356|NCT00837213|530842014|FG001|Overall Study|Withdrawal by Subject|2|||
147184357|NCT00837213|530842013|FG000|Overall Study|not stated|1|||
147184358|NCT00837213|530842014|FG001|Overall Study|not stated|1|||
147184359|NCT04497116|530842017|FG000|Overall Study|Lost to Follow-up|1|||
147184360|NCT04497116|530842018|FG001|Overall Study|Lost to Follow-up|0|||
147184361|NCT04497116|530842019|FG002|Overall Study|Lost to Follow-up|0|||
147184362|NCT04497116|530842020|FG003|Overall Study|Lost to Follow-up|0|||
147184363|NCT04497116|530842021|FG004|Overall Study|Lost to Follow-up|0|||
147184364|NCT04497116|530842022|FG005|Overall Study|Lost to Follow-up|0|||
147184365|NCT04497116|530842023|FG006|Overall Study|Lost to Follow-up|0|||
147184366|NCT04497116|530842024|FG007|Overall Study|Lost to Follow-up|3|||
147184367|NCT04497116|530842025|FG008|Overall Study|Lost to Follow-up|3|||
147184368|NCT04497116|530842026|FG009|Overall Study|Lost to Follow-up|0|||
147184369|NCT04497116|530842027|FG010|Overall Study|Lost to Follow-up|0|||
147184370|NCT04497116|530842028|FG011|Overall Study|Lost to Follow-up|0|||
147184371|NCT04497116|530842029|FG012|Overall Study|Lost to Follow-up|0|||
147184372|NCT04497116|530842030|FG013|Overall Study|Lost to Follow-up|0|||
147184373|NCT04497116|530842031|FG014|Overall Study|Lost to Follow-up|0|||
147184374|NCT04497116|530842032|FG015|Overall Study|Lost to Follow-up|0|||
147184375|NCT04497116|530842033|FG016|Overall Study|Lost to Follow-up|0|||
147184376|NCT04497116|530842034|FG017|Overall Study|Lost to Follow-up|0|||
147184377|NCT04497116|530842035|FG018|Overall Study|Lost to Follow-up|0|||
147184378|NCT04497116|530842036|FG019|Overall Study|Lost to Follow-up|0|||
147184379|NCT04497116|530842037|FG020|Overall Study|Lost to Follow-up|0|||
147184380|NCT04497116|530842038|FG021|Overall Study|Lost to Follow-up|0|||
147184381|NCT04497116|530842039|FG022|Overall Study|Lost to Follow-up|1|||
147184382|NCT04497116|530842040|FG023|Overall Study|Lost to Follow-up|0|||
147184383|NCT04497116|530842041|FG024|Overall Study|Lost to Follow-up|0|||
147184384|NCT04497116|530842017|FG000|Overall Study|Sponsor decision to terminate study|0|||
147184385|NCT04497116|530842018|FG001|Overall Study|Sponsor decision to terminate study|0|||
147184386|NCT04497116|530842019|FG002|Overall Study|Sponsor decision to terminate study|0|||
147184387|NCT04497116|530842020|FG003|Overall Study|Sponsor decision to terminate study|0|||
147184388|NCT04497116|530842021|FG004|Overall Study|Sponsor decision to terminate study|0|||
147184389|NCT04497116|530842022|FG005|Overall Study|Sponsor decision to terminate study|0|||
147247028|NCT03129100|531072778|FG019|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
147247029|NCT03129100|531072779|FG020|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
147184390|NCT04497116|530842023|FG006|Overall Study|Sponsor decision to terminate study|1|||
147593872|NCT02025751|532329054|FG000|Overall Study|Lost to Follow-up|1|||
147184391|NCT04497116|530842024|FG007|Overall Study|Sponsor decision to terminate study|0|||
147184392|NCT04497116|530842025|FG008|Overall Study|Sponsor decision to terminate study|0|||
147184393|NCT04497116|530842026|FG009|Overall Study|Sponsor decision to terminate study|1|||
147184394|NCT04497116|530842027|FG010|Overall Study|Sponsor decision to terminate study|0|||
147184395|NCT04497116|530842028|FG011|Overall Study|Sponsor decision to terminate study|0|||
147184396|NCT04497116|530842029|FG012|Overall Study|Sponsor decision to terminate study|0|||
147184397|NCT04497116|530842030|FG013|Overall Study|Sponsor decision to terminate study|0|||
147184398|NCT04497116|530842031|FG014|Overall Study|Sponsor decision to terminate study|0|||
147184399|NCT04497116|530842032|FG015|Overall Study|Sponsor decision to terminate study|0|||
147184400|NCT04497116|530842033|FG016|Overall Study|Sponsor decision to terminate study|0|||
147184401|NCT04497116|530842034|FG017|Overall Study|Sponsor decision to terminate study|0|||
147184402|NCT04497116|530842035|FG018|Overall Study|Sponsor decision to terminate study|0|||
147184403|NCT04497116|530842036|FG019|Overall Study|Sponsor decision to terminate study|1|||
147448565|NCT00879229|531807896|FG001|Overall Study|Adverse Event|0|||
147328185|NCT00151996|531367944|FG001|Overall Study|Withdrawal by Subject|1|||
147328186|NCT00151996|531367943|FG000|Overall Study|Protocol Violation|1|||
147328187|NCT00151996|531367944|FG001|Overall Study|Protocol Violation|2|||
147658285|NCT03569098|532572235|FG000|Double-Blind Treatment Cycle 1|Lost to Follow-up|1|||
147658286|NCT03569098|532572236|FG001|Double-Blind Treatment Cycle 1|Lost to Follow-up|1|||
147658287|NCT03569098|532572237|FG002|Double-Blind Treatment Cycle 1|Lost to Follow-up|0|||
147184404|NCT04497116|530842037|FG020|Overall Study|Sponsor decision to terminate study|0|||
147184405|NCT04497116|530842038|FG021|Overall Study|Sponsor decision to terminate study|0|||
147328188|NCT00151996|531367943|FG000|Overall Study|Sponsor's decision|0|||
147328189|NCT00151996|531367944|FG001|Overall Study|Sponsor's decision|2|||
147184406|NCT04497116|530842039|FG022|Overall Study|Sponsor decision to terminate study|0|||
147184407|NCT04497116|530842040|FG023|Overall Study|Sponsor decision to terminate study|0|||
147184408|NCT04497116|530842041|FG024|Overall Study|Sponsor decision to terminate study|0|||
147184409|NCT04497116|530842017|FG000|Overall Study|Death|4|||
147658288|NCT03569098|532572235|FG000|Double-Blind Treatment Cycle 1|Technical problems|0|||
147658289|NCT03569098|532572236|FG001|Double-Blind Treatment Cycle 1|Technical problems|0|||
147658290|NCT03569098|532572237|FG002|Double-Blind Treatment Cycle 1|Technical problems|2|||
147658291|NCT03569098|532572235|FG000|Double-Blind Treatment Cycle 1|Physician Decision|1|||
147658292|NCT03569098|532572236|FG001|Double-Blind Treatment Cycle 1|Physician Decision|0|||
147658293|NCT03569098|532572237|FG002|Double-Blind Treatment Cycle 1|Physician Decision|0|||
147658294|NCT03569098|532572235|FG000|Double-Blind Treatment Cycle 1|Protocol deviation|0|||
147658295|NCT03569098|532572236|FG001|Double-Blind Treatment Cycle 1|Protocol deviation|1|||
147658296|NCT03569098|532572237|FG002|Double-Blind Treatment Cycle 1|Protocol deviation|0|||
147658297|NCT03569098|532572235|FG000|Double-Blind Treatment Cycle 1|Other|1|||
147658298|NCT03569098|532572236|FG001|Double-Blind Treatment Cycle 1|Other|0|||
147658299|NCT03569098|532572237|FG002|Double-Blind Treatment Cycle 1|Other|1|||
147658300|NCT03569098|532572235|FG000|Open-Label Treatment Cycle 2|Study terminated by sponsor|0|||
147658301|NCT03569098|532572236|FG001|Open-Label Treatment Cycle 2|Study terminated by sponsor|21|||
147658302|NCT03569098|532572237|FG002|Open-Label Treatment Cycle 2|Study terminated by sponsor|0|||
147658303|NCT03569098|532572235|FG000|Open-Label Treatment Cycle 2|Withdrawal by Subject|0|||
147658304|NCT03569098|532572236|FG001|Open-Label Treatment Cycle 2|Withdrawal by Subject|11|||
147658305|NCT03569098|532572237|FG002|Open-Label Treatment Cycle 2|Withdrawal by Subject|0|||
147658306|NCT03569098|532572235|FG000|Open-Label Treatment Cycle 2|Lost to Follow-up|0|||
147658307|NCT03569098|532572236|FG001|Open-Label Treatment Cycle 2|Lost to Follow-up|3|||
147658308|NCT03569098|532572237|FG002|Open-Label Treatment Cycle 2|Lost to Follow-up|0|||
147658309|NCT03569098|532572235|FG000|Open-Label Treatment Cycle 3|Withdrawal by Subject|0|||
147658310|NCT03569098|532572236|FG001|Open-Label Treatment Cycle 3|Withdrawal by Subject|0|||
147658311|NCT03569098|532572237|FG002|Open-Label Treatment Cycle 3|Withdrawal by Subject|4|||
147658312|NCT03569098|532572235|FG000|Open-Label Treatment Cycle 3|Study terminated by sponsor|0|||
147658313|NCT03569098|532572236|FG001|Open-Label Treatment Cycle 3|Study terminated by sponsor|1|||
147658314|NCT03569098|532572237|FG002|Open-Label Treatment Cycle 3|Study terminated by sponsor|1|||
147658315|NCT03569098|532572235|FG000|Open-Label Treatment Cycle 3|Lost to Follow-up|0|||
147658316|NCT03569098|532572236|FG001|Open-Label Treatment Cycle 3|Lost to Follow-up|0|||
147658317|NCT03569098|532572237|FG002|Open-Label Treatment Cycle 3|Lost to Follow-up|1|||
147658318|NCT02581488|532572245|FG000|Overall Study|Adverse Event|6|||
147658319|NCT02581488|532572246|FG001|Overall Study|Adverse Event|7|||
147184410|NCT04497116|530842018|FG001|Overall Study|Death|5|||
147184411|NCT04497116|530842019|FG002|Overall Study|Death|2|||
147184412|NCT04497116|530842020|FG003|Overall Study|Death|2|||
147184413|NCT04497116|530842021|FG004|Overall Study|Death|1|||
147184414|NCT04497116|530842022|FG005|Overall Study|Death|1|||
147184415|NCT04497116|530842023|FG006|Overall Study|Death|3|||
147184416|NCT04497116|530842024|FG007|Overall Study|Death|10|||
147184417|NCT04497116|530842025|FG008|Overall Study|Death|37|||
147184418|NCT04497116|530842026|FG009|Overall Study|Death|17|||
147184419|NCT04497116|530842027|FG010|Overall Study|Death|2|||
147184420|NCT04497116|530842028|FG011|Overall Study|Death|1|||
147184421|NCT04497116|530842029|FG012|Overall Study|Death|1|||
147184422|NCT04497116|530842030|FG013|Overall Study|Death|3|||
147184423|NCT04497116|530842031|FG014|Overall Study|Death|18|||
147184424|NCT04497116|530842032|FG015|Overall Study|Death|3|||
147328190|NCT00109967|531367947|FG000|Overall Study|Cancel Prior to Treatment|2|||
147328191|NCT00109967|531367948|FG001|Overall Study|Cancel Prior to Treatment|0|||
147184425|NCT04497116|530842033|FG016|Overall Study|Death|2|||
147328192|NCT00109967|531367947|FG000|Overall Study|Adverse Event|12|||
147184426|NCT04497116|530842034|FG017|Overall Study|Death|1|||
147328193|NCT00109967|531367948|FG001|Overall Study|Adverse Event|1|||
147328194|NCT00109967|531367947|FG000|Overall Study|Withdrawal by Subject|5|||
147184427|NCT04497116|530842035|FG018|Overall Study|Death|4|||
147184428|NCT04497116|530842036|FG019|Overall Study|Death|17|||
147184429|NCT04497116|530842037|FG020|Overall Study|Death|1|||
147184430|NCT04497116|530842038|FG021|Overall Study|Death|0|||
147184431|NCT04497116|530842039|FG022|Overall Study|Death|3|||
147184432|NCT04497116|530842040|FG023|Overall Study|Death|5|||
147184433|NCT04497116|530842041|FG024|Overall Study|Death|4|||
147184434|NCT04497116|530842017|FG000|Overall Study|Withdrawal by Subject|1|||
147328195|NCT00109967|531367948|FG001|Overall Study|Withdrawal by Subject|0|||
147328196|NCT00109967|531367947|FG000|Overall Study|Physician Decision|1|||
147328197|NCT00109967|531367948|FG001|Overall Study|Physician Decision|3|||
147328198|NCT00109967|531367947|FG000|Overall Study|Death|0|||
147328199|NCT00109967|531367948|FG001|Overall Study|Death|2|||
147184435|NCT04497116|530842018|FG001|Overall Study|Withdrawal by Subject|0|||
147184436|NCT04497116|530842019|FG002|Overall Study|Withdrawal by Subject|1|||
147184437|NCT04497116|530842020|FG003|Overall Study|Withdrawal by Subject|0|||
147184438|NCT04497116|530842021|FG004|Overall Study|Withdrawal by Subject|0|||
147184439|NCT04497116|530842022|FG005|Overall Study|Withdrawal by Subject|0|||
147328200|NCT04148937|531367949|FG000|Overall Study|Withdrawal by Subject|0|||
147328201|NCT04148937|531367950|FG001|Overall Study|Withdrawal by Subject|0|||
147328202|NCT04148937|531367951|FG002|Overall Study|Withdrawal by Subject|0|||
147328203|NCT04148937|531367952|FG003|Overall Study|Withdrawal by Subject|1|||
147328204|NCT04148937|531367953|FG004|Overall Study|Withdrawal by Subject|0|||
147328205|NCT04148937|531367954|FG005|Overall Study|Withdrawal by Subject|1|||
147328206|NCT04148937|531367955|FG006|Overall Study|Withdrawal by Subject|1|||
147328207|NCT04148937|531367956|FG007|Overall Study|Withdrawal by Subject|0|||
147328208|NCT04148937|531367949|FG000|Overall Study|Lost to Follow-up|0|||
147328209|NCT04148937|531367950|FG001|Overall Study|Lost to Follow-up|0|||
147328210|NCT04148937|531367951|FG002|Overall Study|Lost to Follow-up|1|||
147328211|NCT04148937|531367952|FG003|Overall Study|Lost to Follow-up|0|||
147328212|NCT04148937|531367953|FG004|Overall Study|Lost to Follow-up|0|||
147328213|NCT04148937|531367954|FG005|Overall Study|Lost to Follow-up|2|||
147328214|NCT04148937|531367955|FG006|Overall Study|Lost to Follow-up|0|||
147328215|NCT04148937|531367956|FG007|Overall Study|Lost to Follow-up|0|||
147328216|NCT03107611|531367957|FG000|Overall Study|Adverse Event|1|||
147328217|NCT03107611|531367958|FG001|Overall Study|Adverse Event|0|||
147328218|NCT03107611|531367959|FG002|Overall Study|Adverse Event|2|||
147328219|NCT03107611|531367957|FG000|Overall Study|Lost to Follow-up|3|||
147328220|NCT03107611|531367958|FG001|Overall Study|Lost to Follow-up|3|||
147328221|NCT03107611|531367959|FG002|Overall Study|Lost to Follow-up|3|||
147328222|NCT03107611|531367957|FG000|Overall Study|Protocol Violation|0|||
147328223|NCT03107611|531367958|FG001|Overall Study|Protocol Violation|0|||
147328224|NCT03107611|531367959|FG002|Overall Study|Protocol Violation|1|||
147328225|NCT03107611|531367957|FG000|Overall Study|Withdrawal by Subject|1|||
147328226|NCT03107611|531367958|FG001|Overall Study|Withdrawal by Subject|0|||
147328227|NCT03107611|531367959|FG002|Overall Study|Withdrawal by Subject|1|||
147328228|NCT03107611|531367957|FG000|Overall Study|Worsening signs/symptoms|2|||
147328229|NCT03107611|531367958|FG001|Overall Study|Worsening signs/symptoms|1|||
147328230|NCT03107611|531367959|FG002|Overall Study|Worsening signs/symptoms|2|||
147328231|NCT01020838|531367962|FG000|Overall Study|Death|90|||
147328232|NCT01020838|531367962|FG000|Overall Study|Adverse Event|1|||
147328233|NCT01020838|531367962|FG000|Overall Study|Withdrawal by Subject|9|||
147328234|NCT01020838|531367962|FG000|Overall Study|Lost to Follow-up|6|||
147328235|NCT01020838|531367962|FG000|Overall Study|Most common: Study ended by sponsor|77|||
147328236|NCT01908634|531367965|FG000|Water-based Strawberry Beverage Wit Meal|Withdrawal by Subject|1|||
147328237|NCT01908634|531367965|FG000|Milk-based Strawberry Beverage w/o Meal|Withdrawal by Subject|5|||
147328238|NCT01570751|531367966|FG000|Period A (16 Weeks)|Protocol Violation|1|||
147328239|NCT01570751|531367967|FG001|Period A (16 Weeks)|Protocol Violation|1|||
147328240|NCT01570751|531367966|FG000|Period A (16 Weeks)|Withdrawal criteria|0|||
147328241|NCT01570751|531367967|FG001|Period A (16 Weeks)|Withdrawal criteria|1|||
147184440|NCT04497116|530842023|FG006|Overall Study|Withdrawal by Subject|0|||
147184441|NCT04497116|530842024|FG007|Overall Study|Withdrawal by Subject|7|||
147184442|NCT04497116|530842025|FG008|Overall Study|Withdrawal by Subject|14|||
147184443|NCT04497116|530842026|FG009|Overall Study|Withdrawal by Subject|3|||
147184444|NCT04497116|530842027|FG010|Overall Study|Withdrawal by Subject|3|||
147328242|NCT01570751|531367966|FG000|Period A (16 Weeks)|Unclassified|2|||
147328243|NCT01570751|531367967|FG001|Period A (16 Weeks)|Unclassified|3|||
147328244|NCT01570751|531367966|FG000|Period B (16 Weeks)|Adverse Event|1|||
147328245|NCT01570751|531367967|FG001|Period B (16 Weeks)|Adverse Event|0|||
147328246|NCT01570751|531367966|FG000|Period B (16 Weeks)|Protocol Violation|0|||
147328247|NCT01570751|531367967|FG001|Period B (16 Weeks)|Protocol Violation|1|||
147328248|NCT01072357|531367968|FG000|Overall Study|Lost to Follow-up|0|||
147328249|NCT01072357|531367969|FG001|Overall Study|Lost to Follow-up|1|||
147328250|NCT01876511|531367970|FG000|Overall Study|Disease Progression-clinical/radiologic|11|||
147184445|NCT04497116|530842028|FG011|Overall Study|Withdrawal by Subject|0|||
147184446|NCT04497116|530842029|FG012|Overall Study|Withdrawal by Subject|1|||
147328251|NCT01876511|531367971|FG001|Overall Study|Disease Progression-clinical/radiologic|24|||
147328252|NCT01876511|531367972|FG002|Overall Study|Disease Progression-clinical/radiologic|16|||
147328253|NCT01876511|531367970|FG000|Overall Study|Death (unrelated)|3|||
147328254|NCT01876511|531367971|FG001|Overall Study|Death (unrelated)|0|||
147328255|NCT01876511|531367972|FG002|Overall Study|Death (unrelated)|2|||
147328256|NCT01876511|531367970|FG000|Overall Study|Drug-related Toxicity|5|||
147328257|NCT01876511|531367971|FG001|Overall Study|Drug-related Toxicity|1|||
147184447|NCT04497116|530842030|FG013|Overall Study|Withdrawal by Subject|0|||
147328258|NCT01876511|531367972|FG002|Overall Study|Drug-related Toxicity|6|||
147184448|NCT04497116|530842031|FG014|Overall Study|Withdrawal by Subject|7|||
147184449|NCT04497116|530842032|FG015|Overall Study|Withdrawal by Subject|1|||
147184450|NCT04497116|530842033|FG016|Overall Study|Withdrawal by Subject|3|||
147184451|NCT04497116|530842034|FG017|Overall Study|Withdrawal by Subject|1|||
147184452|NCT04497116|530842035|FG018|Overall Study|Withdrawal by Subject|1|||
147184453|NCT04497116|530842036|FG019|Overall Study|Withdrawal by Subject|5|||
147184454|NCT04497116|530842037|FG020|Overall Study|Withdrawal by Subject|2|||
147184455|NCT04497116|530842038|FG021|Overall Study|Withdrawal by Subject|2|||
147184456|NCT04497116|530842039|FG022|Overall Study|Withdrawal by Subject|2|||
147184457|NCT04497116|530842040|FG023|Overall Study|Withdrawal by Subject|4|||
147184458|NCT04497116|530842041|FG024|Overall Study|Withdrawal by Subject|3|||
147184459|NCT04497116|530842017|FG000|Overall Study|Physician Decision|0|||
147184460|NCT04497116|530842018|FG001|Overall Study|Physician Decision|0|||
147184461|NCT04497116|530842019|FG002|Overall Study|Physician Decision|0|||
147184462|NCT04497116|530842020|FG003|Overall Study|Physician Decision|0|||
147184463|NCT04497116|530842021|FG004|Overall Study|Physician Decision|0|||
147184464|NCT04497116|530842022|FG005|Overall Study|Physician Decision|0|||
147184465|NCT04497116|530842023|FG006|Overall Study|Physician Decision|0|||
147184466|NCT04497116|530842024|FG007|Overall Study|Physician Decision|0|||
147184467|NCT04497116|530842025|FG008|Overall Study|Physician Decision|0|||
147184468|NCT04497116|530842026|FG009|Overall Study|Physician Decision|0|||
147184469|NCT04497116|530842027|FG010|Overall Study|Physician Decision|0|||
147184470|NCT04497116|530842028|FG011|Overall Study|Physician Decision|0|||
147184471|NCT04497116|530842029|FG012|Overall Study|Physician Decision|0|||
147184472|NCT04497116|530842030|FG013|Overall Study|Physician Decision|0|||
147184473|NCT04497116|530842031|FG014|Overall Study|Physician Decision|0|||
147184474|NCT04497116|530842032|FG015|Overall Study|Physician Decision|0|||
147184475|NCT04497116|530842033|FG016|Overall Study|Physician Decision|0|||
147184476|NCT04497116|530842034|FG017|Overall Study|Physician Decision|0|||
147184477|NCT04497116|530842035|FG018|Overall Study|Physician Decision|0|||
147184478|NCT04497116|530842036|FG019|Overall Study|Physician Decision|0|||
147184479|NCT04497116|530842037|FG020|Overall Study|Physician Decision|0|||
147184480|NCT04497116|530842038|FG021|Overall Study|Physician Decision|0|||
147184481|NCT04497116|530842039|FG022|Overall Study|Physician Decision|0|||
147184482|NCT04497116|530842040|FG023|Overall Study|Physician Decision|1|||
147184483|NCT04497116|530842041|FG024|Overall Study|Physician Decision|0|||
147184484|NCT04497116|530842017|FG000|Overall Study|Clinical Progression Related|0|||
147184485|NCT04497116|530842018|FG001|Overall Study|Clinical Progression Related|0|||
147184486|NCT04497116|530842019|FG002|Overall Study|Clinical Progression Related|0|||
147184487|NCT04497116|530842020|FG003|Overall Study|Clinical Progression Related|0|||
147184488|NCT04497116|530842021|FG004|Overall Study|Clinical Progression Related|0|||
147184489|NCT04497116|530842022|FG005|Overall Study|Clinical Progression Related|0|||
147184490|NCT04497116|530842023|FG006|Overall Study|Clinical Progression Related|0|||
147184491|NCT04497116|530842024|FG007|Overall Study|Clinical Progression Related|0|||
147184492|NCT04497116|530842025|FG008|Overall Study|Clinical Progression Related|0|||
147184493|NCT04497116|530842026|FG009|Overall Study|Clinical Progression Related|1|||
147184494|NCT04497116|530842027|FG010|Overall Study|Clinical Progression Related|0|||
147184495|NCT04497116|530842028|FG011|Overall Study|Clinical Progression Related|0|||
147184496|NCT04497116|530842029|FG012|Overall Study|Clinical Progression Related|0|||
147184497|NCT04497116|530842030|FG013|Overall Study|Clinical Progression Related|0|||
147184498|NCT04497116|530842031|FG014|Overall Study|Clinical Progression Related|0|||
147184499|NCT04497116|530842032|FG015|Overall Study|Clinical Progression Related|0|||
147184500|NCT04497116|530842033|FG016|Overall Study|Clinical Progression Related|0|||
147184501|NCT04497116|530842034|FG017|Overall Study|Clinical Progression Related|0|||
147247030|NCT03129100|531072780|FG021|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
147247031|NCT03129100|531072781|FG022|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|0|||
147247032|NCT03129100|531072782|FG023|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|3|||
147247033|NCT03129100|531072783|FG024|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|20|||
147247034|NCT03129100|531072784|FG025|Period 4 (Post Treatment Follow-up)|Withdrawal by Subject|37|||
147247035|NCT03129100|531072759|FG000|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
147247036|NCT03129100|531072760|FG001|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
147247037|NCT03129100|531072761|FG002|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
147247038|NCT03129100|531072762|FG003|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
147247039|NCT03129100|531072763|FG004|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
147184502|NCT04497116|530842035|FG018|Overall Study|Clinical Progression Related|0|||
147184503|NCT04497116|530842036|FG019|Overall Study|Clinical Progression Related|0|||
147184504|NCT04497116|530842037|FG020|Overall Study|Clinical Progression Related|0|||
147184505|NCT04497116|530842038|FG021|Overall Study|Clinical Progression Related|0|||
147184506|NCT04497116|530842039|FG022|Overall Study|Clinical Progression Related|0|||
147328259|NCT01876511|531367970|FG000|Overall Study|Patient Decision|3|||
147184507|NCT04497116|530842040|FG023|Overall Study|Clinical Progression Related|0|||
147184508|NCT04497116|530842041|FG024|Overall Study|Clinical Progression Related|0|||
147184509|NCT01358825|530842045|FG000|Overall Study|Blood sample not drawn|0|||
147184510|NCT01358825|530842046|FG001|Overall Study|Blood sample not drawn|1|||
147184511|NCT04524858|530842051|FG000|Overall Study|Adverse Event|1|||
147184512|NCT02366195|530842057|FG000|Overall Study|Protocol-specified criteria|3|||
147184513|NCT02366195|530842057|FG000|Overall Study|Withdrawal by Subject|9|||
147184514|NCT02366195|530842057|FG000|Overall Study|Lost to Follow-up|1|||
147184515|NCT02366195|530842057|FG000|Overall Study|Death|41|||
147184516|NCT00113841|530842058|FG000|Overall Study|Disease progression|0|||
147184517|NCT00113841|530842059|FG001|Overall Study|Disease progression|2|||
147184518|NCT00113841|530842058|FG000|Overall Study|Non-compliant|1|||
147184519|NCT00113841|530842059|FG001|Overall Study|Non-compliant|0|||
147184520|NCT01788566|530842061|FG000|Overall Study|Death|4|||
147184521|NCT01788566|530842061|FG000|Overall Study|Adverse Event|1|||
147184522|NCT01788566|530842061|FG000|Overall Study|Clinical Progressive Disease|3|||
147184523|NCT00580723|530842062|FG000|Overall Study|Did not want to participate in extension|3|||
147184524|NCT00580723|530842062|FG000|Overall Study|Lost to Follow-up|5|||
147184525|NCT00556998|530842063|FG000|Voriconazole Intravenous (IV)|Adverse Event|1|||
147184526|NCT00556998|530842063|FG000|Voriconazole Intravenous (IV)|Other|4|||
147184527|NCT00556998|530842063|FG000|Voriconazole Oral|Adverse Event|1|||
147184528|NCT00556998|530842063|FG000|Voriconazole Oral|Intolerant of oral treatment|1|||
147184529|NCT03030417|530842066|FG000|Dose Expansion|Disease progression before treatment|0|||
147184530|NCT03030417|530842067|FG001|Dose Expansion|Disease progression before treatment|0|||
147184531|NCT03030417|530842068|FG002|Dose Expansion|Disease progression before treatment|0|||
147184532|NCT03030417|530842069|FG003|Dose Expansion|Disease progression before treatment|0|||
147184533|NCT03030417|530842070|FG004|Dose Expansion|Disease progression before treatment|0|||
147184534|NCT03030417|530842071|FG005|Dose Expansion|Disease progression before treatment|0|||
147184535|NCT03030417|530842072|FG006|Dose Expansion|Disease progression before treatment|0|||
147184536|NCT03030417|530842073|FG007|Dose Expansion|Disease progression before treatment|0|||
147184537|NCT03030417|530842074|FG008|Dose Expansion|Disease progression before treatment|0|||
147184538|NCT03030417|530842075|FG009|Dose Expansion|Disease progression before treatment|0|||
147184539|NCT03030417|530842076|FG010|Dose Expansion|Disease progression before treatment|0|||
147184540|NCT03030417|530842077|FG011|Dose Expansion|Disease progression before treatment|0|||
147184541|NCT03030417|530842078|FG012|Dose Expansion|Disease progression before treatment|1|||
147184542|NCT01539759|530842079|FG000|Overall Study|Lost to Follow-up|6|||
147184543|NCT01539759|530842080|FG001|Overall Study|Lost to Follow-up|8|||
147184544|NCT01076959|530842081|FG000|Overall Study|Adverse Event|767|||
147184545|NCT01076959|530842081|FG000|Overall Study|Lack of Efficacy|849|||
147184546|NCT01076959|530842081|FG000|Overall Study|Non-compliance|274|||
147184547|NCT01076959|530842081|FG000|Overall Study|Lost to Follow-up|241|||
147184548|NCT01076959|530842081|FG000|Overall Study|Other|119|||
147184549|NCT01425801|530842082|FG000|Period 1|Withdrawal by Subject|0|||
147184550|NCT01425801|530842083|FG001|Period 1|Withdrawal by Subject|0|||
147184551|NCT01425801|530842084|FG002|Period 1|Withdrawal by Subject|0|||
147184552|NCT01425801|530842085|FG003|Period 1|Withdrawal by Subject|0|||
147184553|NCT01425801|530842086|FG004|Period 1|Withdrawal by Subject|1|||
147184554|NCT01425801|530842087|FG005|Period 1|Withdrawal by Subject|0|||
147184555|NCT01425801|530842082|FG000|Period 2|Withdrawal by Subject|0|||
147184556|NCT01425801|530842083|FG001|Period 2|Withdrawal by Subject|0|||
147184557|NCT01425801|530842084|FG002|Period 2|Withdrawal by Subject|0|||
147184558|NCT01425801|530842085|FG003|Period 2|Withdrawal by Subject|0|||
147184559|NCT01425801|530842086|FG004|Period 2|Withdrawal by Subject|1|||
147184560|NCT01425801|530842087|FG005|Period 2|Withdrawal by Subject|0|||
147184561|NCT01425801|530842082|FG000|Period 3|Stability criteria not fullfilled|0|||
147184562|NCT01425801|530842083|FG001|Period 3|Stability criteria not fullfilled|0|||
147184563|NCT01425801|530842084|FG002|Period 3|Stability criteria not fullfilled|1|||
147184564|NCT01425801|530842085|FG003|Period 3|Stability criteria not fullfilled|0|||
147184565|NCT01425801|530842086|FG004|Period 3|Stability criteria not fullfilled|0|||
147184566|NCT01425801|530842087|FG005|Period 3|Stability criteria not fullfilled|0|||
147184567|NCT01425801|530842082|FG000|Period 4|Not able to maintain visit schedule|0|||
147184568|NCT01425801|530842083|FG001|Period 4|Not able to maintain visit schedule|0|||
147184569|NCT01425801|530842084|FG002|Period 4|Not able to maintain visit schedule|1|||
147184570|NCT01425801|530842085|FG003|Period 4|Not able to maintain visit schedule|0|||
147184571|NCT01425801|530842086|FG004|Period 4|Not able to maintain visit schedule|0|||
147247040|NCT03129100|531072764|FG005|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
147247041|NCT03129100|531072765|FG006|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
147247042|NCT03129100|531072766|FG007|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
147247043|NCT03129100|531072767|FG008|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
147184572|NCT01425801|530842087|FG005|Period 4|Not able to maintain visit schedule|0|||
147184573|NCT02175017|530842088|FG000|Overall Study|Did not receive the investigational product|1|||
147184574|NCT02175017|530842089|FG001|Overall Study|Did not receive the investigational product|2|||
147184575|NCT02175017|530842088|FG000|Overall Study|Withdrawal by Subject|6|||
147184576|NCT02175017|530842089|FG001|Overall Study|Withdrawal by Subject|3|||
147184577|NCT02175017|530842088|FG000|Overall Study|Met an exclusion criteria|0|||
147184578|NCT02175017|530842089|FG001|Overall Study|Met an exclusion criteria|1|||
147184579|NCT02175017|530842088|FG000|Overall Study|Adverse Event|3|||
147184580|NCT02175017|530842089|FG001|Overall Study|Adverse Event|10|||
147328260|NCT01876511|531367971|FG001|Overall Study|Patient Decision|0|||
147328261|NCT01876511|531367972|FG002|Overall Study|Patient Decision|6|||
147658320|NCT02581488|532572245|FG000|Overall Study|Lost to Follow-up|1|||
147658321|NCT02581488|532572246|FG001|Overall Study|Lost to Follow-up|0|||
147658322|NCT02581488|532572245|FG000|Overall Study|Withdrawal by Subject|1|||
147658323|NCT02581488|532572246|FG001|Overall Study|Withdrawal by Subject|0|||
147184581|NCT02175017|530842088|FG000|Overall Study|Disease progression|20|||
147184582|NCT02175017|530842089|FG001|Overall Study|Disease progression|27|||
147184583|NCT02175017|530842088|FG000|Overall Study|Other than above reasons|3|||
147184584|NCT02175017|530842089|FG001|Overall Study|Other than above reasons|0|||
147184585|NCT02491983|530842090|FG000|Overall Study|Physician Decision|1|||
147184586|NCT02491983|530842091|FG001|Overall Study|Physician Decision|0|||
147184587|NCT02491983|530842090|FG000|Overall Study|Not meet selection criteria|1|||
147184588|NCT02491983|530842091|FG001|Overall Study|Not meet selection criteria|0|||
147184589|NCT02491983|530842090|FG000|Overall Study|Withdrawal by Subject|0|||
147184590|NCT02491983|530842091|FG001|Overall Study|Withdrawal by Subject|1|||
147184591|NCT02330055|530842092|FG000|Overall Study|technical issues|2|||
147184592|NCT02330055|530842093|FG001|Overall Study|technical issues|0|||
147184593|NCT02330055|530842092|FG000|Overall Study|participant forgot to wear device|5|||
147184594|NCT02330055|530842093|FG001|Overall Study|participant forgot to wear device|5|||
147184595|NCT02330055|530842092|FG000|Overall Study|data for less than 60 minutes|3|||
147184596|NCT02330055|530842093|FG001|Overall Study|data for less than 60 minutes|3|||
147184597|NCT02330055|530842092|FG000|Overall Study|participant did not sleep|0|||
147184598|NCT02330055|530842093|FG001|Overall Study|participant did not sleep|1|||
147184599|NCT02959437|530842094|FG000|Overall Study|Death|33|||
147184600|NCT02959437|530842095|FG001|Overall Study|Death|3|||
147184601|NCT02959437|530842096|FG002|Overall Study|Death|0|||
147184602|NCT02959437|530842097|FG003|Overall Study|Death|0|||
147184603|NCT02959437|530842094|FG000|Overall Study|Lost to Follow-up|3|||
147184604|NCT02959437|530842095|FG001|Overall Study|Lost to Follow-up|1|||
147184605|NCT02959437|530842096|FG002|Overall Study|Lost to Follow-up|0|||
147184606|NCT02959437|530842097|FG003|Overall Study|Lost to Follow-up|0|||
147184607|NCT02959437|530842094|FG000|Overall Study|Withdrawal by Subject|11|||
147184608|NCT02959437|530842095|FG001|Overall Study|Withdrawal by Subject|3|||
147184609|NCT02959437|530842096|FG002|Overall Study|Withdrawal by Subject|0|||
147184610|NCT02959437|530842097|FG003|Overall Study|Withdrawal by Subject|0|||
147184611|NCT02959437|530842094|FG000|Overall Study|Progressive Disease|9|||
147184612|NCT02959437|530842095|FG001|Overall Study|Progressive Disease|1|||
147184613|NCT02959437|530842096|FG002|Overall Study|Progressive Disease|0|||
147184614|NCT02959437|530842097|FG003|Overall Study|Progressive Disease|0|||
147184615|NCT02959437|530842094|FG000|Overall Study|Study Terminated by Sponsor|4|||
147184616|NCT02959437|530842095|FG001|Overall Study|Study Terminated by Sponsor|0|||
147184617|NCT02959437|530842096|FG002|Overall Study|Study Terminated by Sponsor|0|||
147184618|NCT02959437|530842097|FG003|Overall Study|Study Terminated by Sponsor|0|||
147184619|NCT02959437|530842094|FG000|Overall Study|Other Unspecified|2|||
147184620|NCT02959437|530842095|FG001|Overall Study|Other Unspecified|0|||
147184621|NCT02959437|530842096|FG002|Overall Study|Other Unspecified|0|||
147184622|NCT02959437|530842097|FG003|Overall Study|Other Unspecified|0|||
147184623|NCT03622814|530842100|FG000|Overall Study|Lost to Follow-up|8|||
147328262|NCT01876511|531367970|FG000|Overall Study|Physician Decision|1|||
147328263|NCT01876511|531367971|FG001|Overall Study|Physician Decision|0|||
147328264|NCT01876511|531367972|FG002|Overall Study|Physician Decision|1|||
147328265|NCT01048788|531367977|FG000|Overall Study|Adverse Event|5|||
147328266|NCT01048788|531367978|FG001|Overall Study|Adverse Event|1|||
147328267|NCT01048788|531367979|FG002|Overall Study|Adverse Event|1|||
147328268|NCT01048788|531367977|FG000|Overall Study|Lack of Efficacy|0|||
147328269|NCT01048788|531367978|FG001|Overall Study|Lack of Efficacy|0|||
147328270|NCT01048788|531367979|FG002|Overall Study|Lack of Efficacy|1|||
147328271|NCT01048788|531367977|FG000|Overall Study|Withdrawal by Subject|0|||
147328272|NCT01048788|531367978|FG001|Overall Study|Withdrawal by Subject|1|||
147328273|NCT01048788|531367979|FG002|Overall Study|Withdrawal by Subject|0|||
147184624|NCT03622814|530842101|FG001|Overall Study|Lost to Follow-up|14|||
147184625|NCT03269994|530842102|FG000|Overall Study|Withdrawal by Subject|4|||
147184626|NCT03269994|530842103|FG001|Overall Study|Withdrawal by Subject|5|||
147184627|NCT03269994|530842102|FG000|Overall Study|Unresectable at surgery|39|||
147184628|NCT03269994|530842103|FG001|Overall Study|Unresectable at surgery|58|||
147448566|NCT00879229|531807895|FG000|Overall Study|Withdrawal by Subject|1|||
147184629|NCT03269994|530842102|FG000|Overall Study|Patient canceled surgery|5|||
147184630|NCT03269994|530842103|FG001|Overall Study|Patient canceled surgery|14|||
147184631|NCT03269994|530842102|FG000|Overall Study|Preoperative progression|14|||
147184632|NCT03269994|530842103|FG001|Overall Study|Preoperative progression|9|||
147184633|NCT03269994|530842102|FG000|Overall Study|Preoperative infection|10|||
147184634|NCT03269994|530842103|FG001|Overall Study|Preoperative infection|4|||
147184635|NCT03269994|530842102|FG000|Overall Study|Kidney insufficiency|1|||
147184636|NCT03269994|530842103|FG001|Overall Study|Kidney insufficiency|0|||
147328274|NCT05419557|531367980|FG000|Overall Study|Lost to Follow-up|11|||
147184637|NCT03269994|530842102|FG000|Overall Study|Drug allergy|0|||
147184638|NCT03269994|530842103|FG001|Overall Study|Drug allergy|2|||
147328275|NCT05419557|531367981|FG001|Overall Study|Lost to Follow-up|4|||
147328276|NCT00588666|531367982|FG000|Overall Study|Adverse Event|4|||
147184639|NCT03269994|530842102|FG000|Overall Study|Operation changed to different resection|9|||
147184640|NCT03269994|530842103|FG001|Overall Study|Operation changed to different resection|0|||
147184641|NCT03269994|530842102|FG000|Overall Study|Preoperative steroid|0|||
147184642|NCT03269994|530842103|FG001|Overall Study|Preoperative steroid|3|||
147184643|NCT03269994|530842102|FG000|Overall Study|Accrual Closed|2|||
147184644|NCT03269994|530842103|FG001|Overall Study|Accrual Closed|0|||
147184645|NCT03269994|530842102|FG000|Overall Study|Operation changed to different resection|0|||
147184646|NCT03269994|530842103|FG001|Overall Study|Operation changed to different resection|10|||
147184647|NCT04417361|530842104|FG000|Overall Study|Withdrawal by Subject|1|||
147184648|NCT04417361|530842105|FG001|Overall Study|Withdrawal by Subject|0|||
147184649|NCT04417361|530842104|FG000|Overall Study|study unexpectedly stopped early due to supply issues with drug/placebo|0|||
147184650|NCT04417361|530842105|FG001|Overall Study|study unexpectedly stopped early due to supply issues with drug/placebo|1|||
147184651|NCT04707469|530842108|FG000|Overall Study|Site closure|0|||
147184652|NCT04707469|530842109|FG001|Overall Study|Site closure|2|||
147184653|NCT04707469|530842110|FG002|Overall Study|Site closure|0|||
147184654|NCT04707469|530842108|FG000|Overall Study|Physician Decision|2|||
147184655|NCT04707469|530842109|FG001|Overall Study|Physician Decision|2|||
147184656|NCT04707469|530842110|FG002|Overall Study|Physician Decision|2|||
147184657|NCT04707469|530842108|FG000|Overall Study|Death|1|||
147184658|NCT04707469|530842109|FG001|Overall Study|Death|6|||
147184659|NCT04707469|530842110|FG002|Overall Study|Death|2|||
147184660|NCT04707469|530842108|FG000|Overall Study|Lost to Follow-up|9|||
147184661|NCT04707469|530842109|FG001|Overall Study|Lost to Follow-up|19|||
147184662|NCT04707469|530842110|FG002|Overall Study|Lost to Follow-up|14|||
147184663|NCT04707469|530842108|FG000|Overall Study|Withdrawal by Subject|17|||
147184664|NCT04707469|530842109|FG001|Overall Study|Withdrawal by Subject|16|||
147184665|NCT04707469|530842110|FG002|Overall Study|Withdrawal by Subject|12|||
147184666|NCT04661150|530842118|FG000|Overall Study|Ongoing in study|19|||
147184667|NCT04661150|530842119|FG001|Overall Study|Ongoing in study|20|||
147184668|NCT04661150|530842118|FG000|Overall Study|Refused surgery and for personal reasons.|0|||
147184669|NCT04661150|530842119|FG001|Overall Study|Refused surgery and for personal reasons.|1|||
147184670|NCT04661150|530842118|FG000|Overall Study|Death|2|||
147184671|NCT04661150|530842119|FG001|Overall Study|Death|0|||
147184672|NCT04965688|530842120|FG000|Overall Study|Withdrawal by Subject|2|||
147184673|NCT03868943|530842121|FG000|Overall Study|Adverse Event|1|||
147184674|NCT02777827|530842122|FG000|Washout Between Periods 3 and 4|Protocol Violation|0|||
147184675|NCT02777827|530842123|FG001|Washout Between Periods 3 and 4|Protocol Violation|0|||
147184676|NCT02777827|530842124|FG002|Washout Between Periods 3 and 4|Protocol Violation|1|||
147184677|NCT02777827|530842125|FG003|Washout Between Periods 3 and 4|Protocol Violation|0|||
147184678|NCT02777827|530842126|FG004|Washout Between Periods 3 and 4|Protocol Violation|0|||
147184679|NCT02777827|530842127|FG005|Washout Between Periods 3 and 4|Protocol Violation|0|||
147184680|NCT04551066|530842128|FG000|Overall Study|Death|5|||
147184681|NCT04551066|530842129|FG001|Overall Study|Death|3|||
147184682|NCT04551066|530842128|FG000|Overall Study|Lost to Follow-up|1|||
147328277|NCT01233050|531367983|FG000|Overall Study|protocol deviation (inclusion/exclusion)|8|||
147328278|NCT01233050|531367984|FG001|Overall Study|protocol deviation (inclusion/exclusion)|6|||
147328279|NCT04304534|531367987|FG000|Overall Study|Subject decision COVID-19 pandemic related|1|||
147328280|NCT04304534|531367988|FG001|Overall Study|Subject decision COVID-19 pandemic related|0|||
147328281|NCT04304534|531367989|FG002|Overall Study|Subject decision COVID-19 pandemic related|1|||
147328282|NCT04304534|531367990|FG003|Overall Study|Subject decision COVID-19 pandemic related|0|||
147328283|NCT04304534|531367987|FG000|Overall Study|Non-Compliance with study drug|0|||
147184683|NCT04551066|530842129|FG001|Overall Study|Lost to Follow-up|0|||
147184684|NCT04551066|530842128|FG000|Overall Study|Sponsor Decision|104|||
147184685|NCT04551066|530842129|FG001|Overall Study|Sponsor Decision|117|||
147184686|NCT04551066|530842128|FG000|Overall Study|Withdrawal by Subject|8|||
147184687|NCT04551066|530842129|FG001|Overall Study|Withdrawal by Subject|2|||
147184688|NCT04551066|530842128|FG000|Overall Study|Awaiting Rollover to Another Study to Receive Ruxolitinib|2|||
147184689|NCT04551066|530842129|FG001|Overall Study|Awaiting Rollover to Another Study to Receive Ruxolitinib|3|||
147184690|NCT04551066|530842128|FG000|Overall Study|Adverse Event|2|||
147184691|NCT04551066|530842129|FG001|Overall Study|Adverse Event|0|||
147184692|NCT04551066|530842128|FG000|Overall Study|Physician Decision|2|||
147184693|NCT04551066|530842129|FG001|Overall Study|Physician Decision|0|||
147184694|NCT04551066|530842128|FG000|Overall Study|Protocol Violation|1|||
147184695|NCT04551066|530842129|FG001|Overall Study|Protocol Violation|0|||
147184696|NCT04551066|530842128|FG000|Overall Study|Lack of Efficacy|0|||
147184697|NCT04551066|530842129|FG001|Overall Study|Lack of Efficacy|1|||
147184698|NCT04551066|530842128|FG000|Overall Study|Concomitant Diagnosis of Mature Plasmacytoid Dendritic Cell Proliferation|0|||
147184699|NCT04551066|530842129|FG001|Overall Study|Concomitant Diagnosis of Mature Plasmacytoid Dendritic Cell Proliferation|1|||
147184700|NCT00369577|530842130|FG000|Overall Study|Withdrawal by Subject|0|||
147184701|NCT00369577|530842131|FG001|Overall Study|Withdrawal by Subject|0|||
147184702|NCT00369577|530842132|FG002|Overall Study|Withdrawal by Subject|1|||
147448567|NCT00879229|531807896|FG001|Overall Study|Withdrawal by Subject|0|||
147448568|NCT00879229|531807895|FG000|Overall Study|Clinical status did not improve|1|||
147184703|NCT03915470|530842133|FG000|Overall Study|Death|3|||
147184704|NCT03915470|530842134|FG001|Overall Study|Death|1|||
147184705|NCT03915470|530842133|FG000|Overall Study|Adverse Event|1|||
147184706|NCT03915470|530842134|FG001|Overall Study|Adverse Event|0|||
147184707|NCT03915470|530842133|FG000|Overall Study|Physician Decision|1|||
147184708|NCT03915470|530842134|FG001|Overall Study|Physician Decision|0|||
147184709|NCT03915470|530842133|FG000|Overall Study|XF-73: Failure to meet RND criteria, Placebo: Surgery was cancelled|1|||
147184710|NCT03915470|530842134|FG001|Overall Study|XF-73: Failure to meet RND criteria, Placebo: Surgery was cancelled|1|||
147184711|NCT00549445|530842140|FG000|Overall Study|Sputum & Blood Samples Not Available|15|||
147184712|NCT00549445|530842141|FG001|Overall Study|Sputum & Blood Samples Not Available|17|||
147184713|NCT01900652|530842142|FG000|Overall Study|Progressive Disease|1|||
147184714|NCT01900652|530842143|FG001|Overall Study|Progressive Disease|0|||
147184715|NCT01900652|530842142|FG000|Overall Study|Consent withdrawn by subject|1|||
147184716|NCT01900652|530842143|FG001|Overall Study|Consent withdrawn by subject|1|||
147184717|NCT01900652|530842142|FG000|Overall Study|Death|3|||
147184718|NCT01900652|530842143|FG001|Overall Study|Death|0|||
147184719|NCT01900652|530842142|FG000|Overall Study|Adverse Event|2|||
147184720|NCT01900652|530842143|FG001|Overall Study|Adverse Event|1|||
147184721|NCT01900652|530842142|FG000|Overall Study|Physician Decision|1|||
147184722|NCT01900652|530842143|FG001|Overall Study|Physician Decision|1|||
147184723|NCT03566082|530842144|FG000|Overall Study|Death|7|||
147184724|NCT03566082|530842144|FG000|Overall Study|Failures (revision required)|2|||
147184725|NCT03566082|530842144|FG000|Overall Study|Lost to Follow-up|8|||
147184726|NCT01389882|530843732|FG000|Overall Study|Respiratory rate > 80/min during study|1|||
147184727|NCT01389882|530843733|FG001|Overall Study|Respiratory rate > 80/min during study|3|||
147184728|NCT01389882|530843732|FG000|Overall Study|Withdrawal by Subject|0|||
147184729|NCT01389882|530843733|FG001|Overall Study|Withdrawal by Subject|1|||
147184730|NCT01045967|530843734|FG000|Second Intervention|Protocol Violation|0|||
147184731|NCT01045967|530843735|FG001|Second Intervention|Protocol Violation|1|||
147184732|NCT03057496|530843736|FG000|Overall Study|Withdrawal by Subject|8|||
147184733|NCT03057496|530843736|FG000|Overall Study|Lost to Follow-up|5|||
147184734|NCT03057496|530843736|FG000|Overall Study|Did not use device during home trial|3|||
147184735|NCT03057496|530843736|FG000|Overall Study|Device failure|2|||
147184736|NCT00280917|530843740|FG000|Overall Study|Adverse Event|1|||
147184737|NCT00280917|530843741|FG001|Overall Study|Adverse Event|1|||
147184738|NCT00280917|530843742|FG002|Overall Study|Adverse Event|4|||
147184739|NCT00280917|530843743|FG003|Overall Study|Adverse Event|1|||
147184740|NCT00280917|530843740|FG000|Overall Study|Change Therapy|1|||
147184741|NCT00280917|530843741|FG001|Overall Study|Change Therapy|2|||
147184742|NCT00280917|530843742|FG002|Overall Study|Change Therapy|0|||
147184743|NCT00280917|530843743|FG003|Overall Study|Change Therapy|0|||
147184744|NCT00280917|530843740|FG000|Overall Study|Withdrawal by Subject|0|||
147184745|NCT00280917|530843741|FG001|Overall Study|Withdrawal by Subject|2|||
147184746|NCT00280917|530843742|FG002|Overall Study|Withdrawal by Subject|0|||
147184747|NCT00280917|530843743|FG003|Overall Study|Withdrawal by Subject|1|||
147184748|NCT00280917|530843740|FG000|Overall Study|Noncompliance|0|||
147184749|NCT00280917|530843741|FG001|Overall Study|Noncompliance|1|||
147184750|NCT00280917|530843742|FG002|Overall Study|Noncompliance|2|||
147184751|NCT00280917|530843743|FG003|Overall Study|Noncompliance|0|||
147184752|NCT03529110|530843744|FG000|Overall Study|Progressive Disease|66|||
147184753|NCT03529110|530843745|FG001|Overall Study|Progressive Disease|158|||
147184754|NCT03529110|530843744|FG000|Overall Study|Clinical Progression|4|||
147184755|NCT03529110|530843745|FG001|Overall Study|Clinical Progression|12|||
147184756|NCT03529110|530843744|FG000|Overall Study|Adverse Event|35|||
147184757|NCT03529110|530843745|FG001|Overall Study|Adverse Event|17|||
147184758|NCT03529110|530843744|FG000|Overall Study|Withdrawal by Subject (from treatment only)|13|||
147184759|NCT03529110|530843745|FG001|Overall Study|Withdrawal by Subject (from treatment only)|11|||
147184760|NCT03529110|530843744|FG000|Overall Study|Lack of Efficacy|3|||
147184761|NCT03529110|530843745|FG001|Overall Study|Lack of Efficacy|3|||
147184762|NCT03529110|530843744|FG000|Overall Study|Physician Decision|2|||
147184763|NCT03529110|530843745|FG001|Overall Study|Physician Decision|8|||
147184764|NCT03529110|530843744|FG000|Overall Study|Miscellaneous|2|||
147184765|NCT03529110|530843745|FG001|Overall Study|Miscellaneous|5|||
147184766|NCT01584232|530843746|FG000|Overall Study|Adverse Event|3|||
147184767|NCT01584232|530843747|FG001|Overall Study|Adverse Event|1|||
147184768|NCT01584232|530843746|FG000|Overall Study|Withdrawal by Subject|2|||
147184769|NCT01584232|530843747|FG001|Overall Study|Withdrawal by Subject|1|||
147184770|NCT01584232|530843746|FG000|Overall Study|Physician Decision|2|||
147184771|NCT01584232|530843747|FG001|Overall Study|Physician Decision|1|||
147184772|NCT01584232|530843746|FG000|Overall Study|Lost to Follow-up|1|||
147184773|NCT01584232|530843747|FG001|Overall Study|Lost to Follow-up|0|||
147448569|NCT00879229|531807896|FG001|Overall Study|Clinical status did not improve|0|||
147184774|NCT02723773|530843749|FG000|Overall Study|Adverse Event|934|||
147184775|NCT02723773|530843750|FG001|Overall Study|Adverse Event|3|||
147184776|NCT02723773|530843751|FG002|Overall Study|Adverse Event|1|||
147328284|NCT04304534|531367988|FG001|Overall Study|Non-Compliance with study drug|1|||
147328285|NCT04304534|531367989|FG002|Overall Study|Non-Compliance with study drug|1|||
147328286|NCT04304534|531367990|FG003|Overall Study|Non-Compliance with study drug|1|||
147328287|NCT04304534|531367987|FG000|Overall Study|Lost to Follow-up|0|||
147328288|NCT04304534|531367988|FG001|Overall Study|Lost to Follow-up|1|||
147328289|NCT04304534|531367989|FG002|Overall Study|Lost to Follow-up|2|||
147328290|NCT04304534|531367990|FG003|Overall Study|Lost to Follow-up|3|||
147328291|NCT04304534|531367987|FG000|Overall Study|Unspecific|4|||
147328292|NCT04304534|531367988|FG001|Overall Study|Unspecific|2|||
147328293|NCT04304534|531367989|FG002|Overall Study|Unspecific|2|||
147328294|NCT04304534|531367990|FG003|Overall Study|Unspecific|2|||
147328295|NCT04304534|531367987|FG000|Overall Study|Technical Problems|2|||
147328296|NCT04304534|531367988|FG001|Overall Study|Technical Problems|2|||
147328297|NCT04304534|531367989|FG002|Overall Study|Technical Problems|3|||
147328298|NCT04304534|531367990|FG003|Overall Study|Technical Problems|4|||
147328299|NCT04304534|531367987|FG000|Overall Study|Death|7|||
147328300|NCT04304534|531367988|FG001|Overall Study|Death|2|||
147328301|NCT04304534|531367989|FG002|Overall Study|Death|4|||
147328302|NCT04304534|531367990|FG003|Overall Study|Death|3|||
147328303|NCT04304534|531367987|FG000|Overall Study|Withdrawal by Subject|7|||
147328304|NCT04304534|531367988|FG001|Overall Study|Withdrawal by Subject|2|||
147328305|NCT04304534|531367989|FG002|Overall Study|Withdrawal by Subject|7|||
147328306|NCT04304534|531367990|FG003|Overall Study|Withdrawal by Subject|4|||
147328307|NCT04304534|531367987|FG000|Overall Study|Physician Decision|4|||
147328308|NCT04304534|531367988|FG001|Overall Study|Physician Decision|9|||
147328309|NCT04304534|531367989|FG002|Overall Study|Physician Decision|9|||
147328310|NCT04304534|531367990|FG003|Overall Study|Physician Decision|5|||
147328311|NCT04304534|531367987|FG000|Overall Study|Subject Decision|34|||
147328312|NCT04304534|531367988|FG001|Overall Study|Subject Decision|25|||
147328313|NCT04304534|531367989|FG002|Overall Study|Subject Decision|25|||
147328314|NCT04304534|531367990|FG003|Overall Study|Subject Decision|26|||
147328315|NCT04304534|531367987|FG000|Overall Study|Adverse Event|35|||
147328316|NCT04304534|531367988|FG001|Overall Study|Adverse Event|40|||
147328317|NCT04304534|531367989|FG002|Overall Study|Adverse Event|39|||
147328318|NCT04304534|531367990|FG003|Overall Study|Adverse Event|44|||
147328319|NCT00464672|531367991|FG000|Overall Study|withdrawal of consent|0|||
147328320|NCT00464672|531367992|FG001|Overall Study|withdrawal of consent|0|||
147328321|NCT00464672|531367993|FG002|Overall Study|withdrawal of consent|0|||
147328322|NCT00464672|531367994|FG003|Overall Study|withdrawal of consent|1|||
147328323|NCT00464672|531367995|FG004|Overall Study|withdrawal of consent|9|||
147328324|NCT00464672|531367996|FG005|Overall Study|withdrawal of consent|4|||
147328325|NCT00464672|531367991|FG000|Overall Study|Lost to Follow-up|25|||
147328326|NCT00464672|531367992|FG001|Overall Study|Lost to Follow-up|10|||
147328327|NCT00464672|531367993|FG002|Overall Study|Lost to Follow-up|0|||
147328328|NCT00464672|531367994|FG003|Overall Study|Lost to Follow-up|0|||
147328329|NCT00464672|531367995|FG004|Overall Study|Lost to Follow-up|1|||
147328330|NCT00464672|531367996|FG005|Overall Study|Lost to Follow-up|0|||
147184777|NCT02723773|530843752|FG003|Overall Study|Adverse Event|9|||
147184778|NCT02723773|530843749|FG000|Overall Study|Protocol Violation|1|||
147184779|NCT02723773|530843750|FG001|Overall Study|Protocol Violation|0|||
147184780|NCT02723773|530843751|FG002|Overall Study|Protocol Violation|0|||
147184781|NCT02723773|530843752|FG003|Overall Study|Protocol Violation|0|||
147184782|NCT02723773|530843749|FG000|Overall Study|Withdrawal by Subject|360|||
147184783|NCT02723773|530843750|FG001|Overall Study|Withdrawal by Subject|5|||
147184784|NCT02723773|530843751|FG002|Overall Study|Withdrawal by Subject|6|||
147184785|NCT02723773|530843752|FG003|Overall Study|Withdrawal by Subject|10|||
147184786|NCT02723773|530843749|FG000|Overall Study|Migrated/moved from study area|37|||
147184787|NCT02723773|530843750|FG001|Overall Study|Migrated/moved from study area|0|||
147184788|NCT02723773|530843751|FG002|Overall Study|Migrated/moved from study area|0|||
147184789|NCT02723773|530843752|FG003|Overall Study|Migrated/moved from study area|1|||
147184790|NCT02723773|530843749|FG000|Overall Study|Lost to Follow-up|198|||
147184791|NCT02723773|530843750|FG001|Overall Study|Lost to Follow-up|0|||
147184792|NCT02723773|530843751|FG002|Overall Study|Lost to Follow-up|0|||
147184793|NCT02723773|530843752|FG003|Overall Study|Lost to Follow-up|0|||
147328331|NCT02299635|531367997|FG000|Overall Study|Adverse Event|2|||
147328332|NCT02299635|531367997|FG000|Overall Study|Death|1|||
147328333|NCT02299635|531367997|FG000|Overall Study|Global deterioration of health status|1|||
147448570|NCT00879229|531807895|FG000|Overall Study|Other|1|||
147184794|NCT02723773|530843749|FG000|Overall Study|Other|189|||
147328334|NCT02299635|531367997|FG000|Overall Study|Objective progression or relapse|10|||
147328335|NCT02299635|531367997|FG000|Overall Study|Withdrawal by Subject|2|||
147328336|NCT02299635|531367997|FG000|Overall Study|Other|3|||
147328337|NCT00601640|531367998|FG000|Overall Study|Withdrawal by Subject|3|||
147328338|NCT00601640|531367999|FG001|Overall Study|Withdrawal by Subject|0|||
147328339|NCT00601640|531368000|FG002|Overall Study|Withdrawal by Subject|7|||
147328340|NCT00601640|531367998|FG000|Overall Study|Death|1|||
147328341|NCT00601640|531367999|FG001|Overall Study|Death|0|||
147328342|NCT00601640|531368000|FG002|Overall Study|Death|0|||
147448571|NCT00879229|531807896|FG001|Overall Study|Other|0|||
147184795|NCT02723773|530843750|FG001|Overall Study|Other|1|||
147658324|NCT02581488|532572245|FG000|Overall Study|Non-Compliance|1|||
147658325|NCT02581488|532572246|FG001|Overall Study|Non-Compliance|0|||
147658326|NCT02581488|532572245|FG000|Overall Study|Protocol Violation|0|||
147658327|NCT02581488|532572246|FG001|Overall Study|Protocol Violation|4|||
147658328|NCT01957579|532572252|FG000|Overall Study|Withdrawal of concent|0|||
147658329|NCT01957579|532572253|FG001|Overall Study|Withdrawal of concent|1|||
147658330|NCT01957579|532572254|FG002|Overall Study|Withdrawal of concent|0|||
147658331|NCT01957579|532572255|FG003|Overall Study|Withdrawal of concent|0|||
147658332|NCT01957579|532572252|FG000|Overall Study|Death|0|||
147658333|NCT01957579|532572253|FG001|Overall Study|Death|0|||
147658334|NCT01957579|532572254|FG002|Overall Study|Death|2|||
147658335|NCT01957579|532572255|FG003|Overall Study|Death|0|||
147658336|NCT01000974|532572257|FG000|Primary Vaccination Phase|Withdrawal by Subject|109|||
147658337|NCT01000974|532572258|FG001|Primary Vaccination Phase|Withdrawal by Subject|17|||
147658338|NCT01000974|532572259|FG002|Primary Vaccination Phase|Withdrawal by Subject|21|||
147658339|NCT01000974|532572257|FG000|Primary Vaccination Phase|Lost to Follow-up|171|||
147658340|NCT01000974|532572258|FG001|Primary Vaccination Phase|Lost to Follow-up|19|||
147658341|NCT01000974|532572259|FG002|Primary Vaccination Phase|Lost to Follow-up|26|||
147658342|NCT01000974|532572257|FG000|Primary Vaccination Phase|Protocol Violation|40|||
147658343|NCT01000974|532572258|FG001|Primary Vaccination Phase|Protocol Violation|3|||
147658344|NCT01000974|532572259|FG002|Primary Vaccination Phase|Protocol Violation|2|||
147658345|NCT01000974|532572257|FG000|Primary Vaccination Phase|Adverse Event|14|||
147658346|NCT01000974|532572258|FG001|Primary Vaccination Phase|Adverse Event|2|||
147658347|NCT01000974|532572259|FG002|Primary Vaccination Phase|Adverse Event|2|||
147658348|NCT01000974|532572257|FG000|Primary Vaccination Phase|Other|4|||
147658349|NCT01000974|532572258|FG001|Primary Vaccination Phase|Other|9|||
147658350|NCT01000974|532572259|FG002|Primary Vaccination Phase|Other|12|||
147658351|NCT01000974|532572257|FG000|Booster Vaccination Phase|Protocol Violation|0|||
147658352|NCT01000974|532572258|FG001|Booster Vaccination Phase|Protocol Violation|0|||
147658353|NCT01000974|532572259|FG002|Booster Vaccination Phase|Protocol Violation|2|||
147658354|NCT01000974|532572257|FG000|Booster Vaccination Phase|Withdrawal by Subject|3|||
147658355|NCT01000974|532572258|FG001|Booster Vaccination Phase|Withdrawal by Subject|1|||
147658356|NCT01000974|532572259|FG002|Booster Vaccination Phase|Withdrawal by Subject|1|||
147658357|NCT01000974|532572257|FG000|Booster Vaccination Phase|Lost to Follow-up|40|||
147658358|NCT01000974|532572258|FG001|Booster Vaccination Phase|Lost to Follow-up|5|||
147658359|NCT01000974|532572259|FG002|Booster Vaccination Phase|Lost to Follow-up|7|||
147658360|NCT01000974|532572257|FG000|Booster Vaccination Phase|Other|24|||
147658361|NCT01000974|532572258|FG001|Booster Vaccination Phase|Other|6|||
147658362|NCT01000974|532572259|FG002|Booster Vaccination Phase|Other|4|||
147658363|NCT03365934|532572260|FG000|Overall Study|Adverse Event|1|||
147658364|NCT03365934|532572260|FG000|Overall Study|Withdrawal by Subject|1|||
147658365|NCT01307891|532572261|FG000|Overall Study|Progressive Disease|3|||
147658366|NCT01307891|532572262|FG001|Overall Study|Progressive Disease|1|||
147658367|NCT00377637|532572264|FG000|Induction Phase|Adverse Event|12|||
147658368|NCT00377637|532572265|FG001|Induction Phase|Adverse Event|21|||
147658369|NCT00377637|532572266|FG002|Induction Phase|Adverse Event|0|||
147658370|NCT00377637|532572267|FG003|Induction Phase|Adverse Event|0|||
147658371|NCT00377637|532572264|FG000|Induction Phase|Deterioration/serum creatinine|2|||
147658372|NCT00377637|532572265|FG001|Induction Phase|Deterioration/serum creatinine|0|||
147658373|NCT00377637|532572266|FG002|Induction Phase|Deterioration/serum creatinine|0|||
147184796|NCT02723773|530843751|FG002|Overall Study|Other|2|||
147184797|NCT02723773|530843752|FG003|Overall Study|Other|2|||
147184798|NCT03654690|530843765|FG000|Overall Study|Withdrawal by Subject|1|||
147184799|NCT03654690|530843766|FG001|Overall Study|Withdrawal by Subject|0|||
147184800|NCT03654690|530843767|FG002|Overall Study|Withdrawal by Subject|0|||
147184801|NCT00742183|530843768|FG000|Overall Study|Adverse Event|2|||
147184802|NCT00742183|530843769|FG001|Overall Study|Adverse Event|2|||
147658374|NCT00377637|532572267|FG003|Induction Phase|Deterioration/serum creatinine|0|||
147658375|NCT00377637|532572264|FG000|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|0|||
147658376|NCT00377637|532572265|FG001|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|1|||
147658377|NCT00377637|532572266|FG002|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|0|||
147658378|NCT00377637|532572267|FG003|Induction Phase|Dose reduction of MMF < 2 g/day for 14 d|0|||
147658379|NCT00377637|532572264|FG000|Induction Phase|Lost to Follow-up|2|||
147658380|NCT00377637|532572265|FG001|Induction Phase|Lost to Follow-up|1|||
147658381|NCT00377637|532572266|FG002|Induction Phase|Lost to Follow-up|0|||
147658382|NCT00377637|532572267|FG003|Induction Phase|Lost to Follow-up|0|||
147658383|NCT00377637|532572264|FG000|Induction Phase|Death|1|||
147658384|NCT00377637|532572265|FG001|Induction Phase|Death|3|||
147658385|NCT00377637|532572266|FG002|Induction Phase|Death|0|||
147184803|NCT00742183|530843768|FG000|Overall Study|Death|1|||
147184804|NCT00742183|530843769|FG001|Overall Study|Death|0|||
147658386|NCT00377637|532572267|FG003|Induction Phase|Death|0|||
147658387|NCT00377637|532572264|FG000|Induction Phase|Withdrawal by Subject|5|||
147658388|NCT00377637|532572265|FG001|Induction Phase|Withdrawal by Subject|6|||
147658389|NCT00377637|532572266|FG002|Induction Phase|Withdrawal by Subject|0|||
147184805|NCT00742183|530843768|FG000|Overall Study|Physician Decision|0|||
147184806|NCT00742183|530843769|FG001|Overall Study|Physician Decision|2|||
147184807|NCT00742183|530843768|FG000|Overall Study|Lost to Follow-up|4|||
147184808|NCT00742183|530843769|FG001|Overall Study|Lost to Follow-up|4|||
147184809|NCT00742183|530843768|FG000|Overall Study|Required skin-graft|1|||
147184810|NCT00742183|530843769|FG001|Overall Study|Required skin-graft|1|||
147184811|NCT00742183|530843768|FG000|Overall Study|Withdrawal by Subject|1|||
147184812|NCT00742183|530843769|FG001|Overall Study|Withdrawal by Subject|0|||
147184813|NCT00742183|530843768|FG000|Overall Study|Lack of Efficacy|0|||
147184814|NCT00742183|530843769|FG001|Overall Study|Lack of Efficacy|3|||
147184815|NCT03922581|530843773|FG000|Overall Study|Lost to Follow-up|20|||
147184816|NCT03922581|530843774|FG001|Overall Study|Lost to Follow-up|9|||
147184817|NCT03922581|530843773|FG000|Overall Study|Physician Decision|1|||
147184818|NCT03922581|530843774|FG001|Overall Study|Physician Decision|1|||
147184819|NCT03922581|530843773|FG000|Overall Study|Withdrawal by Subject|1|||
147184820|NCT03922581|530843774|FG001|Overall Study|Withdrawal by Subject|0|||
147184821|NCT00764699|530843775|FG000|Overall Study|PI left and study terminated|3|||
147184822|NCT01508312|530843776|FG000|Overall Study|Lost to Follow-up|1|||
147184823|NCT01508312|530843777|FG001|Overall Study|Lost to Follow-up|0|||
147184824|NCT01508312|530843778|FG002|Overall Study|Lost to Follow-up|0|||
147184825|NCT01508312|530843779|FG003|Overall Study|Lost to Follow-up|0|||
147184826|NCT01508312|530843776|FG000|Overall Study|Participant's Hodgkin's lymphoma relapsed, proven by a biopsy sample.|0|||
147184827|NCT01508312|530843777|FG001|Overall Study|Participant's Hodgkin's lymphoma relapsed, proven by a biopsy sample.|1|||
147184828|NCT01508312|530843778|FG002|Overall Study|Participant's Hodgkin's lymphoma relapsed, proven by a biopsy sample.|0|||
147184829|NCT01508312|530843779|FG003|Overall Study|Participant's Hodgkin's lymphoma relapsed, proven by a biopsy sample.|0|||
147184830|NCT01508312|530843776|FG000|Overall Study|Adverse Event|0|||
147184831|NCT01508312|530843777|FG001|Overall Study|Adverse Event|0|||
147184832|NCT01508312|530843778|FG002|Overall Study|Adverse Event|2|||
147184833|NCT01508312|530843779|FG003|Overall Study|Adverse Event|0|||
147184834|NCT01508312|530843776|FG000|Overall Study|Lack of Efficacy|0|||
147184835|NCT01508312|530843777|FG001|Overall Study|Lack of Efficacy|0|||
147184836|NCT01508312|530843778|FG002|Overall Study|Lack of Efficacy|1|||
147184837|NCT01508312|530843779|FG003|Overall Study|Lack of Efficacy|0|||
147184838|NCT01508312|530843776|FG000|Overall Study|Withdrawal by Subject|0|||
147184839|NCT01508312|530843777|FG001|Overall Study|Withdrawal by Subject|0|||
147184840|NCT01508312|530843778|FG002|Overall Study|Withdrawal by Subject|1|||
147184841|NCT01508312|530843779|FG003|Overall Study|Withdrawal by Subject|0|||
147184842|NCT02223715|530843780|FG000|Overall Study|Death|31|||
147184843|NCT02223715|530843780|FG000|Overall Study|Lost to Follow-up|73|||
147184844|NCT02107703|530843784|FG000|Overall Study|Withdrawal by Subject|46|||
147184845|NCT02107703|530843785|FG001|Overall Study|Withdrawal by Subject|21|||
147184846|NCT02107703|530843784|FG000|Overall Study|Lost to Follow-up|20|||
147658390|NCT00377637|532572267|FG003|Induction Phase|Withdrawal by Subject|0|||
147658391|NCT00377637|532572264|FG000|Induction Phase|Physician Decision|3|||
147658392|NCT00377637|532572265|FG001|Induction Phase|Physician Decision|1|||
147658393|NCT00377637|532572266|FG002|Induction Phase|Physician Decision|0|||
147658394|NCT00377637|532572267|FG003|Induction Phase|Physician Decision|0|||
147658395|NCT00377637|532572264|FG000|Induction Phase|Sponsor decision|1|||
147658396|NCT00377637|532572265|FG001|Induction Phase|Sponsor decision|2|||
147658397|NCT00377637|532572266|FG002|Induction Phase|Sponsor decision|0|||
147658398|NCT00377637|532572267|FG003|Induction Phase|Sponsor decision|0|||
147658399|NCT00377637|532572264|FG000|Induction Phase|Non-Compliance|1|||
147658400|NCT00377637|532572265|FG001|Induction Phase|Non-Compliance|0|||
147658401|NCT00377637|532572266|FG002|Induction Phase|Non-Compliance|0|||
147658402|NCT00377637|532572267|FG003|Induction Phase|Non-Compliance|0|||
147658403|NCT00377637|532572264|FG000|Induction Phase|Reason for withdrawal is not noted|2|||
147658404|NCT00377637|532572265|FG001|Induction Phase|Reason for withdrawal is not noted|0|||
147658405|NCT00377637|532572266|FG002|Induction Phase|Reason for withdrawal is not noted|0|||
147658406|NCT00377637|532572267|FG003|Induction Phase|Reason for withdrawal is not noted|0|||
147658407|NCT00377637|532572264|FG000|Maintenance Phase|Adverse Event|0|||
147658408|NCT00377637|532572265|FG001|Maintenance Phase|Adverse Event|0|||
147184847|NCT02107703|530843785|FG001|Overall Study|Lost to Follow-up|9|||
147184848|NCT02107703|530843784|FG000|Overall Study|On study treatment/follow up|48|||
147328343|NCT00601640|531367998|FG000|Overall Study|Adverse Event|0|||
147328344|NCT00601640|531367999|FG001|Overall Study|Adverse Event|4|||
147184849|NCT02107703|530843785|FG001|Overall Study|On study treatment/follow up|5|||
147184850|NCT03906071|530843786|FG000|Overall Study|Death|180|||
147184851|NCT03906071|530843787|FG001|Overall Study|Death|185|||
147184852|NCT03906071|530843786|FG000|Overall Study|Lost to Follow-up|3|||
147184853|NCT03906071|530843787|FG001|Overall Study|Lost to Follow-up|3|||
147184854|NCT03906071|530843786|FG000|Overall Study|Withdrawal by Subject|15|||
147184855|NCT03906071|530843787|FG001|Overall Study|Withdrawal by Subject|27|||
147658409|NCT00377637|532572266|FG002|Maintenance Phase|Adverse Event|29|||
147658410|NCT00377637|532572267|FG003|Maintenance Phase|Adverse Event|43|||
147658411|NCT00377637|532572264|FG000|Maintenance Phase|Physician Decision|0|||
147658412|NCT00377637|532572265|FG001|Maintenance Phase|Physician Decision|0|||
147184856|NCT03906071|530843786|FG000|Overall Study|Other|2|||
147184857|NCT03906071|530843787|FG001|Overall Study|Other|1|||
147328345|NCT00601640|531368000|FG002|Overall Study|Adverse Event|2|||
147328346|NCT00601640|531367998|FG000|Overall Study|intercurrent illness|1|||
147328347|NCT00601640|531367999|FG001|Overall Study|intercurrent illness|0|||
147328348|NCT00601640|531368000|FG002|Overall Study|intercurrent illness|0|||
147328349|NCT00601640|531367998|FG000|Overall Study|change in eligibility status|0|||
147328350|NCT00601640|531367999|FG001|Overall Study|change in eligibility status|1|||
147328351|NCT00601640|531368000|FG002|Overall Study|change in eligibility status|1|||
147328352|NCT00015457|531368002|FG000|First Intervention|Adverse Event|0|||
147328353|NCT00015457|531368003|FG001|First Intervention|Adverse Event|2|||
147328354|NCT00015457|531368002|FG000|First Intervention|Lack of Efficacy|0|||
147328355|NCT00015457|531368003|FG001|First Intervention|Lack of Efficacy|1|||
147328356|NCT00015457|531368002|FG000|Second Intervention|Withdrawal by Subject|1|||
147328357|NCT00015457|531368003|FG001|Second Intervention|Withdrawal by Subject|0|||
147328358|NCT01710514|531368008|FG000|Overall Study|Adverse Event|6|||
147328359|NCT01710514|531368009|FG001|Overall Study|Adverse Event|7|||
147328360|NCT01710514|531368008|FG000|Overall Study|Withdrawal by Subject|1|||
147328361|NCT01710514|531368009|FG001|Overall Study|Withdrawal by Subject|0|||
147328362|NCT03404843|531368010|FG000|Overall Study|Study difficulties unrelated to Tx|4|||
147328363|NCT03404843|531368011|FG001|Overall Study|Study difficulties unrelated to Tx|1|||
147328364|NCT02701361|531368012|FG000|Overall Study|Lost to Follow-up|5|||
147328365|NCT02701361|531368013|FG001|Overall Study|Lost to Follow-up|2|||
147328366|NCT02701361|531368014|FG002|Overall Study|Lost to Follow-up|1|||
147328367|NCT02701361|531368012|FG000|Overall Study|Withdrawal by Subject|4|||
147328368|NCT02701361|531368013|FG001|Overall Study|Withdrawal by Subject|0|||
147328369|NCT02701361|531368014|FG002|Overall Study|Withdrawal by Subject|0|||
147328370|NCT02701361|531368012|FG000|Overall Study|timed out in rehab center|0|||
147328371|NCT02701361|531368013|FG001|Overall Study|timed out in rehab center|1|||
147328372|NCT02701361|531368014|FG002|Overall Study|timed out in rehab center|0|||
147328373|NCT02701361|531368012|FG000|Overall Study|incarceration|0|||
147328374|NCT02701361|531368013|FG001|Overall Study|incarceration|0|||
147328375|NCT02701361|531368014|FG002|Overall Study|incarceration|1|||
147328376|NCT02430532|531368024|FG000|Overall Study|Sponsor Decision to Stop Study Early|30|||
147328377|NCT02430532|531368025|FG001|Overall Study|Sponsor Decision to Stop Study Early|25|||
147328378|NCT02430532|531368024|FG000|Overall Study|Consent Withdrawn|0|||
147328379|NCT02430532|531368025|FG001|Overall Study|Consent Withdrawn|2|||
147328380|NCT02430532|531368024|FG000|Overall Study|Adverse Event|0|||
147328381|NCT02430532|531368025|FG001|Overall Study|Adverse Event|1|||
147328382|NCT01190150|531368026|FG000|First Treatment|Withdrawal by Subject|1|||
147328383|NCT01190150|531368027|FG001|First Treatment|Withdrawal by Subject|0|||
147328384|NCT01190150|531368026|FG000|Washout|Withdrawal by Subject|0|||
147328385|NCT01190150|531368027|FG001|Washout|Withdrawal by Subject|1|||
147328386|NCT01190150|531368026|FG000|Washout|Difficulty in adherence|0|||
147328387|NCT01190150|531368027|FG001|Washout|Difficulty in adherence|1|||
147328388|NCT02750709|531368030|FG000|Treatment Period 1|Adverse Event|0|||
147328389|NCT02750709|531368031|FG001|Treatment Period 1|Adverse Event|0|||
147328390|NCT02750709|531368032|FG002|Treatment Period 1|Adverse Event|0|||
147328391|NCT02750709|531368033|FG003|Treatment Period 1|Adverse Event|0|||
147328392|NCT02750709|531368034|FG004|Treatment Period 1|Adverse Event|0|||
147328393|NCT02750709|531368035|FG005|Treatment Period 1|Adverse Event|1|||
147328394|NCT03256344|531368036|FG000|Overall Study|Death|6|||
147328395|NCT03256344|531368037|FG001|Overall Study|Death|22|||
147328396|NCT03256344|531368036|FG000|Overall Study|Withdrawal by Subject|3|||
147328397|NCT03256344|531368037|FG001|Overall Study|Withdrawal by Subject|3|||
147328398|NCT03256344|531368036|FG000|Overall Study|Sponsor Decision|1|||
147328399|NCT03256344|531368037|FG001|Overall Study|Sponsor Decision|0|||
147328400|NCT00580801|531368047|FG000|Overall Study|Physician Decision|1|||
147328401|NCT00580801|531368048|FG001|Overall Study|Physician Decision|0|||
147328402|NCT00580801|531368049|FG002|Overall Study|Physician Decision|0|||
147328403|NCT00580801|531368047|FG000|Overall Study|Adverse Event|2|||
147328404|NCT00580801|531368048|FG001|Overall Study|Adverse Event|0|||
147328405|NCT00580801|531368049|FG002|Overall Study|Adverse Event|0|||
147448572|NCT00513409|531807900|FG000|Overall Study|Adverse Event|0|||
147328406|NCT00580801|531368047|FG000|Overall Study|Lost to Follow-up|2|||
147328407|NCT00580801|531368048|FG001|Overall Study|Lost to Follow-up|0|||
147328408|NCT00580801|531368049|FG002|Overall Study|Lost to Follow-up|0|||
147328409|NCT00580801|531368047|FG000|Overall Study|Reached a virologic endpoint|0|||
147328410|NCT00580801|531368048|FG001|Overall Study|Reached a virologic endpoint|1|||
147328411|NCT00580801|531368049|FG002|Overall Study|Reached a virologic endpoint|2|||
147328412|NCT00580801|531368047|FG000|Overall Study|Participant non-compliant|0|||
147328413|NCT00580801|531368048|FG001|Overall Study|Participant non-compliant|0|||
147328414|NCT00580801|531368049|FG002|Overall Study|Participant non-compliant|1|||
147328415|NCT00580801|531368047|FG000|Overall Study|Travel|1|||
147328416|NCT00580801|531368048|FG001|Overall Study|Travel|0|||
147328417|NCT00580801|531368049|FG002|Overall Study|Travel|0|||
147328418|NCT00502593|531368050|FG000|Overall Study|Withdrawn unspecified reason|1|||
147328419|NCT00502593|531368051|FG001|Overall Study|Withdrawn unspecified reason|1|||
147328420|NCT00502593|531368052|FG002|Overall Study|Withdrawn unspecified reason|3|||
147448573|NCT00513409|531807901|FG001|Overall Study|Adverse Event|1|||
147328421|NCT00502593|531368053|FG003|Overall Study|Withdrawn unspecified reason|1|||
147328422|NCT00502593|531368054|FG004|Overall Study|Withdrawn unspecified reason|2|||
147328423|NCT00502593|531368055|FG005|Overall Study|Withdrawn unspecified reason|0|||
147328424|NCT00502593|531368056|FG006|Overall Study|Withdrawn unspecified reason|2|||
147328425|NCT00502593|531368057|FG007|Overall Study|Withdrawn unspecified reason|0|||
147328426|NCT00502593|531368058|FG008|Overall Study|Withdrawn unspecified reason|0|||
147328427|NCT00502593|531368059|FG009|Overall Study|Withdrawn unspecified reason|0|||
147328428|NCT00502593|531368060|FG010|Overall Study|Withdrawn unspecified reason|0|||
147328429|NCT00502593|531368061|FG011|Overall Study|Withdrawn unspecified reason|0|||
147328430|NCT00502593|531368050|FG000|Overall Study|Withdrawal by Subject|0|||
147328431|NCT00502593|531368051|FG001|Overall Study|Withdrawal by Subject|0|||
147328432|NCT00502593|531368052|FG002|Overall Study|Withdrawal by Subject|6|||
147328433|NCT00502593|531368053|FG003|Overall Study|Withdrawal by Subject|2|||
147328434|NCT00502593|531368054|FG004|Overall Study|Withdrawal by Subject|2|||
147328435|NCT00502593|531368055|FG005|Overall Study|Withdrawal by Subject|0|||
147328436|NCT00502593|531368056|FG006|Overall Study|Withdrawal by Subject|3|||
147328437|NCT00502593|531368057|FG007|Overall Study|Withdrawal by Subject|0|||
147328438|NCT00502593|531368058|FG008|Overall Study|Withdrawal by Subject|3|||
147328439|NCT00502593|531368059|FG009|Overall Study|Withdrawal by Subject|0|||
147328440|NCT00502593|531368060|FG010|Overall Study|Withdrawal by Subject|1|||
147328441|NCT00502593|531368061|FG011|Overall Study|Withdrawal by Subject|0|||
147328442|NCT00502593|531368050|FG000|Overall Study|Lost to Follow-up|2|||
147328443|NCT00502593|531368051|FG001|Overall Study|Lost to Follow-up|1|||
147328444|NCT00502593|531368052|FG002|Overall Study|Lost to Follow-up|1|||
147328445|NCT00502593|531368053|FG003|Overall Study|Lost to Follow-up|1|||
147328446|NCT00502593|531368054|FG004|Overall Study|Lost to Follow-up|0|||
147328447|NCT00502593|531368055|FG005|Overall Study|Lost to Follow-up|0|||
147328448|NCT00502593|531368056|FG006|Overall Study|Lost to Follow-up|0|||
147328449|NCT00502593|531368057|FG007|Overall Study|Lost to Follow-up|0|||
147328450|NCT00502593|531368058|FG008|Overall Study|Lost to Follow-up|3|||
147328451|NCT00502593|531368059|FG009|Overall Study|Lost to Follow-up|0|||
147328452|NCT00502593|531368060|FG010|Overall Study|Lost to Follow-up|1|||
147328453|NCT00502593|531368061|FG011|Overall Study|Lost to Follow-up|0|||
147328454|NCT00880906|531368063|FG000|Overall Study|Lost to Follow-up|0|||
147328455|NCT00880906|531368064|FG001|Overall Study|Lost to Follow-up|1|||
147328456|NCT00880906|531368063|FG000|Overall Study|Did not meet criteria following patholog|12|||
147328457|NCT00880906|531368064|FG001|Overall Study|Did not meet criteria following patholog|6|||
147328458|NCT00544440|531368067|FG000|Overall Study|Other|1|||
147328459|NCT00544440|531368067|FG000|Overall Study|Adverse Event|1|||
147328460|NCT00544440|531368067|FG000|Overall Study|Withdrawal by Subject|2|||
147328461|NCT00544440|531368067|FG000|Overall Study|Subject Non-compliance|1|||
147328462|NCT00544440|531368067|FG000|Overall Study|Progressive Disease|47|||
147328463|NCT00544440|531368067|FG000|Overall Study|Other|5|||
147328464|NCT01460342|531368068|FG000|Overall Study|Adverse Event|5|||
147328465|NCT01460342|531368069|FG001|Overall Study|Adverse Event|4|||
147328466|NCT01460342|531368068|FG000|Overall Study|Lost to Follow-up|1|||
147328467|NCT01460342|531368069|FG001|Overall Study|Lost to Follow-up|2|||
147328468|NCT01460342|531368068|FG000|Overall Study|Protocol Violation|0|||
147328469|NCT01460342|531368069|FG001|Overall Study|Protocol Violation|1|||
147328470|NCT01460342|531368068|FG000|Overall Study|Withdrawal by Subject|3|||
147328471|NCT01460342|531368069|FG001|Overall Study|Withdrawal by Subject|4|||
147328472|NCT01460342|531368068|FG000|Overall Study|Physician Decision|1|||
147328473|NCT01460342|531368069|FG001|Overall Study|Physician Decision|3|||
147328474|NCT01460342|531368068|FG000|Overall Study|Lack of Efficacy|1|||
147328475|NCT01460342|531368069|FG001|Overall Study|Lack of Efficacy|0|||
147328476|NCT03586167|531368070|FG000|Overall Study|Other|1|||
147328477|NCT03586167|531368071|FG001|Overall Study|Other|0|||
147328478|NCT00591838|531368072|FG000|Overall Study|Withdrawal by Subject|0|||
147328479|NCT00591838|531368073|FG001|Overall Study|Withdrawal by Subject|0|||
147328480|NCT00591838|531368074|FG002|Overall Study|Withdrawal by Subject|0|||
147328481|NCT00591838|531368075|FG003|Overall Study|Withdrawal by Subject|1|||
147328482|NCT00591838|531368076|FG004|Overall Study|Withdrawal by Subject|0|||
147328483|NCT02512042|531368078|FG000|Overall Study|Adverse Event|0|||
147328484|NCT02512042|531368079|FG001|Overall Study|Adverse Event|4|||
147328485|NCT02512042|531368078|FG000|Overall Study|Withdrawal by Subject|6|||
147328486|NCT02512042|531368079|FG001|Overall Study|Withdrawal by Subject|6|||
147328487|NCT02512042|531368078|FG000|Overall Study|Non-compliance with study drug|1|||
147328488|NCT02512042|531368079|FG001|Overall Study|Non-compliance with study drug|2|||
147328489|NCT02512042|531368078|FG000|Overall Study|Lost to Follow-up|5|||
147328490|NCT02512042|531368079|FG001|Overall Study|Lost to Follow-up|2|||
147328491|NCT02512042|531368078|FG000|Overall Study|Other|11|||
147328492|NCT02512042|531368079|FG001|Overall Study|Other|11|||
147328493|NCT04163458|531368082|FG000|Overall Study|Protocol Deviation|7|||
147328494|NCT04163458|531368083|FG001|Overall Study|Protocol Deviation|13|||
147328495|NCT04163458|531368082|FG000|Overall Study|Adverse Event|5|||
147328496|NCT04163458|531368083|FG001|Overall Study|Adverse Event|8|||
147328497|NCT04163458|531368082|FG000|Overall Study|Due to COVID-19 pandemic|4|||
147593873|NCT02025751|532329055|FG001|Overall Study|Lost to Follow-up|0|||
147328498|NCT04163458|531368083|FG001|Overall Study|Due to COVID-19 pandemic|2|||
147328499|NCT04163458|531368082|FG000|Overall Study|Participant withdrew consent|2|||
147328500|NCT04163458|531368083|FG001|Overall Study|Participant withdrew consent|3|||
147328501|NCT04163458|531368082|FG000|Overall Study|Randomization failure|2|||
147328502|NCT04163458|531368083|FG001|Overall Study|Randomization failure|2|||
147328503|NCT04163458|531368082|FG000|Overall Study|Other|4|||
147328504|NCT04163458|531368083|FG001|Overall Study|Other|2|||
147328505|NCT04109118|531368088|FG000|Overall Study|Lost to Follow-up|3|||
147328506|NCT03563053|531368089|FG000|Overall Study|Withdrawal by Subject|17|||
147328507|NCT03563053|531368089|FG000|Overall Study|Due to the COVID-19 pandemic|12|||
147328508|NCT03563053|531368089|FG000|Overall Study|Adverse Event|3|||
147328509|NCT03563053|531368089|FG000|Overall Study|Physician Decision|1|||
147328510|NCT03563053|531368089|FG000|Overall Study|study terminated by sponsor|71|||
147328511|NCT00813488|531368090|FG000|Titration Period 1|Adverse Event|6|||
147328512|NCT00813488|531368091|FG001|Titration Period 1|Adverse Event|1|||
147328513|NCT00813488|531368090|FG000|Titration Period 1|Lack of Efficacy|9|||
147184858|NCT00466440|530843788|FG000|Overall Study|Adverse Event|0|||
147184859|NCT00466440|530843789|FG001|Overall Study|Adverse Event|3|||
147184860|NCT00466440|530843790|FG002|Overall Study|Adverse Event|1|||
147184861|NCT00466440|530843788|FG000|Overall Study|Death|1|||
147328514|NCT00813488|531368091|FG001|Titration Period 1|Lack of Efficacy|7|||
147328515|NCT00813488|531368090|FG000|Titration Period 1|Withdrawal by Subject|2|||
147184862|NCT00466440|530843789|FG001|Overall Study|Death|1|||
147184863|NCT00466440|530843790|FG002|Overall Study|Death|0|||
147184864|NCT00466440|530843788|FG000|Overall Study|Progressive disease|13|||
147184865|NCT00466440|530843789|FG001|Overall Study|Progressive disease|5|||
147184866|NCT00466440|530843790|FG002|Overall Study|Progressive disease|4|||
147328516|NCT00813488|531368091|FG001|Titration Period 1|Withdrawal by Subject|2|||
147328517|NCT00813488|531368090|FG000|Titration Period 1|Protocol Violation|4|||
147328518|NCT00813488|531368091|FG001|Titration Period 1|Protocol Violation|3|||
147328519|NCT00813488|531368090|FG000|Titration Period 1|Non-compliance to study medication|4|||
147328520|NCT00813488|531368091|FG001|Titration Period 1|Non-compliance to study medication|1|||
147328521|NCT00813488|531368090|FG000|Titration Period 1|Non-compliance to study procedures|2|||
147328522|NCT00813488|531368091|FG001|Titration Period 1|Non-compliance to study procedures|2|||
147328523|NCT00813488|531368090|FG000|Titration Period 1|Technical Difficulties|0|||
147328524|NCT00813488|531368091|FG001|Titration Period 1|Technical Difficulties|1|||
147328525|NCT00813488|531368090|FG000|Titration Period 2|Adverse Event|2|||
147328526|NCT00813488|531368091|FG001|Titration Period 2|Adverse Event|3|||
147328527|NCT00813488|531368090|FG000|Titration Period 2|Lack of Efficacy|8|||
147328528|NCT00813488|531368091|FG001|Titration Period 2|Lack of Efficacy|4|||
147328529|NCT00813488|531368090|FG000|Titration Period 2|Protocol Violation|3|||
147328530|NCT00813488|531368091|FG001|Titration Period 2|Protocol Violation|2|||
147328531|NCT00813488|531368090|FG000|Titration Period 2|Lost to Follow-up|1|||
147328532|NCT00813488|531368091|FG001|Titration Period 2|Lost to Follow-up|0|||
147328533|NCT00813488|531368090|FG000|Titration Period 2|Non-compliance with study procedures|2|||
147328534|NCT00813488|531368091|FG001|Titration Period 2|Non-compliance with study procedures|1|||
147328535|NCT00813488|531368090|FG000|Double-blind Treatment Period 1|Adverse Event|1|||
147328536|NCT00813488|531368091|FG001|Double-blind Treatment Period 1|Adverse Event|1|||
147328537|NCT00813488|531368090|FG000|Double-blind Treatment Period 1|Withdrawal by Subject|0|||
147328538|NCT00813488|531368091|FG001|Double-blind Treatment Period 1|Withdrawal by Subject|1|||
147328539|NCT00813488|531368090|FG000|Double-blind Treatment Period 1|Protocol Violation|0|||
147328540|NCT00813488|531368091|FG001|Double-blind Treatment Period 1|Protocol Violation|2|||
147328541|NCT00813488|531368090|FG000|Double-blind Treatment Period 1|Lost to Follow-up|0|||
147328542|NCT00813488|531368091|FG001|Double-blind Treatment Period 1|Lost to Follow-up|1|||
147328543|NCT00813488|531368090|FG000|Double-blind Treatment Period 2|Adverse Event|1|||
147328544|NCT00813488|531368091|FG001|Double-blind Treatment Period 2|Adverse Event|0|||
147328545|NCT00813488|531368090|FG000|Double-blind Treatment Period 2|Withdrawal by Subject|1|||
147328546|NCT00813488|531368091|FG001|Double-blind Treatment Period 2|Withdrawal by Subject|1|||
147328547|NCT00813488|531368090|FG000|Double-blind Treatment Period 2|Protocol Violation|2|||
147328548|NCT00813488|531368091|FG001|Double-blind Treatment Period 2|Protocol Violation|0|||
147328549|NCT00813488|531368090|FG000|Double-blind Treatment Period 2|Other|1|||
147328550|NCT00813488|531368091|FG001|Double-blind Treatment Period 2|Other|0|||
147328551|NCT00813488|531368090|FG000|Open-label Extension|Adverse Event|1|||
147328552|NCT00813488|531368091|FG001|Open-label Extension|Adverse Event|2|||
147328553|NCT00813488|531368090|FG000|Open-label Extension|Lack of Efficacy|3|||
147328554|NCT00813488|531368091|FG001|Open-label Extension|Lack of Efficacy|0|||
147328555|NCT00813488|531368090|FG000|Open-label Extension|Withdrawal by Subject|0|||
147328556|NCT00813488|531368091|FG001|Open-label Extension|Withdrawal by Subject|2|||
147328557|NCT00813488|531368090|FG000|Open-label Extension|Protocol Violation|1|||
147328558|NCT00813488|531368091|FG001|Open-label Extension|Protocol Violation|2|||
147328559|NCT00813488|531368090|FG000|Open-label Extension|Non-compliance study medication|4|||
147328560|NCT00813488|531368091|FG001|Open-label Extension|Non-compliance study medication|0|||
147184867|NCT00466440|530843788|FG000|Overall Study|Lost to Follow-up|0|||
147184868|NCT00466440|530843789|FG001|Overall Study|Lost to Follow-up|1|||
147658413|NCT00377637|532572266|FG002|Maintenance Phase|Physician Decision|5|||
147184869|NCT00466440|530843790|FG002|Overall Study|Lost to Follow-up|0|||
147658414|NCT00377637|532572267|FG003|Maintenance Phase|Physician Decision|4|||
147184870|NCT00466440|530843788|FG000|Overall Study|Physician Decision|0|||
147184871|NCT00466440|530843789|FG001|Overall Study|Physician Decision|1|||
147184872|NCT00466440|530843790|FG002|Overall Study|Physician Decision|2|||
147184873|NCT00466440|530843788|FG000|Overall Study|Protocol entry criteria not met|0|||
147184874|NCT00466440|530843789|FG001|Overall Study|Protocol entry criteria not met|0|||
147184875|NCT00466440|530843790|FG002|Overall Study|Protocol entry criteria not met|4|||
147184876|NCT00466440|530843788|FG000|Overall Study|Withdrawal by Subject|0|||
147184877|NCT00466440|530843789|FG001|Overall Study|Withdrawal by Subject|1|||
147184878|NCT00466440|530843790|FG002|Overall Study|Withdrawal by Subject|0|||
147184879|NCT00466440|530843788|FG000|Overall Study|Sponsor decision|0|||
147184880|NCT00466440|530843789|FG001|Overall Study|Sponsor decision|0|||
147184881|NCT00466440|530843790|FG002|Overall Study|Sponsor decision|1|||
147184882|NCT03187132|530843791|FG000|Inpatient Trauma Only|Lost to Follow-up|3|||
147184883|NCT03187132|530843792|FG001|Inpatient Trauma Only|Lost to Follow-up|12|||
147184884|NCT03187132|530843791|FG000|Inpatient Trauma Only|socioeconomic burden|1|||
147184885|NCT03187132|530843792|FG001|Inpatient Trauma Only|socioeconomic burden|0|||
147184886|NCT03187132|530843791|FG000|Inpatient Trauma+Pain Clinic, no Opioid|Lost to Follow-up|0|||
147184887|NCT03187132|530843792|FG001|Inpatient Trauma+Pain Clinic, no Opioid|Lost to Follow-up|5|||
147184888|NCT03187132|530843791|FG000|Inpatient Trauma+Pain Clinic, no Opioid|Disease burden|1|||
147184889|NCT03187132|530843792|FG001|Inpatient Trauma+Pain Clinic, no Opioid|Disease burden|0|||
147184890|NCT03187132|530843791|FG000|Inpatient Trauma+Pain Clinic|Lost to Follow-up|2|||
147184891|NCT03187132|530843792|FG001|Inpatient Trauma+Pain Clinic|Lost to Follow-up|5|||
147184892|NCT03187132|530843791|FG000|Inpatient Trauma+Pain Clinic|Disease burden|1|||
147184893|NCT03187132|530843792|FG001|Inpatient Trauma+Pain Clinic|Disease burden|0|||
147184894|NCT03187132|530843791|FG000|Inpatient Trauma+Pain Clinic|Unhappy with allocation|0|||
147184895|NCT03187132|530843792|FG001|Inpatient Trauma+Pain Clinic|Unhappy with allocation|2|||
147184896|NCT03187132|530843791|FG000|Pain Clinic Only, Fully Remote|Lost to Follow-up|27|||
147184897|NCT03187132|530843792|FG001|Pain Clinic Only, Fully Remote|Lost to Follow-up|47|||
147184898|NCT03187132|530843791|FG000|Pain Clinic Only, Fully Remote|Disease burden|6|||
147184899|NCT03187132|530843792|FG001|Pain Clinic Only, Fully Remote|Disease burden|5|||
147184900|NCT03187132|530843791|FG000|Pain Clinic Only, Fully Remote|Language barrier|0|||
147184901|NCT03187132|530843792|FG001|Pain Clinic Only, Fully Remote|Language barrier|1|||
147184902|NCT03187132|530843791|FG000|Pain Clinic Only, Fully Remote|EMR|0|||
147184903|NCT03187132|530843792|FG001|Pain Clinic Only, Fully Remote|EMR|1|||
147184904|NCT00965081|530843793|FG000|Overall Study|Adverse Event|14|||
147184905|NCT00965081|530843794|FG001|Overall Study|Adverse Event|9|||
147184906|NCT00965081|530843793|FG000|Overall Study|Lack of Efficacy|2|||
147184907|NCT00965081|530843794|FG001|Overall Study|Lack of Efficacy|5|||
147184908|NCT00965081|530843793|FG000|Overall Study|Lost to Follow-up|4|||
147184909|NCT00965081|530843794|FG001|Overall Study|Lost to Follow-up|5|||
147184910|NCT00965081|530843793|FG000|Overall Study|Physician Decision|2|||
147184911|NCT00965081|530843794|FG001|Overall Study|Physician Decision|0|||
147184912|NCT00965081|530843793|FG000|Overall Study|Protocol Violation|2|||
147184913|NCT00965081|530843794|FG001|Overall Study|Protocol Violation|5|||
147184914|NCT00965081|530843793|FG000|Overall Study|Sponsor Decision|1|||
147184915|NCT00965081|530843794|FG001|Overall Study|Sponsor Decision|0|||
147184916|NCT00965081|530843793|FG000|Overall Study|Withdrawal by Subject|4|||
147184917|NCT00965081|530843794|FG001|Overall Study|Withdrawal by Subject|7|||
147184918|NCT00965081|530843793|FG000|Overall Study|Switched to Rescue Arm|5|||
147184919|NCT00965081|530843794|FG001|Overall Study|Switched to Rescue Arm|12|||
147184920|NCT01367834|530843797|FG000|Overall Study|Withdrawal by Subject|2|||
147184921|NCT01367834|530843798|FG001|Overall Study|Withdrawal by Subject|2|||
147184922|NCT01367834|530843797|FG000|Overall Study|Study was ended.|0|||
147184923|NCT01367834|530843798|FG001|Overall Study|Study was ended.|1|||
147184924|NCT00988598|530843799|FG000|Overall Study|Withdrawal by Subject|2|||
147184925|NCT00988598|530843800|FG001|Overall Study|Withdrawal by Subject|0|||
147184926|NCT01141712|530843806|FG000|Overall Study|Disease progression|3|||
147658415|NCT00377637|532572264|FG000|Maintenance Phase|Lost to Follow-up|0|||
147184927|NCT04112810|530843817|FG000|Overall Study|Only 50 pts are evaluable as 1 pt withdrew before treatment.|1|||
147184928|NCT05963022|530843818|FG000|Overall Study|Adverse Event|0|||
147184929|NCT05963022|530843819|FG001|Overall Study|Adverse Event|1|||
147184930|NCT05963022|530843820|FG002|Overall Study|Adverse Event|1|||
147184931|NCT05963022|530843821|FG003|Overall Study|Adverse Event|0|||
147184932|NCT05963022|530843818|FG000|Overall Study|Protocol Violation|0|||
147184933|NCT05963022|530843819|FG001|Overall Study|Protocol Violation|3|||
147184934|NCT05963022|530843820|FG002|Overall Study|Protocol Violation|0|||
147184935|NCT05963022|530843821|FG003|Overall Study|Protocol Violation|0|||
147184936|NCT05963022|530843818|FG000|Overall Study|Pregnancy|0|||
147184937|NCT05963022|530843819|FG001|Overall Study|Pregnancy|1|||
147184938|NCT05963022|530843820|FG002|Overall Study|Pregnancy|1|||
147658416|NCT00377637|532572265|FG001|Maintenance Phase|Lost to Follow-up|0|||
147184939|NCT05963022|530843821|FG003|Overall Study|Pregnancy|1|||
147184940|NCT05963022|530843818|FG000|Overall Study|Withdrawal by Subject|0|||
147184941|NCT05963022|530843819|FG001|Overall Study|Withdrawal by Subject|0|||
147184942|NCT05963022|530843820|FG002|Overall Study|Withdrawal by Subject|2|||
147184943|NCT05963022|530843821|FG003|Overall Study|Withdrawal by Subject|1|||
147184944|NCT05963022|530843818|FG000|Overall Study|Lost to Follow-up|0|||
147184945|NCT05963022|530843819|FG001|Overall Study|Lost to Follow-up|0|||
147184946|NCT05963022|530843820|FG002|Overall Study|Lost to Follow-up|0|||
147184947|NCT05963022|530843821|FG003|Overall Study|Lost to Follow-up|1|||
147184948|NCT05963022|530843818|FG000|Overall Study|Subject Required long-term Initiation of Rescue Antihyperglycemic Medication|0|||
147184949|NCT05963022|530843819|FG001|Overall Study|Subject Required long-term Initiation of Rescue Antihyperglycemic Medication|0|||
147184950|NCT05963022|530843820|FG002|Overall Study|Subject Required long-term Initiation of Rescue Antihyperglycemic Medication|0|||
147184951|NCT05963022|530843821|FG003|Overall Study|Subject Required long-term Initiation of Rescue Antihyperglycemic Medication|1|||
147184952|NCT01012258|530843822|FG000|Overall Study|Death|14|||
147184953|NCT01012258|530843822|FG000|Overall Study|Lost to Follow-up|1|||
147184954|NCT01012258|530843822|FG000|Overall Study|Adverse Event|1|||
147184955|NCT01012258|530843822|FG000|Overall Study|Progressive Disease (PD)|18|||
147184956|NCT01012258|530843822|FG000|Overall Study|Symptomatic Deterioration|1|||
147184957|NCT01012258|530843822|FG000|Overall Study|Another Anti-cancer Drug Received|1|||
147184958|NCT01012258|530843822|FG000|Overall Study|Another Tumor Discovered|1|||
147184959|NCT01012258|530843822|FG000|Overall Study|Ongoing|29|||
147184960|NCT03575403|530843823|FG000|Overall Study|Adverse Event|1|||
147184961|NCT03575403|530843824|FG001|Overall Study|Adverse Event|0|||
147184962|NCT03575403|530843825|FG002|Overall Study|Adverse Event|0|||
147184963|NCT03575403|530843823|FG000|Overall Study|One subject left due to personal reasons unrelated to study-procedures|1|||
147184964|NCT03575403|530843824|FG001|Overall Study|One subject left due to personal reasons unrelated to study-procedures|0|||
147184965|NCT03575403|530843825|FG002|Overall Study|One subject left due to personal reasons unrelated to study-procedures|0|||
147184966|NCT00773513|530843826|FG000|Overall Study|Renal Transplant|254|||
147184967|NCT00773513|530843827|FG001|Overall Study|Renal Transplant|263|||
147184968|NCT00773513|530843826|FG000|Overall Study|Adverse Event / Intercurrent Illness|40|||
147184969|NCT00773513|530843827|FG001|Overall Study|Adverse Event / Intercurrent Illness|48|||
147184970|NCT00773513|530843826|FG000|Overall Study|Withdrew Consent|68|||
147184971|NCT00773513|530843827|FG001|Overall Study|Withdrew Consent|69|||
147184972|NCT00773513|530843826|FG000|Overall Study|Refused Treatment / Did not Cooperate|26|||
147184973|NCT00773513|530843827|FG001|Overall Study|Refused Treatment / Did not Cooperate|32|||
147184974|NCT00773513|530843826|FG000|Overall Study|Failure to Return|22|||
147184975|NCT00773513|530843827|FG001|Overall Study|Failure to Return|8|||
147184976|NCT00773513|530843826|FG000|Overall Study|Insufficient Therapeutic Response|1|||
147184977|NCT00773513|530843827|FG001|Overall Study|Insufficient Therapeutic Response|18|||
147184978|NCT00773513|530843826|FG000|Overall Study|Reason Not Specified|159|||
147184979|NCT00773513|530843827|FG001|Overall Study|Reason Not Specified|126|||
147184980|NCT00773513|530843826|FG000|Overall Study|Death|531|||
147184981|NCT00773513|530843827|FG001|Overall Study|Death|545|||
147184982|NCT03359174|530843831|FG000|Overall Study|Adverse Event|1|||
147184983|NCT01332994|530843835|FG000|Overall Study|Adverse Event|34|||
147184984|NCT01332994|530843835|FG000|Overall Study|Death|1|||
147184985|NCT01332994|530843835|FG000|Overall Study|Lack of Efficacy|1|||
147184986|NCT01332994|530843835|FG000|Overall Study|Lost to Follow-up|4|||
147184987|NCT01332994|530843835|FG000|Overall Study|Protocol Violation|6|||
147184988|NCT01332994|530843835|FG000|Overall Study|Withdrawal by Subject|15|||
147184989|NCT01332994|530843835|FG000|Overall Study|Administrative Problem|2|||
147184990|NCT01332994|530843835|FG000|Overall Study|Other|8|||
147184991|NCT04170543|530843836|FG000|Overall Study|Death|1|||
147184992|NCT04170543|530843837|FG001|Overall Study|Death|1|||
147184993|NCT04170543|530843838|FG002|Overall Study|Death|1|||
147184994|NCT04170543|530843839|FG003|Overall Study|Death|1|||
147184995|NCT04170543|530843840|FG004|Overall Study|Death|1|||
147184996|NCT04170543|530843836|FG000|Overall Study|Lost to Follow-up|3|||
147184997|NCT04170543|530843837|FG001|Overall Study|Lost to Follow-up|3|||
147184998|NCT04170543|530843838|FG002|Overall Study|Lost to Follow-up|0|||
147184999|NCT04170543|530843839|FG003|Overall Study|Lost to Follow-up|3|||
147185000|NCT04170543|530843840|FG004|Overall Study|Lost to Follow-up|1|||
147185001|NCT04170543|530843836|FG000|Overall Study|Withdrawal by Subject|13|||
147185002|NCT04170543|530843837|FG001|Overall Study|Withdrawal by Subject|6|||
147185003|NCT04170543|530843838|FG002|Overall Study|Withdrawal by Subject|5|||
147185004|NCT04170543|530843839|FG003|Overall Study|Withdrawal by Subject|4|||
147185005|NCT04170543|530843840|FG004|Overall Study|Withdrawal by Subject|9|||
147185006|NCT04170543|530843836|FG000|Overall Study|Not able to transition to phase 2b|8|||
147185007|NCT04170543|530843837|FG001|Overall Study|Not able to transition to phase 2b|0|||
147185008|NCT04170543|530843838|FG002|Overall Study|Not able to transition to phase 2b|10|||
147185009|NCT04170543|530843839|FG003|Overall Study|Not able to transition to phase 2b|0|||
147185010|NCT04170543|530843840|FG004|Overall Study|Not able to transition to phase 2b|6|||
147185011|NCT04170543|530843836|FG000|Overall Study|Enrolled in Site with GCP Breach|6|||
147185012|NCT04170543|530843837|FG001|Overall Study|Enrolled in Site with GCP Breach|1|||
147185013|NCT04170543|530843838|FG002|Overall Study|Enrolled in Site with GCP Breach|2|||
147185014|NCT04170543|530843839|FG003|Overall Study|Enrolled in Site with GCP Breach|2|||
147185015|NCT04170543|530843840|FG004|Overall Study|Enrolled in Site with GCP Breach|4|||
147185016|NCT04170543|530843836|FG000|Overall Study|Not Treated|0|||
147185017|NCT04170543|530843837|FG001|Overall Study|Not Treated|0|||
147185018|NCT04170543|530843838|FG002|Overall Study|Not Treated|0|||
147185019|NCT04170543|530843839|FG003|Overall Study|Not Treated|0|||
147185020|NCT04170543|530843840|FG004|Overall Study|Not Treated|2|||
147185021|NCT04170543|530843836|FG000|Overall Study|(CRF)|16|||
147185022|NCT04170543|530843837|FG001|Overall Study|(CRF)|15|||
147185023|NCT04170543|530843838|FG002|Overall Study|(CRF)|12|||
147185024|NCT04170543|530843839|FG003|Overall Study|(CRF)|17|||
147185025|NCT04170543|530843840|FG004|Overall Study|(CRF)|17|||
147185026|NCT04170543|530843836|FG000|Overall Study|Due to COVID-19 Pandemic|1|||
147185027|NCT04170543|530843837|FG001|Overall Study|Due to COVID-19 Pandemic|0|||
147185028|NCT04170543|530843838|FG002|Overall Study|Due to COVID-19 Pandemic|1|||
147185029|NCT04170543|530843839|FG003|Overall Study|Due to COVID-19 Pandemic|0|||
147185030|NCT04170543|530843840|FG004|Overall Study|Due to COVID-19 Pandemic|0|||
147185031|NCT04303559|530843841|FG000|Overall Study|Study closed due to poor enrollment.|1|||
147185032|NCT04378270|530843844|FG000|Overall Study|Lack of Efficacy|1|||
147185033|NCT04378270|530843844|FG000|Overall Study|Withdrawal by Subject|1|||
147185034|NCT04378270|530843844|FG000|Overall Study|Screen Failure|1|||
147328561|NCT00813488|531368090|FG000|Open-label Extension|Non-compliance study procedures|2|||
147328562|NCT00813488|531368091|FG001|Open-label Extension|Non-compliance study procedures|1|||
147328563|NCT00813488|531368090|FG000|Open-label Extension|Other|1|||
147328564|NCT00813488|531368091|FG001|Open-label Extension|Other|0|||
147328565|NCT02926937|531368092|FG000|Overall Study|Adverse Event|0|||
147185035|NCT04378270|530843844|FG000|Overall Study|University Required, Research Covid Shut Down|2|||
147185036|NCT01327599|530843845|FG000|Overall Study|Adverse Event|1|||
147185037|NCT01327599|530843845|FG000|Overall Study|Could Not Attend Visit|1|||
147185038|NCT01327599|530843845|FG000|Overall Study|Withdrawal of Consent|1|||
147185039|NCT01156714|530843846|FG000|Overall Study|Withdrawal by Subject|9|||
147247044|NCT03129100|531072768|FG009|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
147328566|NCT02926937|531368093|FG001|Overall Study|Adverse Event|1|||
147247045|NCT03129100|531072769|FG010|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
147328567|NCT02926937|531368094|FG002|Overall Study|Adverse Event|1|||
147328568|NCT02926937|531368092|FG000|Overall Study|Poor Compliance to Protocol|1|||
147328569|NCT02926937|531368093|FG001|Overall Study|Poor Compliance to Protocol|0|||
147328570|NCT02926937|531368094|FG002|Overall Study|Poor Compliance to Protocol|0|||
147328571|NCT02926937|531368092|FG000|Overall Study|Lost to Follow-up|4|||
147328572|NCT02926937|531368093|FG001|Overall Study|Lost to Follow-up|5|||
147328573|NCT02926937|531368094|FG002|Overall Study|Lost to Follow-up|0|||
147328574|NCT02926937|531368092|FG000|Overall Study|At the Participant's own Request|11|||
147328575|NCT02926937|531368093|FG001|Overall Study|At the Participant's own Request|5|||
147328576|NCT02926937|531368094|FG002|Overall Study|At the Participant's own Request|8|||
147328577|NCT02926937|531368092|FG000|Overall Study|Reason not Specified|3|||
147328578|NCT02926937|531368093|FG001|Overall Study|Reason not Specified|4|||
147328579|NCT02926937|531368094|FG002|Overall Study|Reason not Specified|2|||
147328580|NCT01559090|531368095|FG000|Stage I|Withdrawal by Subject|2|||
147328581|NCT01559090|531368096|FG001|Stage I|Withdrawal by Subject|2|||
147328582|NCT01559090|531368097|FG002|Stage I|Withdrawal by Subject|3|||
147328583|NCT01559090|531368095|FG000|Stage II|Withdrawal by Subject|1|||
147328584|NCT01559090|531368096|FG001|Stage II|Withdrawal by Subject|0|||
147328585|NCT01559090|531368097|FG002|Stage II|Withdrawal by Subject|0|||
147328586|NCT03677375|531368099|FG000|Overall Study|Incomplete procedure|8|||
147328587|NCT03677375|531368099|FG000|Overall Study|Adverse Event|3|||
147185040|NCT01156714|530843847|FG001|Overall Study|Withdrawal by Subject|4|||
147185041|NCT01156714|530843848|FG002|Overall Study|Withdrawal by Subject|3|||
147185042|NCT01132313|530843849|FG000|Overall Study|Lack of Efficacy|1|||
147247046|NCT03129100|531072770|FG011|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
147247047|NCT03129100|531072771|FG012|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
147247048|NCT03129100|531072772|FG013|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
147247049|NCT03129100|531072773|FG014|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
147247050|NCT03129100|531072774|FG015|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
147247051|NCT03129100|531072775|FG016|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
147247052|NCT03129100|531072776|FG017|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
147247053|NCT03129100|531072777|FG018|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
147185043|NCT01132313|530843850|FG001|Overall Study|Lack of Efficacy|0|||
147328588|NCT03677375|531368099|FG000|Overall Study|Physician Decision|1|||
147328589|NCT01143077|531368102|FG000|Overall Study|Lack of Efficacy|0|||
147328590|NCT01143077|531368103|FG001|Overall Study|Lack of Efficacy|2|||
147593874|NCT02025751|532329054|FG000|Overall Study|Adverse Event|0|||
147185044|NCT01132313|530843851|FG002|Overall Study|Lack of Efficacy|0|||
147185045|NCT01132313|530843852|FG003|Overall Study|Lack of Efficacy|0|||
147185046|NCT01132313|530843853|FG004|Overall Study|Lack of Efficacy|0|||
147328591|NCT01143077|531368104|FG002|Overall Study|Lack of Efficacy|1|||
147185047|NCT01132313|530843854|FG005|Overall Study|Lack of Efficacy|0|||
147185048|NCT01132313|530843855|FG006|Overall Study|Lack of Efficacy|0|||
147328592|NCT01143077|531368102|FG000|Overall Study|Adverse Event|5|||
147328593|NCT01143077|531368103|FG001|Overall Study|Adverse Event|6|||
147185049|NCT01132313|530843856|FG007|Overall Study|Lack of Efficacy|3|||
147185050|NCT01132313|530843857|FG008|Overall Study|Lack of Efficacy|14|||
147185051|NCT01132313|530843858|FG009|Overall Study|Lack of Efficacy|16|||
147185052|NCT01132313|530843859|FG010|Overall Study|Lack of Efficacy|0|||
147185053|NCT01132313|530843860|FG011|Overall Study|Lack of Efficacy|0|||
147185054|NCT01132313|530843849|FG000|Overall Study|Not treated|2|||
147185055|NCT01132313|530843850|FG001|Overall Study|Not treated|0|||
147185056|NCT01132313|530843851|FG002|Overall Study|Not treated|0|||
147185057|NCT01132313|530843852|FG003|Overall Study|Not treated|0|||
147185058|NCT01132313|530843853|FG004|Overall Study|Not treated|2|||
147185059|NCT01132313|530843854|FG005|Overall Study|Not treated|1|||
147185060|NCT01132313|530843855|FG006|Overall Study|Not treated|3|||
147185061|NCT01132313|530843856|FG007|Overall Study|Not treated|0|||
147185062|NCT01132313|530843857|FG008|Overall Study|Not treated|0|||
147185063|NCT01132313|530843858|FG009|Overall Study|Not treated|0|||
147185064|NCT01132313|530843859|FG010|Overall Study|Not treated|0|||
147185065|NCT01132313|530843860|FG011|Overall Study|Not treated|0|||
147185066|NCT01132313|530843849|FG000|Overall Study|Adverse Event|0|||
147185067|NCT01132313|530843850|FG001|Overall Study|Adverse Event|0|||
147185068|NCT01132313|530843851|FG002|Overall Study|Adverse Event|4|||
147185069|NCT01132313|530843852|FG003|Overall Study|Adverse Event|10|||
147185070|NCT01132313|530843853|FG004|Overall Study|Adverse Event|19|||
147185071|NCT01132313|530843854|FG005|Overall Study|Adverse Event|6|||
147185072|NCT01132313|530843855|FG006|Overall Study|Adverse Event|5|||
147185073|NCT01132313|530843856|FG007|Overall Study|Adverse Event|3|||
147185074|NCT01132313|530843857|FG008|Overall Study|Adverse Event|7|||
147185075|NCT01132313|530843858|FG009|Overall Study|Adverse Event|2|||
147328594|NCT01143077|531368104|FG002|Overall Study|Adverse Event|5|||
147328595|NCT01143077|531368102|FG000|Overall Study|Lost to Follow-up|2|||
147185076|NCT01132313|530843859|FG010|Overall Study|Adverse Event|0|||
147185077|NCT01132313|530843860|FG011|Overall Study|Adverse Event|0|||
147185078|NCT01132313|530843849|FG000|Overall Study|Protocol Violation|0|||
147185079|NCT01132313|530843850|FG001|Overall Study|Protocol Violation|0|||
147185080|NCT01132313|530843851|FG002|Overall Study|Protocol Violation|0|||
147185081|NCT01132313|530843852|FG003|Overall Study|Protocol Violation|1|||
147185082|NCT01132313|530843853|FG004|Overall Study|Protocol Violation|0|||
147185083|NCT01132313|530843854|FG005|Overall Study|Protocol Violation|0|||
147185084|NCT01132313|530843855|FG006|Overall Study|Protocol Violation|0|||
147185085|NCT01132313|530843856|FG007|Overall Study|Protocol Violation|0|||
147185086|NCT01132313|530843857|FG008|Overall Study|Protocol Violation|0|||
147185087|NCT01132313|530843858|FG009|Overall Study|Protocol Violation|0|||
147185088|NCT01132313|530843859|FG010|Overall Study|Protocol Violation|0|||
147185089|NCT01132313|530843860|FG011|Overall Study|Protocol Violation|0|||
147185090|NCT01132313|530843849|FG000|Overall Study|Lost to Follow-up|0|||
147185091|NCT01132313|530843850|FG001|Overall Study|Lost to Follow-up|0|||
147185092|NCT01132313|530843851|FG002|Overall Study|Lost to Follow-up|1|||
147185093|NCT01132313|530843852|FG003|Overall Study|Lost to Follow-up|0|||
147185094|NCT01132313|530843853|FG004|Overall Study|Lost to Follow-up|0|||
147185095|NCT01132313|530843854|FG005|Overall Study|Lost to Follow-up|0|||
147185096|NCT01132313|530843855|FG006|Overall Study|Lost to Follow-up|0|||
147185097|NCT01132313|530843856|FG007|Overall Study|Lost to Follow-up|1|||
147185098|NCT01132313|530843857|FG008|Overall Study|Lost to Follow-up|0|||
147185099|NCT01132313|530843858|FG009|Overall Study|Lost to Follow-up|0|||
147185100|NCT01132313|530843859|FG010|Overall Study|Lost to Follow-up|0|||
147185101|NCT01132313|530843860|FG011|Overall Study|Lost to Follow-up|0|||
147185102|NCT01132313|530843849|FG000|Overall Study|Withdrawal by Subject|0|||
147185103|NCT01132313|530843850|FG001|Overall Study|Withdrawal by Subject|0|||
147185104|NCT01132313|530843851|FG002|Overall Study|Withdrawal by Subject|3|||
147185105|NCT01132313|530843852|FG003|Overall Study|Withdrawal by Subject|3|||
147185106|NCT01132313|530843853|FG004|Overall Study|Withdrawal by Subject|6|||
147185107|NCT01132313|530843854|FG005|Overall Study|Withdrawal by Subject|0|||
147185108|NCT01132313|530843855|FG006|Overall Study|Withdrawal by Subject|1|||
147185109|NCT01132313|530843856|FG007|Overall Study|Withdrawal by Subject|0|||
147185110|NCT01132313|530843857|FG008|Overall Study|Withdrawal by Subject|0|||
147185111|NCT01132313|530843858|FG009|Overall Study|Withdrawal by Subject|2|||
147185112|NCT01132313|530843859|FG010|Overall Study|Withdrawal by Subject|0|||
147185113|NCT01132313|530843860|FG011|Overall Study|Withdrawal by Subject|0|||
147185114|NCT01132313|530843849|FG000|Overall Study|Lack of antiviral response|0|||
147328596|NCT01143077|531368103|FG001|Overall Study|Lost to Follow-up|3|||
147185115|NCT01132313|530843850|FG001|Overall Study|Lack of antiviral response|0|||
147185116|NCT01132313|530843851|FG002|Overall Study|Lack of antiviral response|12|||
147185117|NCT01132313|530843852|FG003|Overall Study|Lack of antiviral response|18|||
147185118|NCT01132313|530843853|FG004|Overall Study|Lack of antiviral response|18|||
147185119|NCT01132313|530843854|FG005|Overall Study|Lack of antiviral response|18|||
147185120|NCT01132313|530843855|FG006|Overall Study|Lack of antiviral response|21|||
147185121|NCT01132313|530843856|FG007|Overall Study|Lack of antiviral response|0|||
147185122|NCT01132313|530843857|FG008|Overall Study|Lack of antiviral response|0|||
147185123|NCT01132313|530843858|FG009|Overall Study|Lack of antiviral response|0|||
147328597|NCT01143077|531368104|FG002|Overall Study|Lost to Follow-up|4|||
147328598|NCT01143077|531368102|FG000|Overall Study|Protocol Violation|2|||
147328599|NCT01143077|531368103|FG001|Overall Study|Protocol Violation|0|||
147328600|NCT01143077|531368104|FG002|Overall Study|Protocol Violation|0|||
147328601|NCT01143077|531368102|FG000|Overall Study|Withdrawal by Subject|4|||
147328602|NCT01143077|531368103|FG001|Overall Study|Withdrawal by Subject|3|||
147328603|NCT01143077|531368104|FG002|Overall Study|Withdrawal by Subject|3|||
147328604|NCT01143077|531368102|FG000|Overall Study|Non-compliance with study drug|0|||
147328605|NCT01143077|531368103|FG001|Overall Study|Non-compliance with study drug|1|||
147328606|NCT01143077|531368104|FG002|Overall Study|Non-compliance with study drug|1|||
147328607|NCT01143077|531368102|FG000|Overall Study|Administrative|1|||
147328608|NCT01143077|531368103|FG001|Overall Study|Administrative|0|||
147328609|NCT01143077|531368104|FG002|Overall Study|Administrative|0|||
147328610|NCT01143077|531368102|FG000|Overall Study|Principal Investigator Decision|2|||
147328611|NCT01143077|531368103|FG001|Overall Study|Principal Investigator Decision|0|||
147328612|NCT01143077|531368104|FG002|Overall Study|Principal Investigator Decision|1|||
147328613|NCT00124982|531368105|FG000|Short-term Period|Death|1|||
147328614|NCT00124982|531368106|FG001|Short-term Period|Death|1|||
147328615|NCT00124982|531368107|FG002|Short-term Period|Death|0|||
147328616|NCT00124982|531368105|FG000|Short-term Period|Adverse Event|17|||
147328617|NCT00124982|531368106|FG001|Short-term Period|Adverse Event|22|||
147328618|NCT00124982|531368107|FG002|Short-term Period|Adverse Event|0|||
147328619|NCT00124982|531368105|FG000|Short-term Period|Lack of Efficacy|32|||
147328620|NCT00124982|531368106|FG001|Short-term Period|Lack of Efficacy|73|||
147328621|NCT00124982|531368107|FG002|Short-term Period|Lack of Efficacy|0|||
147328622|NCT00124982|531368105|FG000|Short-term Period|Lost to Follow-up|8|||
147328623|NCT00124982|531368106|FG001|Short-term Period|Lost to Follow-up|5|||
147328624|NCT00124982|531368107|FG002|Short-term Period|Lost to Follow-up|0|||
147328625|NCT00124982|531368105|FG000|Short-term Period|Withdrawal of Consent|7|||
147328626|NCT00124982|531368106|FG001|Short-term Period|Withdrawal of Consent|9|||
147328627|NCT00124982|531368107|FG002|Short-term Period|Withdrawal of Consent|0|||
147328628|NCT00124982|531368105|FG000|Short-term Period|Poor/Non-compliance|3|||
147328629|NCT00124982|531368106|FG001|Short-term Period|Poor/Non-compliance|1|||
147328630|NCT00124982|531368107|FG002|Short-term Period|Poor/Non-compliance|0|||
147328631|NCT00124982|531368105|FG000|Short-term Period|No Longer Meets Study Criteria|1|||
147328632|NCT00124982|531368106|FG001|Short-term Period|No Longer Meets Study Criteria|2|||
147328633|NCT00124982|531368107|FG002|Short-term Period|No Longer Meets Study Criteria|0|||
147328634|NCT00124982|531368105|FG000|Short-term Period|Participant Decision|1|||
147328635|NCT00124982|531368106|FG001|Short-term Period|Participant Decision|0|||
147328636|NCT00124982|531368107|FG002|Short-term Period|Participant Decision|0|||
147328637|NCT00124982|531368105|FG000|Short-term Period|Participant Chose Own Doctor|0|||
147328638|NCT00124982|531368106|FG001|Short-term Period|Participant Chose Own Doctor|1|||
147328639|NCT00124982|531368107|FG002|Short-term Period|Participant Chose Own Doctor|0|||
147328640|NCT00124982|531368105|FG000|Short-term Period|Investigator Decision-No Specific AE|1|||
147328641|NCT00124982|531368106|FG001|Short-term Period|Investigator Decision-No Specific AE|0|||
147328642|NCT00124982|531368107|FG002|Short-term Period|Investigator Decision-No Specific AE|0|||
147328643|NCT00124982|531368105|FG000|Short-term Period|Participant Had Lymphopenia|1|||
147328644|NCT00124982|531368106|FG001|Short-term Period|Participant Had Lymphopenia|0|||
147328645|NCT00124982|531368107|FG002|Short-term Period|Participant Had Lymphopenia|0|||
147328646|NCT00124982|531368105|FG000|Long-term Period|Death|0|||
147328647|NCT00124982|531368106|FG001|Long-term Period|Death|0|||
147328648|NCT00124982|531368107|FG002|Long-term Period|Death|1|||
147328649|NCT00124982|531368105|FG000|Long-term Period|Adverse Event|0|||
147328650|NCT00124982|531368106|FG001|Long-term Period|Adverse Event|0|||
147328651|NCT00124982|531368107|FG002|Long-term Period|Adverse Event|17|||
147328652|NCT00124982|531368105|FG000|Long-term Period|Lack of Efficacy|0|||
147328653|NCT00124982|531368106|FG001|Long-term Period|Lack of Efficacy|0|||
147328654|NCT00124982|531368107|FG002|Long-term Period|Lack of Efficacy|46|||
147328655|NCT00124982|531368105|FG000|Long-term Period|Lost to Follow-up|0|||
147328656|NCT00124982|531368106|FG001|Long-term Period|Lost to Follow-up|0|||
147328657|NCT00124982|531368107|FG002|Long-term Period|Lost to Follow-up|4|||
147328658|NCT00124982|531368105|FG000|Long-term Period|Withdrawal by Subject|0|||
147328659|NCT00124982|531368106|FG001|Long-term Period|Withdrawal by Subject|0|||
147328660|NCT00124982|531368107|FG002|Long-term Period|Withdrawal by Subject|16|||
147328661|NCT00124982|531368105|FG000|Long-term Period|Pregnancy|0|||
147328662|NCT00124982|531368106|FG001|Long-term Period|Pregnancy|0|||
147328663|NCT00124982|531368107|FG002|Long-term Period|Pregnancy|1|||
147328664|NCT00124982|531368105|FG000|Long-term Period|Poor/Non-compliance|0|||
147328665|NCT00124982|531368106|FG001|Long-term Period|Poor/Non-compliance|0|||
147328666|NCT00124982|531368107|FG002|Long-term Period|Poor/Non-compliance|2|||
147328667|NCT00124982|531368105|FG000|Long-term Period|Administrative Reason by Sponsor|0|||
147328668|NCT00124982|531368106|FG001|Long-term Period|Administrative Reason by Sponsor|0|||
147328669|NCT00124982|531368107|FG002|Long-term Period|Administrative Reason by Sponsor|1|||
147328670|NCT00124982|531368105|FG000|Long-term Period|Neurologist Recommendation|0|||
147328671|NCT00124982|531368106|FG001|Long-term Period|Neurologist Recommendation|0|||
147593875|NCT02025751|532329055|FG001|Overall Study|Adverse Event|1|||
147328672|NCT00124982|531368107|FG002|Long-term Period|Neurologist Recommendation|1|||
147328673|NCT05273801|531368108|FG000|Overall Study|Physician Decision|1|||
147328674|NCT04257058|531369970|FG000|Overall Study|Lost to Follow-up|31|||
147328675|NCT02030028|531369974|FG000|Overall Study|Withdrawal by Subject|4|||
147328676|NCT02030028|531369974|FG000|Overall Study|lack of transportation|1|||
147328677|NCT01249092|531369977|FG000|Overall Study|Expected side effect of nausea/dyspepsia|1|||
147328678|NCT01249092|531369977|FG000|Overall Study|Unable to tolerate expected SE -nausea|1|||
147328679|NCT02001623|531369984|FG000|Overall Study|Disease Progression|2|||
147328680|NCT02001623|531369985|FG001|Overall Study|Disease Progression|2|||
147328681|NCT02001623|531369986|FG002|Overall Study|Disease Progression|3|||
147328682|NCT02001623|531369987|FG003|Overall Study|Disease Progression|2|||
147328683|NCT02001623|531369988|FG004|Overall Study|Disease Progression|3|||
147328684|NCT02001623|531369989|FG005|Overall Study|Disease Progression|2|||
147328685|NCT02001623|531369990|FG006|Overall Study|Disease Progression|3|||
147328686|NCT02001623|531369991|FG007|Overall Study|Disease Progression|3|||
147328687|NCT02001623|531369992|FG008|Overall Study|Disease Progression|7|||
147328688|NCT02001623|531369993|FG009|Overall Study|Disease Progression|40|||
147328689|NCT02001623|531369994|FG010|Overall Study|Disease Progression|5|||
147328690|NCT02001623|531369995|FG011|Overall Study|Disease Progression|9|||
147328691|NCT02001623|531369996|FG012|Overall Study|Disease Progression|9|||
147328692|NCT02001623|531369997|FG013|Overall Study|Disease Progression|20|||
147328693|NCT02001623|531369998|FG014|Overall Study|Disease Progression|9|||
147328694|NCT02001623|531369984|FG000|Overall Study|Physician Decision|0|||
147328695|NCT02001623|531369985|FG001|Overall Study|Physician Decision|0|||
147328696|NCT02001623|531369986|FG002|Overall Study|Physician Decision|0|||
147328697|NCT02001623|531369987|FG003|Overall Study|Physician Decision|0|||
147328698|NCT02001623|531369988|FG004|Overall Study|Physician Decision|0|||
147328699|NCT02001623|531369989|FG005|Overall Study|Physician Decision|0|||
147328700|NCT02001623|531369990|FG006|Overall Study|Physician Decision|0|||
147328701|NCT02001623|531369991|FG007|Overall Study|Physician Decision|0|||
147328702|NCT02001623|531369992|FG008|Overall Study|Physician Decision|3|||
147328703|NCT02001623|531369993|FG009|Overall Study|Physician Decision|2|||
147328704|NCT02001623|531369994|FG010|Overall Study|Physician Decision|3|||
147328705|NCT02001623|531369995|FG011|Overall Study|Physician Decision|3|||
147328706|NCT02001623|531369996|FG012|Overall Study|Physician Decision|1|||
147328707|NCT02001623|531369997|FG013|Overall Study|Physician Decision|2|||
147328708|NCT02001623|531369998|FG014|Overall Study|Physician Decision|1|||
147328709|NCT02001623|531369984|FG000|Overall Study|Death|0|||
147328710|NCT02001623|531369985|FG001|Overall Study|Death|1|||
147328711|NCT02001623|531369986|FG002|Overall Study|Death|0|||
147328712|NCT02001623|531369987|FG003|Overall Study|Death|0|||
147328713|NCT02001623|531369988|FG004|Overall Study|Death|0|||
147328714|NCT02001623|531369989|FG005|Overall Study|Death|0|||
147328715|NCT02001623|531369990|FG006|Overall Study|Death|0|||
147328716|NCT02001623|531369991|FG007|Overall Study|Death|0|||
147328717|NCT02001623|531369992|FG008|Overall Study|Death|0|||
147328718|NCT02001623|531369993|FG009|Overall Study|Death|0|||
147328719|NCT02001623|531369994|FG010|Overall Study|Death|0|||
147328720|NCT02001623|531369995|FG011|Overall Study|Death|0|||
147328721|NCT02001623|531369996|FG012|Overall Study|Death|0|||
147328722|NCT02001623|531369997|FG013|Overall Study|Death|0|||
147328723|NCT02001623|531369998|FG014|Overall Study|Death|0|||
147328724|NCT02001623|531369984|FG000|Overall Study|Adverse Event|0|||
147328725|NCT02001623|531369985|FG001|Overall Study|Adverse Event|0|||
147328726|NCT02001623|531369986|FG002|Overall Study|Adverse Event|0|||
147328727|NCT02001623|531369987|FG003|Overall Study|Adverse Event|0|||
147328728|NCT02001623|531369988|FG004|Overall Study|Adverse Event|0|||
147328729|NCT02001623|531369989|FG005|Overall Study|Adverse Event|1|||
147328730|NCT02001623|531369990|FG006|Overall Study|Adverse Event|0|||
147328731|NCT02001623|531369991|FG007|Overall Study|Adverse Event|3|||
147328732|NCT02001623|531369992|FG008|Overall Study|Adverse Event|4|||
147328733|NCT02001623|531369993|FG009|Overall Study|Adverse Event|6|||
147328734|NCT02001623|531369994|FG010|Overall Study|Adverse Event|4|||
147328735|NCT02001623|531369995|FG011|Overall Study|Adverse Event|0|||
147328736|NCT02001623|531369996|FG012|Overall Study|Adverse Event|3|||
147328737|NCT02001623|531369997|FG013|Overall Study|Adverse Event|5|||
147328738|NCT02001623|531369998|FG014|Overall Study|Adverse Event|6|||
147328739|NCT02001623|531369984|FG000|Overall Study|Other - Miscellaneous|0|||
147328740|NCT02001623|531369985|FG001|Overall Study|Other - Miscellaneous|0|||
147328741|NCT02001623|531369986|FG002|Overall Study|Other - Miscellaneous|0|||
147328742|NCT02001623|531369987|FG003|Overall Study|Other - Miscellaneous|0|||
147328743|NCT02001623|531369988|FG004|Overall Study|Other - Miscellaneous|0|||
147328744|NCT02001623|531369989|FG005|Overall Study|Other - Miscellaneous|0|||
147328745|NCT02001623|531369990|FG006|Overall Study|Other - Miscellaneous|0|||
147328746|NCT02001623|531369991|FG007|Overall Study|Other - Miscellaneous|0|||
147328747|NCT02001623|531369992|FG008|Overall Study|Other - Miscellaneous|0|||
147328748|NCT02001623|531369993|FG009|Overall Study|Other - Miscellaneous|1|||
147328749|NCT02001623|531369994|FG010|Overall Study|Other - Miscellaneous|0|||
147328750|NCT02001623|531369995|FG011|Overall Study|Other - Miscellaneous|0|||
147328751|NCT02001623|531369996|FG012|Overall Study|Other - Miscellaneous|0|||
147328752|NCT02001623|531369997|FG013|Overall Study|Other - Miscellaneous|1|||
147328753|NCT02001623|531369998|FG014|Overall Study|Other - Miscellaneous|0|||
147328754|NCT02001623|531369984|FG000|Overall Study|Withdrawal by Subject|1|||
147328755|NCT02001623|531369985|FG001|Overall Study|Withdrawal by Subject|0|||
147328756|NCT02001623|531369986|FG002|Overall Study|Withdrawal by Subject|0|||
147328757|NCT02001623|531369987|FG003|Overall Study|Withdrawal by Subject|0|||
147328758|NCT02001623|531369988|FG004|Overall Study|Withdrawal by Subject|0|||
147328759|NCT02001623|531369989|FG005|Overall Study|Withdrawal by Subject|0|||
147328760|NCT02001623|531369990|FG006|Overall Study|Withdrawal by Subject|0|||
147328761|NCT02001623|531369991|FG007|Overall Study|Withdrawal by Subject|0|||
147328762|NCT02001623|531369992|FG008|Overall Study|Withdrawal by Subject|1|||
147328763|NCT02001623|531369993|FG009|Overall Study|Withdrawal by Subject|3|||
147328764|NCT02001623|531369994|FG010|Overall Study|Withdrawal by Subject|2|||
147328765|NCT02001623|531369995|FG011|Overall Study|Withdrawal by Subject|2|||
147328766|NCT02001623|531369996|FG012|Overall Study|Withdrawal by Subject|1|||
147328767|NCT02001623|531369997|FG013|Overall Study|Withdrawal by Subject|5|||
147328768|NCT02001623|531369998|FG014|Overall Study|Withdrawal by Subject|2|||
147328769|NCT02001623|531369984|FG000|Overall Study|Lost to Follow-up|0|||
147328770|NCT02001623|531369985|FG001|Overall Study|Lost to Follow-up|0|||
147328771|NCT02001623|531369986|FG002|Overall Study|Lost to Follow-up|0|||
147448574|NCT00513409|531807900|FG000|Overall Study|Withdrawal by Subject|0|||
147448575|NCT00513409|531807901|FG001|Overall Study|Withdrawal by Subject|2|||
147448576|NCT00513409|531807900|FG000|Overall Study|Lost to Follow-up|0|||
147448577|NCT00513409|531807901|FG001|Overall Study|Lost to Follow-up|1|||
147185124|NCT01132313|530843859|FG010|Overall Study|Lack of antiviral response|1|||
147185125|NCT01132313|530843860|FG011|Overall Study|Lack of antiviral response|0|||
147185126|NCT01132313|530843849|FG000|Overall Study|Other reason not defined above|0|||
147185127|NCT01132313|530843850|FG001|Overall Study|Other reason not defined above|0|||
147185128|NCT01132313|530843851|FG002|Overall Study|Other reason not defined above|0|||
147185129|NCT01132313|530843852|FG003|Overall Study|Other reason not defined above|0|||
147185130|NCT01132313|530843853|FG004|Overall Study|Other reason not defined above|0|||
147185131|NCT01132313|530843854|FG005|Overall Study|Other reason not defined above|0|||
147185132|NCT01132313|530843855|FG006|Overall Study|Other reason not defined above|0|||
147185133|NCT01132313|530843856|FG007|Overall Study|Other reason not defined above|1|||
147185134|NCT01132313|530843857|FG008|Overall Study|Other reason not defined above|0|||
147185135|NCT01132313|530843858|FG009|Overall Study|Other reason not defined above|0|||
147185136|NCT01132313|530843859|FG010|Overall Study|Other reason not defined above|0|||
147185137|NCT01132313|530843860|FG011|Overall Study|Other reason not defined above|0|||
147185138|NCT04266795|530843864|FG000|Overall Study|Adverse Event|10|||
147185139|NCT04266795|530843865|FG001|Overall Study|Adverse Event|19|||
147185140|NCT04266795|530843864|FG000|Overall Study|Death|7|||
147185141|NCT04266795|530843865|FG001|Overall Study|Death|8|||
147185142|NCT04266795|530843864|FG000|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|6|||
147185143|NCT04266795|530843865|FG001|Overall Study|Initiation of Hematopoietic Stem Cell Transplant|2|||
147185144|NCT04266795|530843864|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|1|||
147185145|NCT04266795|530843865|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
147185146|NCT04266795|530843864|FG000|Overall Study|Progressive Disease|12|||
147185147|NCT04266795|530843865|FG001|Overall Study|Progressive Disease|9|||
147185148|NCT04266795|530843864|FG000|Overall Study|Withdrawal by Patient|5|||
147185149|NCT04266795|530843865|FG001|Overall Study|Withdrawal by Patient|6|||
147185150|NCT04266795|530843864|FG000|Overall Study|Disease Relapse|3|||
147185151|NCT04266795|530843865|FG001|Overall Study|Disease Relapse|6|||
147185152|NCT04266795|530843864|FG000|Overall Study|Reason not Specified|12|||
147185153|NCT04266795|530843865|FG001|Overall Study|Reason not Specified|10|||
147185154|NCT04266795|530843864|FG000|Overall Study|Participants Ongoing on Treatment|25|||
147185155|NCT04266795|530843865|FG001|Overall Study|Participants Ongoing on Treatment|23|||
147328772|NCT02001623|531369987|FG003|Overall Study|Lost to Follow-up|0|||
147328773|NCT02001623|531369988|FG004|Overall Study|Lost to Follow-up|0|||
147593876|NCT02025751|532329054|FG000|Overall Study|Physician Decision|0|||
147328774|NCT02001623|531369989|FG005|Overall Study|Lost to Follow-up|0|||
147328775|NCT02001623|531369990|FG006|Overall Study|Lost to Follow-up|0|||
147328776|NCT02001623|531369991|FG007|Overall Study|Lost to Follow-up|0|||
147448578|NCT00513409|531807900|FG000|Overall Study|Physician Decision|1|||
147185156|NCT03043872|530843866|FG000|Overall Study|Withdrawal by Subject|6|||
147185157|NCT03043872|530843867|FG001|Overall Study|Withdrawal by Subject|6|||
147185158|NCT03043872|530843868|FG002|Overall Study|Withdrawal by Subject|15|||
147185159|NCT03043872|530843866|FG000|Overall Study|Lost to Follow-up|2|||
147185160|NCT03043872|530843867|FG001|Overall Study|Lost to Follow-up|1|||
147185161|NCT03043872|530843868|FG002|Overall Study|Lost to Follow-up|1|||
147185162|NCT03043872|530843866|FG000|Overall Study|Death|270|||
147185163|NCT03043872|530843867|FG001|Overall Study|Death|269|||
147185164|NCT03043872|530843868|FG002|Overall Study|Death|296|||
147185165|NCT00434109|530843869|FG000|Overall Study|Physician Decision|9|||
147185166|NCT00434109|530843869|FG000|Overall Study|Adverse Event|5|||
147328777|NCT02001623|531369992|FG008|Overall Study|Lost to Follow-up|0|||
147328778|NCT02001623|531369993|FG009|Overall Study|Lost to Follow-up|1|||
147328779|NCT02001623|531369994|FG010|Overall Study|Lost to Follow-up|0|||
147328780|NCT02001623|531369995|FG011|Overall Study|Lost to Follow-up|0|||
147328781|NCT02001623|531369996|FG012|Overall Study|Lost to Follow-up|0|||
147328782|NCT02001623|531369997|FG013|Overall Study|Lost to Follow-up|0|||
147328783|NCT02001623|531369998|FG014|Overall Study|Lost to Follow-up|0|||
147328784|NCT02001623|531369984|FG000|Overall Study|Start of New Anti-cancer Treatment|0|||
147328785|NCT02001623|531369985|FG001|Overall Study|Start of New Anti-cancer Treatment|0|||
147328786|NCT02001623|531369986|FG002|Overall Study|Start of New Anti-cancer Treatment|0|||
147328787|NCT02001623|531369987|FG003|Overall Study|Start of New Anti-cancer Treatment|0|||
147328788|NCT02001623|531369988|FG004|Overall Study|Start of New Anti-cancer Treatment|0|||
147328789|NCT02001623|531369989|FG005|Overall Study|Start of New Anti-cancer Treatment|0|||
147328790|NCT02001623|531369990|FG006|Overall Study|Start of New Anti-cancer Treatment|0|||
147328791|NCT02001623|531369991|FG007|Overall Study|Start of New Anti-cancer Treatment|0|||
147328792|NCT02001623|531369992|FG008|Overall Study|Start of New Anti-cancer Treatment|0|||
147328793|NCT02001623|531369993|FG009|Overall Study|Start of New Anti-cancer Treatment|0|||
147328794|NCT02001623|531369994|FG010|Overall Study|Start of New Anti-cancer Treatment|0|||
147185167|NCT00434109|530843869|FG000|Overall Study|Protocol Violation|1|||
147185168|NCT00434109|530843869|FG000|Overall Study|had embolism, did not receive sunitinib|3|||
147185169|NCT04186871|530843872|FG000|Overall Study|Lack of Efficacy|0|||
147185170|NCT04186871|530843873|FG001|Overall Study|Lack of Efficacy|1|||
147185171|NCT04186871|530843874|FG002|Overall Study|Lack of Efficacy|0|||
147185172|NCT04186871|530843875|FG003|Overall Study|Lack of Efficacy|0|||
147185173|NCT04186871|530843876|FG004|Overall Study|Lack of Efficacy|1|||
147185174|NCT04186871|530843877|FG005|Overall Study|Lack of Efficacy|1|||
147185175|NCT04186871|530843872|FG000|Overall Study|Adverse Event|1|||
147185176|NCT04186871|530843873|FG001|Overall Study|Adverse Event|1|||
147185177|NCT04186871|530843874|FG002|Overall Study|Adverse Event|0|||
147185178|NCT04186871|530843875|FG003|Overall Study|Adverse Event|0|||
147185179|NCT04186871|530843876|FG004|Overall Study|Adverse Event|0|||
147185180|NCT04186871|530843877|FG005|Overall Study|Adverse Event|2|||
147185181|NCT04186871|530843872|FG000|Overall Study|Study terminated by sponsor|1|||
147185182|NCT04186871|530843873|FG001|Overall Study|Study terminated by sponsor|2|||
147185183|NCT04186871|530843874|FG002|Overall Study|Study terminated by sponsor|0|||
147185184|NCT04186871|530843875|FG003|Overall Study|Study terminated by sponsor|1|||
147185185|NCT04186871|530843876|FG004|Overall Study|Study terminated by sponsor|0|||
147185186|NCT04186871|530843877|FG005|Overall Study|Study terminated by sponsor|0|||
147185187|NCT04186871|530843872|FG000|Overall Study|Other reasons|0|||
147185188|NCT04186871|530843873|FG001|Overall Study|Other reasons|0|||
147185189|NCT04186871|530843874|FG002|Overall Study|Other reasons|0|||
147185190|NCT04186871|530843875|FG003|Overall Study|Other reasons|0|||
147185191|NCT04186871|530843876|FG004|Overall Study|Other reasons|0|||
147185192|NCT04186871|530843877|FG005|Overall Study|Other reasons|1|||
147185193|NCT04186871|530843872|FG000|Overall Study|Withdrawal by Subject|0|||
147185194|NCT04186871|530843873|FG001|Overall Study|Withdrawal by Subject|0|||
147185195|NCT04186871|530843874|FG002|Overall Study|Withdrawal by Subject|0|||
147185196|NCT04186871|530843875|FG003|Overall Study|Withdrawal by Subject|0|||
147185197|NCT04186871|530843876|FG004|Overall Study|Withdrawal by Subject|0|||
147185198|NCT04186871|530843877|FG005|Overall Study|Withdrawal by Subject|1|||
147185199|NCT04186871|530843872|FG000|Overall Study|Lost to Follow-up|0|||
147185200|NCT04186871|530843873|FG001|Overall Study|Lost to Follow-up|0|||
147185201|NCT04186871|530843874|FG002|Overall Study|Lost to Follow-up|0|||
147185202|NCT04186871|530843875|FG003|Overall Study|Lost to Follow-up|0|||
147185203|NCT04186871|530843876|FG004|Overall Study|Lost to Follow-up|0|||
147185204|NCT04186871|530843877|FG005|Overall Study|Lost to Follow-up|1|||
147185205|NCT03790917|530843878|FG000|Overall Study|Death|1|||
147185206|NCT00543387|530843888|FG000|Panel 1 + Panel 2|Adverse Event|0|||
147185207|NCT00543387|530843889|FG001|Panel 1 + Panel 2|Adverse Event|1|||
147185208|NCT00543387|530843890|FG002|Panel 1 + Panel 2|Adverse Event|0|||
147185209|NCT00543387|530843891|FG003|Panel 1 + Panel 2|Adverse Event|0|||
147185210|NCT00543387|530843892|FG004|Panel 1 + Panel 2|Adverse Event|0|||
147185211|NCT00543387|530843893|FG005|Panel 1 + Panel 2|Adverse Event|0|||
147185212|NCT00543387|530843894|FG006|Panel 1 + Panel 2|Adverse Event|0|||
147185213|NCT00543387|530843895|FG007|Panel 1 + Panel 2|Adverse Event|1|||
147185214|NCT00543387|530843896|FG008|Panel 1 + Panel 2|Adverse Event|1|||
147185215|NCT00543387|530843897|FG009|Panel 1 + Panel 2|Adverse Event|0|||
147185216|NCT00543387|530843898|FG010|Panel 1 + Panel 2|Adverse Event|0|||
147185217|NCT00543387|530843888|FG000|Panel 1 + Panel 2|Physician Decision|0|||
147185218|NCT00543387|530843889|FG001|Panel 1 + Panel 2|Physician Decision|0|||
147328795|NCT02001623|531369995|FG011|Overall Study|Start of New Anti-cancer Treatment|1|||
147328796|NCT02001623|531369996|FG012|Overall Study|Start of New Anti-cancer Treatment|0|||
147448579|NCT00513409|531807901|FG001|Overall Study|Physician Decision|0|||
147185219|NCT00543387|530843890|FG002|Panel 1 + Panel 2|Physician Decision|1|||
147185220|NCT00543387|530843891|FG003|Panel 1 + Panel 2|Physician Decision|0|||
147185221|NCT00543387|530843892|FG004|Panel 1 + Panel 2|Physician Decision|0|||
147185222|NCT00543387|530843893|FG005|Panel 1 + Panel 2|Physician Decision|0|||
147185223|NCT00543387|530843894|FG006|Panel 1 + Panel 2|Physician Decision|0|||
147185224|NCT00543387|530843895|FG007|Panel 1 + Panel 2|Physician Decision|1|||
147593877|NCT02025751|532329055|FG001|Overall Study|Physician Decision|1|||
147593878|NCT02025751|532329054|FG000|Overall Study|Withdrawal by Subject|0|||
147185225|NCT00543387|530843896|FG008|Panel 1 + Panel 2|Physician Decision|0|||
147185226|NCT00543387|530843897|FG009|Panel 1 + Panel 2|Physician Decision|0|||
147185227|NCT00543387|530843898|FG010|Panel 1 + Panel 2|Physician Decision|0|||
147185228|NCT00543387|530843888|FG000|Panel 1 + Panel 2|Progressive Disease (PD)|3|||
147185229|NCT00543387|530843889|FG001|Panel 1 + Panel 2|Progressive Disease (PD)|2|||
147185230|NCT00543387|530843890|FG002|Panel 1 + Panel 2|Progressive Disease (PD)|2|||
147185231|NCT00543387|530843891|FG003|Panel 1 + Panel 2|Progressive Disease (PD)|3|||
147185232|NCT00543387|530843892|FG004|Panel 1 + Panel 2|Progressive Disease (PD)|3|||
147185233|NCT00543387|530843893|FG005|Panel 1 + Panel 2|Progressive Disease (PD)|3|||
147185234|NCT00543387|530843894|FG006|Panel 1 + Panel 2|Progressive Disease (PD)|5|||
147185235|NCT00543387|530843895|FG007|Panel 1 + Panel 2|Progressive Disease (PD)|4|||
147185236|NCT00543387|530843896|FG008|Panel 1 + Panel 2|Progressive Disease (PD)|4|||
147185237|NCT00543387|530843897|FG009|Panel 1 + Panel 2|Progressive Disease (PD)|0|||
147185238|NCT00543387|530843898|FG010|Panel 1 + Panel 2|Progressive Disease (PD)|0|||
147185239|NCT00543387|530843888|FG000|Panel 1 + Panel 2|Withdrawal by Subject|0|||
147185240|NCT00543387|530843889|FG001|Panel 1 + Panel 2|Withdrawal by Subject|0|||
147185241|NCT00543387|530843890|FG002|Panel 1 + Panel 2|Withdrawal by Subject|0|||
147185242|NCT00543387|530843891|FG003|Panel 1 + Panel 2|Withdrawal by Subject|0|||
147185243|NCT00543387|530843892|FG004|Panel 1 + Panel 2|Withdrawal by Subject|0|||
147185244|NCT00543387|530843893|FG005|Panel 1 + Panel 2|Withdrawal by Subject|0|||
147185245|NCT00543387|530843894|FG006|Panel 1 + Panel 2|Withdrawal by Subject|1|||
147185246|NCT00543387|530843895|FG007|Panel 1 + Panel 2|Withdrawal by Subject|0|||
147185247|NCT00543387|530843896|FG008|Panel 1 + Panel 2|Withdrawal by Subject|0|||
147185248|NCT00543387|530843897|FG009|Panel 1 + Panel 2|Withdrawal by Subject|0|||
147185249|NCT00543387|530843898|FG010|Panel 1 + Panel 2|Withdrawal by Subject|0|||
147185250|NCT00543387|530843888|FG000|Crossover Participants|Progressive Disease|0|||
147185251|NCT00543387|530843889|FG001|Crossover Participants|Progressive Disease|0|||
147185252|NCT00543387|530843890|FG002|Crossover Participants|Progressive Disease|0|||
147185253|NCT00543387|530843891|FG003|Crossover Participants|Progressive Disease|0|||
147185254|NCT00543387|530843892|FG004|Crossover Participants|Progressive Disease|0|||
147185255|NCT00543387|530843893|FG005|Crossover Participants|Progressive Disease|0|||
147185256|NCT00543387|530843894|FG006|Crossover Participants|Progressive Disease|0|||
147185257|NCT00543387|530843895|FG007|Crossover Participants|Progressive Disease|0|||
147185258|NCT00543387|530843896|FG008|Crossover Participants|Progressive Disease|0|||
147185259|NCT00543387|530843897|FG009|Crossover Participants|Progressive Disease|1|||
147185260|NCT00543387|530843898|FG010|Crossover Participants|Progressive Disease|2|||
147247054|NCT03129100|531072778|FG019|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
147247055|NCT03129100|531072779|FG020|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
147247056|NCT03129100|531072780|FG021|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
147247057|NCT03129100|531072781|FG022|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
147247058|NCT03129100|531072782|FG023|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
147247059|NCT03129100|531072783|FG024|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|2|||
147247060|NCT03129100|531072784|FG025|Period 4 (Post Treatment Follow-up)|COVID 19 Restrictions|0|||
147247061|NCT03129100|531072759|FG000|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
147247062|NCT03129100|531072760|FG001|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
147247063|NCT03129100|531072761|FG002|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
147247064|NCT03129100|531072762|FG003|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
147247065|NCT03129100|531072763|FG004|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
147247066|NCT03129100|531072764|FG005|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
147247067|NCT03129100|531072765|FG006|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
147247068|NCT03129100|531072766|FG007|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
147247069|NCT03129100|531072767|FG008|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
147247070|NCT03129100|531072768|FG009|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
147247071|NCT03129100|531072769|FG010|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
147247072|NCT03129100|531072770|FG011|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
147247073|NCT03129100|531072771|FG012|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
147247074|NCT03129100|531072772|FG013|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
147247075|NCT03129100|531072773|FG014|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
147247076|NCT03129100|531072774|FG015|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
147247077|NCT03129100|531072775|FG016|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
147247078|NCT03129100|531072776|FG017|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
147247079|NCT03129100|531072777|FG018|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
147247080|NCT03129100|531072778|FG019|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
147247081|NCT03129100|531072779|FG020|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
147247082|NCT03129100|531072780|FG021|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
147247083|NCT03129100|531072781|FG022|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
147247084|NCT03129100|531072782|FG023|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
147658417|NCT00377637|532572266|FG002|Maintenance Phase|Lost to Follow-up|3|||
147658418|NCT00377637|532572267|FG003|Maintenance Phase|Lost to Follow-up|1|||
147658419|NCT00377637|532572264|FG000|Maintenance Phase|Withdrawal by Subject|0|||
147658420|NCT00377637|532572265|FG001|Maintenance Phase|Withdrawal by Subject|0|||
147658421|NCT00377637|532572266|FG002|Maintenance Phase|Withdrawal by Subject|3|||
147658422|NCT00377637|532572267|FG003|Maintenance Phase|Withdrawal by Subject|3|||
147658423|NCT00377637|532572264|FG000|Maintenance Phase|Sponsor decision|0|||
147658424|NCT00377637|532572265|FG001|Maintenance Phase|Sponsor decision|0|||
147658425|NCT00377637|532572266|FG002|Maintenance Phase|Sponsor decision|2|||
147658426|NCT00377637|532572267|FG003|Maintenance Phase|Sponsor decision|3|||
147658427|NCT00377637|532572264|FG000|Maintenance Phase|Non-compliance|0|||
147658428|NCT00377637|532572265|FG001|Maintenance Phase|Non-compliance|0|||
147658429|NCT00377637|532572266|FG002|Maintenance Phase|Non-compliance|1|||
147658430|NCT00377637|532572267|FG003|Maintenance Phase|Non-compliance|1|||
147658431|NCT00377637|532572264|FG000|Maintenance Phase|Study medication stopped > 14 days|0|||
147658432|NCT00377637|532572265|FG001|Maintenance Phase|Study medication stopped > 14 days|0|||
147658433|NCT00377637|532572266|FG002|Maintenance Phase|Study medication stopped > 14 days|0|||
147658434|NCT00377637|532572267|FG003|Maintenance Phase|Study medication stopped > 14 days|1|||
147658435|NCT00377637|532572264|FG000|Maintenance Phase|Death|0|||
147658436|NCT00377637|532572265|FG001|Maintenance Phase|Death|0|||
147658437|NCT00377637|532572266|FG002|Maintenance Phase|Death|0|||
147658438|NCT00377637|532572267|FG003|Maintenance Phase|Death|1|||
147658439|NCT00493012|532572269|FG000|Overall Study|Lost to Follow-up|18|||
147658440|NCT00493012|532572270|FG001|Overall Study|Lost to Follow-up|17|||
147658441|NCT04085601|532572271|FG000|Overall Study|Lost to Follow-up|1|||
147658442|NCT04085601|532572272|FG001|Overall Study|Lost to Follow-up|0|||
147658443|NCT04085601|532572271|FG000|Overall Study|Death|1|||
147658444|NCT04085601|532572272|FG001|Overall Study|Death|1|||
147658445|NCT02121795|532572273|FG000|Double-Blind Phase|Randomized but Never Treated|1|||
147658446|NCT02121795|532572274|FG001|Double-Blind Phase|Randomized but Never Treated|4|||
147658447|NCT02121795|532572273|FG000|Double-Blind Phase|Withdrawal by Subject|19|||
147658448|NCT02121795|532572274|FG001|Double-Blind Phase|Withdrawal by Subject|16|||
147658449|NCT02121795|532572273|FG000|Double-Blind Phase|Lost to Follow-up|7|||
147658450|NCT02121795|532572274|FG001|Double-Blind Phase|Lost to Follow-up|4|||
147658451|NCT02121795|532572273|FG000|Double-Blind Phase|Physician Decision|2|||
147658452|NCT02121795|532572274|FG001|Double-Blind Phase|Physician Decision|5|||
147658453|NCT02121795|532572273|FG000|Double-Blind Phase|Adverse Event|5|||
147658454|NCT02121795|532572274|FG001|Double-Blind Phase|Adverse Event|0|||
147658455|NCT02121795|532572273|FG000|Double-Blind Phase|Non-Compliance with Study Drug|3|||
147658456|NCT02121795|532572274|FG001|Double-Blind Phase|Non-Compliance with Study Drug|1|||
147658457|NCT02121795|532572273|FG000|Double-Blind Phase|Protocol Violation|0|||
147658458|NCT02121795|532572274|FG001|Double-Blind Phase|Protocol Violation|3|||
147658459|NCT02121795|532572273|FG000|Double-Blind Phase|Death|1|||
147658460|NCT02121795|532572274|FG001|Double-Blind Phase|Death|1|||
147658461|NCT02121795|532572273|FG000|Open-Label Phase|Physician Decision|8|||
147658462|NCT02121795|532572274|FG001|Open-Label Phase|Physician Decision|8|||
147658463|NCT02121795|532572273|FG000|Open-Label Phase|Withdrawal by Subject|3|||
147658464|NCT02121795|532572274|FG001|Open-Label Phase|Withdrawal by Subject|2|||
147658465|NCT02121795|532572273|FG000|Open-Label Phase|Lost to Follow-up|1|||
147658466|NCT02121795|532572274|FG001|Open-Label Phase|Lost to Follow-up|0|||
147658467|NCT04155463|532572275|FG000|First Intervention (1 Week)|out of town during dietary intervention|0|||
147658468|NCT04155463|532572276|FG001|First Intervention (1 Week)|out of town during dietary intervention|1|||
147658469|NCT00113295|532572277|FG000|Overall Study|Adverse Event|4|||
147658470|NCT00113295|532572278|FG001|Overall Study|Adverse Event|1|||
147658471|NCT00113295|532572277|FG000|Overall Study|Unrelated Medical Illness|1|||
147658472|NCT00113295|532572278|FG001|Overall Study|Unrelated Medical Illness|0|||
147658473|NCT05225558|532572284|FG000|Overall Study|Withdrawal by Subject|4|||
147658474|NCT05225558|532572285|FG001|Overall Study|Withdrawal by Subject|3|||
147658475|NCT05225558|532572284|FG000|Overall Study|Adverse Event|1|||
147658476|NCT05225558|532572285|FG001|Overall Study|Adverse Event|0|||
147658477|NCT05225558|532572284|FG000|Overall Study|If the following treatment failure criteria are met during treatment period|1|||
147658478|NCT05225558|532572285|FG001|Overall Study|If the following treatment failure criteria are met during treatment period|2|||
147658479|NCT05225558|532572284|FG000|Overall Study|When investigators decide that the subject should stop participating in the trial for other reasons|4|||
147185261|NCT00543387|530843888|FG000|Crossover Participants|Study Terminated by Sponsor|0|||
147185262|NCT00543387|530843889|FG001|Crossover Participants|Study Terminated by Sponsor|0|||
147185263|NCT00543387|530843890|FG002|Crossover Participants|Study Terminated by Sponsor|0|||
147185264|NCT00543387|530843891|FG003|Crossover Participants|Study Terminated by Sponsor|0|||
147185265|NCT00543387|530843892|FG004|Crossover Participants|Study Terminated by Sponsor|0|||
147185266|NCT00543387|530843893|FG005|Crossover Participants|Study Terminated by Sponsor|0|||
147185267|NCT00543387|530843894|FG006|Crossover Participants|Study Terminated by Sponsor|0|||
147185268|NCT00543387|530843895|FG007|Crossover Participants|Study Terminated by Sponsor|0|||
147185269|NCT00543387|530843896|FG008|Crossover Participants|Study Terminated by Sponsor|0|||
147185270|NCT00543387|530843897|FG009|Crossover Participants|Study Terminated by Sponsor|0|||
147185271|NCT00543387|530843898|FG010|Crossover Participants|Study Terminated by Sponsor|1|||
147185272|NCT01792115|530843902|FG000|Overall Study|Lost to Follow-up|0|||
147185273|NCT01792115|530843903|FG001|Overall Study|Lost to Follow-up|1|||
147185274|NCT01792115|530843904|FG002|Overall Study|Lost to Follow-up|0|||
147185275|NCT03790111|530845474|FG000|Overall Study|Study did not meet its primary endpoint.|53|||
147185276|NCT02796677|530845479|FG000|Overall Study|Adverse Event|11|||
147328797|NCT02001623|531369997|FG013|Overall Study|Start of New Anti-cancer Treatment|1|||
147328798|NCT02001623|531369998|FG014|Overall Study|Start of New Anti-cancer Treatment|0|||
147328799|NCT02001623|531369984|FG000|Overall Study|Dose Delay Due to Toxicity|0|||
147328800|NCT02001623|531369985|FG001|Overall Study|Dose Delay Due to Toxicity|0|||
147328801|NCT02001623|531369986|FG002|Overall Study|Dose Delay Due to Toxicity|0|||
147328802|NCT02001623|531369987|FG003|Overall Study|Dose Delay Due to Toxicity|0|||
147328803|NCT02001623|531369988|FG004|Overall Study|Dose Delay Due to Toxicity|0|||
147328804|NCT02001623|531369989|FG005|Overall Study|Dose Delay Due to Toxicity|0|||
147328805|NCT02001623|531369990|FG006|Overall Study|Dose Delay Due to Toxicity|0|||
147328806|NCT02001623|531369991|FG007|Overall Study|Dose Delay Due to Toxicity|0|||
147328807|NCT02001623|531369992|FG008|Overall Study|Dose Delay Due to Toxicity|0|||
147328808|NCT02001623|531369993|FG009|Overall Study|Dose Delay Due to Toxicity|0|||
147328809|NCT02001623|531369994|FG010|Overall Study|Dose Delay Due to Toxicity|0|||
147328810|NCT02001623|531369995|FG011|Overall Study|Dose Delay Due to Toxicity|0|||
147185277|NCT02796677|530845480|FG001|Overall Study|Adverse Event|22|||
147185278|NCT02796677|530845481|FG002|Overall Study|Adverse Event|14|||
147185279|NCT02796677|530845482|FG003|Overall Study|Adverse Event|14|||
147185280|NCT02796677|530845479|FG000|Overall Study|Protocol Violation|7|||
147185281|NCT02796677|530845480|FG001|Overall Study|Protocol Violation|5|||
147185282|NCT02796677|530845481|FG002|Overall Study|Protocol Violation|4|||
147185283|NCT02796677|530845482|FG003|Overall Study|Protocol Violation|8|||
147185284|NCT02796677|530845479|FG000|Overall Study|Lost to Follow-up|1|||
147185285|NCT02796677|530845480|FG001|Overall Study|Lost to Follow-up|5|||
147185286|NCT02796677|530845481|FG002|Overall Study|Lost to Follow-up|2|||
147185287|NCT02796677|530845482|FG003|Overall Study|Lost to Follow-up|2|||
147185288|NCT02796677|530845479|FG000|Overall Study|Lack of Efficacy|7|||
147185289|NCT02796677|530845480|FG001|Overall Study|Lack of Efficacy|9|||
147185290|NCT02796677|530845481|FG002|Overall Study|Lack of Efficacy|14|||
147185291|NCT02796677|530845482|FG003|Overall Study|Lack of Efficacy|20|||
147185292|NCT02796677|530845479|FG000|Overall Study|Withdrawal by Subject|4|||
147185293|NCT02796677|530845480|FG001|Overall Study|Withdrawal by Subject|14|||
147185294|NCT02796677|530845481|FG002|Overall Study|Withdrawal by Subject|6|||
147185295|NCT02796677|530845482|FG003|Overall Study|Withdrawal by Subject|7|||
147185296|NCT02796677|530845479|FG000|Overall Study|Progressive disease|6|||
147185297|NCT02796677|530845480|FG001|Overall Study|Progressive disease|15|||
147247085|NCT03129100|531072783|FG024|Period 4 (Post Treatment Follow-up)|Missed follow-up|0|||
147247086|NCT03129100|531072784|FG025|Period 4 (Post Treatment Follow-up)|Missed follow-up|1|||
147247087|NCT03129100|531072759|FG000|Period 4 (Post Treatment Follow-up)|Other|0|||
147247088|NCT03129100|531072760|FG001|Period 4 (Post Treatment Follow-up)|Other|0|||
147247089|NCT03129100|531072761|FG002|Period 4 (Post Treatment Follow-up)|Other|0|||
147247090|NCT03129100|531072762|FG003|Period 4 (Post Treatment Follow-up)|Other|0|||
147247091|NCT03129100|531072763|FG004|Period 4 (Post Treatment Follow-up)|Other|0|||
147247092|NCT03129100|531072764|FG005|Period 4 (Post Treatment Follow-up)|Other|0|||
147247093|NCT03129100|531072765|FG006|Period 4 (Post Treatment Follow-up)|Other|0|||
147247094|NCT03129100|531072766|FG007|Period 4 (Post Treatment Follow-up)|Other|0|||
147247095|NCT03129100|531072767|FG008|Period 4 (Post Treatment Follow-up)|Other|0|||
147247096|NCT03129100|531072768|FG009|Period 4 (Post Treatment Follow-up)|Other|0|||
147247097|NCT03129100|531072769|FG010|Period 4 (Post Treatment Follow-up)|Other|0|||
147247098|NCT03129100|531072770|FG011|Period 4 (Post Treatment Follow-up)|Other|0|||
147247099|NCT03129100|531072771|FG012|Period 4 (Post Treatment Follow-up)|Other|0|||
147247100|NCT03129100|531072772|FG013|Period 4 (Post Treatment Follow-up)|Other|0|||
147247101|NCT03129100|531072773|FG014|Period 4 (Post Treatment Follow-up)|Other|0|||
147247102|NCT03129100|531072774|FG015|Period 4 (Post Treatment Follow-up)|Other|0|||
147247103|NCT03129100|531072775|FG016|Period 4 (Post Treatment Follow-up)|Other|0|||
147247104|NCT03129100|531072776|FG017|Period 4 (Post Treatment Follow-up)|Other|0|||
147247105|NCT03129100|531072777|FG018|Period 4 (Post Treatment Follow-up)|Other|0|||
147247106|NCT03129100|531072778|FG019|Period 4 (Post Treatment Follow-up)|Other|0|||
147247107|NCT03129100|531072779|FG020|Period 4 (Post Treatment Follow-up)|Other|0|||
147247108|NCT03129100|531072780|FG021|Period 4 (Post Treatment Follow-up)|Other|0|||
147247109|NCT03129100|531072781|FG022|Period 4 (Post Treatment Follow-up)|Other|0|||
147247110|NCT03129100|531072782|FG023|Period 4 (Post Treatment Follow-up)|Other|0|||
147247111|NCT03129100|531072783|FG024|Period 4 (Post Treatment Follow-up)|Other|0|||
147247112|NCT03129100|531072784|FG025|Period 4 (Post Treatment Follow-up)|Other|2|||
147247113|NCT01587001|531072787|FG000|Overall Study|Lost to Follow-up|2|||
147247114|NCT01587001|531072788|FG001|Overall Study|Lost to Follow-up|0|||
147247115|NCT01587001|531072787|FG000|Overall Study|Insufficient samples to complete testing|4|||
147328811|NCT02001623|531369996|FG012|Overall Study|Dose Delay Due to Toxicity|0|||
147328812|NCT02001623|531369997|FG013|Overall Study|Dose Delay Due to Toxicity|1|||
147247116|NCT01587001|531072788|FG001|Overall Study|Insufficient samples to complete testing|1|||
147247117|NCT02756013|531072789|FG000|Overall Study|Adverse Event|1|||
147328813|NCT02001623|531369998|FG014|Overall Study|Dose Delay Due to Toxicity|0|||
147328814|NCT01063036|531370005|FG000|Participants Treated With Study Drug|Adverse Event|1|||
147328815|NCT01063036|531370005|FG000|Participants Treated With Study Drug|Protocol Violation|1|||
147328816|NCT01063036|531370005|FG000|Participants Treated With Study Drug|Withdrawal by Subject|2|||
147328817|NCT01063036|531370005|FG000|Participants Treated With Study Drug|Lost to Follow-up|1|||
147328818|NCT01063036|531370005|FG000|Participants Treated With Study Drug|Pregnancy|1|||
147185298|NCT02796677|530845481|FG002|Overall Study|Progressive disease|13|||
147185299|NCT02796677|530845482|FG003|Overall Study|Progressive disease|18|||
147185300|NCT02796677|530845479|FG000|Overall Study|Reason not mentioned|2|||
147185301|NCT02796677|530845480|FG001|Overall Study|Reason not mentioned|3|||
147185302|NCT02796677|530845481|FG002|Overall Study|Reason not mentioned|0|||
147185303|NCT02796677|530845482|FG003|Overall Study|Reason not mentioned|5|||
147185304|NCT03798717|530845483|FG000|Overall Study|Failed Screening|0|||
147185305|NCT03798717|530845484|FG001|Overall Study|Failed Screening|0|||
147185306|NCT03798717|530845485|FG002|Overall Study|Failed Screening|0|||
147185307|NCT03798717|530845486|FG003|Overall Study|Failed Screening|0|||
147185308|NCT03798717|530845487|FG004|Overall Study|Failed Screening|0|||
147185309|NCT03798717|530845488|FG005|Overall Study|Failed Screening|1|||
147185310|NCT03798717|530845483|FG000|Overall Study|Physician Decision|1|||
147185311|NCT03798717|530845484|FG001|Overall Study|Physician Decision|0|||
147185312|NCT03798717|530845485|FG002|Overall Study|Physician Decision|1|||
147185313|NCT03798717|530845486|FG003|Overall Study|Physician Decision|0|||
147185314|NCT03798717|530845487|FG004|Overall Study|Physician Decision|0|||
147185315|NCT03798717|530845488|FG005|Overall Study|Physician Decision|0|||
147185316|NCT03798717|530845483|FG000|Overall Study|Withdrawal by Subject|0|||
147185317|NCT03798717|530845484|FG001|Overall Study|Withdrawal by Subject|0|||
147185318|NCT03798717|530845485|FG002|Overall Study|Withdrawal by Subject|0|||
147185319|NCT03798717|530845486|FG003|Overall Study|Withdrawal by Subject|1|||
147185320|NCT03798717|530845487|FG004|Overall Study|Withdrawal by Subject|0|||
147185321|NCT03798717|530845488|FG005|Overall Study|Withdrawal by Subject|0|||
147185322|NCT03798717|530845483|FG000|Overall Study|Lost to Follow-up|1|||
147185323|NCT03798717|530845484|FG001|Overall Study|Lost to Follow-up|0|||
147247118|NCT02756013|531072789|FG000|Overall Study|Hypersensitivity|1|||
147247119|NCT01197560|531072790|FG000|Overall Study|Adverse Event|6|||
147247120|NCT01197560|531072791|FG001|Overall Study|Adverse Event|8|||
147247121|NCT01197560|531072790|FG000|Overall Study|Death|3|||
147247122|NCT01197560|531072791|FG001|Overall Study|Death|5|||
147247123|NCT01197560|531072790|FG000|Overall Study|Withdrawal by Subject|1|||
147247124|NCT01197560|531072791|FG001|Overall Study|Withdrawal by Subject|1|||
147247125|NCT01197560|531072790|FG000|Overall Study|Disease progression|40|||
147247126|NCT01197560|531072791|FG001|Overall Study|Disease progression|35|||
147247127|NCT01197560|531072790|FG000|Overall Study|Miscellaneous|4|||
147247128|NCT01197560|531072791|FG001|Overall Study|Miscellaneous|3|||
147247129|NCT01197560|531072790|FG000|Overall Study|Missing|0|||
147247130|NCT01197560|531072791|FG001|Overall Study|Missing|1|||
147247131|NCT00211510|531072792|FG000|Overall Study|Physician Decision|3|||
147247132|NCT00211510|531072793|FG001|Overall Study|Physician Decision|1|||
147247133|NCT00211510|531072792|FG000|Overall Study|Withdrawal by Subject|3|||
147247134|NCT00211510|531072793|FG001|Overall Study|Withdrawal by Subject|1|||
147247135|NCT01487200|531072794|FG000|Overall Study|Withdrawal by Subject|0|||
147247136|NCT01487200|531072795|FG001|Overall Study|Withdrawal by Subject|1|||
147247137|NCT01487200|531072796|FG002|Overall Study|Withdrawal by Subject|0|||
147247138|NCT01487200|531072797|FG003|Overall Study|Withdrawal by Subject|0|||
147328819|NCT01063036|531370005|FG000|Post Dosing Follow-up Through 24 Weeks|Lost to Follow-up|1|||
147328820|NCT01063036|531370005|FG000|Post Dosing Follow-up Through 24 Weeks|Withdrawal by Subject|6|||
147328821|NCT01063036|531370005|FG000|Post Dosing Follow-up Through 24 Weeks|Alternative therapy started|32|||
147328822|NCT01977612|531370006|FG000|Overall Study|Lost to Follow-up|1|||
147328823|NCT01977612|531370007|FG001|Overall Study|Lost to Follow-up|1|||
147328824|NCT02715258|531370008|FG000|Overall Study|Withdrawal by Subject|6|||
147328825|NCT02715258|531370009|FG001|Overall Study|Withdrawal by Subject|1|||
147328826|NCT02715258|531370008|FG000|Overall Study|Lost to Follow-up|7|||
147328827|NCT02715258|531370009|FG001|Overall Study|Lost to Follow-up|1|||
147328828|NCT02715258|531370008|FG000|Overall Study|Terminated by Sponsor|0|||
147328829|NCT02715258|531370009|FG001|Overall Study|Terminated by Sponsor|1|||
147328830|NCT02715258|531370008|FG000|Overall Study|Death|0|||
147328831|NCT02715258|531370009|FG001|Overall Study|Death|1|||
147328832|NCT02715258|531370008|FG000|Overall Study|Subject non-compliant|1|||
147185324|NCT03798717|530845485|FG002|Overall Study|Lost to Follow-up|0|||
147185325|NCT03798717|530845486|FG003|Overall Study|Lost to Follow-up|1|||
147185326|NCT03798717|530845487|FG004|Overall Study|Lost to Follow-up|0|||
147328833|NCT02715258|531370009|FG001|Overall Study|Subject non-compliant|1|||
147328834|NCT02715258|531370008|FG000|Overall Study|GCP violation|2|||
147328835|NCT02715258|531370009|FG001|Overall Study|GCP violation|1|||
147185327|NCT03798717|530845488|FG005|Overall Study|Lost to Follow-up|0|||
147247139|NCT01962896|531072798|FG000|Overall Study|Lack of Efficacy|4|||
147247140|NCT02837783|531072799|FG000|Overall Study|Adverse Event|1|||
147247141|NCT02837783|531072800|FG001|Overall Study|Adverse Event|0|||
147448580|NCT00513409|531807900|FG000|Overall Study|Visit 3 not done|1|||
147448581|NCT00513409|531807901|FG001|Overall Study|Visit 3 not done|2|||
147448582|NCT01049035|531807902|FG000|Overall Study|Serious adverse event|0|||
147328836|NCT02955069|531370011|FG000|Overall Study|Adverse Event|7|||
147328837|NCT02955069|531370012|FG001|Overall Study|Adverse Event|2|||
147328838|NCT02955069|531370011|FG000|Overall Study|Death|7|||
147185328|NCT03798717|530845483|FG000|Overall Study|Adverse Event|0|||
147185329|NCT03798717|530845484|FG001|Overall Study|Adverse Event|1|||
147185330|NCT03798717|530845485|FG002|Overall Study|Adverse Event|0|||
147185331|NCT03798717|530845486|FG003|Overall Study|Adverse Event|0|||
147185332|NCT03798717|530845487|FG004|Overall Study|Adverse Event|0|||
147185333|NCT03798717|530845488|FG005|Overall Study|Adverse Event|0|||
147185334|NCT03798717|530845483|FG000|Overall Study|COVID-19 (coronavirus disease) Lockdown|0|||
147185335|NCT03798717|530845484|FG001|Overall Study|COVID-19 (coronavirus disease) Lockdown|0|||
147185336|NCT03798717|530845485|FG002|Overall Study|COVID-19 (coronavirus disease) Lockdown|0|||
147185337|NCT03798717|530845486|FG003|Overall Study|COVID-19 (coronavirus disease) Lockdown|0|||
147185338|NCT03798717|530845487|FG004|Overall Study|COVID-19 (coronavirus disease) Lockdown|1|||
147185339|NCT03798717|530845488|FG005|Overall Study|COVID-19 (coronavirus disease) Lockdown|0|||
147185340|NCT04002960|530845490|FG000|Overall Study|Withdrawn prior to Completion|2|||
147185341|NCT00961181|530845491|FG000|Overall Study|Death|2|||
147185342|NCT00961181|530845491|FG000|Overall Study|Withdrawal by Subject|2|||
147185343|NCT00961181|530845491|FG000|Overall Study|Lost to Follow-up|1|||
147185344|NCT03212326|530845492|FG000|Overall Study|Physician Decision|4|||
147185345|NCT01790594|530845502|FG000|Overall Study|Death|1|||
147185346|NCT01790594|530845503|FG001|Overall Study|Death|0|||
147185347|NCT01790594|530845504|FG002|Overall Study|Death|0|||
147185348|NCT01790594|530845502|FG000|Overall Study|Physician Decision|2|||
147185349|NCT01790594|530845503|FG001|Overall Study|Physician Decision|1|||
147185350|NCT01790594|530845504|FG002|Overall Study|Physician Decision|0|||
147185351|NCT01790594|530845502|FG000|Overall Study|Withdrawal by Subject|2|||
147185352|NCT01790594|530845503|FG001|Overall Study|Withdrawal by Subject|0|||
147185353|NCT01790594|530845504|FG002|Overall Study|Withdrawal by Subject|0|||
147185354|NCT01790594|530845502|FG000|Overall Study|Transplant was not done|0|||
147185355|NCT01790594|530845503|FG001|Overall Study|Transplant was not done|0|||
147185356|NCT01790594|530845504|FG002|Overall Study|Transplant was not done|3|||
147185357|NCT01790594|530845502|FG000|Overall Study|Terminated prior to week 76|0|||
147185358|NCT01790594|530845503|FG001|Overall Study|Terminated prior to week 76|2|||
147185359|NCT01790594|530845504|FG002|Overall Study|Terminated prior to week 76|0|||
147185360|NCT00404651|530845506|FG000|Overall Study|Serious Adverse Event|0|||
147185361|NCT00404651|530845507|FG001|Overall Study|Serious Adverse Event|0|||
147185362|NCT00404651|530845508|FG002|Overall Study|Serious Adverse Event|2|||
147185363|NCT00404651|530845509|FG003|Overall Study|Serious Adverse Event|0|||
147185364|NCT00404651|530845506|FG000|Overall Study|Protocol Violation|10|||
147185365|NCT00404651|530845507|FG001|Overall Study|Protocol Violation|5|||
147185366|NCT00404651|530845508|FG002|Overall Study|Protocol Violation|14|||
147185367|NCT00404651|530845509|FG003|Overall Study|Protocol Violation|5|||
147185368|NCT00404651|530845506|FG000|Overall Study|Lost to Follow-up|15|||
147185369|NCT00404651|530845507|FG001|Overall Study|Lost to Follow-up|11|||
147185370|NCT00404651|530845508|FG002|Overall Study|Lost to Follow-up|13|||
147185371|NCT00404651|530845509|FG003|Overall Study|Lost to Follow-up|10|||
147185372|NCT00404651|530845506|FG000|Overall Study|Withdrawal by Subject|14|||
147185373|NCT00404651|530845507|FG001|Overall Study|Withdrawal by Subject|12|||
147185374|NCT00404651|530845508|FG002|Overall Study|Withdrawal by Subject|16|||
147185375|NCT00404651|530845509|FG003|Overall Study|Withdrawal by Subject|6|||
147328839|NCT02955069|531370012|FG001|Overall Study|Death|3|||
147328840|NCT02955069|531370011|FG000|Overall Study|Physician Decision|10|||
147328841|NCT02955069|531370012|FG001|Overall Study|Physician Decision|2|||
147448583|NCT01049035|531807903|FG001|Overall Study|Serious adverse event|1|||
147448584|NCT01049035|531807904|FG002|Overall Study|Serious adverse event|1|||
147328842|NCT02955069|531370011|FG000|Overall Study|Progressive disease|64|||
147328843|NCT02955069|531370012|FG001|Overall Study|Progressive disease|13|||
147328844|NCT02955069|531370011|FG000|Overall Study|Study terminated by sponsor|4|||
147328845|NCT02955069|531370012|FG001|Overall Study|Study terminated by sponsor|0|||
147328846|NCT02955069|531370011|FG000|Overall Study|Subject/Guardian decision|3|||
147328847|NCT02955069|531370012|FG001|Overall Study|Subject/Guardian decision|1|||
147185376|NCT01121146|530845521|FG000|Overall Study|Death|17|||
147185377|NCT01121146|530845522|FG001|Overall Study|Death|15|||
147185378|NCT01121146|530845521|FG000|Overall Study|Adverse Event|2|||
147185379|NCT01121146|530845522|FG001|Overall Study|Adverse Event|11|||
147185380|NCT01121146|530845521|FG000|Overall Study|Lost to Follow-up|7|||
147185381|NCT01121146|530845522|FG001|Overall Study|Lost to Follow-up|16|||
147185382|NCT05030350|530845528|FG000|Overall Study|Adverse Event|13|||
147185383|NCT05030350|530845528|FG000|Overall Study|Lack of Efficacy|8|||
147185384|NCT05030350|530845528|FG000|Overall Study|Lost to Follow-up|35|||
147185385|NCT05030350|530845528|FG000|Overall Study|Pregnancy|2|||
147328848|NCT00943605|531370013|FG000|Overall Study|Study termination|30|||
147328849|NCT00943605|531370014|FG001|Overall Study|Study termination|30|||
147185386|NCT05030350|530845528|FG000|Overall Study|Protocol Violation|2|||
147185387|NCT05030350|530845528|FG000|Overall Study|Withdrawal by Subject|60|||
147185388|NCT05030350|530845528|FG000|Overall Study|Study terminated by sponsor|349|||
147185389|NCT05030350|530845528|FG000|Overall Study|Positive Drug Screen|4|||
147185390|NCT05030350|530845528|FG000|Overall Study|Other|8|||
147185391|NCT02711137|530845529|FG000|Overall Study|Death|1|||
147185392|NCT02711137|530845530|FG001|Overall Study|Death|4|||
147185393|NCT02711137|530845531|FG002|Overall Study|Death|5|||
147185394|NCT02711137|530845532|FG003|Overall Study|Death|5|||
147185395|NCT02711137|530845533|FG004|Overall Study|Death|3|||
147185396|NCT02711137|530845534|FG005|Overall Study|Death|1|||
147185397|NCT02711137|530845535|FG006|Overall Study|Death|61|||
147185398|NCT02711137|530845536|FG007|Overall Study|Death|3|||
147185399|NCT02711137|530845537|FG008|Overall Study|Death|0|||
147185400|NCT02711137|530845538|FG009|Overall Study|Death|1|||
147185401|NCT02711137|530845539|FG010|Overall Study|Death|1|||
147185402|NCT02711137|530845540|FG011|Overall Study|Death|1|||
147185403|NCT02711137|530845541|FG012|Overall Study|Death|0|||
147247142|NCT02837783|531072799|FG000|Overall Study|Other, Not Specified|1|||
147247143|NCT02837783|531072800|FG001|Overall Study|Other, Not Specified|2|||
147247144|NCT00496054|531072801|FG000|Overall Study|Adverse Event|1|||
147247145|NCT00496054|531072801|FG000|Overall Study|Lost to Follow-up|7|||
147247146|NCT02216591|531072802|FG000|Overall Study|Lost to Follow-up|0|||
147247147|NCT02216591|531072803|FG001|Overall Study|Lost to Follow-up|1|||
147247148|NCT01950741|531072806|FG000|Overall Study|Lost to Follow-up|1|||
147247149|NCT01950741|531072806|FG000|Overall Study|Death|1|||
147247150|NCT01950741|531072806|FG000|Overall Study|Withdrawal by Subject|1|||
147247151|NCT02854631|531072809|FG000|Overall Study|Adverse Event|1|||
147247152|NCT02854631|531072810|FG001|Overall Study|Adverse Event|2|||
147247153|NCT02854631|531072809|FG000|Overall Study|Withdrew Consent|3|||
147247154|NCT02854631|531072810|FG001|Overall Study|Withdrew Consent|2|||
147247155|NCT02854631|531072809|FG000|Overall Study|Investigator's Discretion|2|||
147448585|NCT01049035|531807905|FG003|Overall Study|Serious adverse event|2|||
147658480|NCT05225558|532572285|FG001|Overall Study|When investigators decide that the subject should stop participating in the trial for other reasons|2|||
147658481|NCT03200548|532572286|FG000|Overall Study|Withdrawal by Subject|5|||
147658482|NCT03200548|532572287|FG001|Overall Study|Withdrawal by Subject|11|||
147448586|NCT01049035|531807906|FG004|Overall Study|Serious adverse event|0|||
147448587|NCT01049035|531807907|FG005|Overall Study|Serious adverse event|0|||
147448588|NCT01049035|531807908|FG006|Overall Study|Serious adverse event|0|||
147448589|NCT01049035|531807902|FG000|Overall Study|Other adverse event (AE)|0|||
147448590|NCT01049035|531807903|FG001|Overall Study|Other adverse event (AE)|0|||
147448591|NCT01049035|531807904|FG002|Overall Study|Other adverse event (AE)|0|||
147448592|NCT01049035|531807905|FG003|Overall Study|Other adverse event (AE)|1|||
147448593|NCT01049035|531807906|FG004|Overall Study|Other adverse event (AE)|0|||
147448594|NCT01049035|531807907|FG005|Overall Study|Other adverse event (AE)|0|||
147448595|NCT01049035|531807908|FG006|Overall Study|Other adverse event (AE)|0|||
147448596|NCT01049035|531807902|FG000|Overall Study|Non-compliance with the protocol|12|||
147448597|NCT01049035|531807903|FG001|Overall Study|Non-compliance with the protocol|6|||
147448598|NCT01049035|531807904|FG002|Overall Study|Non-compliance with the protocol|14|||
147448599|NCT01049035|531807905|FG003|Overall Study|Non-compliance with the protocol|5|||
147448600|NCT01049035|531807906|FG004|Overall Study|Non-compliance with the protocol|3|||
147448601|NCT01049035|531807907|FG005|Overall Study|Non-compliance with the protocol|4|||
147448602|NCT01049035|531807908|FG006|Overall Study|Non-compliance with the protocol|10|||
147448603|NCT01049035|531807902|FG000|Overall Study|Lost to Follow-up|5|||
147448604|NCT01049035|531807903|FG001|Overall Study|Lost to Follow-up|4|||
147448605|NCT01049035|531807904|FG002|Overall Study|Lost to Follow-up|4|||
147448606|NCT01049035|531807905|FG003|Overall Study|Lost to Follow-up|1|||
147448607|NCT01049035|531807906|FG004|Overall Study|Lost to Follow-up|0|||
147658483|NCT03200548|532572288|FG002|Overall Study|Withdrawal by Subject|7|||
147185404|NCT02711137|530845542|FG013|Overall Study|Death|0|||
147185405|NCT02711137|530845543|FG014|Overall Study|Death|0|||
147247156|NCT02854631|531072810|FG001|Overall Study|Investigator's Discretion|0|||
147185406|NCT02711137|530845529|FG000|Overall Study|Study Terminated by Sponsor|0|||
147185407|NCT02711137|530845530|FG001|Overall Study|Study Terminated by Sponsor|0|||
147247157|NCT02854631|531072809|FG000|Overall Study|Death|12|||
147448608|NCT01049035|531807907|FG005|Overall Study|Lost to Follow-up|3|||
147448609|NCT01049035|531807908|FG006|Overall Study|Lost to Follow-up|3|||
147448610|NCT01049035|531807902|FG000|Overall Study|Voluntary withdrawal not due to an AE|16|||
147448611|NCT01049035|531807903|FG001|Overall Study|Voluntary withdrawal not due to an AE|10|||
147185408|NCT02711137|530845531|FG002|Overall Study|Study Terminated by Sponsor|1|||
147185409|NCT02711137|530845532|FG003|Overall Study|Study Terminated by Sponsor|0|||
147247158|NCT02854631|531072810|FG001|Overall Study|Death|8|||
147185410|NCT02711137|530845533|FG004|Overall Study|Study Terminated by Sponsor|0|||
147185411|NCT02711137|530845534|FG005|Overall Study|Study Terminated by Sponsor|0|||
147185412|NCT02711137|530845535|FG006|Overall Study|Study Terminated by Sponsor|1|||
147185413|NCT02711137|530845536|FG007|Overall Study|Study Terminated by Sponsor|0|||
147185414|NCT02711137|530845537|FG008|Overall Study|Study Terminated by Sponsor|0|||
147185415|NCT02711137|530845538|FG009|Overall Study|Study Terminated by Sponsor|0|||
147328850|NCT00918957|531370016|FG000|Overall Study|Adverse Event|2|||
147328851|NCT00918957|531370017|FG001|Overall Study|Adverse Event|0|||
147328852|NCT00918957|531370016|FG000|Overall Study|Withdrawal by Subject|1|||
147185416|NCT02711137|530845539|FG010|Overall Study|Study Terminated by Sponsor|0|||
147185417|NCT02711137|530845540|FG011|Overall Study|Study Terminated by Sponsor|0|||
147185418|NCT02711137|530845541|FG012|Overall Study|Study Terminated by Sponsor|0|||
147185419|NCT02711137|530845542|FG013|Overall Study|Study Terminated by Sponsor|0|||
147185420|NCT02711137|530845543|FG014|Overall Study|Study Terminated by Sponsor|0|||
147185421|NCT02711137|530845529|FG000|Overall Study|Physician Decision|1|||
147185422|NCT02711137|530845530|FG001|Overall Study|Physician Decision|0|||
147185423|NCT02711137|530845531|FG002|Overall Study|Physician Decision|2|||
147185424|NCT02711137|530845532|FG003|Overall Study|Physician Decision|1|||
147185425|NCT02711137|530845533|FG004|Overall Study|Physician Decision|1|||
147185426|NCT02711137|530845534|FG005|Overall Study|Physician Decision|0|||
147185427|NCT02711137|530845535|FG006|Overall Study|Physician Decision|12|||
147185428|NCT02711137|530845536|FG007|Overall Study|Physician Decision|2|||
147185429|NCT02711137|530845537|FG008|Overall Study|Physician Decision|1|||
147185430|NCT02711137|530845538|FG009|Overall Study|Physician Decision|1|||
147185431|NCT02711137|530845539|FG010|Overall Study|Physician Decision|3|||
147185432|NCT02711137|530845540|FG011|Overall Study|Physician Decision|2|||
147185433|NCT02711137|530845541|FG012|Overall Study|Physician Decision|1|||
147328853|NCT00918957|531370017|FG001|Overall Study|Withdrawal by Subject|0|||
147328854|NCT01720446|531370018|FG000|Overall Study|Lost to Follow-up|12|||
147328855|NCT01720446|531370019|FG001|Overall Study|Lost to Follow-up|6|||
147328856|NCT01720446|531370020|FG002|Overall Study|Lost to Follow-up|16|||
147328857|NCT01720446|531370021|FG003|Overall Study|Lost to Follow-up|16|||
147328858|NCT01720446|531370018|FG000|Overall Study|Withdrawal by Subject|2|||
147328859|NCT01720446|531370019|FG001|Overall Study|Withdrawal by Subject|5|||
147328860|NCT01720446|531370020|FG002|Overall Study|Withdrawal by Subject|4|||
147328861|NCT01720446|531370021|FG003|Overall Study|Withdrawal by Subject|4|||
147448612|NCT01049035|531807904|FG002|Overall Study|Voluntary withdrawal not due to an AE|8|||
147328864|NCT01956669|531370024|FG000|Overall Study|Disease Progression|12|||
147328865|NCT01956669|531370025|FG001|Overall Study|Disease Progression|7|||
147328866|NCT01956669|531370026|FG002|Overall Study|Disease Progression|7|||
147328867|NCT01956669|531370027|FG003|Overall Study|Disease Progression|8|||
147328868|NCT01956669|531370028|FG004|Overall Study|Disease Progression|4|||
147328869|NCT01956669|531370029|FG005|Overall Study|Disease Progression|3|||
147328870|NCT01956669|531370030|FG006|Overall Study|Disease Progression|5|||
147328871|NCT01956669|531370024|FG000|Overall Study|Adverse Event|0|||
147328872|NCT01956669|531370025|FG001|Overall Study|Adverse Event|2|||
147328873|NCT01956669|531370026|FG002|Overall Study|Adverse Event|2|||
147328874|NCT01956669|531370027|FG003|Overall Study|Adverse Event|1|||
147185434|NCT02711137|530845542|FG013|Overall Study|Physician Decision|1|||
147328875|NCT01956669|531370028|FG004|Overall Study|Adverse Event|0|||
147328876|NCT01956669|531370029|FG005|Overall Study|Adverse Event|0|||
147328877|NCT01956669|531370030|FG006|Overall Study|Adverse Event|0|||
147328878|NCT01956669|531370024|FG000|Overall Study|Physician Decision|0|||
147328879|NCT01956669|531370025|FG001|Overall Study|Physician Decision|2|||
147328880|NCT01956669|531370026|FG002|Overall Study|Physician Decision|0|||
147185435|NCT02711137|530845543|FG014|Overall Study|Physician Decision|2|||
147185436|NCT02711137|530845529|FG000|Overall Study|Other|0|||
147328881|NCT01956669|531370027|FG003|Overall Study|Physician Decision|0|||
147328882|NCT01956669|531370028|FG004|Overall Study|Physician Decision|0|||
147328883|NCT01956669|531370029|FG005|Overall Study|Physician Decision|1|||
147328884|NCT01956669|531370030|FG006|Overall Study|Physician Decision|0|||
147328885|NCT01956669|531370024|FG000|Overall Study|Withdrawal by Subject|0|||
147328886|NCT01956669|531370025|FG001|Overall Study|Withdrawal by Subject|0|||
147328887|NCT01956669|531370026|FG002|Overall Study|Withdrawal by Subject|1|||
147328888|NCT01956669|531370027|FG003|Overall Study|Withdrawal by Subject|1|||
147328889|NCT01956669|531370028|FG004|Overall Study|Withdrawal by Subject|0|||
147328890|NCT01956669|531370029|FG005|Overall Study|Withdrawal by Subject|0|||
147328891|NCT01956669|531370030|FG006|Overall Study|Withdrawal by Subject|1|||
147328892|NCT01131494|531370031|FG000|Overall Study|Withdrawal by Subject|2|||
147185437|NCT02711137|530845530|FG001|Overall Study|Other|1|||
147328893|NCT02145182|531370033|FG000|Overall Study|Adverse Event|4|||
147328894|NCT02145182|531370034|FG001|Overall Study|Adverse Event|1|||
147328895|NCT02145182|531370033|FG000|Overall Study|Death|7|||
147328896|NCT02145182|531370034|FG001|Overall Study|Death|7|||
147328897|NCT02145182|531370033|FG000|Overall Study|Lost to Follow-up|2|||
147328898|NCT02145182|531370034|FG001|Overall Study|Lost to Follow-up|2|||
147328899|NCT02145182|531370033|FG000|Overall Study|Pre-transplant Withdrawal|0|||
147328900|NCT02145182|531370034|FG001|Overall Study|Pre-transplant Withdrawal|2|||
147185438|NCT02711137|530845531|FG002|Overall Study|Other|0|||
147185439|NCT02711137|530845532|FG003|Overall Study|Other|0|||
147185440|NCT02711137|530845533|FG004|Overall Study|Other|0|||
147185441|NCT02711137|530845534|FG005|Overall Study|Other|0|||
147328901|NCT02145182|531370033|FG000|Overall Study|Withdrawal by Subject|5|||
147328902|NCT02145182|531370034|FG001|Overall Study|Withdrawal by Subject|4|||
147328903|NCT01196988|531370036|FG000|Overall Study|Adverse Event|1|||
147328904|NCT01196988|531370037|FG001|Overall Study|Adverse Event|2|||
147185442|NCT02711137|530845535|FG006|Overall Study|Other|3|||
147185443|NCT02711137|530845536|FG007|Overall Study|Other|0|||
147185444|NCT02711137|530845537|FG008|Overall Study|Other|0|||
147185445|NCT02711137|530845538|FG009|Overall Study|Other|0|||
147185446|NCT02711137|530845539|FG010|Overall Study|Other|0|||
147185447|NCT02711137|530845540|FG011|Overall Study|Other|0|||
147185448|NCT02711137|530845541|FG012|Overall Study|Other|0|||
147185449|NCT02711137|530845542|FG013|Overall Study|Other|0|||
147185450|NCT02711137|530845543|FG014|Overall Study|Other|1|||
147185451|NCT02711137|530845529|FG000|Overall Study|Withdrawal by Subject|1|||
147185452|NCT02711137|530845530|FG001|Overall Study|Withdrawal by Subject|0|||
147185453|NCT02711137|530845531|FG002|Overall Study|Withdrawal by Subject|0|||
147185454|NCT02711137|530845532|FG003|Overall Study|Withdrawal by Subject|1|||
147185455|NCT02711137|530845533|FG004|Overall Study|Withdrawal by Subject|1|||
147185456|NCT02711137|530845534|FG005|Overall Study|Withdrawal by Subject|0|||
147185457|NCT02711137|530845535|FG006|Overall Study|Withdrawal by Subject|7|||
147185458|NCT02711137|530845536|FG007|Overall Study|Withdrawal by Subject|0|||
147185459|NCT02711137|530845537|FG008|Overall Study|Withdrawal by Subject|0|||
147185460|NCT02711137|530845538|FG009|Overall Study|Withdrawal by Subject|0|||
147185461|NCT02711137|530845539|FG010|Overall Study|Withdrawal by Subject|0|||
147185462|NCT02711137|530845540|FG011|Overall Study|Withdrawal by Subject|0|||
147185463|NCT02711137|530845541|FG012|Overall Study|Withdrawal by Subject|0|||
147185464|NCT02711137|530845542|FG013|Overall Study|Withdrawal by Subject|1|||
147185465|NCT02711137|530845543|FG014|Overall Study|Withdrawal by Subject|0|||
147185466|NCT02711137|530845529|FG000|Overall Study|Lost to Follow-up|1|||
147185467|NCT02711137|530845530|FG001|Overall Study|Lost to Follow-up|0|||
147185468|NCT02711137|530845531|FG002|Overall Study|Lost to Follow-up|0|||
147185469|NCT02711137|530845532|FG003|Overall Study|Lost to Follow-up|0|||
147185470|NCT02711137|530845533|FG004|Overall Study|Lost to Follow-up|0|||
147185471|NCT02711137|530845534|FG005|Overall Study|Lost to Follow-up|0|||
147185472|NCT02711137|530845535|FG006|Overall Study|Lost to Follow-up|2|||
147185473|NCT02711137|530845536|FG007|Overall Study|Lost to Follow-up|0|||
147185474|NCT02711137|530845537|FG008|Overall Study|Lost to Follow-up|0|||
147185475|NCT02711137|530845538|FG009|Overall Study|Lost to Follow-up|0|||
147185476|NCT02711137|530845539|FG010|Overall Study|Lost to Follow-up|0|||
147185477|NCT02711137|530845540|FG011|Overall Study|Lost to Follow-up|0|||
147185478|NCT02711137|530845541|FG012|Overall Study|Lost to Follow-up|0|||
147185479|NCT02711137|530845542|FG013|Overall Study|Lost to Follow-up|0|||
147185480|NCT02711137|530845543|FG014|Overall Study|Lost to Follow-up|0|||
147185481|NCT01745367|530845555|FG000|Overall Study|Death|1|||
147185482|NCT01745367|530845556|FG001|Overall Study|Death|0|||
147185483|NCT01745367|530845555|FG000|Overall Study|Withdrawal by Subject|1|||
147185484|NCT01745367|530845556|FG001|Overall Study|Withdrawal by Subject|2|||
147185485|NCT01745367|530845555|FG000|Overall Study|Termination of The Study by The Sponsor|6|||
147185486|NCT01745367|530845556|FG001|Overall Study|Termination of The Study by The Sponsor|18|||
147185487|NCT01745367|530845555|FG000|Overall Study|Other Reasons Unspecified|0|||
147185488|NCT01745367|530845556|FG001|Overall Study|Other Reasons Unspecified|2|||
147328905|NCT01196988|531370038|FG002|Overall Study|Adverse Event|0|||
147328906|NCT01196988|531370039|FG003|Overall Study|Adverse Event|0|||
147328907|NCT01196988|531370036|FG000|Overall Study|Withdrawal by Subject|5|||
147328908|NCT01196988|531370037|FG001|Overall Study|Withdrawal by Subject|1|||
147328909|NCT01196988|531370038|FG002|Overall Study|Withdrawal by Subject|4|||
147328910|NCT01196988|531370039|FG003|Overall Study|Withdrawal by Subject|0|||
147328911|NCT01196988|531370036|FG000|Overall Study|Lost to Follow-up|16|||
147328912|NCT01196988|531370037|FG001|Overall Study|Lost to Follow-up|29|||
147328913|NCT01196988|531370038|FG002|Overall Study|Lost to Follow-up|21|||
147328914|NCT01196988|531370039|FG003|Overall Study|Lost to Follow-up|1|||
147328915|NCT01196988|531370036|FG000|Overall Study|Other|2|||
147328916|NCT01196988|531370037|FG001|Overall Study|Other|0|||
147328917|NCT01196988|531370038|FG002|Overall Study|Other|0|||
147328918|NCT01196988|531370039|FG003|Overall Study|Other|0|||
147328919|NCT03999554|531370040|FG000|Overall Study|Lost to Follow-up|4|||
147328920|NCT03999554|531370041|FG001|Overall Study|Lost to Follow-up|5|||
147328921|NCT03999554|531370042|FG002|Overall Study|Lost to Follow-up|4|||
147328922|NCT03999554|531370043|FG003|Overall Study|Lost to Follow-up|5|||
147328923|NCT03999554|531370044|FG004|Overall Study|Lost to Follow-up|8|||
147328924|NCT03999554|531370040|FG000|Overall Study|Protocol Violation|0|||
147328925|NCT03999554|531370041|FG001|Overall Study|Protocol Violation|0|||
147328926|NCT03999554|531370042|FG002|Overall Study|Protocol Violation|5|||
147185489|NCT00354679|530845557|FG000|Overall Study|Patient Not Treated|1|||
147185490|NCT01814527|530845558|FG000|Overall Study|RTP greater than 30 days|6|||
147185491|NCT01814527|530845559|FG001|Overall Study|RTP greater than 30 days|1|||
147185492|NCT03571204|530845560|FG000|Overall Study|Stopped due to COVID-19 pandemic|1|||
147185493|NCT03571204|530845561|FG001|Overall Study|Stopped due to COVID-19 pandemic|1|||
147185494|NCT03571204|530845562|FG002|Overall Study|Stopped due to COVID-19 pandemic|0|||
147185495|NCT03571204|530845560|FG000|Overall Study|Physician Decision|0|||
147185496|NCT03571204|530845561|FG001|Overall Study|Physician Decision|1|||
147185497|NCT03571204|530845562|FG002|Overall Study|Physician Decision|0|||
147328927|NCT03999554|531370043|FG003|Overall Study|Protocol Violation|0|||
147185498|NCT00857285|530845564|FG000|Overall Study|Adverse Event|4|||
147185499|NCT00857285|530845565|FG001|Overall Study|Adverse Event|2|||
147185500|NCT00857285|530845564|FG000|Overall Study|Lack of Efficacy|0|||
147328928|NCT03999554|531370044|FG004|Overall Study|Protocol Violation|0|||
147328929|NCT03999554|531370040|FG000|Overall Study|Pregnancy|0|||
147185501|NCT00857285|530845565|FG001|Overall Study|Lack of Efficacy|2|||
147185502|NCT00857285|530845564|FG000|Overall Study|Protocol Violation|3|||
147185503|NCT00857285|530845565|FG001|Overall Study|Protocol Violation|1|||
147185504|NCT00857285|530845564|FG000|Overall Study|Withdrawal by Subject|4|||
147185505|NCT00857285|530845565|FG001|Overall Study|Withdrawal by Subject|0|||
147185506|NCT00857285|530845564|FG000|Overall Study|Randomization criteria not met|1|||
147185507|NCT00857285|530845565|FG001|Overall Study|Randomization criteria not met|1|||
147185508|NCT03901144|530845570|FG000|Overall Study|Lost to Follow-up|1|||
147185509|NCT03901144|530845571|FG001|Overall Study|Lost to Follow-up|1|||
147185510|NCT03901144|530845572|FG002|Overall Study|Lost to Follow-up|1|||
147185511|NCT03901144|530845573|FG003|Overall Study|Lost to Follow-up|1|||
147185512|NCT03081884|530845574|FG000|Overall Study|deferred prostate cancer treatment|1|||
147185513|NCT03081884|530845574|FG000|Overall Study|metastasis managed with systemic therapy|3|||
147185514|NCT03948334|530845575|FG000|Overall Study|Adverse Event|1|||
147185515|NCT03948334|530845576|FG001|Overall Study|Adverse Event|4|||
147185516|NCT03948334|530845575|FG000|Overall Study|Lack of Efficacy|2|||
147328930|NCT03999554|531370041|FG001|Overall Study|Pregnancy|0|||
147328931|NCT03999554|531370042|FG002|Overall Study|Pregnancy|1|||
147328932|NCT03999554|531370043|FG003|Overall Study|Pregnancy|0|||
147328933|NCT03999554|531370044|FG004|Overall Study|Pregnancy|0|||
147328934|NCT03999554|531370040|FG000|Overall Study|Withdrawal by Subject|2|||
147328935|NCT03999554|531370041|FG001|Overall Study|Withdrawal by Subject|2|||
147328936|NCT03999554|531370042|FG002|Overall Study|Withdrawal by Subject|2|||
147328937|NCT03999554|531370043|FG003|Overall Study|Withdrawal by Subject|1|||
147328938|NCT03999554|531370044|FG004|Overall Study|Withdrawal by Subject|1|||
147328939|NCT03999554|531370040|FG000|Overall Study|failure to comply with protocol requirements|0|||
147328940|NCT03999554|531370041|FG001|Overall Study|failure to comply with protocol requirements|0|||
147185517|NCT03948334|530845576|FG001|Overall Study|Lack of Efficacy|0|||
147185518|NCT03948334|530845575|FG000|Overall Study|Lost to Follow-up|1|||
147185519|NCT03948334|530845576|FG001|Overall Study|Lost to Follow-up|0|||
147185520|NCT03948334|530845575|FG000|Overall Study|Physician Decision|1|||
147185521|NCT03948334|530845576|FG001|Overall Study|Physician Decision|0|||
147185522|NCT03948334|530845575|FG000|Overall Study|Pregnancy|0|||
147185523|NCT03948334|530845576|FG001|Overall Study|Pregnancy|1|||
147185524|NCT03948334|530845575|FG000|Overall Study|Protocol Deviation|1|||
147185525|NCT03948334|530845576|FG001|Overall Study|Protocol Deviation|0|||
147185526|NCT03948334|530845575|FG000|Overall Study|Study terminated by Sponsor|50|||
147185527|NCT03948334|530845576|FG001|Overall Study|Study terminated by Sponsor|51|||
147185528|NCT03948334|530845575|FG000|Overall Study|Subject Decision /Guardian Decision|4|||
147247159|NCT02854631|531072809|FG000|Overall Study|Liver Biopsy Inconsistent With Diagnosis|2|||
147247160|NCT02854631|531072810|FG001|Overall Study|Liver Biopsy Inconsistent With Diagnosis|0|||
147247161|NCT02854631|531072809|FG000|Overall Study|Protocol Violation|0|||
147247162|NCT02854631|531072810|FG001|Overall Study|Protocol Violation|1|||
147247163|NCT02854631|531072809|FG000|Overall Study|Subjects Randomized but Never Treated|2|||
147247164|NCT02854631|531072810|FG001|Overall Study|Subjects Randomized but Never Treated|0|||
147247165|NCT02854631|531072809|FG000|Overall Study|Lost to Follow-up|4|||
147247166|NCT02854631|531072810|FG001|Overall Study|Lost to Follow-up|2|||
147247167|NCT02233647|531072811|FG000|Overall Study|Adverse Event|1|||
147247168|NCT00621153|531072815|FG000|Overall Study|Safety Reason|8|||
147247169|NCT00621153|531072816|FG001|Overall Study|Safety Reason|7|||
147247170|NCT00621153|531072815|FG000|Overall Study|Adverse Event|3|||
147247171|NCT00621153|531072816|FG001|Overall Study|Adverse Event|2|||
147247172|NCT00621153|531072815|FG000|Overall Study|Lost to Follow-up|5|||
147247173|NCT00621153|531072816|FG001|Overall Study|Lost to Follow-up|1|||
147247174|NCT00621153|531072815|FG000|Overall Study|Withdrawal by Subject|4|||
147247175|NCT00621153|531072816|FG001|Overall Study|Withdrawal by Subject|5|||
147247176|NCT00753415|531072817|FG000|Part A|Disease progression|1|||
147247177|NCT00753415|531072818|FG001|Part A|Disease progression|0|||
147247178|NCT00753415|531072819|FG002|Part A|Disease progression|1|||
147247179|NCT00753415|531072820|FG003|Part A|Disease progression|2|||
147247180|NCT00753415|531072821|FG004|Part A|Disease progression|0|||
147247181|NCT00753415|531072822|FG005|Part A|Disease progression|0|||
147247182|NCT00753415|531072823|FG006|Part A|Disease progression|0|||
147247183|NCT00753415|531072824|FG007|Part A|Disease progression|0|||
147247184|NCT00753415|531072825|FG008|Part A|Disease progression|0|||
147247185|NCT00753415|531072826|FG009|Part A|Disease progression|0|||
147247186|NCT00753415|531072817|FG000|Part A|Withdrawal by Subject|0|||
147247187|NCT00753415|531072818|FG001|Part A|Withdrawal by Subject|0|||
147247188|NCT00753415|531072819|FG002|Part A|Withdrawal by Subject|1|||
147247189|NCT00753415|531072820|FG003|Part A|Withdrawal by Subject|0|||
147247190|NCT00753415|531072821|FG004|Part A|Withdrawal by Subject|0|||
147247191|NCT00753415|531072822|FG005|Part A|Withdrawal by Subject|0|||
147247192|NCT00753415|531072823|FG006|Part A|Withdrawal by Subject|0|||
147185529|NCT03948334|530845576|FG001|Overall Study|Subject Decision /Guardian Decision|7|||
147185530|NCT05114473|530845577|FG000|Overall Study|Lost to Follow-up|2|||
147185531|NCT05114473|530845578|FG001|Overall Study|Lost to Follow-up|2|||
147658484|NCT03200548|532572289|FG003|Overall Study|Withdrawal by Subject|6|||
147658485|NCT00875563|532572290|FG000|Overall Study|Death|4|||
147658486|NCT00875563|532572290|FG000|Overall Study|Withdrawal by Subject|7|||
147658487|NCT00875563|532572290|FG000|Overall Study|No long-term (3-5 year) consent|6|||
147658488|NCT00875563|532572290|FG000|Overall Study|Still be eligible for follow-up|7|||
147658489|NCT02896569|532572291|FG000|Overall Study|Lost to Follow-up|2|||
147658490|NCT02896569|532572292|FG001|Overall Study|Lost to Follow-up|1|||
147658491|NCT02896569|532572291|FG000|Overall Study|Physician Decision|1|||
147658492|NCT02896569|532572292|FG001|Overall Study|Physician Decision|3|||
147658493|NCT02896569|532572291|FG000|Overall Study|Adverse Event|0|||
147658494|NCT02896569|532572292|FG001|Overall Study|Adverse Event|1|||
147658495|NCT02896569|532572291|FG000|Overall Study|Withdrawal by Subject|1|||
147658496|NCT02896569|532572292|FG001|Overall Study|Withdrawal by Subject|0|||
147658497|NCT00313846|532572293|FG000|Overall Study|Withdrawal by Subject|2|||
147658498|NCT00313846|532572294|FG001|Overall Study|Withdrawal by Subject|0|||
147658499|NCT00313846|532572293|FG000|Overall Study|Adverse Event|1|||
147658500|NCT00313846|532572294|FG001|Overall Study|Adverse Event|8|||
147658501|NCT00313846|532572293|FG000|Overall Study|Administrative|2|||
147658502|NCT00313846|532572294|FG001|Overall Study|Administrative|3|||
147658503|NCT03257436|532572295|FG000|Overall Study|Withdrawal by Subject|76|||
147658504|NCT03257436|532572295|FG000|Overall Study|Death|19|||
147658505|NCT00970489|532572296|FG000|Overall Study|Death/Withdrew/Criteria Violation|54|||
147658506|NCT00970489|532572297|FG001|Overall Study|Death/Withdrew/Criteria Violation|41|||
147658507|NCT02659943|532572298|FG000|Overall Study|Switched to alternative treatment|1|||
147658508|NCT02659943|532572299|FG001|Overall Study|Switched to alternative treatment|1|||
147658509|NCT02659943|532572300|FG002|Overall Study|Switched to alternative treatment|0|||
147658510|NCT02659943|532572301|FG003|Overall Study|Switched to alternative treatment|2|||
147658511|NCT02659943|532572302|FG004|Overall Study|Switched to alternative treatment|1|||
147658512|NCT02659943|532572303|FG005|Overall Study|Switched to alternative treatment|0|||
147658513|NCT02659943|532572304|FG006|Overall Study|Switched to alternative treatment|1|||
147658514|NCT02659943|532572298|FG000|Overall Study|Disease progression on study|0|||
147658515|NCT02659943|532572299|FG001|Overall Study|Disease progression on study|1|||
147658516|NCT02659943|532572300|FG002|Overall Study|Disease progression on study|1|||
147658517|NCT02659943|532572301|FG003|Overall Study|Disease progression on study|1|||
147658518|NCT02659943|532572302|FG004|Overall Study|Disease progression on study|1|||
147658519|NCT02659943|532572303|FG005|Overall Study|Disease progression on study|4|||
147658520|NCT02659943|532572304|FG006|Overall Study|Disease progression on study|0|||
147658521|NCT02659943|532572298|FG000|Overall Study|Patient's condition per principal investigator|0|||
147658522|NCT02659943|532572299|FG001|Overall Study|Patient's condition per principal investigator|0|||
147658523|NCT02659943|532572300|FG002|Overall Study|Patient's condition per principal investigator|0|||
147658524|NCT02659943|532572301|FG003|Overall Study|Patient's condition per principal investigator|0|||
147658525|NCT02659943|532572302|FG004|Overall Study|Patient's condition per principal investigator|0|||
147658526|NCT02659943|532572303|FG005|Overall Study|Patient's condition per principal investigator|1|||
147658527|NCT02659943|532572304|FG006|Overall Study|Patient's condition per principal investigator|0|||
147658528|NCT02659943|532572298|FG000|Overall Study|Ineligible|0|||
147658529|NCT02659943|532572299|FG001|Overall Study|Ineligible|0|||
147658530|NCT02659943|532572300|FG002|Overall Study|Ineligible|0|||
147658531|NCT02659943|532572301|FG003|Overall Study|Ineligible|0|||
147658532|NCT02659943|532572302|FG004|Overall Study|Ineligible|0|||
147185532|NCT05114473|530845579|FG002|Overall Study|Lost to Follow-up|0|||
147185533|NCT04445662|530845583|FG000|On treatment (0-12 weeks)|Deemed ineligible after randomization due to non-smoking status|1|||
147185534|NCT04445662|530845584|FG001|On treatment (0-12 weeks)|Deemed ineligible after randomization due to non-smoking status|0|||
147185535|NCT04445662|530845583|FG000|On treatment (0-12 weeks)|Withdrawal by Subject|2|||
147185536|NCT04445662|530845584|FG001|On treatment (0-12 weeks)|Withdrawal by Subject|5|||
147185537|NCT04445662|530845583|FG000|On treatment (0-12 weeks)|Withdrawn by PI due to behavioral concerns|1|||
147185538|NCT04445662|530845584|FG001|On treatment (0-12 weeks)|Withdrawn by PI due to behavioral concerns|0|||
147185539|NCT04445662|530845583|FG000|Post-treatment (12-24 weeks)|Death|1|||
147185540|NCT04445662|530845584|FG001|Post-treatment (12-24 weeks)|Death|0|||
147185541|NCT00279916|530845585|FG000|Overall Study|Withdrawal by Subject|4|||
147185542|NCT00279916|530845586|FG001|Overall Study|Withdrawal by Subject|3|||
147185543|NCT00279916|530845585|FG000|Overall Study|Lost to Follow-up|3|||
147185544|NCT00279916|530845586|FG001|Overall Study|Lost to Follow-up|2|||
147185545|NCT01807598|530845587|FG000|Overall Study|Withdrawal by Subject|4|||
147185546|NCT01807598|530845587|FG000|Overall Study|Adverse Event|1|||
147185547|NCT01807598|530845587|FG000|Overall Study|Other Physician Decision|1|||
147185548|NCT00731679|530845589|FG000|Overall Study|Adverse Event|7|||
147185549|NCT00731679|530845590|FG001|Overall Study|Adverse Event|8|||
147185550|NCT00731679|530845589|FG000|Overall Study|Withdrawal by Subject|8|||
147185551|NCT00731679|530845590|FG001|Overall Study|Withdrawal by Subject|8|||
147185552|NCT00731679|530845589|FG000|Overall Study|Lost to Follow-up|7|||
147328941|NCT03999554|531370042|FG002|Overall Study|failure to comply with protocol requirements|0|||
147328942|NCT03999554|531370043|FG003|Overall Study|failure to comply with protocol requirements|1|||
147448613|NCT01049035|531807905|FG003|Overall Study|Voluntary withdrawal not due to an AE|2|||
147448614|NCT01049035|531807906|FG004|Overall Study|Voluntary withdrawal not due to an AE|1|||
147448615|NCT01049035|531807907|FG005|Overall Study|Voluntary withdrawal not due to an AE|5|||
147448616|NCT01049035|531807908|FG006|Overall Study|Voluntary withdrawal not due to an AE|2|||
147448617|NCT00812214|531807914|FG000|Overall Study|Lost to Follow-up|3|||
147448618|NCT00812214|531807915|FG001|Overall Study|Lost to Follow-up|1|||
147448619|NCT01514682|531807916|FG000|Overall Study|Withdrawal by Subject|2|||
147448620|NCT01514682|531807917|FG001|Overall Study|Withdrawal by Subject|3|||
147448621|NCT01514682|531807916|FG000|Overall Study|Physician Decision|4|||
147448622|NCT01514682|531807917|FG001|Overall Study|Physician Decision|3|||
147448623|NCT00132132|531807918|FG000|Overall Study|Lost to Follow-up|7|||
147448624|NCT00132132|531807919|FG001|Overall Study|Lost to Follow-up|2|||
147448625|NCT03605680|531807921|FG000|SB Placebo Run-in Period (1 Week)|Adverse Event|6|||
147448626|NCT03605680|531807922|FG001|SB Placebo Run-in Period (1 Week)|Adverse Event|0|||
147448627|NCT03605680|531807923|FG002|SB Placebo Run-in Period (1 Week)|Adverse Event|0|||
147448628|NCT03605680|531807924|FG003|SB Placebo Run-in Period (1 Week)|Adverse Event|0|||
147448629|NCT03605680|531807921|FG000|SB Placebo Run-in Period (1 Week)|Lack of Efficacy|1|||
147448630|NCT03605680|531807922|FG001|SB Placebo Run-in Period (1 Week)|Lack of Efficacy|0|||
147448631|NCT03605680|531807923|FG002|SB Placebo Run-in Period (1 Week)|Lack of Efficacy|0|||
147448632|NCT03605680|531807924|FG003|SB Placebo Run-in Period (1 Week)|Lack of Efficacy|0|||
147448633|NCT03605680|531807921|FG000|SB Placebo Run-in Period (1 Week)|Lost to Follow-up|9|||
147448634|NCT03605680|531807922|FG001|SB Placebo Run-in Period (1 Week)|Lost to Follow-up|0|||
147448635|NCT03605680|531807923|FG002|SB Placebo Run-in Period (1 Week)|Lost to Follow-up|0|||
147448636|NCT03605680|531807924|FG003|SB Placebo Run-in Period (1 Week)|Lost to Follow-up|0|||
147448637|NCT03605680|531807921|FG000|SB Placebo Run-in Period (1 Week)|Non-compliance With Study Drug|3|||
147448638|NCT03605680|531807922|FG001|SB Placebo Run-in Period (1 Week)|Non-compliance With Study Drug|0|||
147328943|NCT03999554|531370044|FG004|Overall Study|failure to comply with protocol requirements|0|||
147328944|NCT04012853|531370045|FG000|Overall Study|Withdrawal by Subject|1|||
147328945|NCT04012853|531370046|FG001|Overall Study|Withdrawal by Subject|1|||
147328946|NCT04012853|531370045|FG000|Overall Study|Protocol Violation|1|||
147328947|NCT04012853|531370046|FG001|Overall Study|Protocol Violation|0|||
147328948|NCT04012853|531370045|FG000|Overall Study|Unable to tolerate target tDCS intensity|1|||
147328949|NCT04012853|531370046|FG001|Overall Study|Unable to tolerate target tDCS intensity|0|||
147328950|NCT01695317|531370047|FG000|Period 1 in the Cross-over Design|Withdrawal by Subject|2|||
147328951|NCT01695317|531370048|FG001|Period 1 in the Cross-over Design|Withdrawal by Subject|1|||
147328952|NCT01695317|531370047|FG000|Cross-over to Period 2|Withdrawal by Subject|4|||
147328953|NCT01695317|531370048|FG001|Cross-over to Period 2|Withdrawal by Subject|34|||
147328954|NCT03055767|531370049|FG000|Open-Label Period|Lost to Follow-up|0|||
147328955|NCT03055767|531370050|FG001|Open-Label Period|Lost to Follow-up|0|||
147328956|NCT03055767|531370051|FG002|Open-Label Period|Lost to Follow-up|2|||
147328957|NCT03055767|531370052|FG003|Open-Label Period|Lost to Follow-up|0|||
147328958|NCT03055767|531370049|FG000|Open-Label Period|Withdrawal by Subject|0|||
147328959|NCT03055767|531370050|FG001|Open-Label Period|Withdrawal by Subject|0|||
147328960|NCT03055767|531370051|FG002|Open-Label Period|Withdrawal by Subject|0|||
147328961|NCT03055767|531370052|FG003|Open-Label Period|Withdrawal by Subject|1|||
147328962|NCT01466881|531370056|FG000|Overall Study|Ineligible|5|||
147328963|NCT01466881|531370056|FG000|Overall Study|Adverse Event|6|||
147328964|NCT01466881|531370056|FG000|Overall Study|Progression/relapse|20|||
147328965|NCT01466881|531370056|FG000|Overall Study|Death|4|||
147328966|NCT01466881|531370056|FG000|Overall Study|Other reason not protocol specified|5|||
147328967|NCT01101165|531370057|FG000|Period 1|Adverse Event|1|||
147328968|NCT01101165|531370058|FG001|Period 1|Adverse Event|2|||
147328969|NCT01101165|531370057|FG000|Period 1|Withdrawal by Subject|0|||
147328970|NCT01101165|531370058|FG001|Period 1|Withdrawal by Subject|2|||
147328971|NCT01101165|531370057|FG000|Period 1|Positive Drug Screen|0|||
147328972|NCT01101165|531370058|FG001|Period 1|Positive Drug Screen|1|||
147328973|NCT01101165|531370057|FG000|Period 1|Lost to Follow-up|1|||
147328974|NCT01101165|531370058|FG001|Period 1|Lost to Follow-up|0|||
147328975|NCT01101165|531370057|FG000|Period 2|Withdrawal by Subject|3|||
147328976|NCT01101165|531370058|FG001|Period 2|Withdrawal by Subject|1|||
147328977|NCT01101165|531370057|FG000|Period 2|Adverse Event|1|||
147448639|NCT03605680|531807923|FG002|SB Placebo Run-in Period (1 Week)|Non-compliance With Study Drug|0|||
147593879|NCT02025751|532329055|FG001|Overall Study|Withdrawal by Subject|1|||
147593880|NCT00653991|532329056|FG000|3 Month Follow-up|Participant would not respond|150|||
147328978|NCT01101165|531370058|FG001|Period 2|Adverse Event|0|||
147328979|NCT04580303|531370059|FG000|Overall Study|Adverse Event|0|||
147328980|NCT04580303|531370060|FG001|Overall Study|Adverse Event|1|||
147328981|NCT04580303|531370061|FG002|Overall Study|Adverse Event|0|||
147328982|NCT04580303|531370062|FG003|Overall Study|Adverse Event|0|||
147328983|NCT04580303|531370059|FG000|Overall Study|Withdrawal by Subject|0|||
147328984|NCT04580303|531370060|FG001|Overall Study|Withdrawal by Subject|0|||
147185553|NCT00731679|530845590|FG001|Overall Study|Lost to Follow-up|8|||
147185554|NCT00731679|530845589|FG000|Overall Study|Noncompliance|0|||
147185555|NCT00731679|530845590|FG001|Overall Study|Noncompliance|1|||
147185556|NCT00731679|530845589|FG000|Overall Study|Pregnancy|0|||
147185557|NCT00731679|530845590|FG001|Overall Study|Pregnancy|1|||
147185558|NCT02488005|530845593|FG000|Overall Study|Lost to Follow-up|2|||
147185559|NCT03384940|530845594|FG000|Overall Study|Progressive disease|36|||
147185560|NCT03384940|530845595|FG001|Overall Study|Progressive disease|11|||
147185561|NCT03384940|530845596|FG002|Overall Study|Progressive disease|13|||
147185562|NCT03384940|530845594|FG000|Overall Study|Clinical progression|4|||
147185563|NCT03384940|530845595|FG001|Overall Study|Clinical progression|0|||
147185564|NCT03384940|530845596|FG002|Overall Study|Clinical progression|3|||
147185565|NCT03384940|530845594|FG000|Overall Study|Adverse Event|7|||
147185566|NCT03384940|530845595|FG001|Overall Study|Adverse Event|1|||
147185567|NCT03384940|530845596|FG002|Overall Study|Adverse Event|1|||
147185568|NCT03384940|530845594|FG000|Overall Study|Withdrawal by Subject|3|||
147185569|NCT03384940|530845595|FG001|Overall Study|Withdrawal by Subject|1|||
147185570|NCT03384940|530845596|FG002|Overall Study|Withdrawal by Subject|0|||
147185571|NCT03384940|530845594|FG000|Overall Study|Physician Decision|1|||
147185572|NCT03384940|530845595|FG001|Overall Study|Physician Decision|1|||
147185573|NCT03384940|530845596|FG002|Overall Study|Physician Decision|0|||
147328985|NCT04580303|531370061|FG002|Overall Study|Withdrawal by Subject|1|||
147593881|NCT00653991|532329057|FG001|3 Month Follow-up|Participant would not respond|157|||
147185574|NCT03384940|530845594|FG000|Overall Study|Death|2|||
147328986|NCT04580303|531370062|FG003|Overall Study|Withdrawal by Subject|0|||
147328987|NCT01456936|531370069|FG000|Overall Study|Other reason|41|||
147328988|NCT01456936|531370070|FG001|Overall Study|Other reason|30|||
147328989|NCT01456936|531370071|FG002|Overall Study|Other reason|36|||
147328990|NCT01456936|531370072|FG003|Overall Study|Other reason|33|||
147328991|NCT01456936|531370069|FG000|Overall Study|No longer meets eligibility criteria|4|||
147328992|NCT01456936|531370070|FG001|Overall Study|No longer meets eligibility criteria|8|||
147328993|NCT01456936|531370071|FG002|Overall Study|No longer meets eligibility criteria|6|||
147328994|NCT01456936|531370072|FG003|Overall Study|No longer meets eligibility criteria|5|||
147328995|NCT01456936|531370069|FG000|Overall Study|Protocol Violation|4|||
147328996|NCT01456936|531370070|FG001|Overall Study|Protocol Violation|2|||
147328997|NCT01456936|531370071|FG002|Overall Study|Protocol Violation|5|||
147328998|NCT01456936|531370072|FG003|Overall Study|Protocol Violation|5|||
147328999|NCT01456936|531370069|FG000|Overall Study|Pregnancy|1|||
147329000|NCT01456936|531370070|FG001|Overall Study|Pregnancy|0|||
147329001|NCT01456936|531370071|FG002|Overall Study|Pregnancy|0|||
147329002|NCT01456936|531370072|FG003|Overall Study|Pregnancy|1|||
147329003|NCT01456936|531370069|FG000|Overall Study|Insufficient clinical response|4|||
147329004|NCT01456936|531370070|FG001|Overall Study|Insufficient clinical response|4|||
147329005|NCT01456936|531370071|FG002|Overall Study|Insufficient clinical response|14|||
147329006|NCT01456936|531370072|FG003|Overall Study|Insufficient clinical response|13|||
147329007|NCT01456936|531370069|FG000|Overall Study|No longer willing to participate|195|||
147329008|NCT01456936|531370070|FG001|Overall Study|No longer willing to participate|218|||
147329009|NCT01456936|531370071|FG002|Overall Study|No longer willing to participate|224|||
147329010|NCT01456936|531370072|FG003|Overall Study|No longer willing to participate|248|||
147329011|NCT01456936|531370069|FG000|Overall Study|Lost to Follow-up|135|||
147329012|NCT01456936|531370070|FG001|Overall Study|Lost to Follow-up|126|||
147329013|NCT01456936|531370071|FG002|Overall Study|Lost to Follow-up|144|||
147329014|NCT01456936|531370072|FG003|Overall Study|Lost to Follow-up|127|||
147329015|NCT01456936|531370069|FG000|Overall Study|Medication error|0|||
147329016|NCT01456936|531370070|FG001|Overall Study|Medication error|1|||
147329017|NCT01456936|531370071|FG002|Overall Study|Medication error|0|||
147329018|NCT01456936|531370072|FG003|Overall Study|Medication error|1|||
147329019|NCT01456936|531370069|FG000|Overall Study|Adverse event (study drug)|25|||
147329020|NCT01456936|531370070|FG001|Overall Study|Adverse event (study drug)|21|||
147329021|NCT01456936|531370071|FG002|Overall Study|Adverse event (study drug)|26|||
147329022|NCT01456936|531370072|FG003|Overall Study|Adverse event (study drug)|17|||
147329023|NCT01456936|531370069|FG000|Overall Study|Adverse event (study drug unrelated)|9|||
147593882|NCT00653991|532329056|FG000|6 Month Follow-up|Participant would not respond|133|||
147185575|NCT03384940|530845595|FG001|Overall Study|Death|1|||
147185576|NCT03384940|530845596|FG002|Overall Study|Death|0|||
147185577|NCT03384940|530845594|FG000|Overall Study|Other|0|||
147185578|NCT03384940|530845595|FG001|Overall Study|Other|0|||
147185579|NCT03384940|530845596|FG002|Overall Study|Other|1|||
147185580|NCT03089580|530845602|FG000|Overall Study|Lost to Follow-up|2|||
147185581|NCT03087513|530845603|FG000|Second Intervention After 3 hr Washout|Equipment malfunction|2|||
147329024|NCT01456936|531370070|FG001|Overall Study|Adverse event (study drug unrelated)|7|||
147329025|NCT01456936|531370071|FG002|Overall Study|Adverse event (study drug unrelated)|9|||
147329026|NCT01456936|531370072|FG003|Overall Study|Adverse event (study drug unrelated)|9|||
147329027|NCT01456936|531370069|FG000|Overall Study|Death|0|||
147329028|NCT01456936|531370070|FG001|Overall Study|Death|3|||
147329029|NCT01456936|531370071|FG002|Overall Study|Death|1|||
147329030|NCT01456936|531370072|FG003|Overall Study|Death|3|||
147658533|NCT02659943|532572303|FG005|Overall Study|Ineligible|0|||
147658534|NCT02659943|532572304|FG006|Overall Study|Ineligible|1|||
147658535|NCT02659943|532572298|FG000|Overall Study|No longer meets eligibility|0|||
147185582|NCT04628780|530845604|FG000|Overall Study|Death|0|||
147185583|NCT04628780|530845605|FG001|Overall Study|Death|1|||
147185584|NCT04628780|530845606|FG002|Overall Study|Death|0|||
147185585|NCT04628780|530845607|FG003|Overall Study|Death|0|||
147185586|NCT04628780|530845608|FG004|Overall Study|Death|1|||
147185587|NCT04628780|530845609|FG005|Overall Study|Death|0|||
147185588|NCT04628780|530845604|FG000|Overall Study|Physician Decision|2|||
147185589|NCT04628780|530845605|FG001|Overall Study|Physician Decision|0|||
147185590|NCT04628780|530845606|FG002|Overall Study|Physician Decision|0|||
147185591|NCT04628780|530845607|FG003|Overall Study|Physician Decision|0|||
147185592|NCT04628780|530845608|FG004|Overall Study|Physician Decision|2|||
147185593|NCT04628780|530845609|FG005|Overall Study|Physician Decision|0|||
147185594|NCT04628780|530845604|FG000|Overall Study|Progressive disease|2|||
147185595|NCT04628780|530845605|FG001|Overall Study|Progressive disease|2|||
147185596|NCT04628780|530845606|FG002|Overall Study|Progressive disease|2|||
147185597|NCT04628780|530845607|FG003|Overall Study|Progressive disease|3|||
147185598|NCT04628780|530845608|FG004|Overall Study|Progressive disease|9|||
147185599|NCT04628780|530845609|FG005|Overall Study|Progressive disease|4|||
147185600|NCT04628780|530845604|FG000|Overall Study|Withdrawal by Subject|0|||
147185601|NCT04628780|530845605|FG001|Overall Study|Withdrawal by Subject|1|||
147185602|NCT04628780|530845606|FG002|Overall Study|Withdrawal by Subject|2|||
147185603|NCT04628780|530845607|FG003|Overall Study|Withdrawal by Subject|0|||
147185604|NCT04628780|530845608|FG004|Overall Study|Withdrawal by Subject|3|||
147185605|NCT04628780|530845609|FG005|Overall Study|Withdrawal by Subject|1|||
147185606|NCT04628780|530845604|FG000|Overall Study|Global deterioration of health status|0|||
147185607|NCT04628780|530845605|FG001|Overall Study|Global deterioration of health status|0|||
147185608|NCT04628780|530845606|FG002|Overall Study|Global deterioration of health status|0|||
147185609|NCT04628780|530845607|FG003|Overall Study|Global deterioration of health status|0|||
147185610|NCT04628780|530845608|FG004|Overall Study|Global deterioration of health status|1|||
147185611|NCT04628780|530845609|FG005|Overall Study|Global deterioration of health status|1|||
147185612|NCT01987102|530845611|FG000|2 Courses of HDMTX With SOC Rescue|Adverse Event|2|||
147185613|NCT01987102|530845612|FG001|2 Courses of HDMTX With SOC Rescue|Adverse Event|2|||
147185614|NCT01987102|530845611|FG000|2 Courses of HDMTX With SOC Rescue|Laboratory abnormality|1|||
147185615|NCT01987102|530845612|FG001|2 Courses of HDMTX With SOC Rescue|Laboratory abnormality|2|||
147185616|NCT01987102|530845611|FG000|2 Courses of HDMTX With SOC Rescue|Change in planned chemotherapy|1|||
147185617|NCT01987102|530845612|FG001|2 Courses of HDMTX With SOC Rescue|Change in planned chemotherapy|0|||
147185618|NCT01987102|530845611|FG000|2 Courses of HDMTX With SOC Rescue|Protocol Violation|0|||
147185619|NCT01987102|530845612|FG001|2 Courses of HDMTX With SOC Rescue|Protocol Violation|1|||
147185620|NCT01987102|530845611|FG000|2 Courses of HDMTX With SOC Rescue|Incorrectly included|0|||
147185621|NCT01987102|530845612|FG001|2 Courses of HDMTX With SOC Rescue|Incorrectly included|1|||
147185622|NCT01987102|530845611|FG000|2 Courses of HDMTX With MOD Rescue|Adverse Event|0|||
147185623|NCT01987102|530845612|FG001|2 Courses of HDMTX With MOD Rescue|Adverse Event|1|||
147185624|NCT01288989|530845613|FG000|Overall Study|Death|0|||
147185625|NCT01288989|530845614|FG001|Overall Study|Death|0|||
147185626|NCT01288989|530845615|FG002|Overall Study|Death|0|||
147185627|NCT01288989|530845616|FG003|Overall Study|Death|1|||
147185628|NCT01288989|530845617|FG004|Overall Study|Death|0|||
147185629|NCT01288989|530845613|FG000|Overall Study|Dose limiting toxicity|1|||
147185630|NCT01288989|530845614|FG001|Overall Study|Dose limiting toxicity|0|||
147185631|NCT01288989|530845615|FG002|Overall Study|Dose limiting toxicity|0|||
147185632|NCT01288989|530845616|FG003|Overall Study|Dose limiting toxicity|0|||
147185633|NCT01288989|530845617|FG004|Overall Study|Dose limiting toxicity|0|||
147185634|NCT01288989|530845613|FG000|Overall Study|Adverse Event|0|||
147185635|NCT01288989|530845614|FG001|Overall Study|Adverse Event|0|||
147658536|NCT02659943|532572299|FG001|Overall Study|No longer meets eligibility|0|||
147658537|NCT02659943|532572300|FG002|Overall Study|No longer meets eligibility|0|||
147658538|NCT02659943|532572301|FG003|Overall Study|No longer meets eligibility|0|||
147658539|NCT02659943|532572302|FG004|Overall Study|No longer meets eligibility|0|||
147185636|NCT01288989|530845615|FG002|Overall Study|Adverse Event|0|||
147185637|NCT01288989|530845616|FG003|Overall Study|Adverse Event|0|||
147185638|NCT01288989|530845617|FG004|Overall Study|Adverse Event|2|||
147185639|NCT01288989|530845613|FG000|Overall Study|Physician Decision|0|||
147185640|NCT01288989|530845614|FG001|Overall Study|Physician Decision|0|||
147185641|NCT01288989|530845615|FG002|Overall Study|Physician Decision|0|||
147185642|NCT01288989|530845616|FG003|Overall Study|Physician Decision|0|||
147185643|NCT01288989|530845617|FG004|Overall Study|Physician Decision|1|||
147185644|NCT01288989|530845613|FG000|Overall Study|Withdrawal by Subject|0|||
147185645|NCT01288989|530845614|FG001|Overall Study|Withdrawal by Subject|0|||
147448640|NCT03605680|531807924|FG003|SB Placebo Run-in Period (1 Week)|Non-compliance With Study Drug|0|||
147658540|NCT02659943|532572303|FG005|Overall Study|No longer meets eligibility|0|||
147658541|NCT02659943|532572304|FG006|Overall Study|No longer meets eligibility|1|||
147185646|NCT01288989|530845615|FG002|Overall Study|Withdrawal by Subject|0|||
147185647|NCT01288989|530845616|FG003|Overall Study|Withdrawal by Subject|0|||
147329031|NCT01456936|531370069|FG000|Overall Study|Randomized but not treated|21|||
147329032|NCT01456936|531370070|FG001|Overall Study|Randomized but not treated|28|||
147329033|NCT01456936|531370071|FG002|Overall Study|Randomized but not treated|16|||
147329034|NCT01456936|531370072|FG003|Overall Study|Randomized but not treated|21|||
147329035|NCT02317705|531370073|FG000|Overall Study|Withdrawal by Subject|3|||
147329036|NCT02317705|531370073|FG000|Overall Study|Physician Decision|1|||
147329037|NCT02317705|531370073|FG000|Overall Study|Drug not usable|1|||
147329038|NCT03095508|531370074|FG000|Overall Study|Adverse Event|0|||
147329039|NCT03095508|531370075|FG001|Overall Study|Adverse Event|1|||
147329040|NCT01674569|531370076|FG000|Overall Study|Adverse Event|0|||
147448641|NCT03605680|531807921|FG000|SB Placebo Run-in Period (1 Week)|Protocol Deviation|13|||
147329041|NCT01674569|531370077|FG001|Overall Study|Adverse Event|2|||
147329042|NCT01674569|531370078|FG002|Overall Study|Adverse Event|0|||
147329043|NCT01674569|531370079|FG003|Overall Study|Adverse Event|1|||
147329044|NCT01674569|531370080|FG004|Overall Study|Adverse Event|2|||
147329045|NCT01674569|531370081|FG005|Overall Study|Adverse Event|2|||
147329046|NCT01674569|531370076|FG000|Overall Study|Protocol Violation|0|||
147329047|NCT01674569|531370077|FG001|Overall Study|Protocol Violation|1|||
147329048|NCT01674569|531370078|FG002|Overall Study|Protocol Violation|1|||
147448642|NCT03605680|531807922|FG001|SB Placebo Run-in Period (1 Week)|Protocol Deviation|0|||
147448643|NCT03605680|531807923|FG002|SB Placebo Run-in Period (1 Week)|Protocol Deviation|0|||
147448644|NCT03605680|531807924|FG003|SB Placebo Run-in Period (1 Week)|Protocol Deviation|0|||
147448645|NCT03605680|531807921|FG000|SB Placebo Run-in Period (1 Week)|Withdrawal by Subject|12|||
147448646|NCT03605680|531807922|FG001|SB Placebo Run-in Period (1 Week)|Withdrawal by Subject|0|||
147329049|NCT01674569|531370079|FG003|Overall Study|Protocol Violation|0|||
147329050|NCT01674569|531370080|FG004|Overall Study|Protocol Violation|0|||
147329051|NCT01674569|531370081|FG005|Overall Study|Protocol Violation|0|||
147329052|NCT01674569|531370076|FG000|Overall Study|Withdrawal by Subject|0|||
147329053|NCT01674569|531370077|FG001|Overall Study|Withdrawal by Subject|0|||
147329054|NCT01674569|531370078|FG002|Overall Study|Withdrawal by Subject|1|||
147329055|NCT01674569|531370079|FG003|Overall Study|Withdrawal by Subject|0|||
147329056|NCT01674569|531370080|FG004|Overall Study|Withdrawal by Subject|0|||
147329057|NCT01674569|531370081|FG005|Overall Study|Withdrawal by Subject|0|||
147329058|NCT01599325|531370082|FG000|Primary Parent Phase|Adverse Event|5|||
147329059|NCT01599325|531370082|FG000|Primary Parent Phase|Disease Progression|7|||
147329060|NCT01599325|531370082|FG000|Primary Parent Phase|Withdrawal by Subject|20|||
147329061|NCT01599325|531370082|FG000|Primary Parent Phase|Death|13|||
147329062|NCT01599325|531370082|FG000|Primary Parent Phase|Protocol Violation|1|||
147329063|NCT01599325|531370082|FG000|Primary Parent Phase|Lack of Therapeutic Effect|9|||
147329064|NCT01599325|531370082|FG000|Primary Parent Phase|Other|2|||
147329065|NCT01599325|531370082|FG000|Extension Phase|Study Closure|1|||
147448647|NCT03605680|531807923|FG002|SB Placebo Run-in Period (1 Week)|Withdrawal by Subject|0|||
147448648|NCT03605680|531807924|FG003|SB Placebo Run-in Period (1 Week)|Withdrawal by Subject|0|||
147329066|NCT01599325|531370082|FG000|Extension Phase|Stopped to Receive Stem Cell Transplant|1|||
147329067|NCT01599325|531370082|FG000|Extension Phase|Lack of Therapeutic Effect|4|||
147329068|NCT01599325|531370082|FG000|Extension Phase|Disease Progression|1|||
147329069|NCT01599325|531370082|FG000|Extension Phase|Withdrawal by Subject|8|||
147329070|NCT01878890|531370085|FG000|Overall Study|Protocol Violation|0|||
147329071|NCT01878890|531370086|FG001|Overall Study|Protocol Violation|1|||
147448649|NCT03605680|531807921|FG000|SB Placebo Run-in Period (1 Week)|Site Terminated by Sponsor|1|||
147593883|NCT00653991|532329057|FG001|6 Month Follow-up|Participant would not respond|141|||
147593884|NCT02181296|532329058|FG000|Overall Study|Lost to Follow-up|7|||
147593885|NCT02181296|532329059|FG001|Overall Study|Lost to Follow-up|6|||
147593886|NCT02939014|532329060|FG000|Overall Study|Lost to Follow-up|1|||
147593887|NCT02939014|532329061|FG001|Overall Study|Lost to Follow-up|0|||
147593888|NCT02939014|532329060|FG000|Overall Study|Death|4|||
147593889|NCT02939014|532329061|FG001|Overall Study|Death|3|||
147593890|NCT02340221|532329066|FG000|Overall Study|Death|100|||
147593891|NCT02340221|532329067|FG001|Overall Study|Death|197|||
147593892|NCT02340221|532329066|FG000|Overall Study|Withdrawal by Participant|24|||
147593893|NCT02340221|532329067|FG001|Overall Study|Withdrawal by Participant|37|||
147593894|NCT02340221|532329066|FG000|Overall Study|Lost to Follow-up|4|||
147593895|NCT02340221|532329067|FG001|Overall Study|Lost to Follow-up|15|||
147593896|NCT02340221|532329066|FG000|Overall Study|Reason Not Specified|85|||
147593897|NCT02340221|532329067|FG001|Overall Study|Reason Not Specified|165|||
147593898|NCT02340221|532329066|FG000|Overall Study|Study Terminated by Sponsor|1|||
147593899|NCT02340221|532329067|FG001|Overall Study|Study Terminated by Sponsor|3|||
147593900|NCT00518622|532329068|FG000|Overall Study|Lost to Follow-up|0|||
147593901|NCT00518622|532329069|FG001|Overall Study|Lost to Follow-up|0|||
147593902|NCT00518622|532329070|FG002|Overall Study|Lost to Follow-up|1|||
147593903|NCT00518622|532329071|FG003|Overall Study|Lost to Follow-up|0|||
147593904|NCT00518622|532329072|FG004|Overall Study|Lost to Follow-up|0|||
147593905|NCT00518622|532329073|FG005|Overall Study|Lost to Follow-up|0|||
147658542|NCT02659943|532572298|FG000|Overall Study|No treatment, per protocol|0|||
147593906|NCT00518622|532329074|FG006|Overall Study|Lost to Follow-up|0|||
147593907|NCT00518622|532329075|FG007|Overall Study|Lost to Follow-up|0|||
147658543|NCT02659943|532572299|FG001|Overall Study|No treatment, per protocol|0|||
147658544|NCT02659943|532572300|FG002|Overall Study|No treatment, per protocol|0|||
147658545|NCT02659943|532572301|FG003|Overall Study|No treatment, per protocol|0|||
147658546|NCT02659943|532572302|FG004|Overall Study|No treatment, per protocol|0|||
147658547|NCT02659943|532572303|FG005|Overall Study|No treatment, per protocol|0|||
147658548|NCT02659943|532572304|FG006|Overall Study|No treatment, per protocol|3|||
147658549|NCT01723072|532572307|FG000|Overall Study|Withdrawal by Subject|7|||
147658550|NCT01723072|532572308|FG001|Overall Study|Withdrawal by Subject|13|||
147658551|NCT01723072|532572307|FG000|Overall Study|Discon for rescue medication after wk 24|0|||
147658552|NCT01723072|532572308|FG001|Overall Study|Discon for rescue medication after wk 24|5|||
147658553|NCT01723072|532572307|FG000|Overall Study|Other|4|||
147658554|NCT01723072|532572308|FG001|Overall Study|Other|3|||
147658555|NCT01841970|532572309|FG000|Overall Study|Withdrawal by Subject|1|||
147658556|NCT01841970|532572309|FG000|Overall Study|Physician Decision|2|||
147658557|NCT01841970|532572309|FG000|Overall Study|Lost to Follow-up|8|||
147658558|NCT03478371|532572310|FG000|Overall Study|non-compliance|1|||
147658559|NCT03478371|532572310|FG000|Overall Study|Lost to Follow-up|4|||
147658560|NCT03428100|532572311|FG000|Double-Blind Treatment Week 0 to Week 52|Adverse Event|1|||
147658561|NCT03428100|532572312|FG001|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
147658562|NCT03428100|532572313|FG002|Double-Blind Treatment Week 0 to Week 52|Adverse Event|3|||
147658563|NCT03428100|532572314|FG003|Double-Blind Treatment Week 0 to Week 52|Adverse Event|1|||
147658564|NCT03428100|532572315|FG004|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
147658565|NCT03428100|532572316|FG005|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
147658566|NCT03428100|532572317|FG006|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
147658567|NCT03428100|532572318|FG007|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
147658568|NCT03428100|532572319|FG008|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
147658569|NCT03428100|532572320|FG009|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
147658570|NCT03428100|532572321|FG010|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
147658571|NCT03428100|532572322|FG011|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
147658572|NCT03428100|532572323|FG012|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
147658573|NCT03428100|532572324|FG013|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
147658574|NCT03428100|532572325|FG014|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
147658575|NCT03428100|532572326|FG015|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
147329072|NCT01878890|531370087|FG002|Overall Study|Protocol Violation|0|||
147329073|NCT01878890|531370088|FG003|Overall Study|Protocol Violation|0|||
147329074|NCT00567164|531370096|FG000|Overall Study|Withdrawal by Subject|171|||
147329075|NCT00567164|531370097|FG001|Overall Study|Withdrawal by Subject|21|||
147329076|NCT00567164|531370098|FG002|Overall Study|Withdrawal by Subject|17|||
147329077|NCT00567164|531370096|FG000|Overall Study|Protocol Violation|23|||
147329078|NCT00567164|531370097|FG001|Overall Study|Protocol Violation|4|||
147329079|NCT00567164|531370098|FG002|Overall Study|Protocol Violation|2|||
147329080|NCT00567164|531370096|FG000|Overall Study|Adverse Event|92|||
147329081|NCT00567164|531370097|FG001|Overall Study|Adverse Event|13|||
147593908|NCT00518622|532329068|FG000|Overall Study|Study medication taken incorrectly|0|||
147593909|NCT00518622|532329069|FG001|Overall Study|Study medication taken incorrectly|1|||
147593910|NCT00518622|532329070|FG002|Overall Study|Study medication taken incorrectly|0|||
147593911|NCT00518622|532329071|FG003|Overall Study|Study medication taken incorrectly|0|||
147593912|NCT00518622|532329072|FG004|Overall Study|Study medication taken incorrectly|0|||
147593913|NCT00518622|532329073|FG005|Overall Study|Study medication taken incorrectly|0|||
147593914|NCT00518622|532329074|FG006|Overall Study|Study medication taken incorrectly|0|||
147593915|NCT00518622|532329075|FG007|Overall Study|Study medication taken incorrectly|0|||
147593916|NCT03487848|532329076|FG000|Overall Study|Lost to Follow-up|1|||
147593917|NCT00515541|532330524|FG000|Overall Study|Physician Decision|0|||
147593918|NCT00515541|532330525|FG001|Overall Study|Physician Decision|2|||
147593919|NCT00515541|532330526|FG002|Overall Study|Physician Decision|0|||
147593920|NCT00515541|532330527|FG003|Overall Study|Physician Decision|1|||
147593921|NCT00515541|532330524|FG000|Overall Study|No show for appointments|0|||
147593922|NCT00515541|532330525|FG001|Overall Study|No show for appointments|1|||
147593923|NCT00515541|532330526|FG002|Overall Study|No show for appointments|0|||
147593924|NCT00515541|532330527|FG003|Overall Study|No show for appointments|2|||
147593925|NCT00515541|532330524|FG000|Overall Study|Withdrawal by Subject|0|||
147593926|NCT00515541|532330525|FG001|Overall Study|Withdrawal by Subject|2|||
147658576|NCT03428100|532572327|FG016|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
147658577|NCT03428100|532572328|FG017|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
147658578|NCT03428100|532572329|FG018|Double-Blind Treatment Week 0 to Week 52|Adverse Event|0|||
147329082|NCT00567164|531370098|FG002|Overall Study|Adverse Event|9|||
147329083|NCT00567164|531370096|FG000|Overall Study|Death|0|||
147329084|NCT00567164|531370097|FG001|Overall Study|Death|0|||
147329085|NCT00567164|531370098|FG002|Overall Study|Death|1|||
147593927|NCT00515541|532330526|FG002|Overall Study|Withdrawal by Subject|0|||
147658579|NCT03428100|532572311|FG000|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|16|||
147658580|NCT03428100|532572312|FG001|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|10|||
147329086|NCT00567164|531370096|FG000|Overall Study|Lost to Follow-up|202|||
147593928|NCT00515541|532330527|FG003|Overall Study|Withdrawal by Subject|2|||
147593929|NCT04268316|532330528|FG000|Overall Study|Withdrawal by Subject|2|||
147593930|NCT04268316|532330529|FG001|Overall Study|Withdrawal by Subject|1|||
147593931|NCT04268316|532330530|FG002|Overall Study|Withdrawal by Subject|0|||
147593932|NCT02132637|532330532|FG000|Study Period 1|Withdrawal by Subject|0|||
147593933|NCT02132637|532330533|FG001|Study Period 1|Withdrawal by Subject|4|||
147593934|NCT02132637|532330532|FG000|Study Period 1|Physician Decision|1|||
147593935|NCT02132637|532330533|FG001|Study Period 1|Physician Decision|0|||
147593936|NCT02132637|532330532|FG000|Study Period 2 (Crossover)|Adverse Event|0|||
147593937|NCT02132637|532330533|FG001|Study Period 2 (Crossover)|Adverse Event|1|||
147593938|NCT02132637|532330532|FG000|Study Period 2 (Crossover)|Physician Decision|2|||
147593939|NCT02132637|532330533|FG001|Study Period 2 (Crossover)|Physician Decision|0|||
147593940|NCT03197558|532330536|FG000|Overall Study|Tubes not placed|1|||
147593941|NCT00931268|532330547|FG000|Overall Study|Lost to Follow-up|6|||
147593942|NCT03052322|532330549|FG000|Overall Study|Other un-specified|1|||
147593943|NCT03052322|532330550|FG001|Overall Study|Other un-specified|2|||
147593944|NCT03052322|532330549|FG000|Overall Study|Withdrawal by Subject|10|||
147593945|NCT03052322|532330550|FG001|Overall Study|Withdrawal by Subject|9|||
147593946|NCT03052322|532330549|FG000|Overall Study|Death|0|||
147593947|NCT03052322|532330550|FG001|Overall Study|Death|2|||
147593948|NCT03052322|532330549|FG000|Overall Study|Lack of Efficacy|1|||
147593949|NCT03052322|532330550|FG001|Overall Study|Lack of Efficacy|2|||
147593950|NCT03052322|532330549|FG000|Overall Study|Protocol Violation|1|||
147593951|NCT03052322|532330550|FG001|Overall Study|Protocol Violation|0|||
147593952|NCT03052322|532330549|FG000|Overall Study|Lost to Follow-up|2|||
147593953|NCT03052322|532330550|FG001|Overall Study|Lost to Follow-up|4|||
147593954|NCT03052322|532330549|FG000|Overall Study|Adverse Event|6|||
147593955|NCT03052322|532330550|FG001|Overall Study|Adverse Event|13|||
147593956|NCT04920916|532330551|FG000|Phase IIa 60 Day Study|Death|2|||
147593957|NCT04920916|532330552|FG001|Phase IIa 60 Day Study|Death|5|||
147593958|NCT04920916|532330551|FG000|1 Year Follow up (Phone Call)|Death|1|||
147593959|NCT04920916|532330552|FG001|1 Year Follow up (Phone Call)|Death|3|||
147593960|NCT04920916|532330551|FG000|1 Year Follow up Visits|Lost to Follow-up|6|||
147593961|NCT04920916|532330552|FG001|1 Year Follow up Visits|Lost to Follow-up|7|||
147593962|NCT00973765|532330553|FG000|Overall Study|Lost to Follow-up|8|||
147593963|NCT00973765|532330554|FG001|Overall Study|Lost to Follow-up|14|||
147593964|NCT01892657|532330555|FG000|Overall Study|Withdrawal by Subject|6|||
147593965|NCT01892657|532330555|FG000|Overall Study|Protocol Violation|12|||
147593966|NCT00076804|532330556|FG000|Overall Study|Death|9|||
147593967|NCT00076804|532330557|FG001|Overall Study|Death|20|||
147593968|NCT00076804|532330556|FG000|Overall Study|Lost to Follow-up|9|||
147593969|NCT00076804|532330557|FG001|Overall Study|Lost to Follow-up|9|||
147593970|NCT00076804|532330556|FG000|Overall Study|Withdrawal by Subject|10|||
147593971|NCT00076804|532330557|FG001|Overall Study|Withdrawal by Subject|8|||
147593972|NCT00076804|532330556|FG000|Overall Study|Early study Closure|32|||
147593973|NCT00076804|532330557|FG001|Overall Study|Early study Closure|32|||
147593974|NCT00354341|532330558|FG000|Overall Study|Adverse Event|1|||
147247193|NCT00753415|531072824|FG007|Part A|Withdrawal by Subject|0|||
147247194|NCT00753415|531072825|FG008|Part A|Withdrawal by Subject|0|||
147247195|NCT00753415|531072826|FG009|Part A|Withdrawal by Subject|0|||
147247196|NCT00753415|531072817|FG000|Part B|Lost to Follow-up|0|||
147247197|NCT00753415|531072818|FG001|Part B|Lost to Follow-up|0|||
147247198|NCT00753415|531072819|FG002|Part B|Lost to Follow-up|0|||
147247199|NCT00753415|531072820|FG003|Part B|Lost to Follow-up|0|||
147247200|NCT00753415|531072821|FG004|Part B|Lost to Follow-up|0|||
147247201|NCT00753415|531072822|FG005|Part B|Lost to Follow-up|0|||
147247202|NCT00753415|531072823|FG006|Part B|Lost to Follow-up|0|||
147247203|NCT00753415|531072824|FG007|Part B|Lost to Follow-up|1|||
147247204|NCT00753415|531072825|FG008|Part B|Lost to Follow-up|1|||
147247205|NCT00753415|531072826|FG009|Part B|Lost to Follow-up|0|||
147247206|NCT00753415|531072817|FG000|Part B|Disease progression|0|||
147247207|NCT00753415|531072818|FG001|Part B|Disease progression|0|||
147247208|NCT00753415|531072819|FG002|Part B|Disease progression|0|||
147247209|NCT00753415|531072820|FG003|Part B|Disease progression|0|||
147247210|NCT00753415|531072821|FG004|Part B|Disease progression|0|||
147247211|NCT00753415|531072822|FG005|Part B|Disease progression|0|||
147247212|NCT00753415|531072823|FG006|Part B|Disease progression|0|||
147247213|NCT00753415|531072824|FG007|Part B|Disease progression|0|||
147247214|NCT00753415|531072825|FG008|Part B|Disease progression|2|||
147247215|NCT00753415|531072826|FG009|Part B|Disease progression|1|||
147247216|NCT04212650|531072827|FG000|Overall Study|Withdrawal by Subject|1|||
147247217|NCT04212650|531072828|FG001|Overall Study|Withdrawal by Subject|0|||
147247218|NCT01753856|531072830|FG000|Overall Study|Adverse Event|1|||
147247219|NCT01753856|531072831|FG001|Overall Study|Adverse Event|0|||
147247220|NCT01753856|531072830|FG000|Overall Study|Withdrawal by Subject|0|||
147247221|NCT01753856|531072831|FG001|Overall Study|Withdrawal by Subject|2|||
147247222|NCT01753856|531072830|FG000|Overall Study|Sponsor Decision|2|||
147247223|NCT01753856|531072831|FG001|Overall Study|Sponsor Decision|0|||
147247224|NCT00911820|531074427|FG000|Overall Study|RECIST progression|12|||
147185648|NCT01288989|530845617|FG004|Overall Study|Withdrawal by Subject|3|||
147185649|NCT01236521|530845618|FG000|Overall Study|Withdrawal by Subject|12|||
147185650|NCT01236521|530845619|FG001|Overall Study|Withdrawal by Subject|17|||
147185651|NCT01236521|530845618|FG000|Overall Study|Death|2|||
147185652|NCT01236521|530845619|FG001|Overall Study|Death|1|||
147185653|NCT01236521|530845618|FG000|Overall Study|Lost to Follow-up|9|||
147185654|NCT01236521|530845619|FG001|Overall Study|Lost to Follow-up|7|||
147185655|NCT00165672|530845622|FG000|Overall Study|Adverse Event|0|||
147185656|NCT00165672|530845623|FG001|Overall Study|Adverse Event|1|||
147185657|NCT05864586|530845625|FG000|Overall Study|Ineligible|4|||
147185658|NCT05864586|530845626|FG001|Overall Study|Ineligible|12|||
147185659|NCT05864586|530845625|FG000|Overall Study|Pregnancy|0|||
147185660|NCT05864586|530845626|FG001|Overall Study|Pregnancy|1|||
147185661|NCT05864586|530845625|FG000|Overall Study|Withdrawal by Subject|0|||
147185662|NCT05864586|530845626|FG001|Overall Study|Withdrawal by Subject|1|||
147185663|NCT03635424|530845627|FG000|Overall Study|Adverse Event|1|||
147185664|NCT03635424|530845627|FG000|Overall Study|Death|1|||
147185665|NCT03635424|530845627|FG000|Overall Study|Device not implanted|1|||
147185666|NCT05081219|530845628|FG000|Overall Study|Withdrawal by Subject|4|||
147185667|NCT05081219|530845629|FG001|Overall Study|Withdrawal by Subject|0|||
147185668|NCT05081219|530845630|FG002|Overall Study|Withdrawal by Subject|0|||
147185669|NCT05081219|530845631|FG003|Overall Study|Withdrawal by Subject|1|||
147185670|NCT02452424|530845635|FG000|Overall Study|Death|2|||
147185671|NCT02452424|530845636|FG001|Overall Study|Death|2|||
147185672|NCT02452424|530845637|FG002|Overall Study|Death|2|||
147185673|NCT02452424|530845638|FG003|Overall Study|Death|6|||
147185674|NCT02452424|530845639|FG004|Overall Study|Death|2|||
147185675|NCT02452424|530845640|FG005|Overall Study|Death|0|||
147185676|NCT02452424|530845641|FG006|Overall Study|Death|5|||
147185677|NCT02452424|530845642|FG007|Overall Study|Death|1|||
147185678|NCT02452424|530845643|FG008|Overall Study|Death|3|||
147185679|NCT02452424|530845644|FG009|Overall Study|Death|1|||
147185680|NCT02452424|530845645|FG010|Overall Study|Death|0|||
147185681|NCT02452424|530845635|FG000|Overall Study|Lost to Follow-up|0|||
147185682|NCT02452424|530845636|FG001|Overall Study|Lost to Follow-up|1|||
147185683|NCT02452424|530845637|FG002|Overall Study|Lost to Follow-up|1|||
147185684|NCT02452424|530845638|FG003|Overall Study|Lost to Follow-up|0|||
147185685|NCT02452424|530845639|FG004|Overall Study|Lost to Follow-up|0|||
147185686|NCT02452424|530845640|FG005|Overall Study|Lost to Follow-up|0|||
147185687|NCT02452424|530845641|FG006|Overall Study|Lost to Follow-up|0|||
147185688|NCT02452424|530845642|FG007|Overall Study|Lost to Follow-up|0|||
147329087|NCT00567164|531370097|FG001|Overall Study|Lost to Follow-up|23|||
147329088|NCT00567164|531370098|FG002|Overall Study|Lost to Follow-up|21|||
147329089|NCT00567164|531370096|FG000|Overall Study|Pregnancy|20|||
147329090|NCT00567164|531370097|FG001|Overall Study|Pregnancy|4|||
147329091|NCT00567164|531370098|FG002|Overall Study|Pregnancy|6|||
147329092|NCT00567164|531370096|FG000|Overall Study|Primary Reason coded as 'Other'|37|||
147329093|NCT00567164|531370097|FG001|Overall Study|Primary Reason coded as 'Other'|8|||
147329094|NCT00567164|531370098|FG002|Overall Study|Primary Reason coded as 'Other'|16|||
147329095|NCT00567164|531370096|FG000|Overall Study|Missing|1|||
147329096|NCT00567164|531370097|FG001|Overall Study|Missing|0|||
147329097|NCT00567164|531370098|FG002|Overall Study|Missing|0|||
147329098|NCT04044664|531370099|FG000|Stage 1|Adverse Event|3|||
147329099|NCT04044664|531370100|FG001|Stage 1|Adverse Event|3|||
147329100|NCT04044664|531370101|FG002|Stage 1|Adverse Event|1|||
147329101|NCT04044664|531370099|FG000|Stage 1|Lost to Follow-up|3|||
147329102|NCT04044664|531370100|FG001|Stage 1|Lost to Follow-up|2|||
147329103|NCT04044664|531370101|FG002|Stage 1|Lost to Follow-up|2|||
147329104|NCT04044664|531370099|FG000|Stage 1|Withdrawal by Subject|9|||
147329105|NCT04044664|531370100|FG001|Stage 1|Withdrawal by Subject|1|||
147185689|NCT02452424|530845643|FG008|Overall Study|Lost to Follow-up|0|||
147185690|NCT02452424|530845644|FG009|Overall Study|Lost to Follow-up|0|||
147185691|NCT02452424|530845645|FG010|Overall Study|Lost to Follow-up|0|||
147185692|NCT02452424|530845635|FG000|Overall Study|Withdrawal by Subject|0|||
147329106|NCT04044664|531370101|FG002|Stage 1|Withdrawal by Subject|0|||
147329107|NCT04044664|531370099|FG000|Stage 1|noncompliance, personal reason|2|||
147329108|NCT04044664|531370100|FG001|Stage 1|noncompliance, personal reason|0|||
147329109|NCT04044664|531370101|FG002|Stage 1|noncompliance, personal reason|0|||
147185693|NCT02452424|530845636|FG001|Overall Study|Withdrawal by Subject|0|||
147185694|NCT02452424|530845637|FG002|Overall Study|Withdrawal by Subject|3|||
147185695|NCT02452424|530845638|FG003|Overall Study|Withdrawal by Subject|2|||
147185696|NCT02452424|530845639|FG004|Overall Study|Withdrawal by Subject|0|||
147185697|NCT02452424|530845640|FG005|Overall Study|Withdrawal by Subject|0|||
147185698|NCT02452424|530845641|FG006|Overall Study|Withdrawal by Subject|1|||
147185699|NCT02452424|530845642|FG007|Overall Study|Withdrawal by Subject|0|||
147185700|NCT02452424|530845643|FG008|Overall Study|Withdrawal by Subject|1|||
147185701|NCT02452424|530845644|FG009|Overall Study|Withdrawal by Subject|1|||
147185702|NCT02452424|530845645|FG010|Overall Study|Withdrawal by Subject|0|||
147185703|NCT02452424|530845635|FG000|Overall Study|Other|0|||
147185704|NCT02452424|530845636|FG001|Overall Study|Other|0|||
147185705|NCT02452424|530845637|FG002|Overall Study|Other|1|||
147185706|NCT02452424|530845638|FG003|Overall Study|Other|0|||
147185707|NCT02452424|530845639|FG004|Overall Study|Other|0|||
147185708|NCT02452424|530845640|FG005|Overall Study|Other|1|||
147185709|NCT02452424|530845641|FG006|Overall Study|Other|4|||
147185710|NCT02452424|530845642|FG007|Overall Study|Other|3|||
147185711|NCT02452424|530845643|FG008|Overall Study|Other|0|||
147185712|NCT02452424|530845644|FG009|Overall Study|Other|0|||
147185713|NCT02452424|530845645|FG010|Overall Study|Other|1|||
147185714|NCT02452424|530845635|FG000|Overall Study|Progressive disease (per RECIST)|0|||
147185715|NCT02452424|530845636|FG001|Overall Study|Progressive disease (per RECIST)|0|||
147185716|NCT02452424|530845637|FG002|Overall Study|Progressive disease (per RECIST)|0|||
147185717|NCT02452424|530845638|FG003|Overall Study|Progressive disease (per RECIST)|0|||
147185718|NCT02452424|530845639|FG004|Overall Study|Progressive disease (per RECIST)|0|||
147185719|NCT02452424|530845640|FG005|Overall Study|Progressive disease (per RECIST)|0|||
147185720|NCT02452424|530845641|FG006|Overall Study|Progressive disease (per RECIST)|0|||
147185721|NCT02452424|530845642|FG007|Overall Study|Progressive disease (per RECIST)|0|||
147185722|NCT02452424|530845643|FG008|Overall Study|Progressive disease (per RECIST)|2|||
147185723|NCT02452424|530845644|FG009|Overall Study|Progressive disease (per RECIST)|0|||
147185724|NCT02452424|530845645|FG010|Overall Study|Progressive disease (per RECIST)|0|||
147185725|NCT02452424|530845635|FG000|Overall Study|Adverse Event|0|||
147185726|NCT02452424|530845636|FG001|Overall Study|Adverse Event|0|||
147185727|NCT02452424|530845637|FG002|Overall Study|Adverse Event|0|||
147185728|NCT02452424|530845638|FG003|Overall Study|Adverse Event|0|||
147185729|NCT02452424|530845639|FG004|Overall Study|Adverse Event|0|||
147185730|NCT02452424|530845640|FG005|Overall Study|Adverse Event|0|||
147185731|NCT02452424|530845641|FG006|Overall Study|Adverse Event|0|||
147185732|NCT02452424|530845642|FG007|Overall Study|Adverse Event|0|||
147185733|NCT02452424|530845643|FG008|Overall Study|Adverse Event|0|||
147185734|NCT02452424|530845644|FG009|Overall Study|Adverse Event|0|||
147185735|NCT02452424|530845645|FG010|Overall Study|Adverse Event|1|||
147185736|NCT01463306|530845646|FG000|Overall Study|Adverse Event|6|||
147185737|NCT01463306|530845647|FG001|Overall Study|Adverse Event|9|||
147185738|NCT01463306|530845648|FG002|Overall Study|Adverse Event|3|||
147185739|NCT01463306|530845646|FG000|Overall Study|Death|3|||
147185740|NCT01463306|530845647|FG001|Overall Study|Death|3|||
147185741|NCT01463306|530845648|FG002|Overall Study|Death|0|||
147185742|NCT01463306|530845646|FG000|Overall Study|Lack of Efficacy|22|||
147185743|NCT01463306|530845647|FG001|Overall Study|Lack of Efficacy|16|||
147185744|NCT01463306|530845648|FG002|Overall Study|Lack of Efficacy|1|||
147185745|NCT01463306|530845646|FG000|Overall Study|Lost to Follow-up|5|||
147185746|NCT01463306|530845647|FG001|Overall Study|Lost to Follow-up|2|||
147185747|NCT01463306|530845648|FG002|Overall Study|Lost to Follow-up|0|||
147185748|NCT01463306|530845646|FG000|Overall Study|Protocol Violation|4|||
147185749|NCT01463306|530845647|FG001|Overall Study|Protocol Violation|0|||
147185750|NCT01463306|530845648|FG002|Overall Study|Protocol Violation|0|||
147185751|NCT01463306|530845646|FG000|Overall Study|Withdrawal by Subject|19|||
147185752|NCT01463306|530845647|FG001|Overall Study|Withdrawal by Subject|9|||
147185753|NCT01463306|530845648|FG002|Overall Study|Withdrawal by Subject|1|||
147185754|NCT01463306|530845646|FG000|Overall Study|Other|26|||
147185755|NCT01463306|530845647|FG001|Overall Study|Other|13|||
147185756|NCT01463306|530845648|FG002|Overall Study|Other|0|||
147185757|NCT01463306|530845646|FG000|Overall Study|Approval expiry at site|1|||
147185758|NCT01463306|530845647|FG001|Overall Study|Approval expiry at site|0|||
147185759|NCT01463306|530845648|FG002|Overall Study|Approval expiry at site|0|||
147185760|NCT01059318|530845649|FG000|Core Study (26 Week)|Adverse Event|3|||
147185761|NCT01059318|530845649|FG000|Core Study (26 Week)|Withdrawal by Subject|1|||
147185762|NCT01059318|530845649|FG000|Extension (36 Week)|Adverse Event|3|||
147185763|NCT02719171|530847841|FG000|Overall Study|Adverse Event|1|||
147247225|NCT00911820|531074428|FG001|Overall Study|RECIST progression|8|||
147247226|NCT00911820|531074427|FG000|Overall Study|Adverse Event|8|||
147247227|NCT00911820|531074428|FG001|Overall Study|Adverse Event|8|||
147247228|NCT00911820|531074427|FG000|Overall Study|Clinical Progression|7|||
147247229|NCT00911820|531074428|FG001|Overall Study|Clinical Progression|5|||
147247230|NCT00911820|531074427|FG000|Overall Study|Physician Decision|5|||
147247231|NCT00911820|531074428|FG001|Overall Study|Physician Decision|9|||
147185764|NCT02719171|530847842|FG001|Overall Study|Adverse Event|2|||
147185765|NCT02719171|530847843|FG002|Overall Study|Adverse Event|0|||
147185766|NCT02719171|530847844|FG003|Overall Study|Adverse Event|0|||
147185767|NCT02719171|530847845|FG004|Overall Study|Adverse Event|2|||
147185768|NCT02719171|530847841|FG000|Overall Study|Lost to Follow-up|0|||
147185769|NCT02719171|530847842|FG001|Overall Study|Lost to Follow-up|0|||
147185770|NCT02719171|530847843|FG002|Overall Study|Lost to Follow-up|1|||
147185771|NCT02719171|530847844|FG003|Overall Study|Lost to Follow-up|0|||
147247232|NCT00911820|531074427|FG000|Overall Study|Decline in Performance Status|4|||
147247233|NCT00911820|531074428|FG001|Overall Study|Decline in Performance Status|2|||
147185772|NCT02719171|530847845|FG004|Overall Study|Lost to Follow-up|0|||
147247234|NCT00911820|531074427|FG000|Overall Study|Withdrawal by Subject|3|||
147185773|NCT02719171|530847841|FG000|Overall Study|Subject Withdrawal|0|||
147185774|NCT02719171|530847842|FG001|Overall Study|Subject Withdrawal|2|||
147185775|NCT02719171|530847843|FG002|Overall Study|Subject Withdrawal|2|||
147185776|NCT02719171|530847844|FG003|Overall Study|Subject Withdrawal|1|||
147185777|NCT02719171|530847845|FG004|Overall Study|Subject Withdrawal|0|||
147185778|NCT02719171|530847841|FG000|Overall Study|Other|0|||
147185779|NCT02719171|530847842|FG001|Overall Study|Other|0|||
147185780|NCT02719171|530847843|FG002|Overall Study|Other|0|||
147185781|NCT02719171|530847844|FG003|Overall Study|Other|1|||
147185782|NCT02719171|530847845|FG004|Overall Study|Other|0|||
147185783|NCT02614729|530847846|FG000|Overall Study|Withdrawal by Subject|1|||
147185784|NCT02614729|530847847|FG001|Overall Study|Withdrawal by Subject|0|||
147185785|NCT00227721|530847848|FG000|Overall Study|On study, but never treated.|1|||
147185786|NCT02539797|530847858|FG000|Overall Study|Lost to Follow-up|0|||
147185787|NCT02539797|530847859|FG001|Overall Study|Lost to Follow-up|1|||
147185788|NCT02539797|530847860|FG002|Overall Study|Lost to Follow-up|0|||
147185789|NCT01777308|530847868|FG000|Overall Study|Withdrawal by Subject|5|||
147185790|NCT01777308|530847869|FG001|Overall Study|Withdrawal by Subject|1|||
147185791|NCT01777308|530847868|FG000|Overall Study|Migrated/moved from study area|1|||
147185792|NCT01777308|530847869|FG001|Overall Study|Migrated/moved from study area|0|||
147185793|NCT01777308|530847868|FG000|Overall Study|Lost to Follow-up|7|||
147185794|NCT01777308|530847869|FG001|Overall Study|Lost to Follow-up|2|||
147185795|NCT01777308|530847868|FG000|Overall Study|Blood draw refusal at Visit 3|1|||
147185796|NCT01777308|530847869|FG001|Overall Study|Blood draw refusal at Visit 3|0|||
147185797|NCT00383786|530847872|FG000|Overall Study|Protocol Violation|2|||
147185798|NCT00383786|530847873|FG001|Overall Study|Protocol Violation|6|||
147185799|NCT00383786|530847872|FG000|Overall Study|Withdrawal by Subject|2|||
147185800|NCT00383786|530847873|FG001|Overall Study|Withdrawal by Subject|5|||
147185801|NCT00383786|530847872|FG000|Overall Study|Physician Decision|0|||
147185802|NCT00383786|530847873|FG001|Overall Study|Physician Decision|1|||
147185803|NCT00985673|530847874|FG000|Overall Study|Lost to Follow-up|6|||
147185804|NCT00985673|530847875|FG001|Overall Study|Lost to Follow-up|7|||
147185805|NCT00985673|530847876|FG002|Overall Study|Lost to Follow-up|6|||
147185806|NCT00985673|530847877|FG003|Overall Study|Lost to Follow-up|10|||
147185807|NCT00985673|530847878|FG004|Overall Study|Lost to Follow-up|5|||
147185808|NCT00985673|530847879|FG005|Overall Study|Lost to Follow-up|3|||
147185809|NCT00985673|530847874|FG000|Overall Study|Withdrawal by Subject|0|||
147185810|NCT00985673|530847875|FG001|Overall Study|Withdrawal by Subject|4|||
147185811|NCT00985673|530847876|FG002|Overall Study|Withdrawal by Subject|5|||
147185812|NCT00985673|530847877|FG003|Overall Study|Withdrawal by Subject|2|||
147185813|NCT00985673|530847878|FG004|Overall Study|Withdrawal by Subject|2|||
147185814|NCT00985673|530847879|FG005|Overall Study|Withdrawal by Subject|3|||
147185815|NCT00985673|530847874|FG000|Overall Study|Other|1|||
147185816|NCT00985673|530847875|FG001|Overall Study|Other|0|||
147185817|NCT00985673|530847876|FG002|Overall Study|Other|1|||
147185818|NCT00985673|530847877|FG003|Overall Study|Other|0|||
147185819|NCT00985673|530847878|FG004|Overall Study|Other|1|||
147185820|NCT00985673|530847879|FG005|Overall Study|Other|0|||
147185821|NCT00531284|530847882|FG000|Overall Study|Progressive Disease|1|||
147185822|NCT00531284|530847883|FG001|Overall Study|Progressive Disease|3|||
147185823|NCT00531284|530847884|FG002|Overall Study|Progressive Disease|5|||
147185824|NCT00531284|530847885|FG003|Overall Study|Progressive Disease|42|||
147185825|NCT00531284|530847886|FG004|Overall Study|Progressive Disease|4|||
147185826|NCT00531284|530847887|FG005|Overall Study|Progressive Disease|4|||
147185827|NCT00531284|530847888|FG006|Overall Study|Progressive Disease|3|||
147185828|NCT00531284|530847889|FG007|Overall Study|Progressive Disease|8|||
147185829|NCT00531284|530847890|FG008|Overall Study|Progressive Disease|6|||
147185830|NCT00531284|530847891|FG009|Overall Study|Progressive Disease|3|||
147185831|NCT00531284|530847892|FG010|Overall Study|Progressive Disease|3|||
147185832|NCT00531284|530847893|FG011|Overall Study|Progressive Disease|14|||
147185833|NCT00531284|530847894|FG012|Overall Study|Progressive Disease|2|||
147185834|NCT00531284|530847895|FG013|Overall Study|Progressive Disease|1|||
147185835|NCT00531284|530847896|FG014|Overall Study|Progressive Disease|2|||
147185836|NCT00531284|530847897|FG015|Overall Study|Progressive Disease|11|||
147185837|NCT00531284|530847898|FG016|Overall Study|Progressive Disease|5|||
147185838|NCT00531284|530847882|FG000|Overall Study|Adverse Event|0|||
147185839|NCT00531284|530847883|FG001|Overall Study|Adverse Event|1|||
147185840|NCT00531284|530847884|FG002|Overall Study|Adverse Event|1|||
147185841|NCT00531284|530847885|FG003|Overall Study|Adverse Event|7|||
147329110|NCT04044664|531370099|FG000|Stage 1|randomization error|0|||
147185842|NCT00531284|530847886|FG004|Overall Study|Adverse Event|0|||
147185843|NCT00531284|530847887|FG005|Overall Study|Adverse Event|2|||
147185844|NCT00531284|530847888|FG006|Overall Study|Adverse Event|3|||
147185845|NCT00531284|530847889|FG007|Overall Study|Adverse Event|2|||
147185846|NCT00531284|530847890|FG008|Overall Study|Adverse Event|3|||
147185847|NCT00531284|530847891|FG009|Overall Study|Adverse Event|0|||
147185848|NCT00531284|530847892|FG010|Overall Study|Adverse Event|0|||
147185849|NCT00531284|530847893|FG011|Overall Study|Adverse Event|5|||
147185850|NCT00531284|530847894|FG012|Overall Study|Adverse Event|0|||
147185851|NCT00531284|530847895|FG013|Overall Study|Adverse Event|1|||
147185852|NCT00531284|530847896|FG014|Overall Study|Adverse Event|1|||
147185853|NCT00531284|530847897|FG015|Overall Study|Adverse Event|0|||
147593975|NCT00354341|532330559|FG001|Overall Study|Adverse Event|0|||
147593976|NCT00354341|532330558|FG000|Overall Study|Death|0|||
147593977|NCT00354341|532330559|FG001|Overall Study|Death|2|||
147593978|NCT00354341|532330558|FG000|Overall Study|Refused treatment|1|||
147593979|NCT00354341|532330559|FG001|Overall Study|Refused treatment|2|||
147593980|NCT00354341|532330558|FG000|Overall Study|Failure to return|0|||
147593981|NCT00354341|532330559|FG001|Overall Study|Failure to return|1|||
147593982|NCT00354341|532330558|FG000|Overall Study|Other|1|||
147593983|NCT00354341|532330559|FG001|Overall Study|Other|2|||
147329111|NCT04044664|531370100|FG001|Stage 1|randomization error|1|||
147329112|NCT04044664|531370101|FG002|Stage 1|randomization error|0|||
147329113|NCT04044664|531370099|FG000|Stage 2|Adverse Event|2|||
147329114|NCT04044664|531370100|FG001|Stage 2|Adverse Event|0|||
147329115|NCT04044664|531370101|FG002|Stage 2|Adverse Event|0|||
147329116|NCT04044664|531370099|FG000|Stage 2|Lost to Follow-up|3|||
147329117|NCT04044664|531370100|FG001|Stage 2|Lost to Follow-up|2|||
147329118|NCT04044664|531370101|FG002|Stage 2|Lost to Follow-up|1|||
147329119|NCT04044664|531370099|FG000|Stage 2|Withdrawal by Subject|3|||
147329120|NCT04044664|531370100|FG001|Stage 2|Withdrawal by Subject|0|||
147329121|NCT04044664|531370101|FG002|Stage 2|Withdrawal by Subject|0|||
147329122|NCT04044664|531370099|FG000|Stage 2|protocol deviation|1|||
147329123|NCT04044664|531370100|FG001|Stage 2|protocol deviation|0|||
147329124|NCT04044664|531370101|FG002|Stage 2|protocol deviation|0|||
147329125|NCT01744691|531370108|FG000|Overall Study|Progressive Disease|18|||
147329126|NCT01744691|531370108|FG000|Overall Study|Unacceptable toxicity, AE or death|18|||
147329127|NCT01744691|531370108|FG000|Overall Study|Withdrawal of consent for treatment|3|||
147329128|NCT01744691|531370108|FG000|Overall Study|Physician Decision|4|||
147329129|NCT04588480|531370110|FG000|Unblinded Phase: From 6 to 12 Months|Protocol Violation|0|||
147329130|NCT04588480|531370111|FG001|Unblinded Phase: From 6 to 12 Months|Protocol Violation|1|||
147329131|NCT04588480|531370112|FG002|Unblinded Phase: From 6 to 12 Months|Protocol Violation|0|||
147329132|NCT04588480|531370110|FG000|Unblinded Phase: From 6 to 12 Months|Other|2|||
147329133|NCT04588480|531370111|FG001|Unblinded Phase: From 6 to 12 Months|Other|2|||
147329134|NCT04588480|531370112|FG002|Unblinded Phase: From 6 to 12 Months|Other|0|||
147329135|NCT00853827|531370114|FG000|Single Blind Period (1 Week)|Other|4|||
147329136|NCT00853827|531370115|FG001|Single Blind Period (1 Week)|Other|0|||
147329137|NCT00853827|531370114|FG000|Single Blind Period (1 Week)|Adverse Event|9|||
147329138|NCT00853827|531370115|FG001|Single Blind Period (1 Week)|Adverse Event|0|||
147329139|NCT00853827|531370114|FG000|Single Blind Period (1 Week)|Abnormal laboratory value|3|||
147329140|NCT00853827|531370115|FG001|Single Blind Period (1 Week)|Abnormal laboratory value|0|||
147329141|NCT00853827|531370114|FG000|Single Blind Period (1 Week)|Abnormal test procedure result|1|||
147329142|NCT00853827|531370115|FG001|Single Blind Period (1 Week)|Abnormal test procedure result|0|||
147329143|NCT00853827|531370114|FG000|Single Blind Period (1 Week)|Withdrawal by Subject|9|||
147329144|NCT00853827|531370115|FG001|Single Blind Period (1 Week)|Withdrawal by Subject|0|||
147329145|NCT00853827|531370114|FG000|Single Blind Period (1 Week)|Lost to Follow-up|1|||
147329146|NCT00853827|531370115|FG001|Single Blind Period (1 Week)|Lost to Follow-up|0|||
147329147|NCT00853827|531370114|FG000|Single Blind Period (1 Week)|Protocol Violation|12|||
147329148|NCT00853827|531370115|FG001|Single Blind Period (1 Week)|Protocol Violation|0|||
147329149|NCT00853827|531370114|FG000|Double Blind Period (103 Weeks)|Adverse Event|25|||
147329150|NCT00853827|531370115|FG001|Double Blind Period (103 Weeks)|Adverse Event|14|||
147329151|NCT00853827|531370114|FG000|Double Blind Period (103 Weeks)|Abnormal laboratory values|0|||
147329152|NCT00853827|531370115|FG001|Double Blind Period (103 Weeks)|Abnormal laboratory values|3|||
147329153|NCT00853827|531370114|FG000|Double Blind Period (103 Weeks)|Lack of Efficacy|1|||
147329154|NCT00853827|531370115|FG001|Double Blind Period (103 Weeks)|Lack of Efficacy|0|||
147329155|NCT00853827|531370114|FG000|Double Blind Period (103 Weeks)|Patient's no longer requires study drug|3|||
147329156|NCT00853827|531370115|FG001|Double Blind Period (103 Weeks)|Patient's no longer requires study drug|1|||
147329157|NCT00853827|531370114|FG000|Double Blind Period (103 Weeks)|Protocol Violation|2|||
147329158|NCT00853827|531370115|FG001|Double Blind Period (103 Weeks)|Protocol Violation|1|||
147329159|NCT00853827|531370114|FG000|Double Blind Period (103 Weeks)|Withdrawal by Subject|19|||
147329160|NCT00853827|531370115|FG001|Double Blind Period (103 Weeks)|Withdrawal by Subject|18|||
147329161|NCT00853827|531370114|FG000|Double Blind Period (103 Weeks)|Lost to Follow-up|8|||
147329162|NCT00853827|531370115|FG001|Double Blind Period (103 Weeks)|Lost to Follow-up|10|||
147329163|NCT00853827|531370114|FG000|Double Blind Period (103 Weeks)|Administrative problems|45|||
147329164|NCT00853827|531370115|FG001|Double Blind Period (103 Weeks)|Administrative problems|56|||
147329165|NCT00853827|531370114|FG000|Double Blind Period (103 Weeks)|Death|1|||
147329166|NCT00853827|531370115|FG001|Double Blind Period (103 Weeks)|Death|6|||
147329167|NCT00290732|531370117|FG000|Overall Study|Inability to instill drug intraductally.|0|||
147448650|NCT03605680|531807922|FG001|SB Placebo Run-in Period (1 Week)|Site Terminated by Sponsor|0|||
147329168|NCT00290732|531370118|FG001|Overall Study|Inability to instill drug intraductally.|1|||
147329169|NCT00290732|531370119|FG002|Overall Study|Inability to instill drug intraductally.|1|||
147593984|NCT04295135|532330560|FG000|Overall Study|Withdrawal by Subject|2|||
147593985|NCT04295135|532330561|FG001|Overall Study|Withdrawal by Subject|1|||
147593986|NCT04295135|532330560|FG000|Overall Study|Subject left organization|8|||
147448651|NCT03605680|531807923|FG002|SB Placebo Run-in Period (1 Week)|Site Terminated by Sponsor|0|||
147448652|NCT03605680|531807924|FG003|SB Placebo Run-in Period (1 Week)|Site Terminated by Sponsor|0|||
147448653|NCT03605680|531807921|FG000|SB Placebo Run-in Period (1 Week)|Physician Decision|6|||
147448654|NCT03605680|531807922|FG001|SB Placebo Run-in Period (1 Week)|Physician Decision|0|||
147593987|NCT04295135|532330561|FG001|Overall Study|Subject left organization|4|||
147448655|NCT03605680|531807923|FG002|SB Placebo Run-in Period (1 Week)|Physician Decision|0|||
147448656|NCT03605680|531807924|FG003|SB Placebo Run-in Period (1 Week)|Physician Decision|0|||
147448657|NCT03605680|531807921|FG000|SB Placebo Run-in Period (1 Week)|Reason not Specified|87|||
147448658|NCT03605680|531807922|FG001|SB Placebo Run-in Period (1 Week)|Reason not Specified|0|||
147448659|NCT03605680|531807923|FG002|SB Placebo Run-in Period (1 Week)|Reason not Specified|0|||
147448660|NCT03605680|531807924|FG003|SB Placebo Run-in Period (1 Week)|Reason not Specified|0|||
147448661|NCT03605680|531807921|FG000|Double-blind Treatment Period (6 Weeks)|Randomized but Not Treated in Double-Blind Treatment Period|0|||
147448662|NCT03605680|531807922|FG001|Double-blind Treatment Period (6 Weeks)|Randomized but Not Treated in Double-Blind Treatment Period|5|||
147448663|NCT03605680|531807923|FG002|Double-blind Treatment Period (6 Weeks)|Randomized but Not Treated in Double-Blind Treatment Period|7|||
147448664|NCT03605680|531807924|FG003|Double-blind Treatment Period (6 Weeks)|Randomized but Not Treated in Double-Blind Treatment Period|8|||
147448665|NCT03605680|531807921|FG000|Double-blind Treatment Period (6 Weeks)|Adverse Event|0|||
147448666|NCT03605680|531807922|FG001|Double-blind Treatment Period (6 Weeks)|Adverse Event|8|||
147448667|NCT03605680|531807923|FG002|Double-blind Treatment Period (6 Weeks)|Adverse Event|8|||
147448668|NCT03605680|531807924|FG003|Double-blind Treatment Period (6 Weeks)|Adverse Event|3|||
147329170|NCT00290732|531370120|FG003|Overall Study|Inability to instill drug intraductally.|0|||
147329171|NCT00290732|531370121|FG004|Overall Study|Inability to instill drug intraductally.|0|||
147329172|NCT00843193|531370122|FG000|Overall Study|Adverse Event|2|||
147329173|NCT00843193|531370123|FG001|Overall Study|Adverse Event|4|||
147329174|NCT00843193|531370122|FG000|Overall Study|Lack of Efficacy|1|||
147329175|NCT00843193|531370123|FG001|Overall Study|Lack of Efficacy|1|||
147329176|NCT00843193|531370122|FG000|Overall Study|Protocol Violation|1|||
147329177|NCT00843193|531370123|FG001|Overall Study|Protocol Violation|2|||
147448669|NCT03605680|531807921|FG000|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
147448670|NCT03605680|531807922|FG001|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
147448671|NCT03605680|531807923|FG002|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
147593988|NCT01546649|532330565|FG000|Overall Study|Adverse Event|4|||
147593989|NCT01546649|532330566|FG001|Overall Study|Adverse Event|5|||
147593990|NCT01546649|532330565|FG000|Overall Study|Protocol Violation|1|||
147593991|NCT01546649|532330566|FG001|Overall Study|Protocol Violation|0|||
147593992|NCT01546649|532330565|FG000|Overall Study|Lack of Efficacy|1|||
147593993|NCT01546649|532330566|FG001|Overall Study|Lack of Efficacy|0|||
147593994|NCT01546649|532330565|FG000|Overall Study|Recurrence|1|||
147593995|NCT01546649|532330566|FG001|Overall Study|Recurrence|1|||
147593996|NCT01546649|532330565|FG000|Overall Study|Discovery of secondary cancer|0|||
147593997|NCT01546649|532330566|FG001|Overall Study|Discovery of secondary cancer|1|||
147593998|NCT01546649|532330565|FG000|Overall Study|Withdrawal by Subject|1|||
147593999|NCT01546649|532330566|FG001|Overall Study|Withdrawal by Subject|2|||
147594000|NCT05420012|532330570|FG000|Overall Study|Lost to Follow-up|0|||
147594001|NCT05420012|532330571|FG001|Overall Study|Lost to Follow-up|1|||
147594002|NCT01901874|532330575|FG000|Screening Committee Retrospective Review|Protocol Violation|47|||
147594003|NCT01901874|532330575|FG000|30-Day MAE Evaluation|Insufficient Follow-up|1|||
147594004|NCT01901874|532330575|FG000|1-Year (365-Day) MAE Evaluation|Death|7|||
147594005|NCT01901874|532330575|FG000|1-Year (365-Day) MAE Evaluation|Lost to Follow-up|5|||
147594006|NCT01901874|532330575|FG000|1-Year (365-Day) MAE Evaluation|Withdrawal by Subject|2|||
147594007|NCT01901874|532330575|FG000|1-Year (365-Day) MAE Evaluation|Insufficient Follow-up|6|||
147594008|NCT01347866|532330578|FG000|Overall Study|Death|0|||
147594009|NCT01347866|532330579|FG001|Overall Study|Death|0|||
147594010|NCT01347866|532330580|FG002|Overall Study|Death|0|||
147594011|NCT01347866|532330581|FG003|Overall Study|Death|1|||
147594012|NCT01347866|532330582|FG004|Overall Study|Death|2|||
147594013|NCT01347866|532330583|FG005|Overall Study|Death|2|||
147594014|NCT01347866|532330584|FG006|Overall Study|Death|1|||
147594015|NCT01347866|532330585|FG007|Overall Study|Death|0|||
147594016|NCT01347866|532330586|FG008|Overall Study|Death|4|||
147185854|NCT00531284|530847898|FG016|Overall Study|Adverse Event|2|||
147185855|NCT00531284|530847882|FG000|Overall Study|Withdrawal by Subject|1|||
147185856|NCT00531284|530847883|FG001|Overall Study|Withdrawal by Subject|0|||
147594017|NCT01347866|532330587|FG009|Overall Study|Death|1|||
147594018|NCT01347866|532330588|FG010|Overall Study|Death|3|||
147185857|NCT00531284|530847884|FG002|Overall Study|Withdrawal by Subject|0|||
147185858|NCT00531284|530847885|FG003|Overall Study|Withdrawal by Subject|4|||
147185859|NCT00531284|530847886|FG004|Overall Study|Withdrawal by Subject|0|||
147185860|NCT00531284|530847887|FG005|Overall Study|Withdrawal by Subject|0|||
147594019|NCT01347866|532330589|FG011|Overall Study|Death|1|||
147185861|NCT00531284|530847888|FG006|Overall Study|Withdrawal by Subject|0|||
147185862|NCT00531284|530847889|FG007|Overall Study|Withdrawal by Subject|0|||
147329178|NCT00843193|531370122|FG000|Overall Study|Lost to Follow-up|1|||
147448672|NCT03605680|531807924|FG003|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|1|||
147448673|NCT03605680|531807921|FG000|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|0|||
147448674|NCT03605680|531807922|FG001|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|3|||
147448675|NCT03605680|531807923|FG002|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|4|||
147448676|NCT03605680|531807924|FG003|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|3|||
147448677|NCT03605680|531807921|FG000|Double-blind Treatment Period (6 Weeks)|Non-compliance with Study Drug|0|||
147448678|NCT03605680|531807922|FG001|Double-blind Treatment Period (6 Weeks)|Non-compliance with Study Drug|3|||
147448679|NCT03605680|531807923|FG002|Double-blind Treatment Period (6 Weeks)|Non-compliance with Study Drug|1|||
147448680|NCT03605680|531807924|FG003|Double-blind Treatment Period (6 Weeks)|Non-compliance with Study Drug|2|||
147448681|NCT03605680|531807921|FG000|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|0|||
147448682|NCT03605680|531807922|FG001|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|14|||
147594020|NCT01347866|532330590|FG012|Overall Study|Death|2|||
147594021|NCT01347866|532330591|FG013|Overall Study|Death|0|||
147247235|NCT00911820|531074428|FG001|Overall Study|Withdrawal by Subject|4|||
147594022|NCT01347866|532330592|FG014|Overall Study|Death|0|||
147594023|NCT01347866|532330593|FG015|Overall Study|Death|1|||
147247236|NCT00911820|531074427|FG000|Overall Study|Death|1|||
147247237|NCT00911820|531074428|FG001|Overall Study|Death|2|||
147247238|NCT00911820|531074427|FG000|Overall Study|Pursue surgery|1|||
147247239|NCT00911820|531074428|FG001|Overall Study|Pursue surgery|1|||
147247240|NCT00911820|531074427|FG000|Overall Study|Pursue Radiation|1|||
147247241|NCT00911820|531074428|FG001|Overall Study|Pursue Radiation|0|||
147247242|NCT00911820|531074427|FG000|Overall Study|Still on Therapy|2|||
147247243|NCT00911820|531074428|FG001|Overall Study|Still on Therapy|2|||
147247244|NCT00911820|531074427|FG000|Overall Study|Pathology Not Confirmed|1|||
147247245|NCT00911820|531074428|FG001|Overall Study|Pathology Not Confirmed|0|||
147247246|NCT00911820|531074427|FG000|Overall Study|Withdraw before Receive Treatment|0|||
147247247|NCT00911820|531074428|FG001|Overall Study|Withdraw before Receive Treatment|2|||
147247248|NCT00963547|531074432|FG000|Overall Study|Adverse Event|0|||
147247249|NCT00963547|531074433|FG001|Overall Study|Adverse Event|1|||
147247250|NCT00963547|531074434|FG002|Overall Study|Adverse Event|0|||
147247251|NCT00963547|531074435|FG003|Overall Study|Adverse Event|1|||
147247252|NCT00963547|531074436|FG004|Overall Study|Adverse Event|0|||
147247253|NCT00963547|531074437|FG005|Overall Study|Adverse Event|0|||
147247254|NCT00963547|531074438|FG006|Overall Study|Adverse Event|0|||
147247255|NCT00963547|531074432|FG000|Overall Study|Physician Decision|1|||
147247256|NCT00963547|531074433|FG001|Overall Study|Physician Decision|1|||
147247257|NCT00963547|531074434|FG002|Overall Study|Physician Decision|0|||
147247258|NCT00963547|531074435|FG003|Overall Study|Physician Decision|0|||
147247259|NCT00963547|531074436|FG004|Overall Study|Physician Decision|0|||
147247260|NCT00963547|531074437|FG005|Overall Study|Physician Decision|0|||
147247261|NCT00963547|531074438|FG006|Overall Study|Physician Decision|0|||
147247262|NCT00963547|531074432|FG000|Overall Study|Progressive Disease|3|||
147247263|NCT00963547|531074433|FG001|Overall Study|Progressive Disease|8|||
147247264|NCT00963547|531074434|FG002|Overall Study|Progressive Disease|9|||
147247265|NCT00963547|531074435|FG003|Overall Study|Progressive Disease|5|||
147247266|NCT00963547|531074436|FG004|Overall Study|Progressive Disease|0|||
147247267|NCT00963547|531074437|FG005|Overall Study|Progressive Disease|0|||
147247268|NCT00963547|531074438|FG006|Overall Study|Progressive Disease|0|||
147247269|NCT00963547|531074432|FG000|Overall Study|Withdrawal by Subject|0|||
147247270|NCT00963547|531074433|FG001|Overall Study|Withdrawal by Subject|0|||
147247271|NCT00963547|531074434|FG002|Overall Study|Withdrawal by Subject|3|||
147247272|NCT00963547|531074435|FG003|Overall Study|Withdrawal by Subject|0|||
147247273|NCT00963547|531074436|FG004|Overall Study|Withdrawal by Subject|0|||
147247274|NCT00963547|531074437|FG005|Overall Study|Withdrawal by Subject|0|||
147247275|NCT00963547|531074438|FG006|Overall Study|Withdrawal by Subject|0|||
147247276|NCT00963547|531074432|FG000|Overall Study|Reason Unknown|0|||
147247277|NCT00963547|531074433|FG001|Overall Study|Reason Unknown|1|||
147247278|NCT00963547|531074434|FG002|Overall Study|Reason Unknown|0|||
147247279|NCT00963547|531074435|FG003|Overall Study|Reason Unknown|0|||
147247280|NCT00963547|531074436|FG004|Overall Study|Reason Unknown|0|||
147247281|NCT00963547|531074437|FG005|Overall Study|Reason Unknown|0|||
147247282|NCT00963547|531074438|FG006|Overall Study|Reason Unknown|0|||
147247283|NCT02430311|531074441|FG000|Part A|Adverse Event|0|||
147247284|NCT02430311|531074442|FG001|Part A|Adverse Event|1|||
147247285|NCT02430311|531074441|FG000|Part A|Withdrawal by Subject|1|||
147247286|NCT02430311|531074442|FG001|Part A|Withdrawal by Subject|0|||
147247287|NCT02430311|531074441|FG000|Part B|Meet study-specific withdrawal criteria|6|||
147247288|NCT02430311|531074442|FG001|Part B|Meet study-specific withdrawal criteria|6|||
147247289|NCT02430311|531074441|FG000|Part B|Withdrawal by Subject|2|||
147247290|NCT02430311|531074442|FG001|Part B|Withdrawal by Subject|2|||
147247291|NCT02430311|531074441|FG000|Part B|Adverse Event|1|||
147247292|NCT02430311|531074442|FG001|Part B|Adverse Event|0|||
147247293|NCT02430311|531074441|FG000|Part B|Death|1|||
147247294|NCT02430311|531074442|FG001|Part B|Death|0|||
147247295|NCT02511184|531074443|FG000|Overall Study|Death|1|||
147594024|NCT01347866|532330594|FG016|Overall Study|Death|0|||
147247296|NCT02511184|531074444|FG001|Overall Study|Death|0|||
147185863|NCT00531284|530847890|FG008|Overall Study|Withdrawal by Subject|0|||
147185864|NCT00531284|530847891|FG009|Overall Study|Withdrawal by Subject|0|||
147185865|NCT00531284|530847892|FG010|Overall Study|Withdrawal by Subject|0|||
147185866|NCT00531284|530847893|FG011|Overall Study|Withdrawal by Subject|3|||
147185867|NCT00531284|530847894|FG012|Overall Study|Withdrawal by Subject|0|||
147185868|NCT00531284|530847895|FG013|Overall Study|Withdrawal by Subject|1|||
147185869|NCT00531284|530847896|FG014|Overall Study|Withdrawal by Subject|0|||
147185870|NCT00531284|530847897|FG015|Overall Study|Withdrawal by Subject|1|||
147185871|NCT00531284|530847898|FG016|Overall Study|Withdrawal by Subject|1|||
147185872|NCT00531284|530847882|FG000|Overall Study|Other|1|||
147185873|NCT00531284|530847883|FG001|Overall Study|Other|0|||
147185874|NCT00531284|530847884|FG002|Overall Study|Other|0|||
147185875|NCT00531284|530847885|FG003|Overall Study|Other|10|||
147185876|NCT00531284|530847886|FG004|Overall Study|Other|2|||
147185877|NCT00531284|530847887|FG005|Overall Study|Other|1|||
147185878|NCT00531284|530847888|FG006|Overall Study|Other|0|||
147185879|NCT00531284|530847889|FG007|Overall Study|Other|0|||
147185880|NCT00531284|530847890|FG008|Overall Study|Other|2|||
147185881|NCT00531284|530847891|FG009|Overall Study|Other|1|||
147185882|NCT00531284|530847892|FG010|Overall Study|Other|0|||
147185883|NCT00531284|530847893|FG011|Overall Study|Other|2|||
147185884|NCT00531284|530847894|FG012|Overall Study|Other|0|||
147185885|NCT00531284|530847895|FG013|Overall Study|Other|0|||
147185886|NCT00531284|530847896|FG014|Overall Study|Other|1|||
147185887|NCT00531284|530847897|FG015|Overall Study|Other|0|||
147185888|NCT00531284|530847898|FG016|Overall Study|Other|0|||
147185889|NCT02219464|530847900|FG000|Overall Study|Withdrawal by Subject|1|||
147185890|NCT02219464|530847901|FG001|Overall Study|Withdrawal by Subject|0|||
147185891|NCT02219464|530847900|FG000|Overall Study|case cancelled|1|||
147185892|NCT02219464|530847901|FG001|Overall Study|case cancelled|0|||
147185893|NCT02219464|530847900|FG000|Overall Study|catheter malfunction|1|||
147185894|NCT02219464|530847901|FG001|Overall Study|catheter malfunction|0|||
147185895|NCT00984256|530847902|FG000|Overall Study|Withdrawal by Subject|0|||
147185896|NCT00984256|530847903|FG001|Overall Study|Withdrawal by Subject|1|||
147185897|NCT03493945|530847906|FG000|Phase I Dose Escalation|Ineligible|0|||
147185898|NCT03493945|530847907|FG001|Phase I Dose Escalation|Ineligible|0|||
147185899|NCT03493945|530847908|FG002|Phase I Dose Escalation|Ineligible|1|||
147185900|NCT03493945|530847909|FG003|Phase I Dose Escalation|Ineligible|0|||
147185901|NCT03493945|530847910|FG004|Phase I Dose Escalation|Ineligible|0|||
147185902|NCT03493945|530847911|FG005|Phase I Dose Escalation|Ineligible|0|||
147185903|NCT03493945|530847912|FG006|Phase I Dose Escalation|Ineligible|0|||
147185904|NCT03493945|530847906|FG000|Phase I Dose Escalation|New therapy|0|||
147185905|NCT03493945|530847907|FG001|Phase I Dose Escalation|New therapy|1|||
147185906|NCT03493945|530847908|FG002|Phase I Dose Escalation|New therapy|0|||
147185907|NCT03493945|530847909|FG003|Phase I Dose Escalation|New therapy|0|||
147185908|NCT03493945|530847910|FG004|Phase I Dose Escalation|New therapy|0|||
147185909|NCT03493945|530847911|FG005|Phase I Dose Escalation|New therapy|0|||
147185910|NCT03493945|530847912|FG006|Phase I Dose Escalation|New therapy|0|||
147185911|NCT03493945|530847906|FG000|Phase II Dose Expansion|Refused further treatment|0|||
147185912|NCT03493945|530847907|FG001|Phase II Dose Expansion|Refused further treatment|0|||
147185913|NCT03493945|530847908|FG002|Phase II Dose Expansion|Refused further treatment|0|||
147185914|NCT03493945|530847909|FG003|Phase II Dose Expansion|Refused further treatment|0|||
147185915|NCT03493945|530847910|FG004|Phase II Dose Expansion|Refused further treatment|1|||
147185916|NCT03493945|530847911|FG005|Phase II Dose Expansion|Refused further treatment|1|||
147185917|NCT03493945|530847912|FG006|Phase II Dose Expansion|Refused further treatment|0|||
147185918|NCT03493945|530847906|FG000|Phase II Dose Expansion|Switched to alternative therapy|0|||
147448683|NCT03605680|531807923|FG002|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|7|||
147448684|NCT03605680|531807924|FG003|Double-blind Treatment Period (6 Weeks)|Protocol Deviation|5|||
147448685|NCT03605680|531807921|FG000|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|0|||
147448686|NCT03605680|531807922|FG001|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|4|||
147448687|NCT03605680|531807923|FG002|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|4|||
147185919|NCT03493945|530847907|FG001|Phase II Dose Expansion|Switched to alternative therapy|0|||
147185920|NCT03493945|530847908|FG002|Phase II Dose Expansion|Switched to alternative therapy|0|||
147448688|NCT03605680|531807924|FG003|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|7|||
147448689|NCT03605680|531807921|FG000|Double-blind Treatment Period (6 Weeks)|Physician Decision|0|||
147448690|NCT03605680|531807922|FG001|Double-blind Treatment Period (6 Weeks)|Physician Decision|1|||
147594025|NCT01347866|532330578|FG000|Overall Study|Lost to Follow-up|0|||
147185921|NCT03493945|530847909|FG003|Phase II Dose Expansion|Switched to alternative therapy|3|||
147185922|NCT03493945|530847910|FG004|Phase II Dose Expansion|Switched to alternative therapy|0|||
147185923|NCT03493945|530847911|FG005|Phase II Dose Expansion|Switched to alternative therapy|0|||
147185924|NCT03493945|530847912|FG006|Phase II Dose Expansion|Switched to alternative therapy|0|||
147185925|NCT01517750|530847913|FG000|Overall Study|Lost to Follow-up|1|||
147185926|NCT01517750|530847914|FG001|Overall Study|Lost to Follow-up|2|||
147185927|NCT01517750|530847915|FG002|Overall Study|Lost to Follow-up|4|||
147185928|NCT01517750|530847916|FG003|Overall Study|Lost to Follow-up|1|||
147594026|NCT01347866|532330579|FG001|Overall Study|Lost to Follow-up|0|||
147594027|NCT01347866|532330580|FG002|Overall Study|Lost to Follow-up|0|||
147594028|NCT01347866|532330581|FG003|Overall Study|Lost to Follow-up|0|||
147594029|NCT01347866|532330582|FG004|Overall Study|Lost to Follow-up|0|||
147594030|NCT01347866|532330583|FG005|Overall Study|Lost to Follow-up|0|||
147594031|NCT01347866|532330584|FG006|Overall Study|Lost to Follow-up|0|||
147594032|NCT01347866|532330585|FG007|Overall Study|Lost to Follow-up|1|||
147594033|NCT01347866|532330586|FG008|Overall Study|Lost to Follow-up|1|||
147594034|NCT01347866|532330587|FG009|Overall Study|Lost to Follow-up|0|||
147594035|NCT01347866|532330588|FG010|Overall Study|Lost to Follow-up|0|||
147594036|NCT01347866|532330589|FG011|Overall Study|Lost to Follow-up|0|||
147594037|NCT01347866|532330590|FG012|Overall Study|Lost to Follow-up|0|||
147594038|NCT01347866|532330591|FG013|Overall Study|Lost to Follow-up|0|||
147594039|NCT01347866|532330592|FG014|Overall Study|Lost to Follow-up|0|||
147594040|NCT01347866|532330593|FG015|Overall Study|Lost to Follow-up|0|||
147594041|NCT01347866|532330594|FG016|Overall Study|Lost to Follow-up|0|||
147594042|NCT01347866|532330578|FG000|Overall Study|Other|3|||
147594043|NCT01347866|532330579|FG001|Overall Study|Other|1|||
147594044|NCT01347866|532330580|FG002|Overall Study|Other|1|||
147594045|NCT01347866|532330581|FG003|Overall Study|Other|4|||
147594046|NCT01347866|532330582|FG004|Overall Study|Other|5|||
147594047|NCT01347866|532330583|FG005|Overall Study|Other|0|||
147594048|NCT01347866|532330584|FG006|Overall Study|Other|5|||
147594049|NCT01347866|532330585|FG007|Overall Study|Other|3|||
147594050|NCT01347866|532330586|FG008|Overall Study|Other|22|||
147594051|NCT01347866|532330587|FG009|Overall Study|Other|5|||
147594052|NCT01347866|532330588|FG010|Overall Study|Other|0|||
147185929|NCT01307319|530847917|FG000|Overall Study|Adverse Event|2|||
147185930|NCT01307319|530847918|FG001|Overall Study|Adverse Event|2|||
147185931|NCT01307319|530847919|FG002|Overall Study|Adverse Event|1|||
147185932|NCT01307319|530847917|FG000|Overall Study|Lost to Follow-up|1|||
147185933|NCT01307319|530847918|FG001|Overall Study|Lost to Follow-up|0|||
147185934|NCT01307319|530847919|FG002|Overall Study|Lost to Follow-up|1|||
147185935|NCT01307319|530847917|FG000|Overall Study|Protocol Violation|1|||
147185936|NCT01307319|530847918|FG001|Overall Study|Protocol Violation|1|||
147185937|NCT01307319|530847919|FG002|Overall Study|Protocol Violation|0|||
147185938|NCT01307319|530847917|FG000|Overall Study|Withdrawal by Subject|0|||
147185939|NCT01307319|530847918|FG001|Overall Study|Withdrawal by Subject|1|||
147185940|NCT01307319|530847919|FG002|Overall Study|Withdrawal by Subject|2|||
147185941|NCT01307319|530847917|FG000|Overall Study|Other|0|||
147185942|NCT01307319|530847918|FG001|Overall Study|Other|4|||
147185943|NCT01307319|530847919|FG002|Overall Study|Other|3|||
147185944|NCT02735239|530847920|FG000|Overall Study|Adverse Event|0|||
147185945|NCT02735239|530847921|FG001|Overall Study|Adverse Event|0|||
147185946|NCT02735239|530847922|FG002|Overall Study|Adverse Event|4|||
147185947|NCT02735239|530847923|FG003|Overall Study|Adverse Event|0|||
147185948|NCT02735239|530847924|FG004|Overall Study|Adverse Event|0|||
147185949|NCT02735239|530847925|FG005|Overall Study|Adverse Event|0|||
147185950|NCT02735239|530847920|FG000|Overall Study|Death|1|||
147185951|NCT02735239|530847921|FG001|Overall Study|Death|1|||
147185952|NCT02735239|530847922|FG002|Overall Study|Death|0|||
147185953|NCT02735239|530847923|FG003|Overall Study|Death|0|||
147185954|NCT02735239|530847924|FG004|Overall Study|Death|0|||
147185955|NCT02735239|530847925|FG005|Overall Study|Death|0|||
147185956|NCT02735239|530847920|FG000|Overall Study|Physician Decision|0|||
147185957|NCT02735239|530847921|FG001|Overall Study|Physician Decision|0|||
147185958|NCT02735239|530847922|FG002|Overall Study|Physician Decision|1|||
147185959|NCT02735239|530847923|FG003|Overall Study|Physician Decision|0|||
147185960|NCT02735239|530847924|FG004|Overall Study|Physician Decision|0|||
147185961|NCT02735239|530847925|FG005|Overall Study|Physician Decision|0|||
147185962|NCT02735239|530847920|FG000|Overall Study|Progressive disease|3|||
147185963|NCT02735239|530847921|FG001|Overall Study|Progressive disease|1|||
147185964|NCT02735239|530847922|FG002|Overall Study|Progressive disease|3|||
147185965|NCT02735239|530847923|FG003|Overall Study|Progressive disease|0|||
147185966|NCT02735239|530847924|FG004|Overall Study|Progressive disease|0|||
147185967|NCT02735239|530847925|FG005|Overall Study|Progressive disease|2|||
147594053|NCT01347866|532330589|FG011|Overall Study|Other|3|||
147594054|NCT01347866|532330590|FG012|Overall Study|Other|4|||
147594055|NCT01347866|532330591|FG013|Overall Study|Other|4|||
147594056|NCT01347866|532330592|FG014|Overall Study|Other|2|||
147594057|NCT01347866|532330593|FG015|Overall Study|Other|3|||
147594058|NCT01347866|532330594|FG016|Overall Study|Other|0|||
147594059|NCT01347866|532330578|FG000|Overall Study|Subject refused further follow-up|2|||
147594060|NCT01347866|532330579|FG001|Overall Study|Subject refused further follow-up|0|||
147185968|NCT02735239|530847920|FG000|Overall Study|Withdrawal by Subject|0|||
147185969|NCT02735239|530847921|FG001|Overall Study|Withdrawal by Subject|1|||
147185970|NCT02735239|530847922|FG002|Overall Study|Withdrawal by Subject|0|||
147185971|NCT02735239|530847923|FG003|Overall Study|Withdrawal by Subject|0|||
147185972|NCT02735239|530847924|FG004|Overall Study|Withdrawal by Subject|0|||
147594061|NCT01347866|532330580|FG002|Overall Study|Subject refused further follow-up|0|||
147594062|NCT01347866|532330581|FG003|Overall Study|Subject refused further follow-up|2|||
147594063|NCT01347866|532330582|FG004|Overall Study|Subject refused further follow-up|0|||
147448691|NCT03605680|531807923|FG002|Double-blind Treatment Period (6 Weeks)|Physician Decision|2|||
147185973|NCT02735239|530847925|FG005|Overall Study|Withdrawal by Subject|0|||
147185974|NCT02152631|530847927|FG000|Overall Study|Adverse Event|32|||
147185975|NCT02152631|530847928|FG001|Overall Study|Adverse Event|4|||
147185976|NCT02152631|530847927|FG000|Overall Study|Withdrawal by Subject|13|||
147185977|NCT02152631|530847928|FG001|Overall Study|Withdrawal by Subject|16|||
147185978|NCT02152631|530847927|FG000|Overall Study|Noncompliance with study drug|1|||
147185979|NCT02152631|530847928|FG001|Overall Study|Noncompliance with study drug|0|||
147185980|NCT02152631|530847927|FG000|Overall Study|Physician Decision|1|||
147185981|NCT02152631|530847928|FG001|Overall Study|Physician Decision|2|||
147185982|NCT02152631|530847927|FG000|Overall Study|Lost to Follow-up|0|||
147185983|NCT02152631|530847928|FG001|Overall Study|Lost to Follow-up|1|||
147185984|NCT02152631|530847927|FG000|Overall Study|On Treatment|19|||
147185985|NCT02152631|530847928|FG001|Overall Study|On Treatment|3|||
147185986|NCT00527735|530847929|FG000|Overall Study|Disease progression|47|||
147185987|NCT00527735|530847930|FG001|Overall Study|Disease progression|61|||
147185988|NCT00527735|530847931|FG002|Overall Study|Disease progression|53|||
147185989|NCT00527735|530847929|FG000|Overall Study|Death|23|||
147185990|NCT00527735|530847930|FG001|Overall Study|Death|13|||
147185991|NCT00527735|530847931|FG002|Overall Study|Death|15|||
147185992|NCT00527735|530847929|FG000|Overall Study|Completed treatment in treatment phase|14|||
147185993|NCT00527735|530847930|FG001|Overall Study|Completed treatment in treatment phase|13|||
147185994|NCT00527735|530847931|FG002|Overall Study|Completed treatment in treatment phase|18|||
147185995|NCT00527735|530847929|FG000|Overall Study|Adverse Event|10|||
147185996|NCT00527735|530847930|FG001|Overall Study|Adverse Event|6|||
147185997|NCT00527735|530847931|FG002|Overall Study|Adverse Event|7|||
147185998|NCT00527735|530847929|FG000|Overall Study|Not identified|5|||
147185999|NCT00527735|530847930|FG001|Overall Study|Not identified|5|||
147186000|NCT00527735|530847931|FG002|Overall Study|Not identified|5|||
147186001|NCT00527735|530847929|FG000|Overall Study|Withdrawal by Subject|5|||
147186002|NCT00527735|530847930|FG001|Overall Study|Withdrawal by Subject|4|||
147186003|NCT00527735|530847931|FG002|Overall Study|Withdrawal by Subject|3|||
147186004|NCT00527735|530847929|FG000|Overall Study|No longer met study criteria|2|||
147186005|NCT00527735|530847930|FG001|Overall Study|No longer met study criteria|2|||
147186006|NCT00527735|530847931|FG002|Overall Study|No longer met study criteria|1|||
147186007|NCT00527735|530847929|FG000|Overall Study|Lost to Follow-up|0|||
147186008|NCT00527735|530847930|FG001|Overall Study|Lost to Follow-up|0|||
147186009|NCT00527735|530847931|FG002|Overall Study|Lost to Follow-up|3|||
147186010|NCT00527735|530847929|FG000|Overall Study|Poor compliance or noncompliance|0|||
147186011|NCT00527735|530847930|FG001|Overall Study|Poor compliance or noncompliance|1|||
147186012|NCT00527735|530847931|FG002|Overall Study|Poor compliance or noncompliance|1|||
147186013|NCT00527735|530847929|FG000|Overall Study|Completed treatment during maintenance|2|||
147186014|NCT00527735|530847930|FG001|Overall Study|Completed treatment during maintenance|2|||
147186015|NCT00527735|530847931|FG002|Overall Study|Completed treatment during maintenance|1|||
147186016|NCT01855412|530847932|FG000|Overall Study|Death|77|||
147186017|NCT01855412|530847933|FG001|Overall Study|Death|123|||
147186018|NCT01855412|530847934|FG002|Overall Study|Death|30|||
147329179|NCT00843193|531370123|FG001|Overall Study|Lost to Follow-up|0|||
147329180|NCT00843193|531370122|FG000|Overall Study|Physician Decision|0|||
147329181|NCT00843193|531370123|FG001|Overall Study|Physician Decision|1|||
147329182|NCT00843193|531370122|FG000|Overall Study|Withdrawal by Subject|3|||
147329183|NCT00843193|531370123|FG001|Overall Study|Withdrawal by Subject|3|||
147329184|NCT00542386|531370124|FG000|Overall Study|Adverse Event|1|||
147329185|NCT00542386|531370125|FG001|Overall Study|Adverse Event|7|||
147329186|NCT00542386|531370126|FG002|Overall Study|Adverse Event|7|||
147329187|NCT00542386|531370127|FG003|Overall Study|Adverse Event|8|||
147329188|NCT00542386|531370128|FG004|Overall Study|Adverse Event|13|||
147329189|NCT00542386|531370129|FG005|Overall Study|Adverse Event|4|||
147329190|NCT00542386|531370124|FG000|Overall Study|Death|0|||
147329191|NCT00542386|531370125|FG001|Overall Study|Death|0|||
147329192|NCT00542386|531370126|FG002|Overall Study|Death|1|||
147329193|NCT00542386|531370127|FG003|Overall Study|Death|2|||
147329194|NCT00542386|531370128|FG004|Overall Study|Death|1|||
147329195|NCT00542386|531370129|FG005|Overall Study|Death|2|||
147448692|NCT03605680|531807924|FG003|Double-blind Treatment Period (6 Weeks)|Physician Decision|0|||
147448693|NCT03605680|531807921|FG000|Double-blind Treatment Period (6 Weeks)|Reason not Specified|0|||
147186019|NCT01855412|530847932|FG000|Overall Study|Lost to Follow-up|28|||
147186020|NCT01855412|530847933|FG001|Overall Study|Lost to Follow-up|46|||
147186021|NCT01855412|530847934|FG002|Overall Study|Lost to Follow-up|15|||
147186022|NCT01855412|530847932|FG000|Overall Study|Withdrawal by Subject|77|||
147186023|NCT01855412|530847933|FG001|Overall Study|Withdrawal by Subject|123|||
147186024|NCT01855412|530847934|FG002|Overall Study|Withdrawal by Subject|24|||
147186025|NCT01855412|530847932|FG000|Overall Study|Physician Decision|25|||
147186026|NCT01855412|530847933|FG001|Overall Study|Physician Decision|31|||
147186027|NCT01855412|530847934|FG002|Overall Study|Physician Decision|3|||
147186028|NCT01855412|530847932|FG000|Overall Study|Site Closure|4|||
147329196|NCT00542386|531370124|FG000|Overall Study|Lack of Efficacy|32|||
147186029|NCT01855412|530847933|FG001|Overall Study|Site Closure|18|||
147186030|NCT01855412|530847934|FG002|Overall Study|Site Closure|1|||
147186031|NCT01855412|530847932|FG000|Overall Study|Reason not Specified|1|||
147186032|NCT01855412|530847933|FG001|Overall Study|Reason not Specified|2|||
147186033|NCT01855412|530847934|FG002|Overall Study|Reason not Specified|3|||
147186034|NCT00346216|530847936|FG000|Overall Study|Other|181|||
147186035|NCT00346216|530847937|FG001|Overall Study|Other|231|||
147186036|NCT00346216|530847938|FG002|Overall Study|Other|205|||
147186037|NCT00346216|530847936|FG000|Overall Study|No longer willing to participate|600|||
147186038|NCT00346216|530847937|FG001|Overall Study|No longer willing to participate|606|||
147186039|NCT00346216|530847938|FG002|Overall Study|No longer willing to participate|585|||
147186040|NCT00346216|530847936|FG000|Overall Study|Withdrawal by Subject|661|||
147186041|NCT00346216|530847937|FG001|Overall Study|Withdrawal by Subject|692|||
147186042|NCT00346216|530847938|FG002|Overall Study|Withdrawal by Subject|651|||
147186043|NCT00346216|530847936|FG000|Overall Study|Lost to Follow-up|611|||
147186044|NCT00346216|530847937|FG001|Overall Study|Lost to Follow-up|588|||
147186045|NCT00346216|530847938|FG002|Overall Study|Lost to Follow-up|542|||
147186046|NCT00346216|530847936|FG000|Overall Study|Physician Decision|80|||
147186047|NCT00346216|530847937|FG001|Overall Study|Physician Decision|76|||
147186048|NCT00346216|530847938|FG002|Overall Study|Physician Decision|59|||
147186049|NCT00346216|530847936|FG000|Overall Study|Does not meet entrance criteria|13|||
147186050|NCT00346216|530847937|FG001|Overall Study|Does not meet entrance criteria|10|||
147186051|NCT00346216|530847938|FG002|Overall Study|Does not meet entrance criteria|8|||
147186052|NCT00346216|530847936|FG000|Overall Study|Death|189|||
147186053|NCT00346216|530847937|FG001|Overall Study|Death|192|||
147186054|NCT00346216|530847938|FG002|Overall Study|Death|228|||
147186055|NCT00346216|530847936|FG000|Overall Study|Study terminated by sponsor|11|||
147186056|NCT00346216|530847937|FG001|Overall Study|Study terminated by sponsor|4|||
147186057|NCT00346216|530847938|FG002|Overall Study|Study terminated by sponsor|8|||
147186058|NCT00346216|530847936|FG000|Overall Study|Missing Subject Summary Status|62|||
147186059|NCT00346216|530847937|FG001|Overall Study|Missing Subject Summary Status|61|||
147186060|NCT00346216|530847938|FG002|Overall Study|Missing Subject Summary Status|62|||
147186061|NCT01132807|530847939|FG000|Initial ABVD Treatment (2 Cycles)|Withdrawal by Subject|9|||
147186062|NCT01132807|530847940|FG001|Initial ABVD Treatment (2 Cycles)|Withdrawal by Subject|0|||
147186063|NCT01132807|530847941|FG002|Initial ABVD Treatment (2 Cycles)|Withdrawal by Subject|0|||
147186064|NCT01132807|530847939|FG000|Initial ABVD Treatment (2 Cycles)|Ineligible|6|||
147186065|NCT01132807|530847940|FG001|Initial ABVD Treatment (2 Cycles)|Ineligible|0|||
147186066|NCT01132807|530847941|FG002|Initial ABVD Treatment (2 Cycles)|Ineligible|0|||
147186067|NCT02222558|530847942|FG000|Period 1: Single Dose|Withdrawal by Subject|4|||
147186068|NCT02222558|530847943|FG001|Period 1: Single Dose|Withdrawal by Subject|0|||
147186069|NCT02222558|530847944|FG002|Period 1: Single Dose|Withdrawal by Subject|0|||
147186070|NCT02222558|530847945|FG003|Period 1: Single Dose|Withdrawal by Subject|0|||
147186071|NCT02222558|530847946|FG004|Period 1: Single Dose|Withdrawal by Subject|0|||
147186072|NCT02222558|530847947|FG005|Period 1: Single Dose|Withdrawal by Subject|0|||
147186073|NCT02222558|530847942|FG000|Period 3|Withdrawal by Subject|0|||
147186074|NCT02222558|530847943|FG001|Period 3|Withdrawal by Subject|0|||
147186075|NCT02222558|530847944|FG002|Period 3|Withdrawal by Subject|0|||
147186076|NCT02222558|530847945|FG003|Period 3|Withdrawal by Subject|0|||
147186077|NCT02222558|530847946|FG004|Period 3|Withdrawal by Subject|0|||
147186078|NCT02222558|530847947|FG005|Period 3|Withdrawal by Subject|1|||
147186079|NCT02322281|530847950|FG000|Overall Study|Progressive Disease|42|||
147186080|NCT02322281|530847951|FG001|Overall Study|Progressive Disease|14|||
147186081|NCT02322281|530847952|FG002|Overall Study|Progressive Disease|49|||
147186082|NCT02322281|530847950|FG000|Overall Study|Adverse Event|3|||
147186083|NCT02322281|530847951|FG001|Overall Study|Adverse Event|4|||
147186084|NCT02322281|530847952|FG002|Overall Study|Adverse Event|6|||
147186085|NCT02322281|530847950|FG000|Overall Study|Death|3|||
147186086|NCT02322281|530847951|FG001|Overall Study|Death|3|||
147186087|NCT02322281|530847952|FG002|Overall Study|Death|3|||
147186088|NCT02322281|530847950|FG000|Overall Study|Withdrawal by Subject|1|||
147186089|NCT02322281|530847951|FG001|Overall Study|Withdrawal by Subject|1|||
147186090|NCT02322281|530847952|FG002|Overall Study|Withdrawal by Subject|6|||
147186091|NCT02322281|530847950|FG000|Overall Study|Physician Decision|2|||
147186092|NCT02322281|530847951|FG001|Overall Study|Physician Decision|0|||
147186093|NCT02322281|530847952|FG002|Overall Study|Physician Decision|5|||
147186094|NCT02322281|530847950|FG000|Overall Study|Study Terminated by Sponsor|2|||
147186095|NCT02322281|530847951|FG001|Overall Study|Study Terminated by Sponsor|0|||
147186096|NCT02322281|530847952|FG002|Overall Study|Study Terminated by Sponsor|0|||
147186097|NCT02322281|530847950|FG000|Overall Study|Missing|0|||
147186098|NCT02322281|530847951|FG001|Overall Study|Missing|0|||
147186099|NCT02322281|530847952|FG002|Overall Study|Missing|1|||
147186100|NCT02322281|530847950|FG000|Overall Study|Miscellaneous|0|||
147186101|NCT02322281|530847951|FG001|Overall Study|Miscellaneous|0|||
147186102|NCT02322281|530847952|FG002|Overall Study|Miscellaneous|4|||
147186103|NCT00936702|530847956|FG000|Overall Study|Disease progression|34|||
147186104|NCT00936702|530847956|FG000|Overall Study|Adverse Event|8|||
147186105|NCT00936702|530847956|FG000|Overall Study|Withdrawal by Subject|2|||
147186106|NCT00936702|530847956|FG000|Overall Study|Alternative Treatment|1|||
147186107|NCT00936702|530847956|FG000|Overall Study|Other|1|||
147186108|NCT02420093|530847959|FG000|Overall Study|Withdrawal by Subject|1|||
147186109|NCT02420093|530847960|FG001|Overall Study|Withdrawal by Subject|1|||
147186110|NCT03001557|530847962|FG000|Core Phase|Randomized but not treated|0|||
147186111|NCT03001557|530847963|FG001|Core Phase|Randomized but not treated|0|||
147186112|NCT03001557|530847964|FG002|Core Phase|Randomized but not treated|1|||
147186113|NCT03001557|530847965|FG003|Core Phase|Randomized but not treated|0|||
147186114|NCT03001557|530847966|FG004|Core Phase|Randomized but not treated|0|||
147186115|NCT03001557|530847967|FG005|Core Phase|Randomized but not treated|0|||
147186116|NCT03001557|530847968|FG006|Core Phase|Randomized but not treated|0|||
147186117|NCT03001557|530847969|FG007|Core Phase|Randomized but not treated|0|||
147186118|NCT03001557|530847962|FG000|Extension Phase|Adverse Event|0|||
147186119|NCT03001557|530847963|FG001|Extension Phase|Adverse Event|0|||
147186120|NCT03001557|530847964|FG002|Extension Phase|Adverse Event|0|||
147186121|NCT03001557|530847965|FG003|Extension Phase|Adverse Event|0|||
147186122|NCT03001557|530847966|FG004|Extension Phase|Adverse Event|0|||
147186123|NCT03001557|530847967|FG005|Extension Phase|Adverse Event|2|||
147186124|NCT03001557|530847968|FG006|Extension Phase|Adverse Event|0|||
147186125|NCT03001557|530847969|FG007|Extension Phase|Adverse Event|0|||
147186126|NCT03001557|530847962|FG000|Extension Phase|Withdrawal by Subject|0|||
147186127|NCT03001557|530847963|FG001|Extension Phase|Withdrawal by Subject|0|||
147186128|NCT03001557|530847964|FG002|Extension Phase|Withdrawal by Subject|0|||
147186129|NCT03001557|530847965|FG003|Extension Phase|Withdrawal by Subject|0|||
147186130|NCT03001557|530847966|FG004|Extension Phase|Withdrawal by Subject|0|||
147186131|NCT03001557|530847967|FG005|Extension Phase|Withdrawal by Subject|1|||
147186132|NCT03001557|530847968|FG006|Extension Phase|Withdrawal by Subject|5|||
147186133|NCT03001557|530847969|FG007|Extension Phase|Withdrawal by Subject|2|||
147186134|NCT03001557|530847962|FG000|Extension Phase|Lost to Follow-up|0|||
147186135|NCT03001557|530847963|FG001|Extension Phase|Lost to Follow-up|0|||
147186136|NCT03001557|530847964|FG002|Extension Phase|Lost to Follow-up|0|||
147186137|NCT03001557|530847965|FG003|Extension Phase|Lost to Follow-up|0|||
147186138|NCT03001557|530847966|FG004|Extension Phase|Lost to Follow-up|0|||
147186139|NCT03001557|530847967|FG005|Extension Phase|Lost to Follow-up|0|||
147186140|NCT03001557|530847968|FG006|Extension Phase|Lost to Follow-up|2|||
147186141|NCT03001557|530847969|FG007|Extension Phase|Lost to Follow-up|1|||
147186142|NCT03001557|530847962|FG000|Extension Phase|Administrative Reason|0|||
147186143|NCT03001557|530847963|FG001|Extension Phase|Administrative Reason|0|||
147186144|NCT03001557|530847964|FG002|Extension Phase|Administrative Reason|0|||
147186145|NCT03001557|530847965|FG003|Extension Phase|Administrative Reason|0|||
147186146|NCT03001557|530847966|FG004|Extension Phase|Administrative Reason|0|||
147186147|NCT03001557|530847967|FG005|Extension Phase|Administrative Reason|1|||
147186148|NCT03001557|530847968|FG006|Extension Phase|Administrative Reason|3|||
147186149|NCT03001557|530847969|FG007|Extension Phase|Administrative Reason|3|||
147186150|NCT03001557|530847962|FG000|Extension Phase|Loss of caregiver|0|||
147186151|NCT03001557|530847963|FG001|Extension Phase|Loss of caregiver|0|||
147186152|NCT03001557|530847964|FG002|Extension Phase|Loss of caregiver|0|||
147186153|NCT03001557|530847965|FG003|Extension Phase|Loss of caregiver|0|||
147186154|NCT03001557|530847966|FG004|Extension Phase|Loss of caregiver|0|||
147186155|NCT03001557|530847967|FG005|Extension Phase|Loss of caregiver|0|||
147186156|NCT03001557|530847968|FG006|Extension Phase|Loss of caregiver|1|||
147186157|NCT03001557|530847969|FG007|Extension Phase|Loss of caregiver|0|||
147186158|NCT03001557|530847962|FG000|Extension Phase|Others|0|||
147329197|NCT00542386|531370125|FG001|Overall Study|Lack of Efficacy|12|||
147329198|NCT00542386|531370126|FG002|Overall Study|Lack of Efficacy|10|||
147329199|NCT00542386|531370127|FG003|Overall Study|Lack of Efficacy|13|||
147329200|NCT00542386|531370128|FG004|Overall Study|Lack of Efficacy|7|||
147329201|NCT00542386|531370129|FG005|Overall Study|Lack of Efficacy|31|||
147329202|NCT00542386|531370124|FG000|Overall Study|Physician Decision|1|||
147329203|NCT00542386|531370125|FG001|Overall Study|Physician Decision|0|||
147329204|NCT00542386|531370126|FG002|Overall Study|Physician Decision|0|||
147329205|NCT00542386|531370127|FG003|Overall Study|Physician Decision|1|||
147329206|NCT00542386|531370128|FG004|Overall Study|Physician Decision|0|||
147594064|NCT01347866|532330583|FG005|Overall Study|Subject refused further follow-up|1|||
147594065|NCT01347866|532330584|FG006|Overall Study|Subject refused further follow-up|0|||
147186159|NCT03001557|530847963|FG001|Extension Phase|Others|0|||
147186160|NCT03001557|530847964|FG002|Extension Phase|Others|0|||
147186161|NCT03001557|530847965|FG003|Extension Phase|Others|0|||
147186162|NCT03001557|530847966|FG004|Extension Phase|Others|0|||
147329207|NCT00542386|531370129|FG005|Overall Study|Physician Decision|0|||
147329208|NCT00542386|531370124|FG000|Overall Study|Protocol Violation|0|||
147594066|NCT01347866|532330585|FG007|Overall Study|Subject refused further follow-up|0|||
147186163|NCT03001557|530847967|FG005|Extension Phase|Others|1|||
147186164|NCT03001557|530847968|FG006|Extension Phase|Others|3|||
147186165|NCT03001557|530847969|FG007|Extension Phase|Others|0|||
147186166|NCT01794000|530847970|FG000|Double-Blind Phase (DBP)|Adverse Event|5|||
147186167|NCT01794000|530847971|FG001|Double-Blind Phase (DBP)|Adverse Event|2|||
147186168|NCT01794000|530847970|FG000|Double-Blind Phase (DBP)|Death|1|||
147186169|NCT01794000|530847971|FG001|Double-Blind Phase (DBP)|Death|2|||
147186170|NCT01794000|530847970|FG000|Double-Blind Phase (DBP)|Entry Criteria Not Met|2|||
147186171|NCT01794000|530847971|FG001|Double-Blind Phase (DBP)|Entry Criteria Not Met|0|||
147186172|NCT01794000|530847970|FG000|Double-Blind Phase (DBP)|Parent/Caregiver Decision|5|||
147186173|NCT01794000|530847971|FG001|Double-Blind Phase (DBP)|Parent/Caregiver Decision|2|||
147186174|NCT01794000|530847970|FG000|Double-Blind Phase (DBP)|Physician Decision|2|||
147186175|NCT01794000|530847971|FG001|Double-Blind Phase (DBP)|Physician Decision|0|||
147186176|NCT01794000|530847970|FG000|Double-Blind Phase (DBP)|Sponsor Decision|148|||
147186177|NCT01794000|530847971|FG001|Double-Blind Phase (DBP)|Sponsor Decision|149|||
147186178|NCT01794000|530847970|FG000|Double-Blind Phase (DBP)|Withdrawal by Subject|6|||
147186179|NCT01794000|530847971|FG001|Double-Blind Phase (DBP)|Withdrawal by Subject|11|||
147186180|NCT01794000|530847970|FG000|Open-Label Extension Phase (OLE)|Sponsor Decision|3|||
147186181|NCT01794000|530847971|FG001|Open-Label Extension Phase (OLE)|Sponsor Decision|0|||
147186182|NCT00255190|530847974|FG000|Overall Study|Adverse Event|17|||
147186183|NCT00255190|530847975|FG001|Overall Study|Adverse Event|36|||
147186184|NCT00255190|530847974|FG000|Overall Study|Protocol Violation|2|||
147186185|NCT00255190|530847975|FG001|Overall Study|Protocol Violation|2|||
147186186|NCT00255190|530847974|FG000|Overall Study|Lost to Follow-up|10|||
147186187|NCT00255190|530847975|FG001|Overall Study|Lost to Follow-up|27|||
147186188|NCT00255190|530847974|FG000|Overall Study|Withdrew Consent|17|||
147186189|NCT00255190|530847975|FG001|Overall Study|Withdrew Consent|48|||
147186190|NCT00255190|530847974|FG000|Overall Study|Inclusion/Exclusion criteria not met|0|||
147186191|NCT00255190|530847975|FG001|Overall Study|Inclusion/Exclusion criteria not met|1|||
147186192|NCT00255190|530847974|FG000|Overall Study|Erosive esophagitis not healed|0|||
147186193|NCT00255190|530847975|FG001|Overall Study|Erosive esophagitis not healed|20|||
147186194|NCT00255190|530847974|FG000|Overall Study|Various|4|||
147186195|NCT00255190|530847975|FG001|Overall Study|Various|23|||
147186196|NCT01156480|530847981|FG000|Overall Study|change in diagnosis|0|||
147186197|NCT01156480|530847982|FG001|Overall Study|change in diagnosis|1|||
147186198|NCT04537793|530847983|FG000|Part B (24 Weeks)|Adverse Event|0|||
147186199|NCT04537793|530847984|FG001|Part B (24 Weeks)|Adverse Event|1|||
147186200|NCT01308736|530847991|FG000|Overall Study|Did not attend a single session|6|||
147186201|NCT01308736|530847992|FG001|Overall Study|Did not attend a single session|5|||
147186202|NCT01946139|530847993|FG000|Overall Study|Withdrawal by Subject|8|||
147186203|NCT01946139|530847993|FG000|Overall Study|ineligible|8|||
147186204|NCT01946139|530847993|FG000|Overall Study|Specimens not available|4|||
147186205|NCT01363700|530848002|FG000|Epinastine vs Placebo Period1|Withdrawal by Subject|0|||
147186206|NCT01363700|530848003|FG001|Epinastine vs Placebo Period1|Withdrawal by Subject|1|||
147186207|NCT01363700|530848004|FG002|Epinastine vs Placebo Period1|Withdrawal by Subject|0|||
147186208|NCT01363700|530848005|FG003|Epinastine vs Placebo Period1|Withdrawal by Subject|0|||
147186209|NCT01363700|530848006|FG004|Epinastine vs Placebo Period1|Withdrawal by Subject|0|||
147186210|NCT02721875|530848007|FG000|Overall Study|Progressive disease/relapse|1|||
147186211|NCT02721875|530848008|FG001|Overall Study|Progressive disease/relapse|0|||
147186212|NCT01329978|530848013|FG000|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|1|||
147186213|NCT01329978|530848014|FG001|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|2|||
147186214|NCT01329978|530848015|FG002|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|0|||
147186215|NCT01329978|530848016|FG003|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|0|||
147186216|NCT01329978|530848017|FG004|Sofosbuvir+PEG+RBV Treatment Period|Adverse Event|0|||
147186217|NCT01329978|530848013|FG000|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|2|||
147186218|NCT01329978|530848014|FG001|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|8|||
147186219|NCT01329978|530848015|FG002|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|2|||
147186220|NCT01329978|530848016|FG003|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|0|||
147594067|NCT01347866|532330586|FG008|Overall Study|Subject refused further follow-up|4|||
147594068|NCT01347866|532330587|FG009|Overall Study|Subject refused further follow-up|1|||
147186221|NCT01329978|530848017|FG004|Sofosbuvir+PEG+RBV Treatment Period|Lost to Follow-up|0|||
147186222|NCT01329978|530848013|FG000|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|1|||
147186223|NCT01329978|530848014|FG001|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|1|||
147186224|NCT01329978|530848015|FG002|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|3|||
147186225|NCT01329978|530848016|FG003|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|0|||
147186226|NCT01329978|530848017|FG004|Sofosbuvir+PEG+RBV Treatment Period|Withdrawal by Subject|0|||
147186227|NCT01329978|530848013|FG000|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0|||
147247297|NCT02511184|531074443|FG000|Overall Study|Lost to Follow-up|0|||
147247298|NCT02511184|531074444|FG001|Overall Study|Lost to Follow-up|1|||
147247299|NCT02511184|531074443|FG000|Overall Study|Study terminated by sponsor|1|||
147247300|NCT02511184|531074444|FG001|Overall Study|Study terminated by sponsor|5|||
147247301|NCT02511184|531074443|FG000|Overall Study|Withdrawal by Subject|0|||
147247302|NCT02511184|531074444|FG001|Overall Study|Withdrawal by Subject|1|||
147247303|NCT00085631|531074455|FG000|Overall Study|Missing Data|4|||
147247304|NCT00085631|531074456|FG001|Overall Study|Missing Data|11|||
147247305|NCT00085631|531074457|FG002|Overall Study|Missing Data|7|||
147247306|NCT01349790|531074458|FG000|Overall Study|Investigator Judgement|3|||
147247307|NCT01349790|531074458|FG000|Overall Study|Death|2|||
147247308|NCT01349790|531074458|FG000|Overall Study|Withdrawal by Patient|2|||
147247309|NCT01349790|531074458|FG000|Overall Study|Adverse Event|1|||
147329209|NCT00542386|531370125|FG001|Overall Study|Protocol Violation|0|||
147329210|NCT00542386|531370126|FG002|Overall Study|Protocol Violation|1|||
147329211|NCT00542386|531370127|FG003|Overall Study|Protocol Violation|0|||
147329212|NCT00542386|531370128|FG004|Overall Study|Protocol Violation|0|||
147329213|NCT00542386|531370129|FG005|Overall Study|Protocol Violation|4|||
147329214|NCT00542386|531370124|FG000|Overall Study|Withdrawal by Subject|5|||
147329215|NCT00542386|531370125|FG001|Overall Study|Withdrawal by Subject|8|||
147329216|NCT00542386|531370126|FG002|Overall Study|Withdrawal by Subject|10|||
147186228|NCT01329978|530848014|FG001|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|1|||
147186229|NCT01329978|530848015|FG002|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0|||
147186230|NCT01329978|530848016|FG003|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0|||
147186231|NCT01329978|530848017|FG004|Sofosbuvir+PEG+RBV Treatment Period|Subject Was Incarcerated|0|||
147186232|NCT01329978|530848013|FG000|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0|||
147186233|NCT01329978|530848014|FG001|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|1|||
147186234|NCT01329978|530848015|FG002|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0|||
147186235|NCT01329978|530848016|FG003|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0|||
147186236|NCT01329978|530848017|FG004|Sofosbuvir+PEG+RBV Treatment Period|Subject Moved Out of State|0|||
147186237|NCT01329978|530848013|FG000|Rerandomization Treatment Period|Lost to Follow-up|0|||
147186238|NCT01329978|530848014|FG001|Rerandomization Treatment Period|Lost to Follow-up|0|||
147329217|NCT00542386|531370127|FG003|Overall Study|Withdrawal by Subject|11|||
147329218|NCT00542386|531370128|FG004|Overall Study|Withdrawal by Subject|15|||
147329219|NCT00542386|531370129|FG005|Overall Study|Withdrawal by Subject|7|||
147329220|NCT00542386|531370124|FG000|Overall Study|Other Reasons|4|||
147329221|NCT00542386|531370125|FG001|Overall Study|Other Reasons|1|||
147186239|NCT01329978|530848015|FG002|Rerandomization Treatment Period|Lost to Follow-up|0|||
147186240|NCT01329978|530848016|FG003|Rerandomization Treatment Period|Lost to Follow-up|5|||
147186241|NCT01329978|530848017|FG004|Rerandomization Treatment Period|Lost to Follow-up|3|||
147186242|NCT01329978|530848013|FG000|Rerandomization Treatment Period|Withdrawal by Subject|0|||
147186243|NCT01329978|530848014|FG001|Rerandomization Treatment Period|Withdrawal by Subject|0|||
147186244|NCT01329978|530848015|FG002|Rerandomization Treatment Period|Withdrawal by Subject|0|||
147186245|NCT01329978|530848016|FG003|Rerandomization Treatment Period|Withdrawal by Subject|0|||
147186246|NCT01329978|530848017|FG004|Rerandomization Treatment Period|Withdrawal by Subject|1|||
147186247|NCT04896593|530848020|FG000|Overall Study|Withdrawal by Subject|2|||
147186248|NCT04896593|530848020|FG000|Overall Study|Lost to Follow-up|1|||
147186249|NCT04896593|530848020|FG000|Overall Study|Did not complete onboarding|2|||
147186250|NCT00452790|530848021|FG000|Infant Series|Clinical hold - consent withdrawn|118|||
147186251|NCT00452790|530848022|FG001|Infant Series|Clinical hold - consent withdrawn|123|||
147186252|NCT00452790|530848021|FG000|Infant Series|Parent/legal guardian request|8|||
147186253|NCT00452790|530848022|FG001|Infant Series|Parent/legal guardian request|6|||
147186254|NCT00452790|530848021|FG000|Infant Series|Failed to return|4|||
147186255|NCT00452790|530848022|FG001|Infant Series|Failed to return|1|||
147186256|NCT00452790|530848021|FG000|Infant Series|Protocol Violation|1|||
147186257|NCT00452790|530848022|FG001|Infant Series|Protocol Violation|3|||
147186258|NCT00452790|530848021|FG000|Infant Series|Lost to Follow-up|2|||
147186259|NCT00452790|530848022|FG001|Infant Series|Lost to Follow-up|2|||
147186260|NCT00452790|530848021|FG000|Infant Series|Adverse Event|1|||
147186261|NCT00452790|530848022|FG001|Infant Series|Adverse Event|2|||
147329222|NCT00542386|531370126|FG002|Overall Study|Other Reasons|4|||
147329223|NCT00542386|531370127|FG003|Overall Study|Other Reasons|3|||
147329224|NCT00542386|531370128|FG004|Overall Study|Other Reasons|4|||
147329225|NCT00542386|531370129|FG005|Overall Study|Other Reasons|2|||
147329226|NCT02982213|531370130|FG000|Overall Study|Did not complete follow up questionnaire|5|||
147329227|NCT02982213|531370131|FG001|Overall Study|Did not complete follow up questionnaire|1|||
147329228|NCT01104415|531370132|FG000|Core Phase|Consent withdrawn by subjects|1|||
147329229|NCT01104415|531370133|FG001|Core Phase|Consent withdrawn by subjects|0|||
147329230|NCT01104415|531370132|FG000|Extension Period|Progressive disease|0|||
147594069|NCT01347866|532330588|FG010|Overall Study|Subject refused further follow-up|0|||
147329231|NCT01104415|531370133|FG001|Extension Period|Progressive disease|4|||
147329232|NCT01104415|531370132|FG000|Extension Period|Death|0|||
147329233|NCT01104415|531370133|FG001|Extension Period|Death|1|||
147329234|NCT01104415|531370132|FG000|Extension Period|Physician Decision|0|||
147594070|NCT01347866|532330589|FG011|Overall Study|Subject refused further follow-up|0|||
147594071|NCT01347866|532330590|FG012|Overall Study|Subject refused further follow-up|1|||
147186262|NCT00452790|530848021|FG000|Infant Series|Other reasons|1|||
147186263|NCT00452790|530848022|FG001|Infant Series|Other reasons|2|||
147186264|NCT00452790|530848021|FG000|Infant Series|Investigator request|0|||
147186265|NCT00452790|530848022|FG001|Infant Series|Investigator request|1|||
147186266|NCT00452790|530848021|FG000|Infant Series|Death|0|||
147329235|NCT01104415|531370133|FG001|Extension Period|Physician Decision|1|||
147329236|NCT01104415|531370132|FG000|Extension Period|Transition to Study LX1606.302|0|||
147329237|NCT01104415|531370133|FG001|Extension Period|Transition to Study LX1606.302|4|||
147329238|NCT01104415|531370132|FG000|Extension Period|Heart surgery/feeling miserable|0|||
147329239|NCT01104415|531370133|FG001|Extension Period|Heart surgery/feeling miserable|1|||
147186267|NCT00452790|530848022|FG001|Infant Series|Death|1|||
147186268|NCT00452790|530848021|FG000|After Infant Series|Investigator request|10|||
147186269|NCT00452790|530848022|FG001|After Infant Series|Investigator request|10|||
147186270|NCT00452790|530848021|FG000|After Infant Series|Adverse Event|4|||
147186271|NCT00452790|530848022|FG001|After Infant Series|Adverse Event|1|||
147186272|NCT00452790|530848021|FG000|After Infant Series|Parent/legal guardian request|1|||
147186273|NCT00452790|530848022|FG001|After Infant Series|Parent/legal guardian request|3|||
147186274|NCT00452790|530848021|FG000|After Infant Series|Lost to Follow-up|4|||
147186275|NCT00452790|530848022|FG001|After Infant Series|Lost to Follow-up|0|||
147186276|NCT00452790|530848021|FG000|After Infant Series|Failed to return|1|||
147186277|NCT00452790|530848022|FG001|After Infant Series|Failed to return|0|||
147186278|NCT00452790|530848021|FG000|After Infant Series|Other reasons|1|||
147186279|NCT00452790|530848022|FG001|After Infant Series|Other reasons|0|||
147186280|NCT00452790|530848021|FG000|Toddler Dose|Failed to return|0|||
147186281|NCT00452790|530848022|FG001|Toddler Dose|Failed to return|1|||
147186282|NCT00452790|530848021|FG000|Toddler Dose|Parent/legal guardian request|0|||
147186283|NCT00452790|530848022|FG001|Toddler Dose|Parent/legal guardian request|1|||
147186284|NCT00176462|530848033|FG000|Induction (4 Weeks)|Withdrawal by Subject|0|||
147186285|NCT00176462|530848034|FG001|Induction (4 Weeks)|Withdrawal by Subject|2|||
147186286|NCT00176462|530848033|FG000|Induction (4 Weeks)|Death|1|||
147186287|NCT00176462|530848034|FG001|Induction (4 Weeks)|Death|2|||
147186288|NCT00176462|530848033|FG000|Induction (4 Weeks)|Lack of Efficacy|0|||
147186289|NCT00176462|530848034|FG001|Induction (4 Weeks)|Lack of Efficacy|1|||
147186290|NCT00176462|530848033|FG000|Consolidation (12 Weeks)|Patient moved to another state|0|||
147186291|NCT00176462|530848034|FG001|Consolidation (12 Weeks)|Patient moved to another state|1|||
147186292|NCT00176462|530848033|FG000|Consolidation (12 Weeks)|Adverse Event|0|||
147186293|NCT00176462|530848034|FG001|Consolidation (12 Weeks)|Adverse Event|1|||
147186294|NCT00176462|530848033|FG000|Consolidation (12 Weeks)|Lack of Efficacy|0|||
147186295|NCT00176462|530848034|FG001|Consolidation (12 Weeks)|Lack of Efficacy|2|||
147186296|NCT00176462|530848033|FG000|Consolidation (12 Weeks)|Not documented|0|||
147186297|NCT00176462|530848034|FG001|Consolidation (12 Weeks)|Not documented|1|||
147186298|NCT00176462|530848033|FG000|Intensive Continuation (8X8-week Cycles)|Death|1|||
147186299|NCT00176462|530848034|FG001|Intensive Continuation (8X8-week Cycles)|Death|0|||
147186300|NCT00176462|530848033|FG000|Intensive Continuation (8X8-week Cycles)|Lack of Efficacy|0|||
147186301|NCT00176462|530848034|FG001|Intensive Continuation (8X8-week Cycles)|Lack of Efficacy|3|||
147186302|NCT01150097|530848036|FG000|Months 24 to 36 Post-transplantation|Death|2|||
147186303|NCT01150097|530848037|FG001|Months 24 to 36 Post-transplantation|Death|0|||
147186304|NCT01150097|530848038|FG002|Months 24 to 36 Post-transplantation|Death|0|||
147186305|NCT01150097|530848036|FG000|Months 24 to 36 Post-transplantation|Administrative problems|5|||
147186306|NCT01150097|530848037|FG001|Months 24 to 36 Post-transplantation|Administrative problems|2|||
147186307|NCT01150097|530848038|FG002|Months 24 to 36 Post-transplantation|Administrative problems|2|||
147186308|NCT01150097|530848036|FG000|Months 24 to 36 Post-transplantation|Lost to Follow-up|0|||
147186309|NCT01150097|530848037|FG001|Months 24 to 36 Post-transplantation|Lost to Follow-up|0|||
147186310|NCT01150097|530848038|FG002|Months 24 to 36 Post-transplantation|Lost to Follow-up|3|||
147186311|NCT01150097|530848036|FG000|Months 24 to 36 Post-transplantation|Withdrawal by Subject|3|||
147186312|NCT01150097|530848037|FG001|Months 24 to 36 Post-transplantation|Withdrawal by Subject|0|||
147186313|NCT01150097|530848038|FG002|Months 24 to 36 Post-transplantation|Withdrawal by Subject|3|||
147186314|NCT01150097|530848036|FG000|Months 24 to 48 Post-transplantation|Administrative problems|5|||
147186315|NCT01150097|530848037|FG001|Months 24 to 48 Post-transplantation|Administrative problems|4|||
147186316|NCT01150097|530848038|FG002|Months 24 to 48 Post-transplantation|Administrative problems|0|||
147186317|NCT01150097|530848036|FG000|Months 24 to 48 Post-transplantation|Withdrawal by Subject|4|||
147186318|NCT01150097|530848037|FG001|Months 24 to 48 Post-transplantation|Withdrawal by Subject|0|||
147186319|NCT01150097|530848038|FG002|Months 24 to 48 Post-transplantation|Withdrawal by Subject|0|||
147186320|NCT01150097|530848036|FG000|Months 24 to 48 Post-transplantation|Death|2|||
147186321|NCT01150097|530848037|FG001|Months 24 to 48 Post-transplantation|Death|0|||
147186322|NCT01150097|530848038|FG002|Months 24 to 48 Post-transplantation|Death|0|||
147186323|NCT01301833|530848043|FG000|Overall Study|Adverse Event|7|||
147186324|NCT01301833|530848044|FG001|Overall Study|Adverse Event|5|||
147186325|NCT01301833|530848045|FG002|Overall Study|Adverse Event|5|||
147186326|NCT01301833|530848046|FG003|Overall Study|Adverse Event|5|||
147186327|NCT01301833|530848043|FG000|Overall Study|Lack of Efficacy|1|||
147186328|NCT01301833|530848044|FG001|Overall Study|Lack of Efficacy|1|||
147186329|NCT01301833|530848045|FG002|Overall Study|Lack of Efficacy|0|||
147186330|NCT01301833|530848046|FG003|Overall Study|Lack of Efficacy|0|||
147186331|NCT01301833|530848043|FG000|Overall Study|Physician Decision|3|||
147186332|NCT01301833|530848044|FG001|Overall Study|Physician Decision|1|||
147186333|NCT01301833|530848045|FG002|Overall Study|Physician Decision|1|||
147186334|NCT01301833|530848046|FG003|Overall Study|Physician Decision|0|||
147186335|NCT01301833|530848043|FG000|Overall Study|Withdrawal by Subject|3|||
147247310|NCT01349790|531074458|FG000|Overall Study|Lost to Follow-up|1|||
147247311|NCT03902574|531074459|FG000|Overall Study|Urinary drug test was positive on Day 20|0|||
147247312|NCT03902574|531074460|FG001|Overall Study|Urinary drug test was positive on Day 20|0|||
147186336|NCT01301833|530848044|FG001|Overall Study|Withdrawal by Subject|1|||
147186337|NCT01301833|530848045|FG002|Overall Study|Withdrawal by Subject|1|||
147186338|NCT01301833|530848046|FG003|Overall Study|Withdrawal by Subject|2|||
147186339|NCT01301833|530848043|FG000|Overall Study|Personal matter|1|||
147186340|NCT01301833|530848044|FG001|Overall Study|Personal matter|0|||
147186341|NCT01301833|530848045|FG002|Overall Study|Personal matter|0|||
147186342|NCT01301833|530848046|FG003|Overall Study|Personal matter|0|||
147186343|NCT01279681|530848047|FG000|Overall Study|Disease Progression|9|||
147186344|NCT01279681|530848048|FG001|Overall Study|Disease Progression|6|||
147186345|NCT01279681|530848047|FG000|Overall Study|Withdrawal by Subject|3|||
147186346|NCT01279681|530848048|FG001|Overall Study|Withdrawal by Subject|4|||
147186347|NCT01279681|530848047|FG000|Overall Study|Adverse Event|2|||
147186348|NCT01279681|530848048|FG001|Overall Study|Adverse Event|3|||
147186349|NCT01279681|530848047|FG000|Overall Study|Death|0|||
147186350|NCT01279681|530848048|FG001|Overall Study|Death|1|||
147186351|NCT01279681|530848047|FG000|Overall Study|Withdrawal Prior to Beginning Treatment|0|||
147186352|NCT01279681|530848048|FG001|Overall Study|Withdrawal Prior to Beginning Treatment|1|||
147329240|NCT03227757|531371647|FG000|Overall Study|Death|25|||
147329241|NCT03227757|531371647|FG000|Overall Study|Withdrawal|10|||
147329242|NCT03227757|531371647|FG000|Overall Study|Missed visits|1|||
147329243|NCT03227757|531371647|FG000|Overall Study|Lost to Follow-up|2|||
147329244|NCT01144468|531371649|FG000|Overall Study|Lost to Follow-up|4|||
147329245|NCT01144468|531371650|FG001|Overall Study|Lost to Follow-up|7|||
147329246|NCT01144468|531371649|FG000|Overall Study|Adverse Event|3|||
147329247|NCT01144468|531371650|FG001|Overall Study|Adverse Event|2|||
147329248|NCT01144468|531371649|FG000|Overall Study|did not reach 2 year follow up at time of clinical cut off|45|||
147329249|NCT01144468|531371650|FG001|Overall Study|did not reach 2 year follow up at time of clinical cut off|48|||
147329250|NCT02960659|531371651|FG000|Overall Study|Withdrawal by Subject|1|||
147329251|NCT02960659|531371652|FG001|Overall Study|Withdrawal by Subject|0|||
147329252|NCT02960659|531371651|FG000|Overall Study|Poor compliance|0|||
147329253|NCT02960659|531371652|FG001|Overall Study|Poor compliance|1|||
147329254|NCT04199728|531371653|FG000|Overall Study|Adverse Event|1|||
147329255|NCT04199728|531371654|FG001|Overall Study|Adverse Event|0|||
147329256|NCT04199728|531371653|FG000|Overall Study|Withdrawal by Subject|8|||
147329257|NCT04199728|531371654|FG001|Overall Study|Withdrawal by Subject|3|||
147329258|NCT04199728|531371653|FG000|Overall Study|Screen fail after consent|0|||
147329259|NCT04199728|531371654|FG001|Overall Study|Screen fail after consent|1|||
147329260|NCT04199728|531371653|FG000|Overall Study|Early withdraw criteria met|0|||
147329261|NCT04199728|531371654|FG001|Overall Study|Early withdraw criteria met|1|||
147329262|NCT04199728|531371653|FG000|Overall Study|Non-compliance/difficulty with staff|2|||
147329263|NCT04199728|531371654|FG001|Overall Study|Non-compliance/difficulty with staff|0|||
147329264|NCT01331824|531371657|FG000|Overall Study|Adverse Event|2|||
147329265|NCT01331824|531371657|FG000|Overall Study|Death|1|||
147329266|NCT01331824|531371657|FG000|Overall Study|Disease Progression|9|||
147329267|NCT01331824|531371657|FG000|Overall Study|Withdrawal by Subject|1|||
147329268|NCT01091454|531371660|FG000|Overall Study|Ineligible|1|||
147329269|NCT03179787|531371661|FG000|Overall Study|Lost to Follow-up|15|||
147329270|NCT03179787|531371661|FG000|Overall Study|Case report failures|2|||
147329271|NCT03179787|531371661|FG000|Overall Study|Treatment not administered|1|||
147329272|NCT00661778|531371662|FG000|Overall Study|Disease Progression|23|||
147329273|NCT00661778|531371662|FG000|Overall Study|Adverse Event|18|||
147329274|NCT00661778|531371662|FG000|Overall Study|Reason not Specified|6|||
147329275|NCT00661778|531371662|FG000|Overall Study|Protocol Violation|2|||
147329276|NCT00661778|531371662|FG000|Overall Study|Withdrawal of Consent|1|||
147329277|NCT05298111|531371670|FG000|Washout (3 Days)|Withdrawal by Subject|3|||
147329278|NCT05298111|531371671|FG001|Washout (3 Days)|Withdrawal by Subject|3|||
147329279|NCT02380742|531371672|FG000|Overall Study|Withdrawal by Subject|1|||
147329280|NCT02380742|531371673|FG001|Overall Study|Withdrawal by Subject|0|||
147329281|NCT03518112|531371675|FG000|Overall Study|Withdrawal by Subject|1|||
147186353|NCT01279681|530848047|FG000|Overall Study|Physician Decision|1|||
147186354|NCT01279681|530848048|FG001|Overall Study|Physician Decision|0|||
147186355|NCT01279681|530848047|FG000|Overall Study|Other Reason|0|||
147186356|NCT01279681|530848048|FG001|Overall Study|Other Reason|2|||
147186357|NCT02252146|530849917|FG000|Overall Study|Lack of Efficacy|4|||
147186358|NCT02252146|530849917|FG000|Overall Study|Entered hospice care|1|||
147186359|NCT02252146|530849917|FG000|Overall Study|Inability to travel to study site|1|||
147186360|NCT02544321|530849922|FG000|Overall Study|Withdrawal by Subject|1|||
147186361|NCT02544321|530849923|FG001|Overall Study|Withdrawal by Subject|2|||
147186362|NCT02544321|530849922|FG000|Overall Study|Adverse Event|1|||
147329282|NCT01729819|531371678|FG000|Overall Study|Adverse Event|2|||
147329283|NCT01729819|531371679|FG001|Overall Study|Adverse Event|4|||
147448694|NCT03605680|531807922|FG001|Double-blind Treatment Period (6 Weeks)|Reason not Specified|5|||
147186363|NCT02544321|530849923|FG001|Overall Study|Adverse Event|1|||
147329284|NCT01729819|531371678|FG000|Overall Study|Lack of Efficacy|1|||
147329285|NCT01729819|531371679|FG001|Overall Study|Lack of Efficacy|0|||
147329286|NCT01729819|531371678|FG000|Overall Study|Lost to Follow-up|2|||
147329287|NCT01729819|531371679|FG001|Overall Study|Lost to Follow-up|0|||
147329288|NCT01729819|531371678|FG000|Overall Study|Other reason|1|||
147329289|NCT01729819|531371679|FG001|Overall Study|Other reason|0|||
147329290|NCT01729819|531371678|FG000|Overall Study|Protocol Violation|0|||
147329291|NCT01729819|531371679|FG001|Overall Study|Protocol Violation|1|||
147186364|NCT02544321|530849922|FG000|Overall Study|Protocol Violation|0|||
147186365|NCT02544321|530849923|FG001|Overall Study|Protocol Violation|1|||
147186366|NCT04388111|530849924|FG000|Overall Study|Lost to Follow-up|5|||
147186367|NCT04388111|530849925|FG001|Overall Study|Lost to Follow-up|3|||
147186368|NCT04388111|530849924|FG000|Overall Study|Adverse Event|1|||
147186369|NCT04388111|530849925|FG001|Overall Study|Adverse Event|1|||
147186370|NCT04388111|530849924|FG000|Overall Study|Protocol Violation|2|||
147186371|NCT04388111|530849925|FG001|Overall Study|Protocol Violation|4|||
147186372|NCT04388111|530849924|FG000|Overall Study|Withdrawal by Subject|1|||
147186373|NCT04388111|530849925|FG001|Overall Study|Withdrawal by Subject|0|||
147186374|NCT02038153|530849928|FG000|Overall Study|Withdrawal by Subject|1|||
147186375|NCT02647281|530849929|FG000|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
147186376|NCT02647281|530849930|FG001|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
147186377|NCT02647281|530849931|FG002|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
147186378|NCT02647281|530849932|FG003|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
147186379|NCT02647281|530849933|FG004|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
147186380|NCT02647281|530849934|FG005|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
147186381|NCT02647281|530849935|FG006|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
147186382|NCT02647281|530849936|FG007|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|0|||
147186383|NCT02647281|530849937|FG008|Multiple-Ascending Dose(Part 2-115 Days)|Withdrawal by Subject|1|||
147186384|NCT01050634|530849938|FG000|Overall Study|Enrolled, but Not Treated|56|||
147186385|NCT01050634|530849938|FG000|Overall Study|Death|2|||
147186386|NCT01050634|530849938|FG000|Overall Study|Adverse Event|42|||
147186387|NCT01050634|530849938|FG000|Overall Study|Lost to Follow-up|2|||
147186388|NCT01050634|530849938|FG000|Overall Study|Other|21|||
147186389|NCT01050634|530849938|FG000|Overall Study|Ongoing at Date of Cut-Off|5|||
147186390|NCT03347123|530849941|FG000|Overall Study|Death|1|||
147186391|NCT03347123|530849942|FG001|Overall Study|Death|2|||
147186392|NCT03347123|530849943|FG002|Overall Study|Death|0|||
147186393|NCT03347123|530849944|FG003|Overall Study|Death|0|||
147186394|NCT03347123|530849945|FG004|Overall Study|Death|0|||
147186395|NCT03347123|530849946|FG005|Overall Study|Death|0|||
147186396|NCT03347123|530849947|FG006|Overall Study|Death|0|||
147186397|NCT03347123|530849941|FG000|Overall Study|Withdrawal by Subject|1|||
147186398|NCT03347123|530849942|FG001|Overall Study|Withdrawal by Subject|0|||
147186399|NCT03347123|530849943|FG002|Overall Study|Withdrawal by Subject|0|||
147186400|NCT03347123|530849944|FG003|Overall Study|Withdrawal by Subject|0|||
147186401|NCT03347123|530849945|FG004|Overall Study|Withdrawal by Subject|0|||
147186402|NCT03347123|530849946|FG005|Overall Study|Withdrawal by Subject|0|||
147186403|NCT03347123|530849947|FG006|Overall Study|Withdrawal by Subject|0|||
147186404|NCT03347123|530849941|FG000|Overall Study|Reason not Specified|3|||
147186405|NCT03347123|530849942|FG001|Overall Study|Reason not Specified|4|||
147186406|NCT03347123|530849943|FG002|Overall Study|Reason not Specified|0|||
147186407|NCT03347123|530849944|FG003|Overall Study|Reason not Specified|0|||
147186408|NCT03347123|530849945|FG004|Overall Study|Reason not Specified|0|||
147186409|NCT03347123|530849946|FG005|Overall Study|Reason not Specified|0|||
147186410|NCT03347123|530849947|FG006|Overall Study|Reason not Specified|0|||
147186411|NCT03431441|530849955|FG000|Overall Study|Withdrawal by Subject|2|||
147186412|NCT03431441|530849955|FG000|Overall Study|Adverse Event|2|||
147186413|NCT03431441|530849955|FG000|Overall Study|Dispensed Incorrect Replacement Lens|1|||
147186414|NCT01276639|530849956|FG000|Week 0 to 16|Death|1|||
147186415|NCT01276639|530849957|FG001|Week 0 to 16|Death|0|||
147186416|NCT01276639|530849958|FG002|Week 0 to 16|Death|0|||
147186417|NCT01276639|530849959|FG003|Week 0 to 16|Death|0|||
147329292|NCT01729819|531371678|FG000|Overall Study|Withdrawal by Subject|0|||
147329293|NCT01729819|531371679|FG001|Overall Study|Withdrawal by Subject|2|||
147186418|NCT01276639|530849960|FG004|Week 0 to 16|Death|0|||
147186419|NCT01276639|530849956|FG000|Week 0 to 16|Adverse Event|11|||
147186420|NCT01276639|530849957|FG001|Week 0 to 16|Adverse Event|8|||
147186421|NCT01276639|530849958|FG002|Week 0 to 16|Adverse Event|11|||
147186422|NCT01276639|530849959|FG003|Week 0 to 16|Adverse Event|0|||
147186423|NCT01276639|530849960|FG004|Week 0 to 16|Adverse Event|0|||
147186424|NCT01276639|530849956|FG000|Week 0 to 16|Lack of Efficacy|20|||
147448695|NCT03605680|531807923|FG002|Double-blind Treatment Period (6 Weeks)|Reason not Specified|4|||
147594072|NCT01347866|532330591|FG013|Overall Study|Subject refused further follow-up|3|||
147186425|NCT01276639|530849957|FG001|Week 0 to 16|Lack of Efficacy|15|||
147186426|NCT01276639|530849958|FG002|Week 0 to 16|Lack of Efficacy|25|||
147186427|NCT01276639|530849959|FG003|Week 0 to 16|Lack of Efficacy|0|||
147186428|NCT01276639|530849960|FG004|Week 0 to 16|Lack of Efficacy|0|||
147186429|NCT01276639|530849956|FG000|Week 0 to 16|Lost to Follow-up|3|||
147186430|NCT01276639|530849957|FG001|Week 0 to 16|Lost to Follow-up|5|||
147186431|NCT01276639|530849958|FG002|Week 0 to 16|Lost to Follow-up|3|||
147329294|NCT02987543|531371680|FG000|Overall Study|Ongoing study at data cut off|49|||
147448696|NCT03605680|531807924|FG003|Double-blind Treatment Period (6 Weeks)|Reason not Specified|3|||
147448697|NCT03605680|531807921|FG000|Double-blind Treatment Period (6 Weeks)|Reason due to COVID-19|0|||
147448698|NCT03605680|531807922|FG001|Double-blind Treatment Period (6 Weeks)|Reason due to COVID-19|1|||
147448699|NCT03605680|531807923|FG002|Double-blind Treatment Period (6 Weeks)|Reason due to COVID-19|2|||
147448700|NCT03605680|531807924|FG003|Double-blind Treatment Period (6 Weeks)|Reason due to COVID-19|3|||
147448701|NCT03189446|531807925|FG000|Overall Study|Adverse Event|2|||
147448702|NCT03189446|531807925|FG000|Overall Study|Withdrawal by Subject|2|||
147448703|NCT03189446|531807925|FG000|Overall Study|Physician Decision|1|||
147448704|NCT00647556|531807926|FG000|Overall Study|Adverse Event|0|||
147448705|NCT00647556|531807927|FG001|Overall Study|Adverse Event|1|||
147448706|NCT00647556|531807926|FG000|Overall Study|Lost to Follow-up|1|||
147448707|NCT00647556|531807927|FG001|Overall Study|Lost to Follow-up|0|||
147448708|NCT00647556|531807926|FG000|Overall Study|Protocol Violation|0|||
147448709|NCT00647556|531807927|FG001|Overall Study|Protocol Violation|1|||
147448710|NCT00647556|531807926|FG000|Overall Study|Withdrawal by Subject|1|||
147448711|NCT00647556|531807927|FG001|Overall Study|Withdrawal by Subject|0|||
147448712|NCT00647556|531807926|FG000|Overall Study|Surgery for pre-existing neck pain|1|||
147448713|NCT00647556|531807927|FG001|Overall Study|Surgery for pre-existing neck pain|0|||
147448714|NCT05594173|531807928|FG000|Overall Study|Adverse Event|1|||
147448715|NCT05594173|531807928|FG000|Overall Study|COVID-19 Pandemic|2|||
147448716|NCT03865706|531807930|FG000|Overall Study|Death|0|||
147448717|NCT03865706|531807931|FG001|Overall Study|Death|3|||
147448718|NCT03865706|531807932|FG002|Overall Study|Death|1|||
147448719|NCT02095535|531807933|FG000|Recruitment|Protocol Violation|2|||
147448720|NCT02646982|531807934|FG000|Overall Study|Adverse Event|1|||
147448721|NCT02646982|531807935|FG001|Overall Study|Adverse Event|1|||
147448722|NCT02646982|531807934|FG000|Overall Study|Withdrawal by Subject|2|||
147329295|NCT02987543|531371681|FG001|Overall Study|Ongoing study at data cut off|21|||
147329296|NCT02987543|531371682|FG002|Overall Study|Ongoing study at data cut off|19|||
147329297|NCT02987543|531371683|FG003|Overall Study|Ongoing study at data cut off|12|||
147329298|NCT02987543|531371680|FG000|Overall Study|Death|88|||
147329299|NCT02987543|531371681|FG001|Overall Study|Death|54|||
147329300|NCT02987543|531371682|FG002|Overall Study|Death|67|||
147329301|NCT02987543|531371683|FG003|Overall Study|Death|28|||
147329302|NCT02987543|531371680|FG000|Overall Study|Lost to Follow-up|3|||
147329303|NCT02987543|531371681|FG001|Overall Study|Lost to Follow-up|0|||
147329304|NCT02987543|531371682|FG002|Overall Study|Lost to Follow-up|1|||
147448723|NCT02646982|531807935|FG001|Overall Study|Withdrawal by Subject|1|||
147448724|NCT03273166|531807936|FG000|Overall Study|Withdrawn prior to Completion|31|||
147448725|NCT00915681|531807940|FG000|Overall Study|Screening failures|46|||
147448726|NCT03221751|531807941|FG000|Overall Study|lumbar puncture not performed at early termination.|1|||
147448727|NCT03221751|531807942|FG001|Overall Study|lumbar puncture not performed at early termination.|0|||
147448728|NCT00535132|531807948|FG000|Safety Analysis Set|Did Not Receive Study Medication|2|||
147448729|NCT00535132|531807949|FG001|Safety Analysis Set|Did Not Receive Study Medication|2|||
147448730|NCT00535132|531807948|FG000|Intent-to-Treat (ITT) Analysis Set|No Follow-up Efficacy Data|3|||
147448731|NCT00535132|531807949|FG001|Intent-to-Treat (ITT) Analysis Set|No Follow-up Efficacy Data|3|||
147448732|NCT00618410|531807954|FG000|Washout Period (2 Weeks)|Physician Decision|0|||
147448733|NCT00618410|531807955|FG001|Washout Period (2 Weeks)|Physician Decision|1|||
147448734|NCT03948178|531807960|FG000|Overall Study|Protocol Violation|1|||
147448735|NCT03948178|531807960|FG000|Overall Study|Lost to Follow-up|2|||
147448736|NCT03948178|531807960|FG000|Overall Study|Withdrawal by Subject|2|||
147448737|NCT03948178|531807960|FG000|Overall Study|Reason not known|2|||
147448738|NCT03948178|531807960|FG000|Overall Study|Personal reason|14|||
147448739|NCT03948178|531807960|FG000|Overall Study|Disease progression|30|||
147186432|NCT01276639|530849959|FG003|Week 0 to 16|Lost to Follow-up|0|||
147186433|NCT01276639|530849960|FG004|Week 0 to 16|Lost to Follow-up|0|||
147186434|NCT01276639|530849956|FG000|Week 0 to 16|Withdrawal by Subject|8|||
147186435|NCT01276639|530849957|FG001|Week 0 to 16|Withdrawal by Subject|5|||
147186436|NCT01276639|530849958|FG002|Week 0 to 16|Withdrawal by Subject|4|||
147329305|NCT02987543|531371683|FG003|Overall Study|Lost to Follow-up|0|||
147186437|NCT01276639|530849959|FG003|Week 0 to 16|Withdrawal by Subject|0|||
147186438|NCT01276639|530849960|FG004|Week 0 to 16|Withdrawal by Subject|0|||
147329306|NCT02987543|531371680|FG000|Overall Study|Screen failure|0|||
147329307|NCT02987543|531371681|FG001|Overall Study|Screen failure|0|||
147329308|NCT02987543|531371682|FG002|Overall Study|Screen failure|0|||
147329309|NCT02987543|531371683|FG003|Overall Study|Screen failure|1|||
147448740|NCT03948178|531807960|FG000|Overall Study|Adverse Event|12|||
147448741|NCT03948178|531807960|FG000|Overall Study|Sponsor terminated study|164|||
147448742|NCT01297270|531807961|FG000|Overall Study|Adverse Event|19|||
147448743|NCT01297270|531807962|FG001|Overall Study|Adverse Event|32|||
147448744|NCT01297270|531807963|FG002|Overall Study|Adverse Event|5|||
147448745|NCT01297270|531807961|FG000|Overall Study|Lack of Efficacy|15|||
147448746|NCT01297270|531807962|FG001|Overall Study|Lack of Efficacy|17|||
147186439|NCT01276639|530849956|FG000|Week 0 to 16|Other|7|||
147329310|NCT02987543|531371680|FG000|Overall Study|Withdrawal by Subject|21|||
147329311|NCT02987543|531371681|FG001|Overall Study|Withdrawal by Subject|7|||
147186440|NCT01276639|530849957|FG001|Week 0 to 16|Other|7|||
147186441|NCT01276639|530849958|FG002|Week 0 to 16|Other|2|||
147186442|NCT01276639|530849959|FG003|Week 0 to 16|Other|0|||
147186443|NCT01276639|530849960|FG004|Week 0 to 16|Other|0|||
147186444|NCT01276639|530849956|FG000|Week 0 to 16|Randomized, But Not Treated|0|||
147186445|NCT01276639|530849957|FG001|Week 0 to 16|Randomized, But Not Treated|1|||
147186446|NCT01276639|530849958|FG002|Week 0 to 16|Randomized, But Not Treated|0|||
147186447|NCT01276639|530849959|FG003|Week 0 to 16|Randomized, But Not Treated|0|||
147186448|NCT01276639|530849960|FG004|Week 0 to 16|Randomized, But Not Treated|0|||
147186449|NCT01276639|530849956|FG000|Week 16 to 52|Death|1|||
147186450|NCT01276639|530849957|FG001|Week 16 to 52|Death|0|||
147186451|NCT01276639|530849958|FG002|Week 16 to 52|Death|0|||
147186452|NCT01276639|530849959|FG003|Week 16 to 52|Death|0|||
147186453|NCT01276639|530849960|FG004|Week 16 to 52|Death|0|||
147186454|NCT01276639|530849956|FG000|Week 16 to 52|Adverse Event|10|||
147186455|NCT01276639|530849957|FG001|Week 16 to 52|Adverse Event|13|||
147186456|NCT01276639|530849958|FG002|Week 16 to 52|Adverse Event|0|||
147186457|NCT01276639|530849959|FG003|Week 16 to 52|Adverse Event|1|||
147186458|NCT01276639|530849960|FG004|Week 16 to 52|Adverse Event|3|||
147186459|NCT01276639|530849956|FG000|Week 16 to 52|Lack of Efficacy|99|||
147186460|NCT01276639|530849957|FG001|Week 16 to 52|Lack of Efficacy|71|||
147186461|NCT01276639|530849958|FG002|Week 16 to 52|Lack of Efficacy|0|||
147186462|NCT01276639|530849959|FG003|Week 16 to 52|Lack of Efficacy|14|||
147186463|NCT01276639|530849960|FG004|Week 16 to 52|Lack of Efficacy|13|||
147186464|NCT01276639|530849956|FG000|Week 16 to 52|Lost to Follow-up|3|||
147186465|NCT01276639|530849957|FG001|Week 16 to 52|Lost to Follow-up|1|||
147186466|NCT01276639|530849958|FG002|Week 16 to 52|Lost to Follow-up|0|||
147186467|NCT01276639|530849959|FG003|Week 16 to 52|Lost to Follow-up|0|||
147186468|NCT01276639|530849960|FG004|Week 16 to 52|Lost to Follow-up|1|||
147186469|NCT01276639|530849956|FG000|Week 16 to 52|Withdrawal by Subject|4|||
147186470|NCT01276639|530849957|FG001|Week 16 to 52|Withdrawal by Subject|4|||
147186471|NCT01276639|530849958|FG002|Week 16 to 52|Withdrawal by Subject|0|||
147186472|NCT01276639|530849959|FG003|Week 16 to 52|Withdrawal by Subject|0|||
147186473|NCT01276639|530849960|FG004|Week 16 to 52|Withdrawal by Subject|1|||
147186474|NCT01276639|530849956|FG000|Week 16 to 52|Other|10|||
147186475|NCT01276639|530849957|FG001|Week 16 to 52|Other|12|||
147186476|NCT01276639|530849958|FG002|Week 16 to 52|Other|0|||
147186477|NCT01276639|530849959|FG003|Week 16 to 52|Other|1|||
147186478|NCT01276639|530849960|FG004|Week 16 to 52|Other|3|||
147186479|NCT03985761|530849963|FG000|Overall Study|Withdrawal by Subject|2|||
147186480|NCT03985761|530849964|FG001|Overall Study|Withdrawal by Subject|3|||
147186481|NCT03956550|530849965|FG000|Overall Study|Sponsor decision|65|||
147186482|NCT03956550|530849966|FG001|Overall Study|Sponsor decision|66|||
147186483|NCT03956550|530849967|FG002|Overall Study|Sponsor decision|64|||
147186484|NCT03956550|530849965|FG000|Overall Study|Adverse Event|0|||
147186485|NCT03956550|530849966|FG001|Overall Study|Adverse Event|1|||
147186486|NCT03956550|530849967|FG002|Overall Study|Adverse Event|0|||
147186487|NCT03956550|530849965|FG000|Overall Study|Withdrawal by Subject|5|||
147186488|NCT03956550|530849966|FG001|Overall Study|Withdrawal by Subject|5|||
147186489|NCT03956550|530849967|FG002|Overall Study|Withdrawal by Subject|6|||
147186490|NCT03400852|530849968|FG000|Blinded Treatment Period|Physician Decision|0|||
147186491|NCT03400852|530849969|FG001|Blinded Treatment Period|Physician Decision|1|||
147186492|NCT03400852|530849970|FG002|Blinded Treatment Period|Physician Decision|0|||
147186493|NCT03400852|530849968|FG000|Blinded Treatment Period|Adverse Event|1|||
147186494|NCT03400852|530849969|FG001|Blinded Treatment Period|Adverse Event|1|||
147186495|NCT03400852|530849970|FG002|Blinded Treatment Period|Adverse Event|0|||
147186496|NCT03400852|530849968|FG000|Blinded Treatment Period|Study terminated by sponsor|8|||
147186497|NCT03400852|530849969|FG001|Blinded Treatment Period|Study terminated by sponsor|4|||
147186498|NCT03400852|530849970|FG002|Blinded Treatment Period|Study terminated by sponsor|0|||
147186499|NCT03400852|530849968|FG000|Open Label Period|Physician Decision|0|||
147186500|NCT03400852|530849969|FG001|Open Label Period|Physician Decision|0|||
147186501|NCT03400852|530849970|FG002|Open Label Period|Physician Decision|1|||
147186502|NCT03400852|530849968|FG000|Open Label Period|Study terminated by sponsor|0|||
147186503|NCT03400852|530849969|FG001|Open Label Period|Study terminated by sponsor|0|||
147186504|NCT03400852|530849970|FG002|Open Label Period|Study terminated by sponsor|21|||
147186505|NCT01285401|530849971|FG000|Overall Study|Prematurely withdrawn from the study|17|||
147186506|NCT01285401|530849972|FG001|Overall Study|Prematurely withdrawn from the study|29|||
147186507|NCT02366312|530849973|FG000|Overall Study|Lost to Follow-up|0|||
147186508|NCT02366312|530849974|FG001|Overall Study|Lost to Follow-up|1|||
147329312|NCT02987543|531371682|FG002|Overall Study|Withdrawal by Subject|7|||
147329313|NCT02987543|531371683|FG003|Overall Study|Withdrawal by Subject|6|||
147186509|NCT02532465|530849975|FG000|Overall Study|Protocol Violation|1|||
147186510|NCT02532465|530849976|FG001|Overall Study|Protocol Violation|0|||
147186511|NCT02532465|530849975|FG000|Overall Study|Lack of Efficacy|0|||
147186512|NCT02532465|530849976|FG001|Overall Study|Lack of Efficacy|1|||
147186513|NCT03719131|530849978|FG000|Overall Study|Death|1|||
147186514|NCT03719131|530849979|FG001|Overall Study|Death|2|||
147186515|NCT01544920|530849980|FG000|Overall Study|Adverse Event|0|||
147186516|NCT01544920|530849981|FG001|Overall Study|Adverse Event|3|||
147186517|NCT01544920|530849980|FG000|Overall Study|Death|0|||
147186518|NCT01544920|530849981|FG001|Overall Study|Death|1|||
147186519|NCT01544920|530849980|FG000|Overall Study|Lost to Follow-up|11|||
147186520|NCT01544920|530849981|FG001|Overall Study|Lost to Follow-up|12|||
147186521|NCT01544920|530849980|FG000|Overall Study|Protocol Violation|0|||
147186522|NCT01544920|530849981|FG001|Overall Study|Protocol Violation|2|||
147186523|NCT01544920|530849980|FG000|Overall Study|Physician Decision|4|||
147186524|NCT01544920|530849981|FG001|Overall Study|Physician Decision|1|||
147186525|NCT01544920|530849980|FG000|Overall Study|Withdrawal by Subject|4|||
147186526|NCT01544920|530849981|FG001|Overall Study|Withdrawal by Subject|4|||
147186527|NCT03244917|530849987|FG000|Overall Study|Lost to Follow-up|2|||
147186528|NCT03244917|530849988|FG001|Overall Study|Lost to Follow-up|2|||
147186529|NCT01272232|530849989|FG000|Weeks 0-56|Adverse Event|39|||
147186530|NCT01272232|530849990|FG001|Weeks 0-56|Adverse Event|18|||
147186531|NCT01272232|530849991|FG002|Weeks 0-56|Adverse Event|7|||
147186532|NCT01272232|530849989|FG000|Weeks 0-56|Lack of Efficacy|0|||
147186533|NCT01272232|530849990|FG001|Weeks 0-56|Lack of Efficacy|0|||
147186534|NCT01272232|530849991|FG002|Weeks 0-56|Lack of Efficacy|3|||
147186535|NCT01272232|530849989|FG000|Weeks 0-56|Protocol Violation|12|||
147186536|NCT01272232|530849990|FG001|Weeks 0-56|Protocol Violation|8|||
147186537|NCT01272232|530849991|FG002|Weeks 0-56|Protocol Violation|13|||
147186538|NCT01272232|530849989|FG000|Weeks 0-56|Withdrawal criteria|32|||
147186539|NCT01272232|530849990|FG001|Weeks 0-56|Withdrawal criteria|14|||
147186540|NCT01272232|530849991|FG002|Weeks 0-56|Withdrawal criteria|37|||
147186541|NCT01272232|530849989|FG000|Weeks 0-56|Unclassified|16|||
147186542|NCT01272232|530849990|FG001|Weeks 0-56|Unclassified|7|||
147186543|NCT01272232|530849991|FG002|Weeks 0-56|Unclassified|12|||
147186544|NCT01272232|530849989|FG000|Off Drug Follow-up Period (Weeks 56-68)|Adverse Event|1|||
147186545|NCT01272232|530849990|FG001|Off Drug Follow-up Period (Weeks 56-68)|Adverse Event|1|||
147186546|NCT01272232|530849991|FG002|Off Drug Follow-up Period (Weeks 56-68)|Adverse Event|0|||
147186547|NCT01272232|530849989|FG000|Off Drug Follow-up Period (Weeks 56-68)|Lack of Efficacy|1|||
147186548|NCT01272232|530849990|FG001|Off Drug Follow-up Period (Weeks 56-68)|Lack of Efficacy|0|||
147186549|NCT01272232|530849991|FG002|Off Drug Follow-up Period (Weeks 56-68)|Lack of Efficacy|0|||
147186550|NCT01272232|530849989|FG000|Off Drug Follow-up Period (Weeks 56-68)|Protocol Violation|1|||
147186551|NCT01272232|530849990|FG001|Off Drug Follow-up Period (Weeks 56-68)|Protocol Violation|0|||
147186552|NCT01272232|530849991|FG002|Off Drug Follow-up Period (Weeks 56-68)|Protocol Violation|1|||
147186553|NCT01272232|530849989|FG000|Off Drug Follow-up Period (Weeks 56-68)|Withdrawal criteria|9|||
147186554|NCT01272232|530849990|FG001|Off Drug Follow-up Period (Weeks 56-68)|Withdrawal criteria|7|||
147186555|NCT01272232|530849991|FG002|Off Drug Follow-up Period (Weeks 56-68)|Withdrawal criteria|4|||
147186556|NCT01272232|530849989|FG000|Off Drug Follow-up Period (Weeks 56-68)|Unclassified|2|||
147186557|NCT01272232|530849990|FG001|Off Drug Follow-up Period (Weeks 56-68)|Unclassified|2|||
147448747|NCT01297270|531807963|FG002|Overall Study|Lack of Efficacy|15|||
147186558|NCT01272232|530849991|FG002|Off Drug Follow-up Period (Weeks 56-68)|Unclassified|0|||
147186559|NCT02159066|530849992|FG000|Part I|Adverse Event|7|||
147186560|NCT02159066|530849993|FG001|Part I|Adverse Event|5|||
147186561|NCT02159066|530849994|FG002|Part I|Adverse Event|0|||
147186562|NCT02159066|530849995|FG003|Part I|Adverse Event|0|||
147186563|NCT02159066|530849996|FG004|Part I|Adverse Event|0|||
147186564|NCT02159066|530849997|FG005|Part I|Adverse Event|0|||
147186565|NCT02159066|530849992|FG000|Part I|Death|11|||
147186566|NCT02159066|530849993|FG001|Part I|Death|9|||
147186567|NCT02159066|530849994|FG002|Part I|Death|0|||
147186568|NCT02159066|530849995|FG003|Part I|Death|0|||
147186569|NCT02159066|530849996|FG004|Part I|Death|0|||
147186570|NCT02159066|530849997|FG005|Part I|Death|0|||
147186571|NCT02159066|530849992|FG000|Part I|Progressive Disease|37|||
147186572|NCT02159066|530849993|FG001|Part I|Progressive Disease|46|||
147186573|NCT02159066|530849994|FG002|Part I|Progressive Disease|0|||
147186574|NCT02159066|530849995|FG003|Part I|Progressive Disease|0|||
147186575|NCT02159066|530849996|FG004|Part I|Progressive Disease|0|||
147186576|NCT02159066|530849997|FG005|Part I|Progressive Disease|0|||
147186577|NCT02159066|530849992|FG000|Part I|New Therapy for Study Indication|5|||
147186578|NCT02159066|530849993|FG001|Part I|New Therapy for Study Indication|4|||
147186579|NCT02159066|530849994|FG002|Part I|New Therapy for Study Indication|0|||
147186580|NCT02159066|530849995|FG003|Part I|New Therapy for Study Indication|0|||
147186581|NCT02159066|530849996|FG004|Part I|New Therapy for Study Indication|0|||
147186582|NCT02159066|530849997|FG005|Part I|New Therapy for Study Indication|0|||
147186583|NCT02159066|530849992|FG000|Part I|Termination of participants from the study|3|||
147186584|NCT02159066|530849993|FG001|Part I|Termination of participants from the study|3|||
147186585|NCT02159066|530849994|FG002|Part I|Termination of participants from the study|0|||
147186586|NCT02159066|530849995|FG003|Part I|Termination of participants from the study|0|||
147186587|NCT02159066|530849996|FG004|Part I|Termination of participants from the study|0|||
147186588|NCT02159066|530849997|FG005|Part I|Termination of participants from the study|0|||
147448748|NCT01297270|531807961|FG000|Overall Study|Lost to Follow-up|1|||
147448749|NCT01297270|531807962|FG001|Overall Study|Lost to Follow-up|2|||
147186589|NCT02159066|530849992|FG000|Part I|Physician Decision|2|||
147186590|NCT02159066|530849993|FG001|Part I|Physician Decision|9|||
147448750|NCT01297270|531807963|FG002|Overall Study|Lost to Follow-up|1|||
147448751|NCT01297270|531807961|FG000|Overall Study|Protocol Violation|0|||
147448752|NCT01297270|531807962|FG001|Overall Study|Protocol Violation|2|||
147448753|NCT01297270|531807963|FG002|Overall Study|Protocol Violation|0|||
147448754|NCT01297270|531807961|FG000|Overall Study|Withdrawal by Subject|7|||
147448755|NCT01297270|531807962|FG001|Overall Study|Withdrawal by Subject|15|||
147448756|NCT01297270|531807963|FG002|Overall Study|Withdrawal by Subject|7|||
147448757|NCT01297270|531807961|FG000|Overall Study|Other reason not defined above|3|||
147448758|NCT01297270|531807962|FG001|Overall Study|Other reason not defined above|3|||
147448759|NCT01297270|531807963|FG002|Overall Study|Other reason not defined above|1|||
147448760|NCT01297270|531807961|FG000|Overall Study|Not treated|0|||
147448761|NCT01297270|531807962|FG001|Overall Study|Not treated|1|||
147448762|NCT01297270|531807963|FG002|Overall Study|Not treated|0|||
147448763|NCT00401752|531807964|FG000|Overall Study|Adverse Event|2|||
147448764|NCT00401752|531807965|FG001|Overall Study|Adverse Event|5|||
147448765|NCT00401752|531807964|FG000|Overall Study|Withdrawal by Subject|2|||
147448766|NCT00401752|531807965|FG001|Overall Study|Withdrawal by Subject|6|||
147448767|NCT00401752|531807964|FG000|Overall Study|Lost to Follow-up|1|||
147448768|NCT00401752|531807965|FG001|Overall Study|Lost to Follow-up|4|||
147448769|NCT00401752|531807964|FG000|Overall Study|Development of any exclusion criteria|4|||
147448770|NCT00401752|531807965|FG001|Overall Study|Development of any exclusion criteria|2|||
147448771|NCT00401752|531807964|FG000|Overall Study|Physician Decision|1|||
147448772|NCT00401752|531807965|FG001|Overall Study|Physician Decision|1|||
147448773|NCT00382993|531807966|FG000|Migraine Attack 1 (Period 1)|Lost to Follow-up|7|||
147448774|NCT00382993|531807967|FG001|Migraine Attack 1 (Period 1)|Lost to Follow-up|2|||
147448775|NCT00382993|531807966|FG000|Migraine Attack 1 (Period 1)|Withdrawal by Subject|1|||
147448776|NCT00382993|531807967|FG001|Migraine Attack 1 (Period 1)|Withdrawal by Subject|3|||
147448777|NCT00382993|531807966|FG000|Migraine Attack 1 (Period 1)|Lack of opportunity to treat migraine|0|||
147448778|NCT00382993|531807967|FG001|Migraine Attack 1 (Period 1)|Lack of opportunity to treat migraine|5|||
147448779|NCT00382993|531807966|FG000|Migraine Attack 1 (Period 1)|Did not meet Eligibility Criteria|3|||
147448780|NCT00382993|531807967|FG001|Migraine Attack 1 (Period 1)|Did not meet Eligibility Criteria|3|||
147448781|NCT00382993|531807966|FG000|Migraine Attack 1 (Period 1)|Other (no additional data present)|3|||
147448782|NCT00382993|531807967|FG001|Migraine Attack 1 (Period 1)|Other (no additional data present)|5|||
147448783|NCT00382993|531807966|FG000|Migraine Attack 2 (Period 2)|Lost to Follow-up|1|||
147448784|NCT00382993|531807967|FG001|Migraine Attack 2 (Period 2)|Lost to Follow-up|0|||
147448785|NCT00382993|531807966|FG000|Migraine Attack 2 (Period 2)|Lack of opportunity to treat migraine|0|||
147448786|NCT00382993|531807967|FG001|Migraine Attack 2 (Period 2)|Lack of opportunity to treat migraine|1|||
147448787|NCT00382993|531807966|FG000|Migraine Attack 2 (Period 2)|Did not meet Eligibility Criteria|0|||
147448788|NCT00382993|531807967|FG001|Migraine Attack 2 (Period 2)|Did not meet Eligibility Criteria|1|||
147448789|NCT00382993|531807966|FG000|Migraine Attack 2 (Period 2)|Protocol Violation|0|||
147448790|NCT00382993|531807967|FG001|Migraine Attack 2 (Period 2)|Protocol Violation|1|||
147448791|NCT00382993|531807966|FG000|Migraine Attack 2 (Period 2)|Other (no additional data present)|1|||
147448792|NCT00382993|531807967|FG001|Migraine Attack 2 (Period 2)|Other (no additional data present)|1|||
147448793|NCT01965262|531807977|FG000|Second Intervention (7 Days)|Discontinued|0|||
147448794|NCT01965262|531807978|FG001|Second Intervention (7 Days)|Discontinued|1|||
147448795|NCT01965262|531807977|FG000|Second Intervention (7 Days)|Poor lens fit|0|||
147448796|NCT01965262|531807978|FG001|Second Intervention (7 Days)|Poor lens fit|9|||
147448797|NCT01965262|531807977|FG000|Second Intervention (7 Days)|Poor visual acuity|1|||
147448798|NCT01965262|531807978|FG001|Second Intervention (7 Days)|Poor visual acuity|0|||
147448799|NCT01029366|531807979|FG000|Overall Study|Withdrawal by Subject|1|||
147448800|NCT01029366|531807980|FG001|Overall Study|Withdrawal by Subject|0|||
147448801|NCT01029366|531807979|FG000|Overall Study|Death|1|||
147448802|NCT01029366|531807980|FG001|Overall Study|Death|1|||
147448803|NCT01029366|531807979|FG000|Overall Study|disease progression|2|||
147448804|NCT01029366|531807980|FG001|Overall Study|disease progression|0|||
147448805|NCT01029366|531807979|FG000|Overall Study|manufacturing failure|0|||
147448806|NCT01029366|531807980|FG001|Overall Study|manufacturing failure|1|||
147448807|NCT00906087|531807986|FG000|Initial Washout|Withdrawal by Subject|1|||
147329314|NCT02987543|531371680|FG000|Overall Study|Study terminated by sponsor|1|||
147329315|NCT02987543|531371681|FG001|Overall Study|Study terminated by sponsor|0|||
147329316|NCT02987543|531371682|FG002|Overall Study|Study terminated by sponsor|0|||
147329317|NCT02987543|531371683|FG003|Overall Study|Study terminated by sponsor|0|||
147329318|NCT02987543|531371680|FG000|Overall Study|Investigator decision|0|||
147329319|NCT02987543|531371681|FG001|Overall Study|Investigator decision|1|||
147329320|NCT02987543|531371682|FG002|Overall Study|Investigator decision|0|||
147329321|NCT02987543|531371683|FG003|Overall Study|Investigator decision|0|||
147448808|NCT00906087|531807986|FG000|Initial Washout|Physician Decision|1|||
147448809|NCT02941627|531807998|FG000|Overall Study|Death|1|||
147448810|NCT02941627|531807998|FG000|Overall Study|Surgical failure|1|||
147448811|NCT02941627|531807998|FG000|Overall Study|cholesteatoma prevented implantation|1|||
147448812|NCT00606320|531807999|FG000|Overall Study|Adverse Event|3|||
147329322|NCT02987543|531371680|FG000|Overall Study|Disease progression|0|||
147247313|NCT03902574|531074461|FG002|Overall Study|Urinary drug test was positive on Day 20|1|||
147247314|NCT00284050|531074464|FG000|Overall Study|Adverse Event|1|||
147247315|NCT00284050|531074465|FG001|Overall Study|Adverse Event|1|||
147247316|NCT00284050|531074466|FG002|Overall Study|Adverse Event|1|||
147247317|NCT00284050|531074464|FG000|Overall Study|Lack of Efficacy|0|||
147247318|NCT00284050|531074465|FG001|Overall Study|Lack of Efficacy|1|||
147247319|NCT00284050|531074466|FG002|Overall Study|Lack of Efficacy|3|||
147247320|NCT00284050|531074464|FG000|Overall Study|Protocol Violation|0|||
147247321|NCT00284050|531074465|FG001|Overall Study|Protocol Violation|1|||
147247322|NCT00284050|531074466|FG002|Overall Study|Protocol Violation|2|||
147247323|NCT00284050|531074464|FG000|Overall Study|Withdrawal by Subject|2|||
147247324|NCT00284050|531074465|FG001|Overall Study|Withdrawal by Subject|2|||
147247325|NCT00284050|531074466|FG002|Overall Study|Withdrawal by Subject|2|||
147247326|NCT00284050|531074464|FG000|Overall Study|Lost to Follow-up|1|||
147247327|NCT00284050|531074465|FG001|Overall Study|Lost to Follow-up|0|||
147247328|NCT00284050|531074466|FG002|Overall Study|Lost to Follow-up|1|||
147247329|NCT00284050|531074464|FG000|Overall Study|Death|1|||
147247330|NCT00284050|531074465|FG001|Overall Study|Death|0|||
147247331|NCT00284050|531074466|FG002|Overall Study|Death|0|||
147247332|NCT02573350|531074467|FG000|Overall Study|Lost to Follow-up|2|||
147247333|NCT02573350|531074468|FG001|Overall Study|Lost to Follow-up|1|||
147247334|NCT02573350|531074467|FG000|Overall Study|Adverse Event|3|||
147247335|NCT02573350|531074468|FG001|Overall Study|Adverse Event|4|||
147247336|NCT02573350|531074467|FG000|Overall Study|Subject met Withdrawal Criteria|1|||
147247337|NCT02573350|531074468|FG001|Overall Study|Subject met Withdrawal Criteria|1|||
147247338|NCT02573350|531074467|FG000|Overall Study|Subject was Withdrawn from Participation by the Investigator|3|||
147247339|NCT02573350|531074468|FG001|Overall Study|Subject was Withdrawn from Participation by the Investigator|1|||
147247340|NCT02573350|531074467|FG000|Overall Study|Subject withdrew consent to participate|6|||
147247341|NCT02573350|531074468|FG001|Overall Study|Subject withdrew consent to participate|1|||
147247342|NCT02573350|531074467|FG000|Overall Study|Protocol Deviation|1|||
147247343|NCT02573350|531074468|FG001|Overall Study|Protocol Deviation|1|||
147247344|NCT02708121|531074469|FG000|Overall Study|Withdrawn by Study Team|1|||
147247345|NCT02708121|531074470|FG001|Overall Study|Withdrawn by Study Team|1|||
147247346|NCT02708121|531074469|FG000|Overall Study|Withdrawal by Subject|0|||
147247347|NCT02708121|531074470|FG001|Overall Study|Withdrawal by Subject|4|||
147247348|NCT01111149|531074471|FG000|Overall Study|Protocol Violation|1|||
147247349|NCT01111149|531074472|FG001|Overall Study|Protocol Violation|1|||
147247350|NCT01111149|531074473|FG002|Overall Study|Protocol Violation|2|||
147247351|NCT01111149|531074471|FG000|Overall Study|Withdrawal by Subject|1|||
147247352|NCT01111149|531074472|FG001|Overall Study|Withdrawal by Subject|0|||
147247353|NCT01111149|531074473|FG002|Overall Study|Withdrawal by Subject|2|||
147247354|NCT03765918|531074478|FG000|Overall Study|Death|109|||
147247355|NCT03765918|531074479|FG001|Overall Study|Death|127|||
147247356|NCT03765918|531074478|FG000|Overall Study|Lost to Follow-up|2|||
147247357|NCT03765918|531074479|FG001|Overall Study|Lost to Follow-up|3|||
147247358|NCT03765918|531074478|FG000|Overall Study|Withdrawal by Subject|12|||
147247359|NCT03765918|531074479|FG001|Overall Study|Withdrawal by Subject|16|||
147247360|NCT03765918|531074478|FG000|Overall Study|Participants Ongoing|240|||
147247361|NCT03765918|531074479|FG001|Overall Study|Participants Ongoing|205|||
147247362|NCT01484197|531074483|FG000|Treatment Period 1|Adverse Event|1|||
147247363|NCT01484197|531074484|FG001|Treatment Period 1|Adverse Event|0|||
147247364|NCT01484197|531074485|FG002|Treatment Period 1|Adverse Event|0|||
147247365|NCT01484197|531074486|FG003|Treatment Period 1|Adverse Event|0|||
147247366|NCT01484197|531074483|FG000|Treatment Period 2|Subject withdrew consent|0|||
147247367|NCT01484197|531074484|FG001|Treatment Period 2|Subject withdrew consent|0|||
147247368|NCT01484197|531074485|FG002|Treatment Period 2|Subject withdrew consent|0|||
147247369|NCT01484197|531074486|FG003|Treatment Period 2|Subject withdrew consent|1|||
147247370|NCT00814164|531074487|FG000|Overall Study|Progression|7|||
147247371|NCT00814164|531074487|FG000|Overall Study|not stated|7|||
147247372|NCT00814164|531074487|FG000|Overall Study|Death|5|||
147247373|NCT00299975|531074488|FG000|Overall Study|Adverse Event|1|||
147247374|NCT00299975|531074489|FG001|Overall Study|Adverse Event|0|||
147247375|NCT00299975|531074490|FG002|Overall Study|Adverse Event|2|||
147247376|NCT00299975|531074488|FG000|Overall Study|Pregnancy|0|||
147247377|NCT00299975|531074489|FG001|Overall Study|Pregnancy|0|||
147247378|NCT00299975|531074490|FG002|Overall Study|Pregnancy|1|||
147247379|NCT00299975|531074488|FG000|Overall Study|Lack of Efficacy|1|||
147247380|NCT00299975|531074489|FG001|Overall Study|Lack of Efficacy|0|||
147247381|NCT00299975|531074490|FG002|Overall Study|Lack of Efficacy|1|||
147247382|NCT00299975|531074488|FG000|Overall Study|Lost to Follow-up|1|||
147247383|NCT00299975|531074489|FG001|Overall Study|Lost to Follow-up|0|||
147247384|NCT00299975|531074490|FG002|Overall Study|Lost to Follow-up|0|||
147247385|NCT00299975|531074488|FG000|Overall Study|Withdrawal by Subject|0|||
147247386|NCT00299975|531074489|FG001|Overall Study|Withdrawal by Subject|1|||
147247387|NCT00299975|531074490|FG002|Overall Study|Withdrawal by Subject|3|||
147247388|NCT00299975|531074488|FG000|Overall Study|Physician Decision|0|||
147247389|NCT00299975|531074489|FG001|Overall Study|Physician Decision|0|||
147247390|NCT00299975|531074490|FG002|Overall Study|Physician Decision|1|||
147186591|NCT02159066|530849994|FG002|Part I|Physician Decision|0|||
147186592|NCT02159066|530849995|FG003|Part I|Physician Decision|0|||
147186593|NCT02159066|530849996|FG004|Part I|Physician Decision|0|||
147186594|NCT02159066|530849997|FG005|Part I|Physician Decision|0|||
147186595|NCT02159066|530849992|FG000|Part I|Participant/Guardian Decision|9|||
147186596|NCT02159066|530849993|FG001|Part I|Participant/Guardian Decision|3|||
147186597|NCT02159066|530849994|FG002|Part I|Participant/Guardian Decision|0|||
147186598|NCT02159066|530849995|FG003|Part I|Participant/Guardian Decision|0|||
147186599|NCT02159066|530849996|FG004|Part I|Participant/Guardian Decision|0|||
147186600|NCT02159066|530849997|FG005|Part I|Participant/Guardian Decision|0|||
147186601|NCT02159066|530849992|FG000|Part I|Missing Data|1|||
147186602|NCT02159066|530849993|FG001|Part I|Missing Data|0|||
147186603|NCT02159066|530849994|FG002|Part I|Missing Data|0|||
147186604|NCT02159066|530849995|FG003|Part I|Missing Data|0|||
147186605|NCT02159066|530849996|FG004|Part I|Missing Data|0|||
147186606|NCT02159066|530849997|FG005|Part I|Missing Data|0|||
147186607|NCT02159066|530849992|FG000|Part II|Adverse Event|0|||
147186608|NCT02159066|530849993|FG001|Part II|Adverse Event|0|||
147186609|NCT02159066|530849994|FG002|Part II|Adverse Event|1|||
147186610|NCT02159066|530849995|FG003|Part II|Adverse Event|0|||
147186611|NCT02159066|530849996|FG004|Part II|Adverse Event|1|||
147186612|NCT02159066|530849997|FG005|Part II|Adverse Event|1|||
147186613|NCT02159066|530849992|FG000|Part II|Death|0|||
147186614|NCT02159066|530849993|FG001|Part II|Death|0|||
147186615|NCT02159066|530849994|FG002|Part II|Death|1|||
147186616|NCT02159066|530849995|FG003|Part II|Death|0|||
147186617|NCT02159066|530849996|FG004|Part II|Death|2|||
147186618|NCT02159066|530849997|FG005|Part II|Death|1|||
147186619|NCT02159066|530849992|FG000|Part II|Progressive Disease|0|||
147186620|NCT02159066|530849993|FG001|Part II|Progressive Disease|0|||
147186621|NCT02159066|530849994|FG002|Part II|Progressive Disease|35|||
147186622|NCT02159066|530849995|FG003|Part II|Progressive Disease|1|||
147186623|NCT02159066|530849996|FG004|Part II|Progressive Disease|7|||
147186624|NCT02159066|530849997|FG005|Part II|Progressive Disease|4|||
147186625|NCT02159066|530849992|FG000|Part II|New Therapy for Study Indication|0|||
147186626|NCT02159066|530849993|FG001|Part II|New Therapy for Study Indication|0|||
147186627|NCT02159066|530849994|FG002|Part II|New Therapy for Study Indication|0|||
147186628|NCT02159066|530849995|FG003|Part II|New Therapy for Study Indication|0|||
147186629|NCT02159066|530849996|FG004|Part II|New Therapy for Study Indication|1|||
147186630|NCT02159066|530849997|FG005|Part II|New Therapy for Study Indication|0|||
147186631|NCT02159066|530849992|FG000|Part II|Physician Decision|0|||
147186632|NCT02159066|530849993|FG001|Part II|Physician Decision|0|||
147186633|NCT02159066|530849994|FG002|Part II|Physician Decision|1|||
147186634|NCT02159066|530849995|FG003|Part II|Physician Decision|0|||
147186635|NCT02159066|530849996|FG004|Part II|Physician Decision|0|||
147186636|NCT02159066|530849997|FG005|Part II|Physician Decision|0|||
147186637|NCT02159066|530849992|FG000|Part II|Participant/Guardian Decision|0|||
147186638|NCT02159066|530849993|FG001|Part II|Participant/Guardian Decision|0|||
147186639|NCT02159066|530849994|FG002|Part II|Participant/Guardian Decision|0|||
147186640|NCT02159066|530849995|FG003|Part II|Participant/Guardian Decision|0|||
147186641|NCT02159066|530849996|FG004|Part II|Participant/Guardian Decision|2|||
147186642|NCT02159066|530849997|FG005|Part II|Participant/Guardian Decision|0|||
147186643|NCT01135134|530849998|FG000|Overall Study|Adverse Event|1|||
147186644|NCT01135134|530849999|FG001|Overall Study|Adverse Event|1|||
147186645|NCT01135134|530849998|FG000|Overall Study|Did not meet protocol eligibility|1|||
147186646|NCT01135134|530849999|FG001|Overall Study|Did not meet protocol eligibility|0|||
147186647|NCT05470387|530850000|FG000|Overall Study|Protocol Violation|0|||
147186648|NCT05470387|530850001|FG001|Overall Study|Protocol Violation|3|||
147186649|NCT01176058|530850003|FG000|Overall Study|Adverse Event|1|||
147186650|NCT01176058|530850004|FG001|Overall Study|Adverse Event|0|||
147186651|NCT01176058|530850003|FG000|Overall Study|Insufficient clinical response|2|||
147186652|NCT01176058|530850004|FG001|Overall Study|Insufficient clinical response|2|||
147186653|NCT01176058|530850003|FG000|Overall Study|Insufficient mycological response|0|||
147186654|NCT01176058|530850004|FG001|Overall Study|Insufficient mycological response|1|||
147186655|NCT01176058|530850003|FG000|Overall Study|Withdrawal by Subject|1|||
147186656|NCT01176058|530850004|FG001|Overall Study|Withdrawal by Subject|0|||
147186657|NCT00256724|530850007|FG000|Overall Study|Physician Decision|2|||
147186658|NCT00256724|530850008|FG001|Overall Study|Physician Decision|5|||
147186659|NCT00256724|530850007|FG000|Overall Study|Protocol Violation|3|||
147186660|NCT00256724|530850008|FG001|Overall Study|Protocol Violation|3|||
147247391|NCT01169493|531074496|FG000|Period 1 (6 Months)|Withdrawal by Subject|0|||
147247392|NCT01169493|531074497|FG001|Period 1 (6 Months)|Withdrawal by Subject|1|||
147247393|NCT01169493|531074498|FG002|Period 1 (6 Months)|Withdrawal by Subject|2|||
147247394|NCT01169493|531074499|FG003|Period 1 (6 Months)|Withdrawal by Subject|0|||
147247395|NCT01169493|531074500|FG004|Period 1 (6 Months)|Withdrawal by Subject|0|||
147247396|NCT01169493|531074501|FG005|Period 1 (6 Months)|Withdrawal by Subject|3|||
147247397|NCT01169493|531074496|FG000|Period 3 (6 Months)|Adverse Event|0|||
147186661|NCT01217463|530850009|FG000|Overall Study|Adverse Event|8|||
147186662|NCT01217463|530850010|FG001|Overall Study|Adverse Event|5|||
147186663|NCT01217463|530850009|FG000|Overall Study|Physician Decision|0|||
147186664|NCT01217463|530850010|FG001|Overall Study|Physician Decision|1|||
147186665|NCT01217463|530850009|FG000|Overall Study|Withdrawal by Subject|3|||
147186666|NCT01217463|530850010|FG001|Overall Study|Withdrawal by Subject|0|||
147186667|NCT01217463|530850009|FG000|Overall Study|Surgery on the Target Limb|0|||
147186668|NCT01217463|530850010|FG001|Overall Study|Surgery on the Target Limb|1|||
147186669|NCT01217463|530850009|FG000|Overall Study|Patient Non-compliant|1|||
147186670|NCT01217463|530850010|FG001|Overall Study|Patient Non-compliant|0|||
147186671|NCT01217463|530850009|FG000|Overall Study|Other|1|||
147186672|NCT01217463|530850010|FG001|Overall Study|Other|1|||
147186673|NCT01858363|530850013|FG000|Overall Study|Death|35|||
147186674|NCT01858363|530850014|FG001|Overall Study|Death|9|||
147186675|NCT01858363|530850013|FG000|Overall Study|Withdrawal by Subject|28|||
147186676|NCT01858363|530850014|FG001|Overall Study|Withdrawal by Subject|14|||
147186677|NCT01858363|530850013|FG000|Overall Study|Lost to Follow-up|13|||
147186678|NCT01858363|530850014|FG001|Overall Study|Lost to Follow-up|3|||
147186679|NCT01569841|530850021|FG000|Period A (6 Weeks)|Withdrawal by Subject|0|||
147186680|NCT01569841|530850022|FG001|Period A (6 Weeks)|Withdrawal by Subject|1|||
147186681|NCT00057863|530850023|FG000|Overall Study|Death|1|||
147186682|NCT00057863|530850023|FG000|Overall Study|Withdrawal by Subject|2|||
147186683|NCT00764361|530850024|FG000|Overall Study|Withdrawal by Subject|2|||
147186684|NCT00764361|530850025|FG001|Overall Study|Withdrawal by Subject|3|||
147186685|NCT00764361|530850024|FG000|Overall Study|Adverse Event|0|||
147186686|NCT00764361|530850025|FG001|Overall Study|Adverse Event|1|||
147186687|NCT02090426|530850026|FG000|Overall Study|Lost to Follow-up|12|||
147186688|NCT02090426|530850027|FG001|Overall Study|Lost to Follow-up|6|||
147186689|NCT02079038|530850028|FG000|Modified Intent to Treat Population|Withdrawal by Subject|6|||
147186690|NCT02079038|530850029|FG001|Modified Intent to Treat Population|Withdrawal by Subject|5|||
147186691|NCT02079038|530850028|FG000|Modified Intent to Treat Population|Death|1|||
147186692|NCT02079038|530850029|FG001|Modified Intent to Treat Population|Death|0|||
147186693|NCT02079038|530850028|FG000|Completed 6 Months|Lost to Follow-up|2|||
147186694|NCT02079038|530850029|FG001|Completed 6 Months|Lost to Follow-up|1|||
147186695|NCT03480152|530850030|FG000|Phase I|Signed consent. Died before treatment.|1|||
147186696|NCT03480152|530850031|FG001|Phase I|Signed consent. Died before treatment.|0|||
147186697|NCT03480152|530850032|FG002|Phase I|Signed consent. Died before treatment.|0|||
147186698|NCT03634085|530850033|FG000|Overall Study|Adverse Event|1|||
147186699|NCT03634085|530850034|FG001|Overall Study|Adverse Event|0|||
147186700|NCT03634085|530850033|FG000|Overall Study|Withdrawal by Subject|0|||
147186701|NCT03634085|530850034|FG001|Overall Study|Withdrawal by Subject|2|||
147186702|NCT04276233|530850035|FG000|Overall Study|Adverse Event|1|||
147186703|NCT04276233|530850035|FG000|Overall Study|Lost to Follow-up|3|||
147186704|NCT04276233|530850035|FG000|Overall Study|Physician Decision|4|||
147186705|NCT04276233|530850035|FG000|Overall Study|Withdrawal by Subject|2|||
147186706|NCT00148759|530850038|FG000|Overall Study|Withdrawal by Subject|1|||
147186707|NCT00148759|530850039|FG001|Overall Study|Withdrawal by Subject|1|||
147186708|NCT00148759|530850038|FG000|Overall Study|Lost to Follow-up|1|||
147186709|NCT00148759|530850039|FG001|Overall Study|Lost to Follow-up|0|||
147186710|NCT01454596|530850040|FG000|Overall Study|Death|0|||
147186711|NCT01454596|530850041|FG001|Overall Study|Death|0|||
147186712|NCT01454596|530850042|FG002|Overall Study|Death|0|||
147186713|NCT01454596|530850043|FG003|Overall Study|Death|0|||
147186714|NCT01454596|530850044|FG004|Overall Study|Death|0|||
147186715|NCT01454596|530850045|FG005|Overall Study|Death|0|||
147186716|NCT01454596|530850046|FG006|Overall Study|Death|0|||
147186717|NCT01454596|530850047|FG007|Overall Study|Death|0|||
147186718|NCT01454596|530850048|FG008|Overall Study|Death|0|||
147186719|NCT01454596|530850049|FG009|Overall Study|Death|1|||
147186720|NCT01454596|530850050|FG010|Overall Study|Death|1|||
147186721|NCT01454596|530850051|FG011|Overall Study|Death|0|||
147186722|NCT02800863|530850060|FG000|Overall Study|Adverse Event|14|||
147186723|NCT02800863|530850060|FG000|Overall Study|Another Device Implanted|1|||
147186724|NCT02800863|530850060|FG000|Overall Study|Device Explanted|1|||
147186725|NCT02800863|530850060|FG000|Overall Study|Device Has Been Turned Off Since Jan 2019|1|||
147186726|NCT02800863|530850060|FG000|Overall Study|Health Issues|1|||
147186727|NCT02800863|530850060|FG000|Overall Study|Insurance Denial|8|||
147186728|NCT02800863|530850060|FG000|Overall Study|No Perm Implant, Active Pain Pump Implanted|1|||
147329323|NCT02987543|531371681|FG001|Overall Study|Disease progression|0|||
147329324|NCT02987543|531371682|FG002|Overall Study|Disease progression|0|||
147329325|NCT02987543|531371683|FG003|Overall Study|Disease progression|1|||
147329326|NCT01280591|531371688|FG000|Overall Study|Withdrawal by Subject|0|||
147329327|NCT01280591|531371689|FG001|Overall Study|Withdrawal by Subject|0|||
147329328|NCT01280591|531371690|FG002|Overall Study|Withdrawal by Subject|0|||
147186729|NCT02800863|530850060|FG000|Overall Study|Patient Did not Obtain at Least 50% Pain Relief|1|||
147186730|NCT02800863|530850060|FG000|Overall Study|Screen Failure|1|||
147186731|NCT02800863|530850060|FG000|Overall Study|Sponsor Request|6|||
147186732|NCT02800863|530850060|FG000|Overall Study|Death|3|||
147186733|NCT02800863|530850060|FG000|Overall Study|Subject Implant at Another Facility|1|||
147186734|NCT02800863|530850060|FG000|Overall Study|Lost to Follow-up|26|||
147186735|NCT02800863|530850060|FG000|Overall Study|Subject Participation Terminated by Investigator|17|||
147448813|NCT00606320|531807999|FG000|Overall Study|Lack of Efficacy|5|||
147448814|NCT00606320|531807999|FG000|Overall Study|Physician Decision|7|||
147448815|NCT00606320|531807999|FG000|Overall Study|Protocol Violation|8|||
147448816|NCT00606320|531807999|FG000|Overall Study|Withdrawal by Subject|10|||
147448817|NCT00606320|531807999|FG000|Overall Study|Progression to depressive phase|4|||
147448818|NCT00563186|531808000|FG000|Overall Study|LOS<48 hours|97|||
147448819|NCT00563186|531808001|FG001|Overall Study|LOS<48 hours|74|||
147448820|NCT00563186|531808000|FG000|Overall Study|Incomplete data|1|||
147448821|NCT00563186|531808001|FG001|Overall Study|Incomplete data|1|||
147448822|NCT01152021|531808002|FG000|Overall Study|Adverse Event|4|||
147448823|NCT01152021|531808003|FG001|Overall Study|Adverse Event|4|||
147448824|NCT01152021|531808002|FG000|Overall Study|Study drug had expired|1|||
147448825|NCT01152021|531808003|FG001|Overall Study|Study drug had expired|0|||
147186736|NCT02800863|530850060|FG000|Overall Study|Subject and/or Family Request|64|||
147186737|NCT02800863|530850060|FG000|Overall Study|Trial Failure|81|||
147186738|NCT02800863|530850060|FG000|Overall Study|Used Different Battery not Approved for Study at Time of Perm|1|||
147186739|NCT03957551|530850061|FG000|Overall Study|Adverse Event|2|||
147186740|NCT03957551|530850062|FG001|Overall Study|Adverse Event|2|||
147186741|NCT03957551|530850063|FG002|Overall Study|Adverse Event|6|||
147186742|NCT03957551|530850061|FG000|Overall Study|Physician Decision|1|||
147186743|NCT03957551|530850062|FG001|Overall Study|Physician Decision|0|||
147186744|NCT03957551|530850063|FG002|Overall Study|Physician Decision|2|||
147186745|NCT03957551|530850061|FG000|Overall Study|Withdrawal by Subject|1|||
147186746|NCT03957551|530850062|FG001|Overall Study|Withdrawal by Subject|0|||
147186747|NCT03957551|530850063|FG002|Overall Study|Withdrawal by Subject|2|||
147186748|NCT03957551|530850061|FG000|Overall Study|Disease progression|1|||
147186749|NCT03957551|530850062|FG001|Overall Study|Disease progression|0|||
147186750|NCT03957551|530850063|FG002|Overall Study|Disease progression|8|||
147186751|NCT03775486|530850069|FG000|Initial Therapy Phase|Other reason provided|0|||
147186752|NCT03775486|530850070|FG001|Initial Therapy Phase|Other reason provided|15|||
147186753|NCT03775486|530850069|FG000|Initial Therapy Phase|Condition under investigation worsened|0|||
147186754|NCT03775486|530850070|FG001|Initial Therapy Phase|Condition under investigation worsened|67|||
147186755|NCT03775486|530850069|FG000|Initial Therapy Phase|Protocol Violation|0|||
147186756|NCT03775486|530850070|FG001|Initial Therapy Phase|Protocol Violation|2|||
147186757|NCT03775486|530850069|FG000|Initial Therapy Phase|Adverse Event|0|||
147186758|NCT03775486|530850070|FG001|Initial Therapy Phase|Adverse Event|34|||
147186759|NCT03775486|530850069|FG000|Initial Therapy Phase|Withdrawal by Subject|0|||
147186760|NCT03775486|530850070|FG001|Initial Therapy Phase|Withdrawal by Subject|14|||
147186761|NCT03775486|530850069|FG000|Maintenance Phase|Withdrawal by Subject|13|||
147186762|NCT03775486|530850070|FG001|Maintenance Phase|Withdrawal by Subject|12|||
147186763|NCT03775486|530850069|FG000|Maintenance Phase|Death|44|||
147186764|NCT03775486|530850070|FG001|Maintenance Phase|Death|45|||
147186765|NCT01572480|530850071|FG000|Participants Enrolled|Withdrawal by Subject|1|||
147186766|NCT01572480|530850071|FG000|Drug Administration|Discontinued drug/Off Study|1|||
147186767|NCT01572480|530850071|FG000|Initiated Maintenance Therapy|Discontinued maintenance therapy/experienced adverse events and withdrew consent|1|||
147186768|NCT01572480|530850071|FG000|Initiated Maintenance Therapy|Discontinued maintenance therapy/experienced adverse events|2|||
147186769|NCT04194944|530850072|FG000|Overall Study|Lost to Follow-up|3|||
147186770|NCT04194944|530850073|FG001|Overall Study|Lost to Follow-up|0|||
147186771|NCT04194944|530850072|FG000|Overall Study|Withdrawal by Subject|2|||
147186772|NCT04194944|530850073|FG001|Overall Study|Withdrawal by Subject|2|||
147186773|NCT04194944|530850072|FG000|Overall Study|On Treatment|93|||
147186774|NCT04194944|530850073|FG001|Overall Study|On Treatment|30|||
147186775|NCT00801216|530850074|FG000|Overall Study|Screening Failure|2|||
147186776|NCT05214768|530850075|FG000|Induction Period|Withdrawal by Subject|1|||
147186777|NCT05214768|530850076|FG001|Induction Period|Withdrawal by Subject|0|||
147186778|NCT05214768|530850077|FG002|Induction Period|Withdrawal by Subject|0|||
147186779|NCT05214768|530850078|FG003|Induction Period|Withdrawal by Subject|0|||
147186780|NCT05214768|530850079|FG004|Induction Period|Withdrawal by Subject|0|||
147186781|NCT05214768|530850080|FG005|Induction Period|Withdrawal by Subject|0|||
147186782|NCT05214768|530850075|FG000|Induction Period|Physician Decision|1|||
147186783|NCT05214768|530850076|FG001|Induction Period|Physician Decision|0|||
147448826|NCT01152021|531808002|FG000|Overall Study|Physician Decision|1|||
147186784|NCT05214768|530850077|FG002|Induction Period|Physician Decision|0|||
147186785|NCT05214768|530850078|FG003|Induction Period|Physician Decision|0|||
147448827|NCT01152021|531808003|FG001|Overall Study|Physician Decision|1|||
147448828|NCT01152021|531808002|FG000|Overall Study|No access to study drug in Pharmacy|0|||
147448829|NCT01152021|531808003|FG001|Overall Study|No access to study drug in Pharmacy|1|||
147186786|NCT05214768|530850079|FG004|Induction Period|Physician Decision|0|||
147186787|NCT05214768|530850080|FG005|Induction Period|Physician Decision|0|||
147186788|NCT05214768|530850075|FG000|Maintenance Period|Other Reasons|0|||
147186789|NCT05214768|530850076|FG001|Maintenance Period|Other Reasons|0|||
147186790|NCT05214768|530850077|FG002|Maintenance Period|Other Reasons|1|||
147186791|NCT05214768|530850078|FG003|Maintenance Period|Other Reasons|1|||
147186792|NCT05214768|530850079|FG004|Maintenance Period|Other Reasons|0|||
147448830|NCT02595723|531808004|FG000|First Washout (21 Days)|Withdrawal by Subject|1|||
147186793|NCT05214768|530850080|FG005|Maintenance Period|Other Reasons|0|||
147186794|NCT05214768|530850075|FG000|Maintenance Period|Withdrawal by Subject|0|||
147186795|NCT05214768|530850076|FG001|Maintenance Period|Withdrawal by Subject|0|||
147186796|NCT05214768|530850077|FG002|Maintenance Period|Withdrawal by Subject|0|||
147186797|NCT05214768|530850078|FG003|Maintenance Period|Withdrawal by Subject|1|||
147186798|NCT05214768|530850079|FG004|Maintenance Period|Withdrawal by Subject|0|||
147186799|NCT05214768|530850080|FG005|Maintenance Period|Withdrawal by Subject|0|||
147186800|NCT05214768|530850075|FG000|Maintenance Period|Lack of Efficacy|0|||
147186801|NCT05214768|530850076|FG001|Maintenance Period|Lack of Efficacy|0|||
147186802|NCT05214768|530850077|FG002|Maintenance Period|Lack of Efficacy|1|||
147186803|NCT05214768|530850078|FG003|Maintenance Period|Lack of Efficacy|0|||
147186804|NCT05214768|530850079|FG004|Maintenance Period|Lack of Efficacy|1|||
147186805|NCT05214768|530850080|FG005|Maintenance Period|Lack of Efficacy|0|||
147186806|NCT05214768|530850075|FG000|Open Label Extension Period|Physician Decision|0|||
147186807|NCT05214768|530850076|FG001|Open Label Extension Period|Physician Decision|0|||
147186808|NCT05214768|530850077|FG002|Open Label Extension Period|Physician Decision|0|||
147186809|NCT05214768|530850078|FG003|Open Label Extension Period|Physician Decision|0|||
147186810|NCT05214768|530850079|FG004|Open Label Extension Period|Physician Decision|0|||
147186811|NCT05214768|530850080|FG005|Open Label Extension Period|Physician Decision|1|||
147186812|NCT05214768|530850075|FG000|Open Label Extension Period|Lack of Efficacy|0|||
147186813|NCT05214768|530850076|FG001|Open Label Extension Period|Lack of Efficacy|0|||
147186814|NCT05214768|530850077|FG002|Open Label Extension Period|Lack of Efficacy|0|||
147186815|NCT05214768|530850078|FG003|Open Label Extension Period|Lack of Efficacy|0|||
147186816|NCT05214768|530850079|FG004|Open Label Extension Period|Lack of Efficacy|0|||
147186817|NCT05214768|530850080|FG005|Open Label Extension Period|Lack of Efficacy|1|||
147186818|NCT05214768|530850075|FG000|Open Label Extension Period|Ongoing Study|0|||
147186819|NCT05214768|530850076|FG001|Open Label Extension Period|Ongoing Study|0|||
147186820|NCT05214768|530850077|FG002|Open Label Extension Period|Ongoing Study|0|||
147186821|NCT05214768|530850078|FG003|Open Label Extension Period|Ongoing Study|0|||
147186822|NCT05214768|530850079|FG004|Open Label Extension Period|Ongoing Study|0|||
147186823|NCT05214768|530850080|FG005|Open Label Extension Period|Ongoing Study|42|||
147186824|NCT05481359|530850081|FG000|Overall Study|Lost to Follow-up|3|||
147186825|NCT05481359|530850081|FG000|Overall Study|Withdrawal by Subject|1|||
147186826|NCT06235905|530850082|FG000|Overall Study|Adverse Event|1|||
147186827|NCT06235905|530850082|FG000|Overall Study|Non-compliant with protocol procedures|1|||
147186828|NCT00319254|530850083|FG000|Overall Study|Withdrawal by Subject|4|||
147186829|NCT00319254|530850083|FG000|Overall Study|Death|46|||
147186830|NCT00319254|530850083|FG000|Overall Study|Lost to Follow-up|2|||
147186831|NCT00319254|530850083|FG000|Overall Study|Enrolled, Not Treated|2|||
147186832|NCT04177212|530850085|FG000|Overall Study|Withdrawal by Subject|9|||
147186833|NCT04177212|530850086|FG001|Overall Study|Withdrawal by Subject|7|||
147186834|NCT04177212|530850085|FG000|Overall Study|Due to COVID-19 Pandemic|1|||
147186835|NCT04177212|530850086|FG001|Overall Study|Due to COVID-19 Pandemic|2|||
147186836|NCT04177212|530850085|FG000|Overall Study|Physician Decision|1|||
147186837|NCT04177212|530850086|FG001|Overall Study|Physician Decision|0|||
147186838|NCT04177212|530850085|FG000|Overall Study|Lost to Follow-up|0|||
147186839|NCT04177212|530850086|FG001|Overall Study|Lost to Follow-up|3|||
147186840|NCT04177212|530850085|FG000|Overall Study|Adverse Event|0|||
147186841|NCT04177212|530850086|FG001|Overall Study|Adverse Event|1|||
147186842|NCT04177212|530850085|FG000|Overall Study|Other|1|||
147186843|NCT04177212|530850086|FG001|Overall Study|Other|2|||
147186844|NCT01147666|530852146|FG000|Dosing Period 1: 6-Week Treatment|Adverse Event|1|||
147186845|NCT01147666|530852147|FG001|Dosing Period 1: 6-Week Treatment|Adverse Event|1|||
147186846|NCT01147666|530852148|FG002|Dosing Period 1: 6-Week Treatment|Adverse Event|1|||
147186847|NCT01147666|530852149|FG003|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
147186848|NCT01147666|530852150|FG004|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
147186849|NCT01147666|530852151|FG005|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
147329329|NCT01280591|531371691|FG003|Overall Study|Withdrawal by Subject|2|||
147329330|NCT01280591|531371688|FG000|Overall Study|Does not meet exclusion #27 criteria|0|||
147329331|NCT01280591|531371689|FG001|Overall Study|Does not meet exclusion #27 criteria|0|||
147329332|NCT01280591|531371690|FG002|Overall Study|Does not meet exclusion #27 criteria|0|||
147594073|NCT01347866|532330592|FG014|Overall Study|Subject refused further follow-up|1|||
147186850|NCT01147666|530852152|FG006|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
147186851|NCT01147666|530852153|FG007|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
147186852|NCT01147666|530852154|FG008|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
147186853|NCT01147666|530852155|FG009|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
147186854|NCT01147666|530852156|FG010|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
147186855|NCT01147666|530852157|FG011|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
147186856|NCT01147666|530852158|FG012|Dosing Period 1: 6-Week Treatment|Adverse Event|1|||
147186857|NCT01147666|530852159|FG013|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
147186858|NCT01147666|530852160|FG014|Dosing Period 1: 6-Week Treatment|Adverse Event|0|||
147186859|NCT01147666|530852146|FG000|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
147186860|NCT01147666|530852147|FG001|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|1|||
147186861|NCT01147666|530852148|FG002|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
147186862|NCT01147666|530852149|FG003|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
147186863|NCT01147666|530852150|FG004|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|3|||
147186864|NCT01147666|530852151|FG005|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|1|||
147186865|NCT01147666|530852152|FG006|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|2|||
147186866|NCT01147666|530852153|FG007|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|2|||
147186867|NCT01147666|530852154|FG008|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
147186868|NCT01147666|530852155|FG009|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|1|||
147186869|NCT01147666|530852156|FG010|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
147186870|NCT01147666|530852157|FG011|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
147186871|NCT01147666|530852158|FG012|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|1|||
147186872|NCT01147666|530852159|FG013|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|0|||
147329333|NCT01280591|531371691|FG003|Overall Study|Does not meet exclusion #27 criteria|1|||
147329334|NCT02263508|531371692|FG000|Overall Study|Withdrawal by Subject|1|||
147329335|NCT02263508|531371693|FG001|Overall Study|Withdrawal by Subject|23|||
147329336|NCT02263508|531371694|FG002|Overall Study|Withdrawal by Subject|17|||
147329337|NCT02263508|531371692|FG000|Overall Study|Sponsor Decision|12|||
147329338|NCT02263508|531371693|FG001|Overall Study|Sponsor Decision|165|||
147329339|NCT02263508|531371694|FG002|Overall Study|Sponsor Decision|182|||
147329340|NCT02263508|531371692|FG000|Overall Study|Lost to Follow-up|2|||
147329341|NCT02263508|531371693|FG001|Overall Study|Lost to Follow-up|7|||
147329342|NCT02263508|531371694|FG002|Overall Study|Lost to Follow-up|7|||
147329343|NCT02263508|531371692|FG000|Overall Study|Death|6|||
147329344|NCT02263508|531371693|FG001|Overall Study|Death|151|||
147329345|NCT02263508|531371694|FG002|Overall Study|Death|140|||
147329346|NCT01259102|531371696|FG000|Overall Study|Adverse Event|1|||
147329347|NCT01259102|531371697|FG001|Overall Study|Adverse Event|0|||
147329348|NCT01259102|531371698|FG002|Overall Study|Adverse Event|1|||
147329349|NCT01259102|531371699|FG003|Overall Study|Adverse Event|1|||
147329350|NCT01259102|531371700|FG004|Overall Study|Adverse Event|0|||
147329351|NCT01259102|531371696|FG000|Overall Study|Other|0|||
147329352|NCT01259102|531371697|FG001|Overall Study|Other|0|||
147329353|NCT01259102|531371698|FG002|Overall Study|Other|1|||
147329354|NCT01259102|531371699|FG003|Overall Study|Other|1|||
147329355|NCT01259102|531371700|FG004|Overall Study|Other|1|||
147329356|NCT01803646|531371701|FG000|Overall Study|Protocol Violation|1|||
147329357|NCT01803646|531371702|FG001|Overall Study|Protocol Violation|0|||
147329358|NCT01803646|531371701|FG000|Overall Study|Adverse Event|1|||
147329359|NCT01803646|531371702|FG001|Overall Study|Adverse Event|1|||
147329360|NCT01803646|531371701|FG000|Overall Study|Withdrawal by Subject|9|||
147329361|NCT01803646|531371702|FG001|Overall Study|Withdrawal by Subject|6|||
147329362|NCT01803646|531371701|FG000|Overall Study|Randomization error|1|||
147329363|NCT01803646|531371702|FG001|Overall Study|Randomization error|2|||
147329364|NCT01803646|531371701|FG000|Overall Study|Lost to Follow-up|5|||
147329365|NCT01803646|531371702|FG001|Overall Study|Lost to Follow-up|1|||
147186873|NCT01147666|530852160|FG014|Dosing Period 1: 6-Week Treatment|Lack of Efficacy|3|||
147186874|NCT01147666|530852146|FG000|Dosing Period 1: 6-Week Treatment|Death|0|||
147186875|NCT01147666|530852147|FG001|Dosing Period 1: 6-Week Treatment|Death|0|||
147186876|NCT01147666|530852148|FG002|Dosing Period 1: 6-Week Treatment|Death|0|||
147329366|NCT00930813|531371704|FG000|Overall Study|Death|4|||
147329367|NCT00930813|531371705|FG001|Overall Study|Death|5|||
147329368|NCT00930813|531371704|FG000|Overall Study|Withdrawal by Subject|2|||
147329369|NCT00930813|531371705|FG001|Overall Study|Withdrawal by Subject|5|||
147329370|NCT00930813|531371704|FG000|Overall Study|Lost to Follow-up|2|||
147329371|NCT00930813|531371705|FG001|Overall Study|Lost to Follow-up|4|||
147329372|NCT05790408|531371706|FG000|Overall Study|Did not undergo surgery or did not undergo imaging at the time of surgery|3|||
147329373|NCT01064817|531371707|FG000|Study Completion|Physician Decision|1|||
147329374|NCT01064817|531371708|FG001|Study Completion|Physician Decision|0|||
147329375|NCT01064817|531371707|FG000|Study Completion|Withdrawal by Subject|1|||
147329376|NCT01064817|531371708|FG001|Study Completion|Withdrawal by Subject|0|||
147329377|NCT00558363|531371709|FG000|Overall Study|Physician Decision|18|||
147329378|NCT00558363|531371710|FG001|Overall Study|Physician Decision|4|||
147329379|NCT00558363|531371709|FG000|Overall Study|Withdrawal by Subject|11|||
147329380|NCT00558363|531371710|FG001|Overall Study|Withdrawal by Subject|4|||
147329381|NCT00558363|531371709|FG000|Overall Study|Adverse Event|5|||
147329382|NCT00558363|531371710|FG001|Overall Study|Adverse Event|5|||
147329383|NCT00558363|531371709|FG000|Overall Study|Lack of Efficacy|2|||
147448831|NCT02595723|531808005|FG001|First Washout (21 Days)|Withdrawal by Subject|0|||
147329384|NCT00558363|531371710|FG001|Overall Study|Lack of Efficacy|2|||
147329385|NCT00558363|531371709|FG000|Overall Study|Protocol Violation|2|||
147329386|NCT00558363|531371710|FG001|Overall Study|Protocol Violation|1|||
147329387|NCT00558363|531371709|FG000|Overall Study|Lost to Follow-up|0|||
147329388|NCT00558363|531371710|FG001|Overall Study|Lost to Follow-up|1|||
147329389|NCT00558363|531371709|FG000|Overall Study|Met Protocol-defined Stopping Criteria|32|||
147329390|NCT00558363|531371710|FG001|Overall Study|Met Protocol-defined Stopping Criteria|16|||
147329391|NCT00558363|531371709|FG000|Overall Study|Randomized in Error|1|||
147186877|NCT01147666|530852149|FG003|Dosing Period 1: 6-Week Treatment|Death|0|||
147186878|NCT01147666|530852150|FG004|Dosing Period 1: 6-Week Treatment|Death|1|||
147186879|NCT01147666|530852151|FG005|Dosing Period 1: 6-Week Treatment|Death|1|||
147186880|NCT01147666|530852152|FG006|Dosing Period 1: 6-Week Treatment|Death|1|||
147186881|NCT01147666|530852153|FG007|Dosing Period 1: 6-Week Treatment|Death|0|||
147186882|NCT01147666|530852154|FG008|Dosing Period 1: 6-Week Treatment|Death|0|||
147186883|NCT01147666|530852155|FG009|Dosing Period 1: 6-Week Treatment|Death|0|||
147186884|NCT01147666|530852156|FG010|Dosing Period 1: 6-Week Treatment|Death|0|||
147186885|NCT01147666|530852157|FG011|Dosing Period 1: 6-Week Treatment|Death|0|||
147186886|NCT01147666|530852158|FG012|Dosing Period 1: 6-Week Treatment|Death|1|||
147186887|NCT01147666|530852159|FG013|Dosing Period 1: 6-Week Treatment|Death|0|||
147186888|NCT01147666|530852160|FG014|Dosing Period 1: 6-Week Treatment|Death|0|||
147186889|NCT01147666|530852146|FG000|Dosing Period 1: 6-Week Treatment|Protocol Violation|1|||
147186890|NCT01147666|530852147|FG001|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
147186891|NCT01147666|530852148|FG002|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
147186892|NCT01147666|530852149|FG003|Dosing Period 1: 6-Week Treatment|Protocol Violation|1|||
147186893|NCT01147666|530852150|FG004|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
147186894|NCT01147666|530852151|FG005|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
147186895|NCT01147666|530852152|FG006|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
147186896|NCT01147666|530852153|FG007|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
147186897|NCT01147666|530852154|FG008|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
147186898|NCT01147666|530852155|FG009|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
147186899|NCT01147666|530852156|FG010|Dosing Period 1: 6-Week Treatment|Protocol Violation|1|||
147186900|NCT01147666|530852157|FG011|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
147186901|NCT01147666|530852158|FG012|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
147186902|NCT01147666|530852159|FG013|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
147186903|NCT01147666|530852160|FG014|Dosing Period 1: 6-Week Treatment|Protocol Violation|0|||
147186904|NCT01147666|530852146|FG000|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
147186905|NCT01147666|530852147|FG001|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
147186906|NCT01147666|530852148|FG002|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
147186907|NCT01147666|530852149|FG003|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
147186908|NCT01147666|530852150|FG004|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
147186909|NCT01147666|530852151|FG005|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
147186910|NCT01147666|530852152|FG006|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
147186911|NCT01147666|530852153|FG007|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
147186912|NCT01147666|530852154|FG008|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
147186913|NCT01147666|530852155|FG009|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
147186914|NCT01147666|530852156|FG010|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
147186915|NCT01147666|530852157|FG011|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
147186916|NCT01147666|530852158|FG012|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
147186917|NCT01147666|530852159|FG013|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|1|||
147186918|NCT01147666|530852160|FG014|Dosing Period 1: 6-Week Treatment|Withdrawal by Subject|0|||
147186919|NCT01147666|530852146|FG000|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
147186920|NCT01147666|530852147|FG001|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
147186921|NCT01147666|530852148|FG002|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
147186922|NCT01147666|530852149|FG003|Dosing Period 1: 6-Week Treatment|Other than specified|1|||
147186923|NCT01147666|530852150|FG004|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
147186924|NCT01147666|530852151|FG005|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
147186925|NCT01147666|530852152|FG006|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
147186926|NCT01147666|530852153|FG007|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
147186927|NCT01147666|530852154|FG008|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
147186928|NCT01147666|530852155|FG009|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
147448832|NCT02595723|531808006|FG002|First Washout (21 Days)|Withdrawal by Subject|0|||
147448833|NCT02595723|531808004|FG000|First Washout (21 Days)|Lost to Follow-up|1|||
147186929|NCT01147666|530852156|FG010|Dosing Period 1: 6-Week Treatment|Other than specified|2|||
147186930|NCT01147666|530852157|FG011|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
147186931|NCT01147666|530852158|FG012|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
147186932|NCT01147666|530852159|FG013|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
147186933|NCT01147666|530852160|FG014|Dosing Period 1: 6-Week Treatment|Other than specified|0|||
147186934|NCT01147666|530852146|FG000|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
147186935|NCT01147666|530852147|FG001|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
147186936|NCT01147666|530852148|FG002|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
147186937|NCT01147666|530852149|FG003|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
147186938|NCT01147666|530852150|FG004|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
147186939|NCT01147666|530852151|FG005|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
147448834|NCT02595723|531808005|FG001|First Washout (21 Days)|Lost to Follow-up|0|||
147448835|NCT02595723|531808006|FG002|First Washout (21 Days)|Lost to Follow-up|0|||
147186940|NCT01147666|530852152|FG006|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
147186941|NCT01147666|530852153|FG007|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
147186942|NCT01147666|530852154|FG008|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
147186943|NCT01147666|530852155|FG009|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
147186944|NCT01147666|530852156|FG010|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
147186945|NCT01147666|530852157|FG011|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|1|||
147186946|NCT01147666|530852158|FG012|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|1|||
147186947|NCT01147666|530852159|FG013|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|0|||
147186948|NCT01147666|530852160|FG014|Dosing Period 1: 6-Week Treatment|Non-compliance with study drug|1|||
147186949|NCT01147666|530852146|FG000|Dosing Period 2: 19-Week Treatment|Death|0|||
147186950|NCT01147666|530852147|FG001|Dosing Period 2: 19-Week Treatment|Death|0|||
147329392|NCT00558363|531371710|FG001|Overall Study|Randomized in Error|2|||
147329393|NCT00558363|531371709|FG000|Overall Study|Hospitalized; Unable to Continue|0|||
147329394|NCT00558363|531371710|FG001|Overall Study|Hospitalized; Unable to Continue|1|||
147329395|NCT03102710|531371711|FG000|Overall Study|Dental metal affected MRI scan quality|1|||
147329396|NCT03102710|531371712|FG001|Overall Study|Dental metal affected MRI scan quality|0|||
147329397|NCT03102710|531371713|FG002|Overall Study|Dental metal affected MRI scan quality|0|||
147329398|NCT03102710|531371711|FG000|Overall Study|Technical issues during final MRI scan|0|||
147329399|NCT03102710|531371712|FG001|Overall Study|Technical issues during final MRI scan|1|||
147329400|NCT03102710|531371713|FG002|Overall Study|Technical issues during final MRI scan|0|||
147329401|NCT03102710|531371711|FG000|Overall Study|Nausea during MRI scan|0|||
147329402|NCT03102710|531371712|FG001|Overall Study|Nausea during MRI scan|1|||
147329403|NCT03102710|531371713|FG002|Overall Study|Nausea during MRI scan|0|||
147329404|NCT03102710|531371711|FG000|Overall Study|Subject unable to attend final session|0|||
147329405|NCT03102710|531371712|FG001|Overall Study|Subject unable to attend final session|1|||
147329406|NCT03102710|531371713|FG002|Overall Study|Subject unable to attend final session|0|||
147329407|NCT01368406|531371714|FG000|Overall Study|Lost to Follow-up|8|||
147329408|NCT01368406|531371715|FG001|Overall Study|Lost to Follow-up|4|||
147329409|NCT01368406|531371714|FG000|Overall Study|Withdrawal by Subject|8|||
147329410|NCT01368406|531371715|FG001|Overall Study|Withdrawal by Subject|4|||
147329411|NCT01368406|531371714|FG000|Overall Study|relapse of the disease|3|||
147329412|NCT01368406|531371715|FG001|Overall Study|relapse of the disease|2|||
147329413|NCT01368406|531371714|FG000|Overall Study|started working|2|||
147329414|NCT01368406|531371715|FG001|Overall Study|started working|3|||
147329415|NCT01313182|531371716|FG000|Overall Study|Protocol Violation|66|||
147329416|NCT01313182|531371717|FG001|Overall Study|Protocol Violation|92|||
147329417|NCT02759731|531371718|FG000|Overall Study|Did not complete treatment.|8|||
147329418|NCT00606580|531371719|FG000|Overall Study|Lost to Follow-up|1|||
147329419|NCT00606580|531371720|FG001|Overall Study|Lost to Follow-up|1|||
147329420|NCT00606580|531371721|FG002|Overall Study|Lost to Follow-up|4|||
147329421|NCT00606580|531371719|FG000|Overall Study|Clinical failures|1|||
147329422|NCT00606580|531371720|FG001|Overall Study|Clinical failures|0|||
147329423|NCT00606580|531371721|FG002|Overall Study|Clinical failures|12|||
147329424|NCT00606580|531371719|FG000|Overall Study|Withdrawal by investigator|0|||
147329425|NCT00606580|531371720|FG001|Overall Study|Withdrawal by investigator|1|||
147329426|NCT00606580|531371721|FG002|Overall Study|Withdrawal by investigator|6|||
147329427|NCT00606580|531371719|FG000|Overall Study|Withdrawal by Subject|0|||
147329428|NCT00606580|531371720|FG001|Overall Study|Withdrawal by Subject|1|||
147329429|NCT00606580|531371721|FG002|Overall Study|Withdrawal by Subject|0|||
147329430|NCT01833065|531371722|FG000|Overall Study|Adverse Event|6|||
147329431|NCT01833065|531371723|FG001|Overall Study|Adverse Event|1|||
147329432|NCT01833065|531371724|FG002|Overall Study|Adverse Event|0|||
147329433|NCT01833065|531371725|FG003|Overall Study|Adverse Event|2|||
147329434|NCT01833065|531371726|FG004|Overall Study|Adverse Event|3|||
147329435|NCT01833065|531371722|FG000|Overall Study|Protocol Violation|1|||
147329436|NCT01833065|531371723|FG001|Overall Study|Protocol Violation|0|||
147329437|NCT01833065|531371724|FG002|Overall Study|Protocol Violation|0|||
147329438|NCT01833065|531371725|FG003|Overall Study|Protocol Violation|0|||
147329439|NCT01833065|531371726|FG004|Overall Study|Protocol Violation|2|||
147329440|NCT01833065|531371722|FG000|Overall Study|Lost to Follow-up|1|||
147329441|NCT01833065|531371723|FG001|Overall Study|Lost to Follow-up|0|||
147329442|NCT01833065|531371724|FG002|Overall Study|Lost to Follow-up|0|||
147186951|NCT01147666|530852148|FG002|Dosing Period 2: 19-Week Treatment|Death|0|||
147186952|NCT01147666|530852149|FG003|Dosing Period 2: 19-Week Treatment|Death|0|||
147186953|NCT01147666|530852150|FG004|Dosing Period 2: 19-Week Treatment|Death|1|||
147186954|NCT01147666|530852151|FG005|Dosing Period 2: 19-Week Treatment|Death|1|||
147186955|NCT01147666|530852152|FG006|Dosing Period 2: 19-Week Treatment|Death|1|||
147186956|NCT01147666|530852153|FG007|Dosing Period 2: 19-Week Treatment|Death|0|||
147329443|NCT01833065|531371725|FG003|Overall Study|Lost to Follow-up|0|||
147329444|NCT01833065|531371726|FG004|Overall Study|Lost to Follow-up|3|||
147329445|NCT01833065|531371722|FG000|Overall Study|Withdrawal by Subject|6|||
147329446|NCT01833065|531371723|FG001|Overall Study|Withdrawal by Subject|2|||
147329447|NCT01833065|531371724|FG002|Overall Study|Withdrawal by Subject|4|||
147329448|NCT01833065|531371725|FG003|Overall Study|Withdrawal by Subject|3|||
147594074|NCT01347866|532330593|FG015|Overall Study|Subject refused further follow-up|0|||
147594075|NCT01347866|532330594|FG016|Overall Study|Subject refused further follow-up|2|||
147594076|NCT02429934|532330595|FG000|Overall Study|Withdrawal by Subject|0|||
147594077|NCT02429934|532330596|FG001|Overall Study|Withdrawal by Subject|2|||
147594078|NCT02429934|532330595|FG000|Overall Study|Adverse Event|2|||
147594079|NCT02429934|532330596|FG001|Overall Study|Adverse Event|0|||
147594080|NCT02429934|532330595|FG000|Overall Study|Lost to Follow-up|1|||
147594081|NCT02429934|532330596|FG001|Overall Study|Lost to Follow-up|1|||
147594082|NCT02429934|532330595|FG000|Overall Study|Physician Decision|1|||
147594083|NCT02429934|532330596|FG001|Overall Study|Physician Decision|0|||
147594084|NCT00869024|532330597|FG000|Overall Study|Death|2|||
147594085|NCT00869024|532330598|FG001|Overall Study|Death|3|||
147186957|NCT01147666|530852154|FG008|Dosing Period 2: 19-Week Treatment|Death|0|||
147329449|NCT01833065|531371726|FG004|Overall Study|Withdrawal by Subject|11|||
147329450|NCT01833065|531371722|FG000|Overall Study|Subject's substantial non-compliance|0|||
147329451|NCT01833065|531371723|FG001|Overall Study|Subject's substantial non-compliance|1|||
147329452|NCT01833065|531371724|FG002|Overall Study|Subject's substantial non-compliance|0|||
147329453|NCT01833065|531371725|FG003|Overall Study|Subject's substantial non-compliance|0|||
147329454|NCT01833065|531371726|FG004|Overall Study|Subject's substantial non-compliance|0|||
147329455|NCT01833065|531371722|FG000|Overall Study|Trial terminated by sponsor|8|||
147329456|NCT01833065|531371723|FG001|Overall Study|Trial terminated by sponsor|8|||
147329457|NCT01833065|531371724|FG002|Overall Study|Trial terminated by sponsor|7|||
147329458|NCT01833065|531371725|FG003|Overall Study|Trial terminated by sponsor|3|||
147329459|NCT01833065|531371726|FG004|Overall Study|Trial terminated by sponsor|13|||
147329460|NCT01833065|531371722|FG000|Overall Study|Others|2|||
147329461|NCT01833065|531371723|FG001|Overall Study|Others|1|||
147329462|NCT01833065|531371724|FG002|Overall Study|Others|1|||
147329463|NCT01833065|531371725|FG003|Overall Study|Others|1|||
147329464|NCT01833065|531371726|FG004|Overall Study|Others|4|||
147329465|NCT00927823|531371729|FG000|Continuous Dosing Period|Death|0|||
147329466|NCT00927823|531371730|FG001|Continuous Dosing Period|Death|0|||
147329467|NCT00927823|531371731|FG002|Continuous Dosing Period|Death|6|||
147329468|NCT00927823|531371732|FG003|Continuous Dosing Period|Death|0|||
147329469|NCT00927823|531371729|FG000|Continuous Dosing Period|Lost to Follow-up|1|||
147329470|NCT00927823|531371730|FG001|Continuous Dosing Period|Lost to Follow-up|1|||
147329471|NCT00927823|531371731|FG002|Continuous Dosing Period|Lost to Follow-up|9|||
147329472|NCT00927823|531371732|FG003|Continuous Dosing Period|Lost to Follow-up|0|||
147329473|NCT00927823|531371729|FG000|Continuous Dosing Period|Withdrawal by Subject|1|||
147329474|NCT00927823|531371730|FG001|Continuous Dosing Period|Withdrawal by Subject|0|||
147329475|NCT00927823|531371731|FG002|Continuous Dosing Period|Withdrawal by Subject|2|||
147329476|NCT00927823|531371732|FG003|Continuous Dosing Period|Withdrawal by Subject|2|||
147329477|NCT00927823|531371729|FG000|Continuous Dosing Period|Other|1|||
147329478|NCT00927823|531371730|FG001|Continuous Dosing Period|Other|2|||
147329479|NCT00927823|531371731|FG002|Continuous Dosing Period|Other|9|||
147329480|NCT00927823|531371732|FG003|Continuous Dosing Period|Other|3|||
147329481|NCT00828672|531371733|FG000|Study Treatment|Lost to Follow-up|1|||
147329482|NCT00828672|531371734|FG001|Study Treatment|Lost to Follow-up|0|||
147329483|NCT00828672|531371733|FG000|Study Treatment|Adverse Event|0|||
147329484|NCT00828672|531371734|FG001|Study Treatment|Adverse Event|1|||
147329485|NCT00828672|531371733|FG000|Study Treatment|Complete response, no surgery|1|||
147329486|NCT00828672|531371734|FG001|Study Treatment|Complete response, no surgery|1|||
147329487|NCT00828672|531371733|FG000|Post-surgery (<30 Days)|No central review materials|0|||
147329488|NCT00828672|531371734|FG001|Post-surgery (<30 Days)|No central review materials|1|||
147329489|NCT00906698|531371735|FG000|Overall Study|Dose-limiting toxicity (DLT)|0|||
147329490|NCT00906698|531371736|FG001|Overall Study|Dose-limiting toxicity (DLT)|6|||
147329491|NCT00906698|531371737|FG002|Overall Study|Dose-limiting toxicity (DLT)|0|||
147329492|NCT00906698|531371738|FG003|Overall Study|Dose-limiting toxicity (DLT)|0|||
147329493|NCT00906698|531371739|FG004|Overall Study|Dose-limiting toxicity (DLT)|1|||
147329494|NCT00906698|531371740|FG005|Overall Study|Dose-limiting toxicity (DLT)|0|||
147329495|NCT00906698|531371735|FG000|Overall Study|Adverse Event|0|||
147329496|NCT00906698|531371736|FG001|Overall Study|Adverse Event|0|||
147329497|NCT00906698|531371737|FG002|Overall Study|Adverse Event|2|||
147329498|NCT00906698|531371738|FG003|Overall Study|Adverse Event|0|||
147329499|NCT00906698|531371739|FG004|Overall Study|Adverse Event|4|||
147329500|NCT00906698|531371740|FG005|Overall Study|Adverse Event|1|||
147329501|NCT00906698|531371735|FG000|Overall Study|Disease progression|3|||
147329502|NCT00906698|531371736|FG001|Overall Study|Disease progression|12|||
147329503|NCT00906698|531371737|FG002|Overall Study|Disease progression|4|||
147329504|NCT00906698|531371738|FG003|Overall Study|Disease progression|4|||
147329505|NCT00906698|531371739|FG004|Overall Study|Disease progression|12|||
147329506|NCT00906698|531371740|FG005|Overall Study|Disease progression|4|||
147329507|NCT00906698|531371735|FG000|Overall Study|Withdrawal by Subject|0|||
147329508|NCT00906698|531371736|FG001|Overall Study|Withdrawal by Subject|0|||
147329509|NCT00906698|531371737|FG002|Overall Study|Withdrawal by Subject|0|||
147594086|NCT00869024|532330597|FG000|Overall Study|Lost to Follow-up|0|||
147594087|NCT00869024|532330598|FG001|Overall Study|Lost to Follow-up|1|||
147329510|NCT00906698|531371738|FG003|Overall Study|Withdrawal by Subject|0|||
147329511|NCT00906698|531371739|FG004|Overall Study|Withdrawal by Subject|1|||
147329512|NCT00906698|531371740|FG005|Overall Study|Withdrawal by Subject|0|||
147329513|NCT00906698|531371735|FG000|Overall Study|incl. non compliance, lost to follow-up|0|||
147329514|NCT00906698|531371736|FG001|Overall Study|incl. non compliance, lost to follow-up|1|||
147329515|NCT00906698|531371737|FG002|Overall Study|incl. non compliance, lost to follow-up|0|||
147594088|NCT00869024|532330597|FG000|Overall Study|Protocol Violation|0|||
147594089|NCT00869024|532330598|FG001|Overall Study|Protocol Violation|1|||
147594090|NCT01568866|532330599|FG000|Overall Study|Disease Progression|208|||
147329516|NCT00906698|531371738|FG003|Overall Study|incl. non compliance, lost to follow-up|0|||
147329517|NCT00906698|531371739|FG004|Overall Study|incl. non compliance, lost to follow-up|0|||
147329518|NCT00906698|531371740|FG005|Overall Study|incl. non compliance, lost to follow-up|0|||
147329519|NCT00001575|531371748|FG000|Overall Study|Screening failures-Ph I portion|22|||
147594091|NCT01568866|532330600|FG001|Overall Study|Disease Progression|183|||
147594092|NCT01568866|532330599|FG000|Overall Study|Adverse Event|94|||
147594093|NCT01568866|532330600|FG001|Overall Study|Adverse Event|96|||
147594094|NCT01568866|532330599|FG000|Overall Study|Patient Request|55|||
147594095|NCT01568866|532330600|FG001|Overall Study|Patient Request|71|||
147594096|NCT01568866|532330599|FG000|Overall Study|Physician Decision|40|||
147594097|NCT01568866|532330600|FG001|Overall Study|Physician Decision|32|||
147594098|NCT01568866|532330599|FG000|Overall Study|Withdrawal by Subject|19|||
147329520|NCT00001575|531371748|FG000|Overall Study|Withdrawn/deaths|23|||
147329521|NCT00831792|531371749|FG000|Overall Study|Not Eligible|3|||
147329522|NCT00831792|531371749|FG000|Overall Study|Adverse Event|1|||
147329523|NCT00831792|531371749|FG000|Overall Study|Death|1|||
147329524|NCT00831792|531371749|FG000|Overall Study|Lack of Efficacy|1|||
147329525|NCT01242085|531371750|FG000|Overall Study|Withdrawal by Subject|4|||
147329526|NCT01242085|531371751|FG001|Overall Study|Withdrawal by Subject|2|||
147329527|NCT01242085|531371752|FG002|Overall Study|Withdrawal by Subject|0|||
147329528|NCT01242085|531371750|FG000|Overall Study|medically unable to have surgery|4|||
147329529|NCT01242085|531371751|FG001|Overall Study|medically unable to have surgery|5|||
147329530|NCT01242085|531371752|FG002|Overall Study|medically unable to have surgery|0|||
147329531|NCT01178762|531371753|FG000|Overall Study|Lost to Follow-up|15|||
147329532|NCT02377362|531371754|FG000|Part A Second Treatment|Protocol Violation|0|||
147329533|NCT02377362|531371755|FG001|Part A Second Treatment|Protocol Violation|0|||
147329534|NCT02377362|531371756|FG002|Part A Second Treatment|Protocol Violation|0|||
147594099|NCT01568866|532330600|FG001|Overall Study|Withdrawal by Subject|11|||
147594100|NCT01568866|532330599|FG000|Overall Study|Death|10|||
147594101|NCT01568866|532330600|FG001|Overall Study|Death|18|||
147594102|NCT01568866|532330599|FG000|Overall Study|Protocol Non-compliance|2|||
147594103|NCT01568866|532330600|FG001|Overall Study|Protocol Non-compliance|4|||
147594104|NCT01568866|532330599|FG000|Overall Study|Lost to Follow-up|1|||
147594105|NCT01568866|532330600|FG001|Overall Study|Lost to Follow-up|0|||
147594106|NCT01568866|532330599|FG000|Overall Study|Randomized but Not Dosed|9|||
147186958|NCT01147666|530852155|FG009|Dosing Period 2: 19-Week Treatment|Death|0|||
147186959|NCT01147666|530852156|FG010|Dosing Period 2: 19-Week Treatment|Death|0|||
147186960|NCT01147666|530852157|FG011|Dosing Period 2: 19-Week Treatment|Death|0|||
147186961|NCT01147666|530852158|FG012|Dosing Period 2: 19-Week Treatment|Death|1|||
147186962|NCT01147666|530852159|FG013|Dosing Period 2: 19-Week Treatment|Death|0|||
147186963|NCT01147666|530852160|FG014|Dosing Period 2: 19-Week Treatment|Death|0|||
147186964|NCT01147666|530852146|FG000|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
147186965|NCT01147666|530852147|FG001|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
147186966|NCT01147666|530852148|FG002|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
147186967|NCT01147666|530852149|FG003|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
147186968|NCT01147666|530852150|FG004|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|3|||
147186969|NCT01147666|530852151|FG005|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|1|||
147186970|NCT01147666|530852152|FG006|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|2|||
147186971|NCT01147666|530852153|FG007|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|2|||
147186972|NCT01147666|530852154|FG008|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
147186973|NCT01147666|530852155|FG009|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|1|||
147186974|NCT01147666|530852156|FG010|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
147186975|NCT01147666|530852157|FG011|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
147329535|NCT02377362|531371757|FG003|Part A Second Treatment|Protocol Violation|0|||
147329536|NCT02377362|531371758|FG004|Part A Second Treatment|Protocol Violation|1|||
147329537|NCT02377362|531371759|FG005|Part A Second Treatment|Protocol Violation|0|||
147329538|NCT02377362|531371760|FG006|Part A Second Treatment|Protocol Violation|0|||
147329539|NCT02377362|531371761|FG007|Part A Second Treatment|Protocol Violation|0|||
147329540|NCT02377362|531371762|FG008|Part A Second Treatment|Protocol Violation|0|||
147329541|NCT02377362|531371763|FG009|Part A Second Treatment|Protocol Violation|0|||
147329542|NCT02377362|531371764|FG010|Part A Second Treatment|Protocol Violation|0|||
147594107|NCT01568866|532330600|FG001|Overall Study|Randomized but Not Dosed|1|||
147594108|NCT01698775|532330601|FG000|Phase A|Adverse Event|2|||
147594109|NCT01698775|532330602|FG001|Phase A|Adverse Event|1|||
147594110|NCT01698775|532330601|FG000|Phase A|Death|1|||
147186976|NCT01147666|530852158|FG012|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|1|||
147186977|NCT01147666|530852159|FG013|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|0|||
147186978|NCT01147666|530852160|FG014|Dosing Period 2: 19-Week Treatment|Lack of Efficacy|2|||
147186979|NCT01147666|530852146|FG000|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
147186980|NCT01147666|530852147|FG001|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
147186981|NCT01147666|530852148|FG002|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
147186982|NCT01147666|530852149|FG003|Dosing Period 2: 19-Week Treatment|Protocol Violation|1|||
147186983|NCT01147666|530852150|FG004|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
147186984|NCT01147666|530852151|FG005|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
147186985|NCT01147666|530852152|FG006|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
147186986|NCT01147666|530852153|FG007|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
147186987|NCT01147666|530852154|FG008|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
147186988|NCT01147666|530852155|FG009|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
147186989|NCT01147666|530852156|FG010|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
147186990|NCT01147666|530852157|FG011|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
147186991|NCT01147666|530852158|FG012|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
147186992|NCT01147666|530852159|FG013|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
147186993|NCT01147666|530852160|FG014|Dosing Period 2: 19-Week Treatment|Protocol Violation|0|||
147186994|NCT01147666|530852146|FG000|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
147186995|NCT01147666|530852147|FG001|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
147186996|NCT01147666|530852148|FG002|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
147186997|NCT01147666|530852149|FG003|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
147186998|NCT01147666|530852150|FG004|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1|||
147186999|NCT01147666|530852151|FG005|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1|||
147187000|NCT01147666|530852152|FG006|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
147187001|NCT01147666|530852153|FG007|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1|||
147187002|NCT01147666|530852154|FG008|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
147187003|NCT01147666|530852155|FG009|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1|||
147187004|NCT01147666|530852156|FG010|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
147187005|NCT01147666|530852157|FG011|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
147187006|NCT01147666|530852158|FG012|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
147187007|NCT01147666|530852159|FG013|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|1|||
147187008|NCT01147666|530852160|FG014|Dosing Period 2: 19-Week Treatment|Withdrawal by Subject|0|||
147187009|NCT01147666|530852146|FG000|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
147187010|NCT01147666|530852147|FG001|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
147187011|NCT01147666|530852148|FG002|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
147187012|NCT01147666|530852149|FG003|Dosing Period 2: 19-Week Treatment|Other than specified|1|||
147187013|NCT01147666|530852150|FG004|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
147187014|NCT01147666|530852151|FG005|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
147187015|NCT01147666|530852152|FG006|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
147187016|NCT01147666|530852153|FG007|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
147187017|NCT01147666|530852154|FG008|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
147187018|NCT01147666|530852155|FG009|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
147187019|NCT01147666|530852156|FG010|Dosing Period 2: 19-Week Treatment|Other than specified|2|||
147187020|NCT01147666|530852157|FG011|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
147187021|NCT01147666|530852158|FG012|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
147187022|NCT01147666|530852159|FG013|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
147187023|NCT01147666|530852160|FG014|Dosing Period 2: 19-Week Treatment|Other than specified|0|||
147187024|NCT01147666|530852146|FG000|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
147187025|NCT01147666|530852147|FG001|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
147187026|NCT01147666|530852148|FG002|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
147187027|NCT01147666|530852149|FG003|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
147187028|NCT01147666|530852150|FG004|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
147187029|NCT01147666|530852151|FG005|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
147187030|NCT01147666|530852152|FG006|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
147187031|NCT01147666|530852153|FG007|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
147187032|NCT01147666|530852154|FG008|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
147187033|NCT01147666|530852155|FG009|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
147187034|NCT01147666|530852156|FG010|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
147187035|NCT01147666|530852157|FG011|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
147187036|NCT01147666|530852158|FG012|Dosing Period 2: 19-Week Treatment|Adverse Event|1|||
147187037|NCT01147666|530852159|FG013|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
147187038|NCT01147666|530852160|FG014|Dosing Period 2: 19-Week Treatment|Adverse Event|0|||
147187039|NCT01147666|530852146|FG000|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
147187040|NCT01147666|530852147|FG001|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
147247398|NCT01169493|531074497|FG001|Period 3 (6 Months)|Adverse Event|1|||
147448836|NCT04839380|531808007|FG000|Overall Study|Withdrawal by Subject|2|||
147448837|NCT04839380|531808007|FG000|Overall Study|Dosed, but Did Not Complete Run-in Period|3|||
147448838|NCT01087905|531808008|FG000|Overall Study|Lost to Follow-up|24|||
147448839|NCT01087905|531808009|FG001|Overall Study|Lost to Follow-up|28|||
147448840|NCT01087905|531808010|FG002|Overall Study|Lost to Follow-up|18|||
147448841|NCT01087905|531808011|FG003|Overall Study|Lost to Follow-up|31|||
147448842|NCT01087905|531808012|FG004|Overall Study|Lost to Follow-up|27|||
147448843|NCT01087905|531808013|FG005|Overall Study|Lost to Follow-up|25|||
147448844|NCT01087905|531808014|FG006|Overall Study|Lost to Follow-up|20|||
147448845|NCT01087905|531808015|FG007|Overall Study|Lost to Follow-up|24|||
147448846|NCT01087905|531808008|FG000|Overall Study|Withdrawal by Subject|5|||
147448847|NCT01087905|531808009|FG001|Overall Study|Withdrawal by Subject|4|||
147448848|NCT01087905|531808010|FG002|Overall Study|Withdrawal by Subject|4|||
147448849|NCT01087905|531808011|FG003|Overall Study|Withdrawal by Subject|5|||
147448850|NCT01087905|531808012|FG004|Overall Study|Withdrawal by Subject|4|||
147448851|NCT01087905|531808013|FG005|Overall Study|Withdrawal by Subject|3|||
147448852|NCT01087905|531808014|FG006|Overall Study|Withdrawal by Subject|3|||
147448853|NCT01087905|531808015|FG007|Overall Study|Withdrawal by Subject|5|||
147448854|NCT00513500|531808016|FG000|Overall Study|Lost to Follow-up|35|||
147448855|NCT00513500|531808017|FG001|Overall Study|Lost to Follow-up|39|||
147448856|NCT00513500|531808016|FG000|Overall Study|Death|2|||
147448857|NCT00513500|531808017|FG001|Overall Study|Death|1|||
147448858|NCT00513500|531808016|FG000|Overall Study|Hospitalized|4|||
147448859|NCT00513500|531808017|FG001|Overall Study|Hospitalized|14|||
147448860|NCT04288154|531808018|FG000|Overall Study|Withdrawal by Subject|9|||
147187041|NCT01147666|530852148|FG002|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
147187042|NCT01147666|530852149|FG003|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
147187043|NCT01147666|530852150|FG004|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
147187044|NCT01147666|530852151|FG005|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
147187045|NCT01147666|530852152|FG006|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
147187046|NCT01147666|530852153|FG007|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
147187047|NCT01147666|530852154|FG008|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
147187048|NCT01147666|530852155|FG009|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
147187049|NCT01147666|530852156|FG010|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
147187050|NCT01147666|530852157|FG011|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
147187051|NCT01147666|530852158|FG012|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|1|||
147187052|NCT01147666|530852159|FG013|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|0|||
147187053|NCT01147666|530852160|FG014|Dosing Period 2: 19-Week Treatment|Non-compliance with study drug|1|||
147187054|NCT00796666|530852161|FG000|Overall Study|Death|2|||
147187055|NCT00796666|530852162|FG001|Overall Study|Death|4|||
147187056|NCT00796666|530852161|FG000|Overall Study|Withdrawal by Subject|2|||
147187057|NCT00796666|530852162|FG001|Overall Study|Withdrawal by Subject|0|||
147187058|NCT00796666|530852161|FG000|Overall Study|Adverse Event|7|||
147187059|NCT00796666|530852162|FG001|Overall Study|Adverse Event|5|||
147187060|NCT00796666|530852161|FG000|Overall Study|Protocol Violation|1|||
147187061|NCT00796666|530852162|FG001|Overall Study|Protocol Violation|0|||
147187062|NCT00796666|530852161|FG000|Overall Study|Other|1|||
147187063|NCT00796666|530852162|FG001|Overall Study|Other|0|||
147187064|NCT00796666|530852161|FG000|Overall Study|Terminated by sponsor|53|||
147187065|NCT00796666|530852162|FG001|Overall Study|Terminated by sponsor|55|||
147187066|NCT00796666|530852161|FG000|Overall Study|Randomized and not treated|1|||
147187067|NCT00796666|530852162|FG001|Overall Study|Randomized and not treated|0|||
147187068|NCT00474955|530852164|FG000|Overall Study|Adverse Event|2|||
147187069|NCT00474955|530852164|FG000|Overall Study|Drug unavailability|1|||
147187070|NCT00474955|530852164|FG000|Overall Study|Personal reasons|5|||
147187071|NCT02576639|530852165|FG000|Overall Study|Withdrawal by Subject|1|||
147187072|NCT02576639|530852166|FG001|Overall Study|Withdrawal by Subject|2|||
147187073|NCT02576639|530852167|FG002|Overall Study|Withdrawal by Subject|1|||
147187074|NCT02576639|530852168|FG003|Overall Study|Withdrawal by Subject|0|||
147187075|NCT02576639|530852169|FG004|Overall Study|Withdrawal by Subject|1|||
147187076|NCT02576639|530852165|FG000|Overall Study|Adverse Event|1|||
147187077|NCT02576639|530852166|FG001|Overall Study|Adverse Event|0|||
147448861|NCT04288154|531808019|FG001|Overall Study|Withdrawal by Subject|9|||
147187078|NCT02576639|530852167|FG002|Overall Study|Adverse Event|1|||
147187079|NCT02576639|530852168|FG003|Overall Study|Adverse Event|1|||
147187080|NCT02576639|530852169|FG004|Overall Study|Adverse Event|2|||
147187081|NCT02576639|530852165|FG000|Overall Study|Physician Decision|0|||
147247399|NCT01169493|531074498|FG002|Period 3 (6 Months)|Adverse Event|0|||
147448862|NCT00749996|531808020|FG000|Overall Study|Lost to Follow-up|7|||
147448863|NCT00749996|531808021|FG001|Overall Study|Lost to Follow-up|4|||
147187082|NCT02576639|530852166|FG001|Overall Study|Physician Decision|0|||
147187083|NCT02576639|530852167|FG002|Overall Study|Physician Decision|0|||
147187084|NCT02576639|530852168|FG003|Overall Study|Physician Decision|0|||
147187085|NCT02576639|530852169|FG004|Overall Study|Physician Decision|1|||
147247400|NCT01169493|531074499|FG003|Period 3 (6 Months)|Adverse Event|0|||
147329543|NCT02377362|531371765|FG011|Part A Second Treatment|Protocol Violation|0|||
147329544|NCT02377362|531371766|FG012|Part A Second Treatment|Protocol Violation|0|||
147187086|NCT01255423|530852174|FG000|Overall Study|Abnormal Laboratory value|3|||
147187087|NCT01255423|530852175|FG001|Overall Study|Abnormal Laboratory value|2|||
147187088|NCT01255423|530852174|FG000|Overall Study|Use of prohibited medications|0|||
147187089|NCT01255423|530852175|FG001|Overall Study|Use of prohibited medications|1|||
147187090|NCT03367858|530852176|FG000|Intervention + Baseline Scan|Unable to adhere to session timeline|2|||
147187091|NCT03367858|530852177|FG001|Intervention + Baseline Scan|Unable to adhere to session timeline|2|||
147187092|NCT03367858|530852176|FG000|Intervention + Baseline Scan|Withdrawal by Subject|2|||
147187093|NCT03367858|530852177|FG001|Intervention + Baseline Scan|Withdrawal by Subject|0|||
147187094|NCT03367858|530852176|FG000|3 Month Follow Up|Lost to Follow-up|8|||
147187095|NCT03367858|530852177|FG001|3 Month Follow Up|Lost to Follow-up|3|||
147187096|NCT03367858|530852176|FG000|3 Month Follow Up|Moved out of study area|2|||
147187097|NCT03367858|530852177|FG001|3 Month Follow Up|Moved out of study area|6|||
147187098|NCT03367858|530852176|FG000|3 Month Follow Up|Unable to adhere to session timeline|1|||
147187099|NCT03367858|530852177|FG001|3 Month Follow Up|Unable to adhere to session timeline|3|||
147187100|NCT03367858|530852176|FG000|3 Month Follow Up|MRI contraindication|2|||
147187101|NCT03367858|530852177|FG001|3 Month Follow Up|MRI contraindication|1|||
147187102|NCT03367858|530852176|FG000|3 Month Follow Up|Incarcerated|0|||
147187103|NCT03367858|530852177|FG001|3 Month Follow Up|Incarcerated|1|||
147187104|NCT03367858|530852176|FG000|3 Month Follow Up|Withdrawal by Subject|3|||
147187105|NCT03367858|530852177|FG001|3 Month Follow Up|Withdrawal by Subject|0|||
147187106|NCT03367858|530852176|FG000|6 Month Follow Up|Lost to Follow-up|5|||
147187107|NCT03367858|530852177|FG001|6 Month Follow Up|Lost to Follow-up|2|||
147187108|NCT03367858|530852176|FG000|6 Month Follow Up|Withdrawal by Subject|0|||
147187109|NCT03367858|530852177|FG001|6 Month Follow Up|Withdrawal by Subject|1|||
147187110|NCT03367858|530852176|FG000|12 Month Follow Up|Lost to Follow-up|3|||
147187111|NCT03367858|530852177|FG001|12 Month Follow Up|Lost to Follow-up|3|||
147187112|NCT03367858|530852176|FG000|12 Month Follow Up|Withdrawal by Subject|0|||
147187113|NCT03367858|530852177|FG001|12 Month Follow Up|Withdrawal by Subject|1|||
147187114|NCT01859923|530852178|FG000|Overall Study|Adverse Event|0|||
147187115|NCT01859923|530852179|FG001|Overall Study|Adverse Event|0|||
147187116|NCT01859923|530852180|FG002|Overall Study|Adverse Event|1|||
147187117|NCT01859923|530852181|FG003|Overall Study|Adverse Event|1|||
147187118|NCT00101686|530852187|FG000|Overall Study|Progressive Disease|37|||
147187119|NCT00101686|530852188|FG001|Overall Study|Progressive Disease|28|||
147187120|NCT00101686|530852189|FG002|Overall Study|Progressive Disease|37|||
147187121|NCT00101686|530852190|FG003|Overall Study|Progressive Disease|38|||
147187122|NCT00101686|530852191|FG004|Overall Study|Progressive Disease|28|||
147187123|NCT00101686|530852192|FG005|Overall Study|Progressive Disease|25|||
147187124|NCT00101686|530852193|FG006|Overall Study|Progressive Disease|5|||
147187125|NCT00101686|530852194|FG007|Overall Study|Progressive Disease|7|||
147187126|NCT00101686|530852195|FG008|Overall Study|Progressive Disease|10|||
147187127|NCT00101686|530852196|FG009|Overall Study|Progressive Disease|8|||
147187128|NCT00101686|530852187|FG000|Overall Study|initiation other anti-cancer treatment|4|||
147187129|NCT00101686|530852188|FG001|Overall Study|initiation other anti-cancer treatment|3|||
147187130|NCT00101686|530852189|FG002|Overall Study|initiation other anti-cancer treatment|4|||
147187131|NCT00101686|530852190|FG003|Overall Study|initiation other anti-cancer treatment|3|||
147187132|NCT00101686|530852191|FG004|Overall Study|initiation other anti-cancer treatment|1|||
147187133|NCT00101686|530852192|FG005|Overall Study|initiation other anti-cancer treatment|1|||
147187134|NCT00101686|530852193|FG006|Overall Study|initiation other anti-cancer treatment|2|||
147187135|NCT00101686|530852194|FG007|Overall Study|initiation other anti-cancer treatment|2|||
147187136|NCT00101686|530852195|FG008|Overall Study|initiation other anti-cancer treatment|3|||
147187137|NCT00101686|530852196|FG009|Overall Study|initiation other anti-cancer treatment|3|||
147187138|NCT00101686|530852187|FG000|Overall Study|>3 week delay treatment due toxicity|6|||
147187139|NCT00101686|530852188|FG001|Overall Study|>3 week delay treatment due toxicity|2|||
147187140|NCT00101686|530852189|FG002|Overall Study|>3 week delay treatment due toxicity|1|||
147187141|NCT00101686|530852190|FG003|Overall Study|>3 week delay treatment due toxicity|2|||
147187142|NCT00101686|530852191|FG004|Overall Study|>3 week delay treatment due toxicity|7|||
147247401|NCT01169493|531074500|FG004|Period 3 (6 Months)|Adverse Event|0|||
147247402|NCT01169493|531074501|FG005|Period 3 (6 Months)|Adverse Event|0|||
147247403|NCT01169493|531074496|FG000|Period 3 (6 Months)|Physician Decision|0|||
147247404|NCT01169493|531074497|FG001|Period 3 (6 Months)|Physician Decision|1|||
147247405|NCT01169493|531074498|FG002|Period 3 (6 Months)|Physician Decision|1|||
147247406|NCT01169493|531074499|FG003|Period 3 (6 Months)|Physician Decision|0|||
147247407|NCT01169493|531074500|FG004|Period 3 (6 Months)|Physician Decision|0|||
147247408|NCT01169493|531074501|FG005|Period 3 (6 Months)|Physician Decision|0|||
147247409|NCT05228132|531074502|FG000|Overall Study|Investigation Early Termination by Sponsor|2|||
147329545|NCT02377362|531371754|FG000|Part A Third Treatment|Highest dose level 1200 not used|0|||
147329546|NCT02377362|531371755|FG001|Part A Third Treatment|Highest dose level 1200 not used|0|||
147329547|NCT02377362|531371756|FG002|Part A Third Treatment|Highest dose level 1200 not used|0|||
147329548|NCT02377362|531371757|FG003|Part A Third Treatment|Highest dose level 1200 not used|4|||
147187143|NCT00101686|530852192|FG005|Overall Study|>3 week delay treatment due toxicity|3|||
147187144|NCT00101686|530852193|FG006|Overall Study|>3 week delay treatment due toxicity|2|||
147187145|NCT00101686|530852194|FG007|Overall Study|>3 week delay treatment due toxicity|1|||
147187146|NCT00101686|530852195|FG008|Overall Study|>3 week delay treatment due toxicity|3|||
147187147|NCT00101686|530852196|FG009|Overall Study|>3 week delay treatment due toxicity|0|||
147187148|NCT00101686|530852187|FG000|Overall Study|unacceptable toxicity|3|||
147187149|NCT00101686|530852188|FG001|Overall Study|unacceptable toxicity|9|||
147187150|NCT00101686|530852189|FG002|Overall Study|unacceptable toxicity|10|||
147187151|NCT00101686|530852190|FG003|Overall Study|unacceptable toxicity|6|||
147187152|NCT00101686|530852191|FG004|Overall Study|unacceptable toxicity|16|||
147187153|NCT00101686|530852192|FG005|Overall Study|unacceptable toxicity|10|||
147187154|NCT00101686|530852193|FG006|Overall Study|unacceptable toxicity|4|||
147187155|NCT00101686|530852194|FG007|Overall Study|unacceptable toxicity|2|||
147187156|NCT00101686|530852195|FG008|Overall Study|unacceptable toxicity|1|||
147187157|NCT00101686|530852196|FG009|Overall Study|unacceptable toxicity|4|||
147187158|NCT00101686|530852187|FG000|Overall Study|Randomized but did not receive treament|1|||
147187159|NCT00101686|530852188|FG001|Overall Study|Randomized but did not receive treament|6|||
147187160|NCT00101686|530852189|FG002|Overall Study|Randomized but did not receive treament|2|||
147187161|NCT00101686|530852190|FG003|Overall Study|Randomized but did not receive treament|2|||
147187162|NCT00101686|530852191|FG004|Overall Study|Randomized but did not receive treament|2|||
147187163|NCT00101686|530852192|FG005|Overall Study|Randomized but did not receive treament|2|||
147187164|NCT00101686|530852193|FG006|Overall Study|Randomized but did not receive treament|0|||
147187165|NCT00101686|530852194|FG007|Overall Study|Randomized but did not receive treament|1|||
147187166|NCT00101686|530852195|FG008|Overall Study|Randomized but did not receive treament|0|||
147187167|NCT00101686|530852196|FG009|Overall Study|Randomized but did not receive treament|1|||
147187168|NCT00101686|530852187|FG000|Overall Study|intercurrent non-cancer related illness|0|||
147187169|NCT00101686|530852188|FG001|Overall Study|intercurrent non-cancer related illness|0|||
147187170|NCT00101686|530852189|FG002|Overall Study|intercurrent non-cancer related illness|2|||
147187171|NCT00101686|530852190|FG003|Overall Study|intercurrent non-cancer related illness|0|||
147187172|NCT00101686|530852191|FG004|Overall Study|intercurrent non-cancer related illness|1|||
147187173|NCT00101686|530852192|FG005|Overall Study|intercurrent non-cancer related illness|3|||
147187174|NCT00101686|530852193|FG006|Overall Study|intercurrent non-cancer related illness|1|||
147187175|NCT00101686|530852194|FG007|Overall Study|intercurrent non-cancer related illness|0|||
147187176|NCT00101686|530852195|FG008|Overall Study|intercurrent non-cancer related illness|1|||
147187177|NCT00101686|530852196|FG009|Overall Study|intercurrent non-cancer related illness|1|||
147187178|NCT00101686|530852187|FG000|Overall Study|Physician Decision|10|||
147187179|NCT00101686|530852188|FG001|Overall Study|Physician Decision|13|||
147247410|NCT05228132|531074502|FG000|Overall Study|Adverse Event|3|||
147247411|NCT05228132|531074502|FG000|Overall Study|Lost to Follow-up|1|||
147247412|NCT05228132|531074502|FG000|Overall Study|Arteriovenous-fistula mature|1|||
147247413|NCT03167411|531074503|FG000|Overall Study|Adverse Event|0|||
147247414|NCT03167411|531074504|FG001|Overall Study|Adverse Event|1|||
147247415|NCT02266225|531074509|FG000|Overall Study|Lost to Follow-up|2|||
147247416|NCT02266225|531074509|FG000|Overall Study|Death|1|||
147247417|NCT02266225|531074509|FG000|Overall Study|Withdrawal by Subject|13|||
147247418|NCT00642460|531074510|FG000|Part I: 12 Week Double-Blind|Adverse Event|0|||
147247419|NCT00642460|531074511|FG001|Part I: 12 Week Double-Blind|Adverse Event|1|||
147247420|NCT00642460|531074512|FG002|Part I: 12 Week Double-Blind|Adverse Event|1|||
147247421|NCT00642460|531074513|FG003|Part I: 12 Week Double-Blind|Adverse Event|0|||
147247422|NCT00642460|531074514|FG004|Part I: 12 Week Double-Blind|Adverse Event|0|||
147247423|NCT00642460|531074515|FG005|Part I: 12 Week Double-Blind|Adverse Event|0|||
147247424|NCT00642460|531074510|FG000|Part I: 12 Week Double-Blind|Refused Treatment|1|||
147247425|NCT00642460|531074511|FG001|Part I: 12 Week Double-Blind|Refused Treatment|0|||
147247426|NCT00642460|531074512|FG002|Part I: 12 Week Double-Blind|Refused Treatment|0|||
147247427|NCT00642460|531074513|FG003|Part I: 12 Week Double-Blind|Refused Treatment|0|||
147247428|NCT00642460|531074514|FG004|Part I: 12 Week Double-Blind|Refused Treatment|0|||
147247429|NCT00642460|531074515|FG005|Part I: 12 Week Double-Blind|Refused Treatment|0|||
147247430|NCT00642460|531074510|FG000|Part II: Open-Label Up to Week 92|Adverse Event|4|||
147247431|NCT00642460|531074511|FG001|Part II: Open-Label Up to Week 92|Adverse Event|2|||
147247432|NCT00642460|531074512|FG002|Part II: Open-Label Up to Week 92|Adverse Event|0|||
147187180|NCT00101686|530852189|FG002|Overall Study|Physician Decision|6|||
147187181|NCT00101686|530852190|FG003|Overall Study|Physician Decision|7|||
147187182|NCT00101686|530852191|FG004|Overall Study|Physician Decision|8|||
147187183|NCT00101686|530852192|FG005|Overall Study|Physician Decision|9|||
147247433|NCT00642460|531074513|FG003|Part II: Open-Label Up to Week 92|Adverse Event|0|||
147247434|NCT00642460|531074514|FG004|Part II: Open-Label Up to Week 92|Adverse Event|0|||
147247435|NCT00642460|531074515|FG005|Part II: Open-Label Up to Week 92|Adverse Event|0|||
147247436|NCT00642460|531074510|FG000|Part II: Open-Label Up to Week 92|Death|0|||
147247437|NCT00642460|531074511|FG001|Part II: Open-Label Up to Week 92|Death|1|||
147247438|NCT00642460|531074512|FG002|Part II: Open-Label Up to Week 92|Death|0|||
147247439|NCT00642460|531074513|FG003|Part II: Open-Label Up to Week 92|Death|2|||
147187184|NCT00101686|530852193|FG006|Overall Study|Physician Decision|5|||
147187185|NCT00101686|530852194|FG007|Overall Study|Physician Decision|5|||
147187186|NCT00101686|530852195|FG008|Overall Study|Physician Decision|1|||
147187187|NCT00101686|530852196|FG009|Overall Study|Physician Decision|1|||
147187188|NCT00101686|530852187|FG000|Overall Study|Other|1|||
147187189|NCT00101686|530852188|FG001|Overall Study|Other|4|||
147187190|NCT00101686|530852189|FG002|Overall Study|Other|1|||
147187191|NCT00101686|530852190|FG003|Overall Study|Other|6|||
147329549|NCT02377362|531371758|FG004|Part A Third Treatment|Highest dose level 1200 not used|3|||
147187192|NCT00101686|530852191|FG004|Overall Study|Other|2|||
147187193|NCT00101686|530852192|FG005|Overall Study|Other|12|||
147187194|NCT00101686|530852193|FG006|Overall Study|Other|1|||
147187195|NCT00101686|530852194|FG007|Overall Study|Other|5|||
147187196|NCT00101686|530852195|FG008|Overall Study|Other|3|||
147187197|NCT00101686|530852196|FG009|Overall Study|Other|3|||
147187198|NCT00101686|530852187|FG000|Overall Study|Withdrawal by Subject|9|||
147187199|NCT00101686|530852188|FG001|Overall Study|Withdrawal by Subject|8|||
147187200|NCT00101686|530852189|FG002|Overall Study|Withdrawal by Subject|6|||
147187201|NCT00101686|530852190|FG003|Overall Study|Withdrawal by Subject|8|||
147187202|NCT00101686|530852191|FG004|Overall Study|Withdrawal by Subject|8|||
147187203|NCT00101686|530852192|FG005|Overall Study|Withdrawal by Subject|7|||
147187204|NCT00101686|530852193|FG006|Overall Study|Withdrawal by Subject|7|||
147187205|NCT00101686|530852194|FG007|Overall Study|Withdrawal by Subject|7|||
147187206|NCT00101686|530852195|FG008|Overall Study|Withdrawal by Subject|8|||
147187207|NCT00101686|530852196|FG009|Overall Study|Withdrawal by Subject|9|||
147187208|NCT00296816|530852197|FG000|Overall Study|Disease Progression|37|||
147187209|NCT00296816|530852197|FG000|Overall Study|Adverse Event|18|||
147187210|NCT00296816|530852197|FG000|Overall Study|Investigator/Participant request|5|||
147187211|NCT00296816|530852197|FG000|Overall Study|Non-compliance|1|||
147187212|NCT00296816|530852197|FG000|Overall Study|Missing for end of treatment|4|||
147187213|NCT00296816|530852197|FG000|Overall Study|Progression based on CA-125 (biomarker)|2|||
147187214|NCT00296816|530852197|FG000|Overall Study|Poor performance status|1|||
147187215|NCT00296816|530852197|FG000|Overall Study|Relocation to Florida|1|||
147187216|NCT00296816|530852197|FG000|Overall Study|Noncompliance/decision to discontinue|1|||
147187217|NCT00296816|530852197|FG000|Overall Study|Urine protein/creatinine ratio delay|1|||
147187218|NCT00296816|530852197|FG000|Overall Study|Neuropathy/patient preference|1|||
147187219|NCT00296816|530852197|FG000|Overall Study|Proteinuria|1|||
147187220|NCT00296816|530852197|FG000|Overall Study|ineligibility due to radiation treatment|1|||
147187221|NCT00985465|530852198|FG000|Overall Study|Withdrawal by Subject|1|||
147187222|NCT00985465|530852199|FG001|Overall Study|Withdrawal by Subject|2|||
147187223|NCT00985465|530852198|FG000|Overall Study|Considered to be part of the other group|0|||
147187224|NCT00985465|530852199|FG001|Overall Study|Considered to be part of the other group|1|||
147187225|NCT01054456|530852200|FG000|Overall Study|Other|1|||
147187226|NCT00687401|530852201|FG000|Overall Study|Protocol Violation|7|||
147187227|NCT00687401|530852201|FG000|Overall Study|Adverse Event|6|||
147187228|NCT00687401|530852201|FG000|Overall Study|Lack of Efficacy|6|||
147187229|NCT00687401|530852201|FG000|Overall Study|Withdrawal by Subject|4|||
147187230|NCT00687401|530852201|FG000|Overall Study|Did not return for visit|3|||
147187231|NCT00687401|530852201|FG000|Overall Study|For reasons different from those above|4|||
147187232|NCT01721161|530852204|FG000|Overall Study|Adverse Event|2|||
147187233|NCT01721161|530852205|FG001|Overall Study|Adverse Event|3|||
147187234|NCT01721161|530852204|FG000|Overall Study|Lost to Follow-up|1|||
147187235|NCT01721161|530852205|FG001|Overall Study|Lost to Follow-up|2|||
147187236|NCT01721161|530852204|FG000|Overall Study|Withdrawal by Subject|1|||
147187237|NCT01721161|530852205|FG001|Overall Study|Withdrawal by Subject|1|||
147187238|NCT01721161|530852204|FG000|Overall Study|Other|0|||
147187239|NCT01721161|530852205|FG001|Overall Study|Other|1|||
147187240|NCT02888106|530852213|FG000|Overall Study|Withdrawal by Subject|1|||
147187241|NCT02888106|530852214|FG001|Overall Study|Withdrawal by Subject|2|||
147187242|NCT02888106|530852215|FG002|Overall Study|Withdrawal by Subject|0|||
147187243|NCT02888106|530852216|FG003|Overall Study|Withdrawal by Subject|1|||
147187244|NCT02888106|530852217|FG004|Overall Study|Withdrawal by Subject|0|||
147329550|NCT02377362|531371759|FG005|Part A Third Treatment|Highest dose level 1200 not used|4|||
147329551|NCT02377362|531371760|FG006|Part A Third Treatment|Highest dose level 1200 not used|0|||
147329552|NCT02377362|531371761|FG007|Part A Third Treatment|Highest dose level 1200 not used|0|||
147329553|NCT02377362|531371762|FG008|Part A Third Treatment|Highest dose level 1200 not used|0|||
147329554|NCT02377362|531371763|FG009|Part A Third Treatment|Highest dose level 1200 not used|0|||
147329555|NCT02377362|531371764|FG010|Part A Third Treatment|Highest dose level 1200 not used|0|||
147329556|NCT02377362|531371765|FG011|Part A Third Treatment|Highest dose level 1200 not used|0|||
147329557|NCT02377362|531371766|FG012|Part A Third Treatment|Highest dose level 1200 not used|0|||
147329558|NCT02377362|531371754|FG000|Part B Overall|Protocol Violation|0|||
147187245|NCT02888106|530852218|FG005|Overall Study|Withdrawal by Subject|0|||
147187246|NCT02888106|530852213|FG000|Overall Study|Lost to Follow-up|1|||
147187247|NCT02888106|530852214|FG001|Overall Study|Lost to Follow-up|0|||
147187248|NCT02888106|530852215|FG002|Overall Study|Lost to Follow-up|0|||
147187249|NCT02888106|530852216|FG003|Overall Study|Lost to Follow-up|1|||
147187250|NCT02888106|530852217|FG004|Overall Study|Lost to Follow-up|0|||
147187251|NCT02888106|530852218|FG005|Overall Study|Lost to Follow-up|1|||
147187252|NCT02888106|530852213|FG000|Overall Study|Adverse Event|2|||
147187253|NCT02888106|530852214|FG001|Overall Study|Adverse Event|0|||
147187254|NCT02888106|530852215|FG002|Overall Study|Adverse Event|0|||
147187255|NCT02888106|530852216|FG003|Overall Study|Adverse Event|0|||
147187256|NCT02888106|530852217|FG004|Overall Study|Adverse Event|0|||
147187257|NCT02888106|530852218|FG005|Overall Study|Adverse Event|0|||
147187258|NCT02888106|530852213|FG000|Overall Study|Withdrawal of consent|0|||
147187259|NCT02888106|530852214|FG001|Overall Study|Withdrawal of consent|0|||
147187260|NCT02888106|530852215|FG002|Overall Study|Withdrawal of consent|0|||
147187261|NCT02888106|530852216|FG003|Overall Study|Withdrawal of consent|0|||
147187262|NCT02888106|530852217|FG004|Overall Study|Withdrawal of consent|1|||
147187263|NCT02888106|530852218|FG005|Overall Study|Withdrawal of consent|0|||
147187264|NCT02888106|530852213|FG000|Overall Study|Pregnancy|1|||
147187265|NCT02888106|530852214|FG001|Overall Study|Pregnancy|0|||
147187266|NCT02888106|530852215|FG002|Overall Study|Pregnancy|0|||
147187267|NCT02888106|530852216|FG003|Overall Study|Pregnancy|0|||
147187268|NCT02888106|530852217|FG004|Overall Study|Pregnancy|0|||
147187269|NCT02888106|530852218|FG005|Overall Study|Pregnancy|0|||
147187270|NCT00430716|530852223|FG000|Double Blind Phase|Death|1|||
147187271|NCT00430716|530852224|FG001|Double Blind Phase|Death|0|||
147329559|NCT02377362|531371755|FG001|Part B Overall|Protocol Violation|0|||
147187272|NCT00430716|530852225|FG002|Double Blind Phase|Death|0|||
147187273|NCT00430716|530852223|FG000|Double Blind Phase|No longer willing to participate|2|||
147187274|NCT00430716|530852224|FG001|Double Blind Phase|No longer willing to participate|1|||
147187275|NCT00430716|530852225|FG002|Double Blind Phase|No longer willing to participate|1|||
147187276|NCT00430716|530852223|FG000|Double Blind Phase|Other|0|||
147187277|NCT00430716|530852224|FG001|Double Blind Phase|Other|2|||
147187278|NCT00430716|530852225|FG002|Double Blind Phase|Other|0|||
147187279|NCT00430716|530852223|FG000|Double Blind Phase|Study terminated by sponsor|1|||
147187280|NCT00430716|530852224|FG001|Double Blind Phase|Study terminated by sponsor|1|||
147187281|NCT00430716|530852225|FG002|Double Blind Phase|Study terminated by sponsor|2|||
147187282|NCT00430716|530852223|FG000|Double Blind Phase|Adverse Event|1|||
147187283|NCT00430716|530852224|FG001|Double Blind Phase|Adverse Event|1|||
147187284|NCT00430716|530852225|FG002|Double Blind Phase|Adverse Event|3|||
147187285|NCT00430716|530852223|FG000|Double Blind Phase|Not treated|1|||
147187286|NCT00430716|530852224|FG001|Double Blind Phase|Not treated|0|||
147187287|NCT00430716|530852225|FG002|Double Blind Phase|Not treated|0|||
147187288|NCT00430716|530852223|FG000|Open Label Phase|Lost to Follow-up|1|||
147187289|NCT00430716|530852224|FG001|Open Label Phase|Lost to Follow-up|0|||
147187290|NCT00430716|530852225|FG002|Open Label Phase|Lost to Follow-up|1|||
147187291|NCT00430716|530852223|FG000|Open Label Phase|No longer willing to participate|0|||
147187292|NCT00430716|530852224|FG001|Open Label Phase|No longer willing to participate|1|||
147187293|NCT00430716|530852225|FG002|Open Label Phase|No longer willing to participate|1|||
147187294|NCT00430716|530852223|FG000|Open Label Phase|Other|3|||
147187295|NCT00430716|530852224|FG001|Open Label Phase|Other|1|||
147187296|NCT00430716|530852225|FG002|Open Label Phase|Other|1|||
147187297|NCT00430716|530852223|FG000|Open Label Phase|Protocol Violation|1|||
147187298|NCT00430716|530852224|FG001|Open Label Phase|Protocol Violation|0|||
147187299|NCT00430716|530852225|FG002|Open Label Phase|Protocol Violation|0|||
147187300|NCT00430716|530852223|FG000|Open Label Phase|Study terminated by sponsor|4|||
147187301|NCT00430716|530852224|FG001|Open Label Phase|Study terminated by sponsor|5|||
147187302|NCT00430716|530852225|FG002|Open Label Phase|Study terminated by sponsor|4|||
147187303|NCT01433172|530852231|FG000|Overall Study|Withdrawal by Subject|0|||
147187304|NCT01433172|530852232|FG001|Overall Study|Withdrawal by Subject|1|||
147187305|NCT01433172|530852233|FG002|Overall Study|Withdrawal by Subject|0|||
147187306|NCT01433172|530852231|FG000|Overall Study|Disease Progression|0|||
147187307|NCT01433172|530852232|FG001|Overall Study|Disease Progression|0|||
147187308|NCT01433172|530852233|FG002|Overall Study|Disease Progression|1|||
147187309|NCT01433172|530852231|FG000|Overall Study|Death|0|||
147187310|NCT01433172|530852232|FG001|Overall Study|Death|2|||
147187311|NCT01433172|530852233|FG002|Overall Study|Death|0|||
147187312|NCT00104650|530852234|FG000|Treatment Period (25 Weeks)|Physician Decision|0|||
147187313|NCT00104650|530852235|FG001|Treatment Period (25 Weeks)|Physician Decision|0|||
147187314|NCT00104650|530852236|FG002|Treatment Period (25 Weeks)|Physician Decision|1|||
147187315|NCT00104650|530852234|FG000|Treatment Period (25 Weeks)|Withdrawal by Subject|2|||
147187316|NCT00104650|530852235|FG001|Treatment Period (25 Weeks)|Withdrawal by Subject|1|||
147187317|NCT00104650|530852236|FG002|Treatment Period (25 Weeks)|Withdrawal by Subject|1|||
147187318|NCT00104650|530852234|FG000|Treatment Period (25 Weeks)|Death|7|||
147187319|NCT00104650|530852235|FG001|Treatment Period (25 Weeks)|Death|5|||
147187320|NCT00104650|530852236|FG002|Treatment Period (25 Weeks)|Death|6|||
147187321|NCT00104650|530852234|FG000|Treatment Period (25 Weeks)|Disease progression|2|||
147187322|NCT00104650|530852235|FG001|Treatment Period (25 Weeks)|Disease progression|3|||
147187323|NCT00104650|530852236|FG002|Treatment Period (25 Weeks)|Disease progression|2|||
147187324|NCT00104650|530852234|FG000|Treatment Period (25 Weeks)|Ineligibility determined|0|||
147329560|NCT02377362|531371756|FG002|Part B Overall|Protocol Violation|0|||
147329561|NCT02377362|531371757|FG003|Part B Overall|Protocol Violation|0|||
147329562|NCT02377362|531371758|FG004|Part B Overall|Protocol Violation|0|||
147247440|NCT00642460|531074514|FG004|Part II: Open-Label Up to Week 92|Death|0|||
147247441|NCT00642460|531074515|FG005|Part II: Open-Label Up to Week 92|Death|0|||
147247442|NCT00642460|531074510|FG000|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|2|||
147247443|NCT00642460|531074511|FG001|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|3|||
147247444|NCT00642460|531074512|FG002|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0|||
147247445|NCT00642460|531074513|FG003|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0|||
147329563|NCT02377362|531371759|FG005|Part B Overall|Protocol Violation|0|||
147247446|NCT00642460|531074514|FG004|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0|||
147247447|NCT00642460|531074515|FG005|Part II: Open-Label Up to Week 92|Insufficient therapeutic response|0|||
147247448|NCT00642460|531074510|FG000|Part II: Open-Label Up to Week 92|Refused treatment|3|||
147247449|NCT00642460|531074511|FG001|Part II: Open-Label Up to Week 92|Refused treatment|1|||
147247450|NCT00642460|531074512|FG002|Part II: Open-Label Up to Week 92|Refused treatment|0|||
147247451|NCT00642460|531074513|FG003|Part II: Open-Label Up to Week 92|Refused treatment|0|||
147247452|NCT00642460|531074514|FG004|Part II: Open-Label Up to Week 92|Refused treatment|0|||
147329564|NCT02377362|531371760|FG006|Part B Overall|Protocol Violation|0|||
147329565|NCT02377362|531371761|FG007|Part B Overall|Protocol Violation|0|||
147329566|NCT02377362|531371762|FG008|Part B Overall|Protocol Violation|0|||
147329567|NCT02377362|531371763|FG009|Part B Overall|Protocol Violation|1|||
147329568|NCT02377362|531371764|FG010|Part B Overall|Protocol Violation|0|||
147329569|NCT02377362|531371765|FG011|Part B Overall|Protocol Violation|0|||
147329570|NCT02377362|531371766|FG012|Part B Overall|Protocol Violation|0|||
147329571|NCT02377362|531371754|FG000|Part B Overall|Adverse Event|0|||
147329572|NCT02377362|531371755|FG001|Part B Overall|Adverse Event|0|||
147329573|NCT02377362|531371756|FG002|Part B Overall|Adverse Event|0|||
147329574|NCT02377362|531371757|FG003|Part B Overall|Adverse Event|0|||
147329575|NCT02377362|531371758|FG004|Part B Overall|Adverse Event|0|||
147329576|NCT02377362|531371759|FG005|Part B Overall|Adverse Event|0|||
147329577|NCT02377362|531371760|FG006|Part B Overall|Adverse Event|1|||
147329578|NCT02377362|531371761|FG007|Part B Overall|Adverse Event|1|||
147329579|NCT02377362|531371762|FG008|Part B Overall|Adverse Event|0|||
147329580|NCT02377362|531371763|FG009|Part B Overall|Adverse Event|0|||
147329581|NCT02377362|531371764|FG010|Part B Overall|Adverse Event|0|||
147329582|NCT02377362|531371765|FG011|Part B Overall|Adverse Event|0|||
147329583|NCT02377362|531371766|FG012|Part B Overall|Adverse Event|0|||
147329584|NCT02377362|531371754|FG000|Part B Overall|Withdrawal by Subject|0|||
147329585|NCT02377362|531371755|FG001|Part B Overall|Withdrawal by Subject|0|||
147329586|NCT02377362|531371756|FG002|Part B Overall|Withdrawal by Subject|0|||
147329587|NCT02377362|531371757|FG003|Part B Overall|Withdrawal by Subject|0|||
147329588|NCT02377362|531371758|FG004|Part B Overall|Withdrawal by Subject|0|||
147329589|NCT02377362|531371759|FG005|Part B Overall|Withdrawal by Subject|0|||
147329590|NCT02377362|531371760|FG006|Part B Overall|Withdrawal by Subject|1|||
147329591|NCT02377362|531371761|FG007|Part B Overall|Withdrawal by Subject|0|||
147329592|NCT02377362|531371762|FG008|Part B Overall|Withdrawal by Subject|0|||
147329593|NCT02377362|531371763|FG009|Part B Overall|Withdrawal by Subject|0|||
147329594|NCT02377362|531371764|FG010|Part B Overall|Withdrawal by Subject|0|||
147329595|NCT02377362|531371765|FG011|Part B Overall|Withdrawal by Subject|1|||
147329596|NCT02377362|531371766|FG012|Part B Overall|Withdrawal by Subject|0|||
147329597|NCT01549652|531371767|FG000|Overall Study|Did Not Receive Allocated Intervention|0|||
147329598|NCT01549652|531371768|FG001|Overall Study|Did Not Receive Allocated Intervention|0|||
147329599|NCT01549652|531371769|FG002|Overall Study|Did Not Receive Allocated Intervention|2|||
147329600|NCT01549652|531371770|FG003|Overall Study|Did Not Receive Allocated Intervention|0|||
147329601|NCT01549652|531371767|FG000|Overall Study|Study Drug Titration Failure|5|||
147329602|NCT01549652|531371768|FG001|Overall Study|Study Drug Titration Failure|6|||
147329603|NCT01549652|531371769|FG002|Overall Study|Study Drug Titration Failure|0|||
147329604|NCT01549652|531371770|FG003|Overall Study|Study Drug Titration Failure|0|||
147329605|NCT01549652|531371767|FG000|Overall Study|Withdrawal Effect|0|||
147329606|NCT01549652|531371768|FG001|Overall Study|Withdrawal Effect|2|||
147329607|NCT01549652|531371769|FG002|Overall Study|Withdrawal Effect|0|||
147329608|NCT01549652|531371770|FG003|Overall Study|Withdrawal Effect|0|||
147329609|NCT01549652|531371767|FG000|Overall Study|Did Not Return Due to Withdrawal Effect|5|||
147329610|NCT01549652|531371768|FG001|Overall Study|Did Not Return Due to Withdrawal Effect|1|||
147329611|NCT01549652|531371769|FG002|Overall Study|Did Not Return Due to Withdrawal Effect|0|||
147329612|NCT01549652|531371770|FG003|Overall Study|Did Not Return Due to Withdrawal Effect|0|||
147247453|NCT00642460|531074515|FG005|Part II: Open-Label Up to Week 92|Refused treatment|0|||
147247454|NCT00642460|531074510|FG000|Part II: Open-Label Up to Week 92|Failure to return|0|||
147247455|NCT00642460|531074511|FG001|Part II: Open-Label Up to Week 92|Failure to return|1|||
147329613|NCT01549652|531371767|FG000|Overall Study|Problem with Infusion|1|||
147329614|NCT01549652|531371768|FG001|Overall Study|Problem with Infusion|0|||
147594111|NCT01698775|532330602|FG001|Phase A|Death|1|||
147329615|NCT01549652|531371769|FG002|Overall Study|Problem with Infusion|0|||
147329616|NCT01549652|531371770|FG003|Overall Study|Problem with Infusion|0|||
147329617|NCT01549652|531371767|FG000|Overall Study|Titration Non-Compliance|1|||
147329618|NCT01549652|531371768|FG001|Overall Study|Titration Non-Compliance|3|||
147329619|NCT01549652|531371769|FG002|Overall Study|Titration Non-Compliance|4|||
147329620|NCT01549652|531371770|FG003|Overall Study|Titration Non-Compliance|5|||
147329621|NCT01549652|531371767|FG000|Overall Study|Titration Side Effects|0|||
147329622|NCT01549652|531371768|FG001|Overall Study|Titration Side Effects|0|||
147329623|NCT01549652|531371769|FG002|Overall Study|Titration Side Effects|6|||
147329624|NCT01549652|531371770|FG003|Overall Study|Titration Side Effects|3|||
147329625|NCT01549652|531371767|FG000|Overall Study|Withdrawal by Subject|0|||
147329626|NCT01549652|531371768|FG001|Overall Study|Withdrawal by Subject|0|||
147329627|NCT01549652|531371769|FG002|Overall Study|Withdrawal by Subject|5|||
147329628|NCT01549652|531371770|FG003|Overall Study|Withdrawal by Subject|3|||
147329629|NCT03247543|531371773|FG000|Overall Study|Adverse Event|3|||
147329630|NCT03247543|531371774|FG001|Overall Study|Adverse Event|6|||
147329631|NCT03247543|531371775|FG002|Overall Study|Adverse Event|4|||
147329632|NCT03247543|531371773|FG000|Overall Study|Lost to Follow-up|10|||
147329633|NCT03247543|531371774|FG001|Overall Study|Lost to Follow-up|7|||
147329634|NCT03247543|531371775|FG002|Overall Study|Lost to Follow-up|8|||
147329635|NCT03247543|531371773|FG000|Overall Study|Consent withdrawn by caregiver|2|||
147329636|NCT03247543|531371774|FG001|Overall Study|Consent withdrawn by caregiver|2|||
147329637|NCT03247543|531371775|FG002|Overall Study|Consent withdrawn by caregiver|9|||
147329638|NCT03247543|531371773|FG000|Overall Study|Withdrawal by Subject|0|||
147329639|NCT03247543|531371774|FG001|Overall Study|Withdrawal by Subject|0|||
147329640|NCT03247543|531371775|FG002|Overall Study|Withdrawal by Subject|1|||
147329641|NCT03247543|531371773|FG000|Overall Study|Failure to Follow study procedures|1|||
147329642|NCT03247543|531371774|FG001|Overall Study|Failure to Follow study procedures|3|||
147329643|NCT03247543|531371775|FG002|Overall Study|Failure to Follow study procedures|1|||
147329644|NCT03247543|531371773|FG000|Overall Study|Lack of Efficacy|1|||
147329645|NCT03247543|531371774|FG001|Overall Study|Lack of Efficacy|0|||
147329646|NCT03247543|531371775|FG002|Overall Study|Lack of Efficacy|0|||
147329647|NCT03247543|531371773|FG000|Overall Study|Non-compliance with study visits|0|||
147329648|NCT03247543|531371774|FG001|Overall Study|Non-compliance with study visits|1|||
147329649|NCT03247543|531371775|FG002|Overall Study|Non-compliance with study visits|0|||
147329650|NCT02059980|531371779|FG000|Overall Study|Lost to Follow-up|2|||
147329651|NCT02059980|531371780|FG001|Overall Study|Lost to Follow-up|1|||
147329652|NCT05196737|531371782|FG000|Non-intervention Week|Lost to Follow-up|2|||
147329653|NCT05196737|531371782|FG000|Dry Needling Reflex Measurment Week|Protocol Violation|1|||
147329654|NCT03722446|531371783|FG000|Overall Study|Protocol Violation|15|||
147329655|NCT03722446|531371784|FG001|Overall Study|Protocol Violation|2|||
147329656|NCT02908464|531371789|FG000|Overall Study|Withdrawal by Subject|2|||
147329657|NCT02908464|531371790|FG001|Overall Study|Withdrawal by Subject|1|||
147329658|NCT02908464|531371789|FG000|Overall Study|Found ineligible after randomization|0|||
147329659|NCT02908464|531371790|FG001|Overall Study|Found ineligible after randomization|2|||
147329660|NCT02163915|531371791|FG000|Overall Study|Withdrawal by Subject|2|||
147329661|NCT02163915|531371792|FG001|Overall Study|Withdrawal by Subject|0|||
147329662|NCT02163915|531371793|FG002|Overall Study|Withdrawal by Subject|2|||
147329663|NCT02163915|531371794|FG003|Overall Study|Withdrawal by Subject|2|||
147329664|NCT02163915|531371795|FG004|Overall Study|Withdrawal by Subject|2|||
147329665|NCT02163915|531371791|FG000|Overall Study|Study termination|1|||
147329666|NCT02163915|531371792|FG001|Overall Study|Study termination|0|||
147329667|NCT02163915|531371793|FG002|Overall Study|Study termination|0|||
147329668|NCT02163915|531371794|FG003|Overall Study|Study termination|0|||
147329669|NCT02163915|531371795|FG004|Overall Study|Study termination|2|||
147329670|NCT02163915|531371791|FG000|Overall Study|Physician Decision|0|||
147329671|NCT02163915|531371792|FG001|Overall Study|Physician Decision|0|||
147329672|NCT02163915|531371793|FG002|Overall Study|Physician Decision|0|||
147329673|NCT02163915|531371794|FG003|Overall Study|Physician Decision|1|||
147329674|NCT02163915|531371795|FG004|Overall Study|Physician Decision|0|||
147329675|NCT01090024|531373047|FG000|Period 1|Met exclusion criteria|0|||
147329676|NCT01090024|531373048|FG001|Period 1|Met exclusion criteria|0|||
147329677|NCT01090024|531373049|FG002|Period 1|Met exclusion criteria|0|||
147329678|NCT01090024|531373050|FG003|Period 1|Met exclusion criteria|0|||
147329679|NCT01090024|531373051|FG004|Period 1|Met exclusion criteria|0|||
147329680|NCT01090024|531373052|FG005|Period 1|Met exclusion criteria|0|||
147329681|NCT01090024|531373053|FG006|Period 1|Met exclusion criteria|0|||
147329682|NCT01090024|531373054|FG007|Period 1|Met exclusion criteria|0|||
147329683|NCT01090024|531373055|FG008|Period 1|Met exclusion criteria|0|||
147329684|NCT01090024|531373056|FG009|Period 1|Met exclusion criteria|0|||
147329685|NCT01090024|531373057|FG010|Period 1|Met exclusion criteria|0|||
147329686|NCT01090024|531373058|FG011|Period 1|Met exclusion criteria|0|||
147329687|NCT01090024|531373059|FG012|Period 1|Met exclusion criteria|0|||
147329688|NCT01090024|531373060|FG013|Period 1|Met exclusion criteria|0|||
147329689|NCT01090024|531373061|FG014|Period 1|Met exclusion criteria|1|||
147329690|NCT01090024|531373062|FG015|Period 1|Met exclusion criteria|0|||
147448864|NCT00749996|531808020|FG000|Overall Study|Withdrawal by Subject|5|||
147329691|NCT01090024|531373063|FG016|Period 1|Met exclusion criteria|0|||
147329692|NCT01090024|531373064|FG017|Period 1|Met exclusion criteria|0|||
147187325|NCT00104650|530852235|FG001|Treatment Period (25 Weeks)|Ineligibility determined|1|||
147187326|NCT00104650|530852236|FG002|Treatment Period (25 Weeks)|Ineligibility determined|0|||
147187327|NCT00104650|530852234|FG000|Treatment Period (25 Weeks)|Other|1|||
147187328|NCT00104650|530852235|FG001|Treatment Period (25 Weeks)|Other|0|||
147187329|NCT00104650|530852236|FG002|Treatment Period (25 Weeks)|Other|0|||
147187330|NCT00104650|530852234|FG000|Treatment Period (25 Weeks)|Protocol deviation|0|||
147187331|NCT00104650|530852235|FG001|Treatment Period (25 Weeks)|Protocol deviation|1|||
147187332|NCT00104650|530852236|FG002|Treatment Period (25 Weeks)|Protocol deviation|0|||
147187333|NCT00104650|530852234|FG000|Follow-up Period|Physician Decision|1|||
147187334|NCT00104650|530852235|FG001|Follow-up Period|Physician Decision|1|||
147187335|NCT00104650|530852236|FG002|Follow-up Period|Physician Decision|0|||
147187336|NCT00104650|530852234|FG000|Follow-up Period|Adverse Event|1|||
147187337|NCT00104650|530852235|FG001|Follow-up Period|Adverse Event|0|||
147187338|NCT00104650|530852236|FG002|Follow-up Period|Adverse Event|1|||
147187339|NCT00104650|530852234|FG000|Follow-up Period|Withdrawal by Subject|0|||
147187340|NCT00104650|530852235|FG001|Follow-up Period|Withdrawal by Subject|3|||
147187341|NCT00104650|530852236|FG002|Follow-up Period|Withdrawal by Subject|3|||
147187342|NCT00104650|530852234|FG000|Follow-up Period|Death|6|||
147187343|NCT00104650|530852235|FG001|Follow-up Period|Death|6|||
147187344|NCT00104650|530852236|FG002|Follow-up Period|Death|4|||
147187345|NCT00104650|530852234|FG000|Follow-up Period|Disease progression|3|||
147187346|NCT00104650|530852235|FG001|Follow-up Period|Disease progression|1|||
147187347|NCT00104650|530852236|FG002|Follow-up Period|Disease progression|0|||
147187348|NCT00104650|530852234|FG000|Follow-up Period|Lost to Follow-up|0|||
147187349|NCT00104650|530852235|FG001|Follow-up Period|Lost to Follow-up|1|||
147187350|NCT00104650|530852236|FG002|Follow-up Period|Lost to Follow-up|2|||
147187351|NCT00104650|530852234|FG000|Follow-up Period|Other|0|||
147187352|NCT00104650|530852235|FG001|Follow-up Period|Other|1|||
147187353|NCT00104650|530852236|FG002|Follow-up Period|Other|0|||
147187354|NCT02294058|530852237|FG000|Overall Study|Adverse Event|16|||
147187355|NCT02294058|530852238|FG001|Overall Study|Adverse Event|7|||
147187356|NCT02294058|530852239|FG002|Overall Study|Adverse Event|13|||
147187357|NCT02294058|530852237|FG000|Overall Study|Lack of Efficacy|3|||
147187358|NCT02294058|530852238|FG001|Overall Study|Lack of Efficacy|3|||
147187359|NCT02294058|530852239|FG002|Overall Study|Lack of Efficacy|0|||
147187360|NCT02294058|530852237|FG000|Overall Study|Lost to Follow-up|1|||
147187361|NCT02294058|530852238|FG001|Overall Study|Lost to Follow-up|0|||
147187362|NCT02294058|530852239|FG002|Overall Study|Lost to Follow-up|2|||
147187363|NCT02294058|530852237|FG000|Overall Study|Withdrawal by Subject|10|||
147187364|NCT02294058|530852238|FG001|Overall Study|Withdrawal by Subject|14|||
147187365|NCT02294058|530852239|FG002|Overall Study|Withdrawal by Subject|13|||
147187366|NCT02294058|530852237|FG000|Overall Study|Physician Decision|2|||
147187367|NCT02294058|530852238|FG001|Overall Study|Physician Decision|1|||
147187368|NCT02294058|530852239|FG002|Overall Study|Physician Decision|0|||
147187369|NCT02294058|530852237|FG000|Overall Study|Miscellaneous|4|||
147187370|NCT02294058|530852238|FG001|Overall Study|Miscellaneous|1|||
147187371|NCT02294058|530852239|FG002|Overall Study|Miscellaneous|1|||
147187372|NCT01894607|530852240|FG000|Overall Study|Ineligible|1|||
147187373|NCT03084796|530852243|FG000|Overall Study|Adverse Event|4|||
147187374|NCT03084796|530852244|FG001|Overall Study|Adverse Event|5|||
147187375|NCT03084796|530852245|FG002|Overall Study|Adverse Event|6|||
147187376|NCT03084796|530852246|FG003|Overall Study|Adverse Event|2|||
147187377|NCT03084796|530852247|FG004|Overall Study|Adverse Event|3|||
147187378|NCT03084796|530852248|FG005|Overall Study|Adverse Event|5|||
147187379|NCT03084796|530852243|FG000|Overall Study|Withdrawal by Subject|3|||
147187380|NCT03084796|530852244|FG001|Overall Study|Withdrawal by Subject|5|||
147187381|NCT03084796|530852245|FG002|Overall Study|Withdrawal by Subject|2|||
147187382|NCT03084796|530852246|FG003|Overall Study|Withdrawal by Subject|1|||
147187383|NCT03084796|530852247|FG004|Overall Study|Withdrawal by Subject|3|||
147187384|NCT03084796|530852248|FG005|Overall Study|Withdrawal by Subject|0|||
147187385|NCT03084796|530852243|FG000|Overall Study|Protocol Violation|0|||
147187386|NCT03084796|530852244|FG001|Overall Study|Protocol Violation|0|||
147187387|NCT03084796|530852245|FG002|Overall Study|Protocol Violation|1|||
147187388|NCT03084796|530852246|FG003|Overall Study|Protocol Violation|0|||
147187389|NCT03084796|530852247|FG004|Overall Study|Protocol Violation|1|||
147187390|NCT03084796|530852248|FG005|Overall Study|Protocol Violation|1|||
147187391|NCT03084796|530852243|FG000|Overall Study|Lack of Efficacy|0|||
147187392|NCT03084796|530852244|FG001|Overall Study|Lack of Efficacy|0|||
147187393|NCT03084796|530852245|FG002|Overall Study|Lack of Efficacy|1|||
147187394|NCT03084796|530852246|FG003|Overall Study|Lack of Efficacy|0|||
147187395|NCT03084796|530852247|FG004|Overall Study|Lack of Efficacy|1|||
147187396|NCT03084796|530852248|FG005|Overall Study|Lack of Efficacy|0|||
147187397|NCT03084796|530852243|FG000|Overall Study|Lost to Follow-up|0|||
147187398|NCT03084796|530852244|FG001|Overall Study|Lost to Follow-up|0|||
147448865|NCT00749996|531808021|FG001|Overall Study|Withdrawal by Subject|4|||
147187399|NCT03084796|530852245|FG002|Overall Study|Lost to Follow-up|1|||
147187400|NCT03084796|530852246|FG003|Overall Study|Lost to Follow-up|1|||
147187401|NCT03084796|530852247|FG004|Overall Study|Lost to Follow-up|3|||
147187402|NCT03084796|530852248|FG005|Overall Study|Lost to Follow-up|1|||
147187403|NCT03084796|530852243|FG000|Overall Study|Randomization error|0|||
147187404|NCT03084796|530852244|FG001|Overall Study|Randomization error|0|||
147187405|NCT03084796|530852245|FG002|Overall Study|Randomization error|1|||
147187406|NCT03084796|530852246|FG003|Overall Study|Randomization error|0|||
147187407|NCT03084796|530852247|FG004|Overall Study|Randomization error|0|||
147187408|NCT03084796|530852248|FG005|Overall Study|Randomization error|0|||
147187409|NCT00607087|530852253|FG000|Overall Study|Withdrawal by Subject|9|||
147187410|NCT00607087|530852254|FG001|Overall Study|Withdrawal by Subject|4|||
147187411|NCT00607087|530852255|FG002|Overall Study|Withdrawal by Subject|4|||
147187412|NCT00607087|530852253|FG000|Overall Study|Adverse Event|3|||
147187413|NCT00607087|530852254|FG001|Overall Study|Adverse Event|2|||
147187414|NCT00607087|530852255|FG002|Overall Study|Adverse Event|3|||
147187415|NCT00607087|530852253|FG000|Overall Study|Other reason|1|||
147187416|NCT00607087|530852254|FG001|Overall Study|Other reason|5|||
147187417|NCT00607087|530852255|FG002|Overall Study|Other reason|2|||
147187418|NCT00607087|530852253|FG000|Overall Study|Poor compliance to protocol|1|||
147187419|NCT00607087|530852254|FG001|Overall Study|Poor compliance to protocol|0|||
147187420|NCT00607087|530852255|FG002|Overall Study|Poor compliance to protocol|1|||
147187421|NCT00607087|530852253|FG000|Overall Study|Lost to Follow-up|1|||
147187422|NCT00607087|530852254|FG001|Overall Study|Lost to Follow-up|0|||
147187423|NCT00607087|530852255|FG002|Overall Study|Lost to Follow-up|0|||
147187424|NCT00607087|530852253|FG000|Period 1|Withdrawal by Subject|7|||
147187425|NCT00607087|530852254|FG001|Period 1|Withdrawal by Subject|2|||
147187426|NCT00607087|530852255|FG002|Period 1|Withdrawal by Subject|3|||
147187427|NCT00607087|530852253|FG000|Period 1|Adverse Event|3|||
147187428|NCT00607087|530852254|FG001|Period 1|Adverse Event|0|||
147187429|NCT00607087|530852255|FG002|Period 1|Adverse Event|0|||
147187430|NCT00607087|530852253|FG000|Period 1|Poor compliance to protocol|1|||
147187431|NCT00607087|530852254|FG001|Period 1|Poor compliance to protocol|0|||
147187432|NCT00607087|530852255|FG002|Period 1|Poor compliance to protocol|0|||
147187433|NCT00607087|530852253|FG000|Period 1|Lost to Follow-up|1|||
147187434|NCT00607087|530852254|FG001|Period 1|Lost to Follow-up|0|||
147187435|NCT00607087|530852255|FG002|Period 1|Lost to Follow-up|0|||
147187436|NCT00607087|530852253|FG000|Period 1|Other reason|0|||
147187437|NCT00607087|530852254|FG001|Period 1|Other reason|4|||
147187438|NCT00607087|530852255|FG002|Period 1|Other reason|2|||
147187439|NCT00607087|530852253|FG000|Period 2|Withdrawal by Subject|0|||
147187440|NCT00607087|530852254|FG001|Period 2|Withdrawal by Subject|1|||
147187441|NCT00607087|530852255|FG002|Period 2|Withdrawal by Subject|1|||
147187442|NCT00607087|530852253|FG000|Period 2|Other reason|1|||
147187443|NCT00607087|530852254|FG001|Period 2|Other reason|1|||
147187444|NCT00607087|530852255|FG002|Period 2|Other reason|0|||
147187445|NCT00607087|530852253|FG000|Period 2|Adverse Event|0|||
147187446|NCT00607087|530852254|FG001|Period 2|Adverse Event|1|||
147187447|NCT00607087|530852255|FG002|Period 2|Adverse Event|3|||
147187448|NCT00607087|530852253|FG000|Period 2|Poor compliance to protocol|0|||
147187449|NCT00607087|530852254|FG001|Period 2|Poor compliance to protocol|0|||
147187450|NCT00607087|530852255|FG002|Period 2|Poor compliance to protocol|1|||
147187451|NCT00607087|530852253|FG000|Period 3|Withdrawal by Subject|2|||
147187452|NCT00607087|530852254|FG001|Period 3|Withdrawal by Subject|1|||
147187453|NCT00607087|530852255|FG002|Period 3|Withdrawal by Subject|0|||
147187454|NCT00607087|530852253|FG000|Period 3|Adverse Event|0|||
147187455|NCT00607087|530852254|FG001|Period 3|Adverse Event|1|||
147187456|NCT00607087|530852255|FG002|Period 3|Adverse Event|0|||
147187457|NCT02717494|530852256|FG000|First Intervention (Step 1)|Lost to Follow-up|4|||
147187458|NCT02717494|530852257|FG001|First Intervention (Step 1)|Lost to Follow-up|7|||
147187459|NCT02717494|530852258|FG002|First Intervention (Step 1)|Lost to Follow-up|3|||
147247456|NCT00642460|531074512|FG002|Part II: Open-Label Up to Week 92|Failure to return|0|||
147247457|NCT00642460|531074513|FG003|Part II: Open-Label Up to Week 92|Failure to return|0|||
147247458|NCT00642460|531074514|FG004|Part II: Open-Label Up to Week 92|Failure to return|0|||
147247459|NCT00642460|531074515|FG005|Part II: Open-Label Up to Week 92|Failure to return|0|||
147247460|NCT00642460|531074510|FG000|Part II: Open-Label Up to Week 92|Administrative reasons|0|||
147247461|NCT00642460|531074511|FG001|Part II: Open-Label Up to Week 92|Administrative reasons|0|||
147247462|NCT00642460|531074512|FG002|Part II: Open-Label Up to Week 92|Administrative reasons|0|||
147247463|NCT00642460|531074513|FG003|Part II: Open-Label Up to Week 92|Administrative reasons|1|||
147187460|NCT02717494|530852256|FG000|First Intervention (Step 1)|Withdrawal by Subject|2|||
147247464|NCT00642460|531074514|FG004|Part II: Open-Label Up to Week 92|Administrative reasons|0|||
147247465|NCT00642460|531074515|FG005|Part II: Open-Label Up to Week 92|Administrative reasons|0|||
147247466|NCT00642460|531074510|FG000|Part III: Open-Label Up to Week 260|Adverse Event|0|||
147247467|NCT00642460|531074511|FG001|Part III: Open-Label Up to Week 260|Adverse Event|0|||
147187461|NCT02717494|530852257|FG001|First Intervention (Step 1)|Withdrawal by Subject|0|||
147187462|NCT02717494|530852258|FG002|First Intervention (Step 1)|Withdrawal by Subject|1|||
147187463|NCT02717494|530852256|FG000|First Intervention (Step 1)|Death|0|||
147187464|NCT02717494|530852257|FG001|First Intervention (Step 1)|Death|0|||
147187465|NCT02717494|530852258|FG002|First Intervention (Step 1)|Death|1|||
147187466|NCT02717494|530852256|FG000|Second Intervention (Step 2 or Step 3)|Lost to Follow-up|0|||
147187467|NCT02717494|530852257|FG001|Second Intervention (Step 2 or Step 3)|Lost to Follow-up|0|||
147187468|NCT02717494|530852258|FG002|Second Intervention (Step 2 or Step 3)|Lost to Follow-up|4|||
147187469|NCT03370718|530852264|FG000|Overall Study|Withdrawal by Subject|1|||
147187470|NCT05477485|530852269|FG000|Overall Study|Lost to Follow-up|0|||
147187471|NCT05477485|530852270|FG001|Overall Study|Lost to Follow-up|4|||
147187472|NCT06172348|530852271|FG000|Treatment Period 2|Adverse Event|0|||
147187473|NCT06172348|530852272|FG001|Treatment Period 2|Adverse Event|0|||
147187474|NCT06172348|530852273|FG002|Treatment Period 2|Adverse Event|1|||
147187475|NCT06172348|530852274|FG003|Treatment Period 2|Adverse Event|0|||
147187476|NCT06172348|530852275|FG004|Treatment Period 2|Adverse Event|0|||
147187477|NCT06172348|530852276|FG005|Treatment Period 2|Adverse Event|0|||
147187478|NCT03116685|530852277|FG000|Overall Study|Physician Decision|0|||
147187479|NCT03116685|530852278|FG001|Overall Study|Physician Decision|1|||
147187480|NCT05274958|530852279|FG000|Overall Study|Only completed 1 set of PROMs|22|||
147187481|NCT05274958|530852280|FG001|Overall Study|Only completed 1 set of PROMs|35|||
147187482|NCT05579977|530852285|FG000|Treatment Phase|Other|0|||
147187483|NCT05579977|530852286|FG001|Treatment Phase|Other|0|||
147187484|NCT05579977|530852287|FG002|Treatment Phase|Other|0|||
147187485|NCT05579977|530852288|FG003|Treatment Phase|Other|2|||
147187486|NCT05579977|530852289|FG004|Treatment Phase|Other|1|||
147187487|NCT05579977|530852290|FG005|Treatment Phase|Other|2|||
147187488|NCT05579977|530852291|FG006|Treatment Phase|Other|1|||
147187489|NCT05579977|530852292|FG007|Treatment Phase|Other|2|||
147187490|NCT05579977|530852293|FG008|Treatment Phase|Other|2|||
147187491|NCT05579977|530852294|FG009|Treatment Phase|Other|1|||
147187492|NCT05579977|530852295|FG010|Treatment Phase|Other|0|||
147187493|NCT05579977|530852296|FG011|Treatment Phase|Other|0|||
147187494|NCT05579977|530852297|FG012|Treatment Phase|Other|3|||
147187495|NCT05579977|530852285|FG000|Treatment Phase|Treatment with restricted medication needed|2|||
147187496|NCT05579977|530852286|FG001|Treatment Phase|Treatment with restricted medication needed|0|||
147187497|NCT05579977|530852287|FG002|Treatment Phase|Treatment with restricted medication needed|0|||
147187498|NCT05579977|530852288|FG003|Treatment Phase|Treatment with restricted medication needed|0|||
147187499|NCT05579977|530852289|FG004|Treatment Phase|Treatment with restricted medication needed|0|||
147187500|NCT05579977|530852290|FG005|Treatment Phase|Treatment with restricted medication needed|1|||
147187501|NCT05579977|530852291|FG006|Treatment Phase|Treatment with restricted medication needed|0|||
147187502|NCT05579977|530852292|FG007|Treatment Phase|Treatment with restricted medication needed|0|||
147187503|NCT05579977|530852293|FG008|Treatment Phase|Treatment with restricted medication needed|0|||
147187504|NCT05579977|530852294|FG009|Treatment Phase|Treatment with restricted medication needed|0|||
147187505|NCT05579977|530852295|FG010|Treatment Phase|Treatment with restricted medication needed|0|||
147187506|NCT05579977|530852296|FG011|Treatment Phase|Treatment with restricted medication needed|0|||
147187507|NCT05579977|530852297|FG012|Treatment Phase|Treatment with restricted medication needed|0|||
147187508|NCT05579977|530852285|FG000|Treatment Phase|Withdrawal by Subject|2|||
147187509|NCT05579977|530852286|FG001|Treatment Phase|Withdrawal by Subject|0|||
147187510|NCT05579977|530852287|FG002|Treatment Phase|Withdrawal by Subject|0|||
147187511|NCT05579977|530852288|FG003|Treatment Phase|Withdrawal by Subject|1|||
147187512|NCT05579977|530852289|FG004|Treatment Phase|Withdrawal by Subject|2|||
147187513|NCT05579977|530852290|FG005|Treatment Phase|Withdrawal by Subject|0|||
147187514|NCT05579977|530852291|FG006|Treatment Phase|Withdrawal by Subject|1|||
147187515|NCT05579977|530852292|FG007|Treatment Phase|Withdrawal by Subject|8|||
147187516|NCT05579977|530852293|FG008|Treatment Phase|Withdrawal by Subject|3|||
147187517|NCT05579977|530852294|FG009|Treatment Phase|Withdrawal by Subject|3|||
147187518|NCT05579977|530852295|FG010|Treatment Phase|Withdrawal by Subject|5|||
147187519|NCT05579977|530852296|FG011|Treatment Phase|Withdrawal by Subject|1|||
147187520|NCT05579977|530852297|FG012|Treatment Phase|Withdrawal by Subject|3|||
147187521|NCT05579977|530852285|FG000|Treatment Phase|Study terminated by sponsor|70|||
147187522|NCT05579977|530852286|FG001|Treatment Phase|Study terminated by sponsor|70|||
147187523|NCT05579977|530852287|FG002|Treatment Phase|Study terminated by sponsor|61|||
147187524|NCT05579977|530852288|FG003|Treatment Phase|Study terminated by sponsor|59|||
147187525|NCT05579977|530852289|FG004|Treatment Phase|Study terminated by sponsor|63|||
147187526|NCT05579977|530852290|FG005|Treatment Phase|Study terminated by sponsor|53|||
147187527|NCT05579977|530852291|FG006|Treatment Phase|Study terminated by sponsor|66|||
147187528|NCT05579977|530852292|FG007|Treatment Phase|Study terminated by sponsor|48|||
147187529|NCT05579977|530852293|FG008|Treatment Phase|Study terminated by sponsor|47|||
147187530|NCT05579977|530852294|FG009|Treatment Phase|Study terminated by sponsor|37|||
147187531|NCT05579977|530852295|FG010|Treatment Phase|Study terminated by sponsor|44|||
147187532|NCT05579977|530852296|FG011|Treatment Phase|Study terminated by sponsor|36|||
147187533|NCT05579977|530852297|FG012|Treatment Phase|Study terminated by sponsor|32|||
147187534|NCT05579977|530852285|FG000|Treatment Phase|Pregnancy|0|||
147187535|NCT05579977|530852286|FG001|Treatment Phase|Pregnancy|0|||
147187536|NCT05579977|530852287|FG002|Treatment Phase|Pregnancy|0|||
147187537|NCT05579977|530852288|FG003|Treatment Phase|Pregnancy|0|||
147187538|NCT05579977|530852289|FG004|Treatment Phase|Pregnancy|0|||
147187539|NCT05579977|530852290|FG005|Treatment Phase|Pregnancy|0|||
147329693|NCT01090024|531373047|FG000|Period 1|Adverse Event|0|||
147187540|NCT05579977|530852291|FG006|Treatment Phase|Pregnancy|0|||
147187541|NCT05579977|530852292|FG007|Treatment Phase|Pregnancy|0|||
147187542|NCT05579977|530852293|FG008|Treatment Phase|Pregnancy|0|||
147187543|NCT05579977|530852294|FG009|Treatment Phase|Pregnancy|1|||
147187544|NCT05579977|530852295|FG010|Treatment Phase|Pregnancy|0|||
147187545|NCT05579977|530852296|FG011|Treatment Phase|Pregnancy|0|||
147187546|NCT05579977|530852297|FG012|Treatment Phase|Pregnancy|0|||
147187547|NCT05579977|530852285|FG000|Treatment Phase|Physician Decision|0|||
147187548|NCT05579977|530852286|FG001|Treatment Phase|Physician Decision|0|||
147187549|NCT05579977|530852287|FG002|Treatment Phase|Physician Decision|0|||
147187550|NCT05579977|530852288|FG003|Treatment Phase|Physician Decision|0|||
147187551|NCT05579977|530852289|FG004|Treatment Phase|Physician Decision|0|||
147187552|NCT05579977|530852290|FG005|Treatment Phase|Physician Decision|0|||
147187553|NCT05579977|530852291|FG006|Treatment Phase|Physician Decision|0|||
147187554|NCT05579977|530852292|FG007|Treatment Phase|Physician Decision|0|||
147187555|NCT05579977|530852293|FG008|Treatment Phase|Physician Decision|0|||
147187556|NCT05579977|530852294|FG009|Treatment Phase|Physician Decision|0|||
147187557|NCT05579977|530852295|FG010|Treatment Phase|Physician Decision|0|||
147187558|NCT05579977|530852296|FG011|Treatment Phase|Physician Decision|1|||
147187559|NCT05579977|530852297|FG012|Treatment Phase|Physician Decision|0|||
147187560|NCT05579977|530852285|FG000|Treatment Phase|Lost to Follow-up|0|||
147187561|NCT05579977|530852286|FG001|Treatment Phase|Lost to Follow-up|0|||
147187562|NCT05579977|530852287|FG002|Treatment Phase|Lost to Follow-up|0|||
147187563|NCT05579977|530852288|FG003|Treatment Phase|Lost to Follow-up|1|||
147187564|NCT05579977|530852289|FG004|Treatment Phase|Lost to Follow-up|1|||
147187565|NCT05579977|530852290|FG005|Treatment Phase|Lost to Follow-up|1|||
147187566|NCT05579977|530852291|FG006|Treatment Phase|Lost to Follow-up|0|||
147187567|NCT05579977|530852292|FG007|Treatment Phase|Lost to Follow-up|1|||
147187568|NCT05579977|530852293|FG008|Treatment Phase|Lost to Follow-up|2|||
147187569|NCT05579977|530852294|FG009|Treatment Phase|Lost to Follow-up|2|||
147187570|NCT05579977|530852295|FG010|Treatment Phase|Lost to Follow-up|1|||
147187571|NCT05579977|530852296|FG011|Treatment Phase|Lost to Follow-up|4|||
147187572|NCT05579977|530852297|FG012|Treatment Phase|Lost to Follow-up|3|||
147187573|NCT05579977|530852285|FG000|Treatment Phase|Death|1|||
147187574|NCT05579977|530852286|FG001|Treatment Phase|Death|0|||
147187575|NCT05579977|530852287|FG002|Treatment Phase|Death|0|||
147187576|NCT05579977|530852288|FG003|Treatment Phase|Death|0|||
147187577|NCT05579977|530852289|FG004|Treatment Phase|Death|0|||
147187578|NCT05579977|530852290|FG005|Treatment Phase|Death|0|||
147187579|NCT05579977|530852291|FG006|Treatment Phase|Death|0|||
147187580|NCT05579977|530852292|FG007|Treatment Phase|Death|0|||
147187581|NCT05579977|530852293|FG008|Treatment Phase|Death|0|||
147187582|NCT05579977|530852294|FG009|Treatment Phase|Death|0|||
147187583|NCT05579977|530852295|FG010|Treatment Phase|Death|0|||
147187584|NCT05579977|530852296|FG011|Treatment Phase|Death|0|||
147187585|NCT05579977|530852297|FG012|Treatment Phase|Death|0|||
147187586|NCT05579977|530852285|FG000|Treatment Phase|Adverse Event|0|||
147187587|NCT05579977|530852286|FG001|Treatment Phase|Adverse Event|3|||
147187588|NCT05579977|530852287|FG002|Treatment Phase|Adverse Event|11|||
147187589|NCT05579977|530852288|FG003|Treatment Phase|Adverse Event|10|||
147187590|NCT05579977|530852289|FG004|Treatment Phase|Adverse Event|5|||
147187591|NCT05579977|530852290|FG005|Treatment Phase|Adverse Event|17|||
147187592|NCT05579977|530852291|FG006|Treatment Phase|Adverse Event|5|||
147187593|NCT05579977|530852292|FG007|Treatment Phase|Adverse Event|5|||
147187594|NCT05579977|530852293|FG008|Treatment Phase|Adverse Event|12|||
147187595|NCT05579977|530852294|FG009|Treatment Phase|Adverse Event|20|||
147187596|NCT05579977|530852295|FG010|Treatment Phase|Adverse Event|15|||
147187597|NCT05579977|530852296|FG011|Treatment Phase|Adverse Event|24|||
147187598|NCT05579977|530852297|FG012|Treatment Phase|Adverse Event|23|||
147187599|NCT05579977|530852285|FG000|Treatment Phase|Randomized not treated|0|||
147187600|NCT05579977|530852286|FG001|Treatment Phase|Randomized not treated|0|||
147187601|NCT05579977|530852287|FG002|Treatment Phase|Randomized not treated|0|||
147187602|NCT05579977|530852288|FG003|Treatment Phase|Randomized not treated|0|||
147187603|NCT05579977|530852289|FG004|Treatment Phase|Randomized not treated|1|||
147187604|NCT05579977|530852290|FG005|Treatment Phase|Randomized not treated|0|||
147187605|NCT05579977|530852291|FG006|Treatment Phase|Randomized not treated|0|||
147187606|NCT05579977|530852292|FG007|Treatment Phase|Randomized not treated|0|||
147187607|NCT05579977|530852293|FG008|Treatment Phase|Randomized not treated|0|||
147187608|NCT05579977|530852294|FG009|Treatment Phase|Randomized not treated|0|||
147187609|NCT05579977|530852295|FG010|Treatment Phase|Randomized not treated|0|||
147187610|NCT05579977|530852296|FG011|Treatment Phase|Randomized not treated|0|||
147187611|NCT05579977|530852297|FG012|Treatment Phase|Randomized not treated|0|||
147187612|NCT05579977|530852285|FG000|Follow up|Death|1|||
147187613|NCT05579977|530852286|FG001|Follow up|Death|0|||
147187614|NCT05579977|530852287|FG002|Follow up|Death|0|||
147187615|NCT05579977|530852288|FG003|Follow up|Death|0|||
147187616|NCT05579977|530852289|FG004|Follow up|Death|0|||
147187617|NCT05579977|530852290|FG005|Follow up|Death|0|||
147187618|NCT05579977|530852291|FG006|Follow up|Death|0|||
147187619|NCT05579977|530852292|FG007|Follow up|Death|0|||
147187620|NCT05579977|530852293|FG008|Follow up|Death|0|||
147187621|NCT05579977|530852294|FG009|Follow up|Death|0|||
147187622|NCT05579977|530852295|FG010|Follow up|Death|0|||
147187623|NCT05579977|530852296|FG011|Follow up|Death|0|||
147187624|NCT05579977|530852297|FG012|Follow up|Death|0|||
147448866|NCT00749996|531808020|FG000|Overall Study|Protocol Violation|2|||
147448867|NCT00749996|531808021|FG001|Overall Study|Protocol Violation|3|||
147448868|NCT00749996|531808020|FG000|Overall Study|Physician Decision|2|||
147448869|NCT00749996|531808021|FG001|Overall Study|Physician Decision|0|||
147448870|NCT00749996|531808020|FG000|Overall Study|Pregnancy|0|||
147448871|NCT00749996|531808021|FG001|Overall Study|Pregnancy|2|||
147448872|NCT00749996|531808020|FG000|Overall Study|Adverse Event|1|||
147448873|NCT00749996|531808021|FG001|Overall Study|Adverse Event|0|||
147448874|NCT00749996|531808020|FG000|Overall Study|Death|1|||
147329694|NCT01090024|531373048|FG001|Period 1|Adverse Event|0|||
147329695|NCT01090024|531373049|FG002|Period 1|Adverse Event|0|||
147329696|NCT01090024|531373050|FG003|Period 1|Adverse Event|0|||
147329697|NCT01090024|531373051|FG004|Period 1|Adverse Event|0|||
147329698|NCT01090024|531373052|FG005|Period 1|Adverse Event|0|||
147329699|NCT01090024|531373053|FG006|Period 1|Adverse Event|0|||
147329700|NCT01090024|531373054|FG007|Period 1|Adverse Event|0|||
147329701|NCT01090024|531373055|FG008|Period 1|Adverse Event|0|||
147329702|NCT01090024|531373056|FG009|Period 1|Adverse Event|1|||
147329703|NCT01090024|531373057|FG010|Period 1|Adverse Event|0|||
147329704|NCT01090024|531373058|FG011|Period 1|Adverse Event|1|||
147329705|NCT01090024|531373059|FG012|Period 1|Adverse Event|0|||
147187625|NCT05579977|530852285|FG000|Follow up|Lost to Follow-up|0|||
147187626|NCT05579977|530852286|FG001|Follow up|Lost to Follow-up|0|||
147187627|NCT05579977|530852287|FG002|Follow up|Lost to Follow-up|0|||
147187628|NCT05579977|530852288|FG003|Follow up|Lost to Follow-up|1|||
147187629|NCT05579977|530852289|FG004|Follow up|Lost to Follow-up|1|||
147187630|NCT05579977|530852290|FG005|Follow up|Lost to Follow-up|2|||
147187631|NCT05579977|530852291|FG006|Follow up|Lost to Follow-up|1|||
147187632|NCT05579977|530852292|FG007|Follow up|Lost to Follow-up|1|||
147187633|NCT05579977|530852293|FG008|Follow up|Lost to Follow-up|3|||
147187634|NCT05579977|530852294|FG009|Follow up|Lost to Follow-up|2|||
147187635|NCT05579977|530852295|FG010|Follow up|Lost to Follow-up|2|||
147187636|NCT05579977|530852296|FG011|Follow up|Lost to Follow-up|4|||
147187637|NCT05579977|530852297|FG012|Follow up|Lost to Follow-up|4|||
147187638|NCT05579977|530852285|FG000|Follow up|Withdrawal by Subject|2|||
147187639|NCT05579977|530852286|FG001|Follow up|Withdrawal by Subject|0|||
147187640|NCT05579977|530852287|FG002|Follow up|Withdrawal by Subject|0|||
147187641|NCT05579977|530852288|FG003|Follow up|Withdrawal by Subject|0|||
147187642|NCT05579977|530852289|FG004|Follow up|Withdrawal by Subject|1|||
147187643|NCT05579977|530852290|FG005|Follow up|Withdrawal by Subject|0|||
147187644|NCT05579977|530852291|FG006|Follow up|Withdrawal by Subject|1|||
147187645|NCT05579977|530852292|FG007|Follow up|Withdrawal by Subject|4|||
147187646|NCT05579977|530852293|FG008|Follow up|Withdrawal by Subject|2|||
147329706|NCT01090024|531373060|FG013|Period 1|Adverse Event|0|||
147329707|NCT01090024|531373061|FG014|Period 1|Adverse Event|0|||
147329708|NCT01090024|531373062|FG015|Period 1|Adverse Event|0|||
147329709|NCT01090024|531373063|FG016|Period 1|Adverse Event|0|||
147329710|NCT01090024|531373064|FG017|Period 1|Adverse Event|1|||
147329711|NCT01090024|531373047|FG000|Period 1|Withdrawal by Subject|0|||
147329712|NCT01090024|531373048|FG001|Period 1|Withdrawal by Subject|0|||
147329713|NCT01090024|531373049|FG002|Period 1|Withdrawal by Subject|0|||
147448875|NCT00749996|531808021|FG001|Overall Study|Death|0|||
147448876|NCT00996944|531808022|FG000|Double-blind Treatment Period|Adverse Event|2|||
147448877|NCT00996944|531808023|FG001|Double-blind Treatment Period|Adverse Event|1|||
147187647|NCT05579977|530852294|FG009|Follow up|Withdrawal by Subject|3|||
147187648|NCT05579977|530852295|FG010|Follow up|Withdrawal by Subject|3|||
147187649|NCT05579977|530852296|FG011|Follow up|Withdrawal by Subject|1|||
147187650|NCT05579977|530852297|FG012|Follow up|Withdrawal by Subject|3|||
147187651|NCT01611194|530852299|FG000|Overall Study|Lost to Follow-up|0|||
147187652|NCT01611194|530852300|FG001|Overall Study|Lost to Follow-up|1|||
147187653|NCT01611194|530852299|FG000|Overall Study|Withdrawal by Subject|0|||
147187654|NCT01611194|530852300|FG001|Overall Study|Withdrawal by Subject|1|||
147187655|NCT01611194|530852299|FG000|Overall Study|drug use|0|||
147187656|NCT01611194|530852300|FG001|Overall Study|drug use|1|||
147187657|NCT00348673|530852301|FG000|Stage 1|Randomized but not Treated|0|||
147187658|NCT00348673|530852302|FG001|Stage 1|Randomized but not Treated|0|||
147187659|NCT00348673|530852303|FG002|Stage 1|Randomized but not Treated|1|||
147187660|NCT00348673|530852304|FG003|Stage 1|Randomized but not Treated|0|||
147187661|NCT00348673|530852305|FG004|Stage 1|Randomized but not Treated|0|||
147187662|NCT00348673|530852306|FG005|Stage 1|Randomized but not Treated|0|||
147187663|NCT00348673|530852307|FG006|Stage 1|Randomized but not Treated|0|||
147329714|NCT01090024|531373050|FG003|Period 1|Withdrawal by Subject|1|||
147329715|NCT01090024|531373051|FG004|Period 1|Withdrawal by Subject|0|||
147448878|NCT00996944|531808022|FG000|Double-blind Treatment Period|Protocol Violation|1|||
147187664|NCT00348673|530852308|FG007|Stage 1|Randomized but not Treated|0|||
147187665|NCT00348673|530852309|FG008|Stage 1|Randomized but not Treated|0|||
147329716|NCT01090024|531373052|FG005|Period 1|Withdrawal by Subject|0|||
147329717|NCT01090024|531373053|FG006|Period 1|Withdrawal by Subject|0|||
147329718|NCT01090024|531373054|FG007|Period 1|Withdrawal by Subject|0|||
147329719|NCT01090024|531373055|FG008|Period 1|Withdrawal by Subject|0|||
147329720|NCT01090024|531373056|FG009|Period 1|Withdrawal by Subject|0|||
147329721|NCT01090024|531373057|FG010|Period 1|Withdrawal by Subject|0|||
147329722|NCT01090024|531373058|FG011|Period 1|Withdrawal by Subject|0|||
147329723|NCT01090024|531373059|FG012|Period 1|Withdrawal by Subject|0|||
147329724|NCT01090024|531373060|FG013|Period 1|Withdrawal by Subject|0|||
147329725|NCT01090024|531373061|FG014|Period 1|Withdrawal by Subject|0|||
147329726|NCT01090024|531373062|FG015|Period 1|Withdrawal by Subject|0|||
147329727|NCT01090024|531373063|FG016|Period 1|Withdrawal by Subject|0|||
147329728|NCT01090024|531373064|FG017|Period 1|Withdrawal by Subject|0|||
147187666|NCT01712204|530852311|FG000|Overall Study|Adverse Event|3|||
147187667|NCT01712204|530852312|FG001|Overall Study|Adverse Event|1|||
147187668|NCT01712204|530852311|FG000|Overall Study|Withdrawal by Subject|3|||
147187669|NCT01712204|530852312|FG001|Overall Study|Withdrawal by Subject|3|||
147187670|NCT01712204|530852311|FG000|Overall Study|Lost to Follow-up|1|||
147187671|NCT01712204|530852312|FG001|Overall Study|Lost to Follow-up|0|||
147187672|NCT01712204|530852311|FG000|Overall Study|Protocol Violation|1|||
147187673|NCT01712204|530852312|FG001|Overall Study|Protocol Violation|1|||
147187674|NCT02679287|530852313|FG000|Period 1: Randomization-Study Session 1|Regimen not compatible with study|2|||
147187675|NCT02679287|530852314|FG001|Period 1: Randomization-Study Session 1|Regimen not compatible with study|1|||
147187676|NCT02679287|530852313|FG000|Period 1: Randomization-Study Session 1|Work or scheduling conflict|2|||
147187677|NCT02679287|530852314|FG001|Period 1: Randomization-Study Session 1|Work or scheduling conflict|3|||
147187678|NCT02679287|530852313|FG000|Period 1: Randomization-Study Session 1|Disliked mobile system|0|||
147187679|NCT02679287|530852314|FG001|Period 1: Randomization-Study Session 1|Disliked mobile system|1|||
147187680|NCT02679287|530852313|FG000|Period 1: Randomization-Study Session 1|Adverse Event prior to intervention|0|||
147187681|NCT02679287|530852314|FG001|Period 1: Randomization-Study Session 1|Adverse Event prior to intervention|1|||
147187682|NCT02679287|530852313|FG000|Period 2|Work/Scheduling Conflict|1|||
147187683|NCT02679287|530852314|FG001|Period 2|Work/Scheduling Conflict|0|||
147187684|NCT02679287|530852313|FG000|Period 2|Disliked Mobile System|2|||
147187685|NCT02679287|530852314|FG001|Period 2|Disliked Mobile System|0|||
147187686|NCT02679287|530852313|FG000|Period 3|Work/Scheduling Conflict|0|||
147187687|NCT02679287|530852314|FG001|Period 3|Work/Scheduling Conflict|1|||
147187688|NCT01114828|530852315|FG000|Overall Study|Adverse Event|1|||
147187689|NCT01114828|530852316|FG001|Overall Study|Adverse Event|1|||
147187690|NCT01114828|530852315|FG000|Overall Study|Lack of Efficacy|0|||
147187691|NCT01114828|530852316|FG001|Overall Study|Lack of Efficacy|2|||
147187692|NCT01114828|530852315|FG000|Overall Study|Protocol Violation|2|||
147187693|NCT01114828|530852316|FG001|Overall Study|Protocol Violation|0|||
147187694|NCT01114828|530852315|FG000|Overall Study|Withdrawal by Subject|0|||
147187695|NCT01114828|530852316|FG001|Overall Study|Withdrawal by Subject|1|||
147187696|NCT00794950|530852317|FG000|BCG Induction|Withdrawal by Subject|2|||
147187697|NCT00794950|530852317|FG000|BCG Induction|ineligible|3|||
147187698|NCT00794950|530852317|FG000|BCG Induction|noncompliant w. BCG|1|||
147187699|NCT00794950|530852317|FG000|BCG Induction|Adverse Event|1|||
147187700|NCT00794950|530852317|FG000|Beginning Sunitinib Treatment|cystectomy|5|||
147187701|NCT00794950|530852317|FG000|Beginning Sunitinib Treatment|Physician Decision|5|||
147187702|NCT00794950|530852317|FG000|Beginning Sunitinib Treatment|Withdrawal by Subject|1|||
147187703|NCT00794950|530852317|FG000|Beginning Sunitinib Treatment|Lost to Follow-up|1|||
147187704|NCT02485704|530852318|FG000|Overall Study|Lost to Follow-up|4|||
147187705|NCT02485704|530852319|FG001|Overall Study|Lost to Follow-up|5|||
147187706|NCT02485704|530852318|FG000|Overall Study|Withdrawal by Subject|0|||
147187707|NCT02485704|530852319|FG001|Overall Study|Withdrawal by Subject|3|||
147187708|NCT02485704|530852318|FG000|Overall Study|Did Not Meet Inclusion Criteria #2|1|||
147187709|NCT02485704|530852319|FG001|Overall Study|Did Not Meet Inclusion Criteria #2|0|||
147329729|NCT01090024|531373047|FG000|Period 1|Lost to Follow-up|0|||
147329730|NCT01090024|531373048|FG001|Period 1|Lost to Follow-up|1|||
147329731|NCT01090024|531373049|FG002|Period 1|Lost to Follow-up|0|||
147329732|NCT01090024|531373050|FG003|Period 1|Lost to Follow-up|0|||
147187710|NCT01777776|530852320|FG000|Overall Study|Adverse Event|2|||
147187711|NCT01777776|530852321|FG001|Overall Study|Adverse Event|4|||
147187712|NCT01777776|530852322|FG002|Overall Study|Adverse Event|0|||
147187713|NCT01777776|530852323|FG003|Overall Study|Adverse Event|0|||
147187714|NCT01777776|530852320|FG000|Overall Study|Disease Progression|4|||
147187715|NCT01777776|530852321|FG001|Overall Study|Disease Progression|8|||
147187716|NCT01777776|530852322|FG002|Overall Study|Disease Progression|6|||
147329733|NCT01090024|531373051|FG004|Period 1|Lost to Follow-up|0|||
147329734|NCT01090024|531373052|FG005|Period 1|Lost to Follow-up|0|||
147329735|NCT01090024|531373053|FG006|Period 1|Lost to Follow-up|0|||
147329736|NCT01090024|531373054|FG007|Period 1|Lost to Follow-up|0|||
147187717|NCT01777776|530852323|FG003|Overall Study|Disease Progression|3|||
147187718|NCT01777776|530852320|FG000|Overall Study|Withdrawal by Subject|0|||
147187719|NCT01777776|530852321|FG001|Overall Study|Withdrawal by Subject|0|||
147187720|NCT01777776|530852322|FG002|Overall Study|Withdrawal by Subject|0|||
147187721|NCT01777776|530852323|FG003|Overall Study|Withdrawal by Subject|1|||
147329737|NCT01090024|531373055|FG008|Period 1|Lost to Follow-up|0|||
147329738|NCT01090024|531373056|FG009|Period 1|Lost to Follow-up|0|||
147329739|NCT01090024|531373057|FG010|Period 1|Lost to Follow-up|0|||
147329740|NCT01090024|531373058|FG011|Period 1|Lost to Follow-up|0|||
147329741|NCT01090024|531373059|FG012|Period 1|Lost to Follow-up|0|||
147187722|NCT01943591|530852326|FG000|Overall Study|Lost to Follow-up|3|||
147187723|NCT01943591|530852327|FG001|Overall Study|Lost to Follow-up|4|||
147187724|NCT01943591|530852326|FG000|Overall Study|Death|2|||
147187725|NCT01943591|530852327|FG001|Overall Study|Death|7|||
147187726|NCT01131507|530854725|FG000|Overall Study|Adverse Event|1|||
147187727|NCT01131507|530854725|FG000|Overall Study|Lost to Follow-up|1|||
147187728|NCT01131507|530854725|FG000|Overall Study|Withdrawal by Subject|1|||
147187729|NCT05473026|530854731|FG000|Overall Study|Lost to Follow-up|5|||
147187730|NCT05473026|530854732|FG001|Overall Study|Lost to Follow-up|2|||
147187731|NCT02193776|530854733|FG000|Overall Study|Consent withdrawn|1|||
147187732|NCT02193776|530854734|FG001|Overall Study|Consent withdrawn|0|||
147187733|NCT02193776|530854735|FG002|Overall Study|Consent withdrawn|0|||
147187734|NCT02193776|530854736|FG003|Overall Study|Consent withdrawn|0|||
147187735|NCT02193776|530854733|FG000|Overall Study|Failure to comply with protocol|0|||
147187736|NCT02193776|530854734|FG001|Overall Study|Failure to comply with protocol|1|||
147187737|NCT02193776|530854735|FG002|Overall Study|Failure to comply with protocol|0|||
147187738|NCT02193776|530854736|FG003|Overall Study|Failure to comply with protocol|0|||
147187739|NCT02193776|530854733|FG000|Overall Study|Investigator/Sponsor decision|1|||
147187740|NCT02193776|530854734|FG001|Overall Study|Investigator/Sponsor decision|1|||
147187741|NCT02193776|530854735|FG002|Overall Study|Investigator/Sponsor decision|0|||
147187742|NCT02193776|530854736|FG003|Overall Study|Investigator/Sponsor decision|0|||
147187743|NCT02193776|530854733|FG000|Overall Study|Death|1|||
147187744|NCT02193776|530854734|FG001|Overall Study|Death|0|||
147187745|NCT02193776|530854735|FG002|Overall Study|Death|0|||
147187746|NCT02193776|530854736|FG003|Overall Study|Death|0|||
147187747|NCT02193776|530854733|FG000|Overall Study|Adverse event/Specific toxicity|5|||
147187748|NCT02193776|530854734|FG001|Overall Study|Adverse event/Specific toxicity|5|||
147187749|NCT02193776|530854735|FG002|Overall Study|Adverse event/Specific toxicity|2|||
147187750|NCT02193776|530854736|FG003|Overall Study|Adverse event/Specific toxicity|2|||
147187751|NCT01702844|530854737|FG000|Overall Study|Adverse Event|9|||
147187752|NCT01702844|530854737|FG000|Overall Study|Death|1|||
147187753|NCT01702844|530854737|FG000|Overall Study|Withdrawal by Subject|3|||
147187754|NCT01702844|530854737|FG000|Overall Study|Physician Decision|6|||
147187755|NCT00248495|530854743|FG000|Overall Study|Withdrawal by Subject|1|||
147187756|NCT03812380|530854744|FG000|Overall Study|Protocol Violation|3|||
147187757|NCT03812380|530854745|FG001|Overall Study|Protocol Violation|3|||
147187758|NCT03812380|530854744|FG000|Overall Study|Withdrawal by Subject|5|||
147187759|NCT03812380|530854745|FG001|Overall Study|Withdrawal by Subject|4|||
147187760|NCT03812380|530854744|FG000|Overall Study|Early termination of study|14|||
147187761|NCT03812380|530854745|FG001|Overall Study|Early termination of study|14|||
147187762|NCT00981149|530854746|FG000|Overall Study|Lost to Follow-up|1|||
147187763|NCT00981149|530854747|FG001|Overall Study|Lost to Follow-up|2|||
147187764|NCT00981149|530854746|FG000|Overall Study|Withdrawal by Subject|1|||
147187765|NCT00981149|530854747|FG001|Overall Study|Withdrawal by Subject|1|||
147187766|NCT04244253|530854753|FG000|Overall Study|Adverse Event|2|||
147187767|NCT04244253|530854754|FG001|Overall Study|Adverse Event|2|||
147187768|NCT04244253|530854755|FG002|Overall Study|Adverse Event|4|||
147187769|NCT04244253|530854753|FG000|Overall Study|Protocol Violation|1|||
147187770|NCT04244253|530854754|FG001|Overall Study|Protocol Violation|2|||
147187771|NCT04244253|530854755|FG002|Overall Study|Protocol Violation|1|||
147187772|NCT04244253|530854753|FG000|Overall Study|Withdrawal by Subject|0|||
147187773|NCT04244253|530854754|FG001|Overall Study|Withdrawal by Subject|1|||
147187774|NCT04244253|530854755|FG002|Overall Study|Withdrawal by Subject|6|||
147187775|NCT04244253|530854753|FG000|Overall Study|Non-Compliance With Study Drug|0|||
147187776|NCT04244253|530854754|FG001|Overall Study|Non-Compliance With Study Drug|0|||
147187777|NCT04244253|530854755|FG002|Overall Study|Non-Compliance With Study Drug|1|||
147187778|NCT00619515|530854756|FG000|Overall Study|Study Termination by IRB|73|||
147187779|NCT03294590|530854759|FG000|Overall Study|Lost to Follow-up|105|||
147187780|NCT03294590|530854760|FG001|Overall Study|Lost to Follow-up|107|||
147187781|NCT00628030|530854765|FG000|Baseline to Post-Assessment|Lost to Follow-up|28|||
147187782|NCT00628030|530854766|FG001|Baseline to Post-Assessment|Lost to Follow-up|29|||
147187783|NCT00628030|530854765|FG000|Baseline to Post-Assessment|Withdrawal by Subject|5|||
147329742|NCT01090024|531373060|FG013|Period 1|Lost to Follow-up|0|||
147329743|NCT01090024|531373061|FG014|Period 1|Lost to Follow-up|0|||
147329744|NCT01090024|531373062|FG015|Period 1|Lost to Follow-up|0|||
147329745|NCT01090024|531373063|FG016|Period 1|Lost to Follow-up|0|||
147187784|NCT00628030|530854766|FG001|Baseline to Post-Assessment|Withdrawal by Subject|0|||
147187785|NCT00628030|530854765|FG000|Post to 6 Month Follow-up|Lost to Follow-up|32|||
147187786|NCT00628030|530854766|FG001|Post to 6 Month Follow-up|Lost to Follow-up|30|||
147187787|NCT04154943|530854769|FG000|Overall Study|Study Ongoing|68|||
147187788|NCT04154943|530854769|FG000|Overall Study|Lost to Follow-up|1|||
147187789|NCT04154943|530854769|FG000|Overall Study|Decision by the Investigator|1|||
147187790|NCT04154943|530854769|FG000|Overall Study|Death|5|||
147187791|NCT04154943|530854769|FG000|Overall Study|Withdrawal by Subject|4|||
147187792|NCT01292187|530854770|FG000|Overall Study|Adverse Event|10|||
147187793|NCT01292187|530854771|FG001|Overall Study|Adverse Event|5|||
147329746|NCT01090024|531373064|FG017|Period 1|Lost to Follow-up|0|||
147187794|NCT01292187|530854770|FG000|Overall Study|Withdrawal by Subject|6|||
147187795|NCT01292187|530854771|FG001|Overall Study|Withdrawal by Subject|5|||
147187796|NCT01292187|530854770|FG000|Overall Study|All other reasons|1|||
147187797|NCT01292187|530854771|FG001|Overall Study|All other reasons|3|||
147187798|NCT03827655|530854773|FG000|Overall Study|Death|0|||
147187799|NCT03827655|530854774|FG001|Overall Study|Death|0|||
147187800|NCT03827655|530854775|FG002|Overall Study|Death|0|||
147187801|NCT03827655|530854776|FG003|Overall Study|Death|0|||
147187802|NCT03827655|530854777|FG004|Overall Study|Death|1|||
147187803|NCT03827655|530854773|FG000|Overall Study|Protocol Deviation|1|||
147187804|NCT03827655|530854774|FG001|Overall Study|Protocol Deviation|0|||
147187805|NCT03827655|530854775|FG002|Overall Study|Protocol Deviation|1|||
147187806|NCT03827655|530854776|FG003|Overall Study|Protocol Deviation|1|||
147187807|NCT03827655|530854777|FG004|Overall Study|Protocol Deviation|0|||
147187808|NCT03827655|530854773|FG000|Overall Study|Withdrawal by Subject|3|||
147187809|NCT03827655|530854774|FG001|Overall Study|Withdrawal by Subject|2|||
147187810|NCT03827655|530854775|FG002|Overall Study|Withdrawal by Subject|2|||
147187811|NCT03827655|530854776|FG003|Overall Study|Withdrawal by Subject|0|||
147187812|NCT03827655|530854777|FG004|Overall Study|Withdrawal by Subject|1|||
147187813|NCT03827655|530854773|FG000|Overall Study|Reason not Specified|3|||
147187814|NCT03827655|530854774|FG001|Overall Study|Reason not Specified|1|||
147187815|NCT03827655|530854775|FG002|Overall Study|Reason not Specified|1|||
147187816|NCT03827655|530854776|FG003|Overall Study|Reason not Specified|1|||
147187817|NCT03827655|530854777|FG004|Overall Study|Reason not Specified|1|||
147187818|NCT03649217|530854778|FG000|Overall Study|subject had severe ataxia not initially found|1|||
147187819|NCT03649217|530854778|FG000|Overall Study|subject had cognitive issues not initially found|1|||
147187820|NCT01092728|530854779|FG000|Overall Study|Withdrawal by Subject|2|||
147187821|NCT01092728|530854780|FG001|Overall Study|Withdrawal by Subject|0|||
147187822|NCT01092728|530854779|FG000|Overall Study|Adverse Event|0|||
147187823|NCT01092728|530854780|FG001|Overall Study|Adverse Event|1|||
147187824|NCT01092728|530854779|FG000|Overall Study|Disease Progression|1|||
147187825|NCT01092728|530854780|FG001|Overall Study|Disease Progression|13|||
147187826|NCT01092728|530854779|FG000|Overall Study|Prohibited Concomitant Medications|1|||
147187827|NCT01092728|530854780|FG001|Overall Study|Prohibited Concomitant Medications|0|||
147187828|NCT02520726|530854781|FG000|Overall Study|Lost to Follow-up|3|||
147187829|NCT02520726|530854782|FG001|Overall Study|Lost to Follow-up|2|||
147187830|NCT02336607|530854783|FG000|Overall Study|Physician Decision|1|||
147187831|NCT02336607|530854784|FG001|Overall Study|Physician Decision|4|||
147187832|NCT02336607|530854785|FG002|Overall Study|Physician Decision|3|||
147187833|NCT02336607|530854786|FG003|Overall Study|Physician Decision|15|||
147187834|NCT02336607|530854783|FG000|Overall Study|Lack of Efficacy|1|||
147187835|NCT02336607|530854784|FG001|Overall Study|Lack of Efficacy|0|||
147187836|NCT02336607|530854785|FG002|Overall Study|Lack of Efficacy|0|||
147187837|NCT02336607|530854786|FG003|Overall Study|Lack of Efficacy|2|||
147187838|NCT02336607|530854783|FG000|Overall Study|Lost to Follow-up|2|||
147187839|NCT02336607|530854784|FG001|Overall Study|Lost to Follow-up|1|||
147187840|NCT02336607|530854785|FG002|Overall Study|Lost to Follow-up|0|||
147187841|NCT02336607|530854786|FG003|Overall Study|Lost to Follow-up|21|||
147187842|NCT02336607|530854783|FG000|Overall Study|Protocol Violation|0|||
147187843|NCT02336607|530854784|FG001|Overall Study|Protocol Violation|1|||
147187844|NCT02336607|530854785|FG002|Overall Study|Protocol Violation|1|||
147187845|NCT02336607|530854786|FG003|Overall Study|Protocol Violation|3|||
147187846|NCT02336607|530854783|FG000|Overall Study|Adverse Event|0|||
147187847|NCT02336607|530854784|FG001|Overall Study|Adverse Event|2|||
147247468|NCT00642460|531074512|FG002|Part III: Open-Label Up to Week 260|Adverse Event|0|||
147247469|NCT00642460|531074513|FG003|Part III: Open-Label Up to Week 260|Adverse Event|0|||
147247470|NCT00642460|531074514|FG004|Part III: Open-Label Up to Week 260|Adverse Event|7|||
147247471|NCT00642460|531074515|FG005|Part III: Open-Label Up to Week 260|Adverse Event|6|||
147247472|NCT00642460|531074510|FG000|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0|||
147247473|NCT00642460|531074511|FG001|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0|||
147247474|NCT00642460|531074512|FG002|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0|||
147247475|NCT00642460|531074513|FG003|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|0|||
147329747|NCT01090024|531373047|FG000|Period 2|Lost to Follow-up|0|||
147329748|NCT01090024|531373048|FG001|Period 2|Lost to Follow-up|0|||
147187848|NCT02336607|530854785|FG002|Overall Study|Adverse Event|2|||
147247476|NCT00642460|531074514|FG004|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|3|||
147329749|NCT01090024|531373049|FG002|Period 2|Lost to Follow-up|0|||
147329750|NCT01090024|531373050|FG003|Period 2|Lost to Follow-up|1|||
147448879|NCT00996944|531808023|FG001|Double-blind Treatment Period|Protocol Violation|0|||
147187849|NCT02336607|530854786|FG003|Overall Study|Adverse Event|26|||
147187850|NCT02336607|530854783|FG000|Overall Study|Withdrawal by Subject|0|||
147187851|NCT02336607|530854784|FG001|Overall Study|Withdrawal by Subject|2|||
147187852|NCT02336607|530854785|FG002|Overall Study|Withdrawal by Subject|0|||
147187853|NCT02336607|530854786|FG003|Overall Study|Withdrawal by Subject|20|||
147187854|NCT02552966|530854789|FG000|Overall Study|Lost to Follow-up|2|||
147187855|NCT02552966|530854789|FG000|Overall Study|Withdrawal by Subject|3|||
147187856|NCT00721396|530854791|FG000|Overall Study|Adverse Event|4|||
147187857|NCT00721396|530854792|FG001|Overall Study|Adverse Event|7|||
147187858|NCT00721396|530854793|FG002|Overall Study|Adverse Event|2|||
147187859|NCT00721396|530854794|FG003|Overall Study|Adverse Event|0|||
147187860|NCT00721396|530854791|FG000|Overall Study|Withdrawal by Subject|12|||
147187861|NCT00721396|530854792|FG001|Overall Study|Withdrawal by Subject|15|||
147187862|NCT00721396|530854793|FG002|Overall Study|Withdrawal by Subject|3|||
147187863|NCT00721396|530854794|FG003|Overall Study|Withdrawal by Subject|7|||
147187864|NCT00721396|530854791|FG000|Overall Study|Lost to Follow-up|7|||
147187865|NCT00721396|530854792|FG001|Overall Study|Lost to Follow-up|9|||
147187866|NCT00721396|530854793|FG002|Overall Study|Lost to Follow-up|3|||
147187867|NCT00721396|530854794|FG003|Overall Study|Lost to Follow-up|3|||
147187868|NCT00721396|530854791|FG000|Overall Study|Protocol Violation|4|||
147187869|NCT00721396|530854792|FG001|Overall Study|Protocol Violation|3|||
147187870|NCT00721396|530854793|FG002|Overall Study|Protocol Violation|1|||
147187871|NCT00721396|530854794|FG003|Overall Study|Protocol Violation|0|||
147187872|NCT00721396|530854791|FG000|Overall Study|Inappropriate enrollment|0|||
147187873|NCT00721396|530854792|FG001|Overall Study|Inappropriate enrollment|2|||
147187874|NCT00721396|530854793|FG002|Overall Study|Inappropriate enrollment|0|||
147187875|NCT00721396|530854794|FG003|Overall Study|Inappropriate enrollment|0|||
147187876|NCT00721396|530854791|FG000|Overall Study|Administrative reason|3|||
147187877|NCT00721396|530854792|FG001|Overall Study|Administrative reason|0|||
147187878|NCT00721396|530854793|FG002|Overall Study|Administrative reason|1|||
147187879|NCT00721396|530854794|FG003|Overall Study|Administrative reason|0|||
147187880|NCT02365649|530854798|FG000|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
147187881|NCT02365649|530854799|FG001|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
147187882|NCT02365649|530854800|FG002|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
147187883|NCT02365649|530854801|FG003|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|1|||
147187884|NCT02365649|530854802|FG004|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
147187885|NCT02365649|530854803|FG005|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
147187886|NCT02365649|530854804|FG006|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
147187887|NCT02365649|530854805|FG007|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
147187888|NCT02365649|530854806|FG008|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
147187889|NCT02365649|530854807|FG009|Double-Blind Induction (Weeks 1-16)|Requires alternative therapy|0|||
147187890|NCT02365649|530854798|FG000|Double-Blind Induction (Weeks 1-16)|Adverse Event|3|||
147187891|NCT02365649|530854799|FG001|Double-Blind Induction (Weeks 1-16)|Adverse Event|4|||
147187892|NCT02365649|530854800|FG002|Double-Blind Induction (Weeks 1-16)|Adverse Event|0|||
147187893|NCT02365649|530854801|FG003|Double-Blind Induction (Weeks 1-16)|Adverse Event|7|||
147187894|NCT02365649|530854802|FG004|Double-Blind Induction (Weeks 1-16)|Adverse Event|1|||
147187895|NCT02365649|530854803|FG005|Double-Blind Induction (Weeks 1-16)|Adverse Event|2|||
147187896|NCT02365649|530854804|FG006|Double-Blind Induction (Weeks 1-16)|Adverse Event|0|||
147187897|NCT02365649|530854805|FG007|Double-Blind Induction (Weeks 1-16)|Adverse Event|0|||
147187898|NCT02365649|530854806|FG008|Double-Blind Induction (Weeks 1-16)|Adverse Event|0|||
147187899|NCT02365649|530854807|FG009|Double-Blind Induction (Weeks 1-16)|Adverse Event|0|||
147187900|NCT02365649|530854798|FG000|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|3|||
147187901|NCT02365649|530854799|FG001|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|1|||
147187902|NCT02365649|530854800|FG002|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|1|||
147187903|NCT02365649|530854801|FG003|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|1|||
147187904|NCT02365649|530854802|FG004|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|2|||
147187905|NCT02365649|530854803|FG005|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|1|||
147187906|NCT02365649|530854804|FG006|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|0|||
147187907|NCT02365649|530854805|FG007|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|0|||
147187908|NCT02365649|530854806|FG008|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|0|||
147187909|NCT02365649|530854807|FG009|Double-Blind Induction (Weeks 1-16)|Lack of Efficacy|0|||
147187910|NCT02365649|530854798|FG000|Double-Blind Induction (Weeks 1-16)|Other|1|||
147187911|NCT02365649|530854799|FG001|Double-Blind Induction (Weeks 1-16)|Other|0|||
147187912|NCT02365649|530854800|FG002|Double-Blind Induction (Weeks 1-16)|Other|1|||
147187913|NCT02365649|530854801|FG003|Double-Blind Induction (Weeks 1-16)|Other|0|||
147187914|NCT02365649|530854802|FG004|Double-Blind Induction (Weeks 1-16)|Other|1|||
147187915|NCT02365649|530854803|FG005|Double-Blind Induction (Weeks 1-16)|Other|1|||
147187916|NCT02365649|530854804|FG006|Double-Blind Induction (Weeks 1-16)|Other|0|||
147187917|NCT02365649|530854805|FG007|Double-Blind Induction (Weeks 1-16)|Other|0|||
147187918|NCT02365649|530854806|FG008|Double-Blind Induction (Weeks 1-16)|Other|0|||
147187919|NCT02365649|530854807|FG009|Double-Blind Induction (Weeks 1-16)|Other|0|||
147187920|NCT02365649|530854798|FG000|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|2|||
147187921|NCT02365649|530854799|FG001|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
147247477|NCT00642460|531074515|FG005|Part III: Open-Label Up to Week 260|Insufficient therapeutic response|4|||
147247478|NCT00642460|531074510|FG000|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0|||
147247479|NCT00642460|531074511|FG001|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0|||
147247480|NCT00642460|531074512|FG002|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0|||
147329751|NCT01090024|531373051|FG004|Period 2|Lost to Follow-up|0|||
147187922|NCT02365649|530854800|FG002|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|1|||
147187923|NCT02365649|530854801|FG003|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
147187924|NCT02365649|530854802|FG004|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|2|||
147187925|NCT02365649|530854803|FG005|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
147187926|NCT02365649|530854804|FG006|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
147187927|NCT02365649|530854805|FG007|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
147187928|NCT02365649|530854806|FG008|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
147187929|NCT02365649|530854807|FG009|Double-Blind Induction (Weeks 1-16)|Withdrawal by Subject|0|||
147187930|NCT02365649|530854798|FG000|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|1|||
147187931|NCT02365649|530854799|FG001|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
147187932|NCT02365649|530854800|FG002|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
147187933|NCT02365649|530854801|FG003|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
147187934|NCT02365649|530854802|FG004|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|1|||
147187935|NCT02365649|530854803|FG005|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|1|||
147187936|NCT02365649|530854804|FG006|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
147187937|NCT02365649|530854805|FG007|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
147187938|NCT02365649|530854806|FG008|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
147187939|NCT02365649|530854807|FG009|Double-Blind Induction (Weeks 1-16)|Subject Non-Compliance|0|||
147187940|NCT02365649|530854798|FG000|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
147187941|NCT02365649|530854799|FG001|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
147187942|NCT02365649|530854800|FG002|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|1|||
147187943|NCT02365649|530854801|FG003|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
147187944|NCT02365649|530854802|FG004|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
147187945|NCT02365649|530854803|FG005|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
147187946|NCT02365649|530854804|FG006|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
147187947|NCT02365649|530854805|FG007|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
147187948|NCT02365649|530854806|FG008|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
147187949|NCT02365649|530854807|FG009|Double-Blind Induction (Weeks 1-16)|Lost to Follow-up|0|||
147187950|NCT02365649|530854798|FG000|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
147187951|NCT02365649|530854799|FG001|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
147187952|NCT02365649|530854800|FG002|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
147187953|NCT02365649|530854801|FG003|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
147187954|NCT02365649|530854802|FG004|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
147187955|NCT02365649|530854803|FG005|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
147187956|NCT02365649|530854804|FG006|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|2|||
147187957|NCT02365649|530854805|FG007|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
147187958|NCT02365649|530854806|FG008|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
147187959|NCT02365649|530854807|FG009|Double-Blind Extension (Weeks 16-52)|Requires Alternative Therapy|0|||
147187960|NCT02365649|530854798|FG000|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
147187961|NCT02365649|530854799|FG001|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
147187962|NCT02365649|530854800|FG002|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
147187963|NCT02365649|530854801|FG003|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
147187964|NCT02365649|530854802|FG004|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
147187965|NCT02365649|530854803|FG005|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
147187966|NCT02365649|530854804|FG006|Double-Blind Extension (Weeks 16-52)|Adverse Event|6|||
147187967|NCT02365649|530854805|FG007|Double-Blind Extension (Weeks 16-52)|Adverse Event|0|||
147187968|NCT02365649|530854806|FG008|Double-Blind Extension (Weeks 16-52)|Adverse Event|4|||
147187969|NCT02365649|530854807|FG009|Double-Blind Extension (Weeks 16-52)|Adverse Event|4|||
147187970|NCT02365649|530854798|FG000|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
147187971|NCT02365649|530854799|FG001|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
147187972|NCT02365649|530854800|FG002|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
147187973|NCT02365649|530854801|FG003|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
147187974|NCT02365649|530854802|FG004|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
147187975|NCT02365649|530854803|FG005|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|0|||
147187976|NCT02365649|530854804|FG006|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|7|||
147247481|NCT00642460|531074513|FG003|Part III: Open-Label Up to Week 260|Withdrawal by Subject|0|||
147247482|NCT00642460|531074514|FG004|Part III: Open-Label Up to Week 260|Withdrawal by Subject|4|||
147247483|NCT00642460|531074515|FG005|Part III: Open-Label Up to Week 260|Withdrawal by Subject|1|||
147247484|NCT00642460|531074510|FG000|Part III: Open-Label Up to Week 260|Lost to Follow-up|0|||
147247485|NCT00642460|531074511|FG001|Part III: Open-Label Up to Week 260|Lost to Follow-up|0|||
147247486|NCT00642460|531074512|FG002|Part III: Open-Label Up to Week 260|Lost to Follow-up|0|||
147247487|NCT00642460|531074513|FG003|Part III: Open-Label Up to Week 260|Lost to Follow-up|0|||
147247488|NCT00642460|531074514|FG004|Part III: Open-Label Up to Week 260|Lost to Follow-up|1|||
147594112|NCT01698775|532330601|FG000|Phase A|Lack of Efficacy|1|||
147594113|NCT01698775|532330602|FG001|Phase A|Lack of Efficacy|0|||
147187977|NCT02365649|530854805|FG007|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|2|||
147187978|NCT02365649|530854806|FG008|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|8|||
147187979|NCT02365649|530854807|FG009|Double-Blind Extension (Weeks 16-52)|Lack of Efficacy|10|||
147187980|NCT02365649|530854798|FG000|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
147187981|NCT02365649|530854799|FG001|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
147187982|NCT02365649|530854800|FG002|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
147187983|NCT02365649|530854801|FG003|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
147187984|NCT02365649|530854802|FG004|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
147187985|NCT02365649|530854803|FG005|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
147187986|NCT02365649|530854804|FG006|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|1|||
147187987|NCT02365649|530854805|FG007|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|0|||
147187988|NCT02365649|530854806|FG008|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|2|||
147187989|NCT02365649|530854807|FG009|Double-Blind Extension (Weeks 16-52)|Withdrawal by Subject|1|||
147187990|NCT02365649|530854798|FG000|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
147187991|NCT02365649|530854799|FG001|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
147187992|NCT02365649|530854800|FG002|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
147187993|NCT02365649|530854801|FG003|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
147187994|NCT02365649|530854802|FG004|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
147187995|NCT02365649|530854803|FG005|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
147187996|NCT02365649|530854804|FG006|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|2|||
147187997|NCT02365649|530854805|FG007|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
147187998|NCT02365649|530854806|FG008|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|2|||
147187999|NCT02365649|530854807|FG009|Double-Blind Extension (Weeks 16-52)|Subject Noncompliance|0|||
147188000|NCT02021565|530854819|FG000|Baseline Through Intervention|Death|0|||
147188001|NCT02021565|530854820|FG001|Baseline Through Intervention|Death|1|||
147188002|NCT02021565|530854819|FG000|Baseline Through Intervention|Withdrawal by Subject|8|||
147188003|NCT02021565|530854820|FG001|Baseline Through Intervention|Withdrawal by Subject|8|||
147188004|NCT02021565|530854819|FG000|Baseline Through Intervention|Protocol Violation|0|||
147188005|NCT02021565|530854820|FG001|Baseline Through Intervention|Protocol Violation|7|||
147188006|NCT02021565|530854819|FG000|Baseline Through Intervention|Lost to Follow-up|4|||
147188007|NCT02021565|530854820|FG001|Baseline Through Intervention|Lost to Follow-up|2|||
147188008|NCT02021565|530854819|FG000|3-month Follow-up|Death|3|||
147188009|NCT02021565|530854820|FG001|3-month Follow-up|Death|0|||
147188010|NCT02021565|530854819|FG000|3-month Follow-up|Withdrawal by Subject|4|||
147188011|NCT02021565|530854820|FG001|3-month Follow-up|Withdrawal by Subject|0|||
147188012|NCT02021565|530854819|FG000|3-month Follow-up|Protocol Violation|3|||
147188013|NCT02021565|530854820|FG001|3-month Follow-up|Protocol Violation|2|||
147188014|NCT01188772|530854821|FG000|Overall Study|Randomized but Not Treated|0|||
147188015|NCT01188772|530854822|FG001|Overall Study|Randomized but Not Treated|1|||
147188016|NCT01188772|530854823|FG002|Overall Study|Randomized but Not Treated|0|||
147188017|NCT01188772|530854824|FG003|Overall Study|Randomized but Not Treated|0|||
147188018|NCT01188772|530854821|FG000|Overall Study|Adverse Event|0|||
147188019|NCT01188772|530854822|FG001|Overall Study|Adverse Event|1|||
147188020|NCT01188772|530854823|FG002|Overall Study|Adverse Event|2|||
147188021|NCT01188772|530854824|FG003|Overall Study|Adverse Event|0|||
147188022|NCT01188772|530854821|FG000|Overall Study|Lost to Follow-up|4|||
147188023|NCT01188772|530854822|FG001|Overall Study|Lost to Follow-up|1|||
147188024|NCT01188772|530854823|FG002|Overall Study|Lost to Follow-up|1|||
147188025|NCT01188772|530854824|FG003|Overall Study|Lost to Follow-up|1|||
147188026|NCT01188772|530854821|FG000|Overall Study|Non-responder|0|||
147188027|NCT01188772|530854822|FG001|Overall Study|Non-responder|0|||
147188028|NCT01188772|530854823|FG002|Overall Study|Non-responder|3|||
147188029|NCT01188772|530854824|FG003|Overall Study|Non-responder|0|||
147188030|NCT01188772|530854821|FG000|Overall Study|Physician Decision|0|||
147188031|NCT01188772|530854822|FG001|Overall Study|Physician Decision|0|||
147188032|NCT01188772|530854823|FG002|Overall Study|Physician Decision|1|||
147188033|NCT01188772|530854824|FG003|Overall Study|Physician Decision|0|||
147188034|NCT01188772|530854821|FG000|Overall Study|Terminated by Sponsor|0|||
147188035|NCT01188772|530854822|FG001|Overall Study|Terminated by Sponsor|0|||
147188036|NCT01188772|530854823|FG002|Overall Study|Terminated by Sponsor|1|||
147188037|NCT01188772|530854824|FG003|Overall Study|Terminated by Sponsor|0|||
147188038|NCT01188772|530854821|FG000|Overall Study|Treatment Failure|0|||
147188039|NCT01188772|530854822|FG001|Overall Study|Treatment Failure|0|||
147188040|NCT01188772|530854823|FG002|Overall Study|Treatment Failure|1|||
147188041|NCT01188772|530854824|FG003|Overall Study|Treatment Failure|0|||
147188042|NCT01188772|530854821|FG000|Overall Study|Virologic Failure|1|||
147188043|NCT01188772|530854822|FG001|Overall Study|Virologic Failure|0|||
147188044|NCT01188772|530854823|FG002|Overall Study|Virologic Failure|0|||
147329752|NCT01090024|531373052|FG005|Period 2|Lost to Follow-up|0|||
147188045|NCT01188772|530854824|FG003|Overall Study|Virologic Failure|0|||
147188046|NCT01188772|530854821|FG000|Overall Study|Withdrawal by Subject|0|||
147188047|NCT01188772|530854822|FG001|Overall Study|Withdrawal by Subject|0|||
147188048|NCT01188772|530854823|FG002|Overall Study|Withdrawal by Subject|2|||
147188049|NCT01188772|530854824|FG003|Overall Study|Withdrawal by Subject|0|||
147188050|NCT03259555|530854835|FG000|Overall Study|Adverse Event|6|||
147188051|NCT03259555|530854836|FG001|Overall Study|Adverse Event|4|||
147188052|NCT03259555|530854835|FG000|Overall Study|Lack of Efficacy|6|||
147188053|NCT03259555|530854836|FG001|Overall Study|Lack of Efficacy|4|||
147188054|NCT03259555|530854835|FG000|Overall Study|Lost to Follow-up|0|||
147188055|NCT03259555|530854836|FG001|Overall Study|Lost to Follow-up|2|||
147188056|NCT03259555|530854835|FG000|Overall Study|Non-Compliance With Study Drug|1|||
147188057|NCT03259555|530854836|FG001|Overall Study|Non-Compliance With Study Drug|0|||
147188058|NCT03259555|530854835|FG000|Overall Study|Progressive Disease|0|||
147188059|NCT03259555|530854836|FG001|Overall Study|Progressive Disease|2|||
147188060|NCT03259555|530854835|FG000|Overall Study|Withdrawal by Subject|19|||
147188061|NCT03259555|530854836|FG001|Overall Study|Withdrawal by Subject|16|||
147188062|NCT03259555|530854835|FG000|Overall Study|Physician Decision|1|||
147188063|NCT03259555|530854836|FG001|Overall Study|Physician Decision|2|||
147188064|NCT03259555|530854835|FG000|Overall Study|Other|1|||
147188065|NCT03259555|530854836|FG001|Overall Study|Other|0|||
147188066|NCT00154297|530854838|FG000|Overall Study|Death|5|||
147188067|NCT00154297|530854839|FG001|Overall Study|Death|2|||
147188068|NCT00154297|530854838|FG000|Overall Study|Withdrawal by Subject|0|||
147188069|NCT00154297|530854839|FG001|Overall Study|Withdrawal by Subject|5|||
147188070|NCT00154297|530854838|FG000|Overall Study|Lost to Follow-up|3|||
147188071|NCT00154297|530854839|FG001|Overall Study|Lost to Follow-up|0|||
147188072|NCT00650767|530854840|FG000|Overall Study|Adverse Event|0|||
147188073|NCT00650767|530854841|FG001|Overall Study|Adverse Event|3|||
147188074|NCT00650767|530854842|FG002|Overall Study|Adverse Event|10|||
147188075|NCT00650767|530854843|FG003|Overall Study|Adverse Event|8|||
147188076|NCT00650767|530854840|FG000|Overall Study|Death|1|||
147188077|NCT00650767|530854841|FG001|Overall Study|Death|0|||
147188078|NCT00650767|530854842|FG002|Overall Study|Death|0|||
147188079|NCT00650767|530854843|FG003|Overall Study|Death|0|||
147188080|NCT00650767|530854840|FG000|Overall Study|Withdrawal by Subject|2|||
147188081|NCT00650767|530854841|FG001|Overall Study|Withdrawal by Subject|4|||
147188082|NCT00650767|530854842|FG002|Overall Study|Withdrawal by Subject|3|||
147188083|NCT00650767|530854843|FG003|Overall Study|Withdrawal by Subject|3|||
147188084|NCT00650767|530854840|FG000|Overall Study|Lost to Follow-up|1|||
147188085|NCT00650767|530854841|FG001|Overall Study|Lost to Follow-up|1|||
147188086|NCT00650767|530854842|FG002|Overall Study|Lost to Follow-up|1|||
147188087|NCT00650767|530854843|FG003|Overall Study|Lost to Follow-up|0|||
147188088|NCT00650767|530854840|FG000|Overall Study|Other|1|||
147188089|NCT00650767|530854841|FG001|Overall Study|Other|1|||
147188090|NCT00650767|530854842|FG002|Overall Study|Other|0|||
147188091|NCT00650767|530854843|FG003|Overall Study|Other|0|||
147188092|NCT01774799|530854844|FG000|Overall Study|Lost to Follow-up|1|||
147188093|NCT01774799|530854845|FG001|Overall Study|Lost to Follow-up|1|||
147188094|NCT01774799|530854846|FG002|Overall Study|Lost to Follow-up|0|||
147188095|NCT01774799|530854847|FG003|Overall Study|Lost to Follow-up|0|||
147188096|NCT02910466|530854848|FG000|Overall Study|Adverse Event|1|||
147188097|NCT02910466|530854848|FG000|Overall Study|Withdrawal by Subject|3|||
147188098|NCT02910466|530854848|FG000|Overall Study|Lost to Follow-up|5|||
147188099|NCT02910466|530854848|FG000|Overall Study|Due to Food and Drug Administration (FDA) recall|29|||
147188100|NCT02910466|530854848|FG000|Overall Study|Participant didn't meet inclusion criteria|1|||
147188101|NCT01125800|530854849|FG000|Phase I|Protocol Violation|0|||
147188102|NCT01125800|530854850|FG001|Phase I|Protocol Violation|3|||
147188103|NCT01125800|530854851|FG002|Phase I|Protocol Violation|1|||
147188104|NCT01125800|530854852|FG003|Phase I|Protocol Violation|1|||
147188105|NCT01125800|530854853|FG004|Phase I|Protocol Violation|0|||
147188106|NCT01125800|530854849|FG000|Phase I|Adverse Event|2|||
147188107|NCT01125800|530854850|FG001|Phase I|Adverse Event|2|||
147188108|NCT01125800|530854851|FG002|Phase I|Adverse Event|1|||
147188109|NCT01125800|530854852|FG003|Phase I|Adverse Event|7|||
147188110|NCT01125800|530854853|FG004|Phase I|Adverse Event|0|||
147188111|NCT01125800|530854849|FG000|Phase I|Administrative problems|1|||
147188112|NCT01125800|530854850|FG001|Phase I|Administrative problems|0|||
147188113|NCT01125800|530854851|FG002|Phase I|Administrative problems|0|||
147188114|NCT01125800|530854852|FG003|Phase I|Administrative problems|0|||
147188115|NCT01125800|530854853|FG004|Phase I|Administrative problems|0|||
147188116|NCT01125800|530854849|FG000|Phase I|Withdrawal by Subject|0|||
147188117|NCT01125800|530854850|FG001|Phase I|Withdrawal by Subject|0|||
147188118|NCT01125800|530854851|FG002|Phase I|Withdrawal by Subject|1|||
147188119|NCT01125800|530854852|FG003|Phase I|Withdrawal by Subject|0|||
147188120|NCT01125800|530854853|FG004|Phase I|Withdrawal by Subject|0|||
147247489|NCT00642460|531074515|FG005|Part III: Open-Label Up to Week 260|Lost to Follow-up|1|||
147247490|NCT00642460|531074510|FG000|Part III: Open-Label Up to Week 260|Other|0|||
147247491|NCT00642460|531074511|FG001|Part III: Open-Label Up to Week 260|Other|0|||
147247492|NCT00642460|531074512|FG002|Part III: Open-Label Up to Week 260|Other|0|||
147247493|NCT00642460|531074513|FG003|Part III: Open-Label Up to Week 260|Other|0|||
147247494|NCT00642460|531074514|FG004|Part III: Open-Label Up to Week 260|Other|2|||
147247495|NCT00642460|531074515|FG005|Part III: Open-Label Up to Week 260|Other|2|||
147188121|NCT01125800|530854849|FG000|Phase I|Disease progression|5|||
147188122|NCT01125800|530854850|FG001|Phase I|Disease progression|4|||
147188123|NCT01125800|530854851|FG002|Phase I|Disease progression|1|||
147188124|NCT01125800|530854852|FG003|Phase I|Disease progression|3|||
147188125|NCT01125800|530854853|FG004|Phase I|Disease progression|0|||
147188126|NCT01125800|530854849|FG000|Phase II|Protocol Violation|0|||
147188127|NCT01125800|530854850|FG001|Phase II|Protocol Violation|0|||
147188128|NCT01125800|530854851|FG002|Phase II|Protocol Violation|0|||
147188129|NCT01125800|530854852|FG003|Phase II|Protocol Violation|0|||
147188130|NCT01125800|530854853|FG004|Phase II|Protocol Violation|1|||
147188131|NCT01125800|530854849|FG000|Phase II|Adverse Event|0|||
147188132|NCT01125800|530854850|FG001|Phase II|Adverse Event|0|||
147188133|NCT01125800|530854851|FG002|Phase II|Adverse Event|0|||
147188134|NCT01125800|530854852|FG003|Phase II|Adverse Event|0|||
147188135|NCT01125800|530854853|FG004|Phase II|Adverse Event|2|||
147188136|NCT01125800|530854849|FG000|Phase II|Disease progression|0|||
147188137|NCT01125800|530854850|FG001|Phase II|Disease progression|0|||
147188138|NCT01125800|530854851|FG002|Phase II|Disease progression|0|||
147188139|NCT01125800|530854852|FG003|Phase II|Disease progression|1|||
147188140|NCT01125800|530854853|FG004|Phase II|Disease progression|8|||
147188141|NCT03061201|530854854|FG000|Overall Study|Participants Terminated at Month 36|0|||
147188142|NCT03061201|530854855|FG001|Overall Study|Participants Terminated at Month 36|1|||
147188143|NCT03061201|530854856|FG002|Overall Study|Participants Terminated at Month 36|0|||
147188144|NCT03061201|530854857|FG003|Overall Study|Participants Terminated at Month 36|1|||
147188145|NCT03061201|530854854|FG000|Overall Study|Lost to Follow-up|1|||
147188146|NCT03061201|530854855|FG001|Overall Study|Lost to Follow-up|0|||
147188147|NCT03061201|530854856|FG002|Overall Study|Lost to Follow-up|0|||
147188148|NCT03061201|530854857|FG003|Overall Study|Lost to Follow-up|0|||
147188149|NCT04037891|530854858|FG000|Open-label Period|Withdrawal by Subject|1|||
147188150|NCT04037891|530854859|FG001|Open-label Period|Withdrawal by Subject|0|||
147188151|NCT04037891|530854860|FG002|Open-label Period|Withdrawal by Subject|0|||
147188152|NCT04037891|530854858|FG000|Randomized, Double-blind Period|Withdrawal by Subject|0|||
147188153|NCT04037891|530854859|FG001|Randomized, Double-blind Period|Withdrawal by Subject|1|||
147188154|NCT04037891|530854860|FG002|Randomized, Double-blind Period|Withdrawal by Subject|0|||
147188155|NCT03446313|530854862|FG000|Overall Study|Lost to Follow-up|1|||
147188156|NCT03446313|530854863|FG001|Overall Study|Lost to Follow-up|2|||
147188157|NCT03446313|530854862|FG000|Overall Study|Failed primary screening|3|||
147188158|NCT03446313|530854863|FG001|Overall Study|Failed primary screening|0|||
147188159|NCT03446313|530854862|FG000|Overall Study|Diagnosed with terminal cancer|1|||
147188160|NCT03446313|530854863|FG001|Overall Study|Diagnosed with terminal cancer|0|||
147188161|NCT03446313|530854862|FG000|Overall Study|Excluded from analysis|1|||
147188162|NCT03446313|530854863|FG001|Overall Study|Excluded from analysis|1|||
147188163|NCT04491136|530854869|FG000|Overall Study|Patient withdraw informed consent|9|||
147188164|NCT04491136|530854869|FG000|Overall Study|Adverse Event|2|||
147188165|NCT04491136|530854869|FG000|Overall Study|Death|3|||
147188166|NCT04491136|530854869|FG000|Overall Study|Lost to Follow-up|3|||
147188167|NCT04491136|530854869|FG000|Overall Study|Physician Decision|45|||
147188168|NCT04491136|530854869|FG000|Overall Study|sponsor terminated the study early|16|||
147188169|NCT04491136|530854869|FG000|Overall Study|Patient/guardian's decision|1|||
147188170|NCT01505374|530854871|FG000|Overall Study|Lost to Follow-up|1|||
147188171|NCT01505374|530854872|FG001|Overall Study|Lost to Follow-up|0|||
147188172|NCT02360228|530854873|FG000|Overall Study|Withdrawal by Subject|1|||
147188173|NCT02360228|530854874|FG001|Overall Study|Withdrawal by Subject|0|||
147188174|NCT02360228|530854875|FG002|Overall Study|Withdrawal by Subject|0|||
147188175|NCT02360228|530854873|FG000|Overall Study|Self-discontinued medication|0|||
147329753|NCT01090024|531373053|FG006|Period 2|Lost to Follow-up|0|||
147188176|NCT02360228|530854874|FG001|Overall Study|Self-discontinued medication|1|||
147188177|NCT02360228|530854875|FG002|Overall Study|Self-discontinued medication|0|||
147188178|NCT02360228|530854873|FG000|Overall Study|Unstable symptoms during screening|0|||
147188179|NCT02360228|530854874|FG001|Overall Study|Unstable symptoms during screening|0|||
147188180|NCT02360228|530854875|FG002|Overall Study|Unstable symptoms during screening|1|||
147188181|NCT02464410|530854878|FG000|Overall Study|Death|3|||
147188182|NCT02464410|530854879|FG001|Overall Study|Death|4|||
147188183|NCT02464410|530854878|FG000|Overall Study|Lost to Follow-up|7|||
147188184|NCT02464410|530854879|FG001|Overall Study|Lost to Follow-up|9|||
147188185|NCT02464410|530854878|FG000|Overall Study|Withdrawal by Subject|12|||
147188186|NCT02464410|530854879|FG001|Overall Study|Withdrawal by Subject|3|||
147188187|NCT00851786|530854880|FG000|Overall Study|Withdrawal by Subject|0|||
147188188|NCT00851786|530854881|FG001|Overall Study|Withdrawal by Subject|1|||
147188189|NCT00851786|530854880|FG000|Overall Study|Protocol Violation|0|||
147188190|NCT00851786|530854881|FG001|Overall Study|Protocol Violation|1|||
147188191|NCT00851786|530854880|FG000|Overall Study|Lost to Follow-up|1|||
147188192|NCT00851786|530854881|FG001|Overall Study|Lost to Follow-up|0|||
147188193|NCT00851786|530854880|FG000|Overall Study|Incarceration|1|||
147188194|NCT00851786|530854881|FG001|Overall Study|Incarceration|0|||
147188195|NCT00851786|530854880|FG000|Overall Study|Site Closure|1|||
147188196|NCT00851786|530854881|FG001|Overall Study|Site Closure|0|||
147329754|NCT01090024|531373054|FG007|Period 2|Lost to Follow-up|0|||
147188197|NCT00851786|530854880|FG000|Overall Study|Cannot Adhere to Protocol Requirement|2|||
147188198|NCT00851786|530854881|FG001|Overall Study|Cannot Adhere to Protocol Requirement|0|||
147188199|NCT02831764|530856336|FG000|Double-blind Phase (Day1 to Week 96)|Protocol specific withdrawal criteria|0|||
147188200|NCT02831764|530856337|FG001|Double-blind Phase (Day1 to Week 96)|Protocol specific withdrawal criteria|2|||
147188201|NCT02831764|530856338|FG002|Double-blind Phase (Day1 to Week 96)|Protocol specific withdrawal criteria|0|||
147188202|NCT02831764|530856339|FG003|Double-blind Phase (Day1 to Week 96)|Protocol specific withdrawal criteria|0|||
147188203|NCT02831764|530856340|FG004|Double-blind Phase (Day1 to Week 96)|Protocol specific withdrawal criteria|0|||
147188204|NCT02831764|530856336|FG000|Double-blind Phase (Day1 to Week 96)|Withdrawal by Subject|9|||
147188205|NCT02831764|530856337|FG001|Double-blind Phase (Day1 to Week 96)|Withdrawal by Subject|9|||
147188206|NCT02831764|530856338|FG002|Double-blind Phase (Day1 to Week 96)|Withdrawal by Subject|0|||
147188207|NCT02831764|530856339|FG003|Double-blind Phase (Day1 to Week 96)|Withdrawal by Subject|0|||
147188208|NCT02831764|530856340|FG004|Double-blind Phase (Day1 to Week 96)|Withdrawal by Subject|0|||
147188209|NCT02831764|530856336|FG000|Double-blind Phase (Day1 to Week 96)|Physician Decision|3|||
147188210|NCT02831764|530856337|FG001|Double-blind Phase (Day1 to Week 96)|Physician Decision|3|||
147188211|NCT02831764|530856338|FG002|Double-blind Phase (Day1 to Week 96)|Physician Decision|0|||
147188212|NCT02831764|530856339|FG003|Double-blind Phase (Day1 to Week 96)|Physician Decision|0|||
147188213|NCT02831764|530856340|FG004|Double-blind Phase (Day1 to Week 96)|Physician Decision|0|||
147188214|NCT02831764|530856336|FG000|Double-blind Phase (Day1 to Week 96)|Lost to Follow-up|9|||
147188215|NCT02831764|530856337|FG001|Double-blind Phase (Day1 to Week 96)|Lost to Follow-up|7|||
147188216|NCT02831764|530856338|FG002|Double-blind Phase (Day1 to Week 96)|Lost to Follow-up|0|||
147188217|NCT02831764|530856339|FG003|Double-blind Phase (Day1 to Week 96)|Lost to Follow-up|0|||
147188218|NCT02831764|530856340|FG004|Double-blind Phase (Day1 to Week 96)|Lost to Follow-up|0|||
147188219|NCT02831764|530856336|FG000|Double-blind Phase (Day1 to Week 96)|Adverse Event|10|||
147188220|NCT02831764|530856337|FG001|Double-blind Phase (Day1 to Week 96)|Adverse Event|6|||
147188221|NCT02831764|530856338|FG002|Double-blind Phase (Day1 to Week 96)|Adverse Event|0|||
147188222|NCT02831764|530856339|FG003|Double-blind Phase (Day1 to Week 96)|Adverse Event|0|||
147188223|NCT02831764|530856340|FG004|Double-blind Phase (Day1 to Week 96)|Adverse Event|0|||
147188224|NCT02831764|530856336|FG000|Double-blind Phase (Day1 to Week 96)|Lack of Efficacy|5|||
147188225|NCT02831764|530856337|FG001|Double-blind Phase (Day1 to Week 96)|Lack of Efficacy|2|||
147188226|NCT02831764|530856338|FG002|Double-blind Phase (Day1 to Week 96)|Lack of Efficacy|0|||
147188227|NCT02831764|530856339|FG003|Double-blind Phase (Day1 to Week 96)|Lack of Efficacy|0|||
147188228|NCT02831764|530856340|FG004|Double-blind Phase (Day1 to Week 96)|Lack of Efficacy|0|||
147188229|NCT02831764|530856336|FG000|Double-blind Phase (Day1 to Week 96)|Protocol Deviation|5|||
147188230|NCT02831764|530856337|FG001|Double-blind Phase (Day1 to Week 96)|Protocol Deviation|3|||
147188231|NCT02831764|530856338|FG002|Double-blind Phase (Day1 to Week 96)|Protocol Deviation|0|||
147188232|NCT02831764|530856339|FG003|Double-blind Phase (Day1 to Week 96)|Protocol Deviation|0|||
147188233|NCT02831764|530856340|FG004|Double-blind Phase (Day1 to Week 96)|Protocol Deviation|0|||
147188234|NCT02831764|530856336|FG000|Double-blind Phase (Day1 to Week 96)|Randomized, but did not receive treatment|0|||
147188235|NCT02831764|530856337|FG001|Double-blind Phase (Day1 to Week 96)|Randomized, but did not receive treatment|3|||
147188236|NCT02831764|530856338|FG002|Double-blind Phase (Day1 to Week 96)|Randomized, but did not receive treatment|0|||
147188237|NCT02831764|530856339|FG003|Double-blind Phase (Day1 to Week 96)|Randomized, but did not receive treatment|0|||
147188238|NCT02831764|530856340|FG004|Double-blind Phase (Day1 to Week 96)|Randomized, but did not receive treatment|0|||
147188239|NCT02831764|530856336|FG000|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
147188240|NCT02831764|530856337|FG001|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
147188241|NCT02831764|530856338|FG002|Open-label Phase (Week 96 to Week 148)|Adverse Event|1|||
147188242|NCT02831764|530856339|FG003|Open-label Phase (Week 96 to Week 148)|Adverse Event|6|||
147188243|NCT02831764|530856340|FG004|Open-label Phase (Week 96 to Week 148)|Adverse Event|0|||
147188244|NCT02831764|530856336|FG000|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
147188245|NCT02831764|530856337|FG001|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
147188246|NCT02831764|530856338|FG002|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|2|||
147188247|NCT02831764|530856339|FG003|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
147188248|NCT02831764|530856340|FG004|Open-label Phase (Week 96 to Week 148)|Lack of Efficacy|0|||
147188249|NCT02831764|530856336|FG000|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
147188250|NCT02831764|530856337|FG001|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
147188251|NCT02831764|530856338|FG002|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|2|||
147188252|NCT02831764|530856339|FG003|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|2|||
147188253|NCT02831764|530856340|FG004|Open-label Phase (Week 96 to Week 148)|Protocol Deviation|0|||
147188254|NCT02831764|530856336|FG000|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criteria|0|||
147188255|NCT02831764|530856337|FG001|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criteria|0|||
147188256|NCT02831764|530856338|FG002|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criteria|1|||
147247496|NCT00642460|531074510|FG000|Part III: Open-Label Up to Week 260|Death|0|||
147247497|NCT00642460|531074511|FG001|Part III: Open-Label Up to Week 260|Death|0|||
147247498|NCT00642460|531074512|FG002|Part III: Open-Label Up to Week 260|Death|0|||
147188257|NCT02831764|530856339|FG003|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criteria|0|||
147188258|NCT02831764|530856340|FG004|Open-label Phase (Week 96 to Week 148)|Protocol-Specified Withdrawal Criteria|0|||
147188259|NCT02831764|530856336|FG000|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
147188260|NCT02831764|530856337|FG001|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
147188261|NCT02831764|530856338|FG002|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|4|||
147188262|NCT02831764|530856339|FG003|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|7|||
147188263|NCT02831764|530856340|FG004|Open-label Phase (Week 96 to Week 148)|Lost to Follow-up|0|||
147188264|NCT02831764|530856336|FG000|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
147188265|NCT02831764|530856337|FG001|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
147188266|NCT02831764|530856338|FG002|Open-label Phase (Week 96 to Week 148)|Physician Decision|1|||
147188267|NCT02831764|530856339|FG003|Open-label Phase (Week 96 to Week 148)|Physician Decision|3|||
147188268|NCT02831764|530856340|FG004|Open-label Phase (Week 96 to Week 148)|Physician Decision|0|||
147188269|NCT02831764|530856336|FG000|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
147188270|NCT02831764|530856337|FG001|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
147188271|NCT02831764|530856338|FG002|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|7|||
147188272|NCT02831764|530856339|FG003|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|9|||
147188273|NCT02831764|530856340|FG004|Open-label Phase (Week 96 to Week 148)|Withdrawal by Subject|0|||
147188274|NCT02831764|530856336|FG000|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
147188275|NCT02831764|530856337|FG001|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
147188276|NCT02831764|530856338|FG002|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
147188277|NCT02831764|530856339|FG003|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|0|||
147188278|NCT02831764|530856340|FG004|Continuation Phase(Week 148 to Week 280)|Protocol Deviation|1|||
147188279|NCT02831764|530856336|FG000|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
147188280|NCT02831764|530856337|FG001|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
147188281|NCT02831764|530856338|FG002|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
147188282|NCT02831764|530856339|FG003|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|0|||
147188283|NCT02831764|530856340|FG004|Continuation Phase(Week 148 to Week 280)|Lost to Follow-up|2|||
147188284|NCT02831764|530856336|FG000|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
147188285|NCT02831764|530856337|FG001|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
147188286|NCT02831764|530856338|FG002|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
147188287|NCT02831764|530856339|FG003|Continuation Phase(Week 148 to Week 280)|Physician Decision|0|||
147188288|NCT02831764|530856340|FG004|Continuation Phase(Week 148 to Week 280)|Physician Decision|5|||
147188289|NCT02831764|530856336|FG000|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
147188290|NCT02831764|530856337|FG001|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
147188291|NCT02831764|530856338|FG002|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
147188292|NCT02831764|530856339|FG003|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|0|||
147188293|NCT02831764|530856340|FG004|Continuation Phase(Week 148 to Week 280)|Withdrawal by Subject|5|||
147188294|NCT00865345|530856341|FG000|Overall Study|Withdrawal by Subject|2|||
147188295|NCT03737123|530856342|FG000|Study Treatment|Adverse Event|2|||
147188296|NCT03737123|530856343|FG001|Study Treatment|Adverse Event|0|||
147188297|NCT03737123|530856342|FG000|Study Treatment|Disease Progression|2|||
147188298|NCT03737123|530856343|FG001|Study Treatment|Disease Progression|0|||
147188299|NCT03737123|530856342|FG000|Study Treatment|Withdrawal by Subject|2|||
147188300|NCT03737123|530856343|FG001|Study Treatment|Withdrawal by Subject|0|||
147188301|NCT03737123|530856342|FG000|Follow up|Death|1|||
147188302|NCT03737123|530856343|FG001|Follow up|Death|0|||
147188303|NCT03737123|530856342|FG000|Follow up|Withdrawal by Subject|1|||
147247499|NCT00642460|531074513|FG003|Part III: Open-Label Up to Week 260|Death|0|||
147247500|NCT00642460|531074514|FG004|Part III: Open-Label Up to Week 260|Death|0|||
147247501|NCT00642460|531074515|FG005|Part III: Open-Label Up to Week 260|Death|3|||
147247502|NCT00642460|531074510|FG000|Part III: Open-Label Up to Week 260|Administrative reason|0|||
147247503|NCT00642460|531074511|FG001|Part III: Open-Label Up to Week 260|Administrative reason|0|||
147247504|NCT00642460|531074512|FG002|Part III: Open-Label Up to Week 260|Administrative reason|0|||
147247505|NCT00642460|531074513|FG003|Part III: Open-Label Up to Week 260|Administrative reason|0|||
147247506|NCT00642460|531074514|FG004|Part III: Open-Label Up to Week 260|Administrative reason|0|||
147247507|NCT00642460|531074515|FG005|Part III: Open-Label Up to Week 260|Administrative reason|1|||
147247508|NCT00642460|531074510|FG000|Part III: Open-Label Up to Week 260|Refused treatment|0|||
147247509|NCT00642460|531074511|FG001|Part III: Open-Label Up to Week 260|Refused treatment|0|||
147247510|NCT00642460|531074512|FG002|Part III: Open-Label Up to Week 260|Refused treatment|0|||
147247511|NCT00642460|531074513|FG003|Part III: Open-Label Up to Week 260|Refused treatment|0|||
147247512|NCT00642460|531074514|FG004|Part III: Open-Label Up to Week 260|Refused treatment|8|||
147247513|NCT00642460|531074515|FG005|Part III: Open-Label Up to Week 260|Refused treatment|3|||
147247514|NCT02088047|531074516|FG000|Overall Study|Withdrawal by Subject|1|||
147247515|NCT02088047|531074517|FG001|Overall Study|Withdrawal by Subject|0|||
147247516|NCT00660309|531074518|FG000|Overall Study|Adverse Event|2|||
147247517|NCT00660309|531074519|FG001|Overall Study|Adverse Event|0|||
147188304|NCT03737123|530856343|FG001|Follow up|Withdrawal by Subject|0|||
147188305|NCT03737123|530856342|FG000|Follow up|Termination of study|4|||
147188306|NCT03737123|530856343|FG001|Follow up|Termination of study|0|||
147188307|NCT01519323|530856344|FG000|Overall Study|Death|3|||
147188308|NCT01519323|530856345|FG001|Overall Study|Death|2|||
147188309|NCT01519323|530856344|FG000|Overall Study|Study terminated by sponsor|0|||
147188310|NCT01519323|530856345|FG001|Overall Study|Study terminated by sponsor|1|||
147188311|NCT03858049|530856360|FG000|Overall Study|Adverse Event|16|||
147188312|NCT03858049|530856361|FG001|Overall Study|Adverse Event|9|||
147188313|NCT03858049|530856360|FG000|Overall Study|Other|1|||
147188314|NCT03858049|530856361|FG001|Overall Study|Other|1|||
147188315|NCT02079740|530856362|FG000|Phase 1b: Dose Escalation|Adverse Event|0|||
147188316|NCT02079740|530856363|FG001|Phase 1b: Dose Escalation|Adverse Event|0|||
147188317|NCT02079740|530856364|FG002|Phase 1b: Dose Escalation|Adverse Event|0|||
147188318|NCT02079740|530856365|FG003|Phase 1b: Dose Escalation|Adverse Event|0|||
147188319|NCT02079740|530856366|FG004|Phase 1b: Dose Escalation|Adverse Event|1|||
147188320|NCT02079740|530856367|FG005|Phase 1b: Dose Escalation|Adverse Event|0|||
147188321|NCT02079740|530856368|FG006|Phase 1b: Dose Escalation|Adverse Event|0|||
147188322|NCT02079740|530856369|FG007|Phase 1b: Dose Escalation|Adverse Event|0|||
147188323|NCT02079740|530856370|FG008|Phase 1b: Dose Escalation|Adverse Event|0|||
147448880|NCT00996944|531808022|FG000|Double-blind Treatment Period|Study Closed/Terminated|6|||
147448881|NCT00996944|531808023|FG001|Double-blind Treatment Period|Study Closed/Terminated|5|||
147188324|NCT02079740|530856371|FG009|Phase 1b: Dose Escalation|Adverse Event|0|||
147188325|NCT02079740|530856372|FG010|Phase 1b: Dose Escalation|Adverse Event|0|||
147188326|NCT02079740|530856373|FG011|Phase 1b: Dose Escalation|Adverse Event|0|||
147188327|NCT02079740|530856374|FG012|Phase 1b: Dose Escalation|Adverse Event|0|||
147188328|NCT02079740|530856362|FG000|Phase 1b: Dose Escalation|Physician Decision|0|||
147188329|NCT02079740|530856363|FG001|Phase 1b: Dose Escalation|Physician Decision|0|||
147188330|NCT02079740|530856364|FG002|Phase 1b: Dose Escalation|Physician Decision|0|||
147188331|NCT02079740|530856365|FG003|Phase 1b: Dose Escalation|Physician Decision|0|||
147188332|NCT02079740|530856366|FG004|Phase 1b: Dose Escalation|Physician Decision|1|||
147188333|NCT02079740|530856367|FG005|Phase 1b: Dose Escalation|Physician Decision|0|||
147188334|NCT02079740|530856368|FG006|Phase 1b: Dose Escalation|Physician Decision|0|||
147188335|NCT02079740|530856369|FG007|Phase 1b: Dose Escalation|Physician Decision|0|||
147188336|NCT02079740|530856370|FG008|Phase 1b: Dose Escalation|Physician Decision|0|||
147188337|NCT02079740|530856371|FG009|Phase 1b: Dose Escalation|Physician Decision|0|||
147188338|NCT02079740|530856372|FG010|Phase 1b: Dose Escalation|Physician Decision|0|||
147188339|NCT02079740|530856373|FG011|Phase 1b: Dose Escalation|Physician Decision|0|||
147188340|NCT02079740|530856374|FG012|Phase 1b: Dose Escalation|Physician Decision|0|||
147188341|NCT02079740|530856362|FG000|Phase 1b: Dose Escalation|Clinical Progression|0|||
147188342|NCT02079740|530856363|FG001|Phase 1b: Dose Escalation|Clinical Progression|0|||
147188343|NCT02079740|530856364|FG002|Phase 1b: Dose Escalation|Clinical Progression|0|||
147188344|NCT02079740|530856365|FG003|Phase 1b: Dose Escalation|Clinical Progression|0|||
147188345|NCT02079740|530856366|FG004|Phase 1b: Dose Escalation|Clinical Progression|0|||
147188346|NCT02079740|530856367|FG005|Phase 1b: Dose Escalation|Clinical Progression|0|||
147188347|NCT02079740|530856368|FG006|Phase 1b: Dose Escalation|Clinical Progression|0|||
147188348|NCT02079740|530856369|FG007|Phase 1b: Dose Escalation|Clinical Progression|1|||
147188349|NCT02079740|530856370|FG008|Phase 1b: Dose Escalation|Clinical Progression|0|||
147188350|NCT02079740|530856371|FG009|Phase 1b: Dose Escalation|Clinical Progression|0|||
147188351|NCT02079740|530856372|FG010|Phase 1b: Dose Escalation|Clinical Progression|0|||
147188352|NCT02079740|530856373|FG011|Phase 1b: Dose Escalation|Clinical Progression|0|||
147188353|NCT02079740|530856374|FG012|Phase 1b: Dose Escalation|Clinical Progression|0|||
147188354|NCT02079740|530856362|FG000|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
147188355|NCT02079740|530856363|FG001|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
147188356|NCT02079740|530856364|FG002|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
147188357|NCT02079740|530856365|FG003|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
147188358|NCT02079740|530856366|FG004|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
147188359|NCT02079740|530856367|FG005|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
147247518|NCT00660309|531074518|FG000|Overall Study|Withdrawal by Subject|0|||
147247519|NCT00660309|531074519|FG001|Overall Study|Withdrawal by Subject|3|||
147247520|NCT01217814|531074524|FG000|Overall Study|Adverse Event|1|||
147247521|NCT01217814|531074525|FG001|Overall Study|Adverse Event|1|||
147247522|NCT01217814|531074526|FG002|Overall Study|Adverse Event|0|||
147247523|NCT01217814|531074524|FG000|Overall Study|Lack of Efficacy|0|||
147247524|NCT01217814|531074525|FG001|Overall Study|Lack of Efficacy|0|||
147247525|NCT01217814|531074526|FG002|Overall Study|Lack of Efficacy|1|||
147247526|NCT01218243|531074527|FG000|Overall Study|Lack of Efficacy|1|||
147247527|NCT01218243|531074528|FG001|Overall Study|Lack of Efficacy|1|||
147247528|NCT01218243|531074527|FG000|Overall Study|Lost to Follow-up|3|||
147247529|NCT01218243|531074528|FG001|Overall Study|Lost to Follow-up|3|||
147247530|NCT01218243|531074527|FG000|Overall Study|Protocol Violation|5|||
147247531|NCT01218243|531074528|FG001|Overall Study|Protocol Violation|10|||
147247532|NCT00833794|531074533|FG000|Open-label Phase|Adverse Event|225|||
147188360|NCT02079740|530856368|FG006|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
147188361|NCT02079740|530856369|FG007|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|1|||
147188362|NCT02079740|530856370|FG008|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
147188363|NCT02079740|530856371|FG009|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
147188364|NCT02079740|530856372|FG010|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
147188365|NCT02079740|530856373|FG011|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
147188366|NCT02079740|530856374|FG012|Phase 1b: Dose Escalation|Concurrent anticoagulation prohibited on study|0|||
147188367|NCT02079740|530856362|FG000|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
147188368|NCT02079740|530856363|FG001|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
147188369|NCT02079740|530856364|FG002|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
147188370|NCT02079740|530856365|FG003|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
147188371|NCT02079740|530856366|FG004|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
147188372|NCT02079740|530856367|FG005|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
147188373|NCT02079740|530856368|FG006|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
147188374|NCT02079740|530856369|FG007|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
147188375|NCT02079740|530856370|FG008|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
147188376|NCT02079740|530856371|FG009|Phase 2: Expansion Cohorts|Withdrawal by Subject|2|||
147188377|NCT02079740|530856372|FG010|Phase 2: Expansion Cohorts|Withdrawal by Subject|0|||
147188378|NCT02079740|530856373|FG011|Phase 2: Expansion Cohorts|Withdrawal by Subject|1|||
147188379|NCT02079740|530856374|FG012|Phase 2: Expansion Cohorts|Withdrawal by Subject|2|||
147188380|NCT04617782|530856375|FG000|Treatment A - 5 mg TDS|Physician Decision|2|||
147188381|NCT04617782|530856375|FG000|Treatment A - 5 mg TDS|failure to follow site rules|1|||
147188382|NCT04617782|530856375|FG000|Treatment B - 10 mg TDS|Protocol Violation|1|||
147188383|NCT04617782|530856375|FG000|Treatment B - 10 mg TDS|Withdrawal by Subject|1|||
147188384|NCT04617782|530856375|FG000|Treatment C - 10 mg Oral|Protocol Violation|2|||
147188385|NCT04617782|530856375|FG000|Treatment C - 10 mg Oral|failure to follow site rules|1|||
147188386|NCT01474317|530856379|FG000|Overall Study|Adverse Event|1|||
147188387|NCT01474317|530856379|FG000|Overall Study|Subject ineligible for study|1|||
147188388|NCT00387881|530856382|FG000|Overall Study|Lost to Follow-up|23|||
147188389|NCT00387881|530856383|FG001|Overall Study|Lost to Follow-up|23|||
147188390|NCT00387881|530856382|FG000|Overall Study|Protocol Violation|2|||
147188391|NCT00387881|530856383|FG001|Overall Study|Protocol Violation|12|||
147188392|NCT00387881|530856382|FG000|Overall Study|Withdrawal by Subject|15|||
147188393|NCT00387881|530856383|FG001|Overall Study|Withdrawal by Subject|18|||
147188394|NCT00387881|530856382|FG000|Overall Study|Sponsor terminated Study|0|||
147188395|NCT00387881|530856383|FG001|Overall Study|Sponsor terminated Study|1|||
147188396|NCT00387881|530856382|FG000|Overall Study|Not eligible|6|||
147188397|NCT00387881|530856383|FG001|Overall Study|Not eligible|7|||
147188398|NCT00387881|530856382|FG000|Overall Study|No opportunity to treat headache|32|||
147188399|NCT00387881|530856383|FG001|Overall Study|No opportunity to treat headache|34|||
147188400|NCT00387881|530856382|FG000|Overall Study|Not otherwise specified|11|||
147188401|NCT00387881|530856383|FG001|Overall Study|Not otherwise specified|7|||
147188402|NCT00453154|530856384|FG000|Double BIind Maintenance|Adverse Event|0|||
147188403|NCT00453154|530856385|FG001|Double BIind Maintenance|Adverse Event|0|||
147188404|NCT00453154|530856386|FG002|Double BIind Maintenance|Adverse Event|3|||
147188405|NCT00453154|530856387|FG003|Double BIind Maintenance|Adverse Event|12|||
147188406|NCT00453154|530856384|FG000|Double BIind Maintenance|Death|0|||
147188407|NCT00453154|530856385|FG001|Double BIind Maintenance|Death|0|||
147188408|NCT00453154|530856386|FG002|Double BIind Maintenance|Death|2|||
147188409|NCT00453154|530856387|FG003|Double BIind Maintenance|Death|1|||
147188410|NCT00453154|530856384|FG000|Double BIind Maintenance|Withdrawal by Subject|0|||
147188411|NCT00453154|530856385|FG001|Double BIind Maintenance|Withdrawal by Subject|0|||
147188412|NCT00453154|530856386|FG002|Double BIind Maintenance|Withdrawal by Subject|4|||
147188413|NCT00453154|530856387|FG003|Double BIind Maintenance|Withdrawal by Subject|4|||
147188414|NCT00453154|530856384|FG000|Double BIind Maintenance|Progression|0|||
147188415|NCT00453154|530856385|FG001|Double BIind Maintenance|Progression|0|||
147188416|NCT00453154|530856386|FG002|Double BIind Maintenance|Progression|29|||
147188417|NCT00453154|530856387|FG003|Double BIind Maintenance|Progression|26|||
147188418|NCT00453154|530856384|FG000|Double BIind Maintenance|Medical Issues|0|||
147188419|NCT00453154|530856385|FG001|Double BIind Maintenance|Medical Issues|0|||
147188420|NCT00453154|530856386|FG002|Double BIind Maintenance|Medical Issues|3|||
147329755|NCT01090024|531373055|FG008|Period 2|Lost to Follow-up|0|||
147329756|NCT01090024|531373056|FG009|Period 2|Lost to Follow-up|0|||
147329757|NCT01090024|531373057|FG010|Period 2|Lost to Follow-up|0|||
147329758|NCT01090024|531373058|FG011|Period 2|Lost to Follow-up|0|||
147329759|NCT01090024|531373059|FG012|Period 2|Lost to Follow-up|0|||
147329760|NCT01090024|531373060|FG013|Period 2|Lost to Follow-up|0|||
147329761|NCT01090024|531373061|FG014|Period 2|Lost to Follow-up|0|||
147329762|NCT01090024|531373062|FG015|Period 2|Lost to Follow-up|0|||
147329763|NCT01090024|531373063|FG016|Period 2|Lost to Follow-up|0|||
147329764|NCT01090024|531373064|FG017|Period 2|Lost to Follow-up|0|||
147329765|NCT01090024|531373047|FG000|Period 2|Adverse Event|1|||
147329766|NCT01090024|531373048|FG001|Period 2|Adverse Event|0|||
147188421|NCT00453154|530856387|FG003|Double BIind Maintenance|Medical Issues|1|||
147188422|NCT00453154|530856384|FG000|Double BIind Maintenance|Randomized, did not receive therapy|0|||
147188423|NCT00453154|530856385|FG001|Double BIind Maintenance|Randomized, did not receive therapy|0|||
147188424|NCT00453154|530856386|FG002|Double BIind Maintenance|Randomized, did not receive therapy|5|||
147188425|NCT00453154|530856387|FG003|Double BIind Maintenance|Randomized, did not receive therapy|5|||
147188426|NCT03629886|530856388|FG000|Overall Study|Migrated / moved from the study area|0|||
147188427|NCT03629886|530856389|FG001|Overall Study|Migrated / moved from the study area|55|||
147188428|NCT03629886|530856388|FG000|Overall Study|Consent withdrawal, not due to an AE|0|||
147188429|NCT03629886|530856389|FG001|Overall Study|Consent withdrawal, not due to an AE|50|||
147188430|NCT03629886|530856388|FG000|Overall Study|Study vaccine not administrated|0|||
147188431|NCT03629886|530856389|FG001|Overall Study|Study vaccine not administrated|3|||
147188432|NCT03629886|530856388|FG000|Overall Study|Didn't meet inclusion/exclusion criteria|0|||
147188433|NCT03629886|530856389|FG001|Overall Study|Didn't meet inclusion/exclusion criteria|28|||
147188434|NCT03629886|530856388|FG000|Overall Study|Refused vaccination step of the study|0|||
147188435|NCT03629886|530856389|FG001|Overall Study|Refused vaccination step of the study|44|||
147188436|NCT03291067|530856390|FG000|Overall Study|Adverse Event|0|||
147188437|NCT03291067|530856391|FG001|Overall Study|Adverse Event|2|||
147188438|NCT03291067|530856392|FG002|Overall Study|Adverse Event|17|||
147188439|NCT03291067|530856393|FG003|Overall Study|Adverse Event|3|||
147188440|NCT03291067|530856390|FG000|Overall Study|Lost to Follow-up|2|||
147188441|NCT03291067|530856391|FG001|Overall Study|Lost to Follow-up|1|||
147188442|NCT03291067|530856392|FG002|Overall Study|Lost to Follow-up|0|||
147188443|NCT03291067|530856393|FG003|Overall Study|Lost to Follow-up|1|||
147188444|NCT03291067|530856390|FG000|Overall Study|Physician Decision|0|||
147188445|NCT03291067|530856391|FG001|Overall Study|Physician Decision|0|||
147188446|NCT03291067|530856392|FG002|Overall Study|Physician Decision|1|||
147188447|NCT03291067|530856393|FG003|Overall Study|Physician Decision|0|||
147188448|NCT03291067|530856390|FG000|Overall Study|Protocol Violation|5|||
147188449|NCT03291067|530856391|FG001|Overall Study|Protocol Violation|3|||
147188450|NCT03291067|530856392|FG002|Overall Study|Protocol Violation|4|||
147188451|NCT03291067|530856393|FG003|Overall Study|Protocol Violation|2|||
147188452|NCT03291067|530856390|FG000|Overall Study|Withdrawal by Subject|3|||
147188453|NCT03291067|530856391|FG001|Overall Study|Withdrawal by Subject|4|||
147188454|NCT03291067|530856392|FG002|Overall Study|Withdrawal by Subject|7|||
147188455|NCT03291067|530856393|FG003|Overall Study|Withdrawal by Subject|5|||
147188456|NCT03291067|530856390|FG000|Overall Study|Other|0|||
147188457|NCT03291067|530856391|FG001|Overall Study|Other|4|||
147188458|NCT03291067|530856392|FG002|Overall Study|Other|4|||
147188459|NCT03291067|530856393|FG003|Overall Study|Other|6|||
147188460|NCT03683173|530856394|FG000|Completed Follow-up|Unavailable|235|||
147188461|NCT03683173|530856395|FG001|Completed Follow-up|Unavailable|217|||
147188462|NCT03683173|530856394|FG000|Completed Follow-up|Refused|69|||
147188463|NCT03683173|530856395|FG001|Completed Follow-up|Refused|59|||
147188464|NCT03683173|530856394|FG000|Completed Follow-up|Disconnected phone|65|||
147188465|NCT03683173|530856395|FG001|Completed Follow-up|Disconnected phone|95|||
147188466|NCT03683173|530856394|FG000|Completed Follow-up|Health issue/deceased|10|||
147188467|NCT03683173|530856395|FG001|Completed Follow-up|Health issue/deceased|4|||
147188468|NCT03683173|530856394|FG000|Completed Follow-up|Moved away|8|||
147188469|NCT03683173|530856395|FG001|Completed Follow-up|Moved away|1|||
147188470|NCT03016312|530856396|FG000|Overall Study|discontinued before the treatment started|0|||
147188471|NCT03016312|530856397|FG001|Overall Study|discontinued before the treatment started|1|||
147188472|NCT03016312|530856396|FG000|Overall Study|Withdrawal by Subject|37|||
147188473|NCT03016312|530856397|FG001|Overall Study|Withdrawal by Subject|44|||
147188474|NCT03016312|530856396|FG000|Overall Study|Terminated by the Sponsor's decision|100|||
147188475|NCT03016312|530856397|FG001|Overall Study|Terminated by the Sponsor's decision|126|||
147188476|NCT03016312|530856396|FG000|Overall Study|Physician Decision|1|||
147188477|NCT03016312|530856397|FG001|Overall Study|Physician Decision|3|||
147188478|NCT03016312|530856396|FG000|Overall Study|Lost to Follow-up|12|||
147188479|NCT03016312|530856397|FG001|Overall Study|Lost to Follow-up|12|||
147188480|NCT03016312|530856396|FG000|Overall Study|Death|210|||
147188481|NCT03016312|530856397|FG001|Overall Study|Death|184|||
147188482|NCT03016312|530856396|FG000|Overall Study|loss to contact|1|||
147188483|NCT03016312|530856397|FG001|Overall Study|loss to contact|0|||
147188484|NCT03016312|530856396|FG000|Overall Study|started a new cancer therapy|1|||
147188485|NCT03016312|530856397|FG001|Overall Study|started a new cancer therapy|0|||
147188486|NCT00496015|530856398|FG000|Overall Study|Other|1|||
147188487|NCT00496015|530856399|FG001|Overall Study|Other|0|||
147188488|NCT00496015|530856400|FG002|Overall Study|Other|0|||
147188489|NCT00496015|530856401|FG003|Overall Study|Other|1|||
147188490|NCT00496015|530856402|FG004|Overall Study|Other|0|||
147188491|NCT01535807|530856404|FG000|Overall Study|Withdrawal by Subject|1|||
147188492|NCT01535807|530856405|FG001|Overall Study|Withdrawal by Subject|1|||
147188493|NCT01535807|530856404|FG000|Overall Study|Data collection error|1|||
147188494|NCT01535807|530856405|FG001|Overall Study|Data collection error|1|||
147188495|NCT02730728|530856408|FG000|Overall Study|Withdrawal by Subject|0|||
147188496|NCT02730728|530856409|FG001|Overall Study|Withdrawal by Subject|1|||
147247533|NCT00833794|531074534|FG001|Open-label Phase|Adverse Event|0|||
147247534|NCT00833794|531074533|FG000|Open-label Phase|Lack of Efficacy|28|||
147247535|NCT00833794|531074534|FG001|Open-label Phase|Lack of Efficacy|0|||
147448882|NCT00996944|531808022|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
147448883|NCT00996944|531808023|FG001|Double-blind Treatment Period|Withdrawal by Subject|1|||
147188497|NCT02730728|530856410|FG002|Overall Study|Withdrawal by Subject|0|||
147188498|NCT02730728|530856408|FG000|Overall Study|Lack of Efficacy|0|||
147247536|NCT00833794|531074533|FG000|Open-label Phase|Withdrawal by Subject|48|||
147247537|NCT00833794|531074534|FG001|Open-label Phase|Withdrawal by Subject|0|||
147247538|NCT00833794|531074533|FG000|Open-label Phase|Physician Decision|20|||
147247539|NCT00833794|531074534|FG001|Open-label Phase|Physician Decision|0|||
147247540|NCT00833794|531074533|FG000|Open-label Phase|Administrative reason|1|||
147247541|NCT00833794|531074534|FG001|Open-label Phase|Administrative reason|0|||
147247542|NCT00833794|531074533|FG000|Open-label Phase|Protocol Violation|47|||
147247543|NCT00833794|531074534|FG001|Open-label Phase|Protocol Violation|0|||
147188499|NCT02730728|530856409|FG001|Overall Study|Lack of Efficacy|1|||
147188500|NCT02730728|530856410|FG002|Overall Study|Lack of Efficacy|1|||
147188501|NCT02123134|530856422|FG000|Overall Study|Withdrawal of consent|3|||
147188502|NCT02123134|530856423|FG001|Overall Study|Withdrawal of consent|2|||
147188503|NCT02123134|530856422|FG000|Overall Study|Administrative decision|0|||
147188504|NCT02123134|530856423|FG001|Overall Study|Administrative decision|1|||
147188505|NCT01731912|530856429|FG000|Overall Study|noncompliance|2|||
147188506|NCT02043938|530856430|FG000|Overall Study|Withdrawal by Subject|7|||
147188507|NCT02043938|530856430|FG000|Overall Study|Unable to place EEG sensors on patient|1|||
147188508|NCT02043938|530856430|FG000|Overall Study|No show by subject|1|||
147188509|NCT02043938|530856430|FG000|Overall Study|Investigator decision|1|||
147247544|NCT00833794|531074533|FG000|Open-label Phase|Did not complete wash-out period|12|||
147247545|NCT00833794|531074534|FG001|Open-label Phase|Did not complete wash-out period|0|||
147247546|NCT00833794|531074533|FG000|Open-label Phase|enrolled in error (immediately D/C)|1|||
147247547|NCT00833794|531074534|FG001|Open-label Phase|enrolled in error (immediately D/C)|0|||
147247548|NCT00833794|531074533|FG000|Double-blind Phase|Adverse Event|44|||
147247549|NCT00833794|531074534|FG001|Double-blind Phase|Adverse Event|11|||
147247550|NCT00833794|531074533|FG000|Double-blind Phase|Lack of Efficacy|34|||
147247551|NCT00833794|531074534|FG001|Double-blind Phase|Lack of Efficacy|22|||
147247552|NCT00833794|531074533|FG000|Double-blind Phase|Withdrawal by Subject|23|||
147247553|NCT00833794|531074534|FG001|Double-blind Phase|Withdrawal by Subject|6|||
147247554|NCT00833794|531074533|FG000|Double-blind Phase|Physician Decision|4|||
147247555|NCT00833794|531074534|FG001|Double-blind Phase|Physician Decision|7|||
147247556|NCT00833794|531074533|FG000|Double-blind Phase|Administrative reason|1|||
147247557|NCT00833794|531074534|FG001|Double-blind Phase|Administrative reason|3|||
147247558|NCT00471328|531074537|FG000|Core Phase|Adverse Event|18|||
147247559|NCT00471328|531074538|FG001|Core Phase|Adverse Event|6|||
147247560|NCT00471328|531074537|FG000|Core Phase|Death|8|||
147247561|NCT00471328|531074538|FG001|Core Phase|Death|4|||
147247562|NCT00471328|531074537|FG000|Core Phase|Withdrawal by Subject|2|||
147247563|NCT00471328|531074538|FG001|Core Phase|Withdrawal by Subject|2|||
147247564|NCT00471328|531074537|FG000|Core Phase|Abnormal laboratory value|1|||
147247565|NCT00471328|531074538|FG001|Core Phase|Abnormal laboratory value|0|||
147247566|NCT00471328|531074537|FG000|Core Phase|Disease Progression|78|||
147247567|NCT00471328|531074538|FG001|Core Phase|Disease Progression|53|||
147247568|NCT00471328|531074537|FG000|Core Phase|Administrative Problem|0|||
147247569|NCT00471328|531074538|FG001|Core Phase|Administrative Problem|1|||
147247570|NCT00471328|531074537|FG000|Core Phase|Protocol Deviation|0|||
147247571|NCT00471328|531074538|FG001|Core Phase|Protocol Deviation|1|||
147247572|NCT00471328|531074537|FG000|Extension Phase|Adverse Event|3|||
147247573|NCT00471328|531074538|FG001|Extension Phase|Adverse Event|12|||
147247574|NCT00471328|531074537|FG000|Extension Phase|Withdrawal by Subject|0|||
147247575|NCT00471328|531074538|FG001|Extension Phase|Withdrawal by Subject|2|||
147247576|NCT00471328|531074537|FG000|Extension Phase|Death|1|||
147247577|NCT00471328|531074538|FG001|Extension Phase|Death|7|||
147247578|NCT00471328|531074537|FG000|Extension Phase|Protocol Deviation|3|||
147247579|NCT00471328|531074538|FG001|Extension Phase|Protocol Deviation|1|||
147247580|NCT00471328|531074537|FG000|Extension Phase|Treatment duration as per protocol|0|||
147247581|NCT00471328|531074538|FG001|Extension Phase|Treatment duration as per protocol|1|||
147247582|NCT00471328|531074537|FG000|Extension Phase|Disease Progression|32|||
147247583|NCT00471328|531074538|FG001|Extension Phase|Disease Progression|44|||
147247584|NCT00471328|531074537|FG000|Extension Phase|New cancer Therapy|1|||
147247585|NCT00471328|531074538|FG001|Extension Phase|New cancer Therapy|0|||
147247586|NCT00471328|531074537|FG000|Extension Phase|Administrative Problem|1|||
147247587|NCT00471328|531074538|FG001|Extension Phase|Administrative Problem|0|||
147247588|NCT00519831|531074539|FG000|Overall Study|Adverse Event|3|||
147247589|NCT04051008|531074540|FG000|Overall Study|Withdrawal by Subject|2|||
147247590|NCT04051008|531074541|FG001|Overall Study|Withdrawal by Subject|0|||
147247591|NCT04051008|531074542|FG002|Overall Study|Withdrawal by Subject|1|||
147188510|NCT03010527|530856431|FG000|Overall Study|Death|0|||
147188511|NCT03010527|530856432|FG001|Overall Study|Death|0|||
147188512|NCT03010527|530856433|FG002|Overall Study|Death|1|||
147247592|NCT00598832|531074547|FG000|Overall Study|Lack of Efficacy|3|||
147247593|NCT00598832|531074548|FG001|Overall Study|Lack of Efficacy|7|||
147448884|NCT00996944|531808022|FG000|Long-term Treatment Period|Study Closed/Terminated|12|||
147448885|NCT00996944|531808023|FG001|Long-term Treatment Period|Study Closed/Terminated|5|||
147448886|NCT00769184|531808024|FG000|Corticosteroid + LCD/ +Placebo (2 Weeks)|Adverse Event|1|||
147448887|NCT00769184|531808025|FG001|Corticosteroid + LCD/ +Placebo (2 Weeks)|Adverse Event|0|||
147448888|NCT00769184|531808024|FG000|Corticosteroid + LCD/ +Placebo (2 Weeks)|Lost to Follow-up|0|||
147448889|NCT00769184|531808025|FG001|Corticosteroid + LCD/ +Placebo (2 Weeks)|Lost to Follow-up|1|||
147448890|NCT00769184|531808024|FG000|No Treatment (6 Weeks)|Adverse Event|1|||
147448891|NCT00769184|531808025|FG001|No Treatment (6 Weeks)|Adverse Event|1|||
147448892|NCT00385255|531808029|FG000|Overall Study|Serious Adverse Event|1|||
147448893|NCT00385255|531808030|FG001|Overall Study|Serious Adverse Event|2|||
147448894|NCT00385255|531808029|FG000|Overall Study|Protocol Violation|0|||
147448895|NCT00385255|531808030|FG001|Overall Study|Protocol Violation|4|||
147448896|NCT00385255|531808029|FG000|Overall Study|Withdrawal by Subject|0|||
147448897|NCT00385255|531808030|FG001|Overall Study|Withdrawal by Subject|8|||
147448898|NCT00385255|531808029|FG000|Overall Study|Migrated/moved from study area|0|||
147448899|NCT00385255|531808030|FG001|Overall Study|Migrated/moved from study area|1|||
147448900|NCT00385255|531808029|FG000|Overall Study|Lost to Follow-up|20|||
147448901|NCT00385255|531808030|FG001|Overall Study|Lost to Follow-up|58|||
147448902|NCT00583362|531808031|FG000|Overall Study|Adverse Event|44|||
147448903|NCT00583362|531808031|FG000|Overall Study|Lack of Efficacy|22|||
147448904|NCT00583362|531808031|FG000|Overall Study|Lost to Follow-up|4|||
147448905|NCT00583362|531808031|FG000|Overall Study|Non-compliance with study drug|28|||
147448906|NCT00583362|531808031|FG000|Overall Study|Pregnancy|7|||
147448907|NCT00583362|531808031|FG000|Overall Study|Miscommunication of visit window|5|||
147448908|NCT00583362|531808031|FG000|Overall Study|Current site closed|7|||
147448909|NCT00583362|531808031|FG000|Overall Study|Subject not dosed in LBSL99|1|||
147448910|NCT00583362|531808031|FG000|Overall Study|Subject moved out of the country/state|2|||
147448911|NCT00583362|531808031|FG000|Overall Study|Missed visits due to staff changes|1|||
147448912|NCT00583362|531808031|FG000|Overall Study|Misunderstanding of protocol|1|||
147448913|NCT00583362|531808031|FG000|Overall Study|Behavioral problems and non-compliance|1|||
147448914|NCT00583362|531808031|FG000|Overall Study|Sponsor request due to missed doses|1|||
147448915|NCT00583362|531808031|FG000|Overall Study|Physician Decision|19|||
147448916|NCT00583362|531808031|FG000|Overall Study|Protocol Violation|2|||
147448917|NCT00583362|531808031|FG000|Overall Study|Withdrawal by Subject|57|||
147448918|NCT01136655|531808036|FG000|Washout After BUD 160/FM 2.25 (7 Days)|Withdrawal by Subject|1|||
147448919|NCT01136655|531808036|FG000|Washout After BUD 160/FM 4.5 (7 Days)|Adverse Event|1|||
147448920|NCT01136655|531808036|FG000|Washout After BUD 160/FM 9.0 (7 Days)|Withdrawal by Subject|1|||
147448921|NCT01136655|531808036|FG000|Washout After BUD 160/FM 9.0 (7 Days)|Adverse Event|1|||
147448922|NCT02873936|531808039|FG000|Overall Study|Withdrew Consent|4|||
147448923|NCT02873936|531808040|FG001|Overall Study|Withdrew Consent|11|||
147448924|NCT02873936|531808041|FG002|Overall Study|Withdrew Consent|20|||
147448925|NCT02873936|531808039|FG000|Overall Study|Investigator's Discretion|3|||
147448926|NCT02873936|531808040|FG001|Overall Study|Investigator's Discretion|5|||
147448927|NCT02873936|531808041|FG002|Overall Study|Investigator's Discretion|4|||
147448928|NCT02873936|531808039|FG000|Overall Study|Adverse Event|3|||
147448929|NCT02873936|531808040|FG001|Overall Study|Adverse Event|5|||
147448930|NCT02873936|531808041|FG002|Overall Study|Adverse Event|3|||
147448931|NCT02873936|531808039|FG000|Overall Study|Protocol Violation|0|||
147448932|NCT02873936|531808040|FG001|Overall Study|Protocol Violation|1|||
147448933|NCT02873936|531808041|FG002|Overall Study|Protocol Violation|3|||
147448934|NCT02873936|531808039|FG000|Overall Study|Lost to Follow-up|1|||
147247594|NCT00598832|531074547|FG000|Overall Study|Adverse Event|6|||
147247595|NCT00598832|531074548|FG001|Overall Study|Adverse Event|2|||
147247596|NCT00598832|531074547|FG000|Overall Study|Withdrawal by Subject|25|||
147247597|NCT00598832|531074548|FG001|Overall Study|Withdrawal by Subject|36|||
147247598|NCT00598832|531074547|FG000|Overall Study|Protocol Violation|0|||
147247599|NCT00598832|531074548|FG001|Overall Study|Protocol Violation|2|||
147247600|NCT00598832|531074547|FG000|Overall Study|Lost to Follow-up|24|||
147448935|NCT02873936|531808040|FG001|Overall Study|Lost to Follow-up|1|||
147448936|NCT02873936|531808041|FG002|Overall Study|Lost to Follow-up|1|||
147448937|NCT02873936|531808039|FG000|Overall Study|Non-compliance With Study Drug|1|||
147448938|NCT02873936|531808040|FG001|Overall Study|Non-compliance With Study Drug|0|||
147448939|NCT02873936|531808041|FG002|Overall Study|Non-compliance With Study Drug|1|||
147448940|NCT02873936|531808039|FG000|Overall Study|Randomized but not Dosed|1|||
147247601|NCT00598832|531074548|FG001|Overall Study|Lost to Follow-up|29|||
147247602|NCT00598832|531074547|FG000|Overall Study|Pregnancy|2|||
147448941|NCT02873936|531808040|FG001|Overall Study|Randomized but not Dosed|0|||
147448942|NCT02873936|531808041|FG002|Overall Study|Randomized but not Dosed|0|||
147448943|NCT01015768|531808042|FG000|Overall Study|Some subject data unuseable|4|||
147448944|NCT01015768|531808043|FG001|Overall Study|Some subject data unuseable|4|||
147448945|NCT01225731|531808044|FG000|Part 1|Did not meet eligibility criteria|1|||
147247603|NCT00598832|531074548|FG001|Overall Study|Pregnancy|2|||
147247604|NCT00598832|531074547|FG000|Overall Study|Physician Decision|1|||
147188513|NCT03010527|530856431|FG000|Overall Study|Adverse Event|0|||
147188514|NCT03010527|530856432|FG001|Overall Study|Adverse Event|4|||
147188515|NCT03010527|530856433|FG002|Overall Study|Adverse Event|2|||
147188516|NCT03010527|530856431|FG000|Overall Study|Protocol Violation|0|||
147188517|NCT03010527|530856432|FG001|Overall Study|Protocol Violation|1|||
147188518|NCT03010527|530856433|FG002|Overall Study|Protocol Violation|0|||
147188519|NCT03010527|530856431|FG000|Overall Study|Lost to Follow-up|0|||
147188520|NCT03010527|530856432|FG001|Overall Study|Lost to Follow-up|2|||
147188521|NCT03010527|530856433|FG002|Overall Study|Lost to Follow-up|1|||
147188522|NCT03010527|530856431|FG000|Overall Study|Withdrawal by Subject|0|||
147188523|NCT03010527|530856432|FG001|Overall Study|Withdrawal by Subject|3|||
147188524|NCT03010527|530856433|FG002|Overall Study|Withdrawal by Subject|4|||
147188525|NCT03010527|530856431|FG000|Overall Study|WITHDRAWAL CRITERIA #9|0|||
147188526|NCT03010527|530856432|FG001|Overall Study|WITHDRAWAL CRITERIA #9|4|||
147188527|NCT03010527|530856433|FG002|Overall Study|WITHDRAWAL CRITERIA #9|6|||
147188528|NCT03010527|530856431|FG000|Overall Study|WITHDRAWAL CRITERIA #12|0|||
147188529|NCT03010527|530856432|FG001|Overall Study|WITHDRAWAL CRITERIA #12|4|||
147188530|NCT03010527|530856433|FG002|Overall Study|WITHDRAWAL CRITERIA #12|2|||
147188531|NCT03010527|530856431|FG000|Overall Study|PDILI and WITHDRAWAL CRITERIA #9|0|||
147188532|NCT03010527|530856432|FG001|Overall Study|PDILI and WITHDRAWAL CRITERIA #9|1|||
147188533|NCT03010527|530856433|FG002|Overall Study|PDILI and WITHDRAWAL CRITERIA #9|0|||
147188534|NCT01458639|530856434|FG000|Overall Study|Physician Decision|4|||
147188535|NCT01458639|530856434|FG000|Overall Study|Equipment issue|1|||
147188536|NCT01458639|530856434|FG000|Overall Study|Inability to obtain subject blood sample|1|||
147188537|NCT02656017|530856435|FG000|Overall Study|Study burden|3|||
147188538|NCT02656017|530856436|FG001|Overall Study|Study burden|3|||
147188539|NCT02656017|530856435|FG000|Overall Study|Adverse Event|2|||
147188540|NCT02656017|530856436|FG001|Overall Study|Adverse Event|1|||
147188541|NCT02656017|530856435|FG000|Overall Study|Unable/unwilling to take study medication|2|||
147188542|NCT02656017|530856436|FG001|Overall Study|Unable/unwilling to take study medication|1|||
147188543|NCT02656017|530856435|FG000|Overall Study|Began Tolvaptan|1|||
147188544|NCT02656017|530856436|FG001|Overall Study|Began Tolvaptan|1|||
147188545|NCT02656017|530856435|FG000|Overall Study|Withdrawal by Subject|1|||
147188546|NCT02656017|530856436|FG001|Overall Study|Withdrawal by Subject|0|||
147188547|NCT01755234|530856437|FG000|Overall Study|Lost to Follow-up|11|||
147188548|NCT01755234|530856438|FG001|Overall Study|Lost to Follow-up|6|||
147188549|NCT01755234|530856437|FG000|Overall Study|Change in surgical case|2|||
147188550|NCT01755234|530856438|FG001|Overall Study|Change in surgical case|1|||
147188551|NCT01755234|530856437|FG000|Overall Study|case cancelled|1|||
147188552|NCT01755234|530856438|FG001|Overall Study|case cancelled|0|||
147188553|NCT01755234|530856437|FG000|Overall Study|Withdrawal by Subject|0|||
147188554|NCT01755234|530856438|FG001|Overall Study|Withdrawal by Subject|1|||
147188555|NCT01755234|530856437|FG000|Overall Study|unblinded|1|||
147188556|NCT01755234|530856438|FG001|Overall Study|unblinded|0|||
147188557|NCT00622505|530856439|FG000|Overall Study|Adverse Event|9|||
147188558|NCT00622505|530856440|FG001|Overall Study|Adverse Event|7|||
147188559|NCT00622505|530856439|FG000|Overall Study|Abnormal Laboratory Value(s)|3|||
147188560|NCT00622505|530856440|FG001|Overall Study|Abnormal Laboratory Value(s)|5|||
147188561|NCT00622505|530856439|FG000|Overall Study|Abnormal Test Procedure Result(s)|1|||
147188562|NCT00622505|530856440|FG001|Overall Study|Abnormal Test Procedure Result(s)|0|||
147188563|NCT00622505|530856439|FG000|Overall Study|Withdrawal by Subject|12|||
147247605|NCT00598832|531074548|FG001|Overall Study|Physician Decision|4|||
147247606|NCT00598832|531074547|FG000|Overall Study|Non compliance|1|||
147247607|NCT00598832|531074548|FG001|Overall Study|Non compliance|0|||
147247608|NCT02142959|531074556|FG000|Overall Study|Adverse Event|1|||
147247609|NCT02142959|531074557|FG001|Overall Study|Adverse Event|0|||
147247610|NCT02142959|531074558|FG002|Overall Study|Adverse Event|0|||
147247611|NCT02142959|531074556|FG000|Overall Study|Death|0|||
147247612|NCT02142959|531074557|FG001|Overall Study|Death|1|||
147247613|NCT02142959|531074558|FG002|Overall Study|Death|0|||
147329767|NCT01090024|531373049|FG002|Period 2|Adverse Event|0|||
147188564|NCT00622505|530856440|FG001|Overall Study|Withdrawal by Subject|5|||
147188565|NCT00622505|530856439|FG000|Overall Study|Administrative Problems|2|||
147188566|NCT00622505|530856440|FG001|Overall Study|Administrative Problems|4|||
147188567|NCT00622505|530856439|FG000|Overall Study|Death|2|||
147188568|NCT00622505|530856440|FG001|Overall Study|Death|2|||
147188569|NCT01216202|530856451|FG000|Overall Study|Withdrawal by Subject|8|||
147188570|NCT01216202|530856452|FG001|Overall Study|Withdrawal by Subject|0|||
147188571|NCT01216202|530856451|FG000|Overall Study|Death|0|||
147188572|NCT01216202|530856452|FG001|Overall Study|Death|2|||
147188573|NCT01216202|530856451|FG000|Overall Study|Lost to Follow-up|14|||
147247614|NCT02142959|531074556|FG000|Overall Study|Withdrawal by Subject|3|||
147188574|NCT01216202|530856452|FG001|Overall Study|Lost to Follow-up|0|||
147188575|NCT00614380|530856458|FG000|Overall Study|Adverse Event|14|||
147188576|NCT00614380|530856459|FG001|Overall Study|Adverse Event|4|||
147188577|NCT00614380|530856460|FG002|Overall Study|Adverse Event|0|||
147188578|NCT00614380|530856461|FG003|Overall Study|Adverse Event|0|||
147188579|NCT00614380|530856458|FG000|Overall Study|Lost to Follow-up|6|||
147329768|NCT01090024|531373050|FG003|Period 2|Adverse Event|0|||
147329769|NCT01090024|531373051|FG004|Period 2|Adverse Event|0|||
147329770|NCT01090024|531373052|FG005|Period 2|Adverse Event|0|||
147329771|NCT01090024|531373053|FG006|Period 2|Adverse Event|0|||
147329772|NCT01090024|531373054|FG007|Period 2|Adverse Event|0|||
147329773|NCT01090024|531373055|FG008|Period 2|Adverse Event|0|||
147329774|NCT01090024|531373056|FG009|Period 2|Adverse Event|0|||
147188580|NCT00614380|530856459|FG001|Overall Study|Lost to Follow-up|1|||
147188581|NCT00614380|530856460|FG002|Overall Study|Lost to Follow-up|0|||
147188582|NCT00614380|530856461|FG003|Overall Study|Lost to Follow-up|0|||
147188583|NCT00614380|530856458|FG000|Overall Study|Non compliant with the protocol|12|||
147188584|NCT00614380|530856459|FG001|Overall Study|Non compliant with the protocol|2|||
147188585|NCT00614380|530856460|FG002|Overall Study|Non compliant with the protocol|1|||
147188586|NCT00614380|530856461|FG003|Overall Study|Non compliant with the protocol|2|||
147188587|NCT00614380|530856458|FG000|Overall Study|Consent withdrawn|3|||
147188588|NCT00614380|530856459|FG001|Overall Study|Consent withdrawn|1|||
147188589|NCT00614380|530856460|FG002|Overall Study|Consent withdrawn|0|||
147188590|NCT00614380|530856461|FG003|Overall Study|Consent withdrawn|0|||
147329775|NCT01090024|531373057|FG010|Period 2|Adverse Event|0|||
147329776|NCT01090024|531373058|FG011|Period 2|Adverse Event|0|||
147329777|NCT01090024|531373059|FG012|Period 2|Adverse Event|0|||
147329778|NCT01090024|531373060|FG013|Period 2|Adverse Event|0|||
147188591|NCT01506271|530856462|FG000|Overall Study|Progressive disease|0|||
147188592|NCT01506271|530856463|FG001|Overall Study|Progressive disease|1|||
147188593|NCT01506271|530856464|FG002|Overall Study|Progressive disease|0|||
147188594|NCT01506271|530856462|FG000|Overall Study|Protocol Violation|3|||
147188595|NCT01506271|530856463|FG001|Overall Study|Protocol Violation|1|||
147188596|NCT01506271|530856464|FG002|Overall Study|Protocol Violation|0|||
147188597|NCT01506271|530856462|FG000|Overall Study|Death|0|||
147188598|NCT01506271|530856463|FG001|Overall Study|Death|1|||
147188599|NCT01506271|530856464|FG002|Overall Study|Death|0|||
147188600|NCT01506271|530856462|FG000|Overall Study|Adverse Event|0|||
147188601|NCT01506271|530856463|FG001|Overall Study|Adverse Event|2|||
147188602|NCT01506271|530856464|FG002|Overall Study|Adverse Event|0|||
147188603|NCT01506271|530856462|FG000|Overall Study|Insufficient supply of study drug|1|||
147188604|NCT01506271|530856463|FG001|Overall Study|Insufficient supply of study drug|0|||
147188605|NCT01506271|530856464|FG002|Overall Study|Insufficient supply of study drug|0|||
147188606|NCT01506271|530856462|FG000|Overall Study|Withdrawal by Subject|0|||
147329779|NCT01090024|531373061|FG014|Period 2|Adverse Event|0|||
147329780|NCT01090024|531373062|FG015|Period 2|Adverse Event|0|||
147329781|NCT01090024|531373063|FG016|Period 2|Adverse Event|0|||
147329782|NCT01090024|531373064|FG017|Period 2|Adverse Event|0|||
147329783|NCT01090024|531373047|FG000|Period 3|Withdrawal by Subject|0|||
147329784|NCT01090024|531373048|FG001|Period 3|Withdrawal by Subject|0|||
147329785|NCT01090024|531373049|FG002|Period 3|Withdrawal by Subject|0|||
147329786|NCT01090024|531373050|FG003|Period 3|Withdrawal by Subject|0|||
147329787|NCT01090024|531373051|FG004|Period 3|Withdrawal by Subject|0|||
147329788|NCT01090024|531373052|FG005|Period 3|Withdrawal by Subject|0|||
147329789|NCT01090024|531373053|FG006|Period 3|Withdrawal by Subject|0|||
147329790|NCT01090024|531373054|FG007|Period 3|Withdrawal by Subject|0|||
147329791|NCT01090024|531373055|FG008|Period 3|Withdrawal by Subject|0|||
147329792|NCT01090024|531373056|FG009|Period 3|Withdrawal by Subject|0|||
147329793|NCT01090024|531373057|FG010|Period 3|Withdrawal by Subject|0|||
147329794|NCT01090024|531373058|FG011|Period 3|Withdrawal by Subject|0|||
147329795|NCT01090024|531373059|FG012|Period 3|Withdrawal by Subject|0|||
147329796|NCT01090024|531373060|FG013|Period 3|Withdrawal by Subject|0|||
147329797|NCT01090024|531373061|FG014|Period 3|Withdrawal by Subject|0|||
147329798|NCT01090024|531373062|FG015|Period 3|Withdrawal by Subject|1|||
147329799|NCT01090024|531373063|FG016|Period 3|Withdrawal by Subject|0|||
147329800|NCT01090024|531373064|FG017|Period 3|Withdrawal by Subject|0|||
147594114|NCT01698775|532330601|FG000|Phase A|Lost to Follow-up|1|||
147594115|NCT01698775|532330602|FG001|Phase A|Lost to Follow-up|2|||
147594116|NCT01698775|532330601|FG000|Phase A|Protocol Violation|1|||
147594117|NCT01698775|532330602|FG001|Phase A|Protocol Violation|0|||
147594118|NCT01698775|532330601|FG000|Phase A|Withdrawal by Subject|3|||
147188607|NCT01506271|530856463|FG001|Overall Study|Withdrawal by Subject|1|||
147188608|NCT01506271|530856464|FG002|Overall Study|Withdrawal by Subject|1|||
147188609|NCT01506271|530856462|FG000|Overall Study|Lost to Follow-up|0|||
147188610|NCT01506271|530856463|FG001|Overall Study|Lost to Follow-up|1|||
147188611|NCT01506271|530856464|FG002|Overall Study|Lost to Follow-up|2|||
147188612|NCT01391663|530856465|FG000|Overall Study|Withdrawal by Subject|0|||
147188613|NCT01391663|530856466|FG001|Overall Study|Withdrawal by Subject|0|||
147329801|NCT01090024|531373047|FG000|Period 3|Protocol Violation|0|||
147329802|NCT01090024|531373048|FG001|Period 3|Protocol Violation|0|||
147329803|NCT01090024|531373049|FG002|Period 3|Protocol Violation|0|||
147329804|NCT01090024|531373050|FG003|Period 3|Protocol Violation|0|||
147329805|NCT01090024|531373051|FG004|Period 3|Protocol Violation|0|||
147329806|NCT01090024|531373052|FG005|Period 3|Protocol Violation|0|||
147329807|NCT01090024|531373053|FG006|Period 3|Protocol Violation|0|||
147329808|NCT01090024|531373054|FG007|Period 3|Protocol Violation|0|||
147329809|NCT01090024|531373055|FG008|Period 3|Protocol Violation|1|||
147188614|NCT01391663|530856467|FG002|Overall Study|Withdrawal by Subject|1|||
147188615|NCT01391663|530856468|FG003|Overall Study|Withdrawal by Subject|0|||
147188616|NCT00152503|530856470|FG000|Overall Study|Adverse Event|4|||
147188617|NCT04393493|530856471|FG000|First 4 Days of Intervention|Early improvement|5|||
147188618|NCT04393493|530856472|FG001|First 4 Days of Intervention|Early improvement|7|||
147188619|NCT01808196|530856479|FG000|Overall Study|Lost to Follow-up|1|||
147188620|NCT00479713|530856482|FG000|Overall Study|Adverse Event|8|||
147188621|NCT00479713|530856483|FG001|Overall Study|Adverse Event|6|||
147188622|NCT00479713|530856482|FG000|Overall Study|Death|1|||
147188623|NCT00479713|530856483|FG001|Overall Study|Death|0|||
147188624|NCT00479713|530856482|FG000|Overall Study|Lost to Follow-up|0|||
147188625|NCT00479713|530856483|FG001|Overall Study|Lost to Follow-up|1|||
147188626|NCT00479713|530856482|FG000|Overall Study|Protocol Violation|0|||
147188627|NCT00479713|530856483|FG001|Overall Study|Protocol Violation|1|||
147188628|NCT00479713|530856482|FG000|Overall Study|Withdrawal by Subject|4|||
147188629|NCT00479713|530856483|FG001|Overall Study|Withdrawal by Subject|1|||
147188630|NCT01670721|530856484|FG000|Overall Study|Participant's decision|15|||
147188631|NCT01670721|530856484|FG000|Overall Study|Other than specified above|38|||
147188632|NCT00141102|530856485|FG000|Overall Study|Adverse Event|233|||
147188633|NCT00141102|530856486|FG001|Overall Study|Adverse Event|305|||
147188634|NCT00141102|530856485|FG000|Overall Study|Laboratory Abnormality|9|||
147329810|NCT01090024|531373056|FG009|Period 3|Protocol Violation|0|||
147329811|NCT01090024|531373057|FG010|Period 3|Protocol Violation|0|||
147329812|NCT01090024|531373058|FG011|Period 3|Protocol Violation|0|||
147188635|NCT00141102|530856486|FG001|Overall Study|Laboratory Abnormality|33|||
147188636|NCT00141102|530856485|FG000|Overall Study|Lack of Efficacy|21|||
147188637|NCT00141102|530856486|FG001|Overall Study|Lack of Efficacy|26|||
147188638|NCT00141102|530856485|FG000|Overall Study|Lost to Follow-up|29|||
147188639|NCT00141102|530856486|FG001|Overall Study|Lost to Follow-up|32|||
147188640|NCT00141102|530856485|FG000|Overall Study|Other|87|||
147188641|NCT00141102|530856486|FG001|Overall Study|Other|76|||
147188642|NCT00141102|530856485|FG000|Overall Study|Withdrawal by Subject|112|||
147188643|NCT00141102|530856486|FG001|Overall Study|Withdrawal by Subject|142|||
147188644|NCT00141102|530856485|FG000|Overall Study|Randomized But Did Not Receive Treatment|15|||
147188645|NCT00141102|530856486|FG001|Overall Study|Randomized But Did Not Receive Treatment|9|||
147188646|NCT00141102|530856485|FG000|Overall Study|Death|2|||
147188647|NCT00141102|530856486|FG001|Overall Study|Death|2|||
147188648|NCT00866814|530856490|FG000|Overall Study|Lost to Follow-up|12|||
147188649|NCT00866814|530856490|FG000|Overall Study|Adverse Event|2|||
147188650|NCT00866814|530856490|FG000|Overall Study|Physician Decision|1|||
147188651|NCT00866814|530856490|FG000|Overall Study|Death|1|||
147188652|NCT00866814|530856490|FG000|Overall Study|No longer wished to participate|1|||
147188653|NCT00866814|530856490|FG000|Overall Study|Unable to meet follow-up requirements|2|||
147188654|NCT00866814|530856490|FG000|Overall Study|Moved to area without study site|1|||
147188655|NCT01232868|530858015|FG000|Overall Study|Lost to Follow-up|2|||
147188656|NCT01232868|530858016|FG001|Overall Study|Lost to Follow-up|4|||
147188657|NCT04481243|530858017|FG000|Overall Study|Withdrawal by Subject|4|||
147188658|NCT04564846|530858018|FG000|Overall Study|Withdrawal by Subject|2|||
147188659|NCT04564846|530858019|FG001|Overall Study|Withdrawal by Subject|1|||
147188660|NCT04564846|530858018|FG000|Overall Study|Physician Decision|0|||
147188661|NCT04564846|530858019|FG001|Overall Study|Physician Decision|1|||
147188662|NCT04564846|530858018|FG000|Overall Study|Lost to Follow-up|0|||
147188663|NCT04564846|530858019|FG001|Overall Study|Lost to Follow-up|1|||
147188664|NCT04564846|530858018|FG000|Overall Study|Principal Investigator requested that the patient withdraw from the study|1|||
147188665|NCT04564846|530858019|FG001|Overall Study|Principal Investigator requested that the patient withdraw from the study|1|||
147188666|NCT04564846|530858018|FG000|Overall Study|Subject non-compliance|1|||
147188667|NCT04564846|530858019|FG001|Overall Study|Subject non-compliance|0|||
147188668|NCT01342913|530858020|FG000|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|66|||
147188669|NCT01342913|530858021|FG001|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
147188670|NCT01342913|530858022|FG002|2-week Run-in Period|Inclusion/Exclusion Criteria Not Met|0|||
147188671|NCT01342913|530858020|FG000|2-week Run-in Period|Physician Decision|6|||
147188672|NCT01342913|530858021|FG001|2-week Run-in Period|Physician Decision|0|||
147329813|NCT01090024|531373059|FG012|Period 3|Protocol Violation|0|||
147188673|NCT01342913|530858022|FG002|2-week Run-in Period|Physician Decision|0|||
147188674|NCT01342913|530858020|FG000|2-week Run-in Period|Withdrawal by Subject|7|||
147188675|NCT01342913|530858021|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
147188676|NCT01342913|530858022|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
147594119|NCT01698775|532330602|FG001|Phase A|Withdrawal by Subject|4|||
147188677|NCT01342913|530858020|FG000|2-week Run-in Period|Adverse Event|2|||
147188678|NCT01342913|530858021|FG001|2-week Run-in Period|Adverse Event|0|||
147188679|NCT01342913|530858022|FG002|2-week Run-in Period|Adverse Event|0|||
147188680|NCT01342913|530858020|FG000|2-week Run-in Period|Protocol Violation|5|||
147188681|NCT01342913|530858021|FG001|2-week Run-in Period|Protocol Violation|0|||
147188682|NCT01342913|530858022|FG002|2-week Run-in Period|Protocol Violation|0|||
147188683|NCT01342913|530858020|FG000|2-week Run-in Period|Continuation Criteria Not Met|88|||
147329814|NCT01090024|531373060|FG013|Period 3|Protocol Violation|0|||
147658581|NCT03428100|532572313|FG002|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|7|||
147658582|NCT03428100|532572314|FG003|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|6|||
147658583|NCT03428100|532572315|FG004|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
147658584|NCT03428100|532572316|FG005|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
147658585|NCT03428100|532572317|FG006|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
147658586|NCT03428100|532572318|FG007|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
147658587|NCT03428100|532572319|FG008|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
147658588|NCT03428100|532572320|FG009|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
147247615|NCT02142959|531074557|FG001|Overall Study|Withdrawal by Subject|1|||
147247616|NCT02142959|531074558|FG002|Overall Study|Withdrawal by Subject|3|||
147247617|NCT02142959|531074556|FG000|Overall Study|Administrative Reasons|1|||
147247618|NCT02142959|531074557|FG001|Overall Study|Administrative Reasons|0|||
147247619|NCT02142959|531074558|FG002|Overall Study|Administrative Reasons|1|||
147247620|NCT02142959|531074556|FG000|Overall Study|Missing|0|||
147247621|NCT02142959|531074557|FG001|Overall Study|Missing|1|||
147247622|NCT02142959|531074558|FG002|Overall Study|Missing|0|||
147247623|NCT02142959|531074556|FG000|Overall Study|Treatment changed from radiation treatment to chemo|0|||
147247624|NCT02142959|531074557|FG001|Overall Study|Treatment changed from radiation treatment to chemo|0|||
147247625|NCT02142959|531074558|FG002|Overall Study|Treatment changed from radiation treatment to chemo|1|||
147247626|NCT02142959|531074556|FG000|Overall Study|Patient didn't complete end of study visit|0|||
147247627|NCT02142959|531074557|FG001|Overall Study|Patient didn't complete end of study visit|0|||
147247628|NCT02142959|531074558|FG002|Overall Study|Patient didn't complete end of study visit|1|||
147247629|NCT00679302|531074560|FG000|Overall Study|Lost to Follow-up|8|||
147247630|NCT00679302|531074561|FG001|Overall Study|Lost to Follow-up|4|||
147247631|NCT03547687|531074562|FG000|Overall Study|Withdrawal by Subject|1|||
147247632|NCT03547687|531074562|FG000|Overall Study|Death|1|||
147247633|NCT04600921|531074568|FG000|Overall Study|Withdrawal by Subject|3|||
147247634|NCT04600921|531074569|FG001|Overall Study|Withdrawal by Subject|5|||
147658589|NCT03428100|532572321|FG010|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
147247635|NCT04600921|531074568|FG000|Overall Study|Death|0|||
147247636|NCT04600921|531074569|FG001|Overall Study|Death|1|||
147247637|NCT02700815|531076595|FG000|Overall Study|Adverse Event|0|||
147247638|NCT02700815|531076596|FG001|Overall Study|Adverse Event|6|||
147247639|NCT02700815|531076597|FG002|Overall Study|Adverse Event|2|||
147247640|NCT02700815|531076598|FG003|Overall Study|Adverse Event|3|||
147247641|NCT02700815|531076595|FG000|Overall Study|Lack of Efficacy|0|||
147247642|NCT02700815|531076596|FG001|Overall Study|Lack of Efficacy|0|||
147247643|NCT02700815|531076597|FG002|Overall Study|Lack of Efficacy|1|||
147247644|NCT02700815|531076598|FG003|Overall Study|Lack of Efficacy|2|||
147247645|NCT02700815|531076595|FG000|Overall Study|Lost to Follow-up|1|||
147247646|NCT02700815|531076596|FG001|Overall Study|Lost to Follow-up|0|||
147247647|NCT02700815|531076597|FG002|Overall Study|Lost to Follow-up|0|||
147247648|NCT02700815|531076598|FG003|Overall Study|Lost to Follow-up|1|||
147247649|NCT02700815|531076595|FG000|Overall Study|Refusal to continue medication|0|||
147247650|NCT02700815|531076596|FG001|Overall Study|Refusal to continue medication|1|||
147247651|NCT02700815|531076597|FG002|Overall Study|Refusal to continue medication|0|||
147247652|NCT02700815|531076598|FG003|Overall Study|Refusal to continue medication|1|||
147247653|NCT02700815|531076595|FG000|Overall Study|Withdrawal by Subject|0|||
147247654|NCT02700815|531076596|FG001|Overall Study|Withdrawal by Subject|0|||
147247655|NCT02700815|531076597|FG002|Overall Study|Withdrawal by Subject|1|||
147247656|NCT02700815|531076598|FG003|Overall Study|Withdrawal by Subject|0|||
147247657|NCT02239978|531076602|FG000|Overall Study|Withdrawal by Subject|2|||
147247658|NCT02239978|531076603|FG001|Overall Study|Withdrawal by Subject|0|||
147247659|NCT01852110|531076611|FG000|Overall Study|Adverse Event|12|||
147247660|NCT01852110|531076612|FG001|Overall Study|Adverse Event|5|||
147247661|NCT01852110|531076613|FG002|Overall Study|Adverse Event|0|||
147247662|NCT01852110|531076614|FG003|Overall Study|Adverse Event|0|||
147247663|NCT01852110|531076615|FG004|Overall Study|Adverse Event|0|||
147247664|NCT01852110|531076616|FG005|Overall Study|Adverse Event|0|||
147247665|NCT01852110|531076611|FG000|Overall Study|Lost to Follow-up|1|||
147247666|NCT01852110|531076612|FG001|Overall Study|Lost to Follow-up|3|||
147247667|NCT01852110|531076613|FG002|Overall Study|Lost to Follow-up|0|||
147247668|NCT01852110|531076614|FG003|Overall Study|Lost to Follow-up|0|||
147247669|NCT01852110|531076615|FG004|Overall Study|Lost to Follow-up|0|||
147247670|NCT01852110|531076616|FG005|Overall Study|Lost to Follow-up|0|||
147247671|NCT01852110|531076611|FG000|Overall Study|Non-compliance with Study Drug|2|||
147247672|NCT01852110|531076612|FG001|Overall Study|Non-compliance with Study Drug|1|||
147247673|NCT01852110|531076613|FG002|Overall Study|Non-compliance with Study Drug|0|||
147247674|NCT01852110|531076614|FG003|Overall Study|Non-compliance with Study Drug|0|||
147247675|NCT01852110|531076615|FG004|Overall Study|Non-compliance with Study Drug|0|||
147247676|NCT01852110|531076616|FG005|Overall Study|Non-compliance with Study Drug|0|||
147247677|NCT01852110|531076611|FG000|Overall Study|Physician Decision|1|||
147247678|NCT01852110|531076612|FG001|Overall Study|Physician Decision|0|||
147448946|NCT01225731|531808045|FG001|Part 1|Did not meet eligibility criteria|0|||
147448947|NCT01225731|531808046|FG002|Part 1|Did not meet eligibility criteria|0|||
147448948|NCT01225731|531808047|FG003|Part 1|Did not meet eligibility criteria|0|||
147448949|NCT01225731|531808048|FG004|Part 1|Did not meet eligibility criteria|1|||
147448950|NCT01225731|531808049|FG005|Part 1|Did not meet eligibility criteria|0|||
147448951|NCT01225731|531808050|FG006|Part 1|Did not meet eligibility criteria|0|||
147448952|NCT01225731|531808051|FG007|Part 1|Did not meet eligibility criteria|0|||
147448953|NCT01225731|531808052|FG008|Part 1|Did not meet eligibility criteria|0|||
147448954|NCT01225731|531808053|FG009|Part 1|Did not meet eligibility criteria|0|||
147448955|NCT01225731|531808054|FG010|Part 1|Did not meet eligibility criteria|0|||
147448956|NCT01225731|531808055|FG011|Part 1|Did not meet eligibility criteria|0|||
147448957|NCT01225731|531808056|FG012|Part 1|Did not meet eligibility criteria|0|||
147448958|NCT01225731|531808044|FG000|Part 1|Adverse Event|1|||
147448959|NCT01225731|531808045|FG001|Part 1|Adverse Event|2|||
147448960|NCT01225731|531808046|FG002|Part 1|Adverse Event|1|||
147448961|NCT01225731|531808047|FG003|Part 1|Adverse Event|1|||
147448962|NCT01225731|531808048|FG004|Part 1|Adverse Event|1|||
147448963|NCT01225731|531808049|FG005|Part 1|Adverse Event|0|||
147448964|NCT01225731|531808050|FG006|Part 1|Adverse Event|0|||
147448965|NCT01225731|531808051|FG007|Part 1|Adverse Event|0|||
147448966|NCT01225731|531808052|FG008|Part 1|Adverse Event|0|||
147448967|NCT01225731|531808053|FG009|Part 1|Adverse Event|0|||
147448968|NCT01225731|531808054|FG010|Part 1|Adverse Event|0|||
147448969|NCT01225731|531808055|FG011|Part 1|Adverse Event|0|||
147448970|NCT01225731|531808056|FG012|Part 1|Adverse Event|0|||
147448971|NCT01225731|531808044|FG000|Part 1|Withdrawal by Subject|0|||
147448972|NCT01225731|531808045|FG001|Part 1|Withdrawal by Subject|3|||
147329815|NCT01090024|531373061|FG014|Period 3|Protocol Violation|0|||
147329816|NCT01090024|531373062|FG015|Period 3|Protocol Violation|0|||
147329817|NCT01090024|531373063|FG016|Period 3|Protocol Violation|0|||
147329818|NCT01090024|531373064|FG017|Period 3|Protocol Violation|0|||
147329819|NCT01090024|531373047|FG000|Period 3|Adverse Event|0|||
147188684|NCT01342913|530858021|FG001|2-week Run-in Period|Continuation Criteria Not Met|0|||
147188685|NCT01342913|530858022|FG002|2-week Run-in Period|Continuation Criteria Not Met|0|||
147188686|NCT01342913|530858020|FG000|Double-Blind Treatment Period|Adverse Event|0|||
147188687|NCT01342913|530858021|FG001|Double-Blind Treatment Period|Adverse Event|3|||
147188688|NCT01342913|530858022|FG002|Double-Blind Treatment Period|Adverse Event|6|||
147329820|NCT01090024|531373048|FG001|Period 3|Adverse Event|0|||
147329821|NCT01090024|531373049|FG002|Period 3|Adverse Event|0|||
147329822|NCT01090024|531373050|FG003|Period 3|Adverse Event|0|||
147329823|NCT01090024|531373051|FG004|Period 3|Adverse Event|0|||
147329824|NCT01090024|531373052|FG005|Period 3|Adverse Event|1|||
147329825|NCT01090024|531373053|FG006|Period 3|Adverse Event|0|||
147329826|NCT01090024|531373054|FG007|Period 3|Adverse Event|0|||
147329827|NCT01090024|531373055|FG008|Period 3|Adverse Event|0|||
147329828|NCT01090024|531373056|FG009|Period 3|Adverse Event|0|||
147329829|NCT01090024|531373057|FG010|Period 3|Adverse Event|0|||
147329830|NCT01090024|531373058|FG011|Period 3|Adverse Event|0|||
147329831|NCT01090024|531373059|FG012|Period 3|Adverse Event|0|||
147329832|NCT01090024|531373060|FG013|Period 3|Adverse Event|0|||
147329833|NCT01090024|531373061|FG014|Period 3|Adverse Event|0|||
147329834|NCT01090024|531373062|FG015|Period 3|Adverse Event|0|||
147329835|NCT01090024|531373063|FG016|Period 3|Adverse Event|0|||
147329836|NCT01090024|531373064|FG017|Period 3|Adverse Event|0|||
147329837|NCT00149630|531373065|FG000|Overall Study|Incarceration|2|||
147329838|NCT00149630|531373066|FG001|Overall Study|Incarceration|0|||
147329839|NCT00149630|531373065|FG000|Overall Study|Treatment Programs|4|||
147329840|NCT00149630|531373066|FG001|Overall Study|Treatment Programs|5|||
147329841|NCT00149630|531373065|FG000|Overall Study|Adverse Event|2|||
147329842|NCT00149630|531373066|FG001|Overall Study|Adverse Event|0|||
147329843|NCT00567879|531373067|FG000|Overall Study|Adverse Event|2|||
147329844|NCT00567879|531373068|FG001|Overall Study|Adverse Event|0|||
147329845|NCT00567879|531373069|FG002|Overall Study|Adverse Event|1|||
147329846|NCT00567879|531373070|FG003|Overall Study|Adverse Event|0|||
147329847|NCT00567879|531373071|FG004|Overall Study|Adverse Event|1|||
147329848|NCT00567879|531373072|FG005|Overall Study|Adverse Event|0|||
147329849|NCT00567879|531373067|FG000|Overall Study|Abnormal test procedure(s)|0|||
147448973|NCT01225731|531808046|FG002|Part 1|Withdrawal by Subject|0|||
147448974|NCT01225731|531808047|FG003|Part 1|Withdrawal by Subject|0|||
147448975|NCT01225731|531808048|FG004|Part 1|Withdrawal by Subject|4|||
147188689|NCT01342913|530858020|FG000|Double-Blind Treatment Period|Lack of Efficacy|0|||
147448976|NCT01225731|531808049|FG005|Part 1|Withdrawal by Subject|0|||
147188690|NCT01342913|530858021|FG001|Double-Blind Treatment Period|Lack of Efficacy|2|||
147329850|NCT00567879|531373068|FG001|Overall Study|Abnormal test procedure(s)|0|||
147329851|NCT00567879|531373069|FG002|Overall Study|Abnormal test procedure(s)|1|||
147329852|NCT00567879|531373070|FG003|Overall Study|Abnormal test procedure(s)|0|||
147329853|NCT00567879|531373071|FG004|Overall Study|Abnormal test procedure(s)|0|||
147448977|NCT01225731|531808050|FG006|Part 1|Withdrawal by Subject|0|||
147448978|NCT01225731|531808051|FG007|Part 1|Withdrawal by Subject|0|||
147329854|NCT00567879|531373072|FG005|Overall Study|Abnormal test procedure(s)|0|||
147329855|NCT00567879|531373067|FG000|Overall Study|Withdrawal by Subject|0|||
147329856|NCT00567879|531373068|FG001|Overall Study|Withdrawal by Subject|0|||
147329857|NCT00567879|531373069|FG002|Overall Study|Withdrawal by Subject|3|||
147329858|NCT00567879|531373070|FG003|Overall Study|Withdrawal by Subject|1|||
147329859|NCT00567879|531373071|FG004|Overall Study|Withdrawal by Subject|0|||
147329860|NCT00567879|531373072|FG005|Overall Study|Withdrawal by Subject|0|||
147329861|NCT00567879|531373067|FG000|Overall Study|New cancer therapy|0|||
147329862|NCT00567879|531373068|FG001|Overall Study|New cancer therapy|0|||
147329863|NCT00567879|531373069|FG002|Overall Study|New cancer therapy|1|||
147329864|NCT00567879|531373070|FG003|Overall Study|New cancer therapy|0|||
147329865|NCT00567879|531373071|FG004|Overall Study|New cancer therapy|0|||
147329866|NCT00567879|531373072|FG005|Overall Study|New cancer therapy|0|||
147329867|NCT00567879|531373067|FG000|Overall Study|Disease progression|5|||
147329868|NCT00567879|531373068|FG001|Overall Study|Disease progression|7|||
147329869|NCT00567879|531373069|FG002|Overall Study|Disease progression|15|||
147329870|NCT00567879|531373070|FG003|Overall Study|Disease progression|5|||
147329871|NCT00567879|531373071|FG004|Overall Study|Disease progression|11|||
147329872|NCT00567879|531373072|FG005|Overall Study|Disease progression|3|||
147329873|NCT00777556|531373073|FG000|Overall Study|Inappropriate self-selection|34|||
147329874|NCT00777556|531373073|FG000|Overall Study|Dispensed but did not use product|12|||
147329875|NCT00777556|531373073|FG000|Overall Study|Did not complete all 3 follow-up visits|20|||
147329876|NCT00377455|531373075|FG000|Overall Study|Withdrawal by Subject|1|||
147329877|NCT01883492|531373079|FG000|Overall Study|Lost to Follow-up|3|||
147329878|NCT01883492|531373080|FG001|Overall Study|Lost to Follow-up|4|||
147329879|NCT01883492|531373079|FG000|Overall Study|Surgery on contra-lateral hip|0|||
147329880|NCT01883492|531373080|FG001|Overall Study|Surgery on contra-lateral hip|1|||
147329881|NCT01883492|531373079|FG000|Overall Study|Poor X-ray quality|7|||
147329882|NCT01883492|531373080|FG001|Overall Study|Poor X-ray quality|4|||
147329883|NCT01883492|531373079|FG000|Overall Study|Withdrawal by Subject|1|||
147329884|NCT01883492|531373080|FG001|Overall Study|Withdrawal by Subject|0|||
147329885|NCT01883492|531373079|FG000|Overall Study|inappropriate implant used|1|||
147329886|NCT01883492|531373080|FG001|Overall Study|inappropriate implant used|1|||
147329887|NCT01883492|531373079|FG000|Overall Study|bone anatomy did not meet study criteria|1|||
147329888|NCT01883492|531373080|FG001|Overall Study|bone anatomy did not meet study criteria|1|||
147329889|NCT03265210|531373081|FG000|Overall Study|Withdrawal by Subject|7|||
147329890|NCT03265210|531373082|FG001|Overall Study|Withdrawal by Subject|9|||
147329891|NCT03265210|531373081|FG000|Overall Study|Lost to Follow-up|2|||
147329892|NCT03265210|531373082|FG001|Overall Study|Lost to Follow-up|0|||
147329893|NCT03265210|531373081|FG000|Overall Study|Physician Decision|2|||
147329894|NCT03265210|531373082|FG001|Overall Study|Physician Decision|0|||
147188691|NCT01342913|530858022|FG002|Double-Blind Treatment Period|Lack of Efficacy|3|||
147188692|NCT01342913|530858020|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
147188693|NCT01342913|530858021|FG001|Double-Blind Treatment Period|Protocol Violation|6|||
147188694|NCT01342913|530858022|FG002|Double-Blind Treatment Period|Protocol Violation|9|||
147188695|NCT01342913|530858020|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
147188696|NCT01342913|530858021|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
147188697|NCT01342913|530858022|FG002|Double-Blind Treatment Period|Lost to Follow-up|3|||
147188698|NCT01342913|530858020|FG000|Double-Blind Treatment Period|Physician Decision|0|||
147188699|NCT01342913|530858021|FG001|Double-Blind Treatment Period|Physician Decision|2|||
147188700|NCT01342913|530858022|FG002|Double-Blind Treatment Period|Physician Decision|0|||
147188701|NCT01342913|530858020|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
147188702|NCT01342913|530858021|FG001|Double-Blind Treatment Period|Withdrawal by Subject|2|||
147188703|NCT01342913|530858022|FG002|Double-Blind Treatment Period|Withdrawal by Subject|2|||
147188704|NCT05482308|530858025|FG000|Overall Study|Withdrawal by Subject|1|||
147188705|NCT05482308|530858026|FG001|Overall Study|Withdrawal by Subject|0|||
147188706|NCT05482308|530858025|FG000|Overall Study|No longer meets eligibility criteria|0|||
147188707|NCT05482308|530858026|FG001|Overall Study|No longer meets eligibility criteria|1|||
147188708|NCT04319198|530858027|FG000|Overall Study|Adverse Events Resolution or Stabilization|3|||
147188709|NCT04319198|530858028|FG001|Overall Study|Adverse Events Resolution or Stabilization|4|||
147188710|NCT04319198|530858029|FG002|Overall Study|Adverse Events Resolution or Stabilization|0|||
147188711|NCT04319198|530858027|FG000|Overall Study|Death|0|||
147188712|NCT04319198|530858028|FG001|Overall Study|Death|3|||
147188713|NCT04319198|530858029|FG002|Overall Study|Death|3|||
147188714|NCT04319198|530858027|FG000|Overall Study|Reason Not Specified|0|||
147329895|NCT03265210|531373081|FG000|Overall Study|Adverse Event|1|||
147329896|NCT03265210|531373082|FG001|Overall Study|Adverse Event|0|||
147329897|NCT03357341|531373085|FG000|Overall Study|Withdrawal by Subject|3|||
147329898|NCT03357341|531373086|FG001|Overall Study|Withdrawal by Subject|6|||
147329899|NCT03357341|531373085|FG000|Overall Study|Lost to Follow-up|4|||
147329900|NCT03357341|531373086|FG001|Overall Study|Lost to Follow-up|5|||
147329901|NCT03357341|531373085|FG000|Overall Study|Death|0|||
147329902|NCT03357341|531373086|FG001|Overall Study|Death|1|||
147329903|NCT00686517|531373087|FG000|Treatment|Serious Adverse Event|1|||
147329904|NCT00686517|531373088|FG001|Treatment|Serious Adverse Event|2|||
147658590|NCT03428100|532572322|FG011|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
147329905|NCT00686517|531373089|FG002|Treatment|Serious Adverse Event|1|||
147329906|NCT00686517|531373087|FG000|Treatment|Adverse Event|2|||
147329907|NCT00686517|531373088|FG001|Treatment|Adverse Event|0|||
147329908|NCT00686517|531373089|FG002|Treatment|Adverse Event|0|||
147188715|NCT04319198|530858028|FG001|Overall Study|Reason Not Specified|2|||
147188716|NCT04319198|530858029|FG002|Overall Study|Reason Not Specified|4|||
147188717|NCT04319198|530858027|FG000|Overall Study|Withdrawal of Consent|0|||
147188718|NCT04319198|530858028|FG001|Overall Study|Withdrawal of Consent|0|||
147188719|NCT04319198|530858029|FG002|Overall Study|Withdrawal of Consent|5|||
147188720|NCT04319198|530858027|FG000|Overall Study|Site Terminated by Sponsor|0|||
147188721|NCT04319198|530858028|FG001|Overall Study|Site Terminated by Sponsor|1|||
147188722|NCT04319198|530858029|FG002|Overall Study|Site Terminated by Sponsor|0|||
147188723|NCT05801991|530858030|FG000|Overall Study|Lost to Follow-up|1|||
147188724|NCT05801991|530858031|FG001|Overall Study|Lost to Follow-up|0|||
147188725|NCT03489863|530858034|FG000|Overall Study|Withdrawal by Subject|0|||
147188726|NCT03489863|530858035|FG001|Overall Study|Withdrawal by Subject|1|||
147188727|NCT02995980|530858037|FG000|Overall Study|Lost to Follow-up|14|||
147188728|NCT01169103|530858039|FG000|Overall Study|Lost to Follow-up|3|||
147188729|NCT01169103|530858040|FG001|Overall Study|Lost to Follow-up|3|||
147188730|NCT01169103|530858039|FG000|Overall Study|Withdrawal by Subject|3|||
147188731|NCT01169103|530858040|FG001|Overall Study|Withdrawal by Subject|1|||
147188732|NCT02634333|530858041|FG000|Overall Study|Completed out of Window|3|||
147188733|NCT02634333|530858042|FG001|Overall Study|Completed out of Window|2|||
147188734|NCT02634333|530858041|FG000|Overall Study|Missed Visit|5|||
147188735|NCT02634333|530858042|FG001|Overall Study|Missed Visit|2|||
147188736|NCT02634333|530858041|FG000|Overall Study|Lost to Follow-up|12|||
147188737|NCT02634333|530858042|FG001|Overall Study|Lost to Follow-up|7|||
147188738|NCT02634333|530858041|FG000|Overall Study|Withdrawal by Subject|9|||
147188739|NCT02634333|530858042|FG001|Overall Study|Withdrawal by Subject|13|||
147188740|NCT02634333|530858041|FG000|Overall Study|Death|11|||
147188741|NCT02634333|530858042|FG001|Overall Study|Death|8|||
147188742|NCT02611479|530858043|FG000|Baseline Enrollment|Exited study|13|||
147188743|NCT02611479|530858043|FG000|Post-Surgery Follow-up at 30-90 Days|No surgery reported|2|||
147188744|NCT02611479|530858043|FG000|Post-Surgery Follow-up at 1-Year|Lost to Follow-up|18|||
147188745|NCT02611479|530858043|FG000|Data Cleaning|No baseline function or pain metrics|2|||
147188746|NCT03275740|530858047|FG000|Overall Study|Adverse Event|0|||
147188747|NCT03275740|530858048|FG001|Overall Study|Adverse Event|0|||
147188748|NCT03275740|530858049|FG002|Overall Study|Adverse Event|0|||
147188749|NCT03275740|530858050|FG003|Overall Study|Adverse Event|0|||
147188750|NCT03275740|530858051|FG004|Overall Study|Adverse Event|1|||
147188751|NCT03275740|530858052|FG005|Overall Study|Adverse Event|0|||
147188752|NCT03275740|530858053|FG006|Overall Study|Adverse Event|0|||
147188753|NCT03275740|530858054|FG007|Overall Study|Adverse Event|0|||
147188754|NCT03275740|530858055|FG008|Overall Study|Adverse Event|0|||
147188755|NCT03275740|530858056|FG009|Overall Study|Adverse Event|0|||
147188756|NCT03275740|530858057|FG010|Overall Study|Adverse Event|0|||
147247679|NCT01852110|531076613|FG002|Overall Study|Physician Decision|0|||
147247680|NCT01852110|531076614|FG003|Overall Study|Physician Decision|0|||
147247681|NCT01852110|531076615|FG004|Overall Study|Physician Decision|0|||
147247682|NCT01852110|531076616|FG005|Overall Study|Physician Decision|0|||
147247683|NCT01852110|531076611|FG000|Overall Study|Protocol Violation|0|||
147247684|NCT01852110|531076612|FG001|Overall Study|Protocol Violation|1|||
147247685|NCT01852110|531076613|FG002|Overall Study|Protocol Violation|0|||
147247686|NCT01852110|531076614|FG003|Overall Study|Protocol Violation|0|||
147247687|NCT01852110|531076615|FG004|Overall Study|Protocol Violation|0|||
147247688|NCT01852110|531076616|FG005|Overall Study|Protocol Violation|0|||
147247689|NCT01852110|531076611|FG000|Overall Study|Study Terminated by Sponsor|30|||
147247690|NCT01852110|531076612|FG001|Overall Study|Study Terminated by Sponsor|32|||
147247691|NCT01852110|531076613|FG002|Overall Study|Study Terminated by Sponsor|0|||
147247692|NCT01852110|531076614|FG003|Overall Study|Study Terminated by Sponsor|0|||
147247693|NCT01852110|531076615|FG004|Overall Study|Study Terminated by Sponsor|0|||
147247694|NCT01852110|531076616|FG005|Overall Study|Study Terminated by Sponsor|0|||
147247695|NCT01852110|531076611|FG000|Overall Study|Withdrawal by Subject|4|||
147247696|NCT01852110|531076612|FG001|Overall Study|Withdrawal by Subject|4|||
147188757|NCT03275740|530858058|FG011|Overall Study|Adverse Event|0|||
147188758|NCT03275740|530858047|FG000|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
147188759|NCT03275740|530858048|FG001|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
147188760|NCT03275740|530858049|FG002|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
147188761|NCT03275740|530858050|FG003|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
147188762|NCT03275740|530858051|FG004|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
147188763|NCT03275740|530858052|FG005|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|1|||
147188764|NCT03275740|530858053|FG006|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
147247697|NCT01852110|531076613|FG002|Overall Study|Withdrawal by Subject|0|||
147188765|NCT03275740|530858054|FG007|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
147247698|NCT01852110|531076614|FG003|Overall Study|Withdrawal by Subject|0|||
147247699|NCT01852110|531076615|FG004|Overall Study|Withdrawal by Subject|0|||
147247700|NCT01852110|531076616|FG005|Overall Study|Withdrawal by Subject|0|||
147247701|NCT02141282|531076617|FG000|Overall Study|Adverse event, not related to progression|8|||
147247702|NCT02141282|531076618|FG001|Overall Study|Adverse event, not related to progression|1|||
147247703|NCT02141282|531076619|FG002|Overall Study|Adverse event, not related to progression|3|||
147247704|NCT02141282|531076620|FG003|Overall Study|Adverse event, not related to progression|1|||
147247705|NCT02141282|531076617|FG000|Overall Study|Adverse event, related to progression|1|||
147247706|NCT02141282|531076618|FG001|Overall Study|Adverse event, related to progression|0|||
147247707|NCT02141282|531076619|FG002|Overall Study|Adverse event, related to progression|2|||
147247708|NCT02141282|531076620|FG003|Overall Study|Adverse event, related to progression|0|||
147247709|NCT02141282|531076617|FG000|Overall Study|COVID-19 infection|1|||
147247710|NCT02141282|531076618|FG001|Overall Study|COVID-19 infection|0|||
147247711|NCT02141282|531076619|FG002|Overall Study|COVID-19 infection|0|||
147247712|NCT02141282|531076620|FG003|Overall Study|COVID-19 infection|0|||
147247713|NCT02141282|531076617|FG000|Overall Study|Lost to Follow-up|0|||
147247714|NCT02141282|531076618|FG001|Overall Study|Lost to Follow-up|0|||
147247715|NCT02141282|531076619|FG002|Overall Study|Lost to Follow-up|4|||
147247716|NCT02141282|531076620|FG003|Overall Study|Lost to Follow-up|2|||
147247717|NCT02141282|531076617|FG000|Overall Study|Other, not specified|14|||
147247718|NCT02141282|531076618|FG001|Overall Study|Other, not specified|11|||
147247719|NCT02141282|531076619|FG002|Overall Study|Other, not specified|23|||
147247720|NCT02141282|531076620|FG003|Overall Study|Other, not specified|9|||
147247721|NCT02141282|531076617|FG000|Overall Study|Progressive disease, Richter's|4|||
147247722|NCT02141282|531076618|FG001|Overall Study|Progressive disease, Richter's|1|||
147247723|NCT02141282|531076619|FG002|Overall Study|Progressive disease, Richter's|1|||
147247724|NCT02141282|531076620|FG003|Overall Study|Progressive disease, Richter's|1|||
147247725|NCT02141282|531076617|FG000|Overall Study|Progressive disease per protocol|12|||
147247726|NCT02141282|531076618|FG001|Overall Study|Progressive disease per protocol|7|||
147247727|NCT02141282|531076619|FG002|Overall Study|Progressive disease per protocol|9|||
147247728|NCT02141282|531076620|FG003|Overall Study|Progressive disease per protocol|2|||
147247729|NCT02141282|531076617|FG000|Overall Study|Stem cell transplant|1|||
147247730|NCT02141282|531076618|FG001|Overall Study|Stem cell transplant|0|||
147247731|NCT02141282|531076619|FG002|Overall Study|Stem cell transplant|1|||
147448979|NCT01225731|531808052|FG008|Part 1|Withdrawal by Subject|0|||
147448980|NCT01225731|531808053|FG009|Part 1|Withdrawal by Subject|0|||
147448981|NCT01225731|531808054|FG010|Part 1|Withdrawal by Subject|0|||
147247732|NCT02141282|531076620|FG003|Overall Study|Stem cell transplant|0|||
147247733|NCT02141282|531076617|FG000|Overall Study|Study terminated by Sponsor|0|||
147247734|NCT02141282|531076618|FG001|Overall Study|Study terminated by Sponsor|1|||
147247735|NCT02141282|531076619|FG002|Overall Study|Study terminated by Sponsor|0|||
147247736|NCT02141282|531076620|FG003|Overall Study|Study terminated by Sponsor|0|||
147247737|NCT02141282|531076617|FG000|Overall Study|Subject non-compliance|0|||
147247738|NCT02141282|531076618|FG001|Overall Study|Subject non-compliance|0|||
147247739|NCT02141282|531076619|FG002|Overall Study|Subject non-compliance|1|||
147247740|NCT02141282|531076620|FG003|Overall Study|Subject non-compliance|0|||
147247741|NCT02141282|531076617|FG000|Overall Study|Withdrew consent|2|||
147247742|NCT02141282|531076618|FG001|Overall Study|Withdrew consent|0|||
147247743|NCT02141282|531076619|FG002|Overall Study|Withdrew consent|4|||
147247744|NCT02141282|531076620|FG003|Overall Study|Withdrew consent|0|||
147247745|NCT01752907|531076622|FG000|Overall Study|Withdrawal by Subject|4|||
147247746|NCT01752907|531076623|FG001|Overall Study|Withdrawal by Subject|10|||
147247747|NCT01752907|531076622|FG000|Overall Study|Lost to Follow-up|2|||
147247748|NCT01752907|531076623|FG001|Overall Study|Lost to Follow-up|1|||
147247749|NCT01752907|531076622|FG000|Overall Study|Decision by Sponsor|6|||
147247750|NCT01752907|531076623|FG001|Overall Study|Decision by Sponsor|9|||
147247751|NCT03098550|531076624|FG000|Overall Study|Disease Progression|30|||
147247752|NCT03098550|531076625|FG001|Overall Study|Disease Progression|19|||
147247753|NCT03098550|531076626|FG002|Overall Study|Disease Progression|41|||
147247754|NCT03098550|531076624|FG000|Overall Study|Study Drug Toxicity|2|||
147247755|NCT03098550|531076625|FG001|Overall Study|Study Drug Toxicity|1|||
147247756|NCT03098550|531076626|FG002|Overall Study|Study Drug Toxicity|0|||
147247757|NCT03098550|531076624|FG000|Overall Study|Death|1|||
147448982|NCT01225731|531808055|FG011|Part 1|Withdrawal by Subject|0|||
147448983|NCT01225731|531808056|FG012|Part 1|Withdrawal by Subject|0|||
147594120|NCT01698775|532330601|FG000|Phase A|Kidney [transplant]|0|||
147247758|NCT03098550|531076625|FG001|Overall Study|Death|0|||
147247759|NCT03098550|531076626|FG002|Overall Study|Death|0|||
147247760|NCT03098550|531076624|FG000|Overall Study|Adverse Event unrelated to Study Drug|6|||
147247761|NCT03098550|531076625|FG001|Overall Study|Adverse Event unrelated to Study Drug|0|||
147594121|NCT01698775|532330602|FG001|Phase A|Kidney [transplant]|1|||
147247762|NCT03098550|531076626|FG002|Overall Study|Adverse Event unrelated to Study Drug|1|||
147247763|NCT03098550|531076624|FG000|Overall Study|Administrative reason by sponsor|0|||
147247764|NCT03098550|531076625|FG001|Overall Study|Administrative reason by sponsor|0|||
147247765|NCT03098550|531076626|FG002|Overall Study|Administrative reason by sponsor|1|||
147247766|NCT03098550|531076624|FG000|Overall Study|Other reasons|2|||
147247767|NCT03098550|531076625|FG001|Overall Study|Other reasons|0|||
147448984|NCT01225731|531808044|FG000|Part 1|Protocol Violation|0|||
147594122|NCT01698775|532330601|FG000|Phase B|Hyperglycemia Discontinuation Criteria|0|||
147188766|NCT03275740|530858055|FG008|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
147188767|NCT03275740|530858056|FG009|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
147188768|NCT03275740|530858057|FG010|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
147188769|NCT03275740|530858058|FG011|Overall Study|due to coronaviras disease 2019 (COVID-19) pandemic|0|||
147188770|NCT03275740|530858047|FG000|Overall Study|Withdrawal by Subject|0|||
147188771|NCT03275740|530858048|FG001|Overall Study|Withdrawal by Subject|0|||
147188772|NCT03275740|530858049|FG002|Overall Study|Withdrawal by Subject|0|||
147188773|NCT03275740|530858050|FG003|Overall Study|Withdrawal by Subject|0|||
147188774|NCT03275740|530858051|FG004|Overall Study|Withdrawal by Subject|0|||
147188775|NCT03275740|530858052|FG005|Overall Study|Withdrawal by Subject|0|||
147188776|NCT03275740|530858053|FG006|Overall Study|Withdrawal by Subject|0|||
147188777|NCT03275740|530858054|FG007|Overall Study|Withdrawal by Subject|0|||
147188778|NCT03275740|530858055|FG008|Overall Study|Withdrawal by Subject|1|||
147188779|NCT03275740|530858056|FG009|Overall Study|Withdrawal by Subject|1|||
147188780|NCT03275740|530858057|FG010|Overall Study|Withdrawal by Subject|0|||
147188781|NCT03275740|530858058|FG011|Overall Study|Withdrawal by Subject|0|||
147188782|NCT00890825|530858059|FG000|Overall Study|Withdrawal by Subject|1|||
147188783|NCT00890825|530858060|FG001|Overall Study|Withdrawal by Subject|0|||
147188784|NCT00890825|530858059|FG000|Overall Study|Alive at data cut off (DCO)|13|||
147188785|NCT00890825|530858060|FG001|Overall Study|Alive at data cut off (DCO)|14|||
147188786|NCT04701333|530858061|FG000|Overall Study|Lost to Follow-up|3|||
147188787|NCT04701333|530858062|FG001|Overall Study|Lost to Follow-up|7|||
147188788|NCT04701333|530858061|FG000|Overall Study|Withdrawal by Subject|0|||
147188789|NCT04701333|530858062|FG001|Overall Study|Withdrawal by Subject|1|||
147188790|NCT02920892|530858063|FG000|Placebo Lead-In Period|Withdrawal by Subject|1|||
147188791|NCT02920892|530858064|FG001|Placebo Lead-In Period|Withdrawal by Subject|0|||
147188792|NCT02920892|530858065|FG002|Placebo Lead-In Period|Withdrawal by Subject|0|||
147188793|NCT02920892|530858063|FG000|Placebo Lead-In Period|Subject Ineligible|6|||
147188794|NCT02920892|530858064|FG001|Placebo Lead-In Period|Subject Ineligible|0|||
147247768|NCT03098550|531076626|FG002|Overall Study|Other reasons|0|||
147247769|NCT01384760|531076628|FG000|Overall Study|Lost to Follow-up|0|||
147247770|NCT01384760|531076629|FG001|Overall Study|Lost to Follow-up|6|||
147247771|NCT01384760|531076628|FG000|Overall Study|Protocol Violation|16|||
147247772|NCT01384760|531076629|FG001|Overall Study|Protocol Violation|0|||
147247773|NCT00630396|531076630|FG000|Overall Study|Death|4|||
147247774|NCT00630396|531076630|FG000|Overall Study|Lost to Follow-up|3|||
147247775|NCT02990910|531076634|FG000|Overall Study|Lack of Efficacy|6|||
147247776|NCT02990910|531076635|FG001|Overall Study|Lack of Efficacy|10|||
147247777|NCT02989194|531076643|FG000|Overall Study|Study on hold for safety and participant was withdrawn|1|||
147247778|NCT02989194|531076644|FG001|Overall Study|Study on hold for safety and participant was withdrawn|0|||
147247779|NCT02989194|531076645|FG002|Overall Study|Study on hold for safety and participant was withdrawn|0|||
147247780|NCT02989194|531076643|FG000|Overall Study|Lost to Follow-up|0|||
147247781|NCT02989194|531076644|FG001|Overall Study|Lost to Follow-up|1|||
147247782|NCT02989194|531076645|FG002|Overall Study|Lost to Follow-up|0|||
147247783|NCT02989194|531076643|FG000|Overall Study|Withdrawal by Subject|0|||
147247784|NCT02989194|531076644|FG001|Overall Study|Withdrawal by Subject|1|||
147247785|NCT02989194|531076645|FG002|Overall Study|Withdrawal by Subject|0|||
147247786|NCT04160091|531076648|FG000|Overall Study|Terminated by Sponsor|7|||
147247787|NCT04160091|531076649|FG001|Overall Study|Terminated by Sponsor|3|||
147247788|NCT04160091|531076650|FG002|Overall Study|Terminated by Sponsor|5|||
147247789|NCT04160091|531076651|FG003|Overall Study|Terminated by Sponsor|2|||
147247790|NCT04160091|531076648|FG000|Overall Study|Noncompliance|0|||
147247791|NCT04160091|531076649|FG001|Overall Study|Noncompliance|0|||
147247792|NCT04160091|531076650|FG002|Overall Study|Noncompliance|0|||
147247793|NCT04160091|531076651|FG003|Overall Study|Noncompliance|1|||
147247794|NCT04160091|531076648|FG000|Overall Study|Withdrawal by Subject|0|||
147247795|NCT04160091|531076649|FG001|Overall Study|Withdrawal by Subject|0|||
147247796|NCT04160091|531076650|FG002|Overall Study|Withdrawal by Subject|0|||
147247797|NCT04160091|531076651|FG003|Overall Study|Withdrawal by Subject|1|||
147247798|NCT00381095|531076654|FG000|Overall Study|Death|3|||
147247799|NCT00381095|531076655|FG001|Overall Study|Death|4|||
147247800|NCT00381095|531076654|FG000|Overall Study|Lack of Efficacy|2|||
147247801|NCT00381095|531076655|FG001|Overall Study|Lack of Efficacy|4|||
147247802|NCT00381095|531076654|FG000|Overall Study|Other|2|||
147247803|NCT00381095|531076655|FG001|Overall Study|Other|2|||
147247804|NCT00381095|531076654|FG000|Overall Study|Protocol Violation|1|||
147247805|NCT00381095|531076655|FG001|Overall Study|Protocol Violation|1|||
147247806|NCT00381095|531076654|FG000|Overall Study|Withdrawal by Subject|3|||
147188795|NCT02920892|530858065|FG002|Placebo Lead-In Period|Subject Ineligible|0|||
147188796|NCT02920892|530858063|FG000|Placebo Lead-In Period|Subject Screen Fail|4|||
147188797|NCT02920892|530858064|FG001|Placebo Lead-In Period|Subject Screen Fail|0|||
147247807|NCT00381095|531076655|FG001|Overall Study|Withdrawal by Subject|3|||
147247808|NCT00381095|531076654|FG000|Overall Study|Adverse Event|2|||
147247809|NCT00381095|531076655|FG001|Overall Study|Adverse Event|7|||
147188798|NCT02920892|530858065|FG002|Placebo Lead-In Period|Subject Screen Fail|0|||
147329909|NCT00686517|531373087|FG000|Treatment|Poor Protocol Compliance|1|||
147329910|NCT00686517|531373088|FG001|Treatment|Poor Protocol Compliance|0|||
147188799|NCT02920892|530858063|FG000|Placebo-Controlled Period|Withdrawal by Subject|0|||
147188800|NCT02920892|530858064|FG001|Placebo-Controlled Period|Withdrawal by Subject|3|||
147188801|NCT02920892|530858065|FG002|Placebo-Controlled Period|Withdrawal by Subject|5|||
147329911|NCT00686517|531373089|FG002|Treatment|Poor Protocol Compliance|0|||
147329912|NCT00686517|531373087|FG000|Treatment|Protocol Violation|2|||
147329913|NCT00686517|531373088|FG001|Treatment|Protocol Violation|1|||
147329914|NCT00686517|531373089|FG002|Treatment|Protocol Violation|0|||
147329915|NCT01693614|531373092|FG000|Overall Study|Adverse Event|7|||
147329916|NCT01693614|531373093|FG001|Overall Study|Adverse Event|11|||
147329917|NCT01693614|531373094|FG002|Overall Study|Adverse Event|5|||
147329918|NCT01693614|531373092|FG000|Overall Study|Disease progression|11|||
147329919|NCT01693614|531373093|FG001|Overall Study|Disease progression|8|||
147329920|NCT01693614|531373094|FG002|Overall Study|Disease progression|7|||
147329921|NCT01693614|531373092|FG000|Overall Study|Protocol Violation|5|||
147329922|NCT01693614|531373093|FG001|Overall Study|Protocol Violation|2|||
147329923|NCT01693614|531373094|FG002|Overall Study|Protocol Violation|1|||
147329924|NCT01693614|531373092|FG000|Overall Study|Death|1|||
147329925|NCT01693614|531373093|FG001|Overall Study|Death|0|||
147329926|NCT01693614|531373094|FG002|Overall Study|Death|0|||
147329927|NCT01693614|531373092|FG000|Overall Study|Physician Decision|1|||
147329928|NCT01693614|531373093|FG001|Overall Study|Physician Decision|1|||
147329929|NCT01693614|531373094|FG002|Overall Study|Physician Decision|4|||
147329930|NCT01693614|531373092|FG000|Overall Study|Withdrawal by subject/guardian|0|||
147329931|NCT01693614|531373093|FG001|Overall Study|Withdrawal by subject/guardian|0|||
147329932|NCT01693614|531373094|FG002|Overall Study|Withdrawal by subject/guardian|2|||
147329933|NCT01693614|531373092|FG000|Overall Study|Withdrawal by Subject|1|||
147329934|NCT01693614|531373093|FG001|Overall Study|Withdrawal by Subject|0|||
147329935|NCT01693614|531373094|FG002|Overall Study|Withdrawal by Subject|5|||
147329936|NCT00420316|531373097|FG000|Overall Study|Withdrawal by Subject|0|||
147188802|NCT02920892|530858063|FG000|Placebo-Controlled Period|Physician Decision|0|||
147188803|NCT02920892|530858064|FG001|Placebo-Controlled Period|Physician Decision|0|||
147188804|NCT02920892|530858065|FG002|Placebo-Controlled Period|Physician Decision|1|||
147188805|NCT02920892|530858063|FG000|Placebo-Controlled Period|Lost to Follow-up|0|||
147188806|NCT02920892|530858064|FG001|Placebo-Controlled Period|Lost to Follow-up|0|||
147188807|NCT02920892|530858065|FG002|Placebo-Controlled Period|Lost to Follow-up|1|||
147247810|NCT02692716|531076656|FG000|Overall Study|Lost to Follow-up|2|||
147247811|NCT02692716|531076657|FG001|Overall Study|Lost to Follow-up|5|||
147247812|NCT02692716|531076656|FG000|Overall Study|Withdrawal by Subject|3|||
147247813|NCT02692716|531076657|FG001|Overall Study|Withdrawal by Subject|1|||
147247814|NCT00856284|531076658|FG000|Overall Study|Hyperglycemic rescue|231|||
147329937|NCT00420316|531373098|FG001|Overall Study|Withdrawal by Subject|1|||
147329938|NCT00420316|531373097|FG000|Overall Study|Lost to Follow-up|12|||
147329939|NCT00420316|531373098|FG001|Overall Study|Lost to Follow-up|8|||
147329940|NCT02281318|531373099|FG000|Overall Study|Adverse Event|2|||
147329941|NCT02281318|531373100|FG001|Overall Study|Adverse Event|2|||
147329942|NCT02281318|531373099|FG000|Overall Study|Lack of Efficacy|2|||
147329943|NCT02281318|531373100|FG001|Overall Study|Lack of Efficacy|0|||
147329944|NCT02281318|531373099|FG000|Overall Study|Lost to Follow-up|2|||
147329945|NCT02281318|531373100|FG001|Overall Study|Lost to Follow-up|1|||
147329946|NCT02281318|531373099|FG000|Overall Study|Physician Decision|2|||
147329947|NCT02281318|531373100|FG001|Overall Study|Physician Decision|0|||
147329948|NCT02281318|531373099|FG000|Overall Study|Withdrawal by Subject|6|||
147329949|NCT02281318|531373100|FG001|Overall Study|Withdrawal by Subject|2|||
147329950|NCT01281813|531373101|FG000|Overall Study|Adverse Event|0|||
147329951|NCT01281813|531373102|FG001|Overall Study|Adverse Event|0|||
147448985|NCT01225731|531808045|FG001|Part 1|Protocol Violation|0|||
147188808|NCT02920892|530858063|FG000|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
147247815|NCT00856284|531076659|FG001|Overall Study|Hyperglycemic rescue|201|||
147188809|NCT02920892|530858064|FG001|Open-Label Extension (OLE) Period|Withdrawal by Subject|5|||
147247816|NCT00856284|531076660|FG002|Overall Study|Hyperglycemic rescue|235|||
147247817|NCT00856284|531076658|FG000|Overall Study|Adverse Event|60|||
147247818|NCT00856284|531076659|FG001|Overall Study|Adverse Event|74|||
147247819|NCT00856284|531076660|FG002|Overall Study|Adverse Event|82|||
147247820|NCT00856284|531076658|FG000|Overall Study|Major protocol deviation|24|||
147329952|NCT01281813|531373103|FG002|Overall Study|Adverse Event|10|||
147329953|NCT01281813|531373101|FG000|Overall Study|Lost to Follow-up|0|||
147329954|NCT01281813|531373102|FG001|Overall Study|Lost to Follow-up|0|||
147329955|NCT01281813|531373103|FG002|Overall Study|Lost to Follow-up|31|||
147329956|NCT01281813|531373101|FG000|Overall Study|Withdrawal by Subject|0|||
147329957|NCT01281813|531373102|FG001|Overall Study|Withdrawal by Subject|0|||
147329958|NCT01281813|531373103|FG002|Overall Study|Withdrawal by Subject|13|||
147329959|NCT01281813|531373101|FG000|Overall Study|Subject Non-Compliant|0|||
147329960|NCT01281813|531373102|FG001|Overall Study|Subject Non-Compliant|0|||
147329961|NCT01281813|531373103|FG002|Overall Study|Subject Non-Compliant|6|||
147329962|NCT01281813|531373101|FG000|Overall Study|Subject Reached A Virologic Endpoint|0|||
147188810|NCT02920892|530858065|FG002|Open-Label Extension (OLE) Period|Withdrawal by Subject|2|||
147188811|NCT02920892|530858063|FG000|Open-Label Extension (OLE) Period|Study Drug Expiration|0|||
147188812|NCT02920892|530858064|FG001|Open-Label Extension (OLE) Period|Study Drug Expiration|4|||
147188813|NCT02920892|530858065|FG002|Open-Label Extension (OLE) Period|Study Drug Expiration|2|||
147188814|NCT00377520|530858072|FG000|Overall Study|Ineligible (Prior radiation)|1|||
147188815|NCT00660192|530858073|FG000|Overall Study|Lost to Follow-up|2|||
147188816|NCT00660192|530858074|FG001|Overall Study|Lost to Follow-up|3|||
147188817|NCT04908397|530858075|FG000|Overall Study|Withdrawal by Subject|2|||
147188818|NCT00462306|530858076|FG000|Overall Study|insufficient data|0|||
147188819|NCT00462306|530858077|FG001|Overall Study|insufficient data|13|||
147188820|NCT03515824|530858078|FG000|Overall Study|Death|3|||
147188821|NCT03515824|530858079|FG001|Overall Study|Death|2|||
147188822|NCT03515824|530858080|FG002|Overall Study|Death|6|||
147188823|NCT03515824|530858081|FG003|Overall Study|Death|0|||
147188824|NCT03515824|530858078|FG000|Overall Study|Lost to Follow-up|0|||
147188825|NCT03515824|530858079|FG001|Overall Study|Lost to Follow-up|1|||
147188826|NCT03515824|530858080|FG002|Overall Study|Lost to Follow-up|1|||
147188827|NCT03515824|530858081|FG003|Overall Study|Lost to Follow-up|0|||
147188828|NCT03515824|530858078|FG000|Overall Study|Study terminated by sponsor|0|||
147188829|NCT03515824|530858079|FG001|Overall Study|Study terminated by sponsor|1|||
147188830|NCT03515824|530858080|FG002|Overall Study|Study terminated by sponsor|6|||
147188831|NCT03515824|530858081|FG003|Overall Study|Study terminated by sponsor|0|||
147188832|NCT03515824|530858078|FG000|Overall Study|Status not recorded|0|||
147188833|NCT03515824|530858079|FG001|Overall Study|Status not recorded|0|||
147188834|NCT03515824|530858080|FG002|Overall Study|Status not recorded|2|||
147188835|NCT03515824|530858081|FG003|Overall Study|Status not recorded|0|||
147188836|NCT00920855|530858082|FG000|Overall Study|Adverse Event|1|||
147188837|NCT00920855|530858083|FG001|Overall Study|Adverse Event|1|||
147188838|NCT00920855|530858084|FG002|Overall Study|Adverse Event|4|||
147188839|NCT00920855|530858082|FG000|Overall Study|Withdrawal by Subject|2|||
147188840|NCT00920855|530858083|FG001|Overall Study|Withdrawal by Subject|1|||
147188841|NCT00920855|530858084|FG002|Overall Study|Withdrawal by Subject|6|||
147188842|NCT00920855|530858082|FG000|Overall Study|Disease progression|2|||
147188843|NCT00920855|530858083|FG001|Overall Study|Disease progression|1|||
147188844|NCT00920855|530858084|FG002|Overall Study|Disease progression|10|||
147188845|NCT00920855|530858082|FG000|Overall Study|Noncompliance to study medication|0|||
147188846|NCT00920855|530858083|FG001|Overall Study|Noncompliance to study medication|0|||
147188847|NCT00920855|530858084|FG002|Overall Study|Noncompliance to study medication|1|||
147188848|NCT00920855|530858082|FG000|Overall Study|Response plateau; started maintenance|0|||
147188849|NCT00920855|530858083|FG001|Overall Study|Response plateau; started maintenance|0|||
147247821|NCT00856284|531076659|FG001|Overall Study|Major protocol deviation|16|||
147247822|NCT00856284|531076660|FG002|Overall Study|Major protocol deviation|15|||
147247823|NCT00856284|531076658|FG000|Overall Study|Lost to Follow-up|20|||
147247824|NCT00856284|531076659|FG001|Overall Study|Lost to Follow-up|22|||
147247825|NCT00856284|531076660|FG002|Overall Study|Lost to Follow-up|28|||
147247826|NCT00856284|531076658|FG000|Overall Study|Voluntary withdrawal|48|||
147247827|NCT00856284|531076659|FG001|Overall Study|Voluntary withdrawal|52|||
147247828|NCT00856284|531076660|FG002|Overall Study|Voluntary withdrawal|62|||
147247829|NCT00856284|531076658|FG000|Overall Study|Pregnancy|1|||
147247830|NCT00856284|531076659|FG001|Overall Study|Pregnancy|2|||
147247831|NCT00856284|531076660|FG002|Overall Study|Pregnancy|0|||
147247832|NCT00856284|531076658|FG000|Overall Study|Investigator discretion|9|||
147247833|NCT00856284|531076659|FG001|Overall Study|Investigator discretion|8|||
147247834|NCT00856284|531076660|FG002|Overall Study|Investigator discretion|10|||
147247835|NCT00856284|531076658|FG000|Overall Study|Other|15|||
147247836|NCT00856284|531076659|FG001|Overall Study|Other|17|||
147247837|NCT00856284|531076660|FG002|Overall Study|Other|14|||
147247838|NCT00856284|531076658|FG000|Overall Study|Randomized in error|0|||
147247839|NCT00856284|531076659|FG001|Overall Study|Randomized in error|0|||
147247840|NCT00856284|531076660|FG002|Overall Study|Randomized in error|1|||
147247841|NCT04271605|531076661|FG000|Overall Study|The study was terminated because of the duration of funding was only one year.|5|||
147247842|NCT02485301|531076662|FG000|Overall Study|Serious Adverse Events|2|||
147247843|NCT02485301|531076663|FG001|Overall Study|Serious Adverse Events|1|||
147247844|NCT02485301|531076662|FG000|Overall Study|Protocol Violation|0|||
147247845|NCT02485301|531076663|FG001|Overall Study|Protocol Violation|1|||
147247846|NCT02485301|531076662|FG000|Overall Study|Withdrawal by Subject|6|||
147247847|NCT02485301|531076663|FG001|Overall Study|Withdrawal by Subject|7|||
147247848|NCT02485301|531076662|FG000|Overall Study|Migrated/moved from study area|10|||
147247849|NCT02485301|531076663|FG001|Overall Study|Migrated/moved from study area|19|||
147247850|NCT02485301|531076662|FG000|Overall Study|Lost to Follow-up|17|||
147247851|NCT02485301|531076663|FG001|Overall Study|Lost to Follow-up|17|||
147247852|NCT02485301|531076662|FG000|Overall Study|Other|3|||
147247853|NCT02485301|531076663|FG001|Overall Study|Other|4|||
147247854|NCT01059825|531076664|FG000|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
147247855|NCT01059825|531076665|FG001|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
147247856|NCT01059825|531076666|FG002|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
147448986|NCT01225731|531808046|FG002|Part 1|Protocol Violation|0|||
147329963|NCT01281813|531373102|FG001|Overall Study|Subject Reached A Virologic Endpoint|0|||
147329964|NCT01281813|531373103|FG002|Overall Study|Subject Reached A Virologic Endpoint|5|||
147329965|NCT01281813|531373101|FG000|Overall Study|Sponsor's Decision|4|||
147329966|NCT01281813|531373102|FG001|Overall Study|Sponsor's Decision|3|||
147329967|NCT01281813|531373103|FG002|Overall Study|Sponsor's Decision|7|||
147329968|NCT01281813|531373101|FG000|Overall Study|Switched to Commercially Available Medication|0|||
147188850|NCT00920855|530858084|FG002|Overall Study|Response plateau; started maintenance|1|||
147188851|NCT00539994|530858085|FG000|Overall Study|Lost to Follow-up|2|||
147188852|NCT00539994|530858086|FG001|Overall Study|Lost to Follow-up|1|||
147188853|NCT00539994|530858087|FG002|Overall Study|Lost to Follow-up|0|||
147188854|NCT00539994|530858085|FG000|Overall Study|Withdrawal by Subject|1|||
147188855|NCT00539994|530858086|FG001|Overall Study|Withdrawal by Subject|0|||
147188856|NCT00539994|530858087|FG002|Overall Study|Withdrawal by Subject|1|||
147188857|NCT00539994|530858085|FG000|Overall Study|Physician Decision|0|||
147188858|NCT00539994|530858086|FG001|Overall Study|Physician Decision|0|||
147188859|NCT00539994|530858087|FG002|Overall Study|Physician Decision|1|||
147188860|NCT00510835|530858091|FG000|Overall Study|Withdrawal by Subject|6|||
147188861|NCT00510835|530858092|FG001|Overall Study|Withdrawal by Subject|2|||
147188862|NCT00510835|530858093|FG002|Overall Study|Withdrawal by Subject|2|||
147188863|NCT05470985|530858094|FG000|Double Blind Treatment Period|Study terminated by sponsor|1|||
147188864|NCT05470985|530858095|FG001|Double Blind Treatment Period|Study terminated by sponsor|0|||
147188865|NCT05470985|530858094|FG000|Double Blind Treatment Period|Physician Decision|0|||
147188866|NCT05470985|530858095|FG001|Double Blind Treatment Period|Physician Decision|1|||
147188867|NCT05470985|530858094|FG000|Long Term Extension|Adverse Event|0|||
147188868|NCT05470985|530858095|FG001|Long Term Extension|Adverse Event|1|||
147188869|NCT05470985|530858094|FG000|Long Term Extension|Study terminated by sponsor|2|||
147188870|NCT05470985|530858095|FG001|Long Term Extension|Study terminated by sponsor|0|||
147188871|NCT01917747|530858096|FG000|Overall Study|Withdrawal by Subject|1|||
147188872|NCT01917747|530858097|FG001|Overall Study|Withdrawal by Subject|2|||
147188873|NCT01917747|530858096|FG000|Overall Study|Lost to Follow-up|18|||
147188874|NCT01917747|530858097|FG001|Overall Study|Lost to Follow-up|9|||
147188875|NCT02741245|530858099|FG000|Overall Study|Adverse Event|0|||
147188876|NCT02741245|530858100|FG001|Overall Study|Adverse Event|0|||
147188877|NCT02741245|530858101|FG002|Overall Study|Adverse Event|0|||
147188878|NCT02741245|530858102|FG003|Overall Study|Adverse Event|2|||
147188879|NCT02741245|530858103|FG004|Overall Study|Adverse Event|2|||
147188880|NCT02741245|530858099|FG000|Overall Study|Protocol Violation|0|||
147188881|NCT02741245|530858100|FG001|Overall Study|Protocol Violation|1|||
147188882|NCT02741245|530858101|FG002|Overall Study|Protocol Violation|0|||
147188883|NCT02741245|530858102|FG003|Overall Study|Protocol Violation|1|||
147188884|NCT02741245|530858103|FG004|Overall Study|Protocol Violation|0|||
147188885|NCT02741245|530858099|FG000|Overall Study|Withdrawal by Subject|0|||
147188886|NCT02741245|530858100|FG001|Overall Study|Withdrawal by Subject|0|||
147188887|NCT02741245|530858101|FG002|Overall Study|Withdrawal by Subject|0|||
147188888|NCT02741245|530858102|FG003|Overall Study|Withdrawal by Subject|1|||
147188889|NCT02741245|530858103|FG004|Overall Study|Withdrawal by Subject|0|||
147188890|NCT01787461|530858105|FG000|Overall Study|Adverse Event|4|||
147188891|NCT01787461|530858106|FG001|Overall Study|Adverse Event|3|||
147188892|NCT01787461|530858105|FG000|Overall Study|Lost to Follow-up|3|||
147188893|NCT01787461|530858106|FG001|Overall Study|Lost to Follow-up|2|||
147188894|NCT01787461|530858105|FG000|Overall Study|No longer met eligibility criteria|1|||
147188895|NCT01787461|530858106|FG001|Overall Study|No longer met eligibility criteria|0|||
147188896|NCT01787461|530858105|FG000|Overall Study|Withdrawal by Subject|3|||
147188897|NCT01787461|530858106|FG001|Overall Study|Withdrawal by Subject|4|||
147188898|NCT01787461|530858105|FG000|Overall Study|Protocol Violation|3|||
147188899|NCT01787461|530858106|FG001|Overall Study|Protocol Violation|0|||
147188900|NCT03253679|530858107|FG000|Overall Study|Screen Failure|1|||
147188901|NCT04816214|530858109|FG000|Overall Study|Progressive Disease|4|||
147188902|NCT04816214|530858110|FG001|Overall Study|Progressive Disease|0|||
147188903|NCT04816214|530858111|FG002|Overall Study|Progressive Disease|0|||
147188904|NCT04816214|530858109|FG000|Overall Study|Death|1|||
147188905|NCT04816214|530858110|FG001|Overall Study|Death|0|||
147188906|NCT04816214|530858111|FG002|Overall Study|Death|0|||
147188907|NCT04816214|530858109|FG000|Overall Study|Study Terminated by Sponsor|1|||
147188908|NCT04816214|530858110|FG001|Overall Study|Study Terminated by Sponsor|0|||
147188909|NCT04816214|530858111|FG002|Overall Study|Study Terminated by Sponsor|0|||
147188910|NCT02586623|530858112|FG000|Open-Label (Up to 16 Weeks)|Adverse Event|53|||
147188911|NCT02586623|530858113|FG001|Open-Label (Up to 16 Weeks)|Adverse Event|0|||
147188912|NCT02586623|530858114|FG002|Open-Label (Up to 16 Weeks)|Adverse Event|0|||
147188913|NCT02586623|530858112|FG000|Open-Label (Up to 16 Weeks)|Lost to Follow-up|4|||
147188914|NCT02586623|530858113|FG001|Open-Label (Up to 16 Weeks)|Lost to Follow-up|0|||
147188915|NCT02586623|530858114|FG002|Open-Label (Up to 16 Weeks)|Lost to Follow-up|0|||
147188916|NCT02586623|530858112|FG000|Open-Label (Up to 16 Weeks)|Non-Compliance|6|||
147188917|NCT02586623|530858113|FG001|Open-Label (Up to 16 Weeks)|Non-Compliance|0|||
147188918|NCT02586623|530858114|FG002|Open-Label (Up to 16 Weeks)|Non-Compliance|0|||
147188919|NCT02586623|530858112|FG000|Open-Label (Up to 16 Weeks)|Physician Decision|11|||
147188920|NCT02586623|530858113|FG001|Open-Label (Up to 16 Weeks)|Physician Decision|0|||
147188921|NCT02586623|530858114|FG002|Open-Label (Up to 16 Weeks)|Physician Decision|0|||
147188922|NCT02586623|530858112|FG000|Open-Label (Up to 16 Weeks)|Protocol Violation|9|||
147188923|NCT02586623|530858113|FG001|Open-Label (Up to 16 Weeks)|Protocol Violation|0|||
147188924|NCT02586623|530858114|FG002|Open-Label (Up to 16 Weeks)|Protocol Violation|0|||
147188925|NCT02586623|530858112|FG000|Open-Label (Up to 16 Weeks)|Withdrawal by Subject|56|||
147188926|NCT02586623|530858113|FG001|Open-Label (Up to 16 Weeks)|Withdrawal by Subject|0|||
147188927|NCT02586623|530858114|FG002|Open-Label (Up to 16 Weeks)|Withdrawal by Subject|0|||
147188928|NCT02586623|530858112|FG000|Open-Label (Up to 16 Weeks)|Did not meet Open-label entry criteria|30|||
147188929|NCT02586623|530858113|FG001|Open-Label (Up to 16 Weeks)|Did not meet Open-label entry criteria|0|||
147188930|NCT02586623|530858114|FG002|Open-Label (Up to 16 Weeks)|Did not meet Open-label entry criteria|0|||
147188931|NCT02586623|530858112|FG000|Open-Label (Up to 16 Weeks)|Did not meet Randomization Criteria|17|||
147188932|NCT02586623|530858113|FG001|Open-Label (Up to 16 Weeks)|Did not meet Randomization Criteria|0|||
147188933|NCT02586623|530858114|FG002|Open-Label (Up to 16 Weeks)|Did not meet Randomization Criteria|0|||
147188934|NCT02586623|530858112|FG000|Open-Label (Up to 16 Weeks)|Incorrect signing of ICF|2|||
147188935|NCT02586623|530858113|FG001|Open-Label (Up to 16 Weeks)|Incorrect signing of ICF|0|||
147188936|NCT02586623|530858114|FG002|Open-Label (Up to 16 Weeks)|Incorrect signing of ICF|0|||
147188937|NCT02586623|530858112|FG000|Open-Label (Up to 16 Weeks)|Met stopping criteria|4|||
147188938|NCT02586623|530858113|FG001|Open-Label (Up to 16 Weeks)|Met stopping criteria|0|||
147188939|NCT02586623|530858114|FG002|Open-Label (Up to 16 Weeks)|Met stopping criteria|0|||
147188940|NCT02586623|530858112|FG000|Open-Label (Up to 16 Weeks)|Sponsor request to withdraw|3|||
147188941|NCT02586623|530858113|FG001|Open-Label (Up to 16 Weeks)|Sponsor request to withdraw|0|||
147188942|NCT02586623|530858114|FG002|Open-Label (Up to 16 Weeks)|Sponsor request to withdraw|0|||
147188943|NCT02586623|530858112|FG000|Open-Label (Up to 16 Weeks)|Discontinued per medical monitor request|2|||
147188944|NCT02586623|530858113|FG001|Open-Label (Up to 16 Weeks)|Discontinued per medical monitor request|0|||
147188945|NCT02586623|530858114|FG002|Open-Label (Up to 16 Weeks)|Discontinued per medical monitor request|0|||
147188946|NCT02586623|530858112|FG000|Open-Label (Up to 16 Weeks)|Site closing|3|||
147188947|NCT02586623|530858113|FG001|Open-Label (Up to 16 Weeks)|Site closing|0|||
147188948|NCT02586623|530858114|FG002|Open-Label (Up to 16 Weeks)|Site closing|0|||
147188949|NCT02586623|530858112|FG000|Double-Blind (Up to 12 Weeks)|Adverse Event|0|||
147188950|NCT02586623|530858113|FG001|Double-Blind (Up to 12 Weeks)|Adverse Event|6|||
147188951|NCT02586623|530858114|FG002|Double-Blind (Up to 12 Weeks)|Adverse Event|4|||
147188952|NCT02586623|530858112|FG000|Double-Blind (Up to 12 Weeks)|Lost to Follow-up|0|||
147188953|NCT02586623|530858113|FG001|Double-Blind (Up to 12 Weeks)|Lost to Follow-up|1|||
147188954|NCT02586623|530858114|FG002|Double-Blind (Up to 12 Weeks)|Lost to Follow-up|2|||
147188955|NCT02586623|530858112|FG000|Double-Blind (Up to 12 Weeks)|Non-compliance|0|||
147188956|NCT02586623|530858113|FG001|Double-Blind (Up to 12 Weeks)|Non-compliance|1|||
147188957|NCT02586623|530858114|FG002|Double-Blind (Up to 12 Weeks)|Non-compliance|1|||
147188958|NCT02586623|530858112|FG000|Double-Blind (Up to 12 Weeks)|Physician Decision|0|||
147188959|NCT02586623|530858113|FG001|Double-Blind (Up to 12 Weeks)|Physician Decision|0|||
147188960|NCT02586623|530858114|FG002|Double-Blind (Up to 12 Weeks)|Physician Decision|1|||
147188961|NCT02586623|530858112|FG000|Double-Blind (Up to 12 Weeks)|Protocol Violation|0|||
147188962|NCT02586623|530858113|FG001|Double-Blind (Up to 12 Weeks)|Protocol Violation|3|||
147188963|NCT02586623|530858114|FG002|Double-Blind (Up to 12 Weeks)|Protocol Violation|0|||
147188964|NCT02586623|530858112|FG000|Double-Blind (Up to 12 Weeks)|Withdrawal by Subject|0|||
147188965|NCT02586623|530858113|FG001|Double-Blind (Up to 12 Weeks)|Withdrawal by Subject|6|||
147188966|NCT02586623|530858114|FG002|Double-Blind (Up to 12 Weeks)|Withdrawal by Subject|5|||
147188967|NCT02586623|530858112|FG000|Double-Blind (Up to 12 Weeks)|Met the need for intervention criteria|0|||
147188968|NCT02586623|530858113|FG001|Double-Blind (Up to 12 Weeks)|Met the need for intervention criteria|31|||
147188969|NCT02586623|530858114|FG002|Double-Blind (Up to 12 Weeks)|Met the need for intervention criteria|27|||
147188970|NCT02586623|530858112|FG000|Double-Blind (Up to 12 Weeks)|Did not meet randomization criteria|0|||
147188971|NCT02586623|530858113|FG001|Double-Blind (Up to 12 Weeks)|Did not meet randomization criteria|1|||
147188972|NCT02586623|530858114|FG002|Double-Blind (Up to 12 Weeks)|Did not meet randomization criteria|0|||
147188973|NCT05051579|530858118|FG000|Overall Study|Withdrawal by Subject|3|||
147188974|NCT05051579|530858119|FG001|Overall Study|Withdrawal by Subject|5|||
147188975|NCT05051579|530858120|FG002|Overall Study|Withdrawal by Subject|2|||
147188976|NCT05051579|530858121|FG003|Overall Study|Withdrawal by Subject|1|||
147188977|NCT05051579|530858122|FG004|Overall Study|Withdrawal by Subject|4|||
147188978|NCT05051579|530858123|FG005|Overall Study|Withdrawal by Subject|0|||
147188979|NCT05051579|530858124|FG006|Overall Study|Withdrawal by Subject|4|||
147188980|NCT05051579|530858118|FG000|Overall Study|Lost to Follow-up|1|||
147188981|NCT05051579|530858119|FG001|Overall Study|Lost to Follow-up|0|||
147188982|NCT05051579|530858120|FG002|Overall Study|Lost to Follow-up|0|||
147188983|NCT05051579|530858121|FG003|Overall Study|Lost to Follow-up|0|||
147188984|NCT05051579|530858122|FG004|Overall Study|Lost to Follow-up|1|||
147188985|NCT05051579|530858123|FG005|Overall Study|Lost to Follow-up|0|||
147188986|NCT05051579|530858124|FG006|Overall Study|Lost to Follow-up|1|||
147188987|NCT05051579|530858118|FG000|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
147188988|NCT05051579|530858119|FG001|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
147188989|NCT05051579|530858120|FG002|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
147188990|NCT05051579|530858121|FG003|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
147188991|NCT05051579|530858122|FG004|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
147188992|NCT05051579|530858123|FG005|Overall Study|Subject Unable to Visit Due to Working Out of Town|0|||
147188993|NCT05051579|530858124|FG006|Overall Study|Subject Unable to Visit Due to Working Out of Town|1|||
147188994|NCT05051579|530858118|FG000|Overall Study|Adverse Event|2|||
147188995|NCT05051579|530858119|FG001|Overall Study|Adverse Event|1|||
147188996|NCT05051579|530858120|FG002|Overall Study|Adverse Event|0|||
147188997|NCT05051579|530858121|FG003|Overall Study|Adverse Event|4|||
147188998|NCT05051579|530858122|FG004|Overall Study|Adverse Event|1|||
147188999|NCT05051579|530858123|FG005|Overall Study|Adverse Event|2|||
147189000|NCT05051579|530858124|FG006|Overall Study|Adverse Event|0|||
147189001|NCT05051579|530858118|FG000|Overall Study|Inadvertent Enrollment|0|||
147189002|NCT05051579|530858119|FG001|Overall Study|Inadvertent Enrollment|0|||
147189003|NCT05051579|530858120|FG002|Overall Study|Inadvertent Enrollment|0|||
147189004|NCT05051579|530858121|FG003|Overall Study|Inadvertent Enrollment|0|||
147189005|NCT05051579|530858122|FG004|Overall Study|Inadvertent Enrollment|0|||
147189006|NCT05051579|530858123|FG005|Overall Study|Inadvertent Enrollment|0|||
147189007|NCT05051579|530858124|FG006|Overall Study|Inadvertent Enrollment|1|||
147189008|NCT05051579|530858118|FG000|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
147189009|NCT05051579|530858119|FG001|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|1|||
147189010|NCT05051579|530858120|FG002|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
147189011|NCT05051579|530858121|FG003|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
147189012|NCT05051579|530858122|FG004|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
147189013|NCT05051579|530858123|FG005|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
147189014|NCT05051579|530858124|FG006|Overall Study|Subject Could not Tolerate Investigational Product (IP) and was Taken Off|0|||
147189015|NCT05051579|530858118|FG000|Overall Study|Sponsor Decision|0|||
147189016|NCT05051579|530858119|FG001|Overall Study|Sponsor Decision|0|||
147189017|NCT05051579|530858120|FG002|Overall Study|Sponsor Decision|0|||
147189018|NCT05051579|530858121|FG003|Overall Study|Sponsor Decision|0|||
147189019|NCT05051579|530858122|FG004|Overall Study|Sponsor Decision|1|||
147189020|NCT05051579|530858123|FG005|Overall Study|Sponsor Decision|0|||
147189021|NCT05051579|530858124|FG006|Overall Study|Sponsor Decision|0|||
147189022|NCT05051579|530858118|FG000|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
147189023|NCT05051579|530858119|FG001|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
147189024|NCT05051579|530858120|FG002|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
147189025|NCT05051579|530858121|FG003|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
147189026|NCT05051579|530858122|FG004|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|1|||
147189027|NCT05051579|530858123|FG005|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
147189028|NCT05051579|530858124|FG006|Overall Study|Patient was Initially Long Term Follow-up But Contacted and came to Site After Follow-up|0|||
147189029|NCT04332107|530858130|FG000|Day 3|Lost to Follow-up|23|||
147189030|NCT04332107|530858131|FG001|Day 3|Lost to Follow-up|14|||
147189031|NCT04332107|530858130|FG000|Day 3|Missing outcome data|3|||
147189032|NCT04332107|530858131|FG001|Day 3|Missing outcome data|6|||
147189033|NCT04332107|530858130|FG000|Day 14|Lost to Follow-up|13|||
147189034|NCT04332107|530858131|FG001|Day 14|Lost to Follow-up|4|||
147189035|NCT04332107|530858130|FG000|Day 14|Missing outcome data|4|||
147189036|NCT04332107|530858131|FG001|Day 14|Missing outcome data|4|||
147189037|NCT04332107|530858130|FG000|Day 21|Lost to Follow-up|10|||
147189038|NCT04332107|530858131|FG001|Day 21|Lost to Follow-up|2|||
147189039|NCT00717249|530858132|FG000|Overall Study|Lens Discomfort|4|||
147189040|NCT00717249|530858133|FG001|Overall Study|Lens Discomfort|1|||
147189041|NCT00717249|530858132|FG000|Overall Study|Unsatisfactory visual Response|0|||
147189042|NCT00717249|530858133|FG001|Overall Study|Unsatisfactory visual Response|2|||
147189043|NCT00717249|530858132|FG000|Overall Study|Adverse Event|4|||
147189044|NCT00717249|530858133|FG001|Overall Study|Adverse Event|2|||
147189045|NCT00717249|530858132|FG000|Overall Study|Lost to Follow-up|2|||
147247857|NCT01059825|531076667|FG003|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
147247858|NCT01059825|531076668|FG004|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
147189046|NCT00717249|530858133|FG001|Overall Study|Lost to Follow-up|0|||
147189047|NCT00717249|530858132|FG000|Overall Study|Withdrawal by Subject|1|||
147189048|NCT00717249|530858133|FG001|Overall Study|Withdrawal by Subject|2|||
147189049|NCT00717249|530858132|FG000|Overall Study|Pregnancy|6|||
147189050|NCT00717249|530858133|FG001|Overall Study|Pregnancy|3|||
147189051|NCT00717249|530858132|FG000|Overall Study|Protocol Violation|0|||
147189052|NCT00717249|530858133|FG001|Overall Study|Protocol Violation|2|||
147189053|NCT00717249|530858132|FG000|Overall Study|Subject became Ineligible|1|||
147189054|NCT00717249|530858133|FG001|Overall Study|Subject became Ineligible|1|||
147247859|NCT01059825|531076669|FG005|Enrolled, Run-in Period|Adverse event not related to study drug|0|||
147247860|NCT01059825|531076670|FG006|Enrolled, Run-in Period|Adverse event not related to study drug|3|||
147247861|NCT01059825|531076664|FG000|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
147247862|NCT01059825|531076665|FG001|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
147247863|NCT01059825|531076666|FG002|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
147247864|NCT01059825|531076667|FG003|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
147247865|NCT01059825|531076668|FG004|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
147247866|NCT01059825|531076669|FG005|Enrolled, Run-in Period|Did not meet entrance criteria|0|||
147247867|NCT01059825|531076670|FG006|Enrolled, Run-in Period|Did not meet entrance criteria|14|||
147247868|NCT01059825|531076664|FG000|Enrolled, Run-in Period|Lost to Follow-up|0|||
147247869|NCT01059825|531076665|FG001|Enrolled, Run-in Period|Lost to Follow-up|0|||
147247870|NCT01059825|531076666|FG002|Enrolled, Run-in Period|Lost to Follow-up|0|||
147247871|NCT01059825|531076667|FG003|Enrolled, Run-in Period|Lost to Follow-up|0|||
147247872|NCT01059825|531076668|FG004|Enrolled, Run-in Period|Lost to Follow-up|0|||
147247873|NCT01059825|531076669|FG005|Enrolled, Run-in Period|Lost to Follow-up|0|||
147247874|NCT01059825|531076670|FG006|Enrolled, Run-in Period|Lost to Follow-up|5|||
147247875|NCT01059825|531076664|FG000|Enrolled, Run-in Period|Withdrawal by Subject|0|||
147247876|NCT01059825|531076665|FG001|Enrolled, Run-in Period|Withdrawal by Subject|0|||
147247877|NCT01059825|531076666|FG002|Enrolled, Run-in Period|Withdrawal by Subject|0|||
147247878|NCT01059825|531076667|FG003|Enrolled, Run-in Period|Withdrawal by Subject|0|||
147247879|NCT01059825|531076668|FG004|Enrolled, Run-in Period|Withdrawal by Subject|0|||
147247880|NCT01059825|531076669|FG005|Enrolled, Run-in Period|Withdrawal by Subject|0|||
147247881|NCT01059825|531076670|FG006|Enrolled, Run-in Period|Withdrawal by Subject|13|||
147247882|NCT01059825|531076664|FG000|Enrolled, Run-in Period|Other reason not specified|0|||
147247883|NCT01059825|531076665|FG001|Enrolled, Run-in Period|Other reason not specified|0|||
147247884|NCT01059825|531076666|FG002|Enrolled, Run-in Period|Other reason not specified|0|||
147247885|NCT01059825|531076667|FG003|Enrolled, Run-in Period|Other reason not specified|0|||
147247886|NCT01059825|531076668|FG004|Enrolled, Run-in Period|Other reason not specified|0|||
147247887|NCT01059825|531076669|FG005|Enrolled, Run-in Period|Other reason not specified|0|||
147247888|NCT01059825|531076670|FG006|Enrolled, Run-in Period|Other reason not specified|7|||
147247889|NCT01059825|531076664|FG000|Enrolled, Run-in Period|Protocol Violation|0|||
147247890|NCT01059825|531076665|FG001|Enrolled, Run-in Period|Protocol Violation|0|||
147247891|NCT01059825|531076666|FG002|Enrolled, Run-in Period|Protocol Violation|0|||
147247892|NCT01059825|531076667|FG003|Enrolled, Run-in Period|Protocol Violation|0|||
147247893|NCT01059825|531076668|FG004|Enrolled, Run-in Period|Protocol Violation|0|||
147247894|NCT01059825|531076669|FG005|Enrolled, Run-in Period|Protocol Violation|0|||
147247895|NCT01059825|531076670|FG006|Enrolled, Run-in Period|Protocol Violation|5|||
147247896|NCT01059825|531076664|FG000|Treatment Period|Lost to Follow-up|2|||
147247897|NCT01059825|531076665|FG001|Treatment Period|Lost to Follow-up|1|||
147247898|NCT01059825|531076666|FG002|Treatment Period|Lost to Follow-up|0|||
147247899|NCT01059825|531076667|FG003|Treatment Period|Lost to Follow-up|1|||
147247900|NCT01059825|531076668|FG004|Treatment Period|Lost to Follow-up|2|||
147247901|NCT01059825|531076669|FG005|Treatment Period|Lost to Follow-up|0|||
147247902|NCT01059825|531076670|FG006|Treatment Period|Lost to Follow-up|0|||
147247903|NCT01059825|531076664|FG000|Treatment Period|Withdrawal by Subject|3|||
147247904|NCT01059825|531076665|FG001|Treatment Period|Withdrawal by Subject|0|||
147247905|NCT01059825|531076666|FG002|Treatment Period|Withdrawal by Subject|1|||
147247906|NCT01059825|531076667|FG003|Treatment Period|Withdrawal by Subject|5|||
147247907|NCT01059825|531076668|FG004|Treatment Period|Withdrawal by Subject|4|||
147247908|NCT01059825|531076669|FG005|Treatment Period|Withdrawal by Subject|1|||
147247909|NCT01059825|531076670|FG006|Treatment Period|Withdrawal by Subject|0|||
147247910|NCT01059825|531076664|FG000|Treatment Period|Other reason not specified|1|||
147247911|NCT01059825|531076665|FG001|Treatment Period|Other reason not specified|2|||
147247912|NCT01059825|531076666|FG002|Treatment Period|Other reason not specified|1|||
147247913|NCT01059825|531076667|FG003|Treatment Period|Other reason not specified|2|||
147247914|NCT01059825|531076668|FG004|Treatment Period|Other reason not specified|0|||
147247915|NCT01059825|531076669|FG005|Treatment Period|Other reason not specified|0|||
147247916|NCT01059825|531076670|FG006|Treatment Period|Other reason not specified|0|||
147247917|NCT01059825|531076664|FG000|Treatment Period|Protocol Violation|0|||
147247918|NCT01059825|531076665|FG001|Treatment Period|Protocol Violation|0|||
147247919|NCT01059825|531076666|FG002|Treatment Period|Protocol Violation|1|||
147247920|NCT01059825|531076667|FG003|Treatment Period|Protocol Violation|1|||
147247921|NCT01059825|531076668|FG004|Treatment Period|Protocol Violation|1|||
147247922|NCT01059825|531076669|FG005|Treatment Period|Protocol Violation|1|||
147247923|NCT01059825|531076670|FG006|Treatment Period|Protocol Violation|0|||
147247924|NCT01059825|531076664|FG000|Treatment Period|Adverse event related to study drug|1|||
147247925|NCT01059825|531076665|FG001|Treatment Period|Adverse event related to study drug|0|||
147247926|NCT01059825|531076666|FG002|Treatment Period|Adverse event related to study drug|1|||
147247927|NCT01059825|531076667|FG003|Treatment Period|Adverse event related to study drug|1|||
147247928|NCT01059825|531076668|FG004|Treatment Period|Adverse event related to study drug|0|||
147189055|NCT00717249|530858132|FG000|Overall Study|Unsatisfactory Physiological Response|0|||
147189056|NCT00717249|530858133|FG001|Overall Study|Unsatisfactory Physiological Response|1|||
147189057|NCT00717249|530858132|FG000|Overall Study|Gastric Surgery|0|||
147189058|NCT00717249|530858133|FG001|Overall Study|Gastric Surgery|1|||
147189059|NCT00717249|530858132|FG000|Overall Study|Diagnosed with Diabetes|1|||
147189060|NCT00717249|530858133|FG001|Overall Study|Diagnosed with Diabetes|0|||
147189061|NCT00717249|530858132|FG000|Overall Study|Diagnosed with Multiple Scletosis|1|||
147189062|NCT00717249|530858133|FG001|Overall Study|Diagnosed with Multiple Scletosis|0|||
147189063|NCT00717249|530858132|FG000|Overall Study|Subject relocated|1|||
147189064|NCT00717249|530858133|FG001|Overall Study|Subject relocated|0|||
147189065|NCT00717249|530858132|FG000|Overall Study|Headaches|1|||
147189066|NCT00717249|530858133|FG001|Overall Study|Headaches|0|||
147189067|NCT00871871|530858134|FG000|Part I|Adverse Event|0|||
147189068|NCT00871871|530858135|FG001|Part I|Adverse Event|2|||
147189069|NCT00871871|530858136|FG002|Part I|Adverse Event|0|||
147189070|NCT00871871|530858137|FG003|Part I|Adverse Event|0|||
147189071|NCT00871871|530858134|FG000|Part I|Withdrawal by Subject|3|||
147189072|NCT00871871|530858135|FG001|Part I|Withdrawal by Subject|0|||
147189073|NCT00871871|530858136|FG002|Part I|Withdrawal by Subject|0|||
147189074|NCT00871871|530858137|FG003|Part I|Withdrawal by Subject|0|||
147189075|NCT00871871|530858134|FG000|Part I|Laboratory abnormality|0|||
147189076|NCT00871871|530858135|FG001|Part I|Laboratory abnormality|1|||
147189077|NCT00871871|530858136|FG002|Part I|Laboratory abnormality|0|||
147189078|NCT00871871|530858137|FG003|Part I|Laboratory abnormality|0|||
147189079|NCT00871871|530858134|FG000|Part II|Lack of Efficacy|0|||
147189080|NCT00871871|530858135|FG001|Part II|Lack of Efficacy|0|||
147189081|NCT00871871|530858136|FG002|Part II|Lack of Efficacy|1|||
147189082|NCT00871871|530858137|FG003|Part II|Lack of Efficacy|0|||
147189083|NCT00871871|530858134|FG000|Part II|Withdrawal by Subject|0|||
147189084|NCT00871871|530858135|FG001|Part II|Withdrawal by Subject|0|||
147189085|NCT00871871|530858136|FG002|Part II|Withdrawal by Subject|2|||
147189086|NCT00871871|530858137|FG003|Part II|Withdrawal by Subject|1|||
147189087|NCT00871871|530858134|FG000|Part II|Adverse Event|0|||
147189088|NCT00871871|530858135|FG001|Part II|Adverse Event|0|||
147189089|NCT00871871|530858136|FG002|Part II|Adverse Event|1|||
147189090|NCT00871871|530858137|FG003|Part II|Adverse Event|2|||
147189091|NCT00871871|530858134|FG000|Part II|Protocol Violation|0|||
147189092|NCT00871871|530858135|FG001|Part II|Protocol Violation|0|||
147189093|NCT00871871|530858136|FG002|Part II|Protocol Violation|0|||
147189094|NCT00871871|530858137|FG003|Part II|Protocol Violation|1|||
147189095|NCT03863509|530858138|FG000|Overall Study|COVID-19 shutdown period|0|||
147189096|NCT03863509|530858139|FG001|Overall Study|COVID-19 shutdown period|4|||
147189097|NCT03863509|530858140|FG002|Overall Study|COVID-19 shutdown period|0|||
147189098|NCT03863509|530858138|FG000|Overall Study|Missed V2 visit- outside protocol window|4|||
147189099|NCT03863509|530858139|FG001|Overall Study|Missed V2 visit- outside protocol window|3|||
147189100|NCT03863509|530858140|FG002|Overall Study|Missed V2 visit- outside protocol window|1|||
147189101|NCT03863509|530858138|FG000|Overall Study|Lost to Follow-up|8|||
147189102|NCT03863509|530858139|FG001|Overall Study|Lost to Follow-up|0|||
147189103|NCT03863509|530858140|FG002|Overall Study|Lost to Follow-up|2|||
147189104|NCT03863509|530858138|FG000|Overall Study|Did not qualify due to comorbidities, positive COVID-9, high CO, Low CO, Negative nicotine in urine|10|||
147189105|NCT03863509|530858139|FG001|Overall Study|Did not qualify due to comorbidities, positive COVID-9, high CO, Low CO, Negative nicotine in urine|20|||
147189106|NCT03863509|530858140|FG002|Overall Study|Did not qualify due to comorbidities, positive COVID-9, high CO, Low CO, Negative nicotine in urine|2|||
147189107|NCT03863509|530858138|FG000|Overall Study|While cleaning datasets, we realized one participant was enrolled twice.|0|||
147189108|NCT03863509|530858139|FG001|Overall Study|While cleaning datasets, we realized one participant was enrolled twice.|1|||
147189109|NCT03863509|530858140|FG002|Overall Study|While cleaning datasets, we realized one participant was enrolled twice.|0|||
147189110|NCT03799341|530858141|FG000|12-Week Treatment Interval|Withdrawal by Investigator|0|||
147189111|NCT03799341|530858142|FG001|12-Week Treatment Interval|Withdrawal by Investigator|0|||
147189112|NCT03799341|530858143|FG002|12-Week Treatment Interval|Withdrawal by Investigator|1|||
147189113|NCT03799341|530858141|FG000|12-Week Treatment Interval|Withdrawal by Subject|0|||
147189114|NCT03799341|530858142|FG001|12-Week Treatment Interval|Withdrawal by Subject|0|||
147189115|NCT03799341|530858143|FG002|12-Week Treatment Interval|Withdrawal by Subject|1|||
147658591|NCT03428100|532572323|FG012|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
147189116|NCT03799341|530858141|FG000|Post-Tx Evaluation Session|Lost to Follow-up|4|||
147189117|NCT03799341|530858142|FG001|Post-Tx Evaluation Session|Lost to Follow-up|4|||
147189118|NCT03799341|530858143|FG002|Post-Tx Evaluation Session|Lost to Follow-up|0|||
147189119|NCT03799341|530858141|FG000|Post-Tx Evaluation Session|Declined or Unavailable|1|||
147189120|NCT03799341|530858142|FG001|Post-Tx Evaluation Session|Declined or Unavailable|2|||
147189121|NCT03799341|530858143|FG002|Post-Tx Evaluation Session|Declined or Unavailable|0|||
147189122|NCT03799341|530858141|FG000|6-Month Post-Tx Follow-Up Period|Lost to Follow-up|12|||
147189123|NCT03799341|530858142|FG001|6-Month Post-Tx Follow-Up Period|Lost to Follow-up|10|||
147189124|NCT03799341|530858143|FG002|6-Month Post-Tx Follow-Up Period|Lost to Follow-up|0|||
147189125|NCT03799341|530858141|FG000|6-Month Post-Tx Follow-Up Period|Withdrawal by Investigator|1|||
147189126|NCT03799341|530858142|FG001|6-Month Post-Tx Follow-Up Period|Withdrawal by Investigator|0|||
147189127|NCT03799341|530858143|FG002|6-Month Post-Tx Follow-Up Period|Withdrawal by Investigator|0|||
147189128|NCT00990106|530858144|FG000|Overall Study|"too busy to continue"|1|||
147189129|NCT00990106|530858145|FG001|Overall Study|"too busy to continue"|2|||
147189130|NCT00990106|530858144|FG000|Overall Study|Lost to Follow-up|1|||
147189131|NCT00990106|530858145|FG001|Overall Study|Lost to Follow-up|3|||
147189132|NCT00990106|530858144|FG000|Overall Study|Withdrawal by Subject|2|||
147189133|NCT00990106|530858145|FG001|Overall Study|Withdrawal by Subject|1|||
147189134|NCT00990106|530858144|FG000|Overall Study|opted for open label prazosin|1|||
147189135|NCT00990106|530858145|FG001|Overall Study|opted for open label prazosin|1|||
147189136|NCT00990106|530858144|FG000|Overall Study|relocation/deployment|4|||
147189137|NCT00990106|530858145|FG001|Overall Study|relocation/deployment|1|||
147189138|NCT00990106|530858144|FG000|Overall Study|started exclusionary medication|0|||
147189139|NCT00990106|530858145|FG001|Overall Study|started exclusionary medication|1|||
147189140|NCT00990106|530858144|FG000|Overall Study|planned major surgery|0|||
147189141|NCT00990106|530858145|FG001|Overall Study|planned major surgery|1|||
147189142|NCT00990106|530858144|FG000|Overall Study|scheduling conflicts|0|||
147189143|NCT00990106|530858145|FG001|Overall Study|scheduling conflicts|2|||
147189144|NCT03100149|530858146|FG000|Overall Study|Adverse Event|0|||
147189145|NCT03100149|530858147|FG001|Overall Study|Adverse Event|1|||
147189146|NCT03100149|530858148|FG002|Overall Study|Adverse Event|0|||
147189147|NCT03100149|530858146|FG000|Overall Study|Participant Moved out of Country|0|||
147189148|NCT03100149|530858147|FG001|Overall Study|Participant Moved out of Country|0|||
147189149|NCT03100149|530858148|FG002|Overall Study|Participant Moved out of Country|1|||
147189150|NCT03100149|530858146|FG000|Overall Study|Withdrawal by Subject|0|||
147189151|NCT03100149|530858147|FG001|Overall Study|Withdrawal by Subject|3|||
147189152|NCT03100149|530858148|FG002|Overall Study|Withdrawal by Subject|1|||
147189153|NCT00445549|530859265|FG000|Overall Study|progressive disease|12|||
147189154|NCT01405768|530859272|FG000|Overall Study|Didn't complete questionnaire correctly|4|||
147189155|NCT01405768|530859273|FG001|Overall Study|Didn't complete questionnaire correctly|0|||
147189156|NCT02792231|530859280|FG000|Overall Study|Patient/guardian decision|32|||
147189157|NCT02792231|530859281|FG001|Overall Study|Patient/guardian decision|42|||
147189158|NCT02792231|530859280|FG000|Overall Study|Adverse Event|15|||
147189159|NCT02792231|530859281|FG001|Overall Study|Adverse Event|11|||
147189160|NCT02792231|530859280|FG000|Overall Study|Physician Decision|14|||
147189161|NCT02792231|530859281|FG001|Overall Study|Physician Decision|12|||
147189162|NCT02792231|530859280|FG000|Overall Study|Lack of Efficacy|7|||
147189163|NCT02792231|530859281|FG001|Overall Study|Lack of Efficacy|9|||
147189164|NCT02792231|530859280|FG000|Overall Study|Lost to Follow-up|9|||
147189165|NCT02792231|530859281|FG001|Overall Study|Lost to Follow-up|5|||
147189166|NCT02792231|530859280|FG000|Overall Study|Pregnancy|1|||
147189167|NCT02792231|530859281|FG001|Overall Study|Pregnancy|3|||
147189168|NCT02792231|530859280|FG000|Overall Study|Non-compliance with study treatment|2|||
147189169|NCT02792231|530859281|FG001|Overall Study|Non-compliance with study treatment|1|||
147189170|NCT02792231|530859280|FG000|Overall Study|Protocol deviation|2|||
147189171|NCT02792231|530859281|FG001|Overall Study|Protocol deviation|0|||
147189172|NCT02792231|530859280|FG000|Overall Study|Technical problems|0|||
147189173|NCT02792231|530859281|FG001|Overall Study|Technical problems|1|||
147189174|NCT05196828|530859282|FG000|Overall Study|Withdrawal by Subject|2|||
147189175|NCT05196828|530859283|FG001|Overall Study|Withdrawal by Subject|0|||
147189176|NCT05196828|530859282|FG000|Overall Study|Lost to Follow-up|0|||
147189177|NCT05196828|530859283|FG001|Overall Study|Lost to Follow-up|4|||
147189178|NCT05196828|530859282|FG000|Overall Study|Adverse Event|1|||
147189179|NCT05196828|530859283|FG001|Overall Study|Adverse Event|0|||
147329969|NCT01281813|531373102|FG001|Overall Study|Switched to Commercially Available Medication|0|||
147329970|NCT01281813|531373103|FG002|Overall Study|Switched to Commercially Available Medication|26|||
147329971|NCT01281813|531373101|FG000|Overall Study|Other|0|||
147189180|NCT04073186|530859284|FG000|First Wearing Cycle|Time required to complete last two study visits exceeds study deadline|1|||
147189181|NCT04073186|530859284|FG000|First Wearing Cycle|Withdrawal by Subject|1|||
147189182|NCT04073186|530859284|FG000|First Wearing Cycle|Protocol Violation|1|||
147189183|NCT04073186|530859284|FG000|First Wearing Cycle|Lens Discomfort|2|||
147189184|NCT04073186|530859284|FG000|First Wearing Cycle|Unsatisfactory Visual Response due to Test Article|1|||
147189185|NCT04073186|530859284|FG000|Second Wearing Cycle|Adverse Event|1|||
147189186|NCT00473434|530859285|FG000|Overall Study|Physician Decision|3|||
147189187|NCT00473434|530859285|FG000|Overall Study|Withdrawal by Subject|9|||
147189188|NCT00473434|530859285|FG000|Overall Study|Compliance|3|||
147189189|NCT00473434|530859285|FG000|Overall Study|Lack of Efficacy|3|||
147189190|NCT00473434|530859285|FG000|Overall Study|Adverse Event|3|||
147189191|NCT00473434|530859285|FG000|Overall Study|Patient was selling medication to others|1|||
147189192|NCT00473434|530859285|FG000|Overall Study|Safety evaluation|1|||
147189193|NCT00473434|530859285|FG000|Overall Study|Reason not specified|6|||
147189194|NCT00473434|530859285|FG000|Overall Study|Ceased in favor of Paliperidone|1|||
147329972|NCT01281813|531373102|FG001|Overall Study|Other|1|||
147189195|NCT00473434|530859285|FG000|Overall Study|Switching to trial medication|1|||
147189196|NCT00473434|530859285|FG000|Overall Study|No longer required|1|||
147189197|NCT00423657|530859289|FG000|Overall Study|Withdrew consent|10|||
147189198|NCT00423657|530859290|FG001|Overall Study|Withdrew consent|8|||
147189199|NCT00423657|530859289|FG000|Overall Study|Non-compliance|0|||
147189200|NCT00423657|530859290|FG001|Overall Study|Non-compliance|1|||
147189201|NCT00423657|530859289|FG000|Overall Study|Other|15|||
147189202|NCT00423657|530859290|FG001|Overall Study|Other|16|||
147189203|NCT00423657|530859289|FG000|Overall Study|Request of sponsor/investigator|1|||
147189204|NCT00423657|530859290|FG001|Overall Study|Request of sponsor/investigator|0|||
147189205|NCT02748863|530859291|FG000|Treatment Period 1|Adverse Event|0|||
147189206|NCT02748863|530859292|FG001|Treatment Period 1|Adverse Event|1|||
147189207|NCT02748863|530859293|FG002|Treatment Period 1|Adverse Event|0|||
147189208|NCT02748863|530859294|FG003|Treatment Period 1|Adverse Event|0|||
147189209|NCT02748863|530859295|FG004|Treatment Period 1|Adverse Event|0|||
147189210|NCT02748863|530859291|FG000|Treatment Period 1|Lack of Efficacy|0|||
147189211|NCT02748863|530859292|FG001|Treatment Period 1|Lack of Efficacy|0|||
147189212|NCT02748863|530859293|FG002|Treatment Period 1|Lack of Efficacy|1|||
147189213|NCT02748863|530859294|FG003|Treatment Period 1|Lack of Efficacy|0|||
147189214|NCT02748863|530859295|FG004|Treatment Period 1|Lack of Efficacy|0|||
147189215|NCT02748863|530859291|FG000|Treatment Period 1|Withdrawal by Subject|0|||
147189216|NCT02748863|530859292|FG001|Treatment Period 1|Withdrawal by Subject|1|||
147189217|NCT02748863|530859293|FG002|Treatment Period 1|Withdrawal by Subject|1|||
147189218|NCT02748863|530859294|FG003|Treatment Period 1|Withdrawal by Subject|0|||
147189219|NCT02748863|530859295|FG004|Treatment Period 1|Withdrawal by Subject|0|||
147189220|NCT02748863|530859291|FG000|Treatment Period 2|Lost to Follow-up|2|||
147189221|NCT02748863|530859292|FG001|Treatment Period 2|Lost to Follow-up|0|||
147189222|NCT02748863|530859293|FG002|Treatment Period 2|Lost to Follow-up|0|||
147189223|NCT02748863|530859294|FG003|Treatment Period 2|Lost to Follow-up|0|||
147189224|NCT02748863|530859295|FG004|Treatment Period 2|Lost to Follow-up|0|||
147189225|NCT02748863|530859291|FG000|Treatment Period 2|Adverse Event|3|||
147189226|NCT02748863|530859292|FG001|Treatment Period 2|Adverse Event|2|||
147189227|NCT02748863|530859293|FG002|Treatment Period 2|Adverse Event|0|||
147189228|NCT02748863|530859294|FG003|Treatment Period 2|Adverse Event|2|||
147189229|NCT02748863|530859295|FG004|Treatment Period 2|Adverse Event|0|||
147189230|NCT02748863|530859291|FG000|Treatment Period 2|Lack of Efficacy|0|||
147189231|NCT02748863|530859292|FG001|Treatment Period 2|Lack of Efficacy|1|||
147189232|NCT02748863|530859293|FG002|Treatment Period 2|Lack of Efficacy|0|||
147189233|NCT02748863|530859294|FG003|Treatment Period 2|Lack of Efficacy|0|||
147189234|NCT02748863|530859295|FG004|Treatment Period 2|Lack of Efficacy|0|||
147189235|NCT02748863|530859291|FG000|Treatment Period 2|Pregnancy|0|||
147189236|NCT02748863|530859292|FG001|Treatment Period 2|Pregnancy|0|||
147189237|NCT02748863|530859293|FG002|Treatment Period 2|Pregnancy|0|||
147189238|NCT02748863|530859294|FG003|Treatment Period 2|Pregnancy|0|||
147189239|NCT02748863|530859295|FG004|Treatment Period 2|Pregnancy|1|||
147189240|NCT02422498|530859296|FG000|Overall Study|Inevaluable|4|||
147189241|NCT03206216|530859297|FG000|Overall Study|Withdrawal by Subject|0|||
147189242|NCT03206216|530859298|FG001|Overall Study|Withdrawal by Subject|1|||
147189243|NCT00657046|530859299|FG000|Overall Study|Adverse Event|1|||
147189244|NCT00657046|530859300|FG001|Overall Study|Adverse Event|1|||
147189245|NCT00657046|530859301|FG002|Overall Study|Adverse Event|0|||
147189246|NCT00657046|530859299|FG000|Overall Study|Protocol Violation|2|||
147189247|NCT00657046|530859300|FG001|Overall Study|Protocol Violation|2|||
147189248|NCT00657046|530859301|FG002|Overall Study|Protocol Violation|0|||
147189249|NCT00657046|530859299|FG000|Overall Study|Withdrawal by Subject|1|||
147189250|NCT00657046|530859300|FG001|Overall Study|Withdrawal by Subject|0|||
147189251|NCT00657046|530859301|FG002|Overall Study|Withdrawal by Subject|0|||
147189252|NCT00657046|530859299|FG000|Overall Study|Death|0|||
147189253|NCT00657046|530859300|FG001|Overall Study|Death|0|||
147189254|NCT00657046|530859301|FG002|Overall Study|Death|1|||
147189255|NCT00657046|530859299|FG000|Overall Study|Surgery|0|||
147189256|NCT00657046|530859300|FG001|Overall Study|Surgery|0|||
147189257|NCT00657046|530859301|FG002|Overall Study|Surgery|1|||
147247929|NCT01059825|531076669|FG005|Treatment Period|Adverse event related to study drug|0|||
147247930|NCT01059825|531076670|FG006|Treatment Period|Adverse event related to study drug|0|||
147247931|NCT01059825|531076664|FG000|Treatment Period|Insufficient clinical response|3|||
147247932|NCT01059825|531076665|FG001|Treatment Period|Insufficient clinical response|0|||
147189258|NCT06237049|530859302|FG000|Overall Study|Death|0|||
147189259|NCT06237049|530859303|FG001|Overall Study|Death|0|||
147189260|NCT06237049|530859304|FG002|Overall Study|Death|0|||
147189261|NCT06237049|530859305|FG003|Overall Study|Death|1|||
147189262|NCT06237049|530859302|FG000|Overall Study|Lost to Follow-up|11|||
147189263|NCT06237049|530859303|FG001|Overall Study|Lost to Follow-up|5|||
147189264|NCT06237049|530859304|FG002|Overall Study|Lost to Follow-up|8|||
147189265|NCT06237049|530859305|FG003|Overall Study|Lost to Follow-up|8|||
147189266|NCT06237049|530859302|FG000|Overall Study|Protocol Violation|0|||
147189267|NCT06237049|530859303|FG001|Overall Study|Protocol Violation|1|||
147189268|NCT06237049|530859304|FG002|Overall Study|Protocol Violation|0|||
147189269|NCT06237049|530859305|FG003|Overall Study|Protocol Violation|1|||
147189270|NCT06237049|530859302|FG000|Overall Study|Withdrawal by Subject|4|||
147189271|NCT06237049|530859303|FG001|Overall Study|Withdrawal by Subject|2|||
147189272|NCT06237049|530859304|FG002|Overall Study|Withdrawal by Subject|1|||
147189273|NCT06237049|530859305|FG003|Overall Study|Withdrawal by Subject|0|||
147189274|NCT02525471|530859306|FG000|Overall Study|Screen Failure|6|||
147189275|NCT02525471|530859306|FG000|Overall Study|Withdrawal by Subject|4|||
147189276|NCT02525471|530859306|FG000|Overall Study|Death|1|||
147189277|NCT00844376|530859307|FG000|Period 1: First Intervention|Withdrawal by Subject|1|||
147189278|NCT00844376|530859308|FG001|Period 1: First Intervention|Withdrawal by Subject|0|||
147189279|NCT00988884|530859309|FG000|Overall Study|Adverse Event|0|||
147189280|NCT00988884|530859310|FG001|Overall Study|Adverse Event|1|||
147189281|NCT00988884|530859309|FG000|Overall Study|Lost to Follow-up|20|||
147189282|NCT00988884|530859310|FG001|Overall Study|Lost to Follow-up|16|||
147189283|NCT00988884|530859309|FG000|Overall Study|Protocol Violation|0|||
147189284|NCT00988884|530859310|FG001|Overall Study|Protocol Violation|1|||
147189285|NCT00988884|530859309|FG000|Overall Study|Withdrawal by Subject|15|||
147189286|NCT00988884|530859310|FG001|Overall Study|Withdrawal by Subject|18|||
147189287|NCT04621448|530859311|FG000|Baseline to 12 Weeks|Withdrawal by Subject|6|||
147189288|NCT04621448|530859312|FG001|Baseline to 12 Weeks|Withdrawal by Subject|8|||
147189289|NCT04621448|530859313|FG002|Baseline to 12 Weeks|Withdrawal by Subject|6|||
147189290|NCT04621448|530859314|FG003|Baseline to 12 Weeks|Withdrawal by Subject|8|||
147189291|NCT04621448|530859311|FG000|Baseline to 12 Weeks|Lost to Follow-up|0|||
147189292|NCT04621448|530859312|FG001|Baseline to 12 Weeks|Lost to Follow-up|1|||
147189293|NCT04621448|530859313|FG002|Baseline to 12 Weeks|Lost to Follow-up|0|||
147189294|NCT04621448|530859314|FG003|Baseline to 12 Weeks|Lost to Follow-up|1|||
147189295|NCT04621448|530859311|FG000|12 to 24 Weeks|Lost to Follow-up|1|||
147189296|NCT04621448|530859312|FG001|12 to 24 Weeks|Lost to Follow-up|0|||
147189297|NCT04621448|530859313|FG002|12 to 24 Weeks|Lost to Follow-up|1|||
147189298|NCT04621448|530859314|FG003|12 to 24 Weeks|Lost to Follow-up|0|||
147189299|NCT04621448|530859311|FG000|12 to 24 Weeks|Withdrawal by Subject|3|||
147189300|NCT04621448|530859312|FG001|12 to 24 Weeks|Withdrawal by Subject|2|||
147189301|NCT04621448|530859313|FG002|12 to 24 Weeks|Withdrawal by Subject|3|||
147189302|NCT04621448|530859314|FG003|12 to 24 Weeks|Withdrawal by Subject|2|||
147189303|NCT00468299|530859321|FG000|Overall Study|Withdrawal by Subject|0|||
147189304|NCT00468299|530859322|FG001|Overall Study|Withdrawal by Subject|1|||
147189305|NCT03546621|530859323|FG000|Overall Study|Withdrawal by Subject|0|||
147189306|NCT03546621|530859324|FG001|Overall Study|Withdrawal by Subject|1|||
147189307|NCT03546621|530859325|FG002|Overall Study|Withdrawal by Subject|2|||
147189308|NCT03546621|530859326|FG003|Overall Study|Withdrawal by Subject|1|||
147189309|NCT03546621|530859323|FG000|Overall Study|Lost to Follow-up|0|||
147189310|NCT03546621|530859324|FG001|Overall Study|Lost to Follow-up|1|||
147189311|NCT03546621|530859325|FG002|Overall Study|Lost to Follow-up|0|||
147189312|NCT03546621|530859326|FG003|Overall Study|Lost to Follow-up|0|||
147189313|NCT03546621|530859323|FG000|Overall Study|Adverse Event|0|||
147189314|NCT03546621|530859324|FG001|Overall Study|Adverse Event|1|||
147189315|NCT03546621|530859325|FG002|Overall Study|Adverse Event|0|||
147189316|NCT03546621|530859326|FG003|Overall Study|Adverse Event|1|||
147189317|NCT03546621|530859323|FG000|Overall Study|Progressive disease|0|||
147189318|NCT03546621|530859324|FG001|Overall Study|Progressive disease|0|||
147189319|NCT03546621|530859325|FG002|Overall Study|Progressive disease|0|||
147189320|NCT03546621|530859326|FG003|Overall Study|Progressive disease|1|||
147189321|NCT03318549|530859333|FG000|Overall Study|Withdrawal by Subject|5|||
147189322|NCT03318549|530859334|FG001|Overall Study|Withdrawal by Subject|19|||
147189323|NCT03318549|530859335|FG002|Overall Study|Withdrawal by Subject|2|||
147189324|NCT03318549|530859336|FG003|Overall Study|Withdrawal by Subject|0|||
147189325|NCT03318549|530859337|FG004|Overall Study|Withdrawal by Subject|0|||
147189326|NCT03318549|530859338|FG005|Overall Study|Withdrawal by Subject|0|||
147189327|NCT03318549|530859339|FG006|Overall Study|Withdrawal by Subject|0|||
147189328|NCT03318549|530859333|FG000|Overall Study|Physician Decision|0|||
147247933|NCT01059825|531076666|FG002|Treatment Period|Insufficient clinical response|0|||
147448987|NCT01225731|531808047|FG003|Part 1|Protocol Violation|1|||
147448988|NCT01225731|531808048|FG004|Part 1|Protocol Violation|0|||
147448989|NCT01225731|531808049|FG005|Part 1|Protocol Violation|0|||
147448990|NCT01225731|531808050|FG006|Part 1|Protocol Violation|0|||
147448991|NCT01225731|531808051|FG007|Part 1|Protocol Violation|0|||
147448992|NCT01225731|531808052|FG008|Part 1|Protocol Violation|0|||
147448993|NCT01225731|531808053|FG009|Part 1|Protocol Violation|0|||
147448994|NCT01225731|531808054|FG010|Part 1|Protocol Violation|0|||
147189329|NCT03318549|530859334|FG001|Overall Study|Physician Decision|4|||
147189330|NCT03318549|530859335|FG002|Overall Study|Physician Decision|1|||
147189331|NCT03318549|530859336|FG003|Overall Study|Physician Decision|0|||
147189332|NCT03318549|530859337|FG004|Overall Study|Physician Decision|0|||
147189333|NCT03318549|530859338|FG005|Overall Study|Physician Decision|0|||
147189334|NCT03318549|530859339|FG006|Overall Study|Physician Decision|0|||
147189335|NCT03318549|530859333|FG000|Overall Study|Lost to Follow-up|0|||
147189336|NCT03318549|530859334|FG001|Overall Study|Lost to Follow-up|3|||
147189337|NCT03318549|530859335|FG002|Overall Study|Lost to Follow-up|3|||
147189338|NCT03318549|530859336|FG003|Overall Study|Lost to Follow-up|0|||
147189339|NCT03318549|530859337|FG004|Overall Study|Lost to Follow-up|0|||
147448995|NCT01225731|531808055|FG011|Part 1|Protocol Violation|0|||
147448996|NCT01225731|531808056|FG012|Part 1|Protocol Violation|0|||
147189340|NCT03318549|530859338|FG005|Overall Study|Lost to Follow-up|0|||
147189341|NCT03318549|530859339|FG006|Overall Study|Lost to Follow-up|0|||
147189342|NCT03649074|530859343|FG000|Overall Study|Lost to Follow-up|2|||
147189343|NCT03649074|530859344|FG001|Overall Study|Lost to Follow-up|1|||
147189344|NCT03649074|530859343|FG000|Overall Study|Adverse Event|1|||
147189345|NCT03649074|530859344|FG001|Overall Study|Adverse Event|0|||
147189346|NCT03649074|530859343|FG000|Overall Study|Physician Decision|1|||
147189347|NCT03649074|530859344|FG001|Overall Study|Physician Decision|0|||
147189348|NCT03649074|530859343|FG000|Overall Study|Withdrawal by Subject|0|||
147189349|NCT03649074|530859344|FG001|Overall Study|Withdrawal by Subject|2|||
147189350|NCT03649074|530859343|FG000|Overall Study|Withdrawn by Parent/Guardian|1|||
147189351|NCT03649074|530859344|FG001|Overall Study|Withdrawn by Parent/Guardian|2|||
147189352|NCT03649074|530859343|FG000|Overall Study|Other|1|||
147189353|NCT03649074|530859344|FG001|Overall Study|Other|0|||
147189354|NCT03861273|530859351|FG000|Screening Phase (3 Weeks)|Other|1|||
147189355|NCT03861273|530859351|FG000|Screening Phase (3 Weeks)|Screen failure|5|||
147189356|NCT03861273|530859351|FG000|Follow-up Phase (Year 1)|Ongoing|2|||
147189357|NCT03861273|530859351|FG000|Long-Term Follow-Up (Year 2 to Year 6)|Ongoing|42|||
147189358|NCT03861273|530859351|FG000|Long-Term Follow-Up (Year 2 to Year 6)|Withdrawal by Subject|1|||
147189359|NCT00191334|530859354|FG000|Overall Study|Adverse Event|4|||
147189360|NCT00191334|530859354|FG000|Overall Study|Disease Progression or Relapse|8|||
147189361|NCT00191334|530859354|FG000|Overall Study|Physician Decision|1|||
147189362|NCT00191334|530859354|FG000|Overall Study|Withdrawal by Subject|4|||
147189363|NCT01116648|530859355|FG000|Phase 1 Dose Level 3|Adverse Event|0|||
147189364|NCT01116648|530859356|FG001|Phase 1 Dose Level 3|Adverse Event|0|||
147189365|NCT01116648|530859357|FG002|Phase 1 Dose Level 3|Adverse Event|0|||
147189366|NCT01116648|530859358|FG003|Phase 1 Dose Level 3|Adverse Event|2|||
147189367|NCT01116648|530859359|FG004|Phase 1 Dose Level 3|Adverse Event|0|||
147189368|NCT01116648|530859360|FG005|Phase 1 Dose Level 3|Adverse Event|0|||
147189369|NCT01116648|530859361|FG006|Phase 1 Dose Level 3|Adverse Event|0|||
147189370|NCT01116648|530859362|FG007|Phase 1 Dose Level 3|Adverse Event|0|||
147189371|NCT01116648|530859363|FG008|Phase 1 Dose Level 3|Adverse Event|0|||
147329973|NCT01281813|531373103|FG002|Overall Study|Other|39|||
147329974|NCT05257798|531373104|FG000|Follow-up Phase|Lost to Follow-up|1|||
147329975|NCT05257798|531373105|FG001|Follow-up Phase|Lost to Follow-up|0|||
147329976|NCT00703911|531373108|FG000|Overall Study|Death|1|||
147329977|NCT00703911|531373108|FG000|Overall Study|Physician Decision|6|||
147329978|NCT00703911|531373108|FG000|Overall Study|Lost to Follow-up|1|||
147329979|NCT00703911|531373108|FG000|Overall Study|Withdrawal by Subject|2|||
147329980|NCT02082158|531373109|FG000|Overall Study|Withdrawal by Subject|0|||
147329981|NCT02082158|531373110|FG001|Overall Study|Withdrawal by Subject|0|||
147329982|NCT02082158|531373111|FG002|Overall Study|Withdrawal by Subject|0|||
147329983|NCT02082158|531373112|FG003|Overall Study|Withdrawal by Subject|0|||
147329984|NCT02082158|531373113|FG004|Overall Study|Withdrawal by Subject|1|||
147329985|NCT02082158|531373114|FG005|Overall Study|Withdrawal by Subject|0|||
147329986|NCT02082158|531373109|FG000|Overall Study|Failed Fit-testing|8|||
147329987|NCT02082158|531373110|FG001|Overall Study|Failed Fit-testing|8|||
147329988|NCT02082158|531373111|FG002|Overall Study|Failed Fit-testing|14|||
147329989|NCT02082158|531373112|FG003|Overall Study|Failed Fit-testing|4|||
147329990|NCT02082158|531373113|FG004|Overall Study|Failed Fit-testing|3|||
147329991|NCT02082158|531373114|FG005|Overall Study|Failed Fit-testing|7|||
147329992|NCT02274493|531373115|FG000|Overall Study|Withdrawal by Subject|1|||
147329993|NCT00957229|531373122|FG000|Study Start|Adverse Event|0|||
147329994|NCT00957229|531373123|FG001|Study Start|Adverse Event|3|||
147329995|NCT00957229|531373122|FG000|Study Start|Disease Progression|1|||
147329996|NCT00957229|531373123|FG001|Study Start|Disease Progression|0|||
147329997|NCT00957229|531373122|FG000|Reallocated to or Continued Vismodegib|Death|1|||
147329998|NCT00957229|531373123|FG001|Reallocated to or Continued Vismodegib|Death|1|||
147329999|NCT00957229|531373122|FG000|Reallocated to or Continued Vismodegib|Adverse Event|2|||
147330000|NCT00957229|531373123|FG001|Reallocated to or Continued Vismodegib|Adverse Event|1|||
147330001|NCT00543725|531373124|FG000|Overall Study|Adverse Event|18|||
147330002|NCT00543725|531373125|FG001|Overall Study|Adverse Event|27|||
147658592|NCT03428100|532572324|FG013|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
147189372|NCT01116648|530859364|FG009|Phase 1 Dose Level 3|Adverse Event|0|||
147189373|NCT01116648|530859365|FG010|Phase 1 Dose Level 3|Adverse Event|0|||
147330003|NCT00543725|531373124|FG000|Overall Study|Sponsor's Decision|0|||
147658593|NCT03428100|532572325|FG014|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
147330004|NCT00543725|531373125|FG001|Overall Study|Sponsor's Decision|1|||
147189374|NCT01116648|530859366|FG011|Phase 1 Dose Level 3|Adverse Event|0|||
147189375|NCT01116648|530859367|FG012|Phase 1 Dose Level 3|Adverse Event|0|||
147189376|NCT01116648|530859368|FG013|Phase 1 Dose Level 3|Adverse Event|0|||
147189377|NCT01116648|530859369|FG014|Phase 1 Dose Level 3|Adverse Event|0|||
147189378|NCT04539938|530859370|FG000|Overall Study|Death|30|||
147330005|NCT00543725|531373124|FG000|Overall Study|Subject Non-Compliant|4|||
147330006|NCT00543725|531373125|FG001|Overall Study|Subject Non-Compliant|4|||
147330007|NCT00543725|531373124|FG000|Overall Study|Subject Ineligible To Continue The Trial|2|||
147330008|NCT00543725|531373125|FG001|Overall Study|Subject Ineligible To Continue The Trial|0|||
147247934|NCT01059825|531076667|FG003|Treatment Period|Insufficient clinical response|0|||
147247935|NCT01059825|531076668|FG004|Treatment Period|Insufficient clinical response|0|||
147247936|NCT01059825|531076669|FG005|Treatment Period|Insufficient clinical response|0|||
147247937|NCT01059825|531076670|FG006|Treatment Period|Insufficient clinical response|0|||
147247938|NCT01059825|531076664|FG000|Treatment Period|Adverse event not related to study drug|0|||
147247939|NCT01059825|531076665|FG001|Treatment Period|Adverse event not related to study drug|1|||
147247940|NCT01059825|531076666|FG002|Treatment Period|Adverse event not related to study drug|2|||
147247941|NCT01059825|531076667|FG003|Treatment Period|Adverse event not related to study drug|1|||
147189379|NCT04539938|530859370|FG000|Overall Study|Withdrawal by Subject|4|||
147189380|NCT03064490|530859371|FG000|Overall Study|Physician Decision|5|||
147189381|NCT02926638|530859376|FG000|Overall Study|Progression|2|||
147189382|NCT02926638|530859377|FG001|Overall Study|Progression|5|||
147189383|NCT02926638|530859376|FG000|Overall Study|Ineligible|1|||
147189384|NCT02926638|530859377|FG001|Overall Study|Ineligible|0|||
147189385|NCT02926638|530859376|FG000|Overall Study|Not protocol specified|1|||
147189386|NCT02926638|530859377|FG001|Overall Study|Not protocol specified|0|||
147189387|NCT01871519|530859379|FG000|Overall Study|Death|26|||
147189388|NCT01871519|530859379|FG000|Overall Study|Lost to Follow-up|15|||
147189389|NCT01871519|530859379|FG000|Overall Study|Withdrawal by Subject|49|||
147189390|NCT00320515|530859380|FG000|Overall Study|Death|33|||
147189391|NCT00320515|530859380|FG000|Overall Study|Lost to Follow-up|6|||
147189392|NCT00320515|530859380|FG000|Overall Study|Physician Decision|2|||
147189393|NCT00320515|530859380|FG000|Overall Study|Withdrawal by Subject|8|||
147189394|NCT01063153|530859381|FG000|Overall Study|Found Ineligible During Screening|2|||
147189395|NCT01063153|530859382|FG001|Overall Study|Found Ineligible During Screening|0|||
147189396|NCT01063153|530859381|FG000|Overall Study|Lost to Follow-up|0|||
147189397|NCT01063153|530859382|FG001|Overall Study|Lost to Follow-up|7|||
147189398|NCT01063153|530859381|FG000|Overall Study|Withdrawal by Subject|0|||
147189399|NCT01063153|530859382|FG001|Overall Study|Withdrawal by Subject|1|||
147189400|NCT01063153|530859381|FG000|Overall Study|Physician Decision|0|||
147189401|NCT01063153|530859382|FG001|Overall Study|Physician Decision|4|||
147189402|NCT00350844|530859383|FG000|Overall Study|Lost to Follow-up|1|||
147189403|NCT01420926|530859384|FG000|Overall Study|Adverse Event|6|||
147189404|NCT01420926|530859385|FG001|Overall Study|Adverse Event|4|||
147189405|NCT01420926|530859384|FG000|Overall Study|Death|18|||
147189406|NCT01420926|530859385|FG001|Overall Study|Death|17|||
147189407|NCT01420926|530859384|FG000|Overall Study|Withdrawal by Subject|11|||
147189408|NCT01420926|530859385|FG001|Overall Study|Withdrawal by Subject|17|||
147189409|NCT01420926|530859384|FG000|Overall Study|Non-protocol treatment|17|||
147189410|NCT01420926|530859385|FG001|Overall Study|Non-protocol treatment|20|||
147189411|NCT01420926|530859384|FG000|Overall Study|Physician Decision|8|||
147189412|NCT01420926|530859385|FG001|Overall Study|Physician Decision|5|||
147189413|NCT00882440|530860886|FG000|Overall Study|Adverse Event|2|||
147189414|NCT00882440|530860887|FG001|Overall Study|Adverse Event|2|||
147189415|NCT00882440|530860888|FG002|Overall Study|Adverse Event|2|||
147189416|NCT00882440|530860889|FG003|Overall Study|Adverse Event|1|||
147189417|NCT00882440|530860890|FG004|Overall Study|Adverse Event|1|||
147189418|NCT00882440|530860891|FG005|Overall Study|Adverse Event|4|||
147189419|NCT00882440|530860892|FG006|Overall Study|Adverse Event|2|||
147189420|NCT00882440|530860886|FG000|Overall Study|Lack of Efficacy|3|||
147189421|NCT00882440|530860887|FG001|Overall Study|Lack of Efficacy|5|||
147247942|NCT01059825|531076668|FG004|Treatment Period|Adverse event not related to study drug|1|||
147247943|NCT01059825|531076669|FG005|Treatment Period|Adverse event not related to study drug|1|||
147247944|NCT01059825|531076670|FG006|Treatment Period|Adverse event not related to study drug|0|||
147247945|NCT02041286|531076671|FG000|Overall Study|Adverse Event|1|||
147247946|NCT03342690|531076674|FG000|Overall Study|Missing Information|9|||
147247947|NCT03342690|531076674|FG000|Overall Study|Protocol Violation|16|||
147247948|NCT03138889|531076675|FG000|Overall Study|Withdrawal by Subject|5|||
147247949|NCT03138889|531076676|FG001|Overall Study|Withdrawal by Subject|5|||
147247950|NCT03138889|531076677|FG002|Overall Study|Withdrawal by Subject|0|||
147247951|NCT03138889|531076678|FG003|Overall Study|Withdrawal by Subject|2|||
147247952|NCT03138889|531076679|FG004|Overall Study|Withdrawal by Subject|1|||
147247953|NCT03138889|531076680|FG005|Overall Study|Withdrawal by Subject|3|||
147330009|NCT00543725|531373124|FG000|Overall Study|Subject Reached A Virologic Endpoint|22|||
147189422|NCT00882440|530860888|FG002|Overall Study|Lack of Efficacy|2|||
147189423|NCT00882440|530860889|FG003|Overall Study|Lack of Efficacy|0|||
147189424|NCT00882440|530860890|FG004|Overall Study|Lack of Efficacy|0|||
147189425|NCT00882440|530860891|FG005|Overall Study|Lack of Efficacy|3|||
147189426|NCT00882440|530860892|FG006|Overall Study|Lack of Efficacy|0|||
147189427|NCT00882440|530860886|FG000|Overall Study|Lost to Follow-up|2|||
147247954|NCT03138889|531076681|FG006|Overall Study|Withdrawal by Subject|0|||
147189428|NCT00882440|530860887|FG001|Overall Study|Lost to Follow-up|0|||
147189429|NCT00882440|530860888|FG002|Overall Study|Lost to Follow-up|1|||
147189430|NCT00882440|530860889|FG003|Overall Study|Lost to Follow-up|1|||
147189431|NCT00882440|530860890|FG004|Overall Study|Lost to Follow-up|1|||
147189432|NCT00882440|530860891|FG005|Overall Study|Lost to Follow-up|0|||
147247955|NCT03138889|531076682|FG007|Overall Study|Withdrawal by Subject|1|||
147189433|NCT00882440|530860892|FG006|Overall Study|Lost to Follow-up|1|||
147189434|NCT00882440|530860886|FG000|Overall Study|Protocol Violation|0|||
147189435|NCT00882440|530860887|FG001|Overall Study|Protocol Violation|0|||
147189436|NCT00882440|530860888|FG002|Overall Study|Protocol Violation|1|||
147189437|NCT00882440|530860889|FG003|Overall Study|Protocol Violation|1|||
147189438|NCT00882440|530860890|FG004|Overall Study|Protocol Violation|1|||
147189439|NCT00882440|530860891|FG005|Overall Study|Protocol Violation|0|||
147189440|NCT00882440|530860892|FG006|Overall Study|Protocol Violation|0|||
147189441|NCT00882440|530860886|FG000|Overall Study|Withdrawal by Subject|2|||
147189442|NCT00882440|530860887|FG001|Overall Study|Withdrawal by Subject|1|||
147189443|NCT00882440|530860888|FG002|Overall Study|Withdrawal by Subject|1|||
147189444|NCT00882440|530860889|FG003|Overall Study|Withdrawal by Subject|0|||
147189445|NCT00882440|530860890|FG004|Overall Study|Withdrawal by Subject|6|||
147189446|NCT00882440|530860891|FG005|Overall Study|Withdrawal by Subject|0|||
147189447|NCT00882440|530860892|FG006|Overall Study|Withdrawal by Subject|1|||
147189448|NCT00882440|530860886|FG000|Overall Study|Patient Uncooperative|2|||
147189449|NCT00882440|530860887|FG001|Overall Study|Patient Uncooperative|0|||
147189450|NCT00882440|530860888|FG002|Overall Study|Patient Uncooperative|0|||
147189451|NCT00882440|530860889|FG003|Overall Study|Patient Uncooperative|0|||
147189452|NCT00882440|530860890|FG004|Overall Study|Patient Uncooperative|1|||
147189453|NCT00882440|530860891|FG005|Overall Study|Patient Uncooperative|0|||
147189454|NCT00882440|530860892|FG006|Overall Study|Patient Uncooperative|0|||
147189455|NCT01381016|530860894|FG000|Overall Study|Lost to Follow-up|1|||
147189456|NCT01381016|530860895|FG001|Overall Study|Lost to Follow-up|1|||
147189457|NCT01381016|530860894|FG000|Overall Study|Screen Failure|2|||
147189458|NCT01381016|530860895|FG001|Overall Study|Screen Failure|2|||
147189459|NCT01381016|530860894|FG000|Overall Study|Withdrawal by Subject|0|||
147189460|NCT01381016|530860895|FG001|Overall Study|Withdrawal by Subject|1|||
147189461|NCT01381016|530860894|FG000|Overall Study|Physician Decision|0|||
147189462|NCT01381016|530860895|FG001|Overall Study|Physician Decision|2|||
147189463|NCT01451723|530860905|FG000|Overall Study|study halted|6|||
147189464|NCT01451723|530860906|FG001|Overall Study|study halted|5|||
147189465|NCT01329263|530860907|FG000|Overall Study|Lost to Follow-up|4|||
147189466|NCT01329263|530860908|FG001|Overall Study|Lost to Follow-up|21|||
147189467|NCT01329263|530860907|FG000|Overall Study|Withdrawal by Subject|1|||
147189468|NCT01329263|530860908|FG001|Overall Study|Withdrawal by Subject|2|||
147189469|NCT01631435|530860910|FG000|Overall Study|Adverse Event|2|||
147189470|NCT01631435|530860910|FG000|Overall Study|Withdrawal by Subject|2|||
147189471|NCT01631435|530860910|FG000|Overall Study|incomplete study procedure|5|||
147189472|NCT00833040|530860911|FG000|Overall Study|Adverse Event|0|||
147189473|NCT00833040|530860912|FG001|Overall Study|Adverse Event|0|||
147189474|NCT00833040|530860913|FG002|Overall Study|Adverse Event|0|||
147189475|NCT00833040|530860914|FG003|Overall Study|Adverse Event|0|||
147189476|NCT00833040|530860915|FG004|Overall Study|Adverse Event|0|||
147189477|NCT00833040|530860916|FG005|Overall Study|Adverse Event|1|||
147189478|NCT00416624|530860919|FG000|Overall Study|Withdrawal by Subject|1|||
147189479|NCT00416624|530860920|FG001|Overall Study|Withdrawal by Subject|6|||
147189480|NCT00416624|530860921|FG002|Overall Study|Withdrawal by Subject|4|||
147189481|NCT00416624|530860922|FG003|Overall Study|Withdrawal by Subject|9|||
147189482|NCT00416624|530860919|FG000|Overall Study|Death|4|||
147189483|NCT00416624|530860920|FG001|Overall Study|Death|7|||
147189484|NCT00416624|530860921|FG002|Overall Study|Death|7|||
147189485|NCT00416624|530860922|FG003|Overall Study|Death|1|||
147189486|NCT00416624|530860919|FG000|Overall Study|Adverse Event|8|||
147189487|NCT00416624|530860920|FG001|Overall Study|Adverse Event|3|||
147189488|NCT00416624|530860921|FG002|Overall Study|Adverse Event|2|||
147189489|NCT00416624|530860922|FG003|Overall Study|Adverse Event|2|||
147189490|NCT00416624|530860919|FG000|Overall Study|Other|8|||
147189491|NCT00416624|530860920|FG001|Overall Study|Other|11|||
147189492|NCT00416624|530860921|FG002|Overall Study|Other|5|||
147189493|NCT00416624|530860922|FG003|Overall Study|Other|5|||
147189494|NCT00416624|530860919|FG000|Overall Study|Cancel|1|||
147189495|NCT00416624|530860920|FG001|Overall Study|Cancel|0|||
147330010|NCT00543725|531373125|FG001|Overall Study|Subject Reached A Virologic Endpoint|14|||
147189496|NCT00416624|530860921|FG002|Overall Study|Cancel|0|||
147330011|NCT00543725|531373124|FG000|Overall Study|Protocol Violation|0|||
147189497|NCT00416624|530860922|FG003|Overall Study|Cancel|0|||
147189498|NCT01005251|530860923|FG000|Overall Study|Withdrawal by Subject|2|||
147189499|NCT01005251|530860924|FG001|Overall Study|Withdrawal by Subject|5|||
147189500|NCT01005251|530860925|FG002|Overall Study|Withdrawal by Subject|3|||
147189501|NCT01005251|530860926|FG003|Overall Study|Withdrawal by Subject|4|||
147189502|NCT01005251|530860927|FG004|Overall Study|Withdrawal by Subject|9|||
147189503|NCT01005251|530860923|FG000|Overall Study|Eligibility criteria not fulfilled|4|||
147189504|NCT01005251|530860924|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
147189505|NCT01005251|530860925|FG002|Overall Study|Eligibility criteria not fulfilled|4|||
147189506|NCT01005251|530860926|FG003|Overall Study|Eligibility criteria not fulfilled|1|||
147189507|NCT01005251|530860927|FG004|Overall Study|Eligibility criteria not fulfilled|0|||
147189508|NCT01005251|530860923|FG000|Overall Study|Adverse Event|2|||
147189509|NCT01005251|530860924|FG001|Overall Study|Adverse Event|6|||
147330012|NCT00543725|531373125|FG001|Overall Study|Protocol Violation|1|||
147330013|NCT00543725|531373124|FG000|Overall Study|Withdrawal by Subject|4|||
147189510|NCT01005251|530860925|FG002|Overall Study|Adverse Event|8|||
147189511|NCT01005251|530860926|FG003|Overall Study|Adverse Event|5|||
147189512|NCT01005251|530860927|FG004|Overall Study|Adverse Event|4|||
147189513|NCT01005251|530860923|FG000|Overall Study|Protocol Violation|1|||
147189514|NCT01005251|530860924|FG001|Overall Study|Protocol Violation|0|||
147189515|NCT01005251|530860925|FG002|Overall Study|Protocol Violation|0|||
147189516|NCT01005251|530860926|FG003|Overall Study|Protocol Violation|0|||
147189517|NCT01005251|530860927|FG004|Overall Study|Protocol Violation|2|||
147189518|NCT01005251|530860923|FG000|Overall Study|Developed study-specific withdrawal crit|2|||
147189519|NCT01005251|530860924|FG001|Overall Study|Developed study-specific withdrawal crit|0|||
147189520|NCT01005251|530860925|FG002|Overall Study|Developed study-specific withdrawal crit|3|||
147189521|NCT01005251|530860926|FG003|Overall Study|Developed study-specific withdrawal crit|0|||
147189522|NCT01005251|530860927|FG004|Overall Study|Developed study-specific withdrawal crit|1|||
147189523|NCT01005251|530860923|FG000|Overall Study|Lost to Follow-up|1|||
147189524|NCT01005251|530860924|FG001|Overall Study|Lost to Follow-up|4|||
147189525|NCT01005251|530860925|FG002|Overall Study|Lost to Follow-up|2|||
147189526|NCT01005251|530860926|FG003|Overall Study|Lost to Follow-up|0|||
147189527|NCT01005251|530860927|FG004|Overall Study|Lost to Follow-up|0|||
147189528|NCT01005251|530860923|FG000|Overall Study|Physician Decision|0|||
147189529|NCT01005251|530860924|FG001|Overall Study|Physician Decision|0|||
147189530|NCT01005251|530860925|FG002|Overall Study|Physician Decision|0|||
147189531|NCT01005251|530860926|FG003|Overall Study|Physician Decision|0|||
147189532|NCT01005251|530860927|FG004|Overall Study|Physician Decision|2|||
147189533|NCT01005251|530860923|FG000|Overall Study|Patient moved|1|||
147189534|NCT01005251|530860924|FG001|Overall Study|Patient moved|0|||
147189535|NCT01005251|530860925|FG002|Overall Study|Patient moved|0|||
147189536|NCT01005251|530860926|FG003|Overall Study|Patient moved|0|||
147189537|NCT01005251|530860927|FG004|Overall Study|Patient moved|0|||
147189538|NCT01005251|530860923|FG000|Overall Study|Wrong drug dispensed|0|||
147189539|NCT01005251|530860924|FG001|Overall Study|Wrong drug dispensed|1|||
147189540|NCT01005251|530860925|FG002|Overall Study|Wrong drug dispensed|0|||
147189541|NCT01005251|530860926|FG003|Overall Study|Wrong drug dispensed|0|||
147189542|NCT01005251|530860927|FG004|Overall Study|Wrong drug dispensed|0|||
147189543|NCT01005251|530860923|FG000|Overall Study|Randomized in error|0|||
147189544|NCT01005251|530860924|FG001|Overall Study|Randomized in error|0|||
147189545|NCT01005251|530860925|FG002|Overall Study|Randomized in error|1|||
147189546|NCT01005251|530860926|FG003|Overall Study|Randomized in error|1|||
147189547|NCT01005251|530860927|FG004|Overall Study|Randomized in error|0|||
147189548|NCT01005251|530860923|FG000|Overall Study|Lack of Efficacy|0|||
147189549|NCT01005251|530860924|FG001|Overall Study|Lack of Efficacy|0|||
147189550|NCT01005251|530860925|FG002|Overall Study|Lack of Efficacy|1|||
147189551|NCT01005251|530860926|FG003|Overall Study|Lack of Efficacy|1|||
147189552|NCT01005251|530860927|FG004|Overall Study|Lack of Efficacy|0|||
147189553|NCT00962208|530860929|FG000|Overall Study|Could not achieve good vision|9|||
147189554|NCT00962208|530860930|FG001|Overall Study|Could not achieve good vision|0|||
147189555|NCT00962208|530860929|FG000|Overall Study|Contraindicated to continue study|5|||
147189556|NCT00962208|530860930|FG001|Overall Study|Contraindicated to continue study|1|||
147189557|NCT00962208|530860929|FG000|Overall Study|Lost to Follow-up|0|||
147189558|NCT00962208|530860930|FG001|Overall Study|Lost to Follow-up|9|||
147189559|NCT00657540|530860931|FG000|Overall Study|Lost to Follow-up|1|||
147189560|NCT00657540|530860932|FG001|Overall Study|Lost to Follow-up|4|||
147189561|NCT04245111|530860935|FG000|Overall Study|Lost to Follow-up|5|||
147189562|NCT04245111|530860936|FG001|Overall Study|Lost to Follow-up|1|||
147189563|NCT04245111|530860937|FG002|Overall Study|Lost to Follow-up|1|||
147189564|NCT06039579|530860940|FG000|Follow-Up (Day 11-Day 39)|Withdrawal by Subject|0|||
147189565|NCT06039579|530860941|FG001|Follow-Up (Day 11-Day 39)|Withdrawal by Subject|0|||
147189566|NCT06039579|530860942|FG002|Follow-Up (Day 11-Day 39)|Withdrawal by Subject|0|||
147189567|NCT06039579|530860943|FG003|Follow-Up (Day 11-Day 39)|Withdrawal by Subject|0|||
147189568|NCT06039579|530860944|FG004|Follow-Up (Day 11-Day 39)|Withdrawal by Subject|0|||
147189569|NCT06039579|530860945|FG005|Follow-Up (Day 11-Day 39)|Withdrawal by Subject|0|||
147189570|NCT06039579|530860946|FG006|Follow-Up (Day 11-Day 39)|Withdrawal by Subject|0|||
147189571|NCT06039579|530860947|FG007|Follow-Up (Day 11-Day 39)|Withdrawal by Subject|1|||
147189572|NCT02469623|530860948|FG000|Overall Study|Not consented for long-term follow-up|4|||
147189573|NCT02469623|530860948|FG000|Overall Study|Lost to Follow-up|4|||
147189574|NCT02469623|530860948|FG000|Overall Study|Withdrawal by Subject|2|||
147189575|NCT02469623|530860948|FG000|Overall Study|Death|3|||
147189576|NCT03309878|530860949|FG000|Overall Study|Adverse Event|1|||
147189577|NCT03309878|530860950|FG001|Overall Study|Adverse Event|0|||
147189578|NCT03309878|530860951|FG002|Overall Study|Adverse Event|0|||
147189579|NCT03309878|530860952|FG003|Overall Study|Adverse Event|0|||
147189580|NCT03309878|530860949|FG000|Overall Study|Did not maintain eligibility|2|||
147189581|NCT03309878|530860950|FG001|Overall Study|Did not maintain eligibility|1|||
147189582|NCT03309878|530860951|FG002|Overall Study|Did not maintain eligibility|0|||
147189583|NCT03309878|530860952|FG003|Overall Study|Did not maintain eligibility|0|||
147189584|NCT03309878|530860949|FG000|Overall Study|Withdrawal by Subject|0|||
147330014|NCT00543725|531373125|FG001|Overall Study|Withdrawal by Subject|13|||
147330015|NCT00543725|531373124|FG000|Overall Study|Lost to Follow-up|15|||
147330016|NCT00543725|531373125|FG001|Overall Study|Lost to Follow-up|11|||
147330017|NCT00543725|531373124|FG000|Overall Study|Other|3|||
147189585|NCT03309878|530860950|FG001|Overall Study|Withdrawal by Subject|1|||
147189586|NCT03309878|530860951|FG002|Overall Study|Withdrawal by Subject|0|||
147189587|NCT03309878|530860952|FG003|Overall Study|Withdrawal by Subject|0|||
147189588|NCT01096316|530860953|FG000|Overall Study|Lost to Follow-up|15|||
147189589|NCT01096316|530860954|FG001|Overall Study|Lost to Follow-up|9|||
147189590|NCT01884077|530860955|FG000|Overall Study|screen fail|0|||
147189591|NCT01884077|530860956|FG001|Overall Study|screen fail|2|||
147189592|NCT01884077|530860955|FG000|Overall Study|canceled surgery|2|||
147189593|NCT01884077|530860956|FG001|Overall Study|canceled surgery|0|||
147189594|NCT01884077|530860955|FG000|Overall Study|Lost to Follow-up|0|||
147189595|NCT01884077|530860956|FG001|Overall Study|Lost to Follow-up|4|||
147189596|NCT01884077|530860955|FG000|Overall Study|study closed|6|||
147189597|NCT01884077|530860956|FG001|Overall Study|study closed|4|||
147189598|NCT02836652|530860957|FG000|Overall Study|Death|3|||
147189599|NCT02836652|530860958|FG001|Overall Study|Death|3|||
147189600|NCT02836652|530860957|FG000|Overall Study|Transplant/Explant|3|||
147189601|NCT02836652|530860958|FG001|Overall Study|Transplant/Explant|4|||
147189602|NCT02836652|530860957|FG000|Overall Study|Withdrawn|9|||
147189603|NCT02836652|530860958|FG001|Overall Study|Withdrawn|9|||
147189604|NCT02836652|530860957|FG000|Overall Study|Not on treatment regimen post-op day 15|3|||
147189605|NCT02836652|530860958|FG001|Overall Study|Not on treatment regimen post-op day 15|3|||
147189606|NCT02349633|530860959|FG000|Overall Study|Death|0|||
147189607|NCT02349633|530860960|FG001|Overall Study|Death|1|||
147189608|NCT02349633|530860961|FG002|Overall Study|Death|0|||
147189609|NCT02349633|530860962|FG003|Overall Study|Death|0|||
147189610|NCT02349633|530860963|FG004|Overall Study|Death|0|||
147189611|NCT02349633|530860964|FG005|Overall Study|Death|1|||
147189612|NCT02349633|530860965|FG006|Overall Study|Death|1|||
147189613|NCT02349633|530860966|FG007|Overall Study|Death|1|||
147189614|NCT02349633|530860967|FG008|Overall Study|Death|0|||
147189615|NCT02349633|530860968|FG009|Overall Study|Death|1|||
147189616|NCT02349633|530860969|FG010|Overall Study|Death|0|||
147189617|NCT02349633|530860970|FG011|Overall Study|Death|0|||
147189618|NCT02349633|530860971|FG012|Overall Study|Death|0|||
147189619|NCT02349633|530860972|FG013|Overall Study|Death|0|||
147189620|NCT02349633|530860959|FG000|Overall Study|Withdrawal by Subject|0|||
147189621|NCT02349633|530860960|FG001|Overall Study|Withdrawal by Subject|0|||
147189622|NCT02349633|530860961|FG002|Overall Study|Withdrawal by Subject|0|||
147189623|NCT02349633|530860962|FG003|Overall Study|Withdrawal by Subject|1|||
147189624|NCT02349633|530860963|FG004|Overall Study|Withdrawal by Subject|0|||
147189625|NCT02349633|530860964|FG005|Overall Study|Withdrawal by Subject|0|||
147189626|NCT02349633|530860965|FG006|Overall Study|Withdrawal by Subject|0|||
147189627|NCT02349633|530860966|FG007|Overall Study|Withdrawal by Subject|2|||
147330018|NCT00543725|531373125|FG001|Overall Study|Other|3|||
147330019|NCT01250002|531373126|FG000|Overall Study|Change to open surgical procedure|4|||
147330020|NCT01250002|531373127|FG001|Overall Study|Change to open surgical procedure|3|||
147330021|NCT02322216|531373128|FG000|Overall Study|Adverse Event|1|||
147330022|NCT02322216|531373129|FG001|Overall Study|Adverse Event|0|||
147330023|NCT02322216|531373128|FG000|Overall Study|Withdrawal by Subject|1|||
147330024|NCT02322216|531373129|FG001|Overall Study|Withdrawal by Subject|4|||
147189628|NCT02349633|530860967|FG008|Overall Study|Withdrawal by Subject|2|||
147189629|NCT02349633|530860968|FG009|Overall Study|Withdrawal by Subject|1|||
147189630|NCT02349633|530860969|FG010|Overall Study|Withdrawal by Subject|0|||
147189631|NCT02349633|530860970|FG011|Overall Study|Withdrawal by Subject|0|||
147189632|NCT02349633|530860971|FG012|Overall Study|Withdrawal by Subject|0|||
147189633|NCT02349633|530860972|FG013|Overall Study|Withdrawal by Subject|0|||
147189634|NCT02349633|530860959|FG000|Overall Study|Withdrawal of informed consent|0|||
147189635|NCT02349633|530860960|FG001|Overall Study|Withdrawal of informed consent|0|||
147189636|NCT02349633|530860961|FG002|Overall Study|Withdrawal of informed consent|0|||
147189637|NCT02349633|530860962|FG003|Overall Study|Withdrawal of informed consent|1|||
147189638|NCT02349633|530860963|FG004|Overall Study|Withdrawal of informed consent|1|||
147189639|NCT02349633|530860964|FG005|Overall Study|Withdrawal of informed consent|0|||
147330025|NCT01651949|531373133|FG000|Overall Study|Unknown status|4|||
147189640|NCT02349633|530860965|FG006|Overall Study|Withdrawal of informed consent|0|||
147189641|NCT02349633|530860966|FG007|Overall Study|Withdrawal of informed consent|3|||
147189642|NCT02349633|530860967|FG008|Overall Study|Withdrawal of informed consent|0|||
147189643|NCT02349633|530860968|FG009|Overall Study|Withdrawal of informed consent|0|||
147330026|NCT01651949|531373134|FG001|Overall Study|Unknown status|4|||
147330027|NCT01651949|531373135|FG002|Overall Study|Unknown status|0|||
147330028|NCT01651949|531373133|FG000|Overall Study|Lost to Follow-up|30|||
147189644|NCT02349633|530860969|FG010|Overall Study|Withdrawal of informed consent|0|||
147189645|NCT02349633|530860970|FG011|Overall Study|Withdrawal of informed consent|0|||
147189646|NCT02349633|530860971|FG012|Overall Study|Withdrawal of informed consent|0|||
147189647|NCT02349633|530860972|FG013|Overall Study|Withdrawal of informed consent|0|||
147189648|NCT02349633|530860959|FG000|Overall Study|Transition to compassionate use|0|||
147189649|NCT02349633|530860960|FG001|Overall Study|Transition to compassionate use|0|||
147189650|NCT02349633|530860961|FG002|Overall Study|Transition to compassionate use|0|||
147189651|NCT02349633|530860962|FG003|Overall Study|Transition to compassionate use|0|||
147189652|NCT02349633|530860963|FG004|Overall Study|Transition to compassionate use|1|||
147189653|NCT02349633|530860964|FG005|Overall Study|Transition to compassionate use|0|||
147189654|NCT02349633|530860965|FG006|Overall Study|Transition to compassionate use|0|||
147189655|NCT02349633|530860966|FG007|Overall Study|Transition to compassionate use|3|||
147189656|NCT02349633|530860967|FG008|Overall Study|Transition to compassionate use|0|||
147189657|NCT02349633|530860968|FG009|Overall Study|Transition to compassionate use|1|||
147189658|NCT02349633|530860969|FG010|Overall Study|Transition to compassionate use|0|||
147189659|NCT02349633|530860970|FG011|Overall Study|Transition to compassionate use|0|||
147189660|NCT02349633|530860971|FG012|Overall Study|Transition to compassionate use|0|||
147189661|NCT02349633|530860972|FG013|Overall Study|Transition to compassionate use|0|||
147189662|NCT02349633|530860959|FG000|Overall Study|Early termination of survival follow-up|0|||
147189663|NCT02349633|530860960|FG001|Overall Study|Early termination of survival follow-up|0|||
147189664|NCT02349633|530860961|FG002|Overall Study|Early termination of survival follow-up|0|||
147189665|NCT02349633|530860962|FG003|Overall Study|Early termination of survival follow-up|0|||
147189666|NCT02349633|530860963|FG004|Overall Study|Early termination of survival follow-up|0|||
147189667|NCT02349633|530860964|FG005|Overall Study|Early termination of survival follow-up|0|||
147189668|NCT02349633|530860965|FG006|Overall Study|Early termination of survival follow-up|0|||
147189669|NCT02349633|530860966|FG007|Overall Study|Early termination of survival follow-up|4|||
147189670|NCT02349633|530860967|FG008|Overall Study|Early termination of survival follow-up|0|||
147189671|NCT02349633|530860968|FG009|Overall Study|Early termination of survival follow-up|0|||
147189672|NCT02349633|530860969|FG010|Overall Study|Early termination of survival follow-up|0|||
147189673|NCT02349633|530860970|FG011|Overall Study|Early termination of survival follow-up|0|||
147189674|NCT02349633|530860971|FG012|Overall Study|Early termination of survival follow-up|0|||
147189675|NCT02349633|530860972|FG013|Overall Study|Early termination of survival follow-up|0|||
147189676|NCT02349633|530860959|FG000|Overall Study|Termination by sponsor|0|||
147189677|NCT02349633|530860960|FG001|Overall Study|Termination by sponsor|0|||
147189678|NCT02349633|530860961|FG002|Overall Study|Termination by sponsor|0|||
147330029|NCT01651949|531373134|FG001|Overall Study|Lost to Follow-up|56|||
147330030|NCT01651949|531373135|FG002|Overall Study|Lost to Follow-up|20|||
147330031|NCT01651949|531373133|FG000|Overall Study|Protocol Violation|0|||
147330032|NCT01651949|531373134|FG001|Overall Study|Protocol Violation|2|||
147330033|NCT01651949|531373135|FG002|Overall Study|Protocol Violation|1|||
147330034|NCT01651949|531373133|FG000|Overall Study|Physician Decision|0|||
147330035|NCT01651949|531373134|FG001|Overall Study|Physician Decision|2|||
147330036|NCT01651949|531373135|FG002|Overall Study|Physician Decision|0|||
147330037|NCT01651949|531373133|FG000|Overall Study|Adverse Event|0|||
147330038|NCT01651949|531373134|FG001|Overall Study|Adverse Event|2|||
147330039|NCT01651949|531373135|FG002|Overall Study|Adverse Event|1|||
147330040|NCT01651949|531373133|FG000|Overall Study|Screen failure|2|||
147330041|NCT01651949|531373134|FG001|Overall Study|Screen failure|2|||
147330042|NCT01651949|531373135|FG002|Overall Study|Screen failure|0|||
147330043|NCT01651949|531373133|FG000|Overall Study|Withdrawal by Subject|17|||
147330044|NCT01651949|531373134|FG001|Overall Study|Withdrawal by Subject|18|||
147330045|NCT01651949|531373135|FG002|Overall Study|Withdrawal by Subject|9|||
147330046|NCT00678795|531373136|FG000|Overall Study|Adverse Event|7|||
147330047|NCT00678795|531373137|FG001|Overall Study|Adverse Event|3|||
147189679|NCT02349633|530860962|FG003|Overall Study|Termination by sponsor|0|||
147189680|NCT02349633|530860963|FG004|Overall Study|Termination by sponsor|0|||
147189681|NCT02349633|530860964|FG005|Overall Study|Termination by sponsor|0|||
147189682|NCT02349633|530860965|FG006|Overall Study|Termination by sponsor|0|||
147189683|NCT02349633|530860966|FG007|Overall Study|Termination by sponsor|1|||
147189684|NCT02349633|530860967|FG008|Overall Study|Termination by sponsor|0|||
147189685|NCT02349633|530860968|FG009|Overall Study|Termination by sponsor|2|||
147189686|NCT02349633|530860969|FG010|Overall Study|Termination by sponsor|0|||
147330048|NCT00678795|531373136|FG000|Overall Study|Withdrawal by Subject|3|||
147330049|NCT00678795|531373137|FG001|Overall Study|Withdrawal by Subject|0|||
147330050|NCT00678795|531373136|FG000|Overall Study|Protocol Violation|0|||
147330051|NCT00678795|531373137|FG001|Overall Study|Protocol Violation|1|||
147330052|NCT00678795|531373136|FG000|Overall Study|Lost to Follow-up|0|||
147330053|NCT00678795|531373137|FG001|Overall Study|Lost to Follow-up|1|||
147594123|NCT01698775|532330602|FG001|Phase B|Hyperglycemia Discontinuation Criteria|1|||
147189687|NCT02349633|530860970|FG011|Overall Study|Termination by sponsor|0|||
147189688|NCT02349633|530860971|FG012|Overall Study|Termination by sponsor|0|||
147189689|NCT02349633|530860972|FG013|Overall Study|Termination by sponsor|0|||
147330054|NCT00678795|531373136|FG000|Overall Study|Lack of Efficacy|1|||
147330055|NCT00678795|531373137|FG001|Overall Study|Lack of Efficacy|1|||
147330056|NCT01191086|531373138|FG000|Overall Study|Adverse Event|20|||
147330057|NCT01191086|531373138|FG000|Overall Study|Lack of Efficacy|10|||
147330058|NCT01191086|531373138|FG000|Overall Study|Lost to Follow-up|4|||
147330059|NCT01191086|531373138|FG000|Overall Study|Physician Decision|2|||
147247956|NCT00411645|531076683|FG000|Overall Study|Consent Withdrawn|13|||
147247957|NCT00411645|531076684|FG001|Overall Study|Consent Withdrawn|22|||
147247958|NCT00411645|531076683|FG000|Overall Study|Death|56|||
147247959|NCT00411645|531076684|FG001|Overall Study|Death|135|||
147247960|NCT00411645|531076683|FG000|Overall Study|Investigator/Sponsor Decision|10|||
147247961|NCT00411645|531076684|FG001|Overall Study|Investigator/Sponsor Decision|7|||
147247962|NCT00411645|531076683|FG000|Overall Study|Lost to Follow-up|2|||
147247963|NCT00411645|531076684|FG001|Overall Study|Lost to Follow-up|0|||
147247964|NCT04016285|531076685|FG000|Overall Study|Did not progress to surgery|2|||
147247965|NCT04016285|531076686|FG001|Overall Study|Did not progress to surgery|5|||
147247966|NCT04016285|531076685|FG000|Overall Study|Failed to collect outcome data|5|||
147247967|NCT04016285|531076686|FG001|Overall Study|Failed to collect outcome data|3|||
147247968|NCT02509156|531076687|FG000|Randomized Phase|Death|1|||
147247969|NCT02509156|531076688|FG001|Randomized Phase|Death|0|||
147247970|NCT02509156|531076687|FG000|Randomized Phase|Withdrawal by Subject|1|||
147247971|NCT02509156|531076688|FG001|Randomized Phase|Withdrawal by Subject|1|||
147247972|NCT01750242|531076693|FG000|Overall Study|Unreadable Images|3|||
147247973|NCT00006903|531076694|FG000|Overall Study|Still receiving treatment|0|||
147247974|NCT00006903|531076695|FG001|Overall Study|Still receiving treatment|0|||
147247975|NCT00006903|531076696|FG002|Overall Study|Still receiving treatment|1|||
147247976|NCT00006903|531076694|FG000|Overall Study|Refused further treatment|0|||
147247977|NCT00006903|531076695|FG001|Overall Study|Refused further treatment|2|||
147247978|NCT00006903|531076696|FG002|Overall Study|Refused further treatment|1|||
147247979|NCT00006903|531076694|FG000|Overall Study|Adverse Event|0|||
147247980|NCT00006903|531076695|FG001|Overall Study|Adverse Event|0|||
147247981|NCT00006903|531076696|FG002|Overall Study|Adverse Event|1|||
147247982|NCT00006903|531076694|FG000|Overall Study|Death|0|||
147247983|NCT00006903|531076695|FG001|Overall Study|Death|1|||
147247984|NCT00006903|531076696|FG002|Overall Study|Death|0|||
147247985|NCT00006903|531076694|FG000|Overall Study|Patient never treated|0|||
147247986|NCT00006903|531076695|FG001|Overall Study|Patient never treated|0|||
147247987|NCT00006903|531076696|FG002|Overall Study|Patient never treated|1|||
147247988|NCT00006903|531076694|FG000|Overall Study|Ineligible|10|||
147247989|NCT00006903|531076695|FG001|Overall Study|Ineligible|1|||
147247990|NCT00006903|531076696|FG002|Overall Study|Ineligible|2|||
147247991|NCT01909674|531076697|FG000|Overall Study|Withdrawal by Subject|5|||
147247992|NCT01909674|531076698|FG001|Overall Study|Withdrawal by Subject|2|||
147247993|NCT02969369|531076701|FG000|Study|Adverse Event|1|||
147247994|NCT02969369|531076702|FG001|Study|Adverse Event|6|||
147247995|NCT02969369|531076701|FG000|Study|Lack of Efficacy|0|||
147247996|NCT02969369|531076702|FG001|Study|Lack of Efficacy|1|||
147247997|NCT02969369|531076701|FG000|Study|Lost to Follow-up|0|||
147247998|NCT02969369|531076702|FG001|Study|Lost to Follow-up|1|||
147247999|NCT02969369|531076701|FG000|Study|Withdrawal by Subject|3|||
147248000|NCT02969369|531076702|FG001|Study|Withdrawal by Subject|5|||
147248001|NCT02969369|531076701|FG000|Study|WITHDRAWAL BY PI DUE TO OTHER UNDERLYING ILLNESSES|0|||
147248002|NCT02969369|531076702|FG001|Study|WITHDRAWAL BY PI DUE TO OTHER UNDERLYING ILLNESSES|1|||
147248003|NCT02969369|531076701|FG000|Double-blind Period|Adverse Event|1|||
147248004|NCT02969369|531076702|FG001|Double-blind Period|Adverse Event|5|||
147248005|NCT02969369|531076701|FG000|Double-blind Period|Lost to Follow-up|0|||
147248006|NCT02969369|531076702|FG001|Double-blind Period|Lost to Follow-up|1|||
147248007|NCT02969369|531076701|FG000|Double-blind Period|Withdrawal by Subject|2|||
147248008|NCT02969369|531076702|FG001|Double-blind Period|Withdrawal by Subject|3|||
147248009|NCT02969369|531076701|FG000|Double-blind Period|WITHDRAWAL BY PI DUE TO OTHER UNDERLYING ILLNESSES|0|||
147248010|NCT02969369|531076702|FG001|Double-blind Period|WITHDRAWAL BY PI DUE TO OTHER UNDERLYING ILLNESSES|1|||
147248011|NCT02969369|531076701|FG000|Open-label SEP-363856 Period|Adverse Event|0|||
147248012|NCT02969369|531076702|FG001|Open-label SEP-363856 Period|Adverse Event|1|||
147248013|NCT02969369|531076701|FG000|Open-label SEP-363856 Period|Lack of Efficacy|0|||
147248014|NCT02969369|531076702|FG001|Open-label SEP-363856 Period|Lack of Efficacy|1|||
147248015|NCT02969369|531076701|FG000|Open-label SEP-363856 Period|Withdrawal by Subject|1|||
147248016|NCT02969369|531076702|FG001|Open-label SEP-363856 Period|Withdrawal by Subject|2|||
147248017|NCT01980992|531076703|FG000|52 Weeks Blinded Study Treatment|Dosing Symptoms|0|||
147248018|NCT01980992|531076704|FG001|52 Weeks Blinded Study Treatment|Dosing Symptoms|3|||
147248019|NCT01980992|531076703|FG000|52 Weeks Blinded Study Treatment|Withdrawal by Subject|1|||
147248020|NCT01980992|531076704|FG001|52 Weeks Blinded Study Treatment|Withdrawal by Subject|1|||
147248021|NCT01980992|531076703|FG000|52 Weeks Blinded Study Treatment|Non-compliance|1|||
147248022|NCT01980992|531076704|FG001|52 Weeks Blinded Study Treatment|Non-compliance|0|||
147248023|NCT01980992|531076703|FG000|52 Weeks Open Label Active Wheat OIT|Dosing Symptoms|2|||
147248024|NCT01980992|531076704|FG001|52 Weeks Open Label Active Wheat OIT|Dosing Symptoms|0|||
147248025|NCT01980992|531076703|FG000|52 Weeks Open Label Active Wheat OIT|Non-compliance|1|||
147248026|NCT01980992|531076704|FG001|52 Weeks Open Label Active Wheat OIT|Non-compliance|0|||
147248027|NCT01980992|531076703|FG000|52 Weeks Open Label Active Wheat OIT|Lost to Follow-up|0|||
147248028|NCT01980992|531076704|FG001|52 Weeks Open Label Active Wheat OIT|Lost to Follow-up|1|||
147248029|NCT02627144|531076708|FG000|Overall Study|Serious adverse event|32|||
147248030|NCT02627144|531076708|FG000|Overall Study|Cancer progression|171|||
147330060|NCT01191086|531373138|FG000|Overall Study|Withdrawal by Subject|24|||
147330061|NCT01191086|531373138|FG000|Overall Study|Discontinuation criterion met|1|||
147330062|NCT01191086|531373138|FG000|Overall Study|Other|1|||
147330063|NCT02057718|531373141|FG000|Completed Study Treatment Through Wk. 72|Progressive disease|0|||
147330064|NCT02057718|531373142|FG001|Completed Study Treatment Through Wk. 72|Progressive disease|2|||
147330065|NCT02057718|531373141|FG000|Completed Study Treatment Through Wk. 72|Physician Decision|1|||
147330066|NCT02057718|531373142|FG001|Completed Study Treatment Through Wk. 72|Physician Decision|0|||
147330067|NCT02057718|531373141|FG000|Completed Study Treatment Through Wk. 72|Non-compliance with study drug|0|||
147330068|NCT02057718|531373142|FG001|Completed Study Treatment Through Wk. 72|Non-compliance with study drug|1|||
147330069|NCT02057718|531373141|FG000|Completed Study Treatment Through Wk. 72|Adverse Event|0|||
147330070|NCT02057718|531373142|FG001|Completed Study Treatment Through Wk. 72|Adverse Event|3|||
147330071|NCT02057718|531373141|FG000|Completed Study Treatment Through Wk. 72|Consent withdrawn by caregiver|1|||
147330072|NCT02057718|531373142|FG001|Completed Study Treatment Through Wk. 72|Consent withdrawn by caregiver|1|||
147330073|NCT02057718|531373141|FG000|Completed Study Treatment Through Wk. 72|Consent withdrawn by subject|0|||
147330074|NCT02057718|531373142|FG001|Completed Study Treatment Through Wk. 72|Consent withdrawn by subject|1|||
147330075|NCT02057718|531373141|FG000|Completed Study Treatment Through Wk. 72|Liver Transplant|0|||
147330076|NCT02057718|531373142|FG001|Completed Study Treatment Through Wk. 72|Liver Transplant|1|||
147330077|NCT02057718|531373141|FG000|Optional Follow-up Treatment Period|Did not consent to protocol amendment|1|||
147330078|NCT02057718|531373142|FG001|Optional Follow-up Treatment Period|Did not consent to protocol amendment|3|||
147330079|NCT02057718|531373141|FG000|Optional Follow-up Treatment Period|Progressive disease|0|||
147330080|NCT02057718|531373142|FG001|Optional Follow-up Treatment Period|Progressive disease|1|||
147330081|NCT02057718|531373141|FG000|Optional Follow-up Treatment Period|Adverse Event|1|||
147330082|NCT02057718|531373142|FG001|Optional Follow-up Treatment Period|Adverse Event|2|||
147330083|NCT02057718|531373141|FG000|Optional Follow-up Treatment Period|Liver Transplant|0|||
147330084|NCT02057718|531373142|FG001|Optional Follow-up Treatment Period|Liver Transplant|2|||
147330085|NCT00608907|531373148|FG000|Overall Study|Adverse Event|6|||
147330086|NCT00608907|531373149|FG001|Overall Study|Adverse Event|0|||
147330087|NCT00608907|531373150|FG002|Overall Study|Adverse Event|1|||
147330088|NCT00608907|531373148|FG000|Overall Study|Death|1|||
147330089|NCT00608907|531373149|FG001|Overall Study|Death|0|||
147330090|NCT00608907|531373150|FG002|Overall Study|Death|0|||
147330091|NCT00608907|531373148|FG000|Overall Study|Withdrawal by Subject|4|||
147330092|NCT00608907|531373149|FG001|Overall Study|Withdrawal by Subject|0|||
147330093|NCT00608907|531373150|FG002|Overall Study|Withdrawal by Subject|0|||
147330094|NCT00608907|531373148|FG000|Overall Study|Progressive Disease|1|||
147330095|NCT00608907|531373149|FG001|Overall Study|Progressive Disease|0|||
147330096|NCT00608907|531373150|FG002|Overall Study|Progressive Disease|0|||
147330097|NCT00906035|531373151|FG000|Overall Study|Withdrawal by Subject|2|||
147330098|NCT00906035|531373152|FG001|Overall Study|Withdrawal by Subject|3|||
147330099|NCT00906035|531373153|FG002|Overall Study|Withdrawal by Subject|0|||
147330100|NCT03058991|531373154|FG000|Overall Study|Lost to Follow-up|17|||
147330101|NCT03058991|531373155|FG001|Overall Study|Lost to Follow-up|12|||
147330102|NCT03058991|531373156|FG002|Overall Study|Lost to Follow-up|12|||
147330103|NCT03058991|531373154|FG000|Overall Study|Withdrawal by Subject|1|||
147330104|NCT03058991|531373155|FG001|Overall Study|Withdrawal by Subject|0|||
147330105|NCT03058991|531373156|FG002|Overall Study|Withdrawal by Subject|0|||
147330106|NCT01689519|531373157|FG000|Intent to Treat|Death|157|||
147330107|NCT01689519|531373158|FG001|Intent to Treat|Death|167|||
147330108|NCT01689519|531373157|FG000|Intent to Treat|Lost to Follow-up|4|||
147330109|NCT01689519|531373158|FG001|Intent to Treat|Lost to Follow-up|8|||
147330110|NCT01689519|531373157|FG000|Intent to Treat|Other|2|||
147330111|NCT01689519|531373158|FG001|Intent to Treat|Other|4|||
147330112|NCT01689519|531373157|FG000|Intent to Treat|Physician Decision|4|||
147330113|NCT01689519|531373158|FG001|Intent to Treat|Physician Decision|1|||
147330114|NCT01689519|531373157|FG000|Intent to Treat|Study terminated by Spon6sor|59|||
147330115|NCT01689519|531373158|FG001|Intent to Treat|Study terminated by Spon6sor|48|||
147330116|NCT01689519|531373157|FG000|Intent to Treat|Withdrawal by Subject|21|||
147330117|NCT01689519|531373158|FG001|Intent to Treat|Withdrawal by Subject|20|||
147330118|NCT01689519|531373157|FG000|Safety Population|Death|158|||
147330119|NCT01689519|531373158|FG001|Safety Population|Death|165|||
147330120|NCT01689519|531373157|FG000|Safety Population|Lost to Follow-up|4|||
147330121|NCT01689519|531373158|FG001|Safety Population|Lost to Follow-up|8|||
147330122|NCT01689519|531373157|FG000|Safety Population|Other|2|||
147594124|NCT01698775|532330601|FG000|Phase B|Adverse Event|6|||
147594125|NCT01698775|532330602|FG001|Phase B|Adverse Event|3|||
147330123|NCT01689519|531373158|FG001|Safety Population|Other|4|||
147330124|NCT01689519|531373157|FG000|Safety Population|Physician Decision|4|||
147330125|NCT01689519|531373158|FG001|Safety Population|Physician Decision|1|||
147330126|NCT01689519|531373157|FG000|Safety Population|Study Terminated By Sponsor|60|||
147330127|NCT01689519|531373158|FG001|Safety Population|Study Terminated By Sponsor|47|||
147330128|NCT01689519|531373157|FG000|Safety Population|Withdrawal by Subject|20|||
147330129|NCT01689519|531373158|FG001|Safety Population|Withdrawal by Subject|20|||
147448997|NCT01225731|531808044|FG000|Part 2|Protocol Violation|0|||
147189690|NCT02349633|530860959|FG000|Overall Study|Other|0|||
147189691|NCT02349633|530860960|FG001|Overall Study|Other|0|||
147189692|NCT02349633|530860961|FG002|Overall Study|Other|0|||
147189693|NCT02349633|530860962|FG003|Overall Study|Other|0|||
147189694|NCT02349633|530860963|FG004|Overall Study|Other|0|||
147189695|NCT02349633|530860964|FG005|Overall Study|Other|0|||
147189696|NCT02349633|530860965|FG006|Overall Study|Other|0|||
147189697|NCT02349633|530860966|FG007|Overall Study|Other|2|||
147189698|NCT02349633|530860967|FG008|Overall Study|Other|0|||
147189699|NCT02349633|530860968|FG009|Overall Study|Other|0|||
147189700|NCT02349633|530860969|FG010|Overall Study|Other|0|||
147189701|NCT02349633|530860970|FG011|Overall Study|Other|0|||
147189702|NCT02349633|530860971|FG012|Overall Study|Other|0|||
147189703|NCT02349633|530860972|FG013|Overall Study|Other|0|||
147189704|NCT00667628|530860976|FG000|Overall Study|Lost to Follow-up|1|||
147189705|NCT00667628|530860977|FG001|Overall Study|Lost to Follow-up|0|||
147189706|NCT00667628|530860976|FG000|Overall Study|Death|6|||
147189707|NCT00667628|530860977|FG001|Overall Study|Death|6|||
147189708|NCT00667628|530860976|FG000|Overall Study|Investigator Considers in Best Interest|1|||
147189709|NCT00667628|530860977|FG001|Overall Study|Investigator Considers in Best Interest|0|||
147189710|NCT00667628|530860976|FG000|Overall Study|Sponsor Terminated Study|17|||
147189711|NCT00667628|530860977|FG001|Overall Study|Sponsor Terminated Study|21|||
147189712|NCT04663321|530860978|FG000|Overall Study|Study terminated by Sponsor|2|||
147189713|NCT04663321|530860979|FG001|Overall Study|Study terminated by Sponsor|1|||
147189714|NCT04663321|530860980|FG002|Overall Study|Study terminated by Sponsor|2|||
147189715|NCT04663321|530860978|FG000|Overall Study|Withdrawal by Subject|10|||
147189716|NCT04663321|530860979|FG001|Overall Study|Withdrawal by Subject|3|||
147189717|NCT04663321|530860980|FG002|Overall Study|Withdrawal by Subject|2|||
147189718|NCT04663321|530860978|FG000|Overall Study|Not provided|0|||
147189719|NCT04663321|530860979|FG001|Overall Study|Not provided|0|||
147189720|NCT04663321|530860980|FG002|Overall Study|Not provided|1|||
147189721|NCT03360682|530860981|FG000|Overall Study|Adverse Event|3|||
147189722|NCT01962441|530860984|FG000|Randomized Period|Randomized but Never Treated|4|||
147189723|NCT01962441|530860985|FG001|Randomized Period|Randomized but Never Treated|2|||
147189724|NCT01962441|530860986|FG002|Randomized Period|Randomized but Never Treated|3|||
147189725|NCT01962441|530860984|FG000|Randomized Period|Lost to Follow-up|2|||
147189726|NCT01962441|530860985|FG001|Randomized Period|Lost to Follow-up|4|||
147189727|NCT01962441|530860986|FG002|Randomized Period|Lost to Follow-up|4|||
147189728|NCT01962441|530860984|FG000|Randomized Period|Withdrew Consent|3|||
147189729|NCT01962441|530860985|FG001|Randomized Period|Withdrew Consent|3|||
147189730|NCT01962441|530860986|FG002|Randomized Period|Withdrew Consent|2|||
147189731|NCT01962441|530860984|FG000|Randomized Period|Adverse Event|1|||
147189732|NCT01962441|530860985|FG001|Randomized Period|Adverse Event|1|||
147189733|NCT01962441|530860986|FG002|Randomized Period|Adverse Event|0|||
147189734|NCT01962441|530860984|FG000|Randomized Period|Death|0|||
147189735|NCT01962441|530860985|FG001|Randomized Period|Death|0|||
147189736|NCT01962441|530860986|FG002|Randomized Period|Death|2|||
147248031|NCT02627144|531076708|FG000|Overall Study|Death from cancer|20|||
147248032|NCT02627144|531076708|FG000|Overall Study|Death from other cause|8|||
147248033|NCT02627144|531076708|FG000|Overall Study|Refusal of treatment / poor cooperation|38|||
147248034|NCT02627144|531076708|FG000|Overall Study|Administrative reasons|65|||
147248035|NCT02627144|531076708|FG000|Overall Study|Lost to Follow-up|8|||
147248036|NCT02627144|531076708|FG000|Overall Study|Enrolled, not treated|6|||
147248037|NCT02627144|531076708|FG000|Overall Study|Other|17|||
147248038|NCT02651922|531076711|FG000|Overall Study|due to exclusion criteria|2|||
147248039|NCT01366209|531076712|FG000|Overall Study|Adverse Event|6|||
147248040|NCT01366209|531076713|FG001|Overall Study|Adverse Event|7|||
147248041|NCT01366209|531076712|FG000|Overall Study|Withdrawal by Subject|4|||
147248042|NCT01366209|531076713|FG001|Overall Study|Withdrawal by Subject|4|||
147248043|NCT01366209|531076712|FG000|Overall Study|Death|12|||
147248044|NCT01366209|531076713|FG001|Overall Study|Death|19|||
147248045|NCT01366209|531076712|FG000|Overall Study|Lung transplantation|6|||
147248046|NCT01366209|531076713|FG001|Overall Study|Lung transplantation|1|||
147248047|NCT01366209|531076712|FG000|Overall Study|Lost to Follow-up|2|||
147248048|NCT01366209|531076713|FG001|Overall Study|Lost to Follow-up|1|||
147248049|NCT01366209|531076712|FG000|Overall Study|Physician Decision|1|||
147248050|NCT01366209|531076713|FG001|Overall Study|Physician Decision|0|||
147248051|NCT01366209|531076712|FG000|Overall Study|Sponsors decision|0|||
147248052|NCT01366209|531076713|FG001|Overall Study|Sponsors decision|1|||
147248053|NCT01366209|531076712|FG000|Overall Study|Withdrew consent|4|||
147248054|NCT01366209|531076713|FG001|Overall Study|Withdrew consent|3|||
147248055|NCT01053221|531076714|FG000|Overall Study|The study was closed prematurely|5|||
147248056|NCT01053221|531076715|FG001|Overall Study|The study was closed prematurely|9|||
147248057|NCT01465997|531076716|FG000|Overall Study|Adverse Event|12|||
147248058|NCT01465997|531076717|FG001|Overall Study|Adverse Event|22|||
147248059|NCT01465997|531076716|FG000|Overall Study|Lack of Efficacy|13|||
147248060|NCT01465997|531076717|FG001|Overall Study|Lack of Efficacy|1|||
147189737|NCT01962441|530860984|FG000|Randomized Period|Protocol Violation|0|||
147189738|NCT01962441|530860985|FG001|Randomized Period|Protocol Violation|1|||
147658594|NCT03428100|532572326|FG015|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
147189739|NCT01962441|530860986|FG002|Randomized Period|Protocol Violation|0|||
147189740|NCT01962441|530860984|FG000|Retreatment Substudy|Lack of Efficacy|1|||
147189741|NCT01962441|530860985|FG001|Retreatment Substudy|Lack of Efficacy|0|||
147189742|NCT01962441|530860986|FG002|Retreatment Substudy|Lack of Efficacy|0|||
147189743|NCT01962441|530860984|FG000|Retreatment Substudy|Lost to Follow-up|1|||
147189744|NCT01962441|530860985|FG001|Retreatment Substudy|Lost to Follow-up|0|||
147189745|NCT01962441|530860986|FG002|Retreatment Substudy|Lost to Follow-up|0|||
147189746|NCT04862065|530860987|FG000|Screening|Protocol Violation|54|||
147189747|NCT04862065|530860988|FG001|Screening|Protocol Violation|0|||
147189748|NCT04862065|530860989|FG002|Screening|Protocol Violation|0|||
147189749|NCT04862065|530860987|FG000|Screening|Insufficient Sample|1|||
147189750|NCT04862065|530860988|FG001|Screening|Insufficient Sample|0|||
147189751|NCT04862065|530860989|FG002|Screening|Insufficient Sample|0|||
147189752|NCT04862065|530860987|FG000|Follow-Up|Lost to Follow-up|3|||
147189753|NCT04862065|530860988|FG001|Follow-Up|Lost to Follow-up|0|||
147189754|NCT04862065|530860989|FG002|Follow-Up|Lost to Follow-up|0|||
147189755|NCT01453140|530860990|FG000|Overall Study|Adverse Event|3|||
147189756|NCT00743249|530860991|FG000|Overall Study|Adverse Event|0|||
147189757|NCT00743249|530860992|FG001|Overall Study|Adverse Event|4|||
147189758|NCT00743249|530860991|FG000|Overall Study|Patient Decision Unrelated to Ad Event|0|||
147189759|NCT00743249|530860992|FG001|Overall Study|Patient Decision Unrelated to Ad Event|1|||
147189760|NCT00743249|530860991|FG000|Overall Study|Unsuccessful insertion of stent|2|||
147189761|NCT00743249|530860992|FG001|Overall Study|Unsuccessful insertion of stent|1|||
147189762|NCT00718510|530860993|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|0|||
147189763|NCT00718510|530860994|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
147189764|NCT00718510|530860993|FG000|Second Intervention (3 Weeks)|Withdrawal by Subject|1|||
147189765|NCT00718510|530860994|FG001|Second Intervention (3 Weeks)|Withdrawal by Subject|0|||
147189766|NCT02201524|530860995|FG000|Overall Study|Adverse Event|0|||
147189767|NCT02201524|530860996|FG001|Overall Study|Adverse Event|2|||
147189768|NCT02201524|530860997|FG002|Overall Study|Adverse Event|1|||
147189769|NCT02201524|530860998|FG003|Overall Study|Adverse Event|0|||
147189770|NCT02201524|530860995|FG000|Overall Study|Insufficient clinical response|1|||
147189771|NCT02201524|530860996|FG001|Overall Study|Insufficient clinical response|0|||
147189772|NCT02201524|530860997|FG002|Overall Study|Insufficient clinical response|0|||
147189773|NCT02201524|530860998|FG003|Overall Study|Insufficient clinical response|0|||
147189774|NCT02201524|530860995|FG000|Overall Study|Lost to Follow-up|0|||
147189775|NCT02201524|530860996|FG001|Overall Study|Lost to Follow-up|0|||
147189776|NCT02201524|530860997|FG002|Overall Study|Lost to Follow-up|2|||
147189777|NCT02201524|530860998|FG003|Overall Study|Lost to Follow-up|0|||
147189778|NCT02201524|530860995|FG000|Overall Study|No longer meets eligibility criteria|0|||
147189779|NCT02201524|530860996|FG001|Overall Study|No longer meets eligibility criteria|0|||
147189780|NCT02201524|530860997|FG002|Overall Study|No longer meets eligibility criteria|0|||
147189781|NCT02201524|530860998|FG003|Overall Study|No longer meets eligibility criteria|2|||
147248061|NCT01465997|531076716|FG000|Overall Study|Protocol Violation|1|||
147248062|NCT01465997|531076717|FG001|Overall Study|Protocol Violation|4|||
147248063|NCT01465997|531076716|FG000|Overall Study|Lost to Follow-up|6|||
147248064|NCT01465997|531076717|FG001|Overall Study|Lost to Follow-up|9|||
147248065|NCT01465997|531076716|FG000|Overall Study|Withdrawal by Subject|32|||
147248066|NCT01465997|531076717|FG001|Overall Study|Withdrawal by Subject|35|||
147248067|NCT01465997|531076716|FG000|Overall Study|investigator's decision|1|||
147248068|NCT01465997|531076717|FG001|Overall Study|investigator's decision|1|||
147248069|NCT01465997|531076716|FG000|Overall Study|Death|0|||
147248070|NCT01465997|531076717|FG001|Overall Study|Death|1|||
147248071|NCT01465997|531076716|FG000|Overall Study|sponsor's decision|1|||
147248072|NCT01465997|531076717|FG001|Overall Study|sponsor's decision|1|||
147248073|NCT01465997|531076716|FG000|Overall Study|subject withdrew consent|1|||
147248074|NCT01465997|531076717|FG001|Overall Study|subject withdrew consent|0|||
147248075|NCT01465997|531076716|FG000|Overall Study|local lab unblinded site|1|||
147248076|NCT01465997|531076717|FG001|Overall Study|local lab unblinded site|0|||
147248077|NCT01465997|531076716|FG000|Overall Study|withdrew before follow-up|0|||
147248078|NCT01465997|531076717|FG001|Overall Study|withdrew before follow-up|13|||
147248079|NCT01465997|531076716|FG000|Overall Study|decision by site staff|0|||
147248080|NCT01465997|531076717|FG001|Overall Study|decision by site staff|1|||
147248081|NCT01465997|531076716|FG000|Overall Study|subject left participation SP0993|0|||
147248082|NCT01465997|531076717|FG001|Overall Study|subject left participation SP0993|1|||
147248083|NCT02246660|531076718|FG000|Overall Study|Withdrawal by Subject|0|||
147248084|NCT02246660|531076719|FG001|Overall Study|Withdrawal by Subject|1|||
147248085|NCT02246660|531076720|FG002|Overall Study|Withdrawal by Subject|0|||
147189782|NCT02201524|530860995|FG000|Overall Study|Protocol Violation|0|||
147189783|NCT02201524|530860996|FG001|Overall Study|Protocol Violation|0|||
147189784|NCT02201524|530860997|FG002|Overall Study|Protocol Violation|0|||
147189785|NCT02201524|530860998|FG003|Overall Study|Protocol Violation|1|||
147248086|NCT02246660|531076718|FG000|Overall Study|Death|0|||
147248087|NCT02246660|531076719|FG001|Overall Study|Death|0|||
147658595|NCT03428100|532572327|FG016|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
147330130|NCT00559949|531373163|FG000|Overall Study|Progressive Disease during cycle 1|1|||
147330131|NCT00559949|531373163|FG000|Overall Study|Adverse Event|1|||
147330132|NCT00559949|531373163|FG000|Overall Study|Withdrawal by Subject|4|||
147330133|NCT00559949|531373163|FG000|Overall Study|No disease evaluation per protocol|1|||
147330134|NCT00835380|531373168|FG000|Overall Study|Withdrawal by Subject|2|||
147330135|NCT01582945|531373171|FG000|Overall Study|Intolerable side-effects|1|||
147330136|NCT01582945|531373171|FG000|Overall Study|Scheduling conflicts|1|||
147330137|NCT01726023|531373172|FG000|Overall Study|Death|1|||
147330138|NCT01726023|531373173|FG001|Overall Study|Death|1|||
147330139|NCT01726023|531373172|FG000|Overall Study|Lost to Follow-up|5|||
147330140|NCT01726023|531373173|FG001|Overall Study|Lost to Follow-up|10|||
147330141|NCT01726023|531373172|FG000|Overall Study|Other Eligibility criteria|7|||
147330142|NCT01726023|531373173|FG001|Overall Study|Other Eligibility criteria|7|||
147330143|NCT01726023|531373172|FG000|Overall Study|Withdrawal by Subject|16|||
147330144|NCT01726023|531373173|FG001|Overall Study|Withdrawal by Subject|8|||
147330145|NCT03643211|531373176|FG000|Overall Study|Contract violation/deficiency|12|||
147330146|NCT03643211|531373176|FG000|Overall Study|Invalid registration|3|||
147330147|NCT03643211|531373176|FG000|Overall Study|No treatment information|2|||
147330148|NCT03643211|531373176|FG000|Overall Study|No adverse event information - No revisit|4|||
147330149|NCT04858425|531373177|FG000|Overall Study|Adverse Event|2|||
147330150|NCT04858425|531373178|FG001|Overall Study|Adverse Event|2|||
147330151|NCT04858425|531373177|FG000|Overall Study|Withdrawal by Subject|3|||
147330152|NCT04858425|531373178|FG001|Overall Study|Withdrawal by Subject|1|||
147330153|NCT04858425|531373177|FG000|Overall Study|Lost to Follow-up|4|||
147330154|NCT04858425|531373178|FG001|Overall Study|Lost to Follow-up|2|||
147330155|NCT04858425|531373177|FG000|Overall Study|Lost to Follow-up|1|||
147330156|NCT04858425|531373178|FG001|Overall Study|Lost to Follow-up|0|||
147330157|NCT04536077|531373180|FG000|Overall Study|Did not start treatment due to surgery needing to occur urgently|1|||
147330158|NCT04536077|531373181|FG001|Overall Study|Did not start treatment due to surgery needing to occur urgently|0|||
147330159|NCT04536077|531373180|FG000|Overall Study|Did not start treatment due to disease progression and no longer having resectable disease|0|||
147330160|NCT04536077|531373181|FG001|Overall Study|Did not start treatment due to disease progression and no longer having resectable disease|1|||
147330161|NCT04550039|531373186|FG000|Overall Study|discharge to acute care prior to completion of study|2|||
147330162|NCT04550039|531373187|FG001|Overall Study|discharge to acute care prior to completion of study|1|||
147330163|NCT04550039|531373186|FG000|Overall Study|patient self-withdrew from study|0|||
147330164|NCT04550039|531373187|FG001|Overall Study|patient self-withdrew from study|1|||
147330165|NCT01155869|531373193|FG000|Overall Study|Lost to Follow-up|3|||
147330166|NCT01155869|531373194|FG001|Overall Study|Lost to Follow-up|1|||
147330167|NCT02824432|531373196|FG000|Overall Study|Major Protocol Deviation|1|||
147330168|NCT02824432|531373197|FG001|Overall Study|Major Protocol Deviation|0|||
147330169|NCT05824351|531373200|FG000|Overall Study|Adverse Event|6|||
147330170|NCT00828945|531373201|FG000|Overall Study|Death|4|||
147330171|NCT00828945|531373201|FG000|Overall Study|Participant was missing|1|||
147330172|NCT00828945|531373201|FG000|Overall Study|Other|36|||
147330173|NCT02698241|531373204|FG000|Overall Study|Inclusion/exclusion criteria not met|4|||
147330174|NCT02698241|531373204|FG000|Overall Study|Screening not met|7|||
147330175|NCT02698241|531373204|FG000|Overall Study|Withdrawal by Subject|7|||
147330176|NCT02698241|531373204|FG000|Overall Study|Physician Decision|2|||
147330177|NCT02698241|531373204|FG000|Overall Study|Subject underwent system modification|2|||
147330178|NCT02698241|531373204|FG000|Overall Study|Lost to Follow-up|3|||
147330179|NCT02698241|531373204|FG000|Overall Study|Subject on inodrip not safe to continue|6|||
147330180|NCT02698241|531373204|FG000|Overall Study|geographic and licensing issue|1|||
147330181|NCT02698241|531373204|FG000|Overall Study|Death|2|||
147330182|NCT00482729|531374435|FG000|Overall Study|Adverse Event|29|||
147330183|NCT00482729|531374436|FG001|Overall Study|Adverse Event|33|||
147330184|NCT00482729|531374435|FG000|Overall Study|Creatinine/Creatinine Clearance Criteria|0|||
147330185|NCT00482729|531374436|FG001|Overall Study|Creatinine/Creatinine Clearance Criteria|2|||
147330186|NCT00482729|531374435|FG000|Overall Study|Hyperglycemia Criteria|7|||
147330187|NCT00482729|531374436|FG001|Overall Study|Hyperglycemia Criteria|5|||
147330188|NCT00482729|531374435|FG000|Overall Study|Lack of Efficacy|4|||
147330189|NCT00482729|531374436|FG001|Overall Study|Lack of Efficacy|16|||
147330190|NCT00482729|531374435|FG000|Overall Study|Lost to Follow-up|86|||
147330191|NCT00482729|531374436|FG001|Overall Study|Lost to Follow-up|66|||
147330192|NCT00482729|531374435|FG000|Overall Study|Physician Decision|10|||
147330193|NCT00482729|531374436|FG001|Overall Study|Physician Decision|7|||
147330194|NCT00482729|531374435|FG000|Overall Study|Pregnancy|4|||
147330195|NCT00482729|531374436|FG001|Overall Study|Pregnancy|2|||
147330196|NCT00482729|531374435|FG000|Overall Study|Protocol Violation|10|||
147330197|NCT00482729|531374436|FG001|Overall Study|Protocol Violation|18|||
147330198|NCT00482729|531374435|FG000|Overall Study|Withdrawal by Subject|67|||
147330199|NCT00482729|531374436|FG001|Overall Study|Withdrawal by Subject|69|||
147330200|NCT01546155|531374437|FG000|Overall Study|could not tolerate long scan duration|3|||
147330201|NCT02930343|531374438|FG000|Overall Study|Lost to Follow-up|9|||
147330202|NCT02930343|531374439|FG001|Overall Study|Lost to Follow-up|7|||
147330203|NCT03646669|531374443|FG000|Overall Study|Withdrawal by Subject|5|||
147248088|NCT02246660|531076720|FG002|Overall Study|Death|1|||
147248089|NCT02557646|531076723|FG000|Overall Study|Adverse Event|40|||
147248090|NCT02557646|531076723|FG000|Overall Study|Death|1|||
147248091|NCT02557646|531076723|FG000|Overall Study|Lack of Efficacy|186|||
147248092|NCT02557646|531076723|FG000|Overall Study|Withdrawal by Subject|18|||
147248093|NCT02557646|531076723|FG000|Overall Study|Lost to Follow-up|17|||
147248094|NCT02557646|531076723|FG000|Overall Study|Other|14|||
147248095|NCT00496470|531076725|FG000|Overall Study|Adverse Event|8|||
147248096|NCT00496470|531076726|FG001|Overall Study|Adverse Event|10|||
147248097|NCT00496470|531076725|FG000|Overall Study|Withdrawal by Subject|5|||
147248098|NCT00496470|531076726|FG001|Overall Study|Withdrawal by Subject|12|||
147248099|NCT00496470|531076725|FG000|Overall Study|Incorrectly enrolled|13|||
147248100|NCT00496470|531076726|FG001|Overall Study|Incorrectly enrolled|5|||
147248101|NCT00496470|531076725|FG000|Overall Study|Other reason|0|||
147248102|NCT00496470|531076726|FG001|Overall Study|Other reason|2|||
147248103|NCT00729651|531076728|FG000|Overall Study|Withdrawal by Subject|5|||
147248104|NCT00729651|531076729|FG001|Overall Study|Withdrawal by Subject|6|||
147248105|NCT00729651|531076728|FG000|Overall Study|Lost to Follow-up|5|||
147248106|NCT00729651|531076729|FG001|Overall Study|Lost to Follow-up|4|||
147248107|NCT00729651|531076728|FG000|Overall Study|Protocol Violation|0|||
147248108|NCT00729651|531076729|FG001|Overall Study|Protocol Violation|1|||
147248109|NCT00729651|531076728|FG000|Overall Study|Adverse Event|7|||
147248110|NCT00729651|531076729|FG001|Overall Study|Adverse Event|3|||
147248111|NCT00729651|531076728|FG000|Overall Study|Visit 3, 25 OHD level ≤9 ng/mL|0|||
147248112|NCT00729651|531076729|FG001|Overall Study|Visit 3, 25 OHD level ≤9 ng/mL|4|||
147248113|NCT00729651|531076728|FG000|Overall Study|Subject's private reason|2|||
147248114|NCT00729651|531076729|FG001|Overall Study|Subject's private reason|0|||
147248115|NCT01637272|531076732|FG000|Overall Study|Adverse Event|6|||
147248116|NCT01637272|531076732|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
147248117|NCT01637272|531076732|FG000|Overall Study|Withdrawal by Subject|3|||
147248118|NCT01637272|531076732|FG000|Overall Study|Lost to Follow-up|2|||
147248119|NCT01637272|531076732|FG000|Overall Study|completed core, did not enter ext. phase|4|||
147248120|NCT01637272|531076732|FG000|Overall Study|Administrative problems|1|||
147248121|NCT01637272|531076732|FG000|Overall Study|Protocol Violation|2|||
147248122|NCT01496612|531076733|FG000|1st Intervention|Adverse Event|1|||
147248123|NCT01496612|531076734|FG001|1st Intervention|Adverse Event|0|||
147248124|NCT01496612|531076733|FG000|1st Intervention|Withdrawal by Subject|1|||
147248125|NCT01496612|531076734|FG001|1st Intervention|Withdrawal by Subject|0|||
147248126|NCT00291577|531076735|FG000|Overall Study|Adverse Event|1|||
147248127|NCT00291577|531076735|FG000|Overall Study|Other|4|||
147248128|NCT00291577|531076735|FG000|Overall Study|Withdrawal by Subject|2|||
147248129|NCT00291577|531076735|FG000|Overall Study|Lack of Efficacy|14|||
147248130|NCT01666782|531076738|FG000|Overall Study|Received 2 doses of vaccine|0|||
147248131|NCT01666782|531076739|FG001|Overall Study|Received 2 doses of vaccine|1|||
147248132|NCT01666782|531076738|FG000|Overall Study|Enrolled both years; year 1 data used|4|||
147248133|NCT01666782|531076739|FG001|Overall Study|Enrolled both years; year 1 data used|0|||
147248134|NCT03200860|531076753|FG000|Overall Study|Withdrawal by Subject|1|||
147248135|NCT03200860|531076754|FG001|Overall Study|Withdrawal by Subject|0|||
147248136|NCT00844896|531076755|FG000|Overall Study|Lost to Follow-up|12|||
147248137|NCT00844896|531076756|FG001|Overall Study|Lost to Follow-up|16|||
147248138|NCT00844896|531076755|FG000|Overall Study|Parents did not have time to complete|0|||
147248139|NCT00844896|531076756|FG001|Overall Study|Parents did not have time to complete|1|||
147248140|NCT00458211|531076760|FG000|Overall Study|Lack of Efficacy|12|||
147248141|NCT00458211|531076760|FG000|Overall Study|Withdrawal by Subject|2|||
147248142|NCT00458211|531076760|FG000|Overall Study|Protocol Violation|2|||
147248143|NCT04342897|531076761|FG000|Overall Study|Death|7|||
147248144|NCT04342897|531076762|FG001|Overall Study|Death|4|||
147248145|NCT04342897|531076761|FG000|Overall Study|Lost to Follow-up|6|||
147248146|NCT04342897|531076762|FG001|Overall Study|Lost to Follow-up|6|||
147248147|NCT04342897|531076761|FG000|Overall Study|Withdrawal by Subject|1|||
147248148|NCT04342897|531076762|FG001|Overall Study|Withdrawal by Subject|2|||
147248149|NCT02634320|531076767|FG000|Overall Study|Adverse Event|2|||
147248150|NCT02634320|531076767|FG000|Overall Study|Lost to Follow-up|3|||
147248151|NCT02634320|531076767|FG000|Overall Study|Moved out of area|2|||
147248152|NCT02634320|531076767|FG000|Overall Study|Out of window for study visits|1|||
147248153|NCT02634320|531076767|FG000|Overall Study|Protocol Violation|1|||
147248154|NCT02634320|531076767|FG000|Overall Study|Withdrawal by Subject|5|||
147248155|NCT02634320|531076767|FG000|Overall Study|Lack of Efficacy|2|||
147248156|NCT00838578|531076768|FG000|Overall Study|Protocol Violation|2|||
147248157|NCT00357968|531076769|FG000|First Maintenance Dose Phase|Not a PCI patient|47|||
147248158|NCT00357968|531076770|FG001|First Maintenance Dose Phase|Not a PCI patient|42|||
147248159|NCT00357968|531076769|FG000|First Maintenance Dose Phase|Withdrawal by Subject|1|||
147248160|NCT00357968|531076770|FG001|First Maintenance Dose Phase|Withdrawal by Subject|2|||
147248161|NCT03919799|531076771|FG000|DB Period (28 Weeks)|Randomized not treated|1|||
147248162|NCT03919799|531076772|FG001|DB Period (28 Weeks)|Randomized not treated|0|||
147248163|NCT03919799|531076773|FG002|DB Period (28 Weeks)|Randomized not treated|0|||
147248164|NCT03919799|531076774|FG003|DB Period (28 Weeks)|Randomized not treated|0|||
147189786|NCT02201524|530860995|FG000|Overall Study|Withdrawal by Subject|0|||
147189787|NCT02201524|530860996|FG001|Overall Study|Withdrawal by Subject|0|||
147189788|NCT02201524|530860997|FG002|Overall Study|Withdrawal by Subject|1|||
147189789|NCT02201524|530860998|FG003|Overall Study|Withdrawal by Subject|1|||
147189790|NCT02201524|530860995|FG000|Overall Study|Other|1|||
147189791|NCT02201524|530860996|FG001|Overall Study|Other|1|||
147189792|NCT02201524|530860997|FG002|Overall Study|Other|0|||
147189793|NCT02201524|530860998|FG003|Overall Study|Other|0|||
147189794|NCT02653326|530861002|FG000|Overall Study|Lost to Follow-up|10|||
147189795|NCT02653326|530861003|FG001|Overall Study|Lost to Follow-up|7|||
147189796|NCT00231777|530861007|FG000|Overall Study|Lost to Follow-up|3|||
147189797|NCT00231777|530861008|FG001|Overall Study|Lost to Follow-up|0|||
147189798|NCT00231777|530861007|FG000|Overall Study|Other|3|||
147189799|NCT00231777|530861008|FG001|Overall Study|Other|2|||
147189800|NCT01239381|530861013|FG000|Overall Study|Protocol Violation|1|||
147189801|NCT01239381|530861013|FG000|Overall Study|Withdrawal by Subject|1|||
147189802|NCT04678115|530861014|FG000|Overall Study|Lost to Follow-up|1|||
147189803|NCT04678115|530861015|FG001|Overall Study|Lost to Follow-up|0|||
147189804|NCT03550378|530861018|FG000|Overall Study|Death|0|||
147189805|NCT03550378|530861019|FG001|Overall Study|Death|1|||
147189806|NCT04486235|530861020|FG000|Overall Study|Pregnancy|1|||
147189807|NCT04486235|530861021|FG001|Overall Study|Pregnancy|0|||
147189808|NCT04486235|530861020|FG000|Overall Study|Lost to Follow-up|1|||
147189809|NCT04486235|530861021|FG001|Overall Study|Lost to Follow-up|0|||
147189810|NCT04590014|530861022|FG000|Overall Study|Withdrawal by Subject|1|||
147189811|NCT04590014|530861023|FG001|Overall Study|Withdrawal by Subject|0|||
147189812|NCT03935126|530861024|FG000|Overall Study|Study termination by sponsor|3|||
147189813|NCT01091675|530861025|FG000|Overall Study|Adverse Event|7|||
147189814|NCT01091675|530861025|FG000|Overall Study|Lack of Efficacy|27|||
147189815|NCT03040141|530861026|FG000|Overall Study|Death|1|||
147189816|NCT03040141|530861027|FG001|Overall Study|Death|2|||
147189817|NCT03040141|530861028|FG002|Overall Study|Death|3|||
147189818|NCT03040141|530861026|FG000|Overall Study|Withdrawal by Subject|3|||
147189819|NCT03040141|530861027|FG001|Overall Study|Withdrawal by Subject|1|||
147189820|NCT03040141|530861028|FG002|Overall Study|Withdrawal by Subject|1|||
147189821|NCT03040141|530861026|FG000|Overall Study|Subject discharged to nursing home, not able to attend visits|0|||
147189822|NCT03040141|530861027|FG001|Overall Study|Subject discharged to nursing home, not able to attend visits|1|||
147189823|NCT03040141|530861028|FG002|Overall Study|Subject discharged to nursing home, not able to attend visits|0|||
147189824|NCT03040141|530861026|FG000|Overall Study|Subject did not receive study drug or was not confirmed Influenza A positive|0|||
147189825|NCT03040141|530861027|FG001|Overall Study|Subject did not receive study drug or was not confirmed Influenza A positive|2|||
147189826|NCT03040141|530861028|FG002|Overall Study|Subject did not receive study drug or was not confirmed Influenza A positive|2|||
147189827|NCT02426580|530862458|FG000|Overall Study|Death|2|||
147189828|NCT02426580|530862459|FG001|Overall Study|Death|2|||
147189829|NCT02426580|530862458|FG000|Overall Study|Lost to Follow-up|0|||
147189830|NCT02426580|530862459|FG001|Overall Study|Lost to Follow-up|9|||
147189831|NCT02426580|530862458|FG000|Overall Study|transfer to hemodialysis|5|||
147189832|NCT02426580|530862459|FG001|Overall Study|transfer to hemodialysis|5|||
147189833|NCT02426580|530862458|FG000|Overall Study|Kidney transplant|3|||
147189834|NCT02426580|530862459|FG001|Overall Study|Kidney transplant|0|||
147189835|NCT02426580|530862458|FG000|Overall Study|Allergic to egg white|1|||
147189836|NCT02426580|530862459|FG001|Overall Study|Allergic to egg white|0|||
147189837|NCT00383552|530862460|FG000|Overall Study|Adverse Event|7|||
147189838|NCT00383552|530862461|FG001|Overall Study|Adverse Event|6|||
147189839|NCT00383552|530862462|FG002|Overall Study|Adverse Event|9|||
147189840|NCT00383552|530862463|FG003|Overall Study|Adverse Event|6|||
147189841|NCT00383552|530862460|FG000|Overall Study|Lack of Efficacy|4|||
147189842|NCT00383552|530862461|FG001|Overall Study|Lack of Efficacy|13|||
147189843|NCT00383552|530862462|FG002|Overall Study|Lack of Efficacy|29|||
147189844|NCT00383552|530862463|FG003|Overall Study|Lack of Efficacy|42|||
147189845|NCT00383552|530862460|FG000|Overall Study|Lost to Follow-up|0|||
147189846|NCT00383552|530862461|FG001|Overall Study|Lost to Follow-up|1|||
147189847|NCT00383552|530862462|FG002|Overall Study|Lost to Follow-up|5|||
147189848|NCT00383552|530862463|FG003|Overall Study|Lost to Follow-up|1|||
147189849|NCT00383552|530862460|FG000|Overall Study|Did not wish to continue (unrelated)|4|||
147189850|NCT00383552|530862461|FG001|Overall Study|Did not wish to continue (unrelated)|9|||
147189851|NCT00383552|530862462|FG002|Overall Study|Did not wish to continue (unrelated)|5|||
147189852|NCT00383552|530862463|FG003|Overall Study|Did not wish to continue (unrelated)|6|||
147189853|NCT00383552|530862460|FG000|Overall Study|Did not wish to continue (related)|1|||
147189854|NCT00383552|530862461|FG001|Overall Study|Did not wish to continue (related)|0|||
147189855|NCT00383552|530862462|FG002|Overall Study|Did not wish to continue (related)|2|||
147189856|NCT00383552|530862463|FG003|Overall Study|Did not wish to continue (related)|3|||
147189857|NCT00383552|530862460|FG000|Overall Study|Noncompliance with the protocol|11|||
147189858|NCT00383552|530862461|FG001|Overall Study|Noncompliance with the protocol|6|||
147189859|NCT00383552|530862462|FG002|Overall Study|Noncompliance with the protocol|8|||
147189860|NCT00383552|530862463|FG003|Overall Study|Noncompliance with the protocol|10|||
147330204|NCT03646669|531374444|FG001|Overall Study|Withdrawal by Subject|0|||
147330205|NCT00309452|531374445|FG000|Overall Study|Withdrawal by Subject|3|||
147330206|NCT00309452|531374446|FG001|Overall Study|Withdrawal by Subject|0|||
147330207|NCT02814643|531374447|FG000|Overall Study|Lost to Follow-up|0|||
147330208|NCT02814643|531374448|FG001|Overall Study|Lost to Follow-up|1|||
147330209|NCT02814643|531374447|FG000|Overall Study|Withdrawal by Subject|1|||
147330210|NCT02814643|531374448|FG001|Overall Study|Withdrawal by Subject|2|||
147330211|NCT02614560|531374451|FG000|Overall Study|Death|6|||
147330212|NCT02614560|531374452|FG001|Overall Study|Death|2|||
147330213|NCT00549848|531374453|FG000|Overall Study|Death|1|||
147330214|NCT00549848|531374454|FG001|Overall Study|Death|4|||
147330215|NCT00549848|531374455|FG002|Overall Study|Death|13|||
147330216|NCT00549848|531374453|FG000|Overall Study|Physician Decision|0|||
147330217|NCT00549848|531374454|FG001|Overall Study|Physician Decision|0|||
147330218|NCT00549848|531374455|FG002|Overall Study|Physician Decision|4|||
147330219|NCT00549848|531374453|FG000|Overall Study|Bone Marrow (BM) or Extramedullary Relapse|3|||
147330220|NCT00549848|531374454|FG001|Overall Study|Bone Marrow (BM) or Extramedullary Relapse|4|||
147330221|NCT00549848|531374455|FG002|Overall Study|Bone Marrow (BM) or Extramedullary Relapse|4|||
147330222|NCT00549848|531374453|FG000|Overall Study|Failure to achieve Complete Remission (CR)|1|||
147330223|NCT00549848|531374454|FG001|Overall Study|Failure to achieve Complete Remission (CR)|0|||
147330224|NCT00549848|531374455|FG002|Overall Study|Failure to achieve Complete Remission (CR)|1|||
147330225|NCT00549848|531374453|FG000|Overall Study|Participant/Family Withdraw|2|||
147330226|NCT00549848|531374454|FG001|Overall Study|Participant/Family Withdraw|3|||
147330227|NCT00549848|531374455|FG002|Overall Study|Participant/Family Withdraw|5|||
147330228|NCT00549848|531374453|FG000|Overall Study|Second Malignancy|1|||
147330229|NCT00549848|531374454|FG001|Overall Study|Second Malignancy|0|||
147330230|NCT00549848|531374455|FG002|Overall Study|Second Malignancy|0|||
147330231|NCT00549848|531374453|FG000|Overall Study|Transplant|3|||
147330232|NCT00549848|531374454|FG001|Overall Study|Transplant|3|||
147330233|NCT00549848|531374455|FG002|Overall Study|Transplant|18|||
147330234|NCT00549848|531374453|FG000|Overall Study|Unacceptable Toxicity|1|||
147330235|NCT00549848|531374454|FG001|Overall Study|Unacceptable Toxicity|6|||
147330236|NCT00549848|531374455|FG002|Overall Study|Unacceptable Toxicity|6|||
147330237|NCT05193318|531374458|FG000|Acute Intervention (Weeks 1-9 of Study)|Physician Decision|1|||
147330238|NCT05193318|531374458|FG000|Follow-up Phase (Through Week 16)|Lost to Follow-up|1|||
147330239|NCT02846415|531374459|FG000|Overall Study|Lost to Follow-up|2|||
147330240|NCT02846415|531374460|FG001|Overall Study|Lost to Follow-up|0|||
147330241|NCT02846415|531374459|FG000|Overall Study|Withdrawal by Subject|1|||
147330242|NCT02846415|531374460|FG001|Overall Study|Withdrawal by Subject|1|||
147330243|NCT03383887|531374463|FG000|Overall Study|Lost to Follow-up|0|||
147330244|NCT03383887|531374464|FG001|Overall Study|Lost to Follow-up|1|||
147330245|NCT00975806|531374475|FG000|Overall Study|Adverse Event|2|||
147330246|NCT00975806|531374476|FG001|Overall Study|Adverse Event|1|||
147330247|NCT00975806|531374477|FG002|Overall Study|Adverse Event|2|||
147330248|NCT00975806|531374475|FG000|Overall Study|Disease Progression|1|||
147330249|NCT00975806|531374476|FG001|Overall Study|Disease Progression|5|||
147330250|NCT00975806|531374477|FG002|Overall Study|Disease Progression|1|||
147330251|NCT00975806|531374475|FG000|Overall Study|Withdrawal by Subject|1|||
147330252|NCT00975806|531374476|FG001|Overall Study|Withdrawal by Subject|0|||
147330253|NCT00975806|531374477|FG002|Overall Study|Withdrawal by Subject|0|||
147330254|NCT00975806|531374475|FG000|Overall Study|Death|0|||
147330255|NCT00975806|531374476|FG001|Overall Study|Death|1|||
147330256|NCT00975806|531374477|FG002|Overall Study|Death|0|||
147330257|NCT00975806|531374475|FG000|Overall Study|Physician decision and disease related|1|||
147330258|NCT00975806|531374476|FG001|Overall Study|Physician decision and disease related|0|||
147330259|NCT00975806|531374477|FG002|Overall Study|Physician decision and disease related|1|||
147330260|NCT00246012|531374478|FG000|Overall Study|Adverse Event|0|||
147330261|NCT00246012|531374479|FG001|Overall Study|Adverse Event|0|||
147330262|NCT00246012|531374480|FG002|Overall Study|Adverse Event|0|||
147330263|NCT00246012|531374481|FG003|Overall Study|Adverse Event|0|||
147330264|NCT00246012|531374482|FG004|Overall Study|Adverse Event|0|||
147330265|NCT00246012|531374483|FG005|Overall Study|Adverse Event|1|||
147330266|NCT00246012|531374484|FG006|Overall Study|Adverse Event|0|||
147330267|NCT00246012|531374485|FG007|Overall Study|Adverse Event|0|||
147330268|NCT00246012|531374486|FG008|Overall Study|Adverse Event|2|||
147330269|NCT00246012|531374478|FG000|Overall Study|Withdrawal by Subject|0|||
147330270|NCT00246012|531374479|FG001|Overall Study|Withdrawal by Subject|0|||
147330271|NCT00246012|531374480|FG002|Overall Study|Withdrawal by Subject|0|||
147330272|NCT00246012|531374481|FG003|Overall Study|Withdrawal by Subject|0|||
147330273|NCT00246012|531374482|FG004|Overall Study|Withdrawal by Subject|0|||
147330274|NCT00246012|531374483|FG005|Overall Study|Withdrawal by Subject|1|||
147330275|NCT00246012|531374484|FG006|Overall Study|Withdrawal by Subject|0|||
147330276|NCT00246012|531374485|FG007|Overall Study|Withdrawal by Subject|0|||
147330277|NCT00246012|531374486|FG008|Overall Study|Withdrawal by Subject|0|||
147330278|NCT00246012|531374478|FG000|Overall Study|Disease progression|3|||
147330279|NCT00246012|531374479|FG001|Overall Study|Disease progression|1|||
147330280|NCT00246012|531374480|FG002|Overall Study|Disease progression|2|||
147330281|NCT00246012|531374481|FG003|Overall Study|Disease progression|3|||
147330282|NCT00246012|531374482|FG004|Overall Study|Disease progression|3|||
147330283|NCT00246012|531374483|FG005|Overall Study|Disease progression|25|||
147330284|NCT00246012|531374484|FG006|Overall Study|Disease progression|30|||
147330285|NCT00246012|531374485|FG007|Overall Study|Disease progression|27|||
147330286|NCT00246012|531374486|FG008|Overall Study|Disease progression|26|||
147189861|NCT00383552|530862460|FG000|Overall Study|Did not meet protocol eligibility|8|||
147189862|NCT00383552|530862461|FG001|Overall Study|Did not meet protocol eligibility|6|||
147189863|NCT00383552|530862462|FG002|Overall Study|Did not meet protocol eligibility|2|||
147189864|NCT00383552|530862463|FG003|Overall Study|Did not meet protocol eligibility|3|||
147189865|NCT00383552|530862460|FG000|Overall Study|Administrative|1|||
147189866|NCT00383552|530862461|FG001|Overall Study|Administrative|0|||
147189867|NCT00383552|530862462|FG002|Overall Study|Administrative|1|||
147189868|NCT00383552|530862463|FG003|Overall Study|Administrative|1|||
147189869|NCT00966654|530862464|FG000|Overall Study|Study was terminated,PI left institution|12|||
147189870|NCT01600326|530862467|FG000|Overall Study|Lost to Follow-up|1|||
147189871|NCT01600326|530862468|FG001|Overall Study|Lost to Follow-up|1|||
147189872|NCT04456504|530862469|FG000|Overall Study|Lost to Follow-up|2|||
147189873|NCT01393158|530862470|FG000|Overall Study|Adverse Event|1|||
147189874|NCT01393158|530862471|FG001|Overall Study|Adverse Event|0|||
147189875|NCT02173769|530862473|FG000|Overall Study|Protocol Violation|4|||
147189876|NCT02869633|530862474|FG000|Overall Study|Death|2|||
147189877|NCT02869633|530862475|FG001|Overall Study|Death|1|||
147330287|NCT00246012|531374478|FG000|Overall Study|Other|0|||
147330288|NCT00246012|531374479|FG001|Overall Study|Other|0|||
147330289|NCT00246012|531374480|FG002|Overall Study|Other|0|||
147330290|NCT00246012|531374481|FG003|Overall Study|Other|0|||
147330291|NCT00246012|531374482|FG004|Overall Study|Other|0|||
147330292|NCT00246012|531374483|FG005|Overall Study|Other|0|||
147330293|NCT00246012|531374484|FG006|Overall Study|Other|0|||
147330294|NCT00246012|531374485|FG007|Overall Study|Other|1|||
147330295|NCT00246012|531374486|FG008|Overall Study|Other|0|||
147330296|NCT00246012|531374478|FG000|Overall Study|Randomly assigned but not treated|0|||
147330297|NCT00246012|531374479|FG001|Overall Study|Randomly assigned but not treated|0|||
147330298|NCT00246012|531374480|FG002|Overall Study|Randomly assigned but not treated|0|||
147330299|NCT00246012|531374481|FG003|Overall Study|Randomly assigned but not treated|0|||
147330300|NCT00246012|531374482|FG004|Overall Study|Randomly assigned but not treated|0|||
147330301|NCT00246012|531374483|FG005|Overall Study|Randomly assigned but not treated|1|||
147330302|NCT00246012|531374484|FG006|Overall Study|Randomly assigned but not treated|1|||
147330303|NCT00246012|531374485|FG007|Overall Study|Randomly assigned but not treated|0|||
147330304|NCT00246012|531374486|FG008|Overall Study|Randomly assigned but not treated|0|||
147330305|NCT04889664|531374487|FG000|Screen|Lost to Follow-up|1|||
147330306|NCT04889664|531374487|FG000|Screen|Failed to meet screening criteria|1|||
147330307|NCT04889664|531374487|FG000|Study Treatment|Exited by study team due to inappropriate behavior|1|||
147330308|NCT01806714|531374494|FG000|Overall Study|No functioning phone number|200|||
147330309|NCT01806714|531374495|FG001|Overall Study|No functioning phone number|170|||
147330310|NCT02155829|531374496|FG000|Overall Study|Adverse Event|1|||
147330311|NCT02155829|531374497|FG001|Overall Study|Adverse Event|0|||
147330312|NCT02155829|531374496|FG000|Overall Study|Withdrawal by Subject|3|||
147330313|NCT02155829|531374497|FG001|Overall Study|Withdrawal by Subject|3|||
147330314|NCT02155829|531374496|FG000|Overall Study|Protocol Violation|2|||
147330315|NCT02155829|531374497|FG001|Overall Study|Protocol Violation|0|||
147189878|NCT02869633|530862474|FG000|Overall Study|Patient refused follow-up|1|||
147189879|NCT02869633|530862475|FG001|Overall Study|Patient refused follow-up|0|||
147330316|NCT04107805|531374500|FG000|Overall Study|Adverse Event|0|||
147330317|NCT04107805|531374501|FG001|Overall Study|Adverse Event|0|||
147330318|NCT04107805|531374502|FG002|Overall Study|Adverse Event|0|||
147330319|NCT04107805|531374503|FG003|Overall Study|Adverse Event|1|||
147330320|NCT04107805|531374504|FG004|Overall Study|Adverse Event|0|||
147330321|NCT04107805|531374505|FG005|Overall Study|Adverse Event|1|||
147330322|NCT04107805|531374506|FG006|Overall Study|Adverse Event|0|||
147330323|NCT04107805|531374507|FG007|Overall Study|Adverse Event|0|||
147330324|NCT04107805|531374508|FG008|Overall Study|Adverse Event|1|||
147330325|NCT00404079|531374511|FG000|Overall Study|Lost to follow up, adverse event etc|22|||
147330326|NCT00404079|531374512|FG001|Overall Study|Lost to follow up, adverse event etc|20|||
147330327|NCT00771849|531374513|FG000|Overall Study|Lost to Follow-up|1|||
147330328|NCT00771849|531374514|FG001|Overall Study|Lost to Follow-up|2|||
147330329|NCT00771849|531374513|FG000|Overall Study|Withdrawal by Subject|1|||
147330330|NCT00771849|531374514|FG001|Overall Study|Withdrawal by Subject|1|||
147330331|NCT00771849|531374513|FG000|Overall Study|Not vaccinated|0|||
147330332|NCT00771849|531374514|FG001|Overall Study|Not vaccinated|1|||
147330333|NCT01972152|531374517|FG000|First Treatment Visit|Lost to Follow-up|0|||
147330334|NCT01972152|531374518|FG001|First Treatment Visit|Lost to Follow-up|1|||
147330335|NCT01972152|531374519|FG002|First Treatment Visit|Lost to Follow-up|0|||
147189880|NCT02869633|530862474|FG000|Overall Study|Provider discretion|1|||
147189881|NCT02869633|530862475|FG001|Overall Study|Provider discretion|0|||
147189882|NCT02869633|530862474|FG000|Overall Study|Investigator decision|1|||
147189883|NCT02869633|530862475|FG001|Overall Study|Investigator decision|0|||
147330336|NCT01972152|531374520|FG003|First Treatment Visit|Lost to Follow-up|0|||
147330337|NCT01972152|531374521|FG004|First Treatment Visit|Lost to Follow-up|0|||
147189884|NCT02869633|530862474|FG000|Overall Study|Lost to Follow-up|0|||
147189885|NCT02869633|530862475|FG001|Overall Study|Lost to Follow-up|1|||
147189886|NCT02869633|530862474|FG000|Overall Study|Not eligible|6|||
147189887|NCT02869633|530862475|FG001|Overall Study|Not eligible|1|||
147330338|NCT01972152|531374522|FG005|First Treatment Visit|Lost to Follow-up|0|||
147330339|NCT01972152|531374517|FG000|Second Treatment Visit|Protocol Violation|0|||
147330340|NCT01972152|531374518|FG001|Second Treatment Visit|Protocol Violation|1|||
147330341|NCT01972152|531374519|FG002|Second Treatment Visit|Protocol Violation|0|||
147330342|NCT01972152|531374520|FG003|Second Treatment Visit|Protocol Violation|0|||
147330343|NCT01972152|531374521|FG004|Second Treatment Visit|Protocol Violation|0|||
147330344|NCT01972152|531374522|FG005|Second Treatment Visit|Protocol Violation|0|||
147330345|NCT02596035|531374525|FG000|Overall Study|Disease Progression|64|||
147330346|NCT02596035|531374526|FG001|Overall Study|Disease Progression|32|||
147330347|NCT02596035|531374527|FG002|Overall Study|Disease Progression|1|||
147330348|NCT02596035|531374525|FG000|Overall Study|study drug toxicity|12|||
147330349|NCT02596035|531374526|FG001|Overall Study|study drug toxicity|3|||
147330350|NCT02596035|531374527|FG002|Overall Study|study drug toxicity|0|||
147330351|NCT02596035|531374525|FG000|Overall Study|AE unrelated to study drug|5|||
147330352|NCT02596035|531374526|FG001|Overall Study|AE unrelated to study drug|2|||
147330353|NCT02596035|531374527|FG002|Overall Study|AE unrelated to study drug|0|||
147330354|NCT02596035|531374525|FG000|Overall Study|participant request to discontinue study treatment|2|||
147330355|NCT02596035|531374526|FG001|Overall Study|participant request to discontinue study treatment|0|||
147330356|NCT02596035|531374527|FG002|Overall Study|participant request to discontinue study treatment|0|||
147330357|NCT02596035|531374525|FG000|Overall Study|participant withdrew consent|2|||
147330358|NCT02596035|531374526|FG001|Overall Study|participant withdrew consent|2|||
147330359|NCT02596035|531374527|FG002|Overall Study|participant withdrew consent|0|||
147330360|NCT02596035|531374525|FG000|Overall Study|Poor/Non Comlpiance|0|||
147189888|NCT02869633|530862474|FG000|Overall Study|Protocol-defined follow-up period completed|2|||
147189889|NCT02869633|530862475|FG001|Overall Study|Protocol-defined follow-up period completed|1|||
147189890|NCT02869633|530862474|FG000|Overall Study|Withdrawal by Subject|0|||
147189891|NCT02869633|530862475|FG001|Overall Study|Withdrawal by Subject|1|||
147189892|NCT04024891|530862476|FG000|Overall Study|Pregnancy|0|||
147189893|NCT04024891|530862477|FG001|Overall Study|Pregnancy|1|||
147189894|NCT01693029|530862478|FG000|Overall Study|Withdrawal by Subject|15|||
147189895|NCT01693029|530862479|FG001|Overall Study|Withdrawal by Subject|22|||
147189896|NCT01693029|530862478|FG000|Overall Study|Kidney transplantation|7|||
147189897|NCT01693029|530862479|FG001|Overall Study|Kidney transplantation|7|||
147189898|NCT01693029|530862478|FG000|Overall Study|Bindinging anti-EPO antibodies|6|||
147189899|NCT01693029|530862479|FG001|Overall Study|Bindinging anti-EPO antibodies|2|||
147189900|NCT01693029|530862478|FG000|Overall Study|Protocol Violation|6|||
147189901|NCT01693029|530862479|FG001|Overall Study|Protocol Violation|7|||
147189902|NCT01693029|530862478|FG000|Overall Study|Change in dialysis modality|2|||
147189903|NCT01693029|530862479|FG001|Overall Study|Change in dialysis modality|1|||
147189904|NCT01693029|530862478|FG000|Overall Study|Physician Decision|0|||
147189905|NCT01693029|530862479|FG001|Overall Study|Physician Decision|2|||
147189906|NCT01693029|530862478|FG000|Overall Study|Lost to Follow-up|0|||
147189907|NCT01693029|530862479|FG001|Overall Study|Lost to Follow-up|1|||
147189908|NCT01693029|530862478|FG000|Overall Study|Adverse Event|1|||
147189909|NCT01693029|530862479|FG001|Overall Study|Adverse Event|6|||
147189910|NCT01693029|530862478|FG000|Overall Study|Death|5|||
147189911|NCT01693029|530862479|FG001|Overall Study|Death|8|||
147189912|NCT01693029|530862478|FG000|Overall Study|Non-compliance|2|||
147189913|NCT01693029|530862479|FG001|Overall Study|Non-compliance|1|||
147330361|NCT02596035|531374526|FG001|Overall Study|Poor/Non Comlpiance|1|||
147189914|NCT00308139|530862480|FG000|Overall Study|Adverse Event|20|||
147189915|NCT00308139|530862481|FG001|Overall Study|Adverse Event|14|||
147189916|NCT00308139|530862480|FG000|Overall Study|Lost to Follow-up|13|||
147189917|NCT00308139|530862481|FG001|Overall Study|Lost to Follow-up|8|||
147189918|NCT00308139|530862480|FG000|Overall Study|Protocol Violation|3|||
147330362|NCT02596035|531374527|FG002|Overall Study|Poor/Non Comlpiance|0|||
147330363|NCT02596035|531374525|FG000|Overall Study|participant no longer meets study criteria|1|||
147330364|NCT02596035|531374526|FG001|Overall Study|participant no longer meets study criteria|0|||
147189919|NCT00308139|530862481|FG001|Overall Study|Protocol Violation|2|||
147189920|NCT00308139|530862480|FG000|Overall Study|Withdrawal of Consent|40|||
147330365|NCT02596035|531374527|FG002|Overall Study|participant no longer meets study criteria|0|||
147330366|NCT02596035|531374525|FG000|Overall Study|other reasons|11|||
147330367|NCT02596035|531374526|FG001|Overall Study|other reasons|4|||
147189921|NCT00308139|530862481|FG001|Overall Study|Withdrawal of Consent|42|||
147189922|NCT00308139|530862480|FG000|Overall Study|Investigator Decision|11|||
147330368|NCT02596035|531374527|FG002|Overall Study|other reasons|0|||
147330369|NCT00509769|531374528|FG000|Overall Study|Progressive disease|77|||
147189923|NCT00308139|530862481|FG001|Overall Study|Investigator Decision|10|||
147189924|NCT00308139|530862480|FG000|Overall Study|Loss of Glucose Control|5|||
147189925|NCT00308139|530862481|FG001|Overall Study|Loss of Glucose Control|7|||
147189926|NCT00308139|530862480|FG000|Overall Study|Administrative|1|||
147189927|NCT00308139|530862481|FG001|Overall Study|Administrative|4|||
147189928|NCT00308139|530862480|FG000|Overall Study|Other|1|||
147189929|NCT00308139|530862481|FG001|Overall Study|Other|0|||
147189930|NCT02313766|530862484|FG000|Overall Study|surgery cancelled|1|||
147189931|NCT02313766|530862485|FG001|Overall Study|surgery cancelled|0|||
147189932|NCT02313766|530862486|FG002|Overall Study|surgery cancelled|0|||
147189933|NCT02313766|530862484|FG000|Overall Study|Lost to Follow-up|0|||
147189934|NCT02313766|530862485|FG001|Overall Study|Lost to Follow-up|2|||
147189935|NCT02313766|530862486|FG002|Overall Study|Lost to Follow-up|0|||
147189936|NCT02313766|530862484|FG000|Overall Study|Adverse Event|0|||
147189937|NCT02313766|530862485|FG001|Overall Study|Adverse Event|1|||
147189938|NCT02313766|530862486|FG002|Overall Study|Adverse Event|0|||
147189939|NCT00791388|530862490|FG000|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0|||
147189940|NCT00791388|530862491|FG001|Period 1 - 50 mg Dose Group|Withdrawal by Subject|1|||
147189941|NCT00791388|530862492|FG002|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0|||
147189942|NCT00791388|530862493|FG003|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0|||
147189943|NCT00791388|530862494|FG004|Period 1 - 50 mg Dose Group|Withdrawal by Subject|0|||
147189944|NCT00791388|530862490|FG000|Period 2 - 100 mg Dose Group|Withdrawal by Subject|1|||
147189945|NCT00791388|530862491|FG001|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0|||
147189946|NCT00791388|530862492|FG002|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0|||
147189947|NCT00791388|530862493|FG003|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0|||
147189948|NCT00791388|530862494|FG004|Period 2 - 100 mg Dose Group|Withdrawal by Subject|0|||
147189949|NCT00791388|530862490|FG000|Period 4 - 400 mg Dose Group|Adverse Event|0|||
147189950|NCT00791388|530862491|FG001|Period 4 - 400 mg Dose Group|Adverse Event|0|||
147189951|NCT00791388|530862492|FG002|Period 4 - 400 mg Dose Group|Adverse Event|0|||
147189952|NCT00791388|530862493|FG003|Period 4 - 400 mg Dose Group|Adverse Event|0|||
147189953|NCT00791388|530862494|FG004|Period 4 - 400 mg Dose Group|Adverse Event|4|||
147189954|NCT00141453|530862502|FG000|Overall Study|Protocol Violation|6|||
147189955|NCT00141453|530862503|FG001|Overall Study|Protocol Violation|5|||
147189956|NCT00443040|530862504|FG000|Overall Study|Withdrawal by Subject|1|||
147189957|NCT00443040|530862505|FG001|Overall Study|Withdrawal by Subject|0|||
147189958|NCT00443040|530862506|FG002|Overall Study|Withdrawal by Subject|0|||
147189959|NCT00443040|530862504|FG000|Overall Study|Converted to an open laparotomy|3|||
147189960|NCT00443040|530862505|FG001|Overall Study|Converted to an open laparotomy|0|||
147189961|NCT00443040|530862506|FG002|Overall Study|Converted to an open laparotomy|1|||
147189962|NCT02763644|530862509|FG000|Overall Study|Patient/guardian decision|1|||
147189963|NCT02763644|530862510|FG001|Overall Study|Patient/guardian decision|0|||
147189964|NCT02763644|530862509|FG000|Overall Study|Death|1|||
147189965|NCT02763644|530862510|FG001|Overall Study|Death|1|||
147189966|NCT02763644|530862509|FG000|Overall Study|Adverse Event|1|||
147189967|NCT02763644|530862510|FG001|Overall Study|Adverse Event|1|||
147189968|NCT02648204|530862511|FG000|Overall Study|Withdrawal by Subject|12|||
147189969|NCT02648204|530862512|FG001|Overall Study|Withdrawal by Subject|8|||
147189970|NCT02648204|530862513|FG002|Overall Study|Withdrawal by Subject|2|||
147189971|NCT02648204|530862514|FG003|Overall Study|Withdrawal by Subject|6|||
147189972|NCT02648204|530862511|FG000|Overall Study|Lost to Follow-up|5|||
147189973|NCT02648204|530862512|FG001|Overall Study|Lost to Follow-up|8|||
147189974|NCT02648204|530862513|FG002|Overall Study|Lost to Follow-up|4|||
147189975|NCT02648204|530862514|FG003|Overall Study|Lost to Follow-up|6|||
147189976|NCT02648204|530862511|FG000|Overall Study|Missing follow-up information|4|||
147189977|NCT02648204|530862512|FG001|Overall Study|Missing follow-up information|4|||
147189978|NCT02648204|530862513|FG002|Overall Study|Missing follow-up information|4|||
147189979|NCT02648204|530862514|FG003|Overall Study|Missing follow-up information|2|||
147189980|NCT02648204|530862511|FG000|Overall Study|Death|1|||
147189981|NCT02648204|530862512|FG001|Overall Study|Death|1|||
147189982|NCT02648204|530862513|FG002|Overall Study|Death|2|||
147189983|NCT02648204|530862514|FG003|Overall Study|Death|2|||
147189984|NCT02648204|530862511|FG000|Overall Study|Adverse Event|0|||
147189985|NCT02648204|530862512|FG001|Overall Study|Adverse Event|0|||
147189986|NCT02648204|530862513|FG002|Overall Study|Adverse Event|1|||
147189987|NCT02648204|530862514|FG003|Overall Study|Adverse Event|0|||
147189988|NCT01220167|530862519|FG000|Period 3|Urine positive for substance abuse|0|||
147189989|NCT01220167|530862520|FG001|Period 3|Urine positive for substance abuse|1|||
147189990|NCT01220167|530862521|FG002|Period 3|Urine positive for substance abuse|0|||
147189991|NCT01008943|530862522|FG000|Overall Study|Withdrawal by Subject|1|||
147189992|NCT02356159|530862523|FG000|Research Ph, Ph I Dose Level 180mcg/kg|No longer eligible for research phase|0|||
147189993|NCT02356159|530862524|FG001|Research Ph, Ph I Dose Level 180mcg/kg|No longer eligible for research phase|0|||
147189994|NCT02356159|530862525|FG002|Research Ph, Ph I Dose Level 180mcg/kg|No longer eligible for research phase|0|||
147189995|NCT02356159|530862526|FG003|Research Ph, Ph I Dose Level 180mcg/kg|No longer eligible for research phase|0|||
147189996|NCT02356159|530862527|FG004|Research Ph, Ph I Dose Level 180mcg/kg|No longer eligible for research phase|0|||
147189997|NCT02356159|530862528|FG005|Research Ph, Ph I Dose Level 180mcg/kg|No longer eligible for research phase|1|||
147189998|NCT06418152|530862529|FG000|Overall Study|Frequent DBS setting changes|1|||
147189999|NCT06418152|530862529|FG000|Overall Study|Withdrawal by Subject|2|||
147190000|NCT05789745|530862530|FG000|Overall Study|Withdrawal by Subject|0|||
147190001|NCT05789745|530862531|FG001|Overall Study|Withdrawal by Subject|0|||
147190002|NCT05789745|530862532|FG002|Overall Study|Withdrawal by Subject|0|||
147190003|NCT05789745|530862533|FG003|Overall Study|Withdrawal by Subject|0|||
147190004|NCT05789745|530862534|FG004|Overall Study|Withdrawal by Subject|1|||
147190005|NCT02055898|530862539|FG000|First Intervention (5 Days)|Physician Decision|2|||
147190006|NCT02055898|530862540|FG001|First Intervention (5 Days)|Physician Decision|0|||
147190007|NCT02055898|530862539|FG000|First Intervention (5 Days)|Withdrawal by Subject|0|||
147190008|NCT02055898|530862540|FG001|First Intervention (5 Days)|Withdrawal by Subject|1|||
147190009|NCT02314052|530862542|FG000|Cycle One|Adverse Event|0|||
147190010|NCT02314052|530862543|FG001|Cycle One|Adverse Event|0|||
147190011|NCT02314052|530862544|FG002|Cycle One|Adverse Event|0|||
147190012|NCT02314052|530862545|FG003|Cycle One|Adverse Event|1|||
147190013|NCT02314052|530862546|FG004|Cycle One|Adverse Event|0|||
147190014|NCT02314052|530862547|FG005|Cycle One|Adverse Event|0|||
147190015|NCT01960140|530862552|FG000|Period 2 (Days 3-18)|Adverse Event|2|||
147190016|NCT00472108|530862553|FG000|Overall Study|Lost to Follow-up|0|||
147190017|NCT00472108|530862554|FG001|Overall Study|Lost to Follow-up|1|||
147190018|NCT00005906|530862555|FG000|Overall Study|Lack of Efficacy|3|||
147190019|NCT04551989|530862556|FG000|Overall Study|Adverse Event|4|||
147190020|NCT04551989|530862556|FG000|Overall Study|Protocol Violation|3|||
147190021|NCT04551989|530862556|FG000|Overall Study|Lost to Follow-up|1|||
147190022|NCT04551989|530862556|FG000|Overall Study|Physician Decision|3|||
147190023|NCT00686777|530862560|FG000|Overall Study|Adverse Event|2|||
147190024|NCT00686777|530862560|FG000|Overall Study|Pregnancy|1|||
147190025|NCT00686777|530862560|FG000|Overall Study|Withdrawal by Subject|2|||
147190026|NCT00686777|530862560|FG000|Overall Study|Discontinuance Criteria (specified AEs)|4|||
147190027|NCT00686777|530862560|FG000|Overall Study|No Visit|1|||
147248165|NCT03919799|531076775|FG004|DB Period (28 Weeks)|Randomized not treated|0|||
147248166|NCT03919799|531076771|FG000|DB Period (28 Weeks)|Adverse Event|1|||
147248167|NCT03919799|531076772|FG001|DB Period (28 Weeks)|Adverse Event|1|||
147248168|NCT03919799|531076773|FG002|DB Period (28 Weeks)|Adverse Event|1|||
147248169|NCT03919799|531076774|FG003|DB Period (28 Weeks)|Adverse Event|0|||
147248170|NCT03919799|531076775|FG004|DB Period (28 Weeks)|Adverse Event|0|||
147248171|NCT03919799|531076771|FG000|DB Period (28 Weeks)|Withdrawal by Subject|0|||
147248172|NCT03919799|531076772|FG001|DB Period (28 Weeks)|Withdrawal by Subject|1|||
147248173|NCT03919799|531076773|FG002|DB Period (28 Weeks)|Withdrawal by Subject|0|||
147248174|NCT03919799|531076774|FG003|DB Period (28 Weeks)|Withdrawal by Subject|0|||
147248175|NCT03919799|531076775|FG004|DB Period (28 Weeks)|Withdrawal by Subject|0|||
147248176|NCT03919799|531076771|FG000|OLE Period (24 Weeks)|Withdrawal by Subject|0|||
147248177|NCT03919799|531076772|FG001|OLE Period (24 Weeks)|Withdrawal by Subject|2|||
147248178|NCT03919799|531076773|FG002|OLE Period (24 Weeks)|Withdrawal by Subject|0|||
147248179|NCT03919799|531076774|FG003|OLE Period (24 Weeks)|Withdrawal by Subject|0|||
147248180|NCT03919799|531076775|FG004|OLE Period (24 Weeks)|Withdrawal by Subject|0|||
147248181|NCT03919799|531076771|FG000|OLE Period (24 Weeks)|Other-unspecified|0|||
147248182|NCT03919799|531076772|FG001|OLE Period (24 Weeks)|Other-unspecified|1|||
147248183|NCT03919799|531076773|FG002|OLE Period (24 Weeks)|Other-unspecified|0|||
147248184|NCT03919799|531076774|FG003|OLE Period (24 Weeks)|Other-unspecified|0|||
147248185|NCT03919799|531076775|FG004|OLE Period (24 Weeks)|Other-unspecified|0|||
147248186|NCT05425745|531076780|FG000|Overall Study|Withdrawal of Consent|3|||
147248187|NCT05425745|531076781|FG001|Overall Study|Withdrawal of Consent|3|||
147248188|NCT05425745|531076780|FG000|Overall Study|Death|2|||
147248189|NCT05425745|531076781|FG001|Overall Study|Death|3|||
147248190|NCT05425745|531076780|FG000|Overall Study|Lost to Follow-up|1|||
147248191|NCT05425745|531076781|FG001|Overall Study|Lost to Follow-up|2|||
147248192|NCT05425745|531076780|FG000|Overall Study|Adverse Event|0|||
147248193|NCT05425745|531076781|FG001|Overall Study|Adverse Event|1|||
147248194|NCT05425745|531076780|FG000|Overall Study|Did not return for end of study visit|0|||
147248195|NCT05425745|531076781|FG001|Overall Study|Did not return for end of study visit|1|||
147248196|NCT05425745|531076780|FG000|Overall Study|End of study visit completed by phone|1|||
147248197|NCT05425745|531076781|FG001|Overall Study|End of study visit completed by phone|0|||
147248198|NCT05425745|531076780|FG000|Overall Study|Subject decision|1|||
147248199|NCT05425745|531076781|FG001|Overall Study|Subject decision|0|||
147249865|NCT01018186|531083793|FG000|2-week Run-in Period|Did Not Meet Continuation Criteria|97|||
147249866|NCT01018186|531083794|FG001|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
147249867|NCT01018186|531083795|FG002|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
147249868|NCT01018186|531083796|FG003|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
147190028|NCT00883779|530862561|FG000|Primary Study Treatment Phase|Did not receive allocated intervention|4|||
147190029|NCT00883779|530862562|FG001|Primary Study Treatment Phase|Did not receive allocated intervention|4|||
147249869|NCT01018186|531083793|FG000|52-week Double-blind Treatment Period|Adverse Event|0|||
147249870|NCT01018186|531083794|FG001|52-week Double-blind Treatment Period|Adverse Event|5|||
147249871|NCT01018186|531083795|FG002|52-week Double-blind Treatment Period|Adverse Event|3|||
147190030|NCT00883779|530862561|FG000|Primary Study Treatment Phase|Disease progression|75|||
147249872|NCT01018186|531083796|FG003|52-week Double-blind Treatment Period|Adverse Event|6|||
147190031|NCT00883779|530862562|FG001|Primary Study Treatment Phase|Disease progression|59|||
147190032|NCT00883779|530862561|FG000|Primary Study Treatment Phase|Adverse Event|16|||
147190033|NCT00883779|530862562|FG001|Primary Study Treatment Phase|Adverse Event|16|||
147190034|NCT00883779|530862561|FG000|Primary Study Treatment Phase|Death|2|||
147190035|NCT00883779|530862562|FG001|Primary Study Treatment Phase|Death|3|||
147190036|NCT00883779|530862561|FG000|Primary Study Treatment Phase|Refused Treatment|5|||
147190037|NCT00883779|530862562|FG001|Primary Study Treatment Phase|Refused Treatment|4|||
147190038|NCT00883779|530862561|FG000|Primary Study Treatment Phase|Other|3|||
147190039|NCT00883779|530862562|FG001|Primary Study Treatment Phase|Other|0|||
147190040|NCT00883779|530862561|FG000|Post-Study Treatment Phase|Adverse Event|2|||
147190041|NCT00883779|530862562|FG001|Post-Study Treatment Phase|Adverse Event|3|||
147190042|NCT00883779|530862561|FG000|Post-Study Treatment Phase|Death|1|||
147190043|NCT00883779|530862562|FG001|Post-Study Treatment Phase|Death|3|||
147190044|NCT00883779|530862561|FG000|Post-Study Treatment Phase|Protocol Violation|0|||
147190045|NCT00883779|530862562|FG001|Post-Study Treatment Phase|Protocol Violation|1|||
147190046|NCT00883779|530862561|FG000|Post-Study Treatment Phase|Refused Treatment|3|||
147190047|NCT00883779|530862562|FG001|Post-Study Treatment Phase|Refused Treatment|0|||
147190048|NCT00883779|530862561|FG000|Post-Study Treatment Phase|Disease progression|103|||
147190049|NCT00883779|530862562|FG001|Post-Study Treatment Phase|Disease progression|122|||
147190050|NCT00883779|530862561|FG000|Post-Study Treatment Phase|Other|3|||
147190051|NCT00883779|530862562|FG001|Post-Study Treatment Phase|Other|0|||
147190052|NCT00883779|530862561|FG000|Post-Study Treatment Phase|Ongoing in the study|0|||
147190053|NCT00883779|530862562|FG001|Post-Study Treatment Phase|Ongoing in the study|6|||
147190054|NCT00883779|530862561|FG000|Off-study Phase|Death|185|||
147190055|NCT00883779|530862562|FG001|Off-study Phase|Death|174|||
147190056|NCT00883779|530862561|FG000|Off-study Phase|Refused treatment|1|||
147190057|NCT00883779|530862562|FG001|Off-study Phase|Refused treatment|1|||
147190058|NCT00883779|530862561|FG000|Off-study Phase|Failure to return|5|||
147190059|NCT00883779|530862562|FG001|Off-study Phase|Failure to return|6|||
147190060|NCT00883779|530862561|FG000|Off-study Phase|Other|18|||
147190061|NCT00883779|530862562|FG001|Off-study Phase|Other|21|||
147190062|NCT00499681|530862563|FG000|Overall Study|toxicity|0|||
147248200|NCT00793403|531078520|FG000|Overall Study|Other|73|||
147248201|NCT00410046|531078523|FG000|Overall Study|Adverse Event|3|||
147248202|NCT00410046|531078523|FG000|Overall Study|Withdrawal by Subject|1|||
147248203|NCT00410046|531078523|FG000|Overall Study|Lost to Follow-up|1|||
147248204|NCT03909295|531078530|FG000|Overall Study|Adverse Event|2|||
147248205|NCT03909295|531078530|FG000|Overall Study|Study terminated by sponsor|50|||
147248206|NCT03312933|531078534|FG000|Overall Study|Protocol Violation|15|||
147248207|NCT03312933|531078534|FG000|Overall Study|Lost to Follow-up|36|||
147248208|NCT03312933|531078534|FG000|Overall Study|Withdrawal by Subject|3|||
147248209|NCT01549860|531078537|FG000|Overall Study|Withdrawal by Subject|1|||
147248210|NCT01549860|531078538|FG001|Overall Study|Withdrawal by Subject|0|||
147248211|NCT01549860|531078537|FG000|Overall Study|Physician Decision|1|||
147248212|NCT01549860|531078538|FG001|Overall Study|Physician Decision|1|||
147248213|NCT00660023|531078539|FG000|Overall Study|Adverse Event|2|||
147248214|NCT00660023|531078539|FG000|Overall Study|Death|8|||
147248215|NCT00660023|531078539|FG000|Overall Study|Blood Transfusion|5|||
147248216|NCT00660023|531078539|FG000|Overall Study|Renal Transplantation|3|||
147248217|NCT00660023|531078539|FG000|Overall Study|Withdrawal by Subject|1|||
147248218|NCT00660023|531078539|FG000|Overall Study|Missed Pregnancy Test|1|||
147248219|NCT00660023|531078539|FG000|Overall Study|Other Screening Failure|9|||
147248220|NCT04180488|531078540|FG000|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|2|||
147248221|NCT04180488|531078541|FG001|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|1|||
147248222|NCT04180488|531078542|FG002|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|1|||
147248223|NCT04180488|531078543|FG003|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|3|||
147248224|NCT04180488|531078544|FG004|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|2|||
147248225|NCT04180488|531078545|FG005|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|2|||
147248226|NCT04180488|531078540|FG000|Overall Study|Withdrawal by Subject|8|||
147248227|NCT04180488|531078541|FG001|Overall Study|Withdrawal by Subject|4|||
147248228|NCT04180488|531078542|FG002|Overall Study|Withdrawal by Subject|5|||
147248229|NCT04180488|531078543|FG003|Overall Study|Withdrawal by Subject|2|||
147248230|NCT04180488|531078544|FG004|Overall Study|Withdrawal by Subject|8|||
147248231|NCT04180488|531078545|FG005|Overall Study|Withdrawal by Subject|6|||
147248232|NCT04180488|531078540|FG000|Overall Study|Adverse Event|3|||
147330370|NCT00509769|531374528|FG000|Overall Study|Adverse Event|4|||
147330371|NCT00509769|531374528|FG000|Overall Study|Patient's decision|1|||
147190063|NCT00499681|530862564|FG001|Overall Study|toxicity|1|||
147190064|NCT00499681|530862563|FG000|Overall Study|disease progression|0|||
147190065|NCT00499681|530862564|FG001|Overall Study|disease progression|1|||
147190066|NCT00739401|530862569|FG000|Overall Study|patients were not due for the 2 year follow-up|34|||
147248233|NCT04180488|531078541|FG001|Overall Study|Adverse Event|2|||
147248234|NCT04180488|531078542|FG002|Overall Study|Adverse Event|0|||
147190067|NCT00739401|530862569|FG000|Overall Study|Death|3|||
147248235|NCT04180488|531078543|FG003|Overall Study|Adverse Event|0|||
147248236|NCT04180488|531078544|FG004|Overall Study|Adverse Event|0|||
147190068|NCT00739401|530862569|FG000|Overall Study|Withdrawal by Subject|4|||
147190069|NCT04575155|530862570|FG000|2 Month|Withdrawal by Subject|1|||
147190070|NCT04575155|530862571|FG001|2 Month|Withdrawal by Subject|1|||
147190071|NCT04575155|530862570|FG000|2 Month|Lost to Follow-up|5|||
147190072|NCT04575155|530862571|FG001|2 Month|Lost to Follow-up|3|||
147190073|NCT04575155|530862570|FG000|2 Month|Ineligible|1|||
147190074|NCT04575155|530862571|FG001|2 Month|Ineligible|0|||
147190075|NCT03915717|530862574|FG000|Overall Study|EchoMark Not Implanted|6|||
147190076|NCT03748823|530862576|FG000|Randomized Treatment Period|Withdrawal by Subject|1|||
147190077|NCT03748823|530862577|FG001|Randomized Treatment Period|Withdrawal by Subject|0|||
147190078|NCT03748823|530862576|FG000|Randomized Treatment Period|Site Source Document Deviations|1|||
147190079|NCT03748823|530862577|FG001|Randomized Treatment Period|Site Source Document Deviations|6|||
147190080|NCT03748823|530862576|FG000|Extension Period|Withdrawal by Subject|9|||
147190081|NCT03748823|530862577|FG001|Extension Period|Withdrawal by Subject|12|||
147190082|NCT03748823|530862576|FG000|Extension Period|Death|2|||
147190083|NCT03748823|530862577|FG001|Extension Period|Death|2|||
147190084|NCT03748823|530862576|FG000|Extension Period|Other than Specified|0|||
147190085|NCT03748823|530862577|FG001|Extension Period|Other than Specified|1|||
147190086|NCT03748823|530862576|FG000|Extension Period|Protocol Violation|1|||
147190087|NCT03748823|530862577|FG001|Extension Period|Protocol Violation|0|||
147190088|NCT03748823|530862576|FG000|Extension Period|Lost to Follow-up|0|||
147190089|NCT03748823|530862577|FG001|Extension Period|Lost to Follow-up|1|||
147190090|NCT03748823|530862576|FG000|Extension Period|Lack of Efficacy|0|||
147190091|NCT03748823|530862577|FG001|Extension Period|Lack of Efficacy|1|||
147190092|NCT03748823|530862576|FG000|Extension Period|Physician Decision|1|||
147190093|NCT03748823|530862577|FG001|Extension Period|Physician Decision|2|||
147190094|NCT02903160|530862578|FG000|Overall Study|Adverse Event|2|||
147190095|NCT02903160|530862578|FG000|Overall Study|Death|1|||
147190096|NCT02903160|530862578|FG000|Overall Study|Lost to Follow-up|2|||
147190097|NCT02903160|530862578|FG000|Overall Study|Withdrawal by Subject|1|||
147190098|NCT02903160|530862578|FG000|Overall Study|Medical Insurance Barriers|1|||
147190099|NCT01664910|530862581|FG000|Overall Study|Adverse Event|0|||
147190100|NCT01664910|530862582|FG001|Overall Study|Adverse Event|0|||
147190101|NCT01664910|530862583|FG002|Overall Study|Adverse Event|1|||
147248237|NCT04180488|531078545|FG005|Overall Study|Adverse Event|0|||
147248238|NCT04180488|531078540|FG000|Overall Study|Poor compliance to protocol|0|||
147248239|NCT04180488|531078541|FG001|Overall Study|Poor compliance to protocol|0|||
147248240|NCT04180488|531078542|FG002|Overall Study|Poor compliance to protocol|1|||
147248241|NCT04180488|531078543|FG003|Overall Study|Poor compliance to protocol|0|||
147248242|NCT04180488|531078544|FG004|Overall Study|Poor compliance to protocol|0|||
147248243|NCT04180488|531078545|FG005|Overall Study|Poor compliance to protocol|0|||
147248244|NCT03506815|531078546|FG000|Overall Study|Adverse Event|8|||
147248245|NCT03506815|531078547|FG001|Overall Study|Adverse Event|0|||
147248246|NCT03506815|531078546|FG000|Overall Study|End of chemotherapy removal of peripherally inserted central venous catheter|5|||
147248247|NCT03506815|531078547|FG001|Overall Study|End of chemotherapy removal of peripherally inserted central venous catheter|0|||
147248248|NCT03506815|531078546|FG000|Overall Study|Protocol Violation|1|||
147248249|NCT03506815|531078547|FG001|Overall Study|Protocol Violation|0|||
147330372|NCT00509769|531374528|FG000|Overall Study|Physician Decision|8|||
147330373|NCT00509769|531374528|FG000|Overall Study|Use of prohibited therapies during study|1|||
147248250|NCT03506815|531078546|FG000|Overall Study|Elective Surgery|1|||
147330374|NCT04173572|531374529|FG000|Overall Study|Withdrawal by Subject|1|||
147330375|NCT04173572|531374530|FG001|Overall Study|Withdrawal by Subject|5|||
147330376|NCT04173572|531374529|FG000|Overall Study|Lost to Follow-up|3|||
147330377|NCT04173572|531374530|FG001|Overall Study|Lost to Follow-up|1|||
147330378|NCT02873754|531374531|FG000|Overall Study|Lost to Follow-up|5|||
147330379|NCT02873754|531374531|FG000|Overall Study|Couldn't complete study procedures|1|||
147330380|NCT01253226|531374532|FG000|Overall Study|Adverse Event|0|||
147330381|NCT01253226|531374533|FG001|Overall Study|Adverse Event|0|||
147330382|NCT01253226|531374534|FG002|Overall Study|Adverse Event|1|||
147330383|NCT01253226|531374535|FG003|Overall Study|Adverse Event|0|||
147330384|NCT01253226|531374536|FG004|Overall Study|Adverse Event|0|||
147330385|NCT01253226|531374532|FG000|Overall Study|Death|0|||
147330386|NCT01253226|531374533|FG001|Overall Study|Death|1|||
147330387|NCT01253226|531374534|FG002|Overall Study|Death|0|||
147330388|NCT01253226|531374535|FG003|Overall Study|Death|0|||
147330389|NCT01253226|531374536|FG004|Overall Study|Death|0|||
147330390|NCT01253226|531374532|FG000|Overall Study|Physician Decision|0|||
147330391|NCT01253226|531374533|FG001|Overall Study|Physician Decision|0|||
147330392|NCT01253226|531374534|FG002|Overall Study|Physician Decision|0|||
147330393|NCT01253226|531374535|FG003|Overall Study|Physician Decision|0|||
147190102|NCT00867165|530862588|FG000|Overall Study|Adverse Event|3|||
147190103|NCT00867165|530862589|FG001|Overall Study|Adverse Event|0|||
147330394|NCT01253226|531374536|FG004|Overall Study|Physician Decision|2|||
147190104|NCT00867165|530862588|FG000|Overall Study|Withdrawal by Subject|1|||
147190105|NCT00867165|530862589|FG001|Overall Study|Withdrawal by Subject|0|||
147190106|NCT02738008|530862590|FG000|Overall Study|Study Terminated by Sponsor|1|||
147190107|NCT02738008|530862591|FG001|Overall Study|Study Terminated by Sponsor|5|||
147190108|NCT02738008|530862592|FG002|Overall Study|Study Terminated by Sponsor|3|||
147190109|NCT02738008|530862590|FG000|Overall Study|Adverse Event|0|||
147190110|NCT02738008|530862591|FG001|Overall Study|Adverse Event|1|||
147190111|NCT02738008|530862592|FG002|Overall Study|Adverse Event|2|||
147190112|NCT00399516|530862593|FG000|Overall Study|Lost to Follow-up|2|||
147190113|NCT02734693|530862594|FG000|Overall Study|Adverse Event|1|||
147190114|NCT02734693|530862595|FG001|Overall Study|Adverse Event|3|||
147190115|NCT02734693|530862596|FG002|Overall Study|Adverse Event|3|||
147190116|NCT02734693|530862594|FG000|Overall Study|Lack of Efficacy|1|||
147190117|NCT02734693|530862595|FG001|Overall Study|Lack of Efficacy|0|||
147190118|NCT02734693|530862596|FG002|Overall Study|Lack of Efficacy|0|||
147190119|NCT02734693|530862594|FG000|Overall Study|Lost to Follow-up|2|||
147190120|NCT02734693|530862595|FG001|Overall Study|Lost to Follow-up|0|||
147190121|NCT02734693|530862596|FG002|Overall Study|Lost to Follow-up|0|||
147190122|NCT02734693|530862594|FG000|Overall Study|Protocol Violation|1|||
147190123|NCT02734693|530862595|FG001|Overall Study|Protocol Violation|0|||
147190124|NCT02734693|530862596|FG002|Overall Study|Protocol Violation|0|||
147190125|NCT02734693|530862594|FG000|Overall Study|Withdrawal by Subject|1|||
147190126|NCT02734693|530862595|FG001|Overall Study|Withdrawal by Subject|0|||
147190127|NCT02734693|530862596|FG002|Overall Study|Withdrawal by Subject|0|||
147190128|NCT00982735|530862597|FG000|Overall Study|Lost to Follow-up|6|||
147190129|NCT00982735|530862597|FG000|Overall Study|Patient ineligible for trial|224|||
147190130|NCT04879628|530862603|FG000|Part A: DB Period (Up to Week 12)|Adverse event: Related to Coronavirus Disease 2019|0|||
147190131|NCT04879628|530862604|FG001|Part A: DB Period (Up to Week 12)|Adverse event: Related to Coronavirus Disease 2019|0|||
147190132|NCT04879628|530862605|FG002|Part A: DB Period (Up to Week 12)|Adverse event: Related to Coronavirus Disease 2019|1|||
147190133|NCT04879628|530862606|FG003|Part A: DB Period (Up to Week 12)|Adverse event: Related to Coronavirus Disease 2019|0|||
147190134|NCT04879628|530862603|FG000|Part A: DB Period (Up to Week 12)|Withdrawal by Subject|0|||
147190135|NCT04879628|530862604|FG001|Part A: DB Period (Up to Week 12)|Withdrawal by Subject|0|||
147190136|NCT04879628|530862605|FG002|Part A: DB Period (Up to Week 12)|Withdrawal by Subject|1|||
147190137|NCT04879628|530862606|FG003|Part A: DB Period (Up to Week 12)|Withdrawal by Subject|0|||
147190138|NCT04879628|530862603|FG000|Part A: DB Period (Up to Week 12)|Emergency situation due to war in Ukraine|0|||
147190139|NCT04879628|530862604|FG001|Part A: DB Period (Up to Week 12)|Emergency situation due to war in Ukraine|0|||
147190140|NCT04879628|530862605|FG002|Part A: DB Period (Up to Week 12)|Emergency situation due to war in Ukraine|0|||
147190141|NCT04879628|530862606|FG003|Part A: DB Period (Up to Week 12)|Emergency situation due to war in Ukraine|2|||
147190142|NCT04879628|530862603|FG000|Part B: OLE Period (Up to Week 296)|Ongoing at the time of PCD|0|||
147190143|NCT04879628|530862604|FG001|Part B: OLE Period (Up to Week 296)|Ongoing at the time of PCD|0|||
147190144|NCT04879628|530862605|FG002|Part B: OLE Period (Up to Week 296)|Ongoing at the time of PCD|63|||
147190145|NCT04879628|530862606|FG003|Part B: OLE Period (Up to Week 296)|Ongoing at the time of PCD|62|||
147190146|NCT02775916|530862607|FG000|Overall Study|Adverse Event|1|||
147190147|NCT02775916|530862608|FG001|Overall Study|Adverse Event|0|||
147190148|NCT02775916|530862607|FG000|Overall Study|Subject/Guardian Decision|2|||
147190149|NCT02775916|530862608|FG001|Overall Study|Subject/Guardian Decision|0|||
147190150|NCT00948064|530864247|FG000|Phase I|No treatment received|1|||
147190151|NCT00948064|530864248|FG001|Phase I|No treatment received|0|||
147190152|NCT00948064|530864249|FG002|Phase I|No treatment received|0|||
147190153|NCT00948064|530864247|FG000|Phase II|Physician Decision|0|||
147190154|NCT00948064|530864248|FG001|Phase II|Physician Decision|0|||
147190155|NCT00948064|530864249|FG002|Phase II|Physician Decision|1|||
147190156|NCT00948064|530864247|FG000|Phase II|Withdrawal by Subject|0|||
147190157|NCT00948064|530864248|FG001|Phase II|Withdrawal by Subject|1|||
147190158|NCT00948064|530864249|FG002|Phase II|Withdrawal by Subject|0|||
147190159|NCT00644423|530864251|FG000|Overall Study|Lost to Follow-up|1|||
147190160|NCT00644423|530864252|FG001|Overall Study|Lost to Follow-up|1|||
147190161|NCT03096834|530864253|FG000|Double-Blind Treatment Epoch|Protocol deviation|2|||
147190162|NCT03096834|530864254|FG001|Double-Blind Treatment Epoch|Protocol deviation|1|||
147248251|NCT03506815|531078547|FG001|Overall Study|Elective Surgery|0|||
147248252|NCT02899988|531078555|FG000|Induction Period (16 Weeks)|Withdrawal by Subject|2|||
147248253|NCT02899988|531078556|FG001|Induction Period (16 Weeks)|Withdrawal by Subject|1|||
147248254|NCT02899988|531078557|FG002|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
147248255|NCT02899988|531078558|FG003|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
147248256|NCT02899988|531078559|FG004|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
147248257|NCT02899988|531078560|FG005|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
147248258|NCT02899988|531078561|FG006|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
147330395|NCT01253226|531374532|FG000|Overall Study|Withdrawal by Subject|0|||
147330396|NCT01253226|531374533|FG001|Overall Study|Withdrawal by Subject|0|||
147330397|NCT01253226|531374534|FG002|Overall Study|Withdrawal by Subject|0|||
147190163|NCT03096834|530864255|FG002|Double-Blind Treatment Epoch|Protocol deviation|0|||
147190164|NCT03096834|530864256|FG003|Double-Blind Treatment Epoch|Protocol deviation|0|||
147248259|NCT02899988|531078562|FG007|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
147248260|NCT02899988|531078563|FG008|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
147330398|NCT01253226|531374535|FG003|Overall Study|Withdrawal by Subject|1|||
147190165|NCT03096834|530864253|FG000|Double-Blind Treatment Epoch|Pregnancy|0|||
147190166|NCT03096834|530864254|FG001|Double-Blind Treatment Epoch|Pregnancy|1|||
147190167|NCT03096834|530864255|FG002|Double-Blind Treatment Epoch|Pregnancy|0|||
147190168|NCT03096834|530864256|FG003|Double-Blind Treatment Epoch|Pregnancy|0|||
147190169|NCT03096834|530864253|FG000|Double-Blind Treatment Epoch|Subject/guardian decision|1|||
147190170|NCT03096834|530864254|FG001|Double-Blind Treatment Epoch|Subject/guardian decision|1|||
147190171|NCT03096834|530864255|FG002|Double-Blind Treatment Epoch|Subject/guardian decision|0|||
147190172|NCT03096834|530864256|FG003|Double-Blind Treatment Epoch|Subject/guardian decision|0|||
147190173|NCT03096834|530864253|FG000|Open-Label Treatment Epoch|Lack of Efficacy|0|||
147190174|NCT03096834|530864254|FG001|Open-Label Treatment Epoch|Lack of Efficacy|0|||
147190175|NCT03096834|530864255|FG002|Open-Label Treatment Epoch|Lack of Efficacy|15|||
147190176|NCT03096834|530864256|FG003|Open-Label Treatment Epoch|Lack of Efficacy|15|||
147190177|NCT03096834|530864253|FG000|Open-Label Treatment Epoch|Adverse Event|0|||
147190178|NCT03096834|530864254|FG001|Open-Label Treatment Epoch|Adverse Event|0|||
147190179|NCT03096834|530864255|FG002|Open-Label Treatment Epoch|Adverse Event|5|||
147190180|NCT03096834|530864256|FG003|Open-Label Treatment Epoch|Adverse Event|6|||
147190181|NCT03096834|530864253|FG000|Open-Label Treatment Epoch|New therapy for study indication|0|||
147190182|NCT03096834|530864254|FG001|Open-Label Treatment Epoch|New therapy for study indication|0|||
147190183|NCT03096834|530864255|FG002|Open-Label Treatment Epoch|New therapy for study indication|1|||
147190184|NCT03096834|530864256|FG003|Open-Label Treatment Epoch|New therapy for study indication|1|||
147190185|NCT03096834|530864253|FG000|Open-Label Treatment Epoch|Physician Decision|0|||
147190186|NCT03096834|530864254|FG001|Open-Label Treatment Epoch|Physician Decision|0|||
147190187|NCT03096834|530864255|FG002|Open-Label Treatment Epoch|Physician Decision|1|||
147190188|NCT03096834|530864256|FG003|Open-Label Treatment Epoch|Physician Decision|0|||
147190189|NCT03096834|530864253|FG000|Open-Label Treatment Epoch|Pregnancy|0|||
147190190|NCT03096834|530864254|FG001|Open-Label Treatment Epoch|Pregnancy|0|||
147190191|NCT03096834|530864255|FG002|Open-Label Treatment Epoch|Pregnancy|1|||
147190192|NCT03096834|530864256|FG003|Open-Label Treatment Epoch|Pregnancy|0|||
147190193|NCT03096834|530864253|FG000|Open-Label Treatment Epoch|Subject/guardian decision|0|||
147190194|NCT03096834|530864254|FG001|Open-Label Treatment Epoch|Subject/guardian decision|0|||
147190195|NCT03096834|530864255|FG002|Open-Label Treatment Epoch|Subject/guardian decision|9|||
147190196|NCT03096834|530864256|FG003|Open-Label Treatment Epoch|Subject/guardian decision|17|||
147190197|NCT03096834|530864253|FG000|Safety Follow-Up Epoch|New therapy for study indication|0|||
147190198|NCT03096834|530864254|FG001|Safety Follow-Up Epoch|New therapy for study indication|0|||
147190199|NCT03096834|530864255|FG002|Safety Follow-Up Epoch|New therapy for study indication|0|||
147190200|NCT03096834|530864256|FG003|Safety Follow-Up Epoch|New therapy for study indication|1|||
147190201|NCT03096834|530864253|FG000|Safety Follow-Up Epoch|Protocol deviation|0|||
147190202|NCT03096834|530864254|FG001|Safety Follow-Up Epoch|Protocol deviation|0|||
147190203|NCT03096834|530864255|FG002|Safety Follow-Up Epoch|Protocol deviation|0|||
147190204|NCT03096834|530864256|FG003|Safety Follow-Up Epoch|Protocol deviation|1|||
147190205|NCT03096834|530864253|FG000|Safety Follow-Up Epoch|Lost to Follow-up|0|||
147190206|NCT03096834|530864254|FG001|Safety Follow-Up Epoch|Lost to Follow-up|0|||
147190207|NCT03096834|530864255|FG002|Safety Follow-Up Epoch|Lost to Follow-up|1|||
147190208|NCT03096834|530864256|FG003|Safety Follow-Up Epoch|Lost to Follow-up|0|||
147190209|NCT04233801|530864261|FG000|Overall Study|Other than listed|0|||
147190210|NCT04233801|530864262|FG001|Overall Study|Other than listed|0|||
147190211|NCT04233801|530864263|FG002|Overall Study|Other than listed|1|||
147190212|NCT04233801|530864261|FG000|Overall Study|Withdrawal by Subject|0|||
147190213|NCT04233801|530864262|FG001|Overall Study|Withdrawal by Subject|2|||
147190214|NCT04233801|530864263|FG002|Overall Study|Withdrawal by Subject|3|||
147190215|NCT00762359|530864264|FG000|Overall Study|Adverse Event|20|||
147190216|NCT00762359|530864265|FG001|Overall Study|Adverse Event|23|||
147330399|NCT01253226|531374536|FG004|Overall Study|Withdrawal by Subject|0|||
147190217|NCT00762359|530864264|FG000|Overall Study|Protocol Violation|21|||
147190218|NCT00762359|530864265|FG001|Overall Study|Protocol Violation|13|||
147190219|NCT00762359|530864264|FG000|Overall Study|Withdrawal by Subject|13|||
147190220|NCT00762359|530864265|FG001|Overall Study|Withdrawal by Subject|10|||
147190221|NCT00762359|530864264|FG000|Overall Study|Lack of Efficacy|0|||
147248261|NCT02899988|531078564|FG009|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
147248262|NCT02899988|531078565|FG010|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
147248263|NCT02899988|531078555|FG000|Induction Period (16 Weeks)|Adverse Event|0|||
147248264|NCT02899988|531078556|FG001|Induction Period (16 Weeks)|Adverse Event|0|||
147248265|NCT02899988|531078557|FG002|Induction Period (16 Weeks)|Adverse Event|0|||
147248266|NCT02899988|531078558|FG003|Induction Period (16 Weeks)|Adverse Event|2|||
147248267|NCT02899988|531078559|FG004|Induction Period (16 Weeks)|Adverse Event|0|||
147248268|NCT02899988|531078560|FG005|Induction Period (16 Weeks)|Adverse Event|0|||
147248269|NCT02899988|531078561|FG006|Induction Period (16 Weeks)|Adverse Event|0|||
147248270|NCT02899988|531078562|FG007|Induction Period (16 Weeks)|Adverse Event|0|||
147248271|NCT02899988|531078563|FG008|Induction Period (16 Weeks)|Adverse Event|0|||
147248272|NCT02899988|531078564|FG009|Induction Period (16 Weeks)|Adverse Event|0|||
147248273|NCT02899988|531078565|FG010|Induction Period (16 Weeks)|Adverse Event|0|||
147248274|NCT02899988|531078555|FG000|Induction Period (16 Weeks)|Physician Decision|0|||
147248275|NCT02899988|531078556|FG001|Induction Period (16 Weeks)|Physician Decision|1|||
147190222|NCT00762359|530864265|FG001|Overall Study|Lack of Efficacy|4|||
147190223|NCT00762359|530864264|FG000|Overall Study|Institution closed|2|||
147190224|NCT00762359|530864265|FG001|Overall Study|Institution closed|3|||
147190225|NCT00762359|530864264|FG000|Overall Study|Physician Decision|2|||
147190226|NCT00762359|530864265|FG001|Overall Study|Physician Decision|3|||
147190227|NCT00762359|530864264|FG000|Overall Study|Removal|0|||
147190228|NCT00762359|530864265|FG001|Overall Study|Removal|1|||
147190229|NCT00762359|530864264|FG000|Overall Study|Withdrew consent|1|||
147190230|NCT00762359|530864265|FG001|Overall Study|Withdrew consent|0|||
147190231|NCT01690052|530864270|FG000|FIRST INTERVENTION: 4 WEEKS|Lost to Follow-up|1|||
147190232|NCT01690052|530864271|FG001|FIRST INTERVENTION: 4 WEEKS|Lost to Follow-up|2|||
147190233|NCT02421172|530864272|FG000|Period 1|Adverse Event|1|||
147190234|NCT02421172|530864273|FG001|Period 1|Adverse Event|0|||
147190235|NCT02421172|530864274|FG002|Period 1|Adverse Event|0|||
147190236|NCT02421172|530864275|FG003|Period 1|Adverse Event|0|||
147190237|NCT02421172|530864276|FG004|Period 1|Adverse Event|0|||
147190238|NCT02421172|530864272|FG000|Period 1|Lost to Follow-up|3|||
147190239|NCT02421172|530864273|FG001|Period 1|Lost to Follow-up|1|||
147190240|NCT02421172|530864274|FG002|Period 1|Lost to Follow-up|0|||
147190241|NCT02421172|530864275|FG003|Period 1|Lost to Follow-up|0|||
147190242|NCT02421172|530864276|FG004|Period 1|Lost to Follow-up|0|||
147190243|NCT02421172|530864272|FG000|Period 1|Patient/guardian decision|0|||
147190244|NCT02421172|530864273|FG001|Period 1|Patient/guardian decision|1|||
147190245|NCT02421172|530864274|FG002|Period 1|Patient/guardian decision|0|||
147190246|NCT02421172|530864275|FG003|Period 1|Patient/guardian decision|0|||
147190247|NCT02421172|530864276|FG004|Period 1|Patient/guardian decision|0|||
147190248|NCT02421172|530864272|FG000|Period 2|Adverse Event|0|||
147190249|NCT02421172|530864273|FG001|Period 2|Adverse Event|0|||
147190250|NCT02421172|530864274|FG002|Period 2|Adverse Event|4|||
147190251|NCT02421172|530864275|FG003|Period 2|Adverse Event|0|||
147190252|NCT02421172|530864276|FG004|Period 2|Adverse Event|0|||
147190253|NCT02421172|530864272|FG000|Period 2|Lost to Follow-up|0|||
147190254|NCT02421172|530864273|FG001|Period 2|Lost to Follow-up|0|||
147190255|NCT02421172|530864274|FG002|Period 2|Lost to Follow-up|0|||
147190256|NCT02421172|530864275|FG003|Period 2|Lost to Follow-up|1|||
147190257|NCT02421172|530864276|FG004|Period 2|Lost to Follow-up|0|||
147190258|NCT02421172|530864272|FG000|Period 2|Patient/guardian decision|0|||
147190259|NCT02421172|530864273|FG001|Period 2|Patient/guardian decision|0|||
147190260|NCT02421172|530864274|FG002|Period 2|Patient/guardian decision|3|||
147190261|NCT02421172|530864275|FG003|Period 2|Patient/guardian decision|2|||
147190262|NCT02421172|530864276|FG004|Period 2|Patient/guardian decision|1|||
147190263|NCT00928486|530864277|FG000|Overall Study|Adverse Event|2|||
147190264|NCT00928486|530864277|FG000|Overall Study|Disease Progression|7|||
147190265|NCT00928486|530864277|FG000|Overall Study|Withdrawal by Subject|1|||
147190266|NCT00683878|530864282|FG000|Overall Study|Lack of Efficacy|3|||
147190267|NCT00683878|530864283|FG001|Overall Study|Lack of Efficacy|0|||
147190268|NCT00683878|530864284|FG002|Overall Study|Lack of Efficacy|1|||
147190269|NCT00683878|530864282|FG000|Overall Study|Adverse Event|4|||
147190270|NCT00683878|530864283|FG001|Overall Study|Adverse Event|3|||
147190271|NCT00683878|530864284|FG002|Overall Study|Adverse Event|3|||
147190272|NCT00683878|530864282|FG000|Overall Study|Withdrawal by Subject|9|||
147190273|NCT00683878|530864283|FG001|Overall Study|Withdrawal by Subject|8|||
147190274|NCT00683878|530864284|FG002|Overall Study|Withdrawal by Subject|6|||
147190275|NCT00683878|530864282|FG000|Overall Study|Death|0|||
147190276|NCT00683878|530864283|FG001|Overall Study|Death|1|||
147190277|NCT00683878|530864284|FG002|Overall Study|Death|0|||
147190278|NCT00683878|530864282|FG000|Overall Study|Lost to Follow-up|4|||
147190279|NCT00683878|530864283|FG001|Overall Study|Lost to Follow-up|2|||
147190280|NCT00683878|530864284|FG002|Overall Study|Lost to Follow-up|4|||
147190281|NCT00683878|530864282|FG000|Overall Study|Non-compliance, not met criteria etc.|3|||
147190282|NCT00683878|530864283|FG001|Overall Study|Non-compliance, not met criteria etc.|2|||
147190283|NCT00683878|530864284|FG002|Overall Study|Non-compliance, not met criteria etc.|0|||
147190284|NCT02891174|530864306|FG000|First Intervention (24 Hours)|Declined any study medication|1|||
147190285|NCT02891174|530864307|FG001|First Intervention (24 Hours)|Declined any study medication|5|||
147190286|NCT02891174|530864306|FG000|First Intervention (24 Hours)|Discharged prior to cross-over|0|||
147190287|NCT02891174|530864307|FG001|First Intervention (24 Hours)|Discharged prior to cross-over|2|||
147190288|NCT02891174|530864306|FG000|First Intervention (24 Hours)|Withdrew after receiving study drug|2|||
147190289|NCT02891174|530864307|FG001|First Intervention (24 Hours)|Withdrew after receiving study drug|6|||
147190290|NCT02891174|530864306|FG000|Second Intervention (24 Hours)|No blood pressure after cross-over|1|||
147190291|NCT02891174|530864307|FG001|Second Intervention (24 Hours)|No blood pressure after cross-over|0|||
147190292|NCT02891174|530864306|FG000|Second Intervention (24 Hours)|Discharged during second intervention|3|||
147190293|NCT02891174|530864307|FG001|Second Intervention (24 Hours)|Discharged during second intervention|5|||
147190294|NCT02891174|530864306|FG000|Second Intervention (24 Hours)|Withdrew after receiving study drug|2|||
147190295|NCT02891174|530864307|FG001|Second Intervention (24 Hours)|Withdrew after receiving study drug|1|||
147190296|NCT02891174|530864306|FG000|Second Intervention (24 Hours)|Protocol Violation|0|||
147190297|NCT02891174|530864307|FG001|Second Intervention (24 Hours)|Protocol Violation|1|||
147448998|NCT01225731|531808045|FG001|Part 2|Protocol Violation|0|||
147448999|NCT01225731|531808046|FG002|Part 2|Protocol Violation|0|||
147449000|NCT01225731|531808047|FG003|Part 2|Protocol Violation|0|||
147449001|NCT01225731|531808048|FG004|Part 2|Protocol Violation|0|||
147449002|NCT01225731|531808049|FG005|Part 2|Protocol Violation|1|||
147449003|NCT01225731|531808050|FG006|Part 2|Protocol Violation|0|||
147449004|NCT01225731|531808051|FG007|Part 2|Protocol Violation|0|||
147449005|NCT01225731|531808052|FG008|Part 2|Protocol Violation|1|||
147449006|NCT01225731|531808053|FG009|Part 2|Protocol Violation|0|||
147449007|NCT01225731|531808054|FG010|Part 2|Protocol Violation|0|||
147449008|NCT01225731|531808055|FG011|Part 2|Protocol Violation|0|||
147449009|NCT01225731|531808056|FG012|Part 2|Protocol Violation|0|||
147449010|NCT01225731|531808044|FG000|Part 2|Adverse Event|0|||
147449011|NCT01225731|531808045|FG001|Part 2|Adverse Event|0|||
147449012|NCT01225731|531808046|FG002|Part 2|Adverse Event|0|||
147449013|NCT01225731|531808047|FG003|Part 2|Adverse Event|0|||
147449014|NCT01225731|531808048|FG004|Part 2|Adverse Event|0|||
147449015|NCT01225731|531808049|FG005|Part 2|Adverse Event|0|||
147449016|NCT01225731|531808050|FG006|Part 2|Adverse Event|4|||
147449017|NCT01225731|531808051|FG007|Part 2|Adverse Event|4|||
147449018|NCT01225731|531808052|FG008|Part 2|Adverse Event|2|||
147449019|NCT01225731|531808053|FG009|Part 2|Adverse Event|0|||
147449020|NCT01225731|531808054|FG010|Part 2|Adverse Event|0|||
147449021|NCT01225731|531808055|FG011|Part 2|Adverse Event|0|||
147449022|NCT01225731|531808056|FG012|Part 2|Adverse Event|0|||
147449023|NCT01225731|531808044|FG000|Part 2|Lack of Efficacy|0|||
147449024|NCT01225731|531808045|FG001|Part 2|Lack of Efficacy|0|||
147449025|NCT01225731|531808046|FG002|Part 2|Lack of Efficacy|0|||
147449026|NCT01225731|531808047|FG003|Part 2|Lack of Efficacy|0|||
147449027|NCT01225731|531808048|FG004|Part 2|Lack of Efficacy|0|||
147449028|NCT01225731|531808049|FG005|Part 2|Lack of Efficacy|1|||
147449029|NCT01225731|531808050|FG006|Part 2|Lack of Efficacy|0|||
147449030|NCT01225731|531808051|FG007|Part 2|Lack of Efficacy|12|||
147449031|NCT01225731|531808052|FG008|Part 2|Lack of Efficacy|3|||
147449032|NCT01225731|531808053|FG009|Part 2|Lack of Efficacy|0|||
147449033|NCT01225731|531808054|FG010|Part 2|Lack of Efficacy|0|||
147449034|NCT01225731|531808055|FG011|Part 2|Lack of Efficacy|0|||
147449035|NCT01225731|531808056|FG012|Part 2|Lack of Efficacy|0|||
147449036|NCT01225731|531808044|FG000|Part 2|Pregnancy|0|||
147449037|NCT01225731|531808045|FG001|Part 2|Pregnancy|0|||
147449038|NCT01225731|531808046|FG002|Part 2|Pregnancy|0|||
147449039|NCT01225731|531808047|FG003|Part 2|Pregnancy|0|||
147190298|NCT04235140|530864308|FG000|Overall Study|Adverse Event|2|||
147190299|NCT04235140|530864308|FG000|Overall Study|Lost to Follow-up|1|||
147190300|NCT04235140|530864308|FG000|Overall Study|Withdrawal of consent (not due to AE)|4|||
147190301|NCT04235140|530864308|FG000|Overall Study|Commercial drug is available for participants|7|||
147190302|NCT01421017|530864309|FG000|Overall Study|Withdrawal by Subject|2|||
147190303|NCT01421017|530864310|FG001|Overall Study|Withdrawal by Subject|0|||
147190304|NCT01421017|530864311|FG002|Overall Study|Withdrawal by Subject|0|||
147190305|NCT01421017|530864309|FG000|Overall Study|POD|0|||
147190306|NCT01421017|530864310|FG001|Overall Study|POD|6|||
147190307|NCT01421017|530864311|FG002|Overall Study|POD|3|||
147190308|NCT00866177|530864316|FG000|Overall Study|Withdrawal by Subject|1|||
147190309|NCT00866177|530864316|FG000|Overall Study|Not Treated|151|||
147449040|NCT01225731|531808048|FG004|Part 2|Pregnancy|0|||
147190310|NCT00861705|530864317|FG000|Overall Study|Never Began Treatment|7|||
147449041|NCT01225731|531808049|FG005|Part 2|Pregnancy|0|||
147449042|NCT01225731|531808050|FG006|Part 2|Pregnancy|1|||
147449043|NCT01225731|531808051|FG007|Part 2|Pregnancy|0|||
147449044|NCT01225731|531808052|FG008|Part 2|Pregnancy|1|||
147449045|NCT01225731|531808053|FG009|Part 2|Pregnancy|0|||
147449046|NCT01225731|531808054|FG010|Part 2|Pregnancy|0|||
147449047|NCT01225731|531808055|FG011|Part 2|Pregnancy|0|||
147449048|NCT01225731|531808056|FG012|Part 2|Pregnancy|0|||
147449049|NCT01225731|531808044|FG000|Part 2|Lost to Follow-up|0|||
147449050|NCT01225731|531808045|FG001|Part 2|Lost to Follow-up|0|||
147449051|NCT01225731|531808046|FG002|Part 2|Lost to Follow-up|0|||
147449052|NCT01225731|531808047|FG003|Part 2|Lost to Follow-up|0|||
147449053|NCT01225731|531808048|FG004|Part 2|Lost to Follow-up|0|||
147190311|NCT00861705|530864318|FG001|Overall Study|Never Began Treatment|3|||
147190312|NCT00861705|530864319|FG002|Overall Study|Never Began Treatment|0|||
147449054|NCT01225731|531808049|FG005|Part 2|Lost to Follow-up|0|||
147449055|NCT01225731|531808050|FG006|Part 2|Lost to Follow-up|0|||
147449056|NCT01225731|531808051|FG007|Part 2|Lost to Follow-up|3|||
147449057|NCT01225731|531808052|FG008|Part 2|Lost to Follow-up|1|||
147449058|NCT01225731|531808053|FG009|Part 2|Lost to Follow-up|0|||
147449059|NCT01225731|531808054|FG010|Part 2|Lost to Follow-up|0|||
147449060|NCT01225731|531808055|FG011|Part 2|Lost to Follow-up|0|||
147449061|NCT01225731|531808056|FG012|Part 2|Lost to Follow-up|0|||
147449062|NCT01225731|531808044|FG000|Part 2|Physician Decision|0|||
147449063|NCT01225731|531808045|FG001|Part 2|Physician Decision|0|||
147449064|NCT01225731|531808046|FG002|Part 2|Physician Decision|0|||
147449065|NCT01225731|531808047|FG003|Part 2|Physician Decision|0|||
147449066|NCT01225731|531808048|FG004|Part 2|Physician Decision|0|||
147449067|NCT01225731|531808049|FG005|Part 2|Physician Decision|0|||
147449068|NCT01225731|531808050|FG006|Part 2|Physician Decision|0|||
147449069|NCT01225731|531808051|FG007|Part 2|Physician Decision|2|||
147449070|NCT01225731|531808052|FG008|Part 2|Physician Decision|2|||
147190313|NCT00861705|530864320|FG003|Overall Study|Never Began Treatment|1|||
147190314|NCT00088530|530864321|FG000|Overall Study|Progressive/Relapsed Disease|28|||
147190315|NCT00088530|530864322|FG001|Overall Study|Progressive/Relapsed Disease|39|||
147190316|NCT00088530|530864321|FG000|Overall Study|Adverse Event|15|||
147190317|NCT00088530|530864322|FG001|Overall Study|Adverse Event|9|||
147190318|NCT00088530|530864321|FG000|Overall Study|Withdrawal by Subject|2|||
147190319|NCT00088530|530864322|FG001|Overall Study|Withdrawal by Subject|5|||
147190320|NCT00088530|530864321|FG000|Overall Study|Lost to Follow-up|2|||
147190321|NCT00088530|530864322|FG001|Overall Study|Lost to Follow-up|0|||
147190322|NCT00088530|530864321|FG000|Overall Study|Physician Decision|2|||
147190323|NCT00088530|530864322|FG001|Overall Study|Physician Decision|0|||
147190324|NCT00088530|530864321|FG000|Overall Study|Sponsor decision|0|||
147190325|NCT00088530|530864322|FG001|Overall Study|Sponsor decision|1|||
147190326|NCT00088530|530864321|FG000|Overall Study|Patient never treated|1|||
147190327|NCT00088530|530864322|FG001|Overall Study|Patient never treated|0|||
147190328|NCT02694744|530864323|FG000|Overall Study|Adverse Event|2|||
147190329|NCT02694744|530864324|FG001|Overall Study|Adverse Event|1|||
147248276|NCT02899988|531078557|FG002|Induction Period (16 Weeks)|Physician Decision|0|||
147248277|NCT02899988|531078558|FG003|Induction Period (16 Weeks)|Physician Decision|0|||
147248278|NCT02899988|531078559|FG004|Induction Period (16 Weeks)|Physician Decision|0|||
147248279|NCT02899988|531078560|FG005|Induction Period (16 Weeks)|Physician Decision|0|||
147248280|NCT02899988|531078561|FG006|Induction Period (16 Weeks)|Physician Decision|0|||
147330400|NCT00988637|531374537|FG000|Overall Study|Lost to Follow-up|2|||
147330401|NCT00988637|531374538|FG001|Overall Study|Lost to Follow-up|1|||
147330402|NCT00988637|531374537|FG000|Overall Study|Withdrawal by Subject|1|||
147330403|NCT00988637|531374538|FG001|Overall Study|Withdrawal by Subject|1|||
147330404|NCT00988637|531374537|FG000|Overall Study|non-compliance with study drug|0|||
147330405|NCT00988637|531374538|FG001|Overall Study|non-compliance with study drug|1|||
147330406|NCT01543685|531374542|FG000|Overall Study|Lack of Efficacy|1|||
147330407|NCT01543685|531374543|FG001|Overall Study|Lack of Efficacy|2|||
147330408|NCT01543685|531374544|FG002|Overall Study|Lack of Efficacy|2|||
147330409|NCT01543685|531374545|FG003|Overall Study|Lack of Efficacy|0|||
147330410|NCT01543685|531374546|FG004|Overall Study|Lack of Efficacy|2|||
147330411|NCT01543685|531374542|FG000|Overall Study|Adverse Event|2|||
147330412|NCT01543685|531374543|FG001|Overall Study|Adverse Event|1|||
147330413|NCT01543685|531374544|FG002|Overall Study|Adverse Event|0|||
147330414|NCT01543685|531374545|FG003|Overall Study|Adverse Event|0|||
147330415|NCT01543685|531374546|FG004|Overall Study|Adverse Event|2|||
147330416|NCT02685033|531374549|FG000|Overall Study|Withdrawal of Consent|0|||
147330417|NCT02685033|531374550|FG001|Overall Study|Withdrawal of Consent|1|||
147330418|NCT02685033|531374549|FG000|Overall Study|Lost to Follow-up|2|||
147330419|NCT02685033|531374550|FG001|Overall Study|Lost to Follow-up|1|||
147190330|NCT02694744|530864323|FG000|Overall Study|Withdrawal by Subject|2|||
147190331|NCT02694744|530864324|FG001|Overall Study|Withdrawal by Subject|1|||
147248281|NCT02899988|531078562|FG007|Induction Period (16 Weeks)|Physician Decision|0|||
147248282|NCT02899988|531078563|FG008|Induction Period (16 Weeks)|Physician Decision|0|||
147248283|NCT02899988|531078564|FG009|Induction Period (16 Weeks)|Physician Decision|0|||
147248284|NCT02899988|531078565|FG010|Induction Period (16 Weeks)|Physician Decision|0|||
147248285|NCT02899988|531078555|FG000|Maintenance Period (88 Weeks)|Adverse Event|0|||
147248286|NCT02899988|531078556|FG001|Maintenance Period (88 Weeks)|Adverse Event|0|||
147248287|NCT02899988|531078557|FG002|Maintenance Period (88 Weeks)|Adverse Event|0|||
147248288|NCT02899988|531078558|FG003|Maintenance Period (88 Weeks)|Adverse Event|0|||
147248289|NCT02899988|531078559|FG004|Maintenance Period (88 Weeks)|Adverse Event|1|||
147248290|NCT02899988|531078560|FG005|Maintenance Period (88 Weeks)|Adverse Event|2|||
147248291|NCT02899988|531078561|FG006|Maintenance Period (88 Weeks)|Adverse Event|1|||
147248292|NCT02899988|531078562|FG007|Maintenance Period (88 Weeks)|Adverse Event|2|||
147248293|NCT02899988|531078563|FG008|Maintenance Period (88 Weeks)|Adverse Event|2|||
147248294|NCT02899988|531078564|FG009|Maintenance Period (88 Weeks)|Adverse Event|2|||
147248295|NCT02899988|531078565|FG010|Maintenance Period (88 Weeks)|Adverse Event|1|||
147248296|NCT02899988|531078555|FG000|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
147248297|NCT02899988|531078556|FG001|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
147248298|NCT02899988|531078557|FG002|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
147330420|NCT02685033|531374549|FG000|Overall Study|Adverse Event|1|||
147190332|NCT02694744|530864323|FG000|Overall Study|Physician Decision|1|||
147248299|NCT02899988|531078558|FG003|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
147248300|NCT02899988|531078559|FG004|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
147248301|NCT02899988|531078560|FG005|Maintenance Period (88 Weeks)|Lost to Follow-up|1|||
147330421|NCT02685033|531374550|FG001|Overall Study|Adverse Event|0|||
147190333|NCT02694744|530864324|FG001|Overall Study|Physician Decision|2|||
147190334|NCT02694744|530864323|FG000|Overall Study|Lost to Follow-up|1|||
147330422|NCT00708097|531374551|FG000|Period 1|Protocol Violation|0|||
147330423|NCT00708097|531374552|FG001|Period 1|Protocol Violation|1|||
147330424|NCT00708097|531374553|FG002|Period 1|Protocol Violation|0|||
147190335|NCT02694744|530864324|FG001|Overall Study|Lost to Follow-up|0|||
147248302|NCT02899988|531078561|FG006|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
147190336|NCT02694744|530864323|FG000|Overall Study|Taking potassium supplement: exclusion 6|0|||
147190337|NCT02694744|530864324|FG001|Overall Study|Taking potassium supplement: exclusion 6|1|||
147330425|NCT00708097|531374554|FG003|Period 1|Protocol Violation|2|||
147330426|NCT00708097|531374555|FG004|Period 1|Protocol Violation|0|||
147190338|NCT01945021|530864325|FG000|Overall Study|Adverse Event|1|||
147190339|NCT01945021|530864325|FG000|Overall Study|Withdrawal of consent|12|||
147190340|NCT01945021|530864325|FG000|Overall Study|Lost to Follow-up|5|||
147190341|NCT01945021|530864325|FG000|Overall Study|Death|65|||
147190342|NCT02163902|530864326|FG000|Overall Study|Subject's Request|3|||
147190343|NCT02163902|530864327|FG001|Overall Study|Subject's Request|4|||
147190344|NCT02163902|530864326|FG000|Overall Study|Lost to Follow-up|6|||
147190345|NCT02163902|530864327|FG001|Overall Study|Lost to Follow-up|7|||
147190346|NCT02163902|530864326|FG000|Overall Study|Administrative Decision|2|||
147190347|NCT02163902|530864327|FG001|Overall Study|Administrative Decision|2|||
147190348|NCT02898454|530864328|FG000|Overall Study|Adverse Event|4|||
147190349|NCT02898454|530864329|FG001|Overall Study|Adverse Event|1|||
147190350|NCT02898454|530864330|FG002|Overall Study|Adverse Event|2|||
147190351|NCT02898454|530864328|FG000|Overall Study|Protocol Violation|1|||
147190352|NCT02898454|530864329|FG001|Overall Study|Protocol Violation|0|||
147190353|NCT02898454|530864330|FG002|Overall Study|Protocol Violation|1|||
147190354|NCT02898454|530864328|FG000|Overall Study|Lack of Efficacy|4|||
147190355|NCT02898454|530864329|FG001|Overall Study|Lack of Efficacy|1|||
147190356|NCT02898454|530864330|FG002|Overall Study|Lack of Efficacy|0|||
147190357|NCT02898454|530864328|FG000|Overall Study|Withdrawal by Subject|6|||
147330427|NCT00708097|531374551|FG000|Period 1|Other Reason|0|||
147330428|NCT00708097|531374552|FG001|Period 1|Other Reason|0|||
147330429|NCT00708097|531374553|FG002|Period 1|Other Reason|0|||
147330430|NCT00708097|531374554|FG003|Period 1|Other Reason|0|||
147330431|NCT00708097|531374555|FG004|Period 1|Other Reason|1|||
147330432|NCT00708097|531374551|FG000|Period 2|Protocol Violation|0|||
147330433|NCT00708097|531374552|FG001|Period 2|Protocol Violation|1|||
147330434|NCT00708097|531374553|FG002|Period 2|Protocol Violation|1|||
147330435|NCT00708097|531374554|FG003|Period 2|Protocol Violation|1|||
147330436|NCT00708097|531374555|FG004|Period 2|Protocol Violation|0|||
147190358|NCT02898454|530864329|FG001|Overall Study|Withdrawal by Subject|3|||
147190359|NCT02898454|530864330|FG002|Overall Study|Withdrawal by Subject|3|||
147190360|NCT02898454|530864328|FG000|Overall Study|Lost to Follow-up|1|||
147190361|NCT02898454|530864329|FG001|Overall Study|Lost to Follow-up|0|||
147190362|NCT02898454|530864330|FG002|Overall Study|Lost to Follow-up|0|||
147190363|NCT02898454|530864328|FG000|Overall Study|Did Not Met Eligibility Criteria|1|||
147190364|NCT02898454|530864329|FG001|Overall Study|Did Not Met Eligibility Criteria|0|||
147190365|NCT02898454|530864330|FG002|Overall Study|Did Not Met Eligibility Criteria|0|||
147248303|NCT02899988|531078562|FG007|Maintenance Period (88 Weeks)|Lost to Follow-up|1|||
147330437|NCT00603447|531374556|FG000|Overall Study|Adverse Event|0|||
147330438|NCT00603447|531374557|FG001|Overall Study|Adverse Event|1|||
147330439|NCT00603447|531374558|FG002|Overall Study|Adverse Event|1|||
147330440|NCT00603447|531374559|FG003|Overall Study|Adverse Event|2|||
147330441|NCT00603447|531374560|FG004|Overall Study|Adverse Event|1|||
147330442|NCT00603447|531374561|FG005|Overall Study|Adverse Event|2|||
147330443|NCT00603447|531374562|FG006|Overall Study|Adverse Event|10|||
147330444|NCT00603447|531374556|FG000|Overall Study|Other|0|||
147248304|NCT02899988|531078563|FG008|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
147248305|NCT02899988|531078564|FG009|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
147248306|NCT02899988|531078565|FG010|Maintenance Period (88 Weeks)|Lost to Follow-up|0|||
147248307|NCT02899988|531078555|FG000|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
147248308|NCT02899988|531078556|FG001|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
147248309|NCT02899988|531078557|FG002|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
147248310|NCT02899988|531078558|FG003|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
147248311|NCT02899988|531078559|FG004|Maintenance Period (88 Weeks)|Withdrawal by Subject|1|||
147248312|NCT02899988|531078560|FG005|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
147330445|NCT00603447|531374557|FG001|Overall Study|Other|0|||
147330446|NCT00603447|531374558|FG002|Overall Study|Other|1|||
147330447|NCT00603447|531374559|FG003|Overall Study|Other|0|||
147190366|NCT00689390|530864331|FG000|Overall Study|Adverse Event|19|||
147190367|NCT00689390|530864332|FG001|Overall Study|Adverse Event|0|||
147190368|NCT00689390|530864331|FG000|Overall Study|Lost to Follow-up|179|||
147248313|NCT02899988|531078561|FG006|Maintenance Period (88 Weeks)|Withdrawal by Subject|3|||
147248314|NCT02899988|531078562|FG007|Maintenance Period (88 Weeks)|Withdrawal by Subject|2|||
147330448|NCT00603447|531374560|FG004|Overall Study|Other|3|||
147330449|NCT00603447|531374561|FG005|Overall Study|Other|0|||
147330450|NCT00603447|531374562|FG006|Overall Study|Other|13|||
147330451|NCT00603447|531374556|FG000|Overall Study|Withdrew Consent|0|||
147330452|NCT00603447|531374557|FG001|Overall Study|Withdrew Consent|2|||
147190369|NCT00689390|530864332|FG001|Overall Study|Lost to Follow-up|7|||
147190370|NCT00689390|530864331|FG000|Overall Study|Withdrawal by Subject|117|||
147190371|NCT00689390|530864332|FG001|Overall Study|Withdrawal by Subject|3|||
147330453|NCT00603447|531374558|FG002|Overall Study|Withdrew Consent|0|||
147330454|NCT00603447|531374559|FG003|Overall Study|Withdrew Consent|0|||
147449071|NCT01225731|531808053|FG009|Part 2|Physician Decision|0|||
147449072|NCT01225731|531808054|FG010|Part 2|Physician Decision|0|||
147449073|NCT01225731|531808055|FG011|Part 2|Physician Decision|0|||
147449074|NCT01225731|531808056|FG012|Part 2|Physician Decision|0|||
147449075|NCT01225731|531808044|FG000|Part 2|Withdrawal by Subject|0|||
147190372|NCT00689390|530864331|FG000|Overall Study|Withdrew Consent-Retreatment Opportunity|52|||
147190373|NCT00689390|530864332|FG001|Overall Study|Withdrew Consent-Retreatment Opportunity|0|||
147190374|NCT00689390|530864331|FG000|Overall Study|Non-Compliance With Protocol|21|||
147190375|NCT00689390|530864332|FG001|Overall Study|Non-Compliance With Protocol|0|||
147190376|NCT00689390|530864331|FG000|Overall Study|Did Not Meet Protocol Eligibility|1|||
147190377|NCT00689390|530864332|FG001|Overall Study|Did Not Meet Protocol Eligibility|0|||
147190378|NCT00689390|530864331|FG000|Overall Study|Administrative|37|||
147190379|NCT00689390|530864332|FG001|Overall Study|Administrative|0|||
147449076|NCT01225731|531808045|FG001|Part 2|Withdrawal by Subject|0|||
147449077|NCT01225731|531808046|FG002|Part 2|Withdrawal by Subject|0|||
147449078|NCT01225731|531808047|FG003|Part 2|Withdrawal by Subject|0|||
147449079|NCT01225731|531808048|FG004|Part 2|Withdrawal by Subject|0|||
147449080|NCT01225731|531808049|FG005|Part 2|Withdrawal by Subject|1|||
147449081|NCT01225731|531808050|FG006|Part 2|Withdrawal by Subject|3|||
147449082|NCT01225731|531808051|FG007|Part 2|Withdrawal by Subject|4|||
147449083|NCT01225731|531808052|FG008|Part 2|Withdrawal by Subject|1|||
147449084|NCT01225731|531808053|FG009|Part 2|Withdrawal by Subject|0|||
147449085|NCT01225731|531808054|FG010|Part 2|Withdrawal by Subject|0|||
147449086|NCT01225731|531808055|FG011|Part 2|Withdrawal by Subject|0|||
147449087|NCT01225731|531808056|FG012|Part 2|Withdrawal by Subject|0|||
147449088|NCT01225731|531808044|FG000|Part 3|Adverse Event|0|||
147449089|NCT01225731|531808045|FG001|Part 3|Adverse Event|0|||
147449090|NCT01225731|531808046|FG002|Part 3|Adverse Event|0|||
147449091|NCT01225731|531808047|FG003|Part 3|Adverse Event|0|||
147449092|NCT01225731|531808048|FG004|Part 3|Adverse Event|0|||
147449093|NCT01225731|531808049|FG005|Part 3|Adverse Event|0|||
147449094|NCT01225731|531808050|FG006|Part 3|Adverse Event|0|||
147449095|NCT01225731|531808051|FG007|Part 3|Adverse Event|0|||
147190380|NCT02343263|530864333|FG000|Overall Study|Physician Decision|5|||
147190381|NCT02343263|530864334|FG001|Overall Study|Physician Decision|3|||
147449096|NCT01225731|531808052|FG008|Part 3|Adverse Event|0|||
147449097|NCT01225731|531808053|FG009|Part 3|Adverse Event|0|||
147449098|NCT01225731|531808054|FG010|Part 3|Adverse Event|1|||
147449099|NCT01225731|531808055|FG011|Part 3|Adverse Event|1|||
147449100|NCT01225731|531808056|FG012|Part 3|Adverse Event|0|||
147449101|NCT01225731|531808044|FG000|Part 3|Lost to Follow-up|0|||
147449102|NCT01225731|531808045|FG001|Part 3|Lost to Follow-up|0|||
147449103|NCT01225731|531808046|FG002|Part 3|Lost to Follow-up|0|||
147449104|NCT01225731|531808047|FG003|Part 3|Lost to Follow-up|0|||
147190382|NCT02343263|530864335|FG002|Overall Study|Physician Decision|1|||
147190383|NCT04264442|530864339|FG000|Overall Study|Lack of Efficacy|6|||
147190384|NCT04264442|530864339|FG000|Overall Study|Lost to Follow-up|2|||
147190385|NCT04264442|530864339|FG000|Overall Study|Sponsor Decision|23|||
147190386|NCT04264442|530864339|FG000|Overall Study|Withdrawal by Subject|11|||
147190387|NCT04264442|530864339|FG000|Overall Study|Study Termination|5|||
147190388|NCT01384734|530864341|FG000|Overall Study|Adverse Event|0|||
147190389|NCT01384734|530864342|FG001|Overall Study|Adverse Event|3|||
147190390|NCT01384734|530864343|FG002|Overall Study|Adverse Event|0|||
147190391|NCT01384734|530864344|FG003|Overall Study|Adverse Event|2|||
147190392|NCT01384734|530864345|FG004|Overall Study|Adverse Event|7|||
147190393|NCT01384734|530864341|FG000|Overall Study|Death|1|||
147330455|NCT00603447|531374560|FG004|Overall Study|Withdrew Consent|1|||
147330456|NCT00603447|531374561|FG005|Overall Study|Withdrew Consent|0|||
147330457|NCT00603447|531374562|FG006|Overall Study|Withdrew Consent|1|||
147330458|NCT03425643|531374565|FG000|Overall Study|Withdrawal by Subject|10|||
147330459|NCT03425643|531374566|FG001|Overall Study|Withdrawal by Subject|12|||
147330460|NCT03425643|531374565|FG000|Overall Study|Lost to Follow-up|2|||
147330461|NCT03425643|531374566|FG001|Overall Study|Lost to Follow-up|0|||
147330462|NCT03425643|531374565|FG000|Overall Study|Death|109|||
147330463|NCT03425643|531374566|FG001|Overall Study|Death|141|||
147330464|NCT03425643|531374565|FG000|Overall Study|Ongoing in study|276|||
147330465|NCT03425643|531374566|FG001|Overall Study|Ongoing in study|247|||
147330466|NCT03141788|531374567|FG000|Overall Study|Lost to Follow-up|1|||
147330467|NCT03141788|531374567|FG000|Overall Study|Protocol Violation|3|||
147330468|NCT03141788|531374567|FG000|Overall Study|Withdrawal by Subject|4|||
147330469|NCT04133363|531374568|FG000|Overall Study|Lost to Follow-up|2|||
147330470|NCT04133363|531374569|FG001|Overall Study|Lost to Follow-up|1|||
147190394|NCT01384734|530864342|FG001|Overall Study|Death|0|||
147190395|NCT01384734|530864343|FG002|Overall Study|Death|1|||
147330471|NCT04133363|531374570|FG002|Overall Study|Lost to Follow-up|4|||
147330472|NCT01838200|531374571|FG000|Overall Study|Adverse Event|0|||
147449105|NCT01225731|531808048|FG004|Part 3|Lost to Follow-up|0|||
147449106|NCT01225731|531808049|FG005|Part 3|Lost to Follow-up|0|||
147449107|NCT01225731|531808050|FG006|Part 3|Lost to Follow-up|0|||
147449108|NCT01225731|531808051|FG007|Part 3|Lost to Follow-up|0|||
147449109|NCT01225731|531808052|FG008|Part 3|Lost to Follow-up|0|||
147449110|NCT01225731|531808053|FG009|Part 3|Lost to Follow-up|0|||
147449111|NCT01225731|531808054|FG010|Part 3|Lost to Follow-up|1|||
147449112|NCT01225731|531808055|FG011|Part 3|Lost to Follow-up|2|||
147449113|NCT01225731|531808056|FG012|Part 3|Lost to Follow-up|1|||
147449114|NCT01225731|531808044|FG000|Part 3|Physician Decision|0|||
147449115|NCT01225731|531808045|FG001|Part 3|Physician Decision|0|||
147449116|NCT01225731|531808046|FG002|Part 3|Physician Decision|0|||
147449117|NCT01225731|531808047|FG003|Part 3|Physician Decision|0|||
147449118|NCT01225731|531808048|FG004|Part 3|Physician Decision|0|||
147449119|NCT01225731|531808049|FG005|Part 3|Physician Decision|0|||
147449120|NCT01225731|531808050|FG006|Part 3|Physician Decision|0|||
147449121|NCT01225731|531808051|FG007|Part 3|Physician Decision|0|||
147449122|NCT01225731|531808052|FG008|Part 3|Physician Decision|0|||
147449123|NCT01225731|531808053|FG009|Part 3|Physician Decision|0|||
147449124|NCT01225731|531808054|FG010|Part 3|Physician Decision|0|||
147330473|NCT01838200|531374572|FG001|Overall Study|Adverse Event|2|||
147330474|NCT01838200|531374571|FG000|Overall Study|Progressive disease|3|||
147330475|NCT01838200|531374572|FG001|Overall Study|Progressive disease|0|||
147330476|NCT01875250|531376008|FG000|Overall Study|Adverse Event|2|||
147330477|NCT01875250|531376009|FG001|Overall Study|Adverse Event|0|||
147330478|NCT03140176|531376015|FG000|Overall Study|Reason missing|23|||
147330479|NCT03140176|531376015|FG000|Overall Study|Death|33|||
147330480|NCT03140176|531376015|FG000|Overall Study|Disease progression|1|||
147330481|NCT03140176|531376015|FG000|Overall Study|Physician Decision|1|||
147330482|NCT03140176|531376015|FG000|Overall Study|Withdrawal by Subject|1|||
147330483|NCT03140176|531376015|FG000|Overall Study|Lost to Follow-up|15|||
147330484|NCT00470626|531376018|FG000|Overall Study|Lost to Follow-up|10|||
147330485|NCT00470626|531376018|FG000|Overall Study|Withdrawal by Subject|7|||
147330486|NCT02689349|531376019|FG000|Overall Study|Not implanted|4|||
147330487|NCT02689349|531376020|FG001|Overall Study|Not implanted|0|||
147330488|NCT02689349|531376019|FG000|Overall Study|Withdrawal by Subject|9|||
147330489|NCT02689349|531376020|FG001|Overall Study|Withdrawal by Subject|0|||
147330490|NCT00486759|531376024|FG000|Treatment|Adverse event/intercurrent illness|86|||
147330491|NCT00486759|531376025|FG001|Treatment|Adverse event/intercurrent illness|39|||
147330492|NCT00486759|531376024|FG000|Treatment|Insufficient therapeutic response|37|||
147330493|NCT00486759|531376025|FG001|Treatment|Insufficient therapeutic response|39|||
147330494|NCT00486759|531376024|FG000|Treatment|Death|17|||
147330495|NCT00486759|531376025|FG001|Treatment|Death|10|||
147330496|NCT00486759|531376024|FG000|Treatment|Withdrew consent|15|||
147330497|NCT00486759|531376025|FG001|Treatment|Withdrew consent|12|||
147330498|NCT00486759|531376024|FG000|Treatment|Administrative/reason not specified|17|||
147330499|NCT00486759|531376025|FG001|Treatment|Administrative/reason not specified|21|||
147330500|NCT00486759|531376024|FG000|Treatment|Refused treatment|10|||
147330501|NCT00486759|531376025|FG001|Treatment|Refused treatment|7|||
147330502|NCT00486759|531376024|FG000|Treatment|Violation of selection criteria at entry|3|||
147330503|NCT00486759|531376025|FG001|Treatment|Violation of selection criteria at entry|3|||
147330504|NCT00486759|531376024|FG000|Treatment|Other protocol violation|1|||
147330505|NCT00486759|531376025|FG001|Treatment|Other protocol violation|5|||
147330506|NCT00486759|531376024|FG000|Treatment|Failure to return|1|||
147330507|NCT00486759|531376025|FG001|Treatment|Failure to return|1|||
147330508|NCT00486759|531376024|FG000|Safety Follow-up|Insufficient therapeutic response|40|||
147330509|NCT00486759|531376025|FG001|Safety Follow-up|Insufficient therapeutic response|50|||
147330510|NCT00486759|531376024|FG000|Safety Follow-up|Death|40|||
147330511|NCT00486759|531376025|FG001|Safety Follow-up|Death|29|||
147330512|NCT00486759|531376024|FG000|Safety Follow-up|Withdrew consent|32|||
147330513|NCT00486759|531376025|FG001|Safety Follow-up|Withdrew consent|23|||
147330514|NCT00486759|531376024|FG000|Safety Follow-up|Failure to return|9|||
147330515|NCT00486759|531376025|FG001|Safety Follow-up|Failure to return|6|||
147330516|NCT00486759|531376024|FG000|Safety Follow-up|Administrative/not specified|8|||
147330517|NCT00486759|531376025|FG001|Safety Follow-up|Administrative/not specified|6|||
147330518|NCT00486759|531376024|FG000|Safety Follow-up|Refused treatment/did not cooperate|6|||
147449125|NCT01225731|531808055|FG011|Part 3|Physician Decision|1|||
147449126|NCT01225731|531808056|FG012|Part 3|Physician Decision|2|||
147330519|NCT00486759|531376025|FG001|Safety Follow-up|Refused treatment/did not cooperate|4|||
147330520|NCT00486759|531376024|FG000|Safety Follow-up|Adverse event/intercurrent illness|4|||
147330521|NCT00486759|531376025|FG001|Safety Follow-up|Adverse event/intercurrent illness|0|||
147449127|NCT01225731|531808044|FG000|Part 3|Withdrawal by Subject|0|||
147330522|NCT01025843|531376026|FG000|Washout 4|Withdrawal by Subject|0|||
147330523|NCT01025843|531376027|FG001|Washout 4|Withdrawal by Subject|0|||
147330524|NCT01025843|531376028|FG002|Washout 4|Withdrawal by Subject|1|||
147330525|NCT01025843|531376029|FG003|Washout 4|Withdrawal by Subject|1|||
147330526|NCT01025843|531376030|FG004|Washout 4|Withdrawal by Subject|0|||
147330527|NCT01025843|531376031|FG005|Washout 4|Withdrawal by Subject|0|||
147330528|NCT01025843|531376032|FG006|Washout 4|Withdrawal by Subject|0|||
147330529|NCT01025843|531376033|FG007|Washout 4|Withdrawal by Subject|0|||
147449128|NCT01225731|531808045|FG001|Part 3|Withdrawal by Subject|0|||
147449129|NCT01225731|531808046|FG002|Part 3|Withdrawal by Subject|0|||
147449130|NCT01225731|531808047|FG003|Part 3|Withdrawal by Subject|0|||
147449131|NCT01225731|531808048|FG004|Part 3|Withdrawal by Subject|0|||
147449132|NCT01225731|531808049|FG005|Part 3|Withdrawal by Subject|0|||
147190396|NCT01384734|530864344|FG003|Overall Study|Death|0|||
147190397|NCT01384734|530864345|FG004|Overall Study|Death|0|||
147190398|NCT01384734|530864341|FG000|Overall Study|Continuation criteria not met|0|||
147190399|NCT01384734|530864342|FG001|Overall Study|Continuation criteria not met|0|||
147190400|NCT01384734|530864343|FG002|Overall Study|Continuation criteria not met|1|||
147190401|NCT01384734|530864344|FG003|Overall Study|Continuation criteria not met|1|||
147658596|NCT03428100|532572328|FG017|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
147190402|NCT01384734|530864345|FG004|Overall Study|Continuation criteria not met|0|||
147190403|NCT01384734|530864341|FG000|Overall Study|Lack of Efficacy|3|||
147190404|NCT01384734|530864342|FG001|Overall Study|Lack of Efficacy|7|||
147190405|NCT01384734|530864343|FG002|Overall Study|Lack of Efficacy|4|||
147248315|NCT02899988|531078563|FG008|Maintenance Period (88 Weeks)|Withdrawal by Subject|2|||
147248316|NCT02899988|531078564|FG009|Maintenance Period (88 Weeks)|Withdrawal by Subject|0|||
147248317|NCT02899988|531078565|FG010|Maintenance Period (88 Weeks)|Withdrawal by Subject|1|||
147248318|NCT01327885|531078573|FG000|Overall Study|Disease progression-according to RECIST|173|||
147248319|NCT01327885|531078574|FG001|Overall Study|Disease progression-according to RECIST|165|||
147248320|NCT01327885|531078573|FG000|Overall Study|Clinical progression|24|||
147248321|NCT01327885|531078574|FG001|Overall Study|Clinical progression|27|||
147248322|NCT01327885|531078573|FG000|Overall Study|Adverse Event|14|||
147248323|NCT01327885|531078574|FG001|Overall Study|Adverse Event|10|||
147248324|NCT01327885|531078573|FG000|Overall Study|Subject choice|5|||
147248325|NCT01327885|531078574|FG001|Overall Study|Subject choice|10|||
147248326|NCT01327885|531078573|FG000|Overall Study|Other|8|||
147248327|NCT01327885|531078574|FG001|Overall Study|Other|6|||
147248328|NCT01327885|531078573|FG000|Overall Study|Withdrawal of consent from study|3|||
147248329|NCT01327885|531078574|FG001|Overall Study|Withdrawal of consent from study|4|||
147248330|NCT01327885|531078573|FG000|Overall Study|Not treated|1|||
147248331|NCT01327885|531078574|FG001|Overall Study|Not treated|1|||
147248332|NCT01327885|531078573|FG000|Overall Study|Administrative decision|0|||
147248333|NCT01327885|531078574|FG001|Overall Study|Administrative decision|1|||
147248334|NCT00105482|531078583|FG000|Overall Study|Adverse Event|1|||
147248335|NCT00105482|531078584|FG001|Overall Study|Adverse Event|1|||
147248336|NCT00105482|531078583|FG000|Overall Study|Lost to Follow-up|26|||
147248337|NCT00105482|531078584|FG001|Overall Study|Lost to Follow-up|17|||
147248338|NCT00105482|531078583|FG000|Overall Study|Withdrawal by Subject|0|||
147248339|NCT00105482|531078584|FG001|Overall Study|Withdrawal by Subject|1|||
147248340|NCT00105482|531078583|FG000|Overall Study|Lost Interest|29|||
147248341|NCT00105482|531078584|FG001|Overall Study|Lost Interest|32|||
147248342|NCT00105482|531078583|FG000|Overall Study|Scheduling Conflict|2|||
147248343|NCT00105482|531078584|FG001|Overall Study|Scheduling Conflict|3|||
147248344|NCT00105482|531078583|FG000|Overall Study|Withdrawn by PI|1|||
147248345|NCT00105482|531078584|FG001|Overall Study|Withdrawn by PI|1|||
147248346|NCT01749514|531078587|FG000|Overall Study|Lost to Follow-up|0|||
147248347|NCT01749514|531078588|FG001|Overall Study|Lost to Follow-up|0|||
147248348|NCT01749514|531078589|FG002|Overall Study|Lost to Follow-up|0|||
147248349|NCT01749514|531078590|FG003|Overall Study|Lost to Follow-up|0|||
147248350|NCT01749514|531078591|FG004|Overall Study|Lost to Follow-up|0|||
147248351|NCT01749514|531078592|FG005|Overall Study|Lost to Follow-up|0|||
147248352|NCT01749514|531078593|FG006|Overall Study|Lost to Follow-up|0|||
147248353|NCT01749514|531078594|FG007|Overall Study|Lost to Follow-up|1|||
147248354|NCT01749514|531078587|FG000|Overall Study|Withdrawal by Subject|0|||
147248355|NCT01749514|531078588|FG001|Overall Study|Withdrawal by Subject|0|||
147248356|NCT01749514|531078589|FG002|Overall Study|Withdrawal by Subject|0|||
147248357|NCT01749514|531078590|FG003|Overall Study|Withdrawal by Subject|0|||
147248358|NCT01749514|531078591|FG004|Overall Study|Withdrawal by Subject|0|||
147248359|NCT01749514|531078592|FG005|Overall Study|Withdrawal by Subject|1|||
147248360|NCT01749514|531078593|FG006|Overall Study|Withdrawal by Subject|0|||
147248361|NCT01749514|531078594|FG007|Overall Study|Withdrawal by Subject|1|||
147248362|NCT01749514|531078587|FG000|Overall Study|Not Reported|0|||
147248363|NCT01749514|531078588|FG001|Overall Study|Not Reported|0|||
147248364|NCT01749514|531078589|FG002|Overall Study|Not Reported|0|||
147248365|NCT01749514|531078590|FG003|Overall Study|Not Reported|0|||
147248366|NCT01749514|531078591|FG004|Overall Study|Not Reported|0|||
147248367|NCT01749514|531078592|FG005|Overall Study|Not Reported|0|||
147248368|NCT01749514|531078593|FG006|Overall Study|Not Reported|0|||
147248369|NCT01749514|531078594|FG007|Overall Study|Not Reported|5|||
147248370|NCT03042533|531078595|FG000|Overall Study|MD left program|1|||
147248371|NCT03042533|531078596|FG001|Overall Study|MD left program|4|||
147248372|NCT03042533|531078597|FG002|Overall Study|MD left program|1|||
147658597|NCT03428100|532572329|FG018|Double-Blind Treatment Week 0 to Week 52|Lack of Efficacy|0|||
147248373|NCT02547649|531078598|FG000|Overall Study|Lost to Follow-up|3|||
147190406|NCT01384734|530864344|FG003|Overall Study|Lack of Efficacy|4|||
147248374|NCT02547649|531078599|FG001|Overall Study|Lost to Follow-up|1|||
147248375|NCT02547649|531078600|FG002|Overall Study|Lost to Follow-up|1|||
147248376|NCT02547649|531078598|FG000|Overall Study|Not vaccinated|0|||
147248377|NCT02547649|531078599|FG001|Overall Study|Not vaccinated|0|||
147248378|NCT02547649|531078600|FG002|Overall Study|Not vaccinated|1|||
147449133|NCT01225731|531808050|FG006|Part 3|Withdrawal by Subject|0|||
147449134|NCT01225731|531808051|FG007|Part 3|Withdrawal by Subject|0|||
147449135|NCT01225731|531808052|FG008|Part 3|Withdrawal by Subject|0|||
147449136|NCT01225731|531808053|FG009|Part 3|Withdrawal by Subject|0|||
147449137|NCT01225731|531808054|FG010|Part 3|Withdrawal by Subject|4|||
147449138|NCT01225731|531808055|FG011|Part 3|Withdrawal by Subject|6|||
147449139|NCT01225731|531808056|FG012|Part 3|Withdrawal by Subject|4|||
147449140|NCT00577642|531808057|FG000|Overall Study|Clinical Disease Progression|1|||
147449141|NCT04770389|531808058|FG000|Overall Study|Adverse Event|1|||
147449142|NCT04770389|531808059|FG001|Overall Study|Adverse Event|2|||
147449143|NCT04770389|531808060|FG002|Overall Study|Adverse Event|0|||
147449144|NCT04770389|531808061|FG003|Overall Study|Adverse Event|1|||
147449145|NCT04770389|531808058|FG000|Overall Study|Withdrawal by Subject|0|||
147449146|NCT04770389|531808059|FG001|Overall Study|Withdrawal by Subject|2|||
147190407|NCT01384734|530864345|FG004|Overall Study|Lack of Efficacy|2|||
147190408|NCT01384734|530864341|FG000|Overall Study|Lost to Follow-up|5|||
147190409|NCT01384734|530864342|FG001|Overall Study|Lost to Follow-up|3|||
147190410|NCT01384734|530864343|FG002|Overall Study|Lost to Follow-up|3|||
147449147|NCT04770389|531808060|FG002|Overall Study|Withdrawal by Subject|1|||
147449148|NCT04770389|531808061|FG003|Overall Study|Withdrawal by Subject|0|||
147449149|NCT04770389|531808058|FG000|Overall Study|Failed attempt to draw blood|1|||
147190411|NCT01384734|530864344|FG003|Overall Study|Lost to Follow-up|8|||
147190412|NCT01384734|530864345|FG004|Overall Study|Lost to Follow-up|5|||
147190413|NCT01384734|530864341|FG000|Overall Study|Non-compliance with study drug|1|||
147190414|NCT01384734|530864342|FG001|Overall Study|Non-compliance with study drug|2|||
147190415|NCT01384734|530864343|FG002|Overall Study|Non-compliance with study drug|6|||
147190416|NCT01384734|530864344|FG003|Overall Study|Non-compliance with study drug|0|||
147190417|NCT01384734|530864345|FG004|Overall Study|Non-compliance with study drug|2|||
147190418|NCT01384734|530864341|FG000|Overall Study|Pregnancy|0|||
147449150|NCT04770389|531808059|FG001|Overall Study|Failed attempt to draw blood|0|||
147449151|NCT04770389|531808060|FG002|Overall Study|Failed attempt to draw blood|0|||
147449152|NCT04770389|531808061|FG003|Overall Study|Failed attempt to draw blood|0|||
147190419|NCT01384734|530864342|FG001|Overall Study|Pregnancy|1|||
147190420|NCT01384734|530864343|FG002|Overall Study|Pregnancy|0|||
147190421|NCT01384734|530864344|FG003|Overall Study|Pregnancy|0|||
147190422|NCT01384734|530864345|FG004|Overall Study|Pregnancy|1|||
147190423|NCT01384734|530864341|FG000|Overall Study|Sponsor terminated|0|||
147190424|NCT01384734|530864342|FG001|Overall Study|Sponsor terminated|0|||
147190425|NCT01384734|530864343|FG002|Overall Study|Sponsor terminated|0|||
147190426|NCT01384734|530864344|FG003|Overall Study|Sponsor terminated|0|||
147190427|NCT01384734|530864345|FG004|Overall Study|Sponsor terminated|1|||
147190428|NCT01384734|530864341|FG000|Overall Study|Withdrawal by Subject|5|||
147190429|NCT01384734|530864342|FG001|Overall Study|Withdrawal by Subject|5|||
147190430|NCT01384734|530864343|FG002|Overall Study|Withdrawal by Subject|6|||
147190431|NCT01384734|530864344|FG003|Overall Study|Withdrawal by Subject|7|||
147190432|NCT01384734|530864345|FG004|Overall Study|Withdrawal by Subject|9|||
147190433|NCT01384734|530864341|FG000|Overall Study|Investigator relocating|0|||
147190434|NCT01384734|530864342|FG001|Overall Study|Investigator relocating|2|||
147190435|NCT01384734|530864343|FG002|Overall Study|Investigator relocating|0|||
147190436|NCT01384734|530864344|FG003|Overall Study|Investigator relocating|3|||
147190437|NCT01384734|530864345|FG004|Overall Study|Investigator relocating|1|||
147190438|NCT01384734|530864341|FG000|Overall Study|Unable to come back for visit|1|||
147190439|NCT01384734|530864342|FG001|Overall Study|Unable to come back for visit|0|||
147190440|NCT01384734|530864343|FG002|Overall Study|Unable to come back for visit|1|||
147190441|NCT01384734|530864344|FG003|Overall Study|Unable to come back for visit|1|||
147190442|NCT01384734|530864345|FG004|Overall Study|Unable to come back for visit|0|||
147190443|NCT01384734|530864341|FG000|Overall Study|Prison|0|||
147190444|NCT01384734|530864342|FG001|Overall Study|Prison|0|||
147190445|NCT01384734|530864343|FG002|Overall Study|Prison|1|||
147190446|NCT01384734|530864344|FG003|Overall Study|Prison|0|||
147190447|NCT01384734|530864345|FG004|Overall Study|Prison|0|||
147190448|NCT01384734|530864341|FG000|Overall Study|As per Exclusion criteria|0|||
147190449|NCT01384734|530864342|FG001|Overall Study|As per Exclusion criteria|1|||
147190450|NCT01384734|530864343|FG002|Overall Study|As per Exclusion criteria|0|||
147190451|NCT01384734|530864344|FG003|Overall Study|As per Exclusion criteria|0|||
147449153|NCT04770389|531808058|FG000|Overall Study|Left the country|0|||
147449154|NCT04770389|531808059|FG001|Overall Study|Left the country|0|||
147449155|NCT04770389|531808060|FG002|Overall Study|Left the country|1|||
147190452|NCT01384734|530864345|FG004|Overall Study|As per Exclusion criteria|0|||
147190453|NCT01384734|530864341|FG000|Overall Study|Missed End of treatment visit|0|||
147190454|NCT01384734|530864342|FG001|Overall Study|Missed End of treatment visit|0|||
147190455|NCT01384734|530864343|FG002|Overall Study|Missed End of treatment visit|0|||
147190456|NCT01384734|530864344|FG003|Overall Study|Missed End of treatment visit|1|||
147190457|NCT01384734|530864345|FG004|Overall Study|Missed End of treatment visit|0|||
147190458|NCT01384734|530864341|FG000|Overall Study|Adhesion problem|0|||
147190459|NCT01384734|530864342|FG001|Overall Study|Adhesion problem|0|||
147190460|NCT01384734|530864343|FG002|Overall Study|Adhesion problem|0|||
147330530|NCT01025843|531376034|FG008|Washout 4|Withdrawal by Subject|0|||
147330531|NCT01025843|531376035|FG009|Washout 4|Withdrawal by Subject|0|||
147330532|NCT01649791|531376038|FG000|Overall Study|Disease Progression|2|||
147330533|NCT01649791|531376038|FG000|Overall Study|Adverse Event|1|||
147330534|NCT00771667|531376039|FG000|Induction Phase|Adverse Event|5|||
147330535|NCT00771667|531376040|FG001|Induction Phase|Adverse Event|2|||
147330536|NCT00771667|531376041|FG002|Induction Phase|Adverse Event|4|||
147330537|NCT00771667|531376042|FG003|Induction Phase|Adverse Event|1|||
147330538|NCT00771667|531376043|FG004|Induction Phase|Adverse Event|0|||
147330539|NCT00771667|531376044|FG005|Induction Phase|Adverse Event|0|||
147330540|NCT00771667|531376045|FG006|Induction Phase|Adverse Event|0|||
147330541|NCT00771667|531376046|FG007|Induction Phase|Adverse Event|0|||
147330542|NCT00771667|531376047|FG008|Induction Phase|Adverse Event|0|||
147330543|NCT00771667|531376048|FG009|Induction Phase|Adverse Event|0|||
147330544|NCT00771667|531376039|FG000|Induction Phase|Lack of Efficacy|9|||
147330545|NCT00771667|531376040|FG001|Induction Phase|Lack of Efficacy|2|||
147330546|NCT00771667|531376041|FG002|Induction Phase|Lack of Efficacy|4|||
147330547|NCT00771667|531376042|FG003|Induction Phase|Lack of Efficacy|3|||
147330548|NCT00771667|531376043|FG004|Induction Phase|Lack of Efficacy|0|||
147330549|NCT00771667|531376044|FG005|Induction Phase|Lack of Efficacy|0|||
147330550|NCT00771667|531376045|FG006|Induction Phase|Lack of Efficacy|0|||
147330551|NCT00771667|531376046|FG007|Induction Phase|Lack of Efficacy|0|||
147330552|NCT00771667|531376047|FG008|Induction Phase|Lack of Efficacy|0|||
147330553|NCT00771667|531376048|FG009|Induction Phase|Lack of Efficacy|0|||
147330554|NCT00771667|531376039|FG000|Induction Phase|Lost to Follow-up|1|||
147330555|NCT00771667|531376040|FG001|Induction Phase|Lost to Follow-up|0|||
147330556|NCT00771667|531376041|FG002|Induction Phase|Lost to Follow-up|1|||
147330557|NCT00771667|531376042|FG003|Induction Phase|Lost to Follow-up|0|||
147330558|NCT00771667|531376043|FG004|Induction Phase|Lost to Follow-up|0|||
147330559|NCT00771667|531376044|FG005|Induction Phase|Lost to Follow-up|0|||
147330560|NCT00771667|531376045|FG006|Induction Phase|Lost to Follow-up|0|||
147330561|NCT00771667|531376046|FG007|Induction Phase|Lost to Follow-up|0|||
147330562|NCT00771667|531376047|FG008|Induction Phase|Lost to Follow-up|0|||
147330563|NCT00771667|531376048|FG009|Induction Phase|Lost to Follow-up|0|||
147330564|NCT00771667|531376039|FG000|Induction Phase|Other|4|||
147330565|NCT00771667|531376040|FG001|Induction Phase|Other|6|||
147330566|NCT00771667|531376041|FG002|Induction Phase|Other|3|||
147330567|NCT00771667|531376042|FG003|Induction Phase|Other|4|||
147330568|NCT00771667|531376043|FG004|Induction Phase|Other|0|||
147330569|NCT00771667|531376044|FG005|Induction Phase|Other|0|||
147330570|NCT00771667|531376045|FG006|Induction Phase|Other|0|||
147330571|NCT00771667|531376046|FG007|Induction Phase|Other|0|||
147330572|NCT00771667|531376047|FG008|Induction Phase|Other|0|||
147330573|NCT00771667|531376048|FG009|Induction Phase|Other|0|||
147330574|NCT00771667|531376039|FG000|Maintenance Phase|Adverse Event|0|||
147330575|NCT00771667|531376040|FG001|Maintenance Phase|Adverse Event|0|||
147330576|NCT00771667|531376041|FG002|Maintenance Phase|Adverse Event|0|||
147330577|NCT00771667|531376042|FG003|Maintenance Phase|Adverse Event|0|||
147330578|NCT00771667|531376043|FG004|Maintenance Phase|Adverse Event|1|||
147330579|NCT00771667|531376044|FG005|Maintenance Phase|Adverse Event|3|||
147330580|NCT00771667|531376045|FG006|Maintenance Phase|Adverse Event|5|||
147330581|NCT00771667|531376046|FG007|Maintenance Phase|Adverse Event|1|||
147330582|NCT00771667|531376047|FG008|Maintenance Phase|Adverse Event|8|||
147330583|NCT00771667|531376048|FG009|Maintenance Phase|Adverse Event|7|||
147190461|NCT01384734|530864344|FG003|Overall Study|Adhesion problem|1|||
147190462|NCT01384734|530864345|FG004|Overall Study|Adhesion problem|0|||
147190463|NCT01384734|530864341|FG000|Overall Study|Early termination|0|||
147190464|NCT01384734|530864342|FG001|Overall Study|Early termination|0|||
147190465|NCT01384734|530864343|FG002|Overall Study|Early termination|0|||
147190466|NCT01384734|530864344|FG003|Overall Study|Early termination|0|||
147190467|NCT01384734|530864345|FG004|Overall Study|Early termination|1|||
147190468|NCT01384734|530864341|FG000|Overall Study|Physician Decision|1|||
147190469|NCT01384734|530864342|FG001|Overall Study|Physician Decision|0|||
147190470|NCT01384734|530864343|FG002|Overall Study|Physician Decision|0|||
147190471|NCT01384734|530864344|FG003|Overall Study|Physician Decision|0|||
147330584|NCT00771667|531376039|FG000|Maintenance Phase|Lack of Efficacy|0|||
147330585|NCT00771667|531376040|FG001|Maintenance Phase|Lack of Efficacy|0|||
147330586|NCT00771667|531376041|FG002|Maintenance Phase|Lack of Efficacy|0|||
147330587|NCT00771667|531376042|FG003|Maintenance Phase|Lack of Efficacy|0|||
147330588|NCT00771667|531376043|FG004|Maintenance Phase|Lack of Efficacy|1|||
147330589|NCT00771667|531376044|FG005|Maintenance Phase|Lack of Efficacy|3|||
147330590|NCT00771667|531376045|FG006|Maintenance Phase|Lack of Efficacy|3|||
147330591|NCT00771667|531376046|FG007|Maintenance Phase|Lack of Efficacy|2|||
147330592|NCT00771667|531376047|FG008|Maintenance Phase|Lack of Efficacy|11|||
147330593|NCT00771667|531376048|FG009|Maintenance Phase|Lack of Efficacy|7|||
147330594|NCT00771667|531376039|FG000|Maintenance Phase|Other|0|||
147330595|NCT00771667|531376040|FG001|Maintenance Phase|Other|0|||
147190472|NCT01384734|530864345|FG004|Overall Study|Physician Decision|0|||
147190473|NCT01290523|530864346|FG000|Overall Study|Death|3|||
147190474|NCT03071263|530864347|FG000|Overall Study|Adverse Event|1|||
147330596|NCT00771667|531376041|FG002|Maintenance Phase|Other|0|||
147330597|NCT00771667|531376042|FG003|Maintenance Phase|Other|0|||
147190475|NCT03071263|530864348|FG001|Overall Study|Adverse Event|3|||
147190476|NCT03071263|530864347|FG000|Overall Study|Withdrawal by Subject|1|||
147190477|NCT03071263|530864348|FG001|Overall Study|Withdrawal by Subject|3|||
147190478|NCT03071263|530864347|FG000|Overall Study|Physician Decision|1|||
147190479|NCT03071263|530864348|FG001|Overall Study|Physician Decision|0|||
147190480|NCT03071263|530864347|FG000|Overall Study|Participant moved to another city|0|||
147190481|NCT03071263|530864348|FG001|Overall Study|Participant moved to another city|1|||
147190482|NCT00647296|530864350|FG000|Part 1: 12-week Double-Blind Treatment|Withdrawal by Subject|0|||
147190483|NCT00647296|530864351|FG001|Part 1: 12-week Double-Blind Treatment|Withdrawal by Subject|0|||
147190484|NCT00647296|530864352|FG002|Part 1: 12-week Double-Blind Treatment|Withdrawal by Subject|0|||
147190485|NCT00647296|530864353|FG003|Part 1: 12-week Double-Blind Treatment|Withdrawal by Subject|1|||
147190486|NCT00647296|530864350|FG000|Part 1: 12-week Double-Blind Treatment|Adverse Event|1|||
147190487|NCT00647296|530864351|FG001|Part 1: 12-week Double-Blind Treatment|Adverse Event|0|||
147190488|NCT00647296|530864352|FG002|Part 1: 12-week Double-Blind Treatment|Adverse Event|0|||
147190489|NCT00647296|530864353|FG003|Part 1: 12-week Double-Blind Treatment|Adverse Event|1|||
147190490|NCT00647296|530864350|FG000|Part 1: 12-week Double-Blind Treatment|Physician Decision|0|||
147190491|NCT00647296|530864351|FG001|Part 1: 12-week Double-Blind Treatment|Physician Decision|1|||
147190492|NCT00647296|530864352|FG002|Part 1: 12-week Double-Blind Treatment|Physician Decision|0|||
147190493|NCT00647296|530864353|FG003|Part 1: 12-week Double-Blind Treatment|Physician Decision|0|||
147190494|NCT00647296|530864350|FG000|Part 2: 4-week Placebo Washout|Withdrawal by Subject|1|||
147190495|NCT00647296|530864351|FG001|Part 2: 4-week Placebo Washout|Withdrawal by Subject|0|||
147190496|NCT00647296|530864352|FG002|Part 2: 4-week Placebo Washout|Withdrawal by Subject|0|||
147190497|NCT00647296|530864353|FG003|Part 2: 4-week Placebo Washout|Withdrawal by Subject|0|||
147190498|NCT00647296|530864350|FG000|Part 2: 4-week Placebo Washout|Lost to Follow-up|1|||
147190499|NCT00647296|530864351|FG001|Part 2: 4-week Placebo Washout|Lost to Follow-up|0|||
147190500|NCT00647296|530864352|FG002|Part 2: 4-week Placebo Washout|Lost to Follow-up|0|||
147190501|NCT00647296|530864353|FG003|Part 2: 4-week Placebo Washout|Lost to Follow-up|0|||
147190502|NCT00647296|530864350|FG000|Part 2: 4-week Placebo Washout|Death|3|||
147190503|NCT00647296|530864351|FG001|Part 2: 4-week Placebo Washout|Death|0|||
147190504|NCT00647296|530864352|FG002|Part 2: 4-week Placebo Washout|Death|0|||
147190505|NCT00647296|530864353|FG003|Part 2: 4-week Placebo Washout|Death|0|||
147190506|NCT00647296|530864350|FG000|Part 2: 76-week Double-Blind Treatment|Withdrawal by Subject|0|||
147190507|NCT00647296|530864351|FG001|Part 2: 76-week Double-Blind Treatment|Withdrawal by Subject|5|||
147190508|NCT00647296|530864352|FG002|Part 2: 76-week Double-Blind Treatment|Withdrawal by Subject|0|||
147190509|NCT00647296|530864353|FG003|Part 2: 76-week Double-Blind Treatment|Withdrawal by Subject|4|||
147190510|NCT00647296|530864350|FG000|Part 2: 76-week Double-Blind Treatment|Adverse Event|0|||
147190511|NCT00647296|530864351|FG001|Part 2: 76-week Double-Blind Treatment|Adverse Event|1|||
147330598|NCT00771667|531376043|FG004|Maintenance Phase|Other|0|||
147330599|NCT00771667|531376044|FG005|Maintenance Phase|Other|1|||
147330600|NCT00771667|531376045|FG006|Maintenance Phase|Other|2|||
147330601|NCT00771667|531376046|FG007|Maintenance Phase|Other|2|||
147330602|NCT00771667|531376047|FG008|Maintenance Phase|Other|3|||
147330603|NCT00771667|531376048|FG009|Maintenance Phase|Other|3|||
147330604|NCT01897233|531376049|FG000|Part B (24 Weeks)|Adverse Event|1|||
147330605|NCT01897233|531376049|FG000|Part B (24 Weeks)|Withdrawal by Subject|2|||
147330606|NCT01897233|531376049|FG000|Part B (24 Weeks)|Physician Decision|1|||
147330607|NCT04033432|531376058|FG000|Overall Study|Progressive Disease|8|||
147330608|NCT04033432|531376058|FG000|Overall Study|Adverse Event|4|||
147330609|NCT04033432|531376058|FG000|Overall Study|Death|1|||
147330610|NCT00738699|531376062|FG000|Overall Study|Withdrawal by Subject|5|||
147330611|NCT00738699|531376063|FG001|Overall Study|Withdrawal by Subject|0|||
147330612|NCT00738699|531376062|FG000|Overall Study|Lost to Follow-up|1|||
147330613|NCT00738699|531376063|FG001|Overall Study|Lost to Follow-up|0|||
147330614|NCT00738699|531376062|FG000|Overall Study|Death|144|||
147330615|NCT00738699|531376063|FG001|Overall Study|Death|68|||
147330616|NCT00738699|531376062|FG000|Overall Study|Discontinuation of study by Sponsor|123|||
147330617|NCT00738699|531376063|FG001|Overall Study|Discontinuation of study by Sponsor|72|||
147330618|NCT00738699|531376062|FG000|Overall Study|Other|2|||
147330619|NCT00738699|531376063|FG001|Overall Study|Other|0|||
147330620|NCT00868192|531376065|FG000|Overall Study|Ineligible|4|||
147330621|NCT03201809|531376066|FG000|Overall Study|Lost to Follow-up|2|||
147330622|NCT03201809|531376067|FG001|Overall Study|Lost to Follow-up|0|||
147330623|NCT01120275|531376069|FG000|Overall Study|Adverse Event|3|||
147330624|NCT01120275|531376069|FG000|Overall Study|Progression|27|||
147330625|NCT01120275|531376069|FG000|Overall Study|Ineligible|3|||
147330626|NCT01120275|531376069|FG000|Overall Study|Withdrawal by Subject|1|||
147330627|NCT01120275|531376069|FG000|Overall Study|Refusal|1|||
147330628|NCT01120275|531376069|FG000|Overall Study|Not specific|1|||
147330629|NCT02736799|531376073|FG000|Overall Study|stopped study after receipt of Capsule #1 due to sore throat.|0|||
147330630|NCT02736799|531376074|FG001|Overall Study|stopped study after receipt of Capsule #1 due to sore throat.|0|||
147330631|NCT02736799|531376075|FG002|Overall Study|stopped study after receipt of Capsule #1 due to sore throat.|0|||
147330632|NCT02736799|531376076|FG003|Overall Study|stopped study after receipt of Capsule #1 due to sore throat.|1|||
147190512|NCT00647296|530864352|FG002|Part 2: 76-week Double-Blind Treatment|Adverse Event|0|||
147190513|NCT00647296|530864353|FG003|Part 2: 76-week Double-Blind Treatment|Adverse Event|4|||
147190514|NCT00647296|530864350|FG000|Part 2: 76-week Double-Blind Treatment|Lost to Follow-up|0|||
147190515|NCT00647296|530864351|FG001|Part 2: 76-week Double-Blind Treatment|Lost to Follow-up|1|||
147190516|NCT00647296|530864352|FG002|Part 2: 76-week Double-Blind Treatment|Lost to Follow-up|0|||
147190517|NCT00647296|530864353|FG003|Part 2: 76-week Double-Blind Treatment|Lost to Follow-up|0|||
147190518|NCT00647296|530864350|FG000|Part 2: 76-week Double-Blind Treatment|Death|0|||
147190519|NCT00647296|530864351|FG001|Part 2: 76-week Double-Blind Treatment|Death|7|||
147330633|NCT01156116|531376077|FG000|Overall Study|Withdrawal by Subject|3|||
147330634|NCT01156116|531376078|FG001|Overall Study|Withdrawal by Subject|1|||
147330635|NCT01156116|531376077|FG000|Overall Study|CPAP intolerance|2|||
147330636|NCT01156116|531376078|FG001|Overall Study|CPAP intolerance|0|||
147330637|NCT00197015|531376079|FG000|Overall Study|Adverse Event|3|||
147330638|NCT00197015|531376080|FG001|Overall Study|Adverse Event|0|||
147330639|NCT00197015|531376081|FG002|Overall Study|Adverse Event|1|||
147330640|NCT00197015|531376079|FG000|Overall Study|Protocol Violation|0|||
147330641|NCT00197015|531376080|FG001|Overall Study|Protocol Violation|3|||
147330642|NCT00197015|531376081|FG002|Overall Study|Protocol Violation|3|||
147330643|NCT00197015|531376079|FG000|Overall Study|Withdrawal by Subject|17|||
147330644|NCT00197015|531376080|FG001|Overall Study|Withdrawal by Subject|37|||
147330645|NCT00197015|531376081|FG002|Overall Study|Withdrawal by Subject|34|||
147190520|NCT00647296|530864352|FG002|Part 2: 76-week Double-Blind Treatment|Death|0|||
147190521|NCT00647296|530864353|FG003|Part 2: 76-week Double-Blind Treatment|Death|5|||
147190522|NCT00647296|530864350|FG000|Part 2: 76-week Double-Blind Treatment|Inability to attend study visits in person|0|||
147190523|NCT00647296|530864351|FG001|Part 2: 76-week Double-Blind Treatment|Inability to attend study visits in person|1|||
147330646|NCT00197015|531376079|FG000|Overall Study|Lost to Follow-up|28|||
147190524|NCT00647296|530864352|FG002|Part 2: 76-week Double-Blind Treatment|Inability to attend study visits in person|0|||
147190525|NCT00647296|530864353|FG003|Part 2: 76-week Double-Blind Treatment|Inability to attend study visits in person|1|||
147190526|NCT02922725|530864354|FG000|Overall Study|Withdrawal by Subject|1|||
147190527|NCT02922725|530864355|FG001|Overall Study|Withdrawal by Subject|0|||
147190528|NCT02922725|530864356|FG002|Overall Study|Withdrawal by Subject|0|||
147190529|NCT01300234|530864357|FG000|Overall Study|Adverse Event|1|||
147190530|NCT01300234|530864358|FG001|Overall Study|Adverse Event|1|||
147190531|NCT01300234|530864357|FG000|Overall Study|Protocol Violation|2|||
147190532|NCT01300234|530864358|FG001|Overall Study|Protocol Violation|3|||
147190533|NCT01300234|530864357|FG000|Overall Study|Withdrawal by Subject|5|||
147190534|NCT01300234|530864358|FG001|Overall Study|Withdrawal by Subject|9|||
147190535|NCT01300234|530864357|FG000|Overall Study|Lost to Follow-up|14|||
147190536|NCT01300234|530864358|FG001|Overall Study|Lost to Follow-up|12|||
147190537|NCT01300234|530864357|FG000|Overall Study|Pregnancy|2|||
147190538|NCT01300234|530864358|FG001|Overall Study|Pregnancy|1|||
147190539|NCT01300234|530864357|FG000|Overall Study|Participant reached stopping critera|2|||
147190540|NCT01300234|530864358|FG001|Overall Study|Participant reached stopping critera|0|||
147190541|NCT01300234|530864357|FG000|Overall Study|Participant stopped medication|1|||
147190542|NCT01300234|530864358|FG001|Overall Study|Participant stopped medication|1|||
147190543|NCT01300234|530864357|FG000|Overall Study|Participant refused return to hospital|1|||
147190544|NCT01300234|530864358|FG001|Overall Study|Participant refused return to hospital|0|||
147190545|NCT00360412|530864359|FG000|Overall Study|Adverse Event|37|||
147190546|NCT00360412|530864360|FG001|Overall Study|Adverse Event|65|||
147190547|NCT00360412|530864359|FG000|Overall Study|Protocol Violation|2|||
147190548|NCT00360412|530864360|FG001|Overall Study|Protocol Violation|5|||
147190549|NCT00360412|530864359|FG000|Overall Study|Patient withdrew consent|27|||
147190550|NCT00360412|530864360|FG001|Overall Study|Patient withdrew consent|52|||
147190551|NCT00360412|530864359|FG000|Overall Study|Lack of therapeutic efficacy|46|||
147190552|NCT00360412|530864360|FG001|Overall Study|Lack of therapeutic efficacy|61|||
147190553|NCT00360412|530864359|FG000|Overall Study|Physician Decision|2|||
147190554|NCT00360412|530864360|FG001|Overall Study|Physician Decision|4|||
147190555|NCT00360412|530864359|FG000|Overall Study|Other|5|||
147190556|NCT00360412|530864360|FG001|Overall Study|Other|6|||
147190557|NCT00360412|530864359|FG000|Overall Study|Study termination by Sponsor|214|||
147190558|NCT00360412|530864360|FG001|Overall Study|Study termination by Sponsor|469|||
147190559|NCT04612725|530864361|FG000|Overall Study|Adverse Event|1|||
147190560|NCT04612725|530864362|FG001|Overall Study|Adverse Event|3|||
147190561|NCT04612725|530864363|FG002|Overall Study|Adverse Event|1|||
147190562|NCT04612725|530864364|FG003|Overall Study|Adverse Event|0|||
147190563|NCT04612725|530864365|FG004|Overall Study|Adverse Event|1|||
147190564|NCT04612725|530864361|FG000|Overall Study|Lost to Follow-up|0|||
147190565|NCT04612725|530864362|FG001|Overall Study|Lost to Follow-up|1|||
147190566|NCT04612725|530864363|FG002|Overall Study|Lost to Follow-up|0|||
147330647|NCT00197015|531376080|FG001|Overall Study|Lost to Follow-up|46|||
147330648|NCT00197015|531376081|FG002|Overall Study|Lost to Follow-up|37|||
147330649|NCT00197015|531376079|FG000|Overall Study|Other|2|||
147330650|NCT00197015|531376080|FG001|Overall Study|Other|3|||
147449156|NCT04770389|531808061|FG003|Overall Study|Left the country|2|||
147190567|NCT04612725|530864364|FG003|Overall Study|Lost to Follow-up|0|||
147449157|NCT04770389|531808058|FG000|Overall Study|Randomized in error and did not receive study drug|0|||
147449158|NCT04770389|531808059|FG001|Overall Study|Randomized in error and did not receive study drug|0|||
147449159|NCT04770389|531808060|FG002|Overall Study|Randomized in error and did not receive study drug|0|||
147449160|NCT04770389|531808061|FG003|Overall Study|Randomized in error and did not receive study drug|1|||
147449161|NCT04770389|531808058|FG000|Overall Study|Lost to Follow-up|0|||
147449162|NCT04770389|531808059|FG001|Overall Study|Lost to Follow-up|0|||
147449163|NCT04770389|531808060|FG002|Overall Study|Lost to Follow-up|0|||
147449164|NCT04770389|531808061|FG003|Overall Study|Lost to Follow-up|1|||
147449165|NCT04770389|531808058|FG000|Overall Study|Moved away from study site|0|||
147449166|NCT04770389|531808059|FG001|Overall Study|Moved away from study site|1|||
147449167|NCT04770389|531808060|FG002|Overall Study|Moved away from study site|0|||
147449168|NCT04770389|531808061|FG003|Overall Study|Moved away from study site|0|||
147449169|NCT00794157|531808069|FG000|Overall Study|Adverse Event|4|||
147449170|NCT00794157|531808070|FG001|Overall Study|Adverse Event|1|||
147449171|NCT00794157|531808071|FG002|Overall Study|Adverse Event|8|||
147449172|NCT00794157|531808069|FG000|Overall Study|Subject withdrew consent|2|||
147449173|NCT00794157|531808070|FG001|Overall Study|Subject withdrew consent|0|||
147449174|NCT00794157|531808071|FG002|Overall Study|Subject withdrew consent|3|||
147449175|NCT00794157|531808069|FG000|Overall Study|Lost to Follow-up|2|||
147449176|NCT00794157|531808070|FG001|Overall Study|Lost to Follow-up|0|||
147449177|NCT00794157|531808071|FG002|Overall Study|Lost to Follow-up|1|||
147449178|NCT00794157|531808069|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
147449179|NCT00794157|531808070|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
147449180|NCT00794157|531808071|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
147449181|NCT00794157|531808069|FG000|Overall Study|Administrative problems|1|||
147449182|NCT00794157|531808070|FG001|Overall Study|Administrative problems|7|||
147449183|NCT00794157|531808071|FG002|Overall Study|Administrative problems|4|||
147449184|NCT00794157|531808069|FG000|Overall Study|Abnormal test procedure result(s)|0|||
147449185|NCT00794157|531808070|FG001|Overall Study|Abnormal test procedure result(s)|1|||
147449186|NCT00794157|531808071|FG002|Overall Study|Abnormal test procedure result(s)|0|||
147449187|NCT00794157|531808069|FG000|Overall Study|Protocol deviation|0|||
147449188|NCT00794157|531808070|FG001|Overall Study|Protocol deviation|1|||
147449189|NCT00794157|531808071|FG002|Overall Study|Protocol deviation|1|||
147449190|NCT01970501|531808072|FG000|Overall Study|Discontinuation of study by sponsor|16|||
147449191|NCT01970501|531808073|FG001|Overall Study|Discontinuation of study by sponsor|14|||
147449192|NCT01970501|531808072|FG000|Overall Study|Withdrawal by Subject|6|||
147449193|NCT01970501|531808073|FG001|Overall Study|Withdrawal by Subject|7|||
147449194|NCT01970501|531808072|FG000|Overall Study|Adverse Event|2|||
147449195|NCT01970501|531808073|FG001|Overall Study|Adverse Event|4|||
147449196|NCT01970501|531808072|FG000|Overall Study|Death|1|||
147449197|NCT01970501|531808073|FG001|Overall Study|Death|3|||
147449198|NCT01970501|531808072|FG000|Overall Study|Physician Decision|2|||
147449199|NCT01970501|531808073|FG001|Overall Study|Physician Decision|0|||
147449200|NCT01692275|531808074|FG000|Overall Study|Lost to Follow-up|57|||
147190568|NCT04612725|530864365|FG004|Overall Study|Lost to Follow-up|0|||
147190569|NCT04612725|530864361|FG000|Overall Study|Physician Decision|2|||
147449201|NCT01692275|531808075|FG001|Overall Study|Lost to Follow-up|48|||
147449202|NCT01692275|531808074|FG000|Overall Study|Withdrawal by Subject|9|||
147449203|NCT01692275|531808075|FG001|Overall Study|Withdrawal by Subject|11|||
147190570|NCT04612725|530864362|FG001|Overall Study|Physician Decision|0|||
147190571|NCT04612725|530864363|FG002|Overall Study|Physician Decision|0|||
147190572|NCT04612725|530864364|FG003|Overall Study|Physician Decision|0|||
147190573|NCT04612725|530864365|FG004|Overall Study|Physician Decision|0|||
147190574|NCT04612725|530864361|FG000|Overall Study|Study terminated by sponsor|3|||
147190575|NCT04612725|530864362|FG001|Overall Study|Study terminated by sponsor|1|||
147190576|NCT04612725|530864363|FG002|Overall Study|Study terminated by sponsor|2|||
147190577|NCT04612725|530864364|FG003|Overall Study|Study terminated by sponsor|4|||
147190578|NCT04612725|530864365|FG004|Overall Study|Study terminated by sponsor|5|||
147190579|NCT04612725|530864361|FG000|Overall Study|Withdrawal by Subject|8|||
147190580|NCT04612725|530864362|FG001|Overall Study|Withdrawal by Subject|3|||
147190581|NCT04612725|530864363|FG002|Overall Study|Withdrawal by Subject|5|||
147190582|NCT04612725|530864364|FG003|Overall Study|Withdrawal by Subject|1|||
147190583|NCT04612725|530864365|FG004|Overall Study|Withdrawal by Subject|9|||
147190584|NCT04612725|530864361|FG000|Overall Study|Other|0|||
147190585|NCT04612725|530864362|FG001|Overall Study|Other|0|||
147190586|NCT04612725|530864363|FG002|Overall Study|Other|0|||
147190587|NCT04612725|530864364|FG003|Overall Study|Other|0|||
147190588|NCT04612725|530864365|FG004|Overall Study|Other|1|||
147190589|NCT02354235|530864366|FG000|Overall Study|Adverse Event|2|||
147658598|NCT03428100|532572311|FG000|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
147190590|NCT02354235|530864367|FG001|Overall Study|Adverse Event|2|||
147190591|NCT02354235|530864366|FG000|Overall Study|Physician Decision|0|||
147449204|NCT00845650|531808076|FG000|Overall Study|Withdrawal by Subject|0|||
147449205|NCT00845650|531808077|FG001|Overall Study|Withdrawal by Subject|0|||
147190592|NCT02354235|530864367|FG001|Overall Study|Physician Decision|1|||
147190593|NCT02354235|530864366|FG000|Overall Study|Withdrawal by Subject|1|||
147449206|NCT00845650|531808078|FG002|Overall Study|Withdrawal by Subject|0|||
147449207|NCT00845650|531808079|FG003|Overall Study|Withdrawal by Subject|0|||
147449208|NCT00845650|531808080|FG004|Overall Study|Withdrawal by Subject|2|||
147449209|NCT00845650|531808081|FG005|Overall Study|Withdrawal by Subject|0|||
147449210|NCT00845650|531808076|FG000|Overall Study|Lost to Follow-up|0|||
147449211|NCT00845650|531808077|FG001|Overall Study|Lost to Follow-up|0|||
147449212|NCT00845650|531808078|FG002|Overall Study|Lost to Follow-up|3|||
147449213|NCT00845650|531808079|FG003|Overall Study|Lost to Follow-up|1|||
147449214|NCT00845650|531808080|FG004|Overall Study|Lost to Follow-up|0|||
147449215|NCT00845650|531808081|FG005|Overall Study|Lost to Follow-up|1|||
147449216|NCT00845650|531808076|FG000|Overall Study|Sponsor hold on dosing|0|||
147449217|NCT00845650|531808077|FG001|Overall Study|Sponsor hold on dosing|0|||
147449218|NCT00845650|531808078|FG002|Overall Study|Sponsor hold on dosing|0|||
147449219|NCT00845650|531808079|FG003|Overall Study|Sponsor hold on dosing|0|||
147449220|NCT00845650|531808080|FG004|Overall Study|Sponsor hold on dosing|1|||
147449221|NCT00845650|531808081|FG005|Overall Study|Sponsor hold on dosing|1|||
147449222|NCT00845650|531808076|FG000|Overall Study|Unable to access IV line|1|||
147449223|NCT00845650|531808077|FG001|Overall Study|Unable to access IV line|0|||
147449224|NCT00845650|531808078|FG002|Overall Study|Unable to access IV line|0|||
147449225|NCT00845650|531808079|FG003|Overall Study|Unable to access IV line|0|||
147449226|NCT00845650|531808080|FG004|Overall Study|Unable to access IV line|0|||
147449227|NCT00845650|531808081|FG005|Overall Study|Unable to access IV line|0|||
147449228|NCT00814892|531808082|FG000|Overall Study|Disease Progression|1|||
147449229|NCT00814892|531808082|FG000|Overall Study|Study Termination|1|||
147449230|NCT04486950|531808083|FG000|Overall Study|Lost to Follow-up|0|||
147449231|NCT04486950|531808084|FG001|Overall Study|Lost to Follow-up|0|||
147449232|NCT04486950|531808085|FG002|Overall Study|Lost to Follow-up|0|||
147449233|NCT04486950|531808086|FG003|Overall Study|Lost to Follow-up|0|||
147449234|NCT04486950|531808087|FG004|Overall Study|Lost to Follow-up|0|||
147449235|NCT04486950|531808088|FG005|Overall Study|Lost to Follow-up|1|||
147449236|NCT04486950|531808089|FG006|Overall Study|Lost to Follow-up|0|||
147449237|NCT00950664|531808090|FG000|First Intervention|Lost to Follow-up|1|||
147449238|NCT00950664|531808091|FG001|First Intervention|Lost to Follow-up|3|||
147449239|NCT00950664|531808090|FG000|First Intervention|Withdrawal by Subject|2|||
147449240|NCT00950664|531808091|FG001|First Intervention|Withdrawal by Subject|2|||
147449241|NCT01326546|531808092|FG000|Overall Study|Lost to Follow-up|8|||
147449242|NCT01326546|531808093|FG001|Overall Study|Lost to Follow-up|7|||
147449243|NCT01326546|531808092|FG000|Overall Study|Protocol Violation|3|||
147449244|NCT01326546|531808093|FG001|Overall Study|Protocol Violation|4|||
147449245|NCT01326546|531808092|FG000|Overall Study|Pregnancy|0|||
147449246|NCT01326546|531808093|FG001|Overall Study|Pregnancy|1|||
147449247|NCT01326546|531808092|FG000|Overall Study|Adverse Event|1|||
147449248|NCT01326546|531808093|FG001|Overall Study|Adverse Event|0|||
147449249|NCT01326546|531808092|FG000|Overall Study|Withdrawal by Subject|5|||
147449250|NCT01326546|531808093|FG001|Overall Study|Withdrawal by Subject|1|||
147449251|NCT03152019|531808094|FG000|Overall Study|Adverse Event|0|||
147449252|NCT03152019|531808095|FG001|Overall Study|Adverse Event|1|||
147449253|NCT00923130|531808100|FG000|Overall Study|Stopped treatment due to progression|17|||
147449254|NCT00923130|531808100|FG000|Overall Study|Death|1|||
147449255|NCT00923130|531808100|FG000|Overall Study|Discontinued treatment due to toxicities|3|||
147449256|NCT00923130|531808100|FG000|Overall Study|Switched to alternative treatment|2|||
147449257|NCT00923130|531808100|FG000|Overall Study|Refused further treatment|2|||
147449258|NCT04311502|531809458|FG000|Overall Study|Death|1|||
147449259|NCT04311502|531809459|FG001|Overall Study|Death|1|||
147449260|NCT04311502|531809460|FG002|Overall Study|Death|1|||
147449261|NCT04311502|531809458|FG000|Overall Study|Lost to Follow-up|2|||
147449262|NCT04311502|531809459|FG001|Overall Study|Lost to Follow-up|3|||
147449263|NCT04311502|531809460|FG002|Overall Study|Lost to Follow-up|0|||
147449264|NCT04311502|531809458|FG000|Overall Study|Participant is in prison|1|||
147449265|NCT04311502|531809459|FG001|Overall Study|Participant is in prison|0|||
147449266|NCT04311502|531809460|FG002|Overall Study|Participant is in prison|0|||
147449267|NCT04311502|531809458|FG000|Overall Study|Participant moved out of country|1|||
147449268|NCT04311502|531809459|FG001|Overall Study|Participant moved out of country|0|||
147449269|NCT04311502|531809460|FG002|Overall Study|Participant moved out of country|0|||
147449270|NCT04311502|531809458|FG000|Overall Study|Withdrawal by Subject|2|||
147449271|NCT04311502|531809459|FG001|Overall Study|Withdrawal by Subject|0|||
147449272|NCT04311502|531809460|FG002|Overall Study|Withdrawal by Subject|0|||
147449273|NCT04311502|531809458|FG000|Overall Study|DSMB Mandated Extension of follow-up|29|||
147449274|NCT04311502|531809459|FG001|Overall Study|DSMB Mandated Extension of follow-up|0|||
147449275|NCT04311502|531809460|FG002|Overall Study|DSMB Mandated Extension of follow-up|0|||
147594126|NCT01698775|532330601|FG000|Phase B|Death|0|||
147449276|NCT03040999|531809461|FG000|Overall Study|Lost to Follow-up|2|||
147449277|NCT03040999|531809462|FG001|Overall Study|Lost to Follow-up|2|||
147594127|NCT01698775|532330602|FG001|Phase B|Death|1|||
147449278|NCT03040999|531809461|FG000|Overall Study|Withdrawal by Subject|12|||
147449279|NCT03040999|531809462|FG001|Overall Study|Withdrawal by Subject|13|||
147449280|NCT03040999|531809461|FG000|Overall Study|Death|155|||
147594128|NCT01698775|532330601|FG000|Phase B|Lack of Efficacy|0|||
147330651|NCT00197015|531376081|FG002|Overall Study|Other|2|||
147330652|NCT04511650|531376082|FG000|Overall Study|Lost to Follow-up|1|||
147330653|NCT04511650|531376083|FG001|Overall Study|Lost to Follow-up|0|||
147330654|NCT04511650|531376084|FG002|Overall Study|Lost to Follow-up|0|||
147330655|NCT04511650|531376082|FG000|Overall Study|Withdrawal by Subject|1|||
147330656|NCT04511650|531376083|FG001|Overall Study|Withdrawal by Subject|0|||
147330657|NCT04511650|531376084|FG002|Overall Study|Withdrawal by Subject|0|||
147330658|NCT04511650|531376082|FG000|Overall Study|reason not provided|0|||
147330659|NCT04511650|531376083|FG001|Overall Study|reason not provided|0|||
147330660|NCT04511650|531376084|FG002|Overall Study|reason not provided|1|||
147330661|NCT04511650|531376082|FG000|Overall Study|Death|1|||
147330662|NCT04511650|531376083|FG001|Overall Study|Death|1|||
147330663|NCT04511650|531376084|FG002|Overall Study|Death|1|||
147330664|NCT01186848|531376087|FG000|Overall Study|Lost to Follow-up|4|||
147330665|NCT01186848|531376087|FG000|Overall Study|Withdrawal by Subject|2|||
147330666|NCT01186848|531376087|FG000|Overall Study|Adverse Event|2|||
147330667|NCT01490580|531376088|FG000|Overall Study|Parents withdrew consent|0|||
147330668|NCT01490580|531376089|FG001|Overall Study|Parents withdrew consent|2|||
147330669|NCT03593070|531376093|FG000|Overall Study|administrative withdrawal|1|||
147330670|NCT03593070|531376094|FG001|Overall Study|administrative withdrawal|1|||
147330671|NCT03098030|531376097|FG000|Overall Study|Death|10|||
147330672|NCT03098030|531376098|FG001|Overall Study|Death|156|||
147330673|NCT03098030|531376099|FG002|Overall Study|Death|156|||
147330674|NCT03098030|531376100|FG003|Overall Study|Death|82|||
147330675|NCT03098030|531376097|FG000|Overall Study|Withdrawal by Subject|0|||
147330676|NCT03098030|531376098|FG001|Overall Study|Withdrawal by Subject|7|||
147330677|NCT03098030|531376099|FG002|Overall Study|Withdrawal by Subject|8|||
147330678|NCT03098030|531376100|FG003|Overall Study|Withdrawal by Subject|2|||
147330679|NCT03098030|531376097|FG000|Overall Study|Lost to Follow-up|0|||
147330680|NCT03098030|531376098|FG001|Overall Study|Lost to Follow-up|0|||
147330681|NCT03098030|531376099|FG002|Overall Study|Lost to Follow-up|2|||
147330682|NCT03098030|531376100|FG003|Overall Study|Lost to Follow-up|1|||
147330683|NCT03310983|531376101|FG000|Overall Study|Lost to Follow-up|15|||
147330684|NCT03310983|531376102|FG001|Overall Study|Lost to Follow-up|17|||
147330685|NCT03612804|531376103|FG000|Overall Study|Death|0|||
147330686|NCT03612804|531376104|FG001|Overall Study|Death|7|||
147330687|NCT03612804|531376105|FG002|Overall Study|Death|0|||
147330688|NCT03612804|531376106|FG003|Overall Study|Death|8|||
147330689|NCT03612804|531376103|FG000|Overall Study|Medication copay coverage issues|0|||
147330690|NCT03612804|531376104|FG001|Overall Study|Medication copay coverage issues|0|||
147330691|NCT03612804|531376105|FG002|Overall Study|Medication copay coverage issues|0|||
147330692|NCT03612804|531376106|FG003|Overall Study|Medication copay coverage issues|17|||
147330693|NCT03612804|531376103|FG000|Overall Study|Not current smoker at time of screening|0|||
147330694|NCT03612804|531376104|FG001|Overall Study|Not current smoker at time of screening|1|||
147330695|NCT03612804|531376105|FG002|Overall Study|Not current smoker at time of screening|0|||
147330696|NCT03612804|531376106|FG003|Overall Study|Not current smoker at time of screening|3|||
147330697|NCT03612804|531376103|FG000|Overall Study|Non-veteran status|0|||
147330698|NCT03612804|531376104|FG001|Overall Study|Non-veteran status|1|||
147330699|NCT03612804|531376105|FG002|Overall Study|Non-veteran status|0|||
147330700|NCT03612804|531376106|FG003|Overall Study|Non-veteran status|0|||
147330701|NCT03612804|531376103|FG000|Overall Study|Misassignment to a proactive arm provider|0|||
147330702|NCT03612804|531376104|FG001|Overall Study|Misassignment to a proactive arm provider|1|||
147330703|NCT03612804|531376105|FG002|Overall Study|Misassignment to a proactive arm provider|0|||
147330704|NCT03612804|531376106|FG003|Overall Study|Misassignment to a proactive arm provider|0|||
147330705|NCT03612804|531376103|FG000|Overall Study|Provider retired from VA|0|||
147330706|NCT03612804|531376104|FG001|Overall Study|Provider retired from VA|0|||
147330707|NCT03612804|531376105|FG002|Overall Study|Provider retired from VA|2|||
147330708|NCT03612804|531376106|FG003|Overall Study|Provider retired from VA|0|||
147330709|NCT03612804|531376103|FG000|Overall Study|Withdrawal by Subject|0|||
147330710|NCT03612804|531376104|FG001|Overall Study|Withdrawal by Subject|0|||
147330711|NCT03612804|531376105|FG002|Overall Study|Withdrawal by Subject|7|||
147330712|NCT03612804|531376106|FG003|Overall Study|Withdrawal by Subject|0|||
147330713|NCT03612804|531376103|FG000|Overall Study|Provider involved with study activities|1|||
147330714|NCT03612804|531376104|FG001|Overall Study|Provider involved with study activities|0|||
147330715|NCT03612804|531376105|FG002|Overall Study|Provider involved with study activities|0|||
147330716|NCT03612804|531376106|FG003|Overall Study|Provider involved with study activities|0|||
147330717|NCT01656304|531376107|FG000|Overall Study|Ineligible, uncontrolled hypertension|1|||
147330718|NCT04391309|531376108|FG000|Overall Study|Death|1|||
147330719|NCT04391309|531376109|FG001|Overall Study|Death|1|||
147330720|NCT04391309|531376108|FG000|Overall Study|Lost to Follow-up|3|||
147330721|NCT04391309|531376109|FG001|Overall Study|Lost to Follow-up|2|||
147330722|NCT04391309|531376108|FG000|Overall Study|Withdrawal by Subject|2|||
147330723|NCT04391309|531376109|FG001|Overall Study|Withdrawal by Subject|2|||
147330724|NCT00881335|531376110|FG000|Overall Study|Lost to Follow-up|3|||
147330725|NCT00881335|531376111|FG001|Overall Study|Lost to Follow-up|2|||
147330726|NCT00554801|531376113|FG000|Overall Study|left area before completion|5|||
147330727|NCT00554801|531376114|FG001|Overall Study|left area before completion|0|||
147190594|NCT02354235|530864367|FG001|Overall Study|Withdrawal by Subject|3|||
147190595|NCT02354235|530864366|FG000|Overall Study|Conflict with the stopping criteria|0|||
147190596|NCT02354235|530864367|FG001|Overall Study|Conflict with the stopping criteria|1|||
147190597|NCT03069352|530864368|FG000|Overall Study|Ongoing|12|||
147190598|NCT03069352|530864369|FG001|Overall Study|Ongoing|40|||
147190599|NCT02621424|530864370|FG000|Overall Study|Withdrawal by Subject|1|||
147190600|NCT02621424|530864371|FG001|Overall Study|Withdrawal by Subject|2|||
147190601|NCT05148234|530864373|FG000|Phase I|Ineligible|0|||
147190602|NCT05148234|530864374|FG001|Phase I|Ineligible|0|||
147190603|NCT05148234|530864375|FG002|Phase I|Ineligible|0|||
147190604|NCT05148234|530864376|FG003|Phase I|Ineligible|0|||
147190605|NCT05148234|530864377|FG004|Phase I|Ineligible|0|||
147190606|NCT05148234|530864378|FG005|Phase I|Ineligible|0|||
147190607|NCT05148234|530864379|FG006|Phase I|Ineligible|0|||
147190608|NCT05148234|530864380|FG007|Phase I|Ineligible|1|||
147190609|NCT05148234|530864373|FG000|Phase I|Company closed the trial.|0|||
147190610|NCT05148234|530864374|FG001|Phase I|Company closed the trial.|1|||
147190611|NCT05148234|530864375|FG002|Phase I|Company closed the trial.|0|||
147190612|NCT05148234|530864376|FG003|Phase I|Company closed the trial.|0|||
147190613|NCT05148234|530864377|FG004|Phase I|Company closed the trial.|0|||
147190614|NCT05148234|530864378|FG005|Phase I|Company closed the trial.|0|||
147190615|NCT05148234|530864379|FG006|Phase I|Company closed the trial.|0|||
147190616|NCT05148234|530864380|FG007|Phase I|Company closed the trial.|0|||
147190617|NCT01650194|530864381|FG000|Overall Study|Progressive Disease (PD)|35|||
147190618|NCT01650194|530864381|FG000|Overall Study|Withdrawal by Subject|2|||
147190619|NCT01650194|530864381|FG000|Overall Study|Miscellaneous|10|||
147190620|NCT01928927|530864382|FG000|Overall Study|Lost to Follow-up|1|||
147190621|NCT01928927|530864383|FG001|Overall Study|Lost to Follow-up|0|||
147190622|NCT01928927|530864382|FG000|Overall Study|Withdrawal by Subject|1|||
147190623|NCT01928927|530864383|FG001|Overall Study|Withdrawal by Subject|1|||
147190624|NCT04158583|530864384|FG000|Overall Study|Withdrawal by Subject|1|||
147190625|NCT04158583|530864385|FG001|Overall Study|Withdrawal by Subject|1|||
147190626|NCT04158583|530864386|FG002|Overall Study|Withdrawal by Subject|0|||
147190627|NCT04158583|530864387|FG003|Overall Study|Withdrawal by Subject|0|||
147190628|NCT04158583|530864388|FG004|Overall Study|Withdrawal by Subject|1|||
147190629|NCT04158583|530864389|FG005|Overall Study|Withdrawal by Subject|0|||
147190630|NCT04158583|530864390|FG006|Overall Study|Withdrawal by Subject|0|||
147190631|NCT04158583|530864391|FG007|Overall Study|Withdrawal by Subject|0|||
147190632|NCT04158583|530864392|FG008|Overall Study|Withdrawal by Subject|2|||
147190633|NCT04158583|530864393|FG009|Overall Study|Withdrawal by Subject|0|||
147190634|NCT04158583|530864384|FG000|Overall Study|Study Terminated by Sponsor|0|||
147190635|NCT04158583|530864385|FG001|Overall Study|Study Terminated by Sponsor|0|||
147190636|NCT04158583|530864386|FG002|Overall Study|Study Terminated by Sponsor|0|||
147190637|NCT04158583|530864387|FG003|Overall Study|Study Terminated by Sponsor|1|||
147190638|NCT04158583|530864388|FG004|Overall Study|Study Terminated by Sponsor|0|||
147190639|NCT04158583|530864389|FG005|Overall Study|Study Terminated by Sponsor|0|||
147190640|NCT04158583|530864390|FG006|Overall Study|Study Terminated by Sponsor|0|||
147190641|NCT04158583|530864391|FG007|Overall Study|Study Terminated by Sponsor|0|||
147190642|NCT04158583|530864392|FG008|Overall Study|Study Terminated by Sponsor|0|||
147190643|NCT04158583|530864393|FG009|Overall Study|Study Terminated by Sponsor|0|||
147190644|NCT04158583|530864384|FG000|Overall Study|Progressive Disease|1|||
147190645|NCT04158583|530864385|FG001|Overall Study|Progressive Disease|0|||
147190646|NCT04158583|530864386|FG002|Overall Study|Progressive Disease|3|||
147190647|NCT04158583|530864387|FG003|Overall Study|Progressive Disease|5|||
147190648|NCT04158583|530864388|FG004|Overall Study|Progressive Disease|0|||
147190649|NCT04158583|530864389|FG005|Overall Study|Progressive Disease|1|||
147190650|NCT04158583|530864390|FG006|Overall Study|Progressive Disease|6|||
147594129|NCT01698775|532330602|FG001|Phase B|Lack of Efficacy|1|||
147190651|NCT04158583|530864391|FG007|Overall Study|Progressive Disease|2|||
147190652|NCT04158583|530864392|FG008|Overall Study|Progressive Disease|1|||
147190653|NCT04158583|530864393|FG009|Overall Study|Progressive Disease|2|||
147594130|NCT01698775|532330601|FG000|Phase B|Lost to Follow-up|0|||
147190654|NCT04158583|530864384|FG000|Overall Study|Lost to Follow-up|0|||
147190655|NCT04158583|530864385|FG001|Overall Study|Lost to Follow-up|0|||
147190656|NCT04158583|530864386|FG002|Overall Study|Lost to Follow-up|1|||
147190657|NCT04158583|530864387|FG003|Overall Study|Lost to Follow-up|1|||
147190658|NCT04158583|530864388|FG004|Overall Study|Lost to Follow-up|1|||
147190659|NCT04158583|530864389|FG005|Overall Study|Lost to Follow-up|0|||
147190660|NCT04158583|530864390|FG006|Overall Study|Lost to Follow-up|0|||
147190661|NCT04158583|530864391|FG007|Overall Study|Lost to Follow-up|0|||
147190662|NCT04158583|530864392|FG008|Overall Study|Lost to Follow-up|0|||
147190663|NCT04158583|530864393|FG009|Overall Study|Lost to Follow-up|0|||
147190664|NCT04158583|530864384|FG000|Overall Study|Due To Patient Status|0|||
147190665|NCT04158583|530864385|FG001|Overall Study|Due To Patient Status|0|||
147594131|NCT01698775|532330602|FG001|Phase B|Lost to Follow-up|1|||
147594132|NCT01698775|532330601|FG000|Phase B|Physician Decision|1|||
147190666|NCT04158583|530864386|FG002|Overall Study|Due To Patient Status|0|||
147190667|NCT04158583|530864387|FG003|Overall Study|Due To Patient Status|0|||
147190668|NCT04158583|530864388|FG004|Overall Study|Due To Patient Status|0|||
147330728|NCT00554801|531376113|FG000|Overall Study|Withdrawal by Subject|14|||
147330729|NCT00554801|531376114|FG001|Overall Study|Withdrawal by Subject|0|||
147330730|NCT05826431|531376115|FG000|Overall Study|Withdrawal by Subject|1|||
147330731|NCT02104765|531376116|FG000|Overall Study|Lost to Follow-up|0|||
147330732|NCT02104765|531376117|FG001|Overall Study|Lost to Follow-up|0|||
147330733|NCT02104765|531376118|FG002|Overall Study|Lost to Follow-up|1|||
147330734|NCT02104765|531376119|FG003|Overall Study|Lost to Follow-up|0|||
147330735|NCT02104765|531376120|FG004|Overall Study|Lost to Follow-up|0|||
147330736|NCT02104765|531376121|FG005|Overall Study|Lost to Follow-up|0|||
147330737|NCT02104765|531376122|FG006|Overall Study|Lost to Follow-up|0|||
147330738|NCT02104765|531376116|FG000|Overall Study|Withdrawal by Subject|0|||
147330739|NCT02104765|531376117|FG001|Overall Study|Withdrawal by Subject|0|||
147330740|NCT02104765|531376118|FG002|Overall Study|Withdrawal by Subject|0|||
147330741|NCT02104765|531376119|FG003|Overall Study|Withdrawal by Subject|1|||
147330742|NCT02104765|531376120|FG004|Overall Study|Withdrawal by Subject|1|||
147330743|NCT02104765|531376121|FG005|Overall Study|Withdrawal by Subject|0|||
147330744|NCT02104765|531376122|FG006|Overall Study|Withdrawal by Subject|1|||
147190669|NCT04158583|530864389|FG005|Overall Study|Due To Patient Status|0|||
147190670|NCT04158583|530864390|FG006|Overall Study|Due To Patient Status|0|||
147190671|NCT04158583|530864391|FG007|Overall Study|Due To Patient Status|0|||
147190672|NCT04158583|530864392|FG008|Overall Study|Due To Patient Status|1|||
147330745|NCT02357784|531376126|FG000|Overall Study|Withdrawal by Subject|1|||
147190673|NCT04158583|530864393|FG009|Overall Study|Due To Patient Status|0|||
147190674|NCT04158583|530864384|FG000|Overall Study|Death|3|||
147190675|NCT04158583|530864385|FG001|Overall Study|Death|4|||
147190676|NCT04158583|530864386|FG002|Overall Study|Death|2|||
147190677|NCT04158583|530864387|FG003|Overall Study|Death|2|||
147190678|NCT04158583|530864388|FG004|Overall Study|Death|4|||
147190679|NCT04158583|530864389|FG005|Overall Study|Death|3|||
147190680|NCT04158583|530864390|FG006|Overall Study|Death|5|||
147190681|NCT04158583|530864391|FG007|Overall Study|Death|2|||
147190682|NCT04158583|530864392|FG008|Overall Study|Death|0|||
147190683|NCT04158583|530864393|FG009|Overall Study|Death|1|||
147330746|NCT00462943|531376127|FG000|Overall Study|Failure to achieve a response|5|||
147330747|NCT00462943|531376128|FG001|Overall Study|Failure to achieve a response|5|||
147330748|NCT00462943|531376129|FG002|Overall Study|Failure to achieve a response|1|||
147330749|NCT00462943|531376127|FG000|Overall Study|Adverse Event|6|||
147330750|NCT00462943|531376128|FG001|Overall Study|Adverse Event|4|||
147330751|NCT00462943|531376129|FG002|Overall Study|Adverse Event|1|||
147330752|NCT00462943|531376127|FG000|Overall Study|Protocol Violation|1|||
147330753|NCT00462943|531376128|FG001|Overall Study|Protocol Violation|0|||
147330754|NCT00462943|531376129|FG002|Overall Study|Protocol Violation|0|||
147330755|NCT00462943|531376127|FG000|Overall Study|Request of Patient, PI, Sponsor or RA|8|||
147330756|NCT00462943|531376128|FG001|Overall Study|Request of Patient, PI, Sponsor or RA|2|||
147330757|NCT00462943|531376129|FG002|Overall Study|Request of Patient, PI, Sponsor or RA|4|||
147330758|NCT00462943|531376127|FG000|Overall Study|Disease Progression|15|||
147330759|NCT00462943|531376128|FG001|Overall Study|Disease Progression|15|||
147330760|NCT00462943|531376129|FG002|Overall Study|Disease Progression|9|||
147330761|NCT00462943|531376127|FG000|Overall Study|Death|5|||
147330762|NCT00462943|531376128|FG001|Overall Study|Death|2|||
147330763|NCT00462943|531376129|FG002|Overall Study|Death|7|||
147330764|NCT00462943|531376127|FG000|Overall Study|Stem Cell Transplant|1|||
147330765|NCT00462943|531376128|FG001|Overall Study|Stem Cell Transplant|1|||
147330766|NCT00462943|531376129|FG002|Overall Study|Stem Cell Transplant|0|||
147330767|NCT00462943|531376127|FG000|Overall Study|Bone Marrow Transplant|1|||
147330768|NCT00462943|531376128|FG001|Overall Study|Bone Marrow Transplant|0|||
147330769|NCT00462943|531376129|FG002|Overall Study|Bone Marrow Transplant|0|||
147330770|NCT00462943|531376127|FG000|Overall Study|Required Lymphocyte Infusion|1|||
147330771|NCT00462943|531376128|FG001|Overall Study|Required Lymphocyte Infusion|0|||
147330772|NCT00462943|531376129|FG002|Overall Study|Required Lymphocyte Infusion|0|||
147330773|NCT00462943|531376127|FG000|Overall Study|Transplant - not specified|1|||
147330774|NCT00462943|531376128|FG001|Overall Study|Transplant - not specified|0|||
147330775|NCT00462943|531376129|FG002|Overall Study|Transplant - not specified|1|||
147330776|NCT00462943|531376127|FG000|Overall Study|Physician Decision|1|||
147330777|NCT00462943|531376128|FG001|Overall Study|Physician Decision|0|||
147330778|NCT00462943|531376129|FG002|Overall Study|Physician Decision|0|||
147330779|NCT00462943|531376127|FG000|Overall Study|Withdrawal by Subject|0|||
147330780|NCT00462943|531376128|FG001|Overall Study|Withdrawal by Subject|1|||
147330781|NCT00462943|531376129|FG002|Overall Study|Withdrawal by Subject|0|||
147330782|NCT04222959|531376130|FG000|Overall Study|Lost to Follow-up|76|||
147594133|NCT01698775|532330602|FG001|Phase B|Physician Decision|1|||
147190684|NCT04158583|530864384|FG000|Overall Study|Clinical Progression Disease|0|||
147190685|NCT04158583|530864385|FG001|Overall Study|Clinical Progression Disease|0|||
147190686|NCT04158583|530864386|FG002|Overall Study|Clinical Progression Disease|0|||
147330783|NCT04222959|531376131|FG001|Overall Study|Lost to Follow-up|28|||
147330784|NCT02289560|531376136|FG000|Overall Study|Lost to Follow-up|6|||
147330785|NCT02289560|531376136|FG000|Overall Study|Alternative Treatment|4|||
147330786|NCT02289560|531376136|FG000|Overall Study|Inadequate Treatment|2|||
147190687|NCT04158583|530864387|FG003|Overall Study|Clinical Progression Disease|1|||
147190688|NCT04158583|530864388|FG004|Overall Study|Clinical Progression Disease|0|||
147190689|NCT04158583|530864389|FG005|Overall Study|Clinical Progression Disease|0|||
147190690|NCT04158583|530864390|FG006|Overall Study|Clinical Progression Disease|0|||
147190691|NCT04158583|530864391|FG007|Overall Study|Clinical Progression Disease|0|||
147190692|NCT04158583|530864392|FG008|Overall Study|Clinical Progression Disease|0|||
147190693|NCT04158583|530864393|FG009|Overall Study|Clinical Progression Disease|0|||
147330787|NCT02289560|531376136|FG000|Overall Study|Withdrawal by Subject|23|||
147330788|NCT02540213|531376137|FG000|Overall Study|Death/adverse event|18|||
147330789|NCT02540213|531376137|FG000|Overall Study|Administrative reasons|3|||
147330790|NCT02540213|531376137|FG000|Overall Study|Kidney transplant|3|||
147330791|NCT02540213|531376137|FG000|Overall Study|Lack of Efficacy|6|||
147330792|NCT02540213|531376137|FG000|Overall Study|Consent withdrawn|7|||
147330793|NCT02540213|531376137|FG000|Overall Study|Enrolled but not treated|2|||
147330794|NCT00038103|531376140|FG000|Overall Study|Adverse Event|5|||
147330795|NCT00038103|531376141|FG001|Overall Study|Adverse Event|6|||
147330796|NCT00038103|531376140|FG000|Overall Study|Lack of Efficacy|48|||
147330797|NCT00038103|531376141|FG001|Overall Study|Lack of Efficacy|41|||
147330798|NCT00038103|531376140|FG000|Overall Study|Withdrawal by Subject|0|||
147330799|NCT00038103|531376141|FG001|Overall Study|Withdrawal by Subject|3|||
147330800|NCT00038103|531376140|FG000|Overall Study|Lost to Follow-up|0|||
147330801|NCT00038103|531376141|FG001|Overall Study|Lost to Follow-up|3|||
147330802|NCT00038103|531376140|FG000|Overall Study|Protocol Violation|0|||
147330803|NCT00038103|531376141|FG001|Overall Study|Protocol Violation|2|||
147330804|NCT00038103|531376140|FG000|Overall Study|Sponsor Decision|0|||
147330805|NCT00038103|531376141|FG001|Overall Study|Sponsor Decision|1|||
147330806|NCT00038103|531376140|FG000|Overall Study|Randomized/never treated|2|||
147330807|NCT00038103|531376141|FG001|Overall Study|Randomized/never treated|0|||
147330808|NCT01981356|531376147|FG000|Overall Study|Lost to Follow-up|4|||
147330809|NCT01981356|531376148|FG001|Overall Study|Lost to Follow-up|1|||
147330810|NCT01981356|531376147|FG000|Overall Study|Withdrawal by Subject|1|||
147330811|NCT01981356|531376148|FG001|Overall Study|Withdrawal by Subject|1|||
147330812|NCT01981356|531376147|FG000|Overall Study|Protocol Violation|2|||
147330813|NCT01981356|531376148|FG001|Overall Study|Protocol Violation|0|||
147330814|NCT01751724|531376152|FG000|Overall Study|extubated bef.start assigned treatment|1|||
147330815|NCT01751724|531376153|FG001|Overall Study|extubated bef.start assigned treatment|0|||
147330816|NCT01751724|531376152|FG000|Overall Study|withdrawn by parent|0|||
147330817|NCT01751724|531376153|FG001|Overall Study|withdrawn by parent|2|||
147330818|NCT02465359|531376158|FG000|Overall Study|Lack of Efficacy|1|||
147330819|NCT02465359|531376158|FG000|Overall Study|Withdrawal by Subject|1|||
147330820|NCT02465359|531376158|FG000|Overall Study|Adverse Event|1|||
147330821|NCT01278862|531376159|FG000|Overall Study|Lost to Follow-up|1|||
147330822|NCT01278862|531376160|FG001|Overall Study|Lost to Follow-up|1|||
147330823|NCT02952261|531376161|FG000|Overall Study|Withdrawal by Subject|4|||
147330824|NCT02952261|531376162|FG001|Overall Study|Withdrawal by Subject|5|||
147330825|NCT02952261|531376161|FG000|Overall Study|Protocol Violation|1|||
147330826|NCT02952261|531376162|FG001|Overall Study|Protocol Violation|0|||
147330827|NCT00798265|531376163|FG000|Overall Study|Lost to Follow-up|1|||
147330828|NCT00798265|531376164|FG001|Overall Study|Lost to Follow-up|10|||
147330829|NCT00798265|531376163|FG000|Overall Study|Study closing|7|||
147330830|NCT00798265|531376164|FG001|Overall Study|Study closing|6|||
147330831|NCT00798265|531376163|FG000|Overall Study|Withdrawal by Subject|0|||
147330832|NCT00798265|531376164|FG001|Overall Study|Withdrawal by Subject|1|||
147330833|NCT00798265|531376163|FG000|Overall Study|Screen failure|0|||
147330834|NCT00798265|531376164|FG001|Overall Study|Screen failure|1|||
147330835|NCT03354390|531376165|FG000|Level 1|Death|2|||
147330836|NCT03354390|531376166|FG001|Level 1|Death|0|||
147330837|NCT03354390|531376167|FG002|Level 1|Death|0|||
147330838|NCT03354390|531376168|FG003|Level 1|Death|0|||
147190694|NCT04158583|530864384|FG000|Overall Study|Clinical Progression|0|||
147190695|NCT04158583|530864385|FG001|Overall Study|Clinical Progression|0|||
147594134|NCT01698775|532330601|FG000|Phase B|Protocol Violation|1|||
147594135|NCT01698775|532330602|FG001|Phase B|Protocol Violation|1|||
147190696|NCT04158583|530864386|FG002|Overall Study|Clinical Progression|0|||
147190697|NCT04158583|530864387|FG003|Overall Study|Clinical Progression|0|||
147594136|NCT01698775|532330601|FG000|Phase B|Withdrawal by Subject|6|||
147190698|NCT04158583|530864388|FG004|Overall Study|Clinical Progression|1|||
147449281|NCT03040999|531809462|FG001|Overall Study|Death|171|||
147594137|NCT01698775|532330602|FG001|Phase B|Withdrawal by Subject|2|||
147330839|NCT03354390|531376165|FG000|Level 1|Physician Decision|1|||
147330840|NCT03354390|531376166|FG001|Level 1|Physician Decision|0|||
147330841|NCT03354390|531376167|FG002|Level 1|Physician Decision|0|||
147330842|NCT03354390|531376168|FG003|Level 1|Physician Decision|0|||
147330843|NCT03354390|531376165|FG000|Level 2|Physician Decision|0|||
147330844|NCT03354390|531376166|FG001|Level 2|Physician Decision|2|||
147330845|NCT03354390|531376167|FG002|Level 2|Physician Decision|0|||
147330846|NCT03354390|531376168|FG003|Level 2|Physician Decision|0|||
147330847|NCT03354390|531376165|FG000|Level 2|Lack of Efficacy|0|||
147330848|NCT03354390|531376166|FG001|Level 2|Lack of Efficacy|1|||
147330849|NCT03354390|531376167|FG002|Level 2|Lack of Efficacy|0|||
147330850|NCT03354390|531376168|FG003|Level 2|Lack of Efficacy|0|||
147330851|NCT03354390|531376165|FG000|Level 2|Lost to Follow-up|0|||
147330852|NCT03354390|531376166|FG001|Level 2|Lost to Follow-up|1|||
147330853|NCT03354390|531376167|FG002|Level 2|Lost to Follow-up|0|||
147330854|NCT03354390|531376168|FG003|Level 2|Lost to Follow-up|0|||
147330855|NCT03354390|531376165|FG000|Level 3|Death|0|||
147330856|NCT03354390|531376166|FG001|Level 3|Death|0|||
147330857|NCT03354390|531376167|FG002|Level 3|Death|1|||
147330858|NCT03354390|531376168|FG003|Level 3|Death|0|||
147330859|NCT03354390|531376165|FG000|Level 3|Physician Decision|0|||
147330860|NCT03354390|531376166|FG001|Level 3|Physician Decision|0|||
147330861|NCT03354390|531376167|FG002|Level 3|Physician Decision|2|||
147330862|NCT03354390|531376168|FG003|Level 3|Physician Decision|0|||
147330863|NCT03354390|531376165|FG000|Level 4|Death|0|||
147330864|NCT03354390|531376166|FG001|Level 4|Death|0|||
147330865|NCT03354390|531376167|FG002|Level 4|Death|0|||
147330866|NCT03354390|531376168|FG003|Level 4|Death|3|||
147330867|NCT01185522|531377492|FG000|Overall Study|Lack of Efficacy|28|||
147330868|NCT01185522|531377492|FG000|Overall Study|Lost to Follow-up|19|||
147330869|NCT01185522|531377492|FG000|Overall Study|Withdrawal by Subject|10|||
147330870|NCT01185522|531377492|FG000|Overall Study|Poor tolerance|39|||
147330871|NCT01185522|531377492|FG000|Overall Study|Other reasons|12|||
147330872|NCT00954707|531377493|FG000|Overall Study|Death|34|||
147330873|NCT00954707|531377493|FG000|Overall Study|Withdrawal by Subject|100|||
147330874|NCT00954707|531377493|FG000|Overall Study|Lost to Follow-up|33|||
147330875|NCT02962674|531377494|FG000|Overall Study|Study terminated by sponsor prior to completion of all study protocol visits by enrolled subjects.|49|||
147330876|NCT00364286|531377496|FG000|Overall Study|Withdrawal by Subject|1|||
147330877|NCT00364286|531377496|FG000|Overall Study|Adverse Event|2|||
147330878|NCT00628862|531377497|FG000|Overall Study|Adverse Event|6|||
147330879|NCT00628862|531377498|FG001|Overall Study|Adverse Event|8|||
147330880|NCT00628862|531377499|FG002|Overall Study|Adverse Event|10|||
147330881|NCT00628862|531377497|FG000|Overall Study|Withdrawal by Subject|4|||
147330882|NCT00628862|531377498|FG001|Overall Study|Withdrawal by Subject|6|||
147330883|NCT00628862|531377499|FG002|Overall Study|Withdrawal by Subject|11|||
147330884|NCT00628862|531377497|FG000|Overall Study|Lost to Follow-up|0|||
147330885|NCT00628862|531377498|FG001|Overall Study|Lost to Follow-up|2|||
147449282|NCT03040999|531809461|FG000|Overall Study|Physician Decision|0|||
147449283|NCT03040999|531809462|FG001|Overall Study|Physician Decision|3|||
147449284|NCT01979523|531809463|FG000|Overall Study|Withdrawal by Subject|1|||
147330886|NCT00628862|531377499|FG002|Overall Study|Lost to Follow-up|1|||
147330887|NCT00628862|531377497|FG000|Overall Study|Protocol Violation|1|||
147449285|NCT01979523|531809464|FG001|Overall Study|Withdrawal by Subject|0|||
147449286|NCT01339559|531809465|FG000|Overall Study|Adverse Event|92|||
147449287|NCT01339559|531809465|FG000|Overall Study|Death|5|||
147330888|NCT00628862|531377498|FG001|Overall Study|Protocol Violation|0|||
147330889|NCT00628862|531377499|FG002|Overall Study|Protocol Violation|0|||
147330890|NCT00628862|531377497|FG000|Overall Study|COPD Exacerbation|0|||
147330891|NCT00628862|531377498|FG001|Overall Study|COPD Exacerbation|1|||
147330892|NCT00628862|531377499|FG002|Overall Study|COPD Exacerbation|0|||
147330893|NCT01227278|531377502|FG000|Overall Study|Withdrawal by Subject|4|||
147330894|NCT01227278|531377503|FG001|Overall Study|Withdrawal by Subject|4|||
147330895|NCT01227278|531377502|FG000|Overall Study|Death|0|||
147330896|NCT01227278|531377503|FG001|Overall Study|Death|2|||
147330897|NCT01227278|531377502|FG000|Overall Study|Other|1|||
147330898|NCT01227278|531377503|FG001|Overall Study|Other|2|||
147330899|NCT03546907|531377512|FG000|Overall Study|Lack of Efficacy|1|||
147330900|NCT03546907|531377513|FG001|Overall Study|Lack of Efficacy|1|||
147330901|NCT03546907|531377512|FG000|Overall Study|Withdrawal by Subject|8|||
147330902|NCT03546907|531377513|FG001|Overall Study|Withdrawal by Subject|9|||
147330903|NCT03546907|531377512|FG000|Overall Study|Adverse events (AEs)|7|||
147330904|NCT03546907|531377513|FG001|Overall Study|Adverse events (AEs)|10|||
147330905|NCT03546907|531377512|FG000|Overall Study|Other-unspecified|1|||
147330906|NCT03546907|531377513|FG001|Overall Study|Other-unspecified|1|||
147330907|NCT03720210|531377516|FG000|Overall Study|Lost to Follow-up|1|||
147449288|NCT01339559|531809465|FG000|Overall Study|Lack of Efficacy|164|||
147330908|NCT02174562|531377519|FG000|Overall Study|Withdrawal by Subject|7|||
147330909|NCT02174562|531377520|FG001|Overall Study|Withdrawal by Subject|2|||
147330910|NCT02174562|531377519|FG000|Overall Study|Death|2|||
147330911|NCT02174562|531377520|FG001|Overall Study|Death|0|||
147330912|NCT02174562|531377519|FG000|Overall Study|Lost to Follow-up|0|||
147330913|NCT02174562|531377520|FG001|Overall Study|Lost to Follow-up|3|||
147330914|NCT00798096|531377522|FG000|Overall Study|Ongoing|2|||
147449289|NCT01339559|531809465|FG000|Overall Study|Lost to Follow-up|22|||
147330915|NCT03670602|531377523|FG000|Overall Study|Lost to Follow-up|1|||
147330916|NCT03670602|531377524|FG001|Overall Study|Lost to Follow-up|0|||
147330917|NCT03670602|531377523|FG000|Overall Study|Withdrawal by Subject|0|||
147330918|NCT03670602|531377524|FG001|Overall Study|Withdrawal by Subject|3|||
147330919|NCT00864682|531377526|FG000|Overall Study|Protocol Violation|2|||
147330920|NCT00864682|531377527|FG001|Overall Study|Protocol Violation|1|||
147330921|NCT00864682|531377528|FG002|Overall Study|Protocol Violation|2|||
147594138|NCT03864042|532330603|FG000|DDI Phase|Adverse Event|2|||
147594139|NCT03864042|532330604|FG001|DDI Phase|Adverse Event|0|||
147594140|NCT03864042|532330605|FG002|DDI Phase|Adverse Event|0|||
147594141|NCT03864042|532330603|FG000|DDI Phase|Physician Decision|1|||
147594142|NCT03864042|532330604|FG001|DDI Phase|Physician Decision|0|||
147594143|NCT03864042|532330605|FG002|DDI Phase|Physician Decision|0|||
147594144|NCT03864042|532330603|FG000|DDI Phase|Progressive Disease|1|||
147594145|NCT03864042|532330604|FG001|DDI Phase|Progressive Disease|0|||
147594146|NCT03864042|532330605|FG002|DDI Phase|Progressive Disease|0|||
147594147|NCT03864042|532330603|FG000|Post-DDI Phase|Adverse Event|5|||
147594148|NCT03864042|532330604|FG001|Post-DDI Phase|Adverse Event|3|||
147594149|NCT03864042|532330605|FG002|Post-DDI Phase|Adverse Event|2|||
147594150|NCT03864042|532330603|FG000|Post-DDI Phase|Progressive Disease|11|||
147594151|NCT03864042|532330604|FG001|Post-DDI Phase|Progressive Disease|6|||
147594152|NCT03864042|532330605|FG002|Post-DDI Phase|Progressive Disease|13|||
147594153|NCT03864042|532330603|FG000|Post-DDI Phase|Discretion of investigator|1|||
147594154|NCT03864042|532330604|FG001|Post-DDI Phase|Discretion of investigator|1|||
147594155|NCT03864042|532330605|FG002|Post-DDI Phase|Discretion of investigator|0|||
147594156|NCT03864042|532330603|FG000|Post-DDI Phase|Study terminated by sponsor|7|||
147594157|NCT03864042|532330604|FG001|Post-DDI Phase|Study terminated by sponsor|0|||
147594158|NCT03864042|532330605|FG002|Post-DDI Phase|Study terminated by sponsor|0|||
147594159|NCT03864042|532330603|FG000|Post-DDI Phase|Withdrawal of consent|1|||
147594160|NCT03864042|532330604|FG001|Post-DDI Phase|Withdrawal of consent|2|||
147190699|NCT04158583|530864389|FG005|Overall Study|Clinical Progression|0|||
147190700|NCT04158583|530864390|FG006|Overall Study|Clinical Progression|2|||
147330922|NCT00957658|531377529|FG000|Overall Study|Death|1|||
147330923|NCT00957658|531377529|FG000|Overall Study|Lost to Follow-up|4|||
147330924|NCT00957658|531377529|FG000|Overall Study|Withdrawal by Subject|12|||
147190701|NCT04158583|530864391|FG007|Overall Study|Clinical Progression|0|||
147190702|NCT04158583|530864392|FG008|Overall Study|Clinical Progression|0|||
147190703|NCT04158583|530864393|FG009|Overall Study|Clinical Progression|0|||
147190704|NCT04158583|530864384|FG000|Overall Study|Clinical Deterioration|0|||
147190705|NCT04158583|530864385|FG001|Overall Study|Clinical Deterioration|0|||
147190706|NCT04158583|530864386|FG002|Overall Study|Clinical Deterioration|0|||
147190707|NCT04158583|530864387|FG003|Overall Study|Clinical Deterioration|1|||
147190708|NCT04158583|530864388|FG004|Overall Study|Clinical Deterioration|0|||
147190709|NCT04158583|530864389|FG005|Overall Study|Clinical Deterioration|0|||
147190710|NCT04158583|530864390|FG006|Overall Study|Clinical Deterioration|0|||
147190711|NCT04158583|530864391|FG007|Overall Study|Clinical Deterioration|0|||
147190712|NCT04158583|530864392|FG008|Overall Study|Clinical Deterioration|0|||
147190713|NCT04158583|530864393|FG009|Overall Study|Clinical Deterioration|1|||
147190714|NCT03409796|530865759|FG000|Overall Study|Adverse Event|2|||
147190715|NCT03409796|530865760|FG001|Overall Study|Adverse Event|0|||
147190716|NCT03409796|530865759|FG000|Overall Study|Other|0|||
147190717|NCT03409796|530865760|FG001|Overall Study|Other|1|||
147190718|NCT01453049|530865774|FG000|Overall Study|Protocol Violation|2|||
147190719|NCT01453049|530865775|FG001|Overall Study|Protocol Violation|5|||
147190720|NCT01453049|530865774|FG000|Overall Study|Lost to Follow-up|2|||
147190721|NCT01453049|530865775|FG001|Overall Study|Lost to Follow-up|1|||
147190722|NCT01453049|530865774|FG000|Overall Study|Withdrawn When Sponsor Terminated Study|35|||
147190723|NCT01453049|530865775|FG001|Overall Study|Withdrawn When Sponsor Terminated Study|36|||
147190724|NCT01453049|530865774|FG000|Overall Study|Withdrawal by Subject|1|||
147190725|NCT01453049|530865775|FG001|Overall Study|Withdrawal by Subject|0|||
147190726|NCT01453049|530865774|FG000|Overall Study|Randomized in Error|1|||
147190727|NCT01453049|530865775|FG001|Overall Study|Randomized in Error|0|||
147190728|NCT03287791|530865780|FG000|Overall Study|Insufficient Therapeutic Response|0|||
147190729|NCT03287791|530865781|FG001|Overall Study|Insufficient Therapeutic Response|0|||
147190730|NCT03287791|530865782|FG002|Overall Study|Insufficient Therapeutic Response|1|||
147190731|NCT03287791|530865780|FG000|Overall Study|Adverse Event|0|||
147190732|NCT03287791|530865781|FG001|Overall Study|Adverse Event|4|||
147190733|NCT03287791|530865782|FG002|Overall Study|Adverse Event|3|||
147330925|NCT00957658|531377529|FG000|Overall Study|Revision|1|||
147330926|NCT00957658|531377529|FG000|Overall Study|Incomplete 2 yr data|28|||
147330927|NCT00957658|531377529|FG000|Overall Study|Site termination|10|||
147330928|NCT00957658|531377529|FG000|Overall Study|unwilling/unable to return|2|||
147330929|NCT00957658|531377529|FG000|Overall Study|surgery cancelled|2|||
147330930|NCT00957658|531377529|FG000|Overall Study|Protocol Violation|5|||
147330931|NCT02469064|531377530|FG000|Overall Study|Request not to receive intervention.|1|||
147594161|NCT03864042|532330605|FG002|Post-DDI Phase|Withdrawal of consent|0|||
147190734|NCT03287791|530865780|FG000|Overall Study|Withdrawal by Subject|12|||
147190735|NCT03287791|530865781|FG001|Overall Study|Withdrawal by Subject|12|||
147190736|NCT03287791|530865782|FG002|Overall Study|Withdrawal by Subject|17|||
147190737|NCT03287791|530865780|FG000|Overall Study|Missed more than 6 consecutive doses|3|||
147330932|NCT02469064|531377531|FG001|Overall Study|Request not to receive intervention.|3|||
147594162|NCT01244061|532330606|FG000|Overall Study|Death|1|||
147594163|NCT01244061|532330607|FG001|Overall Study|Death|0|||
147594164|NCT01244061|532330606|FG000|Overall Study|Did not meet entrance criteria|1|||
147190738|NCT03287791|530865781|FG001|Overall Study|Missed more than 6 consecutive doses|2|||
147190739|NCT03287791|530865782|FG002|Overall Study|Missed more than 6 consecutive doses|2|||
147190740|NCT03287791|530865780|FG000|Overall Study|Lost to Follow-up|8|||
147658599|NCT03428100|532572312|FG001|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|2|||
147658600|NCT03428100|532572313|FG002|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|2|||
147658601|NCT03428100|532572314|FG003|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
147658602|NCT03428100|532572315|FG004|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
147658603|NCT03428100|532572316|FG005|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
147658604|NCT03428100|532572317|FG006|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
147658605|NCT03428100|532572318|FG007|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
147658606|NCT03428100|532572319|FG008|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
147658607|NCT03428100|532572320|FG009|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
147658608|NCT03428100|532572321|FG010|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
147658609|NCT03428100|532572322|FG011|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
147658610|NCT03428100|532572323|FG012|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
147190741|NCT03287791|530865781|FG001|Overall Study|Lost to Follow-up|14|||
147190742|NCT03287791|530865782|FG002|Overall Study|Lost to Follow-up|11|||
147190743|NCT03287791|530865780|FG000|Overall Study|Protocol Violation|7|||
147190744|NCT03287791|530865781|FG001|Overall Study|Protocol Violation|2|||
147190745|NCT03287791|530865782|FG002|Overall Study|Protocol Violation|1|||
147190746|NCT03287791|530865780|FG000|Overall Study|Participant was enrolled at 2 sites|1|||
147190747|NCT03287791|530865781|FG001|Overall Study|Participant was enrolled at 2 sites|0|||
147190748|NCT03287791|530865782|FG002|Overall Study|Participant was enrolled at 2 sites|1|||
147190749|NCT03287791|530865780|FG000|Overall Study|Too much time between 2 visits|0|||
147190750|NCT03287791|530865781|FG001|Overall Study|Too much time between 2 visits|1|||
147190751|NCT03287791|530865782|FG002|Overall Study|Too much time between 2 visits|0|||
147190752|NCT03287791|530865780|FG000|Overall Study|Non-compliance|0|||
147190753|NCT03287791|530865781|FG001|Overall Study|Non-compliance|1|||
147190754|NCT03287791|530865782|FG002|Overall Study|Non-compliance|0|||
147190755|NCT03287791|530865780|FG000|Overall Study|Did not meet inclusion criteria|1|||
147190756|NCT03287791|530865781|FG001|Overall Study|Did not meet inclusion criteria|0|||
147190757|NCT03287791|530865782|FG002|Overall Study|Did not meet inclusion criteria|0|||
147190758|NCT03095651|530865784|FG000|Overall Study|Lost to Follow-up|1|||
147190759|NCT03095651|530865785|FG001|Overall Study|Lost to Follow-up|1|||
147190760|NCT03095651|530865786|FG002|Overall Study|Lost to Follow-up|0|||
147190761|NCT03095651|530865787|FG003|Overall Study|Lost to Follow-up|1|||
147190762|NCT03095651|530865788|FG004|Overall Study|Lost to Follow-up|0|||
147190763|NCT03095651|530865789|FG005|Overall Study|Lost to Follow-up|0|||
147190764|NCT03095651|530865790|FG006|Overall Study|Lost to Follow-up|0|||
147190765|NCT03095651|530865791|FG007|Overall Study|Lost to Follow-up|0|||
147190766|NCT03095651|530865784|FG000|Overall Study|Withdrawal by Subject|0|||
147190767|NCT03095651|530865785|FG001|Overall Study|Withdrawal by Subject|0|||
147190768|NCT03095651|530865786|FG002|Overall Study|Withdrawal by Subject|0|||
147248379|NCT02547649|531078598|FG000|Overall Study|Withdrawal by Subject|0|||
147248380|NCT02547649|531078599|FG001|Overall Study|Withdrawal by Subject|4|||
147248381|NCT02547649|531078600|FG002|Overall Study|Withdrawal by Subject|2|||
147248382|NCT00171730|531078606|FG000|Overall Study|Adverse Event|3|||
147248383|NCT00171730|531078606|FG000|Overall Study|Abnormal Laboratory Value(s)|1|||
147248384|NCT00171730|531078606|FG000|Overall Study|Unsatisfactory Therapeutic Effect|8|||
147248385|NCT00171730|531078606|FG000|Overall Study|Withdrawal by Subject|3|||
147248386|NCT05025241|531078607|FG000|Screening|Failed Screening|5|||
147248387|NCT05025241|531078607|FG000|Treatment and Follow Up|Adverse Event|3|||
147248388|NCT02220205|531078608|FG000|Overall Study|Withdrawal by Subject|1|||
147248389|NCT02220205|531078609|FG001|Overall Study|Withdrawal by Subject|0|||
147248390|NCT03944954|531078610|FG000|Overall Study|Withdrawal by Subject|22|||
147248391|NCT03944954|531078611|FG001|Overall Study|Withdrawal by Subject|4|||
147248392|NCT03944954|531078610|FG000|Overall Study|Lost to Follow-up|18|||
147248393|NCT03944954|531078611|FG001|Overall Study|Lost to Follow-up|0|||
147248394|NCT03944954|531078610|FG000|Overall Study|Failed Medical Screening|7|||
147248395|NCT03944954|531078611|FG001|Overall Study|Failed Medical Screening|0|||
147248396|NCT02268084|531078614|FG000|Overall Study|Three subjects in the sham had early blind code opening due to symptomatic worsening.|0|||
147248397|NCT02268084|531078615|FG001|Overall Study|Three subjects in the sham had early blind code opening due to symptomatic worsening.|3|||
147248398|NCT02268084|531078614|FG000|Overall Study|Combination of the following, exact numbers not available: Lost to follow-up, voluntary withdrawal|9|||
147248399|NCT02268084|531078615|FG001|Overall Study|Combination of the following, exact numbers not available: Lost to follow-up, voluntary withdrawal|4|||
147248400|NCT05227027|531078616|FG000|Overall Study|Did not finish the onboarding process within the Smoke Free app prior to learning their allocation|10|||
147330933|NCT01585038|531377532|FG000|Overall Study|Adverse Event|2|||
147190769|NCT03095651|530865787|FG003|Overall Study|Withdrawal by Subject|0|||
147190770|NCT03095651|530865788|FG004|Overall Study|Withdrawal by Subject|0|||
147190771|NCT03095651|530865789|FG005|Overall Study|Withdrawal by Subject|1|||
147190772|NCT03095651|530865790|FG006|Overall Study|Withdrawal by Subject|0|||
147330934|NCT01585038|531377533|FG001|Overall Study|Adverse Event|2|||
147330935|NCT02046616|531377534|FG000|24-Week Treatment Period|Anaphylaxis/Serious Hypersensitivity|1|||
147330936|NCT02046616|531377534|FG000|24-Week Treatment Period|Any Other Adverse Event|13|||
147330937|NCT02046616|531377534|FG000|24-Week Treatment Period|Insufficient Therapeutic Response|1|||
147330938|NCT02046616|531377534|FG000|24-Week Treatment Period|Physician Decision|3|||
147330939|NCT02046616|531377534|FG000|24-Week Treatment Period|Other|1|||
147330940|NCT02046616|531377534|FG000|8-Week FU Period|Lost to Follow-up|1|||
147330941|NCT01833832|531377537|FG000|Overall Study|Pt could not be cytoreduced for HIPEC|1|||
147330942|NCT00130637|531377538|FG000|Overall Study|Adverse Event|2|||
147330943|NCT00130637|531377538|FG000|Overall Study|Withdrawal by Subject|1|||
147330944|NCT01591616|531377540|FG000|Overall Study|Withdrawal by Subject|1|||
147330945|NCT01959412|531377541|FG000|Overall Study|Protocol deviation|1|||
147330946|NCT01959412|531377542|FG001|Overall Study|Protocol deviation|1|||
147330947|NCT01959412|531377543|FG002|Overall Study|Protocol deviation|0|||
147330948|NCT01959412|531377544|FG003|Overall Study|Protocol deviation|1|||
147330949|NCT01959412|531377545|FG004|Overall Study|Protocol deviation|3|||
147330950|NCT01959412|531377546|FG005|Overall Study|Protocol deviation|0|||
147330951|NCT01959412|531377541|FG000|Overall Study|Adverse Event|0|||
147330952|NCT01959412|531377542|FG001|Overall Study|Adverse Event|0|||
147330953|NCT01959412|531377543|FG002|Overall Study|Adverse Event|0|||
147330954|NCT01959412|531377544|FG003|Overall Study|Adverse Event|1|||
147330955|NCT01959412|531377545|FG004|Overall Study|Adverse Event|0|||
147330956|NCT01959412|531377546|FG005|Overall Study|Adverse Event|0|||
147330957|NCT00158054|531377547|FG000|Overall Study|Refused to continue|3|||
147330958|NCT00158054|531377548|FG001|Overall Study|Refused to continue|0|||
147330959|NCT00158054|531377547|FG000|Overall Study|Unavailable for follow up|7|||
147330960|NCT00158054|531377548|FG001|Overall Study|Unavailable for follow up|3|||
147330961|NCT04567888|531377553|FG000|Overall Study|Did Not Create Happify for Teens Account|22|||
147330962|NCT04567888|531377554|FG001|Overall Study|Did Not Create Happify for Teens Account|0|||
147330963|NCT04567888|531377553|FG000|Overall Study|Did Not Complete Any Happify for Teens Activities|22|||
147594165|NCT01244061|532330607|FG001|Overall Study|Did not meet entrance criteria|0|||
147594166|NCT01244061|532330606|FG000|Overall Study|Lack of Efficacy|1|||
147594167|NCT01244061|532330607|FG001|Overall Study|Lack of Efficacy|3|||
147594168|NCT01244061|532330606|FG000|Overall Study|Lost to Follow-up|34|||
147594169|NCT01244061|532330607|FG001|Overall Study|Lost to Follow-up|30|||
147594170|NCT01244061|532330606|FG000|Overall Study|Withdrawal by Subject|29|||
147594171|NCT01244061|532330607|FG001|Overall Study|Withdrawal by Subject|46|||
147594172|NCT01244061|532330606|FG000|Overall Study|Other|8|||
147594173|NCT01244061|532330607|FG001|Overall Study|Other|19|||
147330964|NCT04567888|531377554|FG001|Overall Study|Did Not Complete Any Happify for Teens Activities|0|||
147330965|NCT04567888|531377553|FG000|Overall Study|Reported Unusual Birth Year|2|||
147330966|NCT04567888|531377554|FG001|Overall Study|Reported Unusual Birth Year|3|||
147330967|NCT04567888|531377553|FG000|Overall Study|Duplicate Responses|0|||
147330968|NCT04567888|531377554|FG001|Overall Study|Duplicate Responses|1|||
147330969|NCT00414648|531377555|FG000|Overall Study|Adverse Event|5|||
147330970|NCT00414648|531377556|FG001|Overall Study|Adverse Event|5|||
147330971|NCT00414648|531377555|FG000|Overall Study|Death|0|||
147330972|NCT00414648|531377556|FG001|Overall Study|Death|1|||
147330973|NCT00414648|531377555|FG000|Overall Study|Lack of Efficacy|0|||
147330974|NCT00414648|531377556|FG001|Overall Study|Lack of Efficacy|2|||
147330975|NCT00414648|531377555|FG000|Overall Study|Withdrawal by Subject|0|||
147594174|NCT01244061|532330606|FG000|Overall Study|Protocol Violation|1|||
147594175|NCT01244061|532330607|FG001|Overall Study|Protocol Violation|1|||
147594176|NCT01244061|532330606|FG000|Overall Study|Adverse Event|5|||
147594177|NCT01244061|532330607|FG001|Overall Study|Adverse Event|2|||
147594178|NCT01244061|532330606|FG000|Overall Study|Randomized but not treated|2|||
147594179|NCT01244061|532330607|FG001|Overall Study|Randomized but not treated|2|||
147594180|NCT02143583|532330608|FG000|Overall Study|Withdrawal by Subject|1|||
147594181|NCT02143583|532330609|FG001|Overall Study|Withdrawal by Subject|0|||
147594182|NCT02143583|532330610|FG002|Overall Study|Withdrawal by Subject|1|||
147594183|NCT02143583|532330608|FG000|Overall Study|husband illness|0|||
147594184|NCT02143583|532330609|FG001|Overall Study|husband illness|0|||
147594185|NCT02143583|532330610|FG002|Overall Study|husband illness|1|||
147594186|NCT01641133|532330611|FG000|Overall Study|Protocol Violation|0|||
147594187|NCT01641133|532330612|FG001|Overall Study|Protocol Violation|1|||
147594188|NCT01641133|532330613|FG002|Overall Study|Protocol Violation|1|||
147594189|NCT01641133|532330611|FG000|Overall Study|Migrated/moved from study area|5|||
147594190|NCT01641133|532330612|FG001|Overall Study|Migrated/moved from study area|3|||
147594191|NCT01641133|532330613|FG002|Overall Study|Migrated/moved from study area|1|||
147594192|NCT01641133|532330611|FG000|Overall Study|Adverse Event|0|||
147594193|NCT01641133|532330612|FG001|Overall Study|Adverse Event|0|||
147594194|NCT01641133|532330613|FG002|Overall Study|Adverse Event|1|||
147594195|NCT01641133|532330611|FG000|Overall Study|Withdrawal by Subject|5|||
147594196|NCT01641133|532330612|FG001|Overall Study|Withdrawal by Subject|3|||
147594197|NCT01641133|532330613|FG002|Overall Study|Withdrawal by Subject|3|||
147594198|NCT01641133|532330611|FG000|Overall Study|Lost to Follow-up|0|||
147594199|NCT01641133|532330612|FG001|Overall Study|Lost to Follow-up|2|||
147330976|NCT00414648|531377556|FG001|Overall Study|Withdrawal by Subject|1|||
147330977|NCT01194258|531377557|FG000|Titration Period|Withdrawal by Subject|6|||
147330978|NCT01194258|531377558|FG001|Titration Period|Withdrawal by Subject|0|||
147330979|NCT01194258|531377559|FG002|Titration Period|Withdrawal by Subject|0|||
147330980|NCT01194258|531377560|FG003|Titration Period|Withdrawal by Subject|0|||
147330981|NCT01194258|531377561|FG004|Titration Period|Withdrawal by Subject|0|||
147330982|NCT01194258|531377557|FG000|Titration Period|Lost to Follow-up|2|||
147330983|NCT01194258|531377558|FG001|Titration Period|Lost to Follow-up|0|||
147330984|NCT01194258|531377559|FG002|Titration Period|Lost to Follow-up|0|||
147330985|NCT01194258|531377560|FG003|Titration Period|Lost to Follow-up|0|||
147594200|NCT01641133|532330613|FG002|Overall Study|Lost to Follow-up|2|||
147594201|NCT03351231|532330616|FG000|Combination Therapy Period|Administrative reason by the Sponsor|1|||
147594202|NCT03351231|532330616|FG000|Combination Therapy Period|Disease progression|2|||
147594203|NCT03351231|532330616|FG000|Combination Therapy Period|Study drug toxicity|1|||
147594204|NCT03351231|532330616|FG000|Combination Therapy Period|Adverse Event unrelated to study drug|1|||
147330986|NCT01194258|531377561|FG004|Titration Period|Lost to Follow-up|0|||
147330987|NCT01194258|531377557|FG000|Titration Period|Titration failure|3|||
147330988|NCT01194258|531377558|FG001|Titration Period|Titration failure|0|||
147330989|NCT01194258|531377559|FG002|Titration Period|Titration failure|0|||
147330990|NCT01194258|531377560|FG003|Titration Period|Titration failure|0|||
147330991|NCT01194258|531377561|FG004|Titration Period|Titration failure|0|||
147330992|NCT01194258|531377557|FG000|Period 1 (12 Weeks)|Death|0|||
147594205|NCT03351231|532330616|FG000|Safety Follow-Up Period|Participant withdrew consent|1|||
147594206|NCT03351231|532330616|FG000|Safety Follow-Up Period|Other reason|2|||
147594207|NCT03499119|532330619|FG000|Initial Treatment Phase|Protocol Specified Criteria|0|||
147594208|NCT03499119|532330620|FG001|Initial Treatment Phase|Protocol Specified Criteria|0|||
147594209|NCT03499119|532330621|FG002|Initial Treatment Phase|Protocol Specified Criteria|0|||
147594210|NCT03499119|532330622|FG003|Initial Treatment Phase|Protocol Specified Criteria|1|||
147594211|NCT03499119|532330619|FG000|Initial Treatment Phase|Withdrawal by Subject|0|||
147594212|NCT03499119|532330620|FG001|Initial Treatment Phase|Withdrawal by Subject|0|||
147594213|NCT03499119|532330621|FG002|Initial Treatment Phase|Withdrawal by Subject|0|||
147594214|NCT03499119|532330622|FG003|Initial Treatment Phase|Withdrawal by Subject|1|||
147594215|NCT03499119|532330619|FG000|Initial Treatment Phase|Decision by Sponsor|1|||
147594216|NCT03499119|532330620|FG001|Initial Treatment Phase|Decision by Sponsor|0|||
147594217|NCT03499119|532330621|FG002|Initial Treatment Phase|Decision by Sponsor|1|||
147594218|NCT03499119|532330622|FG003|Initial Treatment Phase|Decision by Sponsor|1|||
147594219|NCT03499119|532330619|FG000|Optional Extension Phase|Lost to Follow-up|0|||
147594220|NCT03499119|532330620|FG001|Optional Extension Phase|Lost to Follow-up|0|||
147594221|NCT03499119|532330621|FG002|Optional Extension Phase|Lost to Follow-up|0|||
147594222|NCT03499119|532330622|FG003|Optional Extension Phase|Lost to Follow-up|1|||
147594223|NCT03499119|532330619|FG000|Optional Extension Phase|Withdrawal by Subject|0|||
147594224|NCT03499119|532330620|FG001|Optional Extension Phase|Withdrawal by Subject|0|||
147594225|NCT03499119|532330621|FG002|Optional Extension Phase|Withdrawal by Subject|0|||
147594226|NCT03499119|532330622|FG003|Optional Extension Phase|Withdrawal by Subject|5|||
147594227|NCT03499119|532330619|FG000|Optional Extension Phase|Protocol Specified Criteria|0|||
147594228|NCT03499119|532330620|FG001|Optional Extension Phase|Protocol Specified Criteria|1|||
147594229|NCT03499119|532330621|FG002|Optional Extension Phase|Protocol Specified Criteria|0|||
147594230|NCT03499119|532330622|FG003|Optional Extension Phase|Protocol Specified Criteria|0|||
147594231|NCT02333487|532330623|FG000|Overall Study|Adverse Event|0|||
147594232|NCT02333487|532330624|FG001|Overall Study|Adverse Event|2|||
147594233|NCT02333487|532330625|FG002|Overall Study|Adverse Event|0|||
147594234|NCT00123955|532330626|FG000|Overall Study|Adverse Event|1|||
147594235|NCT00123955|532330627|FG001|Overall Study|Adverse Event|0|||
147594236|NCT00123955|532330626|FG000|Overall Study|Withdrawal by Subject|4|||
147594237|NCT00123955|532330627|FG001|Overall Study|Withdrawal by Subject|3|||
147594238|NCT00123955|532330626|FG000|Overall Study|Death|0|||
147594239|NCT00123955|532330627|FG001|Overall Study|Death|1|||
147594240|NCT01558297|532330628|FG000|Overall Study|Withdrawal by Subject|2|||
147594241|NCT01558297|532330629|FG001|Overall Study|Withdrawal by Subject|2|||
147594242|NCT01558297|532330630|FG002|Overall Study|Withdrawal by Subject|1|||
147594243|NCT01408563|532332393|FG000|Overall Study|Ineligible after consent/ registration|2|||
147594244|NCT02246439|532332395|FG000|Overall Study|Adverse Event|3|||
147594245|NCT02246439|532332396|FG001|Overall Study|Adverse Event|0|||
147594246|NCT02246439|532332395|FG000|Overall Study|Lost to Follow-up|7|||
147594247|NCT02246439|532332396|FG001|Overall Study|Lost to Follow-up|5|||
147594248|NCT02246439|532332395|FG000|Overall Study|Protocol Violation|0|||
147594249|NCT02246439|532332396|FG001|Overall Study|Protocol Violation|2|||
147594250|NCT02246439|532332395|FG000|Overall Study|Physician Decision|0|||
147594251|NCT02246439|532332396|FG001|Overall Study|Physician Decision|1|||
147594252|NCT02246439|532332395|FG000|Overall Study|Unkonwn|1|||
147330993|NCT01194258|531377558|FG001|Period 1 (12 Weeks)|Death|0|||
147330994|NCT01194258|531377559|FG002|Period 1 (12 Weeks)|Death|0|||
147330995|NCT01194258|531377560|FG003|Period 1 (12 Weeks)|Death|0|||
147330996|NCT01194258|531377561|FG004|Period 1 (12 Weeks)|Death|1|||
147594253|NCT02246439|532332396|FG001|Overall Study|Unkonwn|3|||
147594254|NCT02246439|532332395|FG000|Overall Study|Withdrawal by Subject|1|||
147594255|NCT02246439|532332396|FG001|Overall Study|Withdrawal by Subject|0|||
147594256|NCT03439852|532332397|FG000|Baseline to 12 Weeks|Failed complete 12 wk survey|4|||
147594257|NCT03439852|532332398|FG001|Baseline to 12 Weeks|Failed complete 12 wk survey|7|||
147594258|NCT03439852|532332397|FG000|12weeks to 24weeks|failed complete 12 or 24 wk surveys|2|||
147594259|NCT03439852|532332398|FG001|12weeks to 24weeks|failed complete 12 or 24 wk surveys|0|||
147594260|NCT03439852|532332397|FG000|24 Weeks to 36 Weeks Follow up|failed to complete 36 wk survey|1|||
147594261|NCT03439852|532332398|FG001|24 Weeks to 36 Weeks Follow up|failed to complete 36 wk survey|0|||
147594262|NCT02177136|532332403|FG000|DB Phase|Withdrawal by Subject|2|||
147594263|NCT02177136|532332404|FG001|DB Phase|Withdrawal by Subject|0|||
147594264|NCT02177136|532332405|FG002|DB Phase|Withdrawal by Subject|0|||
147594265|NCT02177136|532332406|FG003|DB Phase|Withdrawal by Subject|0|||
147594266|NCT02177136|532332403|FG000|DB Phase|Discontinued Due to Pruritus|1|||
147594267|NCT02177136|532332404|FG001|DB Phase|Discontinued Due to Pruritus|3|||
147594268|NCT02177136|532332405|FG002|DB Phase|Discontinued Due to Pruritus|0|||
147594269|NCT02177136|532332406|FG003|DB Phase|Discontinued Due to Pruritus|0|||
147594270|NCT02177136|532332403|FG000|DB Phase|Adverse Event|3|||
147594271|NCT02177136|532332404|FG001|DB Phase|Adverse Event|2|||
147594272|NCT02177136|532332405|FG002|DB Phase|Adverse Event|3|||
147594273|NCT02177136|532332406|FG003|DB Phase|Adverse Event|0|||
147658611|NCT03428100|532572324|FG013|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
147658612|NCT03428100|532572325|FG014|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
147658613|NCT03428100|532572326|FG015|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
147658614|NCT03428100|532572327|FG016|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
147658615|NCT03428100|532572328|FG017|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
147658616|NCT03428100|532572329|FG018|Double-Blind Treatment Week 0 to Week 52|Protocol Deviation|0|||
147658617|NCT03428100|532572311|FG000|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|4|||
147658618|NCT03428100|532572312|FG001|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
147658619|NCT03428100|532572313|FG002|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
147658620|NCT03428100|532572314|FG003|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
147658621|NCT03428100|532572315|FG004|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
147658622|NCT03428100|532572316|FG005|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
147658623|NCT03428100|532572317|FG006|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
147658624|NCT03428100|532572318|FG007|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
147658625|NCT03428100|532572319|FG008|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
147658626|NCT03428100|532572320|FG009|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
147658627|NCT03428100|532572321|FG010|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
147658628|NCT03428100|532572322|FG011|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
147658629|NCT03428100|532572323|FG012|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
147658630|NCT03428100|532572324|FG013|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
147658631|NCT03428100|532572325|FG014|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
147658632|NCT03428100|532572326|FG015|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
147658633|NCT03428100|532572327|FG016|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
147658634|NCT03428100|532572328|FG017|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
147658635|NCT03428100|532572329|FG018|Double-Blind Treatment Week 0 to Week 52|Withdrawal by Subject|0|||
147658636|NCT03428100|532572311|FG000|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
147658637|NCT03428100|532572312|FG001|Double-Blind Treatment Week 0 to Week 52|Physician Decision|1|||
147658638|NCT03428100|532572313|FG002|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
147658639|NCT03428100|532572314|FG003|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
147658640|NCT03428100|532572315|FG004|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
147658641|NCT03428100|532572316|FG005|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
147594274|NCT02177136|532332403|FG000|DB Phase|Protocol Violation|0|||
147594275|NCT02177136|532332404|FG001|DB Phase|Protocol Violation|0|||
147594276|NCT02177136|532332405|FG002|DB Phase|Protocol Violation|1|||
147658642|NCT03428100|532572317|FG006|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
147658643|NCT03428100|532572318|FG007|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
147658644|NCT03428100|532572319|FG008|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
147658645|NCT03428100|532572320|FG009|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
147658646|NCT03428100|532572321|FG010|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
147190773|NCT03095651|530865791|FG007|Overall Study|Withdrawal by Subject|0|||
147190774|NCT02210000|530865792|FG000|Overall Study|Study Terminated|11|||
147190775|NCT02210000|530865793|FG001|Overall Study|Study Terminated|12|||
147190776|NCT02210000|530865792|FG000|Overall Study|Withdrawal by Subject|7|||
147594277|NCT02177136|532332406|FG003|DB Phase|Protocol Violation|0|||
147594278|NCT02177136|532332403|FG000|DB Phase|Withdrew Consent Prior to Dosing|1|||
147594279|NCT02177136|532332404|FG001|DB Phase|Withdrew Consent Prior to Dosing|0|||
147658647|NCT03428100|532572322|FG011|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
147658648|NCT03428100|532572323|FG012|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
147658649|NCT03428100|532572324|FG013|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
147658650|NCT03428100|532572325|FG014|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
147658651|NCT03428100|532572326|FG015|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
147658652|NCT03428100|532572327|FG016|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
147658653|NCT03428100|532572328|FG017|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
147658654|NCT03428100|532572329|FG018|Double-Blind Treatment Week 0 to Week 52|Physician Decision|0|||
147658655|NCT03428100|532572311|FG000|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
147658656|NCT03428100|532572312|FG001|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
147658657|NCT03428100|532572313|FG002|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
147658658|NCT03428100|532572314|FG003|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
147658659|NCT03428100|532572315|FG004|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
147658660|NCT03428100|532572316|FG005|Long-Term Extension Week 52 to Week 200|Adverse Event|4|||
147658661|NCT03428100|532572317|FG006|Long-Term Extension Week 52 to Week 200|Adverse Event|1|||
147658662|NCT03428100|532572318|FG007|Long-Term Extension Week 52 to Week 200|Adverse Event|2|||
147658663|NCT03428100|532572319|FG008|Long-Term Extension Week 52 to Week 200|Adverse Event|1|||
147658664|NCT03428100|532572320|FG009|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
147658665|NCT03428100|532572321|FG010|Long-Term Extension Week 52 to Week 200|Adverse Event|1|||
147658666|NCT03428100|532572322|FG011|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
147658667|NCT03428100|532572323|FG012|Long-Term Extension Week 52 to Week 200|Adverse Event|3|||
147658668|NCT03428100|532572324|FG013|Long-Term Extension Week 52 to Week 200|Adverse Event|1|||
147658669|NCT03428100|532572325|FG014|Long-Term Extension Week 52 to Week 200|Adverse Event|1|||
147658670|NCT03428100|532572326|FG015|Long-Term Extension Week 52 to Week 200|Adverse Event|1|||
147658671|NCT03428100|532572327|FG016|Long-Term Extension Week 52 to Week 200|Adverse Event|2|||
147658672|NCT03428100|532572328|FG017|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
147658673|NCT03428100|532572329|FG018|Long-Term Extension Week 52 to Week 200|Adverse Event|0|||
147190777|NCT02210000|530865793|FG001|Overall Study|Withdrawal by Subject|1|||
147190778|NCT02210000|530865792|FG000|Overall Study|Adverse Event|1|||
147249873|NCT01018186|531083793|FG000|52-week Double-blind Treatment Period|Lack of Efficacy|0|||
147658674|NCT03428100|532572311|FG000|Long-Term Extension Week 52 to Week 200|Death|0|||
147658675|NCT03428100|532572312|FG001|Long-Term Extension Week 52 to Week 200|Death|0|||
147658676|NCT03428100|532572313|FG002|Long-Term Extension Week 52 to Week 200|Death|0|||
147190779|NCT02210000|530865793|FG001|Overall Study|Adverse Event|5|||
147190780|NCT02210000|530865792|FG000|Overall Study|Lost to Follow-up|0|||
147190781|NCT02210000|530865793|FG001|Overall Study|Lost to Follow-up|2|||
147190782|NCT02210000|530865792|FG000|Overall Study|Physician Decision|0|||
147190783|NCT02210000|530865793|FG001|Overall Study|Physician Decision|1|||
147190784|NCT03585660|530865794|FG000|Overall Study|operator error|1|||
147190785|NCT03585660|530865794|FG000|Overall Study|technical error|2|||
147190786|NCT03585660|530865794|FG000|Overall Study|hip prosthesis|2|||
147190787|NCT03585660|530865794|FG000|Overall Study|did not undergo biopsy|8|||
147190788|NCT03585660|530865794|FG000|Overall Study|scanner problem|2|||
147190789|NCT05635461|530865795|FG000|Period 2: Dosing 2 (Day 1)|Lost to Follow-up|0|||
147190790|NCT05635461|530865796|FG001|Period 2: Dosing 2 (Day 1)|Lost to Follow-up|0|||
147190791|NCT05635461|530865797|FG002|Period 2: Dosing 2 (Day 1)|Lost to Follow-up|0|||
147190792|NCT05635461|530865798|FG003|Period 2: Dosing 2 (Day 1)|Lost to Follow-up|0|||
147190793|NCT05635461|530865799|FG004|Period 2: Dosing 2 (Day 1)|Lost to Follow-up|1|||
147190794|NCT05635461|530865800|FG005|Period 2: Dosing 2 (Day 1)|Lost to Follow-up|0|||
147190795|NCT05635461|530865795|FG000|Period 3: Dosing 3 (Day 1)|Failed Check-In Laboratory|0|||
147190796|NCT05635461|530865796|FG001|Period 3: Dosing 3 (Day 1)|Failed Check-In Laboratory|1|||
147190797|NCT05635461|530865797|FG002|Period 3: Dosing 3 (Day 1)|Failed Check-In Laboratory|0|||
147190798|NCT05635461|530865798|FG003|Period 3: Dosing 3 (Day 1)|Failed Check-In Laboratory|0|||
147190799|NCT05635461|530865799|FG004|Period 3: Dosing 3 (Day 1)|Failed Check-In Laboratory|0|||
147190800|NCT05635461|530865800|FG005|Period 3: Dosing 3 (Day 1)|Failed Check-In Laboratory|0|||
147190801|NCT05635461|530865795|FG000|Period 3: Dosing 3 (Day 1)|Adverse Event|0|||
147190802|NCT05635461|530865796|FG001|Period 3: Dosing 3 (Day 1)|Adverse Event|0|||
147190803|NCT05635461|530865797|FG002|Period 3: Dosing 3 (Day 1)|Adverse Event|0|||
147190804|NCT05635461|530865798|FG003|Period 3: Dosing 3 (Day 1)|Adverse Event|1|||
147190805|NCT05635461|530865799|FG004|Period 3: Dosing 3 (Day 1)|Adverse Event|0|||
147190806|NCT05635461|530865800|FG005|Period 3: Dosing 3 (Day 1)|Adverse Event|0|||
147190807|NCT01620060|530865802|FG000|Overall Study|Adverse Event|9|||
147190808|NCT01620060|530865802|FG000|Overall Study|Protocol Violation|1|||
147190809|NCT01620060|530865802|FG000|Overall Study|Withdrawal by Subject|1|||
147190810|NCT01620060|530865802|FG000|Overall Study|Did not comply with Study Produre|1|||
147190811|NCT01620060|530865802|FG000|Overall Study|Family emergency|1|||
147190812|NCT01620060|530865802|FG000|Overall Study|Per Sponsor Decision|2|||
147190813|NCT02269124|530865803|FG000|Overall Study|Lost to Follow-up|1|||
147190814|NCT02269124|530865804|FG001|Overall Study|Lost to Follow-up|0|||
147190815|NCT02269124|530865803|FG000|Overall Study|Withdrawal by Subject|0|||
147594280|NCT02177136|532332405|FG002|DB Phase|Withdrew Consent Prior to Dosing|0|||
147594281|NCT02177136|532332406|FG003|DB Phase|Withdrew Consent Prior to Dosing|0|||
147594282|NCT02177136|532332403|FG000|LTSE Phase|Withdrawal by Subject|0|||
147594283|NCT02177136|532332404|FG001|LTSE Phase|Withdrawal by Subject|0|||
147594284|NCT02177136|532332405|FG002|LTSE Phase|Withdrawal by Subject|0|||
147594285|NCT02177136|532332406|FG003|LTSE Phase|Withdrawal by Subject|6|||
147594286|NCT02177136|532332403|FG000|LTSE Phase|Adverse Event|0|||
147658677|NCT03428100|532572314|FG003|Long-Term Extension Week 52 to Week 200|Death|0|||
147658678|NCT03428100|532572315|FG004|Long-Term Extension Week 52 to Week 200|Death|0|||
147658679|NCT03428100|532572316|FG005|Long-Term Extension Week 52 to Week 200|Death|0|||
147658680|NCT03428100|532572317|FG006|Long-Term Extension Week 52 to Week 200|Death|0|||
147658681|NCT03428100|532572318|FG007|Long-Term Extension Week 52 to Week 200|Death|1|||
147658682|NCT03428100|532572319|FG008|Long-Term Extension Week 52 to Week 200|Death|0|||
147658683|NCT03428100|532572320|FG009|Long-Term Extension Week 52 to Week 200|Death|0|||
147658684|NCT03428100|532572321|FG010|Long-Term Extension Week 52 to Week 200|Death|0|||
147658685|NCT03428100|532572322|FG011|Long-Term Extension Week 52 to Week 200|Death|0|||
147658686|NCT03428100|532572323|FG012|Long-Term Extension Week 52 to Week 200|Death|0|||
147658687|NCT03428100|532572324|FG013|Long-Term Extension Week 52 to Week 200|Death|0|||
147658688|NCT03428100|532572325|FG014|Long-Term Extension Week 52 to Week 200|Death|0|||
147658689|NCT03428100|532572326|FG015|Long-Term Extension Week 52 to Week 200|Death|0|||
147658690|NCT03428100|532572327|FG016|Long-Term Extension Week 52 to Week 200|Death|0|||
147658691|NCT03428100|532572328|FG017|Long-Term Extension Week 52 to Week 200|Death|0|||
147658692|NCT03428100|532572329|FG018|Long-Term Extension Week 52 to Week 200|Death|0|||
147658693|NCT03428100|532572311|FG000|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|0|||
147190816|NCT02269124|530865804|FG001|Overall Study|Withdrawal by Subject|2|||
147190817|NCT00614575|530865806|FG000|Overall Study|Adverse Event|106|||
147190818|NCT00614575|530865806|FG000|Overall Study|Lost to Follow-up|55|||
147190819|NCT00614575|530865806|FG000|Overall Study|Lack of Efficacy|14|||
147190820|NCT00614575|530865806|FG000|Overall Study|Withdrawal by Subject|6|||
147190821|NCT00614575|530865806|FG000|Overall Study|Death|3|||
147190822|NCT00614575|530865806|FG000|Overall Study|Physician Decision|2|||
147190823|NCT00614575|530865806|FG000|Overall Study|No data were collected.|18|||
147190824|NCT00614575|530865806|FG000|Overall Study|Irregularly enrolled patients|23|||
147190825|NCT00614575|530865806|FG000|Overall Study|No treatment|1|||
147190826|NCT03452540|530865807|FG000|Overall Study|Adverse Event|1|||
147190827|NCT03452540|530865807|FG000|Overall Study|Withdrawal by Subject|1|||
147190828|NCT03452540|530865807|FG000|Overall Study|Other SAE and AE|2|||
147190829|NCT01582061|530865808|FG000|Overall Study|Lack of Efficacy|3|||
147190830|NCT01582061|530865809|FG001|Overall Study|Lack of Efficacy|23|||
147190831|NCT01582061|530865808|FG000|Overall Study|Adverse Event|12|||
147190832|NCT01582061|530865809|FG001|Overall Study|Adverse Event|8|||
147190833|NCT01582061|530865808|FG000|Overall Study|Withdrawal by Subject|10|||
147190834|NCT01582061|530865809|FG001|Overall Study|Withdrawal by Subject|4|||
147190835|NCT01582061|530865808|FG000|Overall Study|Abnormal laboratory value(s)|1|||
147190836|NCT01582061|530865809|FG001|Overall Study|Abnormal laboratory value(s)|0|||
147190837|NCT01582061|530865808|FG000|Overall Study|Death|0|||
147190838|NCT01582061|530865809|FG001|Overall Study|Death|1|||
147190839|NCT01582061|530865808|FG000|Overall Study|condition no longer requires study drug|1|||
147190840|NCT01582061|530865809|FG001|Overall Study|condition no longer requires study drug|0|||
147190841|NCT01582061|530865808|FG000|Overall Study|Lost to Follow-up|1|||
147190842|NCT01582061|530865809|FG001|Overall Study|Lost to Follow-up|0|||
147190843|NCT01045460|530865812|FG000|Overall Study|Physician Decision|3|||
147190844|NCT01045460|530865813|FG001|Overall Study|Physician Decision|2|||
147190845|NCT01045460|530865812|FG000|Overall Study|Lost to Follow-up|0|||
147190846|NCT01045460|530865813|FG001|Overall Study|Lost to Follow-up|1|||
147190847|NCT01045460|530865812|FG000|Overall Study|Lack of Efficacy|3|||
147190848|NCT01045460|530865813|FG001|Overall Study|Lack of Efficacy|0|||
147190849|NCT04664153|530865814|FG000|Overall Study|Lack of Efficacy|0|||
147248401|NCT05227027|531078617|FG001|Overall Study|Did not finish the onboarding process within the Smoke Free app prior to learning their allocation|11|||
147248402|NCT00855920|531078622|FG000|Overall Study|Protocol Violation|0|||
147248403|NCT00855920|531078623|FG001|Overall Study|Protocol Violation|0|||
147248404|NCT00855920|531078624|FG002|Overall Study|Protocol Violation|2|||
147248405|NCT00855920|531078622|FG000|Overall Study|Adverse Event|2|||
147248406|NCT00855920|531078623|FG001|Overall Study|Adverse Event|1|||
147248407|NCT00855920|531078624|FG002|Overall Study|Adverse Event|1|||
147248408|NCT00855920|531078622|FG000|Overall Study|Lack of Efficacy|2|||
147248409|NCT00855920|531078623|FG001|Overall Study|Lack of Efficacy|2|||
147248410|NCT00855920|531078624|FG002|Overall Study|Lack of Efficacy|2|||
147248411|NCT00855920|531078622|FG000|Overall Study|Withdrawal by Subject|2|||
147248412|NCT00855920|531078623|FG001|Overall Study|Withdrawal by Subject|3|||
147248413|NCT00855920|531078624|FG002|Overall Study|Withdrawal by Subject|2|||
147248414|NCT00855920|531078622|FG000|Overall Study|Lost to Follow-up|1|||
147248415|NCT00855920|531078623|FG001|Overall Study|Lost to Follow-up|0|||
147248416|NCT00855920|531078624|FG002|Overall Study|Lost to Follow-up|2|||
147594287|NCT02177136|532332404|FG001|LTSE Phase|Adverse Event|0|||
147594288|NCT02177136|532332405|FG002|LTSE Phase|Adverse Event|0|||
147658694|NCT03428100|532572312|FG001|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|0|||
147658695|NCT03428100|532572313|FG002|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|0|||
147658696|NCT03428100|532572314|FG003|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|0|||
147594289|NCT02177136|532332406|FG003|LTSE Phase|Adverse Event|10|||
147594290|NCT02177136|532332403|FG000|LTSE Phase|Discontinued Due to Pruritus|0|||
147594291|NCT02177136|532332404|FG001|LTSE Phase|Discontinued Due to Pruritus|0|||
147594292|NCT02177136|532332405|FG002|LTSE Phase|Discontinued Due to Pruritus|0|||
147594293|NCT02177136|532332406|FG003|LTSE Phase|Discontinued Due to Pruritus|4|||
147594294|NCT02177136|532332403|FG000|LTSE Phase|Physician Decision|0|||
147594295|NCT02177136|532332404|FG001|LTSE Phase|Physician Decision|0|||
147594296|NCT02177136|532332405|FG002|LTSE Phase|Physician Decision|0|||
147594297|NCT02177136|532332406|FG003|LTSE Phase|Physician Decision|2|||
147594298|NCT02177136|532332403|FG000|LTSE Phase|Lost to Follow-up|0|||
147594299|NCT02177136|532332404|FG001|LTSE Phase|Lost to Follow-up|0|||
147594300|NCT02177136|532332405|FG002|LTSE Phase|Lost to Follow-up|0|||
147594301|NCT02177136|532332406|FG003|LTSE Phase|Lost to Follow-up|1|||
147594302|NCT02177136|532332403|FG000|LTSE Phase|Participant Moved|0|||
147594303|NCT02177136|532332404|FG001|LTSE Phase|Participant Moved|0|||
147594304|NCT02177136|532332405|FG002|LTSE Phase|Participant Moved|0|||
147594305|NCT02177136|532332406|FG003|LTSE Phase|Participant Moved|1|||
147594306|NCT02054130|532332407|FG000|Overall Study|Withdrawal by Subject|4|||
147594307|NCT02054130|532332408|FG001|Overall Study|Withdrawal by Subject|4|||
147594308|NCT02054130|532332409|FG002|Overall Study|Withdrawal by Subject|7|||
147594309|NCT02054130|532332410|FG003|Overall Study|Withdrawal by Subject|10|||
147594310|NCT02054130|532332407|FG000|Overall Study|Death|0|||
147594311|NCT02054130|532332408|FG001|Overall Study|Death|1|||
147594312|NCT02054130|532332409|FG002|Overall Study|Death|0|||
147594313|NCT02054130|532332410|FG003|Overall Study|Death|0|||
147594314|NCT02054130|532332407|FG000|Overall Study|Lost to Follow-up|0|||
147594315|NCT02054130|532332408|FG001|Overall Study|Lost to Follow-up|0|||
147594316|NCT02054130|532332409|FG002|Overall Study|Lost to Follow-up|1|||
147594317|NCT02054130|532332410|FG003|Overall Study|Lost to Follow-up|2|||
147594318|NCT02054130|532332407|FG000|Overall Study|Missed dose|4|||
147594319|NCT02054130|532332408|FG001|Overall Study|Missed dose|6|||
147594320|NCT02054130|532332409|FG002|Overall Study|Missed dose|7|||
147594321|NCT02054130|532332410|FG003|Overall Study|Missed dose|10|||
147594322|NCT01386684|532332411|FG000|Overall Study|Lost to Follow-up|51|||
147594323|NCT01386684|532332411|FG000|Overall Study|Other|51|||
147594324|NCT01386684|532332411|FG000|Overall Study|Death|47|||
147594325|NCT01386684|532332411|FG000|Overall Study|Withdrawal of Consent|44|||
147594326|NCT01386684|532332411|FG000|Overall Study|Alternative Therapy Required|37|||
147594327|NCT01386684|532332411|FG000|Overall Study|Disease Progression|28|||
147594328|NCT01386684|532332411|FG000|Overall Study|Adverse Event|20|||
147594329|NCT01386684|532332411|FG000|Overall Study|Noncompliance|8|||
147594330|NCT01386684|532332411|FG000|Overall Study|Protocol Violation|4|||
147594331|NCT01386684|532332411|FG000|Overall Study|Missing|3|||
147594332|NCT00094458|532332414|FG000|Main Study: Through Week 30|Eligibility criteria not met|3|||
147594333|NCT00094458|532332415|FG001|Main Study: Through Week 30|Eligibility criteria not met|8|||
147594334|NCT00094458|532332416|FG002|Main Study: Through Week 30|Eligibility criteria not met|2|||
147594335|NCT00094458|532332417|FG003|Main Study: Through Week 30|Eligibility criteria not met|0|||
147594336|NCT00094458|532332418|FG004|Main Study: Through Week 30|Eligibility criteria not met|0|||
147594337|NCT00094458|532332419|FG005|Main Study: Through Week 30|Eligibility criteria not met|0|||
147594338|NCT00094458|532332414|FG000|Main Study: Through Week 30|Lost to Follow-up|5|||
147594339|NCT00094458|532332415|FG001|Main Study: Through Week 30|Lost to Follow-up|5|||
147594340|NCT00094458|532332416|FG002|Main Study: Through Week 30|Lost to Follow-up|2|||
147594341|NCT00094458|532332417|FG003|Main Study: Through Week 30|Lost to Follow-up|0|||
147594342|NCT00094458|532332418|FG004|Main Study: Through Week 30|Lost to Follow-up|0|||
147658697|NCT03428100|532572315|FG004|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|2|||
147658698|NCT03428100|532572316|FG005|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|2|||
147658699|NCT03428100|532572317|FG006|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|3|||
147658700|NCT03428100|532572318|FG007|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|4|||
147658701|NCT03428100|532572319|FG008|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|0|||
147658702|NCT03428100|532572320|FG009|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|4|||
147658703|NCT03428100|532572321|FG010|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|4|||
147658704|NCT03428100|532572322|FG011|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|0|||
147658705|NCT03428100|532572323|FG012|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|9|||
147658706|NCT03428100|532572324|FG013|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|9|||
147594343|NCT00094458|532332419|FG005|Main Study: Through Week 30|Lost to Follow-up|0|||
147594344|NCT00094458|532332414|FG000|Main Study: Through Week 30|Withdrawal by Subject|18|||
147594345|NCT00094458|532332415|FG001|Main Study: Through Week 30|Withdrawal by Subject|9|||
147594346|NCT00094458|532332416|FG002|Main Study: Through Week 30|Withdrawal by Subject|7|||
147594347|NCT00094458|532332417|FG003|Main Study: Through Week 30|Withdrawal by Subject|0|||
147594348|NCT00094458|532332418|FG004|Main Study: Through Week 30|Withdrawal by Subject|0|||
147594349|NCT00094458|532332419|FG005|Main Study: Through Week 30|Withdrawal by Subject|0|||
147594350|NCT00094458|532332414|FG000|Main Study: Through Week 30|Adverse Event|38|||
147594351|NCT00094458|532332415|FG001|Main Study: Through Week 30|Adverse Event|20|||
147594352|NCT00094458|532332416|FG002|Main Study: Through Week 30|Adverse Event|28|||
147594353|NCT00094458|532332417|FG003|Main Study: Through Week 30|Adverse Event|0|||
147594354|NCT00094458|532332418|FG004|Main Study: Through Week 30|Adverse Event|0|||
147594355|NCT00094458|532332419|FG005|Main Study: Through Week 30|Adverse Event|0|||
147594356|NCT00094458|532332414|FG000|Main Study: Through Week 30|Death|1|||
147594357|NCT00094458|532332415|FG001|Main Study: Through Week 30|Death|0|||
147594358|NCT00094458|532332416|FG002|Main Study: Through Week 30|Death|0|||
147594359|NCT00094458|532332417|FG003|Main Study: Through Week 30|Death|0|||
147594360|NCT00094458|532332418|FG004|Main Study: Through Week 30|Death|0|||
147594361|NCT00094458|532332419|FG005|Main Study: Through Week 30|Death|0|||
147594362|NCT00094458|532332414|FG000|Main Study: Through Week 30|Other|19|||
147594363|NCT00094458|532332415|FG001|Main Study: Through Week 30|Other|16|||
147594364|NCT00094458|532332416|FG002|Main Study: Through Week 30|Other|9|||
147594365|NCT00094458|532332417|FG003|Main Study: Through Week 30|Other|0|||
147658707|NCT03428100|532572325|FG014|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|6|||
147658708|NCT03428100|532572326|FG015|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|3|||
147658709|NCT03428100|532572327|FG016|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|4|||
147658710|NCT03428100|532572328|FG017|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|4|||
147658711|NCT03428100|532572329|FG018|Long-Term Extension Week 52 to Week 200|Lack of Efficacy|1|||
147658712|NCT03428100|532572311|FG000|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
147658713|NCT03428100|532572312|FG001|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
147658714|NCT03428100|532572313|FG002|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
147658715|NCT03428100|532572314|FG003|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
147658716|NCT03428100|532572315|FG004|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
147658717|NCT03428100|532572316|FG005|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
147658718|NCT03428100|532572317|FG006|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
147658719|NCT03428100|532572318|FG007|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|1|||
147658720|NCT03428100|532572319|FG008|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
147658721|NCT03428100|532572320|FG009|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
147658722|NCT03428100|532572321|FG010|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
147190850|NCT04664153|530865815|FG001|Overall Study|Lack of Efficacy|0|||
147330997|NCT01194258|531377557|FG000|Period 2 (12 Weeks)|Lost to Follow-up|0|||
147594366|NCT00094458|532332418|FG004|Main Study: Through Week 30|Other|0|||
147594367|NCT00094458|532332419|FG005|Main Study: Through Week 30|Other|0|||
147658723|NCT03428100|532572322|FG011|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|2|||
147190851|NCT04664153|530865816|FG002|Overall Study|Lack of Efficacy|1|||
147190852|NCT04664153|530865817|FG003|Overall Study|Lack of Efficacy|0|||
147190853|NCT04664153|530865814|FG000|Overall Study|Physician Decision|0|||
147190854|NCT04664153|530865815|FG001|Overall Study|Physician Decision|0|||
147190855|NCT04664153|530865816|FG002|Overall Study|Physician Decision|1|||
147190856|NCT04664153|530865817|FG003|Overall Study|Physician Decision|0|||
147190857|NCT04664153|530865814|FG000|Overall Study|Withdrawal by Subject|3|||
147190858|NCT04664153|530865815|FG001|Overall Study|Withdrawal by Subject|2|||
147190859|NCT04664153|530865816|FG002|Overall Study|Withdrawal by Subject|1|||
147190860|NCT04664153|530865817|FG003|Overall Study|Withdrawal by Subject|2|||
147190861|NCT04664153|530865814|FG000|Overall Study|Other|0|||
147190862|NCT04664153|530865815|FG001|Overall Study|Other|1|||
147190863|NCT04664153|530865816|FG002|Overall Study|Other|0|||
147190864|NCT04664153|530865817|FG003|Overall Study|Other|0|||
147190865|NCT04664153|530865814|FG000|Overall Study|Adverse Event|4|||
147190866|NCT04664153|530865815|FG001|Overall Study|Adverse Event|0|||
147190867|NCT04664153|530865816|FG002|Overall Study|Adverse Event|1|||
147190868|NCT04664153|530865817|FG003|Overall Study|Adverse Event|0|||
147190869|NCT00524485|530865821|FG000|Overall Study|Withdrawal by Subject|5|||
147190870|NCT01600885|530865824|FG000|First Period|Adverse Event|1|||
147190871|NCT01600885|530865825|FG001|First Period|Adverse Event|1|||
147190872|NCT01600885|530865824|FG000|First Period|moved out of area|1|||
147190873|NCT01600885|530865825|FG001|First Period|moved out of area|0|||
147190874|NCT00642356|530865832|FG000|Overall Study|Adverse Event|1|||
147190875|NCT00642356|530865833|FG001|Overall Study|Adverse Event|0|||
147190876|NCT00642356|530865832|FG000|Overall Study|Protocol Violation|0|||
147190877|NCT00642356|530865833|FG001|Overall Study|Protocol Violation|3|||
147190878|NCT00642356|530865832|FG000|Overall Study|Lack of Efficacy|1|||
147190879|NCT00642356|530865833|FG001|Overall Study|Lack of Efficacy|0|||
147190880|NCT01009060|530865834|FG000|Overall Study|Adverse Event|1|||
147190881|NCT01009060|530865835|FG001|Overall Study|Adverse Event|2|||
147190882|NCT01009060|530865834|FG000|Overall Study|Protocol Violation|0|||
147190883|NCT01009060|530865835|FG001|Overall Study|Protocol Violation|1|||
147190884|NCT01009060|530865834|FG000|Overall Study|Lost to Follow-up|1|||
147190885|NCT01009060|530865835|FG001|Overall Study|Lost to Follow-up|0|||
147190886|NCT01009060|530865834|FG000|Overall Study|Physician Decision|1|||
147594368|NCT00094458|532332414|FG000|Study Extension: Week 30 Through Week 50|Lost to Follow-up|2|||
147594369|NCT00094458|532332415|FG001|Study Extension: Week 30 Through Week 50|Lost to Follow-up|1|||
147594370|NCT00094458|532332416|FG002|Study Extension: Week 30 Through Week 50|Lost to Follow-up|4|||
147449290|NCT01339559|531809465|FG000|Overall Study|Subject choice|89|||
147449291|NCT01339559|531809465|FG000|Overall Study|Protocol Violation|15|||
147449292|NCT01339559|531809465|FG000|Overall Study|Study closure at site|1|||
147449293|NCT01339559|531809465|FG000|Overall Study|Incarcerated|2|||
147449294|NCT01339559|531809465|FG000|Overall Study|Epilepsy surgery|1|||
147449295|NCT01339559|531809465|FG000|Overall Study|Pregnancy planned|2|||
147449296|NCT01339559|531809465|FG000|Overall Study|Left the country|1|||
147449297|NCT01339559|531809465|FG000|Overall Study|Investigator decision|2|||
147449298|NCT01339559|531809465|FG000|Overall Study|Patient didn't wish to continue|1|||
147449299|NCT01339559|531809465|FG000|Overall Study|PI decision|1|||
147449300|NCT00971945|531809466|FG000|Overall Study|Progressive Disease|3|||
147449301|NCT00971945|531809466|FG000|Overall Study|Change in treatment policy|1|||
147449302|NCT00971945|531809466|FG000|Overall Study|Other reasons|2|||
147449303|NCT03354663|531809467|FG000|Enrollment to Catheter Insertion|Did not meet inc/exc criteria|4|||
147449304|NCT03354663|531809467|FG000|Enrollment to Catheter Insertion|Adverse Event|1|||
147449305|NCT03354663|531809467|FG000|Completed 30-day Visit|Withdrawal by Subject|1|||
147449306|NCT03354663|531809467|FG000|Completed 30-day Visit|Missed Visit|1|||
147449307|NCT01661140|531809468|FG000|Open-Label Period|Adverse Event|44|||
147449308|NCT01661140|531809469|FG001|Open-Label Period|Adverse Event|0|||
147449309|NCT01661140|531809470|FG002|Open-Label Period|Adverse Event|0|||
147449310|NCT01661140|531809468|FG000|Open-Label Period|Protocol Violation|3|||
147449311|NCT01661140|531809469|FG001|Open-Label Period|Protocol Violation|0|||
147449312|NCT01661140|531809470|FG002|Open-Label Period|Protocol Violation|0|||
147449313|NCT01661140|531809468|FG000|Open-Label Period|Withdrawal by Subject|5|||
147449314|NCT01661140|531809469|FG001|Open-Label Period|Withdrawal by Subject|0|||
147449315|NCT01661140|531809470|FG002|Open-Label Period|Withdrawal by Subject|0|||
147449316|NCT01661140|531809468|FG000|Open-Label Period|Investigator Decision|3|||
147449317|NCT01661140|531809469|FG001|Open-Label Period|Investigator Decision|0|||
147449318|NCT01661140|531809470|FG002|Open-Label Period|Investigator Decision|0|||
147449319|NCT01661140|531809468|FG000|Open-Label Period|Death|1|||
147449320|NCT01661140|531809469|FG001|Open-Label Period|Death|0|||
147449321|NCT01661140|531809470|FG002|Open-Label Period|Death|0|||
147449322|NCT01661140|531809468|FG000|Open-Label Period|Administrative/Other|1|||
147449323|NCT01661140|531809469|FG001|Open-Label Period|Administrative/Other|0|||
147449324|NCT01661140|531809470|FG002|Open-Label Period|Administrative/Other|0|||
147449325|NCT01661140|531809468|FG000|Open-Label Period|Sponsor termination|16|||
147449326|NCT01661140|531809469|FG001|Open-Label Period|Sponsor termination|0|||
147449327|NCT01661140|531809470|FG002|Open-Label Period|Sponsor termination|0|||
147449328|NCT01661140|531809468|FG000|Open-Label Period|Did not meet EULAR criteria|1|||
147449329|NCT01661140|531809469|FG001|Open-Label Period|Did not meet EULAR criteria|0|||
147449330|NCT01661140|531809470|FG002|Open-Label Period|Did not meet EULAR criteria|0|||
147449331|NCT01661140|531809468|FG000|Open-Label Period|Lost to Follow-up|2|||
147449332|NCT01661140|531809469|FG001|Open-Label Period|Lost to Follow-up|0|||
147449333|NCT01661140|531809470|FG002|Open-Label Period|Lost to Follow-up|0|||
147594371|NCT00094458|532332417|FG003|Study Extension: Week 30 Through Week 50|Lost to Follow-up|0|||
147594372|NCT00094458|532332418|FG004|Study Extension: Week 30 Through Week 50|Lost to Follow-up|0|||
147594373|NCT00094458|532332419|FG005|Study Extension: Week 30 Through Week 50|Lost to Follow-up|0|||
147594374|NCT00094458|532332414|FG000|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|2|||
147594375|NCT00094458|532332415|FG001|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0|||
147594376|NCT00094458|532332416|FG002|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|4|||
147594377|NCT00094458|532332417|FG003|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0|||
147594378|NCT00094458|532332418|FG004|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0|||
147594379|NCT00094458|532332419|FG005|Study Extension: Week 30 Through Week 50|Withdrawal by Subject|0|||
147594380|NCT00094458|532332414|FG000|Study Extension: Week 30 Through Week 50|Adverse Event|3|||
147594381|NCT00094458|532332415|FG001|Study Extension: Week 30 Through Week 50|Adverse Event|9|||
147594382|NCT00094458|532332416|FG002|Study Extension: Week 30 Through Week 50|Adverse Event|7|||
147594383|NCT00094458|532332417|FG003|Study Extension: Week 30 Through Week 50|Adverse Event|0|||
147594384|NCT00094458|532332418|FG004|Study Extension: Week 30 Through Week 50|Adverse Event|0|||
147594385|NCT00094458|532332419|FG005|Study Extension: Week 30 Through Week 50|Adverse Event|0|||
147594386|NCT00094458|532332414|FG000|Study Extension: Week 30 Through Week 50|Other|1|||
147594387|NCT00094458|532332415|FG001|Study Extension: Week 30 Through Week 50|Other|2|||
147594388|NCT00094458|532332416|FG002|Study Extension: Week 30 Through Week 50|Other|3|||
147594389|NCT00094458|532332417|FG003|Study Extension: Week 30 Through Week 50|Other|0|||
147594390|NCT00094458|532332418|FG004|Study Extension: Week 30 Through Week 50|Other|0|||
147594391|NCT00094458|532332419|FG005|Study Extension: Week 30 Through Week 50|Other|0|||
147594392|NCT00094458|532332414|FG000|OLE: Open-Label Extension|Adverse Event|0|||
147594393|NCT00094458|532332415|FG001|OLE: Open-Label Extension|Adverse Event|0|||
147594394|NCT00094458|532332416|FG002|OLE: Open-Label Extension|Adverse Event|0|||
147449334|NCT01661140|531809468|FG000|Double-Blind Period|Refused Treatment|0|||
147190887|NCT01009060|530865835|FG001|Overall Study|Physician Decision|1|||
147449335|NCT01661140|531809469|FG001|Double-Blind Period|Refused Treatment|0|||
147449336|NCT01661140|531809470|FG002|Double-Blind Period|Refused Treatment|1|||
147594395|NCT00094458|532332417|FG003|OLE: Open-Label Extension|Adverse Event|0|||
147594396|NCT00094458|532332418|FG004|OLE: Open-Label Extension|Adverse Event|3|||
147594397|NCT00094458|532332419|FG005|OLE: Open-Label Extension|Adverse Event|4|||
147594398|NCT00094458|532332414|FG000|OLE: Open-Label Extension|Inadequate therapeutic effect|0|||
147594399|NCT00094458|532332415|FG001|OLE: Open-Label Extension|Inadequate therapeutic effect|0|||
147594400|NCT00094458|532332416|FG002|OLE: Open-Label Extension|Inadequate therapeutic effect|0|||
147594401|NCT00094458|532332417|FG003|OLE: Open-Label Extension|Inadequate therapeutic effect|1|||
147594402|NCT00094458|532332418|FG004|OLE: Open-Label Extension|Inadequate therapeutic effect|1|||
147594403|NCT00094458|532332419|FG005|OLE: Open-Label Extension|Inadequate therapeutic effect|0|||
147190888|NCT01009060|530865834|FG000|Overall Study|Withdrawal by Subject|1|||
147190889|NCT01009060|530865835|FG001|Overall Study|Withdrawal by Subject|1|||
147190890|NCT04201431|530865836|FG000|Vaccinations and Primary CHMI|Withdrawal by Subject|6|||
147190891|NCT04201431|530865837|FG001|Vaccinations and Primary CHMI|Withdrawal by Subject|0|||
147190892|NCT04201431|530865838|FG002|Vaccinations and Primary CHMI|Withdrawal by Subject|0|||
147190893|NCT00667888|530865841|FG000|Overall Study|Death|1|||
147190894|NCT00667888|530865842|FG001|Overall Study|Death|1|||
147190895|NCT00667888|530865841|FG000|Overall Study|Withdrawal by Subject|6|||
147190896|NCT00667888|530865842|FG001|Overall Study|Withdrawal by Subject|3|||
147190897|NCT00667888|530865841|FG000|Overall Study|Proceed with other treatment|3|||
147190898|NCT00667888|530865842|FG001|Overall Study|Proceed with other treatment|3|||
147190899|NCT00667888|530865841|FG000|Overall Study|Ineligible after SIM|0|||
147190900|NCT00667888|530865842|FG001|Overall Study|Ineligible after SIM|2|||
147190901|NCT02140047|530865843|FG000|Overall Study|Withdrawal by parent/guardian|1|||
147190902|NCT02140047|530865844|FG001|Overall Study|Withdrawal by parent/guardian|1|||
147190903|NCT02140047|530865845|FG002|Overall Study|Withdrawal by parent/guardian|0|||
147190904|NCT02174731|530865846|FG000|Overall Study|Participant decision|67|||
147190905|NCT02174731|530865847|FG001|Overall Study|Participant decision|64|||
147190906|NCT02174731|530865846|FG000|Overall Study|Incorrect enrolment before randomization|0|||
147190907|NCT02174731|530865847|FG001|Overall Study|Incorrect enrolment before randomization|1|||
147190908|NCT02174731|530865846|FG000|Overall Study|Missing|2|||
147190909|NCT02174731|530865847|FG001|Overall Study|Missing|0|||
147190910|NCT00079040|530865848|FG000|Overall Study|Withdrew before treatment|1|||
147190911|NCT00079040|530865848|FG000|Overall Study|Ineligible|1|||
147190912|NCT03119259|530865849|FG000|Overall Study|Withdrawn as no longer eligible|1|||
147190913|NCT03119259|530865850|FG001|Overall Study|Withdrawn as no longer eligible|0|||
147190914|NCT03119259|530865849|FG000|Overall Study|Withdrawal by Subject|4|||
147190915|NCT03119259|530865850|FG001|Overall Study|Withdrawal by Subject|2|||
147190916|NCT03119259|530865849|FG000|Overall Study|Lost to Follow-up|0|||
147190917|NCT03119259|530865850|FG001|Overall Study|Lost to Follow-up|1|||
147190918|NCT00325897|530865851|FG000|Overall Study|Lost to Follow-up|12|||
147190919|NCT00325897|530865852|FG001|Overall Study|Lost to Follow-up|13|||
147190920|NCT03535974|530865853|FG000|First Intervention Weeks 0-6 (V1-V2)|Adverse Event|0|||
147190921|NCT03535974|530865854|FG001|First Intervention Weeks 0-6 (V1-V2)|Adverse Event|1|||
147190922|NCT03535974|530865855|FG002|First Intervention Weeks 0-6 (V1-V2)|Adverse Event|0|||
147190923|NCT03535974|530865853|FG000|First Intervention Weeks 0-6 (V1-V2)|Withdrawal by Subject|2|||
147190924|NCT03535974|530865854|FG001|First Intervention Weeks 0-6 (V1-V2)|Withdrawal by Subject|1|||
147190925|NCT03535974|530865855|FG002|First Intervention Weeks 0-6 (V1-V2)|Withdrawal by Subject|0|||
147190926|NCT04059549|530865856|FG000|Overall Study|Withdrawal by Subject|2|||
147190927|NCT04059549|530865857|FG001|Overall Study|Withdrawal by Subject|0|||
147190928|NCT00549640|530865858|FG000|Overall Study|Withdrawal by Subject|6|||
147190929|NCT00549640|530865859|FG001|Overall Study|Withdrawal by Subject|12|||
147190930|NCT00549640|530865858|FG000|Overall Study|Adverse Event|5|||
147190931|NCT00549640|530865859|FG001|Overall Study|Adverse Event|0|||
147190932|NCT00549640|530865858|FG000|Overall Study|Lost to Follow-up|7|||
147190933|NCT00549640|530865859|FG001|Overall Study|Lost to Follow-up|4|||
147190934|NCT00626275|530865862|FG000|Part A - Treatment Period 1|Adverse Event|1|||
147190935|NCT00626275|530865863|FG001|Part A - Treatment Period 1|Adverse Event|0|||
147190936|NCT00626275|530865864|FG002|Part A - Treatment Period 1|Adverse Event|0|||
147190937|NCT00626275|530865865|FG003|Part A - Treatment Period 1|Adverse Event|0|||
147190938|NCT00626275|530865866|FG004|Part A - Treatment Period 1|Adverse Event|0|||
147190939|NCT00626275|530865867|FG005|Part A - Treatment Period 1|Adverse Event|0|||
147248417|NCT00855920|531078622|FG000|Overall Study|Death|0|||
147449337|NCT01661140|531809468|FG000|Double-Blind Period|Adverse Event|0|||
147594404|NCT00094458|532332414|FG000|OLE: Open-Label Extension|Patient decision|0|||
147594405|NCT00094458|532332415|FG001|OLE: Open-Label Extension|Patient decision|0|||
147594406|NCT00094458|532332416|FG002|OLE: Open-Label Extension|Patient decision|0|||
147594407|NCT00094458|532332417|FG003|OLE: Open-Label Extension|Patient decision|0|||
147594408|NCT00094458|532332418|FG004|OLE: Open-Label Extension|Patient decision|1|||
147594409|NCT00094458|532332419|FG005|OLE: Open-Label Extension|Patient decision|0|||
147594410|NCT01995266|532332427|FG000|Overall Study|Death|1|||
147594411|NCT01995266|532332427|FG000|Overall Study|Lack of Efficacy|6|||
147594412|NCT01995266|532332427|FG000|Overall Study|Adverse Event|2|||
147248418|NCT00855920|531078623|FG001|Overall Study|Death|1|||
147594413|NCT03247517|532332428|FG000|Overall Study|Adverse Event|0|||
147594414|NCT03247517|532332429|FG001|Overall Study|Adverse Event|4|||
147449338|NCT01661140|531809469|FG001|Double-Blind Period|Adverse Event|16|||
147449339|NCT01661140|531809470|FG002|Double-Blind Period|Adverse Event|18|||
147449340|NCT01661140|531809468|FG000|Double-Blind Period|Protocol Violation|0|||
147449341|NCT01661140|531809469|FG001|Double-Blind Period|Protocol Violation|2|||
147449342|NCT01661140|531809470|FG002|Double-Blind Period|Protocol Violation|3|||
147449343|NCT01661140|531809468|FG000|Double-Blind Period|Withdrawal by Subject|0|||
147449344|NCT01661140|531809469|FG001|Double-Blind Period|Withdrawal by Subject|1|||
147449345|NCT01661140|531809470|FG002|Double-Blind Period|Withdrawal by Subject|3|||
147449346|NCT01661140|531809468|FG000|Double-Blind Period|Investigator's Decision|0|||
147449347|NCT01661140|531809469|FG001|Double-Blind Period|Investigator's Decision|1|||
147449348|NCT01661140|531809470|FG002|Double-Blind Period|Investigator's Decision|2|||
147449349|NCT01661140|531809468|FG000|Double-Blind Period|Sponsor Termination|0|||
147449350|NCT01661140|531809469|FG001|Double-Blind Period|Sponsor Termination|14|||
147449351|NCT01661140|531809470|FG002|Double-Blind Period|Sponsor Termination|17|||
147449352|NCT01661140|531809468|FG000|Double-Blind Period|Administrative/Other|0|||
147449353|NCT01661140|531809469|FG001|Double-Blind Period|Administrative/Other|7|||
147449354|NCT01661140|531809470|FG002|Double-Blind Period|Administrative/Other|6|||
147449355|NCT01137773|531809471|FG000|Overall Study|Death|3|||
147449356|NCT01137773|531809472|FG001|Overall Study|Death|3|||
147449357|NCT01137773|531809471|FG000|Overall Study|Lost to Follow-up|6|||
147449358|NCT01137773|531809472|FG001|Overall Study|Lost to Follow-up|0|||
147449359|NCT03548051|531809473|FG000|Overall Study|Death|1|||
147449360|NCT03548051|531809474|FG001|Overall Study|Death|1|||
147449361|NCT03548051|531809473|FG000|Overall Study|Withdrawal by Subject|1|||
147449362|NCT03548051|531809474|FG001|Overall Study|Withdrawal by Subject|0|||
147449363|NCT00817531|531809476|FG000|Overall Study|Adverse Event|1|||
147449364|NCT00817531|531809476|FG000|Overall Study|Lack of Efficacy|1|||
147449365|NCT02239939|531809477|FG000|Overall Study|Adverse Event|1|||
147449366|NCT02239939|531809478|FG001|Overall Study|Adverse Event|0|||
147449367|NCT02239939|531809477|FG000|Overall Study|Withdrawal by Subject|1|||
147449368|NCT02239939|531809478|FG001|Overall Study|Withdrawal by Subject|1|||
147449369|NCT02239939|531809477|FG000|Overall Study|Lost to Follow-up|0|||
147449370|NCT02239939|531809478|FG001|Overall Study|Lost to Follow-up|1|||
147449371|NCT03325673|531809480|FG000|Overall Study|Adverse Event|4|||
147449372|NCT03325673|531809481|FG001|Overall Study|Adverse Event|0|||
147449373|NCT02590588|531809484|FG000|Overall Study|Adverse Event|1|||
147449374|NCT00763815|531809485|FG000|Overall Study|Adverse Event|14|||
147449375|NCT00763815|531809486|FG001|Overall Study|Adverse Event|29|||
147449376|NCT00763815|531809485|FG000|Overall Study|Lack of Efficacy|10|||
147449377|NCT00763815|531809486|FG001|Overall Study|Lack of Efficacy|11|||
147449378|NCT00763815|531809485|FG000|Overall Study|Poor Compliance to Protocol|6|||
147449379|NCT00763815|531809486|FG001|Overall Study|Poor Compliance to Protocol|6|||
147449380|NCT00763815|531809485|FG000|Overall Study|Lost to Follow-up|2|||
147449381|NCT00763815|531809486|FG001|Overall Study|Lost to Follow-up|4|||
147449382|NCT00763815|531809485|FG000|Overall Study|Early Termination|1|||
147449383|NCT00763815|531809486|FG001|Overall Study|Early Termination|0|||
147449384|NCT00763815|531809485|FG000|Overall Study|Familial and Personal Reasons|9|||
147449385|NCT00763815|531809486|FG001|Overall Study|Familial and Personal Reasons|16|||
147449386|NCT00763815|531809485|FG000|Overall Study|Physician Decision|1|||
147449387|NCT00763815|531809486|FG001|Overall Study|Physician Decision|0|||
147594415|NCT03247517|532332430|FG002|Overall Study|Adverse Event|2|||
147594416|NCT03247517|532332428|FG000|Overall Study|Lost to Follow-up|2|||
147594417|NCT03247517|532332429|FG001|Overall Study|Lost to Follow-up|6|||
147594418|NCT03247517|532332430|FG002|Overall Study|Lost to Follow-up|4|||
147594419|NCT03247517|532332428|FG000|Overall Study|Consent withdrawn by caregiver|1|||
147594420|NCT03247517|532332429|FG001|Overall Study|Consent withdrawn by caregiver|4|||
147594421|NCT03247517|532332430|FG002|Overall Study|Consent withdrawn by caregiver|7|||
147594422|NCT03247517|532332428|FG000|Overall Study|Assent/consent withdrawn by subject|2|||
147594423|NCT03247517|532332429|FG001|Overall Study|Assent/consent withdrawn by subject|3|||
147594424|NCT03247517|532332430|FG002|Overall Study|Assent/consent withdrawn by subject|1|||
147594425|NCT03247517|532332428|FG000|Overall Study|Protocol Violation|0|||
147190940|NCT00626275|530865868|FG006|Part A - Treatment Period 1|Adverse Event|0|||
147190941|NCT00626275|530865869|FG007|Part A - Treatment Period 1|Adverse Event|0|||
147190942|NCT00626275|530865862|FG000|Part A - Treatment Period 1|Withdrawal by Subject|0|||
147190943|NCT00626275|530865863|FG001|Part A - Treatment Period 1|Withdrawal by Subject|0|||
147190944|NCT00626275|530865864|FG002|Part A - Treatment Period 1|Withdrawal by Subject|1|||
147190945|NCT00626275|530865865|FG003|Part A - Treatment Period 1|Withdrawal by Subject|0|||
147190946|NCT00626275|530865866|FG004|Part A - Treatment Period 1|Withdrawal by Subject|0|||
147190947|NCT00626275|530865867|FG005|Part A - Treatment Period 1|Withdrawal by Subject|0|||
147449388|NCT00763815|531809485|FG000|Overall Study|Withdrawal by Subject|7|||
147449389|NCT00763815|531809486|FG001|Overall Study|Withdrawal by Subject|12|||
147449390|NCT00763815|531809485|FG000|Overall Study|Protocol Violation|2|||
147449391|NCT00763815|531809486|FG001|Overall Study|Protocol Violation|5|||
147449392|NCT00763815|531809485|FG000|Overall Study|Sponsor's Decision|0|||
147449393|NCT00763815|531809486|FG001|Overall Study|Sponsor's Decision|1|||
147449394|NCT02559687|531809494|FG000|Overall Study|Death|112|||
147449395|NCT02559687|531809494|FG000|Overall Study|Sponsor Decision|5|||
147594426|NCT03247517|532332429|FG001|Overall Study|Protocol Violation|2|||
147594427|NCT03247517|532332430|FG002|Overall Study|Protocol Violation|0|||
147594428|NCT03247517|532332428|FG000|Overall Study|Multiple reasons|3|||
147594429|NCT03247517|532332429|FG001|Overall Study|Multiple reasons|1|||
147594430|NCT03247517|532332430|FG002|Overall Study|Multiple reasons|0|||
147594431|NCT03310411|532332431|FG000|Period 1|Adverse Event|0|||
147594432|NCT03310411|532332432|FG001|Period 1|Adverse Event|0|||
147594433|NCT03310411|532332433|FG002|Period 1|Adverse Event|0|||
147594434|NCT03310411|532332434|FG003|Period 1|Adverse Event|1|||
147594435|NCT00619112|532332435|FG000|Overall Study|Adverse Event|1|||
147594436|NCT00619112|532332436|FG001|Overall Study|Adverse Event|2|||
147594437|NCT03623386|532332437|FG000|Overall Study|Protocol Violation|3|||
147594438|NCT03623386|532332438|FG001|Overall Study|Protocol Violation|2|||
147594439|NCT03623386|532332439|FG002|Overall Study|Protocol Violation|0|||
147594440|NCT03623386|532332437|FG000|Overall Study|Physician Decision|1|||
147594441|NCT03623386|532332438|FG001|Overall Study|Physician Decision|1|||
147594442|NCT03623386|532332439|FG002|Overall Study|Physician Decision|0|||
147594443|NCT03623386|532332437|FG000|Overall Study|Lost to Follow-up|0|||
147594444|NCT03623386|532332438|FG001|Overall Study|Lost to Follow-up|2|||
147594445|NCT03623386|532332439|FG002|Overall Study|Lost to Follow-up|0|||
147594446|NCT03623386|532332437|FG000|Overall Study|COVID-19|0|||
147594447|NCT03623386|532332438|FG001|Overall Study|COVID-19|1|||
147594448|NCT03623386|532332439|FG002|Overall Study|COVID-19|0|||
147594449|NCT03573505|532332440|FG000|Overall Study|Adverse Event|1|||
147594450|NCT03573505|532332441|FG001|Overall Study|Adverse Event|1|||
147594451|NCT03573505|532332440|FG000|Overall Study|Consent withdrawn|0|||
147594452|NCT03573505|532332441|FG001|Overall Study|Consent withdrawn|1|||
147594453|NCT03573505|532332440|FG000|Overall Study|Disease progression|0|||
147594454|NCT03573505|532332441|FG001|Overall Study|Disease progression|1|||
147594455|NCT03573505|532332440|FG000|Overall Study|Site Terminated by Sponsor|1|||
147594456|NCT03573505|532332441|FG001|Overall Study|Site Terminated by Sponsor|1|||
147594457|NCT03573505|532332440|FG000|Overall Study|Study terminated by sponsor|50|||
147594458|NCT03573505|532332441|FG001|Overall Study|Study terminated by sponsor|45|||
147594459|NCT03573505|532332440|FG000|Overall Study|Reason not specified|0|||
147594460|NCT03573505|532332441|FG001|Overall Study|Reason not specified|1|||
147594461|NCT03573505|532332440|FG000|Overall Study|Death|0|||
147594462|NCT03573505|532332441|FG001|Overall Study|Death|4|||
147594463|NCT02040779|532332442|FG000|Overall Study|Adverse Event|1|||
147594464|NCT02040779|532332443|FG001|Overall Study|Adverse Event|0|||
147594465|NCT02040779|532332444|FG002|Overall Study|Adverse Event|0|||
147594466|NCT02040779|532332442|FG000|Overall Study|Withdrawal by Subject|4|||
147594467|NCT02040779|532332443|FG001|Overall Study|Withdrawal by Subject|1|||
147594468|NCT02040779|532332444|FG002|Overall Study|Withdrawal by Subject|3|||
147594469|NCT02040779|532332442|FG000|Overall Study|Non-compliance|0|||
147594470|NCT02040779|532332443|FG001|Overall Study|Non-compliance|1|||
147594471|NCT02040779|532332444|FG002|Overall Study|Non-compliance|0|||
147594472|NCT02040779|532332442|FG000|Overall Study|Protocol Violation|2|||
147594473|NCT02040779|532332443|FG001|Overall Study|Protocol Violation|1|||
147594474|NCT02040779|532332444|FG002|Overall Study|Protocol Violation|0|||
147594475|NCT02040779|532332442|FG000|Overall Study|Lost to Follow-up|1|||
147594476|NCT02040779|532332443|FG001|Overall Study|Lost to Follow-up|2|||
147594477|NCT02040779|532332444|FG002|Overall Study|Lost to Follow-up|1|||
147594478|NCT02040779|532332442|FG000|Overall Study|Lack of Efficacy|4|||
147594479|NCT02040779|532332443|FG001|Overall Study|Lack of Efficacy|2|||
147594480|NCT02040779|532332444|FG002|Overall Study|Lack of Efficacy|0|||
147594481|NCT02145026|532332449|FG000|Overall Study|Adverse Event|2|||
147594482|NCT02145026|532332449|FG000|Overall Study|Death|4|||
147594483|NCT02145026|532332449|FG000|Overall Study|Withdrawal by Subject|2|||
147248419|NCT00855920|531078624|FG002|Overall Study|Death|0|||
147248420|NCT00855920|531078622|FG000|Overall Study|Decision by the sponsor|0|||
147248421|NCT00855920|531078623|FG001|Overall Study|Decision by the sponsor|1|||
147248422|NCT00855920|531078624|FG002|Overall Study|Decision by the sponsor|1|||
147248423|NCT00855920|531078622|FG000|Overall Study|Other than specified above|1|||
147594484|NCT02145026|532332449|FG000|Overall Study|Physician Decision|4|||
147594485|NCT01621191|532332455|FG000|Overall Study|Adverse Event|9|||
147594486|NCT01621191|532332455|FG000|Overall Study|Withdrawal by Subject|8|||
147594487|NCT01621191|532332455|FG000|Overall Study|Lack of Efficacy|6|||
147594488|NCT01621191|532332455|FG000|Overall Study|Lost to Follow-up|1|||
147594489|NCT01621191|532332455|FG000|Overall Study|Site Removed From Study|1|||
147594490|NCT00038649|532332463|FG000|Overall Study|Adverse Event|9|||
147594491|NCT00942331|532332464|FG000|Overall Study|Did not start treatment|15|||
147594492|NCT00942331|532332465|FG001|Overall Study|Did not start treatment|22|||
147594493|NCT00567476|532332467|FG000|Overall Study|Adverse Event|2|||
147594494|NCT00567476|532332468|FG001|Overall Study|Adverse Event|0|||
147594495|NCT00567476|532332467|FG000|Overall Study|Pregnancy|1|||
147594496|NCT00567476|532332468|FG001|Overall Study|Pregnancy|0|||
147594497|NCT00567476|532332467|FG000|Overall Study|Protocol Violation|4|||
147248424|NCT00855920|531078623|FG001|Overall Study|Other than specified above|1|||
147594498|NCT00567476|532332468|FG001|Overall Study|Protocol Violation|1|||
147594499|NCT00567476|532332467|FG000|Overall Study|Lost to Follow-up|0|||
147594500|NCT00567476|532332468|FG001|Overall Study|Lost to Follow-up|1|||
147449396|NCT02559687|531809494|FG000|Overall Study|Withdrawal by Subject|4|||
147449397|NCT02706873|531809501|FG000|Period 1 (Weeks 1 to 48)|Adverse Event|15|||
147449398|NCT02706873|531809502|FG001|Period 1 (Weeks 1 to 48)|Adverse Event|3|||
147449399|NCT02706873|531809503|FG002|Period 1 (Weeks 1 to 48)|Adverse Event|18|||
147449400|NCT02706873|531809504|FG003|Period 1 (Weeks 1 to 48)|Adverse Event|11|||
147449401|NCT02706873|531809501|FG000|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|22|||
147449402|NCT02706873|531809502|FG001|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|0|||
147594501|NCT00567476|532332467|FG000|Overall Study|Administrative issues|1|||
147594502|NCT00567476|532332468|FG001|Overall Study|Administrative issues|0|||
147658724|NCT03428100|532572323|FG012|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|1|||
147658725|NCT03428100|532572324|FG013|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
147658726|NCT03428100|532572325|FG014|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|2|||
147658727|NCT03428100|532572326|FG015|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
147658728|NCT03428100|532572327|FG016|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
147594503|NCT00567476|532332467|FG000|Overall Study|Medical Decision|0|||
147594504|NCT00567476|532332468|FG001|Overall Study|Medical Decision|1|||
147594505|NCT00567476|532332467|FG000|Overall Study|Non-adherence to protocol|0|||
147594506|NCT00567476|532332468|FG001|Overall Study|Non-adherence to protocol|1|||
147594507|NCT01491035|532332477|FG000|Overall Study|Lost to Follow-up|0|||
147594508|NCT01491035|532332478|FG001|Overall Study|Lost to Follow-up|0|||
147594509|NCT01491035|532332479|FG002|Overall Study|Lost to Follow-up|0|||
147594510|NCT01491035|532332480|FG003|Overall Study|Lost to Follow-up|0|||
147594511|NCT01491035|532332481|FG004|Overall Study|Lost to Follow-up|1|||
147594512|NCT01491035|532332482|FG005|Overall Study|Lost to Follow-up|0|||
147594513|NCT01491035|532332483|FG006|Overall Study|Lost to Follow-up|0|||
147594514|NCT01491035|532332484|FG007|Overall Study|Lost to Follow-up|0|||
147594515|NCT02999477|532332488|FG000|Overall Study|found ineligible after first dose|0|||
147594516|NCT02999477|532332489|FG001|Overall Study|found ineligible after first dose|1|||
147594517|NCT02999477|532332488|FG000|Overall Study|Withdrawal by Subject|1|||
147594518|NCT02999477|532332489|FG001|Overall Study|Withdrawal by Subject|1|||
147594519|NCT01846273|532332490|FG000|Overall Study|Adverse Event|9|||
147594520|NCT01846273|532332491|FG001|Overall Study|Adverse Event|7|||
147594521|NCT01846273|532332492|FG002|Overall Study|Adverse Event|0|||
147594522|NCT01846273|532332490|FG000|Overall Study|Subject withdrew consent|5|||
147594523|NCT01846273|532332491|FG001|Overall Study|Subject withdrew consent|8|||
147594524|NCT01846273|532332492|FG002|Overall Study|Subject withdrew consent|0|||
147594525|NCT01846273|532332490|FG000|Overall Study|Lost to Follow-up|2|||
147594526|NCT01846273|532332491|FG001|Overall Study|Lost to Follow-up|1|||
147594527|NCT01846273|532332492|FG002|Overall Study|Lost to Follow-up|0|||
147594528|NCT01846273|532332490|FG000|Overall Study|Administrative problems|1|||
147594529|NCT01846273|532332491|FG001|Overall Study|Administrative problems|0|||
147594530|NCT01846273|532332492|FG002|Overall Study|Administrative problems|0|||
147594531|NCT01846273|532332490|FG000|Overall Study|Death|2|||
147658729|NCT03428100|532572328|FG017|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|1|||
147658730|NCT03428100|532572329|FG018|Long-Term Extension Week 52 to Week 200|Lost to Follow-up|0|||
147658731|NCT03428100|532572311|FG000|Long-Term Extension Week 52 to Week 200|Other|0|||
147658732|NCT03428100|532572312|FG001|Long-Term Extension Week 52 to Week 200|Other|0|||
147658733|NCT03428100|532572313|FG002|Long-Term Extension Week 52 to Week 200|Other|0|||
147658734|NCT03428100|532572314|FG003|Long-Term Extension Week 52 to Week 200|Other|0|||
147658735|NCT03428100|532572315|FG004|Long-Term Extension Week 52 to Week 200|Other|0|||
147658736|NCT03428100|532572316|FG005|Long-Term Extension Week 52 to Week 200|Other|0|||
147658737|NCT03428100|532572317|FG006|Long-Term Extension Week 52 to Week 200|Other|2|||
147658738|NCT03428100|532572318|FG007|Long-Term Extension Week 52 to Week 200|Other|0|||
147658739|NCT03428100|532572319|FG008|Long-Term Extension Week 52 to Week 200|Other|0|||
147658740|NCT03428100|532572320|FG009|Long-Term Extension Week 52 to Week 200|Other|0|||
147658741|NCT03428100|532572321|FG010|Long-Term Extension Week 52 to Week 200|Other|0|||
147658742|NCT03428100|532572322|FG011|Long-Term Extension Week 52 to Week 200|Other|1|||
147658743|NCT03428100|532572323|FG012|Long-Term Extension Week 52 to Week 200|Other|0|||
147658744|NCT03428100|532572324|FG013|Long-Term Extension Week 52 to Week 200|Other|0|||
147658745|NCT03428100|532572325|FG014|Long-Term Extension Week 52 to Week 200|Other|0|||
147658746|NCT03428100|532572326|FG015|Long-Term Extension Week 52 to Week 200|Other|0|||
147449403|NCT02706873|531809503|FG002|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|12|||
147449404|NCT02706873|531809504|FG003|Period 1 (Weeks 1 to 48)|Withdrawal by Subject|20|||
147449405|NCT02706873|531809501|FG000|Period 1 (Weeks 1 to 48)|Lost to Follow-up|4|||
147449406|NCT02706873|531809502|FG001|Period 1 (Weeks 1 to 48)|Lost to Follow-up|0|||
147594532|NCT01846273|532332491|FG001|Overall Study|Death|1|||
147594533|NCT01846273|532332492|FG002|Overall Study|Death|0|||
147594534|NCT01846273|532332490|FG000|Overall Study|Disease Progression|0|||
147594535|NCT01846273|532332491|FG001|Overall Study|Disease Progression|4|||
147594536|NCT01846273|532332492|FG002|Overall Study|Disease Progression|0|||
147594537|NCT01846273|532332490|FG000|Overall Study|Protocol Deviation|2|||
147594538|NCT01846273|532332491|FG001|Overall Study|Protocol Deviation|3|||
147594539|NCT01846273|532332492|FG002|Overall Study|Protocol Deviation|0|||
147594540|NCT01846273|532332490|FG000|Overall Study|Physician Decision|1|||
147594541|NCT01846273|532332491|FG001|Overall Study|Physician Decision|2|||
147449407|NCT02706873|531809503|FG002|Period 1 (Weeks 1 to 48)|Lost to Follow-up|6|||
147449408|NCT02706873|531809504|FG003|Period 1 (Weeks 1 to 48)|Lost to Follow-up|5|||
147449409|NCT02706873|531809501|FG000|Period 1 (Weeks 1 to 48)|Lack of Efficacy|12|||
147449410|NCT02706873|531809502|FG001|Period 1 (Weeks 1 to 48)|Lack of Efficacy|0|||
147449411|NCT02706873|531809503|FG002|Period 1 (Weeks 1 to 48)|Lack of Efficacy|2|||
147594542|NCT01846273|532332492|FG002|Overall Study|Physician Decision|0|||
147594543|NCT00891839|532332493|FG000|Overall Study|Adverse Event|2|||
147594544|NCT00891839|532332493|FG000|Overall Study|Withdrawal by Subject|2|||
147594545|NCT00891839|532332493|FG000|Overall Study|Disease progression|3|||
147594546|NCT00851643|532332497|FG000|Base Study (Up to 12 Months)|Withdrawal by Subject|1|||
147594547|NCT00851643|532332498|FG001|Base Study (Up to 12 Months)|Withdrawal by Subject|0|||
147594548|NCT00851643|532332499|FG002|Base Study (Up to 12 Months)|Withdrawal by Subject|0|||
147594549|NCT00851643|532332500|FG003|Base Study (Up to 12 Months)|Withdrawal by Subject|0|||
147594550|NCT00851643|532332501|FG004|Base Study (Up to 12 Months)|Withdrawal by Subject|0|||
147594551|NCT00851643|532332502|FG005|Base Study (Up to 12 Months)|Withdrawal by Subject|0|||
147594552|NCT00851643|532332497|FG000|Base Study (Up to 12 Months)|Other|0|||
147594553|NCT00851643|532332498|FG001|Base Study (Up to 12 Months)|Other|0|||
147594554|NCT00851643|532332499|FG002|Base Study (Up to 12 Months)|Other|0|||
147594555|NCT00851643|532332500|FG003|Base Study (Up to 12 Months)|Other|0|||
147594556|NCT00851643|532332501|FG004|Base Study (Up to 12 Months)|Other|0|||
147594557|NCT00851643|532332502|FG005|Base Study (Up to 12 Months)|Other|1|||
147594558|NCT00851643|532332497|FG000|Extension Study (Up to 36 Months)|Lost to Follow-up|4|||
147594559|NCT00851643|532332498|FG001|Extension Study (Up to 36 Months)|Lost to Follow-up|2|||
147594560|NCT00851643|532332499|FG002|Extension Study (Up to 36 Months)|Lost to Follow-up|4|||
147594561|NCT00851643|532332500|FG003|Extension Study (Up to 36 Months)|Lost to Follow-up|1|||
147594562|NCT00851643|532332501|FG004|Extension Study (Up to 36 Months)|Lost to Follow-up|2|||
147594563|NCT00851643|532332502|FG005|Extension Study (Up to 36 Months)|Lost to Follow-up|0|||
147594564|NCT00851643|532332497|FG000|Extension Study (Up to 36 Months)|Moved|0|||
147594565|NCT00851643|532332498|FG001|Extension Study (Up to 36 Months)|Moved|2|||
147594566|NCT00851643|532332499|FG002|Extension Study (Up to 36 Months)|Moved|1|||
147594567|NCT00851643|532332500|FG003|Extension Study (Up to 36 Months)|Moved|1|||
147594568|NCT00851643|532332501|FG004|Extension Study (Up to 36 Months)|Moved|0|||
147594569|NCT00851643|532332502|FG005|Extension Study (Up to 36 Months)|Moved|1|||
147594570|NCT00359788|532332503|FG000|Overall Study|Adverse Event|11|||
147594571|NCT00359788|532332504|FG001|Overall Study|Adverse Event|10|||
147594572|NCT00359788|532332503|FG000|Overall Study|Lack of Efficacy|1|||
147594573|NCT00359788|532332504|FG001|Overall Study|Lack of Efficacy|2|||
147594574|NCT00359788|532332503|FG000|Overall Study|Lost to Follow-up|3|||
147594575|NCT00359788|532332504|FG001|Overall Study|Lost to Follow-up|2|||
147594576|NCT00359788|532332503|FG000|Overall Study|Withdrawal by Subject|4|||
147594577|NCT00359788|532332504|FG001|Overall Study|Withdrawal by Subject|1|||
147330998|NCT01194258|531377558|FG001|Period 2 (12 Weeks)|Lost to Follow-up|0|||
147330999|NCT01194258|531377559|FG002|Period 2 (12 Weeks)|Lost to Follow-up|0|||
147331000|NCT01194258|531377560|FG003|Period 2 (12 Weeks)|Lost to Follow-up|0|||
147331001|NCT01194258|531377561|FG004|Period 2 (12 Weeks)|Lost to Follow-up|2|||
147331002|NCT01194258|531377557|FG000|Period 2 (12 Weeks)|Adverse Event|0|||
147331003|NCT01194258|531377558|FG001|Period 2 (12 Weeks)|Adverse Event|1|||
147331004|NCT01194258|531377559|FG002|Period 2 (12 Weeks)|Adverse Event|0|||
147331005|NCT01194258|531377560|FG003|Period 2 (12 Weeks)|Adverse Event|0|||
147331006|NCT01194258|531377561|FG004|Period 2 (12 Weeks)|Adverse Event|0|||
147331007|NCT01194258|531377557|FG000|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
147331008|NCT01194258|531377558|FG001|Period 2 (12 Weeks)|Withdrawal by Subject|1|||
147331009|NCT01194258|531377559|FG002|Period 2 (12 Weeks)|Withdrawal by Subject|1|||
147331010|NCT01194258|531377560|FG003|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
147331011|NCT01194258|531377561|FG004|Period 2 (12 Weeks)|Withdrawal by Subject|0|||
147331012|NCT00619645|531377562|FG000|Overall Study|Adverse Event|1|||
147331013|NCT02026258|531377563|FG000|Randomized|Did not start treatment|2|||
147331014|NCT02026258|531377564|FG001|Randomized|Did not start treatment|1|||
147331015|NCT02026258|531377563|FG000|Randomized|Change in treatment plan|1|||
147331016|NCT02026258|531377564|FG001|Randomized|Change in treatment plan|0|||
147331017|NCT02026258|531377563|FG000|Randomized|Presence of periodontal disease|1|||
147331018|NCT02026258|531377564|FG001|Randomized|Presence of periodontal disease|1|||
147331019|NCT02026258|531377563|FG000|Recieved Allocated Intervention|Withdrawal by Subject|1|||
147331020|NCT02026258|531377564|FG001|Recieved Allocated Intervention|Withdrawal by Subject|1|||
147331021|NCT02026258|531377563|FG000|Recieved Allocated Intervention|Lost to Follow-up|0|||
147331022|NCT02026258|531377564|FG001|Recieved Allocated Intervention|Lost to Follow-up|1|||
147331023|NCT00383188|531377565|FG000|Overall Study|Adverse Event|4|||
147331024|NCT00383188|531377566|FG001|Overall Study|Adverse Event|7|||
147331025|NCT00383188|531377567|FG002|Overall Study|Adverse Event|9|||
147449412|NCT02706873|531809504|FG003|Period 1 (Weeks 1 to 48)|Lack of Efficacy|4|||
147594578|NCT00359788|532332503|FG000|Overall Study|Protocol Violation|4|||
147594579|NCT00359788|532332504|FG001|Overall Study|Protocol Violation|2|||
147594580|NCT00103402|532332507|FG000|Overall Study|Adverse Event|3|||
147331026|NCT00383188|531377568|FG003|Overall Study|Adverse Event|8|||
147658747|NCT03428100|532572327|FG016|Long-Term Extension Week 52 to Week 200|Other|0|||
147658748|NCT03428100|532572328|FG017|Long-Term Extension Week 52 to Week 200|Other|2|||
147658749|NCT03428100|532572329|FG018|Long-Term Extension Week 52 to Week 200|Other|1|||
147331027|NCT00383188|531377569|FG004|Overall Study|Adverse Event|8|||
147331028|NCT00383188|531377565|FG000|Overall Study|Lack of Efficacy|9|||
147331029|NCT00383188|531377566|FG001|Overall Study|Lack of Efficacy|3|||
147331030|NCT00383188|531377567|FG002|Overall Study|Lack of Efficacy|3|||
147331031|NCT00383188|531377568|FG003|Overall Study|Lack of Efficacy|2|||
147331032|NCT00383188|531377569|FG004|Overall Study|Lack of Efficacy|6|||
147331033|NCT00383188|531377565|FG000|Overall Study|Other|3|||
147331034|NCT00383188|531377566|FG001|Overall Study|Other|1|||
147331035|NCT00383188|531377567|FG002|Overall Study|Other|0|||
147331036|NCT00383188|531377568|FG003|Overall Study|Other|2|||
147331037|NCT00383188|531377569|FG004|Overall Study|Other|6|||
147331038|NCT00383188|531377565|FG000|Overall Study|No longer willing to participate|1|||
147331039|NCT00383188|531377566|FG001|Overall Study|No longer willing to participate|0|||
147331040|NCT00383188|531377567|FG002|Overall Study|No longer willing to participate|1|||
147331041|NCT00383188|531377568|FG003|Overall Study|No longer willing to participate|0|||
147331042|NCT00383188|531377569|FG004|Overall Study|No longer willing to participate|2|||
147331043|NCT00383188|531377565|FG000|Overall Study|Lost to Follow-up|0|||
147331044|NCT00383188|531377566|FG001|Overall Study|Lost to Follow-up|0|||
147331045|NCT00383188|531377567|FG002|Overall Study|Lost to Follow-up|0|||
147331046|NCT00383188|531377568|FG003|Overall Study|Lost to Follow-up|0|||
147331047|NCT00383188|531377569|FG004|Overall Study|Lost to Follow-up|1|||
147331048|NCT04246762|531377570|FG000|Period 1: Cocktail Alone|Protocol Violation|1|||
147331049|NCT00410124|531377571|FG000|Core Phase Double Blind (15 Months)|Adverse Event|36|||
147331050|NCT00410124|531377572|FG001|Core Phase Double Blind (15 Months)|Adverse Event|2|||
147331051|NCT00410124|531377571|FG000|Core Phase Double Blind (15 Months)|Abnormal Laboratory Value|1|||
147331052|NCT00410124|531377572|FG001|Core Phase Double Blind (15 Months)|Abnormal Laboratory Value|0|||
147331053|NCT00410124|531377571|FG000|Core Phase Double Blind (15 Months)|Protocol Violation|2|||
147331054|NCT00410124|531377572|FG001|Core Phase Double Blind (15 Months)|Protocol Violation|1|||
147331055|NCT00410124|531377571|FG000|Core Phase Double Blind (15 Months)|Withdrawal by Subject|13|||
147331056|NCT00410124|531377572|FG001|Core Phase Double Blind (15 Months)|Withdrawal by Subject|2|||
147331057|NCT00410124|531377571|FG000|Core Phase Double Blind (15 Months)|Lost to Follow-up|4|||
147331058|NCT00410124|531377572|FG001|Core Phase Double Blind (15 Months)|Lost to Follow-up|0|||
147331059|NCT00410124|531377571|FG000|Core Phase Double Blind (15 Months)|Administrative Problems|2|||
147331060|NCT00410124|531377572|FG001|Core Phase Double Blind (15 Months)|Administrative Problems|0|||
147331061|NCT00410124|531377571|FG000|Core Phase Double Blind (15 Months)|Death|7|||
147331062|NCT00410124|531377572|FG001|Core Phase Double Blind (15 Months)|Death|4|||
147331063|NCT00410124|531377571|FG000|Core Phase Double Blind (15 Months)|Disease Progression|137|||
147331064|NCT00410124|531377572|FG001|Core Phase Double Blind (15 Months)|Disease Progression|124|||
147331065|NCT00410124|531377571|FG000|Extension Phase - Open Label (45 Months)|Adverse Event|7|||
147331066|NCT00410124|531377572|FG001|Extension Phase - Open Label (45 Months)|Adverse Event|19|||
147331067|NCT00410124|531377571|FG000|Extension Phase - Open Label (45 Months)|Abnormal Laboratory Values|0|||
147331068|NCT00410124|531377572|FG001|Extension Phase - Open Label (45 Months)|Abnormal Laboratory Values|1|||
147331069|NCT00410124|531377571|FG000|Extension Phase - Open Label (45 Months)|Abnormal Test Procedures|0|||
147331070|NCT00410124|531377572|FG001|Extension Phase - Open Label (45 Months)|Abnormal Test Procedures|1|||
147331071|NCT00410124|531377571|FG000|Extension Phase - Open Label (45 Months)|Withdrawal by Subject|1|||
147331072|NCT00410124|531377572|FG001|Extension Phase - Open Label (45 Months)|Withdrawal by Subject|1|||
147331073|NCT00410124|531377571|FG000|Extension Phase - Open Label (45 Months)|Death|2|||
147331074|NCT00410124|531377572|FG001|Extension Phase - Open Label (45 Months)|Death|10|||
147331075|NCT00410124|531377571|FG000|Extension Phase - Open Label (45 Months)|Disease Progression|56|||
147331076|NCT00410124|531377572|FG001|Extension Phase - Open Label (45 Months)|Disease Progression|78|||
147331077|NCT00410124|531377571|FG000|Extension Phase - Open Label (45 Months)|Patient no longer required study drug|1|||
147331078|NCT00410124|531377572|FG001|Extension Phase - Open Label (45 Months)|Patient no longer required study drug|0|||
147331079|NCT00410124|531377571|FG000|Extension Phase - Open Label (45 Months)|Final Primary Analysis|0|||
147331080|NCT00410124|531377572|FG001|Extension Phase - Open Label (45 Months)|Final Primary Analysis|1|||
147331081|NCT00597519|531377573|FG000|Overall Study|Death|1|||
147331082|NCT05484726|531377574|FG000|Overall Study|Protocol Violation|3|||
147331083|NCT05484726|531377575|FG001|Overall Study|Protocol Violation|3|||
147331084|NCT05484726|531377574|FG000|Overall Study|failure to establish gavage feed by 2 weeks of chronological age|4|||
147331085|NCT05484726|531377575|FG001|Overall Study|failure to establish gavage feed by 2 weeks of chronological age|2|||
147331086|NCT05484726|531377574|FG000|Overall Study|HsPDA requiring antifailure therapy|1|||
147331087|NCT05484726|531377575|FG001|Overall Study|HsPDA requiring antifailure therapy|2|||
147331088|NCT05484726|531377574|FG000|Overall Study|continued need of mechanical ventilation|2|||
147331089|NCT05484726|531377575|FG001|Overall Study|continued need of mechanical ventilation|3|||
147331090|NCT05484726|531377574|FG000|Overall Study|Withdrawal by Subject|2|||
147331091|NCT05484726|531377575|FG001|Overall Study|Withdrawal by Subject|3|||
147658750|NCT03428100|532572311|FG000|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
147594581|NCT00103402|532332508|FG001|Overall Study|Adverse Event|4|||
147594582|NCT00103402|532332507|FG000|Overall Study|Lost to Follow-up|8|||
147594583|NCT00103402|532332508|FG001|Overall Study|Lost to Follow-up|7|||
147594584|NCT00103402|532332507|FG000|Overall Study|Dissatisfied/No longer interested|6|||
147594585|NCT00103402|532332508|FG001|Overall Study|Dissatisfied/No longer interested|6|||
147594586|NCT00103402|532332507|FG000|Overall Study|Personal constraints/Other|5|||
147594587|NCT00103402|532332508|FG001|Overall Study|Personal constraints/Other|0|||
147594588|NCT01393730|532332509|FG000|Overall Study|Withdrawal by Subject|3|||
147594589|NCT01393730|532332509|FG000|Overall Study|Other|2|||
147594590|NCT01393730|532332509|FG000|Overall Study|Adverse Event|1|||
147594591|NCT02674061|532332510|FG000|Overall Study|Death|229|||
147594592|NCT02674061|532332511|FG001|Overall Study|Death|77|||
147594593|NCT02674061|532332510|FG000|Overall Study|Lost to Follow-up|3|||
147594594|NCT02674061|532332511|FG001|Overall Study|Lost to Follow-up|3|||
147594595|NCT02674061|532332510|FG000|Overall Study|Withdrawal by Subject|9|||
147594596|NCT02674061|532332511|FG001|Overall Study|Withdrawal by Subject|1|||
147594597|NCT02674061|532332510|FG000|Overall Study|Participation in Study Discontinued by Sponsor|44|||
147594598|NCT02674061|532332511|FG001|Overall Study|Participation in Study Discontinued by Sponsor|10|||
147594599|NCT03334721|532332514|FG000|Overall Study|Withdrawal by Subject|1|||
147594600|NCT03334721|532332515|FG001|Overall Study|Withdrawal by Subject|0|||
147594601|NCT03334721|532332514|FG000|Overall Study|No longer met inclusion/exclusion criter|1|||
147594602|NCT03334721|532332515|FG001|Overall Study|No longer met inclusion/exclusion criter|0|||
147594603|NCT02932228|532332518|FG000|Overall Study|Death|8|||
147594604|NCT02932228|532332519|FG001|Overall Study|Death|23|||
147594605|NCT02932228|532332518|FG000|Overall Study|not eligible upon chart review|2|||
147594606|NCT02932228|532332519|FG001|Overall Study|not eligible upon chart review|5|||
147594607|NCT04189445|532333859|FG000|Overall Study|Withdrawal of consent|8|||
147594608|NCT04189445|532333860|FG001|Overall Study|Withdrawal of consent|1|||
147594609|NCT04189445|532333861|FG002|Overall Study|Withdrawal of consent|0|||
147594610|NCT04189445|532333859|FG000|Overall Study|Study Terminated by Sponsor|25|||
147594611|NCT04189445|532333860|FG001|Overall Study|Study Terminated by Sponsor|3|||
147594612|NCT04189445|532333861|FG002|Overall Study|Study Terminated by Sponsor|0|||
147594613|NCT04189445|532333859|FG000|Overall Study|Death|54|||
147594614|NCT04189445|532333860|FG001|Overall Study|Death|24|||
147594615|NCT04189445|532333861|FG002|Overall Study|Death|0|||
147594616|NCT02960893|532333863|FG000|Randomization Phase (8 Weeks)|Adverse Event|5|||
147594617|NCT02960893|532333864|FG001|Randomization Phase (8 Weeks)|Adverse Event|0|||
147594618|NCT02960893|532333865|FG002|Randomization Phase (8 Weeks)|Adverse Event|0|||
147594619|NCT02960893|532333866|FG003|Randomization Phase (8 Weeks)|Adverse Event|0|||
147594620|NCT02960893|532333863|FG000|Randomization Phase (8 Weeks)|Withdrawal by Participant|2|||
147594621|NCT02960893|532333864|FG001|Randomization Phase (8 Weeks)|Withdrawal by Participant|1|||
147594622|NCT02960893|532333865|FG002|Randomization Phase (8 Weeks)|Withdrawal by Participant|0|||
147594623|NCT02960893|532333866|FG003|Randomization Phase (8 Weeks)|Withdrawal by Participant|0|||
147594624|NCT02960893|532333863|FG000|Randomization Phase (8 Weeks)|Reason Not Specified|0|||
147594625|NCT02960893|532333864|FG001|Randomization Phase (8 Weeks)|Reason Not Specified|1|||
147594626|NCT02960893|532333865|FG002|Randomization Phase (8 Weeks)|Reason Not Specified|0|||
147594627|NCT02960893|532333866|FG003|Randomization Phase (8 Weeks)|Reason Not Specified|0|||
147594628|NCT02960893|532333863|FG000|Open Label Extension Phase (336 Weeks)|Adverse Event|0|||
147594629|NCT02960893|532333864|FG001|Open Label Extension Phase (336 Weeks)|Adverse Event|0|||
147594630|NCT02960893|532333865|FG002|Open Label Extension Phase (336 Weeks)|Adverse Event|4|||
147594631|NCT02960893|532333866|FG003|Open Label Extension Phase (336 Weeks)|Adverse Event|4|||
147594632|NCT02960893|532333863|FG000|Open Label Extension Phase (336 Weeks)|Death|0|||
147594633|NCT02960893|532333864|FG001|Open Label Extension Phase (336 Weeks)|Death|0|||
147594634|NCT02960893|532333865|FG002|Open Label Extension Phase (336 Weeks)|Death|0|||
147594635|NCT02960893|532333866|FG003|Open Label Extension Phase (336 Weeks)|Death|1|||
147594636|NCT02960893|532333863|FG000|Open Label Extension Phase (336 Weeks)|Lost to Follow-up|0|||
147594637|NCT02960893|532333864|FG001|Open Label Extension Phase (336 Weeks)|Lost to Follow-up|0|||
147594638|NCT02960893|532333865|FG002|Open Label Extension Phase (336 Weeks)|Lost to Follow-up|3|||
147594639|NCT02960893|532333866|FG003|Open Label Extension Phase (336 Weeks)|Lost to Follow-up|3|||
147594640|NCT02960893|532333863|FG000|Open Label Extension Phase (336 Weeks)|Physician Decision|0|||
147594641|NCT02960893|532333864|FG001|Open Label Extension Phase (336 Weeks)|Physician Decision|0|||
147594642|NCT02960893|532333865|FG002|Open Label Extension Phase (336 Weeks)|Physician Decision|3|||
147594643|NCT02960893|532333866|FG003|Open Label Extension Phase (336 Weeks)|Physician Decision|2|||
147594644|NCT02960893|532333863|FG000|Open Label Extension Phase (336 Weeks)|Withdrawal by Subject|0|||
147190948|NCT00626275|530865868|FG006|Part A - Treatment Period 1|Withdrawal by Subject|0|||
147594645|NCT02960893|532333864|FG001|Open Label Extension Phase (336 Weeks)|Withdrawal by Subject|0|||
147594646|NCT02960893|532333865|FG002|Open Label Extension Phase (336 Weeks)|Withdrawal by Subject|19|||
147594647|NCT02960893|532333866|FG003|Open Label Extension Phase (336 Weeks)|Withdrawal by Subject|18|||
147594648|NCT02960893|532333863|FG000|Open Label Extension Phase (336 Weeks)|Sponsor Request|0|||
147594649|NCT02960893|532333864|FG001|Open Label Extension Phase (336 Weeks)|Sponsor Request|0|||
147594650|NCT02960893|532333865|FG002|Open Label Extension Phase (336 Weeks)|Sponsor Request|4|||
147594651|NCT02960893|532333866|FG003|Open Label Extension Phase (336 Weeks)|Sponsor Request|2|||
147594652|NCT02960893|532333863|FG000|Open Label Extension Phase (336 Weeks)|Miscellaneous|0|||
147594653|NCT02960893|532333864|FG001|Open Label Extension Phase (336 Weeks)|Miscellaneous|0|||
147594654|NCT02960893|532333865|FG002|Open Label Extension Phase (336 Weeks)|Miscellaneous|3|||
147594655|NCT02960893|532333866|FG003|Open Label Extension Phase (336 Weeks)|Miscellaneous|1|||
147594656|NCT05142566|532333867|FG000|Overall Study|Protocol Violation|1|||
147594657|NCT04718194|532333870|FG000|Overall Study|Withdrawal by Subject|3|||
147594658|NCT04718194|532333871|FG001|Overall Study|Withdrawal by Subject|0|||
147594659|NCT04718194|532333870|FG000|Overall Study|Lost to Follow-up|3|||
147594660|NCT04718194|532333871|FG001|Overall Study|Lost to Follow-up|0|||
147594661|NCT04551911|532333874|FG000|Overall Study|Lost to Follow-up|2|||
147594662|NCT04551911|532333875|FG001|Overall Study|Lost to Follow-up|1|||
147594663|NCT04551911|532333874|FG000|Overall Study|Withdrawal by Subject|10|||
147594664|NCT04551911|532333875|FG001|Overall Study|Withdrawal by Subject|10|||
147594665|NCT04551911|532333874|FG000|Overall Study|Did not receive the study drug|3|||
147594666|NCT04551911|532333875|FG001|Overall Study|Did not receive the study drug|4|||
147594667|NCT01215513|532333876|FG000|Overall Study|Not completed CS42|9|||
147594668|NCT01215513|532333876|FG000|Overall Study|Not enrolled from CS42 to CS42A|21|||
147594669|NCT01215513|532333876|FG000|Overall Study|Adverse event (CS42A)|2|||
147594670|NCT01215513|532333876|FG000|Overall Study|Physician decision (CS42A)|6|||
147594671|NCT01215513|532333876|FG000|Overall Study|Withdrawal by subject (CS42A)|5|||
147594672|NCT01215513|532333876|FG000|Overall Study|Miscellaneous reasons (CS42A)|2|||
147594673|NCT00821873|532333878|FG000|Overall Study|Lost to Follow-up|4|||
147594674|NCT00729248|532333883|FG000|Overall Study|Physician Decision|2|||
147594675|NCT00922272|532333886|FG000|Open-label Phase|Adverse Event|5|||
147594676|NCT00922272|532333887|FG001|Open-label Phase|Adverse Event|0|||
147594677|NCT00922272|532333886|FG000|Open-label Phase|Protocol Violation|1|||
147594678|NCT00922272|532333887|FG001|Open-label Phase|Protocol Violation|0|||
147594679|NCT00922272|532333886|FG000|Open-label Phase|Withdrawal by Subject|11|||
147594680|NCT00922272|532333887|FG001|Open-label Phase|Withdrawal by Subject|0|||
147594681|NCT00922272|532333886|FG000|Open-label Phase|Failure to meet randomization criteria|1|||
147594682|NCT00922272|532333887|FG001|Open-label Phase|Failure to meet randomization criteria|0|||
147594683|NCT00922272|532333886|FG000|Open-label Phase|Withdrawal criteria met|5|||
147594684|NCT00922272|532333887|FG001|Open-label Phase|Withdrawal criteria met|0|||
147594685|NCT00922272|532333886|FG000|Double-blind Phase|Adverse Event|1|||
147594686|NCT00922272|532333887|FG001|Double-blind Phase|Adverse Event|1|||
147594687|NCT00922272|532333886|FG000|Double-blind Phase|Withdrawal by Subject|1|||
147594688|NCT00922272|532333887|FG001|Double-blind Phase|Withdrawal by Subject|1|||
147594689|NCT00922272|532333886|FG000|Double-blind Phase|Lost to Follow-up|2|||
147594690|NCT00922272|532333887|FG001|Double-blind Phase|Lost to Follow-up|1|||
147594691|NCT00922272|532333886|FG000|Double-blind Phase|Withdrawal criteria met|1|||
147594692|NCT00922272|532333887|FG001|Double-blind Phase|Withdrawal criteria met|1|||
147594693|NCT00922272|532333886|FG000|Double-blind Phase|Noncompliance|1|||
147594694|NCT00922272|532333887|FG001|Double-blind Phase|Noncompliance|1|||
147594695|NCT00922272|532333886|FG000|Double-blind Phase|Positive urine drug screen|1|||
147594696|NCT00922272|532333887|FG001|Double-blind Phase|Positive urine drug screen|1|||
147594697|NCT02588950|532333894|FG000|Period 2 (Part A)|Withdrawal by Subject|0|||
147594698|NCT02588950|532333895|FG001|Period 2 (Part A)|Withdrawal by Subject|0|||
147594699|NCT02588950|532333896|FG002|Period 2 (Part A)|Withdrawal by Subject|1|||
147594700|NCT02588950|532333897|FG003|Period 2 (Part A)|Withdrawal by Subject|0|||
147594701|NCT02588950|532333894|FG000|Period 3 (Part B)|Withdrawal by Subject|0|||
147594702|NCT02588950|532333895|FG001|Period 3 (Part B)|Withdrawal by Subject|0|||
147594703|NCT02588950|532333896|FG002|Period 3 (Part B)|Withdrawal by Subject|0|||
147594704|NCT02588950|532333897|FG003|Period 3 (Part B)|Withdrawal by Subject|1|||
147594705|NCT00866658|532333898|FG000|Overall Study|Adverse Event|5|||
147331092|NCT05484726|531377574|FG000|Overall Study|IVH (G III & IV)|2|||
147331093|NCT05484726|531377575|FG001|Overall Study|IVH (G III & IV)|1|||
147331094|NCT05484726|531377574|FG000|Overall Study|NEC (stage II & III)|2|||
147331095|NCT05484726|531377575|FG001|Overall Study|NEC (stage II & III)|3|||
147331096|NCT03396913|531377576|FG000|Overall Study|Lost to Follow-up|0|||
147331097|NCT03396913|531377577|FG001|Overall Study|Lost to Follow-up|6|||
147331098|NCT02781584|531377578|FG000|Pre-treatment Phase|Investigator's Discretion|0|||
147331099|NCT02781584|531377579|FG001|Pre-treatment Phase|Investigator's Discretion|0|||
147594706|NCT00866658|532333899|FG001|Overall Study|Adverse Event|14|||
147594707|NCT00866658|532333898|FG000|Overall Study|Lack of Efficacy|2|||
147594708|NCT00866658|532333899|FG001|Overall Study|Lack of Efficacy|1|||
147594709|NCT00866658|532333898|FG000|Overall Study|Withdrawal by Subject|1|||
147594710|NCT00866658|532333899|FG001|Overall Study|Withdrawal by Subject|0|||
147594711|NCT00866658|532333898|FG000|Overall Study|Protocol Violation|1|||
147594712|NCT00866658|532333899|FG001|Overall Study|Protocol Violation|1|||
147594713|NCT00866658|532333898|FG000|Overall Study|Familial and Personal Reasons|4|||
147658751|NCT03428100|532572312|FG001|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
147594714|NCT00866658|532333899|FG001|Overall Study|Familial and Personal Reasons|5|||
147594715|NCT00652028|532333900|FG000|Overall Study|Adverse Event|1|||
147331100|NCT02781584|531377580|FG002|Pre-treatment Phase|Investigator's Discretion|0|||
147594716|NCT00652028|532333901|FG001|Overall Study|Adverse Event|0|||
147594717|NCT00652028|532333902|FG002|Overall Study|Adverse Event|0|||
147594718|NCT00652028|532333903|FG003|Overall Study|Adverse Event|0|||
147594719|NCT00652028|532333900|FG000|Overall Study|No Longer Meets Entry Criteria|0|||
147594720|NCT00652028|532333901|FG001|Overall Study|No Longer Meets Entry Criteria|1|||
147594721|NCT00652028|532333902|FG002|Overall Study|No Longer Meets Entry Criteria|0|||
147594722|NCT00652028|532333903|FG003|Overall Study|No Longer Meets Entry Criteria|0|||
147594723|NCT00652028|532333900|FG000|Overall Study|Physician Decision|0|||
147594724|NCT00652028|532333901|FG001|Overall Study|Physician Decision|0|||
147594725|NCT00652028|532333902|FG002|Overall Study|Physician Decision|1|||
147594726|NCT00652028|532333903|FG003|Overall Study|Physician Decision|0|||
147594727|NCT02072824|532333904|FG000|Overall Study|Insufficient clinical response|1|||
147594728|NCT02072824|532333905|FG001|Overall Study|Insufficient clinical response|0|||
147594729|NCT02072824|532333906|FG002|Overall Study|Insufficient clinical response|1|||
147594730|NCT02072824|532333904|FG000|Overall Study|No longer willing to participate|1|||
147594731|NCT02072824|532333905|FG001|Overall Study|No longer willing to participate|0|||
147594732|NCT02072824|532333906|FG002|Overall Study|No longer willing to participate|1|||
147594733|NCT02072824|532333904|FG000|Overall Study|Medication error|0|||
147594734|NCT02072824|532333905|FG001|Overall Study|Medication error|1|||
147594735|NCT02072824|532333906|FG002|Overall Study|Medication error|0|||
147594736|NCT02072824|532333904|FG000|Overall Study|Adverse Event|0|||
147594737|NCT02072824|532333905|FG001|Overall Study|Adverse Event|0|||
147594738|NCT02072824|532333906|FG002|Overall Study|Adverse Event|1|||
147594739|NCT02751359|532333907|FG000|Overall Study|Lost to Follow-up|1|||
147594740|NCT02011113|532333908|FG000|Overall Study|Adverse Event|4|||
147594741|NCT02011113|532333908|FG000|Overall Study|Disease Progression (DP)|16|||
147594742|NCT02011113|532333908|FG000|Overall Study|Death|1|||
147594743|NCT02011113|532333908|FG000|Overall Study|Insufficient effect of Pomalidomide|1|||
147594744|NCT02011113|532333908|FG000|Overall Study|Investigator's judgement- DP|3|||
147594745|NCT02011113|532333908|FG000|Overall Study|Study terminated by sponsor|11|||
147594746|NCT02669940|532333911|FG000|Overall Study|Failure to return|0|||
147594747|NCT02669940|532333912|FG001|Overall Study|Failure to return|3|||
147594748|NCT02669940|532333911|FG000|Overall Study|Insufficient follow-up data|1|||
147594749|NCT02669940|532333912|FG001|Overall Study|Insufficient follow-up data|0|||
147594750|NCT05065983|532333921|FG000|Overall Study|Lost to Follow-up|2|||
147594751|NCT00986180|532333922|FG000|Overall Study|Adverse Event|21|||
147594752|NCT00986180|532333923|FG001|Overall Study|Adverse Event|23|||
147594753|NCT00986180|532333922|FG000|Overall Study|Lack of Efficacy|4|||
147594754|NCT00986180|532333923|FG001|Overall Study|Lack of Efficacy|3|||
147594755|NCT00986180|532333922|FG000|Overall Study|Lost to Follow-up|5|||
147594756|NCT00986180|532333923|FG001|Overall Study|Lost to Follow-up|7|||
147594757|NCT00986180|532333922|FG000|Overall Study|Physician Decision|1|||
147594758|NCT00986180|532333923|FG001|Overall Study|Physician Decision|3|||
147594759|NCT00986180|532333922|FG000|Overall Study|Protocol Violation|2|||
147594760|NCT00986180|532333923|FG001|Overall Study|Protocol Violation|0|||
147594761|NCT00986180|532333922|FG000|Overall Study|Withdrawal by Subject|1|||
147594762|NCT00986180|532333923|FG001|Overall Study|Withdrawal by Subject|9|||
147594763|NCT00986180|532333922|FG000|Overall Study|Miscellanies|10|||
147594764|NCT00986180|532333923|FG001|Overall Study|Miscellanies|11|||
147594765|NCT01765582|532333924|FG000|Overall Study|Other|3|||
147594766|NCT01765582|532333925|FG001|Overall Study|Other|6|||
147594767|NCT01765582|532333926|FG002|Overall Study|Other|9|||
147594768|NCT01765582|532333924|FG000|Overall Study|Lost to Follow-up|2|||
147594769|NCT01765582|532333925|FG001|Overall Study|Lost to Follow-up|2|||
147594770|NCT01765582|532333926|FG002|Overall Study|Lost to Follow-up|1|||
147594771|NCT01765582|532333924|FG000|Overall Study|Death|31|||
147594772|NCT01765582|532333925|FG001|Overall Study|Death|36|||
147594773|NCT01765582|532333926|FG002|Overall Study|Death|33|||
147594774|NCT01765582|532333924|FG000|Overall Study|Sponsor Decision|46|||
147594775|NCT01765582|532333925|FG001|Overall Study|Sponsor Decision|42|||
147594776|NCT01765582|532333926|FG002|Overall Study|Sponsor Decision|42|||
147658752|NCT03428100|532572313|FG002|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
147594777|NCT01765582|532333924|FG000|Overall Study|Withdrawal of Consent|11|||
147594778|NCT01765582|532333925|FG001|Overall Study|Withdrawal of Consent|6|||
147594779|NCT01765582|532333926|FG002|Overall Study|Withdrawal of Consent|10|||
147594780|NCT03251963|532333931|FG000|Overall Study|inappropriate Xa level timing|6|||
147594781|NCT03251963|532333932|FG001|Overall Study|inappropriate Xa level timing|3|||
147594782|NCT03251963|532333931|FG000|Overall Study|no peak Xa level drawn|2|||
147658753|NCT03428100|532572314|FG003|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
147594783|NCT03251963|532333932|FG001|Overall Study|no peak Xa level drawn|0|||
147594784|NCT03251963|532333931|FG000|Overall Study|bled prior to Xa level|1|||
147594785|NCT03251963|532333932|FG001|Overall Study|bled prior to Xa level|2|||
147594786|NCT00616941|532333933|FG000|Overall Study|Progressive Disease|1|||
147594787|NCT00616941|532333934|FG001|Overall Study|Progressive Disease|2|||
147594788|NCT00616941|532333935|FG002|Overall Study|Progressive Disease|1|||
147594789|NCT00616941|532333933|FG000|Overall Study|Adverse Event|0|||
147594790|NCT00616941|532333934|FG001|Overall Study|Adverse Event|1|||
147594791|NCT00616941|532333935|FG002|Overall Study|Adverse Event|1|||
147190949|NCT00626275|530865869|FG007|Part A - Treatment Period 1|Withdrawal by Subject|0|||
147190950|NCT00626275|530865862|FG000|Part B|Lost to Follow-up|0|||
147190951|NCT00626275|530865863|FG001|Part B|Lost to Follow-up|0|||
147190952|NCT00626275|530865864|FG002|Part B|Lost to Follow-up|0|||
147190953|NCT00626275|530865865|FG003|Part B|Lost to Follow-up|0|||
147190954|NCT00626275|530865866|FG004|Part B|Lost to Follow-up|0|||
147190955|NCT00626275|530865867|FG005|Part B|Lost to Follow-up|0|||
147190956|NCT00626275|530865868|FG006|Part B|Lost to Follow-up|1|||
147190957|NCT00626275|530865869|FG007|Part B|Lost to Follow-up|0|||
147594792|NCT00616941|532333933|FG000|Overall Study|Subject Non-compliance|0|||
147594793|NCT00616941|532333934|FG001|Overall Study|Subject Non-compliance|0|||
147594794|NCT00616941|532333935|FG002|Overall Study|Subject Non-compliance|1|||
147594795|NCT00616941|532333933|FG000|Overall Study|Unrelated Medical Illness/Complication|0|||
147594796|NCT00616941|532333934|FG001|Overall Study|Unrelated Medical Illness/Complication|2|||
147594797|NCT00616941|532333935|FG002|Overall Study|Unrelated Medical Illness/Complication|0|||
147594798|NCT00616941|532333933|FG000|Overall Study|Vaccination Suspended|0|||
147594799|NCT00616941|532333934|FG001|Overall Study|Vaccination Suspended|0|||
147594800|NCT00616941|532333935|FG002|Overall Study|Vaccination Suspended|3|||
147594801|NCT04392583|532333937|FG000|Overall Study|Participant declined follow-up and subsequently withdrawn|1|||
147594802|NCT03484117|532333941|FG000|Overall Study|Lost to Follow-up|1|||
147594803|NCT03484117|532333942|FG001|Overall Study|Lost to Follow-up|3|||
147594804|NCT03484117|532333941|FG000|Overall Study|Declined participation in exit assess|1|||
147594805|NCT03484117|532333942|FG001|Overall Study|Declined participation in exit assess|1|||
147594806|NCT00003875|532333943|FG000|Overall Study|Screen Failed|1|||
147594807|NCT02303041|532333944|FG000|Overall Study|Adverse Event|1|||
147594808|NCT02303041|532333945|FG001|Overall Study|Adverse Event|2|||
147594809|NCT00886288|532333946|FG000|Overall Study|no respect of the 12 weeks period|657|||
147594810|NCT00886288|532333947|FG001|Overall Study|no respect of the 12 weeks period|227|||
147594811|NCT00886288|532333946|FG000|Overall Study|Lost to Follow-up|86|||
147594812|NCT00886288|532333947|FG001|Overall Study|Lost to Follow-up|0|||
147594813|NCT00289874|532333948|FG000|Overall Study|Adverse Event|1|||
147594814|NCT00289874|532333949|FG001|Overall Study|Adverse Event|5|||
147594815|NCT00289874|532333948|FG000|Overall Study|Lost to Follow-up|1|||
147594816|NCT00289874|532333949|FG001|Overall Study|Lost to Follow-up|1|||
147594817|NCT00289874|532333948|FG000|Overall Study|Protocol Violation|3|||
147594818|NCT00289874|532333949|FG001|Overall Study|Protocol Violation|2|||
147594819|NCT00289874|532333948|FG000|Overall Study|Did not meet eligibility|1|||
147594820|NCT00289874|532333949|FG001|Overall Study|Did not meet eligibility|0|||
147594821|NCT00136318|532333952|FG000|Overall Study|Adverse Event|5|||
147594822|NCT00136318|532333953|FG001|Overall Study|Adverse Event|5|||
147594823|NCT00136318|532333952|FG000|Overall Study|Withdrawal by Subject|2|||
147594824|NCT00136318|532333953|FG001|Overall Study|Withdrawal by Subject|2|||
147594825|NCT03835325|532333954|FG000|Overall Study|Lack of adherence to protocol procedures|1|||
147594826|NCT03835325|532333954|FG000|Overall Study|Selection failure|1|||
147594827|NCT01370213|532333955|FG000|Overall Study|Early Death|1|||
147594828|NCT01370213|532333956|FG001|Overall Study|Early Death|0|||
147594829|NCT01370213|532333957|FG002|Overall Study|Early Death|0|||
147594830|NCT01370213|532333955|FG000|Overall Study|Not evaluable|0|||
147594831|NCT01370213|532333956|FG001|Overall Study|Not evaluable|2|||
147594832|NCT01370213|532333957|FG002|Overall Study|Not evaluable|0|||
147594833|NCT01550744|532333960|FG000|Open-Label|Lost to Follow-up|7|||
147594834|NCT01550744|532333961|FG001|Open-Label|Lost to Follow-up|0|||
147594835|NCT01550744|532333962|FG002|Open-Label|Lost to Follow-up|0|||
147594836|NCT01550744|532333960|FG000|Open-Label|Withdrawal by Subject|13|||
147594837|NCT01550744|532333961|FG001|Open-Label|Withdrawal by Subject|0|||
147594838|NCT01550744|532333962|FG002|Open-Label|Withdrawal by Subject|0|||
147594839|NCT01550744|532333960|FG000|Open-Label|Adverse Event|11|||
147594840|NCT01550744|532333961|FG001|Open-Label|Adverse Event|0|||
147594841|NCT01550744|532333962|FG002|Open-Label|Adverse Event|0|||
147594842|NCT01550744|532333960|FG000|Open-Label|Lack of Efficacy|4|||
147594843|NCT01550744|532333961|FG001|Open-Label|Lack of Efficacy|0|||
147594844|NCT01550744|532333962|FG002|Open-Label|Lack of Efficacy|0|||
147594845|NCT01550744|532333960|FG000|Open-Label|Protocol Violation|4|||
147594846|NCT01550744|532333961|FG001|Open-Label|Protocol Violation|0|||
147594847|NCT01550744|532333962|FG002|Open-Label|Protocol Violation|0|||
147594848|NCT01550744|532333960|FG000|Open-Label|Not all 3 study drug injections received|2|||
147594849|NCT01550744|532333961|FG001|Open-Label|Not all 3 study drug injections received|0|||
147594850|NCT01550744|532333962|FG002|Open-Label|Not all 3 study drug injections received|0|||
147594851|NCT01550744|532333960|FG000|Open-Label|Static PGA-cleared/minimal not achieved|58|||
147594852|NCT01550744|532333961|FG001|Open-Label|Static PGA-cleared/minimal not achieved|0|||
147594853|NCT01550744|532333962|FG002|Open-Label|Static PGA-cleared/minimal not achieved|0|||
147594854|NCT01550744|532333960|FG000|Open-Label|Other|1|||
147594855|NCT01550744|532333961|FG001|Open-Label|Other|0|||
147594856|NCT01550744|532333962|FG002|Open-Label|Other|0|||
147190958|NCT00626275|530865862|FG000|Part B|Withdrawal by Subject|0|||
147190959|NCT00626275|530865863|FG001|Part B|Withdrawal by Subject|0|||
147190960|NCT00626275|530865864|FG002|Part B|Withdrawal by Subject|0|||
147594857|NCT01550744|532333960|FG000|Double-Blind|Lost to Follow-up|0|||
147248425|NCT00855920|531078624|FG002|Overall Study|Other than specified above|1|||
147594858|NCT01550744|532333961|FG001|Double-Blind|Lost to Follow-up|6|||
147594859|NCT01550744|532333962|FG002|Double-Blind|Lost to Follow-up|12|||
147594860|NCT01550744|532333960|FG000|Double-Blind|Withdrawal by Subject|0|||
147594861|NCT01550744|532333961|FG001|Double-Blind|Withdrawal by Subject|2|||
147594862|NCT01550744|532333962|FG002|Double-Blind|Withdrawal by Subject|15|||
147594863|NCT01550744|532333960|FG000|Double-Blind|Adverse Event|0|||
147594864|NCT01550744|532333961|FG001|Double-Blind|Adverse Event|4|||
147594865|NCT01550744|532333962|FG002|Double-Blind|Adverse Event|15|||
147594866|NCT01550744|532333960|FG000|Double-Blind|Death|0|||
147594867|NCT01550744|532333961|FG001|Double-Blind|Death|1|||
147594868|NCT01550744|532333962|FG002|Double-Blind|Death|0|||
147594869|NCT01550744|532333960|FG000|Double-Blind|Lack of Efficacy|0|||
147594870|NCT01550744|532333961|FG001|Double-Blind|Lack of Efficacy|2|||
147594871|NCT01550744|532333962|FG002|Double-Blind|Lack of Efficacy|8|||
147594872|NCT01550744|532333960|FG000|Double-Blind|Protocol Violation|0|||
147594873|NCT01550744|532333961|FG001|Double-Blind|Protocol Violation|0|||
147594874|NCT01550744|532333962|FG002|Double-Blind|Protocol Violation|4|||
147594875|NCT01550744|532333960|FG000|Double-Blind|Pregnancy|0|||
147594876|NCT01550744|532333961|FG001|Double-Blind|Pregnancy|0|||
147594877|NCT01550744|532333962|FG002|Double-Blind|Pregnancy|3|||
147594878|NCT01550744|532333960|FG000|Double-Blind|Other|0|||
147594879|NCT01550744|532333961|FG001|Double-Blind|Other|2|||
147658754|NCT03428100|532572315|FG004|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
147248426|NCT01605877|531078627|FG000|Overall Study|Withdrawal by Subject|1|||
147248427|NCT00687323|531078628|FG000|Overall Study|Death|25|||
147248428|NCT00687323|531078628|FG000|Overall Study|Withdrawal by Subject|1|||
147248429|NCT00687323|531078628|FG000|Overall Study|Excluded from efficacy evaluations|6|||
147248430|NCT00687323|531078628|FG000|Overall Study|Screen failure|148|||
147248431|NCT02132130|531078629|FG000|Overall Study|Lost to Follow-up|0|||
147248432|NCT02132130|531078630|FG001|Overall Study|Lost to Follow-up|2|||
147248433|NCT02132130|531078631|FG002|Overall Study|Lost to Follow-up|0|||
147248434|NCT02132130|531078632|FG003|Overall Study|Lost to Follow-up|0|||
147248435|NCT02132130|531078629|FG000|Overall Study|Withdrawal by Subject|0|||
147248436|NCT02132130|531078630|FG001|Overall Study|Withdrawal by Subject|0|||
147248437|NCT02132130|531078631|FG002|Overall Study|Withdrawal by Subject|0|||
147248438|NCT02132130|531078632|FG003|Overall Study|Withdrawal by Subject|1|||
147248439|NCT02760069|531078633|FG000|Overall Study|Withdrawal by Subject|0|||
147248440|NCT02760069|531078634|FG001|Overall Study|Withdrawal by Subject|1|||
147248441|NCT02760069|531078635|FG002|Overall Study|Withdrawal by Subject|1|||
147248442|NCT00646776|531078645|FG000|Overall Study|Adverse Event|1|||
147248443|NCT00646776|531078646|FG001|Overall Study|Adverse Event|9|||
147248444|NCT00646776|531078645|FG000|Overall Study|Investigator discretion|0|||
147248445|NCT00646776|531078646|FG001|Overall Study|Investigator discretion|4|||
147248446|NCT00600483|531078651|FG000|Overall Study|Lost to Follow-up|26|||
147248447|NCT00600483|531078652|FG001|Overall Study|Lost to Follow-up|47|||
147248448|NCT00600483|531078651|FG000|Overall Study|Randomized but not treated|10|||
147248449|NCT00600483|531078652|FG001|Overall Study|Randomized but not treated|0|||
147248450|NCT01482884|531078661|FG000|Overall Study|Medical decision due to lack of efficacy|0|||
147248451|NCT01482884|531078662|FG001|Overall Study|Medical decision due to lack of efficacy|1|||
147248452|NCT01482884|531078661|FG000|Overall Study|Protocol Violation|1|||
147248453|NCT01482884|531078662|FG001|Overall Study|Protocol Violation|0|||
147248454|NCT01482884|531078661|FG000|Overall Study|Lost to Follow-up|2|||
147248455|NCT01482884|531078662|FG001|Overall Study|Lost to Follow-up|2|||
147248456|NCT01482884|531078661|FG000|Overall Study|Lack of Efficacy|0|||
147248457|NCT01482884|531078662|FG001|Overall Study|Lack of Efficacy|1|||
147248458|NCT01482884|531078661|FG000|Overall Study|Adverse Event|2|||
147248459|NCT01482884|531078662|FG001|Overall Study|Adverse Event|1|||
147248460|NCT01482884|531078661|FG000|Overall Study|Withdrawal by Subject|8|||
147248461|NCT01482884|531078662|FG001|Overall Study|Withdrawal by Subject|13|||
147248462|NCT03031678|531078665|FG000|Overall Study|Study closed prior to completion|1|||
147248463|NCT00439244|531078666|FG000|Overall Study|Adverse Event|5|||
147248464|NCT00439244|531078667|FG001|Overall Study|Adverse Event|2|||
147248465|NCT00439244|531078668|FG002|Overall Study|Adverse Event|3|||
147331101|NCT02781584|531377581|FG003|Pre-treatment Phase|Investigator's Discretion|0|||
147331102|NCT02781584|531377582|FG004|Pre-treatment Phase|Investigator's Discretion|0|||
147331103|NCT02781584|531377583|FG005|Pre-treatment Phase|Investigator's Discretion|0|||
147449413|NCT02706873|531809501|FG000|Period 1 (Weeks 1 to 48)|Other|5|||
147594880|NCT01550744|532333962|FG002|Double-Blind|Other|10|||
147594881|NCT00706381|532333965|FG000|Overall Study|Lost to Follow-up|0|||
147594882|NCT00706381|532333966|FG001|Overall Study|Lost to Follow-up|1|||
147594883|NCT00706381|532333967|FG002|Overall Study|Lost to Follow-up|1|||
147594884|NCT00706381|532333968|FG003|Overall Study|Lost to Follow-up|0|||
147594885|NCT04355663|532333969|FG000|Overall Study|Physician Decision|2|||
147594886|NCT04355663|532333970|FG001|Overall Study|Physician Decision|7|||
147248466|NCT00439244|531078666|FG000|Overall Study|Withdrawal by Subject|3|||
147248467|NCT00439244|531078667|FG001|Overall Study|Withdrawal by Subject|1|||
147594887|NCT04355663|532333971|FG002|Overall Study|Physician Decision|0|||
147594888|NCT04355663|532333969|FG000|Overall Study|Adverse Event|0|||
147594889|NCT04355663|532333970|FG001|Overall Study|Adverse Event|0|||
147190961|NCT00626275|530865865|FG003|Part B|Withdrawal by Subject|0|||
147190962|NCT00626275|530865866|FG004|Part B|Withdrawal by Subject|0|||
147190963|NCT00626275|530865867|FG005|Part B|Withdrawal by Subject|0|||
147190964|NCT00626275|530865868|FG006|Part B|Withdrawal by Subject|0|||
147594890|NCT04355663|532333971|FG002|Overall Study|Adverse Event|1|||
147594891|NCT04355663|532333969|FG000|Overall Study|Withdrawal by Subject|0|||
147594892|NCT04355663|532333970|FG001|Overall Study|Withdrawal by Subject|8|||
147594893|NCT04355663|532333971|FG002|Overall Study|Withdrawal by Subject|3|||
147594894|NCT03395639|532333975|FG000|Main Treatment Period (0 to 4 Months)|Withdrawal by Subject|2|||
147594895|NCT03395639|532333976|FG001|Main Treatment Period (0 to 4 Months)|Withdrawal by Subject|2|||
147594896|NCT03395639|532333977|FG002|Main Treatment Period (0 to 4 Months)|Withdrawal by Subject|0|||
147594897|NCT03395639|532333975|FG000|Main Treatment Period (0 to 4 Months)|Adverse Event|1|||
147594898|NCT03395639|532333976|FG001|Main Treatment Period (0 to 4 Months)|Adverse Event|0|||
147594899|NCT03395639|532333977|FG002|Main Treatment Period (0 to 4 Months)|Adverse Event|0|||
147594900|NCT03395639|532333975|FG000|Main Treatment Period (0 to 4 Months)|Participant discontinued at Principal Investigator discretion|0|||
147594901|NCT03395639|532333976|FG001|Main Treatment Period (0 to 4 Months)|Participant discontinued at Principal Investigator discretion|1|||
147594902|NCT03395639|532333977|FG002|Main Treatment Period (0 to 4 Months)|Participant discontinued at Principal Investigator discretion|0|||
147594903|NCT03395639|532333975|FG000|Extension Period (4-13 Months)|Adverse Event|0|||
147594904|NCT03395639|532333976|FG001|Extension Period (4-13 Months)|Adverse Event|0|||
147594905|NCT03395639|532333977|FG002|Extension Period (4-13 Months)|Adverse Event|2|||
147594906|NCT03395639|532333975|FG000|Extension Period (4-13 Months)|Subject discontinued at PI discretion|0|||
147594907|NCT03395639|532333976|FG001|Extension Period (4-13 Months)|Subject discontinued at PI discretion|0|||
147594908|NCT03395639|532333977|FG002|Extension Period (4-13 Months)|Subject discontinued at PI discretion|1|||
147594909|NCT00995085|532333981|FG000|Overall Study|Withdrawal by Subject|5|||
147594910|NCT02595008|532333982|FG000|Overall Study|Enrolled In Error|1|||
147594911|NCT02595008|532333983|FG001|Overall Study|Enrolled In Error|0|||
147594912|NCT03407118|532333984|FG000|Period 2|Withdrawal by Subject|1|||
147594913|NCT03407118|532333985|FG001|Period 2|Withdrawal by Subject|0|||
147594914|NCT02093221|532333988|FG000|Overall Study|Adverse Event|1|||
147594915|NCT02093221|532333989|FG001|Overall Study|Adverse Event|0|||
147594916|NCT02093221|532333990|FG002|Overall Study|Adverse Event|0|||
147594917|NCT02093221|532333991|FG003|Overall Study|Adverse Event|0|||
147594918|NCT02093221|532333992|FG004|Overall Study|Adverse Event|0|||
147594919|NCT02093221|532333988|FG000|Overall Study|Withdrawal by Subject|1|||
147594920|NCT02093221|532333989|FG001|Overall Study|Withdrawal by Subject|1|||
147594921|NCT02093221|532333990|FG002|Overall Study|Withdrawal by Subject|4|||
147594922|NCT02093221|532333991|FG003|Overall Study|Withdrawal by Subject|1|||
147449414|NCT02706873|531809502|FG001|Period 1 (Weeks 1 to 48)|Other|1|||
147594923|NCT02093221|532333992|FG004|Overall Study|Withdrawal by Subject|1|||
147594924|NCT02093221|532333988|FG000|Overall Study|Lost to Follow-up|2|||
147594925|NCT02093221|532333989|FG001|Overall Study|Lost to Follow-up|0|||
147594926|NCT02093221|532333990|FG002|Overall Study|Lost to Follow-up|1|||
147594927|NCT02093221|532333991|FG003|Overall Study|Lost to Follow-up|1|||
147594928|NCT02093221|532333992|FG004|Overall Study|Lost to Follow-up|0|||
147594929|NCT02093221|532333988|FG000|Overall Study|Death|0|||
147190965|NCT00626275|530865869|FG007|Part B|Withdrawal by Subject|1|||
147190966|NCT01362348|530865870|FG000|Overall Study|Protocol-defined stopping criteria|9|||
147190967|NCT01362348|530865870|FG000|Overall Study|Study closed/terminated|5|||
147190968|NCT02675907|530865871|FG000|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|4|||
147190969|NCT02675907|530865872|FG001|Treatment Phase (48 Hours Post-Dose 1)|Lack of Efficacy|4|||
147190970|NCT02675907|530865871|FG000|Treatment Phase (48 Hours Post-Dose 1)|Withdrawal by Subject|1|||
147190971|NCT02675907|530865872|FG001|Treatment Phase (48 Hours Post-Dose 1)|Withdrawal by Subject|1|||
147190972|NCT02675907|530865871|FG000|Study Overall|Lack of Efficacy|1|||
147190973|NCT02675907|530865872|FG001|Study Overall|Lack of Efficacy|0|||
147190974|NCT02675907|530865871|FG000|Study Overall|Withdrawal by Subject|2|||
147190975|NCT02675907|530865872|FG001|Study Overall|Withdrawal by Subject|2|||
147190976|NCT02675907|530865871|FG000|Study Overall|Lost to Follow-up|0|||
147190977|NCT02675907|530865872|FG001|Study Overall|Lost to Follow-up|2|||
147190978|NCT01611792|530865873|FG000|Initial Period: Time 0|unable to schedule 10 consecutive appts|12|||
147190979|NCT01611792|530865874|FG001|Initial Period: Time 0|unable to schedule 10 consecutive appts|9|||
147190980|NCT01611792|530865873|FG000|Followup: at 6 Months|Lost to Follow-up|6|||
147190981|NCT01611792|530865874|FG001|Followup: at 6 Months|Lost to Follow-up|13|||
147190982|NCT03289208|530865879|FG000|Overall Study|Adverse Event|1|||
147190983|NCT03289208|530865880|FG001|Overall Study|Adverse Event|0|||
147190984|NCT03289208|530865881|FG002|Overall Study|Adverse Event|0|||
147190985|NCT00550407|530865882|FG000|8-16 Week Preliminary (Open-Label) Phase|Adverse Event|55|||
147190986|NCT00550407|530865883|FG001|8-16 Week Preliminary (Open-Label) Phase|Adverse Event|0|||
147190987|NCT00550407|530865884|FG002|8-16 Week Preliminary (Open-Label) Phase|Adverse Event|0|||
147190988|NCT00550407|530865882|FG000|8-16 Week Preliminary (Open-Label) Phase|Lack of Efficacy|39|||
147331104|NCT02781584|531377584|FG006|Pre-treatment Phase|Investigator's Discretion|0|||
147331105|NCT02781584|531377585|FG007|Pre-treatment Phase|Investigator's Discretion|0|||
147331106|NCT02781584|531377586|FG008|Pre-treatment Phase|Investigator's Discretion|0|||
147331107|NCT02781584|531377587|FG009|Pre-treatment Phase|Investigator's Discretion|0|||
147331108|NCT02781584|531377588|FG010|Pre-treatment Phase|Investigator's Discretion|0|||
147331109|NCT02781584|531377589|FG011|Pre-treatment Phase|Investigator's Discretion|2|||
147331110|NCT02781584|531377590|FG012|Pre-treatment Phase|Investigator's Discretion|1|||
147331111|NCT02781584|531377578|FG000|Pre-treatment Phase|Adverse Event|0|||
147331112|NCT02781584|531377579|FG001|Pre-treatment Phase|Adverse Event|0|||
147331113|NCT02781584|531377580|FG002|Pre-treatment Phase|Adverse Event|0|||
147331114|NCT02781584|531377581|FG003|Pre-treatment Phase|Adverse Event|0|||
147449415|NCT02706873|531809503|FG002|Period 1 (Weeks 1 to 48)|Other|2|||
147449416|NCT02706873|531809504|FG003|Period 1 (Weeks 1 to 48)|Other|3|||
147449417|NCT02706873|531809501|FG000|Period 1 (Weeks 1 to 48)|Not Dosed|1|||
147449418|NCT02706873|531809502|FG001|Period 1 (Weeks 1 to 48)|Not Dosed|0|||
147449419|NCT02706873|531809503|FG002|Period 1 (Weeks 1 to 48)|Not Dosed|0|||
147449420|NCT02706873|531809504|FG003|Period 1 (Weeks 1 to 48)|Not Dosed|1|||
147449421|NCT02706873|531809501|FG000|Period 2 (Weeks 48 to 260)|Adverse Event|16|||
147449422|NCT02706873|531809502|FG001|Period 2 (Weeks 48 to 260)|Adverse Event|4|||
147449423|NCT02706873|531809503|FG002|Period 2 (Weeks 48 to 260)|Adverse Event|11|||
147449424|NCT02706873|531809504|FG003|Period 2 (Weeks 48 to 260)|Adverse Event|26|||
147449425|NCT02706873|531809501|FG000|Period 2 (Weeks 48 to 260)|Withdrawal by Subject|32|||
147449426|NCT02706873|531809502|FG001|Period 2 (Weeks 48 to 260)|Withdrawal by Subject|5|||
147449427|NCT02706873|531809503|FG002|Period 2 (Weeks 48 to 260)|Withdrawal by Subject|23|||
147449428|NCT02706873|531809504|FG003|Period 2 (Weeks 48 to 260)|Withdrawal by Subject|27|||
147449429|NCT02706873|531809501|FG000|Period 2 (Weeks 48 to 260)|Lost to Follow-up|17|||
147449430|NCT02706873|531809502|FG001|Period 2 (Weeks 48 to 260)|Lost to Follow-up|0|||
147449431|NCT02706873|531809503|FG002|Period 2 (Weeks 48 to 260)|Lost to Follow-up|10|||
147449432|NCT02706873|531809504|FG003|Period 2 (Weeks 48 to 260)|Lost to Follow-up|6|||
147658755|NCT03428100|532572316|FG005|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
147658756|NCT03428100|532572317|FG006|Long-Term Extension Week 52 to Week 200|Physician Decision|1|||
147331115|NCT02781584|531377582|FG004|Pre-treatment Phase|Adverse Event|0|||
147331116|NCT02781584|531377583|FG005|Pre-treatment Phase|Adverse Event|0|||
147331117|NCT02781584|531377584|FG006|Pre-treatment Phase|Adverse Event|0|||
147331118|NCT02781584|531377585|FG007|Pre-treatment Phase|Adverse Event|0|||
147331119|NCT02781584|531377586|FG008|Pre-treatment Phase|Adverse Event|0|||
147331120|NCT02781584|531377587|FG009|Pre-treatment Phase|Adverse Event|0|||
147331121|NCT02781584|531377588|FG010|Pre-treatment Phase|Adverse Event|0|||
147331122|NCT02781584|531377589|FG011|Pre-treatment Phase|Adverse Event|1|||
147331123|NCT02781584|531377590|FG012|Pre-treatment Phase|Adverse Event|0|||
147658757|NCT03428100|532572318|FG007|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
147658758|NCT03428100|532572319|FG008|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
147658759|NCT03428100|532572320|FG009|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
147658760|NCT03428100|532572321|FG010|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
147658761|NCT03428100|532572322|FG011|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
147658762|NCT03428100|532572323|FG012|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
147658763|NCT03428100|532572324|FG013|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
147658764|NCT03428100|532572325|FG014|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
147658765|NCT03428100|532572326|FG015|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
147658766|NCT03428100|532572327|FG016|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
147658767|NCT03428100|532572328|FG017|Long-Term Extension Week 52 to Week 200|Physician Decision|0|||
147658768|NCT03428100|532572329|FG018|Long-Term Extension Week 52 to Week 200|Physician Decision|1|||
147658769|NCT03428100|532572311|FG000|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|0|||
147658770|NCT03428100|532572312|FG001|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|0|||
147658771|NCT03428100|532572313|FG002|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|0|||
147658772|NCT03428100|532572314|FG003|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|0|||
147658773|NCT03428100|532572315|FG004|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|10|||
147658774|NCT03428100|532572316|FG005|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|4|||
147658775|NCT03428100|532572317|FG006|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|8|||
147658776|NCT03428100|532572318|FG007|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|8|||
147658777|NCT03428100|532572319|FG008|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|3|||
147449433|NCT02706873|531809501|FG000|Period 2 (Weeks 48 to 260)|Lack of Efficacy|11|||
147449434|NCT02706873|531809502|FG001|Period 2 (Weeks 48 to 260)|Lack of Efficacy|0|||
147449435|NCT02706873|531809503|FG002|Period 2 (Weeks 48 to 260)|Lack of Efficacy|1|||
147449436|NCT02706873|531809504|FG003|Period 2 (Weeks 48 to 260)|Lack of Efficacy|1|||
147449437|NCT02706873|531809501|FG000|Period 2 (Weeks 48 to 260)|Coronavirus Disease of 2019 (COVID-19) Infection|0|||
147331124|NCT02781584|531377578|FG000|Treatment Phase|Withdrew Consent|0|||
147331125|NCT02781584|531377579|FG001|Treatment Phase|Withdrew Consent|0|||
147658778|NCT03428100|532572320|FG009|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|7|||
147248468|NCT00439244|531078668|FG002|Overall Study|Withdrawal by Subject|2|||
147658779|NCT03428100|532572321|FG010|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|11|||
147658780|NCT03428100|532572322|FG011|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|11|||
147658781|NCT03428100|532572323|FG012|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|8|||
147658782|NCT03428100|532572324|FG013|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|6|||
147658783|NCT03428100|532572325|FG014|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|12|||
147658784|NCT03428100|532572326|FG015|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|5|||
147658785|NCT03428100|532572327|FG016|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|3|||
147658786|NCT03428100|532572328|FG017|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|1|||
147658787|NCT03428100|532572329|FG018|Long-Term Extension Week 52 to Week 200|Study Terminated by Sponsor|7|||
147658788|NCT03428100|532572311|FG000|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
147658789|NCT03428100|532572312|FG001|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
147658790|NCT03428100|532572313|FG002|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
147658791|NCT03428100|532572314|FG003|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
147658792|NCT03428100|532572315|FG004|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|2|||
147658793|NCT03428100|532572316|FG005|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
147658794|NCT03428100|532572317|FG006|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|5|||
147658795|NCT03428100|532572318|FG007|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|2|||
147658796|NCT03428100|532572319|FG008|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
147658797|NCT03428100|532572320|FG009|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|6|||
147658798|NCT03428100|532572321|FG010|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|13|||
147658799|NCT03428100|532572322|FG011|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|5|||
147658800|NCT03428100|532572323|FG012|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|2|||
147658801|NCT03428100|532572324|FG013|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|5|||
147658802|NCT03428100|532572325|FG014|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|1|||
147658803|NCT03428100|532572326|FG015|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
147658804|NCT03428100|532572327|FG016|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|4|||
147658805|NCT03428100|532572328|FG017|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|2|||
147658806|NCT03428100|532572329|FG018|Long-Term Extension Week 52 to Week 200|Withdrawal by Subject|0|||
147658807|NCT01118663|532572331|FG000|Overall Study|Adverse Event|2|||
147658808|NCT01118663|532572332|FG001|Overall Study|Adverse Event|1|||
147658809|NCT01118663|532572331|FG000|Overall Study|Withdrawal by Subject|0|||
147658810|NCT01118663|532572332|FG001|Overall Study|Withdrawal by Subject|1|||
147658811|NCT04039204|532572333|FG000|Overall Study|Withdrawal by Subject|0|||
147658812|NCT04039204|532572334|FG001|Overall Study|Withdrawal by Subject|2|||
147658813|NCT01189461|532572335|FG000|Overall Study|Lack of Efficacy|13|||
147658814|NCT01189461|532572335|FG000|Overall Study|Lost to Follow-up|1|||
147658815|NCT01189461|532572335|FG000|Overall Study|Withdrawal by Subject|6|||
147658816|NCT01189461|532572335|FG000|Overall Study|Protocol Violation|1|||
147658817|NCT01189461|532572335|FG000|Overall Study|Adverse Event|2|||
147658818|NCT01189461|532572335|FG000|Overall Study|Did not meet entrance criteria|3|||
147658819|NCT01189461|532572335|FG000|Overall Study|Other|8|||
147658820|NCT02282163|532572338|FG000|Overall Study|Protocol Violation|1|||
147658821|NCT03472521|532572339|FG000|Overall Study|Lost to Follow-up|3|||
147658822|NCT03472521|532572340|FG001|Overall Study|Lost to Follow-up|2|||
147658823|NCT03472521|532572339|FG000|Overall Study|Discontinued intervention|3|||
147658824|NCT03472521|532572340|FG001|Overall Study|Discontinued intervention|1|||
147658825|NCT00391872|532574270|FG000|Overall Study|Protocol Violation|7|||
147658826|NCT00391872|532574271|FG001|Overall Study|Protocol Violation|2|||
147248469|NCT00439244|531078666|FG000|Overall Study|Lost to Follow-up|2|||
147248470|NCT00439244|531078667|FG001|Overall Study|Lost to Follow-up|1|||
147248471|NCT00439244|531078668|FG002|Overall Study|Lost to Follow-up|2|||
147248472|NCT00439244|531078666|FG000|Overall Study|Death|0|||
147248473|NCT00439244|531078667|FG001|Overall Study|Death|1|||
147248474|NCT00439244|531078668|FG002|Overall Study|Death|0|||
147248475|NCT00439244|531078666|FG000|Overall Study|Protocol Violation|0|||
147248476|NCT00439244|531078667|FG001|Overall Study|Protocol Violation|1|||
147248477|NCT00439244|531078668|FG002|Overall Study|Protocol Violation|0|||
147248478|NCT00439244|531078666|FG000|Overall Study|Administrative problems|1|||
147248479|NCT00439244|531078667|FG001|Overall Study|Administrative problems|0|||
147248480|NCT00439244|531078668|FG002|Overall Study|Administrative problems|0|||
147248481|NCT04557371|531078671|FG000|Overall Study|Covid-19-related|0|||
147248482|NCT04557371|531078672|FG001|Overall Study|Covid-19-related|1|||
147248483|NCT04557371|531078673|FG002|Overall Study|Covid-19-related|0|||
147248484|NCT04557371|531078671|FG000|Overall Study|Withdrawal by Subject|0|||
147248485|NCT04557371|531078672|FG001|Overall Study|Withdrawal by Subject|1|||
147248486|NCT04557371|531078673|FG002|Overall Study|Withdrawal by Subject|0|||
147248487|NCT04557371|531078671|FG000|Overall Study|Adverse Event|1|||
147248488|NCT04557371|531078672|FG001|Overall Study|Adverse Event|0|||
147594930|NCT02093221|532333989|FG001|Overall Study|Death|1|||
147248489|NCT04557371|531078673|FG002|Overall Study|Adverse Event|0|||
147248490|NCT05109442|531078678|FG000|Overall Study|Withdrawal by Subject|0|||
147248491|NCT05109442|531078679|FG001|Overall Study|Withdrawal by Subject|0|||
147248492|NCT05109442|531078680|FG002|Overall Study|Withdrawal by Subject|1|||
147248493|NCT05109442|531078681|FG003|Overall Study|Withdrawal by Subject|0|||
147594931|NCT02093221|532333990|FG002|Overall Study|Death|0|||
147248494|NCT05109442|531078682|FG004|Overall Study|Withdrawal by Subject|0|||
147248495|NCT05109442|531078683|FG005|Overall Study|Withdrawal by Subject|0|||
147248496|NCT05109442|531078678|FG000|Overall Study|Adverse Event|0|||
147248497|NCT05109442|531078679|FG001|Overall Study|Adverse Event|1|||
147248498|NCT05109442|531078680|FG002|Overall Study|Adverse Event|5|||
147248499|NCT05109442|531078681|FG003|Overall Study|Adverse Event|0|||
147248500|NCT05109442|531078682|FG004|Overall Study|Adverse Event|0|||
147248501|NCT05109442|531078683|FG005|Overall Study|Adverse Event|2|||
147248502|NCT05109442|531078678|FG000|Overall Study|Death|0|||
147248503|NCT05109442|531078679|FG001|Overall Study|Death|0|||
147248504|NCT05109442|531078680|FG002|Overall Study|Death|4|||
147248505|NCT05109442|531078681|FG003|Overall Study|Death|0|||
147248506|NCT05109442|531078682|FG004|Overall Study|Death|0|||
147248507|NCT05109442|531078683|FG005|Overall Study|Death|1|||
147248508|NCT05109442|531078678|FG000|Overall Study|Physician Decision|1|||
147248509|NCT05109442|531078679|FG001|Overall Study|Physician Decision|0|||
147248510|NCT05109442|531078680|FG002|Overall Study|Physician Decision|1|||
147248511|NCT05109442|531078681|FG003|Overall Study|Physician Decision|0|||
147248512|NCT05109442|531078682|FG004|Overall Study|Physician Decision|0|||
147248513|NCT05109442|531078683|FG005|Overall Study|Physician Decision|2|||
147248514|NCT05109442|531078678|FG000|Overall Study|Other than listed|0|||
147248515|NCT05109442|531078679|FG001|Overall Study|Other than listed|0|||
147248516|NCT05109442|531078680|FG002|Overall Study|Other than listed|9|||
147594932|NCT02093221|532333991|FG003|Overall Study|Death|0|||
147594933|NCT02093221|532333992|FG004|Overall Study|Death|0|||
147594934|NCT02093221|532333988|FG000|Overall Study|Protocol Violation|0|||
147594935|NCT02093221|532333989|FG001|Overall Study|Protocol Violation|1|||
147594936|NCT02093221|532333990|FG002|Overall Study|Protocol Violation|0|||
147594937|NCT02093221|532333991|FG003|Overall Study|Protocol Violation|0|||
147594938|NCT02093221|532333992|FG004|Overall Study|Protocol Violation|0|||
147594939|NCT02093221|532333988|FG000|Overall Study|Study termination|6|||
147594940|NCT02093221|532333989|FG001|Overall Study|Study termination|5|||
147594941|NCT02093221|532333990|FG002|Overall Study|Study termination|4|||
147594942|NCT02093221|532333991|FG003|Overall Study|Study termination|6|||
147594943|NCT02093221|532333992|FG004|Overall Study|Study termination|7|||
147594944|NCT02037165|532333995|FG000|Washout Period 4 (6 Days)|Withdrawal by Subject|0|||
147594945|NCT02037165|532333996|FG001|Washout Period 4 (6 Days)|Withdrawal by Subject|0|||
147594946|NCT02037165|532333997|FG002|Washout Period 4 (6 Days)|Withdrawal by Subject|0|||
147594947|NCT02037165|532333998|FG003|Washout Period 4 (6 Days)|Withdrawal by Subject|0|||
147594948|NCT02037165|532333999|FG004|Washout Period 4 (6 Days)|Withdrawal by Subject|1|||
147594949|NCT02220725|532334000|FG000|Overall Study|Lost to Follow-up|0|||
147594950|NCT02220725|532334001|FG001|Overall Study|Lost to Follow-up|0|||
147594951|NCT02220725|532334002|FG002|Overall Study|Lost to Follow-up|0|||
147594952|NCT02220725|532334003|FG003|Overall Study|Lost to Follow-up|1|||
147594953|NCT02220725|532334000|FG000|Overall Study|Withdrawal by Subject|0|||
147594954|NCT02220725|532334001|FG001|Overall Study|Withdrawal by Subject|0|||
147658827|NCT00391872|532574270|FG000|Overall Study|Withdrawal by Subject|296|||
147658828|NCT00391872|532574271|FG001|Overall Study|Withdrawal by Subject|249|||
147658829|NCT00391872|532574270|FG000|Overall Study|Reason unknown|2|||
147658830|NCT00391872|532574271|FG001|Overall Study|Reason unknown|4|||
147190989|NCT00550407|530865883|FG001|8-16 Week Preliminary (Open-Label) Phase|Lack of Efficacy|0|||
147190990|NCT00550407|530865884|FG002|8-16 Week Preliminary (Open-Label) Phase|Lack of Efficacy|0|||
147190991|NCT00550407|530865882|FG000|8-16 Week Preliminary (Open-Label) Phase|Protocol Violation|1|||
147190992|NCT00550407|530865883|FG001|8-16 Week Preliminary (Open-Label) Phase|Protocol Violation|0|||
147190993|NCT00550407|530865884|FG002|8-16 Week Preliminary (Open-Label) Phase|Protocol Violation|0|||
147190994|NCT00550407|530865882|FG000|8-16 Week Preliminary (Open-Label) Phase|Defined Stopping Criteria Reached|1|||
147190995|NCT00550407|530865883|FG001|8-16 Week Preliminary (Open-Label) Phase|Defined Stopping Criteria Reached|0|||
147190996|NCT00550407|530865884|FG002|8-16 Week Preliminary (Open-Label) Phase|Defined Stopping Criteria Reached|0|||
147190997|NCT00550407|530865882|FG000|8-16 Week Preliminary (Open-Label) Phase|Lost to Follow-up|1|||
147190998|NCT00550407|530865883|FG001|8-16 Week Preliminary (Open-Label) Phase|Lost to Follow-up|0|||
147190999|NCT00550407|530865884|FG002|8-16 Week Preliminary (Open-Label) Phase|Lost to Follow-up|0|||
147191000|NCT00550407|530865882|FG000|8-16 Week Preliminary (Open-Label) Phase|Investigator Discretion|8|||
147248517|NCT05109442|531078681|FG003|Overall Study|Other than listed|2|||
147248518|NCT05109442|531078682|FG004|Overall Study|Other than listed|0|||
147248519|NCT05109442|531078683|FG005|Overall Study|Other than listed|8|||
147248520|NCT05109442|531078678|FG000|Overall Study|Lack of Efficacy|3|||
147248521|NCT05109442|531078679|FG001|Overall Study|Lack of Efficacy|5|||
147594955|NCT02220725|532334002|FG002|Overall Study|Withdrawal by Subject|0|||
147658831|NCT00391872|532574270|FG000|Overall Study|Lost to Follow-up|2|||
147594956|NCT02220725|532334003|FG003|Overall Study|Withdrawal by Subject|1|||
147594957|NCT01673698|532334004|FG000|Overall Study|Lost to Follow-up|51|||
147594958|NCT01673698|532334005|FG001|Overall Study|Lost to Follow-up|13|||
147594959|NCT01297322|532334006|FG000|Overall Study|Lost to Follow-up|1|||
147594960|NCT01297322|532334007|FG001|Overall Study|Lost to Follow-up|0|||
147594961|NCT01297322|532334006|FG000|Overall Study|Withdrawal by Subject|0|||
147594962|NCT01297322|532334007|FG001|Overall Study|Withdrawal by Subject|1|||
147594963|NCT01297322|532334006|FG000|Overall Study|Protocol Violation|0|||
147594964|NCT01297322|532334007|FG001|Overall Study|Protocol Violation|3|||
147594965|NCT00712985|532334008|FG000|Overall Study|1 withdrew prior to start of drug|1|||
147594966|NCT00712985|532334008|FG000|Overall Study|1 patient moved out of state|1|||
147594967|NCT00712985|532334008|FG000|Overall Study|Lack of Efficacy|3|||
147594968|NCT01232491|532334009|FG000|Overall Study|Adverse Event|13|||
147594969|NCT01232491|532334010|FG001|Overall Study|Adverse Event|8|||
147594970|NCT01232491|532334009|FG000|Overall Study|Lack of Efficacy|1|||
147594971|NCT01232491|532334010|FG001|Overall Study|Lack of Efficacy|5|||
147594972|NCT01232491|532334009|FG000|Overall Study|Protocol Violation|13|||
147594973|NCT01232491|532334010|FG001|Overall Study|Protocol Violation|11|||
147594974|NCT01232491|532334009|FG000|Overall Study|Withdrawal Criteria|12|||
147594975|NCT01232491|532334010|FG001|Overall Study|Withdrawal Criteria|21|||
147594976|NCT01232491|532334009|FG000|Overall Study|Other|21|||
147594977|NCT01232491|532334010|FG001|Overall Study|Other|18|||
147594978|NCT06204887|532335686|FG000|Overall Study|Lost to Follow-up|3|||
147594979|NCT06204887|532335687|FG001|Overall Study|Lost to Follow-up|4|||
147594980|NCT06204887|532335688|FG002|Overall Study|Lost to Follow-up|1|||
147594981|NCT06204887|532335689|FG003|Overall Study|Lost to Follow-up|6|||
147594982|NCT02522403|532335690|FG000|Overall Study|Lost to Follow-up|2|||
147594983|NCT02522403|532335691|FG001|Overall Study|Lost to Follow-up|2|||
147594984|NCT02522403|532335690|FG000|Overall Study|Withdrawal by Subject|2|||
147594985|NCT02522403|532335691|FG001|Overall Study|Withdrawal by Subject|4|||
147594986|NCT00856973|532335692|FG000|Overall Study|Adverse Event|5|||
147594987|NCT00856973|532335693|FG001|Overall Study|Adverse Event|5|||
147594988|NCT00856973|532335694|FG002|Overall Study|Adverse Event|3|||
147594989|NCT00856973|532335692|FG000|Overall Study|Lost to Follow-up|6|||
147594990|NCT00856973|532335693|FG001|Overall Study|Lost to Follow-up|3|||
147594991|NCT00856973|532335694|FG002|Overall Study|Lost to Follow-up|5|||
147594992|NCT00856973|532335692|FG000|Overall Study|Physician Decision|0|||
147594993|NCT00856973|532335693|FG001|Overall Study|Physician Decision|3|||
147594994|NCT00856973|532335694|FG002|Overall Study|Physician Decision|1|||
147594995|NCT00856973|532335692|FG000|Overall Study|Protocol Violation|1|||
147594996|NCT00856973|532335693|FG001|Overall Study|Protocol Violation|2|||
147594997|NCT00856973|532335694|FG002|Overall Study|Protocol Violation|1|||
147594998|NCT00856973|532335692|FG000|Overall Study|Withdrawal by Subject|13|||
147594999|NCT00856973|532335693|FG001|Overall Study|Withdrawal by Subject|16|||
147595000|NCT00856973|532335694|FG002|Overall Study|Withdrawal by Subject|15|||
147595001|NCT00856973|532335692|FG000|Overall Study|Other|11|||
147595002|NCT00856973|532335693|FG001|Overall Study|Other|12|||
147595003|NCT00856973|532335694|FG002|Overall Study|Other|13|||
147595004|NCT04556552|532335697|FG000|Overall Study|Lost to Follow-up|1|||
147595005|NCT04556552|532335698|FG001|Overall Study|Lost to Follow-up|0|||
147595006|NCT04556552|532335697|FG000|Overall Study|Claustrophobia|0|||
147595007|NCT04556552|532335698|FG001|Overall Study|Claustrophobia|1|||
147595008|NCT04556552|532335697|FG000|Overall Study|Inability to continue|0|||
147595009|NCT04556552|532335698|FG001|Overall Study|Inability to continue|1|||
147595010|NCT01553279|532335699|FG000|Part 1 (Infant Vaccinations)|Lost to Follow-up|1|||
147595011|NCT01553279|532335700|FG001|Part 1 (Infant Vaccinations)|Lost to Follow-up|0|||
147595012|NCT01553279|532335699|FG000|Part 1 (Infant Vaccinations)|Withdrawal by Subject|1|||
147595013|NCT01553279|532335700|FG001|Part 1 (Infant Vaccinations)|Withdrawal by Subject|1|||
147595014|NCT01553279|532335699|FG000|Interim Period|Withdrawal by Subject|2|||
147595015|NCT01553279|532335700|FG001|Interim Period|Withdrawal by Subject|2|||
147595016|NCT01553279|532335699|FG000|Interim Period|Lost to Follow-up|1|||
147595017|NCT01553279|532335700|FG001|Interim Period|Lost to Follow-up|0|||
147595018|NCT01553279|532335699|FG000|Period 2: Toddler Vaccinations|Withdrawal by Subject|0|||
147595019|NCT01553279|532335700|FG001|Period 2: Toddler Vaccinations|Withdrawal by Subject|5|||
147595020|NCT01553279|532335699|FG000|Period 2: Toddler Vaccinations|Lost to Follow-up|3|||
147191001|NCT00550407|530865883|FG001|8-16 Week Preliminary (Open-Label) Phase|Investigator Discretion|0|||
147191002|NCT00550407|530865884|FG002|8-16 Week Preliminary (Open-Label) Phase|Investigator Discretion|0|||
147191003|NCT00550407|530865882|FG000|8-16 Week Preliminary (Open-Label) Phase|Withdrew Consent|6|||
147191004|NCT00550407|530865883|FG001|8-16 Week Preliminary (Open-Label) Phase|Withdrew Consent|0|||
147191005|NCT00550407|530865884|FG002|8-16 Week Preliminary (Open-Label) Phase|Withdrew Consent|0|||
147191006|NCT00550407|530865882|FG000|8-16 Week Preliminary (Open-Label) Phase|Continuation Criteria Not Met|1|||
147191007|NCT00550407|530865883|FG001|8-16 Week Preliminary (Open-Label) Phase|Continuation Criteria Not Met|0|||
147595021|NCT01553279|532335700|FG001|Period 2: Toddler Vaccinations|Lost to Follow-up|2|||
147595022|NCT00605865|532335701|FG000|Overall Study|Protocol Violation|115|||
147595023|NCT03955471|532335702|FG000|Overall Study|Death|22|||
147595024|NCT03955471|532335702|FG000|Overall Study|Lost to Follow-up|1|||
147595025|NCT03955471|532335702|FG000|Overall Study|Withdrawal by Subject|6|||
147595026|NCT03955471|532335702|FG000|Overall Study|Sponsor Decision to Terminate Study|11|||
147595027|NCT01030341|532335705|FG000|Overall Study|Withdrawal by Subject|1|||
147595028|NCT01030341|532335705|FG000|Overall Study|Lost to Follow-up|2|||
147595029|NCT01884311|532335708|FG000|Overall Study|Withdrawal by Subject|3|||
147595030|NCT01884311|532335708|FG000|Overall Study|withdrew consent due to AEs|1|||
147595031|NCT01884311|532335708|FG000|Overall Study|Precautionary measure|1|||
147595032|NCT02856880|532335709|FG000|Overall Study|Withdrawal of consent|1|||
147595033|NCT00793780|532335710|FG000|Overall Study|Withdrawal by Subject|2|||
147595034|NCT00793780|532335711|FG001|Overall Study|Withdrawal by Subject|1|||
147595035|NCT02858492|532335712|FG000|Overall Study|Withdrawal by Subject|0|||
147595036|NCT02858492|532335713|FG001|Overall Study|Withdrawal by Subject|1|||
147595037|NCT02858492|532335714|FG002|Overall Study|Withdrawal by Subject|0|||
147595038|NCT02858492|532335715|FG003|Overall Study|Withdrawal by Subject|1|||
147595039|NCT02858492|532335712|FG000|Overall Study|Adverse Event|0|||
147595040|NCT02858492|532335713|FG001|Overall Study|Adverse Event|0|||
147595041|NCT02858492|532335714|FG002|Overall Study|Adverse Event|0|||
147595042|NCT02858492|532335715|FG003|Overall Study|Adverse Event|3|||
147595043|NCT02858492|532335712|FG000|Overall Study|Lack of Efficacy|0|||
147595044|NCT02858492|532335713|FG001|Overall Study|Lack of Efficacy|0|||
147595045|NCT02858492|532335714|FG002|Overall Study|Lack of Efficacy|0|||
147595046|NCT02858492|532335715|FG003|Overall Study|Lack of Efficacy|1|||
147595047|NCT02858492|532335712|FG000|Overall Study|Protocol defined stopping criteria|0|||
147595048|NCT02858492|532335713|FG001|Overall Study|Protocol defined stopping criteria|0|||
147595049|NCT02858492|532335714|FG002|Overall Study|Protocol defined stopping criteria|0|||
147595050|NCT02858492|532335715|FG003|Overall Study|Protocol defined stopping criteria|1|||
147595051|NCT00573157|532335716|FG000|Overall Study|Adverse Event|3|||
147595052|NCT00573157|532335717|FG001|Overall Study|Adverse Event|1|||
147595053|NCT00573157|532335716|FG000|Overall Study|Other|1|||
147595054|NCT00573157|532335717|FG001|Overall Study|Other|1|||
147595055|NCT01032018|532335718|FG000|Overall Study|Lost to Follow-up|6|||
147595056|NCT01032018|532335719|FG001|Overall Study|Lost to Follow-up|5|||
147595057|NCT01032018|532335718|FG000|Overall Study|Death|0|||
147595058|NCT01032018|532335719|FG001|Overall Study|Death|1|||
147595059|NCT01388166|532335725|FG000|Overall Study|Adverse Event|16|||
147595060|NCT01388166|532335725|FG000|Overall Study|Lost to Follow-up|30|||
147595061|NCT01388166|532335725|FG000|Overall Study|Others than specified above|13|||
147595062|NCT00841906|532335726|FG000|Overall Study|Withdrawal by Subject|2|||
147595063|NCT00841906|532335727|FG001|Overall Study|Withdrawal by Subject|0|||
147595064|NCT01196078|532335728|FG000|Overall Study|Withdrawal by Subject|3|||
147248522|NCT05109442|531078680|FG002|Overall Study|Lack of Efficacy|29|||
147248523|NCT05109442|531078681|FG003|Overall Study|Lack of Efficacy|10|||
147248524|NCT05109442|531078682|FG004|Overall Study|Lack of Efficacy|11|||
147248525|NCT05109442|531078683|FG005|Overall Study|Lack of Efficacy|17|||
147248526|NCT01774968|531078688|FG000|Overall Study|Adverse Event|4|||
147248527|NCT01774968|531078689|FG001|Overall Study|Adverse Event|4|||
147248528|NCT01774968|531078688|FG000|Overall Study|Death|0|||
147248529|NCT01774968|531078689|FG001|Overall Study|Death|1|||
147248530|NCT01774968|531078688|FG000|Overall Study|Lost to Follow-up|1|||
147248531|NCT01774968|531078689|FG001|Overall Study|Lost to Follow-up|3|||
147248532|NCT01774968|531078688|FG000|Overall Study|Physician Decision|5|||
147248533|NCT01774968|531078689|FG001|Overall Study|Physician Decision|1|||
147248534|NCT01774968|531078688|FG000|Overall Study|Protocol Violation|14|||
147248535|NCT01774968|531078689|FG001|Overall Study|Protocol Violation|13|||
147248536|NCT01774968|531078688|FG000|Overall Study|Sponsor Decision|0|||
147248537|NCT01774968|531078689|FG001|Overall Study|Sponsor Decision|2|||
147248538|NCT01774968|531078688|FG000|Overall Study|Withdrawal by Subject|6|||
147248539|NCT01774968|531078689|FG001|Overall Study|Withdrawal by Subject|11|||
147248540|NCT04847557|531078690|FG000|Overall Study|Adverse Event|1|||
147248541|NCT04847557|531078691|FG001|Overall Study|Adverse Event|0|||
147248542|NCT04847557|531078690|FG000|Overall Study|Death|19|||
147248543|NCT04847557|531078691|FG001|Overall Study|Death|15|||
147248544|NCT04847557|531078690|FG000|Overall Study|Lost to Follow-up|3|||
147248545|NCT04847557|531078691|FG001|Overall Study|Lost to Follow-up|6|||
147595065|NCT01196078|532335729|FG001|Overall Study|Withdrawal by Subject|5|||
147595066|NCT01196078|532335728|FG000|Overall Study|Adverse Event|4|||
147595067|NCT01196078|532335729|FG001|Overall Study|Adverse Event|4|||
147595068|NCT01196078|532335728|FG000|Overall Study|Protocol Violation|2|||
147595069|NCT01196078|532335729|FG001|Overall Study|Protocol Violation|1|||
147248546|NCT04847557|531078690|FG000|Overall Study|Physician Decision|1|||
147248547|NCT04847557|531078691|FG001|Overall Study|Physician Decision|0|||
147248548|NCT04847557|531078690|FG000|Overall Study|Protocol Violation|0|||
147248549|NCT04847557|531078691|FG001|Overall Study|Protocol Violation|1|||
147248550|NCT04847557|531078690|FG000|Overall Study|Withdrawal by Subject|8|||
147248551|NCT04847557|531078691|FG001|Overall Study|Withdrawal by Subject|14|||
147248552|NCT01325584|531078692|FG000|Overall Study|Death|1|||
147595070|NCT01196078|532335728|FG000|Overall Study|Lack of Efficacy|17|||
147595071|NCT01196078|532335729|FG001|Overall Study|Lack of Efficacy|23|||
147595072|NCT01196078|532335728|FG000|Overall Study|Lost to Follow-up|1|||
147595073|NCT01196078|532335729|FG001|Overall Study|Lost to Follow-up|0|||
147595074|NCT01196078|532335728|FG000|Overall Study|Death|6|||
147248553|NCT00524368|531080726|FG000|Overall Study|Adverse Event|10|||
147248554|NCT00524368|531080727|FG001|Overall Study|Adverse Event|12|||
147248555|NCT00524368|531080726|FG000|Overall Study|Lost to Follow-up|9|||
147248556|NCT00524368|531080727|FG001|Overall Study|Lost to Follow-up|13|||
147248557|NCT00524368|531080726|FG000|Overall Study|Withdrawal by Subject|4|||
147248558|NCT00524368|531080727|FG001|Overall Study|Withdrawal by Subject|5|||
147248559|NCT00524368|531080726|FG000|Overall Study|Non-compliant|8|||
147248560|NCT00524368|531080727|FG001|Overall Study|Non-compliant|9|||
147248561|NCT00524368|531080726|FG000|Overall Study|Reached a Virologic Endpoint|3|||
147248562|NCT00524368|531080727|FG001|Overall Study|Reached a Virologic Endpoint|2|||
147248563|NCT00524368|531080726|FG000|Overall Study|Sponsor's Decision|2|||
147248564|NCT00524368|531080727|FG001|Overall Study|Sponsor's Decision|0|||
147248565|NCT00524368|531080726|FG000|Overall Study|Ineligible to Continue the study|2|||
147248566|NCT00524368|531080727|FG001|Overall Study|Ineligible to Continue the study|5|||
147248567|NCT00524368|531080726|FG000|Overall Study|Other|3|||
147248568|NCT00524368|531080727|FG001|Overall Study|Other|2|||
147248569|NCT01955733|531080728|FG000|Period 1|Lost to Follow-up|1|||
147248570|NCT01955733|531080729|FG001|Period 1|Lost to Follow-up|0|||
147248571|NCT01955733|531080730|FG002|Period 1|Lost to Follow-up|0|||
147248572|NCT01955733|531080728|FG000|Period 2|Adverse Event|1|||
147248573|NCT01955733|531080729|FG001|Period 2|Adverse Event|0|||
147248574|NCT01955733|531080730|FG002|Period 2|Adverse Event|0|||
147248575|NCT01955733|531080728|FG000|Period 2|Physician Decision|0|||
147248576|NCT01955733|531080729|FG001|Period 2|Physician Decision|0|||
147248577|NCT01955733|531080730|FG002|Period 2|Physician Decision|1|||
147248578|NCT01955733|531080728|FG000|Period 2|Withdrawal by Subject|1|||
147248579|NCT01955733|531080729|FG001|Period 2|Withdrawal by Subject|3|||
147248580|NCT01955733|531080730|FG002|Period 2|Withdrawal by Subject|2|||
147248581|NCT01955733|531080728|FG000|Period 2|Study terminated by sponsor|8|||
147248582|NCT01955733|531080729|FG001|Period 2|Study terminated by sponsor|14|||
147248583|NCT01955733|531080730|FG002|Period 2|Study terminated by sponsor|16|||
147248584|NCT01955733|531080728|FG000|Period 2|Lost to Follow-up|2|||
147248585|NCT01955733|531080729|FG001|Period 2|Lost to Follow-up|0|||
147248586|NCT01955733|531080730|FG002|Period 2|Lost to Follow-up|0|||
147248587|NCT01955733|531080728|FG000|Period 2|Other not defined above|0|||
147248588|NCT01955733|531080729|FG001|Period 2|Other not defined above|2|||
147248589|NCT01955733|531080730|FG002|Period 2|Other not defined above|2|||
147248590|NCT00793598|531080731|FG000|Overall Study|Patient Request|0|||
147248591|NCT00793598|531080732|FG001|Overall Study|Patient Request|1|||
147248592|NCT00793598|531080733|FG002|Overall Study|Patient Request|0|||
147248593|NCT00793598|531080734|FG003|Overall Study|Patient Request|0|||
147248594|NCT00793598|531080735|FG004|Overall Study|Patient Request|0|||
147248595|NCT00793598|531080736|FG005|Overall Study|Patient Request|0|||
147248596|NCT00793598|531080737|FG006|Overall Study|Patient Request|0|||
147248597|NCT00793598|531080738|FG007|Overall Study|Patient Request|0|||
147248598|NCT00793598|531080731|FG000|Overall Study|Protocol Violation|0|||
147248599|NCT00793598|531080732|FG001|Overall Study|Protocol Violation|0|||
147248600|NCT00793598|531080733|FG002|Overall Study|Protocol Violation|0|||
147248601|NCT00793598|531080734|FG003|Overall Study|Protocol Violation|0|||
147248602|NCT00793598|531080735|FG004|Overall Study|Protocol Violation|0|||
147248603|NCT00793598|531080736|FG005|Overall Study|Protocol Violation|0|||
147248604|NCT00793598|531080737|FG006|Overall Study|Protocol Violation|0|||
147595075|NCT01196078|532335729|FG001|Overall Study|Death|4|||
147595076|NCT00127036|532335730|FG000|Overall Study|Insufficient Data for Analysis|6|||
147595077|NCT00127036|532335731|FG001|Overall Study|Insufficient Data for Analysis|11|||
147595078|NCT00127036|532335730|FG000|Overall Study|Screen Failure|2|||
147595079|NCT00127036|532335731|FG001|Overall Study|Screen Failure|0|||
147595080|NCT01797835|532335741|FG000|Overall Study|Lost to Follow-up|31|||
147595081|NCT01797835|532335742|FG001|Overall Study|Lost to Follow-up|27|||
147595082|NCT03001219|532335743|FG000|Proof of Concept|Study Termination by Sponsor|0|||
147595083|NCT03001219|532335744|FG001|Proof of Concept|Study Termination by Sponsor|1|||
147248605|NCT00793598|531080738|FG007|Overall Study|Protocol Violation|1|||
147248606|NCT00793598|531080731|FG000|Overall Study|Subject not dosed|0|||
147248607|NCT00793598|531080732|FG001|Overall Study|Subject not dosed|0|||
147248608|NCT00793598|531080733|FG002|Overall Study|Subject not dosed|0|||
147595084|NCT03001219|532335743|FG000|Proof of Concept|Withdrawal by Subject|0|||
147248609|NCT00793598|531080734|FG003|Overall Study|Subject not dosed|0|||
147595085|NCT03001219|532335744|FG001|Proof of Concept|Withdrawal by Subject|4|||
147248610|NCT00793598|531080735|FG004|Overall Study|Subject not dosed|0|||
147248611|NCT00793598|531080736|FG005|Overall Study|Subject not dosed|1|||
147248612|NCT00793598|531080737|FG006|Overall Study|Subject not dosed|0|||
147248613|NCT00793598|531080738|FG007|Overall Study|Subject not dosed|0|||
147248614|NCT02762266|531080739|FG000|Overall Study|Physician Decision|2|||
147248615|NCT02762266|531080740|FG001|Overall Study|Physician Decision|0|||
147248616|NCT02961751|531080753|FG000|Overall Study|Lost to Follow-up|11|||
147248617|NCT02961751|531080753|FG000|Overall Study|Physician Decision|2|||
147248618|NCT02961751|531080753|FG000|Overall Study|Not Eligible at Enrollment|1|||
147248619|NCT02961751|531080753|FG000|Overall Study|Protocol Violation|1|||
147248620|NCT00842712|531080754|FG000|Safety Run-in Part|Adverse Event|0|||
147248621|NCT00842712|531080755|FG001|Safety Run-in Part|Adverse Event|1|||
147248622|NCT00842712|531080756|FG002|Safety Run-in Part|Adverse Event|0|||
147248623|NCT00842712|531080757|FG003|Safety Run-in Part|Adverse Event|0|||
147248624|NCT00842712|531080758|FG004|Safety Run-in Part|Adverse Event|0|||
147248625|NCT00842712|531080759|FG005|Safety Run-in Part|Adverse Event|0|||
147248626|NCT00842712|531080760|FG006|Safety Run-in Part|Adverse Event|0|||
147248627|NCT00842712|531080754|FG000|Safety Run-in Part|Progressive disease|3|||
147248628|NCT00842712|531080755|FG001|Safety Run-in Part|Progressive disease|1|||
147248629|NCT00842712|531080756|FG002|Safety Run-in Part|Progressive disease|0|||
147248630|NCT00842712|531080757|FG003|Safety Run-in Part|Progressive disease|1|||
147248631|NCT00842712|531080758|FG004|Safety Run-in Part|Progressive disease|0|||
147248632|NCT00842712|531080759|FG005|Safety Run-in Part|Progressive disease|0|||
147248633|NCT00842712|531080760|FG006|Safety Run-in Part|Progressive disease|0|||
147248634|NCT00842712|531080754|FG000|Randomized Part|Randomized but not treated|0|||
147248635|NCT00842712|531080755|FG001|Randomized Part|Randomized but not treated|0|||
147248636|NCT00842712|531080756|FG002|Randomized Part|Randomized but not treated|0|||
147248637|NCT00842712|531080757|FG003|Randomized Part|Randomized but not treated|0|||
147248638|NCT00842712|531080758|FG004|Randomized Part|Randomized but not treated|0|||
147248639|NCT00842712|531080759|FG005|Randomized Part|Randomized but not treated|1|||
147248640|NCT00842712|531080760|FG006|Randomized Part|Randomized but not treated|4|||
147248641|NCT00842712|531080754|FG000|Randomized Part|Ongoing at cut-off date|0|||
147248642|NCT00842712|531080755|FG001|Randomized Part|Ongoing at cut-off date|0|||
147248643|NCT00842712|531080756|FG002|Randomized Part|Ongoing at cut-off date|0|||
147248644|NCT00842712|531080757|FG003|Randomized Part|Ongoing at cut-off date|0|||
147248645|NCT00842712|531080758|FG004|Randomized Part|Ongoing at cut-off date|0|||
147248646|NCT00842712|531080759|FG005|Randomized Part|Ongoing at cut-off date|0|||
147248647|NCT00842712|531080760|FG006|Randomized Part|Ongoing at cut-off date|2|||
147248648|NCT02310568|531080766|FG000|Stage 1 ( 4 Weeks)|Lack of Efficacy|0|||
147248649|NCT02310568|531080767|FG001|Stage 1 ( 4 Weeks)|Lack of Efficacy|0|||
147248650|NCT02310568|531080768|FG002|Stage 1 ( 4 Weeks)|Lack of Efficacy|0|||
147248651|NCT02310568|531080769|FG003|Stage 1 ( 4 Weeks)|Lack of Efficacy|0|||
147248652|NCT02310568|531080770|FG004|Stage 1 ( 4 Weeks)|Lack of Efficacy|1|||
147248653|NCT02310568|531080766|FG000|Stage 1 ( 4 Weeks)|Withdrawal by Participants|1|||
147248654|NCT02310568|531080767|FG001|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0|||
147248655|NCT02310568|531080768|FG002|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0|||
147248656|NCT02310568|531080769|FG003|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0|||
147248657|NCT02310568|531080770|FG004|Stage 1 ( 4 Weeks)|Withdrawal by Participants|0|||
147248658|NCT02310568|531080766|FG000|Stage 1 ( 4 Weeks)|Other|1|||
147248659|NCT02310568|531080767|FG001|Stage 1 ( 4 Weeks)|Other|1|||
147248660|NCT02310568|531080768|FG002|Stage 1 ( 4 Weeks)|Other|0|||
147248661|NCT02310568|531080769|FG003|Stage 1 ( 4 Weeks)|Other|0|||
147248662|NCT02310568|531080770|FG004|Stage 1 ( 4 Weeks)|Other|0|||
147248663|NCT02310568|531080766|FG000|Stage 1 ( 4 Weeks)|Adverse Event|1|||
147248664|NCT02310568|531080767|FG001|Stage 1 ( 4 Weeks)|Adverse Event|1|||
147248665|NCT02310568|531080768|FG002|Stage 1 ( 4 Weeks)|Adverse Event|1|||
147248666|NCT02310568|531080769|FG003|Stage 1 ( 4 Weeks)|Adverse Event|0|||
147248667|NCT02310568|531080770|FG004|Stage 1 ( 4 Weeks)|Adverse Event|0|||
147248668|NCT02310568|531080766|FG000|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0|||
147248669|NCT02310568|531080767|FG001|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0|||
147248670|NCT02310568|531080768|FG002|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0|||
147248671|NCT02310568|531080769|FG003|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|1|||
147248672|NCT02310568|531080770|FG004|Stage 1 ( 4 Weeks)|No Longer Meets Eligibility Criteria|0|||
147248673|NCT02310568|531080766|FG000|Stage 1 ( 4 Weeks)|Lost to Follow-up|0|||
147248674|NCT02310568|531080767|FG001|Stage 1 ( 4 Weeks)|Lost to Follow-up|0|||
147248675|NCT02310568|531080768|FG002|Stage 1 ( 4 Weeks)|Lost to Follow-up|0|||
147248676|NCT02310568|531080769|FG003|Stage 1 ( 4 Weeks)|Lost to Follow-up|1|||
147248677|NCT02310568|531080770|FG004|Stage 1 ( 4 Weeks)|Lost to Follow-up|0|||
147248678|NCT02310568|531080766|FG000|Stage 2 (4 Weeks)|Withdrawal by Participants|1|||
147248679|NCT02310568|531080767|FG001|Stage 2 (4 Weeks)|Withdrawal by Participants|0|||
147248680|NCT02310568|531080768|FG002|Stage 2 (4 Weeks)|Withdrawal by Participants|0|||
147248681|NCT02310568|531080769|FG003|Stage 2 (4 Weeks)|Withdrawal by Participants|1|||
147248682|NCT02310568|531080770|FG004|Stage 2 (4 Weeks)|Withdrawal by Participants|0|||
147248683|NCT02310568|531080766|FG000|Stage 2 (4 Weeks)|Other|0|||
147248684|NCT02310568|531080767|FG001|Stage 2 (4 Weeks)|Other|1|||
147658832|NCT00391872|532574271|FG001|Overall Study|Lost to Follow-up|0|||
147248685|NCT02310568|531080768|FG002|Stage 2 (4 Weeks)|Other|1|||
147248686|NCT02310568|531080769|FG003|Stage 2 (4 Weeks)|Other|0|||
147248687|NCT02310568|531080770|FG004|Stage 2 (4 Weeks)|Other|0|||
147248688|NCT02310568|531080766|FG000|Stage 2 (4 Weeks)|Adverse Event|0|||
147248689|NCT02310568|531080767|FG001|Stage 2 (4 Weeks)|Adverse Event|0|||
147248690|NCT02310568|531080768|FG002|Stage 2 (4 Weeks)|Adverse Event|0|||
147248691|NCT02310568|531080769|FG003|Stage 2 (4 Weeks)|Adverse Event|1|||
147658833|NCT01409915|532574272|FG000|Overall Study|Adverse Event|0|||
147248692|NCT02310568|531080770|FG004|Stage 2 (4 Weeks)|Adverse Event|1|||
147248693|NCT02310568|531080766|FG000|Stage 2 (4 Weeks)|Protocol Violation|0|||
147248694|NCT02310568|531080767|FG001|Stage 2 (4 Weeks)|Protocol Violation|0|||
147248695|NCT02310568|531080768|FG002|Stage 2 (4 Weeks)|Protocol Violation|0|||
147331126|NCT02781584|531377580|FG002|Treatment Phase|Withdrew Consent|0|||
147331127|NCT02781584|531377581|FG003|Treatment Phase|Withdrew Consent|0|||
147331128|NCT02781584|531377582|FG004|Treatment Phase|Withdrew Consent|0|||
147331129|NCT02781584|531377583|FG005|Treatment Phase|Withdrew Consent|1|||
147331130|NCT02781584|531377584|FG006|Treatment Phase|Withdrew Consent|0|||
147331131|NCT02781584|531377585|FG007|Treatment Phase|Withdrew Consent|0|||
147331132|NCT02781584|531377586|FG008|Treatment Phase|Withdrew Consent|0|||
147331133|NCT02781584|531377587|FG009|Treatment Phase|Withdrew Consent|0|||
147331134|NCT02781584|531377588|FG010|Treatment Phase|Withdrew Consent|1|||
147331135|NCT02781584|531377589|FG011|Treatment Phase|Withdrew Consent|2|||
147331136|NCT02781584|531377590|FG012|Treatment Phase|Withdrew Consent|0|||
147331137|NCT02781584|531377578|FG000|Treatment Phase|Adverse Event|0|||
147331138|NCT02781584|531377579|FG001|Treatment Phase|Adverse Event|0|||
147331139|NCT02781584|531377580|FG002|Treatment Phase|Adverse Event|0|||
147331140|NCT02781584|531377581|FG003|Treatment Phase|Adverse Event|0|||
147595086|NCT03001219|532335743|FG000|Proof of Concept|Protocol Deviation|0|||
147595087|NCT03001219|532335744|FG001|Proof of Concept|Protocol Deviation|1|||
147595088|NCT03001219|532335743|FG000|Proof of Concept|Adverse Event|1|||
147595089|NCT03001219|532335744|FG001|Proof of Concept|Adverse Event|1|||
147595090|NCT03001219|532335743|FG000|Proof of Concept|Physician Decision|1|||
147595091|NCT03001219|532335744|FG001|Proof of Concept|Physician Decision|0|||
147191008|NCT00550407|530865884|FG002|8-16 Week Preliminary (Open-Label) Phase|Continuation Criteria Not Met|0|||
147191009|NCT00550407|530865882|FG000|26-Week Randomized Phase|Adverse Event|0|||
147191010|NCT00550407|530865883|FG001|26-Week Randomized Phase|Adverse Event|5|||
147191011|NCT00550407|530865884|FG002|26-Week Randomized Phase|Adverse Event|2|||
147191012|NCT00550407|530865882|FG000|26-Week Randomized Phase|Lack of Efficacy|0|||
147191013|NCT00550407|530865883|FG001|26-Week Randomized Phase|Lack of Efficacy|36|||
147191014|NCT00550407|530865884|FG002|26-Week Randomized Phase|Lack of Efficacy|19|||
147191015|NCT00550407|530865882|FG000|26-Week Randomized Phase|Investigator Discretion|0|||
147191016|NCT00550407|530865883|FG001|26-Week Randomized Phase|Investigator Discretion|1|||
147191017|NCT00550407|530865884|FG002|26-Week Randomized Phase|Investigator Discretion|0|||
147191018|NCT00550407|530865882|FG000|26-Week Randomized Phase|Withdrawal by Subject|0|||
147191019|NCT00550407|530865883|FG001|26-Week Randomized Phase|Withdrawal by Subject|1|||
147191020|NCT00550407|530865884|FG002|26-Week Randomized Phase|Withdrawal by Subject|3|||
147191021|NCT00584415|530865885|FG000|Overall Study|Adverse Event|7|||
147191022|NCT00556894|530865886|FG000|Overall Study|Adverse Event|2|||
147191023|NCT00556894|530865887|FG001|Overall Study|Adverse Event|3|||
147191024|NCT00556894|530865888|FG002|Overall Study|Adverse Event|3|||
147191025|NCT00556894|530865886|FG000|Overall Study|Death|1|||
147191026|NCT00556894|530865887|FG001|Overall Study|Death|0|||
147191027|NCT00556894|530865888|FG002|Overall Study|Death|0|||
147191028|NCT00556894|530865886|FG000|Overall Study|regulatory decision in Bulgaria|10|||
147191029|NCT00556894|530865887|FG001|Overall Study|regulatory decision in Bulgaria|14|||
147191030|NCT00556894|530865888|FG002|Overall Study|regulatory decision in Bulgaria|13|||
147191031|NCT00556894|530865886|FG000|Overall Study|Change in therapy|2|||
147191032|NCT00556894|530865887|FG001|Overall Study|Change in therapy|1|||
147191033|NCT00556894|530865888|FG002|Overall Study|Change in therapy|2|||
147191034|NCT00556894|530865886|FG000|Overall Study|Withdrawal by Subject|1|||
147191035|NCT00556894|530865887|FG001|Overall Study|Withdrawal by Subject|1|||
147191036|NCT00556894|530865888|FG002|Overall Study|Withdrawal by Subject|1|||
147191037|NCT03883581|530865889|FG000|Overall Study|Withdrawal by Subject|4|||
147191038|NCT04750642|530865893|FG000|Overall Study|Adverse Event|1|||
147191039|NCT04750642|530865894|FG001|Overall Study|Adverse Event|0|||
147191040|NCT04750642|530865893|FG000|Overall Study|Withdrawal by Subject|0|||
147191041|NCT04750642|530865894|FG001|Overall Study|Withdrawal by Subject|1|||
147191042|NCT04750642|530865893|FG000|Overall Study|Protocol Violation|0|||
147191043|NCT04750642|530865894|FG001|Overall Study|Protocol Violation|1|||
147191044|NCT00410956|530865895|FG000|Overall Study|Adverse Event|1|||
147191045|NCT00410956|530865895|FG000|Overall Study|Death|2|||
147191046|NCT00410956|530865895|FG000|Overall Study|Lack of Efficacy|10|||
147191047|NCT00410956|530865895|FG000|Overall Study|Physician Decision|6|||
147248696|NCT02310568|531080769|FG003|Stage 2 (4 Weeks)|Protocol Violation|1|||
147595092|NCT03001219|532335743|FG000|Extension Period Analysis|Study Termination by Sponsor|0|||
147595093|NCT03001219|532335744|FG001|Extension Period Analysis|Study Termination by Sponsor|36|||
147595094|NCT03001219|532335743|FG000|Extension Period Analysis|Participant Non-Compliance|0|||
147248697|NCT02310568|531080770|FG004|Stage 2 (4 Weeks)|Protocol Violation|0|||
147331141|NCT02781584|531377582|FG004|Treatment Phase|Adverse Event|0|||
147331142|NCT02781584|531377583|FG005|Treatment Phase|Adverse Event|0|||
147331143|NCT02781584|531377584|FG006|Treatment Phase|Adverse Event|0|||
147248698|NCT02310568|531080766|FG000|Stage 2 (4 Weeks)|Lost to Follow-up|0|||
147248699|NCT02310568|531080767|FG001|Stage 2 (4 Weeks)|Lost to Follow-up|0|||
147248700|NCT02310568|531080768|FG002|Stage 2 (4 Weeks)|Lost to Follow-up|0|||
147248701|NCT02310568|531080769|FG003|Stage 2 (4 Weeks)|Lost to Follow-up|2|||
147248702|NCT02310568|531080770|FG004|Stage 2 (4 Weeks)|Lost to Follow-up|0|||
147248703|NCT01366521|531080775|FG000|Overall Study|Adverse Event|1|||
147331144|NCT02781584|531377585|FG007|Treatment Phase|Adverse Event|1|||
147331145|NCT02781584|531377586|FG008|Treatment Phase|Adverse Event|0|||
147248704|NCT01366521|531080776|FG001|Overall Study|Adverse Event|0|||
147248705|NCT01366521|531080777|FG002|Overall Study|Adverse Event|0|||
147248706|NCT01366521|531080778|FG003|Overall Study|Adverse Event|0|||
147248707|NCT01366521|531080775|FG000|Overall Study|Protocol Violation|0|||
147248708|NCT01366521|531080776|FG001|Overall Study|Protocol Violation|0|||
147248709|NCT01366521|531080777|FG002|Overall Study|Protocol Violation|1|||
147248710|NCT01366521|531080778|FG003|Overall Study|Protocol Violation|0|||
147248711|NCT01366521|531080775|FG000|Overall Study|Physician Decision|0|||
147248712|NCT01366521|531080776|FG001|Overall Study|Physician Decision|0|||
147248713|NCT01366521|531080777|FG002|Overall Study|Physician Decision|1|||
147248714|NCT01366521|531080778|FG003|Overall Study|Physician Decision|0|||
147248715|NCT01366521|531080775|FG000|Overall Study|Withdrawal by Subject|0|||
147248716|NCT01366521|531080776|FG001|Overall Study|Withdrawal by Subject|1|||
147248717|NCT01366521|531080777|FG002|Overall Study|Withdrawal by Subject|0|||
147248718|NCT01366521|531080778|FG003|Overall Study|Withdrawal by Subject|0|||
147248719|NCT03824912|531080782|FG000|Overall Study|Lost to Follow-up|18|||
147248720|NCT03824912|531080783|FG001|Overall Study|Lost to Follow-up|15|||
147248721|NCT03824912|531080784|FG002|Overall Study|Lost to Follow-up|8|||
147248722|NCT03824912|531080782|FG000|Overall Study|Negative Baseline Culture Result|118|||
147248723|NCT03824912|531080783|FG001|Overall Study|Negative Baseline Culture Result|112|||
147248724|NCT03824912|531080784|FG002|Overall Study|Negative Baseline Culture Result|57|||
147248725|NCT03824912|531080782|FG000|Overall Study|Non-Compliance with Study Drug|0|||
147248726|NCT03824912|531080783|FG001|Overall Study|Non-Compliance with Study Drug|0|||
147248727|NCT03824912|531080784|FG002|Overall Study|Non-Compliance with Study Drug|1|||
147248728|NCT03824912|531080782|FG000|Overall Study|Protocol Violation|1|||
147248729|NCT03824912|531080783|FG001|Overall Study|Protocol Violation|4|||
147248730|NCT03824912|531080784|FG002|Overall Study|Protocol Violation|1|||
147248731|NCT03824912|531080782|FG000|Overall Study|Withdrawal by Subject|3|||
147248732|NCT03824912|531080783|FG001|Overall Study|Withdrawal by Subject|2|||
147248733|NCT03824912|531080784|FG002|Overall Study|Withdrawal by Subject|1|||
147248734|NCT03824912|531080782|FG000|Overall Study|Participation in another study|0|||
147248735|NCT03824912|531080783|FG001|Overall Study|Participation in another study|1|||
147248736|NCT03824912|531080784|FG002|Overall Study|Participation in another study|0|||
147248737|NCT02289690|531080787|FG000|Overall Study|Adverse Event Related to Progression|0|||
147248738|NCT02289690|531080788|FG001|Overall Study|Adverse Event Related to Progression|1|||
147248739|NCT02289690|531080789|FG002|Overall Study|Adverse Event Related to Progression|1|||
147248740|NCT02289690|531080790|FG003|Overall Study|Adverse Event Related to Progression|0|||
147248741|NCT02289690|531080791|FG004|Overall Study|Adverse Event Related to Progression|1|||
147248742|NCT02289690|531080792|FG005|Overall Study|Adverse Event Related to Progression|0|||
147248743|NCT02289690|531080793|FG006|Overall Study|Adverse Event Related to Progression|1|||
147248744|NCT02289690|531080794|FG007|Overall Study|Adverse Event Related to Progression|0|||
147248745|NCT02289690|531080795|FG008|Overall Study|Adverse Event Related to Progression|0|||
147248746|NCT02289690|531080796|FG009|Overall Study|Adverse Event Related to Progression|0|||
147248747|NCT02289690|531080787|FG000|Overall Study|Withdrawal by Subject|1|||
147248748|NCT02289690|531080788|FG001|Overall Study|Withdrawal by Subject|0|||
147248749|NCT02289690|531080789|FG002|Overall Study|Withdrawal by Subject|0|||
147248750|NCT02289690|531080790|FG003|Overall Study|Withdrawal by Subject|0|||
147248751|NCT02289690|531080791|FG004|Overall Study|Withdrawal by Subject|1|||
147248752|NCT02289690|531080792|FG005|Overall Study|Withdrawal by Subject|1|||
147248753|NCT02289690|531080793|FG006|Overall Study|Withdrawal by Subject|0|||
147248754|NCT02289690|531080794|FG007|Overall Study|Withdrawal by Subject|0|||
147248755|NCT02289690|531080795|FG008|Overall Study|Withdrawal by Subject|4|||
147248756|NCT02289690|531080796|FG009|Overall Study|Withdrawal by Subject|2|||
147248757|NCT02289690|531080787|FG000|Overall Study|Progressive Disease, Per Protocol|3|||
147248758|NCT02289690|531080788|FG001|Overall Study|Progressive Disease, Per Protocol|2|||
147248759|NCT02289690|531080789|FG002|Overall Study|Progressive Disease, Per Protocol|3|||
147248760|NCT02289690|531080790|FG003|Overall Study|Progressive Disease, Per Protocol|2|||
147248761|NCT02289690|531080791|FG004|Overall Study|Progressive Disease, Per Protocol|5|||
147248762|NCT02289690|531080792|FG005|Overall Study|Progressive Disease, Per Protocol|13|||
147248763|NCT02289690|531080793|FG006|Overall Study|Progressive Disease, Per Protocol|2|||
147248764|NCT02289690|531080794|FG007|Overall Study|Progressive Disease, Per Protocol|0|||
147248765|NCT02289690|531080795|FG008|Overall Study|Progressive Disease, Per Protocol|0|||
147248766|NCT02289690|531080796|FG009|Overall Study|Progressive Disease, Per Protocol|0|||
147248767|NCT02289690|531080787|FG000|Overall Study|Lost to Follow-up|0|||
147248768|NCT02289690|531080788|FG001|Overall Study|Lost to Follow-up|0|||
147331146|NCT02781584|531377587|FG009|Treatment Phase|Adverse Event|0|||
147248769|NCT02289690|531080789|FG002|Overall Study|Lost to Follow-up|0|||
147248770|NCT02289690|531080790|FG003|Overall Study|Lost to Follow-up|0|||
147248771|NCT02289690|531080791|FG004|Overall Study|Lost to Follow-up|0|||
147248772|NCT02289690|531080792|FG005|Overall Study|Lost to Follow-up|0|||
147248773|NCT02289690|531080793|FG006|Overall Study|Lost to Follow-up|0|||
147248774|NCT02289690|531080794|FG007|Overall Study|Lost to Follow-up|1|||
147248775|NCT02289690|531080795|FG008|Overall Study|Lost to Follow-up|0|||
147248776|NCT02289690|531080796|FG009|Overall Study|Lost to Follow-up|2|||
147248777|NCT02289690|531080787|FG000|Overall Study|Death|0|||
147248778|NCT02289690|531080788|FG001|Overall Study|Death|0|||
147595095|NCT03001219|532335744|FG001|Extension Period Analysis|Participant Non-Compliance|1|||
147595096|NCT03001219|532335743|FG000|Extension Period Analysis|Physician Decision|0|||
147595097|NCT03001219|532335744|FG001|Extension Period Analysis|Physician Decision|1|||
147595098|NCT03001219|532335743|FG000|Extension Period Analysis|Adverse Event|1|||
147595099|NCT03001219|532335744|FG001|Extension Period Analysis|Adverse Event|1|||
147595100|NCT03001219|532335743|FG000|Extension Period Analysis|Protocol Deviation|0|||
147248779|NCT02289690|531080789|FG002|Overall Study|Death|0|||
147248780|NCT02289690|531080790|FG003|Overall Study|Death|0|||
147248781|NCT02289690|531080791|FG004|Overall Study|Death|0|||
147248782|NCT02289690|531080792|FG005|Overall Study|Death|0|||
147248783|NCT02289690|531080793|FG006|Overall Study|Death|0|||
147248784|NCT02289690|531080794|FG007|Overall Study|Death|49|||
147248785|NCT02289690|531080795|FG008|Overall Study|Death|45|||
147248786|NCT02289690|531080796|FG009|Overall Study|Death|41|||
147248787|NCT02289690|531080787|FG000|Overall Study|Sponsor Discontinued Study|0|||
147248788|NCT02289690|531080788|FG001|Overall Study|Sponsor Discontinued Study|0|||
147248789|NCT02289690|531080789|FG002|Overall Study|Sponsor Discontinued Study|0|||
147248790|NCT02289690|531080790|FG003|Overall Study|Sponsor Discontinued Study|0|||
147248791|NCT02289690|531080791|FG004|Overall Study|Sponsor Discontinued Study|0|||
147248792|NCT02289690|531080792|FG005|Overall Study|Sponsor Discontinued Study|0|||
147248793|NCT02289690|531080793|FG006|Overall Study|Sponsor Discontinued Study|0|||
147248794|NCT02289690|531080794|FG007|Overall Study|Sponsor Discontinued Study|9|||
147248795|NCT02289690|531080795|FG008|Overall Study|Sponsor Discontinued Study|7|||
147248796|NCT02289690|531080796|FG009|Overall Study|Sponsor Discontinued Study|15|||
147248797|NCT02289690|531080787|FG000|Overall Study|Other|0|||
147248798|NCT02289690|531080788|FG001|Overall Study|Other|0|||
147248799|NCT02289690|531080789|FG002|Overall Study|Other|0|||
147248800|NCT02289690|531080790|FG003|Overall Study|Other|1|||
147248801|NCT02289690|531080791|FG004|Overall Study|Other|1|||
147248802|NCT02289690|531080792|FG005|Overall Study|Other|0|||
147248803|NCT02289690|531080793|FG006|Overall Study|Other|1|||
147248804|NCT02289690|531080794|FG007|Overall Study|Other|2|||
147248805|NCT02289690|531080795|FG008|Overall Study|Other|3|||
147248806|NCT02289690|531080796|FG009|Overall Study|Other|1|||
147248807|NCT02085785|531080799|FG000|Overall Study|Withdrawal by Subject|2|||
147248808|NCT02085785|531080800|FG001|Overall Study|Withdrawal by Subject|1|||
147248809|NCT02085785|531080799|FG000|Overall Study|Lost to Follow-up|0|||
147331147|NCT02781584|531377588|FG010|Treatment Phase|Adverse Event|0|||
147331148|NCT02781584|531377589|FG011|Treatment Phase|Adverse Event|0|||
147331149|NCT02781584|531377590|FG012|Treatment Phase|Adverse Event|0|||
147331150|NCT04771273|531377595|FG000|Dose Escalation Period|Not treated with trial medication|0|||
147331151|NCT04771273|531377596|FG001|Dose Escalation Period|Not treated with trial medication|1|||
147331152|NCT04771273|531377597|FG002|Dose Escalation Period|Not treated with trial medication|1|||
147331153|NCT04771273|531377598|FG003|Dose Escalation Period|Not treated with trial medication|0|||
147331154|NCT04771273|531377595|FG000|Dose Escalation Period|Other reasons than listed|2|||
147595101|NCT03001219|532335744|FG001|Extension Period Analysis|Protocol Deviation|1|||
147595102|NCT03001219|532335743|FG000|Extension Period Analysis|Withdrawal by Subject|4|||
147595103|NCT03001219|532335744|FG001|Extension Period Analysis|Withdrawal by Subject|5|||
147595104|NCT01403064|532335745|FG000|Overall Study|Death|0|||
147595105|NCT01403064|532335746|FG001|Overall Study|Death|0|||
147595106|NCT01403064|532335747|FG002|Overall Study|Death|1|||
147248810|NCT02085785|531080800|FG001|Overall Study|Lost to Follow-up|1|||
147248811|NCT00779467|531080801|FG000|Overall Study|Lack of Efficacy|11|||
147248812|NCT00779467|531080802|FG001|Overall Study|Lack of Efficacy|2|||
147248813|NCT00779467|531080803|FG002|Overall Study|Lack of Efficacy|6|||
147248814|NCT00779467|531080804|FG003|Overall Study|Lack of Efficacy|11|||
147248815|NCT00779467|531080801|FG000|Overall Study|failed inclusion criteria|3|||
147248816|NCT00779467|531080802|FG001|Overall Study|failed inclusion criteria|3|||
147248817|NCT00779467|531080803|FG002|Overall Study|failed inclusion criteria|1|||
147331155|NCT04771273|531377596|FG001|Dose Escalation Period|Other reasons than listed|0|||
147449438|NCT02706873|531809502|FG001|Period 2 (Weeks 48 to 260)|Coronavirus Disease of 2019 (COVID-19) Infection|0|||
147595107|NCT01403064|532335748|FG003|Overall Study|Death|1|||
147595108|NCT01403064|532335745|FG000|Overall Study|Withdrawal by Subject|0|||
147595109|NCT01403064|532335746|FG001|Overall Study|Withdrawal by Subject|0|||
147248818|NCT00779467|531080804|FG003|Overall Study|failed inclusion criteria|2|||
147248819|NCT00779467|531080801|FG000|Overall Study|missing data|1|||
147248820|NCT00779467|531080802|FG001|Overall Study|missing data|0|||
147248821|NCT00779467|531080803|FG002|Overall Study|missing data|1|||
147248822|NCT00779467|531080804|FG003|Overall Study|missing data|4|||
147248823|NCT00779467|531080801|FG000|Overall Study|technical issue|0|||
147248824|NCT00779467|531080802|FG001|Overall Study|technical issue|0|||
147248825|NCT00779467|531080803|FG002|Overall Study|technical issue|2|||
147248826|NCT00779467|531080804|FG003|Overall Study|technical issue|1|||
147248827|NCT00779467|531080801|FG000|Overall Study|unavailable research staff|0|||
147248828|NCT00779467|531080802|FG001|Overall Study|unavailable research staff|0|||
147248829|NCT00779467|531080803|FG002|Overall Study|unavailable research staff|0|||
147449439|NCT02706873|531809503|FG002|Period 2 (Weeks 48 to 260)|Coronavirus Disease of 2019 (COVID-19) Infection|0|||
147449440|NCT02706873|531809504|FG003|Period 2 (Weeks 48 to 260)|Coronavirus Disease of 2019 (COVID-19) Infection|3|||
147449441|NCT02706873|531809501|FG000|Period 2 (Weeks 48 to 260)|COVID-19 Logistic Restrictions|0|||
147449442|NCT02706873|531809502|FG001|Period 2 (Weeks 48 to 260)|COVID-19 Logistic Restrictions|0|||
147449443|NCT02706873|531809503|FG002|Period 2 (Weeks 48 to 260)|COVID-19 Logistic Restrictions|2|||
147449444|NCT02706873|531809504|FG003|Period 2 (Weeks 48 to 260)|COVID-19 Logistic Restrictions|1|||
147449445|NCT02706873|531809501|FG000|Period 2 (Weeks 48 to 260)|Other|14|||
147449446|NCT02706873|531809502|FG001|Period 2 (Weeks 48 to 260)|Other|1|||
147449447|NCT02706873|531809503|FG002|Period 2 (Weeks 48 to 260)|Other|11|||
147449448|NCT02706873|531809504|FG003|Period 2 (Weeks 48 to 260)|Other|17|||
147449449|NCT00440947|531809505|FG000|36-Week Induction Phase|Adverse Event|16|||
147449450|NCT00440947|531809506|FG001|36-Week Induction Phase|Adverse Event|0|||
147449451|NCT00440947|531809507|FG002|36-Week Induction Phase|Adverse Event|0|||
147449452|NCT00440947|531809508|FG003|36-Week Induction Phase|Adverse Event|0|||
147449453|NCT00440947|531809509|FG004|36-Week Induction Phase|Adverse Event|0|||
147449454|NCT00440947|531809505|FG000|36-Week Induction Phase|Insufficient Viral Load Response|11|||
147449455|NCT00440947|531809506|FG001|36-Week Induction Phase|Insufficient Viral Load Response|0|||
147449456|NCT00440947|531809507|FG002|36-Week Induction Phase|Insufficient Viral Load Response|0|||
147449457|NCT00440947|531809508|FG003|36-Week Induction Phase|Insufficient Viral Load Response|0|||
147449458|NCT00440947|531809509|FG004|36-Week Induction Phase|Insufficient Viral Load Response|0|||
147449459|NCT00440947|531809505|FG000|36-Week Induction Phase|Protocol-defined Virologic Failure|5|||
147449460|NCT00440947|531809506|FG001|36-Week Induction Phase|Protocol-defined Virologic Failure|0|||
147449461|NCT00440947|531809507|FG002|36-Week Induction Phase|Protocol-defined Virologic Failure|0|||
147449462|NCT00440947|531809508|FG003|36-Week Induction Phase|Protocol-defined Virologic Failure|0|||
147449463|NCT00440947|531809509|FG004|36-Week Induction Phase|Protocol-defined Virologic Failure|0|||
147449464|NCT00440947|531809505|FG000|36-Week Induction Phase|Non-compliance|10|||
147449465|NCT00440947|531809506|FG001|36-Week Induction Phase|Non-compliance|0|||
147449466|NCT00440947|531809507|FG002|36-Week Induction Phase|Non-compliance|0|||
147449467|NCT00440947|531809508|FG003|36-Week Induction Phase|Non-compliance|0|||
147449468|NCT00440947|531809509|FG004|36-Week Induction Phase|Non-compliance|0|||
147449469|NCT00440947|531809505|FG000|36-Week Induction Phase|Lost to Follow-up|16|||
147449470|NCT00440947|531809506|FG001|36-Week Induction Phase|Lost to Follow-up|0|||
147449471|NCT00440947|531809507|FG002|36-Week Induction Phase|Lost to Follow-up|0|||
147449472|NCT00440947|531809508|FG003|36-Week Induction Phase|Lost to Follow-up|0|||
147449473|NCT00440947|531809509|FG004|36-Week Induction Phase|Lost to Follow-up|0|||
147449474|NCT00440947|531809505|FG000|36-Week Induction Phase|Withdrawal by Subject|7|||
147449475|NCT00440947|531809506|FG001|36-Week Induction Phase|Withdrawal by Subject|0|||
147449476|NCT00440947|531809507|FG002|36-Week Induction Phase|Withdrawal by Subject|0|||
147449477|NCT00440947|531809508|FG003|36-Week Induction Phase|Withdrawal by Subject|0|||
147449478|NCT00440947|531809509|FG004|36-Week Induction Phase|Withdrawal by Subject|0|||
147449479|NCT00440947|531809505|FG000|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|1|||
147449480|NCT00440947|531809506|FG001|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0|||
147449481|NCT00440947|531809507|FG002|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0|||
147449482|NCT00440947|531809508|FG003|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0|||
147248830|NCT00779467|531080804|FG003|Overall Study|unavailable research staff|1|||
147248831|NCT02692703|531080805|FG000|Overall Study|Lost to Follow-up|1|||
147248832|NCT02692703|531080805|FG000|Overall Study|Other|1|||
147248833|NCT04626297|531080806|FG000|Overall Study|Adverse Event|5|||
147248834|NCT04626297|531080807|FG001|Overall Study|Adverse Event|3|||
147248835|NCT04626297|531080806|FG000|Overall Study|Lost to Follow-up|7|||
147248836|NCT04626297|531080807|FG001|Overall Study|Lost to Follow-up|3|||
147248837|NCT04626297|531080806|FG000|Overall Study|Protocol Violation|5|||
147248838|NCT04626297|531080807|FG001|Overall Study|Protocol Violation|1|||
147248839|NCT04626297|531080806|FG000|Overall Study|Withdrawal by Subject|20|||
147248840|NCT04626297|531080807|FG001|Overall Study|Withdrawal by Subject|6|||
147248841|NCT04626297|531080806|FG000|Overall Study|Sponsor decision|2|||
147248842|NCT04626297|531080807|FG001|Overall Study|Sponsor decision|1|||
147248843|NCT04118166|531080808|FG000|Overall Study|Adverse Event|1|||
147248844|NCT00644995|531080809|FG000|Overall Study|Lost to Follow-up|1|||
147248845|NCT00644995|531080810|FG001|Overall Study|Lost to Follow-up|4|||
147248846|NCT00644995|531080809|FG000|Overall Study|Refused|1|||
147248847|NCT00644995|531080810|FG001|Overall Study|Refused|0|||
147248848|NCT00865124|531080817|FG000|Overall Study|Physician Decision|2|||
147248849|NCT00865124|531080818|FG001|Overall Study|Physician Decision|1|||
147248850|NCT00865124|531080819|FG002|Overall Study|Physician Decision|0|||
147248851|NCT00865124|531080817|FG000|Overall Study|Withdrawn consent|2|||
147248852|NCT00865124|531080818|FG001|Overall Study|Withdrawn consent|0|||
147658834|NCT01409915|532574273|FG001|Overall Study|Adverse Event|2|||
147248853|NCT00865124|531080819|FG002|Overall Study|Withdrawn consent|0|||
147248854|NCT02743520|531080820|FG000|Overall Study|Withdrawal by Subject|1|||
147248855|NCT03247530|531080823|FG000|Overall Study|Withdrawal by caregiver|19|||
147248856|NCT03247530|531080824|FG001|Overall Study|Withdrawal by caregiver|8|||
147248857|NCT03247530|531080825|FG002|Overall Study|Withdrawal by caregiver|10|||
147248858|NCT03247530|531080823|FG000|Overall Study|Lost to Follow-up|3|||
147248859|NCT03247530|531080824|FG001|Overall Study|Lost to Follow-up|9|||
147248860|NCT03247530|531080825|FG002|Overall Study|Lost to Follow-up|6|||
147248861|NCT03247530|531080823|FG000|Overall Study|Adverse Event|2|||
147248862|NCT03247530|531080824|FG001|Overall Study|Adverse Event|5|||
147248863|NCT03247530|531080825|FG002|Overall Study|Adverse Event|2|||
147248864|NCT03247530|531080823|FG000|Overall Study|Failure to follow procedure|1|||
147248865|NCT03247530|531080824|FG001|Overall Study|Failure to follow procedure|1|||
147248866|NCT03247530|531080825|FG002|Overall Study|Failure to follow procedure|1|||
147248867|NCT03247530|531080823|FG000|Overall Study|Withdrawal by Subject|1|||
147248868|NCT03247530|531080824|FG001|Overall Study|Withdrawal by Subject|1|||
147248869|NCT03247530|531080825|FG002|Overall Study|Withdrawal by Subject|0|||
147248870|NCT03247530|531080823|FG000|Overall Study|Study medication misuse|0|||
147248871|NCT03247530|531080824|FG001|Overall Study|Study medication misuse|1|||
147248872|NCT03247530|531080825|FG002|Overall Study|Study medication misuse|0|||
147248873|NCT03247530|531080823|FG000|Overall Study|Other, multiple categories|1|||
147248874|NCT03247530|531080824|FG001|Overall Study|Other, multiple categories|3|||
147248875|NCT03247530|531080825|FG002|Overall Study|Other, multiple categories|1|||
147248876|NCT02551731|531080828|FG000|Overall Study|Withdrawal by Subject|2|||
147248877|NCT01678911|531080829|FG000|Second Intervention|Lost to Follow-up|2|||
147248878|NCT01678911|531080830|FG001|Second Intervention|Lost to Follow-up|0|||
147248879|NCT04649060|531080831|FG000|Arm A/Arm B Treatment|Adverse Event|0|||
147248880|NCT04649060|531080832|FG001|Arm A/Arm B Treatment|Adverse Event|3|||
147248881|NCT04649060|531080831|FG000|Arm A/Arm B Treatment|Physician Decision|1|||
147248882|NCT04649060|531080832|FG001|Arm A/Arm B Treatment|Physician Decision|1|||
147248883|NCT04649060|531080831|FG000|Arm A/Arm B Treatment|Progressive Disease|3|||
147248884|NCT04649060|531080832|FG001|Arm A/Arm B Treatment|Progressive Disease|12|||
147248885|NCT04649060|531080831|FG000|Arm A/Arm B Treatment|Study Terminated by Sponsor|17|||
147248886|NCT04649060|531080832|FG001|Arm A/Arm B Treatment|Study Terminated by Sponsor|10|||
147248887|NCT04649060|531080831|FG000|Arm A/Arm B Treatment|Patient Request|1|||
147248888|NCT04649060|531080832|FG001|Arm A/Arm B Treatment|Patient Request|0|||
147248889|NCT04649060|531080831|FG000|Arm A/Arm B Treatment|Failed Criteria for Treatment Initiation|4|||
147248890|NCT04649060|531080832|FG001|Arm A/Arm B Treatment|Failed Criteria for Treatment Initiation|1|||
147248891|NCT04649060|531080831|FG000|Arm A/Arm B Treatment|Other|1|||
147248892|NCT04649060|531080832|FG001|Arm A/Arm B Treatment|Other|0|||
147248893|NCT04649060|531080831|FG000|Crossover (Arm B)|Adverse Event|0|||
147248894|NCT04649060|531080832|FG001|Crossover (Arm B)|Adverse Event|1|||
147248895|NCT04649060|531080831|FG000|Crossover (Arm B)|Lost to Follow-up|0|||
147248896|NCT04649060|531080832|FG001|Crossover (Arm B)|Lost to Follow-up|1|||
147248897|NCT01906008|531080836|FG000|Overall Study|Lost to Follow-up|2|||
147248898|NCT01906008|531080837|FG001|Overall Study|Lost to Follow-up|0|||
147248899|NCT01906008|531080836|FG000|Overall Study|Oxaliplatin toxicity|2|||
147248900|NCT01906008|531080837|FG001|Overall Study|Oxaliplatin toxicity|0|||
147248901|NCT01906008|531080836|FG000|Overall Study|Protocol Violation|0|||
147248902|NCT01906008|531080837|FG001|Overall Study|Protocol Violation|1|||
147248903|NCT01906008|531080836|FG000|Overall Study|Withdrawal by Subject|1|||
147248904|NCT01906008|531080837|FG001|Overall Study|Withdrawal by Subject|5|||
147248905|NCT01906008|531080836|FG000|Overall Study|Did not start study med|3|||
147248906|NCT01906008|531080837|FG001|Overall Study|Did not start study med|4|||
147248907|NCT01906008|531080836|FG000|Overall Study|Oxaliplatin stops|10|||
147248908|NCT01906008|531080837|FG001|Overall Study|Oxaliplatin stops|8|||
147248909|NCT01906008|531080836|FG000|Overall Study|Hospice|1|||
147248910|NCT01906008|531080837|FG001|Overall Study|Hospice|0|||
147248911|NCT01906008|531080836|FG000|Overall Study|Physician Decision|3|||
147248912|NCT01906008|531080837|FG001|Overall Study|Physician Decision|3|||
147248913|NCT01906008|531080836|FG000|Overall Study|Lack of compliance of study med|5|||
147248914|NCT01906008|531080837|FG001|Overall Study|Lack of compliance of study med|3|||
147331156|NCT04771273|531377597|FG002|Dose Escalation Period|Other reasons than listed|2|||
147331157|NCT04771273|531377598|FG003|Dose Escalation Period|Other reasons than listed|1|||
147331158|NCT04771273|531377595|FG000|Dose Escalation Period|Protocol Violation|0|||
147331159|NCT04771273|531377596|FG001|Dose Escalation Period|Protocol Violation|0|||
147331160|NCT04771273|531377597|FG002|Dose Escalation Period|Protocol Violation|3|||
147331161|NCT04771273|531377598|FG003|Dose Escalation Period|Protocol Violation|1|||
147331162|NCT04771273|531377595|FG000|Dose Escalation Period|Burden of study procedures|1|||
147331163|NCT04771273|531377596|FG001|Dose Escalation Period|Burden of study procedures|0|||
147331164|NCT04771273|531377597|FG002|Dose Escalation Period|Burden of study procedures|0|||
147248915|NCT01906008|531080836|FG000|Overall Study|Adverse Event|0|||
147248916|NCT01906008|531080837|FG001|Overall Study|Adverse Event|3|||
147248917|NCT02117648|531080838|FG000|Abemaciclib Alone Period 1|Withdrawal by Subject|1|||
147248918|NCT02117648|531080838|FG000|Abemaciclib Alone Period 1|Adverse Event|1|||
147248919|NCT02117648|531080838|FG000|Abemaciclib + Clarithromycin Period 2|Progressive Disease|1|||
147248920|NCT02117648|531080838|FG000|Abemaciclib + Clarithromycin Period 2|Death|1|||
147248921|NCT02117648|531080838|FG000|Abemaciclib + Clarithromycin Period 2|Adverse Event|1|||
147248922|NCT02117648|531080838|FG000|Abemaciclib + Clarithromycin Period 2|Withdrawal by Subject|1|||
147331165|NCT04771273|531377598|FG003|Dose Escalation Period|Burden of study procedures|0|||
147595110|NCT01403064|532335747|FG002|Overall Study|Withdrawal by Subject|1|||
147595111|NCT01403064|532335748|FG003|Overall Study|Withdrawal by Subject|1|||
147595112|NCT01403064|532335745|FG000|Overall Study|Other|1|||
147595113|NCT01403064|532335746|FG001|Overall Study|Other|0|||
147595114|NCT01403064|532335747|FG002|Overall Study|Other|2|||
147595115|NCT01403064|532335748|FG003|Overall Study|Other|1|||
147595116|NCT02528123|532335749|FG000|Overall Study|Lost to Follow-up|1|||
147595117|NCT03760250|532335750|FG000|Overall Study|Withdrawal by Subject|1|||
147595118|NCT03760250|532335750|FG000|Overall Study|Physician Decision|1|||
147595119|NCT03733210|532335752|FG000|Overall Study|Lymph nodes not collected or not evaluable|4|||
147595120|NCT03733210|532335753|FG001|Overall Study|Lymph nodes not collected or not evaluable|2|||
147595121|NCT02963441|532335762|FG000|Overall Study|Protocol violation or withdrawn|8|||
147595122|NCT02963441|532335762|FG000|Overall Study|Ungradeable by FPRC or IDx|40|||
147595123|NCT02963441|532335762|FG000|Overall Study|IDx-DR insufficient quality|33|||
147595124|NCT04688931|532335763|FG000|Overall Study|Adverse Event|4|||
147595125|NCT04688931|532335764|FG001|Overall Study|Adverse Event|1|||
147595126|NCT04688931|532335763|FG000|Overall Study|Withdrawal by Subject|5|||
147595127|NCT04688931|532335764|FG001|Overall Study|Withdrawal by Subject|16|||
147595128|NCT04688931|532335763|FG000|Overall Study|Physician Decision|3|||
147595129|NCT04688931|532335764|FG001|Overall Study|Physician Decision|5|||
147595130|NCT04688931|532335763|FG000|Overall Study|Noncompliance|0|||
147595131|NCT04688931|532335764|FG001|Overall Study|Noncompliance|1|||
147595132|NCT04688931|532335763|FG000|Overall Study|Lost to Follow-up|1|||
147595133|NCT04688931|532335764|FG001|Overall Study|Lost to Follow-up|3|||
147595134|NCT04688931|532335763|FG000|Overall Study|Randomization Error|3|||
147595135|NCT04688931|532335764|FG001|Overall Study|Randomization Error|0|||
147595136|NCT04688931|532335763|FG000|Overall Study|Not Eligible|1|||
147595137|NCT04688931|532335764|FG001|Overall Study|Not Eligible|3|||
147595138|NCT04688931|532335763|FG000|Overall Study|Disease Progression|0|||
147595139|NCT04688931|532335764|FG001|Overall Study|Disease Progression|2|||
147595140|NCT04688931|532335763|FG000|Overall Study|Sponsor Requirement|1|||
147595141|NCT04688931|532335764|FG001|Overall Study|Sponsor Requirement|1|||
147595142|NCT04688931|532335763|FG000|Overall Study|Other Reason|1|||
147595143|NCT04688931|532335764|FG001|Overall Study|Other Reason|2|||
147595144|NCT00361335|532335765|FG000|IV Period: Baseline to E0|Adverse Event|9|||
147595145|NCT00361335|532335766|FG001|IV Period: Baseline to E0|Adverse Event|4|||
147595146|NCT00361335|532335767|FG002|IV Period: Baseline to E0|Adverse Event|5|||
147595147|NCT00361335|532335768|FG003|IV Period: Baseline to E0|Adverse Event|9|||
147595148|NCT00361335|532335769|FG004|IV Period: Baseline to E0|Adverse Event|8|||
147595149|NCT00361335|532335770|FG005|IV Period: Baseline to E0|Adverse Event|0|||
147595150|NCT00361335|532335771|FG006|IV Period: Baseline to E0|Adverse Event|0|||
147595151|NCT00361335|532335765|FG000|IV Period: Baseline to E0|Lost to Follow-up|1|||
147595152|NCT00361335|532335766|FG001|IV Period: Baseline to E0|Lost to Follow-up|0|||
147595153|NCT00361335|532335767|FG002|IV Period: Baseline to E0|Lost to Follow-up|0|||
147595154|NCT00361335|532335768|FG003|IV Period: Baseline to E0|Lost to Follow-up|2|||
147595155|NCT00361335|532335769|FG004|IV Period: Baseline to E0|Lost to Follow-up|2|||
147595156|NCT00361335|532335770|FG005|IV Period: Baseline to E0|Lost to Follow-up|0|||
147595157|NCT00361335|532335771|FG006|IV Period: Baseline to E0|Lost to Follow-up|0|||
147595158|NCT00361335|532335765|FG000|IV Period: Baseline to E0|Death|1|||
147595159|NCT00361335|532335766|FG001|IV Period: Baseline to E0|Death|1|||
147248923|NCT02117648|531080838|FG000|Abemaciclib Safety-Extension Phase|Progressive Disease|12|||
147248924|NCT02117648|531080838|FG000|Abemaciclib Safety-Extension Phase|Physician Decision|1|||
147248925|NCT02117648|531080838|FG000|Abemaciclib Safety-Extension Phase|Death|3|||
147248926|NCT02117648|531080838|FG000|Abemaciclib Safety-Extension Phase|Withdrawal by Subject|2|||
147248927|NCT02117648|531080838|FG000|Abemaciclib Safety-Extension Phase|Adverse Event|2|||
147248928|NCT02670837|531080840|FG000|Overall Study|Death|2|||
147248929|NCT02670837|531080841|FG001|Overall Study|Death|0|||
147248930|NCT02670837|531080842|FG002|Overall Study|Death|0|||
147248931|NCT01985867|531080843|FG000|Overall Study|Lost to Follow-up|3|||
147248932|NCT01985867|531080844|FG001|Overall Study|Lost to Follow-up|4|||
147248933|NCT01985867|531080843|FG000|Overall Study|Adverse Event|3|||
147248934|NCT01985867|531080844|FG001|Overall Study|Adverse Event|2|||
147248935|NCT01985867|531080843|FG000|Overall Study|Lack of Efficacy|1|||
147248936|NCT01985867|531080844|FG001|Overall Study|Lack of Efficacy|0|||
147248937|NCT04294472|531080845|FG000|Overall Study|Adverse Event|0|||
147248938|NCT04294472|531080846|FG001|Overall Study|Adverse Event|1|||
147248939|NCT04294472|531080847|FG002|Overall Study|Adverse Event|1|||
147248940|NCT04294472|531080845|FG000|Overall Study|Randomized but not treated|0|||
147595160|NCT00361335|532335767|FG002|IV Period: Baseline to E0|Death|1|||
147595161|NCT00361335|532335768|FG003|IV Period: Baseline to E0|Death|1|||
147595162|NCT00361335|532335769|FG004|IV Period: Baseline to E0|Death|0|||
147595163|NCT00361335|532335770|FG005|IV Period: Baseline to E0|Death|0|||
147595164|NCT00361335|532335771|FG006|IV Period: Baseline to E0|Death|0|||
147595165|NCT00361335|532335765|FG000|IV Period: Baseline to E0|Discontinued oral study agent|2|||
147658835|NCT01409915|532574272|FG000|Overall Study|Withdrawal by Subject|0|||
147248941|NCT04294472|531080846|FG001|Overall Study|Randomized but not treated|1|||
147449483|NCT00440947|531809509|FG004|36-Week Induction Phase|Kaposi Lesions Requiring Chemotherapy|0|||
147248942|NCT04294472|531080847|FG002|Overall Study|Randomized but not treated|1|||
147248943|NCT02603419|531080848|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Death|0|||
147248944|NCT02603419|531080849|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Death|1|||
147248945|NCT02603419|531080850|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Death|0|||
147248946|NCT02603419|531080851|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Death|0|||
147248947|NCT02603419|531080852|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Death|0|||
147248948|NCT02603419|531080853|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Death|0|||
147248949|NCT02603419|531080848|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|2|||
147248950|NCT02603419|531080849|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|4|||
147248951|NCT02603419|531080850|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|2|||
147248952|NCT02603419|531080851|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|4|||
147248953|NCT02603419|531080852|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|3|||
147248954|NCT02603419|531080853|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Progressive Disease|0|||
147248955|NCT02603419|531080848|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|2|||
147248956|NCT02603419|531080849|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|0|||
147248957|NCT02603419|531080850|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|3|||
147248958|NCT02603419|531080851|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|0|||
147248959|NCT02603419|531080852|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|1|||
147248960|NCT02603419|531080853|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Adverse Event|0|||
147248961|NCT02603419|531080848|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0|||
147248962|NCT02603419|531080849|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0|||
147248963|NCT02603419|531080850|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0|||
147248964|NCT02603419|531080851|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0|||
147248965|NCT02603419|531080852|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|1|||
147248966|NCT02603419|531080853|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Physician Decision|0|||
147248967|NCT02603419|531080848|FG000|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0|||
147248968|NCT02603419|531080849|FG001|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|1|||
147248969|NCT02603419|531080850|FG002|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0|||
147248970|NCT02603419|531080851|FG003|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0|||
147248971|NCT02603419|531080852|FG004|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0|||
147248972|NCT02603419|531080853|FG005|Lead-in Phase:Maximum Exposure:123Weeks|No Longer Meets Eligibility Criteria|0|||
147248973|NCT02603419|531080848|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Other|2|||
147248974|NCT02603419|531080849|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Other|1|||
147248975|NCT02603419|531080850|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Other|1|||
147248976|NCT02603419|531080851|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Other|0|||
147248977|NCT02603419|531080852|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Other|1|||
147248978|NCT02603419|531080853|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Other|0|||
147248979|NCT02603419|531080848|FG000|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0|||
147248980|NCT02603419|531080849|FG001|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0|||
147248981|NCT02603419|531080850|FG002|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0|||
147248982|NCT02603419|531080851|FG003|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|2|||
147248983|NCT02603419|531080852|FG004|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0|||
147248984|NCT02603419|531080853|FG005|Lead-in Phase:Maximum Exposure:123Weeks|Withdrawal by Subject|0|||
147248985|NCT02603419|531080848|FG000|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0|||
147248986|NCT02603419|531080849|FG001|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0|||
147248987|NCT02603419|531080850|FG002|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0|||
147248988|NCT02603419|531080851|FG003|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0|||
147248989|NCT02603419|531080852|FG004|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|0|||
147248990|NCT02603419|531080853|FG005|Expansion Phase:Maximum Exposure:48Weeks|Lost to Follow-up|1|||
147248991|NCT02603419|531080848|FG000|Expansion Phase:Maximum Exposure:48Weeks|Death|0|||
147248992|NCT02603419|531080849|FG001|Expansion Phase:Maximum Exposure:48Weeks|Death|0|||
147248993|NCT02603419|531080850|FG002|Expansion Phase:Maximum Exposure:48Weeks|Death|0|||
147248994|NCT02603419|531080851|FG003|Expansion Phase:Maximum Exposure:48Weeks|Death|0|||
147248995|NCT02603419|531080852|FG004|Expansion Phase:Maximum Exposure:48Weeks|Death|0|||
147248996|NCT02603419|531080853|FG005|Expansion Phase:Maximum Exposure:48Weeks|Death|1|||
147248997|NCT02603419|531080848|FG000|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0|||
147248998|NCT02603419|531080849|FG001|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0|||
147248999|NCT02603419|531080850|FG002|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0|||
147249000|NCT02603419|531080851|FG003|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0|||
147249001|NCT02603419|531080852|FG004|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|0|||
147249002|NCT02603419|531080853|FG005|Expansion Phase:Maximum Exposure:48Weeks|Withdrawal by Subject|1|||
147249003|NCT03552198|531080854|FG000|Overall Study|Lost to Follow-up|42|||
147249004|NCT03552198|531080855|FG001|Overall Study|Lost to Follow-up|48|||
147249005|NCT03552198|531080856|FG002|Overall Study|Lost to Follow-up|15|||
147249006|NCT03552198|531080857|FG003|Overall Study|Lost to Follow-up|19|||
147249007|NCT03552198|531080854|FG000|Overall Study|Incomplete/unmatched questionnaire|6|||
147249008|NCT03552198|531080855|FG001|Overall Study|Incomplete/unmatched questionnaire|7|||
147249009|NCT03552198|531080856|FG002|Overall Study|Incomplete/unmatched questionnaire|2|||
147249010|NCT03552198|531080857|FG003|Overall Study|Incomplete/unmatched questionnaire|2|||
147249011|NCT03552198|531080854|FG000|Overall Study|Did not receive air alerts|1|||
147249012|NCT03552198|531080855|FG001|Overall Study|Did not receive air alerts|0|||
147249013|NCT03552198|531080856|FG002|Overall Study|Did not receive air alerts|0|||
147249014|NCT03552198|531080857|FG003|Overall Study|Did not receive air alerts|1|||
147249015|NCT06149247|531080858|FG000|Overall Study|Adverse Event|0|||
147249016|NCT06149247|531080859|FG001|Overall Study|Adverse Event|1|||
147249017|NCT02289417|531080860|FG000|Placebo-Controlled Phase Weeks 0-12|Adverse Event|3|||
147249018|NCT02289417|531080861|FG001|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
147249019|NCT02289417|531080862|FG002|Placebo-Controlled Phase Weeks 0-12|Adverse Event|1|||
147249020|NCT02289417|531080863|FG003|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
147249021|NCT02289417|531080864|FG004|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
147249022|NCT02289417|531080865|FG005|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
147249023|NCT02289417|531080866|FG006|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
147249024|NCT02289417|531080867|FG007|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
147249025|NCT02289417|531080868|FG008|Placebo-Controlled Phase Weeks 0-12|Adverse Event|0|||
147249026|NCT02289417|531080860|FG000|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|1|||
147249027|NCT02289417|531080861|FG001|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|3|||
147249028|NCT02289417|531080862|FG002|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|2|||
147249029|NCT02289417|531080863|FG003|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
147249030|NCT02289417|531080864|FG004|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
147249031|NCT02289417|531080865|FG005|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
147249032|NCT02289417|531080866|FG006|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
147249033|NCT02289417|531080867|FG007|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
147249034|NCT02289417|531080868|FG008|Placebo-Controlled Phase Weeks 0-12|Withdrawal by Subject|0|||
147249035|NCT02289417|531080860|FG000|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
147249036|NCT02289417|531080861|FG001|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|1|||
147249037|NCT02289417|531080862|FG002|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
147249038|NCT02289417|531080863|FG003|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
147249039|NCT02289417|531080864|FG004|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
147249040|NCT02289417|531080865|FG005|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
147249041|NCT02289417|531080866|FG006|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
147249042|NCT02289417|531080867|FG007|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
147249043|NCT02289417|531080868|FG008|Placebo-Controlled Phase Weeks 0-12|Lost to Follow-up|0|||
147249044|NCT02289417|531080860|FG000|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|3|||
147249045|NCT02289417|531080861|FG001|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
147249046|NCT02289417|531080862|FG002|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
147249047|NCT02289417|531080863|FG003|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
147249048|NCT02289417|531080864|FG004|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
147249049|NCT02289417|531080865|FG005|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
147249050|NCT02289417|531080866|FG006|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
147249051|NCT02289417|531080867|FG007|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
147249052|NCT02289417|531080868|FG008|Placebo-Controlled Phase Weeks 0-12|Lack of Efficacy|0|||
147249053|NCT02289417|531080860|FG000|Active Treatment Phase Weeks 12-52|Adverse Event|0|||
147249054|NCT02289417|531080861|FG001|Active Treatment Phase Weeks 12-52|Adverse Event|1|||
147249055|NCT02289417|531080862|FG002|Active Treatment Phase Weeks 12-52|Adverse Event|4|||
147249056|NCT02289417|531080863|FG003|Active Treatment Phase Weeks 12-52|Adverse Event|2|||
147249057|NCT02289417|531080864|FG004|Active Treatment Phase Weeks 12-52|Adverse Event|2|||
147249058|NCT02289417|531080865|FG005|Active Treatment Phase Weeks 12-52|Adverse Event|1|||
147249059|NCT02289417|531080866|FG006|Active Treatment Phase Weeks 12-52|Adverse Event|0|||
147249060|NCT02289417|531080867|FG007|Active Treatment Phase Weeks 12-52|Adverse Event|0|||
147249061|NCT02289417|531080868|FG008|Active Treatment Phase Weeks 12-52|Adverse Event|0|||
147249062|NCT02289417|531080860|FG000|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
147249063|NCT02289417|531080861|FG001|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
147249064|NCT02289417|531080862|FG002|Active Treatment Phase Weeks 12-52|Pregnancy|1|||
147249065|NCT02289417|531080863|FG003|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
147249066|NCT02289417|531080864|FG004|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
147249067|NCT02289417|531080865|FG005|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
147249068|NCT02289417|531080866|FG006|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
147249069|NCT02289417|531080867|FG007|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
147249070|NCT02289417|531080868|FG008|Active Treatment Phase Weeks 12-52|Pregnancy|0|||
147249071|NCT02289417|531080860|FG000|Active Treatment Phase Weeks 12-52|Lack of Efficacy|0|||
147249072|NCT02289417|531080861|FG001|Active Treatment Phase Weeks 12-52|Lack of Efficacy|1|||
147249073|NCT02289417|531080862|FG002|Active Treatment Phase Weeks 12-52|Lack of Efficacy|4|||
147595166|NCT00361335|532335766|FG001|IV Period: Baseline to E0|Discontinued oral study agent|1|||
147595167|NCT00361335|532335767|FG002|IV Period: Baseline to E0|Discontinued oral study agent|1|||
147595168|NCT00361335|532335768|FG003|IV Period: Baseline to E0|Discontinued oral study agent|1|||
147595169|NCT00361335|532335769|FG004|IV Period: Baseline to E0|Discontinued oral study agent|2|||
147595170|NCT00361335|532335770|FG005|IV Period: Baseline to E0|Discontinued oral study agent|0|||
147595171|NCT00361335|532335771|FG006|IV Period: Baseline to E0|Discontinued oral study agent|0|||
147595172|NCT00361335|532335765|FG000|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
147595173|NCT00361335|532335766|FG001|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
147595174|NCT00361335|532335767|FG002|IV Period: Baseline to E0|Protocol-prohibited medications|1|||
147595175|NCT00361335|532335768|FG003|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
147595176|NCT00361335|532335769|FG004|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
147595177|NCT00361335|532335770|FG005|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
147595178|NCT00361335|532335771|FG006|IV Period: Baseline to E0|Protocol-prohibited medications|0|||
147595179|NCT00361335|532335765|FG000|IV Period: Baseline to E0|Worsening of RA|0|||
147595180|NCT00361335|532335766|FG001|IV Period: Baseline to E0|Worsening of RA|5|||
147595181|NCT00361335|532335767|FG002|IV Period: Baseline to E0|Worsening of RA|1|||
147595182|NCT00361335|532335768|FG003|IV Period: Baseline to E0|Worsening of RA|4|||
147595183|NCT00361335|532335769|FG004|IV Period: Baseline to E0|Worsening of RA|2|||
147595184|NCT00361335|532335770|FG005|IV Period: Baseline to E0|Worsening of RA|0|||
147595185|NCT00361335|532335771|FG006|IV Period: Baseline to E0|Worsening of RA|0|||
147595186|NCT00361335|532335765|FG000|IV Period: Baseline to E0|Other|2|||
147595187|NCT00361335|532335766|FG001|IV Period: Baseline to E0|Other|9|||
147595188|NCT00361335|532335767|FG002|IV Period: Baseline to E0|Other|9|||
147595189|NCT00361335|532335768|FG003|IV Period: Baseline to E0|Other|3|||
147595190|NCT00361335|532335769|FG004|IV Period: Baseline to E0|Other|2|||
147595191|NCT00361335|532335770|FG005|IV Period: Baseline to E0|Other|0|||
147595192|NCT00361335|532335771|FG006|IV Period: Baseline to E0|Other|0|||
147249074|NCT02289417|531080863|FG003|Active Treatment Phase Weeks 12-52|Lack of Efficacy|6|||
147249075|NCT02289417|531080864|FG004|Active Treatment Phase Weeks 12-52|Lack of Efficacy|2|||
147249076|NCT02289417|531080865|FG005|Active Treatment Phase Weeks 12-52|Lack of Efficacy|3|||
147249077|NCT02289417|531080866|FG006|Active Treatment Phase Weeks 12-52|Lack of Efficacy|0|||
147249078|NCT02289417|531080867|FG007|Active Treatment Phase Weeks 12-52|Lack of Efficacy|0|||
147249079|NCT02289417|531080868|FG008|Active Treatment Phase Weeks 12-52|Lack of Efficacy|0|||
147249080|NCT02289417|531080860|FG000|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
147249081|NCT02289417|531080861|FG001|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
147249082|NCT02289417|531080862|FG002|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|1|||
147249083|NCT02289417|531080863|FG003|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
147249084|NCT02289417|531080864|FG004|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|1|||
147249085|NCT02289417|531080865|FG005|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|1|||
147249086|NCT02289417|531080866|FG006|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
147249087|NCT02289417|531080867|FG007|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
147249088|NCT02289417|531080868|FG008|Active Treatment Phase Weeks 12-52|Withdrawal by Subject|0|||
147249089|NCT02289417|531080860|FG000|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
147249090|NCT02289417|531080861|FG001|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
147249091|NCT02289417|531080862|FG002|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
147249092|NCT02289417|531080863|FG003|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
147249093|NCT02289417|531080864|FG004|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
147249094|NCT02289417|531080865|FG005|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
147249095|NCT02289417|531080866|FG006|Active Treatment Phase Weeks 12-52|Lost to Follow-up|1|||
147249096|NCT02289417|531080867|FG007|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
147249097|NCT02289417|531080868|FG008|Active Treatment Phase Weeks 12-52|Lost to Follow-up|0|||
147249098|NCT02289417|531080860|FG000|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
147249099|NCT02289417|531080861|FG001|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
147249100|NCT02289417|531080862|FG002|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
147249101|NCT02289417|531080863|FG003|Active Treatment Phase Weeks 12-52|Miscellaneous|1|||
147249102|NCT02289417|531080864|FG004|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
147595193|NCT00361335|532335765|FG000|IV Period: Baseline to E0|Lack of Efficacy|5|||
147249103|NCT02289417|531080865|FG005|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
147249104|NCT02289417|531080866|FG006|Active Treatment Phase Weeks 12-52|Miscellaneous|1|||
147249105|NCT02289417|531080867|FG007|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
147249106|NCT02289417|531080868|FG008|Active Treatment Phase Weeks 12-52|Miscellaneous|0|||
147249107|NCT02289417|531080860|FG000|Extension Phase Weeks 52-104|Adverse Event|0|||
147249108|NCT02289417|531080861|FG001|Extension Phase Weeks 52-104|Adverse Event|0|||
147249109|NCT02289417|531080862|FG002|Extension Phase Weeks 52-104|Adverse Event|0|||
147249110|NCT02289417|531080863|FG003|Extension Phase Weeks 52-104|Adverse Event|0|||
147249111|NCT02289417|531080864|FG004|Extension Phase Weeks 52-104|Adverse Event|0|||
147249112|NCT02289417|531080865|FG005|Extension Phase Weeks 52-104|Adverse Event|0|||
147595194|NCT00361335|532335766|FG001|IV Period: Baseline to E0|Lack of Efficacy|9|||
147595195|NCT00361335|532335767|FG002|IV Period: Baseline to E0|Lack of Efficacy|3|||
147249113|NCT02289417|531080866|FG006|Extension Phase Weeks 52-104|Adverse Event|0|||
147249114|NCT02289417|531080867|FG007|Extension Phase Weeks 52-104|Adverse Event|2|||
147249115|NCT02289417|531080868|FG008|Extension Phase Weeks 52-104|Adverse Event|3|||
147249116|NCT02289417|531080860|FG000|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
147249117|NCT02289417|531080861|FG001|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
147249118|NCT02289417|531080862|FG002|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
147595196|NCT00361335|532335768|FG003|IV Period: Baseline to E0|Lack of Efficacy|7|||
147595197|NCT00361335|532335769|FG004|IV Period: Baseline to E0|Lack of Efficacy|8|||
147595198|NCT00361335|532335770|FG005|IV Period: Baseline to E0|Lack of Efficacy|0|||
147595199|NCT00361335|532335771|FG006|IV Period: Baseline to E0|Lack of Efficacy|0|||
147595200|NCT00361335|532335765|FG000|SC Period: Week E0 to Week E24|Adverse Event|0|||
147595201|NCT00361335|532335766|FG001|SC Period: Week E0 to Week E24|Adverse Event|2|||
147249119|NCT02289417|531080863|FG003|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
147249120|NCT02289417|531080864|FG004|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
147249121|NCT02289417|531080865|FG005|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
147249122|NCT02289417|531080866|FG006|Extension Phase Weeks 52-104|Lack of Efficacy|0|||
147249123|NCT02289417|531080867|FG007|Extension Phase Weeks 52-104|Lack of Efficacy|2|||
147249124|NCT02289417|531080868|FG008|Extension Phase Weeks 52-104|Lack of Efficacy|2|||
147249125|NCT02289417|531080860|FG000|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
147249126|NCT02289417|531080861|FG001|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
147249127|NCT02289417|531080862|FG002|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
147249128|NCT02289417|531080863|FG003|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
147249129|NCT02289417|531080864|FG004|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
147249130|NCT02289417|531080865|FG005|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
147249131|NCT02289417|531080866|FG006|Extension Phase Weeks 52-104|Withdrawal by Subject|0|||
147249132|NCT02289417|531080867|FG007|Extension Phase Weeks 52-104|Withdrawal by Subject|2|||
147249133|NCT02289417|531080868|FG008|Extension Phase Weeks 52-104|Withdrawal by Subject|1|||
147249134|NCT02289417|531080860|FG000|Extension Phase Weeks 52-104|Miscellaneous|0|||
147249135|NCT02289417|531080861|FG001|Extension Phase Weeks 52-104|Miscellaneous|0|||
147249136|NCT02289417|531080862|FG002|Extension Phase Weeks 52-104|Miscellaneous|0|||
147249137|NCT02289417|531080863|FG003|Extension Phase Weeks 52-104|Miscellaneous|0|||
147249138|NCT02289417|531080864|FG004|Extension Phase Weeks 52-104|Miscellaneous|0|||
147249139|NCT02289417|531080865|FG005|Extension Phase Weeks 52-104|Miscellaneous|0|||
147249140|NCT02289417|531080866|FG006|Extension Phase Weeks 52-104|Miscellaneous|0|||
147249141|NCT02289417|531080867|FG007|Extension Phase Weeks 52-104|Miscellaneous|1|||
147249142|NCT02289417|531080868|FG008|Extension Phase Weeks 52-104|Miscellaneous|0|||
147249143|NCT04786990|531080869|FG000|Overall Study|Withdrawal by Subject|1|||
147249144|NCT04786990|531080869|FG000|Overall Study|Adverse Event|1|||
147249145|NCT04786990|531080869|FG000|Overall Study|Lost to Follow-up|1|||
147249146|NCT04786990|531080869|FG000|Overall Study|Noncompliance|1|||
147249147|NCT04786990|531080869|FG000|Overall Study|Unable to complete site visits|1|||
147249148|NCT04786990|531080869|FG000|Overall Study|Withdrawal by Parent/Guardian|3|||
147249149|NCT01782222|531080872|FG000|Overall Study|Adverse Event|4|||
147249150|NCT01782222|531080873|FG001|Overall Study|Adverse Event|5|||
147249151|NCT01782222|531080874|FG002|Overall Study|Adverse Event|3|||
147249152|NCT01782222|531080872|FG000|Overall Study|Lack of Efficacy|2|||
147249153|NCT01782222|531080873|FG001|Overall Study|Lack of Efficacy|1|||
147249154|NCT01782222|531080874|FG002|Overall Study|Lack of Efficacy|0|||
147249155|NCT01782222|531080872|FG000|Overall Study|Protocol Violation|1|||
147249156|NCT01782222|531080873|FG001|Overall Study|Protocol Violation|0|||
147249157|NCT01782222|531080874|FG002|Overall Study|Protocol Violation|0|||
147249158|NCT01782222|531080872|FG000|Overall Study|Withdrawal by Subject|1|||
147249159|NCT01782222|531080873|FG001|Overall Study|Withdrawal by Subject|4|||
147249160|NCT01782222|531080874|FG002|Overall Study|Withdrawal by Subject|1|||
147249161|NCT01782222|531080872|FG000|Overall Study|Moved to other state|0|||
147249162|NCT01782222|531080873|FG001|Overall Study|Moved to other state|1|||
147249163|NCT01782222|531080874|FG002|Overall Study|Moved to other state|0|||
147331166|NCT04771273|531377595|FG000|Dose Escalation Period|Change of residence|0|||
147331167|NCT04771273|531377596|FG001|Dose Escalation Period|Change of residence|0|||
147331168|NCT04771273|531377597|FG002|Dose Escalation Period|Change of residence|0|||
147331169|NCT04771273|531377598|FG003|Dose Escalation Period|Change of residence|1|||
147331170|NCT04771273|531377595|FG000|Dose Escalation Period|Perceived lack of efficacy|0|||
147331171|NCT04771273|531377596|FG001|Dose Escalation Period|Perceived lack of efficacy|0|||
147331172|NCT04771273|531377597|FG002|Dose Escalation Period|Perceived lack of efficacy|0|||
147331173|NCT04771273|531377598|FG003|Dose Escalation Period|Perceived lack of efficacy|1|||
147331174|NCT04771273|531377595|FG000|Dose Escalation Period|Adverse Event|8|||
147331175|NCT04771273|531377596|FG001|Dose Escalation Period|Adverse Event|9|||
147331176|NCT04771273|531377597|FG002|Dose Escalation Period|Adverse Event|12|||
147331177|NCT04771273|531377598|FG003|Dose Escalation Period|Adverse Event|2|||
147331178|NCT04771273|531377595|FG000|Maintenance Period|Other than listed|4|||
147331179|NCT04771273|531377596|FG001|Maintenance Period|Other than listed|2|||
147595202|NCT00361335|532335767|FG002|SC Period: Week E0 to Week E24|Adverse Event|1|||
147249164|NCT01756898|531080878|FG000|Overall Study|Adverse Event|7|||
147249165|NCT01756898|531080879|FG001|Overall Study|Adverse Event|1|||
147249166|NCT01756898|531080880|FG002|Overall Study|Adverse Event|0|||
147249167|NCT01756898|531080881|FG003|Overall Study|Adverse Event|0|||
147249168|NCT01756898|531080878|FG000|Overall Study|Lack of Efficacy|4|||
147249169|NCT01756898|531080879|FG001|Overall Study|Lack of Efficacy|7|||
147249170|NCT01756898|531080880|FG002|Overall Study|Lack of Efficacy|6|||
147249171|NCT01756898|531080881|FG003|Overall Study|Lack of Efficacy|6|||
147249172|NCT01756898|531080878|FG000|Overall Study|Lost to Follow-up|2|||
147249173|NCT01756898|531080879|FG001|Overall Study|Lost to Follow-up|4|||
147249174|NCT01756898|531080880|FG002|Overall Study|Lost to Follow-up|2|||
147249175|NCT01756898|531080881|FG003|Overall Study|Lost to Follow-up|3|||
147249176|NCT01756898|531080878|FG000|Overall Study|Protocol Violation|1|||
147249177|NCT01756898|531080879|FG001|Overall Study|Protocol Violation|2|||
147249178|NCT01756898|531080880|FG002|Overall Study|Protocol Violation|2|||
147249179|NCT01756898|531080881|FG003|Overall Study|Protocol Violation|1|||
147249180|NCT01756898|531080878|FG000|Overall Study|Withdrew Consent|5|||
147249181|NCT01756898|531080879|FG001|Overall Study|Withdrew Consent|3|||
147249182|NCT01756898|531080880|FG002|Overall Study|Withdrew Consent|5|||
147249183|NCT01756898|531080881|FG003|Overall Study|Withdrew Consent|6|||
147249184|NCT01756898|531080878|FG000|Overall Study|Other|0|||
147249185|NCT01756898|531080879|FG001|Overall Study|Other|2|||
147249186|NCT01756898|531080880|FG002|Overall Study|Other|2|||
147249187|NCT01756898|531080881|FG003|Overall Study|Other|0|||
147249188|NCT01500694|531080882|FG000|Overall Study|Adverse Event|4|||
147249189|NCT01500694|531080883|FG001|Overall Study|Adverse Event|3|||
147249190|NCT01500694|531080882|FG000|Overall Study|Protocol Violation|0|||
147249191|NCT01500694|531080883|FG001|Overall Study|Protocol Violation|1|||
147249192|NCT01500694|531080882|FG000|Overall Study|Withdrawal by Subject|23|||
147249193|NCT01500694|531080883|FG001|Overall Study|Withdrawal by Subject|14|||
147249194|NCT01500694|531080882|FG000|Overall Study|Lost to Follow-up|2|||
147249195|NCT01500694|531080883|FG001|Overall Study|Lost to Follow-up|3|||
147249196|NCT01500694|531080882|FG000|Overall Study|Lack of Efficacy|14|||
147249197|NCT01500694|531080883|FG001|Overall Study|Lack of Efficacy|5|||
147249198|NCT01500694|531080882|FG000|Overall Study|Other|9|||
147249199|NCT01500694|531080883|FG001|Overall Study|Other|3|||
147249200|NCT02007109|531080884|FG000|Overall Study|Diary not returned or excluded|102|||
147249201|NCT02007109|531080884|FG000|Overall Study|Excluded - Age<7yo|9|||
147249202|NCT03572062|531080886|FG000|Overall Study|Adverse Event|0|||
147249203|NCT03572062|531080887|FG001|Overall Study|Adverse Event|0|||
147249204|NCT03572062|531080888|FG002|Overall Study|Adverse Event|0|||
147249205|NCT03572062|531080889|FG003|Overall Study|Adverse Event|0|||
147249206|NCT03572062|531080890|FG004|Overall Study|Adverse Event|0|||
147249207|NCT03572062|531080891|FG005|Overall Study|Adverse Event|0|||
147249208|NCT03572062|531080892|FG006|Overall Study|Adverse Event|0|||
147249209|NCT03572062|531080893|FG007|Overall Study|Adverse Event|0|||
147249210|NCT03572062|531080894|FG008|Overall Study|Adverse Event|1|||
147249211|NCT03572062|531080895|FG009|Overall Study|Adverse Event|3|||
147249212|NCT03572062|531080886|FG000|Overall Study|Death|0|||
147249213|NCT03572062|531080887|FG001|Overall Study|Death|0|||
147249214|NCT03572062|531080888|FG002|Overall Study|Death|0|||
147249215|NCT03572062|531080889|FG003|Overall Study|Death|0|||
147249216|NCT03572062|531080890|FG004|Overall Study|Death|0|||
147249217|NCT03572062|531080891|FG005|Overall Study|Death|1|||
147249218|NCT03572062|531080892|FG006|Overall Study|Death|0|||
147249219|NCT03572062|531080893|FG007|Overall Study|Death|0|||
147249220|NCT03572062|531080894|FG008|Overall Study|Death|0|||
147249221|NCT03572062|531080895|FG009|Overall Study|Death|0|||
147249222|NCT03572062|531080886|FG000|Overall Study|Lost to Follow-up|0|||
147249223|NCT03572062|531080887|FG001|Overall Study|Lost to Follow-up|0|||
147249224|NCT03572062|531080888|FG002|Overall Study|Lost to Follow-up|0|||
147249225|NCT03572062|531080889|FG003|Overall Study|Lost to Follow-up|0|||
147249226|NCT03572062|531080890|FG004|Overall Study|Lost to Follow-up|0|||
147249227|NCT03572062|531080891|FG005|Overall Study|Lost to Follow-up|1|||
147249228|NCT03572062|531080892|FG006|Overall Study|Lost to Follow-up|1|||
147249229|NCT03572062|531080893|FG007|Overall Study|Lost to Follow-up|0|||
147249230|NCT03572062|531080894|FG008|Overall Study|Lost to Follow-up|0|||
147249231|NCT03572062|531080895|FG009|Overall Study|Lost to Follow-up|0|||
147249232|NCT03572062|531080886|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
147249233|NCT03572062|531080887|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
147249234|NCT03572062|531080888|FG002|Overall Study|No Longer Meets Eligibility Criteria|0|||
147249235|NCT03572062|531080889|FG003|Overall Study|No Longer Meets Eligibility Criteria|0|||
147249236|NCT03572062|531080890|FG004|Overall Study|No Longer Meets Eligibility Criteria|0|||
147249237|NCT03572062|531080891|FG005|Overall Study|No Longer Meets Eligibility Criteria|0|||
147249238|NCT03572062|531080892|FG006|Overall Study|No Longer Meets Eligibility Criteria|0|||
147249239|NCT03572062|531080893|FG007|Overall Study|No Longer Meets Eligibility Criteria|0|||
147249240|NCT03572062|531080894|FG008|Overall Study|No Longer Meets Eligibility Criteria|1|||
147249241|NCT03572062|531080895|FG009|Overall Study|No Longer Meets Eligibility Criteria|0|||
147249242|NCT03572062|531080886|FG000|Overall Study|Study Terminated By Sponsor|0|||
147249243|NCT03572062|531080887|FG001|Overall Study|Study Terminated By Sponsor|0|||
147595203|NCT00361335|532335768|FG003|SC Period: Week E0 to Week E24|Adverse Event|2|||
147595204|NCT00361335|532335769|FG004|SC Period: Week E0 to Week E24|Adverse Event|0|||
147595205|NCT00361335|532335770|FG005|SC Period: Week E0 to Week E24|Adverse Event|0|||
147595206|NCT00361335|532335771|FG006|SC Period: Week E0 to Week E24|Adverse Event|2|||
147595207|NCT00361335|532335765|FG000|SC Period: Week E0 to Week E24|Lost to Follow-up|1|||
147595208|NCT00361335|532335766|FG001|SC Period: Week E0 to Week E24|Lost to Follow-up|0|||
147595209|NCT00361335|532335767|FG002|SC Period: Week E0 to Week E24|Lost to Follow-up|1|||
147249244|NCT03572062|531080888|FG002|Overall Study|Study Terminated By Sponsor|0|||
147249245|NCT03572062|531080889|FG003|Overall Study|Study Terminated By Sponsor|0|||
147249246|NCT03572062|531080890|FG004|Overall Study|Study Terminated By Sponsor|0|||
147249247|NCT03572062|531080891|FG005|Overall Study|Study Terminated By Sponsor|0|||
147249248|NCT03572062|531080892|FG006|Overall Study|Study Terminated By Sponsor|0|||
147249249|NCT03572062|531080893|FG007|Overall Study|Study Terminated By Sponsor|0|||
147249250|NCT03572062|531080894|FG008|Overall Study|Study Terminated By Sponsor|29|||
147249251|NCT03572062|531080895|FG009|Overall Study|Study Terminated By Sponsor|27|||
147249252|NCT03572062|531080886|FG000|Overall Study|Physician Decision|0|||
147249253|NCT03572062|531080887|FG001|Overall Study|Physician Decision|0|||
147249254|NCT03572062|531080888|FG002|Overall Study|Physician Decision|0|||
147249255|NCT03572062|531080889|FG003|Overall Study|Physician Decision|0|||
147249256|NCT03572062|531080890|FG004|Overall Study|Physician Decision|0|||
147249257|NCT03572062|531080891|FG005|Overall Study|Physician Decision|0|||
147249258|NCT03572062|531080892|FG006|Overall Study|Physician Decision|0|||
147249259|NCT03572062|531080893|FG007|Overall Study|Physician Decision|0|||
147249260|NCT03572062|531080894|FG008|Overall Study|Physician Decision|1|||
147249261|NCT03572062|531080895|FG009|Overall Study|Physician Decision|0|||
147249262|NCT03572062|531080886|FG000|Overall Study|Withdrawal by Subject|0|||
147249263|NCT03572062|531080887|FG001|Overall Study|Withdrawal by Subject|0|||
147249264|NCT03572062|531080888|FG002|Overall Study|Withdrawal by Subject|0|||
147249265|NCT03572062|531080889|FG003|Overall Study|Withdrawal by Subject|0|||
147249266|NCT03572062|531080890|FG004|Overall Study|Withdrawal by Subject|0|||
147249267|NCT03572062|531080891|FG005|Overall Study|Withdrawal by Subject|0|||
147249268|NCT03572062|531080892|FG006|Overall Study|Withdrawal by Subject|0|||
147249269|NCT03572062|531080893|FG007|Overall Study|Withdrawal by Subject|0|||
147249270|NCT03572062|531080894|FG008|Overall Study|Withdrawal by Subject|0|||
147249271|NCT03572062|531080895|FG009|Overall Study|Withdrawal by Subject|1|||
147249272|NCT03572062|531080886|FG000|Overall Study|Randomized But Not Treated|0|||
147249273|NCT03572062|531080887|FG001|Overall Study|Randomized But Not Treated|0|||
147249274|NCT03572062|531080888|FG002|Overall Study|Randomized But Not Treated|0|||
147249275|NCT03572062|531080889|FG003|Overall Study|Randomized But Not Treated|0|||
147249276|NCT03572062|531080890|FG004|Overall Study|Randomized But Not Treated|1|||
147249277|NCT03572062|531080891|FG005|Overall Study|Randomized But Not Treated|2|||
147249278|NCT03572062|531080892|FG006|Overall Study|Randomized But Not Treated|0|||
147249279|NCT03572062|531080893|FG007|Overall Study|Randomized But Not Treated|1|||
147249280|NCT03572062|531080894|FG008|Overall Study|Randomized But Not Treated|0|||
147249281|NCT03572062|531080895|FG009|Overall Study|Randomized But Not Treated|0|||
147249282|NCT01858389|531080896|FG000|Overall Study|Death|1|||
147249283|NCT01858389|531080897|FG001|Overall Study|Death|3|||
147249284|NCT01858389|531080896|FG000|Overall Study|Study terminated by sponsor|0|||
147249285|NCT01858389|531080897|FG001|Overall Study|Study terminated by sponsor|2|||
147249286|NCT01858389|531080896|FG000|Overall Study|Withdrawal by Subject|0|||
147249287|NCT01858389|531080897|FG001|Overall Study|Withdrawal by Subject|1|||
147249288|NCT01858389|531080896|FG000|Overall Study|Progressive disease|10|||
147249289|NCT01858389|531080897|FG001|Overall Study|Progressive disease|11|||
147249290|NCT01858389|531080896|FG000|Overall Study|Other|2|||
147249291|NCT01858389|531080897|FG001|Overall Study|Other|4|||
147249292|NCT01858389|531080896|FG000|Overall Study|Adverse Event|3|||
147249293|NCT01858389|531080897|FG001|Overall Study|Adverse Event|1|||
147249294|NCT01858389|531080896|FG000|Overall Study|Did not receive treatment|0|||
147249295|NCT01858389|531080897|FG001|Overall Study|Did not receive treatment|3|||
147249296|NCT01691781|531080898|FG000|Overall Study|Withdrawal by Subject|4|||
147249297|NCT01691781|531080899|FG001|Overall Study|Withdrawal by Subject|3|||
147249298|NCT01691781|531080898|FG000|Overall Study|Physician Decision|1|||
147249299|NCT01691781|531080899|FG001|Overall Study|Physician Decision|1|||
147249300|NCT01691781|531080898|FG000|Overall Study|Protocol Violation|2|||
147249301|NCT01691781|531080899|FG001|Overall Study|Protocol Violation|2|||
147249302|NCT01691781|531080898|FG000|Overall Study|Adverse Event|0|||
147595210|NCT00361335|532335768|FG003|SC Period: Week E0 to Week E24|Lost to Follow-up|0|||
147595211|NCT00361335|532335769|FG004|SC Period: Week E0 to Week E24|Lost to Follow-up|0|||
147249303|NCT01691781|531080899|FG001|Overall Study|Adverse Event|1|||
147249304|NCT03978520|531080900|FG000|Overall Study|Adverse Event|2|||
147249305|NCT03978520|531080901|FG001|Overall Study|Adverse Event|5|||
147249306|NCT03978520|531080902|FG002|Overall Study|Adverse Event|3|||
147249307|NCT03978520|531080903|FG003|Overall Study|Adverse Event|5|||
147595212|NCT00361335|532335770|FG005|SC Period: Week E0 to Week E24|Lost to Follow-up|0|||
147595213|NCT00361335|532335771|FG006|SC Period: Week E0 to Week E24|Lost to Follow-up|1|||
147249308|NCT03978520|531080904|FG004|Overall Study|Adverse Event|6|||
147249309|NCT03978520|531080900|FG000|Overall Study|Withdrawal by Subject|10|||
147249310|NCT03978520|531080901|FG001|Overall Study|Withdrawal by Subject|4|||
147249311|NCT03978520|531080902|FG002|Overall Study|Withdrawal by Subject|5|||
147249312|NCT03978520|531080903|FG003|Overall Study|Withdrawal by Subject|6|||
147249313|NCT03978520|531080904|FG004|Overall Study|Withdrawal by Subject|5|||
147249314|NCT03978520|531080900|FG000|Overall Study|Lost to Follow-up|2|||
147249315|NCT03978520|531080901|FG001|Overall Study|Lost to Follow-up|2|||
147249316|NCT03978520|531080902|FG002|Overall Study|Lost to Follow-up|2|||
147249317|NCT03978520|531080903|FG003|Overall Study|Lost to Follow-up|0|||
147249318|NCT03978520|531080904|FG004|Overall Study|Lost to Follow-up|1|||
147595214|NCT00361335|532335765|FG000|SC Period: Week E0 to Week E24|Death|0|||
147595215|NCT00361335|532335766|FG001|SC Period: Week E0 to Week E24|Death|0|||
147595216|NCT00361335|532335767|FG002|SC Period: Week E0 to Week E24|Death|0|||
147595217|NCT00361335|532335768|FG003|SC Period: Week E0 to Week E24|Death|0|||
147595218|NCT00361335|532335769|FG004|SC Period: Week E0 to Week E24|Death|0|||
147595219|NCT00361335|532335770|FG005|SC Period: Week E0 to Week E24|Death|0|||
147595220|NCT00361335|532335771|FG006|SC Period: Week E0 to Week E24|Death|1|||
147595221|NCT00361335|532335765|FG000|SC Period: Week E0 to Week E24|Worsening of RA|0|||
147595222|NCT00361335|532335766|FG001|SC Period: Week E0 to Week E24|Worsening of RA|1|||
147595223|NCT00361335|532335767|FG002|SC Period: Week E0 to Week E24|Worsening of RA|1|||
147249319|NCT03978520|531080900|FG000|Overall Study|COVID-19 infection|0|||
147249320|NCT03978520|531080901|FG001|Overall Study|COVID-19 infection|1|||
147249321|NCT03978520|531080902|FG002|Overall Study|COVID-19 infection|0|||
147249322|NCT03978520|531080903|FG003|Overall Study|COVID-19 infection|0|||
147249323|NCT03978520|531080904|FG004|Overall Study|COVID-19 infection|0|||
147249324|NCT03978520|531080900|FG000|Overall Study|Other, not specified|9|||
147249325|NCT03978520|531080901|FG001|Overall Study|Other, not specified|4|||
147249326|NCT03978520|531080902|FG002|Overall Study|Other, not specified|1|||
147249327|NCT03978520|531080903|FG003|Overall Study|Other, not specified|1|||
147249328|NCT03978520|531080904|FG004|Overall Study|Other, not specified|2|||
147249329|NCT03978520|531080900|FG000|Overall Study|Sponsor decision based on interim analysis data review|0|||
147249330|NCT03978520|531080901|FG001|Overall Study|Sponsor decision based on interim analysis data review|0|||
147249331|NCT03978520|531080902|FG002|Overall Study|Sponsor decision based on interim analysis data review|0|||
147249332|NCT03978520|531080903|FG003|Overall Study|Sponsor decision based on interim analysis data review|33|||
147249333|NCT03978520|531080904|FG004|Overall Study|Sponsor decision based on interim analysis data review|24|||
147249334|NCT01918085|531080907|FG000|Test Period 1: Strata Strip|Adverse Event|0|||
147249335|NCT01918085|531080908|FG001|Test Period 1: Strata Strip|Adverse Event|1|||
147249336|NCT00580606|531080922|FG000|Open Label (OL)|Lack of Efficacy at Week 116 OFC|2|||
147249337|NCT00580606|531080923|FG001|Open Label (OL)|Lack of Efficacy at Week 116 OFC|1|||
147249338|NCT00580606|531080922|FG000|Open Label (OL)|Withdrawal by Subject|4|||
147249339|NCT00580606|531080923|FG001|Open Label (OL)|Withdrawal by Subject|6|||
147249340|NCT00580606|531080922|FG000|Open Label (OL)|Dosing Symptoms|0|||
147249341|NCT00580606|531080923|FG001|Open Label (OL)|Dosing Symptoms|1|||
147249342|NCT00580606|531080922|FG000|Open Label (OL)|Lost to Follow-up|0|||
147249343|NCT00580606|531080923|FG001|Open Label (OL)|Lost to Follow-up|1|||
147249344|NCT00580606|531080922|FG000|Open Label (OL)|Pregnancy|0|||
147249345|NCT00580606|531080923|FG001|Open Label (OL)|Pregnancy|1|||
147249346|NCT00580606|531080922|FG000|Open Label (OL)|Non-compliance|2|||
147249347|NCT00580606|531080923|FG001|Open Label (OL)|Non-compliance|0|||
147249348|NCT00580606|531080922|FG000|Open Label (OL)|Physician Decision|1|||
147249349|NCT00580606|531080923|FG001|Open Label (OL)|Physician Decision|1|||
147249350|NCT00580606|531080922|FG000|Open Label (OL)|Needed Prohibited Medication|0|||
147249351|NCT00580606|531080923|FG001|Open Label (OL)|Needed Prohibited Medication|1|||
147249352|NCT03655691|531080925|FG000|Overall Study|Adverse Event|0|||
147249353|NCT03655691|531080926|FG001|Overall Study|Adverse Event|0|||
147249354|NCT03655691|531080927|FG002|Overall Study|Adverse Event|1|||
147249355|NCT03655691|531080925|FG000|Overall Study|Lost to Follow-up|1|||
147249356|NCT03655691|531080926|FG001|Overall Study|Lost to Follow-up|1|||
147249357|NCT03655691|531080927|FG002|Overall Study|Lost to Follow-up|2|||
147249358|NCT03655691|531080925|FG000|Overall Study|Protocol Violation|0|||
147249359|NCT03655691|531080926|FG001|Overall Study|Protocol Violation|1|||
147249360|NCT03655691|531080927|FG002|Overall Study|Protocol Violation|0|||
147249361|NCT03655691|531080925|FG000|Overall Study|Withdrawal by Subject|1|||
147249362|NCT03655691|531080926|FG001|Overall Study|Withdrawal by Subject|1|||
147249363|NCT03655691|531080927|FG002|Overall Study|Withdrawal by Subject|0|||
147249364|NCT03694821|531080928|FG000|Overall Study|Study terminated|4|||
147249365|NCT03694821|531080929|FG001|Overall Study|Study terminated|8|||
147249366|NCT03694821|531080930|FG002|Overall Study|Study terminated|4|||
147249367|NCT04102020|531080931|FG000|Overall Study|Adverse Event|1|||
147249368|NCT04102020|531080932|FG001|Overall Study|Adverse Event|0|||
147249369|NCT04102020|531080933|FG002|Overall Study|Adverse Event|0|||
147249370|NCT04102020|531080934|FG003|Overall Study|Adverse Event|1|||
147249371|NCT04102020|531080935|FG004|Overall Study|Adverse Event|0|||
147595224|NCT00361335|532335768|FG003|SC Period: Week E0 to Week E24|Worsening of RA|1|||
147595225|NCT00361335|532335769|FG004|SC Period: Week E0 to Week E24|Worsening of RA|0|||
147249372|NCT04102020|531080931|FG000|Overall Study|Withdrawal by Subject|0|||
147249373|NCT04102020|531080932|FG001|Overall Study|Withdrawal by Subject|1|||
147595226|NCT00361335|532335770|FG005|SC Period: Week E0 to Week E24|Worsening of RA|0|||
147595227|NCT00361335|532335771|FG006|SC Period: Week E0 to Week E24|Worsening of RA|0|||
147595228|NCT00361335|532335765|FG000|SC Period: Week E0 to Week E24|Other|1|||
147595229|NCT00361335|532335766|FG001|SC Period: Week E0 to Week E24|Other|0|||
147595230|NCT00361335|532335767|FG002|SC Period: Week E0 to Week E24|Other|0|||
147595231|NCT00361335|532335768|FG003|SC Period: Week E0 to Week E24|Other|1|||
147595232|NCT00361335|532335769|FG004|SC Period: Week E0 to Week E24|Other|0|||
147595233|NCT00361335|532335770|FG005|SC Period: Week E0 to Week E24|Other|1|||
147658836|NCT01409915|532574273|FG001|Overall Study|Withdrawal by Subject|1|||
147658837|NCT01409915|532574272|FG000|Overall Study|Protocol Violation|1|||
147658838|NCT01409915|532574273|FG001|Overall Study|Protocol Violation|0|||
147658839|NCT04826484|532574274|FG000|Overall Study|Lost to Follow-up|2|||
147658840|NCT04826484|532574275|FG001|Overall Study|Lost to Follow-up|0|||
147658841|NCT00215644|532574277|FG000|Overall Study|Disease Progression|28|||
147658842|NCT00215644|532574278|FG001|Overall Study|Disease Progression|10|||
147658843|NCT00215644|532574277|FG000|Overall Study|Adverse Event|2|||
147658844|NCT00215644|532574278|FG001|Overall Study|Adverse Event|9|||
147658845|NCT00215644|532574277|FG000|Overall Study|Death|1|||
147658846|NCT00215644|532574278|FG001|Overall Study|Death|2|||
147658847|NCT00215644|532574277|FG000|Overall Study|Withdrawal by Subject|1|||
147658848|NCT00215644|532574278|FG001|Overall Study|Withdrawal by Subject|0|||
147658849|NCT00215644|532574277|FG000|Overall Study|Other|3|||
147658850|NCT00215644|532574278|FG001|Overall Study|Other|15|||
147658851|NCT00215644|532574277|FG000|Overall Study|Randomized but Not Treated|1|||
147658852|NCT00215644|532574278|FG001|Overall Study|Randomized but Not Treated|0|||
147658853|NCT00758498|532574282|FG000|Overall Study|Adverse Event|2|||
147658854|NCT00758498|532574283|FG001|Overall Study|Adverse Event|2|||
147658855|NCT00758498|532574284|FG002|Overall Study|Adverse Event|3|||
147658856|NCT00758498|532574282|FG000|Overall Study|Subject legally detained out of state|1|||
147658857|NCT00758498|532574283|FG001|Overall Study|Subject legally detained out of state|0|||
147658858|NCT00758498|532574284|FG002|Overall Study|Subject legally detained out of state|0|||
147249374|NCT04102020|531080933|FG002|Overall Study|Withdrawal by Subject|1|||
147249375|NCT04102020|531080934|FG003|Overall Study|Withdrawal by Subject|1|||
147249376|NCT04102020|531080935|FG004|Overall Study|Withdrawal by Subject|1|||
147249377|NCT04102020|531080931|FG000|Overall Study|Death|1|||
147249378|NCT04102020|531080932|FG001|Overall Study|Death|4|||
147249379|NCT04102020|531080933|FG002|Overall Study|Death|1|||
147249380|NCT04102020|531080934|FG003|Overall Study|Death|1|||
147249381|NCT04102020|531080935|FG004|Overall Study|Death|0|||
147249382|NCT04102020|531080931|FG000|Overall Study|Physician Decision|1|||
147249383|NCT04102020|531080932|FG001|Overall Study|Physician Decision|2|||
147249384|NCT04102020|531080933|FG002|Overall Study|Physician Decision|2|||
147249385|NCT04102020|531080934|FG003|Overall Study|Physician Decision|0|||
147249386|NCT04102020|531080935|FG004|Overall Study|Physician Decision|1|||
147249387|NCT04102020|531080931|FG000|Overall Study|COVID-19 Infection|1|||
147249388|NCT04102020|531080932|FG001|Overall Study|COVID-19 Infection|0|||
147249389|NCT04102020|531080933|FG002|Overall Study|COVID-19 Infection|0|||
147249390|NCT04102020|531080934|FG003|Overall Study|COVID-19 Infection|0|||
147249391|NCT04102020|531080935|FG004|Overall Study|COVID-19 Infection|0|||
147249392|NCT04102020|531080931|FG000|Overall Study|Not disclosed|5|||
147249393|NCT04102020|531080932|FG001|Overall Study|Not disclosed|3|||
147249394|NCT04102020|531080933|FG002|Overall Study|Not disclosed|8|||
147249395|NCT04102020|531080934|FG003|Overall Study|Not disclosed|0|||
147249396|NCT04102020|531080935|FG004|Overall Study|Not disclosed|1|||
147249397|NCT04102020|531080931|FG000|Overall Study|MIssing|1|||
147249398|NCT04102020|531080932|FG001|Overall Study|MIssing|0|||
147249399|NCT04102020|531080933|FG002|Overall Study|MIssing|1|||
147249400|NCT04102020|531080934|FG003|Overall Study|MIssing|1|||
147249401|NCT04102020|531080935|FG004|Overall Study|MIssing|1|||
147249402|NCT04102020|531080931|FG000|Overall Study|Continuing in ongoing study|13|||
147249403|NCT04102020|531080932|FG001|Overall Study|Continuing in ongoing study|13|||
147249404|NCT04102020|531080933|FG002|Overall Study|Continuing in ongoing study|7|||
147249405|NCT04102020|531080934|FG003|Overall Study|Continuing in ongoing study|26|||
147249406|NCT04102020|531080935|FG004|Overall Study|Continuing in ongoing study|12|||
147249407|NCT04419714|531080938|FG000|Overall Study|Technical Fault|5|||
147249408|NCT04419714|531080938|FG000|Overall Study|Protocol Deviation|2|||
147249409|NCT04419714|531080938|FG000|Overall Study|Withdrawal by Subject|1|||
147249410|NCT04221009|531082242|FG000|Overall Study|Withdrawal by Subject|4|||
147249411|NCT02154490|531082243|FG000|Overall Study|No tissue submitted|23|||
147249412|NCT02154490|531082243|FG000|Overall Study|No biomarker results|167|||
147595234|NCT00361335|532335771|FG006|SC Period: Week E0 to Week E24|Other|2|||
147658859|NCT00758498|532574282|FG000|Overall Study|Withdrawal by Subject|0|||
147658860|NCT00758498|532574283|FG001|Overall Study|Withdrawal by Subject|0|||
147249413|NCT02154490|531082243|FG000|Overall Study|Not assigned to a sub-study|270|||
147249414|NCT02154490|531082243|FG000|Overall Study|Did not register to a sub-study|749|||
147249415|NCT02373202|531082244|FG000|Overall Study|Adverse Event|2|||
147249416|NCT02373202|531082245|FG001|Overall Study|Adverse Event|5|||
147249417|NCT02373202|531082246|FG002|Overall Study|Adverse Event|2|||
147658861|NCT00758498|532574284|FG002|Overall Study|Withdrawal by Subject|1|||
147249418|NCT02373202|531082247|FG003|Overall Study|Adverse Event|1|||
147249419|NCT02373202|531082244|FG000|Overall Study|Lack of Efficacy|0|||
147249420|NCT02373202|531082245|FG001|Overall Study|Lack of Efficacy|0|||
147249421|NCT02373202|531082246|FG002|Overall Study|Lack of Efficacy|1|||
147249422|NCT02373202|531082247|FG003|Overall Study|Lack of Efficacy|0|||
147595235|NCT00361335|532335765|FG000|SC Period: Week E0 to Week E24|Lack of Efficacy|0|||
147595236|NCT00361335|532335766|FG001|SC Period: Week E0 to Week E24|Lack of Efficacy|0|||
147595237|NCT00361335|532335767|FG002|SC Period: Week E0 to Week E24|Lack of Efficacy|2|||
147595238|NCT00361335|532335768|FG003|SC Period: Week E0 to Week E24|Lack of Efficacy|0|||
147595239|NCT00361335|532335769|FG004|SC Period: Week E0 to Week E24|Lack of Efficacy|0|||
147595240|NCT00361335|532335770|FG005|SC Period: Week E0 to Week E24|Lack of Efficacy|0|||
147595241|NCT00361335|532335771|FG006|SC Period: Week E0 to Week E24|Lack of Efficacy|3|||
147595242|NCT00714493|532335779|FG000|Overall Study|Adverse Event|11|||
147595243|NCT00714493|532335779|FG000|Overall Study|Death|3|||
147595244|NCT00714493|532335779|FG000|Overall Study|Lack of Efficacy|10|||
147595245|NCT00714493|532335779|FG000|Overall Study|Lost to Follow-up|3|||
147595246|NCT00714493|532335779|FG000|Overall Study|Protocol Violation|12|||
147595247|NCT00714493|532335779|FG000|Overall Study|SUBJECT CHOICE (SUBJECT WITHDREW CONSENT|8|||
147595248|NCT00714493|532335779|FG000|Overall Study|OTHER|2|||
147595249|NCT04505293|532335780|FG000|Overall Study|Lost to Follow-up|2|||
147595250|NCT04505293|532335780|FG000|Overall Study|Withdrawal by Subject|6|||
147595251|NCT04505293|532335780|FG000|Overall Study|CT scan unreadable|277|||
147595252|NCT00506129|532335781|FG000|Overall Study|Disease Progression/Relapse|15|||
147595253|NCT00506129|532335781|FG000|Overall Study|Death|7|||
147595254|NCT01400919|532335785|FG000|Overall Study|Withdrawal by Subject|4|||
147595255|NCT01400919|532335785|FG000|Overall Study|Lost to Follow-up|2|||
147595256|NCT01400919|532335785|FG000|Overall Study|Missed visit|2|||
147595257|NCT00251719|532335786|FG000|Overall Study|Adverse Event|14|||
147595258|NCT00251719|532335787|FG001|Overall Study|Adverse Event|8|||
147595259|NCT00251719|532335788|FG002|Overall Study|Adverse Event|7|||
147595260|NCT00251719|532335786|FG000|Overall Study|Protocol Violation|1|||
147595261|NCT00251719|532335787|FG001|Overall Study|Protocol Violation|1|||
147595262|NCT00251719|532335788|FG002|Overall Study|Protocol Violation|1|||
147595263|NCT00251719|532335786|FG000|Overall Study|Lost to Follow-up|5|||
147595264|NCT00251719|532335787|FG001|Overall Study|Lost to Follow-up|11|||
147595265|NCT00251719|532335788|FG002|Overall Study|Lost to Follow-up|8|||
147595266|NCT00251719|532335786|FG000|Overall Study|Withdrawal by Subject|14|||
147595267|NCT00251719|532335787|FG001|Overall Study|Withdrawal by Subject|12|||
147595268|NCT00251719|532335788|FG002|Overall Study|Withdrawal by Subject|11|||
147595269|NCT00251719|532335786|FG000|Overall Study|Lack of Efficacy|2|||
147595270|NCT00251719|532335787|FG001|Overall Study|Lack of Efficacy|1|||
147595271|NCT00251719|532335788|FG002|Overall Study|Lack of Efficacy|0|||
147595272|NCT00251719|532335786|FG000|Overall Study|Inclusion/exclusion criteria not met|12|||
147595273|NCT00251719|532335787|FG001|Overall Study|Inclusion/exclusion criteria not met|6|||
147595274|NCT00251719|532335788|FG002|Overall Study|Inclusion/exclusion criteria not met|2|||
147595275|NCT00251719|532335786|FG000|Overall Study|Investigator decision|1|||
147595276|NCT00251719|532335787|FG001|Overall Study|Investigator decision|1|||
147595277|NCT00251719|532335788|FG002|Overall Study|Investigator decision|0|||
147595278|NCT00251719|532335786|FG000|Overall Study|Noncompliance|2|||
147595279|NCT00251719|532335787|FG001|Overall Study|Noncompliance|3|||
147595280|NCT00251719|532335788|FG002|Overall Study|Noncompliance|1|||
147595281|NCT00251719|532335786|FG000|Overall Study|Barrett's esophagus|2|||
147595282|NCT00251719|532335787|FG001|Overall Study|Barrett's esophagus|2|||
147595283|NCT00251719|532335788|FG002|Overall Study|Barrett's esophagus|0|||
147595284|NCT01732874|532335791|FG000|Overall Study|Withdrawal by Subject|5|||
147595285|NCT01732874|532335792|FG001|Overall Study|Withdrawal by Subject|1|||
147595286|NCT01732874|532335791|FG000|Overall Study|Death of Infant|3|||
147595287|NCT01732874|532335792|FG001|Overall Study|Death of Infant|2|||
147595288|NCT02923674|532335793|FG000|Overall Study|Clinic Closed Due to COVID-19|14|||
147595289|NCT02923674|532335794|FG001|Overall Study|Clinic Closed Due to COVID-19|11|||
147595290|NCT02923674|532335795|FG002|Overall Study|Clinic Closed Due to COVID-19|14|||
147595291|NCT02923674|532335793|FG000|Overall Study|Lost to Follow-up|7|||
147595292|NCT02923674|532335794|FG001|Overall Study|Lost to Follow-up|12|||
147595293|NCT02923674|532335795|FG002|Overall Study|Lost to Follow-up|7|||
147595294|NCT02923674|532335793|FG000|Overall Study|Problem with intervention|2|||
147595295|NCT02923674|532335794|FG001|Overall Study|Problem with intervention|2|||
147595296|NCT02923674|532335795|FG002|Overall Study|Problem with intervention|1|||
147595297|NCT02923674|532335793|FG000|Overall Study|Adverse Event|3|||
147595298|NCT02923674|532335794|FG001|Overall Study|Adverse Event|1|||
147595299|NCT02923674|532335795|FG002|Overall Study|Adverse Event|1|||
147595300|NCT02923674|532335793|FG000|Overall Study|Withdrawal by Subject|2|||
147595301|NCT02923674|532335794|FG001|Overall Study|Withdrawal by Subject|2|||
147595302|NCT02923674|532335795|FG002|Overall Study|Withdrawal by Subject|2|||
147595303|NCT00688376|532335798|FG000|Double-Blind Phase|Adverse Event|4|||
147249423|NCT02373202|531082244|FG000|Overall Study|Other|0|||
147595304|NCT00688376|532335799|FG001|Double-Blind Phase|Adverse Event|4|||
147595305|NCT00688376|532335798|FG000|Double-Blind Phase|Protocol Violation|1|||
147249424|NCT02373202|531082245|FG001|Overall Study|Other|1|||
147249425|NCT02373202|531082246|FG002|Overall Study|Other|0|||
147249426|NCT02373202|531082247|FG003|Overall Study|Other|0|||
147595306|NCT00688376|532335799|FG001|Double-Blind Phase|Protocol Violation|2|||
147595307|NCT00688376|532335798|FG000|Double-Blind Phase|Withdrawal by Subject|1|||
147595308|NCT00688376|532335799|FG001|Double-Blind Phase|Withdrawal by Subject|0|||
147595309|NCT00688376|532335798|FG000|Double-Blind Phase|Not treated|0|||
147595310|NCT00688376|532335799|FG001|Double-Blind Phase|Not treated|1|||
147595311|NCT00688376|532335798|FG000|Blinded Extension Phase|Adverse Event|3|||
147595312|NCT00688376|532335799|FG001|Blinded Extension Phase|Adverse Event|4|||
147595313|NCT00688376|532335798|FG000|Blinded Extension Phase|Withdrawal by Subject|0|||
147595314|NCT00688376|532335799|FG001|Blinded Extension Phase|Withdrawal by Subject|1|||
147595315|NCT00688376|532335798|FG000|Blinded Extension Phase|Physician Decision|1|||
147595316|NCT00688376|532335799|FG001|Blinded Extension Phase|Physician Decision|0|||
147595317|NCT00688376|532335798|FG000|Blinded Extension Phase|Other|1|||
147595318|NCT00688376|532335799|FG001|Blinded Extension Phase|Other|0|||
147595319|NCT00557076|532335800|FG000|Overall Study|Unblinding|0|||
147595320|NCT00557076|532335801|FG001|Overall Study|Unblinding|1|||
147595321|NCT02335983|532335802|FG000|Overall Study|Sponsor Decision|0|||
147595322|NCT02335983|532335803|FG001|Overall Study|Sponsor Decision|0|||
147595323|NCT02335983|532335804|FG002|Overall Study|Sponsor Decision|1|||
147595324|NCT02335983|532335805|FG003|Overall Study|Sponsor Decision|1|||
147595325|NCT02335983|532335806|FG004|Overall Study|Sponsor Decision|0|||
147595326|NCT02335983|532335807|FG005|Overall Study|Sponsor Decision|1|||
147595327|NCT02335983|532335802|FG000|Overall Study|Withdrawal by Subject|3|||
147595328|NCT02335983|532335803|FG001|Overall Study|Withdrawal by Subject|2|||
147595329|NCT02335983|532335804|FG002|Overall Study|Withdrawal by Subject|2|||
147595330|NCT02335983|532335805|FG003|Overall Study|Withdrawal by Subject|1|||
147595331|NCT02335983|532335806|FG004|Overall Study|Withdrawal by Subject|3|||
147595332|NCT02335983|532335807|FG005|Overall Study|Withdrawal by Subject|9|||
147595333|NCT02335983|532335802|FG000|Overall Study|Death|0|||
147595334|NCT02335983|532335803|FG001|Overall Study|Death|0|||
147595335|NCT02335983|532335804|FG002|Overall Study|Death|2|||
147595336|NCT02335983|532335805|FG003|Overall Study|Death|0|||
147595337|NCT02335983|532335806|FG004|Overall Study|Death|0|||
147595338|NCT02335983|532335807|FG005|Overall Study|Death|0|||
147595339|NCT02335983|532335802|FG000|Overall Study|Lost to Follow-up|0|||
147595340|NCT02335983|532335803|FG001|Overall Study|Lost to Follow-up|0|||
147595341|NCT02335983|532335804|FG002|Overall Study|Lost to Follow-up|0|||
147595342|NCT02335983|532335805|FG003|Overall Study|Lost to Follow-up|0|||
147595343|NCT02335983|532335806|FG004|Overall Study|Lost to Follow-up|0|||
147595344|NCT02335983|532335807|FG005|Overall Study|Lost to Follow-up|1|||
147595345|NCT02335983|532335802|FG000|Overall Study|Protocol Specified Criteria|5|||
147595346|NCT02335983|532335803|FG001|Overall Study|Protocol Specified Criteria|7|||
147595347|NCT02335983|532335804|FG002|Overall Study|Protocol Specified Criteria|27|||
147595348|NCT02335983|532335805|FG003|Overall Study|Protocol Specified Criteria|7|||
147595349|NCT02335983|532335806|FG004|Overall Study|Protocol Specified Criteria|5|||
147595350|NCT02335983|532335807|FG005|Overall Study|Protocol Specified Criteria|21|||
147595351|NCT01070771|532335808|FG000|Overall Study|Adverse Event|2|||
147595352|NCT01070771|532335808|FG000|Overall Study|Protocol Violation|1|||
147595353|NCT03127644|532335809|FG000|Overall Study|Study-specific withdrawal criteria|0|||
147595354|NCT03127644|532335810|FG001|Overall Study|Study-specific withdrawal criteria|0|||
147595355|NCT03127644|532335811|FG002|Overall Study|Study-specific withdrawal criteria|2|||
147595356|NCT04700280|532335814|FG000|Overall Study|Adverse Event|4|||
147595357|NCT04700280|532335815|FG001|Overall Study|Adverse Event|0|||
147595358|NCT04700280|532335814|FG000|Overall Study|Lack of Efficacy|1|||
147595359|NCT04700280|532335815|FG001|Overall Study|Lack of Efficacy|0|||
147595360|NCT04700280|532335814|FG000|Overall Study|Study terminated by sponsor|5|||
147595361|NCT04700280|532335815|FG001|Overall Study|Study terminated by sponsor|3|||
147595362|NCT04700280|532335814|FG000|Overall Study|Other than specified|1|||
147595363|NCT04700280|532335815|FG001|Overall Study|Other than specified|0|||
147595364|NCT00062751|532335816|FG000|Overall Study|Disease progression|24|||
147595365|NCT00062751|532335817|FG001|Overall Study|Disease progression|17|||
147595366|NCT00062751|532335818|FG002|Overall Study|Disease progression|24|||
147595367|NCT00062751|532335819|FG003|Overall Study|Disease progression|2|||
147595368|NCT00062751|532335820|FG004|Overall Study|Disease progression|2|||
147595369|NCT00062751|532335816|FG000|Overall Study|Adverse Event|4|||
147595370|NCT00062751|532335817|FG001|Overall Study|Adverse Event|7|||
147595371|NCT00062751|532335818|FG002|Overall Study|Adverse Event|2|||
147595372|NCT00062751|532335819|FG003|Overall Study|Adverse Event|2|||
147249427|NCT03010254|531082248|FG000|Overall Study|Adverse Event|0|||
147595373|NCT00062751|532335820|FG004|Overall Study|Adverse Event|2|||
147595374|NCT00062751|532335816|FG000|Overall Study|Other|2|||
147595375|NCT00062751|532335817|FG001|Overall Study|Other|3|||
147595376|NCT00062751|532335818|FG002|Overall Study|Other|1|||
147595377|NCT00062751|532335819|FG003|Overall Study|Other|0|||
147595378|NCT00062751|532335820|FG004|Overall Study|Other|1|||
147595379|NCT00062751|532335816|FG000|Overall Study|Withdrawal by Subject|1|||
147595380|NCT00062751|532335817|FG001|Overall Study|Withdrawal by Subject|2|||
147658862|NCT00758498|532574282|FG000|Overall Study|Noncompliance to study procedures|0|||
147658863|NCT00758498|532574283|FG001|Overall Study|Noncompliance to study procedures|0|||
147658864|NCT00758498|532574284|FG002|Overall Study|Noncompliance to study procedures|1|||
147658865|NCT01516736|532574287|FG000|Overall Study|Withdrawal by Subject|10|||
147658866|NCT01516736|532574288|FG001|Overall Study|Withdrawal by Subject|4|||
147658867|NCT01516736|532574287|FG000|Overall Study|Adverse Event|4|||
147658868|NCT01516736|532574288|FG001|Overall Study|Adverse Event|5|||
147658869|NCT01516736|532574287|FG000|Overall Study|Death|3|||
147658870|NCT01516736|532574288|FG001|Overall Study|Death|1|||
147658871|NCT01516736|532574287|FG000|Overall Study|Physician Decision|2|||
147658872|NCT01516736|532574288|FG001|Overall Study|Physician Decision|1|||
147658873|NCT01516736|532574287|FG000|Overall Study|Lack of Efficacy|1|||
147658874|NCT01516736|532574288|FG001|Overall Study|Lack of Efficacy|0|||
147658875|NCT01516736|532574287|FG000|Overall Study|Protocol Violation|0|||
147658876|NCT01516736|532574288|FG001|Overall Study|Protocol Violation|1|||
147658877|NCT01516736|532574287|FG000|Overall Study|Other (not specified)|0|||
147658878|NCT01516736|532574288|FG001|Overall Study|Other (not specified)|1|||
147658879|NCT02781818|532574289|FG000|Overall Study|Lost to Follow-up|4|||
147658880|NCT02781818|532574290|FG001|Overall Study|Lost to Follow-up|2|||
147658881|NCT02781818|532574291|FG002|Overall Study|Lost to Follow-up|1|||
147658882|NCT01877668|532574292|FG000|Overall Study|Death|0|||
147658883|NCT01877668|532574293|FG001|Overall Study|Death|0|||
147658884|NCT01877668|532574294|FG002|Overall Study|Death|0|||
147658885|NCT01877668|532574295|FG003|Overall Study|Death|1|||
147658886|NCT01877668|532574296|FG004|Overall Study|Death|0|||
147658887|NCT01877668|532574292|FG000|Overall Study|No longer met study criteria|1|||
147658888|NCT01877668|532574293|FG001|Overall Study|No longer met study criteria|0|||
147658889|NCT01877668|532574294|FG002|Overall Study|No longer met study criteria|1|||
147658890|NCT01877668|532574295|FG003|Overall Study|No longer met study criteria|0|||
147658891|NCT01877668|532574296|FG004|Overall Study|No longer met study criteria|0|||
147658892|NCT01877668|532574292|FG000|Overall Study|Insufficient clinical response|0|||
147658893|NCT01877668|532574293|FG001|Overall Study|Insufficient clinical response|1|||
147658894|NCT01877668|532574294|FG002|Overall Study|Insufficient clinical response|2|||
147658895|NCT01877668|532574295|FG003|Overall Study|Insufficient clinical response|2|||
147658896|NCT01877668|532574296|FG004|Overall Study|Insufficient clinical response|0|||
147658897|NCT01877668|532574292|FG000|Overall Study|Lost to Follow-up|0|||
147658898|NCT01877668|532574293|FG001|Overall Study|Lost to Follow-up|2|||
147658899|NCT01877668|532574294|FG002|Overall Study|Lost to Follow-up|1|||
147658900|NCT01877668|532574295|FG003|Overall Study|Lost to Follow-up|0|||
147658901|NCT01877668|532574296|FG004|Overall Study|Lost to Follow-up|0|||
147658902|NCT01877668|532574292|FG000|Overall Study|Withdrawal by Subject|2|||
147658903|NCT01877668|532574293|FG001|Overall Study|Withdrawal by Subject|0|||
147658904|NCT01877668|532574294|FG002|Overall Study|Withdrawal by Subject|3|||
147658905|NCT01877668|532574295|FG003|Overall Study|Withdrawal by Subject|2|||
147658906|NCT01877668|532574296|FG004|Overall Study|Withdrawal by Subject|2|||
147658907|NCT01877668|532574292|FG000|Overall Study|Other|1|||
147658908|NCT01877668|532574293|FG001|Overall Study|Other|1|||
147658909|NCT01877668|532574294|FG002|Overall Study|Other|1|||
147658910|NCT01877668|532574295|FG003|Overall Study|Other|1|||
147658911|NCT01877668|532574296|FG004|Overall Study|Other|3|||
147658912|NCT01877668|532574292|FG000|Overall Study|Protocol Violation|1|||
147658913|NCT01877668|532574293|FG001|Overall Study|Protocol Violation|1|||
147658914|NCT01877668|532574294|FG002|Overall Study|Protocol Violation|0|||
147658915|NCT01877668|532574295|FG003|Overall Study|Protocol Violation|0|||
147658916|NCT01877668|532574296|FG004|Overall Study|Protocol Violation|3|||
147658917|NCT01877668|532574292|FG000|Overall Study|Adverse event related to study drug|2|||
147658918|NCT01877668|532574293|FG001|Overall Study|Adverse event related to study drug|2|||
147658919|NCT01877668|532574294|FG002|Overall Study|Adverse event related to study drug|2|||
147658920|NCT01877668|532574295|FG003|Overall Study|Adverse event related to study drug|2|||
147658921|NCT01877668|532574296|FG004|Overall Study|Adverse event related to study drug|1|||
147658922|NCT01877668|532574292|FG000|Overall Study|Adverse event unrelated to study drug|4|||
147658923|NCT01877668|532574293|FG001|Overall Study|Adverse event unrelated to study drug|1|||
147658924|NCT01877668|532574294|FG002|Overall Study|Adverse event unrelated to study drug|2|||
147658925|NCT01877668|532574295|FG003|Overall Study|Adverse event unrelated to study drug|0|||
147658926|NCT01877668|532574296|FG004|Overall Study|Adverse event unrelated to study drug|1|||
147658927|NCT01302418|532574297|FG000|Overall Study|Protocol Violation|9|||
147658928|NCT01302418|532574297|FG000|Overall Study|Non-evaluable|9|||
147658929|NCT01697800|532574298|FG000|Overall Study|Death|0|||
147658930|NCT01697800|532574299|FG001|Overall Study|Death|1|||
147658931|NCT00954122|532574300|FG000|Overall Study|Withdrawal by Subject|5|||
147658932|NCT00954122|532574300|FG000|Overall Study|Adverse Event|1|||
147658933|NCT00954122|532574300|FG000|Overall Study|Safety Reason|1|||
147658934|NCT02485483|532574301|FG000|Overall Study|Depression at baseline|15|||
147658935|NCT02485483|532574302|FG001|Overall Study|Depression at baseline|0|||
147658936|NCT02485483|532574301|FG000|Overall Study|Discontinued after baseline|39|||
147658937|NCT02485483|532574302|FG001|Overall Study|Discontinued after baseline|0|||
147658938|NCT02291029|532574305|FG000|Overall Study|Withdrawal by Subject|0|||
147658939|NCT02291029|532574306|FG001|Overall Study|Withdrawal by Subject|0|||
147658940|NCT02291029|532574307|FG002|Overall Study|Withdrawal by Subject|1|||
147658941|NCT02291029|532574308|FG003|Overall Study|Withdrawal by Subject|0|||
147658942|NCT02291029|532574309|FG004|Overall Study|Withdrawal by Subject|0|||
147249428|NCT03010254|531082249|FG001|Overall Study|Adverse Event|1|||
147249429|NCT03010254|531082248|FG000|Overall Study|Lost to Follow-up|4|||
147249430|NCT03010254|531082249|FG001|Overall Study|Lost to Follow-up|0|||
147249431|NCT03010254|531082248|FG000|Overall Study|Withdrawal by Subject|1|||
147249432|NCT03010254|531082249|FG001|Overall Study|Withdrawal by Subject|1|||
147249433|NCT03010254|531082248|FG000|Overall Study|Other|2|||
147249434|NCT03010254|531082249|FG001|Overall Study|Other|3|||
147249435|NCT00482612|531082254|FG000|In-treatment Period|No study medication administered|0|||
147249436|NCT00482612|531082255|FG001|In-treatment Period|No study medication administered|0|||
147249437|NCT00482612|531082256|FG002|In-treatment Period|No study medication administered|1|||
147249438|NCT00482612|531082257|FG003|In-treatment Period|No study medication administered|0|||
147249439|NCT00482612|531082254|FG000|Follow-up Period|Other|4|||
147249440|NCT00482612|531082255|FG001|Follow-up Period|Other|2|||
147249441|NCT00482612|531082256|FG002|Follow-up Period|Other|1|||
147249442|NCT00482612|531082257|FG003|Follow-up Period|Other|2|||
147249443|NCT00482612|531082254|FG000|Follow-up Period|Lack of compliance|0|||
147449484|NCT00440947|531809505|FG000|36-Week Induction Phase|Took Exclusionary Medications|1|||
147658943|NCT02291029|532574310|FG005|Overall Study|Withdrawal by Subject|0|||
147658944|NCT02291029|532574305|FG000|Overall Study|Adverse Event|0|||
147658945|NCT02291029|532574306|FG001|Overall Study|Adverse Event|1|||
147658946|NCT02291029|532574307|FG002|Overall Study|Adverse Event|0|||
147658947|NCT02291029|532574308|FG003|Overall Study|Adverse Event|0|||
147658948|NCT02291029|532574309|FG004|Overall Study|Adverse Event|0|||
147658949|NCT02291029|532574310|FG005|Overall Study|Adverse Event|0|||
147658950|NCT00522548|532574311|FG000|Overall Study|Adverse Event|2|||
147658951|NCT00522548|532574312|FG001|Overall Study|Adverse Event|2|||
147658952|NCT00522548|532574311|FG000|Overall Study|Withdrawal by Subject|0|||
147658953|NCT00522548|532574312|FG001|Overall Study|Withdrawal by Subject|2|||
147658954|NCT00666211|532574313|FG000|Overall Study|Withdrawal by Subject|10|||
147658955|NCT00666211|532574314|FG001|Overall Study|Withdrawal by Subject|13|||
147658956|NCT00666211|532574313|FG000|Overall Study|went off medication, no more pain|1|||
147658957|NCT00666211|532574314|FG001|Overall Study|went off medication, no more pain|0|||
147658958|NCT00666211|532574313|FG000|Overall Study|patient non-compliant|6|||
147658959|NCT00666211|532574314|FG001|Overall Study|patient non-compliant|6|||
147658960|NCT00666211|532574313|FG000|Overall Study|disease progression|1|||
147658961|NCT00666211|532574314|FG001|Overall Study|disease progression|8|||
147658962|NCT00666211|532574313|FG000|Overall Study|Lost to Follow-up|2|||
147658963|NCT00666211|532574314|FG001|Overall Study|Lost to Follow-up|0|||
147658964|NCT00666211|532574313|FG000|Overall Study|toxicity|0|||
147658965|NCT00666211|532574314|FG001|Overall Study|toxicity|2|||
147658966|NCT00666211|532574313|FG000|Overall Study|hospital admission|0|||
147658967|NCT00666211|532574314|FG001|Overall Study|hospital admission|5|||
147658968|NCT00666211|532574313|FG000|Overall Study|Death|0|||
147658969|NCT00666211|532574314|FG001|Overall Study|Death|2|||
147658970|NCT00666211|532574313|FG000|Overall Study|off tx for other complicating disease|0|||
147658971|NCT00666211|532574314|FG001|Overall Study|off tx for other complicating disease|1|||
147658972|NCT00666211|532574313|FG000|Overall Study|Physician Decision|0|||
147658973|NCT00666211|532574314|FG001|Overall Study|Physician Decision|1|||
147658974|NCT02999789|532574317|FG000|Overall Study|Withdrawal by Subject|0|||
147658975|NCT02999789|532574318|FG001|Overall Study|Withdrawal by Subject|1|||
147658976|NCT02999789|532574317|FG000|Overall Study|Became ineligible|1|||
147658977|NCT02999789|532574318|FG001|Overall Study|Became ineligible|2|||
147658978|NCT04878055|532574321|FG000|Overall Study|Patient transferred in another department|0|||
147658979|NCT04878055|532574322|FG001|Overall Study|Patient transferred in another department|2|||
147658980|NCT04878055|532574321|FG000|Overall Study|Physician Decision|1|||
147658981|NCT04878055|532574322|FG001|Overall Study|Physician Decision|1|||
147658982|NCT04878055|532574321|FG000|Overall Study|Day 60 visit not performed by mistake|0|||
147658983|NCT04878055|532574322|FG001|Overall Study|Day 60 visit not performed by mistake|4|||
147658984|NCT04878055|532574321|FG000|Overall Study|Adverse Event|12|||
147658985|NCT04878055|532574322|FG001|Overall Study|Adverse Event|7|||
147658986|NCT04878055|532574321|FG000|Overall Study|Other|5|||
147249444|NCT00482612|531082255|FG001|Follow-up Period|Lack of compliance|0|||
147249445|NCT00482612|531082256|FG002|Follow-up Period|Lack of compliance|1|||
147249446|NCT00482612|531082257|FG003|Follow-up Period|Lack of compliance|0|||
147658987|NCT04878055|532574322|FG001|Overall Study|Other|0|||
147658988|NCT04878055|532574321|FG000|Overall Study|Withdrawal by Subject|7|||
147249447|NCT00482612|531082254|FG000|Follow-up Period|Lost to Follow-up|0|||
147658989|NCT04878055|532574322|FG001|Overall Study|Withdrawal by Subject|3|||
147658990|NCT04878055|532574321|FG000|Overall Study|Lost to Follow-up|10|||
147658991|NCT04878055|532574322|FG001|Overall Study|Lost to Follow-up|1|||
147658992|NCT02907463|532574323|FG000|Overall Study|Lost to Follow-up|17|||
147658993|NCT02907463|532574323|FG000|Overall Study|Death|10|||
147658994|NCT02907463|532574323|FG000|Overall Study|Withdrawal by Subject|4|||
147595381|NCT00062751|532335818|FG002|Overall Study|Withdrawal by Subject|2|||
147595382|NCT00062751|532335819|FG003|Overall Study|Withdrawal by Subject|1|||
147595383|NCT00062751|532335820|FG004|Overall Study|Withdrawal by Subject|0|||
147595384|NCT00062751|532335816|FG000|Overall Study|Symptomatic deterioration|1|||
147595385|NCT00062751|532335817|FG001|Overall Study|Symptomatic deterioration|1|||
147595386|NCT00062751|532335818|FG002|Overall Study|Symptomatic deterioration|0|||
147595387|NCT00062751|532335819|FG003|Overall Study|Symptomatic deterioration|0|||
147595388|NCT00062751|532335820|FG004|Overall Study|Symptomatic deterioration|1|||
147595389|NCT00062751|532335816|FG000|Overall Study|Death|1|||
147595390|NCT00062751|532335817|FG001|Overall Study|Death|0|||
147595391|NCT00062751|532335818|FG002|Overall Study|Death|1|||
147595392|NCT00062751|532335819|FG003|Overall Study|Death|0|||
147595393|NCT00062751|532335820|FG004|Overall Study|Death|0|||
147595394|NCT03629028|532335821|FG000|Overall Study|Lost to Follow-up|26|||
147595395|NCT03629028|532335822|FG001|Overall Study|Lost to Follow-up|23|||
147595396|NCT03629028|532335821|FG000|Overall Study|Pregnancy|4|||
147595397|NCT03629028|532335822|FG001|Overall Study|Pregnancy|2|||
147249448|NCT00482612|531082255|FG001|Follow-up Period|Lost to Follow-up|4|||
147249449|NCT00482612|531082256|FG002|Follow-up Period|Lost to Follow-up|2|||
147249450|NCT00482612|531082257|FG003|Follow-up Period|Lost to Follow-up|1|||
147249451|NCT00482612|531082254|FG000|Follow-up Period|Adverse Event|4|||
147249452|NCT00482612|531082255|FG001|Follow-up Period|Adverse Event|7|||
147249453|NCT00482612|531082256|FG002|Follow-up Period|Adverse Event|9|||
147249454|NCT00482612|531082257|FG003|Follow-up Period|Adverse Event|0|||
147249455|NCT00482612|531082254|FG000|Follow-up Period|Lack of Efficacy|2|||
147249456|NCT00482612|531082255|FG001|Follow-up Period|Lack of Efficacy|0|||
147249457|NCT00482612|531082256|FG002|Follow-up Period|Lack of Efficacy|1|||
147249458|NCT00482612|531082257|FG003|Follow-up Period|Lack of Efficacy|0|||
147249459|NCT00482612|531082254|FG000|Follow-up Period|Withdrawal by Subject|3|||
147249460|NCT00482612|531082255|FG001|Follow-up Period|Withdrawal by Subject|5|||
147249461|NCT00482612|531082256|FG002|Follow-up Period|Withdrawal by Subject|7|||
147249462|NCT00482612|531082257|FG003|Follow-up Period|Withdrawal by Subject|2|||
147249463|NCT00482612|531082254|FG000|Follow-up Period|Reasons not related to trial|1|||
147249464|NCT00482612|531082255|FG001|Follow-up Period|Reasons not related to trial|0|||
147249465|NCT00482612|531082256|FG002|Follow-up Period|Reasons not related to trial|1|||
147249466|NCT00482612|531082257|FG003|Follow-up Period|Reasons not related to trial|3|||
147249467|NCT00464087|531082260|FG000|Overall Study|No PCI per inclusion criteria|0|||
147249468|NCT00464087|531082261|FG001|Overall Study|No PCI per inclusion criteria|0|||
147249469|NCT00464087|531082262|FG002|Overall Study|No PCI per inclusion criteria|29|||
147249470|NCT00418314|531082264|FG000|Overall Study|Withdrawal by Subject|1|||
147249471|NCT00418314|531082265|FG001|Overall Study|Withdrawal by Subject|2|||
147249472|NCT01224431|531082266|FG000|Overall Study|not randomized|0|||
147249473|NCT01224431|531082267|FG001|Overall Study|not randomized|4|||
147249474|NCT01224431|531082266|FG000|Overall Study|no video record|0|||
147249475|NCT01224431|531082267|FG001|Overall Study|no video record|1|||
147249476|NCT02057406|531082268|FG000|Overall Study|Physician Decision|0|||
147249477|NCT02057406|531082269|FG001|Overall Study|Physician Decision|0|||
147249478|NCT02057406|531082270|FG002|Overall Study|Physician Decision|2|||
147249479|NCT02057406|531082268|FG000|Overall Study|Withdrawal by Subject|0|||
147249480|NCT02057406|531082269|FG001|Overall Study|Withdrawal by Subject|2|||
147249481|NCT02057406|531082270|FG002|Overall Study|Withdrawal by Subject|0|||
147249482|NCT02057406|531082268|FG000|Overall Study|Lost to Follow-up|0|||
147249483|NCT02057406|531082269|FG001|Overall Study|Lost to Follow-up|0|||
147249484|NCT02057406|531082270|FG002|Overall Study|Lost to Follow-up|1|||
147249485|NCT02057406|531082268|FG000|Overall Study|Death|1|||
147249486|NCT02057406|531082269|FG001|Overall Study|Death|0|||
147249487|NCT02057406|531082270|FG002|Overall Study|Death|0|||
147249488|NCT02057406|531082268|FG000|Overall Study|Protocol Violation|0|||
147595398|NCT03629028|532335821|FG000|Overall Study|intolerance to examination|2|||
147595399|NCT03629028|532335822|FG001|Overall Study|intolerance to examination|0|||
147595400|NCT02687360|532335829|FG000|Overall Study|Withdrawal by Subject|3|||
147249489|NCT02057406|531082269|FG001|Overall Study|Protocol Violation|1|||
147249490|NCT02057406|531082270|FG002|Overall Study|Protocol Violation|0|||
147249491|NCT02057406|531082268|FG000|Overall Study|Patient transportation issues|0|||
147249492|NCT02057406|531082269|FG001|Overall Study|Patient transportation issues|0|||
147249493|NCT02057406|531082270|FG002|Overall Study|Patient transportation issues|1|||
147249494|NCT03654651|531082272|FG000|First Intervention (6 Weeks)|Withdrawal by Subject|1|||
147249495|NCT03654651|531082273|FG001|First Intervention (6 Weeks)|Withdrawal by Subject|0|||
147249496|NCT01401283|531082274|FG000|Overall Study|surgery cancelled|5|||
147249497|NCT01401283|531082275|FG001|Overall Study|surgery cancelled|8|||
147249498|NCT01401283|531082274|FG000|Overall Study|preoperative arrhythmia|5|||
147249499|NCT01401283|531082275|FG001|Overall Study|preoperative arrhythmia|0|||
147249500|NCT01401283|531082274|FG000|Overall Study|no central venous access|0|||
147249501|NCT01401283|531082275|FG001|Overall Study|no central venous access|1|||
147249502|NCT01401283|531082274|FG000|Overall Study|suspicion of malignant hyperthermia|0|||
147249503|NCT01401283|531082275|FG001|Overall Study|suspicion of malignant hyperthermia|1|||
147595401|NCT02687360|532335830|FG001|Overall Study|Withdrawal by Subject|0|||
147658995|NCT02907463|532574323|FG000|Overall Study|MIS Approach was not used|2|||
147658996|NCT02907463|532574323|FG000|Overall Study|Not Implanted with Study Device|2|||
147658997|NCT02907463|532574323|FG000|Overall Study|Device Explanted|1|||
147658998|NCT02907463|532574323|FG000|Overall Study|Missing Exit Form|1|||
147658999|NCT00447772|532574327|FG000|Overall Study|Lack of Efficacy|3|||
147659000|NCT00447772|532574327|FG000|Overall Study|Insufficient compliance|6|||
147659001|NCT00447772|532574327|FG000|Overall Study|Discontinuation of drug therapy|1|||
147659002|NCT00447772|532574327|FG000|Overall Study|Lost to Follow-up|9|||
147659003|NCT00447772|532574327|FG000|Overall Study|Withdrawal by Subject|1|||
147659004|NCT00447772|532574327|FG000|Overall Study|Unable to attend all study visits|2|||
147659005|NCT00447772|532574327|FG000|Overall Study|Adverse Event|1|||
147659006|NCT00447772|532574327|FG000|Overall Study|Patient relocated|1|||
147659007|NCT00447772|532574327|FG000|Overall Study|Incomplete documentation at visit 1|1|||
147659008|NCT00447772|532574327|FG000|Overall Study|Chemotherapy for lung cancer|1|||
147659009|NCT00447772|532574327|FG000|Overall Study|Premature re-injection required|1|||
147659010|NCT02849743|532574334|FG000|First Intervention (8 Weeks)|Stopping Criteria Met|0|||
147659011|NCT02849743|532574335|FG001|First Intervention (8 Weeks)|Stopping Criteria Met|1|||
147659012|NCT02849743|532574334|FG000|Second Intervention (8 Weeks)|Withdrawal by Subject|1|||
147659013|NCT02849743|532574335|FG001|Second Intervention (8 Weeks)|Withdrawal by Subject|0|||
147659014|NCT03874013|532574342|FG000|Overall Study|Adverse Event|0|||
147659015|NCT03874013|532574343|FG001|Overall Study|Adverse Event|1|||
147659016|NCT01411852|532574344|FG000|Prehospital Intervention Phase|No qualifying SBP|5|||
147659017|NCT01411852|532574345|FG001|Prehospital Intervention Phase|No qualifying SBP|4|||
147659018|NCT01411852|532574344|FG000|Prehospital Intervention Phase|Cardiopulmonary resuscitation (CPR)|2|||
147249504|NCT02433483|531082276|FG000|Overall Study|Unacceptable toxicity|1|||
147249505|NCT02433483|531082276|FG000|Overall Study|Other antineoplastic therapy/HSCT|1|||
147249506|NCT02904512|531082278|FG000|Overall Study|Withdrawal by Subject|1|||
147249507|NCT02904512|531082279|FG001|Overall Study|Withdrawal by Subject|0|||
147249508|NCT02904512|531082278|FG000|Overall Study|Transferred to ICU|1|||
147249509|NCT02904512|531082279|FG001|Overall Study|Transferred to ICU|0|||
147249510|NCT02904512|531082278|FG000|Overall Study|Minor Bleeding at site of device insertion|1|||
147249511|NCT02904512|531082279|FG001|Overall Study|Minor Bleeding at site of device insertion|0|||
147249512|NCT01963403|531082286|FG000|Overall Study|Lost to Follow-up|2|||
147249513|NCT01963403|531082287|FG001|Overall Study|Lost to Follow-up|3|||
147249514|NCT01963403|531082286|FG000|Overall Study|Implant removal|0|||
147249515|NCT01963403|531082287|FG001|Overall Study|Implant removal|1|||
147249516|NCT00549302|531082292|FG000|Double-Blind|Death|2|||
147249517|NCT00549302|531082293|FG001|Double-Blind|Death|9|||
147249518|NCT00549302|531082294|FG002|Double-Blind|Death|0|||
147249519|NCT00549302|531082292|FG000|Double-Blind|Adverse Event|3|||
147249520|NCT00549302|531082293|FG001|Double-Blind|Adverse Event|16|||
147249521|NCT00549302|531082294|FG002|Double-Blind|Adverse Event|0|||
147331180|NCT04771273|531377597|FG002|Maintenance Period|Other than listed|0|||
147249522|NCT00549302|531082292|FG000|Double-Blind|Withdrawal by Subject|3|||
147249523|NCT00549302|531082293|FG001|Double-Blind|Withdrawal by Subject|8|||
147249524|NCT00549302|531082294|FG002|Double-Blind|Withdrawal by Subject|0|||
147249525|NCT00549302|531082292|FG000|Double-Blind|Investigator Decision|1|||
147249526|NCT00549302|531082293|FG001|Double-Blind|Investigator Decision|5|||
147249527|NCT00549302|531082294|FG002|Double-Blind|Investigator Decision|0|||
147249528|NCT00549302|531082292|FG000|Double-Blind|Sponsor Decision|0|||
147249529|NCT00549302|531082293|FG001|Double-Blind|Sponsor Decision|1|||
147249530|NCT00549302|531082294|FG002|Double-Blind|Sponsor Decision|0|||
147249531|NCT00549302|531082292|FG000|Double-Blind|Lost to Follow-up|1|||
147249532|NCT00549302|531082293|FG001|Double-Blind|Lost to Follow-up|2|||
147249533|NCT00549302|531082294|FG002|Double-Blind|Lost to Follow-up|0|||
147249534|NCT00549302|531082292|FG000|Double-Blind|New Drug Pulmonary Atrial Hypertension|1|||
147249535|NCT00549302|531082293|FG001|Double-Blind|New Drug Pulmonary Atrial Hypertension|10|||
147249536|NCT00549302|531082294|FG002|Double-Blind|New Drug Pulmonary Atrial Hypertension|0|||
147249537|NCT00549302|531082292|FG000|Double-Blind|New condition or starts new therapy|0|||
147249538|NCT00549302|531082293|FG001|Double-Blind|New condition or starts new therapy|2|||
147249539|NCT00549302|531082294|FG002|Double-Blind|New condition or starts new therapy|0|||
147249540|NCT00549302|531082292|FG000|Open-Label|Adverse Event|0|||
147249541|NCT00549302|531082293|FG001|Open-Label|Adverse Event|0|||
147249542|NCT00549302|531082294|FG002|Open-Label|Adverse Event|11|||
147249543|NCT00549302|531082292|FG000|Open-Label|Death|0|||
147659019|NCT01411852|532574345|FG001|Prehospital Intervention Phase|Cardiopulmonary resuscitation (CPR)|2|||
147659020|NCT01411852|532574344|FG000|Prehospital Intervention Phase|Found to be under age|0|||
147659021|NCT01411852|532574345|FG001|Prehospital Intervention Phase|Found to be under age|1|||
147249544|NCT00549302|531082293|FG001|Open-Label|Death|0|||
147249545|NCT00549302|531082294|FG002|Open-Label|Death|40|||
147249546|NCT00549302|531082292|FG000|Open-Label|Investigator Decision|0|||
147249547|NCT00549302|531082293|FG001|Open-Label|Investigator Decision|0|||
147331181|NCT04771273|531377598|FG003|Maintenance Period|Other than listed|3|||
147659022|NCT01411852|532574344|FG000|Prehospital Intervention Phase|Severe head injury with GCS≤8|5|||
147659023|NCT01411852|532574345|FG001|Prehospital Intervention Phase|Severe head injury with GCS≤8|0|||
147595402|NCT02192164|532335831|FG000|Overall Study|Other|8|||
147595403|NCT02192164|532335831|FG000|Overall Study|Withdrawal by Subject|1|||
147595404|NCT02192164|532335831|FG000|Overall Study|Physician Decision|4|||
147595405|NCT02192164|532335831|FG000|Overall Study|Did not meet the exclusion criteria|1|||
147595406|NCT00673933|532335832|FG000|Overall Study|Withdrawal by Subject|2|||
147595407|NCT00673933|532335832|FG000|Overall Study|Lost to Follow-up|1|||
147595408|NCT04932941|532335833|FG000|Overall Study|Lost to Follow-up|3|||
147595409|NCT04932941|532335834|FG001|Overall Study|Lost to Follow-up|1|||
147595410|NCT04932941|532335833|FG000|Overall Study|Withdrawal by Subject|7|||
147595411|NCT04932941|532335834|FG001|Overall Study|Withdrawal by Subject|4|||
147595412|NCT04932941|532335833|FG000|Overall Study|Other|4|||
147595413|NCT04932941|532335834|FG001|Overall Study|Other|2|||
147595414|NCT01583218|532335835|FG000|Overall Study|Withdrawal by Subject|43|||
147595415|NCT01583218|532335836|FG001|Overall Study|Withdrawal by Subject|29|||
147595416|NCT01583218|532335835|FG000|Overall Study|Death|206|||
147595417|NCT01583218|532335836|FG001|Overall Study|Death|211|||
147595418|NCT01583218|532335835|FG000|Overall Study|Lost to Follow-up|11|||
147595419|NCT01583218|532335836|FG001|Overall Study|Lost to Follow-up|17|||
147595420|NCT01583218|532335835|FG000|Overall Study|Adverse event or serious adverse event|3|||
147595421|NCT01583218|532335836|FG001|Overall Study|Adverse event or serious adverse event|3|||
147595422|NCT01583218|532335835|FG000|Overall Study|Patient /Family decision|3|||
147595423|NCT01583218|532335836|FG001|Overall Study|Patient /Family decision|0|||
147595424|NCT01583218|532335835|FG000|Overall Study|Cannot contact patient directly|1|||
147595425|NCT01583218|532335836|FG001|Overall Study|Cannot contact patient directly|2|||
147595426|NCT01583218|532335835|FG000|Overall Study|SOURCE DOCUMENT/COORDINATOR MISSING|0|||
147595427|NCT01583218|532335836|FG001|Overall Study|SOURCE DOCUMENT/COORDINATOR MISSING|2|||
147595428|NCT01583218|532335835|FG000|Overall Study|Patient did not wish to attend visits|0|||
147595429|NCT01583218|532335836|FG001|Overall Study|Patient did not wish to attend visits|1|||
147595430|NCT01583218|532335835|FG000|Overall Study|Patient randomized but not dosed|17|||
147595431|NCT01583218|532335836|FG001|Overall Study|Patient randomized but not dosed|16|||
147595432|NCT01583218|532335835|FG000|Overall Study|Patient was assessed via phone in person|1|||
147595433|NCT01583218|532335836|FG001|Overall Study|Patient was assessed via phone in person|0|||
147595434|NCT01583218|532335835|FG000|Overall Study|Patient deemed ineligible after random|2|||
147595435|NCT01583218|532335836|FG001|Overall Study|Patient deemed ineligible after random|0|||
147595436|NCT01583218|532335835|FG000|Overall Study|Patient was early terminated from study|0|||
147595437|NCT01583218|532335836|FG001|Overall Study|Patient was early terminated from study|1|||
147249548|NCT00549302|531082294|FG002|Open-Label|Investigator Decision|5|||
147249549|NCT00549302|531082292|FG000|Open-Label|Lost to Follow-up|0|||
147249550|NCT00549302|531082293|FG001|Open-Label|Lost to Follow-up|0|||
147249551|NCT00549302|531082294|FG002|Open-Label|Lost to Follow-up|2|||
147249552|NCT00549302|531082292|FG000|Open-Label|Other|0|||
147249553|NCT00549302|531082293|FG001|Open-Label|Other|0|||
147249554|NCT00549302|531082294|FG002|Open-Label|Other|3|||
147249555|NCT00549302|531082292|FG000|Open-Label|New drug pulmonary atrial hypertension|0|||
147249556|NCT00549302|531082293|FG001|Open-Label|New drug pulmonary atrial hypertension|0|||
147249557|NCT00549302|531082294|FG002|Open-Label|New drug pulmonary atrial hypertension|2|||
147249558|NCT00549302|531082292|FG000|Open-Label|Withdrawal by Subject|0|||
147249559|NCT00549302|531082293|FG001|Open-Label|Withdrawal by Subject|0|||
147249560|NCT00549302|531082294|FG002|Open-Label|Withdrawal by Subject|6|||
147249561|NCT03585504|531082295|FG000|Overall Study|Lost to Follow-up|26|||
147249562|NCT03585504|531082296|FG001|Overall Study|Lost to Follow-up|29|||
147249563|NCT01414114|531082297|FG000|Overall Study|Adverse Event|2|||
147249564|NCT01414114|531082297|FG000|Overall Study|Withdrawal by Subject|1|||
147249565|NCT01414114|531082297|FG000|Overall Study|Other|2|||
147249566|NCT05620563|531082298|FG000|Overall Study|Adverse Event|3|||
147249567|NCT05620563|531082299|FG001|Overall Study|Adverse Event|1|||
147249568|NCT05620563|531082298|FG000|Overall Study|Lost to Follow-up|0|||
147249569|NCT05620563|531082299|FG001|Overall Study|Lost to Follow-up|2|||
147249570|NCT05620563|531082298|FG000|Overall Study|Protocol Deviation|1|||
147249571|NCT05620563|531082299|FG001|Overall Study|Protocol Deviation|2|||
147249572|NCT05620563|531082298|FG000|Overall Study|Withdrawal by Subject|3|||
147249573|NCT05620563|531082299|FG001|Overall Study|Withdrawal by Subject|3|||
147249574|NCT05620563|531082298|FG000|Overall Study|Physician Decision|0|||
147249575|NCT05620563|531082299|FG001|Overall Study|Physician Decision|1|||
147249576|NCT03590041|531082303|FG000|Overall Study|Protocol Violation|4|||
147249577|NCT03590041|531082304|FG001|Overall Study|Protocol Violation|3|||
147249578|NCT03590041|531082303|FG000|Overall Study|No session data recorded|14|||
147249579|NCT03590041|531082304|FG001|Overall Study|No session data recorded|2|||
147249580|NCT03519932|531082307|FG000|First Intervention|Adverse Event|1|||
147249581|NCT03519932|531082308|FG001|First Intervention|Adverse Event|3|||
147249582|NCT02254486|531082309|FG000|Overall Study|Adverse Event|1|||
147595438|NCT01583218|532335835|FG000|Overall Study|Patient was randomized due to mistake|1|||
147249583|NCT02254486|531082310|FG001|Overall Study|Adverse Event|1|||
147249584|NCT02254486|531082309|FG000|Overall Study|Lack of Efficacy|1|||
147249585|NCT02254486|531082310|FG001|Overall Study|Lack of Efficacy|0|||
147249586|NCT02254486|531082309|FG000|Overall Study|Lost to Follow-up|2|||
147249587|NCT02254486|531082310|FG001|Overall Study|Lost to Follow-up|4|||
147249588|NCT02254486|531082309|FG000|Overall Study|Protocol Violation|1|||
147249589|NCT02254486|531082310|FG001|Overall Study|Protocol Violation|2|||
147249590|NCT02254486|531082309|FG000|Overall Study|Withdrawal by Subject|17|||
147249591|NCT02254486|531082310|FG001|Overall Study|Withdrawal by Subject|15|||
147249592|NCT02254486|531082309|FG000|Overall Study|GFR<60mL/min|16|||
147249593|NCT02254486|531082310|FG001|Overall Study|GFR<60mL/min|21|||
147249594|NCT02254486|531082309|FG000|Overall Study|Various|12|||
147249595|NCT02254486|531082310|FG001|Overall Study|Various|12|||
147249596|NCT01350414|531082311|FG000|Overall Study|Lost to Follow-up|13|||
147249597|NCT01350414|531082311|FG000|Overall Study|Withdrawal by Subject|4|||
147249598|NCT01350414|531082311|FG000|Overall Study|Physician Decision|2|||
147249599|NCT00010374|531082313|FG000|Overall Study|False positive phrenic nerve test|1|||
147249600|NCT00372112|531082316|FG000|Overall Study|Adverse Event|0|||
147249601|NCT00372112|531082317|FG001|Overall Study|Adverse Event|1|||
147249602|NCT00372112|531082318|FG002|Overall Study|Adverse Event|1|||
147249603|NCT00372112|531082319|FG003|Overall Study|Adverse Event|1|||
147249604|NCT00372112|531082316|FG000|Overall Study|Withdrawal by Subject|0|||
147249605|NCT00372112|531082317|FG001|Overall Study|Withdrawal by Subject|0|||
147249606|NCT00372112|531082318|FG002|Overall Study|Withdrawal by Subject|2|||
147249607|NCT00372112|531082319|FG003|Overall Study|Withdrawal by Subject|1|||
147249608|NCT00372112|531082316|FG000|Overall Study|Exacerbation|0|||
147249609|NCT00372112|531082317|FG001|Overall Study|Exacerbation|0|||
147249610|NCT00372112|531082318|FG002|Overall Study|Exacerbation|0|||
147249611|NCT00372112|531082319|FG003|Overall Study|Exacerbation|1|||
147249612|NCT00372112|531082316|FG000|Overall Study|PR >240 at Visit 3|0|||
147249613|NCT00372112|531082317|FG001|Overall Study|PR >240 at Visit 3|0|||
147249614|NCT00372112|531082318|FG002|Overall Study|PR >240 at Visit 3|0|||
147249615|NCT00372112|531082319|FG003|Overall Study|PR >240 at Visit 3|1|||
147249616|NCT00372112|531082316|FG000|Overall Study|Hepatitis B|1|||
147249617|NCT00372112|531082317|FG001|Overall Study|Hepatitis B|0|||
147249618|NCT00372112|531082318|FG002|Overall Study|Hepatitis B|0|||
147249619|NCT00372112|531082319|FG003|Overall Study|Hepatitis B|0|||
147249620|NCT00372112|531082316|FG000|Overall Study|Other-protocol violation|0|||
147249621|NCT00372112|531082317|FG001|Overall Study|Other-protocol violation|0|||
147249622|NCT00372112|531082318|FG002|Overall Study|Other-protocol violation|1|||
147249623|NCT00372112|531082319|FG003|Overall Study|Other-protocol violation|0|||
147249624|NCT02706691|531082320|FG000|Overall Study|Adverse Event|1|||
147249625|NCT00356369|531082321|FG000|Active Phase|Withdrawal by Subject|2|||
147249626|NCT00356369|531082322|FG001|Active Phase|Withdrawal by Subject|1|||
147249627|NCT02725710|531082323|FG000|Overall Study|Lost to Follow-up|1|||
147249628|NCT02725710|531082324|FG001|Overall Study|Lost to Follow-up|0|||
147249629|NCT02547454|531082325|FG000|Overall Study|Due to hemodialysis|53|||
147249630|NCT02547454|531082325|FG000|Overall Study|Due to transplantation|1|||
147249631|NCT02547454|531082325|FG000|Overall Study|Due to no further need to treat|4|||
147249632|NCT02547454|531082325|FG000|Overall Study|Death|38|||
147249633|NCT02547454|531082325|FG000|Overall Study|Lost to Follow-up|26|||
147249634|NCT02547454|531082325|FG000|Overall Study|Other|39|||
147249635|NCT02547454|531082325|FG000|Overall Study|No data|11|||
147249636|NCT03918447|531082328|FG000|Overall Study|Death|1|||
147249637|NCT03918447|531082329|FG001|Overall Study|Death|0|||
147249638|NCT03918447|531082328|FG000|Overall Study|Lost to Follow-up|13|||
147249639|NCT03918447|531082329|FG001|Overall Study|Lost to Follow-up|6|||
147249640|NCT03918447|531082328|FG000|Overall Study|Withdrawal by Subject|19|||
147249641|NCT03918447|531082329|FG001|Overall Study|Withdrawal by Subject|17|||
147249642|NCT03918447|531082328|FG000|Overall Study|Study Terminated by Sponsor|195|||
147249643|NCT03918447|531082329|FG001|Overall Study|Study Terminated by Sponsor|197|||
147249644|NCT03918447|531082328|FG000|Overall Study|Reason not Specified|0|||
147249645|NCT03918447|531082329|FG001|Overall Study|Reason not Specified|1|||
147249646|NCT03278613|531082330|FG000|Overall Study|Lost to Follow-up|3|||
147249647|NCT03278613|531082331|FG001|Overall Study|Lost to Follow-up|1|||
147249648|NCT01405456|531082332|FG000|Overall Study|Lost to Follow-up|2|||
147249649|NCT01405456|531082333|FG001|Overall Study|Lost to Follow-up|1|||
147249650|NCT01405456|531082332|FG000|Overall Study|Physician Decision|1|||
147249651|NCT01405456|531082333|FG001|Overall Study|Physician Decision|0|||
147249652|NCT05475236|531082335|FG000|Overall Study|Withdrawal by Subject|0|||
147249653|NCT05475236|531082336|FG001|Overall Study|Withdrawal by Subject|1|||
147249654|NCT00477971|531082337|FG000|Overall Study|Disease progression|6|||
147249655|NCT00477971|531082338|FG001|Overall Study|Disease progression|0|||
147249656|NCT00477971|531082337|FG000|Overall Study|Withdrawal by Subject|3|||
147249657|NCT00477971|531082338|FG001|Overall Study|Withdrawal by Subject|1|||
147249658|NCT00477971|531082337|FG000|Overall Study|Adverse Event|3|||
147249659|NCT00477971|531082338|FG001|Overall Study|Adverse Event|0|||
147249660|NCT00477971|531082337|FG000|Overall Study|Death|2|||
147249661|NCT00477971|531082338|FG001|Overall Study|Death|4|||
147249662|NCT00477971|531082337|FG000|Overall Study|Alternative treatment|3|||
147249663|NCT00477971|531082338|FG001|Overall Study|Alternative treatment|1|||
147249664|NCT05355805|531082339|FG000|Overall Study|Lost to Follow-up|6|||
147249665|NCT05355805|531082340|FG001|Overall Study|Lost to Follow-up|11|||
147249666|NCT05355805|531082341|FG002|Overall Study|Lost to Follow-up|10|||
147249667|NCT05355805|531082342|FG003|Overall Study|Lost to Follow-up|6|||
147595439|NCT01583218|532335836|FG001|Overall Study|Patient was randomized due to mistake|0|||
147595440|NCT01583218|532335835|FG000|Overall Study|THE SUBJECT MOVED TO ANOTHER PROVINCE|0|||
147595441|NCT01583218|532335836|FG001|Overall Study|THE SUBJECT MOVED TO ANOTHER PROVINCE|1|||
147595442|NCT01583218|532335835|FG000|Overall Study|Withdraw of consent on day of random|1|||
147595443|NCT01583218|532335836|FG001|Overall Study|Withdraw of consent on day of random|0|||
147595444|NCT02013375|532335839|FG000|Overall Study|Did not engraft|1|||
147595445|NCT02013375|532335839|FG000|Overall Study|Did not engraft|1|||
147595446|NCT01663727|532335842|FG000|Overall Study|Death|161|||
147595447|NCT01663727|532335843|FG001|Overall Study|Death|155|||
147595448|NCT01663727|532335842|FG000|Overall Study|Lost to Follow-up|10|||
147595449|NCT01663727|532335843|FG001|Overall Study|Lost to Follow-up|8|||
147595450|NCT01663727|532335842|FG000|Overall Study|Withdrawal by Subject|18|||
147595451|NCT01663727|532335843|FG001|Overall Study|Withdrawal by Subject|25|||
147595452|NCT01663727|532335842|FG000|Overall Study|Study Terminated|51|||
147595453|NCT01663727|532335843|FG001|Overall Study|Study Terminated|50|||
147595454|NCT01663727|532335842|FG000|Overall Study|Withdrawal by subject and Adverse Event.|1|||
147595455|NCT01663727|532335843|FG001|Overall Study|Withdrawal by subject and Adverse Event.|0|||
147595456|NCT01663727|532335842|FG000|Overall Study|Withdrawal prior to dosing.|1|||
147595457|NCT01663727|532335843|FG001|Overall Study|Withdrawal prior to dosing.|0|||
147595458|NCT01902628|532335844|FG000|Overall Study|Withdrawal of participant's consent|7|||
147595459|NCT01902628|532335844|FG000|Overall Study|Adverse Event|41|||
147595460|NCT01902628|532335844|FG000|Overall Study|Lost to Follow-up|35|||
147249668|NCT05355805|531082339|FG000|Overall Study|Decision by Sponsor|0|||
147249669|NCT05355805|531082340|FG001|Overall Study|Decision by Sponsor|0|||
147249670|NCT05355805|531082341|FG002|Overall Study|Decision by Sponsor|1|||
147249671|NCT05355805|531082342|FG003|Overall Study|Decision by Sponsor|0|||
147249672|NCT05355805|531082339|FG000|Overall Study|Withdrawal by Subject|7|||
147249673|NCT05355805|531082340|FG001|Overall Study|Withdrawal by Subject|14|||
147249674|NCT05355805|531082341|FG002|Overall Study|Withdrawal by Subject|15|||
147249675|NCT05355805|531082342|FG003|Overall Study|Withdrawal by Subject|13|||
147249676|NCT05353985|531082343|FG000|Overall Study|Adverse Event|5|||
147249677|NCT05353985|531082344|FG001|Overall Study|Adverse Event|7|||
147249678|NCT05353985|531082343|FG000|Overall Study|Lost to Follow-up|1|||
147249679|NCT05353985|531082344|FG001|Overall Study|Lost to Follow-up|1|||
147249680|NCT05353985|531082343|FG000|Overall Study|Protocol Violation|1|||
147249681|NCT05353985|531082344|FG001|Overall Study|Protocol Violation|0|||
147249682|NCT05353985|531082343|FG000|Overall Study|Withdrawal by Subject|13|||
147249683|NCT05353985|531082344|FG001|Overall Study|Withdrawal by Subject|17|||
147249684|NCT05353985|531082343|FG000|Overall Study|Reason Not Specified|1|||
147249685|NCT05353985|531082344|FG001|Overall Study|Reason Not Specified|0|||
147249686|NCT05353985|531082343|FG000|Overall Study|Randomized in Error & Not Treated|0|||
147249687|NCT05353985|531082344|FG001|Overall Study|Randomized in Error & Not Treated|1|||
147595461|NCT01045421|532337267|FG000|Phase 1|Progressive Disease|0|||
147595462|NCT01045421|532337268|FG001|Phase 1|Progressive Disease|0|||
147595463|NCT01045421|532337269|FG002|Phase 1|Progressive Disease|0|||
147595464|NCT01045421|532337270|FG003|Phase 1|Progressive Disease|0|||
147595465|NCT01045421|532337271|FG004|Phase 1|Progressive Disease|1|||
147595466|NCT01045421|532337272|FG005|Phase 1|Progressive Disease|0|||
147595467|NCT01045421|532337273|FG006|Phase 1|Progressive Disease|0|||
147595468|NCT01045421|532337274|FG007|Phase 1|Progressive Disease|0|||
147595469|NCT01045421|532337275|FG008|Phase 1|Progressive Disease|0|||
147595470|NCT01045421|532337276|FG009|Phase 1|Progressive Disease|0|||
147595471|NCT01045421|532337277|FG010|Phase 1|Progressive Disease|0|||
147595472|NCT01045421|532337267|FG000|Phase 1|Withdrawal by Subject|0|||
147595473|NCT01045421|532337268|FG001|Phase 1|Withdrawal by Subject|0|||
147595474|NCT01045421|532337269|FG002|Phase 1|Withdrawal by Subject|0|||
147595475|NCT01045421|532337270|FG003|Phase 1|Withdrawal by Subject|1|||
147595476|NCT01045421|532337271|FG004|Phase 1|Withdrawal by Subject|0|||
147595477|NCT01045421|532337272|FG005|Phase 1|Withdrawal by Subject|0|||
147595478|NCT01045421|532337273|FG006|Phase 1|Withdrawal by Subject|0|||
147595479|NCT01045421|532337274|FG007|Phase 1|Withdrawal by Subject|0|||
147595480|NCT01045421|532337275|FG008|Phase 1|Withdrawal by Subject|0|||
147595481|NCT01045421|532337276|FG009|Phase 1|Withdrawal by Subject|0|||
147595482|NCT01045421|532337277|FG010|Phase 1|Withdrawal by Subject|0|||
147595483|NCT01045421|532337267|FG000|Phase 2|Progressive Disease|0|||
147595484|NCT01045421|532337268|FG001|Phase 2|Progressive Disease|0|||
147595485|NCT01045421|532337269|FG002|Phase 2|Progressive Disease|0|||
147595486|NCT01045421|532337270|FG003|Phase 2|Progressive Disease|0|||
147595487|NCT01045421|532337271|FG004|Phase 2|Progressive Disease|0|||
147595488|NCT01045421|532337272|FG005|Phase 2|Progressive Disease|0|||
147595489|NCT01045421|532337273|FG006|Phase 2|Progressive Disease|0|||
147595490|NCT01045421|532337274|FG007|Phase 2|Progressive Disease|1|||
147249688|NCT02782780|531083715|FG000|Overall Study|dropped out after randomization.|7|||
147249689|NCT02782780|531083716|FG001|Overall Study|dropped out after randomization.|5|||
147595491|NCT01045421|532337275|FG008|Phase 2|Progressive Disease|1|||
147595492|NCT01045421|532337276|FG009|Phase 2|Progressive Disease|1|||
147595493|NCT01045421|532337277|FG010|Phase 2|Progressive Disease|1|||
147595494|NCT01045421|532337267|FG000|Phase 2|Death|0|||
147595495|NCT01045421|532337268|FG001|Phase 2|Death|0|||
147595496|NCT01045421|532337269|FG002|Phase 2|Death|0|||
147595497|NCT01045421|532337270|FG003|Phase 2|Death|0|||
147595498|NCT01045421|532337271|FG004|Phase 2|Death|0|||
147595499|NCT01045421|532337272|FG005|Phase 2|Death|0|||
147595500|NCT01045421|532337273|FG006|Phase 2|Death|0|||
147595501|NCT01045421|532337274|FG007|Phase 2|Death|1|||
147595502|NCT01045421|532337275|FG008|Phase 2|Death|1|||
147595503|NCT01045421|532337276|FG009|Phase 2|Death|2|||
147595504|NCT01045421|532337277|FG010|Phase 2|Death|0|||
147595505|NCT01045421|532337267|FG000|Phase 2|Other|0|||
147595506|NCT01045421|532337268|FG001|Phase 2|Other|0|||
147595507|NCT01045421|532337269|FG002|Phase 2|Other|0|||
147595508|NCT01045421|532337270|FG003|Phase 2|Other|0|||
147595509|NCT01045421|532337271|FG004|Phase 2|Other|0|||
147595510|NCT01045421|532337272|FG005|Phase 2|Other|0|||
147595511|NCT01045421|532337273|FG006|Phase 2|Other|0|||
147595512|NCT01045421|532337274|FG007|Phase 2|Other|3|||
147595513|NCT01045421|532337275|FG008|Phase 2|Other|0|||
147595514|NCT01045421|532337276|FG009|Phase 2|Other|0|||
147595515|NCT01045421|532337277|FG010|Phase 2|Other|1|||
147595516|NCT00321828|532337278|FG000|Overall Study|Ineligible|3|||
147595517|NCT00321828|532337278|FG000|Overall Study|No follow up data|1|||
147595518|NCT02307266|532337279|FG000|Overall Study|Adverse Event|3|||
147595519|NCT02307266|532337280|FG001|Overall Study|Adverse Event|1|||
147595520|NCT02307266|532337281|FG002|Overall Study|Adverse Event|5|||
147595521|NCT02307266|532337279|FG000|Overall Study|Withdrawal by Subject|2|||
147595522|NCT02307266|532337280|FG001|Overall Study|Withdrawal by Subject|0|||
147595523|NCT02307266|532337281|FG002|Overall Study|Withdrawal by Subject|1|||
147595524|NCT02307266|532337279|FG000|Overall Study|Lost to Follow-up|3|||
147595525|NCT02307266|532337280|FG001|Overall Study|Lost to Follow-up|0|||
147595526|NCT02307266|532337281|FG002|Overall Study|Lost to Follow-up|0|||
147595527|NCT00858143|532337286|FG000|Overall Study|Adverse Event|16|||
147595528|NCT00858143|532337286|FG000|Overall Study|Lack of Efficacy|4|||
147595529|NCT00858143|532337286|FG000|Overall Study|Death|7|||
147595530|NCT00858143|532337286|FG000|Overall Study|Other|23|||
147595531|NCT03853148|532337287|FG000|Overall Study|Did not fill in or incomplete questionnaire; missing data; could not score questionnaire,|5|||
147595532|NCT03853148|532337288|FG001|Overall Study|Did not fill in or incomplete questionnaire; missing data; could not score questionnaire,|8|||
147595533|NCT03853148|532337289|FG002|Overall Study|Did not fill in or incomplete questionnaire; missing data; could not score questionnaire,|8|||
147595534|NCT03853148|532337290|FG003|Overall Study|Did not fill in or incomplete questionnaire; missing data; could not score questionnaire,|5|||
147595535|NCT00090610|532337291|FG000|Overall Study|Withdrawal by Subject|1|||
147595536|NCT00090610|532337292|FG001|Overall Study|Withdrawal by Subject|1|||
147595537|NCT00059787|532337293|FG000|Overall Study|Adverse Event|13|||
147595538|NCT00059787|532337293|FG000|Overall Study|disease progression|2|||
147595539|NCT00059787|532337293|FG000|Overall Study|ineligible|1|||
147595540|NCT00059787|532337293|FG000|Overall Study|Other|4|||
147595541|NCT01248013|532337294|FG000|Overall Study|Withdrawal by Subject|14|||
147595542|NCT02667288|532337301|FG000|Overall Study|Protocol Violation|5|||
147595543|NCT02667288|532337301|FG000|Overall Study|Lost to Follow-up|3|||
147595544|NCT02667288|532337301|FG000|Overall Study|Withdrawal by Subject|5|||
147595545|NCT04397445|532337302|FG000|Overall Study|Withdrawal by Subject|1|||
147595546|NCT04397445|532337303|FG001|Overall Study|Withdrawal by Subject|0|||
147595547|NCT04397445|532337304|FG002|Overall Study|Withdrawal by Subject|0|||
147595548|NCT04397445|532337305|FG003|Overall Study|Withdrawal by Subject|0|||
147595549|NCT01429051|532337306|FG000|Titration Phase|Death|1|||
147249690|NCT02782780|531083715|FG000|Overall Study|Protocol Violation|0|||
147249691|NCT02782780|531083716|FG001|Overall Study|Protocol Violation|2|||
147249692|NCT00460408|531083719|FG000|Overall Study|Adverse Event|1|||
147249693|NCT00460408|531083720|FG001|Overall Study|Adverse Event|0|||
147249694|NCT00460408|531083721|FG002|Overall Study|Adverse Event|0|||
147249695|NCT00460408|531083722|FG003|Overall Study|Adverse Event|0|||
147249696|NCT00460408|531083719|FG000|Overall Study|Death|7|||
147249697|NCT00460408|531083720|FG001|Overall Study|Death|0|||
147249698|NCT00460408|531083721|FG002|Overall Study|Death|0|||
147249699|NCT00460408|531083722|FG003|Overall Study|Death|0|||
147249700|NCT00460408|531083719|FG000|Overall Study|Lost to Follow-up|11|||
147249701|NCT00460408|531083720|FG001|Overall Study|Lost to Follow-up|0|||
147249702|NCT00460408|531083721|FG002|Overall Study|Lost to Follow-up|1|||
147249703|NCT00460408|531083722|FG003|Overall Study|Lost to Follow-up|0|||
147249704|NCT00460408|531083719|FG000|Overall Study|Withdrawal by Subject|31|||
147249705|NCT00460408|531083720|FG001|Overall Study|Withdrawal by Subject|0|||
147595550|NCT01429051|532337306|FG000|Titration Phase|Withdrawal by Subject|7|||
147595551|NCT01429051|532337306|FG000|Titration Phase|Physician Decision|1|||
147595552|NCT01429051|532337306|FG000|Titration Phase|Unsuccessful titration at any dose|1|||
147595553|NCT01429051|532337306|FG000|Titration Phase|Less than 3 BTP episodes per week|2|||
147595554|NCT01429051|532337306|FG000|Efficacy Phase|Adverse Event|1|||
147595555|NCT01429051|532337306|FG000|Efficacy Phase|Death|1|||
147595556|NCT01429051|532337306|FG000|Tolerability Phase|Death|5|||
147595557|NCT01429051|532337306|FG000|Tolerability Phase|Adverse Event|2|||
147595558|NCT01429051|532337306|FG000|Tolerability Phase|Withdrawal by Subject|5|||
147595559|NCT01429051|532337306|FG000|Tolerability Phase|Physician Decision|1|||
147659024|NCT01411852|532574344|FG000|Hospital Intervention Phase|Severe head injury|5|||
147659025|NCT01411852|532574345|FG001|Hospital Intervention Phase|Severe head injury|4|||
147659026|NCT01411852|532574344|FG000|Hospital Intervention Phase|No qualifying SBP|5|||
147659027|NCT01411852|532574345|FG001|Hospital Intervention Phase|No qualifying SBP|1|||
147659028|NCT01411852|532574344|FG000|Hospital Intervention Phase|Miscommunication error|1|||
147659029|NCT01411852|532574345|FG001|Hospital Intervention Phase|Miscommunication error|2|||
147659030|NCT01411852|532574344|FG000|Hospital Intervention Phase|CPR administered|3|||
147659031|NCT01411852|532574345|FG001|Hospital Intervention Phase|CPR administered|1|||
147659032|NCT01411852|532574344|FG000|Hospital Intervention Phase|Misunderstanding of protocol|4|||
147659033|NCT01411852|532574345|FG001|Hospital Intervention Phase|Misunderstanding of protocol|1|||
147659034|NCT01411852|532574344|FG000|Hospital Intervention Phase|Diagnosis of sepsis|0|||
147659035|NCT01411852|532574345|FG001|Hospital Intervention Phase|Diagnosis of sepsis|2|||
147659036|NCT01411852|532574344|FG000|Hospital Intervention Phase|Diagnosis of dehydration|0|||
147659037|NCT01411852|532574345|FG001|Hospital Intervention Phase|Diagnosis of dehydration|1|||
147659038|NCT01411852|532574344|FG000|Hospital Intervention Phase|Physician/hospital staff noncompliance|0|||
147659039|NCT01411852|532574345|FG001|Hospital Intervention Phase|Physician/hospital staff noncompliance|4|||
147659040|NCT01411852|532574344|FG000|Hospital Intervention Phase|Other ineligible|2|||
147659041|NCT01411852|532574345|FG001|Hospital Intervention Phase|Other ineligible|2|||
147659042|NCT01411852|532574344|FG000|Hospital Intervention Phase|Spinal cord injury|2|||
147659043|NCT01411852|532574345|FG001|Hospital Intervention Phase|Spinal cord injury|0|||
147659044|NCT01411852|532574344|FG000|Hospital Intervention Phase|Withdrawal by Subject|1|||
147659045|NCT01411852|532574345|FG001|Hospital Intervention Phase|Withdrawal by Subject|0|||
147659046|NCT01411852|532574344|FG000|Hospital Intervention Phase|Vascular access failed|1|||
147659047|NCT01411852|532574345|FG001|Hospital Intervention Phase|Vascular access failed|0|||
147659048|NCT01026948|532574349|FG000|Overall Study|Physician Decision|8|||
147659049|NCT02989402|532574351|FG000|Overall Study|Adverse event, or serious adverse event|4|||
147659050|NCT02989402|532574351|FG000|Overall Study|Death|2|||
147659051|NCT02989402|532574351|FG000|Overall Study|Discontinuation of study treatment and premature patient withdrawal|3|||
147659052|NCT02989402|532574351|FG000|Overall Study|Lost to Follow-up|8|||
147659053|NCT02989402|532574351|FG000|Overall Study|Patient no longer on monotherapy|1|||
147659054|NCT02989402|532574351|FG000|Overall Study|Patient stopped Exelon® patch treatment|1|||
147659055|NCT02989402|532574351|FG000|Overall Study|Withdrawal by Subject|7|||
147659056|NCT02989402|532574351|FG000|Overall Study|Other|2|||
147659057|NCT02824627|532574357|FG000|Overall Study|Adverse Event|1|||
147659058|NCT02824627|532574358|FG001|Overall Study|Adverse Event|2|||
147659059|NCT02824627|532574357|FG000|Overall Study|Lost to Follow-up|2|||
147659060|NCT02824627|532574358|FG001|Overall Study|Lost to Follow-up|1|||
147659061|NCT01938846|532574359|FG000|Overall Study|Progressive disease|26|||
147659062|NCT01938846|532574360|FG001|Overall Study|Progressive disease|18|||
147659063|NCT01938846|532574361|FG002|Overall Study|Progressive disease|16|||
147659064|NCT01938846|532574359|FG000|Overall Study|Adverse Event|8|||
147659065|NCT01938846|532574360|FG001|Overall Study|Adverse Event|4|||
147659066|NCT01938846|532574361|FG002|Overall Study|Adverse Event|3|||
147659067|NCT01938846|532574359|FG000|Overall Study|Withdrawal by Subject|2|||
147659068|NCT01938846|532574360|FG001|Overall Study|Withdrawal by Subject|2|||
147659069|NCT01938846|532574361|FG002|Overall Study|Withdrawal by Subject|1|||
147659070|NCT01938846|532574359|FG000|Overall Study|Other than listed|5|||
147659071|NCT01938846|532574360|FG001|Overall Study|Other than listed|1|||
147659072|NCT01938846|532574361|FG002|Overall Study|Other than listed|4|||
147659073|NCT00964028|532574366|FG000|Overall Study|Withdrawal by Subject|0|||
147659074|NCT00964028|532574367|FG001|Overall Study|Withdrawal by Subject|1|||
147659075|NCT01603407|532574368|FG000|Overall Study|Adverse Event|1|||
147659076|NCT01603407|532574369|FG001|Overall Study|Adverse Event|1|||
147659077|NCT01603407|532574370|FG002|Overall Study|Adverse Event|1|||
147659078|NCT01603407|532574368|FG000|Overall Study|Protocol Violation|2|||
147659079|NCT01603407|532574369|FG001|Overall Study|Protocol Violation|2|||
147659080|NCT01603407|532574370|FG002|Overall Study|Protocol Violation|0|||
147659081|NCT01603407|532574368|FG000|Overall Study|Withdrawal by Subject|8|||
147659082|NCT01603407|532574369|FG001|Overall Study|Withdrawal by Subject|5|||
147659083|NCT01603407|532574370|FG002|Overall Study|Withdrawal by Subject|7|||
147659084|NCT01603407|532574368|FG000|Overall Study|Lost to Follow-up|0|||
147659085|NCT01603407|532574369|FG001|Overall Study|Lost to Follow-up|3|||
147249706|NCT00460408|531083721|FG002|Overall Study|Withdrawal by Subject|0|||
147249707|NCT00460408|531083722|FG003|Overall Study|Withdrawal by Subject|0|||
147659086|NCT01603407|532574370|FG002|Overall Study|Lost to Follow-up|2|||
147659087|NCT02106351|532574374|FG000|Treatment Cycle 1|Adverse Event|2|||
147659088|NCT02106351|532574375|FG001|Treatment Cycle 1|Adverse Event|0|||
147659089|NCT02106351|532574376|FG002|Treatment Cycle 1|Adverse Event|0|||
147659090|NCT02106351|532574374|FG000|Treatment Cycle 1|Consent withdrawn|1|||
147659091|NCT02106351|532574375|FG001|Treatment Cycle 1|Consent withdrawn|0|||
147659092|NCT02106351|532574376|FG002|Treatment Cycle 1|Consent withdrawn|2|||
147659093|NCT02106351|532574374|FG000|Treatment Cycle 1|Lost to Follow-up|1|||
147659094|NCT02106351|532574375|FG001|Treatment Cycle 1|Lost to Follow-up|0|||
147659095|NCT02106351|532574376|FG002|Treatment Cycle 1|Lost to Follow-up|0|||
147659096|NCT02106351|532574374|FG000|Treatment Cycle 1|Other|0|||
147659097|NCT02106351|532574375|FG001|Treatment Cycle 1|Other|3|||
147659098|NCT02106351|532574376|FG002|Treatment Cycle 1|Other|1|||
147659099|NCT02106351|532574374|FG000|Treatment Cycle 1|Randomised but not treated|1|||
147659100|NCT02106351|532574375|FG001|Treatment Cycle 1|Randomised but not treated|0|||
147659101|NCT02106351|532574376|FG002|Treatment Cycle 1|Randomised but not treated|1|||
147659102|NCT02106351|532574374|FG000|Treatment Cycle 2|Adverse Event|0|||
147659103|NCT02106351|532574375|FG001|Treatment Cycle 2|Adverse Event|2|||
147659104|NCT02106351|532574376|FG002|Treatment Cycle 2|Adverse Event|0|||
147659105|NCT02106351|532574374|FG000|Treatment Cycle 2|Consent withdrawn|0|||
147659106|NCT02106351|532574375|FG001|Treatment Cycle 2|Consent withdrawn|1|||
147659107|NCT02106351|532574376|FG002|Treatment Cycle 2|Consent withdrawn|1|||
147659108|NCT02106351|532574374|FG000|Treatment Cycle 2|Other|0|||
147249708|NCT00460408|531083719|FG000|Overall Study|Insufficient clinical response|5|||
147249709|NCT00460408|531083720|FG001|Overall Study|Insufficient clinical response|1|||
147249710|NCT00460408|531083721|FG002|Overall Study|Insufficient clinical response|5|||
147249711|NCT00460408|531083722|FG003|Overall Study|Insufficient clinical response|0|||
147659109|NCT02106351|532574375|FG001|Treatment Cycle 2|Other|2|||
147659110|NCT02106351|532574376|FG002|Treatment Cycle 2|Other|2|||
147659111|NCT02106351|532574374|FG000|Treatment Cycle 3|Adverse Event|0|||
147659112|NCT02106351|532574375|FG001|Treatment Cycle 3|Adverse Event|1|||
147659113|NCT02106351|532574376|FG002|Treatment Cycle 3|Adverse Event|0|||
147659114|NCT02106351|532574374|FG000|Treatment Cycle 3|Consent withdrawn|0|||
147659115|NCT02106351|532574375|FG001|Treatment Cycle 3|Consent withdrawn|0|||
147659116|NCT02106351|532574376|FG002|Treatment Cycle 3|Consent withdrawn|2|||
147659117|NCT02106351|532574374|FG000|Treatment Cycle 3|Lost to Follow-up|0|||
147659118|NCT02106351|532574375|FG001|Treatment Cycle 3|Lost to Follow-up|1|||
147659119|NCT02106351|532574376|FG002|Treatment Cycle 3|Lost to Follow-up|0|||
147659120|NCT02106351|532574374|FG000|Treatment Cycle 3|Other|0|||
147659121|NCT02106351|532574375|FG001|Treatment Cycle 3|Other|2|||
147659122|NCT02106351|532574376|FG002|Treatment Cycle 3|Other|3|||
147659123|NCT02106351|532574374|FG000|Treatment Cycle 4|Consent withdrawn|0|||
147659124|NCT02106351|532574375|FG001|Treatment Cycle 4|Consent withdrawn|0|||
147659125|NCT02106351|532574376|FG002|Treatment Cycle 4|Consent withdrawn|2|||
147659126|NCT02106351|532574374|FG000|Treatment Cycle 4|Other|0|||
147659127|NCT02106351|532574375|FG001|Treatment Cycle 4|Other|1|||
147659128|NCT02106351|532574376|FG002|Treatment Cycle 4|Other|0|||
147659129|NCT00069823|532574382|FG000|Overall Study|Did not have follow-up diary cards|6|||
147659130|NCT00069823|532574383|FG001|Overall Study|Did not have follow-up diary cards|3|||
147659131|NCT03560869|532574384|FG000|Overall Study|Withdrawal by Subject|3|||
147659132|NCT03560869|532574385|FG001|Overall Study|Withdrawal by Subject|4|||
147659133|NCT03560869|532574384|FG000|Overall Study|Screening failure|4|||
147659134|NCT03560869|532574385|FG001|Overall Study|Screening failure|4|||
147659135|NCT03560869|532574384|FG000|Overall Study|Withdrawal by PI|0|||
147659136|NCT03560869|532574385|FG001|Overall Study|Withdrawal by PI|1|||
147249712|NCT00460408|531083719|FG000|Overall Study|Other|12|||
147249713|NCT00460408|531083720|FG001|Overall Study|Other|2|||
147249714|NCT00460408|531083721|FG002|Overall Study|Other|0|||
147249715|NCT00460408|531083722|FG003|Overall Study|Other|0|||
147249716|NCT03303079|531083728|FG000|Overall Study|Adverse Event|0|||
147249717|NCT03303079|531083729|FG001|Overall Study|Adverse Event|1|||
147249718|NCT03303079|531083730|FG002|Overall Study|Adverse Event|3|||
147249719|NCT03303079|531083728|FG000|Overall Study|Protocol Violation|5|||
147249720|NCT03303079|531083729|FG001|Overall Study|Protocol Violation|4|||
147249721|NCT03303079|531083730|FG002|Overall Study|Protocol Violation|7|||
147249722|NCT03303079|531083728|FG000|Overall Study|Withdrawal by Subject|2|||
147249723|NCT03303079|531083729|FG001|Overall Study|Withdrawal by Subject|4|||
147249724|NCT03303079|531083730|FG002|Overall Study|Withdrawal by Subject|2|||
147249725|NCT03303079|531083728|FG000|Overall Study|Other than specified|0|||
147249726|NCT03303079|531083729|FG001|Overall Study|Other than specified|2|||
147249727|NCT03303079|531083730|FG002|Overall Study|Other than specified|0|||
147249728|NCT03315208|531083731|FG000|Overall Study|Lost to Follow-up|11|||
147249729|NCT03315208|531083732|FG001|Overall Study|Lost to Follow-up|6|||
147249730|NCT03315208|531083731|FG000|Overall Study|Withdrawal by Subject|2|||
147249731|NCT03315208|531083732|FG001|Overall Study|Withdrawal by Subject|0|||
147249732|NCT02205814|531083748|FG000|Overall Study|Lost to Follow-up|0|||
147249733|NCT02205814|531083749|FG001|Overall Study|Lost to Follow-up|0|||
147249734|NCT02205814|531083750|FG002|Overall Study|Lost to Follow-up|0|||
147659137|NCT01801111|532574386|FG000|Overall Study|Adverse Event|12|||
147659138|NCT01801111|532574386|FG000|Overall Study|Death|8|||
147249735|NCT02205814|531083751|FG003|Overall Study|Lost to Follow-up|1|||
147249736|NCT02205814|531083748|FG000|Overall Study|Lack of Efficacy|1|||
147659139|NCT01801111|532574386|FG000|Overall Study|Physician Decision|5|||
147659140|NCT01801111|532574386|FG000|Overall Study|Other|1|||
147659141|NCT01801111|532574386|FG000|Overall Study|Withdrawal by Subject|4|||
147659142|NCT01801111|532574386|FG000|Overall Study|Study Terminated by Sponsor|27|||
147659143|NCT01801111|532574386|FG000|Overall Study|Progressive Disease|81|||
147659144|NCT01210482|532574387|FG000|Overall Study|Protocol Violation|1|||
147659145|NCT01210482|532574387|FG000|Overall Study|Case Report Forms were not collected|18|||
147331182|NCT04771273|531377595|FG000|Maintenance Period|Burden of study procedures|1|||
147331183|NCT04771273|531377596|FG001|Maintenance Period|Burden of study procedures|0|||
147331184|NCT04771273|531377597|FG002|Maintenance Period|Burden of study procedures|0|||
147249737|NCT02205814|531083749|FG001|Overall Study|Lack of Efficacy|0|||
147249738|NCT02205814|531083750|FG002|Overall Study|Lack of Efficacy|1|||
147249739|NCT02205814|531083751|FG003|Overall Study|Lack of Efficacy|1|||
147249740|NCT02205814|531083748|FG000|Overall Study|Physician Decision|0|||
147249741|NCT02205814|531083749|FG001|Overall Study|Physician Decision|0|||
147249742|NCT02205814|531083750|FG002|Overall Study|Physician Decision|1|||
147249743|NCT02205814|531083751|FG003|Overall Study|Physician Decision|0|||
147249744|NCT02205814|531083748|FG000|Overall Study|Protocol Violation|1|||
147249745|NCT02205814|531083749|FG001|Overall Study|Protocol Violation|0|||
147249746|NCT02205814|531083750|FG002|Overall Study|Protocol Violation|0|||
147249747|NCT02205814|531083751|FG003|Overall Study|Protocol Violation|1|||
147249748|NCT02205814|531083748|FG000|Overall Study|Withdrawal by Subject|0|||
147249749|NCT02205814|531083749|FG001|Overall Study|Withdrawal by Subject|1|||
147249750|NCT02205814|531083750|FG002|Overall Study|Withdrawal by Subject|2|||
147249751|NCT02205814|531083751|FG003|Overall Study|Withdrawal by Subject|1|||
147249752|NCT02205814|531083748|FG000|Overall Study|not compliant with study procedures|0|||
147249753|NCT02205814|531083749|FG001|Overall Study|not compliant with study procedures|0|||
147249754|NCT02205814|531083750|FG002|Overall Study|not compliant with study procedures|1|||
147249755|NCT02205814|531083751|FG003|Overall Study|not compliant with study procedures|0|||
147249756|NCT01426373|531083752|FG000|Overall Study|Adverse Event|6|||
147249757|NCT01426373|531083752|FG000|Overall Study|Lost to Follow-up|14|||
147249758|NCT01426373|531083752|FG000|Overall Study|Participant Convenience|10|||
147249759|NCT01426373|531083752|FG000|Overall Study|Miscellaneous Reasons|4|||
147249760|NCT00143403|531083753|FG000|Overall Study|Adverse Event|3|||
147249761|NCT00143403|531083754|FG001|Overall Study|Adverse Event|8|||
147249762|NCT00143403|531083753|FG000|Overall Study|Death|1|||
147249763|NCT00143403|531083754|FG001|Overall Study|Death|0|||
147249764|NCT00143403|531083753|FG000|Overall Study|Withdrawal by Subject|3|||
147249765|NCT00143403|531083754|FG001|Overall Study|Withdrawal by Subject|12|||
147249766|NCT00143403|531083753|FG000|Overall Study|Relapse|15|||
147249767|NCT00143403|531083754|FG001|Overall Study|Relapse|7|||
147249768|NCT00143403|531083753|FG000|Overall Study|Protocol Violation|2|||
147249769|NCT00143403|531083754|FG001|Overall Study|Protocol Violation|2|||
147249770|NCT00143403|531083753|FG000|Overall Study|specified by site|4|||
147249771|NCT00143403|531083754|FG001|Overall Study|specified by site|9|||
147249772|NCT00143403|531083753|FG000|Overall Study|Randomized Not Treated|7|||
147249773|NCT00143403|531083754|FG001|Overall Study|Randomized Not Treated|8|||
147249774|NCT01574326|531083757|FG000|Overall Study|Randomized but not treated|0|||
147249775|NCT01574326|531083758|FG001|Overall Study|Randomized but not treated|1|||
147249776|NCT01574326|531083757|FG000|Overall Study|Withdrawal by Participant|2|||
147249777|NCT01574326|531083758|FG001|Overall Study|Withdrawal by Participant|4|||
147249778|NCT01574326|531083757|FG000|Overall Study|Physician Decision|5|||
147249779|NCT01574326|531083758|FG001|Overall Study|Physician Decision|3|||
147249780|NCT01574326|531083757|FG000|Overall Study|Adverse Event|1|||
147249781|NCT01574326|531083758|FG001|Overall Study|Adverse Event|3|||
147249782|NCT01574326|531083757|FG000|Overall Study|Other: Mainly kidney transplant|8|||
147249783|NCT01574326|531083758|FG001|Overall Study|Other: Mainly kidney transplant|8|||
147249784|NCT01919723|531083761|FG000|Overall Study|Blood Samples Hemolyzed|2|||
147249785|NCT01919723|531083762|FG001|Overall Study|Blood Samples Hemolyzed|2|||
147249786|NCT04502589|531083763|FG000|Overall Study|Physician Decision|1|||
147249787|NCT04502589|531083764|FG001|Overall Study|Physician Decision|0|||
147249788|NCT00137046|531083770|FG000|Overall Study|Death|2|||
147249789|NCT00137046|531083771|FG001|Overall Study|Death|1|||
147249790|NCT00137046|531083770|FG000|Overall Study|Adverse Event|16|||
147249791|NCT00137046|531083771|FG001|Overall Study|Adverse Event|5|||
147249792|NCT00137046|531083770|FG000|Overall Study|Laboratory Abnormality|2|||
147249793|NCT00137046|531083771|FG001|Overall Study|Laboratory Abnormality|0|||
147249794|NCT00137046|531083770|FG000|Overall Study|Lack of Efficacy|13|||
147249795|NCT00137046|531083771|FG001|Overall Study|Lack of Efficacy|1|||
147249796|NCT00137046|531083770|FG000|Overall Study|Lost to Follow-up|8|||
147249797|NCT00137046|531083771|FG001|Overall Study|Lost to Follow-up|24|||
147249798|NCT00137046|531083770|FG000|Overall Study|Other|23|||
147249799|NCT00137046|531083771|FG001|Overall Study|Other|19|||
147249800|NCT00137046|531083770|FG000|Overall Study|Withdrawal by Subject|33|||
147249801|NCT00137046|531083771|FG001|Overall Study|Withdrawal by Subject|42|||
147331185|NCT04771273|531377598|FG003|Maintenance Period|Burden of study procedures|0|||
147249802|NCT00137046|531083770|FG000|Overall Study|Adverse Event 4 Days after Last Dose|1|||
147249803|NCT00137046|531083771|FG001|Overall Study|Adverse Event 4 Days after Last Dose|0|||
147249804|NCT00137046|531083770|FG000|Overall Study|Withdrew prior to study treatment|1|||
147249805|NCT00137046|531083771|FG001|Overall Study|Withdrew prior to study treatment|1|||
147249806|NCT01288469|531083772|FG000|Overall Study|Adverse Event|4|||
147249807|NCT01288469|531083773|FG001|Overall Study|Adverse Event|1|||
147249808|NCT01288469|531083774|FG002|Overall Study|Adverse Event|1|||
147249809|NCT01288469|531083772|FG000|Overall Study|Poor compliance to protocol|0|||
147331186|NCT04771273|531377595|FG000|Maintenance Period|Change of residence|0|||
147595560|NCT01429051|532337306|FG000|Tolerability Phase|Other|2|||
147595561|NCT03921151|532337307|FG000|Overall Study|Withdrawal by Subject|11|||
147595562|NCT03921151|532337308|FG001|Overall Study|Withdrawal by Subject|16|||
147595563|NCT00857792|532337310|FG000|Overall Study|inadequate image quality for analysis|12|||
147595564|NCT04421586|532337312|FG000|Overall Study|Death|0|||
147595565|NCT04421586|532337313|FG001|Overall Study|Death|1|||
147595566|NCT04421586|532337312|FG000|Overall Study|Lost to Follow-up|2|||
147595567|NCT04421586|532337313|FG001|Overall Study|Lost to Follow-up|2|||
147595568|NCT04421586|532337312|FG000|Overall Study|Withdrawn by PI|1|||
147595569|NCT04421586|532337313|FG001|Overall Study|Withdrawn by PI|0|||
147595570|NCT04421586|532337312|FG000|Overall Study|Infant death (no follow up data or vaccination outcomes)|2|||
147595571|NCT04421586|532337313|FG001|Overall Study|Infant death (no follow up data or vaccination outcomes)|3|||
147595572|NCT01968694|532337314|FG000|Washout (1 Month)|Lost to Follow-up|0|||
147595573|NCT01968694|532337315|FG001|Washout (1 Month)|Lost to Follow-up|1|||
147595574|NCT00846521|532337316|FG000|Overall Study|Withdrawal by Subject|5|||
147595575|NCT00846521|532337316|FG000|Overall Study|Did not meet OGTT/ CGMS criteria|5|||
147595576|NCT00846521|532337316|FG000|Overall Study|Protocol Violation|1|||
147595577|NCT02792959|532337317|FG000|Overall Study|Protocol Violation|1|||
147595578|NCT03201250|532337324|FG000|Overall Study|screen failures|3|||
147659146|NCT01210482|532574387|FG000|Overall Study|Duplicated|2|||
147659147|NCT01210482|532574387|FG000|Overall Study|No Drug Administration|28|||
147659148|NCT01223937|532574388|FG000|Overall Study|Withdrawal by Subject|3|||
147659149|NCT01223937|532574389|FG001|Overall Study|Withdrawal by Subject|2|||
147659150|NCT01223937|532574388|FG000|Overall Study|Lost to Follow-up|1|||
147659151|NCT01223937|532574389|FG001|Overall Study|Lost to Follow-up|4|||
147659152|NCT01223937|532574388|FG000|Overall Study|Adverse Event|1|||
147659153|NCT01223937|532574389|FG001|Overall Study|Adverse Event|4|||
147659154|NCT01223937|532574388|FG000|Overall Study|Protocol Violation|8|||
147595579|NCT03201250|532337325|FG001|Overall Study|screen failures|0|||
147595580|NCT03201250|532337326|FG002|Overall Study|screen failures|0|||
147595581|NCT02408068|532337327|FG000|Treatment 3 (1.5 Days)|Adverse Event|0|||
147595582|NCT02408068|532337328|FG001|Treatment 3 (1.5 Days)|Adverse Event|0|||
147595583|NCT02408068|532337329|FG002|Treatment 3 (1.5 Days)|Adverse Event|1|||
147595584|NCT02408068|532337330|FG003|Treatment 3 (1.5 Days)|Adverse Event|0|||
147595585|NCT02408068|532337331|FG004|Treatment 3 (1.5 Days)|Adverse Event|0|||
147595586|NCT02408068|532337332|FG005|Treatment 3 (1.5 Days)|Adverse Event|0|||
147595587|NCT01780987|532337333|FG000|Overall Study|Adverse Event|0|||
147595588|NCT01780987|532337334|FG001|Overall Study|Adverse Event|4|||
147595589|NCT01780987|532337333|FG000|Overall Study|Withdrawal by Subject|2|||
147595590|NCT01780987|532337334|FG001|Overall Study|Withdrawal by Subject|0|||
147595591|NCT01780987|532337333|FG000|Overall Study|Request of Changing Hospital|0|||
147595592|NCT01780987|532337334|FG001|Overall Study|Request of Changing Hospital|1|||
147595593|NCT01780987|532337333|FG000|Overall Study|Changing Residence|1|||
147595594|NCT01780987|532337334|FG001|Overall Study|Changing Residence|0|||
147595595|NCT01780987|532337333|FG000|Overall Study|Not Receiving any Study Medication|0|||
147595596|NCT01780987|532337334|FG001|Overall Study|Not Receiving any Study Medication|1|||
147595597|NCT04168190|532337335|FG000|Overall Study|Lost to Follow-up|0|||
147595598|NCT04168190|532337336|FG001|Overall Study|Lost to Follow-up|1|||
147595599|NCT04168190|532337337|FG002|Overall Study|Lost to Follow-up|0|||
147595600|NCT04168190|532337338|FG003|Overall Study|Lost to Follow-up|7|||
147595601|NCT04168190|532337339|FG004|Overall Study|Lost to Follow-up|5|||
147595602|NCT04168190|532337335|FG000|Overall Study|Withdrawal by Subject|1|||
147595603|NCT04168190|532337336|FG001|Overall Study|Withdrawal by Subject|0|||
147595604|NCT04168190|532337337|FG002|Overall Study|Withdrawal by Subject|0|||
147659155|NCT01223937|532574389|FG001|Overall Study|Protocol Violation|7|||
147659156|NCT01223937|532574388|FG000|Overall Study|Other|4|||
147659157|NCT01223937|532574389|FG001|Overall Study|Other|1|||
147659158|NCT05176717|532574390|FG000|Overall Study|Sponsor Decision|1|||
147659159|NCT05176717|532574391|FG001|Overall Study|Sponsor Decision|2|||
147659160|NCT05176717|532574392|FG002|Overall Study|Sponsor Decision|2|||
147659161|NCT03284853|532574393|FG000|Overall Study|Adverse Event|40|||
147659162|NCT03284853|532574394|FG001|Overall Study|Adverse Event|4|||
147659163|NCT03284853|532574393|FG000|Overall Study|Withdrawal by Subject|5|||
147331187|NCT04771273|531377596|FG001|Maintenance Period|Change of residence|1|||
147331188|NCT04771273|531377597|FG002|Maintenance Period|Change of residence|3|||
147595605|NCT04168190|532337338|FG003|Overall Study|Withdrawal by Subject|2|||
147595606|NCT04168190|532337339|FG004|Overall Study|Withdrawal by Subject|4|||
147595607|NCT04168190|532337335|FG000|Overall Study|Death|0|||
147595608|NCT04168190|532337336|FG001|Overall Study|Death|0|||
147595609|NCT04168190|532337337|FG002|Overall Study|Death|0|||
147595610|NCT04168190|532337338|FG003|Overall Study|Death|1|||
147595611|NCT04168190|532337339|FG004|Overall Study|Death|0|||
147595612|NCT01640873|532337340|FG000|Overall Study|Protocol Violation|2|||
147595613|NCT01640873|532337341|FG001|Overall Study|Protocol Violation|1|||
147595614|NCT03978091|532337346|FG000|Overall Study|Lost to Follow-up|0|||
147595615|NCT03978091|532337347|FG001|Overall Study|Lost to Follow-up|0|||
147595616|NCT03978091|532337348|FG002|Overall Study|Lost to Follow-up|1|||
147595617|NCT03978091|532337349|FG003|Overall Study|Lost to Follow-up|0|||
147659164|NCT03284853|532574394|FG001|Overall Study|Withdrawal by Subject|1|||
147659165|NCT03284853|532574393|FG000|Overall Study|Lost to Follow-up|1|||
147659166|NCT03284853|532574394|FG001|Overall Study|Lost to Follow-up|0|||
147659167|NCT03284853|532574393|FG000|Overall Study|Lack of Efficacy|1|||
147659168|NCT03284853|532574394|FG001|Overall Study|Lack of Efficacy|0|||
147659169|NCT03284853|532574393|FG000|Overall Study|Disallowed Concurrent Medication|1|||
147659170|NCT03284853|532574394|FG001|Overall Study|Disallowed Concurrent Medication|1|||
147659171|NCT03284853|532574393|FG000|Overall Study|Protocol Violation|3|||
147659172|NCT03284853|532574394|FG001|Overall Study|Protocol Violation|3|||
147659173|NCT03284853|532574393|FG000|Overall Study|Death|0|||
147659174|NCT03284853|532574394|FG001|Overall Study|Death|1|||
147659175|NCT03284853|532574393|FG000|Overall Study|Other - Reason not reported in CSR|4|||
147659176|NCT03284853|532574394|FG001|Overall Study|Other - Reason not reported in CSR|3|||
147659177|NCT00765817|532574395|FG000|Overall Study|Adverse Event|13|||
147659178|NCT00765817|532574396|FG001|Overall Study|Adverse Event|1|||
147659179|NCT00765817|532574395|FG000|Overall Study|Death|0|||
147659180|NCT00765817|532574396|FG001|Overall Study|Death|1|||
147659181|NCT00765817|532574395|FG000|Overall Study|Entry criteria not met|2|||
147659182|NCT00765817|532574396|FG001|Overall Study|Entry criteria not met|2|||
147659183|NCT00765817|532574395|FG000|Overall Study|Loss of glucose control|0|||
147659184|NCT00765817|532574396|FG001|Overall Study|Loss of glucose control|2|||
147659185|NCT00765817|532574395|FG000|Overall Study|Lost to Follow-up|1|||
147659186|NCT00765817|532574396|FG001|Overall Study|Lost to Follow-up|3|||
147659187|NCT00765817|532574395|FG000|Overall Study|Physician Decision|2|||
147659188|NCT00765817|532574396|FG001|Overall Study|Physician Decision|1|||
147659189|NCT00765817|532574395|FG000|Overall Study|Protocol Violation|1|||
147659190|NCT00765817|532574396|FG001|Overall Study|Protocol Violation|1|||
147659191|NCT00765817|532574395|FG000|Overall Study|Subject decision|7|||
147659192|NCT00765817|532574396|FG001|Overall Study|Subject decision|11|||
147659193|NCT02143024|532574398|FG000|Overall Study|Lost to Follow-up|1|||
147659194|NCT02143024|532574399|FG001|Overall Study|Lost to Follow-up|1|||
147659195|NCT02143024|532574398|FG000|Overall Study|Withdrawal by Subject|1|||
147659196|NCT02143024|532574399|FG001|Overall Study|Withdrawal by Subject|0|||
147659197|NCT02308228|532574400|FG000|Overall Study|Adverse Event|3|||
147659198|NCT02308228|532574401|FG001|Overall Study|Adverse Event|4|||
147659199|NCT02308228|532574400|FG000|Overall Study|Withdrawal by Subject|5|||
147659200|NCT02308228|532574401|FG001|Overall Study|Withdrawal by Subject|3|||
147659201|NCT06597084|532574402|FG000|Overall Study|Withdrawal by Subject|4|||
147659202|NCT06597084|532574403|FG001|Overall Study|Withdrawal by Subject|9|||
147659203|NCT06597084|532574402|FG000|Overall Study|Consent was not given by the patient until V2|0|||
147659204|NCT06597084|532574403|FG001|Overall Study|Consent was not given by the patient until V2|3|||
147659205|NCT06597084|532574402|FG000|Overall Study|Physician Decision|1|||
147659206|NCT06597084|532574403|FG001|Overall Study|Physician Decision|0|||
147659207|NCT06597084|532574402|FG000|Overall Study|Adverse Event|3|||
147659208|NCT06597084|532574403|FG001|Overall Study|Adverse Event|2|||
147659209|NCT06597084|532574402|FG000|Overall Study|Death|4|||
147659210|NCT06597084|532574403|FG001|Overall Study|Death|0|||
147659211|NCT06597084|532574402|FG000|Overall Study|Stroke more than 7 days after primary stroke|2|||
147659212|NCT06597084|532574403|FG001|Overall Study|Stroke more than 7 days after primary stroke|6|||
147659213|NCT06597084|532574402|FG000|Overall Study|Lost to Follow-up|4|||
147659214|NCT06597084|532574403|FG001|Overall Study|Lost to Follow-up|2|||
147659215|NCT06597084|532574402|FG000|Overall Study|Other. Not specified|1|||
147659216|NCT06597084|532574403|FG001|Overall Study|Other. Not specified|0|||
147659217|NCT03999749|532574412|FG000|Overall Study|Toxicity|16|||
147659218|NCT03999749|532574412|FG000|Overall Study|Withdrawal by Subject|3|||
147659219|NCT03999749|532574412|FG000|Overall Study|Disease progression|26|||
147659220|NCT03999749|532574412|FG000|Overall Study|Physician Decision|4|||
147659221|NCT03999749|532574412|FG000|Overall Study|Death|5|||
147659222|NCT03999749|532574412|FG000|Overall Study|Patient deemed ineligible after treatment|1|||
147659223|NCT00255164|532574413|FG000|Overall Study|Adverse Event|10|||
147659224|NCT00255164|532574414|FG001|Overall Study|Adverse Event|6|||
147659225|NCT00255164|532574415|FG002|Overall Study|Adverse Event|9|||
147659226|NCT00255164|532574413|FG000|Overall Study|Lost to Follow-up|4|||
147659227|NCT00255164|532574414|FG001|Overall Study|Lost to Follow-up|3|||
147659228|NCT00255164|532574415|FG002|Overall Study|Lost to Follow-up|4|||
147659229|NCT00255164|532574413|FG000|Overall Study|Withdrawal by Subject|18|||
147659230|NCT00255164|532574414|FG001|Overall Study|Withdrawal by Subject|17|||
147659231|NCT00255164|532574415|FG002|Overall Study|Withdrawal by Subject|8|||
147659232|NCT00255164|532574413|FG000|Overall Study|Noncompliance|0|||
147659233|NCT00255164|532574414|FG001|Overall Study|Noncompliance|1|||
147659234|NCT00255164|532574415|FG002|Overall Study|Noncompliance|2|||
147659235|NCT00255164|532574413|FG000|Overall Study|Subject Request/Subject Unavailable|1|||
147659236|NCT00255164|532574414|FG001|Overall Study|Subject Request/Subject Unavailable|1|||
147659237|NCT00255164|532574415|FG002|Overall Study|Subject Request/Subject Unavailable|2|||
147659238|NCT00255164|532574413|FG000|Overall Study|Relapse of Erosive Esophagitis|78|||
147659239|NCT00255164|532574414|FG001|Overall Study|Relapse of Erosive Esophagitis|16|||
147659240|NCT00255164|532574415|FG002|Overall Study|Relapse of Erosive Esophagitis|12|||
147659241|NCT00255164|532574413|FG000|Overall Study|Possible Barrett's Esophagus|1|||
147659242|NCT00255164|532574414|FG001|Overall Study|Possible Barrett's Esophagus|3|||
147659243|NCT00255164|532574415|FG002|Overall Study|Possible Barrett's Esophagus|8|||
147659244|NCT00255164|532574413|FG000|Overall Study|Esophageal Stricture|0|||
147659245|NCT00255164|532574414|FG001|Overall Study|Esophageal Stricture|0|||
147659246|NCT00255164|532574415|FG002|Overall Study|Esophageal Stricture|1|||
147659247|NCT00255164|532574413|FG000|Overall Study|Therapeutic Failure|11|||
147659248|NCT00255164|532574414|FG001|Overall Study|Therapeutic Failure|2|||
147659249|NCT00255164|532574415|FG002|Overall Study|Therapeutic Failure|3|||
147659250|NCT03677869|532574416|FG000|Overall Study|Withdrawal by Subject|1|||
147659251|NCT05219968|532574417|FG000|Week 24 Treatment Period|Treatment administration failure/procedure not attempted|6|||
147659252|NCT05219968|532574418|FG001|Week 24 Treatment Period|Treatment administration failure/procedure not attempted|0|||
147659253|NCT05219968|532574419|FG002|Week 24 Treatment Period|Treatment administration failure/procedure not attempted|0|||
147659254|NCT05219968|532574420|FG003|Week 24 Treatment Period|Treatment administration failure/procedure not attempted|0|||
147659255|NCT05219968|532574421|FG004|Week 24 Treatment Period|Treatment administration failure/procedure not attempted|0|||
147659256|NCT05219968|532574417|FG000|Week 24 Treatment Period|Bilateral dislodgement|13|||
147659257|NCT05219968|532574418|FG001|Week 24 Treatment Period|Bilateral dislodgement|0|||
147659258|NCT05219968|532574419|FG002|Week 24 Treatment Period|Bilateral dislodgement|0|||
147659259|NCT05219968|532574420|FG003|Week 24 Treatment Period|Bilateral dislodgement|0|||
147659260|NCT05219968|532574421|FG004|Week 24 Treatment Period|Bilateral dislodgement|0|||
147659261|NCT05219968|532574417|FG000|Week 24 Treatment Period|Withdrawal by Subject|2|||
147659262|NCT05219968|532574418|FG001|Week 24 Treatment Period|Withdrawal by Subject|2|||
147659263|NCT05219968|532574419|FG002|Week 24 Treatment Period|Withdrawal by Subject|0|||
147659264|NCT05219968|532574420|FG003|Week 24 Treatment Period|Withdrawal by Subject|0|||
147659265|NCT05219968|532574421|FG004|Week 24 Treatment Period|Withdrawal by Subject|0|||
147659266|NCT05219968|532574417|FG000|Week 24 Treatment Period|Adverse Event|3|||
147659267|NCT05219968|532574418|FG001|Week 24 Treatment Period|Adverse Event|0|||
147659268|NCT05219968|532574419|FG002|Week 24 Treatment Period|Adverse Event|0|||
147659269|NCT05219968|532574420|FG003|Week 24 Treatment Period|Adverse Event|0|||
147659270|NCT05219968|532574421|FG004|Week 24 Treatment Period|Adverse Event|0|||
147659271|NCT05219968|532574417|FG000|Week 24 Treatment Period|Physician Decision|0|||
147659272|NCT05219968|532574418|FG001|Week 24 Treatment Period|Physician Decision|1|||
147659273|NCT05219968|532574419|FG002|Week 24 Treatment Period|Physician Decision|0|||
147659274|NCT05219968|532574420|FG003|Week 24 Treatment Period|Physician Decision|0|||
147659275|NCT05219968|532574421|FG004|Week 24 Treatment Period|Physician Decision|0|||
147659276|NCT05219968|532574417|FG000|Week 24 Treatment Period|Other, not specified|3|||
147659277|NCT05219968|532574418|FG001|Week 24 Treatment Period|Other, not specified|0|||
147659278|NCT05219968|532574419|FG002|Week 24 Treatment Period|Other, not specified|0|||
147659279|NCT05219968|532574420|FG003|Week 24 Treatment Period|Other, not specified|0|||
147659280|NCT05219968|532574421|FG004|Week 24 Treatment Period|Other, not specified|0|||
147659281|NCT05219968|532574417|FG000|Safety Extension Period|Treatment administration failure|0|||
147659282|NCT05219968|532574418|FG001|Safety Extension Period|Treatment administration failure|0|||
147659283|NCT05219968|532574419|FG002|Safety Extension Period|Treatment administration failure|0|||
147659284|NCT05219968|532574420|FG003|Safety Extension Period|Treatment administration failure|1|||
147659285|NCT05219968|532574421|FG004|Safety Extension Period|Treatment administration failure|4|||
147659286|NCT05219968|532574417|FG000|Safety Extension Period|Bilateral dislodgement|0|||
147659287|NCT05219968|532574418|FG001|Safety Extension Period|Bilateral dislodgement|0|||
147659288|NCT05219968|532574419|FG002|Safety Extension Period|Bilateral dislodgement|4|||
147659289|NCT05219968|532574420|FG003|Safety Extension Period|Bilateral dislodgement|0|||
147659290|NCT05219968|532574421|FG004|Safety Extension Period|Bilateral dislodgement|1|||
147659291|NCT05219968|532574417|FG000|Safety Extension Period|Withdrawal by Subject|0|||
147659292|NCT05219968|532574418|FG001|Safety Extension Period|Withdrawal by Subject|0|||
147659293|NCT05219968|532574419|FG002|Safety Extension Period|Withdrawal by Subject|2|||
147659294|NCT05219968|532574420|FG003|Safety Extension Period|Withdrawal by Subject|0|||
147659295|NCT05219968|532574421|FG004|Safety Extension Period|Withdrawal by Subject|4|||
147449485|NCT00440947|531809506|FG001|36-Week Induction Phase|Took Exclusionary Medications|0|||
147595618|NCT03978091|532337350|FG004|Overall Study|Lost to Follow-up|0|||
147595619|NCT03978091|532337351|FG005|Overall Study|Lost to Follow-up|0|||
147595620|NCT03978091|532337346|FG000|Overall Study|Withdrawal by Subject|0|||
147595621|NCT03978091|532337347|FG001|Overall Study|Withdrawal by Subject|0|||
147595622|NCT03978091|532337348|FG002|Overall Study|Withdrawal by Subject|0|||
147595623|NCT03978091|532337349|FG003|Overall Study|Withdrawal by Subject|1|||
147595624|NCT03978091|532337350|FG004|Overall Study|Withdrawal by Subject|1|||
147595625|NCT03978091|532337351|FG005|Overall Study|Withdrawal by Subject|0|||
147595626|NCT00257920|532337354|FG000|Period: Washout Period of Two Weeks|Lost to Follow-up|0|||
147595627|NCT00257920|532337355|FG001|Period: Washout Period of Two Weeks|Lost to Follow-up|1|||
147595628|NCT00257920|532337354|FG000|Period: Second Intervention|Other|2|||
147595629|NCT00257920|532337355|FG001|Period: Second Intervention|Other|1|||
147595630|NCT00770692|532337356|FG000|Overall Study|Withdrawal by Subject|7|||
147595631|NCT00770692|532337357|FG001|Overall Study|Withdrawal by Subject|9|||
147595632|NCT00770692|532337358|FG002|Overall Study|Withdrawal by Subject|9|||
147595633|NCT00770692|532337359|FG003|Overall Study|Withdrawal by Subject|6|||
147595634|NCT00770692|532337356|FG000|Overall Study|Adverse Event|3|||
147595635|NCT00770692|532337357|FG001|Overall Study|Adverse Event|0|||
147595636|NCT00770692|532337358|FG002|Overall Study|Adverse Event|4|||
147595637|NCT00770692|532337359|FG003|Overall Study|Adverse Event|4|||
147595638|NCT00770692|532337356|FG000|Overall Study|Investigator judgment|2|||
147595639|NCT00770692|532337357|FG001|Overall Study|Investigator judgment|0|||
147595640|NCT00770692|532337358|FG002|Overall Study|Investigator judgment|1|||
147595641|NCT00770692|532337359|FG003|Overall Study|Investigator judgment|1|||
147595642|NCT03097588|532337362|FG000|Overall Study|Adverse Event|1|||
147595643|NCT03828448|532337365|FG000|Overall Study|Sponsor's Discretion|34|||
147595644|NCT05069155|532337366|FG000|Overall Study|Withdrawal by Subject|1|||
147595645|NCT05069155|532337367|FG001|Overall Study|Withdrawal by Subject|3|||
147595646|NCT02206620|532337368|FG000|Phase I - First Intervention (6 Weeks)|Withdrawal by Subject|1|||
147595647|NCT02206620|532337369|FG001|Phase I - First Intervention (6 Weeks)|Withdrawal by Subject|1|||
147595648|NCT02206620|532337368|FG000|Phase II - Second Intervention (6 Weeks)|Withdrawal by Subject|0|||
147595649|NCT02206620|532337369|FG001|Phase II - Second Intervention (6 Weeks)|Withdrawal by Subject|2|||
147595650|NCT01929031|532337372|FG000|Overall Study|Adverse Event|3|||
147595651|NCT01929031|532337373|FG001|Overall Study|Adverse Event|1|||
147595652|NCT01929031|532337374|FG002|Overall Study|Adverse Event|1|||
147595653|NCT01929031|532337375|FG003|Overall Study|Adverse Event|0|||
147595654|NCT01929031|532337376|FG004|Overall Study|Adverse Event|0|||
147595655|NCT01929031|532337377|FG005|Overall Study|Adverse Event|0|||
147595656|NCT01929031|532337372|FG000|Overall Study|Protocol Violation|1|||
147595657|NCT01929031|532337373|FG001|Overall Study|Protocol Violation|0|||
147595658|NCT01929031|532337374|FG002|Overall Study|Protocol Violation|0|||
147595659|NCT01929031|532337375|FG003|Overall Study|Protocol Violation|0|||
147595660|NCT01929031|532337376|FG004|Overall Study|Protocol Violation|0|||
147595661|NCT01929031|532337377|FG005|Overall Study|Protocol Violation|1|||
147595662|NCT01929031|532337372|FG000|Overall Study|Reason other than specified above|0|||
147595663|NCT01929031|532337373|FG001|Overall Study|Reason other than specified above|1|||
147595664|NCT01929031|532337374|FG002|Overall Study|Reason other than specified above|0|||
147595665|NCT01929031|532337375|FG003|Overall Study|Reason other than specified above|0|||
147595666|NCT01929031|532337376|FG004|Overall Study|Reason other than specified above|1|||
147595667|NCT01929031|532337377|FG005|Overall Study|Reason other than specified above|0|||
147595668|NCT05816200|532337378|FG000|Overall Study|Lost to Follow-up|2|||
147595669|NCT05816200|532337379|FG001|Overall Study|Lost to Follow-up|1|||
147595670|NCT01366443|532337380|FG000|Overall Study|Lost to Follow-up|2|||
147595671|NCT01366443|532337380|FG000|Overall Study|Under 18 yo|1|||
147595672|NCT02394730|532337381|FG000|Overall Study|Lost to Follow-up|1|||
147595673|NCT02394730|532337382|FG001|Overall Study|Lost to Follow-up|0|||
147595674|NCT02394730|532337381|FG000|Overall Study|Withdrawal by Subject|0|||
147595675|NCT02394730|532337382|FG001|Overall Study|Withdrawal by Subject|1|||
147595676|NCT00731549|532337383|FG000|Overall Study|Lost to Follow-up|19|||
147595677|NCT00731549|532337383|FG000|Overall Study|Met withdrawal criteria|24|||
147595678|NCT00731549|532337383|FG000|Overall Study|Physician Decision|16|||
147595679|NCT00731549|532337383|FG000|Overall Study|Withdrawal by Subject|89|||
147595680|NCT00731549|532337383|FG000|Overall Study|Protocol deviation|1|||
147595681|NCT00731549|532337383|FG000|Overall Study|Adverse Event|31|||
147595682|NCT00731549|532337383|FG000|Overall Study|Lack of efficacy with AE|37|||
147595683|NCT00731549|532337383|FG000|Overall Study|Lack of efficacy without AE|6|||
147595684|NCT00588640|532337384|FG000|Overall Study|Physician Decision|1|||
147595685|NCT00588640|532337384|FG000|Overall Study|Ineligible Patient|1|||
147595686|NCT02384850|532337385|FG000|Overall Study|Withdrawal by Subject|2|||
147595687|NCT02384850|532337386|FG001|Overall Study|Withdrawal by Subject|2|||
147595688|NCT00507546|532337387|FG000|Overall Study|Withdrawal by Subject|1|||
147595689|NCT00507546|532337388|FG001|Overall Study|Withdrawal by Subject|0|||
147595690|NCT00507546|532337387|FG000|Overall Study|Protocol Violation|1|||
147595691|NCT00507546|532337388|FG001|Overall Study|Protocol Violation|0|||
147595692|NCT00507546|532337387|FG000|Overall Study|Physician Decision|0|||
147595693|NCT00507546|532337388|FG001|Overall Study|Physician Decision|1|||
147595694|NCT01111019|532337389|FG000|Overall Study|Withdrew Prematurely|2|||
147595695|NCT01111019|532337389|FG000|Overall Study|Other|1|||
147595696|NCT03512262|532337393|FG000|Overall Study|Adverse Event|8|||
147595697|NCT03512262|532337394|FG001|Overall Study|Adverse Event|3|||
147595698|NCT03512262|532337393|FG000|Overall Study|Death (non-treatment emergent)|1|||
147595699|NCT03512262|532337394|FG001|Overall Study|Death (non-treatment emergent)|0|||
147595700|NCT03512262|532337393|FG000|Overall Study|Withdrawal by Subject|17|||
147595701|NCT03512262|532337394|FG001|Overall Study|Withdrawal by Subject|9|||
147595702|NCT03512262|532337393|FG000|Overall Study|Lost to Follow-up|7|||
147595703|NCT03512262|532337394|FG001|Overall Study|Lost to Follow-up|1|||
147595704|NCT03512262|532337393|FG000|Overall Study|Other than Specified|2|||
147595705|NCT03512262|532337394|FG001|Overall Study|Other than Specified|2|||
147595706|NCT01299805|532337395|FG000|Overall Study|Adverse Event|2|||
147595707|NCT01299805|532337396|FG001|Overall Study|Adverse Event|0|||
147595708|NCT00375492|532337398|FG000|Overall Study|Adverse Event|4|||
147595709|NCT00375492|532337399|FG001|Overall Study|Adverse Event|5|||
147595710|NCT00375492|532337398|FG000|Overall Study|Entry Criteria Not Met|0|||
147595711|NCT00375492|532337399|FG001|Overall Study|Entry Criteria Not Met|1|||
147595712|NCT00375492|532337398|FG000|Overall Study|Loss of Glucose Control|0|||
147595713|NCT00375492|532337399|FG001|Overall Study|Loss of Glucose Control|1|||
147595714|NCT00375492|532337398|FG000|Overall Study|Lost to Follow-up|10|||
147659296|NCT05219968|532574417|FG000|Safety Extension Period|Adverse Event|0|||
147659297|NCT05219968|532574418|FG001|Safety Extension Period|Adverse Event|0|||
147659298|NCT05219968|532574419|FG002|Safety Extension Period|Adverse Event|2|||
147659299|NCT05219968|532574420|FG003|Safety Extension Period|Adverse Event|1|||
147659300|NCT05219968|532574421|FG004|Safety Extension Period|Adverse Event|1|||
147659301|NCT05219968|532574417|FG000|Safety Extension Period|Lost to Follow-up|0|||
147659302|NCT05219968|532574418|FG001|Safety Extension Period|Lost to Follow-up|0|||
147659303|NCT05219968|532574419|FG002|Safety Extension Period|Lost to Follow-up|0|||
147659304|NCT05219968|532574420|FG003|Safety Extension Period|Lost to Follow-up|1|||
147659305|NCT05219968|532574421|FG004|Safety Extension Period|Lost to Follow-up|0|||
147659306|NCT04587336|532574424|FG000|Overall Study|Lost to Follow-up|1|||
147659307|NCT04587336|532574425|FG001|Overall Study|Lost to Follow-up|0|||
147659308|NCT03334188|532576141|FG000|Overall Study|Withdrawal by Subject|0|||
147659309|NCT03334188|532576142|FG001|Overall Study|Withdrawal by Subject|1|||
147659310|NCT03334188|532576141|FG000|Overall Study|Death|1|||
147659311|NCT03334188|532576142|FG001|Overall Study|Death|0|||
147659312|NCT03334188|532576141|FG000|Overall Study|Never had qualifying clinic visit|7|||
147659313|NCT03334188|532576142|FG001|Overall Study|Never had qualifying clinic visit|7|||
147659314|NCT03442088|532576149|FG000|Overall Study|Adverse Event|1|||
147659315|NCT03442088|532576149|FG000|Overall Study|Lack of Efficacy|2|||
147659316|NCT03442088|532576149|FG000|Overall Study|Lost to Follow-up|2|||
147659317|NCT01001520|532576150|FG000|Medication Period 1|Withdrawal by Subject|2|||
147659318|NCT01001520|532576151|FG001|Medication Period 1|Withdrawal by Subject|2|||
147659319|NCT01001520|532576150|FG000|Medication Period 1|Ineligible: Positive Urine Drug Screen|0|||
147659320|NCT01001520|532576151|FG001|Medication Period 1|Ineligible: Positive Urine Drug Screen|3|||
147659321|NCT01001520|532576150|FG000|Medication Period 1|Ineligible: fMRI contraindicated metal|0|||
147659322|NCT01001520|532576151|FG001|Medication Period 1|Ineligible: fMRI contraindicated metal|2|||
147659323|NCT01001520|532576150|FG000|Medication Period 1|Ineligible: Claustrophobia in fMRI|2|||
147659324|NCT01001520|532576151|FG001|Medication Period 1|Ineligible: Claustrophobia in fMRI|0|||
147659325|NCT01001520|532576150|FG000|Washout Period|Withdrawal by Subject|2|||
147659326|NCT01001520|532576151|FG001|Washout Period|Withdrawal by Subject|1|||
147659327|NCT01001520|532576150|FG000|Medication Period 2|Withdrawal by Subject|0|||
147659328|NCT01001520|532576151|FG001|Medication Period 2|Withdrawal by Subject|3|||
147659329|NCT00357877|532576154|FG000|Overall Study|Death|2|||
147659330|NCT00357877|532576155|FG001|Overall Study|Death|1|||
147595715|NCT00375492|532337399|FG001|Overall Study|Lost to Follow-up|5|||
147595716|NCT00375492|532337398|FG000|Overall Study|Physician Decision|0|||
147595717|NCT00375492|532337399|FG001|Overall Study|Physician Decision|4|||
147595718|NCT00375492|532337398|FG000|Overall Study|Protocol Violation|6|||
147595719|NCT00375492|532337399|FG001|Overall Study|Protocol Violation|3|||
147595720|NCT00375492|532337398|FG000|Overall Study|Sponsor Decision|0|||
147595721|NCT00375492|532337399|FG001|Overall Study|Sponsor Decision|1|||
147595722|NCT00375492|532337398|FG000|Overall Study|Withdrawal by Subject|6|||
147595723|NCT00375492|532337399|FG001|Overall Study|Withdrawal by Subject|6|||
147595724|NCT04062448|532338662|FG000|Overall Study|Lost to Follow-up|1|||
147595725|NCT04062448|532338662|FG000|Overall Study|Withdrawal by Subject|2|||
147595726|NCT04319718|532338663|FG000|Overall Study|Adverse Event|0|||
147595727|NCT04319718|532338664|FG001|Overall Study|Adverse Event|2|||
147595728|NCT04319718|532338663|FG000|Overall Study|Cervical biopsy not performed since participant did not refrain from sexual activity|1|||
147595729|NCT04319718|532338664|FG001|Overall Study|Cervical biopsy not performed since participant did not refrain from sexual activity|0|||
147595730|NCT00599521|532338669|FG000|Overall Study|Lack of Efficacy|4|||
147595731|NCT00599521|532338670|FG001|Overall Study|Lack of Efficacy|8|||
147659331|NCT00357877|532576154|FG000|Overall Study|Lost to Follow-up|20|||
147659332|NCT00357877|532576155|FG001|Overall Study|Lost to Follow-up|23|||
147659333|NCT00357877|532576154|FG000|Overall Study|Withdrawal by Subject|3|||
147595732|NCT00599521|532338669|FG000|Overall Study|Adverse Event|4|||
147595733|NCT00599521|532338670|FG001|Overall Study|Adverse Event|1|||
147595734|NCT00599521|532338669|FG000|Overall Study|Withdrawal by Subject|28|||
147595735|NCT00599521|532338670|FG001|Overall Study|Withdrawal by Subject|34|||
147659334|NCT00357877|532576155|FG001|Overall Study|Withdrawal by Subject|3|||
147595736|NCT00599521|532338669|FG000|Overall Study|Protocol Violation|1|||
147659335|NCT00357877|532576154|FG000|Overall Study|Administrative withdrawal|1|||
147659336|NCT00357877|532576155|FG001|Overall Study|Administrative withdrawal|1|||
147659337|NCT00357877|532576154|FG000|Overall Study|Other|0|||
147659338|NCT00357877|532576155|FG001|Overall Study|Other|2|||
147659339|NCT04668209|532576156|FG000|Overall Study|Withdrawal by Subject|2|||
147659340|NCT04668209|532576157|FG001|Overall Study|Withdrawal by Subject|2|||
147595737|NCT00599521|532338670|FG001|Overall Study|Protocol Violation|1|||
147595738|NCT00599521|532338669|FG000|Overall Study|Lost to Follow-up|23|||
147595739|NCT00599521|532338670|FG001|Overall Study|Lost to Follow-up|23|||
147595740|NCT00599521|532338669|FG000|Overall Study|Pregnancy|0|||
147595741|NCT00599521|532338670|FG001|Overall Study|Pregnancy|2|||
147595742|NCT01293539|532338672|FG000|Overall Study|Physician Decision|1|||
147595743|NCT00609518|532338674|FG000|Overall Study|Death from Study Disease|32|||
147595744|NCT00609518|532338675|FG001|Overall Study|Death from Study Disease|32|||
147595745|NCT00609518|532338674|FG000|Overall Study|Withdrawal by Subject|5|||
147595746|NCT00609518|532338675|FG001|Overall Study|Withdrawal by Subject|3|||
147331189|NCT04771273|531377598|FG003|Maintenance Period|Change of residence|0|||
147595747|NCT00609518|532338674|FG000|Overall Study|Lost to Follow-up|3|||
147595748|NCT00609518|532338675|FG001|Overall Study|Lost to Follow-up|0|||
147595749|NCT00609518|532338674|FG000|Overall Study|Physician Decision|1|||
147595750|NCT00609518|532338675|FG001|Overall Study|Physician Decision|3|||
147595751|NCT00609518|532338674|FG000|Overall Study|Death from Adverse Event|2|||
147595752|NCT00609518|532338675|FG001|Overall Study|Death from Adverse Event|2|||
147595753|NCT05855616|532338676|FG000|Overall Study|Lost to Follow-up|1|||
147595754|NCT05855616|532338677|FG001|Overall Study|Lost to Follow-up|2|||
147595755|NCT04032158|532338678|FG000|Overall Study|Study Termination|2|||
147595756|NCT04032158|532338679|FG001|Overall Study|Study Termination|1|||
147595757|NCT04322149|532338680|FG000|Overall Study|Adverse Event|1|||
147595758|NCT04322149|532338681|FG001|Overall Study|Adverse Event|1|||
147595759|NCT04322149|532338682|FG002|Overall Study|Adverse Event|0|||
147595760|NCT04322149|532338683|FG003|Overall Study|Adverse Event|0|||
147595761|NCT04322149|532338680|FG000|Overall Study|Withdrawal by Subject|0|||
147595762|NCT04322149|532338681|FG001|Overall Study|Withdrawal by Subject|0|||
147595763|NCT04322149|532338682|FG002|Overall Study|Withdrawal by Subject|0|||
147595764|NCT04322149|532338683|FG003|Overall Study|Withdrawal by Subject|2|||
147595765|NCT04322149|532338680|FG000|Overall Study|Undergoing cancer treatment & was unable to return to site to complete EOS visit within window|0|||
147595766|NCT04322149|532338681|FG001|Overall Study|Undergoing cancer treatment & was unable to return to site to complete EOS visit within window|1|||
147595767|NCT04322149|532338682|FG002|Overall Study|Undergoing cancer treatment & was unable to return to site to complete EOS visit within window|0|||
147595768|NCT04322149|532338683|FG003|Overall Study|Undergoing cancer treatment & was unable to return to site to complete EOS visit within window|0|||
147595769|NCT00912093|532338690|FG000|The Controlled Phase|Death|0|||
147595770|NCT00912093|532338691|FG001|The Controlled Phase|Death|1|||
147595771|NCT00912093|532338692|FG002|The Controlled Phase|Death|0|||
147595772|NCT00912093|532338693|FG003|The Controlled Phase|Death|0|||
147595773|NCT00912093|532338694|FG004|The Controlled Phase|Death|0|||
147595774|NCT00912093|532338690|FG000|The Controlled Phase|Medical Condition|0|||
147595775|NCT00912093|532338691|FG001|The Controlled Phase|Medical Condition|1|||
147595776|NCT00912093|532338692|FG002|The Controlled Phase|Medical Condition|0|||
147595777|NCT00912093|532338693|FG003|The Controlled Phase|Medical Condition|0|||
147595778|NCT00912093|532338694|FG004|The Controlled Phase|Medical Condition|0|||
147595779|NCT00912093|532338690|FG000|The Controlled Phase|Lost to Follow-up|0|||
147595780|NCT00912093|532338691|FG001|The Controlled Phase|Lost to Follow-up|0|||
147595781|NCT00912093|532338692|FG002|The Controlled Phase|Lost to Follow-up|0|||
147595782|NCT00912093|532338693|FG003|The Controlled Phase|Lost to Follow-up|0|||
147595783|NCT00912093|532338694|FG004|The Controlled Phase|Lost to Follow-up|1|||
147595784|NCT00891371|532338699|FG000|Pre-assignment|Inclusion/exclusion|5|||
147595785|NCT00891371|532338699|FG000|Pre-assignment|Consent withdrawal|1|||
147595786|NCT00891371|532338699|FG000|Treatment|Lack of Efficacy|5|||
147595787|NCT00891371|532338699|FG000|Treatment|Adverse Event|2|||
147595788|NCT00891371|532338699|FG000|Treatment|Death|1|||
147595789|NCT00891371|532338699|FG000|Treatment|Lost to Follow-up|1|||
147595790|NCT00450619|532338700|FG000|Overall Study|refused treatment after randomization|2|||
147595791|NCT00450619|532338701|FG001|Overall Study|refused treatment after randomization|0|||
147595792|NCT00450619|532338700|FG000|Overall Study|did not progress; refused further trmt|1|||
147595793|NCT00450619|532338701|FG001|Overall Study|did not progress; refused further trmt|1|||
147595794|NCT00450619|532338700|FG000|Overall Study|Adverse Event|1|||
147595795|NCT00450619|532338701|FG001|Overall Study|Adverse Event|0|||
147595796|NCT02034058|532338702|FG000|Overall Study|Death|3|||
147595797|NCT02836496|532338703|FG000|Overall Study|Adverse Event|2|||
147595798|NCT02836496|532338704|FG001|Overall Study|Adverse Event|1|||
147595799|NCT02836496|532338703|FG000|Overall Study|Withdrawal by Subject|0|||
147595800|NCT02836496|532338704|FG001|Overall Study|Withdrawal by Subject|1|||
147595801|NCT03914950|532338705|FG000|Overall Study|Physician Decision|54|||
147595802|NCT03052959|532338706|FG000|Overall Study|Lost to Follow-up|4|||
147595803|NCT03052959|532338707|FG001|Overall Study|Lost to Follow-up|5|||
147595804|NCT04765384|532338708|FG000|Post-baseline: Adults|Lost to Follow-up|0|||
147595805|NCT04765384|532338709|FG001|Post-baseline: Adults|Lost to Follow-up|1|||
147595806|NCT04765384|532338710|FG002|Post-baseline: Adults|Lost to Follow-up|3|||
147595807|NCT04765384|532338711|FG003|Post-baseline: Adults|Lost to Follow-up|0|||
147595808|NCT04765384|532338712|FG004|Post-baseline: Adults|Lost to Follow-up|0|||
147595809|NCT04765384|532338713|FG005|Post-baseline: Adults|Lost to Follow-up|0|||
147331190|NCT04771273|531377595|FG000|Maintenance Period|Perceived lack of efficacy|0|||
147595810|NCT04765384|532338708|FG000|Post-baseline: Adults|Withdrawal by Subject|2|||
147595811|NCT04765384|532338709|FG001|Post-baseline: Adults|Withdrawal by Subject|1|||
147659341|NCT04668209|532576156|FG000|Overall Study|Lost to Follow-up|3|||
147659342|NCT04668209|532576157|FG001|Overall Study|Lost to Follow-up|4|||
147659343|NCT04668209|532576156|FG000|Overall Study|Subject Expired|2|||
147659344|NCT04668209|532576157|FG001|Overall Study|Subject Expired|0|||
147659345|NCT04668209|532576156|FG000|Overall Study|Withdrawn from study|0|||
147659346|NCT04668209|532576157|FG001|Overall Study|Withdrawn from study|1|||
147659347|NCT04668209|532576156|FG000|Overall Study|Adverse Event|0|||
147659348|NCT04668209|532576157|FG001|Overall Study|Adverse Event|1|||
147659349|NCT00268983|532576167|FG000|Overall Study|Death|3|||
147659350|NCT00268983|532576168|FG001|Overall Study|Death|0|||
147659351|NCT01719380|532576169|FG000|Overall Study|Adverse Event|0|||
147659352|NCT01719380|532576170|FG001|Overall Study|Adverse Event|0|||
147659353|NCT01719380|532576171|FG002|Overall Study|Adverse Event|1|||
147659354|NCT01719380|532576172|FG003|Overall Study|Adverse Event|2|||
147659355|NCT01719380|532576173|FG004|Overall Study|Adverse Event|0|||
147659356|NCT01719380|532576174|FG005|Overall Study|Adverse Event|1|||
147659357|NCT01719380|532576175|FG006|Overall Study|Adverse Event|0|||
147659358|NCT01719380|532576176|FG007|Overall Study|Adverse Event|1|||
147659359|NCT01719380|532576177|FG008|Overall Study|Adverse Event|4|||
147659360|NCT01719380|532576178|FG009|Overall Study|Adverse Event|3|||
147659361|NCT01719380|532576169|FG000|Overall Study|Death|0|||
147659362|NCT01719380|532576170|FG001|Overall Study|Death|1|||
147659363|NCT01719380|532576171|FG002|Overall Study|Death|0|||
147659364|NCT01719380|532576172|FG003|Overall Study|Death|0|||
147659365|NCT01719380|532576173|FG004|Overall Study|Death|0|||
147331191|NCT04771273|531377596|FG001|Maintenance Period|Perceived lack of efficacy|0|||
147331192|NCT04771273|531377597|FG002|Maintenance Period|Perceived lack of efficacy|0|||
147595812|NCT04765384|532338710|FG002|Post-baseline: Adults|Withdrawal by Subject|3|||
147595813|NCT04765384|532338711|FG003|Post-baseline: Adults|Withdrawal by Subject|0|||
147595814|NCT04765384|532338712|FG004|Post-baseline: Adults|Withdrawal by Subject|0|||
147595815|NCT04765384|532338713|FG005|Post-baseline: Adults|Withdrawal by Subject|0|||
147595816|NCT04765384|532338708|FG000|Post-natal: Neonates and Infants|Lost to Follow-up|0|||
147595817|NCT04765384|532338709|FG001|Post-natal: Neonates and Infants|Lost to Follow-up|0|||
147595818|NCT04765384|532338710|FG002|Post-natal: Neonates and Infants|Lost to Follow-up|0|||
147595819|NCT04765384|532338711|FG003|Post-natal: Neonates and Infants|Lost to Follow-up|0|||
147595820|NCT04765384|532338712|FG004|Post-natal: Neonates and Infants|Lost to Follow-up|0|||
147595821|NCT04765384|532338713|FG005|Post-natal: Neonates and Infants|Lost to Follow-up|5|||
147595822|NCT04765384|532338708|FG000|Post-natal: Neonates and Infants|Death|0|||
147595823|NCT04765384|532338709|FG001|Post-natal: Neonates and Infants|Death|0|||
147595824|NCT04765384|532338710|FG002|Post-natal: Neonates and Infants|Death|0|||
147595825|NCT04765384|532338711|FG003|Post-natal: Neonates and Infants|Death|1|||
147595826|NCT04765384|532338712|FG004|Post-natal: Neonates and Infants|Death|0|||
147595827|NCT04765384|532338713|FG005|Post-natal: Neonates and Infants|Death|0|||
147595828|NCT04765384|532338708|FG000|Post-natal: Neonates and Infants|Withdrawal by Parent Or Guardian|0|||
147595829|NCT04765384|532338709|FG001|Post-natal: Neonates and Infants|Withdrawal by Parent Or Guardian|0|||
147595830|NCT04765384|532338710|FG002|Post-natal: Neonates and Infants|Withdrawal by Parent Or Guardian|0|||
147595831|NCT04765384|532338711|FG003|Post-natal: Neonates and Infants|Withdrawal by Parent Or Guardian|0|||
147595832|NCT04765384|532338712|FG004|Post-natal: Neonates and Infants|Withdrawal by Parent Or Guardian|0|||
147595833|NCT04765384|532338713|FG005|Post-natal: Neonates and Infants|Withdrawal by Parent Or Guardian|3|||
147595834|NCT00629265|532338714|FG000|Overall Study|Lost to Follow-up|4|||
147595835|NCT00629265|532338715|FG001|Overall Study|Lost to Follow-up|5|||
147595836|NCT00629265|532338714|FG000|Overall Study|Withdrawal by Subject|11|||
147595837|NCT00629265|532338715|FG001|Overall Study|Withdrawal by Subject|8|||
147595838|NCT00629265|532338714|FG000|Overall Study|Death|1|||
147595839|NCT00629265|532338715|FG001|Overall Study|Death|0|||
147595840|NCT00629265|532338714|FG000|Overall Study|Adverse Event|2|||
147595841|NCT00629265|532338715|FG001|Overall Study|Adverse Event|0|||
147595842|NCT00629265|532338714|FG000|Overall Study|HNC Recurrence|4|||
147595843|NCT00629265|532338715|FG001|Overall Study|HNC Recurrence|0|||
147595844|NCT00629265|532338714|FG000|Overall Study|Other CA Requiring Treatment|1|||
147595845|NCT00629265|532338715|FG001|Overall Study|Other CA Requiring Treatment|3|||
147595846|NCT00629265|532338714|FG000|Overall Study|Needed Esophageal Dilation|4|||
147595847|NCT00629265|532338715|FG001|Overall Study|Needed Esophageal Dilation|1|||
147595848|NCT00629265|532338714|FG000|Overall Study|Unrelated Medical Complications|3|||
147595849|NCT00629265|532338715|FG001|Overall Study|Unrelated Medical Complications|1|||
147595850|NCT00629265|532338714|FG000|Overall Study|Unknown Reason|2|||
147595851|NCT00629265|532338715|FG001|Overall Study|Unknown Reason|2|||
147595852|NCT01169532|532338721|FG000|Overall Study|Withdrawal by Subject|1|||
147595853|NCT02032706|532338722|FG000|Overall Study|Did not qualify|5|||
147659366|NCT01719380|532576174|FG005|Overall Study|Death|0|||
147659367|NCT01719380|532576175|FG006|Overall Study|Death|0|||
147659368|NCT01719380|532576176|FG007|Overall Study|Death|0|||
147659369|NCT01719380|532576177|FG008|Overall Study|Death|3|||
147595854|NCT02032706|532338722|FG000|Overall Study|Protocol Violation|1|||
147659370|NCT01719380|532576178|FG009|Overall Study|Death|3|||
147659371|NCT01719380|532576169|FG000|Overall Study|Participant/Guardian Decision|0|||
147659372|NCT01719380|532576170|FG001|Overall Study|Participant/Guardian Decision|0|||
147659373|NCT01719380|532576171|FG002|Overall Study|Participant/Guardian Decision|1|||
147659374|NCT01719380|532576172|FG003|Overall Study|Participant/Guardian Decision|0|||
147659375|NCT01719380|532576173|FG004|Overall Study|Participant/Guardian Decision|0|||
147659376|NCT01719380|532576174|FG005|Overall Study|Participant/Guardian Decision|0|||
147659377|NCT01719380|532576175|FG006|Overall Study|Participant/Guardian Decision|0|||
147659378|NCT01719380|532576176|FG007|Overall Study|Participant/Guardian Decision|0|||
147659379|NCT01719380|532576177|FG008|Overall Study|Participant/Guardian Decision|2|||
147659380|NCT01719380|532576178|FG009|Overall Study|Participant/Guardian Decision|2|||
147595855|NCT05070546|532338727|FG000|Overall Study|Death|0|||
147595856|NCT05070546|532338728|FG001|Overall Study|Death|0|||
147595857|NCT05070546|532338729|FG002|Overall Study|Death|0|||
147595858|NCT05070546|532338730|FG003|Overall Study|Death|0|||
147595859|NCT05070546|532338731|FG004|Overall Study|Death|0|||
147595860|NCT05070546|532338732|FG005|Overall Study|Death|1|||
147595861|NCT05070546|532338727|FG000|Overall Study|Lost to Follow-up|8|||
147595862|NCT05070546|532338728|FG001|Overall Study|Lost to Follow-up|2|||
147595863|NCT05070546|532338729|FG002|Overall Study|Lost to Follow-up|7|||
147595864|NCT05070546|532338730|FG003|Overall Study|Lost to Follow-up|1|||
147595865|NCT05070546|532338731|FG004|Overall Study|Lost to Follow-up|2|||
147595866|NCT05070546|532338732|FG005|Overall Study|Lost to Follow-up|0|||
147595867|NCT05070546|532338727|FG000|Overall Study|Withdrawal by Subject|1|||
147595868|NCT05070546|532338728|FG001|Overall Study|Withdrawal by Subject|1|||
147595869|NCT05070546|532338729|FG002|Overall Study|Withdrawal by Subject|3|||
147595870|NCT05070546|532338730|FG003|Overall Study|Withdrawal by Subject|0|||
147595871|NCT05070546|532338731|FG004|Overall Study|Withdrawal by Subject|0|||
147595872|NCT05070546|532338732|FG005|Overall Study|Withdrawal by Subject|0|||
147595873|NCT05070546|532338727|FG000|Overall Study|Other|0|||
147595874|NCT05070546|532338728|FG001|Overall Study|Other|0|||
147595875|NCT05070546|532338729|FG002|Overall Study|Other|0|||
147595876|NCT05070546|532338730|FG003|Overall Study|Other|0|||
147595877|NCT05070546|532338731|FG004|Overall Study|Other|3|||
147595878|NCT05070546|532338732|FG005|Overall Study|Other|0|||
147595879|NCT05070546|532338727|FG000|Overall Study|Randomized but not vaccinated|1|||
147595880|NCT05070546|532338728|FG001|Overall Study|Randomized but not vaccinated|0|||
147595881|NCT05070546|532338729|FG002|Overall Study|Randomized but not vaccinated|1|||
147595882|NCT05070546|532338730|FG003|Overall Study|Randomized but not vaccinated|1|||
147595883|NCT05070546|532338731|FG004|Overall Study|Randomized but not vaccinated|3|||
147595884|NCT05070546|532338732|FG005|Overall Study|Randomized but not vaccinated|0|||
147595885|NCT00160641|532338738|FG000|Overall Study|Adverse Event|102|||
147595886|NCT00160641|532338738|FG000|Overall Study|Withdrawal by Subject|87|||
147595887|NCT00160641|532338738|FG000|Overall Study|Lost to Follow-up|8|||
147595888|NCT00160641|532338738|FG000|Overall Study|Lack of Efficacy|12|||
147595889|NCT00160641|532338738|FG000|Overall Study|Protocol Violation|3|||
147595890|NCT00160641|532338738|FG000|Overall Study|Other|9|||
147595891|NCT02787408|532338739|FG000|Overall Study|Death|16|||
147595892|NCT02787408|532338739|FG000|Overall Study|Withdrawal by Subject|1|||
147595893|NCT02787408|532338739|FG000|Overall Study|Non-implanted patient exited post 6 month follow-up visit per protocol|1|||
147595894|NCT01782482|532338740|FG000|Overall Study|Adverse Event|2|||
147595895|NCT01782482|532338741|FG001|Overall Study|Adverse Event|1|||
147595896|NCT01782482|532338740|FG000|Overall Study|Lost to Follow-up|2|||
147595897|NCT01782482|532338741|FG001|Overall Study|Lost to Follow-up|3|||
147595898|NCT01782482|532338740|FG000|Overall Study|Physician Decision|1|||
147595899|NCT01782482|532338741|FG001|Overall Study|Physician Decision|0|||
147595900|NCT01782482|532338740|FG000|Overall Study|Protocol Violation|1|||
147595901|NCT01782482|532338741|FG001|Overall Study|Protocol Violation|0|||
147595902|NCT01782482|532338740|FG000|Overall Study|Withdrawal by Subject|2|||
147595903|NCT01782482|532338741|FG001|Overall Study|Withdrawal by Subject|3|||
147595904|NCT01782482|532338740|FG000|Overall Study|Randomized in Error|2|||
147595905|NCT01782482|532338741|FG001|Overall Study|Randomized in Error|2|||
147595906|NCT01782482|532338740|FG000|Overall Study|Habitually wearing toric lens OS|0|||
147659381|NCT01719380|532576169|FG000|Overall Study|Physician Decision|0|||
147659382|NCT01719380|532576170|FG001|Overall Study|Physician Decision|0|||
147659383|NCT01719380|532576171|FG002|Overall Study|Physician Decision|2|||
147659384|NCT01719380|532576172|FG003|Overall Study|Physician Decision|0|||
147659385|NCT01719380|532576173|FG004|Overall Study|Physician Decision|0|||
147595907|NCT01782482|532338741|FG001|Overall Study|Habitually wearing toric lens OS|1|||
147595908|NCT00985712|532338743|FG000|Overall Study|Adverse Event|0|||
147595909|NCT00985712|532338744|FG001|Overall Study|Adverse Event|1|||
147595910|NCT00985712|532338743|FG000|Overall Study|Lost to Follow-up|2|||
147595911|NCT00985712|532338744|FG001|Overall Study|Lost to Follow-up|2|||
147595912|NCT00985712|532338743|FG000|Overall Study|Protocol Violation|0|||
147595913|NCT00985712|532338744|FG001|Overall Study|Protocol Violation|1|||
147595914|NCT00985712|532338743|FG000|Overall Study|Withdrawal by Subject|4|||
147595915|NCT00985712|532338744|FG001|Overall Study|Withdrawal by Subject|1|||
147595916|NCT00985712|532338743|FG000|Overall Study|Sponsor decision|0|||
147595917|NCT00985712|532338744|FG001|Overall Study|Sponsor decision|2|||
147595918|NCT01194973|532338750|FG000|Screening Period|Screen Failure|3|||
147659422|NCT01064414|532576183|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|2|||
147659423|NCT01064414|532576181|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
147659424|NCT01064414|532576182|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|1|||
147659425|NCT01064414|532576183|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
147659426|NCT01064414|532576181|FG000|Core Period: Baseline to Week 26|Other|4|||
147659427|NCT01064414|532576182|FG001|Core Period: Baseline to Week 26|Other|7|||
147659428|NCT01064414|532576183|FG002|Core Period: Baseline to Week 26|Other|2|||
147659429|NCT01064414|532576181|FG000|Extension Period: Week 26 to Week 52|Adverse Event|2|||
147659430|NCT01064414|532576182|FG001|Extension Period: Week 26 to Week 52|Adverse Event|1|||
147659431|NCT01064414|532576183|FG002|Extension Period: Week 26 to Week 52|Adverse Event|2|||
147659432|NCT01064414|532576181|FG000|Extension Period: Week 26 to Week 52|Death|0|||
147659433|NCT01064414|532576182|FG001|Extension Period: Week 26 to Week 52|Death|1|||
147659434|NCT01064414|532576183|FG002|Extension Period: Week 26 to Week 52|Death|0|||
147659435|NCT01064414|532576181|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|1|||
147659436|NCT01064414|532576182|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
147659437|NCT01064414|532576183|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
147659438|NCT01064414|532576181|FG000|Extension Period: Week 26 to Week 52|Physician Decision|1|||
147659439|NCT01064414|532576182|FG001|Extension Period: Week 26 to Week 52|Physician Decision|0|||
147659440|NCT01064414|532576183|FG002|Extension Period: Week 26 to Week 52|Physician Decision|0|||
147659441|NCT01064414|532576181|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
147659442|NCT01064414|532576182|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
147659443|NCT01064414|532576183|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
147659444|NCT01064414|532576181|FG000|Extension Period: Week 26 to Week 52|Noncompliance with study drug|1|||
147659445|NCT01064414|532576182|FG001|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0|||
147659446|NCT01064414|532576183|FG002|Extension Period: Week 26 to Week 52|Noncompliance with study drug|0|||
147659447|NCT01064414|532576181|FG000|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
147659448|NCT01064414|532576182|FG001|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
147659449|NCT01064414|532576183|FG002|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
147659450|NCT01064414|532576181|FG000|Extension Period: Week 26 to Week 52|Other|5|||
147659451|NCT01064414|532576182|FG001|Extension Period: Week 26 to Week 52|Other|2|||
147659452|NCT01064414|532576183|FG002|Extension Period: Week 26 to Week 52|Other|1|||
147659453|NCT02532374|532576184|FG000|Overall Study|Withdrawal by Subject|1|||
147659454|NCT02532374|532576184|FG000|Overall Study|Physician Decision|1|||
147659455|NCT00716456|532576187|FG000|Overall Study|Adverse Event|0|||
147659456|NCT00716456|532576188|FG001|Overall Study|Adverse Event|2|||
147659457|NCT00716456|532576189|FG002|Overall Study|Adverse Event|0|||
147659458|NCT00807885|532576197|FG000|Overall Study|Lost to Follow-up|0|||
147659459|NCT00807885|532576198|FG001|Overall Study|Lost to Follow-up|0|||
147659460|NCT00807885|532576199|FG002|Overall Study|Lost to Follow-up|0|||
147659461|NCT00807885|532576200|FG003|Overall Study|Lost to Follow-up|0|||
147659462|NCT00807885|532576201|FG004|Overall Study|Lost to Follow-up|0|||
147659463|NCT00807885|532576202|FG005|Overall Study|Lost to Follow-up|1|||
147659464|NCT00807885|532576203|FG006|Overall Study|Lost to Follow-up|0|||
147659465|NCT00807885|532576204|FG007|Overall Study|Lost to Follow-up|0|||
147659466|NCT00807885|532576205|FG008|Overall Study|Lost to Follow-up|0|||
147659467|NCT03489343|532576206|FG000|Overall Study|Documented progressive disease|1|||
147659468|NCT03489343|532576207|FG001|Overall Study|Documented progressive disease|0|||
147659469|NCT03489343|532576208|FG002|Overall Study|Documented progressive disease|3|||
147659470|NCT03489343|532576209|FG003|Overall Study|Documented progressive disease|1|||
147659471|NCT03489343|532576210|FG004|Overall Study|Documented progressive disease|3|||
147659472|NCT03489343|532576211|FG005|Overall Study|Documented progressive disease|5|||
147659473|NCT03489343|532576212|FG006|Overall Study|Documented progressive disease|4|||
147659474|NCT03489343|532576206|FG000|Overall Study|Adverse Event|0|||
147659475|NCT03489343|532576207|FG001|Overall Study|Adverse Event|1|||
147659476|NCT03489343|532576208|FG002|Overall Study|Adverse Event|0|||
147659477|NCT03489343|532576209|FG003|Overall Study|Adverse Event|0|||
147659478|NCT03489343|532576210|FG004|Overall Study|Adverse Event|0|||
147659479|NCT03489343|532576211|FG005|Overall Study|Adverse Event|1|||
147659480|NCT03489343|532576212|FG006|Overall Study|Adverse Event|0|||
147659481|NCT03489343|532576206|FG000|Overall Study|Withdrawal by Subject|0|||
147659482|NCT03489343|532576207|FG001|Overall Study|Withdrawal by Subject|0|||
147659483|NCT03489343|532576208|FG002|Overall Study|Withdrawal by Subject|0|||
147659484|NCT03489343|532576209|FG003|Overall Study|Withdrawal by Subject|1|||
147659485|NCT03489343|532576210|FG004|Overall Study|Withdrawal by Subject|0|||
147659486|NCT03489343|532576211|FG005|Overall Study|Withdrawal by Subject|1|||
147659487|NCT03489343|532576212|FG006|Overall Study|Withdrawal by Subject|1|||
147659488|NCT03489343|532576206|FG000|Overall Study|Clinical progression|0|||
147659489|NCT03489343|532576207|FG001|Overall Study|Clinical progression|0|||
147659490|NCT03489343|532576208|FG002|Overall Study|Clinical progression|0|||
147659491|NCT03489343|532576209|FG003|Overall Study|Clinical progression|1|||
147659492|NCT03489343|532576210|FG004|Overall Study|Clinical progression|0|||
147659493|NCT03489343|532576211|FG005|Overall Study|Clinical progression|0|||
147659494|NCT03489343|532576212|FG006|Overall Study|Clinical progression|1|||
147659495|NCT00327717|532576213|FG000|Overall Study|Adverse Event|6|||
147659496|NCT00327717|532576214|FG001|Overall Study|Adverse Event|6|||
147659497|NCT00327717|532576213|FG000|Overall Study|Lack of Efficacy|0|||
147659498|NCT00327717|532576214|FG001|Overall Study|Lack of Efficacy|1|||
147659499|NCT00327717|532576213|FG000|Overall Study|Withdrawal by Subject|3|||
147659500|NCT00327717|532576214|FG001|Overall Study|Withdrawal by Subject|7|||
147659501|NCT01630135|532576217|FG000|Overall Study|Protocol-defined Stopping Criteria Met|0|||
147659502|NCT01630135|532576218|FG001|Overall Study|Protocol-defined Stopping Criteria Met|2|||
147659503|NCT04767373|532576219|FG000|Overall Study|Death|6|||
147659504|NCT04767373|532576220|FG001|Overall Study|Death|3|||
147659505|NCT04767373|532576219|FG000|Overall Study|Lost to Follow-up|67|||
147659506|NCT04767373|532576220|FG001|Overall Study|Lost to Follow-up|35|||
147659507|NCT04767373|532576219|FG000|Overall Study|Physician Decision|15|||
147659508|NCT04767373|532576220|FG001|Overall Study|Physician Decision|4|||
147659509|NCT04767373|532576219|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
147659510|NCT04767373|532576220|FG001|Overall Study|Randomized By Mistake Without Study Treatment|1|||
147659511|NCT04767373|532576219|FG000|Overall Study|Withdrawal By Parent/Guardian|75|||
147659512|NCT04767373|532576220|FG001|Overall Study|Withdrawal By Parent/Guardian|40|||
147659513|NCT04767373|532576219|FG000|Overall Study|Other|1|||
147659514|NCT04767373|532576220|FG001|Overall Study|Other|2|||
147659515|NCT01502033|532576221|FG000|Overall Study|1 participant had scalp discomfort|1|||
147659516|NCT01502033|532576221|FG000|Overall Study|1 participant had worsening depression|1|||
147659517|NCT01502033|532576221|FG000|Overall Study|1 participant went back to school|1|||
147659518|NCT02658669|532576222|FG000|Overall Study|Lost to Follow-up|7|||
147659519|NCT02658669|532576223|FG001|Overall Study|Lost to Follow-up|5|||
147659520|NCT00186485|532576224|FG000|Overall Study|Lost to Follow-up|3|||
147659521|NCT03804268|532576237|FG000|Overall Study|Adverse Event|2|||
147659522|NCT03804268|532576238|FG001|Overall Study|Adverse Event|2|||
147659523|NCT03804268|532576237|FG000|Overall Study|Withdrawal by Subject|2|||
147659524|NCT03804268|532576238|FG001|Overall Study|Withdrawal by Subject|0|||
147659525|NCT03804268|532576237|FG000|Overall Study|Lost to Follow-up|1|||
147659526|NCT03804268|532576238|FG001|Overall Study|Lost to Follow-up|0|||
147659527|NCT03804268|532576237|FG000|Overall Study|Physician Decision|2|||
147659528|NCT03804268|532576238|FG001|Overall Study|Physician Decision|0|||
147659529|NCT00838097|532576239|FG000|Overall Study|Ineligibility determined|6|||
147659530|NCT00838097|532576239|FG000|Overall Study|Adverse Event|2|||
147659531|NCT00838097|532576239|FG000|Overall Study|Withdrawal by Subject|3|||
147659532|NCT00838097|532576239|FG000|Overall Study|Requirement for alternative therapy|2|||
147659533|NCT00838097|532576239|FG000|Overall Study|Physician Decision|4|||
147659534|NCT00838097|532576239|FG000|Overall Study|Lost to Follow-up|11|||
147659535|NCT00838097|532576239|FG000|Overall Study|Death|6|||
147659536|NCT00838097|532576239|FG000|Overall Study|Protocol-specified criteria|142|||
147659537|NCT03311841|532576242|FG000|14-day Wash-out|Adverse Event|0|||
147659538|NCT03311841|532576243|FG001|14-day Wash-out|Adverse Event|1|||
147659539|NCT03311841|532576244|FG002|14-day Wash-out|Adverse Event|0|||
147659540|NCT03311841|532576245|FG003|14-day Wash-out|Adverse Event|0|||
147659541|NCT03311841|532576246|FG004|14-day Wash-out|Adverse Event|0|||
147659542|NCT03311841|532576242|FG000|14-day Wash-out|Non-Compliance With Study Drug|0|||
147659543|NCT03311841|532576243|FG001|14-day Wash-out|Non-Compliance With Study Drug|0|||
147659544|NCT03311841|532576244|FG002|14-day Wash-out|Non-Compliance With Study Drug|0|||
147659545|NCT03311841|532576245|FG003|14-day Wash-out|Non-Compliance With Study Drug|1|||
147659546|NCT03311841|532576246|FG004|14-day Wash-out|Non-Compliance With Study Drug|0|||
147449501|NCT00440947|531809507|FG002|36-Week Induction Phase|Incarceration|0|||
147449502|NCT00440947|531809508|FG003|36-Week Induction Phase|Incarceration|0|||
147449503|NCT00440947|531809509|FG004|36-Week Induction Phase|Incarceration|0|||
147449504|NCT00440947|531809505|FG000|36-Week Induction Phase|Pregnancy|1|||
147449505|NCT00440947|531809506|FG001|36-Week Induction Phase|Pregnancy|0|||
147449506|NCT00440947|531809507|FG002|36-Week Induction Phase|Pregnancy|0|||
147449507|NCT00440947|531809508|FG003|36-Week Induction Phase|Pregnancy|0|||
147449508|NCT00440947|531809509|FG004|36-Week Induction Phase|Pregnancy|0|||
147449509|NCT00440947|531809505|FG000|48-Week Randomization Phase|Adverse Event|0|||
147449510|NCT00440947|531809506|FG001|48-Week Randomization Phase|Adverse Event|2|||
147449511|NCT00440947|531809507|FG002|48-Week Randomization Phase|Adverse Event|5|||
147449512|NCT00440947|531809508|FG003|48-Week Randomization Phase|Adverse Event|0|||
147449513|NCT00440947|531809509|FG004|48-Week Randomization Phase|Adverse Event|0|||
147449514|NCT00440947|531809505|FG000|48-Week Randomization Phase|Protocol-defined Virologic Failure|0|||
147449515|NCT00440947|531809506|FG001|48-Week Randomization Phase|Protocol-defined Virologic Failure|1|||
147527179|NCT03726320|532084156|FG001|Overall Study|Lost to Follow-up|4|||
147659547|NCT01705977|532576263|FG000|Treatment Period (Year 1)|Withdrawal by Subject|128|||
147659548|NCT01705977|532576264|FG001|Treatment Period (Year 1)|Withdrawal by Subject|128|||
147659549|NCT01705977|532576263|FG000|Treatment Period (Year 1)|Adverse Event|57|||
147659550|NCT01705977|532576264|FG001|Treatment Period (Year 1)|Adverse Event|49|||
147659551|NCT01705977|532576263|FG000|Treatment Period (Year 1)|Protocol Violation|2|||
147659552|NCT01705977|532576264|FG001|Treatment Period (Year 1)|Protocol Violation|4|||
147659553|NCT01705977|532576263|FG000|Treatment Period (Year 1)|Site closure|3|||
147659554|NCT01705977|532576264|FG001|Treatment Period (Year 1)|Site closure|2|||
147659555|NCT01705977|532576263|FG000|Treatment Period (Year 1)|Lost to Follow-up|33|||
147659556|NCT01705977|532576264|FG001|Treatment Period (Year 1)|Lost to Follow-up|37|||
147659557|NCT01705977|532576263|FG000|Treatment Period (Year 1)|Physician Decision|48|||
147659558|NCT01705977|532576264|FG001|Treatment Period (Year 1)|Physician Decision|38|||
147659559|NCT01705977|532576263|FG000|Treatment Period (Year 1)|Missing study conclusion form|2|||
147659560|NCT01705977|532576264|FG001|Treatment Period (Year 1)|Missing study conclusion form|2|||
147659561|NCT01705977|532576263|FG000|Treatment Period (Year 1)|Randomized but not treated|7|||
147659562|NCT01705977|532576264|FG001|Treatment Period (Year 1)|Randomized but not treated|9|||
147659563|NCT01705977|532576263|FG000|Follow-up Period (Years 2 to 5)|Death|58|||
147659564|NCT01705977|532576264|FG001|Follow-up Period (Years 2 to 5)|Death|38|||
147659565|NCT01705977|532576263|FG000|Follow-up Period (Years 2 to 5)|Lost to Follow-up|75|||
147659566|NCT01705977|532576264|FG001|Follow-up Period (Years 2 to 5)|Lost to Follow-up|89|||
147659567|NCT01705977|532576263|FG000|Follow-up Period (Years 2 to 5)|Withdrawal by Subject|44|||
147659568|NCT01705977|532576264|FG001|Follow-up Period (Years 2 to 5)|Withdrawal by Subject|36|||
147659569|NCT01705977|532576263|FG000|Follow-up Period (Years 2 to 5)|Missing|19|||
147659570|NCT01705977|532576264|FG001|Follow-up Period (Years 2 to 5)|Missing|18|||
147659571|NCT02039778|532576269|FG000|Overall Study|Death|2|||
147659572|NCT02039778|532576269|FG000|Overall Study|Withdrawal by Subject|1|||
147659573|NCT02039778|532576269|FG000|Overall Study|Never started the protocol treatment|1|||
147659574|NCT00753675|532576280|FG000|Overall Study|other reason|11|||
147659575|NCT00753675|532576281|FG001|Overall Study|other reason|12|||
147659576|NCT00753675|532576282|FG002|Overall Study|other reason|13|||
147659577|NCT00753675|532576280|FG000|Overall Study|Death|1|||
147659578|NCT00753675|532576281|FG001|Overall Study|Death|2|||
147659579|NCT00753675|532576282|FG002|Overall Study|Death|4|||
147659580|NCT00753675|532576280|FG000|Overall Study|Adverse Event|11|||
147659581|NCT00753675|532576281|FG001|Overall Study|Adverse Event|9|||
147659582|NCT00753675|532576282|FG002|Overall Study|Adverse Event|4|||
147659583|NCT00753675|532576280|FG000|Overall Study|Objective progression of disease|35|||
147659584|NCT00753675|532576281|FG001|Overall Study|Objective progression of disease|35|||
147659585|NCT00753675|532576282|FG002|Overall Study|Objective progression of disease|35|||
147659586|NCT00753675|532576280|FG000|Overall Study|Withdrawal by Subject|0|||
147659587|NCT00753675|532576281|FG001|Overall Study|Withdrawal by Subject|1|||
147659588|NCT00753675|532576282|FG002|Overall Study|Withdrawal by Subject|0|||
147659589|NCT00753675|532576280|FG000|Overall Study|Lost to Follow-up|1|||
147659590|NCT00753675|532576281|FG001|Overall Study|Lost to Follow-up|0|||
147659591|NCT00753675|532576282|FG002|Overall Study|Lost to Follow-up|0|||
147659592|NCT01462110|532576283|FG000|Overall Study|Adverse Event|1|||
147659593|NCT01462110|532576284|FG001|Overall Study|Adverse Event|0|||
147659594|NCT05279131|532576286|FG000|Overall Study|Lost to Follow-up|1|||
147659595|NCT05279131|532576286|FG000|Overall Study|Death|1|||
147659596|NCT05279131|532576286|FG000|Overall Study|Physician Decision|1|||
147659597|NCT02149264|532576292|FG000|Overall Study|Withdrawal by Subject|9|||
147659598|NCT02149264|532576292|FG000|Overall Study|Adverse Event|7|||
147659599|NCT02149264|532576292|FG000|Overall Study|Physician Decision|3|||
147659600|NCT02149264|532576292|FG000|Overall Study|Protocol Violation|1|||
147659601|NCT00672633|532576297|FG000|Overall Study|Withdrawal by Subject|0|||
147659602|NCT00672633|532576298|FG001|Overall Study|Withdrawal by Subject|1|||
147659603|NCT02499120|532576302|FG000|Overall Study|Death|52|||
147659604|NCT02499120|532576303|FG001|Overall Study|Death|43|||
147659605|NCT02499120|532576302|FG000|Overall Study|Lost to Follow-up|1|||
147659606|NCT02499120|532576303|FG001|Overall Study|Lost to Follow-up|2|||
147659607|NCT02499120|532576302|FG000|Overall Study|Participant refused further follow-up|1|||
147659608|NCT02499120|532576303|FG001|Overall Study|Participant refused further follow-up|0|||
147659609|NCT02499120|532576302|FG000|Overall Study|Withdrawal by Subject|2|||
147659610|NCT02499120|532576303|FG001|Overall Study|Withdrawal by Subject|5|||
147659611|NCT02499120|532576302|FG000|Overall Study|Other|9|||
147659612|NCT02499120|532576303|FG001|Overall Study|Other|10|||
147659613|NCT01845597|532577771|FG000|Overall Study|Death|8|||
147659614|NCT01845597|532577771|FG000|Overall Study|Lost to Follow-up|22|||
147659615|NCT00956839|532577777|FG000|Overall Study|Lost to Follow-up|3|||
147659616|NCT00956839|532577778|FG001|Overall Study|Lost to Follow-up|0|||
147659617|NCT00956839|532577779|FG002|Overall Study|Lost to Follow-up|3|||
147659618|NCT00994110|532577780|FG000|Overall Study|Withdrawal by Subject|9|||
147659619|NCT00994110|532577781|FG001|Overall Study|Withdrawal by Subject|9|||
147659620|NCT00994110|532577780|FG000|Overall Study|Not Treated|4|||
147659621|NCT00994110|532577781|FG001|Overall Study|Not Treated|8|||
147659622|NCT00994110|532577780|FG000|Overall Study|Adverse Event|1|||
147659623|NCT00994110|532577781|FG001|Overall Study|Adverse Event|0|||
147659624|NCT00994110|532577780|FG000|Overall Study|Patient not resected|41|||
147659625|NCT00994110|532577781|FG001|Overall Study|Patient not resected|52|||
147659626|NCT00994110|532577780|FG000|Overall Study|Pt not eligible|10|||
147659627|NCT00994110|532577781|FG001|Overall Study|Pt not eligible|5|||
147659628|NCT01914393|532577782|FG000|Overall Study|Protocol Violation|11|||
147659629|NCT01914393|532577783|FG001|Overall Study|Protocol Violation|3|||
147659630|NCT01914393|532577784|FG002|Overall Study|Protocol Violation|19|||
147659631|NCT01914393|532577782|FG000|Overall Study|Lack of Efficacy|11|||
147659632|NCT01914393|532577783|FG001|Overall Study|Lack of Efficacy|16|||
147659633|NCT01914393|532577784|FG002|Overall Study|Lack of Efficacy|5|||
147659634|NCT01914393|532577782|FG000|Overall Study|no reason given|14|||
147659635|NCT01914393|532577783|FG001|Overall Study|no reason given|8|||
147659636|NCT01914393|532577784|FG002|Overall Study|no reason given|16|||
147659637|NCT01914393|532577782|FG000|Overall Study|Adverse Event|29|||
147659638|NCT01914393|532577783|FG001|Overall Study|Adverse Event|18|||
147659639|NCT01914393|532577784|FG002|Overall Study|Adverse Event|31|||
147659640|NCT01914393|532577782|FG000|Overall Study|Withdrawal by Subject|38|||
147659641|NCT01914393|532577783|FG001|Overall Study|Withdrawal by Subject|20|||
147659642|NCT01914393|532577784|FG002|Overall Study|Withdrawal by Subject|47|||
147659643|NCT01914393|532577782|FG000|Overall Study|Lost to Follow-up|12|||
147659644|NCT01914393|532577783|FG001|Overall Study|Lost to Follow-up|6|||
147659645|NCT01914393|532577784|FG002|Overall Study|Lost to Follow-up|19|||
147659646|NCT01914393|532577782|FG000|Overall Study|subject never dosed|0|||
147659647|NCT01914393|532577783|FG001|Overall Study|subject never dosed|0|||
147659648|NCT01914393|532577784|FG002|Overall Study|subject never dosed|1|||
147659649|NCT01111565|532577785|FG000|Phase B (Weeks 0 to 8)|Lost to Follow-up|3|||
147659650|NCT01111565|532577786|FG001|Phase B (Weeks 0 to 8)|Lost to Follow-up|0|||
147659651|NCT01111565|532577787|FG002|Phase B (Weeks 0 to 8)|Lost to Follow-up|0|||
147659652|NCT01111565|532577788|FG003|Phase B (Weeks 0 to 8)|Lost to Follow-up|0|||
147659653|NCT01111565|532577789|FG004|Phase B (Weeks 0 to 8)|Lost to Follow-up|0|||
147659654|NCT01111565|532577785|FG000|Phase B (Weeks 0 to 8)|Adverse Event|1|||
147659655|NCT01111565|532577786|FG001|Phase B (Weeks 0 to 8)|Adverse Event|0|||
147659656|NCT01111565|532577787|FG002|Phase B (Weeks 0 to 8)|Adverse Event|0|||
147659657|NCT01111565|532577788|FG003|Phase B (Weeks 0 to 8)|Adverse Event|0|||
147659658|NCT01111565|532577789|FG004|Phase B (Weeks 0 to 8)|Adverse Event|0|||
147659659|NCT01111565|532577785|FG000|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|58|||
147659660|NCT01111565|532577786|FG001|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|0|||
147659661|NCT01111565|532577787|FG002|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|0|||
147659662|NCT01111565|532577788|FG003|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|0|||
147659663|NCT01111565|532577789|FG004|Phase B (Weeks 0 to 8)|Sponsor Discontinued Study|0|||
147659664|NCT01111565|532577785|FG000|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|1|||
147659665|NCT01111565|532577786|FG001|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|0|||
147659666|NCT01111565|532577787|FG002|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|0|||
147659667|NCT01111565|532577788|FG003|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|0|||
147659668|NCT01111565|532577789|FG004|Phase B (Weeks 0 to 8)|Investigator Withdrew Subject|0|||
147659669|NCT01111565|532577785|FG000|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|1|||
147659670|NCT01111565|532577786|FG001|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|0|||
147659671|NCT01111565|532577787|FG002|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|0|||
147659672|NCT01111565|532577788|FG003|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|0|||
147659673|NCT01111565|532577789|FG004|Phase B (Weeks 0 to 8)|Subject Withdrew Consent|0|||
147659674|NCT01111565|532577785|FG000|Phase B (Weeks 0 to 8)|Protocol Deviation|1|||
147659675|NCT01111565|532577786|FG001|Phase B (Weeks 0 to 8)|Protocol Deviation|0|||
147659676|NCT01111565|532577787|FG002|Phase B (Weeks 0 to 8)|Protocol Deviation|0|||
147659677|NCT01111565|532577788|FG003|Phase B (Weeks 0 to 8)|Protocol Deviation|0|||
147659678|NCT01111565|532577789|FG004|Phase B (Weeks 0 to 8)|Protocol Deviation|0|||
147659679|NCT01111565|532577785|FG000|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|1|||
147659680|NCT01111565|532577786|FG001|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|0|||
147659681|NCT01111565|532577787|FG002|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|0|||
147659682|NCT01111565|532577788|FG003|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|0|||
147659683|NCT01111565|532577789|FG004|Phase B (Weeks 0 to 8)|Lack of Efficacy as Determined by the Investigator|0|||
147659684|NCT01111565|532577785|FG000|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
147659685|NCT01111565|532577786|FG001|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
147659686|NCT01111565|532577787|FG002|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
147659687|NCT01111565|532577788|FG003|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|1|||
147659688|NCT01111565|532577789|FG004|Phase B + and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
147659689|NCT01111565|532577785|FG000|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|0|||
147659690|NCT01111565|532577786|FG001|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|0|||
147659691|NCT01111565|532577787|FG002|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|2|||
147659692|NCT01111565|532577788|FG003|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|0|||
147659693|NCT01111565|532577789|FG004|Phase B + and Phase C (Weeks 9 to 14)|Adverse Event|0|||
147659694|NCT01111565|532577785|FG000|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|0|||
147659695|NCT01111565|532577786|FG001|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|7|||
147659696|NCT01111565|532577787|FG002|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|3|||
147249874|NCT01018186|531083794|FG001|52-week Double-blind Treatment Period|Lack of Efficacy|1|||
147449516|NCT00440947|531809507|FG002|48-Week Randomization Phase|Protocol-defined Virologic Failure|1|||
147659697|NCT01111565|532577788|FG003|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|2|||
147659698|NCT01111565|532577789|FG004|Phase B + and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|3|||
147249875|NCT01018186|531083795|FG002|52-week Double-blind Treatment Period|Lack of Efficacy|4|||
147249876|NCT01018186|531083796|FG003|52-week Double-blind Treatment Period|Lack of Efficacy|1|||
147249877|NCT01018186|531083793|FG000|52-week Double-blind Treatment Period|Protocol Violation|0|||
147249878|NCT01018186|531083794|FG001|52-week Double-blind Treatment Period|Protocol Violation|8|||
147249879|NCT01018186|531083795|FG002|52-week Double-blind Treatment Period|Protocol Violation|8|||
147249880|NCT01018186|531083796|FG003|52-week Double-blind Treatment Period|Protocol Violation|2|||
147249881|NCT01018186|531083793|FG000|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|0|||
147249882|NCT01018186|531083794|FG001|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|14|||
147249883|NCT01018186|531083795|FG002|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|16|||
147249884|NCT01018186|531083796|FG003|52-week Double-blind Treatment Period|Protocol-defined Stopping Criteria|4|||
147249885|NCT01018186|531083793|FG000|52-week Double-blind Treatment Period|Lost to Follow-up|0|||
147249886|NCT01018186|531083794|FG001|52-week Double-blind Treatment Period|Lost to Follow-up|1|||
147249887|NCT01018186|531083795|FG002|52-week Double-blind Treatment Period|Lost to Follow-up|3|||
147331200|NCT04436120|531377601|FG002|Overall Study|neither a de novo biopsy nor a research blood draw|0|||
147331201|NCT04436120|531377602|FG003|Overall Study|neither a de novo biopsy nor a research blood draw|1|||
147331202|NCT04436120|531377603|FG004|Overall Study|neither a de novo biopsy nor a research blood draw|0|||
147331203|NCT04436120|531377604|FG005|Overall Study|neither a de novo biopsy nor a research blood draw|1|||
147331204|NCT04436120|531377605|FG006|Overall Study|neither a de novo biopsy nor a research blood draw|0|||
147331205|NCT01697319|531377609|FG000|Primary Phase|Withdrawal by Subject|1|||
147331206|NCT01697319|531377609|FG000|Extension Phase|Terminated by Sponsor|15|||
147331207|NCT00604721|531377620|FG000|Overall Study|Physician Decision|1|||
147331208|NCT00604721|531377620|FG000|Overall Study|Withdrawal by Subject|1|||
147331209|NCT04776213|531377621|FG000|Overall Study|Other|1|||
147331210|NCT04776213|531377621|FG000|Overall Study|Withdrawal by Subject|7|||
147331211|NCT04776213|531377621|FG000|Overall Study|Protocol Violation|1|||
147331212|NCT04776213|531377621|FG000|Overall Study|Lost to Follow-up|2|||
147331213|NCT01838551|531377623|FG000|Overall Study|Adverse Event|16|||
147331214|NCT01838551|531377623|FG000|Overall Study|Death|1|||
147331215|NCT01838551|531377623|FG000|Overall Study|Lack of Efficacy|10|||
147331216|NCT01838551|531377623|FG000|Overall Study|Physician Decision|4|||
147331217|NCT01838551|531377623|FG000|Overall Study|Withdrawal by Subject|10|||
147331218|NCT01838551|531377623|FG000|Overall Study|No reason reported (2); surgery (2), cancer (1), sponsor request (1), bad clinical condition (1)|7|||
147331219|NCT00906282|531377624|FG000|Preoperative Chemotherapy|Withdrawal by Subject|2|||
147331220|NCT00906282|531377624|FG000|Preoperative Chemotherapy|Not surgical candidates, off study|10|||
147331221|NCT00906282|531377624|FG000|Preoperative Chemotherapy|Progressive disease|6|||
147331222|NCT00906282|531377624|FG000|Preoperative Chemotherapy|Toxicity|1|||
147331223|NCT03395353|531377625|FG000|Overall Study|Adverse Event|20|||
147331224|NCT03395353|531377625|FG000|Overall Study|Protocol Violation|1|||
147331225|NCT03395353|531377625|FG000|Overall Study|Lack of Efficacy|3|||
147596006|NCT00251641|532338767|FG000|Overall Study|Withdrawal by Subject|6|||
147596007|NCT00251641|532338768|FG001|Overall Study|Withdrawal by Subject|8|||
147596008|NCT00251641|532338767|FG000|Overall Study|Protocol Violation|10|||
147596009|NCT00251641|532338768|FG001|Overall Study|Protocol Violation|2|||
147596010|NCT00251641|532338767|FG000|Overall Study|Did not Meet protocol Eligibility|2|||
147596011|NCT00251641|532338768|FG001|Overall Study|Did not Meet protocol Eligibility|1|||
147596012|NCT00251641|532338767|FG000|Overall Study|Switched Treatment|9|||
147596013|NCT00251641|532338768|FG001|Overall Study|Switched Treatment|63|||
147596014|NCT00876018|532338769|FG000|Overall Study|Lost to Follow-up|0|||
147596015|NCT00876018|532338770|FG001|Overall Study|Lost to Follow-up|1|||
147596016|NCT00876018|532338771|FG002|Overall Study|Lost to Follow-up|1|||
147596017|NCT00876018|532338769|FG000|Overall Study|Withdrew Consent due to Adverse Event|5|||
147596018|NCT00876018|532338770|FG001|Overall Study|Withdrew Consent due to Adverse Event|4|||
147596019|NCT00876018|532338771|FG002|Overall Study|Withdrew Consent due to Adverse Event|2|||
147596020|NCT01230892|532338772|FG000|Overall Study|Withdrawal by Subject|1|||
147596021|NCT01230892|532338773|FG001|Overall Study|Withdrawal by Subject|1|||
147596022|NCT01230892|532338772|FG000|Overall Study|Lost to Follow-up|2|||
147596023|NCT01230892|532338773|FG001|Overall Study|Lost to Follow-up|0|||
147596024|NCT00679913|532338774|FG000|Overall Study|Protocol Violation|18|||
147596025|NCT00679913|532338775|FG001|Overall Study|Protocol Violation|13|||
147596026|NCT00725621|532338778|FG000|Overall Study|Adverse Event|25|||
147596027|NCT00725621|532338778|FG000|Overall Study|Lack of Efficacy|46|||
147596028|NCT00725621|532338778|FG000|Overall Study|Withdrawal by Subject|57|||
147596029|NCT00725621|532338778|FG000|Overall Study|Physician Decision|19|||
147331226|NCT03395353|531377625|FG000|Overall Study|Withdrawal by Subject|24|||
147331227|NCT03395353|531377625|FG000|Overall Study|Discontinued visit|1|||
147331228|NCT03395353|531377625|FG000|Overall Study|Refrain from visit due to COVID-19|1|||
147331229|NCT03395353|531377625|FG000|Overall Study|Physician Decision|4|||
147596030|NCT00725621|532338778|FG000|Overall Study|Lost to Follow-up|52|||
147596031|NCT00725621|532338778|FG000|Overall Study|Non-compliance|8|||
147596032|NCT00725621|532338778|FG000|Overall Study|Continued treatment by other physician|6|||
147596033|NCT00725621|532338778|FG000|Overall Study|Switched to other study|1|||
147596034|NCT00725621|532338778|FG000|Overall Study|Switched to other drug|1|||
147659699|NCT01111565|532577785|FG000|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|0|||
147659700|NCT01111565|532577786|FG001|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|0|||
147659701|NCT01111565|532577787|FG002|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|0|||
147659702|NCT01111565|532577788|FG003|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|1|||
147659703|NCT01111565|532577789|FG004|Phase B + and Phase C (Weeks 9 to 14)|Investigator Withdrew Subjects|0|||
147659704|NCT01111565|532577785|FG000|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|0|||
147659705|NCT01111565|532577786|FG001|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|0|||
147659706|NCT01111565|532577787|FG002|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|0|||
147659707|NCT01111565|532577788|FG003|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|0|||
147659708|NCT01111565|532577789|FG004|Phase B + and Phase C (Weeks 9 to 14)|Subjects Withdrew Consent|1|||
147659709|NCT02824224|532577790|FG000|Overall Study|Discontinued, IUS expulsion|0|||
147659710|NCT02824224|532577791|FG001|Overall Study|Discontinued, IUS expulsion|1|||
147659711|NCT02824224|532577790|FG000|Overall Study|Did not show up for allocation visit|2|||
147659712|NCT02824224|532577791|FG001|Overall Study|Did not show up for allocation visit|0|||
147659713|NCT02683239|532577792|FG000|Overall Study|Protocol Violation|35|||
147249888|NCT01018186|531083796|FG003|52-week Double-blind Treatment Period|Lost to Follow-up|4|||
147249889|NCT01018186|531083793|FG000|52-week Double-blind Treatment Period|Physician Decision|0|||
147249890|NCT01018186|531083794|FG001|52-week Double-blind Treatment Period|Physician Decision|1|||
147249891|NCT01018186|531083795|FG002|52-week Double-blind Treatment Period|Physician Decision|0|||
147249892|NCT01018186|531083796|FG003|52-week Double-blind Treatment Period|Physician Decision|3|||
147249893|NCT01018186|531083793|FG000|52-week Double-blind Treatment Period|Withdrawal by Subject|0|||
147249894|NCT01018186|531083794|FG001|52-week Double-blind Treatment Period|Withdrawal by Subject|10|||
147249895|NCT01018186|531083795|FG002|52-week Double-blind Treatment Period|Withdrawal by Subject|7|||
147249896|NCT01018186|531083796|FG003|52-week Double-blind Treatment Period|Withdrawal by Subject|9|||
147249897|NCT02925494|531083797|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|8|||
147659714|NCT02683239|532577793|FG001|Overall Study|Protocol Violation|23|||
147249898|NCT02925494|531083798|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|2|||
147249899|NCT02925494|531083799|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|8|||
147249900|NCT02925494|531083800|FG003|Post-Treatment Follow-Up Period|Withdrawal by Subject|23|||
147249901|NCT02925494|531083797|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|3|||
147249902|NCT02925494|531083798|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|2|||
147249903|NCT02925494|531083799|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|9|||
147249904|NCT02925494|531083800|FG003|Post-Treatment Follow-Up Period|Lost to Follow-up|10|||
147249905|NCT02925494|531083797|FG000|Post-Treatment Follow-Up Period|Other|1|||
147249906|NCT02925494|531083798|FG001|Post-Treatment Follow-Up Period|Other|4|||
147249907|NCT02925494|531083799|FG002|Post-Treatment Follow-Up Period|Other|3|||
147249908|NCT02925494|531083800|FG003|Post-Treatment Follow-Up Period|Other|6|||
147249909|NCT02925494|531083797|FG000|Post-Treatment Follow-Up Period|Required Surgery/ Invasive Intervention|1|||
147249910|NCT02925494|531083798|FG001|Post-Treatment Follow-Up Period|Required Surgery/ Invasive Intervention|2|||
147249911|NCT02925494|531083799|FG002|Post-Treatment Follow-Up Period|Required Surgery/ Invasive Intervention|2|||
147249912|NCT02925494|531083800|FG003|Post-Treatment Follow-Up Period|Required Surgery/ Invasive Intervention|6|||
147249913|NCT02925494|531083797|FG000|Post-Treatment Follow-Up Period|Pregnancy|1|||
147249914|NCT02925494|531083798|FG001|Post-Treatment Follow-Up Period|Pregnancy|0|||
147249915|NCT02925494|531083799|FG002|Post-Treatment Follow-Up Period|Pregnancy|1|||
147249916|NCT02925494|531083800|FG003|Post-Treatment Follow-Up Period|Pregnancy|2|||
147249917|NCT02925494|531083797|FG000|Post-Treatment Follow-Up Period|Non-Compliance|0|||
147249918|NCT02925494|531083798|FG001|Post-Treatment Follow-Up Period|Non-Compliance|0|||
147249919|NCT02925494|531083799|FG002|Post-Treatment Follow-Up Period|Non-Compliance|1|||
147249920|NCT02925494|531083800|FG003|Post-Treatment Follow-Up Period|Non-Compliance|2|||
147249921|NCT02925494|531083797|FG000|Post-Treatment Follow-Up Period|Adverse Event|0|||
147249922|NCT02925494|531083798|FG001|Post-Treatment Follow-Up Period|Adverse Event|0|||
147249923|NCT02925494|531083799|FG002|Post-Treatment Follow-Up Period|Adverse Event|0|||
147249924|NCT02925494|531083800|FG003|Post-Treatment Follow-Up Period|Adverse Event|1|||
147249925|NCT03334448|531083803|FG000|Washout|Personal Reason|0|||
147249926|NCT03334448|531083804|FG001|Washout|Personal Reason|1|||
147249927|NCT03334448|531083805|FG002|Washout|Personal Reason|0|||
147249928|NCT03334448|531083806|FG003|Washout|Personal Reason|0|||
147249929|NCT03334448|531083803|FG000|Washout|Protocol Violation|0|||
147249930|NCT03334448|531083804|FG001|Washout|Protocol Violation|0|||
147249931|NCT03334448|531083805|FG002|Washout|Protocol Violation|0|||
147249932|NCT03334448|531083806|FG003|Washout|Protocol Violation|1|||
147249933|NCT03235154|531083807|FG000|Overall Study|Withdrawal by Subject|1|||
147249934|NCT03235154|531083807|FG000|Overall Study|Adverse Event|1|||
147249935|NCT03235154|531083807|FG000|Overall Study|Lost to Follow-up|2|||
147249936|NCT01922089|531083812|FG000|Overall Study|Adverse Event|18|||
147249937|NCT01922089|531083813|FG001|Overall Study|Adverse Event|13|||
147249938|NCT01922089|531083812|FG000|Overall Study|Protocol Deviation|10|||
147249939|NCT01922089|531083813|FG001|Overall Study|Protocol Deviation|7|||
147449517|NCT00440947|531809508|FG003|48-Week Randomization Phase|Protocol-defined Virologic Failure|0|||
147659715|NCT02683239|532577794|FG002|Overall Study|Protocol Violation|26|||
147659716|NCT02683239|532577795|FG003|Overall Study|Protocol Violation|4|||
147659717|NCT02683239|532577796|FG004|Overall Study|Protocol Violation|35|||
147659718|NCT02683239|532577797|FG005|Overall Study|Protocol Violation|4|||
147659719|NCT02683239|532577798|FG006|Overall Study|Protocol Violation|5|||
147659720|NCT02683239|532577792|FG000|Overall Study|Adverse Event|64|||
147659721|NCT02683239|532577793|FG001|Overall Study|Adverse Event|39|||
147659722|NCT02683239|532577794|FG002|Overall Study|Adverse Event|42|||
147659723|NCT02683239|532577795|FG003|Overall Study|Adverse Event|16|||
147659724|NCT02683239|532577796|FG004|Overall Study|Adverse Event|189|||
147659725|NCT02683239|532577797|FG005|Overall Study|Adverse Event|9|||
147659726|NCT02683239|532577798|FG006|Overall Study|Adverse Event|9|||
147659727|NCT02683239|532577792|FG000|Overall Study|Physician Decision|38|||
147659728|NCT02683239|532577793|FG001|Overall Study|Physician Decision|19|||
147659729|NCT02683239|532577794|FG002|Overall Study|Physician Decision|14|||
147659730|NCT02683239|532577795|FG003|Overall Study|Physician Decision|73|||
147659731|NCT02683239|532577796|FG004|Overall Study|Physician Decision|143|||
147659732|NCT02683239|532577797|FG005|Overall Study|Physician Decision|14|||
147659733|NCT02683239|532577798|FG006|Overall Study|Physician Decision|15|||
147659734|NCT02683239|532577792|FG000|Overall Study|Withdrawal by Subject|187|||
147659735|NCT02683239|532577793|FG001|Overall Study|Withdrawal by Subject|99|||
147659736|NCT02683239|532577794|FG002|Overall Study|Withdrawal by Subject|91|||
147659737|NCT02683239|532577795|FG003|Overall Study|Withdrawal by Subject|18|||
147659738|NCT02683239|532577796|FG004|Overall Study|Withdrawal by Subject|248|||
147659739|NCT02683239|532577797|FG005|Overall Study|Withdrawal by Subject|22|||
147659740|NCT02683239|532577798|FG006|Overall Study|Withdrawal by Subject|28|||
147659741|NCT02683239|532577792|FG000|Overall Study|Lost to Follow-up|77|||
147659742|NCT02683239|532577793|FG001|Overall Study|Lost to Follow-up|24|||
147659743|NCT02683239|532577794|FG002|Overall Study|Lost to Follow-up|25|||
147659744|NCT02683239|532577795|FG003|Overall Study|Lost to Follow-up|7|||
147659745|NCT02683239|532577796|FG004|Overall Study|Lost to Follow-up|88|||
147659746|NCT02683239|532577797|FG005|Overall Study|Lost to Follow-up|8|||
147659747|NCT02683239|532577798|FG006|Overall Study|Lost to Follow-up|11|||
147659748|NCT02683239|532577792|FG000|Overall Study|Death|9|||
147659749|NCT02683239|532577793|FG001|Overall Study|Death|5|||
147659750|NCT02683239|532577794|FG002|Overall Study|Death|8|||
147659751|NCT02683239|532577795|FG003|Overall Study|Death|0|||
147659752|NCT02683239|532577796|FG004|Overall Study|Death|12|||
147659753|NCT02683239|532577797|FG005|Overall Study|Death|1|||
147659754|NCT02683239|532577798|FG006|Overall Study|Death|0|||
147659755|NCT02683239|532577792|FG000|Overall Study|Lack of Efficacy|50|||
147659756|NCT02683239|532577793|FG001|Overall Study|Lack of Efficacy|23|||
147659757|NCT02683239|532577794|FG002|Overall Study|Lack of Efficacy|12|||
147659758|NCT02683239|532577795|FG003|Overall Study|Lack of Efficacy|2|||
147659759|NCT02683239|532577796|FG004|Overall Study|Lack of Efficacy|29|||
147659760|NCT02683239|532577797|FG005|Overall Study|Lack of Efficacy|2|||
147659761|NCT02683239|532577798|FG006|Overall Study|Lack of Efficacy|3|||
147659762|NCT02683239|532577792|FG000|Overall Study|Missing data|0|||
147659763|NCT02683239|532577793|FG001|Overall Study|Missing data|1|||
147659764|NCT02683239|532577794|FG002|Overall Study|Missing data|1|||
147659765|NCT02683239|532577795|FG003|Overall Study|Missing data|0|||
147659766|NCT02683239|532577796|FG004|Overall Study|Missing data|1|||
147659767|NCT02683239|532577797|FG005|Overall Study|Missing data|0|||
147659768|NCT02683239|532577798|FG006|Overall Study|Missing data|0|||
147659769|NCT00368108|532577801|FG000|Overall Study|Adverse Event|38|||
147659770|NCT00368108|532577802|FG001|Overall Study|Adverse Event|26|||
147659771|NCT00368108|532577803|FG002|Overall Study|Adverse Event|44|||
147659772|NCT00368108|532577801|FG000|Overall Study|Abnormal Laboratory Value|0|||
147659773|NCT00368108|532577802|FG001|Overall Study|Abnormal Laboratory Value|0|||
147449518|NCT00440947|531809509|FG004|48-Week Randomization Phase|Protocol-defined Virologic Failure|0|||
147449519|NCT00440947|531809505|FG000|48-Week Randomization Phase|Non-compliance|0|||
147449520|NCT00440947|531809506|FG001|48-Week Randomization Phase|Non-compliance|3|||
147449521|NCT00440947|531809507|FG002|48-Week Randomization Phase|Non-compliance|4|||
147449522|NCT00440947|531809508|FG003|48-Week Randomization Phase|Non-compliance|0|||
147449523|NCT00440947|531809509|FG004|48-Week Randomization Phase|Non-compliance|0|||
147449524|NCT00440947|531809505|FG000|48-Week Randomization Phase|Lost to Follow-up|0|||
147449525|NCT00440947|531809506|FG001|48-Week Randomization Phase|Lost to Follow-up|2|||
147449526|NCT00440947|531809507|FG002|48-Week Randomization Phase|Lost to Follow-up|8|||
147449527|NCT00440947|531809508|FG003|48-Week Randomization Phase|Lost to Follow-up|0|||
147449528|NCT00440947|531809509|FG004|48-Week Randomization Phase|Lost to Follow-up|0|||
147659774|NCT00368108|532577803|FG002|Overall Study|Abnormal Laboratory Value|3|||
147659775|NCT00368108|532577801|FG000|Overall Study|Protocol Violation|5|||
147659776|NCT00368108|532577802|FG001|Overall Study|Protocol Violation|9|||
147659777|NCT00368108|532577803|FG002|Overall Study|Protocol Violation|9|||
147659778|NCT00368108|532577801|FG000|Overall Study|Withdrawal by Subject|9|||
147659779|NCT00368108|532577802|FG001|Overall Study|Withdrawal by Subject|3|||
147659780|NCT00368108|532577803|FG002|Overall Study|Withdrawal by Subject|5|||
147659781|NCT00368108|532577801|FG000|Overall Study|Lack of Efficacy|7|||
147659782|NCT00368108|532577802|FG001|Overall Study|Lack of Efficacy|8|||
147659783|NCT00368108|532577803|FG002|Overall Study|Lack of Efficacy|5|||
147659784|NCT00368108|532577801|FG000|Overall Study|Physician Decision|2|||
147659785|NCT00368108|532577802|FG001|Overall Study|Physician Decision|0|||
147659786|NCT00368108|532577803|FG002|Overall Study|Physician Decision|1|||
147659787|NCT00368108|532577801|FG000|Overall Study|Other|3|||
147659788|NCT00368108|532577802|FG001|Overall Study|Other|7|||
147659789|NCT00368108|532577803|FG002|Overall Study|Other|1|||
147659790|NCT04131712|532577804|FG000|Overall Study|COVID related|0|||
147659791|NCT04131712|532577805|FG001|Overall Study|COVID related|0|||
147659792|NCT04131712|532577806|FG002|Overall Study|COVID related|2|||
147659793|NCT04131712|532577807|FG003|Overall Study|COVID related|0|||
147659794|NCT04131712|532577804|FG000|Overall Study|PI withdrawal, subject could not follow study schedule|0|||
147659795|NCT04131712|532577805|FG001|Overall Study|PI withdrawal, subject could not follow study schedule|0|||
147659796|NCT04131712|532577806|FG002|Overall Study|PI withdrawal, subject could not follow study schedule|1|||
147659797|NCT04131712|532577807|FG003|Overall Study|PI withdrawal, subject could not follow study schedule|0|||
147659798|NCT02299388|532577812|FG000|Overall Study|Withdrawal by Subject|0|||
147659799|NCT02299388|532577813|FG001|Overall Study|Withdrawal by Subject|1|||
147659800|NCT04613739|532577814|FG000|Overall Study|Lost to Follow-up|6|||
147659801|NCT04613739|532577815|FG001|Overall Study|Lost to Follow-up|9|||
147659802|NCT04613739|532577814|FG000|Overall Study|potentially duplicative/fraudulent|1|||
147659803|NCT04613739|532577815|FG001|Overall Study|potentially duplicative/fraudulent|3|||
147659804|NCT00003537|532577816|FG000|Overall Study|Not evalauable|1|||
147659805|NCT01051557|532577817|FG000|Overall Study|Physician Decision|1|||
147659806|NCT01051557|532577818|FG001|Overall Study|Physician Decision|0|||
147659807|NCT01051557|532577819|FG002|Overall Study|Physician Decision|0|||
147659808|NCT01051557|532577820|FG003|Overall Study|Physician Decision|0|||
147659809|NCT01051557|532577821|FG004|Overall Study|Physician Decision|0|||
147659810|NCT01051557|532577822|FG005|Overall Study|Physician Decision|0|||
147659811|NCT01051557|532577823|FG006|Overall Study|Physician Decision|0|||
147659812|NCT01051557|532577817|FG000|Overall Study|disease progression|3|||
147659813|NCT01051557|532577818|FG001|Overall Study|disease progression|3|||
147659814|NCT01051557|532577819|FG002|Overall Study|disease progression|5|||
147659815|NCT01051557|532577820|FG003|Overall Study|disease progression|2|||
147659816|NCT01051557|532577821|FG004|Overall Study|disease progression|4|||
147659817|NCT01051557|532577822|FG005|Overall Study|disease progression|3|||
147659818|NCT01051557|532577823|FG006|Overall Study|disease progression|1|||
147659819|NCT01051557|532577817|FG000|Overall Study|Withdrawal by Subject|0|||
147659820|NCT01051557|532577818|FG001|Overall Study|Withdrawal by Subject|0|||
147659821|NCT01051557|532577819|FG002|Overall Study|Withdrawal by Subject|1|||
147659822|NCT01051557|532577820|FG003|Overall Study|Withdrawal by Subject|0|||
147659823|NCT01051557|532577821|FG004|Overall Study|Withdrawal by Subject|2|||
147659824|NCT01051557|532577822|FG005|Overall Study|Withdrawal by Subject|0|||
147659825|NCT01051557|532577823|FG006|Overall Study|Withdrawal by Subject|1|||
147659826|NCT01051557|532577817|FG000|Overall Study|Adverse Event|0|||
147659827|NCT01051557|532577818|FG001|Overall Study|Adverse Event|0|||
147659828|NCT01051557|532577819|FG002|Overall Study|Adverse Event|0|||
147659829|NCT01051557|532577820|FG003|Overall Study|Adverse Event|1|||
147659830|NCT01051557|532577821|FG004|Overall Study|Adverse Event|1|||
147659831|NCT01051557|532577822|FG005|Overall Study|Adverse Event|3|||
147659832|NCT01051557|532577823|FG006|Overall Study|Adverse Event|4|||
147659833|NCT00130689|532577825|FG000|Overall Study|Progressive Disease|29|||
147659834|NCT00130689|532577825|FG000|Overall Study|Death|1|||
147659835|NCT00130689|532577825|FG000|Overall Study|Clinical Deterioration|4|||
147659836|NCT00130689|532577825|FG000|Overall Study|Withdrawal by Subject|3|||
147659837|NCT00130689|532577825|FG000|Overall Study|Ineligible|6|||
147659838|NCT00766597|532577826|FG000|Overall Study|Unexpected closure of study|4|||
147659839|NCT00766597|532577826|FG000|Overall Study|Without CCR5-tropic virus|5|||
147659840|NCT00943397|532577827|FG000|Overall Study|Adverse Event|0|||
147659841|NCT00943397|532577828|FG001|Overall Study|Adverse Event|6|||
147659842|NCT00943397|532577827|FG000|Overall Study|Lost to Follow-up|0|||
147659843|NCT00943397|532577828|FG001|Overall Study|Lost to Follow-up|4|||
147659844|NCT00943397|532577827|FG000|Overall Study|Protocol Violation|2|||
147659845|NCT00943397|532577828|FG001|Overall Study|Protocol Violation|5|||
147659846|NCT00943397|532577827|FG000|Overall Study|Withdrawal by Subject|1|||
147659847|NCT00943397|532577828|FG001|Overall Study|Withdrawal by Subject|1|||
147659848|NCT00943397|532577827|FG000|Overall Study|Site terminated and other|12|||
147659849|NCT00943397|532577828|FG001|Overall Study|Site terminated and other|56|||
147659850|NCT01254656|532577829|FG000|Overall Study|Discontinued due to termination of study|40|||
147659851|NCT01254656|532577830|FG001|Overall Study|Discontinued due to termination of study|39|||
147659852|NCT01254656|532577831|FG002|Overall Study|Discontinued due to termination of study|13|||
147659853|NCT01254656|532577829|FG000|Overall Study|Lack of Efficacy|3|||
147659854|NCT01254656|532577830|FG001|Overall Study|Lack of Efficacy|0|||
147659855|NCT01254656|532577831|FG002|Overall Study|Lack of Efficacy|0|||
147659856|NCT01254656|532577829|FG000|Overall Study|Lost to Follow-up|1|||
147659857|NCT01254656|532577830|FG001|Overall Study|Lost to Follow-up|0|||
147659858|NCT01254656|532577831|FG002|Overall Study|Lost to Follow-up|2|||
147659859|NCT01254656|532577829|FG000|Overall Study|Withdrawal by Subject|2|||
147659860|NCT01254656|532577830|FG001|Overall Study|Withdrawal by Subject|2|||
147659861|NCT01254656|532577831|FG002|Overall Study|Withdrawal by Subject|1|||
147659862|NCT01254656|532577829|FG000|Overall Study|Pregnancy|0|||
147659863|NCT01254656|532577830|FG001|Overall Study|Pregnancy|0|||
147659864|NCT01254656|532577831|FG002|Overall Study|Pregnancy|2|||
147659865|NCT01254656|532577829|FG000|Overall Study|Adverse Event|1|||
147659866|NCT01254656|532577830|FG001|Overall Study|Adverse Event|1|||
147659867|NCT01254656|532577831|FG002|Overall Study|Adverse Event|0|||
147659868|NCT01254656|532577829|FG000|Overall Study|Death|0|||
147659869|NCT01254656|532577830|FG001|Overall Study|Death|1|||
147659870|NCT01254656|532577831|FG002|Overall Study|Death|0|||
147659871|NCT01178125|532577832|FG000|Overall Study|Lost to Follow-up|397|||
147659872|NCT01178125|532577832|FG000|Overall Study|Adverse Event|244|||
147659873|NCT01178125|532577832|FG000|Overall Study|Withdrawal by Subject|209|||
147659874|NCT01178125|532577832|FG000|Overall Study|Noncompliance|184|||
147659875|NCT01178125|532577832|FG000|Overall Study|Pregnancy|55|||
147659876|NCT01178125|532577832|FG000|Overall Study|Other Reason|39|||
147659877|NCT01178125|532577832|FG000|Overall Study|Sponsor Decision|28|||
147659878|NCT01178125|532577832|FG000|Overall Study|Protocol Violation|17|||
147659879|NCT01178125|532577832|FG000|Overall Study|Investigator Decision|5|||
147659880|NCT02948829|532577833|FG000|Overall Study|Lost to Follow-up|2|||
147659881|NCT02948829|532577833|FG000|Overall Study|Withdrawal by Subject and/or Subject's Parent(s)/ Legally Authorized Representative (LAR)|5|||
147659882|NCT02948829|532577833|FG000|Overall Study|Pregnancy|1|||
147659883|NCT02948829|532577833|FG000|Overall Study|Other: Reason not Specified|8|||
147659884|NCT01004978|532577834|FG000|Overall Study|Disease progression|31|||
147659885|NCT01004978|532577835|FG001|Overall Study|Disease progression|48|||
147659886|NCT01004978|532577834|FG000|Overall Study|Adverse Event|42|||
147659887|NCT01004978|532577835|FG001|Overall Study|Adverse Event|22|||
147659888|NCT01004978|532577834|FG000|Overall Study|Death|3|||
147659889|NCT01004978|532577835|FG001|Overall Study|Death|2|||
147659890|NCT01004978|532577834|FG000|Overall Study|Withdrawal by Subject|16|||
147659891|NCT01004978|532577835|FG001|Overall Study|Withdrawal by Subject|16|||
147659892|NCT01004978|532577834|FG000|Overall Study|Alternative therapy|4|||
147659893|NCT01004978|532577835|FG001|Overall Study|Alternative therapy|8|||
147659894|NCT01004978|532577834|FG000|Overall Study|Physician Decision|6|||
147659895|NCT01004978|532577835|FG001|Overall Study|Physician Decision|3|||
147659896|NCT01004978|532577834|FG000|Overall Study|Other complicating disease|2|||
147659897|NCT01004978|532577835|FG001|Overall Study|Other complicating disease|2|||
147659898|NCT01004978|532577834|FG000|Overall Study|Protocol Violation|2|||
147659899|NCT01004978|532577835|FG001|Overall Study|Protocol Violation|3|||
147659900|NCT01004978|532577834|FG000|Overall Study|Non-compliance|3|||
147659901|NCT01004978|532577835|FG001|Overall Study|Non-compliance|2|||
147659902|NCT01004978|532577834|FG000|Overall Study|Ineligible|1|||
147659903|NCT01004978|532577835|FG001|Overall Study|Ineligible|0|||
147659904|NCT01004978|532577834|FG000|Overall Study|Unblinded|0|||
147659905|NCT01004978|532577835|FG001|Overall Study|Unblinded|1|||
147659906|NCT01004978|532577834|FG000|Overall Study|Performance status worsening|0|||
147659907|NCT01004978|532577835|FG001|Overall Study|Performance status worsening|1|||
147659908|NCT01004978|532577834|FG000|Overall Study|Never started treatment|8|||
147659909|NCT01004978|532577835|FG001|Overall Study|Never started treatment|9|||
147659910|NCT00369915|532577836|FG000|Overall Study|expected side effects|2|||
147659911|NCT00369915|532577837|FG001|Overall Study|expected side effects|1|||
147659912|NCT00369915|532577836|FG000|Overall Study|Withdrawal by Subject|4|||
147659913|NCT00369915|532577837|FG001|Overall Study|Withdrawal by Subject|1|||
147659914|NCT00369915|532577836|FG000|Overall Study|W/drawl by investigators|0|||
147659915|NCT00369915|532577837|FG001|Overall Study|W/drawl by investigators|1|||
147659916|NCT01447407|532577860|FG000|Overall Study|Withdrawal by Subject|2|||
147659917|NCT01447407|532577861|FG001|Overall Study|Withdrawal by Subject|0|||
147331230|NCT03395353|531377625|FG000|Overall Study|Early termination of overall study|33|||
147331231|NCT02013037|531377626|FG000|Overall Study|Death|6|||
147331232|NCT02013037|531377626|FG000|Overall Study|Withdrawal by Subject|1|||
147331233|NCT02013037|531377626|FG000|Overall Study|Awaiting Transplantation|7|||
147331234|NCT02013037|531377626|FG000|Overall Study|Transplanted without DSA|2|||
147331235|NCT00726596|531379115|FG000|Overall Study|Adverse Event|2|||
147331236|NCT00726596|531379116|FG001|Overall Study|Adverse Event|1|||
147659918|NCT01447407|532577862|FG002|Overall Study|Withdrawal by Subject|0|||
147659919|NCT01447407|532577863|FG003|Overall Study|Withdrawal by Subject|1|||
147659920|NCT01447407|532577860|FG000|Overall Study|Physician Decision|0|||
147659921|NCT01447407|532577861|FG001|Overall Study|Physician Decision|0|||
147659922|NCT01447407|532577862|FG002|Overall Study|Physician Decision|1|||
147659923|NCT01447407|532577863|FG003|Overall Study|Physician Decision|1|||
147659924|NCT01348139|532577866|FG000|Period 1|Adverse Event|1|||
147659925|NCT01348139|532577867|FG001|Period 1|Adverse Event|0|||
147659926|NCT01348139|532577868|FG002|Period 1|Adverse Event|0|||
147659927|NCT01348139|532577869|FG003|Period 1|Adverse Event|0|||
147659928|NCT01348139|532577870|FG004|Period 1|Adverse Event|0|||
147659929|NCT01348139|532577871|FG005|Period 1|Adverse Event|0|||
147659930|NCT02762084|532577872|FG000|Overall Study|Withdrawal by Subject|1|||
147659931|NCT02762084|532577873|FG001|Overall Study|Withdrawal by Subject|0|||
147659932|NCT02762084|532577874|FG002|Overall Study|Withdrawal by Subject|0|||
147331237|NCT00726596|531379115|FG000|Overall Study|Withdrawal by Subject|3|||
147331238|NCT00726596|531379116|FG001|Overall Study|Withdrawal by Subject|3|||
147449529|NCT00440947|531809505|FG000|48-Week Randomization Phase|Protocol Violation|0|||
147449530|NCT00440947|531809506|FG001|48-Week Randomization Phase|Protocol Violation|0|||
147449531|NCT00440947|531809507|FG002|48-Week Randomization Phase|Protocol Violation|1|||
147449532|NCT00440947|531809508|FG003|48-Week Randomization Phase|Protocol Violation|0|||
147449533|NCT00440947|531809509|FG004|48-Week Randomization Phase|Protocol Violation|0|||
147449534|NCT00440947|531809505|FG000|48-Week Randomization Phase|Withdrawal by Subject|0|||
147449535|NCT00440947|531809506|FG001|48-Week Randomization Phase|Withdrawal by Subject|2|||
147449536|NCT00440947|531809507|FG002|48-Week Randomization Phase|Withdrawal by Subject|4|||
147449537|NCT00440947|531809508|FG003|48-Week Randomization Phase|Withdrawal by Subject|0|||
147449538|NCT00440947|531809509|FG004|48-Week Randomization Phase|Withdrawal by Subject|0|||
147449539|NCT00440947|531809505|FG000|48-Week Randomization Phase|Pregnancy|0|||
147449540|NCT00440947|531809506|FG001|48-Week Randomization Phase|Pregnancy|0|||
147449541|NCT00440947|531809507|FG002|48-Week Randomization Phase|Pregnancy|1|||
147449542|NCT00440947|531809508|FG003|48-Week Randomization Phase|Pregnancy|0|||
147449543|NCT00440947|531809509|FG004|48-Week Randomization Phase|Pregnancy|0|||
147449544|NCT00440947|531809505|FG000|48-Week Randomization Phase|Incarceration|0|||
147449545|NCT00440947|531809506|FG001|48-Week Randomization Phase|Incarceration|3|||
147449546|NCT00440947|531809507|FG002|48-Week Randomization Phase|Incarceration|0|||
147449547|NCT00440947|531809508|FG003|48-Week Randomization Phase|Incarceration|0|||
147449548|NCT00440947|531809509|FG004|48-Week Randomization Phase|Incarceration|0|||
147449549|NCT00440947|531809505|FG000|48-Week Randomization Phase|Trying to Get Pregnant|0|||
147449550|NCT00440947|531809506|FG001|48-Week Randomization Phase|Trying to Get Pregnant|1|||
147449551|NCT00440947|531809507|FG002|48-Week Randomization Phase|Trying to Get Pregnant|0|||
147449552|NCT00440947|531809508|FG003|48-Week Randomization Phase|Trying to Get Pregnant|0|||
147449553|NCT00440947|531809509|FG004|48-Week Randomization Phase|Trying to Get Pregnant|0|||
147449554|NCT00440947|531809505|FG000|48-Week Randomization Phase|Physician Decision|0|||
147449555|NCT00440947|531809506|FG001|48-Week Randomization Phase|Physician Decision|2|||
147449556|NCT00440947|531809507|FG002|48-Week Randomization Phase|Physician Decision|0|||
147449557|NCT00440947|531809508|FG003|48-Week Randomization Phase|Physician Decision|0|||
147449558|NCT00440947|531809509|FG004|48-Week Randomization Phase|Physician Decision|0|||
147449559|NCT00440947|531809505|FG000|Optional 60-Week Extension Phase|Adverse Event|0|||
147449560|NCT00440947|531809506|FG001|Optional 60-Week Extension Phase|Adverse Event|0|||
147449561|NCT00440947|531809507|FG002|Optional 60-Week Extension Phase|Adverse Event|0|||
147449562|NCT00440947|531809508|FG003|Optional 60-Week Extension Phase|Adverse Event|1|||
147449563|NCT00440947|531809509|FG004|Optional 60-Week Extension Phase|Adverse Event|3|||
147449564|NCT00440947|531809505|FG000|Optional 60-Week Extension Phase|Insufficient Viral Load Response|0|||
147449565|NCT00440947|531809506|FG001|Optional 60-Week Extension Phase|Insufficient Viral Load Response|0|||
147449566|NCT00440947|531809507|FG002|Optional 60-Week Extension Phase|Insufficient Viral Load Response|0|||
147449567|NCT00440947|531809508|FG003|Optional 60-Week Extension Phase|Insufficient Viral Load Response|1|||
147449568|NCT00440947|531809509|FG004|Optional 60-Week Extension Phase|Insufficient Viral Load Response|1|||
147449569|NCT00440947|531809505|FG000|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|0|||
147449570|NCT00440947|531809506|FG001|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|0|||
147449571|NCT00440947|531809507|FG002|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|0|||
147449572|NCT00440947|531809508|FG003|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|3|||
147449573|NCT00440947|531809509|FG004|Optional 60-Week Extension Phase|Protocol-defined Virologic Failure|2|||
147449574|NCT00440947|531809505|FG000|Optional 60-Week Extension Phase|Non-compliance|0|||
147596035|NCT00725621|532338778|FG000|Overall Study|Prepared for elective surgery|1|||
147596036|NCT00725621|532338778|FG000|Overall Study|Reason not specified|55|||
147596037|NCT01189500|532338779|FG000|Period 1: TAMOX Alone|Adverse Event|1|||
147596038|NCT01189500|532338779|FG000|Period 2: Coadministration TAMOX+DVS SR|Withdrawal by Subject|1|||
147596039|NCT01000493|532338780|FG000|Overall Study|Adverse Event|3|||
147596040|NCT01000493|532338781|FG001|Overall Study|Adverse Event|6|||
147596041|NCT01000493|532338780|FG000|Overall Study|Lack of Efficacy|1|||
147596042|NCT01000493|532338781|FG001|Overall Study|Lack of Efficacy|1|||
147596043|NCT01000493|532338780|FG000|Overall Study|Protocol Violation|1|||
147249940|NCT01922089|531083812|FG000|Overall Study|Withdrawal by Subject|3|||
147249941|NCT01922089|531083813|FG001|Overall Study|Withdrawal by Subject|4|||
147249942|NCT01922089|531083812|FG000|Overall Study|administrative problems|4|||
147249943|NCT01922089|531083813|FG001|Overall Study|administrative problems|1|||
147249944|NCT01922089|531083812|FG000|Overall Study|Physician Decision|2|||
147249945|NCT01922089|531083813|FG001|Overall Study|Physician Decision|3|||
147249946|NCT01922089|531083812|FG000|Overall Study|Death|2|||
147249947|NCT01922089|531083813|FG001|Overall Study|Death|1|||
147249948|NCT01922089|531083812|FG000|Overall Study|Lost to Follow-up|0|||
147249949|NCT01922089|531083813|FG001|Overall Study|Lost to Follow-up|1|||
147249950|NCT02496611|531083817|FG000|Overall Study|Lost to Follow-up|2|||
147249951|NCT02496611|531083818|FG001|Overall Study|Lost to Follow-up|1|||
147249952|NCT02496611|531083817|FG000|Overall Study|Withdrawal by Subject|5|||
147249953|NCT02496611|531083818|FG001|Overall Study|Withdrawal by Subject|2|||
147659933|NCT02762084|532577872|FG000|Overall Study|Adverse Event|0|||
147659934|NCT02762084|532577873|FG001|Overall Study|Adverse Event|0|||
147659935|NCT02762084|532577874|FG002|Overall Study|Adverse Event|1|||
147659936|NCT02254772|532577877|FG000|Overall Study|Ineligible|1|||
147659937|NCT02254772|532577877|FG000|Overall Study|Withdrawal by Subject|1|||
147659938|NCT01765296|532577878|FG000|Overall Study|Protocol Violation|0|||
147659939|NCT01765296|532577879|FG001|Overall Study|Protocol Violation|5|||
147659940|NCT01765296|532577880|FG002|Overall Study|Protocol Violation|4|||
147659941|NCT01765296|532577878|FG000|Overall Study|Withdrawal by Subject|4|||
147659942|NCT01765296|532577879|FG001|Overall Study|Withdrawal by Subject|2|||
147659943|NCT01765296|532577880|FG002|Overall Study|Withdrawal by Subject|2|||
147659944|NCT01765296|532577878|FG000|Overall Study|Adverse Event|1|||
147659945|NCT01765296|532577879|FG001|Overall Study|Adverse Event|13|||
147659946|NCT01765296|532577880|FG002|Overall Study|Adverse Event|5|||
147659947|NCT01765296|532577878|FG000|Overall Study|Lack of Efficacy|0|||
147659948|NCT01765296|532577879|FG001|Overall Study|Lack of Efficacy|0|||
147659949|NCT01765296|532577880|FG002|Overall Study|Lack of Efficacy|2|||
147659950|NCT01619852|532577881|FG000|24 Hour Assessment|Withdrawal by Subject|1|||
147659951|NCT01619852|532577882|FG001|24 Hour Assessment|Withdrawal by Subject|1|||
147659952|NCT01619852|532577881|FG000|3 Month Follow up|Lost to Follow-up|31|||
147659953|NCT01619852|532577882|FG001|3 Month Follow up|Lost to Follow-up|34|||
147659954|NCT04556760|532577883|FG000|Treatment Period 1 (72 Hours)|Withdrawal by Subject|0|||
147659955|NCT04556760|532577884|FG001|Treatment Period 1 (72 Hours)|Withdrawal by Subject|1|||
147659956|NCT04556760|532577885|FG002|Treatment Period 1 (72 Hours)|Withdrawal by Subject|0|||
147659957|NCT04556760|532577886|FG003|Treatment Period 1 (72 Hours)|Withdrawal by Subject|0|||
147659958|NCT04556760|532577887|FG004|Treatment Period 1 (72 Hours)|Withdrawal by Subject|0|||
147449575|NCT00440947|531809506|FG001|Optional 60-Week Extension Phase|Non-compliance|0|||
147449576|NCT00440947|531809507|FG002|Optional 60-Week Extension Phase|Non-compliance|0|||
147659959|NCT04556760|532577888|FG005|Treatment Period 1 (72 Hours)|Withdrawal by Subject|0|||
147659960|NCT04556760|532577883|FG000|Treatment Period 1 (72 Hours)|Positive SARS-CoV-2 rapid test for patient's daughter|0|||
147659961|NCT04556760|532577884|FG001|Treatment Period 1 (72 Hours)|Positive SARS-CoV-2 rapid test for patient's daughter|0|||
147659962|NCT04556760|532577885|FG002|Treatment Period 1 (72 Hours)|Positive SARS-CoV-2 rapid test for patient's daughter|0|||
147659963|NCT04556760|532577886|FG003|Treatment Period 1 (72 Hours)|Positive SARS-CoV-2 rapid test for patient's daughter|1|||
147659964|NCT04556760|532577887|FG004|Treatment Period 1 (72 Hours)|Positive SARS-CoV-2 rapid test for patient's daughter|0|||
147659965|NCT04556760|532577888|FG005|Treatment Period 1 (72 Hours)|Positive SARS-CoV-2 rapid test for patient's daughter|0|||
147659966|NCT03075267|532577894|FG000|Overall Study|Protocol Violation|1|||
147659967|NCT03075267|532577895|FG001|Overall Study|Protocol Violation|0|||
147659968|NCT03075267|532577896|FG002|Overall Study|Protocol Violation|0|||
147659969|NCT02168491|532577897|FG000|Overall Study|Withdrawal by Subject|1|||
147659970|NCT00809445|532577898|FG000|1 Month Follow-up|Lost contact|1|||
147659971|NCT00809445|532577899|FG001|1 Month Follow-up|Lost contact|2|||
147659972|NCT00809445|532577900|FG002|1 Month Follow-up|Lost contact|1|||
147449577|NCT00440947|531809508|FG003|Optional 60-Week Extension Phase|Non-compliance|1|||
147449578|NCT00440947|531809509|FG004|Optional 60-Week Extension Phase|Non-compliance|1|||
147449579|NCT00440947|531809505|FG000|Optional 60-Week Extension Phase|Lost to Follow-up|0|||
147449580|NCT00440947|531809506|FG001|Optional 60-Week Extension Phase|Lost to Follow-up|0|||
147449581|NCT00440947|531809507|FG002|Optional 60-Week Extension Phase|Lost to Follow-up|0|||
147449582|NCT00440947|531809508|FG003|Optional 60-Week Extension Phase|Lost to Follow-up|9|||
147449583|NCT00440947|531809509|FG004|Optional 60-Week Extension Phase|Lost to Follow-up|9|||
147449584|NCT00440947|531809505|FG000|Optional 60-Week Extension Phase|Protocol Violation|0|||
147449585|NCT00440947|531809506|FG001|Optional 60-Week Extension Phase|Protocol Violation|0|||
147449586|NCT00440947|531809507|FG002|Optional 60-Week Extension Phase|Protocol Violation|0|||
147449587|NCT00440947|531809508|FG003|Optional 60-Week Extension Phase|Protocol Violation|1|||
147449588|NCT00440947|531809509|FG004|Optional 60-Week Extension Phase|Protocol Violation|0|||
147449589|NCT00440947|531809505|FG000|Optional 60-Week Extension Phase|Withdrawal by Subject|0|||
147449590|NCT00440947|531809506|FG001|Optional 60-Week Extension Phase|Withdrawal by Subject|0|||
147449591|NCT00440947|531809507|FG002|Optional 60-Week Extension Phase|Withdrawal by Subject|0|||
147449592|NCT00440947|531809508|FG003|Optional 60-Week Extension Phase|Withdrawal by Subject|4|||
147449593|NCT00440947|531809509|FG004|Optional 60-Week Extension Phase|Withdrawal by Subject|3|||
147659973|NCT00809445|532577898|FG000|1 Month Follow-up|Withdrew consent|1|||
147659974|NCT00809445|532577899|FG001|1 Month Follow-up|Withdrew consent|1|||
147659975|NCT00809445|532577900|FG002|1 Month Follow-up|Withdrew consent|1|||
147659976|NCT00809445|532577898|FG000|1 Month Follow-up|Death|0|||
147659977|NCT00809445|532577899|FG001|1 Month Follow-up|Death|1|||
147659978|NCT00809445|532577900|FG002|1 Month Follow-up|Death|1|||
147659979|NCT00809445|532577898|FG000|1 Month Follow-up|Incarcerated|0|||
147449594|NCT00440947|531809505|FG000|Optional 60-Week Extension Phase|Pregnancy|0|||
147449595|NCT00440947|531809506|FG001|Optional 60-Week Extension Phase|Pregnancy|0|||
147449596|NCT00440947|531809507|FG002|Optional 60-Week Extension Phase|Pregnancy|0|||
147449597|NCT00440947|531809508|FG003|Optional 60-Week Extension Phase|Pregnancy|3|||
147449598|NCT00440947|531809509|FG004|Optional 60-Week Extension Phase|Pregnancy|0|||
147331239|NCT00357396|531379120|FG000|Overall Study|Adverse Event|1|||
147331240|NCT00357396|531379121|FG001|Overall Study|Adverse Event|0|||
147331241|NCT02488980|531379123|FG000|Overall Study|Protocol Violation|2|||
147331242|NCT02488980|531379124|FG001|Overall Study|Protocol Violation|2|||
147331243|NCT02488980|531379125|FG002|Overall Study|Protocol Violation|2|||
147331244|NCT05174013|531379126|FG000|Overall Study|Lost to Follow-up|0|||
147331245|NCT05174013|531379127|FG001|Overall Study|Lost to Follow-up|0|||
147331246|NCT05174013|531379128|FG002|Overall Study|Lost to Follow-up|0|||
147596044|NCT01000493|532338781|FG001|Overall Study|Protocol Violation|8|||
147596045|NCT01000493|532338780|FG000|Overall Study|Study closed/terminated|25|||
147596046|NCT01000493|532338781|FG001|Overall Study|Study closed/terminated|23|||
147596047|NCT01000493|532338780|FG000|Overall Study|Lost to Follow-up|5|||
147596048|NCT01000493|532338781|FG001|Overall Study|Lost to Follow-up|9|||
147596049|NCT01000493|532338780|FG000|Overall Study|Physician Decision|1|||
147596050|NCT01000493|532338781|FG001|Overall Study|Physician Decision|1|||
147596051|NCT01000493|532338780|FG000|Overall Study|Withdrawal by Subject|3|||
147596052|NCT01000493|532338781|FG001|Overall Study|Withdrawal by Subject|7|||
147596053|NCT00456495|532338782|FG000|Overall Study|Physician Decision|2|||
147596054|NCT01346774|532338783|FG000|Overall Study|Did not take a single dose|6|||
147596055|NCT01346774|532338784|FG001|Overall Study|Did not take a single dose|4|||
147596056|NCT01346774|532338783|FG000|Overall Study|Lost to Follow-up|3|||
147596057|NCT01346774|532338784|FG001|Overall Study|Lost to Follow-up|4|||
147596058|NCT01346774|532338783|FG000|Overall Study|Withdrawal by Subject|1|||
147596059|NCT01346774|532338784|FG001|Overall Study|Withdrawal by Subject|4|||
147596060|NCT01346774|532338783|FG000|Overall Study|Protocol Violation|2|||
147596061|NCT01346774|532338784|FG001|Overall Study|Protocol Violation|3|||
147596062|NCT01346774|532338783|FG000|Overall Study|Adverse Event|1|||
147596063|NCT01346774|532338784|FG001|Overall Study|Adverse Event|2|||
147596064|NCT00609466|532338792|FG000|Overall Study|Withdrawal by Subject|0|||
147596065|NCT00609466|532338793|FG001|Overall Study|Withdrawal by Subject|1|||
147596066|NCT00609466|532338794|FG002|Overall Study|Withdrawal by Subject|1|||
147596067|NCT00609466|532338792|FG000|Overall Study|Adverse Event|2|||
147596068|NCT00609466|532338793|FG001|Overall Study|Adverse Event|3|||
147596069|NCT00609466|532338794|FG002|Overall Study|Adverse Event|1|||
147596070|NCT00609466|532338792|FG000|Overall Study|Lack of Efficacy|0|||
147596071|NCT00609466|532338793|FG001|Overall Study|Lack of Efficacy|2|||
147596072|NCT00609466|532338794|FG002|Overall Study|Lack of Efficacy|2|||
147596073|NCT03510182|532338795|FG000|Overall Study|Withdrawal by Subject|2|||
147596074|NCT01334710|532338802|FG000|Overall Study|Trial was terminated|3|||
147596075|NCT00290251|532338806|FG000|Treatment 1 (Months 2-4)|Withdrawal by Subject|0|||
147596076|NCT00290251|532338807|FG001|Treatment 1 (Months 2-4)|Withdrawal by Subject|0|||
147596077|NCT00290251|532338808|FG002|Treatment 1 (Months 2-4)|Withdrawal by Subject|0|||
147596078|NCT00290251|532338809|FG003|Treatment 1 (Months 2-4)|Withdrawal by Subject|0|||
147596079|NCT00290251|532338810|FG004|Treatment 1 (Months 2-4)|Withdrawal by Subject|0|||
147596080|NCT00290251|532338811|FG005|Treatment 1 (Months 2-4)|Withdrawal by Subject|2|||
147596081|NCT00290251|532338806|FG000|Treatment 1 (Months 2-4)|headache|0|||
147596082|NCT00290251|532338807|FG001|Treatment 1 (Months 2-4)|headache|0|||
147596083|NCT00290251|532338808|FG002|Treatment 1 (Months 2-4)|headache|0|||
147596084|NCT00290251|532338809|FG003|Treatment 1 (Months 2-4)|headache|0|||
147596085|NCT00290251|532338810|FG004|Treatment 1 (Months 2-4)|headache|1|||
147596086|NCT00290251|532338811|FG005|Treatment 1 (Months 2-4)|headache|0|||
147596087|NCT00290251|532338806|FG000|Treatment 1 (Months 2-4)|Out of body experience|0|||
147596088|NCT00290251|532338807|FG001|Treatment 1 (Months 2-4)|Out of body experience|0|||
147596089|NCT00290251|532338808|FG002|Treatment 1 (Months 2-4)|Out of body experience|0|||
147596090|NCT00290251|532338809|FG003|Treatment 1 (Months 2-4)|Out of body experience|1|||
147596091|NCT00290251|532338810|FG004|Treatment 1 (Months 2-4)|Out of body experience|0|||
147596092|NCT00290251|532338811|FG005|Treatment 1 (Months 2-4)|Out of body experience|0|||
147596093|NCT03303625|532340725|FG000|Overall Study|Withdrawal by Subject|2|||
147596094|NCT03303625|532340726|FG001|Overall Study|Withdrawal by Subject|0|||
147596095|NCT03303625|532340727|FG002|Overall Study|Withdrawal by Subject|0|||
147596096|NCT03303625|532340728|FG003|Overall Study|Withdrawal by Subject|0|||
147596097|NCT03340064|532340730|FG000|First Period|Adverse Event, non-fatal|2|||
147596098|NCT03340064|532340731|FG001|First Period|Adverse Event, non-fatal|0|||
147596099|NCT03340064|532340730|FG000|First Period|Lack of Efficacy|3|||
147596100|NCT03340064|532340731|FG001|First Period|Lack of Efficacy|0|||
147596101|NCT03340064|532340730|FG000|Second Period|Adverse Event, non-fatal|1|||
147596102|NCT03340064|532340731|FG001|Second Period|Adverse Event, non-fatal|1|||
147596103|NCT03340064|532340730|FG000|Second Period|Lack of Efficacy|11|||
147596104|NCT03340064|532340731|FG001|Second Period|Lack of Efficacy|0|||
147331247|NCT05174013|531379129|FG003|Overall Study|Lost to Follow-up|1|||
147596105|NCT03340064|532340730|FG000|Second Period|Physician Decision|3|||
147331248|NCT05174013|531379130|FG004|Overall Study|Lost to Follow-up|0|||
147331249|NCT05174013|531379131|FG005|Overall Study|Lost to Follow-up|0|||
147596106|NCT03340064|532340731|FG001|Second Period|Physician Decision|0|||
147596107|NCT03340064|532340730|FG000|Second Period|Withdrawal by Subject|2|||
147659980|NCT00809445|532577899|FG001|1 Month Follow-up|Incarcerated|0|||
147331250|NCT05174013|531379126|FG000|Overall Study|Withdrawal by Subject|0|||
147659981|NCT00809445|532577900|FG002|1 Month Follow-up|Incarcerated|1|||
147659982|NCT00809445|532577898|FG000|6 Month Follow-up|Lost contact|16|||
147659983|NCT00809445|532577899|FG001|6 Month Follow-up|Lost contact|14|||
147659984|NCT00809445|532577900|FG002|6 Month Follow-up|Lost contact|14|||
147659985|NCT00809445|532577898|FG000|6 Month Follow-up|Death|2|||
147659986|NCT00809445|532577899|FG001|6 Month Follow-up|Death|1|||
147659987|NCT00809445|532577900|FG002|6 Month Follow-up|Death|1|||
147659988|NCT00809445|532577898|FG000|6 Month Follow-up|Incarcerated|6|||
147659989|NCT00809445|532577899|FG001|6 Month Follow-up|Incarcerated|8|||
147659990|NCT00809445|532577900|FG002|6 Month Follow-up|Incarcerated|8|||
147659991|NCT00809445|532577898|FG000|6 Month Follow-up|Withdrew consent|0|||
147659992|NCT00809445|532577899|FG001|6 Month Follow-up|Withdrew consent|0|||
147659993|NCT00809445|532577900|FG002|6 Month Follow-up|Withdrew consent|1|||
147659994|NCT01566604|532577902|FG000|Overall Study|Patient's inability to use the device|1|||
147659995|NCT01566604|532577903|FG001|Overall Study|Patient's inability to use the device|0|||
147659996|NCT01566604|532577902|FG000|Overall Study|Administrative problems|1|||
147659997|NCT01566604|532577903|FG001|Overall Study|Administrative problems|0|||
147659998|NCT01566604|532577902|FG000|Overall Study|Lack of Efficacy|1|||
147659999|NCT01566604|532577903|FG001|Overall Study|Lack of Efficacy|2|||
147660000|NCT01566604|532577902|FG000|Overall Study|Protocol deviation|2|||
147660001|NCT01566604|532577903|FG001|Overall Study|Protocol deviation|0|||
147660002|NCT01566604|532577902|FG000|Overall Study|Abnormal laboratory value|2|||
147660003|NCT01566604|532577903|FG001|Overall Study|Abnormal laboratory value|0|||
147660004|NCT01566604|532577902|FG000|Overall Study|Death|4|||
147660005|NCT01566604|532577903|FG001|Overall Study|Death|1|||
147660006|NCT01566604|532577902|FG000|Overall Study|Adverse Event|4|||
147660007|NCT01566604|532577903|FG001|Overall Study|Adverse Event|2|||
147660008|NCT01566604|532577902|FG000|Overall Study|Withdrawal by Subject|9|||
147660009|NCT01566604|532577903|FG001|Overall Study|Withdrawal by Subject|6|||
147660010|NCT01610037|532577905|FG000|All Patients|Adverse Event|27|||
147660011|NCT01610037|532577906|FG001|All Patients|Adverse Event|22|||
147660012|NCT01610037|532577907|FG002|All Patients|Adverse Event|26|||
147660013|NCT01610037|532577905|FG000|All Patients|Withdrawal by Subject|12|||
147660014|NCT01610037|532577906|FG001|All Patients|Withdrawal by Subject|10|||
147660015|NCT01610037|532577907|FG002|All Patients|Withdrawal by Subject|20|||
147660016|NCT01610037|532577905|FG000|All Patients|Unsatisfactory therapeutic effect|9|||
147660017|NCT01610037|532577906|FG001|All Patients|Unsatisfactory therapeutic effect|8|||
147660018|NCT01610037|532577907|FG002|All Patients|Unsatisfactory therapeutic effect|27|||
147660019|NCT01610037|532577905|FG000|All Patients|Death|4|||
147660020|NCT01610037|532577906|FG001|All Patients|Death|2|||
147660021|NCT01610037|532577907|FG002|All Patients|Death|1|||
147660022|NCT01610037|532577905|FG000|All Patients|Protocol deviation|4|||
147660023|NCT01610037|532577906|FG001|All Patients|Protocol deviation|3|||
147660024|NCT01610037|532577907|FG002|All Patients|Protocol deviation|3|||
147660025|NCT01610037|532577905|FG000|All Patients|Abnormal laboratory value|1|||
147660026|NCT01610037|532577906|FG001|All Patients|Abnormal laboratory value|1|||
147660027|NCT01610037|532577907|FG002|All Patients|Abnormal laboratory value|0|||
147660028|NCT01610037|532577905|FG000|All Patients|Administrative problems|1|||
147660029|NCT01610037|532577906|FG001|All Patients|Administrative problems|4|||
147660030|NCT01610037|532577907|FG002|All Patients|Administrative problems|4|||
147660031|NCT01610037|532577905|FG000|All Patients|Lost to Follow-up|1|||
147660032|NCT01610037|532577906|FG001|All Patients|Lost to Follow-up|0|||
147660033|NCT01610037|532577907|FG002|All Patients|Lost to Follow-up|0|||
147660034|NCT01610037|532577905|FG000|All Patients|Abnormal test procedure result(s)|0|||
147660035|NCT01610037|532577906|FG001|All Patients|Abnormal test procedure result(s)|1|||
147660036|NCT01610037|532577907|FG002|All Patients|Abnormal test procedure result(s)|3|||
147660037|NCT01610037|532577905|FG000|Treatment and Follow up Period|Subject withdrew consent|13|||
147660038|NCT01610037|532577906|FG001|Treatment and Follow up Period|Subject withdrew consent|14|||
147660039|NCT01610037|532577907|FG002|Treatment and Follow up Period|Subject withdrew consent|16|||
147660040|NCT01610037|532577905|FG000|Treatment and Follow up Period|Death|10|||
147660041|NCT01610037|532577906|FG001|Treatment and Follow up Period|Death|5|||
147660042|NCT01610037|532577907|FG002|Treatment and Follow up Period|Death|4|||
147660043|NCT01610037|532577905|FG000|Treatment and Follow up Period|Administrative problems|1|||
147660044|NCT01610037|532577906|FG001|Treatment and Follow up Period|Administrative problems|3|||
147660045|NCT01610037|532577907|FG002|Treatment and Follow up Period|Administrative problems|2|||
147660046|NCT01610037|532577905|FG000|Treatment and Follow up Period|Lost to Follow-up|1|||
147660047|NCT01610037|532577906|FG001|Treatment and Follow up Period|Lost to Follow-up|6|||
147660048|NCT01610037|532577907|FG002|Treatment and Follow up Period|Lost to Follow-up|4|||
147660049|NCT00705757|532577909|FG000|Overall Study|Lack of Efficacy|5|||
147660050|NCT00705757|532577910|FG001|Overall Study|Lack of Efficacy|1|||
147249954|NCT02850965|531083819|FG000|Overall Study|Other than listed|3|||
147660051|NCT00705757|532577911|FG002|Overall Study|Lack of Efficacy|3|||
147660052|NCT00705757|532577909|FG000|Overall Study|Lost to Follow-up|7|||
147660053|NCT00705757|532577910|FG001|Overall Study|Lost to Follow-up|6|||
147660054|NCT00705757|532577911|FG002|Overall Study|Lost to Follow-up|6|||
147660055|NCT00705757|532577909|FG000|Overall Study|Withdrawal by Subject|1|||
147660056|NCT00705757|532577910|FG001|Overall Study|Withdrawal by Subject|1|||
147331251|NCT05174013|531379127|FG001|Overall Study|Withdrawal by Subject|0|||
147331252|NCT05174013|531379128|FG002|Overall Study|Withdrawal by Subject|1|||
147331253|NCT05174013|531379129|FG003|Overall Study|Withdrawal by Subject|0|||
147331254|NCT05174013|531379130|FG004|Overall Study|Withdrawal by Subject|0|||
147331255|NCT05174013|531379131|FG005|Overall Study|Withdrawal by Subject|0|||
147331256|NCT02034916|531379132|FG000|Overall Study|Death|39|||
147660057|NCT00705757|532577911|FG002|Overall Study|Withdrawal by Subject|2|||
147660058|NCT00661089|532577912|FG000|Overall Study|1 subject withdrawal|0|||
147660059|NCT00661089|532577913|FG001|Overall Study|1 subject withdrawal|1|||
147660060|NCT00661089|532577912|FG000|Overall Study|death at 8 weeks due to new stroke|0|||
147660061|NCT00661089|532577913|FG001|Overall Study|death at 8 weeks due to new stroke|1|||
147660062|NCT01443858|532577916|FG000|Overall Study|Withdrawal by Subject|9|||
147660063|NCT01443858|532577917|FG001|Overall Study|Withdrawal by Subject|8|||
147660064|NCT01443858|532577918|FG002|Overall Study|Withdrawal by Subject|5|||
147660065|NCT01443858|532577916|FG000|Overall Study|Lack of Efficacy|1|||
147660066|NCT01443858|532577917|FG001|Overall Study|Lack of Efficacy|0|||
147660067|NCT01443858|532577918|FG002|Overall Study|Lack of Efficacy|0|||
147660068|NCT01443858|532577916|FG000|Overall Study|Lost to Follow-up|5|||
147660069|NCT01443858|532577917|FG001|Overall Study|Lost to Follow-up|5|||
147660070|NCT01443858|532577918|FG002|Overall Study|Lost to Follow-up|2|||
147660071|NCT03361306|532577922|FG000|Overall Study|Death|6|||
147660072|NCT00321906|532577923|FG000|Overall Study|Adverse Event|36|||
147660073|NCT00321906|532577924|FG001|Overall Study|Adverse Event|44|||
147660074|NCT00321906|532577923|FG000|Overall Study|Death|9|||
147660075|NCT00321906|532577924|FG001|Overall Study|Death|6|||
147660076|NCT00321906|532577923|FG000|Overall Study|Lost to Follow-up|1|||
147660077|NCT00321906|532577924|FG001|Overall Study|Lost to Follow-up|2|||
147660078|NCT00321906|532577923|FG000|Overall Study|Withdrawal by Subject|0|||
147660079|NCT00321906|532577924|FG001|Overall Study|Withdrawal by Subject|4|||
147660080|NCT01272908|532577926|FG000|Initial Treatment Period|Adverse Event|1|||
147660081|NCT01272908|532577926|FG000|Initial Treatment Period|Lack of Efficacy|5|||
147660082|NCT01272908|532577926|FG000|Initial Treatment Period|Protocol Violation|1|||
147660083|NCT01272908|532577926|FG000|Initial Treatment Period|Withdrawal by Subject|1|||
147660084|NCT01272908|532577926|FG000|Re-Treatment Period|Adverse Event|2|||
147660085|NCT01272908|532577926|FG000|Re-Treatment Period|Lack of Efficacy|3|||
147660086|NCT01272908|532577926|FG000|Re-Treatment Period|Withdrawal by Subject|1|||
147660087|NCT02221648|532577927|FG000|Overall Study|Withdrawal by Subject|3|||
147249955|NCT02850965|531083820|FG001|Overall Study|Other than listed|4|||
147249956|NCT02850965|531083819|FG000|Overall Study|Protocol Violation|0|||
147249957|NCT02850965|531083820|FG001|Overall Study|Protocol Violation|2|||
147249958|NCT02850965|531083819|FG000|Overall Study|Lost to Follow-up|5|||
147249959|NCT02850965|531083820|FG001|Overall Study|Lost to Follow-up|3|||
147249960|NCT02850965|531083819|FG000|Overall Study|Lack of Efficacy|4|||
147249961|NCT02850965|531083820|FG001|Overall Study|Lack of Efficacy|8|||
147249962|NCT02850965|531083819|FG000|Overall Study|Adverse Event|3|||
147249963|NCT02850965|531083820|FG001|Overall Study|Adverse Event|2|||
147249964|NCT02850965|531083819|FG000|Overall Study|Withdrawal by Subject|3|||
147249965|NCT02850965|531083820|FG001|Overall Study|Withdrawal by Subject|4|||
147249966|NCT02850965|531083819|FG000|Overall Study|Physician Decision|0|||
147249967|NCT02850965|531083820|FG001|Overall Study|Physician Decision|1|||
147249968|NCT02850965|531083819|FG000|Overall Study|Randomized but not treated|0|||
147249969|NCT02850965|531083820|FG001|Overall Study|Randomized but not treated|1|||
147249970|NCT02788357|531083824|FG000|Overall Study|Lost to Follow-up|3|||
147249971|NCT02788357|531083825|FG001|Overall Study|Lost to Follow-up|0|||
147249972|NCT01365910|531083826|FG000|Overall Study|Withdrawal by Subject|7|||
147249973|NCT01365910|531083826|FG000|Overall Study|disease progression|18|||
147249974|NCT01365910|531083826|FG000|Overall Study|Adverse Event|3|||
147249975|NCT01365910|531083826|FG000|Overall Study|other complicating disease|1|||
147249976|NCT01365910|531083826|FG000|Overall Study|pt did not get tx, nausea/vomiting|1|||
147249977|NCT00371137|531083827|FG000|Overall Study|Adverse Event|20|||
147331257|NCT02034916|531379133|FG001|Overall Study|Death|28|||
147660088|NCT02221648|532577928|FG001|Overall Study|Withdrawal by Subject|3|||
147660089|NCT00149396|532577929|FG000|Overall Study|Death|15|||
147660090|NCT00149396|532577929|FG000|Overall Study|Withdrawal by Subject|1|||
147660091|NCT00149396|532577929|FG000|Overall Study|Subject noncompliance|2|||
147660092|NCT00149396|532577929|FG000|Overall Study|other treatment|5|||
147249978|NCT00371137|531083828|FG001|Overall Study|Adverse Event|35|||
147249979|NCT00371137|531083829|FG002|Overall Study|Adverse Event|42|||
147249980|NCT00371137|531083827|FG000|Overall Study|Withdrawal by Subject|11|||
147249981|NCT00371137|531083828|FG001|Overall Study|Withdrawal by Subject|10|||
147249982|NCT00371137|531083829|FG002|Overall Study|Withdrawal by Subject|15|||
147249983|NCT00371137|531083827|FG000|Overall Study|Lost to Follow-up|6|||
147331258|NCT02034916|531379132|FG000|Overall Study|Withdrawal by Subject|2|||
147331259|NCT02034916|531379133|FG001|Overall Study|Withdrawal by Subject|1|||
147660093|NCT00810069|532577933|FG000|Lead-in Period I|Adverse Event|43|||
147660094|NCT00810069|532577934|FG001|Lead-in Period I|Adverse Event|0|||
147660095|NCT00810069|532577935|FG002|Lead-in Period I|Adverse Event|0|||
147660096|NCT00810069|532577933|FG000|Lead-in Period I|Lack of Efficacy|1|||
147596108|NCT03340064|532340731|FG001|Second Period|Withdrawal by Subject|1|||
147596109|NCT03340064|532340730|FG000|Second Period|Approved Drug Available For Indication|1|||
147596110|NCT03340064|532340731|FG001|Second Period|Approved Drug Available For Indication|0|||
147249984|NCT00371137|531083828|FG001|Overall Study|Lost to Follow-up|3|||
147249985|NCT00371137|531083829|FG002|Overall Study|Lost to Follow-up|5|||
147249986|NCT00371137|531083827|FG000|Overall Study|Lack of Efficacy|30|||
147249987|NCT00371137|531083828|FG001|Overall Study|Lack of Efficacy|12|||
147249988|NCT00371137|531083829|FG002|Overall Study|Lack of Efficacy|13|||
147449599|NCT00440947|531809505|FG000|Optional 60-Week Extension Phase|Participant Moved|0|||
147660097|NCT00810069|532577934|FG001|Lead-in Period I|Lack of Efficacy|0|||
147660098|NCT00810069|532577935|FG002|Lead-in Period I|Lack of Efficacy|0|||
147660099|NCT00810069|532577933|FG000|Lead-in Period I|Lost to Follow-up|19|||
147660100|NCT00810069|532577934|FG001|Lead-in Period I|Lost to Follow-up|0|||
147660101|NCT00810069|532577935|FG002|Lead-in Period I|Lost to Follow-up|0|||
147596111|NCT03340064|532340730|FG000|Second Period|Protocol-Specified Withdrawal Criterion Met|1|||
147660102|NCT00810069|532577933|FG000|Lead-in Period I|Physician Decision|1|||
147660103|NCT00810069|532577934|FG001|Lead-in Period I|Physician Decision|0|||
147660104|NCT00810069|532577935|FG002|Lead-in Period I|Physician Decision|0|||
147660105|NCT00810069|532577933|FG000|Lead-in Period I|Protocol Violation|1|||
147660106|NCT00810069|532577934|FG001|Lead-in Period I|Protocol Violation|0|||
147660107|NCT00810069|532577935|FG002|Lead-in Period I|Protocol Violation|0|||
147660108|NCT00810069|532577933|FG000|Lead-in Period I|Withdrawal by Subject|46|||
147660109|NCT00810069|532577934|FG001|Lead-in Period I|Withdrawal by Subject|0|||
147660110|NCT00810069|532577935|FG002|Lead-in Period I|Withdrawal by Subject|0|||
147660111|NCT00810069|532577933|FG000|Lead-in Period I|Protocol entry criterion not met|5|||
147660112|NCT00810069|532577934|FG001|Lead-in Period I|Protocol entry criterion not met|0|||
147660113|NCT00810069|532577935|FG002|Lead-in Period I|Protocol entry criterion not met|0|||
147660114|NCT00810069|532577933|FG000|Lead-in Period I|Randomization criteria not met|158|||
147660115|NCT00810069|532577934|FG001|Lead-in Period I|Randomization criteria not met|0|||
147660116|NCT00810069|532577935|FG002|Lead-in Period I|Randomization criteria not met|0|||
147660117|NCT00810069|532577933|FG000|Double-Blind Period II|Adverse Event|0|||
147660118|NCT00810069|532577934|FG001|Double-Blind Period II|Adverse Event|9|||
147660119|NCT00810069|532577935|FG002|Double-Blind Period II|Adverse Event|8|||
147660120|NCT00810069|532577933|FG000|Double-Blind Period II|Lack of Efficacy|0|||
147660121|NCT00810069|532577934|FG001|Double-Blind Period II|Lack of Efficacy|7|||
147660122|NCT00810069|532577935|FG002|Double-Blind Period II|Lack of Efficacy|12|||
147660123|NCT00810069|532577933|FG000|Double-Blind Period II|Lost to Follow-up|0|||
147660124|NCT00810069|532577934|FG001|Double-Blind Period II|Lost to Follow-up|9|||
147660125|NCT00810069|532577935|FG002|Double-Blind Period II|Lost to Follow-up|9|||
147660126|NCT00810069|532577933|FG000|Double-Blind Period II|Physician Decision|0|||
147660127|NCT00810069|532577934|FG001|Double-Blind Period II|Physician Decision|0|||
147660128|NCT00810069|532577935|FG002|Double-Blind Period II|Physician Decision|1|||
147660129|NCT00810069|532577933|FG000|Double-Blind Period II|Withdrawal by Subject|0|||
147660130|NCT00810069|532577934|FG001|Double-Blind Period II|Withdrawal by Subject|21|||
147660131|NCT00810069|532577935|FG002|Double-Blind Period II|Withdrawal by Subject|35|||
147660132|NCT00810069|532577933|FG000|Double-Blind Period II|Protocol entry criterion not met|0|||
147660133|NCT00810069|532577934|FG001|Double-Blind Period II|Protocol entry criterion not met|0|||
147660134|NCT00810069|532577935|FG002|Double-Blind Period II|Protocol entry criterion not met|1|||
147660135|NCT00810069|532577933|FG000|Double-Blind Period II|Clinical relapse|0|||
147660136|NCT00810069|532577934|FG001|Double-Blind Period II|Clinical relapse|3|||
147660137|NCT00810069|532577935|FG002|Double-Blind Period II|Clinical relapse|0|||
147660138|NCT00810069|532577933|FG000|Double-Blind Period II|Protocol Violation|0|||
147660139|NCT00810069|532577934|FG001|Double-Blind Period II|Protocol Violation|7|||
147660140|NCT00810069|532577935|FG002|Double-Blind Period II|Protocol Violation|6|||
147660141|NCT02358031|532579773|FG000|Overall Study|Death|253|||
147449600|NCT00440947|531809506|FG001|Optional 60-Week Extension Phase|Participant Moved|0|||
147596112|NCT03340064|532340731|FG001|Second Period|Protocol-Specified Withdrawal Criterion Met|0|||
147596113|NCT02221037|532340732|FG000|Overall Study|Physician Decision|0|||
147596114|NCT02221037|532340733|FG001|Overall Study|Physician Decision|0|||
147660142|NCT02358031|532579774|FG001|Overall Study|Death|237|||
147660143|NCT02358031|532579775|FG002|Overall Study|Death|266|||
147660144|NCT02358031|532579773|FG000|Overall Study|Lost to Follow-up|1|||
147660145|NCT02358031|532579774|FG001|Overall Study|Lost to Follow-up|1|||
147660146|NCT02358031|532579775|FG002|Overall Study|Lost to Follow-up|0|||
147660147|NCT02358031|532579773|FG000|Overall Study|Withdrawal by Subject|19|||
147660148|NCT02358031|532579774|FG001|Overall Study|Withdrawal by Subject|14|||
147249989|NCT00371137|531083827|FG000|Overall Study|Sponsor Decision|2|||
147660149|NCT02358031|532579775|FG002|Overall Study|Withdrawal by Subject|18|||
147449601|NCT00440947|531809507|FG002|Optional 60-Week Extension Phase|Participant Moved|0|||
147660150|NCT02358031|532579773|FG000|Overall Study|Sponsor Decision|26|||
147660151|NCT02358031|532579774|FG001|Overall Study|Sponsor Decision|28|||
147660152|NCT02358031|532579775|FG002|Overall Study|Sponsor Decision|16|||
147249990|NCT00371137|531083828|FG001|Overall Study|Sponsor Decision|1|||
147596115|NCT02221037|532340734|FG002|Overall Study|Physician Decision|1|||
147596116|NCT02221037|532340735|FG003|Overall Study|Physician Decision|0|||
147449602|NCT00440947|531809508|FG003|Optional 60-Week Extension Phase|Participant Moved|1|||
147449603|NCT00440947|531809509|FG004|Optional 60-Week Extension Phase|Participant Moved|1|||
147449604|NCT00440947|531809505|FG000|Optional 60-Week Extension Phase|Sponsor Request|0|||
147449605|NCT00440947|531809506|FG001|Optional 60-Week Extension Phase|Sponsor Request|0|||
147449606|NCT00440947|531809507|FG002|Optional 60-Week Extension Phase|Sponsor Request|0|||
147449607|NCT00440947|531809508|FG003|Optional 60-Week Extension Phase|Sponsor Request|1|||
147449608|NCT00440947|531809509|FG004|Optional 60-Week Extension Phase|Sponsor Request|1|||
147449609|NCT00440947|531809505|FG000|Optional 60-Week Extension Phase|Sponsor Terminated Site|0|||
147449610|NCT00440947|531809506|FG001|Optional 60-Week Extension Phase|Sponsor Terminated Site|0|||
147449611|NCT00440947|531809507|FG002|Optional 60-Week Extension Phase|Sponsor Terminated Site|0|||
147449612|NCT00440947|531809508|FG003|Optional 60-Week Extension Phase|Sponsor Terminated Site|3|||
147449613|NCT00440947|531809509|FG004|Optional 60-Week Extension Phase|Sponsor Terminated Site|3|||
147449614|NCT00440947|531809505|FG000|Optional 60-Week Extension Phase|Other|0|||
147449615|NCT00440947|531809506|FG001|Optional 60-Week Extension Phase|Other|0|||
147449616|NCT00440947|531809507|FG002|Optional 60-Week Extension Phase|Other|0|||
147449617|NCT00440947|531809508|FG003|Optional 60-Week Extension Phase|Other|1|||
147449618|NCT00440947|531809509|FG004|Optional 60-Week Extension Phase|Other|0|||
147449619|NCT00440947|531809505|FG000|Optional 60-Week Extension Phase|Physician Decision|0|||
147449620|NCT00440947|531809506|FG001|Optional 60-Week Extension Phase|Physician Decision|0|||
147449621|NCT00440947|531809507|FG002|Optional 60-Week Extension Phase|Physician Decision|0|||
147449622|NCT00440947|531809508|FG003|Optional 60-Week Extension Phase|Physician Decision|0|||
147449623|NCT00440947|531809509|FG004|Optional 60-Week Extension Phase|Physician Decision|1|||
147449624|NCT00440947|531809505|FG000|Optional 60-Week Extension Phase|Participant Remained in Cuba|0|||
147449625|NCT00440947|531809506|FG001|Optional 60-Week Extension Phase|Participant Remained in Cuba|0|||
147449626|NCT00440947|531809507|FG002|Optional 60-Week Extension Phase|Participant Remained in Cuba|0|||
147449627|NCT00440947|531809508|FG003|Optional 60-Week Extension Phase|Participant Remained in Cuba|0|||
147449628|NCT00440947|531809509|FG004|Optional 60-Week Extension Phase|Participant Remained in Cuba|1|||
147449629|NCT01827670|531809510|FG000|Overall Study|Withdrawal of Consent|3|||
147449630|NCT01827670|531809511|FG001|Overall Study|Withdrawal of Consent|2|||
147449631|NCT01827670|531809510|FG000|Overall Study|Lost to Follow-up|0|||
147449632|NCT01827670|531809511|FG001|Overall Study|Lost to Follow-up|1|||
147449633|NCT02813694|531809522|FG000|Overall Study|Physician Decision|0|||
147449634|NCT02813694|531809523|FG001|Overall Study|Physician Decision|1|||
147449635|NCT02813694|531809522|FG000|Overall Study|Withdrawal by Subject|10|||
147449636|NCT02813694|531809523|FG001|Overall Study|Withdrawal by Subject|9|||
147449637|NCT02813694|531809522|FG000|Overall Study|Lost to Follow-up|1|||
147449638|NCT02813694|531809523|FG001|Overall Study|Lost to Follow-up|1|||
147449639|NCT02813694|531809522|FG000|Overall Study|Death|3|||
147449640|NCT02813694|531809523|FG001|Overall Study|Death|3|||
147449641|NCT02813694|531809522|FG000|Overall Study|Randomized- did not receive study drug|2|||
147449642|NCT02813694|531809523|FG001|Overall Study|Randomized- did not receive study drug|0|||
147449643|NCT02813694|531809522|FG000|Overall Study|Patient hospitalized|1|||
147449644|NCT02813694|531809523|FG001|Overall Study|Patient hospitalized|0|||
147449645|NCT01347554|531809532|FG000|Overall Study|Lack of Efficacy|7|||
147449646|NCT01347554|531809533|FG001|Overall Study|Lack of Efficacy|11|||
147449647|NCT00004259|531809537|FG000|Overall Study|Protocol Violation|1|||
147449648|NCT00004259|531809538|FG001|Overall Study|Protocol Violation|2|||
147449649|NCT00004259|531809539|FG002|Overall Study|Protocol Violation|0|||
147449650|NCT00004259|531809540|FG003|Overall Study|Protocol Violation|0|||
147449651|NCT00004259|531809537|FG000|Overall Study|Withdrawal by Subject|0|||
147449652|NCT00004259|531809538|FG001|Overall Study|Withdrawal by Subject|2|||
147449653|NCT00004259|531809539|FG002|Overall Study|Withdrawal by Subject|0|||
147449654|NCT00004259|531809540|FG003|Overall Study|Withdrawal by Subject|0|||
147449655|NCT01902290|531809545|FG000|Overall Study|Withdrawal by Subject|19|||
147449656|NCT01902290|531809546|FG001|Overall Study|Withdrawal by Subject|27|||
147449657|NCT01902290|531809545|FG000|Overall Study|Lost to Follow-up|2|||
147449658|NCT01902290|531809546|FG001|Overall Study|Lost to Follow-up|2|||
147449659|NCT01902290|531809545|FG000|Overall Study|Death|1|||
147449660|NCT01902290|531809546|FG001|Overall Study|Death|0|||
147449661|NCT01902290|531809545|FG000|Overall Study|Sponsor Decision|26|||
147449662|NCT01902290|531809546|FG001|Overall Study|Sponsor Decision|24|||
147449663|NCT00517829|531809547|FG000|Overall Study|Adverse Event|22|||
147449664|NCT00517829|531809548|FG001|Overall Study|Adverse Event|34|||
147449665|NCT00517829|531809547|FG000|Overall Study|Disease Progression|39|||
147449666|NCT00517829|531809548|FG001|Overall Study|Disease Progression|32|||
147449667|NCT00517829|531809547|FG000|Overall Study|Patient Request|6|||
147449668|NCT00517829|531809548|FG001|Overall Study|Patient Request|5|||
147449669|NCT00517829|531809547|FG000|Overall Study|Investigator Request|5|||
147449670|NCT00517829|531809548|FG001|Overall Study|Investigator Request|3|||
147449671|NCT00517829|531809547|FG000|Overall Study|Other|3|||
147449672|NCT00517829|531809548|FG001|Overall Study|Other|1|||
147449673|NCT02443883|531809549|FG000|Overall Study|Adverse Event|0|||
147449674|NCT02443883|531809550|FG001|Overall Study|Adverse Event|1|||
147449675|NCT02443883|531809551|FG002|Overall Study|Adverse Event|0|||
147596117|NCT02944383|532340738|FG000|Overall Study|Lost to Follow-up|0|||
147596118|NCT02944383|532340739|FG001|Overall Study|Lost to Follow-up|0|||
147249991|NCT00371137|531083829|FG002|Overall Study|Sponsor Decision|2|||
147249992|NCT00371137|531083827|FG000|Overall Study|Physician Decision|1|||
147249993|NCT00371137|531083828|FG001|Overall Study|Physician Decision|1|||
147249994|NCT00371137|531083829|FG002|Overall Study|Physician Decision|1|||
147249995|NCT00371137|531083827|FG000|Overall Study|Protocol Violation|2|||
147249996|NCT00371137|531083828|FG001|Overall Study|Protocol Violation|1|||
147249997|NCT00371137|531083829|FG002|Overall Study|Protocol Violation|1|||
147249998|NCT02013791|531083830|FG000|Period 1|Lost to Follow-up|0|||
147249999|NCT02013791|531083831|FG001|Period 1|Lost to Follow-up|0|||
147250000|NCT02013791|531083832|FG002|Period 1|Lost to Follow-up|0|||
147250001|NCT02013791|531083833|FG003|Period 1|Lost to Follow-up|1|||
147250002|NCT02013791|531083834|FG004|Period 1|Lost to Follow-up|0|||
147596119|NCT02944383|532340740|FG002|Overall Study|Lost to Follow-up|1|||
147596120|NCT02944383|532340738|FG000|Overall Study|Withdrawal by Subject|1|||
147596121|NCT02944383|532340739|FG001|Overall Study|Withdrawal by Subject|0|||
147596122|NCT02944383|532340740|FG002|Overall Study|Withdrawal by Subject|0|||
147596123|NCT00852969|532340745|FG000|Overall Study|Adverse Event|0|||
147596124|NCT00852969|532340746|FG001|Overall Study|Adverse Event|1|||
147596125|NCT00852969|532340745|FG000|Overall Study|Lost to Follow-up|0|||
147596126|NCT00852969|532340746|FG001|Overall Study|Lost to Follow-up|1|||
147596127|NCT02358343|532340749|FG000|Screening Intervention|Death|0|||
147596128|NCT02358343|532340750|FG001|Screening Intervention|Death|2|||
147596129|NCT02358343|532340751|FG002|Screening Intervention|Death|0|||
147596130|NCT02358343|532340752|FG003|Screening Intervention|Death|0|||
147596131|NCT02358343|532340753|FG004|Screening Intervention|Death|0|||
147596132|NCT02358343|532340749|FG000|Screening Intervention|Withdrawal by Subject|1|||
147596133|NCT02358343|532340750|FG001|Screening Intervention|Withdrawal by Subject|0|||
147596134|NCT02358343|532340751|FG002|Screening Intervention|Withdrawal by Subject|0|||
147596135|NCT02358343|532340752|FG003|Screening Intervention|Withdrawal by Subject|0|||
147596136|NCT02358343|532340753|FG004|Screening Intervention|Withdrawal by Subject|0|||
147596137|NCT02358343|532340749|FG000|Screening Intervention|Determined Ineligible|5|||
147596138|NCT02358343|532340750|FG001|Screening Intervention|Determined Ineligible|6|||
147596139|NCT02358343|532340751|FG002|Screening Intervention|Determined Ineligible|0|||
147596140|NCT02358343|532340752|FG003|Screening Intervention|Determined Ineligible|0|||
147596141|NCT02358343|532340753|FG004|Screening Intervention|Determined Ineligible|0|||
147596142|NCT02358343|532340749|FG000|Comparative Efficacy Trial / Observation|Death|0|||
147596143|NCT02358343|532340750|FG001|Comparative Efficacy Trial / Observation|Death|0|||
147596144|NCT02358343|532340751|FG002|Comparative Efficacy Trial / Observation|Death|2|||
147596145|NCT02358343|532340752|FG003|Comparative Efficacy Trial / Observation|Death|0|||
147596146|NCT02358343|532340753|FG004|Comparative Efficacy Trial / Observation|Death|0|||
147596147|NCT02358343|532340749|FG000|Comparative Efficacy Trial / Observation|Withdrawal by Subject|0|||
147596148|NCT02358343|532340750|FG001|Comparative Efficacy Trial / Observation|Withdrawal by Subject|0|||
147596149|NCT02358343|532340751|FG002|Comparative Efficacy Trial / Observation|Withdrawal by Subject|2|||
147596150|NCT02358343|532340752|FG003|Comparative Efficacy Trial / Observation|Withdrawal by Subject|2|||
147596151|NCT02358343|532340753|FG004|Comparative Efficacy Trial / Observation|Withdrawal by Subject|2|||
147596152|NCT02358343|532340749|FG000|Comparative Efficacy Trial / Observation|Administrative Withdrawal|0|||
147596153|NCT02358343|532340750|FG001|Comparative Efficacy Trial / Observation|Administrative Withdrawal|0|||
147596154|NCT02358343|532340751|FG002|Comparative Efficacy Trial / Observation|Administrative Withdrawal|1|||
147596155|NCT02358343|532340752|FG003|Comparative Efficacy Trial / Observation|Administrative Withdrawal|0|||
147596156|NCT02358343|532340753|FG004|Comparative Efficacy Trial / Observation|Administrative Withdrawal|0|||
147596157|NCT01700049|532340754|FG000|Overall Study|Withdrawal by Subject|1|||
147596158|NCT03084367|532340757|FG000|Overall Study|Lost to Follow-up|32|||
147596159|NCT03084367|532340757|FG000|Overall Study|Withdrawal by Subject|4|||
147596160|NCT03084367|532340757|FG000|Overall Study|Other|1|||
147596161|NCT04325204|532340758|FG000|Overall Study|Death|0|||
147596162|NCT04325204|532340759|FG001|Overall Study|Death|1|||
147596163|NCT04325204|532340758|FG000|Overall Study|Death of dyad partner, after the intervention and prior to the assessment 6 weeks post-intervention|1|||
147596164|NCT04325204|532340759|FG001|Overall Study|Death of dyad partner, after the intervention and prior to the assessment 6 weeks post-intervention|0|||
147596165|NCT04325204|532340758|FG000|Overall Study|Lost to Follow-up|8|||
147596166|NCT04325204|532340759|FG001|Overall Study|Lost to Follow-up|8|||
147596167|NCT04325204|532340758|FG000|Overall Study|Completed the demographic questionnaire but lost to follow-up before beginning the intervention|1|||
147596168|NCT04325204|532340759|FG001|Overall Study|Completed the demographic questionnaire but lost to follow-up before beginning the intervention|1|||
147596169|NCT04710979|532340761|FG000|Overall Study|Lost to Follow-up|2|||
147596170|NCT04710979|532340762|FG001|Overall Study|Lost to Follow-up|4|||
147596171|NCT04710979|532340761|FG000|Overall Study|Withdrawal by Subject|1|||
147596172|NCT04710979|532340762|FG001|Overall Study|Withdrawal by Subject|0|||
147250003|NCT02013791|531083835|FG005|Period 1|Lost to Follow-up|0|||
147250004|NCT02013791|531083836|FG006|Period 1|Lost to Follow-up|1|||
147250005|NCT02013791|531083837|FG007|Period 1|Lost to Follow-up|1|||
147596173|NCT00307034|532340767|FG000|Overall Study|Adverse Event|1|||
147596174|NCT00307034|532340768|FG001|Overall Study|Adverse Event|2|||
147596175|NCT00307034|532340767|FG000|Overall Study|Withdrawal by Subject|1|||
147596176|NCT00307034|532340768|FG001|Overall Study|Withdrawal by Subject|2|||
147596177|NCT00307034|532340767|FG000|Overall Study|Lost to Follow-up|0|||
147596178|NCT00307034|532340768|FG001|Overall Study|Lost to Follow-up|3|||
147596179|NCT03254602|532340774|FG000|Overall Study|Lost to Follow-up|4|||
147596180|NCT02963311|532340777|FG000|Overall Study|Withdrawal by Subject|1|||
147596181|NCT02963311|532340777|FG000|Overall Study|Screen Failure|4|||
147596182|NCT01691820|532340778|FG000|Overall Study|Consent withdrawal (not due to an AE)|9|||
147596183|NCT01691820|532340779|FG001|Overall Study|Consent withdrawal (not due to an AE)|15|||
147596184|NCT01691820|532340778|FG000|Overall Study|Migrated/moved from study area|7|||
147596185|NCT01691820|532340779|FG001|Overall Study|Migrated/moved from study area|4|||
147596186|NCT01691820|532340778|FG000|Overall Study|Lost to Follow-up|6|||
147596187|NCT01691820|532340779|FG001|Overall Study|Lost to Follow-up|17|||
147596188|NCT01691820|532340778|FG000|Overall Study|Other (unspecified)|4|||
147596189|NCT01691820|532340779|FG001|Overall Study|Other (unspecified)|1|||
147596190|NCT04442490|532340781|FG000|Overall Study|Withdrawal by Subject|18|||
147596191|NCT04442490|532340782|FG001|Overall Study|Withdrawal by Subject|10|||
147596192|NCT04442490|532340781|FG000|Overall Study|Lost to Follow-up|7|||
147596193|NCT04442490|532340782|FG001|Overall Study|Lost to Follow-up|7|||
147596194|NCT04442490|532340781|FG000|Overall Study|Adverse Event|2|||
147596195|NCT04442490|532340782|FG001|Overall Study|Adverse Event|6|||
147596196|NCT04442490|532340781|FG000|Overall Study|Noncompliance|3|||
147596197|NCT04442490|532340782|FG001|Overall Study|Noncompliance|1|||
147596198|NCT04442490|532340781|FG000|Overall Study|Physician Decision|2|||
147596199|NCT04442490|532340782|FG001|Overall Study|Physician Decision|1|||
147596200|NCT04442490|532340781|FG000|Overall Study|Reason not Specified|2|||
147596201|NCT04442490|532340782|FG001|Overall Study|Reason not Specified|1|||
147596202|NCT04442490|532340781|FG000|Overall Study|Randomized but not Treated|3|||
147596203|NCT04442490|532340782|FG001|Overall Study|Randomized but not Treated|3|||
147596204|NCT02372071|532340794|FG000|Overall Study|Protocol Violation|18|||
147596205|NCT01449279|532340795|FG000|Overall Study|Lack of Efficacy|5|||
147596206|NCT01449279|532340795|FG000|Overall Study|Toxicity|2|||
147596207|NCT02618408|532340796|FG000|Overall Study|Withdrawal by Subject|1|||
147596208|NCT02618408|532340797|FG001|Overall Study|Withdrawal by Subject|0|||
147596209|NCT02618408|532340798|FG002|Overall Study|Withdrawal by Subject|4|||
147596210|NCT02618408|532340796|FG000|Overall Study|Withdrawal By Parent/Guardian|5|||
147596211|NCT02618408|532340797|FG001|Overall Study|Withdrawal By Parent/Guardian|3|||
147596212|NCT02618408|532340798|FG002|Overall Study|Withdrawal By Parent/Guardian|9|||
147596213|NCT02618408|532340796|FG000|Overall Study|Lost to Follow-up|4|||
147596214|NCT02618408|532340797|FG001|Overall Study|Lost to Follow-up|2|||
147596215|NCT02618408|532340798|FG002|Overall Study|Lost to Follow-up|6|||
147596216|NCT02618408|532340796|FG000|Overall Study|Adverse Event|4|||
147596217|NCT02618408|532340797|FG001|Overall Study|Adverse Event|0|||
147596218|NCT02618408|532340798|FG002|Overall Study|Adverse Event|10|||
147596219|NCT02618408|532340796|FG000|Overall Study|Physician Decision|1|||
147596220|NCT02618408|532340797|FG001|Overall Study|Physician Decision|1|||
147596221|NCT02618408|532340798|FG002|Overall Study|Physician Decision|2|||
147596222|NCT02618408|532340796|FG000|Overall Study|Protocol Violation|1|||
147596223|NCT02618408|532340797|FG001|Overall Study|Protocol Violation|1|||
147596224|NCT02618408|532340798|FG002|Overall Study|Protocol Violation|2|||
147596225|NCT02618408|532340796|FG000|Overall Study|Other, Multiple Categories|0|||
147596226|NCT02618408|532340797|FG001|Overall Study|Other, Multiple Categories|0|||
147596227|NCT02618408|532340798|FG002|Overall Study|Other, Multiple Categories|4|||
147596228|NCT01249365|532340808|FG000|Overall Study|Lost to Follow-up|1|||
147596229|NCT03579966|532340809|FG000|Overall Study|Adverse Event|6|||
147596230|NCT03579966|532340809|FG000|Overall Study|Lost to Follow-up|4|||
147596231|NCT03579966|532340809|FG000|Overall Study|Physician Decision|10|||
147596232|NCT03579966|532340809|FG000|Overall Study|Pregnancy|1|||
147596233|NCT03579966|532340809|FG000|Overall Study|Withdrawal by Subject|16|||
147596234|NCT03579966|532340809|FG000|Overall Study|Study terminated by Sponsor|22|||
147596235|NCT03579966|532340809|FG000|Overall Study|Protocol Violation|1|||
147596236|NCT01340768|532340810|FG000|Overall Study|Lost to Follow-up|10|||
147596237|NCT01340768|532340811|FG001|Overall Study|Lost to Follow-up|4|||
147596238|NCT01340768|532340810|FG000|Overall Study|Withdrawal by Subject|5|||
147596239|NCT01340768|532340811|FG001|Overall Study|Withdrawal by Subject|1|||
147596240|NCT01340768|532340810|FG000|Overall Study|Other|2|||
147596241|NCT01340768|532340811|FG001|Overall Study|Other|0|||
147596242|NCT04049617|532340816|FG000|Overall Study|Adverse Event|0|||
147596243|NCT04049617|532340817|FG001|Overall Study|Adverse Event|0|||
147596244|NCT04049617|532340818|FG002|Overall Study|Adverse Event|0|||
147596245|NCT04049617|532340819|FG003|Overall Study|Adverse Event|1|||
147596246|NCT04049617|532340820|FG004|Overall Study|Adverse Event|0|||
147596247|NCT04049617|532340821|FG005|Overall Study|Adverse Event|0|||
147596248|NCT04049617|532340816|FG000|Overall Study|Death|0|||
147596249|NCT04049617|532340817|FG001|Overall Study|Death|0|||
147660153|NCT05664581|532579776|FG000|Overall Study|Withdrawal by Subject|2|||
147596250|NCT04049617|532340818|FG002|Overall Study|Death|0|||
147660154|NCT03101150|532579777|FG000|Overall Study|Lost to Follow-up|2|||
147660155|NCT03101150|532579778|FG001|Overall Study|Lost to Follow-up|4|||
147660156|NCT03101150|532579777|FG000|Overall Study|Miscarriage|3|||
147660157|NCT03101150|532579778|FG001|Overall Study|Miscarriage|6|||
147660158|NCT01317641|532579780|FG000|Overall Study|Not treated|0|||
147660159|NCT01317641|532579781|FG001|Overall Study|Not treated|0|||
147660160|NCT01317641|532579782|FG002|Overall Study|Not treated|0|||
147660161|NCT01317641|532579783|FG003|Overall Study|Not treated|0|||
147660162|NCT01317641|532579784|FG004|Overall Study|Not treated|0|||
147660163|NCT01317641|532579785|FG005|Overall Study|Not treated|0|||
147660164|NCT01317641|532579786|FG006|Overall Study|Not treated|0|||
147660165|NCT01317641|532579787|FG007|Overall Study|Not treated|1|||
147660166|NCT01317641|532579788|FG008|Overall Study|Not treated|1|||
147660167|NCT01317641|532579780|FG000|Overall Study|Adverse Event|0|||
147660168|NCT01317641|532579781|FG001|Overall Study|Adverse Event|1|||
147660169|NCT01317641|532579782|FG002|Overall Study|Adverse Event|0|||
147660170|NCT01317641|532579783|FG003|Overall Study|Adverse Event|1|||
147660171|NCT01317641|532579784|FG004|Overall Study|Adverse Event|0|||
147660172|NCT01317641|532579785|FG005|Overall Study|Adverse Event|0|||
147660173|NCT01317641|532579786|FG006|Overall Study|Adverse Event|2|||
147660174|NCT01317641|532579787|FG007|Overall Study|Adverse Event|1|||
147660175|NCT01317641|532579788|FG008|Overall Study|Adverse Event|0|||
147660176|NCT01317641|532579780|FG000|Overall Study|Protocol Violation|1|||
147660177|NCT01317641|532579781|FG001|Overall Study|Protocol Violation|0|||
147660178|NCT01317641|532579782|FG002|Overall Study|Protocol Violation|0|||
147660179|NCT01317641|532579783|FG003|Overall Study|Protocol Violation|0|||
147660180|NCT01317641|532579784|FG004|Overall Study|Protocol Violation|0|||
147660181|NCT01317641|532579785|FG005|Overall Study|Protocol Violation|0|||
147660182|NCT01317641|532579786|FG006|Overall Study|Protocol Violation|0|||
147660183|NCT01317641|532579787|FG007|Overall Study|Protocol Violation|0|||
147660184|NCT01317641|532579788|FG008|Overall Study|Protocol Violation|0|||
147660185|NCT01317641|532579780|FG000|Overall Study|Disease progression|0|||
147660186|NCT01317641|532579781|FG001|Overall Study|Disease progression|0|||
147660187|NCT01317641|532579782|FG002|Overall Study|Disease progression|0|||
147660188|NCT01317641|532579783|FG003|Overall Study|Disease progression|0|||
147660189|NCT01317641|532579784|FG004|Overall Study|Disease progression|0|||
147660190|NCT01317641|532579785|FG005|Overall Study|Disease progression|0|||
147660191|NCT01317641|532579786|FG006|Overall Study|Disease progression|0|||
147660192|NCT01317641|532579787|FG007|Overall Study|Disease progression|3|||
147660193|NCT01317641|532579788|FG008|Overall Study|Disease progression|4|||
147660194|NCT01317641|532579780|FG000|Overall Study|Withdrawal by Subject|0|||
147660195|NCT01317641|532579781|FG001|Overall Study|Withdrawal by Subject|0|||
147660196|NCT01317641|532579782|FG002|Overall Study|Withdrawal by Subject|0|||
147660197|NCT01317641|532579783|FG003|Overall Study|Withdrawal by Subject|0|||
147660198|NCT01317641|532579784|FG004|Overall Study|Withdrawal by Subject|0|||
147660199|NCT01317641|532579785|FG005|Overall Study|Withdrawal by Subject|0|||
147660200|NCT01317641|532579786|FG006|Overall Study|Withdrawal by Subject|1|||
147660201|NCT01317641|532579787|FG007|Overall Study|Withdrawal by Subject|0|||
147660202|NCT01317641|532579788|FG008|Overall Study|Withdrawal by Subject|0|||
147660203|NCT00715559|532579789|FG000|Overall Study|medication not tolerated - nausea|1|||
147250006|NCT02013791|531083838|FG008|Period 1|Lost to Follow-up|0|||
147250007|NCT02013791|531083830|FG000|Period 1|Other Miscellaneous Reasons|0|||
147250008|NCT02013791|531083831|FG001|Period 1|Other Miscellaneous Reasons|2|||
147250009|NCT02013791|531083832|FG002|Period 1|Other Miscellaneous Reasons|0|||
147250010|NCT02013791|531083833|FG003|Period 1|Other Miscellaneous Reasons|0|||
147250011|NCT02013791|531083834|FG004|Period 1|Other Miscellaneous Reasons|0|||
147596251|NCT04049617|532340819|FG003|Overall Study|Death|0|||
147596252|NCT04049617|532340820|FG004|Overall Study|Death|0|||
147596253|NCT04049617|532340821|FG005|Overall Study|Death|1|||
147596254|NCT04049617|532340816|FG000|Overall Study|Lost to Follow-up|0|||
147596255|NCT04049617|532340817|FG001|Overall Study|Lost to Follow-up|0|||
147596256|NCT04049617|532340818|FG002|Overall Study|Lost to Follow-up|0|||
147596257|NCT04049617|532340819|FG003|Overall Study|Lost to Follow-up|1|||
147596258|NCT04049617|532340820|FG004|Overall Study|Lost to Follow-up|0|||
147660204|NCT02019550|532579790|FG000|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
147660205|NCT02019550|532579791|FG001|Treatment Period 1 (4 Weeks)|Adverse Event|1|||
147660206|NCT02787304|532579794|FG000|Overall Study|Adverse Event|9|||
147660207|NCT02787304|532579795|FG001|Overall Study|Adverse Event|3|||
147660208|NCT02787304|532579796|FG002|Overall Study|Adverse Event|8|||
147660209|NCT02787304|532579797|FG003|Overall Study|Adverse Event|1|||
147250012|NCT02013791|531083835|FG005|Period 1|Other Miscellaneous Reasons|0|||
147660210|NCT02787304|532579794|FG000|Overall Study|Withdrawal by Subject|1|||
147660211|NCT02787304|532579795|FG001|Overall Study|Withdrawal by Subject|4|||
147660212|NCT02787304|532579796|FG002|Overall Study|Withdrawal by Subject|0|||
147660213|NCT02787304|532579797|FG003|Overall Study|Withdrawal by Subject|0|||
147660214|NCT02787304|532579794|FG000|Overall Study|Lost to Follow-up|1|||
147660215|NCT02787304|532579795|FG001|Overall Study|Lost to Follow-up|0|||
147660216|NCT02787304|532579796|FG002|Overall Study|Lost to Follow-up|0|||
147331260|NCT02034916|531379132|FG000|Overall Study|Lost to Follow-up|4|||
147596259|NCT04049617|532340821|FG005|Overall Study|Lost to Follow-up|0|||
147250013|NCT02013791|531083836|FG006|Period 1|Other Miscellaneous Reasons|0|||
147250014|NCT02013791|531083837|FG007|Period 1|Other Miscellaneous Reasons|0|||
147250015|NCT02013791|531083838|FG008|Period 1|Other Miscellaneous Reasons|0|||
147250016|NCT02170051|531083839|FG000|Overall Study|Withdrawal by Subject|10|||
147250017|NCT02170051|531083840|FG001|Overall Study|Withdrawal by Subject|10|||
147250018|NCT02170051|531083839|FG000|Overall Study|Lost to Follow-up|1|||
147250019|NCT02170051|531083840|FG001|Overall Study|Lost to Follow-up|3|||
147250020|NCT03798483|531083841|FG000|Overall Study|Lost to Follow-up|2|||
147250021|NCT00276744|531083842|FG000|PART A|Reason unknown|98|||
147250022|NCT01835587|531083849|FG000|Overall Study|Disease Recurrence or Relapse|0|||
147250023|NCT01835587|531083850|FG001|Overall Study|Disease Recurrence or Relapse|3|||
147250024|NCT01835587|531083851|FG002|Overall Study|Disease Recurrence or Relapse|0|||
147250025|NCT01835587|531083852|FG003|Overall Study|Disease Recurrence or Relapse|3|||
147250026|NCT01835587|531083849|FG000|Overall Study|Withdrawal by Subject|2|||
147250027|NCT01835587|531083850|FG001|Overall Study|Withdrawal by Subject|0|||
147250028|NCT01835587|531083851|FG002|Overall Study|Withdrawal by Subject|0|||
147250029|NCT01835587|531083852|FG003|Overall Study|Withdrawal by Subject|3|||
147250030|NCT01835587|531083849|FG000|Overall Study|Adverse Event|0|||
147250031|NCT01835587|531083850|FG001|Overall Study|Adverse Event|0|||
147250032|NCT01835587|531083851|FG002|Overall Study|Adverse Event|2|||
147250033|NCT01835587|531083852|FG003|Overall Study|Adverse Event|2|||
147250034|NCT01835587|531083849|FG000|Overall Study|Death|0|||
147331261|NCT02034916|531379133|FG001|Overall Study|Lost to Follow-up|1|||
147331262|NCT02034916|531379132|FG000|Overall Study|Study terminated by sponsor|4|||
147331263|NCT02034916|531379133|FG001|Overall Study|Study terminated by sponsor|5|||
147331264|NCT04842604|531379140|FG000|Overall Study|Death|1|||
147331265|NCT04842604|531379141|FG001|Overall Study|Death|0|||
147331266|NCT04842604|531379140|FG000|Overall Study|Other|4|||
147331267|NCT04842604|531379141|FG001|Overall Study|Other|4|||
147331268|NCT04842604|531379140|FG000|Overall Study|Randomized but not treated|1|||
147331269|NCT04842604|531379141|FG001|Overall Study|Randomized but not treated|0|||
147331270|NCT00344019|531379143|FG000|Overall Study|did not meet final inclusion criteria|0|||
147331271|NCT00344019|531379144|FG001|Overall Study|did not meet final inclusion criteria|0|||
147331272|NCT00344019|531379145|FG002|Overall Study|did not meet final inclusion criteria|74|||
147331273|NCT02503202|531379146|FG000|Base Study: Up to Month 6|Death|1|||
147449676|NCT02443883|531809552|FG003|Overall Study|Adverse Event|0|||
147449677|NCT02443883|531809549|FG000|Overall Study|Lost to Follow-up|3|||
147449678|NCT02443883|531809550|FG001|Overall Study|Lost to Follow-up|2|||
147449679|NCT02443883|531809551|FG002|Overall Study|Lost to Follow-up|1|||
147449680|NCT02443883|531809552|FG003|Overall Study|Lost to Follow-up|0|||
147449681|NCT02443883|531809549|FG000|Overall Study|Physician Decision|1|||
147449682|NCT02443883|531809550|FG001|Overall Study|Physician Decision|1|||
147449683|NCT02443883|531809551|FG002|Overall Study|Physician Decision|0|||
147449684|NCT02443883|531809552|FG003|Overall Study|Physician Decision|3|||
147449685|NCT02443883|531809549|FG000|Overall Study|Withdrawal by Subject|1|||
147449686|NCT02443883|531809550|FG001|Overall Study|Withdrawal by Subject|0|||
147449687|NCT02443883|531809551|FG002|Overall Study|Withdrawal by Subject|0|||
147449688|NCT02443883|531809552|FG003|Overall Study|Withdrawal by Subject|2|||
147449689|NCT02443883|531809549|FG000|Overall Study|Randomized, but never treated|1|||
147449690|NCT02443883|531809550|FG001|Overall Study|Randomized, but never treated|0|||
147449691|NCT02443883|531809551|FG002|Overall Study|Randomized, but never treated|0|||
147449692|NCT02443883|531809552|FG003|Overall Study|Randomized, but never treated|0|||
147449693|NCT02199080|531809553|FG000|Overall Study|Protocol Violation|12|||
147449694|NCT02250274|531809554|FG000|Overall Study|Insufficient blood draw amount|7|||
147449695|NCT02250274|531809555|FG001|Overall Study|Insufficient blood draw amount|6|||
147449696|NCT00446511|531809558|FG000|Overall Study|Adverse Event|7|||
147449697|NCT00446511|531809559|FG001|Overall Study|Adverse Event|2|||
147449698|NCT00446511|531809560|FG002|Overall Study|Adverse Event|3|||
147449699|NCT00446511|531809561|FG003|Overall Study|Adverse Event|1|||
147449700|NCT00446511|531809558|FG000|Overall Study|Protocol Violation|0|||
147449701|NCT00446511|531809559|FG001|Overall Study|Protocol Violation|0|||
147449702|NCT00446511|531809560|FG002|Overall Study|Protocol Violation|0|||
147449703|NCT00446511|531809561|FG003|Overall Study|Protocol Violation|1|||
147449704|NCT00446511|531809558|FG000|Overall Study|Withdrawal by Subject|0|||
147449705|NCT00446511|531809559|FG001|Overall Study|Withdrawal by Subject|0|||
147449706|NCT00446511|531809560|FG002|Overall Study|Withdrawal by Subject|0|||
147449707|NCT00446511|531809561|FG003|Overall Study|Withdrawal by Subject|3|||
147449708|NCT00446511|531809558|FG000|Overall Study|Administrative Problems|3|||
147449709|NCT00446511|531809559|FG001|Overall Study|Administrative Problems|0|||
147449710|NCT00446511|531809560|FG002|Overall Study|Administrative Problems|4|||
147449711|NCT00446511|531809561|FG003|Overall Study|Administrative Problems|1|||
147449712|NCT00835237|531809564|FG000|Overall Study|Lost to Follow-up|4|||
147449713|NCT00835237|531809565|FG001|Overall Study|Lost to Follow-up|0|||
147449714|NCT00835237|531809564|FG000|Overall Study|Withdrawal by Subject|2|||
147449715|NCT00835237|531809565|FG001|Overall Study|Withdrawal by Subject|0|||
147449716|NCT01265550|531809568|FG000|Pre Randomization|Withdrawal by Subject|0|||
147449717|NCT01265550|531809569|FG001|Pre Randomization|Withdrawal by Subject|0|||
147250035|NCT01835587|531083850|FG001|Overall Study|Death|0|||
147250036|NCT01835587|531083851|FG002|Overall Study|Death|0|||
147250037|NCT01835587|531083852|FG003|Overall Study|Death|1|||
147250038|NCT01835587|531083849|FG000|Overall Study|Miscellaneous|0|||
147250039|NCT01835587|531083850|FG001|Overall Study|Miscellaneous|1|||
147250040|NCT01835587|531083851|FG002|Overall Study|Miscellaneous|0|||
147250041|NCT01835587|531083852|FG003|Overall Study|Miscellaneous|0|||
147250042|NCT03310775|531083856|FG000|Overall Study|Lost to Follow-up|2|||
147250043|NCT03310775|531083857|FG001|Overall Study|Lost to Follow-up|3|||
147250044|NCT03310775|531083856|FG000|Overall Study|aggravation of depression|0|||
147250045|NCT03310775|531083857|FG001|Overall Study|aggravation of depression|1|||
147250046|NCT00126568|531083858|FG000|Overall Study|Death|2|||
147250047|NCT03064451|531083859|FG000|Overall Study|Lost to Follow-up|1|||
147250048|NCT03064451|531083859|FG000|Overall Study|Mapping Failure|4|||
147250049|NCT03064451|531083859|FG000|Overall Study|Exited prior to procedure|8|||
147331274|NCT02503202|531379147|FG001|Base Study: Up to Month 6|Death|1|||
147331275|NCT02503202|531379148|FG002|Base Study: Up to Month 6|Death|0|||
147331276|NCT02503202|531379149|FG003|Base Study: Up to Month 6|Death|0|||
147331277|NCT02503202|531379150|FG004|Base Study: Up to Month 6|Death|0|||
147331278|NCT02503202|531379146|FG000|Base Study: Up to Month 6|Lost to Follow-up|11|||
147331279|NCT02503202|531379147|FG001|Base Study: Up to Month 6|Lost to Follow-up|8|||
147331280|NCT02503202|531379148|FG002|Base Study: Up to Month 6|Lost to Follow-up|10|||
147331281|NCT02503202|531379149|FG003|Base Study: Up to Month 6|Lost to Follow-up|5|||
147331282|NCT02503202|531379150|FG004|Base Study: Up to Month 6|Lost to Follow-up|1|||
147331283|NCT02503202|531379146|FG000|Base Study: Up to Month 6|Physician Decision|0|||
147331284|NCT02503202|531379147|FG001|Base Study: Up to Month 6|Physician Decision|0|||
147331285|NCT02503202|531379148|FG002|Base Study: Up to Month 6|Physician Decision|0|||
147331286|NCT02503202|531379149|FG003|Base Study: Up to Month 6|Physician Decision|0|||
147331287|NCT02503202|531379150|FG004|Base Study: Up to Month 6|Physician Decision|1|||
147331288|NCT02503202|531379146|FG000|Base Study: Up to Month 6|Withdrawal by Subject|6|||
147331289|NCT02503202|531379147|FG001|Base Study: Up to Month 6|Withdrawal by Subject|3|||
147331290|NCT02503202|531379148|FG002|Base Study: Up to Month 6|Withdrawal by Subject|4|||
147331291|NCT02503202|531379149|FG003|Base Study: Up to Month 6|Withdrawal by Subject|4|||
147331292|NCT02503202|531379150|FG004|Base Study: Up to Month 6|Withdrawal by Subject|1|||
147449718|NCT01265550|531809570|FG002|Pre Randomization|Withdrawal by Subject|0|||
147449719|NCT01265550|531809571|FG003|Pre Randomization|Withdrawal by Subject|70|||
147449720|NCT01265550|531809568|FG000|Pre Randomization|Technical Exclusions|0|||
147449721|NCT01265550|531809569|FG001|Pre Randomization|Technical Exclusions|0|||
147449722|NCT01265550|531809570|FG002|Pre Randomization|Technical Exclusions|0|||
147449723|NCT01265550|531809571|FG003|Pre Randomization|Technical Exclusions|54|||
147449724|NCT01265550|531809568|FG000|Pre Randomization|GERD, PPI-Responsive|0|||
147449725|NCT01265550|531809569|FG001|Pre Randomization|GERD, PPI-Responsive|0|||
147449726|NCT01265550|531809570|FG002|Pre Randomization|GERD, PPI-Responsive|0|||
147449727|NCT01265550|531809571|FG003|Pre Randomization|GERD, PPI-Responsive|42|||
147449728|NCT01265550|531809568|FG000|Pre Randomization|Non-GERD organic disorders|0|||
147449729|NCT01265550|531809569|FG001|Pre Randomization|Non-GERD organic disorders|0|||
147449730|NCT01265550|531809570|FG002|Pre Randomization|Non-GERD organic disorders|0|||
147449731|NCT01265550|531809571|FG003|Pre Randomization|Non-GERD organic disorders|23|||
147449732|NCT01265550|531809568|FG000|Pre Randomization|Functional heartburn|0|||
147449733|NCT01265550|531809569|FG001|Pre Randomization|Functional heartburn|0|||
147449734|NCT01265550|531809570|FG002|Pre Randomization|Functional heartburn|0|||
147449735|NCT01265550|531809571|FG003|Pre Randomization|Functional heartburn|99|||
147449736|NCT01627860|531809574|FG000|Overall Study|Adverse Event|9|||
147449737|NCT01627860|531809575|FG001|Overall Study|Adverse Event|4|||
147449738|NCT01627860|531809574|FG000|Overall Study|Withdrawal by Subject|2|||
147449739|NCT01627860|531809575|FG001|Overall Study|Withdrawal by Subject|1|||
147449740|NCT01627860|531809574|FG000|Overall Study|Seizure frequency doubled|0|||
147449741|NCT01627860|531809575|FG001|Overall Study|Seizure frequency doubled|1|||
147449742|NCT01627860|531809574|FG000|Overall Study|Protocol Violation|1|||
147449743|NCT01627860|531809575|FG001|Overall Study|Protocol Violation|0|||
147449744|NCT02970292|531809576|FG000|Overall Study|Physician Decision|1|||
147449745|NCT02970292|531809577|FG001|Overall Study|Physician Decision|1|||
147449746|NCT02970292|531809576|FG000|Overall Study|Withdrawal by Subject|11|||
147449747|NCT02970292|531809577|FG001|Overall Study|Withdrawal by Subject|5|||
147449748|NCT02970292|531809576|FG000|Overall Study|Noncompliance with study drug|2|||
147331293|NCT02503202|531379146|FG000|Base Study: Up to Month 6|Randomized not vaccinated|0|||
147449749|NCT02970292|531809577|FG001|Overall Study|Noncompliance with study drug|2|||
147449750|NCT02970292|531809576|FG000|Overall Study|Adverse Event|5|||
147250050|NCT03064451|531083859|FG000|Overall Study|Withdrew consent: 3-month FU visit|1|||
147250051|NCT00750204|531083860|FG000|Overall Study|study halted prematurely|1|||
147250052|NCT00750204|531083861|FG001|Overall Study|study halted prematurely|1|||
147449751|NCT02970292|531809577|FG001|Overall Study|Adverse Event|0|||
147449752|NCT02970292|531809576|FG000|Overall Study|Lack of Efficacy|1|||
147449753|NCT02970292|531809577|FG001|Overall Study|Lack of Efficacy|0|||
147449754|NCT02970292|531809576|FG000|Overall Study|Lost to Follow-up|1|||
147449755|NCT02970292|531809577|FG001|Overall Study|Lost to Follow-up|0|||
147660217|NCT02787304|532579797|FG003|Overall Study|Lost to Follow-up|1|||
147660218|NCT02787304|532579794|FG000|Overall Study|Noncompliance with study drug|0|||
147660219|NCT02787304|532579795|FG001|Overall Study|Noncompliance with study drug|0|||
147660220|NCT02787304|532579796|FG002|Overall Study|Noncompliance with study drug|1|||
147660221|NCT02787304|532579797|FG003|Overall Study|Noncompliance with study drug|0|||
147660222|NCT02787304|532579794|FG000|Overall Study|Physician Decision|0|||
147660223|NCT02787304|532579795|FG001|Overall Study|Physician Decision|0|||
147660224|NCT02787304|532579796|FG002|Overall Study|Physician Decision|1|||
147660225|NCT02787304|532579797|FG003|Overall Study|Physician Decision|0|||
147660226|NCT02787304|532579794|FG000|Overall Study|Study terminated by sponsor|25|||
147660227|NCT02787304|532579795|FG001|Overall Study|Study terminated by sponsor|31|||
147660228|NCT02787304|532579796|FG002|Overall Study|Study terminated by sponsor|31|||
147660229|NCT02787304|532579797|FG003|Overall Study|Study terminated by sponsor|32|||
147250053|NCT04853225|531083864|FG000|Overall Study|Withdrawal by Subject|81|||
147250054|NCT04853225|531083865|FG001|Overall Study|Withdrawal by Subject|4|||
147660230|NCT04771013|532579798|FG000|Overall Study|Withdrawal by Subject|2|||
147660231|NCT04771013|532579799|FG001|Overall Study|Withdrawal by Subject|0|||
147660232|NCT04771013|532579798|FG000|Overall Study|Death|0|||
147660233|NCT04771013|532579799|FG001|Overall Study|Death|5|||
147660234|NCT04771013|532579798|FG000|Overall Study|Referred to another hospital before day 20|0|||
147660235|NCT04771013|532579799|FG001|Overall Study|Referred to another hospital before day 20|1|||
147660236|NCT00823134|532579801|FG000|Overall Study|Invalid measurement|1|||
147660237|NCT00419757|532579805|FG000|Overall Study|Adverse Event|1|||
147660238|NCT00419757|532579806|FG001|Overall Study|Adverse Event|4|||
147660239|NCT00419757|532579805|FG000|Overall Study|Lost to Follow-up|1|||
147660240|NCT00419757|532579806|FG001|Overall Study|Lost to Follow-up|4|||
147660241|NCT00419757|532579805|FG000|Overall Study|Withdrawal by Subject|7|||
147660242|NCT00419757|532579806|FG001|Overall Study|Withdrawal by Subject|1|||
147660243|NCT00419757|532579805|FG000|Overall Study|Protocol Violation|2|||
147660244|NCT00419757|532579806|FG001|Overall Study|Protocol Violation|3|||
147660245|NCT00419757|532579805|FG000|Overall Study|Study specific discontinuation criteria|4|||
147660246|NCT00419757|532579806|FG001|Overall Study|Study specific discontinuation criteria|8|||
147660247|NCT00419757|532579805|FG000|Overall Study|Multiple reasons|3|||
147660248|NCT00419757|532579806|FG001|Overall Study|Multiple reasons|1|||
147660249|NCT00379834|532579811|FG000|Overall Study|Time constraints|2|||
147660250|NCT01519817|532579812|FG000|Overall Study|Withdrawal by Subject|1|||
147660251|NCT01519817|532579813|FG001|Overall Study|Withdrawal by Subject|0|||
147660252|NCT01519817|532579814|FG002|Overall Study|Withdrawal by Subject|0|||
147660253|NCT01519817|532579815|FG003|Overall Study|Withdrawal by Subject|0|||
147660254|NCT01519817|532579812|FG000|Overall Study|Off study due to infection|0|||
147660255|NCT01519817|532579813|FG001|Overall Study|Off study due to infection|0|||
147250055|NCT04853225|531083866|FG002|Overall Study|Withdrawal by Subject|1|||
147250056|NCT04853225|531083864|FG000|Overall Study|Physician Decision|12|||
147250057|NCT04853225|531083865|FG001|Overall Study|Physician Decision|4|||
147250058|NCT04853225|531083866|FG002|Overall Study|Physician Decision|1|||
147250059|NCT04853225|531083864|FG000|Overall Study|Lost to Follow-up|50|||
147250060|NCT04853225|531083865|FG001|Overall Study|Lost to Follow-up|0|||
147250061|NCT04853225|531083866|FG002|Overall Study|Lost to Follow-up|0|||
147250062|NCT04853225|531083864|FG000|Overall Study|Other|102|||
147250063|NCT04853225|531083865|FG001|Overall Study|Other|11|||
147250064|NCT04853225|531083866|FG002|Overall Study|Other|5|||
147250065|NCT04853225|531083864|FG000|Overall Study|Not included in the Full Population due to Investigator discretion|1|||
147250066|NCT04853225|531083865|FG001|Overall Study|Not included in the Full Population due to Investigator discretion|0|||
147250067|NCT04853225|531083866|FG002|Overall Study|Not included in the Full Population due to Investigator discretion|0|||
147250068|NCT04853225|531083864|FG000|Overall Study|Not included in the Full Population due to withdrew consent|1|||
147250069|NCT04853225|531083865|FG001|Overall Study|Not included in the Full Population due to withdrew consent|0|||
147449756|NCT02970292|531809576|FG000|Overall Study|Protocol Violation|2|||
147660256|NCT01519817|532579814|FG002|Overall Study|Off study due to infection|0|||
147660257|NCT01519817|532579815|FG003|Overall Study|Off study due to infection|1|||
147660258|NCT02922153|532579816|FG000|Overall Study|Death|8|||
147660259|NCT02922153|532579817|FG001|Overall Study|Death|1|||
147660260|NCT02922153|532579816|FG000|Overall Study|Lost to Follow-up|1|||
147660261|NCT02922153|532579817|FG001|Overall Study|Lost to Follow-up|0|||
147660262|NCT02922153|532579816|FG000|Overall Study|Physician Decision|1|||
147660263|NCT02922153|532579817|FG001|Overall Study|Physician Decision|1|||
147660264|NCT01325350|532579820|FG000|Overall Study|Adverse Event|3|||
147660265|NCT01325350|532579821|FG001|Overall Study|Adverse Event|3|||
147660266|NCT01325350|532579822|FG002|Overall Study|Adverse Event|3|||
147660267|NCT01325350|532579823|FG003|Overall Study|Adverse Event|1|||
147660268|NCT01325350|532579824|FG004|Overall Study|Adverse Event|2|||
147660269|NCT01325350|532579820|FG000|Overall Study|Pregnancy|0|||
147660270|NCT01325350|532579821|FG001|Overall Study|Pregnancy|0|||
147660271|NCT01325350|532579822|FG002|Overall Study|Pregnancy|1|||
147660272|NCT01325350|532579823|FG003|Overall Study|Pregnancy|0|||
147660273|NCT01325350|532579824|FG004|Overall Study|Pregnancy|1|||
147660274|NCT01325350|532579820|FG000|Overall Study|Lost to Follow-up|1|||
147331294|NCT02503202|531379147|FG001|Base Study: Up to Month 6|Randomized not vaccinated|0|||
147250070|NCT04853225|531083866|FG002|Overall Study|Not included in the Full Population due to withdrew consent|0|||
147250071|NCT01404325|531085756|FG000|Overall Study|Lost to Follow-up|1|||
147250072|NCT01404325|531085757|FG001|Overall Study|Lost to Follow-up|0|||
147250073|NCT01404325|531085756|FG000|Overall Study|Death|2|||
147250074|NCT01404325|531085757|FG001|Overall Study|Death|0|||
147250075|NCT01404325|531085756|FG000|Overall Study|Graft loss/Retransplantation|1|||
147250076|NCT01404325|531085757|FG001|Overall Study|Graft loss/Retransplantation|0|||
147250077|NCT01404325|531085756|FG000|Overall Study|non-specified reason|0|||
147250078|NCT01404325|531085757|FG001|Overall Study|non-specified reason|2|||
147250079|NCT01411228|531085760|FG000|Overall Study|Lost to Follow-up|0|||
147250080|NCT01411228|531085761|FG001|Overall Study|Lost to Follow-up|0|||
147250081|NCT01411228|531085762|FG002|Overall Study|Lost to Follow-up|1|||
147449757|NCT02970292|531809577|FG001|Overall Study|Protocol Violation|0|||
147660275|NCT01325350|532579821|FG001|Overall Study|Lost to Follow-up|0|||
147660276|NCT01325350|532579822|FG002|Overall Study|Lost to Follow-up|5|||
147660277|NCT01325350|532579823|FG003|Overall Study|Lost to Follow-up|1|||
147660278|NCT01325350|532579824|FG004|Overall Study|Lost to Follow-up|5|||
147660279|NCT01325350|532579820|FG000|Overall Study|Personal Reasons|2|||
147660280|NCT01325350|532579821|FG001|Overall Study|Personal Reasons|1|||
147660281|NCT01325350|532579822|FG002|Overall Study|Personal Reasons|6|||
147660282|NCT01325350|532579823|FG003|Overall Study|Personal Reasons|5|||
147660283|NCT01325350|532579824|FG004|Overall Study|Personal Reasons|3|||
147660284|NCT01325350|532579820|FG000|Overall Study|Protocol Violation|0|||
147660285|NCT01325350|532579821|FG001|Overall Study|Protocol Violation|0|||
147660286|NCT01325350|532579822|FG002|Overall Study|Protocol Violation|0|||
147660287|NCT01325350|532579823|FG003|Overall Study|Protocol Violation|1|||
147660288|NCT01325350|532579824|FG004|Overall Study|Protocol Violation|0|||
147660289|NCT01325350|532579820|FG000|Overall Study|Withdrawal by Subject|0|||
147660290|NCT01325350|532579821|FG001|Overall Study|Withdrawal by Subject|0|||
147660291|NCT01325350|532579822|FG002|Overall Study|Withdrawal by Subject|1|||
147660292|NCT01325350|532579823|FG003|Overall Study|Withdrawal by Subject|1|||
147660293|NCT01325350|532579824|FG004|Overall Study|Withdrawal by Subject|0|||
147660294|NCT01325350|532579820|FG000|Overall Study|Did Not Receive Treatment|0|||
147660295|NCT01325350|532579821|FG001|Overall Study|Did Not Receive Treatment|1|||
147660296|NCT01325350|532579822|FG002|Overall Study|Did Not Receive Treatment|1|||
147660297|NCT01325350|532579823|FG003|Overall Study|Did Not Receive Treatment|0|||
147660298|NCT01325350|532579824|FG004|Overall Study|Did Not Receive Treatment|1|||
147660299|NCT01716806|532579827|FG000|Overall Study|Patient withdrawal of consent|4|||
147660300|NCT01716806|532579828|FG001|Overall Study|Patient withdrawal of consent|2|||
147660301|NCT01716806|532579829|FG002|Overall Study|Patient withdrawal of consent|4|||
147660302|NCT01716806|532579830|FG003|Overall Study|Patient withdrawal of consent|3|||
147660303|NCT01716806|532579831|FG004|Overall Study|Patient withdrawal of consent|2|||
147660304|NCT01716806|532579832|FG005|Overall Study|Patient withdrawal of consent|0|||
147660305|NCT01716806|532579827|FG000|Overall Study|Lost to Follow-up|3|||
147660306|NCT01716806|532579828|FG001|Overall Study|Lost to Follow-up|3|||
147660307|NCT01716806|532579829|FG002|Overall Study|Lost to Follow-up|0|||
147660308|NCT01716806|532579830|FG003|Overall Study|Lost to Follow-up|2|||
147660309|NCT01716806|532579831|FG004|Overall Study|Lost to Follow-up|1|||
147660310|NCT01716806|532579832|FG005|Overall Study|Lost to Follow-up|0|||
147660311|NCT01716806|532579827|FG000|Overall Study|Death|13|||
147660312|NCT01716806|532579828|FG001|Overall Study|Death|9|||
147660313|NCT01716806|532579829|FG002|Overall Study|Death|12|||
147660314|NCT01716806|532579830|FG003|Overall Study|Death|4|||
147660315|NCT01716806|532579831|FG004|Overall Study|Death|10|||
147660316|NCT01716806|532579832|FG005|Overall Study|Death|5|||
147660317|NCT01716806|532579827|FG000|Overall Study|Received treatment past data cutoff of up to 16 doses of BV. AEs collected until end of study.|0|||
147660318|NCT01716806|532579828|FG001|Overall Study|Received treatment past data cutoff of up to 16 doses of BV. AEs collected until end of study.|0|||
147660319|NCT01716806|532579829|FG002|Overall Study|Received treatment past data cutoff of up to 16 doses of BV. AEs collected until end of study.|0|||
147660320|NCT01716806|532579830|FG003|Overall Study|Received treatment past data cutoff of up to 16 doses of BV. AEs collected until end of study.|0|||
147660321|NCT01716806|532579831|FG004|Overall Study|Received treatment past data cutoff of up to 16 doses of BV. AEs collected until end of study.|1|||
147660322|NCT01716806|532579832|FG005|Overall Study|Received treatment past data cutoff of up to 16 doses of BV. AEs collected until end of study.|1|||
147660323|NCT01716806|532579827|FG000|Overall Study|PI decision|0|||
147660324|NCT01716806|532579828|FG001|Overall Study|PI decision|0|||
147660325|NCT01716806|532579829|FG002|Overall Study|PI decision|0|||
147660326|NCT01716806|532579830|FG003|Overall Study|PI decision|0|||
147660327|NCT01716806|532579831|FG004|Overall Study|PI decision|1|||
147660328|NCT01716806|532579832|FG005|Overall Study|PI decision|0|||
147660329|NCT01716806|532579827|FG000|Overall Study|Change in performance status|1|||
147660330|NCT01716806|532579828|FG001|Overall Study|Change in performance status|0|||
147250082|NCT01411228|531085760|FG000|Overall Study|Withdrawal by Subject|1|||
147250083|NCT01411228|531085761|FG001|Overall Study|Withdrawal by Subject|0|||
147250084|NCT01411228|531085762|FG002|Overall Study|Withdrawal by Subject|0|||
147250085|NCT01986855|531085763|FG000|Overall Study|Adverse Event|1|||
147660331|NCT01716806|532579829|FG002|Overall Study|Change in performance status|0|||
147660332|NCT01716806|532579830|FG003|Overall Study|Change in performance status|0|||
147660333|NCT01716806|532579831|FG004|Overall Study|Change in performance status|0|||
147660334|NCT01716806|532579832|FG005|Overall Study|Change in performance status|0|||
147660335|NCT01716806|532579827|FG000|Overall Study|Sponsor terminated enrollment into Part C|0|||
147660336|NCT01716806|532579828|FG001|Overall Study|Sponsor terminated enrollment into Part C|0|||
147660337|NCT01716806|532579829|FG002|Overall Study|Sponsor terminated enrollment into Part C|1|||
147660338|NCT01716806|532579830|FG003|Overall Study|Sponsor terminated enrollment into Part C|0|||
147660339|NCT01716806|532579831|FG004|Overall Study|Sponsor terminated enrollment into Part C|0|||
147660340|NCT01716806|532579832|FG005|Overall Study|Sponsor terminated enrollment into Part C|0|||
147660341|NCT01716806|532579827|FG000|Overall Study|Sponsor direction|7|||
147660342|NCT01716806|532579828|FG001|Overall Study|Sponsor direction|8|||
147660343|NCT01716806|532579829|FG002|Overall Study|Sponsor direction|5|||
147660344|NCT01716806|532579830|FG003|Overall Study|Sponsor direction|12|||
147660345|NCT01716806|532579831|FG004|Overall Study|Sponsor direction|16|||
147660346|NCT01716806|532579832|FG005|Overall Study|Sponsor direction|1|||
147660347|NCT03506438|532579833|FG000|Overall Study|Lost to Follow-up|8|||
147660348|NCT03506438|532579834|FG001|Overall Study|Lost to Follow-up|7|||
147660349|NCT03506438|532579835|FG002|Overall Study|Lost to Follow-up|8|||
147660350|NCT03506438|532579836|FG003|Overall Study|Lost to Follow-up|7|||
147660351|NCT03506438|532579837|FG004|Overall Study|Lost to Follow-up|0|||
147660352|NCT03506438|532579838|FG005|Overall Study|Lost to Follow-up|0|||
147660353|NCT01128296|532579839|FG000|Overall Study|Physician Decision|0|||
147660354|NCT01128296|532579840|FG001|Overall Study|Physician Decision|0|||
147660355|NCT01128296|532579841|FG002|Overall Study|Physician Decision|0|||
147660356|NCT01128296|532579842|FG003|Overall Study|Physician Decision|0|||
147660357|NCT01128296|532579843|FG004|Overall Study|Physician Decision|0|||
147660358|NCT01128296|532579844|FG005|Overall Study|Physician Decision|3|||
147660359|NCT01128296|532579839|FG000|Overall Study|Withdrawal by Subject|0|||
147660360|NCT01128296|532579840|FG001|Overall Study|Withdrawal by Subject|0|||
147660361|NCT01128296|532579841|FG002|Overall Study|Withdrawal by Subject|0|||
147660362|NCT01128296|532579842|FG003|Overall Study|Withdrawal by Subject|0|||
147660363|NCT01128296|532579843|FG004|Overall Study|Withdrawal by Subject|0|||
147660364|NCT01128296|532579844|FG005|Overall Study|Withdrawal by Subject|2|||
147660365|NCT02806713|532579847|FG000|Overall Study|Urethral injury during procedure|1|||
147660366|NCT02806713|532579848|FG001|Overall Study|Urethral injury during procedure|0|||
147660367|NCT02806713|532579847|FG000|Overall Study|cancelled surgery|1|||
147660368|NCT02806713|532579848|FG001|Overall Study|cancelled surgery|2|||
147660369|NCT00521365|532579867|FG000|Overall Study|Adverse Event|3|||
147660370|NCT00521365|532579867|FG000|Overall Study|Lost to Follow-up|6|||
147660371|NCT00521365|532579867|FG000|Overall Study|Protocol deviation|2|||
147660372|NCT00521365|532579867|FG000|Overall Study|Drug compliance|3|||
147660373|NCT00521365|532579867|FG000|Overall Study|Usage of not allowed drugs|6|||
147660374|NCT01718483|532579868|FG000|Overall Study|Withdrawal by Subject|14|||
147660375|NCT01718483|532579869|FG001|Overall Study|Withdrawal by Subject|12|||
147660376|NCT01718483|532579868|FG000|Overall Study|Adverse Event|5|||
147660377|NCT01718483|532579869|FG001|Overall Study|Adverse Event|12|||
147660378|NCT01718483|532579868|FG000|Overall Study|Lost to Follow-up|8|||
147660379|NCT01718483|532579869|FG001|Overall Study|Lost to Follow-up|3|||
147660380|NCT01718483|532579868|FG000|Overall Study|Protocol Violation|4|||
147660381|NCT01718483|532579869|FG001|Overall Study|Protocol Violation|2|||
147660382|NCT01718483|532579868|FG000|Overall Study|Other|1|||
147660383|NCT01718483|532579869|FG001|Overall Study|Other|4|||
147660384|NCT01718483|532579868|FG000|Overall Study|Pregnancy|1|||
147331295|NCT02503202|531379148|FG002|Base Study: Up to Month 6|Randomized not vaccinated|1|||
147331296|NCT02503202|531379149|FG003|Base Study: Up to Month 6|Randomized not vaccinated|2|||
147331297|NCT02503202|531379150|FG004|Base Study: Up to Month 6|Randomized not vaccinated|0|||
147331298|NCT02503202|531379146|FG000|Extension: Month 6 to 24|Protocol Violation|0|||
147331299|NCT02503202|531379147|FG001|Extension: Month 6 to 24|Protocol Violation|0|||
147331300|NCT02503202|531379148|FG002|Extension: Month 6 to 24|Protocol Violation|0|||
147331301|NCT02503202|531379149|FG003|Extension: Month 6 to 24|Protocol Violation|1|||
147331302|NCT02503202|531379150|FG004|Extension: Month 6 to 24|Protocol Violation|0|||
147331303|NCT02503202|531379146|FG000|Extension: Month 6 to 24|Death|1|||
147331304|NCT02503202|531379147|FG001|Extension: Month 6 to 24|Death|0|||
147449758|NCT02970292|531809576|FG000|Overall Study|Other|1|||
147660385|NCT01718483|532579869|FG001|Overall Study|Pregnancy|1|||
147660386|NCT01718483|532579868|FG000|Overall Study|Lack of Efficacy|1|||
147660387|NCT01718483|532579869|FG001|Overall Study|Lack of Efficacy|0|||
147660388|NCT04547140|532579872|FG000|Overall Study|Adverse Event|0|||
147660389|NCT04547140|532579873|FG001|Overall Study|Adverse Event|1|||
147660390|NCT04547140|532579872|FG000|Overall Study|Withdrawal by Subject|0|||
147660391|NCT04547140|532579873|FG001|Overall Study|Withdrawal by Subject|1|||
147660392|NCT04547140|532579872|FG000|Overall Study|Lost to Follow-up|3|||
147660393|NCT04547140|532579873|FG001|Overall Study|Lost to Follow-up|1|||
147660394|NCT04547140|532579872|FG000|Overall Study|Death|2|||
147660395|NCT04547140|532579873|FG001|Overall Study|Death|1|||
147331305|NCT02503202|531379148|FG002|Extension: Month 6 to 24|Death|0|||
147660396|NCT04547140|532579872|FG000|Overall Study|Physician Decision (Does not Include Adverse Events)|0|||
147596260|NCT04049617|532340816|FG000|Overall Study|Withdrew consent|0|||
147596261|NCT04049617|532340817|FG001|Overall Study|Withdrew consent|0|||
147596262|NCT04049617|532340818|FG002|Overall Study|Withdrew consent|1|||
147596263|NCT04049617|532340819|FG003|Overall Study|Withdrew consent|0|||
147596264|NCT04049617|532340820|FG004|Overall Study|Withdrew consent|0|||
147596265|NCT04049617|532340821|FG005|Overall Study|Withdrew consent|0|||
147596266|NCT03551496|532340822|FG000|Overall Study|Death|11|||
147596267|NCT03551496|532340823|FG001|Overall Study|Death|7|||
147596268|NCT03551496|532340822|FG000|Overall Study|Withdrawal by Subject|4|||
147596269|NCT03551496|532340823|FG001|Overall Study|Withdrawal by Subject|3|||
147596270|NCT03551496|532340822|FG000|Overall Study|Other Reasons|1|||
147660397|NCT04547140|532579873|FG001|Overall Study|Physician Decision (Does not Include Adverse Events)|1|||
147660398|NCT04547140|532579872|FG000|Overall Study|Pregnancy|1|||
147660399|NCT04547140|532579873|FG001|Overall Study|Pregnancy|0|||
147660400|NCT04547140|532579872|FG000|Overall Study|Reason Not Specified|4|||
147660401|NCT04547140|532579873|FG001|Overall Study|Reason Not Specified|1|||
147660402|NCT00873730|532579874|FG000|Overall Study|Protocol Deviation|5|||
147660403|NCT00873730|532579875|FG001|Overall Study|Protocol Deviation|2|||
147660404|NCT00873730|532579874|FG000|Overall Study|Adverse Event|0|||
147660405|NCT00873730|532579875|FG001|Overall Study|Adverse Event|2|||
147660406|NCT00873730|532579874|FG000|Overall Study|Withdrawal by Subject|0|||
147660407|NCT00873730|532579875|FG001|Overall Study|Withdrawal by Subject|1|||
147250086|NCT01986855|531085764|FG001|Overall Study|Adverse Event|0|||
147250087|NCT01986855|531085765|FG002|Overall Study|Adverse Event|0|||
147250088|NCT01986855|531085763|FG000|Overall Study|Death|3|||
147250089|NCT01986855|531085764|FG001|Overall Study|Death|4|||
147250090|NCT01986855|531085765|FG002|Overall Study|Death|4|||
147250091|NCT01986855|531085763|FG000|Overall Study|Lost to Follow-up|2|||
147250092|NCT01986855|531085764|FG001|Overall Study|Lost to Follow-up|1|||
147250093|NCT01986855|531085765|FG002|Overall Study|Lost to Follow-up|0|||
147250094|NCT01986855|531085763|FG000|Overall Study|Screen Failure|0|||
147250095|NCT01986855|531085764|FG001|Overall Study|Screen Failure|1|||
147250096|NCT01986855|531085765|FG002|Overall Study|Screen Failure|0|||
147250097|NCT01986855|531085763|FG000|Overall Study|Participant Moved|0|||
147250098|NCT01986855|531085764|FG001|Overall Study|Participant Moved|0|||
147250099|NCT01986855|531085765|FG002|Overall Study|Participant Moved|2|||
147250100|NCT01986855|531085763|FG000|Overall Study|Withdrawal by Subject|7|||
147250101|NCT01986855|531085764|FG001|Overall Study|Withdrawal by Subject|8|||
147250102|NCT01986855|531085765|FG002|Overall Study|Withdrawal by Subject|5|||
147250103|NCT00848081|531085766|FG000|Overall Study|Adverse Event|6|||
147250104|NCT00848081|531085767|FG001|Overall Study|Adverse Event|7|||
147250105|NCT00848081|531085766|FG000|Overall Study|Protocol Violation|8|||
147250106|NCT00848081|531085767|FG001|Overall Study|Protocol Violation|5|||
147250107|NCT00848081|531085766|FG000|Overall Study|Lost to Follow-up|1|||
147250108|NCT00848081|531085767|FG001|Overall Study|Lost to Follow-up|0|||
147250109|NCT00848081|531085766|FG000|Overall Study|Physician Decision|0|||
147250110|NCT00848081|531085767|FG001|Overall Study|Physician Decision|3|||
147250111|NCT00848081|531085766|FG000|Overall Study|Withdrawal by Subject|5|||
147250112|NCT00848081|531085767|FG001|Overall Study|Withdrawal by Subject|3|||
147250113|NCT02064868|531085768|FG000|Overall Study|Lost to Follow-up|14|||
147250114|NCT02064868|531085769|FG001|Overall Study|Lost to Follow-up|8|||
147250115|NCT02064868|531085768|FG000|Overall Study|Physician Decision|1|||
147250116|NCT02064868|531085769|FG001|Overall Study|Physician Decision|0|||
147250117|NCT02064868|531085768|FG000|Overall Study|Withdrawal by Subject|14|||
147250118|NCT02064868|531085769|FG001|Overall Study|Withdrawal by Subject|3|||
147250119|NCT02064868|531085768|FG000|Overall Study|Technical Problems or Missing|5|||
147250120|NCT02064868|531085769|FG001|Overall Study|Technical Problems or Missing|2|||
147250121|NCT02670083|531085773|FG000|Overall Study|Adverse Event|16|||
147250122|NCT02670083|531085774|FG001|Overall Study|Adverse Event|13|||
147250123|NCT02670083|531085773|FG000|Overall Study|Death|4|||
147250124|NCT02670083|531085774|FG001|Overall Study|Death|6|||
147250125|NCT02670083|531085773|FG000|Overall Study|Lost to Follow-up|2|||
147250126|NCT02670083|531085774|FG001|Overall Study|Lost to Follow-up|2|||
147250127|NCT02670083|531085773|FG000|Overall Study|Multiple Reasons|9|||
147250128|NCT02670083|531085774|FG001|Overall Study|Multiple Reasons|9|||
147250129|NCT02670083|531085773|FG000|Overall Study|Physician Decision|0|||
147250130|NCT02670083|531085774|FG001|Overall Study|Physician Decision|2|||
147250131|NCT02670083|531085773|FG000|Overall Study|Study Terminated By Sponsor|257|||
147250132|NCT02670083|531085774|FG001|Overall Study|Study Terminated By Sponsor|254|||
147250133|NCT02670083|531085773|FG000|Overall Study|Symptomatic Deterioration|0|||
147250134|NCT02670083|531085774|FG001|Overall Study|Symptomatic Deterioration|2|||
147250135|NCT02670083|531085773|FG000|Overall Study|Withdrawal by Subject|32|||
147250136|NCT02670083|531085774|FG001|Overall Study|Withdrawal by Subject|31|||
147250137|NCT02670083|531085773|FG000|Overall Study|Non-Compliance With Study Drug|1|||
147596271|NCT03551496|532340823|FG001|Overall Study|Other Reasons|0|||
147596272|NCT01524679|532340824|FG000|Overall Study|Lost to Follow-up|1|||
147596273|NCT01524679|532340825|FG001|Overall Study|Lost to Follow-up|4|||
147660408|NCT00873730|532579874|FG000|Overall Study|Sponsor decision|1|||
147660409|NCT00873730|532579875|FG001|Overall Study|Sponsor decision|0|||
147660410|NCT01265394|532579877|FG000|Overall Study|Subjects withdrawn|37|||
147250138|NCT02670083|531085774|FG001|Overall Study|Non-Compliance With Study Drug|0|||
147250139|NCT00609492|531085779|FG000|Overall Study|Withdrawal by Subject|0|||
147250140|NCT00609492|531085780|FG001|Overall Study|Withdrawal by Subject|2|||
147250141|NCT00609492|531085781|FG002|Overall Study|Withdrawal by Subject|3|||
147250142|NCT00609492|531085779|FG000|Overall Study|Lost to Follow-up|1|||
147250143|NCT00609492|531085780|FG001|Overall Study|Lost to Follow-up|1|||
147250144|NCT00609492|531085781|FG002|Overall Study|Lost to Follow-up|4|||
147250145|NCT00720434|531085782|FG000|Double-Blind Period (Week 1-4)|Withdrawal by Subject|0|||
147250146|NCT00720434|531085783|FG001|Double-Blind Period (Week 1-4)|Withdrawal by Subject|1|||
147250147|NCT00720434|531085784|FG002|Double-Blind Period (Week 1-4)|Withdrawal by Subject|0|||
147250148|NCT00720434|531085785|FG003|Double-Blind Period (Week 1-4)|Withdrawal by Subject|0|||
147250149|NCT00720434|531085782|FG000|Open-Label Period (Week 5-72)|Adverse Event|0|||
147250150|NCT00720434|531085783|FG001|Open-Label Period (Week 5-72)|Adverse Event|0|||
147250151|NCT00720434|531085784|FG002|Open-Label Period (Week 5-72)|Adverse Event|0|||
147250152|NCT00720434|531085785|FG003|Open-Label Period (Week 5-72)|Adverse Event|2|||
147250153|NCT00720434|531085782|FG000|Open-Label Period (Week 5-72)|Lost to Follow-up|1|||
147250154|NCT00720434|531085783|FG001|Open-Label Period (Week 5-72)|Lost to Follow-up|0|||
147250155|NCT00720434|531085784|FG002|Open-Label Period (Week 5-72)|Lost to Follow-up|0|||
147250156|NCT00720434|531085785|FG003|Open-Label Period (Week 5-72)|Lost to Follow-up|0|||
147250157|NCT00720434|531085782|FG000|Open-Label Period (Week 5-72)|Withdrawal by Subject|1|||
147250158|NCT00720434|531085783|FG001|Open-Label Period (Week 5-72)|Withdrawal by Subject|0|||
147250159|NCT00720434|531085784|FG002|Open-Label Period (Week 5-72)|Withdrawal by Subject|1|||
147596274|NCT01524679|532340824|FG000|Overall Study|Withdrawal by Subject|4|||
147596275|NCT01524679|532340825|FG001|Overall Study|Withdrawal by Subject|4|||
147596276|NCT01524679|532340824|FG000|Overall Study|Adverse Event|9|||
147250160|NCT00720434|531085785|FG003|Open-Label Period (Week 5-72)|Withdrawal by Subject|0|||
147596277|NCT01524679|532340825|FG001|Overall Study|Adverse Event|0|||
147596278|NCT01524679|532340824|FG000|Overall Study|Protocol Violation|1|||
147596279|NCT01524679|532340825|FG001|Overall Study|Protocol Violation|0|||
147596280|NCT01524679|532340824|FG000|Overall Study|Lack of Efficacy|2|||
147596281|NCT01524679|532340825|FG001|Overall Study|Lack of Efficacy|0|||
147596282|NCT01524679|532340824|FG000|Overall Study|e.g.wish for children, relocation|6|||
147596283|NCT01524679|532340825|FG001|Overall Study|e.g.wish for children, relocation|1|||
147596284|NCT00801099|532340826|FG000|Overall Study|Lost to Follow-up|101|||
147596285|NCT03321630|532340833|FG000|Overall Study|Adverse Event|1|||
147596286|NCT03321630|532340833|FG000|Overall Study|Investigator Discretion|2|||
147596287|NCT03321630|532340833|FG000|Overall Study|Withdrawal by Subject|1|||
147596288|NCT00140426|532340834|FG000|Overall Study|Withdrawal by Subject|0|||
147596289|NCT00140426|532340835|FG001|Overall Study|Withdrawal by Subject|3|||
147596290|NCT00950963|532340836|FG000|Overall Study|Lost to Follow-up|29|||
147596291|NCT00950963|532340837|FG001|Overall Study|Lost to Follow-up|24|||
147596292|NCT00928707|532340840|FG000|Overall Study|Protocol Violation|1|||
147596293|NCT00928707|532340841|FG001|Overall Study|Protocol Violation|0|||
147596294|NCT00132028|532340842|FG000|Overall Study|Adverse Event|7|||
147596295|NCT00132028|532340842|FG000|Overall Study|Death|2|||
147596296|NCT00132028|532340842|FG000|Overall Study|Lack of Efficacy|11|||
147596297|NCT00132028|532340842|FG000|Overall Study|Withdrawal by Subject|2|||
147596298|NCT00132028|532340842|FG000|Overall Study|not eligible|2|||
147596299|NCT00132028|532340842|FG000|Overall Study|Physician Decision|3|||
147596300|NCT02140411|532340843|FG000|Overall Study|Adverse Event|1|||
147596301|NCT02005887|532340854|FG000|Overall Study|Protocol Violation|0|||
147596302|NCT02005887|532340855|FG001|Overall Study|Protocol Violation|2|||
147596303|NCT04771403|532340856|FG000|First Intervention (~76 Hours)|FMPD study stopped after 7 hours: Pod occlusion with hyperglycemia (data not analyzed)|0|||
147596304|NCT04771403|532340857|FG001|First Intervention (~76 Hours)|FMPD study stopped after 7 hours: Pod occlusion with hyperglycemia (data not analyzed)|1|||
147596305|NCT04771403|532340856|FG000|First Intervention (~76 Hours)|MPC study stopped after 8 hours due to algorithm safety concerns (data not analyzed)|1|||
147596306|NCT04771403|532340857|FG001|First Intervention (~76 Hours)|MPC study stopped after 8 hours due to algorithm safety concerns (data not analyzed)|0|||
147596307|NCT04771403|532340856|FG000|First Intervention (~76 Hours)|MPC Study stopped after 34 hrs for safety due to high ketones (data analyzed)|1|||
147596308|NCT04771403|532340857|FG001|First Intervention (~76 Hours)|MPC Study stopped after 34 hrs for safety due to high ketones (data analyzed)|0|||
147596309|NCT04771403|532340856|FG000|First Intervention (~76 Hours)|MPC study stopped after 61 hrs due to cloud server issues (data analyzed)|1|||
147596310|NCT04771403|532340857|FG001|First Intervention (~76 Hours)|MPC study stopped after 61 hrs due to cloud server issues (data analyzed)|0|||
147596311|NCT04771403|532340856|FG000|First Intervention (~76 Hours)|MPC study stopped after 32 hours due to algorithm safety concerns (data analyzed)|1|||
147596312|NCT04771403|532340857|FG001|First Intervention (~76 Hours)|MPC study stopped after 32 hours due to algorithm safety concerns (data analyzed)|0|||
147596313|NCT04771403|532340856|FG000|First Intervention (~76 Hours)|FMPD study stopped after 6 hours due to algorithm safety concerns (data not analyzed)|0|||
147250161|NCT00720434|531085782|FG000|Open-Label Period (Week 5-72)|Other|4|||
147250162|NCT00720434|531085783|FG001|Open-Label Period (Week 5-72)|Other|3|||
147250163|NCT00720434|531085784|FG002|Open-Label Period (Week 5-72)|Other|3|||
147331306|NCT02503202|531379149|FG003|Extension: Month 6 to 24|Death|0|||
147250164|NCT00720434|531085785|FG003|Open-Label Period (Week 5-72)|Other|2|||
147250165|NCT02425046|531085786|FG000|Overall Study|Lost to Follow-up|52|||
147250166|NCT02425046|531085787|FG001|Overall Study|Lost to Follow-up|50|||
147250167|NCT02425046|531085788|FG002|Overall Study|Lost to Follow-up|56|||
147250168|NCT02425046|531085786|FG000|Overall Study|Withdrawal by Subject|16|||
147250169|NCT02425046|531085787|FG001|Overall Study|Withdrawal by Subject|12|||
147250170|NCT02425046|531085788|FG002|Overall Study|Withdrawal by Subject|0|||
147250171|NCT03562481|531085789|FG000|First Intervention|Lost to Follow-up|1|||
147250172|NCT03562481|531085790|FG001|First Intervention|Lost to Follow-up|0|||
147250173|NCT01413191|531085791|FG000|Overall Study|Lost to Follow-up|5|||
147250174|NCT01413191|531085791|FG000|Overall Study|Disease Progression|5|||
147250175|NCT01413191|531085791|FG000|Overall Study|Death|1|||
147250176|NCT00589914|531085803|FG000|Overall Study|Adverse Event|19|||
147250177|NCT00589914|531085804|FG001|Overall Study|Adverse Event|10|||
147250178|NCT00589914|531085803|FG000|Overall Study|Death|2|||
147250179|NCT00589914|531085804|FG001|Overall Study|Death|0|||
147250180|NCT00589914|531085803|FG000|Overall Study|Lack of Efficacy|40|||
147250181|NCT00589914|531085804|FG001|Overall Study|Lack of Efficacy|43|||
147250182|NCT00589914|531085803|FG000|Overall Study|Lost to Follow-up|11|||
147250183|NCT00589914|531085804|FG001|Overall Study|Lost to Follow-up|18|||
147250184|NCT00589914|531085803|FG000|Overall Study|Pregnancy|1|||
147250185|NCT00589914|531085804|FG001|Overall Study|Pregnancy|0|||
147250186|NCT00589914|531085803|FG000|Overall Study|Withdrawal by Subject|55|||
147250187|NCT00589914|531085804|FG001|Overall Study|Withdrawal by Subject|49|||
147250188|NCT00589914|531085803|FG000|Overall Study|Other|22|||
147250189|NCT00589914|531085804|FG001|Overall Study|Other|17|||
147250190|NCT01356966|531085809|FG000|Overall Study|Withdrawal by Subject|1|||
147250191|NCT01356966|531085810|FG001|Overall Study|Withdrawal by Subject|2|||
147250192|NCT01356966|531085809|FG000|Overall Study|Physician Decision|1|||
147250193|NCT01356966|531085810|FG001|Overall Study|Physician Decision|0|||
147250194|NCT02289898|531085817|FG000|Overall Study|Death|5|||
147250195|NCT02289898|531085818|FG001|Overall Study|Death|4|||
147250196|NCT02289898|531085819|FG002|Overall Study|Death|3|||
147250197|NCT02289898|531085817|FG000|Overall Study|Physician Decision|2|||
147250198|NCT02289898|531085818|FG001|Overall Study|Physician Decision|5|||
147250199|NCT02289898|531085819|FG002|Overall Study|Physician Decision|2|||
147250200|NCT02289898|531085817|FG000|Overall Study|Withdrawal by Subject|0|||
147250201|NCT02289898|531085818|FG001|Overall Study|Withdrawal by Subject|4|||
147250202|NCT02289898|531085819|FG002|Overall Study|Withdrawal by Subject|1|||
147250203|NCT02289898|531085817|FG000|Overall Study|Adverse Event|3|||
147250204|NCT02289898|531085818|FG001|Overall Study|Adverse Event|5|||
147250205|NCT02289898|531085819|FG002|Overall Study|Adverse Event|5|||
147250206|NCT02289898|531085817|FG000|Overall Study|Disease progression|34|||
147250207|NCT02289898|531085818|FG001|Overall Study|Disease progression|28|||
147250208|NCT02289898|531085819|FG002|Overall Study|Disease progression|34|||
147250209|NCT02289898|531085817|FG000|Overall Study|Use of another anticancer therapy|0|||
147250210|NCT02289898|531085818|FG001|Overall Study|Use of another anticancer therapy|0|||
147250211|NCT02289898|531085819|FG002|Overall Study|Use of another anticancer therapy|1|||
147250212|NCT02289898|531085817|FG000|Overall Study|Other|8|||
147250213|NCT02289898|531085818|FG001|Overall Study|Other|7|||
147250214|NCT02289898|531085819|FG002|Overall Study|Other|10|||
147250215|NCT00267046|531085820|FG000|Overall Study|Disease progression|4|||
147250216|NCT00267046|531085821|FG001|Overall Study|Disease progression|2|||
147250217|NCT00267046|531085820|FG000|Overall Study|Chemotoxicity|2|||
147250218|NCT00267046|531085821|FG001|Overall Study|Chemotoxicity|0|||
147250219|NCT00267046|531085820|FG000|Overall Study|Open-label palifermin|2|||
147250220|NCT00267046|531085821|FG001|Overall Study|Open-label palifermin|7|||
147250221|NCT00267046|531085820|FG000|Overall Study|Surgery|3|||
147250222|NCT00267046|531085821|FG001|Overall Study|Surgery|1|||
147250223|NCT00267046|531085820|FG000|Overall Study|Withdrawal by Subject|1|||
147250224|NCT00267046|531085821|FG001|Overall Study|Withdrawal by Subject|0|||
147250225|NCT00267046|531085820|FG000|Overall Study|Radiation|0|||
147250226|NCT00267046|531085821|FG001|Overall Study|Radiation|1|||
147250227|NCT00103142|531085822|FG000|Overall Study|Adverse Event|1|||
147250228|NCT00103142|531085823|FG001|Overall Study|Adverse Event|0|||
147250229|NCT00103142|531085822|FG000|Overall Study|Progression of disease|2|||
147250230|NCT00103142|531085823|FG001|Overall Study|Progression of disease|1|||
147250231|NCT01979016|531085824|FG000|Overall Study|Withdrawal by Subject|2|||
147250232|NCT01979016|531085825|FG001|Overall Study|Withdrawal by Subject|0|||
147250233|NCT01979016|531085824|FG000|Overall Study|Adverse Event|0|||
147250234|NCT01979016|531085825|FG001|Overall Study|Adverse Event|1|||
147250235|NCT04983264|531085826|FG000|Part B: Multiple Dose Period|Physician Decision|0|||
147250236|NCT04983264|531085827|FG001|Part B: Multiple Dose Period|Physician Decision|1|||
147250237|NCT04983264|531085828|FG002|Part B: Multiple Dose Period|Physician Decision|0|||
147250238|NCT04983264|531085826|FG000|Part C: Extended Treatment Period|Physician Decision|0|||
147331307|NCT02503202|531379150|FG004|Extension: Month 6 to 24|Death|0|||
147250239|NCT04983264|531085827|FG001|Part C: Extended Treatment Period|Physician Decision|0|||
147250240|NCT04983264|531085828|FG002|Part C: Extended Treatment Period|Physician Decision|1|||
147250241|NCT01124422|531085829|FG000|4-Week Open-label Run-in Phase|Withdrawal by Subject|5|||
147331308|NCT02503202|531379146|FG000|Extension: Month 6 to 24|Lost to Follow-up|4|||
147331309|NCT02503202|531379147|FG001|Extension: Month 6 to 24|Lost to Follow-up|8|||
147331310|NCT02503202|531379148|FG002|Extension: Month 6 to 24|Lost to Follow-up|6|||
147331311|NCT02503202|531379149|FG003|Extension: Month 6 to 24|Lost to Follow-up|10|||
147331312|NCT02503202|531379150|FG004|Extension: Month 6 to 24|Lost to Follow-up|1|||
147331313|NCT02503202|531379146|FG000|Extension: Month 6 to 24|Physician Decision|1|||
147331314|NCT02503202|531379147|FG001|Extension: Month 6 to 24|Physician Decision|0|||
147331315|NCT02503202|531379148|FG002|Extension: Month 6 to 24|Physician Decision|1|||
147331316|NCT02503202|531379149|FG003|Extension: Month 6 to 24|Physician Decision|3|||
147331317|NCT02503202|531379150|FG004|Extension: Month 6 to 24|Physician Decision|0|||
147331318|NCT02503202|531379146|FG000|Extension: Month 6 to 24|Withdrawal by Subject|5|||
147331319|NCT02503202|531379147|FG001|Extension: Month 6 to 24|Withdrawal by Subject|8|||
147331320|NCT02503202|531379148|FG002|Extension: Month 6 to 24|Withdrawal by Subject|2|||
147331321|NCT02503202|531379149|FG003|Extension: Month 6 to 24|Withdrawal by Subject|4|||
147331322|NCT02503202|531379150|FG004|Extension: Month 6 to 24|Withdrawal by Subject|0|||
147331323|NCT01191788|531379153|FG000|Overall Study|Lost to Follow-up|21|||
147331324|NCT01191788|531379154|FG001|Overall Study|Lost to Follow-up|22|||
147331325|NCT00217672|531379158|FG000|Allocation|Ineligible|2|||
147331326|NCT00217672|531379159|FG001|Allocation|Ineligible|0|||
147331327|NCT00217672|531379158|FG000|Treatment|disease progression|33|||
147331328|NCT00217672|531379159|FG001|Treatment|disease progression|4|||
147331329|NCT00217672|531379158|FG000|Treatment|Adverse Event|18|||
147331330|NCT00217672|531379159|FG001|Treatment|Adverse Event|2|||
147331331|NCT00217672|531379158|FG000|Treatment|reqd treatment not permitted by protocol|6|||
147331332|NCT00217672|531379159|FG001|Treatment|reqd treatment not permitted by protocol|0|||
147331333|NCT00217672|531379158|FG000|Treatment|Physician Decision|6|||
147331334|NCT00217672|531379159|FG001|Treatment|Physician Decision|0|||
147331335|NCT00217672|531379158|FG000|Treatment|insurance issues|1|||
147331336|NCT00217672|531379159|FG001|Treatment|insurance issues|1|||
147331337|NCT00217672|531379158|FG000|Treatment|Death|2|||
147331338|NCT00217672|531379159|FG001|Treatment|Death|0|||
147331339|NCT00217672|531379158|FG000|Treatment|secondary malignancy|1|||
147331340|NCT00217672|531379159|FG001|Treatment|secondary malignancy|0|||
147331341|NCT00217672|531379158|FG000|Follow-up|Withdrawal by Subject|4|||
147331342|NCT00217672|531379159|FG001|Follow-up|Withdrawal by Subject|0|||
147331343|NCT00217672|531379158|FG000|Follow-up|Lost to Follow-up|1|||
147331344|NCT00217672|531379159|FG001|Follow-up|Lost to Follow-up|0|||
147331345|NCT00436644|531379170|FG000|Overall Study|Adverse Event|2|||
147331346|NCT00436644|531379170|FG000|Overall Study|Death|1|||
147331347|NCT04364269|531379171|FG000|Overall Study|Adverse Event|1|||
147331348|NCT04364269|531379172|FG001|Overall Study|Adverse Event|0|||
147331349|NCT04364269|531379173|FG002|Overall Study|Adverse Event|0|||
147331350|NCT04364269|531379171|FG000|Overall Study|Withdrawal by Subject|0|||
147331351|NCT04364269|531379172|FG001|Overall Study|Withdrawal by Subject|1|||
147331352|NCT04364269|531379173|FG002|Overall Study|Withdrawal by Subject|0|||
147331353|NCT00878722|531379174|FG000|Overall Study|Progressive disease|3|||
147331354|NCT00878722|531379175|FG001|Overall Study|Progressive disease|3|||
147331355|NCT00878722|531379176|FG002|Overall Study|Progressive disease|3|||
147331356|NCT00878722|531379177|FG003|Overall Study|Progressive disease|7|||
147331357|NCT00878722|531379178|FG004|Overall Study|Progressive disease|7|||
147331358|NCT00878722|531379179|FG005|Overall Study|Progressive disease|1|||
147331359|NCT00878722|531379180|FG006|Overall Study|Progressive disease|4|||
147331360|NCT00878722|531379181|FG007|Overall Study|Progressive disease|3|||
147331361|NCT00878722|531379174|FG000|Overall Study|Death|0|||
147331362|NCT00878722|531379175|FG001|Overall Study|Death|0|||
147331363|NCT00878722|531379176|FG002|Overall Study|Death|0|||
147331364|NCT00878722|531379177|FG003|Overall Study|Death|1|||
147331365|NCT00878722|531379178|FG004|Overall Study|Death|0|||
147331366|NCT00878722|531379179|FG005|Overall Study|Death|1|||
147331367|NCT00878722|531379180|FG006|Overall Study|Death|0|||
147331368|NCT00878722|531379181|FG007|Overall Study|Death|2|||
147331369|NCT00878722|531379174|FG000|Overall Study|Adverse Event|0|||
147331370|NCT00878722|531379175|FG001|Overall Study|Adverse Event|0|||
147331371|NCT00878722|531379176|FG002|Overall Study|Adverse Event|0|||
147331372|NCT00878722|531379177|FG003|Overall Study|Adverse Event|0|||
147331373|NCT00878722|531379178|FG004|Overall Study|Adverse Event|0|||
147331374|NCT00878722|531379179|FG005|Overall Study|Adverse Event|0|||
147331375|NCT00878722|531379180|FG006|Overall Study|Adverse Event|2|||
147331376|NCT00878722|531379181|FG007|Overall Study|Adverse Event|0|||
147331377|NCT00878722|531379174|FG000|Overall Study|Withdrawal by Subject|0|||
147331378|NCT00878722|531379175|FG001|Overall Study|Withdrawal by Subject|0|||
147331379|NCT00878722|531379176|FG002|Overall Study|Withdrawal by Subject|0|||
147331380|NCT00878722|531379177|FG003|Overall Study|Withdrawal by Subject|0|||
147331381|NCT00878722|531379178|FG004|Overall Study|Withdrawal by Subject|0|||
147331382|NCT00878722|531379179|FG005|Overall Study|Withdrawal by Subject|0|||
147331383|NCT00878722|531379180|FG006|Overall Study|Withdrawal by Subject|0|||
147331384|NCT00878722|531379181|FG007|Overall Study|Withdrawal by Subject|2|||
147331385|NCT00878722|531379174|FG000|Overall Study|Relapse|0|||
147331386|NCT00878722|531379175|FG001|Overall Study|Relapse|0|||
147331387|NCT00878722|531379176|FG002|Overall Study|Relapse|0|||
147331388|NCT00878722|531379177|FG003|Overall Study|Relapse|1|||
147331389|NCT00878722|531379178|FG004|Overall Study|Relapse|0|||
147331390|NCT00878722|531379179|FG005|Overall Study|Relapse|0|||
147331391|NCT00878722|531379180|FG006|Overall Study|Relapse|0|||
147331392|NCT00878722|531379181|FG007|Overall Study|Relapse|0|||
147331393|NCT00972504|531379182|FG000|Overall Study|Adverse Event|2|||
147331394|NCT00972504|531379182|FG000|Overall Study|Investigator discretion|1|||
147331395|NCT02878330|531379183|FG000|Overall Study|Death|3|||
147331396|NCT02878330|531379184|FG001|Overall Study|Death|2|||
147596314|NCT04771403|532340857|FG001|First Intervention (~76 Hours)|FMPD study stopped after 6 hours due to algorithm safety concerns (data not analyzed)|1|||
147596315|NCT04771403|532340856|FG000|Second Rest Period (1-10 Weeks)|Subject withdrawn before completing FMPD study due to safety concerns due to keto diet|1|||
147596316|NCT04771403|532340857|FG001|Second Rest Period (1-10 Weeks)|Subject withdrawn before completing FMPD study due to safety concerns due to keto diet|0|||
147596317|NCT04771403|532340856|FG000|Second Intervention Visit (~76 Hours)|FMPD study stopped after 25 hrs due to stopping rules for hypoglycemia (data analyzed)|1|||
147596318|NCT04771403|532340857|FG001|Second Intervention Visit (~76 Hours)|FMPD study stopped after 25 hrs due to stopping rules for hypoglycemia (data analyzed)|0|||
147596319|NCT01615263|532340858|FG000|Overall Study|Post-randomization exclusion|0|||
147596320|NCT01615263|532340859|FG001|Overall Study|Post-randomization exclusion|2|||
147596321|NCT02458092|532340860|FG000|Overall Study|Withdrawal by Subject|1|||
147596322|NCT02458092|532340861|FG001|Overall Study|Withdrawal by Subject|0|||
147596323|NCT01144364|532340872|FG000|Induction Phase|Disease progression|14|||
147596324|NCT01144364|532340873|FG001|Induction Phase|Disease progression|0|||
147596325|NCT01144364|532340874|FG002|Induction Phase|Disease progression|0|||
147596326|NCT01144364|532340872|FG000|Induction Phase|Adverse Event|9|||
147596327|NCT01144364|532340873|FG001|Induction Phase|Adverse Event|0|||
147596328|NCT01144364|532340874|FG002|Induction Phase|Adverse Event|0|||
147596329|NCT01144364|532340872|FG000|Induction Phase|Death|1|||
147596330|NCT01144364|532340873|FG001|Induction Phase|Death|0|||
147596331|NCT01144364|532340874|FG002|Induction Phase|Death|0|||
147596332|NCT01144364|532340872|FG000|Induction Phase|Withdrawal by Subject|1|||
147596333|NCT01144364|532340873|FG001|Induction Phase|Withdrawal by Subject|0|||
147596334|NCT01144364|532340874|FG002|Induction Phase|Withdrawal by Subject|0|||
147596335|NCT01144364|532340872|FG000|Induction Phase|Lost to Follow-up|2|||
147596336|NCT01144364|532340873|FG001|Induction Phase|Lost to Follow-up|0|||
147596337|NCT01144364|532340874|FG002|Induction Phase|Lost to Follow-up|0|||
147596338|NCT01144364|532340872|FG000|Induction Phase|Physician Decision|1|||
147596339|NCT01144364|532340873|FG001|Induction Phase|Physician Decision|0|||
147596340|NCT01144364|532340874|FG002|Induction Phase|Physician Decision|0|||
147596341|NCT01144364|532340872|FG000|Induction Phase|Stable disease|2|||
147596342|NCT01144364|532340873|FG001|Induction Phase|Stable disease|0|||
147596343|NCT01144364|532340874|FG002|Induction Phase|Stable disease|0|||
147596344|NCT01144364|532340872|FG000|Induction Phase|Secondary neoplasia|1|||
147596345|NCT01144364|532340873|FG001|Induction Phase|Secondary neoplasia|0|||
147596346|NCT01144364|532340874|FG002|Induction Phase|Secondary neoplasia|0|||
147596347|NCT01144364|532340872|FG000|Induction Phase|Protocol Violation|1|||
147596348|NCT01144364|532340873|FG001|Induction Phase|Protocol Violation|0|||
147596349|NCT01144364|532340874|FG002|Induction Phase|Protocol Violation|0|||
147596350|NCT01144364|532340872|FG000|Follow-Up/Maintenance Phase|Disease progression|0|||
147596351|NCT01144364|532340873|FG001|Follow-Up/Maintenance Phase|Disease progression|23|||
147596352|NCT01144364|532340874|FG002|Follow-Up/Maintenance Phase|Disease progression|29|||
147596353|NCT01144364|532340872|FG000|Follow-Up/Maintenance Phase|Adverse Event|0|||
147596354|NCT01144364|532340873|FG001|Follow-Up/Maintenance Phase|Adverse Event|3|||
147596355|NCT01144364|532340874|FG002|Follow-Up/Maintenance Phase|Adverse Event|1|||
147596356|NCT01144364|532340872|FG000|Follow-Up/Maintenance Phase|Death|0|||
147596357|NCT01144364|532340873|FG001|Follow-Up/Maintenance Phase|Death|2|||
147596358|NCT01144364|532340874|FG002|Follow-Up/Maintenance Phase|Death|0|||
147596359|NCT01144364|532340872|FG000|Follow-Up/Maintenance Phase|Withdrawal by Subject|0|||
147596360|NCT01144364|532340873|FG001|Follow-Up/Maintenance Phase|Withdrawal by Subject|1|||
147596361|NCT01144364|532340874|FG002|Follow-Up/Maintenance Phase|Withdrawal by Subject|1|||
147596362|NCT01144364|532340872|FG000|Follow-Up/Maintenance Phase|Lost to Follow-up|0|||
147596363|NCT01144364|532340873|FG001|Follow-Up/Maintenance Phase|Lost to Follow-up|1|||
147596364|NCT01144364|532340874|FG002|Follow-Up/Maintenance Phase|Lost to Follow-up|4|||
147596365|NCT01144364|532340872|FG000|Follow-Up/Maintenance Phase|Relapse|0|||
147596366|NCT01144364|532340873|FG001|Follow-Up/Maintenance Phase|Relapse|5|||
147331397|NCT02878330|531379183|FG000|Overall Study|Lost to Follow-up|11|||
147331398|NCT02878330|531379184|FG001|Overall Study|Lost to Follow-up|26|||
147331399|NCT02878330|531379183|FG000|Overall Study|Withdrawal by Subject|11|||
147331400|NCT02878330|531379184|FG001|Overall Study|Withdrawal by Subject|21|||
147331401|NCT02878330|531379183|FG000|Overall Study|Other|4|||
147331402|NCT02878330|531379184|FG001|Overall Study|Other|7|||
147331403|NCT00082810|531379189|FG000|Overall Study|Adverse Event|3|||
147331404|NCT00082810|531379189|FG000|Overall Study|Progressive disease|24|||
147331405|NCT00082810|531379189|FG000|Overall Study|Withdrawal by Subject|4|||
147331406|NCT01321606|531379195|FG000|Overall Study|Lost to Follow-up|0|||
147331407|NCT01321606|531379196|FG001|Overall Study|Lost to Follow-up|0|||
147250242|NCT01124422|531085830|FG001|4-Week Open-label Run-in Phase|Withdrawal by Subject|0|||
147250243|NCT01124422|531085831|FG002|4-Week Open-label Run-in Phase|Withdrawal by Subject|0|||
147250244|NCT01124422|531085829|FG000|4-Week Open-label Run-in Phase|Adverse Event|7|||
147250245|NCT01124422|531085830|FG001|4-Week Open-label Run-in Phase|Adverse Event|0|||
147250246|NCT01124422|531085831|FG002|4-Week Open-label Run-in Phase|Adverse Event|0|||
147250247|NCT01124422|531085829|FG000|4-Week Open-label Run-in Phase|Physician Decision|4|||
147250248|NCT01124422|531085830|FG001|4-Week Open-label Run-in Phase|Physician Decision|0|||
147250249|NCT01124422|531085831|FG002|4-Week Open-label Run-in Phase|Physician Decision|0|||
147250250|NCT01124422|531085829|FG000|4-Week Open-label Run-in Phase|Lost to Follow-up|1|||
147250251|NCT01124422|531085830|FG001|4-Week Open-label Run-in Phase|Lost to Follow-up|0|||
147250252|NCT01124422|531085831|FG002|4-Week Open-label Run-in Phase|Lost to Follow-up|0|||
147250253|NCT01124422|531085829|FG000|4-Week Open-label Run-in Phase|Did Not Meet Continuation Criteria|61|||
147250254|NCT01124422|531085830|FG001|4-Week Open-label Run-in Phase|Did Not Meet Continuation Criteria|0|||
147250255|NCT01124422|531085831|FG002|4-Week Open-label Run-in Phase|Did Not Meet Continuation Criteria|0|||
147250256|NCT01124422|531085829|FG000|4-Week Open-label Run-in Phase|Protocol Violation|5|||
147250257|NCT01124422|531085830|FG001|4-Week Open-label Run-in Phase|Protocol Violation|0|||
147250258|NCT01124422|531085831|FG002|4-Week Open-label Run-in Phase|Protocol Violation|0|||
147250259|NCT01124422|531085829|FG000|4-Week Double-blind Treatment Phase|Withdrawal by Subject|0|||
147250260|NCT01124422|531085830|FG001|4-Week Double-blind Treatment Phase|Withdrawal by Subject|0|||
147250261|NCT01124422|531085831|FG002|4-Week Double-blind Treatment Phase|Withdrawal by Subject|3|||
147250262|NCT01124422|531085829|FG000|4-Week Double-blind Treatment Phase|Adverse Event|0|||
147250263|NCT01124422|531085830|FG001|4-Week Double-blind Treatment Phase|Adverse Event|6|||
147250264|NCT01124422|531085831|FG002|4-Week Double-blind Treatment Phase|Adverse Event|3|||
147250265|NCT01124422|531085829|FG000|4-Week Double-blind Treatment Phase|Physician Decision|0|||
147250266|NCT01124422|531085830|FG001|4-Week Double-blind Treatment Phase|Physician Decision|5|||
147250267|NCT01124422|531085831|FG002|4-Week Double-blind Treatment Phase|Physician Decision|2|||
147250268|NCT01124422|531085829|FG000|4-Week Double-blind Treatment Phase|Lost to Follow-up|0|||
147250269|NCT01124422|531085830|FG001|4-Week Double-blind Treatment Phase|Lost to Follow-up|0|||
147250270|NCT01124422|531085831|FG002|4-Week Double-blind Treatment Phase|Lost to Follow-up|1|||
147250271|NCT00938639|531085832|FG000|Overall Study|Moved away from study area|0|||
147250272|NCT00938639|531085833|FG001|Overall Study|Moved away from study area|1|||
147250273|NCT00938639|531085832|FG000|Overall Study|Lost to Follow-up|1|||
147449759|NCT02970292|531809577|FG001|Overall Study|Other|0|||
147449760|NCT00894556|531809578|FG000|Baseline Phase|Did not meet Randomization Criteria|0|||
147449761|NCT00894556|531809579|FG001|Baseline Phase|Did not meet Randomization Criteria|0|||
147449762|NCT00894556|531809580|FG002|Baseline Phase|Did not meet Randomization Criteria|0|||
147449763|NCT00894556|531809581|FG003|Baseline Phase|Did not meet Randomization Criteria|85|||
147449764|NCT00894556|531809578|FG000|Treatment Phase|Lost to Follow-up|2|||
147449765|NCT00894556|531809579|FG001|Treatment Phase|Lost to Follow-up|3|||
147449766|NCT00894556|531809580|FG002|Treatment Phase|Lost to Follow-up|1|||
147449767|NCT00894556|531809581|FG003|Treatment Phase|Lost to Follow-up|0|||
147449768|NCT00894556|531809578|FG000|Treatment Phase|Lack of Qualifying Event|2|||
147449769|NCT00894556|531809579|FG001|Treatment Phase|Lack of Qualifying Event|1|||
147449770|NCT00894556|531809580|FG002|Treatment Phase|Lack of Qualifying Event|0|||
147449771|NCT00894556|531809581|FG003|Treatment Phase|Lack of Qualifying Event|0|||
147449772|NCT01014689|531809584|FG000|Overall Study|Lack of Efficacy|0|||
147449773|NCT01014689|531809585|FG001|Overall Study|Lack of Efficacy|1|||
147449774|NCT01014689|531809584|FG000|Overall Study|Adverse Event|3|||
147449775|NCT01014689|531809585|FG001|Overall Study|Adverse Event|0|||
147449776|NCT01014689|531809584|FG000|Overall Study|Withdrawal by Subject|5|||
147449777|NCT01014689|531809585|FG001|Overall Study|Withdrawal by Subject|4|||
147449778|NCT01014689|531809584|FG000|Overall Study|Protocol Violation|1|||
147449779|NCT01014689|531809585|FG001|Overall Study|Protocol Violation|1|||
147449780|NCT01014689|531809584|FG000|Overall Study|Lost to Follow-up|3|||
147449781|NCT01014689|531809585|FG001|Overall Study|Lost to Follow-up|7|||
147449782|NCT01014689|531809584|FG000|Overall Study|Pregnancy|1|||
147449783|NCT01014689|531809585|FG001|Overall Study|Pregnancy|0|||
147449784|NCT00333359|531809588|FG000|Overall Study|Adverse Event|29|||
147449785|NCT00333359|531809589|FG001|Overall Study|Adverse Event|35|||
147596367|NCT01144364|532340874|FG002|Follow-Up/Maintenance Phase|Relapse|5|||
147596368|NCT01144364|532340872|FG000|Follow-Up/Maintenance Phase|Physician Decision|0|||
147596369|NCT01144364|532340873|FG001|Follow-Up/Maintenance Phase|Physician Decision|0|||
147596370|NCT01144364|532340874|FG002|Follow-Up/Maintenance Phase|Physician Decision|1|||
147596371|NCT02989168|532340875|FG000|Overall Study|Withdrawal by Subject|2|||
147596372|NCT02989168|532340876|FG001|Overall Study|Withdrawal by Subject|0|||
147250274|NCT00938639|531085833|FG001|Overall Study|Lost to Follow-up|2|||
147250275|NCT00938639|531085832|FG000|Overall Study|Family issues|1|||
147250276|NCT00938639|531085833|FG001|Overall Study|Family issues|1|||
147250277|NCT00938639|531085832|FG000|Overall Study|Participant noncompliance|1|||
147449786|NCT00333359|531809588|FG000|Overall Study|Withdrawal by Subject|19|||
147449787|NCT00333359|531809589|FG001|Overall Study|Withdrawal by Subject|37|||
147449788|NCT00333359|531809588|FG000|Overall Study|Physician Decision|2|||
147449789|NCT00333359|531809589|FG001|Overall Study|Physician Decision|2|||
147250278|NCT00938639|531085833|FG001|Overall Study|Participant noncompliance|0|||
147250279|NCT00142584|531085834|FG000|Overall Study|Sponsor Termination of Study, etc.|72|||
147250280|NCT00142584|531085835|FG001|Overall Study|Sponsor Termination of Study, etc.|16|||
147660411|NCT00115778|532579878|FG000|Overall Study|Withdrawal by Subject|0|||
147660412|NCT00115778|532579879|FG001|Overall Study|Withdrawal by Subject|1|||
147660413|NCT02185417|532579882|FG000|Overall Study|Death|448|||
147660414|NCT02185417|532579883|FG001|Overall Study|Death|446|||
147250281|NCT00142584|531085834|FG000|Overall Study|Withdrawal by Subject|30|||
147250282|NCT00142584|531085835|FG001|Overall Study|Withdrawal by Subject|16|||
147250283|NCT00142584|531085834|FG000|Overall Study|Lost to Follow-up|22|||
147250284|NCT00142584|531085835|FG001|Overall Study|Lost to Follow-up|12|||
147250285|NCT00142584|531085834|FG000|Overall Study|Adverse Event|14|||
147250286|NCT00142584|531085835|FG001|Overall Study|Adverse Event|5|||
147250287|NCT00142584|531085834|FG000|Overall Study|Protocol Violation|4|||
147250288|NCT00142584|531085835|FG001|Overall Study|Protocol Violation|7|||
147250289|NCT00142584|531085834|FG000|Overall Study|Treatment Failure|2|||
147250290|NCT00142584|531085835|FG001|Overall Study|Treatment Failure|0|||
147250291|NCT04326231|531085839|FG000|Overall Study|COVID Withdrawn (limited recruitment within study timeline)|10|||
147250292|NCT00759954|531085840|FG000|Overall Study|Personal reason|1|||
147250293|NCT00759954|531085841|FG001|Overall Study|Personal reason|0|||
147250294|NCT00759954|531085840|FG000|Overall Study|Adverse Event|1|||
147250295|NCT00759954|531085841|FG001|Overall Study|Adverse Event|2|||
147250296|NCT02875860|531085845|FG000|Overall Study|Withdrawal by Subject|0|||
147250297|NCT02875860|531085846|FG001|Overall Study|Withdrawal by Subject|1|||
147250298|NCT01156311|531085850|FG000|2-Month Monotherapy Period|Withdrawal by Subject|1|||
147250299|NCT01156311|531085851|FG001|2-Month Monotherapy Period|Withdrawal by Subject|1|||
147660415|NCT02185417|532579884|FG002|Overall Study|Death|0|||
147250300|NCT01156311|531085852|FG002|2-Month Monotherapy Period|Withdrawal by Subject|0|||
147250301|NCT01156311|531085853|FG003|2-Month Monotherapy Period|Withdrawal by Subject|0|||
147250302|NCT01156311|531085850|FG000|2-Month Monotherapy Period|Physician Decision|0|||
147250303|NCT01156311|531085851|FG001|2-Month Monotherapy Period|Physician Decision|1|||
147250304|NCT01156311|531085852|FG002|2-Month Monotherapy Period|Physician Decision|0|||
147250305|NCT01156311|531085853|FG003|2-Month Monotherapy Period|Physician Decision|0|||
147250306|NCT01156311|531085850|FG000|2-Month Monotherapy Period|Other|1|||
147250307|NCT01156311|531085851|FG001|2-Month Monotherapy Period|Other|0|||
147250308|NCT01156311|531085852|FG002|2-Month Monotherapy Period|Other|0|||
147250309|NCT01156311|531085853|FG003|2-Month Monotherapy Period|Other|0|||
147250310|NCT01156311|531085850|FG000|6-month Add-on Therapy Period|Adverse Event|0|||
147250311|NCT01156311|531085851|FG001|6-month Add-on Therapy Period|Adverse Event|0|||
147250312|NCT01156311|531085852|FG002|6-month Add-on Therapy Period|Adverse Event|7|||
147250313|NCT01156311|531085853|FG003|6-month Add-on Therapy Period|Adverse Event|6|||
147250314|NCT01156311|531085850|FG000|6-month Add-on Therapy Period|Lost to Follow-up|0|||
147250315|NCT01156311|531085851|FG001|6-month Add-on Therapy Period|Lost to Follow-up|0|||
147250316|NCT01156311|531085852|FG002|6-month Add-on Therapy Period|Lost to Follow-up|2|||
147250317|NCT01156311|531085853|FG003|6-month Add-on Therapy Period|Lost to Follow-up|0|||
147250318|NCT01156311|531085850|FG000|6-month Add-on Therapy Period|Disease Activity|0|||
147250319|NCT01156311|531085851|FG001|6-month Add-on Therapy Period|Disease Activity|0|||
147250320|NCT01156311|531085852|FG002|6-month Add-on Therapy Period|Disease Activity|1|||
147250321|NCT01156311|531085853|FG003|6-month Add-on Therapy Period|Disease Activity|2|||
147250322|NCT01156311|531085850|FG000|6-month Add-on Therapy Period|Physician Decision|0|||
147250323|NCT01156311|531085851|FG001|6-month Add-on Therapy Period|Physician Decision|0|||
147250324|NCT01156311|531085852|FG002|6-month Add-on Therapy Period|Physician Decision|1|||
147250325|NCT01156311|531085853|FG003|6-month Add-on Therapy Period|Physician Decision|0|||
147250326|NCT01156311|531085850|FG000|6-month Add-on Therapy Period|Other|0|||
147250327|NCT01156311|531085851|FG001|6-month Add-on Therapy Period|Other|0|||
147250328|NCT01156311|531085852|FG002|6-month Add-on Therapy Period|Other|1|||
147250329|NCT01156311|531085853|FG003|6-month Add-on Therapy Period|Other|2|||
147660416|NCT02185417|532579882|FG000|Overall Study|Withdrawal by Subject|7|||
147660417|NCT02185417|532579883|FG001|Overall Study|Withdrawal by Subject|12|||
147660418|NCT02185417|532579884|FG002|Overall Study|Withdrawal by Subject|0|||
147250330|NCT01741701|531085856|FG000|Overall Study|Adverse Event|5|||
147250331|NCT01741701|531085857|FG001|Overall Study|Adverse Event|1|||
147250332|NCT01741701|531085856|FG000|Overall Study|Withdrawal by Subject|0|||
147250333|NCT01741701|531085857|FG001|Overall Study|Withdrawal by Subject|1|||
147250334|NCT03033394|531085878|FG000|Completed Pharmacokinetic Analysis|Missing data|1|||
147250335|NCT03033394|531085878|FG000|Completed Pharmacokinetic Analysis|Oral dosing not incorporated into pharmacokinetic model|3|||
147250336|NCT03033394|531085878|FG000|Completed Pharmacokinetic Analysis|Level taken at incorrect time|1|||
147250337|NCT03033394|531085878|FG000|Completed Pharmacokinetic Analysis|Pharmacokinetic soffware unable to generate predicted values|1|||
147250338|NCT03033394|531085878|FG000|Completed Final Analysis|1 participant excluded from final analysis as an outlier (>1.5 x interquartile range)|1|||
147250339|NCT02927431|531085880|FG000|Overall Study|Withdrawal by Subject|0|||
147660419|NCT00249873|532579885|FG000|Overall Study|Not treated|7|||
147660420|NCT00249873|532579886|FG001|Overall Study|Not treated|8|||
147660421|NCT00249873|532579885|FG000|Overall Study|Significant thrombocytopenia|9|||
147250340|NCT02927431|531085881|FG001|Overall Study|Withdrawal by Subject|0|||
147250341|NCT02927431|531085882|FG002|Overall Study|Withdrawal by Subject|1|||
147250342|NCT01830972|531085883|FG000|Part II|Withdrawal by Subject|2|||
147250343|NCT01830972|531085884|FG001|Part II|Withdrawal by Subject|2|||
147250344|NCT01830972|531085883|FG000|Part III|Withdrawal by Subject|1|||
147250345|NCT01830972|531085884|FG001|Part III|Withdrawal by Subject|0|||
147250346|NCT01830972|531085883|FG000|Part III|Noncompliance|1|||
147250347|NCT01830972|531085884|FG001|Part III|Noncompliance|0|||
147250348|NCT01830972|531085883|FG000|Part IV|Withdrawal by Subject|2|||
147250349|NCT01830972|531085884|FG001|Part IV|Withdrawal by Subject|1|||
147250350|NCT01830972|531085883|FG000|Part IV|Non-Compliance|1|||
147250351|NCT01830972|531085884|FG001|Part IV|Non-Compliance|0|||
147250352|NCT00673465|531085885|FG000|Part 1/Period 1 (United States)|Protocol Violation|0|||
147250353|NCT00673465|531085886|FG001|Part 1/Period 1 (United States)|Protocol Violation|0|||
147449790|NCT00333359|531809588|FG000|Overall Study|Protocol Non-compliance|2|||
147449791|NCT00333359|531809589|FG001|Overall Study|Protocol Non-compliance|8|||
147449792|NCT00333359|531809588|FG000|Overall Study|Lost to Follow-up|15|||
147449793|NCT00333359|531809589|FG001|Overall Study|Lost to Follow-up|25|||
147449794|NCT00333359|531809588|FG000|Overall Study|Termination or Withdrawal by Sponsor|1|||
147596373|NCT02989168|532340875|FG000|Overall Study|Physician Decision|0|||
147250354|NCT00673465|531085887|FG002|Part 1/Period 1 (United States)|Protocol Violation|0|||
147250355|NCT00673465|531085888|FG003|Part 1/Period 1 (United States)|Protocol Violation|0|||
147250356|NCT00673465|531085889|FG004|Part 1/Period 1 (United States)|Protocol Violation|1|||
147250357|NCT00673465|531085890|FG005|Part 1/Period 1 (United States)|Protocol Violation|1|||
147250358|NCT00673465|531085891|FG006|Part 1/Period 1 (United States)|Protocol Violation|0|||
147250359|NCT00673465|531085892|FG007|Part 1/Period 1 (United States)|Protocol Violation|0|||
147250360|NCT00673465|531085893|FG008|Part 1/Period 1 (United States)|Protocol Violation|0|||
147250361|NCT00673465|531085894|FG009|Part 1/Period 1 (United States)|Protocol Violation|0|||
147250362|NCT00673465|531085895|FG010|Part 1/Period 1 (United States)|Protocol Violation|0|||
147250363|NCT00673465|531085896|FG011|Part 1/Period 1 (United States)|Protocol Violation|0|||
147250364|NCT00673465|531085885|FG000|Part 1/Period 2 (United States)|Protocol Violation|0|||
147250365|NCT00673465|531085886|FG001|Part 1/Period 2 (United States)|Protocol Violation|0|||
147250366|NCT00673465|531085887|FG002|Part 1/Period 2 (United States)|Protocol Violation|0|||
147250367|NCT00673465|531085888|FG003|Part 1/Period 2 (United States)|Protocol Violation|0|||
147250368|NCT00673465|531085889|FG004|Part 1/Period 2 (United States)|Protocol Violation|1|||
147250369|NCT00673465|531085890|FG005|Part 1/Period 2 (United States)|Protocol Violation|0|||
147250370|NCT00673465|531085891|FG006|Part 1/Period 2 (United States)|Protocol Violation|0|||
147250371|NCT00673465|531085892|FG007|Part 1/Period 2 (United States)|Protocol Violation|0|||
147250372|NCT00673465|531085893|FG008|Part 1/Period 2 (United States)|Protocol Violation|0|||
147250373|NCT00673465|531085894|FG009|Part 1/Period 2 (United States)|Protocol Violation|0|||
147250374|NCT00673465|531085895|FG010|Part 1/Period 2 (United States)|Protocol Violation|0|||
147250375|NCT00673465|531085896|FG011|Part 1/Period 2 (United States)|Protocol Violation|0|||
147250376|NCT01829191|531085897|FG000|Overall Study|Relocation|0|||
147250377|NCT01829191|531085898|FG001|Overall Study|Relocation|1|||
147250378|NCT01829191|531085897|FG000|Overall Study|Lens discomfort|0|||
147250379|NCT01829191|531085898|FG001|Overall Study|Lens discomfort|3|||
147250380|NCT01829191|531085897|FG000|Overall Study|Lens handling difficulty|1|||
147250381|NCT01829191|531085898|FG001|Overall Study|Lens handling difficulty|4|||
147250382|NCT01829191|531085897|FG000|Overall Study|Protocol Violation|4|||
147250383|NCT01829191|531085898|FG001|Overall Study|Protocol Violation|1|||
147250384|NCT01829191|531085897|FG000|Overall Study|Withdrawal by Subject|2|||
147250385|NCT01829191|531085898|FG001|Overall Study|Withdrawal by Subject|3|||
147250386|NCT01829191|531085897|FG000|Overall Study|Lost to Follow-up|0|||
147250387|NCT01829191|531085898|FG001|Overall Study|Lost to Follow-up|1|||
147250388|NCT01829191|531085897|FG000|Overall Study|Subject was fit for ortho - k|0|||
147250389|NCT01829191|531085898|FG001|Overall Study|Subject was fit for ortho - k|1|||
147250390|NCT01276353|531085899|FG000|Double-blind|Adverse Event|2|||
147250391|NCT01276353|531085900|FG001|Double-blind|Adverse Event|0|||
147250392|NCT01276353|531085899|FG000|Double-blind|Withdrawal by Subject|1|||
147250393|NCT01276353|531085900|FG001|Double-blind|Withdrawal by Subject|0|||
147250394|NCT01276353|531085899|FG000|Extension|Adverse Event|2|||
147250395|NCT01276353|531085900|FG001|Extension|Adverse Event|5|||
147596374|NCT02989168|532340876|FG001|Overall Study|Physician Decision|1|||
147250396|NCT01276353|531085899|FG000|Extension|Withdrawal by Subject|1|||
147250397|NCT01276353|531085900|FG001|Extension|Withdrawal by Subject|2|||
147250398|NCT01276353|531085899|FG000|Extension|Withdrawal of study drug 4 days in a row|3|||
147250399|NCT01276353|531085900|FG001|Extension|Withdrawal of study drug 4 days in a row|1|||
147449795|NCT00333359|531809589|FG001|Overall Study|Termination or Withdrawal by Sponsor|1|||
147250400|NCT01276353|531085899|FG000|Extension|Physician Decision|1|||
147250401|NCT01276353|531085900|FG001|Extension|Physician Decision|0|||
147250402|NCT01276353|531085899|FG000|Extension|Prohibited concomitant medications|0|||
147250403|NCT01276353|531085900|FG001|Extension|Prohibited concomitant medications|1|||
147250404|NCT00553514|531085901|FG000|Overall Study|Protocol deviation|0|||
147449796|NCT00333359|531809588|FG000|Overall Study|Treatment Failure|3|||
147250405|NCT00553514|531085902|FG001|Overall Study|Protocol deviation|0|||
147250406|NCT00553514|531085903|FG002|Overall Study|Protocol deviation|0|||
147250407|NCT00553514|531085904|FG003|Overall Study|Protocol deviation|1|||
147250408|NCT00553514|531085905|FG004|Overall Study|Protocol deviation|0|||
147250409|NCT00553514|531085901|FG000|Overall Study|Lack of ovarian response|4|||
147250410|NCT00553514|531085902|FG001|Overall Study|Lack of ovarian response|5|||
147449797|NCT00333359|531809589|FG001|Overall Study|Treatment Failure|8|||
147449798|NCT00333359|531809588|FG000|Overall Study|Withdrew before Receiving One Dose|2|||
147449799|NCT00333359|531809589|FG001|Overall Study|Withdrew before Receiving One Dose|6|||
147449800|NCT00805480|531809592|FG000|Overall Study|Withdrawal by Subject|13|||
147449801|NCT00805480|531809593|FG001|Overall Study|Withdrawal by Subject|5|||
147250411|NCT00553514|531085903|FG002|Overall Study|Lack of ovarian response|5|||
147250412|NCT00553514|531085904|FG003|Overall Study|Lack of ovarian response|5|||
147449802|NCT00805480|531809594|FG002|Overall Study|Withdrawal by Subject|11|||
147449803|NCT00805480|531809595|FG003|Overall Study|Withdrawal by Subject|5|||
147449804|NCT00805480|531809592|FG000|Overall Study|Lost to Follow-up|1|||
147449805|NCT00805480|531809593|FG001|Overall Study|Lost to Follow-up|2|||
147449806|NCT00805480|531809594|FG002|Overall Study|Lost to Follow-up|0|||
147449807|NCT00805480|531809595|FG003|Overall Study|Lost to Follow-up|0|||
147449808|NCT00805480|531809592|FG000|Overall Study|Adverse Event|0|||
147449809|NCT00805480|531809593|FG001|Overall Study|Adverse Event|0|||
147449810|NCT00805480|531809594|FG002|Overall Study|Adverse Event|1|||
147449811|NCT00805480|531809595|FG003|Overall Study|Adverse Event|0|||
147449812|NCT04099251|531811292|FG000|Pre-Treatment|Other reasons|1|||
147449813|NCT04099251|531811293|FG001|Pre-Treatment|Other reasons|0|||
147449814|NCT04099251|531811292|FG000|Pre-Treatment|Participant no longer meets study criteria|1|||
147449815|NCT04099251|531811293|FG001|Pre-Treatment|Participant no longer meets study criteria|0|||
147449816|NCT04099251|531811292|FG000|Blinded Treatment Phase|Other reasons|16|||
147449817|NCT04099251|531811293|FG001|Blinded Treatment Phase|Other reasons|7|||
147449818|NCT04099251|531811292|FG000|Blinded Treatment Phase|Disease recurrence|26|||
147449819|NCT04099251|531811293|FG001|Blinded Treatment Phase|Disease recurrence|41|||
147449820|NCT04099251|531811292|FG000|Blinded Treatment Phase|Adverse event unrelated to study drug|11|||
147449821|NCT04099251|531811293|FG001|Blinded Treatment Phase|Adverse event unrelated to study drug|1|||
147449822|NCT04099251|531811292|FG000|Blinded Treatment Phase|Study drug toxicity|94|||
147449823|NCT04099251|531811293|FG001|Blinded Treatment Phase|Study drug toxicity|7|||
147449824|NCT04099251|531811292|FG000|Blinded Treatment Phase|Participant no longer meets study criteria|1|||
147449825|NCT04099251|531811293|FG001|Blinded Treatment Phase|Participant no longer meets study criteria|0|||
147449826|NCT04099251|531811292|FG000|Blinded Treatment Phase|Lost to Follow-up|1|||
147449827|NCT04099251|531811293|FG001|Blinded Treatment Phase|Lost to Follow-up|0|||
147449828|NCT04099251|531811292|FG000|Blinded Treatment Phase|Death|6|||
147449829|NCT04099251|531811293|FG001|Blinded Treatment Phase|Death|2|||
147449830|NCT04099251|531811292|FG000|Blinded Treatment Phase|Withdrawal by Subject|18|||
147449831|NCT04099251|531811293|FG001|Blinded Treatment Phase|Withdrawal by Subject|7|||
147449832|NCT04099251|531811292|FG000|Blinded Treatment Phase|Participant request to discontinue study treatment|29|||
147449833|NCT04099251|531811293|FG001|Blinded Treatment Phase|Participant request to discontinue study treatment|0|||
147449834|NCT04099251|531811292|FG000|Blinded Treatment Phase|Ongoing treatment|64|||
147449835|NCT04099251|531811293|FG001|Blinded Treatment Phase|Ongoing treatment|39|||
147449836|NCT04099251|531811292|FG000|Blinded Treatment Phase|Maximum clinical benefit|1|||
147449837|NCT04099251|531811293|FG001|Blinded Treatment Phase|Maximum clinical benefit|2|||
147449838|NCT04099251|531811292|FG000|Optional Open-Label Phase Pre-Treatment|Participant withdrew consent after re-baseline visit|0|||
147527180|NCT03726320|532084157|FG002|Overall Study|Lost to Follow-up|0|||
147527181|NCT03726320|532084155|FG000|Overall Study|Time Constraints|4|||
147527182|NCT03726320|532084156|FG001|Overall Study|Time Constraints|1|||
147527183|NCT03726320|532084157|FG002|Overall Study|Time Constraints|0|||
147527184|NCT03726320|532084155|FG000|Overall Study|Ineligible after enrollment|3|||
147527185|NCT03726320|532084156|FG001|Overall Study|Ineligible after enrollment|3|||
147250413|NCT00553514|531085905|FG004|Overall Study|Lack of ovarian response|6|||
147250414|NCT00553514|531085901|FG000|Overall Study|Ovarian hyperstimulation syndrome risk|3|||
147250415|NCT00553514|531085902|FG001|Overall Study|Ovarian hyperstimulation syndrome risk|0|||
147250416|NCT00553514|531085903|FG002|Overall Study|Ovarian hyperstimulation syndrome risk|1|||
147250417|NCT00553514|531085904|FG003|Overall Study|Ovarian hyperstimulation syndrome risk|0|||
147250418|NCT00553514|531085905|FG004|Overall Study|Ovarian hyperstimulation syndrome risk|0|||
147250419|NCT00553514|531085901|FG000|Overall Study|Risk of multiple pregnancy|0|||
147250420|NCT00553514|531085902|FG001|Overall Study|Risk of multiple pregnancy|2|||
147527186|NCT03726320|532084157|FG002|Overall Study|Ineligible after enrollment|0|||
147527187|NCT03726320|532084155|FG000|Overall Study|Clinic / insurance issue|2|||
147527188|NCT03726320|532084156|FG001|Overall Study|Clinic / insurance issue|0|||
147527189|NCT03726320|532084157|FG002|Overall Study|Clinic / insurance issue|0|||
147527190|NCT03726320|532084155|FG000|Overall Study|Language barrier|1|||
147527191|NCT03726320|532084156|FG001|Overall Study|Language barrier|0|||
147527192|NCT03726320|532084157|FG002|Overall Study|Language barrier|0|||
147527193|NCT03726320|532084155|FG000|Overall Study|Provider left the clinic|0|||
147250421|NCT00553514|531085903|FG002|Overall Study|Risk of multiple pregnancy|0|||
147250422|NCT00553514|531085904|FG003|Overall Study|Risk of multiple pregnancy|1|||
147250423|NCT00553514|531085905|FG004|Overall Study|Risk of multiple pregnancy|0|||
147250424|NCT00553514|531085901|FG000|Overall Study|Other|1|||
147250425|NCT00553514|531085902|FG001|Overall Study|Other|1|||
147250426|NCT00553514|531085903|FG002|Overall Study|Other|0|||
147449839|NCT04099251|531811293|FG001|Optional Open-Label Phase Pre-Treatment|Participant withdrew consent after re-baseline visit|2|||
147449840|NCT04099251|531811292|FG000|Optional Open-Label Phase Treatment|Disease progression/recurrence|0|||
147449841|NCT04099251|531811293|FG001|Optional Open-Label Phase Treatment|Disease progression/recurrence|5|||
147449842|NCT04099251|531811292|FG000|Optional Open-Label Phase Treatment|Decision by Principal Investigator|0|||
147449843|NCT04099251|531811293|FG001|Optional Open-Label Phase Treatment|Decision by Principal Investigator|1|||
147449844|NCT04099251|531811292|FG000|Optional Open-Label Phase Treatment|Study drug toxicity|0|||
147449845|NCT04099251|531811293|FG001|Optional Open-Label Phase Treatment|Study drug toxicity|2|||
147449846|NCT04099251|531811292|FG000|Optional Open-Label Phase Treatment|Ongoing treatment|2|||
147449847|NCT04099251|531811293|FG001|Optional Open-Label Phase Treatment|Ongoing treatment|17|||
147449848|NCT05032157|531811294|FG000|Overall Study|Adverse Event|12|||
147449849|NCT05032157|531811295|FG001|Overall Study|Adverse Event|7|||
147250427|NCT00553514|531085904|FG003|Overall Study|Other|0|||
147250428|NCT00553514|531085905|FG004|Overall Study|Other|1|||
147250429|NCT04952402|531085906|FG000|Overall Study|Lost to Follow-up|1|||
147250430|NCT04952402|531085907|FG001|Overall Study|Lost to Follow-up|3|||
147250431|NCT04952402|531085906|FG000|Overall Study|Lack Of Venous Access|0|||
147250432|NCT04952402|531085907|FG001|Overall Study|Lack Of Venous Access|1|||
147250433|NCT00726661|531085908|FG000|Overall Study|Lost to Follow-up|36|||
147250434|NCT00726661|531085909|FG001|Overall Study|Lost to Follow-up|11|||
147250435|NCT00726661|531085908|FG000|Overall Study|Withdrawal by Subject|17|||
147250436|NCT00726661|531085909|FG001|Overall Study|Withdrawal by Subject|13|||
147250437|NCT00726661|531085908|FG000|Overall Study|Trial terminated by sponsor|214|||
147250438|NCT00726661|531085909|FG001|Overall Study|Trial terminated by sponsor|187|||
147250439|NCT00726661|531085908|FG000|Overall Study|Death|475|||
147250440|NCT00726661|531085909|FG001|Overall Study|Death|159|||
147250441|NCT00726661|531085908|FG000|Overall Study|Physician Decision|25|||
147250442|NCT00726661|531085909|FG001|Overall Study|Physician Decision|13|||
147250443|NCT00726661|531085908|FG000|Overall Study|Other|47|||
147250444|NCT00726661|531085909|FG001|Overall Study|Other|35|||
147250445|NCT00587639|531085912|FG000|Overall Study|Withdrawal by Subject|1|||
147250446|NCT00160251|531085917|FG000|Prior to Amendment 2|Adverse Event|2|||
147250447|NCT00160251|531085918|FG001|Prior to Amendment 2|Adverse Event|1|||
147449850|NCT05032157|531811294|FG000|Overall Study|Pregnancy|0|||
147449851|NCT05032157|531811295|FG001|Overall Study|Pregnancy|2|||
147449852|NCT05032157|531811294|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
147449853|NCT05032157|531811295|FG001|Overall Study|Unsatisfactory therapeutic effect|7|||
147449854|NCT05032157|531811294|FG000|Overall Study|Protocol Deviation|8|||
147449855|NCT05032157|531811295|FG001|Overall Study|Protocol Deviation|4|||
147449856|NCT05032157|531811294|FG000|Overall Study|Lost to Follow-up|1|||
147449857|NCT05032157|531811295|FG001|Overall Study|Lost to Follow-up|3|||
147449858|NCT05032157|531811294|FG000|Overall Study|Physician Decision|7|||
147449859|NCT05032157|531811295|FG001|Overall Study|Physician Decision|2|||
147449860|NCT05032157|531811294|FG000|Overall Study|Patient Decision|38|||
147449861|NCT05032157|531811295|FG001|Overall Study|Patient Decision|19|||
147449862|NCT02068547|531811296|FG000|Overall Study|Lost to Follow-up|3|||
147449863|NCT02068547|531811297|FG001|Overall Study|Lost to Follow-up|3|||
147449864|NCT02068547|531811296|FG000|Overall Study|Physician Decision|1|||
147449865|NCT02068547|531811297|FG001|Overall Study|Physician Decision|0|||
147660422|NCT00249873|532579886|FG001|Overall Study|Significant thrombocytopenia|8|||
147250448|NCT00160251|531085919|FG002|Prior to Amendment 2|Adverse Event|3|||
147250449|NCT00160251|531085920|FG003|Prior to Amendment 2|Adverse Event|1|||
147250450|NCT00160251|531085921|FG004|Prior to Amendment 2|Adverse Event|1|||
147250451|NCT00160251|531085922|FG005|Prior to Amendment 2|Adverse Event|1|||
147250452|NCT00160251|531085923|FG006|Prior to Amendment 2|Adverse Event|1|||
147250453|NCT00160251|531085924|FG007|Prior to Amendment 2|Adverse Event|0|||
147250454|NCT00160251|531085917|FG000|Prior to Amendment 2|Lack of Efficacy|0|||
147250455|NCT00160251|531085918|FG001|Prior to Amendment 2|Lack of Efficacy|4|||
147449866|NCT03657043|531811298|FG000|Overall Study|Withdrawal by Subject|1|||
147449867|NCT03657043|531811299|FG001|Overall Study|Withdrawal by Subject|1|||
147449868|NCT03657043|531811300|FG002|Overall Study|Withdrawal by Subject|0|||
147250456|NCT00160251|531085919|FG002|Prior to Amendment 2|Lack of Efficacy|37|||
147250457|NCT00160251|531085920|FG003|Prior to Amendment 2|Lack of Efficacy|35|||
147250458|NCT00160251|531085921|FG004|Prior to Amendment 2|Lack of Efficacy|24|||
147250459|NCT00160251|531085922|FG005|Prior to Amendment 2|Lack of Efficacy|55|||
147250460|NCT00160251|531085923|FG006|Prior to Amendment 2|Lack of Efficacy|0|||
147250461|NCT00160251|531085924|FG007|Prior to Amendment 2|Lack of Efficacy|0|||
147250462|NCT00160251|531085917|FG000|Prior to Amendment 2|Lost to Follow-up|0|||
147250463|NCT00160251|531085918|FG001|Prior to Amendment 2|Lost to Follow-up|0|||
147449869|NCT03657043|531811301|FG003|Overall Study|Withdrawal by Subject|0|||
147449870|NCT03657043|531811302|FG004|Overall Study|Withdrawal by Subject|4|||
147250464|NCT00160251|531085919|FG002|Prior to Amendment 2|Lost to Follow-up|1|||
147250465|NCT00160251|531085920|FG003|Prior to Amendment 2|Lost to Follow-up|0|||
147596375|NCT02989168|532340875|FG000|Overall Study|Adverse Event|1|||
147596376|NCT02989168|532340876|FG001|Overall Study|Adverse Event|2|||
147596377|NCT02989168|532340875|FG000|Overall Study|Sponsor stopped study.|1|||
147596378|NCT02989168|532340876|FG001|Overall Study|Sponsor stopped study.|0|||
147596379|NCT03456960|532340877|FG000|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
147596380|NCT03456960|532340878|FG001|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
147596381|NCT03456960|532340879|FG002|Washout Period (at Least 14 Days)|Withdrawal by Subject|1|||
147596382|NCT03456960|532340880|FG003|Washout Period (at Least 14 Days)|Withdrawal by Subject|2|||
147596383|NCT03456960|532340881|FG004|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
147596384|NCT03456960|532340882|FG005|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
147596385|NCT03456960|532340877|FG000|Period 2 (1 Day)|Adverse Event|1|||
147596386|NCT03456960|532340878|FG001|Period 2 (1 Day)|Adverse Event|0|||
147596387|NCT03456960|532340879|FG002|Period 2 (1 Day)|Adverse Event|0|||
147596388|NCT03456960|532340880|FG003|Period 2 (1 Day)|Adverse Event|1|||
147596389|NCT03456960|532340881|FG004|Period 2 (1 Day)|Adverse Event|0|||
147596390|NCT03456960|532340882|FG005|Period 2 (1 Day)|Adverse Event|0|||
147596391|NCT00532935|532340883|FG000|Overall Study|Adverse Event|11|||
147596392|NCT00532935|532340884|FG001|Overall Study|Adverse Event|12|||
147596393|NCT00532935|532340883|FG000|Overall Study|Lack of Efficacy|0|||
147596394|NCT00532935|532340884|FG001|Overall Study|Lack of Efficacy|3|||
147596395|NCT00532935|532340883|FG000|Overall Study|Lost to Follow-up|10|||
147596396|NCT00532935|532340884|FG001|Overall Study|Lost to Follow-up|6|||
147596397|NCT00532935|532340883|FG000|Overall Study|Physician Decision|4|||
147596398|NCT00532935|532340884|FG001|Overall Study|Physician Decision|5|||
147596399|NCT00532935|532340883|FG000|Overall Study|Pregnancy|1|||
147596400|NCT00532935|532340884|FG001|Overall Study|Pregnancy|0|||
147596401|NCT00532935|532340883|FG000|Overall Study|Protocol Violation|4|||
147596402|NCT00532935|532340884|FG001|Overall Study|Protocol Violation|2|||
147596403|NCT00532935|532340883|FG000|Overall Study|Withdrawal by Subject|10|||
147596404|NCT00532935|532340884|FG001|Overall Study|Withdrawal by Subject|9|||
147596405|NCT00532935|532340883|FG000|Overall Study|Protocol Specific Criteria|11|||
147596406|NCT00532935|532340884|FG001|Overall Study|Protocol Specific Criteria|15|||
147596407|NCT01301508|532340885|FG000|Overall Study|Withdrawal by Subject|1|||
147596408|NCT01301508|532340886|FG001|Overall Study|Withdrawal by Subject|2|||
147596409|NCT01301508|532340885|FG000|Overall Study|Lost to Follow-up|0|||
147596410|NCT01301508|532340886|FG001|Overall Study|Lost to Follow-up|1|||
147596411|NCT01300923|532340887|FG000|Overall Study|Physician Decision|0|||
147596412|NCT01300923|532340888|FG001|Overall Study|Physician Decision|2|||
147596413|NCT01940497|532340891|FG000|Overall Study|Adverse Event/Intercurrent Illness|11|||
147596414|NCT01940497|532340892|FG001|Overall Study|Adverse Event/Intercurrent Illness|8|||
147596415|NCT01940497|532340891|FG000|Overall Study|Recurrence of Disease Postsurgery|1|||
147596416|NCT01940497|532340892|FG001|Overall Study|Recurrence of Disease Postsurgery|3|||
147596417|NCT01940497|532340891|FG000|Overall Study|Violation of Entry Criteria|1|||
147596418|NCT01940497|532340892|FG001|Overall Study|Violation of Entry Criteria|1|||
147596419|NCT01940497|532340891|FG000|Overall Study|Refused Treatment|1|||
147596420|NCT01940497|532340892|FG001|Overall Study|Refused Treatment|3|||
147596421|NCT01940497|532340891|FG000|Overall Study|Withdrew Consent|6|||
147596422|NCT01940497|532340892|FG001|Overall Study|Withdrew Consent|2|||
147596423|NCT01940497|532340891|FG000|Overall Study|Administrative/Other|1|||
147596424|NCT01940497|532340892|FG001|Overall Study|Administrative/Other|1|||
147596425|NCT02707861|532340893|FG000|Overall Study|Went onto commercial drug|30|||
147596426|NCT02707861|532340894|FG001|Overall Study|Went onto commercial drug|23|||
147596427|NCT02707861|532340893|FG000|Overall Study|Adverse Event|2|||
147596428|NCT02707861|532340894|FG001|Overall Study|Adverse Event|3|||
147596429|NCT02707861|532340893|FG000|Overall Study|Death|5|||
147596430|NCT02707861|532340894|FG001|Overall Study|Death|2|||
147596431|NCT02707861|532340893|FG000|Overall Study|Lack of Efficacy|0|||
147596432|NCT02707861|532340894|FG001|Overall Study|Lack of Efficacy|2|||
147596433|NCT02707861|532340893|FG000|Overall Study|Physician Decision|1|||
147250466|NCT00160251|531085921|FG004|Prior to Amendment 2|Lost to Follow-up|1|||
147596434|NCT02707861|532340894|FG001|Overall Study|Physician Decision|4|||
147596435|NCT02707861|532340893|FG000|Overall Study|Withdrawal by Subject|2|||
147596436|NCT02707861|532340894|FG001|Overall Study|Withdrawal by Subject|1|||
147596437|NCT02707861|532340893|FG000|Overall Study|Lost to Follow-up|1|||
147596438|NCT02707861|532340894|FG001|Overall Study|Lost to Follow-up|3|||
147596439|NCT03123861|532340895|FG000|Overall Study|Protocol Violation|1|||
147596440|NCT03123861|532340896|FG001|Overall Study|Protocol Violation|1|||
147596441|NCT03123861|532340895|FG000|Overall Study|Withdrawal by Subject|2|||
147596442|NCT03123861|532340896|FG001|Overall Study|Withdrawal by Subject|2|||
147596443|NCT00448136|532340901|FG000|Overall Study|Death|3|||
147596444|NCT00448136|532340902|FG001|Overall Study|Death|8|||
147596445|NCT00448136|532340901|FG000|Overall Study|Investigator's decision (progression)|1|||
147596446|NCT00448136|532340902|FG001|Overall Study|Investigator's decision (progression)|0|||
147596447|NCT03407430|532340905|FG000|Washout|Protocol Violation|1|||
147250467|NCT00160251|531085922|FG005|Prior to Amendment 2|Lost to Follow-up|1|||
147250468|NCT00160251|531085923|FG006|Prior to Amendment 2|Lost to Follow-up|0|||
147250469|NCT00160251|531085924|FG007|Prior to Amendment 2|Lost to Follow-up|0|||
147250470|NCT00160251|531085917|FG000|Prior to Amendment 2|Withdrawal by Subject|3|||
147250471|NCT00160251|531085918|FG001|Prior to Amendment 2|Withdrawal by Subject|1|||
147250472|NCT00160251|531085919|FG002|Prior to Amendment 2|Withdrawal by Subject|3|||
147250473|NCT00160251|531085920|FG003|Prior to Amendment 2|Withdrawal by Subject|4|||
147250474|NCT00160251|531085921|FG004|Prior to Amendment 2|Withdrawal by Subject|2|||
147250475|NCT00160251|531085922|FG005|Prior to Amendment 2|Withdrawal by Subject|3|||
147250476|NCT00160251|531085923|FG006|Prior to Amendment 2|Withdrawal by Subject|3|||
147250477|NCT00160251|531085924|FG007|Prior to Amendment 2|Withdrawal by Subject|0|||
147250478|NCT00160251|531085917|FG000|Prior to Amendment 2|Noncompliance with protocol|1|||
147250479|NCT00160251|531085918|FG001|Prior to Amendment 2|Noncompliance with protocol|0|||
147250480|NCT00160251|531085919|FG002|Prior to Amendment 2|Noncompliance with protocol|0|||
147250481|NCT00160251|531085920|FG003|Prior to Amendment 2|Noncompliance with protocol|0|||
147250482|NCT00160251|531085921|FG004|Prior to Amendment 2|Noncompliance with protocol|0|||
147250483|NCT00160251|531085922|FG005|Prior to Amendment 2|Noncompliance with protocol|0|||
147250484|NCT00160251|531085923|FG006|Prior to Amendment 2|Noncompliance with protocol|0|||
147250485|NCT00160251|531085924|FG007|Prior to Amendment 2|Noncompliance with protocol|0|||
147250486|NCT00160251|531085917|FG000|Prior to Amendment 2|Completed Treatment Phase|3|||
147250487|NCT00160251|531085918|FG001|Prior to Amendment 2|Completed Treatment Phase|0|||
147250488|NCT00160251|531085919|FG002|Prior to Amendment 2|Completed Treatment Phase|0|||
147250489|NCT00160251|531085920|FG003|Prior to Amendment 2|Completed Treatment Phase|0|||
147250490|NCT00160251|531085921|FG004|Prior to Amendment 2|Completed Treatment Phase|0|||
147250491|NCT00160251|531085922|FG005|Prior to Amendment 2|Completed Treatment Phase|23|||
147250492|NCT00160251|531085923|FG006|Prior to Amendment 2|Completed Treatment Phase|0|||
147250493|NCT00160251|531085924|FG007|Prior to Amendment 2|Completed Treatment Phase|0|||
147250494|NCT00160251|531085917|FG000|Post-amendment 2|Adverse Event|0|||
147250495|NCT00160251|531085918|FG001|Post-amendment 2|Adverse Event|0|||
147250496|NCT00160251|531085919|FG002|Post-amendment 2|Adverse Event|0|||
147250497|NCT00160251|531085920|FG003|Post-amendment 2|Adverse Event|0|||
147250498|NCT00160251|531085921|FG004|Post-amendment 2|Adverse Event|0|||
147250499|NCT00160251|531085922|FG005|Post-amendment 2|Adverse Event|0|||
147250500|NCT00160251|531085923|FG006|Post-amendment 2|Adverse Event|0|||
147250501|NCT00160251|531085924|FG007|Post-amendment 2|Adverse Event|20|||
147250502|NCT00160251|531085917|FG000|Post-amendment 2|Lack of Efficacy|0|||
147250503|NCT00160251|531085918|FG001|Post-amendment 2|Lack of Efficacy|0|||
147250504|NCT00160251|531085919|FG002|Post-amendment 2|Lack of Efficacy|0|||
147250505|NCT00160251|531085920|FG003|Post-amendment 2|Lack of Efficacy|0|||
147250506|NCT00160251|531085921|FG004|Post-amendment 2|Lack of Efficacy|0|||
147250507|NCT00160251|531085922|FG005|Post-amendment 2|Lack of Efficacy|0|||
147250508|NCT00160251|531085923|FG006|Post-amendment 2|Lack of Efficacy|0|||
147250509|NCT00160251|531085924|FG007|Post-amendment 2|Lack of Efficacy|24|||
147250510|NCT00160251|531085917|FG000|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
147250511|NCT00160251|531085918|FG001|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
147250512|NCT00160251|531085919|FG002|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
147250513|NCT00160251|531085920|FG003|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
147250514|NCT00160251|531085921|FG004|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
147250515|NCT00160251|531085922|FG005|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
147250516|NCT00160251|531085923|FG006|Post-amendment 2|Lost to follow-up/withdrawal by subject|0|||
147596448|NCT03407430|532340906|FG001|Washout|Protocol Violation|0|||
147596449|NCT00922987|532340908|FG000|Overall Study|Insufficient clinical response|1|||
147596450|NCT00922987|532340908|FG000|Overall Study|Protocol Violation|2|||
147596451|NCT00922987|532340908|FG000|Overall Study|Adverse Event|1|||
147596452|NCT04969861|532340911|FG000|Overall Study|Study was terminated in consonance with discontinuation of bempegaldesleukin program.|1|||
147596453|NCT04969861|532340912|FG001|Overall Study|Study was terminated in consonance with discontinuation of bempegaldesleukin program.|0|||
147596454|NCT04905290|532343148|FG000|Overall Study|Adverse Event|4|||
147596455|NCT04905290|532343148|FG000|Overall Study|Death|2|||
147596456|NCT04905290|532343148|FG000|Overall Study|Withdrawal by Subject|4|||
147596457|NCT04905290|532343148|FG000|Overall Study|Physician Decision|2|||
147596458|NCT04905290|532343148|FG000|Overall Study|Lost to Follow-up|2|||
147596459|NCT04905290|532343148|FG000|Overall Study|Screen Failure|2|||
147596460|NCT04905290|532343148|FG000|Overall Study|Unsuccessful Procedure|2|||
147596461|NCT03295318|532343149|FG000|Overall Study|Withdrawal by Subject prior to initial vaccination|1|||
147250517|NCT00160251|531085924|FG007|Post-amendment 2|Lost to follow-up/withdrawal by subject|11|||
147250518|NCT01574612|531085925|FG000|Overall Study|Adverse Event|3|||
147250519|NCT01574612|531085925|FG000|Overall Study|non compliant with drug|2|||
147250520|NCT01574612|531085925|FG000|Overall Study|Withdrawal by Subject|1|||
147596462|NCT03295318|532343150|FG001|Overall Study|Withdrawal by Subject prior to initial vaccination|0|||
147250521|NCT01574612|531085925|FG000|Overall Study|Lost to Follow-up|2|||
147250522|NCT02407704|531085928|FG000|Overall Study|Lost to Follow-up|0|||
147250523|NCT02407704|531085929|FG001|Overall Study|Lost to Follow-up|0|||
147660423|NCT00249873|532579885|FG000|Overall Study|Severe allergic reaction|8|||
147660424|NCT00249873|532579886|FG001|Overall Study|Severe allergic reaction|1|||
147250524|NCT02407704|531085930|FG002|Overall Study|Lost to Follow-up|0|||
147250525|NCT02407704|531085931|FG003|Overall Study|Lost to Follow-up|2|||
147250526|NCT02407704|531085928|FG000|Overall Study|Protocol Violation|0|||
147250527|NCT02407704|531085929|FG001|Overall Study|Protocol Violation|0|||
147250528|NCT02407704|531085930|FG002|Overall Study|Protocol Violation|0|||
147250529|NCT02407704|531085931|FG003|Overall Study|Protocol Violation|1|||
147250530|NCT02407704|531085928|FG000|Overall Study|Withdrawal by Subject|0|||
147250531|NCT02407704|531085929|FG001|Overall Study|Withdrawal by Subject|0|||
147660425|NCT00249873|532579885|FG000|Overall Study|Serious haemorrhagic Adverse Event|74|||
147660426|NCT00249873|532579886|FG001|Overall Study|Serious haemorrhagic Adverse Event|30|||
147660427|NCT00249873|532579885|FG000|Overall Study|Other Serious Adverse Event|86|||
147660428|NCT00249873|532579886|FG001|Overall Study|Other Serious Adverse Event|97|||
147660429|NCT00249873|532579885|FG000|Overall Study|Qualifying condition not present|20|||
147660430|NCT00249873|532579886|FG001|Overall Study|Qualifying condition not present|23|||
147660431|NCT00249873|532579885|FG000|Overall Study|Contraindication to oral anticoagulant|4|||
147660432|NCT00249873|532579886|FG001|Overall Study|Contraindication to oral anticoagulant|8|||
147660433|NCT00249873|532579885|FG000|Overall Study|Withdrawal by Subject|504|||
147660434|NCT00249873|532579886|FG001|Overall Study|Withdrawal by Subject|466|||
147660435|NCT00249873|532579885|FG000|Overall Study|Lost to Follow-up|4|||
147660436|NCT00249873|532579886|FG001|Overall Study|Lost to Follow-up|7|||
147660437|NCT00249873|532579885|FG000|Overall Study|Minor bleeding|99|||
147660438|NCT00249873|532579886|FG001|Overall Study|Minor bleeding|37|||
147250532|NCT02407704|531085930|FG002|Overall Study|Withdrawal by Subject|1|||
147250533|NCT02407704|531085931|FG003|Overall Study|Withdrawal by Subject|0|||
147250534|NCT00748033|531085932|FG000|Overall Study|Adverse Event|0|||
147660439|NCT00249873|532579885|FG000|Overall Study|Non-compliance|41|||
147660440|NCT00249873|532579886|FG001|Overall Study|Non-compliance|46|||
147660441|NCT00249873|532579885|FG000|Overall Study|Other non serious Adverse Event|112|||
147660442|NCT00249873|532579886|FG001|Overall Study|Other non serious Adverse Event|108|||
147660443|NCT00249873|532579885|FG000|Overall Study|Other contraindicated medication|1|||
147660444|NCT00249873|532579886|FG001|Overall Study|Other contraindicated medication|0|||
147660445|NCT00249873|532579885|FG000|Overall Study|Patient not wish to continue after May08|3|||
147660446|NCT00249873|532579886|FG001|Overall Study|Patient not wish to continue after May08|4|||
147660447|NCT00249873|532579885|FG000|Overall Study|Physician withdrew consent|59|||
147660448|NCT00249873|532579886|FG001|Overall Study|Physician withdrew consent|60|||
147660449|NCT00249873|532579885|FG000|Overall Study|Open label clopidogrel required|31|||
147660450|NCT00249873|532579886|FG001|Overall Study|Open label clopidogrel required|42|||
147660451|NCT00249873|532579885|FG000|Overall Study|Angiotensin II receptor blocker required|1|||
147660452|NCT00249873|532579886|FG001|Overall Study|Angiotensin II receptor blocker required|0|||
147660453|NCT00249873|532579885|FG000|Overall Study|Oral anticoagulant required|159|||
147250535|NCT00748033|531085933|FG001|Overall Study|Adverse Event|1|||
147250536|NCT00434330|531085936|FG000|Overall Study|Adverse Event|0|||
147250537|NCT00434330|531085937|FG001|Overall Study|Adverse Event|0|||
147250538|NCT00434330|531085938|FG002|Overall Study|Adverse Event|1|||
147250539|NCT00434330|531085939|FG003|Overall Study|Adverse Event|0|||
147250540|NCT00434330|531085940|FG004|Overall Study|Adverse Event|0|||
147250541|NCT00434330|531085941|FG005|Overall Study|Adverse Event|0|||
147250542|NCT00434330|531085936|FG000|Overall Study|Death|1|||
147250543|NCT00434330|531085937|FG001|Overall Study|Death|0|||
147250544|NCT00434330|531085938|FG002|Overall Study|Death|0|||
147250545|NCT00434330|531085939|FG003|Overall Study|Death|0|||
147250546|NCT00434330|531085940|FG004|Overall Study|Death|1|||
147250547|NCT00434330|531085941|FG005|Overall Study|Death|1|||
147250548|NCT00434330|531085936|FG000|Overall Study|Withdrawal by Subject|0|||
147250549|NCT00434330|531085937|FG001|Overall Study|Withdrawal by Subject|0|||
147250550|NCT00434330|531085938|FG002|Overall Study|Withdrawal by Subject|1|||
147250551|NCT00434330|531085939|FG003|Overall Study|Withdrawal by Subject|1|||
147250552|NCT00434330|531085940|FG004|Overall Study|Withdrawal by Subject|0|||
147250553|NCT00434330|531085941|FG005|Overall Study|Withdrawal by Subject|0|||
147250554|NCT00434330|531085936|FG000|Overall Study|Renal transplant|0|||
147250555|NCT00434330|531085937|FG001|Overall Study|Renal transplant|0|||
147250556|NCT00434330|531085938|FG002|Overall Study|Renal transplant|0|||
147250557|NCT00434330|531085939|FG003|Overall Study|Renal transplant|1|||
147250558|NCT00434330|531085940|FG004|Overall Study|Renal transplant|0|||
147660454|NCT00249873|532579886|FG001|Overall Study|Oral anticoagulant required|157|||
147660455|NCT00249873|532579885|FG000|Overall Study|Study drug intolerance|5|||
147250559|NCT00434330|531085941|FG005|Overall Study|Renal transplant|0|||
147660456|NCT00249873|532579886|FG001|Overall Study|Study drug intolerance|0|||
147660457|NCT00249873|532579885|FG000|Overall Study|Surgery/ procedure|9|||
147660458|NCT00249873|532579886|FG001|Overall Study|Surgery/ procedure|9|||
147250560|NCT00434330|531085936|FG000|Overall Study|Subject Not Compliant With Study|0|||
147250561|NCT00434330|531085937|FG001|Overall Study|Subject Not Compliant With Study|0|||
147250562|NCT00434330|531085938|FG002|Overall Study|Subject Not Compliant With Study|1|||
147250563|NCT00434330|531085939|FG003|Overall Study|Subject Not Compliant With Study|0|||
147250564|NCT00434330|531085940|FG004|Overall Study|Subject Not Compliant With Study|0|||
147250565|NCT00434330|531085941|FG005|Overall Study|Subject Not Compliant With Study|0|||
147250566|NCT01428453|531085942|FG000|Overall Study|Adverse Event|2|||
147250567|NCT01428453|531085943|FG001|Overall Study|Adverse Event|7|||
147250568|NCT01428453|531085942|FG000|Overall Study|Protocol Violation|1|||
147250569|NCT01428453|531085943|FG001|Overall Study|Protocol Violation|0|||
147250570|NCT01428453|531085942|FG000|Overall Study|Lost to Follow-up|0|||
147250571|NCT01428453|531085943|FG001|Overall Study|Lost to Follow-up|1|||
147250572|NCT01428453|531085942|FG000|Overall Study|Withdrawal by Subject|3|||
147250573|NCT01428453|531085943|FG001|Overall Study|Withdrawal by Subject|1|||
147250574|NCT01996709|531085944|FG000|Overall Study|Withdrawal by Subject|1|||
147250575|NCT01996709|531085945|FG001|Overall Study|Withdrawal by Subject|0|||
147250576|NCT01996709|531085944|FG000|Overall Study|Lost to Follow-up|3|||
147331408|NCT01321606|531379197|FG002|Overall Study|Lost to Follow-up|0|||
147331409|NCT01321606|531379198|FG003|Overall Study|Lost to Follow-up|1|||
147596463|NCT03295318|532343151|FG002|Overall Study|Withdrawal by Subject prior to initial vaccination|0|||
147596464|NCT03295318|532343149|FG000|Overall Study|Death|1|||
147596465|NCT03295318|532343150|FG001|Overall Study|Death|1|||
147596466|NCT03295318|532343151|FG002|Overall Study|Death|1|||
147596467|NCT03295318|532343149|FG000|Overall Study|Protocol Violation|4|||
147596468|NCT03295318|532343150|FG001|Overall Study|Protocol Violation|3|||
147596469|NCT03295318|532343151|FG002|Overall Study|Protocol Violation|3|||
147596470|NCT03295318|532343149|FG000|Overall Study|Withdrawal by Subject|0|||
147596471|NCT03295318|532343150|FG001|Overall Study|Withdrawal by Subject|0|||
147596472|NCT03295318|532343151|FG002|Overall Study|Withdrawal by Subject|1|||
147596473|NCT03295318|532343149|FG000|Overall Study|Subject discontinued due to travel|0|||
147596474|NCT03295318|532343150|FG001|Overall Study|Subject discontinued due to travel|1|||
147596475|NCT03295318|532343151|FG002|Overall Study|Subject discontinued due to travel|0|||
147596476|NCT03747601|532343152|FG000|Overall Study|COVID halt to visits|4|||
147596477|NCT02788045|532343153|FG000|Main Study (Up to Week 72)|Adverse Event|0|||
147596478|NCT02788045|532343154|FG001|Main Study (Up to Week 72)|Adverse Event|1|||
147596479|NCT02788045|532343155|FG002|Main Study (Up to Week 72)|Adverse Event|1|||
147596480|NCT02788045|532343153|FG000|Main Study (Up to Week 72)|Lost to Follow-up|5|||
147596481|NCT02788045|532343154|FG001|Main Study (Up to Week 72)|Lost to Follow-up|4|||
147596482|NCT02788045|532343155|FG002|Main Study (Up to Week 72)|Lost to Follow-up|3|||
147596483|NCT02788045|532343153|FG000|Main Study (Up to Week 72)|Pregnancy|1|||
147596484|NCT02788045|532343154|FG001|Main Study (Up to Week 72)|Pregnancy|1|||
147596485|NCT02788045|532343155|FG002|Main Study (Up to Week 72)|Pregnancy|0|||
147596486|NCT02788045|532343153|FG000|Main Study (Up to Week 72)|Protocol Violation|1|||
147596487|NCT02788045|532343154|FG001|Main Study (Up to Week 72)|Protocol Violation|0|||
147596488|NCT02788045|532343155|FG002|Main Study (Up to Week 72)|Protocol Violation|0|||
147596489|NCT02788045|532343153|FG000|Main Study (Up to Week 72)|Withdrawal by Subject|6|||
147596490|NCT02788045|532343154|FG001|Main Study (Up to Week 72)|Withdrawal by Subject|4|||
147596491|NCT02788045|532343155|FG002|Main Study (Up to Week 72)|Withdrawal by Subject|1|||
147596492|NCT02788045|532343153|FG000|Main Study (Up to Week 72)|Other|3|||
147596493|NCT02788045|532343154|FG001|Main Study (Up to Week 72)|Other|0|||
147596494|NCT02788045|532343155|FG002|Main Study (Up to Week 72)|Other|0|||
147596495|NCT02788045|532343153|FG000|Long Term Extension (From Wk 72 to 264)|Lost to Follow-up|8|||
147596496|NCT02788045|532343154|FG001|Long Term Extension (From Wk 72 to 264)|Lost to Follow-up|0|||
147596497|NCT02788045|532343155|FG002|Long Term Extension (From Wk 72 to 264)|Lost to Follow-up|0|||
147596498|NCT02788045|532343153|FG000|Long Term Extension (From Wk 72 to 264)|Withdrawal by Subject|8|||
147596499|NCT02788045|532343154|FG001|Long Term Extension (From Wk 72 to 264)|Withdrawal by Subject|0|||
147596500|NCT02788045|532343155|FG002|Long Term Extension (From Wk 72 to 264)|Withdrawal by Subject|0|||
147596501|NCT02788045|532343153|FG000|Long Term Extension (From Wk 72 to 264)|Other|1|||
147596502|NCT02788045|532343154|FG001|Long Term Extension (From Wk 72 to 264)|Other|0|||
147596503|NCT02788045|532343155|FG002|Long Term Extension (From Wk 72 to 264)|Other|0|||
147596504|NCT01288053|532343159|FG000|Overall Study|Death|1|||
147596505|NCT03188666|532343160|FG000|Period 1 (28 Weeks Double-blind)|Adverse Event|0|||
147596506|NCT03188666|532343161|FG001|Period 1 (28 Weeks Double-blind)|Adverse Event|1|||
147596507|NCT03188666|532343162|FG002|Period 1 (28 Weeks Double-blind)|Adverse Event|0|||
147596508|NCT03188666|532343163|FG003|Period 1 (28 Weeks Double-blind)|Adverse Event|0|||
147596509|NCT03188666|532343160|FG000|Period 2 (28 Weeks Open-label)|Death|0|||
147596510|NCT03188666|532343161|FG001|Period 2 (28 Weeks Open-label)|Death|0|||
147596511|NCT03188666|532343162|FG002|Period 2 (28 Weeks Open-label)|Death|0|||
147250577|NCT01996709|531085945|FG001|Overall Study|Lost to Follow-up|0|||
147331410|NCT02341625|531379206|FG000|Overall Study|Disease Progression|2|||
147331411|NCT02341625|531379207|FG001|Overall Study|Disease Progression|2|||
147596512|NCT03188666|532343163|FG003|Period 2 (28 Weeks Open-label)|Death|1|||
147596513|NCT03188666|532343160|FG000|Period 3 (20 Weeks Follow-up)|Withdrawal by Subject|0|||
147331412|NCT02341625|531379208|FG002|Overall Study|Disease Progression|3|||
147596514|NCT03188666|532343161|FG001|Period 3 (20 Weeks Follow-up)|Withdrawal by Subject|0|||
147596515|NCT03188666|532343162|FG002|Period 3 (20 Weeks Follow-up)|Withdrawal by Subject|2|||
147250578|NCT01996709|531085944|FG000|Overall Study|Subject Non-Compliant|1|||
147250579|NCT01996709|531085945|FG001|Overall Study|Subject Non-Compliant|0|||
147331413|NCT02341625|531379209|FG003|Overall Study|Disease Progression|6|||
147596516|NCT03188666|532343163|FG003|Period 3 (20 Weeks Follow-up)|Withdrawal by Subject|0|||
147250580|NCT01996709|531085944|FG000|Overall Study|Failed Inclusion/Exclusion Criteria|0|||
147250581|NCT01996709|531085945|FG001|Overall Study|Failed Inclusion/Exclusion Criteria|1|||
147250582|NCT00850564|531085946|FG000|Overall Study|Withdrawal by Subject|2|||
147250583|NCT02564042|531088252|FG000|Overall Study|Adverse Event|4|||
147250584|NCT02564042|531088253|FG001|Overall Study|Adverse Event|4|||
147596517|NCT03188666|532343160|FG000|Period 3 (20 Weeks Follow-up)|Death|0|||
147596518|NCT03188666|532343161|FG001|Period 3 (20 Weeks Follow-up)|Death|0|||
147596519|NCT03188666|532343162|FG002|Period 3 (20 Weeks Follow-up)|Death|1|||
147596520|NCT03188666|532343163|FG003|Period 3 (20 Weeks Follow-up)|Death|2|||
147596521|NCT00144781|532343164|FG000|Overall Study|Adverse Event|0|||
147596522|NCT00144781|532343165|FG001|Overall Study|Adverse Event|1|||
147596523|NCT00144781|532343166|FG002|Overall Study|Adverse Event|0|||
147596524|NCT00144781|532343167|FG003|Overall Study|Adverse Event|0|||
147596525|NCT00144781|532343164|FG000|Overall Study|Non-compliant|0|||
147596526|NCT00144781|532343165|FG001|Overall Study|Non-compliant|1|||
147596527|NCT00144781|532343166|FG002|Overall Study|Non-compliant|0|||
147596528|NCT00144781|532343167|FG003|Overall Study|Non-compliant|0|||
147596529|NCT02068092|532343168|FG000|Overall Study|Physician Decision|2|||
147596530|NCT02068092|532343168|FG000|Overall Study|Adverse Event|2|||
147596531|NCT02068092|532343168|FG000|Overall Study|Lost to Follow-up|4|||
147596532|NCT02068092|532343168|FG000|Overall Study|Withdrawal by Subject|2|||
147596533|NCT03696953|532343169|FG000|Overall Study|Withdrawal by Subject|6|||
147596534|NCT03696953|532343170|FG001|Overall Study|Withdrawal by Subject|1|||
147596535|NCT03696953|532343169|FG000|Overall Study|missed GBS swabs|2|||
147250585|NCT02564042|531088254|FG002|Overall Study|Adverse Event|3|||
147250586|NCT02564042|531088255|FG003|Overall Study|Adverse Event|0|||
147250587|NCT02564042|531088256|FG004|Overall Study|Adverse Event|0|||
147250588|NCT02564042|531088257|FG005|Overall Study|Adverse Event|1|||
147250589|NCT02564042|531088252|FG000|Overall Study|Lost to Follow-up|1|||
147250590|NCT02564042|531088253|FG001|Overall Study|Lost to Follow-up|1|||
147250591|NCT02564042|531088254|FG002|Overall Study|Lost to Follow-up|1|||
147250592|NCT02564042|531088255|FG003|Overall Study|Lost to Follow-up|0|||
147250593|NCT02564042|531088256|FG004|Overall Study|Lost to Follow-up|1|||
147250594|NCT02564042|531088257|FG005|Overall Study|Lost to Follow-up|1|||
147250595|NCT02564042|531088252|FG000|Overall Study|Physician Decision|1|||
147250596|NCT02564042|531088253|FG001|Overall Study|Physician Decision|0|||
147250597|NCT02564042|531088254|FG002|Overall Study|Physician Decision|0|||
147250598|NCT02564042|531088255|FG003|Overall Study|Physician Decision|1|||
147250599|NCT02564042|531088256|FG004|Overall Study|Physician Decision|0|||
147250600|NCT02564042|531088257|FG005|Overall Study|Physician Decision|0|||
147250601|NCT02564042|531088252|FG000|Overall Study|Withdrawal by Subject|5|||
147250602|NCT02564042|531088253|FG001|Overall Study|Withdrawal by Subject|3|||
147250603|NCT02564042|531088254|FG002|Overall Study|Withdrawal by Subject|2|||
147250604|NCT02564042|531088255|FG003|Overall Study|Withdrawal by Subject|2|||
147250605|NCT02564042|531088256|FG004|Overall Study|Withdrawal by Subject|10|||
147250606|NCT02564042|531088257|FG005|Overall Study|Withdrawal by Subject|12|||
147250607|NCT02066233|531088258|FG000|EG Scan II (Day 1)|difficulty intubating subject|6|||
147250608|NCT02066233|531088259|FG001|EG Scan II (Day 1)|difficulty intubating subject|6|||
147250609|NCT01961323|531088265|FG000|Overall Study|Withdrawal by Subject|7|||
147250610|NCT01961323|531088265|FG000|Overall Study|Lost to Follow-up|8|||
147250611|NCT01961323|531088265|FG000|Overall Study|screen failure|34|||
147250612|NCT01285310|531088267|FG000|Placebo Controlled Phase: Weeks 0-24|Adverse Event|3|||
147250613|NCT01285310|531088268|FG001|Placebo Controlled Phase: Weeks 0-24|Adverse Event|4|||
147250614|NCT01285310|531088269|FG002|Placebo Controlled Phase: Weeks 0-24|Adverse Event|6|||
147250615|NCT01285310|531088270|FG003|Placebo Controlled Phase: Weeks 0-24|Adverse Event|0|||
147250616|NCT01285310|531088271|FG004|Placebo Controlled Phase: Weeks 0-24|Adverse Event|0|||
147250617|NCT01285310|531088267|FG000|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|1|||
147250618|NCT01285310|531088268|FG001|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|7|||
147596536|NCT03696953|532343170|FG001|Overall Study|missed GBS swabs|2|||
147596537|NCT03696953|532343169|FG000|Overall Study|lost study bottle containing capsules|2|||
147596538|NCT03696953|532343170|FG001|Overall Study|lost study bottle containing capsules|0|||
147449871|NCT03657043|531811298|FG000|Overall Study|Study closure by Sponsor|0|||
147596539|NCT03696953|532343169|FG000|Overall Study|Premature birth|1|||
147596540|NCT03696953|532343170|FG001|Overall Study|Premature birth|4|||
147250619|NCT01285310|531088269|FG002|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|3|||
147250620|NCT01285310|531088270|FG003|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|0|||
147250621|NCT01285310|531088271|FG004|Placebo Controlled Phase: Weeks 0-24|Lack of Efficacy|0|||
147250622|NCT01285310|531088267|FG000|Placebo Controlled Phase: Weeks 0-24|Non-compliance|1|||
147449872|NCT03657043|531811299|FG001|Overall Study|Study closure by Sponsor|2|||
147449873|NCT03657043|531811300|FG002|Overall Study|Study closure by Sponsor|0|||
147596541|NCT03696953|532343169|FG000|Overall Study|Gestational hypertension|1|||
147596542|NCT03696953|532343170|FG001|Overall Study|Gestational hypertension|1|||
147250623|NCT01285310|531088268|FG001|Placebo Controlled Phase: Weeks 0-24|Non-compliance|0|||
147250624|NCT01285310|531088269|FG002|Placebo Controlled Phase: Weeks 0-24|Non-compliance|2|||
147596543|NCT03696953|532343169|FG000|Overall Study|Gestational diabetes|2|||
147596544|NCT03696953|532343170|FG001|Overall Study|Gestational diabetes|1|||
147596545|NCT03696953|532343169|FG000|Overall Study|Fetal demise-Genetic abnormality|1|||
147596546|NCT03696953|532343170|FG001|Overall Study|Fetal demise-Genetic abnormality|0|||
147596547|NCT03696953|532343169|FG000|Overall Study|Changed prenatal provider|1|||
147596548|NCT03696953|532343170|FG001|Overall Study|Changed prenatal provider|1|||
147596549|NCT03502707|532343171|FG000|Overall Study|Adverse Event|0|||
147596550|NCT03502707|532343172|FG001|Overall Study|Adverse Event|0|||
147596551|NCT03502707|532343173|FG002|Overall Study|Adverse Event|0|||
147596552|NCT03502707|532343174|FG003|Overall Study|Adverse Event|0|||
147596553|NCT03502707|532343175|FG004|Overall Study|Adverse Event|0|||
147596554|NCT03502707|532343176|FG005|Overall Study|Adverse Event|0|||
147596555|NCT03502707|532343177|FG006|Overall Study|Adverse Event|0|||
147596556|NCT03502707|532343178|FG007|Overall Study|Adverse Event|0|||
147596557|NCT03502707|532343179|FG008|Overall Study|Adverse Event|0|||
147596558|NCT03502707|532343180|FG009|Overall Study|Adverse Event|0|||
147596559|NCT03502707|532343181|FG010|Overall Study|Adverse Event|0|||
147596560|NCT03502707|532343182|FG011|Overall Study|Adverse Event|0|||
147596561|NCT03502707|532343183|FG012|Overall Study|Adverse Event|0|||
147596562|NCT03502707|532343184|FG013|Overall Study|Adverse Event|0|||
147596563|NCT03502707|532343185|FG014|Overall Study|Adverse Event|0|||
147596564|NCT03502707|532343186|FG015|Overall Study|Adverse Event|1|||
147596565|NCT03502707|532343187|FG016|Overall Study|Adverse Event|5|||
147596566|NCT03502707|532343188|FG017|Overall Study|Adverse Event|0|||
147596567|NCT03502707|532343171|FG000|Overall Study|Death|0|||
147596568|NCT03502707|532343172|FG001|Overall Study|Death|0|||
147596569|NCT03502707|532343173|FG002|Overall Study|Death|0|||
147596570|NCT03502707|532343174|FG003|Overall Study|Death|1|||
147596571|NCT03502707|532343175|FG004|Overall Study|Death|0|||
147596572|NCT03502707|532343176|FG005|Overall Study|Death|0|||
147596573|NCT03502707|532343177|FG006|Overall Study|Death|0|||
147596574|NCT03502707|532343178|FG007|Overall Study|Death|0|||
147596575|NCT03502707|532343179|FG008|Overall Study|Death|1|||
147596576|NCT03502707|532343180|FG009|Overall Study|Death|1|||
147596577|NCT03502707|532343181|FG010|Overall Study|Death|0|||
147596578|NCT03502707|532343182|FG011|Overall Study|Death|0|||
147596579|NCT03502707|532343183|FG012|Overall Study|Death|1|||
147596580|NCT03502707|532343184|FG013|Overall Study|Death|0|||
147596581|NCT03502707|532343185|FG014|Overall Study|Death|0|||
147596582|NCT03502707|532343186|FG015|Overall Study|Death|1|||
147596583|NCT03502707|532343187|FG016|Overall Study|Death|0|||
147596584|NCT03502707|532343188|FG017|Overall Study|Death|0|||
147596585|NCT03502707|532343171|FG000|Overall Study|Lost to Follow-up|0|||
147596586|NCT03502707|532343172|FG001|Overall Study|Lost to Follow-up|0|||
147596587|NCT03502707|532343173|FG002|Overall Study|Lost to Follow-up|0|||
147596588|NCT03502707|532343174|FG003|Overall Study|Lost to Follow-up|0|||
147596589|NCT03502707|532343175|FG004|Overall Study|Lost to Follow-up|0|||
147596590|NCT03502707|532343176|FG005|Overall Study|Lost to Follow-up|0|||
147596591|NCT03502707|532343177|FG006|Overall Study|Lost to Follow-up|0|||
147596592|NCT03502707|532343178|FG007|Overall Study|Lost to Follow-up|5|||
147596593|NCT03502707|532343179|FG008|Overall Study|Lost to Follow-up|0|||
147596594|NCT03502707|532343180|FG009|Overall Study|Lost to Follow-up|2|||
147596595|NCT03502707|532343181|FG010|Overall Study|Lost to Follow-up|1|||
147596596|NCT03502707|532343182|FG011|Overall Study|Lost to Follow-up|2|||
147596597|NCT03502707|532343183|FG012|Overall Study|Lost to Follow-up|1|||
147596598|NCT03502707|532343184|FG013|Overall Study|Lost to Follow-up|1|||
147596599|NCT03502707|532343185|FG014|Overall Study|Lost to Follow-up|0|||
147596600|NCT03502707|532343186|FG015|Overall Study|Lost to Follow-up|4|||
147596601|NCT03502707|532343187|FG016|Overall Study|Lost to Follow-up|9|||
147596602|NCT03502707|532343188|FG017|Overall Study|Lost to Follow-up|2|||
147596603|NCT03502707|532343171|FG000|Overall Study|Physician Decision|0|||
147596604|NCT03502707|532343172|FG001|Overall Study|Physician Decision|0|||
147596605|NCT03502707|532343173|FG002|Overall Study|Physician Decision|0|||
147250625|NCT01285310|531088270|FG003|Placebo Controlled Phase: Weeks 0-24|Non-compliance|0|||
147250626|NCT01285310|531088271|FG004|Placebo Controlled Phase: Weeks 0-24|Non-compliance|0|||
147596606|NCT03502707|532343174|FG003|Overall Study|Physician Decision|0|||
147596607|NCT03502707|532343175|FG004|Overall Study|Physician Decision|0|||
147596608|NCT03502707|532343176|FG005|Overall Study|Physician Decision|0|||
147596609|NCT03502707|532343177|FG006|Overall Study|Physician Decision|0|||
147596610|NCT03502707|532343178|FG007|Overall Study|Physician Decision|0|||
147250627|NCT01285310|531088267|FG000|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|3|||
147250628|NCT01285310|531088268|FG001|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|3|||
147596611|NCT03502707|532343179|FG008|Overall Study|Physician Decision|2|||
147596612|NCT03502707|532343180|FG009|Overall Study|Physician Decision|1|||
147596613|NCT03502707|532343181|FG010|Overall Study|Physician Decision|0|||
147596614|NCT03502707|532343182|FG011|Overall Study|Physician Decision|0|||
147596615|NCT03502707|532343183|FG012|Overall Study|Physician Decision|0|||
147596616|NCT03502707|532343184|FG013|Overall Study|Physician Decision|0|||
147596617|NCT03502707|532343185|FG014|Overall Study|Physician Decision|1|||
147596618|NCT03502707|532343186|FG015|Overall Study|Physician Decision|3|||
147596619|NCT03502707|532343187|FG016|Overall Study|Physician Decision|0|||
147596620|NCT03502707|532343188|FG017|Overall Study|Physician Decision|0|||
147596621|NCT03502707|532343171|FG000|Overall Study|Protocol Violation|0|||
147596622|NCT03502707|532343172|FG001|Overall Study|Protocol Violation|0|||
147596623|NCT03502707|532343173|FG002|Overall Study|Protocol Violation|0|||
147596624|NCT03502707|532343174|FG003|Overall Study|Protocol Violation|0|||
147596625|NCT03502707|532343175|FG004|Overall Study|Protocol Violation|0|||
147596626|NCT03502707|532343176|FG005|Overall Study|Protocol Violation|0|||
147596627|NCT03502707|532343177|FG006|Overall Study|Protocol Violation|0|||
147596628|NCT03502707|532343178|FG007|Overall Study|Protocol Violation|0|||
147596629|NCT03502707|532343179|FG008|Overall Study|Protocol Violation|0|||
147596630|NCT03502707|532343180|FG009|Overall Study|Protocol Violation|0|||
147596631|NCT03502707|532343181|FG010|Overall Study|Protocol Violation|0|||
147596632|NCT03502707|532343182|FG011|Overall Study|Protocol Violation|0|||
147596633|NCT03502707|532343183|FG012|Overall Study|Protocol Violation|0|||
147596634|NCT03502707|532343184|FG013|Overall Study|Protocol Violation|0|||
147596635|NCT03502707|532343185|FG014|Overall Study|Protocol Violation|0|||
147596636|NCT03502707|532343186|FG015|Overall Study|Protocol Violation|1|||
147596637|NCT03502707|532343187|FG016|Overall Study|Protocol Violation|0|||
147596638|NCT03502707|532343188|FG017|Overall Study|Protocol Violation|0|||
147596639|NCT03502707|532343171|FG000|Overall Study|Withdrawal by Subject|1|||
147596640|NCT03502707|532343172|FG001|Overall Study|Withdrawal by Subject|1|||
147596641|NCT03502707|532343173|FG002|Overall Study|Withdrawal by Subject|0|||
147596642|NCT03502707|532343174|FG003|Overall Study|Withdrawal by Subject|0|||
147596643|NCT03502707|532343175|FG004|Overall Study|Withdrawal by Subject|0|||
147596644|NCT03502707|532343176|FG005|Overall Study|Withdrawal by Subject|2|||
147596645|NCT03502707|532343177|FG006|Overall Study|Withdrawal by Subject|0|||
147596646|NCT03502707|532343178|FG007|Overall Study|Withdrawal by Subject|3|||
147596647|NCT03502707|532343179|FG008|Overall Study|Withdrawal by Subject|1|||
147596648|NCT03502707|532343180|FG009|Overall Study|Withdrawal by Subject|2|||
147596649|NCT03502707|532343181|FG010|Overall Study|Withdrawal by Subject|12|||
147596650|NCT03502707|532343182|FG011|Overall Study|Withdrawal by Subject|23|||
147596651|NCT03502707|532343183|FG012|Overall Study|Withdrawal by Subject|5|||
147596652|NCT03502707|532343184|FG013|Overall Study|Withdrawal by Subject|3|||
147596653|NCT03502707|532343185|FG014|Overall Study|Withdrawal by Subject|3|||
147596654|NCT03502707|532343186|FG015|Overall Study|Withdrawal by Subject|43|||
147596655|NCT03502707|532343187|FG016|Overall Study|Withdrawal by Subject|44|||
147596656|NCT03502707|532343188|FG017|Overall Study|Withdrawal by Subject|18|||
147596657|NCT03502707|532343171|FG000|Overall Study|Sponsor's Decision|1|||
147596658|NCT03502707|532343172|FG001|Overall Study|Sponsor's Decision|0|||
147596659|NCT03502707|532343173|FG002|Overall Study|Sponsor's Decision|0|||
147596660|NCT03502707|532343174|FG003|Overall Study|Sponsor's Decision|0|||
147596661|NCT03502707|532343175|FG004|Overall Study|Sponsor's Decision|0|||
147596662|NCT03502707|532343176|FG005|Overall Study|Sponsor's Decision|0|||
147596663|NCT03502707|532343177|FG006|Overall Study|Sponsor's Decision|0|||
147596664|NCT03502707|532343178|FG007|Overall Study|Sponsor's Decision|0|||
147596665|NCT03502707|532343179|FG008|Overall Study|Sponsor's Decision|0|||
147596666|NCT03502707|532343180|FG009|Overall Study|Sponsor's Decision|1|||
147596667|NCT03502707|532343181|FG010|Overall Study|Sponsor's Decision|0|||
147596668|NCT03502707|532343182|FG011|Overall Study|Sponsor's Decision|0|||
147596669|NCT03502707|532343183|FG012|Overall Study|Sponsor's Decision|0|||
147596670|NCT03502707|532343184|FG013|Overall Study|Sponsor's Decision|0|||
147596671|NCT03502707|532343185|FG014|Overall Study|Sponsor's Decision|0|||
147596672|NCT03502707|532343186|FG015|Overall Study|Sponsor's Decision|2|||
147596673|NCT03502707|532343187|FG016|Overall Study|Sponsor's Decision|1|||
147596674|NCT03502707|532343188|FG017|Overall Study|Sponsor's Decision|0|||
147596675|NCT03502707|532343171|FG000|Overall Study|Initiated Prohibited Medication|0|||
147596676|NCT03502707|532343172|FG001|Overall Study|Initiated Prohibited Medication|0|||
147596677|NCT03502707|532343173|FG002|Overall Study|Initiated Prohibited Medication|0|||
147596678|NCT03502707|532343174|FG003|Overall Study|Initiated Prohibited Medication|0|||
147596679|NCT03502707|532343175|FG004|Overall Study|Initiated Prohibited Medication|0|||
147596680|NCT03502707|532343176|FG005|Overall Study|Initiated Prohibited Medication|0|||
147596681|NCT03502707|532343177|FG006|Overall Study|Initiated Prohibited Medication|0|||
147596682|NCT03502707|532343178|FG007|Overall Study|Initiated Prohibited Medication|0|||
147596683|NCT03502707|532343179|FG008|Overall Study|Initiated Prohibited Medication|0|||
147596684|NCT03502707|532343180|FG009|Overall Study|Initiated Prohibited Medication|0|||
147596685|NCT03502707|532343181|FG010|Overall Study|Initiated Prohibited Medication|0|||
147596686|NCT03502707|532343182|FG011|Overall Study|Initiated Prohibited Medication|0|||
147250629|NCT01285310|531088269|FG002|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|2|||
147596687|NCT03502707|532343183|FG012|Overall Study|Initiated Prohibited Medication|0|||
147596688|NCT03502707|532343184|FG013|Overall Study|Initiated Prohibited Medication|0|||
147596689|NCT03502707|532343185|FG014|Overall Study|Initiated Prohibited Medication|0|||
147596690|NCT03502707|532343186|FG015|Overall Study|Initiated Prohibited Medication|0|||
147596691|NCT03502707|532343187|FG016|Overall Study|Initiated Prohibited Medication|1|||
147596692|NCT03502707|532343188|FG017|Overall Study|Initiated Prohibited Medication|0|||
147596693|NCT03502707|532343171|FG000|Overall Study|Other|0|||
147596694|NCT03502707|532343172|FG001|Overall Study|Other|0|||
147596695|NCT03502707|532343173|FG002|Overall Study|Other|0|||
147596696|NCT03502707|532343174|FG003|Overall Study|Other|0|||
147660459|NCT00249873|532579885|FG000|Overall Study|Event related to cardiac condition|12|||
147660460|NCT00249873|532579886|FG001|Overall Study|Event related to cardiac condition|21|||
147660461|NCT00249873|532579885|FG000|Overall Study|Thromboembolic/outcome event|82|||
147660462|NCT00249873|532579886|FG001|Overall Study|Thromboembolic/outcome event|122|||
147660463|NCT01781962|532579889|FG000|Overall Study|Other Miscellaneous Reasons|5|||
147660464|NCT05417412|532579892|FG000|Overall Study|Lost to Follow-up|2|||
147660465|NCT01576575|532579893|FG000|Buprenorphine Control|Withdrawal by Subject|3|||
147660466|NCT01576575|532579893|FG000|Buprenorphine + Rifampin|Withdrawal by Subject|3|||
147660467|NCT01576575|532579893|FG000|Buprenorphine + Grapefruit|Withdrawal by Subject|1|||
147660468|NCT00274742|532579900|FG000|Overall Study|Adverse Event|0|||
147660469|NCT00274742|532579901|FG001|Overall Study|Adverse Event|4|||
147660470|NCT00274742|532579902|FG002|Overall Study|Adverse Event|1|||
147660471|NCT00274742|532579903|FG003|Overall Study|Adverse Event|4|||
147660472|NCT00274742|532579904|FG004|Overall Study|Adverse Event|12|||
147660473|NCT00274742|532579905|FG005|Overall Study|Adverse Event|3|||
147660474|NCT00274742|532579900|FG000|Overall Study|Lost to Follow-up|0|||
147660475|NCT00274742|532579901|FG001|Overall Study|Lost to Follow-up|0|||
147660476|NCT00274742|532579902|FG002|Overall Study|Lost to Follow-up|0|||
147660477|NCT00274742|532579903|FG003|Overall Study|Lost to Follow-up|0|||
147660478|NCT00274742|532579904|FG004|Overall Study|Lost to Follow-up|1|||
147660479|NCT00274742|532579905|FG005|Overall Study|Lost to Follow-up|0|||
147660480|NCT00274742|532579900|FG000|Overall Study|End of Study|0|||
147660481|NCT00274742|532579901|FG001|Overall Study|End of Study|0|||
147660482|NCT00274742|532579902|FG002|Overall Study|End of Study|0|||
147660483|NCT00274742|532579903|FG003|Overall Study|End of Study|1|||
147660484|NCT00274742|532579904|FG004|Overall Study|End of Study|0|||
147660485|NCT00274742|532579905|FG005|Overall Study|End of Study|0|||
147660486|NCT00274742|532579900|FG000|Overall Study|Disease Progression|0|||
147660487|NCT00274742|532579901|FG001|Overall Study|Disease Progression|1|||
147660488|NCT00274742|532579902|FG002|Overall Study|Disease Progression|1|||
147660489|NCT00274742|532579903|FG003|Overall Study|Disease Progression|0|||
147660490|NCT00274742|532579904|FG004|Overall Study|Disease Progression|1|||
147660491|NCT00274742|532579905|FG005|Overall Study|Disease Progression|0|||
147660492|NCT00274742|532579900|FG000|Overall Study|Other|0|||
147660493|NCT00274742|532579901|FG001|Overall Study|Other|3|||
147660494|NCT00274742|532579902|FG002|Overall Study|Other|0|||
147660495|NCT00274742|532579903|FG003|Overall Study|Other|0|||
147660496|NCT00274742|532579904|FG004|Overall Study|Other|2|||
147660497|NCT00274742|532579905|FG005|Overall Study|Other|0|||
147660498|NCT01951417|532579914|FG000|Overall Study|Withdrawal by Subject|1|||
147449874|NCT03657043|531811301|FG003|Overall Study|Study closure by Sponsor|0|||
147596697|NCT03502707|532343175|FG004|Overall Study|Other|0|||
147596698|NCT03502707|532343176|FG005|Overall Study|Other|0|||
147596699|NCT03502707|532343177|FG006|Overall Study|Other|0|||
147596700|NCT03502707|532343178|FG007|Overall Study|Other|0|||
147596701|NCT03502707|532343179|FG008|Overall Study|Other|1|||
147596702|NCT03502707|532343180|FG009|Overall Study|Other|1|||
147596703|NCT03502707|532343181|FG010|Overall Study|Other|2|||
147596704|NCT03502707|532343182|FG011|Overall Study|Other|0|||
147596705|NCT03502707|532343183|FG012|Overall Study|Other|0|||
147596706|NCT03502707|532343184|FG013|Overall Study|Other|0|||
147596707|NCT03502707|532343185|FG014|Overall Study|Other|0|||
147596708|NCT03502707|532343186|FG015|Overall Study|Other|4|||
147596709|NCT03502707|532343187|FG016|Overall Study|Other|1|||
147596710|NCT03502707|532343188|FG017|Overall Study|Other|0|||
147596711|NCT03502707|532343171|FG000|Overall Study|Randomized but not vaccinated|0|||
147596712|NCT03502707|532343172|FG001|Overall Study|Randomized but not vaccinated|0|||
147596713|NCT03502707|532343173|FG002|Overall Study|Randomized but not vaccinated|0|||
147596714|NCT03502707|532343174|FG003|Overall Study|Randomized but not vaccinated|0|||
147596715|NCT03502707|532343175|FG004|Overall Study|Randomized but not vaccinated|0|||
147596716|NCT03502707|532343176|FG005|Overall Study|Randomized but not vaccinated|0|||
147596717|NCT03502707|532343177|FG006|Overall Study|Randomized but not vaccinated|0|||
147660499|NCT01951417|532579914|FG000|Overall Study|Protocol Violation|2|||
147250630|NCT01285310|531088270|FG003|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|0|||
147250631|NCT01285310|531088271|FG004|Placebo Controlled Phase: Weeks 0-24|Withdrawal by Subject|0|||
147250632|NCT01285310|531088267|FG000|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|0|||
147596718|NCT03502707|532343178|FG007|Overall Study|Randomized but not vaccinated|0|||
147596719|NCT03502707|532343179|FG008|Overall Study|Randomized but not vaccinated|0|||
147660500|NCT01951417|532579914|FG000|Overall Study|Lost to Follow-up|6|||
147660501|NCT00977613|532579915|FG000|Overall Study|Lost to Follow-up|16|||
147660502|NCT01598610|532579920|FG000|Overall Study|Adverse Event|1|||
147660503|NCT03360019|532579923|FG000|Overall Study|Withdrawal by Subject|2|||
147660504|NCT03360019|532579924|FG001|Overall Study|Withdrawal by Subject|0|||
147660505|NCT03360019|532579925|FG002|Overall Study|Withdrawal by Subject|0|||
147660506|NCT03360019|532579923|FG000|Overall Study|Pandemic caused suspension of study activities|6|||
147660507|NCT03360019|532579924|FG001|Overall Study|Pandemic caused suspension of study activities|0|||
147660508|NCT03360019|532579925|FG002|Overall Study|Pandemic caused suspension of study activities|0|||
147250633|NCT01285310|531088268|FG001|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|1|||
147660509|NCT00520039|532579928|FG000|Overall Study|Exclusion criteria met at first visit|7|||
147660510|NCT00520039|532579929|FG001|Overall Study|Exclusion criteria met at first visit|5|||
147660511|NCT00325819|532579931|FG000|Overall Study|Study product lost in mail|2|||
147250634|NCT01285310|531088269|FG002|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|1|||
147250635|NCT01285310|531088270|FG003|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|0|||
147250636|NCT01285310|531088271|FG004|Placebo Controlled Phase: Weeks 0-24|Lost to Follow-up|0|||
147250637|NCT01285310|531088267|FG000|Placebo Controlled Phase: Weeks 0-24|Other|1|||
147250638|NCT01285310|531088268|FG001|Placebo Controlled Phase: Weeks 0-24|Other|0|||
147250639|NCT01285310|531088269|FG002|Placebo Controlled Phase: Weeks 0-24|Other|1|||
147250640|NCT01285310|531088270|FG003|Placebo Controlled Phase: Weeks 0-24|Other|0|||
147250641|NCT01285310|531088271|FG004|Placebo Controlled Phase: Weeks 0-24|Other|0|||
147250642|NCT01285310|531088267|FG000|Active Treatment Phase: Weeks 25-52|Adverse Event|0|||
147250643|NCT01285310|531088268|FG001|Active Treatment Phase: Weeks 25-52|Adverse Event|2|||
147250644|NCT01285310|531088269|FG002|Active Treatment Phase: Weeks 25-52|Adverse Event|3|||
147250645|NCT01285310|531088270|FG003|Active Treatment Phase: Weeks 25-52|Adverse Event|0|||
147250646|NCT01285310|531088271|FG004|Active Treatment Phase: Weeks 25-52|Adverse Event|2|||
147250647|NCT01285310|531088267|FG000|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|0|||
147250648|NCT01285310|531088268|FG001|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|4|||
147250649|NCT01285310|531088269|FG002|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|3|||
147250650|NCT01285310|531088270|FG003|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|1|||
147250651|NCT01285310|531088271|FG004|Active Treatment Phase: Weeks 25-52|Lack of Efficacy|0|||
147250652|NCT01285310|531088267|FG000|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|0|||
147250653|NCT01285310|531088268|FG001|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|3|||
147250654|NCT01285310|531088269|FG002|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|0|||
147250655|NCT01285310|531088270|FG003|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|2|||
147250656|NCT01285310|531088271|FG004|Active Treatment Phase: Weeks 25-52|Withdrawal by Subject|2|||
147250657|NCT01285310|531088267|FG000|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|0|||
147250658|NCT01285310|531088268|FG001|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|21|||
147250659|NCT01285310|531088269|FG002|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|19|||
147250660|NCT01285310|531088270|FG003|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|6|||
147250661|NCT01285310|531088271|FG004|Active Treatment Phase: Weeks 25-52|Study Termination by sponsor|15|||
147250662|NCT01285310|531088267|FG000|Active Treatment Phase: Weeks 25-52|Other|0|||
147250663|NCT01285310|531088268|FG001|Active Treatment Phase: Weeks 25-52|Other|1|||
147250664|NCT01285310|531088269|FG002|Active Treatment Phase: Weeks 25-52|Other|0|||
147250665|NCT01285310|531088270|FG003|Active Treatment Phase: Weeks 25-52|Other|0|||
147250666|NCT01285310|531088271|FG004|Active Treatment Phase: Weeks 25-52|Other|0|||
147250667|NCT01285310|531088267|FG000|Active Treatment Phase: Weeks 25-52|Non-compliance|0|||
147250668|NCT01285310|531088268|FG001|Active Treatment Phase: Weeks 25-52|Non-compliance|1|||
147250669|NCT01285310|531088269|FG002|Active Treatment Phase: Weeks 25-52|Non-compliance|1|||
147250670|NCT01285310|531088270|FG003|Active Treatment Phase: Weeks 25-52|Non-compliance|1|||
147250671|NCT01285310|531088271|FG004|Active Treatment Phase: Weeks 25-52|Non-compliance|0|||
147250672|NCT00514540|531088272|FG000|First-Line Chemo|Withdrawal by Subject|1|||
147250673|NCT00514540|531088272|FG000|First-Line Chemo|Protocol Violation|7|||
147250674|NCT00514540|531088272|FG000|Second-Line|Physician/Patient Decision|31|||
147250675|NCT01996982|531088275|FG000|Overall Study|PI/team left institution|7|||
147250676|NCT01195415|531088296|FG000|Overall Study|No repeat biopsy due to progression|2|||
147250677|NCT01442675|531088297|FG000|Overall Study|Protocol Violation|6|||
147250678|NCT01442675|531088297|FG000|Overall Study|Lost to Follow-up|2|||
147250679|NCT01442675|531088297|FG000|Overall Study|Withdrawal by Subject|4|||
147250680|NCT00752232|531088298|FG000|Overall Study|Protocol Violation|0|||
147250681|NCT00752232|531088299|FG001|Overall Study|Protocol Violation|0|||
147250682|NCT00752232|531088300|FG002|Overall Study|Protocol Violation|0|||
147250683|NCT00752232|531088301|FG003|Overall Study|Protocol Violation|0|||
147250684|NCT00752232|531088302|FG004|Overall Study|Protocol Violation|0|||
147250685|NCT00752232|531088303|FG005|Overall Study|Protocol Violation|1|||
147250686|NCT00752232|531088304|FG006|Overall Study|Protocol Violation|0|||
147250687|NCT00752232|531088298|FG000|Overall Study|Caregiver request|2|||
147250688|NCT00752232|531088299|FG001|Overall Study|Caregiver request|0|||
147331414|NCT02341625|531379210|FG004|Overall Study|Disease Progression|7|||
147331415|NCT02341625|531379211|FG005|Overall Study|Disease Progression|7|||
147331416|NCT02341625|531379212|FG006|Overall Study|Disease Progression|28|||
147331417|NCT02341625|531379213|FG007|Overall Study|Disease Progression|5|||
147331418|NCT02341625|531379214|FG008|Overall Study|Disease Progression|4|||
147331419|NCT02341625|531379215|FG009|Overall Study|Disease Progression|19|||
147331420|NCT02341625|531379206|FG000|Overall Study|Study Drug Toxicity|0|||
147331421|NCT02341625|531379207|FG001|Overall Study|Study Drug Toxicity|0|||
147660512|NCT00325819|532579932|FG001|Overall Study|Study product lost in mail|1|||
147660513|NCT00325819|532579931|FG000|Overall Study|Did not take a dose of study product|4|||
147250689|NCT00752232|531088300|FG002|Overall Study|Caregiver request|0|||
147250690|NCT00752232|531088301|FG003|Overall Study|Caregiver request|0|||
147331422|NCT02341625|531379208|FG002|Overall Study|Study Drug Toxicity|0|||
147331423|NCT02341625|531379209|FG003|Overall Study|Study Drug Toxicity|1|||
147596720|NCT03502707|532343180|FG009|Overall Study|Randomized but not vaccinated|0|||
147596721|NCT03502707|532343181|FG010|Overall Study|Randomized but not vaccinated|0|||
147596722|NCT03502707|532343182|FG011|Overall Study|Randomized but not vaccinated|1|||
147596723|NCT03502707|532343183|FG012|Overall Study|Randomized but not vaccinated|0|||
147596724|NCT03502707|532343184|FG013|Overall Study|Randomized but not vaccinated|0|||
147596725|NCT03502707|532343185|FG014|Overall Study|Randomized but not vaccinated|0|||
147596726|NCT03502707|532343186|FG015|Overall Study|Randomized but not vaccinated|0|||
147596727|NCT03502707|532343187|FG016|Overall Study|Randomized but not vaccinated|0|||
147596728|NCT03502707|532343188|FG017|Overall Study|Randomized but not vaccinated|1|||
147596729|NCT00461253|532343189|FG000|Overall Study|Death|985|||
147596730|NCT00461253|532343190|FG001|Overall Study|Death|0|||
147596731|NCT00461253|532343189|FG000|Overall Study|Protocol Violation|613|||
147596732|NCT00461253|532343190|FG001|Overall Study|Protocol Violation|236|||
147596733|NCT00461253|532343189|FG000|Overall Study|no response|2609|||
147596734|NCT00461253|532343190|FG001|Overall Study|no response|11789|||
147596735|NCT00461253|532343189|FG000|Overall Study|administrative|773|||
147596736|NCT00461253|532343190|FG001|Overall Study|administrative|7773|||
147596737|NCT00541970|532343192|FG000|Month 7|Protocol Violation|9|||
147596738|NCT00541970|532343193|FG001|Month 7|Protocol Violation|13|||
147596739|NCT00541970|532343194|FG002|Month 7|Protocol Violation|11|||
147596740|NCT00541970|532343195|FG003|Month 7|Protocol Violation|5|||
147596741|NCT00541970|532343192|FG000|Month 12|Adverse Event|0|||
147596742|NCT00541970|532343193|FG001|Month 12|Adverse Event|1|||
147596743|NCT00541970|532343194|FG002|Month 12|Adverse Event|1|||
147596744|NCT00541970|532343195|FG003|Month 12|Adverse Event|1|||
147596745|NCT00541970|532343192|FG000|Month 12|Protocol Violation|12|||
147596746|NCT00541970|532343193|FG001|Month 12|Protocol Violation|21|||
147596747|NCT00541970|532343194|FG002|Month 12|Protocol Violation|20|||
147596748|NCT00541970|532343195|FG003|Month 12|Protocol Violation|15|||
147596749|NCT00541970|532343192|FG000|Month 18|Adverse Event|0|||
147596750|NCT00541970|532343193|FG001|Month 18|Adverse Event|1|||
147596751|NCT00541970|532343194|FG002|Month 18|Adverse Event|1|||
147596752|NCT00541970|532343195|FG003|Month 18|Adverse Event|1|||
147596753|NCT00541970|532343192|FG000|Month 18|Protocol Violation|14|||
147596754|NCT00541970|532343193|FG001|Month 18|Protocol Violation|23|||
147596755|NCT00541970|532343194|FG002|Month 18|Protocol Violation|24|||
147596756|NCT00541970|532343195|FG003|Month 18|Protocol Violation|16|||
147596757|NCT00541970|532343192|FG000|Month 24|Adverse Event|0|||
147596758|NCT00541970|532343193|FG001|Month 24|Adverse Event|1|||
147596759|NCT00541970|532343194|FG002|Month 24|Adverse Event|1|||
147596760|NCT00541970|532343195|FG003|Month 24|Adverse Event|1|||
147596761|NCT00541970|532343192|FG000|Month 24|Protocol Violation|29|||
147596762|NCT00541970|532343193|FG001|Month 24|Protocol Violation|31|||
147596763|NCT00541970|532343194|FG002|Month 24|Protocol Violation|31|||
147596764|NCT00541970|532343195|FG003|Month 24|Protocol Violation|21|||
147596765|NCT00541970|532343192|FG000|Month 36|Protocol Violation|61|||
147596766|NCT00541970|532343193|FG001|Month 36|Protocol Violation|66|||
147596767|NCT00541970|532343194|FG002|Month 36|Protocol Violation|66|||
147596768|NCT00541970|532343195|FG003|Month 36|Protocol Violation|60|||
147596769|NCT00541970|532343192|FG000|Month 48|Withdrawal by Subject|2|||
147596770|NCT00541970|532343193|FG001|Month 48|Withdrawal by Subject|4|||
147596771|NCT00541970|532343194|FG002|Month 48|Withdrawal by Subject|4|||
147596772|NCT00541970|532343195|FG003|Month 48|Withdrawal by Subject|2|||
147596773|NCT00541970|532343192|FG000|Month 48|Other|3|||
147596774|NCT00541970|532343193|FG001|Month 48|Other|1|||
147596775|NCT00541970|532343194|FG002|Month 48|Other|1|||
147596776|NCT00541970|532343195|FG003|Month 48|Other|0|||
147596777|NCT00541970|532343192|FG000|Month 48|Lost to Follow-up|66|||
147596778|NCT00541970|532343193|FG001|Month 48|Lost to Follow-up|68|||
147596779|NCT00541970|532343194|FG002|Month 48|Lost to Follow-up|68|||
147596780|NCT00541970|532343195|FG003|Month 48|Lost to Follow-up|73|||
147596781|NCT00541970|532343192|FG000|Month 60|Protocol Violation|78|||
147596782|NCT00541970|532343193|FG001|Month 60|Protocol Violation|77|||
147596783|NCT00541970|532343194|FG002|Month 60|Protocol Violation|82|||
147596784|NCT00541970|532343195|FG003|Month 60|Protocol Violation|72|||
147596785|NCT00062010|532343196|FG000|Overall Study|Ineligible|3|||
147596786|NCT01687478|532343200|FG000|Overall Study|Adverse Event|3|||
147596787|NCT01687478|532343201|FG001|Overall Study|Adverse Event|10|||
147596788|NCT01687478|532343200|FG000|Overall Study|Lost to Follow-up|1|||
147596789|NCT01687478|532343201|FG001|Overall Study|Lost to Follow-up|3|||
147596790|NCT01687478|532343200|FG000|Overall Study|Protocol Violation|0|||
147596791|NCT01687478|532343201|FG001|Overall Study|Protocol Violation|2|||
147596792|NCT01687478|532343200|FG000|Overall Study|Withdrawal by Subject|21|||
147596793|NCT01687478|532343201|FG001|Overall Study|Withdrawal by Subject|19|||
147596794|NCT01687478|532343200|FG000|Overall Study|Physician Decision|1|||
147596795|NCT01687478|532343201|FG001|Overall Study|Physician Decision|3|||
147660514|NCT00325819|532579932|FG001|Overall Study|Did not take a dose of study product|9|||
147596796|NCT01687478|532343200|FG000|Overall Study|Entry Criteria Not Met|6|||
147596797|NCT01687478|532343201|FG001|Overall Study|Entry Criteria Not Met|2|||
147596798|NCT00292188|532343202|FG000|Single-Blind|Adverse Event|14|||
147596799|NCT00292188|532343203|FG001|Single-Blind|Adverse Event|0|||
147331424|NCT02341625|531379210|FG004|Overall Study|Study Drug Toxicity|0|||
147331425|NCT02341625|531379211|FG005|Overall Study|Study Drug Toxicity|3|||
147331426|NCT02341625|531379212|FG006|Overall Study|Study Drug Toxicity|10|||
147331427|NCT02341625|531379213|FG007|Overall Study|Study Drug Toxicity|0|||
147331428|NCT02341625|531379214|FG008|Overall Study|Study Drug Toxicity|0|||
147331429|NCT02341625|531379215|FG009|Overall Study|Study Drug Toxicity|3|||
147331430|NCT02341625|531379206|FG000|Overall Study|Adverse Event Unrelated to Study Drug|0|||
147331431|NCT02341625|531379207|FG001|Overall Study|Adverse Event Unrelated to Study Drug|0|||
147331432|NCT02341625|531379208|FG002|Overall Study|Adverse Event Unrelated to Study Drug|0|||
147331433|NCT02341625|531379209|FG003|Overall Study|Adverse Event Unrelated to Study Drug|0|||
147331434|NCT02341625|531379210|FG004|Overall Study|Adverse Event Unrelated to Study Drug|0|||
147331435|NCT02341625|531379211|FG005|Overall Study|Adverse Event Unrelated to Study Drug|0|||
147331436|NCT02341625|531379212|FG006|Overall Study|Adverse Event Unrelated to Study Drug|2|||
147331437|NCT02341625|531379213|FG007|Overall Study|Adverse Event Unrelated to Study Drug|1|||
147331438|NCT02341625|531379214|FG008|Overall Study|Adverse Event Unrelated to Study Drug|0|||
147331439|NCT02341625|531379215|FG009|Overall Study|Adverse Event Unrelated to Study Drug|2|||
147331440|NCT02341625|531379206|FG000|Overall Study|Participant Request to Discontinue Study Treatment|0|||
147331441|NCT02341625|531379207|FG001|Overall Study|Participant Request to Discontinue Study Treatment|0|||
147331442|NCT02341625|531379208|FG002|Overall Study|Participant Request to Discontinue Study Treatment|0|||
147331443|NCT02341625|531379209|FG003|Overall Study|Participant Request to Discontinue Study Treatment|0|||
147331444|NCT02341625|531379210|FG004|Overall Study|Participant Request to Discontinue Study Treatment|0|||
147331445|NCT02341625|531379211|FG005|Overall Study|Participant Request to Discontinue Study Treatment|0|||
147331446|NCT02341625|531379212|FG006|Overall Study|Participant Request to Discontinue Study Treatment|6|||
147331447|NCT02341625|531379213|FG007|Overall Study|Participant Request to Discontinue Study Treatment|2|||
147331448|NCT02341625|531379214|FG008|Overall Study|Participant Request to Discontinue Study Treatment|0|||
147331449|NCT02341625|531379215|FG009|Overall Study|Participant Request to Discontinue Study Treatment|0|||
147250691|NCT00752232|531088302|FG004|Overall Study|Caregiver request|1|||
147250692|NCT00752232|531088303|FG005|Overall Study|Caregiver request|0|||
147250693|NCT00752232|531088304|FG006|Overall Study|Caregiver request|0|||
147250694|NCT00752232|531088298|FG000|Overall Study|Investigator request|0|||
147250695|NCT00752232|531088299|FG001|Overall Study|Investigator request|0|||
147250696|NCT00752232|531088300|FG002|Overall Study|Investigator request|0|||
147250697|NCT00752232|531088301|FG003|Overall Study|Investigator request|0|||
147250698|NCT00752232|531088302|FG004|Overall Study|Investigator request|1|||
147250699|NCT00752232|531088303|FG005|Overall Study|Investigator request|0|||
147250700|NCT00752232|531088304|FG006|Overall Study|Investigator request|0|||
147250701|NCT00752232|531088298|FG000|Overall Study|Subject request|0|||
147250702|NCT00752232|531088299|FG001|Overall Study|Subject request|0|||
147250703|NCT00752232|531088300|FG002|Overall Study|Subject request|1|||
147250704|NCT00752232|531088301|FG003|Overall Study|Subject request|0|||
147250705|NCT00752232|531088302|FG004|Overall Study|Subject request|0|||
147250706|NCT00752232|531088303|FG005|Overall Study|Subject request|0|||
147250707|NCT00752232|531088304|FG006|Overall Study|Subject request|0|||
147250708|NCT00752232|531088298|FG000|Overall Study|Group home admission|0|||
147250709|NCT00752232|531088299|FG001|Overall Study|Group home admission|0|||
147250710|NCT00752232|531088300|FG002|Overall Study|Group home admission|0|||
147250711|NCT00752232|531088301|FG003|Overall Study|Group home admission|1|||
147250712|NCT00752232|531088302|FG004|Overall Study|Group home admission|0|||
147250713|NCT00752232|531088303|FG005|Overall Study|Group home admission|0|||
147250714|NCT00752232|531088304|FG006|Overall Study|Group home admission|0|||
147250715|NCT00752232|531088298|FG000|Overall Study|Caregiver could not attend the subject|0|||
147250716|NCT00752232|531088299|FG001|Overall Study|Caregiver could not attend the subject|0|||
147250717|NCT00752232|531088300|FG002|Overall Study|Caregiver could not attend the subject|0|||
147250718|NCT00752232|531088301|FG003|Overall Study|Caregiver could not attend the subject|0|||
147250719|NCT00752232|531088302|FG004|Overall Study|Caregiver could not attend the subject|1|||
147250720|NCT00752232|531088303|FG005|Overall Study|Caregiver could not attend the subject|0|||
147250721|NCT00752232|531088304|FG006|Overall Study|Caregiver could not attend the subject|0|||
147250722|NCT00555321|531088305|FG000|Treatment Phase up to 12-months|Adverse Event|6|||
147250723|NCT00555321|531088306|FG001|Treatment Phase up to 12-months|Adverse Event|7|||
147250724|NCT00555321|531088307|FG002|Treatment Phase up to 12-months|Adverse Event|11|||
147250725|NCT00555321|531088308|FG003|Treatment Phase up to 12-months|Adverse Event|7|||
147250726|NCT00555321|531088309|FG004|Treatment Phase up to 12-months|Adverse Event|18|||
147250727|NCT00555321|531088305|FG000|Treatment Phase up to 12-months|Withdrawal by Subject|1|||
147250728|NCT00555321|531088306|FG001|Treatment Phase up to 12-months|Withdrawal by Subject|0|||
147250729|NCT00555321|531088307|FG002|Treatment Phase up to 12-months|Withdrawal by Subject|1|||
147250730|NCT00555321|531088308|FG003|Treatment Phase up to 12-months|Withdrawal by Subject|0|||
147250731|NCT00555321|531088309|FG004|Treatment Phase up to 12-months|Withdrawal by Subject|0|||
147250732|NCT00555321|531088305|FG000|Treatment Phase up to 12-months|Death|2|||
147250733|NCT00555321|531088306|FG001|Treatment Phase up to 12-months|Death|1|||
147596800|NCT00292188|532343204|FG002|Single-Blind|Adverse Event|0|||
147250734|NCT00555321|531088307|FG002|Treatment Phase up to 12-months|Death|4|||
147596801|NCT00292188|532343202|FG000|Single-Blind|Lack of Efficacy|2|||
147596802|NCT00292188|532343203|FG001|Single-Blind|Lack of Efficacy|0|||
147596803|NCT00292188|532343204|FG002|Single-Blind|Lack of Efficacy|0|||
147596804|NCT00292188|532343202|FG000|Single-Blind|Laboratory Abnormality|5|||
147596805|NCT00292188|532343203|FG001|Single-Blind|Laboratory Abnormality|0|||
147596806|NCT00292188|532343204|FG002|Single-Blind|Laboratory Abnormality|0|||
147596807|NCT00292188|532343202|FG000|Single-Blind|Lost to Follow-up|3|||
147596808|NCT00292188|532343203|FG001|Single-Blind|Lost to Follow-up|0|||
147596809|NCT00292188|532343204|FG002|Single-Blind|Lost to Follow-up|0|||
147596810|NCT00292188|532343202|FG000|Single-Blind|Other|77|||
147596811|NCT00292188|532343203|FG001|Single-Blind|Other|0|||
147596812|NCT00292188|532343204|FG002|Single-Blind|Other|0|||
147596813|NCT00292188|532343202|FG000|Single-Blind|Withdrawal by Subject|12|||
147596814|NCT00292188|532343203|FG001|Single-Blind|Withdrawal by Subject|0|||
147596815|NCT00292188|532343204|FG002|Single-Blind|Withdrawal by Subject|0|||
147596816|NCT00292188|532343202|FG000|Single-Blind|Did not receive treatment|1|||
147596817|NCT00292188|532343203|FG001|Single-Blind|Did not receive treatment|0|||
147596818|NCT00292188|532343204|FG002|Single-Blind|Did not receive treatment|0|||
147596819|NCT00292188|532343202|FG000|Double-Blind|Adverse Event|0|||
147596820|NCT00292188|532343203|FG001|Double-Blind|Adverse Event|25|||
147596821|NCT00292188|532343204|FG002|Double-Blind|Adverse Event|9|||
147596822|NCT00292188|532343202|FG000|Double-Blind|Lack of Efficacy|0|||
147596823|NCT00292188|532343203|FG001|Double-Blind|Lack of Efficacy|2|||
147596824|NCT00292188|532343204|FG002|Double-Blind|Lack of Efficacy|12|||
147596825|NCT00292188|532343202|FG000|Double-Blind|Lost to Follow-up|0|||
147596826|NCT00292188|532343203|FG001|Double-Blind|Lost to Follow-up|1|||
147596827|NCT00292188|532343204|FG002|Double-Blind|Lost to Follow-up|0|||
147596828|NCT00292188|532343202|FG000|Double-Blind|Other|0|||
147250735|NCT00555321|531088308|FG003|Treatment Phase up to 12-months|Death|0|||
147250736|NCT00555321|531088309|FG004|Treatment Phase up to 12-months|Death|0|||
147250737|NCT00555321|531088305|FG000|Treatment Phase up to 12-months|Lack of Efficacy|9|||
147250738|NCT00555321|531088306|FG001|Treatment Phase up to 12-months|Lack of Efficacy|8|||
147596829|NCT00292188|532343203|FG001|Double-Blind|Other|3|||
147250739|NCT00555321|531088307|FG002|Treatment Phase up to 12-months|Lack of Efficacy|5|||
147250740|NCT00555321|531088308|FG003|Treatment Phase up to 12-months|Lack of Efficacy|0|||
147596830|NCT00292188|532343204|FG002|Double-Blind|Other|4|||
147596831|NCT00292188|532343202|FG000|Double-Blind|Withdrawal by Subject|0|||
147596832|NCT00292188|532343203|FG001|Double-Blind|Withdrawal by Subject|0|||
147596833|NCT00292188|532343204|FG002|Double-Blind|Withdrawal by Subject|3|||
147596834|NCT00292188|532343202|FG000|Double-Blind|Laboratory Abnormality|0|||
147596835|NCT00292188|532343203|FG001|Double-Blind|Laboratory Abnormality|0|||
147596836|NCT00292188|532343204|FG002|Double-Blind|Laboratory Abnormality|1|||
147596837|NCT00577395|532343205|FG000|Overall Study|Study was terminated early by Sponsor|7|||
147596838|NCT00577395|532343206|FG001|Overall Study|Study was terminated early by Sponsor|6|||
147596839|NCT01206101|532343207|FG000|Overall Study|Adverse Event|1|||
147596840|NCT01206101|532343208|FG001|Overall Study|Adverse Event|0|||
147596841|NCT01206101|532343207|FG000|Overall Study|Physician Decision|0|||
147596842|NCT01206101|532343208|FG001|Overall Study|Physician Decision|1|||
147596843|NCT01206101|532343207|FG000|Overall Study|Unclassified|1|||
147596844|NCT01206101|532343208|FG001|Overall Study|Unclassified|0|||
147596845|NCT04709835|532343211|FG000|Overall Study|Withdrawal by Subject|0|||
147596846|NCT04709835|532343212|FG001|Overall Study|Withdrawal by Subject|1|||
147596847|NCT04709835|532343213|FG002|Overall Study|Withdrawal by Subject|0|||
147596848|NCT01859130|532343214|FG000|Overall Study|Death|4|||
147250741|NCT00555321|531088309|FG004|Treatment Phase up to 12-months|Lack of Efficacy|0|||
147250742|NCT00555321|531088305|FG000|Treatment Phase up to 12-months|Other Reason|1|||
147250743|NCT00555321|531088306|FG001|Treatment Phase up to 12-months|Other Reason|3|||
147250744|NCT00555321|531088307|FG002|Treatment Phase up to 12-months|Other Reason|2|||
147250745|NCT00555321|531088308|FG003|Treatment Phase up to 12-months|Other Reason|0|||
147250746|NCT00555321|531088309|FG004|Treatment Phase up to 12-months|Other Reason|0|||
147250747|NCT00555321|531088305|FG000|Treatment Phase up to 12-months|Never treated|2|||
147250748|NCT00555321|531088306|FG001|Treatment Phase up to 12-months|Never treated|3|||
147250749|NCT00555321|531088307|FG002|Treatment Phase up to 12-months|Never treated|1|||
147250750|NCT00555321|531088308|FG003|Treatment Phase up to 12-months|Never treated|0|||
147596849|NCT01859130|532343214|FG000|Overall Study|Lost to Follow-up|16|||
147596850|NCT01859130|532343214|FG000|Overall Study|Sponsor terminated: 47 Not specified: 3|53|||
147596851|NCT01859130|532343214|FG000|Overall Study|Physician Decision|6|||
147596852|NCT01859130|532343214|FG000|Overall Study|Withdrawal by Subject|17|||
147596853|NCT01859130|532343214|FG000|Overall Study|Adverse Event|11|||
147596854|NCT00103311|532343220|FG000|Overall Study|Lost to Follow-up|1|||
147596855|NCT00103311|532343221|FG001|Overall Study|Lost to Follow-up|0|||
147596856|NCT00103311|532343220|FG000|Overall Study|Withdrawal by Subject|2|||
147596857|NCT00103311|532343221|FG001|Overall Study|Withdrawal by Subject|1|||
147596858|NCT00103311|532343220|FG000|Overall Study|Adverse Event|1|||
147596859|NCT00103311|532343221|FG001|Overall Study|Adverse Event|0|||
147596860|NCT03827564|532343222|FG000|Overall Study|Discontinued due to Study Termination|1|||
147660515|NCT00325819|532579931|FG000|Overall Study|Lost to Follow-up|3|||
147331450|NCT02341625|531379206|FG000|Overall Study|Participant Withdrew Consent|0|||
147331451|NCT02341625|531379207|FG001|Overall Study|Participant Withdrew Consent|0|||
147331452|NCT02341625|531379208|FG002|Overall Study|Participant Withdrew Consent|0|||
147331453|NCT02341625|531379209|FG003|Overall Study|Participant Withdrew Consent|1|||
147331454|NCT02341625|531379210|FG004|Overall Study|Participant Withdrew Consent|0|||
147331455|NCT02341625|531379211|FG005|Overall Study|Participant Withdrew Consent|0|||
147331456|NCT02341625|531379212|FG006|Overall Study|Participant Withdrew Consent|0|||
147331457|NCT02341625|531379213|FG007|Overall Study|Participant Withdrew Consent|0|||
147331458|NCT02341625|531379214|FG008|Overall Study|Participant Withdrew Consent|0|||
147331459|NCT02341625|531379215|FG009|Overall Study|Participant Withdrew Consent|0|||
147331460|NCT02341625|531379206|FG000|Overall Study|Completed Treatment as per Protocol|0|||
147331461|NCT02341625|531379207|FG001|Overall Study|Completed Treatment as per Protocol|0|||
147331462|NCT02341625|531379208|FG002|Overall Study|Completed Treatment as per Protocol|0|||
147449875|NCT03657043|531811302|FG004|Overall Study|Study closure by Sponsor|17|||
147449876|NCT03657043|531811298|FG000|Overall Study|Lost to Follow-up|0|||
147449877|NCT03657043|531811299|FG001|Overall Study|Lost to Follow-up|0|||
147449878|NCT03657043|531811300|FG002|Overall Study|Lost to Follow-up|0|||
147449879|NCT03657043|531811301|FG003|Overall Study|Lost to Follow-up|0|||
147449880|NCT03657043|531811302|FG004|Overall Study|Lost to Follow-up|4|||
147449881|NCT03657043|531811298|FG000|Overall Study|Death|6|||
147449882|NCT03657043|531811299|FG001|Overall Study|Death|5|||
147449883|NCT03657043|531811300|FG002|Overall Study|Death|0|||
147449884|NCT03657043|531811301|FG003|Overall Study|Death|0|||
147449885|NCT03657043|531811302|FG004|Overall Study|Death|53|||
147449886|NCT03657043|531811298|FG000|Overall Study|Met exclusion criteria after enrollment|1|||
147449887|NCT03657043|531811299|FG001|Overall Study|Met exclusion criteria after enrollment|0|||
147449888|NCT03657043|531811300|FG002|Overall Study|Met exclusion criteria after enrollment|0|||
147449889|NCT03657043|531811301|FG003|Overall Study|Met exclusion criteria after enrollment|0|||
147449890|NCT03657043|531811302|FG004|Overall Study|Met exclusion criteria after enrollment|0|||
147449891|NCT03657043|531811298|FG000|Overall Study|Adverse Event|0|||
147449892|NCT03657043|531811299|FG001|Overall Study|Adverse Event|0|||
147449893|NCT03657043|531811300|FG002|Overall Study|Adverse Event|0|||
147449894|NCT03657043|531811301|FG003|Overall Study|Adverse Event|0|||
147449895|NCT03657043|531811302|FG004|Overall Study|Adverse Event|2|||
147449896|NCT03657043|531811298|FG000|Overall Study|Withdrawal - subsequent treatment|0|||
147449897|NCT03657043|531811299|FG001|Overall Study|Withdrawal - subsequent treatment|0|||
147449898|NCT03657043|531811300|FG002|Overall Study|Withdrawal - subsequent treatment|0|||
147449899|NCT03657043|531811301|FG003|Overall Study|Withdrawal - subsequent treatment|0|||
147449900|NCT03657043|531811302|FG004|Overall Study|Withdrawal - subsequent treatment|1|||
147449901|NCT03657043|531811298|FG000|Overall Study|Withdrawal - declined follow-up|0|||
147449902|NCT03657043|531811299|FG001|Overall Study|Withdrawal - declined follow-up|0|||
147449903|NCT03657043|531811300|FG002|Overall Study|Withdrawal - declined follow-up|0|||
147449904|NCT03657043|531811301|FG003|Overall Study|Withdrawal - declined follow-up|0|||
147449905|NCT03657043|531811302|FG004|Overall Study|Withdrawal - declined follow-up|1|||
147449906|NCT03047980|531811303|FG000|Overall Study|Adverse Event|1|||
147250751|NCT00555321|531088309|FG004|Treatment Phase up to 12-months|Never treated|4|||
147250752|NCT00555321|531088305|FG000|Long-term Extension Phase|Adverse Event|2|||
147250753|NCT00555321|531088306|FG001|Long-term Extension Phase|Adverse Event|5|||
147250754|NCT00555321|531088307|FG002|Long-term Extension Phase|Adverse Event|2|||
147250755|NCT00555321|531088308|FG003|Long-term Extension Phase|Adverse Event|1|||
147250756|NCT00555321|531088309|FG004|Long-term Extension Phase|Adverse Event|0|||
147250757|NCT00555321|531088305|FG000|Long-term Extension Phase|Withdrawal by Subject|2|||
147250758|NCT00555321|531088306|FG001|Long-term Extension Phase|Withdrawal by Subject|1|||
147250759|NCT00555321|531088307|FG002|Long-term Extension Phase|Withdrawal by Subject|2|||
147250760|NCT00555321|531088308|FG003|Long-term Extension Phase|Withdrawal by Subject|3|||
147250761|NCT00555321|531088309|FG004|Long-term Extension Phase|Withdrawal by Subject|2|||
147250762|NCT00555321|531088305|FG000|Long-term Extension Phase|Administrative reason by sponsor|23|||
147250763|NCT00555321|531088306|FG001|Long-term Extension Phase|Administrative reason by sponsor|21|||
147250764|NCT00555321|531088307|FG002|Long-term Extension Phase|Administrative reason by sponsor|18|||
147250765|NCT00555321|531088308|FG003|Long-term Extension Phase|Administrative reason by sponsor|31|||
147250766|NCT00555321|531088309|FG004|Long-term Extension Phase|Administrative reason by sponsor|23|||
147250767|NCT00555321|531088305|FG000|Long-term Extension Phase|Death|2|||
147250768|NCT00555321|531088306|FG001|Long-term Extension Phase|Death|0|||
147250769|NCT00555321|531088307|FG002|Long-term Extension Phase|Death|0|||
147250770|NCT00555321|531088308|FG003|Long-term Extension Phase|Death|3|||
147449907|NCT02627495|531811306|FG000|Overall Study|Withdrawal by Subject|4|||
147449908|NCT00880893|531811307|FG000|Overall Study|Protocol Violation|13|||
147331463|NCT02341625|531379209|FG003|Overall Study|Completed Treatment as per Protocol|0|||
147331464|NCT02341625|531379210|FG004|Overall Study|Completed Treatment as per Protocol|0|||
147449909|NCT00880893|531811308|FG001|Overall Study|Protocol Violation|1|||
147449910|NCT00880893|531811307|FG000|Overall Study|Withdrawal by Subject|15|||
147250771|NCT00555321|531088309|FG004|Long-term Extension Phase|Death|0|||
147250772|NCT00555321|531088305|FG000|Long-term Extension Phase|Participant did not meet study criteria|0|||
147250773|NCT00555321|531088306|FG001|Long-term Extension Phase|Participant did not meet study criteria|0|||
147250774|NCT00555321|531088307|FG002|Long-term Extension Phase|Participant did not meet study criteria|0|||
147250775|NCT00555321|531088308|FG003|Long-term Extension Phase|Participant did not meet study criteria|0|||
147596861|NCT03827564|532343223|FG001|Overall Study|Discontinued due to Study Termination|0|||
147596862|NCT00270257|532343224|FG000|Overall Study|Data Safety Monitoring Board (DSMB) halt|412|||
147596863|NCT00270257|532343225|FG001|Overall Study|Data Safety Monitoring Board (DSMB) halt|424|||
147596864|NCT01195103|532343226|FG000|Overall Study|Withdrawal by Subject|1|||
147596865|NCT01195103|532343227|FG001|Overall Study|Withdrawal by Subject|0|||
147596866|NCT01195103|532343228|FG002|Overall Study|Withdrawal by Subject|0|||
147596867|NCT02621034|532343229|FG000|Overall Study|Lost to Follow-up|3|||
147596868|NCT02621034|532343230|FG001|Overall Study|Lost to Follow-up|2|||
147596869|NCT02621034|532343231|FG002|Overall Study|Lost to Follow-up|5|||
147596870|NCT00974974|532343241|FG000|IR CD-LD Dose Adjustment|Adverse Event|0|||
147596871|NCT00974974|532343242|FG001|IR CD-LD Dose Adjustment|Adverse Event|3|||
147596872|NCT00974974|532343241|FG000|IR CD-LD Dose Adjustment|Protocol Violation|0|||
147596873|NCT00974974|532343242|FG001|IR CD-LD Dose Adjustment|Protocol Violation|1|||
147596874|NCT00974974|532343241|FG000|IR CD-LD Dose Adjustment|Noncompliance with study drug|0|||
147596875|NCT00974974|532343242|FG001|IR CD-LD Dose Adjustment|Noncompliance with study drug|1|||
147596876|NCT00974974|532343241|FG000|IR CD-LD Dose Adjustment|Withdrawal by Subject|0|||
147596877|NCT00974974|532343242|FG001|IR CD-LD Dose Adjustment|Withdrawal by Subject|7|||
147596878|NCT00974974|532343241|FG000|IR CD-LD Dose Adjustment|Various|0|||
147596879|NCT00974974|532343242|FG001|IR CD-LD Dose Adjustment|Various|9|||
147596880|NCT00974974|532343241|FG000|IPX066 Dose Conversion|Adverse Event|23|||
147596881|NCT00974974|532343242|FG001|IPX066 Dose Conversion|Adverse Event|0|||
147596882|NCT00974974|532343241|FG000|IPX066 Dose Conversion|Death|2|||
147596883|NCT00974974|532343242|FG001|IPX066 Dose Conversion|Death|0|||
147596884|NCT00974974|532343241|FG000|IPX066 Dose Conversion|Lack of Efficacy|13|||
147596885|NCT00974974|532343242|FG001|IPX066 Dose Conversion|Lack of Efficacy|0|||
147596886|NCT00974974|532343241|FG000|IPX066 Dose Conversion|Withdrawal by Subject|12|||
147596887|NCT00974974|532343242|FG001|IPX066 Dose Conversion|Withdrawal by Subject|0|||
147596888|NCT00974974|532343241|FG000|IPX066 Dose Conversion|Various|3|||
147596889|NCT00974974|532343242|FG001|IPX066 Dose Conversion|Various|0|||
147596890|NCT00974974|532343241|FG000|IPX066 Dose Conversion|Protocol Violation|4|||
147596891|NCT00974974|532343242|FG001|IPX066 Dose Conversion|Protocol Violation|0|||
147596892|NCT00974974|532343241|FG000|Maintenance - Double Blind Treatment|Adverse Event|3|||
147596893|NCT00974974|532343242|FG001|Maintenance - Double Blind Treatment|Adverse Event|3|||
147596894|NCT00974974|532343241|FG000|Maintenance - Double Blind Treatment|Protocol Violation|1|||
147596895|NCT00974974|532343242|FG001|Maintenance - Double Blind Treatment|Protocol Violation|1|||
147596896|NCT00974974|532343241|FG000|Maintenance - Double Blind Treatment|Noncompliance with study drug|0|||
147250776|NCT00555321|531088309|FG004|Long-term Extension Phase|Participant did not meet study criteria|1|||
147250777|NCT00555321|531088305|FG000|Long-term Extension Phase|Other Reason|1|||
147250778|NCT00555321|531088306|FG001|Long-term Extension Phase|Other Reason|0|||
147250779|NCT00555321|531088307|FG002|Long-term Extension Phase|Other Reason|2|||
147250780|NCT00555321|531088308|FG003|Long-term Extension Phase|Other Reason|0|||
147250781|NCT00555321|531088309|FG004|Long-term Extension Phase|Other Reason|0|||
147250782|NCT00005937|531088310|FG000|Overall Study|Lack of Efficacy|5|||
147250783|NCT00563381|531088311|FG000|Overall Study|Adverse Event|264|||
147250784|NCT00563381|531088312|FG001|Overall Study|Adverse Event|292|||
147250785|NCT00563381|531088311|FG000|Overall Study|Protocol Violation|66|||
147250786|NCT00563381|531088312|FG001|Overall Study|Protocol Violation|74|||
147250787|NCT00563381|531088311|FG000|Overall Study|Lost to Follow-up|7|||
147250788|NCT00563381|531088312|FG001|Overall Study|Lost to Follow-up|15|||
147250789|NCT00563381|531088311|FG000|Overall Study|Withdrawal by Subject|192|||
147250790|NCT00563381|531088312|FG001|Overall Study|Withdrawal by Subject|209|||
147250791|NCT00563381|531088311|FG000|Overall Study|Lack of Efficacy|32|||
147250792|NCT00563381|531088312|FG001|Overall Study|Lack of Efficacy|24|||
147250793|NCT00563381|531088311|FG000|Overall Study|Individual different reasons|24|||
147250794|NCT00563381|531088312|FG001|Overall Study|Individual different reasons|34|||
147250795|NCT01957644|531088315|FG000|Overall Study|Adverse Event|4|||
147250796|NCT01957644|531088316|FG001|Overall Study|Adverse Event|2|||
147250797|NCT01957644|531088317|FG002|Overall Study|Adverse Event|0|||
147250798|NCT01957644|531088318|FG003|Overall Study|Adverse Event|0|||
147250799|NCT01957644|531088319|FG004|Overall Study|Adverse Event|1|||
147250800|NCT01957644|531088315|FG000|Overall Study|Progressive disease / relapse|0|||
147250801|NCT01957644|531088316|FG001|Overall Study|Progressive disease / relapse|1|||
147250802|NCT01957644|531088317|FG002|Overall Study|Progressive disease / relapse|0|||
147250803|NCT01957644|531088318|FG003|Overall Study|Progressive disease / relapse|1|||
147250804|NCT01957644|531088319|FG004|Overall Study|Progressive disease / relapse|0|||
147250805|NCT01957644|531088315|FG000|Overall Study|Other reason|1|||
147331465|NCT02341625|531379211|FG005|Overall Study|Completed Treatment as per Protocol|0|||
147596897|NCT00974974|532343242|FG001|Maintenance - Double Blind Treatment|Noncompliance with study drug|1|||
147596898|NCT00974974|532343241|FG000|Maintenance - Double Blind Treatment|Lack of Efficacy|2|||
147596899|NCT00974974|532343242|FG001|Maintenance - Double Blind Treatment|Lack of Efficacy|2|||
147596900|NCT00974974|532343241|FG000|Maintenance - Double Blind Treatment|Lost to Follow-up|0|||
147596901|NCT00974974|532343242|FG001|Maintenance - Double Blind Treatment|Lost to Follow-up|1|||
147596902|NCT00974974|532343241|FG000|Maintenance - Double Blind Treatment|Withdrawal by Subject|5|||
147596903|NCT00974974|532343242|FG001|Maintenance - Double Blind Treatment|Withdrawal by Subject|2|||
147596904|NCT00974974|532343241|FG000|Maintenance - Double Blind Treatment|Various|4|||
147596905|NCT00974974|532343242|FG001|Maintenance - Double Blind Treatment|Various|0|||
147596906|NCT01959035|532343243|FG000|Overall Study|Adverse Event|5|||
147596907|NCT01959035|532343243|FG000|Overall Study|Withdrawal by Subject|4|||
147596908|NCT01959035|532343243|FG000|Overall Study|Lost to Follow-up|1|||
147596909|NCT01959035|532343243|FG000|Overall Study|Other (no primary reason given)|1|||
147596910|NCT02227147|532343244|FG000|Controlled Treatment Period|Adverse Event|4|||
147596911|NCT02227147|532343245|FG001|Controlled Treatment Period|Adverse Event|3|||
147596912|NCT02227147|532343244|FG000|Controlled Treatment Period|Other|2|||
147596913|NCT02227147|532343245|FG001|Controlled Treatment Period|Other|0|||
147596914|NCT02227147|532343244|FG000|Follow-up Period|Other|3|||
147596915|NCT02227147|532343245|FG001|Follow-up Period|Other|5|||
147596916|NCT03347422|532343248|FG000|Part A (26 Weeks)|Adverse Event|3|||
147596917|NCT03347422|532343249|FG001|Part A (26 Weeks)|Adverse Event|0|||
147596918|NCT03347422|532343248|FG000|Part B (149 Weeks)|Lack of Efficacy|1|||
147596919|NCT03347422|532343249|FG001|Part B (149 Weeks)|Lack of Efficacy|2|||
147596920|NCT03347422|532343248|FG000|Part B (149 Weeks)|Adverse Event|0|||
147596921|NCT03347422|532343249|FG001|Part B (149 Weeks)|Adverse Event|1|||
147596922|NCT03347422|532343248|FG000|Part B (149 Weeks)|Withdrawal by Subject|1|||
147596923|NCT03347422|532343249|FG001|Part B (149 Weeks)|Withdrawal by Subject|1|||
147596924|NCT03347422|532343248|FG000|Part B (149 Weeks)|Other|1|||
147596925|NCT03347422|532343249|FG001|Part B (149 Weeks)|Other|0|||
147596926|NCT03709823|532343250|FG000|Overall Study|Adverse Event|0|||
147596927|NCT03709823|532343251|FG001|Overall Study|Adverse Event|0|||
147596928|NCT03709823|532343252|FG002|Overall Study|Adverse Event|1|||
147596929|NCT03709823|532343253|FG003|Overall Study|Adverse Event|0|||
147596930|NCT03709823|532343254|FG004|Overall Study|Adverse Event|0|||
147596931|NCT03709823|532343255|FG005|Overall Study|Adverse Event|0|||
147596932|NCT03709823|532343250|FG000|Overall Study|Lost to Follow-up|2|||
147596933|NCT03709823|532343251|FG001|Overall Study|Lost to Follow-up|2|||
147596934|NCT03709823|532343252|FG002|Overall Study|Lost to Follow-up|2|||
147250806|NCT01957644|531088316|FG001|Overall Study|Other reason|2|||
147250807|NCT01957644|531088317|FG002|Overall Study|Other reason|1|||
147250808|NCT01957644|531088318|FG003|Overall Study|Other reason|1|||
147250809|NCT01957644|531088319|FG004|Overall Study|Other reason|0|||
147250810|NCT01957644|531088315|FG000|Overall Study|Withdrawal by Subject|1|||
147250811|NCT01957644|531088316|FG001|Overall Study|Withdrawal by Subject|0|||
147250812|NCT01957644|531088317|FG002|Overall Study|Withdrawal by Subject|0|||
147250813|NCT01957644|531088318|FG003|Overall Study|Withdrawal by Subject|0|||
147250814|NCT01957644|531088319|FG004|Overall Study|Withdrawal by Subject|0|||
147250815|NCT01957644|531088315|FG000|Overall Study|Protocol Violation|0|||
147250816|NCT01957644|531088316|FG001|Overall Study|Protocol Violation|1|||
147250817|NCT01957644|531088317|FG002|Overall Study|Protocol Violation|0|||
147250818|NCT01957644|531088318|FG003|Overall Study|Protocol Violation|0|||
147250819|NCT01957644|531088319|FG004|Overall Study|Protocol Violation|0|||
147250820|NCT02730455|531088320|FG000|Overall Study|Death|5|||
147250821|NCT02730455|531088321|FG001|Overall Study|Death|6|||
147250822|NCT02730455|531088322|FG002|Overall Study|Death|4|||
147250823|NCT02730455|531088320|FG000|Overall Study|Consent withdrawn|2|||
147250824|NCT02730455|531088321|FG001|Overall Study|Consent withdrawn|4|||
147250825|NCT02730455|531088322|FG002|Overall Study|Consent withdrawn|1|||
147250826|NCT02730455|531088320|FG000|Overall Study|Lost to Follow-up|3|||
147250827|NCT02730455|531088321|FG001|Overall Study|Lost to Follow-up|1|||
147250828|NCT02730455|531088322|FG002|Overall Study|Lost to Follow-up|4|||
147250829|NCT02730455|531088320|FG000|Overall Study|Other|1|||
147596935|NCT03709823|532343253|FG003|Overall Study|Lost to Follow-up|1|||
147596936|NCT03709823|532343254|FG004|Overall Study|Lost to Follow-up|1|||
147660516|NCT00325819|532579932|FG001|Overall Study|Lost to Follow-up|3|||
147250830|NCT02730455|531088321|FG001|Overall Study|Other|1|||
147250831|NCT02730455|531088322|FG002|Overall Study|Other|2|||
147250832|NCT02730455|531088320|FG000|Overall Study|Other|2|||
147250833|NCT02730455|531088321|FG001|Overall Study|Other|2|||
147250834|NCT02730455|531088322|FG002|Overall Study|Other|0|||
147596937|NCT03709823|532343255|FG005|Overall Study|Lost to Follow-up|0|||
147596938|NCT03709823|532343250|FG000|Overall Study|Withdrawal by Subject|1|||
147596939|NCT03709823|532343251|FG001|Overall Study|Withdrawal by Subject|3|||
147596940|NCT03709823|532343252|FG002|Overall Study|Withdrawal by Subject|0|||
147596941|NCT03709823|532343253|FG003|Overall Study|Withdrawal by Subject|0|||
147596942|NCT03709823|532343254|FG004|Overall Study|Withdrawal by Subject|0|||
147596943|NCT03709823|532343255|FG005|Overall Study|Withdrawal by Subject|0|||
147660517|NCT02058589|532579934|FG000|Overall Study|Serious Adverse Event|1|||
147250835|NCT02733367|531088323|FG000|Overall Study|Withdrawal by Subject|6|||
147250836|NCT03049280|531088330|FG000|Overall Study|Physician Decision|1|||
147250837|NCT01683383|531088331|FG000|Overall Study|Infant was not transported|1|||
147596944|NCT03709823|532343250|FG000|Overall Study|Other, Not Specified|0|||
147596945|NCT03709823|532343251|FG001|Overall Study|Other, Not Specified|0|||
147596946|NCT03709823|532343252|FG002|Overall Study|Other, Not Specified|0|||
147596947|NCT03709823|532343253|FG003|Overall Study|Other, Not Specified|1|||
147596948|NCT03709823|532343254|FG004|Overall Study|Other, Not Specified|0|||
147596949|NCT03709823|532343255|FG005|Overall Study|Other, Not Specified|0|||
147596950|NCT00158600|532343258|FG000|Overall Study|unable to commit time to study|0|||
147596951|NCT00158600|532343259|FG001|Overall Study|unable to commit time to study|1|||
147596952|NCT00158600|532343258|FG000|Overall Study|Adverse Event|2|||
147596953|NCT00158600|532343259|FG001|Overall Study|Adverse Event|1|||
147596954|NCT00158600|532343258|FG000|Overall Study|Death|1|||
147596955|NCT00158600|532343259|FG001|Overall Study|Death|0|||
147596956|NCT00158600|532343258|FG000|Overall Study|Withdrawal by Subject|2|||
147596957|NCT00158600|532343259|FG001|Overall Study|Withdrawal by Subject|2|||
147596958|NCT02038907|532343260|FG000|Overall Study|Protocol Violation|0|||
147596959|NCT02038907|532343261|FG001|Overall Study|Protocol Violation|0|||
147596960|NCT02038907|532343262|FG002|Overall Study|Protocol Violation|0|||
147596961|NCT02038907|532343263|FG003|Overall Study|Protocol Violation|0|||
147596962|NCT02038907|532343264|FG004|Overall Study|Protocol Violation|0|||
147596963|NCT02038907|532343265|FG005|Overall Study|Protocol Violation|0|||
147596964|NCT02038907|532343266|FG006|Overall Study|Protocol Violation|0|||
147596965|NCT02038907|532343267|FG007|Overall Study|Protocol Violation|0|||
147596966|NCT02038907|532343268|FG008|Overall Study|Protocol Violation|0|||
147596967|NCT02038907|532343269|FG009|Overall Study|Protocol Violation|0|||
147596968|NCT02038907|532343270|FG010|Overall Study|Protocol Violation|1|||
147596969|NCT02038907|532343271|FG011|Overall Study|Protocol Violation|0|||
147596970|NCT02038907|532343272|FG012|Overall Study|Protocol Violation|0|||
147596971|NCT02038907|532343273|FG013|Overall Study|Protocol Violation|0|||
147596972|NCT02038907|532343260|FG000|Overall Study|Withdrawal by Subject|0|||
147596973|NCT02038907|532343261|FG001|Overall Study|Withdrawal by Subject|0|||
147596974|NCT02038907|532343262|FG002|Overall Study|Withdrawal by Subject|0|||
147596975|NCT02038907|532343263|FG003|Overall Study|Withdrawal by Subject|0|||
147596976|NCT02038907|532343264|FG004|Overall Study|Withdrawal by Subject|0|||
147596977|NCT02038907|532343265|FG005|Overall Study|Withdrawal by Subject|0|||
147596978|NCT02038907|532343266|FG006|Overall Study|Withdrawal by Subject|0|||
147596979|NCT02038907|532343267|FG007|Overall Study|Withdrawal by Subject|0|||
147596980|NCT02038907|532343268|FG008|Overall Study|Withdrawal by Subject|0|||
147596981|NCT02038907|532343269|FG009|Overall Study|Withdrawal by Subject|0|||
147596982|NCT02038907|532343270|FG010|Overall Study|Withdrawal by Subject|1|||
147596983|NCT02038907|532343271|FG011|Overall Study|Withdrawal by Subject|0|||
147596984|NCT02038907|532343272|FG012|Overall Study|Withdrawal by Subject|0|||
147596985|NCT02038907|532343273|FG013|Overall Study|Withdrawal by Subject|0|||
147596986|NCT01246011|532343277|FG000|Overall Study|If needed warfarin clinically, withdrawn|0|||
147596987|NCT01246011|532343278|FG001|Overall Study|If needed warfarin clinically, withdrawn|0|||
147250838|NCT01683383|531088332|FG001|Overall Study|Infant was not transported|0|||
147250839|NCT00996307|531088333|FG000|Overall Study|Adverse Event|0|||
147250840|NCT00996307|531088334|FG001|Overall Study|Adverse Event|1|||
147250841|NCT00996307|531088335|FG002|Overall Study|Adverse Event|0|||
147250842|NCT00996307|531088336|FG003|Overall Study|Adverse Event|0|||
147250843|NCT00996307|531088333|FG000|Overall Study|Withdrawal by Subject|3|||
147250844|NCT00996307|531088334|FG001|Overall Study|Withdrawal by Subject|2|||
147250845|NCT00996307|531088335|FG002|Overall Study|Withdrawal by Subject|5|||
147250846|NCT00996307|531088336|FG003|Overall Study|Withdrawal by Subject|5|||
147250847|NCT00996307|531088333|FG000|Overall Study|Lost to Follow-up|13|||
147250848|NCT00996307|531088334|FG001|Overall Study|Lost to Follow-up|13|||
147250849|NCT00996307|531088335|FG002|Overall Study|Lost to Follow-up|7|||
147250850|NCT00996307|531088336|FG003|Overall Study|Lost to Follow-up|15|||
147250851|NCT00996307|531088333|FG000|Overall Study|Administrative reason|0|||
147250852|NCT00996307|531088334|FG001|Overall Study|Administrative reason|1|||
147250853|NCT00996307|531088335|FG002|Overall Study|Administrative reason|0|||
147250854|NCT00996307|531088336|FG003|Overall Study|Administrative reason|0|||
147596988|NCT01246011|532343279|FG002|Overall Study|If needed warfarin clinically, withdrawn|3|||
147596989|NCT01246011|532343277|FG000|Overall Study|Withdrawal by Subject|0|||
147596990|NCT01246011|532343278|FG001|Overall Study|Withdrawal by Subject|0|||
147596991|NCT01246011|532343279|FG002|Overall Study|Withdrawal by Subject|1|||
147660518|NCT02058589|532579935|FG001|Overall Study|Serious Adverse Event|1|||
147250855|NCT00996307|531088333|FG000|Overall Study|Unable to classify|4|||
147596992|NCT01155024|532343281|FG000|Direct Manufactured Socket 3 Month Trial|Experienced inferior suspension system|0|||
147596993|NCT01155024|532343282|FG001|Direct Manufactured Socket 3 Month Trial|Experienced inferior suspension system|2|||
147596994|NCT01155024|532343281|FG000|Direct Manufactured Socket 3 Month Trial|Lost to Follow-up|0|||
147596995|NCT01155024|532343282|FG001|Direct Manufactured Socket 3 Month Trial|Lost to Follow-up|2|||
147596996|NCT01155024|532343281|FG000|Direct Manufactured Socket 3 Month Trial|Withdrawal by Subject|0|||
147660519|NCT02058589|532579934|FG000|Overall Study|Non-Serious Adverse Event|1|||
147250856|NCT00996307|531088334|FG001|Overall Study|Unable to classify|0|||
147250857|NCT00996307|531088335|FG002|Overall Study|Unable to classify|2|||
147250858|NCT00996307|531088336|FG003|Overall Study|Unable to classify|1|||
147250859|NCT02326025|531088337|FG000|Overall Study|Adverse Event|3|||
147596997|NCT01155024|532343282|FG001|Direct Manufactured Socket 3 Month Trial|Withdrawal by Subject|2|||
147596998|NCT01593696|532343283|FG000|Dose Escalation|Progressive Disease|2|||
147596999|NCT01593696|532343284|FG001|Dose Escalation|Progressive Disease|0|||
147597000|NCT01593696|532343285|FG002|Dose Escalation|Progressive Disease|0|||
147597001|NCT01593696|532343286|FG003|Dose Escalation|Progressive Disease|0|||
147597002|NCT01593696|532343283|FG000|Dose Expansion|Fungal infection|0|||
147597003|NCT01593696|532343284|FG001|Dose Expansion|Fungal infection|0|||
147597004|NCT01593696|532343285|FG002|Dose Expansion|Fungal infection|1|||
147597005|NCT01593696|532343286|FG003|Dose Expansion|Fungal infection|0|||
147597006|NCT01936623|532343287|FG000|Overall Study|Lost to Follow-up|0|||
147597007|NCT01936623|532343288|FG001|Overall Study|Lost to Follow-up|5|||
147597008|NCT02575911|532343289|FG000|Overall Study|Lost to Follow-up|1|||
147597009|NCT01675661|532343290|FG000|Overall Study|Lost to Follow-up|22|||
147597010|NCT01675661|532343291|FG001|Overall Study|Lost to Follow-up|23|||
147597011|NCT01675661|532343290|FG000|Overall Study|Practical problems|9|||
147597012|NCT01675661|532343291|FG001|Overall Study|Practical problems|5|||
147597013|NCT01675661|532343290|FG000|Overall Study|Moved away|5|||
147597014|NCT01675661|532343291|FG001|Overall Study|Moved away|6|||
147597015|NCT01675661|532343290|FG000|Overall Study|Withdrawal by Subject|3|||
147597016|NCT01675661|532343291|FG001|Overall Study|Withdrawal by Subject|7|||
147597017|NCT01675661|532343290|FG000|Overall Study|Physician Decision|0|||
147597018|NCT01675661|532343291|FG001|Overall Study|Physician Decision|2|||
147597019|NCT01675661|532343290|FG000|Overall Study|Death|0|||
147597020|NCT01675661|532343291|FG001|Overall Study|Death|1|||
147597021|NCT01675661|532343290|FG000|Overall Study|Other reason|1|||
147597022|NCT01675661|532343291|FG001|Overall Study|Other reason|2|||
147597023|NCT00987389|532343292|FG000|Overall Study|Ineligible|0|||
147597024|NCT00987389|532343293|FG001|Overall Study|Ineligible|3|||
147597025|NCT00987389|532343294|FG002|Overall Study|Ineligible|0|||
147597026|NCT00987389|532343295|FG003|Overall Study|Ineligible|0|||
147597027|NCT00987389|532343292|FG000|Overall Study|Lost to Follow-up|4|||
147597028|NCT00987389|532343293|FG001|Overall Study|Lost to Follow-up|1|||
147597029|NCT00987389|532343294|FG002|Overall Study|Lost to Follow-up|3|||
147597030|NCT00987389|532343295|FG003|Overall Study|Lost to Follow-up|1|||
147597031|NCT00987389|532343292|FG000|Overall Study|Withdrawal by Subject|4|||
147597032|NCT00987389|532343293|FG001|Overall Study|Withdrawal by Subject|3|||
147597033|NCT00987389|532343294|FG002|Overall Study|Withdrawal by Subject|2|||
147597034|NCT00987389|532343295|FG003|Overall Study|Withdrawal by Subject|1|||
147597035|NCT00987389|532343292|FG000|Overall Study|Withdrawn from Treatment|0|||
147597036|NCT00987389|532343293|FG001|Overall Study|Withdrawn from Treatment|1|||
147597037|NCT00987389|532343294|FG002|Overall Study|Withdrawn from Treatment|0|||
147597038|NCT00987389|532343295|FG003|Overall Study|Withdrawn from Treatment|0|||
147597039|NCT00987389|532343292|FG000|Overall Study|Multiple different reasons|1|||
147597040|NCT00987389|532343293|FG001|Overall Study|Multiple different reasons|0|||
147597041|NCT00987389|532343294|FG002|Overall Study|Multiple different reasons|3|||
147597042|NCT00987389|532343295|FG003|Overall Study|Multiple different reasons|1|||
147597043|NCT02992418|532343296|FG000|Overall Study|Withdrawal by Subject|11|||
147597044|NCT02992418|532343297|FG001|Overall Study|Withdrawal by Subject|12|||
147597045|NCT02992418|532343296|FG000|Overall Study|Non-compliance with the protocol|308|||
147597046|NCT02992418|532343297|FG001|Overall Study|Non-compliance with the protocol|308|||
147660520|NCT02058589|532579935|FG001|Overall Study|Non-Serious Adverse Event|0|||
147250860|NCT02326025|531088338|FG001|Overall Study|Adverse Event|0|||
147250861|NCT02326025|531088337|FG000|Overall Study|Physician Decision|1|||
147250862|NCT02326025|531088338|FG001|Overall Study|Physician Decision|2|||
147250863|NCT02326025|531088337|FG000|Overall Study|Physician and Participant Decision|1|||
147250864|NCT02326025|531088338|FG001|Overall Study|Physician and Participant Decision|0|||
147250865|NCT02326025|531088337|FG000|Overall Study|Withdrawal by Subject|0|||
147250866|NCT02326025|531088338|FG001|Overall Study|Withdrawal by Subject|2|||
147250867|NCT02326025|531088337|FG000|Overall Study|Protocol Violation|0|||
147250868|NCT02326025|531088338|FG001|Overall Study|Protocol Violation|1|||
147250869|NCT00001723|531088339|FG000|Overall Study|Lack of Efficacy|6|||
147597047|NCT02992418|532343296|FG000|Overall Study|Lost to Follow-up|27|||
147597048|NCT02992418|532343297|FG001|Overall Study|Lost to Follow-up|22|||
147597049|NCT00289536|532343298|FG000|Period 3|Lost to Follow-up|0|||
147597050|NCT00289536|532343299|FG001|Period 3|Lost to Follow-up|0|||
147660521|NCT02058589|532579934|FG000|Overall Study|Withdrawal by Subject|0|||
147597051|NCT00289536|532343300|FG002|Period 3|Lost to Follow-up|1|||
147597052|NCT03246126|532343301|FG000|Overall Study|Withdrawal by Subject|0|||
147597053|NCT03246126|532343302|FG001|Overall Study|Withdrawal by Subject|1|||
147597054|NCT04465630|532343305|FG000|Overall Study|Sponsor Decision to terminate the study|54|||
147597055|NCT04465630|532343305|FG000|Overall Study|Screen failure|8|||
147597056|NCT04465630|532343305|FG000|Overall Study|Baseline failure|16|||
147250870|NCT00001723|531088340|FG001|Overall Study|Lack of Efficacy|7|||
147250871|NCT00001723|531088339|FG000|Overall Study|Lack of family interest|4|||
147250872|NCT00001723|531088340|FG001|Overall Study|Lack of family interest|5|||
147597057|NCT01006135|532343306|FG000|Overall Study|Adverse Event|22|||
147597058|NCT01006135|532343306|FG000|Overall Study|Protocol Violation|14|||
147597059|NCT01006135|532343306|FG000|Overall Study|Lost to Follow-up|32|||
147250873|NCT00001723|531088339|FG000|Overall Study|Lost to Follow-up|2|||
147250874|NCT00001723|531088340|FG001|Overall Study|Lost to Follow-up|2|||
147250875|NCT00001723|531088339|FG000|Overall Study|medication intolerance|1|||
147250876|NCT00001723|531088340|FG001|Overall Study|medication intolerance|2|||
147250877|NCT00536198|531088341|FG000|Overall Study|Lost to Follow-up|15|||
147250878|NCT00536198|531088342|FG001|Overall Study|Lost to Follow-up|14|||
147250879|NCT00536198|531088341|FG000|Overall Study|Withdrawal by Subject|16|||
147250880|NCT00536198|531088342|FG001|Overall Study|Withdrawal by Subject|12|||
147250881|NCT00536198|531088341|FG000|Overall Study|Adverse Event|2|||
147250882|NCT00536198|531088342|FG001|Overall Study|Adverse Event|2|||
147250883|NCT00536198|531088341|FG000|Overall Study|Rescue|3|||
147250884|NCT00536198|531088342|FG001|Overall Study|Rescue|9|||
147250885|NCT00536198|531088341|FG000|Overall Study|Pregnancy|1|||
147250886|NCT00536198|531088342|FG001|Overall Study|Pregnancy|1|||
147250887|NCT00536198|531088341|FG000|Overall Study|Protocol Violation|0|||
147250888|NCT00536198|531088342|FG001|Overall Study|Protocol Violation|1|||
147250889|NCT02643082|531088343|FG000|Period 1|Adverse Event|1|||
147331466|NCT02341625|531379212|FG006|Overall Study|Completed Treatment as per Protocol|0|||
147331467|NCT02341625|531379213|FG007|Overall Study|Completed Treatment as per Protocol|0|||
147331468|NCT02341625|531379214|FG008|Overall Study|Completed Treatment as per Protocol|0|||
147331469|NCT02341625|531379215|FG009|Overall Study|Completed Treatment as per Protocol|1|||
147331470|NCT02341625|531379206|FG000|Overall Study|Other Reasons|0|||
147331471|NCT02341625|531379207|FG001|Overall Study|Other Reasons|0|||
147331472|NCT02341625|531379208|FG002|Overall Study|Other Reasons|0|||
147331473|NCT02341625|531379209|FG003|Overall Study|Other Reasons|0|||
147331474|NCT02341625|531379210|FG004|Overall Study|Other Reasons|1|||
147331475|NCT02341625|531379211|FG005|Overall Study|Other Reasons|0|||
147331476|NCT02341625|531379212|FG006|Overall Study|Other Reasons|5|||
147331477|NCT02341625|531379213|FG007|Overall Study|Other Reasons|0|||
147331478|NCT02341625|531379214|FG008|Overall Study|Other Reasons|0|||
147331479|NCT02341625|531379215|FG009|Overall Study|Other Reasons|2|||
147331480|NCT02341625|531379206|FG000|Overall Study|Not Reported|0|||
147331481|NCT02341625|531379207|FG001|Overall Study|Not Reported|0|||
147331482|NCT02341625|531379208|FG002|Overall Study|Not Reported|0|||
147331483|NCT02341625|531379209|FG003|Overall Study|Not Reported|0|||
147331484|NCT02341625|531379210|FG004|Overall Study|Not Reported|0|||
147331485|NCT02341625|531379211|FG005|Overall Study|Not Reported|0|||
147331486|NCT02341625|531379212|FG006|Overall Study|Not Reported|0|||
147331487|NCT02341625|531379213|FG007|Overall Study|Not Reported|0|||
147331488|NCT02341625|531379214|FG008|Overall Study|Not Reported|0|||
147331489|NCT02341625|531379215|FG009|Overall Study|Not Reported|3|||
147331490|NCT01839877|531379218|FG000|Overall Study|Protocol Violation|1|||
147331491|NCT03368001|531379221|FG000|Allocation|Lost to Pretest|16|||
147331492|NCT03368001|531379222|FG001|Allocation|Lost to Pretest|25|||
147331493|NCT03368001|531379221|FG000|Allocation|Completed Pretest but 0 Intervention sessions|8|||
147331494|NCT03368001|531379222|FG001|Allocation|Completed Pretest but 0 Intervention sessions|9|||
147331495|NCT03368001|531379221|FG000|Posttest|Lost to Posttest|7|||
147331496|NCT03368001|531379222|FG001|Posttest|Lost to Posttest|11|||
147331497|NCT03368001|531379221|FG000|Posttest|Discontinued Intervention|6|||
147331498|NCT03368001|531379222|FG001|Posttest|Discontinued Intervention|19|||
147331499|NCT03368001|531379221|FG000|Follow-up|Lost to Follow-up|6|||
147331500|NCT03368001|531379222|FG001|Follow-up|Lost to Follow-up|3|||
147331501|NCT01093534|531379223|FG000|Overall Study|Adverse Event|2|||
147331502|NCT01093534|531379224|FG001|Overall Study|Adverse Event|5|||
147331503|NCT01093534|531379225|FG002|Overall Study|Adverse Event|2|||
147331504|NCT01093534|531379223|FG000|Overall Study|Lack of Efficacy|2|||
147331505|NCT01093534|531379224|FG001|Overall Study|Lack of Efficacy|1|||
147331506|NCT01093534|531379225|FG002|Overall Study|Lack of Efficacy|1|||
147331507|NCT01093534|531379223|FG000|Overall Study|Withdrawal by Subject|5|||
147331508|NCT01093534|531379224|FG001|Overall Study|Withdrawal by Subject|7|||
147331509|NCT01093534|531379225|FG002|Overall Study|Withdrawal by Subject|2|||
147331510|NCT01093534|531379223|FG000|Overall Study|Other|1|||
147331511|NCT01093534|531379224|FG001|Overall Study|Other|3|||
147331512|NCT01093534|531379225|FG002|Overall Study|Other|4|||
147331513|NCT00811057|531379226|FG000|Overall Study|Protocol Violation|5|||
147331514|NCT00811057|531379227|FG001|Overall Study|Protocol Violation|10|||
147331515|NCT00811057|531379228|FG002|Overall Study|Protocol Violation|10|||
147331516|NCT00768651|531379229|FG000|Overall Study|Withdrawal by Subject|1|||
147331517|NCT00995709|531379234|FG000|Overall Study|Adverse Event|4|||
147331518|NCT00995709|531379235|FG001|Overall Study|Adverse Event|2|||
147331519|NCT00995709|531379236|FG002|Overall Study|Adverse Event|0|||
147331520|NCT00995709|531379234|FG000|Overall Study|Lack of Efficacy|0|||
147250890|NCT02643082|531088344|FG001|Period 1|Adverse Event|0|||
147250891|NCT00881712|531088345|FG000|Overall Study|Death|1|||
147250892|NCT00881712|531088346|FG001|Overall Study|Death|0|||
147250893|NCT00881712|531088347|FG002|Overall Study|Death|0|||
147250894|NCT00881712|531088345|FG000|Overall Study|Withdrawal by Subject|1|||
147250895|NCT00881712|531088346|FG001|Overall Study|Withdrawal by Subject|0|||
147331521|NCT00995709|531379235|FG001|Overall Study|Lack of Efficacy|1|||
147331522|NCT00995709|531379236|FG002|Overall Study|Lack of Efficacy|4|||
147250896|NCT00881712|531088347|FG002|Overall Study|Withdrawal by Subject|0|||
147250897|NCT01324999|531088348|FG000|Overall Study|Adverse Event|3|||
147250898|NCT01324999|531088348|FG000|Overall Study|Withdrawal by Subject|2|||
147250899|NCT02505867|531088350|FG000|Overall Study|Lack of Efficacy|6|||
147250900|NCT02505867|531088351|FG001|Overall Study|Lack of Efficacy|6|||
147250901|NCT00230607|531088356|FG000|Overall Study|Other|3|||
147250902|NCT02860169|531088357|FG000|Part A|Withdrawal by Subject|1|||
147250903|NCT02860169|531088357|FG000|Part A|Other (Screening failure)|6|||
147250904|NCT02860169|531088357|FG000|Part A|Other (Survey not completed)|3|||
147250905|NCT02860169|531088357|FG000|Part A|Other (did not completed consent)|1|||
147250906|NCT02860169|531088357|FG000|Part B|Other (Screening failure)|10|||
147250907|NCT02860169|531088357|FG000|Part B|Withdrawal by Subject|1|||
147250908|NCT02860169|531088357|FG000|Part C|Other (Screening failure)|1|||
147250909|NCT00165776|531088358|FG000|Overall Study|Lack of Efficacy|0|||
147250910|NCT00165776|531088359|FG001|Overall Study|Lack of Efficacy|0|||
147250911|NCT00165776|531088360|FG002|Overall Study|Lack of Efficacy|0|||
147250912|NCT00165776|531088361|FG003|Overall Study|Lack of Efficacy|1|||
147250913|NCT00165776|531088358|FG000|Overall Study|Withdrawal by Subject|4|||
147250914|NCT00165776|531088359|FG001|Overall Study|Withdrawal by Subject|1|||
147250915|NCT00165776|531088360|FG002|Overall Study|Withdrawal by Subject|2|||
147250916|NCT00165776|531088361|FG003|Overall Study|Withdrawal by Subject|0|||
147250917|NCT00165776|531088358|FG000|Overall Study|Worsening of Cervical Dystonia|0|||
147250918|NCT00165776|531088359|FG001|Overall Study|Worsening of Cervical Dystonia|0|||
147250919|NCT00165776|531088360|FG002|Overall Study|Worsening of Cervical Dystonia|0|||
147250920|NCT00165776|531088361|FG003|Overall Study|Worsening of Cervical Dystonia|1|||
147250921|NCT01648205|531088369|FG000|Placebo|Pregnancy|1|||
147250922|NCT01648205|531088369|FG000|Placebo|Withdrawal by Subject|1|||
147250923|NCT01648205|531088369|FG000|Placebo|Protocol Violation|2|||
147250924|NCT01648205|531088369|FG000|Ranolazine|Death|1|||
147250925|NCT01648205|531088369|FG000|Ranolazine|Withdrawal by Subject|1|||
147597060|NCT01006135|532343306|FG000|Overall Study|Other|72|||
147597061|NCT01732484|532343308|FG000|Overall Study|Death|7|||
147250926|NCT01648205|531088369|FG000|Ranolazine|Protocol Violation|3|||
147250927|NCT00203996|531088370|FG000|Overall Study|Lost to Follow-up|0|||
147597062|NCT01732484|532343308|FG000|Overall Study|Lost to Follow-up|14|||
147597063|NCT01732484|532343308|FG000|Overall Study|chronical illness|5|||
147597064|NCT01087489|532343309|FG000|Overall Study|enrolled in another VA study|0|||
147597065|NCT01087489|532343310|FG001|Overall Study|enrolled in another VA study|1|||
147597066|NCT01087489|532343309|FG000|Overall Study|Death|0|||
147597067|NCT01087489|532343310|FG001|Overall Study|Death|1|||
147597068|NCT01087489|532343309|FG000|Overall Study|unable to survey by telephone|0|||
147597069|NCT01087489|532343310|FG001|Overall Study|unable to survey by telephone|1|||
147597070|NCT02272634|532343319|FG000|Overall Study|Adverse Event|1|||
147597071|NCT02272634|532343320|FG001|Overall Study|Adverse Event|0|||
147597072|NCT02272634|532343321|FG002|Overall Study|Adverse Event|0|||
147597073|NCT02272634|532343319|FG000|Overall Study|Protocol Violation|0|||
147597074|NCT02272634|532343320|FG001|Overall Study|Protocol Violation|0|||
147597075|NCT02272634|532343321|FG002|Overall Study|Protocol Violation|1|||
147597076|NCT02272634|532343319|FG000|Overall Study|Withdrawal by Subject|0|||
147597077|NCT02272634|532343320|FG001|Overall Study|Withdrawal by Subject|1|||
147597078|NCT02272634|532343321|FG002|Overall Study|Withdrawal by Subject|0|||
147597079|NCT04620135|532343322|FG000|Study Completion|Adverse Event|2|||
147597080|NCT04620135|532343323|FG001|Study Completion|Adverse Event|3|||
147597081|NCT04620135|532343322|FG000|Study Completion|Withdrawal by Subject|2|||
147597082|NCT04620135|532343323|FG001|Study Completion|Withdrawal by Subject|0|||
147250928|NCT00203996|531088371|FG001|Overall Study|Lost to Follow-up|0|||
147250929|NCT00203996|531088372|FG002|Overall Study|Lost to Follow-up|0|||
147250930|NCT00203996|531088373|FG003|Overall Study|Lost to Follow-up|1|||
147250931|NCT00203996|531088374|FG004|Overall Study|Lost to Follow-up|0|||
147250932|NCT00203996|531088375|FG005|Overall Study|Lost to Follow-up|0|||
147250933|NCT00203996|531088376|FG006|Overall Study|Lost to Follow-up|0|||
147597083|NCT01437943|532343324|FG000|Overall Study|Aliskiren trials terminated by Novartis|4|||
147660522|NCT02058589|532579935|FG001|Overall Study|Withdrawal by Subject|1|||
147660523|NCT00490971|532579937|FG000|Acute/Continuation|Adverse Event|62|||
147250934|NCT00203996|531088377|FG007|Overall Study|Lost to Follow-up|0|||
147250935|NCT00203996|531088378|FG008|Overall Study|Lost to Follow-up|0|||
147250936|NCT00203996|531088379|FG009|Overall Study|Lost to Follow-up|0|||
147250937|NCT00203996|531088370|FG000|Overall Study|Protocol Violation|0|||
147250938|NCT00203996|531088371|FG001|Overall Study|Protocol Violation|0|||
147597084|NCT01437943|532343325|FG001|Overall Study|Aliskiren trials terminated by Novartis|2|||
147597085|NCT01437943|532343324|FG000|Overall Study|Subject expressed pregnancy plans|1|||
147597086|NCT01437943|532343325|FG001|Overall Study|Subject expressed pregnancy plans|0|||
147597087|NCT01437943|532343324|FG000|Overall Study|Adverse Event|2|||
147660524|NCT00490971|532579938|FG001|Acute/Continuation|Adverse Event|13|||
147250939|NCT00203996|531088372|FG002|Overall Study|Protocol Violation|0|||
147250940|NCT00203996|531088373|FG003|Overall Study|Protocol Violation|6|||
147250941|NCT00203996|531088374|FG004|Overall Study|Protocol Violation|1|||
147250942|NCT00203996|531088375|FG005|Overall Study|Protocol Violation|0|||
147597088|NCT01437943|532343325|FG001|Overall Study|Adverse Event|0|||
147250943|NCT00203996|531088376|FG006|Overall Study|Protocol Violation|0|||
147250944|NCT00203996|531088377|FG007|Overall Study|Protocol Violation|0|||
147250945|NCT00203996|531088378|FG008|Overall Study|Protocol Violation|0|||
147250946|NCT00203996|531088379|FG009|Overall Study|Protocol Violation|0|||
147250947|NCT00203996|531088370|FG000|Overall Study|Physician Decision|0|||
147250948|NCT00203996|531088371|FG001|Overall Study|Physician Decision|0|||
147250949|NCT00203996|531088372|FG002|Overall Study|Physician Decision|0|||
147250950|NCT00203996|531088373|FG003|Overall Study|Physician Decision|2|||
147250951|NCT00203996|531088374|FG004|Overall Study|Physician Decision|0|||
147250952|NCT00203996|531088375|FG005|Overall Study|Physician Decision|0|||
147250953|NCT00203996|531088376|FG006|Overall Study|Physician Decision|0|||
147250954|NCT00203996|531088377|FG007|Overall Study|Physician Decision|0|||
147250955|NCT00203996|531088378|FG008|Overall Study|Physician Decision|0|||
147250956|NCT00203996|531088379|FG009|Overall Study|Physician Decision|1|||
147250957|NCT00203996|531088370|FG000|Overall Study|CPAP machine malfunction|0|||
147250958|NCT00203996|531088371|FG001|Overall Study|CPAP machine malfunction|0|||
147250959|NCT00203996|531088372|FG002|Overall Study|CPAP machine malfunction|0|||
147250960|NCT00203996|531088373|FG003|Overall Study|CPAP machine malfunction|1|||
147250961|NCT00203996|531088374|FG004|Overall Study|CPAP machine malfunction|0|||
147250962|NCT00203996|531088375|FG005|Overall Study|CPAP machine malfunction|0|||
147250963|NCT00203996|531088376|FG006|Overall Study|CPAP machine malfunction|0|||
147250964|NCT00203996|531088377|FG007|Overall Study|CPAP machine malfunction|0|||
147250965|NCT00203996|531088378|FG008|Overall Study|CPAP machine malfunction|0|||
147250966|NCT00203996|531088379|FG009|Overall Study|CPAP machine malfunction|0|||
147250967|NCT00203996|531088370|FG000|Overall Study|Scheduling issue|0|||
147250968|NCT00203996|531088371|FG001|Overall Study|Scheduling issue|0|||
147250969|NCT00203996|531088372|FG002|Overall Study|Scheduling issue|0|||
147250970|NCT00203996|531088373|FG003|Overall Study|Scheduling issue|0|||
147250971|NCT00203996|531088374|FG004|Overall Study|Scheduling issue|0|||
147250972|NCT00203996|531088375|FG005|Overall Study|Scheduling issue|0|||
147250973|NCT00203996|531088376|FG006|Overall Study|Scheduling issue|0|||
147250974|NCT00203996|531088377|FG007|Overall Study|Scheduling issue|2|||
147250975|NCT00203996|531088378|FG008|Overall Study|Scheduling issue|0|||
147250976|NCT00203996|531088379|FG009|Overall Study|Scheduling issue|0|||
147250977|NCT00897104|531088382|FG000|Overall Study|Lost to Follow-up|12|||
147250978|NCT00897104|531088383|FG001|Overall Study|Lost to Follow-up|17|||
147250979|NCT00897104|531088384|FG002|Overall Study|Lost to Follow-up|2|||
147250980|NCT00897104|531088382|FG000|Overall Study|Pregnancy|0|||
147250981|NCT00897104|531088383|FG001|Overall Study|Pregnancy|1|||
147250982|NCT00897104|531088384|FG002|Overall Study|Pregnancy|0|||
147250983|NCT00897104|531088382|FG000|Overall Study|Protocol Violation|0|||
147250984|NCT00897104|531088383|FG001|Overall Study|Protocol Violation|1|||
147250985|NCT00897104|531088384|FG002|Overall Study|Protocol Violation|0|||
147250986|NCT00897104|531088382|FG000|Overall Study|Withdrawal by Subject|23|||
147250987|NCT00897104|531088383|FG001|Overall Study|Withdrawal by Subject|27|||
147250988|NCT00897104|531088384|FG002|Overall Study|Withdrawal by Subject|3|||
147250989|NCT00897104|531088382|FG000|Overall Study|Abnormal Prestudy Labs|2|||
147250990|NCT00897104|531088383|FG001|Overall Study|Abnormal Prestudy Labs|0|||
147250991|NCT00897104|531088384|FG002|Overall Study|Abnormal Prestudy Labs|0|||
147250992|NCT00897104|531088382|FG000|Overall Study|Abnormal Baseline ECG|2|||
147250993|NCT00897104|531088383|FG001|Overall Study|Abnormal Baseline ECG|2|||
147250994|NCT00897104|531088384|FG002|Overall Study|Abnormal Baseline ECG|0|||
147250995|NCT00897104|531088382|FG000|Overall Study|Need for Concom. Med.|0|||
147250996|NCT00897104|531088383|FG001|Overall Study|Need for Concom. Med.|1|||
147250997|NCT00897104|531088384|FG002|Overall Study|Need for Concom. Med.|1|||
147250998|NCT00897104|531088382|FG000|Overall Study|Lack of Migraine Attack|20|||
147250999|NCT00897104|531088383|FG001|Overall Study|Lack of Migraine Attack|22|||
147251000|NCT00897104|531088384|FG002|Overall Study|Lack of Migraine Attack|1|||
147251001|NCT00897104|531088382|FG000|Overall Study|No Longer Met Inc/Exc Criteria|1|||
147251002|NCT00897104|531088383|FG001|Overall Study|No Longer Met Inc/Exc Criteria|0|||
147251003|NCT00897104|531088384|FG002|Overall Study|No Longer Met Inc/Exc Criteria|0|||
147251004|NCT00897104|531088382|FG000|Overall Study|Other|3|||
147251005|NCT00897104|531088383|FG001|Overall Study|Other|0|||
147251006|NCT00897104|531088384|FG002|Overall Study|Other|0|||
147597089|NCT00502801|532343326|FG000|Treatment Period|Withdrawal by Subject|3|||
147597090|NCT00502801|532343326|FG000|Treatment Period|Adverse Event|7|||
147251007|NCT00897104|531088382|FG000|Overall Study|Protocol Violation|1|||
147251008|NCT00897104|531088383|FG001|Overall Study|Protocol Violation|0|||
147251009|NCT00897104|531088384|FG002|Overall Study|Protocol Violation|0|||
147251010|NCT00897104|531088382|FG000|Overall Study|Withdrawal by Subject|0|||
147251011|NCT00897104|531088383|FG001|Overall Study|Withdrawal by Subject|0|||
147251012|NCT00897104|531088384|FG002|Overall Study|Withdrawal by Subject|1|||
147251013|NCT01937559|531088385|FG000|Overall Study|Physician Decision|3|||
147597091|NCT00502801|532343326|FG000|Treatment Period|Death|14|||
147597092|NCT00502801|532343326|FG000|Treatment Period|OTHER|30|||
147251014|NCT01937559|531088386|FG001|Overall Study|Physician Decision|3|||
147251015|NCT01937559|531088387|FG002|Overall Study|Physician Decision|0|||
147251016|NCT01937559|531088385|FG000|Overall Study|Withdrawal by Subject|6|||
147251017|NCT01937559|531088386|FG001|Overall Study|Withdrawal by Subject|4|||
147251018|NCT01937559|531088387|FG002|Overall Study|Withdrawal by Subject|0|||
147251019|NCT01937559|531088385|FG000|Overall Study|screen fail|2|||
147251020|NCT01937559|531088386|FG001|Overall Study|screen fail|4|||
147251021|NCT01937559|531088387|FG002|Overall Study|screen fail|0|||
147251022|NCT02167893|531088388|FG000|Overall Study|Investigator transferred|85|||
147251023|NCT02167893|531088388|FG000|Overall Study|Investigator health reasons|10|||
147251024|NCT02167893|531088388|FG000|Overall Study|Case report forms not collected|68|||
147251025|NCT04818840|531088389|FG000|Overall Study|Lost to Follow-up|0|||
147251026|NCT04818840|531088390|FG001|Overall Study|Lost to Follow-up|5|||
147251027|NCT04818840|531088389|FG000|Overall Study|Physician Decision|1|||
147251028|NCT04818840|531088390|FG001|Overall Study|Physician Decision|0|||
147251029|NCT04818840|531088389|FG000|Overall Study|Site Terminated by Sponsor|0|||
147251030|NCT04818840|531088390|FG001|Overall Study|Site Terminated by Sponsor|3|||
147251031|NCT04818840|531088389|FG000|Overall Study|Study Terminated by Sponsor|43|||
147251032|NCT04818840|531088390|FG001|Overall Study|Study Terminated by Sponsor|7|||
147331523|NCT00995709|531379234|FG000|Overall Study|Withdrawal by Subject|0|||
147331524|NCT00995709|531379235|FG001|Overall Study|Withdrawal by Subject|4|||
147331525|NCT00995709|531379236|FG002|Overall Study|Withdrawal by Subject|1|||
147331526|NCT00995709|531379234|FG000|Overall Study|Lost to Follow-up|1|||
147331527|NCT00995709|531379235|FG001|Overall Study|Lost to Follow-up|0|||
147331528|NCT00995709|531379236|FG002|Overall Study|Lost to Follow-up|0|||
147331529|NCT00995709|531379234|FG000|Overall Study|Death|0|||
147331530|NCT00995709|531379235|FG001|Overall Study|Death|1|||
147331531|NCT00995709|531379236|FG002|Overall Study|Death|0|||
147331532|NCT00995709|531379234|FG000|Overall Study|Protocol Violation|2|||
147331533|NCT00995709|531379235|FG001|Overall Study|Protocol Violation|1|||
147331534|NCT00995709|531379236|FG002|Overall Study|Protocol Violation|0|||
147331535|NCT03008915|531379239|FG000|Treatment 1|Withdrawal by Subject|0|||
147331536|NCT03008915|531379240|FG001|Treatment 1|Withdrawal by Subject|1|||
147331537|NCT00712166|531379241|FG000|Overall Study|Noncompliance|0|||
147331538|NCT00712166|531379242|FG001|Overall Study|Noncompliance|1|||
147331539|NCT01773122|531379243|FG000|Overall Study|Due to amended age eligibility criteria|3|||
147331540|NCT01773122|531379244|FG001|Overall Study|Due to amended age eligibility criteria|1|||
147449911|NCT00880893|531811308|FG001|Overall Study|Withdrawal by Subject|11|||
147449912|NCT00880893|531811307|FG000|Overall Study|Lost to Follow-up|76|||
147449913|NCT00880893|531811308|FG001|Overall Study|Lost to Follow-up|33|||
147251033|NCT04818840|531088389|FG000|Overall Study|Withdrawal by Subject|0|||
147251034|NCT04818840|531088390|FG001|Overall Study|Withdrawal by Subject|1|||
147251035|NCT00733408|531090037|FG000|Overall Study|Adverse Event|4|||
147251036|NCT00531232|531090038|FG000|Overall Study|Investigator decision|0|||
147251037|NCT00531232|531090039|FG001|Overall Study|Investigator decision|0|||
147251038|NCT00531232|531090040|FG002|Overall Study|Investigator decision|4|||
147251039|NCT00531232|531090038|FG000|Overall Study|Participants refused further treatment|0|||
147251040|NCT00531232|531090039|FG001|Overall Study|Participants refused further treatment|1|||
147251041|NCT00531232|531090040|FG002|Overall Study|Participants refused further treatment|2|||
147251042|NCT00531232|531090038|FG000|Overall Study|Adverse events (AEs)|1|||
147251043|NCT00531232|531090039|FG001|Overall Study|Adverse events (AEs)|2|||
147251044|NCT00531232|531090040|FG002|Overall Study|Adverse events (AEs)|2|||
147251045|NCT00531232|531090038|FG000|Overall Study|Treatment failure|1|||
147251046|NCT00531232|531090039|FG001|Overall Study|Treatment failure|3|||
147251047|NCT00531232|531090040|FG002|Overall Study|Treatment failure|7|||
147251048|NCT00531232|531090038|FG000|Overall Study|Disease recurrence|0|||
147251049|NCT00531232|531090039|FG001|Overall Study|Disease recurrence|0|||
147251050|NCT00531232|531090040|FG002|Overall Study|Disease recurrence|1|||
147251051|NCT00531232|531090038|FG000|Overall Study|Deceased|2|||
147251052|NCT00531232|531090039|FG001|Overall Study|Deceased|2|||
147251053|NCT00531232|531090040|FG002|Overall Study|Deceased|2|||
147251054|NCT00531232|531090038|FG000|Overall Study|Withdrawal by Subject|0|||
147251055|NCT00531232|531090039|FG001|Overall Study|Withdrawal by Subject|1|||
147251056|NCT00531232|531090040|FG002|Overall Study|Withdrawal by Subject|2|||
147251057|NCT00531232|531090038|FG000|Overall Study|Other|0|||
147251058|NCT00531232|531090039|FG001|Overall Study|Other|0|||
147251059|NCT00531232|531090040|FG002|Overall Study|Other|5|||
147251060|NCT01438424|531090041|FG000|Overall Study|Continuing treatment|29|||
147251061|NCT01438424|531090041|FG000|Overall Study|Minimal virologic response|95|||
147251062|NCT01438424|531090041|FG000|Overall Study|Not identified|55|||
147331541|NCT01773122|531379245|FG002|Overall Study|Due to amended age eligibility criteria|0|||
147331542|NCT01773122|531379246|FG003|Overall Study|Due to amended age eligibility criteria|1|||
147331543|NCT01769391|531379247|FG000|Overall Study|Death|10|||
147251063|NCT01438424|531090041|FG000|Overall Study|Withdrawal by Subject|104|||
147251064|NCT01438424|531090041|FG000|Overall Study|Progression of chronic hepatitis B|22|||
147251065|NCT01438424|531090041|FG000|Overall Study|Death|22|||
147251066|NCT01438424|531090041|FG000|Overall Study|Adverse Event|17|||
147331544|NCT01769391|531379248|FG001|Overall Study|Death|1|||
147331545|NCT01769391|531379247|FG000|Overall Study|Adverse Event|0|||
147449914|NCT00880893|531811307|FG000|Overall Study|Serious adverse event|3|||
147251067|NCT01438424|531090041|FG000|Overall Study|Lost to Follow-up|17|||
147331546|NCT01769391|531379248|FG001|Overall Study|Adverse Event|3|||
147597093|NCT00502801|532343326|FG000|End of Therapy to Test of Cure|Withdrawal by Subject|1|||
147597094|NCT00502801|532343326|FG000|End of Therapy to Test of Cure|Lost to Follow-up|2|||
147597095|NCT00502801|532343326|FG000|End of Therapy to Test of Cure|Death|3|||
147597096|NCT00502801|532343326|FG000|End of Therapy to Test of Cure|OTHER|2|||
147597097|NCT03176459|532343329|FG000|Overall Study|Lost to Follow-up|5|||
147597098|NCT03176459|532343330|FG001|Overall Study|Lost to Follow-up|7|||
147597099|NCT00446199|532343331|FG000|Overall Study|Adverse Event|7|||
147251068|NCT01438424|531090041|FG000|Overall Study|Abnormal laboratory test result|14|||
147251069|NCT01438424|531090041|FG000|Overall Study|Need for drug prohibited by protocol|14|||
147251070|NCT01438424|531090041|FG000|Overall Study|Pregnancy|7|||
147251071|NCT01438424|531090041|FG000|Overall Study|No longer met inclusion criteria|1|||
147251072|NCT01438424|531090041|FG000|Overall Study|Participant noncompliance|20|||
147251073|NCT04232124|531090042|FG000|Overall Study|Lost to Follow-up|3|||
147251074|NCT02329730|531090048|FG000|Overall Study|Protocol Violation|0|||
147251075|NCT02329730|531090049|FG001|Overall Study|Protocol Violation|0|||
147251076|NCT02329730|531090050|FG002|Overall Study|Protocol Violation|0|||
147251077|NCT02329730|531090051|FG003|Overall Study|Protocol Violation|0|||
147251078|NCT02329730|531090052|FG004|Overall Study|Protocol Violation|2|||
147251079|NCT02329730|531090053|FG005|Overall Study|Protocol Violation|2|||
147251080|NCT02329730|531090054|FG006|Overall Study|Protocol Violation|0|||
147251081|NCT02329730|531090055|FG007|Overall Study|Protocol Violation|0|||
147251082|NCT02329730|531090056|FG008|Overall Study|Protocol Violation|0|||
147251083|NCT02329730|531090057|FG009|Overall Study|Protocol Violation|0|||
147251084|NCT02329730|531090058|FG010|Overall Study|Protocol Violation|0|||
147251085|NCT02329730|531090059|FG011|Overall Study|Protocol Violation|0|||
147251086|NCT02329730|531090048|FG000|Overall Study|Withdrawal by Subject|0|||
147251087|NCT02329730|531090049|FG001|Overall Study|Withdrawal by Subject|0|||
147251088|NCT02329730|531090050|FG002|Overall Study|Withdrawal by Subject|0|||
147251089|NCT02329730|531090051|FG003|Overall Study|Withdrawal by Subject|0|||
147251090|NCT02329730|531090052|FG004|Overall Study|Withdrawal by Subject|1|||
147251091|NCT02329730|531090053|FG005|Overall Study|Withdrawal by Subject|0|||
147251092|NCT02329730|531090054|FG006|Overall Study|Withdrawal by Subject|1|||
147251093|NCT02329730|531090055|FG007|Overall Study|Withdrawal by Subject|1|||
147251094|NCT02329730|531090056|FG008|Overall Study|Withdrawal by Subject|1|||
147251095|NCT02329730|531090057|FG009|Overall Study|Withdrawal by Subject|1|||
147251096|NCT02329730|531090058|FG010|Overall Study|Withdrawal by Subject|0|||
147251097|NCT02329730|531090059|FG011|Overall Study|Withdrawal by Subject|0|||
147251098|NCT02345850|531090062|FG000|Overall Study|Not transplanted|10|||
147251099|NCT02345850|531090063|FG001|Overall Study|Not transplanted|5|||
147251100|NCT02345850|531090064|FG002|Overall Study|Not transplanted|4|||
147251101|NCT02345850|531090062|FG000|Overall Study|Lost to Follow-up|2|||
147251102|NCT02345850|531090063|FG001|Overall Study|Lost to Follow-up|3|||
147251103|NCT02345850|531090064|FG002|Overall Study|Lost to Follow-up|2|||
147251104|NCT02345850|531090062|FG000|Overall Study|Withdrawal by Subject|1|||
147251105|NCT02345850|531090063|FG001|Overall Study|Withdrawal by Subject|0|||
147251106|NCT02345850|531090064|FG002|Overall Study|Withdrawal by Subject|0|||
147251107|NCT02392247|531090067|FG000|Overall Study|Withdrawal by Subject|1|||
147251108|NCT02392247|531090067|FG000|Overall Study|Surgery cancelled; no data|1|||
147251109|NCT02927080|531090068|FG000|Overall Study|Withdrawal by Subject|0|||
147251110|NCT02927080|531090069|FG001|Overall Study|Withdrawal by Subject|0|||
147251111|NCT02927080|531090070|FG002|Overall Study|Withdrawal by Subject|0|||
147251112|NCT02927080|531090071|FG003|Overall Study|Withdrawal by Subject|0|||
147251113|NCT02927080|531090072|FG004|Overall Study|Withdrawal by Subject|1|||
147251114|NCT02927080|531090073|FG005|Overall Study|Withdrawal by Subject|0|||
147251115|NCT02927080|531090074|FG006|Overall Study|Withdrawal by Subject|1|||
147251116|NCT02927080|531090075|FG007|Overall Study|Withdrawal by Subject|1|||
147251117|NCT02927080|531090076|FG008|Overall Study|Withdrawal by Subject|0|||
147251118|NCT02927080|531090077|FG009|Overall Study|Withdrawal by Subject|2|||
147331547|NCT01769391|531379247|FG000|Overall Study|Progressive Disease|1|||
147597100|NCT00446199|532343332|FG001|Overall Study|Adverse Event|4|||
147597101|NCT00446199|532343333|FG002|Overall Study|Adverse Event|6|||
147597102|NCT00446199|532343334|FG003|Overall Study|Adverse Event|4|||
147597103|NCT00446199|532343331|FG000|Overall Study|Lost to Follow-up|4|||
147251119|NCT02927080|531090068|FG000|Overall Study|Willingness to comply with protocol|0|||
147251120|NCT02927080|531090069|FG001|Overall Study|Willingness to comply with protocol|0|||
147251121|NCT02927080|531090070|FG002|Overall Study|Willingness to comply with protocol|0|||
147251122|NCT02927080|531090071|FG003|Overall Study|Willingness to comply with protocol|0|||
147251123|NCT02927080|531090072|FG004|Overall Study|Willingness to comply with protocol|0|||
147251124|NCT02927080|531090073|FG005|Overall Study|Willingness to comply with protocol|0|||
147251125|NCT02927080|531090074|FG006|Overall Study|Willingness to comply with protocol|0|||
147251126|NCT02927080|531090075|FG007|Overall Study|Willingness to comply with protocol|0|||
147597104|NCT00446199|532343332|FG001|Overall Study|Lost to Follow-up|5|||
147597105|NCT00446199|532343333|FG002|Overall Study|Lost to Follow-up|2|||
147597106|NCT00446199|532343334|FG003|Overall Study|Lost to Follow-up|6|||
147251127|NCT02927080|531090076|FG008|Overall Study|Willingness to comply with protocol|0|||
147331548|NCT01769391|531379248|FG001|Overall Study|Progressive Disease|2|||
147251128|NCT02927080|531090077|FG009|Overall Study|Willingness to comply with protocol|1|||
147251129|NCT02927080|531090068|FG000|Overall Study|Study terminated by Sponsor|0|||
147251130|NCT02927080|531090069|FG001|Overall Study|Study terminated by Sponsor|0|||
147251131|NCT02927080|531090070|FG002|Overall Study|Study terminated by Sponsor|0|||
147251132|NCT02927080|531090071|FG003|Overall Study|Study terminated by Sponsor|0|||
147251133|NCT02927080|531090072|FG004|Overall Study|Study terminated by Sponsor|0|||
147597107|NCT00446199|532343331|FG000|Overall Study|Protocol Violation|1|||
147597108|NCT00446199|532343332|FG001|Overall Study|Protocol Violation|2|||
147597109|NCT00446199|532343333|FG002|Overall Study|Protocol Violation|1|||
147597110|NCT00446199|532343334|FG003|Overall Study|Protocol Violation|3|||
147597111|NCT00446199|532343331|FG000|Overall Study|Withdrawal by Subject|2|||
147597112|NCT00446199|532343332|FG001|Overall Study|Withdrawal by Subject|5|||
147597113|NCT00446199|532343333|FG002|Overall Study|Withdrawal by Subject|9|||
147597114|NCT00446199|532343334|FG003|Overall Study|Withdrawal by Subject|10|||
147597115|NCT00446199|532343331|FG000|Overall Study|Site termination|2|||
147597116|NCT00446199|532343332|FG001|Overall Study|Site termination|0|||
147597117|NCT00446199|532343333|FG002|Overall Study|Site termination|0|||
147597118|NCT00446199|532343334|FG003|Overall Study|Site termination|1|||
147597119|NCT00446199|532343331|FG000|Overall Study|Randomization in Error|2|||
147597120|NCT00446199|532343332|FG001|Overall Study|Randomization in Error|0|||
147597121|NCT00446199|532343333|FG002|Overall Study|Randomization in Error|1|||
147597122|NCT00446199|532343334|FG003|Overall Study|Randomization in Error|1|||
147597123|NCT00446199|532343331|FG000|Overall Study|Lack of Efficacy|1|||
147597124|NCT00446199|532343332|FG001|Overall Study|Lack of Efficacy|0|||
147597125|NCT00446199|532343333|FG002|Overall Study|Lack of Efficacy|0|||
147597126|NCT00446199|532343334|FG003|Overall Study|Lack of Efficacy|1|||
147597127|NCT00446199|532343331|FG000|Overall Study|Non-compliant with study drug|1|||
147597128|NCT00446199|532343332|FG001|Overall Study|Non-compliant with study drug|0|||
147597129|NCT00446199|532343333|FG002|Overall Study|Non-compliant with study drug|5|||
147597130|NCT00446199|532343334|FG003|Overall Study|Non-compliant with study drug|0|||
147597131|NCT00446199|532343331|FG000|Overall Study|Non-compliant with visit schedule|1|||
147597132|NCT00446199|532343332|FG001|Overall Study|Non-compliant with visit schedule|1|||
147597133|NCT00446199|532343333|FG002|Overall Study|Non-compliant with visit schedule|1|||
147597134|NCT00446199|532343334|FG003|Overall Study|Non-compliant with visit schedule|2|||
147597135|NCT00446199|532343331|FG000|Overall Study|Hormone fear|0|||
147597136|NCT00446199|532343332|FG001|Overall Study|Hormone fear|0|||
147597137|NCT00446199|532343333|FG002|Overall Study|Hormone fear|0|||
147597138|NCT00446199|532343334|FG003|Overall Study|Hormone fear|1|||
147597139|NCT00446199|532343331|FG000|Overall Study|Lost interest in study participation|0|||
147597140|NCT00446199|532343332|FG001|Overall Study|Lost interest in study participation|1|||
147597141|NCT00446199|532343333|FG002|Overall Study|Lost interest in study participation|0|||
147660525|NCT00490971|532579939|FG002|Acute/Continuation|Adverse Event|0|||
147251134|NCT02927080|531090073|FG005|Overall Study|Study terminated by Sponsor|0|||
147251135|NCT02927080|531090074|FG006|Overall Study|Study terminated by Sponsor|6|||
147251136|NCT02927080|531090075|FG007|Overall Study|Study terminated by Sponsor|7|||
147251137|NCT02927080|531090076|FG008|Overall Study|Study terminated by Sponsor|2|||
147251138|NCT02927080|531090077|FG009|Overall Study|Study terminated by Sponsor|3|||
147251139|NCT02927080|531090068|FG000|Overall Study|Adverse Event|0|||
147251140|NCT02927080|531090069|FG001|Overall Study|Adverse Event|1|||
147251141|NCT02927080|531090070|FG002|Overall Study|Adverse Event|0|||
147251142|NCT02927080|531090071|FG003|Overall Study|Adverse Event|0|||
147251143|NCT02927080|531090072|FG004|Overall Study|Adverse Event|0|||
147251144|NCT02927080|531090073|FG005|Overall Study|Adverse Event|0|||
147251145|NCT02927080|531090074|FG006|Overall Study|Adverse Event|0|||
147251146|NCT02927080|531090075|FG007|Overall Study|Adverse Event|1|||
147251147|NCT02927080|531090076|FG008|Overall Study|Adverse Event|0|||
147251148|NCT02927080|531090077|FG009|Overall Study|Adverse Event|1|||
147251149|NCT02927080|531090068|FG000|Overall Study|Other|0|||
147251150|NCT02927080|531090069|FG001|Overall Study|Other|0|||
147251151|NCT02927080|531090070|FG002|Overall Study|Other|0|||
147251152|NCT02927080|531090071|FG003|Overall Study|Other|0|||
147597142|NCT00446199|532343334|FG003|Overall Study|Lost interest in study participation|0|||
147597143|NCT00446199|532343331|FG000|Overall Study|In-/Exclusion criterion violated|2|||
147597144|NCT00446199|532343332|FG001|Overall Study|In-/Exclusion criterion violated|1|||
147660526|NCT00490971|532579940|FG003|Acute/Continuation|Adverse Event|0|||
147660527|NCT00490971|532579941|FG004|Acute/Continuation|Adverse Event|0|||
147251153|NCT02927080|531090072|FG004|Overall Study|Other|0|||
147251154|NCT02927080|531090073|FG005|Overall Study|Other|0|||
147251155|NCT02927080|531090074|FG006|Overall Study|Other|1|||
147251156|NCT02927080|531090075|FG007|Overall Study|Other|0|||
147251157|NCT02927080|531090076|FG008|Overall Study|Other|1|||
147251158|NCT02927080|531090077|FG009|Overall Study|Other|0|||
147251159|NCT01991067|531090079|FG000|Overall Study|Lost to Follow-up|6|||
147251160|NCT01991067|531090080|FG001|Overall Study|Lost to Follow-up|5|||
147251161|NCT00224055|531090083|FG000|Overall Study|Adverse Event|9|||
147251162|NCT00224055|531090084|FG001|Overall Study|Adverse Event|3|||
147597145|NCT00446199|532343333|FG002|Overall Study|In-/Exclusion criterion violated|2|||
147660528|NCT00490971|532579937|FG000|Acute/Continuation|Death|2|||
147251163|NCT00224055|531090083|FG000|Overall Study|Lost to Follow-up|1|||
147251164|NCT00224055|531090084|FG001|Overall Study|Lost to Follow-up|2|||
147251165|NCT00224055|531090083|FG000|Overall Study|Protocol Violation|1|||
147251166|NCT00224055|531090084|FG001|Overall Study|Protocol Violation|1|||
147251167|NCT00224055|531090083|FG000|Overall Study|Inclusion Violation|3|||
147251168|NCT00224055|531090084|FG001|Overall Study|Inclusion Violation|6|||
147251169|NCT00224055|531090083|FG000|Overall Study|Withdrawal by Subject|0|||
147251170|NCT00224055|531090084|FG001|Overall Study|Withdrawal by Subject|2|||
147251171|NCT00224055|531090083|FG000|Overall Study|Other|1|||
147251172|NCT00224055|531090084|FG001|Overall Study|Other|0|||
147251173|NCT02068443|531090085|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
147251174|NCT02068443|531090086|FG001|Overall Study|Pretreatment Event/Adverse Event|5|||
147251175|NCT02068443|531090087|FG002|Overall Study|Pretreatment Event/Adverse Event|2|||
147251176|NCT02068443|531090085|FG000|Overall Study|Voluntary Withdrawal|4|||
147251177|NCT02068443|531090086|FG001|Overall Study|Voluntary Withdrawal|0|||
147251178|NCT02068443|531090087|FG002|Overall Study|Voluntary Withdrawal|1|||
147251179|NCT02068443|531090085|FG000|Overall Study|Lack of Efficacy|2|||
147251180|NCT02068443|531090086|FG001|Overall Study|Lack of Efficacy|1|||
147251181|NCT02068443|531090087|FG002|Overall Study|Lack of Efficacy|0|||
147251182|NCT02068443|531090085|FG000|Overall Study|Other Reason Not Specified|1|||
147597146|NCT00446199|532343334|FG003|Overall Study|In-/Exclusion criterion violated|1|||
147597147|NCT00446199|532343331|FG000|Overall Study|Move|0|||
147597148|NCT00446199|532343332|FG001|Overall Study|Move|1|||
147597149|NCT00446199|532343333|FG002|Overall Study|Move|0|||
147597150|NCT00446199|532343334|FG003|Overall Study|Move|0|||
147597151|NCT04221789|532345699|FG000|Overall Study|deviation from protoco|22|||
147597152|NCT04221789|532345700|FG001|Overall Study|deviation from protoco|8|||
147597153|NCT06077487|532345701|FG000|Overall Study|Withdrawal by Subject|0|||
147597154|NCT06077487|532345702|FG001|Overall Study|Withdrawal by Subject|1|||
147597155|NCT04385277|532345703|FG000|Overall Study|Physician Decision|2|||
147597156|NCT04385277|532345703|FG000|Overall Study|Ineligible|1|||
147597157|NCT04385277|532345703|FG000|Overall Study|Patient/Parent Refusal|2|||
147597158|NCT05101486|532345704|FG000|Overall Study|Death|1|||
147597159|NCT05101486|532345705|FG001|Overall Study|Death|0|||
147597160|NCT05101486|532345706|FG002|Overall Study|Death|1|||
147597161|NCT05101486|532345704|FG000|Overall Study|Lost to Follow-up|12|||
147597162|NCT05101486|532345705|FG001|Overall Study|Lost to Follow-up|8|||
147597163|NCT05101486|532345706|FG002|Overall Study|Lost to Follow-up|17|||
147597164|NCT05101486|532345704|FG000|Overall Study|Physician Decision|1|||
147597165|NCT05101486|532345705|FG001|Overall Study|Physician Decision|0|||
147597166|NCT05101486|532345706|FG002|Overall Study|Physician Decision|0|||
147597167|NCT05101486|532345704|FG000|Overall Study|Protocol Violation|0|||
147597168|NCT05101486|532345705|FG001|Overall Study|Protocol Violation|0|||
147597169|NCT05101486|532345706|FG002|Overall Study|Protocol Violation|1|||
147597170|NCT05101486|532345704|FG000|Overall Study|Withdrawal by Subject|5|||
147597171|NCT05101486|532345705|FG001|Overall Study|Withdrawal by Subject|2|||
147597172|NCT05101486|532345706|FG002|Overall Study|Withdrawal by Subject|4|||
147597173|NCT05101486|532345704|FG000|Overall Study|Randomized but not vaccinated|1|||
147597174|NCT05101486|532345705|FG001|Overall Study|Randomized but not vaccinated|1|||
147597175|NCT05101486|532345706|FG002|Overall Study|Randomized but not vaccinated|1|||
147597176|NCT02799095|532345707|FG000|Part A|Adverse Event|1|||
147597177|NCT02799095|532345708|FG001|Part A|Adverse Event|0|||
147597178|NCT02799095|532345709|FG002|Part A|Adverse Event|1|||
147597179|NCT02799095|532345710|FG003|Part A|Adverse Event|4|||
147597180|NCT02799095|532345711|FG004|Part A|Adverse Event|1|||
147597181|NCT02799095|532345712|FG005|Part A|Adverse Event|0|||
147597182|NCT02799095|532345713|FG006|Part A|Adverse Event|0|||
147597183|NCT02799095|532345714|FG007|Part A|Adverse Event|0|||
147660529|NCT00490971|532579938|FG001|Acute/Continuation|Death|0|||
147251183|NCT02068443|531090086|FG001|Overall Study|Other Reason Not Specified|0|||
147251184|NCT02068443|531090087|FG002|Overall Study|Other Reason Not Specified|0|||
147251185|NCT00664742|531090088|FG000|Overall Study|Withdrawn due to adverse events|3|||
147251186|NCT00664742|531090088|FG000|Overall Study|Withdrawal by Subject|31|||
147251187|NCT00664742|531090088|FG000|Overall Study|Lost to Follow-up|92|||
147251188|NCT04317066|531090089|FG000|Overall Study|Sponsor decision|5|||
147597184|NCT02799095|532345715|FG008|Part A|Adverse Event|0|||
147597185|NCT02799095|532345716|FG009|Part A|Adverse Event|0|||
147251189|NCT04317066|531090089|FG000|Overall Study|Death|2|||
147251190|NCT02014597|531090092|FG000|Overall Study|Unable to record log contrast sensitivity|2|||
147251191|NCT02014597|531090093|FG001|Overall Study|Unable to record log contrast sensitivity|1|||
147251192|NCT02825992|531090094|FG000|Overall Study|Withdrawal by Subject|4|||
147251193|NCT02825992|531090094|FG000|Overall Study|Lost to Follow-up|2|||
147251194|NCT02825992|531090094|FG000|Overall Study|Procedure terminated|2|||
147597186|NCT02799095|532345717|FG010|Part A|Adverse Event|0|||
147597187|NCT02799095|532345718|FG011|Part A|Adverse Event|0|||
147597188|NCT02799095|532345719|FG012|Part A|Adverse Event|0|||
147251195|NCT02279173|531090096|FG000|Overall Study|Protocol-specified Criteria|67|||
147597189|NCT02799095|532345720|FG013|Part A|Adverse Event|0|||
147597190|NCT02799095|532345721|FG014|Part A|Adverse Event|0|||
147597191|NCT02799095|532345722|FG015|Part A|Adverse Event|0|||
147251196|NCT02279173|531090096|FG000|Overall Study|Withdrawal by Subject|20|||
147251197|NCT02279173|531090096|FG000|Overall Study|Decision by Sponsor|4|||
147251198|NCT02279173|531090096|FG000|Overall Study|Lost to Follow-up|3|||
147251199|NCT01164956|531090097|FG000|Overall Study|Side Effects|1|||
147251200|NCT01164956|531090098|FG001|Overall Study|Side Effects|0|||
147251201|NCT01164956|531090099|FG002|Overall Study|Side Effects|1|||
147597192|NCT02799095|532345723|FG016|Part A|Adverse Event|0|||
147597193|NCT02799095|532345707|FG000|Part A|Death|0|||
147597194|NCT02799095|532345708|FG001|Part A|Death|0|||
147597195|NCT02799095|532345709|FG002|Part A|Death|0|||
147597196|NCT02799095|532345710|FG003|Part A|Death|0|||
147597197|NCT02799095|532345711|FG004|Part A|Death|0|||
147597198|NCT02799095|532345712|FG005|Part A|Death|0|||
147597199|NCT02799095|532345713|FG006|Part A|Death|3|||
147597200|NCT02799095|532345714|FG007|Part A|Death|0|||
147597201|NCT02799095|532345715|FG008|Part A|Death|0|||
147597202|NCT02799095|532345716|FG009|Part A|Death|0|||
147597203|NCT02799095|532345717|FG010|Part A|Death|0|||
147597204|NCT02799095|532345718|FG011|Part A|Death|0|||
147597205|NCT02799095|532345719|FG012|Part A|Death|0|||
147597206|NCT02799095|532345720|FG013|Part A|Death|0|||
147597207|NCT02799095|532345721|FG014|Part A|Death|0|||
147597208|NCT02799095|532345722|FG015|Part A|Death|0|||
147597209|NCT02799095|532345723|FG016|Part A|Death|0|||
147597210|NCT02799095|532345707|FG000|Part A|Lost to Follow-up|0|||
147597211|NCT02799095|532345708|FG001|Part A|Lost to Follow-up|1|||
147597212|NCT02799095|532345709|FG002|Part A|Lost to Follow-up|0|||
147597213|NCT02799095|532345710|FG003|Part A|Lost to Follow-up|0|||
147597214|NCT02799095|532345711|FG004|Part A|Lost to Follow-up|0|||
147597215|NCT02799095|532345712|FG005|Part A|Lost to Follow-up|0|||
147597216|NCT02799095|532345713|FG006|Part A|Lost to Follow-up|1|||
147597217|NCT02799095|532345714|FG007|Part A|Lost to Follow-up|0|||
147597218|NCT02799095|532345715|FG008|Part A|Lost to Follow-up|0|||
147597219|NCT02799095|532345716|FG009|Part A|Lost to Follow-up|0|||
147597220|NCT02799095|532345717|FG010|Part A|Lost to Follow-up|0|||
147597221|NCT02799095|532345718|FG011|Part A|Lost to Follow-up|0|||
147597222|NCT02799095|532345719|FG012|Part A|Lost to Follow-up|0|||
147597223|NCT02799095|532345720|FG013|Part A|Lost to Follow-up|0|||
147597224|NCT02799095|532345721|FG014|Part A|Lost to Follow-up|0|||
147597225|NCT02799095|532345722|FG015|Part A|Lost to Follow-up|0|||
147597226|NCT02799095|532345723|FG016|Part A|Lost to Follow-up|0|||
147597227|NCT02799095|532345707|FG000|Part A|Progressive Disease|3|||
147597228|NCT02799095|532345708|FG001|Part A|Progressive Disease|3|||
147597229|NCT02799095|532345709|FG002|Part A|Progressive Disease|3|||
147597230|NCT02799095|532345710|FG003|Part A|Progressive Disease|2|||
147597231|NCT02799095|532345711|FG004|Part A|Progressive Disease|2|||
147597232|NCT02799095|532345712|FG005|Part A|Progressive Disease|0|||
147597233|NCT02799095|532345713|FG006|Part A|Progressive Disease|0|||
147597234|NCT02799095|532345714|FG007|Part A|Progressive Disease|0|||
147597235|NCT02799095|532345715|FG008|Part A|Progressive Disease|0|||
147597236|NCT02799095|532345716|FG009|Part A|Progressive Disease|0|||
147597237|NCT02799095|532345717|FG010|Part A|Progressive Disease|0|||
147597238|NCT02799095|532345718|FG011|Part A|Progressive Disease|0|||
147597239|NCT02799095|532345719|FG012|Part A|Progressive Disease|0|||
147597240|NCT02799095|532345720|FG013|Part A|Progressive Disease|0|||
147597241|NCT02799095|532345721|FG014|Part A|Progressive Disease|0|||
147597242|NCT02799095|532345722|FG015|Part A|Progressive Disease|0|||
147597243|NCT02799095|532345723|FG016|Part A|Progressive Disease|0|||
147597244|NCT02799095|532345707|FG000|Part A|Clinical Progression|1|||
147597245|NCT02799095|532345708|FG001|Part A|Clinical Progression|0|||
147597246|NCT02799095|532345709|FG002|Part A|Clinical Progression|2|||
147597247|NCT02799095|532345710|FG003|Part A|Clinical Progression|1|||
147597248|NCT02799095|532345711|FG004|Part A|Clinical Progression|5|||
147597249|NCT02799095|532345712|FG005|Part A|Clinical Progression|0|||
147597250|NCT02799095|532345713|FG006|Part A|Clinical Progression|0|||
147597251|NCT02799095|532345714|FG007|Part A|Clinical Progression|0|||
147597252|NCT02799095|532345715|FG008|Part A|Clinical Progression|0|||
147597253|NCT02799095|532345716|FG009|Part A|Clinical Progression|0|||
147597254|NCT02799095|532345717|FG010|Part A|Clinical Progression|0|||
147597255|NCT02799095|532345718|FG011|Part A|Clinical Progression|0|||
147597256|NCT02799095|532345719|FG012|Part A|Clinical Progression|0|||
147597257|NCT02799095|532345720|FG013|Part A|Clinical Progression|0|||
147597258|NCT02799095|532345721|FG014|Part A|Clinical Progression|0|||
147597259|NCT02799095|532345722|FG015|Part A|Clinical Progression|0|||
147597260|NCT02799095|532345723|FG016|Part A|Clinical Progression|0|||
147597261|NCT02799095|532345707|FG000|Part A|Protocol Deviation|0|||
147597262|NCT02799095|532345708|FG001|Part A|Protocol Deviation|0|||
147597263|NCT02799095|532345709|FG002|Part A|Protocol Deviation|1|||
147597264|NCT02799095|532345710|FG003|Part A|Protocol Deviation|0|||
147597265|NCT02799095|532345711|FG004|Part A|Protocol Deviation|0|||
147597266|NCT02799095|532345712|FG005|Part A|Protocol Deviation|0|||
147597267|NCT02799095|532345713|FG006|Part A|Protocol Deviation|0|||
147597268|NCT02799095|532345714|FG007|Part A|Protocol Deviation|0|||
147597269|NCT02799095|532345715|FG008|Part A|Protocol Deviation|0|||
147597270|NCT02799095|532345716|FG009|Part A|Protocol Deviation|0|||
147597271|NCT02799095|532345717|FG010|Part A|Protocol Deviation|0|||
147251202|NCT00931762|531090100|FG000|Overall Study|Abnormal Laboratory Value (s)|2|||
147251203|NCT00931762|531090100|FG000|Overall Study|Administrative Problems|5|||
147251204|NCT00931762|531090100|FG000|Overall Study|Death|1|||
147251205|NCT00931762|531090100|FG000|Overall Study|Disease Progression|3|||
147251206|NCT00931762|531090100|FG000|Overall Study|Adverse Event (s)|11|||
147251207|NCT00931762|531090100|FG000|Overall Study|Subject withdrew consent|13|||
147251208|NCT01320085|531090101|FG000|Overall Study|Disease Progression|26|||
147251209|NCT01320085|531090102|FG001|Overall Study|Disease Progression|93|||
147251210|NCT01320085|531090103|FG002|Overall Study|Disease Progression|17|||
147251211|NCT01320085|531090101|FG000|Overall Study|Adverse Event|12|||
147251212|NCT01320085|531090102|FG001|Overall Study|Adverse Event|20|||
147251213|NCT01320085|531090103|FG002|Overall Study|Adverse Event|5|||
147251214|NCT01320085|531090101|FG000|Overall Study|Withdrawal by Subject|2|||
147251215|NCT01320085|531090102|FG001|Overall Study|Withdrawal by Subject|4|||
147251216|NCT01320085|531090103|FG002|Overall Study|Withdrawal by Subject|1|||
147251217|NCT01320085|531090101|FG000|Overall Study|Protocol Deviation|1|||
147251218|NCT01320085|531090102|FG001|Overall Study|Protocol Deviation|0|||
147251219|NCT01320085|531090103|FG002|Overall Study|Protocol Deviation|1|||
147251220|NCT01320085|531090101|FG000|Overall Study|Administrative problems|0|||
147251221|NCT01320085|531090102|FG001|Overall Study|Administrative problems|0|||
147251222|NCT01320085|531090103|FG002|Overall Study|Administrative problems|1|||
147251223|NCT01702454|531090104|FG000|Overall Study|Consent withdrawal|0|||
147251224|NCT01702454|531090105|FG001|Overall Study|Consent withdrawal|1|||
147251225|NCT01702454|531090104|FG000|Overall Study|Migrated/moved from study area|0|||
147251226|NCT01702454|531090105|FG001|Overall Study|Migrated/moved from study area|1|||
147251227|NCT01702454|531090104|FG000|Overall Study|Lost to Follow-up|3|||
147251228|NCT01702454|531090105|FG001|Overall Study|Lost to Follow-up|6|||
147251229|NCT00710710|531090106|FG000|Overall Study|Consent withdrawn|2|||
147251230|NCT00710710|531090107|FG001|Overall Study|Consent withdrawn|2|||
147251231|NCT00710710|531090106|FG000|Overall Study|Protocol Violation|0|||
147251232|NCT00710710|531090107|FG001|Overall Study|Protocol Violation|1|||
147251233|NCT00710710|531090106|FG000|Overall Study|Adverse Event|3|||
147251234|NCT00710710|531090107|FG001|Overall Study|Adverse Event|3|||
147251235|NCT00710710|531090106|FG000|Overall Study|Progressive disease|40|||
147251236|NCT00710710|531090107|FG001|Overall Study|Progressive disease|38|||
147251237|NCT03510884|531090108|FG000|Double-blind Period (up to Week 24)|Adverse Event|0|||
147251238|NCT03510884|531090109|FG001|Double-blind Period (up to Week 24)|Adverse Event|0|||
147251239|NCT03510884|531090110|FG002|Double-blind Period (up to Week 24)|Adverse Event|0|||
147251240|NCT03510884|531090111|FG003|Double-blind Period (up to Week 24)|Adverse Event|2|||
147251241|NCT03510884|531090108|FG000|Double-blind Period (up to Week 24)|Participant moved|0|||
147251242|NCT03510884|531090109|FG001|Double-blind Period (up to Week 24)|Participant moved|1|||
147251243|NCT03510884|531090110|FG002|Double-blind Period (up to Week 24)|Participant moved|0|||
147251244|NCT03510884|531090111|FG003|Double-blind Period (up to Week 24)|Participant moved|0|||
147251245|NCT03510884|531090108|FG000|Double-blind Period (up to Week 24)|Life events made continuing too difficult|0|||
147251246|NCT03510884|531090109|FG001|Double-blind Period (up to Week 24)|Life events made continuing too difficult|1|||
147251247|NCT03510884|531090110|FG002|Double-blind Period (up to Week 24)|Life events made continuing too difficult|0|||
147251248|NCT03510884|531090111|FG003|Double-blind Period (up to Week 24)|Life events made continuing too difficult|0|||
147251249|NCT03510884|531090108|FG000|Double-blind Period (up to Week 24)|Participant non-compliance to investigational medicinal product (IMP)|0|||
147251250|NCT03510884|531090109|FG001|Double-blind Period (up to Week 24)|Participant non-compliance to investigational medicinal product (IMP)|2|||
147251251|NCT03510884|531090110|FG002|Double-blind Period (up to Week 24)|Participant non-compliance to investigational medicinal product (IMP)|0|||
147251252|NCT03510884|531090111|FG003|Double-blind Period (up to Week 24)|Participant non-compliance to investigational medicinal product (IMP)|0|||
147251253|NCT03510884|531090108|FG000|Double-blind Period (up to Week 24)|Other than specified above|0|||
147251254|NCT03510884|531090109|FG001|Double-blind Period (up to Week 24)|Other than specified above|0|||
147251255|NCT03510884|531090110|FG002|Double-blind Period (up to Week 24)|Other than specified above|1|||
147331549|NCT01769391|531379247|FG000|Overall Study|Withdrawal by Subject|4|||
147331550|NCT01769391|531379248|FG001|Overall Study|Withdrawal by Subject|3|||
147331551|NCT01769391|531379247|FG000|Overall Study|Investigator Decision|2|||
147331552|NCT01769391|531379248|FG001|Overall Study|Investigator Decision|0|||
147331553|NCT03386929|531379249|FG000|Overall Study|Death|0|||
147331554|NCT03386929|531379250|FG001|Overall Study|Death|0|||
147251256|NCT03510884|531090111|FG003|Double-blind Period (up to Week 24)|Other than specified above|1|||
147251257|NCT03510884|531090108|FG000|Open Label Period (up to Week 104)|Adverse Event|1|||
147251258|NCT03510884|531090109|FG001|Open Label Period (up to Week 104)|Adverse Event|0|||
147251259|NCT03510884|531090110|FG002|Open Label Period (up to Week 104)|Adverse Event|0|||
147251260|NCT03510884|531090111|FG003|Open Label Period (up to Week 104)|Adverse Event|0|||
147331555|NCT03386929|531379251|FG002|Overall Study|Death|1|||
147331556|NCT03386929|531379249|FG000|Overall Study|Withdrawal by Subject|0|||
147331557|NCT03386929|531379250|FG001|Overall Study|Withdrawal by Subject|1|||
147331558|NCT03386929|531379251|FG002|Overall Study|Withdrawal by Subject|0|||
147331559|NCT03386929|531379249|FG000|Overall Study|Physician Decision|0|||
147331560|NCT03386929|531379250|FG001|Overall Study|Physician Decision|0|||
147597272|NCT02799095|532345718|FG011|Part A|Protocol Deviation|0|||
147251261|NCT03510884|531090108|FG000|Open Label Period (up to Week 104)|Lack of Efficacy|0|||
147251262|NCT03510884|531090109|FG001|Open Label Period (up to Week 104)|Lack of Efficacy|1|||
147251263|NCT03510884|531090110|FG002|Open Label Period (up to Week 104)|Lack of Efficacy|0|||
147251264|NCT03510884|531090111|FG003|Open Label Period (up to Week 104)|Lack of Efficacy|0|||
147251265|NCT03510884|531090108|FG000|Open Label Period (up to Week 104)|Participant moved|1|||
147251266|NCT03510884|531090109|FG001|Open Label Period (up to Week 104)|Participant moved|0|||
147251267|NCT03510884|531090110|FG002|Open Label Period (up to Week 104)|Participant moved|1|||
147251268|NCT03510884|531090111|FG003|Open Label Period (up to Week 104)|Participant moved|0|||
147251269|NCT03510884|531090108|FG000|Open Label Period (up to Week 104)|Life events made continuing too difficult|0|||
147251270|NCT03510884|531090109|FG001|Open Label Period (up to Week 104)|Life events made continuing too difficult|1|||
147251271|NCT03510884|531090110|FG002|Open Label Period (up to Week 104)|Life events made continuing too difficult|0|||
147251272|NCT03510884|531090111|FG003|Open Label Period (up to Week 104)|Life events made continuing too difficult|0|||
147251273|NCT03510884|531090108|FG000|Open Label Period (up to Week 104)|Other than specified above|1|||
147251274|NCT03510884|531090109|FG001|Open Label Period (up to Week 104)|Other than specified above|1|||
147251275|NCT03510884|531090110|FG002|Open Label Period (up to Week 104)|Other than specified above|0|||
147251276|NCT03510884|531090111|FG003|Open Label Period (up to Week 104)|Other than specified above|0|||
147251277|NCT02282020|531090112|FG000|Overall Study|Objective Disease Progression|128|||
147251278|NCT02282020|531090113|FG001|Overall Study|Objective Disease Progression|30|||
147251279|NCT02282020|531090112|FG000|Overall Study|Adverse Event|18|||
147251280|NCT02282020|531090113|FG001|Overall Study|Adverse Event|15|||
147251281|NCT02282020|531090112|FG000|Overall Study|Withdrawal by Subject|7|||
147251282|NCT02282020|531090113|FG001|Overall Study|Withdrawal by Subject|10|||
147251283|NCT02282020|531090112|FG000|Overall Study|Miscellaneous|5|||
147251284|NCT02282020|531090113|FG001|Overall Study|Miscellaneous|19|||
147251285|NCT02282020|531090112|FG000|Overall Study|Severe Non-compliance to Protocol|1|||
147251286|NCT02282020|531090113|FG001|Overall Study|Severe Non-compliance to Protocol|0|||
147251287|NCT02282020|531090112|FG000|Overall Study|Developed Discontinuation Criteria|0|||
147251288|NCT02282020|531090113|FG001|Overall Study|Developed Discontinuation Criteria|2|||
147251289|NCT02282020|531090112|FG000|Overall Study|Withdrew Consent Prior to Dosing|0|||
147251290|NCT02282020|531090113|FG001|Overall Study|Withdrew Consent Prior to Dosing|12|||
147251291|NCT01500629|531090114|FG000|Washout Period of 14 to 30 Days|Pregnancy|1|||
147251292|NCT01500629|531090115|FG001|Washout Period of 14 to 30 Days|Pregnancy|0|||
147251293|NCT00849381|531090116|FG000|Overall Study|Adverse Event|1|||
147251294|NCT00849381|531090116|FG000|Overall Study|Lost to Follow-up|129|||
147251295|NCT00849381|531090116|FG000|Overall Study|Protocol Violation|5|||
147251296|NCT00849381|531090116|FG000|Overall Study|Withdrawal by Subject|6|||
147251297|NCT00849381|531090116|FG000|Overall Study|Other|4|||
147251298|NCT04429061|531090120|FG000|Overall Study|Lost to Follow-up|62|||
147251299|NCT04429061|531090121|FG001|Overall Study|Lost to Follow-up|87|||
147251300|NCT04429061|531090120|FG000|Overall Study|Withdrawal by Subject|3|||
147251301|NCT04429061|531090121|FG001|Overall Study|Withdrawal by Subject|4|||
147251302|NCT02618434|531090122|FG000|Overall Study|Withdrawal by Subject|0|||
147251303|NCT02618434|531090123|FG001|Overall Study|Withdrawal by Subject|2|||
147251304|NCT02618434|531090124|FG002|Overall Study|Withdrawal by Subject|3|||
147251305|NCT02618434|531090122|FG000|Overall Study|Withdrawal By Parent/Guardian|5|||
147251306|NCT02618434|531090123|FG001|Overall Study|Withdrawal By Parent/Guardian|6|||
147251307|NCT02618434|531090124|FG002|Overall Study|Withdrawal By Parent/Guardian|9|||
147251308|NCT02618434|531090122|FG000|Overall Study|Lost to Follow-up|3|||
147251309|NCT02618434|531090123|FG001|Overall Study|Lost to Follow-up|1|||
147251310|NCT02618434|531090124|FG002|Overall Study|Lost to Follow-up|3|||
147251311|NCT02618434|531090122|FG000|Overall Study|Adverse Event|1|||
147251312|NCT02618434|531090123|FG001|Overall Study|Adverse Event|0|||
147251313|NCT02618434|531090124|FG002|Overall Study|Adverse Event|12|||
147251314|NCT02618434|531090122|FG000|Overall Study|Physician Decision|0|||
147251315|NCT02618434|531090123|FG001|Overall Study|Physician Decision|1|||
147251316|NCT02618434|531090124|FG002|Overall Study|Physician Decision|0|||
147597273|NCT02799095|532345719|FG012|Part A|Protocol Deviation|0|||
147597274|NCT02799095|532345720|FG013|Part A|Protocol Deviation|0|||
147251317|NCT02618434|531090122|FG000|Overall Study|Protocol Violation|0|||
147251318|NCT02618434|531090123|FG001|Overall Study|Protocol Violation|0|||
147251319|NCT02618434|531090124|FG002|Overall Study|Protocol Violation|1|||
147251320|NCT02618434|531090122|FG000|Overall Study|Other, Multiple categories|1|||
147251321|NCT02618434|531090123|FG001|Overall Study|Other, Multiple categories|1|||
147597275|NCT02799095|532345721|FG014|Part A|Protocol Deviation|0|||
147597276|NCT02799095|532345722|FG015|Part A|Protocol Deviation|0|||
147251322|NCT02618434|531090124|FG002|Overall Study|Other, Multiple categories|1|||
147251323|NCT00885105|531090129|FG000|Overall Study|Withdrawal by Subject|0|||
147251324|NCT00885105|531090130|FG001|Overall Study|Withdrawal by Subject|8|||
147251325|NCT00885105|531090129|FG000|Overall Study|Adverse Event|1|||
147251326|NCT00885105|531090130|FG001|Overall Study|Adverse Event|0|||
147251327|NCT00885105|531090129|FG000|Overall Study|Protocol Violation|0|||
147251328|NCT00885105|531090130|FG001|Overall Study|Protocol Violation|2|||
147597277|NCT02799095|532345723|FG016|Part A|Protocol Deviation|0|||
147251329|NCT02772081|531090131|FG000|Overall Study|Physician Decision|1|||
147251330|NCT02772081|531090132|FG001|Overall Study|Physician Decision|1|||
147597278|NCT02799095|532345707|FG000|Part A|Withdrawal by Subject|0|||
147597279|NCT02799095|532345708|FG001|Part A|Withdrawal by Subject|0|||
147597280|NCT02799095|532345709|FG002|Part A|Withdrawal by Subject|0|||
147597281|NCT02799095|532345710|FG003|Part A|Withdrawal by Subject|1|||
147597282|NCT02799095|532345711|FG004|Part A|Withdrawal by Subject|3|||
147251331|NCT02772081|531090131|FG000|Overall Study|Death|1|||
147251332|NCT02772081|531090132|FG001|Overall Study|Death|1|||
147251333|NCT01402544|531090136|FG000|Overall Study|Withdrawal by Subject|6|||
147251334|NCT01828281|531090137|FG000|Overall Study|Withdrawal by Subject|1|||
147251335|NCT01828281|531090138|FG001|Overall Study|Withdrawal by Subject|0|||
147251336|NCT01442493|531090139|FG000|Overall Study|withdrawn from study|3|||
147251337|NCT01442493|531090140|FG001|Overall Study|withdrawn from study|2|||
147251338|NCT02051608|531090141|FG000|Part 1: Double Blind Treatment|Death|3|||
147251339|NCT02051608|531090142|FG001|Part 1: Double Blind Treatment|Death|3|||
147251340|NCT02051608|531090143|FG002|Part 1: Double Blind Treatment|Death|0|||
147251341|NCT02051608|531090144|FG003|Part 1: Double Blind Treatment|Death|0|||
147251342|NCT02051608|531090141|FG000|Part 1: Double Blind Treatment|Adverse Event|2|||
147251343|NCT02051608|531090142|FG001|Part 1: Double Blind Treatment|Adverse Event|8|||
147251344|NCT02051608|531090143|FG002|Part 1: Double Blind Treatment|Adverse Event|0|||
147251345|NCT02051608|531090144|FG003|Part 1: Double Blind Treatment|Adverse Event|0|||
147251346|NCT02051608|531090141|FG000|Part 1: Double Blind Treatment|Withdrawal by Subject|42|||
147251347|NCT02051608|531090142|FG001|Part 1: Double Blind Treatment|Withdrawal by Subject|29|||
147251348|NCT02051608|531090143|FG002|Part 1: Double Blind Treatment|Withdrawal by Subject|0|||
147251349|NCT02051608|531090144|FG003|Part 1: Double Blind Treatment|Withdrawal by Subject|0|||
147251350|NCT02051608|531090141|FG000|Part 1: Double Blind Treatment|Physician Decision|2|||
147251351|NCT02051608|531090142|FG001|Part 1: Double Blind Treatment|Physician Decision|4|||
147251352|NCT02051608|531090143|FG002|Part 1: Double Blind Treatment|Physician Decision|0|||
147251353|NCT02051608|531090144|FG003|Part 1: Double Blind Treatment|Physician Decision|0|||
147251354|NCT02051608|531090141|FG000|Part 1: Double Blind Treatment|Lost to Follow-up|1|||
147251355|NCT02051608|531090142|FG001|Part 1: Double Blind Treatment|Lost to Follow-up|2|||
147251356|NCT02051608|531090143|FG002|Part 1: Double Blind Treatment|Lost to Follow-up|0|||
147251357|NCT02051608|531090144|FG003|Part 1: Double Blind Treatment|Lost to Follow-up|0|||
147251358|NCT02051608|531090141|FG000|Part 1: Double Blind Treatment|Protocol Violation|0|||
147251359|NCT02051608|531090142|FG001|Part 1: Double Blind Treatment|Protocol Violation|1|||
147251360|NCT02051608|531090143|FG002|Part 1: Double Blind Treatment|Protocol Violation|0|||
147251361|NCT02051608|531090144|FG003|Part 1: Double Blind Treatment|Protocol Violation|0|||
147251362|NCT02051608|531090141|FG000|Part 1: Double Blind Treatment|Non-Compliance|2|||
147251363|NCT02051608|531090142|FG001|Part 1: Double Blind Treatment|Non-Compliance|4|||
147251364|NCT02051608|531090143|FG002|Part 1: Double Blind Treatment|Non-Compliance|0|||
147251365|NCT02051608|531090144|FG003|Part 1: Double Blind Treatment|Non-Compliance|0|||
147251366|NCT02051608|531090141|FG000|Part 1: Double Blind Treatment|Other|6|||
147251367|NCT02051608|531090142|FG001|Part 1: Double Blind Treatment|Other|3|||
147251368|NCT02051608|531090143|FG002|Part 1: Double Blind Treatment|Other|0|||
147251369|NCT02051608|531090144|FG003|Part 1: Double Blind Treatment|Other|0|||
147251370|NCT02051608|531090141|FG000|Part 1: Double Blind Treatment|Part 1 Terminated by Sponsor|3|||
147597283|NCT02799095|532345712|FG005|Part A|Withdrawal by Subject|1|||
147597284|NCT02799095|532345713|FG006|Part A|Withdrawal by Subject|1|||
147597285|NCT02799095|532345714|FG007|Part A|Withdrawal by Subject|0|||
147597286|NCT02799095|532345715|FG008|Part A|Withdrawal by Subject|0|||
147597287|NCT02799095|532345716|FG009|Part A|Withdrawal by Subject|0|||
147597288|NCT02799095|532345717|FG010|Part A|Withdrawal by Subject|0|||
147251371|NCT02051608|531090142|FG001|Part 1: Double Blind Treatment|Part 1 Terminated by Sponsor|2|||
147251372|NCT02051608|531090143|FG002|Part 1: Double Blind Treatment|Part 1 Terminated by Sponsor|0|||
147251373|NCT02051608|531090144|FG003|Part 1: Double Blind Treatment|Part 1 Terminated by Sponsor|0|||
147251374|NCT02051608|531090141|FG000|Part 2: Open-label Extension|Adverse Event|0|||
147251375|NCT02051608|531090142|FG001|Part 2: Open-label Extension|Adverse Event|0|||
147331561|NCT03386929|531379251|FG002|Overall Study|Physician Decision|1|||
147331562|NCT03386929|531379249|FG000|Overall Study|Progression|4|||
147251376|NCT02051608|531090143|FG002|Part 2: Open-label Extension|Adverse Event|6|||
147251377|NCT02051608|531090144|FG003|Part 2: Open-label Extension|Adverse Event|8|||
147597289|NCT02799095|532345718|FG011|Part A|Withdrawal by Subject|0|||
147251378|NCT02051608|531090141|FG000|Part 2: Open-label Extension|Death|0|||
147251379|NCT02051608|531090142|FG001|Part 2: Open-label Extension|Death|0|||
147251380|NCT02051608|531090143|FG002|Part 2: Open-label Extension|Death|7|||
147331563|NCT03386929|531379250|FG001|Overall Study|Progression|4|||
147251381|NCT02051608|531090144|FG003|Part 2: Open-label Extension|Death|4|||
147251382|NCT02051608|531090141|FG000|Part 2: Open-label Extension|Lost to Follow-up|0|||
147251383|NCT02051608|531090142|FG001|Part 2: Open-label Extension|Lost to Follow-up|0|||
147597290|NCT02799095|532345719|FG012|Part A|Withdrawal by Subject|0|||
147597291|NCT02799095|532345720|FG013|Part A|Withdrawal by Subject|0|||
147597292|NCT02799095|532345721|FG014|Part A|Withdrawal by Subject|0|||
147597293|NCT02799095|532345722|FG015|Part A|Withdrawal by Subject|0|||
147660530|NCT00490971|532579939|FG002|Acute/Continuation|Death|0|||
147660531|NCT00490971|532579940|FG003|Acute/Continuation|Death|0|||
147660532|NCT00490971|532579941|FG004|Acute/Continuation|Death|0|||
147660533|NCT00490971|532579937|FG000|Acute/Continuation|Lack of Efficacy|106|||
147660534|NCT00490971|532579938|FG001|Acute/Continuation|Lack of Efficacy|12|||
147660535|NCT00490971|532579939|FG002|Acute/Continuation|Lack of Efficacy|0|||
147660536|NCT00490971|532579940|FG003|Acute/Continuation|Lack of Efficacy|0|||
147660537|NCT00490971|532579941|FG004|Acute/Continuation|Lack of Efficacy|0|||
147660538|NCT00490971|532579937|FG000|Acute/Continuation|Lost to Follow-up|23|||
147660539|NCT00490971|532579938|FG001|Acute/Continuation|Lost to Follow-up|7|||
147660540|NCT00490971|532579939|FG002|Acute/Continuation|Lost to Follow-up|0|||
147660541|NCT00490971|532579940|FG003|Acute/Continuation|Lost to Follow-up|0|||
147660542|NCT00490971|532579941|FG004|Acute/Continuation|Lost to Follow-up|0|||
147660543|NCT00490971|532579937|FG000|Acute/Continuation|Protocol Violation|10|||
147660544|NCT00490971|532579938|FG001|Acute/Continuation|Protocol Violation|2|||
147660545|NCT00490971|532579939|FG002|Acute/Continuation|Protocol Violation|0|||
147660546|NCT00490971|532579940|FG003|Acute/Continuation|Protocol Violation|0|||
147660547|NCT00490971|532579941|FG004|Acute/Continuation|Protocol Violation|0|||
147660548|NCT00490971|532579937|FG000|Acute/Continuation|Withdrawal by Subject|92|||
147660549|NCT00490971|532579938|FG001|Acute/Continuation|Withdrawal by Subject|24|||
147660550|NCT00490971|532579939|FG002|Acute/Continuation|Withdrawal by Subject|0|||
147660551|NCT00490971|532579940|FG003|Acute/Continuation|Withdrawal by Subject|0|||
147660552|NCT00490971|532579941|FG004|Acute/Continuation|Withdrawal by Subject|0|||
147660553|NCT00490971|532579937|FG000|Acute/Continuation|Other|11|||
147251384|NCT02051608|531090143|FG002|Part 2: Open-label Extension|Lost to Follow-up|0|||
147251385|NCT02051608|531090144|FG003|Part 2: Open-label Extension|Lost to Follow-up|1|||
147251386|NCT02051608|531090141|FG000|Part 2: Open-label Extension|Non-Compliance|0|||
147251387|NCT02051608|531090142|FG001|Part 2: Open-label Extension|Non-Compliance|0|||
147251388|NCT02051608|531090143|FG002|Part 2: Open-label Extension|Non-Compliance|1|||
147251389|NCT02051608|531090144|FG003|Part 2: Open-label Extension|Non-Compliance|1|||
147251390|NCT02051608|531090141|FG000|Part 2: Open-label Extension|Withdrawal by Subject|0|||
147251391|NCT02051608|531090142|FG001|Part 2: Open-label Extension|Withdrawal by Subject|0|||
147251392|NCT02051608|531090143|FG002|Part 2: Open-label Extension|Withdrawal by Subject|39|||
147251393|NCT02051608|531090144|FG003|Part 2: Open-label Extension|Withdrawal by Subject|32|||
147251394|NCT02051608|531090141|FG000|Part 2: Open-label Extension|Study Terminated By Sponsor|0|||
147251395|NCT02051608|531090142|FG001|Part 2: Open-label Extension|Study Terminated By Sponsor|0|||
147251396|NCT02051608|531090143|FG002|Part 2: Open-label Extension|Study Terminated By Sponsor|0|||
147251397|NCT02051608|531090144|FG003|Part 2: Open-label Extension|Study Terminated By Sponsor|1|||
147251398|NCT02051608|531090141|FG000|Part 2: Open-label Extension|Physician Decision|0|||
147251399|NCT02051608|531090142|FG001|Part 2: Open-label Extension|Physician Decision|0|||
147251400|NCT02051608|531090143|FG002|Part 2: Open-label Extension|Physician Decision|8|||
147251401|NCT02051608|531090144|FG003|Part 2: Open-label Extension|Physician Decision|5|||
147251402|NCT02051608|531090141|FG000|Part 2: Open-label Extension|Other|0|||
147251403|NCT02051608|531090142|FG001|Part 2: Open-label Extension|Other|0|||
147251404|NCT02051608|531090143|FG002|Part 2: Open-label Extension|Other|9|||
147251405|NCT02051608|531090144|FG003|Part 2: Open-label Extension|Other|9|||
147251406|NCT01083576|531090145|FG000|Overall Study|Treatment Failure|6|||
147251407|NCT01083576|531090146|FG001|Overall Study|Treatment Failure|1|||
147251408|NCT01986985|531090147|FG000|Overall Study|Withdrawal by Subject|4|||
147251409|NCT01986985|531090147|FG000|Overall Study|Scan not completed due to malfunction|3|||
147251410|NCT02709785|531090148|FG000|Overall Study|Withdrawal by Subject|1|||
147251411|NCT02709785|531090149|FG001|Overall Study|Withdrawal by Subject|2|||
147251412|NCT02709785|531090150|FG002|Overall Study|Withdrawal by Subject|1|||
147251413|NCT00533845|531090153|FG000|Overall Study|Physician Decision|1|||
147251414|NCT00533845|531090154|FG001|Overall Study|Physician Decision|0|||
147251415|NCT01348347|531090170|FG000|Overall Study|Withdrawal by Subject|1|||
147251416|NCT01348347|531090171|FG001|Overall Study|Withdrawal by Subject|1|||
147251417|NCT01348347|531090172|FG002|Overall Study|Withdrawal by Subject|1|||
147251418|NCT01348347|531090170|FG000|Overall Study|Progressive disease|2|||
147251419|NCT01348347|531090171|FG001|Overall Study|Progressive disease|5|||
147251420|NCT01348347|531090172|FG002|Overall Study|Progressive disease|5|||
147251421|NCT01867021|531090173|FG000|Overall Study|Adverse Event|0|||
147251422|NCT01867021|531090174|FG001|Overall Study|Adverse Event|1|||
147251423|NCT01867021|531090173|FG000|Overall Study|Not Eligible|0|||
147251424|NCT01867021|531090174|FG001|Overall Study|Not Eligible|1|||
147251425|NCT01867021|531090173|FG000|Overall Study|Death|1|||
147251426|NCT01867021|531090174|FG001|Overall Study|Death|0|||
147251427|NCT01867021|531090173|FG000|Overall Study|Lost to Follow-up|0|||
147251428|NCT01867021|531090174|FG001|Overall Study|Lost to Follow-up|2|||
147251429|NCT01867021|531090173|FG000|Overall Study|Withdrawal by Subject|1|||
147251430|NCT01867021|531090174|FG001|Overall Study|Withdrawal by Subject|6|||
147251431|NCT00640601|531090175|FG000|Overall Study|Adverse Event|43|||
147251432|NCT00640601|531090175|FG000|Overall Study|Withdrawal by Subject|20|||
147660554|NCT00490971|532579938|FG001|Acute/Continuation|Other|4|||
147660555|NCT00490971|532579939|FG002|Acute/Continuation|Other|0|||
147331564|NCT03386929|531379251|FG002|Overall Study|Progression|0|||
147331565|NCT03386929|531379249|FG000|Overall Study|Clinical Monitoring Committee and physician choice|1|||
147331566|NCT03386929|531379250|FG001|Overall Study|Clinical Monitoring Committee and physician choice|1|||
147331567|NCT03386929|531379251|FG002|Overall Study|Clinical Monitoring Committee and physician choice|1|||
147331568|NCT03386929|531379249|FG000|Overall Study|Transfer to SPRING Rollover protocol (EU CT # 2022-500041-24-00) after closing SPRING|1|||
147331569|NCT03386929|531379250|FG001|Overall Study|Transfer to SPRING Rollover protocol (EU CT # 2022-500041-24-00) after closing SPRING|0|||
147331570|NCT03386929|531379251|FG002|Overall Study|Transfer to SPRING Rollover protocol (EU CT # 2022-500041-24-00) after closing SPRING|0|||
147331571|NCT01144182|531379255|FG000|Overall Study|Death|5|||
147331572|NCT01144182|531379256|FG001|Overall Study|Death|6|||
147331573|NCT01144182|531379255|FG000|Overall Study|Withdrawal by Subject|3|||
147331574|NCT01144182|531379256|FG001|Overall Study|Withdrawal by Subject|6|||
147331575|NCT01144182|531379255|FG000|Overall Study|Lost to Follow-up|9|||
147331576|NCT01144182|531379256|FG001|Overall Study|Lost to Follow-up|9|||
147331577|NCT02317016|531379263|FG000|Part A: Day 4-31 (AZD9291 Alone)|Adverse Event|1|||
147331578|NCT02317016|531379263|FG000|Part A: Day 32-34 (Rosuvastatin+AZD9291)|Condition under investigation worsened|1|||
147331579|NCT02317016|531379263|FG000|Part A: Day 32-34 (Rosuvastatin+AZD9291)|Death|1|||
147331580|NCT02317016|531379263|FG000|Part B: Day 35 to End Part B (AZD9291)|Condition under investigation worsened|23|||
147331581|NCT02317016|531379263|FG000|Part B: Day 35 to End Part B (AZD9291)|Adverse Event|1|||
147251433|NCT00640601|531090175|FG000|Overall Study|Protocol Violation|6|||
147251434|NCT00640601|531090175|FG000|Overall Study|Lack of Efficacy|16|||
147251435|NCT00640601|531090175|FG000|Overall Study|Lost to Follow-up|9|||
147251436|NCT00640601|531090175|FG000|Overall Study|Physician Decision|8|||
147251437|NCT00640601|531090175|FG000|Overall Study|treatment naive, combination therapy|10|||
147251438|NCT03681405|531090176|FG000|Overall Study|Found to be ineligible after randomized|1|||
147251439|NCT03681405|531090177|FG001|Overall Study|Found to be ineligible after randomized|0|||
147251440|NCT01958008|531090180|FG000|Overall Study|Worsening of disease under study|0|||
147251441|NCT01958008|531090181|FG001|Overall Study|Worsening of disease under study|0|||
147251442|NCT01958008|531090182|FG002|Overall Study|Worsening of disease under study|1|||
147251443|NCT01958008|531090183|FG003|Overall Study|Worsening of disease under study|0|||
147251444|NCT01958008|531090180|FG000|Overall Study|Other adverse event|1|||
147251445|NCT01958008|531090181|FG001|Overall Study|Other adverse event|0|||
147251446|NCT01958008|531090182|FG002|Overall Study|Other adverse event|0|||
147251447|NCT01958008|531090183|FG003|Overall Study|Other adverse event|0|||
147251448|NCT03789318|531090184|FG000|Overall Study|Adverse Event|0|||
147251449|NCT03789318|531090185|FG001|Overall Study|Adverse Event|0|||
147251450|NCT03789318|531090186|FG002|Overall Study|Adverse Event|1|||
147251451|NCT03789318|531090187|FG003|Overall Study|Adverse Event|1|||
147251452|NCT03789318|531090188|FG004|Overall Study|Adverse Event|0|||
147251453|NCT03789318|531090184|FG000|Overall Study|Lost to Follow-up|0|||
147251454|NCT03789318|531090185|FG001|Overall Study|Lost to Follow-up|0|||
147251455|NCT03789318|531090186|FG002|Overall Study|Lost to Follow-up|1|||
147251456|NCT03789318|531090187|FG003|Overall Study|Lost to Follow-up|0|||
147331582|NCT02317016|531379263|FG000|Part B: Day 35 to End Part B (AZD9291)|Withdrawal by Subject|2|||
147331583|NCT02317016|531379263|FG000|Part B: Day 35 to End Part B (AZD9291)|Death|5|||
147331584|NCT03121950|531379265|FG000|Overall Study|Withdrawal by Subject|11|||
147331585|NCT03121950|531379266|FG001|Overall Study|Withdrawal by Subject|2|||
147331586|NCT00589667|531380860|FG000|Overall Study|Adverse Event|2|||
147331587|NCT00589667|531380860|FG000|Overall Study|Withdrawal by Subject|1|||
147331588|NCT03538041|531380863|FG000|12-Week Treatment Period|Adverse Event|1|||
147331589|NCT03538041|531380864|FG001|12-Week Treatment Period|Adverse Event|1|||
147331590|NCT03538041|531380863|FG000|12-Week Treatment Period|Withdrawal by Subject|0|||
147331591|NCT03538041|531380864|FG001|12-Week Treatment Period|Withdrawal by Subject|1|||
147331592|NCT03538041|531380863|FG000|Treatment Extension Period|Adverse Event|4|||
147331593|NCT03538041|531380864|FG001|Treatment Extension Period|Adverse Event|1|||
147331594|NCT03538041|531380863|FG000|Treatment Extension Period|Physician Decision|1|||
147331595|NCT03538041|531380864|FG001|Treatment Extension Period|Physician Decision|1|||
147331596|NCT03538041|531380863|FG000|Treatment Extension Period|Lack of Efficacy|1|||
147331597|NCT03538041|531380864|FG001|Treatment Extension Period|Lack of Efficacy|4|||
147331598|NCT03538041|531380863|FG000|Treatment Extension Period|Transitioned to Rollover Study|1|||
147331599|NCT03538041|531380864|FG001|Treatment Extension Period|Transitioned to Rollover Study|4|||
147331600|NCT03538041|531380863|FG000|Treatment Extension Period|Death|0|||
147331601|NCT03538041|531380864|FG001|Treatment Extension Period|Death|1|||
147331602|NCT01070888|531380873|FG000|First Intervention (14 Days)|Adverse Event|0|||
147331603|NCT01070888|531380874|FG001|First Intervention (14 Days)|Adverse Event|1|||
147331604|NCT01070888|531380873|FG000|First Intervention (14 Days)|Lost to Follow-up|0|||
147331605|NCT01070888|531380874|FG001|First Intervention (14 Days)|Lost to Follow-up|1|||
147597294|NCT02799095|532345723|FG016|Part A|Withdrawal by Subject|0|||
147251457|NCT03789318|531090188|FG004|Overall Study|Lost to Follow-up|0|||
147251458|NCT03789318|531090184|FG000|Overall Study|Withdrawal by Subject|0|||
147251459|NCT03789318|531090185|FG001|Overall Study|Withdrawal by Subject|0|||
147251460|NCT03789318|531090186|FG002|Overall Study|Withdrawal by Subject|1|||
147251461|NCT03789318|531090187|FG003|Overall Study|Withdrawal by Subject|0|||
147251462|NCT03789318|531090188|FG004|Overall Study|Withdrawal by Subject|0|||
147251463|NCT05126901|531092292|FG000|Overall Study|Withdrawal by Subject|1|||
147251464|NCT05126901|531092293|FG001|Overall Study|Withdrawal by Subject|1|||
147251465|NCT05126901|531092294|FG002|Overall Study|Withdrawal by Subject|4|||
147251466|NCT05126901|531092292|FG000|Overall Study|Adverse Event|0|||
147251467|NCT05126901|531092293|FG001|Overall Study|Adverse Event|0|||
147251468|NCT05126901|531092294|FG002|Overall Study|Adverse Event|1|||
147251469|NCT05126901|531092292|FG000|Overall Study|Lost to Follow-up|0|||
147251470|NCT05126901|531092293|FG001|Overall Study|Lost to Follow-up|2|||
147251471|NCT05126901|531092294|FG002|Overall Study|Lost to Follow-up|0|||
147251472|NCT00754624|531092295|FG000|Overall Study|Adverse Event|16|||
147251473|NCT00754624|531092295|FG000|Overall Study|Death|1|||
147251474|NCT00754624|531092295|FG000|Overall Study|Physician Decision|8|||
147251475|NCT00754624|531092295|FG000|Overall Study|Protocol Violation|1|||
147251476|NCT00754624|531092295|FG000|Overall Study|Withdrawal by Subject|28|||
147251477|NCT00754624|531092295|FG000|Overall Study|Various|12|||
147251478|NCT00754624|531092295|FG000|Overall Study|Lost to Follow-up|3|||
147251479|NCT04067544|531092296|FG000|Overall Study|Unforeseen recruitment issues due to Coronavirus Disease (COVID)-19 pandemic|1|||
147251480|NCT01529346|531092297|FG000|Overall Study|Lost to Follow-up|2|||
147251481|NCT01529346|531092298|FG001|Overall Study|Lost to Follow-up|0|||
147251482|NCT01529346|531092299|FG002|Overall Study|Lost to Follow-up|1|||
147251483|NCT01529346|531092300|FG003|Overall Study|Lost to Follow-up|0|||
147251484|NCT01529346|531092301|FG004|Overall Study|Lost to Follow-up|0|||
147251485|NCT01529346|531092297|FG000|Overall Study|Other|0|||
147251486|NCT01529346|531092298|FG001|Overall Study|Other|1|||
147251487|NCT01529346|531092299|FG002|Overall Study|Other|1|||
147251488|NCT01529346|531092300|FG003|Overall Study|Other|0|||
147251489|NCT01529346|531092301|FG004|Overall Study|Other|0|||
147251490|NCT01499667|531092302|FG000|Overall Study|administrative problems|4|||
147251491|NCT01499667|531092303|FG001|Overall Study|administrative problems|5|||
147251492|NCT01499667|531092304|FG002|Overall Study|administrative problems|5|||
147251493|NCT01499667|531092302|FG000|Overall Study|Protocol Violation|1|||
147251494|NCT01499667|531092303|FG001|Overall Study|Protocol Violation|3|||
147251495|NCT01499667|531092304|FG002|Overall Study|Protocol Violation|2|||
147251496|NCT01499667|531092302|FG000|Overall Study|Adverse Event|0|||
147251497|NCT01499667|531092303|FG001|Overall Study|Adverse Event|2|||
147251498|NCT01499667|531092304|FG002|Overall Study|Adverse Event|2|||
147251499|NCT01499667|531092302|FG000|Overall Study|Withdrawal by Subject|2|||
147251500|NCT01499667|531092303|FG001|Overall Study|Withdrawal by Subject|1|||
147251501|NCT01499667|531092304|FG002|Overall Study|Withdrawal by Subject|1|||
147251502|NCT01499667|531092302|FG000|Overall Study|Lack of Efficacy|2|||
147251503|NCT01499667|531092303|FG001|Overall Study|Lack of Efficacy|0|||
147251504|NCT01499667|531092304|FG002|Overall Study|Lack of Efficacy|0|||
147251505|NCT00460031|531092305|FG000|Overall Study|Adverse Event|5|||
147251506|NCT00460031|531092305|FG000|Overall Study|Withdrawal by Subject|5|||
147251507|NCT00460031|531092305|FG000|Overall Study|Death|1|||
147251508|NCT02506153|531092306|FG000|Overall Study|Adverse Event|359|||
147251509|NCT02506153|531092307|FG001|Overall Study|Adverse Event|114|||
147251510|NCT02506153|531092306|FG000|Overall Study|Refused unrelated to adverse event|127|||
147251511|NCT02506153|531092307|FG001|Overall Study|Refused unrelated to adverse event|18|||
147251512|NCT02506153|531092306|FG000|Overall Study|Progression/relapse|91|||
147251513|NCT02506153|531092307|FG001|Overall Study|Progression/relapse|136|||
147251514|NCT02506153|531092306|FG000|Overall Study|Death|2|||
147251515|NCT02506153|531092307|FG001|Overall Study|Death|1|||
147251516|NCT02506153|531092306|FG000|Overall Study|Other - not protocol specified|23|||
147251517|NCT02506153|531092307|FG001|Overall Study|Other - not protocol specified|12|||
147251518|NCT00311623|531092313|FG000|Overall Study|Physician Decision|0|||
147251519|NCT00311623|531092314|FG001|Overall Study|Physician Decision|0|||
147251520|NCT00311623|531092315|FG002|Overall Study|Physician Decision|2|||
147251521|NCT03103919|531092316|FG000|Overall Study|Adverse Event|2|||
147251522|NCT03103919|531092317|FG001|Overall Study|Adverse Event|2|||
147251523|NCT05682326|531092318|FG000|Overall Study|Withdrawal by Subject|1|||
147251524|NCT05682326|531092319|FG001|Overall Study|Withdrawal by Subject|0|||
147251525|NCT03998189|531092320|FG000|Overall Study|Lack of Efficacy|0|||
147251526|NCT03998189|531092321|FG001|Overall Study|Lack of Efficacy|1|||
147251527|NCT02005445|531092324|FG000|Overall Study|Dual study enrollment|0|||
147251528|NCT02005445|531092325|FG001|Overall Study|Dual study enrollment|1|||
147251529|NCT01881776|531092326|FG000|Overall Study|Lost to Follow-up|1|||
147251530|NCT01881776|531092327|FG001|Overall Study|Lost to Follow-up|2|||
147251531|NCT01881776|531092328|FG002|Overall Study|Lost to Follow-up|1|||
147251532|NCT01881776|531092326|FG000|Overall Study|Protocol Violation|0|||
147251533|NCT01881776|531092327|FG001|Overall Study|Protocol Violation|2|||
147251534|NCT01881776|531092328|FG002|Overall Study|Protocol Violation|1|||
147251535|NCT02320149|531092329|FG000|Overall Study|Adverse Event|3|||
147251536|NCT02320149|531092330|FG001|Overall Study|Adverse Event|7|||
147251537|NCT02320149|531092329|FG000|Overall Study|Withdrawal of Consent|28|||
147251538|NCT02320149|531092330|FG001|Overall Study|Withdrawal of Consent|32|||
147251539|NCT02320149|531092329|FG000|Overall Study|Lost to Follow-up|21|||
147251540|NCT02320149|531092330|FG001|Overall Study|Lost to Follow-up|34|||
147251541|NCT02320149|531092329|FG000|Overall Study|Protocol Violation|2|||
147251542|NCT02320149|531092330|FG001|Overall Study|Protocol Violation|1|||
147251543|NCT02320149|531092329|FG000|Overall Study|Noncompliance with Study Treatment|7|||
147251544|NCT02320149|531092330|FG001|Overall Study|Noncompliance with Study Treatment|2|||
147251545|NCT02320149|531092329|FG000|Overall Study|Lack of Efficacy|0|||
147251546|NCT02320149|531092330|FG001|Overall Study|Lack of Efficacy|1|||
147251547|NCT02320149|531092329|FG000|Overall Study|Other Miscellaneous Reasons|2|||
147251548|NCT02320149|531092330|FG001|Overall Study|Other Miscellaneous Reasons|3|||
147251549|NCT00022633|531092331|FG000|Overall Study|Adverse Event|11|||
147251550|NCT00022633|531092332|FG001|Overall Study|Adverse Event|1|||
147251551|NCT00022633|531092331|FG000|Overall Study|Refusal unrelated to adverse event|1|||
147251552|NCT00022633|531092332|FG001|Overall Study|Refusal unrelated to adverse event|0|||
147251553|NCT00022633|531092331|FG000|Overall Study|Progression/relapse|9|||
147251554|NCT00022633|531092332|FG001|Overall Study|Progression/relapse|2|||
147251555|NCT00022633|531092331|FG000|Overall Study|Death|4|||
147251556|NCT00022633|531092332|FG001|Overall Study|Death|0|||
147251557|NCT00022633|531092331|FG000|Overall Study|Other - not protocol specified|3|||
147251558|NCT00022633|531092332|FG001|Overall Study|Other - not protocol specified|2|||
147251559|NCT00022633|531092331|FG000|Overall Study|Ineligible|4|||
147251560|NCT00022633|531092332|FG001|Overall Study|Ineligible|0|||
147251561|NCT06133348|531092333|FG000|Overall Study|Death|3|||
147251562|NCT06133348|531092333|FG000|Overall Study|Lost to Follow-up|1|||
147251563|NCT06133348|531092333|FG000|Overall Study|Physician Decision|1|||
147251564|NCT06133348|531092333|FG000|Overall Study|Withdrawal by Subject|5|||
147251565|NCT00487747|531092334|FG000|Overall Study|Adverse Event|1|||
147251566|NCT00487747|531092334|FG000|Overall Study|Lost to Follow-up|9|||
147251567|NCT00487747|531092334|FG000|Overall Study|Lack of Efficacy|1|||
147251568|NCT01359449|531092335|FG000|Overall Study|Lost to Follow-up|1|||
147251569|NCT01359449|531092336|FG001|Overall Study|Lost to Follow-up|0|||
147251570|NCT01359449|531092335|FG000|Overall Study|Protocol Violation|0|||
147251571|NCT01359449|531092336|FG001|Overall Study|Protocol Violation|2|||
147251572|NCT01359449|531092335|FG000|Overall Study|Withdrawal by Subject|3|||
147251573|NCT01359449|531092336|FG001|Overall Study|Withdrawal by Subject|2|||
147251574|NCT02036294|531092338|FG000|Overall Study|Death|7|||
147251575|NCT02036294|531092339|FG001|Overall Study|Death|8|||
147251576|NCT02036294|531092338|FG000|Overall Study|Withdrawal by Subject|2|||
147251577|NCT02036294|531092339|FG001|Overall Study|Withdrawal by Subject|3|||
147251578|NCT00429104|531092342|FG000|Overall Study|Protocol Violation|1|||
147251579|NCT01907815|531092343|FG000|Overall Study|Withdrawal by Subject|1|||
147251580|NCT01907815|531092344|FG001|Overall Study|Withdrawal by Subject|0|||
147251581|NCT04997161|531092347|FG000|Overall Study|Study terminated by sponsor|3|||
147251582|NCT02485574|531092352|FG000|Overall Study|dropped out because they failed to undergo CT scan at postoperative 12 months|4|||
147251583|NCT01408914|531092355|FG000|Overall Study|Could not complete tx in protocol period|5|||
147251584|NCT01408914|531092356|FG001|Overall Study|Could not complete tx in protocol period|5|||
147251585|NCT01408914|531092357|FG002|Overall Study|Could not complete tx in protocol period|6|||
147251586|NCT01408914|531092355|FG000|Overall Study|Lost to Follow-up|4|||
147251587|NCT01408914|531092356|FG001|Overall Study|Lost to Follow-up|1|||
147251588|NCT01408914|531092357|FG002|Overall Study|Lost to Follow-up|2|||
147251589|NCT01408914|531092355|FG000|Overall Study|Physician Decision|1|||
147251590|NCT01408914|531092356|FG001|Overall Study|Physician Decision|1|||
147251591|NCT01408914|531092357|FG002|Overall Study|Physician Decision|0|||
147251592|NCT01408914|531092355|FG000|Overall Study|Withdrawal by Subject|1|||
147251593|NCT01408914|531092356|FG001|Overall Study|Withdrawal by Subject|0|||
147251594|NCT01408914|531092357|FG002|Overall Study|Withdrawal by Subject|1|||
147251595|NCT01408914|531092355|FG000|Overall Study|Moved out of study jurisdiction|1|||
147251596|NCT01408914|531092356|FG001|Overall Study|Moved out of study jurisdiction|1|||
147251597|NCT01408914|531092357|FG002|Overall Study|Moved out of study jurisdiction|0|||
147251598|NCT01408914|531092355|FG000|Overall Study|Late exclusion|0|||
147251599|NCT01408914|531092356|FG001|Overall Study|Late exclusion|3|||
147251600|NCT01408914|531092357|FG002|Overall Study|Late exclusion|3|||
147251601|NCT01408914|531092355|FG000|Overall Study|Change in local TB/HIV norms|0|||
147251602|NCT01408914|531092356|FG001|Overall Study|Change in local TB/HIV norms|1|||
147251603|NCT01408914|531092357|FG002|Overall Study|Change in local TB/HIV norms|1|||
147251604|NCT01957553|531092365|FG000|Test Period 1 (21 +- 1 Days)|Lack of Efficacy|2|||
147251605|NCT01957553|531092366|FG001|Test Period 1 (21 +- 1 Days)|Lack of Efficacy|3|||
147251606|NCT01957553|531092365|FG000|Test Period 1 (21 +- 1 Days)|Adverse Event|2|||
147251607|NCT01957553|531092366|FG001|Test Period 1 (21 +- 1 Days)|Adverse Event|0|||
147660556|NCT00490971|532579940|FG003|Acute/Continuation|Other|0|||
147251608|NCT01957553|531092365|FG000|Test Period 1 (21 +- 1 Days)|Withdrawal by Subject|2|||
147251609|NCT01957553|531092366|FG001|Test Period 1 (21 +- 1 Days)|Withdrawal by Subject|0|||
147251610|NCT01957553|531092365|FG000|Test Period 1 (21 +- 1 Days)|screen failure|1|||
147251611|NCT01957553|531092366|FG001|Test Period 1 (21 +- 1 Days)|screen failure|0|||
147251612|NCT01957553|531092365|FG000|Test Period 2 (21 +- 1 Days)|Adverse Event|1|||
147251613|NCT01957553|531092366|FG001|Test Period 2 (21 +- 1 Days)|Adverse Event|3|||
147251614|NCT01957553|531092365|FG000|Test Period 2 (21 +- 1 Days)|Lack of Efficacy|1|||
147660557|NCT00490971|532579941|FG004|Acute/Continuation|Other|0|||
147660558|NCT00490971|532579937|FG000|Maintenance|Adverse Event|0|||
147660559|NCT00490971|532579938|FG001|Maintenance|Adverse Event|0|||
147660560|NCT00490971|532579939|FG002|Maintenance|Adverse Event|4|||
147660561|NCT00490971|532579940|FG003|Maintenance|Adverse Event|5|||
147660562|NCT00490971|532579941|FG004|Maintenance|Adverse Event|7|||
147660563|NCT00490971|532579937|FG000|Maintenance|Death|0|||
147660564|NCT00490971|532579938|FG001|Maintenance|Death|0|||
147660565|NCT00490971|532579939|FG002|Maintenance|Death|0|||
147660566|NCT00490971|532579940|FG003|Maintenance|Death|2|||
147660567|NCT00490971|532579941|FG004|Maintenance|Death|0|||
147660568|NCT00490971|532579937|FG000|Maintenance|Lost to Follow-up|0|||
147660569|NCT00490971|532579938|FG001|Maintenance|Lost to Follow-up|0|||
147660570|NCT00490971|532579939|FG002|Maintenance|Lost to Follow-up|5|||
147660571|NCT00490971|532579940|FG003|Maintenance|Lost to Follow-up|8|||
147660572|NCT00490971|532579941|FG004|Maintenance|Lost to Follow-up|10|||
147660573|NCT00490971|532579937|FG000|Maintenance|Pregnancy|0|||
147660574|NCT00490971|532579938|FG001|Maintenance|Pregnancy|0|||
147660575|NCT00490971|532579939|FG002|Maintenance|Pregnancy|1|||
147660576|NCT00490971|532579940|FG003|Maintenance|Pregnancy|0|||
147660577|NCT00490971|532579941|FG004|Maintenance|Pregnancy|0|||
147660578|NCT00490971|532579937|FG000|Maintenance|Protocol Violation|0|||
147660579|NCT00490971|532579938|FG001|Maintenance|Protocol Violation|0|||
147660580|NCT00490971|532579939|FG002|Maintenance|Protocol Violation|4|||
147660581|NCT00490971|532579940|FG003|Maintenance|Protocol Violation|1|||
147660582|NCT00490971|532579941|FG004|Maintenance|Protocol Violation|1|||
147660583|NCT00490971|532579937|FG000|Maintenance|Withdrawal by Subject|0|||
147660584|NCT00490971|532579938|FG001|Maintenance|Withdrawal by Subject|0|||
147660585|NCT00490971|532579939|FG002|Maintenance|Withdrawal by Subject|26|||
147660586|NCT00490971|532579940|FG003|Maintenance|Withdrawal by Subject|28|||
147660587|NCT00490971|532579941|FG004|Maintenance|Withdrawal by Subject|18|||
147660588|NCT00490971|532579937|FG000|Maintenance|Other|0|||
147660589|NCT00490971|532579938|FG001|Maintenance|Other|0|||
147660590|NCT00490971|532579939|FG002|Maintenance|Other|11|||
147660591|NCT00490971|532579940|FG003|Maintenance|Other|9|||
147660592|NCT00490971|532579941|FG004|Maintenance|Other|3|||
147660593|NCT04754542|532579947|FG000|Overall Study|Subject enrolled in error; did not meet eligibility criteria|1|||
147660594|NCT04754542|532579948|FG001|Overall Study|Subject enrolled in error; did not meet eligibility criteria|1|||
147660595|NCT01212094|532581336|FG000|Year 1: Baseline Monitoring|Study terminated|7|||
147660596|NCT01212094|532581337|FG001|Year 1: Baseline Monitoring|Study terminated|0|||
147660597|NCT01212094|532581338|FG002|Year 1: Baseline Monitoring|Study terminated|0|||
147660598|NCT01212094|532581336|FG000|Year 1: Baseline Monitoring|Withdrawal by Subject|7|||
147660599|NCT01212094|532581337|FG001|Year 1: Baseline Monitoring|Withdrawal by Subject|0|||
147660600|NCT01212094|532581338|FG002|Year 1: Baseline Monitoring|Withdrawal by Subject|0|||
147660601|NCT01212094|532581336|FG000|Year 1: Baseline Monitoring|Started on DMT|2|||
147660602|NCT01212094|532581337|FG001|Year 1: Baseline Monitoring|Started on DMT|0|||
147660603|NCT01212094|532581338|FG002|Year 1: Baseline Monitoring|Started on DMT|0|||
147251615|NCT01957553|531092366|FG001|Test Period 2 (21 +- 1 Days)|Lack of Efficacy|2|||
147251616|NCT01957553|531092365|FG000|Test Period 2 (21 +- 1 Days)|completed early by mistake|0|||
147251617|NCT01957553|531092366|FG001|Test Period 2 (21 +- 1 Days)|completed early by mistake|1|||
147251618|NCT01957553|531092365|FG000|Test Period 2 (21 +- 1 Days)|device deficiency without AE|0|||
147251619|NCT01957553|531092366|FG001|Test Period 2 (21 +- 1 Days)|device deficiency without AE|1|||
147251620|NCT01957553|531092365|FG000|Test Period 2 (21 +- 1 Days)|Other|1|||
147660604|NCT01212094|532581336|FG000|Years 2 & 3: Treatment Randomization|Study terminated|0|||
147660605|NCT01212094|532581337|FG001|Years 2 & 3: Treatment Randomization|Study terminated|4|||
147251621|NCT01957553|531092366|FG001|Test Period 2 (21 +- 1 Days)|Other|0|||
147251622|NCT04044716|531092367|FG000|Overall Study|participant stopped treatment but submitted partial data.|1|||
147251623|NCT04044716|531092368|FG001|Overall Study|participant stopped treatment but submitted partial data.|0|||
147331606|NCT01070888|531380873|FG000|Washout (14 Days)|Physician Decision|1|||
147331607|NCT01070888|531380874|FG001|Washout (14 Days)|Physician Decision|0|||
147331608|NCT02631148|531380875|FG000|Overall Study|8 were ineligible|8|||
147331609|NCT02631148|531380876|FG001|Overall Study|8 were ineligible|0|||
147331610|NCT02631148|531380875|FG000|Overall Study|Withdrawal by Subject|1|||
147331611|NCT02631148|531380876|FG001|Overall Study|Withdrawal by Subject|0|||
147331612|NCT02631148|531380875|FG000|Overall Study|PAH not available to study participant|1|||
147331613|NCT02631148|531380876|FG001|Overall Study|PAH not available to study participant|0|||
147331614|NCT00487578|531380877|FG000|Overall Study|Adverse Event|1|||
147449915|NCT00880893|531811308|FG001|Overall Study|Serious adverse event|0|||
147660606|NCT01212094|532581338|FG002|Years 2 & 3: Treatment Randomization|Study terminated|7|||
147331615|NCT00487578|531380878|FG001|Overall Study|Adverse Event|2|||
147331616|NCT00487578|531380877|FG000|Overall Study|Lack of Efficacy|0|||
147331617|NCT00487578|531380878|FG001|Overall Study|Lack of Efficacy|1|||
147449916|NCT01982292|531811309|FG000|Overall Study|Adverse Event|2|||
147660607|NCT01212094|532581336|FG000|Years 2 & 3: Treatment Randomization|Withdrawal by Subject|0|||
147660608|NCT01212094|532581337|FG001|Years 2 & 3: Treatment Randomization|Withdrawal by Subject|0|||
147660609|NCT01212094|532581338|FG002|Years 2 & 3: Treatment Randomization|Withdrawal by Subject|3|||
147660610|NCT01212094|532581336|FG000|Years 2 & 3: Treatment Randomization|Adverse Event|0|||
147251624|NCT04044716|531092369|FG002|Overall Study|participant stopped treatment but submitted partial data.|0|||
147251625|NCT04044716|531092367|FG000|Overall Study|Lost to Follow-up|2|||
147251626|NCT04044716|531092368|FG001|Overall Study|Lost to Follow-up|3|||
147251627|NCT04044716|531092369|FG002|Overall Study|Lost to Follow-up|0|||
147251628|NCT01714635|531092378|FG000|Overall Study|Discontinued|1|||
147251629|NCT01714635|531092379|FG001|Overall Study|Discontinued|0|||
147251630|NCT01714635|531092380|FG002|Overall Study|Discontinued|2|||
147251631|NCT01714635|531092378|FG000|Overall Study|Missed 6-month exam|1|||
147251632|NCT01714635|531092379|FG001|Overall Study|Missed 6-month exam|0|||
147251633|NCT01714635|531092380|FG002|Overall Study|Missed 6-month exam|0|||
147251634|NCT03672747|531092381|FG000|Overall Study|Lost to Follow-up|1|||
147251635|NCT03672747|531092382|FG001|Overall Study|Lost to Follow-up|1|||
147251636|NCT03672747|531092383|FG002|Overall Study|Lost to Follow-up|2|||
147251637|NCT03672747|531092384|FG003|Overall Study|Lost to Follow-up|2|||
147251638|NCT03672747|531092385|FG004|Overall Study|Lost to Follow-up|2|||
147251639|NCT03672747|531092386|FG005|Overall Study|Lost to Follow-up|1|||
147251640|NCT04285879|531092387|FG000|Overall Study|Lost to Follow-up|1|||
147251641|NCT04285879|531092388|FG001|Overall Study|Lost to Follow-up|8|||
147251642|NCT04285879|531092387|FG000|Overall Study|medical/surgical exclusion|16|||
147251643|NCT04285879|531092388|FG001|Overall Study|medical/surgical exclusion|0|||
147251644|NCT00071513|531092391|FG000|Intervention Component|Withdrawal by Subject|2|||
147251645|NCT00071513|531092392|FG001|Intervention Component|Withdrawal by Subject|3|||
147251646|NCT00071513|531092391|FG000|Follow-up Assessment|Withdrawal by Subject|6|||
147251647|NCT00071513|531092392|FG001|Follow-up Assessment|Withdrawal by Subject|6|||
147251648|NCT03667924|531092393|FG000|Baseline Completed|Lost to Follow-up|0|||
147251649|NCT03667924|531092394|FG001|Baseline Completed|Lost to Follow-up|2|||
147251650|NCT03667924|531092395|FG002|Baseline Completed|Lost to Follow-up|0|||
147251651|NCT03667924|531092393|FG000|1-month Completed/Training (Volunteers)|One client was hospitalized;|1|||
147251652|NCT03667924|531092394|FG001|1-month Completed/Training (Volunteers)|One client was hospitalized;|0|||
147251653|NCT03667924|531092395|FG002|1-month Completed/Training (Volunteers)|One client was hospitalized;|0|||
147251654|NCT03667924|531092393|FG000|1-month Completed/Training (Volunteers)|Did not complete full training|0|||
147251655|NCT03667924|531092394|FG001|1-month Completed/Training (Volunteers)|Did not complete full training|16|||
147251656|NCT03667924|531092395|FG002|1-month Completed/Training (Volunteers)|Did not complete full training|0|||
147251657|NCT03667924|531092393|FG000|1-month Completed/Training (Volunteers)|Lost to Follow-up|0|||
147251658|NCT03667924|531092394|FG001|1-month Completed/Training (Volunteers)|Lost to Follow-up|0|||
147251659|NCT03667924|531092395|FG002|1-month Completed/Training (Volunteers)|Lost to Follow-up|1|||
147251660|NCT03667924|531092393|FG000|3-month/Volunteers Who Enrolled Clients|Death|1|||
147597295|NCT02799095|532345707|FG000|Part A|Rolled Over to Part C, Cohort 4|0|||
147597296|NCT02799095|532345708|FG001|Part A|Rolled Over to Part C, Cohort 4|0|||
147597297|NCT02799095|532345709|FG002|Part A|Rolled Over to Part C, Cohort 4|0|||
147597298|NCT02799095|532345710|FG003|Part A|Rolled Over to Part C, Cohort 4|0|||
147597299|NCT02799095|532345711|FG004|Part A|Rolled Over to Part C, Cohort 4|1|||
147597300|NCT02799095|532345712|FG005|Part A|Rolled Over to Part C, Cohort 4|2|||
147597301|NCT02799095|532345713|FG006|Part A|Rolled Over to Part C, Cohort 4|2|||
147597302|NCT02799095|532345714|FG007|Part A|Rolled Over to Part C, Cohort 4|0|||
147597303|NCT02799095|532345715|FG008|Part A|Rolled Over to Part C, Cohort 4|0|||
147597304|NCT02799095|532345716|FG009|Part A|Rolled Over to Part C, Cohort 4|0|||
147597305|NCT02799095|532345717|FG010|Part A|Rolled Over to Part C, Cohort 4|0|||
147597306|NCT02799095|532345718|FG011|Part A|Rolled Over to Part C, Cohort 4|0|||
147660611|NCT01212094|532581337|FG001|Years 2 & 3: Treatment Randomization|Adverse Event|0|||
147331618|NCT00487578|531380877|FG000|Overall Study|Lost to Follow-up|0|||
147331619|NCT00487578|531380878|FG001|Overall Study|Lost to Follow-up|1|||
147331620|NCT02525796|531380883|FG000|Randomization to Monotherapy for 4 Weeks|Adverse Event|1|||
147331621|NCT02525796|531380884|FG001|Randomization to Monotherapy for 4 Weeks|Adverse Event|1|||
147331622|NCT02525796|531380885|FG002|Randomization to Monotherapy for 4 Weeks|Adverse Event|1|||
147331623|NCT02525796|531380883|FG000|Randomization to Monotherapy for 4 Weeks|Lost to Follow-up|1|||
147331624|NCT02525796|531380884|FG001|Randomization to Monotherapy for 4 Weeks|Lost to Follow-up|0|||
147331625|NCT02525796|531380885|FG002|Randomization to Monotherapy for 4 Weeks|Lost to Follow-up|0|||
147331626|NCT02525796|531380883|FG000|Randomization to Monotherapy for 4 Weeks|Physician Decision|0|||
147449917|NCT01982292|531811310|FG001|Overall Study|Adverse Event|0|||
147331627|NCT02525796|531380884|FG001|Randomization to Monotherapy for 4 Weeks|Physician Decision|1|||
147331628|NCT02525796|531380885|FG002|Randomization to Monotherapy for 4 Weeks|Physician Decision|0|||
147331629|NCT02525796|531380883|FG000|Open-label Addition of Cinacalcet|Withdrawal by Subject|2|||
147331630|NCT02525796|531380884|FG001|Open-label Addition of Cinacalcet|Withdrawal by Subject|0|||
147331631|NCT02525796|531380885|FG002|Open-label Addition of Cinacalcet|Withdrawal by Subject|1|||
147449918|NCT01982292|531811309|FG000|Overall Study|Death|1|||
147251661|NCT03667924|531092394|FG001|3-month/Volunteers Who Enrolled Clients|Death|0|||
147251662|NCT03667924|531092395|FG002|3-month/Volunteers Who Enrolled Clients|Death|0|||
147331632|NCT02525796|531380883|FG000|Open-label Addition of Cinacalcet|Adverse Event|2|||
147597307|NCT02799095|532345719|FG012|Part A|Rolled Over to Part C, Cohort 4|0|||
147597308|NCT02799095|532345720|FG013|Part A|Rolled Over to Part C, Cohort 4|0|||
147597309|NCT02799095|532345721|FG014|Part A|Rolled Over to Part C, Cohort 4|0|||
147597310|NCT02799095|532345722|FG015|Part A|Rolled Over to Part C, Cohort 4|0|||
147597311|NCT02799095|532345723|FG016|Part A|Rolled Over to Part C, Cohort 4|0|||
147597312|NCT02799095|532345707|FG000|Part B|Death|0|||
147597313|NCT02799095|532345708|FG001|Part B|Death|0|||
147597314|NCT02799095|532345709|FG002|Part B|Death|0|||
147597315|NCT02799095|532345710|FG003|Part B|Death|0|||
147597316|NCT02799095|532345711|FG004|Part B|Death|0|||
147597317|NCT02799095|532345712|FG005|Part B|Death|0|||
147597318|NCT02799095|532345713|FG006|Part B|Death|0|||
147597319|NCT02799095|532345714|FG007|Part B|Death|7|||
147597320|NCT02799095|532345715|FG008|Part B|Death|7|||
147597321|NCT02799095|532345716|FG009|Part B|Death|0|||
147597322|NCT02799095|532345717|FG010|Part B|Death|0|||
147597323|NCT02799095|532345718|FG011|Part B|Death|0|||
147597324|NCT02799095|532345719|FG012|Part B|Death|0|||
147597325|NCT02799095|532345720|FG013|Part B|Death|0|||
147597326|NCT02799095|532345721|FG014|Part B|Death|0|||
147597327|NCT02799095|532345722|FG015|Part B|Death|0|||
147597328|NCT02799095|532345723|FG016|Part B|Death|0|||
147597329|NCT02799095|532345707|FG000|Part B|Progressive Disease|0|||
147597330|NCT02799095|532345708|FG001|Part B|Progressive Disease|0|||
147597331|NCT02799095|532345709|FG002|Part B|Progressive Disease|0|||
147597332|NCT02799095|532345710|FG003|Part B|Progressive Disease|0|||
147597333|NCT02799095|532345711|FG004|Part B|Progressive Disease|0|||
147597334|NCT02799095|532345712|FG005|Part B|Progressive Disease|0|||
147597335|NCT02799095|532345713|FG006|Part B|Progressive Disease|0|||
147597336|NCT02799095|532345714|FG007|Part B|Progressive Disease|1|||
147597337|NCT02799095|532345715|FG008|Part B|Progressive Disease|0|||
147597338|NCT02799095|532345716|FG009|Part B|Progressive Disease|0|||
147597339|NCT02799095|532345717|FG010|Part B|Progressive Disease|0|||
147597340|NCT02799095|532345718|FG011|Part B|Progressive Disease|0|||
147597341|NCT02799095|532345719|FG012|Part B|Progressive Disease|0|||
147597342|NCT02799095|532345720|FG013|Part B|Progressive Disease|0|||
147597343|NCT02799095|532345721|FG014|Part B|Progressive Disease|0|||
147597344|NCT02799095|532345722|FG015|Part B|Progressive Disease|0|||
147597345|NCT02799095|532345723|FG016|Part B|Progressive Disease|0|||
147597346|NCT02799095|532345707|FG000|Part B|Withdrawal by Subject|0|||
147597347|NCT02799095|532345708|FG001|Part B|Withdrawal by Subject|0|||
147597348|NCT02799095|532345709|FG002|Part B|Withdrawal by Subject|0|||
147597349|NCT02799095|532345710|FG003|Part B|Withdrawal by Subject|0|||
147597350|NCT02799095|532345711|FG004|Part B|Withdrawal by Subject|0|||
147597351|NCT02799095|532345712|FG005|Part B|Withdrawal by Subject|0|||
147597352|NCT02799095|532345713|FG006|Part B|Withdrawal by Subject|0|||
147597353|NCT02799095|532345714|FG007|Part B|Withdrawal by Subject|10|||
147597354|NCT02799095|532345715|FG008|Part B|Withdrawal by Subject|7|||
147597355|NCT02799095|532345716|FG009|Part B|Withdrawal by Subject|0|||
147597356|NCT02799095|532345717|FG010|Part B|Withdrawal by Subject|0|||
147597357|NCT02799095|532345718|FG011|Part B|Withdrawal by Subject|0|||
147597358|NCT02799095|532345719|FG012|Part B|Withdrawal by Subject|0|||
147597359|NCT02799095|532345720|FG013|Part B|Withdrawal by Subject|0|||
147597360|NCT02799095|532345721|FG014|Part B|Withdrawal by Subject|0|||
147597361|NCT02799095|532345722|FG015|Part B|Withdrawal by Subject|0|||
147597362|NCT02799095|532345723|FG016|Part B|Withdrawal by Subject|0|||
147597363|NCT02799095|532345707|FG000|Part B|Rolled Over to Part C, Cohort 4|0|||
147660612|NCT01212094|532581338|FG002|Years 2 & 3: Treatment Randomization|Adverse Event|1|||
147660613|NCT04980014|532581348|FG000|Overall Study|Participants who are Duplicated|1|||
147660614|NCT04980014|532581348|FG000|Overall Study|Follow-up Failure|13|||
147251663|NCT03667924|531092393|FG000|3-month/Volunteers Who Enrolled Clients|Few clients had memory loss, thus only 5 of 15 volunteers were able to apply their training|0|||
147251664|NCT03667924|531092394|FG001|3-month/Volunteers Who Enrolled Clients|Few clients had memory loss, thus only 5 of 15 volunteers were able to apply their training|10|||
147251665|NCT03667924|531092395|FG002|3-month/Volunteers Who Enrolled Clients|Few clients had memory loss, thus only 5 of 15 volunteers were able to apply their training|0|||
147251666|NCT03667924|531092393|FG000|Post-study Interview Completed|Lost to Follow-up|0|||
147251667|NCT03667924|531092394|FG001|Post-study Interview Completed|Lost to Follow-up|1|||
147251668|NCT03667924|531092395|FG002|Post-study Interview Completed|Lost to Follow-up|0|||
147251669|NCT03358290|531092396|FG000|Overall Study|Study discontinued by Sponsor|0|||
147597364|NCT02799095|532345708|FG001|Part B|Rolled Over to Part C, Cohort 4|0|||
147597365|NCT02799095|532345709|FG002|Part B|Rolled Over to Part C, Cohort 4|0|||
147597366|NCT02799095|532345710|FG003|Part B|Rolled Over to Part C, Cohort 4|0|||
147597367|NCT02799095|532345711|FG004|Part B|Rolled Over to Part C, Cohort 4|0|||
147597368|NCT02799095|532345712|FG005|Part B|Rolled Over to Part C, Cohort 4|0|||
147597369|NCT02799095|532345713|FG006|Part B|Rolled Over to Part C, Cohort 4|0|||
147597370|NCT02799095|532345714|FG007|Part B|Rolled Over to Part C, Cohort 4|26|||
147660615|NCT04980014|532581348|FG000|Overall Study|Participants who did not Receive NesinaAct® Tablet|2|||
147597371|NCT02799095|532345715|FG008|Part B|Rolled Over to Part C, Cohort 4|12|||
147597372|NCT02799095|532345716|FG009|Part B|Rolled Over to Part C, Cohort 4|0|||
147597373|NCT02799095|532345717|FG010|Part B|Rolled Over to Part C, Cohort 4|0|||
147597374|NCT02799095|532345718|FG011|Part B|Rolled Over to Part C, Cohort 4|0|||
147597375|NCT02799095|532345719|FG012|Part B|Rolled Over to Part C, Cohort 4|0|||
147251670|NCT03358290|531092397|FG001|Overall Study|Study discontinued by Sponsor|1|||
147251671|NCT03358290|531092398|FG002|Overall Study|Study discontinued by Sponsor|1|||
147251672|NCT03358290|531092399|FG003|Overall Study|Study discontinued by Sponsor|0|||
147251673|NCT03358290|531092400|FG004|Overall Study|Study discontinued by Sponsor|0|||
147251674|NCT03358290|531092396|FG000|Overall Study|Adverse Event|0|||
147251675|NCT03358290|531092397|FG001|Overall Study|Adverse Event|0|||
147251676|NCT03358290|531092398|FG002|Overall Study|Adverse Event|1|||
147251677|NCT03358290|531092399|FG003|Overall Study|Adverse Event|2|||
147251678|NCT03358290|531092400|FG004|Overall Study|Adverse Event|0|||
147251679|NCT03358290|531092396|FG000|Overall Study|Withdrawal by Subject|0|||
147251680|NCT03358290|531092397|FG001|Overall Study|Withdrawal by Subject|0|||
147251681|NCT03358290|531092398|FG002|Overall Study|Withdrawal by Subject|0|||
147251682|NCT03358290|531092399|FG003|Overall Study|Withdrawal by Subject|0|||
147251683|NCT03358290|531092400|FG004|Overall Study|Withdrawal by Subject|1|||
147251684|NCT02743871|531092401|FG000|Overall Study|Lost to Follow-up|0|||
147251685|NCT02743871|531092402|FG001|Overall Study|Lost to Follow-up|0|||
147251686|NCT02743871|531092403|FG002|Overall Study|Lost to Follow-up|0|||
147251687|NCT02743871|531092404|FG003|Overall Study|Lost to Follow-up|1|||
147251688|NCT02743871|531092405|FG004|Overall Study|Lost to Follow-up|0|||
147251689|NCT02743871|531092406|FG005|Overall Study|Lost to Follow-up|0|||
147251690|NCT02743871|531092407|FG006|Overall Study|Lost to Follow-up|1|||
147251691|NCT02743871|531092408|FG007|Overall Study|Lost to Follow-up|0|||
147251692|NCT02743871|531092409|FG008|Overall Study|Lost to Follow-up|0|||
147251693|NCT02743871|531092410|FG009|Overall Study|Lost to Follow-up|0|||
147251694|NCT02743871|531092411|FG010|Overall Study|Lost to Follow-up|0|||
147251695|NCT02743871|531092412|FG011|Overall Study|Lost to Follow-up|2|||
147251696|NCT02743871|531092413|FG012|Overall Study|Lost to Follow-up|0|||
147251697|NCT02743871|531092414|FG013|Overall Study|Lost to Follow-up|0|||
147251698|NCT02743871|531092401|FG000|Overall Study|Withdrawal by Subject|0|||
147251699|NCT02743871|531092402|FG001|Overall Study|Withdrawal by Subject|0|||
147251700|NCT02743871|531092403|FG002|Overall Study|Withdrawal by Subject|0|||
147251701|NCT02743871|531092404|FG003|Overall Study|Withdrawal by Subject|0|||
147251702|NCT02743871|531092405|FG004|Overall Study|Withdrawal by Subject|0|||
147251703|NCT02743871|531092406|FG005|Overall Study|Withdrawal by Subject|0|||
147251704|NCT02743871|531092407|FG006|Overall Study|Withdrawal by Subject|0|||
147251705|NCT02743871|531092408|FG007|Overall Study|Withdrawal by Subject|0|||
147251706|NCT02743871|531092409|FG008|Overall Study|Withdrawal by Subject|0|||
147251707|NCT02743871|531092410|FG009|Overall Study|Withdrawal by Subject|0|||
147251708|NCT02743871|531092411|FG010|Overall Study|Withdrawal by Subject|1|||
147251709|NCT02743871|531092412|FG011|Overall Study|Withdrawal by Subject|0|||
147251710|NCT02743871|531092413|FG012|Overall Study|Withdrawal by Subject|12|||
147251711|NCT02743871|531092414|FG013|Overall Study|Withdrawal by Subject|6|||
147251712|NCT02743871|531092401|FG000|Overall Study|Adverse Event|1|||
147251713|NCT02743871|531092402|FG001|Overall Study|Adverse Event|0|||
147251714|NCT02743871|531092403|FG002|Overall Study|Adverse Event|0|||
147251715|NCT02743871|531092404|FG003|Overall Study|Adverse Event|0|||
147251716|NCT02743871|531092405|FG004|Overall Study|Adverse Event|0|||
147251717|NCT02743871|531092406|FG005|Overall Study|Adverse Event|0|||
147251718|NCT02743871|531092407|FG006|Overall Study|Adverse Event|0|||
147251719|NCT02743871|531092408|FG007|Overall Study|Adverse Event|0|||
147251720|NCT02743871|531092409|FG008|Overall Study|Adverse Event|0|||
147251721|NCT02743871|531092410|FG009|Overall Study|Adverse Event|0|||
147251722|NCT02743871|531092411|FG010|Overall Study|Adverse Event|0|||
147251723|NCT02743871|531092412|FG011|Overall Study|Adverse Event|0|||
147251724|NCT02743871|531092413|FG012|Overall Study|Adverse Event|0|||
147251725|NCT02743871|531092414|FG013|Overall Study|Adverse Event|0|||
147251726|NCT02743871|531092401|FG000|Overall Study|Other|0|||
147251727|NCT02743871|531092402|FG001|Overall Study|Other|0|||
147251728|NCT02743871|531092403|FG002|Overall Study|Other|0|||
147251729|NCT02743871|531092404|FG003|Overall Study|Other|0|||
147251730|NCT02743871|531092405|FG004|Overall Study|Other|0|||
147251731|NCT02743871|531092406|FG005|Overall Study|Other|0|||
147251732|NCT02743871|531092407|FG006|Overall Study|Other|0|||
147251733|NCT02743871|531092408|FG007|Overall Study|Other|0|||
147251734|NCT02743871|531092409|FG008|Overall Study|Other|0|||
147251735|NCT02743871|531092410|FG009|Overall Study|Other|0|||
147251736|NCT02743871|531092411|FG010|Overall Study|Other|0|||
147251737|NCT02743871|531092412|FG011|Overall Study|Other|1|||
147251738|NCT02743871|531092413|FG012|Overall Study|Other|1|||
147251739|NCT02743871|531092414|FG013|Overall Study|Other|1|||
147251740|NCT02743871|531092401|FG000|Overall Study|Protocol Violation|0|||
147251741|NCT02743871|531092402|FG001|Overall Study|Protocol Violation|0|||
147251742|NCT02743871|531092403|FG002|Overall Study|Protocol Violation|0|||
147251743|NCT02743871|531092404|FG003|Overall Study|Protocol Violation|0|||
147251744|NCT02743871|531092405|FG004|Overall Study|Protocol Violation|0|||
147251745|NCT02743871|531092406|FG005|Overall Study|Protocol Violation|0|||
147251746|NCT02743871|531092407|FG006|Overall Study|Protocol Violation|0|||
147251747|NCT02743871|531092408|FG007|Overall Study|Protocol Violation|0|||
147251748|NCT02743871|531092409|FG008|Overall Study|Protocol Violation|0|||
147251749|NCT02743871|531092410|FG009|Overall Study|Protocol Violation|0|||
147251750|NCT02743871|531092411|FG010|Overall Study|Protocol Violation|0|||
147251751|NCT02743871|531092412|FG011|Overall Study|Protocol Violation|0|||
147251752|NCT02743871|531092413|FG012|Overall Study|Protocol Violation|2|||
147251753|NCT02743871|531092414|FG013|Overall Study|Protocol Violation|0|||
147251754|NCT02484729|531092416|FG000|Overall Study|Failure of IntelliCap Error|0|||
147251755|NCT02484729|531092417|FG001|Overall Study|Failure of IntelliCap Error|0|||
147251756|NCT02484729|531092418|FG002|Overall Study|Failure of IntelliCap Error|0|||
147251757|NCT02484729|531092419|FG003|Overall Study|Failure of IntelliCap Error|0|||
147251758|NCT02484729|531092420|FG004|Overall Study|Failure of IntelliCap Error|0|||
147251759|NCT02484729|531092421|FG005|Overall Study|Failure of IntelliCap Error|0|||
147251760|NCT02484729|531092422|FG006|Overall Study|Failure of IntelliCap Error|0|||
147251761|NCT02484729|531092423|FG007|Overall Study|Failure of IntelliCap Error|0|||
147251762|NCT02484729|531092424|FG008|Overall Study|Failure of IntelliCap Error|0|||
147251763|NCT02484729|531092425|FG009|Overall Study|Failure of IntelliCap Error|1|||
147251764|NCT04772755|531092428|FG000|Overall Study|Withdrawal by Subject|1|||
147251765|NCT04772755|531092429|FG001|Overall Study|Withdrawal by Subject|0|||
147251766|NCT04772755|531092428|FG000|Overall Study|Randomized and subsequently determined to be ineligible|2|||
147251767|NCT04772755|531092429|FG001|Overall Study|Randomized and subsequently determined to be ineligible|3|||
147251768|NCT02480114|531092430|FG000|Overall Study|Not completing surveys|3|||
147251769|NCT02480114|531092431|FG001|Overall Study|Not completing surveys|2|||
147251770|NCT02480114|531092430|FG000|Overall Study|Withdrawal by Subject|2|||
147251771|NCT02480114|531092431|FG001|Overall Study|Withdrawal by Subject|4|||
147251772|NCT02480114|531092430|FG000|Overall Study|Disease progression|3|||
147251773|NCT02480114|531092431|FG001|Overall Study|Disease progression|0|||
147251774|NCT02480114|531092430|FG000|Overall Study|Improper completion of survey|1|||
147251775|NCT02480114|531092431|FG001|Overall Study|Improper completion of survey|1|||
147251776|NCT02480114|531092430|FG000|Overall Study|Not eligible|0|||
147251777|NCT02480114|531092431|FG001|Overall Study|Not eligible|1|||
147251778|NCT01535053|531092432|FG000|Overall Study|Ineligible|1|||
147251779|NCT01535053|531092433|FG001|Overall Study|Ineligible|2|||
147251780|NCT01031069|531092434|FG000|Overall Study|Serious Adverse Event|0|||
147251781|NCT01031069|531092435|FG001|Overall Study|Serious Adverse Event|1|||
147251782|NCT01031069|531092436|FG002|Overall Study|Serious Adverse Event|0|||
147251783|NCT01031069|531092437|FG003|Overall Study|Serious Adverse Event|0|||
147251784|NCT01031069|531092434|FG000|Overall Study|Withdrawal by Subject|2|||
147251785|NCT01031069|531092435|FG001|Overall Study|Withdrawal by Subject|3|||
147251786|NCT01031069|531092436|FG002|Overall Study|Withdrawal by Subject|18|||
147251787|NCT01031069|531092437|FG003|Overall Study|Withdrawal by Subject|18|||
147251788|NCT01031069|531092434|FG000|Overall Study|Migrated/moved from study area|1|||
147251789|NCT01031069|531092435|FG001|Overall Study|Migrated/moved from study area|2|||
147251790|NCT01031069|531092436|FG002|Overall Study|Migrated/moved from study area|1|||
147251791|NCT01031069|531092437|FG003|Overall Study|Migrated/moved from study area|1|||
147251792|NCT01031069|531092434|FG000|Overall Study|Lost to Follow-up|9|||
147251793|NCT01031069|531092435|FG001|Overall Study|Lost to Follow-up|5|||
147251794|NCT01031069|531092436|FG002|Overall Study|Lost to Follow-up|21|||
147251795|NCT01031069|531092437|FG003|Overall Study|Lost to Follow-up|15|||
147251796|NCT01031069|531092434|FG000|Overall Study|Other|0|||
147251797|NCT01031069|531092435|FG001|Overall Study|Other|0|||
147251798|NCT01031069|531092436|FG002|Overall Study|Other|1|||
147251799|NCT01031069|531092437|FG003|Overall Study|Other|0|||
147251800|NCT00512707|531092438|FG000|Overall Study|Lost to Follow-up|5|||
147251801|NCT00512707|531092439|FG001|Overall Study|Lost to Follow-up|11|||
147251802|NCT00512707|531092438|FG000|Overall Study|Developed skin irritation|2|||
147251803|NCT00512707|531092439|FG001|Overall Study|Developed skin irritation|1|||
147251804|NCT00512707|531092438|FG000|Overall Study|Developed a hematocrit exceeding 0.54|2|||
147251805|NCT00512707|531092439|FG001|Overall Study|Developed a hematocrit exceeding 0.54|0|||
147251806|NCT00512707|531092438|FG000|Overall Study|Unable to tolerate the smell of the gel|1|||
147331633|NCT02525796|531380884|FG001|Open-label Addition of Cinacalcet|Adverse Event|2|||
147331634|NCT02525796|531380885|FG002|Open-label Addition of Cinacalcet|Adverse Event|2|||
147331635|NCT00726999|531380886|FG000|Overall Study|Physician Decision|0|||
147331636|NCT00726999|531380887|FG001|Overall Study|Physician Decision|1|||
147331637|NCT00726999|531380886|FG000|Overall Study|Withdrawal by Subject|2|||
147331638|NCT00726999|531380887|FG001|Overall Study|Withdrawal by Subject|0|||
147251807|NCT00512707|531092439|FG001|Overall Study|Unable to tolerate the smell of the gel|0|||
147251808|NCT01317160|531092440|FG000|Overall Study|Incorrect inclusion|1|||
147251809|NCT01317160|531092441|FG001|Overall Study|Incorrect inclusion|1|||
147251810|NCT01317160|531092440|FG000|Overall Study|Lost to Follow-up|3|||
147251811|NCT01317160|531092441|FG001|Overall Study|Lost to Follow-up|3|||
147251812|NCT01317160|531092440|FG000|Overall Study|Withdrawal by Subject|0|||
147251813|NCT01317160|531092441|FG001|Overall Study|Withdrawal by Subject|2|||
147251814|NCT03032705|531092443|FG000|Overall Study|Lost to Follow-up|16|||
147331639|NCT00726999|531380886|FG000|Overall Study|Protocol Violation|1|||
147331640|NCT00726999|531380887|FG001|Overall Study|Protocol Violation|0|||
147331641|NCT00955825|531380888|FG000|Overall Study|Adverse Event|15|||
147251815|NCT03032705|531092444|FG001|Overall Study|Lost to Follow-up|17|||
147251816|NCT03032705|531092443|FG000|Overall Study|did not quality|6|||
147251817|NCT03032705|531092444|FG001|Overall Study|did not quality|6|||
147251818|NCT04405037|531092447|FG000|Overall Study|Withdrawal by Subject|1|||
147251819|NCT04405037|531092448|FG001|Overall Study|Withdrawal by Subject|0|||
147251820|NCT04405037|531092447|FG000|Overall Study|Screen Failure- Received Alvimopan Preoperatively|1|||
147251821|NCT04405037|531092448|FG001|Overall Study|Screen Failure- Received Alvimopan Preoperatively|0|||
147251822|NCT02664441|531094303|FG000|Randomization|Withdrawal by Subject|0|||
147251823|NCT02664441|531094304|FG001|Randomization|Withdrawal by Subject|1|||
147251824|NCT02664441|531094303|FG000|36-week Randomized Trial|Adverse Event|2|||
147251825|NCT02664441|531094304|FG001|36-week Randomized Trial|Adverse Event|0|||
147251826|NCT02664441|531094303|FG000|36-week Randomized Trial|Lost to Follow-up|1|||
147251827|NCT02664441|531094304|FG001|36-week Randomized Trial|Lost to Follow-up|0|||
147251828|NCT02664441|531094303|FG000|36-week Randomized Trial|Withdrawal by Subject|0|||
147251829|NCT02664441|531094304|FG001|36-week Randomized Trial|Withdrawal by Subject|3|||
147251830|NCT02664441|531094303|FG000|18-week Open Label Extension|Adverse Event|1|||
147251831|NCT02664441|531094304|FG001|18-week Open Label Extension|Adverse Event|0|||
147251832|NCT02664441|531094303|FG000|18-week Open Label Extension|Physician Decision|1|||
147251833|NCT02664441|531094304|FG001|18-week Open Label Extension|Physician Decision|0|||
147251834|NCT02664441|531094303|FG000|18-week Open Label Extension|Death|1|||
147251835|NCT02664441|531094304|FG001|18-week Open Label Extension|Death|0|||
147251836|NCT02664441|531094303|FG000|18-week Open Label Extension|Lost to Follow-up|0|||
147251837|NCT02664441|531094304|FG001|18-week Open Label Extension|Lost to Follow-up|1|||
147251838|NCT05040386|531094305|FG000|Overall Study|Withdrawal by Subject|1|||
147251839|NCT05040386|531094306|FG001|Overall Study|Withdrawal by Subject|0|||
147251840|NCT05040386|531094307|FG002|Overall Study|Withdrawal by Subject|1|||
147251841|NCT05040386|531094308|FG003|Overall Study|Withdrawal by Subject|0|||
147251842|NCT05040386|531094305|FG000|Overall Study|Lost to Follow-up|0|||
147251843|NCT05040386|531094306|FG001|Overall Study|Lost to Follow-up|0|||
147251844|NCT05040386|531094307|FG002|Overall Study|Lost to Follow-up|1|||
147251845|NCT05040386|531094308|FG003|Overall Study|Lost to Follow-up|0|||
147251846|NCT00715078|531094310|FG000|Overall Study|Death|29|||
147251847|NCT00715078|531094311|FG001|Overall Study|Death|36|||
147251848|NCT00715078|531094312|FG002|Overall Study|Death|36|||
147251849|NCT00715078|531094310|FG000|Overall Study|Withdrawal by Subject|1|||
147251850|NCT00715078|531094311|FG001|Overall Study|Withdrawal by Subject|0|||
147251851|NCT00715078|531094312|FG002|Overall Study|Withdrawal by Subject|1|||
147251852|NCT00715078|531094310|FG000|Overall Study|Unable to start due to disease prog.|0|||
147251853|NCT00715078|531094311|FG001|Overall Study|Unable to start due to disease prog.|0|||
147251854|NCT00715078|531094312|FG002|Overall Study|Unable to start due to disease prog.|1|||
147251855|NCT02892760|531094313|FG000|Overall Study|Withdrawal by Subject|3|||
147251856|NCT00386776|531094316|FG000|Overall Study|Withdrawal by Subject|8|||
147251857|NCT00588848|531094317|FG000|Overall Study|Physician Decision|0|||
147251858|NCT00588848|531094318|FG001|Overall Study|Physician Decision|3|||
147251859|NCT00249444|531094319|FG000|Overall Study|Lost to Follow-up|2|||
147251860|NCT00249444|531094320|FG001|Overall Study|Lost to Follow-up|2|||
147251861|NCT00249444|531094319|FG000|Overall Study|non-compliant|9|||
147251862|NCT00249444|531094320|FG001|Overall Study|non-compliant|11|||
147251863|NCT00249444|531094319|FG000|Overall Study|Adverse Event|1|||
147251864|NCT00249444|531094320|FG001|Overall Study|Adverse Event|1|||
147251865|NCT00249444|531094319|FG000|Overall Study|life event|0|||
147251866|NCT00249444|531094320|FG001|Overall Study|life event|1|||
147251867|NCT02673489|531094321|FG000|Treatment Period|Lost to Follow-up|3|||
147251868|NCT02673489|531094322|FG001|Treatment Period|Lost to Follow-up|0|||
147251869|NCT02673489|531094321|FG000|Treatment Period|Participant request to discontinue|1|||
147251870|NCT02673489|531094322|FG001|Treatment Period|Participant request to discontinue|1|||
147251871|NCT02673489|531094321|FG000|Treatment Period|Participant moved to another province|1|||
147251872|NCT02673489|531094322|FG001|Treatment Period|Participant moved to another province|0|||
147251873|NCT02673489|531094321|FG000|Treatment Period|Participant was incarcerated|0|||
147251874|NCT02673489|531094322|FG001|Treatment Period|Participant was incarcerated|1|||
147251875|NCT02673489|531094321|FG000|Treatment Period|Adverse Event|0|||
147251876|NCT02673489|531094322|FG001|Treatment Period|Adverse Event|1|||
147251877|NCT02673489|531094321|FG000|Follow Up Period|Unable to return for week 24 follow-up|0|||
147251878|NCT02673489|531094322|FG001|Follow Up Period|Unable to return for week 24 follow-up|1|||
147251879|NCT02673489|531094321|FG000|Follow Up Period|Unable to return for follow-up|0|||
147251880|NCT02673489|531094322|FG001|Follow Up Period|Unable to return for follow-up|1|||
147251881|NCT00082355|531094323|FG000|Initial Results of Thrombolytic Therapy|died of causes unrelated to protocol|1|||
147251882|NCT00082355|531094323|FG000|Initial Results of Thrombolytic Therapy|Withdrawal by Subject|1|||
147251883|NCT00082355|531094323|FG000|5 Year Recurrent Thromboembolism Rate|will be completed 2014|28|||
147251884|NCT00759863|531094324|FG000|Overall Study|Death, moved, or lost contact|20|||
147251885|NCT00759863|531094325|FG001|Overall Study|Death, moved, or lost contact|18|||
147251886|NCT00412854|531094326|FG000|Overall Study|Withdrawn due to adverse events|1|||
147597376|NCT02799095|532345720|FG013|Part B|Rolled Over to Part C, Cohort 4|0|||
147251887|NCT00412854|531094327|FG001|Overall Study|Withdrawn due to adverse events|5|||
147251888|NCT00412854|531094326|FG000|Overall Study|Withdrawn for other reasons|13|||
147597377|NCT02799095|532345721|FG014|Part B|Rolled Over to Part C, Cohort 4|0|||
147597378|NCT02799095|532345722|FG015|Part B|Rolled Over to Part C, Cohort 4|0|||
147597379|NCT02799095|532345723|FG016|Part B|Rolled Over to Part C, Cohort 4|0|||
147251889|NCT00412854|531094327|FG001|Overall Study|Withdrawn for other reasons|11|||
147251890|NCT01084174|531094328|FG000|Overall Study|gastrointestinal symptoms|1|||
147251891|NCT01084174|531094329|FG001|Overall Study|gastrointestinal symptoms|1|||
147251892|NCT01084174|531094328|FG000|Overall Study|Eosinophilic esophagitis|0|||
147251893|NCT01084174|531094329|FG001|Overall Study|Eosinophilic esophagitis|1|||
147251894|NCT01084174|531094328|FG000|Overall Study|Anaphylaxis|0|||
147251895|NCT01084174|531094329|FG001|Overall Study|Anaphylaxis|1|||
147251896|NCT01084174|531094328|FG000|Overall Study|Participant noncompliance|0|||
147251897|NCT01084174|531094329|FG001|Overall Study|Participant noncompliance|1|||
147251898|NCT01594125|531094330|FG000|Overall Study|Withdrawal by Subject|1|||
147251899|NCT01594125|531094331|FG001|Overall Study|Withdrawal by Subject|0|||
147251900|NCT01594125|531094332|FG002|Overall Study|Withdrawal by Subject|0|||
147251901|NCT01594125|531094333|FG003|Overall Study|Withdrawal by Subject|1|||
147251902|NCT01594125|531094334|FG004|Overall Study|Withdrawal by Subject|0|||
147251903|NCT01594125|531094330|FG000|Overall Study|Progressive Disease|3|||
147251904|NCT01594125|531094331|FG001|Overall Study|Progressive Disease|12|||
147251905|NCT01594125|531094332|FG002|Overall Study|Progressive Disease|3|||
147251906|NCT01594125|531094333|FG003|Overall Study|Progressive Disease|3|||
147251907|NCT01594125|531094334|FG004|Overall Study|Progressive Disease|7|||
147251908|NCT01484873|531094335|FG000|Overall Study|Withdrawal by Subject|2|||
147251909|NCT01549392|531094336|FG000|Overall Study|Withdrawal by Subject|1|||
147251910|NCT01549392|531094337|FG001|Overall Study|Withdrawal by Subject|0|||
147251911|NCT02743806|531094338|FG000|Overall Study|Adverse Event|9|||
147251912|NCT02743806|531094338|FG000|Overall Study|Lost to Follow-up|8|||
147251913|NCT02743806|531094338|FG000|Overall Study|Voluntary Withdrawal|54|||
147251914|NCT02743806|531094338|FG000|Overall Study|Study Termination|65|||
147251915|NCT02743806|531094338|FG000|Overall Study|Pregnancy|6|||
147251916|NCT02743806|531094338|FG000|Overall Study|No Longer Clinically Benefiting|27|||
147251917|NCT02743806|531094338|FG000|Overall Study|Reason Not Specified|12|||
147251918|NCT01988103|531094341|FG000|Placebo-Controlled Phase Week 0-16|Adverse Event|3|||
147251919|NCT01988103|531094342|FG001|Placebo-Controlled Phase Week 0-16|Adverse Event|10|||
147251920|NCT01988103|531094343|FG002|Placebo-Controlled Phase Week 0-16|Adverse Event|6|||
147251921|NCT01988103|531094344|FG003|Placebo-Controlled Phase Week 0-16|Adverse Event|0|||
147251922|NCT01988103|531094345|FG004|Placebo-Controlled Phase Week 0-16|Adverse Event|0|||
147251923|NCT01988103|531094341|FG000|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|1|||
147251924|NCT01988103|531094342|FG001|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|2|||
147251925|NCT01988103|531094343|FG002|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|2|||
147251926|NCT01988103|531094344|FG003|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|0|||
147251927|NCT01988103|531094345|FG004|Placebo-Controlled Phase Week 0-16|Lack of Efficacy|0|||
147251928|NCT01988103|531094341|FG000|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|8|||
147251929|NCT01988103|531094342|FG001|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|4|||
147251930|NCT01988103|531094343|FG002|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|1|||
147251931|NCT01988103|531094344|FG003|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|0|||
147251932|NCT01988103|531094345|FG004|Placebo-Controlled Phase Week 0-16|Withdrawal by Subject|0|||
147251933|NCT01988103|531094341|FG000|Active Treatment Phase (Weeks 16-68)|Adverse Event|0|||
147251934|NCT01988103|531094342|FG001|Active Treatment Phase (Weeks 16-68)|Adverse Event|6|||
147251935|NCT01988103|531094343|FG002|Active Treatment Phase (Weeks 16-68)|Adverse Event|3|||
147251936|NCT01988103|531094344|FG003|Active Treatment Phase (Weeks 16-68)|Adverse Event|3|||
147251937|NCT01988103|531094345|FG004|Active Treatment Phase (Weeks 16-68)|Adverse Event|2|||
147251938|NCT01988103|531094341|FG000|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|0|||
147251939|NCT01988103|531094342|FG001|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|1|||
147251940|NCT01988103|531094343|FG002|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|2|||
147251941|NCT01988103|531094344|FG003|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|0|||
147251942|NCT01988103|531094345|FG004|Active Treatment Phase (Weeks 16-68)|Lack of Efficacy|0|||
147251943|NCT01988103|531094341|FG000|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|0|||
147251944|NCT01988103|531094342|FG001|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|5|||
147251945|NCT01988103|531094343|FG002|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|4|||
147251946|NCT01988103|531094344|FG003|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|0|||
147251947|NCT01988103|531094345|FG004|Active Treatment Phase (Weeks 16-68)|Withdrawal by Subject|1|||
147251948|NCT01988103|531094341|FG000|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|0|||
147251949|NCT01988103|531094342|FG001|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|1|||
147251950|NCT01988103|531094343|FG002|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|2|||
147251951|NCT01988103|531094344|FG003|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|0|||
147251952|NCT01988103|531094345|FG004|Active Treatment Phase (Weeks 16-68)|Principal Investigator Signature Missing|2|||
147251953|NCT05492942|531094346|FG000|Overall Study|The clinician did not have an active patient panel eligible for outcome for the full 18 months|10|||
147331642|NCT00955825|531380889|FG001|Overall Study|Adverse Event|2|||
147251954|NCT05492942|531094347|FG001|Overall Study|The clinician did not have an active patient panel eligible for outcome for the full 18 months|7|||
147251955|NCT05492942|531094348|FG002|Overall Study|The clinician did not have an active patient panel eligible for outcome for the full 18 months|8|||
147251956|NCT05492942|531094349|FG003|Overall Study|The clinician did not have an active patient panel eligible for outcome for the full 18 months|13|||
147251957|NCT02598076|531094352|FG000|Overall Study|Lost to Follow-up|2|||
147251958|NCT02598076|531094353|FG001|Overall Study|Lost to Follow-up|3|||
147251959|NCT01946425|531094355|FG000|Overall Study|Protocol Violation|1|||
147251960|NCT01946425|531094356|FG001|Overall Study|Protocol Violation|0|||
147251961|NCT01946425|531094355|FG000|Overall Study|Withdrawal by Subject|1|||
147251962|NCT01946425|531094356|FG001|Overall Study|Withdrawal by Subject|0|||
147251963|NCT03454893|531094361|FG000|Overall Study|Study Terminated by the Sponsor|5|||
147251964|NCT03454893|531094361|FG000|Overall Study|Did not pass screening|4|||
147251965|NCT04876274|531094362|FG000|Overall Study|Lost to Follow-up|9|||
147251966|NCT04876274|531094363|FG001|Overall Study|Lost to Follow-up|12|||
147251967|NCT03414424|531094364|FG000|Overall Study|Screened out after consent|0|||
147251968|NCT03414424|531094365|FG001|Overall Study|Screened out after consent|2|||
147251969|NCT03414424|531094364|FG000|Overall Study|Lost to Follow-up|0|||
147251970|NCT03414424|531094365|FG001|Overall Study|Lost to Follow-up|1|||
147251971|NCT03070782|531094367|FG000|Overall Study|Adverse Event|3|||
147251972|NCT03070782|531094368|FG001|Overall Study|Adverse Event|0|||
147251973|NCT03070782|531094369|FG002|Overall Study|Adverse Event|3|||
147251974|NCT03070782|531094370|FG003|Overall Study|Adverse Event|1|||
147251975|NCT03070782|531094371|FG004|Overall Study|Adverse Event|6|||
147251976|NCT03070782|531094372|FG005|Overall Study|Adverse Event|2|||
147251977|NCT03070782|531094367|FG000|Overall Study|Withdrawal by Subject|2|||
147251978|NCT03070782|531094368|FG001|Overall Study|Withdrawal by Subject|1|||
147251979|NCT03070782|531094369|FG002|Overall Study|Withdrawal by Subject|1|||
147251980|NCT03070782|531094370|FG003|Overall Study|Withdrawal by Subject|0|||
147251981|NCT03070782|531094371|FG004|Overall Study|Withdrawal by Subject|4|||
147251982|NCT03070782|531094372|FG005|Overall Study|Withdrawal by Subject|3|||
147251983|NCT03070782|531094367|FG000|Overall Study|Reason Not Specified|2|||
147251984|NCT03070782|531094368|FG001|Overall Study|Reason Not Specified|0|||
147251985|NCT03070782|531094369|FG002|Overall Study|Reason Not Specified|0|||
147251986|NCT03070782|531094370|FG003|Overall Study|Reason Not Specified|1|||
147251987|NCT03070782|531094371|FG004|Overall Study|Reason Not Specified|2|||
147251988|NCT03070782|531094372|FG005|Overall Study|Reason Not Specified|1|||
147251989|NCT03070782|531094367|FG000|Overall Study|Ineligibility|0|||
147251990|NCT03070782|531094368|FG001|Overall Study|Ineligibility|0|||
147251991|NCT03070782|531094369|FG002|Overall Study|Ineligibility|0|||
147251992|NCT03070782|531094370|FG003|Overall Study|Ineligibility|1|||
147251993|NCT03070782|531094371|FG004|Overall Study|Ineligibility|0|||
147251994|NCT03070782|531094372|FG005|Overall Study|Ineligibility|1|||
147251995|NCT03070782|531094367|FG000|Overall Study|Pregnancy|0|||
147251996|NCT03070782|531094368|FG001|Overall Study|Pregnancy|0|||
147251997|NCT03070782|531094369|FG002|Overall Study|Pregnancy|0|||
147251998|NCT03070782|531094370|FG003|Overall Study|Pregnancy|1|||
147251999|NCT03070782|531094371|FG004|Overall Study|Pregnancy|0|||
147252000|NCT03070782|531094372|FG005|Overall Study|Pregnancy|0|||
147252001|NCT03070782|531094367|FG000|Overall Study|Investigator Judgement|0|||
147252002|NCT03070782|531094368|FG001|Overall Study|Investigator Judgement|0|||
147252003|NCT03070782|531094369|FG002|Overall Study|Investigator Judgement|0|||
147252004|NCT03070782|531094370|FG003|Overall Study|Investigator Judgement|1|||
147252005|NCT03070782|531094371|FG004|Overall Study|Investigator Judgement|0|||
147252006|NCT03070782|531094372|FG005|Overall Study|Investigator Judgement|0|||
147252007|NCT03527966|531094373|FG000|Overall Study|Lost to Follow-up|3|||
147252008|NCT03527966|531094374|FG001|Overall Study|Lost to Follow-up|0|||
147252009|NCT01948050|531094375|FG000|Overall Study|Withdrawal by Subject|0|||
147252010|NCT01948050|531094376|FG001|Overall Study|Withdrawal by Subject|1|||
147252011|NCT02288559|531094377|FG000|Overall Study|Adverse Event|1|||
147252012|NCT02288559|531094378|FG001|Overall Study|Adverse Event|1|||
147252013|NCT02288559|531094379|FG002|Overall Study|Adverse Event|5|||
147252014|NCT02288559|531094380|FG003|Overall Study|Adverse Event|0|||
147252015|NCT02288559|531094377|FG000|Overall Study|Death|0|||
147252016|NCT02288559|531094378|FG001|Overall Study|Death|0|||
147597380|NCT02799095|532345707|FG000|Part C|Adverse Event|0|||
147252017|NCT02288559|531094379|FG002|Overall Study|Death|1|||
147252018|NCT02288559|531094380|FG003|Overall Study|Death|0|||
147252019|NCT02288559|531094377|FG000|Overall Study|Lost to Follow-up|0|||
147252020|NCT02288559|531094378|FG001|Overall Study|Lost to Follow-up|0|||
147597381|NCT02799095|532345708|FG001|Part C|Adverse Event|0|||
147252021|NCT02288559|531094379|FG002|Overall Study|Lost to Follow-up|0|||
147252022|NCT02288559|531094380|FG003|Overall Study|Lost to Follow-up|1|||
147252023|NCT02288559|531094377|FG000|Overall Study|Withdrawal by Subject|0|||
147252024|NCT02288559|531094378|FG001|Overall Study|Withdrawal by Subject|0|||
147252025|NCT02288559|531094379|FG002|Overall Study|Withdrawal by Subject|2|||
147597382|NCT02799095|532345709|FG002|Part C|Adverse Event|0|||
147252026|NCT02288559|531094380|FG003|Overall Study|Withdrawal by Subject|1|||
147252027|NCT02288559|531094377|FG000|Overall Study|Reason Not Specified|0|||
147252028|NCT02288559|531094378|FG001|Overall Study|Reason Not Specified|0|||
147252029|NCT02288559|531094379|FG002|Overall Study|Reason Not Specified|3|||
147252030|NCT02288559|531094380|FG003|Overall Study|Reason Not Specified|0|||
147252031|NCT00558025|531094381|FG000|Overall Study|Adverse Event|1|||
147252032|NCT00558025|531094382|FG001|Overall Study|Adverse Event|1|||
147252033|NCT00558025|531094381|FG000|Overall Study|Withdrawal by Subject|2|||
147252034|NCT00558025|531094382|FG001|Overall Study|Withdrawal by Subject|2|||
147252035|NCT00558025|531094381|FG000|Overall Study|Protocol Violation|1|||
147252036|NCT00558025|531094382|FG001|Overall Study|Protocol Violation|0|||
147252037|NCT01314443|531094383|FG000|Overall Study|Withdrawal by Subject|2|||
147252038|NCT01314443|531094384|FG001|Overall Study|Withdrawal by Subject|1|||
147252039|NCT01314443|531094385|FG002|Overall Study|Withdrawal by Subject|1|||
147252040|NCT01314443|531094386|FG003|Overall Study|Withdrawal by Subject|1|||
147252041|NCT01314443|531094383|FG000|Overall Study|Protocol Violation|2|||
147252042|NCT01314443|531094384|FG001|Overall Study|Protocol Violation|2|||
147252043|NCT01314443|531094385|FG002|Overall Study|Protocol Violation|1|||
147252044|NCT01314443|531094386|FG003|Overall Study|Protocol Violation|1|||
147252045|NCT05247866|531094387|FG000|Overall Study|Adverse Event|2|||
147252046|NCT05247866|531094387|FG000|Overall Study|Lack of Efficacy|1|||
147252047|NCT05247866|531094387|FG000|Overall Study|Protocol Violation|1|||
147252048|NCT05247866|531094387|FG000|Overall Study|Withdrawal by Subject|3|||
147252049|NCT04463719|531094388|FG000|Overall Study|Exclusion criteria identified during clinical visit|2|||
147252050|NCT04463719|531094389|FG001|Overall Study|Exclusion criteria identified during clinical visit|2|||
147252051|NCT04463719|531094390|FG002|Overall Study|Exclusion criteria identified during clinical visit|0|||
147252052|NCT00333866|531094393|FG000|Overall Study|Adverse Event|23|||
147252053|NCT00333866|531094394|FG001|Overall Study|Adverse Event|37|||
147252054|NCT00333866|531094395|FG002|Overall Study|Adverse Event|38|||
147252055|NCT00333866|531094396|FG003|Overall Study|Adverse Event|47|||
147252056|NCT00333866|531094393|FG000|Overall Study|Other|3|||
147252057|NCT00333866|531094394|FG001|Overall Study|Other|2|||
147252058|NCT00333866|531094395|FG002|Overall Study|Other|2|||
147252059|NCT00333866|531094396|FG003|Overall Study|Other|2|||
147252060|NCT00333866|531094393|FG000|Overall Study|Lack of Efficacy|8|||
147252061|NCT00333866|531094394|FG001|Overall Study|Lack of Efficacy|6|||
147252062|NCT00333866|531094395|FG002|Overall Study|Lack of Efficacy|3|||
147252063|NCT00333866|531094396|FG003|Overall Study|Lack of Efficacy|5|||
147252064|NCT00333866|531094393|FG000|Overall Study|Lost to Follow-up|1|||
147252065|NCT00333866|531094394|FG001|Overall Study|Lost to Follow-up|2|||
147252066|NCT00333866|531094395|FG002|Overall Study|Lost to Follow-up|2|||
147252067|NCT00333866|531094396|FG003|Overall Study|Lost to Follow-up|2|||
147252068|NCT00333866|531094393|FG000|Overall Study|Withdrawal by Subject|8|||
147252069|NCT00333866|531094394|FG001|Overall Study|Withdrawal by Subject|14|||
147252070|NCT00333866|531094395|FG002|Overall Study|Withdrawal by Subject|4|||
147252071|NCT00333866|531094396|FG003|Overall Study|Withdrawal by Subject|9|||
147252072|NCT00333866|531094393|FG000|Overall Study|Randomized but not Treated|5|||
147252073|NCT00333866|531094394|FG001|Overall Study|Randomized but not Treated|3|||
147252074|NCT00333866|531094395|FG002|Overall Study|Randomized but not Treated|2|||
147252075|NCT00333866|531094396|FG003|Overall Study|Randomized but not Treated|1|||
147252076|NCT06073119|531094397|FG000|Overall Study|Adverse Event|1|||
147252077|NCT06073119|531094398|FG001|Overall Study|Adverse Event|3|||
147252078|NCT06073119|531094399|FG002|Overall Study|Adverse Event|0|||
147252079|NCT06073119|531094400|FG003|Overall Study|Adverse Event|0|||
147252080|NCT06073119|531094401|FG004|Overall Study|Adverse Event|1|||
147252081|NCT06073119|531094402|FG005|Overall Study|Adverse Event|0|||
147252082|NCT06073119|531094397|FG000|Overall Study|Non-compliance with study schedule|1|||
147331643|NCT00955825|531380888|FG000|Overall Study|Withdrawal by Subject|4|||
147331644|NCT00955825|531380889|FG001|Overall Study|Withdrawal by Subject|6|||
147331645|NCT00955825|531380888|FG000|Overall Study|Any other reason not above-mentioned|7|||
147331646|NCT00955825|531380889|FG001|Overall Study|Any other reason not above-mentioned|9|||
147331647|NCT00393848|531380894|FG000|Overall Study|Surgical schedule|0|||
147331648|NCT00393848|531380895|FG001|Overall Study|Surgical schedule|0|||
147331649|NCT00393848|531380896|FG002|Overall Study|Surgical schedule|0|||
147331650|NCT00393848|531380897|FG003|Overall Study|Surgical schedule|1|||
147449919|NCT01982292|531811310|FG001|Overall Study|Death|0|||
147449920|NCT01982292|531811309|FG000|Overall Study|Lost to Follow-up|2|||
147449921|NCT01982292|531811310|FG001|Overall Study|Lost to Follow-up|0|||
147449922|NCT01982292|531811309|FG000|Overall Study|Non-Compliance With Study Treatment|1|||
147252083|NCT06073119|531094398|FG001|Overall Study|Non-compliance with study schedule|0|||
147252084|NCT06073119|531094399|FG002|Overall Study|Non-compliance with study schedule|0|||
147252085|NCT06073119|531094400|FG003|Overall Study|Non-compliance with study schedule|0|||
147252086|NCT06073119|531094401|FG004|Overall Study|Non-compliance with study schedule|1|||
147252087|NCT06073119|531094402|FG005|Overall Study|Non-compliance with study schedule|0|||
147252088|NCT06073119|531094397|FG000|Overall Study|Withdrawal by Subject|4|||
147252089|NCT06073119|531094398|FG001|Overall Study|Withdrawal by Subject|4|||
147331651|NCT00393848|531380894|FG000|Overall Study|Personal reasons|0|||
147449923|NCT01982292|531811310|FG001|Overall Study|Non-Compliance With Study Treatment|0|||
147252090|NCT06073119|531094399|FG002|Overall Study|Withdrawal by Subject|3|||
147252091|NCT06073119|531094400|FG003|Overall Study|Withdrawal by Subject|5|||
147252092|NCT06073119|531094401|FG004|Overall Study|Withdrawal by Subject|3|||
147252093|NCT06073119|531094402|FG005|Overall Study|Withdrawal by Subject|1|||
147252094|NCT06073119|531094397|FG000|Overall Study|Other|2|||
147252095|NCT06073119|531094398|FG001|Overall Study|Other|4|||
147252096|NCT06073119|531094399|FG002|Overall Study|Other|1|||
147252097|NCT06073119|531094400|FG003|Overall Study|Other|0|||
147252098|NCT06073119|531094401|FG004|Overall Study|Other|1|||
147252099|NCT06073119|531094402|FG005|Overall Study|Other|0|||
147252100|NCT02393547|531094405|FG000|Overall Study|Adverse Event|2|||
147252101|NCT02393547|531094405|FG000|Overall Study|Withdrawal by Subject|3|||
147252102|NCT02393547|531094405|FG000|Overall Study|Lost to Follow-up|1|||
147252103|NCT02979522|531094406|FG000|Overall Study|Post-Treatment Follow-up (PFSFU and OSFU)|0|||
147252104|NCT02979522|531094407|FG001|Overall Study|Post-Treatment Follow-up (PFSFU and OSFU)|28|||
147252105|NCT02979522|531094406|FG000|Overall Study|Particpants Ongoing in Long-Term Safety Follow-Up|8|||
147252106|NCT02979522|531094407|FG001|Overall Study|Particpants Ongoing in Long-Term Safety Follow-Up|23|||
147252107|NCT05185089|531094408|FG000|First Intervention (4 weeks)|Adverse Event|0|||
147252108|NCT05185089|531094409|FG001|First Intervention (4 weeks)|Adverse Event|0|||
147252109|NCT05185089|531094410|FG002|First Intervention (4 weeks)|Adverse Event|0|||
147252110|NCT05185089|531094411|FG003|First Intervention (4 weeks)|Adverse Event|1|||
147252111|NCT05185089|531094408|FG000|Second Intervention (4 weeks)|Death|0|||
147252112|NCT05185089|531094409|FG001|Second Intervention (4 weeks)|Death|1|||
147252113|NCT05185089|531094410|FG002|Second Intervention (4 weeks)|Death|0|||
147252114|NCT05185089|531094411|FG003|Second Intervention (4 weeks)|Death|0|||
147252115|NCT05185089|531094408|FG000|Second Intervention (4 weeks)|Adverse Event|1|||
147252116|NCT05185089|531094409|FG001|Second Intervention (4 weeks)|Adverse Event|0|||
147252117|NCT05185089|531094410|FG002|Second Intervention (4 weeks)|Adverse Event|0|||
147252118|NCT05185089|531094411|FG003|Second Intervention (4 weeks)|Adverse Event|0|||
147252119|NCT00667368|531094412|FG000|Overall Study|Lost to Follow-up|176|||
147252120|NCT00667368|531094413|FG001|Overall Study|Lost to Follow-up|155|||
147331652|NCT00393848|531380895|FG001|Overall Study|Personal reasons|0|||
147331653|NCT00393848|531380896|FG002|Overall Study|Personal reasons|2|||
147252121|NCT00667368|531094412|FG000|Overall Study|Discontinued early|24|||
147252122|NCT00667368|531094413|FG001|Overall Study|Discontinued early|17|||
147252123|NCT00191789|531094415|FG000|Overall Study|Adverse Event|5|||
147252124|NCT00191789|531094415|FG000|Overall Study|Patient: Satisfactory Response|5|||
147252125|NCT00191789|531094415|FG000|Overall Study|Patient/Physician: Satisfactory Response|4|||
147252126|NCT00191789|531094415|FG000|Overall Study|Withdrawal by Subject|4|||
147252127|NCT00191789|531094415|FG000|Overall Study|Death - Possibly Study Drug Related|4|||
147252128|NCT00191789|531094415|FG000|Overall Study|Progressive Disease/Lack of Efficacy|2|||
147252129|NCT00191789|531094415|FG000|Overall Study|Death - Not Study-Drug Related|1|||
147252130|NCT05582889|531094416|FG000|Overall Study|Health event|3|||
147252131|NCT05582889|531094417|FG001|Overall Study|Health event|2|||
147252132|NCT05582889|531094416|FG000|Overall Study|Lost to Follow-up|2|||
147252133|NCT05582889|531094417|FG001|Overall Study|Lost to Follow-up|4|||
147252134|NCT06112756|531094418|FG000|Overall Study|Withdrawal by Subject|0|||
147252135|NCT06112756|531094419|FG001|Overall Study|Withdrawal by Subject|2|||
147252136|NCT06112756|531094418|FG000|Overall Study|Subject took an out of state job and had to early terminate|1|||
147252137|NCT06112756|531094419|FG001|Overall Study|Subject took an out of state job and had to early terminate|0|||
147252138|NCT06112756|531094418|FG000|Overall Study|Adverse Event|2|||
147252139|NCT06112756|531094419|FG001|Overall Study|Adverse Event|2|||
147252140|NCT04551092|531094420|FG000|Overall Study|Lost to Follow-up|7|||
147252141|NCT04551092|531094420|FG000|Overall Study|Withdrawal by Subject|4|||
147252142|NCT01712490|531094421|FG000|Overall Study|Ongoing|601|||
147252143|NCT01712490|531094422|FG001|Overall Study|Ongoing|586|||
147252144|NCT01712490|531094421|FG000|Overall Study|Other|11|||
147252145|NCT01712490|531094422|FG001|Overall Study|Other|11|||
147252146|NCT01712490|531094421|FG000|Overall Study|Withdrawal by Subject|36|||
147252147|NCT01712490|531094422|FG001|Overall Study|Withdrawal by Subject|44|||
147252148|NCT01712490|531094421|FG000|Overall Study|Lost to Follow-up|16|||
147252149|NCT01712490|531094422|FG001|Overall Study|Lost to Follow-up|29|||
147252150|NCT03060629|531094427|FG000|Overall Study|Death|4|||
147252151|NCT03060629|531094428|FG001|Overall Study|Death|5|||
147252152|NCT03060629|531094427|FG000|Overall Study|Withdrawal by Subject|50|||
147252153|NCT03060629|531094428|FG001|Overall Study|Withdrawal by Subject|35|||
147252154|NCT03060629|531094427|FG000|Overall Study|Unable to Adhere to Visit Schedule|21|||
147252155|NCT03060629|531094428|FG001|Overall Study|Unable to Adhere to Visit Schedule|23|||
147252156|NCT03060629|531094427|FG000|Overall Study|Participant Relocate|15|||
147252157|NCT03060629|531094428|FG001|Overall Study|Participant Relocate|15|||
147252158|NCT03060629|531094427|FG000|Overall Study|Unable to Contact Participant|34|||
147252159|NCT03060629|531094428|FG001|Overall Study|Unable to Contact Participant|23|||
147252160|NCT03060629|531094427|FG000|Overall Study|Investigator Decision|7|||
147252161|NCT03060629|531094428|FG001|Overall Study|Investigator Decision|7|||
147252162|NCT03060629|531094427|FG000|Overall Study|Study Terminated by Sponsor|1100|||
147331654|NCT00393848|531380897|FG003|Overall Study|Personal reasons|0|||
147660616|NCT04980014|532581348|FG000|Overall Study|Participants who Have Been Administered NesinaAct® Tablet prior to the consent|2|||
147252163|NCT03060629|531094428|FG001|Overall Study|Study Terminated by Sponsor|1123|||
147252164|NCT03060629|531094427|FG000|Overall Study|Other|4|||
147252165|NCT03060629|531094428|FG001|Overall Study|Other|4|||
147252166|NCT01862874|531094429|FG000|Overall Study|Randomized not treated|1|||
147252167|NCT01862874|531094430|FG001|Overall Study|Randomized not treated|0|||
147252168|NCT01862874|531094429|FG000|Overall Study|Adverse Event|0|||
147252169|NCT01862874|531094430|FG001|Overall Study|Adverse Event|3|||
147252170|NCT01862874|531094429|FG000|Overall Study|Lost to Follow-up|26|||
147252171|NCT01862874|531094430|FG001|Overall Study|Lost to Follow-up|29|||
147252172|NCT01862874|531094429|FG000|Overall Study|Physician Decision|5|||
147252173|NCT01862874|531094430|FG001|Overall Study|Physician Decision|3|||
147252174|NCT01862874|531094429|FG000|Overall Study|Withdrawn by parent/guardian|1|||
147252175|NCT01862874|531094430|FG001|Overall Study|Withdrawn by parent/guardian|1|||
147252176|NCT01862874|531094429|FG000|Overall Study|Withdrawal by Subject|46|||
147252177|NCT01862874|531094430|FG001|Overall Study|Withdrawal by Subject|40|||
147252178|NCT01862874|531094429|FG000|Overall Study|Death|0|||
147252179|NCT01862874|531094430|FG001|Overall Study|Death|1|||
147252180|NCT01129960|531094434|FG000|Overall Study|Withdrawal by Subject|3|||
147252181|NCT01129960|531094435|FG001|Overall Study|Withdrawal by Subject|0|||
147252182|NCT01129960|531094436|FG002|Overall Study|Withdrawal by Subject|3|||
147252183|NCT01129960|531094437|FG003|Overall Study|Withdrawal by Subject|2|||
147252184|NCT01129960|531094434|FG000|Overall Study|Lack of Efficacy|1|||
147252185|NCT01129960|531094435|FG001|Overall Study|Lack of Efficacy|1|||
147252186|NCT01129960|531094436|FG002|Overall Study|Lack of Efficacy|1|||
147252187|NCT01129960|531094437|FG003|Overall Study|Lack of Efficacy|1|||
147252188|NCT01129960|531094434|FG000|Overall Study|Adverse Event|23|||
147252189|NCT01129960|531094435|FG001|Overall Study|Adverse Event|16|||
147252190|NCT01129960|531094436|FG002|Overall Study|Adverse Event|16|||
147252191|NCT01129960|531094437|FG003|Overall Study|Adverse Event|7|||
147252192|NCT01129960|531094434|FG000|Overall Study|Protocol Violation|1|||
147252193|NCT01129960|531094435|FG001|Overall Study|Protocol Violation|2|||
147252194|NCT01129960|531094436|FG002|Overall Study|Protocol Violation|3|||
147252195|NCT01129960|531094437|FG003|Overall Study|Protocol Violation|0|||
147252196|NCT01129960|531094434|FG000|Overall Study|Lost to Follow-up|0|||
147252197|NCT01129960|531094435|FG001|Overall Study|Lost to Follow-up|2|||
147252198|NCT01129960|531094436|FG002|Overall Study|Lost to Follow-up|3|||
147252199|NCT01129960|531094437|FG003|Overall Study|Lost to Follow-up|3|||
147252200|NCT01129960|531094434|FG000|Overall Study|Discontinuation of the study by Sponsor|0|||
147252201|NCT01129960|531094435|FG001|Overall Study|Discontinuation of the study by Sponsor|1|||
147252202|NCT01129960|531094436|FG002|Overall Study|Discontinuation of the study by Sponsor|0|||
147252203|NCT01129960|531094437|FG003|Overall Study|Discontinuation of the study by Sponsor|0|||
147252204|NCT01129960|531094434|FG000|Overall Study|Physician Decision|1|||
147252205|NCT01129960|531094435|FG001|Overall Study|Physician Decision|0|||
147252206|NCT01129960|531094436|FG002|Overall Study|Physician Decision|0|||
147252207|NCT01129960|531094437|FG003|Overall Study|Physician Decision|0|||
147252208|NCT01129960|531094434|FG000|Overall Study|Pregnancy|1|||
147252209|NCT01129960|531094435|FG001|Overall Study|Pregnancy|0|||
147252210|NCT01129960|531094436|FG002|Overall Study|Pregnancy|0|||
147252211|NCT01129960|531094437|FG003|Overall Study|Pregnancy|0|||
147252212|NCT03198234|531094438|FG000|Overall Study|Relapse of primary disease|0|||
147252213|NCT03198234|531094439|FG001|Overall Study|Relapse of primary disease|1|||
147252214|NCT03198234|531094440|FG002|Overall Study|Relapse of primary disease|0|||
147252215|NCT03228537|531094445|FG000|Neoadjuvant|Adverse Event|2|||
147252216|NCT03228537|531094445|FG000|Neoadjuvant|Progression/Relapse|4|||
147252217|NCT03228537|531094445|FG000|Neoadjuvant|Death|1|||
147331655|NCT02192606|531380898|FG000|Overall Study|surgery type was changed|1|||
147331656|NCT02192606|531380899|FG001|Overall Study|surgery type was changed|1|||
147331657|NCT02192606|531380898|FG000|Overall Study|Physician Decision|1|||
147252218|NCT03228537|531094445|FG000|Surgery|Death|1|||
147252219|NCT03228537|531094445|FG000|Surgery|Other - Not Protocol Specified|2|||
147252220|NCT03228537|531094445|FG000|Maintenance|Refusal Unrelated to Adverse Event|1|||
147252221|NCT03228537|531094445|FG000|Maintenance|Progression/Relapse|10|||
147252222|NCT01782495|531094446|FG000|Overall Study|Adverse Event|0|||
147252223|NCT01782495|531094447|FG001|Overall Study|Adverse Event|0|||
147252224|NCT01782495|531094448|FG002|Overall Study|Adverse Event|0|||
147252225|NCT01782495|531094449|FG003|Overall Study|Adverse Event|0|||
147252226|NCT01782495|531094450|FG004|Overall Study|Adverse Event|0|||
147252227|NCT01782495|531094451|FG005|Overall Study|Adverse Event|0|||
147252228|NCT01782495|531094452|FG006|Overall Study|Adverse Event|0|||
147252229|NCT01782495|531094453|FG007|Overall Study|Adverse Event|2|||
147252230|NCT01782495|531094454|FG008|Overall Study|Adverse Event|0|||
147252231|NCT01782495|531094455|FG009|Overall Study|Adverse Event|0|||
147252232|NCT01782495|531094456|FG010|Overall Study|Adverse Event|0|||
147252233|NCT01782495|531094446|FG000|Overall Study|Withdrew Consent|0|||
147252234|NCT01782495|531094447|FG001|Overall Study|Withdrew Consent|1|||
147252235|NCT01782495|531094448|FG002|Overall Study|Withdrew Consent|0|||
147252236|NCT01782495|531094449|FG003|Overall Study|Withdrew Consent|0|||
147252237|NCT01782495|531094450|FG004|Overall Study|Withdrew Consent|0|||
147252238|NCT01782495|531094451|FG005|Overall Study|Withdrew Consent|0|||
147252239|NCT01782495|531094452|FG006|Overall Study|Withdrew Consent|0|||
147252240|NCT01782495|531094453|FG007|Overall Study|Withdrew Consent|1|||
147252241|NCT01782495|531094454|FG008|Overall Study|Withdrew Consent|0|||
147252242|NCT01782495|531094455|FG009|Overall Study|Withdrew Consent|0|||
147252243|NCT01782495|531094456|FG010|Overall Study|Withdrew Consent|0|||
147252244|NCT01927367|531094457|FG000|Overall Study|Withdrawal by Subject|7|||
147252245|NCT01927367|531094458|FG001|Overall Study|Withdrawal by Subject|4|||
147252246|NCT01927367|531094457|FG000|Overall Study|No baseline data|0|||
147252247|NCT01927367|531094458|FG001|Overall Study|No baseline data|1|||
147252248|NCT02622321|531094461|FG000|Overall Study|Withdrawal by Subject|2|||
147597383|NCT02799095|532345710|FG003|Part C|Adverse Event|0|||
147597384|NCT02799095|532345711|FG004|Part C|Adverse Event|0|||
147252249|NCT02622321|531094462|FG001|Overall Study|Withdrawal by Subject|0|||
147252250|NCT02622321|531094463|FG002|Overall Study|Withdrawal by Subject|0|||
147252251|NCT02622321|531094464|FG003|Overall Study|Withdrawal by Subject|0|||
147252252|NCT02622321|531094461|FG000|Overall Study|Death|0|||
147252253|NCT02622321|531094462|FG001|Overall Study|Death|0|||
147252254|NCT02622321|531094463|FG002|Overall Study|Death|1|||
147252255|NCT02622321|531094464|FG003|Overall Study|Death|0|||
147252256|NCT02622321|531094461|FG000|Overall Study|Physician Decision|1|||
147252257|NCT02622321|531094462|FG001|Overall Study|Physician Decision|0|||
147252258|NCT02622321|531094463|FG002|Overall Study|Physician Decision|0|||
147252259|NCT02622321|531094464|FG003|Overall Study|Physician Decision|0|||
147252260|NCT00965718|531094467|FG000|Overall Study|Withdrawal by Subject|4|||
147252261|NCT00241280|531094468|FG000|Overall Study|Adverse Event|2|||
147252262|NCT00241280|531094469|FG001|Overall Study|Adverse Event|6|||
147252263|NCT00241280|531094468|FG000|Overall Study|Discomfort|11|||
147252264|NCT00241280|531094469|FG001|Overall Study|Discomfort|16|||
147252265|NCT00241280|531094468|FG000|Overall Study|Pregnancy|1|||
147252266|NCT00241280|531094469|FG001|Overall Study|Pregnancy|5|||
147252267|NCT00241280|531094468|FG000|Overall Study|Lost to Follow-up|5|||
147252268|NCT00241280|531094469|FG001|Overall Study|Lost to Follow-up|8|||
147252269|NCT00241280|531094468|FG000|Overall Study|Withdrawal by Subject|7|||
147252270|NCT00241280|531094469|FG001|Overall Study|Withdrawal by Subject|4|||
147252271|NCT00241280|531094468|FG000|Overall Study|Protocol Violation|4|||
147252272|NCT00241280|531094469|FG001|Overall Study|Protocol Violation|10|||
147252273|NCT00241280|531094468|FG000|Overall Study|Relocation|4|||
147252274|NCT00241280|531094469|FG001|Overall Study|Relocation|4|||
147252275|NCT00241280|531094468|FG000|Overall Study|Unsatisfactory Physiological Response|1|||
147252276|NCT00241280|531094469|FG001|Overall Study|Unsatisfactory Physiological Response|1|||
147252277|NCT00241280|531094468|FG000|Overall Study|Unsatisfactory Visual Response|1|||
147252278|NCT00241280|531094469|FG001|Overall Study|Unsatisfactory Visual Response|1|||
147252279|NCT00241280|531094468|FG000|Overall Study|Diabetic|1|||
147252280|NCT00241280|531094469|FG001|Overall Study|Diabetic|0|||
147252281|NCT00241280|531094468|FG000|Overall Study|Subject Ineligible/Dispensed|9|||
147252282|NCT00241280|531094469|FG001|Overall Study|Subject Ineligible/Dispensed|6|||
147252283|NCT00241280|531094468|FG000|Overall Study|Dispensed incorrect test article|1|||
147252284|NCT00241280|531094469|FG001|Overall Study|Dispensed incorrect test article|2|||
147252285|NCT00241280|531094468|FG000|Overall Study|Unacceptable Fit|0|||
147252286|NCT00241280|531094469|FG001|Overall Study|Unacceptable Fit|1|||
147252287|NCT00241280|531094468|FG000|Overall Study|Scheduling Conflict|0|||
147252288|NCT00241280|531094469|FG001|Overall Study|Scheduling Conflict|2|||
147252289|NCT00241280|531094468|FG000|Overall Study|History of Ocular Surgery|0|||
147252290|NCT00241280|531094469|FG001|Overall Study|History of Ocular Surgery|1|||
147252291|NCT00241280|531094468|FG000|Overall Study|Coating on Lens|1|||
147252292|NCT00241280|531094469|FG001|Overall Study|Coating on Lens|0|||
147252293|NCT00241280|531094468|FG000|Overall Study|Excessive Dryness|0|||
147252294|NCT00241280|531094469|FG001|Overall Study|Excessive Dryness|1|||
147252295|NCT01634360|531094471|FG000|Overall Study|Adverse Event|10|||
147252296|NCT01634360|531094472|FG001|Overall Study|Adverse Event|34|||
147331658|NCT02192606|531380899|FG001|Overall Study|Physician Decision|2|||
147331659|NCT02192606|531380898|FG000|Overall Study|3D equipment rep unable to join|0|||
147331660|NCT02192606|531380899|FG001|Overall Study|3D equipment rep unable to join|1|||
147331661|NCT01458210|531380906|FG000|Ortho-Cyclen Alone (Period 1)|Withdrawal by Subject|2|||
147252297|NCT01634360|531094471|FG000|Overall Study|subject withdrew consent|13|||
147252298|NCT01634360|531094472|FG001|Overall Study|subject withdrew consent|23|||
147597385|NCT02799095|532345712|FG005|Part C|Adverse Event|0|||
147252299|NCT01634360|531094471|FG000|Overall Study|Protocol Violation|1|||
147252300|NCT01634360|531094472|FG001|Overall Study|Protocol Violation|1|||
147252301|NCT01634360|531094471|FG000|Overall Study|Lack of Efficacy|4|||
147252302|NCT01634360|531094472|FG001|Overall Study|Lack of Efficacy|14|||
147252303|NCT01634360|531094471|FG000|Overall Study|Other|3|||
147252304|NCT01634360|531094472|FG001|Overall Study|Other|20|||
147252305|NCT01634360|531094471|FG000|Overall Study|Study termination by sponsor|18|||
147252306|NCT01634360|531094472|FG001|Overall Study|Study termination by sponsor|44|||
147252307|NCT02260921|531094479|FG000|Overall Study|Adverse Event|1|||
147252308|NCT02260921|531094480|FG001|Overall Study|Adverse Event|0|||
147252309|NCT02260921|531094479|FG000|Overall Study|Lost to Follow-up|4|||
147252310|NCT02260921|531094480|FG001|Overall Study|Lost to Follow-up|3|||
147252311|NCT02260921|531094479|FG000|Overall Study|Withdraw Consent|4|||
147597386|NCT02799095|532345713|FG006|Part C|Adverse Event|0|||
147252312|NCT02260921|531094480|FG001|Overall Study|Withdraw Consent|1|||
147252313|NCT02260921|531094479|FG000|Overall Study|Death|1|||
147252314|NCT02260921|531094480|FG001|Overall Study|Death|0|||
147252315|NCT02260921|531094479|FG000|Overall Study|Prohibited Treatment for Knee Pain|4|||
147252316|NCT02260921|531094480|FG001|Overall Study|Prohibited Treatment for Knee Pain|0|||
147252317|NCT01244425|531094481|FG000|Overall Study|Withdrawal by Subject|2|||
147252318|NCT01244425|531094482|FG001|Overall Study|Withdrawal by Subject|2|||
147252319|NCT01244425|531094481|FG000|Overall Study|Adverse Event|1|||
147252320|NCT01244425|531094482|FG001|Overall Study|Adverse Event|1|||
147252321|NCT02999854|531094483|FG000|Active Study Phase (up to 18 Months)|Screen failures|7|||
147252322|NCT02999854|531094484|FG001|Active Study Phase (up to 18 Months)|Screen failures|2|||
147252323|NCT02999854|531094483|FG000|Active Study Phase (up to 18 Months)|Discontinued before HSCT|8|||
147252324|NCT02999854|531094484|FG001|Active Study Phase (up to 18 Months)|Discontinued before HSCT|2|||
147252325|NCT02999854|531094483|FG000|Active Study Phase (up to 18 Months)|Death|7|||
147252326|NCT02999854|531094484|FG001|Active Study Phase (up to 18 Months)|Death|5|||
147252327|NCT02999854|531094483|FG000|Active Study Phase (up to 18 Months)|Completed 2 year follow-up|1|||
147252328|NCT02999854|531094484|FG001|Active Study Phase (up to 18 Months)|Completed 2 year follow-up|0|||
147252329|NCT02999854|531094483|FG000|Active Study Phase (up to 18 Months)|End of study after HSCT but before treatment|1|||
147252330|NCT02999854|531094484|FG001|Active Study Phase (up to 18 Months)|End of study after HSCT but before treatment|0|||
147252331|NCT02999854|531094483|FG000|Long Term Safety FU (up to 24 Months)|Death|1|||
147252332|NCT02999854|531094484|FG001|Long Term Safety FU (up to 24 Months)|Death|1|||
147252333|NCT02999854|531094483|FG000|Long Term Safety FU (up to 24 Months)|Withdrawal by Subject|1|||
147252334|NCT02999854|531094484|FG001|Long Term Safety FU (up to 24 Months)|Withdrawal by Subject|1|||
147252335|NCT02999854|531094483|FG000|Long Term Safety FU (up to 24 Months)|Lost to Follow-up|1|||
147252336|NCT02999854|531094484|FG001|Long Term Safety FU (up to 24 Months)|Lost to Follow-up|1|||
147252337|NCT02848651|531094485|FG000|Overall Study|Death|85|||
147252338|NCT02848651|531094485|FG000|Overall Study|Lost to Follow-up|1|||
147252339|NCT02848651|531094485|FG000|Overall Study|Non-Compliance|1|||
147252340|NCT02848651|531094485|FG000|Overall Study|Symptomatic Deterioration|1|||
147252341|NCT02848651|531094485|FG000|Overall Study|Physician Decision|4|||
147252342|NCT02848651|531094485|FG000|Overall Study|Withdrawal by Subject|14|||
147252343|NCT04140292|531094486|FG000|Overall Study|Restriction on outpatient visits due to COVID-19.|4|||
147252344|NCT04140292|531094487|FG001|Overall Study|Restriction on outpatient visits due to COVID-19.|16|||
147252345|NCT01853826|531096089|FG000|Overall Study|Patients who switched to commercial drug|11|||
147252346|NCT01853826|531096089|FG000|Overall Study|Patient refused to continue medication|21|||
147252347|NCT01853826|531096089|FG000|Overall Study|Lost to Follow-up|2|||
147252348|NCT01853826|531096089|FG000|Overall Study|Non-compliant with protocol|4|||
147252349|NCT01853826|531096089|FG000|Overall Study|Other adverse events (AE)|62|||
147252350|NCT01853826|531096089|FG000|Overall Study|Worsening or AE of underlying cancer disease|24|||
147252351|NCT01853826|531096089|FG000|Overall Study|Progressive disease|342|||
147252352|NCT01853826|531096089|FG000|Overall Study|Other than listed|13|||
147252353|NCT01853826|531096089|FG000|Overall Study|Not treated - not signed privacy informed consent|2|||
147252354|NCT03653637|531096090|FG000|Overall Study|Death|1|||
147252355|NCT03653637|531096091|FG001|Overall Study|Death|3|||
147252356|NCT03653637|531096090|FG000|Overall Study|Lost to Follow-up|29|||
147252357|NCT03653637|531096091|FG001|Overall Study|Lost to Follow-up|30|||
147252358|NCT03653637|531096090|FG000|Overall Study|Physician Decision|1|||
147252359|NCT03653637|531096091|FG001|Overall Study|Physician Decision|1|||
147597387|NCT02799095|532345714|FG007|Part C|Adverse Event|0|||
147597388|NCT02799095|532345715|FG008|Part C|Adverse Event|0|||
147597389|NCT02799095|532345716|FG009|Part C|Adverse Event|0|||
147597390|NCT02799095|532345717|FG010|Part C|Adverse Event|3|||
147597391|NCT02799095|532345718|FG011|Part C|Adverse Event|1|||
147597392|NCT02799095|532345719|FG012|Part C|Adverse Event|0|||
147252360|NCT03653637|531096090|FG000|Overall Study|Withdrawal by Subject|7|||
147252361|NCT03653637|531096091|FG001|Overall Study|Withdrawal by Subject|4|||
147252362|NCT05661942|531096093|FG000|Overall Study|Nine patients were excluded due to change in hemodynamic status and consent withdrawal.|2|||
147252363|NCT05661942|531096094|FG001|Overall Study|Nine patients were excluded due to change in hemodynamic status and consent withdrawal.|7|||
147597393|NCT02799095|532345720|FG013|Part C|Adverse Event|1|||
147597394|NCT02799095|532345721|FG014|Part C|Adverse Event|0|||
147597395|NCT02799095|532345722|FG015|Part C|Adverse Event|0|||
147597396|NCT02799095|532345723|FG016|Part C|Adverse Event|0|||
147597397|NCT02799095|532345707|FG000|Part C|Death|0|||
147252364|NCT02081690|531096106|FG000|Overall Study|Death|3|||
147597398|NCT02799095|532345708|FG001|Part C|Death|0|||
147597399|NCT02799095|532345709|FG002|Part C|Death|0|||
147597400|NCT02799095|532345710|FG003|Part C|Death|0|||
147597401|NCT02799095|532345711|FG004|Part C|Death|0|||
147597402|NCT02799095|532345712|FG005|Part C|Death|0|||
147597403|NCT02799095|532345713|FG006|Part C|Death|0|||
147597404|NCT02799095|532345714|FG007|Part C|Death|0|||
147597405|NCT02799095|532345715|FG008|Part C|Death|0|||
147597406|NCT02799095|532345716|FG009|Part C|Death|0|||
147252365|NCT02081690|531096106|FG000|Overall Study|Physician Decision|3|||
147252366|NCT02081690|531096106|FG000|Overall Study|Withdrawal by Subject|1|||
147252367|NCT00982488|531096109|FG000|Overall Study|Administrative reason by sponsor|81|||
147252368|NCT00982488|531096110|FG001|Overall Study|Administrative reason by sponsor|3|||
147252369|NCT00982488|531096111|FG002|Overall Study|Administrative reason by sponsor|11|||
147252370|NCT00982488|531096112|FG003|Overall Study|Administrative reason by sponsor|0|||
147252371|NCT00982488|531096113|FG004|Overall Study|Administrative reason by sponsor|0|||
147252372|NCT00982488|531096109|FG000|Overall Study|Adverse event unrelated to study drug|5|||
147252373|NCT00982488|531096110|FG001|Overall Study|Adverse event unrelated to study drug|1|||
147252374|NCT00982488|531096111|FG002|Overall Study|Adverse event unrelated to study drug|0|||
147252375|NCT00982488|531096112|FG003|Overall Study|Adverse event unrelated to study drug|0|||
147252376|NCT00982488|531096113|FG004|Overall Study|Adverse event unrelated to study drug|0|||
147252377|NCT00982488|531096109|FG000|Overall Study|Death|11|||
147252378|NCT00982488|531096110|FG001|Overall Study|Death|0|||
147252379|NCT00982488|531096111|FG002|Overall Study|Death|2|||
147252380|NCT00982488|531096112|FG003|Overall Study|Death|0|||
147252381|NCT00982488|531096113|FG004|Overall Study|Death|0|||
147252382|NCT00982488|531096109|FG000|Overall Study|Disease progression|30|||
147252383|NCT00982488|531096110|FG001|Overall Study|Disease progression|5|||
147252384|NCT00982488|531096111|FG002|Overall Study|Disease progression|10|||
147252385|NCT00982488|531096112|FG003|Overall Study|Disease progression|1|||
147252386|NCT00982488|531096113|FG004|Overall Study|Disease progression|1|||
147252387|NCT00982488|531096109|FG000|Overall Study|Lost to Follow-up|1|||
147252388|NCT00982488|531096110|FG001|Overall Study|Lost to Follow-up|0|||
147252389|NCT00982488|531096111|FG002|Overall Study|Lost to Follow-up|0|||
147252390|NCT00982488|531096112|FG003|Overall Study|Lost to Follow-up|0|||
147252391|NCT00982488|531096113|FG004|Overall Study|Lost to Follow-up|0|||
147252392|NCT00982488|531096109|FG000|Overall Study|Maximum clinical benefit|1|||
147252393|NCT00982488|531096110|FG001|Overall Study|Maximum clinical benefit|1|||
147252394|NCT00982488|531096111|FG002|Overall Study|Maximum clinical benefit|1|||
147252395|NCT00982488|531096112|FG003|Overall Study|Maximum clinical benefit|0|||
147252396|NCT00982488|531096113|FG004|Overall Study|Maximum clinical benefit|0|||
147252397|NCT00982488|531096109|FG000|Overall Study|Other|15|||
147252398|NCT00982488|531096110|FG001|Overall Study|Other|1|||
147252399|NCT00982488|531096111|FG002|Overall Study|Other|3|||
147252400|NCT00982488|531096112|FG003|Overall Study|Other|1|||
147252401|NCT00982488|531096113|FG004|Overall Study|Other|0|||
147252402|NCT00982488|531096109|FG000|Overall Study|Poor compliance/noncompliance|0|||
147252403|NCT00982488|531096110|FG001|Overall Study|Poor compliance/noncompliance|1|||
147252404|NCT00982488|531096111|FG002|Overall Study|Poor compliance/noncompliance|0|||
147252405|NCT00982488|531096112|FG003|Overall Study|Poor compliance/noncompliance|0|||
147252406|NCT00982488|531096113|FG004|Overall Study|Poor compliance/noncompliance|0|||
147252407|NCT00982488|531096109|FG000|Overall Study|Stem cell transplant|2|||
147252408|NCT00982488|531096110|FG001|Overall Study|Stem cell transplant|0|||
147252409|NCT00982488|531096111|FG002|Overall Study|Stem cell transplant|0|||
147252410|NCT00982488|531096112|FG003|Overall Study|Stem cell transplant|1|||
147252411|NCT00982488|531096113|FG004|Overall Study|Stem cell transplant|0|||
147252412|NCT00982488|531096109|FG000|Overall Study|Study drug toxicity|34|||
147252413|NCT00982488|531096110|FG001|Overall Study|Study drug toxicity|1|||
147252414|NCT00982488|531096111|FG002|Overall Study|Study drug toxicity|6|||
147252415|NCT00982488|531096112|FG003|Overall Study|Study drug toxicity|0|||
147252416|NCT00982488|531096113|FG004|Overall Study|Study drug toxicity|0|||
147252417|NCT00982488|531096109|FG000|Overall Study|Withdrawal by Subject|5|||
147252418|NCT00982488|531096110|FG001|Overall Study|Withdrawal by Subject|1|||
147252419|NCT00982488|531096111|FG002|Overall Study|Withdrawal by Subject|1|||
147252420|NCT00982488|531096112|FG003|Overall Study|Withdrawal by Subject|0|||
147252421|NCT00982488|531096113|FG004|Overall Study|Withdrawal by Subject|0|||
147252422|NCT04203238|531096114|FG000|Overall Study|Withdrawal by Subject|1|||
147252423|NCT04203238|531096115|FG001|Overall Study|Withdrawal by Subject|1|||
147252424|NCT04203238|531096114|FG000|Overall Study|Covid-19|3|||
147449924|NCT01982292|531811309|FG000|Overall Study|Protocol Deviation|1|||
147597407|NCT02799095|532345717|FG010|Part C|Death|7|||
147597408|NCT02799095|532345718|FG011|Part C|Death|5|||
147597409|NCT02799095|532345719|FG012|Part C|Death|6|||
147597410|NCT02799095|532345720|FG013|Part C|Death|8|||
147597411|NCT02799095|532345721|FG014|Part C|Death|1|||
147597412|NCT02799095|532345722|FG015|Part C|Death|8|||
147252425|NCT04203238|531096115|FG001|Overall Study|Covid-19|0|||
147252426|NCT01134783|531096116|FG000|Overall Study|Pregnancy|16|||
147252427|NCT01134783|531096117|FG001|Overall Study|Pregnancy|8|||
147252428|NCT01134783|531096116|FG000|Overall Study|Withdrawal by Subject|15|||
147252429|NCT01134783|531096117|FG001|Overall Study|Withdrawal by Subject|9|||
147252430|NCT01134783|531096116|FG000|Overall Study|Lost to Follow-up|5|||
147597413|NCT02799095|532345723|FG016|Part C|Death|1|||
147449925|NCT01982292|531811310|FG001|Overall Study|Protocol Deviation|0|||
147597414|NCT02799095|532345707|FG000|Part C|Lost to Follow-up|0|||
147597415|NCT02799095|532345708|FG001|Part C|Lost to Follow-up|0|||
147331662|NCT01458210|531380906|FG000|Ortho-Cyclen Alone (Period 1)|Lost to Follow-up|2|||
147331663|NCT01458210|531380906|FG000|Ortho-Cyclen + Dulaglutide (Period 2)|Withdrawal by Subject|2|||
147331664|NCT01458210|531380906|FG000|Ortho-Cyclen + Dulaglutide (Period 2)|Adverse Event|1|||
147660617|NCT04980014|532581348|FG000|Overall Study|Participants who Violated Inclusion/Exclusion Criteria|57|||
147660618|NCT02317991|532581349|FG000|Overall Study|Adverse Event|12|||
147660619|NCT02317991|532581349|FG000|Overall Study|Death|4|||
147252431|NCT01134783|531096117|FG001|Overall Study|Lost to Follow-up|20|||
147252432|NCT00001596|531096119|FG000|Overall Study|Death|1|||
147252433|NCT00001596|531096120|FG001|Overall Study|Death|0|||
147252434|NCT00001596|531096119|FG000|Overall Study|Withdrawal by Subject|3|||
147252435|NCT00001596|531096120|FG001|Overall Study|Withdrawal by Subject|1|||
147252436|NCT00001596|531096119|FG000|Overall Study|Study Termination|12|||
147252437|NCT00001596|531096120|FG001|Overall Study|Study Termination|9|||
147252438|NCT00001596|531096119|FG000|Overall Study|Adverse Event|1|||
147252439|NCT00001596|531096120|FG001|Overall Study|Adverse Event|0|||
147252440|NCT00180414|531096129|FG000|Overall Study|Study cancellation due to lack of overall enrollments|4|||
147252441|NCT00180414|531096130|FG001|Overall Study|Study cancellation due to lack of overall enrollments|4|||
147252442|NCT00463346|531096131|FG000|Overall Study|Withdrawal by Subject|3|||
147252443|NCT00463346|531096132|FG001|Overall Study|Withdrawal by Subject|3|||
147252444|NCT01572909|531096134|FG000|Overall Study|Adverse Event|7|||
147252445|NCT01572909|531096135|FG001|Overall Study|Adverse Event|2|||
147252446|NCT01572909|531096134|FG000|Overall Study|Death|3|||
147252447|NCT01572909|531096135|FG001|Overall Study|Death|1|||
147252448|NCT01572909|531096134|FG000|Overall Study|Lost to Follow-up|8|||
147252449|NCT01572909|531096135|FG001|Overall Study|Lost to Follow-up|7|||
147252450|NCT01572909|531096134|FG000|Overall Study|Physician Decision|1|||
147252451|NCT01572909|531096135|FG001|Overall Study|Physician Decision|1|||
147252452|NCT01572909|531096134|FG000|Overall Study|Technical Issues|1|||
147252453|NCT01572909|531096135|FG001|Overall Study|Technical Issues|0|||
147252454|NCT01572909|531096134|FG000|Overall Study|Withdrawal by Subject|12|||
147252455|NCT01572909|531096135|FG001|Overall Study|Withdrawal by Subject|11|||
147252456|NCT01572909|531096134|FG000|Overall Study|Infarct, comorbidity, Pt refusal of exam|0|||
147252457|NCT01572909|531096135|FG001|Overall Study|Infarct, comorbidity, Pt refusal of exam|3|||
147252458|NCT03641651|531096140|FG000|Overall Study|organizational issues at one study site|1|||
147252459|NCT04779489|531096141|FG000|Overall Study|Physician Decision|1|||
147252460|NCT00951665|531096142|FG000|Phase 1b|Adverse Event|2|||
147252461|NCT00951665|531096143|FG001|Phase 1b|Adverse Event|1|||
147252462|NCT00951665|531096144|FG002|Phase 1b|Adverse Event|0|||
147252463|NCT00951665|531096145|FG003|Phase 1b|Adverse Event|1|||
147252464|NCT00951665|531096146|FG004|Phase 1b|Adverse Event|0|||
147252465|NCT00951665|531096147|FG005|Phase 1b|Adverse Event|0|||
147252466|NCT00951665|531096142|FG000|Phase 1b|Death|1|||
147252467|NCT00951665|531096143|FG001|Phase 1b|Death|0|||
147252468|NCT00951665|531096144|FG002|Phase 1b|Death|2|||
147252469|NCT00951665|531096145|FG003|Phase 1b|Death|0|||
147252470|NCT00951665|531096146|FG004|Phase 1b|Death|0|||
147252471|NCT00951665|531096147|FG005|Phase 1b|Death|0|||
147252472|NCT00951665|531096142|FG000|Phase 1b|Physician Decision|4|||
147252473|NCT00951665|531096143|FG001|Phase 1b|Physician Decision|0|||
147252474|NCT00951665|531096144|FG002|Phase 1b|Physician Decision|1|||
147252475|NCT00951665|531096145|FG003|Phase 1b|Physician Decision|0|||
147252476|NCT00951665|531096146|FG004|Phase 1b|Physician Decision|0|||
147252477|NCT00951665|531096147|FG005|Phase 1b|Physician Decision|0|||
147252478|NCT00951665|531096142|FG000|Phase 1b|Withdrawal by Subject|0|||
147252479|NCT00951665|531096143|FG001|Phase 1b|Withdrawal by Subject|1|||
147252480|NCT00951665|531096144|FG002|Phase 1b|Withdrawal by Subject|0|||
147252481|NCT00951665|531096145|FG003|Phase 1b|Withdrawal by Subject|0|||
147252482|NCT00951665|531096146|FG004|Phase 1b|Withdrawal by Subject|0|||
147252483|NCT00951665|531096147|FG005|Phase 1b|Withdrawal by Subject|0|||
147252484|NCT00951665|531096142|FG000|Phase 1b|Disease Progression|13|||
147252485|NCT00951665|531096143|FG001|Phase 1b|Disease Progression|2|||
147252486|NCT00951665|531096144|FG002|Phase 1b|Disease Progression|14|||
147252487|NCT00951665|531096145|FG003|Phase 1b|Disease Progression|0|||
147252488|NCT00951665|531096146|FG004|Phase 1b|Disease Progression|0|||
147252489|NCT00951665|531096147|FG005|Phase 1b|Disease Progression|0|||
147252490|NCT00951665|531096142|FG000|Phase 1b|Protocol Violation|2|||
147252491|NCT00951665|531096143|FG001|Phase 1b|Protocol Violation|0|||
147252492|NCT00951665|531096144|FG002|Phase 1b|Protocol Violation|0|||
147252493|NCT00951665|531096145|FG003|Phase 1b|Protocol Violation|0|||
147252494|NCT00951665|531096146|FG004|Phase 1b|Protocol Violation|0|||
147252495|NCT00951665|531096147|FG005|Phase 1b|Protocol Violation|0|||
147252496|NCT00951665|531096142|FG000|Phase 2a|Adverse Event|0|||
147252497|NCT00951665|531096143|FG001|Phase 2a|Adverse Event|0|||
147252498|NCT00951665|531096144|FG002|Phase 2a|Adverse Event|0|||
147252499|NCT00951665|531096145|FG003|Phase 2a|Adverse Event|0|||
147252500|NCT00951665|531096146|FG004|Phase 2a|Adverse Event|2|||
147252501|NCT00951665|531096147|FG005|Phase 2a|Adverse Event|0|||
147252502|NCT00951665|531096142|FG000|Phase 2a|Death|0|||
147252503|NCT00951665|531096143|FG001|Phase 2a|Death|0|||
147252504|NCT00951665|531096144|FG002|Phase 2a|Death|0|||
147252505|NCT00951665|531096145|FG003|Phase 2a|Death|0|||
147449926|NCT01982292|531811309|FG000|Overall Study|Patient/Guardian Decision|3|||
147449927|NCT01982292|531811310|FG001|Overall Study|Patient/Guardian Decision|1|||
147597416|NCT02799095|532345709|FG002|Part C|Lost to Follow-up|0|||
147597417|NCT02799095|532345710|FG003|Part C|Lost to Follow-up|0|||
147252506|NCT00951665|531096146|FG004|Phase 2a|Death|1|||
147252507|NCT00951665|531096147|FG005|Phase 2a|Death|1|||
147252508|NCT00951665|531096142|FG000|Phase 2a|Lost to Follow-up|0|||
147252509|NCT00951665|531096143|FG001|Phase 2a|Lost to Follow-up|0|||
147252510|NCT00951665|531096144|FG002|Phase 2a|Lost to Follow-up|0|||
147252511|NCT00951665|531096145|FG003|Phase 2a|Lost to Follow-up|0|||
147252512|NCT00951665|531096146|FG004|Phase 2a|Lost to Follow-up|1|||
147252513|NCT00951665|531096147|FG005|Phase 2a|Lost to Follow-up|0|||
147252514|NCT00951665|531096142|FG000|Phase 2a|Physician Decision|0|||
147252515|NCT00951665|531096143|FG001|Phase 2a|Physician Decision|0|||
147252516|NCT00951665|531096144|FG002|Phase 2a|Physician Decision|0|||
147252517|NCT00951665|531096145|FG003|Phase 2a|Physician Decision|0|||
147252518|NCT00951665|531096146|FG004|Phase 2a|Physician Decision|0|||
147252519|NCT00951665|531096147|FG005|Phase 2a|Physician Decision|1|||
147252520|NCT00951665|531096142|FG000|Phase 2a|Withdrawal by Subject|0|||
147252521|NCT00951665|531096143|FG001|Phase 2a|Withdrawal by Subject|0|||
147252522|NCT00951665|531096144|FG002|Phase 2a|Withdrawal by Subject|0|||
147252523|NCT00951665|531096145|FG003|Phase 2a|Withdrawal by Subject|0|||
147252524|NCT00951665|531096146|FG004|Phase 2a|Withdrawal by Subject|2|||
147252525|NCT00951665|531096147|FG005|Phase 2a|Withdrawal by Subject|0|||
147252526|NCT00951665|531096142|FG000|Phase 2a|Disease Progression|0|||
147252527|NCT00951665|531096143|FG001|Phase 2a|Disease Progression|0|||
147252528|NCT00951665|531096144|FG002|Phase 2a|Disease Progression|0|||
147252529|NCT00951665|531096145|FG003|Phase 2a|Disease Progression|0|||
147252530|NCT00951665|531096146|FG004|Phase 2a|Disease Progression|6|||
147252531|NCT00951665|531096147|FG005|Phase 2a|Disease Progression|5|||
147252532|NCT02723084|531096149|FG000|Overall Study|Withdrawal by Subject|1|||
147252533|NCT02723084|531096150|FG001|Overall Study|Withdrawal by Subject|1|||
147252534|NCT02723084|531096149|FG000|Overall Study|Lost to Follow-up|3|||
147252535|NCT02723084|531096150|FG001|Overall Study|Lost to Follow-up|0|||
147252536|NCT00415909|531096154|FG000|Overall Study|Withdrawal by Subject|2|||
147252537|NCT00415909|531096154|FG000|Overall Study|Death|1|||
147252538|NCT05024058|531096155|FG000|Treatment|Study terminated by sponsor|5|||
147252539|NCT05024058|531096156|FG001|Treatment|Study terminated by sponsor|6|||
147252540|NCT05024058|531096157|FG002|Treatment|Study terminated by sponsor|4|||
147252541|NCT05024058|531096158|FG003|Treatment|Study terminated by sponsor|2|||
147252542|NCT05024058|531096159|FG004|Treatment|Study terminated by sponsor|3|||
147252543|NCT05024058|531096160|FG005|Treatment|Study terminated by sponsor|3|||
147252544|NCT05024058|531096161|FG006|Treatment|Study terminated by sponsor|1|||
147252545|NCT05024058|531096162|FG007|Treatment|Study terminated by sponsor|3|||
147252546|NCT05024058|531096163|FG008|Treatment|Study terminated by sponsor|6|||
147252547|NCT05024058|531096164|FG009|Treatment|Study terminated by sponsor|6|||
147252548|NCT05024058|531096155|FG000|Follow-up|Withdrawal by Subject|1|||
147252549|NCT05024058|531096156|FG001|Follow-up|Withdrawal by Subject|0|||
147252550|NCT05024058|531096157|FG002|Follow-up|Withdrawal by Subject|1|||
147252551|NCT05024058|531096158|FG003|Follow-up|Withdrawal by Subject|0|||
147252552|NCT05024058|531096159|FG004|Follow-up|Withdrawal by Subject|0|||
147252553|NCT05024058|531096160|FG005|Follow-up|Withdrawal by Subject|0|||
147252554|NCT05024058|531096161|FG006|Follow-up|Withdrawal by Subject|0|||
147252555|NCT05024058|531096162|FG007|Follow-up|Withdrawal by Subject|1|||
147252556|NCT05024058|531096163|FG008|Follow-up|Withdrawal by Subject|0|||
147252557|NCT05024058|531096164|FG009|Follow-up|Withdrawal by Subject|1|||
147252558|NCT02734810|531096168|FG000|Overall Study|Adverse Event|1|||
147252559|NCT02734810|531096169|FG001|Overall Study|Adverse Event|0|||
147252560|NCT02734810|531096168|FG000|Overall Study|Lack of Efficacy|1|||
147252561|NCT02734810|531096169|FG001|Overall Study|Lack of Efficacy|0|||
147597418|NCT02799095|532345711|FG004|Part C|Lost to Follow-up|0|||
147252562|NCT00127712|531096173|FG000|Overall Study|Adverse Event|3|||
147252563|NCT00127712|531096174|FG001|Overall Study|Adverse Event|0|||
147252564|NCT00127712|531096173|FG000|Overall Study|Lack of GI access to continue|2|||
147252565|NCT00127712|531096174|FG001|Overall Study|Lack of GI access to continue|0|||
147252566|NCT00407563|531096175|FG000|Overall Study|Patient continues on treatment|1|||
147252567|NCT02450903|531096176|FG000|Overall Study|Adverse Event|3|||
147252568|NCT02450903|531096176|FG000|Overall Study|Progressive disease|15|||
147252569|NCT02450903|531096176|FG000|Overall Study|Switched to commercial drug|1|||
147252570|NCT02450903|531096176|FG000|Overall Study|Subject/guardian decision|1|||
147252571|NCT00449540|531096188|FG000|Pretreatment Phase|No migraine experienced|66|||
147252572|NCT00449540|531096189|FG001|Pretreatment Phase|No migraine experienced|0|||
147252573|NCT00449540|531096190|FG002|Pretreatment Phase|No migraine experienced|0|||
147252574|NCT00449540|531096188|FG000|Treatment Phase|did not experience or treat migraine|0|||
147252575|NCT00449540|531096189|FG001|Treatment Phase|did not experience or treat migraine|20|||
147252576|NCT00449540|531096190|FG002|Treatment Phase|did not experience or treat migraine|17|||
147252577|NCT04545866|531096191|FG000|Overall Study|Withdrawal by Parent(s)/Legal Guardian(s)|1|||
147252578|NCT04545866|531096192|FG001|Overall Study|Withdrawal by Parent(s)/Legal Guardian(s)|0|||
147597419|NCT02799095|532345712|FG005|Part C|Lost to Follow-up|0|||
147597420|NCT02799095|532345713|FG006|Part C|Lost to Follow-up|0|||
147597421|NCT02799095|532345714|FG007|Part C|Lost to Follow-up|0|||
147597422|NCT02799095|532345715|FG008|Part C|Lost to Follow-up|0|||
147597423|NCT02799095|532345716|FG009|Part C|Lost to Follow-up|0|||
147597424|NCT02799095|532345717|FG010|Part C|Lost to Follow-up|1|||
147597425|NCT02799095|532345718|FG011|Part C|Lost to Follow-up|1|||
147597426|NCT02799095|532345719|FG012|Part C|Lost to Follow-up|1|||
147597427|NCT02799095|532345720|FG013|Part C|Lost to Follow-up|3|||
147597428|NCT02799095|532345721|FG014|Part C|Lost to Follow-up|0|||
147597429|NCT02799095|532345722|FG015|Part C|Lost to Follow-up|0|||
147597430|NCT02799095|532345723|FG016|Part C|Lost to Follow-up|0|||
147597431|NCT02799095|532345707|FG000|Part C|Progressive Disease|0|||
147597432|NCT02799095|532345708|FG001|Part C|Progressive Disease|0|||
147597433|NCT02799095|532345709|FG002|Part C|Progressive Disease|0|||
147597434|NCT02799095|532345710|FG003|Part C|Progressive Disease|0|||
147597435|NCT02799095|532345711|FG004|Part C|Progressive Disease|0|||
147597436|NCT02799095|532345712|FG005|Part C|Progressive Disease|0|||
147597437|NCT02799095|532345713|FG006|Part C|Progressive Disease|0|||
147597438|NCT02799095|532345714|FG007|Part C|Progressive Disease|0|||
147597439|NCT02799095|532345715|FG008|Part C|Progressive Disease|0|||
147597440|NCT02799095|532345716|FG009|Part C|Progressive Disease|2|||
147597441|NCT02799095|532345717|FG010|Part C|Progressive Disease|13|||
147597442|NCT02799095|532345718|FG011|Part C|Progressive Disease|2|||
147660620|NCT02317991|532581349|FG000|Overall Study|Withdrawal by Subject|8|||
147660621|NCT02317991|532581349|FG000|Overall Study|Progressive Disease|41|||
147660622|NCT02692586|532581355|FG000|Overall Study|Death from undiagnosed breast cancer through 30-day follow-up|1|||
147252579|NCT04545866|531096191|FG000|Overall Study|Withdrawal by Physician|1|||
147252580|NCT04545866|531096192|FG001|Overall Study|Withdrawal by Physician|0|||
147252581|NCT01013701|531096197|FG000|Overall Study|study prematurely terminated|7|||
147252582|NCT03241342|531096198|FG000|Overall Study|Adverse Event|5|||
147252583|NCT03241342|531096199|FG001|Overall Study|Adverse Event|8|||
147252584|NCT03241342|531096200|FG002|Overall Study|Adverse Event|4|||
147252585|NCT03241342|531096198|FG000|Overall Study|Lack of Efficacy|0|||
147252586|NCT03241342|531096199|FG001|Overall Study|Lack of Efficacy|0|||
147252587|NCT03241342|531096200|FG002|Overall Study|Lack of Efficacy|1|||
147252588|NCT03241342|531096198|FG000|Overall Study|noncompliance with study drug|2|||
147252589|NCT03241342|531096199|FG001|Overall Study|noncompliance with study drug|1|||
147252590|NCT03241342|531096200|FG002|Overall Study|noncompliance with study drug|1|||
147252591|NCT03241342|531096198|FG000|Overall Study|sponsor decision|0|||
147252592|NCT03241342|531096199|FG001|Overall Study|sponsor decision|1|||
147252593|NCT03241342|531096200|FG002|Overall Study|sponsor decision|2|||
147252594|NCT03241342|531096198|FG000|Overall Study|not reported|15|||
147252595|NCT03241342|531096199|FG001|Overall Study|not reported|21|||
147252596|NCT03241342|531096200|FG002|Overall Study|not reported|19|||
147252597|NCT00556712|531096202|FG000|Overall Study|Adverse Event|7|||
147252598|NCT00556712|531096203|FG001|Overall Study|Adverse Event|19|||
147252599|NCT00556712|531096202|FG000|Overall Study|Death|5|||
147252600|NCT00556712|531096203|FG001|Overall Study|Death|10|||
147252601|NCT00556712|531096202|FG000|Overall Study|Progressive Disease|383|||
147252602|NCT00556712|531096203|FG001|Overall Study|Progressive Disease|320|||
147252603|NCT00556712|531096202|FG000|Overall Study|Protocol Violation|3|||
147252604|NCT00556712|531096203|FG001|Overall Study|Protocol Violation|2|||
147252605|NCT00556712|531096202|FG000|Overall Study|Refused Treatment|17|||
147252606|NCT00556712|531096203|FG001|Overall Study|Refused Treatment|16|||
147252607|NCT00556712|531096202|FG000|Overall Study|Failure to Return|2|||
147252608|NCT00556712|531096203|FG001|Overall Study|Failure to Return|3|||
147252609|NCT00556712|531096202|FG000|Overall Study|Other|2|||
147252610|NCT00556712|531096203|FG001|Overall Study|Other|2|||
147252611|NCT00556712|531096202|FG000|Overall Study|Ongoing at Data Cutoff|32|||
147252612|NCT00556712|531096203|FG001|Overall Study|Ongoing at Data Cutoff|66|||
147252613|NCT01059799|531096206|FG000|Overall Study|Adverse Event|2|||
147252614|NCT01059799|531096207|FG001|Overall Study|Adverse Event|3|||
147252615|NCT01059799|531096206|FG000|Overall Study|Lack of Efficacy|1|||
147252616|NCT01059799|531096207|FG001|Overall Study|Lack of Efficacy|0|||
147252617|NCT01059799|531096206|FG000|Overall Study|Protocol Violation|3|||
147449928|NCT01982292|531811309|FG000|Overall Study|Technical Problems|2|||
147660623|NCT02692586|532581355|FG000|Overall Study|Received adjunctive thrombolytics|2|||
147252618|NCT01059799|531096207|FG001|Overall Study|Protocol Violation|2|||
147252619|NCT01059799|531096206|FG000|Overall Study|Withdrawal criteria|13|||
147252620|NCT01059799|531096207|FG001|Overall Study|Withdrawal criteria|2|||
147252621|NCT01059799|531096206|FG000|Overall Study|Other|12|||
147252622|NCT01059799|531096207|FG001|Overall Study|Other|3|||
147252623|NCT01962207|531096210|FG000|Persistence Phase (5 Years)|Lost to Follow-up|2|||
147252624|NCT01962207|531096211|FG001|Persistence Phase (5 Years)|Lost to Follow-up|1|||
147252625|NCT01962207|531096212|FG002|Persistence Phase (5 Years)|Lost to Follow-up|5|||
147252626|NCT01962207|531096213|FG003|Persistence Phase (5 Years)|Lost to Follow-up|2|||
147252627|NCT01962207|531096210|FG000|Persistence Phase (5 Years)|Migrated/moved from study area|2|||
147597443|NCT02799095|532345719|FG012|Part C|Progressive Disease|0|||
147597444|NCT02799095|532345720|FG013|Part C|Progressive Disease|1|||
147597445|NCT02799095|532345721|FG014|Part C|Progressive Disease|0|||
147252628|NCT01962207|531096211|FG001|Persistence Phase (5 Years)|Migrated/moved from study area|0|||
147252629|NCT01962207|531096212|FG002|Persistence Phase (5 Years)|Migrated/moved from study area|4|||
147252630|NCT01962207|531096213|FG003|Persistence Phase (5 Years)|Migrated/moved from study area|0|||
147252631|NCT01962207|531096210|FG000|Persistence Phase (5 Years)|Withdrawal by Subject|4|||
147252632|NCT01962207|531096211|FG001|Persistence Phase (5 Years)|Withdrawal by Subject|5|||
147252633|NCT01962207|531096212|FG002|Persistence Phase (5 Years)|Withdrawal by Subject|18|||
147252634|NCT01962207|531096213|FG003|Persistence Phase (5 Years)|Withdrawal by Subject|4|||
147252635|NCT01962207|531096210|FG000|Persistence Phase (5 Years)|Eligibility criteria not fulfilled|0|||
147597446|NCT02799095|532345722|FG015|Part C|Progressive Disease|0|||
147597447|NCT02799095|532345723|FG016|Part C|Progressive Disease|0|||
147252636|NCT01962207|531096211|FG001|Persistence Phase (5 Years)|Eligibility criteria not fulfilled|0|||
147252637|NCT01962207|531096212|FG002|Persistence Phase (5 Years)|Eligibility criteria not fulfilled|3|||
147252638|NCT01962207|531096213|FG003|Persistence Phase (5 Years)|Eligibility criteria not fulfilled|1|||
147252639|NCT01962207|531096210|FG000|Persistence Phase (5 Years)|Adverse Event|0|||
147252640|NCT01962207|531096211|FG001|Persistence Phase (5 Years)|Adverse Event|0|||
147252641|NCT01962207|531096212|FG002|Persistence Phase (5 Years)|Adverse Event|1|||
147252642|NCT01962207|531096213|FG003|Persistence Phase (5 Years)|Adverse Event|0|||
147252643|NCT01962207|531096210|FG000|Persistence Phase (5 Years)|Missed at least 1 persistence visit|21|||
147252644|NCT01962207|531096211|FG001|Persistence Phase (5 Years)|Missed at least 1 persistence visit|7|||
147252645|NCT01962207|531096212|FG002|Persistence Phase (5 Years)|Missed at least 1 persistence visit|13|||
147252646|NCT01962207|531096213|FG003|Persistence Phase (5 Years)|Missed at least 1 persistence visit|5|||
147252647|NCT03036072|531096217|FG000|Overall Study|Death|0|||
147252648|NCT03036072|531096218|FG001|Overall Study|Death|1|||
147252649|NCT03036072|531096217|FG000|Overall Study|Withdrawal by Subject|0|||
147252650|NCT03036072|531096218|FG001|Overall Study|Withdrawal by Subject|1|||
147252651|NCT03036072|531096217|FG000|Overall Study|Physician Decision|0|||
147252652|NCT03036072|531096218|FG001|Overall Study|Physician Decision|1|||
147252653|NCT02671422|531096219|FG000|Overall Study|Lost to Follow-up|1|||
147252654|NCT02671422|531096219|FG000|Overall Study|Adverse Event|68|||
147252655|NCT02671422|531096219|FG000|Overall Study|Lack of Efficacy|1|||
147252656|NCT02671422|531096219|FG000|Overall Study|Lost to Follow-up|4|||
147252657|NCT02671422|531096219|FG000|Overall Study|Withdrawal by Subject|7|||
147252658|NCT02671422|531096219|FG000|Overall Study|Progressive Disease|156|||
147252659|NCT02671422|531096219|FG000|Overall Study|Worsening of Disease|4|||
147252660|NCT02671422|531096219|FG000|Overall Study|Sponsor decision|5|||
147252661|NCT02671422|531096219|FG000|Overall Study|Adverse Event unrelated to Vargatef®|8|||
147252662|NCT02671422|531096219|FG000|Overall Study|Not treated with Vargatef®|3|||
147252663|NCT02671422|531096219|FG000|Overall Study|Other not defined above|3|||
147252664|NCT02289079|531096220|FG000|Overall Study|Physician Decision|2|||
147252665|NCT02289079|531096221|FG001|Overall Study|Physician Decision|0|||
147252666|NCT02289079|531096220|FG000|Overall Study|Lost to Follow-up|0|||
147252667|NCT02289079|531096221|FG001|Overall Study|Lost to Follow-up|1|||
147252668|NCT00662363|531096222|FG000|Overall Study|Withdrawal by Subject|6|||
147252669|NCT00662363|531096223|FG001|Overall Study|Withdrawal by Subject|5|||
147252670|NCT00662363|531096222|FG000|Overall Study|Adverse Event|0|||
147252671|NCT00662363|531096223|FG001|Overall Study|Adverse Event|3|||
147252672|NCT00662363|531096222|FG000|Overall Study|Discharged early from rehab|4|||
147252673|NCT00662363|531096223|FG001|Overall Study|Discharged early from rehab|1|||
147252674|NCT00662363|531096222|FG000|Overall Study|Protocol Violation|1|||
147252675|NCT00662363|531096223|FG001|Overall Study|Protocol Violation|1|||
147252676|NCT01905657|531096224|FG000|Overall Study|Adverse Event|23|||
147252677|NCT01905657|531096225|FG001|Overall Study|Adverse Event|17|||
147252678|NCT01905657|531096226|FG002|Overall Study|Adverse Event|18|||
147252679|NCT01905657|531096224|FG000|Overall Study|Clinical Progression|103|||
147252680|NCT01905657|531096225|FG001|Overall Study|Clinical Progression|78|||
147252681|NCT01905657|531096226|FG002|Overall Study|Clinical Progression|59|||
147252682|NCT01905657|531096224|FG000|Overall Study|Death|40|||
147252683|NCT01905657|531096225|FG001|Overall Study|Death|43|||
147252684|NCT01905657|531096226|FG002|Overall Study|Death|47|||
147252685|NCT01905657|531096224|FG000|Overall Study|Excluded Medication|13|||
147252686|NCT01905657|531096225|FG001|Overall Study|Excluded Medication|16|||
147252687|NCT01905657|531096226|FG002|Overall Study|Excluded Medication|9|||
147252688|NCT01905657|531096224|FG000|Overall Study|Lost to Follow-up|1|||
147252689|NCT01905657|531096225|FG001|Overall Study|Lost to Follow-up|2|||
147252690|NCT01905657|531096226|FG002|Overall Study|Lost to Follow-up|1|||
147252691|NCT01905657|531096224|FG000|Overall Study|Physician Decision|5|||
147252692|NCT01905657|531096225|FG001|Overall Study|Physician Decision|8|||
147252693|NCT01905657|531096226|FG002|Overall Study|Physician Decision|12|||
147597448|NCT02799095|532345707|FG000|Part C|Clinical Progression|0|||
147597449|NCT02799095|532345708|FG001|Part C|Clinical Progression|0|||
147252694|NCT01905657|531096224|FG000|Overall Study|Protocol Violation|2|||
147252695|NCT01905657|531096225|FG001|Overall Study|Protocol Violation|1|||
147252696|NCT01905657|531096226|FG002|Overall Study|Protocol Violation|1|||
147252697|NCT01905657|531096224|FG000|Overall Study|Screen Failure|0|||
147597450|NCT02799095|532345709|FG002|Part C|Clinical Progression|0|||
147252698|NCT01905657|531096225|FG001|Overall Study|Screen Failure|1|||
147252699|NCT01905657|531096226|FG002|Overall Study|Screen Failure|0|||
147252700|NCT01905657|531096224|FG000|Overall Study|Withdrawal by Subject|15|||
147252701|NCT01905657|531096225|FG001|Overall Study|Withdrawal by Subject|21|||
147252702|NCT01905657|531096226|FG002|Overall Study|Withdrawal by Subject|53|||
147252703|NCT01905657|531096224|FG000|Overall Study|Sponsor Decision|1|||
147252704|NCT01905657|531096225|FG001|Overall Study|Sponsor Decision|0|||
147252705|NCT01905657|531096226|FG002|Overall Study|Sponsor Decision|0|||
147252706|NCT04080297|531096227|FG000|Overall Study|Adverse Event|1|||
147252707|NCT04080297|531096228|FG001|Overall Study|Adverse Event|3|||
147252708|NCT04080297|531096227|FG000|Overall Study|concurrent illness|1|||
147252709|NCT04080297|531096228|FG001|Overall Study|concurrent illness|0|||
147252710|NCT02744391|531096229|FG000|Overall Study|Lost to Follow-up|9|||
147252711|NCT02744391|531096229|FG000|Overall Study|Physician Decision|2|||
147252712|NCT02744391|531096229|FG000|Overall Study|Withdrawal by Subject|3|||
147252713|NCT05838742|531096230|FG000|Overall Study|Adverse Event|2|||
147252714|NCT05838742|531096231|FG001|Overall Study|Adverse Event|0|||
147252715|NCT05838742|531096232|FG002|Overall Study|Adverse Event|1|||
147252716|NCT05838742|531096233|FG003|Overall Study|Adverse Event|0|||
147252717|NCT05838742|531096234|FG004|Overall Study|Adverse Event|1|||
147252718|NCT05838742|531096230|FG000|Overall Study|Lost to Follow-up|1|||
147252719|NCT05838742|531096231|FG001|Overall Study|Lost to Follow-up|1|||
147252720|NCT05838742|531096232|FG002|Overall Study|Lost to Follow-up|1|||
147252721|NCT05838742|531096233|FG003|Overall Study|Lost to Follow-up|0|||
147252722|NCT05838742|531096234|FG004|Overall Study|Lost to Follow-up|0|||
147252723|NCT05838742|531096230|FG000|Overall Study|Physician Decision|0|||
147252724|NCT05838742|531096231|FG001|Overall Study|Physician Decision|0|||
147252725|NCT05838742|531096232|FG002|Overall Study|Physician Decision|0|||
147252726|NCT05838742|531096233|FG003|Overall Study|Physician Decision|0|||
147252727|NCT05838742|531096234|FG004|Overall Study|Physician Decision|1|||
147252728|NCT05838742|531096230|FG000|Overall Study|Withdrawal by Subject|8|||
147252729|NCT05838742|531096231|FG001|Overall Study|Withdrawal by Subject|3|||
147252730|NCT05838742|531096232|FG002|Overall Study|Withdrawal by Subject|3|||
147252731|NCT05838742|531096233|FG003|Overall Study|Withdrawal by Subject|1|||
147252732|NCT05838742|531096234|FG004|Overall Study|Withdrawal by Subject|4|||
147252733|NCT05838742|531096230|FG000|Overall Study|STUDY TERMINATED BY SPONSOR|68|||
147252734|NCT05838742|531096231|FG001|Overall Study|STUDY TERMINATED BY SPONSOR|34|||
147252735|NCT05838742|531096232|FG002|Overall Study|STUDY TERMINATED BY SPONSOR|33|||
147252736|NCT05838742|531096233|FG003|Overall Study|STUDY TERMINATED BY SPONSOR|34|||
147252737|NCT05838742|531096234|FG004|Overall Study|STUDY TERMINATED BY SPONSOR|32|||
147252738|NCT05838742|531096230|FG000|Overall Study|Lack of Efficacy|0|||
147252739|NCT05838742|531096231|FG001|Overall Study|Lack of Efficacy|0|||
147252740|NCT05838742|531096232|FG002|Overall Study|Lack of Efficacy|0|||
147252741|NCT05838742|531096233|FG003|Overall Study|Lack of Efficacy|1|||
147252742|NCT05838742|531096234|FG004|Overall Study|Lack of Efficacy|0|||
147252743|NCT05838742|531096230|FG000|Overall Study|Randomized, not treated|2|||
147252744|NCT05838742|531096231|FG001|Overall Study|Randomized, not treated|1|||
147252745|NCT05838742|531096232|FG002|Overall Study|Randomized, not treated|0|||
147252746|NCT05838742|531096233|FG003|Overall Study|Randomized, not treated|1|||
147252747|NCT05838742|531096234|FG004|Overall Study|Randomized, not treated|0|||
147252748|NCT05119569|531096239|FG000|Double Blind Treatment Phase|Withdrawal by Subject|2|||
147331665|NCT02224924|531380907|FG000|Overall Study|Withdrawal by Subject|7|||
147331666|NCT02224924|531380908|FG001|Overall Study|Withdrawal by Subject|6|||
147331667|NCT02224924|531380907|FG000|Overall Study|Biopsy cancelled|20|||
147331668|NCT02224924|531380908|FG001|Overall Study|Biopsy cancelled|14|||
147331669|NCT02224924|531380907|FG000|Overall Study|Intra procedural exclusion - sealant deployed|23|||
147597451|NCT02799095|532345710|FG003|Part C|Clinical Progression|0|||
147597452|NCT02799095|532345711|FG004|Part C|Clinical Progression|0|||
147597453|NCT02799095|532345712|FG005|Part C|Clinical Progression|0|||
147597454|NCT02799095|532345713|FG006|Part C|Clinical Progression|0|||
147252749|NCT05119569|531096240|FG001|Double Blind Treatment Phase|Withdrawal by Subject|2|||
147252750|NCT05119569|531096241|FG002|Double Blind Treatment Phase|Withdrawal by Subject|0|||
147252751|NCT05119569|531096242|FG003|Double Blind Treatment Phase|Withdrawal by Subject|0|||
147252752|NCT05119569|531096239|FG000|Double Blind Treatment Phase|Adverse Event|6|||
147252753|NCT05119569|531096240|FG001|Double Blind Treatment Phase|Adverse Event|0|||
147252754|NCT05119569|531096241|FG002|Double Blind Treatment Phase|Adverse Event|0|||
147252755|NCT05119569|531096242|FG003|Double Blind Treatment Phase|Adverse Event|0|||
147252756|NCT05119569|531096239|FG000|Open Label Extension Phase|Ongoing in the study|0|||
147252757|NCT05119569|531096240|FG001|Open Label Extension Phase|Ongoing in the study|0|||
147252758|NCT05119569|531096241|FG002|Open Label Extension Phase|Ongoing in the study|65|||
147252759|NCT05119569|531096242|FG003|Open Label Extension Phase|Ongoing in the study|34|||
147252760|NCT02623439|531096245|FG000|Overall Study|Withdrawal by Subject|1|||
147252761|NCT02623439|531096245|FG000|Overall Study|Screen Failure|1|||
147331670|NCT02224924|531380908|FG001|Overall Study|Intra procedural exclusion - sealant deployed|11|||
147597455|NCT02799095|532345714|FG007|Part C|Clinical Progression|0|||
147252762|NCT04484142|531096249|FG000|Overall Study|Adverse Event|13|||
147252763|NCT04484142|531096249|FG000|Overall Study|Progressive Disease|87|||
147597456|NCT02799095|532345715|FG008|Part C|Clinical Progression|0|||
147597457|NCT02799095|532345716|FG009|Part C|Clinical Progression|1|||
147597458|NCT02799095|532345717|FG010|Part C|Clinical Progression|3|||
147597459|NCT02799095|532345718|FG011|Part C|Clinical Progression|0|||
147597460|NCT02799095|532345719|FG012|Part C|Clinical Progression|0|||
147597461|NCT02799095|532345720|FG013|Part C|Clinical Progression|1|||
147597462|NCT02799095|532345721|FG014|Part C|Clinical Progression|0|||
147597463|NCT02799095|532345722|FG015|Part C|Clinical Progression|0|||
147597464|NCT02799095|532345723|FG016|Part C|Clinical Progression|0|||
147597465|NCT02799095|532345707|FG000|Part C|Withdrawal by Subject|0|||
147597466|NCT02799095|532345708|FG001|Part C|Withdrawal by Subject|0|||
147597467|NCT02799095|532345709|FG002|Part C|Withdrawal by Subject|0|||
147597468|NCT02799095|532345710|FG003|Part C|Withdrawal by Subject|0|||
147597469|NCT02799095|532345711|FG004|Part C|Withdrawal by Subject|0|||
147597470|NCT02799095|532345712|FG005|Part C|Withdrawal by Subject|0|||
147597471|NCT02799095|532345713|FG006|Part C|Withdrawal by Subject|0|||
147597472|NCT02799095|532345714|FG007|Part C|Withdrawal by Subject|0|||
147597473|NCT02799095|532345715|FG008|Part C|Withdrawal by Subject|0|||
147597474|NCT02799095|532345716|FG009|Part C|Withdrawal by Subject|0|||
147597475|NCT02799095|532345717|FG010|Part C|Withdrawal by Subject|13|||
147597476|NCT02799095|532345718|FG011|Part C|Withdrawal by Subject|15|||
147597477|NCT02799095|532345719|FG012|Part C|Withdrawal by Subject|13|||
147597478|NCT02799095|532345720|FG013|Part C|Withdrawal by Subject|21|||
147597479|NCT02799095|532345721|FG014|Part C|Withdrawal by Subject|0|||
147597480|NCT02799095|532345722|FG015|Part C|Withdrawal by Subject|12|||
147597481|NCT02799095|532345723|FG016|Part C|Withdrawal by Subject|1|||
147597482|NCT02799095|532345707|FG000|Part C|Physician Decision|0|||
147597483|NCT02799095|532345708|FG001|Part C|Physician Decision|0|||
147597484|NCT02799095|532345709|FG002|Part C|Physician Decision|0|||
147597485|NCT02799095|532345710|FG003|Part C|Physician Decision|0|||
147597486|NCT02799095|532345711|FG004|Part C|Physician Decision|0|||
147597487|NCT02799095|532345712|FG005|Part C|Physician Decision|0|||
147597488|NCT02799095|532345713|FG006|Part C|Physician Decision|0|||
147597489|NCT02799095|532345714|FG007|Part C|Physician Decision|0|||
147597490|NCT02799095|532345715|FG008|Part C|Physician Decision|0|||
147597491|NCT02799095|532345716|FG009|Part C|Physician Decision|0|||
147597492|NCT02799095|532345717|FG010|Part C|Physician Decision|1|||
147597493|NCT02799095|532345718|FG011|Part C|Physician Decision|0|||
147597494|NCT02799095|532345719|FG012|Part C|Physician Decision|0|||
147597495|NCT02799095|532345720|FG013|Part C|Physician Decision|0|||
147597496|NCT02799095|532345721|FG014|Part C|Physician Decision|0|||
147597497|NCT02799095|532345722|FG015|Part C|Physician Decision|0|||
147597498|NCT02799095|532345723|FG016|Part C|Physician Decision|0|||
147597499|NCT02799095|532345707|FG000|Part C|Other|0|||
147597500|NCT02799095|532345708|FG001|Part C|Other|0|||
147597501|NCT02799095|532345709|FG002|Part C|Other|0|||
147597502|NCT02799095|532345710|FG003|Part C|Other|0|||
147597503|NCT02799095|532345711|FG004|Part C|Other|0|||
147597504|NCT02799095|532345712|FG005|Part C|Other|0|||
147597505|NCT02799095|532345713|FG006|Part C|Other|0|||
147597506|NCT02799095|532345714|FG007|Part C|Other|0|||
147597507|NCT02799095|532345715|FG008|Part C|Other|0|||
147597508|NCT02799095|532345716|FG009|Part C|Other|0|||
147597509|NCT02799095|532345717|FG010|Part C|Other|0|||
147597510|NCT02799095|532345718|FG011|Part C|Other|2|||
147597511|NCT02799095|532345719|FG012|Part C|Other|2|||
147597512|NCT02799095|532345720|FG013|Part C|Other|0|||
147597513|NCT02799095|532345721|FG014|Part C|Other|0|||
147597514|NCT02799095|532345722|FG015|Part C|Other|0|||
147597515|NCT02799095|532345723|FG016|Part C|Other|0|||
147597516|NCT01933113|532345724|FG000|Overall Study|Fractured nonfunctioning lead.|1|||
147597517|NCT02297438|532345725|FG000|Overall Study|Death|79|||
147597518|NCT02297438|532345726|FG001|Overall Study|Death|86|||
147597519|NCT02297438|532345725|FG000|Overall Study|Lost to Follow-up|9|||
147597520|NCT02297438|532345726|FG001|Overall Study|Lost to Follow-up|7|||
147597521|NCT02297438|532345725|FG000|Overall Study|Withdrawal by Subject|7|||
147597522|NCT02297438|532345726|FG001|Overall Study|Withdrawal by Subject|0|||
147597523|NCT02297438|532345725|FG000|Overall Study|Other|9|||
147597524|NCT02297438|532345726|FG001|Overall Study|Other|5|||
147597525|NCT02297438|532345725|FG000|Overall Study|Ongoing|65|||
147597526|NCT02297438|532345726|FG001|Overall Study|Ongoing|73|||
147597527|NCT04092894|532345727|FG000|Overall Study|Withdrawal by Subject|2|||
147597528|NCT04092894|532345728|FG001|Overall Study|Withdrawal by Subject|4|||
147597529|NCT04092894|532345727|FG000|Overall Study|Discontinued EEG after randomization|10|||
147597530|NCT04092894|532345728|FG001|Overall Study|Discontinued EEG after randomization|6|||
147597531|NCT02935686|532345729|FG000|Main Study (Week 0 up to Week 72)|Adverse Event|1|||
147597532|NCT02935686|532345730|FG001|Main Study (Week 0 up to Week 72)|Adverse Event|0|||
147597533|NCT02935686|532345731|FG002|Main Study (Week 0 up to Week 72)|Adverse Event|0|||
147597534|NCT02935686|532345732|FG003|Main Study (Week 0 up to Week 72)|Adverse Event|0|||
147597535|NCT02935686|532345733|FG004|Main Study (Week 0 up to Week 72)|Adverse Event|0|||
147597536|NCT02935686|532345729|FG000|Main Study (Week 0 up to Week 72)|Lost to Follow-up|4|||
147597537|NCT02935686|532345730|FG001|Main Study (Week 0 up to Week 72)|Lost to Follow-up|1|||
147597538|NCT02935686|532345731|FG002|Main Study (Week 0 up to Week 72)|Lost to Follow-up|2|||
147597539|NCT02935686|532345732|FG003|Main Study (Week 0 up to Week 72)|Lost to Follow-up|0|||
147597540|NCT02935686|532345733|FG004|Main Study (Week 0 up to Week 72)|Lost to Follow-up|0|||
147597541|NCT02935686|532345729|FG000|Main Study (Week 0 up to Week 72)|Pregnancy|0|||
147597542|NCT02935686|532345730|FG001|Main Study (Week 0 up to Week 72)|Pregnancy|2|||
147597543|NCT02935686|532345731|FG002|Main Study (Week 0 up to Week 72)|Pregnancy|0|||
147597544|NCT02935686|532345732|FG003|Main Study (Week 0 up to Week 72)|Pregnancy|0|||
147597545|NCT02935686|532345733|FG004|Main Study (Week 0 up to Week 72)|Pregnancy|0|||
147597546|NCT02935686|532345729|FG000|Main Study (Week 0 up to Week 72)|Withdrawal by Subject|2|||
147597547|NCT02935686|532345730|FG001|Main Study (Week 0 up to Week 72)|Withdrawal by Subject|9|||
147597548|NCT02935686|532345731|FG002|Main Study (Week 0 up to Week 72)|Withdrawal by Subject|0|||
147597549|NCT02935686|532345732|FG003|Main Study (Week 0 up to Week 72)|Withdrawal by Subject|0|||
147597550|NCT02935686|532345733|FG004|Main Study (Week 0 up to Week 72)|Withdrawal by Subject|0|||
147597551|NCT02935686|532345729|FG000|Main Study (Week 0 up to Week 72)|Other|0|||
147597552|NCT02935686|532345730|FG001|Main Study (Week 0 up to Week 72)|Other|1|||
147597553|NCT02935686|532345731|FG002|Main Study (Week 0 up to Week 72)|Other|0|||
147597554|NCT02935686|532345732|FG003|Main Study (Week 0 up to Week 72)|Other|0|||
147597555|NCT02935686|532345733|FG004|Main Study (Week 0 up to Week 72)|Other|0|||
147597556|NCT02935686|532345729|FG000|Main Study (Week 0 up to Week 72)|Randomized but not vaccinated|0|||
147597557|NCT02935686|532345730|FG001|Main Study (Week 0 up to Week 72)|Randomized but not vaccinated|3|||
147597558|NCT02935686|532345731|FG002|Main Study (Week 0 up to Week 72)|Randomized but not vaccinated|0|||
147597559|NCT02935686|532345732|FG003|Main Study (Week 0 up to Week 72)|Randomized but not vaccinated|0|||
147597560|NCT02935686|532345733|FG004|Main Study (Week 0 up to Week 72)|Randomized but not vaccinated|0|||
147597561|NCT02935686|532345729|FG000|Long-term Extension (Week 72 - 216)|Lost to Follow-up|2|||
147597562|NCT02935686|532345730|FG001|Long-term Extension (Week 72 - 216)|Lost to Follow-up|8|||
147597563|NCT02935686|532345731|FG002|Long-term Extension (Week 72 - 216)|Lost to Follow-up|0|||
147597564|NCT02935686|532345732|FG003|Long-term Extension (Week 72 - 216)|Lost to Follow-up|0|||
147597565|NCT02935686|532345733|FG004|Long-term Extension (Week 72 - 216)|Lost to Follow-up|0|||
147597566|NCT02935686|532345729|FG000|Long-term Extension (Week 72 - 216)|Withdrawal by Subject|0|||
147597567|NCT02935686|532345730|FG001|Long-term Extension (Week 72 - 216)|Withdrawal by Subject|4|||
147597568|NCT02935686|532345731|FG002|Long-term Extension (Week 72 - 216)|Withdrawal by Subject|0|||
147597569|NCT02935686|532345732|FG003|Long-term Extension (Week 72 - 216)|Withdrawal by Subject|0|||
147597570|NCT02935686|532345733|FG004|Long-term Extension (Week 72 - 216)|Withdrawal by Subject|0|||
147597571|NCT02935686|532345729|FG000|Long-term Extension (Week 72 - 216)|Adverse Event|0|||
147597572|NCT02935686|532345730|FG001|Long-term Extension (Week 72 - 216)|Adverse Event|1|||
147597573|NCT02935686|532345731|FG002|Long-term Extension (Week 72 - 216)|Adverse Event|0|||
147597574|NCT02935686|532345732|FG003|Long-term Extension (Week 72 - 216)|Adverse Event|0|||
147597575|NCT02935686|532345733|FG004|Long-term Extension (Week 72 - 216)|Adverse Event|0|||
147597576|NCT02935686|532345729|FG000|Late Boost Vaccination (Week 192 - 288)|Adverse Event|0|||
147597577|NCT02935686|532345730|FG001|Late Boost Vaccination (Week 192 - 288)|Adverse Event|0|||
147597578|NCT02935686|532345731|FG002|Late Boost Vaccination (Week 192 - 288)|Adverse Event|0|||
147597579|NCT02935686|532345732|FG003|Late Boost Vaccination (Week 192 - 288)|Adverse Event|0|||
147597580|NCT02935686|532345733|FG004|Late Boost Vaccination (Week 192 - 288)|Adverse Event|1|||
147597581|NCT02935686|532345729|FG000|Late Boost Vaccination (Week 192 - 288)|Lost to Follow-up|0|||
147597582|NCT02935686|532345730|FG001|Late Boost Vaccination (Week 192 - 288)|Lost to Follow-up|0|||
147597583|NCT02935686|532345731|FG002|Late Boost Vaccination (Week 192 - 288)|Lost to Follow-up|0|||
147597584|NCT02935686|532345732|FG003|Late Boost Vaccination (Week 192 - 288)|Lost to Follow-up|2|||
147597585|NCT02935686|532345733|FG004|Late Boost Vaccination (Week 192 - 288)|Lost to Follow-up|1|||
147597586|NCT00759902|532345736|FG000|Overall Study|Adverse Event|0|||
147597587|NCT00759902|532345737|FG001|Overall Study|Adverse Event|1|||
147597588|NCT02128217|532345740|FG000|Overall Study|Lost to Follow-up|0|||
147597589|NCT02128217|532345741|FG001|Overall Study|Lost to Follow-up|1|||
147597590|NCT05071313|532345742|FG000|Overall Study|Lost to Follow-up|17|||
147597591|NCT05071313|532345743|FG001|Overall Study|Lost to Follow-up|10|||
147597592|NCT05071313|532345742|FG000|Overall Study|Physician Decision|1|||
147597593|NCT05071313|532345743|FG001|Overall Study|Physician Decision|6|||
147597594|NCT05071313|532345742|FG000|Overall Study|Death|1|||
147597595|NCT05071313|532345743|FG001|Overall Study|Death|0|||
147597596|NCT05071313|532345742|FG000|Overall Study|Withdrawal by Subject|10|||
147597597|NCT05071313|532345743|FG001|Overall Study|Withdrawal by Subject|15|||
147597598|NCT05071313|532345742|FG000|Overall Study|Other|1|||
147597599|NCT05071313|532345743|FG001|Overall Study|Other|0|||
147597600|NCT05071313|532345742|FG000|Overall Study|Randomized but not vaccinated|4|||
147597601|NCT05071313|532345743|FG001|Overall Study|Randomized but not vaccinated|2|||
147331671|NCT02224924|531380907|FG000|Overall Study|Intra procedural exclusion - sealant not deployed|20|||
147597602|NCT01183221|532345744|FG000|3 Weeks Wash Out|Lost to Follow-up|1|||
147597603|NCT01183221|532345745|FG001|3 Weeks Wash Out|Lost to Follow-up|1|||
147597604|NCT00678041|532345746|FG000|Overall Study|Physician Decision|5|||
147597605|NCT00678041|532345747|FG001|Overall Study|Physician Decision|5|||
147597606|NCT00807248|532345749|FG000|Overall Study|Adverse Event|1|||
147660624|NCT03316586|532581363|FG000|Overall Study|Adverse Event|2|||
147331672|NCT02224924|531380908|FG001|Overall Study|Intra procedural exclusion - sealant not deployed|35|||
147331673|NCT01616654|531380909|FG000|Overall Study|Lack of Efficacy|1|||
147331674|NCT01616654|531380910|FG001|Overall Study|Lack of Efficacy|0|||
147331675|NCT01616654|531380911|FG002|Overall Study|Lack of Efficacy|0|||
147331676|NCT01616654|531380912|FG003|Overall Study|Lack of Efficacy|0|||
147252764|NCT04484142|531096249|FG000|Overall Study|Clinical Progression|10|||
147252765|NCT04484142|531096249|FG000|Overall Study|Withdrawal by Subject|6|||
147252766|NCT04484142|531096249|FG000|Overall Study|Physician Decision|1|||
147252767|NCT03700671|531096250|FG000|Overall Study|Lack of Efficacy|1|||
147252768|NCT03700671|531096251|FG001|Overall Study|Lack of Efficacy|2|||
147252769|NCT05371509|531096252|FG000|Overall Study|Physician Decision|1|||
147252770|NCT05371509|531096253|FG001|Overall Study|Physician Decision|0|||
147252771|NCT03578367|531096254|FG000|Overall Study|Adverse Event|0|||
147252772|NCT03578367|531096255|FG001|Overall Study|Adverse Event|3|||
147252773|NCT03578367|531096256|FG002|Overall Study|Adverse Event|0|||
147252774|NCT03578367|531096257|FG003|Overall Study|Adverse Event|5|||
147252775|NCT03578367|531096254|FG000|Overall Study|Withdrawal by Subject|2|||
147252776|NCT03578367|531096255|FG001|Overall Study|Withdrawal by Subject|2|||
147252777|NCT03578367|531096256|FG002|Overall Study|Withdrawal by Subject|1|||
147252778|NCT03578367|531096257|FG003|Overall Study|Withdrawal by Subject|3|||
147252779|NCT03578367|531096254|FG000|Overall Study|Physician Decision|0|||
147252780|NCT03578367|531096255|FG001|Overall Study|Physician Decision|0|||
147252781|NCT03578367|531096256|FG002|Overall Study|Physician Decision|14|||
147252782|NCT03578367|531096257|FG003|Overall Study|Physician Decision|0|||
147252783|NCT03578367|531096254|FG000|Overall Study|Death|1|||
147252784|NCT03578367|531096255|FG001|Overall Study|Death|0|||
147252785|NCT03578367|531096256|FG002|Overall Study|Death|0|||
147252786|NCT03578367|531096257|FG003|Overall Study|Death|0|||
147252787|NCT03578367|531096254|FG000|Overall Study|Not treated|0|||
147252788|NCT03578367|531096255|FG001|Overall Study|Not treated|0|||
147252789|NCT03578367|531096256|FG002|Overall Study|Not treated|1|||
147252790|NCT03578367|531096257|FG003|Overall Study|Not treated|0|||
147252791|NCT00397982|531098215|FG000|Overall Study|Withdrawal by Subject|1|||
147252792|NCT00397982|531098215|FG000|Overall Study|Adverse Event|1|||
147252793|NCT00397982|531098215|FG000|Overall Study|noncompliance|1|||
147252794|NCT00397982|531098215|FG000|Overall Study|Unrelated health issues|1|||
147252795|NCT01199289|531098219|FG000|Overall Study|Ineligibility determined|2|||
147252796|NCT01199289|531098220|FG001|Overall Study|Ineligibility determined|1|||
147252797|NCT01199289|531098221|FG002|Overall Study|Ineligibility determined|0|||
147252798|NCT01199289|531098222|FG003|Overall Study|Ineligibility determined|0|||
147252799|NCT01199289|531098219|FG000|Overall Study|Protocol Violation|1|||
147252800|NCT01199289|531098220|FG001|Overall Study|Protocol Violation|0|||
147252801|NCT01199289|531098221|FG002|Overall Study|Protocol Violation|0|||
147252802|NCT01199289|531098222|FG003|Overall Study|Protocol Violation|1|||
147252803|NCT01199289|531098219|FG000|Overall Study|Noncompliance|1|||
147252804|NCT01199289|531098220|FG001|Overall Study|Noncompliance|0|||
147252805|NCT01199289|531098221|FG002|Overall Study|Noncompliance|2|||
147252806|NCT01199289|531098222|FG003|Overall Study|Noncompliance|0|||
147252807|NCT01199289|531098219|FG000|Overall Study|Adverse Event|0|||
147252808|NCT01199289|531098220|FG001|Overall Study|Adverse Event|3|||
147252809|NCT01199289|531098221|FG002|Overall Study|Adverse Event|1|||
147252810|NCT01199289|531098222|FG003|Overall Study|Adverse Event|4|||
147252811|NCT01199289|531098219|FG000|Overall Study|Full consent withdrawn|2|||
147252812|NCT01199289|531098220|FG001|Overall Study|Full consent withdrawn|2|||
147252813|NCT01199289|531098221|FG002|Overall Study|Full consent withdrawn|2|||
147252814|NCT01199289|531098222|FG003|Overall Study|Full consent withdrawn|3|||
147252815|NCT01199289|531098219|FG000|Overall Study|Administrative decision|0|||
147252816|NCT01199289|531098220|FG001|Overall Study|Administrative decision|0|||
147252817|NCT01199289|531098221|FG002|Overall Study|Administrative decision|0|||
147252818|NCT01199289|531098222|FG003|Overall Study|Administrative decision|1|||
147331677|NCT01616654|531380913|FG004|Overall Study|Lack of Efficacy|1|||
147331678|NCT01616654|531380909|FG000|Overall Study|Adverse Event|0|||
147331679|NCT01616654|531380910|FG001|Overall Study|Adverse Event|1|||
147331680|NCT01616654|531380911|FG002|Overall Study|Adverse Event|2|||
147331681|NCT01616654|531380912|FG003|Overall Study|Adverse Event|1|||
147252819|NCT01199289|531098219|FG000|Overall Study|Lost to Follow-up|0|||
147252820|NCT01199289|531098220|FG001|Overall Study|Lost to Follow-up|0|||
147252821|NCT01199289|531098221|FG002|Overall Study|Lost to Follow-up|0|||
147252822|NCT01199289|531098222|FG003|Overall Study|Lost to Follow-up|1|||
147252823|NCT01199289|531098219|FG000|Overall Study|Protocol-specified criteria|3|||
147252824|NCT01199289|531098220|FG001|Overall Study|Protocol-specified criteria|0|||
147252825|NCT01199289|531098221|FG002|Overall Study|Protocol-specified criteria|0|||
147252826|NCT01199289|531098222|FG003|Overall Study|Protocol-specified criteria|1|||
147252827|NCT01199289|531098219|FG000|Overall Study|Pregnancy|0|||
147252828|NCT01199289|531098220|FG001|Overall Study|Pregnancy|1|||
147252829|NCT01199289|531098221|FG002|Overall Study|Pregnancy|0|||
147252830|NCT01199289|531098222|FG003|Overall Study|Pregnancy|1|||
147252831|NCT03055260|531098223|FG000|Overall Study|Withdrawal by Subject|1|||
147252832|NCT03055260|531098224|FG001|Overall Study|Withdrawal by Subject|0|||
147331682|NCT01616654|531380913|FG004|Overall Study|Adverse Event|0|||
147331683|NCT01616654|531380909|FG000|Overall Study|Withdrawal by Subject|2|||
147331684|NCT01616654|531380910|FG001|Overall Study|Withdrawal by Subject|2|||
147597607|NCT00807248|532345750|FG001|Overall Study|Adverse Event|2|||
147597608|NCT00807248|532345751|FG002|Overall Study|Adverse Event|2|||
147597609|NCT00807248|532345752|FG003|Overall Study|Adverse Event|6|||
147597610|NCT00807248|532345749|FG000|Overall Study|Lack of Efficacy|14|||
147597611|NCT00807248|532345750|FG001|Overall Study|Lack of Efficacy|4|||
147597612|NCT00807248|532345751|FG002|Overall Study|Lack of Efficacy|8|||
147597613|NCT00807248|532345752|FG003|Overall Study|Lack of Efficacy|3|||
147597614|NCT00807248|532345749|FG000|Overall Study|Protocol Violation|0|||
147597615|NCT00807248|532345750|FG001|Overall Study|Protocol Violation|1|||
147597616|NCT00807248|532345751|FG002|Overall Study|Protocol Violation|1|||
147597617|NCT00807248|532345752|FG003|Overall Study|Protocol Violation|0|||
147597618|NCT00807248|532345749|FG000|Overall Study|Withdrawal of Consent|5|||
147597619|NCT00807248|532345750|FG001|Overall Study|Withdrawal of Consent|5|||
147597620|NCT00807248|532345751|FG002|Overall Study|Withdrawal of Consent|5|||
147597621|NCT00807248|532345752|FG003|Overall Study|Withdrawal of Consent|5|||
147597622|NCT00807248|532345749|FG000|Overall Study|Lost to Follow-up|1|||
147597623|NCT00807248|532345750|FG001|Overall Study|Lost to Follow-up|0|||
147597624|NCT00807248|532345751|FG002|Overall Study|Lost to Follow-up|0|||
147597625|NCT00807248|532345752|FG003|Overall Study|Lost to Follow-up|0|||
147597626|NCT00807248|532345749|FG000|Overall Study|Other Reason|0|||
147597627|NCT00807248|532345750|FG001|Overall Study|Other Reason|0|||
147597628|NCT00807248|532345751|FG002|Overall Study|Other Reason|2|||
147597629|NCT00807248|532345752|FG003|Overall Study|Other Reason|0|||
147597630|NCT02444793|532345753|FG000|Overall Study|Lost to Follow-up|2|||
147597631|NCT02444793|532345754|FG001|Overall Study|Lost to Follow-up|2|||
147597632|NCT02444793|532345755|FG002|Overall Study|Lost to Follow-up|0|||
147597633|NCT02444793|532345756|FG003|Overall Study|Lost to Follow-up|0|||
147597634|NCT02444793|532345753|FG000|Overall Study|Death|0|||
147597635|NCT02444793|532345754|FG001|Overall Study|Death|3|||
147597636|NCT02444793|532345755|FG002|Overall Study|Death|0|||
147597637|NCT02444793|532345756|FG003|Overall Study|Death|0|||
147597638|NCT02444793|532345753|FG000|Overall Study|Other|0|||
147597639|NCT02444793|532345754|FG001|Overall Study|Other|0|||
147597640|NCT02444793|532345755|FG002|Overall Study|Other|2|||
147597641|NCT02444793|532345756|FG003|Overall Study|Other|0|||
147597642|NCT02444793|532345753|FG000|Overall Study|Objective progression or relapse|9|||
147597643|NCT02444793|532345754|FG001|Overall Study|Objective progression or relapse|1|||
147597644|NCT02444793|532345755|FG002|Overall Study|Objective progression or relapse|2|||
147597645|NCT02444793|532345756|FG003|Overall Study|Objective progression or relapse|3|||
147597646|NCT02504671|532345761|FG000|Overall Study|Withdrawal by Subject|1|||
147597647|NCT02504671|532345762|FG001|Overall Study|Withdrawal by Subject|5|||
147597648|NCT02504671|532345763|FG002|Overall Study|Withdrawal by Subject|4|||
147597649|NCT02504671|532345764|FG003|Overall Study|Withdrawal by Subject|4|||
147597650|NCT02504671|532345765|FG004|Overall Study|Withdrawal by Subject|5|||
147597651|NCT02504671|532345766|FG005|Overall Study|Withdrawal by Subject|3|||
147597652|NCT02504671|532345761|FG000|Overall Study|Lack of Efficacy|1|||
147597653|NCT02504671|532345762|FG001|Overall Study|Lack of Efficacy|3|||
147597654|NCT02504671|532345763|FG002|Overall Study|Lack of Efficacy|1|||
147597655|NCT02504671|532345764|FG003|Overall Study|Lack of Efficacy|0|||
147597656|NCT02504671|532345765|FG004|Overall Study|Lack of Efficacy|4|||
147597657|NCT02504671|532345766|FG005|Overall Study|Lack of Efficacy|4|||
147597658|NCT02504671|532345761|FG000|Overall Study|Adverse Event|1|||
147597659|NCT02504671|532345762|FG001|Overall Study|Adverse Event|1|||
147597660|NCT02504671|532345763|FG002|Overall Study|Adverse Event|0|||
147597661|NCT02504671|532345764|FG003|Overall Study|Adverse Event|1|||
147597662|NCT02504671|532345765|FG004|Overall Study|Adverse Event|0|||
147597663|NCT02504671|532345766|FG005|Overall Study|Adverse Event|2|||
147597664|NCT02504671|532345761|FG000|Overall Study|Protocol Violation|2|||
147597665|NCT02504671|532345762|FG001|Overall Study|Protocol Violation|1|||
147597666|NCT02504671|532345763|FG002|Overall Study|Protocol Violation|0|||
147331685|NCT01616654|531380911|FG002|Overall Study|Withdrawal by Subject|3|||
147331686|NCT01616654|531380912|FG003|Overall Study|Withdrawal by Subject|1|||
147597667|NCT02504671|532345764|FG003|Overall Study|Protocol Violation|0|||
147597668|NCT02504671|532345765|FG004|Overall Study|Protocol Violation|0|||
147597669|NCT02504671|532345766|FG005|Overall Study|Protocol Violation|1|||
147597670|NCT02504671|532345761|FG000|Overall Study|Lost to Follow-up|0|||
147597671|NCT02504671|532345762|FG001|Overall Study|Lost to Follow-up|0|||
147597672|NCT02504671|532345763|FG002|Overall Study|Lost to Follow-up|2|||
147597673|NCT02504671|532345764|FG003|Overall Study|Lost to Follow-up|0|||
147597674|NCT02504671|532345765|FG004|Overall Study|Lost to Follow-up|0|||
147331687|NCT01616654|531380913|FG004|Overall Study|Withdrawal by Subject|5|||
147597675|NCT02504671|532345766|FG005|Overall Study|Lost to Follow-up|1|||
147597676|NCT02504671|532345761|FG000|Overall Study|Protocol defined stopping criteria|7|||
147597677|NCT02504671|532345762|FG001|Overall Study|Protocol defined stopping criteria|4|||
147597678|NCT02504671|532345763|FG002|Overall Study|Protocol defined stopping criteria|3|||
147597679|NCT02504671|532345764|FG003|Overall Study|Protocol defined stopping criteria|5|||
147597680|NCT02504671|532345765|FG004|Overall Study|Protocol defined stopping criteria|3|||
147660625|NCT03316586|532581363|FG000|Overall Study|Physician Decision|3|||
147660626|NCT03316586|532581363|FG000|Overall Study|Lack of Efficacy|10|||
147660627|NCT03316586|532581363|FG000|Overall Study|still on treatment|1|||
147660628|NCT03316586|532581363|FG000|Overall Study|Patient needed radiation therapy|1|||
147660629|NCT03316586|532581363|FG000|Overall Study|Physician Decision to send patient for breast surgery|1|||
147660630|NCT01053741|532581364|FG000|2nd Study Intervention|Physician Decision|0|||
147660631|NCT01053741|532581365|FG001|2nd Study Intervention|Physician Decision|1|||
147660632|NCT01396083|532581367|FG000|Overall Study|Adverse Event|2|||
147660633|NCT01396083|532581368|FG001|Overall Study|Adverse Event|28|||
147660634|NCT01396083|532581367|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
147660635|NCT01396083|532581368|FG001|Overall Study|Unsatisfactory therapeutic effect|13|||
147660636|NCT01396083|532581367|FG000|Overall Study|Consent withdrawn|4|||
147660637|NCT01396083|532581368|FG001|Overall Study|Consent withdrawn|5|||
147660638|NCT01396083|532581367|FG000|Overall Study|Protocol deviation(s)|0|||
147660639|NCT01396083|532581368|FG001|Overall Study|Protocol deviation(s)|1|||
147660640|NCT01396083|532581367|FG000|Overall Study|Abnormal laboratory value(s)|1|||
147660641|NCT01396083|532581368|FG001|Overall Study|Abnormal laboratory value(s)|0|||
147660642|NCT01396083|532581367|FG000|Overall Study|Administrative problems|1|||
147660643|NCT01396083|532581368|FG001|Overall Study|Administrative problems|0|||
147660644|NCT01396083|532581367|FG000|Overall Study|Lost to Follow-up|1|||
147660645|NCT01396083|532581368|FG001|Overall Study|Lost to Follow-up|0|||
147660646|NCT00619827|532581369|FG000|Overall Study|Adverse Event|1|||
147660647|NCT00619827|532581370|FG001|Overall Study|Adverse Event|2|||
147660648|NCT00619827|532581369|FG000|Overall Study|Withdrawal by Subject|2|||
147660649|NCT00619827|532581370|FG001|Overall Study|Withdrawal by Subject|2|||
147660650|NCT00735709|532581371|FG000|Overall Study|Adverse Event|2|||
147660651|NCT00735709|532581372|FG001|Overall Study|Adverse Event|3|||
147660652|NCT00735709|532581373|FG002|Overall Study|Adverse Event|1|||
147660653|NCT00735709|532581374|FG003|Overall Study|Adverse Event|5|||
147660654|NCT00735709|532581371|FG000|Overall Study|Lack of Efficacy|8|||
147660655|NCT00735709|532581372|FG001|Overall Study|Lack of Efficacy|4|||
147660656|NCT00735709|532581373|FG002|Overall Study|Lack of Efficacy|2|||
147660657|NCT00735709|532581374|FG003|Overall Study|Lack of Efficacy|3|||
147660658|NCT00735709|532581371|FG000|Overall Study|Noncompliance|0|||
147660659|NCT00735709|532581372|FG001|Overall Study|Noncompliance|0|||
147660660|NCT00735709|532581373|FG002|Overall Study|Noncompliance|1|||
147660661|NCT00735709|532581374|FG003|Overall Study|Noncompliance|0|||
147660662|NCT00735709|532581371|FG000|Overall Study|Protocol deviations|1|||
147660663|NCT00735709|532581372|FG001|Overall Study|Protocol deviations|2|||
147660664|NCT00735709|532581373|FG002|Overall Study|Protocol deviations|1|||
147660665|NCT00735709|532581374|FG003|Overall Study|Protocol deviations|1|||
147660666|NCT00735709|532581371|FG000|Overall Study|Voluntary Withdrawal|1|||
147660667|NCT00735709|532581372|FG001|Overall Study|Voluntary Withdrawal|3|||
147660668|NCT00735709|532581373|FG002|Overall Study|Voluntary Withdrawal|5|||
147660669|NCT00735709|532581374|FG003|Overall Study|Voluntary Withdrawal|7|||
147660670|NCT00735709|532581371|FG000|Overall Study|Lost to Follow-up|0|||
147660671|NCT00735709|532581372|FG001|Overall Study|Lost to Follow-up|1|||
147660672|NCT00735709|532581373|FG002|Overall Study|Lost to Follow-up|1|||
147660673|NCT00735709|532581374|FG003|Overall Study|Lost to Follow-up|1|||
147660674|NCT00735709|532581371|FG000|Overall Study|Excluded medication|1|||
147597681|NCT02504671|532345766|FG005|Overall Study|Protocol defined stopping criteria|3|||
147597682|NCT00210249|532345767|FG000|Overall Study|Lost to Follow-up|5|||
147597683|NCT00210249|532345767|FG000|Overall Study|Protocol Violation|11|||
147597684|NCT03222583|532345768|FG000|Overall Study|Withdrawal by Subject|3|||
147597685|NCT03222583|532345769|FG001|Overall Study|Withdrawal by Subject|3|||
147597686|NCT03222583|532345768|FG000|Overall Study|Lost to Follow-up|1|||
147597687|NCT03222583|532345769|FG001|Overall Study|Lost to Follow-up|0|||
147597688|NCT03222583|532345768|FG000|Overall Study|Other|1|||
147331688|NCT01616654|531380909|FG000|Overall Study|Protocol Violation|0|||
147597689|NCT03222583|532345769|FG001|Overall Study|Other|3|||
147597690|NCT04280705|532345770|FG000|Overall Study|Enrolled but not treated|4|||
147597691|NCT04280705|532345771|FG001|Overall Study|Enrolled but not treated|10|||
147597692|NCT04280705|532345770|FG000|Overall Study|Physician Decision|1|||
147597693|NCT04280705|532345771|FG001|Overall Study|Physician Decision|0|||
147597694|NCT04280705|532345770|FG000|Overall Study|Withdrawal by Subject|7|||
147660675|NCT00735709|532581372|FG001|Overall Study|Excluded medication|0|||
147660676|NCT00735709|532581373|FG002|Overall Study|Excluded medication|0|||
147660677|NCT00735709|532581374|FG003|Overall Study|Excluded medication|1|||
147660678|NCT03150082|532581376|FG000|Treatment Period 1 (Up to 4 Weeks)|Adverse Event|1|||
147597695|NCT04280705|532345771|FG001|Overall Study|Withdrawal by Subject|9|||
147660679|NCT03150082|532581377|FG001|Treatment Period 1 (Up to 4 Weeks)|Adverse Event|0|||
147660680|NCT02119299|532581378|FG000|Overall Study|Withdrawal by Subject|7|||
147660681|NCT02119299|532581378|FG000|Overall Study|Lack of Efficacy|1|||
147660682|NCT02119299|532581378|FG000|Overall Study|Pregnancy|1|||
147660683|NCT04110314|532581379|FG000|Overall Study|Did not meet inclusion criteria|35255|||
147597696|NCT04280705|532345770|FG000|Overall Study|Adverse Event|0|||
147597697|NCT04280705|532345771|FG001|Overall Study|Adverse Event|4|||
147660684|NCT04110314|532581380|FG001|Overall Study|Did not meet inclusion criteria|35104|||
147597698|NCT04280705|532345770|FG000|Overall Study|Transferred to another hospital|1|||
147597699|NCT04280705|532345771|FG001|Overall Study|Transferred to another hospital|1|||
147597700|NCT02518919|532345774|FG000|Overall Study|Protocol Violation|1|||
147597701|NCT02518919|532345775|FG001|Overall Study|Protocol Violation|1|||
147597702|NCT02518919|532345776|FG002|Overall Study|Protocol Violation|2|||
147597703|NCT04498403|532345777|FG000|Overall Study|Adverse Event|1|||
147597704|NCT04498403|532345778|FG001|Overall Study|Adverse Event|0|||
147597705|NCT04498403|532345777|FG000|Overall Study|Study Terminated By Sponsor|29|||
147597706|NCT04498403|532345778|FG001|Overall Study|Study Terminated By Sponsor|10|||
147597707|NCT02031458|532345779|FG000|May 8, 2015 to January 11, 2019|Death|89|||
147597708|NCT02031458|532345780|FG001|May 8, 2015 to January 11, 2019|Death|193|||
147597709|NCT02031458|532345781|FG002|May 8, 2015 to January 11, 2019|Death|198|||
147597710|NCT02031458|532345779|FG000|May 8, 2015 to January 11, 2019|Lost to Follow-up|2|||
147597711|NCT02031458|532345780|FG001|May 8, 2015 to January 11, 2019|Lost to Follow-up|5|||
147597712|NCT02031458|532345781|FG002|May 8, 2015 to January 11, 2019|Lost to Follow-up|8|||
147597713|NCT02031458|532345779|FG000|May 8, 2015 to January 11, 2019|Switched over to commercial Atezolizumab|1|||
147597714|NCT02031458|532345780|FG001|May 8, 2015 to January 11, 2019|Switched over to commercial Atezolizumab|6|||
147597715|NCT02031458|532345781|FG002|May 8, 2015 to January 11, 2019|Switched over to commercial Atezolizumab|6|||
147597716|NCT02031458|532345779|FG000|May 8, 2015 to January 11, 2019|Physician Decision|2|||
147597717|NCT02031458|532345780|FG001|May 8, 2015 to January 11, 2019|Physician Decision|3|||
147597718|NCT02031458|532345781|FG002|May 8, 2015 to January 11, 2019|Physician Decision|3|||
147597719|NCT02031458|532345779|FG000|May 8, 2015 to January 11, 2019|Protocol Violation|7|||
147597720|NCT02031458|532345780|FG001|May 8, 2015 to January 11, 2019|Protocol Violation|4|||
147597721|NCT02031458|532345781|FG002|May 8, 2015 to January 11, 2019|Protocol Violation|0|||
147597722|NCT02031458|532345779|FG000|May 8, 2015 to January 11, 2019|Study Terminated by Sponsor|24|||
147597723|NCT02031458|532345780|FG001|May 8, 2015 to January 11, 2019|Study Terminated by Sponsor|42|||
147597724|NCT02031458|532345781|FG002|May 8, 2015 to January 11, 2019|Study Terminated by Sponsor|23|||
147597725|NCT02031458|532345779|FG000|May 8, 2015 to January 11, 2019|Withdrawal by Subject|13|||
147597726|NCT02031458|532345780|FG001|May 8, 2015 to January 11, 2019|Withdrawal by Subject|16|||
147597727|NCT02031458|532345781|FG002|May 8, 2015 to January 11, 2019|Withdrawal by Subject|14|||
147597728|NCT02031458|532345779|FG000|Baseline to May 8, 2015|Death|36|||
147597729|NCT02031458|532345780|FG001|Baseline to May 8, 2015|Death|87|||
147597730|NCT02031458|532345781|FG002|Baseline to May 8, 2015|Death|100|||
147597731|NCT02031458|532345779|FG000|Baseline to May 8, 2015|Protocol Violation|7|||
147597732|NCT02031458|532345780|FG001|Baseline to May 8, 2015|Protocol Violation|4|||
147597733|NCT02031458|532345781|FG002|Baseline to May 8, 2015|Protocol Violation|0|||
147597734|NCT02031458|532345779|FG000|Baseline to May 8, 2015|Physician Decision|0|||
147597735|NCT02031458|532345780|FG001|Baseline to May 8, 2015|Physician Decision|1|||
147597736|NCT02031458|532345781|FG002|Baseline to May 8, 2015|Physician Decision|0|||
147597737|NCT02031458|532345779|FG000|Baseline to May 8, 2015|Unknown Reason|0|||
147597738|NCT02031458|532345780|FG001|Baseline to May 8, 2015|Unknown Reason|1|||
147597739|NCT02031458|532345781|FG002|Baseline to May 8, 2015|Unknown Reason|2|||
147597740|NCT02031458|532345779|FG000|Baseline to May 8, 2015|Withdrawal by Subject|6|||
147597741|NCT02031458|532345780|FG001|Baseline to May 8, 2015|Withdrawal by Subject|9|||
147597742|NCT02031458|532345781|FG002|Baseline to May 8, 2015|Withdrawal by Subject|3|||
147597743|NCT02031458|532345779|FG000|Baseline to May 8, 2015|On Survival Follow-Up|46|||
147597744|NCT02031458|532345780|FG001|Baseline to May 8, 2015|On Survival Follow-Up|83|||
147597745|NCT02031458|532345781|FG002|Baseline to May 8, 2015|On Survival Follow-Up|73|||
147597746|NCT02031458|532345779|FG000|Baseline to May 8, 2015|On Treatment|43|||
147597747|NCT02031458|532345780|FG001|Baseline to May 8, 2015|On Treatment|81|||
147597748|NCT02031458|532345781|FG002|Baseline to May 8, 2015|On Treatment|73|||
147597749|NCT02031458|532345779|FG000|Baseline to May 8, 2015|Lost to Follow-up|1|||
147597750|NCT02031458|532345780|FG001|Baseline to May 8, 2015|Lost to Follow-up|1|||
147597751|NCT02031458|532345781|FG002|Baseline to May 8, 2015|Lost to Follow-up|2|||
147597752|NCT03188718|532345784|FG000|Overall Study|Participant noncompliance|4|||
147597753|NCT03188718|532345784|FG000|Overall Study|Withdrawal by Subject|1|||
147597754|NCT03188718|532345784|FG000|Overall Study|Device failure|3|||
147597755|NCT02049450|532345785|FG000|Overall Study|Adverse Event|2|||
147597756|NCT02049450|532345785|FG000|Overall Study|Withdrawal by Subject|1|||
147597757|NCT02049450|532345785|FG000|Overall Study|Patients/guardian decision|1|||
147597758|NCT00394524|532345789|FG000|Overall Study|Protocol Violation|2|||
147597759|NCT00394524|532345790|FG001|Overall Study|Protocol Violation|3|||
147597760|NCT00394524|532345789|FG000|Overall Study|Death|1|||
147597761|NCT00394524|532345790|FG001|Overall Study|Death|0|||
147597762|NCT00394524|532345789|FG000|Overall Study|Withdrawal by Subject|0|||
147597763|NCT00394524|532345790|FG001|Overall Study|Withdrawal by Subject|1|||
147597764|NCT01462318|532345791|FG000|Main Study / TP-DI Study|Other|2|||
147597765|NCT01462318|532345792|FG001|Main Study / TP-DI Study|Other|0|||
147597766|NCT01462318|532345793|FG002|Main Study / TP-DI Study|Other|0|||
147597767|NCT01462318|532345791|FG000|Main Study / TP-DI Study|Withdrawal by Subject|2|||
147597768|NCT01462318|532345792|FG001|Main Study / TP-DI Study|Withdrawal by Subject|0|||
147597769|NCT01462318|532345793|FG002|Main Study / TP-DI Study|Withdrawal by Subject|0|||
147597770|NCT01462318|532345791|FG000|Main Study / TP-DI Study|Adverse Event|4|||
147597771|NCT01462318|532345792|FG001|Main Study / TP-DI Study|Adverse Event|0|||
147597772|NCT01462318|532345793|FG002|Main Study / TP-DI Study|Adverse Event|0|||
147597773|NCT01462318|532345791|FG000|Extension Phase|Lost to Follow-up|0|||
147597774|NCT01462318|532345792|FG001|Extension Phase|Lost to Follow-up|0|||
147597775|NCT01462318|532345793|FG002|Extension Phase|Lost to Follow-up|1|||
147597776|NCT01462318|532345791|FG000|Extension Phase|Other|0|||
147597777|NCT01462318|532345792|FG001|Extension Phase|Other|0|||
147597778|NCT01462318|532345793|FG002|Extension Phase|Other|1|||
147597779|NCT01462318|532345791|FG000|Extension Phase|Disease Progression|0|||
147597780|NCT01462318|532345792|FG001|Extension Phase|Disease Progression|0|||
147597781|NCT01462318|532345793|FG002|Extension Phase|Disease Progression|1|||
147597782|NCT01462318|532345791|FG000|Extension Phase|Withdrawal by Subject|0|||
147597783|NCT01462318|532345792|FG001|Extension Phase|Withdrawal by Subject|0|||
147597784|NCT01462318|532345793|FG002|Extension Phase|Withdrawal by Subject|15|||
147597785|NCT01462318|532345791|FG000|Extension Phase|Investigator Decision|0|||
147597786|NCT01462318|532345792|FG001|Extension Phase|Investigator Decision|0|||
147597787|NCT01462318|532345793|FG002|Extension Phase|Investigator Decision|5|||
147597788|NCT01462318|532345791|FG000|Extension Phase|Adverse Event|0|||
147597789|NCT01462318|532345792|FG001|Extension Phase|Adverse Event|0|||
147597790|NCT01462318|532345793|FG002|Extension Phase|Adverse Event|22|||
147597791|NCT00369655|532345799|FG000|Overall Study|Refusal of further treatment|2|||
147597792|NCT02397408|532345800|FG000|Overall Study|Physician Decision|4|||
147597793|NCT02397408|532345800|FG000|Overall Study|Surgery not completed within protocol timeframe|2|||
147597794|NCT01646138|532345801|FG000|Overall Study|Lost to Follow-up|0|||
147597795|NCT01646138|532345802|FG001|Overall Study|Lost to Follow-up|0|||
147597796|NCT01646138|532345803|FG002|Overall Study|Lost to Follow-up|0|||
147597797|NCT01646138|532345804|FG003|Overall Study|Lost to Follow-up|0|||
147597798|NCT01646138|532345805|FG004|Overall Study|Lost to Follow-up|2|||
147597799|NCT01683838|532345806|FG000|Overall Study|Adverse Event|12|||
147597800|NCT01683838|532345807|FG001|Overall Study|Adverse Event|2|||
147597801|NCT01683838|532345806|FG000|Overall Study|Protocol Violation|3|||
147597802|NCT01683838|532345807|FG001|Overall Study|Protocol Violation|1|||
147597803|NCT01683838|532345806|FG000|Overall Study|Withdrawal by Subject|6|||
147597804|NCT01683838|532345807|FG001|Overall Study|Withdrawal by Subject|5|||
147597805|NCT01683838|532345806|FG000|Overall Study|Lost to Follow-up|1|||
147597806|NCT01683838|532345807|FG001|Overall Study|Lost to Follow-up|1|||
147597807|NCT01683838|532345806|FG000|Overall Study|Other|4|||
147597808|NCT01683838|532345807|FG001|Overall Study|Other|3|||
147597809|NCT03397771|532345808|FG000|Overall Study|2 erroneously randomized, never treated|3|||
147597810|NCT03397771|532345809|FG001|Overall Study|2 erroneously randomized, never treated|1|||
147597811|NCT03397771|532345808|FG000|Overall Study|Withdrawal by Subject|1|||
147597812|NCT03397771|532345809|FG001|Overall Study|Withdrawal by Subject|3|||
147597813|NCT03397771|532345808|FG000|Overall Study|Protocol Violation|2|||
147597814|NCT03397771|532345809|FG001|Overall Study|Protocol Violation|2|||
147597815|NCT03397771|532345808|FG000|Overall Study|Adverse Event|2|||
147597816|NCT03397771|532345809|FG001|Overall Study|Adverse Event|1|||
147597817|NCT04078126|532345813|FG000|Washout|Study put on hold due to COVID-19|0|||
147597818|NCT04078126|532345814|FG001|Washout|Study put on hold due to COVID-19|2|||
147597819|NCT04078126|532345813|FG000|Period 2|Study put on hold due to COVID-19|1|||
147597820|NCT04078126|532345814|FG001|Period 2|Study put on hold due to COVID-19|1|||
147597821|NCT02669758|532345815|FG000|Overall Study|Withdrawal by Subject|43|||
147597822|NCT02669758|532345815|FG000|Overall Study|Lost to Follow-up|19|||
147597823|NCT02669758|532345815|FG000|Overall Study|Adverse Event|16|||
147597824|NCT02669758|532345815|FG000|Overall Study|Non-Compliance with Study Drug|8|||
147597825|NCT02669758|532345815|FG000|Overall Study|Lack of Efficacy|5|||
147660685|NCT04110314|532581381|FG002|Overall Study|Did not meet inclusion criteria|35636|||
147660686|NCT04110314|532581382|FG003|Overall Study|Did not meet inclusion criteria|35135|||
147252833|NCT02507505|531098225|FG000|Overall Study|Withdrawal by Subject|13|||
147252834|NCT02507505|531098226|FG001|Overall Study|Withdrawal by Subject|11|||
147252835|NCT02507505|531098225|FG000|Overall Study|Participant unable to be contacted within 60-day interview window|56|||
147252836|NCT02507505|531098226|FG001|Overall Study|Participant unable to be contacted within 60-day interview window|44|||
147252837|NCT02507505|531098225|FG000|Overall Study|Participant contacted but walking status was unknown|14|||
147252838|NCT02507505|531098226|FG001|Overall Study|Participant contacted but walking status was unknown|16|||
147252839|NCT02507505|531098225|FG000|Overall Study|Death before receipt of anesthesia|0|||
147252840|NCT02507505|531098226|FG001|Overall Study|Death before receipt of anesthesia|1|||
147252841|NCT00967798|531098227|FG000|Overall Study|Withdrawal by Subject|5|||
147597826|NCT02669758|532345815|FG000|Overall Study|Pregnancy|1|||
147597827|NCT02669758|532345815|FG000|Overall Study|Study noncompliance|1|||
147597828|NCT02669758|532345815|FG000|Overall Study|Protocol Violation|1|||
147597829|NCT02149108|532345816|FG000|Overall Study|Not treated|1|||
147597830|NCT02149108|532345817|FG001|Overall Study|Not treated|2|||
147597831|NCT02149108|532345816|FG000|Overall Study|Progressive Disease (PD)|324|||
147597832|NCT02149108|532345817|FG001|Overall Study|Progressive Disease (PD)|318|||
147660687|NCT04110314|532581383|FG004|Overall Study|Did not meet inclusion criteria|35247|||
147660688|NCT04110314|532581384|FG005|Overall Study|Did not meet inclusion criteria|35727|||
147331689|NCT01616654|531380910|FG001|Overall Study|Protocol Violation|5|||
147331690|NCT01616654|531380911|FG002|Overall Study|Protocol Violation|2|||
147331691|NCT01616654|531380912|FG003|Overall Study|Protocol Violation|4|||
147331692|NCT01616654|531380913|FG004|Overall Study|Protocol Violation|4|||
147331693|NCT01616654|531380909|FG000|Overall Study|Lost to Follow-up|1|||
147331694|NCT01616654|531380910|FG001|Overall Study|Lost to Follow-up|0|||
147331695|NCT01616654|531380911|FG002|Overall Study|Lost to Follow-up|3|||
147331696|NCT01616654|531380912|FG003|Overall Study|Lost to Follow-up|2|||
147331697|NCT01616654|531380913|FG004|Overall Study|Lost to Follow-up|1|||
147331698|NCT01616654|531380909|FG000|Overall Study|Pregnancy|1|||
147331699|NCT01616654|531380910|FG001|Overall Study|Pregnancy|0|||
147331700|NCT01616654|531380911|FG002|Overall Study|Pregnancy|0|||
147331701|NCT01616654|531380912|FG003|Overall Study|Pregnancy|0|||
147331702|NCT01616654|531380913|FG004|Overall Study|Pregnancy|1|||
147331703|NCT04379713|531380930|FG000|Overall Study|Adverse Event|2|||
147331704|NCT04379713|531380931|FG001|Overall Study|Adverse Event|0|||
147331705|NCT04379713|531380930|FG000|Overall Study|Physician Decision|2|||
147331706|NCT04379713|531380931|FG001|Overall Study|Physician Decision|1|||
147331707|NCT04379713|531380930|FG000|Overall Study|Protocol Violation|11|||
147331708|NCT04379713|531380931|FG001|Overall Study|Protocol Violation|6|||
147331709|NCT04379713|531380930|FG000|Overall Study|No longer met eligibility criteria|14|||
147331710|NCT04379713|531380931|FG001|Overall Study|No longer met eligibility criteria|11|||
147331711|NCT04379713|531380930|FG000|Overall Study|Withdrawal by parent/guardian|36|||
147331712|NCT04379713|531380931|FG001|Overall Study|Withdrawal by parent/guardian|15|||
147331713|NCT04379713|531380930|FG000|Overall Study|Lost to Follow-up|31|||
147331714|NCT04379713|531380931|FG001|Overall Study|Lost to Follow-up|21|||
147331715|NCT03808883|531380932|FG000|Overall Study|Withdrawal by Subject|2|||
147331716|NCT03808883|531380933|FG001|Overall Study|Withdrawal by Subject|0|||
147331717|NCT03808883|531380932|FG000|Overall Study|Did not complete pre test or post test survey|4|||
147331718|NCT03808883|531380933|FG001|Overall Study|Did not complete pre test or post test survey|3|||
147331719|NCT02371746|531380945|FG000|Overall Study|Consent withdrawn|0|||
147331720|NCT02371746|531380946|FG001|Overall Study|Consent withdrawn|0|||
147331721|NCT02371746|531380947|FG002|Overall Study|Consent withdrawn|0|||
147331722|NCT02371746|531380948|FG003|Overall Study|Consent withdrawn|0|||
147331723|NCT02371746|531380949|FG004|Overall Study|Consent withdrawn|0|||
147331724|NCT02371746|531380950|FG005|Overall Study|Consent withdrawn|0|||
147331725|NCT02371746|531380951|FG006|Overall Study|Consent withdrawn|1|||
147331726|NCT02613364|531380952|FG000|Overall Study|Other|19|||
147331727|NCT02613364|531380953|FG001|Overall Study|Other|29|||
147331728|NCT02613364|531380954|FG002|Overall Study|Other|17|||
147331729|NCT02613364|531380952|FG000|Overall Study|Too time consuming|21|||
147331730|NCT02613364|531380953|FG001|Overall Study|Too time consuming|26|||
147331731|NCT02613364|531380954|FG002|Overall Study|Too time consuming|26|||
147331732|NCT02613364|531380952|FG000|Overall Study|Withdrawal by Subject|13|||
147331733|NCT02613364|531380953|FG001|Overall Study|Withdrawal by Subject|18|||
147331734|NCT02613364|531380954|FG002|Overall Study|Withdrawal by Subject|17|||
147331735|NCT02613364|531380952|FG000|Overall Study|Medical|12|||
147331736|NCT02613364|531380953|FG001|Overall Study|Medical|13|||
147331737|NCT02613364|531380954|FG002|Overall Study|Medical|9|||
147331738|NCT02613364|531380952|FG000|Overall Study|Disliked Study Procedure|1|||
147331739|NCT02613364|531380953|FG001|Overall Study|Disliked Study Procedure|1|||
147331740|NCT02613364|531380954|FG002|Overall Study|Disliked Study Procedure|4|||
147331741|NCT02613364|531380952|FG000|Overall Study|Disliked Intervention|0|||
147331742|NCT02613364|531380953|FG001|Overall Study|Disliked Intervention|3|||
147331743|NCT02613364|531380954|FG002|Overall Study|Disliked Intervention|3|||
147331744|NCT01909336|531380955|FG000|Overall Study|Lost to Follow-up|4|||
147331745|NCT01909336|531380956|FG001|Overall Study|Lost to Follow-up|2|||
147331746|NCT01909336|531380957|FG002|Overall Study|Lost to Follow-up|2|||
147331747|NCT01909336|531380955|FG000|Overall Study|Physician Decision|0|||
147331748|NCT01909336|531380956|FG001|Overall Study|Physician Decision|1|||
147331749|NCT01909336|531380957|FG002|Overall Study|Physician Decision|1|||
147331750|NCT01235949|531380958|FG000|Primary Phase|Migrated/moved from study area|1|||
147331751|NCT01235949|531380959|FG001|Primary Phase|Migrated/moved from study area|1|||
147331752|NCT01235949|531380960|FG002|Primary Phase|Migrated/moved from study area|0|||
147331753|NCT01235949|531380961|FG003|Primary Phase|Migrated/moved from study area|0|||
147331754|NCT01235949|531380962|FG004|Primary Phase|Migrated/moved from study area|1|||
147331755|NCT01235949|531380963|FG005|Primary Phase|Migrated/moved from study area|2|||
147331756|NCT01235949|531380964|FG006|Primary Phase|Migrated/moved from study area|0|||
147331757|NCT01235949|531380965|FG007|Primary Phase|Migrated/moved from study area|0|||
147331758|NCT01235949|531380966|FG008|Primary Phase|Migrated/moved from study area|0|||
147331759|NCT01235949|531380967|FG009|Primary Phase|Migrated/moved from study area|0|||
147331760|NCT01235949|531380968|FG010|Primary Phase|Migrated/moved from study area|0|||
147331761|NCT01235949|531380969|FG011|Primary Phase|Migrated/moved from study area|0|||
147331762|NCT01235949|531380970|FG012|Primary Phase|Migrated/moved from study area|0|||
147331763|NCT01235949|531380971|FG013|Primary Phase|Migrated/moved from study area|0|||
147331764|NCT01235949|531380972|FG014|Primary Phase|Migrated/moved from study area|0|||
147331765|NCT01235949|531380973|FG015|Primary Phase|Migrated/moved from study area|0|||
147660689|NCT02326272|532581385|FG000|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
147660690|NCT02326272|532581386|FG001|Initial Period (Week 0 to Week 16)|Adverse Event|3|||
147660691|NCT02326272|532581387|FG002|Initial Period (Week 0 to Week 16)|Adverse Event|1|||
147660692|NCT02326272|532581388|FG003|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
147660693|NCT02326272|532581389|FG004|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
147660694|NCT02326272|532581390|FG005|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
147660695|NCT02326272|532581391|FG006|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
147660696|NCT02326272|532581392|FG007|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
147660697|NCT02326272|532581393|FG008|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
147660698|NCT02326272|532581394|FG009|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
147660699|NCT02326272|532581395|FG010|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
147660700|NCT02326272|532581396|FG011|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
147660701|NCT02326272|532581397|FG012|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
147660702|NCT02326272|532581398|FG013|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
147660703|NCT02326272|532581399|FG014|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
147660704|NCT02326272|532581385|FG000|Initial Period (Week 0 to Week 16)|Lost to Follow-up|1|||
147660705|NCT02326272|532581386|FG001|Initial Period (Week 0 to Week 16)|Lost to Follow-up|2|||
147660706|NCT02326272|532581387|FG002|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
147660707|NCT02326272|532581388|FG003|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
147660708|NCT02326272|532581389|FG004|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
147660709|NCT02326272|532581390|FG005|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
147660710|NCT02326272|532581391|FG006|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
147660711|NCT02326272|532581392|FG007|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
147660712|NCT02326272|532581393|FG008|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
147660713|NCT02326272|532581394|FG009|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
147660714|NCT02326272|532581395|FG010|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
147660715|NCT02326272|532581396|FG011|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
147660716|NCT02326272|532581397|FG012|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
147660717|NCT02326272|532581398|FG013|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
147660718|NCT02326272|532581399|FG014|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
147660719|NCT02326272|532581385|FG000|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|3|||
147660720|NCT02326272|532581386|FG001|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|2|||
147660721|NCT02326272|532581387|FG002|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|1|||
147660722|NCT02326272|532581388|FG003|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
147660723|NCT02326272|532581389|FG004|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
147660724|NCT02326272|532581390|FG005|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
147660725|NCT02326272|532581391|FG006|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
147660726|NCT02326272|532581392|FG007|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
147660727|NCT02326272|532581393|FG008|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
147660728|NCT02326272|532581394|FG009|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
147660729|NCT02326272|532581395|FG010|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
147660730|NCT02326272|532581396|FG011|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
147660731|NCT02326272|532581397|FG012|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
147660732|NCT02326272|532581398|FG013|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
147660733|NCT02326272|532581399|FG014|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
147660734|NCT02326272|532581385|FG000|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
147660735|NCT02326272|532581386|FG001|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
147660736|NCT02326272|532581387|FG002|Initial Period (Week 0 to Week 16)|Moved from the study area|1|||
147660737|NCT02326272|532581388|FG003|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
147660738|NCT02326272|532581389|FG004|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
147660739|NCT02326272|532581390|FG005|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
147660740|NCT02326272|532581391|FG006|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
147660741|NCT02326272|532581392|FG007|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
147660742|NCT02326272|532581393|FG008|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
147660743|NCT02326272|532581394|FG009|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
147660744|NCT02326272|532581395|FG010|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
147660745|NCT02326272|532581396|FG011|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
147660746|NCT02326272|532581397|FG012|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
147660747|NCT02326272|532581398|FG013|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
147660748|NCT02326272|532581399|FG014|Initial Period (Week 0 to Week 16)|Moved from the study area|0|||
147660749|NCT02326272|532581385|FG000|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
147252842|NCT00967798|531098228|FG001|Overall Study|Withdrawal by Subject|2|||
147449929|NCT01982292|531811310|FG001|Overall Study|Technical Problems|0|||
147660750|NCT02326272|532581386|FG001|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
147252843|NCT00967798|531098227|FG000|Overall Study|Lost to Follow-up|4|||
147449930|NCT01496885|531811319|FG000|Overall Study|Lost to Follow-up|13|||
147252844|NCT00967798|531098228|FG001|Overall Study|Lost to Follow-up|1|||
147597833|NCT02149108|532345816|FG000|Overall Study|Worsening/adverse event cancer disease|31|||
147597834|NCT02149108|532345817|FG001|Overall Study|Worsening/adverse event cancer disease|32|||
147597835|NCT02149108|532345816|FG000|Overall Study|Other Adverse Event (AE)|8|||
147597836|NCT02149108|532345817|FG001|Overall Study|Other Adverse Event (AE)|18|||
147597837|NCT02149108|532345816|FG000|Overall Study|Other not defined above|0|||
147597838|NCT02149108|532345817|FG001|Overall Study|Other not defined above|2|||
147597839|NCT02149108|532345816|FG000|Overall Study|Refusal to continue trial medication|15|||
147597840|NCT02149108|532345817|FG001|Overall Study|Refusal to continue trial medication|11|||
147597841|NCT02149108|532345816|FG000|Overall Study|Lost to Follow-up|1|||
147252845|NCT01409564|531098229|FG000|Overall Study|low medication compliance|4|||
147252846|NCT01409564|531098230|FG001|Overall Study|low medication compliance|3|||
147252847|NCT01409564|531098229|FG000|Overall Study|brain abnormalities found in T1 MR|1|||
147252848|NCT01409564|531098230|FG001|Overall Study|brain abnormalities found in T1 MR|2|||
147252849|NCT00254540|531098231|FG000|Overall Study|Adverse Event|6|||
147252850|NCT00254540|531098232|FG001|Overall Study|Adverse Event|7|||
147252851|NCT00254540|531098231|FG000|Overall Study|Lack of Efficacy|13|||
147252852|NCT00254540|531098232|FG001|Overall Study|Lack of Efficacy|13|||
147252853|NCT00254540|531098231|FG000|Overall Study|Death|0|||
147252854|NCT00254540|531098232|FG001|Overall Study|Death|1|||
147252855|NCT00254540|531098231|FG000|Overall Study|Laboratory Test Abnormality|0|||
147252856|NCT00254540|531098232|FG001|Overall Study|Laboratory Test Abnormality|1|||
147252857|NCT00225251|531098233|FG000|Overall Study|Withdrawal by Subject|1|||
147252858|NCT00225251|531098234|FG001|Overall Study|Withdrawal by Subject|1|||
147252859|NCT03045328|531098235|FG000|Overall Study|Withdrawal by Subject|2|||
147252860|NCT00592839|531098238|FG000|Overall Study|Withdrawal by Subject|1|||
147252861|NCT00592839|531098239|FG001|Overall Study|Withdrawal by Subject|1|||
147252862|NCT00592839|531098240|FG002|Overall Study|Withdrawal by Subject|3|||
147252863|NCT00592839|531098238|FG000|Overall Study|Protocol Violation|1|||
147252864|NCT00592839|531098239|FG001|Overall Study|Protocol Violation|1|||
147252865|NCT00592839|531098240|FG002|Overall Study|Protocol Violation|2|||
147252866|NCT00592839|531098238|FG000|Overall Study|Adverse Event|0|||
147252867|NCT00592839|531098239|FG001|Overall Study|Adverse Event|1|||
147252868|NCT00592839|531098240|FG002|Overall Study|Adverse Event|0|||
147252869|NCT00592839|531098238|FG000|Overall Study|Lost to Follow-up|0|||
147252870|NCT00592839|531098239|FG001|Overall Study|Lost to Follow-up|1|||
147252871|NCT00592839|531098240|FG002|Overall Study|Lost to Follow-up|1|||
147252872|NCT01313767|531098241|FG000|Overall Study|Adverse Event|1|||
147252873|NCT01313767|531098242|FG001|Overall Study|Adverse Event|0|||
147252874|NCT01313767|531098241|FG000|Overall Study|Lost to Follow-up|1|||
147252875|NCT01313767|531098242|FG001|Overall Study|Lost to Follow-up|0|||
147252876|NCT01313767|531098241|FG000|Overall Study|Withdrawal by Subject|2|||
147252877|NCT01313767|531098242|FG001|Overall Study|Withdrawal by Subject|1|||
147252878|NCT01313767|531098241|FG000|Overall Study|Protocol Violation|3|||
147252879|NCT01313767|531098242|FG001|Overall Study|Protocol Violation|1|||
147252880|NCT00157950|531098243|FG000|Overall Study|Death|1|||
147252881|NCT00157950|531098244|FG001|Overall Study|Death|0|||
147252882|NCT01287897|531098245|FG000|Overall Study|Adverse Event|5|||
147252883|NCT01287897|531098246|FG001|Overall Study|Adverse Event|3|||
147252884|NCT01287897|531098247|FG002|Overall Study|Adverse Event|6|||
147252885|NCT01287897|531098248|FG003|Overall Study|Adverse Event|4|||
147252886|NCT01287897|531098245|FG000|Overall Study|Lack of Efficacy|2|||
147252887|NCT01287897|531098246|FG001|Overall Study|Lack of Efficacy|0|||
147252888|NCT01287897|531098247|FG002|Overall Study|Lack of Efficacy|0|||
147252889|NCT01287897|531098248|FG003|Overall Study|Lack of Efficacy|0|||
147252890|NCT01287897|531098245|FG000|Overall Study|Protocol Violation|1|||
147252891|NCT01287897|531098246|FG001|Overall Study|Protocol Violation|1|||
147252892|NCT01287897|531098247|FG002|Overall Study|Protocol Violation|0|||
147252893|NCT01287897|531098248|FG003|Overall Study|Protocol Violation|1|||
147252894|NCT01287897|531098245|FG000|Overall Study|Lost to Follow-up|0|||
147252895|NCT01287897|531098246|FG001|Overall Study|Lost to Follow-up|0|||
147252896|NCT01287897|531098247|FG002|Overall Study|Lost to Follow-up|2|||
147252897|NCT01287897|531098248|FG003|Overall Study|Lost to Follow-up|0|||
147252898|NCT01287897|531098245|FG000|Overall Study|Withdrawal by Subject|1|||
147252899|NCT01287897|531098246|FG001|Overall Study|Withdrawal by Subject|5|||
147252900|NCT01287897|531098247|FG002|Overall Study|Withdrawal by Subject|3|||
147252901|NCT01287897|531098248|FG003|Overall Study|Withdrawal by Subject|2|||
147252902|NCT01287897|531098245|FG000|Overall Study|Not consented properly|0|||
147252903|NCT01287897|531098246|FG001|Overall Study|Not consented properly|1|||
147252904|NCT01287897|531098247|FG002|Overall Study|Not consented properly|0|||
147252905|NCT01287897|531098248|FG003|Overall Study|Not consented properly|0|||
147252906|NCT01287897|531098245|FG000|Overall Study|Not meeting entrance criteria|1|||
147252907|NCT01287897|531098246|FG001|Overall Study|Not meeting entrance criteria|1|||
147252908|NCT01287897|531098247|FG002|Overall Study|Not meeting entrance criteria|0|||
147252909|NCT01287897|531098248|FG003|Overall Study|Not meeting entrance criteria|0|||
147660751|NCT02326272|532581387|FG002|Initial Period (Week 0 to Week 16)|Missed two doses|1|||
147660752|NCT02326272|532581388|FG003|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
147660753|NCT02326272|532581389|FG004|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
147660754|NCT02326272|532581390|FG005|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
147660755|NCT02326272|532581391|FG006|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
147660756|NCT02326272|532581392|FG007|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
147660757|NCT02326272|532581393|FG008|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
147660758|NCT02326272|532581394|FG009|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
147660759|NCT02326272|532581395|FG010|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
147660760|NCT02326272|532581396|FG011|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
147660761|NCT02326272|532581397|FG012|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
147660762|NCT02326272|532581398|FG013|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
147660763|NCT02326272|532581399|FG014|Initial Period (Week 0 to Week 16)|Missed two doses|0|||
147660764|NCT02326272|532581385|FG000|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
147660765|NCT02326272|532581386|FG001|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
147660766|NCT02326272|532581387|FG002|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|1|||
147660767|NCT02326272|532581388|FG003|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
147660768|NCT02326272|532581389|FG004|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
147660769|NCT02326272|532581390|FG005|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
147660770|NCT02326272|532581391|FG006|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
147660771|NCT02326272|532581392|FG007|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
147660772|NCT02326272|532581393|FG008|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
147660773|NCT02326272|532581394|FG009|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
147660774|NCT02326272|532581395|FG010|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
147660775|NCT02326272|532581396|FG011|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
147660776|NCT02326272|532581397|FG012|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
147660777|NCT02326272|532581398|FG013|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
147660778|NCT02326272|532581399|FG014|Initial Period (Week 0 to Week 16)|Lost to follow-up after completing wk16|0|||
147660779|NCT02326272|532581385|FG000|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
147660780|NCT02326272|532581386|FG001|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
147660781|NCT02326272|532581387|FG002|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|1|||
147660782|NCT02326272|532581388|FG003|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
147660783|NCT02326272|532581389|FG004|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
147660784|NCT02326272|532581390|FG005|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
147660785|NCT02326272|532581391|FG006|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
147660786|NCT02326272|532581392|FG007|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
147660787|NCT02326272|532581393|FG008|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
147660788|NCT02326272|532581394|FG009|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
147660789|NCT02326272|532581395|FG010|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
147660790|NCT02326272|532581396|FG011|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
147660791|NCT02326272|532581397|FG012|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
147660792|NCT02326272|532581398|FG013|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
147660793|NCT02326272|532581399|FG014|Initial Period (Week 0 to Week 16)|Consent withdrawn after completing wk16|0|||
147660794|NCT02326272|532581385|FG000|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
147660795|NCT02326272|532581386|FG001|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
147660796|NCT02326272|532581387|FG002|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
147660797|NCT02326272|532581388|FG003|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
147660798|NCT02326272|532581389|FG004|Maintenance Period (Week 16 to Week 48)|Adverse Event|2|||
147660799|NCT02326272|532581390|FG005|Maintenance Period (Week 16 to Week 48)|Adverse Event|3|||
147660800|NCT02326272|532581391|FG006|Maintenance Period (Week 16 to Week 48)|Adverse Event|4|||
147660801|NCT02326272|532581392|FG007|Maintenance Period (Week 16 to Week 48)|Adverse Event|2|||
147660802|NCT02326272|532581393|FG008|Maintenance Period (Week 16 to Week 48)|Adverse Event|1|||
147660803|NCT02326272|532581394|FG009|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
147660804|NCT02326272|532581395|FG010|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
147660805|NCT02326272|532581396|FG011|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
147660806|NCT02326272|532581397|FG012|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
147660807|NCT02326272|532581398|FG013|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
147449931|NCT01496885|531811319|FG000|Overall Study|Withdrawal by Subject|7|||
147449932|NCT01496885|531811319|FG000|Overall Study|Clinically significant change in subject status that prevented compliance or impacted stroke outcome|2|||
147660808|NCT02326272|532581399|FG014|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
147660809|NCT02326272|532581385|FG000|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
147660810|NCT02326272|532581386|FG001|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
147660811|NCT02326272|532581387|FG002|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
147660812|NCT02326272|532581388|FG003|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
147660813|NCT02326272|532581389|FG004|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
147660814|NCT02326272|532581390|FG005|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|2|||
147660815|NCT02326272|532581391|FG006|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|1|||
147660816|NCT02326272|532581392|FG007|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
147660817|NCT02326272|532581393|FG008|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|1|||
147660818|NCT02326272|532581394|FG009|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|1|||
147660819|NCT02326272|532581395|FG010|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
147660820|NCT02326272|532581396|FG011|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
147660821|NCT02326272|532581397|FG012|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
147660822|NCT02326272|532581398|FG013|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
147660823|NCT02326272|532581399|FG014|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
147660824|NCT02326272|532581385|FG000|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
147660825|NCT02326272|532581386|FG001|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
147660826|NCT02326272|532581387|FG002|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
147660827|NCT02326272|532581388|FG003|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
147660828|NCT02326272|532581389|FG004|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
147660829|NCT02326272|532581390|FG005|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|2|||
147660830|NCT02326272|532581391|FG006|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
147660831|NCT02326272|532581392|FG007|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|2|||
147660832|NCT02326272|532581393|FG008|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
147660833|NCT02326272|532581394|FG009|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
147660834|NCT02326272|532581395|FG010|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
147660835|NCT02326272|532581396|FG011|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
147660836|NCT02326272|532581397|FG012|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
147660837|NCT02326272|532581398|FG013|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
147660838|NCT02326272|532581399|FG014|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
147660839|NCT02326272|532581385|FG000|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
147660840|NCT02326272|532581386|FG001|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
147660841|NCT02326272|532581387|FG002|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
147660842|NCT02326272|532581388|FG003|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
147660843|NCT02326272|532581389|FG004|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
147660844|NCT02326272|532581390|FG005|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|3|||
147660845|NCT02326272|532581391|FG006|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
147660846|NCT02326272|532581392|FG007|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
147660847|NCT02326272|532581393|FG008|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
147660848|NCT02326272|532581394|FG009|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
147660849|NCT02326272|532581395|FG010|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
147660850|NCT02326272|532581396|FG011|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
147660851|NCT02326272|532581397|FG012|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
147660852|NCT02326272|532581398|FG013|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
147660853|NCT02326272|532581399|FG014|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
147660854|NCT02326272|532581385|FG000|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
147660855|NCT02326272|532581386|FG001|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
147660856|NCT02326272|532581387|FG002|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
147660857|NCT02326272|532581388|FG003|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
147660858|NCT02326272|532581389|FG004|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
147660859|NCT02326272|532581390|FG005|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
147660860|NCT02326272|532581391|FG006|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
147660861|NCT02326272|532581392|FG007|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|1|||
147660862|NCT02326272|532581393|FG008|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
147660863|NCT02326272|532581394|FG009|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
147660864|NCT02326272|532581395|FG010|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
147660865|NCT02326272|532581396|FG011|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
147660866|NCT02326272|532581397|FG012|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
147660867|NCT02326272|532581398|FG013|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
147660868|NCT02326272|532581399|FG014|Maintenance Period (Week 16 to Week 48)|Subject moved out of state|0|||
147660869|NCT02326272|532581385|FG000|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
147660870|NCT02326272|532581386|FG001|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
147660871|NCT02326272|532581387|FG002|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
147331766|NCT01235949|531380974|FG016|Primary Phase|Migrated/moved from study area|0|||
147331767|NCT01235949|531380975|FG017|Primary Phase|Migrated/moved from study area|0|||
147597842|NCT02149108|532345817|FG001|Overall Study|Lost to Follow-up|0|||
147597843|NCT01156142|532345818|FG000|Overall Study|Withdrawal by Subject|8|||
147597844|NCT01156142|532345819|FG001|Overall Study|Withdrawal by Subject|6|||
147597845|NCT01156142|532345818|FG000|Overall Study|Ineligible|0|||
147597846|NCT01156142|532345819|FG001|Overall Study|Ineligible|1|||
147597847|NCT00893737|532345820|FG000|Overall Study|Adverse Event|4|||
147597848|NCT00893737|532345820|FG000|Overall Study|Withdrawal by Subject|2|||
147597849|NCT00893737|532345820|FG000|Overall Study|Lost to Follow-up|6|||
147597850|NCT03981419|532345821|FG000|Overall Study|Due to Coronavirus Disease-2019 (COVID-19)|0|||
147597851|NCT03981419|532345822|FG001|Overall Study|Due to Coronavirus Disease-2019 (COVID-19)|1|||
147597852|NCT01330459|532345823|FG000|Overall Study|Physician Decision|0|||
147597853|NCT01330459|532345824|FG001|Overall Study|Physician Decision|2|||
147597854|NCT00895947|532345826|FG000|Overall Study|Adverse Event|3|||
147597855|NCT00895947|532345827|FG001|Overall Study|Adverse Event|4|||
147597856|NCT00895947|532345826|FG000|Overall Study|Lost to Follow-up|3|||
147597857|NCT00895947|532345827|FG001|Overall Study|Lost to Follow-up|4|||
147597858|NCT00895947|532345826|FG000|Overall Study|Protocol Violation|4|||
147597859|NCT00895947|532345827|FG001|Overall Study|Protocol Violation|2|||
147597860|NCT00895947|532345826|FG000|Overall Study|Withdrawal by Subject|2|||
147597861|NCT00895947|532345827|FG001|Overall Study|Withdrawal by Subject|0|||
147597862|NCT04647721|532345832|FG000|Overall Study|Withdrawal by Subject|0|||
147597863|NCT04647721|532345833|FG001|Overall Study|Withdrawal by Subject|2|||
147597864|NCT04647721|532345832|FG000|Overall Study|Lost to Follow-up|2|||
147597865|NCT04647721|532345833|FG001|Overall Study|Lost to Follow-up|0|||
147597866|NCT01974440|532345835|FG000|Overall Study|Lost to Follow-up|7|||
147597867|NCT01974440|532345836|FG001|Overall Study|Lost to Follow-up|7|||
147597868|NCT01974440|532345835|FG000|Overall Study|Withdrawal by Subject|24|||
147597869|NCT01974440|532345836|FG001|Overall Study|Withdrawal by Subject|20|||
147597870|NCT01974440|532345835|FG000|Overall Study|Sponsor decision|109|||
147597871|NCT01974440|532345836|FG001|Overall Study|Sponsor decision|110|||
147597872|NCT00857259|532345840|FG000|Overall Study|Protocol Violation|1|||
147597873|NCT00857259|532345841|FG001|Overall Study|Protocol Violation|0|||
147597874|NCT00857259|532345842|FG002|Overall Study|Protocol Violation|1|||
147597875|NCT02701413|532345843|FG000|Overall Study|Withdrawal by Subject|7|||
147597876|NCT02701413|532345844|FG001|Overall Study|Withdrawal by Subject|11|||
147597877|NCT02138136|532345845|FG000|Overall Study|Protocol Violation|4|||
147597878|NCT02138136|532345845|FG000|Overall Study|Physician Decision|7|||
147597879|NCT02138136|532345845|FG000|Overall Study|Lack of Efficacy|35|||
147597880|NCT02138136|532345845|FG000|Overall Study|Pregnancy|2|||
147597881|NCT02138136|532345845|FG000|Overall Study|Adverse Event|18|||
147597882|NCT02138136|532345845|FG000|Overall Study|Withdrawal by Subject|36|||
147597883|NCT02138136|532345845|FG000|Overall Study|Lost to Follow-up|32|||
147597884|NCT02138136|532345845|FG000|Overall Study|Withdrawn by Sponsor|5|||
147597885|NCT01359644|532345850|FG000|Treatment Period|Lack of Efficacy|0|||
147597886|NCT01359644|532345851|FG001|Treatment Period|Lack of Efficacy|1|||
147597887|NCT01359644|532345852|FG002|Treatment Period|Lack of Efficacy|0|||
147597888|NCT01359644|532345853|FG003|Treatment Period|Lack of Efficacy|0|||
147597889|NCT01359644|532345854|FG004|Treatment Period|Lack of Efficacy|0|||
147597890|NCT01359644|532345855|FG005|Treatment Period|Lack of Efficacy|0|||
147660872|NCT02326272|532581388|FG003|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
147660873|NCT02326272|532581389|FG004|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
147252910|NCT01287897|531098245|FG000|Overall Study|Other|1|||
147252911|NCT01287897|531098246|FG001|Overall Study|Other|0|||
147252912|NCT01287897|531098247|FG002|Overall Study|Other|1|||
147252913|NCT01287897|531098248|FG003|Overall Study|Other|0|||
147252914|NCT02902965|531098253|FG000|Overall Study|Withdrawal by Subject|10|||
147252915|NCT00293254|531098254|FG000|Primary Study - Double-Blind Week 0-48|Never Treated|2|||
147252916|NCT00293254|531098255|FG001|Primary Study - Double-Blind Week 0-48|Never Treated|0|||
147252917|NCT00293254|531098254|FG000|Primary Study - Double-Blind Week 0-48|Adverse Event|2|||
147252918|NCT00293254|531098255|FG001|Primary Study - Double-Blind Week 0-48|Adverse Event|1|||
147252919|NCT00293254|531098254|FG000|Primary Study - Double-Blind Week 0-48|Death|5|||
147252920|NCT00293254|531098255|FG001|Primary Study - Double-Blind Week 0-48|Death|2|||
147252921|NCT00293254|531098254|FG000|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|2|||
147252922|NCT00293254|531098255|FG001|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|2|||
147252923|NCT00293254|531098254|FG000|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|3|||
147252924|NCT00293254|531098255|FG001|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|1|||
147252925|NCT00293254|531098254|FG000|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|5|||
147331768|NCT01235949|531380958|FG000|Primary Phase|Adverse Event|0|||
147597891|NCT01359644|532345856|FG006|Treatment Period|Lack of Efficacy|0|||
147597892|NCT01359644|532345857|FG007|Treatment Period|Lack of Efficacy|0|||
147597893|NCT01359644|532345858|FG008|Treatment Period|Lack of Efficacy|0|||
147597894|NCT01359644|532345859|FG009|Treatment Period|Lack of Efficacy|0|||
147597895|NCT01359644|532345850|FG000|Treatment Period|Adverse Event|0|||
147597896|NCT01359644|532345851|FG001|Treatment Period|Adverse Event|0|||
147660874|NCT02326272|532581390|FG005|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
147660875|NCT02326272|532581391|FG006|Maintenance Period (Week 16 to Week 48)|Pregnancy|1|||
147660876|NCT02326272|532581392|FG007|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
147660877|NCT02326272|532581393|FG008|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
147660878|NCT02326272|532581394|FG009|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
147660879|NCT02326272|532581395|FG010|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
147660880|NCT02326272|532581396|FG011|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
147660881|NCT02326272|532581397|FG012|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
147660882|NCT02326272|532581398|FG013|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
147660883|NCT02326272|532581399|FG014|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
147660884|NCT02326272|532581385|FG000|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
147660885|NCT02326272|532581386|FG001|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
147660886|NCT02326272|532581387|FG002|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
147660887|NCT02326272|532581388|FG003|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
147660888|NCT02326272|532581389|FG004|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
147660889|NCT02326272|532581390|FG005|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
147660890|NCT02326272|532581391|FG006|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
147660891|NCT02326272|532581392|FG007|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
147660892|NCT02326272|532581393|FG008|Maintenance Period (Week 16 to Week 48)|Non-compliance|1|||
147660893|NCT02326272|532581394|FG009|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
147660894|NCT02326272|532581395|FG010|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
147660895|NCT02326272|532581396|FG011|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
147660896|NCT02326272|532581397|FG012|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
147660897|NCT02326272|532581398|FG013|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
147660898|NCT02326272|532581399|FG014|Maintenance Period (Week 16 to Week 48)|Non-compliance|0|||
147660899|NCT02326272|532581385|FG000|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
147660900|NCT02326272|532581386|FG001|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
147660901|NCT02326272|532581387|FG002|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
147660902|NCT02326272|532581388|FG003|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
147660903|NCT02326272|532581389|FG004|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
147660904|NCT02326272|532581390|FG005|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|2|||
147660905|NCT02326272|532581391|FG006|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|1|||
147660906|NCT02326272|532581392|FG007|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|1|||
147660907|NCT02326272|532581393|FG008|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|2|||
147660908|NCT02326272|532581394|FG009|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
147660909|NCT02326272|532581395|FG010|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
147660910|NCT02326272|532581396|FG011|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
147660911|NCT02326272|532581397|FG012|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
147660912|NCT02326272|532581398|FG013|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
147660913|NCT02326272|532581399|FG014|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
147660914|NCT02326272|532581385|FG000|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
147660915|NCT02326272|532581386|FG001|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
147660916|NCT02326272|532581387|FG002|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
147660917|NCT02326272|532581388|FG003|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
147331769|NCT01235949|531380959|FG001|Primary Phase|Adverse Event|0|||
147331770|NCT01235949|531380960|FG002|Primary Phase|Adverse Event|0|||
147331771|NCT01235949|531380961|FG003|Primary Phase|Adverse Event|1|||
147331772|NCT01235949|531380962|FG004|Primary Phase|Adverse Event|0|||
147331773|NCT01235949|531380963|FG005|Primary Phase|Adverse Event|0|||
147331774|NCT01235949|531380964|FG006|Primary Phase|Adverse Event|0|||
147331775|NCT01235949|531380965|FG007|Primary Phase|Adverse Event|0|||
147331776|NCT01235949|531380966|FG008|Primary Phase|Adverse Event|0|||
147597897|NCT01359644|532345852|FG002|Treatment Period|Adverse Event|1|||
147597898|NCT01359644|532345853|FG003|Treatment Period|Adverse Event|0|||
147597899|NCT01359644|532345854|FG004|Treatment Period|Adverse Event|0|||
147597900|NCT01359644|532345855|FG005|Treatment Period|Adverse Event|1|||
147597901|NCT01359644|532345856|FG006|Treatment Period|Adverse Event|0|||
147597902|NCT01359644|532345857|FG007|Treatment Period|Adverse Event|0|||
147597903|NCT01359644|532345858|FG008|Treatment Period|Adverse Event|0|||
147660918|NCT02326272|532581389|FG004|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
147331777|NCT01235949|531380967|FG009|Primary Phase|Adverse Event|0|||
147331778|NCT01235949|531380968|FG010|Primary Phase|Adverse Event|0|||
147449933|NCT01496885|531811319|FG000|Overall Study|Death|1|||
147449934|NCT02669017|531811321|FG000|Overall Study|Death|1|||
147449935|NCT02669017|531811322|FG001|Overall Study|Death|2|||
147449936|NCT02669017|531811323|FG002|Overall Study|Death|2|||
147597904|NCT01359644|532345859|FG009|Treatment Period|Adverse Event|0|||
147597905|NCT01359644|532345850|FG000|Treatment Period|Lost to Follow-up|0|||
147331779|NCT01235949|531380969|FG011|Primary Phase|Adverse Event|0|||
147660919|NCT02326272|532581390|FG005|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|1|||
147660920|NCT02326272|532581391|FG006|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
147660921|NCT02326272|532581392|FG007|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
147660922|NCT02326272|532581393|FG008|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
147660923|NCT02326272|532581394|FG009|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
147660924|NCT02326272|532581395|FG010|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
147660925|NCT02326272|532581396|FG011|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
147660926|NCT02326272|532581397|FG012|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
147660927|NCT02326272|532581398|FG013|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
147660928|NCT02326272|532581399|FG014|Maintenance Period (Week 16 to Week 48)|Adverse event after completing wk48|0|||
147660929|NCT02326272|532581385|FG000|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
147660930|NCT02326272|532581386|FG001|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
147660931|NCT02326272|532581387|FG002|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
147660932|NCT02326272|532581388|FG003|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
147660933|NCT02326272|532581389|FG004|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
147660934|NCT02326272|532581390|FG005|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
147660935|NCT02326272|532581391|FG006|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|1|||
147660936|NCT02326272|532581392|FG007|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
147660937|NCT02326272|532581393|FG008|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
147660938|NCT02326272|532581394|FG009|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
147660939|NCT02326272|532581395|FG010|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
147660940|NCT02326272|532581396|FG011|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
147660941|NCT02326272|532581397|FG012|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
147660942|NCT02326272|532581398|FG013|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
147660943|NCT02326272|532581399|FG014|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after wk48|0|||
147331780|NCT01235949|531380970|FG012|Primary Phase|Adverse Event|0|||
147331781|NCT01235949|531380971|FG013|Primary Phase|Adverse Event|0|||
147331782|NCT01235949|531380972|FG014|Primary Phase|Adverse Event|0|||
147331783|NCT01235949|531380973|FG015|Primary Phase|Adverse Event|0|||
147331784|NCT01235949|531380974|FG016|Primary Phase|Adverse Event|0|||
147331785|NCT01235949|531380975|FG017|Primary Phase|Adverse Event|0|||
147331786|NCT01235949|531380958|FG000|Primary Phase|Withdrawal by Subject|3|||
147331787|NCT01235949|531380959|FG001|Primary Phase|Withdrawal by Subject|2|||
147331788|NCT01235949|531380960|FG002|Primary Phase|Withdrawal by Subject|2|||
147331789|NCT01235949|531380961|FG003|Primary Phase|Withdrawal by Subject|0|||
147331790|NCT01235949|531380962|FG004|Primary Phase|Withdrawal by Subject|0|||
147331791|NCT01235949|531380963|FG005|Primary Phase|Withdrawal by Subject|3|||
147331792|NCT01235949|531380964|FG006|Primary Phase|Withdrawal by Subject|0|||
147331793|NCT01235949|531380965|FG007|Primary Phase|Withdrawal by Subject|0|||
147331794|NCT01235949|531380966|FG008|Primary Phase|Withdrawal by Subject|0|||
147331795|NCT01235949|531380967|FG009|Primary Phase|Withdrawal by Subject|0|||
147331796|NCT01235949|531380968|FG010|Primary Phase|Withdrawal by Subject|0|||
147331797|NCT01235949|531380969|FG011|Primary Phase|Withdrawal by Subject|0|||
147331798|NCT01235949|531380970|FG012|Primary Phase|Withdrawal by Subject|0|||
147331799|NCT01235949|531380971|FG013|Primary Phase|Withdrawal by Subject|0|||
147331800|NCT01235949|531380972|FG014|Primary Phase|Withdrawal by Subject|0|||
147331801|NCT01235949|531380973|FG015|Primary Phase|Withdrawal by Subject|0|||
147331802|NCT01235949|531380974|FG016|Primary Phase|Withdrawal by Subject|0|||
147331803|NCT01235949|531380975|FG017|Primary Phase|Withdrawal by Subject|0|||
147331804|NCT01235949|531380958|FG000|Primary Phase|Lost to Follow-up|0|||
147331805|NCT01235949|531380959|FG001|Primary Phase|Lost to Follow-up|0|||
147331806|NCT01235949|531380960|FG002|Primary Phase|Lost to Follow-up|1|||
147331807|NCT01235949|531380961|FG003|Primary Phase|Lost to Follow-up|1|||
147331808|NCT01235949|531380962|FG004|Primary Phase|Lost to Follow-up|0|||
147331809|NCT01235949|531380963|FG005|Primary Phase|Lost to Follow-up|2|||
147331810|NCT01235949|531380964|FG006|Primary Phase|Lost to Follow-up|0|||
147331811|NCT01235949|531380965|FG007|Primary Phase|Lost to Follow-up|0|||
147331812|NCT01235949|531380966|FG008|Primary Phase|Lost to Follow-up|0|||
147331813|NCT01235949|531380967|FG009|Primary Phase|Lost to Follow-up|0|||
147331814|NCT01235949|531380968|FG010|Primary Phase|Lost to Follow-up|0|||
147331815|NCT01235949|531380969|FG011|Primary Phase|Lost to Follow-up|0|||
147331816|NCT01235949|531380970|FG012|Primary Phase|Lost to Follow-up|0|||
147331817|NCT01235949|531380971|FG013|Primary Phase|Lost to Follow-up|0|||
147331818|NCT01235949|531380972|FG014|Primary Phase|Lost to Follow-up|0|||
147331819|NCT01235949|531380973|FG015|Primary Phase|Lost to Follow-up|0|||
147331820|NCT01235949|531380974|FG016|Primary Phase|Lost to Follow-up|0|||
147331821|NCT01235949|531380975|FG017|Primary Phase|Lost to Follow-up|0|||
147331822|NCT01235949|531380958|FG000|Booster Phase|Migrated/moved from study area|0|||
147449937|NCT02669017|531811324|FG003|Overall Study|Death|3|||
147331823|NCT01235949|531380959|FG001|Booster Phase|Migrated/moved from study area|0|||
147331824|NCT01235949|531380960|FG002|Booster Phase|Migrated/moved from study area|0|||
147331825|NCT01235949|531380961|FG003|Booster Phase|Migrated/moved from study area|0|||
147331826|NCT01235949|531380962|FG004|Booster Phase|Migrated/moved from study area|0|||
147331827|NCT01235949|531380963|FG005|Booster Phase|Migrated/moved from study area|0|||
147331828|NCT01235949|531380964|FG006|Booster Phase|Migrated/moved from study area|0|||
147331829|NCT01235949|531380965|FG007|Booster Phase|Migrated/moved from study area|0|||
147331830|NCT01235949|531380966|FG008|Booster Phase|Migrated/moved from study area|0|||
147331831|NCT01235949|531380967|FG009|Booster Phase|Migrated/moved from study area|0|||
147331832|NCT01235949|531380968|FG010|Booster Phase|Migrated/moved from study area|0|||
147331833|NCT01235949|531380969|FG011|Booster Phase|Migrated/moved from study area|1|||
147331834|NCT01235949|531380970|FG012|Booster Phase|Migrated/moved from study area|1|||
147331835|NCT01235949|531380971|FG013|Booster Phase|Migrated/moved from study area|0|||
147331836|NCT01235949|531380972|FG014|Booster Phase|Migrated/moved from study area|0|||
147331837|NCT01235949|531380973|FG015|Booster Phase|Migrated/moved from study area|0|||
147331838|NCT01235949|531380974|FG016|Booster Phase|Migrated/moved from study area|0|||
147331839|NCT01235949|531380975|FG017|Booster Phase|Migrated/moved from study area|1|||
147331840|NCT01235949|531380958|FG000|Booster Phase|Adverse Event|0|||
147331841|NCT01235949|531380959|FG001|Booster Phase|Adverse Event|0|||
147331842|NCT01235949|531380960|FG002|Booster Phase|Adverse Event|0|||
147331843|NCT01235949|531380961|FG003|Booster Phase|Adverse Event|0|||
147331844|NCT01235949|531380962|FG004|Booster Phase|Adverse Event|0|||
147331845|NCT01235949|531380963|FG005|Booster Phase|Adverse Event|0|||
147331846|NCT01235949|531380964|FG006|Booster Phase|Adverse Event|0|||
147331847|NCT01235949|531380965|FG007|Booster Phase|Adverse Event|0|||
147331848|NCT01235949|531380966|FG008|Booster Phase|Adverse Event|0|||
147331849|NCT01235949|531380967|FG009|Booster Phase|Adverse Event|0|||
147331850|NCT01235949|531380968|FG010|Booster Phase|Adverse Event|0|||
147331851|NCT01235949|531380969|FG011|Booster Phase|Adverse Event|0|||
147331852|NCT01235949|531380970|FG012|Booster Phase|Adverse Event|0|||
147331853|NCT01235949|531380971|FG013|Booster Phase|Adverse Event|0|||
147331854|NCT01235949|531380972|FG014|Booster Phase|Adverse Event|0|||
147331855|NCT01235949|531380973|FG015|Booster Phase|Adverse Event|1|||
147331856|NCT01235949|531380974|FG016|Booster Phase|Adverse Event|0|||
147331857|NCT01235949|531380975|FG017|Booster Phase|Adverse Event|0|||
147331858|NCT01235949|531380958|FG000|Booster Phase|Withdrawal by Subject|0|||
147331859|NCT01235949|531380959|FG001|Booster Phase|Withdrawal by Subject|0|||
147331860|NCT01235949|531380960|FG002|Booster Phase|Withdrawal by Subject|0|||
147331861|NCT01235949|531380961|FG003|Booster Phase|Withdrawal by Subject|0|||
147331862|NCT01235949|531380962|FG004|Booster Phase|Withdrawal by Subject|0|||
147331863|NCT01235949|531380963|FG005|Booster Phase|Withdrawal by Subject|0|||
147331864|NCT01235949|531380964|FG006|Booster Phase|Withdrawal by Subject|0|||
147331865|NCT01235949|531380965|FG007|Booster Phase|Withdrawal by Subject|1|||
147331866|NCT01235949|531380966|FG008|Booster Phase|Withdrawal by Subject|1|||
147331867|NCT01235949|531380967|FG009|Booster Phase|Withdrawal by Subject|0|||
147331868|NCT01235949|531380968|FG010|Booster Phase|Withdrawal by Subject|1|||
147331869|NCT01235949|531380969|FG011|Booster Phase|Withdrawal by Subject|1|||
147331870|NCT01235949|531380970|FG012|Booster Phase|Withdrawal by Subject|2|||
147331871|NCT01235949|531380971|FG013|Booster Phase|Withdrawal by Subject|0|||
147597906|NCT01359644|532345851|FG001|Treatment Period|Lost to Follow-up|0|||
147597907|NCT01359644|532345852|FG002|Treatment Period|Lost to Follow-up|0|||
147597908|NCT01359644|532345853|FG003|Treatment Period|Lost to Follow-up|0|||
147597909|NCT01359644|532345854|FG004|Treatment Period|Lost to Follow-up|0|||
147597910|NCT01359644|532345855|FG005|Treatment Period|Lost to Follow-up|1|||
147597911|NCT01359644|532345856|FG006|Treatment Period|Lost to Follow-up|0|||
147597912|NCT01359644|532345857|FG007|Treatment Period|Lost to Follow-up|0|||
147597913|NCT01359644|532345858|FG008|Treatment Period|Lost to Follow-up|0|||
147597914|NCT01359644|532345859|FG009|Treatment Period|Lost to Follow-up|0|||
147597915|NCT01359644|532345850|FG000|Follow-up Period|Withdrawal by Subject|0|||
147597916|NCT01359644|532345851|FG001|Follow-up Period|Withdrawal by Subject|0|||
147597917|NCT01359644|532345852|FG002|Follow-up Period|Withdrawal by Subject|0|||
147597918|NCT01359644|532345853|FG003|Follow-up Period|Withdrawal by Subject|0|||
147597919|NCT01359644|532345854|FG004|Follow-up Period|Withdrawal by Subject|0|||
147597920|NCT01359644|532345855|FG005|Follow-up Period|Withdrawal by Subject|1|||
147331872|NCT01235949|531380972|FG014|Booster Phase|Withdrawal by Subject|2|||
147331873|NCT01235949|531380973|FG015|Booster Phase|Withdrawal by Subject|0|||
147331874|NCT01235949|531380974|FG016|Booster Phase|Withdrawal by Subject|0|||
147331875|NCT01235949|531380975|FG017|Booster Phase|Withdrawal by Subject|0|||
147331876|NCT01235949|531380958|FG000|Booster Phase|Lost to Follow-up|0|||
147331877|NCT01235949|531380959|FG001|Booster Phase|Lost to Follow-up|0|||
147331878|NCT01235949|531380960|FG002|Booster Phase|Lost to Follow-up|0|||
147331879|NCT01235949|531380961|FG003|Booster Phase|Lost to Follow-up|0|||
147331880|NCT01235949|531380962|FG004|Booster Phase|Lost to Follow-up|0|||
147597921|NCT01359644|532345856|FG006|Follow-up Period|Withdrawal by Subject|0|||
147597922|NCT01359644|532345857|FG007|Follow-up Period|Withdrawal by Subject|0|||
147597923|NCT01359644|532345858|FG008|Follow-up Period|Withdrawal by Subject|0|||
147597924|NCT01359644|532345859|FG009|Follow-up Period|Withdrawal by Subject|0|||
147597925|NCT01359644|532345850|FG000|Follow-up Period|Lost to Follow-up|0|||
147597926|NCT01359644|532345851|FG001|Follow-up Period|Lost to Follow-up|0|||
147597927|NCT01359644|532345852|FG002|Follow-up Period|Lost to Follow-up|0|||
147597928|NCT01359644|532345853|FG003|Follow-up Period|Lost to Follow-up|0|||
147597929|NCT01359644|532345854|FG004|Follow-up Period|Lost to Follow-up|0|||
147597930|NCT01359644|532345855|FG005|Follow-up Period|Lost to Follow-up|0|||
147597931|NCT01359644|532345856|FG006|Follow-up Period|Lost to Follow-up|1|||
147597932|NCT01359644|532345857|FG007|Follow-up Period|Lost to Follow-up|2|||
147597933|NCT01359644|532345858|FG008|Follow-up Period|Lost to Follow-up|0|||
147597934|NCT01359644|532345859|FG009|Follow-up Period|Lost to Follow-up|0|||
147597935|NCT01660334|532345861|FG000|Overall Study|Lost to Follow-up|1|||
147597936|NCT00311311|532345862|FG000|Overall Study|Adverse Event|3|||
147597937|NCT00311311|532345863|FG001|Overall Study|Adverse Event|2|||
147597938|NCT00311311|532345862|FG000|Overall Study|Withdrawal by Subject|1|||
147597939|NCT00311311|532345863|FG001|Overall Study|Withdrawal by Subject|1|||
147597940|NCT00311311|532345862|FG000|Overall Study|Noncompliance|0|||
147597941|NCT00311311|532345863|FG001|Overall Study|Noncompliance|1|||
147597942|NCT00311311|532345862|FG000|Overall Study|Study Termination by Sponsor|3|||
147597943|NCT00311311|532345863|FG001|Overall Study|Study Termination by Sponsor|4|||
147597944|NCT00311311|532345862|FG000|Overall Study|Death|1|||
147597945|NCT00311311|532345863|FG001|Overall Study|Death|0|||
147597946|NCT00311311|532345862|FG000|Overall Study|Lack of ancillary assistance|0|||
147597947|NCT00311311|532345863|FG001|Overall Study|Lack of ancillary assistance|1|||
147597948|NCT00546572|532345864|FG000|Vax 1 / Year 0|Randomized, not treated|1|||
147597949|NCT00546572|532345865|FG001|Vax 1 / Year 0|Randomized, not treated|1|||
147597950|NCT00546572|532345864|FG000|Vax 1 / Year 0|Withdrawal by Subject|3|||
147597951|NCT00546572|532345865|FG001|Vax 1 / Year 0|Withdrawal by Subject|2|||
147597952|NCT00546572|532345864|FG000|Vax 1 / Year 0|Protocol Violation|3|||
147597953|NCT00546572|532345865|FG001|Vax 1 / Year 0|Protocol Violation|4|||
147597954|NCT00546572|532345864|FG000|Vax 1 / Year 0|Death|2|||
147597955|NCT00546572|532345865|FG001|Vax 1 / Year 0|Death|2|||
147597956|NCT00546572|532345864|FG000|Vax 1 / Year 0|Adverse Event|0|||
147597957|NCT00546572|532345865|FG001|Vax 1 / Year 0|Adverse Event|1|||
147597958|NCT00546572|532345864|FG000|Vax 1 / Year 0|Lost to Follow-up|0|||
147597959|NCT00546572|532345865|FG001|Vax 1 / Year 0|Lost to Follow-up|1|||
147597960|NCT00546572|532345864|FG000|Vax 1 / Year 0|6-Month Contact; withdraw before Vax 2|64|||
147597961|NCT00546572|532345865|FG001|Vax 1 / Year 0|6-Month Contact; withdraw before Vax 2|59|||
147597962|NCT00546572|532345864|FG000|Vax 2 / Year 1|Other|1|||
147597963|NCT00546572|532345865|FG001|Vax 2 / Year 1|Other|1|||
147597964|NCT00546572|532345864|FG000|Vax 2 / Year 1|Adverse Event|1|||
147597965|NCT00546572|532345865|FG001|Vax 2 / Year 1|Adverse Event|0|||
147597966|NCT00546572|532345864|FG000|Vax 2 / Year 1|Vax 2; withdraw before 6-Month Contact|2|||
147597967|NCT00546572|532345865|FG001|Vax 2 / Year 1|Vax 2; withdraw before 6-Month Contact|1|||
147597968|NCT00988065|532345866|FG000|Overall Study|Adverse Event|4|||
147597969|NCT00988065|532345867|FG001|Overall Study|Adverse Event|10|||
147597970|NCT00988065|532345868|FG002|Overall Study|Adverse Event|2|||
147597971|NCT00988065|532345866|FG000|Overall Study|Lost to Follow-up|1|||
147597972|NCT00988065|532345867|FG001|Overall Study|Lost to Follow-up|2|||
147597973|NCT00988065|532345868|FG002|Overall Study|Lost to Follow-up|2|||
147597974|NCT00988065|532345866|FG000|Overall Study|Subject withdrew consent|3|||
147597975|NCT00988065|532345867|FG001|Overall Study|Subject withdrew consent|5|||
147597976|NCT00988065|532345868|FG002|Overall Study|Subject withdrew consent|2|||
147597977|NCT00988065|532345866|FG000|Overall Study|Noncompliance with protocol|5|||
147597978|NCT00988065|532345867|FG001|Overall Study|Noncompliance with protocol|6|||
147597979|NCT00988065|532345868|FG002|Overall Study|Noncompliance with protocol|9|||
147597980|NCT03979820|532345869|FG000|Overall Study|Protocol Violation|1|||
147597981|NCT03979820|532345870|FG001|Overall Study|Protocol Violation|0|||
147597982|NCT03979820|532345871|FG002|Overall Study|Protocol Violation|0|||
147597983|NCT03979820|532345872|FG003|Overall Study|Protocol Violation|0|||
147597984|NCT03979820|532345869|FG000|Overall Study|Withdrawal by Subject|0|||
147597985|NCT03979820|532345870|FG001|Overall Study|Withdrawal by Subject|0|||
147597986|NCT03979820|532345871|FG002|Overall Study|Withdrawal by Subject|1|||
147597987|NCT03979820|532345872|FG003|Overall Study|Withdrawal by Subject|0|||
147597988|NCT03979820|532345869|FG000|Overall Study|Permanent discontinuation of the trial due to Covid-19 pandemic|5|||
147597989|NCT03979820|532345870|FG001|Overall Study|Permanent discontinuation of the trial due to Covid-19 pandemic|0|||
147597990|NCT03979820|532345871|FG002|Overall Study|Permanent discontinuation of the trial due to Covid-19 pandemic|0|||
147597991|NCT03979820|532345872|FG003|Overall Study|Permanent discontinuation of the trial due to Covid-19 pandemic|10|||
147449938|NCT02669017|531811325|FG004|Overall Study|Death|8|||
147597992|NCT02685202|532345873|FG000|Overall Study|Lost to Follow-up|9|||
147597993|NCT01229735|532345874|FG000|Overall Study|Lack of Efficacy|8|||
147597994|NCT01229735|532345875|FG001|Overall Study|Lack of Efficacy|8|||
147597995|NCT01229735|532345874|FG000|Overall Study|Protocol Violation|13|||
147597996|NCT01229735|532345875|FG001|Overall Study|Protocol Violation|8|||
147449939|NCT02669017|531811326|FG005|Overall Study|Death|18|||
147660944|NCT02326272|532581385|FG000|Open-label Period (Week 48 to Week 144)|Death|0|||
147660945|NCT02326272|532581386|FG001|Open-label Period (Week 48 to Week 144)|Death|0|||
147660946|NCT02326272|532581387|FG002|Open-label Period (Week 48 to Week 144)|Death|0|||
147660947|NCT02326272|532581388|FG003|Open-label Period (Week 48 to Week 144)|Death|0|||
147660948|NCT02326272|532581389|FG004|Open-label Period (Week 48 to Week 144)|Death|0|||
147660949|NCT02326272|532581390|FG005|Open-label Period (Week 48 to Week 144)|Death|0|||
147660950|NCT02326272|532581391|FG006|Open-label Period (Week 48 to Week 144)|Death|0|||
147660951|NCT02326272|532581392|FG007|Open-label Period (Week 48 to Week 144)|Death|0|||
147660952|NCT02326272|532581393|FG008|Open-label Period (Week 48 to Week 144)|Death|0|||
147660953|NCT02326272|532581394|FG009|Open-label Period (Week 48 to Week 144)|Death|0|||
147660954|NCT02326272|532581395|FG010|Open-label Period (Week 48 to Week 144)|Death|0|||
147660955|NCT02326272|532581396|FG011|Open-label Period (Week 48 to Week 144)|Death|0|||
147660956|NCT02326272|532581397|FG012|Open-label Period (Week 48 to Week 144)|Death|1|||
147660957|NCT02326272|532581398|FG013|Open-label Period (Week 48 to Week 144)|Death|0|||
147660958|NCT02326272|532581399|FG014|Open-label Period (Week 48 to Week 144)|Death|0|||
147660959|NCT02326272|532581385|FG000|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
147660960|NCT02326272|532581386|FG001|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
147660961|NCT02326272|532581387|FG002|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
147660962|NCT02326272|532581388|FG003|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
147660963|NCT02326272|532581389|FG004|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
147660964|NCT02326272|532581390|FG005|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
147660965|NCT02326272|532581391|FG006|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
147660966|NCT02326272|532581392|FG007|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
147660967|NCT02326272|532581393|FG008|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
147660968|NCT02326272|532581394|FG009|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
147660969|NCT02326272|532581395|FG010|Open-label Period (Week 48 to Week 144)|Adverse Event|1|||
147660970|NCT02326272|532581396|FG011|Open-label Period (Week 48 to Week 144)|Adverse Event|8|||
147660971|NCT02326272|532581397|FG012|Open-label Period (Week 48 to Week 144)|Adverse Event|3|||
147660972|NCT02326272|532581398|FG013|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
147660973|NCT02326272|532581399|FG014|Open-label Period (Week 48 to Week 144)|Adverse Event|1|||
147660974|NCT02326272|532581385|FG000|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
147660975|NCT02326272|532581386|FG001|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
147660976|NCT02326272|532581387|FG002|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
147660977|NCT02326272|532581388|FG003|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
147660978|NCT02326272|532581389|FG004|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
147660979|NCT02326272|532581390|FG005|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
147660980|NCT02326272|532581391|FG006|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
147660981|NCT02326272|532581392|FG007|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
147660982|NCT02326272|532581393|FG008|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
147660983|NCT02326272|532581394|FG009|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
147660984|NCT02326272|532581395|FG010|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
147660985|NCT02326272|532581396|FG011|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
147660986|NCT02326272|532581397|FG012|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
147660987|NCT02326272|532581398|FG013|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
147660988|NCT02326272|532581399|FG014|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
147660989|NCT02326272|532581385|FG000|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
147660990|NCT02326272|532581386|FG001|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
147660991|NCT02326272|532581387|FG002|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
147660992|NCT02326272|532581388|FG003|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
147660993|NCT02326272|532581389|FG004|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
147660994|NCT02326272|532581390|FG005|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
147660995|NCT02326272|532581391|FG006|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
147660996|NCT02326272|532581392|FG007|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
147660997|NCT02326272|532581393|FG008|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
147660998|NCT02326272|532581394|FG009|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
147660999|NCT02326272|532581395|FG010|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
147661000|NCT02326272|532581396|FG011|Open-label Period (Week 48 to Week 144)|Protocol Violation|1|||
147661001|NCT02326272|532581397|FG012|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
147661002|NCT02326272|532581398|FG013|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
147661003|NCT02326272|532581399|FG014|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
147661004|NCT02326272|532581385|FG000|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
147661005|NCT02326272|532581386|FG001|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
147661006|NCT02326272|532581387|FG002|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
147661007|NCT02326272|532581388|FG003|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
147661008|NCT02326272|532581389|FG004|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
147331881|NCT01235949|531380963|FG005|Booster Phase|Lost to Follow-up|0|||
147331882|NCT01235949|531380964|FG006|Booster Phase|Lost to Follow-up|0|||
147331883|NCT01235949|531380965|FG007|Booster Phase|Lost to Follow-up|0|||
147331884|NCT01235949|531380966|FG008|Booster Phase|Lost to Follow-up|1|||
147331885|NCT01235949|531380967|FG009|Booster Phase|Lost to Follow-up|1|||
147331886|NCT01235949|531380968|FG010|Booster Phase|Lost to Follow-up|1|||
147331887|NCT01235949|531380969|FG011|Booster Phase|Lost to Follow-up|1|||
147331888|NCT01235949|531380970|FG012|Booster Phase|Lost to Follow-up|0|||
147331889|NCT01235949|531380971|FG013|Booster Phase|Lost to Follow-up|0|||
147331890|NCT01235949|531380972|FG014|Booster Phase|Lost to Follow-up|0|||
147331891|NCT01235949|531380973|FG015|Booster Phase|Lost to Follow-up|0|||
147331892|NCT01235949|531380974|FG016|Booster Phase|Lost to Follow-up|0|||
147331893|NCT01235949|531380975|FG017|Booster Phase|Lost to Follow-up|1|||
147331894|NCT00754936|531380976|FG000|Overall Study|Lost to Follow-up|3|||
147331895|NCT00754936|531380976|FG000|Overall Study|Physician Decision|1|||
147331896|NCT00754936|531380976|FG000|Overall Study|Withdrawal by Subject|2|||
147449940|NCT02669017|531811327|FG006|Overall Study|Death|10|||
147449941|NCT02669017|531811328|FG007|Overall Study|Death|47|||
147449942|NCT02669017|531811329|FG008|Overall Study|Death|20|||
147449943|NCT02669017|531811321|FG000|Overall Study|Withdrawal by Subject|0|||
147449944|NCT02669017|531811322|FG001|Overall Study|Withdrawal by Subject|0|||
147449945|NCT02669017|531811323|FG002|Overall Study|Withdrawal by Subject|0|||
147449946|NCT02669017|531811324|FG003|Overall Study|Withdrawal by Subject|1|||
147449947|NCT02669017|531811325|FG004|Overall Study|Withdrawal by Subject|2|||
147597997|NCT01229735|532345874|FG000|Overall Study|Lost to Follow-up|0|||
147597998|NCT01229735|532345875|FG001|Overall Study|Lost to Follow-up|2|||
147597999|NCT01229735|532345874|FG000|Overall Study|Withdrawal by Subject|18|||
147598000|NCT01229735|532345875|FG001|Overall Study|Withdrawal by Subject|17|||
147598001|NCT01229735|532345874|FG000|Overall Study|Other Reason|13|||
147598002|NCT01229735|532345875|FG001|Overall Study|Other Reason|10|||
147598003|NCT01229735|532345874|FG000|Overall Study|SAE, non-fatal|0|||
147598004|NCT01229735|532345875|FG001|Overall Study|SAE, non-fatal|4|||
147598005|NCT01229735|532345874|FG000|Overall Study|AE, non-serious non-fatal|13|||
147598006|NCT01229735|532345875|FG001|Overall Study|AE, non-serious non-fatal|17|||
147598007|NCT01229735|532345874|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
147598008|NCT01229735|532345875|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
147598009|NCT02130882|532345876|FG000|Overall Study|Withdrawal by Subject|0|||
147598010|NCT02130882|532345877|FG001|Overall Study|Withdrawal by Subject|1|||
147598011|NCT02615171|532345891|FG000|Overall Study|Lost to Follow-up|2|||
147598012|NCT02615171|532345892|FG001|Overall Study|Lost to Follow-up|1|||
147598013|NCT00741936|532345900|FG000|Overall Study|Lost to Follow-up|1|||
147598014|NCT00741936|532345901|FG001|Overall Study|Lost to Follow-up|1|||
147598015|NCT00741936|532345900|FG000|Overall Study|Adverse Event|3|||
147598016|NCT00741936|532345901|FG001|Overall Study|Adverse Event|4|||
147598017|NCT00741936|532345900|FG000|Overall Study|Pregnancy|0|||
147598018|NCT00741936|532345901|FG001|Overall Study|Pregnancy|1|||
147598019|NCT00741936|532345900|FG000|Overall Study|Protocol Violation|2|||
147598020|NCT00741936|532345901|FG001|Overall Study|Protocol Violation|0|||
147598021|NCT00741936|532345900|FG000|Overall Study|Lack of Efficacy|0|||
147598022|NCT00741936|532345901|FG001|Overall Study|Lack of Efficacy|2|||
147598023|NCT00741936|532345900|FG000|Overall Study|Low compliance|3|||
147598024|NCT00741936|532345901|FG001|Overall Study|Low compliance|0|||
147598025|NCT00369382|532345902|FG000|Overall Study|Death|0|||
147598026|NCT00369382|532345903|FG001|Overall Study|Death|2|||
147598027|NCT00369382|532345902|FG000|Overall Study|Physician Decision|2|||
147598028|NCT00369382|532345903|FG001|Overall Study|Physician Decision|1|||
147598029|NCT00369382|532345902|FG000|Overall Study|Withdrawal by Subject|5|||
147598030|NCT00369382|532345903|FG001|Overall Study|Withdrawal by Subject|0|||
147598031|NCT00369382|532345902|FG000|Overall Study|Randomized, not treated|2|||
147598032|NCT00369382|532345903|FG001|Overall Study|Randomized, not treated|0|||
147598033|NCT00369382|532345902|FG000|Overall Study|Other|1|||
147598034|NCT00369382|532345903|FG001|Overall Study|Other|0|||
147598035|NCT05011123|532347713|FG000|Overall Study|Withdrawal by Subject|4|||
147598036|NCT05011123|532347714|FG001|Overall Study|Withdrawal by Subject|2|||
147598037|NCT05011123|532347713|FG000|Overall Study|Lost to Follow-up|7|||
147331897|NCT00754936|531380976|FG000|Overall Study|Side Effects|3|||
147598038|NCT05011123|532347714|FG001|Overall Study|Lost to Follow-up|6|||
147598039|NCT05011123|532347713|FG000|Overall Study|Ongoing at the time of DBL date|36|||
147331898|NCT00754936|531380976|FG000|Overall Study|Inter-current medical events|3|||
147331899|NCT00371566|531380981|FG000|Treatment Phase|Withdrawal by Subject|0|||
147331900|NCT00371566|531380982|FG001|Treatment Phase|Withdrawal by Subject|1|||
147598040|NCT05011123|532347714|FG001|Overall Study|Ongoing at the time of DBL date|10|||
147331901|NCT00371566|531380981|FG000|Treatment Phase|Adverse Event|0|||
147449948|NCT02669017|531811326|FG005|Overall Study|Withdrawal by Subject|0|||
147598041|NCT05011123|532347713|FG000|Overall Study|Randomized but did not receive vaccination|1|||
147598042|NCT05011123|532347714|FG001|Overall Study|Randomized but did not receive vaccination|0|||
147598043|NCT03845296|532347726|FG000|Overall Study|On Treatment|2|||
147598044|NCT03845296|532347727|FG001|Overall Study|On Treatment|1|||
147598045|NCT03845296|532347726|FG000|Overall Study|Adverse Event|4|||
147331902|NCT00371566|531380982|FG001|Treatment Phase|Adverse Event|1|||
147331903|NCT00371566|531380981|FG000|Treatment Phase|Protocol Violation|0|||
147331904|NCT00371566|531380982|FG001|Treatment Phase|Protocol Violation|1|||
147331905|NCT00371566|531380981|FG000|Chemoradiation Phase|Physician Decision|2|||
147331906|NCT00371566|531380982|FG001|Chemoradiation Phase|Physician Decision|0|||
147331907|NCT00371566|531380981|FG000|Chemoradiation Phase|Withdrawal by Subject|0|||
147331908|NCT00371566|531380982|FG001|Chemoradiation Phase|Withdrawal by Subject|1|||
147331909|NCT00371566|531380981|FG000|Chemoradiation Phase|Non compliant|0|||
147331910|NCT00371566|531380982|FG001|Chemoradiation Phase|Non compliant|1|||
147331911|NCT00371566|531380981|FG000|Chemoradiation Phase|Progressive Disease|1|||
147331912|NCT00371566|531380982|FG001|Chemoradiation Phase|Progressive Disease|1|||
147331913|NCT00371566|531380981|FG000|Chemoradiation Phase|Death|2|||
147331914|NCT00371566|531380982|FG001|Chemoradiation Phase|Death|0|||
147331915|NCT00371566|531380981|FG000|Follow Up Phase|Death|0|||
147331916|NCT00371566|531380982|FG001|Follow Up Phase|Death|5|||
147331917|NCT00371566|531380981|FG000|Follow Up Phase|Disease progression|1|||
147331918|NCT00371566|531380982|FG001|Follow Up Phase|Disease progression|0|||
147331919|NCT00371566|531380981|FG000|Follow Up Phase|Withdrawal by Subject|0|||
147331920|NCT00371566|531380982|FG001|Follow Up Phase|Withdrawal by Subject|1|||
147331921|NCT00371566|531380981|FG000|Follow Up Phase|Physician Decision|1|||
147331922|NCT00371566|531380982|FG001|Follow Up Phase|Physician Decision|1|||
147331923|NCT00371566|531380981|FG000|Follow Up Phase|Lost to Follow-up|1|||
147331924|NCT00371566|531380982|FG001|Follow Up Phase|Lost to Follow-up|0|||
147331925|NCT02914522|531380983|FG000|Induction Study: Up to Week 11|Adverse Event|5|||
147331926|NCT02914522|531380984|FG001|Induction Study: Up to Week 11|Adverse Event|6|||
147331927|NCT02914522|531380985|FG002|Induction Study: Up to Week 11|Adverse Event|4|||
147331928|NCT02914522|531380986|FG003|Induction Study: Up to Week 11|Adverse Event|18|||
147331929|NCT02914522|531380987|FG004|Induction Study: Up to Week 11|Adverse Event|14|||
147331930|NCT02914522|531380988|FG005|Induction Study: Up to Week 11|Adverse Event|10|||
147331931|NCT02914522|531380989|FG006|Induction Study: Up to Week 11|Adverse Event|0|||
147331932|NCT02914522|531380990|FG007|Induction Study: Up to Week 11|Adverse Event|0|||
147331933|NCT02914522|531380991|FG008|Induction Study: Up to Week 11|Adverse Event|0|||
147331934|NCT02914522|531380992|FG009|Induction Study: Up to Week 11|Adverse Event|0|||
147331935|NCT02914522|531380993|FG010|Induction Study: Up to Week 11|Adverse Event|0|||
147331936|NCT02914522|531380983|FG000|Induction Study: Up to Week 11|Withdrew Consent|4|||
147331937|NCT02914522|531380984|FG001|Induction Study: Up to Week 11|Withdrew Consent|11|||
147331938|NCT02914522|531380985|FG002|Induction Study: Up to Week 11|Withdrew Consent|4|||
147331939|NCT02914522|531380986|FG003|Induction Study: Up to Week 11|Withdrew Consent|6|||
147331940|NCT02914522|531380987|FG004|Induction Study: Up to Week 11|Withdrew Consent|3|||
147331941|NCT02914522|531380988|FG005|Induction Study: Up to Week 11|Withdrew Consent|3|||
147331942|NCT02914522|531380989|FG006|Induction Study: Up to Week 11|Withdrew Consent|0|||
147331943|NCT02914522|531380990|FG007|Induction Study: Up to Week 11|Withdrew Consent|0|||
147331944|NCT02914522|531380991|FG008|Induction Study: Up to Week 11|Withdrew Consent|0|||
147331945|NCT02914522|531380992|FG009|Induction Study: Up to Week 11|Withdrew Consent|0|||
147331946|NCT02914522|531380993|FG010|Induction Study: Up to Week 11|Withdrew Consent|0|||
147331947|NCT02914522|531380983|FG000|Induction Study: Up to Week 11|Protocol Violation|0|||
147331948|NCT02914522|531380984|FG001|Induction Study: Up to Week 11|Protocol Violation|2|||
147331949|NCT02914522|531380985|FG002|Induction Study: Up to Week 11|Protocol Violation|1|||
147331950|NCT02914522|531380986|FG003|Induction Study: Up to Week 11|Protocol Violation|3|||
147331951|NCT02914522|531380987|FG004|Induction Study: Up to Week 11|Protocol Violation|4|||
147331952|NCT02914522|531380988|FG005|Induction Study: Up to Week 11|Protocol Violation|2|||
147331953|NCT02914522|531380989|FG006|Induction Study: Up to Week 11|Protocol Violation|0|||
147331954|NCT02914522|531380990|FG007|Induction Study: Up to Week 11|Protocol Violation|0|||
147331955|NCT02914522|531380991|FG008|Induction Study: Up to Week 11|Protocol Violation|0|||
147331956|NCT02914522|531380992|FG009|Induction Study: Up to Week 11|Protocol Violation|0|||
147331957|NCT02914522|531380993|FG010|Induction Study: Up to Week 11|Protocol Violation|0|||
147331958|NCT02914522|531380983|FG000|Induction Study: Up to Week 11|Lost to Follow-up|0|||
147598046|NCT03845296|532347727|FG001|Overall Study|Adverse Event|11|||
147598047|NCT03845296|532347726|FG000|Overall Study|Refusal unrelated to adverse event|0|||
147598048|NCT03845296|532347727|FG001|Overall Study|Refusal unrelated to adverse event|1|||
147598049|NCT03845296|532347726|FG000|Overall Study|Progression/relapse|14|||
147598050|NCT03845296|532347727|FG001|Overall Study|Progression/relapse|18|||
147598051|NCT03845296|532347726|FG000|Overall Study|Death|4|||
147598052|NCT03845296|532347727|FG001|Overall Study|Death|0|||
147449949|NCT02669017|531811327|FG006|Overall Study|Withdrawal by Subject|0|||
147598053|NCT03845296|532347726|FG000|Overall Study|Other - not protocol specified|1|||
147331959|NCT02914522|531380984|FG001|Induction Study: Up to Week 11|Lost to Follow-up|2|||
147331960|NCT02914522|531380985|FG002|Induction Study: Up to Week 11|Lost to Follow-up|1|||
147331961|NCT02914522|531380986|FG003|Induction Study: Up to Week 11|Lost to Follow-up|1|||
147331962|NCT02914522|531380987|FG004|Induction Study: Up to Week 11|Lost to Follow-up|0|||
147331963|NCT02914522|531380988|FG005|Induction Study: Up to Week 11|Lost to Follow-up|0|||
147449950|NCT02669017|531811328|FG007|Overall Study|Withdrawal by Subject|2|||
147598054|NCT03845296|532347727|FG001|Overall Study|Other - not protocol specified|3|||
147661009|NCT02326272|532581390|FG005|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
147661010|NCT02326272|532581391|FG006|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
147661011|NCT02326272|532581392|FG007|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
147661012|NCT02326272|532581393|FG008|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
147661013|NCT02326272|532581394|FG009|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
147661014|NCT02326272|532581395|FG010|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|1|||
147661015|NCT02326272|532581396|FG011|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
147661016|NCT02326272|532581397|FG012|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|2|||
147661017|NCT02326272|532581398|FG013|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
147661018|NCT02326272|532581399|FG014|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|3|||
147661019|NCT02326272|532581385|FG000|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
147661020|NCT02326272|532581386|FG001|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
147661021|NCT02326272|532581387|FG002|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
147661022|NCT02326272|532581388|FG003|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
147661023|NCT02326272|532581389|FG004|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
147661024|NCT02326272|532581390|FG005|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
147661025|NCT02326272|532581391|FG006|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
147331964|NCT02914522|531380989|FG006|Induction Study: Up to Week 11|Lost to Follow-up|0|||
147331965|NCT02914522|531380990|FG007|Induction Study: Up to Week 11|Lost to Follow-up|0|||
147331966|NCT02914522|531380991|FG008|Induction Study: Up to Week 11|Lost to Follow-up|0|||
147598055|NCT06218823|532347730|FG000|Overall Study|Death|3|||
147598056|NCT06218823|532347731|FG001|Overall Study|Death|0|||
147598057|NCT06218823|532347730|FG000|Overall Study|Lost to Follow-up|0|||
147598058|NCT06218823|532347731|FG001|Overall Study|Lost to Follow-up|2|||
147598059|NCT04732221|532347732|FG000|Base Period|Death|2|||
147598060|NCT04732221|532347733|FG001|Base Period|Death|0|||
147598061|NCT04732221|532347734|FG002|Base Period|Death|0|||
147598062|NCT04732221|532347735|FG003|Base Period|Death|0|||
147598063|NCT04732221|532347736|FG004|Base Period|Death|0|||
147598064|NCT04732221|532347737|FG005|Base Period|Death|0|||
147598065|NCT04732221|532347738|FG006|Base Period|Death|0|||
147598066|NCT04732221|532347732|FG000|Base Period|Withdrawal by Subject|0|||
147598067|NCT04732221|532347733|FG001|Base Period|Withdrawal by Subject|1|||
147598068|NCT04732221|532347734|FG002|Base Period|Withdrawal by Subject|1|||
147598069|NCT04732221|532347735|FG003|Base Period|Withdrawal by Subject|0|||
147598070|NCT04732221|532347736|FG004|Base Period|Withdrawal by Subject|0|||
147598071|NCT04732221|532347737|FG005|Base Period|Withdrawal by Subject|0|||
147598072|NCT04732221|532347738|FG006|Base Period|Withdrawal by Subject|0|||
147598073|NCT04732221|532347732|FG000|Extension Period|Adverse Event|0|||
147598074|NCT04732221|532347733|FG001|Extension Period|Adverse Event|0|||
147598075|NCT04732221|532347734|FG002|Extension Period|Adverse Event|0|||
147598076|NCT04732221|532347735|FG003|Extension Period|Adverse Event|0|||
147598077|NCT04732221|532347736|FG004|Extension Period|Adverse Event|0|||
147598078|NCT04732221|532347737|FG005|Extension Period|Adverse Event|1|||
147598079|NCT04732221|532347738|FG006|Extension Period|Adverse Event|0|||
147598080|NCT04732221|532347732|FG000|Extension Period|Death|0|||
147598081|NCT04732221|532347733|FG001|Extension Period|Death|0|||
147598082|NCT04732221|532347734|FG002|Extension Period|Death|0|||
147598083|NCT04732221|532347735|FG003|Extension Period|Death|0|||
147598084|NCT04732221|532347736|FG004|Extension Period|Death|1|||
147598085|NCT04732221|532347737|FG005|Extension Period|Death|0|||
147598086|NCT04732221|532347738|FG006|Extension Period|Death|2|||
147598087|NCT04732221|532347732|FG000|Extension Period|Pregnancy|0|||
147598088|NCT04732221|532347733|FG001|Extension Period|Pregnancy|0|||
147598089|NCT04732221|532347734|FG002|Extension Period|Pregnancy|0|||
147598090|NCT04732221|532347735|FG003|Extension Period|Pregnancy|0|||
147598091|NCT04732221|532347736|FG004|Extension Period|Pregnancy|1|||
147598092|NCT04732221|532347737|FG005|Extension Period|Pregnancy|0|||
147598093|NCT04732221|532347738|FG006|Extension Period|Pregnancy|0|||
147598094|NCT04732221|532347732|FG000|Extension Period|Sponsors Decision|0|||
147598095|NCT04732221|532347733|FG001|Extension Period|Sponsors Decision|0|||
147598096|NCT04732221|532347734|FG002|Extension Period|Sponsors Decision|0|||
147598097|NCT04732221|532347735|FG003|Extension Period|Sponsors Decision|0|||
147598098|NCT04732221|532347736|FG004|Extension Period|Sponsors Decision|41|||
147598099|NCT04732221|532347737|FG005|Extension Period|Sponsors Decision|40|||
147598100|NCT04732221|532347738|FG006|Extension Period|Sponsors Decision|40|||
147598101|NCT04732221|532347732|FG000|Extension Period|Withdrawal by Subject|0|||
147331967|NCT02914522|531380992|FG009|Induction Study: Up to Week 11|Lost to Follow-up|0|||
147598102|NCT04732221|532347733|FG001|Extension Period|Withdrawal by Subject|0|||
147598103|NCT04732221|532347734|FG002|Extension Period|Withdrawal by Subject|0|||
147598104|NCT04732221|532347735|FG003|Extension Period|Withdrawal by Subject|0|||
147598105|NCT04732221|532347736|FG004|Extension Period|Withdrawal by Subject|1|||
147598106|NCT04732221|532347737|FG005|Extension Period|Withdrawal by Subject|5|||
147598107|NCT04732221|532347738|FG006|Extension Period|Withdrawal by Subject|2|||
147598108|NCT05327816|532347743|FG000|Overall Study|Lost to Follow-up|1|||
147598109|NCT05327816|532347744|FG001|Overall Study|Lost to Follow-up|0|||
147661026|NCT02326272|532581392|FG007|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
147661027|NCT02326272|532581393|FG008|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
147661028|NCT02326272|532581394|FG009|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
147661029|NCT02326272|532581395|FG010|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
147661030|NCT02326272|532581396|FG011|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|4|||
147661031|NCT02326272|532581397|FG012|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
147661032|NCT02326272|532581398|FG013|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
147661033|NCT02326272|532581399|FG014|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|2|||
147661034|NCT02326272|532581385|FG000|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
147661035|NCT02326272|532581386|FG001|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
147661036|NCT02326272|532581387|FG002|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
147661037|NCT02326272|532581388|FG003|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
147661038|NCT02326272|532581389|FG004|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
147661039|NCT02326272|532581390|FG005|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
147661040|NCT02326272|532581391|FG006|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
147661041|NCT02326272|532581392|FG007|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
147661042|NCT02326272|532581393|FG008|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
147661043|NCT02326272|532581394|FG009|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
147661044|NCT02326272|532581395|FG010|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
147661045|NCT02326272|532581396|FG011|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|1|||
147661046|NCT02326272|532581397|FG012|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|3|||
147661047|NCT02326272|532581398|FG013|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
147661048|NCT02326272|532581399|FG014|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|3|||
147661049|NCT02326272|532581385|FG000|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
147661050|NCT02326272|532581386|FG001|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
147661051|NCT02326272|532581387|FG002|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
147661052|NCT02326272|532581388|FG003|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
147661053|NCT02326272|532581389|FG004|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
147661054|NCT02326272|532581390|FG005|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
147661055|NCT02326272|532581391|FG006|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
147661056|NCT02326272|532581392|FG007|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
147661057|NCT02326272|532581393|FG008|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
147661058|NCT02326272|532581394|FG009|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
147661059|NCT02326272|532581395|FG010|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
147661060|NCT02326272|532581396|FG011|Open-label Period (Week 48 to Week 144)|Loss of efficacy|1|||
147661061|NCT02326272|532581397|FG012|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
147661062|NCT02326272|532581398|FG013|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
147661063|NCT02326272|532581399|FG014|Open-label Period (Week 48 to Week 144)|Loss of efficacy|0|||
147661064|NCT02326272|532581385|FG000|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
147661065|NCT02326272|532581386|FG001|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
147661066|NCT02326272|532581387|FG002|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
147661067|NCT02326272|532581388|FG003|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
147661068|NCT02326272|532581389|FG004|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
147661069|NCT02326272|532581390|FG005|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
147661070|NCT02326272|532581391|FG006|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
147661071|NCT02326272|532581392|FG007|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
147661072|NCT02326272|532581393|FG008|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
147661073|NCT02326272|532581394|FG009|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
147661074|NCT02326272|532581395|FG010|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
147661075|NCT02326272|532581396|FG011|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
147661076|NCT02326272|532581397|FG012|Open-label Period (Week 48 to Week 144)|Pregnancy|1|||
147661077|NCT02326272|532581398|FG013|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
147661078|NCT02326272|532581399|FG014|Open-label Period (Week 48 to Week 144)|Pregnancy|0|||
147661079|NCT00735943|532581405|FG000|Overall Study|Lost to Follow-up|1|||
147661080|NCT00735943|532581405|FG000|Overall Study|Adverse Event|1|||
147661081|NCT00974311|532581408|FG000|DB Phase (up to 24 Months)|Lost to Follow-up|5|||
147661082|NCT00974311|532581409|FG001|DB Phase (up to 24 Months)|Lost to Follow-up|2|||
147661083|NCT00974311|532581408|FG000|DB Phase (up to 24 Months)|Death|561|||
147661084|NCT00974311|532581409|FG001|DB Phase (up to 24 Months)|Death|298|||
147661085|NCT00974311|532581408|FG000|DB Phase (up to 24 Months)|Withdrawal by Subject|16|||
147661086|NCT00974311|532581409|FG001|DB Phase (up to 24 Months)|Withdrawal by Subject|7|||
147661087|NCT00974311|532581408|FG000|DB Phase (up to 24 Months)|Study Terminated by Sponsor|108|||
147661088|NCT00974311|532581409|FG001|DB Phase (up to 24 Months)|Study Terminated by Sponsor|42|||
147661089|NCT00974311|532581408|FG000|DB Phase (up to 24 Months)|Other|1|||
147661090|NCT00974311|532581409|FG001|DB Phase (up to 24 Months)|Other|0|||
147661091|NCT00974311|532581408|FG000|OLE Phase (up to 77 Months)|Death|14|||
147661092|NCT00974311|532581409|FG001|OLE Phase (up to 77 Months)|Death|21|||
147598110|NCT05327816|532347745|FG002|Overall Study|Lost to Follow-up|0|||
147598111|NCT05327816|532347746|FG003|Overall Study|Lost to Follow-up|0|||
147598112|NCT05327816|532347747|FG004|Overall Study|Lost to Follow-up|0|||
147598113|NCT05327816|532347748|FG005|Overall Study|Lost to Follow-up|0|||
147598114|NCT05327816|532347749|FG006|Overall Study|Lost to Follow-up|0|||
147598115|NCT05327816|532347750|FG007|Overall Study|Lost to Follow-up|0|||
147598116|NCT05327816|532347751|FG008|Overall Study|Lost to Follow-up|0|||
147598117|NCT05327816|532347752|FG009|Overall Study|Lost to Follow-up|1|||
147598118|NCT05327816|532347753|FG010|Overall Study|Lost to Follow-up|0|||
147598119|NCT05327816|532347743|FG000|Overall Study|Withdrawal by Subject|0|||
147598120|NCT05327816|532347744|FG001|Overall Study|Withdrawal by Subject|0|||
147598121|NCT05327816|532347745|FG002|Overall Study|Withdrawal by Subject|0|||
147598122|NCT05327816|532347746|FG003|Overall Study|Withdrawal by Subject|0|||
147598123|NCT05327816|532347747|FG004|Overall Study|Withdrawal by Subject|1|||
147598124|NCT05327816|532347748|FG005|Overall Study|Withdrawal by Subject|1|||
147598125|NCT05327816|532347749|FG006|Overall Study|Withdrawal by Subject|0|||
147598126|NCT05327816|532347750|FG007|Overall Study|Withdrawal by Subject|0|||
147598127|NCT05327816|532347751|FG008|Overall Study|Withdrawal by Subject|0|||
147598128|NCT05327816|532347752|FG009|Overall Study|Withdrawal by Subject|0|||
147598129|NCT05327816|532347753|FG010|Overall Study|Withdrawal by Subject|0|||
147598130|NCT05327816|532347743|FG000|Overall Study|Study Terminated by Sponsor|11|||
147598131|NCT05327816|532347744|FG001|Overall Study|Study Terminated by Sponsor|12|||
147598132|NCT05327816|532347745|FG002|Overall Study|Study Terminated by Sponsor|12|||
147598133|NCT05327816|532347746|FG003|Overall Study|Study Terminated by Sponsor|12|||
147598134|NCT05327816|532347747|FG004|Overall Study|Study Terminated by Sponsor|11|||
147598135|NCT05327816|532347748|FG005|Overall Study|Study Terminated by Sponsor|11|||
147598136|NCT05327816|532347749|FG006|Overall Study|Study Terminated by Sponsor|11|||
147598137|NCT05327816|532347750|FG007|Overall Study|Study Terminated by Sponsor|11|||
147598138|NCT05327816|532347751|FG008|Overall Study|Study Terminated by Sponsor|11|||
147598139|NCT05327816|532347752|FG009|Overall Study|Study Terminated by Sponsor|11|||
147598140|NCT05327816|532347753|FG010|Overall Study|Study Terminated by Sponsor|12|||
147598141|NCT05327816|532347743|FG000|Overall Study|Randomized but not treated|0|||
147598142|NCT05327816|532347744|FG001|Overall Study|Randomized but not treated|0|||
147598143|NCT05327816|532347745|FG002|Overall Study|Randomized but not treated|0|||
147598144|NCT05327816|532347746|FG003|Overall Study|Randomized but not treated|0|||
147598145|NCT05327816|532347747|FG004|Overall Study|Randomized but not treated|0|||
147598146|NCT05327816|532347748|FG005|Overall Study|Randomized but not treated|0|||
147598147|NCT05327816|532347749|FG006|Overall Study|Randomized but not treated|1|||
147598148|NCT05327816|532347750|FG007|Overall Study|Randomized but not treated|1|||
147598149|NCT05327816|532347751|FG008|Overall Study|Randomized but not treated|1|||
147598150|NCT05327816|532347752|FG009|Overall Study|Randomized but not treated|0|||
147598151|NCT05327816|532347753|FG010|Overall Study|Randomized but not treated|0|||
147598152|NCT03107026|532347754|FG000|Overall Study|Adverse Event|2|||
147598153|NCT03107026|532347755|FG001|Overall Study|Adverse Event|14|||
147598154|NCT03107026|532347756|FG002|Overall Study|Adverse Event|23|||
147598155|NCT03107026|532347754|FG000|Overall Study|Lost to Follow-up|12|||
147598156|NCT03107026|532347755|FG001|Overall Study|Lost to Follow-up|12|||
147598157|NCT03107026|532347756|FG002|Overall Study|Lost to Follow-up|13|||
147598158|NCT03107026|532347754|FG000|Overall Study|Protocol Violation|1|||
147598159|NCT03107026|532347755|FG001|Overall Study|Protocol Violation|2|||
147598160|NCT03107026|532347756|FG002|Overall Study|Protocol Violation|0|||
147598161|NCT03107026|532347754|FG000|Overall Study|Pregnancy|1|||
147598162|NCT03107026|532347755|FG001|Overall Study|Pregnancy|0|||
147598163|NCT03107026|532347756|FG002|Overall Study|Pregnancy|0|||
147598164|NCT03107026|532347754|FG000|Overall Study|Withdrawal by Subject|13|||
147598165|NCT03107026|532347755|FG001|Overall Study|Withdrawal by Subject|5|||
147598166|NCT03107026|532347756|FG002|Overall Study|Withdrawal by Subject|17|||
147598167|NCT03107026|532347754|FG000|Overall Study|non compliance with study visits|1|||
147598168|NCT03107026|532347755|FG001|Overall Study|non compliance with study visits|2|||
147598169|NCT03107026|532347756|FG002|Overall Study|non compliance with study visits|0|||
147598170|NCT03107026|532347754|FG000|Overall Study|non-compliance with study drug|2|||
147598171|NCT03107026|532347755|FG001|Overall Study|non-compliance with study drug|2|||
147598172|NCT03107026|532347756|FG002|Overall Study|non-compliance with study drug|3|||
147598173|NCT03107026|532347754|FG000|Overall Study|Physician Decision|0|||
147598174|NCT03107026|532347755|FG001|Overall Study|Physician Decision|1|||
147598175|NCT03107026|532347756|FG002|Overall Study|Physician Decision|0|||
147598176|NCT03596151|532347759|FG000|Overall Study|Withdrawal by Subject|1|||
147598177|NCT01951885|532347761|FG000|Overall Study|ineligible due to a change in conditioning regimen|0|||
147598178|NCT01951885|532347762|FG001|Overall Study|ineligible due to a change in conditioning regimen|1|||
147598179|NCT01951885|532347761|FG000|Overall Study|Adverse Event|1|||
147598180|NCT01951885|532347762|FG001|Overall Study|Adverse Event|0|||
147598181|NCT01951885|532347761|FG000|Overall Study|Withdrawal by Subject|0|||
147598182|NCT01951885|532347762|FG001|Overall Study|Withdrawal by Subject|1|||
147598183|NCT01951885|532347761|FG000|Overall Study|ineligible due to a change in donor|0|||
147598184|NCT01951885|532347762|FG001|Overall Study|ineligible due to a change in donor|1|||
147598185|NCT01951885|532347761|FG000|Overall Study|ineligible after experiencing cardiac issues|0|||
147331968|NCT02914522|531380993|FG010|Induction Study: Up to Week 11|Lost to Follow-up|0|||
147331969|NCT02914522|531380983|FG000|Induction Study: Up to Week 11|Investigator's Discretion|0|||
147331970|NCT02914522|531380984|FG001|Induction Study: Up to Week 11|Investigator's Discretion|0|||
147331971|NCT02914522|531380985|FG002|Induction Study: Up to Week 11|Investigator's Discretion|0|||
147331972|NCT02914522|531380986|FG003|Induction Study: Up to Week 11|Investigator's Discretion|0|||
147331973|NCT02914522|531380987|FG004|Induction Study: Up to Week 11|Investigator's Discretion|1|||
147331974|NCT02914522|531380988|FG005|Induction Study: Up to Week 11|Investigator's Discretion|0|||
147331975|NCT02914522|531380989|FG006|Induction Study: Up to Week 11|Investigator's Discretion|0|||
147331976|NCT02914522|531380990|FG007|Induction Study: Up to Week 11|Investigator's Discretion|0|||
147331977|NCT02914522|531380991|FG008|Induction Study: Up to Week 11|Investigator's Discretion|0|||
147331978|NCT02914522|531380992|FG009|Induction Study: Up to Week 11|Investigator's Discretion|0|||
147331979|NCT02914522|531380993|FG010|Induction Study: Up to Week 11|Investigator's Discretion|0|||
147331980|NCT02914522|531380983|FG000|Induction Study: Up to Week 11|Non-compliance With Study Drug|1|||
147331981|NCT02914522|531380984|FG001|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
147661093|NCT00974311|532581408|FG000|OLE Phase (up to 77 Months)|Study Terminated by Sponsor|78|||
147661094|NCT00974311|532581409|FG001|OLE Phase (up to 77 Months)|Study Terminated by Sponsor|26|||
147661095|NCT00974311|532581408|FG000|OLE Phase (up to 77 Months)|Other|15|||
147661096|NCT00974311|532581409|FG001|OLE Phase (up to 77 Months)|Other|2|||
147661097|NCT00974311|532581408|FG000|OLE Phase (up to 77 Months)|Withdrawal by Subject|2|||
147661098|NCT00974311|532581409|FG001|OLE Phase (up to 77 Months)|Withdrawal by Subject|1|||
147331982|NCT02914522|531380985|FG002|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
147331983|NCT02914522|531380986|FG003|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
147331984|NCT02914522|531380987|FG004|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
147331985|NCT02914522|531380988|FG005|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
147331986|NCT02914522|531380989|FG006|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
147331987|NCT02914522|531380990|FG007|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
147331988|NCT02914522|531380991|FG008|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
147331989|NCT02914522|531380992|FG009|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
147331990|NCT02914522|531380993|FG010|Induction Study: Up to Week 11|Non-compliance With Study Drug|0|||
147331991|NCT02914522|531380983|FG000|Induction Study: Up to Week 11|Pregnancy|0|||
147331992|NCT02914522|531380984|FG001|Induction Study: Up to Week 11|Pregnancy|0|||
147661099|NCT03131167|532581410|FG000|Overall Study|Other (Unspecified)|0|||
147661100|NCT03131167|532581411|FG001|Overall Study|Other (Unspecified)|0|||
147661101|NCT03131167|532581412|FG002|Overall Study|Other (Unspecified)|0|||
147661102|NCT03131167|532581413|FG003|Overall Study|Other (Unspecified)|0|||
147661103|NCT03131167|532581414|FG004|Overall Study|Other (Unspecified)|0|||
147661104|NCT03131167|532581415|FG005|Overall Study|Other (Unspecified)|1|||
147661105|NCT03131167|532581416|FG006|Overall Study|Other (Unspecified)|0|||
147661106|NCT03131167|532581417|FG007|Overall Study|Other (Unspecified)|0|||
147661107|NCT03131167|532581418|FG008|Overall Study|Other (Unspecified)|0|||
147661108|NCT03131167|532581419|FG009|Overall Study|Other (Unspecified)|0|||
147661109|NCT03131167|532581420|FG010|Overall Study|Other (Unspecified)|0|||
147661110|NCT03131167|532581421|FG011|Overall Study|Other (Unspecified)|0|||
147661111|NCT03131167|532581422|FG012|Overall Study|Other (Unspecified)|0|||
147661112|NCT00643201|532581425|FG000|Randomized, Completed 6 Months of Study|Death|20|||
147661113|NCT00643201|532581426|FG001|Randomized, Completed 6 Months of Study|Death|26|||
147661114|NCT00643201|532581425|FG000|Randomized, Completed 6 Months of Study|Adverse Event|150|||
147661115|NCT00643201|532581426|FG001|Randomized, Completed 6 Months of Study|Adverse Event|182|||
147661116|NCT00643201|532581425|FG000|Randomized, Completed 6 Months of Study|Withdrawal by Subject|49|||
147661117|NCT00643201|532581426|FG001|Randomized, Completed 6 Months of Study|Withdrawal by Subject|49|||
147661118|NCT00643201|532581425|FG000|Randomized, Completed 6 Months of Study|Lost to Follow-up|14|||
147661119|NCT00643201|532581426|FG001|Randomized, Completed 6 Months of Study|Lost to Follow-up|14|||
147661120|NCT00643201|532581425|FG000|Randomized, Completed 6 Months of Study|Poor or non-compliance|20|||
147661121|NCT00643201|532581426|FG001|Randomized, Completed 6 Months of Study|Poor or non-compliance|23|||
147661122|NCT00643201|532581425|FG000|Randomized, Completed 6 Months of Study|Pregnancy|3|||
147661123|NCT00643201|532581426|FG001|Randomized, Completed 6 Months of Study|Pregnancy|2|||
147661124|NCT00643201|532581425|FG000|Randomized, Completed 6 Months of Study|Fails to meet inclusion/exclusion|13|||
147661125|NCT00643201|532581426|FG001|Randomized, Completed 6 Months of Study|Fails to meet inclusion/exclusion|9|||
147661126|NCT00643201|532581425|FG000|Randomized, Completed 6 Months of Study|Administrative reason|1|||
147661127|NCT00643201|532581426|FG001|Randomized, Completed 6 Months of Study|Administrative reason|1|||
147331993|NCT02914522|531380985|FG002|Induction Study: Up to Week 11|Pregnancy|0|||
147331994|NCT02914522|531380986|FG003|Induction Study: Up to Week 11|Pregnancy|0|||
147331995|NCT02914522|531380987|FG004|Induction Study: Up to Week 11|Pregnancy|1|||
147331996|NCT02914522|531380988|FG005|Induction Study: Up to Week 11|Pregnancy|0|||
147331997|NCT02914522|531380989|FG006|Induction Study: Up to Week 11|Pregnancy|0|||
147331998|NCT02914522|531380990|FG007|Induction Study: Up to Week 11|Pregnancy|0|||
147331999|NCT02914522|531380991|FG008|Induction Study: Up to Week 11|Pregnancy|0|||
147661128|NCT00643201|532581425|FG000|Randomized, Completed 6 Months of Study|Other|107|||
147661129|NCT00643201|532581426|FG001|Randomized, Completed 6 Months of Study|Other|107|||
147332000|NCT02914522|531380992|FG009|Induction Study: Up to Week 11|Pregnancy|0|||
147332001|NCT02914522|531380993|FG010|Induction Study: Up to Week 11|Pregnancy|0|||
147332002|NCT02914522|531380983|FG000|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
147332003|NCT02914522|531380984|FG001|Induction Study: Up to Week 11|Did not Receive Study Drug|1|||
147332004|NCT02914522|531380985|FG002|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
147332005|NCT02914522|531380986|FG003|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
147332006|NCT02914522|531380987|FG004|Induction Study: Up to Week 11|Did not Receive Study Drug|1|||
147332007|NCT02914522|531380988|FG005|Induction Study: Up to Week 11|Did not Receive Study Drug|1|||
147332008|NCT02914522|531380989|FG006|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
147332009|NCT02914522|531380990|FG007|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
147332010|NCT02914522|531380991|FG008|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
147332011|NCT02914522|531380992|FG009|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
147332012|NCT02914522|531380993|FG010|Induction Study: Up to Week 11|Did not Receive Study Drug|0|||
147332013|NCT02914522|531380983|FG000|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
147332014|NCT02914522|531380984|FG001|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
147332015|NCT02914522|531380985|FG002|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
147332016|NCT02914522|531380986|FG003|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
147332017|NCT02914522|531380987|FG004|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
147332018|NCT02914522|531380988|FG005|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|0|||
147332019|NCT02914522|531380989|FG006|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|34|||
147332020|NCT02914522|531380990|FG007|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|49|||
147332021|NCT02914522|531380991|FG008|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|53|||
147332022|NCT02914522|531380992|FG009|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|39|||
147332023|NCT02914522|531380993|FG010|Maintenance Study: Week 11 to Week 58|Protocol-specified Disease Worsening|21|||
147332024|NCT02914522|531380983|FG000|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
147332025|NCT02914522|531380984|FG001|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
147332026|NCT02914522|531380985|FG002|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
147449951|NCT02669017|531811329|FG008|Overall Study|Withdrawal by Subject|2|||
147449952|NCT02669017|531811321|FG000|Overall Study|Lost to Follow-up|0|||
147449953|NCT02669017|531811322|FG001|Overall Study|Lost to Follow-up|0|||
147598186|NCT01951885|532347762|FG001|Overall Study|ineligible after experiencing cardiac issues|1|||
147598187|NCT00824616|532347763|FG000|Overall Study|Adverse Event|2|||
147598188|NCT00824616|532347764|FG001|Overall Study|Adverse Event|1|||
147598189|NCT00824616|532347763|FG000|Overall Study|Creatinine/Creatinine Clearance|0|||
147598190|NCT00824616|532347764|FG001|Overall Study|Creatinine/Creatinine Clearance|2|||
147598191|NCT00824616|532347763|FG000|Overall Study|Hyperglycemia|1|||
147598192|NCT00824616|532347764|FG001|Overall Study|Hyperglycemia|1|||
147598193|NCT00824616|532347763|FG000|Overall Study|Lack of Efficacy|2|||
147598194|NCT00824616|532347764|FG001|Overall Study|Lack of Efficacy|1|||
147598195|NCT00824616|532347763|FG000|Overall Study|Lost to Follow-up|0|||
147598196|NCT00824616|532347764|FG001|Overall Study|Lost to Follow-up|1|||
147598197|NCT00824616|532347763|FG000|Overall Study|Withdrawal by Subject|1|||
147598198|NCT00824616|532347764|FG001|Overall Study|Withdrawal by Subject|1|||
147598199|NCT04711902|532347765|FG000|Treatment Period 2 (From Week 16)|Participant decision|0|||
147598200|NCT04711902|532347766|FG001|Treatment Period 2 (From Week 16)|Participant decision|0|||
147598201|NCT04711902|532347767|FG002|Treatment Period 2 (From Week 16)|Participant decision|2|||
147598202|NCT04711902|532347768|FG003|Treatment Period 2 (From Week 16)|Participant decision|0|||
147598203|NCT04711902|532347769|FG004|Treatment Period 2 (From Week 16)|Participant decision|0|||
147598204|NCT04711902|532347770|FG005|Treatment Period 2 (From Week 16)|Participant decision|0|||
147598205|NCT00368979|532347774|FG000|Overall Study|Adverse Event|9|||
147598206|NCT00368979|532347775|FG001|Overall Study|Adverse Event|16|||
147598207|NCT00368979|532347774|FG000|Overall Study|Lack of Efficacy|5|||
147598208|NCT00368979|532347775|FG001|Overall Study|Lack of Efficacy|3|||
147598209|NCT00368979|532347774|FG000|Overall Study|Other|3|||
147598210|NCT00368979|532347775|FG001|Overall Study|Other|1|||
147598211|NCT00368979|532347774|FG000|Overall Study|Lost to Follow-up|1|||
147598212|NCT00368979|532347775|FG001|Overall Study|Lost to Follow-up|0|||
147598213|NCT00368979|532347774|FG000|Overall Study|Protocol Violation|2|||
147598214|NCT00368979|532347775|FG001|Overall Study|Protocol Violation|1|||
147598215|NCT00368979|532347774|FG000|Overall Study|Withdrawal by Subject|5|||
147598216|NCT00368979|532347775|FG001|Overall Study|Withdrawal by Subject|9|||
147598217|NCT02238626|532347776|FG000|Overall Study|Adverse Event|3|||
147598218|NCT02238626|532347777|FG001|Overall Study|Adverse Event|5|||
147598219|NCT02238626|532347778|FG002|Overall Study|Adverse Event|0|||
147598220|NCT02238626|532347779|FG003|Overall Study|Adverse Event|3|||
147598221|NCT02238626|532347776|FG000|Overall Study|Lost to Follow-up|2|||
147598222|NCT02238626|532347777|FG001|Overall Study|Lost to Follow-up|4|||
147598223|NCT02238626|532347778|FG002|Overall Study|Lost to Follow-up|2|||
147598224|NCT02238626|532347779|FG003|Overall Study|Lost to Follow-up|2|||
147598225|NCT02238626|532347776|FG000|Overall Study|Withdrawal by Subject|0|||
147332027|NCT02914522|531380986|FG003|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
147332028|NCT02914522|531380987|FG004|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
147332029|NCT02914522|531380988|FG005|Maintenance Study: Week 11 to Week 58|Adverse Event|0|||
147332030|NCT02914522|531380989|FG006|Maintenance Study: Week 11 to Week 58|Adverse Event|7|||
147332031|NCT02914522|531380990|FG007|Maintenance Study: Week 11 to Week 58|Adverse Event|2|||
147332032|NCT02914522|531380991|FG008|Maintenance Study: Week 11 to Week 58|Adverse Event|10|||
147332033|NCT02914522|531380992|FG009|Maintenance Study: Week 11 to Week 58|Adverse Event|4|||
147332034|NCT02914522|531380993|FG010|Maintenance Study: Week 11 to Week 58|Adverse Event|3|||
147332035|NCT02914522|531380983|FG000|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
147332036|NCT02914522|531380984|FG001|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
147332037|NCT02914522|531380985|FG002|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
147332038|NCT02914522|531380986|FG003|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
147332039|NCT02914522|531380987|FG004|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
147332040|NCT02914522|531380988|FG005|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
147332041|NCT02914522|531380989|FG006|Maintenance Study: Week 11 to Week 58|Protocol Violation|5|||
147332042|NCT02914522|531380990|FG007|Maintenance Study: Week 11 to Week 58|Protocol Violation|5|||
147449954|NCT02669017|531811323|FG002|Overall Study|Lost to Follow-up|0|||
147598226|NCT02238626|532347777|FG001|Overall Study|Withdrawal by Subject|3|||
147598227|NCT02238626|532347778|FG002|Overall Study|Withdrawal by Subject|0|||
147598228|NCT02238626|532347779|FG003|Overall Study|Withdrawal by Subject|1|||
147598229|NCT02238626|532347776|FG000|Overall Study|Death|0|||
147598230|NCT02238626|532347777|FG001|Overall Study|Death|0|||
147598231|NCT02238626|532347778|FG002|Overall Study|Death|1|||
147598232|NCT02238626|532347779|FG003|Overall Study|Death|1|||
147598233|NCT02238626|532347776|FG000|Overall Study|Other|0|||
147598234|NCT02238626|532347777|FG001|Overall Study|Other|2|||
147598235|NCT02238626|532347778|FG002|Overall Study|Other|0|||
147598236|NCT02238626|532347779|FG003|Overall Study|Other|0|||
147598237|NCT05183217|532347785|FG000|Overall Study|Withdrawal by Subject|1|||
147598238|NCT05183217|532347786|FG001|Overall Study|Withdrawal by Subject|1|||
147598239|NCT03412396|532347787|FG000|Overall Study|Withdrawal by Subject|2|||
147598240|NCT03412396|532347787|FG000|Overall Study|"stopped apalutamide at <9 weeks after initiation"|1|||
147598241|NCT03412396|532347787|FG000|Overall Study|Did not undergo RP|2|||
147598242|NCT01383135|532347797|FG000|Overall Study|Not Scanned / Imaged|1|||
147598243|NCT01383135|532347798|FG001|Overall Study|Not Scanned / Imaged|0|||
147598244|NCT01383135|532347799|FG002|Overall Study|Not Scanned / Imaged|1|||
147598245|NCT01383135|532347800|FG003|Overall Study|Not Scanned / Imaged|0|||
147598246|NCT03167723|532347804|FG000|Overall Study|Protocol Violation|4|||
147598247|NCT03167723|532347805|FG001|Overall Study|Protocol Violation|6|||
147598248|NCT01297465|532347807|FG000|Overall Study|Lack of Ovarian Response|1|||
147598249|NCT01297465|532347808|FG001|Overall Study|Lack of Ovarian Response|1|||
147598250|NCT01297465|532347807|FG000|Overall Study|Ovarian hyperstimulation syndrome risk|0|||
147598251|NCT01297465|532347808|FG001|Overall Study|Ovarian hyperstimulation syndrome risk|1|||
147598252|NCT01297465|532347807|FG000|Overall Study|No Oocytes Retrieved|1|||
147598253|NCT01297465|532347808|FG001|Overall Study|No Oocytes Retrieved|1|||
147598254|NCT01297465|532347807|FG000|Overall Study|Poor oocyte quality|0|||
147598255|NCT01297465|532347808|FG001|Overall Study|Poor oocyte quality|1|||
147598256|NCT01297465|532347807|FG000|Overall Study|No Fertilization|6|||
147598257|NCT01297465|532347808|FG001|Overall Study|No Fertilization|4|||
147598258|NCT01297465|532347807|FG000|Overall Study|All Embryos Discarded|0|||
147598259|NCT01297465|532347808|FG001|Overall Study|All Embryos Discarded|1|||
147598260|NCT01297465|532347807|FG000|Overall Study|Intention to Freeze all Embryos|0|||
147598261|NCT01297465|532347808|FG001|Overall Study|Intention to Freeze all Embryos|1|||
147598262|NCT02455050|532347809|FG000|Treatment Period 1|Lost to Follow-up|1|||
147598263|NCT02455050|532347810|FG001|Treatment Period 1|Lost to Follow-up|1|||
147598264|NCT02455050|532347811|FG002|Treatment Period 1|Lost to Follow-up|1|||
147598265|NCT02455050|532347812|FG003|Treatment Period 1|Lost to Follow-up|2|||
147598266|NCT02455050|532347809|FG000|Treatment Period 2|Lost to Follow-up|1|||
147598267|NCT02455050|532347810|FG001|Treatment Period 2|Lost to Follow-up|0|||
147598268|NCT02455050|532347811|FG002|Treatment Period 2|Lost to Follow-up|2|||
147598269|NCT02455050|532347812|FG003|Treatment Period 2|Lost to Follow-up|1|||
147598270|NCT03402750|532347813|FG000|Overall Study|Lost to Follow-up|2|||
147598271|NCT03402750|532347814|FG001|Overall Study|Lost to Follow-up|1|||
147598272|NCT02981303|532347815|FG000|Overall Study|Progressive Disease|17|||
147598273|NCT02981303|532347816|FG001|Overall Study|Progressive Disease|37|||
147598274|NCT02981303|532347815|FG000|Overall Study|Adverse Event|1|||
147598275|NCT02981303|532347816|FG001|Overall Study|Adverse Event|4|||
147598276|NCT02981303|532347815|FG000|Overall Study|Withdrawal by Subject|0|||
147598277|NCT02981303|532347816|FG001|Overall Study|Withdrawal by Subject|1|||
147598278|NCT02325518|532347817|FG000|Overall Study|Adverse Event|4|||
147598279|NCT02325518|532347818|FG001|Overall Study|Adverse Event|1|||
147598280|NCT02325518|532347817|FG000|Overall Study|Physician Decision|0|||
147598281|NCT02325518|532347818|FG001|Overall Study|Physician Decision|1|||
147661130|NCT00643201|532581425|FG000|Completed Study Follow Up|Death|28|||
147661131|NCT00643201|532581426|FG001|Completed Study Follow Up|Death|34|||
147598282|NCT02325518|532347817|FG000|Overall Study|Withdrawal by Subject|0|||
147598283|NCT02325518|532347818|FG001|Overall Study|Withdrawal by Subject|1|||
147598284|NCT03393806|532347821|FG000|Overall Study|Physician Decision|1|||
147598285|NCT03393806|532347822|FG001|Overall Study|Physician Decision|0|||
147598286|NCT01259115|532347823|FG000|Period 1|Adverse Event|1|||
147598287|NCT01259115|532347824|FG001|Period 1|Adverse Event|0|||
147598288|NCT01259115|532347823|FG000|Period 1|Protocol Violation|2|||
147598289|NCT01259115|532347824|FG001|Period 1|Protocol Violation|0|||
147598290|NCT01259115|532347823|FG000|Period 1|Lost to Follow-up|0|||
147598291|NCT01259115|532347824|FG001|Period 1|Lost to Follow-up|1|||
147598292|NCT01259115|532347823|FG000|Period 2|Adverse Event|1|||
147598293|NCT01259115|532347824|FG001|Period 2|Adverse Event|0|||
147598294|NCT01971970|532347825|FG000|Baseline Until Week 6|Stopped anti-TNF use|1|||
147598295|NCT01971970|532347826|FG001|Baseline Until Week 6|Stopped anti-TNF use|0|||
147598296|NCT01971970|532347825|FG000|Week 6 Until Week 8|Stopped anti-TNF use|0|||
147598297|NCT01971970|532347826|FG001|Week 6 Until Week 8|Stopped anti-TNF use|1|||
147598298|NCT01971970|532347825|FG000|Week 14 Until Week 22|Lost to Follow-up|0|||
147598299|NCT01971970|532347826|FG001|Week 14 Until Week 22|Lost to Follow-up|1|||
147598300|NCT01971970|532347825|FG000|Week 22 Until Week 52|Stopped anti-TNF use|7|||
147598301|NCT01971970|532347826|FG001|Week 22 Until Week 52|Stopped anti-TNF use|3|||
147598302|NCT01971970|532347825|FG000|Week 22 Until Week 52|Stopped anti-TNF use without escalation because of antibody-to-infliximab (ATI) formation|1|||
147598303|NCT01971970|532347826|FG001|Week 22 Until Week 52|Stopped anti-TNF use without escalation because of antibody-to-infliximab (ATI) formation|0|||
147598304|NCT01971970|532347825|FG000|Week 22 Until Week 52|Stopped anti-TNF due to endoscopic improvement 1 year after start|0|||
147598305|NCT01971970|532347826|FG001|Week 22 Until Week 52|Stopped anti-TNF due to endoscopic improvement 1 year after start|1|||
147598306|NCT01971970|532347825|FG000|Week 52 Until Week 78|Stopped anti-TNF use|1|||
147598307|NCT01971970|532347826|FG001|Week 52 Until Week 78|Stopped anti-TNF use|3|||
147598308|NCT00848107|532347827|FG000|Overall Study|Lost to Follow-up|2|||
147598309|NCT00848107|532347827|FG000|Overall Study|Withdrawal by Subject|8|||
147598310|NCT00848107|532347827|FG000|Overall Study|Adverse Event|9|||
147598311|NCT00848107|532347827|FG000|Overall Study|Death|1|||
147598312|NCT00848107|532347827|FG000|Overall Study|Pregnancy|1|||
147598313|NCT01831765|532347828|FG000|Overall Study|Lack of Efficacy|1|||
147598314|NCT01831765|532347829|FG001|Overall Study|Lack of Efficacy|0|||
147598315|NCT01831765|532347830|FG002|Overall Study|Lack of Efficacy|0|||
147598316|NCT01831765|532347828|FG000|Overall Study|Other, sponsor withdrew subject|0|||
147598317|NCT01831765|532347829|FG001|Overall Study|Other, sponsor withdrew subject|1|||
147598318|NCT01831765|532347830|FG002|Overall Study|Other, sponsor withdrew subject|0|||
147598319|NCT01831765|532347828|FG000|Overall Study|Pregnancy|1|||
147598320|NCT01831765|532347829|FG001|Overall Study|Pregnancy|1|||
147598321|NCT01831765|532347830|FG002|Overall Study|Pregnancy|2|||
147598322|NCT01831765|532347828|FG000|Overall Study|Death|0|||
147598323|NCT01831765|532347829|FG001|Overall Study|Death|1|||
147598324|NCT01831765|532347830|FG002|Overall Study|Death|1|||
147598325|NCT01831765|532347828|FG000|Overall Study|Other, site closed|1|||
147598326|NCT01831765|532347829|FG001|Overall Study|Other, site closed|1|||
147598327|NCT01831765|532347830|FG002|Overall Study|Other, site closed|0|||
147598328|NCT01831765|532347828|FG000|Overall Study|Adverse Event|5|||
147598329|NCT01831765|532347829|FG001|Overall Study|Adverse Event|3|||
147598330|NCT01831765|532347830|FG002|Overall Study|Adverse Event|3|||
147598331|NCT01831765|532347828|FG000|Overall Study|Withdrawal by Subject|22|||
147598332|NCT01831765|532347829|FG001|Overall Study|Withdrawal by Subject|7|||
147598333|NCT01831765|532347830|FG002|Overall Study|Withdrawal by Subject|17|||
147598334|NCT01831765|532347828|FG000|Overall Study|Withdrawal criteria|12|||
147598335|NCT01831765|532347829|FG001|Overall Study|Withdrawal criteria|10|||
147598336|NCT01831765|532347830|FG002|Overall Study|Withdrawal criteria|16|||
147598337|NCT01831765|532347828|FG000|Overall Study|Lost to Follow-up|2|||
147598338|NCT01831765|532347829|FG001|Overall Study|Lost to Follow-up|3|||
147598339|NCT01831765|532347830|FG002|Overall Study|Lost to Follow-up|3|||
147598340|NCT00507130|532347831|FG000|Overall Study|Lost to Follow-up|0|||
147598341|NCT00507130|532347832|FG001|Overall Study|Lost to Follow-up|0|||
147598342|NCT00507130|532347833|FG002|Overall Study|Lost to Follow-up|1|||
147598343|NCT00507130|532347834|FG003|Overall Study|Lost to Follow-up|1|||
147598344|NCT00507130|532347831|FG000|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|1|||
147598345|NCT00507130|532347832|FG001|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|0|||
147598346|NCT00507130|532347833|FG002|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|0|||
147598347|NCT00507130|532347834|FG003|Overall Study|SERIOUS EVENT OF ASTHMA EXACERBATION|0|||
147598348|NCT02524730|532347835|FG000|Overall Study|Lost to Follow-up|5|||
147598349|NCT02524730|532347835|FG000|Overall Study|Withdrawal by Subject|18|||
147598350|NCT02524730|532347835|FG000|Overall Study|Death|10|||
147598351|NCT02524730|532347835|FG000|Overall Study|Adverse Event|8|||
147598352|NCT02524730|532347835|FG000|Overall Study|Protocol Violation|1|||
147598353|NCT02524730|532347835|FG000|Overall Study|Subjects received Scorpio NRG PS (Posterior Stabilizing)|4|||
147598354|NCT00859586|532347836|FG000|Overall Study|Donors|4|||
147598355|NCT00080938|532347841|FG000|Overall Study|Adverse Event|3|||
147598356|NCT00080938|532347841|FG000|Overall Study|Withdrawal by Subject|6|||
147332043|NCT02914522|531380991|FG008|Maintenance Study: Week 11 to Week 58|Protocol Violation|3|||
147332044|NCT02914522|531380992|FG009|Maintenance Study: Week 11 to Week 58|Protocol Violation|0|||
147332045|NCT02914522|531380993|FG010|Maintenance Study: Week 11 to Week 58|Protocol Violation|1|||
147332046|NCT02914522|531380983|FG000|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
147332047|NCT02914522|531380984|FG001|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
147332048|NCT02914522|531380985|FG002|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
147332049|NCT02914522|531380986|FG003|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
147332050|NCT02914522|531380987|FG004|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
147332051|NCT02914522|531380988|FG005|Maintenance Study: Week 11 to Week 58|Withdrew Consent|0|||
147332052|NCT02914522|531380989|FG006|Maintenance Study: Week 11 to Week 58|Withdrew Consent|4|||
147332053|NCT02914522|531380990|FG007|Maintenance Study: Week 11 to Week 58|Withdrew Consent|1|||
147332054|NCT02914522|531380991|FG008|Maintenance Study: Week 11 to Week 58|Withdrew Consent|6|||
147332055|NCT02914522|531380992|FG009|Maintenance Study: Week 11 to Week 58|Withdrew Consent|3|||
147332056|NCT02914522|531380993|FG010|Maintenance Study: Week 11 to Week 58|Withdrew Consent|4|||
147332057|NCT02914522|531380983|FG000|Maintenance Study: Week 11 to Week 58|Death|0|||
147332058|NCT02914522|531380984|FG001|Maintenance Study: Week 11 to Week 58|Death|0|||
147332059|NCT02914522|531380985|FG002|Maintenance Study: Week 11 to Week 58|Death|0|||
147332060|NCT02914522|531380986|FG003|Maintenance Study: Week 11 to Week 58|Death|0|||
147332061|NCT02914522|531380987|FG004|Maintenance Study: Week 11 to Week 58|Death|0|||
147332062|NCT02914522|531380988|FG005|Maintenance Study: Week 11 to Week 58|Death|0|||
147332063|NCT02914522|531380989|FG006|Maintenance Study: Week 11 to Week 58|Death|2|||
147332064|NCT02914522|531380990|FG007|Maintenance Study: Week 11 to Week 58|Death|0|||
147332065|NCT02914522|531380991|FG008|Maintenance Study: Week 11 to Week 58|Death|0|||
147332066|NCT02914522|531380992|FG009|Maintenance Study: Week 11 to Week 58|Death|0|||
147332067|NCT02914522|531380993|FG010|Maintenance Study: Week 11 to Week 58|Death|0|||
147332068|NCT02914522|531380983|FG000|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
147332069|NCT02914522|531380984|FG001|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
147332070|NCT02914522|531380985|FG002|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
147332071|NCT02914522|531380986|FG003|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
147449955|NCT02669017|531811324|FG003|Overall Study|Lost to Follow-up|0|||
147598357|NCT00080938|532347841|FG000|Overall Study|Death|2|||
147598358|NCT00080938|532347841|FG000|Overall Study|Lack of Efficacy|7|||
147598359|NCT00080938|532347841|FG000|Overall Study|other disease|1|||
147598360|NCT00080938|532347841|FG000|Overall Study|Not started protocol therapy|1|||
147598361|NCT00080938|532347841|FG000|Overall Study|Ineligible|4|||
147598362|NCT00706511|532347848|FG000|Overall Study|Withdrawal by Subject|1|||
147598363|NCT00706511|532347849|FG001|Overall Study|Withdrawal by Subject|0|||
147598364|NCT00706511|532347850|FG002|Overall Study|Withdrawal by Subject|0|||
147598365|NCT00706511|532347851|FG003|Overall Study|Withdrawal by Subject|0|||
147598366|NCT02605993|532347852|FG000|Extension Period|Participant underwent bone marrow transplantation due to chronic myelomonocytic leukemia|0|||
147598367|NCT02605993|532347853|FG001|Extension Period|Participant underwent bone marrow transplantation due to chronic myelomonocytic leukemia|0|||
147598368|NCT02605993|532347854|FG002|Extension Period|Participant underwent bone marrow transplantation due to chronic myelomonocytic leukemia|1|||
147598369|NCT02605993|532347855|FG003|Extension Period|Participant underwent bone marrow transplantation due to chronic myelomonocytic leukemia|0|||
147598370|NCT03493386|532347860|FG000|Part 1, Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
147598371|NCT03493386|532347861|FG001|Part 1, Washout Period (at Least 5 Days)|Withdrawal by Subject|1|||
147598372|NCT03493386|532347862|FG002|Part 1, Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
147598373|NCT03493386|532347863|FG003|Part 1, Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
147598374|NCT04645966|532347864|FG000|Vaccination Phase|Adverse Event|1|||
147598375|NCT04645966|532347865|FG001|Vaccination Phase|Adverse Event|0|||
147598376|NCT04645966|532347866|FG002|Vaccination Phase|Adverse Event|0|||
147598377|NCT04645966|532347867|FG003|Vaccination Phase|Adverse Event|0|||
147598378|NCT04645966|532347868|FG004|Vaccination Phase|Adverse Event|0|||
147598379|NCT04645966|532347869|FG005|Vaccination Phase|Adverse Event|0|||
147598380|NCT04645966|532347870|FG006|Vaccination Phase|Adverse Event|1|||
147598381|NCT04645966|532347871|FG007|Vaccination Phase|Adverse Event|0|||
147598382|NCT04645966|532347872|FG008|Vaccination Phase|Adverse Event|0|||
147598383|NCT04645966|532347864|FG000|Vaccination Phase|Death|0|||
147598384|NCT04645966|532347865|FG001|Vaccination Phase|Death|0|||
147598385|NCT04645966|532347866|FG002|Vaccination Phase|Death|0|||
147598386|NCT04645966|532347867|FG003|Vaccination Phase|Death|0|||
147598387|NCT04645966|532347868|FG004|Vaccination Phase|Death|0|||
147598388|NCT04645966|532347869|FG005|Vaccination Phase|Death|1|||
147598389|NCT04645966|532347870|FG006|Vaccination Phase|Death|0|||
147598390|NCT04645966|532347871|FG007|Vaccination Phase|Death|0|||
147598391|NCT04645966|532347872|FG008|Vaccination Phase|Death|0|||
147598392|NCT04645966|532347864|FG000|Vaccination Phase|Protocol Violation|0|||
147598393|NCT04645966|532347865|FG001|Vaccination Phase|Protocol Violation|0|||
147598394|NCT04645966|532347866|FG002|Vaccination Phase|Protocol Violation|0|||
147598395|NCT04645966|532347867|FG003|Vaccination Phase|Protocol Violation|0|||
147598396|NCT04645966|532347868|FG004|Vaccination Phase|Protocol Violation|1|||
147598397|NCT04645966|532347869|FG005|Vaccination Phase|Protocol Violation|0|||
147332072|NCT02914522|531380987|FG004|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
147332073|NCT02914522|531380988|FG005|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
147332074|NCT02914522|531380989|FG006|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
147332075|NCT02914522|531380990|FG007|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|1|||
147332076|NCT02914522|531380991|FG008|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|2|||
147332077|NCT02914522|531380992|FG009|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
147332078|NCT02914522|531380993|FG010|Maintenance Study: Week 11 to Week 58|Investigator's Discretion|0|||
147332079|NCT02914522|531380983|FG000|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
147332080|NCT02914522|531380984|FG001|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
147332081|NCT02914522|531380985|FG002|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
147332082|NCT02914522|531380986|FG003|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
147332083|NCT02914522|531380987|FG004|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
147332084|NCT02914522|531380988|FG005|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
147332085|NCT02914522|531380989|FG006|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
147332086|NCT02914522|531380990|FG007|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
147332087|NCT02914522|531380991|FG008|Maintenance Study: Week 11 to Week 58|Pregnancy|1|||
147332088|NCT02914522|531380992|FG009|Maintenance Study: Week 11 to Week 58|Pregnancy|2|||
147332089|NCT02914522|531380993|FG010|Maintenance Study: Week 11 to Week 58|Pregnancy|0|||
147332090|NCT02914522|531380983|FG000|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
147332091|NCT02914522|531380984|FG001|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
147332092|NCT02914522|531380985|FG002|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
147332093|NCT02914522|531380986|FG003|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
147332094|NCT02914522|531380987|FG004|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
147332095|NCT02914522|531380988|FG005|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
147332096|NCT02914522|531380989|FG006|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
147332097|NCT02914522|531380990|FG007|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
147332098|NCT02914522|531380991|FG008|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
147449956|NCT02669017|531811325|FG004|Overall Study|Lost to Follow-up|0|||
147449957|NCT02669017|531811326|FG005|Overall Study|Lost to Follow-up|0|||
147598398|NCT04645966|532347870|FG006|Vaccination Phase|Protocol Violation|0|||
147598399|NCT04645966|532347871|FG007|Vaccination Phase|Protocol Violation|0|||
147598400|NCT04645966|532347872|FG008|Vaccination Phase|Protocol Violation|0|||
147598401|NCT04645966|532347864|FG000|Vaccination Phase|Study terminated by sponsor|0|||
147598402|NCT04645966|532347865|FG001|Vaccination Phase|Study terminated by sponsor|0|||
147598403|NCT04645966|532347866|FG002|Vaccination Phase|Study terminated by sponsor|14|||
147598404|NCT04645966|532347867|FG003|Vaccination Phase|Study terminated by sponsor|15|||
147598405|NCT04645966|532347868|FG004|Vaccination Phase|Study terminated by sponsor|47|||
147598406|NCT04645966|532347869|FG005|Vaccination Phase|Study terminated by sponsor|43|||
147598407|NCT04645966|532347870|FG006|Vaccination Phase|Study terminated by sponsor|29|||
147598408|NCT04645966|532347871|FG007|Vaccination Phase|Study terminated by sponsor|29|||
147598409|NCT04645966|532347872|FG008|Vaccination Phase|Study terminated by sponsor|12|||
147598410|NCT04645966|532347864|FG000|Vaccination Phase|Withdrawal by parent/guardian|0|||
147598411|NCT04645966|532347865|FG001|Vaccination Phase|Withdrawal by parent/guardian|0|||
147598412|NCT04645966|532347866|FG002|Vaccination Phase|Withdrawal by parent/guardian|2|||
147598413|NCT04645966|532347867|FG003|Vaccination Phase|Withdrawal by parent/guardian|1|||
147598414|NCT04645966|532347868|FG004|Vaccination Phase|Withdrawal by parent/guardian|3|||
147598415|NCT04645966|532347869|FG005|Vaccination Phase|Withdrawal by parent/guardian|4|||
147598416|NCT04645966|532347870|FG006|Vaccination Phase|Withdrawal by parent/guardian|0|||
147598417|NCT04645966|532347871|FG007|Vaccination Phase|Withdrawal by parent/guardian|2|||
147598418|NCT04645966|532347872|FG008|Vaccination Phase|Withdrawal by parent/guardian|0|||
147598419|NCT04645966|532347864|FG000|Vaccination Phase|Other|0|||
147598420|NCT04645966|532347865|FG001|Vaccination Phase|Other|0|||
147598421|NCT04645966|532347866|FG002|Vaccination Phase|Other|0|||
147598422|NCT04645966|532347867|FG003|Vaccination Phase|Other|0|||
147598423|NCT04645966|532347868|FG004|Vaccination Phase|Other|0|||
147598424|NCT04645966|532347869|FG005|Vaccination Phase|Other|2|||
147598425|NCT04645966|532347870|FG006|Vaccination Phase|Other|0|||
147598426|NCT04645966|532347871|FG007|Vaccination Phase|Other|0|||
147598427|NCT04645966|532347872|FG008|Vaccination Phase|Other|0|||
147598428|NCT04645966|532347864|FG000|Vaccination Phase|Lost to Follow-up|0|||
147598429|NCT04645966|532347865|FG001|Vaccination Phase|Lost to Follow-up|0|||
147598430|NCT04645966|532347866|FG002|Vaccination Phase|Lost to Follow-up|0|||
147598431|NCT04645966|532347867|FG003|Vaccination Phase|Lost to Follow-up|0|||
147598432|NCT04645966|532347868|FG004|Vaccination Phase|Lost to Follow-up|0|||
147598433|NCT04645966|532347869|FG005|Vaccination Phase|Lost to Follow-up|0|||
147598434|NCT04645966|532347870|FG006|Vaccination Phase|Lost to Follow-up|0|||
147661132|NCT00643201|532581425|FG000|Completed Study Follow Up|Withdrawal by Subject|23|||
147332099|NCT02914522|531380992|FG009|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|1|||
147332100|NCT02914522|531380993|FG010|Maintenance Study: Week 11 to Week 58|Non-compliance With Study Drug|0|||
147661133|NCT00643201|532581426|FG001|Completed Study Follow Up|Withdrawal by Subject|29|||
147661134|NCT00643201|532581425|FG000|Completed Study Follow Up|Lost to Follow-up|18|||
147661135|NCT00643201|532581426|FG001|Completed Study Follow Up|Lost to Follow-up|16|||
147661136|NCT00643201|532581425|FG000|Completed Study Follow Up|non-specified|1|||
147661137|NCT00643201|532581426|FG001|Completed Study Follow Up|non-specified|0|||
147661138|NCT03933449|532581434|FG000|Overall Study|Adverse Event|6|||
147661139|NCT03933449|532581435|FG001|Overall Study|Adverse Event|4|||
147661140|NCT03933449|532581434|FG000|Overall Study|Death|55|||
147661141|NCT03933449|532581435|FG001|Overall Study|Death|57|||
147661142|NCT03933449|532581434|FG000|Overall Study|Sponsor Decision|1|||
147661143|NCT03933449|532581435|FG001|Overall Study|Sponsor Decision|0|||
147661144|NCT01158261|532581436|FG000|Overall Study|Lost to Follow-up|9|||
147661145|NCT01158261|532581436|FG000|Overall Study|Death|7|||
147661146|NCT01158261|532581436|FG000|Overall Study|Withdrawal by Subject|1|||
147661147|NCT02899065|532581437|FG000|Randomization to 7 Day Follow Up Contact|Withdrawal by Subject|1|||
147661148|NCT02899065|532581438|FG001|Randomization to 7 Day Follow Up Contact|Withdrawal by Subject|5|||
147661149|NCT02899065|532581437|FG000|Day 7 to 4 Week Follow Up Contact|Withdrawal by Subject|3|||
147661150|NCT02899065|532581438|FG001|Day 7 to 4 Week Follow Up Contact|Withdrawal by Subject|0|||
147661151|NCT02899065|532581437|FG000|Day 7 to 4 Week Follow Up Contact|Lost to Follow-up|21|||
147661152|NCT02899065|532581438|FG001|Day 7 to 4 Week Follow Up Contact|Lost to Follow-up|16|||
147661153|NCT00971867|532581439|FG000|Overall Study|Adverse Event|4|||
147661154|NCT00971867|532581439|FG000|Overall Study|Participant Withdrew Consent|1|||
147661155|NCT00971867|532581439|FG000|Overall Study|Disease Progression|6|||
147661156|NCT02983045|532581441|FG000|Overall Study|Withdrawal by Subject|0|||
147661157|NCT02983045|532581442|FG001|Overall Study|Withdrawal by Subject|1|||
147661158|NCT02983045|532581443|FG002|Overall Study|Withdrawal by Subject|0|||
147661159|NCT02983045|532581444|FG003|Overall Study|Withdrawal by Subject|5|||
147661160|NCT02983045|532581445|FG004|Overall Study|Withdrawal by Subject|0|||
147661161|NCT02983045|532581446|FG005|Overall Study|Withdrawal by Subject|72|||
147661162|NCT02983045|532581447|FG006|Overall Study|Withdrawal by Subject|0|||
147661163|NCT02983045|532581448|FG007|Overall Study|Withdrawal by Subject|0|||
147661164|NCT02983045|532581449|FG008|Overall Study|Withdrawal by Subject|0|||
147661165|NCT02983045|532581450|FG009|Overall Study|Withdrawal by Subject|2|||
147661166|NCT02983045|532581441|FG000|Overall Study|Lost to Follow-up|0|||
147661167|NCT02983045|532581442|FG001|Overall Study|Lost to Follow-up|0|||
147661168|NCT02983045|532581443|FG002|Overall Study|Lost to Follow-up|0|||
147661169|NCT02983045|532581444|FG003|Overall Study|Lost to Follow-up|0|||
147661170|NCT02983045|532581445|FG004|Overall Study|Lost to Follow-up|0|||
147661171|NCT02983045|532581446|FG005|Overall Study|Lost to Follow-up|10|||
147661172|NCT02983045|532581447|FG006|Overall Study|Lost to Follow-up|0|||
147661173|NCT02983045|532581448|FG007|Overall Study|Lost to Follow-up|0|||
147661174|NCT02983045|532581449|FG008|Overall Study|Lost to Follow-up|0|||
147661175|NCT02983045|532581450|FG009|Overall Study|Lost to Follow-up|0|||
147661176|NCT00905424|532581453|FG000|Overall Study|Lost to Follow-up|3|||
147661177|NCT00905424|532581454|FG001|Overall Study|Lost to Follow-up|3|||
147661178|NCT00905424|532581453|FG000|Overall Study|Withdrawal by Subject|1|||
147661179|NCT00905424|532581454|FG001|Overall Study|Withdrawal by Subject|2|||
147661180|NCT00905424|532581453|FG000|Overall Study|Adverse Event|4|||
147661181|NCT00905424|532581454|FG001|Overall Study|Adverse Event|2|||
147661182|NCT00905424|532581453|FG000|Overall Study|Non-compliance with study medication|2|||
147661183|NCT00905424|532581454|FG001|Overall Study|Non-compliance with study medication|0|||
147661184|NCT00905424|532581453|FG000|Overall Study|Sponsor decision|1|||
147252926|NCT00293254|531098255|FG001|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|1|||
147252927|NCT00293254|531098254|FG000|Primary Study - Double-Blind Week 0-48|Moved or trial terminated at site|1|||
147252928|NCT00293254|531098255|FG001|Primary Study - Double-Blind Week 0-48|Moved or trial terminated at site|0|||
147252929|NCT00293254|531098254|FG000|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|35|||
147252930|NCT00293254|531098255|FG001|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|57|||
147252931|NCT00293254|531098254|FG000|Extension - Double-Blind Week 49-156|Adverse Event|4|||
147252932|NCT00293254|531098255|FG001|Extension - Double-Blind Week 49-156|Adverse Event|1|||
147252933|NCT00293254|531098254|FG000|Extension - Double-Blind Week 49-156|Death|4|||
147252934|NCT00293254|531098255|FG001|Extension - Double-Blind Week 49-156|Death|1|||
147252935|NCT00293254|531098254|FG000|Extension - Double-Blind Week 49-156|Lack of Efficacy|3|||
147252936|NCT00293254|531098255|FG001|Extension - Double-Blind Week 49-156|Lack of Efficacy|4|||
147252937|NCT00293254|531098254|FG000|Extension - Double-Blind Week 49-156|Lost to Follow-up|3|||
147252938|NCT00293254|531098255|FG001|Extension - Double-Blind Week 49-156|Lost to Follow-up|3|||
147661185|NCT00905424|532581454|FG001|Overall Study|Sponsor decision|0|||
147449958|NCT02669017|531811327|FG006|Overall Study|Lost to Follow-up|0|||
147661186|NCT00905424|532581453|FG000|Overall Study|Positive urine drug screen|0|||
147661187|NCT00905424|532581454|FG001|Overall Study|Positive urine drug screen|1|||
147661188|NCT00905424|532581453|FG000|Overall Study|Non-adherence to visit schedule|0|||
147661189|NCT00905424|532581454|FG001|Overall Study|Non-adherence to visit schedule|1|||
147661190|NCT00379899|532581455|FG000|Overall Study|Adverse Event|7|||
147661191|NCT00379899|532581456|FG001|Overall Study|Adverse Event|3|||
147661192|NCT00379899|532581455|FG000|Overall Study|Death|10|||
147661193|NCT00379899|532581456|FG001|Overall Study|Death|10|||
147661194|NCT00379899|532581455|FG000|Overall Study|Lost to Follow-up|2|||
147661195|NCT00379899|532581456|FG001|Overall Study|Lost to Follow-up|4|||
147661196|NCT00379899|532581455|FG000|Overall Study|Physician Decision|3|||
147661197|NCT00379899|532581456|FG001|Overall Study|Physician Decision|4|||
147661198|NCT00379899|532581455|FG000|Overall Study|Withdrawal by Subject|5|||
147661199|NCT00379899|532581456|FG001|Overall Study|Withdrawal by Subject|5|||
147661200|NCT00379899|532581455|FG000|Overall Study|Ineligibility determined|0|||
147661201|NCT00379899|532581456|FG001|Overall Study|Ineligibility determined|1|||
147661202|NCT00379899|532581455|FG000|Overall Study|Noncompliance|1|||
147661203|NCT00379899|532581456|FG001|Overall Study|Noncompliance|1|||
147661204|NCT00379899|532581455|FG000|Overall Study|Parathyroidectomy|0|||
147661205|NCT00379899|532581456|FG001|Overall Study|Parathyroidectomy|2|||
147661206|NCT00379899|532581455|FG000|Overall Study|Renal transplantation|5|||
147661207|NCT00379899|532581456|FG001|Overall Study|Renal transplantation|4|||
147661208|NCT00379899|532581455|FG000|Overall Study|Coronary artery bypass graft|1|||
147661209|NCT00379899|532581456|FG001|Overall Study|Coronary artery bypass graft|1|||
147661210|NCT00379899|532581455|FG000|Overall Study|Other protocol-specified criteria|3|||
147661211|NCT00379899|532581456|FG001|Overall Study|Other protocol-specified criteria|4|||
147661212|NCT00379899|532581455|FG000|Overall Study|Other|3|||
147661213|NCT00379899|532581456|FG001|Overall Study|Other|1|||
147661214|NCT01922258|532581457|FG000|Overall Study|Lost to Follow-up|1|||
147661215|NCT01922258|532581458|FG001|Overall Study|Lost to Follow-up|1|||
147661216|NCT01922258|532581457|FG000|Overall Study|Adverse Event|9|||
147661217|NCT01922258|532581458|FG001|Overall Study|Adverse Event|2|||
147661218|NCT01922258|532581457|FG000|Overall Study|Met Withdrawal Criteria|0|||
147661219|NCT01922258|532581458|FG001|Overall Study|Met Withdrawal Criteria|4|||
147661220|NCT01922258|532581457|FG000|Overall Study|Withdrawn by the Investigator|1|||
147661221|NCT01922258|532581458|FG001|Overall Study|Withdrawn by the Investigator|4|||
147661222|NCT01922258|532581457|FG000|Overall Study|Withdrawal by participant|5|||
147661223|NCT01922258|532581458|FG001|Overall Study|Withdrawal by participant|5|||
147661224|NCT05225389|532581459|FG000|Overall Study|Three participants were discontinued by the Investigator on day 7 due to positive COVID-19 tests.|3|||
147661225|NCT01585246|532581460|FG000|Overall Study|Lost to Follow-up|0|||
147661226|NCT01585246|532581461|FG001|Overall Study|Lost to Follow-up|0|||
147661227|NCT01585246|532581462|FG002|Overall Study|Lost to Follow-up|2|||
147661228|NCT01585246|532581463|FG003|Overall Study|Lost to Follow-up|1|||
147661229|NCT01585246|532581464|FG004|Overall Study|Lost to Follow-up|0|||
147661230|NCT01585246|532581460|FG000|Overall Study|Protocol Violation|0|||
147661231|NCT01585246|532581461|FG001|Overall Study|Protocol Violation|0|||
147661232|NCT01585246|532581462|FG002|Overall Study|Protocol Violation|0|||
147661233|NCT01585246|532581463|FG003|Overall Study|Protocol Violation|0|||
147661234|NCT01585246|532581464|FG004|Overall Study|Protocol Violation|1|||
147661235|NCT01585246|532581460|FG000|Overall Study|Withdrawal by Subject|0|||
147661236|NCT01585246|532581461|FG001|Overall Study|Withdrawal by Subject|0|||
147661237|NCT01585246|532581462|FG002|Overall Study|Withdrawal by Subject|1|||
147661238|NCT01585246|532581463|FG003|Overall Study|Withdrawal by Subject|2|||
147661239|NCT01585246|532581464|FG004|Overall Study|Withdrawal by Subject|1|||
147661240|NCT01585246|532581460|FG000|Overall Study|Other|0|||
147661241|NCT01585246|532581461|FG001|Overall Study|Other|1|||
147598435|NCT04645966|532347871|FG007|Vaccination Phase|Lost to Follow-up|1|||
147598436|NCT04645966|532347872|FG008|Vaccination Phase|Lost to Follow-up|0|||
147598437|NCT04645966|532347864|FG000|Vaccination Phase|No longer meets eligibility criteria|0|||
147598438|NCT04645966|532347865|FG001|Vaccination Phase|No longer meets eligibility criteria|0|||
147598439|NCT04645966|532347866|FG002|Vaccination Phase|No longer meets eligibility criteria|0|||
147598440|NCT04645966|532347867|FG003|Vaccination Phase|No longer meets eligibility criteria|0|||
147598441|NCT04645966|532347868|FG004|Vaccination Phase|No longer meets eligibility criteria|0|||
147598442|NCT04645966|532347869|FG005|Vaccination Phase|No longer meets eligibility criteria|0|||
147598443|NCT04645966|532347870|FG006|Vaccination Phase|No longer meets eligibility criteria|0|||
147598444|NCT04645966|532347871|FG007|Vaccination Phase|No longer meets eligibility criteria|1|||
147598445|NCT04645966|532347872|FG008|Vaccination Phase|No longer meets eligibility criteria|0|||
147598446|NCT04645966|532347864|FG000|Follow-up Phase|Lost to Follow-up|0|||
147598447|NCT04645966|532347865|FG001|Follow-up Phase|Lost to Follow-up|0|||
147661242|NCT01585246|532581462|FG002|Overall Study|Other|1|||
147661243|NCT01585246|532581463|FG003|Overall Study|Other|1|||
147661244|NCT01585246|532581464|FG004|Overall Study|Other|0|||
147661245|NCT04552132|532581465|FG000|Overall Study|Lost to Follow-up|4|||
147661246|NCT04552132|532581466|FG001|Overall Study|Lost to Follow-up|3|||
147661247|NCT04552132|532581465|FG000|Overall Study|Protocol Violation|1|||
147661248|NCT04552132|532581466|FG001|Overall Study|Protocol Violation|0|||
147661249|NCT01657162|532581467|FG000|Overall Study|Adverse Event|26|||
147449959|NCT02669017|531811328|FG007|Overall Study|Lost to Follow-up|0|||
147598448|NCT04645966|532347866|FG002|Follow-up Phase|Lost to Follow-up|0|||
147661250|NCT01657162|532581468|FG001|Overall Study|Adverse Event|36|||
147661251|NCT01657162|532581467|FG000|Overall Study|Withdrawal by Subject|13|||
147661252|NCT01657162|532581468|FG001|Overall Study|Withdrawal by Subject|13|||
147598449|NCT04645966|532347867|FG003|Follow-up Phase|Lost to Follow-up|0|||
147598450|NCT04645966|532347868|FG004|Follow-up Phase|Lost to Follow-up|0|||
147598451|NCT04645966|532347869|FG005|Follow-up Phase|Lost to Follow-up|0|||
147598452|NCT04645966|532347870|FG006|Follow-up Phase|Lost to Follow-up|0|||
147598453|NCT04645966|532347871|FG007|Follow-up Phase|Lost to Follow-up|1|||
147598454|NCT04645966|532347872|FG008|Follow-up Phase|Lost to Follow-up|0|||
147598455|NCT02116608|532347878|FG000|Overall Study|Lost to Follow-up|0|||
147598456|NCT02116608|532347879|FG001|Overall Study|Lost to Follow-up|0|||
147332101|NCT00177216|531380994|FG000|Overall Study|Withdrawal by Subject|6|||
147332102|NCT00177216|531380995|FG001|Overall Study|Withdrawal by Subject|3|||
147332103|NCT00177216|531380996|FG002|Overall Study|Withdrawal by Subject|1|||
147332104|NCT01264718|531381003|FG000|Overall Study|Lost to Follow-up|3|||
147332105|NCT01264718|531381004|FG001|Overall Study|Lost to Follow-up|2|||
147332106|NCT01264718|531381003|FG000|Overall Study|Withdrawal by Subject|9|||
147332107|NCT01264718|531381004|FG001|Overall Study|Withdrawal by Subject|15|||
147332108|NCT01264718|531381003|FG000|Overall Study|Loss of Medicaid/CHIP eligibility|37|||
147332109|NCT01264718|531381004|FG001|Overall Study|Loss of Medicaid/CHIP eligibility|26|||
147332110|NCT03545984|531381005|FG000|Overall Study|CSF cases not present during rotation|11|||
147598457|NCT02116608|532347880|FG002|Overall Study|Lost to Follow-up|1|||
147332111|NCT03545984|531381006|FG001|Overall Study|CSF cases not present during rotation|9|||
147332112|NCT01768676|531381007|FG000|Overall Study|Adverse Event|3|||
147332113|NCT01768676|531381008|FG001|Overall Study|Adverse Event|3|||
147332114|NCT01768676|531381007|FG000|Overall Study|Lost to Follow-up|13|||
147332115|NCT01768676|531381008|FG001|Overall Study|Lost to Follow-up|16|||
147332116|NCT01768676|531381007|FG000|Overall Study|Protocol Violation|1|||
147332117|NCT01768676|531381008|FG001|Overall Study|Protocol Violation|1|||
147332118|NCT01768676|531381007|FG000|Overall Study|Physician Decision|4|||
147332119|NCT01768676|531381008|FG001|Overall Study|Physician Decision|1|||
147332120|NCT01768676|531381007|FG000|Overall Study|Withdrawal by Subject|3|||
147332121|NCT01768676|531381008|FG001|Overall Study|Withdrawal by Subject|10|||
147332122|NCT03183518|531381012|FG000|Overall Study|Other (Not specified)|2|||
147332123|NCT03183518|531381012|FG000|Overall Study|Other (Withdrawal of consent)|1|||
147332124|NCT04248829|531381013|FG000|Overall Study|Disease progression|44|||
147332125|NCT04248829|531381014|FG001|Overall Study|Disease progression|109|||
147332126|NCT04248829|531381013|FG000|Overall Study|Adverse Event|19|||
147332127|NCT04248829|531381014|FG001|Overall Study|Adverse Event|18|||
147332128|NCT04248829|531381013|FG000|Overall Study|Withdrawal by Subject|11|||
147332129|NCT04248829|531381014|FG001|Overall Study|Withdrawal by Subject|2|||
147332130|NCT04248829|531381013|FG000|Overall Study|Lost to Follow-up|0|||
147332131|NCT04248829|531381014|FG001|Overall Study|Lost to Follow-up|1|||
147332132|NCT04248829|531381013|FG000|Overall Study|Death|12|||
147332133|NCT04248829|531381014|FG001|Overall Study|Death|14|||
147332134|NCT04248829|531381013|FG000|Overall Study|Physician Decision|2|||
147598458|NCT02116608|532347878|FG000|Overall Study|Physician Decision|0|||
147598459|NCT02116608|532347879|FG001|Overall Study|Physician Decision|1|||
147598460|NCT02116608|532347880|FG002|Overall Study|Physician Decision|0|||
147598461|NCT02116608|532347878|FG000|Overall Study|Death|0|||
147598462|NCT02116608|532347879|FG001|Overall Study|Death|1|||
147598463|NCT02116608|532347880|FG002|Overall Study|Death|0|||
147598464|NCT00988442|532347882|FG000|Overall Study|Death|1|||
147598465|NCT00988442|532347883|FG001|Overall Study|Death|2|||
147598466|NCT00988442|532347882|FG000|Overall Study|Lost to Follow-up|0|||
147598467|NCT00988442|532347883|FG001|Overall Study|Lost to Follow-up|1|||
147598468|NCT00988442|532347882|FG000|Overall Study|Early Study Closure|29|||
147598469|NCT00988442|532347883|FG001|Overall Study|Early Study Closure|25|||
147598470|NCT01460901|532347888|FG000|Overall Study|Withdrawal by Subject|2|||
147598471|NCT00117325|532347889|FG000|Overall Study|Adverse Event|3|||
147598472|NCT00117325|532347890|FG001|Overall Study|Adverse Event|3|||
147598473|NCT00117325|532347889|FG000|Overall Study|Lost to Follow-up|1|||
147598474|NCT00117325|532347890|FG001|Overall Study|Lost to Follow-up|1|||
147598475|NCT00117325|532347889|FG000|Overall Study|Protocol Violation|2|||
147598476|NCT00117325|532347890|FG001|Overall Study|Protocol Violation|3|||
147598477|NCT00117325|532347889|FG000|Overall Study|Withdrawal by Subject|3|||
147598478|NCT00117325|532347890|FG001|Overall Study|Withdrawal by Subject|2|||
147598479|NCT00117325|532347889|FG000|Overall Study|Lack of Efficacy|1|||
147598480|NCT00117325|532347890|FG001|Overall Study|Lack of Efficacy|0|||
147598481|NCT00117325|532347889|FG000|Overall Study|Use of prohibited medicine|1|||
147598482|NCT00117325|532347890|FG001|Overall Study|Use of prohibited medicine|2|||
147598483|NCT00117325|532347889|FG000|Overall Study|Early termination|1|||
147332135|NCT04248829|531381014|FG001|Overall Study|Physician Decision|4|||
147332136|NCT04248829|531381013|FG000|Overall Study|Any reason not specifically recorded|0|||
147332137|NCT04248829|531381014|FG001|Overall Study|Any reason not specifically recorded|2|||
147332138|NCT02132702|531381015|FG000|Overall Study|Protocol Violation|2|||
147332139|NCT02132702|531381015|FG000|Overall Study|Adverse Event|3|||
147332140|NCT02132702|531381015|FG000|Overall Study|Withdrawal by Subject|3|||
147332141|NCT01867580|531381017|FG000|Overall Study|Withdrawal by Subject|2|||
147332142|NCT01867580|531381018|FG001|Overall Study|Withdrawal by Subject|3|||
147598484|NCT00117325|532347890|FG001|Overall Study|Early termination|1|||
147598485|NCT00117325|532347889|FG000|Overall Study|Admisnitrative|1|||
147598486|NCT00117325|532347890|FG001|Overall Study|Admisnitrative|0|||
147252939|NCT00293254|531098254|FG000|Extension - Double-Blind Week 49-156|Withdrawal by Subject|12|||
147252940|NCT00293254|531098255|FG001|Extension - Double-Blind Week 49-156|Withdrawal by Subject|8|||
147252941|NCT00293254|531098254|FG000|Extension - Double-Blind Week 49-156|Participant Moved/Site Stopped Trial|6|||
147252942|NCT00293254|531098255|FG001|Extension - Double-Blind Week 49-156|Participant Moved/Site Stopped Trial|3|||
147252943|NCT00293254|531098254|FG000|Extension - Double-Blind Week 49-156|Other Reason|10|||
147252944|NCT00293254|531098255|FG001|Extension - Double-Blind Week 49-156|Other Reason|2|||
147252945|NCT00293254|531098254|FG000|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|15|||
147252946|NCT00293254|531098255|FG001|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|7|||
147252947|NCT00293254|531098254|FG000|Extension - Open-Label Week 157-240|Adverse Event|2|||
147252948|NCT00293254|531098255|FG001|Extension - Open-Label Week 157-240|Adverse Event|1|||
147252949|NCT00293254|531098254|FG000|Extension - Open-Label Week 157-240|Lack of Efficacy|1|||
147252950|NCT00293254|531098255|FG001|Extension - Open-Label Week 157-240|Lack of Efficacy|0|||
147252951|NCT00293254|531098254|FG000|Extension - Open-Label Week 157-240|Withdrawal by Subject|1|||
147252952|NCT00293254|531098255|FG001|Extension - Open-Label Week 157-240|Withdrawal by Subject|0|||
147252953|NCT00293254|531098254|FG000|Extension - Open-Label Week 157-240|Lost to Follow-up|2|||
147252954|NCT00293254|531098255|FG001|Extension - Open-Label Week 157-240|Lost to Follow-up|0|||
147252955|NCT00293254|531098254|FG000|Extension - Open-Label Week 157-240|Other Reason|4|||
147252956|NCT00293254|531098255|FG001|Extension - Open-Label Week 157-240|Other Reason|0|||
147252957|NCT00293254|531098254|FG000|Open-Label Post Virologic Failure Phase|Adverse Event|4|||
147252958|NCT00293254|531098255|FG001|Open-Label Post Virologic Failure Phase|Adverse Event|7|||
147252959|NCT00293254|531098254|FG000|Open-Label Post Virologic Failure Phase|Lack of Efficacy|16|||
147252960|NCT00293254|531098255|FG001|Open-Label Post Virologic Failure Phase|Lack of Efficacy|14|||
147252961|NCT00293254|531098254|FG000|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|6|||
147252962|NCT00293254|531098255|FG001|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|3|||
147252963|NCT00293254|531098254|FG000|Open-Label Post Virologic Failure Phase|Lost to Follow-up|3|||
147252964|NCT00293254|531098255|FG001|Open-Label Post Virologic Failure Phase|Lost to Follow-up|0|||
147252965|NCT00293254|531098254|FG000|Open-Label Post Virologic Failure Phase|Participant Moved/Site Stopped Trial|1|||
147252966|NCT00293254|531098255|FG001|Open-Label Post Virologic Failure Phase|Participant Moved/Site Stopped Trial|1|||
147252967|NCT00293254|531098254|FG000|Open-Label Post Virologic Failure Phase|Other Reason|1|||
147252968|NCT00293254|531098255|FG001|Open-Label Post Virologic Failure Phase|Other Reason|2|||
147252969|NCT02259582|531098256|FG000|Overall Study|Physician Decision|0|||
147252970|NCT02259582|531098257|FG001|Overall Study|Physician Decision|1|||
147252971|NCT02259582|531098258|FG002|Overall Study|Physician Decision|0|||
147252972|NCT02259582|531098256|FG000|Overall Study|Death|0|||
147252973|NCT02259582|531098257|FG001|Overall Study|Death|0|||
147252974|NCT02259582|531098258|FG002|Overall Study|Death|1|||
147252975|NCT02259582|531098256|FG000|Overall Study|Adverse Event|1|||
147252976|NCT02259582|531098257|FG001|Overall Study|Adverse Event|0|||
147252977|NCT02259582|531098258|FG002|Overall Study|Adverse Event|1|||
147252978|NCT02259582|531098256|FG000|Overall Study|Withdrawal by Subject|0|||
147252979|NCT02259582|531098257|FG001|Overall Study|Withdrawal by Subject|0|||
147252980|NCT02259582|531098258|FG002|Overall Study|Withdrawal by Subject|1|||
147252981|NCT02259582|531098256|FG000|Overall Study|Disease progression|14|||
147252982|NCT02259582|531098257|FG001|Overall Study|Disease progression|15|||
147252983|NCT02259582|531098258|FG002|Overall Study|Disease progression|17|||
147252984|NCT02259582|531098256|FG000|Overall Study|Lack of Subject Adherence to Protocol|1|||
147252985|NCT02259582|531098257|FG001|Overall Study|Lack of Subject Adherence to Protocol|1|||
147252986|NCT02259582|531098258|FG002|Overall Study|Lack of Subject Adherence to Protocol|1|||
147598487|NCT01941940|532347891|FG000|Overall Study|Adverse Event|11|||
147598488|NCT01941940|532347891|FG000|Overall Study|Lost to Follow-up|2|||
147598489|NCT01941940|532347891|FG000|Overall Study|Physician Decision|2|||
147598490|NCT01941940|532347891|FG000|Overall Study|Withdrawal by Subject|15|||
147598491|NCT01941940|532347891|FG000|Overall Study|Death|1|||
147598492|NCT01941940|532347891|FG000|Overall Study|Other|1|||
147598493|NCT01941940|532347891|FG000|Overall Study|Other|1|||
147598494|NCT04394351|532349834|FG000|Part A (16 Weeks)|Adverse Event|1|||
147598495|NCT04394351|532349835|FG001|Part A (16 Weeks)|Adverse Event|0|||
147598496|NCT04394351|532349836|FG002|Part A (16 Weeks)|Adverse Event|0|||
147252987|NCT02335489|531098259|FG000|Overall Study|Sponsor terminated study|4|||
147252988|NCT02335489|531098259|FG000|Overall Study|Lost to Follow-up|1|||
147252989|NCT02335489|531098259|FG000|Overall Study|Withdrawal by Subject|2|||
147252990|NCT02335489|531098259|FG000|Overall Study|Physician Decision|2|||
147252991|NCT02335489|531098259|FG000|Overall Study|Lack of Efficacy|1|||
147252992|NCT00503308|531098266|FG000|Overall Study|Protocol Violation|2|||
147252993|NCT00503308|531098267|FG001|Overall Study|Protocol Violation|1|||
147252994|NCT00531050|531098269|FG000|Part 1: Period 1|Adverse Event|0|||
147332143|NCT01867580|531381017|FG000|Overall Study|Physician Decision|17|||
147598497|NCT04394351|532349837|FG003|Part A (16 Weeks)|Adverse Event|0|||
147598498|NCT04394351|532349838|FG004|Part A (16 Weeks)|Adverse Event|0|||
147598499|NCT04394351|532349839|FG005|Part A (16 Weeks)|Adverse Event|0|||
147598500|NCT04394351|532349840|FG006|Part A (16 Weeks)|Adverse Event|0|||
147598501|NCT04394351|532349841|FG007|Part A (16 Weeks)|Adverse Event|0|||
147598502|NCT04394351|532349834|FG000|Part A (16 Weeks)|Physician Decision|0|||
147252995|NCT00531050|531098270|FG001|Part 1: Period 1|Adverse Event|1|||
147252996|NCT00531050|531098271|FG002|Part 1: Period 1|Adverse Event|0|||
147252997|NCT00531050|531098272|FG003|Part 1: Period 1|Adverse Event|0|||
147252998|NCT00531050|531098273|FG004|Part 1: Period 1|Adverse Event|0|||
147252999|NCT00531050|531098274|FG005|Part 1: Period 1|Adverse Event|0|||
147253000|NCT00531050|531098269|FG000|Part 1: Period 1|Protocol Deviation|0|||
147253001|NCT00531050|531098270|FG001|Part 1: Period 1|Protocol Deviation|0|||
147253002|NCT00531050|531098271|FG002|Part 1: Period 1|Protocol Deviation|0|||
147253003|NCT00531050|531098272|FG003|Part 1: Period 1|Protocol Deviation|1|||
147253004|NCT00531050|531098273|FG004|Part 1: Period 1|Protocol Deviation|0|||
147332144|NCT01867580|531381018|FG001|Overall Study|Physician Decision|12|||
147332145|NCT01867580|531381017|FG000|Overall Study|Lost to Follow-up|3|||
147332146|NCT01867580|531381018|FG001|Overall Study|Lost to Follow-up|5|||
147332147|NCT01867580|531381017|FG000|Overall Study|Sponsor terminated study|1|||
147332148|NCT01867580|531381018|FG001|Overall Study|Sponsor terminated study|0|||
147332149|NCT01867580|531381017|FG000|Overall Study|Missed follow-up assessment|2|||
147332150|NCT01867580|531381018|FG001|Overall Study|Missed follow-up assessment|1|||
147332151|NCT01867580|531381017|FG000|Overall Study|Interruption to therapy|3|||
147332152|NCT01867580|531381018|FG001|Overall Study|Interruption to therapy|0|||
147332153|NCT01867580|531381017|FG000|Overall Study|Osteomyelitis|0|||
147332154|NCT01867580|531381018|FG001|Overall Study|Osteomyelitis|1|||
147332155|NCT01867580|531381017|FG000|Overall Study|Continuation of therapy|0|||
147332156|NCT01867580|531381018|FG001|Overall Study|Continuation of therapy|1|||
147332157|NCT01867580|531381017|FG000|Overall Study|Wound recurrence|0|||
147332158|NCT01867580|531381018|FG001|Overall Study|Wound recurrence|1|||
147332159|NCT01304147|531381019|FG000|Second Intervention (7days)|Withdrawal by Subject|1|||
147332160|NCT01304147|531381020|FG001|Second Intervention (7days)|Withdrawal by Subject|1|||
147332161|NCT01244828|531381021|FG000|Overall Study|Adverse Event|37|||
147332162|NCT01244828|531381021|FG000|Overall Study|Withdrawal by Subject|31|||
147332163|NCT01244828|531381021|FG000|Overall Study|Lack of Efficacy|7|||
147332164|NCT01244828|531381021|FG000|Overall Study|Lost to Follow-up|2|||
147332165|NCT01244828|531381021|FG000|Overall Study|Other reason (not specified)|1|||
147332166|NCT05233085|531381023|FG000|Overall Study|Adverse Event|1|||
147332167|NCT05233085|531381024|FG001|Overall Study|Adverse Event|0|||
147332168|NCT05233085|531381025|FG002|Overall Study|Adverse Event|0|||
147332169|NCT05233085|531381026|FG003|Overall Study|Adverse Event|0|||
147332170|NCT05052983|531381027|FG000|Overall Study|Lack of Efficacy|3|||
147332171|NCT05052983|531381028|FG001|Overall Study|Lack of Efficacy|12|||
147332172|NCT05052983|531381027|FG000|Overall Study|Adverse Event|1|||
147332173|NCT05052983|531381028|FG001|Overall Study|Adverse Event|0|||
147332174|NCT02812966|531381031|FG000|Overall Study|Death|1|||
147332175|NCT02812966|531381032|FG001|Overall Study|Death|0|||
147332176|NCT01066923|531381033|FG000|Overall Study|Withdrawal by Subject|3|||
147332177|NCT01066923|531381034|FG001|Overall Study|Withdrawal by Subject|3|||
147332178|NCT01066923|531381035|FG002|Overall Study|Withdrawal by Subject|8|||
147332179|NCT01066923|531381036|FG003|Overall Study|Withdrawal by Subject|8|||
147332180|NCT05147233|531383163|FG000|Overall Study|Adverse Event|0|||
147332181|NCT05147233|531383164|FG001|Overall Study|Adverse Event|1|||
147332182|NCT05147233|531383163|FG000|Overall Study|Lost to Follow-up|1|||
147332183|NCT05147233|531383164|FG001|Overall Study|Lost to Follow-up|1|||
147332184|NCT05147233|531383163|FG000|Overall Study|Protocol Violation|0|||
147332185|NCT05147233|531383164|FG001|Overall Study|Protocol Violation|1|||
147332186|NCT05147233|531383163|FG000|Overall Study|Withdrawal by Subject|2|||
147332187|NCT05147233|531383164|FG001|Overall Study|Withdrawal by Subject|1|||
147332188|NCT02577523|531383173|FG000|Overall Study|Adverse Event|1|||
147332189|NCT02577523|531383174|FG001|Overall Study|Adverse Event|1|||
147332190|NCT02577523|531383173|FG000|Overall Study|Lack of Efficacy|1|||
147332191|NCT02577523|531383174|FG001|Overall Study|Lack of Efficacy|1|||
147253005|NCT00531050|531098274|FG005|Part 1: Period 1|Protocol Deviation|0|||
147332192|NCT02577523|531383173|FG000|Overall Study|Withdrawal by Subject|1|||
147449960|NCT02669017|531811329|FG008|Overall Study|Lost to Follow-up|1|||
147598503|NCT04394351|532349835|FG001|Part A (16 Weeks)|Physician Decision|1|||
147598504|NCT04394351|532349836|FG002|Part A (16 Weeks)|Physician Decision|0|||
147598505|NCT04394351|532349837|FG003|Part A (16 Weeks)|Physician Decision|0|||
147253006|NCT00531050|531098269|FG000|Part 1: Period 3|Adverse Event|1|||
147332193|NCT02577523|531383174|FG001|Overall Study|Withdrawal by Subject|0|||
147332194|NCT00150176|531383176|FG000|Overall Study|Adverse Event|16|||
147332195|NCT00150176|531383177|FG001|Overall Study|Adverse Event|53|||
147332196|NCT00150176|531383176|FG000|Overall Study|Relapse/Impending relapse, non-AE|10|||
147332197|NCT00150176|531383177|FG001|Overall Study|Relapse/Impending relapse, non-AE|39|||
147332198|NCT00150176|531383176|FG000|Overall Study|Withdrawal by Subject|19|||
147332199|NCT00150176|531383177|FG001|Overall Study|Withdrawal by Subject|12|||
147332200|NCT00150176|531383176|FG000|Overall Study|Lost to Follow-up|3|||
147332201|NCT00150176|531383177|FG001|Overall Study|Lost to Follow-up|3|||
147332202|NCT00150176|531383176|FG000|Overall Study|OTHER|11|||
147332203|NCT00150176|531383177|FG001|Overall Study|OTHER|13|||
147332204|NCT02385669|531383178|FG000|Overall Study|Adverse Event|2|||
147332205|NCT02810080|531383179|FG000|Overall Study|Adverse Event|3|||
147253007|NCT00531050|531098270|FG001|Part 1: Period 3|Adverse Event|0|||
147253008|NCT00531050|531098271|FG002|Part 1: Period 3|Adverse Event|0|||
147253009|NCT00531050|531098272|FG003|Part 1: Period 3|Adverse Event|0|||
147253010|NCT00531050|531098273|FG004|Part 1: Period 3|Adverse Event|0|||
147253011|NCT00531050|531098274|FG005|Part 1: Period 3|Adverse Event|0|||
147253012|NCT00531050|531098269|FG000|Part 2: Period 1|Adverse Event|0|||
147253013|NCT00531050|531098270|FG001|Part 2: Period 1|Adverse Event|0|||
147253014|NCT00531050|531098271|FG002|Part 2: Period 1|Adverse Event|0|||
147253015|NCT00531050|531098272|FG003|Part 2: Period 1|Adverse Event|0|||
147253016|NCT00531050|531098273|FG004|Part 2: Period 1|Adverse Event|0|||
147253017|NCT00531050|531098274|FG005|Part 2: Period 1|Adverse Event|1|||
147253018|NCT00531050|531098269|FG000|Part 2: Period 3|Abnormal test procedure|1|||
147253019|NCT00531050|531098270|FG001|Part 2: Period 3|Abnormal test procedure|0|||
147253020|NCT00531050|531098271|FG002|Part 2: Period 3|Abnormal test procedure|0|||
147253021|NCT00531050|531098272|FG003|Part 2: Period 3|Abnormal test procedure|0|||
147253022|NCT00531050|531098273|FG004|Part 2: Period 3|Abnormal test procedure|0|||
147253023|NCT00531050|531098274|FG005|Part 2: Period 3|Abnormal test procedure|1|||
147253024|NCT02233309|531098277|FG000|Overall Study|Physician Decision|5|||
147253025|NCT00232817|531098281|FG000|Overall Study|Protocol Violation|2|||
147253026|NCT00232817|531098282|FG001|Overall Study|Protocol Violation|1|||
147253027|NCT00799487|531098283|FG000|Dose Adjustment Period|Lost to Follow-up|1|||
147253028|NCT00799487|531098284|FG001|Dose Adjustment Period|Lost to Follow-up|0|||
147253029|NCT00799487|531098285|FG002|Dose Adjustment Period|Lost to Follow-up|0|||
147253030|NCT00799487|531098283|FG000|Dose Adjustment Period|Adverse Event|2|||
147253031|NCT00799487|531098284|FG001|Dose Adjustment Period|Adverse Event|0|||
147253032|NCT00799487|531098285|FG002|Dose Adjustment Period|Adverse Event|0|||
147253033|NCT00799487|531098283|FG000|Dose Adjustment Period|Optimal Dose Not Achieved|8|||
147253034|NCT00799487|531098284|FG001|Dose Adjustment Period|Optimal Dose Not Achieved|0|||
147253035|NCT00799487|531098285|FG002|Dose Adjustment Period|Optimal Dose Not Achieved|0|||
147253036|NCT00799487|531098283|FG000|Dose Adjustment Period|Investigator Discretion|2|||
147253037|NCT00799487|531098284|FG001|Dose Adjustment Period|Investigator Discretion|0|||
147253038|NCT00799487|531098285|FG002|Dose Adjustment Period|Investigator Discretion|0|||
147253039|NCT00799487|531098283|FG000|Dose Adjustment Period|Withdrawal by Subject|3|||
147253040|NCT00799487|531098284|FG001|Dose Adjustment Period|Withdrawal by Subject|0|||
147253041|NCT00799487|531098285|FG002|Dose Adjustment Period|Withdrawal by Subject|0|||
147253042|NCT00799487|531098283|FG000|Dose Adjustment Period|Parent to home school child (exclusion)|1|||
147253043|NCT00799487|531098284|FG001|Dose Adjustment Period|Parent to home school child (exclusion)|0|||
147253044|NCT00799487|531098285|FG002|Dose Adjustment Period|Parent to home school child (exclusion)|0|||
147253045|NCT00799487|531098283|FG000|Dose Adjustment Period|Child too young (exclusion)|1|||
147253046|NCT00799487|531098284|FG001|Dose Adjustment Period|Child too young (exclusion)|0|||
147253047|NCT00799487|531098285|FG002|Dose Adjustment Period|Child too young (exclusion)|0|||
147253048|NCT00799487|531098283|FG000|Dose Adjustment Period|Missed laboratory day 1|1|||
147253049|NCT00799487|531098284|FG001|Dose Adjustment Period|Missed laboratory day 1|0|||
147253050|NCT00799487|531098285|FG002|Dose Adjustment Period|Missed laboratory day 1|0|||
147253051|NCT00799487|531098283|FG000|Dose Adjustment Period|ADHD RS-IV rating scale >85th percentile|2|||
147253052|NCT00799487|531098284|FG001|Dose Adjustment Period|ADHD RS-IV rating scale >85th percentile|0|||
147253053|NCT00799487|531098285|FG002|Dose Adjustment Period|ADHD RS-IV rating scale >85th percentile|0|||
147253054|NCT00799487|531098283|FG000|Double-Blind Assessment Period|Lost to Follow-up|0|||
147253055|NCT00799487|531098284|FG001|Double-Blind Assessment Period|Lost to Follow-up|0|||
147253056|NCT00799487|531098285|FG002|Double-Blind Assessment Period|Lost to Follow-up|1|||
147253057|NCT00799487|531098283|FG000|Double-Blind Assessment Period|Subject was out of the state|0|||
147253058|NCT00799487|531098284|FG001|Double-Blind Assessment Period|Subject was out of the state|0|||
147253059|NCT00799487|531098285|FG002|Double-Blind Assessment Period|Subject was out of the state|1|||
147253060|NCT00799487|531098283|FG000|Double-Blind Assessment Period|Overslept and missed lab day 2|0|||
147253061|NCT00799487|531098284|FG001|Double-Blind Assessment Period|Overslept and missed lab day 2|1|||
147253062|NCT00799487|531098285|FG002|Double-Blind Assessment Period|Overslept and missed lab day 2|0|||
147253063|NCT04481750|531098286|FG000|Period 1 (Fasted)|Adverse Event|0|||
147253064|NCT04481750|531098287|FG001|Period 1 (Fasted)|Adverse Event|0|||
147253065|NCT04481750|531098288|FG002|Period 1 (Fasted)|Adverse Event|1|||
147253066|NCT04481750|531098289|FG003|Period 1 (Fasted)|Adverse Event|0|||
147253067|NCT04481750|531098290|FG004|Period 1 (Fasted)|Adverse Event|0|||
147253068|NCT04481750|531098291|FG005|Period 1 (Fasted)|Adverse Event|0|||
147253069|NCT04481750|531098292|FG006|Period 1 (Fasted)|Adverse Event|0|||
147253070|NCT04481750|531098293|FG007|Period 1 (Fasted)|Adverse Event|0|||
147253071|NCT04481750|531098294|FG008|Period 1 (Fasted)|Adverse Event|0|||
147253072|NCT04481750|531098295|FG009|Period 1 (Fasted)|Adverse Event|0|||
147253073|NCT04481750|531098296|FG010|Period 1 (Fasted)|Adverse Event|0|||
147253074|NCT03263442|531098297|FG000|Inpatient Phase|Death|1|||
147253075|NCT03263442|531098298|FG001|Inpatient Phase|Death|0|||
147253076|NCT03263442|531098297|FG000|Inpatient Phase|Withdrawal by Subject|1|||
147253077|NCT03263442|531098298|FG001|Inpatient Phase|Withdrawal by Subject|0|||
147253078|NCT03263442|531098297|FG000|Inpatient Phase|Inadequate Drug Exposure|0|||
147253079|NCT03263442|531098298|FG001|Inpatient Phase|Inadequate Drug Exposure|1|||
147253080|NCT03263442|531098297|FG000|1-month Follow-Up|Lost to Follow-up|1|||
147253081|NCT03263442|531098298|FG001|1-month Follow-Up|Lost to Follow-up|0|||
147253082|NCT03263442|531098297|FG000|3-month Follow-Up|Lost to Follow-up|1|||
147253083|NCT03263442|531098298|FG001|3-month Follow-Up|Lost to Follow-up|3|||
147253084|NCT03263442|531098297|FG000|6-month Follow-Up|Lost to Follow-up|2|||
147253085|NCT03263442|531098298|FG001|6-month Follow-Up|Lost to Follow-up|2|||
147253086|NCT01463878|531098299|FG000|Overall Study|no longer met criteria for tube feed|2|||
147253087|NCT01463878|531098300|FG001|Overall Study|no longer met criteria for tube feed|2|||
147253088|NCT03804879|531098301|FG000|Overall Study|Adverse Event|3|||
147253089|NCT03804879|531098302|FG001|Overall Study|Adverse Event|0|||
147253090|NCT03804879|531098301|FG000|Overall Study|Study Terminated By Sponsor|10|||
147253091|NCT03804879|531098302|FG001|Overall Study|Study Terminated By Sponsor|12|||
147253092|NCT03804879|531098301|FG000|Overall Study|Withdrawal by Subject|3|||
147253093|NCT03804879|531098302|FG001|Overall Study|Withdrawal by Subject|1|||
147253094|NCT02436889|531098303|FG000|Overall Study|No improvement in symptoms|1|||
147253095|NCT02436889|531098304|FG001|Overall Study|No improvement in symptoms|0|||
147253096|NCT02436889|531098303|FG000|Overall Study|Does not like/could not tolerate medicat|0|||
147253097|NCT02436889|531098304|FG001|Overall Study|Does not like/could not tolerate medicat|1|||
147253098|NCT01034462|531098305|FG000|Overall Study|Adverse Event|7|||
147253099|NCT01034462|531098306|FG001|Overall Study|Adverse Event|17|||
147253100|NCT01034462|531098305|FG000|Overall Study|Lack of Efficacy|4|||
147253101|NCT01034462|531098306|FG001|Overall Study|Lack of Efficacy|4|||
147253102|NCT01034462|531098305|FG000|Overall Study|Protocol Violation|10|||
147253103|NCT01034462|531098306|FG001|Overall Study|Protocol Violation|7|||
147253104|NCT01034462|531098305|FG000|Overall Study|Withdrawal by Subject|9|||
147253105|NCT01034462|531098306|FG001|Overall Study|Withdrawal by Subject|8|||
147253106|NCT01034462|531098305|FG000|Overall Study|Lost to Follow-up|14|||
147253107|NCT01034462|531098306|FG001|Overall Study|Lost to Follow-up|16|||
147253108|NCT01034462|531098305|FG000|Overall Study|Other reasons|1|||
147253109|NCT01034462|531098306|FG001|Overall Study|Other reasons|2|||
147253110|NCT00708643|531098307|FG000|Overall Study|Adverse Event|0|||
147253111|NCT00708643|531098308|FG001|Overall Study|Adverse Event|1|||
147253112|NCT00227903|531098309|FG000|Overall Study|Withdrawal by Subject|2|||
147253113|NCT00227903|531098310|FG001|Overall Study|Withdrawal by Subject|5|||
147253114|NCT00227903|531098309|FG000|Overall Study|Subject moved out of area|1|||
147253115|NCT00227903|531098310|FG001|Overall Study|Subject moved out of area|2|||
147253116|NCT00227903|531098309|FG000|Overall Study|Lost to Follow-up|1|||
147253117|NCT00227903|531098310|FG001|Overall Study|Lost to Follow-up|3|||
147253118|NCT00227903|531098309|FG000|Overall Study|Miscarriage|1|||
147253119|NCT00227903|531098310|FG001|Overall Study|Miscarriage|0|||
147253120|NCT04273217|531098311|FG000|Overall Study|Lost to Follow-up|0|||
147253121|NCT04273217|531098312|FG001|Overall Study|Lost to Follow-up|0|||
147253122|NCT04273217|531098313|FG002|Overall Study|Lost to Follow-up|0|||
147253123|NCT04273217|531098314|FG003|Overall Study|Lost to Follow-up|0|||
147253124|NCT04273217|531098315|FG004|Overall Study|Lost to Follow-up|0|||
147253125|NCT04273217|531098316|FG005|Overall Study|Lost to Follow-up|1|||
147253126|NCT04273217|531098311|FG000|Overall Study|Participant non-compliance|0|||
147253127|NCT04273217|531098312|FG001|Overall Study|Participant non-compliance|0|||
147253128|NCT04273217|531098313|FG002|Overall Study|Participant non-compliance|0|||
147253129|NCT04273217|531098314|FG003|Overall Study|Participant non-compliance|0|||
147253130|NCT04273217|531098315|FG004|Overall Study|Participant non-compliance|1|||
147253131|NCT04273217|531098316|FG005|Overall Study|Participant non-compliance|0|||
147253132|NCT04273217|531098311|FG000|Overall Study|Positive urine drug screen|1|||
147253133|NCT04273217|531098312|FG001|Overall Study|Positive urine drug screen|0|||
147253134|NCT04273217|531098313|FG002|Overall Study|Positive urine drug screen|1|||
147253135|NCT04273217|531098314|FG003|Overall Study|Positive urine drug screen|0|||
147253136|NCT04273217|531098315|FG004|Overall Study|Positive urine drug screen|0|||
147253137|NCT04273217|531098316|FG005|Overall Study|Positive urine drug screen|1|||
147253138|NCT03720470|531098319|FG000|Treatment Period: First Part 16 Weeks|Adverse Event|5|||
147253139|NCT03720470|531098320|FG001|Treatment Period: First Part 16 Weeks|Adverse Event|0|||
147253140|NCT03720470|531098321|FG002|Treatment Period: First Part 16 Weeks|Adverse Event|0|||
147253141|NCT03720470|531098322|FG003|Treatment Period: First Part 16 Weeks|Adverse Event|5|||
147598506|NCT04394351|532349838|FG004|Part A (16 Weeks)|Physician Decision|0|||
147253142|NCT03720470|531098323|FG004|Treatment Period: First Part 16 Weeks|Adverse Event|8|||
147253143|NCT03720470|531098324|FG005|Treatment Period: First Part 16 Weeks|Adverse Event|6|||
147253144|NCT03720470|531098319|FG000|Treatment Period: First Part 16 Weeks|Lack of Efficacy|0|||
147253145|NCT03720470|531098320|FG001|Treatment Period: First Part 16 Weeks|Lack of Efficacy|0|||
147253146|NCT03720470|531098321|FG002|Treatment Period: First Part 16 Weeks|Lack of Efficacy|0|||
147253147|NCT03720470|531098322|FG003|Treatment Period: First Part 16 Weeks|Lack of Efficacy|1|||
147253148|NCT03720470|531098323|FG004|Treatment Period: First Part 16 Weeks|Lack of Efficacy|0|||
147253149|NCT03720470|531098324|FG005|Treatment Period: First Part 16 Weeks|Lack of Efficacy|1|||
147253150|NCT03720470|531098319|FG000|Treatment Period: First Part 16 Weeks|Lost to Follow-up|1|||
147253151|NCT03720470|531098320|FG001|Treatment Period: First Part 16 Weeks|Lost to Follow-up|0|||
147253152|NCT03720470|531098321|FG002|Treatment Period: First Part 16 Weeks|Lost to Follow-up|0|||
147253153|NCT03720470|531098322|FG003|Treatment Period: First Part 16 Weeks|Lost to Follow-up|2|||
147253154|NCT03720470|531098323|FG004|Treatment Period: First Part 16 Weeks|Lost to Follow-up|1|||
147253155|NCT03720470|531098324|FG005|Treatment Period: First Part 16 Weeks|Lost to Follow-up|2|||
147253156|NCT03720470|531098319|FG000|Treatment Period: First Part 16 Weeks|Pregnancy|0|||
147253157|NCT03720470|531098320|FG001|Treatment Period: First Part 16 Weeks|Pregnancy|0|||
147253158|NCT03720470|531098321|FG002|Treatment Period: First Part 16 Weeks|Pregnancy|0|||
147253159|NCT03720470|531098322|FG003|Treatment Period: First Part 16 Weeks|Pregnancy|0|||
147253160|NCT03720470|531098323|FG004|Treatment Period: First Part 16 Weeks|Pregnancy|1|||
147253161|NCT03720470|531098324|FG005|Treatment Period: First Part 16 Weeks|Pregnancy|1|||
147253162|NCT03720470|531098319|FG000|Treatment Period: First Part 16 Weeks|Protocol deviation|2|||
147253163|NCT03720470|531098320|FG001|Treatment Period: First Part 16 Weeks|Protocol deviation|0|||
147253164|NCT03720470|531098321|FG002|Treatment Period: First Part 16 Weeks|Protocol deviation|0|||
147253165|NCT03720470|531098322|FG003|Treatment Period: First Part 16 Weeks|Protocol deviation|2|||
147253166|NCT03720470|531098323|FG004|Treatment Period: First Part 16 Weeks|Protocol deviation|2|||
147253167|NCT03720470|531098324|FG005|Treatment Period: First Part 16 Weeks|Protocol deviation|1|||
147253168|NCT03720470|531098319|FG000|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|5|||
147253169|NCT03720470|531098320|FG001|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|0|||
147253170|NCT03720470|531098321|FG002|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|0|||
147253171|NCT03720470|531098322|FG003|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|9|||
147253172|NCT03720470|531098323|FG004|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|3|||
147253173|NCT03720470|531098324|FG005|Treatment Period: First Part 16 Weeks|Withdrawal by Subject|6|||
147253174|NCT03720470|531098319|FG000|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|0|||
147253175|NCT03720470|531098320|FG001|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|0|||
147253176|NCT03720470|531098321|FG002|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|0|||
147253177|NCT03720470|531098322|FG003|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|1|||
147253178|NCT03720470|531098323|FG004|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|1|||
147253179|NCT03720470|531098324|FG005|Treatment Period: First Part 16 Weeks|Medication Error Without Associated Adverse Event|0|||
147253180|NCT03720470|531098319|FG000|Treatment Period: First Part 16 Weeks|Other|1|||
147253181|NCT03720470|531098320|FG001|Treatment Period: First Part 16 Weeks|Other|0|||
147253182|NCT03720470|531098321|FG002|Treatment Period: First Part 16 Weeks|Other|0|||
147253183|NCT03720470|531098322|FG003|Treatment Period: First Part 16 Weeks|Other|1|||
147253184|NCT03720470|531098323|FG004|Treatment Period: First Part 16 Weeks|Other|2|||
147253185|NCT03720470|531098324|FG005|Treatment Period: First Part 16 Weeks|Other|2|||
147253186|NCT03720470|531098319|FG000|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0|||
147253187|NCT03720470|531098320|FG001|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0|||
147253188|NCT03720470|531098321|FG002|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0|||
147253189|NCT03720470|531098322|FG003|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0|||
147253190|NCT03720470|531098323|FG004|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|0|||
147253191|NCT03720470|531098324|FG005|Treatment Period: First Part 16 Weeks|Randomized But Not Treated|1|||
147253192|NCT03720470|531098319|FG000|Treatment Period: Final 4 Weeks|Adverse Event|0|||
147253193|NCT03720470|531098320|FG001|Treatment Period: Final 4 Weeks|Adverse Event|0|||
147253194|NCT03720470|531098321|FG002|Treatment Period: Final 4 Weeks|Adverse Event|0|||
147253195|NCT03720470|531098322|FG003|Treatment Period: Final 4 Weeks|Adverse Event|2|||
147253196|NCT03720470|531098323|FG004|Treatment Period: Final 4 Weeks|Adverse Event|1|||
147253197|NCT03720470|531098324|FG005|Treatment Period: Final 4 Weeks|Adverse Event|1|||
147253198|NCT03720470|531098319|FG000|Treatment Period: Final 4 Weeks|Lack of Efficacy|0|||
147253199|NCT03720470|531098320|FG001|Treatment Period: Final 4 Weeks|Lack of Efficacy|0|||
147253200|NCT03720470|531098321|FG002|Treatment Period: Final 4 Weeks|Lack of Efficacy|1|||
147253201|NCT03720470|531098322|FG003|Treatment Period: Final 4 Weeks|Lack of Efficacy|0|||
147253202|NCT03720470|531098323|FG004|Treatment Period: Final 4 Weeks|Lack of Efficacy|0|||
147253203|NCT03720470|531098324|FG005|Treatment Period: Final 4 Weeks|Lack of Efficacy|0|||
147253204|NCT03720470|531098319|FG000|Treatment Period: Final 4 Weeks|Lost to Follow-up|0|||
147332206|NCT02810080|531383180|FG001|Overall Study|Adverse Event|0|||
147332207|NCT02810080|531383179|FG000|Overall Study|Death|0|||
147332208|NCT02810080|531383180|FG001|Overall Study|Death|2|||
147332209|NCT02810080|531383179|FG000|Overall Study|Physician Decision|4|||
147332210|NCT02810080|531383180|FG001|Overall Study|Physician Decision|0|||
147253205|NCT03720470|531098320|FG001|Treatment Period: Final 4 Weeks|Lost to Follow-up|0|||
147253206|NCT03720470|531098321|FG002|Treatment Period: Final 4 Weeks|Lost to Follow-up|0|||
147253207|NCT03720470|531098322|FG003|Treatment Period: Final 4 Weeks|Lost to Follow-up|1|||
147253208|NCT03720470|531098323|FG004|Treatment Period: Final 4 Weeks|Lost to Follow-up|0|||
147253209|NCT03720470|531098324|FG005|Treatment Period: Final 4 Weeks|Lost to Follow-up|1|||
147332211|NCT02810080|531383179|FG000|Overall Study|Withdrawal by Subject|0|||
147253210|NCT03720470|531098319|FG000|Treatment Period: Final 4 Weeks|Pregnancy|0|||
147253211|NCT03720470|531098320|FG001|Treatment Period: Final 4 Weeks|Pregnancy|0|||
147332212|NCT02810080|531383180|FG001|Overall Study|Withdrawal by Subject|2|||
147332213|NCT03923491|531383181|FG000|Overall Study|Lost to Follow-up|5|||
147332214|NCT03923491|531383182|FG001|Overall Study|Lost to Follow-up|8|||
147332215|NCT03923491|531383181|FG000|Overall Study|Withdrawal by Subject|4|||
147332216|NCT03923491|531383182|FG001|Overall Study|Withdrawal by Subject|6|||
147332217|NCT00753012|531383184|FG000|Overall Study|Ineligible, abnormal cardiac histo|1|||
147332218|NCT00753012|531383185|FG001|Overall Study|Ineligible, abnormal cardiac histo|0|||
147332219|NCT00753012|531383184|FG000|Overall Study|Adverse Event|2|||
147332220|NCT00753012|531383185|FG001|Overall Study|Adverse Event|0|||
147332221|NCT00753012|531383184|FG000|Overall Study|Withdrawal by Subject|0|||
147332222|NCT00753012|531383185|FG001|Overall Study|Withdrawal by Subject|1|||
147332223|NCT00753012|531383184|FG000|Overall Study|Lost to Follow-up|4|||
147332224|NCT00753012|531383185|FG001|Overall Study|Lost to Follow-up|0|||
147332225|NCT00753012|531383184|FG000|Overall Study|Confounded endpoint data|1|||
147332226|NCT00753012|531383185|FG001|Overall Study|Confounded endpoint data|0|||
147332227|NCT01027286|531383186|FG000|Overall Study|Unable to Obtain Required Blood Volume|1|||
147332228|NCT01027286|531383187|FG001|Overall Study|Unable to Obtain Required Blood Volume|0|||
147332229|NCT01027286|531383186|FG000|Overall Study|Lost to Follow-up|0|||
147332230|NCT01027286|531383187|FG001|Overall Study|Lost to Follow-up|1|||
147332231|NCT00545844|531383188|FG000|Overall Study|Lost to Follow-up|9|||
147332232|NCT00545844|531383188|FG000|Overall Study|Protocol Violation|1|||
147332233|NCT00545844|531383188|FG000|Overall Study|Withdrawal by Subject|2|||
147253212|NCT03720470|531098321|FG002|Treatment Period: Final 4 Weeks|Pregnancy|0|||
147253213|NCT03720470|531098322|FG003|Treatment Period: Final 4 Weeks|Pregnancy|0|||
147598507|NCT04394351|532349839|FG005|Part A (16 Weeks)|Physician Decision|0|||
147253214|NCT03720470|531098323|FG004|Treatment Period: Final 4 Weeks|Pregnancy|0|||
147253215|NCT03720470|531098324|FG005|Treatment Period: Final 4 Weeks|Pregnancy|1|||
147253216|NCT03720470|531098319|FG000|Treatment Period: Final 4 Weeks|Protocol Deviation|0|||
147253217|NCT03720470|531098320|FG001|Treatment Period: Final 4 Weeks|Protocol Deviation|0|||
147253218|NCT03720470|531098321|FG002|Treatment Period: Final 4 Weeks|Protocol Deviation|1|||
147253219|NCT03720470|531098322|FG003|Treatment Period: Final 4 Weeks|Protocol Deviation|0|||
147253220|NCT03720470|531098323|FG004|Treatment Period: Final 4 Weeks|Protocol Deviation|0|||
147253221|NCT03720470|531098324|FG005|Treatment Period: Final 4 Weeks|Protocol Deviation|0|||
147253222|NCT03720470|531098319|FG000|Treatment Period: Final 4 Weeks|Withdrawal by Subject|0|||
147253223|NCT03720470|531098320|FG001|Treatment Period: Final 4 Weeks|Withdrawal by Subject|1|||
147253224|NCT03720470|531098321|FG002|Treatment Period: Final 4 Weeks|Withdrawal by Subject|0|||
147253225|NCT03720470|531098322|FG003|Treatment Period: Final 4 Weeks|Withdrawal by Subject|2|||
147253226|NCT03720470|531098323|FG004|Treatment Period: Final 4 Weeks|Withdrawal by Subject|2|||
147253227|NCT03720470|531098324|FG005|Treatment Period: Final 4 Weeks|Withdrawal by Subject|2|||
147253228|NCT03720470|531098319|FG000|Treatment Period: Final 4 Weeks|Other|0|||
147253229|NCT03720470|531098320|FG001|Treatment Period: Final 4 Weeks|Other|1|||
147253230|NCT03720470|531098321|FG002|Treatment Period: Final 4 Weeks|Other|0|||
147253231|NCT03720470|531098322|FG003|Treatment Period: Final 4 Weeks|Other|2|||
147253232|NCT03720470|531098323|FG004|Treatment Period: Final 4 Weeks|Other|1|||
147253233|NCT03720470|531098324|FG005|Treatment Period: Final 4 Weeks|Other|0|||
147253234|NCT06079320|531098327|FG000|Follow up Phase|Lost to Follow-up|1|||
147253235|NCT06079320|531098328|FG001|Follow up Phase|Lost to Follow-up|0|||
147253236|NCT03428360|531098329|FG000|Overall Study|Informed consent withdrawn|5|||
147253237|NCT03428360|531098329|FG000|Overall Study|Withdrawal by Subject|4|||
147253238|NCT03428360|531098329|FG000|Overall Study|Lost to Follow-up|5|||
147253239|NCT03428360|531098329|FG000|Overall Study|Physician Decision|2|||
147253240|NCT03428360|531098329|FG000|Overall Study|Informed consent withdrawn|5|||
147253241|NCT03428360|531098329|FG000|Overall Study|Study terminated by sponsor|10|||
147253242|NCT03428360|531098329|FG000|Overall Study|Non-compliant with study|1|||
147332234|NCT00094809|531383189|FG000|Overall Study|Protocol deviation|2|||
147332235|NCT00094809|531383190|FG001|Overall Study|Protocol deviation|2|||
147332236|NCT00094809|531383189|FG000|Overall Study|Noncompliance|1|||
147332237|NCT00094809|531383190|FG001|Overall Study|Noncompliance|0|||
147332238|NCT00094809|531383189|FG000|Overall Study|Adverse Event|3|||
147253243|NCT03428360|531098329|FG000|Overall Study|Non-compliant with study drug|3|||
147253244|NCT03428360|531098329|FG000|Overall Study|Death|3|||
147253245|NCT03428360|531098329|FG000|Overall Study|Adverse Event|1|||
147253246|NCT03428360|531098329|FG000|Overall Study|Not on antiepileptic drug|1|||
147253247|NCT01414855|531098332|FG000|Overall Study|Death|17|||
147253248|NCT01414855|531098332|FG000|Overall Study|Lost to Follow-up|5|||
147253249|NCT01414855|531098332|FG000|Overall Study|Withdrawal by Subject|7|||
147253250|NCT04851314|531098333|FG000|Overall Study|Unable to complete research set-up procedures|0|||
147253251|NCT04851314|531098334|FG001|Overall Study|Unable to complete research set-up procedures|2|||
147332239|NCT00094809|531383190|FG001|Overall Study|Adverse Event|1|||
147332240|NCT00094809|531383189|FG000|Overall Study|Withdrawal by Subject|8|||
147332241|NCT00094809|531383190|FG001|Overall Study|Withdrawal by Subject|9|||
147332242|NCT00094809|531383189|FG000|Overall Study|Disease progression|3|||
147332243|NCT00094809|531383190|FG001|Overall Study|Disease progression|3|||
147598508|NCT04394351|532349840|FG006|Part A (16 Weeks)|Physician Decision|0|||
147332244|NCT00094809|531383189|FG000|Overall Study|Physician Decision|3|||
147332245|NCT00094809|531383190|FG001|Overall Study|Physician Decision|5|||
147598509|NCT04394351|532349841|FG007|Part A (16 Weeks)|Physician Decision|0|||
147598510|NCT04394351|532349834|FG000|Part A (16 Weeks)|Withdrawal by Subject|0|||
147598511|NCT04394351|532349835|FG001|Part A (16 Weeks)|Withdrawal by Subject|1|||
147598512|NCT04394351|532349836|FG002|Part A (16 Weeks)|Withdrawal by Subject|0|||
147598513|NCT04394351|532349837|FG003|Part A (16 Weeks)|Withdrawal by Subject|0|||
147598514|NCT04394351|532349838|FG004|Part A (16 Weeks)|Withdrawal by Subject|0|||
147253252|NCT04851314|531098333|FG000|Overall Study|Change in Anesthesia Plan (patient no longer meets inclusion criteria)|3|||
147253253|NCT04851314|531098334|FG001|Overall Study|Change in Anesthesia Plan (patient no longer meets inclusion criteria)|2|||
147253254|NCT03266094|531098337|FG000|Overall Study|Lost to Follow-up|1|||
147253255|NCT03266094|531098337|FG000|Overall Study|Withdrawal by Subject|1|||
147253256|NCT00368355|531098338|FG000|Overall Study|Adverse Event|1|||
147253257|NCT00368355|531098339|FG001|Overall Study|Adverse Event|0|||
147253258|NCT00368355|531098338|FG000|Overall Study|Death|2|||
147253259|NCT00368355|531098339|FG001|Overall Study|Death|4|||
147253260|NCT00368355|531098338|FG000|Overall Study|Relapse|6|||
147253261|NCT00368355|531098339|FG001|Overall Study|Relapse|10|||
147253262|NCT00368355|531098338|FG000|Overall Study|Subsequent transplant|0|||
147253263|NCT00368355|531098339|FG001|Overall Study|Subsequent transplant|3|||
147253264|NCT00368355|531098338|FG000|Overall Study|Treatment - hematopoietic cell product|2|||
147253265|NCT00368355|531098339|FG001|Overall Study|Treatment - hematopoietic cell product|0|||
147253266|NCT03473808|531098344|FG000|Overall Study|Withdrawal by Subject|1|||
147253267|NCT03171415|531098345|FG000|Overall Study|Lost to Follow-up|0|||
147253268|NCT03171415|531098346|FG001|Overall Study|Lost to Follow-up|0|||
147253269|NCT03171415|531098347|FG002|Overall Study|Lost to Follow-up|0|||
147253270|NCT03171415|531098348|FG003|Overall Study|Lost to Follow-up|0|||
147253271|NCT03171415|531098349|FG004|Overall Study|Lost to Follow-up|2|||
147253272|NCT04059094|531098350|FG000|Overall Study|Adverse Event|0|||
147253273|NCT04059094|531098351|FG001|Overall Study|Adverse Event|0|||
147253274|NCT04059094|531098352|FG002|Overall Study|Adverse Event|0|||
147253275|NCT04059094|531098353|FG003|Overall Study|Adverse Event|0|||
147253276|NCT04059094|531098354|FG004|Overall Study|Adverse Event|1|||
147253277|NCT04059094|531098350|FG000|Overall Study|Not willing to travel due to COVID-19 pandemic|0|||
147253278|NCT04059094|531098351|FG001|Overall Study|Not willing to travel due to COVID-19 pandemic|2|||
147253279|NCT04059094|531098352|FG002|Overall Study|Not willing to travel due to COVID-19 pandemic|0|||
147253280|NCT04059094|531098353|FG003|Overall Study|Not willing to travel due to COVID-19 pandemic|0|||
147253281|NCT04059094|531098354|FG004|Overall Study|Not willing to travel due to COVID-19 pandemic|0|||
147253282|NCT01339429|531098355|FG000|Overall Study|Withdrawal by Subject|1|||
147253283|NCT01339429|531098355|FG000|Overall Study|Physician Decision|3|||
147253284|NCT01085591|531098362|FG000|Overall Study|Adverse Event|0|||
147253285|NCT01085591|531098363|FG001|Overall Study|Adverse Event|1|||
147253286|NCT01085591|531098364|FG002|Overall Study|Adverse Event|3|||
147253287|NCT01085591|531098362|FG000|Overall Study|Physician Decision|1|||
147253288|NCT01085591|531098363|FG001|Overall Study|Physician Decision|0|||
147253289|NCT01085591|531098364|FG002|Overall Study|Physician Decision|1|||
147253290|NCT01085591|531098362|FG000|Overall Study|Withdrawal by Subject|0|||
147253291|NCT01085591|531098363|FG001|Overall Study|Withdrawal by Subject|2|||
147253292|NCT01085591|531098364|FG002|Overall Study|Withdrawal by Subject|1|||
147253293|NCT01085591|531098362|FG000|Overall Study|Lost to Follow-up|0|||
147253294|NCT01085591|531098363|FG001|Overall Study|Lost to Follow-up|1|||
147253295|NCT01085591|531098364|FG002|Overall Study|Lost to Follow-up|1|||
147253296|NCT01085591|531098362|FG000|Overall Study|Protocol Violation|1|||
147253297|NCT01085591|531098363|FG001|Overall Study|Protocol Violation|1|||
147253298|NCT01085591|531098364|FG002|Overall Study|Protocol Violation|1|||
147253299|NCT01085591|531098362|FG000|Overall Study|Other|0|||
147253300|NCT01085591|531098363|FG001|Overall Study|Other|1|||
147253301|NCT01085591|531098364|FG002|Overall Study|Other|0|||
147253302|NCT01085591|531098362|FG000|Overall Study|Not Properly Consented|1|||
147253303|NCT01085591|531098363|FG001|Overall Study|Not Properly Consented|0|||
147253304|NCT01085591|531098364|FG002|Overall Study|Not Properly Consented|0|||
147253305|NCT00459667|531098367|FG000|Overall Study|Adverse Event|9|||
147253306|NCT00459667|531098368|FG001|Overall Study|Adverse Event|12|||
147253307|NCT00459667|531098369|FG002|Overall Study|Adverse Event|8|||
147253308|NCT00459667|531098367|FG000|Overall Study|Lost to Follow-up|5|||
147253309|NCT00459667|531098368|FG001|Overall Study|Lost to Follow-up|9|||
147253310|NCT00459667|531098369|FG002|Overall Study|Lost to Follow-up|3|||
147253311|NCT00459667|531098367|FG000|Overall Study|Pregnancy|1|||
147253312|NCT00459667|531098368|FG001|Overall Study|Pregnancy|1|||
147253313|NCT00459667|531098369|FG002|Overall Study|Pregnancy|1|||
147598515|NCT04394351|532349839|FG005|Part A (16 Weeks)|Withdrawal by Subject|0|||
147598516|NCT04394351|532349840|FG006|Part A (16 Weeks)|Withdrawal by Subject|0|||
147253314|NCT00459667|531098367|FG000|Overall Study|Protocol Violation|1|||
147253315|NCT00459667|531098368|FG001|Overall Study|Protocol Violation|0|||
147253316|NCT00459667|531098369|FG002|Overall Study|Protocol Violation|0|||
147253317|NCT00459667|531098367|FG000|Overall Study|Withdrawal by Subject|3|||
147253318|NCT00459667|531098368|FG001|Overall Study|Withdrawal by Subject|5|||
147253319|NCT00459667|531098369|FG002|Overall Study|Withdrawal by Subject|5|||
147253320|NCT00459667|531098367|FG000|Overall Study|Other disease modifying treatment|1|||
147253321|NCT00459667|531098368|FG001|Overall Study|Other disease modifying treatment|2|||
147253322|NCT00459667|531098369|FG002|Overall Study|Other disease modifying treatment|1|||
147253323|NCT00459667|531098367|FG000|Overall Study|Other reason (incl. 2 missing subjects)|12|||
147253324|NCT00459667|531098368|FG001|Overall Study|Other reason (incl. 2 missing subjects)|15|||
147253325|NCT00459667|531098369|FG002|Overall Study|Other reason (incl. 2 missing subjects)|1|||
147253326|NCT00459667|531098367|FG000|Overall Study|No treatment administered|6|||
147253327|NCT00459667|531098368|FG001|Overall Study|No treatment administered|3|||
147253328|NCT00459667|531098369|FG002|Overall Study|No treatment administered|1|||
147253329|NCT00396591|531098370|FG000|Overall Study|Disease Progression|13|||
147253330|NCT00396591|531098370|FG000|Overall Study|Adverse Event|2|||
147253331|NCT00396591|531098370|FG000|Overall Study|Participant request|1|||
147253332|NCT03851302|531098378|FG000|Screening (1 Day)|Withdrawal by Subject|0|||
147253333|NCT03851302|531098379|FG001|Screening (1 Day)|Withdrawal by Subject|0|||
147253334|NCT03851302|531098380|FG002|Screening (1 Day)|Withdrawal by Subject|0|||
147253335|NCT03851302|531098381|FG003|Screening (1 Day)|Withdrawal by Subject|1|||
147253336|NCT03851302|531098382|FG004|Screening (1 Day)|Withdrawal by Subject|0|||
147253337|NCT03851302|531098383|FG005|Screening (1 Day)|Withdrawal by Subject|0|||
147253338|NCT03851302|531098378|FG000|Screening (1 Day)|Screened out|0|||
147253339|NCT03851302|531098379|FG001|Screening (1 Day)|Screened out|0|||
147253340|NCT03851302|531098380|FG002|Screening (1 Day)|Screened out|1|||
147253341|NCT03851302|531098381|FG003|Screening (1 Day)|Screened out|1|||
147253342|NCT03851302|531098382|FG004|Screening (1 Day)|Screened out|0|||
147253343|NCT03851302|531098383|FG005|Screening (1 Day)|Screened out|0|||
147253344|NCT03851302|531098378|FG000|First Intervention (1 Day)|Withdrawal by Subject|1|||
147253345|NCT03851302|531098379|FG001|First Intervention (1 Day)|Withdrawal by Subject|0|||
147253346|NCT03851302|531098380|FG002|First Intervention (1 Day)|Withdrawal by Subject|0|||
147253347|NCT03851302|531098381|FG003|First Intervention (1 Day)|Withdrawal by Subject|0|||
147253348|NCT03851302|531098382|FG004|First Intervention (1 Day)|Withdrawal by Subject|0|||
147253349|NCT03851302|531098383|FG005|First Intervention (1 Day)|Withdrawal by Subject|0|||
147253350|NCT04434092|531098384|FG000|Primary Treatment Period:Baseline-Week24|Physician Decision|2|||
147253351|NCT04434092|531098385|FG001|Primary Treatment Period:Baseline-Week24|Physician Decision|0|||
147253352|NCT04434092|531098386|FG002|Primary Treatment Period:Baseline-Week24|Physician Decision|0|||
147253353|NCT04434092|531098384|FG000|Primary Treatment Period:Baseline-Week24|Withdrawal by Subject|2|||
147253354|NCT04434092|531098385|FG001|Primary Treatment Period:Baseline-Week24|Withdrawal by Subject|0|||
147253355|NCT04434092|531098386|FG002|Primary Treatment Period:Baseline-Week24|Withdrawal by Subject|0|||
147253356|NCT04434092|531098384|FG000|Primary Treatment Period:Baseline-Week24|Lost to Follow-up|1|||
147253357|NCT04434092|531098385|FG001|Primary Treatment Period:Baseline-Week24|Lost to Follow-up|0|||
147253358|NCT04434092|531098386|FG002|Primary Treatment Period:Baseline-Week24|Lost to Follow-up|0|||
147253359|NCT04434092|531098384|FG000|Primary Treatment Period:Baseline-Week24|Death|1|||
147253360|NCT04434092|531098385|FG001|Primary Treatment Period:Baseline-Week24|Death|1|||
147253361|NCT04434092|531098386|FG002|Primary Treatment Period:Baseline-Week24|Death|0|||
147253362|NCT04434092|531098384|FG000|Extension Treatment Period:Week 25-5 Yrs|Treatment (Crovalimab) Ongoing|127|||
147253363|NCT04434092|531098385|FG001|Extension Treatment Period:Week 25-5 Yrs|Treatment (Crovalimab) Ongoing|65|||
147253364|NCT04434092|531098386|FG002|Extension Treatment Period:Week 25-5 Yrs|Treatment (Crovalimab) Ongoing|6|||
147253365|NCT04434092|531098384|FG000|Extension Treatment Period:Week 25-5 Yrs|Withdrawal by Subject|2|||
147253366|NCT04434092|531098385|FG001|Extension Treatment Period:Week 25-5 Yrs|Withdrawal by Subject|2|||
147253367|NCT04434092|531098386|FG002|Extension Treatment Period:Week 25-5 Yrs|Withdrawal by Subject|0|||
147253368|NCT04434092|531098384|FG000|Extension Treatment Period:Week 25-5 Yrs|Adverse Event|0|||
147253369|NCT04434092|531098385|FG001|Extension Treatment Period:Week 25-5 Yrs|Adverse Event|1|||
147253370|NCT04434092|531098386|FG002|Extension Treatment Period:Week 25-5 Yrs|Adverse Event|0|||
147253371|NCT00903617|531099959|FG000|Overall Study|Adverse Event|0|||
147253372|NCT00903617|531099960|FG001|Overall Study|Adverse Event|1|||
147253373|NCT00903617|531099961|FG002|Overall Study|Adverse Event|1|||
147253374|NCT00903617|531099962|FG003|Overall Study|Adverse Event|0|||
147253375|NCT00903617|531099959|FG000|Overall Study|Protocol-defined stopping criteria|0|||
147253376|NCT00903617|531099960|FG001|Overall Study|Protocol-defined stopping criteria|2|||
147253377|NCT00903617|531099961|FG002|Overall Study|Protocol-defined stopping criteria|0|||
147253378|NCT00903617|531099962|FG003|Overall Study|Protocol-defined stopping criteria|0|||
147253379|NCT00903617|531099959|FG000|Overall Study|Lost to Follow-up|2|||
147253380|NCT00903617|531099960|FG001|Overall Study|Lost to Follow-up|0|||
147253381|NCT00903617|531099961|FG002|Overall Study|Lost to Follow-up|1|||
147253382|NCT00903617|531099962|FG003|Overall Study|Lost to Follow-up|1|||
147253383|NCT00903617|531099959|FG000|Overall Study|Withdrawal by Subject|1|||
147332246|NCT00094809|531383189|FG000|Overall Study|Lost to Follow-up|6|||
147332247|NCT00094809|531383190|FG001|Overall Study|Lost to Follow-up|6|||
147253384|NCT00903617|531099960|FG001|Overall Study|Withdrawal by Subject|2|||
147253385|NCT00903617|531099961|FG002|Overall Study|Withdrawal by Subject|3|||
147253386|NCT00903617|531099962|FG003|Overall Study|Withdrawal by Subject|0|||
147253387|NCT00475176|531099963|FG000|Overall Study|Adverse Event|2|||
147253388|NCT00475176|531099963|FG000|Overall Study|Withdrawal by Subject|1|||
147253389|NCT00475176|531099963|FG000|Overall Study|Protocol Violation|1|||
147253390|NCT01853046|531099964|FG000|Overall Study|Withdrawal by Subject|1|||
147332248|NCT00094809|531383189|FG000|Overall Study|Death|19|||
147332249|NCT00094809|531383190|FG001|Overall Study|Death|25|||
147332250|NCT00094809|531383189|FG000|Overall Study|Protocol-specified criteria|1|||
147332251|NCT00094809|531383190|FG001|Overall Study|Protocol-specified criteria|1|||
147332252|NCT00094809|531383189|FG000|Overall Study|Other|2|||
147332253|NCT00094809|531383190|FG001|Overall Study|Other|4|||
147332254|NCT00094809|531383189|FG000|Overall Study|Informed consent signed after treatment|1|||
147332255|NCT00094809|531383190|FG001|Overall Study|Informed consent signed after treatment|0|||
147332256|NCT00094809|531383189|FG000|Overall Study|Study drug not received|2|||
147332257|NCT00094809|531383190|FG001|Overall Study|Study drug not received|8|||
147332258|NCT00094809|531383189|FG000|Overall Study|Other|1|||
147332259|NCT00094809|531383190|FG001|Overall Study|Other|1|||
147332260|NCT01329328|531383191|FG000|Overall Study|Withdrawal by Subject|2|||
147332261|NCT01329328|531383192|FG001|Overall Study|Withdrawal by Subject|4|||
147332262|NCT01329328|531383193|FG002|Overall Study|Withdrawal by Subject|3|||
147332263|NCT01370694|531383204|FG000|Overall Study|Switched to rituximab|4|||
147332264|NCT01370694|531383204|FG000|Overall Study|Progressive disease|2|||
147332265|NCT02957539|531383206|FG000|Baseline to Week 16|Lost to Follow-up|8|||
147332266|NCT02957539|531383207|FG001|Baseline to Week 16|Lost to Follow-up|10|||
147332267|NCT02957539|531383208|FG002|Baseline to Week 16|Lost to Follow-up|16|||
147332268|NCT02957539|531383206|FG000|Baseline to Week 16|Withdrawal by Subject|14|||
147332269|NCT02957539|531383207|FG001|Baseline to Week 16|Withdrawal by Subject|4|||
147332270|NCT02957539|531383208|FG002|Baseline to Week 16|Withdrawal by Subject|5|||
147332271|NCT02957539|531383206|FG000|Week 16 to 32|Withdrawal by Subject|3|||
147332272|NCT02957539|531383207|FG001|Week 16 to 32|Withdrawal by Subject|3|||
147332273|NCT02957539|531383208|FG002|Week 16 to 32|Withdrawal by Subject|1|||
147332274|NCT02957539|531383206|FG000|Week 16 to 32|Lost to Follow-up|8|||
147332275|NCT02957539|531383207|FG001|Week 16 to 32|Lost to Follow-up|7|||
147332276|NCT02957539|531383208|FG002|Week 16 to 32|Lost to Follow-up|5|||
147332277|NCT02957539|531383206|FG000|Week 32 to Week 52|Lost to Follow-up|11|||
147332278|NCT02957539|531383207|FG001|Week 32 to Week 52|Lost to Follow-up|16|||
147332279|NCT02957539|531383208|FG002|Week 32 to Week 52|Lost to Follow-up|27|||
147332280|NCT02957539|531383206|FG000|Week 32 to Week 52|Withdrawal by Subject|0|||
147332281|NCT02957539|531383207|FG001|Week 32 to Week 52|Withdrawal by Subject|1|||
147332282|NCT02957539|531383208|FG002|Week 32 to Week 52|Withdrawal by Subject|0|||
147332283|NCT01565928|531383210|FG000|Overall Study|Adverse Event|3|||
147332284|NCT01565928|531383210|FG000|Overall Study|Other|3|||
147332285|NCT01565928|531383210|FG000|Overall Study|Progressive Disease|13|||
147332286|NCT01565928|531383210|FG000|Overall Study|Withdrawal by Subject|1|||
147332287|NCT01565928|531383210|FG000|Overall Study|Death|2|||
147332288|NCT01119950|531383211|FG000|Overall Study|Adverse Event|25|||
147332289|NCT01119950|531383211|FG000|Overall Study|Withdrawal by Subject|9|||
147332290|NCT01119950|531383211|FG000|Overall Study|Protocol Violation|5|||
147253391|NCT01853046|531099965|FG001|Overall Study|Withdrawal by Subject|1|||
147253392|NCT01853046|531099964|FG000|Overall Study|Adverse Event|4|||
147253393|NCT01853046|531099965|FG001|Overall Study|Adverse Event|2|||
147253394|NCT01853046|531099964|FG000|Overall Study|Disease progression|13|||
147253395|NCT01853046|531099965|FG001|Overall Study|Disease progression|3|||
147253396|NCT00065507|531099968|FG000|Overall Study|Death|16|||
147253397|NCT00065507|531099969|FG001|Overall Study|Death|17|||
147253398|NCT00065507|531099968|FG000|Overall Study|Adverse Event|4|||
147253399|NCT00065507|531099969|FG001|Overall Study|Adverse Event|3|||
147253400|NCT00065507|531099968|FG000|Overall Study|Lack of Efficacy|0|||
147253401|NCT00065507|531099969|FG001|Overall Study|Lack of Efficacy|6|||
147253402|NCT00065507|531099968|FG000|Overall Study|Poor/Non-compliance|3|||
147253403|NCT00065507|531099969|FG001|Overall Study|Poor/Non-compliance|2|||
147253404|NCT00065507|531099968|FG000|Overall Study|Lost to Follow-up|3|||
147253405|NCT00065507|531099969|FG001|Overall Study|Lost to Follow-up|0|||
147253406|NCT00065507|531099968|FG000|Overall Study|Subject Withdrew Consent|2|||
147253407|NCT00065507|531099969|FG001|Overall Study|Subject Withdrew Consent|1|||
147253408|NCT00065507|531099968|FG000|Overall Study|Subject No Longer Meets Study Criteria|1|||
147253409|NCT00065507|531099969|FG001|Overall Study|Subject No Longer Meets Study Criteria|0|||
147253410|NCT01475331|531099970|FG000|Overall Study|Osteophyte obstruction of the proximal|1|||
147253411|NCT01475331|531099971|FG001|Overall Study|Osteophyte obstruction of the proximal|0|||
147253412|NCT01475331|531099970|FG000|Overall Study|excessive main duct communication|1|||
147253413|NCT01475331|531099971|FG001|Overall Study|excessive main duct communication|1|||
147253414|NCT01475331|531099970|FG000|Overall Study|Loss of needle positioning due pt. cough|1|||
147253415|NCT01475331|531099971|FG001|Overall Study|Loss of needle positioning due pt. cough|0|||
147253416|NCT01475331|531099970|FG000|Overall Study|Sign of malignancy during the procedure|2|||
147253417|NCT01475331|531099971|FG001|Overall Study|Sign of malignancy during the procedure|0|||
147253418|NCT01475331|531099970|FG000|Overall Study|cyst found to be prohibitively small|0|||
147253419|NCT01475331|531099971|FG001|Overall Study|cyst found to be prohibitively small|1|||
147253420|NCT00462761|531099972|FG000|Overall Study|Adverse Event|6|||
147253421|NCT00462761|531099972|FG000|Overall Study|Withdrawal by Subject|9|||
147332291|NCT01119950|531383211|FG000|Overall Study|Lost to Follow-up|4|||
147332292|NCT01119950|531383211|FG000|Overall Study|Administrative|2|||
147332293|NCT01119950|531383211|FG000|Overall Study|Abnormal lab value|1|||
147332294|NCT01119950|531383211|FG000|Overall Study|Death|1|||
147332295|NCT00139737|531383216|FG000|Overall Study|Withdrawal by Subject|190|||
147332296|NCT00139737|531383216|FG000|Overall Study|Adverse Event|58|||
147332297|NCT00139737|531383216|FG000|Overall Study|Lack of Efficacy|40|||
147332298|NCT00139737|531383216|FG000|Overall Study|Lost to Follow-up|8|||
147332299|NCT00139737|531383216|FG000|Overall Study|Death|3|||
147332300|NCT00139737|531383216|FG000|Overall Study|Laboratory Abnormality|2|||
147332301|NCT00139737|531383216|FG000|Overall Study|Protocol Violation|18|||
147332302|NCT00139737|531383216|FG000|Overall Study|Withdrew During Screening Phase|8|||
147332303|NCT00139737|531383216|FG000|Overall Study|Did Not Meet Entrance Criteria|1|||
147332304|NCT00139737|531383216|FG000|Overall Study|Screened, Not Treated|13|||
147332305|NCT03525119|531383220|FG000|Overall Study|Adverse Event|0|||
147332306|NCT03525119|531383221|FG001|Overall Study|Adverse Event|1|||
147332307|NCT03525119|531383222|FG002|Overall Study|Adverse Event|0|||
147332308|NCT03525119|531383220|FG000|Overall Study|Lost to Follow-up|32|||
147332309|NCT03525119|531383221|FG001|Overall Study|Lost to Follow-up|33|||
147332310|NCT03525119|531383222|FG002|Overall Study|Lost to Follow-up|37|||
147332311|NCT03525119|531383220|FG000|Overall Study|Withdrawal by Subject|5|||
147332312|NCT03525119|531383221|FG001|Overall Study|Withdrawal by Subject|4|||
147332313|NCT03525119|531383222|FG002|Overall Study|Withdrawal by Subject|2|||
147332314|NCT03525119|531383220|FG000|Overall Study|Reason not Specified|2|||
147332315|NCT03525119|531383221|FG001|Overall Study|Reason not Specified|1|||
147253422|NCT00462761|531099972|FG000|Overall Study|Physician Decision|5|||
147332316|NCT03525119|531383222|FG002|Overall Study|Reason not Specified|2|||
147332317|NCT03525119|531383220|FG000|Overall Study|Randomized but not Vaccinated|1|||
147332318|NCT03525119|531383221|FG001|Overall Study|Randomized but not Vaccinated|0|||
147332319|NCT03525119|531383222|FG002|Overall Study|Randomized but not Vaccinated|2|||
147332320|NCT01713530|531383223|FG000|Overall Study|Adverse Event|0|||
147332321|NCT01713530|531383224|FG001|Overall Study|Adverse Event|5|||
147332322|NCT01713530|531383223|FG000|Overall Study|Withdrawal criteria|21|||
147332323|NCT01713530|531383224|FG001|Overall Study|Withdrawal criteria|12|||
147332324|NCT01713530|531383223|FG000|Overall Study|Unclassified|4|||
147332325|NCT01713530|531383224|FG001|Overall Study|Unclassified|2|||
147332326|NCT00758602|531383227|FG000|Overall Study|Adverse Event|11|||
147332327|NCT00758602|531383228|FG001|Overall Study|Adverse Event|10|||
147332328|NCT00758602|531383227|FG000|Overall Study|Lost to Follow-up|4|||
147332329|NCT00758602|531383228|FG001|Overall Study|Lost to Follow-up|3|||
147332330|NCT00758602|531383227|FG000|Overall Study|Withdrawal by Subject|1|||
147253423|NCT00462761|531099972|FG000|Overall Study|Disease progression|43|||
147253424|NCT00462761|531099972|FG000|Overall Study|Death|12|||
147253425|NCT00462761|531099972|FG000|Overall Study|Other|1|||
147253426|NCT01244906|531099973|FG000|Overall Study|Death|2|||
147253427|NCT01244906|531099973|FG000|Overall Study|Progression of disease post treatment|6|||
147253428|NCT03480750|531099974|FG000|Overall Study|Withdrawal by Subject|0|||
147253429|NCT03480750|531099975|FG001|Overall Study|Withdrawal by Subject|1|||
147253430|NCT03480750|531099976|FG002|Overall Study|Withdrawal by Subject|0|||
147253431|NCT03480750|531099977|FG003|Overall Study|Withdrawal by Subject|0|||
147253432|NCT03480750|531099978|FG004|Overall Study|Withdrawal by Subject|0|||
147253433|NCT03480750|531099979|FG005|Overall Study|Withdrawal by Subject|0|||
147253434|NCT03480750|531099974|FG000|Overall Study|The interruption in Trientine shippment|0|||
147253435|NCT03480750|531099975|FG001|Overall Study|The interruption in Trientine shippment|0|||
147253436|NCT03480750|531099976|FG002|Overall Study|The interruption in Trientine shippment|0|||
147253437|NCT03480750|531099977|FG003|Overall Study|The interruption in Trientine shippment|0|||
147253438|NCT03480750|531099978|FG004|Overall Study|The interruption in Trientine shippment|0|||
147253439|NCT03480750|531099979|FG005|Overall Study|The interruption in Trientine shippment|1|||
147253440|NCT00723892|531099980|FG000|Overall Study|Participant not tracked|33|||
147253441|NCT00723892|531099981|FG001|Overall Study|Participant not tracked|35|||
147332331|NCT00758602|531383228|FG001|Overall Study|Withdrawal by Subject|3|||
147332332|NCT00758602|531383227|FG000|Overall Study|Protocol Violation|0|||
147598517|NCT04394351|532349841|FG007|Part A (16 Weeks)|Withdrawal by Subject|0|||
147598518|NCT04394351|532349834|FG000|Part B (36 Weeks)|Adverse Event|0|||
147598519|NCT04394351|532349835|FG001|Part B (36 Weeks)|Adverse Event|0|||
147253442|NCT00723892|531099980|FG000|Overall Study|Virological criterion|24|||
147253443|NCT00723892|531099981|FG001|Overall Study|Virological criterion|9|||
147332333|NCT00758602|531383228|FG001|Overall Study|Protocol Violation|2|||
147332334|NCT00758602|531383227|FG000|Overall Study|Death|0|||
147332335|NCT00758602|531383228|FG001|Overall Study|Death|1|||
147332336|NCT00758602|531383227|FG000|Overall Study|Reason not specified|3|||
147598520|NCT04394351|532349836|FG002|Part B (36 Weeks)|Adverse Event|0|||
147332337|NCT00758602|531383228|FG001|Overall Study|Reason not specified|3|||
147332338|NCT03939819|531383229|FG000|Overall Study|Death|2|||
147332339|NCT03939819|531383230|FG001|Overall Study|Death|0|||
147332340|NCT05046132|531383231|FG000|Overall Study|Adverse Event|4|||
147332341|NCT05046132|531383232|FG001|Overall Study|Adverse Event|0|||
147332342|NCT05046132|531383233|FG002|Overall Study|Adverse Event|0|||
147332343|NCT05046132|531383231|FG000|Overall Study|Withdrawal by Subject|3|||
147253444|NCT00723892|531099980|FG000|Overall Study|Withdrawal by Subject|6|||
147253445|NCT00723892|531099981|FG001|Overall Study|Withdrawal by Subject|9|||
147253446|NCT00723892|531099980|FG000|Overall Study|End planned|11|||
147253447|NCT00723892|531099981|FG001|Overall Study|End planned|7|||
147253448|NCT00723892|531099980|FG000|Overall Study|Bad tolerance|5|||
147253449|NCT00723892|531099981|FG001|Overall Study|Bad tolerance|5|||
147253450|NCT00723892|531099980|FG000|Overall Study|Multiple reasons|17|||
147661253|NCT01657162|532581467|FG000|Overall Study|Continuing Significant Deterioration|9|||
147253451|NCT00723892|531099981|FG001|Overall Study|Multiple reasons|12|||
147253452|NCT00723892|531099980|FG000|Overall Study|Other|6|||
147253453|NCT00723892|531099981|FG001|Overall Study|Other|3|||
147253454|NCT00723892|531099980|FG000|Overall Study|Study end|1|||
147253455|NCT00723892|531099981|FG001|Overall Study|Study end|3|||
147253456|NCT00723892|531099980|FG000|Overall Study|Weight loss|1|||
147253457|NCT00723892|531099981|FG001|Overall Study|Weight loss|3|||
147253458|NCT00723892|531099980|FG000|Overall Study|Alcohol abuse|0|||
147253459|NCT00723892|531099981|FG001|Overall Study|Alcohol abuse|1|||
147253460|NCT00723892|531099980|FG000|Overall Study|Intercurrent infection|2|||
147253461|NCT00723892|531099981|FG001|Overall Study|Intercurrent infection|0|||
147253462|NCT00723892|531099980|FG000|Overall Study|Drug addiction|1|||
147253463|NCT00723892|531099981|FG001|Overall Study|Drug addiction|0|||
147253464|NCT04532099|531099982|FG000|First Wear Period (30 Days)|Withdrawal by Subject|1|||
147253465|NCT04532099|531099983|FG001|First Wear Period (30 Days)|Withdrawal by Subject|0|||
147253466|NCT04532099|531099984|FG002|First Wear Period (30 Days)|Withdrawal by Subject|0|||
147253467|NCT00498602|531099989|FG000|Overall Study|Death|0|||
147253468|NCT00498602|531099990|FG001|Overall Study|Death|0|||
147253469|NCT00498602|531099991|FG002|Overall Study|Death|0|||
147253470|NCT00498602|531099992|FG003|Overall Study|Death|0|||
147253471|NCT00498602|531099993|FG004|Overall Study|Death|0|||
147253472|NCT00498602|531099994|FG005|Overall Study|Death|1|||
147253473|NCT00498602|531099995|FG006|Overall Study|Death|0|||
147253474|NCT00498602|531099989|FG000|Overall Study|Lack of Efficacy|1|||
147253475|NCT00498602|531099990|FG001|Overall Study|Lack of Efficacy|0|||
147253476|NCT00498602|531099991|FG002|Overall Study|Lack of Efficacy|0|||
147253477|NCT00498602|531099992|FG003|Overall Study|Lack of Efficacy|0|||
147253478|NCT00498602|531099993|FG004|Overall Study|Lack of Efficacy|0|||
147253479|NCT00498602|531099994|FG005|Overall Study|Lack of Efficacy|0|||
147253480|NCT00498602|531099995|FG006|Overall Study|Lack of Efficacy|0|||
147253481|NCT00498602|531099989|FG000|Overall Study|Lost to Follow-up|0|||
147253482|NCT00498602|531099990|FG001|Overall Study|Lost to Follow-up|2|||
147253483|NCT00498602|531099991|FG002|Overall Study|Lost to Follow-up|0|||
147253484|NCT00498602|531099992|FG003|Overall Study|Lost to Follow-up|2|||
147253485|NCT00498602|531099993|FG004|Overall Study|Lost to Follow-up|0|||
147253486|NCT00498602|531099994|FG005|Overall Study|Lost to Follow-up|0|||
147253487|NCT00498602|531099995|FG006|Overall Study|Lost to Follow-up|0|||
147253488|NCT00498602|531099989|FG000|Overall Study|Adverse Event (AE) related to Study Drug|1|||
147253489|NCT00498602|531099990|FG001|Overall Study|Adverse Event (AE) related to Study Drug|0|||
147253490|NCT00498602|531099991|FG002|Overall Study|Adverse Event (AE) related to Study Drug|3|||
147253491|NCT00498602|531099992|FG003|Overall Study|Adverse Event (AE) related to Study Drug|2|||
147253492|NCT00498602|531099993|FG004|Overall Study|Adverse Event (AE) related to Study Drug|0|||
147253493|NCT00498602|531099994|FG005|Overall Study|Adverse Event (AE) related to Study Drug|1|||
147253494|NCT00498602|531099995|FG006|Overall Study|Adverse Event (AE) related to Study Drug|0|||
147253495|NCT00498602|531099989|FG000|Overall Study|AE not related to Study Drug|1|||
147253496|NCT00498602|531099990|FG001|Overall Study|AE not related to Study Drug|3|||
147253497|NCT00498602|531099991|FG002|Overall Study|AE not related to Study Drug|0|||
147253498|NCT00498602|531099992|FG003|Overall Study|AE not related to Study Drug|0|||
147253499|NCT00498602|531099993|FG004|Overall Study|AE not related to Study Drug|2|||
147253500|NCT00498602|531099994|FG005|Overall Study|AE not related to Study Drug|2|||
147253501|NCT00498602|531099995|FG006|Overall Study|AE not related to Study Drug|1|||
147253502|NCT00498602|531099989|FG000|Overall Study|Caregiver Request|2|||
147253503|NCT00498602|531099990|FG001|Overall Study|Caregiver Request|2|||
147253504|NCT00498602|531099991|FG002|Overall Study|Caregiver Request|2|||
147253505|NCT00498602|531099992|FG003|Overall Study|Caregiver Request|0|||
147253506|NCT00498602|531099993|FG004|Overall Study|Caregiver Request|1|||
147253507|NCT00498602|531099994|FG005|Overall Study|Caregiver Request|2|||
147332344|NCT05046132|531383232|FG001|Overall Study|Withdrawal by Subject|0|||
147332345|NCT05046132|531383233|FG002|Overall Study|Withdrawal by Subject|0|||
147332346|NCT05046132|531383231|FG000|Overall Study|Positive Covid19 Result.|0|||
147332347|NCT05046132|531383232|FG001|Overall Study|Positive Covid19 Result.|1|||
147449961|NCT02669017|531811321|FG000|Overall Study|Miscellaneous|0|||
147253508|NCT00498602|531099995|FG006|Overall Study|Caregiver Request|0|||
147253509|NCT00498602|531099989|FG000|Overall Study|Investigator Request|0|||
147253510|NCT00498602|531099990|FG001|Overall Study|Investigator Request|0|||
147253511|NCT00498602|531099991|FG002|Overall Study|Investigator Request|1|||
147253512|NCT00498602|531099992|FG003|Overall Study|Investigator Request|0|||
147253513|NCT00498602|531099993|FG004|Overall Study|Investigator Request|0|||
147253514|NCT00498602|531099994|FG005|Overall Study|Investigator Request|0|||
147661254|NCT01657162|532581468|FG001|Overall Study|Continuing Significant Deterioration|3|||
147661255|NCT01657162|532581467|FG000|Overall Study|Refusal of Treatment|4|||
147661256|NCT01657162|532581468|FG001|Overall Study|Refusal of Treatment|6|||
147661257|NCT01657162|532581467|FG000|Overall Study|Lost to Follow-up|3|||
147661258|NCT01657162|532581468|FG001|Overall Study|Lost to Follow-up|4|||
147661259|NCT01657162|532581467|FG000|Overall Study|Death|2|||
147661260|NCT01657162|532581468|FG001|Overall Study|Death|3|||
147253515|NCT00498602|531099995|FG006|Overall Study|Investigator Request|0|||
147253516|NCT00498602|531099989|FG000|Overall Study|Subject Request|3|||
147253517|NCT00498602|531099990|FG001|Overall Study|Subject Request|0|||
147253518|NCT00498602|531099991|FG002|Overall Study|Subject Request|1|||
147253519|NCT00498602|531099992|FG003|Overall Study|Subject Request|1|||
147253520|NCT00498602|531099993|FG004|Overall Study|Subject Request|1|||
147253521|NCT00498602|531099994|FG005|Overall Study|Subject Request|4|||
147253522|NCT00498602|531099995|FG006|Overall Study|Subject Request|1|||
147253523|NCT00498602|531099989|FG000|Overall Study|Other|2|||
147253524|NCT00498602|531099990|FG001|Overall Study|Other|3|||
147253525|NCT00498602|531099991|FG002|Overall Study|Other|1|||
147253526|NCT00498602|531099992|FG003|Overall Study|Other|0|||
147253527|NCT00498602|531099993|FG004|Overall Study|Other|0|||
147253528|NCT00498602|531099994|FG005|Overall Study|Other|3|||
147253529|NCT00498602|531099995|FG006|Overall Study|Other|0|||
147253530|NCT01113801|531099999|FG000|Overall Study|Adverse Event|4|||
147253531|NCT01113801|531100000|FG001|Overall Study|Adverse Event|0|||
147253532|NCT01113801|531100001|FG002|Overall Study|Adverse Event|2|||
147253533|NCT01113801|531100002|FG003|Overall Study|Adverse Event|6|||
147253534|NCT01113801|531099999|FG000|Overall Study|Death|4|||
147253535|NCT01113801|531100000|FG001|Overall Study|Death|5|||
147253536|NCT01113801|531100001|FG002|Overall Study|Death|3|||
147253537|NCT01113801|531100002|FG003|Overall Study|Death|4|||
147253538|NCT01113801|531099999|FG000|Overall Study|Protocol Violation|0|||
147253539|NCT01113801|531100000|FG001|Overall Study|Protocol Violation|1|||
147253540|NCT01113801|531100001|FG002|Overall Study|Protocol Violation|0|||
147253541|NCT01113801|531100002|FG003|Overall Study|Protocol Violation|0|||
147253542|NCT01113801|531099999|FG000|Overall Study|Withdrawal by Subject|9|||
147253543|NCT01113801|531100000|FG001|Overall Study|Withdrawal by Subject|7|||
147253544|NCT01113801|531100001|FG002|Overall Study|Withdrawal by Subject|7|||
147253545|NCT01113801|531100002|FG003|Overall Study|Withdrawal by Subject|8|||
147253546|NCT01113801|531099999|FG000|Overall Study|Physician Decision|2|||
147253547|NCT01113801|531100000|FG001|Overall Study|Physician Decision|2|||
147253548|NCT01113801|531100001|FG002|Overall Study|Physician Decision|3|||
147253549|NCT01113801|531100002|FG003|Overall Study|Physician Decision|3|||
147253550|NCT01113801|531099999|FG000|Overall Study|Sponsor Decision|15|||
147253551|NCT01113801|531100000|FG001|Overall Study|Sponsor Decision|21|||
147253552|NCT01113801|531100001|FG002|Overall Study|Sponsor Decision|20|||
147253553|NCT01113801|531100002|FG003|Overall Study|Sponsor Decision|15|||
147253554|NCT01113801|531099999|FG000|Overall Study|Clinical Endpoint (ESRD)|7|||
147253555|NCT01113801|531100000|FG001|Overall Study|Clinical Endpoint (ESRD)|4|||
147253556|NCT01113801|531100001|FG002|Overall Study|Clinical Endpoint (ESRD)|2|||
147253557|NCT01113801|531100002|FG003|Overall Study|Clinical Endpoint (ESRD)|5|||
147253558|NCT01949051|531100005|FG000|Treatment Period 1 (7 Days)|Protocol Violation|1|||
147253559|NCT01949051|531100006|FG001|Treatment Period 1 (7 Days)|Protocol Violation|0|||
147253560|NCT01949051|531100007|FG002|Treatment Period 1 (7 Days)|Protocol Violation|0|||
147253561|NCT01949051|531100008|FG003|Treatment Period 1 (7 Days)|Protocol Violation|1|||
147253562|NCT01949051|531100009|FG004|Treatment Period 1 (7 Days)|Protocol Violation|0|||
147253563|NCT01949051|531100010|FG005|Treatment Period 1 (7 Days)|Protocol Violation|0|||
147253564|NCT01949051|531100005|FG000|Treatment Period 1 (7 Days)|Lost to Follow-up|1|||
147253565|NCT01949051|531100006|FG001|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
147253566|NCT01949051|531100007|FG002|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
147253567|NCT01949051|531100008|FG003|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
147253568|NCT01949051|531100009|FG004|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
147253569|NCT01949051|531100010|FG005|Treatment Period 1 (7 Days)|Lost to Follow-up|0|||
147253570|NCT01949051|531100005|FG000|Treatment Period 2 (7 Days)|Protocol Violation|0|||
147253571|NCT01949051|531100006|FG001|Treatment Period 2 (7 Days)|Protocol Violation|0|||
147253572|NCT01949051|531100007|FG002|Treatment Period 2 (7 Days)|Protocol Violation|0|||
147253573|NCT01949051|531100008|FG003|Treatment Period 2 (7 Days)|Protocol Violation|0|||
147253574|NCT01949051|531100009|FG004|Treatment Period 2 (7 Days)|Protocol Violation|0|||
147253575|NCT01949051|531100010|FG005|Treatment Period 2 (7 Days)|Protocol Violation|1|||
147253576|NCT01949051|531100005|FG000|Treatment Period 2 (7 Days)|Lost to Follow-up|0|||
147253577|NCT01949051|531100006|FG001|Treatment Period 2 (7 Days)|Lost to Follow-up|1|||
147253578|NCT01949051|531100007|FG002|Treatment Period 2 (7 Days)|Lost to Follow-up|0|||
147253579|NCT01949051|531100008|FG003|Treatment Period 2 (7 Days)|Lost to Follow-up|0|||
147449962|NCT02669017|531811322|FG001|Overall Study|Miscellaneous|0|||
147661261|NCT01657162|532581467|FG000|Overall Study|Inability to Complete Study Procedures|1|||
147253580|NCT01949051|531100009|FG004|Treatment Period 2 (7 Days)|Lost to Follow-up|0|||
147253581|NCT01949051|531100010|FG005|Treatment Period 2 (7 Days)|Lost to Follow-up|0|||
147253582|NCT01949051|531100005|FG000|Treatment Period 2 (7 Days)|Withdrawal by Subject|0|||
147598521|NCT04394351|532349837|FG003|Part B (36 Weeks)|Adverse Event|0|||
147598522|NCT04394351|532349838|FG004|Part B (36 Weeks)|Adverse Event|0|||
147598523|NCT04394351|532349839|FG005|Part B (36 Weeks)|Adverse Event|0|||
147598524|NCT04394351|532349840|FG006|Part B (36 Weeks)|Adverse Event|1|||
147598525|NCT04394351|532349841|FG007|Part B (36 Weeks)|Adverse Event|0|||
147598526|NCT04394351|532349834|FG000|Part C: (Up to Wk108+12Wk Follow-up)|Physician Decision|0|||
147598527|NCT04394351|532349835|FG001|Part C: (Up to Wk108+12Wk Follow-up)|Physician Decision|0|||
147253583|NCT01949051|531100006|FG001|Treatment Period 2 (7 Days)|Withdrawal by Subject|0|||
147253584|NCT01949051|531100007|FG002|Treatment Period 2 (7 Days)|Withdrawal by Subject|1|||
147253585|NCT01949051|531100008|FG003|Treatment Period 2 (7 Days)|Withdrawal by Subject|0|||
147253586|NCT01949051|531100009|FG004|Treatment Period 2 (7 Days)|Withdrawal by Subject|0|||
147253587|NCT01949051|531100010|FG005|Treatment Period 2 (7 Days)|Withdrawal by Subject|0|||
147253588|NCT01506479|531100012|FG000|Overall Study|Lost to Follow-up|1|||
147253589|NCT01506479|531100013|FG001|Overall Study|Lost to Follow-up|2|||
147253590|NCT01506479|531100014|FG002|Overall Study|Lost to Follow-up|2|||
147253591|NCT01506479|531100012|FG000|Overall Study|Withdrawal by Subject|1|||
147253592|NCT01506479|531100013|FG001|Overall Study|Withdrawal by Subject|2|||
147253593|NCT01506479|531100014|FG002|Overall Study|Withdrawal by Subject|1|||
147253594|NCT01506479|531100012|FG000|Overall Study|Missing assessment|1|||
147253595|NCT01506479|531100013|FG001|Overall Study|Missing assessment|0|||
147253596|NCT01506479|531100014|FG002|Overall Study|Missing assessment|0|||
147253597|NCT01506479|531100012|FG000|Overall Study|Adverse Event|0|||
147253598|NCT01506479|531100013|FG001|Overall Study|Adverse Event|1|||
147253599|NCT01506479|531100014|FG002|Overall Study|Adverse Event|0|||
147253600|NCT01846507|531100015|FG000|Overall Study|Lost to Follow-up|4|||
147253601|NCT01846507|531100015|FG000|Overall Study|Protocol Violation|1|||
147253602|NCT01846507|531100015|FG000|Overall Study|Missing data|2|||
147253603|NCT01782859|531100016|FG000|Overall Study|Protocol Violation|6|||
147253604|NCT01782859|531100017|FG001|Overall Study|Protocol Violation|6|||
147253605|NCT01782859|531100016|FG000|Overall Study|Withdrawal by Subject|0|||
147253606|NCT01782859|531100017|FG001|Overall Study|Withdrawal by Subject|1|||
147253607|NCT04483011|531100020|FG000|Washout (7 Days)|Withdrawal by Subject|0|||
147253608|NCT04483011|531100021|FG001|Washout (7 Days)|Withdrawal by Subject|1|||
147253609|NCT00276159|531100022|FG000|Overall Study|Did not receive all 24 doses of 852A|6|||
147253610|NCT02426892|531100025|FG000|Overall Study|Adverse Event|2|||
147253611|NCT02426892|531100025|FG000|Overall Study|Lack of Efficacy|17|||
147253612|NCT02426892|531100025|FG000|Overall Study|Withdrawal by Subject|1|||
147253613|NCT03402386|531100026|FG000|Overall Study|Adverse Event|3|||
147253614|NCT03402386|531100026|FG000|Overall Study|Physician Decision|1|||
147253615|NCT03402386|531100026|FG000|Overall Study|Difficult to control Hb|2|||
147253616|NCT01896531|531100027|FG000|Overall Study|Death|57|||
147253617|NCT01896531|531100028|FG001|Overall Study|Death|59|||
147253618|NCT01896531|531100027|FG000|Overall Study|Lost to Follow-up|3|||
147253619|NCT01896531|531100028|FG001|Overall Study|Lost to Follow-up|0|||
147253620|NCT01896531|531100027|FG000|Overall Study|Non-compliance|0|||
147253621|NCT01896531|531100028|FG001|Overall Study|Non-compliance|1|||
147253622|NCT01896531|531100027|FG000|Overall Study|Study Ended by Sponsor|7|||
147253623|NCT01896531|531100028|FG001|Overall Study|Study Ended by Sponsor|20|||
147253624|NCT01896531|531100027|FG000|Overall Study|Withdrawal by Subject|3|||
147253625|NCT01896531|531100028|FG001|Overall Study|Withdrawal by Subject|2|||
147253626|NCT01896531|531100027|FG000|Overall Study|Death Prior to Treatment|1|||
147253627|NCT01896531|531100028|FG001|Overall Study|Death Prior to Treatment|0|||
147253628|NCT00268996|531100029|FG000|Overall Study|Adverse Event|11|||
147253629|NCT00268996|531100030|FG001|Overall Study|Adverse Event|7|||
147253630|NCT00268996|531100029|FG000|Overall Study|Lost to Follow-up|3|||
147253631|NCT00268996|531100030|FG001|Overall Study|Lost to Follow-up|1|||
147253632|NCT00268996|531100029|FG000|Overall Study|Withdrawal by Subject|5|||
147253633|NCT00268996|531100030|FG001|Overall Study|Withdrawal by Subject|11|||
147253634|NCT00268996|531100029|FG000|Overall Study|Non-compliance|1|||
147253635|NCT00268996|531100030|FG001|Overall Study|Non-compliance|0|||
147253636|NCT00268996|531100029|FG000|Overall Study|Other|1|||
147253637|NCT00268996|531100030|FG001|Overall Study|Other|1|||
147253638|NCT02956486|531100031|FG000|Core Phase|Adverse Event|51|||
147253639|NCT02956486|531100032|FG001|Core Phase|Adverse Event|88|||
147253640|NCT02956486|531100033|FG002|Core Phase|Adverse Event|0|||
147253641|NCT02956486|531100031|FG000|Core Phase|Lost to Follow-up|8|||
147253642|NCT02956486|531100032|FG001|Core Phase|Lost to Follow-up|6|||
147449963|NCT02669017|531811323|FG002|Overall Study|Miscellaneous|0|||
147449964|NCT02669017|531811324|FG003|Overall Study|Miscellaneous|0|||
147253643|NCT02956486|531100033|FG002|Core Phase|Lost to Follow-up|0|||
147253644|NCT02956486|531100031|FG000|Core Phase|Inadequate therapeutic effect|4|||
147253645|NCT02956486|531100032|FG001|Core Phase|Inadequate therapeutic effect|5|||
147253646|NCT02956486|531100033|FG002|Core Phase|Inadequate therapeutic effect|0|||
147253647|NCT02956486|531100031|FG000|Core Phase|Withdrawal by Subject|101|||
147253648|NCT02956486|531100032|FG001|Core Phase|Withdrawal by Subject|104|||
147253649|NCT02956486|531100033|FG002|Core Phase|Withdrawal by Subject|0|||
147253650|NCT02956486|531100031|FG000|Core Phase|Study terminated by sponsor|888|||
147449965|NCT02669017|531811325|FG004|Overall Study|Miscellaneous|2|||
147598528|NCT04394351|532349836|FG002|Part C: (Up to Wk108+12Wk Follow-up)|Physician Decision|0|||
147598529|NCT04394351|532349837|FG003|Part C: (Up to Wk108+12Wk Follow-up)|Physician Decision|0|||
147598530|NCT04394351|532349838|FG004|Part C: (Up to Wk108+12Wk Follow-up)|Physician Decision|0|||
147598531|NCT04394351|532349839|FG005|Part C: (Up to Wk108+12Wk Follow-up)|Physician Decision|0|||
147598532|NCT04394351|532349840|FG006|Part C: (Up to Wk108+12Wk Follow-up)|Physician Decision|0|||
147598533|NCT04394351|532349841|FG007|Part C: (Up to Wk108+12Wk Follow-up)|Physician Decision|3|||
147253651|NCT02956486|531100032|FG001|Core Phase|Study terminated by sponsor|848|||
147253652|NCT02956486|531100033|FG002|Core Phase|Study terminated by sponsor|0|||
147253653|NCT02956486|531100031|FG000|Core Phase|Other|27|||
147253654|NCT02956486|531100032|FG001|Core Phase|Other|18|||
147253655|NCT02956486|531100033|FG002|Core Phase|Other|0|||
147253656|NCT02956486|531100031|FG000|Core Phase|Not treated|0|||
147253657|NCT02956486|531100032|FG001|Core Phase|Not treated|3|||
147253658|NCT02956486|531100033|FG002|Core Phase|Not treated|0|||
147253659|NCT02956486|531100031|FG000|Extension Phase|Adverse Event|0|||
147253660|NCT02956486|531100032|FG001|Extension Phase|Adverse Event|0|||
147253661|NCT02956486|531100033|FG002|Extension Phase|Adverse Event|2|||
147253662|NCT02956486|531100031|FG000|Extension Phase|Study terminated by sponsor|0|||
147253663|NCT02956486|531100032|FG001|Extension Phase|Study terminated by sponsor|0|||
147253664|NCT02956486|531100033|FG002|Extension Phase|Study terminated by sponsor|16|||
147253665|NCT02956486|531100031|FG000|Extension Phase|Not Treated|0|||
147253666|NCT02956486|531100032|FG001|Extension Phase|Not Treated|0|||
147253667|NCT02956486|531100033|FG002|Extension Phase|Not Treated|1|||
147253668|NCT03325075|531100036|FG000|Part B: Follow-up (Up to 364 Days)|Lost to Follow-up|2|||
147253669|NCT03325075|531100037|FG001|Part B: Follow-up (Up to 364 Days)|Lost to Follow-up|0|||
147253670|NCT03325075|531100038|FG002|Part B: Follow-up (Up to 364 Days)|Lost to Follow-up|0|||
147253671|NCT03325075|531100039|FG003|Part B: Follow-up (Up to 364 Days)|Lost to Follow-up|0|||
147253672|NCT03325075|531100036|FG000|Part B: Follow-up (Up to 364 Days)|Withdrawal by Subject|0|||
147253673|NCT03325075|531100037|FG001|Part B: Follow-up (Up to 364 Days)|Withdrawal by Subject|1|||
147253674|NCT03325075|531100038|FG002|Part B: Follow-up (Up to 364 Days)|Withdrawal by Subject|0|||
147253675|NCT03325075|531100039|FG003|Part B: Follow-up (Up to 364 Days)|Withdrawal by Subject|0|||
147253676|NCT03325075|531100036|FG000|Part B: Follow-up (Up to 364 Days)|Other than specified|0|||
147253677|NCT03325075|531100037|FG001|Part B: Follow-up (Up to 364 Days)|Other than specified|1|||
147253678|NCT03325075|531100038|FG002|Part B: Follow-up (Up to 364 Days)|Other than specified|0|||
147253679|NCT03325075|531100039|FG003|Part B: Follow-up (Up to 364 Days)|Other than specified|2|||
147253680|NCT00422591|531100040|FG000|Overall Study|Physician Decision|4|||
147253681|NCT00422591|531100040|FG000|Overall Study|Withdrawal by Subject|2|||
147253682|NCT02377466|531100043|FG000|Overall Study|Other: Randomized and not treated|0|||
147253683|NCT02377466|531100044|FG001|Overall Study|Other: Randomized and not treated|2|||
147253684|NCT04210310|531100045|FG000|Overall Study|Lost to Follow-up|32|||
147253685|NCT04210310|531100046|FG001|Overall Study|Lost to Follow-up|1|||
147253686|NCT00330616|531100047|FG000|Overall Study|Adverse Event|13|||
147253687|NCT00330616|531100047|FG000|Overall Study|Lack of Efficacy|1|||
147253688|NCT00330616|531100047|FG000|Overall Study|Lost to Follow-up|2|||
147253689|NCT00330616|531100047|FG000|Overall Study|Withdrawal by Subject|4|||
147253690|NCT00330616|531100047|FG000|Overall Study|Other|1|||
147253691|NCT02617511|531100054|FG000|Overall Study|Withdrawal by Subject|1|||
147253692|NCT02617511|531100055|FG001|Overall Study|Withdrawal by Subject|0|||
147253693|NCT00255047|531100056|FG000|Overall Study|Serious Adverse Events|2|||
147253694|NCT00255047|531100057|FG001|Overall Study|Serious Adverse Events|1|||
147253695|NCT00255047|531100058|FG002|Overall Study|Serious Adverse Events|2|||
147253696|NCT00255047|531100059|FG003|Overall Study|Serious Adverse Events|1|||
147253697|NCT00255047|531100056|FG000|Overall Study|Adverse Event|0|||
147253698|NCT00255047|531100057|FG001|Overall Study|Adverse Event|3|||
147253699|NCT00255047|531100058|FG002|Overall Study|Adverse Event|2|||
147253700|NCT00255047|531100059|FG003|Overall Study|Adverse Event|1|||
147253701|NCT00255047|531100056|FG000|Overall Study|Protocol Violation|13|||
147253702|NCT00255047|531100057|FG001|Overall Study|Protocol Violation|13|||
147253703|NCT00255047|531100058|FG002|Overall Study|Protocol Violation|16|||
147253704|NCT00255047|531100059|FG003|Overall Study|Protocol Violation|20|||
147253705|NCT00255047|531100056|FG000|Overall Study|Lost to Follow-up|9|||
147253706|NCT00255047|531100057|FG001|Overall Study|Lost to Follow-up|8|||
147253707|NCT00255047|531100058|FG002|Overall Study|Lost to Follow-up|5|||
147253708|NCT00255047|531100059|FG003|Overall Study|Lost to Follow-up|6|||
147253709|NCT00255047|531100056|FG000|Overall Study|Withdrawal by Subject|24|||
147253710|NCT00255047|531100057|FG001|Overall Study|Withdrawal by Subject|23|||
147253711|NCT00255047|531100058|FG002|Overall Study|Withdrawal by Subject|25|||
147253712|NCT00255047|531100059|FG003|Overall Study|Withdrawal by Subject|18|||
147253713|NCT01585194|531100060|FG000|Overall Study|Withdrawal by Subject|1|||
147253714|NCT01585194|531100060|FG000|Overall Study|Physician Decision|2|||
147253715|NCT01585194|531100060|FG000|Overall Study|Lack of insurance|1|||
147253716|NCT01333059|531100061|FG000|Overall Study|Physician Decision|3|||
147253717|NCT01333059|531100062|FG001|Overall Study|Physician Decision|3|||
147253718|NCT01333059|531100061|FG000|Overall Study|Protocol Violation|3|||
147253719|NCT01333059|531100062|FG001|Overall Study|Protocol Violation|0|||
147253720|NCT03035409|531100074|FG000|Overall Study|Adverse Event|5|||
147253721|NCT03035409|531100074|FG000|Overall Study|Death|2|||
147253722|NCT03035409|531100074|FG000|Overall Study|Withdrawal by Subject|2|||
147253723|NCT03035409|531100074|FG000|Overall Study|Non compliance|4|||
147253724|NCT03035409|531100074|FG000|Overall Study|Patient was jittery|1|||
147253725|NCT03035409|531100074|FG000|Overall Study|Did not like Questionnaire|1|||
147253726|NCT03035409|531100074|FG000|Overall Study|Aspartate Aminotransferase increased|1|||
147253727|NCT03035409|531100074|FG000|Overall Study|Did not like taking drugs|1|||
147253728|NCT01405742|531100077|FG000|Overall Study|Lost to Follow-up|1|||
147253729|NCT01405742|531100078|FG001|Overall Study|Lost to Follow-up|0|||
147253730|NCT02056340|531100079|FG000|Overall Study|Lost to Follow-up|5|||
147253731|NCT02056340|531100080|FG001|Overall Study|Lost to Follow-up|5|||
147253732|NCT02056340|531100079|FG000|Overall Study|Withdrawal by Subject|2|||
147253733|NCT02056340|531100080|FG001|Overall Study|Withdrawal by Subject|6|||
147253734|NCT04900220|531100082|FG000|Overall Study|Lost to Follow-up|1|||
147253735|NCT04900220|531100083|FG001|Overall Study|Lost to Follow-up|1|||
147253736|NCT02028065|531100084|FG000|Randomization Through Start Treatment|Not treated|1|||
147253737|NCT02028065|531100085|FG001|Randomization Through Start Treatment|Not treated|3|||
147253738|NCT02028065|531100086|FG002|Randomization Through Start Treatment|Not treated|3|||
147253739|NCT02028065|531100084|FG000|Treatment Through Study Completion|Lost to Follow-up|2|||
147253740|NCT02028065|531100085|FG001|Treatment Through Study Completion|Lost to Follow-up|4|||
147253741|NCT02028065|531100086|FG002|Treatment Through Study Completion|Lost to Follow-up|6|||
147253742|NCT02028065|531100084|FG000|Treatment Through Study Completion|Physician Decision|1|||
147253743|NCT02028065|531100085|FG001|Treatment Through Study Completion|Physician Decision|0|||
147253744|NCT02028065|531100086|FG002|Treatment Through Study Completion|Physician Decision|0|||
147253745|NCT02028065|531100084|FG000|Treatment Through Study Completion|Protocol Violation|1|||
147253746|NCT02028065|531100085|FG001|Treatment Through Study Completion|Protocol Violation|4|||
147253747|NCT02028065|531100086|FG002|Treatment Through Study Completion|Protocol Violation|0|||
147253748|NCT02028065|531100084|FG000|Treatment Through Study Completion|Withdrawal by Subject|5|||
147253749|NCT02028065|531100085|FG001|Treatment Through Study Completion|Withdrawal by Subject|4|||
147253750|NCT02028065|531100086|FG002|Treatment Through Study Completion|Withdrawal by Subject|3|||
147253751|NCT02028065|531100084|FG000|Treatment Through Study Completion|Adverse Event|3|||
147253752|NCT02028065|531100085|FG001|Treatment Through Study Completion|Adverse Event|3|||
147253753|NCT02028065|531100086|FG002|Treatment Through Study Completion|Adverse Event|5|||
147253754|NCT02107482|531100090|FG000|Overall Study|inconveinence|2|||
147253755|NCT02107482|531100090|FG000|Overall Study|Lost to Follow-up|1|||
147253756|NCT02107482|531100090|FG000|Overall Study|Lack of Efficacy|1|||
147253757|NCT00867009|531100091|FG000|Induction Period|Nonserious Adverse Event|5|||
147253758|NCT00867009|531100091|FG000|Induction Period|Serious Adverse Event|10|||
147253759|NCT00867009|531100091|FG000|Induction Period|Death due to serious adverse event|6|||
147253760|NCT00867009|531100091|FG000|Induction Period|Death due to Study Disease|4|||
147253761|NCT00867009|531100091|FG000|Induction Period|Protocol Violation|1|||
147253762|NCT00867009|531100091|FG000|Induction Period|Withdrawal by Subject|8|||
147253763|NCT00867009|531100091|FG000|Induction Period|Physician Decision|3|||
147253764|NCT00867009|531100091|FG000|Induction Period|Progressive Disease (PD)|25|||
147253765|NCT00867009|531100091|FG000|Maintenance Period|On-going in the Study at Data Cut-off|4|||
147253766|NCT03128892|531100094|FG000|Overall Study|Withdrawal by Subject|2|||
147253767|NCT03128892|531100094|FG000|Overall Study|Physician Decision|1|||
147253768|NCT01850524|531100097|FG000|Overall Study|Lost to Follow-up|5|||
147253769|NCT01850524|531100098|FG001|Overall Study|Lost to Follow-up|10|||
147253770|NCT01850524|531100097|FG000|Overall Study|Withdrawal by Subject|24|||
147253771|NCT01850524|531100098|FG001|Overall Study|Withdrawal by Subject|22|||
147253772|NCT01850524|531100097|FG000|Overall Study|Reason not Specified|142|||
147253773|NCT01850524|531100098|FG001|Overall Study|Reason not Specified|141|||
147253774|NCT00847704|531100099|FG000|Overall Study|Withdrawal by Subject|1|||
147253775|NCT02111850|531100100|FG000|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
147253776|NCT02111850|531100101|FG001|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
147253777|NCT02111850|531100102|FG002|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
147253778|NCT02111850|531100103|FG003|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
147253779|NCT02111850|531100104|FG004|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|1|||
147253780|NCT02111850|531100105|FG005|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
147253781|NCT02111850|531100106|FG006|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
147253782|NCT02111850|531100107|FG007|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
147253783|NCT02111850|531100108|FG008|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
147598534|NCT04394351|532349834|FG000|Part C: (Up to Wk108+12Wk Follow-up)|Withdrawal by Subject|0|||
147598535|NCT04394351|532349835|FG001|Part C: (Up to Wk108+12Wk Follow-up)|Withdrawal by Subject|0|||
147598536|NCT04394351|532349836|FG002|Part C: (Up to Wk108+12Wk Follow-up)|Withdrawal by Subject|0|||
147598537|NCT04394351|532349837|FG003|Part C: (Up to Wk108+12Wk Follow-up)|Withdrawal by Subject|0|||
147449966|NCT02669017|531811326|FG005|Overall Study|Miscellaneous|1|||
147253784|NCT02111850|531100109|FG009|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
147253785|NCT02111850|531100110|FG010|Phase 1 Dose Escalation|Participant found to be ineligible and not treated.|0|||
147253786|NCT00195676|531100111|FG000|Period O - Open-label Treatment|Adverse Event|82|||
147253787|NCT00195676|531100111|FG000|Period O - Open-label Treatment|Death|6|||
147253788|NCT00195676|531100111|FG000|Period O - Open-label Treatment|Lack of Efficacy|198|||
147253789|NCT00195676|531100111|FG000|Period O - Open-label Treatment|Lost to Follow-up|91|||
147253790|NCT00195676|531100111|FG000|Period O - Open-label Treatment|Protocol Violation|12|||
147253791|NCT00195676|531100111|FG000|Period O - Open-label Treatment|Withdrawal by Subject|147|||
147253792|NCT00195676|531100111|FG000|Period O - Open-label Treatment|Administrative reasons|2|||
147253793|NCT00195676|531100111|FG000|Period O - Open-label Treatment|Other reasons|68|||
147253794|NCT00195676|531100111|FG000|Period W (Withdrawal) - No Treatment|Adverse Event|4|||
147253795|NCT00195676|531100111|FG000|Period W (Withdrawal) - No Treatment|Death|2|||
147253796|NCT00195676|531100111|FG000|Period W (Withdrawal) - No Treatment|Lost to Follow-up|11|||
147253797|NCT00195676|531100111|FG000|Period W (Withdrawal) - No Treatment|Withdrawal by Subject|46|||
147253798|NCT00195676|531100111|FG000|Period W (Withdrawal) - No Treatment|Relapse (PGA >= 3)|397|||
147253799|NCT00195676|531100111|FG000|Period W (Withdrawal) - No Treatment|Period W Close-out|129|||
147253800|NCT00195676|531100111|FG000|Period W (Withdrawal) - No Treatment|Administrative reasons|1|||
147253801|NCT00195676|531100111|FG000|Period W (Withdrawal) - No Treatment|Other reasons|18|||
147253802|NCT00195676|531100111|FG000|Period R - Retreatment 16 Weeks|Adverse Event|4|||
147253803|NCT00195676|531100111|FG000|Period R - Retreatment 16 Weeks|Lack of Efficacy|5|||
147253804|NCT00195676|531100111|FG000|Period R - Retreatment 16 Weeks|Lost to Follow-up|11|||
147253805|NCT00195676|531100111|FG000|Period R - Retreatment 16 Weeks|Withdrawal by Subject|9|||
147253806|NCT00195676|531100111|FG000|Period R - Retreatment 16 Weeks|Other reasons|6|||
147253807|NCT03334903|531100113|FG000|Overall Study|Use of medical marijuana - determined ineligible later in study|1|||
147253808|NCT03334903|531100114|FG001|Overall Study|Use of medical marijuana - determined ineligible later in study|0|||
147253809|NCT03334903|531100113|FG000|Overall Study|Protocol Violation|1|||
147253810|NCT03334903|531100114|FG001|Overall Study|Protocol Violation|3|||
147253811|NCT03334903|531100113|FG000|Overall Study|Surgery postponed|1|||
147253812|NCT03334903|531100114|FG001|Overall Study|Surgery postponed|0|||
147253813|NCT03334903|531100113|FG000|Overall Study|Adverse Event|1|||
147253814|NCT03334903|531100114|FG001|Overall Study|Adverse Event|1|||
147253815|NCT03334903|531100113|FG000|Overall Study|Withdrawal by Subject|0|||
147598538|NCT04394351|532349838|FG004|Part C: (Up to Wk108+12Wk Follow-up)|Withdrawal by Subject|0|||
147598539|NCT04394351|532349839|FG005|Part C: (Up to Wk108+12Wk Follow-up)|Withdrawal by Subject|0|||
147598540|NCT04394351|532349840|FG006|Part C: (Up to Wk108+12Wk Follow-up)|Withdrawal by Subject|0|||
147253816|NCT03334903|531100114|FG001|Overall Study|Withdrawal by Subject|1|||
147598541|NCT04394351|532349841|FG007|Part C: (Up to Wk108+12Wk Follow-up)|Withdrawal by Subject|16|||
147253817|NCT02879305|531100115|FG000|Overall Study|Investigator Site Closed|55|||
147253818|NCT02879305|531100116|FG001|Overall Study|Investigator Site Closed|57|||
147253819|NCT02879305|531100115|FG000|Overall Study|Withdrawal by Subject|44|||
147253820|NCT02879305|531100116|FG001|Overall Study|Withdrawal by Subject|42|||
147253821|NCT02879305|531100115|FG000|Overall Study|Lost to Follow-up|17|||
147253822|NCT02879305|531100116|FG001|Overall Study|Lost to Follow-up|12|||
147253823|NCT02879305|531100115|FG000|Overall Study|Other|1|||
147253824|NCT02879305|531100116|FG001|Overall Study|Other|0|||
147253825|NCT02636868|531101634|FG000|Overall Study|Death|0|||
147253826|NCT02636868|531101635|FG001|Overall Study|Death|1|||
147253827|NCT02636868|531101636|FG002|Overall Study|Death|2|||
147253828|NCT03220217|531101637|FG000|Overall Study|Withdrawal by Subject|0|||
147253829|NCT03220217|531101638|FG001|Overall Study|Withdrawal by Subject|1|||
147253830|NCT03220217|531101639|FG002|Overall Study|Withdrawal by Subject|0|||
147253831|NCT03220217|531101637|FG000|Overall Study|Subject Missed Procedure|0|||
147253832|NCT03220217|531101638|FG001|Overall Study|Subject Missed Procedure|0|||
147253833|NCT03220217|531101639|FG002|Overall Study|Subject Missed Procedure|1|||
147253834|NCT03025542|531101640|FG000|Overall Study|Adverse Event|0|||
147253835|NCT03025542|531101641|FG001|Overall Study|Adverse Event|2|||
147253836|NCT03025542|531101640|FG000|Overall Study|Lost to Follow-up|1|||
147253837|NCT03025542|531101641|FG001|Overall Study|Lost to Follow-up|0|||
147253838|NCT03025542|531101640|FG000|Overall Study|Withdrawal by Subject|1|||
147253839|NCT03025542|531101641|FG001|Overall Study|Withdrawal by Subject|0|||
147253840|NCT00501293|531101642|FG000|Optimization Period|Enrolled in error|1|||
147253841|NCT00501293|531101643|FG001|Optimization Period|Enrolled in error|0|||
147253842|NCT00501293|531101642|FG000|Maintenance Period|Withdrawal by Subject|14|||
147253843|NCT00501293|531101643|FG001|Maintenance Period|Withdrawal by Subject|13|||
147598542|NCT04394351|532349834|FG000|Part C: (Up to Wk108+12Wk Follow-up)|Protocol Violation|0|||
147253844|NCT00501293|531101642|FG000|Maintenance Period|Lost to Follow-up|12|||
147253845|NCT00501293|531101643|FG001|Maintenance Period|Lost to Follow-up|7|||
147253846|NCT00501293|531101642|FG000|Maintenance Period|Adverse Event|6|||
147253847|NCT00501293|531101643|FG001|Maintenance Period|Adverse Event|6|||
147253848|NCT00501293|531101642|FG000|Maintenance Period|Protocol Violation|2|||
147449967|NCT02669017|531811327|FG006|Overall Study|Miscellaneous|1|||
147449968|NCT02669017|531811328|FG007|Overall Study|Miscellaneous|13|||
147253849|NCT00501293|531101643|FG001|Maintenance Period|Protocol Violation|1|||
147253850|NCT00501293|531101642|FG000|Maintenance Period|Lack of Efficacy|4|||
147253851|NCT00501293|531101643|FG001|Maintenance Period|Lack of Efficacy|1|||
147253852|NCT00501293|531101642|FG000|Maintenance Period|Noncompliant with study medication|5|||
147253853|NCT00501293|531101643|FG001|Maintenance Period|Noncompliant with study medication|0|||
147253854|NCT00501293|531101642|FG000|Maintenance Period|Went into rehabilitation|1|||
147253855|NCT00501293|531101643|FG001|Maintenance Period|Went into rehabilitation|0|||
147253856|NCT00501293|531101642|FG000|Maintenance Period|Would not wear patch|1|||
147253857|NCT00501293|531101643|FG001|Maintenance Period|Would not wear patch|0|||
147253858|NCT00501293|531101642|FG000|Maintenance Period|Application site reaction|1|||
147253859|NCT00501293|531101643|FG001|Maintenance Period|Application site reaction|0|||
147253860|NCT00488345|531101644|FG000|Overall Study|Adverse Event|0|||
147253861|NCT00488345|531101645|FG001|Overall Study|Adverse Event|1|||
147253862|NCT00488345|531101646|FG002|Overall Study|Adverse Event|1|||
147253863|NCT00488345|531101644|FG000|Overall Study|Unable to administer antibiotics at home|0|||
147253864|NCT00488345|531101645|FG001|Overall Study|Unable to administer antibiotics at home|1|||
147253865|NCT00488345|531101646|FG002|Overall Study|Unable to administer antibiotics at home|0|||
147253866|NCT00488345|531101644|FG000|Overall Study|Institutional Review Board review|0|||
147253867|NCT00488345|531101645|FG001|Overall Study|Institutional Review Board review|0|||
147253868|NCT00488345|531101646|FG002|Overall Study|Institutional Review Board review|1|||
147253869|NCT00488345|531101644|FG000|Overall Study|Surgical team recommendation|0|||
147253870|NCT00488345|531101645|FG001|Overall Study|Surgical team recommendation|1|||
147253871|NCT00488345|531101646|FG002|Overall Study|Surgical team recommendation|0|||
147253872|NCT00488345|531101644|FG000|Overall Study|Parent/legal guardian request|0|||
147253873|NCT00488345|531101645|FG001|Overall Study|Parent/legal guardian request|1|||
147253874|NCT00488345|531101646|FG002|Overall Study|Parent/legal guardian request|1|||
147253875|NCT03518073|531101649|FG000|Overall Study|Adverse Event|2|||
147253876|NCT03518073|531101650|FG001|Overall Study|Adverse Event|4|||
147253877|NCT03518073|531101651|FG002|Overall Study|Adverse Event|2|||
147253878|NCT03518073|531101649|FG000|Overall Study|Death|2|||
147253879|NCT03518073|531101650|FG001|Overall Study|Death|1|||
147253880|NCT03518073|531101651|FG002|Overall Study|Death|3|||
147253881|NCT03518073|531101649|FG000|Overall Study|Lost to Follow-up|1|||
147253882|NCT03518073|531101650|FG001|Overall Study|Lost to Follow-up|0|||
147253883|NCT03518073|531101651|FG002|Overall Study|Lost to Follow-up|1|||
147253884|NCT03518073|531101649|FG000|Overall Study|Physician Decision|5|||
147253885|NCT03518073|531101650|FG001|Overall Study|Physician Decision|0|||
147253886|NCT03518073|531101651|FG002|Overall Study|Physician Decision|2|||
147253887|NCT03518073|531101649|FG000|Overall Study|Progressive disease|1|||
147253888|NCT03518073|531101650|FG001|Overall Study|Progressive disease|1|||
147253889|NCT03518073|531101651|FG002|Overall Study|Progressive disease|1|||
147253890|NCT03518073|531101649|FG000|Overall Study|Protocol Violation|1|||
147253891|NCT03518073|531101650|FG001|Overall Study|Protocol Violation|0|||
147253892|NCT03518073|531101651|FG002|Overall Study|Protocol Violation|0|||
147253893|NCT03518073|531101649|FG000|Overall Study|Withdrawal by Subject|30|||
147253894|NCT03518073|531101650|FG001|Overall Study|Withdrawal by Subject|34|||
147253895|NCT03518073|531101651|FG002|Overall Study|Withdrawal by Subject|29|||
147253896|NCT03518073|531101649|FG000|Overall Study|Withdrawal Due To Caregiver Circumstances|1|||
147253897|NCT03518073|531101650|FG001|Overall Study|Withdrawal Due To Caregiver Circumstances|6|||
147253898|NCT03518073|531101651|FG002|Overall Study|Withdrawal Due To Caregiver Circumstances|7|||
147253899|NCT03518073|531101649|FG000|Overall Study|Covid-19|1|||
147253900|NCT03518073|531101650|FG001|Overall Study|Covid-19|2|||
147253901|NCT03518073|531101651|FG002|Overall Study|Covid-19|1|||
147253902|NCT03045081|531101652|FG000|Overall Study|Withdrawal by Subject|6|||
147253903|NCT03045081|531101653|FG001|Overall Study|Withdrawal by Subject|11|||
147253904|NCT00708162|531101658|FG000|Randomized Phase|Randomized but Not Treated|7|||
147253905|NCT00708162|531101659|FG001|Randomized Phase|Randomized but Not Treated|5|||
147253906|NCT00708162|531101658|FG000|Randomized Phase|Participant Noncompliance|40|||
147253907|NCT00708162|531101659|FG001|Randomized Phase|Participant Noncompliance|32|||
147253908|NCT00708162|531101658|FG000|Randomized Phase|Lost to Follow-up|34|||
147253909|NCT00708162|531101659|FG001|Randomized Phase|Lost to Follow-up|34|||
147253910|NCT00708162|531101658|FG000|Randomized Phase|Withdrew Consent|31|||
147253911|NCT00708162|531101659|FG001|Randomized Phase|Withdrew Consent|22|||
147253912|NCT00708162|531101658|FG000|Randomized Phase|Lack of Efficacy|14|||
147253913|NCT00708162|531101659|FG001|Randomized Phase|Lack of Efficacy|19|||
147253914|NCT00708162|531101658|FG000|Randomized Phase|Protocol Violation|10|||
147253915|NCT00708162|531101659|FG001|Randomized Phase|Protocol Violation|11|||
147253916|NCT00708162|531101658|FG000|Randomized Phase|Adverse Event|8|||
147253917|NCT00708162|531101659|FG001|Randomized Phase|Adverse Event|12|||
147253918|NCT00708162|531101658|FG000|Randomized Phase|Investigator's Discretion|7|||
147253919|NCT00708162|531101659|FG001|Randomized Phase|Investigator's Discretion|10|||
147253920|NCT00708162|531101658|FG000|Randomized Phase|Death|2|||
147253921|NCT00708162|531101659|FG001|Randomized Phase|Death|9|||
147253922|NCT00708162|531101658|FG000|Randomized Phase|Pregnancy|3|||
147253923|NCT00708162|531101659|FG001|Randomized Phase|Pregnancy|0|||
147253924|NCT00708162|531101658|FG000|Open-Label Phase|Lost to Follow-up|10|||
147253925|NCT00708162|531101659|FG001|Open-Label Phase|Lost to Follow-up|8|||
147253926|NCT00708162|531101658|FG000|Open-Label Phase|Withdrew Consent|12|||
147253927|NCT00708162|531101659|FG001|Open-Label Phase|Withdrew Consent|6|||
147253928|NCT00708162|531101658|FG000|Open-Label Phase|Participant Noncompliance|7|||
147253929|NCT00708162|531101659|FG001|Open-Label Phase|Participant Noncompliance|7|||
147253930|NCT00708162|531101658|FG000|Open-Label Phase|Lack of Efficacy|7|||
147253931|NCT00708162|531101659|FG001|Open-Label Phase|Lack of Efficacy|4|||
147253932|NCT00708162|531101658|FG000|Open-Label Phase|Investigator's Discretion|3|||
147253933|NCT00708162|531101659|FG001|Open-Label Phase|Investigator's Discretion|2|||
147253934|NCT00708162|531101658|FG000|Open-Label Phase|Death|3|||
147253935|NCT00708162|531101659|FG001|Open-Label Phase|Death|1|||
147253936|NCT00708162|531101658|FG000|Open-Label Phase|Adverse Event|1|||
147253937|NCT00708162|531101659|FG001|Open-Label Phase|Adverse Event|2|||
147253938|NCT00708162|531101658|FG000|Open-Label Phase|Other|1|||
147253939|NCT00708162|531101659|FG001|Open-Label Phase|Other|0|||
147253940|NCT00100815|531101660|FG000|Overall Study|Progression|24|||
147253941|NCT00100815|531101660|FG000|Overall Study|Adverse Event|18|||
147253942|NCT00100815|531101660|FG000|Overall Study|Death|4|||
147253943|NCT00100815|531101660|FG000|Overall Study|Other|3|||
147253944|NCT04984993|531101661|FG000|Overall Study|Withdrawal by Subject|8|||
147253945|NCT04984993|531101662|FG001|Overall Study|Withdrawal by Subject|2|||
147253946|NCT04984993|531101661|FG000|Overall Study|Lost to Follow-up|2|||
147253947|NCT04984993|531101662|FG001|Overall Study|Lost to Follow-up|2|||
147253948|NCT04984993|531101661|FG000|Overall Study|Both patients moved to another country|4|||
147253949|NCT04984993|531101662|FG001|Overall Study|Both patients moved to another country|0|||
147253950|NCT02436356|531101663|FG000|Overall Study|Excluded by MRI Screening|0|||
147253951|NCT02436356|531101664|FG001|Overall Study|Excluded by MRI Screening|0|||
147253952|NCT02436356|531101665|FG002|Overall Study|Excluded by MRI Screening|2|||
147253953|NCT02436356|531101663|FG000|Overall Study|Lost to Follow-up|0|||
147253954|NCT02436356|531101664|FG001|Overall Study|Lost to Follow-up|1|||
147253955|NCT02436356|531101665|FG002|Overall Study|Lost to Follow-up|0|||
147598543|NCT04394351|532349835|FG001|Part C: (Up to Wk108+12Wk Follow-up)|Protocol Violation|0|||
147598544|NCT04394351|532349836|FG002|Part C: (Up to Wk108+12Wk Follow-up)|Protocol Violation|0|||
147598545|NCT04394351|532349837|FG003|Part C: (Up to Wk108+12Wk Follow-up)|Protocol Violation|0|||
147598546|NCT04394351|532349838|FG004|Part C: (Up to Wk108+12Wk Follow-up)|Protocol Violation|0|||
147598547|NCT04394351|532349839|FG005|Part C: (Up to Wk108+12Wk Follow-up)|Protocol Violation|0|||
147253956|NCT02436356|531101663|FG000|Overall Study|Surgical Approach (Dorsal not volar)|1|||
147253957|NCT02436356|531101664|FG001|Overall Study|Surgical Approach (Dorsal not volar)|0|||
147253958|NCT02436356|531101665|FG002|Overall Study|Surgical Approach (Dorsal not volar)|0|||
147253959|NCT02436356|531101663|FG000|Overall Study|Excluded due to other medical conditions|3|||
147253960|NCT02436356|531101664|FG001|Overall Study|Excluded due to other medical conditions|0|||
147253961|NCT02436356|531101665|FG002|Overall Study|Excluded due to other medical conditions|0|||
147253962|NCT02436356|531101663|FG000|Overall Study|Withdrawal by Subject|1|||
147253963|NCT02436356|531101664|FG001|Overall Study|Withdrawal by Subject|0|||
147332348|NCT05046132|531383233|FG002|Overall Study|Positive Covid19 Result.|0|||
147332349|NCT02148133|531383235|FG000|Overall Study|Investigator discretion|1|||
147332350|NCT02148133|531383235|FG000|Overall Study|Lack of Efficacy|1|||
147332351|NCT02148133|531383235|FG000|Overall Study|Protocol deviation|1|||
147332352|NCT02148133|531383235|FG000|Overall Study|Protocol-defined stopping criteria|2|||
147332353|NCT00855465|531383236|FG000|Treatment Period|Adverse Event|4|||
147332354|NCT00855465|531383237|FG001|Treatment Period|Adverse Event|2|||
147332355|NCT00855465|531383236|FG000|Treatment Period|Death|2|||
147332356|NCT00855465|531383237|FG001|Treatment Period|Death|2|||
147332357|NCT00855465|531383236|FG000|Treatment Period|Lack of Efficacy|2|||
147332358|NCT00855465|531383237|FG001|Treatment Period|Lack of Efficacy|1|||
147332359|NCT00855465|531383236|FG000|Treatment Period|Non-compliance|1|||
147332360|NCT00855465|531383237|FG001|Treatment Period|Non-compliance|0|||
147332361|NCT00855465|531383236|FG000|Treatment Period|Protocol Violation|2|||
147332362|NCT00855465|531383237|FG001|Treatment Period|Protocol Violation|0|||
147332363|NCT00855465|531383236|FG000|Treatment Period|Withdrawal by Subject|2|||
147598548|NCT04394351|532349840|FG006|Part C: (Up to Wk108+12Wk Follow-up)|Protocol Violation|0|||
147332364|NCT00855465|531383237|FG001|Treatment Period|Withdrawal by Subject|0|||
147332365|NCT00855465|531383236|FG000|Treatment Period|Not treated|1|||
147332366|NCT00855465|531383237|FG001|Treatment Period|Not treated|0|||
147253964|NCT02436356|531101665|FG002|Overall Study|Withdrawal by Subject|0|||
147332367|NCT00855465|531383236|FG000|Follow-up Period (FUP)|Adverse Event|0|||
147332368|NCT00855465|531383237|FG001|Follow-up Period (FUP)|Adverse Event|1|||
147449969|NCT02669017|531811329|FG008|Overall Study|Miscellaneous|2|||
147253965|NCT04577118|531101670|FG000|Overall Study|Withdrawal by Subject|4|||
147253966|NCT02611778|531101671|FG000|Overall Study|Withdrawal by Subject|2|||
147253967|NCT02611778|531101672|FG001|Overall Study|Withdrawal by Subject|8|||
147332369|NCT00855465|531383236|FG000|Follow-up Period (FUP)|Death|0|||
147332370|NCT00855465|531383237|FG001|Follow-up Period (FUP)|Death|1|||
147449970|NCT01289015|531811330|FG000|Overall Study|Protocol Violation|12|||
147253968|NCT02611778|531101671|FG000|Overall Study|Adverse Event|1|||
147332371|NCT00855465|531383236|FG000|Follow-up Period (FUP)|Lost to Follow-up|3|||
147332372|NCT00855465|531383237|FG001|Follow-up Period (FUP)|Lost to Follow-up|0|||
147332373|NCT00855465|531383236|FG000|Follow-up Period (FUP)|Withdrawal by Subject|4|||
147332374|NCT00855465|531383237|FG001|Follow-up Period (FUP)|Withdrawal by Subject|0|||
147332375|NCT00855465|531383236|FG000|Follow-up Period (FUP)|Missing|1|||
147332376|NCT00855465|531383237|FG001|Follow-up Period (FUP)|Missing|0|||
147332377|NCT00079183|531383238|FG000|Overall Study|Withdrawal by Subject|4|||
147332378|NCT00079183|531383238|FG000|Overall Study|Study medication non-compliance|2|||
147332379|NCT00079183|531383238|FG000|Overall Study|Specimen collection non-compliance|1|||
147332380|NCT01157182|531383239|FG000|Washout of 28 Days|Adverse Event|2|||
147332381|NCT01157182|531383240|FG001|Washout of 28 Days|Adverse Event|0|||
147332382|NCT03743246|531383241|FG000|Pre-Treatment Period|Failure to meet treatment criteria|0|||
147332383|NCT03743246|531383242|FG001|Pre-Treatment Period|Failure to meet treatment criteria|0|||
147332384|NCT03743246|531383243|FG002|Pre-Treatment Period|Failure to meet treatment criteria|2|||
147332385|NCT03743246|531383244|FG003|Pre-Treatment Period|Failure to meet treatment criteria|0|||
147332386|NCT03743246|531383241|FG000|Pre-Treatment Period|Death|0|||
147332387|NCT03743246|531383242|FG001|Pre-Treatment Period|Death|1|||
147253969|NCT02611778|531101672|FG001|Overall Study|Adverse Event|2|||
147332388|NCT03743246|531383243|FG002|Pre-Treatment Period|Death|0|||
147332389|NCT03743246|531383244|FG003|Pre-Treatment Period|Death|1|||
147332390|NCT03743246|531383241|FG000|Pre-Treatment Period|Study Drug Manufacturing Failure|1|||
147332391|NCT03743246|531383242|FG001|Pre-Treatment Period|Study Drug Manufacturing Failure|0|||
147332392|NCT03743246|531383243|FG002|Pre-Treatment Period|Study Drug Manufacturing Failure|0|||
147332393|NCT03743246|531383244|FG003|Pre-Treatment Period|Study Drug Manufacturing Failure|0|||
147332394|NCT03743246|531383241|FG000|Lymphodepleting Chemotherapy|Progressive Disease|1|||
147332395|NCT03743246|531383242|FG001|Lymphodepleting Chemotherapy|Progressive Disease|0|||
147332396|NCT03743246|531383243|FG002|Lymphodepleting Chemotherapy|Progressive Disease|0|||
147332397|NCT03743246|531383244|FG003|Lymphodepleting Chemotherapy|Progressive Disease|0|||
147332398|NCT03743246|531383241|FG000|Treatment Period (JCAR017 Infusion)|Other Reason|1|||
147332399|NCT03743246|531383242|FG001|Treatment Period (JCAR017 Infusion)|Other Reason|0|||
147332400|NCT03743246|531383243|FG002|Treatment Period (JCAR017 Infusion)|Other Reason|0|||
147332401|NCT03743246|531383244|FG003|Treatment Period (JCAR017 Infusion)|Other Reason|0|||
147332402|NCT03743246|531383241|FG000|Treatment Period (JCAR017 Infusion)|Lost to Follow-up|0|||
147332403|NCT03743246|531383242|FG001|Treatment Period (JCAR017 Infusion)|Lost to Follow-up|1|||
147332404|NCT03743246|531383243|FG002|Treatment Period (JCAR017 Infusion)|Lost to Follow-up|0|||
147332405|NCT03743246|531383244|FG003|Treatment Period (JCAR017 Infusion)|Lost to Follow-up|0|||
147332406|NCT03743246|531383241|FG000|Treatment Period (JCAR017 Infusion)|Progressive Disease|1|||
147332407|NCT03743246|531383242|FG001|Treatment Period (JCAR017 Infusion)|Progressive Disease|0|||
147449971|NCT01289015|531811331|FG001|Overall Study|Protocol Violation|9|||
147449972|NCT01289015|531811330|FG000|Overall Study|Adverse Event|3|||
147253970|NCT02611778|531101671|FG000|Overall Study|Death|2|||
147253971|NCT02611778|531101672|FG001|Overall Study|Death|1|||
147253972|NCT02611778|531101671|FG000|Overall Study|Protocol Violation|1|||
147253973|NCT02611778|531101672|FG001|Overall Study|Protocol Violation|0|||
147253974|NCT02611778|531101671|FG000|Overall Study|Lost to Follow-up|3|||
147253975|NCT02611778|531101672|FG001|Overall Study|Lost to Follow-up|1|||
147253976|NCT02611778|531101671|FG000|Overall Study|Need for alternative treatment|1|||
147253977|NCT02611778|531101672|FG001|Overall Study|Need for alternative treatment|0|||
147253978|NCT02611778|531101671|FG000|Overall Study|Other Reason|2|||
147253979|NCT02611778|531101672|FG001|Overall Study|Other Reason|1|||
147253980|NCT02746874|531101673|FG000|Overall Study|Withdrawal by Subject|0|||
147253981|NCT02746874|531101674|FG001|Overall Study|Withdrawal by Subject|1|||
147253982|NCT02746874|531101673|FG000|Overall Study|Surgery Date Changed|0|||
147253983|NCT02746874|531101674|FG001|Overall Study|Surgery Date Changed|2|||
147253984|NCT02574247|531101689|FG000|Overall Study|Withdrawal by Subject|1|||
147253985|NCT02574247|531101690|FG001|Overall Study|Withdrawal by Subject|0|||
147253986|NCT02574247|531101691|FG002|Overall Study|Withdrawal by Subject|0|||
147253987|NCT02574247|531101689|FG000|Overall Study|Did not meet inclusion criteria|4|||
147253988|NCT02574247|531101690|FG001|Overall Study|Did not meet inclusion criteria|3|||
147253989|NCT02574247|531101691|FG002|Overall Study|Did not meet inclusion criteria|5|||
147253990|NCT01382446|531101692|FG000|Overall Study|Withdrawal by Subject|0|||
147253991|NCT01382446|531101693|FG001|Overall Study|Withdrawal by Subject|1|||
147253992|NCT01382446|531101692|FG000|Overall Study|Removal from Mechanical Ventilation|3|||
147253993|NCT01382446|531101693|FG001|Overall Study|Removal from Mechanical Ventilation|3|||
147253994|NCT00770289|531101703|FG000|Overall Study|Other|6|||
147253995|NCT02659631|531101706|FG000|Overall Study|Lost to Follow-up|0|||
147253996|NCT02659631|531101707|FG001|Overall Study|Lost to Follow-up|0|||
147253997|NCT02659631|531101708|FG002|Overall Study|Lost to Follow-up|2|||
147253998|NCT02659631|531101709|FG003|Overall Study|Lost to Follow-up|0|||
147253999|NCT02659631|531101710|FG004|Overall Study|Lost to Follow-up|0|||
147254000|NCT02659631|531101711|FG005|Overall Study|Lost to Follow-up|1|||
147332408|NCT03743246|531383243|FG002|Treatment Period (JCAR017 Infusion)|Progressive Disease|0|||
147332409|NCT03743246|531383244|FG003|Treatment Period (JCAR017 Infusion)|Progressive Disease|0|||
147254001|NCT02659631|531101712|FG006|Overall Study|Lost to Follow-up|0|||
147254002|NCT02659631|531101713|FG007|Overall Study|Lost to Follow-up|0|||
147254003|NCT02659631|531101714|FG008|Overall Study|Lost to Follow-up|0|||
147254004|NCT02659631|531101715|FG009|Overall Study|Lost to Follow-up|0|||
147254005|NCT02659631|531101706|FG000|Overall Study|Withdrawal prior to treatment|0|||
147254006|NCT02659631|531101707|FG001|Overall Study|Withdrawal prior to treatment|0|||
147254007|NCT02659631|531101708|FG002|Overall Study|Withdrawal prior to treatment|0|||
147254008|NCT02659631|531101709|FG003|Overall Study|Withdrawal prior to treatment|0|||
147254009|NCT02659631|531101710|FG004|Overall Study|Withdrawal prior to treatment|1|||
147254010|NCT02659631|531101711|FG005|Overall Study|Withdrawal prior to treatment|0|||
147254011|NCT02659631|531101712|FG006|Overall Study|Withdrawal prior to treatment|0|||
147254012|NCT02659631|531101713|FG007|Overall Study|Withdrawal prior to treatment|0|||
147254013|NCT02659631|531101714|FG008|Overall Study|Withdrawal prior to treatment|0|||
147254014|NCT02659631|531101715|FG009|Overall Study|Withdrawal prior to treatment|0|||
147254015|NCT02659631|531101706|FG000|Overall Study|Participant refused further follow-up|0|||
147254016|NCT02659631|531101707|FG001|Overall Study|Participant refused further follow-up|0|||
147254017|NCT02659631|531101708|FG002|Overall Study|Participant refused further follow-up|0|||
147254018|NCT02659631|531101709|FG003|Overall Study|Participant refused further follow-up|1|||
147254019|NCT02659631|531101710|FG004|Overall Study|Participant refused further follow-up|0|||
147254020|NCT02659631|531101711|FG005|Overall Study|Participant refused further follow-up|0|||
147254021|NCT02659631|531101712|FG006|Overall Study|Participant refused further follow-up|0|||
147254022|NCT02659631|531101713|FG007|Overall Study|Participant refused further follow-up|0|||
147598549|NCT04394351|532349841|FG007|Part C: (Up to Wk108+12Wk Follow-up)|Protocol Violation|2|||
147598550|NCT04394351|532349834|FG000|Part C: (Up to Wk108+12Wk Follow-up)|Other|0|||
147598551|NCT04394351|532349835|FG001|Part C: (Up to Wk108+12Wk Follow-up)|Other|0|||
147598552|NCT04394351|532349836|FG002|Part C: (Up to Wk108+12Wk Follow-up)|Other|0|||
147598553|NCT04394351|532349837|FG003|Part C: (Up to Wk108+12Wk Follow-up)|Other|0|||
147598554|NCT04394351|532349838|FG004|Part C: (Up to Wk108+12Wk Follow-up)|Other|0|||
147254023|NCT02659631|531101714|FG008|Overall Study|Participant refused further follow-up|1|||
147254024|NCT02659631|531101715|FG009|Overall Study|Participant refused further follow-up|0|||
147254025|NCT02659631|531101706|FG000|Overall Study|Death (follow-up phase)|1|||
147254026|NCT02659631|531101707|FG001|Overall Study|Death (follow-up phase)|2|||
147254027|NCT02659631|531101708|FG002|Overall Study|Death (follow-up phase)|1|||
147254028|NCT02659631|531101709|FG003|Overall Study|Death (follow-up phase)|1|||
147254029|NCT02659631|531101710|FG004|Overall Study|Death (follow-up phase)|3|||
147254030|NCT02659631|531101711|FG005|Overall Study|Death (follow-up phase)|2|||
147254031|NCT02659631|531101712|FG006|Overall Study|Death (follow-up phase)|0|||
147254032|NCT02659631|531101713|FG007|Overall Study|Death (follow-up phase)|3|||
147254033|NCT02659631|531101714|FG008|Overall Study|Death (follow-up phase)|1|||
147254034|NCT02659631|531101715|FG009|Overall Study|Death (follow-up phase)|0|||
147254035|NCT02659631|531101706|FG000|Overall Study|Death (treatment phase)|0|||
147254036|NCT02659631|531101707|FG001|Overall Study|Death (treatment phase)|0|||
147254037|NCT02659631|531101708|FG002|Overall Study|Death (treatment phase)|0|||
147254038|NCT02659631|531101709|FG003|Overall Study|Death (treatment phase)|0|||
147254039|NCT02659631|531101710|FG004|Overall Study|Death (treatment phase)|1|||
147254040|NCT02659631|531101711|FG005|Overall Study|Death (treatment phase)|0|||
147254041|NCT02659631|531101712|FG006|Overall Study|Death (treatment phase)|1|||
147254042|NCT02659631|531101713|FG007|Overall Study|Death (treatment phase)|0|||
147254043|NCT02659631|531101714|FG008|Overall Study|Death (treatment phase)|0|||
147254044|NCT02659631|531101715|FG009|Overall Study|Death (treatment phase)|0|||
147254045|NCT00495170|531101716|FG000|Overall Study|Lost to Follow-up|9|||
147254046|NCT00495170|531101716|FG000|Overall Study|Withdrawal by Subject|3|||
147254047|NCT00495170|531101716|FG000|Overall Study|Inappropriate staging|8|||
147254048|NCT04191499|531101717|FG000|Overall Study|Adverse Event|1|||
147254049|NCT04191499|531101718|FG001|Overall Study|Adverse Event|0|||
147254050|NCT04191499|531101717|FG000|Overall Study|Death|42|||
147254051|NCT04191499|531101718|FG001|Overall Study|Death|55|||
147254052|NCT04191499|531101717|FG000|Overall Study|Lost to Follow-up|4|||
147254053|NCT04191499|531101718|FG001|Overall Study|Lost to Follow-up|1|||
147254054|NCT04191499|531101717|FG000|Overall Study|Physician Decision|1|||
147254055|NCT04191499|531101718|FG001|Overall Study|Physician Decision|0|||
147254056|NCT04191499|531101717|FG000|Overall Study|Progressive Disease|1|||
147254057|NCT04191499|531101718|FG001|Overall Study|Progressive Disease|0|||
147254058|NCT04191499|531101717|FG000|Overall Study|Symptomatic Deterioration|1|||
147254059|NCT04191499|531101718|FG001|Overall Study|Symptomatic Deterioration|0|||
147254060|NCT04191499|531101717|FG000|Overall Study|Withdrawal by Subject|7|||
147254061|NCT04191499|531101718|FG001|Overall Study|Withdrawal by Subject|11|||
147254062|NCT04191499|531101717|FG000|Overall Study|Ongoing in the study|104|||
147598555|NCT04394351|532349839|FG005|Part C: (Up to Wk108+12Wk Follow-up)|Other|0|||
147598556|NCT04394351|532349840|FG006|Part C: (Up to Wk108+12Wk Follow-up)|Other|0|||
147254063|NCT04191499|531101718|FG001|Overall Study|Ongoing in the study|97|||
147254064|NCT00680745|531101719|FG000|Overall Study|Withdrawal by Subject|8|||
147254065|NCT00680745|531101720|FG001|Overall Study|Withdrawal by Subject|3|||
147254066|NCT00680745|531101721|FG002|Overall Study|Withdrawal by Subject|2|||
147598557|NCT04394351|532349841|FG007|Part C: (Up to Wk108+12Wk Follow-up)|Other|32|||
147598558|NCT01106014|532349842|FG000|Overall Study|Morbidity or Mortality primary endpoint|155|||
147598559|NCT01106014|532349843|FG001|Overall Study|Morbidity or Mortality primary endpoint|242|||
147254067|NCT00680745|531101722|FG003|Overall Study|Withdrawal by Subject|8|||
147254068|NCT00680745|531101719|FG000|Overall Study|Lost to Follow-up|0|||
147254069|NCT00680745|531101720|FG001|Overall Study|Lost to Follow-up|1|||
147254070|NCT00680745|531101721|FG002|Overall Study|Lost to Follow-up|1|||
147254071|NCT00680745|531101722|FG003|Overall Study|Lost to Follow-up|0|||
147254072|NCT00680745|531101719|FG000|Overall Study|Death|1|||
147254073|NCT00680745|531101720|FG001|Overall Study|Death|0|||
147254074|NCT00680745|531101721|FG002|Overall Study|Death|1|||
147254075|NCT00680745|531101722|FG003|Overall Study|Death|0|||
147254076|NCT00680745|531101719|FG000|Overall Study|Adverse Event|5|||
147254077|NCT00680745|531101720|FG001|Overall Study|Adverse Event|3|||
147254078|NCT00680745|531101721|FG002|Overall Study|Adverse Event|3|||
147254079|NCT00680745|531101722|FG003|Overall Study|Adverse Event|3|||
147254080|NCT00680745|531101719|FG000|Overall Study|Poor/Non-compliance|0|||
147254081|NCT00680745|531101720|FG001|Overall Study|Poor/Non-compliance|3|||
147254082|NCT00680745|531101721|FG002|Overall Study|Poor/Non-compliance|0|||
147254083|NCT00680745|531101722|FG003|Overall Study|Poor/Non-compliance|0|||
147254084|NCT00680745|531101719|FG000|Overall Study|Subject No Longer Meets Study Criteria|0|||
147254085|NCT00680745|531101720|FG001|Overall Study|Subject No Longer Meets Study Criteria|2|||
147254086|NCT00680745|531101721|FG002|Overall Study|Subject No Longer Meets Study Criteria|0|||
147254087|NCT00680745|531101722|FG003|Overall Study|Subject No Longer Meets Study Criteria|2|||
147254088|NCT00680745|531101719|FG000|Overall Study|False Treatment|0|||
147254089|NCT00680745|531101720|FG001|Overall Study|False Treatment|1|||
147254090|NCT00680745|531101721|FG002|Overall Study|False Treatment|3|||
147254091|NCT00680745|531101722|FG003|Overall Study|False Treatment|0|||
147254092|NCT01928329|531101723|FG000|Overall Study|Withdrew Consent Prior to Receiving Drug|1|||
147254093|NCT01928329|531101724|FG001|Overall Study|Withdrew Consent Prior to Receiving Drug|3|||
147254094|NCT01928329|531101723|FG000|Overall Study|Removed from Study Prior to Receiving Dr|0|||
147254095|NCT01928329|531101724|FG001|Overall Study|Removed from Study Prior to Receiving Dr|1|||
147254096|NCT01928329|531101723|FG000|Overall Study|Adverse Event|5|||
147254097|NCT01928329|531101724|FG001|Overall Study|Adverse Event|3|||
147254098|NCT01928329|531101723|FG000|Overall Study|Stopping Rule: Lost Greater than 5kg|4|||
147254099|NCT01928329|531101724|FG001|Overall Study|Stopping Rule: Lost Greater than 5kg|1|||
147254100|NCT01928329|531101723|FG000|Overall Study|Withdrawal by Subject|1|||
147254101|NCT01928329|531101724|FG001|Overall Study|Withdrawal by Subject|5|||
147254102|NCT01928329|531101723|FG000|Overall Study|Physician Decision|1|||
147254103|NCT01928329|531101724|FG001|Overall Study|Physician Decision|1|||
147254104|NCT00811473|531101725|FG000|Overall Study|Adverse Event|3|||
147254105|NCT00811473|531101726|FG001|Overall Study|Adverse Event|12|||
147254106|NCT00811473|531101725|FG000|Overall Study|Lost to Follow-up|5|||
147254107|NCT00811473|531101726|FG001|Overall Study|Lost to Follow-up|1|||
147254108|NCT00811473|531101725|FG000|Overall Study|Withdrawal by Subject|2|||
147254109|NCT00811473|531101726|FG001|Overall Study|Withdrawal by Subject|4|||
147254110|NCT00811473|531101725|FG000|Overall Study|Severe non-compliance to protocol|2|||
147254111|NCT00811473|531101726|FG001|Overall Study|Severe non-compliance to protocol|4|||
147254112|NCT00811473|531101725|FG000|Overall Study|Lack of therapeutic response|4|||
147254113|NCT00811473|531101726|FG001|Overall Study|Lack of therapeutic response|1|||
147598560|NCT01106014|532349842|FG000|Overall Study|Adverse Event|78|||
147254114|NCT00811473|531101725|FG000|Overall Study|Condition under investigation worsened|1|||
147254115|NCT00811473|531101726|FG001|Overall Study|Condition under investigation worsened|3|||
147254116|NCT00811473|531101725|FG000|Overall Study|Other 2|4|||
147254117|NCT00811473|531101726|FG001|Overall Study|Other 2|1|||
147254118|NCT00811473|531101725|FG000|Overall Study|Incorrect Enrollment|1|||
147254119|NCT00811473|531101726|FG001|Overall Study|Incorrect Enrollment|0|||
147254120|NCT00811473|531101725|FG000|Overall Study|Safety Reasons|1|||
147254121|NCT00811473|531101726|FG001|Overall Study|Safety Reasons|0|||
147254122|NCT01119131|531101736|FG000|Overall Study|Adverse Event|1|||
147254123|NCT01119131|531101737|FG001|Overall Study|Adverse Event|1|||
147254124|NCT01119131|531101738|FG002|Overall Study|Adverse Event|1|||
147254125|NCT01119131|531101736|FG000|Overall Study|Non-Compliance|1|||
147254126|NCT01119131|531101737|FG001|Overall Study|Non-Compliance|0|||
147254127|NCT01119131|531101738|FG002|Overall Study|Non-Compliance|4|||
147254128|NCT01119131|531101736|FG000|Overall Study|Physician Decision|0|||
147254129|NCT01119131|531101737|FG001|Overall Study|Physician Decision|0|||
147254130|NCT01119131|531101738|FG002|Overall Study|Physician Decision|1|||
147254131|NCT00732615|531101739|FG000|Overall Study|Withdrawal by Subject|3|||
147254132|NCT00732615|531101740|FG001|Overall Study|Withdrawal by Subject|1|||
147254133|NCT00732615|531101739|FG000|Overall Study|Lost to Follow-up|0|||
147254134|NCT00732615|531101740|FG001|Overall Study|Lost to Follow-up|1|||
147254135|NCT00732615|531101739|FG000|Overall Study|Adverse Event|0|||
147254136|NCT00732615|531101740|FG001|Overall Study|Adverse Event|2|||
147254137|NCT00732615|531101739|FG000|Overall Study|Physician Decision|3|||
147254138|NCT00732615|531101740|FG001|Overall Study|Physician Decision|0|||
147598561|NCT01106014|532349843|FG001|Overall Study|Adverse Event|42|||
147254139|NCT00732615|531101739|FG000|Overall Study|Non-Compliance, Subject/Physician Dec.|1|||
147254140|NCT00732615|531101740|FG001|Overall Study|Non-Compliance, Subject/Physician Dec.|1|||
147254141|NCT00993291|531101741|FG000|Overall Study|Withdrawal by Subject|1|||
147254142|NCT00003492|531101742|FG000|Overall Study|Not evaluable|6|||
147254143|NCT03566823|531101743|FG000|Overall Study|Lack of Efficacy|0|||
147254144|NCT03566823|531101744|FG001|Overall Study|Lack of Efficacy|1|||
147254145|NCT03566823|531101745|FG002|Overall Study|Lack of Efficacy|0|||
147254146|NCT03566823|531101743|FG000|Overall Study|Withdrawal by Subject|1|||
147254147|NCT03566823|531101744|FG001|Overall Study|Withdrawal by Subject|2|||
147254148|NCT03566823|531101745|FG002|Overall Study|Withdrawal by Subject|0|||
147254149|NCT03566823|531101743|FG000|Overall Study|Adverse Event|1|||
147254150|NCT03566823|531101744|FG001|Overall Study|Adverse Event|0|||
147254151|NCT03566823|531101745|FG002|Overall Study|Adverse Event|2|||
147254152|NCT04446377|531101746|FG000|Overall Study|Withdrawal by Subject|6|||
147254153|NCT04446377|531101747|FG001|Overall Study|Withdrawal by Subject|1|||
147254154|NCT04446377|531101746|FG000|Overall Study|Physician Decision|1|||
147254155|NCT04446377|531101747|FG001|Overall Study|Physician Decision|1|||
147254156|NCT04446377|531101746|FG000|Overall Study|Lost to Follow-up|0|||
147254157|NCT04446377|531101747|FG001|Overall Study|Lost to Follow-up|2|||
147254158|NCT04446377|531101746|FG000|Overall Study|Not eligible|0|||
147254159|NCT04446377|531101747|FG001|Overall Study|Not eligible|1|||
147254160|NCT01414075|531101748|FG000|Overall Study|Adverse Event|1|||
147254161|NCT01414075|531101749|FG001|Overall Study|Adverse Event|0|||
147254162|NCT01414075|531101750|FG002|Overall Study|Adverse Event|1|||
147254163|NCT01414075|531101751|FG003|Overall Study|Adverse Event|0|||
147254164|NCT01414075|531101748|FG000|Overall Study|Death|1|||
147254165|NCT01414075|531101749|FG001|Overall Study|Death|0|||
147254166|NCT01414075|531101750|FG002|Overall Study|Death|0|||
147254167|NCT01414075|531101751|FG003|Overall Study|Death|1|||
147254168|NCT01414075|531101748|FG000|Overall Study|Withdrawal by Subject|0|||
147254169|NCT01414075|531101749|FG001|Overall Study|Withdrawal by Subject|0|||
147254170|NCT01414075|531101750|FG002|Overall Study|Withdrawal by Subject|0|||
147254171|NCT01414075|531101751|FG003|Overall Study|Withdrawal by Subject|1|||
147254172|NCT01414075|531101748|FG000|Overall Study|Other than specified|1|||
147254173|NCT01414075|531101749|FG001|Overall Study|Other than specified|0|||
147254174|NCT01414075|531101750|FG002|Overall Study|Other than specified|1|||
147254175|NCT01414075|531101751|FG003|Overall Study|Other than specified|0|||
147254176|NCT01187043|531101754|FG000|Overall Study|Adverse Event|0|||
147254177|NCT01187043|531101755|FG001|Overall Study|Adverse Event|0|||
147254178|NCT01187043|531101756|FG002|Overall Study|Adverse Event|0|||
147254179|NCT01187043|531101757|FG003|Overall Study|Adverse Event|0|||
147254180|NCT01187043|531101758|FG004|Overall Study|Adverse Event|1|||
147254181|NCT01187043|531101754|FG000|Overall Study|Unable to make scheduled visits|1|||
147254182|NCT01187043|531101755|FG001|Overall Study|Unable to make scheduled visits|0|||
147254183|NCT01187043|531101756|FG002|Overall Study|Unable to make scheduled visits|4|||
147254184|NCT01187043|531101757|FG003|Overall Study|Unable to make scheduled visits|0|||
147254185|NCT01187043|531101758|FG004|Overall Study|Unable to make scheduled visits|1|||
147254186|NCT04903626|531101759|FG000|Overall Study|Lost to Follow-up|6|||
147254187|NCT04903626|531101759|FG000|Overall Study|Withdrawal by Subject|1|||
147254188|NCT04903626|531101759|FG000|Overall Study|Other, Not Specified|1|||
147254189|NCT00573534|531101760|FG000|Overall Study|oppositional behavior|3|||
147254190|NCT00927784|531101763|FG000|Overall Study|Death|1|||
147254191|NCT00927784|531101764|FG001|Overall Study|Death|0|||
147254192|NCT00927784|531101763|FG000|Overall Study|Withdrawal by Subject|1|||
147254193|NCT00927784|531101764|FG001|Overall Study|Withdrawal by Subject|0|||
147254194|NCT02457910|531101765|FG000|Overall Study|Withdrawal by Subject|0|||
147254195|NCT02457910|531101766|FG001|Overall Study|Withdrawal by Subject|0|||
147254196|NCT02457910|531101767|FG002|Overall Study|Withdrawal by Subject|0|||
147254197|NCT02457910|531101768|FG003|Overall Study|Withdrawal by Subject|0|||
147254198|NCT02457910|531101769|FG004|Overall Study|Withdrawal by Subject|0|||
147449973|NCT01289015|531811331|FG001|Overall Study|Adverse Event|0|||
147598562|NCT01106014|532349842|FG000|Overall Study|Withdrawal by Subject|43|||
147598563|NCT01106014|532349843|FG001|Overall Study|Withdrawal by Subject|37|||
147598564|NCT01106014|532349842|FG000|Overall Study|Administrative reason|7|||
147598565|NCT01106014|532349843|FG001|Overall Study|Administrative reason|6|||
147598566|NCT01106014|532349842|FG000|Overall Study|Lost to Follow-up|2|||
147254199|NCT02457910|531101770|FG005|Overall Study|Withdrawal by Subject|1|||
147254200|NCT02457910|531101765|FG000|Overall Study|Adverse Event|0|||
147254201|NCT02457910|531101766|FG001|Overall Study|Adverse Event|2|||
147254202|NCT02457910|531101767|FG002|Overall Study|Adverse Event|1|||
147254203|NCT02457910|531101768|FG003|Overall Study|Adverse Event|1|||
147254204|NCT02457910|531101769|FG004|Overall Study|Adverse Event|1|||
147254205|NCT02457910|531101770|FG005|Overall Study|Adverse Event|3|||
147254206|NCT02457910|531101765|FG000|Overall Study|Disease progression|3|||
147254207|NCT02457910|531101766|FG001|Overall Study|Disease progression|3|||
147598567|NCT01106014|532349843|FG001|Overall Study|Lost to Follow-up|3|||
147254208|NCT02457910|531101767|FG002|Overall Study|Disease progression|1|||
147254209|NCT02457910|531101768|FG003|Overall Study|Disease progression|1|||
147254210|NCT02457910|531101769|FG004|Overall Study|Disease progression|4|||
147254211|NCT02457910|531101770|FG005|Overall Study|Disease progression|6|||
147254212|NCT02457910|531101765|FG000|Overall Study|Other complicating illness|0|||
147254213|NCT02457910|531101766|FG001|Overall Study|Other complicating illness|0|||
147254214|NCT02457910|531101767|FG002|Overall Study|Other complicating illness|0|||
147254215|NCT02457910|531101768|FG003|Overall Study|Other complicating illness|0|||
147254216|NCT02457910|531101769|FG004|Overall Study|Other complicating illness|0|||
147254217|NCT02457910|531101770|FG005|Overall Study|Other complicating illness|1|||
147254218|NCT02457910|531101765|FG000|Overall Study|Death|0|||
147254219|NCT02457910|531101766|FG001|Overall Study|Death|0|||
147254220|NCT02457910|531101767|FG002|Overall Study|Death|1|||
147254221|NCT02457910|531101768|FG003|Overall Study|Death|0|||
147598568|NCT00658658|532349850|FG000|Overall Study|Withdrawal by Subject|0|||
147598569|NCT00658658|532349851|FG001|Overall Study|Withdrawal by Subject|1|||
147598570|NCT00658658|532349852|FG002|Overall Study|Withdrawal by Subject|0|||
147598571|NCT00658658|532349853|FG003|Overall Study|Withdrawal by Subject|0|||
147254222|NCT02457910|531101769|FG004|Overall Study|Death|0|||
147254223|NCT02457910|531101770|FG005|Overall Study|Death|0|||
147254224|NCT00467259|531101771|FG000|Overall Study|Adverse Event|24|||
147254225|NCT00467259|531101772|FG001|Overall Study|Adverse Event|90|||
147254226|NCT00467259|531101771|FG000|Overall Study|Protocol Violation|1|||
147254227|NCT00467259|531101772|FG001|Overall Study|Protocol Violation|7|||
147254228|NCT00467259|531101771|FG000|Overall Study|Withdrawal by Subject|34|||
147254229|NCT00467259|531101772|FG001|Overall Study|Withdrawal by Subject|108|||
147254230|NCT00467259|531101771|FG000|Overall Study|Physician Decision|0|||
147254231|NCT00467259|531101772|FG001|Overall Study|Physician Decision|2|||
147254232|NCT00467259|531101771|FG000|Overall Study|Lost to Follow-up|14|||
147254233|NCT00467259|531101772|FG001|Overall Study|Lost to Follow-up|34|||
147332410|NCT03743246|531383241|FG000|Treatment Period (JCAR017 Infusion)|Death|1|||
147332411|NCT03743246|531383242|FG001|Treatment Period (JCAR017 Infusion)|Death|0|||
147332412|NCT03743246|531383243|FG002|Treatment Period (JCAR017 Infusion)|Death|0|||
147332413|NCT03743246|531383244|FG003|Treatment Period (JCAR017 Infusion)|Death|0|||
147332414|NCT03743246|531383241|FG000|Treatment Period (JCAR017 Infusion)|Study Terminated by Sponsor|1|||
147332415|NCT03743246|531383242|FG001|Treatment Period (JCAR017 Infusion)|Study Terminated by Sponsor|0|||
147598572|NCT00658658|532349854|FG004|Overall Study|Withdrawal by Subject|0|||
147598573|NCT00658658|532349850|FG000|Overall Study|Death|4|||
147254234|NCT00467259|531101771|FG000|Overall Study|Site Closed|2|||
147254235|NCT00467259|531101772|FG001|Overall Study|Site Closed|1|||
147254236|NCT02196558|531101773|FG000|Treatment Phase (12 Weeks)|Adverse Event|0|||
147254237|NCT02196558|531101774|FG001|Treatment Phase (12 Weeks)|Adverse Event|2|||
147254238|NCT02196558|531101775|FG002|Treatment Phase (12 Weeks)|Adverse Event|0|||
147254239|NCT02196558|531101773|FG000|Treatment Phase (12 Weeks)|Participant Choice|0|||
147254240|NCT02196558|531101774|FG001|Treatment Phase (12 Weeks)|Participant Choice|1|||
147254241|NCT02196558|531101775|FG002|Treatment Phase (12 Weeks)|Participant Choice|1|||
147254242|NCT02196558|531101773|FG000|Treatment Phase (12 Weeks)|Progression of Disease|0|||
147254243|NCT02196558|531101774|FG001|Treatment Phase (12 Weeks)|Progression of Disease|0|||
147254244|NCT02196558|531101775|FG002|Treatment Phase (12 Weeks)|Progression of Disease|1|||
147254245|NCT02196558|531101773|FG000|Extension Phase (40 Weeks)|Adverse Event|1|||
147254246|NCT02196558|531101774|FG001|Extension Phase (40 Weeks)|Adverse Event|2|||
147254247|NCT02196558|531101775|FG002|Extension Phase (40 Weeks)|Adverse Event|0|||
147254248|NCT02196558|531101773|FG000|Extension Phase (40 Weeks)|Inadequate therapeutic effect|1|||
147254249|NCT02196558|531101774|FG001|Extension Phase (40 Weeks)|Inadequate therapeutic effect|1|||
147254250|NCT02196558|531101775|FG002|Extension Phase (40 Weeks)|Inadequate therapeutic effect|1|||
147254251|NCT00576927|531101776|FG000|Clinical Assessment|Lack of Efficacy|24|||
147254252|NCT00576927|531101776|FG000|Clinical Assessment|Death|1|||
147254253|NCT00576927|531101776|FG000|Clinical Assessment|Withdrawal by Subject|10|||
147254254|NCT00576927|531101776|FG000|Clinical Assessment|Physician Decision|1|||
147254255|NCT00576927|531101776|FG000|Baseline|Physician Decision|9|||
147254256|NCT00576927|531101776|FG000|Baseline|Medication Change by PCP of subject|1|||
147254257|NCT00576927|531101776|FG000|Baseline|Withdrawal by Subject|3|||
147254258|NCT00576927|531101776|FG000|Sleep Hygiene Behavioral Intervention|Responded to intervention|4|||
147254259|NCT00576927|531101776|FG000|Sleep Hygiene Behavioral Intervention|Death|1|||
147254260|NCT00576927|531101776|FG000|Sleep Hygiene Behavioral Intervention|Medication Change by PCP for subject|1|||
147254261|NCT00576927|531101776|FG000|Sleep Hygiene Behavioral Intervention|Withdrawal by Subject|1|||
147254262|NCT00576927|531101776|FG000|Sleep Hygiene With the Placebo|Withdrawal by Subject|1|||
147254263|NCT01846611|531101786|FG000|Overall Study|Lost to Follow-up|4|||
147254264|NCT01846611|531101787|FG001|Overall Study|Lost to Follow-up|6|||
147254265|NCT01846611|531101786|FG000|Overall Study|Withdrawal by Subject|15|||
147254266|NCT01846611|531101787|FG001|Overall Study|Withdrawal by Subject|19|||
147254267|NCT01846611|531101786|FG000|Overall Study|Other|19|||
147254268|NCT01846611|531101787|FG001|Overall Study|Other|18|||
147254269|NCT00541034|531101788|FG000|Overall Study|Non-Compliance|3|||
147254270|NCT00680043|531101790|FG000|Overall Study|Withdrawal by Subject|1|||
147332416|NCT03743246|531383243|FG002|Treatment Period (JCAR017 Infusion)|Study Terminated by Sponsor|0|||
147332417|NCT03743246|531383244|FG003|Treatment Period (JCAR017 Infusion)|Study Terminated by Sponsor|0|||
147332418|NCT00530842|531383245|FG000|Overall Study|Adverse Event|10|||
147332419|NCT00530842|531383246|FG001|Overall Study|Adverse Event|6|||
147598574|NCT00658658|532349851|FG001|Overall Study|Death|0|||
147598575|NCT00658658|532349852|FG002|Overall Study|Death|0|||
147332420|NCT00530842|531383245|FG000|Overall Study|Lack of Efficacy|2|||
147332421|NCT00530842|531383246|FG001|Overall Study|Lack of Efficacy|1|||
147332422|NCT00530842|531383245|FG000|Overall Study|Lost to Follow-up|0|||
147332423|NCT00530842|531383246|FG001|Overall Study|Lost to Follow-up|4|||
147332424|NCT00530842|531383245|FG000|Overall Study|Protocol Violation|3|||
147598576|NCT00658658|532349853|FG003|Overall Study|Death|1|||
147598577|NCT00658658|532349854|FG004|Overall Study|Death|1|||
147598578|NCT00658658|532349850|FG000|Overall Study|Disease Progression|0|||
147598579|NCT00658658|532349851|FG001|Overall Study|Disease Progression|1|||
147598580|NCT00658658|532349852|FG002|Overall Study|Disease Progression|0|||
147254271|NCT00680043|531101791|FG001|Overall Study|Withdrawal by Subject|0|||
147254272|NCT00680043|531101792|FG002|Overall Study|Withdrawal by Subject|0|||
147254273|NCT00680043|531101790|FG000|Overall Study|Patient Not Compliant With Study Reqs.|0|||
147254274|NCT00680043|531101791|FG001|Overall Study|Patient Not Compliant With Study Reqs.|1|||
147254275|NCT00680043|531101792|FG002|Overall Study|Patient Not Compliant With Study Reqs.|0|||
147254276|NCT00680043|531101790|FG000|Overall Study|Renal Transplant|1|||
147254277|NCT00680043|531101791|FG001|Overall Study|Renal Transplant|0|||
147254278|NCT00680043|531101792|FG002|Overall Study|Renal Transplant|4|||
147254279|NCT03061331|531101793|FG000|Washout Period (8 Weeks)|Adverse Event|2|||
147254280|NCT03061331|531101794|FG001|Washout Period (8 Weeks)|Adverse Event|1|||
147254281|NCT01980875|531101795|FG000|Overall Study|Withdrew Consent|1|||
147254282|NCT01980875|531101796|FG001|Overall Study|Withdrew Consent|1|||
147254283|NCT01980875|531101797|FG002|Overall Study|Withdrew Consent|1|||
147254284|NCT01980875|531101795|FG000|Overall Study|Study Terminated by Sponsor|7|||
147254285|NCT01980875|531101796|FG001|Overall Study|Study Terminated by Sponsor|24|||
147254286|NCT01980875|531101797|FG002|Overall Study|Study Terminated by Sponsor|22|||
147254287|NCT01980875|531101795|FG000|Overall Study|Lost to Follow-up|0|||
147254288|NCT01980875|531101796|FG001|Overall Study|Lost to Follow-up|0|||
147254289|NCT01980875|531101797|FG002|Overall Study|Lost to Follow-up|1|||
147254290|NCT00513474|531101798|FG000|Overall Study|Death|6|||
147254291|NCT00513474|531101799|FG001|Overall Study|Death|9|||
147254292|NCT00513474|531101798|FG000|Overall Study|Participant Withdrew Consent|1|||
147254293|NCT00513474|531101799|FG001|Overall Study|Participant Withdrew Consent|0|||
147254294|NCT01686633|531101800|FG000|Overall Study|Lack of Efficacy|33|||
147254295|NCT01686633|531101801|FG001|Overall Study|Lack of Efficacy|13|||
147254296|NCT01686633|531101802|FG002|Overall Study|Lack of Efficacy|11|||
147254297|NCT01686633|531101800|FG000|Overall Study|Withdrawal by Subject|8|||
147254298|NCT01686633|531101801|FG001|Overall Study|Withdrawal by Subject|8|||
147254299|NCT01686633|531101802|FG002|Overall Study|Withdrawal by Subject|5|||
147254300|NCT01686633|531101800|FG000|Overall Study|Physician Decision|3|||
147254301|NCT01686633|531101801|FG001|Overall Study|Physician Decision|4|||
147254302|NCT01686633|531101802|FG002|Overall Study|Physician Decision|4|||
147254303|NCT01686633|531101800|FG000|Overall Study|Adverse Event|4|||
147254304|NCT01686633|531101801|FG001|Overall Study|Adverse Event|3|||
147254305|NCT01686633|531101802|FG002|Overall Study|Adverse Event|3|||
147254306|NCT01686633|531101800|FG000|Overall Study|Protocol Violation|2|||
147254307|NCT01686633|531101801|FG001|Overall Study|Protocol Violation|3|||
147254308|NCT01686633|531101802|FG002|Overall Study|Protocol Violation|0|||
147254309|NCT01686633|531101800|FG000|Overall Study|Protocol-defined Stopping Criteria|1|||
147254310|NCT01686633|531101801|FG001|Overall Study|Protocol-defined Stopping Criteria|0|||
147254311|NCT01686633|531101802|FG002|Overall Study|Protocol-defined Stopping Criteria|1|||
147254312|NCT01686633|531101800|FG000|Overall Study|Lost to Follow-up|0|||
147254313|NCT01686633|531101801|FG001|Overall Study|Lost to Follow-up|1|||
147254314|NCT01686633|531101802|FG002|Overall Study|Lost to Follow-up|1|||
147254315|NCT01189812|531101808|FG000|Overall Study|Withdrawal by Subject|2|||
147332425|NCT00530842|531383246|FG001|Overall Study|Protocol Violation|2|||
147661262|NCT01657162|532581468|FG001|Overall Study|Inability to Complete Study Procedures|7|||
147661263|NCT01657162|532581467|FG000|Overall Study|Protocol Violation|1|||
147661264|NCT01657162|532581468|FG001|Overall Study|Protocol Violation|0|||
147254316|NCT01189812|531101809|FG001|Overall Study|Withdrawal by Subject|3|||
147254317|NCT01189812|531101808|FG000|Overall Study|Adverse Event|1|||
147661265|NCT01657162|532581467|FG000|Overall Study|Hypersensitivity to Alendronate|0|||
147254318|NCT01189812|531101809|FG001|Overall Study|Adverse Event|0|||
147254319|NCT01189812|531101808|FG000|Overall Study|Out of Window|4|||
147254320|NCT01189812|531101809|FG001|Overall Study|Out of Window|3|||
147254321|NCT01189812|531101808|FG000|Overall Study|Moved out of State|1|||
147254322|NCT01189812|531101809|FG001|Overall Study|Moved out of State|2|||
147254323|NCT02200445|531101811|FG000|Overall Study|Lack of Efficacy|1|||
147254324|NCT02200445|531101812|FG001|Overall Study|Lack of Efficacy|2|||
147332426|NCT00530842|531383245|FG000|Overall Study|Withdrawal by Subject|4|||
147332427|NCT00530842|531383246|FG001|Overall Study|Withdrawal by Subject|5|||
147449974|NCT01289015|531811330|FG000|Overall Study|Lost to Follow-up|33|||
147598581|NCT00658658|532349853|FG003|Overall Study|Disease Progression|1|||
147598582|NCT00658658|532349854|FG004|Overall Study|Disease Progression|3|||
147254325|NCT02200445|531101813|FG002|Overall Study|Lack of Efficacy|2|||
147332428|NCT00530842|531383245|FG000|Overall Study|Individual different reasons|4|||
147332429|NCT00530842|531383246|FG001|Overall Study|Individual different reasons|3|||
147332430|NCT00530842|531383245|FG000|Period 1|Adverse Event|7|||
147332431|NCT00530842|531383246|FG001|Period 1|Adverse Event|3|||
147332432|NCT00530842|531383245|FG000|Period 1|Lack of Efficacy|1|||
147332433|NCT00530842|531383246|FG001|Period 1|Lack of Efficacy|1|||
147332434|NCT00530842|531383245|FG000|Period 1|Protocol Violation|2|||
147332435|NCT00530842|531383246|FG001|Period 1|Protocol Violation|1|||
147332436|NCT00530842|531383245|FG000|Period 1|Withdrawal by Subject|2|||
147332437|NCT00530842|531383246|FG001|Period 1|Withdrawal by Subject|3|||
147332438|NCT00530842|531383245|FG000|Period 1|Individual different reasons|2|||
147332439|NCT00530842|531383246|FG001|Period 1|Individual different reasons|3|||
147332440|NCT00530842|531383245|FG000|Period 2|Adverse Event|3|||
147332441|NCT00530842|531383246|FG001|Period 2|Adverse Event|3|||
147332442|NCT00530842|531383245|FG000|Period 2|Lack of Efficacy|1|||
147254326|NCT02200445|531101811|FG000|Overall Study|Adverse Event|0|||
147254327|NCT02200445|531101812|FG001|Overall Study|Adverse Event|2|||
147254328|NCT02200445|531101813|FG002|Overall Study|Adverse Event|0|||
147254329|NCT00587561|531103640|FG000|Overall Study|Lost to Follow-up|6|||
147254330|NCT00587561|531103641|FG001|Overall Study|Lost to Follow-up|4|||
147254331|NCT03204981|531103643|FG000|Overall Study|Physician Decision|2|||
147254332|NCT03204981|531103643|FG000|Overall Study|Screen failures (no inducible VT or PVCs)|4|||
147254333|NCT04244786|531103646|FG000|Overall Study|Adverse Event|0|||
147254334|NCT04244786|531103647|FG001|Overall Study|Adverse Event|0|||
147254335|NCT04244786|531103648|FG002|Overall Study|Adverse Event|2|||
147254336|NCT04244786|531103646|FG000|Overall Study|Withdrawal by Subject|0|||
147254337|NCT04244786|531103647|FG001|Overall Study|Withdrawal by Subject|0|||
147254338|NCT04244786|531103648|FG002|Overall Study|Withdrawal by Subject|5|||
147254339|NCT00613938|531103649|FG000|Overall Study|Withdrawal by Subject|2|||
147254340|NCT00613938|531103650|FG001|Overall Study|Withdrawal by Subject|4|||
147254341|NCT00613938|531103651|FG002|Overall Study|Withdrawal by Subject|9|||
147254342|NCT00613938|531103652|FG003|Overall Study|Withdrawal by Subject|9|||
147254343|NCT00613938|531103649|FG000|Overall Study|Adverse Event|1|||
147254344|NCT00613938|531103650|FG001|Overall Study|Adverse Event|4|||
147254345|NCT00613938|531103651|FG002|Overall Study|Adverse Event|8|||
147254346|NCT00613938|531103652|FG003|Overall Study|Adverse Event|5|||
147254347|NCT00613938|531103649|FG000|Overall Study|Lack of Efficacy|16|||
147254348|NCT00613938|531103650|FG001|Overall Study|Lack of Efficacy|18|||
147254349|NCT00613938|531103651|FG002|Overall Study|Lack of Efficacy|5|||
147254350|NCT00613938|531103652|FG003|Overall Study|Lack of Efficacy|9|||
147254351|NCT00613938|531103649|FG000|Overall Study|Other|1|||
147254352|NCT00613938|531103650|FG001|Overall Study|Other|2|||
147254353|NCT00613938|531103651|FG002|Overall Study|Other|1|||
147254354|NCT00613938|531103652|FG003|Overall Study|Other|3|||
147254355|NCT00623727|531103653|FG000|Double Blind (DB)|Adverse Event|1|||
147254356|NCT00623727|531103654|FG001|Double Blind (DB)|Adverse Event|3|||
147254357|NCT00623727|531103653|FG000|Double Blind (DB)|Physician Decision|0|||
147254358|NCT00623727|531103654|FG001|Double Blind (DB)|Physician Decision|1|||
147254359|NCT00623727|531103653|FG000|Double Blind (DB)|Withdrawal by Subject|8|||
147254360|NCT00623727|531103654|FG001|Double Blind (DB)|Withdrawal by Subject|2|||
147254361|NCT00623727|531103653|FG000|Double Blind (DB)|Lack of Efficacy|2|||
147254362|NCT00623727|531103654|FG001|Double Blind (DB)|Lack of Efficacy|2|||
147254363|NCT00623727|531103653|FG000|Double Blind (DB)|Termination of the double-blind period|22|||
147254364|NCT00623727|531103654|FG001|Double Blind (DB)|Termination of the double-blind period|21|||
147254365|NCT00623727|531103653|FG000|Double Blind (DB)|Lost to Follow-up|1|||
147254366|NCT00623727|531103654|FG001|Double Blind (DB)|Lost to Follow-up|1|||
147254367|NCT00623727|531103653|FG000|Double Blind (DB)|Protocol Violation|2|||
147254368|NCT00623727|531103654|FG001|Double Blind (DB)|Protocol Violation|2|||
147254369|NCT00623727|531103653|FG000|Open Label Follow-up|Withdrawal by Subject|0|||
147254370|NCT00623727|531103654|FG001|Open Label Follow-up|Withdrawal by Subject|1|||
147254371|NCT00623727|531103653|FG000|Open Label Follow-up|Study termination|0|||
147254372|NCT00623727|531103654|FG001|Open Label Follow-up|Study termination|6|||
147254373|NCT00623727|531103653|FG000|Open Label Follow-up|Participant convenience|0|||
147254374|NCT00623727|531103654|FG001|Open Label Follow-up|Participant convenience|1|||
147254375|NCT03745937|531103655|FG000|Overall Study|Withdrawal by Subject|0|||
147254376|NCT03745937|531103656|FG001|Overall Study|Withdrawal by Subject|0|||
147332443|NCT00530842|531383246|FG001|Period 2|Lack of Efficacy|0|||
147598583|NCT00658658|532349850|FG000|Overall Study|Protocol-specified Criteria|1|||
147598584|NCT00658658|532349851|FG001|Overall Study|Protocol-specified Criteria|0|||
147254377|NCT03745937|531103657|FG002|Overall Study|Withdrawal by Subject|0|||
147254378|NCT03745937|531103658|FG003|Overall Study|Withdrawal by Subject|1|||
147332444|NCT00530842|531383245|FG000|Period 2|Lost to Follow-up|0|||
147332445|NCT00530842|531383246|FG001|Period 2|Lost to Follow-up|4|||
147332446|NCT00530842|531383245|FG000|Period 2|Protocol Violation|1|||
147598585|NCT00658658|532349852|FG002|Overall Study|Protocol-specified Criteria|0|||
147598586|NCT00658658|532349853|FG003|Overall Study|Protocol-specified Criteria|0|||
147254379|NCT03745937|531103655|FG000|Overall Study|Not-specifed|0|||
147332447|NCT00530842|531383246|FG001|Period 2|Protocol Violation|0|||
147254380|NCT03745937|531103656|FG001|Overall Study|Not-specifed|1|||
147254381|NCT03745937|531103657|FG002|Overall Study|Not-specifed|0|||
147254382|NCT03745937|531103658|FG003|Overall Study|Not-specifed|1|||
147254383|NCT00312494|531103660|FG000|Overall Study|Randomized; not treated with study drug|9|||
147254384|NCT00312494|531103661|FG001|Overall Study|Randomized; not treated with study drug|10|||
147254385|NCT00312494|531103662|FG002|Overall Study|Randomized; not treated with study drug|5|||
147254386|NCT00312494|531103660|FG000|Overall Study|Adverse Event|33|||
147254387|NCT00312494|531103661|FG001|Overall Study|Adverse Event|15|||
147254388|NCT00312494|531103662|FG002|Overall Study|Adverse Event|11|||
147254389|NCT00312494|531103660|FG000|Overall Study|Lack of Efficacy|4|||
147254390|NCT00312494|531103661|FG001|Overall Study|Lack of Efficacy|6|||
147254391|NCT00312494|531103662|FG002|Overall Study|Lack of Efficacy|8|||
147254392|NCT00312494|531103660|FG000|Overall Study|Laboratory abnormality|1|||
147254393|NCT00312494|531103661|FG001|Overall Study|Laboratory abnormality|0|||
147254394|NCT00312494|531103662|FG002|Overall Study|Laboratory abnormality|0|||
147254395|NCT00312494|531103660|FG000|Overall Study|Lost to Follow-up|8|||
147254396|NCT00312494|531103661|FG001|Overall Study|Lost to Follow-up|8|||
147254397|NCT00312494|531103662|FG002|Overall Study|Lost to Follow-up|8|||
147254398|NCT00312494|531103660|FG000|Overall Study|Withdrawal by Subject|6|||
147254399|NCT00312494|531103661|FG001|Overall Study|Withdrawal by Subject|9|||
147254400|NCT00312494|531103662|FG002|Overall Study|Withdrawal by Subject|10|||
147254401|NCT00312494|531103660|FG000|Overall Study|Other|10|||
147254402|NCT00312494|531103661|FG001|Overall Study|Other|10|||
147254403|NCT00312494|531103662|FG002|Overall Study|Other|1|||
147254404|NCT01104636|531103664|FG000|Overall Study|Lack of Efficacy|43|||
147254405|NCT01104636|531103664|FG000|Overall Study|Lost to Follow-up|24|||
147254406|NCT01104636|531103664|FG000|Overall Study|Withdrawal by Subject|4|||
147254407|NCT01104636|531103664|FG000|Overall Study|Other|43|||
147254408|NCT01104636|531103664|FG000|Overall Study|Study terminated by sponsor|1|||
147254409|NCT01104636|531103664|FG000|Overall Study|Pregnancy|2|||
147254410|NCT01104636|531103664|FG000|Overall Study|Adverse Event|40|||
147254411|NCT01104636|531103664|FG000|Overall Study|Ongoing|21|||
147254412|NCT01710033|531103669|FG000|Stage 2|Adverse Event|0|||
147254413|NCT01710033|531103670|FG001|Stage 2|Adverse Event|0|||
147254414|NCT01710033|531103671|FG002|Stage 2|Adverse Event|0|||
147254415|NCT01710033|531103672|FG003|Stage 2|Adverse Event|0|||
147254416|NCT01710033|531103673|FG004|Stage 2|Adverse Event|1|||
147254417|NCT01525550|531103674|FG000|Overall Study|Lost to Follow-up|8|||
147254418|NCT01525550|531103675|FG001|Overall Study|Lost to Follow-up|2|||
147254419|NCT01525550|531103674|FG000|Overall Study|Death|19|||
147254420|NCT01525550|531103675|FG001|Overall Study|Death|28|||
147254421|NCT01525550|531103674|FG000|Overall Study|Other|0|||
147598587|NCT00658658|532349854|FG004|Overall Study|Protocol-specified Criteria|0|||
147598588|NCT00658658|532349850|FG000|Overall Study|Other|0|||
147598589|NCT00658658|532349851|FG001|Overall Study|Other|0|||
147254422|NCT01525550|531103675|FG001|Overall Study|Other|4|||
147254423|NCT01525550|531103674|FG000|Overall Study|Sponsor's Decision|30|||
147254424|NCT01525550|531103675|FG001|Overall Study|Sponsor's Decision|11|||
147254425|NCT01525550|531103674|FG000|Overall Study|Withdrawal by Subject|4|||
147254426|NCT01525550|531103675|FG001|Overall Study|Withdrawal by Subject|0|||
147254427|NCT02877082|531103676|FG000|Overall Study|Trial was closed early|5|||
147254428|NCT03318315|531103677|FG000|Overall Study|Lost to Follow-up|3|||
147254429|NCT03318315|531103678|FG001|Overall Study|Lost to Follow-up|2|||
147254430|NCT03318315|531103679|FG002|Overall Study|Lost to Follow-up|1|||
147254431|NCT03318315|531103677|FG000|Overall Study|Protocol Violation|1|||
147254432|NCT03318315|531103678|FG001|Overall Study|Protocol Violation|1|||
147254433|NCT03318315|531103679|FG002|Overall Study|Protocol Violation|1|||
147254434|NCT03318315|531103677|FG000|Overall Study|Withdrawal by Subject|0|||
147254435|NCT03318315|531103678|FG001|Overall Study|Withdrawal by Subject|0|||
147332448|NCT00530842|531383245|FG000|Period 2|Withdrawal by Subject|1|||
147332449|NCT00530842|531383246|FG001|Period 2|Withdrawal by Subject|2|||
147332450|NCT00530842|531383245|FG000|Period 2|Individual different reasons|2|||
147332451|NCT00530842|531383246|FG001|Period 2|Individual different reasons|0|||
147449975|NCT01289015|531811331|FG001|Overall Study|Lost to Follow-up|17|||
147449976|NCT01289015|531811330|FG000|Overall Study|Withdrawal by Subject|17|||
147598590|NCT00658658|532349852|FG002|Overall Study|Other|0|||
147254436|NCT03318315|531103679|FG002|Overall Study|Withdrawal by Subject|2|||
147254437|NCT00810407|531103680|FG000|Overall Study|Protocol Violation|3|||
147254438|NCT00810407|531103680|FG000|Overall Study|No Visit After First Day of Treatment|3|||
147254439|NCT02968563|531103681|FG000|Overall Study|Adverse Event|0|||
147254440|NCT02968563|531103682|FG001|Overall Study|Adverse Event|6|||
147254441|NCT02968563|531103681|FG000|Overall Study|Death|1|||
147254442|NCT02968563|531103682|FG001|Overall Study|Death|1|||
147254443|NCT02968563|531103681|FG000|Overall Study|Lost to Follow-up|0|||
147254444|NCT02968563|531103682|FG001|Overall Study|Lost to Follow-up|1|||
147254445|NCT03287804|531103683|FG000|Overall Study|Death|1|||
147254446|NCT03287804|531103683|FG000|Overall Study|Physician Decision|2|||
147254447|NCT03287804|531103683|FG000|Overall Study|Progressive disease|8|||
147254448|NCT04008030|531103686|FG000|Pre-Treatment|Withdrawal by Subject|0|||
147254449|NCT04008030|531103687|FG001|Pre-Treatment|Withdrawal by Subject|0|||
147254450|NCT04008030|531103688|FG002|Pre-Treatment|Withdrawal by Subject|9|||
147254451|NCT04008030|531103686|FG000|Pre-Treatment|Participant no longer meets study criteria|2|||
147254452|NCT04008030|531103687|FG001|Pre-Treatment|Participant no longer meets study criteria|1|||
147254453|NCT04008030|531103688|FG002|Pre-Treatment|Participant no longer meets study criteria|2|||
147254454|NCT04008030|531103686|FG000|Pre-Treatment|Other reasons|0|||
147254455|NCT04008030|531103687|FG001|Pre-Treatment|Other reasons|1|||
147254456|NCT04008030|531103688|FG002|Pre-Treatment|Other reasons|6|||
147254457|NCT04008030|531103686|FG000|Treatment|Withdrawal by Subject|1|||
147254458|NCT04008030|531103687|FG001|Treatment|Withdrawal by Subject|1|||
147254459|NCT04008030|531103688|FG002|Treatment|Withdrawal by Subject|1|||
147254460|NCT04008030|531103686|FG000|Treatment|Death|2|||
147254461|NCT04008030|531103687|FG001|Treatment|Death|4|||
147254462|NCT04008030|531103688|FG002|Treatment|Death|0|||
147254463|NCT04008030|531103686|FG000|Treatment|Pregnancy|0|||
147254464|NCT04008030|531103687|FG001|Treatment|Pregnancy|1|||
147254465|NCT04008030|531103688|FG002|Treatment|Pregnancy|0|||
147254466|NCT04008030|531103686|FG000|Treatment|Participant no longer meets study criteria|0|||
147254467|NCT04008030|531103687|FG001|Treatment|Participant no longer meets study criteria|1|||
147254468|NCT04008030|531103688|FG002|Treatment|Participant no longer meets study criteria|0|||
147254469|NCT04008030|531103686|FG000|Treatment|Other reasons|5|||
147254470|NCT04008030|531103687|FG001|Treatment|Other reasons|13|||
147254471|NCT04008030|531103688|FG002|Treatment|Other reasons|6|||
147254472|NCT04008030|531103686|FG000|Treatment|Disease Progression|137|||
147254473|NCT04008030|531103687|FG001|Treatment|Disease Progression|82|||
147254474|NCT04008030|531103688|FG002|Treatment|Disease Progression|85|||
147254475|NCT04008030|531103686|FG000|Treatment|Study drug toxicity|28|||
147254476|NCT04008030|531103687|FG001|Treatment|Study drug toxicity|48|||
147254477|NCT04008030|531103688|FG002|Treatment|Study drug toxicity|8|||
147254478|NCT04008030|531103686|FG000|Treatment|Adverse Event unrelated to study drug|28|||
147254479|NCT04008030|531103687|FG001|Treatment|Adverse Event unrelated to study drug|22|||
147254480|NCT04008030|531103688|FG002|Treatment|Adverse Event unrelated to study drug|6|||
147254481|NCT04008030|531103686|FG000|Treatment|Maximum Clinical Benefit|0|||
147254482|NCT04008030|531103687|FG001|Treatment|Maximum Clinical Benefit|1|||
147254483|NCT04008030|531103688|FG002|Treatment|Maximum Clinical Benefit|9|||
147254484|NCT04008030|531103686|FG000|Treatment|On-going treatment|13|||
147254485|NCT04008030|531103687|FG001|Treatment|On-going treatment|20|||
147254486|NCT04008030|531103688|FG002|Treatment|On-going treatment|0|||
147254487|NCT03108027|531103689|FG000|Period 1|Subject/Guardian Decision|0|||
147254488|NCT03108027|531103690|FG001|Period 1|Subject/Guardian Decision|0|||
147254489|NCT03108027|531103691|FG002|Period 1|Subject/Guardian Decision|0|||
147254490|NCT03108027|531103692|FG003|Period 1|Subject/Guardian Decision|2|||
147254491|NCT03108027|531103693|FG004|Period 1|Subject/Guardian Decision|0|||
147254492|NCT03108027|531103694|FG005|Period 1|Subject/Guardian Decision|0|||
147254493|NCT03108027|531103689|FG000|Period 3|Adverse Event|0|||
147254494|NCT03108027|531103690|FG001|Period 3|Adverse Event|1|||
147254495|NCT03108027|531103691|FG002|Period 3|Adverse Event|0|||
147254496|NCT03108027|531103692|FG003|Period 3|Adverse Event|0|||
147254497|NCT03108027|531103693|FG004|Period 3|Adverse Event|0|||
147254498|NCT03108027|531103694|FG005|Period 3|Adverse Event|0|||
147254499|NCT03178773|531103695|FG000|Overall Study|Death|0|||
147254500|NCT03178773|531103696|FG001|Overall Study|Death|1|||
147254501|NCT03178773|531103695|FG000|Overall Study|Lost to Follow-up|29|||
147254502|NCT03178773|531103696|FG001|Overall Study|Lost to Follow-up|25|||
147254503|NCT03178773|531103695|FG000|Overall Study|Withdrawal by Subject|10|||
147254504|NCT03178773|531103696|FG001|Overall Study|Withdrawal by Subject|14|||
147254505|NCT02733991|531103698|FG000|Overall Study|Adverse Event|1|||
147254506|NCT02733991|531103699|FG001|Overall Study|Adverse Event|0|||
147254507|NCT02733991|531103698|FG000|Overall Study|Withdrawal by Subject|0|||
147254508|NCT02733991|531103699|FG001|Overall Study|Withdrawal by Subject|5|||
147254509|NCT02141997|531103703|FG000|Overall Study|Adverse Event|0|||
147254510|NCT02141997|531103704|FG001|Overall Study|Adverse Event|2|||
147254511|NCT02141997|531103705|FG002|Overall Study|Adverse Event|0|||
147254512|NCT02141997|531103706|FG003|Overall Study|Adverse Event|1|||
147254513|NCT02141997|531103703|FG000|Overall Study|Participant noncompliance|1|||
147254514|NCT02141997|531103704|FG001|Overall Study|Participant noncompliance|0|||
147254515|NCT02141997|531103705|FG002|Overall Study|Participant noncompliance|0|||
147254516|NCT02141997|531103706|FG003|Overall Study|Participant noncompliance|0|||
147449977|NCT01289015|531811331|FG001|Overall Study|Withdrawal by Subject|8|||
147254517|NCT02141997|531103703|FG000|Overall Study|Withdrew consent|1|||
147254518|NCT02141997|531103704|FG001|Overall Study|Withdrew consent|0|||
147254519|NCT02141997|531103705|FG002|Overall Study|Withdrew consent|3|||
147449978|NCT01289015|531811330|FG000|Overall Study|Disease progression|1|||
147598591|NCT00658658|532349853|FG003|Overall Study|Other|0|||
147254520|NCT02141997|531103706|FG003|Overall Study|Withdrew consent|0|||
147254521|NCT02141997|531103703|FG000|Overall Study|Other|1|||
147254522|NCT02141997|531103704|FG001|Overall Study|Other|4|||
147254523|NCT02141997|531103705|FG002|Overall Study|Other|0|||
147254524|NCT02141997|531103706|FG003|Overall Study|Other|0|||
147598592|NCT00658658|532349854|FG004|Overall Study|Other|1|||
147254525|NCT01496313|531103707|FG000|Randomized Period (up to 14 Months)|Adverse Event|1|||
147598593|NCT03182244|532349856|FG000|Treatment Period (Upto 1917 Days)|Adverse Event|8|||
147598594|NCT03182244|532349857|FG001|Treatment Period (Upto 1917 Days)|Adverse Event|9|||
147598595|NCT03182244|532349856|FG000|Treatment Period (Upto 1917 Days)|Death|19|||
147254526|NCT01496313|531103708|FG001|Randomized Period (up to 14 Months)|Adverse Event|5|||
147254527|NCT01496313|531103709|FG002|Randomized Period (up to 14 Months)|Adverse Event|0|||
147254528|NCT01496313|531103710|FG003|Randomized Period (up to 14 Months)|Adverse Event|0|||
147254529|NCT01496313|531103711|FG004|Randomized Period (up to 14 Months)|Adverse Event|0|||
147254530|NCT01496313|531103712|FG005|Randomized Period (up to 14 Months)|Adverse Event|0|||
147254531|NCT01496313|531103707|FG000|Randomized Period (up to 14 Months)|Condition Under Investigation Worsened|2|||
147254532|NCT01496313|531103708|FG001|Randomized Period (up to 14 Months)|Condition Under Investigation Worsened|3|||
147254533|NCT01496313|531103709|FG002|Randomized Period (up to 14 Months)|Condition Under Investigation Worsened|0|||
147254534|NCT01496313|531103710|FG003|Randomized Period (up to 14 Months)|Condition Under Investigation Worsened|0|||
147254535|NCT01496313|531103711|FG004|Randomized Period (up to 14 Months)|Condition Under Investigation Worsened|0|||
147254536|NCT01496313|531103712|FG005|Randomized Period (up to 14 Months)|Condition Under Investigation Worsened|0|||
147254537|NCT01496313|531103707|FG000|Randomized Period (up to 14 Months)|Study-specific Discontinuation Criteria|0|||
147254538|NCT01496313|531103708|FG001|Randomized Period (up to 14 Months)|Study-specific Discontinuation Criteria|2|||
147254539|NCT01496313|531103709|FG002|Randomized Period (up to 14 Months)|Study-specific Discontinuation Criteria|0|||
147254540|NCT01496313|531103710|FG003|Randomized Period (up to 14 Months)|Study-specific Discontinuation Criteria|0|||
147254541|NCT01496313|531103711|FG004|Randomized Period (up to 14 Months)|Study-specific Discontinuation Criteria|0|||
147254542|NCT01496313|531103712|FG005|Randomized Period (up to 14 Months)|Study-specific Discontinuation Criteria|0|||
147254543|NCT01496313|531103707|FG000|Randomized Period (up to 14 Months)|Participant Decision|1|||
147254544|NCT01496313|531103708|FG001|Randomized Period (up to 14 Months)|Participant Decision|3|||
147254545|NCT01496313|531103709|FG002|Randomized Period (up to 14 Months)|Participant Decision|0|||
147254546|NCT01496313|531103710|FG003|Randomized Period (up to 14 Months)|Participant Decision|0|||
147254547|NCT01496313|531103711|FG004|Randomized Period (up to 14 Months)|Participant Decision|0|||
147254548|NCT01496313|531103712|FG005|Randomized Period (up to 14 Months)|Participant Decision|0|||
147254549|NCT01496313|531103707|FG000|Randomized Period (up to 14 Months)|Other|1|||
147254550|NCT01496313|531103708|FG001|Randomized Period (up to 14 Months)|Other|2|||
147254551|NCT01496313|531103709|FG002|Randomized Period (up to 14 Months)|Other|0|||
147254552|NCT01496313|531103710|FG003|Randomized Period (up to 14 Months)|Other|0|||
147598596|NCT03182244|532349857|FG001|Treatment Period (Upto 1917 Days)|Death|8|||
147598597|NCT03182244|532349856|FG000|Treatment Period (Upto 1917 Days)|Miscellaneous|12|||
147598598|NCT03182244|532349857|FG001|Treatment Period (Upto 1917 Days)|Miscellaneous|0|||
147598599|NCT03182244|532349856|FG000|Treatment Period (Upto 1917 Days)|Disease Relapse|41|||
147598600|NCT03182244|532349857|FG001|Treatment Period (Upto 1917 Days)|Disease Relapse|5|||
147598601|NCT03182244|532349856|FG000|Treatment Period (Upto 1917 Days)|Physician Decision|5|||
147598602|NCT03182244|532349857|FG001|Treatment Period (Upto 1917 Days)|Physician Decision|10|||
147598603|NCT03182244|532349856|FG000|Treatment Period (Upto 1917 Days)|Withdrawal by Subject|10|||
147661266|NCT01657162|532581468|FG001|Overall Study|Hypersensitivity to Alendronate|1|||
147661267|NCT01657162|532581467|FG000|Overall Study|Other than Specified|0|||
147661268|NCT01657162|532581468|FG001|Overall Study|Other than Specified|2|||
147661269|NCT01261390|532581469|FG000|Overall Study|Significant Concurrent Illness|1|||
147661270|NCT01261390|532581470|FG001|Overall Study|Significant Concurrent Illness|0|||
147661271|NCT01261390|532581471|FG002|Overall Study|Significant Concurrent Illness|1|||
147661272|NCT01261390|532581472|FG003|Overall Study|Significant Concurrent Illness|0|||
147661273|NCT01261390|532581469|FG000|Overall Study|Dissatisfaction with Treatment|2|||
147661274|NCT01261390|532581470|FG001|Overall Study|Dissatisfaction with Treatment|1|||
147254553|NCT01496313|531103711|FG004|Randomized Period (up to 14 Months)|Other|0|||
147254554|NCT01496313|531103712|FG005|Randomized Period (up to 14 Months)|Other|0|||
147598604|NCT03182244|532349857|FG001|Treatment Period (Upto 1917 Days)|Withdrawal by Subject|28|||
147598605|NCT03182244|532349856|FG000|Treatment Period (Upto 1917 Days)|Protocol Violation|4|||
147598606|NCT03182244|532349857|FG001|Treatment Period (Upto 1917 Days)|Protocol Violation|1|||
147598607|NCT03182244|532349856|FG000|Treatment Period (Upto 1917 Days)|Progressive Disease|18|||
147598608|NCT03182244|532349857|FG001|Treatment Period (Upto 1917 Days)|Progressive Disease|9|||
147598609|NCT03182244|532349856|FG000|Treatment Period (Upto 1917 Days)|Lack of Efficacy|20|||
147598610|NCT03182244|532349857|FG001|Treatment Period (Upto 1917 Days)|Lack of Efficacy|43|||
147598611|NCT03182244|532349856|FG000|Long Term Follow-up (Up to 1232 Days)|Miscellaneous|4|||
147254555|NCT01496313|531103707|FG000|Open-Label Period (Month 14 to 2 Years)|Study-specific Withdrawal Criteria|0|||
147598612|NCT03182244|532349857|FG001|Long Term Follow-up (Up to 1232 Days)|Miscellaneous|3|||
147598613|NCT03182244|532349856|FG000|Long Term Follow-up (Up to 1232 Days)|Withdrawal by Subject|5|||
147661275|NCT01261390|532581471|FG002|Overall Study|Dissatisfaction with Treatment|1|||
147661276|NCT01261390|532581472|FG003|Overall Study|Dissatisfaction with Treatment|2|||
147661277|NCT01261390|532581469|FG000|Overall Study|Relocation|0|||
147661278|NCT01261390|532581470|FG001|Overall Study|Relocation|1|||
147661279|NCT01261390|532581471|FG002|Overall Study|Relocation|0|||
147661280|NCT01261390|532581472|FG003|Overall Study|Relocation|0|||
147254556|NCT01496313|531103708|FG001|Open-Label Period (Month 14 to 2 Years)|Study-specific Withdrawal Criteria|0|||
147254557|NCT01496313|531103709|FG002|Open-Label Period (Month 14 to 2 Years)|Study-specific Withdrawal Criteria|0|||
147254558|NCT01496313|531103710|FG003|Open-Label Period (Month 14 to 2 Years)|Study-specific Withdrawal Criteria|0|||
147254559|NCT01496313|531103711|FG004|Open-Label Period (Month 14 to 2 Years)|Study-specific Withdrawal Criteria|0|||
147254560|NCT01496313|531103712|FG005|Open-Label Period (Month 14 to 2 Years)|Study-specific Withdrawal Criteria|1|||
147254561|NCT01496313|531103707|FG000|Open-Label Period (Month 14 to 2 Years)|Participant Decision|0|||
147254562|NCT01496313|531103708|FG001|Open-Label Period (Month 14 to 2 Years)|Participant Decision|0|||
147254563|NCT01496313|531103709|FG002|Open-Label Period (Month 14 to 2 Years)|Participant Decision|0|||
147254564|NCT01496313|531103710|FG003|Open-Label Period (Month 14 to 2 Years)|Participant Decision|0|||
147254565|NCT01496313|531103711|FG004|Open-Label Period (Month 14 to 2 Years)|Participant Decision|0|||
147254566|NCT01496313|531103712|FG005|Open-Label Period (Month 14 to 2 Years)|Participant Decision|3|||
147254567|NCT01496313|531103707|FG000|Open-Label Period (Month 14 to 2 Years)|Other|0|||
147254568|NCT01496313|531103708|FG001|Open-Label Period (Month 14 to 2 Years)|Other|0|||
147254569|NCT01496313|531103709|FG002|Open-Label Period (Month 14 to 2 Years)|Other|2|||
147254570|NCT01496313|531103710|FG003|Open-Label Period (Month 14 to 2 Years)|Other|2|||
147254571|NCT01496313|531103711|FG004|Open-Label Period (Month 14 to 2 Years)|Other|1|||
147254572|NCT01496313|531103712|FG005|Open-Label Period (Month 14 to 2 Years)|Other|7|||
147254573|NCT00451321|531103714|FG000|Overall Study|Lost to Follow-up|3|||
147254574|NCT00451321|531103715|FG001|Overall Study|Lost to Follow-up|3|||
147254575|NCT00451321|531103716|FG002|Overall Study|Lost to Follow-up|1|||
147254576|NCT00451321|531103717|FG003|Overall Study|Lost to Follow-up|3|||
147254577|NCT00451321|531103718|FG004|Overall Study|Lost to Follow-up|0|||
147254578|NCT00451321|531103719|FG005|Overall Study|Lost to Follow-up|1|||
147254579|NCT00451321|531103720|FG006|Overall Study|Lost to Follow-up|0|||
147254580|NCT00451321|531103721|FG007|Overall Study|Lost to Follow-up|0|||
147254581|NCT00451321|531103714|FG000|Overall Study|Withdrawal by Subject|3|||
147254582|NCT00451321|531103715|FG001|Overall Study|Withdrawal by Subject|1|||
147254583|NCT00451321|531103716|FG002|Overall Study|Withdrawal by Subject|0|||
147254584|NCT00451321|531103717|FG003|Overall Study|Withdrawal by Subject|4|||
147254585|NCT00451321|531103718|FG004|Overall Study|Withdrawal by Subject|0|||
147254586|NCT00451321|531103719|FG005|Overall Study|Withdrawal by Subject|0|||
147254587|NCT00451321|531103720|FG006|Overall Study|Withdrawal by Subject|0|||
147254588|NCT00451321|531103721|FG007|Overall Study|Withdrawal by Subject|0|||
147254589|NCT00451321|531103714|FG000|Overall Study|Study closed/terminated|1|||
147254590|NCT00451321|531103715|FG001|Overall Study|Study closed/terminated|1|||
147254591|NCT00451321|531103716|FG002|Overall Study|Study closed/terminated|17|||
147254592|NCT00451321|531103717|FG003|Overall Study|Study closed/terminated|5|||
147254593|NCT00451321|531103718|FG004|Overall Study|Study closed/terminated|7|||
147254594|NCT00451321|531103719|FG005|Overall Study|Study closed/terminated|7|||
147254595|NCT00451321|531103720|FG006|Overall Study|Study closed/terminated|5|||
147661281|NCT01261390|532581469|FG000|Overall Study|Loss of Interest in the Study|3|||
147254596|NCT00451321|531103721|FG007|Overall Study|Study closed/terminated|3|||
147254597|NCT00451321|531103714|FG000|Overall Study|Sponsor decision to amend protocol|0|||
147254598|NCT00451321|531103715|FG001|Overall Study|Sponsor decision to amend protocol|0|||
147254599|NCT00451321|531103716|FG002|Overall Study|Sponsor decision to amend protocol|0|||
147254600|NCT00451321|531103717|FG003|Overall Study|Sponsor decision to amend protocol|0|||
147254601|NCT00451321|531103718|FG004|Overall Study|Sponsor decision to amend protocol|0|||
147254602|NCT00451321|531103719|FG005|Overall Study|Sponsor decision to amend protocol|1|||
147254603|NCT00451321|531103720|FG006|Overall Study|Sponsor decision to amend protocol|1|||
147254604|NCT00451321|531103721|FG007|Overall Study|Sponsor decision to amend protocol|3|||
147254605|NCT00909389|531103725|FG000|Overall Study|Adverse Event|6|||
147254606|NCT00909389|531103725|FG000|Overall Study|Death|4|||
147254607|NCT00909389|531103725|FG000|Overall Study|Poor Compliance|16|||
147254608|NCT00909389|531103725|FG000|Overall Study|Lost to Follow-up|4|||
147254609|NCT00909389|531103725|FG000|Overall Study|No Information|103|||
147254610|NCT01528254|531103726|FG000|Overall Study|Administrative problems|96|||
147254611|NCT01528254|531103727|FG001|Overall Study|Administrative problems|94|||
147254612|NCT01528254|531103726|FG000|Overall Study|Adverse Event|28|||
147254613|NCT01528254|531103727|FG001|Overall Study|Adverse Event|44|||
147254614|NCT01528254|531103726|FG000|Overall Study|Lost to Follow-up|17|||
147254615|NCT01528254|531103727|FG001|Overall Study|Lost to Follow-up|24|||
147254616|NCT01528254|531103726|FG000|Overall Study|Death|13|||
147254617|NCT01528254|531103727|FG001|Overall Study|Death|9|||
147254618|NCT01528254|531103726|FG000|Overall Study|Protocol deviation|9|||
147254619|NCT01528254|531103727|FG001|Overall Study|Protocol deviation|19|||
147254620|NCT01528254|531103726|FG000|Overall Study|New therapy for study indication|8|||
147254621|NCT01528254|531103727|FG001|Overall Study|New therapy for study indication|6|||
147254622|NCT01528254|531103726|FG000|Overall Study|Unsatisfactory therapeutic effect|6|||
147332452|NCT02534350|531383247|FG000|Overall Study|Randomized But Not Treated|1|||
147332453|NCT02534350|531383248|FG001|Overall Study|Randomized But Not Treated|0|||
147332454|NCT02534350|531383247|FG000|Overall Study|Protocol Violation|1|||
147661282|NCT01261390|532581470|FG001|Overall Study|Loss of Interest in the Study|1|||
147254623|NCT01528254|531103727|FG001|Overall Study|Unsatisfactory therapeutic effect|8|||
147254624|NCT01528254|531103726|FG000|Overall Study|Withdrawal by Subject|5|||
147254625|NCT01528254|531103727|FG001|Overall Study|Withdrawal by Subject|4|||
147254626|NCT01528254|531103726|FG000|Overall Study|Abnormal laboratory value(s)|3|||
147254627|NCT01528254|531103727|FG001|Overall Study|Abnormal laboratory value(s)|7|||
147254628|NCT01528254|531103726|FG000|Overall Study|Abnormal test procedure result(s)|1|||
147254629|NCT01528254|531103727|FG001|Overall Study|Abnormal test procedure result(s)|0|||
147254630|NCT01528254|531103726|FG000|Overall Study|No longer requires study drug|1|||
147254631|NCT01528254|531103727|FG001|Overall Study|No longer requires study drug|1|||
147254632|NCT00737282|531103728|FG000|Overall Study|Study prematurely terminated|175|||
147254633|NCT02763189|531103729|FG000|Overall Study|Device failure|0|||
147254634|NCT02763189|531103730|FG001|Overall Study|Device failure|2|||
147254635|NCT02049957|531103731|FG000|Overall Study|Progressive Disease|5|||
147254636|NCT02049957|531103732|FG001|Overall Study|Progressive Disease|4|||
147254637|NCT02049957|531103733|FG002|Overall Study|Progressive Disease|2|||
147254638|NCT02049957|531103734|FG003|Overall Study|Progressive Disease|2|||
147254639|NCT02049957|531103735|FG004|Overall Study|Progressive Disease|6|||
147254640|NCT02049957|531103736|FG005|Overall Study|Progressive Disease|35|||
147254641|NCT02049957|531103737|FG006|Overall Study|Progressive Disease|7|||
147254642|NCT02049957|531103738|FG007|Overall Study|Progressive Disease|26|||
147254643|NCT02049957|531103739|FG008|Overall Study|Progressive Disease|6|||
147254644|NCT02049957|531103731|FG000|Overall Study|Adverse Event|1|||
147254645|NCT02049957|531103732|FG001|Overall Study|Adverse Event|1|||
147254646|NCT02049957|531103733|FG002|Overall Study|Adverse Event|1|||
147254647|NCT02049957|531103734|FG003|Overall Study|Adverse Event|0|||
147254648|NCT02049957|531103735|FG004|Overall Study|Adverse Event|0|||
147254649|NCT02049957|531103736|FG005|Overall Study|Adverse Event|5|||
147254650|NCT02049957|531103737|FG006|Overall Study|Adverse Event|0|||
147254651|NCT02049957|531103738|FG007|Overall Study|Adverse Event|6|||
147254652|NCT02049957|531103739|FG008|Overall Study|Adverse Event|1|||
147254653|NCT02049957|531103731|FG000|Overall Study|Study Terminated by Sponsor|0|||
147598614|NCT03182244|532349857|FG001|Long Term Follow-up (Up to 1232 Days)|Withdrawal by Subject|8|||
147598615|NCT03182244|532349856|FG000|Long Term Follow-up (Up to 1232 Days)|Lost to Follow-up|6|||
147598616|NCT03182244|532349857|FG001|Long Term Follow-up (Up to 1232 Days)|Lost to Follow-up|7|||
147254654|NCT02049957|531103732|FG001|Overall Study|Study Terminated by Sponsor|1|||
147254655|NCT02049957|531103733|FG002|Overall Study|Study Terminated by Sponsor|0|||
147254656|NCT02049957|531103734|FG003|Overall Study|Study Terminated by Sponsor|0|||
147332455|NCT02534350|531383248|FG001|Overall Study|Protocol Violation|0|||
147332456|NCT02534350|531383247|FG000|Overall Study|Withdrew Consent|2|||
147332457|NCT02534350|531383248|FG001|Overall Study|Withdrew Consent|0|||
147332458|NCT01161498|531383249|FG000|Overall Study|Disease Progression|0|||
147332459|NCT01161498|531383250|FG001|Overall Study|Disease Progression|1|||
147332460|NCT02807493|531383251|FG000|Overall Study|Adverse Event|5|||
147332461|NCT02807493|531383252|FG001|Overall Study|Adverse Event|2|||
147332462|NCT02807493|531383251|FG000|Overall Study|Lost to Follow-up|6|||
147332463|NCT02807493|531383252|FG001|Overall Study|Lost to Follow-up|0|||
147332464|NCT02807493|531383251|FG000|Overall Study|Physician Decision|4|||
147332465|NCT02807493|531383252|FG001|Overall Study|Physician Decision|1|||
147332466|NCT02807493|531383251|FG000|Overall Study|Protocol Violation|7|||
147332467|NCT02807493|531383252|FG001|Overall Study|Protocol Violation|0|||
147332468|NCT02807493|531383251|FG000|Overall Study|Withdrawal by Subject|17|||
147332469|NCT02807493|531383252|FG001|Overall Study|Withdrawal by Subject|10|||
147332470|NCT02807493|531383251|FG000|Overall Study|Other withdrawal|17|||
147332471|NCT02807493|531383252|FG001|Overall Study|Other withdrawal|0|||
147332472|NCT02807493|531383251|FG000|Overall Study|C-Section Prior to Stage 2 of Labor|31|||
147332473|NCT02807493|531383252|FG001|Overall Study|C-Section Prior to Stage 2 of Labor|39|||
147449979|NCT01289015|531811331|FG001|Overall Study|Disease progression|0|||
147449980|NCT01289015|531811330|FG000|Overall Study|Negative baseline culture and others|33|||
147449981|NCT01289015|531811331|FG001|Overall Study|Negative baseline culture and others|20|||
147598617|NCT03182244|532349856|FG000|Long Term Follow-up (Up to 1232 Days)|Death|76|||
147449982|NCT01485627|531811335|FG000|Overall Study|Patient withdrew|6|||
147449983|NCT01485627|531811336|FG001|Overall Study|Patient withdrew|5|||
147449984|NCT01485627|531811335|FG000|Overall Study|Patient died|3|||
147449985|NCT01485627|531811336|FG001|Overall Study|Patient died|1|||
147254657|NCT02049957|531103735|FG004|Overall Study|Study Terminated by Sponsor|0|||
147254658|NCT02049957|531103736|FG005|Overall Study|Study Terminated by Sponsor|0|||
147254659|NCT02049957|531103737|FG006|Overall Study|Study Terminated by Sponsor|1|||
147449986|NCT01485627|531811335|FG000|Overall Study|Patient lost to followup|0|||
147598618|NCT03182244|532349857|FG001|Long Term Follow-up (Up to 1232 Days)|Death|75|||
147598619|NCT02492880|532349858|FG000|Overall Study|Lost to Follow-up|1|||
147254660|NCT02049957|531103738|FG007|Overall Study|Study Terminated by Sponsor|0|||
147254661|NCT02049957|531103739|FG008|Overall Study|Study Terminated by Sponsor|0|||
147332474|NCT01493778|531383253|FG000|Overall Study|Withdrawal by Subject|8|||
147332475|NCT01227707|531383254|FG000|Overall Study|Adverse Event|10|||
147598620|NCT02492880|532349858|FG000|Overall Study|Protocol Violation|1|||
147332476|NCT01227707|531383254|FG000|Overall Study|Progression of disease|3|||
147332477|NCT01227707|531383254|FG000|Overall Study|Withdrawal by Subject|1|||
147598621|NCT03186781|532349859|FG000|Overall Study|Lost to Follow-up|0|||
147598622|NCT03186781|532349860|FG001|Overall Study|Lost to Follow-up|0|||
147598623|NCT03186781|532349861|FG002|Overall Study|Lost to Follow-up|1|||
147598624|NCT03186781|532349862|FG003|Overall Study|Lost to Follow-up|0|||
147598625|NCT03186781|532349863|FG004|Overall Study|Lost to Follow-up|1|||
147598626|NCT03186781|532349864|FG005|Overall Study|Lost to Follow-up|0|||
147598627|NCT03186781|532349859|FG000|Overall Study|Moved from Area|0|||
147598628|NCT03186781|532349860|FG001|Overall Study|Moved from Area|0|||
147598629|NCT03186781|532349861|FG002|Overall Study|Moved from Area|0|||
147598630|NCT03186781|532349862|FG003|Overall Study|Moved from Area|0|||
147598631|NCT03186781|532349863|FG004|Overall Study|Moved from Area|1|||
147598632|NCT03186781|532349864|FG005|Overall Study|Moved from Area|0|||
147598633|NCT03186781|532349859|FG000|Overall Study|Withdrawal by Subject|0|||
147598634|NCT03186781|532349860|FG001|Overall Study|Withdrawal by Subject|0|||
147598635|NCT03186781|532349861|FG002|Overall Study|Withdrawal by Subject|0|||
147598636|NCT03186781|532349862|FG003|Overall Study|Withdrawal by Subject|0|||
147598637|NCT03186781|532349863|FG004|Overall Study|Withdrawal by Subject|1|||
147598638|NCT03186781|532349864|FG005|Overall Study|Withdrawal by Subject|0|||
147598639|NCT00667810|532349865|FG000|Overall Study|Adverse Event|13|||
147598640|NCT00667810|532349866|FG001|Overall Study|Adverse Event|14|||
147598641|NCT00667810|532349867|FG002|Overall Study|Adverse Event|19|||
147598642|NCT00667810|532349868|FG003|Overall Study|Adverse Event|1|||
147598643|NCT00667810|532349865|FG000|Overall Study|Death|1|||
147598644|NCT00667810|532349866|FG001|Overall Study|Death|1|||
147598645|NCT00667810|532349867|FG002|Overall Study|Death|3|||
147598646|NCT00667810|532349868|FG003|Overall Study|Death|0|||
147598647|NCT00667810|532349865|FG000|Overall Study|Lack of Efficacy|1|||
147598648|NCT00667810|532349866|FG001|Overall Study|Lack of Efficacy|0|||
147598649|NCT00667810|532349867|FG002|Overall Study|Lack of Efficacy|2|||
147598650|NCT00667810|532349868|FG003|Overall Study|Lack of Efficacy|0|||
147598651|NCT00667810|532349865|FG000|Overall Study|Lost to Follow-up|1|||
147598652|NCT00667810|532349866|FG001|Overall Study|Lost to Follow-up|4|||
147598653|NCT00667810|532349867|FG002|Overall Study|Lost to Follow-up|2|||
147598654|NCT00667810|532349868|FG003|Overall Study|Lost to Follow-up|0|||
147598655|NCT00667810|532349865|FG000|Overall Study|Physician Decision|1|||
147598656|NCT00667810|532349866|FG001|Overall Study|Physician Decision|1|||
147598657|NCT00667810|532349867|FG002|Overall Study|Physician Decision|2|||
147598658|NCT00667810|532349868|FG003|Overall Study|Physician Decision|0|||
147598659|NCT00667810|532349865|FG000|Overall Study|Protocol Violation|0|||
147598660|NCT00667810|532349866|FG001|Overall Study|Protocol Violation|2|||
147598661|NCT00667810|532349867|FG002|Overall Study|Protocol Violation|0|||
147598662|NCT00667810|532349868|FG003|Overall Study|Protocol Violation|0|||
147598663|NCT00667810|532349865|FG000|Overall Study|Withdrawal by Subject|14|||
147598664|NCT00667810|532349866|FG001|Overall Study|Withdrawal by Subject|20|||
147254662|NCT02049957|531103731|FG000|Overall Study|Withdrawal by Subject|0|||
147254663|NCT02049957|531103732|FG001|Overall Study|Withdrawal by Subject|0|||
147254664|NCT02049957|531103733|FG002|Overall Study|Withdrawal by Subject|0|||
147254665|NCT02049957|531103734|FG003|Overall Study|Withdrawal by Subject|1|||
147254666|NCT02049957|531103735|FG004|Overall Study|Withdrawal by Subject|0|||
147254667|NCT02049957|531103736|FG005|Overall Study|Withdrawal by Subject|2|||
147254668|NCT02049957|531103737|FG006|Overall Study|Withdrawal by Subject|0|||
147254669|NCT02049957|531103738|FG007|Overall Study|Withdrawal by Subject|3|||
147254670|NCT02049957|531103739|FG008|Overall Study|Withdrawal by Subject|1|||
147254671|NCT02049957|531103731|FG000|Overall Study|Physician Decision|0|||
147254672|NCT02049957|531103732|FG001|Overall Study|Physician Decision|0|||
147254673|NCT02049957|531103733|FG002|Overall Study|Physician Decision|0|||
147254674|NCT02049957|531103734|FG003|Overall Study|Physician Decision|0|||
147254675|NCT02049957|531103735|FG004|Overall Study|Physician Decision|0|||
147254676|NCT02049957|531103736|FG005|Overall Study|Physician Decision|1|||
147254677|NCT02049957|531103737|FG006|Overall Study|Physician Decision|0|||
147254678|NCT02049957|531103738|FG007|Overall Study|Physician Decision|0|||
147254679|NCT02049957|531103739|FG008|Overall Study|Physician Decision|0|||
147254680|NCT03557151|531103740|FG000|Randomization to 3 Months|Lost to Follow-up|2|||
147254681|NCT03557151|531103741|FG001|Randomization to 3 Months|Lost to Follow-up|2|||
147598665|NCT00667810|532349867|FG002|Overall Study|Withdrawal by Subject|29|||
147598666|NCT00667810|532349868|FG003|Overall Study|Withdrawal by Subject|1|||
147598667|NCT00667810|532349865|FG000|Overall Study|Discontinuation of Study by Sponsor|130|||
147598668|NCT00667810|532349866|FG001|Overall Study|Discontinuation of Study by Sponsor|118|||
147598669|NCT00667810|532349867|FG002|Overall Study|Discontinuation of Study by Sponsor|155|||
147598670|NCT00667810|532349868|FG003|Overall Study|Discontinuation of Study by Sponsor|0|||
147598671|NCT00667810|532349865|FG000|Overall Study|Failed to Return|0|||
147598672|NCT00667810|532349866|FG001|Overall Study|Failed to Return|0|||
147598673|NCT00667810|532349867|FG002|Overall Study|Failed to Return|2|||
147598674|NCT00667810|532349868|FG003|Overall Study|Failed to Return|0|||
147598675|NCT00667810|532349865|FG000|Overall Study|Loss of Caregiver|0|||
147598676|NCT00667810|532349866|FG001|Overall Study|Loss of Caregiver|1|||
147598677|NCT00667810|532349867|FG002|Overall Study|Loss of Caregiver|3|||
147598678|NCT00667810|532349868|FG003|Overall Study|Loss of Caregiver|0|||
147598679|NCT00667810|532349865|FG000|Overall Study|Vasogenic Edema Recurrence|0|||
147332478|NCT01227707|531383254|FG000|Overall Study|Patient non-compliance|3|||
147332479|NCT01227707|531383254|FG000|Overall Study|Medical decision|6|||
147332480|NCT01227707|531383254|FG000|Overall Study|Death|1|||
147332481|NCT00823979|531383267|FG000|Overall Study|Lack of Efficacy|13|||
147332482|NCT00823979|531383268|FG001|Overall Study|Lack of Efficacy|16|||
147332483|NCT00823979|531383269|FG002|Overall Study|Lack of Efficacy|9|||
147332484|NCT00823979|531383267|FG000|Overall Study|Lost to Follow-up|2|||
147332485|NCT00823979|531383268|FG001|Overall Study|Lost to Follow-up|1|||
147332486|NCT00823979|531383269|FG002|Overall Study|Lost to Follow-up|0|||
147332487|NCT00823979|531383267|FG000|Overall Study|Withdrawal by Subject|2|||
147332488|NCT00823979|531383268|FG001|Overall Study|Withdrawal by Subject|3|||
147332489|NCT00823979|531383269|FG002|Overall Study|Withdrawal by Subject|2|||
147332490|NCT00823979|531383267|FG000|Overall Study|Protocol Violation|1|||
147332491|NCT00823979|531383268|FG001|Overall Study|Protocol Violation|1|||
147332492|NCT00823979|531383269|FG002|Overall Study|Protocol Violation|0|||
147332493|NCT00823979|531383267|FG000|Overall Study|Pregnancy|0|||
147332494|NCT00823979|531383268|FG001|Overall Study|Pregnancy|1|||
147332495|NCT00823979|531383269|FG002|Overall Study|Pregnancy|0|||
147332496|NCT00823979|531383267|FG000|Overall Study|Adverse Event|0|||
147332497|NCT00823979|531383268|FG001|Overall Study|Adverse Event|2|||
147332498|NCT00823979|531383269|FG002|Overall Study|Adverse Event|4|||
147332499|NCT00823979|531383267|FG000|Overall Study|Other|2|||
147332500|NCT00823979|531383268|FG001|Overall Study|Other|0|||
147332501|NCT00823979|531383269|FG002|Overall Study|Other|1|||
147332502|NCT00823979|531383267|FG000|Overall Study|Randomized but not Treated|4|||
147332503|NCT00823979|531383268|FG001|Overall Study|Randomized but not Treated|3|||
147332504|NCT00823979|531383269|FG002|Overall Study|Randomized but not Treated|1|||
147332505|NCT00823979|531383267|FG000|Overall Study|Study Terminated by Sponsor|5|||
147332506|NCT00823979|531383268|FG001|Overall Study|Study Terminated by Sponsor|5|||
147332507|NCT00823979|531383269|FG002|Overall Study|Study Terminated by Sponsor|7|||
147332508|NCT03523091|531383270|FG000|Overall Study|Lower dose due to elevated post void residual (PVR)|1|||
147332509|NCT03523091|531383271|FG001|Overall Study|Lower dose due to elevated post void residual (PVR)|0|||
147332510|NCT03523091|531383270|FG000|Overall Study|Withdrawal by Subject|0|||
147254682|NCT03557151|531103740|FG000|6 to 9 Months|moved out of state/discontinued care at Nemours|2|||
147254683|NCT03557151|531103741|FG001|6 to 9 Months|moved out of state/discontinued care at Nemours|0|||
147254684|NCT03557151|531103740|FG000|9 to 12 Months (End of Study)|moved out of state/discontinued care at Nemours|0|||
147254685|NCT03557151|531103741|FG001|9 to 12 Months (End of Study)|moved out of state/discontinued care at Nemours|2|||
147254686|NCT02810392|531103742|FG000|Overall Study|Subject too ill to continue|1|||
147254687|NCT02810392|531103743|FG001|Overall Study|Subject too ill to continue|0|||
147254688|NCT02810392|531103742|FG000|Overall Study|COVID 19 research restrictions|0|||
147254689|NCT02810392|531103743|FG001|Overall Study|COVID 19 research restrictions|1|||
147254690|NCT00840294|531103744|FG000|Overall Study|Withdrawal by Subject|2|||
147254691|NCT00840294|531103745|FG001|Overall Study|Withdrawal by Subject|1|||
147254692|NCT00840294|531103744|FG000|Overall Study|Protocol Violation|1|||
147254693|NCT00840294|531103745|FG001|Overall Study|Protocol Violation|3|||
147254694|NCT00840294|531103744|FG000|Overall Study|Illness|0|||
147254695|NCT00840294|531103745|FG001|Overall Study|Illness|1|||
147254696|NCT04868890|531103755|FG000|Overall Study|Death|2|||
147254697|NCT04868890|531103756|FG001|Overall Study|Death|1|||
147254698|NCT04868890|531103755|FG000|Overall Study|Withdrawal by Subject|1|||
147254699|NCT04868890|531103756|FG001|Overall Study|Withdrawal by Subject|5|||
147254700|NCT02669433|531103759|FG000|Overall Study|Protocol Violation|0|||
147254701|NCT02669433|531103760|FG001|Overall Study|Protocol Violation|4|||
147254702|NCT02669433|531103761|FG002|Overall Study|Protocol Violation|1|||
147254703|NCT02669433|531103759|FG000|Overall Study|Disease Progression|1|||
147254704|NCT02669433|531103760|FG001|Overall Study|Disease Progression|0|||
147254705|NCT02669433|531103761|FG002|Overall Study|Disease Progression|0|||
147254706|NCT02669433|531103759|FG000|Overall Study|Physician Decision|1|||
147254707|NCT02669433|531103760|FG001|Overall Study|Physician Decision|1|||
147254708|NCT02669433|531103761|FG002|Overall Study|Physician Decision|0|||
147254709|NCT02669433|531103759|FG000|Overall Study|Adverse Event|6|||
147254710|NCT02669433|531103760|FG001|Overall Study|Adverse Event|7|||
147254711|NCT02669433|531103761|FG002|Overall Study|Adverse Event|10|||
147254712|NCT02669433|531103759|FG000|Overall Study|Sponsor Termination|1|||
147332511|NCT03523091|531383271|FG001|Overall Study|Withdrawal by Subject|3|||
147332512|NCT03523091|531383270|FG000|Overall Study|Increase Botox dose|0|||
147332513|NCT03523091|531383271|FG001|Overall Study|Increase Botox dose|1|||
147332514|NCT00741988|531383272|FG000|Overall Study|Adverse Event|2|||
147332515|NCT00741988|531383273|FG001|Overall Study|Adverse Event|4|||
147332516|NCT00741988|531383272|FG000|Overall Study|Lack of Efficacy|2|||
147332517|NCT00741988|531383273|FG001|Overall Study|Lack of Efficacy|0|||
147332518|NCT02685488|531383280|FG000|Overall Study|Withdrawal by Subject|0|||
147332519|NCT02685488|531383281|FG001|Overall Study|Withdrawal by Subject|1|||
147254713|NCT02669433|531103760|FG001|Overall Study|Sponsor Termination|0|||
147254714|NCT02669433|531103761|FG002|Overall Study|Sponsor Termination|1|||
147332520|NCT05019729|531383282|FG000|Overall Study|Back up control participants who did not receive L9LS or CHMI because they were not needed|0|||
147449987|NCT01485627|531811336|FG001|Overall Study|Patient lost to followup|1|||
147332521|NCT05019729|531383283|FG001|Overall Study|Back up control participants who did not receive L9LS or CHMI because they were not needed|0|||
147332522|NCT05019729|531383284|FG002|Overall Study|Back up control participants who did not receive L9LS or CHMI because they were not needed|0|||
147332523|NCT05019729|531383285|FG003|Overall Study|Back up control participants who did not receive L9LS or CHMI because they were not needed|0|||
147332524|NCT05019729|531383286|FG004|Overall Study|Back up control participants who did not receive L9LS or CHMI because they were not needed|3|||
147332525|NCT05019729|531383287|FG005|Overall Study|Back up control participants who did not receive L9LS or CHMI because they were not needed|0|||
147332526|NCT03254394|531383290|FG000|Overall Study|Withdrawal by Subject|0|||
147332527|NCT03254394|531383291|FG001|Overall Study|Withdrawal by Subject|2|||
147332528|NCT00208767|531383292|FG000|Overall Study|Adverse Event|9|||
147332529|NCT00208767|531383293|FG001|Overall Study|Adverse Event|1|||
147332530|NCT00208767|531383292|FG000|Overall Study|Withdrawal by Subject|14|||
147332531|NCT00208767|531383293|FG001|Overall Study|Withdrawal by Subject|3|||
147332532|NCT00208767|531383292|FG000|Overall Study|Death|1|||
147332533|NCT00208767|531383293|FG001|Overall Study|Death|0|||
147332534|NCT00208767|531383292|FG000|Overall Study|Lost to Follow-up|3|||
147332535|NCT00208767|531383293|FG001|Overall Study|Lost to Follow-up|3|||
147332536|NCT00536380|531383300|FG000|Overall Study|Adverse Event|0|||
147332537|NCT00536380|531383301|FG001|Overall Study|Adverse Event|2|||
147332538|NCT00536380|531383302|FG002|Overall Study|Adverse Event|2|||
147332539|NCT00536380|531383300|FG000|Overall Study|Lost to Follow-up|0|||
147332540|NCT00536380|531383301|FG001|Overall Study|Lost to Follow-up|0|||
147332541|NCT00536380|531383302|FG002|Overall Study|Lost to Follow-up|1|||
147332542|NCT00536380|531383300|FG000|Overall Study|Withdrawal unrelated to study drug|2|||
147332543|NCT00536380|531383301|FG001|Overall Study|Withdrawal unrelated to study drug|0|||
147332544|NCT00536380|531383302|FG002|Overall Study|Withdrawal unrelated to study drug|1|||
147332545|NCT00536380|531383300|FG000|Overall Study|Withdrawal related to study drug|7|||
147332546|NCT00536380|531383301|FG001|Overall Study|Withdrawal related to study drug|5|||
147332547|NCT00536380|531383302|FG002|Overall Study|Withdrawal related to study drug|2|||
147332548|NCT00536380|531383300|FG000|Overall Study|Noncompliance with protocol|3|||
147332549|NCT00536380|531383301|FG001|Overall Study|Noncompliance with protocol|2|||
147332550|NCT00536380|531383302|FG002|Overall Study|Noncompliance with protocol|2|||
147332551|NCT00536380|531383300|FG000|Overall Study|Did not meet protocol eligibility|0|||
147332552|NCT00536380|531383301|FG001|Overall Study|Did not meet protocol eligibility|0|||
147332553|NCT00536380|531383302|FG002|Overall Study|Did not meet protocol eligibility|1|||
147332554|NCT00536380|531383300|FG000|Overall Study|Administrative|0|||
147332555|NCT00536380|531383301|FG001|Overall Study|Administrative|0|||
147332556|NCT00536380|531383302|FG002|Overall Study|Administrative|1|||
147332557|NCT00387465|531383303|FG000|Overall Study|Withdrawal by Subject|0|||
147332558|NCT00387465|531383304|FG001|Overall Study|Withdrawal by Subject|1|||
147332559|NCT00387465|531383305|FG002|Overall Study|Withdrawal by Subject|0|||
147332560|NCT03418324|531383306|FG000|Overall Study|Death|0|||
147332561|NCT03418324|531383307|FG001|Overall Study|Death|1|||
147332562|NCT03418324|531383306|FG000|Overall Study|Physician Decision|1|||
147332563|NCT03418324|531383307|FG001|Overall Study|Physician Decision|1|||
147332564|NCT00290706|531383311|FG000|Overall Study|Withdrawal by Subject|2|||
147332565|NCT00290706|531383312|FG001|Overall Study|Withdrawal by Subject|0|||
147332566|NCT00290706|531383313|FG002|Overall Study|Withdrawal by Subject|0|||
147332567|NCT00290706|531383314|FG003|Overall Study|Withdrawal by Subject|0|||
147332568|NCT00290706|531383311|FG000|Overall Study|Progressive Disease|3|||
147332569|NCT00290706|531383312|FG001|Overall Study|Progressive Disease|5|||
147332570|NCT00290706|531383313|FG002|Overall Study|Progressive Disease|4|||
147332571|NCT00290706|531383314|FG003|Overall Study|Progressive Disease|10|||
147449988|NCT01485627|531811335|FG000|Overall Study|Caregiver withdrew|3|||
147449989|NCT01485627|531811336|FG001|Overall Study|Caregiver withdrew|3|||
147254715|NCT02669433|531103759|FG000|Overall Study|Withdrawal by Subject|5|||
147254716|NCT02669433|531103760|FG001|Overall Study|Withdrawal by Subject|1|||
147254717|NCT02669433|531103761|FG002|Overall Study|Withdrawal by Subject|0|||
147254718|NCT02669433|531103759|FG000|Overall Study|Withdrawal by Caregiver|1|||
147254719|NCT02669433|531103760|FG001|Overall Study|Withdrawal by Caregiver|0|||
147254720|NCT02669433|531103761|FG002|Overall Study|Withdrawal by Caregiver|2|||
147254721|NCT02669433|531103759|FG000|Overall Study|Death|0|||
147254722|NCT02669433|531103760|FG001|Overall Study|Death|1|||
147254723|NCT02669433|531103761|FG002|Overall Study|Death|1|||
147254724|NCT02157298|531103769|FG000|Overall Study|Adverse Event|1|||
147332572|NCT00290706|531383311|FG000|Overall Study|Adverse Event|0|||
147332573|NCT00290706|531383312|FG001|Overall Study|Adverse Event|1|||
147332574|NCT00290706|531383313|FG002|Overall Study|Adverse Event|2|||
147332575|NCT00290706|531383314|FG003|Overall Study|Adverse Event|0|||
147254725|NCT02157298|531103770|FG001|Overall Study|Adverse Event|0|||
147254726|NCT02157298|531103769|FG000|Overall Study|Subject no longer meets study criteria|1|||
147254727|NCT02157298|531103770|FG001|Overall Study|Subject no longer meets study criteria|2|||
147332576|NCT00290706|531383311|FG000|Overall Study|Receive auto transplant or radiation|0|||
147332577|NCT00290706|531383312|FG001|Overall Study|Receive auto transplant or radiation|0|||
147332578|NCT00290706|531383313|FG002|Overall Study|Receive auto transplant or radiation|0|||
147332579|NCT00290706|531383314|FG003|Overall Study|Receive auto transplant or radiation|1|||
147598680|NCT00667810|532349866|FG001|Overall Study|Vasogenic Edema Recurrence|3|||
147598681|NCT00667810|532349867|FG002|Overall Study|Vasogenic Edema Recurrence|0|||
147254728|NCT02157298|531103769|FG000|Overall Study|Poor/Non-compliance|1|||
147254729|NCT02157298|531103770|FG001|Overall Study|Poor/Non-compliance|0|||
147254730|NCT02157298|531103769|FG000|Overall Study|Withdrawal by Subject|1|||
147254731|NCT02157298|531103770|FG001|Overall Study|Withdrawal by Subject|0|||
147254732|NCT00883116|531103775|FG000|Overall Study|Adverse event unrelated to study drug|5|||
147254733|NCT00883116|531103776|FG001|Overall Study|Adverse event unrelated to study drug|10|||
147254734|NCT00883116|531103775|FG000|Overall Study|Death|6|||
147254735|NCT00883116|531103776|FG001|Overall Study|Death|2|||
147254736|NCT00883116|531103775|FG000|Overall Study|Disease progression|130|||
147254737|NCT00883116|531103776|FG001|Overall Study|Disease progression|128|||
147254738|NCT00883116|531103775|FG000|Overall Study|Lost to Follow-up|0|||
147254739|NCT00883116|531103776|FG001|Overall Study|Lost to Follow-up|1|||
147254740|NCT00883116|531103775|FG000|Overall Study|Maximum clinical benefit|13|||
147254741|NCT00883116|531103776|FG001|Overall Study|Maximum clinical benefit|46|||
147254742|NCT00883116|531103775|FG000|Overall Study|Not identified|3|||
147254743|NCT00883116|531103776|FG001|Overall Study|Not identified|6|||
147254744|NCT00883116|531103775|FG000|Overall Study|Study drug toxicity|36|||
147254745|NCT00883116|531103776|FG001|Overall Study|Study drug toxicity|16|||
147254746|NCT00883116|531103775|FG000|Overall Study|Withdrawal by Subject|14|||
147254747|NCT00883116|531103776|FG001|Overall Study|Withdrawal by Subject|8|||
147254748|NCT00883116|531103775|FG000|Overall Study|No longer meets study criteria|2|||
147254749|NCT00883116|531103776|FG001|Overall Study|No longer meets study criteria|2|||
147254750|NCT03715764|531103777|FG000|Baseline (Randomized (n=69)|Withdrawal by Subject|2|||
147254751|NCT03715764|531103778|FG001|Baseline (Randomized (n=69)|Withdrawal by Subject|3|||
147254752|NCT03715764|531103777|FG000|3 Month Follow-up|Lost to Follow-up|2|||
147254753|NCT03715764|531103778|FG001|3 Month Follow-up|Lost to Follow-up|2|||
147332580|NCT00290706|531383311|FG000|Overall Study|Physician Decision|0|||
147332581|NCT00290706|531383312|FG001|Overall Study|Physician Decision|0|||
147332582|NCT00290706|531383313|FG002|Overall Study|Physician Decision|0|||
147332583|NCT00290706|531383314|FG003|Overall Study|Physician Decision|1|||
147332584|NCT00605033|531383316|FG000|Overall Study|Adverse Event|2|||
147332585|NCT00605033|531383317|FG001|Overall Study|Adverse Event|2|||
147332586|NCT00605033|531383316|FG000|Overall Study|Lost to Follow-up|1|||
147332587|NCT00605033|531383317|FG001|Overall Study|Lost to Follow-up|1|||
147332588|NCT00605033|531383316|FG000|Overall Study|Withdrawal by Subject|3|||
147332589|NCT00605033|531383317|FG001|Overall Study|Withdrawal by Subject|4|||
147332590|NCT00605033|531383316|FG000|Overall Study|Protocol Violation|1|||
147332591|NCT00605033|531383317|FG001|Overall Study|Protocol Violation|1|||
147332592|NCT01196429|531383318|FG000|Overall Study|Ineligible - inadequate pathology|1|||
147332593|NCT01196429|531383319|FG001|Overall Study|Ineligible - inadequate pathology|0|||
147332594|NCT01196429|531383318|FG000|Overall Study|Ineligible - wrong cell type|1|||
147332595|NCT01196429|531383319|FG001|Overall Study|Ineligible - wrong cell type|0|||
147332596|NCT01196429|531383318|FG000|Overall Study|Refused - Never Treated|1|||
147332597|NCT01196429|531383319|FG001|Overall Study|Refused - Never Treated|0|||
147332598|NCT03768206|531383320|FG000|Overall Study|Lost to Follow-up|2|||
147332599|NCT03768206|531383321|FG001|Overall Study|Lost to Follow-up|1|||
147332600|NCT03768206|531383320|FG000|Overall Study|Withdrawal by Subject|0|||
147332601|NCT03768206|531383321|FG001|Overall Study|Withdrawal by Subject|1|||
147332602|NCT00849147|531383324|FG000|Overall Study|Withdrawal by Subject|1|||
147332603|NCT00849147|531383324|FG000|Overall Study|Protocol Violation|2|||
147332604|NCT00849147|531383324|FG000|Overall Study|Disease Relapse/Progression|2|||
147332605|NCT04517864|531385491|FG000|Placebo-Controlled Phase|Adverse Event|1|||
147332606|NCT04517864|531385492|FG001|Placebo-Controlled Phase|Adverse Event|0|||
147332607|NCT04517864|531385493|FG002|Placebo-Controlled Phase|Adverse Event|0|||
147332608|NCT04517864|531385491|FG000|Placebo-Controlled Phase|Lost to Follow-up|1|||
147332609|NCT04517864|531385492|FG001|Placebo-Controlled Phase|Lost to Follow-up|1|||
147332610|NCT04517864|531385493|FG002|Placebo-Controlled Phase|Lost to Follow-up|0|||
147332611|NCT04517864|531385491|FG000|Placebo-Controlled Phase|Protocol Violation|1|||
147332612|NCT04517864|531385492|FG001|Placebo-Controlled Phase|Protocol Violation|0|||
147332613|NCT04517864|531385493|FG002|Placebo-Controlled Phase|Protocol Violation|0|||
147332614|NCT04517864|531385491|FG000|Placebo-Controlled Phase|Withdrawal by Subject|1|||
147332615|NCT04517864|531385492|FG001|Placebo-Controlled Phase|Withdrawal by Subject|1|||
147332616|NCT04517864|531385493|FG002|Placebo-Controlled Phase|Withdrawal by Subject|0|||
147332617|NCT04517864|531385491|FG000|Active Therapy Extension Phase|Adverse Event|1|||
147332618|NCT04517864|531385492|FG001|Active Therapy Extension Phase|Adverse Event|0|||
147332619|NCT04517864|531385493|FG002|Active Therapy Extension Phase|Adverse Event|0|||
147598682|NCT00667810|532349868|FG003|Overall Study|Vasogenic Edema Recurrence|0|||
147598683|NCT00667810|532349865|FG000|Overall Study|Other|6|||
147332620|NCT04517864|531385491|FG000|Active Therapy Extension Phase|Lack of Efficacy|1|||
147598684|NCT00667810|532349866|FG001|Overall Study|Other|6|||
147332621|NCT04517864|531385492|FG001|Active Therapy Extension Phase|Lack of Efficacy|0|||
147332622|NCT04517864|531385493|FG002|Active Therapy Extension Phase|Lack of Efficacy|0|||
147332623|NCT04517864|531385491|FG000|Active Therapy Extension Phase|Lost to Follow-up|0|||
147598685|NCT00667810|532349867|FG002|Overall Study|Other|5|||
147254754|NCT03715764|531103777|FG000|3 Month Follow-up|Withdrawal by Subject|1|||
147254755|NCT03715764|531103778|FG001|3 Month Follow-up|Withdrawal by Subject|1|||
147254756|NCT03715764|531103777|FG000|6 Month Follow-up|Lost to Follow-up|3|||
147254757|NCT03715764|531103778|FG001|6 Month Follow-up|Lost to Follow-up|0|||
147254758|NCT03715764|531103777|FG000|12 Month Follow-up|Lost to Follow-up|2|||
147254759|NCT03715764|531103778|FG001|12 Month Follow-up|Lost to Follow-up|3|||
147254760|NCT03715764|531103777|FG000|12 Month Follow-up|Pregnancy|0|||
147254761|NCT03715764|531103778|FG001|12 Month Follow-up|Pregnancy|1|||
147254762|NCT03715764|531103777|FG000|12 Month Follow-up|Surgery|2|||
147254763|NCT03715764|531103778|FG001|12 Month Follow-up|Surgery|0|||
147254764|NCT03715764|531103777|FG000|12 Month Follow-up|Wrong address|1|||
147254765|NCT03715764|531103778|FG001|12 Month Follow-up|Wrong address|0|||
147254766|NCT03715764|531103777|FG000|12 Month Follow-up|No symptoms|1|||
147254767|NCT03715764|531103778|FG001|12 Month Follow-up|No symptoms|0|||
147254768|NCT03715764|531103777|FG000|12 Month Follow-up|Changed primary care centre|0|||
147254769|NCT03715764|531103778|FG001|12 Month Follow-up|Changed primary care centre|1|||
147254770|NCT01361464|531103781|FG000|Overall Study|Death|1|||
147254771|NCT01361464|531103781|FG000|Overall Study|Withdrawal by Subject|2|||
147254772|NCT01722071|531103782|FG000|Overall Study|Protocol Violation|1|||
147254773|NCT01722071|531103783|FG001|Overall Study|Protocol Violation|0|||
147254774|NCT01106898|531103784|FG000|Overall Study|Adverse Event|6|||
147254775|NCT00818662|531103785|FG000|Overall Study|Adverse Event|5|||
147254776|NCT00818662|531103786|FG001|Overall Study|Adverse Event|14|||
147254777|NCT00818662|531103787|FG002|Overall Study|Adverse Event|4|||
147254778|NCT00818662|531103788|FG003|Overall Study|Adverse Event|3|||
147254779|NCT00818662|531103785|FG000|Overall Study|Withdrawal by Subject|5|||
147254780|NCT00818662|531103786|FG001|Overall Study|Withdrawal by Subject|4|||
147254781|NCT00818662|531103787|FG002|Overall Study|Withdrawal by Subject|2|||
147254782|NCT00818662|531103788|FG003|Overall Study|Withdrawal by Subject|2|||
147254783|NCT00818662|531103785|FG000|Overall Study|Death|1|||
147254784|NCT00818662|531103786|FG001|Overall Study|Death|3|||
147254785|NCT00818662|531103787|FG002|Overall Study|Death|0|||
147254786|NCT00818662|531103788|FG003|Overall Study|Death|0|||
147254787|NCT00818662|531103785|FG000|Overall Study|Physician Decision|1|||
147254788|NCT00818662|531103786|FG001|Overall Study|Physician Decision|0|||
147254789|NCT00818662|531103787|FG002|Overall Study|Physician Decision|0|||
147254790|NCT00818662|531103788|FG003|Overall Study|Physician Decision|0|||
147254791|NCT00818662|531103785|FG000|Overall Study|Lost to Follow-up|0|||
147254792|NCT00818662|531103786|FG001|Overall Study|Lost to Follow-up|0|||
147254793|NCT00818662|531103787|FG002|Overall Study|Lost to Follow-up|0|||
147254794|NCT00818662|531103788|FG003|Overall Study|Lost to Follow-up|1|||
147254795|NCT00818662|531103785|FG000|Overall Study|Unwilling or Unable to Participate|4|||
147254796|NCT00818662|531103786|FG001|Overall Study|Unwilling or Unable to Participate|6|||
147254797|NCT00818662|531103787|FG002|Overall Study|Unwilling or Unable to Participate|2|||
147254798|NCT00818662|531103788|FG003|Overall Study|Unwilling or Unable to Participate|4|||
147254799|NCT00818662|531103785|FG000|Overall Study|Protocol Violation|1|||
147254800|NCT00818662|531103786|FG001|Overall Study|Protocol Violation|1|||
147254801|NCT00818662|531103787|FG002|Overall Study|Protocol Violation|0|||
147254802|NCT00818662|531103788|FG003|Overall Study|Protocol Violation|0|||
147254803|NCT00818662|531103785|FG000|Overall Study|Requires a Prohibited Medication|1|||
147254804|NCT00818662|531103786|FG001|Overall Study|Requires a Prohibited Medication|0|||
147254805|NCT00818662|531103787|FG002|Overall Study|Requires a Prohibited Medication|0|||
147254806|NCT00818662|531103788|FG003|Overall Study|Requires a Prohibited Medication|0|||
147254807|NCT00818662|531103785|FG000|Overall Study|Safety Risk|1|||
147254808|NCT00818662|531103786|FG001|Overall Study|Safety Risk|1|||
147254809|NCT00818662|531103787|FG002|Overall Study|Safety Risk|0|||
147254810|NCT00818662|531103788|FG003|Overall Study|Safety Risk|1|||
147254811|NCT00818662|531103785|FG000|Overall Study|Study Partner Unwilling or Unable|3|||
147254812|NCT00818662|531103786|FG001|Overall Study|Study Partner Unwilling or Unable|2|||
147254813|NCT00818662|531103787|FG002|Overall Study|Study Partner Unwilling or Unable|1|||
147254814|NCT00818662|531103788|FG003|Overall Study|Study Partner Unwilling or Unable|1|||
147254815|NCT00818662|531103785|FG000|Overall Study|Participant's health declined|0|||
147254816|NCT00818662|531103786|FG001|Overall Study|Participant's health declined|0|||
147254817|NCT00818662|531103787|FG002|Overall Study|Participant's health declined|0|||
147254818|NCT00818662|531103788|FG003|Overall Study|Participant's health declined|1|||
147254819|NCT00818662|531103785|FG000|Overall Study|Caregiver to pursue other treatment|0|||
147332624|NCT04517864|531385492|FG001|Active Therapy Extension Phase|Lost to Follow-up|1|||
147332625|NCT04517864|531385493|FG002|Active Therapy Extension Phase|Lost to Follow-up|0|||
147332626|NCT04517864|531385491|FG000|Active Therapy Extension Phase|Physician Decision|1|||
147598686|NCT00667810|532349868|FG003|Overall Study|Other|0|||
147254820|NCT00818662|531103786|FG001|Overall Study|Caregiver to pursue other treatment|1|||
147254821|NCT00818662|531103787|FG002|Overall Study|Caregiver to pursue other treatment|0|||
147254822|NCT00818662|531103788|FG003|Overall Study|Caregiver to pursue other treatment|0|||
147254823|NCT00818662|531103785|FG000|Overall Study|Moving out of state|0|||
147332627|NCT04517864|531385492|FG001|Active Therapy Extension Phase|Physician Decision|0|||
147254824|NCT00818662|531103786|FG001|Overall Study|Moving out of state|0|||
147254825|NCT00818662|531103787|FG002|Overall Study|Moving out of state|0|||
147254826|NCT00818662|531103788|FG003|Overall Study|Moving out of state|1|||
147254827|NCT00818662|531103785|FG000|Overall Study|Declined move to another study site|1|||
147254828|NCT00818662|531103786|FG001|Overall Study|Declined move to another study site|0|||
147254829|NCT00818662|531103787|FG002|Overall Study|Declined move to another study site|0|||
147254830|NCT00818662|531103788|FG003|Overall Study|Declined move to another study site|0|||
147254831|NCT00818662|531103785|FG000|Overall Study|Change in living situation|0|||
147254832|NCT00818662|531103786|FG001|Overall Study|Change in living situation|0|||
147254833|NCT00818662|531103787|FG002|Overall Study|Change in living situation|0|||
147449990|NCT01485627|531811335|FG000|Overall Study|Caregiver lost to follow up|11|||
147449991|NCT01485627|531811336|FG001|Overall Study|Caregiver lost to follow up|12|||
147449992|NCT01485627|531811335|FG000|Overall Study|Caregiver died|1|||
147449993|NCT01485627|531811336|FG001|Overall Study|Caregiver died|0|||
147449994|NCT01485627|531811335|FG000|Overall Study|caregiver was not bereaved|42|||
147449995|NCT01485627|531811336|FG001|Overall Study|caregiver was not bereaved|35|||
147449996|NCT01709149|531811338|FG000|Open-label Lead-in Phase|Adverse Event|109|||
147449997|NCT01709149|531811339|FG001|Open-label Lead-in Phase|Adverse Event|0|||
147254834|NCT00818662|531103788|FG003|Overall Study|Change in living situation|1|||
147254835|NCT00818662|531103785|FG000|Overall Study|Study partner decision|0|||
147254836|NCT00818662|531103786|FG001|Overall Study|Study partner decision|0|||
147254837|NCT00818662|531103787|FG002|Overall Study|Study partner decision|0|||
147254838|NCT00818662|531103788|FG003|Overall Study|Study partner decision|1|||
147254839|NCT00818662|531103785|FG000|Overall Study|Admitted to long term nursing care|0|||
147254840|NCT00818662|531103786|FG001|Overall Study|Admitted to long term nursing care|1|||
147254841|NCT00818662|531103787|FG002|Overall Study|Admitted to long term nursing care|0|||
147254842|NCT00818662|531103788|FG003|Overall Study|Admitted to long term nursing care|0|||
147254843|NCT03021265|531103789|FG000|Overall Study|Adverse Event|29|||
147254844|NCT03021265|531103789|FG000|Overall Study|Lack of Efficacy|3|||
147254845|NCT03021265|531103789|FG000|Overall Study|Improved|17|||
147254846|NCT03021265|531103789|FG000|Overall Study|Lost to Follow-up|67|||
147254847|NCT03021265|531103789|FG000|Overall Study|No reason given|2|||
147254848|NCT03021265|531103789|FG000|Overall Study|No visit since the first visit|4|||
147254849|NCT01338493|531103790|FG000|Enrolled|Withdrawal by Subject|1|||
147254850|NCT01338493|531103790|FG000|Enrolled|Patient not implanted|4|||
147254851|NCT01338493|531103790|FG000|Discharge|Death|1|||
147254852|NCT01338493|531103790|FG000|Discharge|Missed visit|1|||
147254853|NCT01338493|531103790|FG000|6 Months Follow up|Lost to Follow-up|11|||
147254854|NCT01338493|531103790|FG000|6 Months Follow up|Missed visit|8|||
147254855|NCT01338493|531103790|FG000|12 Months Follow up|Lost to Follow-up|9|||
147254856|NCT01472081|531103791|FG000|Overall Study|Continuing treatment at time of analysis|1|||
147254857|NCT01472081|531103792|FG001|Overall Study|Continuing treatment at time of analysis|4|||
147254858|NCT01472081|531103793|FG002|Overall Study|Continuing treatment at time of analysis|1|||
147254859|NCT01472081|531103794|FG003|Overall Study|Continuing treatment at time of analysis|8|||
147254860|NCT01472081|531103795|FG004|Overall Study|Continuing treatment at time of analysis|9|||
147254861|NCT01472081|531103796|FG005|Overall Study|Continuing treatment at time of analysis|0|||
147254862|NCT01472081|531103791|FG000|Overall Study|Disease Progression|4|||
147254863|NCT01472081|531103792|FG001|Overall Study|Disease Progression|10|||
147254864|NCT01472081|531103793|FG002|Overall Study|Disease Progression|12|||
147254865|NCT01472081|531103794|FG003|Overall Study|Disease Progression|31|||
147254866|NCT01472081|531103795|FG004|Overall Study|Disease Progression|22|||
147254867|NCT01472081|531103796|FG005|Overall Study|Disease Progression|3|||
147254868|NCT01472081|531103791|FG000|Overall Study|Study drug toxicity|2|||
147254869|NCT01472081|531103792|FG001|Overall Study|Study drug toxicity|9|||
147254870|NCT01472081|531103793|FG002|Overall Study|Study drug toxicity|4|||
147254871|NCT01472081|531103794|FG003|Overall Study|Study drug toxicity|6|||
147254872|NCT01472081|531103795|FG004|Overall Study|Study drug toxicity|13|||
147254873|NCT01472081|531103796|FG005|Overall Study|Study drug toxicity|2|||
147254874|NCT01472081|531103791|FG000|Overall Study|Death|0|||
147254875|NCT01472081|531103792|FG001|Overall Study|Death|0|||
147449998|NCT01709149|531811340|FG002|Open-label Lead-in Phase|Adverse Event|0|||
147449999|NCT01709149|531811338|FG000|Open-label Lead-in Phase|Withdrawal by Subject|2|||
147450000|NCT01709149|531811339|FG001|Open-label Lead-in Phase|Withdrawal by Subject|0|||
147598687|NCT01561430|532349869|FG000|Overall Study|Adverse Event|0|||
147598688|NCT01561430|532349870|FG001|Overall Study|Adverse Event|0|||
147598689|NCT01561430|532349871|FG002|Overall Study|Adverse Event|3|||
147598690|NCT01561430|532349872|FG003|Overall Study|Adverse Event|1|||
147254876|NCT01472081|531103793|FG002|Overall Study|Death|0|||
147254877|NCT01472081|531103794|FG003|Overall Study|Death|0|||
147254878|NCT01472081|531103795|FG004|Overall Study|Death|1|||
147254879|NCT01472081|531103796|FG005|Overall Study|Death|0|||
147254880|NCT01472081|531103791|FG000|Overall Study|Adverse Event unrelated to study drug|0|||
147254881|NCT01472081|531103792|FG001|Overall Study|Adverse Event unrelated to study drug|0|||
147254882|NCT01472081|531103793|FG002|Overall Study|Adverse Event unrelated to study drug|0|||
147254883|NCT01472081|531103794|FG003|Overall Study|Adverse Event unrelated to study drug|0|||
147254884|NCT01472081|531103795|FG004|Overall Study|Adverse Event unrelated to study drug|1|||
147254885|NCT01472081|531103796|FG005|Overall Study|Adverse Event unrelated to study drug|0|||
147254886|NCT01472081|531103791|FG000|Overall Study|Withdrawal by Subject|0|||
147254887|NCT01472081|531103792|FG001|Overall Study|Withdrawal by Subject|0|||
147254888|NCT01472081|531103793|FG002|Overall Study|Withdrawal by Subject|0|||
147254889|NCT01472081|531103794|FG003|Overall Study|Withdrawal by Subject|0|||
147254890|NCT01472081|531103795|FG004|Overall Study|Withdrawal by Subject|0|||
147254891|NCT01472081|531103796|FG005|Overall Study|Withdrawal by Subject|1|||
147254892|NCT01472081|531103791|FG000|Overall Study|Poor/non-compliance|0|||
147254893|NCT01472081|531103792|FG001|Overall Study|Poor/non-compliance|0|||
147254894|NCT01472081|531103793|FG002|Overall Study|Poor/non-compliance|1|||
147254895|NCT01472081|531103794|FG003|Overall Study|Poor/non-compliance|0|||
147254896|NCT01472081|531103795|FG004|Overall Study|Poor/non-compliance|1|||
147254897|NCT01472081|531103796|FG005|Overall Study|Poor/non-compliance|0|||
147254898|NCT01472081|531103791|FG000|Overall Study|No longer meets study criteria|0|||
147254899|NCT01472081|531103792|FG001|Overall Study|No longer meets study criteria|0|||
147254900|NCT01472081|531103793|FG002|Overall Study|No longer meets study criteria|1|||
147254901|NCT01472081|531103794|FG003|Overall Study|No longer meets study criteria|0|||
147254902|NCT01472081|531103795|FG004|Overall Study|No longer meets study criteria|0|||
147254903|NCT01472081|531103796|FG005|Overall Study|No longer meets study criteria|0|||
147254904|NCT01472081|531103791|FG000|Overall Study|Subject request to discontinue treatment|0|||
147254905|NCT01472081|531103792|FG001|Overall Study|Subject request to discontinue treatment|3|||
147254906|NCT01472081|531103793|FG002|Overall Study|Subject request to discontinue treatment|1|||
147254907|NCT01472081|531103794|FG003|Overall Study|Subject request to discontinue treatment|1|||
147254908|NCT01472081|531103795|FG004|Overall Study|Subject request to discontinue treatment|0|||
147254909|NCT01472081|531103796|FG005|Overall Study|Subject request to discontinue treatment|0|||
147254910|NCT01698801|531103797|FG000|Treatment Phase|Adverse Event|4|||
147254911|NCT01698801|531103797|FG000|Treatment Phase|Protocol Violation|1|||
147254912|NCT01698801|531103797|FG000|Treatment Phase|Other|4|||
147254913|NCT01698801|531103797|FG000|Treatment Phase|Withdrawal by Subject|1|||
147254914|NCT01698801|531103797|FG000|Treatment Phase|Disease progression|1|||
147254915|NCT01698801|531103797|FG000|Follow Up Phase|Withdrawal by Subject|1|||
147254916|NCT01698801|531103797|FG000|Follow Up Phase|Death|4|||
147254917|NCT00656474|531103798|FG000|Overall Study|Other Reason|1|||
147254918|NCT01614067|531103799|FG000|Overall Study|Pregnancy|1|||
147254919|NCT01614067|531103800|FG001|Overall Study|Pregnancy|0|||
147254920|NCT01614067|531103799|FG000|Overall Study|Physician Decision|6|||
147254921|NCT01614067|531103800|FG001|Overall Study|Physician Decision|5|||
147254922|NCT01614067|531103799|FG000|Overall Study|Withdrawal by Subject|0|||
147254923|NCT01614067|531103800|FG001|Overall Study|Withdrawal by Subject|1|||
147254924|NCT01614067|531103799|FG000|Overall Study|Study terminated early by sponsor and was unable to collect data|8|||
147254925|NCT01614067|531103800|FG001|Overall Study|Study terminated early by sponsor and was unable to collect data|9|||
147254926|NCT01505868|531103801|FG000|Overall Study|Withdrawal by Subject|1|||
147332628|NCT04517864|531385493|FG002|Active Therapy Extension Phase|Physician Decision|0|||
147332629|NCT04517864|531385491|FG000|Active Therapy Extension Phase|Withdrawal by Subject|8|||
147332630|NCT04517864|531385492|FG001|Active Therapy Extension Phase|Withdrawal by Subject|8|||
147332631|NCT04517864|531385493|FG002|Active Therapy Extension Phase|Withdrawal by Subject|0|||
147332632|NCT04517864|531385491|FG000|Extension Phase|Adverse Event|0|||
147332633|NCT04517864|531385492|FG001|Extension Phase|Adverse Event|0|||
147332634|NCT04517864|531385493|FG002|Extension Phase|Adverse Event|1|||
147332635|NCT04517864|531385491|FG000|Extension Phase|Lack of Efficacy|0|||
147332636|NCT04517864|531385492|FG001|Extension Phase|Lack of Efficacy|0|||
147332637|NCT04517864|531385493|FG002|Extension Phase|Lack of Efficacy|2|||
147661283|NCT01261390|532581471|FG002|Overall Study|Loss of Interest in the Study|0|||
147254927|NCT01505868|531103802|FG001|Overall Study|Withdrawal by Subject|0|||
147254928|NCT01505868|531103803|FG002|Overall Study|Withdrawal by Subject|0|||
147254929|NCT01505868|531103804|FG003|Overall Study|Withdrawal by Subject|0|||
147254930|NCT01505868|531103805|FG004|Overall Study|Withdrawal by Subject|0|||
147254931|NCT02998840|531103808|FG000|Overall Study|Lost to Follow-up|1|||
147254932|NCT02998840|531103809|FG001|Overall Study|Lost to Follow-up|1|||
147254933|NCT02998840|531103810|FG002|Overall Study|Lost to Follow-up|2|||
147254934|NCT02998840|531103811|FG003|Overall Study|Lost to Follow-up|3|||
147254935|NCT02998840|531103808|FG000|Overall Study|Withdrawal by Subject|1|||
147254936|NCT02998840|531103809|FG001|Overall Study|Withdrawal by Subject|1|||
147254937|NCT02998840|531103810|FG002|Overall Study|Withdrawal by Subject|0|||
147254938|NCT02998840|531103811|FG003|Overall Study|Withdrawal by Subject|1|||
147254939|NCT02998840|531103808|FG000|Overall Study|Unplanned travel, family emergency, sponsor request, work schedule|2|||
147254940|NCT02998840|531103809|FG001|Overall Study|Unplanned travel, family emergency, sponsor request, work schedule|1|||
147332638|NCT04517864|531385491|FG000|Extension Phase|Study Terminated By Sponsor|0|||
147332639|NCT04517864|531385492|FG001|Extension Phase|Study Terminated By Sponsor|0|||
147332640|NCT04517864|531385493|FG002|Extension Phase|Study Terminated By Sponsor|32|||
147332641|NCT04517864|531385491|FG000|Extension Phase|Withdrawal by Subject|0|||
147450001|NCT01709149|531811340|FG002|Open-label Lead-in Phase|Withdrawal by Subject|0|||
147450002|NCT01709149|531811338|FG000|Open-label Lead-in Phase|Death|1|||
147254941|NCT02998840|531103810|FG002|Overall Study|Unplanned travel, family emergency, sponsor request, work schedule|0|||
147254942|NCT02998840|531103811|FG003|Overall Study|Unplanned travel, family emergency, sponsor request, work schedule|1|||
147598691|NCT01561430|532349869|FG000|Overall Study|Withdrawal by Subject|0|||
147598692|NCT01561430|532349870|FG001|Overall Study|Withdrawal by Subject|0|||
147598693|NCT01561430|532349871|FG002|Overall Study|Withdrawal by Subject|1|||
147598694|NCT01561430|532349872|FG003|Overall Study|Withdrawal by Subject|0|||
147254943|NCT02625259|531103812|FG000|First Intervention (Day 1)|Other|0|||
147254944|NCT02625259|531103813|FG001|First Intervention (Day 1)|Other|0|||
147254945|NCT02625259|531103814|FG002|First Intervention (Day 1)|Other|1|||
147254946|NCT02625259|531103815|FG003|First Intervention (Day 1)|Other|0|||
147254947|NCT02625259|531103816|FG004|First Intervention (Day 1)|Other|0|||
147254948|NCT02625259|531103812|FG000|First Intervention (Day 1)|Adverse Event|2|||
147254949|NCT02625259|531103813|FG001|First Intervention (Day 1)|Adverse Event|1|||
147254950|NCT02625259|531103814|FG002|First Intervention (Day 1)|Adverse Event|0|||
147254951|NCT02625259|531103815|FG003|First Intervention (Day 1)|Adverse Event|0|||
147254952|NCT02625259|531103816|FG004|First Intervention (Day 1)|Adverse Event|0|||
147254953|NCT02625259|531103812|FG000|First Intervention (Day 1)|Withdrawal by Subject|0|||
147254954|NCT02625259|531103813|FG001|First Intervention (Day 1)|Withdrawal by Subject|0|||
147254955|NCT02625259|531103814|FG002|First Intervention (Day 1)|Withdrawal by Subject|0|||
147254956|NCT02625259|531103815|FG003|First Intervention (Day 1)|Withdrawal by Subject|1|||
147254957|NCT02625259|531103816|FG004|First Intervention (Day 1)|Withdrawal by Subject|0|||
147254958|NCT00665847|531103820|FG000|Overall Study|Adverse Event|8|||
147254959|NCT00665847|531103820|FG000|Overall Study|Withdrawal by Subject|2|||
147254960|NCT00665847|531103820|FG000|Overall Study|Subject non-compliant|8|||
147254961|NCT00665847|531103820|FG000|Overall Study|Subject reached a virologic endpoint|4|||
147254962|NCT00665847|531103820|FG000|Overall Study|Resistance to TMC125|1|||
147254963|NCT00665847|531103820|FG000|Overall Study|Subject ineligible to continue the trial|1|||
147254964|NCT00665847|531103820|FG000|Overall Study|Switch to Commercial Medication|1|||
147254965|NCT00511667|531103821|FG000|Overall Study|Adverse Event|1|||
147254966|NCT00511667|531103822|FG001|Overall Study|Adverse Event|0|||
147254967|NCT00511667|531103821|FG000|Overall Study|Protocol Violation|1|||
147254968|NCT00511667|531103822|FG001|Overall Study|Protocol Violation|1|||
147254969|NCT00511667|531103821|FG000|Overall Study|Withdrawal by Subject|2|||
147254970|NCT00511667|531103822|FG001|Overall Study|Withdrawal by Subject|0|||
147254971|NCT00511667|531103821|FG000|Overall Study|Site terminated|6|||
147254972|NCT00511667|531103822|FG001|Overall Study|Site terminated|1|||
147254973|NCT00511667|531103821|FG000|Overall Study|Other|2|||
147254974|NCT00511667|531103822|FG001|Overall Study|Other|1|||
147254975|NCT03605303|531103823|FG000|Period 1|Study Terminated|2|||
147254976|NCT03605303|531103824|FG001|Period 1|Study Terminated|1|||
147254977|NCT04702997|531103825|FG000|Overall Study|Withdrawal by Subject|1|||
147254978|NCT04702997|531103826|FG001|Overall Study|Withdrawal by Subject|1|||
147254979|NCT03274687|531106477|FG000|Overall Study|Protocol Violation|1|||
147254980|NCT03274687|531106478|FG001|Overall Study|Protocol Violation|1|||
147254981|NCT01706003|531106482|FG000|Overall Study|Withdrawal by Subject|2|||
147254982|NCT01706003|531106483|FG001|Overall Study|Withdrawal by Subject|0|||
147254983|NCT01706003|531106482|FG000|Overall Study|Not scheduled|3|||
147254984|NCT01706003|531106483|FG001|Overall Study|Not scheduled|0|||
147254985|NCT01706003|531106482|FG000|Overall Study|Lost to Follow-up|6|||
147254986|NCT01706003|531106483|FG001|Overall Study|Lost to Follow-up|4|||
147254987|NCT03182829|531106486|FG000|Overall Study|Protocol Violation|12|||
147254988|NCT03182829|531106487|FG001|Overall Study|Protocol Violation|12|||
147254989|NCT03182829|531106486|FG000|Overall Study|Other|4|||
147254990|NCT03182829|531106487|FG001|Overall Study|Other|3|||
147254991|NCT03316131|531106488|FG000|Treatment Period 2|Protocol deviation|1|||
147254992|NCT03316131|531106489|FG001|Treatment Period 2|Protocol deviation|0|||
147254993|NCT05608005|531106491|FG000|Overall Study|Adverse Event|2|||
147254994|NCT05608005|531106492|FG001|Overall Study|Adverse Event|1|||
147254995|NCT05608005|531106493|FG002|Overall Study|Adverse Event|3|||
147254996|NCT05608005|531106491|FG000|Overall Study|Protocol Violation|2|||
147254997|NCT05608005|531106492|FG001|Overall Study|Protocol Violation|3|||
147254998|NCT05608005|531106493|FG002|Overall Study|Protocol Violation|0|||
147254999|NCT05608005|531106491|FG000|Overall Study|Withdrawal by Subject|10|||
147255000|NCT05608005|531106492|FG001|Overall Study|Withdrawal by Subject|12|||
147255001|NCT05608005|531106493|FG002|Overall Study|Withdrawal by Subject|4|||
147255002|NCT05608005|531106491|FG000|Overall Study|Lost to Follow-up|25|||
147255003|NCT05608005|531106492|FG001|Overall Study|Lost to Follow-up|27|||
147255004|NCT05608005|531106493|FG002|Overall Study|Lost to Follow-up|15|||
147598695|NCT01561430|532349869|FG000|Overall Study|Physician Decision|0|||
147255005|NCT05608005|531106491|FG000|Overall Study|Participants were not vaccinated or withdrew for other reasons|6|||
147255006|NCT05608005|531106492|FG001|Overall Study|Participants were not vaccinated or withdrew for other reasons|7|||
147255007|NCT05608005|531106493|FG002|Overall Study|Participants were not vaccinated or withdrew for other reasons|0|||
147255008|NCT03020407|531106497|FG000|Overall Study|Withdrawal by Subject|2|||
147255009|NCT03020407|531106498|FG001|Overall Study|Withdrawal by Subject|1|||
147255010|NCT03020407|531106497|FG000|Overall Study|Lost to Follow-up|2|||
147255011|NCT03020407|531106498|FG001|Overall Study|Lost to Follow-up|3|||
147255012|NCT03020407|531106497|FG000|Overall Study|Protocol Violation|0|||
147255013|NCT03020407|531106498|FG001|Overall Study|Protocol Violation|1|||
147255014|NCT01585428|531106499|FG000|Overall Study|Death during treatment|1|||
147255015|NCT01585428|531106500|FG001|Overall Study|Death during treatment|0|||
147255016|NCT02699554|531106501|FG000|Overall Study|Lost to Follow-up|9|||
147255017|NCT00788151|531106502|FG000|Overall Study|Other adverse event|0|||
147598696|NCT01561430|532349870|FG001|Overall Study|Physician Decision|1|||
147598697|NCT01561430|532349871|FG002|Overall Study|Physician Decision|0|||
147598698|NCT01561430|532349872|FG003|Overall Study|Physician Decision|0|||
147598699|NCT01561430|532349869|FG000|Overall Study|Sponsor Decision|1|||
147255018|NCT00788151|531106503|FG001|Overall Study|Other adverse event|2|||
147255019|NCT00788151|531106502|FG000|Overall Study|Protocol Violation|0|||
147255020|NCT00788151|531106503|FG001|Overall Study|Protocol Violation|1|||
147255021|NCT00788151|531106502|FG000|Overall Study|Withdrawal by Subject|13|||
147255022|NCT00788151|531106503|FG001|Overall Study|Withdrawal by Subject|6|||
147255023|NCT00788151|531106502|FG000|Overall Study|Enrolled but not treated|1|||
147255024|NCT00788151|531106503|FG001|Overall Study|Enrolled but not treated|1|||
147255025|NCT00503009|531106506|FG000|Overall Study|Protocol Violation|1|||
147255026|NCT00503009|531106507|FG001|Overall Study|Protocol Violation|0|||
147255027|NCT00503009|531106508|FG002|Overall Study|Protocol Violation|1|||
147255028|NCT00503009|531106506|FG000|Overall Study|Withdrawal by Subject|0|||
147255029|NCT00503009|531106507|FG001|Overall Study|Withdrawal by Subject|1|||
147255030|NCT00503009|531106508|FG002|Overall Study|Withdrawal by Subject|1|||
147255031|NCT00503009|531106506|FG000|Overall Study|Physician Decision|0|||
147255032|NCT00503009|531106507|FG001|Overall Study|Physician Decision|1|||
147255033|NCT00503009|531106508|FG002|Overall Study|Physician Decision|1|||
147255034|NCT01349803|531106510|FG000|Overall Study|Adverse Event|0|||
147255035|NCT01349803|531106511|FG001|Overall Study|Adverse Event|0|||
147255036|NCT01349803|531106512|FG002|Overall Study|Adverse Event|0|||
147255037|NCT01349803|531106513|FG003|Overall Study|Adverse Event|2|||
147255038|NCT01349803|531106510|FG000|Overall Study|Withdrawal by Subject|1|||
147255039|NCT01349803|531106511|FG001|Overall Study|Withdrawal by Subject|0|||
147255040|NCT01349803|531106512|FG002|Overall Study|Withdrawal by Subject|0|||
147255041|NCT01349803|531106513|FG003|Overall Study|Withdrawal by Subject|0|||
147255042|NCT01349803|531106510|FG000|Overall Study|Protocol-specified criteria|0|||
147255043|NCT01349803|531106511|FG001|Overall Study|Protocol-specified criteria|1|||
147255044|NCT01349803|531106512|FG002|Overall Study|Protocol-specified criteria|3|||
147255045|NCT01349803|531106513|FG003|Overall Study|Protocol-specified criteria|0|||
147255046|NCT02169739|531106514|FG000|Overall Study|Lost to Follow-up|0|||
147255047|NCT02169739|531106515|FG001|Overall Study|Lost to Follow-up|4|||
147255048|NCT03635957|531106516|FG000|Run-In Period|Lost to Follow-up|1|||
147255049|NCT03635957|531106516|FG000|Pegloticase + IMM Period|Lack of Efficacy|3|||
147255050|NCT00350636|531106517|FG000|Overall Study|Adverse Event|19|||
147255051|NCT00350636|531106518|FG001|Overall Study|Adverse Event|13|||
147255052|NCT00350636|531106517|FG000|Overall Study|Protocol Violation|1|||
147255053|NCT00350636|531106518|FG001|Overall Study|Protocol Violation|3|||
147255054|NCT00350636|531106517|FG000|Overall Study|Withdrawal by Subject|13|||
147255055|NCT00350636|531106518|FG001|Overall Study|Withdrawal by Subject|17|||
147255056|NCT00350636|531106517|FG000|Overall Study|Lost to Follow-up|9|||
147255057|NCT00350636|531106518|FG001|Overall Study|Lost to Follow-up|8|||
147255058|NCT00350636|531106517|FG000|Overall Study|Physician Decision|0|||
147255059|NCT00350636|531106518|FG001|Overall Study|Physician Decision|2|||
147255060|NCT00350636|531106517|FG000|Overall Study|Other|1|||
147255061|NCT00350636|531106518|FG001|Overall Study|Other|2|||
147255062|NCT01647282|531106524|FG000|Overall Study|Physician Decision|7|||
147255063|NCT01647282|531106525|FG001|Overall Study|Physician Decision|5|||
147255064|NCT01042236|531106526|FG000|Treatment Period 1|Adverse Event|0|||
147255065|NCT01042236|531106527|FG001|Treatment Period 1|Adverse Event|1|||
147255066|NCT01042236|531106528|FG002|Treatment Period 1|Adverse Event|0|||
147255067|NCT01042236|531106529|FG003|Treatment Period 1|Adverse Event|0|||
147255068|NCT01042236|531106530|FG004|Treatment Period 1|Adverse Event|1|||
147255069|NCT01042236|531106531|FG005|Treatment Period 1|Adverse Event|0|||
147255070|NCT01042236|531106526|FG000|Treatment Period 3|Adverse Event|0|||
147255071|NCT01042236|531106527|FG001|Treatment Period 3|Adverse Event|0|||
147255072|NCT01042236|531106528|FG002|Treatment Period 3|Adverse Event|0|||
147255073|NCT01042236|531106529|FG003|Treatment Period 3|Adverse Event|1|||
147255074|NCT01042236|531106530|FG004|Treatment Period 3|Adverse Event|0|||
147255075|NCT01042236|531106531|FG005|Treatment Period 3|Adverse Event|0|||
147598700|NCT01561430|532349870|FG001|Overall Study|Sponsor Decision|14|||
147598701|NCT01561430|532349871|FG002|Overall Study|Sponsor Decision|13|||
147255076|NCT01042236|531106526|FG000|Treatment Period 3|Protocol Violation|0|||
147255077|NCT01042236|531106527|FG001|Treatment Period 3|Protocol Violation|0|||
147255078|NCT01042236|531106528|FG002|Treatment Period 3|Protocol Violation|0|||
147255079|NCT01042236|531106529|FG003|Treatment Period 3|Protocol Violation|1|||
147255080|NCT01042236|531106530|FG004|Treatment Period 3|Protocol Violation|0|||
147255081|NCT01042236|531106531|FG005|Treatment Period 3|Protocol Violation|0|||
147255082|NCT02522286|531106536|FG000|Overall Study|Withdrawal by Subject|3|||
147255083|NCT02522286|531106537|FG001|Overall Study|Withdrawal by Subject|0|||
147255084|NCT02522286|531106538|FG002|Overall Study|Withdrawal by Subject|0|||
147255085|NCT02522286|531106539|FG003|Overall Study|Withdrawal by Subject|3|||
147255086|NCT03683758|531106546|FG000|Overall Study|Non-study commitment conflict|1|||
147598702|NCT01561430|532349872|FG003|Overall Study|Sponsor Decision|12|||
147255087|NCT03683758|531106547|FG001|Overall Study|Non-study commitment conflict|3|||
147255088|NCT03683758|531106546|FG000|Overall Study|Illness preventing participation|1|||
147255089|NCT03683758|531106547|FG001|Overall Study|Illness preventing participation|0|||
147255090|NCT03683758|531106546|FG000|Overall Study|Adverse Event|1|||
147255091|NCT03683758|531106547|FG001|Overall Study|Adverse Event|0|||
147255092|NCT01172847|531106548|FG000|Overall Study|Withdrawal by Subject|3|||
147255093|NCT01163279|531106549|FG000|Overall Study|Withdrawal by Subject|2|||
147255094|NCT01163279|531106550|FG001|Overall Study|Withdrawal by Subject|0|||
147255095|NCT02411292|531106552|FG000|Overall Study|Discharged before 3rd enoxaparin dose|16|||
147255096|NCT02411292|531106552|FG000|Overall Study|Death|2|||
147255097|NCT02411292|531106552|FG000|Overall Study|Lost to Follow-up|3|||
147255098|NCT00303498|531106553|FG000|Run-In-Phase (10 Weeks)|Adverse Event|5|||
147255099|NCT00303498|531106554|FG001|Run-In-Phase (10 Weeks)|Adverse Event|1|||
147255100|NCT00303498|531106553|FG000|Run-In-Phase (10 Weeks)|Physician Decision|0|||
147255101|NCT00303498|531106554|FG001|Run-In-Phase (10 Weeks)|Physician Decision|1|||
147255102|NCT00303498|531106553|FG000|Run-In-Phase (10 Weeks)|Withdrawal by Subject|5|||
147255103|NCT00303498|531106554|FG001|Run-In-Phase (10 Weeks)|Withdrawal by Subject|0|||
147255104|NCT00303498|531106553|FG000|Run-In-Phase (10 Weeks)|Sponsor Decision|6|||
147255105|NCT00303498|531106554|FG001|Run-In-Phase (10 Weeks)|Sponsor Decision|3|||
147255106|NCT00303498|531106553|FG000|Run-In-Phase (10 Weeks)|Other|4|||
147255107|NCT00303498|531106554|FG001|Run-In-Phase (10 Weeks)|Other|1|||
147255108|NCT00303498|531106553|FG000|Run-In-Phase (10 Weeks)|Treatment Interrupted More Than 7 Days|3|||
147255109|NCT00303498|531106554|FG001|Run-In-Phase (10 Weeks)|Treatment Interrupted More Than 7 Days|2|||
147255110|NCT00303498|531106553|FG000|Run-In-Phase (10 Weeks)|Unable to Tolerate 25 mg Dose|1|||
147255111|NCT00303498|531106554|FG001|Run-In-Phase (10 Weeks)|Unable to Tolerate 25 mg Dose|0|||
147255112|NCT00303498|531106553|FG000|Maintenance Phase (24 Weeks)|Elevation in Liver Enzyme Values|1|||
147255113|NCT00303498|531106554|FG001|Maintenance Phase (24 Weeks)|Elevation in Liver Enzyme Values|0|||
147255114|NCT00303498|531106553|FG000|Maintenance Phase (24 Weeks)|Death|1|||
147255115|NCT00303498|531106554|FG001|Maintenance Phase (24 Weeks)|Death|0|||
147255116|NCT00303498|531106553|FG000|Maintenance Phase (24 Weeks)|Adverse Event|2|||
147255117|NCT00303498|531106554|FG001|Maintenance Phase (24 Weeks)|Adverse Event|1|||
147255118|NCT00303498|531106553|FG000|Maintenance Phase (24 Weeks)|Physician Decision|1|||
147255119|NCT00303498|531106554|FG001|Maintenance Phase (24 Weeks)|Physician Decision|0|||
147255120|NCT00303498|531106553|FG000|Maintenance Phase (24 Weeks)|Withdrawal by Subject|3|||
147255121|NCT00303498|531106554|FG001|Maintenance Phase (24 Weeks)|Withdrawal by Subject|4|||
147255122|NCT00303498|531106553|FG000|Maintenance Phase (24 Weeks)|Sponsor Decision|4|||
147255123|NCT00303498|531106554|FG001|Maintenance Phase (24 Weeks)|Sponsor Decision|0|||
147255124|NCT00303498|531106553|FG000|Maintenance Phase (24 Weeks)|Other|1|||
147255125|NCT00303498|531106554|FG001|Maintenance Phase (24 Weeks)|Other|0|||
147255126|NCT00303498|531106553|FG000|Maintenance Phase (24 Weeks)|Treatment Interrupted More Than 7 Days|1|||
147255127|NCT00303498|531106554|FG001|Maintenance Phase (24 Weeks)|Treatment Interrupted More Than 7 Days|2|||
147255128|NCT00303498|531106553|FG000|Maintenance Phase (24 Weeks)|Required Chronic Heart Failure Treatment|0|||
147255129|NCT00303498|531106554|FG001|Maintenance Phase (24 Weeks)|Required Chronic Heart Failure Treatment|1|||
147255130|NCT00453921|531106555|FG000|Overall Study|Withdrawal by Subject|1|||
147255131|NCT00453921|531106556|FG001|Overall Study|Withdrawal by Subject|1|||
147255132|NCT00453921|531106557|FG002|Overall Study|Withdrawal by Subject|1|||
147255133|NCT00453921|531106558|FG003|Overall Study|Withdrawal by Subject|1|||
147255134|NCT00453921|531106555|FG000|Overall Study|Lost to Follow-up|0|||
147255135|NCT00453921|531106556|FG001|Overall Study|Lost to Follow-up|0|||
147255136|NCT00453921|531106557|FG002|Overall Study|Lost to Follow-up|1|||
147255137|NCT00453921|531106558|FG003|Overall Study|Lost to Follow-up|0|||
147255138|NCT00174915|531106561|FG000|Overall Study|Lost to Follow-up|19|||
147255139|NCT00174915|531106562|FG001|Overall Study|Lost to Follow-up|17|||
147255140|NCT00174915|531106563|FG002|Overall Study|Lost to Follow-up|9|||
147255141|NCT00174915|531106564|FG003|Overall Study|Lost to Follow-up|17|||
147255142|NCT00174915|531106565|FG004|Overall Study|Lost to Follow-up|10|||
147255143|NCT00174915|531106561|FG000|Overall Study|Adverse Event|18|||
147255144|NCT00174915|531106562|FG001|Overall Study|Adverse Event|16|||
147255145|NCT00174915|531106563|FG002|Overall Study|Adverse Event|11|||
147255146|NCT00174915|531106564|FG003|Overall Study|Adverse Event|18|||
147255147|NCT00174915|531106565|FG004|Overall Study|Adverse Event|5|||
147255148|NCT00174915|531106561|FG000|Overall Study|Personal Reason(s)|16|||
147255149|NCT00174915|531106562|FG001|Overall Study|Personal Reason(s)|16|||
147255150|NCT00174915|531106563|FG002|Overall Study|Personal Reason(s)|9|||
147255151|NCT00174915|531106564|FG003|Overall Study|Personal Reason(s)|9|||
147255152|NCT00174915|531106565|FG004|Overall Study|Personal Reason(s)|9|||
147255153|NCT00174915|531106561|FG000|Overall Study|Other|15|||
147255154|NCT00174915|531106562|FG001|Overall Study|Other|8|||
147255155|NCT00174915|531106563|FG002|Overall Study|Other|6|||
147255156|NCT00174915|531106564|FG003|Overall Study|Other|5|||
147255157|NCT00174915|531106565|FG004|Overall Study|Other|3|||
147255158|NCT00174915|531106561|FG000|Overall Study|Gout Flare|13|||
147255159|NCT00174915|531106562|FG001|Overall Study|Gout Flare|6|||
147255160|NCT00174915|531106563|FG002|Overall Study|Gout Flare|8|||
147255161|NCT00174915|531106564|FG003|Overall Study|Gout Flare|1|||
147255162|NCT00174915|531106565|FG004|Overall Study|Gout Flare|0|||
147255163|NCT00174915|531106561|FG000|Overall Study|Protocol Violation|6|||
147332642|NCT04517864|531385492|FG001|Extension Phase|Withdrawal by Subject|0|||
147332643|NCT04517864|531385493|FG002|Extension Phase|Withdrawal by Subject|3|||
147332644|NCT04517864|531385491|FG000|Extension Phase|Approved Drug Available for Indication|0|||
147332645|NCT04517864|531385492|FG001|Extension Phase|Approved Drug Available for Indication|0|||
147332646|NCT04517864|531385493|FG002|Extension Phase|Approved Drug Available for Indication|7|||
147332647|NCT01049503|531385494|FG000|Overall Study|Lost to Follow-up|11|||
147332648|NCT01049503|531385495|FG001|Overall Study|Lost to Follow-up|12|||
147332649|NCT01049503|531385496|FG002|Overall Study|Lost to Follow-up|24|||
147332650|NCT01049503|531385497|FG003|Overall Study|Lost to Follow-up|26|||
147332651|NCT01049503|531385498|FG004|Overall Study|Lost to Follow-up|27|||
147332652|NCT01049503|531385499|FG005|Overall Study|Lost to Follow-up|8|||
147255164|NCT00174915|531106562|FG001|Overall Study|Protocol Violation|3|||
147255165|NCT00174915|531106563|FG002|Overall Study|Protocol Violation|3|||
147255166|NCT00174915|531106564|FG003|Overall Study|Protocol Violation|6|||
147255167|NCT00174915|531106565|FG004|Overall Study|Protocol Violation|3|||
147255168|NCT00174915|531106561|FG000|Overall Study|Therapeutic Failure|6|||
147332653|NCT00028769|531385500|FG000|Overall Study|Adverse Event|2|||
147332654|NCT00028769|531385500|FG000|Overall Study|Refusal Unrelated to Adverse Events|1|||
147332655|NCT00028769|531385500|FG000|Overall Study|Progression or Death|31|||
147332656|NCT00028769|531385500|FG000|Overall Study|Other - Not Protocol Specified|1|||
147332657|NCT00028769|531385500|FG000|Overall Study|Ineligible|5|||
147332658|NCT00028769|531385500|FG000|Overall Study|Not Analyzable|1|||
147255169|NCT00174915|531106562|FG001|Overall Study|Therapeutic Failure|3|||
147255170|NCT00174915|531106563|FG002|Overall Study|Therapeutic Failure|2|||
147255171|NCT00174915|531106564|FG003|Overall Study|Therapeutic Failure|1|||
147255172|NCT00174915|531106565|FG004|Overall Study|Therapeutic Failure|3|||
147255173|NCT02232425|531106566|FG000|Overall Study|Lost to Follow-up|6|||
147255174|NCT02232425|531106567|FG001|Overall Study|Lost to Follow-up|2|||
147255175|NCT02232425|531106566|FG000|Overall Study|Adverse Event|2|||
147255176|NCT02232425|531106567|FG001|Overall Study|Adverse Event|0|||
147255177|NCT02232425|531106566|FG000|Overall Study|Withdrawal by Subject|5|||
147255178|NCT02232425|531106567|FG001|Overall Study|Withdrawal by Subject|6|||
147255179|NCT02232425|531106566|FG000|Overall Study|Lack of Efficacy|1|||
147255180|NCT02232425|531106567|FG001|Overall Study|Lack of Efficacy|0|||
147255181|NCT03060447|531106568|FG000|Overall Study|Withdrawal by Subject|2|||
147255182|NCT03060447|531106569|FG001|Overall Study|Withdrawal by Subject|0|||
147255183|NCT00665353|531106570|FG000|Study Step 1|Adverse Event|1|||
147255184|NCT00665353|531106570|FG000|Study Step 1|Withdrawal by Subject|2|||
147255185|NCT00665353|531106570|FG000|Study Step 2|Lost to Follow-up|2|||
147255186|NCT00665353|531106570|FG000|Study Step 2|Lack of Efficacy|12|||
147255187|NCT01870583|531106571|FG000|Overall Study|Protocol Violation|0|||
147255188|NCT01870583|531106572|FG001|Overall Study|Protocol Violation|5|||
147255189|NCT01870583|531106573|FG002|Overall Study|Protocol Violation|3|||
147255190|NCT01870583|531106571|FG000|Overall Study|Lost to Follow-up|11|||
147255191|NCT01870583|531106572|FG001|Overall Study|Lost to Follow-up|13|||
147255192|NCT01870583|531106573|FG002|Overall Study|Lost to Follow-up|5|||
147255193|NCT01601626|531106577|FG000|Overall Study|Death|1|||
147255194|NCT01601626|531106578|FG001|Overall Study|Death|1|||
147255195|NCT01601626|531106579|FG002|Overall Study|Death|1|||
147255196|NCT01601626|531106577|FG000|Overall Study|Lost to Follow-up|1|||
147255197|NCT01601626|531106578|FG001|Overall Study|Lost to Follow-up|2|||
147255198|NCT01601626|531106579|FG002|Overall Study|Lost to Follow-up|0|||
147255199|NCT01601626|531106577|FG000|Overall Study|Unable to Get to Clinic|0|||
147255200|NCT01601626|531106578|FG001|Overall Study|Unable to Get to Clinic|1|||
147255201|NCT01601626|531106579|FG002|Overall Study|Unable to Get to Clinic|0|||
147255202|NCT01601626|531106577|FG000|Overall Study|Withdrawal by Subject|0|||
147255203|NCT01601626|531106578|FG001|Overall Study|Withdrawal by Subject|1|||
147255204|NCT01601626|531106579|FG002|Overall Study|Withdrawal by Subject|1|||
147255205|NCT01601626|531106577|FG000|Overall Study|Not Willing to Adhere to Requirements|1|||
147255206|NCT01601626|531106578|FG001|Overall Study|Not Willing to Adhere to Requirements|0|||
147255207|NCT01601626|531106579|FG002|Overall Study|Not Willing to Adhere to Requirements|0|||
147255208|NCT03045887|531106581|FG000|Part A,Washout Period 1(4 Weeks)|Physician Decision|3|||
147255209|NCT03045887|531106582|FG001|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
147255210|NCT03045887|531106583|FG002|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
147255211|NCT03045887|531106584|FG003|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
147255212|NCT03045887|531106585|FG004|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
147255213|NCT03045887|531106586|FG005|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
147255214|NCT03045887|531106587|FG006|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
147255215|NCT03045887|531106588|FG007|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
147255216|NCT03045887|531106589|FG008|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
147255217|NCT03045887|531106590|FG009|Part A,Washout Period 1(4 Weeks)|Physician Decision|0|||
147255218|NCT03045887|531106581|FG000|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
147255219|NCT03045887|531106582|FG001|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
147332659|NCT01499134|531385503|FG000|Overall Study|Withdrawal by Subject|0|||
147332660|NCT01499134|531385504|FG001|Overall Study|Withdrawal by Subject|1|||
147332661|NCT01198275|531385505|FG000|Overall Study|Adverse Event|2|||
147332662|NCT01198275|531385506|FG001|Overall Study|Adverse Event|3|||
147332663|NCT01198275|531385505|FG000|Overall Study|spontaneous return to sinus rhythm|4|||
147332664|NCT01198275|531385506|FG001|Overall Study|spontaneous return to sinus rhythm|2|||
147332665|NCT00391846|531385507|FG000|Overall Study|Adverse Event|4|||
147332666|NCT00391846|531385508|FG001|Overall Study|Adverse Event|1|||
147332667|NCT00391846|531385507|FG000|Overall Study|Did not meet the required elig. crit|2|||
147332668|NCT00391846|531385508|FG001|Overall Study|Did not meet the required elig. crit|2|||
147332669|NCT00391846|531385507|FG000|Overall Study|Withdrawal by Subject|2|||
147332670|NCT00391846|531385508|FG001|Overall Study|Withdrawal by Subject|3|||
147332671|NCT00391846|531385507|FG000|Overall Study|Developed study specific DC criteria|0|||
147332672|NCT00391846|531385508|FG001|Overall Study|Developed study specific DC criteria|1|||
147332673|NCT00970307|531385511|FG000|Overall Study|Serious Adverse Event|1|||
147332674|NCT00970307|531385512|FG001|Overall Study|Serious Adverse Event|0|||
147332675|NCT00970307|531385513|FG002|Overall Study|Serious Adverse Event|0|||
147332676|NCT00970307|531385511|FG000|Overall Study|Withdrawal by Subject|2|||
147332677|NCT00970307|531385512|FG001|Overall Study|Withdrawal by Subject|3|||
147332678|NCT00970307|531385513|FG002|Overall Study|Withdrawal by Subject|2|||
147332679|NCT01811706|531385514|FG000|First Intervention ( 4 Weeks)|Adverse Event|1|||
147332680|NCT01811706|531385515|FG001|First Intervention ( 4 Weeks)|Adverse Event|0|||
147598703|NCT04234984|532349880|FG000|Follow-up at 6 Weeks|Lost to Follow-up|2|||
147598704|NCT04234984|532349880|FG000|Follow-up at the Second Time Point|Death|1|||
147643968|NCT02255552|532516684|FG000|Overall Study|Withdrawal by Subject|1|||
147255220|NCT03045887|531106583|FG002|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
147255221|NCT03045887|531106584|FG003|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|1|||
147255222|NCT03045887|531106585|FG004|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
147255223|NCT03045887|531106586|FG005|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
147255224|NCT03045887|531106587|FG006|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
147255225|NCT03045887|531106588|FG007|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
147255226|NCT03045887|531106589|FG008|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
147255227|NCT03045887|531106590|FG009|Part A,Washout Period 1(4 Weeks)|Withdrawal by Subject|0|||
147255228|NCT03045887|531106581|FG000|Part A, Period 2 (1 Day)|Adverse Event|1|||
147255229|NCT03045887|531106582|FG001|Part A, Period 2 (1 Day)|Adverse Event|0|||
147255230|NCT03045887|531106583|FG002|Part A, Period 2 (1 Day)|Adverse Event|0|||
147255231|NCT03045887|531106584|FG003|Part A, Period 2 (1 Day)|Adverse Event|0|||
147255232|NCT03045887|531106585|FG004|Part A, Period 2 (1 Day)|Adverse Event|0|||
147255233|NCT03045887|531106586|FG005|Part A, Period 2 (1 Day)|Adverse Event|0|||
147255234|NCT03045887|531106587|FG006|Part A, Period 2 (1 Day)|Adverse Event|0|||
147255235|NCT03045887|531106588|FG007|Part A, Period 2 (1 Day)|Adverse Event|0|||
147255236|NCT03045887|531106589|FG008|Part A, Period 2 (1 Day)|Adverse Event|0|||
147255237|NCT03045887|531106590|FG009|Part A, Period 2 (1 Day)|Adverse Event|0|||
147255238|NCT03045887|531106581|FG000|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
147255239|NCT03045887|531106582|FG001|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
147255240|NCT03045887|531106583|FG002|Part A,Washout Period 2 (4 Weeks)|Physician Decision|1|||
147255241|NCT03045887|531106584|FG003|Part A,Washout Period 2 (4 Weeks)|Physician Decision|1|||
147255242|NCT03045887|531106585|FG004|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
147255243|NCT03045887|531106586|FG005|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
147255244|NCT03045887|531106587|FG006|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
147255245|NCT03045887|531106588|FG007|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
147255246|NCT03045887|531106589|FG008|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
147255247|NCT03045887|531106590|FG009|Part A,Washout Period 2 (4 Weeks)|Physician Decision|0|||
147255248|NCT03045887|531106581|FG000|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
147255249|NCT03045887|531106582|FG001|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
147255250|NCT03045887|531106583|FG002|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
147255251|NCT03045887|531106584|FG003|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|1|||
147255252|NCT03045887|531106585|FG004|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
147332681|NCT03823300|531385518|FG000|Overall Study|Withdrawal by Subject|16|||
147332682|NCT03823300|531385519|FG001|Overall Study|Withdrawal by Subject|22|||
147332683|NCT03823300|531385518|FG000|Overall Study|Death|10|||
147332684|NCT03823300|531385519|FG001|Overall Study|Death|14|||
147332685|NCT03823300|531385518|FG000|Overall Study|Adverse Event|3|||
147332686|NCT03823300|531385519|FG001|Overall Study|Adverse Event|5|||
147332687|NCT03823300|531385518|FG000|Overall Study|Physician Decision|1|||
147332688|NCT03823300|531385519|FG001|Overall Study|Physician Decision|7|||
147332689|NCT03823300|531385518|FG000|Overall Study|Lost to Follow-up|1|||
147332690|NCT03823300|531385519|FG001|Overall Study|Lost to Follow-up|3|||
147332691|NCT03823300|531385518|FG000|Overall Study|Protocol Violation|1|||
147332692|NCT03823300|531385519|FG001|Overall Study|Protocol Violation|1|||
147255253|NCT03045887|531106586|FG005|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
147255254|NCT03045887|531106587|FG006|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
147332693|NCT03823300|531385518|FG000|Overall Study|Lack of Efficacy|1|||
147255255|NCT03045887|531106588|FG007|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
147255256|NCT03045887|531106589|FG008|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
147598705|NCT04234984|532349880|FG000|Follow-up at the Second Time Point|Mentally unable to fill in the questionnaire|1|||
147598706|NCT01055132|532349881|FG000|Period 1 (5-9 Days)|unsatisfactory lens fitting performance|1|||
147598707|NCT01055132|532349882|FG001|Period 1 (5-9 Days)|unsatisfactory lens fitting performance|0|||
147598708|NCT01055132|532349881|FG000|Period 2 (5-9 Days)|Unsatisfactory lens fitting performance|0|||
147598709|NCT01055132|532349882|FG001|Period 2 (5-9 Days)|Unsatisfactory lens fitting performance|1|||
147598710|NCT00415194|532349883|FG000|Overall Study|Adverse Event|37|||
147598711|NCT00415194|532349884|FG001|Overall Study|Adverse Event|32|||
147255257|NCT03045887|531106590|FG009|Part A,Washout Period 2 (4 Weeks)|Withdrawal by Subject|0|||
147255258|NCT02632552|531106591|FG000|Overall Study|Lost to Follow-up|14|||
147255259|NCT02632552|531106592|FG001|Overall Study|Lost to Follow-up|8|||
147255260|NCT02632552|531106591|FG000|Overall Study|Withdrawal by Subject|2|||
147255261|NCT02632552|531106592|FG001|Overall Study|Withdrawal by Subject|0|||
147255262|NCT02632552|531106591|FG000|Overall Study|Did not receive allocated protocol (did not enroll in texting program)|7|||
147255263|NCT02632552|531106592|FG001|Overall Study|Did not receive allocated protocol (did not enroll in texting program)|2|||
147255264|NCT02132767|531106593|FG000|Overall Study|Death|3|||
147255265|NCT02132767|531106594|FG001|Overall Study|Death|2|||
147255266|NCT02132767|531106593|FG000|Overall Study|Withdrawal by Subject|10|||
147255267|NCT02132767|531106594|FG001|Overall Study|Withdrawal by Subject|9|||
147255268|NCT02132767|531106593|FG000|Overall Study|Lost to Follow-up|4|||
147255269|NCT02132767|531106594|FG001|Overall Study|Lost to Follow-up|4|||
147255270|NCT00778700|531106597|FG000|Overall Study|Adverse Event|6|||
147255271|NCT00778700|531106598|FG001|Overall Study|Adverse Event|1|||
147255272|NCT00778700|531106599|FG002|Overall Study|Adverse Event|3|||
147255273|NCT00778700|531106600|FG003|Overall Study|Adverse Event|5|||
147255274|NCT00778700|531106597|FG000|Overall Study|Protocol Violation|1|||
147255275|NCT00778700|531106598|FG001|Overall Study|Protocol Violation|1|||
147255276|NCT00778700|531106599|FG002|Overall Study|Protocol Violation|0|||
147255277|NCT00778700|531106600|FG003|Overall Study|Protocol Violation|0|||
147255278|NCT00778700|531106597|FG000|Overall Study|Subject Withdrew Consent|6|||
147255279|NCT00778700|531106598|FG001|Overall Study|Subject Withdrew Consent|4|||
147255280|NCT00778700|531106599|FG002|Overall Study|Subject Withdrew Consent|1|||
147255281|NCT00778700|531106600|FG003|Overall Study|Subject Withdrew Consent|4|||
147255282|NCT00778700|531106597|FG000|Overall Study|Lost to Follow-up|3|||
147255283|NCT00778700|531106598|FG001|Overall Study|Lost to Follow-up|1|||
147255284|NCT00778700|531106599|FG002|Overall Study|Lost to Follow-up|0|||
147255285|NCT00778700|531106600|FG003|Overall Study|Lost to Follow-up|1|||
147255286|NCT00778700|531106597|FG000|Overall Study|Reason not Specified|2|||
147255287|NCT00778700|531106598|FG001|Overall Study|Reason not Specified|0|||
147255288|NCT00778700|531106599|FG002|Overall Study|Reason not Specified|1|||
147255289|NCT00778700|531106600|FG003|Overall Study|Reason not Specified|3|||
147255290|NCT00778700|531106597|FG000|Overall Study|Other|0|||
147255291|NCT00778700|531106598|FG001|Overall Study|Other|0|||
147255292|NCT00778700|531106599|FG002|Overall Study|Other|1|||
147255293|NCT00778700|531106600|FG003|Overall Study|Other|0|||
147255294|NCT03914326|531106601|FG000|Overall Study|Withdrawal by Subject|27|||
147255295|NCT03914326|531106602|FG001|Overall Study|Withdrawal by Subject|34|||
147255296|NCT03914326|531106601|FG000|Overall Study|Lost to Follow-up|43|||
147255297|NCT03914326|531106602|FG001|Overall Study|Lost to Follow-up|51|||
147255298|NCT03914326|531106601|FG000|Overall Study|Randomised more than once|0|||
147255299|NCT03914326|531106602|FG001|Overall Study|Randomised more than once|1|||
147255300|NCT03274440|531106603|FG000|Overall Study|Time commitment too great|1|||
147255301|NCT03274440|531106604|FG001|Overall Study|Time commitment too great|0|||
147255302|NCT03274440|531106605|FG002|Overall Study|Time commitment too great|0|||
147255303|NCT03274440|531106606|FG003|Overall Study|Time commitment too great|1|||
147255304|NCT03274440|531106607|FG004|Overall Study|Time commitment too great|0|||
147255305|NCT03274440|531106608|FG005|Overall Study|Time commitment too great|0|||
147255306|NCT01291173|531106609|FG000|Overall Study|Adverse Event|0|||
147255307|NCT01291173|531106610|FG001|Overall Study|Adverse Event|3|||
147255308|NCT01291173|531106611|FG002|Overall Study|Adverse Event|1|||
147255309|NCT01291173|531106612|FG003|Overall Study|Adverse Event|3|||
147255310|NCT01291173|531106609|FG000|Overall Study|Protocol Violation|7|||
147255311|NCT01291173|531106610|FG001|Overall Study|Protocol Violation|2|||
147598712|NCT00415194|532349883|FG000|Overall Study|Entry Criteria Not Met|4|||
147255312|NCT01291173|531106611|FG002|Overall Study|Protocol Violation|2|||
147255313|NCT01291173|531106612|FG003|Overall Study|Protocol Violation|5|||
147255314|NCT01291173|531106609|FG000|Overall Study|Withdrawal by Subject|6|||
147255315|NCT01291173|531106610|FG001|Overall Study|Withdrawal by Subject|4|||
147255316|NCT01291173|531106611|FG002|Overall Study|Withdrawal by Subject|4|||
147255317|NCT01291173|531106612|FG003|Overall Study|Withdrawal by Subject|2|||
147255318|NCT01291173|531106609|FG000|Overall Study|Lost to Follow-up|4|||
147255319|NCT01291173|531106610|FG001|Overall Study|Lost to Follow-up|6|||
147255320|NCT01291173|531106611|FG002|Overall Study|Lost to Follow-up|3|||
147255321|NCT01291173|531106612|FG003|Overall Study|Lost to Follow-up|2|||
147255322|NCT01291173|531106609|FG000|Overall Study|Unable to meet visit schedule|0|||
147332694|NCT03823300|531385519|FG001|Overall Study|Lack of Efficacy|1|||
147332695|NCT03823300|531385518|FG000|Overall Study|Not Eligible|0|||
147255323|NCT01291173|531106610|FG001|Overall Study|Unable to meet visit schedule|0|||
147255324|NCT01291173|531106611|FG002|Overall Study|Unable to meet visit schedule|1|||
147255325|NCT01291173|531106612|FG003|Overall Study|Unable to meet visit schedule|0|||
147255326|NCT01291173|531106609|FG000|Overall Study|Lack of compliance|0|||
147255327|NCT01291173|531106610|FG001|Overall Study|Lack of compliance|0|||
147255328|NCT01291173|531106611|FG002|Overall Study|Lack of compliance|0|||
147332696|NCT03823300|531385519|FG001|Overall Study|Not Eligible|1|||
147332697|NCT03823300|531385518|FG000|Overall Study|Other|1|||
147255329|NCT01291173|531106612|FG003|Overall Study|Lack of compliance|1|||
147255330|NCT01291173|531106609|FG000|Overall Study|Subject was unblinded|0|||
147255331|NCT01291173|531106610|FG001|Overall Study|Subject was unblinded|0|||
147255332|NCT01291173|531106611|FG002|Overall Study|Subject was unblinded|1|||
147255333|NCT01291173|531106612|FG003|Overall Study|Subject was unblinded|0|||
147255334|NCT01291173|531106609|FG000|Overall Study|Excluded therapy|0|||
147255335|NCT01291173|531106610|FG001|Overall Study|Excluded therapy|0|||
147255336|NCT01291173|531106611|FG002|Overall Study|Excluded therapy|1|||
147255337|NCT01291173|531106612|FG003|Overall Study|Excluded therapy|0|||
147255338|NCT00390858|531106613|FG000|Overall Study|Adverse Event|6|||
147255339|NCT00390858|531106614|FG001|Overall Study|Adverse Event|2|||
147255340|NCT00390858|531106613|FG000|Overall Study|Lack of Efficacy|0|||
147255341|NCT00390858|531106614|FG001|Overall Study|Lack of Efficacy|1|||
147255342|NCT00390858|531106613|FG000|Overall Study|Withdrawal by Subject|3|||
147255343|NCT00390858|531106614|FG001|Overall Study|Withdrawal by Subject|4|||
147255344|NCT00450450|531106618|FG000|Overall Study|Death|1|||
147255345|NCT00450450|531106619|FG001|Overall Study|Death|3|||
147255346|NCT00450450|531106618|FG000|Overall Study|Relapse|2|||
147255347|NCT00450450|531106619|FG001|Overall Study|Relapse|0|||
147255348|NCT00450450|531106618|FG000|Overall Study|Missing Data|2|||
147255349|NCT00450450|531106619|FG001|Overall Study|Missing Data|0|||
147255350|NCT01705652|531106625|FG000|Overall Study|Adverse Event|1|||
147255351|NCT01705652|531106626|FG001|Overall Study|Adverse Event|0|||
147255352|NCT01705652|531106625|FG000|Overall Study|Withdrawal by Subject|1|||
147255353|NCT01705652|531106626|FG001|Overall Study|Withdrawal by Subject|2|||
147255354|NCT01705652|531106625|FG000|Overall Study|non-compliance|1|||
147255355|NCT01705652|531106626|FG001|Overall Study|non-compliance|1|||
147255356|NCT00309842|531106628|FG000|Overall Study|Lost to Follow-up|1|||
147255357|NCT03564145|531106629|FG000|Overall Study|Adverse Event|4|||
147255358|NCT03564145|531106629|FG000|Overall Study|Lost to Follow-up|21|||
147255359|NCT03564145|531106629|FG000|Overall Study|Protocol Violation|2|||
147255360|NCT03564145|531106629|FG000|Overall Study|Withdrawal by Subject|48|||
147255361|NCT03564145|531106629|FG000|Overall Study|Study Terminated by Sponsor|146|||
147255362|NCT03564145|531106629|FG000|Overall Study|Physician Decision|1|||
147255363|NCT03564145|531106629|FG000|Overall Study|Other Than Specified|1|||
147255364|NCT03564145|531106629|FG000|Overall Study|Pregnancy|1|||
147255365|NCT01386554|531106635|FG000|Overall Study|Lost to Follow-up|0|||
147255366|NCT01386554|531106636|FG001|Overall Study|Lost to Follow-up|0|||
147255367|NCT01386554|531106637|FG002|Overall Study|Lost to Follow-up|1|||
147255368|NCT01386554|531106635|FG000|Overall Study|Adverse Event|2|||
147255369|NCT01386554|531106636|FG001|Overall Study|Adverse Event|5|||
147255370|NCT01386554|531106637|FG002|Overall Study|Adverse Event|2|||
147255371|NCT01386554|531106635|FG000|Overall Study|Progressive disease|1|||
147255372|NCT01386554|531106636|FG001|Overall Study|Progressive disease|2|||
147255373|NCT01386554|531106637|FG002|Overall Study|Progressive disease|2|||
147255374|NCT01386554|531106635|FG000|Overall Study|Administration of live vaccines|0|||
147255375|NCT01386554|531106636|FG001|Overall Study|Administration of live vaccines|1|||
147255376|NCT01386554|531106637|FG002|Overall Study|Administration of live vaccines|0|||
147255377|NCT01386554|531106635|FG000|Overall Study|Investigator discretion|0|||
147255378|NCT01386554|531106636|FG001|Overall Study|Investigator discretion|0|||
147255379|NCT01386554|531106637|FG002|Overall Study|Investigator discretion|1|||
147255380|NCT01386554|531106635|FG000|Overall Study|Reason not collected|0|||
147255381|NCT01386554|531106636|FG001|Overall Study|Reason not collected|1|||
147255382|NCT01386554|531106637|FG002|Overall Study|Reason not collected|0|||
147255383|NCT00353262|531106638|FG000|Overall Study|Adverse Event|8|||
147255384|NCT00353262|531106638|FG000|Overall Study|Withdrawal by Subject|2|||
147255385|NCT00353262|531106638|FG000|Overall Study|Insufficient Therapeutic Response|13|||
147332698|NCT03823300|531385519|FG001|Overall Study|Other|0|||
147255386|NCT00353262|531106638|FG000|Overall Study|Progression|1|||
147255387|NCT00353262|531106638|FG000|Overall Study|Surgery|4|||
147255388|NCT00353262|531106638|FG000|Overall Study|Break from Chemotherapy|1|||
147255389|NCT05286307|531106639|FG000|Overall Study|Incomplete outcome assessments|2|||
147255390|NCT05286307|531106640|FG001|Overall Study|Incomplete outcome assessments|1|||
147332699|NCT00943735|531385520|FG000|Overall Study|Adverse Event|12|||
147332700|NCT00943735|531385520|FG000|Overall Study|Withdrawal by Subject|8|||
147255391|NCT05286307|531106639|FG000|Overall Study|Discovery of multi-ligamentous injury intra-operatively|0|||
147255392|NCT05286307|531106640|FG001|Overall Study|Discovery of multi-ligamentous injury intra-operatively|1|||
147332701|NCT00943735|531385520|FG000|Overall Study|Death|1|||
147255393|NCT05286307|531106639|FG000|Overall Study|Lost to follow up at 6 months|25|||
147255394|NCT05286307|531106640|FG001|Overall Study|Lost to follow up at 6 months|35|||
147255395|NCT05286307|531106639|FG000|Overall Study|Study medication not available|1|||
147255396|NCT05286307|531106640|FG001|Overall Study|Study medication not available|1|||
147255397|NCT02759471|531106641|FG000|Overall Study|discomfort|2|||
147255398|NCT02554812|531106642|FG000|Overall Study|Adverse Event|2|||
147255399|NCT02554812|531106643|FG001|Overall Study|Adverse Event|5|||
147255400|NCT02554812|531106644|FG002|Overall Study|Adverse Event|3|||
147255401|NCT02554812|531106645|FG003|Overall Study|Adverse Event|0|||
147255402|NCT02554812|531106646|FG004|Overall Study|Adverse Event|5|||
147255403|NCT02554812|531106647|FG005|Overall Study|Adverse Event|0|||
147255404|NCT02554812|531106648|FG006|Overall Study|Adverse Event|1|||
147255405|NCT02554812|531106649|FG007|Overall Study|Adverse Event|6|||
147255406|NCT02554812|531106650|FG008|Overall Study|Adverse Event|2|||
147255407|NCT02554812|531106651|FG009|Overall Study|Adverse Event|2|||
147255408|NCT02554812|531106652|FG010|Overall Study|Adverse Event|1|||
147255409|NCT02554812|531106653|FG011|Overall Study|Adverse Event|2|||
147255410|NCT02554812|531106654|FG012|Overall Study|Adverse Event|0|||
147255411|NCT02554812|531106655|FG013|Overall Study|Adverse Event|3|||
147255412|NCT02554812|531106656|FG014|Overall Study|Adverse Event|2|||
147255413|NCT02554812|531106657|FG015|Overall Study|Adverse Event|1|||
147255414|NCT02554812|531106658|FG016|Overall Study|Adverse Event|0|||
147255415|NCT02554812|531106659|FG017|Overall Study|Adverse Event|1|||
147255416|NCT02554812|531106660|FG018|Overall Study|Adverse Event|0|||
147255417|NCT02554812|531106661|FG019|Overall Study|Adverse Event|0|||
147255418|NCT02554812|531106662|FG020|Overall Study|Adverse Event|0|||
147255419|NCT02554812|531106663|FG021|Overall Study|Adverse Event|2|||
147255420|NCT02554812|531106664|FG022|Overall Study|Adverse Event|1|||
147255421|NCT02554812|531106665|FG023|Overall Study|Adverse Event|1|||
147255422|NCT02554812|531106666|FG024|Overall Study|Adverse Event|1|||
147255423|NCT02554812|531106667|FG025|Overall Study|Adverse Event|2|||
147255424|NCT02554812|531106668|FG026|Overall Study|Adverse Event|1|||
147255425|NCT02554812|531106642|FG000|Overall Study|Death|1|||
147255426|NCT02554812|531106643|FG001|Overall Study|Death|2|||
147255427|NCT02554812|531106644|FG002|Overall Study|Death|2|||
147255428|NCT02554812|531106645|FG003|Overall Study|Death|2|||
147255429|NCT02554812|531106646|FG004|Overall Study|Death|0|||
147255430|NCT02554812|531106647|FG005|Overall Study|Death|1|||
147255431|NCT02554812|531106648|FG006|Overall Study|Death|1|||
147255432|NCT02554812|531106649|FG007|Overall Study|Death|1|||
147255433|NCT02554812|531106650|FG008|Overall Study|Death|0|||
147255434|NCT02554812|531106651|FG009|Overall Study|Death|0|||
147255435|NCT02554812|531106652|FG010|Overall Study|Death|0|||
147255436|NCT02554812|531106653|FG011|Overall Study|Death|0|||
147255437|NCT02554812|531106654|FG012|Overall Study|Death|0|||
147255438|NCT02554812|531106655|FG013|Overall Study|Death|0|||
147255439|NCT02554812|531106656|FG014|Overall Study|Death|1|||
147255440|NCT02554812|531106657|FG015|Overall Study|Death|1|||
147255441|NCT02554812|531106658|FG016|Overall Study|Death|1|||
147255442|NCT02554812|531106659|FG017|Overall Study|Death|0|||
147255443|NCT02554812|531106660|FG018|Overall Study|Death|1|||
147255444|NCT02554812|531106661|FG019|Overall Study|Death|2|||
147255445|NCT02554812|531106662|FG020|Overall Study|Death|0|||
147255446|NCT02554812|531106663|FG021|Overall Study|Death|1|||
147255447|NCT02554812|531106664|FG022|Overall Study|Death|1|||
147255448|NCT02554812|531106665|FG023|Overall Study|Death|0|||
147255449|NCT02554812|531106666|FG024|Overall Study|Death|0|||
147255450|NCT02554812|531106667|FG025|Overall Study|Death|0|||
147255451|NCT02554812|531106668|FG026|Overall Study|Death|0|||
147255452|NCT02554812|531106642|FG000|Overall Study|Lost to Follow-up|0|||
147255453|NCT02554812|531106643|FG001|Overall Study|Lost to Follow-up|1|||
147255454|NCT02554812|531106644|FG002|Overall Study|Lost to Follow-up|0|||
147255455|NCT02554812|531106645|FG003|Overall Study|Lost to Follow-up|0|||
147255456|NCT02554812|531106646|FG004|Overall Study|Lost to Follow-up|0|||
147255457|NCT02554812|531106647|FG005|Overall Study|Lost to Follow-up|0|||
147255458|NCT02554812|531106648|FG006|Overall Study|Lost to Follow-up|0|||
147255459|NCT02554812|531106649|FG007|Overall Study|Lost to Follow-up|0|||
147255460|NCT02554812|531106650|FG008|Overall Study|Lost to Follow-up|0|||
147255461|NCT02554812|531106651|FG009|Overall Study|Lost to Follow-up|0|||
147255462|NCT02554812|531106652|FG010|Overall Study|Lost to Follow-up|0|||
147255463|NCT02554812|531106653|FG011|Overall Study|Lost to Follow-up|0|||
147255464|NCT02554812|531106654|FG012|Overall Study|Lost to Follow-up|0|||
147255465|NCT02554812|531106655|FG013|Overall Study|Lost to Follow-up|0|||
147255466|NCT02554812|531106656|FG014|Overall Study|Lost to Follow-up|0|||
147255467|NCT02554812|531106657|FG015|Overall Study|Lost to Follow-up|0|||
147255468|NCT02554812|531106658|FG016|Overall Study|Lost to Follow-up|0|||
147255469|NCT02554812|531106659|FG017|Overall Study|Lost to Follow-up|0|||
147255470|NCT02554812|531106660|FG018|Overall Study|Lost to Follow-up|0|||
147255471|NCT02554812|531106661|FG019|Overall Study|Lost to Follow-up|0|||
147255472|NCT02554812|531106662|FG020|Overall Study|Lost to Follow-up|0|||
147255473|NCT02554812|531106663|FG021|Overall Study|Lost to Follow-up|0|||
147255474|NCT02554812|531106664|FG022|Overall Study|Lost to Follow-up|0|||
147255475|NCT02554812|531106665|FG023|Overall Study|Lost to Follow-up|0|||
147255476|NCT02554812|531106666|FG024|Overall Study|Lost to Follow-up|0|||
147255477|NCT02554812|531106667|FG025|Overall Study|Lost to Follow-up|0|||
147255478|NCT02554812|531106668|FG026|Overall Study|Lost to Follow-up|0|||
147255479|NCT02554812|531106642|FG000|Overall Study|Global deterioration of health status|4|||
147255480|NCT02554812|531106643|FG001|Overall Study|Global deterioration of health status|3|||
147255481|NCT02554812|531106644|FG002|Overall Study|Global deterioration of health status|3|||
147255482|NCT02554812|531106645|FG003|Overall Study|Global deterioration of health status|2|||
147255483|NCT02554812|531106646|FG004|Overall Study|Global deterioration of health status|5|||
147255484|NCT02554812|531106647|FG005|Overall Study|Global deterioration of health status|0|||
147255485|NCT02554812|531106648|FG006|Overall Study|Global deterioration of health status|2|||
147255486|NCT02554812|531106649|FG007|Overall Study|Global deterioration of health status|1|||
147255487|NCT02554812|531106650|FG008|Overall Study|Global deterioration of health status|1|||
147255488|NCT02554812|531106651|FG009|Overall Study|Global deterioration of health status|1|||
147255489|NCT02554812|531106652|FG010|Overall Study|Global deterioration of health status|2|||
147255490|NCT02554812|531106653|FG011|Overall Study|Global deterioration of health status|1|||
147255491|NCT02554812|531106654|FG012|Overall Study|Global deterioration of health status|0|||
147255492|NCT02554812|531106655|FG013|Overall Study|Global deterioration of health status|0|||
147255493|NCT02554812|531106656|FG014|Overall Study|Global deterioration of health status|0|||
147255494|NCT02554812|531106657|FG015|Overall Study|Global deterioration of health status|1|||
147255495|NCT02554812|531106658|FG016|Overall Study|Global deterioration of health status|0|||
147255496|NCT02554812|531106659|FG017|Overall Study|Global deterioration of health status|0|||
147255497|NCT02554812|531106660|FG018|Overall Study|Global deterioration of health status|0|||
147255498|NCT02554812|531106661|FG019|Overall Study|Global deterioration of health status|0|||
147255499|NCT02554812|531106662|FG020|Overall Study|Global deterioration of health status|0|||
147255500|NCT02554812|531106663|FG021|Overall Study|Global deterioration of health status|0|||
147255501|NCT02554812|531106664|FG022|Overall Study|Global deterioration of health status|0|||
147255502|NCT02554812|531106665|FG023|Overall Study|Global deterioration of health status|0|||
147255503|NCT02554812|531106666|FG024|Overall Study|Global deterioration of health status|0|||
147255504|NCT02554812|531106667|FG025|Overall Study|Global deterioration of health status|0|||
147255505|NCT02554812|531106668|FG026|Overall Study|Global deterioration of health status|0|||
147255506|NCT02554812|531106642|FG000|Overall Study|Progressive disease|20|||
147255507|NCT02554812|531106643|FG001|Overall Study|Progressive disease|16|||
147255508|NCT02554812|531106644|FG002|Overall Study|Progressive disease|19|||
147255509|NCT02554812|531106645|FG003|Overall Study|Progressive disease|18|||
147255510|NCT02554812|531106646|FG004|Overall Study|Progressive disease|21|||
147255511|NCT02554812|531106647|FG005|Overall Study|Progressive disease|15|||
147255512|NCT02554812|531106648|FG006|Overall Study|Progressive disease|6|||
147255513|NCT02554812|531106649|FG007|Overall Study|Progressive disease|13|||
147255514|NCT02554812|531106650|FG008|Overall Study|Progressive disease|6|||
147255515|NCT02554812|531106651|FG009|Overall Study|Progressive disease|6|||
147255516|NCT02554812|531106652|FG010|Overall Study|Progressive disease|8|||
147255517|NCT02554812|531106653|FG011|Overall Study|Progressive disease|8|||
147255518|NCT02554812|531106654|FG012|Overall Study|Progressive disease|6|||
147255519|NCT02554812|531106655|FG013|Overall Study|Progressive disease|10|||
147255520|NCT02554812|531106656|FG014|Overall Study|Progressive disease|20|||
147255521|NCT02554812|531106657|FG015|Overall Study|Progressive disease|6|||
147255522|NCT02554812|531106658|FG016|Overall Study|Progressive disease|3|||
147255523|NCT02554812|531106659|FG017|Overall Study|Progressive disease|3|||
147255524|NCT02554812|531106660|FG018|Overall Study|Progressive disease|11|||
147255525|NCT02554812|531106661|FG019|Overall Study|Progressive disease|7|||
147255526|NCT02554812|531106662|FG020|Overall Study|Progressive disease|11|||
147255527|NCT02554812|531106663|FG021|Overall Study|Progressive disease|6|||
147255528|NCT02554812|531106664|FG022|Overall Study|Progressive disease|9|||
147598713|NCT00415194|532349884|FG001|Overall Study|Entry Criteria Not Met|8|||
147255529|NCT02554812|531106665|FG023|Overall Study|Progressive disease|9|||
147255530|NCT02554812|531106666|FG024|Overall Study|Progressive disease|4|||
147255531|NCT02554812|531106667|FG025|Overall Study|Progressive disease|5|||
147255532|NCT02554812|531106668|FG026|Overall Study|Progressive disease|5|||
147255533|NCT02554812|531106642|FG000|Overall Study|Other|0|||
147255534|NCT02554812|531106643|FG001|Overall Study|Other|0|||
147255535|NCT02554812|531106644|FG002|Overall Study|Other|2|||
147255536|NCT02554812|531106645|FG003|Overall Study|Other|3|||
147255537|NCT02554812|531106646|FG004|Overall Study|Other|2|||
147255538|NCT02554812|531106647|FG005|Overall Study|Other|1|||
147255539|NCT02554812|531106648|FG006|Overall Study|Other|0|||
147255540|NCT02554812|531106649|FG007|Overall Study|Other|0|||
147255541|NCT02554812|531106650|FG008|Overall Study|Other|1|||
147255542|NCT02554812|531106651|FG009|Overall Study|Other|1|||
147255543|NCT02554812|531106652|FG010|Overall Study|Other|0|||
147255544|NCT02554812|531106653|FG011|Overall Study|Other|0|||
147255545|NCT02554812|531106654|FG012|Overall Study|Other|1|||
147255546|NCT02554812|531106655|FG013|Overall Study|Other|0|||
147255547|NCT02554812|531106656|FG014|Overall Study|Other|1|||
147255548|NCT02554812|531106657|FG015|Overall Study|Other|0|||
147255549|NCT02554812|531106658|FG016|Overall Study|Other|0|||
147255550|NCT02554812|531106659|FG017|Overall Study|Other|0|||
147598714|NCT00415194|532349883|FG000|Overall Study|Lost to Follow-up|1|||
147255551|NCT02554812|531106660|FG018|Overall Study|Other|0|||
147255552|NCT02554812|531106661|FG019|Overall Study|Other|0|||
147255553|NCT02554812|531106662|FG020|Overall Study|Other|0|||
147255554|NCT02554812|531106663|FG021|Overall Study|Other|2|||
147255555|NCT02554812|531106664|FG022|Overall Study|Other|0|||
147255556|NCT02554812|531106665|FG023|Overall Study|Other|0|||
147255557|NCT02554812|531106666|FG024|Overall Study|Other|0|||
147255558|NCT02554812|531106667|FG025|Overall Study|Other|0|||
147255559|NCT02554812|531106668|FG026|Overall Study|Other|0|||
147598715|NCT00415194|532349884|FG001|Overall Study|Lost to Follow-up|0|||
147598716|NCT00415194|532349883|FG000|Overall Study|Physician Decision|10|||
147598717|NCT00415194|532349884|FG001|Overall Study|Physician Decision|16|||
147598718|NCT00415194|532349883|FG000|Overall Study|Progressive Disease|180|||
147598719|NCT00415194|532349884|FG001|Overall Study|Progressive Disease|217|||
147598720|NCT00415194|532349883|FG000|Overall Study|Protocol Violation|4|||
147598721|NCT00415194|532349884|FG001|Overall Study|Protocol Violation|2|||
147598722|NCT00415194|532349883|FG000|Overall Study|Withdrawal by Subject|28|||
147598723|NCT00415194|532349884|FG001|Overall Study|Withdrawal by Subject|21|||
147598724|NCT00415194|532349883|FG000|Overall Study|Death Due to Study Disease|26|||
147598725|NCT00415194|532349884|FG001|Overall Study|Death Due to Study Disease|29|||
147598726|NCT00415194|532349883|FG000|Overall Study|Death Due to Study Drug Related AE|11|||
147255560|NCT02554812|531106642|FG000|Overall Study|Withdrawal by Subject|1|||
147255561|NCT02554812|531106643|FG001|Overall Study|Withdrawal by Subject|0|||
147255562|NCT02554812|531106644|FG002|Overall Study|Withdrawal by Subject|0|||
147255563|NCT02554812|531106645|FG003|Overall Study|Withdrawal by Subject|2|||
147255564|NCT02554812|531106646|FG004|Overall Study|Withdrawal by Subject|2|||
147255565|NCT02554812|531106647|FG005|Overall Study|Withdrawal by Subject|3|||
147255566|NCT02554812|531106648|FG006|Overall Study|Withdrawal by Subject|0|||
147255567|NCT02554812|531106649|FG007|Overall Study|Withdrawal by Subject|0|||
147255568|NCT02554812|531106650|FG008|Overall Study|Withdrawal by Subject|1|||
147255569|NCT02554812|531106651|FG009|Overall Study|Withdrawal by Subject|1|||
147255570|NCT02554812|531106652|FG010|Overall Study|Withdrawal by Subject|0|||
147255571|NCT02554812|531106653|FG011|Overall Study|Withdrawal by Subject|1|||
147255572|NCT02554812|531106654|FG012|Overall Study|Withdrawal by Subject|1|||
147255573|NCT02554812|531106655|FG013|Overall Study|Withdrawal by Subject|1|||
147255574|NCT02554812|531106656|FG014|Overall Study|Withdrawal by Subject|1|||
147255575|NCT02554812|531106657|FG015|Overall Study|Withdrawal by Subject|1|||
147255576|NCT02554812|531106658|FG016|Overall Study|Withdrawal by Subject|3|||
147255577|NCT02554812|531106659|FG017|Overall Study|Withdrawal by Subject|1|||
147255578|NCT02554812|531106660|FG018|Overall Study|Withdrawal by Subject|0|||
147255579|NCT02554812|531106661|FG019|Overall Study|Withdrawal by Subject|2|||
147255580|NCT02554812|531106662|FG020|Overall Study|Withdrawal by Subject|0|||
147255581|NCT02554812|531106663|FG021|Overall Study|Withdrawal by Subject|1|||
147255582|NCT02554812|531106664|FG022|Overall Study|Withdrawal by Subject|0|||
147255583|NCT02554812|531106665|FG023|Overall Study|Withdrawal by Subject|1|||
147255584|NCT02554812|531106666|FG024|Overall Study|Withdrawal by Subject|0|||
147255585|NCT02554812|531106667|FG025|Overall Study|Withdrawal by Subject|0|||
147255586|NCT02554812|531106668|FG026|Overall Study|Withdrawal by Subject|1|||
147255587|NCT02554812|531106642|FG000|Overall Study|Physician Decision|1|||
147255588|NCT02554812|531106643|FG001|Overall Study|Physician Decision|0|||
147255589|NCT02554812|531106644|FG002|Overall Study|Physician Decision|0|||
147255590|NCT02554812|531106645|FG003|Overall Study|Physician Decision|1|||
147255591|NCT02554812|531106646|FG004|Overall Study|Physician Decision|0|||
147255592|NCT02554812|531106647|FG005|Overall Study|Physician Decision|1|||
147255593|NCT02554812|531106648|FG006|Overall Study|Physician Decision|0|||
147255594|NCT02554812|531106649|FG007|Overall Study|Physician Decision|0|||
147255595|NCT02554812|531106650|FG008|Overall Study|Physician Decision|0|||
147598727|NCT00415194|532349884|FG001|Overall Study|Death Due to Study Drug Related AE|1|||
147598728|NCT00415194|532349883|FG000|Overall Study|Death Due to Procedural Related AE|0|||
147255596|NCT02554812|531106651|FG009|Overall Study|Physician Decision|0|||
147255597|NCT02554812|531106652|FG010|Overall Study|Physician Decision|1|||
147255598|NCT02554812|531106653|FG011|Overall Study|Physician Decision|0|||
147255599|NCT02554812|531106654|FG012|Overall Study|Physician Decision|0|||
147255600|NCT02554812|531106655|FG013|Overall Study|Physician Decision|0|||
147255601|NCT02554812|531106656|FG014|Overall Study|Physician Decision|0|||
147255602|NCT02554812|531106657|FG015|Overall Study|Physician Decision|0|||
147255603|NCT02554812|531106658|FG016|Overall Study|Physician Decision|1|||
147255604|NCT02554812|531106659|FG017|Overall Study|Physician Decision|1|||
147255605|NCT02554812|531106660|FG018|Overall Study|Physician Decision|0|||
147255606|NCT02554812|531106661|FG019|Overall Study|Physician Decision|1|||
147255607|NCT02554812|531106662|FG020|Overall Study|Physician Decision|1|||
147598729|NCT00415194|532349884|FG001|Overall Study|Death Due to Procedural Related AE|1|||
147598730|NCT00415194|532349883|FG000|Overall Study|Death Due to AE (Other Causes)|27|||
147255608|NCT02554812|531106663|FG021|Overall Study|Physician Decision|0|||
147255609|NCT02554812|531106664|FG022|Overall Study|Physician Decision|1|||
147255610|NCT02554812|531106665|FG023|Overall Study|Physician Decision|0|||
147255611|NCT02554812|531106666|FG024|Overall Study|Physician Decision|0|||
147255612|NCT02554812|531106667|FG025|Overall Study|Physician Decision|0|||
147255613|NCT02554812|531106668|FG026|Overall Study|Physician Decision|0|||
147255614|NCT02554812|531106642|FG000|Overall Study|Study terminated by sponsor|0|||
147255615|NCT02554812|531106643|FG001|Overall Study|Study terminated by sponsor|0|||
147255616|NCT02554812|531106644|FG002|Overall Study|Study terminated by sponsor|0|||
147255617|NCT02554812|531106645|FG003|Overall Study|Study terminated by sponsor|0|||
147255618|NCT02554812|531106646|FG004|Overall Study|Study terminated by sponsor|0|||
147255619|NCT02554812|531106647|FG005|Overall Study|Study terminated by sponsor|0|||
147255620|NCT02554812|531106648|FG006|Overall Study|Study terminated by sponsor|0|||
147255621|NCT02554812|531106649|FG007|Overall Study|Study terminated by sponsor|0|||
147255622|NCT02554812|531106650|FG008|Overall Study|Study terminated by sponsor|0|||
147255623|NCT02554812|531106651|FG009|Overall Study|Study terminated by sponsor|0|||
147255624|NCT02554812|531106652|FG010|Overall Study|Study terminated by sponsor|0|||
147255625|NCT02554812|531106653|FG011|Overall Study|Study terminated by sponsor|0|||
147255626|NCT02554812|531106654|FG012|Overall Study|Study terminated by sponsor|0|||
147255627|NCT02554812|531106655|FG013|Overall Study|Study terminated by sponsor|0|||
147255628|NCT02554812|531106656|FG014|Overall Study|Study terminated by sponsor|0|||
147255629|NCT02554812|531106657|FG015|Overall Study|Study terminated by sponsor|0|||
147255630|NCT02554812|531106658|FG016|Overall Study|Study terminated by sponsor|0|||
147255631|NCT02554812|531106659|FG017|Overall Study|Study terminated by sponsor|0|||
147255632|NCT02554812|531106660|FG018|Overall Study|Study terminated by sponsor|0|||
147255633|NCT02554812|531106661|FG019|Overall Study|Study terminated by sponsor|0|||
147255634|NCT02554812|531106662|FG020|Overall Study|Study terminated by sponsor|0|||
147255635|NCT02554812|531106663|FG021|Overall Study|Study terminated by sponsor|0|||
147255636|NCT02554812|531106664|FG022|Overall Study|Study terminated by sponsor|0|||
147255637|NCT02554812|531106665|FG023|Overall Study|Study terminated by sponsor|0|||
147255638|NCT02554812|531106666|FG024|Overall Study|Study terminated by sponsor|1|||
147598731|NCT00415194|532349884|FG001|Overall Study|Death Due to AE (Other Causes)|15|||
147598732|NCT00969540|532349885|FG000|Overall Study|Lost to Follow-up|1|||
147598733|NCT00969540|532349886|FG001|Overall Study|Lost to Follow-up|1|||
147255639|NCT02554812|531106667|FG025|Overall Study|Study terminated by sponsor|0|||
147255640|NCT02554812|531106668|FG026|Overall Study|Study terminated by sponsor|0|||
147255641|NCT02554812|531106642|FG000|Overall Study|No longer meets eligibility criteria|0|||
147255642|NCT02554812|531106643|FG001|Overall Study|No longer meets eligibility criteria|1|||
147255643|NCT02554812|531106644|FG002|Overall Study|No longer meets eligibility criteria|0|||
147255644|NCT02554812|531106645|FG003|Overall Study|No longer meets eligibility criteria|0|||
147255645|NCT02554812|531106646|FG004|Overall Study|No longer meets eligibility criteria|0|||
147255646|NCT02554812|531106647|FG005|Overall Study|No longer meets eligibility criteria|0|||
147255647|NCT02554812|531106648|FG006|Overall Study|No longer meets eligibility criteria|0|||
147255648|NCT02554812|531106649|FG007|Overall Study|No longer meets eligibility criteria|0|||
147255649|NCT02554812|531106650|FG008|Overall Study|No longer meets eligibility criteria|0|||
147255650|NCT02554812|531106651|FG009|Overall Study|No longer meets eligibility criteria|0|||
147255651|NCT02554812|531106652|FG010|Overall Study|No longer meets eligibility criteria|0|||
147255652|NCT02554812|531106653|FG011|Overall Study|No longer meets eligibility criteria|0|||
147255653|NCT02554812|531106654|FG012|Overall Study|No longer meets eligibility criteria|0|||
147255654|NCT02554812|531106655|FG013|Overall Study|No longer meets eligibility criteria|0|||
147255655|NCT02554812|531106656|FG014|Overall Study|No longer meets eligibility criteria|0|||
147255656|NCT02554812|531106657|FG015|Overall Study|No longer meets eligibility criteria|0|||
147255657|NCT02554812|531106658|FG016|Overall Study|No longer meets eligibility criteria|0|||
147255658|NCT02554812|531106659|FG017|Overall Study|No longer meets eligibility criteria|0|||
147255659|NCT02554812|531106660|FG018|Overall Study|No longer meets eligibility criteria|0|||
147255660|NCT02554812|531106661|FG019|Overall Study|No longer meets eligibility criteria|0|||
147255661|NCT02554812|531106662|FG020|Overall Study|No longer meets eligibility criteria|0|||
147255662|NCT02554812|531106663|FG021|Overall Study|No longer meets eligibility criteria|0|||
147255663|NCT02554812|531106664|FG022|Overall Study|No longer meets eligibility criteria|0|||
147255664|NCT02554812|531106665|FG023|Overall Study|No longer meets eligibility criteria|0|||
147255665|NCT02554812|531106666|FG024|Overall Study|No longer meets eligibility criteria|0|||
147255666|NCT02554812|531106667|FG025|Overall Study|No longer meets eligibility criteria|0|||
147255667|NCT02554812|531106668|FG026|Overall Study|No longer meets eligibility criteria|0|||
147255668|NCT01103284|531106669|FG000|Overall Study|Death|2|||
147255669|NCT01103284|531106670|FG001|Overall Study|Death|0|||
147598734|NCT05297578|532349895|FG000|Overall Study|Lost to Follow-up|1|||
147598735|NCT05297578|532349896|FG001|Overall Study|Lost to Follow-up|1|||
147598736|NCT05297578|532349897|FG002|Overall Study|Lost to Follow-up|2|||
147255670|NCT01103284|531106669|FG000|Overall Study|Lost to Follow-up|9|||
147255671|NCT01103284|531106670|FG001|Overall Study|Lost to Follow-up|10|||
147255672|NCT01103284|531106669|FG000|Overall Study|Pregnancy|3|||
147255673|NCT01103284|531106670|FG001|Overall Study|Pregnancy|1|||
147332702|NCT00943735|531385520|FG000|Overall Study|Other|8|||
147255674|NCT01103284|531106669|FG000|Overall Study|Protocol Violation|12|||
147255675|NCT01103284|531106670|FG001|Overall Study|Protocol Violation|5|||
147255676|NCT01103284|531106669|FG000|Overall Study|Adverse Event|0|||
147255677|NCT01103284|531106670|FG001|Overall Study|Adverse Event|5|||
147598737|NCT05297578|532349898|FG003|Overall Study|Lost to Follow-up|1|||
147255678|NCT01103284|531106669|FG000|Overall Study|Withdrawal by Subject|14|||
147255679|NCT01103284|531106670|FG001|Overall Study|Withdrawal by Subject|18|||
147255680|NCT01103284|531106669|FG000|Overall Study|Dermal Hypersensitivity|0|||
147255681|NCT01103284|531106670|FG001|Overall Study|Dermal Hypersensitivity|1|||
147255682|NCT01103284|531106669|FG000|Overall Study|Termination by the Sponsor|0|||
147255683|NCT01103284|531106670|FG001|Overall Study|Termination by the Sponsor|1|||
147255684|NCT01103284|531106669|FG000|Overall Study|Not described|2|||
147255685|NCT01103284|531106670|FG001|Overall Study|Not described|1|||
147255686|NCT01103284|531106669|FG000|Overall Study|Missing CRF entries for study completion|0|||
147255687|NCT01103284|531106670|FG001|Overall Study|Missing CRF entries for study completion|2|||
147255688|NCT00696696|531107822|FG000|Overall Study|Adverse Event|5|||
147255689|NCT00696696|531107822|FG000|Overall Study|Withdrawal by Subject|8|||
147255690|NCT00696696|531107822|FG000|Overall Study|Physician Decision|2|||
147255691|NCT00696696|531107822|FG000|Overall Study|Death|3|||
147255692|NCT02642614|531107823|FG000|Overall Study|Adverse Event|1|||
147255693|NCT02642614|531107824|FG001|Overall Study|Adverse Event|1|||
147255694|NCT02642614|531107825|FG002|Overall Study|Adverse Event|2|||
147255695|NCT02642614|531107826|FG003|Overall Study|Adverse Event|2|||
147255696|NCT02642614|531107823|FG000|Overall Study|Lost to Follow-up|1|||
147255697|NCT02642614|531107824|FG001|Overall Study|Lost to Follow-up|0|||
147255698|NCT02642614|531107825|FG002|Overall Study|Lost to Follow-up|0|||
147255699|NCT02642614|531107826|FG003|Overall Study|Lost to Follow-up|0|||
147255700|NCT02642614|531107823|FG000|Overall Study|Withdrawal by Subject|1|||
147255701|NCT02642614|531107824|FG001|Overall Study|Withdrawal by Subject|1|||
147255702|NCT02642614|531107825|FG002|Overall Study|Withdrawal by Subject|0|||
147255703|NCT02642614|531107826|FG003|Overall Study|Withdrawal by Subject|0|||
147255704|NCT00936910|531107827|FG000|Overall Study|Lack of Efficacy|3|||
147255705|NCT01485640|531107828|FG000|Overall Study|Adverse Event|10|||
147255706|NCT01485640|531107828|FG000|Overall Study|Lack of Efficacy|2|||
147255707|NCT01485640|531107828|FG000|Overall Study|Protocol Violation|1|||
147255708|NCT01485640|531107828|FG000|Overall Study|Withdrawal by Subject|14|||
147255709|NCT01485640|531107828|FG000|Overall Study|Terminated by Sponsor|95|||
147255710|NCT02057198|531107831|FG000|Overall Study|Death|0|||
147255711|NCT02057198|531107832|FG001|Overall Study|Death|0|||
147255712|NCT02057198|531107833|FG002|Overall Study|Death|1|||
147255713|NCT02057198|531107831|FG000|Overall Study|Discharged early; lost to followup|0|||
147255714|NCT02057198|531107832|FG001|Overall Study|Discharged early; lost to followup|1|||
147255715|NCT02057198|531107833|FG002|Overall Study|Discharged early; lost to followup|0|||
147255716|NCT02355691|531107834|FG000|Overall Study|Loss of Research Personnel|7|||
147255717|NCT02355691|531107835|FG001|Overall Study|Loss of Research Personnel|9|||
147255718|NCT03232281|531107837|FG000|Overall Study|Adverse Event|1|||
147255719|NCT03232281|531107838|FG001|Overall Study|Adverse Event|1|||
147255720|NCT03232281|531107837|FG000|Overall Study|Withdrawal by Subject|5|||
147255721|NCT03232281|531107838|FG001|Overall Study|Withdrawal by Subject|4|||
147255722|NCT03232281|531107837|FG000|Overall Study|Protocol Deviation|1|||
147255723|NCT03232281|531107838|FG001|Overall Study|Protocol Deviation|1|||
147255724|NCT02345811|531107840|FG000|First Intervention|Withdrawal by Subject|1|||
147255725|NCT02345811|531107841|FG001|First Intervention|Withdrawal by Subject|1|||
147255726|NCT02489344|531107843|FG000|ACT13739 (Initial Study): 26 Weeks|Adverse Event|1|||
147255727|NCT02489344|531107843|FG000|ACT13739 (Initial Study): 26 Weeks|Lost to Follow-up|1|||
147255728|NCT02489344|531107843|FG000|LTS14116 (Extension Study): 31 Months|Adverse Event|1|||
147255729|NCT02489344|531107843|FG000|LTS14116 (Extension Study): 31 Months|Treatment completed/Study not completed|2|||
147255730|NCT00605813|531107844|FG000|Overall Study|Protocol Violation|25|||
147255731|NCT00573755|531107849|FG000|Overall Study|Still receiving treatment|1|||
147255732|NCT00573755|531107850|FG001|Overall Study|Still receiving treatment|0|||
147255733|NCT00546637|531107861|FG000|Overall Study|Adverse Event|46|||
147255734|NCT00546637|531107862|FG001|Overall Study|Adverse Event|20|||
147255735|NCT00546637|531107861|FG000|Overall Study|Lack of Efficacy|5|||
147255736|NCT00546637|531107862|FG001|Overall Study|Lack of Efficacy|5|||
147255737|NCT00546637|531107861|FG000|Overall Study|Lost to Follow-up|2|||
147255738|NCT00546637|531107862|FG001|Overall Study|Lost to Follow-up|2|||
147255739|NCT00546637|531107861|FG000|Overall Study|Other|10|||
147255740|NCT00546637|531107862|FG001|Overall Study|Other|12|||
147255741|NCT00546637|531107861|FG000|Overall Study|Withdrawal by Subject|7|||
147255742|NCT00546637|531107862|FG001|Overall Study|Withdrawal by Subject|9|||
147255743|NCT00546637|531107861|FG000|Overall Study|Randomized, but not treated|3|||
147255744|NCT00546637|531107862|FG001|Overall Study|Randomized, but not treated|1|||
147255745|NCT03227029|531107863|FG000|Overall Study|Child Wheezed (no treatment)|0|||
147255746|NCT03227029|531107864|FG001|Overall Study|Child Wheezed (no treatment)|1|||
147255747|NCT03227029|531107865|FG002|Overall Study|Child Wheezed (no treatment)|0|||
147255748|NCT03227029|531107863|FG000|Overall Study|No post RSV season visit due to COVID|3|||
147255749|NCT03227029|531107864|FG001|Overall Study|No post RSV season visit due to COVID|3|||
147255750|NCT03227029|531107865|FG002|Overall Study|No post RSV season visit due to COVID|2|||
147255751|NCT03227029|531107863|FG000|Overall Study|Not able to get to clinic|0|||
147255752|NCT03227029|531107864|FG001|Overall Study|Not able to get to clinic|0|||
147255753|NCT03227029|531107865|FG002|Overall Study|Not able to get to clinic|1|||
147598738|NCT05297578|532349895|FG000|Overall Study|Death|0|||
147598739|NCT05297578|532349896|FG001|Overall Study|Death|1|||
147598740|NCT05297578|532349897|FG002|Overall Study|Death|0|||
147598741|NCT05297578|532349898|FG003|Overall Study|Death|0|||
147598742|NCT05297578|532349895|FG000|Overall Study|Withdrawal by Subject|0|||
147598743|NCT05297578|532349896|FG001|Overall Study|Withdrawal by Subject|0|||
147598744|NCT05297578|532349897|FG002|Overall Study|Withdrawal by Subject|1|||
147598745|NCT05297578|532349898|FG003|Overall Study|Withdrawal by Subject|0|||
147598746|NCT02266134|532349900|FG000|Clinics #1-2: Beginning Aug 2015|Lost to Follow-up|6|||
147661284|NCT01261390|532581472|FG003|Overall Study|Loss of Interest in the Study|0|||
147661285|NCT01261390|532581469|FG000|Overall Study|Lost to Follow-up|1|||
147661286|NCT01261390|532581470|FG001|Overall Study|Lost to Follow-up|6|||
147661287|NCT01261390|532581471|FG002|Overall Study|Lost to Follow-up|5|||
147661288|NCT01261390|532581472|FG003|Overall Study|Lost to Follow-up|6|||
147661289|NCT03421379|532581473|FG000|Period 1|Withdrawal by Subject|0|||
147661290|NCT03421379|532581474|FG001|Period 1|Withdrawal by Subject|1|||
147661291|NCT03421379|532581473|FG000|Period 1|Physician Decision|1|||
147661292|NCT03421379|532581474|FG001|Period 1|Physician Decision|1|||
147661293|NCT03421379|532581473|FG000|Period 1|Did not receive treatment|1|||
147661294|NCT03421379|532581474|FG001|Period 1|Did not receive treatment|2|||
147661295|NCT01497067|532581476|FG000|Overall Study|Lost to Follow-up|56|||
147661296|NCT01497067|532581476|FG000|Overall Study|Adverse Event|3|||
147661297|NCT01497067|532581476|FG000|Overall Study|Patient decision unrel to Adverse Event|10|||
147661298|NCT01497067|532581476|FG000|Overall Study|Other|13|||
147255754|NCT03227029|531107863|FG000|Overall Study|Withdrawal by Subject|1|||
147255755|NCT03227029|531107864|FG001|Overall Study|Withdrawal by Subject|0|||
147255756|NCT03227029|531107865|FG002|Overall Study|Withdrawal by Subject|0|||
147255757|NCT03227029|531107863|FG000|Overall Study|Unable to receive treatment in time (no treatment)|0|||
147255758|NCT03227029|531107864|FG001|Overall Study|Unable to receive treatment in time (no treatment)|0|||
147255759|NCT03227029|531107865|FG002|Overall Study|Unable to receive treatment in time (no treatment)|1|||
147255760|NCT02024867|531107868|FG000|Overall Study|Protocol Violation|3|||
147255761|NCT02024867|531107869|FG001|Overall Study|Protocol Violation|3|||
147255762|NCT02024867|531107868|FG000|Overall Study|Lost to Follow-up|6|||
147255763|NCT02024867|531107869|FG001|Overall Study|Lost to Follow-up|4|||
147255764|NCT02865187|531107870|FG000|Overall Study|Lost to Follow-up|12|||
147255765|NCT02865187|531107871|FG001|Overall Study|Lost to Follow-up|7|||
147255766|NCT02865187|531107870|FG000|Overall Study|Adverse Event|1|||
147255767|NCT02865187|531107871|FG001|Overall Study|Adverse Event|0|||
147255768|NCT04267133|531107872|FG000|Overall Study|Withdrawal by Subject|1|||
147255769|NCT04267133|531107872|FG000|Overall Study|Adverse Event|4|||
147255770|NCT01110707|531107873|FG000|Overall Study|Protocol Violation|0|||
147255771|NCT01110707|531107874|FG001|Overall Study|Protocol Violation|3|||
147255772|NCT02268864|531107875|FG000|Overall Study|Withdrawal by Subject|2|||
147255773|NCT02268864|531107876|FG001|Overall Study|Withdrawal by Subject|0|||
147255774|NCT02268864|531107877|FG002|Overall Study|Withdrawal by Subject|0|||
147255775|NCT02268864|531107875|FG000|Overall Study|Death|0|||
147255776|NCT02268864|531107876|FG001|Overall Study|Death|1|||
147255777|NCT02268864|531107877|FG002|Overall Study|Death|0|||
147255778|NCT02612428|531107880|FG000|VTL-308|Death|14|||
147255779|NCT02612428|531107881|FG001|VTL-308|Death|16|||
147255780|NCT02612428|531107880|FG000|VTL-308|Withdrawal by Subject|0|||
147255781|NCT02612428|531107881|FG001|VTL-308|Withdrawal by Subject|1|||
147255782|NCT02612428|531107880|FG000|VTL-308E|Death|9|||
147255783|NCT02612428|531107881|FG001|VTL-308E|Death|7|||
147255784|NCT02612428|531107880|FG000|VTL-308E|Lost to Follow-up|2|||
147255785|NCT02612428|531107881|FG001|VTL-308E|Lost to Follow-up|0|||
147255786|NCT02064166|531107884|FG000|Overall Study|Adverse Event|1|||
147255787|NCT02064166|531107885|FG001|Overall Study|Adverse Event|0|||
147255788|NCT00597766|531107890|FG000|Follow-up 1, Week 4|Withdrawal by Subject|1|||
147255789|NCT00597766|531107891|FG001|Follow-up 1, Week 4|Withdrawal by Subject|0|||
147255790|NCT00597766|531107892|FG002|Follow-up 1, Week 4|Withdrawal by Subject|0|||
147255791|NCT00597766|531107890|FG000|Follow-up 2, Week 8|Lost to Follow-up|0|||
147255792|NCT00597766|531107891|FG001|Follow-up 2, Week 8|Lost to Follow-up|0|||
147255793|NCT00597766|531107892|FG002|Follow-up 2, Week 8|Lost to Follow-up|1|||
147255794|NCT04339296|531107894|FG000|Overall Study|Refuse to participate after allocation|1|||
147255795|NCT04339296|531107895|FG001|Overall Study|Refuse to participate after allocation|1|||
147255796|NCT04339296|531107894|FG000|Overall Study|Withdrew after completion of baseline|2|||
147255797|NCT04339296|531107895|FG001|Overall Study|Withdrew after completion of baseline|1|||
147255798|NCT04339296|531107894|FG000|Overall Study|Lost to Follow-up|0|||
147255799|NCT04339296|531107895|FG001|Overall Study|Lost to Follow-up|4|||
147255800|NCT04339296|531107894|FG000|Overall Study|Discontinued intervention|5|||
147255801|NCT04339296|531107895|FG001|Overall Study|Discontinued intervention|3|||
147255802|NCT02375113|531107900|FG000|Overall Study|Undisclosed Reason(s).|1|||
147255803|NCT02375113|531107901|FG001|Overall Study|Undisclosed Reason(s).|1|||
147255804|NCT02375113|531107900|FG000|Overall Study|Poor adherence (<70%).|1|||
147255805|NCT02375113|531107901|FG001|Overall Study|Poor adherence (<70%).|0|||
147598747|NCT02266134|532349901|FG001|Clinics #1-2: Beginning Aug 2015|Lost to Follow-up|3|||
147661299|NCT03771963|532581477|FG000|Overall Study|Lost to Follow-up|22|||
147255806|NCT02375113|531107900|FG000|Overall Study|Discomfort of ingesting daily protein sh|0|||
147255807|NCT02375113|531107901|FG001|Overall Study|Discomfort of ingesting daily protein sh|1|||
147255808|NCT00877383|531107904|FG000|Overall Study|Adverse Event|13|||
147255809|NCT00877383|531107905|FG001|Overall Study|Adverse Event|14|||
147255810|NCT00877383|531107904|FG000|Overall Study|Lost to Follow-up|5|||
147255811|NCT00877383|531107905|FG001|Overall Study|Lost to Follow-up|3|||
147255812|NCT00877383|531107904|FG000|Overall Study|Subject withdrew consent|3|||
147255813|NCT00877383|531107905|FG001|Overall Study|Subject withdrew consent|12|||
147255814|NCT00877383|531107904|FG000|Overall Study|Subject no longer requires study drug|2|||
147255815|NCT00877383|531107905|FG001|Overall Study|Subject no longer requires study drug|0|||
147255816|NCT00877383|531107904|FG000|Overall Study|Administrative problems|2|||
147255817|NCT00877383|531107905|FG001|Overall Study|Administrative problems|0|||
147255818|NCT00877383|531107904|FG000|Overall Study|Protocol deviation|2|||
147255819|NCT00877383|531107905|FG001|Overall Study|Protocol deviation|6|||
147255820|NCT00877383|531107904|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
147255821|NCT00877383|531107905|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
147255822|NCT00877383|531107904|FG000|Overall Study|Death|1|||
147255823|NCT00877383|531107905|FG001|Overall Study|Death|2|||
147255824|NCT00459108|531107906|FG000|Overall Study|Withdrawal by Subject|5|||
147598748|NCT02266134|532349902|FG002|Clinics #1-2: Beginning Aug 2015|Lost to Follow-up|0|||
147598749|NCT02266134|532349903|FG003|Clinics #1-2: Beginning Aug 2015|Lost to Follow-up|0|||
147598750|NCT02266134|532349900|FG000|Clinics #3-6: Beginning Dec 2015|Lost to Follow-up|8|||
147598751|NCT02266134|532349901|FG001|Clinics #3-6: Beginning Dec 2015|Lost to Follow-up|2|||
147598752|NCT02266134|532349902|FG002|Clinics #3-6: Beginning Dec 2015|Lost to Follow-up|0|||
147598753|NCT02266134|532349903|FG003|Clinics #3-6: Beginning Dec 2015|Lost to Follow-up|0|||
147661300|NCT03771963|532581477|FG000|Overall Study|Withdrawal of Consent|10|||
147661301|NCT03066830|532581478|FG000|Overall Study|At the Participant's own Request|16|||
147661302|NCT03066830|532581479|FG001|Overall Study|At the Participant's own Request|17|||
147661303|NCT03066830|532581478|FG000|Overall Study|Other|3|||
147661304|NCT03066830|532581479|FG001|Overall Study|Other|0|||
147661305|NCT03066830|532581478|FG000|Overall Study|Poor Compliance to Protocol|1|||
147661306|NCT03066830|532581479|FG001|Overall Study|Poor Compliance to Protocol|0|||
147661307|NCT03066830|532581478|FG000|Overall Study|Adverse Event|2|||
147661308|NCT03066830|532581479|FG001|Overall Study|Adverse Event|2|||
147661309|NCT03066830|532581478|FG000|Overall Study|Lost to Follow-up|11|||
147661310|NCT03066830|532581479|FG001|Overall Study|Lost to Follow-up|3|||
147661311|NCT04888494|532581481|FG000|Overall Study|Lost to Follow-up|2|||
147661312|NCT04888494|532581482|FG001|Overall Study|Lost to Follow-up|3|||
147661313|NCT04888494|532581481|FG000|Overall Study|We dropped the participant due to safety concerns for the staff.|1|||
147661314|NCT04888494|532581482|FG001|Overall Study|We dropped the participant due to safety concerns for the staff.|0|||
147661315|NCT03430856|532581483|FG000|Overall Study|Adverse Event|0|||
147661316|NCT03430856|532581484|FG001|Overall Study|Adverse Event|1|||
147661317|NCT03430856|532581485|FG002|Overall Study|Adverse Event|0|||
147661318|NCT03430856|532581483|FG000|Overall Study|Rescue criteria|1|||
147661319|NCT03430856|532581484|FG001|Overall Study|Rescue criteria|1|||
147661320|NCT03430856|532581485|FG002|Overall Study|Rescue criteria|0|||
147661321|NCT03430856|532581483|FG000|Overall Study|Voluntary withdrawal of consent|1|||
147661322|NCT03430856|532581484|FG001|Overall Study|Voluntary withdrawal of consent|1|||
147661323|NCT03430856|532581485|FG002|Overall Study|Voluntary withdrawal of consent|1|||
147661324|NCT00565604|532581489|FG000|Overall Study|Failure to treat|2|||
147661325|NCT00565604|532581489|FG000|Overall Study|Lost to Follow-up|2|||
147661326|NCT01051921|532582992|FG000|Overall Study|Physician Decision|9|||
147661327|NCT01051921|532582992|FG000|Overall Study|Adverse Event|8|||
147661328|NCT01051921|532582992|FG000|Overall Study|Withdrawal by Subject|7|||
147661329|NCT01051921|532582992|FG000|Overall Study|Lost to Follow-up|4|||
147661330|NCT01051921|532582992|FG000|Overall Study|virological failure|1|||
147661331|NCT01051921|532582992|FG000|Overall Study|patient moved|1|||
147661332|NCT01001429|532582993|FG000|Overall Study|surgery cancelled|0|||
147255825|NCT00459108|531107906|FG000|Overall Study|Adverse Event|3|||
147255826|NCT00459108|531107906|FG000|Overall Study|Death|2|||
147255827|NCT00459108|531107906|FG000|Overall Study|Progression|1|||
147450003|NCT01709149|531811339|FG001|Open-label Lead-in Phase|Death|0|||
147598754|NCT02266134|532349900|FG000|Clinics #7-10: Beginning May 2016|Lost to Follow-up|10|||
147598755|NCT02266134|532349901|FG001|Clinics #7-10: Beginning May 2016|Lost to Follow-up|5|||
147661333|NCT01001429|532582994|FG001|Overall Study|surgery cancelled|1|||
147661334|NCT03934216|532582997|FG000|Overall Study|Other Reasons|5|||
147661335|NCT03934216|532582998|FG001|Overall Study|Other Reasons|5|||
147661336|NCT03934216|532582997|FG000|Overall Study|Adverse Event|22|||
147661337|NCT03934216|532582998|FG001|Overall Study|Adverse Event|11|||
147661338|NCT03934216|532582997|FG000|Overall Study|Lack of Efficacy|8|||
147661339|NCT03934216|532582998|FG001|Overall Study|Lack of Efficacy|7|||
147661340|NCT03934216|532582997|FG000|Overall Study|Lost to Follow-up|2|||
147661341|NCT03934216|532582998|FG001|Overall Study|Lost to Follow-up|0|||
147661342|NCT03934216|532582997|FG000|Overall Study|Non-Compliance with Study Drug|1|||
147255828|NCT02062879|531107912|FG000|Overall Study|Withdrawal by Subject|4|||
147255829|NCT02062879|531107913|FG001|Overall Study|Withdrawal by Subject|1|||
147661343|NCT03934216|532582998|FG001|Overall Study|Non-Compliance with Study Drug|1|||
147661344|NCT03934216|532582997|FG000|Overall Study|Pregnancy|1|||
147661345|NCT03934216|532582998|FG001|Overall Study|Pregnancy|0|||
147661346|NCT03934216|532582997|FG000|Overall Study|Withdrawal by Subject|18|||
147661347|NCT03934216|532582998|FG001|Overall Study|Withdrawal by Subject|6|||
147661348|NCT03934216|532582997|FG000|Overall Study|Randomized but not treated|1|||
147661349|NCT03934216|532582998|FG001|Overall Study|Randomized but not treated|1|||
147661350|NCT01063855|532582999|FG000|Overall Study|Adverse Event|4|||
147661351|NCT01063855|532583000|FG001|Overall Study|Adverse Event|4|||
147661352|NCT01063855|532582999|FG000|Overall Study|Death|0|||
147661353|NCT01063855|532583000|FG001|Overall Study|Death|1|||
147661354|NCT01063855|532582999|FG000|Overall Study|Lost to Follow-up|8|||
147661355|NCT01063855|532583000|FG001|Overall Study|Lost to Follow-up|4|||
147661356|NCT01063855|532582999|FG000|Overall Study|Pregnancy|1|||
147661357|NCT01063855|532583000|FG001|Overall Study|Pregnancy|0|||
147661358|NCT01063855|532582999|FG000|Overall Study|Lack of Efficacy|0|||
147661359|NCT01063855|532583000|FG001|Overall Study|Lack of Efficacy|1|||
147661360|NCT01063855|532582999|FG000|Overall Study|Withdrawal by Subject|11|||
147661361|NCT01063855|532583000|FG001|Overall Study|Withdrawal by Subject|8|||
147661362|NCT01063855|532582999|FG000|Overall Study|Reason not specified|13|||
147661363|NCT01063855|532583000|FG001|Overall Study|Reason not specified|11|||
147661364|NCT01165307|532583001|FG000|Overall Study|Lost to Follow-up|11|||
147661365|NCT01165307|532583002|FG001|Overall Study|Lost to Follow-up|3|||
147661366|NCT01165307|532583001|FG000|Overall Study|Withdrawal by Subject|2|||
147661367|NCT01165307|532583002|FG001|Overall Study|Withdrawal by Subject|0|||
147661368|NCT01165307|532583001|FG000|Overall Study|Subject not available for contact|1|||
147661369|NCT01165307|532583002|FG001|Overall Study|Subject not available for contact|0|||
147661370|NCT03627832|532583007|FG000|Overall Study|Withdrawal by Subject|10|||
147661371|NCT03627832|532583008|FG001|Overall Study|Withdrawal by Subject|1|||
147661372|NCT00048035|532583014|FG000|Core Period|Early Withdrawals|4|||
147661373|NCT00048035|532583015|FG001|Core Period|Early Withdrawals|2|||
147661374|NCT00048035|532583016|FG002|Core Period|Early Withdrawals|1|||
147661375|NCT00048035|532583017|FG003|Core Period|Early Withdrawals|1|||
147661376|NCT00048035|532583018|FG004|Core Period|Early Withdrawals|1|||
147661377|NCT00048035|532583019|FG005|Core Period|Early Withdrawals|1|||
147661378|NCT00048035|532583020|FG006|Core Period|Early Withdrawals|0|||
147661379|NCT00048035|532583021|FG007|Core Period|Early Withdrawals|0|||
147661380|NCT00048035|532583014|FG000|Extension Year 1|Early Withdrawals|0|||
147661381|NCT00048035|532583015|FG001|Extension Year 1|Early Withdrawals|0|||
147661382|NCT00048035|532583016|FG002|Extension Year 1|Early Withdrawals|0|||
147661383|NCT00048035|532583017|FG003|Extension Year 1|Early Withdrawals|0|||
147661384|NCT00048035|532583018|FG004|Extension Year 1|Early Withdrawals|0|||
147661385|NCT00048035|532583019|FG005|Extension Year 1|Early Withdrawals|0|||
147661386|NCT00048035|532583020|FG006|Extension Year 1|Early Withdrawals|11|||
147661387|NCT00048035|532583021|FG007|Extension Year 1|Early Withdrawals|11|||
147661388|NCT00048035|532583014|FG000|Extension Year 2|Early Withdrawals|0|||
147661389|NCT00048035|532583015|FG001|Extension Year 2|Early Withdrawals|0|||
147661390|NCT00048035|532583016|FG002|Extension Year 2|Early Withdrawals|0|||
147661391|NCT00048035|532583017|FG003|Extension Year 2|Early Withdrawals|0|||
147661392|NCT00048035|532583018|FG004|Extension Year 2|Early Withdrawals|0|||
147661393|NCT00048035|532583019|FG005|Extension Year 2|Early Withdrawals|0|||
147661394|NCT00048035|532583020|FG006|Extension Year 2|Early Withdrawals|3|||
147661395|NCT00048035|532583021|FG007|Extension Year 2|Early Withdrawals|3|||
147661396|NCT05137717|532583022|FG000|Overall Study|Death|2|||
147661397|NCT05137717|532583022|FG000|Overall Study|Withdrawal by Subject|6|||
147661398|NCT02619617|532583023|FG000|Period 2 SOM230 - 2nd Attack|Protocol Violation|0|||
147661399|NCT02619617|532583024|FG001|Period 2 SOM230 - 2nd Attack|Protocol Violation|1|||
147661400|NCT02619617|532583023|FG000|Period 2 SOM230 - 2nd Attack|Physician Decision|0|||
147661401|NCT02619617|532583024|FG001|Period 2 SOM230 - 2nd Attack|Physician Decision|3|||
147661402|NCT00509899|532583026|FG000|Overall Study|Progressive disease|1|||
147661403|NCT00509899|532583027|FG001|Overall Study|Progressive disease|3|||
147661404|NCT00509899|532583028|FG002|Overall Study|Progressive disease|5|||
147661405|NCT00509899|532583029|FG003|Overall Study|Progressive disease|1|||
147661406|NCT00509899|532583030|FG004|Overall Study|Progressive disease|0|||
147661407|NCT00509899|532583031|FG005|Overall Study|Progressive disease|1|||
147661408|NCT00509899|532583032|FG006|Overall Study|Progressive disease|0|||
147661409|NCT00509899|532583033|FG007|Overall Study|Progressive disease|0|||
147661410|NCT00509899|532583026|FG000|Overall Study|Unacceptable Toxicity|1|||
147661411|NCT00509899|532583027|FG001|Overall Study|Unacceptable Toxicity|0|||
147332703|NCT00943735|531385520|FG000|Overall Study|Other|3|||
147661412|NCT00509899|532583028|FG002|Overall Study|Unacceptable Toxicity|0|||
147661413|NCT00509899|532583029|FG003|Overall Study|Unacceptable Toxicity|2|||
147661414|NCT00509899|532583030|FG004|Overall Study|Unacceptable Toxicity|0|||
147661415|NCT00509899|532583031|FG005|Overall Study|Unacceptable Toxicity|0|||
147661416|NCT00509899|532583032|FG006|Overall Study|Unacceptable Toxicity|0|||
147661417|NCT00509899|532583033|FG007|Overall Study|Unacceptable Toxicity|0|||
147661418|NCT00509899|532583026|FG000|Overall Study|Withdrawal by Subject|6|||
147661419|NCT00509899|532583027|FG001|Overall Study|Withdrawal by Subject|2|||
147255830|NCT00056407|531107914|FG000|Overall Study|Adverse Event|282|||
147255831|NCT00056407|531107915|FG001|Overall Study|Adverse Event|364|||
147255832|NCT00056407|531107914|FG000|Overall Study|Withdrawal by Subject|377|||
147255833|NCT00056407|531107915|FG001|Overall Study|Withdrawal by Subject|361|||
147255834|NCT00056407|531107914|FG000|Overall Study|Lost to Follow-up|123|||
147255835|NCT00056407|531107915|FG001|Overall Study|Lost to Follow-up|113|||
147598756|NCT02266134|532349902|FG002|Clinics #7-10: Beginning May 2016|Lost to Follow-up|0|||
147598757|NCT02266134|532349903|FG003|Clinics #7-10: Beginning May 2016|Lost to Follow-up|0|||
147598758|NCT02266134|532349900|FG000|Clinics #7-10: Beginning May 2016|Withdrawal by Subject|3|||
147598759|NCT02266134|532349901|FG001|Clinics #7-10: Beginning May 2016|Withdrawal by Subject|0|||
147598760|NCT02266134|532349902|FG002|Clinics #7-10: Beginning May 2016|Withdrawal by Subject|0|||
147598761|NCT02266134|532349903|FG003|Clinics #7-10: Beginning May 2016|Withdrawal by Subject|0|||
147598762|NCT02266134|532349900|FG000|Clinics #11-12: Beginning Dec 2016|Lost to Follow-up|6|||
147598763|NCT02266134|532349901|FG001|Clinics #11-12: Beginning Dec 2016|Lost to Follow-up|2|||
147598764|NCT02266134|532349902|FG002|Clinics #11-12: Beginning Dec 2016|Lost to Follow-up|0|||
147598765|NCT02266134|532349903|FG003|Clinics #11-12: Beginning Dec 2016|Lost to Follow-up|0|||
147598766|NCT02266134|532349900|FG000|Clinics #11-12: Beginning Dec 2016|Withdrawal by Subject|3|||
147598767|NCT02266134|532349901|FG001|Clinics #11-12: Beginning Dec 2016|Withdrawal by Subject|0|||
147598768|NCT02266134|532349902|FG002|Clinics #11-12: Beginning Dec 2016|Withdrawal by Subject|0|||
147598769|NCT02266134|532349903|FG003|Clinics #11-12: Beginning Dec 2016|Withdrawal by Subject|0|||
147598770|NCT02731326|532349908|FG000|Overall Study|Withdrawal by Subject|4|||
147598771|NCT02731326|532349909|FG001|Overall Study|Withdrawal by Subject|1|||
147598772|NCT02731326|532349908|FG000|Overall Study|No Cardioversion or Ablation Procedure|1|||
147598773|NCT02731326|532349909|FG001|Overall Study|No Cardioversion or Ablation Procedure|6|||
147598774|NCT02731326|532349908|FG000|Overall Study|Discharged without AliveCor|10|||
147598775|NCT02731326|532349909|FG001|Overall Study|Discharged without AliveCor|0|||
147598776|NCT02731326|532349908|FG000|Overall Study|Duplicate Participant|1|||
147598777|NCT02731326|532349909|FG001|Overall Study|Duplicate Participant|1|||
147598778|NCT00762437|532349913|FG000|Overall Study|Lost to Follow-up|7|||
147598779|NCT00762437|532349913|FG000|Overall Study|Missed final study visit|11|||
147598780|NCT00762437|532349913|FG000|Overall Study|No treatment (unable to attach sleeve to participant)|1|||
147598781|NCT00302081|532349914|FG000|Overall Study|Adverse Event|6|||
147598782|NCT00302081|532349915|FG001|Overall Study|Adverse Event|5|||
147598783|NCT00302081|532349916|FG002|Overall Study|Adverse Event|4|||
147598784|NCT00302081|532349914|FG000|Overall Study|Lost to Follow-up|21|||
147598785|NCT00302081|532349915|FG001|Overall Study|Lost to Follow-up|18|||
147598786|NCT00302081|532349916|FG002|Overall Study|Lost to Follow-up|28|||
147598787|NCT00302081|532349914|FG000|Overall Study|Withdrawal by Subject|8|||
147598788|NCT00302081|532349915|FG001|Overall Study|Withdrawal by Subject|12|||
147598789|NCT00302081|532349916|FG002|Overall Study|Withdrawal by Subject|8|||
147598790|NCT00302081|532349914|FG000|Overall Study|Protocol Violation|5|||
147598791|NCT00302081|532349915|FG001|Overall Study|Protocol Violation|1|||
147598792|NCT00302081|532349916|FG002|Overall Study|Protocol Violation|2|||
147598793|NCT00302081|532349914|FG000|Overall Study|Lack of Efficacy|1|||
147598794|NCT00302081|532349915|FG001|Overall Study|Lack of Efficacy|0|||
147598795|NCT00302081|532349916|FG002|Overall Study|Lack of Efficacy|5|||
147598796|NCT00302081|532349914|FG000|Overall Study|Death|2|||
147598797|NCT00302081|532349915|FG001|Overall Study|Death|1|||
147598798|NCT00302081|532349916|FG002|Overall Study|Death|0|||
147598799|NCT00302081|532349914|FG000|Overall Study|Other|13|||
147598800|NCT00302081|532349915|FG001|Overall Study|Other|6|||
147598801|NCT00302081|532349916|FG002|Overall Study|Other|5|||
147598802|NCT04480710|532349917|FG000|Overall Study|Adverse Event|0|||
147598803|NCT04480710|532349918|FG001|Overall Study|Adverse Event|2|||
147598804|NCT04480710|532349919|FG002|Overall Study|Adverse Event|0|||
147598805|NCT04480710|532349920|FG003|Overall Study|Adverse Event|0|||
147598806|NCT04480710|532349917|FG000|Overall Study|Withdrawal by Subject|0|||
147598807|NCT04480710|532349918|FG001|Overall Study|Withdrawal by Subject|1|||
147598808|NCT04480710|532349919|FG002|Overall Study|Withdrawal by Subject|0|||
147598809|NCT04480710|532349920|FG003|Overall Study|Withdrawal by Subject|0|||
147598810|NCT04480710|532349917|FG000|Overall Study|Physician Decision|0|||
147598811|NCT04480710|532349918|FG001|Overall Study|Physician Decision|0|||
147598812|NCT04480710|532349919|FG002|Overall Study|Physician Decision|1|||
147598813|NCT04480710|532349920|FG003|Overall Study|Physician Decision|0|||
147598814|NCT05084963|532349922|FG000|Overall Study|Withdrawal by Subject|0|||
147598815|NCT05084963|532349923|FG001|Overall Study|Withdrawal by Subject|0|||
147598816|NCT05084963|532349924|FG002|Overall Study|Withdrawal by Subject|1|||
147598817|NCT03569228|532349925|FG000|Overall Study|Withdrawal by PI|0|||
147598818|NCT03569228|532349926|FG001|Overall Study|Withdrawal by PI|0|||
147598819|NCT03569228|532349927|FG002|Overall Study|Withdrawal by PI|2|||
147598820|NCT03569228|532349928|FG003|Overall Study|Withdrawal by PI|2|||
147598821|NCT03569228|532349929|FG004|Overall Study|Withdrawal by PI|1|||
147255836|NCT00056407|531107914|FG000|Overall Study|Protocol Violation|104|||
147598822|NCT03569228|532349930|FG005|Overall Study|Withdrawal by PI|0|||
147255837|NCT00056407|531107915|FG001|Overall Study|Protocol Violation|95|||
147598823|NCT03569228|532349931|FG006|Overall Study|Withdrawal by PI|0|||
147598824|NCT03569228|532349932|FG007|Overall Study|Withdrawal by PI|0|||
147598825|NCT03569228|532349933|FG008|Overall Study|Withdrawal by PI|0|||
147598826|NCT03569228|532349925|FG000|Overall Study|Lost to Follow-up|0|||
147255838|NCT00056407|531107914|FG000|Overall Study|Diagnosed with Prostate Cancer|202|||
147255839|NCT00056407|531107915|FG001|Overall Study|Diagnosed with Prostate Cancer|166|||
147255840|NCT00056407|531107914|FG000|Overall Study|"Listed as Other on Case Report Form"|98|||
147255841|NCT00056407|531107915|FG001|Overall Study|"Listed as Other on Case Report Form"|60|||
147255842|NCT00056407|531107914|FG000|Overall Study|Missing|25|||
147255843|NCT00056407|531107915|FG001|Overall Study|Missing|34|||
147255844|NCT00616655|531107916|FG000|Overall Study|Adverse Event|10|||
147255845|NCT00616655|531107917|FG001|Overall Study|Adverse Event|7|||
147255846|NCT00616655|531107918|FG002|Overall Study|Adverse Event|12|||
147255847|NCT00616655|531107916|FG000|Overall Study|Lack of Efficacy|5|||
147255848|NCT00616655|531107917|FG001|Overall Study|Lack of Efficacy|5|||
147255849|NCT00616655|531107918|FG002|Overall Study|Lack of Efficacy|5|||
147255850|NCT00616655|531107916|FG000|Overall Study|Lost to Follow-up|3|||
147255851|NCT00616655|531107917|FG001|Overall Study|Lost to Follow-up|12|||
147255852|NCT00616655|531107918|FG002|Overall Study|Lost to Follow-up|10|||
147255853|NCT00616655|531107916|FG000|Overall Study|Protocol Violation|2|||
147255854|NCT00616655|531107917|FG001|Overall Study|Protocol Violation|4|||
147255855|NCT00616655|531107918|FG002|Overall Study|Protocol Violation|3|||
147255856|NCT00616655|531107916|FG000|Overall Study|Withdrawal by Subject|9|||
147255857|NCT00616655|531107917|FG001|Overall Study|Withdrawal by Subject|7|||
147255858|NCT00616655|531107918|FG002|Overall Study|Withdrawal by Subject|11|||
147255859|NCT00616655|531107916|FG000|Overall Study|Does not meet in/ex criteria|0|||
147255860|NCT00616655|531107917|FG001|Overall Study|Does not meet in/ex criteria|0|||
147255861|NCT00616655|531107918|FG002|Overall Study|Does not meet in/ex criteria|2|||
147255862|NCT00616655|531107916|FG000|Overall Study|Other|6|||
147255863|NCT00616655|531107917|FG001|Overall Study|Other|6|||
147255864|NCT00616655|531107918|FG002|Overall Study|Other|5|||
147255865|NCT03761147|531107919|FG000|Overall Study|Withdrawal by Subject|6|||
147255866|NCT03761147|531107920|FG001|Overall Study|Withdrawal by Subject|1|||
147255867|NCT03761147|531107919|FG000|Overall Study|Adverse Event|1|||
147255868|NCT03761147|531107920|FG001|Overall Study|Adverse Event|3|||
147255869|NCT01026792|531107921|FG000|Overall Study|Protocol Violation|1|||
147255870|NCT02626520|531107924|FG000|Overall Study|Physician Decision|1|||
147255871|NCT02626520|531107925|FG001|Overall Study|Physician Decision|1|||
147255872|NCT02626520|531107924|FG000|Overall Study|Adverse Event|0|||
147255873|NCT02626520|531107925|FG001|Overall Study|Adverse Event|4|||
147255874|NCT02626520|531107924|FG000|Overall Study|Lack of Efficacy|0|||
147255875|NCT02626520|531107925|FG001|Overall Study|Lack of Efficacy|2|||
147255876|NCT02626520|531107924|FG000|Overall Study|Did not start protocol therapy|0|||
147255877|NCT02626520|531107925|FG001|Overall Study|Did not start protocol therapy|2|||
147255878|NCT02626520|531107924|FG000|Overall Study|Study terminated|0|||
147255879|NCT02626520|531107925|FG001|Overall Study|Study terminated|1|||
147255880|NCT00492115|531107926|FG000|Overall Study|Withdrawal by Subject|3|||
147255881|NCT00492115|531107927|FG001|Overall Study|Withdrawal by Subject|4|||
147255882|NCT02045797|531107930|FG000|Overall Study|Adverse Event|3|||
147255883|NCT02045797|531107931|FG001|Overall Study|Adverse Event|1|||
147255884|NCT02045797|531107932|FG002|Overall Study|Adverse Event|0|||
147255885|NCT02045797|531107930|FG000|Overall Study|Lack of Efficacy|1|||
147255886|NCT02045797|531107931|FG001|Overall Study|Lack of Efficacy|0|||
147255887|NCT02045797|531107932|FG002|Overall Study|Lack of Efficacy|0|||
147255888|NCT02045797|531107930|FG000|Overall Study|Lost to Follow-up|2|||
147255889|NCT02045797|531107931|FG001|Overall Study|Lost to Follow-up|3|||
147255890|NCT02045797|531107932|FG002|Overall Study|Lost to Follow-up|1|||
147255891|NCT02045797|531107930|FG000|Overall Study|Physician Decision|0|||
147255892|NCT02045797|531107931|FG001|Overall Study|Physician Decision|1|||
147255893|NCT02045797|531107932|FG002|Overall Study|Physician Decision|0|||
147255894|NCT02045797|531107930|FG000|Overall Study|Withdrawal by Subject|1|||
147255895|NCT02045797|531107931|FG001|Overall Study|Withdrawal by Subject|2|||
147255896|NCT02045797|531107932|FG002|Overall Study|Withdrawal by Subject|0|||
147255897|NCT01786629|531109368|FG000|Overall Study|Lack of Efficacy|0|||
147598827|NCT03569228|532349926|FG001|Overall Study|Lost to Follow-up|0|||
147598828|NCT03569228|532349927|FG002|Overall Study|Lost to Follow-up|0|||
147255898|NCT01786629|531109369|FG001|Overall Study|Lack of Efficacy|4|||
147255899|NCT01786629|531109368|FG000|Overall Study|Adverse Event|0|||
147255900|NCT01786629|531109369|FG001|Overall Study|Adverse Event|1|||
147255901|NCT00410761|531109370|FG000|Randomized Treatment Period|Adverse Event|34|||
147255902|NCT00410761|531109371|FG001|Randomized Treatment Period|Adverse Event|3|||
147255903|NCT00410761|531109370|FG000|Randomized Treatment Period|Objective Disease Progression|103|||
147255904|NCT00410761|531109371|FG001|Randomized Treatment Period|Objective Disease Progression|68|||
147255905|NCT00410761|531109370|FG000|Randomized Treatment Period|Withdrawal by Subject|11|||
147255906|NCT00410761|531109371|FG001|Randomized Treatment Period|Withdrawal by Subject|6|||
147255907|NCT00410761|531109370|FG000|Randomized Treatment Period|Other|69|||
147255908|NCT00410761|531109371|FG001|Randomized Treatment Period|Other|21|||
147332704|NCT00486330|531385521|FG000|Overall Study|Adverse Event|2|||
147255909|NCT00410761|531109370|FG000|Randomized Treatment Period|Randomized but did not Receive Treatment|0|||
147255910|NCT00410761|531109371|FG001|Randomized Treatment Period|Randomized but did not Receive Treatment|1|||
147255911|NCT00410761|531109370|FG000|Open-Label Treatment Period|Adverse Event|13|||
147255912|NCT00410761|531109371|FG001|Open-Label Treatment Period|Adverse Event|15|||
147255913|NCT00410761|531109370|FG000|Open-Label Treatment Period|Objective Disease Progression|42|||
147255914|NCT00410761|531109371|FG001|Open-Label Treatment Period|Objective Disease Progression|27|||
147255915|NCT00410761|531109370|FG000|Open-Label Treatment Period|Withdrawal by Subject|8|||
147255916|NCT00410761|531109371|FG001|Open-Label Treatment Period|Withdrawal by Subject|7|||
147255917|NCT00410761|531109370|FG000|Open-Label Treatment Period|Other|18|||
147255918|NCT00410761|531109371|FG001|Open-Label Treatment Period|Other|9|||
147255919|NCT02369341|531109373|FG000|Overall Study|Migrated/moved from study area|1|||
147255920|NCT02369341|531109374|FG001|Overall Study|Migrated/moved from study area|0|||
147255921|NCT00674661|531109375|FG000|Overall Study|Other|5|||
147598829|NCT03569228|532349928|FG003|Overall Study|Lost to Follow-up|0|||
147255922|NCT00674661|531109376|FG001|Overall Study|Other|7|||
147255923|NCT00674661|531109375|FG000|Overall Study|Lost to Follow-up|6|||
147255924|NCT00674661|531109376|FG001|Overall Study|Lost to Follow-up|3|||
147255925|NCT00674661|531109375|FG000|Overall Study|Withdrawal by Subject|0|||
147255926|NCT00674661|531109376|FG001|Overall Study|Withdrawal by Subject|5|||
147255927|NCT00003901|531109377|FG000|Overall Study|Adverse Event|1|||
147255928|NCT00003901|531109377|FG000|Overall Study|Withdrawal by Subject|1|||
147255929|NCT00003901|531109377|FG000|Overall Study|Ineligible|6|||
147255930|NCT00003901|531109377|FG000|Overall Study|CT Scan not within protocol requirement|2|||
147255931|NCT00003901|531109377|FG000|Overall Study|Chest X-Ray not done prior registration|1|||
147255932|NCT00003901|531109377|FG000|Overall Study|Medical problems|6|||
147255933|NCT02707991|531109378|FG000|Overall Study|Protocol Violation|1|||
147255934|NCT02707991|531109379|FG001|Overall Study|Protocol Violation|0|||
147255935|NCT02707991|531109378|FG000|Overall Study|Became ineligible|0|||
147255936|NCT02707991|531109379|FG001|Overall Study|Became ineligible|1|||
147255937|NCT00857220|531109380|FG000|Overall Study|Adverse Event|35|||
147255938|NCT00857220|531109380|FG000|Overall Study|Death|1|||
147255939|NCT00857220|531109380|FG000|Overall Study|Lack of Efficacy|11|||
147255940|NCT00857220|531109380|FG000|Overall Study|Lost to Follow-up|30|||
147255941|NCT00857220|531109380|FG000|Overall Study|Physician Decision|4|||
147255942|NCT00857220|531109380|FG000|Overall Study|Protocol Violation|16|||
147255943|NCT00857220|531109380|FG000|Overall Study|Withdrawal by Subject|67|||
147255944|NCT00857220|531109380|FG000|Overall Study|Clinical Hold|6|||
147255945|NCT00857220|531109380|FG000|Overall Study|Site Closed|5|||
147255946|NCT00857220|531109380|FG000|Overall Study|Miscellaneous|8|||
147332705|NCT00813904|531385522|FG000|Overall Study|Death|1|||
147598830|NCT03569228|532349929|FG004|Overall Study|Lost to Follow-up|0|||
147598831|NCT03569228|532349930|FG005|Overall Study|Lost to Follow-up|0|||
147598832|NCT03569228|532349931|FG006|Overall Study|Lost to Follow-up|0|||
147598833|NCT03569228|532349932|FG007|Overall Study|Lost to Follow-up|0|||
147598834|NCT03569228|532349933|FG008|Overall Study|Lost to Follow-up|1|||
147598835|NCT03569228|532349925|FG000|Overall Study|Screen Fail|2|||
147598836|NCT03569228|532349926|FG001|Overall Study|Screen Fail|2|||
147598837|NCT03569228|532349927|FG002|Overall Study|Screen Fail|1|||
147598838|NCT03569228|532349928|FG003|Overall Study|Screen Fail|1|||
147598839|NCT03569228|532349929|FG004|Overall Study|Screen Fail|1|||
147598840|NCT03569228|532349930|FG005|Overall Study|Screen Fail|3|||
147598841|NCT03569228|532349931|FG006|Overall Study|Screen Fail|1|||
147598842|NCT03569228|532349932|FG007|Overall Study|Screen Fail|5|||
147598843|NCT03569228|532349933|FG008|Overall Study|Screen Fail|2|||
147598844|NCT05442866|532349934|FG000|Overall Study|Death|1|||
147598845|NCT05442866|532349934|FG000|Overall Study|Lost to Follow-up|9|||
147598846|NCT05442866|532349934|FG000|Overall Study|Protocol Violation|1|||
147598847|NCT03819049|532349935|FG000|Overall Study|Lost to Follow-up|1|||
147598848|NCT03819049|532349936|FG001|Overall Study|Lost to Follow-up|2|||
147598849|NCT03819049|532349937|FG002|Overall Study|Lost to Follow-up|9|||
147598850|NCT03819049|532349938|FG003|Overall Study|Lost to Follow-up|0|||
147598851|NCT03819049|532349939|FG004|Overall Study|Lost to Follow-up|3|||
147598852|NCT03819049|532349940|FG005|Overall Study|Lost to Follow-up|1|||
147661420|NCT00509899|532583028|FG002|Overall Study|Withdrawal by Subject|3|||
147255947|NCT03187262|531109381|FG000|Induction|Lack of Efficacy|2|||
147255948|NCT03187262|531109381|FG000|Induction|Progressive Disease|4|||
147255949|NCT03187262|531109381|FG000|Consolidation|Progressive Disease|5|||
147255950|NCT01166763|531109386|FG000|Overall Study|Withdrawal by Subject|3|||
147255951|NCT01909479|531109387|FG000|From Baseline to Week 26|Adverse Event|3|||
147255952|NCT01909479|531109388|FG001|From Baseline to Week 26|Adverse Event|2|||
147255953|NCT01909479|531109387|FG000|From Baseline to Week 26|Withdrawal by Subject|3|||
147598853|NCT03819049|532349941|FG006|Overall Study|Lost to Follow-up|0|||
147598854|NCT03819049|532349935|FG000|Overall Study|Withdrawal by Subject|0|||
147598855|NCT03819049|532349936|FG001|Overall Study|Withdrawal by Subject|0|||
147598856|NCT03819049|532349937|FG002|Overall Study|Withdrawal by Subject|18|||
147598857|NCT03819049|532349938|FG003|Overall Study|Withdrawal by Subject|0|||
147598858|NCT03819049|532349939|FG004|Overall Study|Withdrawal by Subject|10|||
147598859|NCT03819049|532349940|FG005|Overall Study|Withdrawal by Subject|9|||
147661421|NCT00509899|532583029|FG003|Overall Study|Withdrawal by Subject|0|||
147255954|NCT01909479|531109388|FG001|From Baseline to Week 26|Withdrawal by Subject|6|||
147255955|NCT01909479|531109387|FG000|From Baseline to Week 26|Site and study closed by PI|0|||
147598860|NCT03819049|532349941|FG006|Overall Study|Withdrawal by Subject|1|||
147598861|NCT03819049|532349935|FG000|Overall Study|Ongoing|0|||
147598862|NCT03819049|532349936|FG001|Overall Study|Ongoing|0|||
147598863|NCT03819049|532349937|FG002|Overall Study|Ongoing|75|||
147598864|NCT03819049|532349938|FG003|Overall Study|Ongoing|0|||
147598865|NCT03819049|532349939|FG004|Overall Study|Ongoing|41|||
147255956|NCT01909479|531109388|FG001|From Baseline to Week 26|Site and study closed by PI|1|||
147255957|NCT01909479|531109387|FG000|26 - 52 Weeks|Adverse Event|0|||
147255958|NCT01909479|531109388|FG001|26 - 52 Weeks|Adverse Event|1|||
147255959|NCT01909479|531109387|FG000|26 - 52 Weeks|Withdrawal by Subject|2|||
147255960|NCT01909479|531109388|FG001|26 - 52 Weeks|Withdrawal by Subject|1|||
147255961|NCT01909479|531109387|FG000|26 - 52 Weeks|Lost to Follow-up|1|||
147255962|NCT01909479|531109388|FG001|26 - 52 Weeks|Lost to Follow-up|0|||
147255963|NCT01909479|531109387|FG000|52 Weeks to End of Study|Withdrawal by Subject|18|||
147255964|NCT01909479|531109388|FG001|52 Weeks to End of Study|Withdrawal by Subject|8|||
147255965|NCT01909479|531109387|FG000|52 Weeks to End of Study|Adverse Event|2|||
147255966|NCT01909479|531109388|FG001|52 Weeks to End of Study|Adverse Event|1|||
147255967|NCT01909479|531109387|FG000|52 Weeks to End of Study|Death|0|||
147255968|NCT01909479|531109388|FG001|52 Weeks to End of Study|Death|1|||
147255969|NCT01909479|531109387|FG000|52 Weeks to End of Study|Lost to Follow-up|1|||
147255970|NCT01909479|531109388|FG001|52 Weeks to End of Study|Lost to Follow-up|0|||
147255971|NCT01909479|531109387|FG000|52 Weeks to End of Study|Protocol Violation|1|||
147255972|NCT01909479|531109388|FG001|52 Weeks to End of Study|Protocol Violation|0|||
147255973|NCT01909479|531109387|FG000|52 Weeks to End of Study|Progressive disease|1|||
147255974|NCT01909479|531109388|FG001|52 Weeks to End of Study|Progressive disease|1|||
147255975|NCT01909479|531109387|FG000|52 Weeks to End of Study|Personal reasons|2|||
147255976|NCT01909479|531109388|FG001|52 Weeks to End of Study|Personal reasons|1|||
147255977|NCT01909479|531109387|FG000|52 Weeks to End of Study|Sponsor's decision|1|||
147255978|NCT01909479|531109388|FG001|52 Weeks to End of Study|Sponsor's decision|1|||
147255979|NCT01909479|531109387|FG000|52 Weeks to End of Study|Study termination by sponsor|0|||
147255980|NCT01909479|531109388|FG001|52 Weeks to End of Study|Study termination by sponsor|1|||
147255981|NCT01909479|531109387|FG000|52 Weeks to End of Study|Lack of contact|1|||
147255982|NCT01909479|531109388|FG001|52 Weeks to End of Study|Lack of contact|0|||
147255983|NCT01909479|531109387|FG000|52 Weeks to End of Study|Occurrence of malignancy|1|||
147255984|NCT01909479|531109388|FG001|52 Weeks to End of Study|Occurrence of malignancy|0|||
147255985|NCT01909479|531109387|FG000|52 Weeks to End of Study|Diabetes not controlled|0|||
147255986|NCT01909479|531109388|FG001|52 Weeks to End of Study|Diabetes not controlled|1|||
147255987|NCT00383149|531109392|FG000|Overall Study|Adverse Event not Related to Study Drug|3|||
147255988|NCT00383149|531109392|FG000|Overall Study|Death|2|||
147255989|NCT00383149|531109392|FG000|Overall Study|Disease Progression|38|||
147255990|NCT00383149|531109392|FG000|Overall Study|Lost to Follow-up|1|||
147255991|NCT00383149|531109392|FG000|Overall Study|Other|1|||
147255992|NCT00383149|531109392|FG000|Overall Study|Study Drug Toxicity|4|||
147255993|NCT00383149|531109392|FG000|Overall Study|Request to Discontinue Treatment|4|||
147255994|NCT00383149|531109392|FG000|Overall Study|Participant Withdrew Consent|1|||
147255995|NCT03721276|531109393|FG000|Overall Study|Lost to Follow-up|5|||
147255996|NCT03721276|531109394|FG001|Overall Study|Lost to Follow-up|3|||
147255997|NCT03721276|531109393|FG000|Overall Study|Adverse Event|0|||
147255998|NCT03721276|531109394|FG001|Overall Study|Adverse Event|1|||
147255999|NCT01340898|531109397|FG000|Primary Phase|Serious Adverse Events|0|||
147256000|NCT01340898|531109398|FG001|Primary Phase|Serious Adverse Events|0|||
147256001|NCT01340898|531109399|FG002|Primary Phase|Serious Adverse Events|1|||
147256002|NCT01340898|531109397|FG000|Primary Phase|Withdrawal by Subject|8|||
147256003|NCT01340898|531109398|FG001|Primary Phase|Withdrawal by Subject|7|||
147256004|NCT01340898|531109399|FG002|Primary Phase|Withdrawal by Subject|5|||
147256005|NCT01340898|531109397|FG000|Primary Phase|Migrated/moved from study area|4|||
147256006|NCT01340898|531109398|FG001|Primary Phase|Migrated/moved from study area|1|||
147256007|NCT01340898|531109399|FG002|Primary Phase|Migrated/moved from study area|0|||
147256008|NCT01340898|531109397|FG000|Primary Phase|Lost to Follow-up|4|||
147256009|NCT01340898|531109398|FG001|Primary Phase|Lost to Follow-up|1|||
147256010|NCT01340898|531109399|FG002|Primary Phase|Lost to Follow-up|0|||
147256011|NCT01340898|531109397|FG000|Booster Phase|Withdrawal by Subject|3|||
147256012|NCT01340898|531109398|FG001|Booster Phase|Withdrawal by Subject|0|||
147256013|NCT01340898|531109399|FG002|Booster Phase|Withdrawal by Subject|4|||
147256014|NCT01340898|531109397|FG000|Booster Phase|Migrated/moved from study area|3|||
147256015|NCT01340898|531109398|FG001|Booster Phase|Migrated/moved from study area|0|||
147256016|NCT01340898|531109399|FG002|Booster Phase|Migrated/moved from study area|0|||
147256017|NCT01340898|531109397|FG000|Booster Phase|Lost to Follow-up|4|||
147256018|NCT01340898|531109398|FG001|Booster Phase|Lost to Follow-up|2|||
147256019|NCT01340898|531109399|FG002|Booster Phase|Lost to Follow-up|3|||
147256020|NCT01214629|531109401|FG000|Overall Study|Progressive Disease|1|||
147256021|NCT01214629|531109402|FG001|Overall Study|Progressive Disease|1|||
147598866|NCT03819049|532349940|FG005|Overall Study|Ongoing|0|||
147598867|NCT03819049|532349941|FG006|Overall Study|Ongoing|0|||
147256022|NCT01214629|531109403|FG002|Overall Study|Progressive Disease|0|||
147256023|NCT01214629|531109404|FG003|Overall Study|Progressive Disease|1|||
147256024|NCT01214629|531109405|FG004|Overall Study|Progressive Disease|2|||
147256025|NCT01214629|531109406|FG005|Overall Study|Progressive Disease|3|||
147256026|NCT01214629|531109407|FG006|Overall Study|Progressive Disease|1|||
147256027|NCT01214629|531109408|FG007|Overall Study|Progressive Disease|1|||
147256028|NCT01214629|531109409|FG008|Overall Study|Progressive Disease|1|||
147598868|NCT03819049|532349935|FG000|Overall Study|Other|0|||
147598869|NCT03819049|532349936|FG001|Overall Study|Other|0|||
147256029|NCT01214629|531109410|FG009|Overall Study|Progressive Disease|5|||
147256030|NCT01214629|531109411|FG010|Overall Study|Progressive Disease|1|||
147256031|NCT01214629|531109401|FG000|Overall Study|Adverse Event|0|||
147256032|NCT01214629|531109402|FG001|Overall Study|Adverse Event|0|||
147256033|NCT01214629|531109403|FG002|Overall Study|Adverse Event|0|||
147256034|NCT01214629|531109404|FG003|Overall Study|Adverse Event|1|||
147256035|NCT01214629|531109405|FG004|Overall Study|Adverse Event|0|||
147256036|NCT01214629|531109406|FG005|Overall Study|Adverse Event|1|||
147256037|NCT01214629|531109407|FG006|Overall Study|Adverse Event|0|||
147256038|NCT01214629|531109408|FG007|Overall Study|Adverse Event|0|||
147256039|NCT01214629|531109409|FG008|Overall Study|Adverse Event|0|||
147256040|NCT01214629|531109410|FG009|Overall Study|Adverse Event|1|||
147256041|NCT01214629|531109411|FG010|Overall Study|Adverse Event|0|||
147256042|NCT01214629|531109401|FG000|Overall Study|Physician Decision|0|||
147256043|NCT01214629|531109402|FG001|Overall Study|Physician Decision|0|||
147256044|NCT01214629|531109403|FG002|Overall Study|Physician Decision|0|||
147256045|NCT01214629|531109404|FG003|Overall Study|Physician Decision|0|||
147256046|NCT01214629|531109405|FG004|Overall Study|Physician Decision|0|||
147256047|NCT01214629|531109406|FG005|Overall Study|Physician Decision|0|||
147256048|NCT01214629|531109407|FG006|Overall Study|Physician Decision|0|||
147256049|NCT01214629|531109408|FG007|Overall Study|Physician Decision|0|||
147256050|NCT01214629|531109409|FG008|Overall Study|Physician Decision|0|||
147256051|NCT01214629|531109410|FG009|Overall Study|Physician Decision|0|||
147256052|NCT01214629|531109411|FG010|Overall Study|Physician Decision|1|||
147256053|NCT01214629|531109401|FG000|Overall Study|Withdrawal by Subject|0|||
147256054|NCT01214629|531109402|FG001|Overall Study|Withdrawal by Subject|0|||
147256055|NCT01214629|531109403|FG002|Overall Study|Withdrawal by Subject|0|||
147256056|NCT01214629|531109404|FG003|Overall Study|Withdrawal by Subject|0|||
147256057|NCT01214629|531109405|FG004|Overall Study|Withdrawal by Subject|0|||
147256058|NCT01214629|531109406|FG005|Overall Study|Withdrawal by Subject|0|||
147256059|NCT01214629|531109407|FG006|Overall Study|Withdrawal by Subject|0|||
147256060|NCT01214629|531109408|FG007|Overall Study|Withdrawal by Subject|0|||
147256061|NCT01214629|531109409|FG008|Overall Study|Withdrawal by Subject|0|||
147256062|NCT01214629|531109410|FG009|Overall Study|Withdrawal by Subject|1|||
147256063|NCT01214629|531109411|FG010|Overall Study|Withdrawal by Subject|0|||
147256064|NCT00416078|531109417|FG000|Overall Study|Death|3|||
147256065|NCT00416078|531109418|FG001|Overall Study|Death|4|||
147256066|NCT00416078|531109417|FG000|Overall Study|Withdrawal by Subject|3|||
147256067|NCT00416078|531109418|FG001|Overall Study|Withdrawal by Subject|2|||
147256068|NCT00416078|531109417|FG000|Overall Study|Physician Decision|1|||
147256069|NCT00416078|531109418|FG001|Overall Study|Physician Decision|0|||
147256070|NCT00416078|531109417|FG000|Overall Study|Lost to Follow-up|4|||
147256071|NCT00416078|531109418|FG001|Overall Study|Lost to Follow-up|2|||
147256072|NCT01829230|531109420|FG000|Overall Study|Protocol Violation|0|||
147256073|NCT01829230|531109421|FG001|Overall Study|Protocol Violation|2|||
147598870|NCT03819049|532349937|FG002|Overall Study|Other|2|||
147598871|NCT03819049|532349938|FG003|Overall Study|Other|0|||
147598872|NCT03819049|532349939|FG004|Overall Study|Other|0|||
147598873|NCT03819049|532349940|FG005|Overall Study|Other|0|||
147256074|NCT01829230|531109420|FG000|Overall Study|Withdrawal by Subject|0|||
147256075|NCT01829230|531109421|FG001|Overall Study|Withdrawal by Subject|1|||
147256076|NCT01829230|531109420|FG000|Overall Study|Lost to Follow-up|1|||
147256077|NCT01829230|531109421|FG001|Overall Study|Lost to Follow-up|1|||
147256078|NCT00461682|531109422|FG000|Overall Study|Protocol Violation|1|||
147256079|NCT04128267|531109429|FG000|Overall Study|Withdrawal by Subject|6|||
147256080|NCT04128267|531109429|FG000|Overall Study|Death|2|||
147256081|NCT04128267|531109429|FG000|Overall Study|Disease progression|1|||
147256082|NCT04128267|531109429|FG000|Overall Study|Participant had other medical issues|4|||
147256083|NCT04128267|531109429|FG000|Overall Study|Participant failed to respond to multiple attempts to contact|2|||
147256084|NCT04501666|531109430|FG000|Overall Study|Physician Decision|0|||
147256085|NCT04501666|531109431|FG001|Overall Study|Physician Decision|1|||
147256086|NCT04501666|531109430|FG000|Overall Study|Adverse Event|12|||
147256087|NCT04501666|531109431|FG001|Overall Study|Adverse Event|4|||
147256088|NCT04501666|531109430|FG000|Overall Study|Subject's request|10|||
147256089|NCT04501666|531109431|FG001|Overall Study|Subject's request|6|||
147256090|NCT04501666|531109430|FG000|Overall Study|Protocol Deviation|2|||
147256091|NCT04501666|531109431|FG001|Overall Study|Protocol Deviation|1|||
147256092|NCT04501666|531109430|FG000|Overall Study|Other-- site permanently closing|0|||
147256093|NCT04501666|531109431|FG001|Overall Study|Other-- site permanently closing|1|||
147256094|NCT00553150|531109432|FG000|Overall Study|Withdrawal by Subject|0|||
147598874|NCT03819049|532349941|FG006|Overall Study|Other|0|||
147256095|NCT00553150|531109433|FG001|Overall Study|Withdrawal by Subject|0|||
147256096|NCT00553150|531109434|FG002|Overall Study|Withdrawal by Subject|0|||
147256097|NCT00553150|531109435|FG003|Overall Study|Withdrawal by Subject|2|||
147256098|NCT00553150|531109432|FG000|Overall Study|Protocol Violation|0|||
147256099|NCT00553150|531109433|FG001|Overall Study|Protocol Violation|0|||
147256100|NCT00553150|531109434|FG002|Overall Study|Protocol Violation|0|||
147256101|NCT00553150|531109435|FG003|Overall Study|Protocol Violation|1|||
147256102|NCT00553150|531109432|FG000|Overall Study|Ineligible|0|||
147256103|NCT00553150|531109433|FG001|Overall Study|Ineligible|0|||
147256104|NCT00553150|531109434|FG002|Overall Study|Ineligible|0|||
147256105|NCT00553150|531109435|FG003|Overall Study|Ineligible|1|||
147256106|NCT03204305|531109436|FG000|Overall Study|Lost to Follow-up|6|||
147256107|NCT03204305|531109437|FG001|Overall Study|Lost to Follow-up|4|||
147256108|NCT03204305|531109438|FG002|Overall Study|Lost to Follow-up|0|||
147256109|NCT03204305|531109439|FG003|Overall Study|Lost to Follow-up|0|||
147256110|NCT03204305|531109436|FG000|Overall Study|Physician Decision|1|||
147256111|NCT03204305|531109437|FG001|Overall Study|Physician Decision|0|||
147256112|NCT03204305|531109438|FG002|Overall Study|Physician Decision|0|||
147256113|NCT03204305|531109439|FG003|Overall Study|Physician Decision|0|||
147256114|NCT03204305|531109436|FG000|Overall Study|failure to place arterial line|2|||
147256115|NCT03204305|531109437|FG001|Overall Study|failure to place arterial line|1|||
147256116|NCT03204305|531109438|FG002|Overall Study|failure to place arterial line|0|||
147256117|NCT03204305|531109439|FG003|Overall Study|failure to place arterial line|0|||
147256118|NCT03204305|531109436|FG000|Overall Study|Withdrawal by Subject|2|||
147256119|NCT03204305|531109437|FG001|Overall Study|Withdrawal by Subject|0|||
147256120|NCT03204305|531109438|FG002|Overall Study|Withdrawal by Subject|0|||
147256121|NCT03204305|531109439|FG003|Overall Study|Withdrawal by Subject|0|||
147256122|NCT01165554|531109440|FG000|Overall Study|Withdrawal by Subject|23|||
147256123|NCT00535223|531109444|FG000|Overall Study|Withdrawal by Subject|4|||
147598875|NCT03819049|532349935|FG000|Overall Study|Randomized but not vaccinated|0|||
147598876|NCT03819049|532349936|FG001|Overall Study|Randomized but not vaccinated|0|||
147598877|NCT03819049|532349937|FG002|Overall Study|Randomized but not vaccinated|0|||
147598878|NCT03819049|532349938|FG003|Overall Study|Randomized but not vaccinated|1|||
147598879|NCT03819049|532349939|FG004|Overall Study|Randomized but not vaccinated|0|||
147598880|NCT03819049|532349940|FG005|Overall Study|Randomized but not vaccinated|2|||
147598881|NCT03819049|532349941|FG006|Overall Study|Randomized but not vaccinated|1|||
147598882|NCT03819049|532349935|FG000|Overall Study|Physician Decision|0|||
147598883|NCT03819049|532349936|FG001|Overall Study|Physician Decision|0|||
147598884|NCT03819049|532349937|FG002|Overall Study|Physician Decision|0|||
147598885|NCT03819049|532349938|FG003|Overall Study|Physician Decision|0|||
147598886|NCT03819049|532349939|FG004|Overall Study|Physician Decision|0|||
147598887|NCT03819049|532349940|FG005|Overall Study|Physician Decision|0|||
147598888|NCT03819049|532349941|FG006|Overall Study|Physician Decision|1|||
147598889|NCT01986010|532349942|FG000|Overall Study|Adverse Event|0|||
147598890|NCT01986010|532349943|FG001|Overall Study|Adverse Event|1|||
147598891|NCT01986010|532349944|FG002|Overall Study|Adverse Event|0|||
147598892|NCT01986010|532349945|FG003|Overall Study|Adverse Event|0|||
147598893|NCT01986010|532349946|FG004|Overall Study|Adverse Event|0|||
147598894|NCT01986010|532349947|FG005|Overall Study|Adverse Event|0|||
147598895|NCT01986010|532349948|FG006|Overall Study|Adverse Event|0|||
147598896|NCT01986010|532349949|FG007|Overall Study|Adverse Event|0|||
147598897|NCT01986010|532349950|FG008|Overall Study|Adverse Event|0|||
147598898|NCT01986010|532349951|FG009|Overall Study|Adverse Event|0|||
147598899|NCT01986010|532349952|FG010|Overall Study|Adverse Event|0|||
147598900|NCT01986010|532349953|FG011|Overall Study|Adverse Event|0|||
147598901|NCT01986010|532349954|FG012|Overall Study|Adverse Event|0|||
147598902|NCT01986010|532349955|FG013|Overall Study|Adverse Event|0|||
147598903|NCT01986010|532349956|FG014|Overall Study|Adverse Event|0|||
147598904|NCT01986010|532349957|FG015|Overall Study|Adverse Event|1|||
147598905|NCT01986010|532349958|FG016|Overall Study|Adverse Event|0|||
147598906|NCT01986010|532349942|FG000|Overall Study|Lost to Follow-up|2|||
147598907|NCT01986010|532349943|FG001|Overall Study|Lost to Follow-up|1|||
147598908|NCT01986010|532349944|FG002|Overall Study|Lost to Follow-up|2|||
147598909|NCT01986010|532349945|FG003|Overall Study|Lost to Follow-up|2|||
147598910|NCT01986010|532349946|FG004|Overall Study|Lost to Follow-up|2|||
147598911|NCT01986010|532349947|FG005|Overall Study|Lost to Follow-up|2|||
147598912|NCT01986010|532349948|FG006|Overall Study|Lost to Follow-up|0|||
147598913|NCT01986010|532349949|FG007|Overall Study|Lost to Follow-up|0|||
147598914|NCT01986010|532349950|FG008|Overall Study|Lost to Follow-up|4|||
147598915|NCT01986010|532349951|FG009|Overall Study|Lost to Follow-up|2|||
147598916|NCT01986010|532349952|FG010|Overall Study|Lost to Follow-up|0|||
147598917|NCT01986010|532349953|FG011|Overall Study|Lost to Follow-up|1|||
147256124|NCT00535223|531109445|FG001|Overall Study|Withdrawal by Subject|1|||
147256125|NCT02953314|531109446|FG000|Overall Study|Adverse Event|0|||
147256126|NCT02953314|531109447|FG001|Overall Study|Adverse Event|1|||
147256127|NCT02953314|531109446|FG000|Overall Study|Withdrawal of consent (not due to AE)|0|||
147598918|NCT01986010|532349954|FG012|Overall Study|Lost to Follow-up|1|||
147598919|NCT01986010|532349955|FG013|Overall Study|Lost to Follow-up|1|||
147598920|NCT01986010|532349956|FG014|Overall Study|Lost to Follow-up|2|||
147256128|NCT02953314|531109447|FG001|Overall Study|Withdrawal of consent (not due to AE)|2|||
147256129|NCT00101907|531109451|FG000|Overall Study|Adverse Event|1|||
147256130|NCT00101907|531109452|FG001|Overall Study|Adverse Event|0|||
147256131|NCT00101907|531109453|FG002|Overall Study|Adverse Event|0|||
147256132|NCT00101907|531109454|FG003|Overall Study|Adverse Event|0|||
147256133|NCT00101907|531109455|FG004|Overall Study|Adverse Event|0|||
147256134|NCT00101907|531109456|FG005|Overall Study|Adverse Event|0|||
147256135|NCT00101907|531109451|FG000|Overall Study|Death|0|||
147256136|NCT00101907|531109452|FG001|Overall Study|Death|1|||
147256137|NCT00101907|531109453|FG002|Overall Study|Death|0|||
147256138|NCT00101907|531109454|FG003|Overall Study|Death|0|||
147256139|NCT00101907|531109455|FG004|Overall Study|Death|3|||
147256140|NCT00101907|531109456|FG005|Overall Study|Death|0|||
147256141|NCT00101907|531109451|FG000|Overall Study|Physician Decision|0|||
147256142|NCT00101907|531109452|FG001|Overall Study|Physician Decision|0|||
147256143|NCT00101907|531109453|FG002|Overall Study|Physician Decision|0|||
147256144|NCT00101907|531109454|FG003|Overall Study|Physician Decision|1|||
147256145|NCT00101907|531109455|FG004|Overall Study|Physician Decision|1|||
147256146|NCT00101907|531109456|FG005|Overall Study|Physician Decision|0|||
147256147|NCT00101907|531109451|FG000|Overall Study|Withdrawal by Subject|1|||
147256148|NCT00101907|531109452|FG001|Overall Study|Withdrawal by Subject|0|||
147256149|NCT00101907|531109453|FG002|Overall Study|Withdrawal by Subject|1|||
147256150|NCT00101907|531109454|FG003|Overall Study|Withdrawal by Subject|0|||
147256151|NCT00101907|531109455|FG004|Overall Study|Withdrawal by Subject|1|||
147256152|NCT00101907|531109456|FG005|Overall Study|Withdrawal by Subject|0|||
147256153|NCT01765153|531109457|FG000|Training Phase 1|Format of intervention differed|1|||
147256154|NCT01765153|531109458|FG001|Training Phase 1|Format of intervention differed|0|||
147256155|NCT01765153|531109457|FG000|Training Phase 1|Poor participation in intervention|0|||
147256156|NCT01765153|531109458|FG001|Training Phase 1|Poor participation in intervention|1|||
147256157|NCT01765153|531109457|FG000|Rest Phase 1|Withdrawal by Subject|0|||
147256158|NCT01765153|531109458|FG001|Rest Phase 1|Withdrawal by Subject|1|||
147256159|NCT01765153|531109457|FG000|Training Phase 2|Withdrawal by Subject|0|||
147256160|NCT01765153|531109458|FG001|Training Phase 2|Withdrawal by Subject|1|||
147256161|NCT01765153|531109457|FG000|Rest Phase 2|Lost to Follow-up|2|||
147256162|NCT01765153|531109458|FG001|Rest Phase 2|Lost to Follow-up|1|||
147256163|NCT03915496|531109461|FG000|Overall Study|Adverse Event|2|||
147256164|NCT03915496|531109462|FG001|Overall Study|Adverse Event|1|||
147598921|NCT01986010|532349957|FG015|Overall Study|Lost to Follow-up|0|||
147598922|NCT01986010|532349958|FG016|Overall Study|Lost to Follow-up|0|||
147598923|NCT01986010|532349942|FG000|Overall Study|Physician Decision|0|||
147598924|NCT01986010|532349943|FG001|Overall Study|Physician Decision|0|||
147598925|NCT01986010|532349944|FG002|Overall Study|Physician Decision|0|||
147598926|NCT01986010|532349945|FG003|Overall Study|Physician Decision|0|||
147598927|NCT01986010|532349946|FG004|Overall Study|Physician Decision|0|||
147598928|NCT01986010|532349947|FG005|Overall Study|Physician Decision|0|||
147598929|NCT01986010|532349948|FG006|Overall Study|Physician Decision|0|||
147598930|NCT01986010|532349949|FG007|Overall Study|Physician Decision|0|||
147598931|NCT01986010|532349950|FG008|Overall Study|Physician Decision|0|||
147598932|NCT01986010|532349951|FG009|Overall Study|Physician Decision|0|||
147598933|NCT01986010|532349952|FG010|Overall Study|Physician Decision|0|||
147598934|NCT01986010|532349953|FG011|Overall Study|Physician Decision|0|||
147598935|NCT01986010|532349954|FG012|Overall Study|Physician Decision|0|||
147598936|NCT01986010|532349955|FG013|Overall Study|Physician Decision|0|||
147598937|NCT01986010|532349956|FG014|Overall Study|Physician Decision|1|||
147598938|NCT01986010|532349957|FG015|Overall Study|Physician Decision|0|||
147598939|NCT01986010|532349958|FG016|Overall Study|Physician Decision|0|||
147598940|NCT01986010|532349942|FG000|Overall Study|Withdrawal by Subject|2|||
147598941|NCT01986010|532349943|FG001|Overall Study|Withdrawal by Subject|2|||
147598942|NCT01986010|532349944|FG002|Overall Study|Withdrawal by Subject|3|||
147598943|NCT01986010|532349945|FG003|Overall Study|Withdrawal by Subject|0|||
147598944|NCT01986010|532349946|FG004|Overall Study|Withdrawal by Subject|2|||
147598945|NCT01986010|532349947|FG005|Overall Study|Withdrawal by Subject|4|||
147598946|NCT01986010|532349948|FG006|Overall Study|Withdrawal by Subject|0|||
147598947|NCT01986010|532349949|FG007|Overall Study|Withdrawal by Subject|0|||
147598948|NCT01986010|532349950|FG008|Overall Study|Withdrawal by Subject|0|||
147256165|NCT03915496|531109463|FG002|Overall Study|Adverse Event|2|||
147256166|NCT02663674|531109464|FG000|Overall Study|Lost to Follow-up|5|||
147256167|NCT02663674|531109465|FG001|Overall Study|Lost to Follow-up|4|||
147256168|NCT02663674|531109464|FG000|Overall Study|Withdrawal by Subject|1|||
147256169|NCT02663674|531109465|FG001|Overall Study|Withdrawal by Subject|4|||
147256170|NCT02663674|531109464|FG000|Overall Study|Physician Decision|1|||
147256171|NCT02663674|531109465|FG001|Overall Study|Physician Decision|1|||
147256172|NCT02663674|531109464|FG000|Overall Study|Other Event (Health Related)|0|||
147256173|NCT02663674|531109465|FG001|Overall Study|Other Event (Health Related)|1|||
147256174|NCT02472795|531109466|FG000|Overall Study|Adverse Event|0|||
147256175|NCT02472795|531109467|FG001|Overall Study|Adverse Event|1|||
147598949|NCT01986010|532349951|FG009|Overall Study|Withdrawal by Subject|0|||
147598950|NCT01986010|532349952|FG010|Overall Study|Withdrawal by Subject|0|||
147256176|NCT02472795|531109468|FG002|Overall Study|Adverse Event|0|||
147256177|NCT02472795|531109469|FG003|Overall Study|Adverse Event|0|||
147256178|NCT02472795|531109470|FG004|Overall Study|Adverse Event|2|||
147256179|NCT02472795|531109466|FG000|Overall Study|Withdrawal by Subject|0|||
147256180|NCT02472795|531109467|FG001|Overall Study|Withdrawal by Subject|0|||
147256181|NCT02472795|531109468|FG002|Overall Study|Withdrawal by Subject|0|||
147256182|NCT02472795|531109469|FG003|Overall Study|Withdrawal by Subject|0|||
147256183|NCT02472795|531109470|FG004|Overall Study|Withdrawal by Subject|1|||
147256184|NCT04166513|531109471|FG000|Behavioral Assessment 1|Withdrawal by Subject|0|||
147256185|NCT04166513|531109472|FG001|Behavioral Assessment 1|Withdrawal by Subject|1|||
147256186|NCT04166513|531109473|FG002|Behavioral Assessment 1|Withdrawal by Subject|0|||
147256187|NCT04166513|531109474|FG003|Behavioral Assessment 1|Withdrawal by Subject|0|||
147256188|NCT04166513|531109471|FG000|Behavioral Assessment 1|Investigator Withdrawn|0|||
147256189|NCT04166513|531109472|FG001|Behavioral Assessment 1|Investigator Withdrawn|0|||
147256190|NCT04166513|531109473|FG002|Behavioral Assessment 1|Investigator Withdrawn|0|||
147256191|NCT04166513|531109474|FG003|Behavioral Assessment 1|Investigator Withdrawn|1|||
147256192|NCT04166513|531109471|FG000|Therapy Cycle B|Withdrawal by Subject|0|||
147256193|NCT04166513|531109472|FG001|Therapy Cycle B|Withdrawal by Subject|1|||
147256194|NCT04166513|531109473|FG002|Therapy Cycle B|Withdrawal by Subject|0|||
147256195|NCT04166513|531109474|FG003|Therapy Cycle B|Withdrawal by Subject|0|||
147256196|NCT04166513|531109471|FG000|Behavioral Assessment 4|Lost to Follow-up|1|||
147256197|NCT04166513|531109472|FG001|Behavioral Assessment 4|Lost to Follow-up|0|||
147450004|NCT01709149|531811340|FG002|Open-label Lead-in Phase|Death|0|||
147450005|NCT01709149|531811338|FG000|Open-label Lead-in Phase|Protocol Violation|3|||
147256198|NCT04166513|531109473|FG002|Behavioral Assessment 4|Lost to Follow-up|1|||
147256199|NCT04166513|531109474|FG003|Behavioral Assessment 4|Lost to Follow-up|1|||
147256200|NCT04166513|531109471|FG000|Behavioral Assessment 4|Withdrawal by Subject|2|||
147256201|NCT04166513|531109472|FG001|Behavioral Assessment 4|Withdrawal by Subject|2|||
147256202|NCT04166513|531109473|FG002|Behavioral Assessment 4|Withdrawal by Subject|1|||
147256203|NCT04166513|531109474|FG003|Behavioral Assessment 4|Withdrawal by Subject|0|||
147256204|NCT04219891|531109477|FG000|Overall Study|Lost to Follow-up|3|||
147450006|NCT01709149|531811339|FG001|Open-label Lead-in Phase|Protocol Violation|0|||
147598951|NCT01986010|532349953|FG011|Overall Study|Withdrawal by Subject|2|||
147598952|NCT01986010|532349954|FG012|Overall Study|Withdrawal by Subject|0|||
147598953|NCT01986010|532349955|FG013|Overall Study|Withdrawal by Subject|1|||
147598954|NCT01986010|532349956|FG014|Overall Study|Withdrawal by Subject|2|||
147598955|NCT01986010|532349957|FG015|Overall Study|Withdrawal by Subject|0|||
147598956|NCT01986010|532349958|FG016|Overall Study|Withdrawal by Subject|0|||
147598957|NCT01986010|532349942|FG000|Overall Study|Status Not Recorded|2|||
147598958|NCT01986010|532349943|FG001|Overall Study|Status Not Recorded|4|||
147598959|NCT01986010|532349944|FG002|Overall Study|Status Not Recorded|2|||
147598960|NCT01986010|532349945|FG003|Overall Study|Status Not Recorded|0|||
147598961|NCT01986010|532349946|FG004|Overall Study|Status Not Recorded|1|||
147598962|NCT01986010|532349947|FG005|Overall Study|Status Not Recorded|2|||
147598963|NCT01986010|532349948|FG006|Overall Study|Status Not Recorded|0|||
147598964|NCT01986010|532349949|FG007|Overall Study|Status Not Recorded|0|||
147598965|NCT01986010|532349950|FG008|Overall Study|Status Not Recorded|2|||
147598966|NCT01986010|532349951|FG009|Overall Study|Status Not Recorded|1|||
147598967|NCT01986010|532349952|FG010|Overall Study|Status Not Recorded|7|||
147598968|NCT01986010|532349953|FG011|Overall Study|Status Not Recorded|7|||
147598969|NCT01986010|532349954|FG012|Overall Study|Status Not Recorded|9|||
147598970|NCT01986010|532349955|FG013|Overall Study|Status Not Recorded|9|||
147598971|NCT01986010|532349956|FG014|Overall Study|Status Not Recorded|5|||
147598972|NCT01986010|532349957|FG015|Overall Study|Status Not Recorded|10|||
147598973|NCT01986010|532349958|FG016|Overall Study|Status Not Recorded|4|||
147598974|NCT01335997|532349961|FG000|Period I and II|Adverse Event|63|||
147598975|NCT01335997|532349962|FG001|Period I and II|Adverse Event|43|||
147598976|NCT01335997|532349961|FG000|Period I and II|Noncompliance with Study Drug|1|||
147598977|NCT01335997|532349962|FG001|Period I and II|Noncompliance with Study Drug|1|||
147598978|NCT01335997|532349961|FG000|Period I and II|Lost to Follow-up|3|||
147598979|NCT01335997|532349962|FG001|Period I and II|Lost to Follow-up|5|||
147598980|NCT01335997|532349961|FG000|Period I and II|Withdrawal by Subject|9|||
147598981|NCT01335997|532349962|FG001|Period I and II|Withdrawal by Subject|4|||
147598982|NCT01335997|532349961|FG000|Period I and II|Study Terminated by Sponsor|406|||
147598983|NCT01335997|532349962|FG001|Period I and II|Study Terminated by Sponsor|415|||
147598984|NCT01335997|532349961|FG000|Period I and II|Protocol Violation|9|||
147661422|NCT00509899|532583030|FG004|Overall Study|Withdrawal by Subject|3|||
147256205|NCT04219891|531109477|FG000|Overall Study|Withdrawal by Subject|2|||
147256206|NCT00597012|531109478|FG000|Overall Study|Death|1|||
147256207|NCT00597012|531109479|FG001|Overall Study|Death|1|||
147256208|NCT00597012|531109478|FG000|Overall Study|Underwent Total Knee Replacement (TKR)|3|||
147256209|NCT00597012|531109479|FG001|Overall Study|Underwent Total Knee Replacement (TKR)|1|||
147256210|NCT00597012|531109478|FG000|Overall Study|Withdrawal by Subject|7|||
147256211|NCT00597012|531109479|FG001|Overall Study|Withdrawal by Subject|4|||
147256212|NCT00597012|531109478|FG000|Overall Study|Ineligible|2|||
147256213|NCT00597012|531109479|FG001|Overall Study|Ineligible|0|||
147661423|NCT00509899|532583031|FG005|Overall Study|Withdrawal by Subject|2|||
147661424|NCT00509899|532583032|FG006|Overall Study|Withdrawal by Subject|0|||
147661425|NCT00509899|532583033|FG007|Overall Study|Withdrawal by Subject|0|||
147661426|NCT00509899|532583026|FG000|Overall Study|Physician Decision|4|||
147661427|NCT00509899|532583027|FG001|Overall Study|Physician Decision|2|||
147661428|NCT00509899|532583028|FG002|Overall Study|Physician Decision|7|||
147661429|NCT00509899|532583029|FG003|Overall Study|Physician Decision|0|||
147661430|NCT00509899|532583030|FG004|Overall Study|Physician Decision|1|||
147661431|NCT00509899|532583031|FG005|Overall Study|Physician Decision|4|||
147661432|NCT00509899|532583032|FG006|Overall Study|Physician Decision|0|||
147661433|NCT00509899|532583033|FG007|Overall Study|Physician Decision|0|||
147661434|NCT00509899|532583026|FG000|Overall Study|Intercurrent Illness|1|||
147661435|NCT00509899|532583027|FG001|Overall Study|Intercurrent Illness|0|||
147661436|NCT00509899|532583028|FG002|Overall Study|Intercurrent Illness|0|||
147661437|NCT00509899|532583029|FG003|Overall Study|Intercurrent Illness|1|||
147661438|NCT00509899|532583030|FG004|Overall Study|Intercurrent Illness|0|||
147661439|NCT00509899|532583031|FG005|Overall Study|Intercurrent Illness|1|||
147661440|NCT00509899|532583032|FG006|Overall Study|Intercurrent Illness|0|||
147661441|NCT00509899|532583033|FG007|Overall Study|Intercurrent Illness|0|||
147661442|NCT00509899|532583026|FG000|Overall Study|Death|2|||
147661443|NCT00509899|532583027|FG001|Overall Study|Death|2|||
147661444|NCT00509899|532583028|FG002|Overall Study|Death|3|||
147661445|NCT00509899|532583029|FG003|Overall Study|Death|0|||
147332706|NCT01405924|531385523|FG000|Overall Study|Protocol Violation|8|||
147661446|NCT00509899|532583030|FG004|Overall Study|Death|1|||
147661447|NCT00509899|532583031|FG005|Overall Study|Death|1|||
147661448|NCT00509899|532583032|FG006|Overall Study|Death|1|||
147661449|NCT00509899|532583033|FG007|Overall Study|Death|1|||
147661450|NCT00509899|532583026|FG000|Overall Study|Lack of Efficacy|1|||
147661451|NCT00509899|532583027|FG001|Overall Study|Lack of Efficacy|0|||
147661452|NCT00509899|532583028|FG002|Overall Study|Lack of Efficacy|2|||
147661453|NCT00509899|532583029|FG003|Overall Study|Lack of Efficacy|0|||
147661454|NCT00509899|532583030|FG004|Overall Study|Lack of Efficacy|0|||
147661455|NCT00509899|532583031|FG005|Overall Study|Lack of Efficacy|1|||
147661456|NCT00509899|532583032|FG006|Overall Study|Lack of Efficacy|0|||
147661457|NCT00509899|532583033|FG007|Overall Study|Lack of Efficacy|0|||
147661458|NCT01711983|532583038|FG000|6-Month Clinical Success Evaluation|Missed Echocardiograph|32|||
147661459|NCT01711983|532583038|FG000|6-Month Closure Evaluation|Technical Failure (No Test Device)|26|||
147661460|NCT01711983|532583038|FG000|36-Month Closure Evaluation|Test Device Removal|2|||
147256214|NCT00597012|531109478|FG000|Overall Study|Lost to Follow-up|0|||
147256215|NCT00597012|531109479|FG001|Overall Study|Lost to Follow-up|2|||
147256216|NCT00670800|531110761|FG000|Overall Study|2 controls were insulin resistant|0|||
147256217|NCT00670800|531110762|FG001|Overall Study|2 controls were insulin resistant|2|||
147256218|NCT03712904|531110764|FG000|Overall Study|Death|0|||
147256219|NCT03712904|531110765|FG001|Overall Study|Death|1|||
147256220|NCT03712904|531110764|FG000|Overall Study|Withdrawal by Subject|0|||
147256221|NCT03712904|531110765|FG001|Overall Study|Withdrawal by Subject|1|||
147256222|NCT03712904|531110764|FG000|Overall Study|progression/eye removed before 2 years (unable to complete testing)|1|||
147256223|NCT03712904|531110765|FG001|Overall Study|progression/eye removed before 2 years (unable to complete testing)|0|||
147256224|NCT01852942|531110766|FG000|Overall Study|Physician Decision|1|||
147256225|NCT01852942|531110767|FG001|Overall Study|Physician Decision|0|||
147256226|NCT01852942|531110766|FG000|Overall Study|Death|1|||
147256227|NCT01852942|531110767|FG001|Overall Study|Death|1|||
147256228|NCT01852942|531110766|FG000|Overall Study|Withdrawal by Subject|2|||
147256229|NCT01852942|531110767|FG001|Overall Study|Withdrawal by Subject|3|||
147256230|NCT01852942|531110766|FG000|Overall Study|Lost to Follow-up|1|||
147256231|NCT01852942|531110767|FG001|Overall Study|Lost to Follow-up|2|||
147256232|NCT04568590|531110768|FG000|Overall Study|Subjects were not Vaccine-hesitant|437|||
147256233|NCT04708886|531110772|FG000|Year 2: Alendronate|Withdrawal by Subject|1|||
147256234|NCT04708886|531110772|FG000|Year 2: Alendronate|Lost to Follow-up|1|||
147256235|NCT01372501|531110778|FG000|Overall Study|Adverse Event|4|||
147256236|NCT01372501|531110778|FG000|Overall Study|Device migration|1|||
147256237|NCT05333900|531110779|FG000|Overall Study|Protocol Violation|0|||
147256238|NCT05333900|531110780|FG001|Overall Study|Protocol Violation|1|||
147256239|NCT05333900|531110779|FG000|Overall Study|Withdrawal by Subject|0|||
147256240|NCT05333900|531110780|FG001|Overall Study|Withdrawal by Subject|1|||
147661461|NCT01711983|532583038|FG000|36-Month Closure Evaluation|Missed Echocardiograph|62|||
147661462|NCT00737100|532583039|FG000|Overall Study|Adverse Event|6|||
147661463|NCT00737100|532583040|FG001|Overall Study|Adverse Event|5|||
147661464|NCT00737100|532583041|FG002|Overall Study|Adverse Event|3|||
147661465|NCT00737100|532583039|FG000|Overall Study|Lost to Follow-up|0|||
147661466|NCT00737100|532583040|FG001|Overall Study|Lost to Follow-up|1|||
147661467|NCT00737100|532583041|FG002|Overall Study|Lost to Follow-up|0|||
147256241|NCT05333900|531110779|FG000|Overall Study|COVID-19 Pandemic|1|||
147256242|NCT05333900|531110780|FG001|Overall Study|COVID-19 Pandemic|1|||
147661468|NCT00737100|532583039|FG000|Overall Study|Withdrawal by Subject|0|||
147661469|NCT00737100|532583040|FG001|Overall Study|Withdrawal by Subject|0|||
147661470|NCT00737100|532583041|FG002|Overall Study|Withdrawal by Subject|3|||
147661471|NCT00737100|532583039|FG000|Overall Study|Reason discontinued not explained above|1|||
147661472|NCT00737100|532583040|FG001|Overall Study|Reason discontinued not explained above|1|||
147661473|NCT00737100|532583041|FG002|Overall Study|Reason discontinued not explained above|1|||
147661474|NCT03713684|532583044|FG000|Overall Study|Adverse Event|1|||
147661475|NCT03713684|532583045|FG001|Overall Study|Adverse Event|3|||
147661476|NCT03713684|532583046|FG002|Overall Study|Adverse Event|1|||
147661477|NCT03713684|532583047|FG003|Overall Study|Adverse Event|0|||
147661478|NCT03713684|532583044|FG000|Overall Study|Poor compliance to protocol|2|||
147661479|NCT03713684|532583045|FG001|Overall Study|Poor compliance to protocol|1|||
147661480|NCT03713684|532583046|FG002|Overall Study|Poor compliance to protocol|0|||
147661481|NCT03713684|532583047|FG003|Overall Study|Poor compliance to protocol|1|||
147661482|NCT03713684|532583044|FG000|Overall Study|Withdrawal by Subject|14|||
147661483|NCT03713684|532583045|FG001|Overall Study|Withdrawal by Subject|6|||
147661484|NCT03713684|532583046|FG002|Overall Study|Withdrawal by Subject|14|||
147661485|NCT03713684|532583047|FG003|Overall Study|Withdrawal by Subject|16|||
147661486|NCT03713684|532583044|FG000|Overall Study|Other than specified|69|||
147661487|NCT03713684|532583045|FG001|Overall Study|Other than specified|77|||
147661488|NCT03713684|532583046|FG002|Overall Study|Other than specified|73|||
147661489|NCT03713684|532583047|FG003|Overall Study|Other than specified|70|||
147661490|NCT00528424|532583048|FG000|Overall Study|Lost to Follow-up|13|||
147661491|NCT00528424|532583048|FG000|Overall Study|Withdrew consent|2|||
147661492|NCT00528424|532583048|FG000|Overall Study|Administrative reason|2|||
147661493|NCT00528424|532583048|FG000|Overall Study|Other|12|||
147661494|NCT02595502|532583049|FG000|Period 1|Adverse Event|0|||
147661495|NCT02595502|532583050|FG001|Period 1|Adverse Event|1|||
147661496|NCT02595502|532583049|FG000|Period 1|Withdrawal by Subject|1|||
147661497|NCT02595502|532583050|FG001|Period 1|Withdrawal by Subject|0|||
147661498|NCT02595502|532583049|FG000|Period 1|Lost to Follow-up|0|||
147661499|NCT02595502|532583050|FG001|Period 1|Lost to Follow-up|1|||
147661500|NCT02595502|532583049|FG000|Period 2|Adverse Event|1|||
147661501|NCT02595502|532583050|FG001|Period 2|Adverse Event|1|||
147256243|NCT01277523|531110783|FG000|Overall Study|Adverse Event|1|||
147256244|NCT01277523|531110784|FG001|Overall Study|Adverse Event|0|||
147256245|NCT01277523|531110785|FG002|Overall Study|Adverse Event|0|||
147256246|NCT01277523|531110783|FG000|Overall Study|Protocol Violation|2|||
147256247|NCT01277523|531110784|FG001|Overall Study|Protocol Violation|0|||
147256248|NCT01277523|531110785|FG002|Overall Study|Protocol Violation|0|||
147256249|NCT01277523|531110783|FG000|Overall Study|Other Reason not Defined|0|||
147661502|NCT02595502|532583049|FG000|Period 2|Received incorrect lens at Period 1|0|||
147256250|NCT01277523|531110784|FG001|Overall Study|Other Reason not Defined|1|||
147256251|NCT01277523|531110785|FG002|Overall Study|Other Reason not Defined|0|||
147256252|NCT03724812|531110786|FG000|Overall Study|Missed Visit|1|||
147256253|NCT03724812|531110786|FG000|Overall Study|Death|2|||
147256254|NCT03724812|531110786|FG000|Overall Study|Withdrawal by Subject|1|||
147256255|NCT01851720|531110787|FG000|Overall Study|Lost to Follow-up|0|||
147256256|NCT01851720|531110788|FG001|Overall Study|Lost to Follow-up|1|||
147256257|NCT02389998|531110791|FG000|Overall Study|car accident|1|||
147256258|NCT02389998|531110792|FG001|Overall Study|car accident|0|||
147256259|NCT03525574|531110793|FG000|Overall Study|Adverse Event|15|||
147256260|NCT03525574|531110794|FG001|Overall Study|Adverse Event|0|||
147256261|NCT03525574|531110793|FG000|Overall Study|Withdrawal of consent (not due to AE)|18|||
147256262|NCT03525574|531110794|FG001|Overall Study|Withdrawal of consent (not due to AE)|0|||
147256263|NCT03525574|531110793|FG000|Overall Study|Lost to Follow-up|4|||
147256264|NCT03525574|531110794|FG001|Overall Study|Lost to Follow-up|0|||
147256265|NCT03525574|531110793|FG000|Overall Study|Commercial drug is Available for participant|48|||
147256266|NCT03525574|531110794|FG001|Overall Study|Commercial drug is Available for participant|0|||
147256267|NCT03525574|531110793|FG000|Overall Study|Death|1|||
147256268|NCT03525574|531110794|FG001|Overall Study|Death|0|||
147256269|NCT03525574|531110793|FG000|Overall Study|Other non-compliance|2|||
147256270|NCT03525574|531110794|FG001|Overall Study|Other non-compliance|0|||
147256271|NCT03525574|531110793|FG000|Overall Study|Physician Decision|6|||
147256272|NCT03525574|531110794|FG001|Overall Study|Physician Decision|0|||
147256273|NCT03525574|531110793|FG000|Overall Study|Other|58|||
147256274|NCT03525574|531110794|FG001|Overall Study|Other|0|||
147256275|NCT03525574|531110793|FG000|Overall Study|Enrolled but never dosed|1|||
147256276|NCT03525574|531110794|FG001|Overall Study|Enrolled but never dosed|0|||
147256277|NCT03525574|531110793|FG000|Overall Study|Not enrolled in 105 study|0|||
147256278|NCT03525574|531110794|FG001|Overall Study|Not enrolled in 105 study|3|||
147256279|NCT01770379|531110797|FG000|Overall Study|Technical issues|1|||
147256280|NCT01770379|531110798|FG001|Overall Study|Technical issues|0|||
147256281|NCT01770379|531110799|FG002|Overall Study|Technical issues|0|||
147256282|NCT01770379|531110797|FG000|Overall Study|Withdrawal by Subject|7|||
147256283|NCT01770379|531110798|FG001|Overall Study|Withdrawal by Subject|10|||
147256284|NCT01770379|531110799|FG002|Overall Study|Withdrawal by Subject|7|||
147661503|NCT02595502|532583050|FG001|Period 2|Received incorrect lens at Period 1|1|||
147661504|NCT02595502|532583049|FG000|Period 3|Protocol Violation|0|||
147661505|NCT02595502|532583050|FG001|Period 3|Protocol Violation|1|||
147661506|NCT02595502|532583049|FG000|Period 3|Lost to Follow-up|1|||
147661507|NCT02595502|532583050|FG001|Period 3|Lost to Follow-up|0|||
147661508|NCT02595502|532583049|FG000|Period 3|Received Incorrect Treatment at period 3|0|||
147661509|NCT02595502|532583050|FG001|Period 3|Received Incorrect Treatment at period 3|1|||
147661510|NCT03286218|532583051|FG000|Qualification Phase Period 1|Adverse Event|1|||
147661511|NCT03286218|532583052|FG001|Qualification Phase Period 1|Adverse Event|0|||
147661512|NCT03286218|532583053|FG002|Qualification Phase Period 1|Adverse Event|0|||
147661513|NCT03286218|532583054|FG003|Qualification Phase Period 1|Adverse Event|0|||
147661514|NCT03286218|532583055|FG004|Qualification Phase Period 1|Adverse Event|0|||
147661515|NCT03286218|532583056|FG005|Qualification Phase Period 1|Adverse Event|0|||
147256285|NCT01770379|531110797|FG000|Overall Study|study terminated by sponsor|22|||
147256286|NCT01770379|531110798|FG001|Overall Study|study terminated by sponsor|23|||
147256287|NCT01770379|531110799|FG002|Overall Study|study terminated by sponsor|22|||
147256288|NCT01770379|531110797|FG000|Overall Study|Protocol Violation|0|||
147256289|NCT01770379|531110798|FG001|Overall Study|Protocol Violation|1|||
147256290|NCT01770379|531110799|FG002|Overall Study|Protocol Violation|1|||
147256291|NCT01770379|531110797|FG000|Overall Study|Physician Decision|0|||
147256292|NCT01770379|531110798|FG001|Overall Study|Physician Decision|1|||
147256293|NCT01770379|531110799|FG002|Overall Study|Physician Decision|2|||
147256294|NCT01770379|531110797|FG000|Overall Study|Lost to Follow-up|0|||
147598985|NCT01335997|532349962|FG001|Period I and II|Protocol Violation|10|||
147598986|NCT01335997|532349961|FG000|Period I and II|Physician Decision|2|||
147598987|NCT01335997|532349962|FG001|Period I and II|Physician Decision|1|||
147598988|NCT01335997|532349961|FG000|Period III|Adverse Event|0|||
147598989|NCT01335997|532349962|FG001|Period III|Adverse Event|2|||
147256295|NCT01770379|531110798|FG001|Overall Study|Lost to Follow-up|0|||
147256296|NCT01770379|531110799|FG002|Overall Study|Lost to Follow-up|2|||
147256297|NCT01770379|531110797|FG000|Overall Study|Lack of Efficacy|8|||
147256298|NCT01770379|531110798|FG001|Overall Study|Lack of Efficacy|6|||
147256299|NCT01770379|531110799|FG002|Overall Study|Lack of Efficacy|6|||
147256300|NCT01770379|531110797|FG000|Overall Study|Adverse Event|1|||
147256301|NCT01770379|531110798|FG001|Overall Study|Adverse Event|3|||
147256302|NCT01770379|531110799|FG002|Overall Study|Adverse Event|2|||
147256303|NCT01074450|531110808|FG000|First Intervention|Emesis in Dosing Interval|0|||
147256304|NCT01074450|531110809|FG001|First Intervention|Emesis in Dosing Interval|2|||
147256305|NCT01074450|531110808|FG000|Second Intervention|Protocol Violation|1|||
147256306|NCT01074450|531110809|FG001|Second Intervention|Protocol Violation|0|||
147256307|NCT01074450|531110808|FG000|Second Intervention|Physician Decision|0|||
147598990|NCT01335997|532349961|FG000|Period III|Study Terminated by Sponsor|77|||
147256308|NCT01074450|531110809|FG001|Second Intervention|Physician Decision|1|||
147256309|NCT02728895|531110810|FG000|Overall Study|Other|1|||
147256310|NCT02728895|531110811|FG001|Overall Study|Other|2|||
147256311|NCT02728895|531110810|FG000|Overall Study|Withdrawal by Subject|0|||
147598991|NCT01335997|532349962|FG001|Period III|Study Terminated by Sponsor|76|||
147598992|NCT01335997|532349961|FG000|Period III|Protocol Violation|0|||
147598993|NCT01335997|532349962|FG001|Period III|Protocol Violation|1|||
147256312|NCT02728895|531110811|FG001|Overall Study|Withdrawal by Subject|3|||
147256313|NCT02769247|531110812|FG000|Overall Study|Withdrawal by Subject|1|||
147256314|NCT02769247|531110813|FG001|Overall Study|Withdrawal by Subject|0|||
147256315|NCT02769247|531110814|FG002|Overall Study|Withdrawal by Subject|0|||
147256316|NCT02769247|531110815|FG003|Overall Study|Withdrawal by Subject|1|||
147256317|NCT02769247|531110812|FG000|Overall Study|Protocol Violation|0|||
147256318|NCT02769247|531110813|FG001|Overall Study|Protocol Violation|0|||
147256319|NCT02769247|531110814|FG002|Overall Study|Protocol Violation|1|||
147256320|NCT02769247|531110815|FG003|Overall Study|Protocol Violation|0|||
147256321|NCT02769247|531110812|FG000|Overall Study|Physician Decision|1|||
147256322|NCT02769247|531110813|FG001|Overall Study|Physician Decision|0|||
147256323|NCT02769247|531110814|FG002|Overall Study|Physician Decision|0|||
147256324|NCT02769247|531110815|FG003|Overall Study|Physician Decision|0|||
147256325|NCT02150954|531110819|FG000|Overall Study|Protocol Violation|1|||
147256326|NCT02150954|531110820|FG001|Overall Study|Protocol Violation|0|||
147256327|NCT01086540|531110830|FG000|Overall Study|Death|3|||
147256328|NCT01086540|531110831|FG001|Overall Study|Death|1|||
147256329|NCT01086540|531110830|FG000|Overall Study|Physician Decision|2|||
147598994|NCT01335997|532349961|FG000|Period III|Lost to Follow-up|1|||
147598995|NCT01335997|532349962|FG001|Period III|Lost to Follow-up|0|||
147598996|NCT00536263|532349963|FG000|Overall Study|Adverse Event|5|||
147661516|NCT03286218|532583057|FG006|Qualification Phase Period 1|Adverse Event|0|||
147256330|NCT01086540|531110831|FG001|Overall Study|Physician Decision|1|||
147661517|NCT03286218|532583058|FG007|Qualification Phase Period 1|Adverse Event|0|||
147661518|NCT03286218|532583059|FG008|Qualification Phase Period 1|Adverse Event|0|||
147661519|NCT03286218|532583060|FG009|Qualification Phase Period 1|Adverse Event|0|||
147661520|NCT03286218|532583061|FG010|Qualification Phase Period 1|Adverse Event|0|||
147661521|NCT03286218|532583062|FG011|Qualification Phase Period 1|Adverse Event|0|||
147256331|NCT01086540|531110830|FG000|Overall Study|Addition of new therapy for PAH|1|||
147598997|NCT00536263|532349964|FG001|Overall Study|Adverse Event|5|||
147661522|NCT03286218|532583051|FG000|Qualification Phase Period 1|Withdrawal by Subject|0|||
147256332|NCT01086540|531110831|FG001|Overall Study|Addition of new therapy for PAH|0|||
147256333|NCT03164928|531110832|FG000|Overall Study|Lost to Follow-up|1|||
147256334|NCT03164928|531110833|FG001|Overall Study|Lost to Follow-up|0|||
147256335|NCT01998737|531110834|FG000|Overall Study|Corrupted database|23|||
147256336|NCT01998737|531110835|FG001|Overall Study|Corrupted database|0|||
147256337|NCT00326950|531110837|FG000|Overall Study|Progressive Disease|1|||
147256338|NCT05407675|531110846|FG000|Overall Study|Withdrawal by Subject|0|||
147256339|NCT05407675|531110847|FG001|Overall Study|Withdrawal by Subject|2|||
147256340|NCT05407675|531110848|FG002|Overall Study|Withdrawal by Subject|3|||
147256341|NCT05407675|531110849|FG003|Overall Study|Withdrawal by Subject|5|||
147256342|NCT05407675|531110850|FG004|Overall Study|Withdrawal by Subject|0|||
147256343|NCT05407675|531110851|FG005|Overall Study|Withdrawal by Subject|2|||
147256344|NCT05407675|531110852|FG006|Overall Study|Withdrawal by Subject|0|||
147256345|NCT05407675|531110853|FG007|Overall Study|Withdrawal by Subject|0|||
147256346|NCT05407675|531110854|FG008|Overall Study|Withdrawal by Subject|2|||
147256347|NCT05407675|531110855|FG009|Overall Study|Withdrawal by Subject|0|||
147256348|NCT05407675|531110856|FG010|Overall Study|Withdrawal by Subject|1|||
147256349|NCT05407675|531110857|FG011|Overall Study|Withdrawal by Subject|0|||
147256350|NCT05407675|531110858|FG012|Overall Study|Withdrawal by Subject|0|||
147256351|NCT05407675|531110846|FG000|Overall Study|Site terminated by sponsor|0|||
147256352|NCT05407675|531110847|FG001|Overall Study|Site terminated by sponsor|0|||
147256353|NCT05407675|531110848|FG002|Overall Study|Site terminated by sponsor|1|||
147256354|NCT05407675|531110849|FG003|Overall Study|Site terminated by sponsor|0|||
147256355|NCT05407675|531110850|FG004|Overall Study|Site terminated by sponsor|2|||
147256356|NCT05407675|531110851|FG005|Overall Study|Site terminated by sponsor|0|||
147256357|NCT05407675|531110852|FG006|Overall Study|Site terminated by sponsor|1|||
147256358|NCT05407675|531110853|FG007|Overall Study|Site terminated by sponsor|0|||
147256359|NCT05407675|531110854|FG008|Overall Study|Site terminated by sponsor|0|||
147256360|NCT05407675|531110855|FG009|Overall Study|Site terminated by sponsor|2|||
147256361|NCT05407675|531110856|FG010|Overall Study|Site terminated by sponsor|2|||
147256362|NCT05407675|531110857|FG011|Overall Study|Site terminated by sponsor|2|||
147256363|NCT05407675|531110858|FG012|Overall Study|Site terminated by sponsor|1|||
147256364|NCT05407675|531110846|FG000|Overall Study|Disease Progression|0|||
147256365|NCT05407675|531110847|FG001|Overall Study|Disease Progression|0|||
147256366|NCT05407675|531110848|FG002|Overall Study|Disease Progression|0|||
147256367|NCT05407675|531110849|FG003|Overall Study|Disease Progression|0|||
147256368|NCT05407675|531110850|FG004|Overall Study|Disease Progression|0|||
147256369|NCT05407675|531110851|FG005|Overall Study|Disease Progression|0|||
147256370|NCT05407675|531110852|FG006|Overall Study|Disease Progression|0|||
147256371|NCT05407675|531110853|FG007|Overall Study|Disease Progression|0|||
147256372|NCT05407675|531110854|FG008|Overall Study|Disease Progression|0|||
147256373|NCT05407675|531110855|FG009|Overall Study|Disease Progression|0|||
147256374|NCT05407675|531110856|FG010|Overall Study|Disease Progression|1|||
147256375|NCT05407675|531110857|FG011|Overall Study|Disease Progression|0|||
147256376|NCT05407675|531110858|FG012|Overall Study|Disease Progression|0|||
147256377|NCT05407675|531110846|FG000|Overall Study|Physician Decision|0|||
147256378|NCT05407675|531110847|FG001|Overall Study|Physician Decision|0|||
147256379|NCT05407675|531110848|FG002|Overall Study|Physician Decision|0|||
147450007|NCT01709149|531811340|FG002|Open-label Lead-in Phase|Protocol Violation|0|||
147598998|NCT00536263|532349965|FG002|Overall Study|Adverse Event|7|||
147598999|NCT00536263|532349963|FG000|Overall Study|Lost to Follow-up|3|||
147599000|NCT00536263|532349964|FG001|Overall Study|Lost to Follow-up|4|||
147599001|NCT00536263|532349965|FG002|Overall Study|Lost to Follow-up|4|||
147599002|NCT00536263|532349963|FG000|Overall Study|Subject withdrew - not treatment related|2|||
147599003|NCT00536263|532349964|FG001|Overall Study|Subject withdrew - not treatment related|0|||
147599004|NCT00536263|532349965|FG002|Overall Study|Subject withdrew - not treatment related|5|||
147599005|NCT00536263|532349963|FG000|Overall Study|Subject withdrew - treatment related|0|||
147599006|NCT00536263|532349964|FG001|Overall Study|Subject withdrew - treatment related|3|||
147599007|NCT00536263|532349965|FG002|Overall Study|Subject withdrew - treatment related|2|||
147599008|NCT00536263|532349963|FG000|Overall Study|Noncompliance with protocol|0|||
147599009|NCT00536263|532349964|FG001|Overall Study|Noncompliance with protocol|0|||
147599010|NCT00536263|532349965|FG002|Overall Study|Noncompliance with protocol|1|||
147599011|NCT00536263|532349963|FG000|Overall Study|Did not meet protocol eligibility|1|||
147599012|NCT00536263|532349964|FG001|Overall Study|Did not meet protocol eligibility|2|||
147599013|NCT00536263|532349965|FG002|Overall Study|Did not meet protocol eligibility|2|||
147599014|NCT00826449|532349966|FG000|Overall Study|Disease Progression|4|||
147599015|NCT00826449|532349966|FG000|Overall Study|Withdrawal by Subject|1|||
147256380|NCT05407675|531110849|FG003|Overall Study|Physician Decision|0|||
147256381|NCT05407675|531110850|FG004|Overall Study|Physician Decision|0|||
147256382|NCT05407675|531110851|FG005|Overall Study|Physician Decision|0|||
147256383|NCT05407675|531110852|FG006|Overall Study|Physician Decision|0|||
147256384|NCT05407675|531110853|FG007|Overall Study|Physician Decision|0|||
147256385|NCT05407675|531110854|FG008|Overall Study|Physician Decision|0|||
147256386|NCT05407675|531110855|FG009|Overall Study|Physician Decision|0|||
147256387|NCT05407675|531110856|FG010|Overall Study|Physician Decision|1|||
147256388|NCT05407675|531110857|FG011|Overall Study|Physician Decision|0|||
147256389|NCT05407675|531110858|FG012|Overall Study|Physician Decision|0|||
147256390|NCT05407675|531110846|FG000|Overall Study|Other reasons|0|||
147256391|NCT05407675|531110847|FG001|Overall Study|Other reasons|0|||
147256392|NCT05407675|531110848|FG002|Overall Study|Other reasons|0|||
147256393|NCT05407675|531110849|FG003|Overall Study|Other reasons|0|||
147256394|NCT05407675|531110850|FG004|Overall Study|Other reasons|0|||
147256395|NCT05407675|531110851|FG005|Overall Study|Other reasons|0|||
147256396|NCT05407675|531110852|FG006|Overall Study|Other reasons|0|||
147256397|NCT05407675|531110853|FG007|Overall Study|Other reasons|0|||
147256398|NCT05407675|531110854|FG008|Overall Study|Other reasons|1|||
147256399|NCT05407675|531110855|FG009|Overall Study|Other reasons|1|||
147256400|NCT05407675|531110856|FG010|Overall Study|Other reasons|1|||
147256401|NCT05407675|531110857|FG011|Overall Study|Other reasons|1|||
147256402|NCT05407675|531110858|FG012|Overall Study|Other reasons|0|||
147256403|NCT05407675|531110846|FG000|Overall Study|Death|3|||
147256404|NCT05407675|531110847|FG001|Overall Study|Death|4|||
147256405|NCT05407675|531110848|FG002|Overall Study|Death|3|||
147256406|NCT05407675|531110849|FG003|Overall Study|Death|6|||
147256407|NCT05407675|531110850|FG004|Overall Study|Death|0|||
147256408|NCT05407675|531110851|FG005|Overall Study|Death|2|||
147256409|NCT05407675|531110852|FG006|Overall Study|Death|4|||
147256410|NCT05407675|531110853|FG007|Overall Study|Death|2|||
147256411|NCT05407675|531110854|FG008|Overall Study|Death|2|||
147256412|NCT05407675|531110855|FG009|Overall Study|Death|4|||
147256413|NCT05407675|531110856|FG010|Overall Study|Death|2|||
147256414|NCT05407675|531110857|FG011|Overall Study|Death|1|||
147256415|NCT05407675|531110858|FG012|Overall Study|Death|0|||
147256416|NCT05407675|531110846|FG000|Overall Study|Adverse Event|0|||
147256417|NCT05407675|531110847|FG001|Overall Study|Adverse Event|0|||
147256418|NCT05407675|531110848|FG002|Overall Study|Adverse Event|0|||
147256419|NCT05407675|531110849|FG003|Overall Study|Adverse Event|0|||
147256420|NCT05407675|531110850|FG004|Overall Study|Adverse Event|1|||
147256421|NCT05407675|531110851|FG005|Overall Study|Adverse Event|0|||
147256422|NCT05407675|531110852|FG006|Overall Study|Adverse Event|0|||
147256423|NCT05407675|531110853|FG007|Overall Study|Adverse Event|0|||
147256424|NCT05407675|531110854|FG008|Overall Study|Adverse Event|0|||
147256425|NCT05407675|531110855|FG009|Overall Study|Adverse Event|0|||
147256426|NCT05407675|531110856|FG010|Overall Study|Adverse Event|0|||
147256427|NCT05407675|531110857|FG011|Overall Study|Adverse Event|1|||
147256428|NCT05407675|531110858|FG012|Overall Study|Adverse Event|0|||
147256429|NCT05407675|531110846|FG000|Overall Study|Ongoing Treatment|0|||
147256430|NCT05407675|531110847|FG001|Overall Study|Ongoing Treatment|0|||
147256431|NCT05407675|531110848|FG002|Overall Study|Ongoing Treatment|0|||
147256432|NCT05407675|531110849|FG003|Overall Study|Ongoing Treatment|0|||
147256433|NCT05407675|531110850|FG004|Overall Study|Ongoing Treatment|0|||
147256434|NCT05407675|531110851|FG005|Overall Study|Ongoing Treatment|0|||
147256435|NCT05407675|531110852|FG006|Overall Study|Ongoing Treatment|0|||
147256436|NCT05407675|531110853|FG007|Overall Study|Ongoing Treatment|0|||
147599016|NCT01103466|532349967|FG000|First Period (14 +/- 3 Days)|Protocol Violation|2|||
147599017|NCT01103466|532349968|FG001|First Period (14 +/- 3 Days)|Protocol Violation|0|||
147599018|NCT01103466|532349969|FG002|First Period (14 +/- 3 Days)|Protocol Violation|0|||
147256437|NCT05407675|531110854|FG008|Overall Study|Ongoing Treatment|1|||
147256438|NCT05407675|531110855|FG009|Overall Study|Ongoing Treatment|0|||
147256439|NCT05407675|531110856|FG010|Overall Study|Ongoing Treatment|0|||
147256440|NCT05407675|531110857|FG011|Overall Study|Ongoing Treatment|0|||
147256441|NCT05407675|531110858|FG012|Overall Study|Ongoing Treatment|0|||
147256442|NCT00742001|531110859|FG000|Overall Study|Withdrawn; health exclusion (flu)|0|||
147256443|NCT00742001|531110860|FG001|Overall Study|Withdrawn; health exclusion (flu)|0|||
147256444|NCT00742001|531110861|FG002|Overall Study|Withdrawn; health exclusion (flu)|1|||
147256445|NCT00137423|531110862|FG000|Overall Study|Adverse Event|7|||
147256446|NCT00137423|531110863|FG001|Overall Study|Adverse Event|9|||
147256447|NCT00137423|531110862|FG000|Overall Study|consent withdrawn|1|||
147256448|NCT00137423|531110863|FG001|Overall Study|consent withdrawn|1|||
147256449|NCT00137423|531110862|FG000|Overall Study|Lack of Efficacy|31|||
147256450|NCT00137423|531110863|FG001|Overall Study|Lack of Efficacy|33|||
147256451|NCT00137423|531110862|FG000|Overall Study|Death|0|||
147256452|NCT00137423|531110863|FG001|Overall Study|Death|1|||
147256453|NCT04105998|531110865|FG000|Second Study Day|Altered frequency and times of measurements on both study days|2|||
147256454|NCT04105998|531110866|FG001|Second Study Day|Altered frequency and times of measurements on both study days|0|||
147256455|NCT01050257|531110867|FG000|Overall Study|Adverse Event|4|||
147256456|NCT01050257|531110868|FG001|Overall Study|Adverse Event|4|||
147256457|NCT01050257|531110869|FG002|Overall Study|Adverse Event|2|||
147256458|NCT01050257|531110867|FG000|Overall Study|Admin/Other (did not switch to oral)|6|||
147256459|NCT01050257|531110868|FG001|Overall Study|Admin/Other (did not switch to oral)|2|||
147256460|NCT01050257|531110869|FG002|Overall Study|Admin/Other (did not switch to oral)|2|||
147256461|NCT01050257|531110867|FG000|Overall Study|Withdrawal by Subject|0|||
147256462|NCT01050257|531110868|FG001|Overall Study|Withdrawal by Subject|3|||
147256463|NCT01050257|531110869|FG002|Overall Study|Withdrawal by Subject|0|||
147256464|NCT01050257|531110867|FG000|Overall Study|No reason specified|0|||
147256465|NCT01050257|531110868|FG001|Overall Study|No reason specified|0|||
147256466|NCT01050257|531110869|FG002|Overall Study|No reason specified|2|||
147256467|NCT01050257|531110867|FG000|Overall Study|Refused treatment/ Did not Cooperate|1|||
147256468|NCT01050257|531110868|FG001|Overall Study|Refused treatment/ Did not Cooperate|1|||
147256469|NCT01050257|531110869|FG002|Overall Study|Refused treatment/ Did not Cooperate|0|||
147256470|NCT01050257|531110867|FG000|Overall Study|Violation criteria|0|||
147256471|NCT01050257|531110868|FG001|Overall Study|Violation criteria|1|||
147256472|NCT01050257|531110869|FG002|Overall Study|Violation criteria|0|||
147256473|NCT01050257|531110867|FG000|Overall Study|Failure to return|0|||
147256474|NCT01050257|531110868|FG001|Overall Study|Failure to return|2|||
147256475|NCT01050257|531110869|FG002|Overall Study|Failure to return|0|||
147256476|NCT01050257|531110867|FG000|Overall Study|Death|0|||
147256477|NCT01050257|531110868|FG001|Overall Study|Death|0|||
147256478|NCT01050257|531110869|FG002|Overall Study|Death|1|||
147256479|NCT00171223|531110870|FG000|Overall Study|Adverse Event (Non-fatal)|6|||
147256480|NCT00171223|531110871|FG001|Overall Study|Adverse Event (Non-fatal)|5|||
147256481|NCT00171223|531110872|FG002|Overall Study|Adverse Event (Non-fatal)|19|||
147256482|NCT00171223|531110870|FG000|Overall Study|Abnormal Laboratory Value (s)|4|||
147256483|NCT00171223|531110871|FG001|Overall Study|Abnormal Laboratory Value (s)|2|||
147256484|NCT00171223|531110872|FG002|Overall Study|Abnormal Laboratory Value (s)|3|||
147256485|NCT00171223|531110870|FG000|Overall Study|Abnormal Procedure|1|||
147256486|NCT00171223|531110871|FG001|Overall Study|Abnormal Procedure|0|||
147256487|NCT00171223|531110872|FG002|Overall Study|Abnormal Procedure|0|||
147256488|NCT00171223|531110870|FG000|Overall Study|Unsatisfactory Therapeutic Effect|57|||
147256489|NCT00171223|531110871|FG001|Overall Study|Unsatisfactory Therapeutic Effect|43|||
147256490|NCT00171223|531110872|FG002|Overall Study|Unsatisfactory Therapeutic Effect|52|||
147256491|NCT00171223|531110870|FG000|Overall Study|No Longer Requires Study Drug (Bone Marrow Transplant)|2|||
147256492|NCT00171223|531110871|FG001|Overall Study|No Longer Requires Study Drug (Bone Marrow Transplant)|4|||
147256493|NCT00171223|531110872|FG002|Overall Study|No Longer Requires Study Drug (Bone Marrow Transplant)|2|||
147256494|NCT00171223|531110870|FG000|Overall Study|Protocol Violation|2|||
147256495|NCT00171223|531110871|FG001|Overall Study|Protocol Violation|2|||
147256496|NCT00171223|531110872|FG002|Overall Study|Protocol Violation|3|||
147256497|NCT00171223|531110870|FG000|Overall Study|Participant Withdrew Consent|12|||
147256498|NCT00171223|531110871|FG001|Overall Study|Participant Withdrew Consent|21|||
147256499|NCT00171223|531110872|FG002|Overall Study|Participant Withdrew Consent|15|||
147256500|NCT00171223|531110870|FG000|Overall Study|Lost to Follow-up|5|||
147256501|NCT00171223|531110871|FG001|Overall Study|Lost to Follow-up|2|||
147256502|NCT00171223|531110872|FG002|Overall Study|Lost to Follow-up|3|||
147256503|NCT00171223|531110870|FG000|Overall Study|Administrative Problems|4|||
147256504|NCT00171223|531110871|FG001|Overall Study|Administrative Problems|7|||
147256505|NCT00171223|531110872|FG002|Overall Study|Administrative Problems|6|||
147256506|NCT00171223|531110870|FG000|Overall Study|Adverse Event (Serious Fatal)|6|||
147256507|NCT00171223|531110871|FG001|Overall Study|Adverse Event (Serious Fatal)|8|||
147256508|NCT00171223|531110872|FG002|Overall Study|Adverse Event (Serious Fatal)|9|||
147256509|NCT00171223|531110870|FG000|Overall Study|Not Specified (No Data Collected After Cut-off)|41|||
147256510|NCT00171223|531110871|FG001|Overall Study|Not Specified (No Data Collected After Cut-off)|47|||
147256511|NCT00171223|531110872|FG002|Overall Study|Not Specified (No Data Collected After Cut-off)|58|||
147256512|NCT02604212|531110874|FG000|Overall Study|Study Terminated by Sponsor|2|||
147256513|NCT02604212|531110875|FG001|Overall Study|Study Terminated by Sponsor|1|||
147256514|NCT02604212|531110876|FG002|Overall Study|Study Terminated by Sponsor|3|||
147256515|NCT02604212|531110877|FG003|Overall Study|Study Terminated by Sponsor|3|||
147256516|NCT02604212|531110874|FG000|Overall Study|Withdrawal by Subject|0|||
147256517|NCT02604212|531110875|FG001|Overall Study|Withdrawal by Subject|0|||
147256518|NCT02604212|531110876|FG002|Overall Study|Withdrawal by Subject|1|||
147256519|NCT02604212|531110877|FG003|Overall Study|Withdrawal by Subject|0|||
147256520|NCT00278109|531110878|FG000|Overall Study|Adverse Event|3|||
147256521|NCT00278109|531110878|FG000|Overall Study|social circumstances|1|||
147256522|NCT02580357|531110879|FG000|Overall Study|Lost to Follow-up|2|||
147256523|NCT02580357|531110880|FG001|Overall Study|Lost to Follow-up|0|||
147256524|NCT02580357|531110881|FG002|Overall Study|Lost to Follow-up|0|||
147256525|NCT02580357|531110879|FG000|Overall Study|Protocol Violation|1|||
147256526|NCT02580357|531110880|FG001|Overall Study|Protocol Violation|0|||
147332707|NCT01405924|531385523|FG000|Overall Study|Missing/Incomplete Data|2|||
147599019|NCT01103466|532349967|FG000|Second Period (14 +/- 3 Days)|Adverse Event|2|||
147256527|NCT02580357|531110881|FG002|Overall Study|Protocol Violation|0|||
147256528|NCT00453544|531110892|FG000|Overall Study|Withdrawal by Subject|1|||
147256529|NCT00453544|531110893|FG001|Overall Study|Withdrawal by Subject|0|||
147256530|NCT00453544|531110894|FG002|Overall Study|Withdrawal by Subject|0|||
147256531|NCT00453544|531110895|FG003|Overall Study|Withdrawal by Subject|0|||
147256532|NCT00453544|531110892|FG000|Overall Study|Primary outcome measure not completed|1|||
147256533|NCT00453544|531110893|FG001|Overall Study|Primary outcome measure not completed|1|||
147256534|NCT00453544|531110894|FG002|Overall Study|Primary outcome measure not completed|0|||
147256535|NCT00453544|531110895|FG003|Overall Study|Primary outcome measure not completed|1|||
147256536|NCT00450333|531110898|FG000|Overall Study|Study terminated|47|||
147256537|NCT00450333|531110899|FG001|Overall Study|Study terminated|54|||
147256538|NCT00450333|531110900|FG002|Overall Study|Study terminated|16|||
147256539|NCT00450333|531110901|FG003|Overall Study|Study terminated|21|||
147256540|NCT00450333|531110898|FG000|Overall Study|Adverse Event|1|||
147256541|NCT00450333|531110899|FG001|Overall Study|Adverse Event|7|||
147256542|NCT00450333|531110900|FG002|Overall Study|Adverse Event|2|||
147256543|NCT00450333|531110901|FG003|Overall Study|Adverse Event|2|||
147256544|NCT00450333|531110898|FG000|Overall Study|Protocol Violation|1|||
147256545|NCT00450333|531110899|FG001|Overall Study|Protocol Violation|0|||
147256546|NCT00450333|531110900|FG002|Overall Study|Protocol Violation|1|||
147256547|NCT00450333|531110901|FG003|Overall Study|Protocol Violation|0|||
147256548|NCT00450333|531110898|FG000|Overall Study|Withdrawal by Subject|1|||
147256549|NCT00450333|531110899|FG001|Overall Study|Withdrawal by Subject|0|||
147256550|NCT00450333|531110900|FG002|Overall Study|Withdrawal by Subject|3|||
147256551|NCT00450333|531110901|FG003|Overall Study|Withdrawal by Subject|0|||
147256552|NCT00450333|531110898|FG000|Overall Study|Kidney transplant|1|||
147256553|NCT00450333|531110899|FG001|Overall Study|Kidney transplant|0|||
147256554|NCT00450333|531110900|FG002|Overall Study|Kidney transplant|1|||
147256555|NCT00450333|531110901|FG003|Overall Study|Kidney transplant|3|||
147256556|NCT00450333|531110898|FG000|Overall Study|Death|3|||
147256557|NCT00450333|531110899|FG001|Overall Study|Death|2|||
147256558|NCT00450333|531110900|FG002|Overall Study|Death|2|||
147256559|NCT00450333|531110901|FG003|Overall Study|Death|2|||
147256560|NCT00202644|531112036|FG000|Overall Study|Adverse Event|12|||
147256561|NCT00202644|531112037|FG001|Overall Study|Adverse Event|13|||
147256562|NCT00202644|531112036|FG000|Overall Study|Withdrawal by Subject|8|||
147256563|NCT00202644|531112037|FG001|Overall Study|Withdrawal by Subject|6|||
147256564|NCT00202644|531112036|FG000|Overall Study|Lack of Efficacy|6|||
147256565|NCT00202644|531112037|FG001|Overall Study|Lack of Efficacy|6|||
147256566|NCT00202644|531112036|FG000|Overall Study|Lost to Follow-up|0|||
147256567|NCT00202644|531112037|FG001|Overall Study|Lost to Follow-up|1|||
147256568|NCT00202644|531112036|FG000|Overall Study|Other|9|||
147256569|NCT00202644|531112037|FG001|Overall Study|Other|1|||
147256570|NCT02750592|531112038|FG000|Overall Study|Adverse Event|3|||
147256571|NCT02750592|531112038|FG000|Overall Study|Lack of Efficacy|2|||
147256572|NCT02981342|531112041|FG000|Overall Study|Adverse Event|0|||
147256573|NCT02981342|531112042|FG001|Overall Study|Adverse Event|0|||
147256574|NCT02981342|531112043|FG002|Overall Study|Adverse Event|0|||
147256575|NCT02981342|531112044|FG003|Overall Study|Adverse Event|1|||
147256576|NCT02981342|531112041|FG000|Overall Study|Death|0|||
147256577|NCT02981342|531112042|FG001|Overall Study|Death|9|||
147256578|NCT02981342|531112043|FG002|Overall Study|Death|9|||
147256579|NCT02981342|531112044|FG003|Overall Study|Death|4|||
147256580|NCT02981342|531112041|FG000|Overall Study|Withdrawal by Subject|0|||
147256581|NCT02981342|531112042|FG001|Overall Study|Withdrawal by Subject|0|||
147256582|NCT02981342|531112043|FG002|Overall Study|Withdrawal by Subject|3|||
147256583|NCT02981342|531112044|FG003|Overall Study|Withdrawal by Subject|1|||
147256584|NCT02981342|531112041|FG000|Overall Study|Study closed by sponsor|0|||
147256585|NCT02981342|531112042|FG001|Overall Study|Study closed by sponsor|0|||
147256586|NCT02981342|531112043|FG002|Overall Study|Study closed by sponsor|1|||
147256587|NCT02981342|531112044|FG003|Overall Study|Study closed by sponsor|1|||
147256588|NCT02981342|531112041|FG000|Overall Study|Randomized, Never Treated|0|||
147256589|NCT02981342|531112042|FG001|Overall Study|Randomized, Never Treated|1|||
147256590|NCT02981342|531112043|FG002|Overall Study|Randomized, Never Treated|0|||
147256591|NCT02981342|531112044|FG003|Overall Study|Randomized, Never Treated|7|||
147256592|NCT02981342|531112041|FG000|Overall Study|Lost to Follow-up|0|||
147256593|NCT02981342|531112042|FG001|Overall Study|Lost to Follow-up|1|||
147256594|NCT02981342|531112043|FG002|Overall Study|Lost to Follow-up|0|||
147256595|NCT02981342|531112044|FG003|Overall Study|Lost to Follow-up|0|||
147256596|NCT01132482|531112045|FG000|Overall Study|Adverse Event|1|||
147256597|NCT01132482|531112046|FG001|Overall Study|Adverse Event|0|||
147256598|NCT01394523|531112047|FG000|Overall Study|Unable to place block|1|||
147256599|NCT01394523|531112048|FG001|Overall Study|Unable to place block|0|||
147256600|NCT01394523|531112049|FG002|Overall Study|Unable to place block|0|||
147256601|NCT00469092|531112050|FG000|Overall Study|Adverse Event|5|||
147256602|NCT00469092|531112051|FG001|Overall Study|Adverse Event|4|||
147256603|NCT00469092|531112050|FG000|Overall Study|Lack of Efficacy|1|||
147256604|NCT00469092|531112051|FG001|Overall Study|Lack of Efficacy|0|||
147256605|NCT00469092|531112050|FG000|Overall Study|Lost to Follow-up|1|||
147256606|NCT00469092|531112051|FG001|Overall Study|Lost to Follow-up|2|||
147256607|NCT00469092|531112050|FG000|Overall Study|Protocol Violation|3|||
147256608|NCT00469092|531112051|FG001|Overall Study|Protocol Violation|3|||
147256609|NCT00469092|531112050|FG000|Overall Study|Withdrawal by Subject|4|||
147256610|NCT00469092|531112051|FG001|Overall Study|Withdrawal by Subject|4|||
147256611|NCT00469092|531112050|FG000|Overall Study|Withdrawal Criteria|3|||
147256612|NCT00469092|531112051|FG001|Overall Study|Withdrawal Criteria|4|||
147256613|NCT00469092|531112050|FG000|Overall Study|Incorrectly Randomised|4|||
147256614|NCT00469092|531112051|FG001|Overall Study|Incorrectly Randomised|3|||
147256615|NCT00469092|531112050|FG000|Overall Study|Contraindication metformin/glimepiride|1|||
147256616|NCT00469092|531112051|FG001|Overall Study|Contraindication metformin/glimepiride|0|||
147332708|NCT02506257|531385524|FG000|Overall Study|Adverse Event|0|||
147256617|NCT00469092|531112050|FG000|Overall Study|Use of lipid lowering drug|1|||
147256618|NCT00469092|531112051|FG001|Overall Study|Use of lipid lowering drug|0|||
147256619|NCT00469092|531112050|FG000|Overall Study|Hypoglycaemic Episodes|1|||
147256620|NCT00469092|531112051|FG001|Overall Study|Hypoglycaemic Episodes|1|||
147256621|NCT00469092|531112050|FG000|Overall Study|Abnormal lab value|1|||
147256622|NCT00469092|531112051|FG001|Overall Study|Abnormal lab value|0|||
147256623|NCT00469092|531112050|FG000|Overall Study|Use of Corticosteroid|1|||
147256624|NCT00469092|531112051|FG001|Overall Study|Use of Corticosteroid|0|||
147256625|NCT05811234|531112059|FG000|Overall Study|Loss of Effectiveness|2|||
147256626|NCT05811234|531112059|FG000|Overall Study|Adverse Event|4|||
147256627|NCT05811234|531112059|FG000|Overall Study|Pregnancy|1|||
147256628|NCT05811234|531112059|FG000|Overall Study|Disease progression|1|||
147256629|NCT05811234|531112059|FG000|Overall Study|Withdrawal by Subject|4|||
147256630|NCT05811234|531112059|FG000|Overall Study|Lost to Follow-up|13|||
147256631|NCT05811234|531112059|FG000|Overall Study|Personal reason, or the patient stops taking the study treatment|1|||
147256632|NCT04499781|531112060|FG000|Overall Study|Lost to Follow-up|2|||
147256633|NCT04499781|531112061|FG001|Overall Study|Lost to Follow-up|3|||
147256634|NCT04499781|531112060|FG000|Overall Study|Withdrawal by Subject|2|||
147256635|NCT04499781|531112061|FG001|Overall Study|Withdrawal by Subject|0|||
147256636|NCT01275833|531112062|FG000|Overall Study|Study terminated|1|||
147256637|NCT01275833|531112063|FG001|Overall Study|Study terminated|1|||
147256638|NCT00227305|531112064|FG000|Overall Study|Adverse Event|40|||
147256639|NCT00227305|531112064|FG000|Overall Study|Withdrawal by Subject|42|||
147256640|NCT00227305|531112064|FG000|Overall Study|Lost to Follow-up|33|||
147256641|NCT00227305|531112064|FG000|Overall Study|Study specific discontinuation|13|||
147256642|NCT00227305|531112064|FG000|Overall Study|MOVED OUT OF AREA|3|||
147256643|NCT00227305|531112064|FG000|Overall Study|Lack of Efficacy|7|||
147256644|NCT00227305|531112064|FG000|Overall Study|Physician Decision|3|||
147256645|NCT00227305|531112064|FG000|Overall Study|PERIOD SHORTENED FROM 6 wks to 4 wks|1|||
147256646|NCT00227305|531112064|FG000|Overall Study|LEAVING TOWN FOR 6 WEEKS|1|||
147256647|NCT00227305|531112064|FG000|Overall Study|NECESSITY OF USING ANTI DEPRESSANT|1|||
147256648|NCT02118012|531112065|FG000|Overall Study|Adverse Event|0|||
147256649|NCT02118012|531112066|FG001|Overall Study|Adverse Event|1|||
147256650|NCT02118012|531112065|FG000|Overall Study|Physician Decision|0|||
147256651|NCT02118012|531112066|FG001|Overall Study|Physician Decision|1|||
147256652|NCT04519645|531112070|FG000|Enrollment Period (Up to 36 Hours)|Adverse Event|1|||
147256653|NCT04519645|531112071|FG001|Enrollment Period (Up to 36 Hours)|Adverse Event|0|||
147256654|NCT04519645|531112072|FG002|Enrollment Period (Up to 36 Hours)|Adverse Event|0|||
147256655|NCT04519645|531112070|FG000|Enrollment Period (Up to 36 Hours)|Withdrawal by Parent/Guardian|1|||
147256656|NCT04519645|531112071|FG001|Enrollment Period (Up to 36 Hours)|Withdrawal by Parent/Guardian|0|||
147256657|NCT04519645|531112072|FG002|Enrollment Period (Up to 36 Hours)|Withdrawal by Parent/Guardian|0|||
147256658|NCT04519645|531112070|FG000|Enrollment Period (Up to 36 Hours)|Protocol Violation|1|||
147256659|NCT04519645|531112071|FG001|Enrollment Period (Up to 36 Hours)|Protocol Violation|0|||
147256660|NCT04519645|531112072|FG002|Enrollment Period (Up to 36 Hours)|Protocol Violation|0|||
147256661|NCT04519645|531112070|FG000|Treatment Period (Up to 96 Hours)|Consent withdrawn by parent/guardian,not due to AE|0|||
147256662|NCT04519645|531112071|FG001|Treatment Period (Up to 96 Hours)|Consent withdrawn by parent/guardian,not due to AE|1|||
147256663|NCT04519645|531112072|FG002|Treatment Period (Up to 96 Hours)|Consent withdrawn by parent/guardian,not due to AE|0|||
147256664|NCT03742037|531112080|FG000|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
147256665|NCT03742037|531112081|FG001|Treatment Period 1 (1st Dose - Month 6)|Death|1|||
147256666|NCT03742037|531112082|FG002|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
147256667|NCT03742037|531112083|FG003|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
147256668|NCT03742037|531112084|FG004|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
147256669|NCT03742037|531112085|FG005|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
147256670|NCT03742037|531112086|FG006|Treatment Period 1 (1st Dose - Month 6)|Death|0|||
147256671|NCT03742037|531112080|FG000|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|0|||
147256672|NCT03742037|531112081|FG001|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|1|||
147256673|NCT03742037|531112082|FG002|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|4|||
147256674|NCT03742037|531112083|FG003|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|0|||
147256675|NCT03742037|531112084|FG004|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|0|||
147256676|NCT03742037|531112085|FG005|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|3|||
147256677|NCT03742037|531112086|FG006|Treatment Period 1 (1st Dose - Month 6)|Adverse Event|2|||
147256678|NCT03742037|531112080|FG000|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|4|||
147256679|NCT03742037|531112081|FG001|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|1|||
147256680|NCT03742037|531112082|FG002|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|2|||
147256681|NCT03742037|531112083|FG003|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|0|||
147256682|NCT03742037|531112084|FG004|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|0|||
147256683|NCT03742037|531112085|FG005|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|2|||
147256684|NCT03742037|531112086|FG006|Treatment Period 1 (1st Dose - Month 6)|Withdrawal by Subject|4|||
147332709|NCT02506257|531385525|FG001|Overall Study|Adverse Event|2|||
147332710|NCT02506257|531385526|FG002|Overall Study|Adverse Event|3|||
147256685|NCT03742037|531112080|FG000|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|0|||
147256686|NCT03742037|531112081|FG001|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|1|||
147256687|NCT03742037|531112082|FG002|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|0|||
147256688|NCT03742037|531112083|FG003|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|0|||
147256689|NCT03742037|531112084|FG004|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|0|||
147256690|NCT03742037|531112085|FG005|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|1|||
147256691|NCT03742037|531112086|FG006|Treatment Period 1 (1st Dose - Month 6)|Lost to Follow-up|0|||
147256692|NCT03742037|531112080|FG000|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|1|||
147256693|NCT03742037|531112081|FG001|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|3|||
147256694|NCT03742037|531112082|FG002|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|7|||
147256695|NCT03742037|531112083|FG003|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|0|||
147256696|NCT03742037|531112084|FG004|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|0|||
147256697|NCT03742037|531112085|FG005|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|6|||
147256698|NCT03742037|531112086|FG006|Treatment Period 1 (1st Dose - Month 6)|pre-specified criteria|1|||
147256699|NCT03742037|531112080|FG000|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
147256700|NCT03742037|531112081|FG001|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
147256701|NCT03742037|531112082|FG002|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
147256702|NCT03742037|531112083|FG003|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
147256703|NCT03742037|531112084|FG004|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
147256704|NCT03742037|531112085|FG005|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|1|||
147256705|NCT03742037|531112086|FG006|Treatment Period 1 (1st Dose - Month 6)|Randomized but no study treatment taken|0|||
147256706|NCT03742037|531112080|FG000|Treatment Period 1 (1st Dose - Month 6)|Other reasons|2|||
147256707|NCT03742037|531112081|FG001|Treatment Period 1 (1st Dose - Month 6)|Other reasons|0|||
147256708|NCT03742037|531112082|FG002|Treatment Period 1 (1st Dose - Month 6)|Other reasons|2|||
147256709|NCT03742037|531112083|FG003|Treatment Period 1 (1st Dose - Month 6)|Other reasons|0|||
147256710|NCT03742037|531112084|FG004|Treatment Period 1 (1st Dose - Month 6)|Other reasons|0|||
147256711|NCT03742037|531112085|FG005|Treatment Period 1 (1st Dose - Month 6)|Other reasons|2|||
147256712|NCT03742037|531112086|FG006|Treatment Period 1 (1st Dose - Month 6)|Other reasons|1|||
147256713|NCT03742037|531112080|FG000|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
147256714|NCT03742037|531112081|FG001|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
147256715|NCT03742037|531112082|FG002|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
147256716|NCT03742037|531112083|FG003|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
147256717|NCT03742037|531112084|FG004|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
147256718|NCT03742037|531112085|FG005|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|0|||
147256719|NCT03742037|531112086|FG006|Treatment Period 1 (1st Dose - Month 6)|Lack of Efficacy|1|||
147256720|NCT03742037|531112080|FG000|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|1|||
147256721|NCT03742037|531112081|FG001|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|2|||
147256722|NCT03742037|531112082|FG002|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|3|||
147256723|NCT03742037|531112083|FG003|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|1|||
147256724|NCT03742037|531112084|FG004|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|0|||
147256725|NCT03742037|531112085|FG005|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|0|||
147256726|NCT03742037|531112086|FG006|Treatment Period 2 (Month 6 - Month 12)|Adverse Event|4|||
147256727|NCT03742037|531112080|FG000|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|0|||
147599020|NCT01103466|532349968|FG001|Second Period (14 +/- 3 Days)|Adverse Event|1|||
147599021|NCT01103466|532349969|FG002|Second Period (14 +/- 3 Days)|Adverse Event|0|||
147256728|NCT03742037|531112081|FG001|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|0|||
147256729|NCT03742037|531112082|FG002|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|2|||
147256730|NCT03742037|531112083|FG003|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|2|||
147256731|NCT03742037|531112084|FG004|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|0|||
147256732|NCT03742037|531112085|FG005|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|0|||
147256733|NCT03742037|531112086|FG006|Treatment Period 2 (Month 6 - Month 12)|Withdrawal by Subject|1|||
147256734|NCT03742037|531112080|FG000|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|0|||
147256735|NCT03742037|531112081|FG001|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|1|||
147256736|NCT03742037|531112082|FG002|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|2|||
147256737|NCT03742037|531112083|FG003|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|0|||
147256738|NCT03742037|531112084|FG004|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|0|||
147256739|NCT03742037|531112085|FG005|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|0|||
147256740|NCT03742037|531112086|FG006|Treatment Period 2 (Month 6 - Month 12)|Lost to Follow-up|0|||
147256741|NCT03742037|531112080|FG000|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|1|||
147599022|NCT01103466|532349967|FG000|Second Period (14 +/- 3 Days)|Lack of Efficacy|0|||
147599023|NCT01103466|532349968|FG001|Second Period (14 +/- 3 Days)|Lack of Efficacy|1|||
147599024|NCT01103466|532349969|FG002|Second Period (14 +/- 3 Days)|Lack of Efficacy|1|||
147599025|NCT01103466|532349967|FG000|Third Period (14 +/- 3 Days)|Adverse Event|1|||
147599026|NCT01103466|532349968|FG001|Third Period (14 +/- 3 Days)|Adverse Event|0|||
147256742|NCT03742037|531112081|FG001|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|0|||
147256743|NCT03742037|531112082|FG002|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|0|||
147256744|NCT03742037|531112083|FG003|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|0|||
147256745|NCT03742037|531112084|FG004|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|0|||
147256746|NCT03742037|531112085|FG005|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|0|||
147256747|NCT03742037|531112086|FG006|Treatment Period 2 (Month 6 - Month 12)|Lack of Efficacy|1|||
147256748|NCT03742037|531112080|FG000|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|0|||
147256749|NCT03742037|531112081|FG001|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|1|||
147256750|NCT03742037|531112082|FG002|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|3|||
147256751|NCT03742037|531112083|FG003|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|2|||
147256752|NCT03742037|531112084|FG004|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|0|||
147661523|NCT03286218|532583052|FG001|Qualification Phase Period 1|Withdrawal by Subject|1|||
147661524|NCT03286218|532583053|FG002|Qualification Phase Period 1|Withdrawal by Subject|0|||
147661525|NCT03286218|532583054|FG003|Qualification Phase Period 1|Withdrawal by Subject|0|||
147661526|NCT03286218|532583055|FG004|Qualification Phase Period 1|Withdrawal by Subject|0|||
147661527|NCT03286218|532583056|FG005|Qualification Phase Period 1|Withdrawal by Subject|0|||
147256753|NCT03742037|531112085|FG005|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|0|||
147256754|NCT03742037|531112086|FG006|Treatment Period 2 (Month 6 - Month 12)|pre-specified criteria|2|||
147256755|NCT03742037|531112080|FG000|Treatment Period 2 (Month 6 - Month 12)|Other reasons|2|||
147256756|NCT03742037|531112081|FG001|Treatment Period 2 (Month 6 - Month 12)|Other reasons|0|||
147256757|NCT03742037|531112082|FG002|Treatment Period 2 (Month 6 - Month 12)|Other reasons|2|||
147256758|NCT03742037|531112083|FG003|Treatment Period 2 (Month 6 - Month 12)|Other reasons|0|||
147256759|NCT03742037|531112084|FG004|Treatment Period 2 (Month 6 - Month 12)|Other reasons|0|||
147661528|NCT03286218|532583057|FG006|Qualification Phase Period 1|Withdrawal by Subject|0|||
147661529|NCT03286218|532583058|FG007|Qualification Phase Period 1|Withdrawal by Subject|0|||
147661530|NCT03286218|532583059|FG008|Qualification Phase Period 1|Withdrawal by Subject|0|||
147661531|NCT03286218|532583060|FG009|Qualification Phase Period 1|Withdrawal by Subject|0|||
147661532|NCT03286218|532583061|FG010|Qualification Phase Period 1|Withdrawal by Subject|0|||
147661533|NCT03286218|532583062|FG011|Qualification Phase Period 1|Withdrawal by Subject|0|||
147661534|NCT03286218|532583051|FG000|Qualification Phase Period 2|Adverse Event|0|||
147256760|NCT03742037|531112085|FG005|Treatment Period 2 (Month 6 - Month 12)|Other reasons|0|||
147256761|NCT03742037|531112086|FG006|Treatment Period 2 (Month 6 - Month 12)|Other reasons|1|||
147256762|NCT03742037|531112080|FG000|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
147256763|NCT03742037|531112081|FG001|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
147256764|NCT03742037|531112082|FG002|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|1|||
147256765|NCT03742037|531112083|FG003|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
147256766|NCT03742037|531112084|FG004|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
147256767|NCT03742037|531112085|FG005|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
147256768|NCT03742037|531112086|FG006|Treatment Period 2 (Month 6 - Month 12)|Discontinued study treatment in Treatment Period 1, re-randomized in error|0|||
147256769|NCT04447755|531112087|FG000|Overall Study|Death|9|||
147256770|NCT04447755|531112088|FG001|Overall Study|Death|16|||
147256771|NCT04447755|531112089|FG002|Overall Study|Death|8|||
147256772|NCT04447755|531112090|FG003|Overall Study|Death|9|||
147256773|NCT04447755|531112091|FG004|Overall Study|Death|8|||
147256774|NCT04447755|531112092|FG005|Overall Study|Death|9|||
147256775|NCT04447755|531112093|FG006|Overall Study|Death|55|||
147256776|NCT04447755|531112087|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
147256777|NCT04447755|531112088|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
147256778|NCT04447755|531112089|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
147256779|NCT04447755|531112090|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
147256780|NCT04447755|531112091|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
147256781|NCT04447755|531112092|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
147256782|NCT04447755|531112093|FG006|Overall Study|Withdrawal by Parent/Guardian|0|||
147256783|NCT04447755|531112087|FG000|Overall Study|Sponsor Decision|0|||
147256784|NCT04447755|531112088|FG001|Overall Study|Sponsor Decision|0|||
147256785|NCT04447755|531112089|FG002|Overall Study|Sponsor Decision|0|||
147256786|NCT04447755|531112090|FG003|Overall Study|Sponsor Decision|0|||
147256787|NCT04447755|531112091|FG004|Overall Study|Sponsor Decision|1|||
147256788|NCT04447755|531112092|FG005|Overall Study|Sponsor Decision|0|||
147256789|NCT04447755|531112093|FG006|Overall Study|Sponsor Decision|10|||
147256790|NCT04447755|531112087|FG000|Overall Study|Lost to Follow-up|0|||
147256791|NCT04447755|531112088|FG001|Overall Study|Lost to Follow-up|0|||
147256792|NCT04447755|531112089|FG002|Overall Study|Lost to Follow-up|0|||
147661535|NCT03286218|532583052|FG001|Qualification Phase Period 2|Adverse Event|1|||
147661536|NCT03286218|532583053|FG002|Qualification Phase Period 2|Adverse Event|0|||
147661537|NCT03286218|532583054|FG003|Qualification Phase Period 2|Adverse Event|0|||
147256793|NCT04447755|531112090|FG003|Overall Study|Lost to Follow-up|0|||
147256794|NCT04447755|531112091|FG004|Overall Study|Lost to Follow-up|0|||
147256795|NCT04447755|531112092|FG005|Overall Study|Lost to Follow-up|0|||
147256796|NCT04447755|531112093|FG006|Overall Study|Lost to Follow-up|1|||
147256797|NCT00619801|531112096|FG000|Overall Study|Lack of Efficacy|0|||
147256798|NCT00619801|531112097|FG001|Overall Study|Lack of Efficacy|1|||
147256799|NCT00619801|531112096|FG000|Overall Study|Withdrawal by Subject|1|||
147256800|NCT00619801|531112097|FG001|Overall Study|Withdrawal by Subject|1|||
147256801|NCT00619801|531112096|FG000|Overall Study|Loss of efficacy|0|||
147256802|NCT00619801|531112097|FG001|Overall Study|Loss of efficacy|1|||
147256803|NCT03855280|531112105|FG000|Treatment Phase|Adverse Event|1|||
147256804|NCT03855280|531112105|FG000|Treatment Phase|Withdrawal by Subject|1|||
147256805|NCT03855280|531112105|FG000|Continuation Phase|Protocol Violation|1|||
147256806|NCT03855280|531112105|FG000|Continuation Phase|Adverse Event|1|||
147256807|NCT03855280|531112105|FG000|Continuation Phase|Sponsor Concluded Study|1|||
147256808|NCT00969150|531112106|FG000|Overall Study|Adverse Event|4|||
147256809|NCT00969150|531112107|FG001|Overall Study|Adverse Event|14|||
147256810|NCT00969150|531112106|FG000|Overall Study|Lack of Efficacy|1|||
147256811|NCT00969150|531112107|FG001|Overall Study|Lack of Efficacy|1|||
147256812|NCT00969150|531112106|FG000|Overall Study|Protocol Violation|9|||
147599027|NCT01103466|532349969|FG002|Third Period (14 +/- 3 Days)|Adverse Event|0|||
147599028|NCT01103466|532349967|FG000|Third Period (14 +/- 3 Days)|Lack of Efficacy|1|||
147256813|NCT00969150|531112107|FG001|Overall Study|Protocol Violation|12|||
147256814|NCT00969150|531112106|FG000|Overall Study|Withdrawal by Subject|13|||
147256815|NCT00969150|531112107|FG001|Overall Study|Withdrawal by Subject|9|||
147256816|NCT00969150|531112106|FG000|Overall Study|Lost to Follow-up|5|||
147256817|NCT00969150|531112107|FG001|Overall Study|Lost to Follow-up|4|||
147256818|NCT00969150|531112106|FG000|Overall Study|Other reasons|1|||
147256819|NCT00969150|531112107|FG001|Overall Study|Other reasons|0|||
147256820|NCT00642941|531112113|FG000|Overall Study|Physician Decision|3|||
147256821|NCT00642941|531112114|FG001|Overall Study|Physician Decision|1|||
147256822|NCT00642941|531112115|FG002|Overall Study|Physician Decision|0|||
147256823|NCT00642941|531112116|FG003|Overall Study|Physician Decision|0|||
147256824|NCT00642941|531112117|FG004|Overall Study|Physician Decision|0|||
147599029|NCT01103466|532349968|FG001|Third Period (14 +/- 3 Days)|Lack of Efficacy|0|||
147599030|NCT01103466|532349969|FG002|Third Period (14 +/- 3 Days)|Lack of Efficacy|0|||
147599031|NCT01103466|532349967|FG000|Third Period (14 +/- 3 Days)|not satisfied with product|0|||
147599032|NCT01103466|532349968|FG001|Third Period (14 +/- 3 Days)|not satisfied with product|0|||
147256825|NCT00642941|531112118|FG005|Overall Study|Physician Decision|0|||
147256826|NCT00642941|531112119|FG006|Overall Study|Physician Decision|1|||
147256827|NCT00642941|531112120|FG007|Overall Study|Physician Decision|0|||
147256828|NCT00642941|531112121|FG008|Overall Study|Physician Decision|0|||
147256829|NCT00642941|531112122|FG009|Overall Study|Physician Decision|1|||
147256830|NCT00642941|531112123|FG010|Overall Study|Physician Decision|0|||
147256831|NCT00642941|531112124|FG011|Overall Study|Physician Decision|1|||
147256832|NCT00642941|531112113|FG000|Overall Study|Death|4|||
147256833|NCT00642941|531112114|FG001|Overall Study|Death|0|||
147256834|NCT00642941|531112115|FG002|Overall Study|Death|1|||
147256835|NCT00642941|531112116|FG003|Overall Study|Death|1|||
147256836|NCT00642941|531112117|FG004|Overall Study|Death|2|||
147256837|NCT00642941|531112118|FG005|Overall Study|Death|1|||
147256838|NCT00642941|531112119|FG006|Overall Study|Death|0|||
147256839|NCT00642941|531112120|FG007|Overall Study|Death|0|||
147256840|NCT00642941|531112121|FG008|Overall Study|Death|0|||
147256841|NCT00642941|531112122|FG009|Overall Study|Death|0|||
147256842|NCT00642941|531112123|FG010|Overall Study|Death|0|||
147599033|NCT01103466|532349969|FG002|Third Period (14 +/- 3 Days)|not satisfied with product|1|||
147256843|NCT00642941|531112124|FG011|Overall Study|Death|1|||
147256844|NCT00642941|531112113|FG000|Overall Study|Study closed by Sponsor|0|||
147256845|NCT00642941|531112114|FG001|Overall Study|Study closed by Sponsor|1|||
147256846|NCT00642941|531112115|FG002|Overall Study|Study closed by Sponsor|0|||
147256847|NCT00642941|531112116|FG003|Overall Study|Study closed by Sponsor|0|||
147256848|NCT00642941|531112117|FG004|Overall Study|Study closed by Sponsor|0|||
147256849|NCT00642941|531112118|FG005|Overall Study|Study closed by Sponsor|0|||
147256850|NCT00642941|531112119|FG006|Overall Study|Study closed by Sponsor|0|||
147256851|NCT00642941|531112120|FG007|Overall Study|Study closed by Sponsor|0|||
147256852|NCT00642941|531112121|FG008|Overall Study|Study closed by Sponsor|0|||
147256853|NCT00642941|531112122|FG009|Overall Study|Study closed by Sponsor|0|||
147256854|NCT00642941|531112123|FG010|Overall Study|Study closed by Sponsor|0|||
147256855|NCT00642941|531112124|FG011|Overall Study|Study closed by Sponsor|0|||
147256856|NCT00642941|531112113|FG000|Overall Study|Withdrawal by Subject|1|||
147256857|NCT00642941|531112114|FG001|Overall Study|Withdrawal by Subject|0|||
147256858|NCT00642941|531112115|FG002|Overall Study|Withdrawal by Subject|0|||
147256859|NCT00642941|531112116|FG003|Overall Study|Withdrawal by Subject|2|||
147256860|NCT00642941|531112117|FG004|Overall Study|Withdrawal by Subject|0|||
147256861|NCT00642941|531112118|FG005|Overall Study|Withdrawal by Subject|0|||
147256862|NCT00642941|531112119|FG006|Overall Study|Withdrawal by Subject|2|||
147256863|NCT00642941|531112120|FG007|Overall Study|Withdrawal by Subject|0|||
147599034|NCT02994940|532349972|FG000|Overall Study|Did not receive study medications: Study drug not available prior to anesthesia induction|6|||
147599035|NCT02994940|532349973|FG001|Overall Study|Did not receive study medications: Study drug not available prior to anesthesia induction|0|||
147599036|NCT02994940|532349972|FG000|Overall Study|Did not receive study medications: vomited after ingestion|1|||
147256864|NCT00642941|531112121|FG008|Overall Study|Withdrawal by Subject|1|||
147256865|NCT00642941|531112122|FG009|Overall Study|Withdrawal by Subject|0|||
147256866|NCT00642941|531112123|FG010|Overall Study|Withdrawal by Subject|0|||
147256867|NCT00642941|531112124|FG011|Overall Study|Withdrawal by Subject|1|||
147256868|NCT00642941|531112113|FG000|Overall Study|Protocol Violation|0|||
147256869|NCT00642941|531112114|FG001|Overall Study|Protocol Violation|0|||
147256870|NCT00642941|531112115|FG002|Overall Study|Protocol Violation|0|||
147256871|NCT00642941|531112116|FG003|Overall Study|Protocol Violation|0|||
147256872|NCT00642941|531112117|FG004|Overall Study|Protocol Violation|0|||
147256873|NCT00642941|531112118|FG005|Overall Study|Protocol Violation|0|||
147256874|NCT00642941|531112119|FG006|Overall Study|Protocol Violation|1|||
147256875|NCT00642941|531112120|FG007|Overall Study|Protocol Violation|0|||
147256876|NCT00642941|531112121|FG008|Overall Study|Protocol Violation|0|||
147256877|NCT00642941|531112122|FG009|Overall Study|Protocol Violation|0|||
147256878|NCT00642941|531112123|FG010|Overall Study|Protocol Violation|0|||
147256879|NCT00642941|531112124|FG011|Overall Study|Protocol Violation|0|||
147256880|NCT00642941|531112113|FG000|Overall Study|Adverse Event|1|||
147256881|NCT00642941|531112114|FG001|Overall Study|Adverse Event|1|||
147256882|NCT00642941|531112115|FG002|Overall Study|Adverse Event|0|||
147256883|NCT00642941|531112116|FG003|Overall Study|Adverse Event|0|||
147256884|NCT00642941|531112117|FG004|Overall Study|Adverse Event|0|||
147256885|NCT00642941|531112118|FG005|Overall Study|Adverse Event|0|||
147256886|NCT00642941|531112119|FG006|Overall Study|Adverse Event|1|||
147256887|NCT00642941|531112120|FG007|Overall Study|Adverse Event|1|||
147256888|NCT00642941|531112121|FG008|Overall Study|Adverse Event|0|||
147256889|NCT00642941|531112122|FG009|Overall Study|Adverse Event|1|||
147256890|NCT00642941|531112123|FG010|Overall Study|Adverse Event|0|||
147256891|NCT00642941|531112124|FG011|Overall Study|Adverse Event|0|||
147256892|NCT00642941|531112113|FG000|Overall Study|Other|1|||
147256893|NCT00642941|531112114|FG001|Overall Study|Other|1|||
147256894|NCT00642941|531112115|FG002|Overall Study|Other|1|||
147256895|NCT00642941|531112116|FG003|Overall Study|Other|1|||
147256896|NCT00642941|531112117|FG004|Overall Study|Other|0|||
147256897|NCT00642941|531112118|FG005|Overall Study|Other|1|||
147256898|NCT00642941|531112119|FG006|Overall Study|Other|0|||
147256899|NCT00642941|531112120|FG007|Overall Study|Other|1|||
147256900|NCT00642941|531112121|FG008|Overall Study|Other|0|||
147256901|NCT00642941|531112122|FG009|Overall Study|Other|0|||
147256902|NCT00642941|531112123|FG010|Overall Study|Other|0|||
147256903|NCT00642941|531112124|FG011|Overall Study|Other|1|||
147256904|NCT00642941|531112113|FG000|Overall Study|Disease progression|60|||
147256905|NCT00642941|531112114|FG001|Overall Study|Disease progression|50|||
147256906|NCT00642941|531112115|FG002|Overall Study|Disease progression|5|||
147256907|NCT00642941|531112116|FG003|Overall Study|Disease progression|36|||
147256908|NCT00642941|531112117|FG004|Overall Study|Disease progression|23|||
147256909|NCT00642941|531112118|FG005|Overall Study|Disease progression|39|||
147256910|NCT00642941|531112119|FG006|Overall Study|Disease progression|18|||
147256911|NCT00642941|531112120|FG007|Overall Study|Disease progression|12|||
147256912|NCT00642941|531112121|FG008|Overall Study|Disease progression|10|||
147256913|NCT00642941|531112122|FG009|Overall Study|Disease progression|7|||
147256914|NCT00642941|531112123|FG010|Overall Study|Disease progression|12|||
147256915|NCT00642941|531112124|FG011|Overall Study|Disease progression|7|||
147256916|NCT03051607|531112125|FG000|Overall Study|Adverse Event|66|||
147256917|NCT03338855|531112127|FG000|Overall Study|Withdrawn as birth control pill stopped|1|||
147256918|NCT03338855|531112128|FG001|Overall Study|Withdrawn as birth control pill stopped|0|||
147256919|NCT00455429|531112129|FG000|Overall Study|Study Terminated by Sponsor|0|||
147256920|NCT00455429|531112130|FG001|Overall Study|Study Terminated by Sponsor|0|||
147256921|NCT00455429|531112131|FG002|Overall Study|Study Terminated by Sponsor|0|||
147256922|NCT00455429|531112132|FG003|Overall Study|Study Terminated by Sponsor|3|||
147256923|NCT00455429|531112129|FG000|Overall Study|Lost to Follow-up|1|||
147256924|NCT00455429|531112130|FG001|Overall Study|Lost to Follow-up|0|||
147256925|NCT00455429|531112131|FG002|Overall Study|Lost to Follow-up|0|||
147256926|NCT00455429|531112132|FG003|Overall Study|Lost to Follow-up|3|||
147256927|NCT00455429|531112129|FG000|Overall Study|Withdrawal by Subject|0|||
147256928|NCT00455429|531112130|FG001|Overall Study|Withdrawal by Subject|1|||
147256929|NCT00455429|531112131|FG002|Overall Study|Withdrawal by Subject|1|||
147256930|NCT00455429|531112132|FG003|Overall Study|Withdrawal by Subject|0|||
147256931|NCT00455429|531112129|FG000|Overall Study|Lack of Efficacy|0|||
147256932|NCT00455429|531112130|FG001|Overall Study|Lack of Efficacy|1|||
147256933|NCT00455429|531112131|FG002|Overall Study|Lack of Efficacy|0|||
147256934|NCT00455429|531112132|FG003|Overall Study|Lack of Efficacy|1|||
147256935|NCT00455429|531112129|FG000|Overall Study|Adverse Event|0|||
147256936|NCT00455429|531112130|FG001|Overall Study|Adverse Event|1|||
147256937|NCT00455429|531112131|FG002|Overall Study|Adverse Event|0|||
147256938|NCT00455429|531112132|FG003|Overall Study|Adverse Event|3|||
147332711|NCT02506257|531385527|FG003|Overall Study|Adverse Event|0|||
147256939|NCT00455429|531112129|FG000|Overall Study|Randomly assigned but not treated|0|||
147256940|NCT00455429|531112130|FG001|Overall Study|Randomly assigned but not treated|0|||
147256941|NCT00455429|531112131|FG002|Overall Study|Randomly assigned but not treated|0|||
147256942|NCT00455429|531112132|FG003|Overall Study|Randomly assigned but not treated|2|||
147256943|NCT00455429|531112129|FG000|Overall Study|Personal Reason|1|||
147256944|NCT00455429|531112130|FG001|Overall Study|Personal Reason|0|||
147256945|NCT00455429|531112131|FG002|Overall Study|Personal Reason|0|||
147256946|NCT00455429|531112132|FG003|Overall Study|Personal Reason|0|||
147256947|NCT00455429|531112129|FG000|Overall Study|Non-compliance|0|||
147256948|NCT00455429|531112130|FG001|Overall Study|Non-compliance|0|||
147256949|NCT00455429|531112131|FG002|Overall Study|Non-compliance|0|||
147256950|NCT00455429|531112132|FG003|Overall Study|Non-compliance|1|||
147256951|NCT00455429|531112129|FG000|Overall Study|Other|0|||
147256952|NCT00455429|531112130|FG001|Overall Study|Other|2|||
147661538|NCT03286218|532583055|FG004|Qualification Phase Period 2|Adverse Event|0|||
147661539|NCT03286218|532583056|FG005|Qualification Phase Period 2|Adverse Event|0|||
147661540|NCT03286218|532583057|FG006|Qualification Phase Period 2|Adverse Event|0|||
147661541|NCT03286218|532583058|FG007|Qualification Phase Period 2|Adverse Event|0|||
147661542|NCT03286218|532583059|FG008|Qualification Phase Period 2|Adverse Event|0|||
147661543|NCT03286218|532583060|FG009|Qualification Phase Period 2|Adverse Event|0|||
147661544|NCT03286218|532583061|FG010|Qualification Phase Period 2|Adverse Event|0|||
147661545|NCT03286218|532583062|FG011|Qualification Phase Period 2|Adverse Event|0|||
147661546|NCT03286218|532583051|FG000|Qualification Phase Period 2|Failure to meet randomization criteria|14|||
147661547|NCT03286218|532583052|FG001|Qualification Phase Period 2|Failure to meet randomization criteria|15|||
147661548|NCT03286218|532583053|FG002|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
147661549|NCT03286218|532583054|FG003|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
147661550|NCT03286218|532583055|FG004|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
147661551|NCT03286218|532583056|FG005|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
147661552|NCT03286218|532583057|FG006|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
147661553|NCT03286218|532583058|FG007|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
147661554|NCT03286218|532583059|FG008|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
147661555|NCT03286218|532583060|FG009|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
147661556|NCT03286218|532583061|FG010|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
147661557|NCT03286218|532583062|FG011|Qualification Phase Period 2|Failure to meet randomization criteria|0|||
147661558|NCT03286218|532583051|FG000|Qualification Phase Period 2|Lost to Follow-up|0|||
147661559|NCT03286218|532583052|FG001|Qualification Phase Period 2|Lost to Follow-up|1|||
147661560|NCT03286218|532583053|FG002|Qualification Phase Period 2|Lost to Follow-up|0|||
147661561|NCT03286218|532583054|FG003|Qualification Phase Period 2|Lost to Follow-up|0|||
147661562|NCT03286218|532583055|FG004|Qualification Phase Period 2|Lost to Follow-up|0|||
147256953|NCT00455429|531112131|FG002|Overall Study|Other|0|||
147256954|NCT00455429|531112132|FG003|Overall Study|Other|1|||
147256955|NCT04948450|531112133|FG000|Overall Study|Return home|1|||
147256956|NCT04948450|531112134|FG001|Overall Study|Return home|3|||
147256957|NCT00529542|531112136|FG000|Overall Study|Withdrawal by Subject|1|||
147256958|NCT00529542|531112137|FG001|Overall Study|Withdrawal by Subject|0|||
147256959|NCT00529542|531112136|FG000|Overall Study|Lost to Follow-up|0|||
147256960|NCT00529542|531112137|FG001|Overall Study|Lost to Follow-up|1|||
147256961|NCT04788953|531114240|FG000|Overall Study|Adverse Event|1|||
147256962|NCT04788953|531114241|FG001|Overall Study|Adverse Event|1|||
147256963|NCT04788953|531114240|FG000|Overall Study|Withdrawal by Subject|1|||
147256964|NCT04788953|531114241|FG001|Overall Study|Withdrawal by Subject|0|||
147256965|NCT04788953|531114240|FG000|Overall Study|Protocol Violation|0|||
147256966|NCT04788953|531114241|FG001|Overall Study|Protocol Violation|1|||
147599037|NCT02994940|532349973|FG001|Overall Study|Did not receive study medications: vomited after ingestion|0|||
147599038|NCT02994940|532349972|FG000|Overall Study|Did not receive study medications: red dye allergy|0|||
147256967|NCT02092662|531114242|FG000|Overall Study|Lost to Follow-up|13|||
147256968|NCT02092662|531114243|FG001|Overall Study|Lost to Follow-up|0|||
147256969|NCT03424265|531114246|FG000|Overall Study|screening failure|1|||
147256970|NCT03424265|531114247|FG001|Overall Study|screening failure|0|||
147256971|NCT03424265|531114246|FG000|Overall Study|Withdrawal by Subject|0|||
147332712|NCT02506257|531385524|FG000|Overall Study|Protocol Violation|0|||
147599039|NCT02994940|532349973|FG001|Overall Study|Did not receive study medications: red dye allergy|1|||
147599040|NCT02331368|532349978|FG000|Overall Study|Withdrawal by Subject|3|||
147599041|NCT02302859|532349988|FG000|Overall Study|Lost Phone|1|||
147599042|NCT02302859|532349989|FG001|Overall Study|Lost Phone|1|||
147599043|NCT02302859|532349988|FG000|Overall Study|Withdrawal by Subject|0|||
147599044|NCT02302859|532349989|FG001|Overall Study|Withdrawal by Subject|1|||
147599045|NCT01355159|532349992|FG000|Overall Study|Withdrew consent|39|||
147599046|NCT01355159|532349993|FG001|Overall Study|Withdrew consent|47|||
147599047|NCT01355159|532349992|FG000|Overall Study|No primary outcome data|17|||
147599048|NCT01355159|532349993|FG001|Overall Study|No primary outcome data|11|||
147599049|NCT01355159|532349992|FG000|Overall Study|Spontaneous abortion (<20 weeks)|22|||
147661563|NCT03286218|532583056|FG005|Qualification Phase Period 2|Lost to Follow-up|0|||
147661564|NCT03286218|532583057|FG006|Qualification Phase Period 2|Lost to Follow-up|0|||
147661565|NCT03286218|532583058|FG007|Qualification Phase Period 2|Lost to Follow-up|0|||
147661566|NCT03286218|532583059|FG008|Qualification Phase Period 2|Lost to Follow-up|0|||
147661567|NCT03286218|532583060|FG009|Qualification Phase Period 2|Lost to Follow-up|0|||
147256972|NCT03424265|531114247|FG001|Overall Study|Withdrawal by Subject|2|||
147256973|NCT00391274|531114257|FG000|Overall Study|Death Due to Study Disease|55|||
147256974|NCT00391274|531114258|FG001|Overall Study|Death Due to Study Disease|45|||
147256975|NCT00391274|531114257|FG000|Overall Study|Lost to Follow-up|0|||
147256976|NCT00391274|531114258|FG001|Overall Study|Lost to Follow-up|3|||
147256977|NCT00391274|531114257|FG000|Overall Study|Physician Decision|4|||
147256978|NCT00391274|531114258|FG001|Overall Study|Physician Decision|2|||
147256979|NCT00391274|531114257|FG000|Overall Study|Withdrawal by Subject|0|||
147256980|NCT00391274|531114258|FG001|Overall Study|Withdrawal by Subject|3|||
147256981|NCT00391274|531114257|FG000|Overall Study|Death Due to Adverse Event|1|||
147256982|NCT00391274|531114258|FG001|Overall Study|Death Due to Adverse Event|3|||
147256983|NCT00391274|531114257|FG000|Overall Study|Death Due to Indeterminate Cause|1|||
147256984|NCT00391274|531114258|FG001|Overall Study|Death Due to Indeterminate Cause|0|||
147256985|NCT00391274|531114257|FG000|Overall Study|Death Not Study Related|0|||
147256986|NCT00391274|531114258|FG001|Overall Study|Death Not Study Related|1|||
147256987|NCT00894322|531114260|FG000|Overall Study|Withdrawal by Subject|1|||
147256988|NCT00894322|531114261|FG001|Overall Study|Withdrawal by Subject|0|||
147256989|NCT00894322|531114262|FG002|Overall Study|Withdrawal by Subject|0|||
147256990|NCT03447990|531114273|FG000|Overall Study|Withdrawal by Subject|0|||
147256991|NCT03447990|531114274|FG001|Overall Study|Withdrawal by Subject|0|||
147256992|NCT03447990|531114275|FG002|Overall Study|Withdrawal by Subject|0|||
147256993|NCT03447990|531114276|FG003|Overall Study|Withdrawal by Subject|0|||
147256994|NCT03447990|531114277|FG004|Overall Study|Withdrawal by Subject|0|||
147256995|NCT03447990|531114278|FG005|Overall Study|Withdrawal by Subject|0|||
147256996|NCT03447990|531114279|FG006|Overall Study|Withdrawal by Subject|1|||
147256997|NCT02738450|531114282|FG000|Overall Study|Withdrawal by Subject|0|||
147256998|NCT02738450|531114283|FG001|Overall Study|Withdrawal by Subject|2|||
147256999|NCT02738450|531114284|FG002|Overall Study|Withdrawal by Subject|0|||
147257000|NCT03559257|531114285|FG000|Double Blind Treatment Period|Withdrawal by Subject|2|||
147257001|NCT03559257|531114286|FG001|Double Blind Treatment Period|Withdrawal by Subject|1|||
147257002|NCT03559257|531114285|FG000|Double Blind Treatment Period|Protocol Violation|1|||
147257003|NCT03559257|531114286|FG001|Double Blind Treatment Period|Protocol Violation|4|||
147257004|NCT03559257|531114285|FG000|Double Blind Treatment Period|Lack of Efficacy|1|||
147257005|NCT03559257|531114286|FG001|Double Blind Treatment Period|Lack of Efficacy|1|||
147257006|NCT03559257|531114285|FG000|Double Blind Treatment Period|Adverse Event|0|||
147257007|NCT03559257|531114286|FG001|Double Blind Treatment Period|Adverse Event|1|||
147257008|NCT03559257|531114285|FG000|Double Blind Treatment Period|Screen Failure|0|||
147257009|NCT03559257|531114286|FG001|Double Blind Treatment Period|Screen Failure|1|||
147257010|NCT03559257|531114285|FG000|Open-label Treatment Period|Adverse Event|1|||
147257011|NCT03559257|531114286|FG001|Open-label Treatment Period|Adverse Event|4|||
147257012|NCT03559257|531114285|FG000|Open-label Treatment Period|Lack of Efficacy|3|||
147257013|NCT03559257|531114286|FG001|Open-label Treatment Period|Lack of Efficacy|2|||
147257014|NCT03559257|531114285|FG000|Open-label Treatment Period|Withdrawal by Subject|3|||
147257015|NCT03559257|531114286|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
147257016|NCT03559257|531114285|FG000|Open-label Treatment Period|Protocol Violation|2|||
147257017|NCT03559257|531114286|FG001|Open-label Treatment Period|Protocol Violation|0|||
147257018|NCT03559257|531114285|FG000|Open-label Treatment Period|Lost to Follow-up|1|||
147257019|NCT03559257|531114286|FG001|Open-label Treatment Period|Lost to Follow-up|0|||
147257020|NCT03559257|531114285|FG000|Open-label Treatment Period|Physician Decision|0|||
147257021|NCT03559257|531114286|FG001|Open-label Treatment Period|Physician Decision|1|||
147257022|NCT01387347|531114288|FG000|Overall Study|Lost to Follow-up|2|||
147257023|NCT01387347|531114289|FG001|Overall Study|Lost to Follow-up|1|||
147257024|NCT03251079|531114290|FG000|Overall Study|Withdrawal by Subject|1|||
147257025|NCT00423150|531114299|FG000|Overall Study|Adverse Event|11|||
147257026|NCT00423150|531114299|FG000|Overall Study|Progression of disease being studied|69|||
147257027|NCT00423150|531114299|FG000|Overall Study|Withdrawal by Subject|1|||
147257028|NCT00423150|531114299|FG000|Overall Study|Non-compliance with protocol|1|||
147257029|NCT00423150|531114299|FG000|Overall Study|Administrative|4|||
147257030|NCT01603459|531114308|FG000|Overall Study|Adverse Event|5|||
147257031|NCT01603459|531114308|FG000|Overall Study|Withdrawal by Subject|5|||
147257032|NCT01603459|531114308|FG000|Overall Study|Lost to Follow-up|3|||
147257033|NCT01603459|531114308|FG000|Overall Study|Predefined discontinuation criteria|3|||
147257034|NCT01603459|531114308|FG000|Overall Study|Non-compliance|1|||
147257035|NCT01603459|531114308|FG000|Overall Study|Administrative reason|1|||
147257036|NCT00399360|531114310|FG000|Overall Study|Lost to Follow-up|2|||
147257037|NCT00399360|531114311|FG001|Overall Study|Lost to Follow-up|1|||
147661568|NCT03286218|532583061|FG010|Qualification Phase Period 2|Lost to Follow-up|0|||
147661569|NCT03286218|532583062|FG011|Qualification Phase Period 2|Lost to Follow-up|0|||
147257038|NCT00399360|531114312|FG002|Overall Study|Lost to Follow-up|2|||
147257039|NCT00399360|531114313|FG003|Overall Study|Lost to Follow-up|4|||
147257040|NCT00399360|531114310|FG000|Overall Study|Adverse Event|0|||
147257041|NCT00399360|531114311|FG001|Overall Study|Adverse Event|0|||
147257042|NCT00399360|531114312|FG002|Overall Study|Adverse Event|1|||
147257043|NCT00399360|531114313|FG003|Overall Study|Adverse Event|0|||
147257044|NCT00399360|531114310|FG000|Overall Study|Withdrawal by Subject|0|||
147257045|NCT00399360|531114311|FG001|Overall Study|Withdrawal by Subject|2|||
147257046|NCT00399360|531114312|FG002|Overall Study|Withdrawal by Subject|0|||
147257047|NCT00399360|531114313|FG003|Overall Study|Withdrawal by Subject|2|||
147257048|NCT01641692|531114316|FG000|Treatment Period 1|Adverse Event|1|||
147257049|NCT01641692|531114317|FG001|Treatment Period 1|Adverse Event|0|||
147257050|NCT01641692|531114318|FG002|Treatment Period 1|Adverse Event|0|||
147257051|NCT01641692|531114319|FG003|Treatment Period 1|Adverse Event|0|||
147257052|NCT01641692|531114320|FG004|Treatment Period 1|Adverse Event|0|||
147257053|NCT01641692|531114321|FG005|Treatment Period 1|Adverse Event|0|||
147257054|NCT01641692|531114322|FG006|Treatment Period 1|Adverse Event|0|||
147257055|NCT01641692|531114323|FG007|Treatment Period 1|Adverse Event|0|||
147257056|NCT01641692|531114316|FG000|Treatment Period 1|Lack of Efficacy|0|||
147257057|NCT01641692|531114317|FG001|Treatment Period 1|Lack of Efficacy|0|||
147257058|NCT01641692|531114318|FG002|Treatment Period 1|Lack of Efficacy|0|||
147257059|NCT01641692|531114319|FG003|Treatment Period 1|Lack of Efficacy|0|||
147257060|NCT01641692|531114320|FG004|Treatment Period 1|Lack of Efficacy|0|||
147257061|NCT01641692|531114321|FG005|Treatment Period 1|Lack of Efficacy|0|||
147257062|NCT01641692|531114322|FG006|Treatment Period 1|Lack of Efficacy|0|||
147257063|NCT01641692|531114323|FG007|Treatment Period 1|Lack of Efficacy|1|||
147257064|NCT01641692|531114316|FG000|Treatment Period 1|Protocol Violation|1|||
147257065|NCT01641692|531114317|FG001|Treatment Period 1|Protocol Violation|0|||
147257066|NCT01641692|531114318|FG002|Treatment Period 1|Protocol Violation|0|||
147257067|NCT01641692|531114319|FG003|Treatment Period 1|Protocol Violation|0|||
147257068|NCT01641692|531114320|FG004|Treatment Period 1|Protocol Violation|2|||
147257069|NCT01641692|531114321|FG005|Treatment Period 1|Protocol Violation|0|||
147257070|NCT01641692|531114322|FG006|Treatment Period 1|Protocol Violation|0|||
147257071|NCT01641692|531114323|FG007|Treatment Period 1|Protocol Violation|0|||
147257072|NCT01641692|531114316|FG000|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
147257073|NCT01641692|531114317|FG001|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
147257074|NCT01641692|531114318|FG002|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
147257075|NCT01641692|531114319|FG003|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
147599050|NCT01355159|532349993|FG001|Overall Study|Spontaneous abortion (<20 weeks)|15|||
147599051|NCT01355159|532349992|FG000|Overall Study|Early intrauterine fetal death|6|||
147599052|NCT01355159|532349993|FG001|Overall Study|Early intrauterine fetal death|6|||
147599053|NCT02357342|532349997|FG000|First 6 Months|Death|2|||
147599054|NCT02357342|532349998|FG001|First 6 Months|Death|0|||
147599055|NCT01674647|532349999|FG000|Treatment Period|Death|4|||
147599056|NCT01674647|532350000|FG001|Treatment Period|Death|1|||
147599057|NCT01674647|532349999|FG000|Treatment Period|Efficacy outcome reached|0|||
147599058|NCT01674647|532350000|FG001|Treatment Period|Efficacy outcome reached|1|||
147599059|NCT01674647|532349999|FG000|Treatment Period|Physician Decision|3|||
147599060|NCT01674647|532350000|FG001|Treatment Period|Physician Decision|1|||
147599061|NCT01674647|532349999|FG000|Treatment Period|Adverse Event|60|||
147599062|NCT01674647|532350000|FG001|Treatment Period|Adverse Event|22|||
147599063|NCT01674647|532349999|FG000|Treatment Period|Non-compliance with study drug|3|||
147599064|NCT01674647|532350000|FG001|Treatment Period|Non-compliance with study drug|0|||
147599065|NCT01674647|532349999|FG000|Treatment Period|Lost to Follow-up|1|||
147599066|NCT01674647|532350000|FG001|Treatment Period|Lost to Follow-up|1|||
147599067|NCT01674647|532349999|FG000|Treatment Period|Withdrawal by Subject|19|||
147599068|NCT01674647|532350000|FG001|Treatment Period|Withdrawal by Subject|16|||
147599069|NCT01674647|532349999|FG000|Treatment Period|Switching to other therapy|5|||
147599070|NCT01674647|532350000|FG001|Treatment Period|Switching to other therapy|2|||
147599071|NCT01674647|532349999|FG000|Treatment Period|Logistical difficulties|5|||
147599072|NCT01674647|532350000|FG001|Treatment Period|Logistical difficulties|8|||
147599073|NCT01674647|532349999|FG000|Treatment Period|Treatment failure|0|||
147599074|NCT01674647|532350000|FG001|Treatment Period|Treatment failure|14|||
147599075|NCT01674647|532349999|FG000|Treatment Period|Protocol Violation|56|||
147599076|NCT01674647|532350000|FG001|Treatment Period|Protocol Violation|36|||
147599077|NCT01674647|532349999|FG000|30-day Safety Follow-up Period|Death|3|||
147599078|NCT01674647|532350000|FG001|30-day Safety Follow-up Period|Death|2|||
147599079|NCT01674647|532349999|FG000|30-day Safety Follow-up Period|Non-compliance with study drug|0|||
147599080|NCT01674647|532350000|FG001|30-day Safety Follow-up Period|Non-compliance with study drug|1|||
147599081|NCT01674647|532349999|FG000|30-day Safety Follow-up Period|Protocol Violation|39|||
147599082|NCT01674647|532350000|FG001|30-day Safety Follow-up Period|Protocol Violation|22|||
147257076|NCT01641692|531114320|FG004|Treatment Period 1|Protocol-defined Stopping Criteria|1|||
147257077|NCT01641692|531114321|FG005|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
147257078|NCT01641692|531114322|FG006|Treatment Period 1|Protocol-defined Stopping Criteria|0|||
147257079|NCT01641692|531114323|FG007|Treatment Period 1|Protocol-defined Stopping Criteria|1|||
147257080|NCT01641692|531114316|FG000|Treatment Period 1|Lost to Follow-up|0|||
147257081|NCT01641692|531114317|FG001|Treatment Period 1|Lost to Follow-up|0|||
147257082|NCT01641692|531114318|FG002|Treatment Period 1|Lost to Follow-up|1|||
147257083|NCT01641692|531114319|FG003|Treatment Period 1|Lost to Follow-up|0|||
147257084|NCT01641692|531114320|FG004|Treatment Period 1|Lost to Follow-up|0|||
147257085|NCT01641692|531114321|FG005|Treatment Period 1|Lost to Follow-up|0|||
147257086|NCT01641692|531114322|FG006|Treatment Period 1|Lost to Follow-up|0|||
147257087|NCT01641692|531114323|FG007|Treatment Period 1|Lost to Follow-up|0|||
147257088|NCT01641692|531114316|FG000|Treatment Period 1|Physician Decision|0|||
147257089|NCT01641692|531114317|FG001|Treatment Period 1|Physician Decision|0|||
147257090|NCT01641692|531114318|FG002|Treatment Period 1|Physician Decision|0|||
147257091|NCT01641692|531114319|FG003|Treatment Period 1|Physician Decision|0|||
147257092|NCT01641692|531114320|FG004|Treatment Period 1|Physician Decision|1|||
147257093|NCT01641692|531114321|FG005|Treatment Period 1|Physician Decision|0|||
147257094|NCT01641692|531114322|FG006|Treatment Period 1|Physician Decision|0|||
147257095|NCT01641692|531114323|FG007|Treatment Period 1|Physician Decision|0|||
147257096|NCT01641692|531114316|FG000|Treatment Period 1|Withdrawal by Subject|0|||
147257097|NCT01641692|531114317|FG001|Treatment Period 1|Withdrawal by Subject|0|||
147257098|NCT01641692|531114318|FG002|Treatment Period 1|Withdrawal by Subject|0|||
147257099|NCT01641692|531114319|FG003|Treatment Period 1|Withdrawal by Subject|0|||
147257100|NCT01641692|531114320|FG004|Treatment Period 1|Withdrawal by Subject|0|||
147257101|NCT01641692|531114321|FG005|Treatment Period 1|Withdrawal by Subject|2|||
147257102|NCT01641692|531114322|FG006|Treatment Period 1|Withdrawal by Subject|0|||
147257103|NCT01641692|531114323|FG007|Treatment Period 1|Withdrawal by Subject|1|||
147257104|NCT01641692|531114316|FG000|Washout Period 1 (12-14 Days)|Adverse Event|2|||
147257105|NCT01641692|531114317|FG001|Washout Period 1 (12-14 Days)|Adverse Event|0|||
147257106|NCT01641692|531114318|FG002|Washout Period 1 (12-14 Days)|Adverse Event|0|||
147257107|NCT01641692|531114319|FG003|Washout Period 1 (12-14 Days)|Adverse Event|0|||
147661570|NCT03286218|532583051|FG000|Qualification Phase Period 2|Protocol Violation|2|||
147257108|NCT01641692|531114320|FG004|Washout Period 1 (12-14 Days)|Adverse Event|0|||
147257109|NCT01641692|531114321|FG005|Washout Period 1 (12-14 Days)|Adverse Event|0|||
147257110|NCT01641692|531114322|FG006|Washout Period 1 (12-14 Days)|Adverse Event|0|||
147257111|NCT01641692|531114323|FG007|Washout Period 1 (12-14 Days)|Adverse Event|0|||
147661571|NCT03286218|532583052|FG001|Qualification Phase Period 2|Protocol Violation|0|||
147661572|NCT03286218|532583053|FG002|Qualification Phase Period 2|Protocol Violation|0|||
147661573|NCT03286218|532583054|FG003|Qualification Phase Period 2|Protocol Violation|0|||
147661574|NCT03286218|532583055|FG004|Qualification Phase Period 2|Protocol Violation|0|||
147661575|NCT03286218|532583056|FG005|Qualification Phase Period 2|Protocol Violation|0|||
147661576|NCT03286218|532583057|FG006|Qualification Phase Period 2|Protocol Violation|0|||
147661577|NCT03286218|532583058|FG007|Qualification Phase Period 2|Protocol Violation|0|||
147661578|NCT03286218|532583059|FG008|Qualification Phase Period 2|Protocol Violation|0|||
147661579|NCT03286218|532583060|FG009|Qualification Phase Period 2|Protocol Violation|0|||
147661580|NCT03286218|532583061|FG010|Qualification Phase Period 2|Protocol Violation|0|||
147661581|NCT03286218|532583062|FG011|Qualification Phase Period 2|Protocol Violation|0|||
147661582|NCT03286218|532583051|FG000|Qualification Phase Period 2|Withdrawal by Subject|1|||
147661583|NCT03286218|532583052|FG001|Qualification Phase Period 2|Withdrawal by Subject|2|||
147661584|NCT03286218|532583053|FG002|Qualification Phase Period 2|Withdrawal by Subject|0|||
147661585|NCT03286218|532583054|FG003|Qualification Phase Period 2|Withdrawal by Subject|0|||
147661586|NCT03286218|532583055|FG004|Qualification Phase Period 2|Withdrawal by Subject|0|||
147661587|NCT03286218|532583056|FG005|Qualification Phase Period 2|Withdrawal by Subject|0|||
147661588|NCT03286218|532583057|FG006|Qualification Phase Period 2|Withdrawal by Subject|0|||
147257112|NCT01641692|531114316|FG000|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
147257113|NCT01641692|531114317|FG001|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
147257114|NCT01641692|531114318|FG002|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
147257115|NCT01641692|531114319|FG003|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
147257116|NCT01641692|531114320|FG004|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
147257117|NCT01641692|531114321|FG005|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
147257118|NCT01641692|531114322|FG006|Washout Period 1 (12-14 Days)|Protocol Violation|1|||
147257119|NCT01641692|531114323|FG007|Washout Period 1 (12-14 Days)|Protocol Violation|0|||
147257120|NCT01641692|531114316|FG000|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|1|||
147257121|NCT01641692|531114317|FG001|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
147257122|NCT01641692|531114318|FG002|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|3|||
147257123|NCT01641692|531114319|FG003|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|1|||
147257124|NCT01641692|531114320|FG004|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|3|||
147257125|NCT01641692|531114321|FG005|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
147257126|NCT01641692|531114322|FG006|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
147257127|NCT01641692|531114323|FG007|Washout Period 1 (12-14 Days)|Protocol-defined Stopping Criteria|1|||
147257128|NCT01641692|531114316|FG000|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
147332713|NCT02506257|531385525|FG001|Overall Study|Protocol Violation|0|||
147661589|NCT03286218|532583058|FG007|Qualification Phase Period 2|Withdrawal by Subject|0|||
147661590|NCT03286218|532583059|FG008|Qualification Phase Period 2|Withdrawal by Subject|0|||
147661591|NCT03286218|532583060|FG009|Qualification Phase Period 2|Withdrawal by Subject|0|||
147661592|NCT03286218|532583061|FG010|Qualification Phase Period 2|Withdrawal by Subject|0|||
147257129|NCT01641692|531114317|FG001|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
147257130|NCT01641692|531114318|FG002|Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
147257131|NCT01641692|531114319|FG003|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
147257132|NCT01641692|531114320|FG004|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
147257133|NCT01641692|531114321|FG005|Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
147257134|NCT01641692|531114322|FG006|Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
147257135|NCT01641692|531114323|FG007|Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
147257136|NCT01641692|531114316|FG000|Treatment Period 2|Lack of Efficacy|1|||
147257137|NCT01641692|531114317|FG001|Treatment Period 2|Lack of Efficacy|0|||
147257138|NCT01641692|531114318|FG002|Treatment Period 2|Lack of Efficacy|0|||
147257139|NCT01641692|531114319|FG003|Treatment Period 2|Lack of Efficacy|0|||
147257140|NCT01641692|531114320|FG004|Treatment Period 2|Lack of Efficacy|0|||
147257141|NCT01641692|531114321|FG005|Treatment Period 2|Lack of Efficacy|0|||
147257142|NCT01641692|531114322|FG006|Treatment Period 2|Lack of Efficacy|0|||
147257143|NCT01641692|531114323|FG007|Treatment Period 2|Lack of Efficacy|0|||
147257144|NCT01641692|531114316|FG000|Treatment Period 2|Protocol-defined Stopping Criteria|1|||
147257145|NCT01641692|531114317|FG001|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
147257146|NCT01641692|531114318|FG002|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
147257147|NCT01641692|531114319|FG003|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
147257148|NCT01641692|531114320|FG004|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
147257149|NCT01641692|531114321|FG005|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
147257150|NCT01641692|531114322|FG006|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
147257151|NCT01641692|531114323|FG007|Treatment Period 2|Protocol-defined Stopping Criteria|0|||
147257152|NCT01641692|531114316|FG000|Treatment Period 2|Lost to Follow-up|0|||
147257153|NCT01641692|531114317|FG001|Treatment Period 2|Lost to Follow-up|0|||
147257154|NCT01641692|531114318|FG002|Treatment Period 2|Lost to Follow-up|0|||
147257155|NCT01641692|531114319|FG003|Treatment Period 2|Lost to Follow-up|0|||
147257156|NCT01641692|531114320|FG004|Treatment Period 2|Lost to Follow-up|0|||
147257157|NCT01641692|531114321|FG005|Treatment Period 2|Lost to Follow-up|1|||
147257158|NCT01641692|531114322|FG006|Treatment Period 2|Lost to Follow-up|0|||
147257159|NCT01641692|531114323|FG007|Treatment Period 2|Lost to Follow-up|0|||
147257160|NCT01641692|531114316|FG000|Treatment Period 2|Withdrawal by Subject|1|||
147257161|NCT01641692|531114317|FG001|Treatment Period 2|Withdrawal by Subject|0|||
147257162|NCT01641692|531114318|FG002|Treatment Period 2|Withdrawal by Subject|0|||
147661593|NCT03286218|532583062|FG011|Qualification Phase Period 2|Withdrawal by Subject|0|||
147661594|NCT03286218|532583051|FG000|Treatment Phase Period 1|Withdrawal by Subject|0|||
147661595|NCT03286218|532583052|FG001|Treatment Phase Period 1|Withdrawal by Subject|0|||
147257163|NCT01641692|531114319|FG003|Treatment Period 2|Withdrawal by Subject|0|||
147257164|NCT01641692|531114320|FG004|Treatment Period 2|Withdrawal by Subject|0|||
147257165|NCT01641692|531114321|FG005|Treatment Period 2|Withdrawal by Subject|1|||
147257166|NCT01641692|531114322|FG006|Treatment Period 2|Withdrawal by Subject|0|||
147257167|NCT01641692|531114323|FG007|Treatment Period 2|Withdrawal by Subject|1|||
147257168|NCT01641692|531114316|FG000|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
147257169|NCT01641692|531114317|FG001|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
147257170|NCT01641692|531114318|FG002|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
147257171|NCT01641692|531114319|FG003|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
147257172|NCT01641692|531114320|FG004|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|3|||
147257173|NCT01641692|531114321|FG005|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
147257174|NCT01641692|531114322|FG006|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|1|||
147257175|NCT01641692|531114323|FG007|Washout Period 2 (12-14 Days)|Protocol-defined Stopping Criteria|0|||
147257176|NCT01641692|531114316|FG000|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
147257177|NCT01641692|531114317|FG001|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
147257178|NCT01641692|531114318|FG002|Washout Period 2 (12-14 Days)|Withdrawal by Subject|1|||
147257179|NCT01641692|531114319|FG003|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
147257180|NCT01641692|531114320|FG004|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
147257181|NCT01641692|531114321|FG005|Washout Period 2 (12-14 Days)|Withdrawal by Subject|1|||
147257182|NCT01641692|531114322|FG006|Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
147257183|NCT01641692|531114323|FG007|Washout Period 2 (12-14 Days)|Withdrawal by Subject|1|||
147257184|NCT01641692|531114316|FG000|Treatment Period 3|Adverse Event|0|||
147257185|NCT01641692|531114317|FG001|Treatment Period 3|Adverse Event|0|||
147661596|NCT03286218|532583053|FG002|Treatment Phase Period 1|Withdrawal by Subject|1|||
147661597|NCT03286218|532583054|FG003|Treatment Phase Period 1|Withdrawal by Subject|1|||
147661598|NCT03286218|532583055|FG004|Treatment Phase Period 1|Withdrawal by Subject|0|||
147257186|NCT01641692|531114318|FG002|Treatment Period 3|Adverse Event|0|||
147257187|NCT01641692|531114319|FG003|Treatment Period 3|Adverse Event|0|||
147257188|NCT01641692|531114320|FG004|Treatment Period 3|Adverse Event|0|||
147257189|NCT01641692|531114321|FG005|Treatment Period 3|Adverse Event|0|||
147257190|NCT01641692|531114322|FG006|Treatment Period 3|Adverse Event|1|||
147257191|NCT01641692|531114323|FG007|Treatment Period 3|Adverse Event|0|||
147257192|NCT01641692|531114316|FG000|Treatment Period 3|Protocol Violation|0|||
147257193|NCT01641692|531114317|FG001|Treatment Period 3|Protocol Violation|0|||
147257194|NCT01641692|531114318|FG002|Treatment Period 3|Protocol Violation|1|||
147257195|NCT01641692|531114319|FG003|Treatment Period 3|Protocol Violation|0|||
147257196|NCT01641692|531114320|FG004|Treatment Period 3|Protocol Violation|0|||
147257197|NCT01641692|531114321|FG005|Treatment Period 3|Protocol Violation|0|||
147257198|NCT01641692|531114322|FG006|Treatment Period 3|Protocol Violation|0|||
147257199|NCT01641692|531114323|FG007|Treatment Period 3|Protocol Violation|0|||
147257200|NCT01641692|531114316|FG000|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
147257201|NCT01641692|531114317|FG001|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
147257202|NCT01641692|531114318|FG002|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
147257203|NCT01641692|531114319|FG003|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
147257204|NCT01641692|531114320|FG004|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
147257205|NCT01641692|531114321|FG005|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
147257206|NCT01641692|531114322|FG006|Treatment Period 3|Protocol-defined Stopping Criteria|1|||
147257207|NCT01641692|531114323|FG007|Treatment Period 3|Protocol-defined Stopping Criteria|0|||
147257208|NCT01641692|531114316|FG000|Treatment Period 3|Lost to Follow-up|0|||
147257209|NCT01641692|531114317|FG001|Treatment Period 3|Lost to Follow-up|1|||
147257210|NCT01641692|531114318|FG002|Treatment Period 3|Lost to Follow-up|0|||
147257211|NCT01641692|531114319|FG003|Treatment Period 3|Lost to Follow-up|0|||
147257212|NCT01641692|531114320|FG004|Treatment Period 3|Lost to Follow-up|0|||
147257213|NCT01641692|531114321|FG005|Treatment Period 3|Lost to Follow-up|0|||
147257214|NCT01641692|531114322|FG006|Treatment Period 3|Lost to Follow-up|0|||
147257215|NCT01641692|531114323|FG007|Treatment Period 3|Lost to Follow-up|0|||
147257216|NCT01641692|531114316|FG000|Washout Period 3 or Follow-up|Protocol Violation|0|||
147257217|NCT01641692|531114317|FG001|Washout Period 3 or Follow-up|Protocol Violation|0|||
147257218|NCT01641692|531114318|FG002|Washout Period 3 or Follow-up|Protocol Violation|0|||
147257219|NCT01641692|531114319|FG003|Washout Period 3 or Follow-up|Protocol Violation|0|||
147257220|NCT01641692|531114320|FG004|Washout Period 3 or Follow-up|Protocol Violation|0|||
147257221|NCT01641692|531114321|FG005|Washout Period 3 or Follow-up|Protocol Violation|1|||
147257222|NCT01641692|531114322|FG006|Washout Period 3 or Follow-up|Protocol Violation|0|||
147257223|NCT01641692|531114323|FG007|Washout Period 3 or Follow-up|Protocol Violation|0|||
147257224|NCT01641692|531114316|FG000|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1|||
147257225|NCT01641692|531114317|FG001|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|0|||
147257226|NCT01641692|531114318|FG002|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1|||
147257227|NCT01641692|531114319|FG003|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1|||
147257228|NCT01641692|531114320|FG004|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|0|||
147257229|NCT01641692|531114321|FG005|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1|||
147257230|NCT01641692|531114322|FG006|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|1|||
147257231|NCT01641692|531114323|FG007|Washout Period 3 or Follow-up|Protocol-defined Stopping Criteria|0|||
147257232|NCT01474876|531114324|FG000|Overall Study|Adverse Event|11|||
147257233|NCT01474876|531114325|FG001|Overall Study|Adverse Event|5|||
147257234|NCT01474876|531114326|FG002|Overall Study|Adverse Event|0|||
147257235|NCT01474876|531114324|FG000|Overall Study|Serious Adverse Event|2|||
147257236|NCT01474876|531114325|FG001|Overall Study|Serious Adverse Event|3|||
147257237|NCT01474876|531114326|FG002|Overall Study|Serious Adverse Event|0|||
147257238|NCT01474876|531114324|FG000|Overall Study|Lost to Follow-up|5|||
147257239|NCT01474876|531114325|FG001|Overall Study|Lost to Follow-up|4|||
147257240|NCT01474876|531114326|FG002|Overall Study|Lost to Follow-up|0|||
147257241|NCT01474876|531114324|FG000|Overall Study|Investigator's decision|28|||
147257242|NCT01474876|531114325|FG001|Overall Study|Investigator's decision|6|||
147257243|NCT01474876|531114326|FG002|Overall Study|Investigator's decision|0|||
147257244|NCT01474876|531114324|FG000|Overall Study|Patient's request|19|||
147257245|NCT01474876|531114325|FG001|Overall Study|Patient's request|5|||
147257246|NCT01474876|531114326|FG002|Overall Study|Patient's request|0|||
147257247|NCT01474876|531114324|FG000|Overall Study|Investigator's decision and pt request|1|||
147257248|NCT01474876|531114325|FG001|Overall Study|Investigator's decision and pt request|0|||
147257249|NCT01474876|531114326|FG002|Overall Study|Investigator's decision and pt request|0|||
147257250|NCT02291055|531114327|FG000|Overall Study|Death|2|||
147257251|NCT02291055|531114328|FG001|Overall Study|Death|2|||
147257252|NCT02291055|531114329|FG002|Overall Study|Death|5|||
147257253|NCT02291055|531114330|FG003|Overall Study|Death|8|||
147257254|NCT02291055|531114331|FG004|Overall Study|Death|12|||
147257255|NCT02291055|531114327|FG000|Overall Study|Lost to Follow-up|0|||
147257256|NCT02291055|531114328|FG001|Overall Study|Lost to Follow-up|0|||
147257257|NCT02291055|531114329|FG002|Overall Study|Lost to Follow-up|0|||
147257258|NCT02291055|531114330|FG003|Overall Study|Lost to Follow-up|1|||
147257259|NCT02291055|531114331|FG004|Overall Study|Lost to Follow-up|2|||
147257260|NCT02291055|531114327|FG000|Overall Study|Withdrawal by Subject|3|||
147257261|NCT02291055|531114328|FG001|Overall Study|Withdrawal by Subject|1|||
147257262|NCT02291055|531114329|FG002|Overall Study|Withdrawal by Subject|1|||
147257263|NCT02291055|531114330|FG003|Overall Study|Withdrawal by Subject|5|||
147257264|NCT02291055|531114331|FG004|Overall Study|Withdrawal by Subject|10|||
147257265|NCT02291055|531114327|FG000|Overall Study|Progressive Disease|0|||
147257266|NCT02291055|531114328|FG001|Overall Study|Progressive Disease|0|||
147257267|NCT02291055|531114329|FG002|Overall Study|Progressive Disease|1|||
147257268|NCT02291055|531114330|FG003|Overall Study|Progressive Disease|4|||
147257269|NCT02291055|531114331|FG004|Overall Study|Progressive Disease|2|||
147257270|NCT02291055|531114327|FG000|Overall Study|Study Terminated by Sponsor|0|||
147257271|NCT02291055|531114328|FG001|Overall Study|Study Terminated by Sponsor|0|||
147257272|NCT02291055|531114329|FG002|Overall Study|Study Terminated by Sponsor|0|||
147257273|NCT02291055|531114330|FG003|Overall Study|Study Terminated by Sponsor|5|||
147257274|NCT02291055|531114331|FG004|Overall Study|Study Terminated by Sponsor|1|||
147257275|NCT02291055|531114327|FG000|Overall Study|Other|0|||
147257276|NCT02291055|531114328|FG001|Overall Study|Other|2|||
147257277|NCT02291055|531114329|FG002|Overall Study|Other|1|||
147661599|NCT03286218|532583056|FG005|Treatment Phase Period 1|Withdrawal by Subject|1|||
147257278|NCT02291055|531114330|FG003|Overall Study|Other|4|||
147257279|NCT02291055|531114331|FG004|Overall Study|Other|0|||
147257280|NCT01523886|531114334|FG000|Overall Study|surgery cancelled|0|||
147257281|NCT01523886|531114335|FG001|Overall Study|surgery cancelled|1|||
147257282|NCT00733746|531114347|FG000|Overall Study|Ineligible|5|||
147332714|NCT02506257|531385526|FG002|Overall Study|Protocol Violation|1|||
147332715|NCT02506257|531385527|FG003|Overall Study|Protocol Violation|0|||
147332716|NCT00964366|531385528|FG000|Overall Study|Did not qualify at Day 1|1|||
147332717|NCT00964366|531385529|FG001|Overall Study|Did not qualify at Day 1|0|||
147332718|NCT00964366|531385528|FG000|Overall Study|Withdrawal by Subject|0|||
147332719|NCT00964366|531385529|FG001|Overall Study|Withdrawal by Subject|1|||
147332720|NCT02393716|531385530|FG000|Overall Study|Death|29|||
147332721|NCT02393716|531385530|FG000|Overall Study|Withdrawal by Subject|8|||
147332722|NCT02393716|531385530|FG000|Overall Study|Device Explanted|8|||
147661600|NCT03286218|532583057|FG006|Treatment Phase Period 1|Withdrawal by Subject|0|||
147257283|NCT01173718|531114350|FG000|Overall Study|Death|17|||
147257284|NCT01173718|531114350|FG000|Overall Study|Abandonment of study graft|27|||
147257285|NCT01367158|531114351|FG000|Overall Study|Withdrew consent|0|||
147257286|NCT01367158|531114352|FG001|Overall Study|Withdrew consent|2|||
147257287|NCT01367158|531114353|FG002|Overall Study|Withdrew consent|1|||
147257288|NCT01367158|531114354|FG003|Overall Study|Withdrew consent|0|||
147257289|NCT01367158|531114355|FG004|Overall Study|Withdrew consent|2|||
147257290|NCT01367158|531114356|FG005|Overall Study|Withdrew consent|0|||
147257291|NCT01367158|531114357|FG006|Overall Study|Withdrew consent|0|||
147257292|NCT01367158|531114358|FG007|Overall Study|Withdrew consent|1|||
147332723|NCT02393716|531385530|FG000|Overall Study|Missed visit|16|||
147661601|NCT03286218|532583058|FG007|Treatment Phase Period 1|Withdrawal by Subject|0|||
147661602|NCT03286218|532583059|FG008|Treatment Phase Period 1|Withdrawal by Subject|0|||
147661603|NCT03286218|532583060|FG009|Treatment Phase Period 1|Withdrawal by Subject|0|||
147661604|NCT03286218|532583061|FG010|Treatment Phase Period 1|Withdrawal by Subject|0|||
147661605|NCT03286218|532583062|FG011|Treatment Phase Period 1|Withdrawal by Subject|1|||
147661606|NCT03286218|532583051|FG000|Treatment Phase Period 4|Withdrawal by Subject|0|||
147661607|NCT03286218|532583052|FG001|Treatment Phase Period 4|Withdrawal by Subject|0|||
147661608|NCT03286218|532583053|FG002|Treatment Phase Period 4|Withdrawal by Subject|0|||
147661609|NCT03286218|532583054|FG003|Treatment Phase Period 4|Withdrawal by Subject|0|||
147661610|NCT03286218|532583055|FG004|Treatment Phase Period 4|Withdrawal by Subject|0|||
147661611|NCT03286218|532583056|FG005|Treatment Phase Period 4|Withdrawal by Subject|0|||
147661612|NCT03286218|532583057|FG006|Treatment Phase Period 4|Withdrawal by Subject|0|||
147661613|NCT03286218|532583058|FG007|Treatment Phase Period 4|Withdrawal by Subject|0|||
147661614|NCT03286218|532583059|FG008|Treatment Phase Period 4|Withdrawal by Subject|0|||
147661615|NCT03286218|532583060|FG009|Treatment Phase Period 4|Withdrawal by Subject|0|||
147661616|NCT03286218|532583061|FG010|Treatment Phase Period 4|Withdrawal by Subject|0|||
147661617|NCT03286218|532583062|FG011|Treatment Phase Period 4|Withdrawal by Subject|1|||
147661618|NCT00458003|532583063|FG000|Overall Study|Non protocol spinal anesthesia|1|||
147661619|NCT00458003|532583064|FG001|Overall Study|Non protocol spinal anesthesia|1|||
147661620|NCT01278342|532583067|FG000|Overall Study|Physician Decision|0|||
147661621|NCT01278342|532583068|FG001|Overall Study|Physician Decision|1|||
147332724|NCT01924767|531385533|FG000|Overall Study|Adverse Event|1|||
147332725|NCT01924767|531385534|FG001|Overall Study|Adverse Event|0|||
147332726|NCT01924767|531385535|FG002|Overall Study|Adverse Event|1|||
147661622|NCT01278342|532583069|FG002|Overall Study|Physician Decision|0|||
147661623|NCT01278342|532583067|FG000|Overall Study|Lost to Follow-up|1|||
147661624|NCT01278342|532583068|FG001|Overall Study|Lost to Follow-up|0|||
147661625|NCT01278342|532583069|FG002|Overall Study|Lost to Follow-up|0|||
147257293|NCT01367158|531114359|FG008|Overall Study|Withdrew consent|0|||
147257294|NCT01367158|531114360|FG009|Overall Study|Withdrew consent|0|||
147257295|NCT01367158|531114361|FG010|Overall Study|Withdrew consent|0|||
147257296|NCT01367158|531114351|FG000|Overall Study|Lost to Follow-up|0|||
147257297|NCT01367158|531114352|FG001|Overall Study|Lost to Follow-up|0|||
147257298|NCT01367158|531114353|FG002|Overall Study|Lost to Follow-up|0|||
147257299|NCT01367158|531114354|FG003|Overall Study|Lost to Follow-up|1|||
147257300|NCT01367158|531114355|FG004|Overall Study|Lost to Follow-up|0|||
147257301|NCT01367158|531114356|FG005|Overall Study|Lost to Follow-up|2|||
147257302|NCT01367158|531114357|FG006|Overall Study|Lost to Follow-up|0|||
147257303|NCT01367158|531114358|FG007|Overall Study|Lost to Follow-up|1|||
147257304|NCT01367158|531114359|FG008|Overall Study|Lost to Follow-up|0|||
147257305|NCT01367158|531114360|FG009|Overall Study|Lost to Follow-up|0|||
147257306|NCT01367158|531114361|FG010|Overall Study|Lost to Follow-up|1|||
147257307|NCT01367158|531114351|FG000|Overall Study|Protocol Violation|0|||
147257308|NCT01367158|531114352|FG001|Overall Study|Protocol Violation|1|||
147257309|NCT01367158|531114353|FG002|Overall Study|Protocol Violation|0|||
147599083|NCT01674647|532349999|FG000|30-day Safety Follow-up Period|Logistical difficulties|1|||
147599084|NCT01674647|532350000|FG001|30-day Safety Follow-up Period|Logistical difficulties|3|||
147599085|NCT01674647|532349999|FG000|30-day Safety Follow-up Period|Withdrawal by Subject|7|||
147599086|NCT01674647|532350000|FG001|30-day Safety Follow-up Period|Withdrawal by Subject|8|||
147599087|NCT01674647|532349999|FG000|30-day Safety Follow-up Period|Lost to Follow-up|8|||
147257310|NCT01367158|531114354|FG003|Overall Study|Protocol Violation|0|||
147599088|NCT01674647|532350000|FG001|30-day Safety Follow-up Period|Lost to Follow-up|5|||
147599089|NCT03212521|532350002|FG000|Overall Study|Adverse Event|1|||
147599090|NCT03212521|532350002|FG000|Overall Study|Lost to Follow-up|4|||
147599091|NCT03212521|532350002|FG000|Overall Study|Withdrawal by Subject|1|||
147599092|NCT03212521|532350002|FG000|Overall Study|Other|1|||
147599093|NCT00444457|532350003|FG000|Infant Series|Other|0|||
147599094|NCT00444457|532350004|FG001|Infant Series|Other|1|||
147599095|NCT00444457|532350005|FG002|Infant Series|Other|0|||
147599096|NCT00444457|532350006|FG003|Infant Series|Other|0|||
147599097|NCT00444457|532350003|FG000|Infant Series|Parent or legal guardian request|18|||
147599098|NCT00444457|532350004|FG001|Infant Series|Parent or legal guardian request|29|||
147599099|NCT00444457|532350005|FG002|Infant Series|Parent or legal guardian request|34|||
147599100|NCT00444457|532350006|FG003|Infant Series|Parent or legal guardian request|14|||
147599101|NCT00444457|532350003|FG000|Infant Series|Lost to Follow-up|10|||
147599102|NCT00444457|532350004|FG001|Infant Series|Lost to Follow-up|11|||
147599103|NCT00444457|532350005|FG002|Infant Series|Lost to Follow-up|7|||
147599104|NCT00444457|532350006|FG003|Infant Series|Lost to Follow-up|6|||
147599105|NCT00444457|532350003|FG000|Infant Series|Protocol Violation|16|||
147599106|NCT00444457|532350004|FG001|Infant Series|Protocol Violation|8|||
147599107|NCT00444457|532350005|FG002|Infant Series|Protocol Violation|6|||
147599108|NCT00444457|532350006|FG003|Infant Series|Protocol Violation|3|||
147599109|NCT00444457|532350003|FG000|Infant Series|Failed to return|5|||
147599110|NCT00444457|532350004|FG001|Infant Series|Failed to return|4|||
147599111|NCT00444457|532350005|FG002|Infant Series|Failed to return|4|||
147599112|NCT00444457|532350006|FG003|Infant Series|Failed to return|2|||
147599113|NCT00444457|532350003|FG000|Infant Series|Investigator request|4|||
147599114|NCT00444457|532350004|FG001|Infant Series|Investigator request|3|||
147599115|NCT00444457|532350005|FG002|Infant Series|Investigator request|3|||
147599116|NCT00444457|532350006|FG003|Infant Series|Investigator request|2|||
147599117|NCT00444457|532350003|FG000|Infant Series|Other|0|||
147599118|NCT00444457|532350004|FG001|Infant Series|Other|2|||
147599119|NCT00444457|532350005|FG002|Infant Series|Other|4|||
147599120|NCT00444457|532350006|FG003|Infant Series|Other|0|||
147599121|NCT00444457|532350003|FG000|Infant Series|Adverse Event|1|||
147599122|NCT00444457|532350004|FG001|Infant Series|Adverse Event|2|||
147599123|NCT00444457|532350005|FG002|Infant Series|Adverse Event|2|||
147599124|NCT00444457|532350006|FG003|Infant Series|Adverse Event|0|||
147599125|NCT00444457|532350003|FG000|Infant Series|Death|0|||
147599126|NCT00444457|532350004|FG001|Infant Series|Death|1|||
147599127|NCT00444457|532350005|FG002|Infant Series|Death|1|||
147599128|NCT00444457|532350006|FG003|Infant Series|Death|1|||
147599129|NCT00444457|532350003|FG000|After Infant Series|Other|0|||
147599130|NCT00444457|532350004|FG001|After Infant Series|Other|1|||
147599131|NCT00444457|532350005|FG002|After Infant Series|Other|1|||
147599132|NCT00444457|532350006|FG003|After Infant Series|Other|1|||
147599133|NCT00444457|532350003|FG000|After Infant Series|Parent or legal guardian request|4|||
147599134|NCT00444457|532350004|FG001|After Infant Series|Parent or legal guardian request|11|||
147599135|NCT00444457|532350005|FG002|After Infant Series|Parent or legal guardian request|6|||
147599136|NCT00444457|532350006|FG003|After Infant Series|Parent or legal guardian request|3|||
147599137|NCT00444457|532350003|FG000|After Infant Series|Failed to return|7|||
147599138|NCT00444457|532350004|FG001|After Infant Series|Failed to return|6|||
147599139|NCT00444457|532350005|FG002|After Infant Series|Failed to return|5|||
147599140|NCT00444457|532350006|FG003|After Infant Series|Failed to return|1|||
147599141|NCT00444457|532350003|FG000|After Infant Series|Lost to Follow-up|5|||
147599142|NCT00444457|532350004|FG001|After Infant Series|Lost to Follow-up|5|||
147661626|NCT01278342|532583067|FG000|Overall Study|Administrative problems|2|||
147257311|NCT01367158|531114355|FG004|Overall Study|Protocol Violation|0|||
147257312|NCT01367158|531114356|FG005|Overall Study|Protocol Violation|0|||
147257313|NCT01367158|531114357|FG006|Overall Study|Protocol Violation|0|||
147257314|NCT01367158|531114358|FG007|Overall Study|Protocol Violation|0|||
147599143|NCT00444457|532350005|FG002|After Infant Series|Lost to Follow-up|5|||
147599144|NCT00444457|532350006|FG003|After Infant Series|Lost to Follow-up|2|||
147599145|NCT00444457|532350003|FG000|After Infant Series|Protocol Violation|2|||
147257315|NCT01367158|531114359|FG008|Overall Study|Protocol Violation|0|||
147257316|NCT01367158|531114360|FG009|Overall Study|Protocol Violation|0|||
147257317|NCT01367158|531114361|FG010|Overall Study|Protocol Violation|0|||
147257318|NCT01499563|531114362|FG000|Overall Study|Withdrawal by Subject|10|||
147257319|NCT01499563|531114363|FG001|Overall Study|Withdrawal by Subject|11|||
147257320|NCT01499563|531114364|FG002|Overall Study|Withdrawal by Subject|7|||
147257321|NCT01499563|531114365|FG003|Overall Study|Withdrawal by Subject|8|||
147257322|NCT01499563|531114362|FG000|Overall Study|Physician Decision|2|||
147257323|NCT01499563|531114363|FG001|Overall Study|Physician Decision|1|||
147257324|NCT01499563|531114364|FG002|Overall Study|Physician Decision|3|||
147257325|NCT01499563|531114365|FG003|Overall Study|Physician Decision|0|||
147257326|NCT01499563|531114362|FG000|Overall Study|Specific Request of Sponsor or Investigator|2|||
147257327|NCT01499563|531114363|FG001|Overall Study|Specific Request of Sponsor or Investigator|0|||
147257328|NCT01499563|531114364|FG002|Overall Study|Specific Request of Sponsor or Investigator|1|||
147257329|NCT01499563|531114365|FG003|Overall Study|Specific Request of Sponsor or Investigator|1|||
147257330|NCT01499563|531114362|FG000|Overall Study|Adverse Event|2|||
147257331|NCT01499563|531114363|FG001|Overall Study|Adverse Event|0|||
147257332|NCT01499563|531114364|FG002|Overall Study|Adverse Event|1|||
147257333|NCT01499563|531114365|FG003|Overall Study|Adverse Event|3|||
147257334|NCT01499563|531114362|FG000|Overall Study|Lack of Efficacy|0|||
147257335|NCT01499563|531114363|FG001|Overall Study|Lack of Efficacy|1|||
147257336|NCT01499563|531114364|FG002|Overall Study|Lack of Efficacy|6|||
147257337|NCT01499563|531114365|FG003|Overall Study|Lack of Efficacy|3|||
147257338|NCT01499563|531114362|FG000|Overall Study|Other|8|||
147257339|NCT01499563|531114363|FG001|Overall Study|Other|6|||
147257340|NCT01499563|531114364|FG002|Overall Study|Other|6|||
147257341|NCT01499563|531114365|FG003|Overall Study|Other|4|||
147257342|NCT03658538|531114368|FG000|Overall Study|Death|2|||
147257343|NCT03658538|531114369|FG001|Overall Study|Death|1|||
147257344|NCT03658538|531114368|FG000|Overall Study|Cancer diagnosis|1|||
147257345|NCT03658538|531114369|FG001|Overall Study|Cancer diagnosis|0|||
147257346|NCT03658538|531114368|FG000|Overall Study|Change residence|1|||
147257347|NCT03658538|531114369|FG001|Overall Study|Change residence|2|||
147257348|NCT03658538|531114368|FG000|Overall Study|Lost to Follow-up|3|||
147257349|NCT03658538|531114369|FG001|Overall Study|Lost to Follow-up|3|||
147257350|NCT03658538|531114368|FG000|Overall Study|Unblinded|2|||
147257351|NCT03658538|531114369|FG001|Overall Study|Unblinded|3|||
147257352|NCT03658538|531114368|FG000|Overall Study|Physician Decision|0|||
147257353|NCT03658538|531114369|FG001|Overall Study|Physician Decision|1|||
147257354|NCT03658538|531114368|FG000|Overall Study|Incomplete clinical visit at 6 months due to illness|1|||
147257355|NCT03658538|531114369|FG001|Overall Study|Incomplete clinical visit at 6 months due to illness|0|||
147332727|NCT01924767|531385536|FG003|Overall Study|Adverse Event|0|||
147332728|NCT01924767|531385537|FG004|Overall Study|Adverse Event|0|||
147599146|NCT00444457|532350004|FG001|After Infant Series|Protocol Violation|4|||
147599147|NCT00444457|532350005|FG002|After Infant Series|Protocol Violation|2|||
147599148|NCT00444457|532350006|FG003|After Infant Series|Protocol Violation|2|||
147599149|NCT00444457|532350003|FG000|After Infant Series|Adverse Event|2|||
147599150|NCT00444457|532350004|FG001|After Infant Series|Adverse Event|2|||
147599151|NCT00444457|532350005|FG002|After Infant Series|Adverse Event|0|||
147599152|NCT00444457|532350006|FG003|After Infant Series|Adverse Event|0|||
147599153|NCT00444457|532350003|FG000|After Infant Series|Investigator request|0|||
147599154|NCT00444457|532350004|FG001|After Infant Series|Investigator request|0|||
147599155|NCT00444457|532350005|FG002|After Infant Series|Investigator request|0|||
147599156|NCT00444457|532350006|FG003|After Infant Series|Investigator request|1|||
147599157|NCT00444457|532350003|FG000|After Infant Series|Other|0|||
147599158|NCT00444457|532350004|FG001|After Infant Series|Other|1|||
147599159|NCT00444457|532350005|FG002|After Infant Series|Other|0|||
147599160|NCT00444457|532350006|FG003|After Infant Series|Other|0|||
147599161|NCT00444457|532350003|FG000|Toddler Dose|Lost to Follow-up|4|||
147599162|NCT00444457|532350004|FG001|Toddler Dose|Lost to Follow-up|1|||
147599163|NCT00444457|532350005|FG002|Toddler Dose|Lost to Follow-up|1|||
147599164|NCT00444457|532350006|FG003|Toddler Dose|Lost to Follow-up|3|||
147599165|NCT00444457|532350003|FG000|Toddler Dose|Failed to return|2|||
147599166|NCT00444457|532350004|FG001|Toddler Dose|Failed to return|2|||
147599167|NCT00444457|532350005|FG002|Toddler Dose|Failed to return|1|||
147599168|NCT00444457|532350006|FG003|Toddler Dose|Failed to return|3|||
147599169|NCT00444457|532350003|FG000|Toddler Dose|Parent or legal guardian request|0|||
147599170|NCT00444457|532350004|FG001|Toddler Dose|Parent or legal guardian request|3|||
147599171|NCT00444457|532350005|FG002|Toddler Dose|Parent or legal guardian request|2|||
147661627|NCT01278342|532583068|FG001|Overall Study|Administrative problems|0|||
147257356|NCT03658538|531114368|FG000|Overall Study|Evicted from home|1|||
147257357|NCT03658538|531114369|FG001|Overall Study|Evicted from home|0|||
147257358|NCT05198843|531114370|FG000|Overall Study|Lack of Efficacy|1|||
147257359|NCT02588833|531114371|FG000|Part 1|Withdrawal by Subject|1|||
147257360|NCT02588833|531114372|FG001|Part 1|Withdrawal by Subject|0|||
147257361|NCT02588833|531114371|FG000|Part 2A|Physician Decision|0|||
147257362|NCT02588833|531114372|FG001|Part 2A|Physician Decision|1|||
147257363|NCT02588833|531114371|FG000|Part 2A|Withdrawal by Subject|0|||
147257364|NCT02588833|531114372|FG001|Part 2A|Withdrawal by Subject|1|||
147661628|NCT01278342|532583069|FG002|Overall Study|Administrative problems|0|||
147661629|NCT01278342|532583067|FG000|Overall Study|Other|1|||
147661630|NCT01278342|532583068|FG001|Overall Study|Other|0|||
147661631|NCT01278342|532583069|FG002|Overall Study|Other|0|||
147661632|NCT04742673|532583073|FG000|Overall Study|Did not receive any study drug and not included in assessments or results|4|||
147661633|NCT04742673|532583074|FG001|Overall Study|Did not receive any study drug and not included in assessments or results|3|||
147661634|NCT04073303|532583076|FG000|Overall Study|Adverse Event|0|||
147661635|NCT04073303|532583077|FG001|Overall Study|Adverse Event|2|||
147661636|NCT04073303|532583076|FG000|Overall Study|Withdrawal by Subject|16|||
147661637|NCT04073303|532583077|FG001|Overall Study|Withdrawal by Subject|36|||
147661638|NCT04073303|532583076|FG000|Overall Study|Lost to Follow-up|6|||
147661639|NCT04073303|532583077|FG001|Overall Study|Lost to Follow-up|1|||
147661640|NCT04073303|532583076|FG000|Overall Study|Protocol Deviation|0|||
147661641|NCT04073303|532583077|FG001|Overall Study|Protocol Deviation|4|||
147661642|NCT04073303|532583076|FG000|Overall Study|Other|1|||
147661643|NCT04073303|532583077|FG001|Overall Study|Other|1|||
147661644|NCT00426764|532583083|FG000|Overall Study|Protocol Violation|1|||
147661645|NCT00426764|532583083|FG000|Overall Study|Withdrawal by Subject|4|||
147661646|NCT00426764|532583083|FG000|Overall Study|Physician Decision|6|||
147661647|NCT00426764|532583083|FG000|Overall Study|Compassionate Use|1|||
147661648|NCT00426764|532583083|FG000|Overall Study|Progressive Disease|83|||
147661649|NCT00426764|532583083|FG000|Overall Study|Adverse Event|24|||
147661650|NCT00426764|532583083|FG000|Overall Study|Other|1|||
147661651|NCT00426764|532583083|FG000|Overall Study|Death|1|||
147661652|NCT00426764|532583083|FG000|Overall Study|Other Reasons (Miscellaneous)|10|||
147661653|NCT00096538|532583091|FG000|Overall Study|Withdrawal by Subject|1|||
147661654|NCT02686164|532583093|FG000|Overall Study|Adverse Event|1|||
147661655|NCT02686164|532583093|FG000|Overall Study|Withdrawal of consent|1|||
147661656|NCT02686164|532583093|FG000|Overall Study|Clinical progression|1|||
147661657|NCT01691378|532583094|FG000|Overall Study|Withdrawal by Subject|2|||
147661658|NCT01691378|532583095|FG001|Overall Study|Withdrawal by Subject|0|||
147661659|NCT01691378|532583094|FG000|Overall Study|Lost to Follow-up|5|||
147661660|NCT01691378|532583095|FG001|Overall Study|Lost to Follow-up|2|||
147661661|NCT02324361|532583098|FG000|Overall Study|Lost to Follow-up|5|||
147661662|NCT02324361|532583099|FG001|Overall Study|Lost to Follow-up|2|||
147661663|NCT00003471|532583104|FG000|Overall Study|Not evaluable|4|||
147661664|NCT00715403|532583105|FG000|Overall Study|Progressive disease|0|||
147661665|NCT00715403|532583106|FG001|Overall Study|Progressive disease|1|||
147661666|NCT00715403|532583107|FG002|Overall Study|Progressive disease|3|||
147661667|NCT00715403|532583108|FG003|Overall Study|Progressive disease|9|||
147661668|NCT00715403|532583109|FG004|Overall Study|Progressive disease|5|||
147661669|NCT00715403|532583110|FG005|Overall Study|Progressive disease|14|||
147661670|NCT00715403|532583111|FG006|Overall Study|Progressive disease|1|||
147661671|NCT00715403|532583105|FG000|Overall Study|Dose limiting Toxicity (DLT)|0|||
147661672|NCT00715403|532583106|FG001|Overall Study|Dose limiting Toxicity (DLT)|0|||
147661673|NCT00715403|532583107|FG002|Overall Study|Dose limiting Toxicity (DLT)|0|||
147661674|NCT00715403|532583108|FG003|Overall Study|Dose limiting Toxicity (DLT)|0|||
147661675|NCT00715403|532583109|FG004|Overall Study|Dose limiting Toxicity (DLT)|0|||
147661676|NCT00715403|532583110|FG005|Overall Study|Dose limiting Toxicity (DLT)|1|||
147661677|NCT00715403|532583111|FG006|Overall Study|Dose limiting Toxicity (DLT)|0|||
147661678|NCT00715403|532583105|FG000|Overall Study|Other Adverse Event than DLT|1|||
147661679|NCT00715403|532583106|FG001|Overall Study|Other Adverse Event than DLT|0|||
147661680|NCT00715403|532583107|FG002|Overall Study|Other Adverse Event than DLT|0|||
147661681|NCT00715403|532583108|FG003|Overall Study|Other Adverse Event than DLT|0|||
147661682|NCT00715403|532583109|FG004|Overall Study|Other Adverse Event than DLT|0|||
147661683|NCT00715403|532583110|FG005|Overall Study|Other Adverse Event than DLT|2|||
147661684|NCT00715403|532583111|FG006|Overall Study|Other Adverse Event than DLT|0|||
147332729|NCT01193153|531385538|FG000|Open-label Lead in Period|Lost to Follow-up|32|||
147332730|NCT01193153|531385539|FG001|Open-label Lead in Period|Lost to Follow-up|0|||
147332731|NCT01193153|531385538|FG000|Open-label Lead in Period|Pregnancy|1|||
147661685|NCT00715403|532583105|FG000|Overall Study|Protocol Violation|0|||
147661686|NCT00715403|532583106|FG001|Overall Study|Protocol Violation|0|||
147661687|NCT00715403|532583107|FG002|Overall Study|Protocol Violation|0|||
147661688|NCT00715403|532583108|FG003|Overall Study|Protocol Violation|0|||
147661689|NCT00715403|532583109|FG004|Overall Study|Protocol Violation|0|||
147661690|NCT00715403|532583110|FG005|Overall Study|Protocol Violation|1|||
147661691|NCT00715403|532583111|FG006|Overall Study|Protocol Violation|0|||
147661692|NCT00715403|532583105|FG000|Overall Study|Other reason not defined above|0|||
147661693|NCT00715403|532583106|FG001|Overall Study|Other reason not defined above|0|||
147661694|NCT00715403|532583107|FG002|Overall Study|Other reason not defined above|1|||
147661695|NCT00715403|532583108|FG003|Overall Study|Other reason not defined above|0|||
147661696|NCT00715403|532583109|FG004|Overall Study|Other reason not defined above|1|||
147332732|NCT01193153|531385539|FG001|Open-label Lead in Period|Pregnancy|0|||
147661697|NCT00715403|532583110|FG005|Overall Study|Other reason not defined above|1|||
147661698|NCT00715403|532583111|FG006|Overall Study|Other reason not defined above|0|||
147661699|NCT04235504|532583115|FG000|Study Phase|Withdrawal by Subject|5|||
147257365|NCT02588833|531114371|FG000|Part 2B|Adverse Event|0|||
147257366|NCT02588833|531114372|FG001|Part 2B|Adverse Event|1|||
147257367|NCT02588833|531114371|FG000|Part 2C|Adverse Event|0|||
147257368|NCT02588833|531114372|FG001|Part 2C|Adverse Event|1|||
147257369|NCT02588833|531114371|FG000|Part 2C|Withdrawal by Subject|0|||
147257370|NCT02588833|531114372|FG001|Part 2C|Withdrawal by Subject|1|||
147257371|NCT02588833|531114371|FG000|Part 3 (Safety Follow-up)|Other|0|||
147257372|NCT02588833|531114372|FG001|Part 3 (Safety Follow-up)|Other|2|||
147257373|NCT03333044|531114373|FG000|Overall Study|Pregnancy|1|||
147257374|NCT03333044|531114374|FG001|Overall Study|Pregnancy|0|||
147257375|NCT03333044|531114375|FG002|Overall Study|Pregnancy|0|||
147257376|NCT03333044|531114373|FG000|Overall Study|Lost to Follow-up|0|||
147257377|NCT03333044|531114374|FG001|Overall Study|Lost to Follow-up|14|||
147257378|NCT03333044|531114375|FG002|Overall Study|Lost to Follow-up|6|||
147257379|NCT03649711|531114378|FG000|Overall Study|Adverse Event|0|||
147257380|NCT03649711|531114379|FG001|Overall Study|Adverse Event|1|||
147257381|NCT03649711|531114380|FG002|Overall Study|Adverse Event|0|||
147257382|NCT03649711|531114378|FG000|Overall Study|Kidney Transplant|1|||
147257383|NCT03649711|531114379|FG001|Overall Study|Kidney Transplant|0|||
147257384|NCT03649711|531114380|FG002|Overall Study|Kidney Transplant|0|||
147257385|NCT02921776|531114381|FG000|Overall Study|patient deterioration, fatigue|2|||
147257386|NCT02921776|531114382|FG001|Overall Study|patient deterioration, fatigue|6|||
147257387|NCT02921776|531114383|FG002|Overall Study|patient deterioration, fatigue|0|||
147257388|NCT02921776|531114384|FG003|Overall Study|patient deterioration, fatigue|0|||
147257389|NCT02921776|531114385|FG004|Overall Study|patient deterioration, fatigue|0|||
147257390|NCT02921776|531114386|FG005|Overall Study|patient deterioration, fatigue|0|||
147257391|NCT02921776|531114387|FG006|Overall Study|patient deterioration, fatigue|0|||
147257392|NCT02921776|531114388|FG007|Overall Study|patient deterioration, fatigue|0|||
147332733|NCT01193153|531385538|FG000|Open-label Lead in Period|Withdrawal by Subject|69|||
147332734|NCT01193153|531385539|FG001|Open-label Lead in Period|Withdrawal by Subject|0|||
147332735|NCT01193153|531385538|FG000|Open-label Lead in Period|> 6 Weeks Between 2 Study Drug|4|||
147332736|NCT01193153|531385539|FG001|Open-label Lead in Period|> 6 Weeks Between 2 Study Drug|0|||
147332737|NCT01193153|531385538|FG000|Open-label Lead in Period|Other|14|||
147332738|NCT01193153|531385539|FG001|Open-label Lead in Period|Other|0|||
147332739|NCT01193153|531385538|FG000|Open-label Lead in Period|Subject Failed Stabilization Criteria|47|||
147332740|NCT01193153|531385539|FG001|Open-label Lead in Period|Subject Failed Stabilization Criteria|0|||
147332741|NCT01193153|531385538|FG000|Open-label Lead in Period|Adverse Event|41|||
147332742|NCT01193153|531385539|FG001|Open-label Lead in Period|Adverse Event|0|||
147332743|NCT01193153|531385538|FG000|Open-label Lead in Period|Death|1|||
147599172|NCT00444457|532350006|FG003|Toddler Dose|Parent or legal guardian request|1|||
147599173|NCT00444457|532350003|FG000|Toddler Dose|Protocol Violation|1|||
147599174|NCT00444457|532350004|FG001|Toddler Dose|Protocol Violation|0|||
147599175|NCT00444457|532350005|FG002|Toddler Dose|Protocol Violation|0|||
147599176|NCT00444457|532350006|FG003|Toddler Dose|Protocol Violation|1|||
147599177|NCT00914459|532350009|FG000|Overall Study|Protocol Violation|0|||
147599178|NCT00914459|532350010|FG001|Overall Study|Protocol Violation|1|||
147599179|NCT00914459|532350009|FG000|Overall Study|Parent/Legal guardian request|1|||
147599180|NCT00914459|532350010|FG001|Overall Study|Parent/Legal guardian request|0|||
147599181|NCT01661179|532350011|FG000|Overall Study|Death|1|||
147599182|NCT01661179|532350011|FG000|Overall Study|Withdrawal by Subject|1|||
147599183|NCT01661179|532350011|FG000|Overall Study|Other Eligibility criteria|4|||
147599184|NCT01602965|532350012|FG000|Overall Study|Lost to Follow-up|4|||
147599185|NCT01602965|532350013|FG001|Overall Study|Lost to Follow-up|2|||
147599186|NCT03118570|532350014|FG000|Overall Study|Adverse Event|2|||
147599187|NCT03118570|532350015|FG001|Overall Study|Adverse Event|0|||
147599188|NCT03118570|532350016|FG002|Overall Study|Adverse Event|0|||
147599189|NCT03118570|532350017|FG003|Overall Study|Adverse Event|0|||
147599190|NCT03118570|532350018|FG004|Overall Study|Adverse Event|3|||
147599191|NCT03118570|532350014|FG000|Overall Study|Withdrawal by Subject|0|||
147599192|NCT03118570|532350015|FG001|Overall Study|Withdrawal by Subject|1|||
147599193|NCT03118570|532350016|FG002|Overall Study|Withdrawal by Subject|4|||
147599194|NCT03118570|532350017|FG003|Overall Study|Withdrawal by Subject|0|||
147661700|NCT04235504|532583116|FG001|Study Phase|Withdrawal by Subject|2|||
147661701|NCT04235504|532583117|FG002|Study Phase|Withdrawal by Subject|0|||
147257393|NCT02921776|531114381|FG000|Overall Study|Withdrawal by Subject|0|||
147257394|NCT02921776|531114382|FG001|Overall Study|Withdrawal by Subject|2|||
147257395|NCT02921776|531114383|FG002|Overall Study|Withdrawal by Subject|0|||
147257396|NCT02921776|531114384|FG003|Overall Study|Withdrawal by Subject|1|||
147257397|NCT02921776|531114385|FG004|Overall Study|Withdrawal by Subject|1|||
147257398|NCT02921776|531114386|FG005|Overall Study|Withdrawal by Subject|0|||
147257399|NCT02921776|531114387|FG006|Overall Study|Withdrawal by Subject|8|||
147257400|NCT02921776|531114388|FG007|Overall Study|Withdrawal by Subject|1|||
147257401|NCT02921776|531114381|FG000|Overall Study|Death|0|||
147257402|NCT02921776|531114382|FG001|Overall Study|Death|0|||
147599195|NCT03118570|532350018|FG004|Overall Study|Withdrawal by Subject|1|||
147599196|NCT03118570|532350014|FG000|Overall Study|Lost to Follow-up|2|||
147599197|NCT03118570|532350015|FG001|Overall Study|Lost to Follow-up|3|||
147599198|NCT03118570|532350016|FG002|Overall Study|Lost to Follow-up|1|||
147599199|NCT03118570|532350017|FG003|Overall Study|Lost to Follow-up|0|||
147599200|NCT03118570|532350018|FG004|Overall Study|Lost to Follow-up|1|||
147599201|NCT03118570|532350014|FG000|Overall Study|Other, Not Specified|1|||
147599202|NCT03118570|532350015|FG001|Overall Study|Other, Not Specified|3|||
147599203|NCT03118570|532350016|FG002|Overall Study|Other, Not Specified|0|||
147599204|NCT03118570|532350017|FG003|Overall Study|Other, Not Specified|0|||
147599205|NCT03118570|532350018|FG004|Overall Study|Other, Not Specified|0|||
147257403|NCT02921776|531114383|FG002|Overall Study|Death|0|||
147257404|NCT02921776|531114384|FG003|Overall Study|Death|2|||
147257405|NCT02921776|531114385|FG004|Overall Study|Death|0|||
147257406|NCT02921776|531114386|FG005|Overall Study|Death|0|||
147257407|NCT02921776|531114387|FG006|Overall Study|Death|0|||
147599206|NCT03071094|532350022|FG000|Overall Study|Death|1|||
147599207|NCT03071094|532350023|FG001|Overall Study|Death|1|||
147599208|NCT03071094|532350022|FG000|Overall Study|Adverse Event|1|||
147599209|NCT03071094|532350023|FG001|Overall Study|Adverse Event|0|||
147599210|NCT02312063|532350024|FG000|Overall Study|Withdrawal by Subject|0|||
147599211|NCT02312063|532350025|FG001|Overall Study|Withdrawal by Subject|1|||
147599212|NCT00321737|532350031|FG000|Overall Study|Relapse of Erosive Esophagitis|76|||
147599213|NCT00321737|532350032|FG001|Overall Study|Relapse of Erosive Esophagitis|25|||
147599214|NCT00321737|532350033|FG002|Overall Study|Relapse of Erosive Esophagitis|19|||
147599215|NCT00321737|532350031|FG000|Overall Study|Adverse Event|11|||
147599216|NCT00321737|532350032|FG001|Overall Study|Adverse Event|3|||
147599217|NCT00321737|532350033|FG002|Overall Study|Adverse Event|6|||
147599218|NCT00321737|532350031|FG000|Overall Study|Lost to Follow-up|5|||
147599219|NCT00321737|532350032|FG001|Overall Study|Lost to Follow-up|5|||
147599220|NCT00321737|532350033|FG002|Overall Study|Lost to Follow-up|6|||
147599221|NCT00321737|532350031|FG000|Overall Study|Withdrawal by Subject|19|||
147599222|NCT00321737|532350032|FG001|Overall Study|Withdrawal by Subject|12|||
147599223|NCT00321737|532350033|FG002|Overall Study|Withdrawal by Subject|17|||
147599224|NCT00321737|532350031|FG000|Overall Study|Protocol Violation|0|||
147599225|NCT00321737|532350032|FG001|Overall Study|Protocol Violation|0|||
147599226|NCT00321737|532350033|FG002|Overall Study|Protocol Violation|1|||
147599227|NCT00321737|532350031|FG000|Overall Study|Unmet Inclusion/Exclusion Criteria|1|||
147599228|NCT00321737|532350032|FG001|Overall Study|Unmet Inclusion/Exclusion Criteria|0|||
147599229|NCT00321737|532350033|FG002|Overall Study|Unmet Inclusion/Exclusion Criteria|0|||
147599230|NCT00321737|532350031|FG000|Overall Study|Possible Barrett's Esophagus|2|||
147599231|NCT00321737|532350032|FG001|Overall Study|Possible Barrett's Esophagus|1|||
147599232|NCT00321737|532350033|FG002|Overall Study|Possible Barrett's Esophagus|1|||
147599233|NCT00321737|532350031|FG000|Overall Study|Therapeutic Failure|6|||
147599234|NCT00321737|532350032|FG001|Overall Study|Therapeutic Failure|0|||
147599235|NCT00321737|532350033|FG002|Overall Study|Therapeutic Failure|2|||
147599236|NCT00321737|532350031|FG000|Overall Study|Pregnancy|0|||
147599237|NCT00321737|532350032|FG001|Overall Study|Pregnancy|2|||
147599238|NCT00321737|532350033|FG002|Overall Study|Pregnancy|0|||
147599239|NCT00321737|532350031|FG000|Overall Study|Noncompliance|2|||
147599240|NCT00321737|532350032|FG001|Overall Study|Noncompliance|0|||
147599241|NCT00321737|532350033|FG002|Overall Study|Noncompliance|0|||
147599242|NCT00321737|532350031|FG000|Overall Study|Subject Request/ Subject Unavailable|0|||
147599243|NCT00321737|532350032|FG001|Overall Study|Subject Request/ Subject Unavailable|0|||
147599244|NCT00321737|532350033|FG002|Overall Study|Subject Request/ Subject Unavailable|2|||
147599245|NCT01079832|532350034|FG000|Overall Study|Withdrawal by Subject|1|||
147599246|NCT02283294|532350035|FG000|Overall Study|Lost to Follow-up|1|||
147599247|NCT02283294|532350036|FG001|Overall Study|Lost to Follow-up|1|||
147599248|NCT02283294|532350035|FG000|Overall Study|Withdrawal by Subject|1|||
147599249|NCT02283294|532350036|FG001|Overall Study|Withdrawal by Subject|6|||
147599250|NCT02283294|532350035|FG000|Overall Study|Protocol Violation|1|||
147599251|NCT02283294|532350036|FG001|Overall Study|Protocol Violation|0|||
147599252|NCT02283294|532350035|FG000|Overall Study|Thrombus on transesophageal echocardiogram|0|||
147257408|NCT02921776|531114388|FG007|Overall Study|Death|0|||
147257409|NCT02921776|531114381|FG000|Overall Study|extubation or early discharge|0|||
147257410|NCT02921776|531114382|FG001|Overall Study|extubation or early discharge|0|||
147257411|NCT02921776|531114383|FG002|Overall Study|extubation or early discharge|0|||
147257412|NCT02921776|531114384|FG003|Overall Study|extubation or early discharge|5|||
147257413|NCT02921776|531114385|FG004|Overall Study|extubation or early discharge|5|||
147257414|NCT02921776|531114386|FG005|Overall Study|extubation or early discharge|0|||
147257415|NCT02921776|531114387|FG006|Overall Study|extubation or early discharge|0|||
147257416|NCT02921776|531114388|FG007|Overall Study|extubation or early discharge|0|||
147257417|NCT02921776|531114381|FG000|Overall Study|Lost to Follow-up|0|||
147599253|NCT02283294|532350036|FG001|Overall Study|Thrombus on transesophageal echocardiogram|1|||
147599254|NCT00594646|532350037|FG000|Overall Study|Withdrawal by Subject|1|||
147599255|NCT00594646|532350037|FG000|Overall Study|Lost to Follow-up|15|||
147599256|NCT01769339|532350038|FG000|Overall Study|Lost to Follow-up|42|||
147599257|NCT01769339|532350038|FG000|Overall Study|Adverse Event|1|||
147599258|NCT01195272|532350039|FG000|Overall Study|Adverse Event|1|||
147599259|NCT01195272|532350039|FG000|Overall Study|Lack of Efficacy|3|||
147257418|NCT02921776|531114382|FG001|Overall Study|Lost to Follow-up|0|||
147257419|NCT02921776|531114383|FG002|Overall Study|Lost to Follow-up|0|||
147257420|NCT02921776|531114384|FG003|Overall Study|Lost to Follow-up|0|||
147257421|NCT02921776|531114385|FG004|Overall Study|Lost to Follow-up|0|||
147257422|NCT02921776|531114386|FG005|Overall Study|Lost to Follow-up|2|||
147257423|NCT02921776|531114387|FG006|Overall Study|Lost to Follow-up|3|||
147257424|NCT02921776|531114388|FG007|Overall Study|Lost to Follow-up|6|||
147257425|NCT04537234|531114390|FG000|Overall Study|Withdrawal by Subject|2|||
147257426|NCT04537234|531114391|FG001|Overall Study|Withdrawal by Subject|0|||
147257427|NCT01721330|531114392|FG000|Overall Study|Withdrawal by Subject|0|||
147257428|NCT01721330|531114393|FG001|Overall Study|Withdrawal by Subject|1|||
147257429|NCT00296374|531114394|FG000|Overall Study|Adverse Event|14|||
147257430|NCT00296374|531114395|FG001|Overall Study|Adverse Event|10|||
147257431|NCT00296374|531114396|FG002|Overall Study|Adverse Event|7|||
147257432|NCT00296374|531114394|FG000|Overall Study|Withdrawal by Subject|3|||
147257433|NCT00296374|531114395|FG001|Overall Study|Withdrawal by Subject|5|||
147257434|NCT00296374|531114396|FG002|Overall Study|Withdrawal by Subject|11|||
147257435|NCT00296374|531114394|FG000|Overall Study|Incorrect enrollment|3|||
147257436|NCT00296374|531114395|FG001|Overall Study|Incorrect enrollment|3|||
147257437|NCT00296374|531114396|FG002|Overall Study|Incorrect enrollment|4|||
147257438|NCT00296374|531114394|FG000|Overall Study|Protocol Violation|1|||
147257439|NCT00296374|531114395|FG001|Overall Study|Protocol Violation|2|||
147257440|NCT00296374|531114396|FG002|Overall Study|Protocol Violation|3|||
147257441|NCT00296374|531114394|FG000|Overall Study|Lost to Follow-up|3|||
147257442|NCT00296374|531114395|FG001|Overall Study|Lost to Follow-up|1|||
147257443|NCT00296374|531114396|FG002|Overall Study|Lost to Follow-up|1|||
147257444|NCT00296374|531114394|FG000|Overall Study|Relocated to another state|1|||
147257445|NCT00296374|531114395|FG001|Overall Study|Relocated to another state|0|||
147257446|NCT00296374|531114396|FG002|Overall Study|Relocated to another state|0|||
147257447|NCT00296374|531114394|FG000|Overall Study|Stopped drug before end of study visit|0|||
147257448|NCT00296374|531114395|FG001|Overall Study|Stopped drug before end of study visit|1|||
147257449|NCT00296374|531114396|FG002|Overall Study|Stopped drug before end of study visit|0|||
147257450|NCT00296374|531114394|FG000|Overall Study|Nephrologist introduced ACE|0|||
147257451|NCT00296374|531114395|FG001|Overall Study|Nephrologist introduced ACE|1|||
147257452|NCT00296374|531114396|FG002|Overall Study|Nephrologist introduced ACE|0|||
147257453|NCT00296374|531114394|FG000|Overall Study|Pregnancy|0|||
147257454|NCT00296374|531114395|FG001|Overall Study|Pregnancy|0|||
147257455|NCT00296374|531114396|FG002|Overall Study|Pregnancy|2|||
147257456|NCT00296374|531114394|FG000|Overall Study|Other|0|||
147257457|NCT00296374|531114395|FG001|Overall Study|Other|0|||
147257458|NCT00296374|531114396|FG002|Overall Study|Other|1|||
147257459|NCT04318080|531116351|FG000|Overall Study|Study closed by sponsor|10|||
147257460|NCT04318080|531116352|FG001|Overall Study|Study closed by sponsor|22|||
147257461|NCT04318080|531116351|FG000|Overall Study|Death|3|||
147257462|NCT04318080|531116352|FG001|Overall Study|Death|9|||
147257463|NCT04318080|531116351|FG000|Overall Study|Withdrawal by Subject|1|||
147257464|NCT04318080|531116352|FG001|Overall Study|Withdrawal by Subject|0|||
147257465|NCT04318080|531116351|FG000|Overall Study|Protocol Deviation|1|||
147257466|NCT04318080|531116352|FG001|Overall Study|Protocol Deviation|0|||
147257467|NCT06308822|531116353|FG000|Overall Study|Mutation Status Not Confirmed|17|||
147257468|NCT06308822|531116353|FG000|Overall Study|Adverse Event|1|||
147257469|NCT06308822|531116353|FG000|Overall Study|Death|5|||
147257470|NCT06308822|531116353|FG000|Overall Study|Disease progression|8|||
147257471|NCT06308822|531116353|FG000|Overall Study|Withdrawal by Subject|1|||
147257472|NCT06308822|531116353|FG000|Overall Study|Physician Decision|3|||
147257473|NCT04734652|531116359|FG000|Overall Study|Withdrawal by Subject|2|||
147257474|NCT04734652|531116360|FG001|Overall Study|Withdrawal by Subject|0|||
147257475|NCT04734652|531116359|FG000|Overall Study|Death|0|||
147257476|NCT04734652|531116360|FG001|Overall Study|Death|1|||
147257477|NCT01921179|531116364|FG000|5 Week Randomized GOALS vs EDU Training|Withdrawal by Subject|3|||
147257478|NCT01921179|531116365|FG001|5 Week Randomized GOALS vs EDU Training|Withdrawal by Subject|3|||
147257479|NCT01921179|531116364|FG000|Long Term Follow-up After GOALS Training|Lost to Follow-up|2|||
147257480|NCT01921179|531116365|FG001|Long Term Follow-up After GOALS Training|Lost to Follow-up|0|||
147257481|NCT01190254|531116370|FG000|Overall Study|Adverse Event|3|||
147257482|NCT01190254|531116371|FG001|Overall Study|Adverse Event|6|||
147257483|NCT01190254|531116372|FG002|Overall Study|Adverse Event|8|||
147257484|NCT01190254|531116370|FG000|Overall Study|Lack of Efficacy|7|||
147257485|NCT01190254|531116371|FG001|Overall Study|Lack of Efficacy|4|||
147257486|NCT01190254|531116372|FG002|Overall Study|Lack of Efficacy|5|||
147257487|NCT01190254|531116370|FG000|Overall Study|Lost to Follow-up|4|||
147257488|NCT01190254|531116371|FG001|Overall Study|Lost to Follow-up|2|||
147257489|NCT01190254|531116372|FG002|Overall Study|Lost to Follow-up|0|||
147257490|NCT01190254|531116370|FG000|Overall Study|Withdrawal by Subject|4|||
147257491|NCT01190254|531116371|FG001|Overall Study|Withdrawal by Subject|5|||
147257492|NCT01190254|531116372|FG002|Overall Study|Withdrawal by Subject|7|||
147257493|NCT01190254|531116370|FG000|Overall Study|Protocol Violation|2|||
147257494|NCT01190254|531116371|FG001|Overall Study|Protocol Violation|0|||
147257495|NCT01190254|531116372|FG002|Overall Study|Protocol Violation|2|||
147599260|NCT03548064|532352346|FG000|Overall Study|Withdrawal by Subject|0|||
147599261|NCT03548064|532352347|FG001|Overall Study|Withdrawal by Subject|0|||
147599262|NCT03548064|532352348|FG002|Overall Study|Withdrawal by Subject|0|||
147599263|NCT03548064|532352349|FG003|Overall Study|Withdrawal by Subject|1|||
147599264|NCT03548064|532352350|FG004|Overall Study|Withdrawal by Subject|0|||
147257496|NCT01190254|531116370|FG000|Overall Study|Did not meet protocol eligibility|1|||
147257497|NCT01190254|531116371|FG001|Overall Study|Did not meet protocol eligibility|0|||
147257498|NCT01190254|531116372|FG002|Overall Study|Did not meet protocol eligibility|0|||
147257499|NCT04146545|531116373|FG000|Overall Study|deemed ineligible after randomization|1|||
147257500|NCT04146545|531116374|FG001|Overall Study|deemed ineligible after randomization|0|||
147257501|NCT01729754|531116375|FG000|Part 1|Adverse Event|2|||
147257502|NCT01729754|531116376|FG001|Part 1|Adverse Event|0|||
147257503|NCT01729754|531116377|FG002|Part 1|Adverse Event|0|||
147257504|NCT01729754|531116378|FG003|Part 1|Adverse Event|1|||
147257505|NCT01729754|531116379|FG004|Part 1|Adverse Event|0|||
147257506|NCT01729754|531116380|FG005|Part 1|Adverse Event|0|||
147257507|NCT01729754|531116381|FG006|Part 1|Adverse Event|2|||
147257508|NCT01729754|531116382|FG007|Part 1|Adverse Event|0|||
147257509|NCT01729754|531116383|FG008|Part 1|Adverse Event|0|||
147257510|NCT01729754|531116384|FG009|Part 1|Adverse Event|5|||
147257511|NCT01729754|531116375|FG000|Part 1|Lack of Efficacy|1|||
147257512|NCT01729754|531116376|FG001|Part 1|Lack of Efficacy|0|||
147661702|NCT04235504|532583118|FG003|Study Phase|Withdrawal by Subject|0|||
147661703|NCT04235504|532583115|FG000|Continuation Phase|Withdrawal by Subject|0|||
147599265|NCT03548064|532352351|FG005|Overall Study|Withdrawal by Subject|0|||
147599266|NCT03548064|532352352|FG006|Overall Study|Withdrawal by Subject|0|||
147599267|NCT03548064|532352353|FG007|Overall Study|Withdrawal by Subject|0|||
147599268|NCT03548064|532352346|FG000|Overall Study|Lost to Follow-up|0|||
147599269|NCT03548064|532352347|FG001|Overall Study|Lost to Follow-up|0|||
147599270|NCT03548064|532352348|FG002|Overall Study|Lost to Follow-up|0|||
147661704|NCT04235504|532583116|FG001|Continuation Phase|Withdrawal by Subject|4|||
147661705|NCT04235504|532583117|FG002|Continuation Phase|Withdrawal by Subject|0|||
147661706|NCT04235504|532583118|FG003|Continuation Phase|Withdrawal by Subject|0|||
147661707|NCT04235504|532583115|FG000|Continuation Phase|Adverse Event|0|||
147661708|NCT04235504|532583116|FG001|Continuation Phase|Adverse Event|1|||
147661709|NCT04235504|532583117|FG002|Continuation Phase|Adverse Event|0|||
147661710|NCT04235504|532583118|FG003|Continuation Phase|Adverse Event|0|||
147661711|NCT04235504|532583115|FG000|Continuation Phase|Physician Decision|1|||
147661712|NCT04235504|532583116|FG001|Continuation Phase|Physician Decision|2|||
147661713|NCT04235504|532583117|FG002|Continuation Phase|Physician Decision|1|||
147661714|NCT04235504|532583118|FG003|Continuation Phase|Physician Decision|0|||
147661715|NCT00101868|532583125|FG000|Overall Study|Death|10|||
147661716|NCT00101868|532583126|FG001|Overall Study|Death|10|||
147661717|NCT00101868|532583125|FG000|Overall Study|Withdrawal by Subject|8|||
147661718|NCT00101868|532583126|FG001|Overall Study|Withdrawal by Subject|9|||
147661719|NCT00101868|532583125|FG000|Overall Study|Protocol Violation|3|||
147661720|NCT00101868|532583126|FG001|Overall Study|Protocol Violation|0|||
147661721|NCT00101868|532583125|FG000|Overall Study|Lost to Follow-up|8|||
147661722|NCT00101868|532583126|FG001|Overall Study|Lost to Follow-up|13|||
147661723|NCT03839394|532583127|FG000|Overall Study|Lost to Follow-up|6|||
147661724|NCT03839394|532583128|FG001|Overall Study|Lost to Follow-up|8|||
147661725|NCT03839394|532583127|FG000|Overall Study|Withdrawal by Subject|0|||
147661726|NCT03839394|532583128|FG001|Overall Study|Withdrawal by Subject|2|||
147661727|NCT04001803|532583129|FG000|Intervention Phase (Up to Month 12)|Adverse Event|5|||
147661728|NCT04001803|532583129|FG000|Intervention Phase (Up to Month 12)|Protocol Violation|3|||
147257513|NCT01729754|531116377|FG002|Part 1|Lack of Efficacy|0|||
147257514|NCT01729754|531116378|FG003|Part 1|Lack of Efficacy|0|||
147257515|NCT01729754|531116379|FG004|Part 1|Lack of Efficacy|0|||
147257516|NCT01729754|531116380|FG005|Part 1|Lack of Efficacy|0|||
147257517|NCT01729754|531116381|FG006|Part 1|Lack of Efficacy|2|||
147257518|NCT01729754|531116382|FG007|Part 1|Lack of Efficacy|0|||
147257519|NCT01729754|531116383|FG008|Part 1|Lack of Efficacy|0|||
147257520|NCT01729754|531116384|FG009|Part 1|Lack of Efficacy|0|||
147257521|NCT01729754|531116375|FG000|Part 1|Lost to Follow-up|1|||
147257522|NCT01729754|531116376|FG001|Part 1|Lost to Follow-up|0|||
147257523|NCT01729754|531116377|FG002|Part 1|Lost to Follow-up|0|||
147257524|NCT01729754|531116378|FG003|Part 1|Lost to Follow-up|2|||
147257525|NCT01729754|531116379|FG004|Part 1|Lost to Follow-up|0|||
147257526|NCT01729754|531116380|FG005|Part 1|Lost to Follow-up|0|||
147332744|NCT01193153|531385539|FG001|Open-label Lead in Period|Death|0|||
147257527|NCT01729754|531116381|FG006|Part 1|Lost to Follow-up|3|||
147257528|NCT01729754|531116382|FG007|Part 1|Lost to Follow-up|0|||
147257529|NCT01729754|531116383|FG008|Part 1|Lost to Follow-up|0|||
147599271|NCT03548064|532352349|FG003|Overall Study|Lost to Follow-up|0|||
147661729|NCT04001803|532583129|FG000|Intervention Phase (Up to Month 12)|Physician Decision|1|||
147661730|NCT04001803|532583129|FG000|Intervention Phase (Up to Month 12)|Withdrawal by Subject|4|||
147661731|NCT04001803|532583129|FG000|Extension Phase (From Months 13 to 30)|Adverse Event|2|||
147661732|NCT04001803|532583129|FG000|Extension Phase (From Months 13 to 30)|Protocol Violation|1|||
147661733|NCT04001803|532583129|FG000|Extension Phase (From Months 13 to 30)|Lost to Follow-up|1|||
147599272|NCT03548064|532352350|FG004|Overall Study|Lost to Follow-up|2|||
147599273|NCT03548064|532352351|FG005|Overall Study|Lost to Follow-up|0|||
147599274|NCT03548064|532352352|FG006|Overall Study|Lost to Follow-up|0|||
147599275|NCT03548064|532352353|FG007|Overall Study|Lost to Follow-up|0|||
147599276|NCT03548064|532352346|FG000|Overall Study|Covid-19 Pandemic|0|||
147257530|NCT01729754|531116384|FG009|Part 1|Lost to Follow-up|3|||
147257531|NCT01729754|531116375|FG000|Part 1|Non-compliance with Study Drug|1|||
147257532|NCT01729754|531116376|FG001|Part 1|Non-compliance with Study Drug|0|||
147257533|NCT01729754|531116377|FG002|Part 1|Non-compliance with Study Drug|0|||
147257534|NCT01729754|531116378|FG003|Part 1|Non-compliance with Study Drug|0|||
147257535|NCT01729754|531116379|FG004|Part 1|Non-compliance with Study Drug|0|||
147257536|NCT01729754|531116380|FG005|Part 1|Non-compliance with Study Drug|0|||
147257537|NCT01729754|531116381|FG006|Part 1|Non-compliance with Study Drug|0|||
147257538|NCT01729754|531116382|FG007|Part 1|Non-compliance with Study Drug|0|||
147257539|NCT01729754|531116383|FG008|Part 1|Non-compliance with Study Drug|0|||
147257540|NCT01729754|531116384|FG009|Part 1|Non-compliance with Study Drug|0|||
147257541|NCT01729754|531116375|FG000|Part 1|Physician Decision|0|||
147257542|NCT01729754|531116376|FG001|Part 1|Physician Decision|0|||
147257543|NCT01729754|531116377|FG002|Part 1|Physician Decision|0|||
147257544|NCT01729754|531116378|FG003|Part 1|Physician Decision|0|||
147257545|NCT01729754|531116379|FG004|Part 1|Physician Decision|0|||
147257546|NCT01729754|531116380|FG005|Part 1|Physician Decision|0|||
147257547|NCT01729754|531116381|FG006|Part 1|Physician Decision|0|||
147257548|NCT01729754|531116382|FG007|Part 1|Physician Decision|0|||
147257549|NCT01729754|531116383|FG008|Part 1|Physician Decision|0|||
147257550|NCT01729754|531116384|FG009|Part 1|Physician Decision|4|||
147257551|NCT01729754|531116375|FG000|Part 1|Pregnancy|0|||
147257552|NCT01729754|531116376|FG001|Part 1|Pregnancy|0|||
147257553|NCT01729754|531116377|FG002|Part 1|Pregnancy|0|||
147257554|NCT01729754|531116378|FG003|Part 1|Pregnancy|1|||
147257555|NCT01729754|531116379|FG004|Part 1|Pregnancy|0|||
147257556|NCT01729754|531116380|FG005|Part 1|Pregnancy|0|||
147257557|NCT01729754|531116381|FG006|Part 1|Pregnancy|0|||
147257558|NCT01729754|531116382|FG007|Part 1|Pregnancy|0|||
147257559|NCT01729754|531116383|FG008|Part 1|Pregnancy|0|||
147257560|NCT01729754|531116384|FG009|Part 1|Pregnancy|1|||
147257561|NCT01729754|531116375|FG000|Part 1|Progressive Disease|0|||
147257562|NCT01729754|531116376|FG001|Part 1|Progressive Disease|0|||
147257563|NCT01729754|531116377|FG002|Part 1|Progressive Disease|0|||
147257564|NCT01729754|531116378|FG003|Part 1|Progressive Disease|0|||
147257565|NCT01729754|531116379|FG004|Part 1|Progressive Disease|0|||
147257566|NCT01729754|531116380|FG005|Part 1|Progressive Disease|0|||
147257567|NCT01729754|531116381|FG006|Part 1|Progressive Disease|0|||
147257568|NCT01729754|531116382|FG007|Part 1|Progressive Disease|0|||
147257569|NCT01729754|531116383|FG008|Part 1|Progressive Disease|0|||
147257570|NCT01729754|531116384|FG009|Part 1|Progressive Disease|1|||
147257571|NCT01729754|531116375|FG000|Part 1|Protocol Violation|2|||
147257572|NCT01729754|531116376|FG001|Part 1|Protocol Violation|0|||
147257573|NCT01729754|531116377|FG002|Part 1|Protocol Violation|0|||
147599277|NCT03548064|532352347|FG001|Overall Study|Covid-19 Pandemic|0|||
147599278|NCT03548064|532352348|FG002|Overall Study|Covid-19 Pandemic|0|||
147599279|NCT03548064|532352349|FG003|Overall Study|Covid-19 Pandemic|0|||
147599280|NCT03548064|532352350|FG004|Overall Study|Covid-19 Pandemic|10|||
147599281|NCT03548064|532352351|FG005|Overall Study|Covid-19 Pandemic|3|||
147257574|NCT01729754|531116378|FG003|Part 1|Protocol Violation|1|||
147257575|NCT01729754|531116379|FG004|Part 1|Protocol Violation|0|||
147257576|NCT01729754|531116380|FG005|Part 1|Protocol Violation|0|||
147599282|NCT03548064|532352352|FG006|Overall Study|Covid-19 Pandemic|0|||
147599283|NCT03548064|532352353|FG007|Overall Study|Covid-19 Pandemic|0|||
147599284|NCT04941729|532352354|FG000|Overall Study|Death|0|||
147599285|NCT04941729|532352355|FG001|Overall Study|Death|1|||
147599286|NCT04941729|532352354|FG000|Overall Study|Study terminated by sponsor|11|||
147599287|NCT04941729|532352355|FG001|Overall Study|Study terminated by sponsor|10|||
147599288|NCT00006721|532352356|FG000|Overall Study|Adverse Event|0|||
147257577|NCT01729754|531116381|FG006|Part 1|Protocol Violation|1|||
147257578|NCT01729754|531116382|FG007|Part 1|Protocol Violation|0|||
147257579|NCT01729754|531116383|FG008|Part 1|Protocol Violation|0|||
147257580|NCT01729754|531116384|FG009|Part 1|Protocol Violation|0|||
147257581|NCT01729754|531116375|FG000|Part 1|Withdrawal by Subject|5|||
147257582|NCT01729754|531116376|FG001|Part 1|Withdrawal by Subject|0|||
147257583|NCT01729754|531116377|FG002|Part 1|Withdrawal by Subject|0|||
147257584|NCT01729754|531116378|FG003|Part 1|Withdrawal by Subject|7|||
147257585|NCT01729754|531116379|FG004|Part 1|Withdrawal by Subject|0|||
147257586|NCT01729754|531116380|FG005|Part 1|Withdrawal by Subject|0|||
147257587|NCT01729754|531116381|FG006|Part 1|Withdrawal by Subject|5|||
147257588|NCT01729754|531116382|FG007|Part 1|Withdrawal by Subject|0|||
147257589|NCT01729754|531116383|FG008|Part 1|Withdrawal by Subject|0|||
147257590|NCT01729754|531116384|FG009|Part 1|Withdrawal by Subject|6|||
147257591|NCT01729754|531116375|FG000|Part 1|Other Protocol Specified Criteria|2|||
147599289|NCT00006721|532352357|FG001|Overall Study|Adverse Event|4|||
147599290|NCT00006721|532352358|FG002|Overall Study|Adverse Event|4|||
147599291|NCT00006721|532352356|FG000|Overall Study|Refusal Unrelated to Adverse Event|1|||
147599292|NCT00006721|532352357|FG001|Overall Study|Refusal Unrelated to Adverse Event|0|||
147257592|NCT01729754|531116376|FG001|Part 1|Other Protocol Specified Criteria|0|||
147257593|NCT01729754|531116377|FG002|Part 1|Other Protocol Specified Criteria|0|||
147257594|NCT01729754|531116378|FG003|Part 1|Other Protocol Specified Criteria|0|||
147257595|NCT01729754|531116379|FG004|Part 1|Other Protocol Specified Criteria|0|||
147257596|NCT01729754|531116380|FG005|Part 1|Other Protocol Specified Criteria|0|||
147257597|NCT01729754|531116381|FG006|Part 1|Other Protocol Specified Criteria|1|||
147257598|NCT01729754|531116382|FG007|Part 1|Other Protocol Specified Criteria|0|||
147257599|NCT01729754|531116383|FG008|Part 1|Other Protocol Specified Criteria|0|||
147257600|NCT01729754|531116384|FG009|Part 1|Other Protocol Specified Criteria|4|||
147257601|NCT01729754|531116375|FG000|Part 2|Adverse Event|2|||
147257602|NCT01729754|531116376|FG001|Part 2|Adverse Event|0|||
147257603|NCT01729754|531116377|FG002|Part 2|Adverse Event|0|||
147257604|NCT01729754|531116378|FG003|Part 2|Adverse Event|0|||
147257605|NCT01729754|531116379|FG004|Part 2|Adverse Event|0|||
147257606|NCT01729754|531116380|FG005|Part 2|Adverse Event|0|||
147257607|NCT01729754|531116381|FG006|Part 2|Adverse Event|0|||
147257608|NCT01729754|531116382|FG007|Part 2|Adverse Event|0|||
147257609|NCT01729754|531116383|FG008|Part 2|Adverse Event|1|||
147257610|NCT01729754|531116384|FG009|Part 2|Adverse Event|2|||
147257611|NCT01729754|531116375|FG000|Part 2|Lack of Efficacy|0|||
147257612|NCT01729754|531116376|FG001|Part 2|Lack of Efficacy|0|||
147257613|NCT01729754|531116377|FG002|Part 2|Lack of Efficacy|0|||
147257614|NCT01729754|531116378|FG003|Part 2|Lack of Efficacy|0|||
147257615|NCT01729754|531116379|FG004|Part 2|Lack of Efficacy|0|||
147257616|NCT01729754|531116380|FG005|Part 2|Lack of Efficacy|0|||
147599293|NCT00006721|532352358|FG002|Overall Study|Refusal Unrelated to Adverse Event|8|||
147599294|NCT00006721|532352356|FG000|Overall Study|Progression/Relapse|0|||
147599295|NCT00006721|532352357|FG001|Overall Study|Progression/Relapse|1|||
147599296|NCT00006721|532352358|FG002|Overall Study|Progression/Relapse|2|||
147599297|NCT00006721|532352356|FG000|Overall Study|Death|0|||
147599298|NCT00006721|532352357|FG001|Overall Study|Death|1|||
147599299|NCT00006721|532352358|FG002|Overall Study|Death|2|||
147599300|NCT00006721|532352356|FG000|Overall Study|Other - Not Protocol Specified|0|||
147599301|NCT00006721|532352357|FG001|Overall Study|Other - Not Protocol Specified|7|||
147599302|NCT00006721|532352358|FG002|Overall Study|Other - Not Protocol Specified|7|||
147599303|NCT00006721|532352356|FG000|Overall Study|Ineligible|2|||
147599304|NCT00006721|532352357|FG001|Overall Study|Ineligible|12|||
147599305|NCT00006721|532352358|FG002|Overall Study|Ineligible|10|||
147599306|NCT00006721|532352356|FG000|Overall Study|Eligible but no Treatment Received|1|||
147599307|NCT00006721|532352357|FG001|Overall Study|Eligible but no Treatment Received|0|||
147599308|NCT00006721|532352358|FG002|Overall Study|Eligible but no Treatment Received|0|||
147599309|NCT03653507|532352359|FG000|Overall Study|Miscellaneous|28|||
147599310|NCT03653507|532352360|FG001|Overall Study|Miscellaneous|19|||
147599311|NCT03653507|532352359|FG000|Overall Study|Withdrawal by Subject|37|||
147599312|NCT03653507|532352360|FG001|Overall Study|Withdrawal by Subject|22|||
147599313|NCT03653507|532352359|FG000|Overall Study|Protocol Deviation|2|||
147599314|NCT03653507|532352360|FG001|Overall Study|Protocol Deviation|1|||
147599315|NCT03653507|532352359|FG000|Overall Study|Progressive disease|117|||
147599316|NCT03653507|532352360|FG001|Overall Study|Progressive disease|168|||
147599317|NCT03653507|532352359|FG000|Overall Study|Lost to Follow-up|1|||
147599318|NCT03653507|532352360|FG001|Overall Study|Lost to Follow-up|1|||
147599319|NCT03653507|532352359|FG000|Overall Study|Death|25|||
147599320|NCT03653507|532352360|FG001|Overall Study|Death|22|||
147599321|NCT03653507|532352359|FG000|Overall Study|Adverse Event|35|||
147599322|NCT03653507|532352360|FG001|Overall Study|Adverse Event|14|||
147599323|NCT03986138|532352365|FG000|First MRI Examination|Physician Decision|0|||
147599324|NCT03986138|532352366|FG001|First MRI Examination|Physician Decision|1|||
147599325|NCT03986138|532352365|FG000|First MRI Examination|Other reason (mainly technical issues with MRI machine)|1|||
147599326|NCT03986138|532352366|FG001|First MRI Examination|Other reason (mainly technical issues with MRI machine)|2|||
147599327|NCT03986138|532352365|FG000|Washout|Withdrawal by Subject|4|||
147599328|NCT03986138|532352366|FG001|Washout|Withdrawal by Subject|5|||
147599329|NCT03986138|532352365|FG000|Washout|Lost to Follow-up|0|||
147599330|NCT03986138|532352366|FG001|Washout|Lost to Follow-up|2|||
147599331|NCT03986138|532352365|FG000|Washout|Adverse Event|1|||
147599332|NCT03986138|532352366|FG001|Washout|Adverse Event|1|||
147599333|NCT03986138|532352365|FG000|Washout|Other reason|5|||
147599334|NCT03986138|532352366|FG001|Washout|Other reason|5|||
147599335|NCT03986138|532352365|FG000|Second MRI Examination|Withdrawal by Subject|0|||
147599336|NCT03986138|532352366|FG001|Second MRI Examination|Withdrawal by Subject|2|||
147599337|NCT04305587|532352367|FG000|Overall Study|Withdrawal by Subject|0|||
147599338|NCT04305587|532352368|FG001|Overall Study|Withdrawal by Subject|0|||
147599339|NCT04305587|532352369|FG002|Overall Study|Withdrawal by Subject|0|||
147257617|NCT01729754|531116381|FG006|Part 2|Lack of Efficacy|0|||
147332745|NCT01193153|531385538|FG000|Open-label Lead in Period|Lack of Efficacy|26|||
147599340|NCT04305587|532352370|FG003|Overall Study|Withdrawal by Subject|1|||
147599341|NCT04305587|532352371|FG004|Overall Study|Withdrawal by Subject|0|||
147257618|NCT01729754|531116382|FG007|Part 2|Lack of Efficacy|0|||
147257619|NCT01729754|531116383|FG008|Part 2|Lack of Efficacy|2|||
147257620|NCT01729754|531116384|FG009|Part 2|Lack of Efficacy|2|||
147257621|NCT01729754|531116375|FG000|Part 2|Lost to Follow-up|0|||
147599342|NCT04305587|532352372|FG005|Overall Study|Withdrawal by Subject|0|||
147599343|NCT04305587|532352373|FG006|Overall Study|Withdrawal by Subject|0|||
147257622|NCT01729754|531116376|FG001|Part 2|Lost to Follow-up|0|||
147257623|NCT01729754|531116377|FG002|Part 2|Lost to Follow-up|0|||
147257624|NCT01729754|531116378|FG003|Part 2|Lost to Follow-up|2|||
147257625|NCT01729754|531116379|FG004|Part 2|Lost to Follow-up|0|||
147257626|NCT01729754|531116380|FG005|Part 2|Lost to Follow-up|0|||
147257627|NCT01729754|531116381|FG006|Part 2|Lost to Follow-up|0|||
147257628|NCT01729754|531116382|FG007|Part 2|Lost to Follow-up|1|||
147257629|NCT01729754|531116383|FG008|Part 2|Lost to Follow-up|0|||
147257630|NCT01729754|531116384|FG009|Part 2|Lost to Follow-up|2|||
147257631|NCT01729754|531116375|FG000|Part 2|Non-Compliance with Study Drug|0|||
147257632|NCT01729754|531116376|FG001|Part 2|Non-Compliance with Study Drug|0|||
147257633|NCT01729754|531116377|FG002|Part 2|Non-Compliance with Study Drug|0|||
147257634|NCT01729754|531116378|FG003|Part 2|Non-Compliance with Study Drug|0|||
147257635|NCT01729754|531116379|FG004|Part 2|Non-Compliance with Study Drug|0|||
147257636|NCT01729754|531116380|FG005|Part 2|Non-Compliance with Study Drug|0|||
147257637|NCT01729754|531116381|FG006|Part 2|Non-Compliance with Study Drug|0|||
147257638|NCT01729754|531116382|FG007|Part 2|Non-Compliance with Study Drug|0|||
147257639|NCT01729754|531116383|FG008|Part 2|Non-Compliance with Study Drug|0|||
147257640|NCT01729754|531116384|FG009|Part 2|Non-Compliance with Study Drug|1|||
147257641|NCT01729754|531116375|FG000|Part 2|Pregnancy|0|||
147257642|NCT01729754|531116376|FG001|Part 2|Pregnancy|0|||
147257643|NCT01729754|531116377|FG002|Part 2|Pregnancy|0|||
147257644|NCT01729754|531116378|FG003|Part 2|Pregnancy|1|||
147257645|NCT01729754|531116379|FG004|Part 2|Pregnancy|0|||
147257646|NCT01729754|531116380|FG005|Part 2|Pregnancy|0|||
147257647|NCT01729754|531116381|FG006|Part 2|Pregnancy|0|||
147599344|NCT04305587|532352374|FG007|Overall Study|Withdrawal by Subject|0|||
147257648|NCT01729754|531116382|FG007|Part 2|Pregnancy|0|||
147257649|NCT01729754|531116383|FG008|Part 2|Pregnancy|0|||
147257650|NCT01729754|531116384|FG009|Part 2|Pregnancy|1|||
147257651|NCT01729754|531116375|FG000|Part 2|Withdrawal by Subject|3|||
147257652|NCT01729754|531116376|FG001|Part 2|Withdrawal by Subject|0|||
147257653|NCT01729754|531116377|FG002|Part 2|Withdrawal by Subject|0|||
147257654|NCT01729754|531116378|FG003|Part 2|Withdrawal by Subject|2|||
147257655|NCT01729754|531116379|FG004|Part 2|Withdrawal by Subject|0|||
147257656|NCT01729754|531116380|FG005|Part 2|Withdrawal by Subject|0|||
147257657|NCT01729754|531116381|FG006|Part 2|Withdrawal by Subject|0|||
147257658|NCT01729754|531116382|FG007|Part 2|Withdrawal by Subject|1|||
147257659|NCT01729754|531116383|FG008|Part 2|Withdrawal by Subject|1|||
147257660|NCT01729754|531116384|FG009|Part 2|Withdrawal by Subject|4|||
147257661|NCT01729754|531116375|FG000|Part 2|Other Protocol Specified Criteria|1|||
147257662|NCT01729754|531116376|FG001|Part 2|Other Protocol Specified Criteria|0|||
147257663|NCT01729754|531116377|FG002|Part 2|Other Protocol Specified Criteria|0|||
147599345|NCT04305587|532352375|FG008|Overall Study|Withdrawal by Subject|0|||
147599346|NCT01523457|532352376|FG000|Overall Study|Withdrawal by Subject|7|||
147599347|NCT01523457|532352377|FG001|Overall Study|Withdrawal by Subject|2|||
147599348|NCT01367665|532352378|FG000|Overall Study|Death|102|||
147599349|NCT01367665|532352379|FG001|Overall Study|Death|19|||
147599350|NCT01367665|532352378|FG000|Overall Study|Lost to Follow-up|222|||
147599351|NCT01367665|532352379|FG001|Overall Study|Lost to Follow-up|22|||
147599352|NCT01367665|532352378|FG000|Overall Study|Not Done|118|||
147599353|NCT01367665|532352379|FG001|Overall Study|Not Done|14|||
147599354|NCT02752906|532352380|FG000|Overall Study|Protocol Violation|2|||
147599355|NCT02752906|532352381|FG001|Overall Study|Protocol Violation|1|||
147599356|NCT02752906|532352380|FG000|Overall Study|Withdrawal by Subject|2|||
147599357|NCT02752906|532352381|FG001|Overall Study|Withdrawal by Subject|2|||
147599358|NCT02752906|532352380|FG000|Overall Study|Lost to Follow-up|3|||
147599359|NCT02752906|532352381|FG001|Overall Study|Lost to Follow-up|2|||
147599360|NCT01200992|532352382|FG000|Overall Study|Study terminated early|35|||
147599361|NCT01200992|532352383|FG001|Overall Study|Study terminated early|41|||
147599362|NCT01200992|532352382|FG000|Overall Study|Randomized but not treated|2|||
147599363|NCT01200992|532352383|FG001|Overall Study|Randomized but not treated|0|||
147599364|NCT00792935|532352384|FG000|Overall Study|Adverse Event|2|||
147599365|NCT00792935|532352385|FG001|Overall Study|Adverse Event|1|||
147599366|NCT00792935|532352384|FG000|Overall Study|Lost to Follow-up|0|||
147599367|NCT00792935|532352385|FG001|Overall Study|Lost to Follow-up|1|||
147599368|NCT00792935|532352384|FG000|Overall Study|Protocol Violation|2|||
147599369|NCT00792935|532352385|FG001|Overall Study|Protocol Violation|0|||
147661734|NCT04001803|532583129|FG000|Extension Phase (From Months 13 to 30)|Withdrawal by Subject|2|||
147257664|NCT01729754|531116378|FG003|Part 2|Other Protocol Specified Criteria|0|||
147257665|NCT01729754|531116379|FG004|Part 2|Other Protocol Specified Criteria|0|||
147257666|NCT01729754|531116380|FG005|Part 2|Other Protocol Specified Criteria|0|||
147257667|NCT01729754|531116381|FG006|Part 2|Other Protocol Specified Criteria|0|||
147257668|NCT01729754|531116382|FG007|Part 2|Other Protocol Specified Criteria|1|||
147257669|NCT01729754|531116383|FG008|Part 2|Other Protocol Specified Criteria|0|||
147257670|NCT01729754|531116384|FG009|Part 2|Other Protocol Specified Criteria|0|||
147257671|NCT01729754|531116375|FG000|Part 3|Adverse Event|0|||
147257672|NCT01729754|531116376|FG001|Part 3|Adverse Event|0|||
147257673|NCT01729754|531116377|FG002|Part 3|Adverse Event|1|||
147661735|NCT04001803|532583129|FG000|Long-term Follow-up Phase(Up to Week 52)|Lost to Follow-up|1|||
147661736|NCT04001803|532583129|FG000|Long-term Follow-up Phase(Up to Week 52)|Withdrawal by Subject|2|||
147661737|NCT01931397|532583132|FG000|Overall Study|Physician Decision|2|||
147661738|NCT01931397|532583132|FG000|Overall Study|Withdrawal by Subject|8|||
147661739|NCT01931397|532583132|FG000|Overall Study|moved out of state|1|||
147661740|NCT02329327|532583136|FG000|Overall Study|Death|78|||
147661741|NCT02329327|532583137|FG001|Overall Study|Death|0|||
147661742|NCT02329327|532583136|FG000|Overall Study|Withdrawal by Subject|3|||
147661743|NCT02329327|532583137|FG001|Overall Study|Withdrawal by Subject|0|||
147661744|NCT02329327|532583136|FG000|Overall Study|Lost to Follow-up|4|||
147661745|NCT02329327|532583137|FG001|Overall Study|Lost to Follow-up|0|||
147661746|NCT02493517|532583138|FG000|Overall Study|Protocol Violation|1|||
147661747|NCT02493517|532583139|FG001|Overall Study|Protocol Violation|2|||
147661748|NCT02493517|532583138|FG000|Overall Study|Withdrawal by Subject|1|||
147661749|NCT02493517|532583139|FG001|Overall Study|Withdrawal by Subject|2|||
147661750|NCT02493517|532583138|FG000|Overall Study|Adverse Event|0|||
147661751|NCT02493517|532583139|FG001|Overall Study|Adverse Event|2|||
147661752|NCT02493517|532583138|FG000|Overall Study|Missed study visit|0|||
147661753|NCT02493517|532583139|FG001|Overall Study|Missed study visit|1|||
147661754|NCT01367249|532583140|FG000|Overall Study|Withdrawal by Subject|6|||
147661755|NCT01367249|532583141|FG001|Overall Study|Withdrawal by Subject|6|||
147661756|NCT01367249|532583140|FG000|Overall Study|Other|3|||
147661757|NCT01367249|532583141|FG001|Overall Study|Other|10|||
147661758|NCT03718429|532583142|FG000|Adjunctive Rivaroxaban 2.5 mg|Withdrawal by Subject|0|||
147661759|NCT03718429|532583143|FG001|Adjunctive Rivaroxaban 2.5 mg|Withdrawal by Subject|1|||
147661760|NCT03718429|532583144|FG002|Adjunctive Rivaroxaban 2.5 mg|Withdrawal by Subject|1|||
147661761|NCT03718429|532583145|FG003|Adjunctive Rivaroxaban 2.5 mg|Withdrawal by Subject|0|||
147661762|NCT05404711|532583146|FG000|Completed Study Visit|Withdrawal by Subject|1|||
147661763|NCT05404711|532583146|FG000|Completed 75-gram, 2-hour CGM-OGTT|Incomplete due to illness|1|||
147661764|NCT05404711|532583146|FG000|Completed 75-gram, 2-hour CGM-OGTT|CGM fell off early|3|||
147661765|NCT05404711|532583146|FG000|Valid 75-gram, 2-hour CGM-OGTT|No date/time recorded|4|||
147661766|NCT05404711|532583146|FG000|Valid 75-gram, 2-hour CGM-OGTT|Vomited after drinking glucose beverage at home|1|||
147661767|NCT05404711|532583146|FG000|Completed, Valid Lab-OGTT and CGM-OGTT|Incomplete glucose beverage for lab-OGTT|1|||
147661768|NCT02346877|532583147|FG000|Overall Study|Adverse Event|1|||
147661769|NCT02346877|532583148|FG001|Overall Study|Adverse Event|0|||
147661770|NCT02346877|532583147|FG000|Overall Study|Administrative Decision|1|||
147661771|NCT02346877|532583148|FG001|Overall Study|Administrative Decision|0|||
147661772|NCT02346877|532583147|FG000|Overall Study|Sponsor Decision|12|||
147661773|NCT02346877|532583148|FG001|Overall Study|Sponsor Decision|0|||
147661774|NCT02346877|532583147|FG000|Overall Study|Missing|5|||
147661775|NCT02346877|532583148|FG001|Overall Study|Missing|0|||
147661776|NCT01817075|532583149|FG000|Overall Study|Adverse Event|7|||
147661777|NCT01817075|532583150|FG001|Overall Study|Adverse Event|5|||
147661778|NCT01817075|532583149|FG000|Overall Study|Physician Decision|9|||
147661779|NCT01817075|532583150|FG001|Overall Study|Physician Decision|12|||
147661780|NCT01817075|532583149|FG000|Overall Study|Withdrawal by Subject|31|||
147661781|NCT01817075|532583150|FG001|Overall Study|Withdrawal by Subject|15|||
147661782|NCT01817075|532583149|FG000|Overall Study|Received Sorafenib after enrollment|0|||
147661783|NCT01817075|532583150|FG001|Overall Study|Received Sorafenib after enrollment|1|||
147661784|NCT01817075|532583149|FG000|Overall Study|Ineligible|0|||
147599370|NCT00792935|532352384|FG000|Overall Study|Withdrawal by Subject|0|||
147599371|NCT00792935|532352385|FG001|Overall Study|Withdrawal by Subject|1|||
147599372|NCT02622113|532352390|FG000|Overall Study|Adverse Event|4|||
147599373|NCT02622113|532352391|FG001|Overall Study|Adverse Event|4|||
147599374|NCT02622113|532352390|FG000|Overall Study|Physician Decision|0|||
147599375|NCT02622113|532352391|FG001|Overall Study|Physician Decision|1|||
147599376|NCT02622113|532352390|FG000|Overall Study|Withdrawal by Subject|0|||
147599377|NCT02622113|532352391|FG001|Overall Study|Withdrawal by Subject|2|||
147599378|NCT02622113|532352390|FG000|Overall Study|Stopping Criteria|1|||
147599379|NCT02622113|532352391|FG001|Overall Study|Stopping Criteria|3|||
147599380|NCT03514641|532352403|FG000|603A: 0-12 Week Study Period|Protocol Violation|3|||
147599381|NCT03514641|532352404|FG001|603A: 0-12 Week Study Period|Protocol Violation|3|||
147599382|NCT03514641|532352405|FG002|603A: 0-12 Week Study Period|Protocol Violation|0|||
147599383|NCT03514641|532352406|FG003|603A: 0-12 Week Study Period|Protocol Violation|0|||
147661785|NCT01817075|532583150|FG001|Overall Study|Ineligible|2|||
147661786|NCT01395810|532583157|FG000|Overall Study|Adverse Event|0|||
147661787|NCT01395810|532583158|FG001|Overall Study|Adverse Event|1|||
147661788|NCT01395810|532583159|FG002|Overall Study|Adverse Event|0|||
147661789|NCT01395810|532583160|FG003|Overall Study|Adverse Event|0|||
147661790|NCT01395810|532583157|FG000|Overall Study|Lack of Efficacy|0|||
147661791|NCT01395810|532583158|FG001|Overall Study|Lack of Efficacy|1|||
147599384|NCT03514641|532352403|FG000|603A: 0-12 Week Study Period|Adverse Event|5|||
147661792|NCT01395810|532583159|FG002|Overall Study|Lack of Efficacy|0|||
147661793|NCT01395810|532583160|FG003|Overall Study|Lack of Efficacy|0|||
147661794|NCT01395810|532583157|FG000|Overall Study|Withdrawal criteria|0|||
147661795|NCT01395810|532583158|FG001|Overall Study|Withdrawal criteria|2|||
147661796|NCT01395810|532583159|FG002|Overall Study|Withdrawal criteria|0|||
147661797|NCT01395810|532583160|FG003|Overall Study|Withdrawal criteria|0|||
147661798|NCT01395810|532583157|FG000|Overall Study|Unclassified|2|||
147661799|NCT01395810|532583158|FG001|Overall Study|Unclassified|0|||
147661800|NCT01395810|532583159|FG002|Overall Study|Unclassified|0|||
147661801|NCT01395810|532583160|FG003|Overall Study|Unclassified|0|||
147661802|NCT03877224|532583163|FG000|Overall Study|Death|3|||
147661803|NCT03877224|532583164|FG001|Overall Study|Death|2|||
147661804|NCT03877224|532583163|FG000|Overall Study|Withdrawal by Subject|1|||
147661805|NCT03877224|532583164|FG001|Overall Study|Withdrawal by Subject|6|||
147661806|NCT03877224|532583163|FG000|Overall Study|Participant is alive, just unable to come for visits|1|||
147661807|NCT03877224|532583164|FG001|Overall Study|Participant is alive, just unable to come for visits|0|||
147661808|NCT03234036|532585533|FG000|Part 1:Washout Period 1 (Up to 10 Days)|Adverse Event|1|||
147661809|NCT03234036|532585534|FG001|Part 1:Washout Period 1 (Up to 10 Days)|Adverse Event|1|||
147661810|NCT03234036|532585535|FG002|Part 1:Washout Period 1 (Up to 10 Days)|Adverse Event|0|||
147661811|NCT03234036|532585536|FG003|Part 1:Washout Period 1 (Up to 10 Days)|Adverse Event|0|||
147661812|NCT02163395|532585537|FG000|Overall Study|Withdrawal by Subject|1|||
147661813|NCT02163395|532585537|FG000|Overall Study|Lost to Follow-up|3|||
147661814|NCT02163395|532585537|FG000|Overall Study|Adverse Event|1|||
147661815|NCT00165503|532585542|FG000|Overall Study|Death|1|||
147661816|NCT00165503|532585542|FG000|Overall Study|Lost to Follow-up|12|||
147661817|NCT00165503|532585542|FG000|Overall Study|Unresectable|3|||
147661818|NCT02346708|532585543|FG000|Overall Study|Adverse Event|2|||
147661819|NCT02346708|532585544|FG001|Overall Study|Adverse Event|0|||
147661820|NCT02346708|532585543|FG000|Overall Study|Protocol Violation|0|||
147661821|NCT02346708|532585544|FG001|Overall Study|Protocol Violation|1|||
147661822|NCT02976519|532585545|FG000|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
147661823|NCT02976519|532585546|FG001|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|1|||
147661824|NCT02976519|532585547|FG002|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
147661825|NCT02976519|532585548|FG003|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
147661826|NCT02976519|532585549|FG004|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
147661827|NCT02976519|532585550|FG005|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
147661828|NCT02976519|532585551|FG006|Treatment Period 1 (Part 1 and Part 2)|Adverse Event|0|||
147661829|NCT02976519|532585545|FG000|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
147661830|NCT02976519|532585546|FG001|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
147661831|NCT02976519|532585547|FG002|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
147661832|NCT02976519|532585548|FG003|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|1|||
147661833|NCT02976519|532585549|FG004|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
147661834|NCT02976519|532585550|FG005|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
147661835|NCT02976519|532585551|FG006|Treatment Period 1 (Part 1 and Part 2)|Withdrawal by Subject|0|||
147661836|NCT02976519|532585545|FG000|Wash-out Period (Part 2 Only)|Reason not listed|0|||
147661837|NCT02976519|532585546|FG001|Wash-out Period (Part 2 Only)|Reason not listed|0|||
147661838|NCT02976519|532585547|FG002|Wash-out Period (Part 2 Only)|Reason not listed|0|||
147661839|NCT02976519|532585548|FG003|Wash-out Period (Part 2 Only)|Reason not listed|0|||
147661840|NCT02976519|532585549|FG004|Wash-out Period (Part 2 Only)|Reason not listed|0|||
147661841|NCT02976519|532585550|FG005|Wash-out Period (Part 2 Only)|Reason not listed|0|||
147661842|NCT02976519|532585551|FG006|Wash-out Period (Part 2 Only)|Reason not listed|1|||
147661843|NCT02976519|532585545|FG000|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
147661844|NCT02976519|532585546|FG001|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
147661845|NCT02976519|532585547|FG002|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
147661846|NCT02976519|532585548|FG003|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
147661847|NCT02976519|532585549|FG004|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
147661848|NCT02976519|532585550|FG005|Wash-out Period (Part 2 Only)|Withdrawal by Subject|0|||
147661849|NCT02976519|532585551|FG006|Wash-out Period (Part 2 Only)|Withdrawal by Subject|1|||
147661850|NCT02976519|532585545|FG000|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
147661851|NCT02976519|532585546|FG001|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
147661852|NCT02976519|532585547|FG002|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
147661853|NCT02976519|532585548|FG003|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
147661854|NCT02976519|532585549|FG004|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
147661855|NCT02976519|532585550|FG005|Treatment Period 2 (Part 2 Only)|Adverse Event|0|||
147661856|NCT02976519|532585551|FG006|Treatment Period 2 (Part 2 Only)|Adverse Event|1|||
147661857|NCT00928434|532585554|FG000|Overall Study|Adverse Event|14|||
147661858|NCT00928434|532585555|FG001|Overall Study|Adverse Event|5|||
147661859|NCT00928434|532585556|FG002|Overall Study|Adverse Event|18|||
147661860|NCT00928434|532585554|FG000|Overall Study|Protocol Violation|5|||
147661861|NCT00928434|532585555|FG001|Overall Study|Protocol Violation|0|||
147661862|NCT00928434|532585556|FG002|Overall Study|Protocol Violation|8|||
147661863|NCT00928434|532585554|FG000|Overall Study|Physician Decision|2|||
147661864|NCT00928434|532585555|FG001|Overall Study|Physician Decision|0|||
147661865|NCT00928434|532585556|FG002|Overall Study|Physician Decision|3|||
147661866|NCT00928434|532585554|FG000|Overall Study|Lost to Follow-up|1|||
147661867|NCT00928434|532585555|FG001|Overall Study|Lost to Follow-up|0|||
147599385|NCT03514641|532352404|FG001|603A: 0-12 Week Study Period|Adverse Event|2|||
147661868|NCT00928434|532585556|FG002|Overall Study|Lost to Follow-up|3|||
147661869|NCT00928434|532585554|FG000|Overall Study|Withdrawal by Subject|5|||
147661870|NCT00928434|532585555|FG001|Overall Study|Withdrawal by Subject|3|||
147661871|NCT00928434|532585556|FG002|Overall Study|Withdrawal by Subject|2|||
147661872|NCT00928434|532585554|FG000|Overall Study|PSA failure (>2 ng/mL) at Visit 8|10|||
147661873|NCT00928434|532585555|FG001|Overall Study|PSA failure (>2 ng/mL) at Visit 8|4|||
147661874|NCT00928434|532585556|FG002|Overall Study|PSA failure (>2 ng/mL) at Visit 8|7|||
147661875|NCT00928434|532585554|FG000|Overall Study|PSA failure (>2 ng/mL) on other visit|2|||
147661876|NCT00928434|532585555|FG001|Overall Study|PSA failure (>2 ng/mL) on other visit|1|||
147661877|NCT00928434|532585556|FG002|Overall Study|PSA failure (>2 ng/mL) on other visit|1|||
147257674|NCT01729754|531116378|FG003|Part 3|Adverse Event|0|||
147599386|NCT03514641|532352405|FG002|603A: 0-12 Week Study Period|Adverse Event|0|||
147599387|NCT03514641|532352406|FG003|603A: 0-12 Week Study Period|Adverse Event|0|||
147599388|NCT03514641|532352403|FG000|603A: 0-12 Week Study Period|Withdrawal by Subject|7|||
147599389|NCT03514641|532352404|FG001|603A: 0-12 Week Study Period|Withdrawal by Subject|5|||
147599390|NCT03514641|532352405|FG002|603A: 0-12 Week Study Period|Withdrawal by Subject|0|||
147599391|NCT03514641|532352406|FG003|603A: 0-12 Week Study Period|Withdrawal by Subject|0|||
147599392|NCT03514641|532352403|FG000|603A: 0-12 Week Study Period|Lost to Follow-up|10|||
147599393|NCT03514641|532352404|FG001|603A: 0-12 Week Study Period|Lost to Follow-up|9|||
147599394|NCT03514641|532352405|FG002|603A: 0-12 Week Study Period|Lost to Follow-up|0|||
147599395|NCT03514641|532352406|FG003|603A: 0-12 Week Study Period|Lost to Follow-up|0|||
147599396|NCT03514641|532352403|FG000|603A: 0-12 Week Study Period|Physician Decision|1|||
147599397|NCT03514641|532352404|FG001|603A: 0-12 Week Study Period|Physician Decision|0|||
147599398|NCT03514641|532352405|FG002|603A: 0-12 Week Study Period|Physician Decision|0|||
147599399|NCT03514641|532352406|FG003|603A: 0-12 Week Study Period|Physician Decision|0|||
147599400|NCT03514641|532352403|FG000|603A: 0-12 Week Study Period|Lack of Efficacy|1|||
147599401|NCT03514641|532352404|FG001|603A: 0-12 Week Study Period|Lack of Efficacy|0|||
147599402|NCT03514641|532352405|FG002|603A: 0-12 Week Study Period|Lack of Efficacy|0|||
147599403|NCT03514641|532352406|FG003|603A: 0-12 Week Study Period|Lack of Efficacy|0|||
147599404|NCT03514641|532352403|FG000|603A: 0-12 Week Study Period|24 hr ABPM not enough readings|0|||
147599405|NCT03514641|532352404|FG001|603A: 0-12 Week Study Period|24 hr ABPM not enough readings|1|||
147599406|NCT03514641|532352405|FG002|603A: 0-12 Week Study Period|24 hr ABPM not enough readings|0|||
147599407|NCT03514641|532352406|FG003|603A: 0-12 Week Study Period|24 hr ABPM not enough readings|0|||
147599408|NCT03514641|532352403|FG000|603B: 24-36 Week Study Period|Protocol Violation|0|||
147599409|NCT03514641|532352404|FG001|603B: 24-36 Week Study Period|Protocol Violation|0|||
147599410|NCT03514641|532352405|FG002|603B: 24-36 Week Study Period|Protocol Violation|0|||
147599411|NCT03514641|532352406|FG003|603B: 24-36 Week Study Period|Protocol Violation|2|||
147599412|NCT03514641|532352403|FG000|603B: 24-36 Week Study Period|Adverse Event|0|||
147599413|NCT03514641|532352404|FG001|603B: 24-36 Week Study Period|Adverse Event|0|||
147599414|NCT03514641|532352405|FG002|603B: 24-36 Week Study Period|Adverse Event|3|||
147599415|NCT03514641|532352406|FG003|603B: 24-36 Week Study Period|Adverse Event|1|||
147599416|NCT03514641|532352403|FG000|603B: 24-36 Week Study Period|Withdrawal by Subject|0|||
147599417|NCT03514641|532352404|FG001|603B: 24-36 Week Study Period|Withdrawal by Subject|0|||
147599418|NCT03514641|532352405|FG002|603B: 24-36 Week Study Period|Withdrawal by Subject|2|||
147257675|NCT01729754|531116379|FG004|Part 3|Adverse Event|0|||
147257676|NCT01729754|531116380|FG005|Part 3|Adverse Event|5|||
147257677|NCT01729754|531116381|FG006|Part 3|Adverse Event|0|||
147257678|NCT01729754|531116382|FG007|Part 3|Adverse Event|0|||
147257679|NCT01729754|531116383|FG008|Part 3|Adverse Event|0|||
147257680|NCT01729754|531116384|FG009|Part 3|Adverse Event|3|||
147257681|NCT01729754|531116375|FG000|Part 3|Death|0|||
147257682|NCT01729754|531116376|FG001|Part 3|Death|0|||
147257683|NCT01729754|531116377|FG002|Part 3|Death|0|||
147257684|NCT01729754|531116378|FG003|Part 3|Death|0|||
147257685|NCT01729754|531116379|FG004|Part 3|Death|0|||
147257686|NCT01729754|531116380|FG005|Part 3|Death|2|||
147257687|NCT01729754|531116381|FG006|Part 3|Death|0|||
147257688|NCT01729754|531116382|FG007|Part 3|Death|0|||
147257689|NCT01729754|531116383|FG008|Part 3|Death|0|||
147257690|NCT01729754|531116384|FG009|Part 3|Death|0|||
147257691|NCT01729754|531116375|FG000|Part 3|Lack of Efficacy|0|||
147599419|NCT03514641|532352406|FG003|603B: 24-36 Week Study Period|Withdrawal by Subject|3|||
147599420|NCT03514641|532352403|FG000|603B: 24-36 Week Study Period|Lost to Follow-up|0|||
147599421|NCT03514641|532352404|FG001|603B: 24-36 Week Study Period|Lost to Follow-up|0|||
147661878|NCT00928434|532585554|FG000|Overall Study|Other (not meeting above criteria)|5|||
147257692|NCT01729754|531116376|FG001|Part 3|Lack of Efficacy|0|||
147257693|NCT01729754|531116377|FG002|Part 3|Lack of Efficacy|0|||
147257694|NCT01729754|531116378|FG003|Part 3|Lack of Efficacy|0|||
147257695|NCT01729754|531116379|FG004|Part 3|Lack of Efficacy|2|||
147257696|NCT01729754|531116380|FG005|Part 3|Lack of Efficacy|0|||
147257697|NCT01729754|531116381|FG006|Part 3|Lack of Efficacy|0|||
147257698|NCT01729754|531116382|FG007|Part 3|Lack of Efficacy|0|||
147257699|NCT01729754|531116383|FG008|Part 3|Lack of Efficacy|0|||
147257700|NCT01729754|531116384|FG009|Part 3|Lack of Efficacy|4|||
147599422|NCT03514641|532352405|FG002|603B: 24-36 Week Study Period|Lost to Follow-up|6|||
147599423|NCT03514641|532352406|FG003|603B: 24-36 Week Study Period|Lost to Follow-up|6|||
147599424|NCT03514641|532352403|FG000|603B: 24-36 Week Study Period|24 hr ABPM not enough readings|0|||
147599425|NCT03514641|532352404|FG001|603B: 24-36 Week Study Period|24 hr ABPM not enough readings|0|||
147599426|NCT03514641|532352405|FG002|603B: 24-36 Week Study Period|24 hr ABPM not enough readings|3|||
147599427|NCT03514641|532352406|FG003|603B: 24-36 Week Study Period|24 hr ABPM not enough readings|3|||
147599428|NCT01345175|532352407|FG000|Overall Study|Physician Decision|0|||
147599429|NCT01345175|532352408|FG001|Overall Study|Physician Decision|1|||
147599430|NCT01345175|532352407|FG000|Overall Study|Withdrawal by Subject|1|||
147599431|NCT01345175|532352408|FG001|Overall Study|Withdrawal by Subject|1|||
147599432|NCT01345175|532352407|FG000|Overall Study|Failed to complete BFI|3|||
147599433|NCT01345175|532352408|FG001|Overall Study|Failed to complete BFI|2|||
147599434|NCT01345175|532352407|FG000|Overall Study|Stopped taking medication|2|||
147599435|NCT01345175|532352408|FG001|Overall Study|Stopped taking medication|2|||
147599436|NCT00505375|532352409|FG000|Overall Study|Death|1|||
147661879|NCT00928434|532585555|FG001|Overall Study|Other (not meeting above criteria)|1|||
147661880|NCT00928434|532585556|FG002|Overall Study|Other (not meeting above criteria)|2|||
147661881|NCT02154139|532585563|FG000|Overall Study|Injection not administered|2|||
147661882|NCT02154139|532585563|FG000|Overall Study|Other|2|||
147661883|NCT02154139|532585563|FG000|Overall Study|Investigator transferred|3|||
147661884|NCT00473655|532585564|FG000|Overall Study|Lost to Follow-up|9|||
147661885|NCT00473655|532585565|FG001|Overall Study|Lost to Follow-up|5|||
147661886|NCT00473655|532585566|FG002|Overall Study|Lost to Follow-up|8|||
147661887|NCT02087774|532585568|FG000|Overall Study|Were absent day of data collection|8|||
147661888|NCT02087774|532585569|FG001|Overall Study|Were absent day of data collection|20|||
147661889|NCT00243919|532585577|FG000|Overall Study|Death|3|||
147661890|NCT00243919|532585578|FG001|Overall Study|Death|4|||
147661891|NCT00243919|532585579|FG002|Overall Study|Death|6|||
147661892|NCT00243919|532585577|FG000|Overall Study|Withdrawal by Subject|6|||
147661893|NCT00243919|532585578|FG001|Overall Study|Withdrawal by Subject|6|||
147661894|NCT00243919|532585579|FG002|Overall Study|Withdrawal by Subject|2|||
147661895|NCT00243919|532585577|FG000|Overall Study|Lost to Follow-up|6|||
147661896|NCT00243919|532585578|FG001|Overall Study|Lost to Follow-up|7|||
147661897|NCT00243919|532585579|FG002|Overall Study|Lost to Follow-up|3|||
147661898|NCT00243919|532585577|FG000|Overall Study|Administrative Error|1|||
147661899|NCT00243919|532585578|FG001|Overall Study|Administrative Error|0|||
147661900|NCT00243919|532585579|FG002|Overall Study|Administrative Error|0|||
147661901|NCT00243919|532585577|FG000|Overall Study|Physician Decision|1|||
147661902|NCT00243919|532585578|FG001|Overall Study|Physician Decision|1|||
147661903|NCT00243919|532585579|FG002|Overall Study|Physician Decision|0|||
147661904|NCT04176939|532585581|FG000|Overall Study|Withdrawal by Subject|5|||
147661905|NCT04176939|532585581|FG000|Overall Study|Migrated / Moved From The Study Area|1|||
147661906|NCT04176939|532585581|FG000|Overall Study|Lost to Follow-up|2|||
147661907|NCT04176939|532585581|FG000|Overall Study|Unspecified reason|4|||
147661908|NCT04176939|532585581|FG000|Overall Study|Adverse Event Requiring Expedited Reporting|7|||
147661909|NCT02157519|532585584|FG000|Overall Study|Death|3|||
147661910|NCT02157519|532585585|FG001|Overall Study|Death|1|||
147661911|NCT02157519|532585584|FG000|Overall Study|Withdrawal by Subject|7|||
147661912|NCT02157519|532585585|FG001|Overall Study|Withdrawal by Subject|0|||
147661913|NCT02157519|532585584|FG000|Overall Study|Lost to Follow-up|1|||
147661914|NCT02157519|532585585|FG001|Overall Study|Lost to Follow-up|0|||
147661915|NCT01656395|532585586|FG000|Overall Study|Adverse Event|1|||
147661916|NCT01656395|532585587|FG001|Overall Study|Adverse Event|14|||
147661917|NCT01656395|532585588|FG002|Overall Study|Adverse Event|5|||
147661918|NCT01656395|532585589|FG003|Overall Study|Adverse Event|4|||
147661919|NCT01656395|532585590|FG004|Overall Study|Adverse Event|5|||
147661920|NCT01656395|532585591|FG005|Overall Study|Adverse Event|7|||
147661921|NCT01656395|532585592|FG006|Overall Study|Adverse Event|0|||
147661922|NCT01656395|532585593|FG007|Overall Study|Adverse Event|0|||
147661923|NCT01656395|532585586|FG000|Overall Study|Lack of Efficacy|1|||
147661924|NCT01656395|532585587|FG001|Overall Study|Lack of Efficacy|8|||
147661925|NCT01656395|532585588|FG002|Overall Study|Lack of Efficacy|6|||
147661926|NCT01656395|532585589|FG003|Overall Study|Lack of Efficacy|1|||
147661927|NCT01656395|532585590|FG004|Overall Study|Lack of Efficacy|1|||
147661928|NCT01656395|532585591|FG005|Overall Study|Lack of Efficacy|6|||
147661929|NCT01656395|532585592|FG006|Overall Study|Lack of Efficacy|0|||
147661930|NCT01656395|532585593|FG007|Overall Study|Lack of Efficacy|0|||
147661931|NCT01656395|532585586|FG000|Overall Study|Lost to Follow-up|1|||
147661932|NCT01656395|532585587|FG001|Overall Study|Lost to Follow-up|0|||
147450008|NCT01709149|531811338|FG000|Double-blind, Placebo-controlled Phase|Adverse Event|0|||
147599437|NCT00505375|532352410|FG001|Overall Study|Death|0|||
147599438|NCT00505375|532352409|FG000|Overall Study|Withdrawal by Subject|2|||
147661933|NCT01656395|532585588|FG002|Overall Study|Lost to Follow-up|0|||
147661934|NCT01656395|532585589|FG003|Overall Study|Lost to Follow-up|0|||
147661935|NCT01656395|532585590|FG004|Overall Study|Lost to Follow-up|0|||
147661936|NCT01656395|532585591|FG005|Overall Study|Lost to Follow-up|0|||
147661937|NCT01656395|532585592|FG006|Overall Study|Lost to Follow-up|0|||
147661938|NCT01656395|532585593|FG007|Overall Study|Lost to Follow-up|0|||
147661939|NCT01656395|532585586|FG000|Overall Study|Non-Compliance with Study Drug|1|||
147661940|NCT01656395|532585587|FG001|Overall Study|Non-Compliance with Study Drug|1|||
147661941|NCT01656395|532585588|FG002|Overall Study|Non-Compliance with Study Drug|0|||
147661942|NCT01656395|532585589|FG003|Overall Study|Non-Compliance with Study Drug|0|||
147661943|NCT01656395|532585590|FG004|Overall Study|Non-Compliance with Study Drug|1|||
147661944|NCT01656395|532585591|FG005|Overall Study|Non-Compliance with Study Drug|1|||
147661945|NCT01656395|532585592|FG006|Overall Study|Non-Compliance with Study Drug|0|||
147661946|NCT01656395|532585593|FG007|Overall Study|Non-Compliance with Study Drug|0|||
147661947|NCT01656395|532585586|FG000|Overall Study|Other|0|||
147661948|NCT01656395|532585587|FG001|Overall Study|Other|0|||
147661949|NCT01656395|532585588|FG002|Overall Study|Other|1|||
147661950|NCT01656395|532585589|FG003|Overall Study|Other|0|||
147661951|NCT01656395|532585590|FG004|Overall Study|Other|0|||
147661952|NCT01656395|532585591|FG005|Overall Study|Other|1|||
147661953|NCT01656395|532585592|FG006|Overall Study|Other|0|||
147661954|NCT01656395|532585593|FG007|Overall Study|Other|0|||
147661955|NCT01656395|532585586|FG000|Overall Study|Physician Decision|2|||
147661956|NCT01656395|532585587|FG001|Overall Study|Physician Decision|3|||
147661957|NCT01656395|532585588|FG002|Overall Study|Physician Decision|3|||
147661958|NCT01656395|532585589|FG003|Overall Study|Physician Decision|2|||
147661959|NCT01656395|532585590|FG004|Overall Study|Physician Decision|3|||
147661960|NCT01656395|532585591|FG005|Overall Study|Physician Decision|3|||
147661961|NCT01656395|532585592|FG006|Overall Study|Physician Decision|0|||
147661962|NCT01656395|532585593|FG007|Overall Study|Physician Decision|0|||
147661963|NCT01656395|532585586|FG000|Overall Study|Pregnancy|0|||
147661964|NCT01656395|532585587|FG001|Overall Study|Pregnancy|0|||
147661965|NCT01656395|532585588|FG002|Overall Study|Pregnancy|1|||
147661966|NCT01656395|532585589|FG003|Overall Study|Pregnancy|0|||
147661967|NCT01656395|532585590|FG004|Overall Study|Pregnancy|0|||
147661968|NCT01656395|532585591|FG005|Overall Study|Pregnancy|0|||
147661969|NCT01656395|532585592|FG006|Overall Study|Pregnancy|0|||
147661970|NCT01656395|532585593|FG007|Overall Study|Pregnancy|0|||
147661971|NCT01656395|532585586|FG000|Overall Study|Progressive Disease|0|||
147661972|NCT01656395|532585587|FG001|Overall Study|Progressive Disease|0|||
147661973|NCT01656395|532585588|FG002|Overall Study|Progressive Disease|0|||
147661974|NCT01656395|532585589|FG003|Overall Study|Progressive Disease|0|||
147661975|NCT01656395|532585590|FG004|Overall Study|Progressive Disease|0|||
147661976|NCT01656395|532585591|FG005|Overall Study|Progressive Disease|1|||
147661977|NCT01656395|532585592|FG006|Overall Study|Progressive Disease|0|||
147661978|NCT01656395|532585593|FG007|Overall Study|Progressive Disease|0|||
147661979|NCT01656395|532585586|FG000|Overall Study|Protocol Violation|6|||
147661980|NCT01656395|532585587|FG001|Overall Study|Protocol Violation|6|||
147661981|NCT01656395|532585588|FG002|Overall Study|Protocol Violation|9|||
147661982|NCT01656395|532585589|FG003|Overall Study|Protocol Violation|2|||
147661983|NCT01656395|532585590|FG004|Overall Study|Protocol Violation|4|||
147661984|NCT01656395|532585591|FG005|Overall Study|Protocol Violation|10|||
147661985|NCT01656395|532585592|FG006|Overall Study|Protocol Violation|0|||
147661986|NCT01656395|532585593|FG007|Overall Study|Protocol Violation|0|||
147661987|NCT01656395|532585586|FG000|Overall Study|Screen Failure|2|||
147661988|NCT01656395|532585587|FG001|Overall Study|Screen Failure|1|||
147661989|NCT01656395|532585588|FG002|Overall Study|Screen Failure|7|||
147661990|NCT01656395|532585589|FG003|Overall Study|Screen Failure|1|||
147661991|NCT01656395|532585590|FG004|Overall Study|Screen Failure|0|||
147661992|NCT01656395|532585591|FG005|Overall Study|Screen Failure|8|||
147661993|NCT01656395|532585592|FG006|Overall Study|Screen Failure|0|||
147661994|NCT01656395|532585593|FG007|Overall Study|Screen Failure|0|||
147661995|NCT01656395|532585586|FG000|Overall Study|Withdrawal by Subject|3|||
147661996|NCT01656395|532585587|FG001|Overall Study|Withdrawal by Subject|1|||
147661997|NCT01656395|532585588|FG002|Overall Study|Withdrawal by Subject|4|||
147661998|NCT01656395|532585589|FG003|Overall Study|Withdrawal by Subject|2|||
147661999|NCT01656395|532585590|FG004|Overall Study|Withdrawal by Subject|0|||
147662000|NCT01656395|532585591|FG005|Overall Study|Withdrawal by Subject|3|||
147662001|NCT01656395|532585592|FG006|Overall Study|Withdrawal by Subject|0|||
147662002|NCT01656395|532585593|FG007|Overall Study|Withdrawal by Subject|0|||
147662003|NCT04919317|532585597|FG000|Hospitalization and Wound Follow-up|Protocol Violation|0|||
147662004|NCT04919317|532585598|FG001|Hospitalization and Wound Follow-up|Protocol Violation|5|||
147257701|NCT01729754|531116375|FG000|Part 3|Lost to Follow-up|0|||
147257702|NCT01729754|531116376|FG001|Part 3|Lost to Follow-up|1|||
147257703|NCT01729754|531116377|FG002|Part 3|Lost to Follow-up|2|||
147662005|NCT04919317|532585597|FG000|SF-36 Quality of Life Survey Completion|Lost to Follow-up|12|||
147662006|NCT04919317|532585598|FG001|SF-36 Quality of Life Survey Completion|Lost to Follow-up|6|||
147662007|NCT00230048|532585599|FG000|Overall Study|Lost to Follow-up|13|||
147662008|NCT00230048|532585600|FG001|Overall Study|Lost to Follow-up|18|||
147662009|NCT00676403|532585603|FG000|Overall Study|Adverse Event|1|||
147662010|NCT00676403|532585604|FG001|Overall Study|Adverse Event|2|||
147662011|NCT00676403|532585605|FG002|Overall Study|Adverse Event|0|||
147662012|NCT00676403|532585606|FG003|Overall Study|Adverse Event|5|||
147662013|NCT00676403|532585607|FG004|Overall Study|Adverse Event|1|||
147662014|NCT00676403|532585608|FG005|Overall Study|Adverse Event|2|||
147599439|NCT00505375|532352410|FG001|Overall Study|Withdrawal by Subject|2|||
147599440|NCT00505375|532352409|FG000|Overall Study|Lost to Follow-up|0|||
147599441|NCT00505375|532352410|FG001|Overall Study|Lost to Follow-up|2|||
147599442|NCT00505375|532352409|FG000|Overall Study|Pregnancy|1|||
147599443|NCT00505375|532352410|FG001|Overall Study|Pregnancy|0|||
147599444|NCT00505375|532352409|FG000|Overall Study|Travel issues|0|||
147599445|NCT00505375|532352410|FG001|Overall Study|Travel issues|1|||
147599446|NCT04112173|532352413|FG000|Overall Study|Study terminated due to COVID-19 pandemic|1|||
147599447|NCT02570113|532352416|FG000|Overall Study|Withdrawal by Subject|3|||
147599448|NCT02746471|532352417|FG000|Overall Study|Death|43|||
147599449|NCT02746471|532352417|FG000|Overall Study|Exited before 36 months|1119|||
147599450|NCT02564211|532352418|FG000|Overall Study|Adverse Event|4|||
147599451|NCT00622466|532352420|FG000|Overall Study|Death|1|||
147599452|NCT00622466|532352420|FG000|Overall Study|Adverse Event|1|||
147599453|NCT00622466|532352420|FG000|Overall Study|Withdrawal by Subject|2|||
147599454|NCT04492020|532352422|FG000|Overall Study|Adverse Event|1|||
147599455|NCT04492020|532352423|FG001|Overall Study|Adverse Event|3|||
147599456|NCT04492020|532352422|FG000|Overall Study|Withdrawal by Subject|4|||
147599457|NCT04492020|532352423|FG001|Overall Study|Withdrawal by Subject|3|||
147599458|NCT04492020|532352422|FG000|Overall Study|Lost to Follow-up|4|||
147599459|NCT04492020|532352423|FG001|Overall Study|Lost to Follow-up|3|||
147599460|NCT04492020|532352422|FG000|Overall Study|Protocol Violation|5|||
147599461|NCT04492020|532352423|FG001|Overall Study|Protocol Violation|2|||
147599462|NCT04492020|532352422|FG000|Overall Study|Lack of Qualifying Event|25|||
147599463|NCT04492020|532352423|FG001|Overall Study|Lack of Qualifying Event|27|||
147599464|NCT04492020|532352422|FG000|Overall Study|Non-compliance with Study Drug|2|||
147599465|NCT04492020|532352423|FG001|Overall Study|Non-compliance with Study Drug|1|||
147599466|NCT04594707|532352424|FG000|Overall Study|Adverse Event|0|||
147599467|NCT04594707|532352425|FG001|Overall Study|Adverse Event|0|||
147599468|NCT04594707|532352426|FG002|Overall Study|Adverse Event|1|||
147599469|NCT04594707|532352424|FG000|Overall Study|Death|0|||
147599470|NCT04594707|532352425|FG001|Overall Study|Death|2|||
147599471|NCT04594707|532352426|FG002|Overall Study|Death|2|||
147599472|NCT04594707|532352424|FG000|Overall Study|Lung Transplant|0|||
147599473|NCT04594707|532352425|FG001|Overall Study|Lung Transplant|0|||
147599474|NCT04594707|532352426|FG002|Overall Study|Lung Transplant|1|||
147599475|NCT04594707|532352424|FG000|Overall Study|Grade 4 infusion related reaction (IRR)|1|||
147599476|NCT04594707|532352425|FG001|Overall Study|Grade 4 infusion related reaction (IRR)|0|||
147599477|NCT04594707|532352426|FG002|Overall Study|Grade 4 infusion related reaction (IRR)|0|||
147599478|NCT04594707|532352424|FG000|Overall Study|Study Terminated By Sponsor|19|||
147599479|NCT04594707|532352425|FG001|Overall Study|Study Terminated By Sponsor|47|||
147599480|NCT04594707|532352426|FG002|Overall Study|Study Terminated By Sponsor|41|||
147599481|NCT04594707|532352424|FG000|Overall Study|Withdrawal by Subject|1|||
147599482|NCT04594707|532352425|FG001|Overall Study|Withdrawal by Subject|0|||
147599483|NCT04594707|532352426|FG002|Overall Study|Withdrawal by Subject|2|||
147599484|NCT04585789|532352427|FG000|FU Phase: Week 48 to Week 96|Lost to Follow-up|1|||
147599485|NCT04585789|532352428|FG001|FU Phase: Week 48 to Week 96|Lost to Follow-up|0|||
147599486|NCT04585789|532352429|FG002|FU Phase: Week 48 to Week 96|Lost to Follow-up|0|||
147599487|NCT04585789|532352427|FG000|FU Phase: Week 48 to Week 96|Withdrawal by Subject|1|||
147599488|NCT04585789|532352428|FG001|FU Phase: Week 48 to Week 96|Withdrawal by Subject|0|||
147599489|NCT04585789|532352429|FG002|FU Phase: Week 48 to Week 96|Withdrawal by Subject|0|||
147599490|NCT01175811|532352430|FG000|Overall Study|Adverse Event|1|||
147599491|NCT01175811|532352431|FG001|Overall Study|Adverse Event|1|||
147599492|NCT01175811|532352430|FG000|Overall Study|Entry criteria not met|3|||
147599493|NCT01175811|532352431|FG001|Overall Study|Entry criteria not met|1|||
147599494|NCT01175811|532352430|FG000|Overall Study|Lack of Efficacy|1|||
147599495|NCT01175811|532352431|FG001|Overall Study|Lack of Efficacy|0|||
147599496|NCT01175811|532352430|FG000|Overall Study|Lost to Follow-up|3|||
147599497|NCT01175811|532352431|FG001|Overall Study|Lost to Follow-up|2|||
147599498|NCT01175811|532352430|FG000|Overall Study|Physician Decision|1|||
147599499|NCT01175811|532352431|FG001|Overall Study|Physician Decision|1|||
147599500|NCT01175811|532352430|FG000|Overall Study|Protocol Violation|1|||
147599501|NCT01175811|532352431|FG001|Overall Study|Protocol Violation|2|||
147599502|NCT01175811|532352430|FG000|Overall Study|Withdrawal by Subject|6|||
147599503|NCT01175811|532352431|FG001|Overall Study|Withdrawal by Subject|7|||
147599504|NCT00326963|532352432|FG000|Overall Study|Adverse Event|2|||
147599505|NCT00326963|532352432|FG000|Overall Study|Injection site reaction|1|||
147599506|NCT00326963|532352432|FG000|Overall Study|Death|1|||
147599507|NCT00326963|532352432|FG000|Overall Study|Failure to return|10|||
147599508|NCT00326963|532352432|FG000|Overall Study|Withdrawal by Subject|10|||
147599509|NCT00326963|532352432|FG000|Overall Study|Refused treatment / did not cooperate|5|||
147599510|NCT00326963|532352432|FG000|Overall Study|Violation of selection criteria at entry|2|||
147662015|NCT00676403|532585603|FG000|Overall Study|Lost to Follow-up|0|||
147599511|NCT00326963|532352432|FG000|Overall Study|Other protocol violation|1|||
147599512|NCT00326963|532352432|FG000|Overall Study|Administrative / other|1|||
147599513|NCT01447420|532352436|FG000|Overall Study|Adverse Event|2|||
147599514|NCT01447420|532352437|FG001|Overall Study|Adverse Event|4|||
147257704|NCT01729754|531116378|FG003|Part 3|Lost to Follow-up|0|||
147257705|NCT01729754|531116379|FG004|Part 3|Lost to Follow-up|0|||
147257706|NCT01729754|531116380|FG005|Part 3|Lost to Follow-up|3|||
147257707|NCT01729754|531116381|FG006|Part 3|Lost to Follow-up|0|||
147257708|NCT01729754|531116382|FG007|Part 3|Lost to Follow-up|0|||
147257709|NCT01729754|531116383|FG008|Part 3|Lost to Follow-up|1|||
147257710|NCT01729754|531116384|FG009|Part 3|Lost to Follow-up|0|||
147257711|NCT01729754|531116375|FG000|Part 3|Physician Decision|0|||
147257712|NCT01729754|531116376|FG001|Part 3|Physician Decision|0|||
147257713|NCT01729754|531116377|FG002|Part 3|Physician Decision|1|||
147257714|NCT01729754|531116378|FG003|Part 3|Physician Decision|0|||
147257715|NCT01729754|531116379|FG004|Part 3|Physician Decision|0|||
147257716|NCT01729754|531116380|FG005|Part 3|Physician Decision|0|||
147257717|NCT01729754|531116381|FG006|Part 3|Physician Decision|0|||
147257718|NCT01729754|531116382|FG007|Part 3|Physician Decision|0|||
147257719|NCT01729754|531116383|FG008|Part 3|Physician Decision|0|||
147257720|NCT01729754|531116384|FG009|Part 3|Physician Decision|0|||
147257721|NCT01729754|531116375|FG000|Part 3|Withdrawal by Subject|0|||
147257722|NCT01729754|531116376|FG001|Part 3|Withdrawal by Subject|4|||
147257723|NCT01729754|531116377|FG002|Part 3|Withdrawal by Subject|1|||
147257724|NCT01729754|531116378|FG003|Part 3|Withdrawal by Subject|0|||
147257725|NCT01729754|531116379|FG004|Part 3|Withdrawal by Subject|2|||
147257726|NCT01729754|531116380|FG005|Part 3|Withdrawal by Subject|1|||
147257727|NCT01729754|531116381|FG006|Part 3|Withdrawal by Subject|0|||
147257728|NCT01729754|531116382|FG007|Part 3|Withdrawal by Subject|2|||
147257729|NCT01729754|531116383|FG008|Part 3|Withdrawal by Subject|0|||
147257730|NCT01729754|531116384|FG009|Part 3|Withdrawal by Subject|0|||
147257731|NCT01729754|531116375|FG000|Part 3|Other Protocol Specified Criteria|0|||
147257732|NCT01729754|531116376|FG001|Part 3|Other Protocol Specified Criteria|0|||
147257733|NCT01729754|531116377|FG002|Part 3|Other Protocol Specified Criteria|0|||
147257734|NCT01729754|531116378|FG003|Part 3|Other Protocol Specified Criteria|0|||
147257735|NCT01729754|531116379|FG004|Part 3|Other Protocol Specified Criteria|0|||
147257736|NCT01729754|531116380|FG005|Part 3|Other Protocol Specified Criteria|2|||
147257737|NCT01729754|531116381|FG006|Part 3|Other Protocol Specified Criteria|0|||
147257738|NCT01729754|531116382|FG007|Part 3|Other Protocol Specified Criteria|1|||
147257739|NCT01729754|531116383|FG008|Part 3|Other Protocol Specified Criteria|0|||
147257740|NCT01729754|531116384|FG009|Part 3|Other Protocol Specified Criteria|0|||
147257741|NCT00773292|531116385|FG000|Treatment 48 Weeks|Adverse Event|1|||
147257742|NCT00773292|531116385|FG000|Treatment 48 Weeks|Lack of Efficacy|1|||
147257743|NCT04729127|531116386|FG000|Overall Study|Suspended/Terminated EI Services|4|||
147257744|NCT04729127|531116387|FG001|Overall Study|Suspended/Terminated EI Services|0|||
147257745|NCT04729127|531116388|FG002|Overall Study|Suspended/Terminated EI Services|4|||
147257746|NCT04729127|531116389|FG003|Overall Study|Suspended/Terminated EI Services|6|||
147257747|NCT04729127|531116390|FG004|Overall Study|Suspended/Terminated EI Services|0|||
147257748|NCT04729127|531116391|FG005|Overall Study|Suspended/Terminated EI Services|6|||
147257749|NCT04729127|531116392|FG006|Overall Study|Suspended/Terminated EI Services|2|||
147257750|NCT04729127|531116393|FG007|Overall Study|Suspended/Terminated EI Services|0|||
147257751|NCT04729127|531116394|FG008|Overall Study|Suspended/Terminated EI Services|2|||
147257752|NCT04729127|531116386|FG000|Overall Study|Withdrawal by Subject|1|||
147257753|NCT04729127|531116387|FG001|Overall Study|Withdrawal by Subject|0|||
147257754|NCT04729127|531116388|FG002|Overall Study|Withdrawal by Subject|1|||
147257755|NCT04729127|531116389|FG003|Overall Study|Withdrawal by Subject|0|||
147257756|NCT04729127|531116390|FG004|Overall Study|Withdrawal by Subject|0|||
147257757|NCT04729127|531116391|FG005|Overall Study|Withdrawal by Subject|0|||
147257758|NCT04729127|531116392|FG006|Overall Study|Withdrawal by Subject|0|||
147257759|NCT04729127|531116393|FG007|Overall Study|Withdrawal by Subject|0|||
147257760|NCT04729127|531116394|FG008|Overall Study|Withdrawal by Subject|0|||
147257761|NCT04729127|531116386|FG000|Overall Study|Switched Agency/Setting|1|||
147257762|NCT04729127|531116387|FG001|Overall Study|Switched Agency/Setting|0|||
147257763|NCT04729127|531116388|FG002|Overall Study|Switched Agency/Setting|1|||
147257764|NCT04729127|531116389|FG003|Overall Study|Switched Agency/Setting|1|||
147257765|NCT04729127|531116390|FG004|Overall Study|Switched Agency/Setting|0|||
147257766|NCT04729127|531116391|FG005|Overall Study|Switched Agency/Setting|1|||
147257767|NCT04729127|531116392|FG006|Overall Study|Switched Agency/Setting|1|||
147257768|NCT04729127|531116393|FG007|Overall Study|Switched Agency/Setting|0|||
147257769|NCT04729127|531116394|FG008|Overall Study|Switched Agency/Setting|1|||
147257770|NCT00542919|531116397|FG000|Overall Study|Adverse Event|1|||
147257771|NCT00542919|531116398|FG001|Overall Study|Adverse Event|5|||
147257772|NCT00542919|531116399|FG002|Overall Study|Adverse Event|1|||
147257773|NCT00542919|531116397|FG000|Overall Study|Withdrawal by Subject|1|||
147257774|NCT00542919|531116398|FG001|Overall Study|Withdrawal by Subject|0|||
147257775|NCT00542919|531116399|FG002|Overall Study|Withdrawal by Subject|3|||
147257776|NCT00542919|531116397|FG000|Overall Study|Physician Decision|2|||
147257777|NCT00542919|531116398|FG001|Overall Study|Physician Decision|2|||
147257778|NCT00542919|531116399|FG002|Overall Study|Physician Decision|1|||
147257779|NCT00542919|531116397|FG000|Overall Study|Sponsor Decision|1|||
147257780|NCT00542919|531116398|FG001|Overall Study|Sponsor Decision|0|||
147257781|NCT00542919|531116399|FG002|Overall Study|Sponsor Decision|0|||
147257782|NCT00542919|531116397|FG000|Overall Study|Lost to Follow-up|2|||
147257783|NCT00542919|531116398|FG001|Overall Study|Lost to Follow-up|0|||
147257784|NCT00542919|531116399|FG002|Overall Study|Lost to Follow-up|1|||
147257785|NCT03388138|531116410|FG000|Overall Study|Protocol Violation|1|||
147257786|NCT03388138|531116411|FG001|Overall Study|Protocol Violation|0|||
147257787|NCT01528072|531116412|FG000|Overall Study|Withdrawal by Subject|5|||
147257788|NCT01528072|531116412|FG000|Overall Study|Physician Decision|1|||
147257789|NCT01528072|531116412|FG000|Overall Study|Determined not eligible by AEAC|1|||
147257790|NCT01528072|531116412|FG000|Overall Study|Missed Visit|2|||
147257791|NCT01528072|531116412|FG000|Overall Study|Lost to Follow-up|5|||
147257792|NCT01528072|531116412|FG000|Overall Study|Explanted|2|||
147257793|NCT01528072|531116412|FG000|Overall Study|Site Closure|4|||
147257794|NCT01528072|531116412|FG000|Overall Study|Death|2|||
147257795|NCT01528072|531116412|FG000|Overall Study|Early Termination of Study|52|||
147257796|NCT04014075|531116414|FG000|Overall Study|Progressive Disease|53|||
147257797|NCT04014075|531116414|FG000|Overall Study|Adverse Event|15|||
147257798|NCT04014075|531116414|FG000|Overall Study|Clinical Progression|4|||
147257799|NCT04014075|531116414|FG000|Overall Study|Death|2|||
147257800|NCT04014075|531116414|FG000|Overall Study|Withdrawal by Subject|2|||
147257801|NCT04014075|531116414|FG000|Overall Study|Miscellaneous|2|||
147257802|NCT04014075|531116414|FG000|Overall Study|Physician Decision|1|||
147257803|NCT04741074|531116419|FG000|Overall Study|Withdrawal by Subject|1|||
147257804|NCT04741074|531116420|FG001|Overall Study|Withdrawal by Subject|1|||
147257805|NCT04741074|531116419|FG000|Overall Study|Study terminated prematurely|1|||
147257806|NCT04741074|531116420|FG001|Overall Study|Study terminated prematurely|0|||
147257807|NCT02432846|531116421|FG000|Overall Study (4 Arms/Strata)|Death|3|||
147257808|NCT02432846|531116422|FG001|Overall Study (4 Arms/Strata)|Death|2|||
147599515|NCT01447420|532352438|FG002|Overall Study|Adverse Event|2|||
147599516|NCT01447420|532352436|FG000|Overall Study|Protocol Violation|3|||
147599517|NCT01447420|532352437|FG001|Overall Study|Protocol Violation|3|||
147599518|NCT01447420|532352438|FG002|Overall Study|Protocol Violation|0|||
147599519|NCT01447420|532352436|FG000|Overall Study|Withdrawal by Subject|4|||
147599520|NCT01447420|532352437|FG001|Overall Study|Withdrawal by Subject|1|||
147599521|NCT01447420|532352438|FG002|Overall Study|Withdrawal by Subject|0|||
147599522|NCT01447420|532352436|FG000|Overall Study|Lack of Efficacy|1|||
147599523|NCT01447420|532352437|FG001|Overall Study|Lack of Efficacy|19|||
147599524|NCT01447420|532352438|FG002|Overall Study|Lack of Efficacy|8|||
147599525|NCT04562155|532352440|FG000|Overall Study|COVID-19 pandemic|0|||
147599526|NCT04562155|532352441|FG001|Overall Study|COVID-19 pandemic|0|||
147599527|NCT04562155|532352442|FG002|Overall Study|COVID-19 pandemic|0|||
147599528|NCT04562155|532352443|FG003|Overall Study|COVID-19 pandemic|1|||
147599529|NCT04562155|532352440|FG000|Overall Study|Adverse Event|7|||
147257809|NCT02432846|531116423|FG002|Overall Study (4 Arms/Strata)|Death|4|||
147257810|NCT02432846|531116424|FG003|Overall Study (4 Arms/Strata)|Death|3|||
147257811|NCT02432846|531116425|FG004|Overall Study (4 Arms/Strata)|Death|0|||
147599530|NCT04562155|532352441|FG001|Overall Study|Adverse Event|3|||
147599531|NCT04562155|532352442|FG002|Overall Study|Adverse Event|8|||
147599532|NCT04562155|532352443|FG003|Overall Study|Adverse Event|1|||
147599533|NCT04562155|532352440|FG000|Overall Study|Withdrawal by Subject|3|||
147599534|NCT04562155|532352441|FG001|Overall Study|Withdrawal by Subject|6|||
147257812|NCT02432846|531116426|FG005|Overall Study (4 Arms/Strata)|Death|0|||
147257813|NCT02432846|531116421|FG000|Overall Study (4 Arms/Strata)|Adverse Event|0|||
147257814|NCT02432846|531116422|FG001|Overall Study (4 Arms/Strata)|Adverse Event|1|||
147257815|NCT02432846|531116423|FG002|Overall Study (4 Arms/Strata)|Adverse Event|1|||
147257816|NCT02432846|531116424|FG003|Overall Study (4 Arms/Strata)|Adverse Event|0|||
147257817|NCT02432846|531116425|FG004|Overall Study (4 Arms/Strata)|Adverse Event|0|||
147257818|NCT02432846|531116426|FG005|Overall Study (4 Arms/Strata)|Adverse Event|0|||
147257819|NCT02432846|531116421|FG000|Overall Study (4 Arms/Strata)|Physician Decision|2|||
147257820|NCT02432846|531116422|FG001|Overall Study (4 Arms/Strata)|Physician Decision|0|||
147257821|NCT02432846|531116423|FG002|Overall Study (4 Arms/Strata)|Physician Decision|0|||
147257822|NCT02432846|531116424|FG003|Overall Study (4 Arms/Strata)|Physician Decision|0|||
147257823|NCT02432846|531116425|FG004|Overall Study (4 Arms/Strata)|Physician Decision|0|||
147257824|NCT02432846|531116426|FG005|Overall Study (4 Arms/Strata)|Physician Decision|0|||
147599535|NCT04562155|532352442|FG002|Overall Study|Withdrawal by Subject|3|||
147599536|NCT04562155|532352443|FG003|Overall Study|Withdrawal by Subject|3|||
147599537|NCT04562155|532352440|FG000|Overall Study|Participant personal reason|1|||
147257825|NCT02432846|531116421|FG000|Overall Study (4 Arms/Strata)|Withdrawal by Subject|2|||
147257826|NCT02432846|531116422|FG001|Overall Study (4 Arms/Strata)|Withdrawal by Subject|0|||
147257827|NCT02432846|531116423|FG002|Overall Study (4 Arms/Strata)|Withdrawal by Subject|1|||
147257828|NCT02432846|531116424|FG003|Overall Study (4 Arms/Strata)|Withdrawal by Subject|1|||
147257829|NCT02432846|531116425|FG004|Overall Study (4 Arms/Strata)|Withdrawal by Subject|0|||
147257830|NCT02432846|531116426|FG005|Overall Study (4 Arms/Strata)|Withdrawal by Subject|0|||
147257831|NCT02432846|531116421|FG000|Overall Study (4 Arms/Strata)|Other (reason not specified)|0|||
147257832|NCT02432846|531116422|FG001|Overall Study (4 Arms/Strata)|Other (reason not specified)|0|||
147599538|NCT04562155|532352441|FG001|Overall Study|Participant personal reason|0|||
147599539|NCT04562155|532352442|FG002|Overall Study|Participant personal reason|2|||
147257833|NCT02432846|531116423|FG002|Overall Study (4 Arms/Strata)|Other (reason not specified)|2|||
147257834|NCT02432846|531116424|FG003|Overall Study (4 Arms/Strata)|Other (reason not specified)|1|||
147257835|NCT02432846|531116425|FG004|Overall Study (4 Arms/Strata)|Other (reason not specified)|0|||
147257836|NCT02432846|531116426|FG005|Overall Study (4 Arms/Strata)|Other (reason not specified)|0|||
147257837|NCT02432846|531116421|FG000|Overall Study (4 Arms/Strata)|Disease progression|8|||
147257838|NCT02432846|531116422|FG001|Overall Study (4 Arms/Strata)|Disease progression|5|||
147257839|NCT02432846|531116423|FG002|Overall Study (4 Arms/Strata)|Disease progression|15|||
147257840|NCT02432846|531116424|FG003|Overall Study (4 Arms/Strata)|Disease progression|9|||
147257841|NCT02432846|531116425|FG004|Overall Study (4 Arms/Strata)|Disease progression|0|||
147257842|NCT02432846|531116426|FG005|Overall Study (4 Arms/Strata)|Disease progression|0|||
147257843|NCT02432846|531116421|FG000|Overall Study (4 Arms/Strata)|Lost to Follow-up|0|||
147257844|NCT02432846|531116422|FG001|Overall Study (4 Arms/Strata)|Lost to Follow-up|0|||
147257845|NCT02432846|531116423|FG002|Overall Study (4 Arms/Strata)|Lost to Follow-up|1|||
147257846|NCT02432846|531116424|FG003|Overall Study (4 Arms/Strata)|Lost to Follow-up|0|||
147257847|NCT02432846|531116425|FG004|Overall Study (4 Arms/Strata)|Lost to Follow-up|0|||
147257848|NCT02432846|531116426|FG005|Overall Study (4 Arms/Strata)|Lost to Follow-up|0|||
147257849|NCT02432846|531116421|FG000|Overall Study (2 Total/Combined Groups)|Death|0|||
147257850|NCT02432846|531116422|FG001|Overall Study (2 Total/Combined Groups)|Death|0|||
147257851|NCT02432846|531116423|FG002|Overall Study (2 Total/Combined Groups)|Death|0|||
147257852|NCT02432846|531116424|FG003|Overall Study (2 Total/Combined Groups)|Death|0|||
147257853|NCT02432846|531116425|FG004|Overall Study (2 Total/Combined Groups)|Death|7|||
147257854|NCT02432846|531116426|FG005|Overall Study (2 Total/Combined Groups)|Death|5|||
147257855|NCT02432846|531116421|FG000|Overall Study (2 Total/Combined Groups)|Adverse Event|0|||
147599540|NCT04562155|532352443|FG003|Overall Study|Participant personal reason|1|||
147599541|NCT00851318|532352444|FG000|Overall Study|Withdrawal by Subject|7|||
147599542|NCT00851318|532352445|FG001|Overall Study|Withdrawal by Subject|1|||
147599543|NCT00851318|532352446|FG002|Overall Study|Withdrawal by Subject|5|||
147599544|NCT00851318|532352447|FG003|Overall Study|Withdrawal by Subject|3|||
147257856|NCT02432846|531116422|FG001|Overall Study (2 Total/Combined Groups)|Adverse Event|0|||
147257857|NCT02432846|531116423|FG002|Overall Study (2 Total/Combined Groups)|Adverse Event|0|||
147257858|NCT02432846|531116424|FG003|Overall Study (2 Total/Combined Groups)|Adverse Event|0|||
147257859|NCT02432846|531116425|FG004|Overall Study (2 Total/Combined Groups)|Adverse Event|1|||
147257860|NCT02432846|531116426|FG005|Overall Study (2 Total/Combined Groups)|Adverse Event|1|||
147257861|NCT02432846|531116421|FG000|Overall Study (2 Total/Combined Groups)|Physician Decision|0|||
147257862|NCT02432846|531116422|FG001|Overall Study (2 Total/Combined Groups)|Physician Decision|0|||
147257863|NCT02432846|531116423|FG002|Overall Study (2 Total/Combined Groups)|Physician Decision|0|||
147257864|NCT02432846|531116424|FG003|Overall Study (2 Total/Combined Groups)|Physician Decision|0|||
147257865|NCT02432846|531116425|FG004|Overall Study (2 Total/Combined Groups)|Physician Decision|2|||
147599545|NCT00851318|532352444|FG000|Overall Study|Adverse Event|13|||
147662016|NCT00676403|532585604|FG001|Overall Study|Lost to Follow-up|0|||
147662017|NCT00676403|532585605|FG002|Overall Study|Lost to Follow-up|0|||
147257866|NCT02432846|531116426|FG005|Overall Study (2 Total/Combined Groups)|Physician Decision|0|||
147257867|NCT02432846|531116421|FG000|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|0|||
147257868|NCT02432846|531116422|FG001|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|0|||
147599546|NCT00851318|532352445|FG001|Overall Study|Adverse Event|2|||
147662018|NCT00676403|532585606|FG003|Overall Study|Lost to Follow-up|0|||
147599547|NCT00851318|532352446|FG002|Overall Study|Adverse Event|9|||
147599548|NCT00851318|532352447|FG003|Overall Study|Adverse Event|12|||
147662019|NCT00676403|532585607|FG004|Overall Study|Lost to Follow-up|0|||
147257869|NCT02432846|531116423|FG002|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|0|||
147257870|NCT02432846|531116424|FG003|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|0|||
147599549|NCT00851318|532352444|FG000|Overall Study|Pregnancy|0|||
147599550|NCT00851318|532352445|FG001|Overall Study|Pregnancy|0|||
147599551|NCT00851318|532352446|FG002|Overall Study|Pregnancy|1|||
147599552|NCT00851318|532352447|FG003|Overall Study|Pregnancy|1|||
147599553|NCT00851318|532352444|FG000|Overall Study|Lack of Efficacy|8|||
147599554|NCT00851318|532352445|FG001|Overall Study|Lack of Efficacy|2|||
147599555|NCT00851318|532352446|FG002|Overall Study|Lack of Efficacy|4|||
147599556|NCT00851318|532352447|FG003|Overall Study|Lack of Efficacy|2|||
147599557|NCT00851318|532352444|FG000|Overall Study|Non-compliance with Study Procedures|2|||
147662020|NCT00676403|532585608|FG005|Overall Study|Lost to Follow-up|1|||
147662021|NCT00676403|532585603|FG000|Overall Study|Reason Unspecified|1|||
147662022|NCT00676403|532585604|FG001|Overall Study|Reason Unspecified|0|||
147257871|NCT02432846|531116425|FG004|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|3|||
147257872|NCT02432846|531116426|FG005|Overall Study (2 Total/Combined Groups)|Withdrawal by Subject|1|||
147599558|NCT00851318|532352445|FG001|Overall Study|Non-compliance with Study Procedures|0|||
147599559|NCT00851318|532352446|FG002|Overall Study|Non-compliance with Study Procedures|1|||
147599560|NCT00851318|532352447|FG003|Overall Study|Non-compliance with Study Procedures|0|||
147662023|NCT00676403|532585605|FG002|Overall Study|Reason Unspecified|1|||
147662024|NCT00676403|532585606|FG003|Overall Study|Reason Unspecified|0|||
147662025|NCT00676403|532585607|FG004|Overall Study|Reason Unspecified|0|||
147257873|NCT02432846|531116421|FG000|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|0|||
147662026|NCT00676403|532585608|FG005|Overall Study|Reason Unspecified|1|||
147662027|NCT00676403|532585603|FG000|Overall Study|Withdrawal by Subject|0|||
147662028|NCT00676403|532585604|FG001|Overall Study|Withdrawal by Subject|0|||
147662029|NCT00676403|532585605|FG002|Overall Study|Withdrawal by Subject|0|||
147662030|NCT00676403|532585606|FG003|Overall Study|Withdrawal by Subject|0|||
147662031|NCT00676403|532585607|FG004|Overall Study|Withdrawal by Subject|0|||
147662032|NCT00676403|532585608|FG005|Overall Study|Withdrawal by Subject|1|||
147662033|NCT00297648|532585609|FG000|Overall Study|Adverse Event|13|||
147662034|NCT00297648|532585609|FG000|Overall Study|Lack of Efficacy|18|||
147662035|NCT00297648|532585609|FG000|Overall Study|Lost to Follow-up|1|||
147662036|NCT00297648|532585609|FG000|Overall Study|Withdrawal by Subject|3|||
147662037|NCT00297648|532585609|FG000|Overall Study|Other: Incompliance|1|||
147257874|NCT02432846|531116422|FG001|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|0|||
147257875|NCT02432846|531116423|FG002|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|0|||
147257876|NCT02432846|531116424|FG003|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|0|||
147257877|NCT02432846|531116425|FG004|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|2|||
147257878|NCT02432846|531116426|FG005|Overall Study (2 Total/Combined Groups)|Other (reason not specified)|1|||
147257879|NCT02432846|531116421|FG000|Overall Study (2 Total/Combined Groups)|Disease progression|0|||
147662038|NCT03225170|532585610|FG000|Overall Study|Lost to Follow-up|4|||
147662039|NCT03225170|532585611|FG001|Overall Study|Lost to Follow-up|4|||
147662040|NCT03225170|532585612|FG002|Overall Study|Lost to Follow-up|0|||
147662041|NCT03225170|532585610|FG000|Overall Study|Did not complete intervention/control writing exercise|0|||
147662042|NCT03225170|532585611|FG001|Overall Study|Did not complete intervention/control writing exercise|1|||
147662043|NCT03225170|532585612|FG002|Overall Study|Did not complete intervention/control writing exercise|0|||
147662044|NCT02048722|532585613|FG000|2 Cycles of Treatment|Adverse Event|2|||
147662045|NCT02048722|532585613|FG000|2 Cycles of Treatment|Withdrawal by Subject|4|||
147662046|NCT02048722|532585613|FG000|2 Cycles of Treatment|Progressive Disease|2|||
147662047|NCT02048722|532585613|FG000|Reached 1st Response/Continued Treatment|Progressive Disease|10|||
147662048|NCT02048722|532585613|FG000|Follow up 5 Years or Cut of Timepoint|Death|24|||
147662049|NCT02048722|532585613|FG000|Follow up 5 Years or Cut of Timepoint|Withdrawal by Subject|3|||
147257880|NCT02432846|531116422|FG001|Overall Study (2 Total/Combined Groups)|Disease progression|0|||
147257881|NCT02432846|531116423|FG002|Overall Study (2 Total/Combined Groups)|Disease progression|0|||
147257882|NCT02432846|531116424|FG003|Overall Study (2 Total/Combined Groups)|Disease progression|0|||
147257883|NCT02432846|531116425|FG004|Overall Study (2 Total/Combined Groups)|Disease progression|23|||
147257884|NCT02432846|531116426|FG005|Overall Study (2 Total/Combined Groups)|Disease progression|14|||
147257885|NCT02432846|531116421|FG000|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|0|||
147257886|NCT02432846|531116422|FG001|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|0|||
147257887|NCT02432846|531116423|FG002|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|0|||
147257888|NCT02432846|531116424|FG003|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|0|||
147257889|NCT02432846|531116425|FG004|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|1|||
147257890|NCT02432846|531116426|FG005|Overall Study (2 Total/Combined Groups)|Lost to Follow-up|0|||
147257891|NCT01912287|531116431|FG000|Overall Study|Ineligible|1|||
147257892|NCT01912287|531116432|FG001|Overall Study|Ineligible|0|||
147257893|NCT01912287|531116433|FG002|Overall Study|Ineligible|1|||
147257894|NCT01912287|531116431|FG000|Overall Study|No-show|0|||
147662050|NCT05209880|532585615|FG000|1-Month Follow-up|Spoke with Doctor|5|||
147662051|NCT05209880|532585616|FG001|1-Month Follow-up|Spoke with Doctor|5|||
147662052|NCT05209880|532585615|FG000|1-Month Follow-up|Lost to Follow-up|7|||
147662053|NCT05209880|532585616|FG001|1-Month Follow-up|Lost to Follow-up|9|||
147257895|NCT01912287|531116432|FG001|Overall Study|No-show|0|||
147257896|NCT01912287|531116433|FG002|Overall Study|No-show|1|||
147257897|NCT01912287|531116431|FG000|Overall Study|Dissatisfaction with assigned treatment|4|||
147257898|NCT01912287|531116432|FG001|Overall Study|Dissatisfaction with assigned treatment|2|||
147257899|NCT01912287|531116433|FG002|Overall Study|Dissatisfaction with assigned treatment|1|||
147257900|NCT01912287|531116431|FG000|Overall Study|Felt treatment no longer needed|0|||
147257901|NCT01912287|531116432|FG001|Overall Study|Felt treatment no longer needed|1|||
147257902|NCT01912287|531116433|FG002|Overall Study|Felt treatment no longer needed|0|||
147257903|NCT01912287|531116431|FG000|Overall Study|Life circumstances|4|||
147257904|NCT01912287|531116432|FG001|Overall Study|Life circumstances|2|||
147257905|NCT01912287|531116433|FG002|Overall Study|Life circumstances|0|||
147257906|NCT01912287|531116431|FG000|Overall Study|Lost Interest|1|||
147257907|NCT01912287|531116432|FG001|Overall Study|Lost Interest|0|||
147257908|NCT01912287|531116433|FG002|Overall Study|Lost Interest|0|||
147257909|NCT01912287|531116431|FG000|Overall Study|Uknown reason - subject drop out|5|||
147257910|NCT01912287|531116432|FG001|Overall Study|Uknown reason - subject drop out|7|||
147662054|NCT05209880|532585615|FG000|1-Month Follow-up|Discontinued|0|||
147662055|NCT05209880|532585616|FG001|1-Month Follow-up|Discontinued|1|||
147662056|NCT05209880|532585615|FG000|3-Month Follow-up|Spoke with Doctor|17|||
147662057|NCT05209880|532585616|FG001|3-Month Follow-up|Spoke with Doctor|7|||
147257911|NCT01912287|531116433|FG002|Overall Study|Uknown reason - subject drop out|3|||
147257912|NCT01912287|531116431|FG000|Overall Study|Missed Assesment|1|||
147257913|NCT01912287|531116432|FG001|Overall Study|Missed Assesment|1|||
147257914|NCT01912287|531116433|FG002|Overall Study|Missed Assesment|1|||
147257915|NCT01912287|531116431|FG000|Overall Study|Scheduling/change in availability|17|||
147257916|NCT01912287|531116432|FG001|Overall Study|Scheduling/change in availability|10|||
147257917|NCT01912287|531116433|FG002|Overall Study|Scheduling/change in availability|8|||
147257918|NCT03226392|531116434|FG000|Overall Study|Protocol Deviation|1|||
147257919|NCT03226392|531116435|FG001|Overall Study|Protocol Deviation|0|||
147257920|NCT03226392|531116434|FG000|Overall Study|Physician Decision|1|||
147257921|NCT03226392|531116435|FG001|Overall Study|Physician Decision|0|||
147257922|NCT03226392|531116434|FG000|Overall Study|Lost to Follow-up|1|||
147257923|NCT03226392|531116435|FG001|Overall Study|Lost to Follow-up|0|||
147257924|NCT03226392|531116434|FG000|Overall Study|Adverse Event|1|||
147257925|NCT03226392|531116435|FG001|Overall Study|Adverse Event|0|||
147257926|NCT03226392|531116434|FG000|Overall Study|Technical Problems|0|||
147257927|NCT03226392|531116435|FG001|Overall Study|Technical Problems|2|||
147257928|NCT03226392|531116434|FG000|Overall Study|Subject/Guardian Decision|7|||
147257929|NCT03226392|531116435|FG001|Overall Study|Subject/Guardian Decision|6|||
147257930|NCT00937157|531116436|FG000|Overall Study|Pregnancy|1|||
147257931|NCT00937157|531116436|FG000|Overall Study|Lost to Follow-up|3|||
147257932|NCT01998633|531116437|FG000|Overall Study|Death|1|||
147257933|NCT02631850|531116438|FG000|Treatment Period|Lost to Follow-up|0|||
147257934|NCT02631850|531116439|FG001|Treatment Period|Lost to Follow-up|1|||
147257935|NCT02631850|531116440|FG002|Treatment Period|Lost to Follow-up|0|||
147257936|NCT02631850|531116441|FG003|Treatment Period|Lost to Follow-up|0|||
147257937|NCT02631850|531116438|FG000|Treatment Period|Protocol Violation|1|||
147257938|NCT02631850|531116439|FG001|Treatment Period|Protocol Violation|0|||
147257939|NCT02631850|531116440|FG002|Treatment Period|Protocol Violation|0|||
147257940|NCT02631850|531116441|FG003|Treatment Period|Protocol Violation|0|||
147257941|NCT02631850|531116438|FG000|Treatment Period|Withdrawal by Subject|0|||
147257942|NCT02631850|531116439|FG001|Treatment Period|Withdrawal by Subject|5|||
147257943|NCT02631850|531116440|FG002|Treatment Period|Withdrawal by Subject|2|||
147257944|NCT02631850|531116441|FG003|Treatment Period|Withdrawal by Subject|2|||
147257945|NCT02631850|531116438|FG000|Treatment Period|Adverse Event|1|||
147257946|NCT02631850|531116439|FG001|Treatment Period|Adverse Event|0|||
147257947|NCT02631850|531116440|FG002|Treatment Period|Adverse Event|2|||
147257948|NCT02631850|531116441|FG003|Treatment Period|Adverse Event|3|||
147257949|NCT02631850|531116438|FG000|Treatment Period|Family medical issue|1|||
147257950|NCT02631850|531116439|FG001|Treatment Period|Family medical issue|0|||
147257951|NCT02631850|531116440|FG002|Treatment Period|Family medical issue|0|||
147257952|NCT02631850|531116441|FG003|Treatment Period|Family medical issue|0|||
147257953|NCT02631850|531116438|FG000|6 Month Follow up|Lost to Follow-up|5|||
147257954|NCT02631850|531116439|FG001|6 Month Follow up|Lost to Follow-up|8|||
147257955|NCT02631850|531116440|FG002|6 Month Follow up|Lost to Follow-up|3|||
147257956|NCT02631850|531116441|FG003|6 Month Follow up|Lost to Follow-up|5|||
147257957|NCT02631850|531116438|FG000|6 Month Follow up|Withdrawal by Subject|1|||
147257958|NCT02631850|531116439|FG001|6 Month Follow up|Withdrawal by Subject|0|||
147257959|NCT02631850|531116440|FG002|6 Month Follow up|Withdrawal by Subject|0|||
147257960|NCT02631850|531116441|FG003|6 Month Follow up|Withdrawal by Subject|2|||
147257961|NCT02631850|531116438|FG000|6 Month Follow up|Adverse Event|1|||
147257962|NCT02631850|531116439|FG001|6 Month Follow up|Adverse Event|4|||
147257963|NCT02631850|531116440|FG002|6 Month Follow up|Adverse Event|1|||
147257964|NCT02631850|531116441|FG003|6 Month Follow up|Adverse Event|3|||
147257965|NCT02631850|531116438|FG000|6 Month Follow up|moved out of state, transportation issues, family medical issue|0|||
147257966|NCT02631850|531116439|FG001|6 Month Follow up|moved out of state, transportation issues, family medical issue|1|||
147257967|NCT02631850|531116440|FG002|6 Month Follow up|moved out of state, transportation issues, family medical issue|2|||
147257968|NCT02631850|531116441|FG003|6 Month Follow up|moved out of state, transportation issues, family medical issue|1|||
147257969|NCT01462084|531116443|FG000|Overall Study|Withdrawal by Subject|1|||
147257970|NCT01462084|531116444|FG001|Overall Study|Withdrawal by Subject|0|||
147257971|NCT01462084|531116443|FG000|Overall Study|Protocol Violation|1|||
147257972|NCT01462084|531116444|FG001|Overall Study|Protocol Violation|1|||
147257973|NCT03992781|531116445|FG000|Overall Study|Lost to Follow-up|5|||
147257974|NCT03992781|531116445|FG000|Overall Study|Adverse Event|1|||
147257975|NCT03992781|531116445|FG000|Overall Study|Lack of Efficacy|5|||
147257976|NCT01996826|531116446|FG000|Overall Study|Lost to Follow-up|6|||
147257977|NCT01996826|531116447|FG001|Overall Study|Lost to Follow-up|2|||
147257978|NCT01996826|531116446|FG000|Overall Study|Physician Decision|1|||
147257979|NCT01996826|531116447|FG001|Overall Study|Physician Decision|1|||
147257980|NCT00695396|531116448|FG000|Overall Study|Study Closed Prematurely|5|||
147257981|NCT00695396|531116449|FG001|Overall Study|Study Closed Prematurely|6|||
147257982|NCT00695396|531116450|FG002|Overall Study|Study Closed Prematurely|8|||
147257983|NCT00695396|531116448|FG000|Overall Study|Withdrawal by Subject|2|||
147257984|NCT00695396|531116449|FG001|Overall Study|Withdrawal by Subject|2|||
147257985|NCT00695396|531116450|FG002|Overall Study|Withdrawal by Subject|0|||
147257986|NCT00518323|531116452|FG000|Overall Study|Lack of Efficacy|14|||
147257987|NCT00518323|531116453|FG001|Overall Study|Lack of Efficacy|2|||
147450009|NCT01709149|531811339|FG001|Double-blind, Placebo-controlled Phase|Adverse Event|12|||
147450010|NCT01709149|531811340|FG002|Double-blind, Placebo-controlled Phase|Adverse Event|78|||
147450011|NCT01709149|531811338|FG000|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
147450012|NCT01709149|531811339|FG001|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|7|||
147450013|NCT01709149|531811340|FG002|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|12|||
147450014|NCT01709149|531811338|FG000|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
147450015|NCT01709149|531811339|FG001|Double-blind, Placebo-controlled Phase|Physician Decision|2|||
147450016|NCT01709149|531811340|FG002|Double-blind, Placebo-controlled Phase|Physician Decision|5|||
147450017|NCT01709149|531811338|FG000|Double-blind, Placebo-controlled Phase|Death|0|||
147450018|NCT01709149|531811339|FG001|Double-blind, Placebo-controlled Phase|Death|2|||
147450019|NCT01709149|531811340|FG002|Double-blind, Placebo-controlled Phase|Death|0|||
147450020|NCT01709149|531811338|FG000|Double-blind, Placebo-controlled Phase|not defined|0|||
147450021|NCT01709149|531811339|FG001|Double-blind, Placebo-controlled Phase|not defined|1|||
147257988|NCT00518323|531116454|FG002|Overall Study|Lack of Efficacy|4|||
147599561|NCT00851318|532352444|FG000|Overall Study|Physician Decision|0|||
147599562|NCT00851318|532352445|FG001|Overall Study|Physician Decision|0|||
147599563|NCT00851318|532352446|FG002|Overall Study|Physician Decision|1|||
147599564|NCT00851318|532352447|FG003|Overall Study|Physician Decision|1|||
147257989|NCT00518323|531116455|FG003|Overall Study|Lack of Efficacy|20|||
147257990|NCT00518323|531116452|FG000|Overall Study|Withdrawal by Subject|1|||
147257991|NCT00518323|531116453|FG001|Overall Study|Withdrawal by Subject|2|||
147257992|NCT00518323|531116454|FG002|Overall Study|Withdrawal by Subject|4|||
147257993|NCT00518323|531116455|FG003|Overall Study|Withdrawal by Subject|2|||
147257994|NCT00518323|531116452|FG000|Overall Study|Lost to Follow-up|0|||
147257995|NCT00518323|531116453|FG001|Overall Study|Lost to Follow-up|2|||
147257996|NCT00518323|531116454|FG002|Overall Study|Lost to Follow-up|1|||
147257997|NCT00518323|531116455|FG003|Overall Study|Lost to Follow-up|3|||
147257998|NCT00518323|531116452|FG000|Overall Study|Adverse Event|1|||
147257999|NCT00518323|531116453|FG001|Overall Study|Adverse Event|1|||
147258000|NCT00518323|531116454|FG002|Overall Study|Adverse Event|1|||
147258001|NCT00518323|531116455|FG003|Overall Study|Adverse Event|0|||
147258002|NCT00518323|531116452|FG000|Overall Study|Prohibited medication and others|3|||
147258003|NCT00518323|531116453|FG001|Overall Study|Prohibited medication and others|1|||
147258004|NCT00518323|531116454|FG002|Overall Study|Prohibited medication and others|1|||
147258005|NCT00518323|531116455|FG003|Overall Study|Prohibited medication and others|0|||
147258006|NCT02278263|531116457|FG000|Overall Study|Protocol Violation|7|||
147258007|NCT02278263|531116458|FG001|Overall Study|Protocol Violation|0|||
147258008|NCT02278263|531116459|FG002|Overall Study|Protocol Violation|9|||
147258009|NCT01514760|531116460|FG000|Overall Study|Lost to Follow-up|2|||
147258010|NCT01132547|531116461|FG000|Overall Study|Withdrawal by Subject|3|||
147258011|NCT01132547|531116462|FG001|Overall Study|Withdrawal by Subject|1|||
147258012|NCT01132547|531116461|FG000|Overall Study|Death|1|||
147258013|NCT01132547|531116462|FG001|Overall Study|Death|0|||
147258014|NCT02710045|531116463|FG000|Overall Study|Death|1|||
147258015|NCT02710045|531116464|FG001|Overall Study|Death|2|||
147258016|NCT02710045|531116465|FG002|Overall Study|Death|0|||
147258017|NCT02710045|531116463|FG000|Overall Study|Withdrawal by Subject|6|||
147258018|NCT02710045|531116464|FG001|Overall Study|Withdrawal by Subject|6|||
147258019|NCT02710045|531116465|FG002|Overall Study|Withdrawal by Subject|2|||
147258020|NCT02710045|531116463|FG000|Overall Study|Protocol Violation|1|||
147258021|NCT02710045|531116464|FG001|Overall Study|Protocol Violation|2|||
147258022|NCT02710045|531116465|FG002|Overall Study|Protocol Violation|3|||
147258023|NCT02710045|531116463|FG000|Overall Study|Lost to Follow-up|3|||
147258024|NCT02710045|531116464|FG001|Overall Study|Lost to Follow-up|6|||
147258025|NCT02710045|531116465|FG002|Overall Study|Lost to Follow-up|7|||
147258026|NCT02710045|531116463|FG000|Overall Study|Physician Decision|0|||
147258027|NCT02710045|531116464|FG001|Overall Study|Physician Decision|0|||
147258028|NCT02710045|531116465|FG002|Overall Study|Physician Decision|1|||
147258029|NCT02710045|531116463|FG000|Overall Study|Poor Attendance|0|||
147258030|NCT02710045|531116464|FG001|Overall Study|Poor Attendance|1|||
147258031|NCT02710045|531116465|FG002|Overall Study|Poor Attendance|0|||
147258032|NCT00071760|531116471|FG000|Overall Study|Adverse Event|2|||
147258033|NCT00071760|531116472|FG001|Overall Study|Adverse Event|1|||
147258034|NCT00071760|531116471|FG000|Overall Study|Lost to Follow-up|0|||
147258035|NCT00071760|531116472|FG001|Overall Study|Lost to Follow-up|3|||
147258036|NCT00071760|531116471|FG000|Overall Study|Protocol Violation|1|||
147258037|NCT00071760|531116472|FG001|Overall Study|Protocol Violation|0|||
147258038|NCT00071760|531116471|FG000|Overall Study|Withdrawal by Subject|0|||
147258039|NCT00071760|531116472|FG001|Overall Study|Withdrawal by Subject|1|||
147258040|NCT00071760|531116471|FG000|Overall Study|Insufficient Viral Load Response|1|||
147450022|NCT01709149|531811340|FG002|Double-blind, Placebo-controlled Phase|not defined|2|||
147450023|NCT01709149|531811338|FG000|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
147450024|NCT01709149|531811339|FG001|Double-blind, Placebo-controlled Phase|Lost to Follow-up|2|||
147599565|NCT01442688|532352448|FG000|First Intervention|Withdrawal by Subject|1|||
147599566|NCT01442688|532352449|FG001|First Intervention|Withdrawal by Subject|0|||
147599567|NCT01442688|532352448|FG000|First Intervention|subject incarcerated|1|||
147599568|NCT01442688|532352449|FG001|First Intervention|subject incarcerated|0|||
147599569|NCT01442688|532352448|FG000|Second Intervention|Adverse Event|1|||
147599570|NCT01442688|532352449|FG001|Second Intervention|Adverse Event|0|||
147599571|NCT02643355|532352450|FG000|Overall Study|Withdrawal by Subject|1|||
147258041|NCT00071760|531116472|FG001|Overall Study|Insufficient Viral Load Response|1|||
147258042|NCT00071760|531116471|FG000|Overall Study|Lack of availability of RTV|1|||
147258043|NCT00071760|531116472|FG001|Overall Study|Lack of availability of RTV|0|||
147258044|NCT00071760|531116471|FG000|Overall Study|Physician Decision|2|||
147258045|NCT00071760|531116472|FG001|Overall Study|Physician Decision|1|||
147258046|NCT00071760|531116471|FG000|Overall Study|Relocation|0|||
147258047|NCT00071760|531116472|FG001|Overall Study|Relocation|1|||
147258048|NCT02335099|531116473|FG000|Treatment|Withdrawal by Subject|1|||
147258049|NCT02335099|531116474|FG001|Treatment|Withdrawal by Subject|3|||
147258050|NCT02335099|531116473|FG000|Treatment|Lost to Follow-up|2|||
147258051|NCT02335099|531116474|FG001|Treatment|Lost to Follow-up|0|||
147258052|NCT02335099|531116473|FG000|Treatment|Death|1|||
147258053|NCT02335099|531116474|FG001|Treatment|Death|0|||
147258054|NCT02335099|531116473|FG000|Treatment|Adverse Event|1|||
147258055|NCT02335099|531116474|FG001|Treatment|Adverse Event|2|||
147258056|NCT02335099|531116473|FG000|Follow-up|Death|0|||
147258057|NCT02335099|531116474|FG001|Follow-up|Death|1|||
147258058|NCT01288287|531116475|FG000|Overall Study|Lost to Follow-up|8|||
147258059|NCT01288287|531116475|FG000|Overall Study|Withdrawal by Subject|4|||
147258060|NCT01288287|531116475|FG000|Overall Study|Lack of Efficacy|13|||
147258061|NCT01288287|531116475|FG000|Overall Study|Other Reason|13|||
147258062|NCT01288287|531116475|FG000|Overall Study|Unknown Reason|1|||
147258063|NCT01288287|531116475|FG000|Overall Study|Unknown Status|7|||
147258064|NCT03519347|531116476|FG000|Interventional Crossover Period 1|Death|0|||
147258065|NCT03519347|531116477|FG001|Interventional Crossover Period 1|Death|0|||
147258066|NCT03519347|531116478|FG002|Interventional Crossover Period 1|Death|0|||
147258067|NCT03519347|531116479|FG003|Interventional Crossover Period 1|Death|1|||
147258068|NCT02515045|531116490|FG000|Overall Study|Adverse Event|0|||
147258069|NCT02515045|531116491|FG001|Overall Study|Adverse Event|3|||
147258070|NCT02515045|531116492|FG002|Overall Study|Adverse Event|3|||
147258071|NCT02515045|531116490|FG000|Overall Study|Lost to Follow-up|0|||
147258072|NCT02515045|531116491|FG001|Overall Study|Lost to Follow-up|1|||
147258073|NCT02515045|531116492|FG002|Overall Study|Lost to Follow-up|1|||
147258074|NCT01412021|531116493|FG000|Overall Study|Case Report Forms Not Retrieved|7|||
147258075|NCT01412021|531116493|FG000|Overall Study|Treatment Prior to Approval|3|||
147258076|NCT01412021|531116493|FG000|Overall Study|Transferred to Other Hospital|9|||
147258077|NCT03255382|531116494|FG000|Overall Study|Adverse Event|3|||
147258078|NCT03255382|531116495|FG001|Overall Study|Adverse Event|0|||
147258079|NCT03255382|531116494|FG000|Overall Study|Lost to Follow-up|2|||
147258080|NCT03255382|531116495|FG001|Overall Study|Lost to Follow-up|0|||
147258081|NCT03255382|531116494|FG000|Overall Study|Withdrawal by Subject|2|||
147258082|NCT03255382|531116495|FG001|Overall Study|Withdrawal by Subject|0|||
147258083|NCT03255382|531116494|FG000|Overall Study|Other|6|||
147258084|NCT03255382|531116495|FG001|Overall Study|Other|0|||
147258085|NCT00238121|531116498|FG000|Overall Study|Withdrawal by Subject|1|||
147258086|NCT00238121|531116499|FG001|Overall Study|Withdrawal by Subject|1|||
147258087|NCT00238121|531116498|FG000|Overall Study|Adverse Event|2|||
147258088|NCT00238121|531116499|FG001|Overall Study|Adverse Event|1|||
147258089|NCT02221284|531116500|FG000|Overall Study|Case Report Forms Uncollected|56|||
147258090|NCT02221284|531116500|FG000|Overall Study|Protocol Deviation|5|||
147258091|NCT00484939|531116501|FG000|Overall Study|Death|9|||
147258092|NCT00484939|531116502|FG001|Overall Study|Death|13|||
147258093|NCT00484939|531116501|FG000|Overall Study|Adverse Event|22|||
147258094|NCT00484939|531116502|FG001|Overall Study|Adverse Event|12|||
147258095|NCT00484939|531116501|FG000|Overall Study|Patient Withdrew Consent|19|||
147258096|NCT00484939|531116502|FG001|Overall Study|Patient Withdrew Consent|10|||
147258097|NCT00484939|531116501|FG000|Overall Study|Protocol Violation|3|||
147258098|NCT00484939|531116502|FG001|Overall Study|Protocol Violation|3|||
147258099|NCT00484939|531116501|FG000|Overall Study|Lost to Follow-up|0|||
147258100|NCT00484939|531116502|FG001|Overall Study|Lost to Follow-up|3|||
147258101|NCT00484939|531116501|FG000|Overall Study|Discretion of Investigator or Sponsor|7|||
147258102|NCT00484939|531116502|FG001|Overall Study|Discretion of Investigator or Sponsor|3|||
147258103|NCT00484939|531116501|FG000|Overall Study|Disease progression|67|||
147258104|NCT00484939|531116502|FG001|Overall Study|Disease progression|88|||
147258105|NCT00484939|531116501|FG000|Overall Study|Screen Failure|2|||
147258106|NCT00484939|531116502|FG001|Overall Study|Screen Failure|2|||
147258107|NCT00484939|531116501|FG000|Overall Study|Reason Not Specified|11|||
147258108|NCT00484939|531116502|FG001|Overall Study|Reason Not Specified|6|||
147258109|NCT00449644|531116505|FG000|Overall Study|Adverse Event|0|||
147258110|NCT00449644|531116506|FG001|Overall Study|Adverse Event|0|||
147258111|NCT00449644|531116507|FG002|Overall Study|Adverse Event|3|||
147258112|NCT00449644|531116508|FG003|Overall Study|Adverse Event|5|||
147258113|NCT00449644|531116505|FG000|Overall Study|Death|1|||
147258114|NCT00449644|531116506|FG001|Overall Study|Death|0|||
147258115|NCT00449644|531116507|FG002|Overall Study|Death|6|||
147258116|NCT00449644|531116508|FG003|Overall Study|Death|1|||
147258117|NCT00449644|531116505|FG000|Overall Study|Lost to Follow-up|1|||
147258118|NCT00449644|531116506|FG001|Overall Study|Lost to Follow-up|1|||
147258119|NCT00449644|531116507|FG002|Overall Study|Lost to Follow-up|5|||
147258120|NCT00449644|531116508|FG003|Overall Study|Lost to Follow-up|3|||
147258121|NCT00449644|531116505|FG000|Overall Study|Pregnancy|0|||
147258122|NCT00449644|531116506|FG001|Overall Study|Pregnancy|0|||
147258123|NCT00449644|531116507|FG002|Overall Study|Pregnancy|3|||
147258124|NCT00449644|531116508|FG003|Overall Study|Pregnancy|2|||
147258125|NCT00449644|531116505|FG000|Overall Study|Protocol Violation|4|||
147258126|NCT00449644|531116506|FG001|Overall Study|Protocol Violation|4|||
147258127|NCT00449644|531116507|FG002|Overall Study|Protocol Violation|3|||
147258128|NCT00449644|531116508|FG003|Overall Study|Protocol Violation|7|||
147258129|NCT00449644|531116505|FG000|Overall Study|Withdrawal by Subject|3|||
147258130|NCT00449644|531116506|FG001|Overall Study|Withdrawal by Subject|4|||
147258131|NCT00449644|531116507|FG002|Overall Study|Withdrawal by Subject|6|||
147258132|NCT00449644|531116508|FG003|Overall Study|Withdrawal by Subject|7|||
147258133|NCT00449644|531116505|FG000|Overall Study|Inclusion/exclusion criteria not met|0|||
147450025|NCT01709149|531811340|FG002|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
147258134|NCT00449644|531116506|FG001|Overall Study|Inclusion/exclusion criteria not met|0|||
147258135|NCT00449644|531116507|FG002|Overall Study|Inclusion/exclusion criteria not met|2|||
147258136|NCT00449644|531116508|FG003|Overall Study|Inclusion/exclusion criteria not met|6|||
147258137|NCT00449644|531116505|FG000|Overall Study|Other|1|||
147258138|NCT00449644|531116506|FG001|Overall Study|Other|4|||
147258139|NCT00449644|531116507|FG002|Overall Study|Other|1|||
147258140|NCT00449644|531116508|FG003|Overall Study|Other|0|||
147258141|NCT00449644|531116505|FG000|Overall Study|Rolled-over to treatment with TMC207|0|||
147258142|NCT00449644|531116506|FG001|Overall Study|Rolled-over to treatment with TMC207|0|||
147258143|NCT00449644|531116507|FG002|Overall Study|Rolled-over to treatment with TMC207|0|||
147258144|NCT00449644|531116508|FG003|Overall Study|Rolled-over to treatment with TMC207|1|||
147258145|NCT02226003|531116513|FG000|Overall Study|Lost to Follow-up|2|||
147258146|NCT02226003|531116514|FG001|Overall Study|Lost to Follow-up|1|||
147258147|NCT02226003|531116515|FG002|Overall Study|Lost to Follow-up|3|||
147258148|NCT02226003|531116513|FG000|Overall Study|Withdrawal by Subject|0|||
147258149|NCT02226003|531116514|FG001|Overall Study|Withdrawal by Subject|0|||
147258150|NCT02226003|531116515|FG002|Overall Study|Withdrawal by Subject|3|||
147258151|NCT03279692|531116518|FG000|Overall Study|Withdrawal by Subject|1|||
147258152|NCT07114198|531116524|FG000|Overall Study|Protocol Violation|1|||
147258153|NCT07114198|531116525|FG001|Overall Study|Protocol Violation|1|||
147258154|NCT00483379|531118342|FG000|Treatment Period|Adverse Event|1|||
147258155|NCT00483379|531118343|FG001|Treatment Period|Adverse Event|0|||
147258156|NCT00483379|531118342|FG000|Treatment Period|Withdrawal by Subject|1|||
147258157|NCT00483379|531118343|FG001|Treatment Period|Withdrawal by Subject|0|||
147450026|NCT03509350|531811341|FG000|Overall Study|Withdrawal by Subject|0|||
147258158|NCT00536107|531118345|FG000|Overall Study|Death|5|||
147258159|NCT00536107|531118346|FG001|Overall Study|Death|1|||
147258160|NCT00536107|531118345|FG000|Overall Study|Incorrect enrolment|1|||
147258161|NCT00536107|531118346|FG001|Overall Study|Incorrect enrolment|0|||
147258162|NCT00536107|531118345|FG000|Overall Study|Withdrawal by Subject|0|||
147258163|NCT00536107|531118346|FG001|Overall Study|Withdrawal by Subject|1|||
147258164|NCT00536107|531118345|FG000|Overall Study|Study Termination|2|||
147258165|NCT00536107|531118346|FG001|Overall Study|Study Termination|4|||
147258166|NCT00371254|531118347|FG000|Overall Study|Disease progression|13|||
147258167|NCT00371254|531118348|FG001|Overall Study|Disease progression|13|||
147258168|NCT00371254|531118347|FG000|Overall Study|Study drug toxicity|3|||
147258169|NCT00371254|531118348|FG001|Overall Study|Study drug toxicity|5|||
147258170|NCT00371254|531118347|FG000|Overall Study|Subject request|5|||
147258171|NCT00371254|531118348|FG001|Overall Study|Subject request|0|||
147258172|NCT00371254|531118347|FG000|Overall Study|Investigator Decision|2|||
147258173|NCT00371254|531118348|FG001|Overall Study|Investigator Decision|0|||
147258174|NCT00371254|531118347|FG000|Overall Study|Adverse event unrelated to study drug|0|||
147258175|NCT00371254|531118348|FG001|Overall Study|Adverse event unrelated to study drug|1|||
147258176|NCT00371254|531118347|FG000|Overall Study|Lost to Follow-up|0|||
147450027|NCT03509350|531811342|FG001|Overall Study|Withdrawal by Subject|2|||
147450028|NCT01425203|531811343|FG000|Treatment Phase|DC during PR Lead-in Phase|3|||
147450029|NCT01425203|531811344|FG001|Treatment Phase|DC during PR Lead-in Phase|1|||
147450030|NCT01425203|531811345|FG002|Treatment Phase|DC during PR Lead-in Phase|0|||
147258177|NCT00371254|531118348|FG001|Overall Study|Lost to Follow-up|1|||
147258178|NCT00371254|531118347|FG000|Overall Study|Withdrawal by Subject|0|||
147599572|NCT02643355|532352451|FG001|Overall Study|Withdrawal by Subject|3|||
147599573|NCT02643355|532352450|FG000|Overall Study|Protocol Violation|0|||
147599574|NCT02643355|532352451|FG001|Overall Study|Protocol Violation|2|||
147599575|NCT05961215|532352452|FG000|Overall Study|Withdrawal by Subject|1|||
147599576|NCT05187013|532352453|FG000|Overall Study|Withdrawal by Subject|1|||
147599577|NCT05187013|532352454|FG001|Overall Study|Withdrawal by Subject|1|||
147599578|NCT05187013|532352455|FG002|Overall Study|Withdrawal by Subject|0|||
147599579|NCT05187013|532352453|FG000|Overall Study|Death|0|||
147599580|NCT05187013|532352454|FG001|Overall Study|Death|1|||
147258179|NCT00371254|531118348|FG001|Overall Study|Withdrawal by Subject|1|||
147258180|NCT03329690|531118351|FG000|Overall Study|Progressive disease per RECIST|85|||
147258181|NCT03329690|531118352|FG001|Overall Study|Progressive disease per RECIST|44|||
147258182|NCT03329690|531118353|FG002|Overall Study|Progressive disease per RECIST|6|||
147258183|NCT03329690|531118354|FG003|Overall Study|Progressive disease per RECIST|16|||
147258184|NCT03329690|531118355|FG004|Overall Study|Progressive disease per RECIST|20|||
147258185|NCT03329690|531118351|FG000|Overall Study|Clinical progression|7|||
147258186|NCT03329690|531118352|FG001|Overall Study|Clinical progression|4|||
147258187|NCT03329690|531118353|FG002|Overall Study|Clinical progression|1|||
147258188|NCT03329690|531118354|FG003|Overall Study|Clinical progression|1|||
147258189|NCT03329690|531118355|FG004|Overall Study|Clinical progression|1|||
147258190|NCT03329690|531118351|FG000|Overall Study|Adverse Event|22|||
147258191|NCT03329690|531118352|FG001|Overall Study|Adverse Event|4|||
147258192|NCT03329690|531118353|FG002|Overall Study|Adverse Event|0|||
147258193|NCT03329690|531118354|FG003|Overall Study|Adverse Event|1|||
147258194|NCT03329690|531118355|FG004|Overall Study|Adverse Event|2|||
147258195|NCT03329690|531118351|FG000|Overall Study|Death|2|||
147258196|NCT03329690|531118352|FG001|Overall Study|Death|0|||
147258197|NCT03329690|531118353|FG002|Overall Study|Death|0|||
147258198|NCT03329690|531118354|FG003|Overall Study|Death|1|||
147258199|NCT03329690|531118355|FG004|Overall Study|Death|0|||
147258200|NCT03329690|531118351|FG000|Overall Study|Withdrawal by Subject|2|||
147258201|NCT03329690|531118352|FG001|Overall Study|Withdrawal by Subject|3|||
147258202|NCT03329690|531118353|FG002|Overall Study|Withdrawal by Subject|0|||
147258203|NCT03329690|531118354|FG003|Overall Study|Withdrawal by Subject|1|||
147258204|NCT03329690|531118355|FG004|Overall Study|Withdrawal by Subject|0|||
147258205|NCT03329690|531118351|FG000|Overall Study|Physician Decision|1|||
147258206|NCT03329690|531118352|FG001|Overall Study|Physician Decision|0|||
147258207|NCT03329690|531118353|FG002|Overall Study|Physician Decision|0|||
147258208|NCT03329690|531118354|FG003|Overall Study|Physician Decision|0|||
147258209|NCT03329690|531118355|FG004|Overall Study|Physician Decision|1|||
147258210|NCT03329690|531118351|FG000|Overall Study|Miscellaneous|6|||
147258211|NCT03329690|531118352|FG001|Overall Study|Miscellaneous|0|||
147258212|NCT03329690|531118353|FG002|Overall Study|Miscellaneous|0|||
147258213|NCT03329690|531118354|FG003|Overall Study|Miscellaneous|0|||
147258214|NCT03329690|531118355|FG004|Overall Study|Miscellaneous|0|||
147258215|NCT03329690|531118351|FG000|Overall Study|Did not receive treatment|1|||
147599581|NCT05187013|532352455|FG002|Overall Study|Death|0|||
147599582|NCT05187013|532352453|FG000|Overall Study|Lost to Follow-up|20|||
147599583|NCT05187013|532352454|FG001|Overall Study|Lost to Follow-up|17|||
147258216|NCT03329690|531118352|FG001|Overall Study|Did not receive treatment|0|||
147258217|NCT03329690|531118353|FG002|Overall Study|Did not receive treatment|0|||
147258218|NCT03329690|531118354|FG003|Overall Study|Did not receive treatment|1|||
147258219|NCT03329690|531118355|FG004|Overall Study|Did not receive treatment|0|||
147258220|NCT01817725|531118356|FG000|Overall Study|Withdrawal by Subject|1|||
147258221|NCT02337907|531118357|FG000|Overall Study|Other than listed|1|||
147258222|NCT02337907|531118358|FG001|Overall Study|Other than listed|0|||
147258223|NCT02337907|531118359|FG002|Overall Study|Other than listed|0|||
147258224|NCT02337907|531118360|FG003|Overall Study|Other than listed|1|||
147258225|NCT02337907|531118361|FG004|Overall Study|Other than listed|1|||
147258226|NCT02337907|531118362|FG005|Overall Study|Other than listed|0|||
147258227|NCT02337907|531118357|FG000|Overall Study|Withdrawal by Subject|2|||
147258228|NCT02337907|531118358|FG001|Overall Study|Withdrawal by Subject|3|||
147258229|NCT02337907|531118359|FG002|Overall Study|Withdrawal by Subject|0|||
147258230|NCT02337907|531118360|FG003|Overall Study|Withdrawal by Subject|2|||
147258231|NCT02337907|531118361|FG004|Overall Study|Withdrawal by Subject|5|||
147258232|NCT02337907|531118362|FG005|Overall Study|Withdrawal by Subject|0|||
147258233|NCT02337907|531118357|FG000|Overall Study|Lost to Follow-up|0|||
147258234|NCT02337907|531118358|FG001|Overall Study|Lost to Follow-up|0|||
147258235|NCT02337907|531118359|FG002|Overall Study|Lost to Follow-up|0|||
147450031|NCT01425203|531811343|FG000|Treatment Phase|Failure at futility timepoint|8|||
147450032|NCT01425203|531811344|FG001|Treatment Phase|Failure at futility timepoint|27|||
147450033|NCT01425203|531811345|FG002|Treatment Phase|Failure at futility timepoint|0|||
147599584|NCT05187013|532352455|FG002|Overall Study|Lost to Follow-up|0|||
147599585|NCT05187013|532352453|FG000|Overall Study|Ongoing Participants|3|||
147258236|NCT02337907|531118360|FG003|Overall Study|Lost to Follow-up|0|||
147258237|NCT02337907|531118361|FG004|Overall Study|Lost to Follow-up|0|||
147258238|NCT02337907|531118362|FG005|Overall Study|Lost to Follow-up|1|||
147258239|NCT02337907|531118357|FG000|Overall Study|Adverse Event|1|||
147258240|NCT02337907|531118358|FG001|Overall Study|Adverse Event|1|||
147258241|NCT02337907|531118359|FG002|Overall Study|Adverse Event|1|||
147258242|NCT02337907|531118360|FG003|Overall Study|Adverse Event|1|||
147258243|NCT02337907|531118361|FG004|Overall Study|Adverse Event|4|||
147258244|NCT02337907|531118362|FG005|Overall Study|Adverse Event|0|||
147450034|NCT01425203|531811343|FG000|Treatment Phase|Other virologic failure criteria|5|||
147258245|NCT00909779|531118363|FG000|Overall Study|Adverse Event|53|||
147258246|NCT00909779|531118364|FG001|Overall Study|Adverse Event|55|||
147258247|NCT00909779|531118363|FG000|Overall Study|Lack of Efficacy|7|||
147258248|NCT00909779|531118364|FG001|Overall Study|Lack of Efficacy|4|||
147258249|NCT00909779|531118363|FG000|Overall Study|Lost to Follow-up|19|||
147258250|NCT00909779|531118364|FG001|Overall Study|Lost to Follow-up|15|||
147258251|NCT00909779|531118363|FG000|Overall Study|Physician Decision|8|||
147258252|NCT00909779|531118364|FG001|Overall Study|Physician Decision|2|||
147258253|NCT00909779|531118363|FG000|Overall Study|Protocol Violation|2|||
147662058|NCT05209880|532585615|FG000|3-Month Follow-up|Lost to Follow-up|8|||
147662059|NCT05209880|532585616|FG001|3-Month Follow-up|Lost to Follow-up|10|||
147662060|NCT05209880|532585615|FG000|3-Month Follow-up|Discontinued|1|||
147662061|NCT05209880|532585616|FG001|3-Month Follow-up|Discontinued|3|||
147258254|NCT00909779|531118364|FG001|Overall Study|Protocol Violation|5|||
147258255|NCT00909779|531118363|FG000|Overall Study|Withdrawal by Subject|116|||
147662062|NCT05209880|532585615|FG000|6-Month Follow-up|Spoke with Doctor|25|||
147662063|NCT05209880|532585616|FG001|6-Month Follow-up|Spoke with Doctor|14|||
147662064|NCT05209880|532585615|FG000|6-Month Follow-up|Lost to Follow-up|9|||
147662065|NCT05209880|532585616|FG001|6-Month Follow-up|Lost to Follow-up|14|||
147662066|NCT05209880|532585615|FG000|6-Month Follow-up|Discontinued|1|||
147662067|NCT05209880|532585616|FG001|6-Month Follow-up|Discontinued|3|||
147662068|NCT05635045|532585621|FG000|Overall Study|measurements were not usable due material error in imaging agent supplied|0|||
147662069|NCT05635045|532585622|FG001|Overall Study|measurements were not usable due material error in imaging agent supplied|0|||
147662070|NCT05635045|532585623|FG002|Overall Study|measurements were not usable due material error in imaging agent supplied|1|||
147662071|NCT05635045|532585624|FG003|Overall Study|measurements were not usable due material error in imaging agent supplied|0|||
147662072|NCT03143101|532585630|FG000|Overall Study|Withdrawal by Subject|0|||
147662073|NCT03143101|532585631|FG001|Overall Study|Withdrawal by Subject|1|||
147662074|NCT03143101|532585632|FG002|Overall Study|Withdrawal by Subject|0|||
147662075|NCT03143101|532585630|FG000|Overall Study|Lost to Follow-up|2|||
147662076|NCT03143101|532585631|FG001|Overall Study|Lost to Follow-up|2|||
147662077|NCT03143101|532585632|FG002|Overall Study|Lost to Follow-up|0|||
147662078|NCT05227118|532585633|FG000|Overall Study|Adverse Event|0|||
147662079|NCT05227118|532585634|FG001|Overall Study|Adverse Event|0|||
147662080|NCT05227118|532585635|FG002|Overall Study|Adverse Event|1|||
147662081|NCT05227118|532585636|FG003|Overall Study|Adverse Event|0|||
147258256|NCT00909779|531118364|FG001|Overall Study|Withdrawal by Subject|80|||
147258257|NCT00909779|531118363|FG000|Overall Study|Site Ceasing Operation|2|||
147258258|NCT00909779|531118364|FG001|Overall Study|Site Ceasing Operation|2|||
147258259|NCT00909779|531118363|FG000|Overall Study|Medical Monitor Decision|1|||
147258260|NCT00909779|531118364|FG001|Overall Study|Medical Monitor Decision|0|||
147258261|NCT00909779|531118363|FG000|Overall Study|Noncompliance|1|||
147258262|NCT00909779|531118364|FG001|Overall Study|Noncompliance|1|||
147258263|NCT00909779|531118363|FG000|Overall Study|Randomized in error|1|||
147258264|NCT00909779|531118364|FG001|Overall Study|Randomized in error|1|||
147258265|NCT01592344|531118365|FG000|Overall Study|Adverse Event|1|||
147258266|NCT01592344|531118366|FG001|Overall Study|Adverse Event|1|||
147258267|NCT01592344|531118365|FG000|Overall Study|Lack of Efficacy|1|||
147258268|NCT01592344|531118366|FG001|Overall Study|Lack of Efficacy|0|||
147258269|NCT01592344|531118365|FG000|Overall Study|not available at primary outcome visit|2|||
147258270|NCT01592344|531118366|FG001|Overall Study|not available at primary outcome visit|4|||
147258271|NCT03165110|531118368|FG000|Overall Study|Anroid phone software incompatibility|1|||
147258272|NCT00730912|531118373|FG000|Overall Study|Discontinued|0|||
147258273|NCT00730912|531118374|FG001|Overall Study|Discontinued|0|||
147258274|NCT00730912|531118375|FG002|Overall Study|Discontinued|1|||
147258275|NCT03311659|531118383|FG000|Overall Study|Protocol Violation|1|||
147258276|NCT00613015|531118386|FG000|Overall Study|Lost to Follow-up|0|||
147258277|NCT00613015|531118387|FG001|Overall Study|Lost to Follow-up|1|||
147258278|NCT00613015|531118388|FG002|Overall Study|Lost to Follow-up|3|||
147258279|NCT00613015|531118389|FG003|Overall Study|Lost to Follow-up|3|||
147258280|NCT00613015|531118390|FG004|Overall Study|Lost to Follow-up|2|||
147258281|NCT00613015|531118391|FG005|Overall Study|Lost to Follow-up|3|||
147258282|NCT01179477|531118394|FG000|Overall Study|Death|542|||
147258283|NCT01179477|531118394|FG000|Overall Study|Unsuccessful implant|80|||
147258284|NCT01179477|531118394|FG000|Overall Study|Non-death withdrawal|438|||
147258285|NCT01179477|531118394|FG000|Overall Study|Did not complete final visit|27|||
147258286|NCT04327388|531118396|FG000|Overall Study|Adverse Event|17|||
147258287|NCT04327388|531118397|FG001|Overall Study|Adverse Event|18|||
147258288|NCT04327388|531118398|FG002|Overall Study|Adverse Event|9|||
147258289|NCT04327388|531118396|FG000|Overall Study|Other|1|||
147662082|NCT05227118|532585633|FG000|Overall Study|Withdrawal by Subject|0|||
147662083|NCT05227118|532585634|FG001|Overall Study|Withdrawal by Subject|0|||
147258290|NCT04327388|531118397|FG001|Overall Study|Other|2|||
147258291|NCT04327388|531118398|FG002|Overall Study|Other|0|||
147258292|NCT04327388|531118396|FG000|Overall Study|Randomized and not treated|2|||
147258293|NCT04327388|531118397|FG001|Overall Study|Randomized and not treated|0|||
147258294|NCT04327388|531118398|FG002|Overall Study|Randomized and not treated|2|||
147258295|NCT04829318|531118399|FG000|Overall Study|Adverse Event|6|||
147258296|NCT04829318|531118399|FG000|Overall Study|Death|1|||
147258297|NCT04829318|531118399|FG000|Overall Study|Lost to Follow-up|1|||
147599586|NCT05187013|532352454|FG001|Overall Study|Ongoing Participants|5|||
147599587|NCT05187013|532352455|FG002|Overall Study|Ongoing Participants|0|||
147599588|NCT04480021|532352456|FG000|Overall Study|Lost to Follow-up|3|||
147599589|NCT04480021|532352457|FG001|Overall Study|Lost to Follow-up|4|||
147599590|NCT01096368|532352458|FG000|Overall Study|Death|0|||
147599591|NCT01096368|532352459|FG001|Overall Study|Death|1|||
147599592|NCT01096368|532352460|FG002|Overall Study|Death|0|||
147599593|NCT01096368|532352461|FG003|Overall Study|Death|0|||
147599594|NCT01096368|532352462|FG004|Overall Study|Death|0|||
147599595|NCT01096368|532352458|FG000|Overall Study|Physician Decision|0|||
147599596|NCT01096368|532352459|FG001|Overall Study|Physician Decision|13|||
147599597|NCT01096368|532352460|FG002|Overall Study|Physician Decision|2|||
147258298|NCT04829318|531118399|FG000|Overall Study|Physician Decision|1|||
147258299|NCT04829318|531118399|FG000|Overall Study|Withdrawal by Subject|19|||
147258300|NCT04829318|531118399|FG000|Overall Study|Site terminated by sponsor|1|||
147258301|NCT04829318|531118399|FG000|Overall Study|Sponsor decision|5|||
147662084|NCT05227118|532585635|FG002|Overall Study|Withdrawal by Subject|2|||
147662085|NCT05227118|532585636|FG003|Overall Study|Withdrawal by Subject|0|||
147662086|NCT01435759|532585637|FG000|Antidepressant Lead-in Phase|Adverse Event|40|||
147662087|NCT01435759|532585638|FG001|Antidepressant Lead-in Phase|Adverse Event|0|||
147662088|NCT01435759|532585639|FG002|Antidepressant Lead-in Phase|Adverse Event|0|||
147599598|NCT01096368|532352461|FG003|Overall Study|Physician Decision|4|||
147662089|NCT01435759|532585640|FG003|Antidepressant Lead-in Phase|Adverse Event|0|||
147662090|NCT01435759|532585641|FG004|Antidepressant Lead-in Phase|Adverse Event|0|||
147662091|NCT01435759|532585642|FG005|Antidepressant Lead-in Phase|Adverse Event|0|||
147662092|NCT01435759|532585637|FG000|Antidepressant Lead-in Phase|Protocol Violation|16|||
147662093|NCT01435759|532585638|FG001|Antidepressant Lead-in Phase|Protocol Violation|0|||
147662094|NCT01435759|532585639|FG002|Antidepressant Lead-in Phase|Protocol Violation|0|||
147662095|NCT01435759|532585640|FG003|Antidepressant Lead-in Phase|Protocol Violation|0|||
147662096|NCT01435759|532585641|FG004|Antidepressant Lead-in Phase|Protocol Violation|0|||
147662097|NCT01435759|532585642|FG005|Antidepressant Lead-in Phase|Protocol Violation|0|||
147662098|NCT01435759|532585637|FG000|Antidepressant Lead-in Phase|Withdrawal by Subject|74|||
147662099|NCT01435759|532585638|FG001|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
147662100|NCT01435759|532585639|FG002|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
147662101|NCT01435759|532585640|FG003|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
147662102|NCT01435759|532585641|FG004|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
147662103|NCT01435759|532585642|FG005|Antidepressant Lead-in Phase|Withdrawal by Subject|0|||
147662104|NCT01435759|532585637|FG000|Antidepressant Lead-in Phase|Lost to Follow-up|83|||
147662105|NCT01435759|532585638|FG001|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
147662106|NCT01435759|532585639|FG002|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
147662107|NCT01435759|532585640|FG003|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
147662108|NCT01435759|532585641|FG004|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
147662109|NCT01435759|532585642|FG005|Antidepressant Lead-in Phase|Lost to Follow-up|0|||
147662110|NCT01435759|532585637|FG000|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|10|||
147258302|NCT04829318|531118399|FG000|Overall Study|Other|1|||
147258303|NCT00728130|531118400|FG000|Overall Study|Withdrawal by Subject|1|||
147258304|NCT00728130|531118400|FG000|Overall Study|Paperwork not completed in time|1|||
147258305|NCT00728130|531118400|FG000|Overall Study|Physician Decision|1|||
147258306|NCT04053023|531118403|FG000|Part A: Period 2 (Day 20 to Day 38)|Adverse Event|1|||
147258307|NCT04053023|531118404|FG001|Part A: Period 2 (Day 20 to Day 38)|Adverse Event|0|||
147258308|NCT02073279|531118405|FG000|Double-blind Period|Adverse Event|1|||
147258309|NCT02073279|531118406|FG001|Double-blind Period|Adverse Event|1|||
147258310|NCT02073279|531118405|FG000|Double-blind Period|Switched to another treatment|1|||
147258311|NCT02073279|531118406|FG001|Double-blind Period|Switched to another treatment|2|||
147258312|NCT02073279|531118405|FG000|Double-blind Period|Protocol Violation|0|||
147258313|NCT02073279|531118406|FG001|Double-blind Period|Protocol Violation|1|||
147599599|NCT01096368|532352462|FG004|Overall Study|Physician Decision|6|||
147662111|NCT01435759|532585638|FG001|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
147662112|NCT01435759|532585639|FG002|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
147662113|NCT01435759|532585640|FG003|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
147662114|NCT01435759|532585641|FG004|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
147662115|NCT01435759|532585642|FG005|Antidepressant Lead-in Phase|Met BP or Pulse Withdrawal Criteria|0|||
147662116|NCT01435759|532585637|FG000|Antidepressant Lead-in Phase|Other|119|||
147662117|NCT01435759|532585638|FG001|Antidepressant Lead-in Phase|Other|0|||
147662118|NCT01435759|532585639|FG002|Antidepressant Lead-in Phase|Other|0|||
147662119|NCT01435759|532585640|FG003|Antidepressant Lead-in Phase|Other|0|||
147662120|NCT01435759|532585641|FG004|Antidepressant Lead-in Phase|Other|0|||
147662121|NCT01435759|532585642|FG005|Antidepressant Lead-in Phase|Other|0|||
147662122|NCT01435759|532585637|FG000|Double-blind Phase|Adverse Event|7|||
147258314|NCT02073279|531118405|FG000|Double-blind Period|Refused Treatment/Did Not Cooperate|0|||
147599600|NCT01096368|532352458|FG000|Overall Study|Withdrawal by Subject|0|||
147258315|NCT02073279|531118406|FG001|Double-blind Period|Refused Treatment/Did Not Cooperate|1|||
147599601|NCT01096368|532352459|FG001|Overall Study|Withdrawal by Subject|52|||
147662123|NCT01435759|532585638|FG001|Double-blind Phase|Adverse Event|0|||
147662124|NCT01435759|532585639|FG002|Double-blind Phase|Adverse Event|1|||
147662125|NCT01435759|532585640|FG003|Double-blind Phase|Adverse Event|1|||
147662126|NCT01435759|532585641|FG004|Double-blind Phase|Adverse Event|1|||
147662127|NCT01435759|532585642|FG005|Double-blind Phase|Adverse Event|3|||
147662128|NCT01435759|532585637|FG000|Double-blind Phase|Protocol Violation|2|||
147662129|NCT01435759|532585638|FG001|Double-blind Phase|Protocol Violation|0|||
147662130|NCT01435759|532585639|FG002|Double-blind Phase|Protocol Violation|1|||
147662131|NCT01435759|532585640|FG003|Double-blind Phase|Protocol Violation|2|||
147662132|NCT01435759|532585641|FG004|Double-blind Phase|Protocol Violation|0|||
147662133|NCT01435759|532585642|FG005|Double-blind Phase|Protocol Violation|1|||
147662134|NCT01435759|532585637|FG000|Double-blind Phase|Withdrawal by Subject|17|||
147662135|NCT01435759|532585638|FG001|Double-blind Phase|Withdrawal by Subject|4|||
147662136|NCT01435759|532585639|FG002|Double-blind Phase|Withdrawal by Subject|3|||
147662137|NCT01435759|532585640|FG003|Double-blind Phase|Withdrawal by Subject|4|||
147662138|NCT01435759|532585641|FG004|Double-blind Phase|Withdrawal by Subject|2|||
147662139|NCT01435759|532585642|FG005|Double-blind Phase|Withdrawal by Subject|2|||
147662140|NCT01435759|532585637|FG000|Double-blind Phase|Lost to Follow-up|31|||
147662141|NCT01435759|532585638|FG001|Double-blind Phase|Lost to Follow-up|1|||
147662142|NCT01435759|532585639|FG002|Double-blind Phase|Lost to Follow-up|2|||
147662143|NCT01435759|532585640|FG003|Double-blind Phase|Lost to Follow-up|0|||
147662144|NCT01435759|532585641|FG004|Double-blind Phase|Lost to Follow-up|3|||
147662145|NCT01435759|532585642|FG005|Double-blind Phase|Lost to Follow-up|3|||
147662146|NCT01435759|532585637|FG000|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|1|||
147662147|NCT01435759|532585638|FG001|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0|||
147662148|NCT01435759|532585639|FG002|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0|||
147662149|NCT01435759|532585640|FG003|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0|||
147662150|NCT01435759|532585641|FG004|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|3|||
147662151|NCT01435759|532585642|FG005|Double-blind Phase|Met BP or Pulse Withdrawal Criteria|0|||
147662152|NCT01435759|532585637|FG000|Double-blind Phase|Other|8|||
147662153|NCT01435759|532585638|FG001|Double-blind Phase|Other|2|||
147662154|NCT01435759|532585639|FG002|Double-blind Phase|Other|0|||
147662155|NCT01435759|532585640|FG003|Double-blind Phase|Other|2|||
147662156|NCT01435759|532585641|FG004|Double-blind Phase|Other|0|||
147662157|NCT01435759|532585642|FG005|Double-blind Phase|Other|0|||
147662158|NCT03727841|532585645|FG000|Overall Study|Physician Decision|3|||
147662159|NCT03727841|532585646|FG001|Overall Study|Physician Decision|1|||
147258316|NCT02073279|531118405|FG000|Double-blind Period|Withdrawal by Subject|2|||
147258317|NCT02073279|531118406|FG001|Double-blind Period|Withdrawal by Subject|2|||
147258318|NCT02073279|531118405|FG000|Open-label Extension Period|Adverse Event|1|||
147258319|NCT02073279|531118406|FG001|Open-label Extension Period|Adverse Event|0|||
147258320|NCT02073279|531118405|FG000|Open-label Extension Period|Lack of Efficacy|1|||
147258321|NCT02073279|531118406|FG001|Open-label Extension Period|Lack of Efficacy|0|||
147258322|NCT02073279|531118405|FG000|Open-label Extension Period|Lost to Follow-up|0|||
147258323|NCT02073279|531118406|FG001|Open-label Extension Period|Lost to Follow-up|4|||
147258324|NCT02073279|531118405|FG000|Open-label Extension Period|Switched to another treatment|1|||
147258325|NCT02073279|531118406|FG001|Open-label Extension Period|Switched to another treatment|4|||
147258326|NCT02073279|531118405|FG000|Open-label Extension Period|Protocol Violation|0|||
147258327|NCT02073279|531118406|FG001|Open-label Extension Period|Protocol Violation|1|||
147258328|NCT02073279|531118405|FG000|Open-label Extension Period|Refused Treatment/Did Not Cooperate|0|||
147258329|NCT02073279|531118406|FG001|Open-label Extension Period|Refused Treatment/Did Not Cooperate|1|||
147258330|NCT02073279|531118405|FG000|Open-label Extension Period|Withdrawal by Subject|4|||
147662160|NCT03126786|532585647|FG000|Overall Study|Adverse Event|3|||
147662161|NCT03126786|532585648|FG001|Overall Study|Adverse Event|0|||
147662162|NCT03126786|532585647|FG000|Overall Study|Lost to Follow-up|0|||
147662163|NCT03126786|532585648|FG001|Overall Study|Lost to Follow-up|1|||
147662164|NCT03126786|532585647|FG000|Overall Study|Withdrawal by Subject|3|||
147662165|NCT03126786|532585648|FG001|Overall Study|Withdrawal by Subject|1|||
147662166|NCT01601496|532585649|FG000|Overall Study|Physician Decision|1|||
147662167|NCT01601496|532585649|FG000|Overall Study|Withdrawal by Subject|1|||
147662168|NCT01601496|532585649|FG000|Overall Study|Lost to Follow-up|6|||
147662169|NCT01601496|532585649|FG000|Overall Study|Death|4|||
147662170|NCT01601496|532585649|FG000|Overall Study|Other: patient refusal to continue|3|||
147662171|NCT03243305|532585650|FG000|Overall Study|Lost to Follow-up|250|||
147662172|NCT03243305|532585650|FG000|Overall Study|Withdrawal by Subject|170|||
147662173|NCT03243305|532585650|FG000|Overall Study|Pregnancy|104|||
147662174|NCT03243305|532585650|FG000|Overall Study|Non-Compliance with Study Drug|38|||
147662175|NCT03243305|532585650|FG000|Overall Study|Adverse Event|23|||
147662176|NCT03243305|532585650|FG000|Overall Study|No sexually active|26|||
147662177|NCT03243305|532585650|FG000|Overall Study|Physician Decision|22|||
147662178|NCT03243305|532585650|FG000|Overall Study|Protocol Violation|22|||
147662179|NCT03243305|532585650|FG000|Overall Study|Study method no longer primary method|12|||
147662180|NCT03243305|532585650|FG000|Overall Study|Study Terminated by Sponsor|1|||
147662181|NCT03243305|532585650|FG000|Overall Study|Early terminations|267|||
147662182|NCT02689804|532585651|FG000|Overall Study|Withdrawal by Subject|2|||
147662183|NCT02689804|532585652|FG001|Overall Study|Withdrawal by Subject|0|||
147662184|NCT00227539|532585653|FG000|Overall Study|Protocol Violation|1|||
147662185|NCT00673257|532585655|FG000|Overall Study|Withdrawal by Subject|4|||
147662186|NCT00673257|532585655|FG000|Overall Study|Unable to obtain specimen|1|||
147662187|NCT01166750|532585662|FG000|Overall Study|Lost to Follow-up|1|||
147662188|NCT01166750|532585663|FG001|Overall Study|Lost to Follow-up|0|||
147662189|NCT04396626|532585664|FG000|Overall Study|Premature termination of study|975|||
147662190|NCT02417753|532585667|FG000|Overall Study|Death|1|||
147662191|NCT03113968|532585668|FG000|Overall Study|Withdrawal by Subject|31|||
147662192|NCT03113968|532585669|FG001|Overall Study|Withdrawal by Subject|4|||
147662193|NCT04805671|532585670|FG000|Overall Study|Death|2|||
147662194|NCT04805671|532585671|FG001|Overall Study|Death|7|||
147662195|NCT04805671|532585670|FG000|Overall Study|Lost to Follow-up|1|||
147662196|NCT04805671|532585671|FG001|Overall Study|Lost to Follow-up|0|||
147662197|NCT04805671|532585670|FG000|Overall Study|Withdrawal by Subject|9|||
147662198|NCT04805671|532585671|FG001|Overall Study|Withdrawal by Subject|7|||
147662199|NCT04805671|532585670|FG000|Overall Study|Study terminated prematurely; participants active in the study discontinued from the trial.|178|||
147662200|NCT04805671|532585671|FG001|Overall Study|Study terminated prematurely; participants active in the study discontinued from the trial.|177|||
147662201|NCT02111174|532585674|FG000|Treatment and Primary Outcome|Ineligible (not used in analysis)|1|||
147332746|NCT01193153|531385539|FG001|Open-label Lead in Period|Lack of Efficacy|0|||
147332747|NCT01193153|531385538|FG000|Open-label Stabilization Period|Adverse Event|9|||
147332748|NCT01193153|531385539|FG001|Open-label Stabilization Period|Adverse Event|0|||
147332749|NCT01193153|531385538|FG000|Open-label Stabilization Period|Death|2|||
147332750|NCT01193153|531385539|FG001|Open-label Stabilization Period|Death|0|||
147332751|NCT01193153|531385538|FG000|Open-label Stabilization Period|Lost to Follow-up|10|||
147332752|NCT01193153|531385539|FG001|Open-label Stabilization Period|Lost to Follow-up|0|||
147332753|NCT01193153|531385538|FG000|Open-label Stabilization Period|Lack of Efficacy|5|||
147332754|NCT01193153|531385539|FG001|Open-label Stabilization Period|Lack of Efficacy|0|||
147332755|NCT01193153|531385538|FG000|Open-label Stabilization Period|Withdrawal by Subject|29|||
147332756|NCT01193153|531385539|FG001|Open-label Stabilization Period|Withdrawal by Subject|0|||
147332757|NCT01193153|531385538|FG000|Open-label Stabilization Period|Subject Failed Stabilization Criteria|35|||
147332758|NCT01193153|531385539|FG001|Open-label Stabilization Period|Subject Failed Stabilization Criteria|0|||
147332759|NCT01193153|531385538|FG000|Open-label Stabilization Period|Other|8|||
147332760|NCT01193153|531385539|FG001|Open-label Stabilization Period|Other|0|||
147332761|NCT01193153|531385538|FG000|Double Blind Relapse Prevention Period|Other|2|||
147332762|NCT01193153|531385539|FG001|Double Blind Relapse Prevention Period|Other|3|||
147332763|NCT01193153|531385538|FG000|Double Blind Relapse Prevention Period|Adverse Event|12|||
147332764|NCT01193153|531385539|FG001|Double Blind Relapse Prevention Period|Adverse Event|3|||
147332765|NCT01193153|531385538|FG000|Double Blind Relapse Prevention Period|Death|2|||
147332766|NCT01193153|531385539|FG001|Double Blind Relapse Prevention Period|Death|0|||
147332767|NCT01193153|531385538|FG000|Double Blind Relapse Prevention Period|Lost to Follow-up|2|||
147332768|NCT01193153|531385539|FG001|Double Blind Relapse Prevention Period|Lost to Follow-up|9|||
147332769|NCT01193153|531385538|FG000|Double Blind Relapse Prevention Period|Pregnancy|1|||
147332770|NCT01193153|531385539|FG001|Double Blind Relapse Prevention Period|Pregnancy|0|||
147332771|NCT01193153|531385538|FG000|Double Blind Relapse Prevention Period|Withdrawal by Subject|19|||
147332772|NCT01193153|531385539|FG001|Double Blind Relapse Prevention Period|Withdrawal by Subject|30|||
147332773|NCT01193153|531385538|FG000|Double Blind Relapse Prevention Period|Experienced Relapse|25|||
147332774|NCT01193153|531385539|FG001|Double Blind Relapse Prevention Period|Experienced Relapse|57|||
147332775|NCT01193153|531385538|FG000|Double Blind Relapse Prevention Period|> 6 Weeks Between 2 Study Drug|1|||
147332776|NCT01193153|531385539|FG001|Double Blind Relapse Prevention Period|> 6 Weeks Between 2 Study Drug|3|||
147332777|NCT01648140|531385540|FG000|Overall Study|Physician Decision|1|||
147332778|NCT01648140|531385541|FG001|Overall Study|Physician Decision|0|||
147332779|NCT01648140|531385542|FG002|Overall Study|Physician Decision|0|||
147332780|NCT01648140|531385543|FG003|Overall Study|Physician Decision|0|||
147332781|NCT01648140|531385540|FG000|Overall Study|Lack of Efficacy|4|||
147332782|NCT01648140|531385541|FG001|Overall Study|Lack of Efficacy|7|||
147332783|NCT01648140|531385542|FG002|Overall Study|Lack of Efficacy|1|||
147332784|NCT01648140|531385543|FG003|Overall Study|Lack of Efficacy|0|||
147332785|NCT01648140|531385540|FG000|Overall Study|Adverse Event|3|||
147332786|NCT01648140|531385541|FG001|Overall Study|Adverse Event|1|||
147332787|NCT01648140|531385542|FG002|Overall Study|Adverse Event|2|||
147332788|NCT01648140|531385543|FG003|Overall Study|Adverse Event|0|||
147332789|NCT01648140|531385540|FG000|Overall Study|Withdrawal by Subject|2|||
147662202|NCT02111174|532585675|FG001|Treatment and Primary Outcome|Ineligible (not used in analysis)|0|||
147332790|NCT01648140|531385541|FG001|Overall Study|Withdrawal by Subject|3|||
147332791|NCT01648140|531385542|FG002|Overall Study|Withdrawal by Subject|3|||
147332792|NCT01648140|531385543|FG003|Overall Study|Withdrawal by Subject|2|||
147332793|NCT01648140|531385540|FG000|Overall Study|Lost to Follow-up|2|||
147332794|NCT01648140|531385541|FG001|Overall Study|Lost to Follow-up|1|||
147662203|NCT02111174|532585674|FG000|Treatment and Primary Outcome|Withdrawal by Subject|2|||
147662204|NCT02111174|532585675|FG001|Treatment and Primary Outcome|Withdrawal by Subject|2|||
147258331|NCT02073279|531118406|FG001|Open-label Extension Period|Withdrawal by Subject|5|||
147258332|NCT01994629|531118407|FG000|Overall Study|Withdrawal by Subject|1|||
147258333|NCT01994629|531118408|FG001|Overall Study|Withdrawal by Subject|0|||
147258334|NCT01994629|531118407|FG000|Overall Study|Lost to Follow-up|0|||
147258335|NCT01994629|531118408|FG001|Overall Study|Lost to Follow-up|3|||
147258336|NCT03338062|531118409|FG000|Overall Study|Alternative Therapy|1|||
147258337|NCT03338062|531118410|FG001|Overall Study|Alternative Therapy|0|||
147258338|NCT01558752|531118411|FG000|Overall Study|Physician Decision|2|||
147258339|NCT01558752|531118412|FG001|Overall Study|Physician Decision|0|||
147258340|NCT04340362|531118415|FG000|Overall Study|Withdrawal of consent (not due to adverse event)|1|||
147258341|NCT04387435|531118420|FG000|Overall Study|Physician Decision|1|||
147258342|NCT00975481|531118421|FG000|Second Intervention Period|Adverse Event|2|||
147258343|NCT00975481|531118422|FG001|Second Intervention Period|Adverse Event|1|||
147258344|NCT00975481|531118423|FG002|Second Intervention Period|Adverse Event|0|||
147258345|NCT00975481|531118424|FG003|Second Intervention Period|Adverse Event|0|||
147258346|NCT00975481|531118425|FG004|Second Intervention Period|Adverse Event|0|||
147258347|NCT00975481|531118426|FG005|Second Intervention Period|Adverse Event|0|||
147258348|NCT00975481|531118421|FG000|Second Intervention Period|Withdrawal by Subject|0|||
147258349|NCT00975481|531118422|FG001|Second Intervention Period|Withdrawal by Subject|0|||
147258350|NCT00975481|531118423|FG002|Second Intervention Period|Withdrawal by Subject|1|||
147258351|NCT00975481|531118424|FG003|Second Intervention Period|Withdrawal by Subject|0|||
147258352|NCT00975481|531118425|FG004|Second Intervention Period|Withdrawal by Subject|0|||
147258353|NCT00975481|531118426|FG005|Second Intervention Period|Withdrawal by Subject|0|||
147258354|NCT00975481|531118421|FG000|Fourth Intervention Period|Withdrawal by Subject|0|||
147258355|NCT00975481|531118422|FG001|Fourth Intervention Period|Withdrawal by Subject|0|||
147258356|NCT00975481|531118423|FG002|Fourth Intervention Period|Withdrawal by Subject|1|||
147258357|NCT00975481|531118424|FG003|Fourth Intervention Period|Withdrawal by Subject|1|||
147258358|NCT00975481|531118425|FG004|Fourth Intervention Period|Withdrawal by Subject|0|||
147258359|NCT00975481|531118426|FG005|Fourth Intervention Period|Withdrawal by Subject|0|||
147258360|NCT00975481|531118421|FG000|Fifth Intervention Period|Withdrawal by Subject|0|||
147258361|NCT00975481|531118422|FG001|Fifth Intervention Period|Withdrawal by Subject|0|||
147258362|NCT00975481|531118423|FG002|Fifth Intervention Period|Withdrawal by Subject|0|||
147258363|NCT00975481|531118424|FG003|Fifth Intervention Period|Withdrawal by Subject|0|||
147258364|NCT00975481|531118425|FG004|Fifth Intervention Period|Withdrawal by Subject|1|||
147258365|NCT00975481|531118426|FG005|Fifth Intervention Period|Withdrawal by Subject|0|||
147258366|NCT03630120|531118427|FG000|Overall Study|Disease progression|0|||
147258367|NCT03630120|531118428|FG001|Overall Study|Disease progression|1|||
147258368|NCT03630120|531118429|FG002|Overall Study|Disease progression|1|||
147258369|NCT03630120|531118430|FG003|Overall Study|Disease progression|1|||
147258370|NCT01519960|531118431|FG000|Overall Study|Withdrawal from the study|26|||
147258371|NCT01519960|531118432|FG001|Overall Study|Withdrawal from the study|22|||
147258372|NCT01519960|531118433|FG002|Overall Study|Withdrawal from the study|5|||
147258373|NCT00561080|531118434|FG000|Vaccination Period (up to Month 4)|Adverse Event|0|||
147258374|NCT00561080|531118435|FG001|Vaccination Period (up to Month 4)|Adverse Event|4|||
147258375|NCT00561080|531118436|FG002|Vaccination Period (up to Month 4)|Adverse Event|6|||
147258376|NCT00561080|531118434|FG000|Vaccination Period (up to Month 4)|Definitive Contra-indication|0|||
147258377|NCT00561080|531118435|FG001|Vaccination Period (up to Month 4)|Definitive Contra-indication|2|||
147258378|NCT00561080|531118436|FG002|Vaccination Period (up to Month 4)|Definitive Contra-indication|3|||
147258379|NCT00561080|531118434|FG000|Vaccination Period (up to Month 4)|Protocol Violation|0|||
147258380|NCT00561080|531118435|FG001|Vaccination Period (up to Month 4)|Protocol Violation|1|||
147258381|NCT00561080|531118436|FG002|Vaccination Period (up to Month 4)|Protocol Violation|3|||
147258382|NCT00561080|531118434|FG000|Vaccination Period (up to Month 4)|Withdrawal by Subject|3|||
147258383|NCT00561080|531118435|FG001|Vaccination Period (up to Month 4)|Withdrawal by Subject|16|||
147258384|NCT00561080|531118436|FG002|Vaccination Period (up to Month 4)|Withdrawal by Subject|13|||
147258385|NCT00561080|531118434|FG000|Vaccination Period (up to Month 4)|Lost to Follow-up|0|||
147258386|NCT00561080|531118435|FG001|Vaccination Period (up to Month 4)|Lost to Follow-up|1|||
147258387|NCT00561080|531118436|FG002|Vaccination Period (up to Month 4)|Lost to Follow-up|0|||
147258388|NCT00561080|531118434|FG000|Vaccination Period (up to Month 4)|Other|0|||
147258389|NCT00561080|531118435|FG001|Vaccination Period (up to Month 4)|Other|2|||
147599602|NCT01096368|532352460|FG002|Overall Study|Withdrawal by Subject|0|||
147258390|NCT00561080|531118436|FG002|Vaccination Period (up to Month 4)|Other|1|||
147258391|NCT00561080|531118434|FG000|12-month Post Last Dose Follow-up|Adverse Event|3|||
147258392|NCT00561080|531118435|FG001|12-month Post Last Dose Follow-up|Adverse Event|3|||
147258393|NCT00561080|531118436|FG002|12-month Post Last Dose Follow-up|Adverse Event|1|||
147258394|NCT00561080|531118434|FG000|12-month Post Last Dose Follow-up|Protocol Violation|0|||
147258395|NCT00561080|531118435|FG001|12-month Post Last Dose Follow-up|Protocol Violation|0|||
147258396|NCT00561080|531118436|FG002|12-month Post Last Dose Follow-up|Protocol Violation|4|||
147258397|NCT00561080|531118434|FG000|12-month Post Last Dose Follow-up|Withdrawal by Subject|2|||
147332795|NCT01648140|531385542|FG002|Overall Study|Lost to Follow-up|2|||
147599603|NCT01096368|532352461|FG003|Overall Study|Withdrawal by Subject|10|||
147599604|NCT01096368|532352462|FG004|Overall Study|Withdrawal by Subject|14|||
147599605|NCT01096368|532352458|FG000|Overall Study|Ineligible|0|||
147258398|NCT00561080|531118435|FG001|12-month Post Last Dose Follow-up|Withdrawal by Subject|6|||
147258399|NCT00561080|531118436|FG002|12-month Post Last Dose Follow-up|Withdrawal by Subject|5|||
147258400|NCT00561080|531118434|FG000|12-month Post Last Dose Follow-up|Lost to Follow-up|2|||
147258401|NCT00561080|531118435|FG001|12-month Post Last Dose Follow-up|Lost to Follow-up|0|||
147258402|NCT00561080|531118436|FG002|12-month Post Last Dose Follow-up|Lost to Follow-up|0|||
147258403|NCT02951156|531118437|FG000|Overall Study|Death|3|||
147258404|NCT02951156|531118438|FG001|Overall Study|Death|8|||
147258405|NCT02951156|531118439|FG002|Overall Study|Death|5|||
147258406|NCT02951156|531118437|FG000|Overall Study|Progressive disease|1|||
147258407|NCT02951156|531118438|FG001|Overall Study|Progressive disease|0|||
147258408|NCT02951156|531118439|FG002|Overall Study|Progressive disease|1|||
147258409|NCT02951156|531118437|FG000|Overall Study|Withdrawal by Subject|0|||
147258410|NCT02951156|531118438|FG001|Overall Study|Withdrawal by Subject|0|||
147258411|NCT02951156|531118439|FG002|Overall Study|Withdrawal by Subject|1|||
147258412|NCT02951156|531118437|FG000|Overall Study|Study terminated by sponsor|0|||
147258413|NCT02951156|531118438|FG001|Overall Study|Study terminated by sponsor|0|||
147258414|NCT02951156|531118439|FG002|Overall Study|Study terminated by sponsor|1|||
147258415|NCT02951156|531118437|FG000|Overall Study|Other|5|||
147258416|NCT02951156|531118438|FG001|Overall Study|Other|1|||
147258417|NCT02951156|531118439|FG002|Overall Study|Other|2|||
147258418|NCT01092182|531118440|FG000|Overall Study|Death|0|||
147258419|NCT01092182|531118441|FG001|Overall Study|Death|5|||
147258420|NCT01092182|531118442|FG002|Overall Study|Death|3|||
147258421|NCT01092182|531118440|FG000|Overall Study|participant safety|1|||
147258422|NCT01092182|531118441|FG001|Overall Study|participant safety|2|||
147258423|NCT01092182|531118442|FG002|Overall Study|participant safety|0|||
147258424|NCT01092182|531118440|FG000|Overall Study|Physician Decision|0|||
147258425|NCT01092182|531118441|FG001|Overall Study|Physician Decision|6|||
147258426|NCT01092182|531118442|FG002|Overall Study|Physician Decision|0|||
147258427|NCT01092182|531118440|FG000|Overall Study|Did not meet criteria|0|||
147258428|NCT01092182|531118441|FG001|Overall Study|Did not meet criteria|0|||
147258429|NCT01092182|531118442|FG002|Overall Study|Did not meet criteria|25|||
147258430|NCT01092182|531118440|FG000|Overall Study|Non-compliance|0|||
147258431|NCT01092182|531118441|FG001|Overall Study|Non-compliance|3|||
147258432|NCT01092182|531118442|FG002|Overall Study|Non-compliance|0|||
147258433|NCT01092182|531118440|FG000|Overall Study|Participant refused follow-up|0|||
147258434|NCT01092182|531118441|FG001|Overall Study|Participant refused follow-up|2|||
147258435|NCT01092182|531118442|FG002|Overall Study|Participant refused follow-up|0|||
147258436|NCT01166178|531118443|FG000|Overall Study|Withdrawal by Subject|1|||
147258437|NCT01166178|531118444|FG001|Overall Study|Withdrawal by Subject|0|||
147258438|NCT01166178|531118443|FG000|Overall Study|Study was terminated|20|||
147258439|NCT01166178|531118444|FG001|Overall Study|Study was terminated|8|||
147450035|NCT01425203|531811344|FG001|Treatment Phase|Other virologic failure criteria|3|||
147450036|NCT01425203|531811345|FG002|Treatment Phase|Other virologic failure criteria|0|||
147450037|NCT01425203|531811343|FG000|Treatment Phase|Unidentified reasons|11|||
147450038|NCT01425203|531811344|FG001|Treatment Phase|Unidentified reasons|5|||
147450039|NCT01425203|531811345|FG002|Treatment Phase|Unidentified reasons|0|||
147450040|NCT01425203|531811343|FG000|Treatment Phase|Did not receive treatment|0|||
147450041|NCT01425203|531811344|FG001|Treatment Phase|Did not receive treatment|1|||
147450042|NCT01425203|531811345|FG002|Treatment Phase|Did not receive treatment|0|||
147258440|NCT00624052|531118445|FG000|Overall Study|Adverse Event|7|||
147258441|NCT00624052|531118446|FG001|Overall Study|Adverse Event|6|||
147258442|NCT00624052|531118447|FG002|Overall Study|Adverse Event|0|||
147258443|NCT00624052|531118448|FG003|Overall Study|Adverse Event|3|||
147258444|NCT00624052|531118445|FG000|Overall Study|Lack of Efficacy|1|||
147258445|NCT00624052|531118446|FG001|Overall Study|Lack of Efficacy|1|||
147258446|NCT00624052|531118447|FG002|Overall Study|Lack of Efficacy|0|||
147258447|NCT00624052|531118448|FG003|Overall Study|Lack of Efficacy|0|||
147258448|NCT00624052|531118445|FG000|Overall Study|Lost to Follow-up|2|||
147258449|NCT00624052|531118446|FG001|Overall Study|Lost to Follow-up|3|||
147258450|NCT00624052|531118447|FG002|Overall Study|Lost to Follow-up|1|||
147258451|NCT00624052|531118448|FG003|Overall Study|Lost to Follow-up|0|||
147258452|NCT00624052|531118445|FG000|Overall Study|Non compliant with the protocol|2|||
147450043|NCT01425203|531811343|FG000|Crossover Phase|Failure at futility timepoint|0|||
147258453|NCT00624052|531118446|FG001|Overall Study|Non compliant with the protocol|1|||
147258454|NCT00624052|531118447|FG002|Overall Study|Non compliant with the protocol|1|||
147258455|NCT00624052|531118448|FG003|Overall Study|Non compliant with the protocol|1|||
147258456|NCT00624052|531118445|FG000|Overall Study|Consent withdrawn|3|||
147258457|NCT00624052|531118446|FG001|Overall Study|Consent withdrawn|1|||
147258458|NCT00624052|531118447|FG002|Overall Study|Consent withdrawn|1|||
147258459|NCT00624052|531118448|FG003|Overall Study|Consent withdrawn|0|||
147258460|NCT00624052|531118445|FG000|Overall Study|Changed job/ran out if meds|0|||
147258461|NCT00624052|531118446|FG001|Overall Study|Changed job/ran out if meds|2|||
147258462|NCT00624052|531118447|FG002|Overall Study|Changed job/ran out if meds|0|||
147258463|NCT00624052|531118448|FG003|Overall Study|Changed job/ran out if meds|0|||
147258464|NCT02466555|531118449|FG000|Overall Study|Lost to Follow-up|2|||
147258465|NCT03839212|531118450|FG000|Overall Study|COVID-19 related suspension of research activities.|4|||
147332796|NCT01648140|531385543|FG003|Overall Study|Lost to Follow-up|0|||
147332797|NCT01988233|531385550|FG000|Overall Study|Lost to Follow-up|64|||
147332798|NCT01988233|531385551|FG001|Overall Study|Lost to Follow-up|51|||
147332799|NCT03781336|531385556|FG000|Overall Study|Withdrawal by Subject|2|||
147258466|NCT02113956|531118451|FG000|Intervention End (5 Weeks Post Baseline)|Withdrawal by Subject|5|||
147258467|NCT02113956|531118452|FG001|Intervention End (5 Weeks Post Baseline)|Withdrawal by Subject|1|||
147258468|NCT02113956|531118451|FG000|Intervention End (5 Weeks Post Baseline)|Lost to Follow-up|4|||
147258469|NCT02113956|531118452|FG001|Intervention End (5 Weeks Post Baseline)|Lost to Follow-up|3|||
147258470|NCT02113956|531118451|FG000|3 Month Post-intervention|Lost to Follow-up|4|||
147258471|NCT02113956|531118452|FG001|3 Month Post-intervention|Lost to Follow-up|2|||
147258472|NCT01498458|531118453|FG000|Overall Study|Adverse Event|4|||
147258473|NCT01498458|531118453|FG000|Overall Study|Physician Decision|3|||
147258474|NCT02446990|531118454|FG000|Overall Study|Death|485|||
147258475|NCT02446990|531118455|FG001|Overall Study|Death|458|||
147258476|NCT02446990|531118454|FG000|Overall Study|Lost to Follow-up|3|||
147258477|NCT02446990|531118455|FG001|Overall Study|Lost to Follow-up|1|||
147258478|NCT02446990|531118454|FG000|Overall Study|Physician Decision|1|||
147258479|NCT02446990|531118455|FG001|Overall Study|Physician Decision|0|||
147258480|NCT02446990|531118454|FG000|Overall Study|Withdrawal by Subject|231|||
147258481|NCT02446990|531118455|FG001|Overall Study|Withdrawal by Subject|199|||
147258482|NCT01064401|531118456|FG000|Overall Study|Adverse Event|47|||
147258483|NCT01064401|531118457|FG001|Overall Study|Adverse Event|56|||
147258484|NCT01064401|531118456|FG000|Overall Study|Lack of Efficacy|46|||
147258485|NCT01064401|531118457|FG001|Overall Study|Lack of Efficacy|23|||
147258486|NCT01064401|531118456|FG000|Overall Study|Lost to Follow-up|12|||
147258487|NCT01064401|531118457|FG001|Overall Study|Lost to Follow-up|9|||
147258488|NCT01064401|531118456|FG000|Overall Study|Consent Withdrawn|98|||
147258489|NCT01064401|531118457|FG001|Overall Study|Consent Withdrawn|80|||
147258490|NCT01064401|531118456|FG000|Overall Study|Investigator Decision|4|||
147258491|NCT01064401|531118457|FG001|Overall Study|Investigator Decision|6|||
147258492|NCT01064401|531118456|FG000|Overall Study|Death|4|||
147258493|NCT01064401|531118457|FG001|Overall Study|Death|0|||
147258494|NCT01064401|531118456|FG000|Overall Study|Pregnancy|4|||
147258495|NCT01064401|531118457|FG001|Overall Study|Pregnancy|7|||
147258496|NCT01064401|531118456|FG000|Overall Study|Noncompliance|7|||
147258497|NCT01064401|531118457|FG001|Overall Study|Noncompliance|8|||
147258498|NCT01064401|531118456|FG000|Overall Study|Site Closure|4|||
147258499|NCT01064401|531118457|FG001|Overall Study|Site Closure|5|||
147258500|NCT01064401|531118456|FG000|Overall Study|Other|2|||
147258501|NCT01064401|531118457|FG001|Overall Study|Other|1|||
147258502|NCT03158051|531118458|FG000|Overall Study|Lost to Follow-up|41|||
147258503|NCT03158051|531118459|FG001|Overall Study|Lost to Follow-up|47|||
147258504|NCT03158051|531118458|FG000|Overall Study|Physician Decision|6|||
147258505|NCT03158051|531118459|FG001|Overall Study|Physician Decision|7|||
147258506|NCT03158051|531118458|FG000|Overall Study|Withdrawal by Subject|24|||
147258507|NCT03158051|531118459|FG001|Overall Study|Withdrawal by Subject|15|||
147258508|NCT03158051|531118458|FG000|Overall Study|Death|0|||
147258509|NCT03158051|531118459|FG001|Overall Study|Death|1|||
147258510|NCT02738151|531118460|FG000|Overall Study|Randomized but not treated|4|||
147258511|NCT02738151|531118461|FG001|Overall Study|Randomized but not treated|1|||
147258512|NCT02738151|531118460|FG000|Overall Study|Adverse Event|4|||
147258513|NCT02738151|531118461|FG001|Overall Study|Adverse Event|5|||
147258514|NCT02738151|531118460|FG000|Overall Study|Hypoglycemia|0|||
147332800|NCT03781336|531385557|FG001|Overall Study|Withdrawal by Subject|2|||
147332801|NCT03987451|531385558|FG000|Overall Study|Lost to Follow-up|1|||
147332802|NCT03987451|531385559|FG001|Overall Study|Lost to Follow-up|0|||
147332803|NCT03987451|531385558|FG000|Overall Study|Withdrawal by Subject|1|||
147332804|NCT03987451|531385559|FG001|Overall Study|Withdrawal by Subject|1|||
147332805|NCT01183780|531385560|FG000|Overall Study|Withdrawal by Subject|25|||
147450044|NCT01425203|531811344|FG001|Crossover Phase|Failure at futility timepoint|0|||
147450045|NCT01425203|531811345|FG002|Crossover Phase|Failure at futility timepoint|3|||
147599606|NCT01096368|532352459|FG001|Overall Study|Ineligible|3|||
147599607|NCT01096368|532352460|FG002|Overall Study|Ineligible|2|||
147599608|NCT01096368|532352461|FG003|Overall Study|Ineligible|0|||
147258515|NCT02738151|531118461|FG001|Overall Study|Hypoglycemia|1|||
147258516|NCT02738151|531118460|FG000|Overall Study|Poor Compliance to Protocol|4|||
147258517|NCT02738151|531118461|FG001|Overall Study|Poor Compliance to Protocol|3|||
147258518|NCT02738151|531118460|FG000|Overall Study|Other than specified above|11|||
147258519|NCT02738151|531118461|FG001|Overall Study|Other than specified above|21|||
147258520|NCT04199117|531118473|FG000|Overall Study|Withdrawal by Subject|3|||
147258521|NCT04199117|531118474|FG001|Overall Study|Withdrawal by Subject|0|||
147332806|NCT01183780|531385561|FG001|Overall Study|Withdrawal by Subject|14|||
147258522|NCT04199117|531118475|FG002|Overall Study|Withdrawal by Subject|0|||
147258523|NCT04199117|531118476|FG003|Overall Study|Withdrawal by Subject|1|||
147258524|NCT04199117|531118477|FG004|Overall Study|Withdrawal by Subject|1|||
147258525|NCT04199117|531118478|FG005|Overall Study|Withdrawal by Subject|0|||
147258526|NCT04199117|531118479|FG006|Overall Study|Withdrawal by Subject|0|||
147258527|NCT04199117|531118480|FG007|Overall Study|Withdrawal by Subject|2|||
147258528|NCT04199117|531118481|FG008|Overall Study|Withdrawal by Subject|0|||
147258529|NCT04199117|531118482|FG009|Overall Study|Withdrawal by Subject|0|||
147258530|NCT04199117|531118483|FG010|Overall Study|Withdrawal by Subject|1|||
147258531|NCT04199117|531118484|FG011|Overall Study|Withdrawal by Subject|1|||
147258532|NCT04199117|531118485|FG012|Overall Study|Withdrawal by Subject|2|||
147258533|NCT04199117|531118486|FG013|Overall Study|Withdrawal by Subject|1|||
147258534|NCT04199117|531118487|FG014|Overall Study|Withdrawal by Subject|1|||
147258535|NCT04199117|531118488|FG015|Overall Study|Withdrawal by Subject|1|||
147258536|NCT04199117|531118473|FG000|Overall Study|Death|1|||
147258537|NCT04199117|531118474|FG001|Overall Study|Death|1|||
147258538|NCT04199117|531118475|FG002|Overall Study|Death|0|||
147258539|NCT04199117|531118476|FG003|Overall Study|Death|0|||
147258540|NCT04199117|531118477|FG004|Overall Study|Death|0|||
147258541|NCT04199117|531118478|FG005|Overall Study|Death|0|||
147258542|NCT04199117|531118479|FG006|Overall Study|Death|0|||
147258543|NCT04199117|531118480|FG007|Overall Study|Death|0|||
147258544|NCT04199117|531118481|FG008|Overall Study|Death|0|||
147258545|NCT04199117|531118482|FG009|Overall Study|Death|0|||
147258546|NCT04199117|531118483|FG010|Overall Study|Death|0|||
147258547|NCT04199117|531118484|FG011|Overall Study|Death|1|||
147258548|NCT04199117|531118485|FG012|Overall Study|Death|0|||
147258549|NCT04199117|531118486|FG013|Overall Study|Death|1|||
147258550|NCT04199117|531118487|FG014|Overall Study|Death|0|||
147258551|NCT04199117|531118488|FG015|Overall Study|Death|0|||
147258552|NCT04199117|531118473|FG000|Overall Study|Withdrawal by PI|0|||
147258553|NCT04199117|531118474|FG001|Overall Study|Withdrawal by PI|0|||
147258554|NCT04199117|531118475|FG002|Overall Study|Withdrawal by PI|0|||
147258555|NCT04199117|531118476|FG003|Overall Study|Withdrawal by PI|0|||
147258556|NCT04199117|531118477|FG004|Overall Study|Withdrawal by PI|0|||
147258557|NCT04199117|531118478|FG005|Overall Study|Withdrawal by PI|0|||
147258558|NCT04199117|531118479|FG006|Overall Study|Withdrawal by PI|0|||
147258559|NCT04199117|531118480|FG007|Overall Study|Withdrawal by PI|0|||
147258560|NCT04199117|531118481|FG008|Overall Study|Withdrawal by PI|0|||
147258561|NCT04199117|531118482|FG009|Overall Study|Withdrawal by PI|0|||
147258562|NCT04199117|531118483|FG010|Overall Study|Withdrawal by PI|0|||
147258563|NCT04199117|531118484|FG011|Overall Study|Withdrawal by PI|0|||
147258564|NCT04199117|531118485|FG012|Overall Study|Withdrawal by PI|1|||
147258565|NCT04199117|531118486|FG013|Overall Study|Withdrawal by PI|0|||
147258566|NCT04199117|531118487|FG014|Overall Study|Withdrawal by PI|0|||
147258567|NCT04199117|531118488|FG015|Overall Study|Withdrawal by PI|0|||
147258568|NCT02926924|531119585|FG000|Overall Study|withdrawal - reason unknown|0|||
147258569|NCT02926924|531119586|FG001|Overall Study|withdrawal - reason unknown|1|||
147258570|NCT03970733|531119589|FG000|Main Study Phase (18 Months)|Withdrawal by Subject|0|||
147258571|NCT03970733|531119590|FG001|Main Study Phase (18 Months)|Withdrawal by Subject|7|||
147258572|NCT03970733|531119591|FG002|Main Study Phase (18 Months)|Withdrawal by Subject|2|||
147258573|NCT03970733|531119592|FG003|Main Study Phase (18 Months)|Withdrawal by Subject|0|||
147258574|NCT03970733|531119593|FG004|Main Study Phase (18 Months)|Withdrawal by Subject|0|||
147258575|NCT03970733|531119589|FG000|Main Study Phase (18 Months)|Moved from study area|2|||
147258576|NCT03970733|531119590|FG001|Main Study Phase (18 Months)|Moved from study area|1|||
147258577|NCT03970733|531119591|FG002|Main Study Phase (18 Months)|Moved from study area|0|||
147258578|NCT03970733|531119592|FG003|Main Study Phase (18 Months)|Moved from study area|0|||
147258579|NCT03970733|531119593|FG004|Main Study Phase (18 Months)|Moved from study area|0|||
147258580|NCT03970733|531119589|FG000|Main Study Phase (18 Months)|Lost to Follow-up|5|||
147258581|NCT03970733|531119590|FG001|Main Study Phase (18 Months)|Lost to Follow-up|5|||
147258582|NCT03970733|531119591|FG002|Main Study Phase (18 Months)|Lost to Follow-up|3|||
147258583|NCT03970733|531119592|FG003|Main Study Phase (18 Months)|Lost to Follow-up|0|||
147258584|NCT03970733|531119593|FG004|Main Study Phase (18 Months)|Lost to Follow-up|0|||
147258585|NCT03970733|531119589|FG000|Main Study Phase (18 Months)|Other|1|||
147258586|NCT03970733|531119590|FG001|Main Study Phase (18 Months)|Other|1|||
147258587|NCT03970733|531119591|FG002|Main Study Phase (18 Months)|Other|0|||
147258588|NCT03970733|531119592|FG003|Main Study Phase (18 Months)|Other|0|||
147258589|NCT03970733|531119593|FG004|Main Study Phase (18 Months)|Other|0|||
147258590|NCT03970733|531119589|FG000|Booster Phase (Approx. 12 Months)|Lost to Follow-up|0|||
147258591|NCT03970733|531119590|FG001|Booster Phase (Approx. 12 Months)|Lost to Follow-up|0|||
147258592|NCT03970733|531119591|FG002|Booster Phase (Approx. 12 Months)|Lost to Follow-up|0|||
147258593|NCT03970733|531119592|FG003|Booster Phase (Approx. 12 Months)|Lost to Follow-up|0|||
147258594|NCT03970733|531119593|FG004|Booster Phase (Approx. 12 Months)|Lost to Follow-up|1|||
147258595|NCT01139450|531119597|FG000|Overall Study|Withdrawal by Subject|7|||
147258596|NCT01139450|531119598|FG001|Overall Study|Withdrawal by Subject|10|||
147332807|NCT01183780|531385560|FG000|Overall Study|Lost to Follow-up|6|||
147258597|NCT01139450|531119599|FG002|Overall Study|Withdrawal by Subject|13|||
147258598|NCT01139450|531119597|FG000|Overall Study|Lack of Efficacy|3|||
147258599|NCT01139450|531119598|FG001|Overall Study|Lack of Efficacy|1|||
147258600|NCT01139450|531119599|FG002|Overall Study|Lack of Efficacy|8|||
147258601|NCT01139450|531119597|FG000|Overall Study|Protocol Violation|6|||
147258602|NCT01139450|531119598|FG001|Overall Study|Protocol Violation|5|||
147258603|NCT01139450|531119599|FG002|Overall Study|Protocol Violation|2|||
147258604|NCT01139450|531119597|FG000|Overall Study|Lost to Follow-up|9|||
147258605|NCT01139450|531119598|FG001|Overall Study|Lost to Follow-up|7|||
147258606|NCT01139450|531119599|FG002|Overall Study|Lost to Follow-up|11|||
147258607|NCT01139450|531119597|FG000|Overall Study|Administrative|0|||
147258608|NCT01139450|531119598|FG001|Overall Study|Administrative|0|||
147258609|NCT01139450|531119599|FG002|Overall Study|Administrative|1|||
147258610|NCT01139450|531119597|FG000|Overall Study|Adverse Event|2|||
147258611|NCT01139450|531119598|FG001|Overall Study|Adverse Event|2|||
147258612|NCT01139450|531119599|FG002|Overall Study|Adverse Event|3|||
147258613|NCT02385266|531119606|FG000|Overall Study|Withdrawal by Subject|1|||
147258614|NCT02385266|531119607|FG001|Overall Study|Withdrawal by Subject|3|||
147258615|NCT03662542|531119610|FG000|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|3|||
147258616|NCT03662542|531119611|FG001|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
147258617|NCT03662542|531119612|FG002|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
147258618|NCT03662542|531119613|FG003|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
147258619|NCT03662542|531119614|FG004|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
147258620|NCT03662542|531119615|FG005|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
147258621|NCT03662542|531119616|FG006|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
147258622|NCT03662542|531119617|FG007|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
147258623|NCT03662542|531119618|FG008|Combination Phase ( Week 0- Week 12)|Withdrawal by Subject|0|||
147258624|NCT03662542|531119610|FG000|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
147258625|NCT03662542|531119611|FG001|Combination Phase ( Week 0- Week 12)|Adverse Event|1|||
147258626|NCT03662542|531119612|FG002|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
147258627|NCT03662542|531119613|FG003|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
147258628|NCT03662542|531119614|FG004|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
147258629|NCT03662542|531119615|FG005|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
147258630|NCT03662542|531119616|FG006|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
147258631|NCT03662542|531119617|FG007|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
147258632|NCT03662542|531119618|FG008|Combination Phase ( Week 0- Week 12)|Adverse Event|0|||
147258633|NCT03662542|531119610|FG000|Combination Phase ( Week 0- Week 12)|Other|1|||
147258634|NCT03662542|531119611|FG001|Combination Phase ( Week 0- Week 12)|Other|0|||
147258635|NCT03662542|531119612|FG002|Combination Phase ( Week 0- Week 12)|Other|0|||
147258636|NCT03662542|531119613|FG003|Combination Phase ( Week 0- Week 12)|Other|0|||
147258637|NCT03662542|531119614|FG004|Combination Phase ( Week 0- Week 12)|Other|0|||
147258638|NCT03662542|531119615|FG005|Combination Phase ( Week 0- Week 12)|Other|0|||
147258639|NCT03662542|531119616|FG006|Combination Phase ( Week 0- Week 12)|Other|0|||
147258640|NCT03662542|531119617|FG007|Combination Phase ( Week 0- Week 12)|Other|0|||
147258641|NCT03662542|531119618|FG008|Combination Phase ( Week 0- Week 12)|Other|0|||
147258642|NCT03662542|531119610|FG000|Combination Phase ( Week 0- Week 12)|COVID-19|1|||
147258643|NCT03662542|531119611|FG001|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
147258644|NCT03662542|531119612|FG002|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
147258645|NCT03662542|531119613|FG003|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
147258646|NCT03662542|531119614|FG004|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
147258647|NCT03662542|531119615|FG005|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
147258648|NCT03662542|531119616|FG006|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
147258649|NCT03662542|531119617|FG007|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
147258650|NCT03662542|531119618|FG008|Combination Phase ( Week 0- Week 12)|COVID-19|0|||
147258651|NCT03662542|531119610|FG000|Monotherapy Phase (Week 12-Week 38)|Death|0|||
147258652|NCT03662542|531119611|FG001|Monotherapy Phase (Week 12-Week 38)|Death|0|||
147258653|NCT03662542|531119612|FG002|Monotherapy Phase (Week 12-Week 38)|Death|0|||
147258654|NCT03662542|531119613|FG003|Monotherapy Phase (Week 12-Week 38)|Death|0|||
147258655|NCT03662542|531119614|FG004|Monotherapy Phase (Week 12-Week 38)|Death|0|||
147258656|NCT03662542|531119615|FG005|Monotherapy Phase (Week 12-Week 38)|Death|1|||
147258657|NCT03662542|531119616|FG006|Monotherapy Phase (Week 12-Week 38)|Death|0|||
147258658|NCT03662542|531119617|FG007|Monotherapy Phase (Week 12-Week 38)|Death|0|||
147258659|NCT03662542|531119618|FG008|Monotherapy Phase (Week 12-Week 38)|Death|0|||
147258660|NCT03662542|531119610|FG000|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
147258661|NCT03662542|531119611|FG001|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
147258662|NCT03662542|531119612|FG002|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
147258663|NCT03662542|531119613|FG003|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|1|||
147258664|NCT03662542|531119614|FG004|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|1|||
147258665|NCT03662542|531119615|FG005|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
147258666|NCT03662542|531119616|FG006|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
147599609|NCT01096368|532352462|FG004|Overall Study|Ineligible|25|||
147599610|NCT01096368|532352458|FG000|Overall Study|Did not start treatment|0|||
147599611|NCT01096368|532352459|FG001|Overall Study|Did not start treatment|4|||
147599612|NCT01096368|532352460|FG002|Overall Study|Did not start treatment|4|||
147599613|NCT01096368|532352461|FG003|Overall Study|Did not start treatment|0|||
147599614|NCT01096368|532352462|FG004|Overall Study|Did not start treatment|0|||
147258667|NCT03662542|531119617|FG007|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
147258668|NCT03662542|531119618|FG008|Monotherapy Phase (Week 12-Week 38)|Lost to Follow-up|0|||
147258669|NCT03662542|531119610|FG000|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|0|||
147258670|NCT03662542|531119611|FG001|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|0|||
147258671|NCT03662542|531119612|FG002|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|0|||
147258672|NCT03662542|531119613|FG003|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|4|||
147258673|NCT03662542|531119614|FG004|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|1|||
147258674|NCT03662542|531119615|FG005|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|1|||
147258675|NCT03662542|531119616|FG006|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|0|||
147258676|NCT03662542|531119617|FG007|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|0|||
147258677|NCT03662542|531119618|FG008|Monotherapy Phase (Week 12-Week 38)|Withdrawal by Subject|0|||
147258678|NCT03662542|531119610|FG000|Monotherapy Phase (Week 12-Week 38)|Other|0|||
147258679|NCT03662542|531119611|FG001|Monotherapy Phase (Week 12-Week 38)|Other|0|||
147258680|NCT03662542|531119612|FG002|Monotherapy Phase (Week 12-Week 38)|Other|0|||
147258681|NCT03662542|531119613|FG003|Monotherapy Phase (Week 12-Week 38)|Other|0|||
147258682|NCT03662542|531119614|FG004|Monotherapy Phase (Week 12-Week 38)|Other|1|||
147258683|NCT03662542|531119615|FG005|Monotherapy Phase (Week 12-Week 38)|Other|2|||
147258684|NCT03662542|531119616|FG006|Monotherapy Phase (Week 12-Week 38)|Other|0|||
147258685|NCT03662542|531119617|FG007|Monotherapy Phase (Week 12-Week 38)|Other|0|||
147258686|NCT03662542|531119618|FG008|Monotherapy Phase (Week 12-Week 38)|Other|0|||
147258687|NCT03662542|531119610|FG000|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
147258688|NCT03662542|531119611|FG001|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
147258689|NCT03662542|531119612|FG002|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
147258690|NCT03662542|531119613|FG003|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
147258691|NCT03662542|531119614|FG004|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
147258692|NCT03662542|531119615|FG005|Monotherapy Phase (Week 12-Week 38)|Adverse Event|2|||
147258693|NCT03662542|531119616|FG006|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
147258694|NCT03662542|531119617|FG007|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
147258695|NCT03662542|531119618|FG008|Monotherapy Phase (Week 12-Week 38)|Adverse Event|0|||
147258696|NCT03662542|531119610|FG000|Safety Follow-up (Week 38- Week 50)|Death|0|||
147258697|NCT03662542|531119611|FG001|Safety Follow-up (Week 38- Week 50)|Death|0|||
147258698|NCT03662542|531119612|FG002|Safety Follow-up (Week 38- Week 50)|Death|0|||
147258699|NCT03662542|531119613|FG003|Safety Follow-up (Week 38- Week 50)|Death|0|||
147258700|NCT03662542|531119614|FG004|Safety Follow-up (Week 38- Week 50)|Death|0|||
147258701|NCT03662542|531119615|FG005|Safety Follow-up (Week 38- Week 50)|Death|0|||
147258702|NCT03662542|531119616|FG006|Safety Follow-up (Week 38- Week 50)|Death|0|||
147258703|NCT03662542|531119617|FG007|Safety Follow-up (Week 38- Week 50)|Death|1|||
147258704|NCT03662542|531119618|FG008|Safety Follow-up (Week 38- Week 50)|Death|0|||
147258705|NCT03662542|531119610|FG000|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
147258706|NCT03662542|531119611|FG001|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
147258707|NCT03662542|531119612|FG002|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
147258708|NCT03662542|531119613|FG003|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
147258709|NCT03662542|531119614|FG004|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
147258710|NCT03662542|531119615|FG005|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
147258711|NCT03662542|531119616|FG006|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|1|||
147258712|NCT03662542|531119617|FG007|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|0|||
147258713|NCT03662542|531119618|FG008|Safety Follow-up (Week 38- Week 50)|Lost to Follow-up|1|||
147258714|NCT03662542|531119610|FG000|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
147258715|NCT03662542|531119611|FG001|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
147258716|NCT03662542|531119612|FG002|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
147258717|NCT03662542|531119613|FG003|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
147258718|NCT03662542|531119614|FG004|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
147258719|NCT03662542|531119615|FG005|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
147258720|NCT03662542|531119616|FG006|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|1|||
147258721|NCT03662542|531119617|FG007|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|0|||
147258722|NCT03662542|531119618|FG008|Safety Follow-up (Week 38- Week 50)|Withdrawal by Subject|2|||
147258723|NCT03662542|531119610|FG000|Safety Follow-up (Week 38- Week 50)|Other|0|||
147258724|NCT03662542|531119611|FG001|Safety Follow-up (Week 38- Week 50)|Other|0|||
147258725|NCT03662542|531119612|FG002|Safety Follow-up (Week 38- Week 50)|Other|0|||
147258726|NCT03662542|531119613|FG003|Safety Follow-up (Week 38- Week 50)|Other|0|||
147258727|NCT03662542|531119614|FG004|Safety Follow-up (Week 38- Week 50)|Other|0|||
147258728|NCT03662542|531119615|FG005|Safety Follow-up (Week 38- Week 50)|Other|0|||
147258729|NCT03662542|531119616|FG006|Safety Follow-up (Week 38- Week 50)|Other|1|||
147258730|NCT03662542|531119617|FG007|Safety Follow-up (Week 38- Week 50)|Other|6|||
147258731|NCT03662542|531119618|FG008|Safety Follow-up (Week 38- Week 50)|Other|2|||
147258732|NCT01217060|531119619|FG000|Overall Study|Withdrawal by Subject|1|||
147258733|NCT01859494|531119623|FG000|Overall Study|Adverse Event|1|||
147258734|NCT02357901|531119625|FG000|Run-In Period (Days -14 to Day -1)|Run-In failures|161|||
147258735|NCT02357901|531119626|FG001|Run-In Period (Days -14 to Day -1)|Run-In failures|0|||
147258736|NCT02357901|531119627|FG002|Run-In Period (Days -14 to Day -1)|Run-In failures|0|||
147450046|NCT01425203|531811343|FG000|Crossover Phase|Other virologic failure criteria|0|||
147450047|NCT01425203|531811344|FG001|Crossover Phase|Other virologic failure criteria|0|||
147450048|NCT01425203|531811345|FG002|Crossover Phase|Other virologic failure criteria|3|||
147450049|NCT04951037|531811350|FG000|Overall Study|Lost to Follow-up|16|||
147258737|NCT02357901|531119628|FG003|Run-In Period (Days -14 to Day -1)|Run-In failures|0|||
147258738|NCT02357901|531119625|FG000|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|0|||
147258739|NCT02357901|531119626|FG001|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|26|||
147258740|NCT02357901|531119627|FG002|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|23|||
147258741|NCT02357901|531119628|FG003|Treatment Period (Day 1 to Week 24)|Lost to Follow-up|12|||
147258742|NCT02357901|531119625|FG000|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|0|||
147258743|NCT02357901|531119626|FG001|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|20|||
147258744|NCT02357901|531119627|FG002|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|21|||
147258745|NCT02357901|531119628|FG003|Treatment Period (Day 1 to Week 24)|Withdrawal by Subject|18|||
147258746|NCT02357901|531119625|FG000|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|0|||
147258747|NCT02357901|531119626|FG001|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|3|||
147258748|NCT02357901|531119627|FG002|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|5|||
147258749|NCT02357901|531119628|FG003|Treatment Period (Day 1 to Week 24)|Lack of Efficacy|18|||
147258750|NCT02357901|531119625|FG000|Treatment Period (Day 1 to Week 24)|Adverse Event|0|||
147258751|NCT02357901|531119626|FG001|Treatment Period (Day 1 to Week 24)|Adverse Event|6|||
147258752|NCT02357901|531119627|FG002|Treatment Period (Day 1 to Week 24)|Adverse Event|10|||
147258753|NCT02357901|531119628|FG003|Treatment Period (Day 1 to Week 24)|Adverse Event|2|||
147258754|NCT02357901|531119625|FG000|Treatment Period (Day 1 to Week 24)|Protocol Violation|0|||
147258755|NCT02357901|531119626|FG001|Treatment Period (Day 1 to Week 24)|Protocol Violation|2|||
147258756|NCT02357901|531119627|FG002|Treatment Period (Day 1 to Week 24)|Protocol Violation|5|||
147258757|NCT02357901|531119628|FG003|Treatment Period (Day 1 to Week 24)|Protocol Violation|0|||
147258758|NCT02357901|531119625|FG000|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|0|||
147258759|NCT02357901|531119626|FG001|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|1|||
147258760|NCT02357901|531119627|FG002|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|1|||
147258761|NCT02357901|531119628|FG003|Treatment Period (Day 1 to Week 24)|Withdrawal symptoms|3|||
147258762|NCT02357901|531119625|FG000|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|0|||
147258763|NCT02357901|531119626|FG001|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|2|||
147258764|NCT02357901|531119627|FG002|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|0|||
147258765|NCT02357901|531119628|FG003|Treatment Period (Day 1 to Week 24)|Non-compliance with study drug|2|||
147258766|NCT02357901|531119625|FG000|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|0|||
147258767|NCT02357901|531119626|FG001|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|1|||
147258768|NCT02357901|531119627|FG002|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|0|||
147258769|NCT02357901|531119628|FG003|Treatment Period (Day 1 to Week 24)|Subject withdrawn by investigator|3|||
147258770|NCT02357901|531119625|FG000|Treatment Period (Day 1 to Week 24)|Physician Decision|0|||
147258771|NCT02357901|531119626|FG001|Treatment Period (Day 1 to Week 24)|Physician Decision|0|||
147258772|NCT02357901|531119627|FG002|Treatment Period (Day 1 to Week 24)|Physician Decision|1|||
147258773|NCT02357901|531119628|FG003|Treatment Period (Day 1 to Week 24)|Physician Decision|1|||
147258774|NCT02357901|531119625|FG000|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|0|||
147258775|NCT02357901|531119626|FG001|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|17|||
147258776|NCT02357901|531119627|FG002|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|6|||
147258777|NCT02357901|531119628|FG003|Treatment Period (Day 1 to Week 24)|site closed by sponsor, incarceration...|7|||
147258778|NCT00491387|531119637|FG000|Overall Study|study terminated|20|||
147258779|NCT00413192|531119640|FG000|Overall Study|Disease progression|26|||
147258780|NCT00413192|531119641|FG001|Overall Study|Disease progression|31|||
147258781|NCT00413192|531119642|FG002|Overall Study|Disease progression|16|||
147258782|NCT00413192|531119643|FG003|Overall Study|Disease progression|25|||
147258783|NCT00413192|531119640|FG000|Overall Study|Toxicity|3|||
147258784|NCT00413192|531119641|FG001|Overall Study|Toxicity|2|||
147258785|NCT00413192|531119642|FG002|Overall Study|Toxicity|2|||
147258786|NCT00413192|531119643|FG003|Overall Study|Toxicity|2|||
147258787|NCT00413192|531119640|FG000|Overall Study|Withdrawal by Subject|3|||
147258788|NCT00413192|531119641|FG001|Overall Study|Withdrawal by Subject|5|||
147258789|NCT00413192|531119642|FG002|Overall Study|Withdrawal by Subject|0|||
147258790|NCT00413192|531119643|FG003|Overall Study|Withdrawal by Subject|1|||
147258791|NCT00413192|531119640|FG000|Overall Study|Intercurrent illness|0|||
147258792|NCT00413192|531119641|FG001|Overall Study|Intercurrent illness|0|||
147258793|NCT00413192|531119642|FG002|Overall Study|Intercurrent illness|0|||
147258794|NCT00413192|531119643|FG003|Overall Study|Intercurrent illness|1|||
147450050|NCT04951037|531811350|FG000|Overall Study|Withdrawal by Subject|5|||
147527194|NCT03726320|532084156|FG001|Overall Study|Provider left the clinic|0|||
147527195|NCT03726320|532084157|FG002|Overall Study|Provider left the clinic|1|||
147527196|NCT02028182|532084160|FG000|Overall Study|Protocol Violation|2|||
147527197|NCT01684930|532084163|FG000|Overall Study|Withdrawal by Subject|3|||
147527198|NCT01684930|532084164|FG001|Overall Study|Withdrawal by Subject|1|||
147662205|NCT02111174|532585674|FG000|Secondary Outcomes (2 and 3 Month f/u)|Lost to Follow-up|8|||
147258795|NCT00413192|531119640|FG000|Overall Study|Intercurrent death|0|||
147258796|NCT00413192|531119641|FG001|Overall Study|Intercurrent death|1|||
147258797|NCT00413192|531119642|FG002|Overall Study|Intercurrent death|0|||
147258798|NCT00413192|531119643|FG003|Overall Study|Intercurrent death|0|||
147258799|NCT00413192|531119640|FG000|Overall Study|Other|5|||
147258800|NCT00413192|531119641|FG001|Overall Study|Other|1|||
147258801|NCT00413192|531119642|FG002|Overall Study|Other|1|||
147258802|NCT00413192|531119643|FG003|Overall Study|Other|2|||
147258803|NCT00413192|531119640|FG000|Overall Study|Not treated|0|||
147258804|NCT00413192|531119641|FG001|Overall Study|Not treated|0|||
147258805|NCT00413192|531119642|FG002|Overall Study|Not treated|0|||
147258806|NCT00413192|531119643|FG003|Overall Study|Not treated|1|||
147258807|NCT03814746|531119644|FG000|Overall Study|Participant decision|9|||
147258808|NCT03814746|531119645|FG001|Overall Study|Participant decision|6|||
147258809|NCT03814746|531119646|FG002|Overall Study|Participant decision|15|||
147258810|NCT03814746|531119644|FG000|Overall Study|Physician Decision|2|||
147258811|NCT03814746|531119645|FG001|Overall Study|Physician Decision|2|||
147258812|NCT03814746|531119646|FG002|Overall Study|Physician Decision|4|||
147258813|NCT03814746|531119644|FG000|Overall Study|Death|2|||
147258814|NCT03814746|531119645|FG001|Overall Study|Death|2|||
147258815|NCT03814746|531119646|FG002|Overall Study|Death|2|||
147258816|NCT03814746|531119644|FG000|Overall Study|Adverse Event|2|||
147258817|NCT03814746|531119645|FG001|Overall Study|Adverse Event|2|||
147258818|NCT03814746|531119646|FG002|Overall Study|Adverse Event|1|||
147258819|NCT03814746|531119644|FG000|Overall Study|Lost to Follow-up|2|||
147258820|NCT03814746|531119645|FG001|Overall Study|Lost to Follow-up|1|||
147258821|NCT03814746|531119646|FG002|Overall Study|Lost to Follow-up|2|||
147258822|NCT03814746|531119644|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
147258823|NCT03814746|531119645|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
147258824|NCT03814746|531119646|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
147258825|NCT03814746|531119644|FG000|Overall Study|Pregnancy|0|||
147258826|NCT03814746|531119645|FG001|Overall Study|Pregnancy|1|||
147258827|NCT03814746|531119646|FG002|Overall Study|Pregnancy|1|||
147258828|NCT03814746|531119644|FG000|Overall Study|Protocol Violation|1|||
147258829|NCT03814746|531119645|FG001|Overall Study|Protocol Violation|0|||
147258830|NCT03814746|531119646|FG002|Overall Study|Protocol Violation|0|||
147258831|NCT05089682|531119647|FG000|Overall Study|Withdrawal by Subject|2|||
147258832|NCT00772707|531119652|FG000|Overall Study|Withdrawn|3|||
147258833|NCT01266460|531119653|FG000|Overall Study|Adverse Event|3|||
147258834|NCT01266460|531119653|FG000|Overall Study|Withdrawal by Subject|5|||
147258835|NCT01266460|531119653|FG000|Overall Study|Disease Progression|18|||
147258836|NCT01266460|531119653|FG000|Overall Study|Not otherwise specified|8|||
147258837|NCT04351087|531119664|FG000|Overall Study|Lost to Follow-up|7|||
147258838|NCT04351087|531119665|FG001|Overall Study|Lost to Follow-up|3|||
147258839|NCT04351087|531119664|FG000|Overall Study|Withdrawal by Subject|3|||
147258840|NCT04351087|531119665|FG001|Overall Study|Withdrawal by Subject|4|||
147258841|NCT04351087|531119664|FG000|Overall Study|Lack of Efficacy|3|||
147258842|NCT04351087|531119665|FG001|Overall Study|Lack of Efficacy|2|||
147258843|NCT05517382|531119666|FG000|Overall Study|Lost to Follow-up|0|||
147258844|NCT05517382|531119667|FG001|Overall Study|Lost to Follow-up|1|||
147258845|NCT01374087|531119675|FG000|Overall Study|Adverse Event|1|||
147258846|NCT01374087|531119676|FG001|Overall Study|Adverse Event|0|||
147258847|NCT01374087|531119675|FG000|Overall Study|Disease progression|2|||
147527199|NCT01277757|532084165|FG000|Overall Study|Disease Progression|1|||
147258848|NCT01374087|531119676|FG001|Overall Study|Disease progression|2|||
147258849|NCT01374087|531119675|FG000|Overall Study|Study discontinued|13|||
147258850|NCT01374087|531119676|FG001|Overall Study|Study discontinued|13|||
147258851|NCT00271947|531119679|FG000|Overall Study|Lost to Follow-up|1|||
147258852|NCT01522365|531119682|FG000|Overall Study|Withdrawal by Subject|1|||
147258853|NCT01522365|531119683|FG001|Overall Study|Withdrawal by Subject|1|||
147258854|NCT01522365|531119682|FG000|Overall Study|Lost to Follow-up|1|||
147258855|NCT01522365|531119683|FG001|Overall Study|Lost to Follow-up|1|||
147258856|NCT00651755|531119684|FG000|Cycle 1 (First 21 Days)|Withdrawal by Subject|1|||
147258857|NCT00651755|531119685|FG001|Cycle 1 (First 21 Days)|Withdrawal by Subject|0|||
147258858|NCT00651755|531119684|FG000|Cycle 2 (Second 21 Days)|Not Evaluable|0|||
147258859|NCT00651755|531119685|FG001|Cycle 2 (Second 21 Days)|Not Evaluable|1|||
147258860|NCT04170348|531119686|FG000|Overall Study|Lost to Follow-up|2|||
147258861|NCT04170348|531119687|FG001|Overall Study|Lost to Follow-up|2|||
147258862|NCT04170348|531119686|FG000|Overall Study|Withdrawal by Subject|1|||
147527200|NCT01277757|532084165|FG000|Overall Study|Withdrawal by Subject|1|||
147527201|NCT03808298|532084166|FG000|Overall Study|Adverse Event|3|||
147527202|NCT03808298|532084166|FG000|Overall Study|Physician Decision|1|||
147527203|NCT03808298|532084166|FG000|Overall Study|Withdrawal by Subject|1|||
147527204|NCT03808298|532084166|FG000|Overall Study|Positive Urine Drug Screen at Check-in|3|||
147527205|NCT01004822|532084167|FG000|Overall Study|Objective progression or relapse|3|||
147527206|NCT01004822|532084168|FG001|Overall Study|Objective progression or relapse|3|||
147527207|NCT01004822|532084169|FG002|Overall Study|Objective progression or relapse|0|||
147527208|NCT01004822|532084170|FG003|Overall Study|Objective progression or relapse|1|||
147258863|NCT04170348|531119687|FG001|Overall Study|Withdrawal by Subject|5|||
147258864|NCT04170348|531119686|FG000|Overall Study|Non-adherence|1|||
147258865|NCT04170348|531119687|FG001|Overall Study|Non-adherence|1|||
147258866|NCT04170348|531119686|FG000|Overall Study|Adverse Event|1|||
147258867|NCT04170348|531119687|FG001|Overall Study|Adverse Event|0|||
147258868|NCT01120756|531119688|FG000|Overall Study|Withdrawal by Subject|1|||
147258869|NCT01120756|531119689|FG001|Overall Study|Withdrawal by Subject|1|||
147258870|NCT00679263|531119698|FG000|Visit 2/Dose 1|Adverse Event|1|||
147258871|NCT00679263|531119699|FG001|Visit 2/Dose 1|Adverse Event|0|||
147258872|NCT00679263|531119700|FG002|Visit 2/Dose 1|Adverse Event|0|||
147258873|NCT00679263|531119698|FG000|Visit 2/Dose 1|subject not compliance|1|||
147258874|NCT00679263|531119699|FG001|Visit 2/Dose 1|subject not compliance|1|||
147258875|NCT00679263|531119700|FG002|Visit 2/Dose 1|subject not compliance|0|||
147258876|NCT05104567|531119701|FG000|Overall Study|Adverse event: Related to Coronavirus Disease 2019 (COVID-19)|0|||
147258877|NCT05104567|531119702|FG001|Overall Study|Adverse event: Related to Coronavirus Disease 2019 (COVID-19)|1|||
147258878|NCT05104567|531119703|FG002|Overall Study|Adverse event: Related to Coronavirus Disease 2019 (COVID-19)|0|||
147258879|NCT05104567|531119704|FG003|Overall Study|Adverse event: Related to Coronavirus Disease 2019 (COVID-19)|0|||
147258880|NCT05104567|531119705|FG004|Overall Study|Adverse event: Related to Coronavirus Disease 2019 (COVID-19)|0|||
147258881|NCT05104567|531119706|FG005|Overall Study|Adverse event: Related to Coronavirus Disease 2019 (COVID-19)|0|||
147258882|NCT05104567|531119707|FG006|Overall Study|Adverse event: Related to Coronavirus Disease 2019 (COVID-19)|0|||
147258883|NCT05104567|531119701|FG000|Overall Study|Adverse event: Not related to COVID-19|0|||
147258884|NCT05104567|531119702|FG001|Overall Study|Adverse event: Not related to COVID-19|5|||
147258885|NCT05104567|531119703|FG002|Overall Study|Adverse event: Not related to COVID-19|3|||
147258886|NCT05104567|531119704|FG003|Overall Study|Adverse event: Not related to COVID-19|1|||
147258887|NCT05104567|531119705|FG004|Overall Study|Adverse event: Not related to COVID-19|3|||
147258888|NCT05104567|531119706|FG005|Overall Study|Adverse event: Not related to COVID-19|2|||
147258889|NCT05104567|531119707|FG006|Overall Study|Adverse event: Not related to COVID-19|0|||
147258890|NCT05104567|531119701|FG000|Overall Study|Progressive disease|3|||
147258891|NCT05104567|531119702|FG001|Overall Study|Progressive disease|13|||
147258892|NCT05104567|531119703|FG002|Overall Study|Progressive disease|13|||
147258893|NCT05104567|531119704|FG003|Overall Study|Progressive disease|17|||
147258894|NCT05104567|531119705|FG004|Overall Study|Progressive disease|17|||
147258895|NCT05104567|531119706|FG005|Overall Study|Progressive disease|28|||
147258896|NCT05104567|531119707|FG006|Overall Study|Progressive disease|24|||
147258897|NCT05104567|531119701|FG000|Overall Study|Withdrawal by Subject|1|||
147258898|NCT05104567|531119702|FG001|Overall Study|Withdrawal by Subject|1|||
147258899|NCT05104567|531119703|FG002|Overall Study|Withdrawal by Subject|2|||
147258900|NCT05104567|531119704|FG003|Overall Study|Withdrawal by Subject|0|||
147258901|NCT05104567|531119705|FG004|Overall Study|Withdrawal by Subject|0|||
147258902|NCT05104567|531119706|FG005|Overall Study|Withdrawal by Subject|0|||
147258903|NCT05104567|531119707|FG006|Overall Study|Withdrawal by Subject|0|||
147258904|NCT05104567|531119701|FG000|Overall Study|Other|1|||
147258905|NCT05104567|531119702|FG001|Overall Study|Other|1|||
147258906|NCT05104567|531119703|FG002|Overall Study|Other|1|||
147258907|NCT05104567|531119704|FG003|Overall Study|Other|0|||
147258908|NCT05104567|531119705|FG004|Overall Study|Other|0|||
147258909|NCT05104567|531119706|FG005|Overall Study|Other|0|||
147258910|NCT05104567|531119707|FG006|Overall Study|Other|0|||
147258911|NCT01464346|531119711|FG000|Overall Study|Withdrawal by Subject|0|||
147258912|NCT01464346|531119712|FG001|Overall Study|Withdrawal by Subject|0|||
147258913|NCT01464346|531119713|FG002|Overall Study|Withdrawal by Subject|1|||
147258914|NCT02295995|531119714|FG000|Overall Study|Lost to Follow-up|5|||
147258915|NCT02295995|531119715|FG001|Overall Study|Lost to Follow-up|1|||
147258916|NCT02005250|531119717|FG000|Overall Study|Lost to Follow-up|15|||
147258917|NCT02005250|531119718|FG001|Overall Study|Lost to Follow-up|5|||
147258918|NCT00378209|531119721|FG000|Overall Study|Progressive disease|11|||
147258919|NCT00378209|531119721|FG000|Overall Study|Adverse Event|3|||
147258920|NCT00378209|531119721|FG000|Overall Study|Initiation of non-protocol therapy|3|||
147258921|NCT00378209|531119721|FG000|Overall Study|Physician Decision|3|||
147258922|NCT00378209|531119721|FG000|Overall Study|Death|1|||
147258923|NCT00378209|531119721|FG000|Overall Study|Treatment delay|1|||
147258924|NCT01252940|531119725|FG000|Main Study Phase|Randomized but not treated|4|||
147258925|NCT01252940|531119726|FG001|Main Study Phase|Randomized but not treated|2|||
147662206|NCT02111174|532585675|FG001|Secondary Outcomes (2 and 3 Month f/u)|Lost to Follow-up|6|||
147662207|NCT02111174|532585674|FG000|Secondary Outcomes (2 and 3 Month f/u)|Death|0|||
147258926|NCT01252940|531119725|FG000|Main Study Phase|Adverse Event|3|||
147258927|NCT01252940|531119726|FG001|Main Study Phase|Adverse Event|1|||
147258928|NCT01252940|531119725|FG000|Main Study Phase|Lack of Efficacy|1|||
147258929|NCT01252940|531119726|FG001|Main Study Phase|Lack of Efficacy|0|||
147258930|NCT01252940|531119725|FG000|Main Study Phase|Lost to Follow-up|6|||
147258931|NCT01252940|531119726|FG001|Main Study Phase|Lost to Follow-up|1|||
147258932|NCT01252940|531119725|FG000|Main Study Phase|Physician Decision|1|||
147258933|NCT01252940|531119726|FG001|Main Study Phase|Physician Decision|0|||
147258934|NCT01252940|531119725|FG000|Main Study Phase|Protocol Violation|4|||
147258935|NCT01252940|531119726|FG001|Main Study Phase|Protocol Violation|2|||
147258936|NCT01252940|531119725|FG000|Main Study Phase|Withdrawal by Subject|6|||
147258937|NCT01252940|531119726|FG001|Main Study Phase|Withdrawal by Subject|5|||
147258938|NCT01252940|531119725|FG000|Main Study Phase|Subject Non-compliance|1|||
147258939|NCT01252940|531119726|FG001|Main Study Phase|Subject Non-compliance|1|||
147258940|NCT01252940|531119725|FG000|Extension Phase|Adverse Event|2|||
147258941|NCT01252940|531119726|FG001|Extension Phase|Adverse Event|1|||
147258942|NCT01252940|531119725|FG000|Extension Phase|Lack of Efficacy|1|||
147258943|NCT01252940|531119726|FG001|Extension Phase|Lack of Efficacy|0|||
147258944|NCT01252940|531119725|FG000|Extension Phase|Lost to Follow-up|5|||
147258945|NCT01252940|531119726|FG001|Extension Phase|Lost to Follow-up|0|||
147258946|NCT01252940|531119725|FG000|Extension Phase|Physician Decision|0|||
147258947|NCT01252940|531119726|FG001|Extension Phase|Physician Decision|1|||
147258948|NCT01252940|531119725|FG000|Extension Phase|Subject Non-compliance|1|||
147258949|NCT01252940|531119726|FG001|Extension Phase|Subject Non-compliance|0|||
147258950|NCT01252940|531119725|FG000|Extension Phase|Withdrawal by Subject|1|||
147258951|NCT01252940|531119726|FG001|Extension Phase|Withdrawal by Subject|1|||
147258952|NCT01239368|531122137|FG000|Overall Study|Principal investigator discretion|1|||
147258953|NCT01239368|531122138|FG001|Overall Study|Principal investigator discretion|0|||
147258954|NCT01239368|531122139|FG002|Overall Study|Principal investigator discretion|0|||
147258955|NCT01239368|531122140|FG003|Overall Study|Principal investigator discretion|0|||
147258956|NCT01239368|531122141|FG004|Overall Study|Principal investigator discretion|1|||
147258957|NCT01239368|531122142|FG005|Overall Study|Principal investigator discretion|2|||
147258958|NCT01239368|531122143|FG006|Overall Study|Principal investigator discretion|0|||
147258959|NCT01239368|531122144|FG007|Overall Study|Principal investigator discretion|0|||
147258960|NCT01239368|531122145|FG008|Overall Study|Principal investigator discretion|0|||
147258961|NCT01239368|531122146|FG009|Overall Study|Principal investigator discretion|1|||
147258962|NCT01239368|531122137|FG000|Overall Study|Disease progression on study|1|||
147258963|NCT01239368|531122138|FG001|Overall Study|Disease progression on study|1|||
147258964|NCT01239368|531122139|FG002|Overall Study|Disease progression on study|1|||
147258965|NCT01239368|531122140|FG003|Overall Study|Disease progression on study|1|||
147258966|NCT01239368|531122141|FG004|Overall Study|Disease progression on study|4|||
147258967|NCT01239368|531122142|FG005|Overall Study|Disease progression on study|2|||
147258968|NCT01239368|531122143|FG006|Overall Study|Disease progression on study|5|||
147258969|NCT01239368|531122144|FG007|Overall Study|Disease progression on study|0|||
147258970|NCT01239368|531122145|FG008|Overall Study|Disease progression on study|0|||
147258971|NCT01239368|531122146|FG009|Overall Study|Disease progression on study|2|||
147258972|NCT01239368|531122137|FG000|Overall Study|Refused further treatment|0|||
147258973|NCT01239368|531122138|FG001|Overall Study|Refused further treatment|0|||
147258974|NCT01239368|531122139|FG002|Overall Study|Refused further treatment|0|||
147258975|NCT01239368|531122140|FG003|Overall Study|Refused further treatment|0|||
147258976|NCT01239368|531122141|FG004|Overall Study|Refused further treatment|0|||
147258977|NCT01239368|531122142|FG005|Overall Study|Refused further treatment|0|||
147258978|NCT01239368|531122143|FG006|Overall Study|Refused further treatment|0|||
147258979|NCT01239368|531122144|FG007|Overall Study|Refused further treatment|0|||
147258980|NCT01239368|531122145|FG008|Overall Study|Refused further treatment|0|||
147258981|NCT01239368|531122146|FG009|Overall Study|Refused further treatment|1|||
147258982|NCT01239368|531122137|FG000|Overall Study|Death|0|||
147258983|NCT01239368|531122138|FG001|Overall Study|Death|0|||
147258984|NCT01239368|531122139|FG002|Overall Study|Death|0|||
147258985|NCT01239368|531122140|FG003|Overall Study|Death|0|||
147258986|NCT01239368|531122141|FG004|Overall Study|Death|0|||
147258987|NCT01239368|531122142|FG005|Overall Study|Death|0|||
147258988|NCT01239368|531122143|FG006|Overall Study|Death|1|||
147258989|NCT01239368|531122144|FG007|Overall Study|Death|0|||
147258990|NCT01239368|531122145|FG008|Overall Study|Death|0|||
147258991|NCT01239368|531122146|FG009|Overall Study|Death|0|||
147258992|NCT04709575|531122147|FG000|Overall Study|Withdrawal by Subject|6|||
147258993|NCT04709575|531122148|FG001|Overall Study|Withdrawal by Subject|2|||
147258994|NCT04709575|531122147|FG000|Overall Study|Lost to Follow-up|2|||
147258995|NCT04709575|531122148|FG001|Overall Study|Lost to Follow-up|2|||
147258996|NCT04709575|531122147|FG000|Overall Study|Adverse Event|1|||
147258997|NCT04709575|531122148|FG001|Overall Study|Adverse Event|0|||
147258998|NCT04709575|531122147|FG000|Overall Study|Protocol Violation|1|||
147258999|NCT04709575|531122148|FG001|Overall Study|Protocol Violation|1|||
147259000|NCT03181399|531122150|FG000|6 Months on Treatment|Protocol non-compliance|7|||
147259001|NCT03181399|531122150|FG000|6 Months on Treatment|Adverse Event|4|||
147259002|NCT03181399|531122150|FG000|6 Months on Treatment|Tried alternative treatment|2|||
147259003|NCT03181399|531122150|FG000|6 Months on Treatment|Lost to Follow-up|2|||
147259004|NCT03181399|531122150|FG000|6 Months on Treatment|Personal reasons|1|||
147259005|NCT03181399|531122150|FG000|3 Months Off-treatment|Parent unable to travel|1|||
147259006|NCT01536379|531122151|FG000|Overall Study|Adverse Event|1|||
147259007|NCT01536379|531122152|FG001|Overall Study|Adverse Event|2|||
147259008|NCT01536379|531122151|FG000|Overall Study|Withdrawal by Subject|1|||
147527209|NCT01004822|532084171|FG004|Overall Study|Objective progression or relapse|2|||
147259009|NCT01536379|531122152|FG001|Overall Study|Withdrawal by Subject|1|||
147259010|NCT04439253|531122161|FG000|Overall Study|Adverse Event|1|||
147259011|NCT04439253|531122161|FG000|Overall Study|Disease progression|2|||
147259012|NCT04439253|531122161|FG000|Overall Study|Complicating disease|1|||
147259013|NCT03971695|531122162|FG000|End of Part I and Part II - Washout|Did not participate in part II of study|6|||
147259014|NCT03971695|531122163|FG001|End of Part I and Part II - Washout|Did not participate in part II of study|6|||
147259015|NCT03971695|531122164|FG002|End of Part I and Part II - Washout|Did not participate in part II of study|6|||
147259016|NCT03971695|531122165|FG003|End of Part I and Part II - Washout|Did not participate in part II of study|5|||
147259017|NCT03971695|531122166|FG004|End of Part I and Part II - Washout|Did not participate in part II of study|9|||
147259018|NCT03971695|531122167|FG005|End of Part I and Part II - Washout|Did not participate in part II of study|6|||
147259019|NCT03971695|531122168|FG006|End of Part I and Part II - Washout|Did not participate in part II of study|6|||
147259020|NCT03971695|531122169|FG007|End of Part I and Part II - Washout|Did not participate in part II of study|6|||
147259021|NCT03971695|531122170|FG008|End of Part I and Part II - Washout|Did not participate in part II of study|5|||
147259022|NCT03971695|531122171|FG009|End of Part I and Part II - Washout|Did not participate in part II of study|6|||
147259023|NCT03971695|531122172|FG010|End of Part I and Part II - Washout|Did not participate in part II of study|0|||
147259024|NCT03971695|531122173|FG011|End of Part I and Part II - Washout|Did not participate in part II of study|0|||
147259025|NCT03971695|531122174|FG012|End of Part I and Part II - Washout|Did not participate in part II of study|0|||
147259026|NCT00939809|531122175|FG000|Overall Study|Adverse Event|2|||
147259027|NCT00939809|531122175|FG000|Overall Study|Death|1|||
147259028|NCT04447417|531122176|FG000|Overall Study|Withdrawal by Subject|1|||
147259029|NCT04447417|531122177|FG001|Overall Study|Withdrawal by Subject|0|||
147259030|NCT04447417|531122176|FG000|Overall Study|Failure to meet inclusion criteria|1|||
147259031|NCT04447417|531122177|FG001|Overall Study|Failure to meet inclusion criteria|0|||
147259032|NCT04447417|531122176|FG000|Overall Study|Lost to Follow-up|1|||
147259033|NCT04447417|531122177|FG001|Overall Study|Lost to Follow-up|0|||
147259034|NCT00702403|531122179|FG000|From Consent to Engraftment|Progressive leukemia|6|||
147259035|NCT00702403|531122179|FG000|From Consent to Engraftment|Critically ill|2|||
147259036|NCT00702403|531122179|FG000|From Consent to Engraftment|Corrected QT interval (QTc) >450 msec|2|||
147259037|NCT00702403|531122179|FG000|From Consent to Engraftment|Myocardial infarction|1|||
147259038|NCT00702403|531122179|FG000|From Consent to Engraftment|ANC<1500, plts<20K or hyperbilirubinemia|4|||
147259039|NCT00702403|531122179|FG000|From Consent to Engraftment|Miscellaneous (unanticipated) other|2|||
147259040|NCT00702403|531122179|FG000|From Engraftment to Study Completion|Failed pre-1st dose criteria|11|||
147259041|NCT00702403|531122179|FG000|From Engraftment to Study Completion|Relapse (1 Central Nervous System, 3 BM)|4|||
147259042|NCT00702403|531122179|FG000|From Engraftment to Study Completion|Non-compliance|2|||
147259043|NCT00702403|531122179|FG000|From Engraftment to Study Completion|Adenocarcinoma|1|||
147259044|NCT00702403|531122179|FG000|From Engraftment to Study Completion|Liver GVHD|1|||
147259045|NCT00702403|531122179|FG000|From Engraftment to Study Completion|Suicide|1|||
147259046|NCT00702403|531122179|FG000|From Engraftment to Study Completion|Acute respiratory distress syndrome|1|||
147259047|NCT00702403|531122179|FG000|From Engraftment to Study Completion|Dyspnea (unrelated to nilotinib)|1|||
147259048|NCT00702403|531122179|FG000|From Engraftment to Study Completion|Toxicity attributed to Nilotinib|5|||
147259049|NCT00858442|531122183|FG000|Compression:Start to Finish|Lost to Follow-up|1|||
147259050|NCT00858442|531122184|FG001|Compression:Start to Finish|Lost to Follow-up|3|||
147450051|NCT04951037|531811350|FG000|Overall Study|Completed study assessments but did not complete the intervention|10|||
147450052|NCT05630937|531811353|FG000|Overall Study|Study terminated by sponsor|1|||
147450053|NCT05630937|531811354|FG001|Overall Study|Study terminated by sponsor|1|||
147259051|NCT02016625|531122187|FG000|Cyclo or Tac (Single Dose, Day 1)|not treated|0|||
147259052|NCT02016625|531122188|FG001|Cyclo or Tac (Single Dose, Day 1)|not treated|1|||
147259053|NCT02016625|531122187|FG000|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|Adverse Event|1|||
147259054|NCT02016625|531122188|FG001|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|Adverse Event|0|||
147259055|NCT02016625|531122187|FG000|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|not specified above|2|||
147259056|NCT02016625|531122188|FG001|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)|not specified above|0|||
147259057|NCT02155738|531122189|FG000|Overall Study|Missing critical information|1|||
147259058|NCT02155738|531122190|FG001|Overall Study|Missing critical information|0|||
147259059|NCT02155738|531122191|FG002|Overall Study|Missing critical information|0|||
147259060|NCT02155738|531122192|FG003|Overall Study|Missing critical information|1|||
147259061|NCT02356783|531122194|FG000|Overall Study|Lost to Follow-up|1|||
147259062|NCT02356783|531122195|FG001|Overall Study|Lost to Follow-up|3|||
147450054|NCT05630937|531811355|FG002|Overall Study|Study terminated by sponsor|8|||
147450055|NCT05630937|531811356|FG003|Overall Study|Study terminated by sponsor|0|||
147259063|NCT02603809|531122196|FG000|Overall Study|Withdrawal by Subject|4|||
147259064|NCT02603809|531122197|FG001|Overall Study|Withdrawal by Subject|1|||
147259065|NCT02603809|531122198|FG002|Overall Study|Withdrawal by Subject|2|||
147259066|NCT02603809|531122199|FG003|Overall Study|Withdrawal by Subject|3|||
147259067|NCT02603809|531122200|FG004|Overall Study|Withdrawal by Subject|3|||
147259068|NCT02603809|531122201|FG005|Overall Study|Withdrawal by Subject|4|||
147450056|NCT05630937|531811353|FG000|Overall Study|Lost to Follow-up|0|||
147450057|NCT05630937|531811354|FG001|Overall Study|Lost to Follow-up|0|||
147259069|NCT02603809|531122196|FG000|Overall Study|Lost to Follow-up|2|||
147259070|NCT02603809|531122197|FG001|Overall Study|Lost to Follow-up|3|||
147259071|NCT02603809|531122198|FG002|Overall Study|Lost to Follow-up|1|||
147259072|NCT02603809|531122199|FG003|Overall Study|Lost to Follow-up|4|||
147259073|NCT02603809|531122200|FG004|Overall Study|Lost to Follow-up|2|||
147259074|NCT02603809|531122201|FG005|Overall Study|Lost to Follow-up|2|||
147259075|NCT02603809|531122196|FG000|Overall Study|Pre-specified discontinuation criteria|3|||
147259076|NCT02603809|531122197|FG001|Overall Study|Pre-specified discontinuation criteria|3|||
147259077|NCT02603809|531122198|FG002|Overall Study|Pre-specified discontinuation criteria|2|||
147259078|NCT02603809|531122199|FG003|Overall Study|Pre-specified discontinuation criteria|2|||
147259079|NCT02603809|531122200|FG004|Overall Study|Pre-specified discontinuation criteria|3|||
147259080|NCT02603809|531122201|FG005|Overall Study|Pre-specified discontinuation criteria|1|||
147259081|NCT02603809|531122196|FG000|Overall Study|Physician Decision|0|||
147259082|NCT02603809|531122197|FG001|Overall Study|Physician Decision|0|||
147259083|NCT02603809|531122198|FG002|Overall Study|Physician Decision|0|||
147259084|NCT02603809|531122199|FG003|Overall Study|Physician Decision|1|||
147259085|NCT02603809|531122200|FG004|Overall Study|Physician Decision|2|||
147259086|NCT02603809|531122201|FG005|Overall Study|Physician Decision|1|||
147259087|NCT02603809|531122196|FG000|Overall Study|Adverse Event|3|||
147259088|NCT02603809|531122197|FG001|Overall Study|Adverse Event|0|||
147259089|NCT02603809|531122198|FG002|Overall Study|Adverse Event|2|||
147259090|NCT02603809|531122199|FG003|Overall Study|Adverse Event|2|||
147259091|NCT02603809|531122200|FG004|Overall Study|Adverse Event|1|||
147259092|NCT02603809|531122201|FG005|Overall Study|Adverse Event|1|||
147259093|NCT02603809|531122196|FG000|Overall Study|Lack of Efficacy|0|||
147259094|NCT02603809|531122197|FG001|Overall Study|Lack of Efficacy|1|||
147259095|NCT02603809|531122198|FG002|Overall Study|Lack of Efficacy|0|||
147259096|NCT02603809|531122199|FG003|Overall Study|Lack of Efficacy|0|||
147259097|NCT02603809|531122200|FG004|Overall Study|Lack of Efficacy|0|||
147259098|NCT02603809|531122201|FG005|Overall Study|Lack of Efficacy|1|||
147259099|NCT00380978|531122203|FG000|Overall Study|Refused allocated intervention|0|||
147259100|NCT00380978|531122204|FG001|Overall Study|Refused allocated intervention|6|||
147259101|NCT00380978|531122203|FG000|Overall Study|Wrong study envelope|0|||
147259102|NCT00380978|531122204|FG001|Overall Study|Wrong study envelope|2|||
147259103|NCT00380978|531122203|FG000|Overall Study|Allocation prior to analgesia request|1|||
147259104|NCT00380978|531122204|FG001|Overall Study|Allocation prior to analgesia request|2|||
147259105|NCT00380978|531122203|FG000|Overall Study|Parous patient|1|||
147259106|NCT00380978|531122204|FG001|Overall Study|Parous patient|0|||
147259107|NCT01254227|531122205|FG000|Overall Study|Withdrawal by Subject|6|||
147259108|NCT01254227|531122205|FG000|Overall Study|Lost to Follow-up|6|||
147259109|NCT01254227|531122205|FG000|Overall Study|Adverse Event|5|||
147259110|NCT01254227|531122205|FG000|Overall Study|Abnormal test procedure result|5|||
147259111|NCT01254227|531122205|FG000|Overall Study|Administrative problems|2|||
147259112|NCT01254227|531122205|FG000|Overall Study|Death|1|||
147259113|NCT01254227|531122205|FG000|Overall Study|Protocol deviation|1|||
147259114|NCT00887354|531122206|FG000|Treatment Phase (Week 0 to Week 26)|Death|0|||
147259115|NCT00887354|531122207|FG001|Treatment Phase (Week 0 to Week 26)|Death|1|||
147259116|NCT00887354|531122206|FG000|Treatment Phase (Week 0 to Week 26)|Sponsor Decision|1|||
147259117|NCT00887354|531122207|FG001|Treatment Phase (Week 0 to Week 26)|Sponsor Decision|1|||
147259118|NCT00887354|531122206|FG000|Treatment Phase (Week 0 to Week 26)|Physician Decision|2|||
147259119|NCT00887354|531122207|FG001|Treatment Phase (Week 0 to Week 26)|Physician Decision|1|||
147259120|NCT00887354|531122206|FG000|Treatment Phase (Week 0 to Week 26)|Withdrawal by Subject|14|||
147259121|NCT00887354|531122207|FG001|Treatment Phase (Week 0 to Week 26)|Withdrawal by Subject|8|||
147259122|NCT00887354|531122206|FG000|Treatment Phase (Week 0 to Week 26)|Adverse Event|3|||
147259123|NCT00887354|531122207|FG001|Treatment Phase (Week 0 to Week 26)|Adverse Event|3|||
147259124|NCT00887354|531122206|FG000|Treatment Phase (Week 0 to Week 26)|Lost to Follow-up|2|||
147259125|NCT00887354|531122207|FG001|Treatment Phase (Week 0 to Week 26)|Lost to Follow-up|1|||
147259126|NCT00887354|531122206|FG000|Treatment Phase (Week 0 to Week 26)|Entry Criteria Not Met|3|||
147259127|NCT00887354|531122207|FG001|Treatment Phase (Week 0 to Week 26)|Entry Criteria Not Met|3|||
147259128|NCT00887354|531122206|FG000|Treatment Phase (Week 0 to Week 26)|Caregiver Decision|1|||
147259129|NCT00887354|531122207|FG001|Treatment Phase (Week 0 to Week 26)|Caregiver Decision|2|||
147259130|NCT00887354|531122206|FG000|Treatment Phase (Week 0 to Week 26)|No efficacy data|20|||
147259131|NCT00887354|531122207|FG001|Treatment Phase (Week 0 to Week 26)|No efficacy data|25|||
147259132|NCT00887354|531122206|FG000|Treatment Phase (Week 0 to Week 26)|Not Treated|5|||
147259133|NCT00887354|531122207|FG001|Treatment Phase (Week 0 to Week 26)|Not Treated|3|||
147259134|NCT00887354|531122206|FG000|Open Label Phase (Week 26 to Week 78)|Death|0|||
147259135|NCT00887354|531122207|FG001|Open Label Phase (Week 26 to Week 78)|Death|2|||
147259136|NCT00887354|531122206|FG000|Open Label Phase (Week 26 to Week 78)|Physician Decision|0|||
147259137|NCT00887354|531122207|FG001|Open Label Phase (Week 26 to Week 78)|Physician Decision|1|||
147259138|NCT00887354|531122206|FG000|Open Label Phase (Week 26 to Week 78)|Withdrawal by Subject|1|||
147259139|NCT00887354|531122207|FG001|Open Label Phase (Week 26 to Week 78)|Withdrawal by Subject|2|||
147259140|NCT00887354|531122206|FG000|Open Label Phase (Week 26 to Week 78)|Adverse Event|1|||
147332808|NCT01183780|531385561|FG001|Overall Study|Lost to Follow-up|11|||
147662208|NCT02111174|532585675|FG001|Secondary Outcomes (2 and 3 Month f/u)|Death|1|||
147662209|NCT00901342|532585676|FG000|Overall Study|Adverse Event|1|||
147259141|NCT00887354|531122207|FG001|Open Label Phase (Week 26 to Week 78)|Adverse Event|0|||
147259142|NCT00887354|531122206|FG000|Open Label Phase (Week 26 to Week 78)|Lost to Follow-up|1|||
147259143|NCT00887354|531122207|FG001|Open Label Phase (Week 26 to Week 78)|Lost to Follow-up|1|||
147259144|NCT01466348|531122210|FG000|Period I - First Intervention|Withdrawal by Subject|0|||
147259145|NCT01466348|531122211|FG001|Period I - First Intervention|Withdrawal by Subject|1|||
147259146|NCT00192504|531122214|FG000|Overall Study|Lost to Follow-up|1|||
147259147|NCT00192504|531122215|FG001|Overall Study|Lost to Follow-up|0|||
147259148|NCT00192504|531122216|FG002|Overall Study|Lost to Follow-up|0|||
147259149|NCT00192504|531122217|FG003|Overall Study|Lost to Follow-up|0|||
147259150|NCT00192504|531122214|FG000|Overall Study|Dosing window missed|0|||
147259151|NCT00192504|531122215|FG001|Overall Study|Dosing window missed|0|||
147259152|NCT00192504|531122216|FG002|Overall Study|Dosing window missed|1|||
147259153|NCT00192504|531122217|FG003|Overall Study|Dosing window missed|0|||
147259154|NCT03989440|531122218|FG000|Overall Study|COVID-19 travel restrictions|0|||
147259155|NCT03989440|531122219|FG001|Overall Study|COVID-19 travel restrictions|0|||
147259156|NCT03989440|531122220|FG002|Overall Study|COVID-19 travel restrictions|1|||
147259157|NCT03989440|531122221|FG003|Overall Study|COVID-19 travel restrictions|0|||
147259158|NCT03989440|531122222|FG004|Overall Study|COVID-19 travel restrictions|0|||
147259159|NCT03989440|531122223|FG005|Overall Study|COVID-19 travel restrictions|0|||
147259160|NCT03989440|531122218|FG000|Overall Study|Unsuccessful lumbar puncture|0|||
147259161|NCT03989440|531122219|FG001|Overall Study|Unsuccessful lumbar puncture|0|||
147259162|NCT03989440|531122220|FG002|Overall Study|Unsuccessful lumbar puncture|0|||
147259163|NCT03989440|531122221|FG003|Overall Study|Unsuccessful lumbar puncture|1|||
147259164|NCT03989440|531122222|FG004|Overall Study|Unsuccessful lumbar puncture|0|||
147259165|NCT03989440|531122223|FG005|Overall Study|Unsuccessful lumbar puncture|0|||
147259166|NCT02189473|531122226|FG000|Overall Study|Death|22|||
147259167|NCT02189473|531122227|FG001|Overall Study|Death|23|||
147259168|NCT02189473|531122226|FG000|Overall Study|Lost to Follow-up|1|||
147259169|NCT02189473|531122227|FG001|Overall Study|Lost to Follow-up|2|||
147259170|NCT01955161|531122228|FG000|Overall Study|Withdrawal before treatment|2|||
147259171|NCT01955161|531122229|FG001|Overall Study|Withdrawal before treatment|0|||
147259172|NCT01955161|531122230|FG002|Overall Study|Withdrawal before treatment|1|||
147259173|NCT01955161|531122228|FG000|Overall Study|Adverse Event|10|||
147259174|NCT01955161|531122229|FG001|Overall Study|Adverse Event|14|||
147259175|NCT01955161|531122230|FG002|Overall Study|Adverse Event|15|||
147259176|NCT01955161|531122228|FG000|Overall Study|Death|1|||
147259177|NCT01955161|531122229|FG001|Overall Study|Death|1|||
147259178|NCT01955161|531122230|FG002|Overall Study|Death|3|||
147259179|NCT01955161|531122228|FG000|Overall Study|Withdrawal by Subject|9|||
147259180|NCT01955161|531122229|FG001|Overall Study|Withdrawal by Subject|8|||
147259181|NCT01955161|531122230|FG002|Overall Study|Withdrawal by Subject|12|||
147259182|NCT01955161|531122228|FG000|Overall Study|Protocol Violation|2|||
147259183|NCT01955161|531122229|FG001|Overall Study|Protocol Violation|0|||
147259184|NCT01955161|531122230|FG002|Overall Study|Protocol Violation|0|||
147259185|NCT01955161|531122228|FG000|Overall Study|Other reason: physician decision|0|||
147259186|NCT01955161|531122229|FG001|Overall Study|Other reason: physician decision|1|||
147259187|NCT01955161|531122230|FG002|Overall Study|Other reason: physician decision|1|||
147259188|NCT01955161|531122228|FG000|Overall Study|Other reason: disallowed medication|1|||
147259189|NCT01955161|531122229|FG001|Overall Study|Other reason: disallowed medication|0|||
147259190|NCT01955161|531122230|FG002|Overall Study|Other reason: disallowed medication|1|||
147259191|NCT01955161|531122228|FG000|Overall Study|Other reason: caregiver unavailable|1|||
147259192|NCT01955161|531122229|FG001|Overall Study|Other reason: caregiver unavailable|0|||
147259193|NCT01955161|531122230|FG002|Overall Study|Other reason: caregiver unavailable|0|||
147259194|NCT01955161|531122228|FG000|Overall Study|Other reason: moved to nursing home|0|||
147259195|NCT01955161|531122229|FG001|Overall Study|Other reason: moved to nursing home|1|||
147259196|NCT01955161|531122230|FG002|Overall Study|Other reason: moved to nursing home|0|||
147259197|NCT01955161|531122228|FG000|Overall Study|Other reason: insufficient compliance|0|||
147259198|NCT01955161|531122229|FG001|Overall Study|Other reason: insufficient compliance|0|||
147259199|NCT01955161|531122230|FG002|Overall Study|Other reason: insufficient compliance|1|||
147662210|NCT00901342|532585676|FG000|Overall Study|Death|4|||
147662211|NCT00901342|532585676|FG000|Overall Study|Disease progression|1|||
147259200|NCT01955161|531122228|FG000|Overall Study|Other reason: primary biliary cirrhosis|1|||
147259201|NCT01955161|531122229|FG001|Overall Study|Other reason: primary biliary cirrhosis|0|||
147259202|NCT01955161|531122230|FG002|Overall Study|Other reason: primary biliary cirrhosis|0|||
147259203|NCT01955161|531122228|FG000|Overall Study|Other reason: patient's will|0|||
147259204|NCT01955161|531122229|FG001|Overall Study|Other reason: patient's will|0|||
147259205|NCT01955161|531122230|FG002|Overall Study|Other reason: patient's will|1|||
147259206|NCT02784821|531122231|FG000|Overall Study|Death|0|||
147259207|NCT02784821|531122232|FG001|Overall Study|Death|5|||
147259208|NCT02784821|531122233|FG002|Overall Study|Death|4|||
147259209|NCT02784821|531122234|FG003|Overall Study|Death|5|||
147662212|NCT00901342|532585676|FG000|Overall Study|Withdrawal by Subject|9|||
147259210|NCT02794103|531122235|FG000|Overall Study|Loss to follow up due to high sedation|3|||
147259211|NCT04608500|531122236|FG000|Overall Study|Adverse Event|2|||
147259212|NCT04608500|531122237|FG001|Overall Study|Adverse Event|0|||
147259213|NCT04608500|531122236|FG000|Overall Study|Lost to Follow-up|15|||
147259214|NCT04608500|531122237|FG001|Overall Study|Lost to Follow-up|9|||
147259215|NCT04608500|531122236|FG000|Overall Study|Participant request|11|||
147259216|NCT04608500|531122237|FG001|Overall Study|Participant request|7|||
147259217|NCT04608500|531122236|FG000|Overall Study|Protocol Violation|1|||
147259218|NCT04608500|531122237|FG001|Overall Study|Protocol Violation|0|||
147259219|NCT04608500|531122236|FG000|Overall Study|Other|6|||
147259220|NCT04608500|531122237|FG001|Overall Study|Other|2|||
147259221|NCT01881230|531122243|FG000|Overall Study|Death|2|||
147259222|NCT01881230|531122244|FG001|Overall Study|Death|0|||
147259223|NCT01881230|531122245|FG002|Overall Study|Death|1|||
147259224|NCT01881230|531122243|FG000|Overall Study|Adverse Event|9|||
147259225|NCT01881230|531122244|FG001|Overall Study|Adverse Event|13|||
147259226|NCT01881230|531122245|FG002|Overall Study|Adverse Event|12|||
147259227|NCT01881230|531122243|FG000|Overall Study|Progressive Disease|31|||
147259228|NCT01881230|531122244|FG001|Overall Study|Progressive Disease|35|||
147259229|NCT01881230|531122245|FG002|Overall Study|Progressive Disease|36|||
147259230|NCT01881230|531122243|FG000|Overall Study|Symptomatic Deterioration|3|||
147259231|NCT01881230|531122244|FG001|Overall Study|Symptomatic Deterioration|3|||
147259232|NCT01881230|531122245|FG002|Overall Study|Symptomatic Deterioration|1|||
147259233|NCT01881230|531122243|FG000|Overall Study|Withdrawal by Subject|6|||
147259234|NCT01881230|531122244|FG001|Overall Study|Withdrawal by Subject|4|||
147259235|NCT01881230|531122245|FG002|Overall Study|Withdrawal by Subject|6|||
147259236|NCT01881230|531122243|FG000|Overall Study|Physician Decision|4|||
147259237|NCT01881230|531122244|FG001|Overall Study|Physician Decision|3|||
147259238|NCT01881230|531122245|FG002|Overall Study|Physician Decision|6|||
147259239|NCT01881230|531122243|FG000|Overall Study|Non-Compliance with Study Drug|1|||
147259240|NCT01881230|531122244|FG001|Overall Study|Non-Compliance with Study Drug|2|||
147259241|NCT01881230|531122245|FG002|Overall Study|Non-Compliance with Study Drug|0|||
147259242|NCT01881230|531122243|FG000|Overall Study|Given Commercially Available Drug|0|||
147259243|NCT01881230|531122244|FG001|Overall Study|Given Commercially Available Drug|0|||
147259244|NCT01881230|531122245|FG002|Overall Study|Given Commercially Available Drug|2|||
147259245|NCT01881230|531122243|FG000|Overall Study|Protocol Violation|1|||
147259246|NCT01881230|531122244|FG001|Overall Study|Protocol Violation|1|||
147259247|NCT01881230|531122245|FG002|Overall Study|Protocol Violation|0|||
147259248|NCT01881230|531122243|FG000|Overall Study|Miscellaneous|3|||
147259249|NCT01881230|531122244|FG001|Overall Study|Miscellaneous|3|||
147259250|NCT01881230|531122245|FG002|Overall Study|Miscellaneous|0|||
147259251|NCT01881230|531122243|FG000|Overall Study|Untreated: Other|0|||
147259252|NCT01881230|531122244|FG001|Overall Study|Untreated: Other|0|||
147259253|NCT01881230|531122245|FG002|Overall Study|Untreated: Other|1|||
147259254|NCT01881230|531122243|FG000|Overall Study|Untreated: Death|0|||
147259255|NCT01881230|531122244|FG001|Overall Study|Untreated: Death|0|||
147259256|NCT01881230|531122245|FG002|Overall Study|Untreated: Death|1|||
147259257|NCT01881230|531122243|FG000|Overall Study|Untreated: Withdrawal Before Study Start|1|||
147259258|NCT01881230|531122244|FG001|Overall Study|Untreated: Withdrawal Before Study Start|0|||
147259259|NCT01881230|531122245|FG002|Overall Study|Untreated: Withdrawal Before Study Start|0|||
147259260|NCT05123222|531122246|FG000|Overall Study|Lost to Follow-up|2|||
147259261|NCT05123222|531122247|FG001|Overall Study|Lost to Follow-up|0|||
147259262|NCT05123222|531122248|FG002|Overall Study|Lost to Follow-up|0|||
147259263|NCT05123222|531122249|FG003|Overall Study|Lost to Follow-up|0|||
147259264|NCT05123222|531122246|FG000|Overall Study|Protocol Violation|0|||
147259265|NCT05123222|531122247|FG001|Overall Study|Protocol Violation|0|||
147259266|NCT05123222|531122248|FG002|Overall Study|Protocol Violation|1|||
147259267|NCT05123222|531122249|FG003|Overall Study|Protocol Violation|0|||
147259268|NCT00112502|531122250|FG000|Overall Study|Withdrawal by Subject|0|||
147259269|NCT00112502|531122251|FG001|Overall Study|Withdrawal by Subject|1|||
147259270|NCT00112502|531122252|FG002|Overall Study|Withdrawal by Subject|1|||
147259271|NCT00112502|531122253|FG003|Overall Study|Withdrawal by Subject|4|||
147259272|NCT00112502|531122254|FG004|Overall Study|Withdrawal by Subject|2|||
147259273|NCT00112502|531122255|FG005|Overall Study|Withdrawal by Subject|5|||
147259274|NCT00112502|531122256|FG006|Overall Study|Withdrawal by Subject|3|||
147259275|NCT00112502|531122257|FG007|Overall Study|Withdrawal by Subject|7|||
147259276|NCT00914810|531122260|FG000|Overall Study|Withdrawal by Subject|1|||
147259277|NCT00914810|531122261|FG001|Overall Study|Withdrawal by Subject|0|||
147259278|NCT00914810|531122260|FG000|Overall Study|Relocated out of state|1|||
147259279|NCT00914810|531122261|FG001|Overall Study|Relocated out of state|0|||
147332809|NCT00770965|531385564|FG000|Safety Set|Withdrawal by Subject|0|||
147259280|NCT00914810|531122260|FG000|Overall Study|Hospitalized and unable to follow up.|0|||
147259281|NCT00914810|531122261|FG001|Overall Study|Hospitalized and unable to follow up.|1|||
147259282|NCT02747420|531122262|FG000|Overall Study|Lost to Follow-up|4|||
147259283|NCT02747420|531122263|FG001|Overall Study|Lost to Follow-up|2|||
147259284|NCT02747420|531122262|FG000|Overall Study|Withdrawal by Subject|3|||
147259285|NCT02747420|531122263|FG001|Overall Study|Withdrawal by Subject|2|||
147259286|NCT05129488|531122264|FG000|Overall Study|Protocol Violation|3|||
147259287|NCT00265343|531122265|FG000|Overall Study|Adverse Event|10|||
147259288|NCT00265343|531122266|FG001|Overall Study|Adverse Event|7|||
147259289|NCT00265343|531122265|FG000|Overall Study|Withdrawal by Subject|3|||
147259290|NCT00265343|531122266|FG001|Overall Study|Withdrawal by Subject|9|||
147259291|NCT00265343|531122265|FG000|Overall Study|Other|8|||
147259292|NCT00265343|531122266|FG001|Overall Study|Other|3|||
147259293|NCT02608268|531122267|FG000|Overall Study|Adverse Event|0|||
147259294|NCT02608268|531122268|FG001|Overall Study|Adverse Event|0|||
147259295|NCT02608268|531122269|FG002|Overall Study|Adverse Event|1|||
147259296|NCT02608268|531122270|FG003|Overall Study|Adverse Event|0|||
147259297|NCT02608268|531122271|FG004|Overall Study|Adverse Event|0|||
147259298|NCT02608268|531122272|FG005|Overall Study|Adverse Event|0|||
147259299|NCT02608268|531122273|FG006|Overall Study|Adverse Event|0|||
147259300|NCT02608268|531122274|FG007|Overall Study|Adverse Event|0|||
147259301|NCT02608268|531122275|FG008|Overall Study|Adverse Event|0|||
147259302|NCT02608268|531122276|FG009|Overall Study|Adverse Event|0|||
147259303|NCT02608268|531122277|FG010|Overall Study|Adverse Event|0|||
147259304|NCT02608268|531122278|FG011|Overall Study|Adverse Event|0|||
147259305|NCT02608268|531122279|FG012|Overall Study|Adverse Event|2|||
147259306|NCT02608268|531122280|FG013|Overall Study|Adverse Event|0|||
147259307|NCT02608268|531122281|FG014|Overall Study|Adverse Event|0|||
147259308|NCT02608268|531122282|FG015|Overall Study|Adverse Event|0|||
147259309|NCT02608268|531122283|FG016|Overall Study|Adverse Event|0|||
147259310|NCT02608268|531122284|FG017|Overall Study|Adverse Event|0|||
147259311|NCT02608268|531122285|FG018|Overall Study|Adverse Event|0|||
147259312|NCT02608268|531122286|FG019|Overall Study|Adverse Event|0|||
147259313|NCT02608268|531122287|FG020|Overall Study|Adverse Event|1|||
147259314|NCT02608268|531122288|FG021|Overall Study|Adverse Event|1|||
147259315|NCT02608268|531122289|FG022|Overall Study|Adverse Event|0|||
147259316|NCT02608268|531122290|FG023|Overall Study|Adverse Event|0|||
147259317|NCT02608268|531122291|FG024|Overall Study|Adverse Event|1|||
147259318|NCT02608268|531122292|FG025|Overall Study|Adverse Event|0|||
147259319|NCT02608268|531122293|FG026|Overall Study|Adverse Event|0|||
147259320|NCT02608268|531122294|FG027|Overall Study|Adverse Event|0|||
147259321|NCT02608268|531122295|FG028|Overall Study|Adverse Event|1|||
147259322|NCT02608268|531122296|FG029|Overall Study|Adverse Event|0|||
147259323|NCT02608268|531122267|FG000|Overall Study|Death|1|||
147259324|NCT02608268|531122268|FG001|Overall Study|Death|0|||
147259325|NCT02608268|531122269|FG002|Overall Study|Death|0|||
147259326|NCT02608268|531122270|FG003|Overall Study|Death|0|||
147259327|NCT02608268|531122271|FG004|Overall Study|Death|0|||
147259328|NCT02608268|531122272|FG005|Overall Study|Death|0|||
147259329|NCT02608268|531122273|FG006|Overall Study|Death|0|||
147259330|NCT02608268|531122274|FG007|Overall Study|Death|0|||
147259331|NCT02608268|531122275|FG008|Overall Study|Death|1|||
147259332|NCT02608268|531122276|FG009|Overall Study|Death|1|||
147259333|NCT02608268|531122277|FG010|Overall Study|Death|0|||
147259334|NCT02608268|531122278|FG011|Overall Study|Death|0|||
147259335|NCT02608268|531122279|FG012|Overall Study|Death|0|||
147259336|NCT02608268|531122280|FG013|Overall Study|Death|0|||
147259337|NCT02608268|531122281|FG014|Overall Study|Death|0|||
147259338|NCT02608268|531122282|FG015|Overall Study|Death|1|||
147259339|NCT02608268|531122283|FG016|Overall Study|Death|0|||
147259340|NCT02608268|531122284|FG017|Overall Study|Death|1|||
147259341|NCT02608268|531122285|FG018|Overall Study|Death|0|||
147259342|NCT02608268|531122286|FG019|Overall Study|Death|1|||
147259343|NCT02608268|531122287|FG020|Overall Study|Death|1|||
147259344|NCT02608268|531122288|FG021|Overall Study|Death|0|||
147259345|NCT02608268|531122289|FG022|Overall Study|Death|0|||
147259346|NCT02608268|531122290|FG023|Overall Study|Death|0|||
147450058|NCT05630937|531811355|FG002|Overall Study|Lost to Follow-up|1|||
147450059|NCT05630937|531811356|FG003|Overall Study|Lost to Follow-up|0|||
147259347|NCT02608268|531122291|FG024|Overall Study|Death|1|||
147259348|NCT02608268|531122292|FG025|Overall Study|Death|2|||
147450060|NCT05630937|531811353|FG000|Overall Study|Enrolled but not treated|0|||
147259349|NCT02608268|531122293|FG026|Overall Study|Death|0|||
147259350|NCT02608268|531122294|FG027|Overall Study|Death|1|||
147259351|NCT02608268|531122295|FG028|Overall Study|Death|4|||
147259352|NCT02608268|531122296|FG029|Overall Study|Death|0|||
147259353|NCT02608268|531122267|FG000|Overall Study|Physician Decision|0|||
147259354|NCT02608268|531122268|FG001|Overall Study|Physician Decision|0|||
147259355|NCT02608268|531122269|FG002|Overall Study|Physician Decision|0|||
147259356|NCT02608268|531122270|FG003|Overall Study|Physician Decision|0|||
147259357|NCT02608268|531122271|FG004|Overall Study|Physician Decision|0|||
147259358|NCT02608268|531122272|FG005|Overall Study|Physician Decision|0|||
147450061|NCT05630937|531811354|FG001|Overall Study|Enrolled but not treated|0|||
147259359|NCT02608268|531122273|FG006|Overall Study|Physician Decision|0|||
147259360|NCT02608268|531122274|FG007|Overall Study|Physician Decision|0|||
147259361|NCT02608268|531122275|FG008|Overall Study|Physician Decision|0|||
147259362|NCT02608268|531122276|FG009|Overall Study|Physician Decision|0|||
147259363|NCT02608268|531122277|FG010|Overall Study|Physician Decision|1|||
147259364|NCT02608268|531122278|FG011|Overall Study|Physician Decision|0|||
147259365|NCT02608268|531122279|FG012|Overall Study|Physician Decision|0|||
147599615|NCT01096368|532352458|FG000|Overall Study|Progressive disease|0|||
147259366|NCT02608268|531122280|FG013|Overall Study|Physician Decision|1|||
147259367|NCT02608268|531122281|FG014|Overall Study|Physician Decision|0|||
147259368|NCT02608268|531122282|FG015|Overall Study|Physician Decision|0|||
147259369|NCT02608268|531122283|FG016|Overall Study|Physician Decision|0|||
147259370|NCT02608268|531122284|FG017|Overall Study|Physician Decision|0|||
147259371|NCT02608268|531122285|FG018|Overall Study|Physician Decision|0|||
147259372|NCT02608268|531122286|FG019|Overall Study|Physician Decision|0|||
147259373|NCT02608268|531122287|FG020|Overall Study|Physician Decision|0|||
147259374|NCT02608268|531122288|FG021|Overall Study|Physician Decision|0|||
147259375|NCT02608268|531122289|FG022|Overall Study|Physician Decision|1|||
147259376|NCT02608268|531122290|FG023|Overall Study|Physician Decision|1|||
147259377|NCT02608268|531122291|FG024|Overall Study|Physician Decision|1|||
147259378|NCT02608268|531122292|FG025|Overall Study|Physician Decision|0|||
147259379|NCT02608268|531122293|FG026|Overall Study|Physician Decision|0|||
147259380|NCT02608268|531122294|FG027|Overall Study|Physician Decision|2|||
147259381|NCT02608268|531122295|FG028|Overall Study|Physician Decision|1|||
147259382|NCT02608268|531122296|FG029|Overall Study|Physician Decision|1|||
147259383|NCT02608268|531122267|FG000|Overall Study|Progressive disease|12|||
147259384|NCT02608268|531122268|FG001|Overall Study|Progressive disease|8|||
147259385|NCT02608268|531122269|FG002|Overall Study|Progressive disease|13|||
147259386|NCT02608268|531122270|FG003|Overall Study|Progressive disease|5|||
147259387|NCT02608268|531122271|FG004|Overall Study|Progressive disease|2|||
147259388|NCT02608268|531122272|FG005|Overall Study|Progressive disease|4|||
147259389|NCT02608268|531122273|FG006|Overall Study|Progressive disease|6|||
147259390|NCT02608268|531122274|FG007|Overall Study|Progressive disease|2|||
147259391|NCT02608268|531122275|FG008|Overall Study|Progressive disease|5|||
147259392|NCT02608268|531122276|FG009|Overall Study|Progressive disease|6|||
147599616|NCT01096368|532352459|FG001|Overall Study|Progressive disease|6|||
147259393|NCT02608268|531122277|FG010|Overall Study|Progressive disease|5|||
147259394|NCT02608268|531122278|FG011|Overall Study|Progressive disease|5|||
147259395|NCT02608268|531122279|FG012|Overall Study|Progressive disease|4|||
147450062|NCT05630937|531811355|FG002|Overall Study|Enrolled but not treated|0|||
147259396|NCT02608268|531122280|FG013|Overall Study|Progressive disease|11|||
147259397|NCT02608268|531122281|FG014|Overall Study|Progressive disease|6|||
147259398|NCT02608268|531122282|FG015|Overall Study|Progressive disease|3|||
147259399|NCT02608268|531122283|FG016|Overall Study|Progressive disease|5|||
147259400|NCT02608268|531122284|FG017|Overall Study|Progressive disease|5|||
147259401|NCT02608268|531122285|FG018|Overall Study|Progressive disease|5|||
147259402|NCT02608268|531122286|FG019|Overall Study|Progressive disease|2|||
147259403|NCT02608268|531122287|FG020|Overall Study|Progressive disease|10|||
147259404|NCT02608268|531122288|FG021|Overall Study|Progressive disease|4|||
147259405|NCT02608268|531122289|FG022|Overall Study|Progressive disease|5|||
147259406|NCT02608268|531122290|FG023|Overall Study|Progressive disease|5|||
147259407|NCT02608268|531122291|FG024|Overall Study|Progressive disease|3|||
147259408|NCT02608268|531122292|FG025|Overall Study|Progressive disease|11|||
147259409|NCT02608268|531122293|FG026|Overall Study|Progressive disease|16|||
147259410|NCT02608268|531122294|FG027|Overall Study|Progressive disease|11|||
147259411|NCT02608268|531122295|FG028|Overall Study|Progressive disease|10|||
147259412|NCT02608268|531122296|FG029|Overall Study|Progressive disease|15|||
147259413|NCT02608268|531122267|FG000|Overall Study|Subject/guardian decision|1|||
147259414|NCT02608268|531122268|FG001|Overall Study|Subject/guardian decision|1|||
147259415|NCT02608268|531122269|FG002|Overall Study|Subject/guardian decision|2|||
147259416|NCT02608268|531122270|FG003|Overall Study|Subject/guardian decision|0|||
147259417|NCT02608268|531122271|FG004|Overall Study|Subject/guardian decision|0|||
147259418|NCT02608268|531122272|FG005|Overall Study|Subject/guardian decision|0|||
147259419|NCT02608268|531122273|FG006|Overall Study|Subject/guardian decision|0|||
147259420|NCT02608268|531122274|FG007|Overall Study|Subject/guardian decision|0|||
147259421|NCT02608268|531122275|FG008|Overall Study|Subject/guardian decision|2|||
147599617|NCT01096368|532352460|FG002|Overall Study|Progressive disease|0|||
147599618|NCT01096368|532352461|FG003|Overall Study|Progressive disease|10|||
147599619|NCT01096368|532352462|FG004|Overall Study|Progressive disease|3|||
147259422|NCT02608268|531122276|FG009|Overall Study|Subject/guardian decision|2|||
147259423|NCT02608268|531122277|FG010|Overall Study|Subject/guardian decision|0|||
147259424|NCT02608268|531122278|FG011|Overall Study|Subject/guardian decision|1|||
147259425|NCT02608268|531122279|FG012|Overall Study|Subject/guardian decision|0|||
147259426|NCT02608268|531122280|FG013|Overall Study|Subject/guardian decision|1|||
147259427|NCT02608268|531122281|FG014|Overall Study|Subject/guardian decision|0|||
147259428|NCT02608268|531122282|FG015|Overall Study|Subject/guardian decision|1|||
147259429|NCT02608268|531122283|FG016|Overall Study|Subject/guardian decision|0|||
147259430|NCT02608268|531122284|FG017|Overall Study|Subject/guardian decision|0|||
147259431|NCT02608268|531122285|FG018|Overall Study|Subject/guardian decision|1|||
147259432|NCT02608268|531122286|FG019|Overall Study|Subject/guardian decision|0|||
147259433|NCT02608268|531122287|FG020|Overall Study|Subject/guardian decision|0|||
147259434|NCT02608268|531122288|FG021|Overall Study|Subject/guardian decision|0|||
147259435|NCT02608268|531122289|FG022|Overall Study|Subject/guardian decision|1|||
147259436|NCT02608268|531122290|FG023|Overall Study|Subject/guardian decision|0|||
147259437|NCT02608268|531122291|FG024|Overall Study|Subject/guardian decision|0|||
147259438|NCT02608268|531122292|FG025|Overall Study|Subject/guardian decision|1|||
147599620|NCT01096368|532352458|FG000|Overall Study|Other|0|||
147259439|NCT02608268|531122293|FG026|Overall Study|Subject/guardian decision|1|||
147259440|NCT02608268|531122294|FG027|Overall Study|Subject/guardian decision|1|||
147259441|NCT02608268|531122295|FG028|Overall Study|Subject/guardian decision|1|||
147599621|NCT01096368|532352459|FG001|Overall Study|Other|0|||
147599622|NCT01096368|532352460|FG002|Overall Study|Other|1|||
147259442|NCT02608268|531122296|FG029|Overall Study|Subject/guardian decision|0|||
147259443|NCT00706641|531122301|FG000|Dasatinib Administration|Withdrawal by Subject|1|||
147259444|NCT00706641|531122301|FG000|Dasatinib Administration|Ineligible after start of therapy|1|||
147259445|NCT00706641|531122301|FG000|Radical Cystectomy|Deemed unresectable upon exploration|1|||
147259446|NCT04782856|531122305|FG000|Overall Study|Withdrawal by Subject|0|||
147259447|NCT04782856|531122306|FG001|Overall Study|Withdrawal by Subject|1|||
147259448|NCT02535741|531122307|FG000|Overall Study|Adverse Event|3|||
147259449|NCT02535741|531122307|FG000|Overall Study|Withdrawal by Subject|9|||
147259450|NCT02535741|531122307|FG000|Overall Study|Lost to Follow-up|10|||
147259451|NCT02535741|531122307|FG000|Overall Study|Exclusion criteria: Bilateral implant|4|||
147259452|NCT02535741|531122307|FG000|Overall Study|Missing data|6|||
147259453|NCT01030523|531122308|FG000|Initial Study (5 Years)|Death|1|||
147259454|NCT01030523|531122309|FG001|Initial Study (5 Years)|Death|0|||
147259455|NCT01030523|531122308|FG000|Initial Study (5 Years)|Lost to Follow-up|4|||
147259456|NCT01030523|531122309|FG001|Initial Study (5 Years)|Lost to Follow-up|5|||
147259457|NCT01030523|531122308|FG000|Initial Study (5 Years)|Implant failure|1|||
147259458|NCT01030523|531122309|FG001|Initial Study (5 Years)|Implant failure|0|||
147259459|NCT01030523|531122308|FG000|Follow-up Extension (10 Years)|Lost to Follow-up|5|||
147259460|NCT01030523|531122309|FG001|Follow-up Extension (10 Years)|Lost to Follow-up|4|||
147259461|NCT01030523|531122308|FG000|Follow-up Extension (10 Years)|Withdrawal by Subject|1|||
147259462|NCT01030523|531122309|FG001|Follow-up Extension (10 Years)|Withdrawal by Subject|3|||
147259463|NCT01030523|531122308|FG000|Follow-up Extension (10 Years)|Adverse Event|1|||
147259464|NCT01030523|531122309|FG001|Follow-up Extension (10 Years)|Adverse Event|2|||
147259465|NCT00798369|531122312|FG000|Overall Study|Subject withdrew consent|0|||
147259466|NCT00798369|531122313|FG001|Overall Study|Subject withdrew consent|0|||
147259467|NCT00798369|531122314|FG002|Overall Study|Subject withdrew consent|1|||
147259468|NCT00798369|531122315|FG003|Overall Study|Subject withdrew consent|1|||
147259469|NCT00798369|531122316|FG004|Overall Study|Subject withdrew consent|0|||
147259470|NCT00798369|531122317|FG005|Overall Study|Subject withdrew consent|2|||
147259471|NCT00798369|531122312|FG000|Overall Study|Lost to Follow-up|1|||
147259472|NCT00798369|531122313|FG001|Overall Study|Lost to Follow-up|1|||
147259473|NCT00798369|531122314|FG002|Overall Study|Lost to Follow-up|1|||
147259474|NCT00798369|531122315|FG003|Overall Study|Lost to Follow-up|0|||
147259475|NCT00798369|531122316|FG004|Overall Study|Lost to Follow-up|1|||
147259476|NCT00798369|531122317|FG005|Overall Study|Lost to Follow-up|0|||
147259477|NCT00798369|531122312|FG000|Overall Study|Adminstrative problems|0|||
147259478|NCT00798369|531122313|FG001|Overall Study|Adminstrative problems|0|||
147259479|NCT00798369|531122314|FG002|Overall Study|Adminstrative problems|0|||
147259480|NCT00798369|531122315|FG003|Overall Study|Adminstrative problems|0|||
147259481|NCT00798369|531122316|FG004|Overall Study|Adminstrative problems|0|||
147259482|NCT00798369|531122317|FG005|Overall Study|Adminstrative problems|1|||
147259483|NCT01454570|531122326|FG000|Overall Study|Withdrawal by Subject|2|||
147259484|NCT01454570|531122326|FG000|Overall Study|Screen Failure|7|||
147259485|NCT03188094|531122334|FG000|Overall Study|Screen failure|1|||
147259486|NCT03188094|531122335|FG001|Overall Study|Screen failure|0|||
147259487|NCT03188094|531122336|FG002|Overall Study|Screen failure|0|||
147259488|NCT03188094|531122334|FG000|Overall Study|Pregnancy|3|||
147259489|NCT03188094|531122335|FG001|Overall Study|Pregnancy|0|||
147259490|NCT03188094|531122336|FG002|Overall Study|Pregnancy|0|||
147259491|NCT03188094|531122334|FG000|Overall Study|Ineligible|1|||
147259492|NCT03188094|531122335|FG001|Overall Study|Ineligible|0|||
147259493|NCT03188094|531122336|FG002|Overall Study|Ineligible|0|||
147259494|NCT03188094|531122334|FG000|Overall Study|Lost to Follow-up|0|||
147259495|NCT03188094|531122335|FG001|Overall Study|Lost to Follow-up|0|||
147259496|NCT03188094|531122336|FG002|Overall Study|Lost to Follow-up|17|||
147259497|NCT04007094|531122337|FG000|Overall Study|Lost to Follow-up|1|||
147259498|NCT04007094|531122338|FG001|Overall Study|Lost to Follow-up|1|||
147259499|NCT04350788|531122344|FG000|Overall Study|Lost to Follow-up|6|||
147259500|NCT04350788|531122345|FG001|Overall Study|Lost to Follow-up|2|||
147259501|NCT04350788|531122344|FG000|Overall Study|Withdrawal by Subject|2|||
147259502|NCT04350788|531122345|FG001|Overall Study|Withdrawal by Subject|4|||
147259503|NCT04350788|531122344|FG000|Overall Study|Protocol Violation|4|||
147259504|NCT04350788|531122345|FG001|Overall Study|Protocol Violation|0|||
147599623|NCT01096368|532352461|FG003|Overall Study|Other|0|||
147259505|NCT01581307|531122346|FG000|Overall Study|Withdrawal by Subject|1|||
147259506|NCT02070744|531122349|FG000|PC Phase (12 Weeks)|Randomized, but not treated|0|||
147259507|NCT02070744|531122350|FG001|PC Phase (12 Weeks)|Randomized, but not treated|0|||
147259508|NCT02070744|531122351|FG002|PC Phase (12 Weeks)|Randomized, but not treated|0|||
147259509|NCT02070744|531122352|FG003|PC Phase (12 Weeks)|Randomized, but not treated|1|||
147332810|NCT00770965|531385565|FG001|Safety Set|Withdrawal by Subject|0|||
147599624|NCT01096368|532352462|FG004|Overall Study|Other|0|||
147259510|NCT02070744|531122353|FG004|PC Phase (12 Weeks)|Randomized, but not treated|0|||
147450063|NCT05630937|531811356|FG003|Overall Study|Enrolled but not treated|1|||
147450064|NCT00267748|531811358|FG000|Non-randomized Period|Progressive disease|10|||
147450065|NCT00267748|531811359|FG001|Non-randomized Period|Progressive disease|0|||
147599625|NCT01096368|532352458|FG000|Overall Study|Treated with institutional review|0|||
147259511|NCT02070744|531122349|FG000|OLE Phase (48 Weeks)|Withdrawal by Subject|0|||
147259512|NCT02070744|531122350|FG001|OLE Phase (48 Weeks)|Withdrawal by Subject|0|||
147259513|NCT02070744|531122351|FG002|OLE Phase (48 Weeks)|Withdrawal by Subject|0|||
147259514|NCT02070744|531122352|FG003|OLE Phase (48 Weeks)|Withdrawal by Subject|0|||
147259515|NCT02070744|531122353|FG004|OLE Phase (48 Weeks)|Withdrawal by Subject|2|||
147259516|NCT02070744|531122349|FG000|OLE Phase (48 Weeks)|Other|0|||
147259517|NCT02070744|531122350|FG001|OLE Phase (48 Weeks)|Other|0|||
147259518|NCT02070744|531122351|FG002|OLE Phase (48 Weeks)|Other|0|||
147259519|NCT02070744|531122352|FG003|OLE Phase (48 Weeks)|Other|0|||
147259520|NCT02070744|531122353|FG004|OLE Phase (48 Weeks)|Other|1|||
147259521|NCT01894581|531122354|FG000|Overall Study|Withdrawal by Subject|2|||
147259522|NCT01894581|531122355|FG001|Overall Study|Withdrawal by Subject|3|||
147259523|NCT01894581|531122354|FG000|Overall Study|Screen Failure|3|||
147259524|NCT01894581|531122355|FG001|Overall Study|Screen Failure|4|||
147259525|NCT03795298|531122356|FG000|Overall Study|Death|34|||
147259526|NCT03795298|531122357|FG001|Overall Study|Death|29|||
147259527|NCT03795298|531122356|FG000|Overall Study|Death > 1095 day (not included in endpoint analyses)|1|||
147259528|NCT03795298|531122357|FG001|Overall Study|Death > 1095 day (not included in endpoint analyses)|2|||
147259529|NCT03795298|531122356|FG000|Overall Study|Lost to Follow-up|28|||
147259530|NCT03795298|531122357|FG001|Overall Study|Lost to Follow-up|17|||
147259531|NCT03795298|531122356|FG000|Overall Study|Physician Decision|5|||
147259532|NCT03795298|531122357|FG001|Overall Study|Physician Decision|4|||
147259533|NCT03795298|531122356|FG000|Overall Study|Withdrawal by Subject|43|||
147259534|NCT03795298|531122357|FG001|Overall Study|Withdrawal by Subject|28|||
147259535|NCT03795298|531122356|FG000|Overall Study|Reason not reported|7|||
147259536|NCT03795298|531122357|FG001|Overall Study|Reason not reported|9|||
147259537|NCT04383743|531122358|FG000|Overall Study|Withdrawal by Subject|1|||
147259538|NCT04383743|531122358|FG000|Overall Study|Adverse Event|1|||
147259539|NCT05478252|531122361|FG000|Overall Study|Withdrawal by Subject|2|||
147259540|NCT05478252|531122362|FG001|Overall Study|Withdrawal by Subject|3|||
147259541|NCT05478252|531122361|FG000|Overall Study|Lost to Follow-up|4|||
147259542|NCT05478252|531122362|FG001|Overall Study|Lost to Follow-up|2|||
147259543|NCT05478252|531122361|FG000|Overall Study|Physician Decision|1|||
147259544|NCT05478252|531122362|FG001|Overall Study|Physician Decision|1|||
147259545|NCT05478252|531122361|FG000|Overall Study|Death|1|||
147259546|NCT05478252|531122362|FG001|Overall Study|Death|0|||
147259547|NCT03482791|531122367|FG000|Overall Study|Patient did not start treatment due to physician decision|1|||
147259548|NCT03482791|531122368|FG001|Overall Study|Patient did not start treatment due to physician decision|0|||
147259549|NCT01816893|531122369|FG000|Washout Period|Withdrawal by Subject|2|||
147259550|NCT01816893|531122370|FG001|Washout Period|Withdrawal by Subject|0|||
147259551|NCT04475588|531124035|FG000|Overall Study|Adverse Event|2|||
147259552|NCT04475588|531124036|FG001|Overall Study|Adverse Event|0|||
147259553|NCT01327300|531124037|FG000|Washout (3 Weeks)|Withdrawal by Subject|1|||
147259554|NCT01327300|531124038|FG001|Washout (3 Weeks)|Withdrawal by Subject|0|||
147259555|NCT03020823|531124039|FG000|Overall Study|Physician Decision|4|||
147259556|NCT03020823|531124039|FG000|Overall Study|Lack of Efficacy|4|||
147259557|NCT03020823|531124039|FG000|Overall Study|Adverse Event|2|||
147259558|NCT03739112|531124040|FG000|Overall Study|Adverse Event|2|||
147259559|NCT03739112|531124041|FG001|Overall Study|Adverse Event|2|||
147259560|NCT03739112|531124040|FG000|Overall Study|Withdrawal by Subject|38|||
147259561|NCT03739112|531124041|FG001|Overall Study|Withdrawal by Subject|19|||
147259562|NCT03739112|531124040|FG000|Overall Study|Lost to Follow-up|31|||
147259563|NCT03739112|531124041|FG001|Overall Study|Lost to Follow-up|33|||
147259564|NCT03739112|531124040|FG000|Overall Study|Protocol Deviation|12|||
147259565|NCT03739112|531124041|FG001|Overall Study|Protocol Deviation|9|||
147259566|NCT03739112|531124040|FG000|Overall Study|Physician Decision|1|||
147259567|NCT03739112|531124041|FG001|Overall Study|Physician Decision|0|||
147259568|NCT03739112|531124040|FG000|Overall Study|Death (Classified as Withdrawn from the Study by the Investigator as a Result of Death)|12|||
147259569|NCT03739112|531124041|FG001|Overall Study|Death (Classified as Withdrawn from the Study by the Investigator as a Result of Death)|16|||
147259570|NCT03739112|531124040|FG000|Overall Study|Site went on hold|65|||
147259571|NCT03739112|531124041|FG001|Overall Study|Site went on hold|67|||
147259572|NCT03739112|531124040|FG000|Overall Study|Other than specified|8|||
147259573|NCT03739112|531124041|FG001|Overall Study|Other than specified|5|||
147259574|NCT03739112|531124040|FG000|Overall Study|Randomized but not vaccinated|31|||
147259575|NCT03739112|531124041|FG001|Overall Study|Randomized but not vaccinated|25|||
147259576|NCT00588822|531124043|FG000|Overall Study|progression of disease|8|||
147259577|NCT04762680|531124045|FG000|Phase 2|Adverse Event|0|||
147259578|NCT04762680|531124046|FG001|Phase 2|Adverse Event|1|||
147259579|NCT04762680|531124047|FG002|Phase 2|Adverse Event|0|||
147259580|NCT04762680|531124048|FG003|Phase 2|Adverse Event|0|||
147332811|NCT00770965|531385566|FG002|Safety Set|Withdrawal by Subject|0|||
147599626|NCT01096368|532352459|FG001|Overall Study|Treated with institutional review|0|||
147259581|NCT04762680|531124049|FG004|Phase 2|Adverse Event|0|||
147259582|NCT04762680|531124050|FG005|Phase 2|Adverse Event|0|||
147259583|NCT04762680|531124051|FG006|Phase 2|Adverse Event|0|||
147259584|NCT04762680|531124052|FG007|Phase 2|Adverse Event|0|||
147259585|NCT04762680|531124053|FG008|Phase 2|Adverse Event|0|||
147259586|NCT04762680|531124054|FG009|Phase 2|Adverse Event|0|||
147259587|NCT04762680|531124055|FG010|Phase 2|Adverse Event|0|||
147259588|NCT04762680|531124056|FG011|Phase 2|Adverse Event|0|||
147259589|NCT04762680|531124057|FG012|Phase 2|Adverse Event|0|||
147259590|NCT04762680|531124058|FG013|Phase 2|Adverse Event|0|||
147259591|NCT04762680|531124059|FG014|Phase 2|Adverse Event|0|||
147259592|NCT04762680|531124060|FG015|Phase 2|Adverse Event|0|||
147259593|NCT04762680|531124061|FG016|Phase 2|Adverse Event|0|||
147259594|NCT04762680|531124062|FG017|Phase 2|Adverse Event|0|||
147259595|NCT04762680|531124063|FG018|Phase 2|Adverse Event|0|||
147259596|NCT04762680|531124064|FG019|Phase 2|Adverse Event|0|||
147259597|NCT04762680|531124065|FG020|Phase 2|Adverse Event|0|||
147259598|NCT04762680|531124066|FG021|Phase 2|Adverse Event|0|||
147259599|NCT04762680|531124045|FG000|Phase 2|Protocol Violation|5|||
147259600|NCT04762680|531124046|FG001|Phase 2|Protocol Violation|5|||
147259601|NCT04762680|531124047|FG002|Phase 2|Protocol Violation|1|||
147259602|NCT04762680|531124048|FG003|Phase 2|Protocol Violation|0|||
147259603|NCT04762680|531124049|FG004|Phase 2|Protocol Violation|0|||
147259604|NCT04762680|531124050|FG005|Phase 2|Protocol Violation|0|||
147259605|NCT04762680|531124051|FG006|Phase 2|Protocol Violation|0|||
147259606|NCT04762680|531124052|FG007|Phase 2|Protocol Violation|0|||
147259607|NCT04762680|531124053|FG008|Phase 2|Protocol Violation|0|||
147259608|NCT04762680|531124054|FG009|Phase 2|Protocol Violation|0|||
147259609|NCT04762680|531124055|FG010|Phase 2|Protocol Violation|0|||
147259610|NCT04762680|531124056|FG011|Phase 2|Protocol Violation|0|||
147259611|NCT04762680|531124057|FG012|Phase 2|Protocol Violation|0|||
147259612|NCT04762680|531124058|FG013|Phase 2|Protocol Violation|0|||
147259613|NCT04762680|531124059|FG014|Phase 2|Protocol Violation|0|||
147259614|NCT04762680|531124060|FG015|Phase 2|Protocol Violation|0|||
147259615|NCT04762680|531124061|FG016|Phase 2|Protocol Violation|0|||
147259616|NCT04762680|531124062|FG017|Phase 2|Protocol Violation|0|||
147259617|NCT04762680|531124063|FG018|Phase 2|Protocol Violation|0|||
147259618|NCT04762680|531124064|FG019|Phase 2|Protocol Violation|0|||
147259619|NCT04762680|531124065|FG020|Phase 2|Protocol Violation|0|||
147259620|NCT04762680|531124066|FG021|Phase 2|Protocol Violation|0|||
147259621|NCT04762680|531124045|FG000|Phase 2|Withdrawal by Subject|23|||
147259622|NCT04762680|531124046|FG001|Phase 2|Withdrawal by Subject|21|||
147259623|NCT04762680|531124047|FG002|Phase 2|Withdrawal by Subject|28|||
147259624|NCT04762680|531124048|FG003|Phase 2|Withdrawal by Subject|0|||
147259625|NCT04762680|531124049|FG004|Phase 2|Withdrawal by Subject|0|||
147259626|NCT04762680|531124050|FG005|Phase 2|Withdrawal by Subject|0|||
147259627|NCT04762680|531124051|FG006|Phase 2|Withdrawal by Subject|0|||
147259628|NCT04762680|531124052|FG007|Phase 2|Withdrawal by Subject|0|||
147259629|NCT04762680|531124053|FG008|Phase 2|Withdrawal by Subject|0|||
147259630|NCT04762680|531124054|FG009|Phase 2|Withdrawal by Subject|0|||
147259631|NCT04762680|531124055|FG010|Phase 2|Withdrawal by Subject|0|||
147259632|NCT04762680|531124056|FG011|Phase 2|Withdrawal by Subject|0|||
147259633|NCT04762680|531124057|FG012|Phase 2|Withdrawal by Subject|0|||
147259634|NCT04762680|531124058|FG013|Phase 2|Withdrawal by Subject|0|||
147259635|NCT04762680|531124059|FG014|Phase 2|Withdrawal by Subject|0|||
147259636|NCT04762680|531124060|FG015|Phase 2|Withdrawal by Subject|0|||
147259637|NCT04762680|531124061|FG016|Phase 2|Withdrawal by Subject|0|||
147259638|NCT04762680|531124062|FG017|Phase 2|Withdrawal by Subject|0|||
147259639|NCT04762680|531124063|FG018|Phase 2|Withdrawal by Subject|0|||
147259640|NCT04762680|531124064|FG019|Phase 2|Withdrawal by Subject|0|||
147259641|NCT04762680|531124065|FG020|Phase 2|Withdrawal by Subject|0|||
147259642|NCT04762680|531124066|FG021|Phase 2|Withdrawal by Subject|0|||
147259643|NCT04762680|531124045|FG000|Phase 2|Lost to Follow-up|14|||
147259644|NCT04762680|531124046|FG001|Phase 2|Lost to Follow-up|8|||
147259645|NCT04762680|531124047|FG002|Phase 2|Lost to Follow-up|9|||
147259646|NCT04762680|531124048|FG003|Phase 2|Lost to Follow-up|0|||
147259647|NCT04762680|531124049|FG004|Phase 2|Lost to Follow-up|0|||
147259648|NCT04762680|531124050|FG005|Phase 2|Lost to Follow-up|0|||
147259649|NCT04762680|531124051|FG006|Phase 2|Lost to Follow-up|0|||
147259650|NCT04762680|531124052|FG007|Phase 2|Lost to Follow-up|0|||
147259651|NCT04762680|531124053|FG008|Phase 2|Lost to Follow-up|0|||
147259652|NCT04762680|531124054|FG009|Phase 2|Lost to Follow-up|0|||
147259653|NCT04762680|531124055|FG010|Phase 2|Lost to Follow-up|0|||
147259654|NCT04762680|531124056|FG011|Phase 2|Lost to Follow-up|0|||
147259655|NCT04762680|531124057|FG012|Phase 2|Lost to Follow-up|0|||
147259656|NCT04762680|531124058|FG013|Phase 2|Lost to Follow-up|0|||
147259657|NCT04762680|531124059|FG014|Phase 2|Lost to Follow-up|0|||
147259658|NCT04762680|531124060|FG015|Phase 2|Lost to Follow-up|0|||
147259659|NCT04762680|531124061|FG016|Phase 2|Lost to Follow-up|0|||
147259660|NCT04762680|531124062|FG017|Phase 2|Lost to Follow-up|0|||
147259661|NCT04762680|531124063|FG018|Phase 2|Lost to Follow-up|0|||
147259662|NCT04762680|531124064|FG019|Phase 2|Lost to Follow-up|0|||
147259663|NCT04762680|531124065|FG020|Phase 2|Lost to Follow-up|0|||
147599627|NCT01096368|532352460|FG002|Overall Study|Treated with institutional review|0|||
147599628|NCT01096368|532352461|FG003|Overall Study|Treated with institutional review|0|||
147259664|NCT04762680|531124066|FG021|Phase 2|Lost to Follow-up|0|||
147259665|NCT04762680|531124045|FG000|Phase 3|Adverse Event|0|||
147259666|NCT04762680|531124046|FG001|Phase 3|Adverse Event|0|||
147259667|NCT04762680|531124047|FG002|Phase 3|Adverse Event|0|||
147259668|NCT04762680|531124048|FG003|Phase 3|Adverse Event|1|||
147259669|NCT04762680|531124049|FG004|Phase 3|Adverse Event|0|||
147259670|NCT04762680|531124050|FG005|Phase 3|Adverse Event|0|||
147259671|NCT04762680|531124051|FG006|Phase 3|Adverse Event|0|||
147259672|NCT04762680|531124052|FG007|Phase 3|Adverse Event|0|||
147259673|NCT04762680|531124053|FG008|Phase 3|Adverse Event|0|||
147259674|NCT04762680|531124054|FG009|Phase 3|Adverse Event|0|||
147259675|NCT04762680|531124055|FG010|Phase 3|Adverse Event|0|||
147259676|NCT04762680|531124056|FG011|Phase 3|Adverse Event|0|||
147259677|NCT04762680|531124057|FG012|Phase 3|Adverse Event|0|||
147259678|NCT04762680|531124058|FG013|Phase 3|Adverse Event|0|||
147259679|NCT04762680|531124059|FG014|Phase 3|Adverse Event|0|||
147259680|NCT04762680|531124060|FG015|Phase 3|Adverse Event|0|||
147259681|NCT04762680|531124061|FG016|Phase 3|Adverse Event|0|||
147259682|NCT04762680|531124062|FG017|Phase 3|Adverse Event|3|||
147259683|NCT04762680|531124063|FG018|Phase 3|Adverse Event|0|||
147259684|NCT04762680|531124064|FG019|Phase 3|Adverse Event|0|||
147259685|NCT04762680|531124065|FG020|Phase 3|Adverse Event|0|||
147259686|NCT04762680|531124066|FG021|Phase 3|Adverse Event|0|||
147259687|NCT04762680|531124045|FG000|Phase 3|Protocol Violation|0|||
147259688|NCT04762680|531124046|FG001|Phase 3|Protocol Violation|0|||
147259689|NCT04762680|531124047|FG002|Phase 3|Protocol Violation|0|||
147259690|NCT04762680|531124048|FG003|Phase 3|Protocol Violation|4|||
147259691|NCT04762680|531124049|FG004|Phase 3|Protocol Violation|1|||
147259692|NCT04762680|531124050|FG005|Phase 3|Protocol Violation|5|||
147259693|NCT04762680|531124051|FG006|Phase 3|Protocol Violation|1|||
147259694|NCT04762680|531124052|FG007|Phase 3|Protocol Violation|0|||
147259695|NCT04762680|531124053|FG008|Phase 3|Protocol Violation|0|||
147259696|NCT04762680|531124054|FG009|Phase 3|Protocol Violation|0|||
147259697|NCT04762680|531124055|FG010|Phase 3|Protocol Violation|0|||
147259698|NCT04762680|531124056|FG011|Phase 3|Protocol Violation|2|||
147259699|NCT04762680|531124057|FG012|Phase 3|Protocol Violation|3|||
147259700|NCT04762680|531124058|FG013|Phase 3|Protocol Violation|0|||
147259701|NCT04762680|531124059|FG014|Phase 3|Protocol Violation|0|||
147259702|NCT04762680|531124060|FG015|Phase 3|Protocol Violation|1|||
147259703|NCT04762680|531124061|FG016|Phase 3|Protocol Violation|0|||
147259704|NCT04762680|531124062|FG017|Phase 3|Protocol Violation|10|||
147259705|NCT04762680|531124063|FG018|Phase 3|Protocol Violation|0|||
147259706|NCT04762680|531124064|FG019|Phase 3|Protocol Violation|0|||
147259707|NCT04762680|531124065|FG020|Phase 3|Protocol Violation|0|||
147259708|NCT04762680|531124066|FG021|Phase 3|Protocol Violation|0|||
147259709|NCT04762680|531124045|FG000|Phase 3|Withdrawal by Subject|0|||
147259710|NCT04762680|531124046|FG001|Phase 3|Withdrawal by Subject|0|||
147259711|NCT04762680|531124047|FG002|Phase 3|Withdrawal by Subject|0|||
147259712|NCT04762680|531124048|FG003|Phase 3|Withdrawal by Subject|13|||
147259713|NCT04762680|531124049|FG004|Phase 3|Withdrawal by Subject|17|||
147259714|NCT04762680|531124050|FG005|Phase 3|Withdrawal by Subject|12|||
147259715|NCT04762680|531124051|FG006|Phase 3|Withdrawal by Subject|8|||
147259716|NCT04762680|531124052|FG007|Phase 3|Withdrawal by Subject|3|||
147259717|NCT04762680|531124053|FG008|Phase 3|Withdrawal by Subject|2|||
147259718|NCT04762680|531124054|FG009|Phase 3|Withdrawal by Subject|4|||
147259719|NCT04762680|531124055|FG010|Phase 3|Withdrawal by Subject|3|||
147259720|NCT04762680|531124056|FG011|Phase 3|Withdrawal by Subject|1|||
147259721|NCT04762680|531124057|FG012|Phase 3|Withdrawal by Subject|3|||
147259722|NCT04762680|531124058|FG013|Phase 3|Withdrawal by Subject|2|||
147259723|NCT04762680|531124059|FG014|Phase 3|Withdrawal by Subject|1|||
147259724|NCT04762680|531124060|FG015|Phase 3|Withdrawal by Subject|4|||
147259725|NCT04762680|531124061|FG016|Phase 3|Withdrawal by Subject|6|||
147259726|NCT04762680|531124062|FG017|Phase 3|Withdrawal by Subject|32|||
147259727|NCT04762680|531124063|FG018|Phase 3|Withdrawal by Subject|0|||
147259728|NCT04762680|531124064|FG019|Phase 3|Withdrawal by Subject|0|||
147259729|NCT04762680|531124065|FG020|Phase 3|Withdrawal by Subject|0|||
147332812|NCT00770965|531385567|FG003|Safety Set|Withdrawal by Subject|1|||
147599629|NCT01096368|532352462|FG004|Overall Study|Treated with institutional review|1|||
147259730|NCT04762680|531124066|FG021|Phase 3|Withdrawal by Subject|0|||
147259731|NCT04762680|531124045|FG000|Phase 3|Lost to Follow-up|0|||
147259732|NCT04762680|531124046|FG001|Phase 3|Lost to Follow-up|0|||
147259733|NCT04762680|531124047|FG002|Phase 3|Lost to Follow-up|0|||
147259734|NCT04762680|531124048|FG003|Phase 3|Lost to Follow-up|9|||
147259735|NCT04762680|531124049|FG004|Phase 3|Lost to Follow-up|22|||
147259736|NCT04762680|531124050|FG005|Phase 3|Lost to Follow-up|24|||
147259737|NCT04762680|531124051|FG006|Phase 3|Lost to Follow-up|2|||
147259738|NCT04762680|531124052|FG007|Phase 3|Lost to Follow-up|4|||
147259739|NCT04762680|531124053|FG008|Phase 3|Lost to Follow-up|6|||
147259740|NCT04762680|531124054|FG009|Phase 3|Lost to Follow-up|4|||
147259741|NCT04762680|531124055|FG010|Phase 3|Lost to Follow-up|3|||
147259742|NCT04762680|531124056|FG011|Phase 3|Lost to Follow-up|0|||
147259743|NCT04762680|531124057|FG012|Phase 3|Lost to Follow-up|5|||
147259744|NCT04762680|531124058|FG013|Phase 3|Lost to Follow-up|4|||
147259745|NCT04762680|531124059|FG014|Phase 3|Lost to Follow-up|6|||
147259746|NCT04762680|531124060|FG015|Phase 3|Lost to Follow-up|1|||
147259747|NCT04762680|531124061|FG016|Phase 3|Lost to Follow-up|1|||
147259748|NCT04762680|531124062|FG017|Phase 3|Lost to Follow-up|66|||
147259749|NCT04762680|531124063|FG018|Phase 3|Lost to Follow-up|0|||
147259750|NCT04762680|531124064|FG019|Phase 3|Lost to Follow-up|0|||
147259751|NCT04762680|531124065|FG020|Phase 3|Lost to Follow-up|0|||
147259752|NCT04762680|531124066|FG021|Phase 3|Lost to Follow-up|0|||
147259753|NCT04762680|531124045|FG000|Phase 3 - Exploratory|Withdrawal by Subject|0|||
147259754|NCT04762680|531124046|FG001|Phase 3 - Exploratory|Withdrawal by Subject|0|||
147259755|NCT04762680|531124047|FG002|Phase 3 - Exploratory|Withdrawal by Subject|0|||
147259756|NCT04762680|531124048|FG003|Phase 3 - Exploratory|Withdrawal by Subject|0|||
147259757|NCT04762680|531124049|FG004|Phase 3 - Exploratory|Withdrawal by Subject|0|||
147259758|NCT04762680|531124050|FG005|Phase 3 - Exploratory|Withdrawal by Subject|0|||
147259759|NCT04762680|531124051|FG006|Phase 3 - Exploratory|Withdrawal by Subject|0|||
147259760|NCT04762680|531124052|FG007|Phase 3 - Exploratory|Withdrawal by Subject|0|||
147259761|NCT04762680|531124053|FG008|Phase 3 - Exploratory|Withdrawal by Subject|0|||
147599630|NCT06354998|532352463|FG000|Overall Study|Withdrawal by Subject|3|||
147599631|NCT06354998|532352464|FG001|Overall Study|Withdrawal by Subject|0|||
147599632|NCT01568320|532352465|FG000|Overall Study|Death|20|||
147599633|NCT01568320|532352465|FG000|Overall Study|Lost to Follow-up|9|||
147599634|NCT01568320|532352465|FG000|Overall Study|Withdrawal by Subject|10|||
147599635|NCT01568320|532352465|FG000|Overall Study|Conversion to open repair|1|||
147259762|NCT04762680|531124054|FG009|Phase 3 - Exploratory|Withdrawal by Subject|0|||
147259763|NCT04762680|531124055|FG010|Phase 3 - Exploratory|Withdrawal by Subject|0|||
147259764|NCT04762680|531124056|FG011|Phase 3 - Exploratory|Withdrawal by Subject|0|||
147259765|NCT04762680|531124057|FG012|Phase 3 - Exploratory|Withdrawal by Subject|0|||
147259766|NCT04762680|531124058|FG013|Phase 3 - Exploratory|Withdrawal by Subject|0|||
147259767|NCT04762680|531124059|FG014|Phase 3 - Exploratory|Withdrawal by Subject|0|||
147259768|NCT04762680|531124060|FG015|Phase 3 - Exploratory|Withdrawal by Subject|0|||
147259769|NCT04762680|531124061|FG016|Phase 3 - Exploratory|Withdrawal by Subject|0|||
147259770|NCT04762680|531124062|FG017|Phase 3 - Exploratory|Withdrawal by Subject|0|||
147259771|NCT04762680|531124063|FG018|Phase 3 - Exploratory|Withdrawal by Subject|0|||
147259772|NCT04762680|531124064|FG019|Phase 3 - Exploratory|Withdrawal by Subject|0|||
147259773|NCT04762680|531124065|FG020|Phase 3 - Exploratory|Withdrawal by Subject|0|||
147259774|NCT04762680|531124066|FG021|Phase 3 - Exploratory|Withdrawal by Subject|1|||
147259775|NCT04762680|531124045|FG000|Phase 3 - Exploratory|Lost to Follow-up|0|||
147259776|NCT04762680|531124046|FG001|Phase 3 - Exploratory|Lost to Follow-up|0|||
147259777|NCT04762680|531124047|FG002|Phase 3 - Exploratory|Lost to Follow-up|0|||
147259778|NCT04762680|531124048|FG003|Phase 3 - Exploratory|Lost to Follow-up|0|||
147259779|NCT04762680|531124049|FG004|Phase 3 - Exploratory|Lost to Follow-up|0|||
147259780|NCT04762680|531124050|FG005|Phase 3 - Exploratory|Lost to Follow-up|0|||
147259781|NCT04762680|531124051|FG006|Phase 3 - Exploratory|Lost to Follow-up|0|||
147259782|NCT04762680|531124052|FG007|Phase 3 - Exploratory|Lost to Follow-up|0|||
147259783|NCT04762680|531124053|FG008|Phase 3 - Exploratory|Lost to Follow-up|0|||
147259784|NCT04762680|531124054|FG009|Phase 3 - Exploratory|Lost to Follow-up|0|||
147259785|NCT04762680|531124055|FG010|Phase 3 - Exploratory|Lost to Follow-up|0|||
147259786|NCT04762680|531124056|FG011|Phase 3 - Exploratory|Lost to Follow-up|0|||
147259787|NCT04762680|531124057|FG012|Phase 3 - Exploratory|Lost to Follow-up|0|||
147259788|NCT04762680|531124058|FG013|Phase 3 - Exploratory|Lost to Follow-up|0|||
147259789|NCT04762680|531124059|FG014|Phase 3 - Exploratory|Lost to Follow-up|0|||
147259790|NCT04762680|531124060|FG015|Phase 3 - Exploratory|Lost to Follow-up|0|||
147259791|NCT04762680|531124061|FG016|Phase 3 - Exploratory|Lost to Follow-up|0|||
147259792|NCT04762680|531124062|FG017|Phase 3 - Exploratory|Lost to Follow-up|0|||
147259793|NCT04762680|531124063|FG018|Phase 3 - Exploratory|Lost to Follow-up|0|||
147259794|NCT04762680|531124064|FG019|Phase 3 - Exploratory|Lost to Follow-up|1|||
147259795|NCT04762680|531124065|FG020|Phase 3 - Exploratory|Lost to Follow-up|0|||
147259796|NCT04762680|531124066|FG021|Phase 3 - Exploratory|Lost to Follow-up|0|||
147259797|NCT02082210|531124067|FG000|Overall Study|Death|0|||
147259798|NCT02082210|531124068|FG001|Overall Study|Death|0|||
147259799|NCT02082210|531124069|FG002|Overall Study|Death|1|||
147259800|NCT02082210|531124070|FG003|Overall Study|Death|1|||
147259801|NCT02082210|531124071|FG004|Overall Study|Death|1|||
147259802|NCT02082210|531124072|FG005|Overall Study|Death|0|||
147259803|NCT02082210|531124067|FG000|Overall Study|Withdrawal by Subject|0|||
147259804|NCT02082210|531124068|FG001|Overall Study|Withdrawal by Subject|0|||
147259805|NCT02082210|531124069|FG002|Overall Study|Withdrawal by Subject|0|||
147259806|NCT02082210|531124070|FG003|Overall Study|Withdrawal by Subject|1|||
147259807|NCT02082210|531124071|FG004|Overall Study|Withdrawal by Subject|2|||
147259808|NCT02082210|531124072|FG005|Overall Study|Withdrawal by Subject|2|||
147259809|NCT02082210|531124067|FG000|Overall Study|Clinical Progression|0|||
147259810|NCT02082210|531124068|FG001|Overall Study|Clinical Progression|0|||
147643969|NCT02255552|532516685|FG001|Overall Study|Withdrawal by Subject|4|||
147259811|NCT02082210|531124069|FG002|Overall Study|Clinical Progression|0|||
147259812|NCT02082210|531124070|FG003|Overall Study|Clinical Progression|1|||
147259813|NCT02082210|531124071|FG004|Overall Study|Clinical Progression|0|||
147259814|NCT02082210|531124072|FG005|Overall Study|Clinical Progression|0|||
147259815|NCT02082210|531124067|FG000|Overall Study|No Post-Baseline Tumor Assesment|0|||
147259816|NCT02082210|531124068|FG001|Overall Study|No Post-Baseline Tumor Assesment|0|||
147259817|NCT02082210|531124069|FG002|Overall Study|No Post-Baseline Tumor Assesment|1|||
147259818|NCT02082210|531124070|FG003|Overall Study|No Post-Baseline Tumor Assesment|2|||
147259819|NCT02082210|531124071|FG004|Overall Study|No Post-Baseline Tumor Assesment|0|||
147259820|NCT02082210|531124072|FG005|Overall Study|No Post-Baseline Tumor Assesment|0|||
147259821|NCT02082210|531124067|FG000|Overall Study|Physician Decision|0|||
147259822|NCT02082210|531124068|FG001|Overall Study|Physician Decision|0|||
147259823|NCT02082210|531124069|FG002|Overall Study|Physician Decision|1|||
147259824|NCT02082210|531124070|FG003|Overall Study|Physician Decision|1|||
147259825|NCT02082210|531124071|FG004|Overall Study|Physician Decision|0|||
147259826|NCT02082210|531124072|FG005|Overall Study|Physician Decision|0|||
147259827|NCT02436759|531124077|FG000|Overall Study|Adverse Event|3|||
147259828|NCT02436759|531124078|FG001|Overall Study|Adverse Event|0|||
147259829|NCT02436759|531124077|FG000|Overall Study|Protocol Violation|1|||
147259830|NCT02436759|531124078|FG001|Overall Study|Protocol Violation|0|||
147259831|NCT02436759|531124077|FG000|Overall Study|Withdrawal by Subject|0|||
147259832|NCT02436759|531124078|FG001|Overall Study|Withdrawal by Subject|1|||
147259833|NCT01727141|531124079|FG000|Overall Study|Physician Decision|0|||
147259834|NCT01727141|531124080|FG001|Overall Study|Physician Decision|1|||
147259835|NCT01727141|531124081|FG002|Overall Study|Physician Decision|0|||
147259836|NCT01727141|531124082|FG003|Overall Study|Physician Decision|2|||
147259837|NCT01727141|531124079|FG000|Overall Study|Lost to Follow-up|0|||
147259838|NCT01727141|531124080|FG001|Overall Study|Lost to Follow-up|2|||
147259839|NCT01727141|531124081|FG002|Overall Study|Lost to Follow-up|0|||
147259840|NCT01727141|531124082|FG003|Overall Study|Lost to Follow-up|0|||
147259841|NCT01727141|531124079|FG000|Overall Study|Death|0|||
147259842|NCT01727141|531124080|FG001|Overall Study|Death|1|||
147259843|NCT01727141|531124081|FG002|Overall Study|Death|1|||
147259844|NCT01727141|531124082|FG003|Overall Study|Death|1|||
147259845|NCT01727141|531124079|FG000|Overall Study|Protocol deviation|1|||
147259846|NCT01727141|531124080|FG001|Overall Study|Protocol deviation|1|||
147259847|NCT01727141|531124081|FG002|Overall Study|Protocol deviation|0|||
147259848|NCT01727141|531124082|FG003|Overall Study|Protocol deviation|1|||
147259849|NCT01727141|531124079|FG000|Overall Study|Withdrawal by Subject|4|||
147259850|NCT01727141|531124080|FG001|Overall Study|Withdrawal by Subject|4|||
147259851|NCT01727141|531124081|FG002|Overall Study|Withdrawal by Subject|2|||
147259852|NCT01727141|531124082|FG003|Overall Study|Withdrawal by Subject|11|||
147259853|NCT02584504|531124083|FG000|Double-blind Treatment|Participant withdrew consent|0|||
147259854|NCT02584504|531124084|FG001|Double-blind Treatment|Participant withdrew consent|0|||
147259855|NCT02584504|531124085|FG002|Double-blind Treatment|Participant withdrew consent|1|||
147259856|NCT02584504|531124083|FG000|Double-blind Treatment|Adverse Event|0|||
147259857|NCT02584504|531124084|FG001|Double-blind Treatment|Adverse Event|1|||
147259858|NCT02584504|531124085|FG002|Double-blind Treatment|Adverse Event|0|||
147259859|NCT02584504|531124083|FG000|Double-blind Treatment|Family Matter|0|||
147259860|NCT02584504|531124084|FG001|Double-blind Treatment|Family Matter|1|||
147259861|NCT02584504|531124085|FG002|Double-blind Treatment|Family Matter|0|||
147259862|NCT02584504|531124083|FG000|Open-label Treatment|Participant withdrew consent|0|||
147259863|NCT02584504|531124084|FG001|Open-label Treatment|Participant withdrew consent|0|||
147259864|NCT02584504|531124085|FG002|Open-label Treatment|Participant withdrew consent|4|||
147259865|NCT02584504|531124083|FG000|Open-label Treatment|Adverse Event|2|||
147259866|NCT02584504|531124084|FG001|Open-label Treatment|Adverse Event|2|||
147259867|NCT02584504|531124085|FG002|Open-label Treatment|Adverse Event|3|||
147259868|NCT02584504|531124083|FG000|Open-label Treatment|Physician Decision|0|||
147259869|NCT02584504|531124084|FG001|Open-label Treatment|Physician Decision|1|||
147259870|NCT02584504|531124085|FG002|Open-label Treatment|Physician Decision|0|||
147259871|NCT02584504|531124083|FG000|Open-label Treatment|Entered but not treated|0|||
147259872|NCT02584504|531124084|FG001|Open-label Treatment|Entered but not treated|1|||
147259873|NCT02584504|531124085|FG002|Open-label Treatment|Entered but not treated|1|||
147259874|NCT01290666|531124087|FG000|Overall Study|Lost to Follow-up|11|||
147259875|NCT01290666|531124087|FG000|Overall Study|Withdrawal by Subject|23|||
147259876|NCT01290666|531124087|FG000|Overall Study|Early Termination of Study|4|||
147259877|NCT01652664|531124090|FG000|Overall Study|Treatment Failure|5|||
147259878|NCT01652664|531124091|FG001|Overall Study|Treatment Failure|1|||
147259879|NCT01652664|531124090|FG000|Overall Study|Inadequate IOP control|1|||
147259880|NCT01652664|531124091|FG001|Overall Study|Inadequate IOP control|0|||
147259881|NCT00297037|531124092|FG000|Overall Study|Withdrawal by Subject|2|||
147259882|NCT00297037|531124093|FG001|Overall Study|Withdrawal by Subject|0|||
147259883|NCT00581776|531124094|FG000|Overall Study|Disease progression or no response|3|||
147259884|NCT03538158|531124095|FG000|Overall Study|Lost to Follow-up|13|||
147259885|NCT03538158|531124096|FG001|Overall Study|Lost to Follow-up|7|||
147259886|NCT03538158|531124095|FG000|Overall Study|Withdrawal by Subject|2|||
147259887|NCT03538158|531124096|FG001|Overall Study|Withdrawal by Subject|1|||
147259888|NCT03425331|531124097|FG000|Overall Study|Withdrawal by Subject|1|||
147259889|NCT03425331|531124097|FG000|Overall Study|Death|1|||
147599636|NCT01568320|532352465|FG000|Overall Study|Patient fell outside of the consented window, data outside of the consented 5-year was not collected|1|||
147599637|NCT01616953|532352466|FG000|Overall Study|Lost to Follow-up|1|||
147599638|NCT01616953|532352467|FG001|Overall Study|Lost to Follow-up|0|||
147599639|NCT01616953|532352466|FG000|Overall Study|lack of bone and soft tissue|1|||
147259890|NCT03425331|531124097|FG000|Overall Study|Adverse Event|1|||
147259891|NCT03425331|531124097|FG000|Overall Study|Disease Progression|2|||
147259892|NCT01413360|531124100|FG000|Overall Study|Lost to Follow-up|2|||
147259893|NCT01413360|531124100|FG000|Overall Study|Adverse Event|1|||
147259894|NCT02246673|531124103|FG000|Overall Study|Sponsor Decision|1|||
147259895|NCT02246673|531124104|FG001|Overall Study|Sponsor Decision|0|||
147259896|NCT02246673|531124105|FG002|Overall Study|Sponsor Decision|0|||
147259897|NCT02246673|531124106|FG003|Overall Study|Sponsor Decision|0|||
147259898|NCT02246673|531124107|FG004|Overall Study|Sponsor Decision|0|||
147259899|NCT02246673|531124103|FG000|Overall Study|Withdrawal by Subject|0|||
147259900|NCT02246673|531124104|FG001|Overall Study|Withdrawal by Subject|0|||
147259901|NCT02246673|531124105|FG002|Overall Study|Withdrawal by Subject|0|||
147259902|NCT02246673|531124106|FG003|Overall Study|Withdrawal by Subject|0|||
147259903|NCT02246673|531124107|FG004|Overall Study|Withdrawal by Subject|1|||
147259904|NCT02246673|531124103|FG000|Overall Study|Lost to Follow-up|0|||
147259905|NCT02246673|531124104|FG001|Overall Study|Lost to Follow-up|0|||
147259906|NCT02246673|531124105|FG002|Overall Study|Lost to Follow-up|0|||
147259907|NCT02246673|531124106|FG003|Overall Study|Lost to Follow-up|1|||
147259908|NCT02246673|531124107|FG004|Overall Study|Lost to Follow-up|0|||
147259909|NCT02246673|531124103|FG000|Overall Study|Protocol Violation|0|||
147259910|NCT02246673|531124104|FG001|Overall Study|Protocol Violation|0|||
147259911|NCT02246673|531124105|FG002|Overall Study|Protocol Violation|0|||
147259912|NCT02246673|531124106|FG003|Overall Study|Protocol Violation|1|||
147259913|NCT02246673|531124107|FG004|Overall Study|Protocol Violation|0|||
147259914|NCT02418468|531124109|FG000|Overall Study|Adverse Event|1|||
147259915|NCT02418468|531124110|FG001|Overall Study|Adverse Event|0|||
147259916|NCT02418468|531124109|FG000|Overall Study|Withdrawal of informed consent|1|||
147259917|NCT02418468|531124110|FG001|Overall Study|Withdrawal of informed consent|1|||
147259918|NCT02914769|531124111|FG000|Overall Study|Protocol Violation|3|||
147259919|NCT02914769|531124112|FG001|Overall Study|Protocol Violation|2|||
147259920|NCT02914769|531124111|FG000|Overall Study|Withdrawal by Subject|0|||
147259921|NCT02914769|531124112|FG001|Overall Study|Withdrawal by Subject|1|||
147259922|NCT04356963|531124116|FG000|First Session|Withdrawal by Subject|1|||
147259923|NCT04356963|531124116|FG000|Second Session|Withdrawal by Subject|3|||
147259924|NCT04356963|531124116|FG000|Second Session|Lost to Follow-up|1|||
147259925|NCT04356963|531124116|FG000|Third Session|Lost to Follow-up|6|||
147259926|NCT04356963|531124116|FG000|Third Session|Withdrawal by Subject|1|||
147259927|NCT00099437|531124118|FG000|Overall Study|Lost to Follow-up|30|||
147259928|NCT00099437|531124119|FG001|Overall Study|Lost to Follow-up|33|||
147259929|NCT00099437|531124118|FG000|Overall Study|Death|293|||
147259930|NCT00099437|531124119|FG001|Overall Study|Death|261|||
147259931|NCT00099437|531124118|FG000|Overall Study|Withdrawal by Subject|6|||
147259932|NCT00099437|531124119|FG001|Overall Study|Withdrawal by Subject|10|||
147259933|NCT00099437|531124118|FG000|Overall Study|Ongoing in FU but not on treatment|37|||
147259934|NCT00099437|531124119|FG001|Overall Study|Ongoing in FU but not on treatment|45|||
147259935|NCT02410954|531124120|FG000|Overall Study|Unable to collect usable data due to initial protocol issues|6|||
147259936|NCT02410954|531124121|FG001|Overall Study|Unable to collect usable data due to initial protocol issues|0|||
147259937|NCT02410954|531124120|FG000|Overall Study|Instrument malfunction generated unusable data|8|||
147259938|NCT02410954|531124121|FG001|Overall Study|Instrument malfunction generated unusable data|0|||
147259939|NCT02738333|531124122|FG000|Overall Study|Death|1|||
147259940|NCT02738333|531124123|FG001|Overall Study|Death|0|||
147259941|NCT02738333|531124124|FG002|Overall Study|Death|0|||
147259942|NCT02738333|531124122|FG000|Overall Study|Lost to Follow-up|1|||
147259943|NCT02738333|531124123|FG001|Overall Study|Lost to Follow-up|0|||
147259944|NCT02738333|531124124|FG002|Overall Study|Lost to Follow-up|0|||
147259945|NCT00791518|531124125|FG000|Overall Study|Protocol Violation|93|||
147259946|NCT02488681|531124126|FG000|Overall Study|Implant unsuccessful|7|||
147599640|NCT01616953|532352467|FG001|Overall Study|lack of bone and soft tissue|0|||
147259947|NCT05413369|531124127|FG000|Overall Study|Adverse Event|1|||
147259948|NCT05413369|531124128|FG001|Overall Study|Adverse Event|1|||
147259949|NCT05413369|531124127|FG000|Overall Study|Withdrawal by Subject|13|||
147259950|NCT05413369|531124128|FG001|Overall Study|Withdrawal by Subject|4|||
147259951|NCT05413369|531124127|FG000|Overall Study|Non-compliance with study schedule|2|||
147259952|NCT05413369|531124128|FG001|Overall Study|Non-compliance with study schedule|1|||
147259953|NCT05413369|531124127|FG000|Overall Study|Other|1|||
147259954|NCT05413369|531124128|FG001|Overall Study|Other|1|||
147259955|NCT02809677|531124130|FG000|Overall Study|Withdrawal by Subject|8|||
147259956|NCT00720057|531124133|FG000|Overall Study|Lost to Follow-up|0|||
147259957|NCT00720057|531124134|FG001|Overall Study|Lost to Follow-up|2|||
147259958|NCT00720057|531124133|FG000|Overall Study|Protocol Violation|1|||
147259959|NCT00720057|531124134|FG001|Overall Study|Protocol Violation|0|||
147259960|NCT00720057|531124133|FG000|Overall Study|Withdrawal by Subject|0|||
147259961|NCT00720057|531124134|FG001|Overall Study|Withdrawal by Subject|1|||
147259962|NCT04969224|531124137|FG000|Overall Study|Adverse Event|1|||
147259963|NCT04969224|531124137|FG000|Overall Study|Enrolled but never dosed|1|||
147259964|NCT01498952|531124142|FG000|Overall Study|Death|2|||
147259965|NCT01498952|531124143|FG001|Overall Study|Death|2|||
147259966|NCT01498952|531124144|FG002|Overall Study|Death|0|||
147259967|NCT01498952|531124145|FG003|Overall Study|Death|0|||
147259968|NCT01498952|531124146|FG004|Overall Study|Death|0|||
147259969|NCT02726074|531124147|FG000|Overall Study|Withdrawal by Subject|4|||
147259970|NCT02726074|531124147|FG000|Overall Study|Adverse Event|14|||
147259971|NCT02726074|531124147|FG000|Overall Study|Protocol Violation|3|||
147259972|NCT02726074|531124147|FG000|Overall Study|Lost to Follow-up|2|||
147259973|NCT02726074|531124147|FG000|Overall Study|Others|3|||
147259974|NCT00579826|531124148|FG000|Overall Study|Withdrawal by Subject|5|||
147259975|NCT00579826|531124149|FG001|Overall Study|Withdrawal by Subject|3|||
147259976|NCT01679002|531124150|FG000|Overall Study|Adverse Event|1|||
147259977|NCT01679002|531124151|FG001|Overall Study|Adverse Event|1|||
147259978|NCT01679002|531124152|FG002|Overall Study|Adverse Event|0|||
147259979|NCT05172544|531124153|FG000|Overall Study|Withdrawal by Subject|1|||
147259980|NCT05172544|531124154|FG001|Overall Study|Withdrawal by Subject|0|||
147259981|NCT05172544|531124155|FG002|Overall Study|Withdrawal by Subject|0|||
147259982|NCT05172544|531124153|FG000|Overall Study|Physician Decision|0|||
147259983|NCT05172544|531124154|FG001|Overall Study|Physician Decision|0|||
147259984|NCT05172544|531124155|FG002|Overall Study|Physician Decision|1|||
147259985|NCT00454987|531124156|FG000|Booster Period (NCT00258700)|Adverse Event|1|||
147259986|NCT00454987|531124157|FG001|Booster Period (NCT00258700)|Adverse Event|0|||
147259987|NCT00454987|531124158|FG002|Booster Period (NCT00258700)|Adverse Event|0|||
147259988|NCT00454987|531124156|FG000|Booster Period (NCT00258700)|Withdrawal by Subject|0|||
147259989|NCT00454987|531124157|FG001|Booster Period (NCT00258700)|Withdrawal by Subject|1|||
147259990|NCT00454987|531124158|FG002|Booster Period (NCT00258700)|Withdrawal by Subject|0|||
147259991|NCT00454987|531124156|FG000|Booster Period (NCT00258700)|Lost to Follow-up|1|||
147259992|NCT00454987|531124157|FG001|Booster Period (NCT00258700)|Lost to Follow-up|0|||
147259993|NCT00454987|531124158|FG002|Booster Period (NCT00258700)|Lost to Follow-up|0|||
147259994|NCT01176266|531124159|FG000|Overall Study|Death|6|||
147259995|NCT01176266|531124159|FG000|Overall Study|Withdrawal by Subject|3|||
147259996|NCT02642432|531124160|FG000|Overall Study|Adverse Event|2|||
147259997|NCT02642432|531124160|FG000|Overall Study|Withdrew Consent|1|||
147259998|NCT02642432|531124160|FG000|Overall Study|Lost to Follow-up|2|||
147259999|NCT02642432|531124160|FG000|Overall Study|Other|3|||
147260000|NCT03999892|531124161|FG000|Overall Study|Lost to Follow-up|1|||
147260001|NCT01848756|531124162|FG000|Overall Study|Adverse Event|1|||
147260002|NCT01848756|531124162|FG000|Overall Study|Withdrawal by Subject|1|||
147260003|NCT01848756|531124162|FG000|Overall Study|Enrolled in Error|1|||
147260004|NCT03245008|531124163|FG000|Overall Study|Adverse Event|15|||
147260005|NCT03245008|531124164|FG001|Overall Study|Adverse Event|18|||
147260006|NCT03245008|531124165|FG002|Overall Study|Adverse Event|15|||
147260007|NCT03245008|531124166|FG003|Overall Study|Adverse Event|0|||
147260008|NCT03245008|531124167|FG004|Overall Study|Adverse Event|1|||
147260009|NCT03245008|531124163|FG000|Overall Study|Lack of Efficacy|0|||
147260010|NCT03245008|531124164|FG001|Overall Study|Lack of Efficacy|1|||
147260011|NCT03245008|531124165|FG002|Overall Study|Lack of Efficacy|0|||
147260012|NCT03245008|531124166|FG003|Overall Study|Lack of Efficacy|0|||
147260013|NCT03245008|531124167|FG004|Overall Study|Lack of Efficacy|0|||
147260014|NCT03245008|531124163|FG000|Overall Study|Lost to Follow-up|4|||
147260015|NCT03245008|531124164|FG001|Overall Study|Lost to Follow-up|1|||
147260016|NCT03245008|531124165|FG002|Overall Study|Lost to Follow-up|0|||
147260017|NCT03245008|531124166|FG003|Overall Study|Lost to Follow-up|0|||
147260018|NCT03245008|531124167|FG004|Overall Study|Lost to Follow-up|1|||
147260019|NCT03245008|531124163|FG000|Overall Study|Physician Decision|1|||
147260020|NCT03245008|531124164|FG001|Overall Study|Physician Decision|3|||
147260021|NCT03245008|531124165|FG002|Overall Study|Physician Decision|4|||
147260022|NCT03245008|531124166|FG003|Overall Study|Physician Decision|0|||
147260023|NCT03245008|531124167|FG004|Overall Study|Physician Decision|0|||
147599641|NCT00816361|532352469|FG000|Overall Study|Withdrawal by Subject|0|||
147260024|NCT03245008|531124163|FG000|Overall Study|Protocol Violation|0|||
147260025|NCT03245008|531124164|FG001|Overall Study|Protocol Violation|1|||
147260026|NCT03245008|531124165|FG002|Overall Study|Protocol Violation|0|||
147260027|NCT03245008|531124166|FG003|Overall Study|Protocol Violation|0|||
147260028|NCT03245008|531124167|FG004|Overall Study|Protocol Violation|0|||
147260029|NCT03245008|531124163|FG000|Overall Study|Withdrawal by Subject|20|||
147260030|NCT03245008|531124164|FG001|Overall Study|Withdrawal by Subject|19|||
147599642|NCT00816361|532352470|FG001|Overall Study|Withdrawal by Subject|0|||
147260031|NCT03245008|531124165|FG002|Overall Study|Withdrawal by Subject|11|||
147260032|NCT03245008|531124166|FG003|Overall Study|Withdrawal by Subject|0|||
147260033|NCT03245008|531124167|FG004|Overall Study|Withdrawal by Subject|0|||
147260034|NCT03245008|531124163|FG000|Overall Study|Discontinuation of 3 mg q4w and 6 mg q8w doses|0|||
147599643|NCT00816361|532352471|FG002|Overall Study|Withdrawal by Subject|0|||
147260035|NCT03245008|531124164|FG001|Overall Study|Discontinuation of 3 mg q4w and 6 mg q8w doses|0|||
147260036|NCT03245008|531124165|FG002|Overall Study|Discontinuation of 3 mg q4w and 6 mg q8w doses|0|||
147260037|NCT03245008|531124166|FG003|Overall Study|Discontinuation of 3 mg q4w and 6 mg q8w doses|27|||
147260038|NCT03245008|531124167|FG004|Overall Study|Discontinuation of 3 mg q4w and 6 mg q8w doses|27|||
147260039|NCT03245008|531124163|FG000|Overall Study|Failure to meet randomization criteria|0|||
147260040|NCT03245008|531124164|FG001|Overall Study|Failure to meet randomization criteria|1|||
147260041|NCT03245008|531124165|FG002|Overall Study|Failure to meet randomization criteria|0|||
147260042|NCT03245008|531124166|FG003|Overall Study|Failure to meet randomization criteria|1|||
147260043|NCT03245008|531124167|FG004|Overall Study|Failure to meet randomization criteria|0|||
147260044|NCT02075658|531124168|FG000|Overall Study|Physician Decision|2|||
147260045|NCT02075658|531124169|FG001|Overall Study|Physician Decision|2|||
147260046|NCT01286012|531124170|FG000|Overall Study|Adverse Event|3|||
147260047|NCT01286012|531124171|FG001|Overall Study|Adverse Event|3|||
147260048|NCT01286012|531124170|FG000|Overall Study|Death|2|||
147260049|NCT01286012|531124171|FG001|Overall Study|Death|3|||
147260050|NCT01286012|531124170|FG000|Overall Study|Protocol Violation|1|||
147260051|NCT01286012|531124171|FG001|Overall Study|Protocol Violation|1|||
147260052|NCT01286012|531124170|FG000|Overall Study|Withdrawal by Subject|4|||
147260053|NCT01286012|531124171|FG001|Overall Study|Withdrawal by Subject|4|||
147260054|NCT01286012|531124170|FG000|Overall Study|Physician Decision|2|||
147260055|NCT01286012|531124171|FG001|Overall Study|Physician Decision|0|||
147260056|NCT01286012|531124170|FG000|Overall Study|peritoneal dialysis, randomized in error|1|||
147260057|NCT01286012|531124171|FG001|Overall Study|peritoneal dialysis, randomized in error|3|||
147260058|NCT01602380|531124175|FG000|Overall Study|Death|147|||
147260059|NCT01602380|531124176|FG001|Overall Study|Death|145|||
147260060|NCT01602380|531124175|FG000|Overall Study|Withdrawal by Subject|39|||
147260061|NCT01602380|531124176|FG001|Overall Study|Withdrawal by Subject|41|||
147260062|NCT01602380|531124175|FG000|Overall Study|Lost to Follow-up|15|||
147260063|NCT01602380|531124176|FG001|Overall Study|Lost to Follow-up|12|||
147260064|NCT01602380|531124175|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
147260065|NCT01602380|531124176|FG001|Overall Study|Eligibility criteria not fulfilled|3|||
147260066|NCT01602380|531124175|FG000|Overall Study|Other|2|||
147260067|NCT01602380|531124176|FG001|Overall Study|Other|0|||
147260068|NCT04307446|531126317|FG000|Overall Study|Lost to Follow-up|2|||
147260069|NCT04307446|531126318|FG001|Overall Study|Lost to Follow-up|0|||
147260070|NCT01063764|531126322|FG000|1st Period (From Week 8 to Week 22)|Adverse Event|4|||
147260071|NCT01063764|531126322|FG000|1st Period (From Week 8 to Week 22)|Lack of Efficacy|6|||
147260072|NCT01063764|531126322|FG000|1st Period (From Week 8 to Week 22)|Withdrawal by Subject|1|||
147260073|NCT01063764|531126322|FG000|2nd Period (Week 22 to the End of Study)|Adverse Event|3|||
147260074|NCT01063764|531126322|FG000|2nd Period (Week 22 to the End of Study)|Lack of Efficacy|9|||
147260075|NCT01063764|531126322|FG000|2nd Period (Week 22 to the End of Study)|Withdrawal by Subject|7|||
147260076|NCT01063764|531126322|FG000|2nd Period (Week 22 to the End of Study)|Protocol Violation|1|||
147260077|NCT00697515|531126323|FG000|Dose Optimization Period|Adverse Event|4|||
147260078|NCT00697515|531126324|FG001|Dose Optimization Period|Adverse Event|0|||
147260079|NCT00697515|531126323|FG000|Dose Optimization Period|Withdrawal by Subject|5|||
147260080|NCT00697515|531126324|FG001|Dose Optimization Period|Withdrawal by Subject|0|||
147260081|NCT00697515|531126323|FG000|Dose Optimization Period|Lost to Follow-up|2|||
147260082|NCT00697515|531126324|FG001|Dose Optimization Period|Lost to Follow-up|0|||
147260083|NCT00697515|531126323|FG000|Dose Optimization Period|sponsor request|2|||
147260084|NCT00697515|531126324|FG001|Dose Optimization Period|sponsor request|0|||
147260085|NCT00697515|531126323|FG000|Dose Optimization Period|called to active duty|1|||
147260086|NCT00697515|531126324|FG001|Dose Optimization Period|called to active duty|0|||
147260087|NCT00697515|531126323|FG000|Dose Optimization Period|elevated QTc|1|||
147260088|NCT00697515|531126324|FG001|Dose Optimization Period|elevated QTc|0|||
147260089|NCT00697515|531126323|FG000|First Intervention (Crossover Period)|Natural disaster|8|||
147260090|NCT00697515|531126324|FG001|First Intervention (Crossover Period)|Natural disaster|9|||
147260091|NCT00697515|531126323|FG000|First Intervention (Crossover Period)|Adverse Event|0|||
147260092|NCT00697515|531126324|FG001|First Intervention (Crossover Period)|Adverse Event|2|||
147260093|NCT00697515|531126323|FG000|First Intervention (Crossover Period)|Withdrawal by Subject|2|||
147260094|NCT00697515|531126324|FG001|First Intervention (Crossover Period)|Withdrawal by Subject|1|||
147260095|NCT00697515|531126323|FG000|Second Intervention (Crossover Period)|Withdrawal by Subject|1|||
147260096|NCT00697515|531126324|FG001|Second Intervention (Crossover Period)|Withdrawal by Subject|1|||
147260097|NCT02205333|531126330|FG000|Overall Study|Death|5|||
147260098|NCT02205333|531126331|FG001|Overall Study|Death|6|||
147260099|NCT02205333|531126332|FG002|Overall Study|Death|2|||
147260100|NCT02205333|531126333|FG003|Overall Study|Death|6|||
147260101|NCT02205333|531126334|FG004|Overall Study|Death|5|||
147599644|NCT00816361|532352472|FG003|Overall Study|Withdrawal by Subject|0|||
147260102|NCT02205333|531126335|FG005|Overall Study|Death|3|||
147332813|NCT00770965|531385564|FG000|Safety Set|Protocol deviation|0|||
147599645|NCT00816361|532352473|FG004|Overall Study|Withdrawal by Subject|1|||
147260103|NCT02205333|531126336|FG006|Overall Study|Death|3|||
147599646|NCT00816361|532352474|FG005|Overall Study|Withdrawal by Subject|2|||
147260104|NCT02205333|531126337|FG007|Overall Study|Death|2|||
147260105|NCT02205333|531126338|FG008|Overall Study|Death|0|||
147260106|NCT02205333|531126330|FG000|Overall Study|Withdrawal by Subject|1|||
147260107|NCT02205333|531126331|FG001|Overall Study|Withdrawal by Subject|0|||
147260108|NCT02205333|531126332|FG002|Overall Study|Withdrawal by Subject|0|||
147260109|NCT02205333|531126333|FG003|Overall Study|Withdrawal by Subject|1|||
147260110|NCT02205333|531126334|FG004|Overall Study|Withdrawal by Subject|0|||
147260111|NCT02205333|531126335|FG005|Overall Study|Withdrawal by Subject|0|||
147260112|NCT02205333|531126336|FG006|Overall Study|Withdrawal by Subject|2|||
147260113|NCT02205333|531126337|FG007|Overall Study|Withdrawal by Subject|0|||
147260114|NCT02205333|531126338|FG008|Overall Study|Withdrawal by Subject|0|||
147260115|NCT03054870|531126340|FG000|Day of Ventilation Imaging|Protocol Violation|4|||
147260116|NCT03054870|531126340|FG000|Day of Ventilation Imaging|Lost to Follow-up|1|||
147260117|NCT02009046|531126341|FG000|Overall Study|Lost to Follow-up|256|||
147260118|NCT02009046|531126342|FG001|Overall Study|Lost to Follow-up|206|||
147260119|NCT00304356|531126344|FG000|Nitazoxanide|Physician Decision|5|||
147260120|NCT00304356|531126344|FG000|Nitazoxanide|Physician Decision|1|||
147260121|NCT00304356|531126344|FG000|Nitazoxanide|number is 0|1|||
147260122|NCT00304356|531126344|FG000|Nitazoxanide|Physician Decision|1|||
147260123|NCT00304356|531126344|FG000|Nitazoxanide|Physician Decision|1|||
147260124|NCT00304356|531126344|FG000|Nitazoxanide|Physician Decision|1|||
147260125|NCT04120974|531126348|FG000|Overall Study|Death|1|||
147260126|NCT04120974|531126348|FG000|Overall Study|Physician Decision|1|||
147260127|NCT04120974|531126348|FG000|Overall Study|Lost to Follow-up|6|||
147260128|NCT00973479|531126351|FG000|Overall Study|Lost to Follow-up|0|||
147260129|NCT00973479|531126352|FG001|Overall Study|Lost to Follow-up|3|||
147260130|NCT00973479|531126351|FG000|Overall Study|Death|2|||
147260131|NCT00973479|531126352|FG001|Overall Study|Death|2|||
147260132|NCT00973479|531126351|FG000|Overall Study|Withdrawal by Subject|15|||
147260133|NCT00973479|531126352|FG001|Overall Study|Withdrawal by Subject|16|||
147260134|NCT00973479|531126351|FG000|Overall Study|Lack of Efficacy|5|||
147260135|NCT00973479|531126352|FG001|Overall Study|Lack of Efficacy|7|||
147260136|NCT00973479|531126351|FG000|Overall Study|Adverse Event|12|||
147260137|NCT00973479|531126352|FG001|Overall Study|Adverse Event|32|||
147260138|NCT00973479|531126351|FG000|Overall Study|Protocol Violation|2|||
147260139|NCT00973479|531126352|FG001|Overall Study|Protocol Violation|2|||
147260140|NCT00973479|531126351|FG000|Overall Study|Other|1|||
147260141|NCT00973479|531126352|FG001|Overall Study|Other|7|||
147260142|NCT05075850|531126353|FG000|Overall Study|Did not completed follow-up questionnaires|34|||
147260143|NCT04256785|531126354|FG000|Overall Study|Adverse Event|8|||
147260144|NCT04256785|531126355|FG001|Overall Study|Adverse Event|6|||
147260145|NCT04256785|531126354|FG000|Overall Study|Lack of Efficacy|3|||
147260146|NCT04256785|531126355|FG001|Overall Study|Lack of Efficacy|4|||
147260147|NCT04256785|531126354|FG000|Overall Study|Lost to Follow-up|7|||
147260148|NCT04256785|531126355|FG001|Overall Study|Lost to Follow-up|7|||
147260149|NCT04256785|531126354|FG000|Overall Study|Protocol Violation|1|||
147260150|NCT04256785|531126355|FG001|Overall Study|Protocol Violation|0|||
147260151|NCT04256785|531126354|FG000|Overall Study|Withdrawal by Subject|4|||
147260152|NCT04256785|531126355|FG001|Overall Study|Withdrawal by Subject|1|||
147260153|NCT04256785|531126354|FG000|Overall Study|Surgery or quarantined due to Covid-19|5|||
147260154|NCT04256785|531126355|FG001|Overall Study|Surgery or quarantined due to Covid-19|7|||
147260155|NCT01154218|531126356|FG000|Third Intervention Period|Adverse Event|0|||
147260156|NCT01154218|531126357|FG001|Third Intervention Period|Adverse Event|1|||
147260157|NCT01154218|531126358|FG002|Third Intervention Period|Adverse Event|0|||
147260158|NCT01154218|531126359|FG003|Third Intervention Period|Adverse Event|0|||
147260159|NCT01154218|531126356|FG000|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
147260160|NCT01154218|531126357|FG001|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
147260161|NCT01154218|531126358|FG002|Washout Period (at Least 14 Days)|Withdrawal by Subject|0|||
147260162|NCT01154218|531126359|FG003|Washout Period (at Least 14 Days)|Withdrawal by Subject|1|||
147260163|NCT01154218|531126356|FG000|Fourth Intervention Period|Withdrawal by Subject|1|||
147260164|NCT01154218|531126357|FG001|Fourth Intervention Period|Withdrawal by Subject|0|||
147260165|NCT01154218|531126358|FG002|Fourth Intervention Period|Withdrawal by Subject|0|||
147260166|NCT01154218|531126359|FG003|Fourth Intervention Period|Withdrawal by Subject|0|||
147260167|NCT01265849|531126360|FG000|Overall Study|Randomized//Treatment not initiated|1|||
147260168|NCT01265849|531126361|FG001|Overall Study|Randomized//Treatment not initiated|4|||
147260169|NCT01265849|531126362|FG002|Overall Study|Randomized//Treatment not initiated|0|||
147260170|NCT01265849|531126360|FG000|Overall Study|Physician Decision|1|||
147260171|NCT01265849|531126361|FG001|Overall Study|Physician Decision|2|||
147260172|NCT01265849|531126362|FG002|Overall Study|Physician Decision|0|||
147260173|NCT01265849|531126360|FG000|Overall Study|Lost to Follow-up|18|||
147260174|NCT01265849|531126361|FG001|Overall Study|Lost to Follow-up|15|||
147260175|NCT01265849|531126362|FG002|Overall Study|Lost to Follow-up|5|||
147260176|NCT01265849|531126360|FG000|Overall Study|Not otherwise specified|1|||
147260177|NCT01265849|531126361|FG001|Overall Study|Not otherwise specified|6|||
147332814|NCT00770965|531385565|FG001|Safety Set|Protocol deviation|0|||
147260178|NCT01265849|531126362|FG002|Overall Study|Not otherwise specified|1|||
147260179|NCT01265849|531126360|FG000|Overall Study|Withdrawal by Subject|25|||
147260180|NCT01265849|531126361|FG001|Overall Study|Withdrawal by Subject|34|||
147260181|NCT01265849|531126362|FG002|Overall Study|Withdrawal by Subject|13|||
147260182|NCT00362115|531126363|FG000|Overall Study|Adverse Event|0|||
147260183|NCT00362115|531126364|FG001|Overall Study|Adverse Event|1|||
147260184|NCT00362115|531126365|FG002|Overall Study|Adverse Event|1|||
147260185|NCT00362115|531126366|FG003|Overall Study|Adverse Event|1|||
147260186|NCT00362115|531126367|FG004|Overall Study|Adverse Event|2|||
147260187|NCT00362115|531126368|FG005|Overall Study|Adverse Event|2|||
147260188|NCT00362115|531126369|FG006|Overall Study|Adverse Event|1|||
147260189|NCT00362115|531126363|FG000|Overall Study|Protocol Violation|0|||
147260190|NCT00362115|531126364|FG001|Overall Study|Protocol Violation|0|||
147260191|NCT00362115|531126365|FG002|Overall Study|Protocol Violation|0|||
147260192|NCT00362115|531126366|FG003|Overall Study|Protocol Violation|0|||
147260193|NCT00362115|531126367|FG004|Overall Study|Protocol Violation|0|||
147260194|NCT00362115|531126368|FG005|Overall Study|Protocol Violation|1|||
147260195|NCT00362115|531126369|FG006|Overall Study|Protocol Violation|0|||
147260196|NCT00362115|531126363|FG000|Overall Study|Lost to Follow-up|0|||
147260197|NCT00362115|531126364|FG001|Overall Study|Lost to Follow-up|1|||
147260198|NCT00362115|531126365|FG002|Overall Study|Lost to Follow-up|0|||
147260199|NCT00362115|531126366|FG003|Overall Study|Lost to Follow-up|0|||
147260200|NCT00362115|531126367|FG004|Overall Study|Lost to Follow-up|2|||
147260201|NCT00362115|531126368|FG005|Overall Study|Lost to Follow-up|0|||
147260202|NCT00362115|531126369|FG006|Overall Study|Lost to Follow-up|1|||
147260203|NCT00362115|531126363|FG000|Overall Study|Withdrawal by Subject|1|||
147260204|NCT00362115|531126364|FG001|Overall Study|Withdrawal by Subject|3|||
147260205|NCT00362115|531126365|FG002|Overall Study|Withdrawal by Subject|1|||
147260206|NCT00362115|531126366|FG003|Overall Study|Withdrawal by Subject|0|||
147260207|NCT00362115|531126367|FG004|Overall Study|Withdrawal by Subject|1|||
147260208|NCT00362115|531126368|FG005|Overall Study|Withdrawal by Subject|3|||
147260209|NCT00362115|531126369|FG006|Overall Study|Withdrawal by Subject|4|||
147260210|NCT00362115|531126363|FG000|Overall Study|Lack of Efficacy|1|||
147260211|NCT00362115|531126364|FG001|Overall Study|Lack of Efficacy|0|||
147450066|NCT00267748|531811360|FG002|Non-randomized Period|Progressive disease|0|||
147450067|NCT00267748|531811358|FG000|Non-randomized Period|Adverse Event|8|||
147450068|NCT00267748|531811359|FG001|Non-randomized Period|Adverse Event|0|||
147450069|NCT00267748|531811360|FG002|Non-randomized Period|Adverse Event|0|||
147260212|NCT00362115|531126365|FG002|Overall Study|Lack of Efficacy|5|||
147260213|NCT00362115|531126366|FG003|Overall Study|Lack of Efficacy|2|||
147450070|NCT00267748|531811358|FG000|Non-randomized Period|Death|1|||
147450071|NCT00267748|531811359|FG001|Non-randomized Period|Death|0|||
147450072|NCT00267748|531811360|FG002|Non-randomized Period|Death|0|||
147450073|NCT00267748|531811358|FG000|Non-randomized Period|Participant not willing to participate|1|||
147450074|NCT00267748|531811359|FG001|Non-randomized Period|Participant not willing to participate|0|||
147450075|NCT00267748|531811360|FG002|Non-randomized Period|Participant not willing to participate|0|||
147450076|NCT00267748|531811358|FG000|Non-randomized Period|Other|3|||
147450077|NCT00267748|531811359|FG001|Non-randomized Period|Other|0|||
147450078|NCT00267748|531811360|FG002|Non-randomized Period|Other|0|||
147450079|NCT00267748|531811358|FG000|Randomized Period|Death|0|||
147450080|NCT00267748|531811359|FG001|Randomized Period|Death|2|||
147450081|NCT00267748|531811360|FG002|Randomized Period|Death|3|||
147450082|NCT00267748|531811358|FG000|Randomized Period|Adverse Event|0|||
147450083|NCT00267748|531811359|FG001|Randomized Period|Adverse Event|23|||
147260214|NCT00362115|531126367|FG004|Overall Study|Lack of Efficacy|2|||
147260215|NCT00362115|531126368|FG005|Overall Study|Lack of Efficacy|0|||
147260216|NCT00362115|531126369|FG006|Overall Study|Lack of Efficacy|3|||
147260217|NCT00362115|531126363|FG000|Overall Study|Physician Decision|0|||
147260218|NCT00362115|531126364|FG001|Overall Study|Physician Decision|0|||
147260219|NCT00362115|531126365|FG002|Overall Study|Physician Decision|0|||
147260220|NCT00362115|531126366|FG003|Overall Study|Physician Decision|0|||
147260221|NCT00362115|531126367|FG004|Overall Study|Physician Decision|0|||
147260222|NCT00362115|531126368|FG005|Overall Study|Physician Decision|0|||
147260223|NCT00362115|531126369|FG006|Overall Study|Physician Decision|3|||
147450084|NCT00267748|531811360|FG002|Randomized Period|Adverse Event|25|||
147260224|NCT00362115|531126363|FG000|Overall Study|Other|0|||
147450085|NCT00267748|531811358|FG000|Randomized Period|Global deterioration of health status|0|||
147260225|NCT00362115|531126364|FG001|Overall Study|Other|1|||
147260226|NCT00362115|531126365|FG002|Overall Study|Other|0|||
147450086|NCT00267748|531811359|FG001|Randomized Period|Global deterioration of health status|6|||
147260227|NCT00362115|531126366|FG003|Overall Study|Other|1|||
147260228|NCT00362115|531126367|FG004|Overall Study|Other|0|||
147450087|NCT00267748|531811360|FG002|Randomized Period|Global deterioration of health status|7|||
147450088|NCT00267748|531811358|FG000|Randomized Period|Lost to Follow-up|0|||
147450089|NCT00267748|531811359|FG001|Randomized Period|Lost to Follow-up|1|||
147260229|NCT00362115|531126368|FG005|Overall Study|Other|1|||
147260230|NCT00362115|531126369|FG006|Overall Study|Other|0|||
147260231|NCT01170091|531126371|FG000|Overall Study|Missing efficacy evaluation|3|||
147260232|NCT01170091|531126371|FG000|Overall Study|Treatment duration is less than 4 weeks|21|||
147260233|NCT03194321|531126372|FG000|Overall Study|Withdrawal by Subject|1|||
147332815|NCT00770965|531385566|FG002|Safety Set|Protocol deviation|1|||
147332816|NCT00770965|531385567|FG003|Safety Set|Protocol deviation|0|||
147599647|NCT00816361|532352475|FG006|Overall Study|Withdrawal by Subject|0|||
147260234|NCT03194321|531126372|FG000|Overall Study|Lost to Follow-up|1|||
147260235|NCT03194321|531126372|FG000|Overall Study|Travel for Follow-up|1|||
147260236|NCT00271609|531126373|FG000|Overall Study|Adverse Event|11|||
147260237|NCT00271609|531126374|FG001|Overall Study|Adverse Event|3|||
147260238|NCT00271609|531126373|FG000|Overall Study|Withdrawal by Subject|2|||
147260239|NCT00271609|531126374|FG001|Overall Study|Withdrawal by Subject|0|||
147260240|NCT02188589|531126375|FG000|Overall Study|Withdrawal by Subject|5|||
147260241|NCT03341533|531126378|FG000|Overall Study|Withdrawal by Subject|1|||
147599648|NCT00816361|532352476|FG007|Overall Study|Withdrawal by Subject|2|||
147599649|NCT00816361|532352477|FG008|Overall Study|Withdrawal by Subject|1|||
147599650|NCT00816361|532352469|FG000|Overall Study|Death|4|||
147599651|NCT00816361|532352470|FG001|Overall Study|Death|3|||
147599652|NCT00816361|532352471|FG002|Overall Study|Death|3|||
147260242|NCT03341533|531126379|FG001|Overall Study|Withdrawal by Subject|1|||
147260243|NCT03341533|531126378|FG000|Overall Study|Not eligible after randomization|2|||
147260244|NCT03341533|531126379|FG001|Overall Study|Not eligible after randomization|1|||
147260245|NCT00643682|531126380|FG000|Overall Study|did not keep appointment|522|||
147260246|NCT00643682|531126381|FG001|Overall Study|did not keep appointment|509|||
147260247|NCT03755414|531126383|FG000|Overall Study|Did not continue with treatment due to low donor collection|2|||
147260248|NCT03755414|531126384|FG001|Overall Study|Did not continue with treatment due to low donor collection|1|||
147260249|NCT03755414|531126385|FG002|Overall Study|Did not continue with treatment due to low donor collection|0|||
147260250|NCT03755414|531126383|FG000|Overall Study|Recipient did not continue with treatment due to low donor cell collection|0|||
147260251|NCT03755414|531126384|FG001|Overall Study|Recipient did not continue with treatment due to low donor cell collection|0|||
147260252|NCT03755414|531126385|FG002|Overall Study|Recipient did not continue with treatment due to low donor cell collection|2|||
147260253|NCT03755414|531126383|FG000|Overall Study|Non-compliance|0|||
147260254|NCT03755414|531126384|FG001|Overall Study|Non-compliance|1|||
147260255|NCT03755414|531126385|FG002|Overall Study|Non-compliance|0|||
147260256|NCT02153112|531126386|FG000|Overall Study|Adverse Event|0|||
147260257|NCT02153112|531126387|FG001|Overall Study|Adverse Event|0|||
147260258|NCT02153112|531126388|FG002|Overall Study|Adverse Event|1|||
147260259|NCT02153112|531126389|FG003|Overall Study|Adverse Event|0|||
147260260|NCT02153112|531126390|FG004|Overall Study|Adverse Event|0|||
147260261|NCT02153112|531126391|FG005|Overall Study|Adverse Event|0|||
147260262|NCT02153112|531126392|FG006|Overall Study|Adverse Event|0|||
147260263|NCT02153112|531126393|FG007|Overall Study|Adverse Event|0|||
147260264|NCT02153112|531126394|FG008|Overall Study|Adverse Event|0|||
147260265|NCT02153112|531126395|FG009|Overall Study|Adverse Event|0|||
147260266|NCT02153112|531126386|FG000|Overall Study|Lost to Follow-up|1|||
147260267|NCT02153112|531126387|FG001|Overall Study|Lost to Follow-up|1|||
147260268|NCT02153112|531126388|FG002|Overall Study|Lost to Follow-up|0|||
147260269|NCT02153112|531126389|FG003|Overall Study|Lost to Follow-up|0|||
147260270|NCT02153112|531126390|FG004|Overall Study|Lost to Follow-up|2|||
147260271|NCT02153112|531126391|FG005|Overall Study|Lost to Follow-up|1|||
147260272|NCT02153112|531126392|FG006|Overall Study|Lost to Follow-up|1|||
147260273|NCT02153112|531126393|FG007|Overall Study|Lost to Follow-up|0|||
147260274|NCT02153112|531126394|FG008|Overall Study|Lost to Follow-up|1|||
147260275|NCT02153112|531126395|FG009|Overall Study|Lost to Follow-up|1|||
147260276|NCT02153112|531126386|FG000|Overall Study|Withdrawal by Subject|3|||
147260277|NCT02153112|531126387|FG001|Overall Study|Withdrawal by Subject|1|||
147260278|NCT02153112|531126388|FG002|Overall Study|Withdrawal by Subject|2|||
147260279|NCT02153112|531126389|FG003|Overall Study|Withdrawal by Subject|2|||
147260280|NCT02153112|531126390|FG004|Overall Study|Withdrawal by Subject|1|||
147260281|NCT02153112|531126391|FG005|Overall Study|Withdrawal by Subject|1|||
147260282|NCT02153112|531126392|FG006|Overall Study|Withdrawal by Subject|7|||
147260283|NCT02153112|531126393|FG007|Overall Study|Withdrawal by Subject|2|||
147260284|NCT02153112|531126394|FG008|Overall Study|Withdrawal by Subject|13|||
147260285|NCT02153112|531126395|FG009|Overall Study|Withdrawal by Subject|12|||
147260286|NCT02153112|531126386|FG000|Overall Study|Reason not Specified|0|||
147260287|NCT02153112|531126387|FG001|Overall Study|Reason not Specified|0|||
147260288|NCT02153112|531126388|FG002|Overall Study|Reason not Specified|0|||
147260289|NCT02153112|531126389|FG003|Overall Study|Reason not Specified|0|||
147260290|NCT02153112|531126390|FG004|Overall Study|Reason not Specified|0|||
147260291|NCT02153112|531126391|FG005|Overall Study|Reason not Specified|0|||
147260292|NCT02153112|531126392|FG006|Overall Study|Reason not Specified|0|||
147260293|NCT02153112|531126393|FG007|Overall Study|Reason not Specified|0|||
147260294|NCT02153112|531126394|FG008|Overall Study|Reason not Specified|1|||
147260295|NCT02153112|531126395|FG009|Overall Study|Reason not Specified|1|||
147332817|NCT00770965|531385564|FG000|Excluded Set|Administrative problems|14|||
147260296|NCT00003641|531126401|FG000|Overall Study|Withdrawal by Subject|0|||
147599653|NCT00816361|532352472|FG003|Overall Study|Death|3|||
147599654|NCT00816361|532352473|FG004|Overall Study|Death|1|||
147599655|NCT00816361|532352474|FG005|Overall Study|Death|1|||
147599656|NCT00816361|532352475|FG006|Overall Study|Death|3|||
147662213|NCT02849587|532585677|FG000|Overall Study|Oral THC > 5ng/mL prior to treatment (indicating likely recent use)|2|||
147260297|NCT00003641|531126402|FG001|Overall Study|Withdrawal by Subject|100|||
147260298|NCT00003641|531126401|FG000|Overall Study|Adverse Event|0|||
147260299|NCT00003641|531126402|FG001|Overall Study|Adverse Event|38|||
147260300|NCT00003641|531126401|FG000|Overall Study|Disease progression|0|||
147260301|NCT00003641|531126402|FG001|Overall Study|Disease progression|2|||
147260302|NCT00003641|531126401|FG000|Overall Study|Unknown/missing|0|||
147260303|NCT00003641|531126402|FG001|Overall Study|Unknown/missing|22|||
147260304|NCT00003641|531126401|FG000|Overall Study|Should not receive interferon therapy|2|||
147260305|NCT00003641|531126402|FG001|Overall Study|Should not receive interferon therapy|0|||
147260306|NCT00003641|531126401|FG000|Overall Study|Never started interferon|567|||
147260307|NCT00003641|531126402|FG001|Overall Study|Never started interferon|12|||
147260308|NCT02154581|531126406|FG000|Overall Study|Lost to Follow-up|7|||
147260309|NCT02154581|531126407|FG001|Overall Study|Lost to Follow-up|8|||
147260310|NCT00878709|531126408|FG000|Overall Study|Withdrawal by Subject|197|||
147260311|NCT00878709|531126409|FG001|Overall Study|Withdrawal by Subject|120|||
147260312|NCT00878709|531126408|FG000|Overall Study|Lost to Follow-up|35|||
147260313|NCT00878709|531126409|FG001|Overall Study|Lost to Follow-up|33|||
147260314|NCT00878709|531126408|FG000|Overall Study|Other Reasons|93|||
147260315|NCT00878709|531126409|FG001|Overall Study|Other Reasons|84|||
147260316|NCT02225743|531126410|FG000|Overall Study|Withdrawal by Subject|18|||
147260317|NCT00768300|531126415|FG000|Overall Study|Randomized but not treated|1|||
147260318|NCT00768300|531126416|FG001|Overall Study|Randomized but not treated|1|||
147260319|NCT00768300|531126415|FG000|Overall Study|Adverse Event|10|||
147260320|NCT00768300|531126416|FG001|Overall Study|Adverse Event|2|||
147260321|NCT00768300|531126415|FG000|Overall Study|Protocol Violation|6|||
147260322|NCT00768300|531126416|FG001|Overall Study|Protocol Violation|1|||
147260323|NCT00768300|531126415|FG000|Overall Study|Withdrawal by Subject|13|||
147260324|NCT00768300|531126416|FG001|Overall Study|Withdrawal by Subject|7|||
147260325|NCT00768300|531126415|FG000|Overall Study|Physician Decision|2|||
147260326|NCT00768300|531126416|FG001|Overall Study|Physician Decision|3|||
147260327|NCT00768300|531126415|FG000|Overall Study|Study discontinued by Sponsor|271|||
147260328|NCT00768300|531126416|FG001|Overall Study|Study discontinued by Sponsor|140|||
147260329|NCT00768300|531126415|FG000|Overall Study|Death|21|||
147260330|NCT00768300|531126416|FG001|Overall Study|Death|5|||
147260331|NCT00768300|531126415|FG000|Overall Study|Subject moved to pursue lung transplant|1|||
147260332|NCT00768300|531126416|FG001|Overall Study|Subject moved to pursue lung transplant|1|||
147260333|NCT00768300|531126415|FG000|Overall Study|Screen failure following randomization|1|||
147260334|NCT00768300|531126416|FG001|Overall Study|Screen failure following randomization|0|||
147260335|NCT00768300|531126415|FG000|Overall Study|Received lung transplant|1|||
147260336|NCT00768300|531126416|FG001|Overall Study|Received lung transplant|1|||
147260337|NCT00768300|531126415|FG000|Overall Study|Lost to Follow-up|0|||
147260338|NCT00768300|531126416|FG001|Overall Study|Lost to Follow-up|1|||
147260339|NCT00768300|531126415|FG000|Overall Study|Began prohibited concomitant medication|0|||
147260340|NCT00768300|531126416|FG001|Overall Study|Began prohibited concomitant medication|1|||
147260341|NCT00768300|531126415|FG000|Overall Study|Treated but never dosed with Study drug|1|||
147260342|NCT00768300|531126416|FG001|Overall Study|Treated but never dosed with Study drug|0|||
147260343|NCT00768300|531126415|FG000|Overall Study|Missing data|1|||
147260344|NCT00768300|531126416|FG001|Overall Study|Missing data|0|||
147260345|NCT02068222|531126419|FG000|Overall Study|Lost to Follow-up|1|||
147260346|NCT01675128|531126420|FG000|Overall Study|Disease progression on study|1|||
147260347|NCT01675128|531126421|FG001|Overall Study|Disease progression on study|1|||
147260348|NCT01675128|531126422|FG002|Overall Study|Disease progression on study|1|||
147260349|NCT01675128|531126420|FG000|Overall Study|Refused further treatment|1|||
147260350|NCT01675128|531126421|FG001|Overall Study|Refused further treatment|0|||
147260351|NCT01675128|531126422|FG002|Overall Study|Refused further treatment|0|||
147260352|NCT01675128|531126420|FG000|Overall Study|Pulmonary complication; off study|0|||
147260353|NCT01675128|531126421|FG001|Overall Study|Pulmonary complication; off study|1|||
147260354|NCT01675128|531126422|FG002|Overall Study|Pulmonary complication; off study|0|||
147260355|NCT03526458|531126423|FG000|Overall Study|Surgeries rescheduled or cancelled due to COVID|2|||
147260356|NCT03526458|531126424|FG001|Overall Study|Surgeries rescheduled or cancelled due to COVID|2|||
147260357|NCT03526458|531126423|FG000|Overall Study|Stone passed, surgery cancelled|2|||
147260358|NCT03526458|531126424|FG001|Overall Study|Stone passed, surgery cancelled|1|||
147260359|NCT03526458|531126423|FG000|Overall Study|Withdrawal by Subject|1|||
147260360|NCT03526458|531126424|FG001|Overall Study|Withdrawal by Subject|0|||
147260361|NCT03526458|531126423|FG000|Overall Study|Physician Decision|2|||
147260362|NCT03526458|531126424|FG001|Overall Study|Physician Decision|1|||
147260363|NCT03526458|531126423|FG000|Overall Study|Lack of equipment|1|||
147260364|NCT03526458|531126424|FG001|Overall Study|Lack of equipment|1|||
147260365|NCT03011307|531126425|FG000|Overall Study|Did not receive study drug: blood pressure or heart rate instability before spinal injection|3|||
147260366|NCT03011307|531126426|FG001|Overall Study|Did not receive study drug: blood pressure or heart rate instability before spinal injection|2|||
147260367|NCT03011307|531126425|FG000|Overall Study|Did not receive study drug: unable to place spinal needle|2|||
147332818|NCT00770965|531385565|FG001|Excluded Set|Administrative problems|12|||
147260368|NCT03011307|531126426|FG001|Overall Study|Did not receive study drug: unable to place spinal needle|0|||
147260369|NCT03011307|531126425|FG000|Overall Study|Did not receive study drug: unable to obtain study drug from formulating pharmacy|1|||
147260370|NCT03011307|531126426|FG001|Overall Study|Did not receive study drug: unable to obtain study drug from formulating pharmacy|0|||
147260371|NCT01782664|531126427|FG000|Overall Study|Adverse Event|2|||
147260372|NCT01782664|531126428|FG001|Overall Study|Adverse Event|2|||
147260373|NCT01782664|531126429|FG002|Overall Study|Adverse Event|2|||
147260374|NCT01782664|531126430|FG003|Overall Study|Adverse Event|2|||
147260375|NCT01782664|531126431|FG004|Overall Study|Adverse Event|0|||
147260376|NCT01782664|531126432|FG005|Overall Study|Adverse Event|0|||
147260377|NCT01782664|531126427|FG000|Overall Study|Lack of Efficacy|2|||
147260378|NCT01782664|531126428|FG001|Overall Study|Lack of Efficacy|0|||
147260379|NCT01782664|531126429|FG002|Overall Study|Lack of Efficacy|2|||
147260380|NCT01782664|531126430|FG003|Overall Study|Lack of Efficacy|2|||
147260381|NCT01782664|531126431|FG004|Overall Study|Lack of Efficacy|0|||
147260382|NCT01782664|531126432|FG005|Overall Study|Lack of Efficacy|0|||
147260383|NCT01782664|531126427|FG000|Overall Study|Protocol Violation|0|||
147260384|NCT01782664|531126428|FG001|Overall Study|Protocol Violation|1|||
147260385|NCT01782664|531126429|FG002|Overall Study|Protocol Violation|0|||
147260386|NCT01782664|531126430|FG003|Overall Study|Protocol Violation|1|||
147260387|NCT01782664|531126431|FG004|Overall Study|Protocol Violation|0|||
147260388|NCT01782664|531126432|FG005|Overall Study|Protocol Violation|0|||
147260389|NCT01782664|531126427|FG000|Overall Study|Withdrawal by Subject|2|||
147260390|NCT01782664|531126428|FG001|Overall Study|Withdrawal by Subject|2|||
147260391|NCT01782664|531126429|FG002|Overall Study|Withdrawal by Subject|0|||
147260392|NCT01782664|531126430|FG003|Overall Study|Withdrawal by Subject|0|||
147260393|NCT01782664|531126431|FG004|Overall Study|Withdrawal by Subject|0|||
147260394|NCT01782664|531126432|FG005|Overall Study|Withdrawal by Subject|0|||
147260395|NCT00698581|531126435|FG000|Overall Study|Lack of Efficacy|23|||
147260396|NCT00698581|531126436|FG001|Overall Study|Lack of Efficacy|11|||
147260397|NCT00698581|531126435|FG000|Overall Study|Withdrawal by Subject|6|||
147260398|NCT00698581|531126436|FG001|Overall Study|Withdrawal by Subject|0|||
147260399|NCT00698581|531126435|FG000|Overall Study|Other reason|9|||
147260400|NCT00698581|531126436|FG001|Overall Study|Other reason|1|||
147260401|NCT00698581|531126435|FG000|Overall Study|SAE, non-fatal|1|||
147260402|NCT00698581|531126436|FG001|Overall Study|SAE, non-fatal|0|||
147260403|NCT00698581|531126435|FG000|Overall Study|AE, non-serious non-fatal|4|||
147260404|NCT00698581|531126436|FG001|Overall Study|AE, non-serious non-fatal|0|||
147260405|NCT00698581|531126435|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
147260406|NCT00698581|531126436|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
147260407|NCT00698581|531126435|FG000|Overall Study|AE of unknown type|1|||
147260408|NCT00698581|531126436|FG001|Overall Study|AE of unknown type|0|||
147260409|NCT03760146|531126437|FG000|Overall Study|Adverse Event|11|||
147260410|NCT03760146|531126438|FG001|Overall Study|Adverse Event|8|||
147260411|NCT03760146|531126439|FG002|Overall Study|Adverse Event|0|||
147260412|NCT03760146|531126440|FG003|Overall Study|Adverse Event|0|||
147260413|NCT03760146|531126441|FG004|Overall Study|Adverse Event|0|||
147260414|NCT03760146|531126442|FG005|Overall Study|Adverse Event|0|||
147260415|NCT03760146|531126437|FG000|Overall Study|Death|1|||
147260416|NCT03760146|531126438|FG001|Overall Study|Death|0|||
147260417|NCT03760146|531126439|FG002|Overall Study|Death|0|||
147260418|NCT03760146|531126440|FG003|Overall Study|Death|0|||
147260419|NCT03760146|531126441|FG004|Overall Study|Death|0|||
147260420|NCT03760146|531126442|FG005|Overall Study|Death|0|||
147260421|NCT03760146|531126437|FG000|Overall Study|Lost to Follow-up|41|||
147260422|NCT03760146|531126438|FG001|Overall Study|Lost to Follow-up|28|||
147260423|NCT03760146|531126439|FG002|Overall Study|Lost to Follow-up|9|||
147260424|NCT03760146|531126440|FG003|Overall Study|Lost to Follow-up|2|||
147260425|NCT03760146|531126441|FG004|Overall Study|Lost to Follow-up|14|||
147260426|NCT03760146|531126442|FG005|Overall Study|Lost to Follow-up|8|||
147260427|NCT03760146|531126437|FG000|Overall Study|No longer met eligibility criteria|3|||
147260428|NCT03760146|531126438|FG001|Overall Study|No longer met eligibility criteria|9|||
147260429|NCT03760146|531126439|FG002|Overall Study|No longer met eligibility criteria|0|||
147260430|NCT03760146|531126440|FG003|Overall Study|No longer met eligibility criteria|0|||
147260431|NCT03760146|531126441|FG004|Overall Study|No longer met eligibility criteria|1|||
147260432|NCT03760146|531126442|FG005|Overall Study|No longer met eligibility criteria|0|||
147260433|NCT03760146|531126437|FG000|Overall Study|Protocol Violation|21|||
147260434|NCT03760146|531126438|FG001|Overall Study|Protocol Violation|13|||
147260435|NCT03760146|531126439|FG002|Overall Study|Protocol Violation|1|||
147260436|NCT03760146|531126440|FG003|Overall Study|Protocol Violation|0|||
147260437|NCT03760146|531126441|FG004|Overall Study|Protocol Violation|1|||
147260438|NCT03760146|531126442|FG005|Overall Study|Protocol Violation|0|||
147260439|NCT03760146|531126437|FG000|Overall Study|Withdrawal by Subject|19|||
147260440|NCT03760146|531126438|FG001|Overall Study|Withdrawal by Subject|20|||
147260441|NCT03760146|531126439|FG002|Overall Study|Withdrawal by Subject|1|||
147260442|NCT03760146|531126440|FG003|Overall Study|Withdrawal by Subject|0|||
147260443|NCT03760146|531126441|FG004|Overall Study|Withdrawal by Subject|1|||
147260444|NCT03760146|531126442|FG005|Overall Study|Withdrawal by Subject|0|||
147260445|NCT01082965|531126443|FG000|Overall Study|Protocol Violation|0|||
147260446|NCT01082965|531126444|FG001|Overall Study|Protocol Violation|1|||
147260447|NCT01082965|531126443|FG000|Overall Study|Other|1|||
147260448|NCT01082965|531126444|FG001|Overall Study|Other|1|||
147260449|NCT03642717|531126445|FG000|Overall Study|Lost to Follow-up|2|||
147260450|NCT03642717|531126445|FG000|Overall Study|Inclusion/exclusion criteria violation|33|||
147260451|NCT03642717|531126445|FG000|Overall Study|Taken study drug prior to contract date|3|||
147260452|NCT02587065|531126446|FG000|Overall Study|Adverse Event|14|||
147260453|NCT02587065|531126446|FG000|Overall Study|Withdrawal of Informed Consent (IC)|5|||
147260454|NCT02587065|531126446|FG000|Overall Study|Non-adherence to the Protocol|3|||
147260455|NCT02587065|531126446|FG000|Overall Study|Discontinuation of Study Medication|2|||
147260456|NCT02587065|531126446|FG000|Overall Study|Reason not Specified|3|||
147260457|NCT04056195|531126450|FG000|Overall Study|Adverse Event|1|||
147260458|NCT04056195|531126451|FG001|Overall Study|Adverse Event|0|||
147260459|NCT04056195|531126452|FG002|Overall Study|Adverse Event|0|||
147260460|NCT04056195|531126450|FG000|Overall Study|Withdrawal by Subject|0|||
147260461|NCT04056195|531126451|FG001|Overall Study|Withdrawal by Subject|1|||
147260462|NCT04056195|531126452|FG002|Overall Study|Withdrawal by Subject|1|||
147260463|NCT04056195|531126450|FG000|Overall Study|Physician Decision|1|||
147260464|NCT04056195|531126451|FG001|Overall Study|Physician Decision|1|||
147260465|NCT04056195|531126452|FG002|Overall Study|Physician Decision|1|||
147260466|NCT02406651|531126453|FG000|Overall Study|30 subjects dosed based on initial screening. 3 subjects were removed because they screened fail.|3|||
147260467|NCT00718328|531126458|FG000|Overall Study|Lost to Follow-up|1|||
147260468|NCT00718328|531126459|FG001|Overall Study|Lost to Follow-up|0|||
147260469|NCT02865915|531126460|FG000|Overall Study|Pregnancy|1|||
147260470|NCT02865915|531126461|FG001|Overall Study|Pregnancy|0|||
147260471|NCT02865915|531126460|FG000|Overall Study|Withdrawal by Subject|1|||
147260472|NCT02865915|531126461|FG001|Overall Study|Withdrawal by Subject|1|||
147260473|NCT02865915|531126460|FG000|Overall Study|Adverse Event|0|||
147260474|NCT02865915|531126461|FG001|Overall Study|Adverse Event|4|||
147260475|NCT02865915|531126460|FG000|Overall Study|Lost to Follow-up|0|||
147260476|NCT02865915|531126461|FG001|Overall Study|Lost to Follow-up|1|||
147260477|NCT02865915|531126460|FG000|Overall Study|Protocol Violation|0|||
147260478|NCT02865915|531126461|FG001|Overall Study|Protocol Violation|1|||
147260479|NCT02865915|531126460|FG000|Overall Study|Study terminated by sponsor|23|||
147260480|NCT02865915|531126461|FG001|Overall Study|Study terminated by sponsor|18|||
147260481|NCT02865915|531126460|FG000|Overall Study|Dosing group discontinued|0|||
147260482|NCT02865915|531126461|FG001|Overall Study|Dosing group discontinued|5|||
147260483|NCT00663052|531126464|FG000|Overall Study|Adverse Event|6|||
147260484|NCT00663052|531126465|FG001|Overall Study|Adverse Event|3|||
147260485|NCT00663052|531126464|FG000|Overall Study|Discontinuation of Study by Sponsor|2|||
147260486|NCT00663052|531126465|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
147260487|NCT00663052|531126464|FG000|Overall Study|Protocol Violation|1|||
147260488|NCT00663052|531126465|FG001|Overall Study|Protocol Violation|0|||
147260489|NCT00663052|531126464|FG000|Overall Study|Withdrawal by Subject|2|||
147260490|NCT00663052|531126465|FG001|Overall Study|Withdrawal by Subject|5|||
147260491|NCT00663052|531126464|FG000|Overall Study|Unsatisfactory Response - Efficacy|1|||
147260492|NCT00663052|531126465|FG001|Overall Study|Unsatisfactory Response - Efficacy|1|||
147260493|NCT00663052|531126464|FG000|Overall Study|Other|0|||
147260494|NCT00663052|531126465|FG001|Overall Study|Other|1|||
147260495|NCT05497284|531126468|FG000|Overall Study|Adverse Event|1|||
147260496|NCT05497284|531126469|FG001|Overall Study|Adverse Event|0|||
147260497|NCT05497284|531126468|FG000|Overall Study|Physician Decision|0|||
147260498|NCT05497284|531126469|FG001|Overall Study|Physician Decision|1|||
147260499|NCT05497284|531126468|FG000|Overall Study|Study terminated by sponsor|7|||
147260500|NCT05497284|531126469|FG001|Overall Study|Study terminated by sponsor|4|||
147260501|NCT05497284|531126468|FG000|Overall Study|Subject Decision|0|||
147260502|NCT05497284|531126469|FG001|Overall Study|Subject Decision|1|||
147260503|NCT05760300|531126470|FG000|Overall Study|Adverse Event|0|||
147260504|NCT05760300|531126471|FG001|Overall Study|Adverse Event|0|||
147260505|NCT05760300|531126472|FG002|Overall Study|Adverse Event|1|||
147260506|NCT05760300|531126473|FG003|Overall Study|Adverse Event|0|||
147260507|NCT05760300|531126470|FG000|Overall Study|Participant Decision|1|||
147260508|NCT05760300|531126471|FG001|Overall Study|Participant Decision|0|||
147260509|NCT05760300|531126472|FG002|Overall Study|Participant Decision|0|||
147260510|NCT05760300|531126473|FG003|Overall Study|Participant Decision|0|||
147260511|NCT03878446|531126474|FG000|Overall Study|Withdrawn by parent or guardian|1|||
147260512|NCT03878446|531126475|FG001|Overall Study|Withdrawn by parent or guardian|0|||
147260513|NCT03878446|531126476|FG002|Overall Study|Withdrawn by parent or guardian|0|||
147260514|NCT03878446|531126477|FG003|Overall Study|Withdrawn by parent or guardian|0|||
147260515|NCT03878446|531126478|FG004|Overall Study|Withdrawn by parent or guardian|0|||
147260516|NCT05041322|531126479|FG000|Baseline|Withdrawal by Subject|1|||
147260517|NCT05041322|531126480|FG001|Baseline|Withdrawal by Subject|0|||
147260518|NCT05041322|531126479|FG000|Treatment 1 (14 Days)|Adverse Event|1|||
147260519|NCT05041322|531126480|FG001|Treatment 1 (14 Days)|Adverse Event|0|||
147260520|NCT05041322|531126479|FG000|Treatment 1 (14 Days)|Withdrawal by Subject|1|||
147260521|NCT05041322|531126480|FG001|Treatment 1 (14 Days)|Withdrawal by Subject|1|||
147599657|NCT00816361|532352476|FG007|Overall Study|Death|7|||
147599658|NCT00816361|532352477|FG008|Overall Study|Death|8|||
147599659|NCT00816361|532352469|FG000|Overall Study|Other|0|||
147599660|NCT00816361|532352470|FG001|Overall Study|Other|0|||
147260522|NCT04814433|531126481|FG000|Overall Study|Survey not returned|4|||
147260523|NCT04814433|531126482|FG001|Overall Study|Survey not returned|8|||
147260524|NCT04814433|531126483|FG002|Overall Study|Survey not returned|4|||
147260525|NCT04814433|531126484|FG003|Overall Study|Survey not returned|5|||
147260526|NCT01545817|531127749|FG000|Pazopanib|Disease progression|51|||
147260527|NCT01545817|531127750|FG001|Pazopanib|Disease progression|0|||
147260528|NCT01545817|531127749|FG000|Pazopanib|Adverse Event|19|||
147260529|NCT01545817|531127750|FG001|Pazopanib|Adverse Event|0|||
147260530|NCT01545817|531127749|FG000|Pazopanib|Other reason|4|||
147260531|NCT01545817|531127750|FG001|Pazopanib|Other reason|0|||
147260532|NCT01545817|531127749|FG000|Everolimus|Other reason|0|||
147260533|NCT01545817|531127750|FG001|Everolimus|Other reason|7|||
147260534|NCT01545817|531127749|FG000|Everolimus|Disease progression|0|||
147260535|NCT01545817|531127750|FG001|Everolimus|Disease progression|25|||
147260536|NCT01545817|531127749|FG000|Everolimus|Adverse Event|0|||
147260537|NCT01545817|531127750|FG001|Everolimus|Adverse Event|6|||
147260538|NCT02967692|531127751|FG000|Overall Study|Progressive disease|3|||
147260539|NCT02967692|531127752|FG001|Overall Study|Progressive disease|15|||
147260540|NCT02967692|531127753|FG002|Overall Study|Progressive disease|114|||
147260541|NCT02967692|531127754|FG003|Overall Study|Progressive disease|151|||
147260542|NCT02967692|531127751|FG000|Overall Study|Subject/guardian decision|1|||
147260543|NCT02967692|531127752|FG001|Overall Study|Subject/guardian decision|1|||
147260544|NCT02967692|531127753|FG002|Overall Study|Subject/guardian decision|14|||
147260545|NCT02967692|531127754|FG003|Overall Study|Subject/guardian decision|22|||
147260546|NCT02967692|531127751|FG000|Overall Study|Death|0|||
147260547|NCT02967692|531127752|FG001|Overall Study|Death|1|||
147260548|NCT02967692|531127753|FG002|Overall Study|Death|13|||
147662214|NCT02849587|532585678|FG001|Overall Study|Oral THC > 5ng/mL prior to treatment (indicating likely recent use)|3|||
147662215|NCT02849587|532585679|FG002|Overall Study|Oral THC > 5ng/mL prior to treatment (indicating likely recent use)|2|||
147662216|NCT02849587|532585677|FG000|Overall Study|Withdrawal by Subject|0|||
147662217|NCT02849587|532585678|FG001|Overall Study|Withdrawal by Subject|1|||
147662218|NCT02849587|532585679|FG002|Overall Study|Withdrawal by Subject|0|||
147662219|NCT03380377|532585682|FG000|Overall Study|Physician Decision|1|||
147662220|NCT03380377|532585682|FG000|Overall Study|Withdrawal by Subject|1|||
147260549|NCT02967692|531127754|FG003|Overall Study|Death|13|||
147260550|NCT02967692|531127751|FG000|Overall Study|Protocol deviation|1|||
147260551|NCT02967692|531127752|FG001|Overall Study|Protocol deviation|0|||
147260552|NCT02967692|531127753|FG002|Overall Study|Protocol deviation|1|||
147260553|NCT02967692|531127754|FG003|Overall Study|Protocol deviation|1|||
147260554|NCT02967692|531127751|FG000|Overall Study|Lost to Follow-up|0|||
147260555|NCT02967692|531127752|FG001|Overall Study|Lost to Follow-up|0|||
147260556|NCT02967692|531127753|FG002|Overall Study|Lost to Follow-up|1|||
147260557|NCT02967692|531127754|FG003|Overall Study|Lost to Follow-up|0|||
147260558|NCT02967692|531127751|FG000|Overall Study|Physician Decision|0|||
147260559|NCT02967692|531127752|FG001|Overall Study|Physician Decision|0|||
147260560|NCT02967692|531127753|FG002|Overall Study|Physician Decision|22|||
147260561|NCT02967692|531127754|FG003|Overall Study|Physician Decision|13|||
147260562|NCT02967692|531127751|FG000|Overall Study|Adverse Event|2|||
147260563|NCT02967692|531127752|FG001|Overall Study|Adverse Event|9|||
147260564|NCT02967692|531127753|FG002|Overall Study|Adverse Event|60|||
147260565|NCT02967692|531127754|FG003|Overall Study|Adverse Event|28|||
147260566|NCT02967692|531127751|FG000|Overall Study|Study terminated by sponsor|2|||
147260567|NCT02967692|531127752|FG001|Overall Study|Study terminated by sponsor|1|||
147260568|NCT02967692|531127753|FG002|Overall Study|Study terminated by sponsor|42|||
147260569|NCT02967692|531127754|FG003|Overall Study|Study terminated by sponsor|37|||
147599661|NCT00816361|532352471|FG002|Overall Study|Other|0|||
147599662|NCT00816361|532352472|FG003|Overall Study|Other|0|||
147260570|NCT00066066|531127757|FG000|Overall Study|Lost to Follow-up|6|||
147599663|NCT00816361|532352473|FG004|Overall Study|Other|0|||
147599664|NCT00816361|532352474|FG005|Overall Study|Other|0|||
147599665|NCT00816361|532352475|FG006|Overall Study|Other|0|||
147662221|NCT02716779|532585683|FG000|Monotherapy|Adverse Event|0|||
147260571|NCT00066066|531127758|FG001|Overall Study|Lost to Follow-up|4|||
147260572|NCT00066066|531127759|FG002|Overall Study|Lost to Follow-up|7|||
147260573|NCT00066066|531127760|FG003|Overall Study|Lost to Follow-up|4|||
147260574|NCT00066066|531127761|FG004|Overall Study|Lost to Follow-up|3|||
147260575|NCT00066066|531127762|FG005|Overall Study|Lost to Follow-up|5|||
147260576|NCT02603432|531127773|FG000|Overall Study|Adverse Event|1|||
147260577|NCT02603432|531127774|FG001|Overall Study|Adverse Event|0|||
147260578|NCT02603432|531127773|FG000|Overall Study|Death|221|||
147599666|NCT00816361|532352476|FG007|Overall Study|Other|0|||
147599667|NCT00816361|532352477|FG008|Overall Study|Other|1|||
147260579|NCT02603432|531127774|FG001|Overall Study|Death|242|||
147260580|NCT02603432|531127773|FG000|Overall Study|Lost to Follow-up|3|||
147260581|NCT02603432|531127774|FG001|Overall Study|Lost to Follow-up|9|||
147599668|NCT01394952|532352478|FG000|Overall Study|Lost to Follow-up|0|||
147599669|NCT01394952|532352479|FG001|Overall Study|Lost to Follow-up|5|||
147260582|NCT02603432|531127773|FG000|Overall Study|Progressive Disease|7|||
147260583|NCT02603432|531127774|FG001|Overall Study|Progressive Disease|5|||
147260584|NCT02603432|531127773|FG000|Overall Study|Withdrawal by Subject|12|||
147260585|NCT02603432|531127774|FG001|Overall Study|Withdrawal by Subject|18|||
147260586|NCT02603432|531127773|FG000|Overall Study|No Longer Meets Eligibility Criteria|3|||
147260587|NCT02603432|531127774|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
147260588|NCT02603432|531127773|FG000|Overall Study|Study terminated by sponsor|74|||
147260589|NCT02603432|531127774|FG001|Overall Study|Study terminated by sponsor|75|||
147260590|NCT02603432|531127773|FG000|Overall Study|Other|13|||
147260591|NCT02603432|531127774|FG001|Overall Study|Other|0|||
147260592|NCT02759120|531127783|FG000|Overall Study|Death|34|||
147260593|NCT02759120|531127784|FG001|Overall Study|Death|36|||
147260594|NCT02759120|531127783|FG000|Overall Study|Lost to Follow-up|4|||
147260595|NCT02759120|531127784|FG001|Overall Study|Lost to Follow-up|7|||
147260596|NCT02759120|531127783|FG000|Overall Study|Physician Decision|3|||
147260597|NCT02759120|531127784|FG001|Overall Study|Physician Decision|0|||
147260598|NCT02759120|531127783|FG000|Overall Study|Withdrawal by Subject|28|||
147260599|NCT02759120|531127784|FG001|Overall Study|Withdrawal by Subject|15|||
147260600|NCT02759120|531127783|FG000|Overall Study|Moved out of area|3|||
147260601|NCT02759120|531127784|FG001|Overall Study|Moved out of area|4|||
147260602|NCT02759120|531127783|FG000|Overall Study|Lung transplant|3|||
147260603|NCT02759120|531127784|FG001|Overall Study|Lung transplant|5|||
147260604|NCT02759120|531127783|FG000|Overall Study|Other reason not completed|10|||
147260605|NCT02759120|531127784|FG001|Overall Study|Other reason not completed|12|||
147260606|NCT02063854|531127786|FG000|Overall Study|Pretreatment Event/Adverse Event|13|||
147260607|NCT02063854|531127787|FG001|Overall Study|Pretreatment Event/Adverse Event|10|||
147260608|NCT02063854|531127788|FG002|Overall Study|Pretreatment Event/Adverse Event|13|||
147260609|NCT02063854|531127789|FG003|Overall Study|Pretreatment Event/Adverse Event|8|||
147260610|NCT02063854|531127790|FG004|Overall Study|Pretreatment Event/Adverse Event|7|||
147260611|NCT02063854|531127791|FG005|Overall Study|Pretreatment Event/Adverse Event|18|||
147260612|NCT02063854|531127792|FG006|Overall Study|Pretreatment Event/Adverse Event|4|||
147260613|NCT02063854|531127786|FG000|Overall Study|Major Protocol Deviation|0|||
147260614|NCT02063854|531127787|FG001|Overall Study|Major Protocol Deviation|0|||
147260615|NCT02063854|531127788|FG002|Overall Study|Major Protocol Deviation|3|||
147260616|NCT02063854|531127789|FG003|Overall Study|Major Protocol Deviation|0|||
147260617|NCT02063854|531127790|FG004|Overall Study|Major Protocol Deviation|0|||
147260618|NCT02063854|531127791|FG005|Overall Study|Major Protocol Deviation|0|||
147260619|NCT02063854|531127792|FG006|Overall Study|Major Protocol Deviation|0|||
147260620|NCT02063854|531127786|FG000|Overall Study|Voluntary Withdrawal|2|||
147260621|NCT02063854|531127787|FG001|Overall Study|Voluntary Withdrawal|0|||
147260622|NCT02063854|531127788|FG002|Overall Study|Voluntary Withdrawal|8|||
147260623|NCT02063854|531127789|FG003|Overall Study|Voluntary Withdrawal|1|||
147260624|NCT02063854|531127790|FG004|Overall Study|Voluntary Withdrawal|3|||
147332819|NCT00770965|531385566|FG002|Excluded Set|Administrative problems|12|||
147332820|NCT00770965|531385567|FG003|Excluded Set|Administrative problems|10|||
147332821|NCT00770965|531385564|FG000|Excluded Set|Withdrawal by Subject|1|||
147332822|NCT00770965|531385565|FG001|Excluded Set|Withdrawal by Subject|1|||
147332823|NCT00770965|531385566|FG002|Excluded Set|Withdrawal by Subject|2|||
147260625|NCT02063854|531127791|FG005|Overall Study|Voluntary Withdrawal|6|||
147260626|NCT02063854|531127792|FG006|Overall Study|Voluntary Withdrawal|1|||
147260627|NCT02063854|531127786|FG000|Overall Study|Surgical Dental Work Performed/Planned|5|||
147260628|NCT02063854|531127787|FG001|Overall Study|Surgical Dental Work Performed/Planned|2|||
147260629|NCT02063854|531127788|FG002|Overall Study|Surgical Dental Work Performed/Planned|6|||
147260630|NCT02063854|531127789|FG003|Overall Study|Surgical Dental Work Performed/Planned|1|||
147260631|NCT02063854|531127790|FG004|Overall Study|Surgical Dental Work Performed/Planned|1|||
147260632|NCT02063854|531127791|FG005|Overall Study|Surgical Dental Work Performed/Planned|6|||
147260633|NCT02063854|531127792|FG006|Overall Study|Surgical Dental Work Performed/Planned|1|||
147260634|NCT02063854|531127786|FG000|Overall Study|Reason Not Specified|1|||
147332824|NCT00770965|531385567|FG003|Excluded Set|Withdrawal by Subject|3|||
147260635|NCT02063854|531127787|FG001|Overall Study|Reason Not Specified|0|||
147260636|NCT02063854|531127788|FG002|Overall Study|Reason Not Specified|0|||
147260637|NCT02063854|531127789|FG003|Overall Study|Reason Not Specified|0|||
147260638|NCT02063854|531127790|FG004|Overall Study|Reason Not Specified|0|||
147260639|NCT02063854|531127791|FG005|Overall Study|Reason Not Specified|0|||
147260640|NCT02063854|531127792|FG006|Overall Study|Reason Not Specified|0|||
147260641|NCT02063854|531127786|FG000|Overall Study|Did Not Receive Study Drug|0|||
147260642|NCT02063854|531127787|FG001|Overall Study|Did Not Receive Study Drug|0|||
147260643|NCT02063854|531127788|FG002|Overall Study|Did Not Receive Study Drug|0|||
147260644|NCT02063854|531127789|FG003|Overall Study|Did Not Receive Study Drug|0|||
147260645|NCT02063854|531127790|FG004|Overall Study|Did Not Receive Study Drug|0|||
147260646|NCT02063854|531127791|FG005|Overall Study|Did Not Receive Study Drug|1|||
147260647|NCT02063854|531127792|FG006|Overall Study|Did Not Receive Study Drug|0|||
147260648|NCT00930579|531127795|FG000|Overall Study|Withdrawal by Subject|1|||
147260649|NCT00930579|531127795|FG000|Overall Study|Discontinued due to rescheduled surgery|1|||
147332825|NCT00880048|531385584|FG000|Overall Study|Adverse Event|2|||
147332826|NCT00880048|531385585|FG001|Overall Study|Adverse Event|3|||
147332827|NCT00880048|531385586|FG002|Overall Study|Adverse Event|5|||
147332828|NCT00880048|531385584|FG000|Overall Study|Lack of Efficacy|1|||
147332829|NCT00880048|531385585|FG001|Overall Study|Lack of Efficacy|2|||
147332830|NCT00880048|531385586|FG002|Overall Study|Lack of Efficacy|2|||
147332831|NCT00880048|531385584|FG000|Overall Study|Protocol Violation|4|||
147332832|NCT00880048|531385585|FG001|Overall Study|Protocol Violation|6|||
147332833|NCT00880048|531385586|FG002|Overall Study|Protocol Violation|5|||
147332834|NCT00880048|531385584|FG000|Overall Study|Lost to Follow-up|6|||
147332835|NCT00880048|531385585|FG001|Overall Study|Lost to Follow-up|6|||
147332836|NCT00880048|531385586|FG002|Overall Study|Lost to Follow-up|5|||
147332837|NCT00880048|531385584|FG000|Overall Study|Physician Decision|1|||
147599670|NCT01394952|532352478|FG000|Overall Study|Withdrawal by Subject|10|||
147599671|NCT01394952|532352479|FG001|Overall Study|Withdrawal by Subject|5|||
147599672|NCT01394952|532352478|FG000|Overall Study|Physician Decision|2|||
147599673|NCT01394952|532352479|FG001|Overall Study|Physician Decision|0|||
147599674|NCT01394952|532352478|FG000|Overall Study|Sponsor Decision|5|||
147599675|NCT01394952|532352479|FG001|Overall Study|Sponsor Decision|7|||
147599676|NCT02440568|532352480|FG000|Overall Study|Death|1|||
147599677|NCT02440568|532352481|FG001|Overall Study|Death|3|||
147599678|NCT02440568|532352482|FG002|Overall Study|Death|4|||
147599679|NCT02440568|532352483|FG003|Overall Study|Death|2|||
147599680|NCT02440568|532352480|FG000|Overall Study|Lack of Efficacy|2|||
147599681|NCT02440568|532352481|FG001|Overall Study|Lack of Efficacy|0|||
147260650|NCT02255981|531127796|FG000|Overall Study|Lost to Follow-up|3|||
147260651|NCT02255981|531127796|FG000|Overall Study|Withdrawal by Subject|1|||
147260652|NCT01046682|531127797|FG000|Overall Study|Adverse Event|2|||
147260653|NCT01046682|531127798|FG001|Overall Study|Adverse Event|0|||
147260654|NCT00107198|531127804|FG000|Overall Study|Lack of Efficacy|28|||
147260655|NCT00107198|531127804|FG000|Overall Study|Lost to Follow-up|12|||
147260656|NCT00107198|531127804|FG000|Overall Study|Protocol Violation|1|||
147260657|NCT00107198|531127804|FG000|Overall Study|Withdrawal by Subject|6|||
147260658|NCT00107198|531127804|FG000|Overall Study|Ineligible|5|||
147260659|NCT00949325|531127805|FG000|Overall Study|Adverse Event|0|||
147260660|NCT00949325|531127806|FG001|Overall Study|Adverse Event|2|||
147260661|NCT00949325|531127807|FG002|Overall Study|Adverse Event|0|||
147260662|NCT00751348|531127808|FG000|Overall Study|Withdrawal by Subject|5|||
147260663|NCT00751348|531127809|FG001|Overall Study|Withdrawal by Subject|2|||
147260664|NCT00751348|531127808|FG000|Overall Study|Migration from study area|1|||
147260665|NCT00751348|531127809|FG001|Overall Study|Migration from study area|0|||
147260666|NCT05533632|531127810|FG000|Overall Study|Participant no longer wants to participate in study, has other priorities|1|||
147260667|NCT05533632|531127810|FG000|Overall Study|Participant moved to another city and will not come back to Santiago|1|||
147260668|NCT05533632|531127810|FG000|Overall Study|Lost to Follow-up|1|||
147260669|NCT05533632|531127810|FG000|Overall Study|Withdrawal by Subject|4|||
147260670|NCT05533632|531127810|FG000|Overall Study|Adverse Event|4|||
147260671|NCT00741039|531127811|FG000|Overall Study|Patient non-compliance|2|||
147260672|NCT00741039|531127812|FG001|Overall Study|Patient non-compliance|0|||
147260673|NCT01712854|531127813|FG000|Overall Study|Physician Decision|1|||
147260674|NCT03886220|531127814|FG000|Treatment Period|Discontinued study drug during the treatment period|5|||
147260675|NCT03886220|531127815|FG001|Treatment Period|Discontinued study drug during the treatment period|12|||
147260676|NCT03886220|531127814|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|1|||
147260677|NCT03886220|531127815|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
147260678|NCT03886220|531127814|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|1|||
147260679|NCT03886220|531127815|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|2|||
147260680|NCT00322842|531127816|FG000|Overall Study|Withdrawal by Subject|0|||
147260681|NCT00322842|531127817|FG001|Overall Study|Withdrawal by Subject|1|||
147260682|NCT00322842|531127816|FG000|Overall Study|Lost to Follow-up|0|||
147260683|NCT00322842|531127817|FG001|Overall Study|Lost to Follow-up|1|||
147260684|NCT00322842|531127816|FG000|Overall Study|Refused transplant|1|||
147260685|NCT00322842|531127817|FG001|Overall Study|Refused transplant|0|||
147332838|NCT00880048|531385585|FG001|Overall Study|Physician Decision|1|||
147599682|NCT02440568|532352482|FG002|Overall Study|Lack of Efficacy|1|||
147599683|NCT02440568|532352483|FG003|Overall Study|Lack of Efficacy|0|||
147599684|NCT02440568|532352480|FG000|Overall Study|Lost to Follow-up|1|||
147599685|NCT02440568|532352481|FG001|Overall Study|Lost to Follow-up|0|||
147260686|NCT00322842|531127816|FG000|Overall Study|Death|1|||
147599686|NCT02440568|532352482|FG002|Overall Study|Lost to Follow-up|0|||
147599687|NCT02440568|532352483|FG003|Overall Study|Lost to Follow-up|0|||
147599688|NCT01763684|532352485|FG000|Overall Study|Study terminated early due to low enrollment|126|||
147260687|NCT00322842|531127817|FG001|Overall Study|Death|0|||
147260688|NCT03082599|531127818|FG000|Overall Study|Lost to Follow-up|1|||
147260689|NCT03082599|531127819|FG001|Overall Study|Lost to Follow-up|0|||
147260690|NCT00281684|531127832|FG000|Overall Study|Lost to Follow-up|0|||
147260691|NCT00281684|531127833|FG001|Overall Study|Lost to Follow-up|0|||
147260692|NCT00281684|531127834|FG002|Overall Study|Lost to Follow-up|1|||
147332839|NCT00880048|531385586|FG002|Overall Study|Physician Decision|7|||
147260693|NCT00281684|531127835|FG003|Overall Study|Lost to Follow-up|0|||
147643970|NCT01447446|532516686|FG000|Overall Study|Death|6|||
147260694|NCT00281684|531127832|FG000|Overall Study|Withdrawal by Subject|1|||
147260695|NCT00281684|531127833|FG001|Overall Study|Withdrawal by Subject|0|||
147260696|NCT00281684|531127834|FG002|Overall Study|Withdrawal by Subject|0|||
147260697|NCT00281684|531127835|FG003|Overall Study|Withdrawal by Subject|0|||
147260698|NCT01559012|531127838|FG000|Overall Study|Withdrawal by Subject|0|||
147260699|NCT01559012|531127839|FG001|Overall Study|Withdrawal by Subject|1|||
147260700|NCT00946712|531127842|FG000|Overall Study|Adverse Event|118|||
147260701|NCT00946712|531127843|FG001|Overall Study|Adverse Event|124|||
147260702|NCT00946712|531127842|FG000|Overall Study|Disease progression|308|||
147260703|NCT00946712|531127843|FG001|Overall Study|Disease progression|404|||
147260704|NCT00946712|531127842|FG000|Overall Study|Death|21|||
147332840|NCT00880048|531385584|FG000|Overall Study|Withdrawal by Subject|5|||
147599689|NCT01763684|532352486|FG001|Overall Study|Study terminated early due to low enrollment|127|||
147599690|NCT01763684|532352485|FG000|Overall Study|Study surgery not performed|7|||
147260705|NCT00946712|531127843|FG001|Overall Study|Death|22|||
147260706|NCT00946712|531127842|FG000|Overall Study|No treatment given|25|||
147260707|NCT00946712|531127843|FG001|Overall Study|No treatment given|29|||
147260708|NCT00946712|531127842|FG000|Overall Study|Other reasons|61|||
147260709|NCT00946712|531127843|FG001|Overall Study|Other reasons|73|||
147260710|NCT00946712|531127842|FG000|Overall Study|On Treatment|0|||
147260711|NCT00946712|531127843|FG001|Overall Study|On Treatment|4|||
147260712|NCT00946712|531127842|FG000|Overall Study|Ineligible|14|||
147260713|NCT00946712|531127843|FG001|Overall Study|Ineligible|6|||
147260714|NCT00302458|531127844|FG000|Overall Study|Lost to Follow-up|1|||
147260715|NCT00302458|531127844|FG000|Overall Study|Ineligible after screening|1|||
147260716|NCT00302458|531127844|FG000|Overall Study|Withdrawal by Subject|1|||
147260717|NCT00853723|531127845|FG000|Overall Study|Adverse Event|3|||
147260718|NCT00853723|531127846|FG001|Overall Study|Adverse Event|4|||
147260719|NCT00853723|531127847|FG002|Overall Study|Adverse Event|1|||
147260720|NCT00853723|531127845|FG000|Overall Study|Withdrawal by Subject|2|||
147260721|NCT00853723|531127846|FG001|Overall Study|Withdrawal by Subject|1|||
147260722|NCT00853723|531127847|FG002|Overall Study|Withdrawal by Subject|0|||
147260723|NCT00853723|531127845|FG000|Overall Study|Protocol Violation|1|||
147260724|NCT00853723|531127846|FG001|Overall Study|Protocol Violation|2|||
147260725|NCT00853723|531127847|FG002|Overall Study|Protocol Violation|1|||
147260726|NCT00445965|531127848|FG000|Overall Study|Adverse Event|2|||
147260727|NCT00445965|531127848|FG000|Overall Study|Physician Decision|1|||
147260728|NCT00445965|531127848|FG000|Overall Study|Enrolled but not treated|1|||
147260729|NCT00445965|531127848|FG000|Overall Study|Removed due to progressive disease|29|||
147260730|NCT02447081|531127849|FG000|Overall Study|Death|161|||
147260731|NCT02447081|531127849|FG000|Overall Study|Lost to Follow-up|36|||
147260732|NCT02447081|531127849|FG000|Overall Study|Visit not completed|17|||
147260733|NCT02447081|531127849|FG000|Overall Study|unsuccessful implant procedure|10|||
147260734|NCT05778786|531127852|FG000|Period 1|COVID-19 Related|3|||
147260735|NCT05778786|531127853|FG001|Period 1|COVID-19 Related|3|||
147260736|NCT05778786|531127852|FG000|Period 1|Withdrew Consent during Study|1|||
147260737|NCT05778786|531127853|FG001|Period 1|Withdrew Consent during Study|0|||
147260738|NCT05778786|531127852|FG000|Period 2|Unsatisfactory Lens Fitting due to Study Lens|0|||
147260739|NCT05778786|531127853|FG001|Period 2|Unsatisfactory Lens Fitting due to Study Lens|1|||
147260740|NCT05778786|531127852|FG000|Period 2|Other: Incorrect Study Lens Dispensed|0|||
147260741|NCT05778786|531127853|FG001|Period 2|Other: Incorrect Study Lens Dispensed|1|||
147260742|NCT02867709|531127854|FG000|Treatment Period|Adverse Event|1|||
147260743|NCT02867709|531127855|FG001|Treatment Period|Adverse Event|1|||
147260744|NCT02867709|531127856|FG002|Treatment Period|Adverse Event|2|||
147260745|NCT02867709|531127854|FG000|Treatment Period|Withdrawal of Consent|7|||
147260746|NCT02867709|531127855|FG001|Treatment Period|Withdrawal of Consent|9|||
147260747|NCT02867709|531127856|FG002|Treatment Period|Withdrawal of Consent|8|||
147260748|NCT02867709|531127854|FG000|Treatment Period|Lost to Follow-up|17|||
147260749|NCT02867709|531127855|FG001|Treatment Period|Lost to Follow-up|20|||
147260750|NCT02867709|531127856|FG002|Treatment Period|Lost to Follow-up|20|||
147260751|NCT02867709|531127854|FG000|Treatment Period|Lack of Qualifying Event|42|||
147332841|NCT00880048|531385585|FG001|Overall Study|Withdrawal by Subject|8|||
147332842|NCT00880048|531385586|FG002|Overall Study|Withdrawal by Subject|5|||
147332843|NCT00880048|531385584|FG000|Overall Study|Study closed/terminated|9|||
147332844|NCT00880048|531385585|FG001|Overall Study|Study closed/terminated|7|||
147260752|NCT02867709|531127855|FG001|Treatment Period|Lack of Qualifying Event|55|||
147260753|NCT02867709|531127856|FG002|Treatment Period|Lack of Qualifying Event|42|||
147260754|NCT02867709|531127854|FG000|Treatment Period|Protocol Violation|3|||
147260755|NCT02867709|531127855|FG001|Treatment Period|Protocol Violation|2|||
147260756|NCT02867709|531127856|FG002|Treatment Period|Protocol Violation|3|||
147260757|NCT02867709|531127854|FG000|Safety Follow-up Period|Withdrawal of Consent|1|||
147260758|NCT02867709|531127855|FG001|Safety Follow-up Period|Withdrawal of Consent|8|||
147260759|NCT02867709|531127856|FG002|Safety Follow-up Period|Withdrawal of Consent|6|||
147260760|NCT02867709|531127854|FG000|Safety Follow-up Period|Lost to Follow-up|10|||
147260761|NCT02867709|531127855|FG001|Safety Follow-up Period|Lost to Follow-up|5|||
147260762|NCT02867709|531127856|FG002|Safety Follow-up Period|Lost to Follow-up|7|||
147260763|NCT02867709|531127854|FG000|Safety Follow-up Period|Pregnancy|0|||
147332845|NCT00880048|531385586|FG002|Overall Study|Study closed/terminated|6|||
147332846|NCT01069341|531385587|FG000|Overall Study|Lost to Follow-up|1|||
147332847|NCT02950558|531385591|FG000|Overall Study|Lost to Follow-up|2|||
147332848|NCT02950558|531385592|FG001|Overall Study|Lost to Follow-up|0|||
147332849|NCT01184508|531385593|FG000|Overall Study|Adverse Event|4|||
147332850|NCT01184508|531385594|FG001|Overall Study|Adverse Event|6|||
147332851|NCT01184508|531385593|FG000|Overall Study|Lack of Efficacy|1|||
147332852|NCT01184508|531385594|FG001|Overall Study|Lack of Efficacy|1|||
147332853|NCT01184508|531385593|FG000|Overall Study|Lost to Follow-up|1|||
147332854|NCT01184508|531385594|FG001|Overall Study|Lost to Follow-up|1|||
147332855|NCT01184508|531385593|FG000|Overall Study|Physician Decision|1|||
147599691|NCT01763684|532352486|FG001|Overall Study|Study surgery not performed|6|||
147599692|NCT00643565|532352489|FG000|Overall Study|Death|12|||
147599693|NCT00643565|532352490|FG001|Overall Study|Death|11|||
147599694|NCT00643565|532352489|FG000|Overall Study|Withdrawal by Subject|4|||
147599695|NCT00643565|532352490|FG001|Overall Study|Withdrawal by Subject|1|||
147599696|NCT00643565|532352489|FG000|Overall Study|Lost to Follow-up|0|||
147599697|NCT00643565|532352490|FG001|Overall Study|Lost to Follow-up|6|||
147599698|NCT00643565|532352489|FG000|Overall Study|Other|7|||
147599699|NCT00643565|532352490|FG001|Overall Study|Other|8|||
147599700|NCT00643565|532352489|FG000|Overall Study|Refused Treatment / Did Not Cooperate|0|||
147599701|NCT00643565|532352490|FG001|Overall Study|Refused Treatment / Did Not Cooperate|1|||
147599702|NCT00643565|532352489|FG000|Overall Study|Recurrence of Disease|2|||
147599703|NCT00643565|532352490|FG001|Overall Study|Recurrence of Disease|1|||
147599704|NCT00643565|532352489|FG000|Overall Study|Progression of Disease|18|||
147599705|NCT00643565|532352490|FG001|Overall Study|Progression of Disease|14|||
147599706|NCT00643565|532352489|FG000|Overall Study|Protocol Violation|3|||
147599707|NCT00643565|532352490|FG001|Overall Study|Protocol Violation|0|||
147599708|NCT00643565|532352489|FG000|Overall Study|Did Not Cooperate|0|||
147260764|NCT02867709|531127855|FG001|Safety Follow-up Period|Pregnancy|1|||
147260765|NCT02867709|531127856|FG002|Safety Follow-up Period|Pregnancy|0|||
147260766|NCT02867709|531127854|FG000|Safety Follow-up Period|Protocol Violation|0|||
147260767|NCT02867709|531127855|FG001|Safety Follow-up Period|Protocol Violation|1|||
147260768|NCT02867709|531127856|FG002|Safety Follow-up Period|Protocol Violation|1|||
147260769|NCT03615105|531127859|FG000|Overall Study|Protocol Violation|1|||
147260770|NCT03615105|531127860|FG001|Overall Study|Protocol Violation|0|||
147260771|NCT03615105|531127861|FG002|Overall Study|Protocol Violation|0|||
147260772|NCT03615105|531127859|FG000|Overall Study|Death|0|||
147260773|NCT03615105|531127860|FG001|Overall Study|Death|2|||
147260774|NCT03615105|531127861|FG002|Overall Study|Death|0|||
147260775|NCT03313804|531127862|FG000|Treatment|Death|5|||
147260776|NCT03313804|531127862|FG000|Treatment|still on treatment|2|||
147260777|NCT03313804|531127862|FG000|Follow Up|still on follow up|3|||
147260778|NCT01502423|531127863|FG000|Overall Study|Withdrawal by Subject|0|||
147260779|NCT01502423|531127864|FG001|Overall Study|Withdrawal by Subject|1|||
147260780|NCT00567892|531127865|FG000|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|0|||
147260781|NCT00567892|531127866|FG001|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|0|||
147260782|NCT00567892|531127867|FG002|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|1|||
147260783|NCT00567892|531127868|FG003|First Treatment (2 or 4 Weeks)|Withdrawal by Subject|4|||
147260784|NCT00567892|531127865|FG000|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|0|||
147260785|NCT00567892|531127866|FG001|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|0|||
147260786|NCT00567892|531127867|FG002|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|0|||
147260787|NCT00567892|531127868|FG003|Second Treatment (2 or 4 Weeks)|Withdrawal by Subject|1|||
147260788|NCT04690751|531127870|FG000|Overall Study|Protocol Violation|0|||
147260789|NCT04690751|531127871|FG001|Overall Study|Protocol Violation|1|||
147260790|NCT04690751|531127872|FG002|Overall Study|Protocol Violation|0|||
147260791|NCT04690751|531127873|FG003|Overall Study|Protocol Violation|1|||
147260792|NCT04690751|531127874|FG004|Overall Study|Protocol Violation|2|||
147260793|NCT04690751|531127875|FG005|Overall Study|Protocol Violation|0|||
147260794|NCT04690751|531127870|FG000|Overall Study|Adverse Event|0|||
147260795|NCT04690751|531127871|FG001|Overall Study|Adverse Event|0|||
147332856|NCT01184508|531385594|FG001|Overall Study|Physician Decision|0|||
147332857|NCT01184508|531385593|FG000|Overall Study|Protocol Violation|3|||
147332858|NCT01184508|531385594|FG001|Overall Study|Protocol Violation|1|||
147332859|NCT01184508|531385593|FG000|Overall Study|Sponsor Decision|5|||
147260796|NCT04690751|531127872|FG002|Overall Study|Adverse Event|1|||
147599709|NCT00643565|532352490|FG001|Overall Study|Did Not Cooperate|1|||
147599710|NCT00643565|532352489|FG000|Overall Study|Administrative|22|||
147599711|NCT00643565|532352490|FG001|Overall Study|Administrative|16|||
147599712|NCT00643565|532352489|FG000|Overall Study|Adverse Event|5|||
147260797|NCT04690751|531127873|FG003|Overall Study|Adverse Event|0|||
147260798|NCT04690751|531127874|FG004|Overall Study|Adverse Event|0|||
147260799|NCT04690751|531127875|FG005|Overall Study|Adverse Event|0|||
147260800|NCT04690751|531127870|FG000|Overall Study|Positive urine drug screen test|0|||
147332860|NCT01184508|531385594|FG001|Overall Study|Sponsor Decision|2|||
147332861|NCT01184508|531385593|FG000|Overall Study|Withdrawal by Subject|1|||
147599713|NCT00643565|532352490|FG001|Overall Study|Adverse Event|8|||
147599714|NCT02562482|532352491|FG000|Overall Study|Enrolled, but did not receive product|4|||
147260801|NCT04690751|531127871|FG001|Overall Study|Positive urine drug screen test|0|||
147260802|NCT04690751|531127872|FG002|Overall Study|Positive urine drug screen test|0|||
147260803|NCT04690751|531127873|FG003|Overall Study|Positive urine drug screen test|0|||
147260804|NCT04690751|531127874|FG004|Overall Study|Positive urine drug screen test|1|||
147260805|NCT04690751|531127875|FG005|Overall Study|Positive urine drug screen test|0|||
147260806|NCT01344161|531127876|FG000|Overall Study|Lost to Follow-up|4|||
147260807|NCT01344161|531127877|FG001|Overall Study|Lost to Follow-up|1|||
147260808|NCT01344161|531127876|FG000|Overall Study|Pregnancy|0|||
147260809|NCT01344161|531127877|FG001|Overall Study|Pregnancy|1|||
147260810|NCT01344161|531127876|FG000|Overall Study|Protocol Violation|1|||
147260811|NCT01344161|531127877|FG001|Overall Study|Protocol Violation|1|||
147260812|NCT04364620|531127878|FG000|Overall Study|Disease Progression|20|||
147260813|NCT04364620|531127878|FG000|Overall Study|Adverse Event|5|||
147260814|NCT04364620|531127878|FG000|Overall Study|Physician Decision|4|||
147260815|NCT04364620|531127878|FG000|Overall Study|Death|3|||
147260816|NCT04364620|531127878|FG000|Overall Study|Other|2|||
147260817|NCT04364620|531127878|FG000|Overall Study|Withdrawal by Subject|1|||
147260818|NCT03257631|531129240|FG000|Overall Study|Death|1|||
147260819|NCT03257631|531129241|FG001|Overall Study|Death|0|||
147260820|NCT03257631|531129242|FG002|Overall Study|Death|1|||
147260821|NCT03257631|531129243|FG003|Overall Study|Death|1|||
147260822|NCT03257631|531129240|FG000|Overall Study|Progressive Disease|10|||
147260823|NCT03257631|531129241|FG001|Overall Study|Progressive Disease|9|||
147260824|NCT03257631|531129242|FG002|Overall Study|Progressive Disease|17|||
147260825|NCT03257631|531129243|FG003|Overall Study|Progressive Disease|8|||
147260826|NCT03257631|531129240|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
147260827|NCT03257631|531129241|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
147260828|NCT03257631|531129242|FG002|Overall Study|Withdrawal by Parent/Guardian|2|||
147260829|NCT03257631|531129243|FG003|Overall Study|Withdrawal by Parent/Guardian|1|||
147260830|NCT03257631|531129240|FG000|Overall Study|Adverse Event|0|||
147260831|NCT03257631|531129241|FG001|Overall Study|Adverse Event|0|||
147260832|NCT03257631|531129242|FG002|Overall Study|Adverse Event|2|||
147260833|NCT03257631|531129243|FG003|Overall Study|Adverse Event|0|||
147260834|NCT02529137|531129244|FG000|Overall Study|Discontinuation for different reasons|8|||
147260835|NCT01649375|531129245|FG000|Up to Week 16|Adverse Event|2|||
147260836|NCT01649375|531129246|FG001|Up to Week 16|Adverse Event|5|||
147260837|NCT01649375|531129247|FG002|Up to Week 16|Adverse Event|4|||
147260838|NCT01649375|531129248|FG003|Up to Week 16|Adverse Event|0|||
147260839|NCT01649375|531129249|FG004|Up to Week 16|Adverse Event|0|||
147260840|NCT01649375|531129245|FG000|Up to Week 16|Lack of Efficacy|0|||
147260841|NCT01649375|531129246|FG001|Up to Week 16|Lack of Efficacy|0|||
147260842|NCT01649375|531129247|FG002|Up to Week 16|Lack of Efficacy|1|||
147260843|NCT01649375|531129248|FG003|Up to Week 16|Lack of Efficacy|0|||
147260844|NCT01649375|531129249|FG004|Up to Week 16|Lack of Efficacy|0|||
147260845|NCT01649375|531129245|FG000|Up to Week 16|Physician Decision|0|||
147599715|NCT02562482|532352492|FG001|Overall Study|Enrolled, but did not receive product|0|||
147599716|NCT02562482|532352491|FG000|Overall Study|Lost to Follow-up|9|||
147599717|NCT02562482|532352492|FG001|Overall Study|Lost to Follow-up|6|||
147599718|NCT02562482|532352491|FG000|Overall Study|Moved from area|2|||
147599719|NCT02562482|532352492|FG001|Overall Study|Moved from area|3|||
147599720|NCT02562482|532352491|FG000|Overall Study|Withdrawal by Subject|5|||
147599721|NCT02562482|532352492|FG001|Overall Study|Withdrawal by Subject|3|||
147599722|NCT02562482|532352491|FG000|Overall Study|Physician Decision|1|||
147599723|NCT02562482|532352492|FG001|Overall Study|Physician Decision|3|||
147599724|NCT02562482|532352491|FG000|Overall Study|Illness/Injury unrelated to product|0|||
147599725|NCT02562482|532352492|FG001|Overall Study|Illness/Injury unrelated to product|1|||
147599726|NCT00975286|532352493|FG000|Overall Study|Adverse Event|9|||
147260846|NCT01649375|531129246|FG001|Up to Week 16|Physician Decision|0|||
147260847|NCT01649375|531129247|FG002|Up to Week 16|Physician Decision|1|||
147260848|NCT01649375|531129248|FG003|Up to Week 16|Physician Decision|0|||
147260849|NCT01649375|531129249|FG004|Up to Week 16|Physician Decision|0|||
147260850|NCT01649375|531129245|FG000|Up to Week 16|Withdrawal by Subject|2|||
147599727|NCT00975286|532352494|FG001|Overall Study|Adverse Event|19|||
147599728|NCT00975286|532352493|FG000|Overall Study|Protocol Violation|1|||
147260851|NCT01649375|531129246|FG001|Up to Week 16|Withdrawal by Subject|1|||
147260852|NCT01649375|531129247|FG002|Up to Week 16|Withdrawal by Subject|2|||
147260853|NCT01649375|531129248|FG003|Up to Week 16|Withdrawal by Subject|0|||
147332862|NCT01184508|531385594|FG001|Overall Study|Withdrawal by Subject|3|||
147332863|NCT01184508|531385593|FG000|Overall Study|Randomized, Not Treated|0|||
147599729|NCT00975286|532352494|FG001|Overall Study|Protocol Violation|2|||
147260854|NCT01649375|531129249|FG004|Up to Week 16|Withdrawal by Subject|0|||
147260855|NCT01649375|531129245|FG000|Up to Week 16|Death|1|||
147260856|NCT01649375|531129246|FG001|Up to Week 16|Death|0|||
147260857|NCT01649375|531129247|FG002|Up to Week 16|Death|0|||
147260858|NCT01649375|531129248|FG003|Up to Week 16|Death|0|||
147260859|NCT01649375|531129249|FG004|Up to Week 16|Death|0|||
147260860|NCT01649375|531129245|FG000|Week 16 up to Week 260|Lack of Efficacy|7|||
147332864|NCT01184508|531385594|FG001|Overall Study|Randomized, Not Treated|1|||
147260861|NCT01649375|531129246|FG001|Week 16 up to Week 260|Lack of Efficacy|4|||
147260862|NCT01649375|531129247|FG002|Week 16 up to Week 260|Lack of Efficacy|0|||
147260863|NCT01649375|531129248|FG003|Week 16 up to Week 260|Lack of Efficacy|4|||
147260864|NCT01649375|531129249|FG004|Week 16 up to Week 260|Lack of Efficacy|2|||
147260865|NCT01649375|531129245|FG000|Week 16 up to Week 260|Non-compliance|0|||
147260866|NCT01649375|531129246|FG001|Week 16 up to Week 260|Non-compliance|1|||
147260867|NCT01649375|531129247|FG002|Week 16 up to Week 260|Non-compliance|0|||
147260868|NCT01649375|531129248|FG003|Week 16 up to Week 260|Non-compliance|1|||
147260869|NCT01649375|531129249|FG004|Week 16 up to Week 260|Non-compliance|0|||
147260870|NCT01649375|531129245|FG000|Week 16 up to Week 260|Physician Decision|0|||
147260871|NCT01649375|531129246|FG001|Week 16 up to Week 260|Physician Decision|2|||
147260872|NCT01649375|531129247|FG002|Week 16 up to Week 260|Physician Decision|0|||
147260873|NCT01649375|531129248|FG003|Week 16 up to Week 260|Physician Decision|0|||
147260874|NCT01649375|531129249|FG004|Week 16 up to Week 260|Physician Decision|0|||
147260875|NCT01649375|531129245|FG000|Week 16 up to Week 260|Technical issues|0|||
147260876|NCT01649375|531129246|FG001|Week 16 up to Week 260|Technical issues|1|||
147260877|NCT01649375|531129247|FG002|Week 16 up to Week 260|Technical issues|0|||
147260878|NCT01649375|531129248|FG003|Week 16 up to Week 260|Technical issues|1|||
147260879|NCT01649375|531129249|FG004|Week 16 up to Week 260|Technical issues|0|||
147260880|NCT01649375|531129245|FG000|Week 16 up to Week 260|Withdrawal by Subject|7|||
147260881|NCT01649375|531129246|FG001|Week 16 up to Week 260|Withdrawal by Subject|2|||
147260882|NCT01649375|531129247|FG002|Week 16 up to Week 260|Withdrawal by Subject|0|||
147260883|NCT01649375|531129248|FG003|Week 16 up to Week 260|Withdrawal by Subject|3|||
147260884|NCT01649375|531129249|FG004|Week 16 up to Week 260|Withdrawal by Subject|1|||
147260885|NCT01649375|531129245|FG000|Week 16 up to Week 260|Death|1|||
147260886|NCT01649375|531129246|FG001|Week 16 up to Week 260|Death|1|||
147260887|NCT01649375|531129247|FG002|Week 16 up to Week 260|Death|0|||
147260888|NCT01649375|531129248|FG003|Week 16 up to Week 260|Death|0|||
147260889|NCT01649375|531129249|FG004|Week 16 up to Week 260|Death|0|||
147260890|NCT01649375|531129245|FG000|Week 16 up to Week 260|Adverse Event|5|||
147662222|NCT02716779|532585684|FG001|Monotherapy|Adverse Event|1|||
147260891|NCT01649375|531129246|FG001|Week 16 up to Week 260|Adverse Event|2|||
147260892|NCT01649375|531129247|FG002|Week 16 up to Week 260|Adverse Event|0|||
147260893|NCT01649375|531129248|FG003|Week 16 up to Week 260|Adverse Event|3|||
147260894|NCT01649375|531129249|FG004|Week 16 up to Week 260|Adverse Event|2|||
147260895|NCT01124604|531129250|FG000|Overall Study|Adverse Event|10|||
147260896|NCT01124604|531129251|FG001|Overall Study|Adverse Event|1|||
147260897|NCT01124604|531129250|FG000|Overall Study|Lack of Efficacy|1|||
147260898|NCT01124604|531129251|FG001|Overall Study|Lack of Efficacy|0|||
147260899|NCT01124604|531129250|FG000|Overall Study|Withdrawal by Subject|4|||
147260900|NCT01124604|531129251|FG001|Overall Study|Withdrawal by Subject|0|||
147260901|NCT01124604|531129250|FG000|Overall Study|Disease Progression|0|||
147260902|NCT01124604|531129251|FG001|Overall Study|Disease Progression|1|||
147260903|NCT03102918|531129252|FG000|Overall Study|Protocol Violation|1|||
147260904|NCT03102918|531129253|FG001|Overall Study|Protocol Violation|0|||
147260905|NCT04765358|531129254|FG000|Overall Study|Withdrawal by Subject|1|||
147260906|NCT01660711|531129255|FG000|Overall Study|Adverse Event|7|||
147260907|NCT01660711|531129255|FG000|Overall Study|Withdrawal by Subject|1|||
147260908|NCT00952341|531129257|FG000|Cycle 1|Adverse Event|4|||
147260909|NCT00952341|531129258|FG001|Cycle 1|Adverse Event|1|||
147260910|NCT00952341|531129257|FG000|Cycle 1|Withdrawal by Subject|3|||
147260911|NCT00952341|531129258|FG001|Cycle 1|Withdrawal by Subject|8|||
147260912|NCT00952341|531129257|FG000|Cycle 1|Protocol Violation|2|||
147260913|NCT00952341|531129258|FG001|Cycle 1|Protocol Violation|1|||
147260914|NCT00952341|531129257|FG000|Cycle 1|Lost to Follow-up|11|||
147260915|NCT00952341|531129258|FG001|Cycle 1|Lost to Follow-up|2|||
147260916|NCT00952341|531129257|FG000|Cycle 1|Physician Decision|0|||
147662223|NCT02716779|532585685|FG002|Monotherapy|Adverse Event|1|||
147662224|NCT02716779|532585683|FG000|Combination Therapy|Adverse Event|0|||
147450090|NCT00267748|531811360|FG002|Randomized Period|Lost to Follow-up|0|||
147260917|NCT00952341|531129258|FG001|Cycle 1|Physician Decision|1|||
147260918|NCT00952341|531129257|FG000|Cycle 2|Withdrawal by Subject|1|||
147260919|NCT00952341|531129258|FG001|Cycle 2|Withdrawal by Subject|1|||
147260920|NCT00952341|531129257|FG000|Cycle 2|Protocol Violation|1|||
147260921|NCT00952341|531129258|FG001|Cycle 2|Protocol Violation|0|||
147260922|NCT00952341|531129257|FG000|Cycle 2|Lost to Follow-up|6|||
147260923|NCT00952341|531129258|FG001|Cycle 2|Lost to Follow-up|9|||
147260924|NCT00952341|531129257|FG000|Cycle 2|Physician Decision|1|||
147260925|NCT00952341|531129258|FG001|Cycle 2|Physician Decision|1|||
147260926|NCT00952341|531129257|FG000|Cycle 2|Progressive Disease|0|||
147260927|NCT00952341|531129258|FG001|Cycle 2|Progressive Disease|1|||
147260928|NCT02066467|531129261|FG000|Overall Study|Did not undergo implant procedure|24|||
147260929|NCT02066467|531129261|FG000|Overall Study|Attempted to implant withoput success|43|||
147260930|NCT02066467|531129261|FG000|Overall Study|Consent ineligible|1|||
147662225|NCT02716779|532585684|FG001|Combination Therapy|Adverse Event|2|||
147260931|NCT02066467|531129261|FG000|Overall Study|Death|54|||
147260932|NCT02066467|531129261|FG000|Overall Study|Lost to Follow-up|51|||
147260933|NCT02066467|531129261|FG000|Overall Study|Adverse Event|20|||
147260934|NCT02066467|531129261|FG000|Overall Study|Withdrawal by Subject|16|||
147260935|NCT02066467|531129261|FG000|Overall Study|Physician Decision|2|||
147260936|NCT02066467|531129261|FG000|Overall Study|Not defined|4|||
147260937|NCT01316276|531129262|FG000|Overall Study|Death|1|||
147260938|NCT01316276|531129262|FG000|Overall Study|Adverse Event|19|||
147260939|NCT01316276|531129262|FG000|Overall Study|Withdrawal of consent|24|||
147260940|NCT01316276|531129262|FG000|Overall Study|Lost to Follow-up|1|||
147662226|NCT02716779|532585685|FG002|Combination Therapy|Adverse Event|1|||
147662227|NCT02600923|532585688|FG000|Overall Study|Death|10|||
147662228|NCT02600923|532585688|FG000|Overall Study|Adverse Event|3|||
147662229|NCT02600923|532585688|FG000|Overall Study|Global deterioration of health status|2|||
147662230|NCT02600923|532585688|FG000|Overall Study|Insufficient clinical response|6|||
147662231|NCT02600923|532585688|FG000|Overall Study|Lost to Follow-up|1|||
147662232|NCT02600923|532585688|FG000|Overall Study|Withdrawal by Subject|5|||
147662233|NCT02600923|532585688|FG000|Overall Study|Objective progression or relapse|50|||
147662234|NCT02600923|532585688|FG000|Overall Study|Study terminated by Sponsor|53|||
147662235|NCT02600923|532585688|FG000|Overall Study|Not treated|1|||
147662236|NCT00792909|532585689|FG000|Overall Study|Withdrawal by Subject|0|||
147260941|NCT01316276|531129262|FG000|Overall Study|Other|22|||
147260942|NCT03056755|531129264|FG000|Treatment- Core Phase|Progressive disease|89|||
147260943|NCT03056755|531129265|FG001|Treatment- Core Phase|Progressive disease|88|||
147260944|NCT03056755|531129266|FG002|Treatment- Core Phase|Progressive disease|90|||
147260945|NCT03056755|531129264|FG000|Treatment- Core Phase|Adverse Event|20|||
147260946|NCT03056755|531129265|FG001|Treatment- Core Phase|Adverse Event|14|||
147260947|NCT03056755|531129266|FG002|Treatment- Core Phase|Adverse Event|13|||
147260948|NCT03056755|531129264|FG000|Treatment- Core Phase|Physician Decision|7|||
147260949|NCT03056755|531129265|FG001|Treatment- Core Phase|Physician Decision|13|||
147260950|NCT03056755|531129266|FG002|Treatment- Core Phase|Physician Decision|5|||
147260951|NCT03056755|531129264|FG000|Treatment- Core Phase|Subject/guardian decision|5|||
147260952|NCT03056755|531129265|FG001|Treatment- Core Phase|Subject/guardian decision|8|||
147260953|NCT03056755|531129266|FG002|Treatment- Core Phase|Subject/guardian decision|4|||
147260954|NCT03056755|531129264|FG000|Treatment- Core Phase|Death|3|||
147260955|NCT03056755|531129265|FG001|Treatment- Core Phase|Death|2|||
147260956|NCT03056755|531129266|FG002|Treatment- Core Phase|Death|4|||
147260957|NCT03056755|531129264|FG000|Treatment- Core Phase|Protocol deviation|1|||
147260958|NCT03056755|531129265|FG001|Treatment- Core Phase|Protocol deviation|1|||
147260959|NCT03056755|531129266|FG002|Treatment- Core Phase|Protocol deviation|0|||
147260960|NCT03056755|531129264|FG000|Treatment- Core Phase|Technical problems|1|||
147260961|NCT03056755|531129265|FG001|Treatment- Core Phase|Technical problems|0|||
147260962|NCT03056755|531129266|FG002|Treatment- Core Phase|Technical problems|0|||
147260963|NCT03056755|531129264|FG000|Post-treatment Efficacy - Core Phase|On-going at the time of the data cut-off date (29-Jul-2022)|1|||
147260964|NCT03056755|531129265|FG001|Post-treatment Efficacy - Core Phase|On-going at the time of the data cut-off date (29-Jul-2022)|1|||
147260965|NCT03056755|531129266|FG002|Post-treatment Efficacy - Core Phase|On-going at the time of the data cut-off date (29-Jul-2022)|2|||
147260966|NCT03056755|531129264|FG000|Post-treatment Efficacy - Core Phase|Progressive disease|11|||
147260967|NCT03056755|531129265|FG001|Post-treatment Efficacy - Core Phase|Progressive disease|9|||
147260968|NCT03056755|531129266|FG002|Post-treatment Efficacy - Core Phase|Progressive disease|5|||
147260969|NCT03056755|531129264|FG000|Post-treatment Efficacy - Core Phase|Adverse Event|1|||
147260970|NCT03056755|531129265|FG001|Post-treatment Efficacy - Core Phase|Adverse Event|1|||
147599730|NCT00975286|532352493|FG000|Overall Study|Withdrawal by Subject|0|||
147599731|NCT00975286|532352494|FG001|Overall Study|Withdrawal by Subject|2|||
147599732|NCT00975286|532352493|FG000|Overall Study|Familial and Personal Reasons|2|||
147599733|NCT00975286|532352494|FG001|Overall Study|Familial and Personal Reasons|2|||
147599734|NCT00975286|532352493|FG000|Overall Study|Poor Compliance to Protocol|0|||
147599735|NCT00975286|532352494|FG001|Overall Study|Poor Compliance to Protocol|2|||
147599736|NCT00975286|532352493|FG000|Overall Study|Sponsor Decision|0|||
147599737|NCT00975286|532352494|FG001|Overall Study|Sponsor Decision|2|||
147599738|NCT01490866|532352495|FG000|FOLFOX/Bevacizumab Treatment|Disease Progression|6|||
147599739|NCT01490866|532352495|FG000|FOLFOX/Bevacizumab Treatment|Adverse Event|6|||
147260971|NCT03056755|531129266|FG002|Post-treatment Efficacy - Core Phase|Adverse Event|0|||
147260972|NCT03056755|531129264|FG000|Post-treatment Efficacy - Core Phase|Death|1|||
147260973|NCT03056755|531129265|FG001|Post-treatment Efficacy - Core Phase|Death|3|||
147662237|NCT00792909|532585690|FG001|Overall Study|Withdrawal by Subject|1|||
147662238|NCT00792909|532585691|FG002|Overall Study|Withdrawal by Subject|0|||
147662239|NCT00689338|532585698|FG000|Overall Study|Death|65|||
147260974|NCT03056755|531129266|FG002|Post-treatment Efficacy - Core Phase|Death|0|||
147260975|NCT04461015|531129269|FG000|Overall Study|IV access lost during the study|0|||
147599740|NCT01490866|532352495|FG000|FOLFOX/Bevacizumab Treatment|Withdrawal by Subject|5|||
147599741|NCT01490866|532352495|FG000|FOLFOX/Bevacizumab Treatment|Protocol Violation|1|||
147599742|NCT01490866|532352495|FG000|FOLFOX/Bevacizumab Treatment|Intercurrent illness|1|||
147662240|NCT00689338|532585698|FG000|Overall Study|Adverse Event|13|||
147662241|NCT00689338|532585698|FG000|Overall Study|Insufficient Clinical Response|1|||
147260976|NCT04461015|531129270|FG001|Overall Study|IV access lost during the study|1|||
147260977|NCT04461015|531129269|FG000|Overall Study|Withdrawal by Subject|0|||
147260978|NCT04461015|531129270|FG001|Overall Study|Withdrawal by Subject|1|||
147450091|NCT00267748|531811358|FG000|Randomized Period|Objective progression or relapse|0|||
147599743|NCT01490866|532352495|FG000|FOLFOX/Bevacizumab Treatment|Physician Decision|2|||
147599744|NCT01490866|532352495|FG000|Axitinib Maintenance Therapy|Disease Progression|30|||
147599745|NCT01490866|532352495|FG000|Axitinib Maintenance Therapy|Adverse Event|12|||
147599746|NCT01490866|532352495|FG000|Axitinib Maintenance Therapy|Withdrawal by Subject|3|||
147599747|NCT01490866|532352495|FG000|Axitinib Maintenance Therapy|Protocol Violation|2|||
147260979|NCT00464568|531129271|FG000|Overall Study|Adverse Event|2|||
147260980|NCT03406858|531129276|FG000|Overall Study|Failure to receive treatment drug.|1|||
147260981|NCT03406858|531129276|FG000|Overall Study|ineligible|1|||
147260982|NCT00405587|531129277|FG000|Overall Study|Death|0|||
147260983|NCT00405587|531129278|FG001|Overall Study|Death|0|||
147260984|NCT00405587|531129279|FG002|Overall Study|Death|0|||
147260985|NCT00405587|531129280|FG003|Overall Study|Death|1|||
147260986|NCT00405587|531129277|FG000|Overall Study|Disease Progression|22|||
147260987|NCT00405587|531129278|FG001|Overall Study|Disease Progression|23|||
147260988|NCT00405587|531129279|FG002|Overall Study|Disease Progression|21|||
147260989|NCT00405587|531129280|FG003|Overall Study|Disease Progression|17|||
147260990|NCT00405587|531129277|FG000|Overall Study|Physician Decision|3|||
147260991|NCT00405587|531129278|FG001|Overall Study|Physician Decision|2|||
147260992|NCT00405587|531129279|FG002|Overall Study|Physician Decision|0|||
147260993|NCT00405587|531129280|FG003|Overall Study|Physician Decision|0|||
147260994|NCT00405587|531129277|FG000|Overall Study|Adverse Event|1|||
147260995|NCT00405587|531129278|FG001|Overall Study|Adverse Event|0|||
147260996|NCT00405587|531129279|FG002|Overall Study|Adverse Event|0|||
147260997|NCT00405587|531129280|FG003|Overall Study|Adverse Event|0|||
147260998|NCT00405587|531129277|FG000|Overall Study|Lost to Follow-up|0|||
147260999|NCT00405587|531129278|FG001|Overall Study|Lost to Follow-up|1|||
147261000|NCT00405587|531129279|FG002|Overall Study|Lost to Follow-up|1|||
147261001|NCT00405587|531129280|FG003|Overall Study|Lost to Follow-up|0|||
147261002|NCT00405587|531129277|FG000|Overall Study|Radiation induced necrosis|0|||
147261003|NCT00405587|531129278|FG001|Overall Study|Radiation induced necrosis|1|||
147261004|NCT00405587|531129279|FG002|Overall Study|Radiation induced necrosis|0|||
147261005|NCT00405587|531129280|FG003|Overall Study|Radiation induced necrosis|0|||
147261006|NCT00405587|531129277|FG000|Overall Study|Withdrawal by Subject|0|||
147261007|NCT00405587|531129278|FG001|Overall Study|Withdrawal by Subject|0|||
147261008|NCT00405587|531129279|FG002|Overall Study|Withdrawal by Subject|0|||
147261009|NCT00405587|531129280|FG003|Overall Study|Withdrawal by Subject|2|||
147261010|NCT00405587|531129277|FG000|Overall Study|Participant not dosed|0|||
147261011|NCT00405587|531129278|FG001|Overall Study|Participant not dosed|1|||
147261012|NCT00405587|531129279|FG002|Overall Study|Participant not dosed|0|||
147261013|NCT00405587|531129280|FG003|Overall Study|Participant not dosed|0|||
147261014|NCT02419742|531129281|FG000|Overall Study|Adverse Event|2|||
147261015|NCT02419742|531129282|FG001|Overall Study|Adverse Event|0|||
147261016|NCT02419742|531129281|FG000|Overall Study|Disease Progression|0|||
147261017|NCT02419742|531129282|FG001|Overall Study|Disease Progression|1|||
147261018|NCT02419742|531129281|FG000|Overall Study|Withdrew Consent|2|||
147261019|NCT02419742|531129282|FG001|Overall Study|Withdrew Consent|1|||
147261020|NCT02419742|531129281|FG000|Overall Study|Any other reason which the Investigator deemed participant unsuitable for enrollment into the study|1|||
147261021|NCT02419742|531129282|FG001|Overall Study|Any other reason which the Investigator deemed participant unsuitable for enrollment into the study|0|||
147261022|NCT00507442|531129287|FG000|Overall Study|Adverse Event|8|||
147261023|NCT00507442|531129288|FG001|Overall Study|Adverse Event|11|||
147261024|NCT00507442|531129289|FG002|Overall Study|Adverse Event|4|||
147261025|NCT00507442|531129290|FG003|Overall Study|Adverse Event|1|||
147261026|NCT00507442|531129287|FG000|Overall Study|Protocol Violation|0|||
147261027|NCT00507442|531129288|FG001|Overall Study|Protocol Violation|1|||
147261028|NCT00507442|531129289|FG002|Overall Study|Protocol Violation|0|||
147261029|NCT00507442|531129290|FG003|Overall Study|Protocol Violation|0|||
147261030|NCT00507442|531129287|FG000|Overall Study|Lost to Follow-up|0|||
147261031|NCT00507442|531129288|FG001|Overall Study|Lost to Follow-up|0|||
147261032|NCT00507442|531129289|FG002|Overall Study|Lost to Follow-up|1|||
147261033|NCT00507442|531129290|FG003|Overall Study|Lost to Follow-up|0|||
147261034|NCT00507442|531129287|FG000|Overall Study|Physician Decision|0|||
147261035|NCT00507442|531129288|FG001|Overall Study|Physician Decision|2|||
147261036|NCT00507442|531129289|FG002|Overall Study|Physician Decision|4|||
147261037|NCT00507442|531129290|FG003|Overall Study|Physician Decision|1|||
147450092|NCT00267748|531811359|FG001|Randomized Period|Objective progression or relapse|77|||
147599748|NCT01490866|532352495|FG000|Axitinib Maintenance Therapy|Intercurrent illness|2|||
147599749|NCT04135196|532352496|FG000|Overall Study|Lost to Follow-up|8|||
147261038|NCT00507442|531129287|FG000|Overall Study|Progressive Disease|2|||
147261039|NCT00507442|531129288|FG001|Overall Study|Progressive Disease|4|||
147261040|NCT00507442|531129289|FG002|Overall Study|Progressive Disease|2|||
147261041|NCT00507442|531129290|FG003|Overall Study|Progressive Disease|0|||
147261042|NCT00507442|531129287|FG000|Overall Study|Withdrawal by Subject|4|||
147261043|NCT00507442|531129288|FG001|Overall Study|Withdrawal by Subject|4|||
147261044|NCT00507442|531129289|FG002|Overall Study|Withdrawal by Subject|2|||
147261045|NCT00507442|531129290|FG003|Overall Study|Withdrawal by Subject|1|||
147261046|NCT00507442|531129287|FG000|Overall Study|Other|2|||
147450093|NCT00267748|531811360|FG002|Randomized Period|Objective progression or relapse|86|||
147450094|NCT00267748|531811358|FG000|Randomized Period|Withdrawal by Subject|0|||
147450095|NCT00267748|531811359|FG001|Randomized Period|Withdrawal by Subject|9|||
147599750|NCT04135196|532352497|FG001|Overall Study|Lost to Follow-up|7|||
147599751|NCT04135196|532352498|FG002|Overall Study|Lost to Follow-up|8|||
147599752|NCT04135196|532352499|FG003|Overall Study|Lost to Follow-up|9|||
147599753|NCT04135196|532352500|FG004|Overall Study|Lost to Follow-up|1|||
147261047|NCT00507442|531129288|FG001|Overall Study|Other|5|||
147261048|NCT00507442|531129289|FG002|Overall Study|Other|2|||
147261049|NCT00507442|531129290|FG003|Overall Study|Other|2|||
147261050|NCT02672423|531129292|FG000|Period 1|Adverse Event|0|||
147261051|NCT02672423|531129293|FG001|Period 1|Adverse Event|0|||
147261052|NCT02672423|531129294|FG002|Period 1|Adverse Event|0|||
147261053|NCT02672423|531129295|FG003|Period 1|Adverse Event|0|||
147261054|NCT02672423|531129296|FG004|Period 1|Adverse Event|1|||
147261055|NCT02672423|531129297|FG005|Period 1|Adverse Event|0|||
147261056|NCT02672423|531129298|FG006|Period 1|Adverse Event|0|||
147261057|NCT02672423|531129299|FG007|Period 1|Adverse Event|0|||
147261058|NCT02672423|531129300|FG008|Period 1|Adverse Event|0|||
147261059|NCT02672423|531129301|FG009|Period 1|Adverse Event|0|||
147261060|NCT02672423|531129292|FG000|Period 2|Withdrawal by Subject|0|||
147261061|NCT02672423|531129293|FG001|Period 2|Withdrawal by Subject|0|||
147261062|NCT02672423|531129294|FG002|Period 2|Withdrawal by Subject|1|||
147261063|NCT02672423|531129295|FG003|Period 2|Withdrawal by Subject|0|||
147261064|NCT02672423|531129296|FG004|Period 2|Withdrawal by Subject|0|||
147261065|NCT02672423|531129297|FG005|Period 2|Withdrawal by Subject|0|||
147261066|NCT02672423|531129298|FG006|Period 2|Withdrawal by Subject|0|||
147261067|NCT02672423|531129299|FG007|Period 2|Withdrawal by Subject|0|||
147261068|NCT02672423|531129300|FG008|Period 2|Withdrawal by Subject|0|||
147261069|NCT02672423|531129301|FG009|Period 2|Withdrawal by Subject|0|||
147261070|NCT02672423|531129292|FG000|Period 3|Withdrawal by Subject|0|||
147261071|NCT02672423|531129293|FG001|Period 3|Withdrawal by Subject|0|||
147261072|NCT02672423|531129294|FG002|Period 3|Withdrawal by Subject|0|||
147261073|NCT02672423|531129295|FG003|Period 3|Withdrawal by Subject|0|||
147261074|NCT02672423|531129296|FG004|Period 3|Withdrawal by Subject|0|||
147261075|NCT02672423|531129297|FG005|Period 3|Withdrawal by Subject|0|||
147261076|NCT02672423|531129298|FG006|Period 3|Withdrawal by Subject|0|||
147261077|NCT02672423|531129299|FG007|Period 3|Withdrawal by Subject|1|||
147261078|NCT02672423|531129300|FG008|Period 3|Withdrawal by Subject|0|||
147261079|NCT02672423|531129301|FG009|Period 3|Withdrawal by Subject|0|||
147261080|NCT02672423|531129292|FG000|Period 3|Physician Decision|0|||
147261081|NCT02672423|531129293|FG001|Period 3|Physician Decision|0|||
147261082|NCT02672423|531129294|FG002|Period 3|Physician Decision|0|||
147261083|NCT02672423|531129295|FG003|Period 3|Physician Decision|0|||
147261084|NCT02672423|531129296|FG004|Period 3|Physician Decision|0|||
147261085|NCT02672423|531129297|FG005|Period 3|Physician Decision|1|||
147450096|NCT00267748|531811360|FG002|Randomized Period|Withdrawal by Subject|2|||
147450097|NCT00267748|531811358|FG000|Randomized Period|Other|0|||
147450098|NCT00267748|531811359|FG001|Randomized Period|Other|9|||
147261086|NCT02672423|531129298|FG006|Period 3|Physician Decision|0|||
147261087|NCT02672423|531129299|FG007|Period 3|Physician Decision|0|||
147261088|NCT02672423|531129300|FG008|Period 3|Physician Decision|0|||
147261089|NCT02672423|531129301|FG009|Period 3|Physician Decision|0|||
147261090|NCT02864251|531129314|FG000|Pre-Treatment|Adverse Event Unrelated to Study drug|1|||
147261091|NCT02864251|531129315|FG001|Pre-Treatment|Adverse Event Unrelated to Study drug|0|||
147261092|NCT02864251|531129316|FG002|Pre-Treatment|Adverse Event Unrelated to Study drug|0|||
147261093|NCT02864251|531129314|FG000|Pre-Treatment|Withdrawal by Participant|0|||
147261094|NCT02864251|531129315|FG001|Pre-Treatment|Withdrawal by Participant|0|||
147261095|NCT02864251|531129316|FG002|Pre-Treatment|Withdrawal by Participant|4|||
147261096|NCT02864251|531129314|FG000|Pre-Treatment|Participant no Longer Meets Study Criteria|2|||
147261097|NCT02864251|531129315|FG001|Pre-Treatment|Participant no Longer Meets Study Criteria|1|||
147261098|NCT02864251|531129316|FG002|Pre-Treatment|Participant no Longer Meets Study Criteria|2|||
147261099|NCT02864251|531129314|FG000|Pre-Treatment|Other Reasons|0|||
147261100|NCT02864251|531129315|FG001|Pre-Treatment|Other Reasons|1|||
147261101|NCT02864251|531129316|FG002|Pre-Treatment|Other Reasons|1|||
147261102|NCT02864251|531129314|FG000|Treatment|Disease Progression|109|||
147261103|NCT02864251|531129315|FG001|Treatment|Disease Progression|52|||
147450099|NCT00267748|531811360|FG002|Randomized Period|Other|6|||
147261104|NCT02864251|531129316|FG002|Treatment|Disease Progression|101|||
147261105|NCT02864251|531129314|FG000|Treatment|Study Drug Toxicity|9|||
147261106|NCT02864251|531129315|FG001|Treatment|Study Drug Toxicity|4|||
147261107|NCT02864251|531129316|FG002|Treatment|Study Drug Toxicity|10|||
147261108|NCT02864251|531129314|FG000|Treatment|Death|0|||
147450100|NCT00267748|531811358|FG000|Randomized Period|randomized but not treated|0|||
147261109|NCT02864251|531129315|FG001|Treatment|Death|2|||
147261110|NCT02864251|531129316|FG002|Treatment|Death|3|||
147261111|NCT02864251|531129314|FG000|Treatment|Adverse Event Unrelated to Study Drug|1|||
147261112|NCT02864251|531129315|FG001|Treatment|Adverse Event Unrelated to Study Drug|1|||
147261113|NCT02864251|531129316|FG002|Treatment|Adverse Event Unrelated to Study Drug|6|||
147599754|NCT04135196|532352496|FG000|Overall Study|Pregnancy|0|||
147261114|NCT02864251|531129314|FG000|Treatment|Participant Requested to Discontinue Study Treatment|8|||
147261115|NCT02864251|531129315|FG001|Treatment|Participant Requested to Discontinue Study Treatment|0|||
147261116|NCT02864251|531129316|FG002|Treatment|Participant Requested to Discontinue Study Treatment|5|||
147261117|NCT02864251|531129314|FG000|Treatment|Withdrawal by Participant|8|||
147261118|NCT02864251|531129315|FG001|Treatment|Withdrawal by Participant|5|||
147261119|NCT02864251|531129316|FG002|Treatment|Withdrawal by Participant|13|||
147261120|NCT02864251|531129314|FG000|Treatment|Maximum Clinical Benefit|1|||
147261121|NCT02864251|531129315|FG001|Treatment|Maximum Clinical Benefit|0|||
147261122|NCT02864251|531129316|FG002|Treatment|Maximum Clinical Benefit|1|||
147261123|NCT02864251|531129314|FG000|Treatment|Participant no Longer Meets Study Criteria|0|||
147261124|NCT02864251|531129315|FG001|Treatment|Participant no Longer Meets Study Criteria|1|||
147261125|NCT02864251|531129316|FG002|Treatment|Participant no Longer Meets Study Criteria|0|||
147261126|NCT02864251|531129314|FG000|Treatment|Other Reasons|1|||
147261127|NCT02864251|531129315|FG001|Treatment|Other Reasons|1|||
147261128|NCT02864251|531129316|FG002|Treatment|Other Reasons|4|||
147261129|NCT02864251|531129314|FG000|Treatment|Administrative Reason by Sponsor|1|||
147261130|NCT02864251|531129315|FG001|Treatment|Administrative Reason by Sponsor|0|||
147261131|NCT02864251|531129316|FG002|Treatment|Administrative Reason by Sponsor|0|||
147261132|NCT03506373|531129317|FG000|Overall Study|Adverse Event|6|||
147261133|NCT03506373|531129317|FG000|Overall Study|Withdrawal by Subject|2|||
147261134|NCT03506373|531129317|FG000|Overall Study|Disease progression|5|||
147261135|NCT03506373|531129317|FG000|Overall Study|Other|3|||
147261136|NCT00885755|531129318|FG000|Part I: Trastuzumab+Taxane|Adverse Event|1|||
147261137|NCT00885755|531129319|FG001|Part I: Trastuzumab+Taxane|Adverse Event|0|||
147261138|NCT00885755|531129320|FG002|Part I: Trastuzumab+Taxane|Adverse Event|0|||
147261139|NCT00885755|531129318|FG000|Part I: Trastuzumab+Taxane|Unknown Reason|16|||
147332865|NCT00319436|531385600|FG000|Overall Study|Withdrawal by Subject|6|||
147261140|NCT00885755|531129319|FG001|Part I: Trastuzumab+Taxane|Unknown Reason|0|||
147261141|NCT00885755|531129320|FG002|Part I: Trastuzumab+Taxane|Unknown Reason|0|||
147261142|NCT00885755|531129318|FG000|Part I: Trastuzumab+Taxane|Sufficient Response Achieved|1|||
147261143|NCT00885755|531129319|FG001|Part I: Trastuzumab+Taxane|Sufficient Response Achieved|0|||
147261144|NCT00885755|531129320|FG002|Part I: Trastuzumab+Taxane|Sufficient Response Achieved|0|||
147261145|NCT00885755|531129318|FG000|Part I: Trastuzumab+Taxane|Death|0|||
147261146|NCT00885755|531129319|FG001|Part I: Trastuzumab+Taxane|Death|0|||
147261147|NCT00885755|531129320|FG002|Part I: Trastuzumab+Taxane|Death|1|||
147261148|NCT00885755|531129318|FG000|Part II: Trastuzumab + Capecitabine.|Unknown Reason|5|||
147261149|NCT00885755|531129319|FG001|Part II: Trastuzumab + Capecitabine.|Unknown Reason|0|||
147261150|NCT00885755|531129320|FG002|Part II: Trastuzumab + Capecitabine.|Unknown Reason|0|||
147261151|NCT02120950|531129329|FG000|Overall Study|Adverse Event|5|||
147261152|NCT02120950|531129330|FG001|Overall Study|Adverse Event|4|||
147261153|NCT02120950|531129331|FG002|Overall Study|Adverse Event|3|||
147261154|NCT02120950|531129329|FG000|Overall Study|Death|3|||
147261155|NCT02120950|531129330|FG001|Overall Study|Death|0|||
147261156|NCT02120950|531129331|FG002|Overall Study|Death|1|||
147261157|NCT02120950|531129329|FG000|Overall Study|Withdrawal by Subject|6|||
147261158|NCT02120950|531129330|FG001|Overall Study|Withdrawal by Subject|3|||
147261159|NCT02120950|531129331|FG002|Overall Study|Withdrawal by Subject|2|||
147261160|NCT02120950|531129329|FG000|Overall Study|Protocol Violation|1|||
147261161|NCT02120950|531129330|FG001|Overall Study|Protocol Violation|1|||
147261162|NCT02120950|531129331|FG002|Overall Study|Protocol Violation|7|||
147261163|NCT02120950|531129329|FG000|Overall Study|Other reasons|5|||
147261164|NCT02120950|531129330|FG001|Overall Study|Other reasons|4|||
147261165|NCT02120950|531129331|FG002|Overall Study|Other reasons|1|||
147261166|NCT02120950|531129329|FG000|Overall Study|Lost to Follow-up|0|||
147261167|NCT02120950|531129330|FG001|Overall Study|Lost to Follow-up|2|||
147261168|NCT02120950|531129331|FG002|Overall Study|Lost to Follow-up|1|||
147261169|NCT01852812|531129332|FG000|Overall Study|Adverse Event|0|||
147261170|NCT01852812|531129333|FG001|Overall Study|Adverse Event|0|||
147261171|NCT01852812|531129334|FG002|Overall Study|Adverse Event|1|||
147261172|NCT01852812|531129332|FG000|Overall Study|Non-compliance With Study Drug|0|||
147261173|NCT01852812|531129333|FG001|Overall Study|Non-compliance With Study Drug|1|||
147261174|NCT01852812|531129334|FG002|Overall Study|Non-compliance With Study Drug|0|||
147261175|NCT02625090|531129338|FG000|Overall Study|Participant wants to be pregnant|2|||
147332866|NCT00319436|531385601|FG001|Overall Study|Withdrawal by Subject|7|||
147261176|NCT02625090|531129338|FG000|Overall Study|For the Promoter|1|||
147332867|NCT00790790|531385602|FG000|Study Period 2: Therapy Phase|Adverse Event|3|||
147261177|NCT02625090|531129338|FG000|Overall Study|Sponsor's Decision|9|||
147261178|NCT02625090|531129338|FG000|Overall Study|Somnolence|1|||
147261179|NCT02625090|531129338|FG000|Overall Study|Study terminated by Sponsor|7|||
147261180|NCT02625090|531129338|FG000|Overall Study|Negative Benefit/Risk|1|||
147261181|NCT02625090|531129338|FG000|Overall Study|Protocol Deviation|2|||
147261182|NCT02625090|531129338|FG000|Overall Study|Lack of Efficacy|16|||
147261183|NCT02625090|531129338|FG000|Overall Study|Adverse Event|3|||
147261184|NCT02250443|531129339|FG000|Overall Study|Administrative problems|7|||
147261185|NCT02250443|531129339|FG000|Overall Study|Adverse Event|3|||
147332868|NCT00790790|531385603|FG001|Study Period 2: Therapy Phase|Adverse Event|16|||
147261186|NCT01549964|531129340|FG000|24-Week Treatment Period|Study Terminated by Sponsor|50|||
147261187|NCT01549964|531129341|FG001|24-Week Treatment Period|Study Terminated by Sponsor|104|||
147261188|NCT01549964|531129342|FG002|24-Week Treatment Period|Study Terminated by Sponsor|104|||
147261189|NCT01549964|531129343|FG003|24-Week Treatment Period|Study Terminated by Sponsor|105|||
147261190|NCT01549964|531129340|FG000|24-Week Treatment Period|Voluntary Withdrawal|6|||
147261191|NCT01549964|531129341|FG001|24-Week Treatment Period|Voluntary Withdrawal|3|||
147261192|NCT01549964|531129342|FG002|24-Week Treatment Period|Voluntary Withdrawal|3|||
147261193|NCT01549964|531129343|FG003|24-Week Treatment Period|Voluntary Withdrawal|8|||
147261194|NCT01549964|531129340|FG000|24-Week Treatment Period|Pretreatment Event/Adverse Event|1|||
147261195|NCT01549964|531129341|FG001|24-Week Treatment Period|Pretreatment Event/Adverse Event|4|||
147261196|NCT01549964|531129342|FG002|24-Week Treatment Period|Pretreatment Event/Adverse Event|4|||
147261197|NCT01549964|531129343|FG003|24-Week Treatment Period|Pretreatment Event/Adverse Event|4|||
147261198|NCT01549964|531129340|FG000|24-Week Treatment Period|Lost to Follow-up|1|||
147261199|NCT01549964|531129341|FG001|24-Week Treatment Period|Lost to Follow-up|0|||
147261200|NCT01549964|531129342|FG002|24-Week Treatment Period|Lost to Follow-up|1|||
147261201|NCT01549964|531129343|FG003|24-Week Treatment Period|Lost to Follow-up|2|||
147261202|NCT01549964|531129340|FG000|24-Week Treatment Period|Lack of Efficacy|1|||
147261203|NCT01549964|531129341|FG001|24-Week Treatment Period|Lack of Efficacy|0|||
147261204|NCT01549964|531129342|FG002|24-Week Treatment Period|Lack of Efficacy|1|||
147261205|NCT01549964|531129343|FG003|24-Week Treatment Period|Lack of Efficacy|1|||
147261206|NCT01549964|531129340|FG000|24-Week Treatment Period|Other|1|||
147261207|NCT01549964|531129341|FG001|24-Week Treatment Period|Other|0|||
147261208|NCT01549964|531129342|FG002|24-Week Treatment Period|Other|1|||
147261209|NCT01549964|531129343|FG003|24-Week Treatment Period|Other|0|||
147261210|NCT01549964|531129340|FG000|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|0|||
147261211|NCT01549964|531129341|FG001|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|0|||
147261212|NCT01549964|531129342|FG002|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|1|||
147261213|NCT01549964|531129343|FG003|24-Week Treatment Period|Metformin/Sitagliptin Contraindication|0|||
147261214|NCT01549964|531129340|FG000|24-Week Treatment Period|Randomized but Not Treated|0|||
147261215|NCT01549964|531129341|FG001|24-Week Treatment Period|Randomized but Not Treated|0|||
147261216|NCT01549964|531129342|FG002|24-Week Treatment Period|Randomized but Not Treated|0|||
147261217|NCT01549964|531129343|FG003|24-Week Treatment Period|Randomized but Not Treated|1|||
147261218|NCT01549964|531129340|FG000|24-Week Treatment Period|Completion Status Unknown|1|||
147261219|NCT01549964|531129341|FG001|24-Week Treatment Period|Completion Status Unknown|0|||
147261220|NCT01549964|531129342|FG002|24-Week Treatment Period|Completion Status Unknown|1|||
147261221|NCT01549964|531129343|FG003|24-Week Treatment Period|Completion Status Unknown|0|||
147261222|NCT01549964|531129340|FG000|80-Week Extension Period|Pregnancy|0|||
147261223|NCT01549964|531129341|FG001|80-Week Extension Period|Pregnancy|0|||
147261224|NCT01549964|531129342|FG002|80-Week Extension Period|Pregnancy|1|||
147261225|NCT01549964|531129343|FG003|80-Week Extension Period|Pregnancy|0|||
147261226|NCT01549964|531129340|FG000|80-Week Extension Period|Study Terminated by Sponsor|65|||
147261227|NCT01549964|531129341|FG001|80-Week Extension Period|Study Terminated by Sponsor|137|||
147261228|NCT01549964|531129342|FG002|80-Week Extension Period|Study Terminated by Sponsor|132|||
147261229|NCT01549964|531129343|FG003|80-Week Extension Period|Study Terminated by Sponsor|132|||
147261230|NCT01549964|531129340|FG000|80-Week Extension Period|Voluntary Withdrawal|0|||
147261231|NCT01549964|531129341|FG001|80-Week Extension Period|Voluntary Withdrawal|1|||
147261232|NCT01549964|531129342|FG002|80-Week Extension Period|Voluntary Withdrawal|4|||
147261233|NCT01549964|531129343|FG003|80-Week Extension Period|Voluntary Withdrawal|2|||
147261234|NCT01549964|531129340|FG000|80-Week Extension Period|Lost to Follow-up|1|||
147261235|NCT01549964|531129341|FG001|80-Week Extension Period|Lost to Follow-up|0|||
147261236|NCT01549964|531129342|FG002|80-Week Extension Period|Lost to Follow-up|2|||
147261237|NCT01549964|531129343|FG003|80-Week Extension Period|Lost to Follow-up|1|||
147261238|NCT01549964|531129340|FG000|80-Week Extension Period|Pretreatment Event/Adverse Event|0|||
147261239|NCT01549964|531129341|FG001|80-Week Extension Period|Pretreatment Event/Adverse Event|0|||
147261240|NCT01549964|531129342|FG002|80-Week Extension Period|Pretreatment Event/Adverse Event|1|||
147261241|NCT01549964|531129343|FG003|80-Week Extension Period|Pretreatment Event/Adverse Event|2|||
147261242|NCT02290821|531129344|FG000|Overall Study|Withdrawal by Subject|1|||
147261243|NCT02290821|531129345|FG001|Overall Study|Withdrawal by Subject|1|||
147261244|NCT02290821|531129344|FG000|Overall Study|Unable or unwilling to cooperate with|2|||
147450101|NCT00267748|531811359|FG001|Randomized Period|randomized but not treated|0|||
147450102|NCT00267748|531811360|FG002|Randomized Period|randomized but not treated|3|||
147261245|NCT02290821|531129345|FG001|Overall Study|Unable or unwilling to cooperate with|0|||
147261246|NCT02290821|531129344|FG000|Overall Study|Lost to Follow-up|3|||
147261247|NCT02290821|531129345|FG001|Overall Study|Lost to Follow-up|2|||
147261248|NCT02438722|531129346|FG000|Overall Study|Adverse Event|12|||
147261249|NCT02438722|531129347|FG001|Overall Study|Adverse Event|9|||
147261250|NCT02438722|531129346|FG000|Overall Study|Refusal unrelated to AE|2|||
147261251|NCT02438722|531129347|FG001|Overall Study|Refusal unrelated to AE|5|||
147261252|NCT02438722|531129346|FG000|Overall Study|Disease progression/relapse|46|||
147261253|NCT02438722|531129347|FG001|Overall Study|Disease progression/relapse|51|||
147261254|NCT02438722|531129346|FG000|Overall Study|Death|0|||
147261255|NCT02438722|531129347|FG001|Overall Study|Death|3|||
147261256|NCT02438722|531129346|FG000|Overall Study|Physician Decision|2|||
147261257|NCT02438722|531129347|FG001|Overall Study|Physician Decision|2|||
147261258|NCT02438722|531129346|FG000|Overall Study|Exceeded protocol-specified maximum treatment delay unrelated to AE|1|||
147261259|NCT02438722|531129347|FG001|Overall Study|Exceeded protocol-specified maximum treatment delay unrelated to AE|0|||
147261260|NCT02438722|531129346|FG000|Overall Study|Withdrawal by Subject|0|||
147261261|NCT02438722|531129347|FG001|Overall Study|Withdrawal by Subject|1|||
147261262|NCT02438722|531129346|FG000|Overall Study|On protocol treatment|15|||
147261263|NCT02438722|531129347|FG001|Overall Study|On protocol treatment|14|||
147261264|NCT02438722|531129346|FG000|Overall Study|Did not receive protocol treatment|5|||
147261265|NCT02438722|531129347|FG001|Overall Study|Did not receive protocol treatment|0|||
147261266|NCT01520363|531129353|FG000|Overall Study|Withdrawal by Subject|2|||
147261267|NCT01520363|531129354|FG001|Overall Study|Withdrawal by Subject|0|||
147261268|NCT04191382|531129361|FG000|Overall Study|Withdrawal by Subject|1|||
147261269|NCT04191382|531129362|FG001|Overall Study|Withdrawal by Subject|0|||
147261270|NCT04191382|531129363|FG002|Overall Study|Withdrawal by Subject|0|||
147261271|NCT05237206|531129364|FG000|Overall Study|screen failure-did not receive treatment|8|||
147261272|NCT05237206|531129364|FG000|Overall Study|did not receive treatment|3|||
147261273|NCT01476696|531129365|FG000|Overall Study|Sponsor decision|2|||
147261274|NCT01476696|531129366|FG001|Overall Study|Sponsor decision|1|||
147261275|NCT01476696|531129367|FG002|Overall Study|Sponsor decision|0|||
147261276|NCT01476696|531129365|FG000|Overall Study|Withdrawal by Subject|1|||
147261277|NCT01476696|531129366|FG001|Overall Study|Withdrawal by Subject|0|||
147261278|NCT01476696|531129367|FG002|Overall Study|Withdrawal by Subject|0|||
147261279|NCT03965962|531129375|FG000|Overall Study|Adverse Event|1|||
147261280|NCT03965962|531129376|FG001|Overall Study|Adverse Event|0|||
147261281|NCT03965962|531129377|FG002|Overall Study|Adverse Event|0|||
147261282|NCT03965962|531129378|FG003|Overall Study|Adverse Event|0|||
147261283|NCT03965962|531129375|FG000|Overall Study|Protocol Violation|21|||
147261284|NCT03965962|531129376|FG001|Overall Study|Protocol Violation|4|||
147261285|NCT03965962|531129377|FG002|Overall Study|Protocol Violation|10|||
147261286|NCT03965962|531129378|FG003|Overall Study|Protocol Violation|5|||
147261287|NCT03965962|531129375|FG000|Overall Study|Lost to Follow-up|0|||
147261288|NCT03965962|531129376|FG001|Overall Study|Lost to Follow-up|1|||
147261289|NCT03965962|531129377|FG002|Overall Study|Lost to Follow-up|0|||
147261290|NCT03965962|531129378|FG003|Overall Study|Lost to Follow-up|0|||
147261291|NCT03965962|531129375|FG000|Overall Study|Withdrawal by Subject|3|||
147261292|NCT03965962|531129376|FG001|Overall Study|Withdrawal by Subject|0|||
147261293|NCT03965962|531129377|FG002|Overall Study|Withdrawal by Subject|0|||
147261294|NCT03965962|531129378|FG003|Overall Study|Withdrawal by Subject|1|||
147261295|NCT00578942|531129379|FG000|Overall Study|Lost to Follow-up|1|||
147261296|NCT01400516|531129380|FG000|Primary Trial|Withdrawal by Subject|0|||
147261297|NCT01400516|531129381|FG001|Primary Trial|Withdrawal by Subject|2|||
147261298|NCT04439318|531129382|FG000|Overall Study|Ineligible|1|||
147261299|NCT04439318|531129382|FG000|Overall Study|Never Started Treatment|3|||
147261300|NCT04439318|531129382|FG000|Overall Study|Adverse Event|10|||
147261301|NCT04439318|531129382|FG000|Overall Study|Death|2|||
147261302|NCT04439318|531129382|FG000|Overall Study|Disease Progression|25|||
147261303|NCT04439318|531129382|FG000|Overall Study|Other Complicating Disease|2|||
147261304|NCT04439318|531129382|FG000|Overall Study|Withdrawal by Subject|4|||
147261305|NCT04439318|531129382|FG000|Overall Study|Patient Refusal - Prefers Different Therapy|1|||
147261306|NCT04439318|531129382|FG000|Overall Study|Non-Compliance|1|||
147261307|NCT04439318|531129382|FG000|Overall Study|Still on Treatment|1|||
147261308|NCT00156533|531130954|FG000|Overall Study|Withdrawn - Medication Expiration|0|||
147261309|NCT00156533|531130955|FG001|Overall Study|Withdrawn - Medication Expiration|2|||
147261310|NCT00156533|531130956|FG002|Overall Study|Withdrawn - Medication Expiration|1|||
147261311|NCT00156533|531130957|FG003|Overall Study|Withdrawn - Medication Expiration|0|||
147261312|NCT00156533|531130954|FG000|Overall Study|Withdrawal by Subject|1|||
147261313|NCT00156533|531130955|FG001|Overall Study|Withdrawal by Subject|0|||
147261314|NCT00156533|531130956|FG002|Overall Study|Withdrawal by Subject|0|||
147599755|NCT04135196|532352497|FG001|Overall Study|Pregnancy|0|||
147599756|NCT04135196|532352498|FG002|Overall Study|Pregnancy|1|||
147261315|NCT00156533|531130957|FG003|Overall Study|Withdrawal by Subject|1|||
147261316|NCT00156533|531130954|FG000|Overall Study|Failed Screening|1|||
147261317|NCT00156533|531130955|FG001|Overall Study|Failed Screening|0|||
147261318|NCT00156533|531130956|FG002|Overall Study|Failed Screening|1|||
147599757|NCT04135196|532352499|FG003|Overall Study|Pregnancy|0|||
147261319|NCT00156533|531130957|FG003|Overall Study|Failed Screening|1|||
147261320|NCT01541969|531130960|FG000|Double-blind (0-12 Weeks)|Dominant pitch match not possible|0|||
147261321|NCT01541969|531130961|FG001|Double-blind (0-12 Weeks)|Dominant pitch match not possible|1|||
147261322|NCT01541969|531130960|FG000|Double-blind (0-12 Weeks)|Pitch shifted out of fitting range|1|||
147261323|NCT01541969|531130961|FG001|Double-blind (0-12 Weeks)|Pitch shifted out of fitting range|1|||
147261324|NCT01541969|531130960|FG000|Double-blind (0-12 Weeks)|Withdrawal by Subject|2|||
147599758|NCT04135196|532352500|FG004|Overall Study|Pregnancy|0|||
147599759|NCT04135196|532352496|FG000|Overall Study|Withdrawal by Subject|0|||
147599760|NCT04135196|532352497|FG001|Overall Study|Withdrawal by Subject|0|||
147261325|NCT01541969|531130961|FG001|Double-blind (0-12 Weeks)|Withdrawal by Subject|0|||
147261326|NCT01541969|531130960|FG000|Double-blind (0-12 Weeks)|Lost to Follow-up|1|||
147261327|NCT01541969|531130961|FG001|Double-blind (0-12 Weeks)|Lost to Follow-up|0|||
147261328|NCT01541969|531130960|FG000|Double-blind (0-12 Weeks)|Adverse Event|2|||
147261329|NCT01541969|531130961|FG001|Double-blind (0-12 Weeks)|Adverse Event|0|||
147261330|NCT01541969|531130960|FG000|Open Label Extension (12-36 Weeks)|Pitch shifted out of fitting range|1|||
147261331|NCT01541969|531130961|FG001|Open Label Extension (12-36 Weeks)|Pitch shifted out of fitting range|1|||
147261332|NCT01541969|531130960|FG000|Open Label Extension (12-36 Weeks)|Prescription adjusted: tones inaudible|1|||
147261333|NCT01541969|531130961|FG001|Open Label Extension (12-36 Weeks)|Prescription adjusted: tones inaudible|0|||
147261334|NCT01541969|531130960|FG000|Open Label Extension (12-36 Weeks)|Withdrawal by Subject|1|||
147261335|NCT01541969|531130961|FG001|Open Label Extension (12-36 Weeks)|Withdrawal by Subject|1|||
147261336|NCT01541969|531130960|FG000|Open Label Extension (12-36 Weeks)|Lost to Follow-up|6|||
147261337|NCT01541969|531130961|FG001|Open Label Extension (12-36 Weeks)|Lost to Follow-up|8|||
147261338|NCT01541969|531130960|FG000|Open Label Extension (12-36 Weeks)|Adverse Event|2|||
147261339|NCT01541969|531130961|FG001|Open Label Extension (12-36 Weeks)|Adverse Event|3|||
147261340|NCT01365507|531130962|FG000|Overall Study|Withdrawal Criteria|8|||
147261341|NCT01365507|531130963|FG001|Overall Study|Withdrawal Criteria|5|||
147261342|NCT01365507|531130962|FG000|Overall Study|Unclassified|1|||
147261343|NCT01365507|531130963|FG001|Overall Study|Unclassified|4|||
147261344|NCT03265249|531130966|FG000|Overall Study|Withdrawal by Subject|0|||
147261345|NCT03265249|531130967|FG001|Overall Study|Withdrawal by Subject|1|||
147261346|NCT01614990|531130968|FG000|Overall Study|Protocol Violation|1|||
147261347|NCT01614990|531130969|FG001|Overall Study|Protocol Violation|1|||
147261348|NCT02255500|531130976|FG000|Overall Study|Withdrawal by Subject|1|||
147261349|NCT02255500|531130977|FG001|Overall Study|Withdrawal by Subject|0|||
147261350|NCT01012622|531130978|FG000|Overall Study|Withdrawal by Subject|6|||
147261351|NCT01012622|531130978|FG000|Overall Study|Lost to Follow-up|5|||
147261352|NCT01012622|531130978|FG000|Overall Study|Adverse Event|7|||
147261353|NCT01012622|531130978|FG000|Overall Study|non-compliance with the drug|9|||
147261354|NCT01012622|531130978|FG000|Overall Study|Other|1|||
147261355|NCT01012622|531130978|FG000|Overall Study|screening failure|1|||
147261356|NCT01012622|531130978|FG000|Overall Study|withdrawal of consent by a parent|2|||
147261357|NCT04254978|531130979|FG000|Initial Treatment Period (ITP)|Withdrawal by Subject|3|||
147261358|NCT04254978|531130979|FG000|Initial Treatment Period (ITP)|Adverse Event|5|||
147261359|NCT04254978|531130979|FG000|Initial Treatment Period (ITP)|Lack of Efficacy|1|||
147261360|NCT04254978|531130979|FG000|Additional Treatment Period (ATP)|Withdrawal by Subject|3|||
147261361|NCT04254978|531130979|FG000|Additional Treatment Period (ATP)|Physician Decision|1|||
147261362|NCT04254978|531130979|FG000|Additional Treatment Period (ATP)|Adverse Event|7|||
147261363|NCT02515942|531130980|FG000|Overall Study|Adverse Event|5|||
147261364|NCT02515942|531130981|FG001|Overall Study|Adverse Event|0|||
147261365|NCT02515942|531130982|FG002|Overall Study|Adverse Event|0|||
147261366|NCT02515942|531130980|FG000|Overall Study|Death|0|||
147261367|NCT02515942|531130981|FG001|Overall Study|Death|0|||
147261368|NCT02515942|531130982|FG002|Overall Study|Death|1|||
147261369|NCT02515942|531130980|FG000|Overall Study|Lack of Efficacy|0|||
147261370|NCT02515942|531130981|FG001|Overall Study|Lack of Efficacy|0|||
147261371|NCT02515942|531130982|FG002|Overall Study|Lack of Efficacy|1|||
147261372|NCT02515942|531130980|FG000|Overall Study|Lost to Follow-up|2|||
147261373|NCT02515942|531130981|FG001|Overall Study|Lost to Follow-up|0|||
147261374|NCT02515942|531130982|FG002|Overall Study|Lost to Follow-up|0|||
147261375|NCT02515942|531130980|FG000|Overall Study|Withdrawal by Subject|0|||
147261376|NCT02515942|531130981|FG001|Overall Study|Withdrawal by Subject|3|||
147261377|NCT02515942|531130982|FG002|Overall Study|Withdrawal by Subject|2|||
147261378|NCT00666757|531130985|FG000|Overall Study|Lost to Follow-up|39|||
147261379|NCT00666757|531130986|FG001|Overall Study|Lost to Follow-up|35|||
147261380|NCT00666757|531130985|FG000|Overall Study|Protocol Violation|23|||
147261381|NCT00666757|531130986|FG001|Overall Study|Protocol Violation|24|||
147261382|NCT00666757|531130985|FG000|Overall Study|Adverse Event|22|||
147261383|NCT00666757|531130986|FG001|Overall Study|Adverse Event|12|||
147261384|NCT00666757|531130985|FG000|Overall Study|Withdrawal by Subject|13|||
147261385|NCT00666757|531130986|FG001|Overall Study|Withdrawal by Subject|17|||
147261386|NCT00666757|531130985|FG000|Overall Study|Lack of Efficacy|3|||
147261387|NCT00666757|531130986|FG001|Overall Study|Lack of Efficacy|6|||
147261388|NCT00666757|531130985|FG000|Overall Study|Physician Decision|0|||
147261389|NCT00666757|531130986|FG001|Overall Study|Physician Decision|2|||
147261390|NCT00666757|531130985|FG000|Overall Study|Sponsor decision|0|||
147261391|NCT00666757|531130986|FG001|Overall Study|Sponsor decision|1|||
147599761|NCT04135196|532352498|FG002|Overall Study|Withdrawal by Subject|0|||
147599762|NCT04135196|532352499|FG003|Overall Study|Withdrawal by Subject|0|||
147261392|NCT01723163|531130989|FG000|Treatment Phase|Withdrawal by Subject|14|||
147599763|NCT04135196|532352500|FG004|Overall Study|Withdrawal by Subject|1|||
147261393|NCT01723163|531130990|FG001|Treatment Phase|Withdrawal by Subject|6|||
147261394|NCT01723163|531130989|FG000|Treatment Phase|Withdrawal by PI|5|||
147261395|NCT01723163|531130990|FG001|Treatment Phase|Withdrawal by PI|1|||
147450103|NCT03245450|531811361|FG000|Overall Study|Radiological disease progression|3|||
147450104|NCT03245450|531811362|FG001|Overall Study|Radiological disease progression|3|||
147450105|NCT03245450|531811363|FG002|Overall Study|Radiological disease progression|2|||
147450106|NCT03245450|531811364|FG003|Overall Study|Radiological disease progression|2|||
147450107|NCT03245450|531811365|FG004|Overall Study|Radiological disease progression|7|||
147450108|NCT03245450|531811366|FG005|Overall Study|Radiological disease progression|6|||
147450109|NCT03245450|531811367|FG006|Overall Study|Radiological disease progression|6|||
147450110|NCT03245450|531811361|FG000|Overall Study|Clinical disease progression|0|||
147450111|NCT03245450|531811362|FG001|Overall Study|Clinical disease progression|0|||
147450112|NCT03245450|531811363|FG002|Overall Study|Clinical disease progression|1|||
147450113|NCT03245450|531811364|FG003|Overall Study|Clinical disease progression|0|||
147450114|NCT03245450|531811365|FG004|Overall Study|Clinical disease progression|0|||
147450115|NCT03245450|531811366|FG005|Overall Study|Clinical disease progression|2|||
147450116|NCT03245450|531811367|FG006|Overall Study|Clinical disease progression|0|||
147450117|NCT03245450|531811361|FG000|Overall Study|Other|0|||
147450118|NCT03245450|531811362|FG001|Overall Study|Other|0|||
147450119|NCT03245450|531811363|FG002|Overall Study|Other|0|||
147450120|NCT03245450|531811364|FG003|Overall Study|Other|1|||
147450121|NCT03245450|531811365|FG004|Overall Study|Other|1|||
147450122|NCT03245450|531811366|FG005|Overall Study|Other|1|||
147450123|NCT03245450|531811367|FG006|Overall Study|Other|1|||
147450124|NCT03245450|531811361|FG000|Overall Study|Withdrawal by Subject|0|||
147450125|NCT03245450|531811362|FG001|Overall Study|Withdrawal by Subject|1|||
147450126|NCT03245450|531811363|FG002|Overall Study|Withdrawal by Subject|0|||
147450127|NCT03245450|531811364|FG003|Overall Study|Withdrawal by Subject|0|||
147450128|NCT03245450|531811365|FG004|Overall Study|Withdrawal by Subject|0|||
147261396|NCT01723163|531130989|FG000|3-Month Follow-up|Withdrawal by Subject|1|||
147261397|NCT01723163|531130990|FG001|3-Month Follow-up|Withdrawal by Subject|0|||
147261398|NCT01723163|531130989|FG000|3-Month Follow-up|Unable to Contact|12|||
147261399|NCT01723163|531130990|FG001|3-Month Follow-up|Unable to Contact|19|||
147261400|NCT01723163|531130989|FG000|6-Month Follow-up|Death|1|||
147261401|NCT01723163|531130990|FG001|6-Month Follow-up|Death|0|||
147261402|NCT01723163|531130989|FG000|6-Month Follow-up|Unable to Contact|17|||
147261403|NCT01723163|531130990|FG001|6-Month Follow-up|Unable to Contact|15|||
147261404|NCT01723163|531130989|FG000|12-Month Follow-up|Death|1|||
147261405|NCT01723163|531130990|FG001|12-Month Follow-up|Death|0|||
147261406|NCT01723163|531130989|FG000|12-Month Follow-up|Unable to Contact|23|||
147261407|NCT01723163|531130990|FG001|12-Month Follow-up|Unable to Contact|28|||
147261408|NCT02510794|531130991|FG000|Overall Study|Adverse Event|0|||
147261409|NCT02510794|531130992|FG001|Overall Study|Adverse Event|1|||
147261410|NCT02510794|531130993|FG002|Overall Study|Adverse Event|0|||
147261411|NCT02510794|531130994|FG003|Overall Study|Adverse Event|0|||
147261412|NCT02510794|531130991|FG000|Overall Study|Death|1|||
147261413|NCT02510794|531130992|FG001|Overall Study|Death|2|||
147261414|NCT02510794|531130993|FG002|Overall Study|Death|1|||
147261415|NCT02510794|531130994|FG003|Overall Study|Death|1|||
147261416|NCT02510794|531130991|FG000|Overall Study|Lack of Efficacy|3|||
147261417|NCT02510794|531130992|FG001|Overall Study|Lack of Efficacy|1|||
147261418|NCT02510794|531130993|FG002|Overall Study|Lack of Efficacy|1|||
147261419|NCT02510794|531130994|FG003|Overall Study|Lack of Efficacy|0|||
147261420|NCT02510794|531130991|FG000|Overall Study|Participant moved out of the area|0|||
147450129|NCT03245450|531811366|FG005|Overall Study|Withdrawal by Subject|0|||
147450130|NCT03245450|531811367|FG006|Overall Study|Withdrawal by Subject|0|||
147450131|NCT03245450|531811361|FG000|Overall Study|Adverse Event|0|||
147450132|NCT03245450|531811362|FG001|Overall Study|Adverse Event|0|||
147450133|NCT03245450|531811363|FG002|Overall Study|Adverse Event|0|||
147450134|NCT03245450|531811364|FG003|Overall Study|Adverse Event|0|||
147450135|NCT03245450|531811365|FG004|Overall Study|Adverse Event|1|||
147450136|NCT03245450|531811366|FG005|Overall Study|Adverse Event|0|||
147450137|NCT03245450|531811367|FG006|Overall Study|Adverse Event|2|||
147450138|NCT05098041|531811372|FG000|Period 1 (1 Day)|Withdrawal by Subject|1|||
147450139|NCT00464334|531811373|FG000|Overall Study|Adverse Event|0|||
147450140|NCT00464334|531811374|FG001|Overall Study|Adverse Event|0|||
147450141|NCT00464334|531811375|FG002|Overall Study|Adverse Event|0|||
147450142|NCT00464334|531811376|FG003|Overall Study|Adverse Event|1|||
147450143|NCT00464334|531811377|FG004|Overall Study|Adverse Event|1|||
147450144|NCT00464334|531811378|FG005|Overall Study|Adverse Event|1|||
147261421|NCT02510794|531130992|FG001|Overall Study|Participant moved out of the area|0|||
147450145|NCT00464334|531811379|FG006|Overall Study|Adverse Event|0|||
147450146|NCT00464334|531811380|FG007|Overall Study|Adverse Event|0|||
147450147|NCT00464334|531811381|FG008|Overall Study|Adverse Event|2|||
147450148|NCT00464334|531811382|FG009|Overall Study|Adverse Event|1|||
147450149|NCT00464334|531811383|FG010|Overall Study|Adverse Event|2|||
147261422|NCT02510794|531130993|FG002|Overall Study|Participant moved out of the area|0|||
147261423|NCT02510794|531130994|FG003|Overall Study|Participant moved out of the area|1|||
147261424|NCT02510794|531130991|FG000|Overall Study|Physician Decision|3|||
147261425|NCT02510794|531130992|FG001|Overall Study|Physician Decision|0|||
147261426|NCT02510794|531130993|FG002|Overall Study|Physician Decision|0|||
147599764|NCT03201211|532352501|FG000|Overall Study|Adverse Event|1|||
147599765|NCT03201211|532352502|FG001|Overall Study|Adverse Event|0|||
147599766|NCT03201211|532352503|FG002|Overall Study|Adverse Event|0|||
147599767|NCT03201211|532352501|FG000|Overall Study|Protocol Violation|1|||
147599768|NCT03201211|532352502|FG001|Overall Study|Protocol Violation|0|||
147599769|NCT03201211|532352503|FG002|Overall Study|Protocol Violation|0|||
147261427|NCT02510794|531130994|FG003|Overall Study|Physician Decision|0|||
147261428|NCT02510794|531130991|FG000|Overall Study|Protocol Violation|0|||
147261429|NCT02510794|531130992|FG001|Overall Study|Protocol Violation|0|||
147261430|NCT02510794|531130993|FG002|Overall Study|Protocol Violation|1|||
147261431|NCT02510794|531130994|FG003|Overall Study|Protocol Violation|0|||
147261432|NCT02510794|531130991|FG000|Overall Study|Withdrawal by Subject|1|||
147261433|NCT02510794|531130992|FG001|Overall Study|Withdrawal by Subject|2|||
147261434|NCT02510794|531130993|FG002|Overall Study|Withdrawal by Subject|4|||
147261435|NCT02510794|531130994|FG003|Overall Study|Withdrawal by Subject|3|||
147261436|NCT01856790|531130997|FG000|Closed Loop Control|Withdrawal by Subject|2|||
147261437|NCT01856790|531130997|FG000|Closed Loop Control + Liraglutide|Withdrawal by Subject|2|||
147261438|NCT02731729|531130998|FG000|Overall Study|Death|2|||
147261439|NCT02731729|531130999|FG001|Overall Study|Death|2|||
147261440|NCT02731729|531130998|FG000|Overall Study|Study terminated by Sponsor|6|||
147261441|NCT02731729|531130999|FG001|Overall Study|Study terminated by Sponsor|6|||
147261442|NCT02731729|531130998|FG000|Overall Study|Withdrawal by Subject|1|||
147261443|NCT02731729|531130999|FG001|Overall Study|Withdrawal by Subject|0|||
147261444|NCT01344447|531131000|FG000|Overall Study|Adverse Event|1|||
147261445|NCT01344447|531131000|FG000|Overall Study|Protocol Violation|1|||
147261446|NCT01344447|531131000|FG000|Overall Study|Withdrawal by Subject|1|||
147261447|NCT01344447|531131000|FG000|Overall Study|The contrast was not seen|1|||
147261448|NCT01344447|531131000|FG000|Overall Study|Physician Decision|1|||
147261449|NCT01344447|531131000|FG000|Overall Study|MRA unsuccessful|1|||
147261450|NCT01344447|531131000|FG000|Overall Study|Bolus tracking failed|1|||
147261451|NCT01344447|531131000|FG000|Overall Study|Error of power injector|1|||
147261452|NCT03446040|531131001|FG000|Overall Study|Disease progression|3|||
147261453|NCT03446040|531131002|FG001|Overall Study|Disease progression|3|||
147261454|NCT03446040|531131003|FG002|Overall Study|Disease progression|3|||
147261455|NCT03446040|531131004|FG003|Overall Study|Disease progression|4|||
147261456|NCT03446040|531131005|FG004|Overall Study|Disease progression|4|||
147261457|NCT03446040|531131006|FG005|Overall Study|Disease progression|6|||
147261458|NCT03446040|531131007|FG006|Overall Study|Disease progression|3|||
147261459|NCT03446040|531131008|FG007|Overall Study|Disease progression|4|||
147261460|NCT03446040|531131009|FG008|Overall Study|Disease progression|2|||
147261461|NCT03446040|531131010|FG009|Overall Study|Disease progression|4|||
147261462|NCT03446040|531131011|FG010|Overall Study|Disease progression|9|||
147261463|NCT03446040|531131012|FG011|Overall Study|Disease progression|3|||
147261464|NCT03446040|531131013|FG012|Overall Study|Disease progression|7|||
147261465|NCT03446040|531131014|FG013|Overall Study|Disease progression|7|||
147261466|NCT03446040|531131001|FG000|Overall Study|Study drug toxicity|0|||
147261467|NCT03446040|531131002|FG001|Overall Study|Study drug toxicity|0|||
147261468|NCT03446040|531131003|FG002|Overall Study|Study drug toxicity|0|||
147261469|NCT03446040|531131004|FG003|Overall Study|Study drug toxicity|0|||
147261470|NCT03446040|531131005|FG004|Overall Study|Study drug toxicity|0|||
147261471|NCT03446040|531131006|FG005|Overall Study|Study drug toxicity|0|||
147261472|NCT03446040|531131007|FG006|Overall Study|Study drug toxicity|0|||
147261473|NCT03446040|531131008|FG007|Overall Study|Study drug toxicity|0|||
147261474|NCT03446040|531131009|FG008|Overall Study|Study drug toxicity|1|||
147261475|NCT03446040|531131010|FG009|Overall Study|Study drug toxicity|0|||
147261476|NCT03446040|531131011|FG010|Overall Study|Study drug toxicity|0|||
147261477|NCT03446040|531131012|FG011|Overall Study|Study drug toxicity|0|||
147261478|NCT03446040|531131013|FG012|Overall Study|Study drug toxicity|0|||
147599770|NCT03201211|532352501|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
147599771|NCT03201211|532352502|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
147599772|NCT03201211|532352503|FG002|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|1|||
147261479|NCT03446040|531131014|FG013|Overall Study|Study drug toxicity|0|||
147261480|NCT03446040|531131001|FG000|Overall Study|Adverse Event|0|||
147261481|NCT03446040|531131002|FG001|Overall Study|Adverse Event|0|||
147261482|NCT03446040|531131003|FG002|Overall Study|Adverse Event|0|||
147599773|NCT03201211|532352501|FG000|Overall Study|OTHER unknown reasons|0|||
147599774|NCT03201211|532352502|FG001|Overall Study|OTHER unknown reasons|1|||
147261483|NCT03446040|531131004|FG003|Overall Study|Adverse Event|0|||
147261484|NCT03446040|531131005|FG004|Overall Study|Adverse Event|0|||
147261485|NCT03446040|531131006|FG005|Overall Study|Adverse Event|2|||
147261486|NCT03446040|531131007|FG006|Overall Study|Adverse Event|0|||
147261487|NCT03446040|531131008|FG007|Overall Study|Adverse Event|0|||
147261488|NCT03446040|531131009|FG008|Overall Study|Adverse Event|1|||
147261489|NCT03446040|531131010|FG009|Overall Study|Adverse Event|0|||
147261490|NCT03446040|531131011|FG010|Overall Study|Adverse Event|0|||
147261491|NCT03446040|531131012|FG011|Overall Study|Adverse Event|0|||
147261492|NCT03446040|531131013|FG012|Overall Study|Adverse Event|0|||
147261493|NCT03446040|531131014|FG013|Overall Study|Adverse Event|0|||
147261494|NCT03446040|531131001|FG000|Overall Study|Death|0|||
147261495|NCT03446040|531131002|FG001|Overall Study|Death|0|||
147261496|NCT03446040|531131003|FG002|Overall Study|Death|0|||
147599775|NCT03201211|532352503|FG002|Overall Study|OTHER unknown reasons|0|||
147599776|NCT01970865|532352504|FG000|Overall Study|Death|3|||
147599777|NCT01970865|532352505|FG001|Overall Study|Death|2|||
147599778|NCT01970865|532352506|FG002|Overall Study|Death|3|||
147599779|NCT01970865|532352507|FG003|Overall Study|Death|6|||
147599780|NCT01970865|532352508|FG004|Overall Study|Death|9|||
147599781|NCT01970865|532352509|FG005|Overall Study|Death|3|||
147261497|NCT03446040|531131004|FG003|Overall Study|Death|0|||
147261498|NCT03446040|531131005|FG004|Overall Study|Death|0|||
147261499|NCT03446040|531131006|FG005|Overall Study|Death|0|||
147261500|NCT03446040|531131007|FG006|Overall Study|Death|0|||
147261501|NCT03446040|531131008|FG007|Overall Study|Death|0|||
147261502|NCT03446040|531131009|FG008|Overall Study|Death|0|||
147261503|NCT03446040|531131010|FG009|Overall Study|Death|0|||
147261504|NCT03446040|531131011|FG010|Overall Study|Death|1|||
147261505|NCT03446040|531131012|FG011|Overall Study|Death|0|||
147261506|NCT03446040|531131013|FG012|Overall Study|Death|0|||
147261507|NCT03446040|531131014|FG013|Overall Study|Death|2|||
147261508|NCT03446040|531131001|FG000|Overall Study|Participant requested to discontinue study treatment|0|||
147261509|NCT03446040|531131002|FG001|Overall Study|Participant requested to discontinue study treatment|0|||
147261510|NCT03446040|531131003|FG002|Overall Study|Participant requested to discontinue study treatment|0|||
147261511|NCT03446040|531131004|FG003|Overall Study|Participant requested to discontinue study treatment|0|||
147261512|NCT03446040|531131005|FG004|Overall Study|Participant requested to discontinue study treatment|0|||
147261513|NCT03446040|531131006|FG005|Overall Study|Participant requested to discontinue study treatment|0|||
147261514|NCT03446040|531131007|FG006|Overall Study|Participant requested to discontinue study treatment|0|||
147261515|NCT03446040|531131008|FG007|Overall Study|Participant requested to discontinue study treatment|0|||
147261516|NCT03446040|531131009|FG008|Overall Study|Participant requested to discontinue study treatment|0|||
147261517|NCT03446040|531131010|FG009|Overall Study|Participant requested to discontinue study treatment|0|||
147261518|NCT03446040|531131011|FG010|Overall Study|Participant requested to discontinue study treatment|0|||
147261519|NCT03446040|531131012|FG011|Overall Study|Participant requested to discontinue study treatment|1|||
147261520|NCT03446040|531131013|FG012|Overall Study|Participant requested to discontinue study treatment|0|||
147261521|NCT03446040|531131014|FG013|Overall Study|Participant requested to discontinue study treatment|0|||
147261522|NCT03446040|531131001|FG000|Overall Study|Participant withdrew consent|0|||
147261523|NCT03446040|531131002|FG001|Overall Study|Participant withdrew consent|0|||
147261524|NCT03446040|531131003|FG002|Overall Study|Participant withdrew consent|0|||
147450150|NCT00464334|531811373|FG000|Overall Study|Lack of Efficacy|0|||
147261525|NCT03446040|531131004|FG003|Overall Study|Participant withdrew consent|0|||
147261526|NCT03446040|531131005|FG004|Overall Study|Participant withdrew consent|0|||
147261527|NCT03446040|531131006|FG005|Overall Study|Participant withdrew consent|1|||
147261528|NCT03446040|531131007|FG006|Overall Study|Participant withdrew consent|0|||
147261529|NCT03446040|531131008|FG007|Overall Study|Participant withdrew consent|1|||
147261530|NCT03446040|531131009|FG008|Overall Study|Participant withdrew consent|0|||
147261531|NCT03446040|531131010|FG009|Overall Study|Participant withdrew consent|0|||
147261532|NCT03446040|531131011|FG010|Overall Study|Participant withdrew consent|0|||
147261533|NCT03446040|531131012|FG011|Overall Study|Participant withdrew consent|0|||
147261534|NCT03446040|531131013|FG012|Overall Study|Participant withdrew consent|0|||
147261535|NCT03446040|531131014|FG013|Overall Study|Participant withdrew consent|0|||
147261536|NCT03446040|531131001|FG000|Overall Study|Not reported|0|||
147261537|NCT03446040|531131002|FG001|Overall Study|Not reported|0|||
147261538|NCT03446040|531131003|FG002|Overall Study|Not reported|1|||
147261539|NCT03446040|531131004|FG003|Overall Study|Not reported|0|||
147261540|NCT03446040|531131005|FG004|Overall Study|Not reported|0|||
147261541|NCT03446040|531131006|FG005|Overall Study|Not reported|0|||
147261542|NCT03446040|531131007|FG006|Overall Study|Not reported|0|||
147261543|NCT03446040|531131008|FG007|Overall Study|Not reported|0|||
147261544|NCT03446040|531131009|FG008|Overall Study|Not reported|0|||
147261545|NCT03446040|531131010|FG009|Overall Study|Not reported|0|||
147261546|NCT03446040|531131011|FG010|Overall Study|Not reported|0|||
147261547|NCT03446040|531131012|FG011|Overall Study|Not reported|0|||
147261548|NCT03446040|531131013|FG012|Overall Study|Not reported|0|||
147261549|NCT03446040|531131014|FG013|Overall Study|Not reported|0|||
147261550|NCT00456521|531131015|FG000|Overall Study|Adverse Event|150|||
147261551|NCT00456521|531131016|FG001|Overall Study|Adverse Event|25|||
147261552|NCT00456521|531131015|FG000|Overall Study|Withdrawal by Subject|43|||
147450151|NCT00464334|531811374|FG001|Overall Study|Lack of Efficacy|1|||
147261553|NCT00456521|531131016|FG001|Overall Study|Withdrawal by Subject|24|||
147599782|NCT01970865|532352510|FG006|Overall Study|Death|2|||
147599783|NCT01970865|532352511|FG007|Overall Study|Death|3|||
147261554|NCT00456521|531131015|FG000|Overall Study|Lost to Follow-up|22|||
147261555|NCT00456521|531131016|FG001|Overall Study|Lost to Follow-up|17|||
147261556|NCT00456521|531131015|FG000|Overall Study|Lack of Efficacy|3|||
147261557|NCT00456521|531131016|FG001|Overall Study|Lack of Efficacy|6|||
147599784|NCT01970865|532352512|FG008|Overall Study|Death|2|||
147261558|NCT00456521|531131015|FG000|Overall Study|Protocol Violation|4|||
147261559|NCT00456521|531131016|FG001|Overall Study|Protocol Violation|0|||
147261560|NCT00456521|531131015|FG000|Overall Study|Pregnancy|1|||
147261561|NCT00456521|531131016|FG001|Overall Study|Pregnancy|1|||
147261562|NCT00456521|531131015|FG000|Overall Study|Drug non-compliance, moved, other|26|||
147261563|NCT00456521|531131016|FG001|Overall Study|Drug non-compliance, moved, other|11|||
147261564|NCT00076011|531131020|FG000|Overall Study|Death|1|||
147261565|NCT00076011|531131020|FG000|Overall Study|Adverse Event|10|||
147261566|NCT00076011|531131020|FG000|Overall Study|Lack of Efficacy|25|||
147261567|NCT00076011|531131020|FG000|Overall Study|Withdrawal by Subject|1|||
147261568|NCT00076011|531131020|FG000|Overall Study|Study terminated by sponsor|3|||
147261569|NCT00076011|531131020|FG000|Overall Study|Other|11|||
147261570|NCT00076011|531131020|FG000|Overall Study|Ongoing|1|||
147261571|NCT06027866|531131025|FG000|Overall Study|Withdrawal by Subject|2|||
147261572|NCT04343521|531131026|FG000|Overall Study|Adverse Event|0|||
147261573|NCT04343521|531131027|FG001|Overall Study|Adverse Event|2|||
147261574|NCT04343521|531131026|FG000|Overall Study|Death|1|||
147261575|NCT04343521|531131027|FG001|Overall Study|Death|2|||
147261576|NCT04343521|531131026|FG000|Overall Study|Lost to follow-up due to moving from the cluster|327|||
147261577|NCT04343521|531131027|FG001|Overall Study|Lost to follow-up due to moving from the cluster|393|||
147261578|NCT04343521|531131026|FG000|Overall Study|Withdrawal by Subject|70|||
147261579|NCT04343521|531131027|FG001|Overall Study|Withdrawal by Subject|95|||
147261580|NCT04343521|531131026|FG000|Overall Study|Withdrawal by study team|6|||
147261581|NCT04343521|531131027|FG001|Overall Study|Withdrawal by study team|12|||
147261582|NCT02939560|531131028|FG000|Overall Study|Withdrawal by Subject|2|||
147261583|NCT02939560|531131028|FG000|Overall Study|Protocol Violation|1|||
147261584|NCT03340025|531131029|FG000|Overall Study|Lost to Follow-up|2|||
147261585|NCT03340025|531131030|FG001|Overall Study|Lost to Follow-up|2|||
147261586|NCT02420691|531131033|FG000|Overall Study|Adverse Event|3|||
147261587|NCT02420691|531131033|FG000|Overall Study|Withdrawal by Subject|3|||
147261588|NCT03897179|531131036|FG000|Overall Study|Withdrawal by Subject|1|||
147261589|NCT00704535|531131037|FG000|Overall Study|Adverse Event|2|||
147261590|NCT00704535|531131037|FG000|Overall Study|Death|2|||
147261591|NCT00704535|531131037|FG000|Overall Study|Lost to Follow-up|8|||
147261592|NCT00704535|531131037|FG000|Overall Study|Protocol Violation|10|||
147261593|NCT00704535|531131037|FG000|Overall Study|Completed status not on Case Report Form|124|||
147261594|NCT05694546|531131041|FG000|Overall Study|Lost to Follow-up|11|||
147261595|NCT00768144|531131045|FG000|Overall Study|Adverse Event|13|||
147261596|NCT00768144|531131045|FG000|Overall Study|Progressive Disease|21|||
147261597|NCT00768144|531131045|FG000|Overall Study|Patient or MD Decision to End Treatment|1|||
147261598|NCT00768144|531131045|FG000|Overall Study|Pt Withdrew Consent|1|||
147261599|NCT01150123|531131046|FG000|Overall Study|Withdrawal by Subject|1|||
147261600|NCT01150123|531131047|FG001|Overall Study|Withdrawal by Subject|1|||
147261601|NCT01150123|531131048|FG002|Overall Study|Withdrawal by Subject|2|||
147261602|NCT01150123|531131049|FG003|Overall Study|Withdrawal by Subject|1|||
147261603|NCT01150123|531131050|FG004|Overall Study|Withdrawal by Subject|1|||
147261604|NCT01150123|531131051|FG005|Overall Study|Withdrawal by Subject|1|||
147261605|NCT01150123|531131052|FG006|Overall Study|Withdrawal by Subject|0|||
147261606|NCT01150123|531131053|FG007|Overall Study|Withdrawal by Subject|3|||
147261607|NCT01150123|531131054|FG008|Overall Study|Withdrawal by Subject|2|||
147261608|NCT01150123|531131055|FG009|Overall Study|Withdrawal by Subject|0|||
147261609|NCT01150123|531131056|FG010|Overall Study|Withdrawal by Subject|1|||
147261610|NCT01150123|531131057|FG011|Overall Study|Withdrawal by Subject|0|||
147261611|NCT01150123|531131058|FG012|Overall Study|Withdrawal by Subject|1|||
147261612|NCT01150123|531131059|FG013|Overall Study|Withdrawal by Subject|0|||
147261613|NCT01150123|531131060|FG014|Overall Study|Withdrawal by Subject|0|||
147261614|NCT01150123|531131061|FG015|Overall Study|Withdrawal by Subject|1|||
147261615|NCT01150123|531131062|FG016|Overall Study|Withdrawal by Subject|0|||
147261616|NCT01150123|531131063|FG017|Overall Study|Withdrawal by Subject|1|||
147261617|NCT01150123|531131046|FG000|Overall Study|Lost to Follow-up|2|||
147261618|NCT01150123|531131047|FG001|Overall Study|Lost to Follow-up|1|||
147599785|NCT01970865|532352513|FG009|Overall Study|Death|2|||
147599786|NCT01970865|532352514|FG010|Overall Study|Death|8|||
147599787|NCT01970865|532352515|FG011|Overall Study|Death|13|||
147261619|NCT01150123|531131048|FG002|Overall Study|Lost to Follow-up|2|||
147261620|NCT01150123|531131049|FG003|Overall Study|Lost to Follow-up|2|||
147261621|NCT01150123|531131050|FG004|Overall Study|Lost to Follow-up|2|||
147261622|NCT01150123|531131051|FG005|Overall Study|Lost to Follow-up|5|||
147261623|NCT01150123|531131052|FG006|Overall Study|Lost to Follow-up|0|||
147261624|NCT01150123|531131053|FG007|Overall Study|Lost to Follow-up|0|||
147261625|NCT01150123|531131054|FG008|Overall Study|Lost to Follow-up|3|||
147261626|NCT01150123|531131055|FG009|Overall Study|Lost to Follow-up|1|||
147261627|NCT01150123|531131056|FG010|Overall Study|Lost to Follow-up|1|||
147261628|NCT01150123|531131057|FG011|Overall Study|Lost to Follow-up|1|||
147261629|NCT01150123|531131058|FG012|Overall Study|Lost to Follow-up|2|||
147261630|NCT01150123|531131059|FG013|Overall Study|Lost to Follow-up|0|||
147261631|NCT01150123|531131060|FG014|Overall Study|Lost to Follow-up|0|||
147261632|NCT01150123|531131061|FG015|Overall Study|Lost to Follow-up|0|||
147261633|NCT01150123|531131062|FG016|Overall Study|Lost to Follow-up|0|||
147261634|NCT01150123|531131063|FG017|Overall Study|Lost to Follow-up|0|||
147261635|NCT01466387|531131066|FG000|Overall Study|Adverse Event|0|||
147261636|NCT01466387|531131067|FG001|Overall Study|Adverse Event|0|||
147261637|NCT01466387|531131068|FG002|Overall Study|Adverse Event|1|||
147261638|NCT01466387|531131069|FG003|Overall Study|Adverse Event|1|||
147261639|NCT01466387|531131070|FG004|Overall Study|Adverse Event|0|||
147261640|NCT01466387|531131071|FG005|Overall Study|Adverse Event|0|||
147261641|NCT01466387|531131066|FG000|Overall Study|Lost to Follow-up|0|||
147261642|NCT01466387|531131067|FG001|Overall Study|Lost to Follow-up|0|||
147261643|NCT01466387|531131068|FG002|Overall Study|Lost to Follow-up|0|||
147261644|NCT01466387|531131069|FG003|Overall Study|Lost to Follow-up|0|||
147261645|NCT01466387|531131070|FG004|Overall Study|Lost to Follow-up|0|||
147261646|NCT01466387|531131071|FG005|Overall Study|Lost to Follow-up|1|||
147261647|NCT01466387|531131066|FG000|Overall Study|Protocol Violation|1|||
147261648|NCT01466387|531131067|FG001|Overall Study|Protocol Violation|0|||
147261649|NCT01466387|531131068|FG002|Overall Study|Protocol Violation|0|||
147261650|NCT01466387|531131069|FG003|Overall Study|Protocol Violation|1|||
147261651|NCT01466387|531131070|FG004|Overall Study|Protocol Violation|0|||
147261652|NCT01466387|531131071|FG005|Overall Study|Protocol Violation|0|||
147261653|NCT01319877|531131074|FG000|Overall Study|Lost to Follow-up|100|||
147261654|NCT01319877|531131075|FG001|Overall Study|Lost to Follow-up|37|||
147261655|NCT01319877|531131074|FG000|Overall Study|Physician Decision|2|||
147261656|NCT01319877|531131075|FG001|Overall Study|Physician Decision|0|||
147261657|NCT01319877|531131074|FG000|Overall Study|Disease Progression|2|||
147261658|NCT01319877|531131075|FG001|Overall Study|Disease Progression|2|||
147261659|NCT01319877|531131074|FG000|Overall Study|Withdrawal by Subject|0|||
147261660|NCT01319877|531131075|FG001|Overall Study|Withdrawal by Subject|1|||
147261661|NCT01319877|531131074|FG000|Overall Study|Reason Not Specified|4|||
147261662|NCT01319877|531131075|FG001|Overall Study|Reason Not Specified|5|||
147261663|NCT00832585|531131076|FG000|Overall Study|Withdrawal by Subject|1|||
147261664|NCT00832585|531131076|FG000|Overall Study|Lost to Follow-up|1|||
147261665|NCT02347189|531131078|FG000|Overall Study|No implant attempted of study device|9|||
147261666|NCT02347189|531131078|FG000|Overall Study|No primary outcome data available|2|||
147261667|NCT02677987|531131080|FG000|Overall Study|Withdrawal by Subject|3|||
147261668|NCT02677987|531131081|FG001|Overall Study|Withdrawal by Subject|0|||
147261669|NCT02677987|531131080|FG000|Overall Study|Lost to Follow-up|1|||
147261670|NCT02677987|531131081|FG001|Overall Study|Lost to Follow-up|0|||
147261671|NCT04404855|531131082|FG000|Overall Study|Subjects who did not complete were either screened positive for infection or non compliant|69|||
147261672|NCT04404855|531131083|FG001|Overall Study|Subjects who did not complete were either screened positive for infection or non compliant|35|||
147261673|NCT00735878|531131084|FG000|Phase I- Dose Determination|Withdrawal by Subject|0|||
147261674|NCT00735878|531131085|FG001|Phase I- Dose Determination|Withdrawal by Subject|0|||
147261675|NCT00735878|531131086|FG002|Phase I- Dose Determination|Withdrawal by Subject|1|||
147261676|NCT00673179|531131087|FG000|Overall Study|Toxicity/Complications|3|||
147261677|NCT00673179|531131088|FG001|Overall Study|Toxicity/Complications|0|||
147261678|NCT01531387|531131091|FG000|Overall Study|Early termination of study|11|||
147261679|NCT01531387|531131092|FG001|Overall Study|Early termination of study|11|||
147261680|NCT04248933|531131093|FG000|Overall Study|Lost to Follow-up|9|||
147261681|NCT04248933|531131093|FG000|Overall Study|Withdrawal by Subject|2|||
147261682|NCT03200899|531131094|FG000|Overall Study|Lost to Follow-up|10|||
147261683|NCT03200899|531131095|FG001|Overall Study|Lost to Follow-up|23|||
147261684|NCT00549562|531131111|FG000|Overall Study|Adverse Event|1|||
147261685|NCT00549562|531131111|FG000|Overall Study|Lack of Efficacy|1|||
147261686|NCT00323115|531131115|FG000|Vaccine Administration|Adverse Event|1|||
147261687|NCT00323115|531131115|FG000|Adjuvant Therapy & Survival Follow-Up|Death|8|||
147261688|NCT02946047|531131116|FG000|Overall Study|Adverse Event|1|||
147261689|NCT02946047|531131117|FG001|Overall Study|Adverse Event|0|||
147261690|NCT02946047|531131118|FG002|Overall Study|Adverse Event|0|||
147261691|NCT02946047|531131119|FG003|Overall Study|Adverse Event|0|||
147261692|NCT00699972|531132894|FG000|Overall Study|Adverse Event|7|||
147261693|NCT00699972|531132895|FG001|Overall Study|Adverse Event|9|||
147261694|NCT00699972|531132896|FG002|Overall Study|Adverse Event|24|||
147261695|NCT00699972|531132894|FG000|Overall Study|Lost to Follow-up|0|||
147261696|NCT00699972|531132895|FG001|Overall Study|Lost to Follow-up|2|||
147261697|NCT00699972|531132896|FG002|Overall Study|Lost to Follow-up|0|||
147261698|NCT00699972|531132894|FG000|Overall Study|Withdrawal by Subject|3|||
147261699|NCT00699972|531132895|FG001|Overall Study|Withdrawal by Subject|7|||
147261700|NCT00699972|531132896|FG002|Overall Study|Withdrawal by Subject|4|||
147261701|NCT00699972|531132894|FG000|Overall Study|Lack of Efficacy|2|||
147261702|NCT00699972|531132895|FG001|Overall Study|Lack of Efficacy|0|||
147261703|NCT00699972|531132896|FG002|Overall Study|Lack of Efficacy|2|||
147261704|NCT00699972|531132894|FG000|Overall Study|Administrative/Other|3|||
147261705|NCT00699972|531132895|FG001|Overall Study|Administrative/Other|1|||
147261706|NCT00699972|531132896|FG002|Overall Study|Administrative/Other|4|||
147261707|NCT00699972|531132894|FG000|Overall Study|Randomized, Not Treated|1|||
147261708|NCT00699972|531132895|FG001|Overall Study|Randomized, Not Treated|0|||
147261709|NCT00699972|531132896|FG002|Overall Study|Randomized, Not Treated|1|||
147261710|NCT00902564|531132898|FG000|Overall Study|Withdrawal by Subject|2|||
147261711|NCT00277212|531132899|FG000|Phase 1 - Single-Blind Treatment|Lack of Efficacy|61|||
147261712|NCT00277212|531132900|FG001|Phase 1 - Single-Blind Treatment|Lack of Efficacy|0|||
147261713|NCT00277212|531132901|FG002|Phase 1 - Single-Blind Treatment|Lack of Efficacy|0|||
147261714|NCT00277212|531132899|FG000|Phase 1 - Single-Blind Treatment|Adverse Event|93|||
147261715|NCT00277212|531132900|FG001|Phase 1 - Single-Blind Treatment|Adverse Event|0|||
147261716|NCT00277212|531132901|FG002|Phase 1 - Single-Blind Treatment|Adverse Event|0|||
147261717|NCT00277212|531132899|FG000|Phase 1 - Single-Blind Treatment|Withdrawal by Subject|96|||
147261718|NCT00277212|531132900|FG001|Phase 1 - Single-Blind Treatment|Withdrawal by Subject|0|||
147261719|NCT00277212|531132901|FG002|Phase 1 - Single-Blind Treatment|Withdrawal by Subject|0|||
147261720|NCT00277212|531132899|FG000|Phase 1 - Single-Blind Treatment|Lost to Follow-up|87|||
147261721|NCT00277212|531132900|FG001|Phase 1 - Single-Blind Treatment|Lost to Follow-up|0|||
147261722|NCT00277212|531132901|FG002|Phase 1 - Single-Blind Treatment|Lost to Follow-up|0|||
147261723|NCT00277212|531132899|FG000|Phase 1 - Single-Blind Treatment|Poor/Noncompliance|35|||
147261724|NCT00277212|531132900|FG001|Phase 1 - Single-Blind Treatment|Poor/Noncompliance|0|||
147261725|NCT00277212|531132901|FG002|Phase 1 - Single-Blind Treatment|Poor/Noncompliance|0|||
147261726|NCT00277212|531132899|FG000|Phase 1 - Single-Blind Treatment|Pregnancy|6|||
147261727|NCT00277212|531132900|FG001|Phase 1 - Single-Blind Treatment|Pregnancy|0|||
147261728|NCT00277212|531132901|FG002|Phase 1 - Single-Blind Treatment|Pregnancy|0|||
147261729|NCT00277212|531132899|FG000|Phase 1 - Single-Blind Treatment|Subject No Longer Met Study Criteria|44|||
147261730|NCT00277212|531132900|FG001|Phase 1 - Single-Blind Treatment|Subject No Longer Met Study Criteria|0|||
147261731|NCT00277212|531132901|FG002|Phase 1 - Single-Blind Treatment|Subject No Longer Met Study Criteria|0|||
147261732|NCT00277212|531132899|FG000|Phase 1 - Single-Blind Treatment|Administrative Reason by Sponsor|1|||
147261733|NCT00277212|531132900|FG001|Phase 1 - Single-Blind Treatment|Administrative Reason by Sponsor|0|||
147261734|NCT00277212|531132901|FG002|Phase 1 - Single-Blind Treatment|Administrative Reason by Sponsor|0|||
147261735|NCT00277212|531132899|FG000|Phase 1 - Single-Blind Treatment|Other Reasons|12|||
147261736|NCT00277212|531132900|FG001|Phase 1 - Single-Blind Treatment|Other Reasons|0|||
147261737|NCT00277212|531132901|FG002|Phase 1 - Single-Blind Treatment|Other Reasons|0|||
147261738|NCT00277212|531132899|FG000|Phase 2 - Double-Blind Treatment|Lack of Efficacy|0|||
147261739|NCT00277212|531132900|FG001|Phase 2 - Double-Blind Treatment|Lack of Efficacy|54|||
147261740|NCT00277212|531132901|FG002|Phase 2 - Double-Blind Treatment|Lack of Efficacy|39|||
147261741|NCT00277212|531132899|FG000|Phase 2 - Double-Blind Treatment|Adverse Event|0|||
147261742|NCT00277212|531132900|FG001|Phase 2 - Double-Blind Treatment|Adverse Event|10|||
147261743|NCT00277212|531132901|FG002|Phase 2 - Double-Blind Treatment|Adverse Event|16|||
147261744|NCT00277212|531132899|FG000|Phase 2 - Double-Blind Treatment|Withdrawal by Subject|0|||
147261745|NCT00277212|531132900|FG001|Phase 2 - Double-Blind Treatment|Withdrawal by Subject|17|||
147261746|NCT00277212|531132901|FG002|Phase 2 - Double-Blind Treatment|Withdrawal by Subject|16|||
147261747|NCT00277212|531132899|FG000|Phase 2 - Double-Blind Treatment|Lost to Follow-up|0|||
147261748|NCT00277212|531132900|FG001|Phase 2 - Double-Blind Treatment|Lost to Follow-up|18|||
147261749|NCT00277212|531132901|FG002|Phase 2 - Double-Blind Treatment|Lost to Follow-up|18|||
147261750|NCT00277212|531132899|FG000|Phase 2 - Double-Blind Treatment|Poor/Noncompliance|0|||
147261751|NCT00277212|531132900|FG001|Phase 2 - Double-Blind Treatment|Poor/Noncompliance|7|||
147261752|NCT00277212|531132901|FG002|Phase 2 - Double-Blind Treatment|Poor/Noncompliance|8|||
147261753|NCT00277212|531132899|FG000|Phase 2 - Double-Blind Treatment|Pregnancy|0|||
147261754|NCT00277212|531132900|FG001|Phase 2 - Double-Blind Treatment|Pregnancy|2|||
147261755|NCT00277212|531132901|FG002|Phase 2 - Double-Blind Treatment|Pregnancy|2|||
147261756|NCT00277212|531132899|FG000|Phase 2 - Double-Blind Treatment|Subject No Longer Meets Study Criteria|0|||
147261757|NCT00277212|531132900|FG001|Phase 2 - Double-Blind Treatment|Subject No Longer Meets Study Criteria|4|||
147261758|NCT00277212|531132901|FG002|Phase 2 - Double-Blind Treatment|Subject No Longer Meets Study Criteria|6|||
147450152|NCT00464334|531811375|FG002|Overall Study|Lack of Efficacy|0|||
147450153|NCT00464334|531811376|FG003|Overall Study|Lack of Efficacy|0|||
147450154|NCT00464334|531811377|FG004|Overall Study|Lack of Efficacy|0|||
147450155|NCT00464334|531811378|FG005|Overall Study|Lack of Efficacy|0|||
147261759|NCT00277212|531132899|FG000|Phase 2 - Double-Blind Treatment|Administrative Reasons By Sponsor|0|||
147261760|NCT00277212|531132900|FG001|Phase 2 - Double-Blind Treatment|Administrative Reasons By Sponsor|1|||
147261761|NCT00277212|531132901|FG002|Phase 2 - Double-Blind Treatment|Administrative Reasons By Sponsor|3|||
147261762|NCT00277212|531132899|FG000|Phase 2 - Double-Blind Treatment|Other reasons|0|||
147261763|NCT00277212|531132900|FG001|Phase 2 - Double-Blind Treatment|Other reasons|7|||
147450156|NCT00464334|531811379|FG006|Overall Study|Lack of Efficacy|0|||
147450157|NCT00464334|531811380|FG007|Overall Study|Lack of Efficacy|0|||
147450158|NCT00464334|531811381|FG008|Overall Study|Lack of Efficacy|0|||
147450159|NCT00464334|531811382|FG009|Overall Study|Lack of Efficacy|0|||
147450160|NCT00464334|531811383|FG010|Overall Study|Lack of Efficacy|0|||
147261764|NCT00277212|531132901|FG002|Phase 2 - Double-Blind Treatment|Other reasons|5|||
147261765|NCT03336216|531132907|FG000|Randomization|Not reported|2|||
147261766|NCT03336216|531132908|FG001|Randomization|Not reported|0|||
147261767|NCT03336216|531132909|FG002|Randomization|Not reported|1|||
147261768|NCT03336216|531132910|FG003|Randomization|Not reported|0|||
147599788|NCT01970865|532352516|FG012|Overall Study|Death|25|||
147599789|NCT01970865|532352517|FG013|Overall Study|Death|46|||
147599790|NCT01970865|532352518|FG014|Overall Study|Death|37|||
147599791|NCT01970865|532352519|FG015|Overall Study|Death|22|||
147599792|NCT01970865|532352520|FG016|Overall Study|Death|1|||
147599793|NCT01970865|532352521|FG017|Overall Study|Death|17|||
147599794|NCT01970865|532352504|FG000|Overall Study|Lost to Follow-up|0|||
147599795|NCT01970865|532352505|FG001|Overall Study|Lost to Follow-up|0|||
147261769|NCT03336216|531132907|FG000|Randomization|Other reasons|1|||
147261770|NCT03336216|531132908|FG001|Randomization|Other reasons|1|||
147261771|NCT03336216|531132909|FG002|Randomization|Other reasons|1|||
147261772|NCT03336216|531132910|FG003|Randomization|Other reasons|0|||
147261773|NCT03336216|531132907|FG000|Randomization|Participant no longer meets study criteria|0|||
147261774|NCT03336216|531132908|FG001|Randomization|Participant no longer meets study criteria|2|||
147261775|NCT03336216|531132909|FG002|Randomization|Participant no longer meets study criteria|4|||
147261776|NCT03336216|531132910|FG003|Randomization|Participant no longer meets study criteria|1|||
147261777|NCT03336216|531132907|FG000|Randomization|Lost to Follow-up|1|||
147261778|NCT03336216|531132908|FG001|Randomization|Lost to Follow-up|0|||
147261779|NCT03336216|531132909|FG002|Randomization|Lost to Follow-up|0|||
147261780|NCT03336216|531132910|FG003|Randomization|Lost to Follow-up|0|||
147261781|NCT03336216|531132907|FG000|Randomization|Participant withdrew consent|9|||
147261782|NCT03336216|531132908|FG001|Randomization|Participant withdrew consent|1|||
147261783|NCT03336216|531132909|FG002|Randomization|Participant withdrew consent|0|||
147261784|NCT03336216|531132910|FG003|Randomization|Participant withdrew consent|0|||
147261785|NCT03336216|531132907|FG000|Randomization|Adverse Event|1|||
147261786|NCT03336216|531132908|FG001|Randomization|Adverse Event|1|||
147261787|NCT03336216|531132909|FG002|Randomization|Adverse Event|0|||
147261788|NCT03336216|531132910|FG003|Randomization|Adverse Event|0|||
147261789|NCT03336216|531132907|FG000|Treatment|Adverse Event|2|||
147261790|NCT03336216|531132908|FG001|Treatment|Adverse Event|3|||
147261791|NCT03336216|531132909|FG002|Treatment|Adverse Event|4|||
147261792|NCT03336216|531132910|FG003|Treatment|Adverse Event|4|||
147261793|NCT03336216|531132907|FG000|Treatment|Participant request to discontinue treatment|2|||
147261794|NCT03336216|531132908|FG001|Treatment|Participant request to discontinue treatment|1|||
147261795|NCT03336216|531132909|FG002|Treatment|Participant request to discontinue treatment|2|||
147261796|NCT03336216|531132910|FG003|Treatment|Participant request to discontinue treatment|2|||
147261797|NCT03336216|531132907|FG000|Treatment|Participant withdrew consent|7|||
147261798|NCT03336216|531132908|FG001|Treatment|Participant withdrew consent|2|||
147261799|NCT03336216|531132909|FG002|Treatment|Participant withdrew consent|3|||
147261800|NCT03336216|531132910|FG003|Treatment|Participant withdrew consent|2|||
147261801|NCT03336216|531132907|FG000|Treatment|Death|2|||
147261802|NCT03336216|531132908|FG001|Treatment|Death|3|||
147261803|NCT03336216|531132909|FG002|Treatment|Death|3|||
147261804|NCT03336216|531132910|FG003|Treatment|Death|4|||
147261805|NCT03336216|531132907|FG000|Treatment|Participant no longer meets study criteria|0|||
147261806|NCT03336216|531132908|FG001|Treatment|Participant no longer meets study criteria|1|||
147261807|NCT03336216|531132909|FG002|Treatment|Participant no longer meets study criteria|0|||
147261808|NCT03336216|531132910|FG003|Treatment|Participant no longer meets study criteria|0|||
147261809|NCT03336216|531132907|FG000|Treatment|Other reasons|2|||
147261810|NCT03336216|531132908|FG001|Treatment|Other reasons|0|||
147261811|NCT03336216|531132909|FG002|Treatment|Other reasons|0|||
147261812|NCT03336216|531132910|FG003|Treatment|Other reasons|3|||
147261813|NCT03336216|531132907|FG000|Treatment|Disease progression|23|||
147261814|NCT03336216|531132908|FG001|Treatment|Disease progression|34|||
147261815|NCT03336216|531132909|FG002|Treatment|Disease progression|33|||
147261816|NCT03336216|531132910|FG003|Treatment|Disease progression|26|||
147261817|NCT03336216|531132907|FG000|Treatment|Study drug toxicity|0|||
147261818|NCT03336216|531132908|FG001|Treatment|Study drug toxicity|3|||
147261819|NCT03336216|531132909|FG002|Treatment|Study drug toxicity|2|||
147599796|NCT01970865|532352506|FG002|Overall Study|Lost to Follow-up|0|||
147599797|NCT01970865|532352507|FG003|Overall Study|Lost to Follow-up|1|||
147599798|NCT01970865|532352508|FG004|Overall Study|Lost to Follow-up|1|||
147599799|NCT01970865|532352509|FG005|Overall Study|Lost to Follow-up|0|||
147261820|NCT03336216|531132910|FG003|Treatment|Study drug toxicity|0|||
147261821|NCT03336216|531132907|FG000|Treatment|Adverse Event unrelated to study drug|1|||
147261822|NCT03336216|531132908|FG001|Treatment|Adverse Event unrelated to study drug|1|||
147261823|NCT03336216|531132909|FG002|Treatment|Adverse Event unrelated to study drug|1|||
147261824|NCT03336216|531132910|FG003|Treatment|Adverse Event unrelated to study drug|0|||
147261825|NCT03336216|531132907|FG000|Treatment|Disease Recurrence|1|||
147261826|NCT03336216|531132908|FG001|Treatment|Disease Recurrence|0|||
147261827|NCT03336216|531132909|FG002|Treatment|Disease Recurrence|0|||
147261828|NCT03336216|531132910|FG003|Treatment|Disease Recurrence|0|||
147261829|NCT00922766|531132911|FG000|Overall Study|Death|3|||
147261830|NCT00922766|531132911|FG000|Overall Study|Withdrawal by Subject|2|||
147261831|NCT00922766|531132911|FG000|Overall Study|Other|1|||
147261832|NCT00922766|531132911|FG000|Overall Study|Adverse Event|1|||
147599800|NCT01970865|532352510|FG006|Overall Study|Lost to Follow-up|0|||
147599801|NCT01970865|532352511|FG007|Overall Study|Lost to Follow-up|0|||
147599802|NCT01970865|532352512|FG008|Overall Study|Lost to Follow-up|0|||
147261833|NCT01231581|531132917|FG000|Overall Study|Lost to Follow-up|2|||
147599803|NCT01970865|532352513|FG009|Overall Study|Lost to Follow-up|0|||
147599804|NCT01970865|532352514|FG010|Overall Study|Lost to Follow-up|1|||
147599805|NCT01970865|532352515|FG011|Overall Study|Lost to Follow-up|0|||
147599806|NCT01970865|532352516|FG012|Overall Study|Lost to Follow-up|2|||
147599807|NCT01970865|532352517|FG013|Overall Study|Lost to Follow-up|0|||
147599808|NCT01970865|532352518|FG014|Overall Study|Lost to Follow-up|1|||
147599809|NCT01970865|532352519|FG015|Overall Study|Lost to Follow-up|4|||
147599810|NCT01970865|532352520|FG016|Overall Study|Lost to Follow-up|0|||
147599811|NCT01970865|532352521|FG017|Overall Study|Lost to Follow-up|1|||
147599812|NCT01970865|532352504|FG000|Overall Study|Other|0|||
147599813|NCT01970865|532352505|FG001|Overall Study|Other|1|||
147599814|NCT01970865|532352506|FG002|Overall Study|Other|0|||
147599815|NCT01970865|532352507|FG003|Overall Study|Other|1|||
147599816|NCT01970865|532352508|FG004|Overall Study|Other|1|||
147261834|NCT01231581|531132918|FG001|Overall Study|Lost to Follow-up|2|||
147261835|NCT01231581|531132917|FG000|Overall Study|Withdrawal by Subject|6|||
147261836|NCT01231581|531132918|FG001|Overall Study|Withdrawal by Subject|9|||
147261837|NCT01231581|531132917|FG000|Overall Study|Study Closed/Terminated|6|||
147261838|NCT01231581|531132918|FG001|Overall Study|Study Closed/Terminated|5|||
147261839|NCT01231581|531132917|FG000|Overall Study|Death|65|||
147261840|NCT01231581|531132918|FG001|Overall Study|Death|64|||
147261841|NCT01231581|531132917|FG000|Overall Study|Ongoing|1|||
147261842|NCT01231581|531132918|FG001|Overall Study|Ongoing|0|||
147261843|NCT01957462|531132919|FG000|Test Period 1|Withdrawal by Subject|1|||
147261844|NCT01957462|531132920|FG001|Test Period 1|Withdrawal by Subject|0|||
147261845|NCT01957462|531132919|FG000|Test Period 1|Adverse Event|1|||
147261846|NCT01957462|531132920|FG001|Test Period 1|Adverse Event|0|||
147261847|NCT05954052|531132921|FG000|Overall Study|Adverse Event|1|||
147261848|NCT03616912|531132922|FG000|Overall Study|Adverse Event|17|||
147261849|NCT03616912|531132923|FG001|Overall Study|Adverse Event|21|||
147261850|NCT03616912|531132924|FG002|Overall Study|Adverse Event|9|||
147261851|NCT03616912|531132925|FG003|Overall Study|Adverse Event|0|||
147261852|NCT03616912|531132926|FG004|Overall Study|Adverse Event|0|||
147261853|NCT03616912|531132927|FG005|Overall Study|Adverse Event|0|||
147261854|NCT03616912|531132922|FG000|Overall Study|Death|1|||
147261855|NCT03616912|531132923|FG001|Overall Study|Death|1|||
147261856|NCT03616912|531132924|FG002|Overall Study|Death|0|||
147261857|NCT03616912|531132925|FG003|Overall Study|Death|0|||
147261858|NCT03616912|531132926|FG004|Overall Study|Death|0|||
147261859|NCT03616912|531132927|FG005|Overall Study|Death|0|||
147261860|NCT03616912|531132922|FG000|Overall Study|Lack of Efficacy|13|||
147261861|NCT03616912|531132923|FG001|Overall Study|Lack of Efficacy|6|||
147261862|NCT03616912|531132924|FG002|Overall Study|Lack of Efficacy|8|||
147261863|NCT03616912|531132925|FG003|Overall Study|Lack of Efficacy|4|||
147261864|NCT03616912|531132926|FG004|Overall Study|Lack of Efficacy|5|||
147261865|NCT03616912|531132927|FG005|Overall Study|Lack of Efficacy|1|||
147261866|NCT03616912|531132922|FG000|Overall Study|Lost to Follow-up|1|||
147261867|NCT03616912|531132923|FG001|Overall Study|Lost to Follow-up|2|||
147261868|NCT03616912|531132924|FG002|Overall Study|Lost to Follow-up|3|||
147261869|NCT03616912|531132925|FG003|Overall Study|Lost to Follow-up|0|||
147261870|NCT03616912|531132926|FG004|Overall Study|Lost to Follow-up|0|||
147261871|NCT03616912|531132927|FG005|Overall Study|Lost to Follow-up|0|||
147261872|NCT03616912|531132922|FG000|Overall Study|Due to Epidemic/Pandemic|4|||
147261873|NCT03616912|531132923|FG001|Overall Study|Due to Epidemic/Pandemic|2|||
147261874|NCT03616912|531132924|FG002|Overall Study|Due to Epidemic/Pandemic|5|||
147261875|NCT03616912|531132925|FG003|Overall Study|Due to Epidemic/Pandemic|0|||
147261876|NCT03616912|531132926|FG004|Overall Study|Due to Epidemic/Pandemic|0|||
147261877|NCT03616912|531132927|FG005|Overall Study|Due to Epidemic/Pandemic|0|||
147261878|NCT03616912|531132922|FG000|Overall Study|Withdrawal by Subject|12|||
147261879|NCT03616912|531132923|FG001|Overall Study|Withdrawal by Subject|12|||
147599817|NCT01970865|532352509|FG005|Overall Study|Other|0|||
147599818|NCT01970865|532352510|FG006|Overall Study|Other|1|||
147599819|NCT01970865|532352511|FG007|Overall Study|Other|0|||
147599820|NCT01970865|532352512|FG008|Overall Study|Other|0|||
147599821|NCT01970865|532352513|FG009|Overall Study|Other|0|||
147599822|NCT01970865|532352514|FG010|Overall Study|Other|2|||
147599823|NCT01970865|532352515|FG011|Overall Study|Other|3|||
147599824|NCT01970865|532352516|FG012|Overall Study|Other|8|||
147261880|NCT03616912|531132924|FG002|Overall Study|Withdrawal by Subject|15|||
147261881|NCT03616912|531132925|FG003|Overall Study|Withdrawal by Subject|2|||
147261882|NCT03616912|531132926|FG004|Overall Study|Withdrawal by Subject|0|||
147261883|NCT03616912|531132927|FG005|Overall Study|Withdrawal by Subject|2|||
147261884|NCT03616912|531132922|FG000|Overall Study|Study Terminated by Sponsor|0|||
147261885|NCT03616912|531132923|FG001|Overall Study|Study Terminated by Sponsor|0|||
147261886|NCT03616912|531132924|FG002|Overall Study|Study Terminated by Sponsor|0|||
147261887|NCT03616912|531132925|FG003|Overall Study|Study Terminated by Sponsor|10|||
147261888|NCT03616912|531132926|FG004|Overall Study|Study Terminated by Sponsor|9|||
147261889|NCT03616912|531132927|FG005|Overall Study|Study Terminated by Sponsor|11|||
147599825|NCT01970865|532352517|FG013|Overall Study|Other|3|||
147599826|NCT01970865|532352518|FG014|Overall Study|Other|2|||
147261890|NCT03616912|531132922|FG000|Overall Study|Protocol Deviation|1|||
147261891|NCT03616912|531132923|FG001|Overall Study|Protocol Deviation|1|||
147261892|NCT03616912|531132924|FG002|Overall Study|Protocol Deviation|0|||
147261893|NCT03616912|531132925|FG003|Overall Study|Protocol Deviation|0|||
147261894|NCT03616912|531132926|FG004|Overall Study|Protocol Deviation|0|||
147261895|NCT03616912|531132927|FG005|Overall Study|Protocol Deviation|0|||
147261896|NCT03616912|531132922|FG000|Overall Study|Pregnancy|1|||
147261897|NCT03616912|531132923|FG001|Overall Study|Pregnancy|0|||
147261898|NCT03616912|531132924|FG002|Overall Study|Pregnancy|4|||
147261899|NCT03616912|531132925|FG003|Overall Study|Pregnancy|0|||
147261900|NCT03616912|531132926|FG004|Overall Study|Pregnancy|0|||
147261901|NCT03616912|531132927|FG005|Overall Study|Pregnancy|0|||
147261902|NCT03616912|531132922|FG000|Overall Study|Protocol Violation|1|||
147261903|NCT03616912|531132923|FG001|Overall Study|Protocol Violation|0|||
147261904|NCT03616912|531132924|FG002|Overall Study|Protocol Violation|2|||
147261905|NCT03616912|531132925|FG003|Overall Study|Protocol Violation|0|||
147261906|NCT03616912|531132926|FG004|Overall Study|Protocol Violation|0|||
147261907|NCT03616912|531132927|FG005|Overall Study|Protocol Violation|0|||
147261908|NCT03616912|531132922|FG000|Overall Study|Physician Decision|2|||
147261909|NCT03616912|531132923|FG001|Overall Study|Physician Decision|0|||
147261910|NCT03616912|531132924|FG002|Overall Study|Physician Decision|0|||
147261911|NCT03616912|531132925|FG003|Overall Study|Physician Decision|0|||
147261912|NCT03616912|531132926|FG004|Overall Study|Physician Decision|1|||
147261913|NCT03616912|531132927|FG005|Overall Study|Physician Decision|0|||
147261914|NCT03616912|531132922|FG000|Overall Study|Randomized But Never Treated|0|||
147261915|NCT03616912|531132923|FG001|Overall Study|Randomized But Never Treated|2|||
147261916|NCT03616912|531132924|FG002|Overall Study|Randomized But Never Treated|0|||
147261917|NCT03616912|531132925|FG003|Overall Study|Randomized But Never Treated|0|||
147261918|NCT03616912|531132926|FG004|Overall Study|Randomized But Never Treated|0|||
147261919|NCT03616912|531132927|FG005|Overall Study|Randomized But Never Treated|0|||
147261920|NCT02474199|531132928|FG000|Overall Study|Lost to Follow-up|1|||
147261921|NCT02474199|531132929|FG001|Overall Study|Lost to Follow-up|0|||
147261922|NCT02474199|531132930|FG002|Overall Study|Lost to Follow-up|0|||
147261923|NCT02474199|531132931|FG003|Overall Study|Lost to Follow-up|0|||
147261924|NCT02474199|531132928|FG000|Overall Study|Withdrawal by Subject|1|||
147261925|NCT02474199|531132929|FG001|Overall Study|Withdrawal by Subject|2|||
147261926|NCT02474199|531132930|FG002|Overall Study|Withdrawal by Subject|0|||
147261927|NCT02474199|531132931|FG003|Overall Study|Withdrawal by Subject|1|||
147261928|NCT02474199|531132928|FG000|Overall Study|Did not receive Tregs due to insufficient manufacture|0|||
147261929|NCT02474199|531132929|FG001|Overall Study|Did not receive Tregs due to insufficient manufacture|1|||
147261930|NCT02474199|531132930|FG002|Overall Study|Did not receive Tregs due to insufficient manufacture|0|||
147261931|NCT02474199|531132931|FG003|Overall Study|Did not receive Tregs due to insufficient manufacture|0|||
147599827|NCT01970865|532352519|FG015|Overall Study|Other|3|||
147261932|NCT02474199|531132928|FG000|Overall Study|Did not meet eligibility criteria|0|||
147261933|NCT02474199|531132929|FG001|Overall Study|Did not meet eligibility criteria|0|||
147261934|NCT02474199|531132930|FG002|Overall Study|Did not meet eligibility criteria|2|||
147261935|NCT02474199|531132931|FG003|Overall Study|Did not meet eligibility criteria|2|||
147261936|NCT03090100|531132932|FG000|Overall Study|Adverse Event|9|||
147261937|NCT03090100|531132933|FG001|Overall Study|Adverse Event|11|||
147261938|NCT03090100|531132932|FG000|Overall Study|Pregnancy|1|||
147261939|NCT03090100|531132933|FG001|Overall Study|Pregnancy|1|||
147261940|NCT03090100|531132932|FG000|Overall Study|Lack of Efficacy|2|||
147332869|NCT00790790|531385604|FG002|Study Period 2: Therapy Phase|Adverse Event|16|||
147599828|NCT01970865|532352520|FG016|Overall Study|Other|0|||
147599829|NCT01970865|532352521|FG017|Overall Study|Other|2|||
147599830|NCT01970865|532352504|FG000|Overall Study|Participant refused further follow-up|0|||
147599831|NCT01970865|532352505|FG001|Overall Study|Participant refused further follow-up|0|||
147599832|NCT01970865|532352506|FG002|Overall Study|Participant refused further follow-up|0|||
147599833|NCT01970865|532352507|FG003|Overall Study|Participant refused further follow-up|2|||
147599834|NCT01970865|532352508|FG004|Overall Study|Participant refused further follow-up|3|||
147599835|NCT01970865|532352509|FG005|Overall Study|Participant refused further follow-up|0|||
147599836|NCT01970865|532352510|FG006|Overall Study|Participant refused further follow-up|0|||
147599837|NCT01970865|532352511|FG007|Overall Study|Participant refused further follow-up|0|||
147599838|NCT01970865|532352512|FG008|Overall Study|Participant refused further follow-up|0|||
147332870|NCT00790790|531385602|FG000|Study Period 2: Therapy Phase|Protocol Violation|1|||
147599839|NCT01970865|532352513|FG009|Overall Study|Participant refused further follow-up|0|||
147643971|NCT01447446|532516687|FG001|Overall Study|Death|3|||
147261941|NCT03090100|531132933|FG001|Overall Study|Lack of Efficacy|7|||
147261942|NCT03090100|531132932|FG000|Overall Study|Lost to Follow-up|2|||
147261943|NCT03090100|531132933|FG001|Overall Study|Lost to Follow-up|2|||
147261944|NCT03090100|531132932|FG000|Overall Study|Withdrawal by Subject|7|||
147261945|NCT03090100|531132933|FG001|Overall Study|Withdrawal by Subject|19|||
147261946|NCT03090100|531132932|FG000|Overall Study|Protocol Violation|2|||
147261947|NCT03090100|531132933|FG001|Overall Study|Protocol Violation|6|||
147261948|NCT03090100|531132932|FG000|Overall Study|Non-compliance|2|||
147261949|NCT03090100|531132933|FG001|Overall Study|Non-compliance|0|||
147599840|NCT01970865|532352514|FG010|Overall Study|Participant refused further follow-up|1|||
147599841|NCT01970865|532352515|FG011|Overall Study|Participant refused further follow-up|4|||
147599842|NCT01970865|532352516|FG012|Overall Study|Participant refused further follow-up|7|||
147261950|NCT03090100|531132932|FG000|Overall Study|Other|2|||
147261951|NCT03090100|531132933|FG001|Overall Study|Other|2|||
147261952|NCT00159588|531132934|FG000|5 Month Follow-up|Withdrawal by Subject|2|||
147261953|NCT00159588|531132935|FG001|5 Month Follow-up|Withdrawal by Subject|4|||
147261954|NCT00159588|531132936|FG002|5 Month Follow-up|Withdrawal by Subject|2|||
147261955|NCT00605475|531132937|FG000|Overall Study|Abnormal Laboratory Values|0|||
147261956|NCT00605475|531132938|FG001|Overall Study|Abnormal Laboratory Values|0|||
147261957|NCT00605475|531132939|FG002|Overall Study|Abnormal Laboratory Values|0|||
147261958|NCT00605475|531132940|FG003|Overall Study|Abnormal Laboratory Values|0|||
147261959|NCT00605475|531132941|FG004|Overall Study|Abnormal Laboratory Values|0|||
147261960|NCT00605475|531132942|FG005|Overall Study|Abnormal Laboratory Values|0|||
147261961|NCT00605475|531132943|FG006|Overall Study|Abnormal Laboratory Values|0|||
147261962|NCT00605475|531132944|FG007|Overall Study|Abnormal Laboratory Values|0|||
147261963|NCT00605475|531132945|FG008|Overall Study|Abnormal Laboratory Values|1|||
147261964|NCT00605475|531132946|FG009|Overall Study|Abnormal Laboratory Values|0|||
147261965|NCT00605475|531132937|FG000|Overall Study|Administrative problems|0|||
147261966|NCT00605475|531132938|FG001|Overall Study|Administrative problems|0|||
147261967|NCT00605475|531132939|FG002|Overall Study|Administrative problems|0|||
147261968|NCT00605475|531132940|FG003|Overall Study|Administrative problems|0|||
147261969|NCT00605475|531132941|FG004|Overall Study|Administrative problems|0|||
147261970|NCT00605475|531132942|FG005|Overall Study|Administrative problems|0|||
147261971|NCT00605475|531132943|FG006|Overall Study|Administrative problems|1|||
147261972|NCT00605475|531132944|FG007|Overall Study|Administrative problems|0|||
147261973|NCT00605475|531132945|FG008|Overall Study|Administrative problems|0|||
147261974|NCT00605475|531132946|FG009|Overall Study|Administrative problems|0|||
147261975|NCT00605475|531132937|FG000|Overall Study|Lost to Follow-up|0|||
147261976|NCT00605475|531132938|FG001|Overall Study|Lost to Follow-up|0|||
147261977|NCT00605475|531132939|FG002|Overall Study|Lost to Follow-up|0|||
147261978|NCT00605475|531132940|FG003|Overall Study|Lost to Follow-up|0|||
147261979|NCT00605475|531132941|FG004|Overall Study|Lost to Follow-up|0|||
147261980|NCT00605475|531132942|FG005|Overall Study|Lost to Follow-up|0|||
147261981|NCT00605475|531132943|FG006|Overall Study|Lost to Follow-up|0|||
147261982|NCT00605475|531132944|FG007|Overall Study|Lost to Follow-up|0|||
147261983|NCT00605475|531132945|FG008|Overall Study|Lost to Follow-up|1|||
147261984|NCT00605475|531132946|FG009|Overall Study|Lost to Follow-up|1|||
147261985|NCT00605475|531132937|FG000|Overall Study|Protocol Violation|0|||
147261986|NCT00605475|531132938|FG001|Overall Study|Protocol Violation|0|||
147261987|NCT00605475|531132939|FG002|Overall Study|Protocol Violation|0|||
147261988|NCT00605475|531132940|FG003|Overall Study|Protocol Violation|0|||
147261989|NCT00605475|531132941|FG004|Overall Study|Protocol Violation|1|||
147261990|NCT00605475|531132942|FG005|Overall Study|Protocol Violation|0|||
147261991|NCT00605475|531132943|FG006|Overall Study|Protocol Violation|0|||
147261992|NCT00605475|531132944|FG007|Overall Study|Protocol Violation|0|||
147261993|NCT00605475|531132945|FG008|Overall Study|Protocol Violation|0|||
147261994|NCT00605475|531132946|FG009|Overall Study|Protocol Violation|0|||
147261995|NCT00605475|531132937|FG000|Overall Study|Withdrawal by Subject|0|||
147261996|NCT00605475|531132938|FG001|Overall Study|Withdrawal by Subject|0|||
147261997|NCT00605475|531132939|FG002|Overall Study|Withdrawal by Subject|0|||
147261998|NCT00605475|531132940|FG003|Overall Study|Withdrawal by Subject|0|||
147261999|NCT00605475|531132941|FG004|Overall Study|Withdrawal by Subject|0|||
147262000|NCT00605475|531132942|FG005|Overall Study|Withdrawal by Subject|2|||
147262001|NCT00605475|531132943|FG006|Overall Study|Withdrawal by Subject|0|||
147262002|NCT00605475|531132944|FG007|Overall Study|Withdrawal by Subject|0|||
147262003|NCT00605475|531132945|FG008|Overall Study|Withdrawal by Subject|0|||
147262004|NCT00605475|531132946|FG009|Overall Study|Withdrawal by Subject|1|||
147262005|NCT02596854|531132947|FG000|Overall Study|Withdrawn|8|||
147262006|NCT03615326|531132955|FG000|Overall Study|Death|266|||
147262007|NCT03615326|531132956|FG001|Overall Study|Death|286|||
147262008|NCT03615326|531132957|FG002|Overall Study|Death|14|||
147599843|NCT01970865|532352517|FG013|Overall Study|Participant refused further follow-up|8|||
147599844|NCT01970865|532352518|FG014|Overall Study|Participant refused further follow-up|3|||
147262009|NCT03615326|531132958|FG003|Overall Study|Death|17|||
147262010|NCT03615326|531132955|FG000|Overall Study|Lost to Follow-up|0|||
147262011|NCT03615326|531132956|FG001|Overall Study|Lost to Follow-up|1|||
147262012|NCT03615326|531132957|FG002|Overall Study|Lost to Follow-up|0|||
147262013|NCT03615326|531132958|FG003|Overall Study|Lost to Follow-up|0|||
147262014|NCT03615326|531132955|FG000|Overall Study|Withdrawal by Subject|1|||
147262015|NCT03615326|531132956|FG001|Overall Study|Withdrawal by Subject|3|||
147262016|NCT03615326|531132957|FG002|Overall Study|Withdrawal by Subject|0|||
147262017|NCT03615326|531132958|FG003|Overall Study|Withdrawal by Subject|0|||
147262018|NCT03615326|531132955|FG000|Overall Study|Participants Ongoing|83|||
147262019|NCT03615326|531132956|FG001|Overall Study|Participants Ongoing|58|||
147262020|NCT03615326|531132957|FG002|Overall Study|Participants Ongoing|6|||
147262021|NCT03615326|531132958|FG003|Overall Study|Participants Ongoing|3|||
147599845|NCT01970865|532352519|FG015|Overall Study|Participant refused further follow-up|11|||
147599846|NCT01970865|532352520|FG016|Overall Study|Participant refused further follow-up|0|||
147599847|NCT01970865|532352521|FG017|Overall Study|Participant refused further follow-up|6|||
147599848|NCT01946191|532352522|FG000|Allocation|Did not complete orientation|1|||
147599849|NCT01946191|532352523|FG001|Allocation|Did not complete orientation|1|||
147599850|NCT01946191|532352522|FG000|Follow-Up, 24-mo Endpoint|Withdrawal by Subject|4|||
147599851|NCT01946191|532352523|FG001|Follow-Up, 24-mo Endpoint|Withdrawal by Subject|2|||
147599852|NCT01946191|532352522|FG000|Follow-Up, 24-mo Endpoint|Protocol Violation|0|||
147599853|NCT01946191|532352523|FG001|Follow-Up, 24-mo Endpoint|Protocol Violation|1|||
147599854|NCT01946191|532352522|FG000|Follow-Up, 24-mo Endpoint|Lost to Follow-up|13|||
147599855|NCT01946191|532352523|FG001|Follow-Up, 24-mo Endpoint|Lost to Follow-up|15|||
147599856|NCT01083810|532352524|FG000|Overall Study|Lost to Follow-up|23|||
147599857|NCT01083810|532352525|FG001|Overall Study|Lost to Follow-up|11|||
147599858|NCT01083810|532352526|FG002|Overall Study|Lost to Follow-up|4|||
147599859|NCT01083810|532352524|FG000|Overall Study|Adverse Event|15|||
147599860|NCT01083810|532352525|FG001|Overall Study|Adverse Event|11|||
147599861|NCT01083810|532352526|FG002|Overall Study|Adverse Event|4|||
147599862|NCT01083810|532352524|FG000|Overall Study|Withdrawal by Subject|7|||
147599863|NCT01083810|532352525|FG001|Overall Study|Withdrawal by Subject|2|||
147599864|NCT01083810|532352526|FG002|Overall Study|Withdrawal by Subject|4|||
147599865|NCT01083810|532352524|FG000|Overall Study|Reason not reported|6|||
147599866|NCT01083810|532352525|FG001|Overall Study|Reason not reported|1|||
147599867|NCT01083810|532352526|FG002|Overall Study|Reason not reported|1|||
147599868|NCT01083810|532352524|FG000|Overall Study|Non-compliance|4|||
147599869|NCT01083810|532352525|FG001|Overall Study|Non-compliance|7|||
147599870|NCT01083810|532352526|FG002|Overall Study|Non-compliance|2|||
147262022|NCT05071183|531132959|FG000|Overall Study|Death|1|||
147262023|NCT05071183|531132960|FG001|Overall Study|Death|2|||
147262024|NCT05071183|531132961|FG002|Overall Study|Death|0|||
147262025|NCT05071183|531132959|FG000|Overall Study|Other Reasons|1|||
147262026|NCT05071183|531132960|FG001|Overall Study|Other Reasons|3|||
147262027|NCT05071183|531132961|FG002|Overall Study|Other Reasons|2|||
147262028|NCT02046148|531132962|FG000|Overall Study|Lost to Follow-up|1|||
147262029|NCT02046148|531132963|FG001|Overall Study|Lost to Follow-up|1|||
147262030|NCT02046148|531132962|FG000|Overall Study|Withdrawal by Subject|0|||
147262031|NCT02046148|531132963|FG001|Overall Study|Withdrawal by Subject|2|||
147262032|NCT02532647|531132966|FG000|Overall Study|Did not receive trial medication|1|||
147262033|NCT02532647|531132967|FG001|Overall Study|Did not receive trial medication|0|||
147262034|NCT02532647|531132968|FG002|Overall Study|Did not receive trial medication|1|||
147262035|NCT01480076|531132969|FG000|Overall Study|Run-in Failure|52|||
147262036|NCT01480076|531132969|FG000|Overall Study|Adverse Event|39|||
147262037|NCT01480076|531132969|FG000|Overall Study|Death|2|||
147262038|NCT01480076|531132969|FG000|Overall Study|Disease Progression|5|||
147262039|NCT01480076|531132969|FG000|Overall Study|Non-compliance With Study Protocol|15|||
147262040|NCT01480076|531132969|FG000|Overall Study|Withdrawal by Subject|105|||
147262041|NCT01480076|531132969|FG000|Overall Study|Lost to Follow-up|7|||
147262042|NCT01480076|531132969|FG000|Overall Study|Investigator Decision|13|||
147262043|NCT01480076|531132969|FG000|Overall Study|Other|52|||
147262044|NCT02503332|531132970|FG000|Overall Study|Adverse Event|17|||
147262045|NCT02503332|531132971|FG001|Overall Study|Adverse Event|5|||
147262046|NCT02503332|531132972|FG002|Overall Study|Adverse Event|3|||
147262047|NCT02503332|531132973|FG003|Overall Study|Adverse Event|1|||
147262048|NCT02503332|531132970|FG000|Overall Study|Investigator's Decision|5|||
147262049|NCT02503332|531132971|FG001|Overall Study|Investigator's Decision|1|||
147262050|NCT02503332|531132972|FG002|Overall Study|Investigator's Decision|0|||
147262051|NCT02503332|531132973|FG003|Overall Study|Investigator's Decision|0|||
147262052|NCT02503332|531132970|FG000|Overall Study|Sponsor's Decision|1|||
147262053|NCT02503332|531132971|FG001|Overall Study|Sponsor's Decision|0|||
147262054|NCT02503332|531132972|FG002|Overall Study|Sponsor's Decision|0|||
147262055|NCT02503332|531132973|FG003|Overall Study|Sponsor's Decision|1|||
147262056|NCT02503332|531132970|FG000|Overall Study|Subject Request|6|||
147262057|NCT02503332|531132971|FG001|Overall Study|Subject Request|5|||
147262058|NCT02503332|531132972|FG002|Overall Study|Subject Request|2|||
147262059|NCT02503332|531132973|FG003|Overall Study|Subject Request|1|||
147262060|NCT02503332|531132970|FG000|Overall Study|Death|0|||
147450161|NCT00464334|531811373|FG000|Overall Study|Lost to Follow-up|0|||
147599871|NCT01083810|532352524|FG000|Overall Study|Simplification|4|||
147599872|NCT01083810|532352525|FG001|Overall Study|Simplification|1|||
147262061|NCT02503332|531132971|FG001|Overall Study|Death|2|||
147262062|NCT02503332|531132972|FG002|Overall Study|Death|2|||
147262063|NCT02503332|531132973|FG003|Overall Study|Death|0|||
147262064|NCT02503332|531132970|FG000|Overall Study|Other|5|||
147262065|NCT02503332|531132971|FG001|Overall Study|Other|6|||
147262066|NCT02503332|531132972|FG002|Overall Study|Other|1|||
147262067|NCT02503332|531132973|FG003|Overall Study|Other|1|||
147599873|NCT01083810|532352526|FG002|Overall Study|Simplification|0|||
147599874|NCT01083810|532352524|FG000|Overall Study|Death|2|||
147599875|NCT01083810|532352525|FG001|Overall Study|Death|2|||
147599876|NCT01083810|532352526|FG002|Overall Study|Death|3|||
147262068|NCT02424383|531132974|FG000|Overall Study|Withdrawal by Subject|32|||
147262069|NCT02424383|531132974|FG000|Overall Study|Death|170|||
147262070|NCT02424383|531132974|FG000|Overall Study|Sponsor's decision|3|||
147262071|NCT02424383|531132974|FG000|Overall Study|Investigator's decision|44|||
147262072|NCT02424383|531132974|FG000|Overall Study|Lost to Follow-up|81|||
147262073|NCT02424383|531132974|FG000|Overall Study|Other|7|||
147262074|NCT02424383|531132974|FG000|Overall Study|Ineligible for Major Protocol Deviation|39|||
147262075|NCT00325754|531132978|FG000|Overall Study|Adverse Event|4|||
147262076|NCT00325754|531132979|FG001|Overall Study|Adverse Event|1|||
147262077|NCT04649164|531132986|FG000|Overall Study|Withdrawal by Subject|1|||
147262078|NCT04649164|531132987|FG001|Overall Study|Withdrawal by Subject|1|||
147262079|NCT04649164|531132988|FG002|Overall Study|Withdrawal by Subject|2|||
147262080|NCT04649164|531132986|FG000|Overall Study|Participant's care recipient expired|0|||
147262081|NCT04649164|531132987|FG001|Overall Study|Participant's care recipient expired|0|||
147262082|NCT04649164|531132988|FG002|Overall Study|Participant's care recipient expired|2|||
147262083|NCT03168464|531132989|FG000|Overall Study|Death|9|||
147262084|NCT03168464|531132989|FG000|Overall Study|Progression of disease|6|||
147262085|NCT00634088|531132994|FG000|Time Period 1: Dose Level 1|Disease progression|2|||
147262086|NCT00634088|531132995|FG001|Time Period 1: Dose Level 1|Disease progression|0|||
147262087|NCT00634088|531132996|FG002|Time Period 1: Dose Level 1|Disease progression|0|||
147262088|NCT00634088|531132997|FG003|Time Period 1: Dose Level 1|Disease progression|0|||
147262089|NCT00634088|531132994|FG000|Time Period 1: Dose Level 1|Physician Decision|1|||
147262090|NCT00634088|531132995|FG001|Time Period 1: Dose Level 1|Physician Decision|0|||
147262091|NCT00634088|531132996|FG002|Time Period 1: Dose Level 1|Physician Decision|0|||
147262092|NCT00634088|531132997|FG003|Time Period 1: Dose Level 1|Physician Decision|0|||
147262093|NCT00634088|531132994|FG000|Time Period 1: Dose Level 1|Adverse Event|3|||
147262094|NCT00634088|531132995|FG001|Time Period 1: Dose Level 1|Adverse Event|0|||
147599877|NCT01083810|532352524|FG000|Overall Study|Co-morbidities|1|||
147599878|NCT01083810|532352525|FG001|Overall Study|Co-morbidities|0|||
147599879|NCT01083810|532352526|FG002|Overall Study|Co-morbidities|0|||
147599880|NCT01083810|532352524|FG000|Overall Study|Participation in study|1|||
147599881|NCT01083810|532352525|FG001|Overall Study|Participation in study|0|||
147599882|NCT01083810|532352526|FG002|Overall Study|Participation in study|0|||
147599883|NCT01083810|532352524|FG000|Overall Study|Therapy break|1|||
147599884|NCT01083810|532352525|FG001|Overall Study|Therapy break|2|||
147599885|NCT01083810|532352526|FG002|Overall Study|Therapy break|2|||
147599886|NCT01083810|532352524|FG000|Overall Study|Virologic failure|1|||
147599887|NCT01083810|532352525|FG001|Overall Study|Virologic failure|8|||
147599888|NCT01083810|532352526|FG002|Overall Study|Virologic failure|0|||
147599889|NCT02041091|532352527|FG000|Treatment|Adverse Event|3|||
147599890|NCT02041091|532352528|FG001|Treatment|Adverse Event|3|||
147599891|NCT02041091|532352527|FG000|Treatment|Withdrawal by Subject|2|||
147599892|NCT02041091|532352528|FG001|Treatment|Withdrawal by Subject|4|||
147599893|NCT02041091|532352527|FG000|Treatment|Physician Decision|1|||
147599894|NCT02041091|532352528|FG001|Treatment|Physician Decision|0|||
147599895|NCT02041091|532352527|FG000|Treatment|Sponsor Decision|15|||
147599896|NCT02041091|532352528|FG001|Treatment|Sponsor Decision|16|||
147599897|NCT02041091|532352527|FG000|Treatment|Lost to Follow-up|1|||
147599898|NCT02041091|532352528|FG001|Treatment|Lost to Follow-up|0|||
147599899|NCT02041091|532352527|FG000|Optional Safety Extension Period|Adverse Event|4|||
147599900|NCT02041091|532352528|FG001|Optional Safety Extension Period|Adverse Event|2|||
147599901|NCT02041091|532352527|FG000|Optional Safety Extension Period|Withdrawal by Subject|5|||
147262095|NCT00634088|531132996|FG002|Time Period 1: Dose Level 1|Adverse Event|0|||
147262096|NCT00634088|531132997|FG003|Time Period 1: Dose Level 1|Adverse Event|0|||
147262097|NCT00634088|531132994|FG000|Time Period 2: Dose Level 2|Adverse Event|0|||
147262098|NCT00634088|531132995|FG001|Time Period 2: Dose Level 2|Adverse Event|2|||
147262099|NCT00634088|531132996|FG002|Time Period 2: Dose Level 2|Adverse Event|0|||
147262100|NCT00634088|531132997|FG003|Time Period 2: Dose Level 2|Adverse Event|0|||
147262101|NCT00634088|531132994|FG000|Time Period 2: Dose Level 2|Progressive disease|0|||
147262102|NCT00634088|531132995|FG001|Time Period 2: Dose Level 2|Progressive disease|1|||
147262103|NCT00634088|531132996|FG002|Time Period 2: Dose Level 2|Progressive disease|0|||
147262104|NCT00634088|531132997|FG003|Time Period 2: Dose Level 2|Progressive disease|0|||
147262105|NCT00634088|531132994|FG000|Time Period 3: Dose Level 3|Progressive disease|0|||
147262106|NCT00634088|531132995|FG001|Time Period 3: Dose Level 3|Progressive disease|0|||
147262107|NCT00634088|531132996|FG002|Time Period 3: Dose Level 3|Progressive disease|1|||
147262108|NCT00634088|531132997|FG003|Time Period 3: Dose Level 3|Progressive disease|0|||
147262109|NCT01251380|531133002|FG000|Overall Study|Other (Not otherwise specified)|12|||
147262110|NCT01251380|531133002|FG000|Overall Study|Withdrawal by Subject|6|||
147599902|NCT02041091|532352528|FG001|Optional Safety Extension Period|Withdrawal by Subject|2|||
147599903|NCT02041091|532352527|FG000|Optional Safety Extension Period|Protocol Violation|2|||
147599904|NCT02041091|532352528|FG001|Optional Safety Extension Period|Protocol Violation|0|||
147599905|NCT02041091|532352527|FG000|Optional Safety Extension Period|Physician Decision|2|||
147599906|NCT02041091|532352528|FG001|Optional Safety Extension Period|Physician Decision|1|||
147599907|NCT02041091|532352527|FG000|Optional Safety Extension Period|Sponsor Decision|70|||
147643972|NCT01447446|532516688|FG002|Overall Study|Death|2|||
147262111|NCT01251380|531133002|FG000|Overall Study|Lack of Efficacy|1|||
147262112|NCT01251380|531133002|FG000|Overall Study|Adverse Event|1|||
147262113|NCT01251380|531133002|FG000|Overall Study|Lost to Follow-up|2|||
147262114|NCT00600756|531133003|FG000|Analysis After 6 Months|Adverse Event|43|||
147262115|NCT00600756|531133004|FG001|Analysis After 6 Months|Adverse Event|33|||
147262116|NCT00600756|531133003|FG000|Analysis After 6 Months|Withdrawal by Subject|38|||
147262117|NCT00600756|531133004|FG001|Analysis After 6 Months|Withdrawal by Subject|30|||
147262118|NCT00600756|531133003|FG000|Analysis After 6 Months|Incorrect Enrollment|12|||
147262119|NCT00600756|531133004|FG001|Analysis After 6 Months|Incorrect Enrollment|21|||
147262120|NCT00600756|531133003|FG000|Analysis After 6 Months|worsening symptom, lack of efficacy|11|||
147262121|NCT00600756|531133004|FG001|Analysis After 6 Months|worsening symptom, lack of efficacy|14|||
147262122|NCT00600756|531133003|FG000|Analysis After 6 Months|Severe non-compliance to protocol|11|||
147262123|NCT00600756|531133004|FG001|Analysis After 6 Months|Severe non-compliance to protocol|11|||
147262124|NCT00600756|531133003|FG000|Analysis After 6 Months|Lost to Follow-up|10|||
147262125|NCT00600756|531133004|FG001|Analysis After 6 Months|Lost to Follow-up|8|||
147262126|NCT00600756|531133003|FG000|Analysis After 6 Months|Study-specific discontinuation criteria|6|||
147262127|NCT00600756|531133004|FG001|Analysis After 6 Months|Study-specific discontinuation criteria|3|||
147262128|NCT00600756|531133003|FG000|Overall Study Analysis After 12 Months|Adverse Event|53|||
147262129|NCT00600756|531133004|FG001|Overall Study Analysis After 12 Months|Adverse Event|44|||
147262130|NCT00600756|531133003|FG000|Overall Study Analysis After 12 Months|Withdrawal by Subject|51|||
147262131|NCT00600756|531133004|FG001|Overall Study Analysis After 12 Months|Withdrawal by Subject|41|||
147262132|NCT00600756|531133003|FG000|Overall Study Analysis After 12 Months|Incorrect enrollment|21|||
147262133|NCT00600756|531133004|FG001|Overall Study Analysis After 12 Months|Incorrect enrollment|29|||
147262134|NCT00600756|531133003|FG000|Overall Study Analysis After 12 Months|worsening symptom, lack of efficacy|17|||
147262135|NCT00600756|531133004|FG001|Overall Study Analysis After 12 Months|worsening symptom, lack of efficacy|20|||
147262136|NCT00600756|531133003|FG000|Overall Study Analysis After 12 Months|Severe non-compliance to protocol|16|||
147262137|NCT00600756|531133004|FG001|Overall Study Analysis After 12 Months|Severe non-compliance to protocol|20|||
147262138|NCT00600756|531133003|FG000|Overall Study Analysis After 12 Months|Lost to Follow-up|16|||
147262139|NCT00600756|531133004|FG001|Overall Study Analysis After 12 Months|Lost to Follow-up|13|||
147262140|NCT00600756|531133003|FG000|Overall Study Analysis After 12 Months|Study-specific discontinuation criteria|9|||
147262141|NCT00600756|531133004|FG001|Overall Study Analysis After 12 Months|Study-specific discontinuation criteria|9|||
147262142|NCT02063737|531133006|FG000|Overall Study|Lost to Follow-up|11|||
147262143|NCT02063737|531133007|FG001|Overall Study|Lost to Follow-up|4|||
147262144|NCT00439556|531133008|FG000|Overall Study|Patient was taken off study for non-comp|0|||
147262145|NCT00439556|531133009|FG001|Overall Study|Patient was taken off study for non-comp|1|||
147262146|NCT00439556|531133010|FG002|Overall Study|Patient was taken off study for non-comp|0|||
147262147|NCT01826487|531133018|FG000|Overall Study|Adverse Event|1|||
147262148|NCT01826487|531133019|FG001|Overall Study|Adverse Event|1|||
147262149|NCT01826487|531133018|FG000|Overall Study|Lost to Follow-up|1|||
147262150|NCT01826487|531133019|FG001|Overall Study|Lost to Follow-up|0|||
147262151|NCT01826487|531133018|FG000|Overall Study|Withdrawal by Subject|1|||
147262152|NCT01826487|531133019|FG001|Overall Study|Withdrawal by Subject|3|||
147262153|NCT01826487|531133018|FG000|Overall Study|Protocol Violation|1|||
147262154|NCT01826487|531133019|FG001|Overall Study|Protocol Violation|1|||
147262155|NCT01358357|531133020|FG000|Open Label Phase|Adverse Event|0|||
147262156|NCT01358357|531133021|FG001|Open Label Phase|Adverse Event|0|||
147262157|NCT01358357|531133022|FG002|Open Label Phase|Adverse Event|59|||
147262158|NCT01358357|531133020|FG000|Open Label Phase|Lack of Efficacy|0|||
147262159|NCT01358357|531133021|FG001|Open Label Phase|Lack of Efficacy|0|||
147262160|NCT01358357|531133022|FG002|Open Label Phase|Lack of Efficacy|107|||
147262161|NCT01358357|531133020|FG000|Open Label Phase|Lost to Follow-up|0|||
147262162|NCT01358357|531133021|FG001|Open Label Phase|Lost to Follow-up|0|||
147262163|NCT01358357|531133022|FG002|Open Label Phase|Lost to Follow-up|76|||
147262164|NCT01358357|531133020|FG000|Open Label Phase|Protocol Violation|0|||
147262165|NCT01358357|531133021|FG001|Open Label Phase|Protocol Violation|0|||
147262166|NCT01358357|531133022|FG002|Open Label Phase|Protocol Violation|45|||
147262167|NCT01358357|531133020|FG000|Open Label Phase|Withdrawal by Subject|0|||
147332871|NCT00790790|531385603|FG001|Study Period 2: Therapy Phase|Protocol Violation|1|||
147332872|NCT00790790|531385604|FG002|Study Period 2: Therapy Phase|Protocol Violation|0|||
147332873|NCT00790790|531385602|FG000|Study Period 2: Therapy Phase|Withdrawal by Subject|7|||
147332874|NCT00790790|531385603|FG001|Study Period 2: Therapy Phase|Withdrawal by Subject|0|||
147262168|NCT01358357|531133021|FG001|Open Label Phase|Withdrawal by Subject|0|||
147262169|NCT01358357|531133022|FG002|Open Label Phase|Withdrawal by Subject|112|||
147262170|NCT01358357|531133020|FG000|Open Label Phase|Did not meet criteria for DB phase|0|||
147262171|NCT01358357|531133021|FG001|Open Label Phase|Did not meet criteria for DB phase|0|||
147262172|NCT01358357|531133022|FG002|Open Label Phase|Did not meet criteria for DB phase|16|||
147262173|NCT01358357|531133020|FG000|Open Label Phase|Terminated at study completion|0|||
147262174|NCT01358357|531133021|FG001|Open Label Phase|Terminated at study completion|0|||
147332875|NCT00790790|531385604|FG002|Study Period 2: Therapy Phase|Withdrawal by Subject|2|||
147332876|NCT00790790|531385602|FG000|Study Period 2: Therapy Phase|Lack of Efficacy|1|||
147262175|NCT01358357|531133022|FG002|Open Label Phase|Terminated at study completion|5|||
147262176|NCT01358357|531133020|FG000|Open Label Phase|Mood episode|0|||
147262177|NCT01358357|531133021|FG001|Open Label Phase|Mood episode|0|||
147262178|NCT01358357|531133022|FG002|Open Label Phase|Mood episode|42|||
147262179|NCT01358357|531133020|FG000|Double-Blind Phase|Adverse Event|8|||
147262180|NCT01358357|531133021|FG001|Double-Blind Phase|Adverse Event|5|||
147262181|NCT01358357|531133022|FG002|Double-Blind Phase|Adverse Event|0|||
147262182|NCT01358357|531133020|FG000|Double-Blind Phase|Lost to Follow-up|5|||
147262183|NCT01358357|531133021|FG001|Double-Blind Phase|Lost to Follow-up|7|||
147262184|NCT01358357|531133022|FG002|Double-Blind Phase|Lost to Follow-up|0|||
147262185|NCT01358357|531133020|FG000|Double-Blind Phase|Protocol Violation|1|||
147262186|NCT01358357|531133021|FG001|Double-Blind Phase|Protocol Violation|11|||
147262187|NCT01358357|531133022|FG002|Double-Blind Phase|Protocol Violation|0|||
147262188|NCT01358357|531133020|FG000|Double-Blind Phase|Protocol Violation|16|||
147262189|NCT01358357|531133021|FG001|Double-Blind Phase|Protocol Violation|12|||
147262190|NCT01358357|531133022|FG002|Double-Blind Phase|Protocol Violation|0|||
147262191|NCT01358357|531133020|FG000|Double-Blind Phase|Terminated at study completion|2|||
147262192|NCT01358357|531133021|FG001|Double-Blind Phase|Terminated at study completion|0|||
147262193|NCT01358357|531133022|FG002|Double-Blind Phase|Terminated at study completion|0|||
147262194|NCT01358357|531133020|FG000|Double-Blind Phase|Recurrence of mood event|48|||
147262195|NCT01358357|531133021|FG001|Double-Blind Phase|Recurrence of mood event|64|||
147262196|NCT01358357|531133022|FG002|Double-Blind Phase|Recurrence of mood event|0|||
147262197|NCT01358357|531133020|FG000|Double-Blind Phase|Administrative|0|||
147262198|NCT01358357|531133021|FG001|Double-Blind Phase|Administrative|1|||
147262199|NCT01358357|531133022|FG002|Double-Blind Phase|Administrative|0|||
147262200|NCT02171260|531133027|FG000|Overall Study|Death|0|||
147262201|NCT02171260|531133028|FG001|Overall Study|Death|0|||
147262202|NCT02171260|531133029|FG002|Overall Study|Death|0|||
147262203|NCT02171260|531133030|FG003|Overall Study|Death|1|||
147262204|NCT02171260|531133027|FG000|Overall Study|Physician Decision|1|||
147262205|NCT02171260|531133028|FG001|Overall Study|Physician Decision|0|||
147262206|NCT02171260|531133029|FG002|Overall Study|Physician Decision|1|||
147262207|NCT02171260|531133030|FG003|Overall Study|Physician Decision|0|||
147262208|NCT02171260|531133027|FG000|Overall Study|Withdrawal by Subject|1|||
147262209|NCT02171260|531133028|FG001|Overall Study|Withdrawal by Subject|0|||
147262210|NCT02171260|531133029|FG002|Overall Study|Withdrawal by Subject|0|||
147262211|NCT02171260|531133030|FG003|Overall Study|Withdrawal by Subject|0|||
147262212|NCT02171260|531133027|FG000|Overall Study|Evidence of progressive disease|4|||
147262213|NCT02171260|531133028|FG001|Overall Study|Evidence of progressive disease|6|||
147262214|NCT02171260|531133029|FG002|Overall Study|Evidence of progressive disease|4|||
147262215|NCT02171260|531133030|FG003|Overall Study|Evidence of progressive disease|4|||
147262216|NCT00323492|531133035|FG000|Study Phase 1|Adverse Event|2|||
147262217|NCT00323492|531133036|FG001|Study Phase 1|Adverse Event|0|||
147262218|NCT00323492|531133037|FG002|Study Phase 1|Adverse Event|0|||
147262219|NCT00323492|531133035|FG000|Study Phase 2|Adverse Event|1|||
147262220|NCT00323492|531133036|FG001|Study Phase 2|Adverse Event|0|||
147262221|NCT00323492|531133037|FG002|Study Phase 2|Adverse Event|0|||
147262222|NCT00323492|531133035|FG000|Study Phase 2|Physician Decision|1|||
147262223|NCT00323492|531133036|FG001|Study Phase 2|Physician Decision|0|||
147262224|NCT00323492|531133037|FG002|Study Phase 2|Physician Decision|0|||
147262225|NCT00323492|531133035|FG000|Study Phase 2|Lost to Follow-up|1|||
147262226|NCT00323492|531133036|FG001|Study Phase 2|Lost to Follow-up|0|||
147262227|NCT00323492|531133037|FG002|Study Phase 2|Lost to Follow-up|0|||
147262228|NCT00323492|531133035|FG000|Study Phase 2|Withdrawal by Subject|0|||
147262229|NCT00323492|531133036|FG001|Study Phase 2|Withdrawal by Subject|1|||
147262230|NCT00323492|531133037|FG002|Study Phase 2|Withdrawal by Subject|0|||
147262231|NCT00323492|531133035|FG000|Study Phase 2|Noncompliance with study schedule|0|||
147262232|NCT00323492|531133036|FG001|Study Phase 2|Noncompliance with study schedule|0|||
147262233|NCT00323492|531133037|FG002|Study Phase 2|Noncompliance with study schedule|1|||
147262234|NCT00323492|531133035|FG000|Study Phase 2|Protocol Violation|1|||
147332877|NCT00790790|531385603|FG001|Study Period 2: Therapy Phase|Lack of Efficacy|0|||
147332878|NCT00790790|531385604|FG002|Study Period 2: Therapy Phase|Lack of Efficacy|3|||
147332879|NCT00790790|531385602|FG000|Study Period 2: Therapy Phase|Physician Decision|0|||
147332880|NCT00790790|531385603|FG001|Study Period 2: Therapy Phase|Physician Decision|1|||
147332881|NCT00790790|531385604|FG002|Study Period 2: Therapy Phase|Physician Decision|0|||
147332882|NCT02808338|531385606|FG000|Screening|Screen Failure|10|||
147332883|NCT02808338|531385606|FG000|Overnight In-lab Polysomonography|Withdrawal by Subject|1|||
147332884|NCT02808338|531385606|FG000|Overnight In-lab Polysomonography|Reason not given|1|||
147332885|NCT02194933|531385607|FG000|Overall Study|Lost to Follow-up|1|||
147643973|NCT01447446|532516689|FG003|Overall Study|Death|1|||
147262235|NCT00323492|531133036|FG001|Study Phase 2|Protocol Violation|0|||
147262236|NCT00323492|531133037|FG002|Study Phase 2|Protocol Violation|0|||
147262237|NCT02486042|531133038|FG000|Overall Study|Physician Decision|1|||
147262238|NCT02486042|531133039|FG001|Overall Study|Physician Decision|7|||
147332886|NCT02194933|531385608|FG001|Overall Study|Lost to Follow-up|2|||
147262239|NCT02486042|531133038|FG000|Overall Study|Hospital transfer|2|||
147262240|NCT02486042|531133039|FG001|Overall Study|Hospital transfer|2|||
147332887|NCT02194933|531385607|FG000|Overall Study|Participant met withdrawal criteria|1|||
147332888|NCT02194933|531385608|FG001|Overall Study|Participant met withdrawal criteria|3|||
147332889|NCT02194933|531385607|FG000|Overall Study|Withdrawal by Subject|0|||
147332890|NCT02194933|531385608|FG001|Overall Study|Withdrawal by Subject|2|||
147332891|NCT02194933|531385607|FG000|Overall Study|Lack of Efficacy|1|||
147332892|NCT02194933|531385608|FG001|Overall Study|Lack of Efficacy|2|||
147332893|NCT02000817|531385611|FG000|Overall Study|Withdrawal by Subject|2|||
147262241|NCT02486042|531133038|FG000|Overall Study|Withdrawal by Subject|0|||
147262242|NCT02486042|531133039|FG001|Overall Study|Withdrawal by Subject|2|||
147262243|NCT03320564|531133042|FG000|Overall Study|Protocol Violation|1|||
147262244|NCT04668950|531133046|FG000|Overall Study|Started medication more than 7 days after symptom onset|18|||
147262245|NCT04668950|531133047|FG001|Overall Study|Started medication more than 7 days after symptom onset|14|||
147262246|NCT04668950|531133046|FG000|Overall Study|Could not confirm started study medication|15|||
147262247|NCT04668950|531133047|FG001|Overall Study|Could not confirm started study medication|15|||
147262248|NCT04668950|531133046|FG000|Overall Study|Could not confirm baseline status|6|||
147262249|NCT04668950|531133047|FG001|Overall Study|Could not confirm baseline status|2|||
147262250|NCT04668950|531133046|FG000|Overall Study|Drop out and did not start medication|15|||
147262251|NCT04668950|531133047|FG001|Overall Study|Drop out and did not start medication|17|||
147262252|NCT04668950|531133046|FG000|Overall Study|Deteriorated at or before baseline assessment|6|||
147262253|NCT04668950|531133047|FG001|Overall Study|Deteriorated at or before baseline assessment|9|||
147262254|NCT04668950|531133046|FG000|Overall Study|Other|2|||
147262255|NCT04668950|531133047|FG001|Overall Study|Other|4|||
147262256|NCT03979638|531133048|FG000|Period 1|Physician Decision|1|||
147599908|NCT02041091|532352528|FG001|Optional Safety Extension Period|Sponsor Decision|74|||
147599909|NCT02041091|532352527|FG000|Optional Safety Extension Period|Lost to Follow-up|2|||
147599910|NCT02041091|532352528|FG001|Optional Safety Extension Period|Lost to Follow-up|3|||
147599911|NCT01855074|532352529|FG000|Overall Study|Adverse Event|1|||
147599912|NCT01855074|532352529|FG000|Overall Study|Lost to Follow-up|4|||
147599913|NCT01855074|532352529|FG000|Overall Study|Withdrawal by Subject|8|||
147599914|NCT01855074|532352529|FG000|Overall Study|Started but not treated|1|||
147599915|NCT01150890|532352530|FG000|Overall Study|Other|0|||
147599916|NCT01150890|532352531|FG001|Overall Study|Other|1|||
147599917|NCT01150890|532352532|FG002|Overall Study|Other|0|||
147599918|NCT01150890|532352533|FG003|Overall Study|Other|2|||
147599919|NCT01150890|532352530|FG000|Overall Study|Pregnancy|0|||
147599920|NCT01150890|532352531|FG001|Overall Study|Pregnancy|0|||
147599921|NCT01150890|532352532|FG002|Overall Study|Pregnancy|0|||
147599922|NCT01150890|532352533|FG003|Overall Study|Pregnancy|1|||
147599923|NCT01150890|532352530|FG000|Overall Study|Administrative Decision|4|||
147599924|NCT01150890|532352531|FG001|Overall Study|Administrative Decision|4|||
147662242|NCT00689338|532585698|FG000|Overall Study|Lack of Efficacy|6|||
147262257|NCT03979638|531133049|FG001|Period 1|Physician Decision|1|||
147262258|NCT03979638|531133048|FG000|Period 1|Withdrawal by Subject|4|||
147262259|NCT03979638|531133049|FG001|Period 1|Withdrawal by Subject|3|||
147262260|NCT03979638|531133048|FG000|Period 1|Study terminated by Sponsor|1|||
147262261|NCT03979638|531133049|FG001|Period 1|Study terminated by Sponsor|3|||
147262262|NCT03979638|531133048|FG000|Period 1|Protocol Violation|1|||
147262263|NCT03979638|531133049|FG001|Period 1|Protocol Violation|0|||
147262264|NCT03979638|531133048|FG000|Period 2|Study terminated by Sponsor|1|||
147262265|NCT03979638|531133049|FG001|Period 2|Study terminated by Sponsor|1|||
147262266|NCT00600938|531133054|FG000|Core Study|Abnormal test procedure result(s)|3|||
147262267|NCT00600938|531133055|FG001|Core Study|Abnormal test procedure result(s)|2|||
147262268|NCT00600938|531133056|FG002|Core Study|Abnormal test procedure result(s)|0|||
147262269|NCT00600938|531133057|FG003|Core Study|Abnormal test procedure result(s)|0|||
147262270|NCT00600938|531133054|FG000|Core Study|Unsatisfactory therapeutic effect|1|||
147262271|NCT00600938|531133055|FG001|Core Study|Unsatisfactory therapeutic effect|2|||
147262272|NCT00600938|531133056|FG002|Core Study|Unsatisfactory therapeutic effect|0|||
147262273|NCT00600938|531133057|FG003|Core Study|Unsatisfactory therapeutic effect|0|||
147262274|NCT00600938|531133054|FG000|Core Study|Patient withdrew consent|7|||
147262275|NCT00600938|531133055|FG001|Core Study|Patient withdrew consent|12|||
147332894|NCT02000817|531385612|FG001|Overall Study|Withdrawal by Subject|0|||
147332895|NCT02000817|531385613|FG002|Overall Study|Withdrawal by Subject|0|||
147332896|NCT02000817|531385614|FG003|Overall Study|Withdrawal by Subject|0|||
147262276|NCT00600938|531133056|FG002|Core Study|Patient withdrew consent|0|||
147262277|NCT00600938|531133057|FG003|Core Study|Patient withdrew consent|0|||
147332897|NCT02000817|531385611|FG000|Overall Study|Adverse Event|0|||
147599925|NCT01150890|532352532|FG002|Overall Study|Administrative Decision|5|||
147262278|NCT00600938|531133054|FG000|Core Study|Lost to Follow-up|3|||
147262279|NCT00600938|531133055|FG001|Core Study|Lost to Follow-up|2|||
147332898|NCT02000817|531385612|FG001|Overall Study|Adverse Event|1|||
147332899|NCT02000817|531385613|FG002|Overall Study|Adverse Event|0|||
147332900|NCT02000817|531385614|FG003|Overall Study|Adverse Event|0|||
147599926|NCT01150890|532352533|FG003|Overall Study|Administrative Decision|6|||
147599927|NCT01150890|532352530|FG000|Overall Study|Ineligibility determined|0|||
147599928|NCT01150890|532352531|FG001|Overall Study|Ineligibility determined|1|||
147262280|NCT00600938|531133056|FG002|Core Study|Lost to Follow-up|0|||
147262281|NCT00600938|531133057|FG003|Core Study|Lost to Follow-up|0|||
147262282|NCT00600938|531133054|FG000|Core Study|Death|1|||
147262283|NCT00600938|531133055|FG001|Core Study|Death|1|||
147262284|NCT00600938|531133056|FG002|Core Study|Death|0|||
147262285|NCT00600938|531133057|FG003|Core Study|Death|0|||
147262286|NCT00600938|531133054|FG000|Core Study|Protocol Violation|1|||
147262287|NCT00600938|531133055|FG001|Core Study|Protocol Violation|2|||
147262288|NCT00600938|531133056|FG002|Core Study|Protocol Violation|0|||
147262289|NCT00600938|531133057|FG003|Core Study|Protocol Violation|0|||
147262290|NCT00600938|531133054|FG000|Extension Study|Adverse Event|1|||
147262291|NCT00600938|531133055|FG001|Extension Study|Adverse Event|0|||
147262292|NCT00600938|531133056|FG002|Extension Study|Adverse Event|2|||
147262293|NCT00600938|531133057|FG003|Extension Study|Adverse Event|0|||
147262294|NCT00600938|531133054|FG000|Extension Study|Abnormal test procedure results|0|||
147262295|NCT00600938|531133055|FG001|Extension Study|Abnormal test procedure results|1|||
147262296|NCT00600938|531133056|FG002|Extension Study|Abnormal test procedure results|1|||
147262297|NCT00600938|531133057|FG003|Extension Study|Abnormal test procedure results|1|||
147262298|NCT00600938|531133054|FG000|Extension Study|Unsatisfactory therapeutic effect|4|||
147262299|NCT00600938|531133055|FG001|Extension Study|Unsatisfactory therapeutic effect|1|||
147262300|NCT00600938|531133056|FG002|Extension Study|Unsatisfactory therapeutic effect|1|||
147262301|NCT00600938|531133057|FG003|Extension Study|Unsatisfactory therapeutic effect|0|||
147262302|NCT00600938|531133054|FG000|Extension Study|Withdrawal by Subject|2|||
147262303|NCT00600938|531133055|FG001|Extension Study|Withdrawal by Subject|2|||
147262304|NCT00600938|531133056|FG002|Extension Study|Withdrawal by Subject|3|||
147262305|NCT00600938|531133057|FG003|Extension Study|Withdrawal by Subject|0|||
147262306|NCT00600938|531133054|FG000|Extension Study|Lost to Follow-up|1|||
147262307|NCT00600938|531133055|FG001|Extension Study|Lost to Follow-up|1|||
147262308|NCT00600938|531133056|FG002|Extension Study|Lost to Follow-up|2|||
147262309|NCT00600938|531133057|FG003|Extension Study|Lost to Follow-up|0|||
147262310|NCT00600938|531133054|FG000|Extension Study|Death|1|||
147262311|NCT00600938|531133055|FG001|Extension Study|Death|0|||
147262312|NCT00600938|531133056|FG002|Extension Study|Death|0|||
147262313|NCT00600938|531133057|FG003|Extension Study|Death|0|||
147262314|NCT04220411|531133058|FG000|Overall Study|Adverse Event|0|||
147262315|NCT04220411|531133059|FG001|Overall Study|Adverse Event|0|||
147262316|NCT04220411|531133060|FG002|Overall Study|Adverse Event|0|||
147262317|NCT04220411|531133061|FG003|Overall Study|Adverse Event|1|||
147262318|NCT02680639|531133062|FG000|Screening Period|Screen Failure|7|||
147262319|NCT02680639|531133063|FG001|Screening Period|Screen Failure|0|||
147262320|NCT02680639|531133064|FG002|Screening Period|Screen Failure|0|||
147262321|NCT02496533|531133066|FG000|Overall Study|Lack of data on outcome|3|||
147262322|NCT02496533|531133067|FG001|Overall Study|Lack of data on outcome|0|||
147262323|NCT02496533|531133066|FG000|Overall Study|Patient did not complete all measures|0|||
147262324|NCT02496533|531133067|FG001|Overall Study|Patient did not complete all measures|4|||
147262325|NCT02496533|531133066|FG000|Overall Study|Late for radiologic testing|0|||
147262326|NCT02496533|531133067|FG001|Overall Study|Late for radiologic testing|2|||
147262327|NCT00502697|531134989|FG000|Overall Study|Withdrawal by Subject|3|||
147262328|NCT00502697|531134990|FG001|Overall Study|Withdrawal by Subject|1|||
147262329|NCT00502697|531134989|FG000|Overall Study|disenrolled due to pregnancy loss|3|||
147262330|NCT00502697|531134990|FG001|Overall Study|disenrolled due to pregnancy loss|5|||
147262331|NCT00502697|531134989|FG000|Overall Study|found not to meet eligibility criteria|3|||
147262332|NCT00502697|531134990|FG001|Overall Study|found not to meet eligibility criteria|4|||
147262333|NCT00502697|531134989|FG000|Overall Study|did not meet assignment criteria|4|||
147262334|NCT00502697|531134990|FG001|Overall Study|did not meet assignment criteria|2|||
147262335|NCT02268409|531134995|FG000|Overall Study|Reason for discontinuation not reported by the investigator|2|||
147262336|NCT02268409|531134995|FG000|Overall Study|Death|1|||
147262337|NCT02268409|531134995|FG000|Overall Study|Lost to Follow-up|1|||
147262338|NCT02268409|531134995|FG000|Overall Study|Protocol Violation|3|||
147262339|NCT02268409|531134995|FG000|Overall Study|Participation in study terminated by Sponsor|25|||
147262340|NCT02268409|531134995|FG000|Overall Study|Withdrawal by Subject|5|||
147262341|NCT00489853|531134996|FG000|Wash-out Period 1|Withdrawal by Subject|1|||
147262342|NCT00489853|531134997|FG001|Wash-out Period 1|Withdrawal by Subject|0|||
147262343|NCT00489853|531134998|FG002|Wash-out Period 1|Withdrawal by Subject|0|||
147262344|NCT00489853|531134996|FG000|Wash-out Period 1|Adverse Event|0|||
147262345|NCT00489853|531134997|FG001|Wash-out Period 1|Adverse Event|1|||
147332901|NCT02000817|531385611|FG000|Overall Study|Lost to Follow-up|0|||
147262346|NCT00489853|531134998|FG002|Wash-out Period 1|Adverse Event|1|||
147332902|NCT02000817|531385612|FG001|Overall Study|Lost to Follow-up|0|||
147262347|NCT00489853|531134996|FG000|Wash-out Period 1|Protocol Violation|0|||
147262348|NCT00489853|531134997|FG001|Wash-out Period 1|Protocol Violation|1|||
147262349|NCT00489853|531134998|FG002|Wash-out Period 1|Protocol Violation|1|||
147262350|NCT00489853|531134996|FG000|Wash-out Period 1|Study-specific discontinuation criteria|0|||
147262351|NCT00489853|531134997|FG001|Wash-out Period 1|Study-specific discontinuation criteria|1|||
147262352|NCT00489853|531134998|FG002|Wash-out Period 1|Study-specific discontinuation criteria|4|||
147262353|NCT00489853|531134996|FG000|Wash-out Period 2|Adverse Event|1|||
147332903|NCT02000817|531385613|FG002|Overall Study|Lost to Follow-up|1|||
147262354|NCT00489853|531134997|FG001|Wash-out Period 2|Adverse Event|1|||
147262355|NCT00489853|531134998|FG002|Wash-out Period 2|Adverse Event|0|||
147262356|NCT00489853|531134996|FG000|Wash-out Period 2|Study specific discontinuation criteria|3|||
147262357|NCT00489853|531134997|FG001|Wash-out Period 2|Study specific discontinuation criteria|2|||
147262358|NCT00489853|531134998|FG002|Wash-out Period 2|Study specific discontinuation criteria|2|||
147262359|NCT00489853|531134996|FG000|Treatment Period 3|Study specific discontinuation criteria|0|||
147262360|NCT00489853|531134997|FG001|Treatment Period 3|Study specific discontinuation criteria|1|||
147262361|NCT00489853|531134998|FG002|Treatment Period 3|Study specific discontinuation criteria|0|||
147262362|NCT04865354|531134999|FG000|First Wear Period (8 Days)|Withdrawal by Subject|1|||
147262363|NCT04865354|531135000|FG001|First Wear Period (8 Days)|Withdrawal by Subject|0|||
147262364|NCT04865354|531134999|FG000|First Wear Period (8 Days)|Lost to Follow-up|0|||
147262365|NCT04865354|531135000|FG001|First Wear Period (8 Days)|Lost to Follow-up|1|||
147262366|NCT04865354|531134999|FG000|Second Wear Period (8 Days)|Protocol deviation, dispensed wrong powers|1|||
147262367|NCT04865354|531135000|FG001|Second Wear Period (8 Days)|Protocol deviation, dispensed wrong powers|0|||
147262368|NCT03873987|531135001|FG000|Overall Study|Adverse Event|1|||
147262369|NCT03873987|531135002|FG001|Overall Study|Adverse Event|0|||
147262370|NCT03873987|531135001|FG000|Overall Study|staff was unable to start a new IV line|1|||
147262371|NCT03873987|531135002|FG001|Overall Study|staff was unable to start a new IV line|0|||
147262372|NCT03873987|531135001|FG000|Overall Study|Lost to Follow-up|0|||
147262373|NCT03873987|531135002|FG001|Overall Study|Lost to Follow-up|1|||
147262374|NCT01465022|531135003|FG000|Overall Study|Lost to Follow-up|15|||
147262375|NCT01465022|531135004|FG001|Overall Study|Lost to Follow-up|14|||
147262376|NCT01465022|531135005|FG002|Overall Study|Lost to Follow-up|0|||
147262377|NCT01465022|531135003|FG000|Overall Study|Breastfeeding discontinuation before 8 w|8|||
147262378|NCT01465022|531135004|FG001|Overall Study|Breastfeeding discontinuation before 8 w|9|||
147262379|NCT01465022|531135005|FG002|Overall Study|Breastfeeding discontinuation before 8 w|0|||
147262380|NCT01465022|531135003|FG000|Overall Study|Not Randomized|0|||
147262381|NCT01465022|531135004|FG001|Overall Study|Not Randomized|0|||
147262382|NCT01465022|531135005|FG002|Overall Study|Not Randomized|70|||
147262383|NCT00004888|531135006|FG000|Overall Study|Adverse Event|5|||
147262384|NCT00004888|531135007|FG001|Overall Study|Adverse Event|10|||
147262385|NCT00004888|531135006|FG000|Overall Study|Withdrawal by Subject|0|||
147262386|NCT00004888|531135007|FG001|Overall Study|Withdrawal by Subject|3|||
147262387|NCT00004888|531135006|FG000|Overall Study|Physician Decision|1|||
147262388|NCT00004888|531135007|FG001|Overall Study|Physician Decision|1|||
147262389|NCT00004888|531135006|FG000|Overall Study|Progressive Disease|4|||
147262390|NCT00004888|531135007|FG001|Overall Study|Progressive Disease|9|||
147262391|NCT00004888|531135006|FG000|Overall Study|Death without progressive disease|0|||
147262392|NCT00004888|531135007|FG001|Overall Study|Death without progressive disease|1|||
147262393|NCT00004888|531135006|FG000|Overall Study|Toxic death|1|||
147262394|NCT00004888|531135007|FG001|Overall Study|Toxic death|0|||
147262395|NCT00136084|531135008|FG000|Overall Study|Death|12|||
147262396|NCT00136084|531135009|FG001|Overall Study|Death|5|||
147262397|NCT00136084|531135008|FG000|Overall Study|Unacceptable toxicity|8|||
147262398|NCT00136084|531135009|FG001|Overall Study|Unacceptable toxicity|11|||
147262399|NCT00136084|531135008|FG000|Overall Study|Relapse|20|||
147262400|NCT00136084|531135009|FG001|Overall Study|Relapse|23|||
147262401|NCT00136084|531135008|FG000|Overall Study|Lost to Follow-up|2|||
147262402|NCT00136084|531135009|FG001|Overall Study|Lost to Follow-up|0|||
147262403|NCT00136084|531135008|FG000|Overall Study|No Response|1|||
147262404|NCT00136084|531135009|FG001|Overall Study|No Response|2|||
147262405|NCT00136084|531135008|FG000|Overall Study|Withdrawal by Subject|5|||
147262406|NCT00136084|531135009|FG001|Overall Study|Withdrawal by Subject|1|||
147262407|NCT02520011|531135010|FG000|Overall Study|Adverse Event|0|||
147262408|NCT02520011|531135011|FG001|Overall Study|Adverse Event|1|||
147262409|NCT02520011|531135012|FG002|Overall Study|Adverse Event|2|||
147262410|NCT02520011|531135010|FG000|Overall Study|Death|0|||
147262411|NCT02520011|531135011|FG001|Overall Study|Death|8|||
147262412|NCT02520011|531135012|FG002|Overall Study|Death|1|||
147262413|NCT02520011|531135010|FG000|Overall Study|Lack of Efficacy|4|||
147262414|NCT02520011|531135011|FG001|Overall Study|Lack of Efficacy|26|||
147262415|NCT02520011|531135012|FG002|Overall Study|Lack of Efficacy|4|||
147262416|NCT02520011|531135010|FG000|Overall Study|Physician Decision|0|||
147262417|NCT02520011|531135011|FG001|Overall Study|Physician Decision|2|||
147262418|NCT02520011|531135012|FG002|Overall Study|Physician Decision|0|||
147262419|NCT02520011|531135010|FG000|Overall Study|Withdrawal by Subject|1|||
147262420|NCT02520011|531135011|FG001|Overall Study|Withdrawal by Subject|3|||
147262421|NCT02520011|531135012|FG002|Overall Study|Withdrawal by Subject|0|||
147262422|NCT02520011|531135010|FG000|Overall Study|Protocol Deviation|0|||
147262423|NCT02520011|531135011|FG001|Overall Study|Protocol Deviation|1|||
147262424|NCT02520011|531135012|FG002|Overall Study|Protocol Deviation|0|||
147262425|NCT02520011|531135010|FG000|Overall Study|Patient went to hospice|0|||
147262426|NCT02520011|531135011|FG001|Overall Study|Patient went to hospice|1|||
147262427|NCT02520011|531135012|FG002|Overall Study|Patient went to hospice|0|||
147262428|NCT02520011|531135010|FG000|Overall Study|Progressive disease following response|0|||
147262429|NCT02520011|531135011|FG001|Overall Study|Progressive disease following response|4|||
147262430|NCT02520011|531135012|FG002|Overall Study|Progressive disease following response|2|||
147262431|NCT03239470|531135015|FG000|Polyclonal Treg Infusion|Baseline Pemphigus Disease Area Index (PDAI) >12, thus ineligible for PolyTregs infusion.|1|||
147262432|NCT03239470|531135016|FG001|Polyclonal Treg Infusion|Baseline Pemphigus Disease Area Index (PDAI) >12, thus ineligible for PolyTregs infusion.|0|||
147262433|NCT02622828|531135017|FG000|Overall Study|participant withdrew|3|||
147262434|NCT01921829|531135018|FG000|Overall Study|Withdrawal by Subject|0|||
147262435|NCT01921829|531135019|FG001|Overall Study|Withdrawal by Subject|1|||
147262436|NCT04091646|531135020|FG000|Overall Study|Adverse Event|2|||
147262437|NCT04091646|531135021|FG001|Overall Study|Adverse Event|1|||
147262438|NCT04091646|531135020|FG000|Overall Study|Lost to Follow-up|6|||
147262439|NCT04091646|531135021|FG001|Overall Study|Lost to Follow-up|2|||
147262440|NCT04091646|531135020|FG000|Overall Study|Protocol Violation|0|||
147262441|NCT04091646|531135021|FG001|Overall Study|Protocol Violation|1|||
147262442|NCT04091646|531135020|FG000|Overall Study|Withdrawal by Subject|4|||
147262443|NCT04091646|531135021|FG001|Overall Study|Withdrawal by Subject|1|||
147262444|NCT04091646|531135020|FG000|Overall Study|Participant Incarcerated|1|||
147262445|NCT04091646|531135021|FG001|Overall Study|Participant Incarcerated|0|||
147262446|NCT01762943|531135023|FG000|Overall Study|Physician Decision|1|||
147262447|NCT01762943|531135024|FG001|Overall Study|Physician Decision|1|||
147262448|NCT01762943|531135023|FG000|Overall Study|Protocol Violation|1|||
147262449|NCT01762943|531135024|FG001|Overall Study|Protocol Violation|0|||
147262450|NCT01762943|531135023|FG000|Overall Study|Withdrawal by Subject|2|||
147262451|NCT01762943|531135024|FG001|Overall Study|Withdrawal by Subject|1|||
147262452|NCT00539838|531135025|FG000|Overall Study|Fail to return|2|||
147262453|NCT00539838|531135026|FG001|Overall Study|Fail to return|0|||
147262454|NCT00539838|531135027|FG002|Overall Study|Fail to return|0|||
147262455|NCT00539838|531135025|FG000|Overall Study|Withdrawal by Subject|0|||
147262456|NCT00539838|531135026|FG001|Overall Study|Withdrawal by Subject|4|||
147262457|NCT00539838|531135027|FG002|Overall Study|Withdrawal by Subject|0|||
147262458|NCT00539838|531135025|FG000|Overall Study|Death|0|||
147262459|NCT00539838|531135026|FG001|Overall Study|Death|2|||
147262460|NCT00539838|531135027|FG002|Overall Study|Death|0|||
147262461|NCT00539838|531135025|FG000|Overall Study|Did not cooperate|1|||
147262462|NCT00539838|531135026|FG001|Overall Study|Did not cooperate|0|||
147262463|NCT00539838|531135027|FG002|Overall Study|Did not cooperate|1|||
147262464|NCT00539838|531135025|FG000|Overall Study|Administrative|4|||
147262465|NCT00539838|531135026|FG001|Overall Study|Administrative|0|||
147262466|NCT00539838|531135027|FG002|Overall Study|Administrative|8|||
147262467|NCT02658890|531135030|FG000|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
147262468|NCT02658890|531135031|FG001|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
147262469|NCT02658890|531135032|FG002|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
147262470|NCT02658890|531135033|FG003|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
147262471|NCT02658890|531135034|FG004|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
147262472|NCT02658890|531135035|FG005|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
147262473|NCT02658890|531135036|FG006|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
147262474|NCT02658890|531135037|FG007|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
147262475|NCT02658890|531135038|FG008|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|1|||
147262476|NCT02658890|531135039|FG009|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
147262477|NCT02658890|531135040|FG010|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
147262478|NCT02658890|531135041|FG011|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
147262479|NCT02658890|531135042|FG012|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
147262480|NCT02658890|531135043|FG013|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
147262481|NCT02658890|531135044|FG014|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
147262482|NCT02658890|531135045|FG015|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
147262483|NCT02658890|531135046|FG016|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
147262484|NCT02658890|531135047|FG017|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
147262485|NCT02658890|531135048|FG018|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
147262486|NCT02658890|531135049|FG019|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
147262487|NCT02658890|531135050|FG020|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
147262488|NCT02658890|531135051|FG021|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
147262489|NCT02658890|531135052|FG022|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
147262490|NCT02658890|531135053|FG023|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
147262491|NCT02658890|531135054|FG024|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
147262492|NCT02658890|531135055|FG025|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
147262493|NCT02658890|531135056|FG026|Pre-Treatment Phase|Participant No Longer Meets Study Criteria|0|||
147262494|NCT02658890|531135030|FG000|Treatment Phase|Adverse Event|0|||
147262495|NCT02658890|531135031|FG001|Treatment Phase|Adverse Event|1|||
147262496|NCT02658890|531135032|FG002|Treatment Phase|Adverse Event|2|||
147262497|NCT02658890|531135033|FG003|Treatment Phase|Adverse Event|2|||
147262498|NCT02658890|531135034|FG004|Treatment Phase|Adverse Event|1|||
147450162|NCT00464334|531811374|FG001|Overall Study|Lost to Follow-up|0|||
147262499|NCT02658890|531135035|FG005|Treatment Phase|Adverse Event|0|||
147262500|NCT02658890|531135036|FG006|Treatment Phase|Adverse Event|0|||
147262501|NCT02658890|531135037|FG007|Treatment Phase|Adverse Event|2|||
147262502|NCT02658890|531135038|FG008|Treatment Phase|Adverse Event|1|||
147262503|NCT02658890|531135039|FG009|Treatment Phase|Adverse Event|2|||
147262504|NCT02658890|531135040|FG010|Treatment Phase|Adverse Event|3|||
147262505|NCT02658890|531135041|FG011|Treatment Phase|Adverse Event|0|||
147262506|NCT02658890|531135042|FG012|Treatment Phase|Adverse Event|1|||
147262507|NCT02658890|531135043|FG013|Treatment Phase|Adverse Event|4|||
147262508|NCT02658890|531135044|FG014|Treatment Phase|Adverse Event|0|||
147262509|NCT02658890|531135045|FG015|Treatment Phase|Adverse Event|0|||
147262510|NCT02658890|531135046|FG016|Treatment Phase|Adverse Event|0|||
147262511|NCT02658890|531135047|FG017|Treatment Phase|Adverse Event|0|||
147262512|NCT02658890|531135048|FG018|Treatment Phase|Adverse Event|5|||
147262513|NCT02658890|531135049|FG019|Treatment Phase|Adverse Event|1|||
147262514|NCT02658890|531135050|FG020|Treatment Phase|Adverse Event|3|||
147262515|NCT02658890|531135051|FG021|Treatment Phase|Adverse Event|0|||
147262516|NCT02658890|531135052|FG022|Treatment Phase|Adverse Event|5|||
147262517|NCT02658890|531135053|FG023|Treatment Phase|Adverse Event|0|||
147262518|NCT02658890|531135054|FG024|Treatment Phase|Adverse Event|0|||
147262519|NCT02658890|531135055|FG025|Treatment Phase|Adverse Event|2|||
147262520|NCT02658890|531135056|FG026|Treatment Phase|Adverse Event|1|||
147262521|NCT02658890|531135030|FG000|Treatment Phase|Death|0|||
147262522|NCT02658890|531135031|FG001|Treatment Phase|Death|0|||
147262523|NCT02658890|531135032|FG002|Treatment Phase|Death|0|||
147262524|NCT02658890|531135033|FG003|Treatment Phase|Death|0|||
147262525|NCT02658890|531135034|FG004|Treatment Phase|Death|0|||
147262526|NCT02658890|531135035|FG005|Treatment Phase|Death|0|||
147262527|NCT02658890|531135036|FG006|Treatment Phase|Death|0|||
147262528|NCT02658890|531135037|FG007|Treatment Phase|Death|0|||
147262529|NCT02658890|531135038|FG008|Treatment Phase|Death|0|||
147262530|NCT02658890|531135039|FG009|Treatment Phase|Death|0|||
147262531|NCT02658890|531135040|FG010|Treatment Phase|Death|0|||
147262532|NCT02658890|531135041|FG011|Treatment Phase|Death|0|||
147262533|NCT02658890|531135042|FG012|Treatment Phase|Death|0|||
147262534|NCT02658890|531135043|FG013|Treatment Phase|Death|0|||
147262535|NCT02658890|531135044|FG014|Treatment Phase|Death|0|||
147262536|NCT02658890|531135045|FG015|Treatment Phase|Death|0|||
147262537|NCT02658890|531135046|FG016|Treatment Phase|Death|0|||
147262538|NCT02658890|531135047|FG017|Treatment Phase|Death|0|||
147262539|NCT02658890|531135048|FG018|Treatment Phase|Death|1|||
147262540|NCT02658890|531135049|FG019|Treatment Phase|Death|0|||
147262541|NCT02658890|531135050|FG020|Treatment Phase|Death|0|||
147262542|NCT02658890|531135051|FG021|Treatment Phase|Death|0|||
147262543|NCT02658890|531135052|FG022|Treatment Phase|Death|0|||
147262544|NCT02658890|531135053|FG023|Treatment Phase|Death|0|||
147262545|NCT02658890|531135054|FG024|Treatment Phase|Death|0|||
147262546|NCT02658890|531135055|FG025|Treatment Phase|Death|0|||
147262547|NCT02658890|531135056|FG026|Treatment Phase|Death|0|||
147262548|NCT02658890|531135030|FG000|Treatment Phase|Lost to Follow-up|0|||
147262549|NCT02658890|531135031|FG001|Treatment Phase|Lost to Follow-up|0|||
147262550|NCT02658890|531135032|FG002|Treatment Phase|Lost to Follow-up|0|||
147262551|NCT02658890|531135033|FG003|Treatment Phase|Lost to Follow-up|0|||
147262552|NCT02658890|531135034|FG004|Treatment Phase|Lost to Follow-up|0|||
147262553|NCT02658890|531135035|FG005|Treatment Phase|Lost to Follow-up|0|||
147262554|NCT02658890|531135036|FG006|Treatment Phase|Lost to Follow-up|1|||
147262555|NCT02658890|531135037|FG007|Treatment Phase|Lost to Follow-up|0|||
147262556|NCT02658890|531135038|FG008|Treatment Phase|Lost to Follow-up|0|||
147262557|NCT02658890|531135039|FG009|Treatment Phase|Lost to Follow-up|0|||
147262558|NCT02658890|531135040|FG010|Treatment Phase|Lost to Follow-up|0|||
147262559|NCT02658890|531135041|FG011|Treatment Phase|Lost to Follow-up|0|||
147262560|NCT02658890|531135042|FG012|Treatment Phase|Lost to Follow-up|0|||
147262561|NCT02658890|531135043|FG013|Treatment Phase|Lost to Follow-up|0|||
147262562|NCT02658890|531135044|FG014|Treatment Phase|Lost to Follow-up|0|||
147262563|NCT02658890|531135045|FG015|Treatment Phase|Lost to Follow-up|0|||
147262564|NCT02658890|531135046|FG016|Treatment Phase|Lost to Follow-up|0|||
147262565|NCT02658890|531135047|FG017|Treatment Phase|Lost to Follow-up|0|||
147262566|NCT02658890|531135048|FG018|Treatment Phase|Lost to Follow-up|0|||
147262567|NCT02658890|531135049|FG019|Treatment Phase|Lost to Follow-up|0|||
147262568|NCT02658890|531135050|FG020|Treatment Phase|Lost to Follow-up|0|||
147450163|NCT00464334|531811375|FG002|Overall Study|Lost to Follow-up|1|||
147262569|NCT02658890|531135051|FG021|Treatment Phase|Lost to Follow-up|0|||
147450164|NCT00464334|531811376|FG003|Overall Study|Lost to Follow-up|0|||
147262570|NCT02658890|531135052|FG022|Treatment Phase|Lost to Follow-up|0|||
147262571|NCT02658890|531135053|FG023|Treatment Phase|Lost to Follow-up|0|||
147262572|NCT02658890|531135054|FG024|Treatment Phase|Lost to Follow-up|0|||
147262573|NCT02658890|531135055|FG025|Treatment Phase|Lost to Follow-up|0|||
147262574|NCT02658890|531135056|FG026|Treatment Phase|Lost to Follow-up|0|||
147262575|NCT02658890|531135030|FG000|Treatment Phase|Maximum Clinical Benefit|0|||
147262576|NCT02658890|531135031|FG001|Treatment Phase|Maximum Clinical Benefit|0|||
147262577|NCT02658890|531135032|FG002|Treatment Phase|Maximum Clinical Benefit|0|||
147262578|NCT02658890|531135033|FG003|Treatment Phase|Maximum Clinical Benefit|0|||
147262579|NCT02658890|531135034|FG004|Treatment Phase|Maximum Clinical Benefit|0|||
147262580|NCT02658890|531135035|FG005|Treatment Phase|Maximum Clinical Benefit|0|||
147262581|NCT02658890|531135036|FG006|Treatment Phase|Maximum Clinical Benefit|0|||
147262582|NCT02658890|531135037|FG007|Treatment Phase|Maximum Clinical Benefit|0|||
147262583|NCT02658890|531135038|FG008|Treatment Phase|Maximum Clinical Benefit|0|||
147262584|NCT02658890|531135039|FG009|Treatment Phase|Maximum Clinical Benefit|0|||
147262585|NCT02658890|531135040|FG010|Treatment Phase|Maximum Clinical Benefit|0|||
147262586|NCT02658890|531135041|FG011|Treatment Phase|Maximum Clinical Benefit|0|||
147262587|NCT02658890|531135042|FG012|Treatment Phase|Maximum Clinical Benefit|0|||
147262588|NCT02658890|531135043|FG013|Treatment Phase|Maximum Clinical Benefit|1|||
147262589|NCT02658890|531135044|FG014|Treatment Phase|Maximum Clinical Benefit|0|||
147262590|NCT02658890|531135045|FG015|Treatment Phase|Maximum Clinical Benefit|0|||
147262591|NCT02658890|531135046|FG016|Treatment Phase|Maximum Clinical Benefit|0|||
147262592|NCT02658890|531135047|FG017|Treatment Phase|Maximum Clinical Benefit|0|||
147262593|NCT02658890|531135048|FG018|Treatment Phase|Maximum Clinical Benefit|1|||
147262594|NCT02658890|531135049|FG019|Treatment Phase|Maximum Clinical Benefit|0|||
147262595|NCT02658890|531135050|FG020|Treatment Phase|Maximum Clinical Benefit|0|||
147262596|NCT02658890|531135051|FG021|Treatment Phase|Maximum Clinical Benefit|0|||
147262597|NCT02658890|531135052|FG022|Treatment Phase|Maximum Clinical Benefit|2|||
147262598|NCT02658890|531135053|FG023|Treatment Phase|Maximum Clinical Benefit|0|||
147262599|NCT02658890|531135054|FG024|Treatment Phase|Maximum Clinical Benefit|0|||
147262600|NCT02658890|531135055|FG025|Treatment Phase|Maximum Clinical Benefit|0|||
147262601|NCT02658890|531135056|FG026|Treatment Phase|Maximum Clinical Benefit|0|||
147262602|NCT02658890|531135030|FG000|Treatment Phase|Non-compliance With Study Drug|0|||
147262603|NCT02658890|531135031|FG001|Treatment Phase|Non-compliance With Study Drug|0|||
147262604|NCT02658890|531135032|FG002|Treatment Phase|Non-compliance With Study Drug|1|||
147262605|NCT02658890|531135033|FG003|Treatment Phase|Non-compliance With Study Drug|0|||
147262606|NCT02658890|531135034|FG004|Treatment Phase|Non-compliance With Study Drug|0|||
147262607|NCT02658890|531135035|FG005|Treatment Phase|Non-compliance With Study Drug|0|||
147262608|NCT02658890|531135036|FG006|Treatment Phase|Non-compliance With Study Drug|0|||
147262609|NCT02658890|531135037|FG007|Treatment Phase|Non-compliance With Study Drug|0|||
147262610|NCT02658890|531135038|FG008|Treatment Phase|Non-compliance With Study Drug|0|||
147262611|NCT02658890|531135039|FG009|Treatment Phase|Non-compliance With Study Drug|0|||
147262612|NCT02658890|531135040|FG010|Treatment Phase|Non-compliance With Study Drug|0|||
147262613|NCT02658890|531135041|FG011|Treatment Phase|Non-compliance With Study Drug|0|||
147262614|NCT02658890|531135042|FG012|Treatment Phase|Non-compliance With Study Drug|0|||
147262615|NCT02658890|531135043|FG013|Treatment Phase|Non-compliance With Study Drug|0|||
147262616|NCT02658890|531135044|FG014|Treatment Phase|Non-compliance With Study Drug|0|||
147262617|NCT02658890|531135045|FG015|Treatment Phase|Non-compliance With Study Drug|0|||
147262618|NCT02658890|531135046|FG016|Treatment Phase|Non-compliance With Study Drug|0|||
147262619|NCT02658890|531135047|FG017|Treatment Phase|Non-compliance With Study Drug|0|||
147262620|NCT02658890|531135048|FG018|Treatment Phase|Non-compliance With Study Drug|1|||
147262621|NCT02658890|531135049|FG019|Treatment Phase|Non-compliance With Study Drug|0|||
147262622|NCT02658890|531135050|FG020|Treatment Phase|Non-compliance With Study Drug|0|||
147262623|NCT02658890|531135051|FG021|Treatment Phase|Non-compliance With Study Drug|0|||
147262624|NCT02658890|531135052|FG022|Treatment Phase|Non-compliance With Study Drug|0|||
147262625|NCT02658890|531135053|FG023|Treatment Phase|Non-compliance With Study Drug|0|||
147262626|NCT02658890|531135054|FG024|Treatment Phase|Non-compliance With Study Drug|0|||
147262627|NCT02658890|531135055|FG025|Treatment Phase|Non-compliance With Study Drug|0|||
147262628|NCT02658890|531135056|FG026|Treatment Phase|Non-compliance With Study Drug|0|||
147262629|NCT02658890|531135030|FG000|Treatment Phase|Other Reasons|0|||
147262630|NCT02658890|531135031|FG001|Treatment Phase|Other Reasons|0|||
147262631|NCT02658890|531135032|FG002|Treatment Phase|Other Reasons|0|||
147262632|NCT02658890|531135033|FG003|Treatment Phase|Other Reasons|0|||
147262633|NCT02658890|531135034|FG004|Treatment Phase|Other Reasons|0|||
147262634|NCT02658890|531135035|FG005|Treatment Phase|Other Reasons|0|||
147599929|NCT01150890|532352532|FG002|Overall Study|Ineligibility determined|0|||
147262635|NCT02658890|531135036|FG006|Treatment Phase|Other Reasons|1|||
147599930|NCT01150890|532352533|FG003|Overall Study|Ineligibility determined|0|||
147262636|NCT02658890|531135037|FG007|Treatment Phase|Other Reasons|0|||
147262637|NCT02658890|531135038|FG008|Treatment Phase|Other Reasons|1|||
147262638|NCT02658890|531135039|FG009|Treatment Phase|Other Reasons|0|||
147262639|NCT02658890|531135040|FG010|Treatment Phase|Other Reasons|0|||
147262640|NCT02658890|531135041|FG011|Treatment Phase|Other Reasons|0|||
147332904|NCT02000817|531385614|FG003|Overall Study|Lost to Follow-up|0|||
147332905|NCT04210180|531385621|FG000|Overall Study|Withdrawal by Subject|2|||
147262641|NCT02658890|531135042|FG012|Treatment Phase|Other Reasons|0|||
147262642|NCT02658890|531135043|FG013|Treatment Phase|Other Reasons|2|||
147262643|NCT02658890|531135044|FG014|Treatment Phase|Other Reasons|0|||
147262644|NCT02658890|531135045|FG015|Treatment Phase|Other Reasons|0|||
147262645|NCT02658890|531135046|FG016|Treatment Phase|Other Reasons|0|||
147262646|NCT02658890|531135047|FG017|Treatment Phase|Other Reasons|0|||
147262647|NCT02658890|531135048|FG018|Treatment Phase|Other Reasons|1|||
147262648|NCT02658890|531135049|FG019|Treatment Phase|Other Reasons|0|||
147450165|NCT00464334|531811377|FG004|Overall Study|Lost to Follow-up|1|||
147599931|NCT01150890|532352530|FG000|Overall Study|Adverse Event|0|||
147450166|NCT00464334|531811378|FG005|Overall Study|Lost to Follow-up|0|||
147262649|NCT02658890|531135050|FG020|Treatment Phase|Other Reasons|0|||
147262650|NCT02658890|531135051|FG021|Treatment Phase|Other Reasons|0|||
147262651|NCT02658890|531135052|FG022|Treatment Phase|Other Reasons|0|||
147262652|NCT02658890|531135053|FG023|Treatment Phase|Other Reasons|0|||
147262653|NCT02658890|531135054|FG024|Treatment Phase|Other Reasons|1|||
147262654|NCT02658890|531135055|FG025|Treatment Phase|Other Reasons|0|||
147262655|NCT02658890|531135056|FG026|Treatment Phase|Other Reasons|1|||
147262656|NCT02658890|531135030|FG000|Treatment Phase|Progressive Disease|6|||
147262657|NCT02658890|531135031|FG001|Treatment Phase|Progressive Disease|7|||
147262658|NCT02658890|531135032|FG002|Treatment Phase|Progressive Disease|6|||
147262659|NCT02658890|531135033|FG003|Treatment Phase|Progressive Disease|12|||
147262660|NCT02658890|531135034|FG004|Treatment Phase|Progressive Disease|6|||
147262661|NCT02658890|531135035|FG005|Treatment Phase|Progressive Disease|18|||
147262662|NCT02658890|531135036|FG006|Treatment Phase|Progressive Disease|12|||
147262663|NCT02658890|531135037|FG007|Treatment Phase|Progressive Disease|19|||
147262664|NCT02658890|531135038|FG008|Treatment Phase|Progressive Disease|26|||
147262665|NCT02658890|531135039|FG009|Treatment Phase|Progressive Disease|8|||
147262666|NCT02658890|531135040|FG010|Treatment Phase|Progressive Disease|7|||
147262667|NCT02658890|531135041|FG011|Treatment Phase|Progressive Disease|9|||
147262668|NCT02658890|531135042|FG012|Treatment Phase|Progressive Disease|8|||
147262669|NCT02658890|531135043|FG013|Treatment Phase|Progressive Disease|29|||
147262670|NCT02658890|531135044|FG014|Treatment Phase|Progressive Disease|6|||
147262671|NCT02658890|531135045|FG015|Treatment Phase|Progressive Disease|2|||
147262672|NCT02658890|531135046|FG016|Treatment Phase|Progressive Disease|32|||
147262673|NCT02658890|531135047|FG017|Treatment Phase|Progressive Disease|14|||
147262674|NCT02658890|531135048|FG018|Treatment Phase|Progressive Disease|40|||
147262675|NCT02658890|531135049|FG019|Treatment Phase|Progressive Disease|32|||
147262676|NCT02658890|531135050|FG020|Treatment Phase|Progressive Disease|19|||
147262677|NCT02658890|531135051|FG021|Treatment Phase|Progressive Disease|30|||
147262678|NCT02658890|531135052|FG022|Treatment Phase|Progressive Disease|15|||
147262679|NCT02658890|531135053|FG023|Treatment Phase|Progressive Disease|0|||
147262680|NCT02658890|531135054|FG024|Treatment Phase|Progressive Disease|0|||
147262681|NCT02658890|531135055|FG025|Treatment Phase|Progressive Disease|14|||
147262682|NCT02658890|531135056|FG026|Treatment Phase|Progressive Disease|11|||
147262683|NCT02658890|531135030|FG000|Treatment Phase|Study Drug Toxicity|0|||
147262684|NCT02658890|531135031|FG001|Treatment Phase|Study Drug Toxicity|0|||
147262685|NCT02658890|531135032|FG002|Treatment Phase|Study Drug Toxicity|2|||
147262686|NCT02658890|531135033|FG003|Treatment Phase|Study Drug Toxicity|0|||
147262687|NCT02658890|531135034|FG004|Treatment Phase|Study Drug Toxicity|0|||
147262688|NCT02658890|531135035|FG005|Treatment Phase|Study Drug Toxicity|0|||
147262689|NCT02658890|531135036|FG006|Treatment Phase|Study Drug Toxicity|0|||
147262690|NCT02658890|531135037|FG007|Treatment Phase|Study Drug Toxicity|0|||
147262691|NCT02658890|531135038|FG008|Treatment Phase|Study Drug Toxicity|3|||
147262692|NCT02658890|531135039|FG009|Treatment Phase|Study Drug Toxicity|0|||
147262693|NCT02658890|531135040|FG010|Treatment Phase|Study Drug Toxicity|1|||
147262694|NCT02658890|531135041|FG011|Treatment Phase|Study Drug Toxicity|1|||
147262695|NCT02658890|531135042|FG012|Treatment Phase|Study Drug Toxicity|2|||
147262696|NCT02658890|531135043|FG013|Treatment Phase|Study Drug Toxicity|9|||
147262697|NCT02658890|531135044|FG014|Treatment Phase|Study Drug Toxicity|0|||
147262698|NCT02658890|531135045|FG015|Treatment Phase|Study Drug Toxicity|1|||
147262699|NCT02658890|531135046|FG016|Treatment Phase|Study Drug Toxicity|1|||
147262700|NCT02658890|531135047|FG017|Treatment Phase|Study Drug Toxicity|0|||
147262701|NCT02658890|531135048|FG018|Treatment Phase|Study Drug Toxicity|8|||
147262702|NCT02658890|531135049|FG019|Treatment Phase|Study Drug Toxicity|3|||
147262703|NCT02658890|531135050|FG020|Treatment Phase|Study Drug Toxicity|2|||
147262704|NCT02658890|531135051|FG021|Treatment Phase|Study Drug Toxicity|0|||
147262705|NCT02658890|531135052|FG022|Treatment Phase|Study Drug Toxicity|8|||
147262706|NCT02658890|531135053|FG023|Treatment Phase|Study Drug Toxicity|0|||
147262707|NCT02658890|531135054|FG024|Treatment Phase|Study Drug Toxicity|0|||
147262708|NCT02658890|531135055|FG025|Treatment Phase|Study Drug Toxicity|2|||
147262709|NCT02658890|531135056|FG026|Treatment Phase|Study Drug Toxicity|0|||
147262710|NCT02658890|531135030|FG000|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
147262711|NCT02658890|531135031|FG001|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
147262712|NCT02658890|531135032|FG002|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
147262713|NCT02658890|531135033|FG003|Treatment Phase|Participant No Longer Meets Study Criteria|1|||
147262714|NCT02658890|531135034|FG004|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
147262715|NCT02658890|531135035|FG005|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
147262716|NCT02658890|531135036|FG006|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
147262717|NCT02658890|531135037|FG007|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
147262718|NCT02658890|531135038|FG008|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
147262719|NCT02658890|531135039|FG009|Treatment Phase|Participant No Longer Meets Study Criteria|1|||
147262720|NCT02658890|531135040|FG010|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
147262721|NCT02658890|531135041|FG011|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
147262722|NCT02658890|531135042|FG012|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
147262723|NCT02658890|531135043|FG013|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
147262724|NCT02658890|531135044|FG014|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
147262725|NCT02658890|531135045|FG015|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
147262726|NCT02658890|531135046|FG016|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
147262727|NCT02658890|531135047|FG017|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
147262728|NCT02658890|531135048|FG018|Treatment Phase|Participant No Longer Meets Study Criteria|1|||
147262729|NCT02658890|531135049|FG019|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
147262730|NCT02658890|531135050|FG020|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
147262731|NCT02658890|531135051|FG021|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
147262732|NCT02658890|531135052|FG022|Treatment Phase|Participant No Longer Meets Study Criteria|1|||
147262733|NCT02658890|531135053|FG023|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
147262734|NCT02658890|531135054|FG024|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
147262735|NCT02658890|531135055|FG025|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
147262736|NCT02658890|531135056|FG026|Treatment Phase|Participant No Longer Meets Study Criteria|0|||
147262737|NCT02658890|531135030|FG000|Treatment Phase|Withdrawal by Subject|0|||
147262738|NCT02658890|531135031|FG001|Treatment Phase|Withdrawal by Subject|1|||
147262739|NCT02658890|531135032|FG002|Treatment Phase|Withdrawal by Subject|0|||
147262740|NCT02658890|531135033|FG003|Treatment Phase|Withdrawal by Subject|0|||
147262741|NCT02658890|531135034|FG004|Treatment Phase|Withdrawal by Subject|0|||
147262742|NCT02658890|531135035|FG005|Treatment Phase|Withdrawal by Subject|0|||
147262743|NCT02658890|531135036|FG006|Treatment Phase|Withdrawal by Subject|1|||
147262744|NCT02658890|531135037|FG007|Treatment Phase|Withdrawal by Subject|0|||
147262745|NCT02658890|531135038|FG008|Treatment Phase|Withdrawal by Subject|0|||
147262746|NCT02658890|531135039|FG009|Treatment Phase|Withdrawal by Subject|1|||
147262747|NCT02658890|531135040|FG010|Treatment Phase|Withdrawal by Subject|0|||
147262748|NCT02658890|531135041|FG011|Treatment Phase|Withdrawal by Subject|0|||
147262749|NCT02658890|531135042|FG012|Treatment Phase|Withdrawal by Subject|1|||
147262750|NCT02658890|531135043|FG013|Treatment Phase|Withdrawal by Subject|3|||
147262751|NCT02658890|531135044|FG014|Treatment Phase|Withdrawal by Subject|0|||
147262752|NCT02658890|531135045|FG015|Treatment Phase|Withdrawal by Subject|0|||
147262753|NCT02658890|531135046|FG016|Treatment Phase|Withdrawal by Subject|1|||
147262754|NCT02658890|531135047|FG017|Treatment Phase|Withdrawal by Subject|0|||
147262755|NCT02658890|531135048|FG018|Treatment Phase|Withdrawal by Subject|4|||
147262756|NCT02658890|531135049|FG019|Treatment Phase|Withdrawal by Subject|3|||
147262757|NCT02658890|531135050|FG020|Treatment Phase|Withdrawal by Subject|0|||
147262758|NCT02658890|531135051|FG021|Treatment Phase|Withdrawal by Subject|4|||
147262759|NCT02658890|531135052|FG022|Treatment Phase|Withdrawal by Subject|1|||
147262760|NCT02658890|531135053|FG023|Treatment Phase|Withdrawal by Subject|1|||
147262761|NCT02658890|531135054|FG024|Treatment Phase|Withdrawal by Subject|0|||
147262762|NCT02658890|531135055|FG025|Treatment Phase|Withdrawal by Subject|0|||
147262763|NCT02658890|531135056|FG026|Treatment Phase|Withdrawal by Subject|0|||
147262764|NCT03314584|531135064|FG000|Overall Study|Withdrawal by Subject|3|||
147262765|NCT03314584|531135065|FG001|Overall Study|Withdrawal by Subject|3|||
147262766|NCT03314584|531135064|FG000|Overall Study|Lost to Follow-up|4|||
147262767|NCT03314584|531135065|FG001|Overall Study|Lost to Follow-up|0|||
147262768|NCT01589445|531135068|FG000|001 (Pioglitazone) -3 Months|Protocol Violation|1|||
147262769|NCT01589445|531135068|FG000|001 (Pioglitazone) -3 Months|Withdrawal by Subject|1|||
147262770|NCT01589445|531135068|FG000|001 (Pioglitazone) -3 Months|Lost to Follow-up|2|||
147262771|NCT01589445|531135068|FG000|001 (Pioglitazone) -3 Months|Lack of Efficacy|1|||
147262772|NCT01589445|531135068|FG000|001 (Pioglitazone) -3 Months|biasedness about the double blind method|2|||
147262773|NCT01589445|531135068|FG000|002 (Metformin)-3 Months|Lack of Efficacy|1|||
147262774|NCT01589445|531135068|FG000|002 (Metformin)-3 Months|Lost to Follow-up|2|||
147262775|NCT01589445|531135068|FG000|002 (Metformin)-3 Months|Protocol Violation|2|||
147262776|NCT01589445|531135068|FG000|002 (Metformin)-3 Months|Adverse Event|2|||
147262777|NCT01589445|531135068|FG000|002 (Metformin)-3 Months|Husbands of female patients refrained|2|||
147262778|NCT01752855|531135071|FG000|Overall Study|Adverse Event|1|||
147262779|NCT01752855|531135072|FG001|Overall Study|Adverse Event|0|||
147262780|NCT01752855|531135071|FG000|Overall Study|Withdrew Consent|0|||
147262781|NCT01752855|531135072|FG001|Overall Study|Withdrew Consent|2|||
147262782|NCT01752855|531135071|FG000|Overall Study|Lack of Efficacy|0|||
147262783|NCT01752855|531135072|FG001|Overall Study|Lack of Efficacy|2|||
147262784|NCT02439320|531135076|FG000|Overall Study|Adverse Event|0|||
147262785|NCT02439320|531135077|FG001|Overall Study|Adverse Event|2|||
147262786|NCT02439320|531135078|FG002|Overall Study|Adverse Event|0|||
147262787|NCT02439320|531135076|FG000|Overall Study|Lost to Follow-up|37|||
147262788|NCT02439320|531135077|FG001|Overall Study|Lost to Follow-up|34|||
147332906|NCT03538054|531385622|FG000|Baseline Phase (2 Weeks)|Physician Decision|1|||
147332907|NCT03538054|531385622|FG000|Placebo Phase (5 Weeks)|Withdrawal by Subject|2|||
147332908|NCT03538054|531385622|FG000|Dextromethorphan Phase (10 Weeks)|Withdrawal by Subject|2|||
147262789|NCT02439320|531135078|FG002|Overall Study|Lost to Follow-up|42|||
147262790|NCT02439320|531135076|FG000|Overall Study|Death|0|||
147262791|NCT02439320|531135077|FG001|Overall Study|Death|1|||
147262792|NCT02439320|531135078|FG002|Overall Study|Death|0|||
147262793|NCT02439320|531135076|FG000|Overall Study|Noncompliance with Protocol|10|||
147262794|NCT02439320|531135077|FG001|Overall Study|Noncompliance with Protocol|11|||
147262795|NCT02439320|531135078|FG002|Overall Study|Noncompliance with Protocol|7|||
147262796|NCT02439320|531135076|FG000|Overall Study|Pregnancy|0|||
147262797|NCT02439320|531135077|FG001|Overall Study|Pregnancy|1|||
147262798|NCT02439320|531135078|FG002|Overall Study|Pregnancy|1|||
147262799|NCT02439320|531135076|FG000|Overall Study|Withdrawal by Subject|12|||
147262800|NCT02439320|531135077|FG001|Overall Study|Withdrawal by Subject|16|||
147262801|NCT02439320|531135078|FG002|Overall Study|Withdrawal by Subject|14|||
147262802|NCT02439320|531135076|FG000|Overall Study|Physician Decision|2|||
147262803|NCT02439320|531135077|FG001|Overall Study|Physician Decision|1|||
147262804|NCT02439320|531135078|FG002|Overall Study|Physician Decision|0|||
147262805|NCT02439320|531135076|FG000|Overall Study|Sponsor Request|0|||
147262806|NCT02439320|531135077|FG001|Overall Study|Sponsor Request|2|||
147262807|NCT02439320|531135078|FG002|Overall Study|Sponsor Request|1|||
147262808|NCT02439320|531135076|FG000|Overall Study|Randomization Failure|35|||
147262809|NCT02439320|531135077|FG001|Overall Study|Randomization Failure|46|||
147262810|NCT02439320|531135078|FG002|Overall Study|Randomization Failure|34|||
147262811|NCT03343483|531135080|FG000|Overall Study|Death|0|||
147262812|NCT03343483|531135081|FG001|Overall Study|Death|3|||
147262813|NCT03343483|531135080|FG000|Overall Study|Lost to Follow-up|9|||
147262814|NCT03343483|531135081|FG001|Overall Study|Lost to Follow-up|13|||
147262815|NCT03343483|531135080|FG000|Overall Study|Withdrawal by Subject|8|||
147262816|NCT03343483|531135081|FG001|Overall Study|Withdrawal by Subject|17|||
147262817|NCT01505608|531135082|FG000|Phase I|Lack of Efficacy|0|||
147262818|NCT01505608|531135083|FG001|Phase I|Lack of Efficacy|4|||
147262819|NCT01505608|531135082|FG000|Phase I|Adverse Event|0|||
147262820|NCT01505608|531135083|FG001|Phase I|Adverse Event|1|||
147262821|NCT01505608|531135082|FG000|Phase I|Withdrawal by Subject|0|||
147262822|NCT01505608|531135083|FG001|Phase I|Withdrawal by Subject|1|||
147262823|NCT01505608|531135082|FG000|Phase II|Lack of Efficacy|2|||
147262824|NCT01505608|531135083|FG001|Phase II|Lack of Efficacy|1|||
147262825|NCT01505608|531135082|FG000|Phase II|Protocol Violation|0|||
147262826|NCT01505608|531135083|FG001|Phase II|Protocol Violation|1|||
147262827|NCT01488097|531135084|FG000|Overall Study|Lost to Follow-up|1|||
147262828|NCT01577758|531135085|FG000|Dose Escalation Phase|Adverse Event|0|||
147262829|NCT01577758|531135086|FG001|Dose Escalation Phase|Adverse Event|0|||
147262830|NCT01577758|531135087|FG002|Dose Escalation Phase|Adverse Event|0|||
147262831|NCT01577758|531135088|FG003|Dose Escalation Phase|Adverse Event|0|||
147262832|NCT01577758|531135089|FG004|Dose Escalation Phase|Adverse Event|0|||
147262833|NCT01577758|531135090|FG005|Dose Escalation Phase|Adverse Event|2|||
147262834|NCT01577758|531135091|FG006|Dose Escalation Phase|Adverse Event|1|||
147262835|NCT01577758|531135092|FG007|Dose Escalation Phase|Adverse Event|0|||
147262836|NCT01577758|531135085|FG000|Dose Escalation Phase|Symptomatic Deterioration|0|||
147262837|NCT01577758|531135086|FG001|Dose Escalation Phase|Symptomatic Deterioration|0|||
147262838|NCT01577758|531135087|FG002|Dose Escalation Phase|Symptomatic Deterioration|1|||
147262839|NCT01577758|531135088|FG003|Dose Escalation Phase|Symptomatic Deterioration|0|||
147262840|NCT01577758|531135089|FG004|Dose Escalation Phase|Symptomatic Deterioration|1|||
147262841|NCT01577758|531135090|FG005|Dose Escalation Phase|Symptomatic Deterioration|1|||
147262842|NCT01577758|531135091|FG006|Dose Escalation Phase|Symptomatic Deterioration|0|||
147262843|NCT01577758|531135092|FG007|Dose Escalation Phase|Symptomatic Deterioration|0|||
147262844|NCT01577758|531135085|FG000|Dose Escalation Phase|Withdrawal by Subject|0|||
147262845|NCT01577758|531135086|FG001|Dose Escalation Phase|Withdrawal by Subject|0|||
147262846|NCT01577758|531135087|FG002|Dose Escalation Phase|Withdrawal by Subject|0|||
147262847|NCT01577758|531135088|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
147262848|NCT01577758|531135089|FG004|Dose Escalation Phase|Withdrawal by Subject|0|||
147262849|NCT01577758|531135090|FG005|Dose Escalation Phase|Withdrawal by Subject|1|||
147262850|NCT01577758|531135091|FG006|Dose Escalation Phase|Withdrawal by Subject|0|||
147262851|NCT01577758|531135092|FG007|Dose Escalation Phase|Withdrawal by Subject|0|||
147262852|NCT01577758|531135085|FG000|Dose Escalation Phase|Progression Disease|2|||
147262853|NCT01577758|531135086|FG001|Dose Escalation Phase|Progression Disease|2|||
147262854|NCT01577758|531135087|FG002|Dose Escalation Phase|Progression Disease|1|||
147262855|NCT01577758|531135088|FG003|Dose Escalation Phase|Progression Disease|2|||
147262856|NCT01577758|531135089|FG004|Dose Escalation Phase|Progression Disease|5|||
147262857|NCT01577758|531135090|FG005|Dose Escalation Phase|Progression Disease|0|||
147262858|NCT01577758|531135091|FG006|Dose Escalation Phase|Progression Disease|0|||
147262859|NCT01577758|531135092|FG007|Dose Escalation Phase|Progression Disease|0|||
147262860|NCT01577758|531135085|FG000|mCRC Expansion Phase|Symptomatic Deterioration|0|||
147262861|NCT01577758|531135086|FG001|mCRC Expansion Phase|Symptomatic Deterioration|0|||
147450167|NCT00464334|531811379|FG006|Overall Study|Lost to Follow-up|1|||
147262862|NCT01577758|531135087|FG002|mCRC Expansion Phase|Symptomatic Deterioration|0|||
147262863|NCT01577758|531135088|FG003|mCRC Expansion Phase|Symptomatic Deterioration|0|||
147262864|NCT01577758|531135089|FG004|mCRC Expansion Phase|Symptomatic Deterioration|0|||
147262865|NCT01577758|531135090|FG005|mCRC Expansion Phase|Symptomatic Deterioration|0|||
147262866|NCT01577758|531135091|FG006|mCRC Expansion Phase|Symptomatic Deterioration|0|||
147262867|NCT01577758|531135092|FG007|mCRC Expansion Phase|Symptomatic Deterioration|4|||
147262868|NCT01577758|531135085|FG000|mCRC Expansion Phase|Withdrawal by Subject|0|||
147262869|NCT01577758|531135086|FG001|mCRC Expansion Phase|Withdrawal by Subject|0|||
147262870|NCT01577758|531135087|FG002|mCRC Expansion Phase|Withdrawal by Subject|0|||
147262871|NCT01577758|531135088|FG003|mCRC Expansion Phase|Withdrawal by Subject|0|||
147262872|NCT01577758|531135089|FG004|mCRC Expansion Phase|Withdrawal by Subject|0|||
147262873|NCT01577758|531135090|FG005|mCRC Expansion Phase|Withdrawal by Subject|0|||
147262874|NCT01577758|531135091|FG006|mCRC Expansion Phase|Withdrawal by Subject|0|||
147262875|NCT01577758|531135092|FG007|mCRC Expansion Phase|Withdrawal by Subject|2|||
147262876|NCT01577758|531135085|FG000|mCRC Expansion Phase|Progression Disease|0|||
147262877|NCT01577758|531135086|FG001|mCRC Expansion Phase|Progression Disease|0|||
147262878|NCT01577758|531135087|FG002|mCRC Expansion Phase|Progression Disease|0|||
147262879|NCT01577758|531135088|FG003|mCRC Expansion Phase|Progression Disease|0|||
147262880|NCT01577758|531135089|FG004|mCRC Expansion Phase|Progression Disease|0|||
147262881|NCT01577758|531135090|FG005|mCRC Expansion Phase|Progression Disease|0|||
147262882|NCT01577758|531135091|FG006|mCRC Expansion Phase|Progression Disease|0|||
147262883|NCT01577758|531135092|FG007|mCRC Expansion Phase|Progression Disease|19|||
147262884|NCT01293240|531135093|FG000|Overall Study|Noncompliance|2|||
147262885|NCT02404350|531135097|FG000|Overall Study|Adverse Event|2|||
147262886|NCT02404350|531135098|FG001|Overall Study|Adverse Event|2|||
147262887|NCT02404350|531135099|FG002|Overall Study|Adverse Event|3|||
147262888|NCT02404350|531135100|FG003|Overall Study|Adverse Event|9|||
147262889|NCT02404350|531135097|FG000|Overall Study|Lack of Efficacy|3|||
147262890|NCT02404350|531135098|FG001|Overall Study|Lack of Efficacy|1|||
147262891|NCT02404350|531135099|FG002|Overall Study|Lack of Efficacy|0|||
147262892|NCT02404350|531135100|FG003|Overall Study|Lack of Efficacy|3|||
147262893|NCT02404350|531135097|FG000|Overall Study|Lost to Follow-up|2|||
147262894|NCT02404350|531135098|FG001|Overall Study|Lost to Follow-up|0|||
147262895|NCT02404350|531135099|FG002|Overall Study|Lost to Follow-up|0|||
147262896|NCT02404350|531135100|FG003|Overall Study|Lost to Follow-up|1|||
147262897|NCT02404350|531135097|FG000|Overall Study|Physician Decision|1|||
147262898|NCT02404350|531135098|FG001|Overall Study|Physician Decision|0|||
147262899|NCT02404350|531135099|FG002|Overall Study|Physician Decision|0|||
147262900|NCT02404350|531135100|FG003|Overall Study|Physician Decision|2|||
147262901|NCT02404350|531135097|FG000|Overall Study|Pregnancy|0|||
147262902|NCT02404350|531135098|FG001|Overall Study|Pregnancy|0|||
147262903|NCT02404350|531135099|FG002|Overall Study|Pregnancy|0|||
147262904|NCT02404350|531135100|FG003|Overall Study|Pregnancy|1|||
147262905|NCT02404350|531135097|FG000|Overall Study|Withdrawal by Subject|7|||
147262906|NCT02404350|531135098|FG001|Overall Study|Withdrawal by Subject|3|||
147262907|NCT02404350|531135099|FG002|Overall Study|Withdrawal by Subject|3|||
147262908|NCT02404350|531135100|FG003|Overall Study|Withdrawal by Subject|19|||
147262909|NCT02404350|531135097|FG000|Overall Study|Due to Non-compliance with treatment|0|||
147262910|NCT02404350|531135098|FG001|Overall Study|Due to Non-compliance with treatment|0|||
147262911|NCT02404350|531135099|FG002|Overall Study|Due to Non-compliance with treatment|0|||
147262912|NCT02404350|531135100|FG003|Overall Study|Due to Non-compliance with treatment|1|||
147262913|NCT02404350|531135097|FG000|Overall Study|Due to Technical problems|0|||
147262914|NCT02404350|531135098|FG001|Overall Study|Due to Technical problems|0|||
147262915|NCT02404350|531135099|FG002|Overall Study|Due to Technical problems|0|||
147262916|NCT02404350|531135100|FG003|Overall Study|Due to Technical problems|1|||
147262917|NCT03261947|531135101|FG000|Overall Study|Death|10|||
147262918|NCT03261947|531135102|FG001|Overall Study|Death|13|||
147262919|NCT03261947|531135103|FG002|Overall Study|Death|17|||
147262920|NCT03261947|531135104|FG003|Overall Study|Death|12|||
147262921|NCT03261947|531135105|FG004|Overall Study|Death|8|||
147262922|NCT03261947|531135101|FG000|Overall Study|Lost to Follow-up|0|||
147262923|NCT03261947|531135102|FG001|Overall Study|Lost to Follow-up|0|||
147262924|NCT03261947|531135103|FG002|Overall Study|Lost to Follow-up|2|||
147262925|NCT03261947|531135104|FG003|Overall Study|Lost to Follow-up|1|||
147262926|NCT03261947|531135105|FG004|Overall Study|Lost to Follow-up|0|||
147262927|NCT03261947|531135101|FG000|Overall Study|Withdrawal by Subject|0|||
147262928|NCT03261947|531135102|FG001|Overall Study|Withdrawal by Subject|0|||
147332909|NCT02351180|531385625|FG000|Overall Study|Withdrawal by Subject|1|||
147332910|NCT02351180|531385626|FG001|Overall Study|Withdrawal by Subject|0|||
147332911|NCT02754479|531385627|FG000|Overall Study|Lost to Follow-up|1|||
147262929|NCT03261947|531135103|FG002|Overall Study|Withdrawal by Subject|3|||
147262930|NCT03261947|531135104|FG003|Overall Study|Withdrawal by Subject|0|||
147262931|NCT03261947|531135105|FG004|Overall Study|Withdrawal by Subject|1|||
147262932|NCT03261947|531135101|FG000|Overall Study|Site Terminated by Sponsor|0|||
147262933|NCT03261947|531135102|FG001|Overall Study|Site Terminated by Sponsor|0|||
147262934|NCT03261947|531135103|FG002|Overall Study|Site Terminated by Sponsor|4|||
147262935|NCT03261947|531135104|FG003|Overall Study|Site Terminated by Sponsor|7|||
147262936|NCT03261947|531135105|FG004|Overall Study|Site Terminated by Sponsor|5|||
147262937|NCT03261947|531135101|FG000|Overall Study|Reason not Specified|2|||
147332912|NCT02299336|531385630|FG000|Overall Study|Withdrawal by Subject|11|||
147262938|NCT03261947|531135102|FG001|Overall Study|Reason not Specified|0|||
147262939|NCT03261947|531135103|FG002|Overall Study|Reason not Specified|4|||
147262940|NCT03261947|531135104|FG003|Overall Study|Reason not Specified|1|||
147262941|NCT03261947|531135105|FG004|Overall Study|Reason not Specified|3|||
147262942|NCT03969992|531135106|FG000|Part 1: Birth to Discharge/40 Weeks PMA|Withdrawal by Subject|1|||
147262943|NCT03969992|531135107|FG001|Part 1: Birth to Discharge/40 Weeks PMA|Withdrawal by Subject|0|||
147262944|NCT03969992|531135108|FG002|Part 1: Birth to Discharge/40 Weeks PMA|Withdrawal by Subject|3|||
147262945|NCT03969992|531135106|FG000|Part 1: Birth to Discharge/40 Weeks PMA|Death|2|||
147262946|NCT03969992|531135107|FG001|Part 1: Birth to Discharge/40 Weeks PMA|Death|3|||
147262947|NCT03969992|531135108|FG002|Part 1: Birth to Discharge/40 Weeks PMA|Death|2|||
147262948|NCT03969992|531135106|FG000|Part 2: Discharge/40 Wks PMA to 12 Mos|Lost to Follow-up|12|||
147262949|NCT03969992|531135107|FG001|Part 2: Discharge/40 Wks PMA to 12 Mos|Lost to Follow-up|8|||
147262950|NCT03969992|531135108|FG002|Part 2: Discharge/40 Wks PMA to 12 Mos|Lost to Follow-up|9|||
147262951|NCT03969992|531135106|FG000|Part 2: Discharge/40 Wks PMA to 12 Mos|Physician Decision|0|||
147262952|NCT03969992|531135107|FG001|Part 2: Discharge/40 Wks PMA to 12 Mos|Physician Decision|0|||
147262953|NCT03969992|531135108|FG002|Part 2: Discharge/40 Wks PMA to 12 Mos|Physician Decision|1|||
147262954|NCT03969992|531135106|FG000|Part 2: Discharge/40 Wks PMA to 12 Mos|Withdrawal by Subject|3|||
147262955|NCT03969992|531135107|FG001|Part 2: Discharge/40 Wks PMA to 12 Mos|Withdrawal by Subject|1|||
147262956|NCT03969992|531135108|FG002|Part 2: Discharge/40 Wks PMA to 12 Mos|Withdrawal by Subject|0|||
147262957|NCT01324388|531135109|FG000|Part 1 of Study|Adverse Event|2|||
147262958|NCT01324388|531135110|FG001|Part 1 of Study|Adverse Event|0|||
147262959|NCT01324388|531135111|FG002|Part 1 of Study|Adverse Event|0|||
147262960|NCT01324388|531135112|FG003|Part 1 of Study|Adverse Event|0|||
147262961|NCT01324388|531135109|FG000|Part 1 of Study|Protocol Violation|1|||
147262962|NCT01324388|531135110|FG001|Part 1 of Study|Protocol Violation|2|||
147262963|NCT01324388|531135111|FG002|Part 1 of Study|Protocol Violation|0|||
147262964|NCT01324388|531135112|FG003|Part 1 of Study|Protocol Violation|0|||
147262965|NCT01324388|531135109|FG000|Part 1 of Study|Physician Decision|1|||
147262966|NCT01324388|531135110|FG001|Part 1 of Study|Physician Decision|0|||
147262967|NCT01324388|531135111|FG002|Part 1 of Study|Physician Decision|0|||
147262968|NCT01324388|531135112|FG003|Part 1 of Study|Physician Decision|0|||
147262969|NCT01324388|531135109|FG000|Part 2 of Study: First Intervention|Protocol Violation|0|||
147262970|NCT01324388|531135110|FG001|Part 2 of Study: First Intervention|Protocol Violation|0|||
147262971|NCT01324388|531135111|FG002|Part 2 of Study: First Intervention|Protocol Violation|0|||
147262972|NCT01324388|531135112|FG003|Part 2 of Study: First Intervention|Protocol Violation|1|||
147262973|NCT01324388|531135109|FG000|Part 2 of Study: Second Intervention|Withdrawal by Subject|0|||
147262974|NCT01324388|531135110|FG001|Part 2 of Study: Second Intervention|Withdrawal by Subject|0|||
147262975|NCT01324388|531135111|FG002|Part 2 of Study: Second Intervention|Withdrawal by Subject|1|||
147262976|NCT01324388|531135112|FG003|Part 2 of Study: Second Intervention|Withdrawal by Subject|0|||
147262977|NCT01405963|531135113|FG000|Overall Study|Moved Away|2|||
147262978|NCT01405963|531135114|FG001|Overall Study|Moved Away|0|||
147262979|NCT01405963|531135113|FG000|Overall Study|Adverse Event|0|||
147262980|NCT01405963|531135114|FG001|Overall Study|Adverse Event|1|||
147262981|NCT01405963|531135113|FG000|Overall Study|Lost to Follow-up|0|||
147262982|NCT01405963|531135114|FG001|Overall Study|Lost to Follow-up|1|||
147262983|NCT01498640|531135115|FG000|Overall Study|Lost to Follow-up|1|||
147262984|NCT01498640|531135115|FG000|Overall Study|Death|1|||
147262985|NCT01498640|531135115|FG000|Overall Study|Other|3|||
147262986|NCT01737047|531135116|FG000|Overall Study|Death|10|||
147262987|NCT01737047|531135117|FG001|Overall Study|Death|0|||
147262988|NCT01737047|531135118|FG002|Overall Study|Death|1|||
147262989|NCT01737047|531135116|FG000|Overall Study|Withdrawal by Subject|17|||
147262990|NCT01737047|531135117|FG001|Overall Study|Withdrawal by Subject|11|||
147262991|NCT01737047|531135118|FG002|Overall Study|Withdrawal by Subject|4|||
147262992|NCT00129129|531135119|FG000|Primary Phase|Adverse Event|2|||
147262993|NCT00129129|531135120|FG001|Primary Phase|Adverse Event|1|||
147262994|NCT00129129|531135121|FG002|Primary Phase|Adverse Event|0|||
147262995|NCT00129129|531135122|FG003|Primary Phase|Adverse Event|0|||
147262996|NCT00129129|531135123|FG004|Primary Phase|Adverse Event|0|||
147262997|NCT00129129|531135119|FG000|Primary Phase|Withdrawal by Subject|12|||
147262998|NCT00129129|531135120|FG001|Primary Phase|Withdrawal by Subject|10|||
147262999|NCT00129129|531135121|FG002|Primary Phase|Withdrawal by Subject|0|||
147263000|NCT00129129|531135122|FG003|Primary Phase|Withdrawal by Subject|0|||
147263001|NCT00129129|531135123|FG004|Primary Phase|Withdrawal by Subject|0|||
147263002|NCT00129129|531135119|FG000|Primary Phase|Migration from study area|1|||
147263003|NCT00129129|531135120|FG001|Primary Phase|Migration from study area|3|||
147263004|NCT00129129|531135121|FG002|Primary Phase|Migration from study area|0|||
147263005|NCT00129129|531135122|FG003|Primary Phase|Migration from study area|0|||
147263006|NCT00129129|531135123|FG004|Primary Phase|Migration from study area|0|||
147263007|NCT00129129|531135119|FG000|Primary Phase|Lost to Follow-up|8|||
147263008|NCT00129129|531135120|FG001|Primary Phase|Lost to Follow-up|6|||
147263009|NCT00129129|531135121|FG002|Primary Phase|Lost to Follow-up|0|||
147263010|NCT00129129|531135122|FG003|Primary Phase|Lost to Follow-up|0|||
147263011|NCT00129129|531135123|FG004|Primary Phase|Lost to Follow-up|0|||
147263012|NCT00129129|531135119|FG000|Primary Phase|Other|2|||
147263013|NCT00129129|531135120|FG001|Primary Phase|Other|5|||
147263014|NCT00129129|531135121|FG002|Primary Phase|Other|0|||
147263015|NCT00129129|531135122|FG003|Primary Phase|Other|0|||
147263016|NCT00129129|531135123|FG004|Primary Phase|Other|0|||
147263017|NCT00129129|531135119|FG000|Fourth Dose Phase|Lost to Follow-up|4|||
147263018|NCT00129129|531135120|FG001|Fourth Dose Phase|Lost to Follow-up|0|||
147263019|NCT00129129|531135121|FG002|Fourth Dose Phase|Lost to Follow-up|0|||
147263020|NCT00129129|531135122|FG003|Fourth Dose Phase|Lost to Follow-up|2|||
147263021|NCT00129129|531135123|FG004|Fourth Dose Phase|Lost to Follow-up|2|||
147263022|NCT00129129|531135119|FG000|Fourth Dose Phase|Withdrawal by Subject|0|||
147263023|NCT00129129|531135120|FG001|Fourth Dose Phase|Withdrawal by Subject|0|||
147263024|NCT00129129|531135121|FG002|Fourth Dose Phase|Withdrawal by Subject|0|||
147263025|NCT00129129|531135122|FG003|Fourth Dose Phase|Withdrawal by Subject|0|||
147263026|NCT00129129|531135123|FG004|Fourth Dose Phase|Withdrawal by Subject|1|||
147263027|NCT00129129|531135119|FG000|Fourth Dose Phase|Migration from study area|0|||
147263028|NCT00129129|531135120|FG001|Fourth Dose Phase|Migration from study area|0|||
147263029|NCT00129129|531135121|FG002|Fourth Dose Phase|Migration from study area|0|||
147263030|NCT00129129|531135122|FG003|Fourth Dose Phase|Migration from study area|0|||
147263031|NCT00129129|531135123|FG004|Fourth Dose Phase|Migration from study area|2|||
147263032|NCT00129129|531135119|FG000|Fourth Dose Phase|Other|0|||
147263033|NCT00129129|531135120|FG001|Fourth Dose Phase|Other|0|||
147263034|NCT00129129|531135121|FG002|Fourth Dose Phase|Other|0|||
147263035|NCT00129129|531135122|FG003|Fourth Dose Phase|Other|1|||
147263036|NCT00129129|531135123|FG004|Fourth Dose Phase|Other|1|||
147263037|NCT00129129|531135119|FG000|Fourth Dose Phase|Protocol Violation|0|||
147263038|NCT00129129|531135120|FG001|Fourth Dose Phase|Protocol Violation|0|||
147263039|NCT00129129|531135121|FG002|Fourth Dose Phase|Protocol Violation|0|||
147263040|NCT00129129|531135122|FG003|Fourth Dose Phase|Protocol Violation|1|||
147263041|NCT00129129|531135123|FG004|Fourth Dose Phase|Protocol Violation|0|||
147263042|NCT03089606|531135124|FG000|Overall Study|Progression after Cycle 1|1|||
147263043|NCT00335972|531135125|FG000|Overall Study|not given treatments|0|||
147263044|NCT00335972|531135126|FG001|Overall Study|not given treatments|3|||
147263045|NCT02140567|531135128|FG000|Overall Study|Problems with recording equipment|6|||
147263046|NCT02802592|531135130|FG000|Overall Study|Study terminated due to loss of funding|4|||
147263047|NCT02882854|531135131|FG000|Overall Study|Lost to Follow-up|1|||
147263048|NCT02882854|531135132|FG001|Overall Study|Lost to Follow-up|2|||
147263049|NCT02882854|531135131|FG000|Overall Study|Physician Decision|0|||
147263050|NCT02882854|531135132|FG001|Overall Study|Physician Decision|1|||
147263051|NCT00352846|531135139|FG000|Overall Study|Disease progression|0|||
147263052|NCT00352846|531135140|FG001|Overall Study|Disease progression|2|||
147263053|NCT00352846|531135139|FG000|Overall Study|Withdrawal by Subject|3|||
147263054|NCT00352846|531135140|FG001|Overall Study|Withdrawal by Subject|8|||
147263055|NCT00352846|531135139|FG000|Overall Study|Ineligible|3|||
147263056|NCT00352846|531135140|FG001|Overall Study|Ineligible|2|||
147263057|NCT00352846|531135139|FG000|Overall Study|Non-compliance|2|||
147263058|NCT00352846|531135140|FG001|Overall Study|Non-compliance|0|||
147263059|NCT00352846|531135139|FG000|Overall Study|Death|0|||
147263060|NCT00352846|531135140|FG001|Overall Study|Death|1|||
147263061|NCT00788827|531135141|FG000|Overall Study|Lack of Efficacy|2|||
147263062|NCT01527682|531135142|FG000|Overall Study|Protocol Violation|8|||
147263063|NCT04837131|531135146|FG000|Overall Study|Death|1|||
147263064|NCT04837131|531135146|FG000|Overall Study|Withdrawal by Subject|1|||
147263065|NCT04837131|531135146|FG000|Overall Study|Adverse Event|1|||
147263066|NCT04837131|531135146|FG000|Overall Study|Protocol Violation|1|||
147263067|NCT00589108|531136491|FG000|Overall Study|Lost to Follow-up|1|||
147263068|NCT00589108|531136492|FG001|Overall Study|Lost to Follow-up|1|||
147263069|NCT00589108|531136493|FG002|Overall Study|Lost to Follow-up|1|||
147263070|NCT00589108|531136491|FG000|Overall Study|Death|3|||
147263071|NCT00589108|531136492|FG001|Overall Study|Death|3|||
147263072|NCT00589108|531136493|FG002|Overall Study|Death|4|||
147263073|NCT03256552|531136494|FG000|Overall Study|Protocol Violation|1|||
147263074|NCT03256552|531136494|FG000|Overall Study|Physician Decision|1|||
147263075|NCT03256552|531136494|FG000|Overall Study|Adverse Event|1|||
147263076|NCT03256552|531136494|FG000|Overall Study|Withdrawal by Subject|2|||
147263077|NCT02579265|531136504|FG000|Overall Study|Weaned off earlier than 28 days|44|||
147450168|NCT00464334|531811380|FG007|Overall Study|Lost to Follow-up|0|||
147263078|NCT02579265|531136505|FG001|Overall Study|Weaned off earlier than 28 days|43|||
147263079|NCT02579265|531136504|FG000|Overall Study|Adverse Event|2|||
147263080|NCT02579265|531136505|FG001|Overall Study|Adverse Event|0|||
147263081|NCT02579265|531136504|FG000|Overall Study|Any other reason not specified|0|||
147263082|NCT02579265|531136505|FG001|Overall Study|Any other reason not specified|2|||
147263083|NCT02579265|531136504|FG000|Overall Study|Withdrawal by Subject|2|||
147263084|NCT02579265|531136505|FG001|Overall Study|Withdrawal by Subject|0|||
147263085|NCT02579265|531136504|FG000|Overall Study|Physician Decision|1|||
147263086|NCT02579265|531136505|FG001|Overall Study|Physician Decision|0|||
147263087|NCT02579265|531136504|FG000|Overall Study|Withdrawal due to increased conjugated bilirubin|1|||
147263088|NCT02579265|531136505|FG001|Overall Study|Withdrawal due to increased conjugated bilirubin|0|||
147263089|NCT02174848|531136506|FG000|Overall Study|Adverse Event|2|||
147263090|NCT02174848|531136507|FG001|Overall Study|Adverse Event|1|||
147263091|NCT02174848|531136506|FG000|Overall Study|Withdrawal by Subject|3|||
147263092|NCT02174848|531136507|FG001|Overall Study|Withdrawal by Subject|3|||
147263093|NCT02174848|531136506|FG000|Overall Study|Lost to Follow-up|0|||
147263094|NCT02174848|531136507|FG001|Overall Study|Lost to Follow-up|1|||
147263095|NCT02174848|531136506|FG000|Overall Study|Worsening of disease|1|||
147263096|NCT02174848|531136507|FG001|Overall Study|Worsening of disease|1|||
147263097|NCT02174848|531136506|FG000|Overall Study|Unable to comply with study requirements|1|||
147263098|NCT02174848|531136507|FG001|Overall Study|Unable to comply with study requirements|0|||
147263099|NCT00644969|531136511|FG000|Treatment Phase|Randomized, not treated|1|||
147263100|NCT00644969|531136512|FG001|Treatment Phase|Randomized, not treated|0|||
147263101|NCT00644969|531136511|FG000|Treatment Phase|Adverse Event|3|||
147263102|NCT00644969|531136512|FG001|Treatment Phase|Adverse Event|0|||
147263103|NCT00644969|531136511|FG000|Treatment Phase|Withdrawal by Subject|4|||
147263104|NCT00644969|531136512|FG001|Treatment Phase|Withdrawal by Subject|0|||
147263105|NCT00644969|531136511|FG000|Treatment Phase|Lost to Follow-up|2|||
147263106|NCT00644969|531136512|FG001|Treatment Phase|Lost to Follow-up|2|||
147263107|NCT00644969|531136511|FG000|Treatment Phase|Other|4|||
147263108|NCT00644969|531136512|FG001|Treatment Phase|Other|1|||
147263109|NCT00644969|531136511|FG000|Post Treatment Phase|Death|1|||
147263110|NCT00644969|531136512|FG001|Post Treatment Phase|Death|0|||
147263111|NCT00644969|531136511|FG000|Post Treatment Phase|Withdrawal by Subject|4|||
147263112|NCT00644969|531136512|FG001|Post Treatment Phase|Withdrawal by Subject|2|||
147263113|NCT00644969|531136511|FG000|Post Treatment Phase|Lost to Follow-up|4|||
147263114|NCT00644969|531136512|FG001|Post Treatment Phase|Lost to Follow-up|1|||
147263115|NCT00644969|531136511|FG000|Post Treatment Phase|Other|1|||
147263116|NCT00644969|531136512|FG001|Post Treatment Phase|Other|0|||
147263117|NCT02449239|531136513|FG000|Induction Phase|Lack of Efficacy|64|||
147263118|NCT02449239|531136513|FG000|Induction Phase|Adverse Event|1|||
147263119|NCT02449239|531136513|FG000|Induction Phase|Lost to Follow-up|1|||
147263120|NCT02449239|531136513|FG000|Induction Phase|Protocol Violation|1|||
147263121|NCT02449239|531136513|FG000|Induction Phase|Physician Decision|1|||
147263122|NCT02449239|531136513|FG000|Induction Phase|Patient was determined by the sponsor to be ineligible for enrollment|1|||
147263123|NCT02449239|531136513|FG000|Induction Phase|Withdrawal by Subject|1|||
147263124|NCT02449239|531136513|FG000|Maintenance Month 3|Lack of Efficacy|14|||
147263125|NCT02449239|531136513|FG000|Maintenance Month 6|Lack of Efficacy|10|||
147263126|NCT02449239|531136513|FG000|Maintenance Month 6|Adverse Event|2|||
147263127|NCT02449239|531136513|FG000|Maintenance Month 6|Physician Decision|1|||
147263128|NCT02449239|531136513|FG000|Maintenance Month 9|Lack of Efficacy|2|||
147263129|NCT02449239|531136513|FG000|Maintenance Month 9|Started ibrutinib for CLL|1|||
147263130|NCT02449239|531136513|FG000|Maintenance Month 12|Lack of Efficacy|5|||
147263131|NCT02449239|531136513|FG000|Maintenance Month 12|Withdrawal by Subject|1|||
147263132|NCT02449239|531136513|FG000|Maintenance Month 12|Subject moved from area|1|||
147263133|NCT02449239|531136513|FG000|Maintenance Month 15|Lack of Efficacy|1|||
147263134|NCT02449239|531136513|FG000|Maintenance Month 21|Lack of Efficacy|1|||
147263135|NCT02449239|531136513|FG000|Maintenance Month 21|Sponsor decision|1|||
147263136|NCT03509675|531136514|FG000|First Intervention (7 Days)|Lost to Follow-up|3|||
147263137|NCT03509675|531136515|FG001|First Intervention (7 Days)|Lost to Follow-up|3|||
147263138|NCT03509675|531136514|FG000|First Intervention (7 Days)|Lack of Efficacy|2|||
147263139|NCT03509675|531136515|FG001|First Intervention (7 Days)|Lack of Efficacy|1|||
147263140|NCT03509675|531136514|FG000|Second Intervention )7 Days)|Withdrawal by Subject|1|||
147263141|NCT03509675|531136515|FG001|Second Intervention )7 Days)|Withdrawal by Subject|0|||
147263142|NCT03509675|531136514|FG000|Second Intervention )7 Days)|Lost Rinse B|1|||
147263143|NCT03509675|531136515|FG001|Second Intervention )7 Days)|Lost Rinse B|0|||
147263144|NCT05620576|531136518|FG000|Overall Study|Adverse Event|1|||
147263145|NCT05620576|531136519|FG001|Overall Study|Adverse Event|1|||
147263146|NCT05620576|531136518|FG000|Overall Study|Lost to Follow-up|3|||
147263147|NCT05620576|531136519|FG001|Overall Study|Lost to Follow-up|1|||
147263148|NCT05620576|531136518|FG000|Overall Study|Physician Decision|0|||
147263149|NCT05620576|531136519|FG001|Overall Study|Physician Decision|1|||
147263150|NCT05620576|531136518|FG000|Overall Study|Protocol Deviation|1|||
147263151|NCT05620576|531136519|FG001|Overall Study|Protocol Deviation|1|||
147263152|NCT05620576|531136518|FG000|Overall Study|Withdrawal by Subject|2|||
147263153|NCT05620576|531136519|FG001|Overall Study|Withdrawal by Subject|3|||
147263154|NCT06134817|531136527|FG000|Overall Study|Physician Departure - termination of study|1|||
147263155|NCT00278954|531136528|FG000|Overall Study|Adverse Event|3|||
147662243|NCT00689338|532585698|FG000|Overall Study|Other|8|||
147263156|NCT00278954|531136528|FG000|Overall Study|Lost to Follow-up|1|||
147263157|NCT00278954|531136528|FG000|Overall Study|Withdrawal by Subject|1|||
147263158|NCT02211131|531136544|FG000|Overall Study|Death|26|||
147263159|NCT02211131|531136545|FG001|Overall Study|Death|16|||
147263160|NCT02211131|531136544|FG000|Overall Study|Lost to Follow-up|4|||
147263161|NCT02211131|531136545|FG001|Overall Study|Lost to Follow-up|3|||
147263162|NCT02211131|531136544|FG000|Overall Study|Decision by Sponsor|1|||
147662244|NCT00689338|532585698|FG000|Overall Study|Did not Meet Entrance Criteria|27|||
147263163|NCT02211131|531136545|FG001|Overall Study|Decision by Sponsor|1|||
147263164|NCT02211131|531136544|FG000|Overall Study|Withdrawal by Subject|3|||
147263165|NCT02211131|531136545|FG001|Overall Study|Withdrawal by Subject|8|||
147263166|NCT05664490|531136547|FG000|Overall Study|Withdrawal by Subject|0|||
147263167|NCT05664490|531136548|FG001|Overall Study|Withdrawal by Subject|1|||
147263168|NCT05664490|531136547|FG000|Overall Study|Lost to Follow-up|14|||
147263169|NCT05664490|531136548|FG001|Overall Study|Lost to Follow-up|22|||
147263170|NCT05442554|531136549|FG000|Overall Study|Adverse Event|1|||
147263171|NCT01990495|531136554|FG000|Overall Study|Physician Decision|5|||
147263172|NCT01990495|531136555|FG001|Overall Study|Physician Decision|4|||
147263173|NCT01478321|531136556|FG000|Concurrent Therapy (5 Weeks)|Adverse Event|4|||
147263174|NCT01478321|531136556|FG000|Concurrent Therapy (5 Weeks)|Death|2|||
147263175|NCT01478321|531136556|FG000|Concurrent Therapy (5 Weeks)|Withdrawal by Subject|5|||
147263176|NCT01478321|531136556|FG000|Concurrent Therapy (5 Weeks)|Progressive Disease|5|||
147263177|NCT01478321|531136556|FG000|Started Adjuvant Therapy|Withdrawal by Subject|1|||
147263178|NCT01478321|531136556|FG000|Adjuvant Therapy Until PD or Toxicity|Death|1|||
147263179|NCT01478321|531136556|FG000|Adjuvant Therapy Until PD or Toxicity|Withdrawal by Subject|1|||
147263180|NCT01478321|531136556|FG000|Adjuvant Therapy Until PD or Toxicity|Progressive Disease|8|||
147263181|NCT05389657|531136571|FG000|Overall Study|Lost to Follow-up|7|||
147263182|NCT05389657|531136572|FG001|Overall Study|Lost to Follow-up|8|||
147263183|NCT02039674|531136576|FG000|Overall Study|Adverse Event|0|||
147263184|NCT02039674|531136577|FG001|Overall Study|Adverse Event|0|||
147263185|NCT02039674|531136578|FG002|Overall Study|Adverse Event|0|||
147263186|NCT02039674|531136579|FG003|Overall Study|Adverse Event|1|||
147263187|NCT02039674|531136580|FG004|Overall Study|Adverse Event|0|||
147263188|NCT02039674|531136581|FG005|Overall Study|Adverse Event|0|||
147263189|NCT02039674|531136582|FG006|Overall Study|Adverse Event|0|||
147263190|NCT02039674|531136583|FG007|Overall Study|Adverse Event|0|||
147263191|NCT02039674|531136584|FG008|Overall Study|Adverse Event|2|||
147263192|NCT02039674|531136585|FG009|Overall Study|Adverse Event|1|||
147263193|NCT02039674|531136586|FG010|Overall Study|Adverse Event|0|||
147263194|NCT02039674|531136587|FG011|Overall Study|Adverse Event|2|||
147263195|NCT02039674|531136588|FG012|Overall Study|Adverse Event|3|||
147263196|NCT02039674|531136589|FG013|Overall Study|Adverse Event|1|||
147263197|NCT02039674|531136576|FG000|Overall Study|Death|2|||
147263198|NCT02039674|531136577|FG001|Overall Study|Death|0|||
147263199|NCT02039674|531136578|FG002|Overall Study|Death|2|||
147263200|NCT02039674|531136579|FG003|Overall Study|Death|3|||
147263201|NCT02039674|531136580|FG004|Overall Study|Death|0|||
147263202|NCT02039674|531136581|FG005|Overall Study|Death|0|||
147263203|NCT02039674|531136582|FG006|Overall Study|Death|1|||
147263204|NCT02039674|531136583|FG007|Overall Study|Death|0|||
147263205|NCT02039674|531136584|FG008|Overall Study|Death|2|||
147263206|NCT02039674|531136585|FG009|Overall Study|Death|0|||
147263207|NCT02039674|531136586|FG010|Overall Study|Death|1|||
147263208|NCT02039674|531136587|FG011|Overall Study|Death|3|||
147263209|NCT02039674|531136588|FG012|Overall Study|Death|2|||
147263210|NCT02039674|531136589|FG013|Overall Study|Death|8|||
147263211|NCT02039674|531136576|FG000|Overall Study|Excluded Medication|1|||
147263212|NCT02039674|531136577|FG001|Overall Study|Excluded Medication|1|||
147263213|NCT02039674|531136578|FG002|Overall Study|Excluded Medication|0|||
147263214|NCT02039674|531136579|FG003|Overall Study|Excluded Medication|1|||
147263215|NCT02039674|531136580|FG004|Overall Study|Excluded Medication|0|||
147263216|NCT02039674|531136581|FG005|Overall Study|Excluded Medication|1|||
147263217|NCT02039674|531136582|FG006|Overall Study|Excluded Medication|0|||
147263218|NCT02039674|531136583|FG007|Overall Study|Excluded Medication|0|||
147263219|NCT02039674|531136584|FG008|Overall Study|Excluded Medication|2|||
147263220|NCT02039674|531136585|FG009|Overall Study|Excluded Medication|3|||
147263221|NCT02039674|531136586|FG010|Overall Study|Excluded Medication|5|||
147263222|NCT02039674|531136587|FG011|Overall Study|Excluded Medication|6|||
147263223|NCT02039674|531136588|FG012|Overall Study|Excluded Medication|8|||
147263224|NCT02039674|531136589|FG013|Overall Study|Excluded Medication|3|||
147263225|NCT02039674|531136576|FG000|Overall Study|Lost to Follow-up|0|||
147263226|NCT02039674|531136577|FG001|Overall Study|Lost to Follow-up|0|||
147263227|NCT02039674|531136578|FG002|Overall Study|Lost to Follow-up|0|||
147263228|NCT02039674|531136579|FG003|Overall Study|Lost to Follow-up|0|||
147263229|NCT02039674|531136580|FG004|Overall Study|Lost to Follow-up|1|||
147332913|NCT02299336|531385630|FG000|Overall Study|Adverse Event|1|||
147263230|NCT02039674|531136581|FG005|Overall Study|Lost to Follow-up|1|||
147263231|NCT02039674|531136582|FG006|Overall Study|Lost to Follow-up|0|||
147263232|NCT02039674|531136583|FG007|Overall Study|Lost to Follow-up|0|||
147263233|NCT02039674|531136584|FG008|Overall Study|Lost to Follow-up|0|||
147263234|NCT02039674|531136585|FG009|Overall Study|Lost to Follow-up|0|||
147263235|NCT02039674|531136586|FG010|Overall Study|Lost to Follow-up|0|||
147263236|NCT02039674|531136587|FG011|Overall Study|Lost to Follow-up|2|||
147263237|NCT02039674|531136588|FG012|Overall Study|Lost to Follow-up|2|||
147263238|NCT02039674|531136589|FG013|Overall Study|Lost to Follow-up|1|||
147263239|NCT02039674|531136576|FG000|Overall Study|Physician Decision|0|||
147263240|NCT02039674|531136577|FG001|Overall Study|Physician Decision|0|||
147263241|NCT02039674|531136578|FG002|Overall Study|Physician Decision|0|||
147332914|NCT02299336|531385630|FG000|Overall Study|Death|1|||
147263242|NCT02039674|531136579|FG003|Overall Study|Physician Decision|0|||
147263243|NCT02039674|531136580|FG004|Overall Study|Physician Decision|0|||
147263244|NCT02039674|531136581|FG005|Overall Study|Physician Decision|0|||
147263245|NCT02039674|531136582|FG006|Overall Study|Physician Decision|0|||
147263246|NCT02039674|531136583|FG007|Overall Study|Physician Decision|0|||
147263247|NCT02039674|531136584|FG008|Overall Study|Physician Decision|0|||
147263248|NCT02039674|531136585|FG009|Overall Study|Physician Decision|0|||
147263249|NCT02039674|531136586|FG010|Overall Study|Physician Decision|0|||
147263250|NCT02039674|531136587|FG011|Overall Study|Physician Decision|1|||
147263251|NCT02039674|531136588|FG012|Overall Study|Physician Decision|1|||
147263252|NCT02039674|531136589|FG013|Overall Study|Physician Decision|0|||
147263253|NCT02039674|531136576|FG000|Overall Study|Progressive Disease|8|||
147263254|NCT02039674|531136577|FG001|Overall Study|Progressive Disease|8|||
147263255|NCT02039674|531136578|FG002|Overall Study|Progressive Disease|6|||
147263256|NCT02039674|531136579|FG003|Overall Study|Progressive Disease|7|||
147263257|NCT02039674|531136580|FG004|Overall Study|Progressive Disease|9|||
147263258|NCT02039674|531136581|FG005|Overall Study|Progressive Disease|10|||
147263259|NCT02039674|531136582|FG006|Overall Study|Progressive Disease|1|||
147263260|NCT02039674|531136583|FG007|Overall Study|Progressive Disease|3|||
147263261|NCT02039674|531136584|FG008|Overall Study|Progressive Disease|6|||
147263262|NCT02039674|531136585|FG009|Overall Study|Progressive Disease|4|||
147263263|NCT02039674|531136586|FG010|Overall Study|Progressive Disease|0|||
147263264|NCT02039674|531136587|FG011|Overall Study|Progressive Disease|34|||
147263265|NCT02039674|531136588|FG012|Overall Study|Progressive Disease|34|||
147263266|NCT02039674|531136589|FG013|Overall Study|Progressive Disease|18|||
147263267|NCT02039674|531136576|FG000|Overall Study|Withdrawal by Subject|1|||
147263268|NCT02039674|531136577|FG001|Overall Study|Withdrawal by Subject|2|||
147263269|NCT02039674|531136578|FG002|Overall Study|Withdrawal by Subject|3|||
147263270|NCT02039674|531136579|FG003|Overall Study|Withdrawal by Subject|0|||
147263271|NCT02039674|531136580|FG004|Overall Study|Withdrawal by Subject|1|||
147263272|NCT02039674|531136581|FG005|Overall Study|Withdrawal by Subject|0|||
147263273|NCT02039674|531136582|FG006|Overall Study|Withdrawal by Subject|0|||
147263274|NCT02039674|531136583|FG007|Overall Study|Withdrawal by Subject|0|||
147263275|NCT02039674|531136584|FG008|Overall Study|Withdrawal by Subject|0|||
147263276|NCT02039674|531136585|FG009|Overall Study|Withdrawal by Subject|1|||
147263277|NCT02039674|531136586|FG010|Overall Study|Withdrawal by Subject|1|||
147263278|NCT02039674|531136587|FG011|Overall Study|Withdrawal by Subject|4|||
147263279|NCT02039674|531136588|FG012|Overall Study|Withdrawal by Subject|6|||
147263280|NCT02039674|531136589|FG013|Overall Study|Withdrawal by Subject|2|||
147263281|NCT02039674|531136576|FG000|Overall Study|Clinical Progression|0|||
147263282|NCT02039674|531136577|FG001|Overall Study|Clinical Progression|0|||
147263283|NCT02039674|531136578|FG002|Overall Study|Clinical Progression|0|||
147263284|NCT02039674|531136579|FG003|Overall Study|Clinical Progression|0|||
147263285|NCT02039674|531136580|FG004|Overall Study|Clinical Progression|0|||
147263286|NCT02039674|531136581|FG005|Overall Study|Clinical Progression|0|||
147263287|NCT02039674|531136582|FG006|Overall Study|Clinical Progression|1|||
147263288|NCT02039674|531136583|FG007|Overall Study|Clinical Progression|0|||
147263289|NCT02039674|531136584|FG008|Overall Study|Clinical Progression|0|||
147263290|NCT02039674|531136585|FG009|Overall Study|Clinical Progression|0|||
147263291|NCT02039674|531136586|FG010|Overall Study|Clinical Progression|0|||
147263292|NCT02039674|531136587|FG011|Overall Study|Clinical Progression|0|||
147263293|NCT02039674|531136588|FG012|Overall Study|Clinical Progression|1|||
147263294|NCT02039674|531136589|FG013|Overall Study|Clinical Progression|0|||
147263295|NCT02039674|531136576|FG000|Overall Study|Sponsor Decision|1|||
147263296|NCT02039674|531136577|FG001|Overall Study|Sponsor Decision|1|||
147263297|NCT02039674|531136578|FG002|Overall Study|Sponsor Decision|1|||
147263298|NCT02039674|531136579|FG003|Overall Study|Sponsor Decision|1|||
147263299|NCT02039674|531136580|FG004|Overall Study|Sponsor Decision|1|||
147263300|NCT02039674|531136581|FG005|Overall Study|Sponsor Decision|0|||
147263301|NCT02039674|531136582|FG006|Overall Study|Sponsor Decision|0|||
147263302|NCT02039674|531136583|FG007|Overall Study|Sponsor Decision|0|||
147263303|NCT02039674|531136584|FG008|Overall Study|Sponsor Decision|0|||
147263304|NCT02039674|531136585|FG009|Overall Study|Sponsor Decision|3|||
147263305|NCT02039674|531136586|FG010|Overall Study|Sponsor Decision|0|||
147263306|NCT02039674|531136587|FG011|Overall Study|Sponsor Decision|8|||
147263307|NCT02039674|531136588|FG012|Overall Study|Sponsor Decision|5|||
147662245|NCT00689338|532585698|FG000|Overall Study|Lost to Follow-up|5|||
147662246|NCT00689338|532585698|FG000|Overall Study|Withdrawal by Subject|3|||
147263308|NCT02039674|531136589|FG013|Overall Study|Sponsor Decision|0|||
147263309|NCT02039674|531136576|FG000|Overall Study|Other|0|||
147263310|NCT02039674|531136577|FG001|Overall Study|Other|0|||
147263311|NCT02039674|531136578|FG002|Overall Study|Other|0|||
147263312|NCT02039674|531136579|FG003|Overall Study|Other|0|||
147263313|NCT02039674|531136580|FG004|Overall Study|Other|0|||
147263314|NCT02039674|531136581|FG005|Overall Study|Other|0|||
147263315|NCT02039674|531136582|FG006|Overall Study|Other|0|||
147263316|NCT02039674|531136583|FG007|Overall Study|Other|0|||
147263317|NCT02039674|531136584|FG008|Overall Study|Other|0|||
147263318|NCT02039674|531136585|FG009|Overall Study|Other|0|||
147263319|NCT02039674|531136586|FG010|Overall Study|Other|0|||
147263320|NCT02039674|531136587|FG011|Overall Study|Other|0|||
147263321|NCT02039674|531136588|FG012|Overall Study|Other|1|||
147263322|NCT02039674|531136589|FG013|Overall Study|Other|0|||
147263323|NCT01408030|531136591|FG000|Treatment Phase (on Drug)|Lost to Follow-up|1|||
147263324|NCT01408030|531136592|FG001|Treatment Phase (on Drug)|Lost to Follow-up|0|||
147263325|NCT01408030|531136593|FG002|Treatment Phase (on Drug)|Lost to Follow-up|1|||
147263326|NCT01408030|531136594|FG003|Treatment Phase (on Drug)|Lost to Follow-up|0|||
147263327|NCT01408030|531136591|FG000|Treatment Phase (on Drug)|Lack of Efficacy|2|||
147263328|NCT01408030|531136592|FG001|Treatment Phase (on Drug)|Lack of Efficacy|6|||
147263329|NCT01408030|531136593|FG002|Treatment Phase (on Drug)|Lack of Efficacy|0|||
147263330|NCT01408030|531136594|FG003|Treatment Phase (on Drug)|Lack of Efficacy|3|||
147263331|NCT01408030|531136591|FG000|Treatment Phase (on Drug)|Protocol Violation|0|||
147263332|NCT01408030|531136592|FG001|Treatment Phase (on Drug)|Protocol Violation|1|||
147263333|NCT01408030|531136593|FG002|Treatment Phase (on Drug)|Protocol Violation|0|||
147263334|NCT01408030|531136594|FG003|Treatment Phase (on Drug)|Protocol Violation|0|||
147263335|NCT01408030|531136591|FG000|Observation Phase (Off Drug)|Lost to Follow-up|0|||
147263336|NCT01408030|531136592|FG001|Observation Phase (Off Drug)|Lost to Follow-up|2|||
147263337|NCT01408030|531136593|FG002|Observation Phase (Off Drug)|Lost to Follow-up|2|||
147263338|NCT01408030|531136594|FG003|Observation Phase (Off Drug)|Lost to Follow-up|0|||
147263339|NCT01408030|531136591|FG000|Observation Phase (Off Drug)|Withdrawal by Subject|3|||
147263340|NCT01408030|531136592|FG001|Observation Phase (Off Drug)|Withdrawal by Subject|2|||
147263341|NCT01408030|531136593|FG002|Observation Phase (Off Drug)|Withdrawal by Subject|1|||
147263342|NCT01408030|531136594|FG003|Observation Phase (Off Drug)|Withdrawal by Subject|3|||
147263343|NCT01408030|531136591|FG000|Observation Phase (Off Drug)|Physician Decision|0|||
147263344|NCT01408030|531136592|FG001|Observation Phase (Off Drug)|Physician Decision|1|||
147263345|NCT01408030|531136593|FG002|Observation Phase (Off Drug)|Physician Decision|2|||
147263346|NCT01408030|531136594|FG003|Observation Phase (Off Drug)|Physician Decision|0|||
147263347|NCT01408030|531136591|FG000|Observation Phase (Off Drug)|Other|1|||
147263348|NCT01408030|531136592|FG001|Observation Phase (Off Drug)|Other|1|||
147263349|NCT01408030|531136593|FG002|Observation Phase (Off Drug)|Other|1|||
147263350|NCT01408030|531136594|FG003|Observation Phase (Off Drug)|Other|1|||
147263351|NCT02590939|531136595|FG000|Overall Study|Withdrawal by Subject|3|||
147263352|NCT02590939|531136596|FG001|Overall Study|Withdrawal by Subject|1|||
147263353|NCT02590939|531136595|FG000|Overall Study|Failed the nociceptive test|2|||
147263354|NCT02590939|531136596|FG001|Overall Study|Failed the nociceptive test|1|||
147263355|NCT03774433|531136597|FG000|Overall Study|Participants who completed less than 12 EMAs are not included in the final analysis|14|||
147263356|NCT00108160|531136598|FG000|Overall Study|Lost to Follow-up|25|||
147263357|NCT00108160|531136599|FG001|Overall Study|Lost to Follow-up|12|||
147263358|NCT00108160|531136598|FG000|Overall Study|Death|1|||
147263359|NCT00108160|531136599|FG001|Overall Study|Death|2|||
147263360|NCT00108160|531136598|FG000|Overall Study|Withdrawal by Subject|4|||
147263361|NCT00108160|531136599|FG001|Overall Study|Withdrawal by Subject|2|||
147263362|NCT00108160|531136598|FG000|Overall Study|Protocol Violation|9|||
147263363|NCT00108160|531136599|FG001|Overall Study|Protocol Violation|5|||
147263364|NCT02385084|531136600|FG000|Period 2|Protocol Violation|0|||
147263365|NCT02385084|531136601|FG001|Period 2|Protocol Violation|0|||
147263366|NCT02385084|531136602|FG002|Period 2|Protocol Violation|1|||
147263367|NCT02385084|531136603|FG003|Period 2|Protocol Violation|0|||
147263368|NCT02385084|531136604|FG004|Period 2|Protocol Violation|0|||
147263369|NCT02385084|531136605|FG005|Period 2|Protocol Violation|0|||
147263370|NCT05045144|531136606|FG000|Overall Study|Lost to Follow-up|3|||
147263371|NCT05045144|531136607|FG001|Overall Study|Lost to Follow-up|2|||
147263372|NCT05045144|531136608|FG002|Overall Study|Lost to Follow-up|3|||
147263373|NCT05045144|531136609|FG003|Overall Study|Lost to Follow-up|5|||
147263374|NCT05045144|531136610|FG004|Overall Study|Lost to Follow-up|13|||
147263375|NCT05045144|531136606|FG000|Overall Study|Withdrawal by Subject|0|||
147263376|NCT05045144|531136607|FG001|Overall Study|Withdrawal by Subject|1|||
147263377|NCT05045144|531136608|FG002|Overall Study|Withdrawal by Subject|0|||
147263378|NCT05045144|531136609|FG003|Overall Study|Withdrawal by Subject|0|||
147263379|NCT05045144|531136610|FG004|Overall Study|Withdrawal by Subject|0|||
147263380|NCT05045144|531136606|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
147263381|NCT05045144|531136607|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
147263382|NCT05045144|531136608|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
147263383|NCT05045144|531136609|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
147263384|NCT05045144|531136610|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
147263385|NCT02081079|531136612|FG000|Overall Study|Lack of Efficacy|3|||
147263386|NCT02081079|531136613|FG001|Overall Study|Lack of Efficacy|2|||
147263387|NCT02081079|531136612|FG000|Overall Study|Lost to Follow-up|1|||
147263388|NCT02081079|531136613|FG001|Overall Study|Lost to Follow-up|0|||
147263389|NCT02968979|531136614|FG000|Overall Study|Protocol Violation|7|||
147263390|NCT02968979|531136614|FG000|Overall Study|Withdrawal by Subject|1|||
147263391|NCT00729183|531136615|FG000|Overall Study|Adverse Event|11|||
147263392|NCT00729183|531136616|FG001|Overall Study|Adverse Event|5|||
147263393|NCT00729183|531136615|FG000|Overall Study|Lack of Efficacy|0|||
147263394|NCT00729183|531136616|FG001|Overall Study|Lack of Efficacy|1|||
147263395|NCT00729183|531136615|FG000|Overall Study|Lost to Follow-up|3|||
147263396|NCT00729183|531136616|FG001|Overall Study|Lost to Follow-up|1|||
147263397|NCT00729183|531136615|FG000|Overall Study|Physician Decision|1|||
147263398|NCT00729183|531136616|FG001|Overall Study|Physician Decision|1|||
147263399|NCT00729183|531136615|FG000|Overall Study|Protocol Violation|1|||
147263400|NCT00729183|531136616|FG001|Overall Study|Protocol Violation|0|||
147263401|NCT00729183|531136615|FG000|Overall Study|Withdrawal by Subject|9|||
147263402|NCT00729183|531136616|FG001|Overall Study|Withdrawal by Subject|7|||
147263403|NCT01359254|531136623|FG000|Overall Study|Death|1|||
147263404|NCT01359254|531136624|FG001|Overall Study|Death|0|||
147263405|NCT02678676|531136627|FG000|Overall Study|Death|619|||
147263406|NCT02678676|531136628|FG001|Overall Study|Death|649|||
147263407|NCT02678676|531136627|FG000|Overall Study|Withdrawal by Subject|13|||
147263408|NCT02678676|531136628|FG001|Overall Study|Withdrawal by Subject|5|||
147263409|NCT02678676|531136627|FG000|Overall Study|Lost to Follow-up|171|||
147263410|NCT02678676|531136628|FG001|Overall Study|Lost to Follow-up|151|||
147263411|NCT02678676|531136627|FG000|Overall Study|Unconfirmed for lost to follow-up|85|||
147263412|NCT02678676|531136628|FG001|Overall Study|Unconfirmed for lost to follow-up|67|||
147263413|NCT00851799|531136629|FG000|Overall Study|Death|1|||
147263414|NCT00851799|531136630|FG001|Overall Study|Death|0|||
147263415|NCT00851799|531136631|FG002|Overall Study|Death|1|||
147263416|NCT00851799|531136629|FG000|Overall Study|Lost to Follow-up|5|||
147263417|NCT00851799|531136630|FG001|Overall Study|Lost to Follow-up|3|||
147263418|NCT00851799|531136631|FG002|Overall Study|Lost to Follow-up|10|||
147263419|NCT00851799|531136629|FG000|Overall Study|Not able to get to clinic|8|||
147263420|NCT00851799|531136630|FG001|Overall Study|Not able to get to clinic|5|||
147263421|NCT00851799|531136631|FG002|Overall Study|Not able to get to clinic|9|||
147263422|NCT00851799|531136629|FG000|Overall Study|Not willing to adhere to requirements|1|||
147263423|NCT00851799|531136630|FG001|Overall Study|Not willing to adhere to requirements|2|||
147263424|NCT00851799|531136631|FG002|Overall Study|Not willing to adhere to requirements|2|||
147263425|NCT00851799|531136629|FG000|Overall Study|Withdrew consent prior study completion|1|||
147263426|NCT00851799|531136630|FG001|Overall Study|Withdrew consent prior study completion|2|||
147263427|NCT00851799|531136631|FG002|Overall Study|Withdrew consent prior study completion|1|||
147263428|NCT00851799|531136629|FG000|Overall Study|Severe Debilitation|0|||
147263429|NCT00851799|531136630|FG001|Overall Study|Severe Debilitation|1|||
147263430|NCT00851799|531136631|FG002|Overall Study|Severe Debilitation|0|||
147263431|NCT00851799|531136629|FG000|Overall Study|Completed protocol due to pregnancy|0|||
147263432|NCT00851799|531136630|FG001|Overall Study|Completed protocol due to pregnancy|0|||
147263433|NCT00851799|531136631|FG002|Overall Study|Completed protocol due to pregnancy|1|||
147263434|NCT01449526|531136632|FG000|Overall Study|Lost to Follow-up|1|||
147263435|NCT01449526|531136633|FG001|Overall Study|Lost to Follow-up|2|||
147263436|NCT01449526|531136632|FG000|Overall Study|Withdrawal by Subject|1|||
147263437|NCT01449526|531136633|FG001|Overall Study|Withdrawal by Subject|1|||
147263438|NCT01449526|531136632|FG000|Overall Study|Symptoms/complaints|0|||
147263439|NCT01449526|531136633|FG001|Overall Study|Symptoms/complaints|1|||
147263440|NCT01449526|531136632|FG000|Overall Study|Lack of Motivation|0|||
147263441|NCT01449526|531136633|FG001|Overall Study|Lack of Motivation|1|||
147263442|NCT01449526|531136632|FG000|Overall Study|Cannot maintain visits|0|||
147263443|NCT01449526|531136633|FG001|Overall Study|Cannot maintain visits|1|||
147263444|NCT04365556|531136634|FG000|Overall Study|No longer eligible due to treatment plan|1|||
147263445|NCT04365556|531136635|FG001|Overall Study|No longer eligible due to treatment plan|0|||
147263446|NCT04365556|531136634|FG000|Overall Study|Lost to Follow-up|3|||
147263447|NCT04365556|531136635|FG001|Overall Study|Lost to Follow-up|2|||
147263448|NCT02181556|531138370|FG000|Overall Study|Withdrawal by Subject|1|||
147263449|NCT05083442|531138373|FG000|Overall Study|Lost to Follow-up|1|||
147263450|NCT05083442|531138374|FG001|Overall Study|Lost to Follow-up|0|||
147263451|NCT05083442|531138373|FG000|Overall Study|Lack of Efficacy|0|||
147263452|NCT05083442|531138374|FG001|Overall Study|Lack of Efficacy|1|||
147263453|NCT05083442|531138373|FG000|Overall Study|Withdrawal by Subject|1|||
147263454|NCT05083442|531138374|FG001|Overall Study|Withdrawal by Subject|3|||
147263455|NCT05083442|531138373|FG000|Overall Study|scheduling difficulties|1|||
147263456|NCT05083442|531138374|FG001|Overall Study|scheduling difficulties|2|||
147263457|NCT01023581|531138380|FG000|Overall Study|Adverse Event|4|||
147263458|NCT01023581|531138381|FG001|Overall Study|Adverse Event|4|||
147263459|NCT01023581|531138382|FG002|Overall Study|Adverse Event|7|||
147263460|NCT01023581|531138383|FG003|Overall Study|Adverse Event|3|||
147263461|NCT01023581|531138384|FG004|Overall Study|Adverse Event|2|||
147263462|NCT01023581|531138385|FG005|Overall Study|Adverse Event|5|||
147263463|NCT01023581|531138386|FG006|Overall Study|Adverse Event|11|||
147263464|NCT01023581|531138380|FG000|Overall Study|Major protocol deviation|2|||
147263465|NCT01023581|531138381|FG001|Overall Study|Major protocol deviation|0|||
147263466|NCT01023581|531138382|FG002|Overall Study|Major protocol deviation|3|||
147263467|NCT01023581|531138383|FG003|Overall Study|Major protocol deviation|0|||
147263468|NCT01023581|531138384|FG004|Overall Study|Major protocol deviation|0|||
147263469|NCT01023581|531138385|FG005|Overall Study|Major protocol deviation|0|||
147263470|NCT01023581|531138386|FG006|Overall Study|Major protocol deviation|0|||
147599932|NCT01150890|532352531|FG001|Overall Study|Adverse Event|0|||
147263471|NCT01023581|531138380|FG000|Overall Study|Lost to Follow-up|4|||
147263472|NCT01023581|531138381|FG001|Overall Study|Lost to Follow-up|8|||
147263473|NCT01023581|531138382|FG002|Overall Study|Lost to Follow-up|7|||
147263474|NCT01023581|531138383|FG003|Overall Study|Lost to Follow-up|2|||
147263475|NCT01023581|531138384|FG004|Overall Study|Lost to Follow-up|5|||
147263476|NCT01023581|531138385|FG005|Overall Study|Lost to Follow-up|2|||
147263477|NCT01023581|531138386|FG006|Overall Study|Lost to Follow-up|2|||
147263478|NCT01023581|531138380|FG000|Overall Study|Withdrawal by Subject|13|||
147263479|NCT01023581|531138381|FG001|Overall Study|Withdrawal by Subject|8|||
147263480|NCT01023581|531138382|FG002|Overall Study|Withdrawal by Subject|16|||
147263481|NCT01023581|531138383|FG003|Overall Study|Withdrawal by Subject|10|||
147263482|NCT01023581|531138384|FG004|Overall Study|Withdrawal by Subject|6|||
147263483|NCT01023581|531138385|FG005|Overall Study|Withdrawal by Subject|8|||
147263484|NCT01023581|531138386|FG006|Overall Study|Withdrawal by Subject|5|||
147263485|NCT01023581|531138380|FG000|Overall Study|Pregnancy|0|||
147263486|NCT01023581|531138381|FG001|Overall Study|Pregnancy|0|||
147263487|NCT01023581|531138382|FG002|Overall Study|Pregnancy|0|||
147263488|NCT01023581|531138383|FG003|Overall Study|Pregnancy|2|||
147263489|NCT01023581|531138384|FG004|Overall Study|Pregnancy|0|||
147263490|NCT01023581|531138385|FG005|Overall Study|Pregnancy|1|||
147263491|NCT01023581|531138386|FG006|Overall Study|Pregnancy|0|||
147263492|NCT01023581|531138380|FG000|Overall Study|Lack of Efficacy|9|||
147263493|NCT01023581|531138381|FG001|Overall Study|Lack of Efficacy|3|||
147263494|NCT01023581|531138382|FG002|Overall Study|Lack of Efficacy|6|||
147263495|NCT01023581|531138383|FG003|Overall Study|Lack of Efficacy|2|||
147263496|NCT01023581|531138384|FG004|Overall Study|Lack of Efficacy|1|||
147263497|NCT01023581|531138385|FG005|Overall Study|Lack of Efficacy|2|||
147263498|NCT01023581|531138386|FG006|Overall Study|Lack of Efficacy|1|||
147263499|NCT01023581|531138380|FG000|Overall Study|Physician Decision|2|||
147263500|NCT01023581|531138381|FG001|Overall Study|Physician Decision|0|||
147263501|NCT01023581|531138382|FG002|Overall Study|Physician Decision|2|||
147263502|NCT01023581|531138383|FG003|Overall Study|Physician Decision|1|||
147263503|NCT01023581|531138384|FG004|Overall Study|Physician Decision|1|||
147263504|NCT01023581|531138385|FG005|Overall Study|Physician Decision|1|||
147263505|NCT01023581|531138386|FG006|Overall Study|Physician Decision|1|||
147263506|NCT01023581|531138380|FG000|Overall Study|Other|1|||
147263507|NCT01023581|531138381|FG001|Overall Study|Other|0|||
147263508|NCT01023581|531138382|FG002|Overall Study|Other|1|||
147263509|NCT01023581|531138383|FG003|Overall Study|Other|0|||
147263510|NCT01023581|531138384|FG004|Overall Study|Other|1|||
147263511|NCT01023581|531138385|FG005|Overall Study|Other|0|||
147263512|NCT01023581|531138386|FG006|Overall Study|Other|0|||
147263513|NCT01176292|531138390|FG000|Overall Study|Lost to Follow-up|2|||
147263514|NCT01176292|531138391|FG001|Overall Study|Lost to Follow-up|4|||
147263515|NCT01176292|531138390|FG000|Overall Study|Adverse Event|1|||
147263516|NCT01176292|531138391|FG001|Overall Study|Adverse Event|1|||
147263517|NCT01176292|531138390|FG000|Overall Study|Physician Decision|0|||
147263518|NCT01176292|531138391|FG001|Overall Study|Physician Decision|2|||
147263519|NCT01176292|531138390|FG000|Overall Study|Has not scheduled one-year visit yet|2|||
147263520|NCT01176292|531138391|FG001|Overall Study|Has not scheduled one-year visit yet|2|||
147263521|NCT00997503|531138392|FG000|Overall Study|Death|53|||
147263522|NCT00997503|531138392|FG000|Overall Study|Withdrawal by Subject|76|||
147263523|NCT00997503|531138392|FG000|Overall Study|Lost to Follow-up|33|||
147263524|NCT00997503|531138392|FG000|Overall Study|Adverse Event|3|||
147263525|NCT00997503|531138392|FG000|Overall Study|Physician Decision|10|||
147263526|NCT00997503|531138392|FG000|Overall Study|Missed 12-month follow-up|85|||
147263527|NCT00997503|531138392|FG000|Overall Study|Other reason|13|||
147263528|NCT01933048|531138393|FG000|Overall Study|Lost to Follow-up|15|||
147263529|NCT01933048|531138394|FG001|Overall Study|Lost to Follow-up|18|||
147263530|NCT01933048|531138393|FG000|Overall Study|personal reasons|1|||
147263531|NCT01933048|531138394|FG001|Overall Study|personal reasons|1|||
147263532|NCT01933048|531138393|FG000|Overall Study|Protocol Violation|7|||
147263533|NCT01933048|531138394|FG001|Overall Study|Protocol Violation|8|||
147263534|NCT01933048|531138393|FG000|Overall Study|Physician Decision|1|||
147263535|NCT01933048|531138394|FG001|Overall Study|Physician Decision|0|||
147263536|NCT01933048|531138393|FG000|Overall Study|unknown reasons|1|||
147263537|NCT01933048|531138394|FG001|Overall Study|unknown reasons|1|||
147263538|NCT00380393|531138395|FG000|Month 8 (Cross-sectional Visit)|Withdrawal by Subject|6|||
147263539|NCT00380393|531138396|FG001|Month 8 (Cross-sectional Visit)|Withdrawal by Subject|5|||
147263540|NCT00380393|531138395|FG000|Month 8 (Cross-sectional Visit)|Lost to Follow-up|0|||
147263541|NCT00380393|531138396|FG001|Month 8 (Cross-sectional Visit)|Lost to Follow-up|1|||
147263542|NCT00380393|531138395|FG000|Month 8 (Cross-sectional Visit)|Migrated/moved from study area|37|||
147263543|NCT00380393|531138396|FG001|Month 8 (Cross-sectional Visit)|Migrated/moved from study area|29|||
147263544|NCT00380393|531138395|FG000|Month 8 (Cross-sectional Visit)|Serious Adverse Event|1|||
147263545|NCT00380393|531138396|FG001|Month 8 (Cross-sectional Visit)|Serious Adverse Event|1|||
147263546|NCT00380393|531138395|FG000|Month 8 (Cross-sectional Visit)|Others|5|||
147263547|NCT00380393|531138396|FG001|Month 8 (Cross-sectional Visit)|Others|4|||
147263548|NCT00380393|531138395|FG000|Month 14|Withdrawal by Subject|9|||
147263549|NCT00380393|531138396|FG001|Month 14|Withdrawal by Subject|7|||
147263550|NCT00380393|531138395|FG000|Month 14|Death|1|||
147263551|NCT00380393|531138396|FG001|Month 14|Death|0|||
147263552|NCT00380393|531138395|FG000|Month 14|Lost to Follow-up|0|||
147263553|NCT00380393|531138396|FG001|Month 14|Lost to Follow-up|1|||
147263554|NCT00380393|531138395|FG000|Month 14|Migrated/moved from study area|39|||
147263555|NCT00380393|531138396|FG001|Month 14|Migrated/moved from study area|42|||
147263556|NCT00380393|531138395|FG000|Month 14|Protocol Violation|2|||
147263557|NCT00380393|531138396|FG001|Month 14|Protocol Violation|0|||
147263558|NCT00380393|531138395|FG000|Month 14|Others|6|||
147263559|NCT00380393|531138396|FG001|Month 14|Others|6|||
147263560|NCT02780804|531138397|FG000|Overall Study|Death|1|||
147263561|NCT02780804|531138398|FG001|Overall Study|Death|0|||
147263562|NCT02780804|531138399|FG002|Overall Study|Death|0|||
147263563|NCT02780804|531138397|FG000|Overall Study|Lack of Efficacy|5|||
147263564|NCT02780804|531138398|FG001|Overall Study|Lack of Efficacy|8|||
147263565|NCT02780804|531138399|FG002|Overall Study|Lack of Efficacy|4|||
147263566|NCT02780804|531138397|FG000|Overall Study|Physician Decision|0|||
147263567|NCT02780804|531138398|FG001|Overall Study|Physician Decision|0|||
147263568|NCT02780804|531138399|FG002|Overall Study|Physician Decision|2|||
147263569|NCT02780804|531138397|FG000|Overall Study|Withdrawal by Subject|0|||
147263570|NCT02780804|531138398|FG001|Overall Study|Withdrawal by Subject|1|||
147263571|NCT02780804|531138399|FG002|Overall Study|Withdrawal by Subject|0|||
147263572|NCT02476968|531138400|FG000|Overall Study|Other|0|||
147263573|NCT02476968|531138401|FG001|Overall Study|Other|2|||
147263574|NCT02476968|531138402|FG002|Overall Study|Other|0|||
147263575|NCT02476968|531138400|FG000|Overall Study|Lost to Follow-up|10|||
147263576|NCT02476968|531138401|FG001|Overall Study|Lost to Follow-up|0|||
147263577|NCT02476968|531138402|FG002|Overall Study|Lost to Follow-up|1|||
147263578|NCT02476968|531138400|FG000|Overall Study|Death|48|||
147263579|NCT02476968|531138401|FG001|Overall Study|Death|8|||
147263580|NCT02476968|531138402|FG002|Overall Study|Death|1|||
147263581|NCT02476968|531138400|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
147263582|NCT02476968|531138401|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
147263583|NCT02476968|531138402|FG002|Overall Study|Eligibility criteria not fulfilled|1|||
147263584|NCT02476968|531138400|FG000|Overall Study|Patient decision|37|||
147263585|NCT02476968|531138401|FG001|Overall Study|Patient decision|8|||
147263586|NCT02476968|531138402|FG002|Overall Study|Patient decision|0|||
147263587|NCT01859507|531138403|FG000|Overall Study|left the country|4|||
147263588|NCT04476030|531138404|FG000|Overall Study|Withdrawal by Subject|20|||
147263589|NCT04476030|531138405|FG001|Overall Study|Withdrawal by Subject|16|||
147263590|NCT04476030|531138404|FG000|Overall Study|Adverse Event|10|||
147263591|NCT04476030|531138405|FG001|Overall Study|Adverse Event|11|||
147263592|NCT04476030|531138404|FG000|Overall Study|Lost to Follow-up|7|||
147263593|NCT04476030|531138405|FG001|Overall Study|Lost to Follow-up|4|||
147263594|NCT04476030|531138404|FG000|Overall Study|Physician Decision|1|||
147263595|NCT04476030|531138405|FG001|Overall Study|Physician Decision|1|||
147263596|NCT04476030|531138404|FG000|Overall Study|Protocol Deviation|2|||
147263597|NCT04476030|531138405|FG001|Overall Study|Protocol Deviation|0|||
147263598|NCT04476030|531138404|FG000|Overall Study|Non-compliance with Investigational Product (IP)|1|||
147263599|NCT04476030|531138405|FG001|Overall Study|Non-compliance with Investigational Product (IP)|0|||
147263600|NCT04476030|531138404|FG000|Overall Study|Randomized but not Dosed|2|||
147263601|NCT04476030|531138405|FG001|Overall Study|Randomized but not Dosed|8|||
147263602|NCT02404311|531138406|FG000|Part A: Month 0-18|Death|2|||
147263603|NCT02404311|531138407|FG001|Part A: Month 0-18|Death|0|||
147263604|NCT02404311|531138408|FG002|Part A: Month 0-18|Death|0|||
147263605|NCT02404311|531138409|FG003|Part A: Month 0-18|Death|0|||
147263606|NCT02404311|531138410|FG004|Part A: Month 0-18|Death|0|||
147263607|NCT02404311|531138406|FG000|Part A: Month 0-18|Physician Decision|1|||
147263608|NCT02404311|531138407|FG001|Part A: Month 0-18|Physician Decision|0|||
147263609|NCT02404311|531138408|FG002|Part A: Month 0-18|Physician Decision|0|||
147263610|NCT02404311|531138409|FG003|Part A: Month 0-18|Physician Decision|0|||
147263611|NCT02404311|531138410|FG004|Part A: Month 0-18|Physician Decision|0|||
147263612|NCT02404311|531138406|FG000|Part A: Month 0-18|Lost to Follow-up|4|||
147263613|NCT02404311|531138407|FG001|Part A: Month 0-18|Lost to Follow-up|2|||
147263614|NCT02404311|531138408|FG002|Part A: Month 0-18|Lost to Follow-up|0|||
147263615|NCT02404311|531138409|FG003|Part A: Month 0-18|Lost to Follow-up|0|||
147263616|NCT02404311|531138410|FG004|Part A: Month 0-18|Lost to Follow-up|0|||
147263617|NCT02404311|531138406|FG000|Part A: Month 0-18|Withdrawal by Subject|6|||
147263618|NCT02404311|531138407|FG001|Part A: Month 0-18|Withdrawal by Subject|2|||
147263619|NCT02404311|531138408|FG002|Part A: Month 0-18|Withdrawal by Subject|0|||
147263620|NCT02404311|531138409|FG003|Part A: Month 0-18|Withdrawal by Subject|0|||
147263621|NCT02404311|531138410|FG004|Part A: Month 0-18|Withdrawal by Subject|0|||
147263622|NCT02404311|531138406|FG000|Part A: Month 0-18|HIV Infection|6|||
147263623|NCT02404311|531138407|FG001|Part A: Month 0-18|HIV Infection|2|||
147599933|NCT01150890|532352532|FG002|Overall Study|Adverse Event|2|||
147263624|NCT02404311|531138408|FG002|Part A: Month 0-18|HIV Infection|0|||
147263625|NCT02404311|531138409|FG003|Part A: Month 0-18|HIV Infection|0|||
147263626|NCT02404311|531138410|FG004|Part A: Month 0-18|HIV Infection|0|||
147263627|NCT02404311|531138406|FG000|Part A: Month 0-18|Participant unable to adhere|7|||
147263628|NCT02404311|531138407|FG001|Part A: Month 0-18|Participant unable to adhere|0|||
147263629|NCT02404311|531138408|FG002|Part A: Month 0-18|Participant unable to adhere|0|||
147263630|NCT02404311|531138409|FG003|Part A: Month 0-18|Participant unable to adhere|0|||
147263631|NCT02404311|531138410|FG004|Part A: Month 0-18|Participant unable to adhere|0|||
147263632|NCT02256891|531138415|FG000|Overall Study|Death|0|||
147263633|NCT02256891|531138416|FG001|Overall Study|Death|2|||
147263634|NCT02256891|531138415|FG000|Overall Study|Lost to Follow-up|0|||
147263635|NCT02256891|531138416|FG001|Overall Study|Lost to Follow-up|3|||
147263636|NCT02256891|531138415|FG000|Overall Study|Physician Decision|7|||
147263637|NCT02256891|531138416|FG001|Overall Study|Physician Decision|3|||
147263638|NCT02256891|531138415|FG000|Overall Study|Screen Fail|5|||
147263639|NCT02256891|531138416|FG001|Overall Study|Screen Fail|4|||
147263640|NCT02256891|531138415|FG000|Overall Study|Equipment Malfunction|0|||
147263641|NCT02256891|531138416|FG001|Overall Study|Equipment Malfunction|1|||
147263642|NCT04171414|531138425|FG000|Overall Study|Death|1|||
147263643|NCT04171414|531138425|FG000|Overall Study|Withdrawal by Subject|1|||
147263644|NCT04920123|531138428|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|2|||
147263645|NCT04920123|531138429|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
147263646|NCT04920123|531138430|FG002|First Intervention (12 Weeks)|Withdrawal by Subject|2|||
147263647|NCT00218296|531138436|FG000|Overall Study|Lost to Follow-up|9|||
147263648|NCT00218296|531138437|FG001|Overall Study|Lost to Follow-up|7|||
147263649|NCT00218296|531138436|FG000|Overall Study|Withdrawal by Subject|36|||
147263650|NCT00218296|531138437|FG001|Overall Study|Withdrawal by Subject|47|||
147263651|NCT00218296|531138436|FG000|Overall Study|Randomized but did not enter treatment|66|||
147263652|NCT00218296|531138437|FG001|Overall Study|Randomized but did not enter treatment|67|||
147263653|NCT02586493|531138442|FG000|Overall Study|Adverse Event|4|||
147263654|NCT02586493|531138442|FG000|Overall Study|Protocol Violation|6|||
147263655|NCT02586493|531138442|FG000|Overall Study|Lost to Follow-up|1|||
147263656|NCT02586493|531138442|FG000|Overall Study|Withdrawal by Subject|1|||
147263657|NCT03412084|531138444|FG000|Overall Study|Withdrawal by Subject|2|||
147263658|NCT03412084|531138445|FG001|Overall Study|Withdrawal by Subject|0|||
147263659|NCT03412084|531138444|FG000|Overall Study|Participant moved|1|||
147263660|NCT03412084|531138445|FG001|Overall Study|Participant moved|0|||
147263661|NCT03412084|531138444|FG000|Overall Study|Lost to Follow-up|1|||
147263662|NCT03412084|531138445|FG001|Overall Study|Lost to Follow-up|1|||
147263663|NCT01928862|531138446|FG000|Overall Study|Lost to Follow-up|1|||
147263664|NCT01928862|531138447|FG001|Overall Study|Lost to Follow-up|0|||
147263665|NCT01928862|531138448|FG002|Overall Study|Lost to Follow-up|0|||
147263666|NCT01928862|531138449|FG003|Overall Study|Lost to Follow-up|0|||
147263667|NCT01928862|531138450|FG004|Overall Study|Lost to Follow-up|1|||
147263668|NCT02053753|531138454|FG000|Overall Study|Withdrawal by Subject|2|||
147263669|NCT02053753|531138455|FG001|Overall Study|Withdrawal by Subject|4|||
147263670|NCT02053753|531138454|FG000|Overall Study|Decision by Sponsor|1|||
147263671|NCT02053753|531138455|FG001|Overall Study|Decision by Sponsor|1|||
147263672|NCT02053753|531138454|FG000|Overall Study|Lost to Follow-up|4|||
147263673|NCT02053753|531138455|FG001|Overall Study|Lost to Follow-up|3|||
147263674|NCT02972632|531138456|FG000|Overall Study|Pretreatment Event/Adverse Event|3|||
147263675|NCT02972632|531138456|FG000|Overall Study|Lost to Follow-up|4|||
147263676|NCT02972632|531138456|FG000|Overall Study|Voluntary Withdrawal|10|||
147263677|NCT02023151|531138457|FG000|Overall Study|Lost to Follow-up|4|||
147263678|NCT04064294|531138458|FG000|Overall Study|Adverse Event|1|||
147263679|NCT04064294|531138459|FG001|Overall Study|Adverse Event|0|||
147263680|NCT04064294|531138460|FG002|Overall Study|Adverse Event|0|||
147263681|NCT03450707|531138461|FG000|Overall Study|Outside enrollment window|4|||
147263682|NCT03450707|531138462|FG001|Overall Study|Outside enrollment window|1|||
147263683|NCT03450707|531138461|FG000|Overall Study|Death|1|||
147263684|NCT03450707|531138462|FG001|Overall Study|Death|0|||
147263685|NCT03450707|531138461|FG000|Overall Study|Indication for thiamine|1|||
147263686|NCT03450707|531138462|FG001|Overall Study|Indication for thiamine|1|||
147263687|NCT03450707|531138461|FG000|Overall Study|Evidence of traumatic brain injury|1|||
147263688|NCT03450707|531138462|FG001|Overall Study|Evidence of traumatic brain injury|0|||
147263689|NCT03450707|531138461|FG000|Overall Study|Following commands|0|||
147263690|NCT03450707|531138462|FG001|Overall Study|Following commands|3|||
147263691|NCT03450707|531138461|FG000|Overall Study|Lactate < 3.5|0|||
147263692|NCT03450707|531138462|FG001|Overall Study|Lactate < 3.5|2|||
147263693|NCT03450707|531138461|FG000|Overall Study|Rearrest with ECMO|0|||
147263694|NCT03450707|531138462|FG001|Overall Study|Rearrest with ECMO|1|||
147263695|NCT03450707|531138461|FG000|Overall Study|Indication for thiamine + head CT results|0|||
147263696|NCT03450707|531138462|FG001|Overall Study|Indication for thiamine + head CT results|1|||
147263697|NCT03450707|531138461|FG000|Overall Study|Family/patient goals of care|0|||
147263698|NCT03450707|531138462|FG001|Overall Study|Family/patient goals of care|1|||
147263699|NCT00481195|531138463|FG000|Overall Study|Adverse Event|16|||
147263700|NCT00481195|531138464|FG001|Overall Study|Adverse Event|11|||
147263701|NCT00481195|531138463|FG000|Overall Study|Lack of Efficacy|1|||
147263702|NCT00481195|531138464|FG001|Overall Study|Lack of Efficacy|3|||
147263703|NCT00481195|531138463|FG000|Overall Study|Lost to Follow-up|4|||
147263704|NCT00481195|531138464|FG001|Overall Study|Lost to Follow-up|6|||
147263705|NCT00481195|531138463|FG000|Overall Study|Physician Decision|3|||
147263706|NCT00481195|531138464|FG001|Overall Study|Physician Decision|1|||
147263707|NCT00481195|531138463|FG000|Overall Study|Protocol Violation|10|||
147263708|NCT00481195|531138464|FG001|Overall Study|Protocol Violation|7|||
147263709|NCT00481195|531138463|FG000|Overall Study|Withdrawal by Subject|3|||
147263710|NCT00481195|531138464|FG001|Overall Study|Withdrawal by Subject|9|||
147263711|NCT00481195|531138463|FG000|Overall Study|Miscellaneous|2|||
147263712|NCT00481195|531138464|FG001|Overall Study|Miscellaneous|2|||
147263713|NCT02932904|531138471|FG000|Overall Study|Reason not Specified|1|||
147263714|NCT02932904|531138472|FG001|Overall Study|Reason not Specified|0|||
147263715|NCT02932904|531138473|FG002|Overall Study|Reason not Specified|2|||
147263716|NCT02932904|531138474|FG003|Overall Study|Reason not Specified|2|||
147263717|NCT02932904|531138471|FG000|Overall Study|Noncompliance with Study Drug|2|||
147263718|NCT02932904|531138472|FG001|Overall Study|Noncompliance with Study Drug|3|||
147263719|NCT02932904|531138473|FG002|Overall Study|Noncompliance with Study Drug|3|||
147263720|NCT02932904|531138474|FG003|Overall Study|Noncompliance with Study Drug|4|||
147263721|NCT02932904|531138471|FG000|Overall Study|Pregnancy|0|||
147263722|NCT02932904|531138472|FG001|Overall Study|Pregnancy|1|||
147263723|NCT02932904|531138473|FG002|Overall Study|Pregnancy|1|||
147263724|NCT02932904|531138474|FG003|Overall Study|Pregnancy|0|||
147263725|NCT02932904|531138471|FG000|Overall Study|Study Termination|0|||
147263726|NCT02932904|531138472|FG001|Overall Study|Study Termination|1|||
147263727|NCT02932904|531138473|FG002|Overall Study|Study Termination|0|||
147263728|NCT02932904|531138474|FG003|Overall Study|Study Termination|0|||
147263729|NCT02932904|531138471|FG000|Overall Study|Voluntary Withdrawal|2|||
147263730|NCT02932904|531138472|FG001|Overall Study|Voluntary Withdrawal|1|||
147263731|NCT02932904|531138473|FG002|Overall Study|Voluntary Withdrawal|4|||
147263732|NCT02932904|531138474|FG003|Overall Study|Voluntary Withdrawal|2|||
147263733|NCT02932904|531138471|FG000|Overall Study|Lost to Follow-up|5|||
147263734|NCT02932904|531138472|FG001|Overall Study|Lost to Follow-up|3|||
147263735|NCT02932904|531138473|FG002|Overall Study|Lost to Follow-up|6|||
147263736|NCT02932904|531138474|FG003|Overall Study|Lost to Follow-up|0|||
147263737|NCT02932904|531138471|FG000|Overall Study|Significant Protocol Deviation|2|||
147263738|NCT02932904|531138472|FG001|Overall Study|Significant Protocol Deviation|3|||
147263739|NCT02932904|531138473|FG002|Overall Study|Significant Protocol Deviation|6|||
147263740|NCT02932904|531138474|FG003|Overall Study|Significant Protocol Deviation|1|||
147263741|NCT02932904|531138471|FG000|Overall Study|Pretreatment Event/Adverse Event|3|||
147263742|NCT02932904|531138472|FG001|Overall Study|Pretreatment Event/Adverse Event|5|||
147263743|NCT02932904|531138473|FG002|Overall Study|Pretreatment Event/Adverse Event|1|||
147263744|NCT02932904|531138474|FG003|Overall Study|Pretreatment Event/Adverse Event|3|||
147263745|NCT02932904|531138471|FG000|Overall Study|Randomized But Not Treated|1|||
147263746|NCT02932904|531138472|FG001|Overall Study|Randomized But Not Treated|1|||
147263747|NCT02932904|531138473|FG002|Overall Study|Randomized But Not Treated|0|||
147263748|NCT02932904|531138474|FG003|Overall Study|Randomized But Not Treated|2|||
147263749|NCT00337103|531138478|FG000|Overall Study|Progressive Disease|414|||
147263750|NCT00337103|531138479|FG001|Overall Study|Progressive Disease|410|||
147263751|NCT00337103|531138478|FG000|Overall Study|Adverse Event|45|||
147263752|NCT00337103|531138479|FG001|Overall Study|Adverse Event|59|||
147263753|NCT00337103|531138478|FG000|Overall Study|Subject Choice|34|||
147263754|NCT00337103|531138479|FG001|Overall Study|Subject Choice|27|||
147263755|NCT00337103|531138478|FG000|Overall Study|Clinical Progression|27|||
147263756|NCT00337103|531138479|FG001|Overall Study|Clinical Progression|24|||
147263757|NCT00337103|531138478|FG000|Overall Study|Physician Decision|15|||
147263758|NCT00337103|531138479|FG001|Overall Study|Physician Decision|14|||
147263759|NCT00337103|531138478|FG000|Overall Study|Withdrawal by Subject|8|||
147263760|NCT00337103|531138479|FG001|Overall Study|Withdrawal by Subject|5|||
147263761|NCT00337103|531138478|FG000|Overall Study|Other|5|||
147263762|NCT00337103|531138479|FG001|Overall Study|Other|6|||
147263763|NCT00337103|531138478|FG000|Overall Study|Entry Criteria Not Met|4|||
147263764|NCT00337103|531138479|FG001|Overall Study|Entry Criteria Not Met|1|||
147263765|NCT00337103|531138478|FG000|Overall Study|Lost to Follow-up|1|||
147263766|NCT00337103|531138479|FG001|Overall Study|Lost to Follow-up|2|||
147263767|NCT00337103|531138478|FG000|Overall Study|Death|1|||
147263768|NCT00337103|531138479|FG001|Overall Study|Death|0|||
147263769|NCT02016482|531138480|FG000|Period A|Adverse Event|3|||
147263770|NCT02016482|531138481|FG001|Period A|Adverse Event|5|||
147263771|NCT02016482|531138480|FG000|Period A|Withdrawal by Subject|3|||
147263772|NCT02016482|531138481|FG001|Period A|Withdrawal by Subject|4|||
147263773|NCT02016482|531138480|FG000|Period A|Lost to Follow-up|3|||
147332915|NCT02299336|531385630|FG000|Overall Study|Lost to Follow-up|1|||
147263774|NCT02016482|531138481|FG001|Period A|Lost to Follow-up|3|||
147263775|NCT02016482|531138480|FG000|Period A|Lack of Efficacy|2|||
147263776|NCT02016482|531138481|FG001|Period A|Lack of Efficacy|1|||
147332916|NCT02106442|531385634|FG000|Overall Study|Case Report Forms Uncollected|7|||
147263777|NCT02016482|531138480|FG000|Period A|Other|3|||
147263778|NCT02016482|531138481|FG001|Period A|Other|0|||
147263779|NCT02016482|531138480|FG000|Period A|Protocol Violation|0|||
147263780|NCT02016482|531138481|FG001|Period A|Protocol Violation|1|||
147263781|NCT02016482|531138480|FG000|Period A|Required Alternative/Prohibited Therapy|0|||
147263782|NCT02016482|531138481|FG001|Period A|Required Alternative/Prohibited Therapy|1|||
147263783|NCT02016482|531138480|FG000|Period B|Withdrawal by Subject|1|||
147263784|NCT02016482|531138481|FG001|Period B|Withdrawal by Subject|1|||
147263785|NCT02016482|531138480|FG000|Period B|Lost to Follow-up|2|||
147263786|NCT02016482|531138481|FG001|Period B|Lost to Follow-up|0|||
147263787|NCT02016482|531138480|FG000|Period B|Lack of Efficacy|6|||
147263788|NCT02016482|531138481|FG001|Period B|Lack of Efficacy|4|||
147263789|NCT02016482|531138480|FG000|Period B|Other|4|||
147263790|NCT02016482|531138481|FG001|Period B|Other|0|||
147263791|NCT02016482|531138480|FG000|Period B|Required Alternative/Prohibited Therapy|0|||
147263792|NCT02016482|531138481|FG001|Period B|Required Alternative/Prohibited Therapy|2|||
147263793|NCT01289847|531138482|FG000|Overall Study|Patient could not comply with visits|1|||
147263794|NCT03975647|531138495|FG000|Overall Study|Death|71|||
147263795|NCT03975647|531138496|FG001|Overall Study|Death|63|||
147263796|NCT03975647|531138495|FG000|Overall Study|Lost to Follow-up|2|||
147263797|NCT03975647|531138496|FG001|Overall Study|Lost to Follow-up|2|||
147263798|NCT03975647|531138495|FG000|Overall Study|Subject withdrawal of consent|7|||
147263799|NCT03975647|531138496|FG001|Overall Study|Subject withdrawal of consent|11|||
147263800|NCT02965703|531138507|FG000|Overall Study|Withdrawal by Subject|6|||
147263801|NCT02965703|531138508|FG001|Overall Study|Withdrawal by Subject|3|||
147263802|NCT02965703|531138509|FG002|Overall Study|Withdrawal by Subject|1|||
147263803|NCT02965703|531138507|FG000|Overall Study|Protocol Violation|1|||
147450169|NCT00464334|531811381|FG008|Overall Study|Lost to Follow-up|0|||
147450170|NCT00464334|531811382|FG009|Overall Study|Lost to Follow-up|0|||
147450171|NCT00464334|531811383|FG010|Overall Study|Lost to Follow-up|2|||
147450172|NCT00464334|531811373|FG000|Overall Study|Progressive Disease|0|||
147450173|NCT00464334|531811374|FG001|Overall Study|Progressive Disease|0|||
147450174|NCT00464334|531811375|FG002|Overall Study|Progressive Disease|0|||
147450175|NCT00464334|531811376|FG003|Overall Study|Progressive Disease|0|||
147450176|NCT00464334|531811377|FG004|Overall Study|Progressive Disease|0|||
147450177|NCT00464334|531811378|FG005|Overall Study|Progressive Disease|1|||
147450178|NCT00464334|531811379|FG006|Overall Study|Progressive Disease|0|||
147450179|NCT00464334|531811380|FG007|Overall Study|Progressive Disease|0|||
147450180|NCT00464334|531811381|FG008|Overall Study|Progressive Disease|1|||
147450181|NCT00464334|531811382|FG009|Overall Study|Progressive Disease|0|||
147450182|NCT00464334|531811383|FG010|Overall Study|Progressive Disease|0|||
147450183|NCT00464334|531811373|FG000|Overall Study|Study Terminated by Sponsor|0|||
147450184|NCT00464334|531811374|FG001|Overall Study|Study Terminated by Sponsor|0|||
147450185|NCT00464334|531811375|FG002|Overall Study|Study Terminated by Sponsor|0|||
147450186|NCT00464334|531811376|FG003|Overall Study|Study Terminated by Sponsor|1|||
147450187|NCT00464334|531811377|FG004|Overall Study|Study Terminated by Sponsor|0|||
147450188|NCT00464334|531811378|FG005|Overall Study|Study Terminated by Sponsor|0|||
147450189|NCT00464334|531811379|FG006|Overall Study|Study Terminated by Sponsor|0|||
147450190|NCT00464334|531811380|FG007|Overall Study|Study Terminated by Sponsor|0|||
147450191|NCT00464334|531811381|FG008|Overall Study|Study Terminated by Sponsor|0|||
147450192|NCT00464334|531811382|FG009|Overall Study|Study Terminated by Sponsor|0|||
147450193|NCT00464334|531811383|FG010|Overall Study|Study Terminated by Sponsor|0|||
147450194|NCT00464334|531811373|FG000|Overall Study|Withdrawal by Subject|1|||
147450195|NCT00464334|531811374|FG001|Overall Study|Withdrawal by Subject|7|||
147263804|NCT02965703|531138508|FG001|Overall Study|Protocol Violation|0|||
147263805|NCT02965703|531138509|FG002|Overall Study|Protocol Violation|0|||
147263806|NCT02965703|531138507|FG000|Overall Study|Adverse Event|1|||
147263807|NCT02965703|531138508|FG001|Overall Study|Adverse Event|1|||
147263808|NCT02965703|531138509|FG002|Overall Study|Adverse Event|0|||
147263809|NCT02965703|531138507|FG000|Overall Study|Lost to Follow-up|2|||
147263810|NCT02965703|531138508|FG001|Overall Study|Lost to Follow-up|1|||
147263811|NCT02965703|531138509|FG002|Overall Study|Lost to Follow-up|1|||
147263812|NCT01471379|531138510|FG000|Overall Study|Adverse Event|1|||
147263813|NCT01471379|531138511|FG001|Overall Study|Adverse Event|0|||
147263814|NCT01471379|531138512|FG002|Overall Study|Adverse Event|0|||
147450196|NCT00464334|531811375|FG002|Overall Study|Withdrawal by Subject|4|||
147450197|NCT00464334|531811376|FG003|Overall Study|Withdrawal by Subject|2|||
147450198|NCT00464334|531811377|FG004|Overall Study|Withdrawal by Subject|2|||
147450199|NCT00464334|531811378|FG005|Overall Study|Withdrawal by Subject|2|||
147450200|NCT00464334|531811379|FG006|Overall Study|Withdrawal by Subject|2|||
147450201|NCT00464334|531811380|FG007|Overall Study|Withdrawal by Subject|1|||
147263815|NCT01471379|531138510|FG000|Overall Study|Study terminated|0|||
147263816|NCT01471379|531138511|FG001|Overall Study|Study terminated|1|||
147450202|NCT00464334|531811381|FG008|Overall Study|Withdrawal by Subject|3|||
147450203|NCT00464334|531811382|FG009|Overall Study|Withdrawal by Subject|0|||
147450204|NCT00464334|531811383|FG010|Overall Study|Withdrawal by Subject|0|||
147450205|NCT02898259|531811386|FG000|Overall Study|Adverse Event|0|||
147450206|NCT02898259|531811387|FG001|Overall Study|Adverse Event|0|||
147450207|NCT02898259|531811388|FG002|Overall Study|Adverse Event|1|||
147450208|NCT02898259|531811389|FG003|Overall Study|Adverse Event|0|||
147662247|NCT00689338|532585698|FG000|Overall Study|Protocol Violation|15|||
147263817|NCT01471379|531138512|FG002|Overall Study|Study terminated|0|||
147263818|NCT03745144|531138513|FG000|Run-in-Period (Day 0 to Day 28)|Other|4|||
147450209|NCT02898259|531811390|FG004|Overall Study|Adverse Event|0|||
147263819|NCT03745144|531138514|FG001|Run-in-Period (Day 0 to Day 28)|Other|0|||
147263820|NCT03745144|531138515|FG002|Run-in-Period (Day 0 to Day 28)|Other|0|||
147263821|NCT03745144|531138513|FG000|Period 1|Other|0|||
147263822|NCT03745144|531138514|FG001|Period 1|Other|0|||
147263823|NCT03745144|531138515|FG002|Period 1|Other|1|||
147263824|NCT01124643|531138526|FG000|Overall Study|Death|1|||
147263825|NCT01342510|531138527|FG000|Overall Study|Protocol Violation|12|||
147263826|NCT01342510|531138528|FG001|Overall Study|Protocol Violation|6|||
147263827|NCT01342510|531138529|FG002|Overall Study|Protocol Violation|13|||
147263828|NCT01342510|531138530|FG003|Overall Study|Protocol Violation|11|||
147263829|NCT05756790|531138531|FG000|Overall Study|Withdrawal by Subject|1|||
147263830|NCT05756790|531138532|FG001|Overall Study|Withdrawal by Subject|1|||
147263831|NCT05756790|531138533|FG002|Overall Study|Withdrawal by Subject|1|||
147263832|NCT05756790|531138534|FG003|Overall Study|Withdrawal by Subject|1|||
147263833|NCT05756790|531138535|FG004|Overall Study|Withdrawal by Subject|0|||
147263834|NCT05756790|531138536|FG005|Overall Study|Withdrawal by Subject|0|||
147263835|NCT05756790|531138531|FG000|Overall Study|Protocol Violation|0|||
147263836|NCT05756790|531138532|FG001|Overall Study|Protocol Violation|0|||
147263837|NCT05756790|531138533|FG002|Overall Study|Protocol Violation|1|||
147263838|NCT05756790|531138534|FG003|Overall Study|Protocol Violation|1|||
147263839|NCT05756790|531138535|FG004|Overall Study|Protocol Violation|0|||
147263840|NCT05756790|531138536|FG005|Overall Study|Protocol Violation|0|||
147263841|NCT05756790|531138531|FG000|Overall Study|Ineligible|0|||
147263842|NCT05756790|531138532|FG001|Overall Study|Ineligible|0|||
147263843|NCT05756790|531138533|FG002|Overall Study|Ineligible|0|||
147263844|NCT05756790|531138534|FG003|Overall Study|Ineligible|0|||
147263845|NCT05756790|531138535|FG004|Overall Study|Ineligible|2|||
147263846|NCT05756790|531138536|FG005|Overall Study|Ineligible|2|||
147263847|NCT00228917|531139935|FG000|Overall Study|Migrated/moved from study area|0|||
147263848|NCT00228917|531139936|FG001|Overall Study|Migrated/moved from study area|0|||
147263849|NCT00228917|531139937|FG002|Overall Study|Migrated/moved from study area|0|||
147263850|NCT00228917|531139938|FG003|Overall Study|Migrated/moved from study area|0|||
147263851|NCT00228917|531139939|FG004|Overall Study|Migrated/moved from study area|0|||
147263852|NCT00228917|531139940|FG005|Overall Study|Migrated/moved from study area|2|||
147263853|NCT00228917|531139941|FG006|Overall Study|Migrated/moved from study area|0|||
147263854|NCT00228917|531139942|FG007|Overall Study|Migrated/moved from study area|0|||
147263855|NCT00409617|531139943|FG000|Overall Study|Adverse Event|57|||
147263856|NCT00409617|531139943|FG000|Overall Study|Lack of Efficacy|54|||
147263857|NCT00409617|531139943|FG000|Overall Study|Lost to Follow-up|2|||
147263858|NCT00409617|531139943|FG000|Overall Study|Protocol Violation|24|||
147263859|NCT00409617|531139943|FG000|Overall Study|Withdrawal by Subject|8|||
147263860|NCT00409617|531139943|FG000|Overall Study|Administrative reasons|1|||
147263861|NCT00409617|531139943|FG000|Overall Study|Not described|14|||
147263862|NCT00149747|531139949|FG000|Overall Study|Death|1|||
147263863|NCT00149747|531139950|FG001|Overall Study|Death|0|||
147263864|NCT00149747|531139949|FG000|Overall Study|Withdrawal by Subject|3|||
147263865|NCT00149747|531139950|FG001|Overall Study|Withdrawal by Subject|3|||
147263866|NCT01085097|531139959|FG000|Overall Study|Adverse Event|0|||
147263867|NCT01085097|531139960|FG001|Overall Study|Adverse Event|0|||
147263868|NCT01085097|531139961|FG002|Overall Study|Adverse Event|2|||
147263869|NCT01085097|531139959|FG000|Overall Study|Treatment failure|2|||
147263870|NCT01085097|531139960|FG001|Overall Study|Treatment failure|0|||
147263871|NCT01085097|531139961|FG002|Overall Study|Treatment failure|0|||
147263872|NCT03742141|531139966|FG000|Overall Study|no surgery or post-operative laryngoscopy|50|||
147263873|NCT00850395|531139971|FG000|Overall Study|Death|1|||
147263874|NCT00850395|531139971|FG000|Overall Study|Adverse Event|1|||
147263875|NCT00850395|531139971|FG000|Overall Study|Insufficient clinical response|3|||
147263876|NCT00850395|531139971|FG000|Overall Study|Other|5|||
147263877|NCT06049043|531139972|FG000|Overall Study|Lost to Follow-up|11|||
147263878|NCT06049043|531139973|FG001|Overall Study|Lost to Follow-up|9|||
147263879|NCT01354496|531139980|FG000|Period 1|Adverse Event|0|||
147263880|NCT01354496|531139981|FG001|Period 1|Adverse Event|0|||
147263881|NCT01354496|531139982|FG002|Period 1|Adverse Event|1|||
147263882|NCT01354496|531139983|FG003|Period 1|Adverse Event|0|||
147263883|NCT01354496|531139984|FG004|Period 1|Adverse Event|0|||
147263884|NCT01354496|531139985|FG005|Period 1|Adverse Event|0|||
147263885|NCT01354496|531139980|FG000|Period 1|Physician Decision|0|||
147332917|NCT02106442|531385634|FG000|Overall Study|Protocol Deviation|30|||
147450210|NCT02898259|531811386|FG000|Overall Study|Lack of Efficacy|1|||
147263886|NCT01354496|531139981|FG001|Period 1|Physician Decision|0|||
147263887|NCT01354496|531139982|FG002|Period 1|Physician Decision|1|||
147263888|NCT01354496|531139983|FG003|Period 1|Physician Decision|0|||
147263889|NCT01354496|531139984|FG004|Period 1|Physician Decision|0|||
147263890|NCT01354496|531139985|FG005|Period 1|Physician Decision|0|||
147263891|NCT01354496|531139980|FG000|Period 2|Adverse Event|0|||
147263892|NCT01354496|531139981|FG001|Period 2|Adverse Event|0|||
147263893|NCT01354496|531139982|FG002|Period 2|Adverse Event|0|||
147263894|NCT01354496|531139983|FG003|Period 2|Adverse Event|1|||
147263895|NCT01354496|531139984|FG004|Period 2|Adverse Event|0|||
147263896|NCT01354496|531139985|FG005|Period 2|Adverse Event|0|||
147263897|NCT01354496|531139980|FG000|Washout (at Least 14 Days)|Scheduling Conflict|0|||
147263898|NCT01354496|531139981|FG001|Washout (at Least 14 Days)|Scheduling Conflict|1|||
147263899|NCT01354496|531139982|FG002|Washout (at Least 14 Days)|Scheduling Conflict|0|||
147263900|NCT01354496|531139983|FG003|Washout (at Least 14 Days)|Scheduling Conflict|1|||
147263901|NCT01354496|531139984|FG004|Washout (at Least 14 Days)|Scheduling Conflict|0|||
147263902|NCT01354496|531139985|FG005|Washout (at Least 14 Days)|Scheduling Conflict|0|||
147263903|NCT01524692|531139986|FG000|Overall Study|Withdrawal by Subject|3|||
147263904|NCT03190889|531139987|FG000|Overall Study|Lost to Follow-up|7|||
147263905|NCT03190889|531139988|FG001|Overall Study|Lost to Follow-up|7|||
147263906|NCT03190889|531139989|FG002|Overall Study|Lost to Follow-up|3|||
147263907|NCT03190889|531139987|FG000|Overall Study|Withdrawal by Subject|1|||
147263908|NCT03190889|531139988|FG001|Overall Study|Withdrawal by Subject|1|||
147263909|NCT03190889|531139989|FG002|Overall Study|Withdrawal by Subject|2|||
147263910|NCT03190889|531139987|FG000|Overall Study|Did not complete protocol|4|||
147599934|NCT01150890|532352533|FG003|Overall Study|Adverse Event|0|||
147599935|NCT01150890|532352530|FG000|Overall Study|Withdrawal by Subject|0|||
147599936|NCT01150890|532352531|FG001|Overall Study|Withdrawal by Subject|0|||
147599937|NCT01150890|532352532|FG002|Overall Study|Withdrawal by Subject|2|||
147599938|NCT01150890|532352533|FG003|Overall Study|Withdrawal by Subject|1|||
147263911|NCT03190889|531139988|FG001|Overall Study|Did not complete protocol|9|||
147263912|NCT03190889|531139989|FG002|Overall Study|Did not complete protocol|0|||
147263913|NCT03190889|531139987|FG000|Overall Study|COVID-19|1|||
147263914|NCT03190889|531139988|FG001|Overall Study|COVID-19|0|||
147263915|NCT03190889|531139989|FG002|Overall Study|COVID-19|2|||
147263916|NCT04007523|531139990|FG000|Overall Study|Withdrawal by Subject|0|||
147263917|NCT04007523|531139991|FG001|Overall Study|Withdrawal by Subject|1|||
147263918|NCT04007523|531139992|FG002|Overall Study|Withdrawal by Subject|1|||
147263919|NCT04007523|531139993|FG003|Overall Study|Withdrawal by Subject|0|||
147263920|NCT04007523|531139990|FG000|Overall Study|ICU Transfer|0|||
147263921|NCT04007523|531139991|FG001|Overall Study|ICU Transfer|1|||
147263922|NCT04007523|531139992|FG002|Overall Study|ICU Transfer|0|||
147263923|NCT04007523|531139993|FG003|Overall Study|ICU Transfer|0|||
147263924|NCT04007523|531139990|FG000|Overall Study|COVID hospital closure|0|||
147263925|NCT04007523|531139991|FG001|Overall Study|COVID hospital closure|0|||
147263926|NCT04007523|531139992|FG002|Overall Study|COVID hospital closure|1|||
147263927|NCT04007523|531139993|FG003|Overall Study|COVID hospital closure|2|||
147263928|NCT04007523|531139990|FG000|Overall Study|Surgery cancelled|0|||
147263929|NCT04007523|531139991|FG001|Overall Study|Surgery cancelled|0|||
147263930|NCT04007523|531139992|FG002|Overall Study|Surgery cancelled|1|||
147263931|NCT04007523|531139993|FG003|Overall Study|Surgery cancelled|1|||
147263932|NCT02136576|531139995|FG000|Overall Study|Lost to Follow-up|2|||
147263933|NCT02136576|531139996|FG001|Overall Study|Lost to Follow-up|0|||
147263934|NCT02136576|531139997|FG002|Overall Study|Lost to Follow-up|0|||
147263935|NCT02197806|531139998|FG000|Overall Study|Adverse Event|0|||
147263936|NCT02197806|531139999|FG001|Overall Study|Adverse Event|1|||
147263937|NCT02197806|531140000|FG002|Overall Study|Adverse Event|0|||
147263938|NCT02197806|531140001|FG003|Overall Study|Adverse Event|1|||
147263939|NCT00537381|531140003|FG000|Overall Study|Adverse Event|13|||
147263940|NCT00537381|531140004|FG001|Overall Study|Adverse Event|9|||
147263941|NCT00537381|531140003|FG000|Overall Study|Death|3|||
147263942|NCT00537381|531140004|FG001|Overall Study|Death|3|||
147263943|NCT00537381|531140003|FG000|Overall Study|Withdrawal by Subject|5|||
147263944|NCT00537381|531140004|FG001|Overall Study|Withdrawal by Subject|14|||
147263945|NCT00537381|531140003|FG000|Overall Study|Physician Decision|7|||
147263946|NCT00537381|531140004|FG001|Overall Study|Physician Decision|6|||
147263947|NCT00537381|531140003|FG000|Overall Study|Disease Progression|9|||
147263948|NCT00537381|531140004|FG001|Overall Study|Disease Progression|18|||
147263949|NCT00537381|531140003|FG000|Overall Study|Sponsor decision|14|||
147263950|NCT00537381|531140004|FG001|Overall Study|Sponsor decision|9|||
147263951|NCT00537381|531140003|FG000|Overall Study|Other|5|||
147263952|NCT00537381|531140004|FG001|Overall Study|Other|3|||
147263953|NCT00500292|531140011|FG000|Overall Study|Adverse Event|3|||
147263954|NCT00500292|531140012|FG001|Overall Study|Adverse Event|6|||
147599939|NCT01150890|532352530|FG000|Overall Study|Disease progression|0|||
147263955|NCT00500292|531140013|FG002|Overall Study|Adverse Event|4|||
147263956|NCT00500292|531140011|FG000|Overall Study|Condition under investigation worsened|21|||
147263957|NCT00500292|531140012|FG001|Overall Study|Condition under investigation worsened|23|||
147263958|NCT00500292|531140013|FG002|Overall Study|Condition under investigation worsened|19|||
147263959|NCT00500292|531140011|FG000|Overall Study|Withdrawal by Subject|0|||
147263960|NCT00500292|531140012|FG001|Overall Study|Withdrawal by Subject|1|||
147263961|NCT00500292|531140013|FG002|Overall Study|Withdrawal by Subject|0|||
147263962|NCT00500292|531140011|FG000|Overall Study|Other|1|||
147263963|NCT00500292|531140012|FG001|Overall Study|Other|1|||
147263964|NCT00500292|531140013|FG002|Overall Study|Other|4|||
147263965|NCT03065244|531140014|FG000|Overall Study|Lost to Follow-up|1|||
147263966|NCT03065244|531140015|FG001|Overall Study|Lost to Follow-up|1|||
147450211|NCT02898259|531811387|FG001|Overall Study|Lack of Efficacy|1|||
147263967|NCT03065244|531140014|FG000|Overall Study|Diagnosed with a different disease|1|||
147450212|NCT02898259|531811388|FG002|Overall Study|Lack of Efficacy|3|||
147263968|NCT03065244|531140015|FG001|Overall Study|Diagnosed with a different disease|1|||
147263969|NCT03065244|531140014|FG000|Overall Study|Protocol Violation|0|||
147263970|NCT03065244|531140015|FG001|Overall Study|Protocol Violation|1|||
147263971|NCT03065244|531140014|FG000|Overall Study|Withdrawal by Subject|1|||
147263972|NCT03065244|531140015|FG001|Overall Study|Withdrawal by Subject|1|||
147263973|NCT03717480|531140016|FG000|Overall Study|Never received investigational product due to product viability limitations.|1|||
147263974|NCT01708174|531140017|FG000|Treatment Period|Withdrawal by Subject|1|||
147263975|NCT01708174|531140018|FG001|Treatment Period|Withdrawal by Subject|0|||
147263976|NCT01708174|531140019|FG002|Treatment Period|Withdrawal by Subject|0|||
147263977|NCT01708174|531140017|FG000|Treatment Period|Progressive disease|0|||
147263978|NCT01708174|531140018|FG001|Treatment Period|Progressive disease|1|||
147263979|NCT01708174|531140019|FG002|Treatment Period|Progressive disease|0|||
147263980|NCT01708174|531140017|FG000|Treatment Period|Death|0|||
147263981|NCT01708174|531140018|FG001|Treatment Period|Death|0|||
147263982|NCT01708174|531140019|FG002|Treatment Period|Death|1|||
147263983|NCT01708174|531140017|FG000|Treatment Period|Adverse Event|0|||
147263984|NCT01708174|531140018|FG001|Treatment Period|Adverse Event|1|||
147263985|NCT01708174|531140019|FG002|Treatment Period|Adverse Event|0|||
147263986|NCT01894152|531140020|FG000|Overall Study|No DMR and no Stent thrombosis|151|||
147263987|NCT02741700|531140021|FG000|Overall Study|Lost to Follow-up|17|||
147263988|NCT02741700|531140022|FG001|Overall Study|Lost to Follow-up|8|||
147263989|NCT02741700|531140021|FG000|Overall Study|Withdrawal by Subject|2|||
147263990|NCT02741700|531140022|FG001|Overall Study|Withdrawal by Subject|5|||
147263991|NCT02741700|531140021|FG000|Overall Study|Physician Decision|3|||
147263992|NCT02741700|531140022|FG001|Overall Study|Physician Decision|0|||
147599940|NCT01150890|532352531|FG001|Overall Study|Disease progression|7|||
147599941|NCT01150890|532352532|FG002|Overall Study|Disease progression|3|||
147599942|NCT01150890|532352533|FG003|Overall Study|Disease progression|7|||
147263993|NCT02741700|531140021|FG000|Overall Study|Moved out of State|0|||
147263994|NCT02741700|531140022|FG001|Overall Study|Moved out of State|1|||
147263995|NCT02741700|531140021|FG000|Overall Study|Death|4|||
147263996|NCT02741700|531140022|FG001|Overall Study|Death|5|||
147263997|NCT00923559|531140023|FG000|Overall Study|Lost to Follow-up|2|||
147263998|NCT00923559|531140024|FG001|Overall Study|Lost to Follow-up|3|||
147263999|NCT01774786|531140025|FG000|Overall Study|Death|300|||
147264000|NCT01774786|531140026|FG001|Overall Study|Death|319|||
147264001|NCT01774786|531140025|FG000|Overall Study|Lost to Follow-up|6|||
147264002|NCT01774786|531140026|FG001|Overall Study|Lost to Follow-up|7|||
147264003|NCT01774786|531140025|FG000|Overall Study|Withdrawal by Subject|18|||
147264004|NCT01774786|531140026|FG001|Overall Study|Withdrawal by Subject|14|||
147264005|NCT01774786|531140025|FG000|Overall Study|Physician Decision|2|||
147264006|NCT01774786|531140026|FG001|Overall Study|Physician Decision|0|||
147264007|NCT01774786|531140025|FG000|Overall Study|Non-compliance|0|||
147264008|NCT01774786|531140026|FG001|Overall Study|Non-compliance|1|||
147264009|NCT01774786|531140025|FG000|Overall Study|Reason Not Specified|2|||
147264010|NCT01774786|531140026|FG001|Overall Study|Reason Not Specified|5|||
147264011|NCT02268812|531140027|FG000|Overall Study|Adverse Event|8|||
147264012|NCT02268812|531140028|FG001|Overall Study|Adverse Event|26|||
147264013|NCT02268812|531140029|FG002|Overall Study|Adverse Event|7|||
147264014|NCT02268812|531140030|FG003|Overall Study|Adverse Event|10|||
147264015|NCT02268812|531140027|FG000|Overall Study|Protocol deviation|0|||
147264016|NCT02268812|531140028|FG001|Overall Study|Protocol deviation|0|||
147264017|NCT02268812|531140029|FG002|Overall Study|Protocol deviation|1|||
147264018|NCT02268812|531140030|FG003|Overall Study|Protocol deviation|0|||
147264019|NCT02268812|531140027|FG000|Overall Study|Withdrawal by Subject|0|||
147264020|NCT02268812|531140028|FG001|Overall Study|Withdrawal by Subject|1|||
147264021|NCT02268812|531140029|FG002|Overall Study|Withdrawal by Subject|0|||
147264022|NCT02268812|531140030|FG003|Overall Study|Withdrawal by Subject|0|||
147264023|NCT02268812|531140027|FG000|Overall Study|Physician Decision|3|||
147264024|NCT02268812|531140028|FG001|Overall Study|Physician Decision|1|||
147264025|NCT02268812|531140029|FG002|Overall Study|Physician Decision|0|||
147264026|NCT02268812|531140030|FG003|Overall Study|Physician Decision|1|||
147264027|NCT02268812|531140027|FG000|Overall Study|Other|5|||
147264028|NCT02268812|531140028|FG001|Overall Study|Other|4|||
147264029|NCT02268812|531140029|FG002|Overall Study|Other|1|||
147264030|NCT02268812|531140030|FG003|Overall Study|Other|3|||
147264031|NCT04544293|531140031|FG000|Double-blind|Adverse Event|2|||
147264032|NCT04544293|531140032|FG001|Double-blind|Adverse Event|1|||
147264033|NCT04544293|531140031|FG000|Double-blind|Pregnancy|0|||
147264034|NCT04544293|531140032|FG001|Double-blind|Pregnancy|1|||
147264035|NCT04544293|531140031|FG000|Double-blind|Lost to Follow-up|0|||
147599943|NCT05424042|532356260|FG000|Overall Study|Withdrawal by Subject|2|||
147264036|NCT04544293|531140032|FG001|Double-blind|Lost to Follow-up|1|||
147264037|NCT04544293|531140031|FG000|Open-Label Extension|Study ongoing|79|||
147264038|NCT04544293|531140032|FG001|Open-Label Extension|Study ongoing|81|||
147264039|NCT01951157|531140038|FG000|Overall Study|Progressive Disease|12|||
147264040|NCT01951157|531140039|FG001|Overall Study|Progressive Disease|13|||
147264041|NCT01951157|531140040|FG002|Overall Study|Progressive Disease|10|||
147264042|NCT01951157|531140038|FG000|Overall Study|Treatment-unrelated AE|1|||
147643974|NCT01447446|532516690|FG004|Overall Study|Death|7|||
147264043|NCT01951157|531140039|FG001|Overall Study|Treatment-unrelated AE|0|||
147264044|NCT01951157|531140040|FG002|Overall Study|Treatment-unrelated AE|3|||
147264045|NCT01951157|531140038|FG000|Overall Study|Study Termination|0|||
147264046|NCT01951157|531140039|FG001|Overall Study|Study Termination|0|||
147264047|NCT01951157|531140040|FG002|Overall Study|Study Termination|1|||
147264048|NCT01951157|531140038|FG000|Overall Study|Physician Decision|5|||
147264049|NCT01951157|531140039|FG001|Overall Study|Physician Decision|3|||
147264050|NCT01951157|531140040|FG002|Overall Study|Physician Decision|2|||
147264051|NCT01951157|531140038|FG000|Overall Study|Non-treatmentrelated death|2|||
147264052|NCT01951157|531140039|FG001|Overall Study|Non-treatmentrelated death|2|||
147264053|NCT01951157|531140040|FG002|Overall Study|Non-treatmentrelated death|2|||
147264054|NCT01951157|531140038|FG000|Overall Study|No treated|0|||
147264055|NCT01951157|531140039|FG001|Overall Study|No treated|1|||
147264056|NCT01951157|531140040|FG002|Overall Study|No treated|0|||
147264057|NCT01951157|531140038|FG000|Overall Study|Treatment-related AE|2|||
147264058|NCT01951157|531140039|FG001|Overall Study|Treatment-related AE|0|||
147264059|NCT01951157|531140040|FG002|Overall Study|Treatment-related AE|4|||
147264060|NCT01951157|531140038|FG000|Overall Study|Consent withdrawn by subject|0|||
147264061|NCT01951157|531140039|FG001|Overall Study|Consent withdrawn by subject|1|||
147264062|NCT01951157|531140040|FG002|Overall Study|Consent withdrawn by subject|3|||
147264063|NCT01951157|531140038|FG000|Overall Study|Treatment-related death|0|||
147264064|NCT01951157|531140039|FG001|Overall Study|Treatment-related death|2|||
147264065|NCT01951157|531140040|FG002|Overall Study|Treatment-related death|0|||
147264066|NCT00744627|531140041|FG000|Overall Study|Adverse Event|6|||
147264067|NCT00744627|531140042|FG001|Overall Study|Adverse Event|9|||
147264068|NCT00744627|531140041|FG000|Overall Study|Lack of Efficacy|7|||
147264069|NCT00744627|531140042|FG001|Overall Study|Lack of Efficacy|3|||
147264070|NCT00744627|531140041|FG000|Overall Study|Noncompliance|0|||
147264071|NCT00744627|531140042|FG001|Overall Study|Noncompliance|1|||
147264072|NCT00744627|531140041|FG000|Overall Study|Protocol Deviations|0|||
147264073|NCT00744627|531140042|FG001|Overall Study|Protocol Deviations|2|||
147264074|NCT00744627|531140041|FG000|Overall Study|Voluntary Withdrawal|9|||
147264075|NCT00744627|531140042|FG001|Overall Study|Voluntary Withdrawal|6|||
147264076|NCT00744627|531140041|FG000|Overall Study|Lost to Follow-up|2|||
147264077|NCT00744627|531140042|FG001|Overall Study|Lost to Follow-up|1|||
147264078|NCT00744627|531140041|FG000|Overall Study|Other|1|||
147264079|NCT00744627|531140042|FG001|Overall Study|Other|0|||
147264080|NCT02268786|531140043|FG000|Overall Study|No Euploid Embryos available|42|||
147264081|NCT02268786|531140044|FG001|Overall Study|No Euploid Embryos available|0|||
147264082|NCT02268786|531140043|FG000|Overall Study|Withdrawal by Subject|7|||
147264083|NCT02268786|531140044|FG001|Overall Study|Withdrawal by Subject|14|||
147264084|NCT02268786|531140043|FG000|Overall Study|Thaw Failure|6|||
147264085|NCT02268786|531140044|FG001|Overall Study|Thaw Failure|4|||
147264086|NCT02268786|531140043|FG000|Overall Study|Protocol Violation|1|||
147264087|NCT02268786|531140044|FG001|Overall Study|Protocol Violation|0|||
147264088|NCT01062555|531140046|FG000|Phase 1|Death|10|||
147264089|NCT01062555|531140047|FG001|Phase 1|Death|17|||
147264090|NCT01062555|531140048|FG002|Phase 1|Death|0|||
147264091|NCT01062555|531140049|FG003|Phase 1|Death|0|||
147264092|NCT01062555|531140046|FG000|Phase 1|Graft Failure|12|||
147264093|NCT01062555|531140047|FG001|Phase 1|Graft Failure|8|||
147264094|NCT01062555|531140048|FG002|Phase 1|Graft Failure|0|||
147264095|NCT01062555|531140049|FG003|Phase 1|Graft Failure|0|||
147264096|NCT01062555|531140046|FG000|Phase 1|Withdrawal by Subject|1|||
147264097|NCT01062555|531140047|FG001|Phase 1|Withdrawal by Subject|1|||
147264098|NCT01062555|531140048|FG002|Phase 1|Withdrawal by Subject|0|||
147264099|NCT01062555|531140049|FG003|Phase 1|Withdrawal by Subject|0|||
147264100|NCT01062555|531140046|FG000|Phase 2|Death|0|||
147264101|NCT01062555|531140047|FG001|Phase 2|Death|0|||
147264102|NCT01062555|531140048|FG002|Phase 2|Death|8|||
147264103|NCT01062555|531140049|FG003|Phase 2|Death|3|||
147264104|NCT01062555|531140046|FG000|Phase 2|Graft failure|0|||
147264105|NCT01062555|531140047|FG001|Phase 2|Graft failure|0|||
147264106|NCT01062555|531140048|FG002|Phase 2|Graft failure|7|||
147264107|NCT01062555|531140049|FG003|Phase 2|Graft failure|4|||
147264108|NCT01062555|531140046|FG000|Phase 2|Withdrawal by Subject|0|||
147264109|NCT01062555|531140047|FG001|Phase 2|Withdrawal by Subject|0|||
147264110|NCT01062555|531140048|FG002|Phase 2|Withdrawal by Subject|0|||
147264111|NCT01062555|531140049|FG003|Phase 2|Withdrawal by Subject|7|||
147264112|NCT01062555|531140046|FG000|Phase 2|Protocol Violation|0|||
147264113|NCT01062555|531140047|FG001|Phase 2|Protocol Violation|0|||
147264114|NCT01062555|531140048|FG002|Phase 2|Protocol Violation|0|||
147264115|NCT01062555|531140049|FG003|Phase 2|Protocol Violation|3|||
147264116|NCT01062555|531140046|FG000|Phase 2|Physician Decision|0|||
147264117|NCT01062555|531140047|FG001|Phase 2|Physician Decision|0|||
147264118|NCT01062555|531140048|FG002|Phase 2|Physician Decision|0|||
147264119|NCT01062555|531140049|FG003|Phase 2|Physician Decision|17|||
147264120|NCT03560531|531140050|FG000|Overall Study|Death|4|||
147264121|NCT03560531|531140051|FG001|Overall Study|Death|1|||
147264122|NCT03560531|531140052|FG002|Overall Study|Death|1|||
147264123|NCT03560531|531140053|FG003|Overall Study|Death|2|||
147264124|NCT03560531|531140054|FG004|Overall Study|Death|6|||
147264125|NCT03560531|531140055|FG005|Overall Study|Death|1|||
147264126|NCT03560531|531140056|FG006|Overall Study|Death|4|||
147264127|NCT03560531|531140057|FG007|Overall Study|Death|8|||
147264128|NCT03560531|531140058|FG008|Overall Study|Death|1|||
147264129|NCT03560531|531140059|FG009|Overall Study|Death|3|||
147264130|NCT03560531|531140060|FG010|Overall Study|Death|2|||
147264131|NCT03560531|531140061|FG011|Overall Study|Death|0|||
147264132|NCT03560531|531140062|FG012|Overall Study|Death|4|||
147264133|NCT03560531|531140063|FG013|Overall Study|Death|1|||
147264134|NCT03560531|531140050|FG000|Overall Study|Lost to Follow-up|1|||
147264135|NCT03560531|531140051|FG001|Overall Study|Lost to Follow-up|1|||
147264136|NCT03560531|531140052|FG002|Overall Study|Lost to Follow-up|0|||
147264137|NCT03560531|531140053|FG003|Overall Study|Lost to Follow-up|0|||
147264138|NCT03560531|531140054|FG004|Overall Study|Lost to Follow-up|0|||
147264139|NCT03560531|531140055|FG005|Overall Study|Lost to Follow-up|0|||
147264140|NCT03560531|531140056|FG006|Overall Study|Lost to Follow-up|1|||
147264141|NCT03560531|531140057|FG007|Overall Study|Lost to Follow-up|0|||
147264142|NCT03560531|531140058|FG008|Overall Study|Lost to Follow-up|0|||
147264143|NCT03560531|531140059|FG009|Overall Study|Lost to Follow-up|0|||
147264144|NCT03560531|531140060|FG010|Overall Study|Lost to Follow-up|0|||
147264145|NCT03560531|531140061|FG011|Overall Study|Lost to Follow-up|0|||
147264146|NCT03560531|531140062|FG012|Overall Study|Lost to Follow-up|0|||
147264147|NCT03560531|531140063|FG013|Overall Study|Lost to Follow-up|0|||
147264148|NCT03560531|531140050|FG000|Overall Study|Withdrawal by Subject|1|||
147264149|NCT03560531|531140051|FG001|Overall Study|Withdrawal by Subject|0|||
147264150|NCT03560531|531140052|FG002|Overall Study|Withdrawal by Subject|0|||
147264151|NCT03560531|531140053|FG003|Overall Study|Withdrawal by Subject|0|||
147264152|NCT03560531|531140054|FG004|Overall Study|Withdrawal by Subject|0|||
147264153|NCT03560531|531140055|FG005|Overall Study|Withdrawal by Subject|0|||
147264154|NCT03560531|531140056|FG006|Overall Study|Withdrawal by Subject|0|||
147264155|NCT03560531|531140057|FG007|Overall Study|Withdrawal by Subject|3|||
147264156|NCT03560531|531140058|FG008|Overall Study|Withdrawal by Subject|2|||
147264157|NCT03560531|531140059|FG009|Overall Study|Withdrawal by Subject|0|||
147264158|NCT03560531|531140060|FG010|Overall Study|Withdrawal by Subject|0|||
147264159|NCT03560531|531140061|FG011|Overall Study|Withdrawal by Subject|0|||
147264160|NCT03560531|531140062|FG012|Overall Study|Withdrawal by Subject|2|||
147264161|NCT03560531|531140063|FG013|Overall Study|Withdrawal by Subject|0|||
147264162|NCT03560531|531140050|FG000|Overall Study|Study end per-protocol|1|||
147264163|NCT03560531|531140051|FG001|Overall Study|Study end per-protocol|1|||
147264164|NCT03560531|531140052|FG002|Overall Study|Study end per-protocol|2|||
147264165|NCT03560531|531140053|FG003|Overall Study|Study end per-protocol|0|||
147264166|NCT03560531|531140054|FG004|Overall Study|Study end per-protocol|1|||
147264167|NCT03560531|531140055|FG005|Overall Study|Study end per-protocol|0|||
147264168|NCT03560531|531140056|FG006|Overall Study|Study end per-protocol|0|||
147264169|NCT03560531|531140057|FG007|Overall Study|Study end per-protocol|0|||
147264170|NCT03560531|531140058|FG008|Overall Study|Study end per-protocol|0|||
147264171|NCT03560531|531140059|FG009|Overall Study|Study end per-protocol|0|||
147264172|NCT03560531|531140060|FG010|Overall Study|Study end per-protocol|0|||
147264173|NCT03560531|531140061|FG011|Overall Study|Study end per-protocol|0|||
147264174|NCT03560531|531140062|FG012|Overall Study|Study end per-protocol|0|||
147264175|NCT03560531|531140063|FG013|Overall Study|Study end per-protocol|0|||
147264176|NCT03560531|531140050|FG000|Overall Study|Early study termination by sponsor|9|||
147264177|NCT03560531|531140051|FG001|Overall Study|Early study termination by sponsor|0|||
147264178|NCT03560531|531140052|FG002|Overall Study|Early study termination by sponsor|0|||
147264179|NCT03560531|531140053|FG003|Overall Study|Early study termination by sponsor|4|||
147264180|NCT03560531|531140054|FG004|Overall Study|Early study termination by sponsor|8|||
147264181|NCT03560531|531140055|FG005|Overall Study|Early study termination by sponsor|2|||
147264182|NCT03560531|531140056|FG006|Overall Study|Early study termination by sponsor|5|||
147264183|NCT03560531|531140057|FG007|Overall Study|Early study termination by sponsor|64|||
147264184|NCT03560531|531140058|FG008|Overall Study|Early study termination by sponsor|7|||
147264185|NCT03560531|531140059|FG009|Overall Study|Early study termination by sponsor|2|||
147264186|NCT03560531|531140060|FG010|Overall Study|Early study termination by sponsor|16|||
147264187|NCT03560531|531140061|FG011|Overall Study|Early study termination by sponsor|2|||
147264188|NCT03560531|531140062|FG012|Overall Study|Early study termination by sponsor|6|||
147264189|NCT03560531|531140063|FG013|Overall Study|Early study termination by sponsor|2|||
147264190|NCT01200797|531140064|FG000|Overall Study|symptomatic deterioration|2|||
147264191|NCT01200797|531140064|FG000|Overall Study|Adverse Event|4|||
147264192|NCT01200797|531140064|FG000|Overall Study|Disease Progression|13|||
147264193|NCT00642668|531140065|FG000|Overall Study|Lost to Follow-up|1|||
147264194|NCT00642668|531140065|FG000|Overall Study|Adverse Event|2|||
147264195|NCT00642668|531140065|FG000|Overall Study|Death|2|||
147264196|NCT00642668|531140065|FG000|Overall Study|Insufficient Therapeutic Response|1|||
147264197|NCT00642668|531140065|FG000|Overall Study|Failure to Return|1|||
147264198|NCT00642668|531140065|FG000|Overall Study|Dialysis Initiation|5|||
147264199|NCT00642668|531140065|FG000|Overall Study|Blood Transfusion|2|||
147264200|NCT03608774|531140066|FG000|Overall Study|Lost to Follow-up|5|||
147264201|NCT03608774|531140067|FG001|Overall Study|Lost to Follow-up|5|||
147264202|NCT03608774|531140066|FG000|Overall Study|Withdrawal by Subject|1|||
147264203|NCT03608774|531140067|FG001|Overall Study|Withdrawal by Subject|0|||
147264204|NCT03608774|531140066|FG000|Overall Study|Protocol Violation|1|||
147264205|NCT03608774|531140067|FG001|Overall Study|Protocol Violation|0|||
147264206|NCT03608774|531140066|FG000|Overall Study|Not eligible at enrollment|0|||
147264207|NCT03608774|531140067|FG001|Overall Study|Not eligible at enrollment|1|||
147264208|NCT03608774|531140066|FG000|Overall Study|Health related event|0|||
147264209|NCT03608774|531140067|FG001|Overall Study|Health related event|1|||
147264210|NCT01586819|531140068|FG000|Overall Study|Withdrawal by Subject|1|||
147264211|NCT01586819|531140069|FG001|Overall Study|Withdrawal by Subject|0|||
147264212|NCT02028988|531140070|FG000|Overall Study|Withdrawal by Subject|2|||
147264213|NCT01063595|531140071|FG000|Enrolled in Study and Randomized|Reason not Specified|1|||
147264214|NCT01063595|531140072|FG001|Enrolled in Study and Randomized|Reason not Specified|0|||
147264215|NCT01063595|531140071|FG000|Enrolled in Study and Randomized|Adverse Event|0|||
147264216|NCT01063595|531140072|FG001|Enrolled in Study and Randomized|Adverse Event|1|||
147264217|NCT01063595|531140071|FG000|Enrolled in Study and Randomized|Withdrawn by the Investigator|0|||
147264218|NCT01063595|531140072|FG001|Enrolled in Study and Randomized|Withdrawn by the Investigator|1|||
147264219|NCT01063595|531140071|FG000|First Intervention|Adverse Event|1|||
147264220|NCT01063595|531140072|FG001|First Intervention|Adverse Event|4|||
147264221|NCT01063595|531140071|FG000|First Intervention|Withdrawal by Subject|1|||
147264222|NCT01063595|531140072|FG001|First Intervention|Withdrawal by Subject|0|||
147264223|NCT01063595|531140071|FG000|First Intervention|Reason not Specified|0|||
147264224|NCT01063595|531140072|FG001|First Intervention|Reason not Specified|1|||
147264225|NCT01623596|531140073|FG000|Overall Study|Abnormal laboratory values|2|||
147264226|NCT01623596|531140074|FG001|Overall Study|Abnormal laboratory values|0|||
147264227|NCT01623596|531140073|FG000|Overall Study|Administrative problems|9|||
147264228|NCT01623596|531140074|FG001|Overall Study|Administrative problems|13|||
147264229|NCT01623596|531140073|FG000|Overall Study|Adverse Event|20|||
147264230|NCT01623596|531140074|FG001|Overall Study|Adverse Event|29|||
147264231|NCT01623596|531140073|FG000|Overall Study|Death|0|||
147264232|NCT01623596|531140074|FG001|Overall Study|Death|2|||
147264233|NCT01623596|531140073|FG000|Overall Study|Lost to Follow-up|12|||
147264234|NCT01623596|531140074|FG001|Overall Study|Lost to Follow-up|16|||
147264235|NCT01623596|531140073|FG000|Overall Study|Withdrawal by Subject|13|||
147264236|NCT01623596|531140074|FG001|Overall Study|Withdrawal by Subject|31|||
147264237|NCT01623596|531140073|FG000|Overall Study|Patient no longer requires study drug|1|||
147264238|NCT01623596|531140074|FG001|Overall Study|Patient no longer requires study drug|0|||
147264239|NCT01623596|531140073|FG000|Overall Study|Protocol Violation|0|||
147264240|NCT01623596|531140074|FG001|Overall Study|Protocol Violation|6|||
147264241|NCT01623596|531140073|FG000|Overall Study|Lack of Efficacy|5|||
147264242|NCT01623596|531140074|FG001|Overall Study|Lack of Efficacy|3|||
147264243|NCT00747435|531140075|FG000|Overall Study|Lost to Follow-up|2|||
147264244|NCT00747435|531140075|FG000|Overall Study|Withdrawal by Subject|3|||
147264245|NCT00747435|531140075|FG000|Overall Study|Still undergoing follow up|1|||
147264246|NCT04059146|531140076|FG000|Overall Study|Withdrawal by Subject|0|||
147264247|NCT04059146|531140077|FG001|Overall Study|Withdrawal by Subject|1|||
147264248|NCT01324349|531140078|FG000|Overall Study|Death|1|||
147264249|NCT01324349|531140079|FG001|Overall Study|Death|1|||
147264250|NCT01324349|531140078|FG000|Overall Study|Withdrawal by Subject|0|||
147264251|NCT01324349|531140079|FG001|Overall Study|Withdrawal by Subject|1|||
147264252|NCT00748215|531140080|FG000|Overall Study|Withdrawal by Subject|7|||
147264253|NCT00748215|531140081|FG001|Overall Study|Withdrawal by Subject|7|||
147264254|NCT00748215|531140080|FG000|Overall Study|Treatment change|2|||
147264255|NCT00748215|531140081|FG001|Overall Study|Treatment change|1|||
147264256|NCT00748215|531140080|FG000|Overall Study|Change in patient condition|0|||
147264257|NCT00748215|531140081|FG001|Overall Study|Change in patient condition|3|||
147264258|NCT00748215|531140080|FG000|Overall Study|Non-compliant|0|||
147264259|NCT00748215|531140081|FG001|Overall Study|Non-compliant|2|||
147264260|NCT00748215|531140080|FG000|Overall Study|Adverse Event|0|||
147264261|NCT00748215|531140081|FG001|Overall Study|Adverse Event|5|||
147264262|NCT00574405|531141628|FG000|Overall Study|Withdrawal by Subject|3|||
147662248|NCT00808067|532585699|FG000|Overall Study|Major/minor bleed|30|||
147662249|NCT00808067|532585700|FG001|Overall Study|Major/minor bleed|44|||
147332918|NCT01212757|531385638|FG000|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|4|||
147264263|NCT00574405|531141629|FG001|Overall Study|Withdrawal by Subject|2|||
147264264|NCT03026257|531141632|FG000|Overall Study|Adverse Event|3|||
147264265|NCT03026257|531141633|FG001|Overall Study|Adverse Event|0|||
147264266|NCT03026257|531141634|FG002|Overall Study|Adverse Event|0|||
147264267|NCT03026257|531141635|FG003|Overall Study|Adverse Event|0|||
147264268|NCT03026257|531141636|FG004|Overall Study|Adverse Event|0|||
147264269|NCT03026257|531141637|FG005|Overall Study|Adverse Event|0|||
147264270|NCT03026257|531141632|FG000|Overall Study|Lost to Follow-up|1|||
147264271|NCT03026257|531141633|FG001|Overall Study|Lost to Follow-up|0|||
147264272|NCT03026257|531141634|FG002|Overall Study|Lost to Follow-up|0|||
147264273|NCT03026257|531141635|FG003|Overall Study|Lost to Follow-up|0|||
147264274|NCT03026257|531141636|FG004|Overall Study|Lost to Follow-up|0|||
147264275|NCT03026257|531141637|FG005|Overall Study|Lost to Follow-up|0|||
147264276|NCT03026257|531141632|FG000|Overall Study|Protocol Violation|1|||
147264277|NCT03026257|531141633|FG001|Overall Study|Protocol Violation|0|||
147264278|NCT03026257|531141634|FG002|Overall Study|Protocol Violation|0|||
147264279|NCT03026257|531141635|FG003|Overall Study|Protocol Violation|1|||
147264280|NCT03026257|531141636|FG004|Overall Study|Protocol Violation|1|||
147264281|NCT03026257|531141637|FG005|Overall Study|Protocol Violation|0|||
147264282|NCT03026257|531141632|FG000|Overall Study|Withdrawal by Subject|1|||
147264283|NCT03026257|531141633|FG001|Overall Study|Withdrawal by Subject|1|||
147264284|NCT03026257|531141634|FG002|Overall Study|Withdrawal by Subject|0|||
147264285|NCT03026257|531141635|FG003|Overall Study|Withdrawal by Subject|0|||
147264286|NCT03026257|531141636|FG004|Overall Study|Withdrawal by Subject|0|||
147264287|NCT03026257|531141637|FG005|Overall Study|Withdrawal by Subject|0|||
147264288|NCT04380857|531141639|FG000|Overall Study|Lost to Follow-up|3|||
147264289|NCT04380857|531141640|FG001|Overall Study|Lost to Follow-up|3|||
147264290|NCT00427635|531141641|FG000|Treatment Phase|Withdrawal by Subject|1|||
147264291|NCT00427635|531141642|FG001|Treatment Phase|Withdrawal by Subject|0|||
147264292|NCT00427635|531141641|FG000|Study Completion to Safety Follow-up|Lost to Follow-up|0|||
147264293|NCT00427635|531141642|FG001|Study Completion to Safety Follow-up|Lost to Follow-up|1|||
147264294|NCT02558790|531141643|FG000|Overall Study|Lost to Follow-up|2|||
147264295|NCT02558790|531141643|FG000|Overall Study|Physician Decision|1|||
147264296|NCT02558790|531141643|FG000|Overall Study|Withdrawal by Subject|1|||
147264297|NCT02558790|531141643|FG000|Overall Study|Screen Fail|3|||
147264298|NCT00838201|531141644|FG000|Overall Study|Investigator decision, or other reasons|2|||
147264299|NCT00838201|531141645|FG001|Overall Study|Investigator decision, or other reasons|3|||
147264300|NCT00838201|531141644|FG000|Overall Study|Noncompliance|0|||
147264301|NCT00838201|531141645|FG001|Overall Study|Noncompliance|1|||
147264302|NCT00838201|531141644|FG000|Overall Study|Administrative decision|1|||
147264303|NCT00838201|531141645|FG001|Overall Study|Administrative decision|2|||
147264304|NCT00838201|531141644|FG000|Overall Study|Disease progression|3|||
147264305|NCT00838201|531141645|FG001|Overall Study|Disease progression|3|||
147264306|NCT00838201|531141644|FG000|Overall Study|Consent withdrawn|16|||
147264307|NCT00838201|531141645|FG001|Overall Study|Consent withdrawn|19|||
147264308|NCT00838201|531141644|FG000|Overall Study|Lost to Follow-up|4|||
147264309|NCT00838201|531141645|FG001|Overall Study|Lost to Follow-up|3|||
147264310|NCT00838201|531141644|FG000|Overall Study|Adverse Event|5|||
147264311|NCT00838201|531141645|FG001|Overall Study|Adverse Event|9|||
147264312|NCT00838201|531141644|FG000|Overall Study|Death|11|||
147264313|NCT00838201|531141645|FG001|Overall Study|Death|13|||
147264314|NCT02042924|531141649|FG000|Overall Study|Early Death|1|||
147264315|NCT04033003|531141650|FG000|T1 (34 Wks Gestation - 3 Wks Postpartum)|Lost to Follow-up|113|||
147264316|NCT04033003|531141651|FG001|T1 (34 Wks Gestation - 3 Wks Postpartum)|Lost to Follow-up|190|||
147264317|NCT04033003|531141650|FG000|T1 (34 Wks Gestation - 3 Wks Postpartum)|Protocol Violation|115|||
147264318|NCT04033003|531141651|FG001|T1 (34 Wks Gestation - 3 Wks Postpartum)|Protocol Violation|0|||
147264319|NCT04033003|531141650|FG000|T1 (34 Wks Gestation - 3 Wks Postpartum)|Withdrawal by Subject|2|||
147264320|NCT04033003|531141651|FG001|T1 (34 Wks Gestation - 3 Wks Postpartum)|Withdrawal by Subject|6|||
147264321|NCT04033003|531141650|FG000|T1 (34 Wks Gestation - 3 Wks Postpartum)|No longer meets criteria|30|||
147264322|NCT04033003|531141651|FG001|T1 (34 Wks Gestation - 3 Wks Postpartum)|No longer meets criteria|19|||
147264323|NCT04033003|531141650|FG000|T1 (34 Wks Gestation - 3 Wks Postpartum)|Death|0|||
147264324|NCT04033003|531141651|FG001|T1 (34 Wks Gestation - 3 Wks Postpartum)|Death|1|||
147264325|NCT04033003|531141650|FG000|T2 (6 - 12 Weeks Postpartum)|Lost to Follow-up|133|||
147264326|NCT04033003|531141651|FG001|T2 (6 - 12 Weeks Postpartum)|Lost to Follow-up|247|||
147264327|NCT04033003|531141650|FG000|T2 (6 - 12 Weeks Postpartum)|Protocol Violation|4|||
147264328|NCT04033003|531141651|FG001|T2 (6 - 12 Weeks Postpartum)|Protocol Violation|0|||
147264329|NCT04033003|531141650|FG000|T2 (6 - 12 Weeks Postpartum)|Withdrawal by Subject|5|||
147264330|NCT04033003|531141651|FG001|T2 (6 - 12 Weeks Postpartum)|Withdrawal by Subject|3|||
147264331|NCT04033003|531141650|FG000|T2 (6 - 12 Weeks Postpartum)|No longer meets criteria|1|||
147264332|NCT04033003|531141651|FG001|T2 (6 - 12 Weeks Postpartum)|No longer meets criteria|10|||
147264333|NCT04033003|531141650|FG000|T2 (6 - 12 Weeks Postpartum)|Death|2|||
147264334|NCT04033003|531141651|FG001|T2 (6 - 12 Weeks Postpartum)|Death|2|||
147264335|NCT04033003|531141650|FG000|T3 (5 - 8 Month Postpartum)|Lost to Follow-up|96|||
147264336|NCT04033003|531141651|FG001|T3 (5 - 8 Month Postpartum)|Lost to Follow-up|165|||
147264337|NCT04033003|531141650|FG000|T3 (5 - 8 Month Postpartum)|Withdrawal by Subject|3|||
147264338|NCT04033003|531141651|FG001|T3 (5 - 8 Month Postpartum)|Withdrawal by Subject|5|||
147264339|NCT04033003|531141650|FG000|T4 (11 -14 Months Postpartum)|Lost to Follow-up|89|||
147264340|NCT04033003|531141651|FG001|T4 (11 -14 Months Postpartum)|Lost to Follow-up|150|||
147264341|NCT01714310|531141652|FG000|Open Lisdexamfetamine Titration|Protocol Violation|0|||
147264342|NCT01714310|531141653|FG001|Open Lisdexamfetamine Titration|Protocol Violation|0|||
147264343|NCT01714310|531141654|FG002|Open Lisdexamfetamine Titration|Protocol Violation|1|||
147264344|NCT01714310|531141652|FG000|Open Lisdexamfetamine Titration|Adverse Event|0|||
147264345|NCT01714310|531141653|FG001|Open Lisdexamfetamine Titration|Adverse Event|0|||
147264346|NCT01714310|531141654|FG002|Open Lisdexamfetamine Titration|Adverse Event|3|||
147264347|NCT01714310|531141652|FG000|Double Blind Adjunctive Treatment|Adverse Event|1|||
147264348|NCT01714310|531141653|FG001|Double Blind Adjunctive Treatment|Adverse Event|1|||
147264349|NCT01714310|531141654|FG002|Double Blind Adjunctive Treatment|Adverse Event|0|||
147264350|NCT01714310|531141652|FG000|Double Blind Adjunctive Treatment|Protocol Violation|1|||
147264351|NCT01714310|531141653|FG001|Double Blind Adjunctive Treatment|Protocol Violation|2|||
147264352|NCT01714310|531141654|FG002|Double Blind Adjunctive Treatment|Protocol Violation|0|||
147264353|NCT02487394|531141655|FG000|Phase 1|Withdrawal by Subject|0|||
147264354|NCT02487394|531141656|FG001|Phase 1|Withdrawal by Subject|1|||
147264355|NCT00826267|531141661|FG000|Overall Study|Other Adverse Event|1|||
147264356|NCT00826267|531141662|FG001|Overall Study|Other Adverse Event|0|||
147264357|NCT00826267|531141663|FG002|Overall Study|Other Adverse Event|0|||
147264358|NCT01675882|531141680|FG000|Overall Study|Adverse Event|0|||
147264359|NCT01675882|531141681|FG001|Overall Study|Adverse Event|2|||
147264360|NCT01675882|531141682|FG002|Overall Study|Adverse Event|1|||
147264361|NCT01675882|531141683|FG003|Overall Study|Adverse Event|0|||
147264362|NCT01675882|531141680|FG000|Overall Study|Participant unwilling to continue|2|||
147264363|NCT01675882|531141681|FG001|Overall Study|Participant unwilling to continue|4|||
147264364|NCT01675882|531141682|FG002|Overall Study|Participant unwilling to continue|2|||
147264365|NCT01675882|531141683|FG003|Overall Study|Participant unwilling to continue|1|||
147264366|NCT01675882|531141680|FG000|Overall Study|Lost to Follow-up|0|||
147264367|NCT01675882|531141681|FG001|Overall Study|Lost to Follow-up|1|||
147264368|NCT01675882|531141682|FG002|Overall Study|Lost to Follow-up|0|||
147264369|NCT01675882|531141683|FG003|Overall Study|Lost to Follow-up|0|||
147264370|NCT01675882|531141680|FG000|Overall Study|Non-compliance|0|||
147264371|NCT01675882|531141681|FG001|Overall Study|Non-compliance|0|||
147264372|NCT01675882|531141682|FG002|Overall Study|Non-compliance|0|||
147264373|NCT01675882|531141683|FG003|Overall Study|Non-compliance|1|||
147264374|NCT02711800|531141687|FG000|Overall Study|Lost to Follow-up|1|||
147264375|NCT02711800|531141687|FG000|Overall Study|Withdrawal by Subject|1|||
147264376|NCT00314574|531141700|FG000|Overall Study|Death|3|||
147264377|NCT00314574|531141701|FG001|Overall Study|Death|0|||
147264378|NCT00314574|531141700|FG000|Overall Study|Adverse Event|11|||
147264379|NCT00314574|531141701|FG001|Overall Study|Adverse Event|16|||
147264380|NCT00314574|531141700|FG000|Overall Study|Lost to Follow-up|19|||
147264381|NCT00314574|531141701|FG001|Overall Study|Lost to Follow-up|25|||
147264382|NCT00314574|531141700|FG000|Overall Study|Withdrawal by Subject|33|||
147264383|NCT00314574|531141701|FG001|Overall Study|Withdrawal by Subject|22|||
147264384|NCT00314574|531141700|FG000|Overall Study|Physician Decision|22|||
147264385|NCT00314574|531141701|FG001|Overall Study|Physician Decision|15|||
147264386|NCT00314574|531141700|FG000|Overall Study|Pregnancy|6|||
147264387|NCT00314574|531141701|FG001|Overall Study|Pregnancy|4|||
147264388|NCT00314574|531141700|FG000|Overall Study|Data unknown at database lock|0|||
147264389|NCT00314574|531141701|FG001|Overall Study|Data unknown at database lock|1|||
147264390|NCT00449956|531141702|FG000|Overall Study|Adverse Event|7|||
147264391|NCT00449956|531141703|FG001|Overall Study|Adverse Event|1|||
147264392|NCT00449956|531141704|FG002|Overall Study|Adverse Event|6|||
147264393|NCT00449956|531141702|FG000|Overall Study|Lack of Efficacy|0|||
147264394|NCT00449956|531141703|FG001|Overall Study|Lack of Efficacy|0|||
147264395|NCT00449956|531141704|FG002|Overall Study|Lack of Efficacy|1|||
147264396|NCT00449956|531141702|FG000|Overall Study|Protocol Violation|1|||
147264397|NCT00449956|531141703|FG001|Overall Study|Protocol Violation|1|||
147264398|NCT00449956|531141704|FG002|Overall Study|Protocol Violation|1|||
147264399|NCT00449956|531141702|FG000|Overall Study|Withdrawal by Subject|0|||
147264400|NCT00449956|531141703|FG001|Overall Study|Withdrawal by Subject|1|||
147264401|NCT00449956|531141704|FG002|Overall Study|Withdrawal by Subject|0|||
147264402|NCT00449956|531141702|FG000|Overall Study|Physician Decision|2|||
147264403|NCT00449956|531141703|FG001|Overall Study|Physician Decision|1|||
147264404|NCT00449956|531141704|FG002|Overall Study|Physician Decision|1|||
147264405|NCT01446965|531141709|FG000|Randominization|One site was dismissed due to IRB irregularity|30|||
147264406|NCT01446965|531141710|FG001|Randominization|One site was dismissed due to IRB irregularity|16|||
147264407|NCT01446965|531141709|FG000|Participants Followed and Analyzed|Lost to Follow-up|10|||
147264408|NCT01446965|531141710|FG001|Participants Followed and Analyzed|Lost to Follow-up|12|||
147264409|NCT00004412|531141711|FG000|Randomized Period|Moved to Crossover Period|3|||
147450213|NCT02898259|531811389|FG003|Overall Study|Lack of Efficacy|0|||
147450214|NCT02898259|531811390|FG004|Overall Study|Lack of Efficacy|0|||
147264410|NCT00004412|531141712|FG001|Randomized Period|Moved to Crossover Period|0|||
147264411|NCT00004412|531141713|FG002|Randomized Period|Moved to Crossover Period|0|||
147264412|NCT03144180|531141719|FG000|Overall Study|STAT Delivery|1|||
147264413|NCT03144180|531141720|FG001|Overall Study|STAT Delivery|1|||
147264414|NCT03144180|531141719|FG000|Overall Study|Provider forgot to fill out forms|1|||
147264415|NCT03144180|531141720|FG001|Overall Study|Provider forgot to fill out forms|3|||
147264416|NCT03144180|531141719|FG000|Overall Study|Provider forgot to use the Q-cup|0|||
147264417|NCT03144180|531141720|FG001|Overall Study|Provider forgot to use the Q-cup|1|||
147264418|NCT03144180|531141719|FG000|Overall Study|Scrub tech removed tube cap|0|||
147264419|NCT03144180|531141720|FG001|Overall Study|Scrub tech removed tube cap|1|||
147264420|NCT03387813|531141723|FG000|Overall Study|Death|40|||
147264421|NCT03387813|531141724|FG001|Overall Study|Death|37|||
147264422|NCT03387813|531141725|FG002|Overall Study|Death|190|||
147264423|NCT03387813|531141723|FG000|Overall Study|Withdrawal by Subject|9|||
147264424|NCT03387813|531141724|FG001|Overall Study|Withdrawal by Subject|19|||
147264425|NCT03387813|531141725|FG002|Overall Study|Withdrawal by Subject|32|||
147264426|NCT03387813|531141723|FG000|Overall Study|Lost to Follow-up|3|||
147264427|NCT03387813|531141724|FG001|Overall Study|Lost to Follow-up|9|||
147264428|NCT03387813|531141725|FG002|Overall Study|Lost to Follow-up|15|||
147264429|NCT03387813|531141723|FG000|Overall Study|Non-Compliance|6|||
147264430|NCT03387813|531141724|FG001|Overall Study|Non-Compliance|6|||
147264431|NCT03387813|531141725|FG002|Overall Study|Non-Compliance|31|||
147264432|NCT03387813|531141723|FG000|Overall Study|Subject In Hospice/Relocated/Severe COVID-19/On Transplant List/PI Discretion|7|||
147264433|NCT03387813|531141724|FG001|Overall Study|Subject In Hospice/Relocated/Severe COVID-19/On Transplant List/PI Discretion|10|||
147264434|NCT03387813|531141725|FG002|Overall Study|Subject In Hospice/Relocated/Severe COVID-19/On Transplant List/PI Discretion|14|||
147264435|NCT03161483|531141728|FG000|Placebo Controlled Phase|Participant Withdrew Consent|0|||
147264436|NCT03161483|531141729|FG001|Placebo Controlled Phase|Participant Withdrew Consent|1|||
147264437|NCT03161483|531141730|FG002|Placebo Controlled Phase|Participant Withdrew Consent|0|||
147264438|NCT03161483|531141731|FG003|Placebo Controlled Phase|Participant Withdrew Consent|0|||
147264439|NCT03161483|531141728|FG000|Treatment Period|Death|1|||
147264440|NCT03161483|531141729|FG001|Treatment Period|Death|0|||
147264441|NCT03161483|531141730|FG002|Treatment Period|Death|0|||
147264442|NCT03161483|531141731|FG003|Treatment Period|Death|0|||
147264443|NCT03161483|531141728|FG000|Treatment Period|Adverse Event|5|||
147264444|NCT03161483|531141729|FG001|Treatment Period|Adverse Event|2|||
147264445|NCT03161483|531141730|FG002|Treatment Period|Adverse Event|1|||
147264446|NCT03161483|531141731|FG003|Treatment Period|Adverse Event|11|||
147264447|NCT03161483|531141728|FG000|Treatment Period|Pregnancy|1|||
147264448|NCT03161483|531141729|FG001|Treatment Period|Pregnancy|0|||
147264449|NCT03161483|531141730|FG002|Treatment Period|Pregnancy|0|||
147264450|NCT03161483|531141731|FG003|Treatment Period|Pregnancy|0|||
147264451|NCT03161483|531141728|FG000|Treatment Period|Lack of Efficacy|0|||
147264452|NCT03161483|531141729|FG001|Treatment Period|Lack of Efficacy|0|||
147264453|NCT03161483|531141730|FG002|Treatment Period|Lack of Efficacy|0|||
147264454|NCT03161483|531141731|FG003|Treatment Period|Lack of Efficacy|1|||
147264455|NCT03161483|531141728|FG000|Treatment Period|Withdrawal by Subject|2|||
147264456|NCT03161483|531141729|FG001|Treatment Period|Withdrawal by Subject|5|||
147264457|NCT03161483|531141730|FG002|Treatment Period|Withdrawal by Subject|2|||
147264458|NCT03161483|531141731|FG003|Treatment Period|Withdrawal by Subject|6|||
147264459|NCT03161483|531141728|FG000|Treatment Period|Lost to Follow-up|0|||
147264460|NCT03161483|531141729|FG001|Treatment Period|Lost to Follow-up|0|||
147264461|NCT03161483|531141730|FG002|Treatment Period|Lost to Follow-up|0|||
147264462|NCT03161483|531141731|FG003|Treatment Period|Lost to Follow-up|1|||
147264463|NCT03161483|531141728|FG000|Treatment Period|Protocol Violation|0|||
147264464|NCT03161483|531141729|FG001|Treatment Period|Protocol Violation|0|||
147264465|NCT03161483|531141730|FG002|Treatment Period|Protocol Violation|0|||
147264466|NCT03161483|531141731|FG003|Treatment Period|Protocol Violation|1|||
147264467|NCT03161483|531141728|FG000|Treatment Period|Other reasons|1|||
147450215|NCT02898259|531811386|FG000|Overall Study|Lost to Follow-up|0|||
147662250|NCT00808067|532585699|FG000|Overall Study|Outcome event - other|33|||
147662251|NCT00808067|532585700|FG001|Overall Study|Outcome event - other|25|||
147662252|NCT00808067|532585699|FG000|Overall Study|Adverse Event|111|||
147662253|NCT00808067|532585700|FG001|Overall Study|Adverse Event|121|||
147662254|NCT00808067|532585699|FG000|Overall Study|Hospitalization (not including surgery)|18|||
147662255|NCT00808067|532585700|FG001|Overall Study|Hospitalization (not including surgery)|17|||
147662256|NCT00808067|532585699|FG000|Overall Study|Hospitalization due to surgery|37|||
147662257|NCT00808067|532585700|FG001|Overall Study|Hospitalization due to surgery|40|||
147662258|NCT00808067|532585699|FG000|Overall Study|Reduced creatinine clearance|53|||
147662259|NCT00808067|532585700|FG001|Overall Study|Reduced creatinine clearance|55|||
147662260|NCT00808067|532585699|FG000|Overall Study|Elevated LFT results|7|||
147662261|NCT00808067|532585700|FG001|Overall Study|Elevated LFT results|3|||
147662262|NCT00808067|532585699|FG000|Overall Study|Patient refused to take study medication|65|||
147662263|NCT00808067|532585700|FG001|Overall Study|Patient refused to take study medication|76|||
147662264|NCT00808067|532585699|FG000|Overall Study|Missing|1|||
147662265|NCT00808067|532585700|FG001|Overall Study|Missing|0|||
147662266|NCT00808067|532585699|FG000|Overall Study|Death|1|||
147662267|NCT00808067|532585700|FG001|Overall Study|Death|1|||
147662268|NCT00808067|532585699|FG000|Overall Study|Procedure|6|||
147264468|NCT03161483|531141729|FG001|Treatment Period|Other reasons|1|||
147264469|NCT03161483|531141730|FG002|Treatment Period|Other reasons|0|||
147264470|NCT03161483|531141731|FG003|Treatment Period|Other reasons|0|||
147264471|NCT03925324|531141734|FG000|Overall Study|Death|1|||
147264472|NCT03925324|531141735|FG001|Overall Study|Death|1|||
147264473|NCT00794196|531141736|FG000|Overall Study|Lost to Follow-up|5|||
147264474|NCT00794196|531141737|FG001|Overall Study|Lost to Follow-up|23|||
147264475|NCT02129803|531141741|FG000|Overall Study|Protocol Violation|4|||
147264476|NCT02129803|531141742|FG001|Overall Study|Protocol Violation|0|||
147264477|NCT02129803|531141741|FG000|Overall Study|Physician Decision|0|||
147264478|NCT02129803|531141742|FG001|Overall Study|Physician Decision|1|||
147264479|NCT02129803|531141741|FG000|Overall Study|Difficulty sleeping|1|||
147264480|NCT02129803|531141742|FG001|Overall Study|Difficulty sleeping|0|||
147264481|NCT02129803|531141741|FG000|Overall Study|Morning headache|0|||
147264482|NCT02129803|531141742|FG001|Overall Study|Morning headache|1|||
147264483|NCT02129803|531141741|FG000|Overall Study|Withdrawal by Subject|1|||
147264484|NCT02129803|531141742|FG001|Overall Study|Withdrawal by Subject|1|||
147264485|NCT02871739|531141749|FG000|Overall Study|Lost to Follow-up|3|||
147264486|NCT02871739|531141750|FG001|Overall Study|Lost to Follow-up|2|||
147264487|NCT02871739|531141751|FG002|Overall Study|Lost to Follow-up|0|||
147264488|NCT02871739|531141752|FG003|Overall Study|Lost to Follow-up|2|||
147264489|NCT03818516|531141753|FG000|Overall Study|Exclusion due to positive UDS (THC) test|1|||
147264490|NCT04372602|531141754|FG000|Overall Study|Withdrawal by Subject|1|||
147264491|NCT04372602|531141755|FG001|Overall Study|Withdrawal by Subject|1|||
147264492|NCT04372602|531141754|FG000|Overall Study|Adverse Event|0|||
147264493|NCT04372602|531141755|FG001|Overall Study|Adverse Event|1|||
147264494|NCT04372602|531141754|FG000|Overall Study|Transitioned to comfort care|0|||
147264495|NCT04372602|531141755|FG001|Overall Study|Transitioned to comfort care|1|||
147264496|NCT00594464|531141756|FG000|Overall Study|Withdrawal by Subject|1|||
147264497|NCT00594464|531141756|FG000|Overall Study|Delay in operation|2|||
147264498|NCT02907359|531141757|FG000|Overall Study|Death|234|||
147264499|NCT02907359|531141758|FG001|Overall Study|Death|117|||
147264500|NCT02907359|531141757|FG000|Overall Study|Withdrawal by Subject|6|||
147264501|NCT02907359|531141758|FG001|Overall Study|Withdrawal by Subject|11|||
147264502|NCT02907359|531141757|FG000|Overall Study|Lost to Follow-up|1|||
147264503|NCT02907359|531141758|FG001|Overall Study|Lost to Follow-up|0|||
147264504|NCT04809220|531141761|FG000|Overall Study|Adverse Event|4|||
147264505|NCT04809220|531141762|FG001|Overall Study|Adverse Event|0|||
147264506|NCT04809220|531141761|FG000|Overall Study|Death|1|||
147264507|NCT04809220|531141762|FG001|Overall Study|Death|0|||
147264508|NCT04809220|531141761|FG000|Overall Study|Lost to Follow-up|3|||
147264509|NCT04809220|531141762|FG001|Overall Study|Lost to Follow-up|0|||
147264510|NCT04809220|531141761|FG000|Overall Study|Physician Decision|0|||
147264511|NCT04809220|531141762|FG001|Overall Study|Physician Decision|1|||
147264512|NCT04809220|531141761|FG000|Overall Study|Withdrawal by Subject|9|||
147264513|NCT04809220|531141762|FG001|Overall Study|Withdrawal by Subject|5|||
147264514|NCT04809220|531141761|FG000|Overall Study|Due to long-term overseas business trips|1|||
147264515|NCT04809220|531141762|FG001|Overall Study|Due to long-term overseas business trips|0|||
147264516|NCT02120794|531141766|FG000|Overall Study|Withdrawal by Subject|43|||
147264517|NCT02120794|531141766|FG000|Overall Study|Adverse Event|10|||
147264518|NCT02120794|531141766|FG000|Overall Study|Physician Decision|4|||
147264519|NCT02120794|531141766|FG000|Overall Study|Due to insurance coverage|1|||
147264520|NCT00994240|531141768|FG000|Overall Study|Lost to Follow-up|3|||
147264521|NCT00994240|531141769|FG001|Overall Study|Lost to Follow-up|2|||
147264522|NCT00994240|531141768|FG000|Overall Study|Withdrawal by Subject|1|||
147264523|NCT00994240|531141769|FG001|Overall Study|Withdrawal by Subject|0|||
147264524|NCT00994240|531141768|FG000|Overall Study|study termination|2|||
147264525|NCT00994240|531141769|FG001|Overall Study|study termination|3|||
147264526|NCT00896337|531141774|FG000|Overall Study|Death|7|||
147264527|NCT00896337|531141774|FG000|Overall Study|Withdrawal by Subject|7|||
147264528|NCT00896337|531141774|FG000|Overall Study|Lost to Follow-up|11|||
147264529|NCT02910167|531141785|FG000|Overall Study|Adverse Event|1|||
147264530|NCT02910167|531141785|FG000|Overall Study|Lost to Follow-up|18|||
147264531|NCT01418937|531141786|FG000|Overall Study|Lost to Follow-up|5|||
147264532|NCT01418937|531141786|FG000|Overall Study|Protocol Violation|1|||
147264533|NCT01418937|531141786|FG000|Overall Study|Pregnancy|1|||
147264534|NCT01418937|531141786|FG000|Overall Study|Withdrawal by Subject|1|||
147264535|NCT01828034|531143534|FG000|Overall Study|Withdrawal by Subject|0|||
147264536|NCT01828034|531143535|FG001|Overall Study|Withdrawal by Subject|0|||
147264537|NCT01828034|531143536|FG002|Overall Study|Withdrawal by Subject|0|||
147450216|NCT02898259|531811387|FG001|Overall Study|Lost to Follow-up|0|||
147450217|NCT02898259|531811388|FG002|Overall Study|Lost to Follow-up|1|||
147450218|NCT02898259|531811389|FG003|Overall Study|Lost to Follow-up|0|||
147450219|NCT02898259|531811390|FG004|Overall Study|Lost to Follow-up|0|||
147599944|NCT05424042|532356261|FG001|Overall Study|Withdrawal by Subject|0|||
147264538|NCT01828034|531143537|FG003|Overall Study|Withdrawal by Subject|1|||
147264539|NCT04327999|531143544|FG000|Overall Study|Protocol Violation|1|||
147264540|NCT02872116|531143549|FG000|Pre-Treatment|Disease Progression|0|||
147264541|NCT02872116|531143550|FG001|Pre-Treatment|Disease Progression|1|||
147264542|NCT02872116|531143551|FG002|Pre-Treatment|Disease Progression|0|||
147264543|NCT02872116|531143549|FG000|Pre-Treatment|Adverse event unrelated to study drug|0|||
147264544|NCT02872116|531143550|FG001|Pre-Treatment|Adverse event unrelated to study drug|2|||
147264545|NCT02872116|531143551|FG002|Pre-Treatment|Adverse event unrelated to study drug|1|||
147264546|NCT02872116|531143549|FG000|Pre-Treatment|Participants request to discontinue study treatment|0|||
147264547|NCT02872116|531143550|FG001|Pre-Treatment|Participants request to discontinue study treatment|2|||
147450220|NCT02898259|531811386|FG000|Overall Study|Transformation before study began|0|||
147264548|NCT02872116|531143551|FG002|Pre-Treatment|Participants request to discontinue study treatment|0|||
147264549|NCT02872116|531143549|FG000|Pre-Treatment|Participant withdrew consent|2|||
147264550|NCT02872116|531143550|FG001|Pre-Treatment|Participant withdrew consent|20|||
147264551|NCT02872116|531143551|FG002|Pre-Treatment|Participant withdrew consent|3|||
147264552|NCT02872116|531143549|FG000|Pre-Treatment|Participant no longer meets study criteria|4|||
147264553|NCT02872116|531143550|FG001|Pre-Treatment|Participant no longer meets study criteria|0|||
147264554|NCT02872116|531143551|FG002|Pre-Treatment|Participant no longer meets study criteria|0|||
147264555|NCT02872116|531143549|FG000|Pre-Treatment|Other reasons|1|||
147264556|NCT02872116|531143550|FG001|Pre-Treatment|Other reasons|2|||
147264557|NCT02872116|531143551|FG002|Pre-Treatment|Other reasons|2|||
147264558|NCT02872116|531143549|FG000|Treatment|Death|121|||
147264559|NCT02872116|531143550|FG001|Treatment|Death|94|||
147264560|NCT02872116|531143551|FG002|Treatment|Death|68|||
147264561|NCT02872116|531143549|FG000|Treatment|Lost to Follow-up|5|||
147264562|NCT02872116|531143550|FG001|Treatment|Lost to Follow-up|7|||
147264563|NCT02872116|531143551|FG002|Treatment|Lost to Follow-up|3|||
147264564|NCT02872116|531143549|FG000|Treatment|Participant withdrew consent|20|||
147264565|NCT02872116|531143550|FG001|Treatment|Participant withdrew consent|40|||
147264566|NCT02872116|531143551|FG002|Treatment|Participant withdrew consent|8|||
147264567|NCT02872116|531143549|FG000|Treatment|Other reasons|13|||
147264568|NCT02872116|531143550|FG001|Treatment|Other reasons|12|||
147264569|NCT02872116|531143551|FG002|Treatment|Other reasons|5|||
147264570|NCT02346136|531143552|FG000|Overall Study|Withdrawal by Subject|7|||
147264571|NCT02346136|531143553|FG001|Overall Study|Withdrawal by Subject|5|||
147264572|NCT02346136|531143552|FG000|Overall Study|Death|1|||
147264573|NCT02346136|531143553|FG001|Overall Study|Death|0|||
147264574|NCT02346136|531143552|FG000|Overall Study|Study termination|14|||
147264575|NCT02346136|531143553|FG001|Overall Study|Study termination|18|||
147264576|NCT03735667|531143554|FG000|1 Year PE Main Randomized and Roll-in|Death|40|||
147264577|NCT03735667|531143555|FG001|1 Year PE Main Randomized and Roll-in|Death|31|||
147264578|NCT03735667|531143556|FG002|1 Year PE Main Randomized and Roll-in|Death|7|||
147264579|NCT03735667|531143554|FG000|1 Year PE Main Randomized and Roll-in|Lost to Follow-up|3|||
147264580|NCT03735667|531143555|FG001|1 Year PE Main Randomized and Roll-in|Lost to Follow-up|2|||
147264581|NCT03735667|531143556|FG002|1 Year PE Main Randomized and Roll-in|Lost to Follow-up|0|||
147264582|NCT03735667|531143554|FG000|1 Year PE Main Randomized and Roll-in|Physician Decision|4|||
147264583|NCT03735667|531143555|FG001|1 Year PE Main Randomized and Roll-in|Physician Decision|2|||
147264584|NCT03735667|531143556|FG002|1 Year PE Main Randomized and Roll-in|Physician Decision|0|||
147264585|NCT03735667|531143554|FG000|1 Year PE Main Randomized and Roll-in|Withdrawal by Subject|27|||
147264586|NCT03735667|531143555|FG001|1 Year PE Main Randomized and Roll-in|Withdrawal by Subject|24|||
147264587|NCT03735667|531143556|FG002|1 Year PE Main Randomized and Roll-in|Withdrawal by Subject|2|||
147264588|NCT03735667|531143554|FG000|1 Year PE Main Randomized and Roll-in|1-Year Visit Not Done|28|||
147264589|NCT03735667|531143555|FG001|1 Year PE Main Randomized and Roll-in|1-Year Visit Not Done|29|||
147264590|NCT03735667|531143556|FG002|1 Year PE Main Randomized and Roll-in|1-Year Visit Not Done|9|||
147264591|NCT03735667|531143554|FG000|1 Year PE Main Randomized and Roll-in|Other|1|||
147264592|NCT03735667|531143555|FG001|1 Year PE Main Randomized and Roll-in|Other|2|||
147264593|NCT03735667|531143556|FG002|1 Year PE Main Randomized and Roll-in|Other|0|||
147264594|NCT03735667|531143554|FG000|4D-CT Substudy (Subset of Main RCT)|Death|8|||
147264595|NCT03735667|531143555|FG001|4D-CT Substudy (Subset of Main RCT)|Death|5|||
147264596|NCT03735667|531143556|FG002|4D-CT Substudy (Subset of Main RCT)|Death|0|||
147264597|NCT03735667|531143554|FG000|4D-CT Substudy (Subset of Main RCT)|Withdrawal by Subject|4|||
147264598|NCT03735667|531143555|FG001|4D-CT Substudy (Subset of Main RCT)|Withdrawal by Subject|4|||
147264599|NCT03735667|531143556|FG002|4D-CT Substudy (Subset of Main RCT)|Withdrawal by Subject|0|||
147264600|NCT03735667|531143554|FG000|4D-CT Substudy (Subset of Main RCT)|Lost to Follow-up|1|||
147264601|NCT03735667|531143555|FG001|4D-CT Substudy (Subset of Main RCT)|Lost to Follow-up|0|||
147264602|NCT03735667|531143556|FG002|4D-CT Substudy (Subset of Main RCT)|Lost to Follow-up|0|||
147264603|NCT03735667|531143554|FG000|4D-CT Substudy (Subset of Main RCT)|Physician Decision|1|||
147264604|NCT03735667|531143555|FG001|4D-CT Substudy (Subset of Main RCT)|Physician Decision|1|||
147264605|NCT03735667|531143556|FG002|4D-CT Substudy (Subset of Main RCT)|Physician Decision|0|||
147264606|NCT03735667|531143554|FG000|4D-CT Substudy (Subset of Main RCT)|Other|0|||
147264607|NCT03735667|531143555|FG001|4D-CT Substudy (Subset of Main RCT)|Other|1|||
147264608|NCT03735667|531143556|FG002|4D-CT Substudy (Subset of Main RCT)|Other|0|||
147264609|NCT03735667|531143554|FG000|4D-CT Substudy (Subset of Main RCT)|1-Year Visit Not Done|3|||
147264610|NCT03735667|531143555|FG001|4D-CT Substudy (Subset of Main RCT)|1-Year Visit Not Done|3|||
147264611|NCT03735667|531143556|FG002|4D-CT Substudy (Subset of Main RCT)|1-Year Visit Not Done|0|||
147264612|NCT02308735|531143557|FG000|Overall Study|Physician Decision|2|||
147264613|NCT02308735|531143558|FG001|Overall Study|Physician Decision|0|||
147264614|NCT02308735|531143559|FG002|Overall Study|Physician Decision|0|||
147264615|NCT02308735|531143560|FG003|Overall Study|Physician Decision|2|||
147264616|NCT00006478|531143568|FG000|Overall Study|Vaccine could not be produced|1|||
147264617|NCT00006478|531143568|FG000|Overall Study|Physician Decision|6|||
147450221|NCT02898259|531811387|FG001|Overall Study|Transformation before study began|0|||
147264618|NCT00743652|531143569|FG000|Overall Study|Parent/Legal Guardian Request|3|||
147264619|NCT00743652|531143570|FG001|Overall Study|Parent/Legal Guardian Request|2|||
147264620|NCT00743652|531143571|FG002|Overall Study|Parent/Legal Guardian Request|2|||
147264621|NCT00743652|531143572|FG003|Overall Study|Parent/Legal Guardian Request|2|||
147264622|NCT00743652|531143573|FG004|Overall Study|Parent/Legal Guardian Request|0|||
147264623|NCT00743652|531143569|FG000|Overall Study|Adverse Event|3|||
147264624|NCT00743652|531143570|FG001|Overall Study|Adverse Event|0|||
147264625|NCT00743652|531143571|FG002|Overall Study|Adverse Event|0|||
147264626|NCT00743652|531143572|FG003|Overall Study|Adverse Event|0|||
147264627|NCT00743652|531143573|FG004|Overall Study|Adverse Event|0|||
147264628|NCT00743652|531143569|FG000|Overall Study|Death|2|||
147264629|NCT00743652|531143570|FG001|Overall Study|Death|0|||
147264630|NCT00743652|531143571|FG002|Overall Study|Death|0|||
147264631|NCT00743652|531143572|FG003|Overall Study|Death|0|||
147264632|NCT00743652|531143573|FG004|Overall Study|Death|0|||
147264633|NCT00743652|531143569|FG000|Overall Study|Investigator Request|0|||
147264634|NCT00743652|531143570|FG001|Overall Study|Investigator Request|0|||
147264635|NCT00743652|531143571|FG002|Overall Study|Investigator Request|0|||
147264636|NCT00743652|531143572|FG003|Overall Study|Investigator Request|2|||
147264637|NCT00743652|531143573|FG004|Overall Study|Investigator Request|0|||
147264638|NCT00743652|531143569|FG000|Overall Study|Other|1|||
147264639|NCT00743652|531143570|FG001|Overall Study|Other|1|||
147264640|NCT00743652|531143571|FG002|Overall Study|Other|0|||
147264641|NCT00743652|531143572|FG003|Overall Study|Other|0|||
147264642|NCT00743652|531143573|FG004|Overall Study|Other|0|||
147264643|NCT00743652|531143569|FG000|Overall Study|Lost to Follow-up|1|||
147264644|NCT00743652|531143570|FG001|Overall Study|Lost to Follow-up|0|||
147264645|NCT00743652|531143571|FG002|Overall Study|Lost to Follow-up|0|||
147264646|NCT00743652|531143572|FG003|Overall Study|Lost to Follow-up|0|||
147264647|NCT00743652|531143573|FG004|Overall Study|Lost to Follow-up|0|||
147264648|NCT02547129|531143574|FG000|Overall Study|Difficulty with ongoing infection|1|||
147264649|NCT02547129|531143575|FG001|Overall Study|Difficulty with ongoing infection|0|||
147264650|NCT00805766|531143576|FG000|Screening Period|Adverse Event|1|||
147264651|NCT00805766|531143576|FG000|Screening Period|Lack of Efficacy|2|||
147264652|NCT00805766|531143576|FG000|Screening Period|Pregnancy|1|||
147264653|NCT00805766|531143576|FG000|Screening Period|Responder|2|||
147264654|NCT00805766|531143576|FG000|Increased Dose Period|Adverse Event|4|||
147264655|NCT00805766|531143576|FG000|Increased Dose Period|Lack of Efficacy|7|||
147264656|NCT00805766|531143576|FG000|Increased Dose Period|Pregnancy|1|||
147264657|NCT00805766|531143576|FG000|Increased Dose Period|Withdrawal by Subject|1|||
147264658|NCT03373383|531143579|FG000|Treatment Period: Wk0-16|Adverse Event|7|||
147264659|NCT03373383|531143580|FG001|Treatment Period: Wk0-16|Adverse Event|6|||
147264660|NCT03373383|531143581|FG002|Treatment Period: Wk0-16|Adverse Event|11|||
147264661|NCT03373383|531143582|FG003|Treatment Period: Wk0-16|Adverse Event|15|||
147264662|NCT03373383|531143583|FG004|Treatment Period: Wk0-16|Adverse Event|21|||
147662269|NCT00808067|532585700|FG001|Overall Study|Procedure|7|||
147264663|NCT03373383|531143579|FG000|Treatment Period: Wk0-16|Lack of Efficacy|2|||
147264664|NCT03373383|531143580|FG001|Treatment Period: Wk0-16|Lack of Efficacy|1|||
147264665|NCT03373383|531143581|FG002|Treatment Period: Wk0-16|Lack of Efficacy|0|||
147264666|NCT03373383|531143582|FG003|Treatment Period: Wk0-16|Lack of Efficacy|0|||
147264667|NCT03373383|531143583|FG004|Treatment Period: Wk0-16|Lack of Efficacy|0|||
147264668|NCT03373383|531143579|FG000|Treatment Period: Wk0-16|Protocol Violation|0|||
147264669|NCT03373383|531143580|FG001|Treatment Period: Wk0-16|Protocol Violation|4|||
147264670|NCT03373383|531143581|FG002|Treatment Period: Wk0-16|Protocol Violation|2|||
147264671|NCT03373383|531143582|FG003|Treatment Period: Wk0-16|Protocol Violation|1|||
147264672|NCT03373383|531143583|FG004|Treatment Period: Wk0-16|Protocol Violation|0|||
147264673|NCT03373383|531143579|FG000|Treatment Period: Wk0-16|Lost to Follow-up|2|||
147264674|NCT03373383|531143580|FG001|Treatment Period: Wk0-16|Lost to Follow-up|0|||
147662270|NCT00808067|532585699|FG000|Overall Study|Withdrawal by Subject|21|||
147662271|NCT00808067|532585700|FG001|Overall Study|Withdrawal by Subject|25|||
147264675|NCT03373383|531143581|FG002|Treatment Period: Wk0-16|Lost to Follow-up|0|||
147264676|NCT03373383|531143582|FG003|Treatment Period: Wk0-16|Lost to Follow-up|0|||
147264677|NCT03373383|531143583|FG004|Treatment Period: Wk0-16|Lost to Follow-up|0|||
147264678|NCT03373383|531143579|FG000|Treatment Period: Wk0-16|Withdrawal by Subject|2|||
147264679|NCT03373383|531143580|FG001|Treatment Period: Wk0-16|Withdrawal by Subject|3|||
147264680|NCT03373383|531143581|FG002|Treatment Period: Wk0-16|Withdrawal by Subject|2|||
147264681|NCT03373383|531143582|FG003|Treatment Period: Wk0-16|Withdrawal by Subject|3|||
147264682|NCT03373383|531143583|FG004|Treatment Period: Wk0-16|Withdrawal by Subject|3|||
147264683|NCT03373383|531143579|FG000|Treatment Period: Wk0-16|As advised by the sponsor|0|||
147264684|NCT03373383|531143580|FG001|Treatment Period: Wk0-16|As advised by the sponsor|1|||
147264685|NCT03373383|531143581|FG002|Treatment Period: Wk0-16|As advised by the sponsor|0|||
147264686|NCT03373383|531143582|FG003|Treatment Period: Wk0-16|As advised by the sponsor|0|||
147264687|NCT03373383|531143583|FG004|Treatment Period: Wk0-16|As advised by the sponsor|0|||
147264688|NCT03373383|531143579|FG000|Treatment Period: Wk0-16|By opinion of investigator|0|||
147264689|NCT03373383|531143580|FG001|Treatment Period: Wk0-16|By opinion of investigator|0|||
147264690|NCT03373383|531143581|FG002|Treatment Period: Wk0-16|By opinion of investigator|0|||
147264691|NCT03373383|531143582|FG003|Treatment Period: Wk0-16|By opinion of investigator|1|||
147264692|NCT03373383|531143583|FG004|Treatment Period: Wk0-16|By opinion of investigator|0|||
147662272|NCT00808067|532585699|FG000|Overall Study|Site closed|4|||
147662273|NCT00808067|532585700|FG001|Overall Study|Site closed|3|||
147264693|NCT03373383|531143579|FG000|Treatment Period: Wk0-16|Sponsor decision|0|||
147264694|NCT03373383|531143580|FG001|Treatment Period: Wk0-16|Sponsor decision|0|||
147264695|NCT03373383|531143581|FG002|Treatment Period: Wk0-16|Sponsor decision|0|||
147264696|NCT03373383|531143582|FG003|Treatment Period: Wk0-16|Sponsor decision|1|||
147264697|NCT03373383|531143583|FG004|Treatment Period: Wk0-16|Sponsor decision|0|||
147264698|NCT03373383|531143579|FG000|Post-Treatment Period: Wk16-23|Participant decided not to roll over|1|||
147264699|NCT03373383|531143580|FG001|Post-Treatment Period: Wk16-23|Participant decided not to roll over|0|||
147264700|NCT03373383|531143581|FG002|Post-Treatment Period: Wk16-23|Participant decided not to roll over|0|||
147264701|NCT03373383|531143582|FG003|Post-Treatment Period: Wk16-23|Participant decided not to roll over|0|||
147264702|NCT03373383|531143583|FG004|Post-Treatment Period: Wk16-23|Participant decided not to roll over|0|||
147264703|NCT02159521|531143584|FG000|Overall Study|Enrolled but not treated|3|||
147264704|NCT02159521|531143584|FG000|Overall Study|Withdrawal by Subject|7|||
147264705|NCT02159521|531143584|FG000|Overall Study|Lost to Follow-up|6|||
147264706|NCT02159521|531143584|FG000|Overall Study|Death|1|||
147264707|NCT02159521|531143584|FG000|Overall Study|Other than specified|1|||
147264708|NCT00694369|531143585|FG000|Overall Study|Adverse Event|0|||
147264709|NCT00694369|531143586|FG001|Overall Study|Adverse Event|1|||
147264710|NCT00694369|531143587|FG002|Overall Study|Adverse Event|0|||
147264711|NCT00694369|531143588|FG003|Overall Study|Adverse Event|1|||
147264712|NCT00694369|531143589|FG004|Overall Study|Adverse Event|3|||
147264713|NCT00694369|531143585|FG000|Overall Study|Lost to Follow-up|0|||
147264714|NCT00694369|531143586|FG001|Overall Study|Lost to Follow-up|0|||
147264715|NCT00694369|531143587|FG002|Overall Study|Lost to Follow-up|1|||
147264716|NCT00694369|531143588|FG003|Overall Study|Lost to Follow-up|1|||
147264717|NCT00694369|531143589|FG004|Overall Study|Lost to Follow-up|0|||
147264718|NCT00694369|531143585|FG000|Overall Study|Physician Decision|0|||
147264719|NCT00694369|531143586|FG001|Overall Study|Physician Decision|0|||
147264720|NCT00694369|531143587|FG002|Overall Study|Physician Decision|0|||
147264721|NCT00694369|531143588|FG003|Overall Study|Physician Decision|0|||
147264722|NCT00694369|531143589|FG004|Overall Study|Physician Decision|1|||
147264723|NCT00694369|531143585|FG000|Overall Study|Protocol Violation|0|||
147264724|NCT00694369|531143586|FG001|Overall Study|Protocol Violation|1|||
147264725|NCT00694369|531143587|FG002|Overall Study|Protocol Violation|0|||
147264726|NCT00694369|531143588|FG003|Overall Study|Protocol Violation|0|||
147264727|NCT00694369|531143589|FG004|Overall Study|Protocol Violation|0|||
147264728|NCT00694369|531143585|FG000|Overall Study|Withdrawal by Subject|1|||
147264729|NCT00694369|531143586|FG001|Overall Study|Withdrawal by Subject|1|||
147264730|NCT00694369|531143587|FG002|Overall Study|Withdrawal by Subject|1|||
147264731|NCT00694369|531143588|FG003|Overall Study|Withdrawal by Subject|1|||
147264732|NCT00694369|531143589|FG004|Overall Study|Withdrawal by Subject|2|||
147264733|NCT00907374|531143590|FG000|Overall Study|Noncompliant w/study protocol at <3 mos|2|||
147264734|NCT00907374|531143591|FG001|Overall Study|Noncompliant w/study protocol at <3 mos|2|||
147264735|NCT03131440|531143596|FG000|Overall Study|Withdrawal by Subject|1|||
147264736|NCT03131440|531143597|FG001|Overall Study|Withdrawal by Subject|3|||
147264737|NCT03131440|531143598|FG002|Overall Study|Withdrawal by Subject|0|||
147264738|NCT03131440|531143599|FG003|Overall Study|Withdrawal by Subject|0|||
147264739|NCT03131440|531143600|FG004|Overall Study|Withdrawal by Subject|1|||
147264740|NCT03131440|531143601|FG005|Overall Study|Withdrawal by Subject|0|||
147264741|NCT03131440|531143602|FG006|Overall Study|Withdrawal by Subject|0|||
147264742|NCT03131440|531143603|FG007|Overall Study|Withdrawal by Subject|1|||
147264743|NCT03131440|531143604|FG008|Overall Study|Withdrawal by Subject|1|||
147264744|NCT03131440|531143605|FG009|Overall Study|Withdrawal by Subject|1|||
147264745|NCT03131440|531143606|FG010|Overall Study|Withdrawal by Subject|0|||
147264746|NCT03131440|531143607|FG011|Overall Study|Withdrawal by Subject|1|||
147264747|NCT03131440|531143608|FG012|Overall Study|Withdrawal by Subject|1|||
147264748|NCT03131440|531143609|FG013|Overall Study|Withdrawal by Subject|0|||
147264749|NCT03131440|531143610|FG014|Overall Study|Withdrawal by Subject|1|||
147264750|NCT03131440|531143611|FG015|Overall Study|Withdrawal by Subject|0|||
147264751|NCT03131440|531143612|FG016|Overall Study|Withdrawal by Subject|0|||
147264752|NCT03131440|531143613|FG017|Overall Study|Withdrawal by Subject|0|||
147264753|NCT03131440|531143614|FG018|Overall Study|Withdrawal by Subject|1|||
147662274|NCT00808067|532585699|FG000|Overall Study|Physician Decision|47|||
147264754|NCT03131440|531143615|FG019|Overall Study|Withdrawal by Subject|0|||
147264755|NCT03131440|531143616|FG020|Overall Study|Withdrawal by Subject|1|||
147264756|NCT03131440|531143617|FG021|Overall Study|Withdrawal by Subject|1|||
147264757|NCT03131440|531143618|FG022|Overall Study|Withdrawal by Subject|1|||
147264758|NCT03131440|531143619|FG023|Overall Study|Withdrawal by Subject|0|||
147264759|NCT03131440|531143620|FG024|Overall Study|Withdrawal by Subject|0|||
147264760|NCT03131440|531143621|FG025|Overall Study|Withdrawal by Subject|0|||
147264761|NCT03131440|531143622|FG026|Overall Study|Withdrawal by Subject|0|||
147264762|NCT03131440|531143623|FG027|Overall Study|Withdrawal by Subject|0|||
147264763|NCT03131440|531143624|FG028|Overall Study|Withdrawal by Subject|0|||
147264764|NCT03131440|531143625|FG029|Overall Study|Withdrawal by Subject|0|||
147264765|NCT03131440|531143626|FG030|Overall Study|Withdrawal by Subject|1|||
147599945|NCT05424042|532356262|FG002|Overall Study|Withdrawal by Subject|4|||
147599946|NCT05424042|532356260|FG000|Overall Study|Lost to Follow-up|0|||
147599947|NCT05424042|532356261|FG001|Overall Study|Lost to Follow-up|0|||
147599948|NCT05424042|532356262|FG002|Overall Study|Lost to Follow-up|1|||
147599949|NCT05091307|532356263|FG000|Overall Study|Death|0|||
147599950|NCT05091307|532356264|FG001|Overall Study|Death|0|||
147599951|NCT05091307|532356265|FG002|Overall Study|Death|1|||
147599952|NCT05091307|532356266|FG003|Overall Study|Death|0|||
147599953|NCT05091307|532356263|FG000|Overall Study|Lost to Follow-up|33|||
147662275|NCT00808067|532585700|FG001|Overall Study|Physician Decision|38|||
147662276|NCT00808067|532585699|FG000|Overall Study|Protocol Violation|3|||
147662277|NCT00808067|532585700|FG001|Overall Study|Protocol Violation|11|||
147264766|NCT03131440|531143627|FG031|Overall Study|Withdrawal by Subject|0|||
147264767|NCT03131440|531143596|FG000|Overall Study|Lost to Follow-up|0|||
147264768|NCT03131440|531143597|FG001|Overall Study|Lost to Follow-up|0|||
147264769|NCT03131440|531143598|FG002|Overall Study|Lost to Follow-up|0|||
147264770|NCT03131440|531143599|FG003|Overall Study|Lost to Follow-up|0|||
147264771|NCT03131440|531143600|FG004|Overall Study|Lost to Follow-up|0|||
147264772|NCT03131440|531143601|FG005|Overall Study|Lost to Follow-up|1|||
147264773|NCT03131440|531143602|FG006|Overall Study|Lost to Follow-up|0|||
147264774|NCT03131440|531143603|FG007|Overall Study|Lost to Follow-up|0|||
147264775|NCT03131440|531143604|FG008|Overall Study|Lost to Follow-up|0|||
147264776|NCT03131440|531143605|FG009|Overall Study|Lost to Follow-up|0|||
147264777|NCT03131440|531143606|FG010|Overall Study|Lost to Follow-up|0|||
147264778|NCT03131440|531143607|FG011|Overall Study|Lost to Follow-up|0|||
147264779|NCT03131440|531143608|FG012|Overall Study|Lost to Follow-up|0|||
147264780|NCT03131440|531143609|FG013|Overall Study|Lost to Follow-up|0|||
147264781|NCT03131440|531143610|FG014|Overall Study|Lost to Follow-up|0|||
147264782|NCT03131440|531143611|FG015|Overall Study|Lost to Follow-up|0|||
147264783|NCT03131440|531143612|FG016|Overall Study|Lost to Follow-up|0|||
147264784|NCT03131440|531143613|FG017|Overall Study|Lost to Follow-up|0|||
147264785|NCT03131440|531143614|FG018|Overall Study|Lost to Follow-up|0|||
147264786|NCT03131440|531143615|FG019|Overall Study|Lost to Follow-up|2|||
147264787|NCT03131440|531143616|FG020|Overall Study|Lost to Follow-up|1|||
147264788|NCT03131440|531143617|FG021|Overall Study|Lost to Follow-up|0|||
147264789|NCT03131440|531143618|FG022|Overall Study|Lost to Follow-up|1|||
147264790|NCT03131440|531143619|FG023|Overall Study|Lost to Follow-up|0|||
147264791|NCT03131440|531143620|FG024|Overall Study|Lost to Follow-up|1|||
147264792|NCT03131440|531143621|FG025|Overall Study|Lost to Follow-up|0|||
147264793|NCT03131440|531143622|FG026|Overall Study|Lost to Follow-up|0|||
147264794|NCT03131440|531143623|FG027|Overall Study|Lost to Follow-up|2|||
147264795|NCT03131440|531143624|FG028|Overall Study|Lost to Follow-up|0|||
147264796|NCT03131440|531143625|FG029|Overall Study|Lost to Follow-up|2|||
147264797|NCT03131440|531143626|FG030|Overall Study|Lost to Follow-up|0|||
147264798|NCT03131440|531143627|FG031|Overall Study|Lost to Follow-up|0|||
147264799|NCT03131440|531143596|FG000|Overall Study|Death|0|||
147264800|NCT03131440|531143597|FG001|Overall Study|Death|0|||
147264801|NCT03131440|531143598|FG002|Overall Study|Death|0|||
147264802|NCT03131440|531143599|FG003|Overall Study|Death|0|||
147264803|NCT03131440|531143600|FG004|Overall Study|Death|0|||
147264804|NCT03131440|531143601|FG005|Overall Study|Death|0|||
147264805|NCT03131440|531143602|FG006|Overall Study|Death|0|||
147264806|NCT03131440|531143603|FG007|Overall Study|Death|0|||
147264807|NCT03131440|531143604|FG008|Overall Study|Death|0|||
147264808|NCT03131440|531143605|FG009|Overall Study|Death|0|||
147264809|NCT03131440|531143606|FG010|Overall Study|Death|0|||
147264810|NCT03131440|531143607|FG011|Overall Study|Death|0|||
147264811|NCT03131440|531143608|FG012|Overall Study|Death|0|||
147264812|NCT03131440|531143609|FG013|Overall Study|Death|0|||
147264813|NCT03131440|531143610|FG014|Overall Study|Death|0|||
147264814|NCT03131440|531143611|FG015|Overall Study|Death|0|||
147264815|NCT03131440|531143612|FG016|Overall Study|Death|0|||
147264816|NCT03131440|531143613|FG017|Overall Study|Death|0|||
147264817|NCT03131440|531143614|FG018|Overall Study|Death|0|||
147264818|NCT03131440|531143615|FG019|Overall Study|Death|0|||
147599954|NCT05091307|532356264|FG001|Overall Study|Lost to Follow-up|33|||
147264819|NCT03131440|531143616|FG020|Overall Study|Death|0|||
147264820|NCT03131440|531143617|FG021|Overall Study|Death|0|||
147264821|NCT03131440|531143618|FG022|Overall Study|Death|0|||
147264822|NCT03131440|531143619|FG023|Overall Study|Death|0|||
147264823|NCT03131440|531143620|FG024|Overall Study|Death|0|||
147599955|NCT05091307|532356265|FG002|Overall Study|Lost to Follow-up|2|||
147264824|NCT03131440|531143621|FG025|Overall Study|Death|1|||
147599956|NCT05091307|532356266|FG003|Overall Study|Lost to Follow-up|0|||
147599957|NCT05091307|532356263|FG000|Overall Study|Physician Decision|1|||
147264825|NCT03131440|531143622|FG026|Overall Study|Death|0|||
147264826|NCT03131440|531143623|FG027|Overall Study|Death|0|||
147264827|NCT03131440|531143624|FG028|Overall Study|Death|0|||
147264828|NCT03131440|531143625|FG029|Overall Study|Death|0|||
147264829|NCT03131440|531143626|FG030|Overall Study|Death|0|||
147264830|NCT03131440|531143627|FG031|Overall Study|Death|0|||
147264831|NCT00746941|531143630|FG000|Overall Study|Death|2|||
147599958|NCT05091307|532356264|FG001|Overall Study|Physician Decision|0|||
147599959|NCT05091307|532356265|FG002|Overall Study|Physician Decision|0|||
147264832|NCT00746941|531143631|FG001|Overall Study|Death|0|||
147264833|NCT00746941|531143632|FG002|Overall Study|Death|0|||
147264834|NCT00746941|531143633|FG003|Overall Study|Death|6|||
147264835|NCT00746941|531143630|FG000|Overall Study|Physician Decision|0|||
147264836|NCT00746941|531143631|FG001|Overall Study|Physician Decision|0|||
147264837|NCT00746941|531143632|FG002|Overall Study|Physician Decision|2|||
147264838|NCT00746941|531143633|FG003|Overall Study|Physician Decision|0|||
147264839|NCT00746941|531143630|FG000|Overall Study|Withdrawal by Subject|3|||
147264840|NCT00746941|531143631|FG001|Overall Study|Withdrawal by Subject|0|||
147264841|NCT00746941|531143632|FG002|Overall Study|Withdrawal by Subject|0|||
147264842|NCT00746941|531143633|FG003|Overall Study|Withdrawal by Subject|2|||
147264843|NCT00746941|531143630|FG000|Overall Study|Other, reason not provided|2|||
147264844|NCT00746941|531143631|FG001|Overall Study|Other, reason not provided|4|||
147264845|NCT00746941|531143632|FG002|Overall Study|Other, reason not provided|0|||
147264846|NCT00746941|531143633|FG003|Overall Study|Other, reason not provided|4|||
147264847|NCT00746941|531143630|FG000|Overall Study|Adverse Event|0|||
147264848|NCT00746941|531143631|FG001|Overall Study|Adverse Event|0|||
147264849|NCT00746941|531143632|FG002|Overall Study|Adverse Event|0|||
147264850|NCT00746941|531143633|FG003|Overall Study|Adverse Event|1|||
147264851|NCT04371380|531143637|FG000|Oral Lead-in Phase (Up to Day 28)|Physician Decision|1|||
147264852|NCT04371380|531143638|FG001|Oral Lead-in Phase (Up to Day 28)|Physician Decision|0|||
147264853|NCT04371380|531143639|FG002|Oral Lead-in Phase (Up to Day 28)|Physician Decision|0|||
147264854|NCT01640366|531143643|FG000|Overall Study|Withdrawal by Subject|1|||
147264855|NCT01640366|531143643|FG000|Overall Study|Protocol Violation|16|||
147264856|NCT01640366|531143643|FG000|Overall Study|Lost to Follow-up|5|||
147264857|NCT02739269|531143644|FG000|Overall Study|Protocol Violation|5|||
147264858|NCT02739269|531143645|FG001|Overall Study|Protocol Violation|0|||
147264859|NCT02739269|531143644|FG000|Overall Study|Cycle cancellation|2|||
147264860|NCT02739269|531143645|FG001|Overall Study|Cycle cancellation|2|||
147264861|NCT02739269|531143644|FG000|Overall Study|Withdrawal by Subject|0|||
147264862|NCT02739269|531143645|FG001|Overall Study|Withdrawal by Subject|2|||
147264863|NCT00405548|531143648|FG000|Overall Study|Cognitive Memory problems on study day|1|||
147264864|NCT00405548|531143649|FG001|Overall Study|Cognitive Memory problems on study day|0|||
147264865|NCT00405548|531143648|FG000|Overall Study|Amyloidosis on study echo-exclusionary|0|||
147264866|NCT00405548|531143649|FG001|Overall Study|Amyloidosis on study echo-exclusionary|1|||
147264867|NCT00405548|531143648|FG000|Overall Study|Unable to self-administer shots|1|||
147264868|NCT00405548|531143649|FG001|Overall Study|Unable to self-administer shots|0|||
147264869|NCT00405548|531143648|FG000|Overall Study|Venous access failed during study day|1|||
147264870|NCT00405548|531143649|FG001|Overall Study|Venous access failed during study day|0|||
147264871|NCT00405548|531143648|FG000|Overall Study|Withdrawal by Subject|1|||
147264872|NCT00405548|531143649|FG001|Overall Study|Withdrawal by Subject|0|||
147264873|NCT01709695|531143650|FG000|Overall Study|Withdrawal by Subject|1|||
147264874|NCT01709695|531143651|FG001|Overall Study|Withdrawal by Subject|1|||
147264875|NCT00680901|531143655|FG000|Overall Study|Ongoing: On Study Treatment|1|||
147264876|NCT00680901|531143656|FG001|Overall Study|Ongoing: On Study Treatment|0|||
147264877|NCT00680901|531143655|FG000|Overall Study|Ongoing: In Follow Up|1|||
147599960|NCT05091307|532356266|FG003|Overall Study|Physician Decision|0|||
147599961|NCT05091307|532356263|FG000|Overall Study|Protocol Violation|1|||
147599962|NCT05091307|532356264|FG001|Overall Study|Protocol Violation|0|||
147264878|NCT00680901|531143656|FG001|Overall Study|Ongoing: In Follow Up|0|||
147264879|NCT00680901|531143655|FG000|Overall Study|Adverse Event|1|||
147264880|NCT00680901|531143656|FG001|Overall Study|Adverse Event|1|||
147264881|NCT00680901|531143655|FG000|Overall Study|Lost to Follow-up|3|||
147264882|NCT00680901|531143656|FG001|Overall Study|Lost to Follow-up|5|||
147264883|NCT00680901|531143655|FG000|Overall Study|Subject decided to withdraw from the study|4|||
147264884|NCT00680901|531143656|FG001|Overall Study|Subject decided to withdraw from the study|15|||
147264885|NCT00680901|531143655|FG000|Overall Study|Sponsor decision|1|||
147264886|NCT00680901|531143656|FG001|Overall Study|Sponsor decision|0|||
147264887|NCT00680901|531143655|FG000|Overall Study|Physician Decision|0|||
147599963|NCT05091307|532356265|FG002|Overall Study|Protocol Violation|0|||
147264888|NCT00680901|531143656|FG001|Overall Study|Physician Decision|2|||
147264889|NCT00680901|531143655|FG000|Overall Study|Subject reached protocol defined stopping criteria|1|||
147332919|NCT01212757|531385639|FG001|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|5|||
147332920|NCT01212757|531385640|FG002|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|12|||
147332921|NCT01212757|531385641|FG003|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
147332922|NCT01212757|531385642|FG004|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
147599964|NCT05091307|532356266|FG003|Overall Study|Protocol Violation|0|||
147264890|NCT00680901|531143656|FG001|Overall Study|Subject reached protocol defined stopping criteria|0|||
147264891|NCT00680901|531143655|FG000|Overall Study|Other protocol defined stopping criteria|17|||
147264892|NCT00680901|531143656|FG001|Overall Study|Other protocol defined stopping criteria|17|||
147264893|NCT00075582|531143657|FG000|Overall Study|Adverse Event|3|||
147264894|NCT00075582|531143658|FG001|Overall Study|Adverse Event|1|||
147264895|NCT00075582|531143657|FG000|Overall Study|Lack of Efficacy|4|||
147599965|NCT05091307|532356263|FG000|Overall Study|Withdrawal by Subject|16|||
147599966|NCT05091307|532356264|FG001|Overall Study|Withdrawal by Subject|16|||
147264896|NCT00075582|531143658|FG001|Overall Study|Lack of Efficacy|8|||
147264897|NCT00075582|531143657|FG000|Overall Study|Physician Decision|5|||
147264898|NCT00075582|531143658|FG001|Overall Study|Physician Decision|8|||
147264899|NCT00075582|531143657|FG000|Overall Study|Withdrawal by Subject|2|||
147264900|NCT00075582|531143658|FG001|Overall Study|Withdrawal by Subject|2|||
147264901|NCT00075582|531143657|FG000|Overall Study|Ineligible for study|36|||
147264902|NCT00075582|531143658|FG001|Overall Study|Ineligible for study|16|||
147264903|NCT01148511|531143660|FG000|Exposed to Study Drug|Protocol Violation|2|||
147264904|NCT01148511|531143661|FG001|Exposed to Study Drug|Protocol Violation|0|||
147264905|NCT01148511|531143662|FG002|Exposed to Study Drug|Protocol Violation|0|||
147264906|NCT01148511|531143660|FG000|Exposed to Study Drug|Lost to Follow-up|4|||
147264907|NCT01148511|531143661|FG001|Exposed to Study Drug|Lost to Follow-up|0|||
147264908|NCT01148511|531143662|FG002|Exposed to Study Drug|Lost to Follow-up|0|||
147264909|NCT01148511|531143660|FG000|Randomized|Adverse Event|0|||
147264910|NCT01148511|531143661|FG001|Randomized|Adverse Event|1|||
147264911|NCT01148511|531143662|FG002|Randomized|Adverse Event|0|||
147264912|NCT01148511|531143660|FG000|Randomized|Protocol Violation|0|||
147264913|NCT01148511|531143661|FG001|Randomized|Protocol Violation|2|||
147264914|NCT01148511|531143662|FG002|Randomized|Protocol Violation|1|||
147264915|NCT01148511|531143660|FG000|Randomized|Lost to Follow-up|0|||
147264916|NCT01148511|531143661|FG001|Randomized|Lost to Follow-up|1|||
147264917|NCT01148511|531143662|FG002|Randomized|Lost to Follow-up|1|||
147264918|NCT01148511|531143660|FG000|Randomized|Consent withdrawal|0|||
147264919|NCT01148511|531143661|FG001|Randomized|Consent withdrawal|5|||
147264920|NCT01148511|531143662|FG002|Randomized|Consent withdrawal|3|||
147264921|NCT01148511|531143660|FG000|Randomized|Other|0|||
147264922|NCT01148511|531143661|FG001|Randomized|Other|1|||
147264923|NCT01148511|531143662|FG002|Randomized|Other|1|||
147264924|NCT01644175|531143663|FG000|Overall Study|Randomized But Not Treated|0|||
147264925|NCT01644175|531143664|FG001|Overall Study|Randomized But Not Treated|2|||
147264926|NCT01644175|531143663|FG000|Overall Study|Adverse Event|8|||
147264927|NCT01644175|531143664|FG001|Overall Study|Adverse Event|13|||
147264928|NCT01644175|531143663|FG000|Overall Study|Death|1|||
147264929|NCT01644175|531143664|FG001|Overall Study|Death|2|||
147264930|NCT01644175|531143663|FG000|Overall Study|Poor compliance to protocol|9|||
147264931|NCT01644175|531143664|FG001|Overall Study|Poor compliance to protocol|10|||
147264932|NCT01644175|531143663|FG000|Overall Study|Physician Decision|1|||
147264933|NCT01644175|531143664|FG001|Overall Study|Physician Decision|2|||
147264934|NCT01644175|531143663|FG000|Overall Study|Participant Moved|1|||
147264935|NCT01644175|531143664|FG001|Overall Study|Participant Moved|2|||
147264936|NCT01644175|531143663|FG000|Overall Study|Consent withdrawn by participant|3|||
147264937|NCT01644175|531143664|FG001|Overall Study|Consent withdrawn by participant|4|||
147264938|NCT01644175|531143663|FG000|Overall Study|Related to Autoinjector Administration|2|||
147264939|NCT01644175|531143664|FG001|Overall Study|Related to Autoinjector Administration|1|||
147264940|NCT01644175|531143663|FG000|Overall Study|Last visit outside protocol visit window|4|||
147264941|NCT01644175|531143664|FG001|Overall Study|Last visit outside protocol visit window|11|||
147264942|NCT01644175|531143663|FG000|Overall Study|Selection criteria finally not met|0|||
147264943|NCT01644175|531143664|FG001|Overall Study|Selection criteria finally not met|1|||
147599967|NCT05091307|532356265|FG002|Overall Study|Withdrawal by Subject|0|||
147599968|NCT05091307|532356266|FG003|Overall Study|Withdrawal by Subject|1|||
147599969|NCT05091307|532356263|FG000|Overall Study|Covid-19 Vaccine/Treatment|14|||
147599970|NCT05091307|532356264|FG001|Overall Study|Covid-19 Vaccine/Treatment|15|||
147264944|NCT01644175|531143663|FG000|Overall Study|Site closure|2|||
147264945|NCT01644175|531143664|FG001|Overall Study|Site closure|2|||
147264946|NCT01644175|531143663|FG000|Overall Study|Lost to Follow-up|1|||
147264947|NCT01644175|531143664|FG001|Overall Study|Lost to Follow-up|0|||
147264948|NCT01644175|531143663|FG000|Overall Study|Other than specified above|0|||
147264949|NCT01644175|531143664|FG001|Overall Study|Other than specified above|3|||
147264950|NCT01177540|531143665|FG000|Overall Study|Adverse Event|1|||
147264951|NCT01177540|531143666|FG001|Overall Study|Adverse Event|0|||
147264952|NCT02818777|531143672|FG000|Overall Study|Adverse Event|3|||
147264953|NCT00856908|531143688|FG000|Overall Study|Lost to Follow-up|1|||
147264954|NCT00856908|531143689|FG001|Overall Study|Lost to Follow-up|0|||
147599971|NCT05091307|532356265|FG002|Overall Study|Covid-19 Vaccine/Treatment|1|||
147599972|NCT05091307|532356266|FG003|Overall Study|Covid-19 Vaccine/Treatment|1|||
147599973|NCT05091307|532356263|FG000|Overall Study|Initiated Prohibited Medication|1|||
147264955|NCT01070316|531143694|FG000|Extension Phase|Lack of Efficacy|3|||
147264956|NCT01070316|531143694|FG000|Extension Phase|Withdrawal by Subject|1|||
147264957|NCT02013167|531143698|FG000|Overall Study|Withdrawal by Subject|15|||
147264958|NCT02013167|531143699|FG001|Overall Study|Withdrawal by Subject|14|||
147264959|NCT02013167|531143698|FG000|Overall Study|Sponsor Decision|1|||
147264960|NCT02013167|531143699|FG001|Overall Study|Sponsor Decision|3|||
147264961|NCT02013167|531143698|FG000|Overall Study|Lost to Follow-up|0|||
147264962|NCT02013167|531143699|FG001|Overall Study|Lost to Follow-up|1|||
147264963|NCT02013167|531143698|FG000|Overall Study|Death|85|||
147264964|NCT02013167|531143699|FG001|Overall Study|Death|160|||
147264965|NCT00842348|531143702|FG000|Patients Randomised in Study 726|Did not enter Study 729|59|||
147264966|NCT00842348|531143703|FG001|Patients Randomised in Study 726|Did not enter Study 729|56|||
147264967|NCT00842348|531143702|FG000|Study 729|Disease progression/death|19|||
147264968|NCT00842348|531143703|FG001|Study 729|Disease progression/death|30|||
147264969|NCT00842348|531143702|FG000|Study 729|Adverse Event|1|||
147264970|NCT00842348|531143703|FG001|Study 729|Adverse Event|1|||
147264971|NCT00842348|531143702|FG000|Study 729|Protocol Violation|1|||
147264972|NCT00842348|531143703|FG001|Study 729|Protocol Violation|1|||
147264973|NCT00842348|531143702|FG000|Study 729|Withdrawal by Subject|2|||
147264974|NCT00842348|531143703|FG001|Study 729|Withdrawal by Subject|4|||
147264975|NCT00842348|531143702|FG000|Study 729|Due to Sponsor stopping the study|1|||
147264976|NCT00842348|531143703|FG001|Study 729|Due to Sponsor stopping the study|1|||
147264977|NCT00842348|531143702|FG000|Study 729|Due to non-availability of IP|0|||
147264978|NCT00842348|531143703|FG001|Study 729|Due to non-availability of IP|1|||
147264979|NCT00842348|531143702|FG000|Study 729|Sponsor's decision|1|||
147264980|NCT00842348|531143703|FG001|Study 729|Sponsor's decision|0|||
147264981|NCT00842348|531143702|FG000|Study 729|Surgical resection|1|||
147264982|NCT00842348|531143703|FG001|Study 729|Surgical resection|0|||
147264983|NCT01113879|531143706|FG000|Period 1: Block 1|Withdrawal by Subject|2|||
147264984|NCT01113879|531143707|FG001|Period 1: Block 1|Withdrawal by Subject|0|||
147264985|NCT00026793|531143708|FG000|Overall Study|Death on study due to underlying disease|4|||
147264986|NCT00026793|531143708|FG000|Overall Study|Physician Decision|2|||
147264987|NCT00026793|531143708|FG000|Overall Study|Off study|2|||
147264988|NCT04151290|531143709|FG000|Overall Study|The COVID-19 Pandemic made it hard for subjects to complete the study.|286|||
147264989|NCT01132495|531143710|FG000|Overall Study|Various reasons|40|||
147264990|NCT01132495|531143711|FG001|Overall Study|Various reasons|38|||
147264991|NCT01132495|531143712|FG002|Overall Study|Various reasons|20|||
147264992|NCT01132495|531143713|FG003|Overall Study|Various reasons|12|||
147264993|NCT00082433|531143716|FG000|Overall Study|Adverse Event|12|||
147264994|NCT00082433|531143717|FG001|Overall Study|Adverse Event|17|||
147264995|NCT00082433|531143716|FG000|Overall Study|Death|8|||
147264996|NCT00082433|531143717|FG001|Overall Study|Death|18|||
147264997|NCT00082433|531143716|FG000|Overall Study|Disease Progression/Relapse|270|||
147264998|NCT00082433|531143717|FG001|Overall Study|Disease Progression/Relapse|388|||
147264999|NCT00082433|531143716|FG000|Overall Study|Physician Decision|50|||
147265000|NCT00082433|531143717|FG001|Overall Study|Physician Decision|61|||
147265001|NCT00082433|531143716|FG000|Overall Study|Lost to Follow-up|1|||
147265002|NCT00082433|531143717|FG001|Overall Study|Lost to Follow-up|2|||
147265003|NCT00082433|531143716|FG000|Overall Study|Study Drug Toxicity|179|||
147265004|NCT00082433|531143717|FG001|Overall Study|Study Drug Toxicity|66|||
147265005|NCT00082433|531143716|FG000|Overall Study|Withdrawal by Subject|55|||
147265006|NCT00082433|531143717|FG001|Overall Study|Withdrawal by Subject|30|||
147265007|NCT00082433|531143716|FG000|Overall Study|Still On Treatment|2|||
147265008|NCT00082433|531143717|FG001|Overall Study|Still On Treatment|1|||
147265009|NCT00082433|531143716|FG000|Overall Study|Not Treated|12|||
147265010|NCT00082433|531143717|FG001|Overall Study|Not Treated|11|||
147265011|NCT00082433|531143716|FG000|Overall Study|Ineligible|2|||
147265012|NCT00082433|531143717|FG001|Overall Study|Ineligible|1|||
147265013|NCT00082433|531143716|FG000|Overall Study|Noncompliance|2|||
147265014|NCT00082433|531143717|FG001|Overall Study|Noncompliance|1|||
147265015|NCT00082433|531143716|FG000|Overall Study|New primary cancer|1|||
147265016|NCT00082433|531143717|FG001|Overall Study|New primary cancer|0|||
147265017|NCT00082433|531143716|FG000|Overall Study|Impending surgery|0|||
147265018|NCT00082433|531143717|FG001|Overall Study|Impending surgery|1|||
147265019|NCT02276612|531143720|FG000|Overall Study|Death|1|||
147265020|NCT02276612|531143721|FG001|Overall Study|Death|0|||
147332923|NCT01212757|531385643|FG005|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
147332924|NCT01212757|531385644|FG006|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
147332925|NCT01212757|531385645|FG007|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
147332926|NCT01212757|531385646|FG008|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
147332927|NCT01212757|531385638|FG000|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|3|||
147332928|NCT01212757|531385639|FG001|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|2|||
147332929|NCT01212757|531385640|FG002|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|2|||
147332930|NCT01212757|531385641|FG003|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
147332931|NCT01212757|531385642|FG004|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
147332932|NCT01212757|531385643|FG005|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
147332933|NCT01212757|531385644|FG006|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
147265021|NCT02276612|531143720|FG000|Overall Study|Pregnancy|1|||
147265022|NCT02276612|531143721|FG001|Overall Study|Pregnancy|0|||
147332934|NCT01212757|531385645|FG007|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
147265023|NCT02276612|531143720|FG000|Overall Study|Withdrew Consent|1|||
147265024|NCT02276612|531143721|FG001|Overall Study|Withdrew Consent|0|||
147265025|NCT02276612|531143720|FG000|Overall Study|Lost to Follow-up|1|||
147265026|NCT02276612|531143721|FG001|Overall Study|Lost to Follow-up|0|||
147265027|NCT01796197|531143722|FG000|Overall Study|Lost to Follow-up|1|||
147265028|NCT01796197|531143722|FG000|Overall Study|Lack of Efficacy|1|||
147265029|NCT04097821|531143723|FG000|Overall Study|Subject Decision|0|||
147265030|NCT04097821|531143724|FG001|Overall Study|Subject Decision|0|||
147265031|NCT04097821|531143725|FG002|Overall Study|Subject Decision|0|||
147265032|NCT04097821|531143726|FG003|Overall Study|Subject Decision|1|||
147265033|NCT04097821|531143727|FG004|Overall Study|Subject Decision|2|||
147265034|NCT04097821|531143728|FG005|Overall Study|Subject Decision|2|||
147265035|NCT04097821|531143729|FG006|Overall Study|Subject Decision|0|||
147265036|NCT04097821|531143730|FG007|Overall Study|Subject Decision|1|||
147265037|NCT04097821|531143723|FG000|Overall Study|Death|0|||
147265038|NCT04097821|531143724|FG001|Overall Study|Death|0|||
147265039|NCT04097821|531143725|FG002|Overall Study|Death|3|||
147265040|NCT04097821|531143726|FG003|Overall Study|Death|1|||
147265041|NCT04097821|531143727|FG004|Overall Study|Death|0|||
147265042|NCT04097821|531143728|FG005|Overall Study|Death|0|||
147265043|NCT04097821|531143729|FG006|Overall Study|Death|0|||
147265044|NCT04097821|531143730|FG007|Overall Study|Death|0|||
147265045|NCT04097821|531143723|FG000|Overall Study|Physician Decision|1|||
147265046|NCT04097821|531143724|FG001|Overall Study|Physician Decision|2|||
147265047|NCT04097821|531143725|FG002|Overall Study|Physician Decision|0|||
147265048|NCT04097821|531143726|FG003|Overall Study|Physician Decision|0|||
147265049|NCT04097821|531143727|FG004|Overall Study|Physician Decision|0|||
147265050|NCT04097821|531143728|FG005|Overall Study|Physician Decision|0|||
147265051|NCT04097821|531143729|FG006|Overall Study|Physician Decision|0|||
147265052|NCT04097821|531143730|FG007|Overall Study|Physician Decision|0|||
147265053|NCT04097821|531143723|FG000|Overall Study|Adverse Event|0|||
147265054|NCT04097821|531143724|FG001|Overall Study|Adverse Event|0|||
147265055|NCT04097821|531143725|FG002|Overall Study|Adverse Event|1|||
147265056|NCT04097821|531143726|FG003|Overall Study|Adverse Event|1|||
147265057|NCT04097821|531143727|FG004|Overall Study|Adverse Event|0|||
147265058|NCT04097821|531143728|FG005|Overall Study|Adverse Event|0|||
147265059|NCT04097821|531143729|FG006|Overall Study|Adverse Event|0|||
147265060|NCT04097821|531143730|FG007|Overall Study|Adverse Event|0|||
147265061|NCT04097821|531143723|FG000|Overall Study|New Therapy For Study Indication|0|||
147265062|NCT04097821|531143724|FG001|Overall Study|New Therapy For Study Indication|0|||
147265063|NCT04097821|531143725|FG002|Overall Study|New Therapy For Study Indication|0|||
147265064|NCT04097821|531143726|FG003|Overall Study|New Therapy For Study Indication|0|||
147265065|NCT04097821|531143727|FG004|Overall Study|New Therapy For Study Indication|0|||
147265066|NCT04097821|531143728|FG005|Overall Study|New Therapy For Study Indication|0|||
147265067|NCT04097821|531143729|FG006|Overall Study|New Therapy For Study Indication|1|||
147265068|NCT04097821|531143730|FG007|Overall Study|New Therapy For Study Indication|0|||
147265069|NCT00244712|531143731|FG000|Overall Study|Adverse Event|20|||
147265070|NCT00244712|531143732|FG001|Overall Study|Adverse Event|21|||
147265071|NCT00244712|531143731|FG000|Overall Study|Protocol-Defined Virologic Failure|8|||
147265072|NCT00244712|531143732|FG001|Overall Study|Protocol-Defined Virologic Failure|6|||
147265073|NCT00244712|531143731|FG000|Overall Study|Lack of Compliance|10|||
147265074|NCT00244712|531143732|FG001|Overall Study|Lack of Compliance|11|||
147265075|NCT00244712|531143731|FG000|Overall Study|Lost to Follow-up|45|||
147265076|NCT00244712|531143732|FG001|Overall Study|Lost to Follow-up|52|||
147265077|NCT00244712|531143731|FG000|Overall Study|Withdrawal by Subject|13|||
147265078|NCT00244712|531143732|FG001|Overall Study|Withdrawal by Subject|23|||
147265079|NCT00244712|531143731|FG000|Overall Study|Protocol Violation, disease progression|13|||
147265080|NCT00244712|531143732|FG001|Overall Study|Protocol Violation, disease progression|11|||
147265081|NCT02776917|531143733|FG000|Overall Study|Screen failures. One subject ended treatment early due to disease related symptoms|7|||
147265082|NCT02620046|531143734|FG000|Overall Study|Adverse Event|22|||
147332935|NCT01212757|531385646|FG008|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
147332936|NCT01212757|531385638|FG000|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|7|||
147332937|NCT01212757|531385639|FG001|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|9|||
147332938|NCT01212757|531385640|FG002|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|3|||
147332939|NCT01212757|531385641|FG003|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
147599974|NCT05091307|532356264|FG001|Overall Study|Initiated Prohibited Medication|0|||
147265083|NCT02620046|531143735|FG001|Overall Study|Adverse Event|42|||
147265084|NCT02620046|531143734|FG000|Overall Study|Lost to Follow-up|4|||
147599975|NCT05091307|532356265|FG002|Overall Study|Initiated Prohibited Medication|0|||
147265085|NCT02620046|531143735|FG001|Overall Study|Lost to Follow-up|10|||
147265086|NCT02620046|531143734|FG000|Overall Study|Withdrawal by Subject|36|||
147265087|NCT02620046|531143735|FG001|Overall Study|Withdrawal by Subject|66|||
147265088|NCT02620046|531143734|FG000|Overall Study|Site Termination|3|||
147332940|NCT01212757|531385642|FG004|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
147332941|NCT01212757|531385643|FG005|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
147265089|NCT02620046|531143735|FG001|Overall Study|Site Termination|3|||
147265090|NCT02620046|531143734|FG000|Overall Study|Pregnancy|3|||
147265091|NCT02620046|531143735|FG001|Overall Study|Pregnancy|7|||
147265092|NCT02620046|531143734|FG000|Overall Study|Lack of Efficacy|81|||
147265093|NCT02620046|531143735|FG001|Overall Study|Lack of Efficacy|146|||
147265094|NCT02620046|531143734|FG000|Overall Study|Leukopenia or Lymphopenia|1|||
147265095|NCT02620046|531143735|FG001|Overall Study|Leukopenia or Lymphopenia|0|||
147265096|NCT02620046|531143734|FG000|Overall Study|Reason Not Specified|13|||
147265097|NCT02620046|531143735|FG001|Overall Study|Reason Not Specified|21|||
147265098|NCT02620046|531143734|FG000|Overall Study|Significant Protocol Deviation|0|||
147265099|NCT02620046|531143735|FG001|Overall Study|Significant Protocol Deviation|1|||
147265100|NCT00403273|531145585|FG000|Overall Study|Lost to Follow-up|3|||
147265101|NCT00403273|531145586|FG001|Overall Study|Lost to Follow-up|2|||
147265102|NCT00403273|531145585|FG000|Overall Study|Physician Decision|0|||
147265103|NCT00403273|531145586|FG001|Overall Study|Physician Decision|1|||
147265104|NCT00403273|531145585|FG000|Overall Study|pt. wanted to have a surgical procedure|0|||
147265105|NCT00403273|531145586|FG001|Overall Study|pt. wanted to have a surgical procedure|1|||
147265106|NCT01336738|531145588|FG000|Overall Study|Adverse Event|0|||
147265107|NCT01336738|531145589|FG001|Overall Study|Adverse Event|3|||
147265108|NCT01336738|531145590|FG002|Overall Study|Adverse Event|2|||
147265109|NCT01336738|531145591|FG003|Overall Study|Adverse Event|1|||
147265110|NCT01336738|531145592|FG004|Overall Study|Adverse Event|3|||
147265111|NCT01336738|531145588|FG000|Overall Study|Lost to Follow-up|2|||
147265112|NCT01336738|531145589|FG001|Overall Study|Lost to Follow-up|1|||
147265113|NCT01336738|531145590|FG002|Overall Study|Lost to Follow-up|2|||
147265114|NCT01336738|531145591|FG003|Overall Study|Lost to Follow-up|2|||
147265115|NCT01336738|531145592|FG004|Overall Study|Lost to Follow-up|2|||
147265116|NCT01336738|531145588|FG000|Overall Study|Did not meet entrance criteria|0|||
147265117|NCT01336738|531145589|FG001|Overall Study|Did not meet entrance criteria|1|||
147265118|NCT01336738|531145590|FG002|Overall Study|Did not meet entrance criteria|0|||
147265119|NCT01336738|531145591|FG003|Overall Study|Did not meet entrance criteria|0|||
147265120|NCT01336738|531145592|FG004|Overall Study|Did not meet entrance criteria|0|||
147265121|NCT01336738|531145588|FG000|Overall Study|Protocol Violation|0|||
147265122|NCT01336738|531145589|FG001|Overall Study|Protocol Violation|1|||
147265123|NCT01336738|531145590|FG002|Overall Study|Protocol Violation|0|||
147265124|NCT01336738|531145591|FG003|Overall Study|Protocol Violation|0|||
147265125|NCT01336738|531145592|FG004|Overall Study|Protocol Violation|0|||
147265126|NCT01336738|531145588|FG000|Overall Study|Withdrawal by Subject|2|||
147265127|NCT01336738|531145589|FG001|Overall Study|Withdrawal by Subject|0|||
147265128|NCT01336738|531145590|FG002|Overall Study|Withdrawal by Subject|2|||
147265129|NCT01336738|531145591|FG003|Overall Study|Withdrawal by Subject|1|||
147265130|NCT01336738|531145592|FG004|Overall Study|Withdrawal by Subject|1|||
147265131|NCT01336738|531145588|FG000|Overall Study|Other|3|||
147265132|NCT01336738|531145589|FG001|Overall Study|Other|3|||
147265133|NCT01336738|531145590|FG002|Overall Study|Other|2|||
147265134|NCT01336738|531145591|FG003|Overall Study|Other|3|||
147265135|NCT01336738|531145592|FG004|Overall Study|Other|4|||
147265136|NCT01083433|531145593|FG000|Overall Study|Lost to Follow-up|2|||
147265137|NCT01083433|531145594|FG001|Overall Study|Lost to Follow-up|1|||
147265138|NCT01083433|531145595|FG002|Overall Study|Lost to Follow-up|1|||
147265139|NCT01083433|531145593|FG000|Overall Study|Withdrawal by Subject|0|||
147265140|NCT01083433|531145594|FG001|Overall Study|Withdrawal by Subject|5|||
147265141|NCT01083433|531145595|FG002|Overall Study|Withdrawal by Subject|3|||
147265142|NCT01083433|531145593|FG000|Overall Study|Pregnancy|0|||
147265143|NCT01083433|531145594|FG001|Overall Study|Pregnancy|0|||
147265144|NCT01083433|531145595|FG002|Overall Study|Pregnancy|1|||
147265145|NCT01332149|531145597|FG000|Overall Study|Adverse Event|11|||
147265146|NCT01332149|531145598|FG001|Overall Study|Adverse Event|9|||
147265147|NCT01332149|531145597|FG000|Overall Study|Other unspecified|5|||
147265148|NCT01332149|531145598|FG001|Overall Study|Other unspecified|7|||
147265149|NCT01332149|531145597|FG000|Overall Study|Protocol Violation|1|||
147265150|NCT01332149|531145598|FG001|Overall Study|Protocol Violation|3|||
147265151|NCT01332149|531145597|FG000|Overall Study|Withdrawal by Subject|4|||
147265152|NCT01332149|531145598|FG001|Overall Study|Withdrawal by Subject|5|||
147265153|NCT01332149|531145597|FG000|Overall Study|Lost to Follow-up|1|||
147265154|NCT01332149|531145598|FG001|Overall Study|Lost to Follow-up|1|||
147265155|NCT01332149|531145597|FG000|Overall Study|Insufficient clinical response|4|||
147265156|NCT01332149|531145598|FG001|Overall Study|Insufficient clinical response|7|||
147265157|NCT01332149|531145597|FG000|Overall Study|Did not meet entrance criteria|3|||
147265158|NCT01332149|531145598|FG001|Overall Study|Did not meet entrance criteria|4|||
147265159|NCT01332149|531145597|FG000|Overall Study|Randomized but not treated|1|||
147265160|NCT01332149|531145598|FG001|Overall Study|Randomized but not treated|2|||
147265161|NCT04615949|531145603|FG000|Overall Study|Withdrawal by Subject|2|||
147265162|NCT04615949|531145604|FG001|Overall Study|Withdrawal by Subject|4|||
147332942|NCT01212757|531385644|FG006|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
147332943|NCT01212757|531385645|FG007|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
147265163|NCT04615949|531145603|FG000|Overall Study|Lost to Follow-up|2|||
147265164|NCT04615949|531145604|FG001|Overall Study|Lost to Follow-up|2|||
147265165|NCT04615949|531145603|FG000|Overall Study|Death|0|||
147265166|NCT04615949|531145604|FG001|Overall Study|Death|2|||
147643975|NCT01447446|532516691|FG005|Overall Study|Death|0|||
147265167|NCT03036566|531145605|FG000|Overall Study|Lost to Follow-up|3|||
147265168|NCT05458856|531145606|FG000|Overall Study|Withdrawal by Subject|5|||
147265169|NCT05458856|531145606|FG000|Overall Study|Death|4|||
147265170|NCT05458856|531145606|FG000|Overall Study|Protocol Deviation|3|||
147265171|NCT05458856|531145606|FG000|Overall Study|Physician Decision|1|||
147265172|NCT01852292|531145607|FG000|Overall Study|Untreated - did not receive study drug|3|||
147643976|NCT01447446|532516686|FG000|Overall Study|Adverse Event|3|||
147265173|NCT01852292|531145608|FG001|Overall Study|Untreated - did not receive study drug|1|||
147265174|NCT01852292|531145607|FG000|Overall Study|Death|9|||
147265175|NCT01852292|531145608|FG001|Overall Study|Death|8|||
147265176|NCT01852292|531145607|FG000|Overall Study|Patient/guardian decision|8|||
147265177|NCT01852292|531145608|FG001|Overall Study|Patient/guardian decision|4|||
147265178|NCT01852292|531145607|FG000|Overall Study|Adverse Event|8|||
147265179|NCT01852292|531145608|FG001|Overall Study|Adverse Event|11|||
147265180|NCT01852292|531145607|FG000|Overall Study|Physician Decision|6|||
147265181|NCT01852292|531145608|FG001|Overall Study|Physician Decision|2|||
147265182|NCT01852292|531145607|FG000|Overall Study|Protocol Violation|2|||
147265183|NCT01852292|531145608|FG001|Overall Study|Protocol Violation|0|||
147265184|NCT01852292|531145607|FG000|Overall Study|Non-compliance with study treatment|1|||
147265185|NCT01852292|531145608|FG001|Overall Study|Non-compliance with study treatment|0|||
147265186|NCT01852292|531145607|FG000|Overall Study|Study terminated by Sponsor|0|||
147265187|NCT01852292|531145608|FG001|Overall Study|Study terminated by Sponsor|1|||
147265188|NCT01852292|531145607|FG000|Overall Study|Progressive disease|42|||
147265189|NCT01852292|531145608|FG001|Overall Study|Progressive disease|52|||
147265190|NCT01572038|531145612|FG000|Overall Study|Death|648|||
147265191|NCT01572038|531145612|FG000|Overall Study|Withdrawal by Subject|204|||
147265192|NCT01572038|531145612|FG000|Overall Study|Lost to Follow-up|81|||
147265193|NCT01572038|531145612|FG000|Overall Study|Physician Decision|20|||
147265194|NCT01572038|531145612|FG000|Overall Study|Patient Decision|14|||
147265195|NCT01572038|531145612|FG000|Overall Study|Progressive Disease|8|||
147265196|NCT01572038|531145612|FG000|Overall Study|Site Closed Before Completing Form|6|||
147265197|NCT01572038|531145612|FG000|Overall Study|Enrolled into Another Trial|3|||
147265198|NCT01572038|531145612|FG000|Overall Study|Participated in Another Trial|3|||
147265199|NCT01572038|531145612|FG000|Overall Study|Termination by Sponsor|2|||
147265200|NCT01572038|531145612|FG000|Overall Study|Patient Deterioration|1|||
147265201|NCT01572038|531145612|FG000|Overall Study|Sponsor Decision|1|||
147265202|NCT01888497|531145613|FG000|Washout Period 1|Withdrawal by Subject|0|||
147265203|NCT01888497|531145614|FG001|Washout Period 1|Withdrawal by Subject|0|||
147265204|NCT01888497|531145615|FG002|Washout Period 1|Withdrawal by Subject|1|||
147265205|NCT01888497|531145616|FG003|Washout Period 1|Withdrawal by Subject|1|||
147265206|NCT01888497|531145613|FG000|Washout Period 2|Adverse Event|0|||
147265207|NCT01888497|531145614|FG001|Washout Period 2|Adverse Event|0|||
147265208|NCT01888497|531145615|FG002|Washout Period 2|Adverse Event|0|||
147265209|NCT01888497|531145616|FG003|Washout Period 2|Adverse Event|1|||
147265210|NCT01888497|531145613|FG000|Washout Period 2|Withdrawal by Subject|0|||
147265211|NCT01888497|531145614|FG001|Washout Period 2|Withdrawal by Subject|0|||
147265212|NCT01888497|531145615|FG002|Washout Period 2|Withdrawal by Subject|0|||
147265213|NCT01888497|531145616|FG003|Washout Period 2|Withdrawal by Subject|1|||
147265214|NCT04152447|531145617|FG000|Overall Study|Lost to Follow-up|1|||
147265215|NCT04152447|531145618|FG001|Overall Study|Lost to Follow-up|0|||
147265216|NCT04152447|531145617|FG000|Overall Study|Treatment plan switched to an ineligible criteria|1|||
147265217|NCT04152447|531145618|FG001|Overall Study|Treatment plan switched to an ineligible criteria|1|||
147265218|NCT04152447|531145617|FG000|Overall Study|Withdrawal by Subject|0|||
147265219|NCT04152447|531145618|FG001|Overall Study|Withdrawal by Subject|1|||
147265220|NCT04152447|531145617|FG000|Overall Study|Found ineligible after enrolling|1|||
147265221|NCT04152447|531145618|FG001|Overall Study|Found ineligible after enrolling|1|||
147265222|NCT04152447|531145617|FG000|Overall Study|Did not receive VR headset in time.|0|||
147265223|NCT04152447|531145618|FG001|Overall Study|Did not receive VR headset in time.|2|||
147265224|NCT04013191|531145619|FG000|Overall Study|Adverse Event|1|||
147265225|NCT04013191|531145620|FG001|Overall Study|Adverse Event|0|||
147265226|NCT03711162|531145629|FG000|Overall Study|Adverse Event|5|||
147265227|NCT03711162|531145630|FG001|Overall Study|Adverse Event|2|||
147265228|NCT03711162|531145631|FG002|Overall Study|Adverse Event|4|||
147265229|NCT03711162|531145629|FG000|Overall Study|Death|11|||
147265230|NCT03711162|531145630|FG001|Overall Study|Death|7|||
147265231|NCT03711162|531145631|FG002|Overall Study|Death|8|||
147265232|NCT03711162|531145629|FG000|Overall Study|Lost to Follow-up|1|||
147265233|NCT03711162|531145630|FG001|Overall Study|Lost to Follow-up|0|||
147265234|NCT03711162|531145631|FG002|Overall Study|Lost to Follow-up|1|||
147265235|NCT03711162|531145629|FG000|Overall Study|Study Terminated by Sponsor|139|||
147265236|NCT03711162|531145630|FG001|Overall Study|Study Terminated by Sponsor|152|||
147265237|NCT03711162|531145631|FG002|Overall Study|Study Terminated by Sponsor|146|||
147265238|NCT03711162|531145629|FG000|Overall Study|Withdrawal by Subject|17|||
147265239|NCT03711162|531145630|FG001|Overall Study|Withdrawal by Subject|10|||
147265240|NCT03711162|531145631|FG002|Overall Study|Withdrawal by Subject|10|||
147265241|NCT03711162|531145629|FG000|Overall Study|Miscellaneous|1|||
147265242|NCT03711162|531145630|FG001|Overall Study|Miscellaneous|2|||
147265243|NCT03711162|531145631|FG002|Overall Study|Miscellaneous|2|||
147265244|NCT03711162|531145629|FG000|Overall Study|Not Treated|1|||
147265245|NCT03711162|531145630|FG001|Overall Study|Not Treated|0|||
147265246|NCT03711162|531145631|FG002|Overall Study|Not Treated|1|||
147265247|NCT03711162|531145629|FG000|Overall Study|Physician Decision|0|||
147265248|NCT03711162|531145630|FG001|Overall Study|Physician Decision|2|||
147265249|NCT03711162|531145631|FG002|Overall Study|Physician Decision|0|||
147265250|NCT03711162|531145629|FG000|Overall Study|Lack of Efficacy|0|||
147265251|NCT03711162|531145630|FG001|Overall Study|Lack of Efficacy|0|||
147265252|NCT03711162|531145631|FG002|Overall Study|Lack of Efficacy|2|||
147265253|NCT03711162|531145629|FG000|Overall Study|Protocol Specified Withdrawal Criteria Met|0|||
147265254|NCT03711162|531145630|FG001|Overall Study|Protocol Specified Withdrawal Criteria Met|0|||
147265255|NCT03711162|531145631|FG002|Overall Study|Protocol Specified Withdrawal Criteria Met|1|||
147265256|NCT03034954|531145632|FG000|Overall Study|Machine malfunction; did not reach 3 mA|1|||
147265257|NCT03034954|531145633|FG001|Overall Study|Machine malfunction; did not reach 3 mA|0|||
147265258|NCT01275066|531145640|FG000|Overall Study|Withdrawal by Subject|0|||
147265259|NCT01275066|531145641|FG001|Overall Study|Withdrawal by Subject|0|||
147265260|NCT01275066|531145642|FG002|Overall Study|Withdrawal by Subject|1|||
147265261|NCT01275066|531145640|FG000|Overall Study|Not Diagnosed w/ Disease|1|||
147265262|NCT01275066|531145641|FG001|Overall Study|Not Diagnosed w/ Disease|0|||
147265263|NCT01275066|531145642|FG002|Overall Study|Not Diagnosed w/ Disease|0|||
147265264|NCT00394212|531145645|FG000|Overall Study|Lost to Follow-up|3|||
147265265|NCT00394212|531145646|FG001|Overall Study|Lost to Follow-up|0|||
147265266|NCT00394212|531145645|FG000|Overall Study|Withdrawal by Subject|4|||
147265267|NCT00394212|531145646|FG001|Overall Study|Withdrawal by Subject|1|||
147265268|NCT00588445|531145647|FG000|Overall Study|Protocol Violation|1|||
147265269|NCT00588445|531145647|FG000|Overall Study|Withdrawal by Subject|3|||
147265270|NCT00588445|531145647|FG000|Overall Study|Disease Progression|1|||
147265271|NCT00588445|531145647|FG000|Overall Study|Not Treated|10|||
147265272|NCT03240133|531145648|FG000|Overall Study|Withdrawal by Subject|0|||
147265273|NCT03240133|531145649|FG001|Overall Study|Withdrawal by Subject|1|||
147265274|NCT03240133|531145650|FG002|Overall Study|Withdrawal by Subject|0|||
147265275|NCT03240133|531145648|FG000|Overall Study|Adverse Event|1|||
147265276|NCT03240133|531145649|FG001|Overall Study|Adverse Event|1|||
147265277|NCT03240133|531145650|FG002|Overall Study|Adverse Event|0|||
147265278|NCT03240133|531145648|FG000|Overall Study|Rash|1|||
147265279|NCT03240133|531145649|FG001|Overall Study|Rash|0|||
147265280|NCT03240133|531145650|FG002|Overall Study|Rash|0|||
147265281|NCT03240133|531145648|FG000|Overall Study|sponsor closure/completion of Part 1 of the study|1|||
147265282|NCT03240133|531145649|FG001|Overall Study|sponsor closure/completion of Part 1 of the study|0|||
147265283|NCT03240133|531145650|FG002|Overall Study|sponsor closure/completion of Part 1 of the study|0|||
147265284|NCT03240133|531145648|FG000|Overall Study|Intercurrent illness.|0|||
147265285|NCT03240133|531145649|FG001|Overall Study|Intercurrent illness.|1|||
147265286|NCT03240133|531145650|FG002|Overall Study|Intercurrent illness.|0|||
147265287|NCT03240133|531145648|FG000|Overall Study|Sponsor/competent authority/IRB/IEC discontinuation|0|||
147265288|NCT03240133|531145649|FG001|Overall Study|Sponsor/competent authority/IRB/IEC discontinuation|0|||
147265289|NCT03240133|531145650|FG002|Overall Study|Sponsor/competent authority/IRB/IEC discontinuation|1|||
147265290|NCT00116831|531145653|FG000|Overall Study|Adverse Event|14|||
147265291|NCT00116831|531145654|FG001|Overall Study|Adverse Event|16|||
147265292|NCT00116831|531145653|FG000|Overall Study|Baseline IVUS determined unevaluable|12|||
147265293|NCT00116831|531145654|FG001|Overall Study|Baseline IVUS determined unevaluable|11|||
147265294|NCT00116831|531145653|FG000|Overall Study|Lost to Follow-up|8|||
147265295|NCT00116831|531145654|FG001|Overall Study|Lost to Follow-up|6|||
147265296|NCT00116831|531145653|FG000|Overall Study|Protocol Violation|3|||
147265297|NCT00116831|531145654|FG001|Overall Study|Protocol Violation|6|||
147265298|NCT00116831|531145653|FG000|Overall Study|Hypoglycaemic events|1|||
147265299|NCT00116831|531145654|FG001|Overall Study|Hypoglycaemic events|0|||
147265300|NCT00116831|531145653|FG000|Overall Study|Low haemoglobin on screening|1|||
147265301|NCT00116831|531145654|FG001|Overall Study|Low haemoglobin on screening|0|||
147265302|NCT00116831|531145653|FG000|Overall Study|Withdrawn investigational product|1|||
147265303|NCT00116831|531145654|FG001|Overall Study|Withdrawn investigational product|0|||
147265304|NCT00116831|531145653|FG000|Overall Study|Withdrawal by Subject|32|||
147265305|NCT00116831|531145654|FG001|Overall Study|Withdrawal by Subject|32|||
147265306|NCT00116831|531145653|FG000|Overall Study|Insufficient therapeutic effect|0|||
147265307|NCT00116831|531145654|FG001|Overall Study|Insufficient therapeutic effect|1|||
147265308|NCT00116831|531145653|FG000|Overall Study|Missing data for participant|1|||
147265309|NCT00116831|531145654|FG001|Overall Study|Missing data for participant|0|||
147265310|NCT04904185|531145655|FG000|Overall Study|Expansion failure|1|||
147265311|NCT04904185|531145656|FG001|Overall Study|Expansion failure|0|||
147265312|NCT04904185|531145655|FG000|Overall Study|Late response on prior treatment|1|||
147265313|NCT04904185|531145656|FG001|Overall Study|Late response on prior treatment|0|||
147265314|NCT02945410|531145657|FG000|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
147265315|NCT02945410|531145658|FG001|Intervention 1 (5 Days)|Withdrawal by Subject|3|||
147265316|NCT02945410|531145659|FG002|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
147265317|NCT02945410|531145660|FG003|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
147265318|NCT02945410|531145661|FG004|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
147265319|NCT02945410|531145662|FG005|Intervention 1 (5 Days)|Withdrawal by Subject|0|||
147265320|NCT02945410|531145657|FG000|Intervention 1 (5 Days)|Adverse Event|1|||
147265321|NCT02945410|531145658|FG001|Intervention 1 (5 Days)|Adverse Event|0|||
147265322|NCT02945410|531145659|FG002|Intervention 1 (5 Days)|Adverse Event|0|||
147265323|NCT02945410|531145660|FG003|Intervention 1 (5 Days)|Adverse Event|0|||
147643977|NCT01447446|532516687|FG001|Overall Study|Adverse Event|0|||
147265324|NCT02945410|531145661|FG004|Intervention 1 (5 Days)|Adverse Event|0|||
147265325|NCT02945410|531145662|FG005|Intervention 1 (5 Days)|Adverse Event|1|||
147265326|NCT02945410|531145657|FG000|Washout 1 (14 Days)|Withdrawal by Subject|0|||
147265327|NCT02945410|531145658|FG001|Washout 1 (14 Days)|Withdrawal by Subject|0|||
147265328|NCT02945410|531145659|FG002|Washout 1 (14 Days)|Withdrawal by Subject|2|||
147265329|NCT02945410|531145660|FG003|Washout 1 (14 Days)|Withdrawal by Subject|0|||
147265330|NCT02945410|531145661|FG004|Washout 1 (14 Days)|Withdrawal by Subject|1|||
147265331|NCT02945410|531145662|FG005|Washout 1 (14 Days)|Withdrawal by Subject|0|||
147265332|NCT00110812|531145665|FG000|Main Study|Death|0|||
147265333|NCT00110812|531145666|FG001|Main Study|Death|0|||
147265334|NCT00110812|531145667|FG002|Main Study|Death|2|||
147265335|NCT00110812|531145665|FG000|Main Study|Withdrawal by Subject|0|||
147265336|NCT00110812|531145666|FG001|Main Study|Withdrawal by Subject|0|||
147265337|NCT00110812|531145667|FG002|Main Study|Withdrawal by Subject|1|||
147265338|NCT00110812|531145665|FG000|Main Study|Lost to Follow-up|8|||
147265339|NCT00110812|531145666|FG001|Main Study|Lost to Follow-up|11|||
147265340|NCT00110812|531145667|FG002|Main Study|Lost to Follow-up|10|||
147265341|NCT00110812|531145665|FG000|Extended Follow-up|Death|1|||
147265342|NCT00110812|531145666|FG001|Extended Follow-up|Death|0|||
147265343|NCT00110812|531145667|FG002|Extended Follow-up|Death|3|||
147265344|NCT00110812|531145665|FG000|Extended Follow-up|Withdrawal by Subject|0|||
147599976|NCT05091307|532356266|FG003|Overall Study|Initiated Prohibited Medication|0|||
147599977|NCT05091307|532356263|FG000|Overall Study|Other|4|||
147599978|NCT05091307|532356264|FG001|Overall Study|Other|4|||
147599979|NCT05091307|532356265|FG002|Overall Study|Other|0|||
147265345|NCT00110812|531145666|FG001|Extended Follow-up|Withdrawal by Subject|1|||
147265346|NCT00110812|531145667|FG002|Extended Follow-up|Withdrawal by Subject|0|||
147265347|NCT00110812|531145665|FG000|Extended Follow-up|Lost to Follow-up|1|||
147265348|NCT00110812|531145666|FG001|Extended Follow-up|Lost to Follow-up|3|||
147265349|NCT00110812|531145667|FG002|Extended Follow-up|Lost to Follow-up|1|||
147265350|NCT00735371|531145670|FG000|Overall Study|Adverse Event|3|||
147265351|NCT00735371|531145671|FG001|Overall Study|Adverse Event|3|||
147265352|NCT00735371|531145672|FG002|Overall Study|Adverse Event|4|||
147265353|NCT00735371|531145673|FG003|Overall Study|Adverse Event|1|||
147265354|NCT00735371|531145670|FG000|Overall Study|Protocol Violation|2|||
147265355|NCT00735371|531145671|FG001|Overall Study|Protocol Violation|2|||
147265356|NCT00735371|531145672|FG002|Overall Study|Protocol Violation|0|||
147265357|NCT00735371|531145673|FG003|Overall Study|Protocol Violation|3|||
147265358|NCT00735371|531145670|FG000|Overall Study|Withdrawal by Subject|0|||
147265359|NCT00735371|531145671|FG001|Overall Study|Withdrawal by Subject|2|||
147265360|NCT00735371|531145672|FG002|Overall Study|Withdrawal by Subject|2|||
147265361|NCT00735371|531145673|FG003|Overall Study|Withdrawal by Subject|0|||
147265362|NCT00735371|531145670|FG000|Overall Study|Lost to Follow-up|1|||
147265363|NCT00735371|531145671|FG001|Overall Study|Lost to Follow-up|1|||
147265364|NCT00735371|531145672|FG002|Overall Study|Lost to Follow-up|3|||
147265365|NCT00735371|531145673|FG003|Overall Study|Lost to Follow-up|1|||
147265366|NCT00735371|531145670|FG000|Overall Study|Lack of Efficacy|4|||
147265367|NCT00735371|531145671|FG001|Overall Study|Lack of Efficacy|2|||
147265368|NCT00735371|531145672|FG002|Overall Study|Lack of Efficacy|0|||
147265369|NCT00735371|531145673|FG003|Overall Study|Lack of Efficacy|4|||
147265370|NCT00735371|531145670|FG000|Overall Study|Sponsor Decision|3|||
147265371|NCT00735371|531145671|FG001|Overall Study|Sponsor Decision|1|||
147265372|NCT00735371|531145672|FG002|Overall Study|Sponsor Decision|0|||
147265373|NCT00735371|531145673|FG003|Overall Study|Sponsor Decision|1|||
147265374|NCT00735371|531145670|FG000|Overall Study|Protocol Violation|0|||
147265375|NCT00735371|531145671|FG001|Overall Study|Protocol Violation|1|||
147265376|NCT00735371|531145672|FG002|Overall Study|Protocol Violation|2|||
147265377|NCT00735371|531145673|FG003|Overall Study|Protocol Violation|0|||
147265378|NCT00735371|531145670|FG000|Overall Study|Prior Vyvanse Exposure|1|||
147265379|NCT00735371|531145671|FG001|Overall Study|Prior Vyvanse Exposure|1|||
147265380|NCT00735371|531145672|FG002|Overall Study|Prior Vyvanse Exposure|0|||
147265381|NCT00735371|531145673|FG003|Overall Study|Prior Vyvanse Exposure|0|||
147265382|NCT00735371|531145670|FG000|Overall Study|Exclusion criteria|1|||
147265383|NCT00735371|531145671|FG001|Overall Study|Exclusion criteria|0|||
147265384|NCT00735371|531145672|FG002|Overall Study|Exclusion criteria|0|||
147265385|NCT00735371|531145673|FG003|Overall Study|Exclusion criteria|0|||
147265386|NCT01604343|531145674|FG000|Prior to W52 Administration(Through W52)|Lost to Follow-up|5|||
147265387|NCT01604343|531145675|FG001|Prior to W52 Administration(Through W52)|Lost to Follow-up|0|||
147265388|NCT01604343|531145676|FG002|Prior to W52 Administration(Through W52)|Lost to Follow-up|4|||
147265389|NCT01604343|531145677|FG003|Prior to W52 Administration(Through W52)|Lost to Follow-up|0|||
147265390|NCT01604343|531145678|FG004|Prior to W52 Administration(Through W52)|Lost to Follow-up|3|||
147265391|NCT01604343|531145674|FG000|Prior to W52 Administration(Through W52)|Withdrawal by Subject|19|||
147265392|NCT01604343|531145675|FG001|Prior to W52 Administration(Through W52)|Withdrawal by Subject|0|||
147265393|NCT01604343|531145676|FG002|Prior to W52 Administration(Through W52)|Withdrawal by Subject|12|||
147332944|NCT01212757|531385646|FG008|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
147599980|NCT05091307|532356266|FG003|Overall Study|Other|0|||
147599981|NCT05091307|532356263|FG000|Overall Study|Randomized but not vaccinated|0|||
147265394|NCT01604343|531145677|FG003|Prior to W52 Administration(Through W52)|Withdrawal by Subject|0|||
147265395|NCT01604343|531145678|FG004|Prior to W52 Administration(Through W52)|Withdrawal by Subject|16|||
147265396|NCT01604343|531145674|FG000|Prior to W52 Administration(Through W52)|Adverse Event|25|||
147265397|NCT01604343|531145675|FG001|Prior to W52 Administration(Through W52)|Adverse Event|0|||
147265398|NCT01604343|531145676|FG002|Prior to W52 Administration(Through W52)|Adverse Event|41|||
147265399|NCT01604343|531145677|FG003|Prior to W52 Administration(Through W52)|Adverse Event|0|||
147265400|NCT01604343|531145678|FG004|Prior to W52 Administration(Through W52)|Adverse Event|42|||
147265401|NCT01604343|531145674|FG000|Prior to W52 Administration(Through W52)|Death|5|||
147265402|NCT01604343|531145675|FG001|Prior to W52 Administration(Through W52)|Death|0|||
147265403|NCT01604343|531145676|FG002|Prior to W52 Administration(Through W52)|Death|2|||
147265404|NCT01604343|531145677|FG003|Prior to W52 Administration(Through W52)|Death|0|||
147265405|NCT01604343|531145678|FG004|Prior to W52 Administration(Through W52)|Death|4|||
147265406|NCT01604343|531145674|FG000|Prior to W52 Administration(Through W52)|Lack of Efficacy|24|||
147265407|NCT01604343|531145675|FG001|Prior to W52 Administration(Through W52)|Lack of Efficacy|0|||
147265408|NCT01604343|531145676|FG002|Prior to W52 Administration(Through W52)|Lack of Efficacy|5|||
147265409|NCT01604343|531145677|FG003|Prior to W52 Administration(Through W52)|Lack of Efficacy|0|||
147265410|NCT01604343|531145678|FG004|Prior to W52 Administration(Through W52)|Lack of Efficacy|14|||
147265411|NCT01604343|531145674|FG000|Prior to W52 Administration(Through W52)|Physician Decision|4|||
147265412|NCT01604343|531145675|FG001|Prior to W52 Administration(Through W52)|Physician Decision|0|||
147265413|NCT01604343|531145676|FG002|Prior to W52 Administration(Through W52)|Physician Decision|1|||
147265414|NCT01604343|531145677|FG003|Prior to W52 Administration(Through W52)|Physician Decision|0|||
147265415|NCT01604343|531145678|FG004|Prior to W52 Administration(Through W52)|Physician Decision|2|||
147265416|NCT01604343|531145674|FG000|Prior to W52 Administration(Through W52)|Pregnancy|1|||
147265417|NCT01604343|531145675|FG001|Prior to W52 Administration(Through W52)|Pregnancy|0|||
147265418|NCT01604343|531145676|FG002|Prior to W52 Administration(Through W52)|Pregnancy|1|||
147265419|NCT01604343|531145677|FG003|Prior to W52 Administration(Through W52)|Pregnancy|0|||
147265420|NCT01604343|531145678|FG004|Prior to W52 Administration(Through W52)|Pregnancy|0|||
147265421|NCT01604343|531145674|FG000|Prior to W52 Administration(Through W52)|Other|15|||
147265422|NCT01604343|531145675|FG001|Prior to W52 Administration(Through W52)|Other|0|||
147265423|NCT01604343|531145676|FG002|Prior to W52 Administration(Through W52)|Other|10|||
147265424|NCT01604343|531145677|FG003|Prior to W52 Administration(Through W52)|Other|0|||
147265425|NCT01604343|531145678|FG004|Prior to W52 Administration(Through W52)|Other|6|||
147265426|NCT01604343|531145674|FG000|Week 52 to Week 104|Lost to Follow-up|0|||
147265427|NCT01604343|531145675|FG001|Week 52 to Week 104|Lost to Follow-up|2|||
147265428|NCT01604343|531145676|FG002|Week 52 to Week 104|Lost to Follow-up|4|||
147265429|NCT01604343|531145677|FG003|Week 52 to Week 104|Lost to Follow-up|2|||
147265430|NCT01604343|531145678|FG004|Week 52 to Week 104|Lost to Follow-up|1|||
147265431|NCT01604343|531145674|FG000|Week 52 to Week 104|Withdrawal by Subject|0|||
147265432|NCT01604343|531145675|FG001|Week 52 to Week 104|Withdrawal by Subject|7|||
147265433|NCT01604343|531145676|FG002|Week 52 to Week 104|Withdrawal by Subject|12|||
147265434|NCT01604343|531145677|FG003|Week 52 to Week 104|Withdrawal by Subject|8|||
147265435|NCT01604343|531145678|FG004|Week 52 to Week 104|Withdrawal by Subject|4|||
147265436|NCT01604343|531145674|FG000|Week 52 to Week 104|Adverse Event|0|||
147265437|NCT01604343|531145675|FG001|Week 52 to Week 104|Adverse Event|12|||
147265438|NCT01604343|531145676|FG002|Week 52 to Week 104|Adverse Event|26|||
147265439|NCT01604343|531145677|FG003|Week 52 to Week 104|Adverse Event|21|||
147265440|NCT01604343|531145678|FG004|Week 52 to Week 104|Adverse Event|27|||
147265441|NCT01604343|531145674|FG000|Week 52 to Week 104|Death|0|||
147265442|NCT01604343|531145675|FG001|Week 52 to Week 104|Death|4|||
147265443|NCT01604343|531145676|FG002|Week 52 to Week 104|Death|2|||
147265444|NCT01604343|531145677|FG003|Week 52 to Week 104|Death|5|||
147265445|NCT01604343|531145678|FG004|Week 52 to Week 104|Death|0|||
147265446|NCT01604343|531145674|FG000|Week 52 to Week 104|Lack of Efficacy|0|||
147265447|NCT01604343|531145675|FG001|Week 52 to Week 104|Lack of Efficacy|6|||
147265448|NCT01604343|531145676|FG002|Week 52 to Week 104|Lack of Efficacy|11|||
147265449|NCT01604343|531145677|FG003|Week 52 to Week 104|Lack of Efficacy|2|||
147265450|NCT01604343|531145678|FG004|Week 52 to Week 104|Lack of Efficacy|3|||
147265451|NCT01604343|531145674|FG000|Week 52 to Week 104|Physician Decision|0|||
147265452|NCT01604343|531145675|FG001|Week 52 to Week 104|Physician Decision|1|||
147265453|NCT01604343|531145676|FG002|Week 52 to Week 104|Physician Decision|0|||
147265454|NCT01604343|531145677|FG003|Week 52 to Week 104|Physician Decision|0|||
147265455|NCT01604343|531145678|FG004|Week 52 to Week 104|Physician Decision|2|||
147265456|NCT01604343|531145674|FG000|Week 52 to Week 104|Pregnancy|0|||
147265457|NCT01604343|531145675|FG001|Week 52 to Week 104|Pregnancy|0|||
147265458|NCT01604343|531145676|FG002|Week 52 to Week 104|Pregnancy|1|||
147265459|NCT01604343|531145677|FG003|Week 52 to Week 104|Pregnancy|2|||
147265460|NCT01604343|531145678|FG004|Week 52 to Week 104|Pregnancy|1|||
147265461|NCT01604343|531145674|FG000|Week 52 to Week 104|Other|0|||
147265462|NCT01604343|531145675|FG001|Week 52 to Week 104|Other|11|||
147332945|NCT01212757|531385638|FG000|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|3|||
147265463|NCT01604343|531145676|FG002|Week 52 to Week 104|Other|11|||
147265464|NCT01604343|531145677|FG003|Week 52 to Week 104|Other|6|||
147265465|NCT01604343|531145678|FG004|Week 52 to Week 104|Other|3|||
147265466|NCT01604343|531145674|FG000|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|3|||
147265467|NCT01604343|531145675|FG001|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|1|||
147265468|NCT01604343|531145676|FG002|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|2|||
147265469|NCT01604343|531145677|FG003|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|1|||
147265470|NCT01604343|531145678|FG004|Safety Follow-up Period (Week 104-120)|Lost to Follow-up|1|||
147265471|NCT01604343|531145674|FG000|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|12|||
147265472|NCT01604343|531145675|FG001|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|4|||
147265473|NCT01604343|531145676|FG002|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|11|||
147265474|NCT01604343|531145677|FG003|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|3|||
147265475|NCT01604343|531145678|FG004|Safety Follow-up Period (Week 104-120)|Withdrawal by Subject|14|||
147265476|NCT01604343|531145674|FG000|Safety Follow-up Period (Week 104-120)|Other|15|||
147332946|NCT01212757|531385639|FG001|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
147332947|NCT01212757|531385640|FG002|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|1|||
147332948|NCT01212757|531385641|FG003|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
147332949|NCT01212757|531385642|FG004|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
147332950|NCT01212757|531385643|FG005|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
147332951|NCT01212757|531385644|FG006|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
147332952|NCT01212757|531385645|FG007|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
147332953|NCT01212757|531385646|FG008|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
147332954|NCT01212757|531385638|FG000|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1|||
147332955|NCT01212757|531385639|FG001|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1|||
147332956|NCT01212757|531385640|FG002|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|2|||
147332957|NCT01212757|531385641|FG003|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
147332958|NCT01212757|531385642|FG004|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
147332959|NCT01212757|531385643|FG005|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
147332960|NCT01212757|531385644|FG006|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
147332961|NCT01212757|531385645|FG007|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
147332962|NCT01212757|531385646|FG008|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
147332963|NCT01212757|531385638|FG000|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
147332964|NCT01212757|531385639|FG001|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1|||
147332965|NCT01212757|531385640|FG002|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1|||
147332966|NCT01212757|531385641|FG003|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
147332967|NCT01212757|531385642|FG004|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
147332968|NCT01212757|531385643|FG005|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
147332969|NCT01212757|531385644|FG006|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
147332970|NCT01212757|531385645|FG007|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
147332971|NCT01212757|531385646|FG008|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
147332972|NCT01212757|531385638|FG000|Placebo-controlled Phase (Week 0 - 24)|Other|1|||
147332973|NCT01212757|531385639|FG001|Placebo-controlled Phase (Week 0 - 24)|Other|2|||
147332974|NCT01212757|531385640|FG002|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
147332975|NCT01212757|531385641|FG003|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
147332976|NCT01212757|531385642|FG004|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
147332977|NCT01212757|531385643|FG005|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
147332978|NCT01212757|531385644|FG006|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
147332979|NCT01212757|531385645|FG007|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
147332980|NCT01212757|531385646|FG008|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
147332981|NCT01212757|531385638|FG000|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0|||
147332982|NCT01212757|531385639|FG001|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|2|||
147332983|NCT01212757|531385640|FG002|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|3|||
147332984|NCT01212757|531385641|FG003|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|1|||
147332985|NCT01212757|531385642|FG004|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0|||
147332986|NCT01212757|531385643|FG005|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|2|||
147332987|NCT01212757|531385644|FG006|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0|||
147332988|NCT01212757|531385645|FG007|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0|||
147332989|NCT01212757|531385646|FG008|Active Treatment Phase (Weeks 24 - 52)|Adverse Event|0|||
147332990|NCT01212757|531385638|FG000|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0|||
147332991|NCT01212757|531385639|FG001|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|5|||
147332992|NCT01212757|531385640|FG002|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|7|||
147332993|NCT01212757|531385641|FG003|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|4|||
147332994|NCT01212757|531385642|FG004|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0|||
147332995|NCT01212757|531385643|FG005|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|2|||
147599982|NCT05091307|532356264|FG001|Overall Study|Randomized but not vaccinated|2|||
147599983|NCT05091307|532356265|FG002|Overall Study|Randomized but not vaccinated|0|||
147332996|NCT01212757|531385644|FG006|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0|||
147599984|NCT05091307|532356266|FG003|Overall Study|Randomized but not vaccinated|0|||
147599985|NCT03611543|532356267|FG000|Overall Study|Withdrawal by Subject|4|||
147332997|NCT01212757|531385645|FG007|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0|||
147332998|NCT01212757|531385646|FG008|Active Treatment Phase (Weeks 24 - 52)|Lack of Efficacy|0|||
147332999|NCT01212757|531385638|FG000|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
147333000|NCT01212757|531385639|FG001|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
147333001|NCT01212757|531385640|FG002|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|2|||
147333002|NCT01212757|531385641|FG003|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
147333003|NCT01212757|531385642|FG004|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
147333004|NCT01212757|531385643|FG005|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
147333005|NCT01212757|531385644|FG006|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
147333006|NCT01212757|531385645|FG007|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
147333007|NCT01212757|531385646|FG008|Active Treatment Phase (Weeks 24 - 52)|Non-compliance with Study Drug|0|||
147333008|NCT01212757|531385638|FG000|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
147265477|NCT01604343|531145675|FG001|Safety Follow-up Period (Week 104-120)|Other|2|||
147265478|NCT01604343|531145676|FG002|Safety Follow-up Period (Week 104-120)|Other|20|||
147265479|NCT01604343|531145677|FG003|Safety Follow-up Period (Week 104-120)|Other|6|||
147265480|NCT01604343|531145678|FG004|Safety Follow-up Period (Week 104-120)|Other|14|||
147265481|NCT00097721|531145679|FG000|Overall Study|Adverse Event|8|||
147265482|NCT00097721|531145680|FG001|Overall Study|Adverse Event|1|||
147265483|NCT00097721|531145679|FG000|Overall Study|Withdrawal by Subject|6|||
147265484|NCT00097721|531145680|FG001|Overall Study|Withdrawal by Subject|1|||
147265485|NCT00097721|531145679|FG000|Overall Study|Progressive Disease|55|||
147265486|NCT00097721|531145680|FG001|Overall Study|Progressive Disease|27|||
147265487|NCT00097721|531145679|FG000|Overall Study|Physician Decision|1|||
147265488|NCT00097721|531145680|FG001|Overall Study|Physician Decision|3|||
147265489|NCT00097721|531145679|FG000|Overall Study|Reason not given|1|||
147265490|NCT00097721|531145680|FG001|Overall Study|Reason not given|1|||
147265491|NCT02871375|531145681|FG000|Period 1, First 14 Days of Wear|Inclusion criteria not met|0|||
147265492|NCT02871375|531145682|FG001|Period 1, First 14 Days of Wear|Inclusion criteria not met|1|||
147265493|NCT01988571|531145683|FG000|Overall Study|Death|3|||
147265494|NCT01988571|531145684|FG001|Overall Study|Death|1|||
147265495|NCT01988571|531145683|FG000|Overall Study|Physician Decision|2|||
147265496|NCT01988571|531145684|FG001|Overall Study|Physician Decision|1|||
147265497|NCT01988571|531145683|FG000|Overall Study|Lost to Follow-up|3|||
147265498|NCT01988571|531145684|FG001|Overall Study|Lost to Follow-up|0|||
147265499|NCT01988571|531145683|FG000|Overall Study|Withdrawal by Subject|31|||
147265500|NCT01988571|531145684|FG001|Overall Study|Withdrawal by Subject|33|||
147265501|NCT03792672|531145688|FG000|Washout Period 3 (10 Days)|Withdrawal by Subject|1|||
147265502|NCT03792672|531145689|FG001|Washout Period 3 (10 Days)|Withdrawal by Subject|0|||
147265503|NCT03792672|531145690|FG002|Washout Period 3 (10 Days)|Withdrawal by Subject|0|||
147265504|NCT03792672|531145691|FG003|Washout Period 3 (10 Days)|Withdrawal by Subject|2|||
147265505|NCT03792672|531145692|FG004|Washout Period 3 (10 Days)|Withdrawal by Subject|0|||
147265506|NCT03792672|531145693|FG005|Washout Period 3 (10 Days)|Withdrawal by Subject|0|||
147265507|NCT03792672|531145688|FG000|Washout Period 3 (10 Days)|Physician Decision|0|||
147265508|NCT03792672|531145689|FG001|Washout Period 3 (10 Days)|Physician Decision|0|||
147265509|NCT03792672|531145690|FG002|Washout Period 3 (10 Days)|Physician Decision|1|||
147265510|NCT03792672|531145691|FG003|Washout Period 3 (10 Days)|Physician Decision|0|||
147265511|NCT03792672|531145692|FG004|Washout Period 3 (10 Days)|Physician Decision|0|||
147265512|NCT03792672|531145693|FG005|Washout Period 3 (10 Days)|Physician Decision|0|||
147265513|NCT03792672|531145688|FG000|Treatment Period 4 (2 Days)|Other|1|||
147265514|NCT03792672|531145689|FG001|Treatment Period 4 (2 Days)|Other|0|||
147265515|NCT03792672|531145690|FG002|Treatment Period 4 (2 Days)|Other|0|||
147265516|NCT03792672|531145691|FG003|Treatment Period 4 (2 Days)|Other|0|||
147265517|NCT03792672|531145692|FG004|Treatment Period 4 (2 Days)|Other|0|||
147265518|NCT03792672|531145693|FG005|Treatment Period 4 (2 Days)|Other|0|||
147265519|NCT00453999|531145694|FG000|Overall Study|Adverse Event|1|||
147265520|NCT00453999|531145695|FG001|Overall Study|Adverse Event|2|||
147265521|NCT00453999|531145696|FG002|Overall Study|Adverse Event|1|||
147265522|NCT00453999|531145694|FG000|Overall Study|Lost to Follow-up|0|||
147265523|NCT00453999|531145695|FG001|Overall Study|Lost to Follow-up|1|||
147265524|NCT00453999|531145696|FG002|Overall Study|Lost to Follow-up|1|||
147333009|NCT01212757|531385639|FG001|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|3|||
147333010|NCT01212757|531385640|FG002|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|7|||
147333011|NCT01212757|531385641|FG003|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|3|||
147662278|NCT00808067|532585699|FG000|Overall Study|Patient elected|7|||
147662279|NCT00808067|532585700|FG001|Overall Study|Patient elected|9|||
147662280|NCT00808067|532585699|FG000|Overall Study|Site closed for cause|19|||
147265525|NCT00453999|531145694|FG000|Overall Study|Withdrawal by Subject|2|||
147265526|NCT00453999|531145695|FG001|Overall Study|Withdrawal by Subject|1|||
147265527|NCT00453999|531145696|FG002|Overall Study|Withdrawal by Subject|1|||
147265528|NCT00453999|531145694|FG000|Overall Study|Subject Request|2|||
147265529|NCT00453999|531145695|FG001|Overall Study|Subject Request|1|||
147265530|NCT00453999|531145696|FG002|Overall Study|Subject Request|0|||
147265531|NCT04238728|531145708|FG000|Overall Study|Withdrawal by Subject|1|||
147265532|NCT04238728|531145708|FG000|Overall Study|Lost to Follow-up|2|||
147265533|NCT01417481|531145717|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|0|||
147265534|NCT01417481|531145718|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|2|||
147265535|NCT01907828|531145719|FG000|Overall Study|Exclusion criteria not met|0|||
147265536|NCT01907828|531145720|FG001|Overall Study|Exclusion criteria not met|1|||
147265537|NCT01907828|531145719|FG000|Overall Study|Withdrawal by Subject|3|||
147265538|NCT01907828|531145720|FG001|Overall Study|Withdrawal by Subject|4|||
147265539|NCT01907828|531145719|FG000|Overall Study|Lost to Follow-up|3|||
147265540|NCT01907828|531145720|FG001|Overall Study|Lost to Follow-up|0|||
147265541|NCT01907828|531145719|FG000|Overall Study|Participant refused 24-month follow-up|1|||
147265542|NCT01907828|531145720|FG001|Overall Study|Participant refused 24-month follow-up|0|||
147265543|NCT01907828|531145719|FG000|Overall Study|Participant met exclusion criteria|0|||
147265544|NCT01907828|531145720|FG001|Overall Study|Participant met exclusion criteria|1|||
147265545|NCT00829296|531145721|FG000|Overall Study|Adverse Event|5|||
147265546|NCT00829296|531145722|FG001|Overall Study|Adverse Event|4|||
147265547|NCT04960228|531145727|FG000|Overall Study|Withdrawal by Subject|216|||
147265548|NCT04960228|531145728|FG001|Overall Study|Withdrawal by Subject|35|||
147265549|NCT04960228|531145727|FG000|Overall Study|Failed attention check|69|||
147265550|NCT04960228|531145728|FG001|Overall Study|Failed attention check|148|||
147265551|NCT04960228|531145727|FG000|Overall Study|Flagged for response quality by Dynata|3|||
147265552|NCT04960228|531145728|FG001|Overall Study|Flagged for response quality by Dynata|3|||
147265553|NCT03029624|531145729|FG000|Overall Study|Adverse Event|1|||
147599986|NCT03611543|532356268|FG001|Overall Study|Withdrawal by Subject|4|||
147265554|NCT03029624|531145729|FG000|Overall Study|Withdrawal by Subject|1|||
147265555|NCT03029624|531145729|FG000|Overall Study|Lack of Efficacy|1|||
147265556|NCT03029624|531145729|FG000|Overall Study|MRI need|2|||
147265557|NCT01364428|531145730|FG000|Overall Study|Adverse Event|1|||
147265558|NCT01364428|531145731|FG001|Overall Study|Adverse Event|2|||
147265559|NCT01364428|531145730|FG000|Overall Study|Protocol Violation|2|||
147265560|NCT01364428|531145731|FG001|Overall Study|Protocol Violation|0|||
147265561|NCT01364428|531145730|FG000|Overall Study|Withdrawal Criteria|14|||
147265562|NCT01364428|531145731|FG001|Overall Study|Withdrawal Criteria|10|||
147265563|NCT01364428|531145730|FG000|Overall Study|Other|3|||
147265564|NCT01364428|531145731|FG001|Overall Study|Other|3|||
147265565|NCT01987427|531145732|FG000|Overall Study|Adverse Event|4|||
147265566|NCT01987427|531145733|FG001|Overall Study|Adverse Event|2|||
147265567|NCT01987427|531145734|FG002|Overall Study|Adverse Event|8|||
147265568|NCT01987427|531145732|FG000|Overall Study|Lost to Follow-up|6|||
147265569|NCT01987427|531145733|FG001|Overall Study|Lost to Follow-up|6|||
147265570|NCT01987427|531145734|FG002|Overall Study|Lost to Follow-up|9|||
147265571|NCT01987427|531145732|FG000|Overall Study|Withdrawal by Subject|2|||
147265572|NCT01987427|531145733|FG001|Overall Study|Withdrawal by Subject|1|||
147265573|NCT01987427|531145734|FG002|Overall Study|Withdrawal by Subject|3|||
147265574|NCT01987427|531145732|FG000|Overall Study|Lack of Efficacy|1|||
147265575|NCT01987427|531145733|FG001|Overall Study|Lack of Efficacy|0|||
147265576|NCT01987427|531145734|FG002|Overall Study|Lack of Efficacy|0|||
147265577|NCT01987427|531145732|FG000|Overall Study|Other|1|||
147265578|NCT01987427|531145733|FG001|Overall Study|Other|1|||
147265579|NCT01987427|531145734|FG002|Overall Study|Other|0|||
147265580|NCT01073865|531145735|FG000|Overall Study|Reasons other than below|19|||
147265581|NCT01073865|531145736|FG001|Overall Study|Reasons other than below|31|||
147265582|NCT01073865|531145735|FG000|Overall Study|Lost to Follow-up|1|||
147265583|NCT01073865|531145736|FG001|Overall Study|Lost to Follow-up|1|||
147265584|NCT01073865|531145735|FG000|Overall Study|Death|3|||
147265585|NCT01073865|531145736|FG001|Overall Study|Death|2|||
147265586|NCT01073865|531145735|FG000|Overall Study|Withdrawal by Subject|5|||
147265587|NCT01073865|531145736|FG001|Overall Study|Withdrawal by Subject|5|||
147265588|NCT01256593|531145741|FG000|Overall Study|Protocol Violation|26|||
147599987|NCT03611543|532356267|FG000|Overall Study|Physician Decision|1|||
147599988|NCT03611543|532356268|FG001|Overall Study|Physician Decision|1|||
147333012|NCT01212757|531385642|FG004|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|1|||
147599989|NCT03611543|532356267|FG000|Overall Study|Protocol Violation|2|||
147599990|NCT03611543|532356268|FG001|Overall Study|Protocol Violation|2|||
147333013|NCT01212757|531385643|FG005|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|3|||
147265589|NCT01256593|531145741|FG000|Overall Study|No Drug Administration Information|2|||
147265590|NCT01256593|531145741|FG000|Overall Study|No Visit After Treatment|186|||
147265591|NCT04414553|531145742|FG000|Overall Study|Lost to Follow-up|20|||
147265592|NCT02689258|531145743|FG000|Overall Study|Subject Non-Compliance|0|||
147265593|NCT02689258|531145744|FG001|Overall Study|Subject Non-Compliance|1|||
147265594|NCT02689258|531145745|FG002|Overall Study|Subject Non-Compliance|0|||
147265595|NCT02689258|531145746|FG003|Overall Study|Subject Non-Compliance|0|||
147265596|NCT02689258|531145747|FG004|Overall Study|Subject Non-Compliance|0|||
147265597|NCT02689258|531145748|FG005|Overall Study|Subject Non-Compliance|0|||
147265598|NCT02689258|531145749|FG006|Overall Study|Subject Non-Compliance|0|||
147333014|NCT01212757|531385644|FG006|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
147599991|NCT03611543|532356267|FG000|Overall Study|Device failure|2|||
147599992|NCT03611543|532356268|FG001|Overall Study|Device failure|2|||
147265599|NCT02689258|531145750|FG007|Overall Study|Subject Non-Compliance|0|||
147265600|NCT02689258|531145751|FG008|Overall Study|Subject Non-Compliance|0|||
147265601|NCT02689258|531145752|FG009|Overall Study|Subject Non-Compliance|0|||
147265602|NCT02689258|531145753|FG010|Overall Study|Subject Non-Compliance|0|||
147265603|NCT02689258|531145754|FG011|Overall Study|Subject Non-Compliance|0|||
147265604|NCT02689258|531145743|FG000|Overall Study|Subject Refusal to Continue|0|||
147599993|NCT03611543|532356267|FG000|Overall Study|Missing information|5|||
147599994|NCT03611543|532356268|FG001|Overall Study|Missing information|5|||
147599995|NCT03047473|532356275|FG000|Overall Study|Lost to Follow-up|2|||
147599996|NCT01167257|532356276|FG000|Overall Study|Lost to Follow-up|2|||
147599997|NCT01167257|532356277|FG001|Overall Study|Lost to Follow-up|2|||
147599998|NCT01167257|532356276|FG000|Overall Study|Withdrew consent|1|||
147599999|NCT01167257|532356277|FG001|Overall Study|Withdrew consent|1|||
147600000|NCT03283319|532356279|FG000|Overall Study|Lost to Follow-up|5|||
147600001|NCT03283319|532356280|FG001|Overall Study|Lost to Follow-up|4|||
147600002|NCT03283319|532356281|FG002|Overall Study|Lost to Follow-up|5|||
147600003|NCT03283319|532356282|FG003|Overall Study|Lost to Follow-up|5|||
147600004|NCT03283319|532356283|FG004|Overall Study|Lost to Follow-up|4|||
147600005|NCT03283319|532356284|FG005|Overall Study|Lost to Follow-up|3|||
147600006|NCT03283319|532356279|FG000|Overall Study|Withdrawal by Subject|2|||
147600007|NCT03283319|532356280|FG001|Overall Study|Withdrawal by Subject|2|||
147600008|NCT03283319|532356281|FG002|Overall Study|Withdrawal by Subject|2|||
147600009|NCT03283319|532356282|FG003|Overall Study|Withdrawal by Subject|1|||
147600010|NCT03283319|532356283|FG004|Overall Study|Withdrawal by Subject|0|||
147600011|NCT03283319|532356284|FG005|Overall Study|Withdrawal by Subject|1|||
147600012|NCT03283319|532356279|FG000|Overall Study|BARDA regulatory agency or IRB decision|0|||
147600013|NCT03283319|532356280|FG001|Overall Study|BARDA regulatory agency or IRB decision|0|||
147600014|NCT03283319|532356281|FG002|Overall Study|BARDA regulatory agency or IRB decision|0|||
147600015|NCT03283319|532356282|FG003|Overall Study|BARDA regulatory agency or IRB decision|1|||
147600016|NCT03283319|532356283|FG004|Overall Study|BARDA regulatory agency or IRB decision|0|||
147600017|NCT03283319|532356284|FG005|Overall Study|BARDA regulatory agency or IRB decision|0|||
147600018|NCT00721630|532356285|FG000|Overall Study|Participant found to be ineligible|1|||
147600019|NCT02213510|532356287|FG000|Overall Study|Death|0|||
147600020|NCT02213510|532356288|FG001|Overall Study|Death|1|||
147600021|NCT02213510|532356287|FG000|Overall Study|Lost to Follow-up|1|||
147600022|NCT02213510|532356288|FG001|Overall Study|Lost to Follow-up|0|||
147600023|NCT03954834|532356289|FG000|Overall Study|Adverse Event|1|||
147600024|NCT03954834|532356290|FG001|Overall Study|Adverse Event|3|||
147600025|NCT03954834|532356291|FG002|Overall Study|Adverse Event|1|||
147600026|NCT03954834|532356292|FG003|Overall Study|Adverse Event|1|||
147600027|NCT03954834|532356289|FG000|Overall Study|Death|0|||
147600028|NCT03954834|532356290|FG001|Overall Study|Death|0|||
147600029|NCT03954834|532356291|FG002|Overall Study|Death|0|||
147600030|NCT03954834|532356292|FG003|Overall Study|Death|1|||
147600031|NCT03954834|532356289|FG000|Overall Study|Physician Decision|0|||
147600032|NCT03954834|532356290|FG001|Overall Study|Physician Decision|1|||
147600033|NCT03954834|532356291|FG002|Overall Study|Physician Decision|0|||
147600034|NCT03954834|532356292|FG003|Overall Study|Physician Decision|2|||
147265605|NCT02689258|531145744|FG001|Overall Study|Subject Refusal to Continue|1|||
147265606|NCT02689258|531145745|FG002|Overall Study|Subject Refusal to Continue|0|||
147265607|NCT02689258|531145746|FG003|Overall Study|Subject Refusal to Continue|0|||
147265608|NCT02689258|531145747|FG004|Overall Study|Subject Refusal to Continue|0|||
147265609|NCT02689258|531145748|FG005|Overall Study|Subject Refusal to Continue|0|||
147333015|NCT01212757|531385645|FG007|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
147333016|NCT01212757|531385646|FG008|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
147333017|NCT01212757|531385638|FG000|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
147333018|NCT01212757|531385639|FG001|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|1|||
147333019|NCT01212757|531385640|FG002|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
147333020|NCT01212757|531385641|FG003|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
147333021|NCT01212757|531385642|FG004|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|1|||
147333022|NCT01212757|531385643|FG005|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
147333023|NCT01212757|531385644|FG006|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
147333024|NCT01212757|531385645|FG007|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
147333025|NCT01212757|531385646|FG008|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
147333026|NCT01212757|531385638|FG000|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
147333027|NCT01212757|531385639|FG001|Active Treatment Phase (Weeks 24 - 52)|Other|1|||
147450222|NCT02898259|531811388|FG002|Overall Study|Transformation before study began|0|||
147450223|NCT02898259|531811389|FG003|Overall Study|Transformation before study began|1|||
147600035|NCT03954834|532356289|FG000|Overall Study|Protocol Violation|1|||
147600036|NCT03954834|532356290|FG001|Overall Study|Protocol Violation|0|||
147600037|NCT03954834|532356291|FG002|Overall Study|Protocol Violation|0|||
147600038|NCT03954834|532356292|FG003|Overall Study|Protocol Violation|1|||
147600039|NCT03954834|532356289|FG000|Overall Study|Withdrawal by Subject|2|||
147600040|NCT03954834|532356290|FG001|Overall Study|Withdrawal by Subject|3|||
147333028|NCT01212757|531385640|FG002|Active Treatment Phase (Weeks 24 - 52)|Other|1|||
147333029|NCT01212757|531385641|FG003|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
147333030|NCT01212757|531385642|FG004|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
147333031|NCT01212757|531385643|FG005|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
147333032|NCT01212757|531385644|FG006|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
147333033|NCT01212757|531385645|FG007|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
147333034|NCT01212757|531385646|FG008|Active Treatment Phase (Weeks 24 - 52)|Other|0|||
147333035|NCT01212757|531385638|FG000|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
147333036|NCT01212757|531385639|FG001|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
147333037|NCT01212757|531385640|FG002|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
147333038|NCT01212757|531385641|FG003|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
147333039|NCT01212757|531385642|FG004|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
147333040|NCT01212757|531385643|FG005|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
147600041|NCT03954834|532356291|FG002|Overall Study|Withdrawal by Subject|13|||
147600042|NCT03954834|532356292|FG003|Overall Study|Withdrawal by Subject|6|||
147600043|NCT03954834|532356289|FG000|Overall Study|Participant left the country|0|||
147600044|NCT03954834|532356290|FG001|Overall Study|Participant left the country|0|||
147600045|NCT03954834|532356291|FG002|Overall Study|Participant left the country|1|||
147600046|NCT03954834|532356292|FG003|Overall Study|Participant left the country|0|||
147600047|NCT03954834|532356289|FG000|Overall Study|Lost to Follow-up|3|||
147600048|NCT03954834|532356290|FG001|Overall Study|Lost to Follow-up|2|||
147600049|NCT03954834|532356291|FG002|Overall Study|Lost to Follow-up|3|||
147265610|NCT02689258|531145749|FG006|Overall Study|Subject Refusal to Continue|0|||
147265611|NCT02689258|531145750|FG007|Overall Study|Subject Refusal to Continue|0|||
147265612|NCT02689258|531145751|FG008|Overall Study|Subject Refusal to Continue|1|||
147265613|NCT02689258|531145752|FG009|Overall Study|Subject Refusal to Continue|0|||
147265614|NCT02689258|531145753|FG010|Overall Study|Subject Refusal to Continue|0|||
147265615|NCT02689258|531145754|FG011|Overall Study|Subject Refusal to Continue|1|||
147265616|NCT02689258|531145743|FG000|Overall Study|Other|0|||
147265617|NCT02689258|531145744|FG001|Overall Study|Other|2|||
147265618|NCT02689258|531145745|FG002|Overall Study|Other|0|||
147265619|NCT02689258|531145746|FG003|Overall Study|Other|0|||
147265620|NCT02689258|531145747|FG004|Overall Study|Other|1|||
147265621|NCT02689258|531145748|FG005|Overall Study|Other|0|||
147265622|NCT02689258|531145749|FG006|Overall Study|Other|0|||
147265623|NCT02689258|531145750|FG007|Overall Study|Other|0|||
147265624|NCT02689258|531145751|FG008|Overall Study|Other|1|||
147265625|NCT02689258|531145752|FG009|Overall Study|Other|0|||
147265626|NCT02689258|531145753|FG010|Overall Study|Other|0|||
147265627|NCT02689258|531145754|FG011|Overall Study|Other|0|||
147265628|NCT04753164|531145758|FG000|Overall Study|Adverse Event|0|||
147265629|NCT04753164|531145759|FG001|Overall Study|Adverse Event|2|||
147265630|NCT04753164|531145758|FG000|Overall Study|Withdrawal by Subject|9|||
147265631|NCT04753164|531145759|FG001|Overall Study|Withdrawal by Subject|7|||
147265632|NCT04753164|531145758|FG000|Overall Study|Lost to Follow-up|6|||
147265633|NCT04753164|531145759|FG001|Overall Study|Lost to Follow-up|6|||
147265634|NCT04753164|531145758|FG000|Overall Study|Other|12|||
147265635|NCT04753164|531145759|FG001|Overall Study|Other|5|||
147265636|NCT04258605|531145762|FG000|Overall Study|Death|1|||
147265637|NCT04258605|531145763|FG001|Overall Study|Death|0|||
147265638|NCT04258605|531145762|FG000|Overall Study|Early study termination|21|||
147265639|NCT04258605|531145763|FG001|Overall Study|Early study termination|2|||
147265640|NCT01712256|531145775|FG000|Overall Study|Lost to Follow-up|1|||
147265641|NCT00962104|531145776|FG000|Overall Study|Adverse Event|10|||
147333041|NCT01212757|531385644|FG006|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
147333042|NCT01212757|531385645|FG007|Long-Term Safety Phase (Year 2)|Miscellaneous|0|||
147333043|NCT01212757|531385646|FG008|Long-Term Safety Phase (Year 2)|Miscellaneous|1|||
147333044|NCT01212757|531385638|FG000|Long-Term Safety Phase (Year 2)|Adverse Event|0|||
147333045|NCT01212757|531385639|FG001|Long-Term Safety Phase (Year 2)|Adverse Event|1|||
147333046|NCT01212757|531385640|FG002|Long-Term Safety Phase (Year 2)|Adverse Event|1|||
147600050|NCT03954834|532356292|FG003|Overall Study|Lost to Follow-up|5|||
147600051|NCT03786718|532356295|FG000|Overall Study|Lost to Follow-up|3|||
147662281|NCT00808067|532585700|FG001|Overall Study|Site closed for cause|19|||
147662282|NCT00808067|532585699|FG000|Overall Study|Other reason not defined above|5|||
147600052|NCT03786718|532356295|FG000|Overall Study|Withdrawal by Subject|1|||
147265642|NCT00962104|531145777|FG001|Overall Study|Adverse Event|3|||
147265643|NCT00962104|531145776|FG000|Overall Study|Entry Criteria Not Met|1|||
147265644|NCT00962104|531145777|FG001|Overall Study|Entry Criteria Not Met|2|||
147265645|NCT00962104|531145776|FG000|Overall Study|Lack of Efficacy|0|||
147265646|NCT00962104|531145777|FG001|Overall Study|Lack of Efficacy|1|||
147265647|NCT00962104|531145776|FG000|Overall Study|Lost to Follow-up|10|||
147265648|NCT00962104|531145777|FG001|Overall Study|Lost to Follow-up|4|||
147333047|NCT01212757|531385641|FG003|Long-Term Safety Phase (Year 2)|Adverse Event|0|||
147662283|NCT00808067|532585700|FG001|Overall Study|Other reason not defined above|5|||
147662284|NCT00808067|532585699|FG000|Overall Study|Excluded from analysis|13|||
147265649|NCT00962104|531145776|FG000|Overall Study|Physician Decision|1|||
147265650|NCT00962104|531145777|FG001|Overall Study|Physician Decision|0|||
147265651|NCT00962104|531145776|FG000|Overall Study|Protocol Violation|6|||
147265652|NCT00962104|531145777|FG001|Overall Study|Protocol Violation|8|||
147265653|NCT00962104|531145776|FG000|Overall Study|Sponsor Decision|0|||
147265654|NCT00962104|531145777|FG001|Overall Study|Sponsor Decision|1|||
147265655|NCT00962104|531145776|FG000|Overall Study|Withdrawal by Subject|10|||
147265656|NCT00962104|531145777|FG001|Overall Study|Withdrawal by Subject|6|||
147265657|NCT00962104|531145776|FG000|Overall Study|Other|2|||
147265658|NCT00962104|531145777|FG001|Overall Study|Other|0|||
147265659|NCT01077804|531145781|FG000|Overall Study|Unreachable|102|||
147265660|NCT01077804|531145781|FG000|Overall Study|Refused to continue|79|||
147265661|NCT01077804|531145781|FG000|Overall Study|Other|18|||
147265662|NCT01454726|531147873|FG000|Overall Study|Withdrawal by Subject|0|||
147265663|NCT01454726|531147874|FG001|Overall Study|Withdrawal by Subject|1|||
147265664|NCT04200248|531147875|FG000|Overall Study|Personal reasons|0|||
147265665|NCT04200248|531147876|FG001|Overall Study|Personal reasons|0|||
147265666|NCT04200248|531147877|FG002|Overall Study|Personal reasons|1|||
147265667|NCT04200248|531147875|FG000|Overall Study|Discontinued prior to treatment|3|||
147265668|NCT04200248|531147876|FG001|Overall Study|Discontinued prior to treatment|3|||
147265669|NCT04200248|531147877|FG002|Overall Study|Discontinued prior to treatment|2|||
147265670|NCT01886833|531147878|FG000|Overall Study|IgA not available from both periods|204|||
147265671|NCT02342704|531147881|FG000|Overall Study|Physician Decision|0|||
147265672|NCT02342704|531147882|FG001|Overall Study|Physician Decision|3|||
147265673|NCT02342704|531147881|FG000|Overall Study|Sponsor Termination|49|||
147265674|NCT02342704|531147882|FG001|Overall Study|Sponsor Termination|43|||
147265675|NCT02342704|531147881|FG000|Overall Study|Other|0|||
147265676|NCT02342704|531147882|FG001|Overall Study|Other|1|||
147265677|NCT02342704|531147881|FG000|Overall Study|Withdrawal by Subject|1|||
147265678|NCT02342704|531147882|FG001|Overall Study|Withdrawal by Subject|0|||
147265679|NCT02342704|531147881|FG000|Overall Study|Lost to Follow-up|2|||
147265680|NCT02342704|531147882|FG001|Overall Study|Lost to Follow-up|1|||
147265681|NCT02342704|531147881|FG000|Overall Study|Adverse Event|1|||
147265682|NCT02342704|531147882|FG001|Overall Study|Adverse Event|3|||
147265683|NCT00302003|531147884|FG000|Overall Study|Lack of Efficacy|62|||
147265684|NCT00302003|531147884|FG000|Overall Study|Lost to Follow-up|1|||
147265685|NCT00302003|531147884|FG000|Overall Study|Physician Decision|2|||
147265686|NCT00302003|531147884|FG000|Overall Study|Withdrawal by Subject|5|||
147265687|NCT00302003|531147884|FG000|Overall Study|Ineligible|9|||
147265688|NCT00302003|531147884|FG000|Overall Study|Protocol Violation|1|||
147265689|NCT01218516|531147885|FG000|Combination Therapy (up to 4.5 Months)|Death|2|||
147265690|NCT01218516|531147886|FG001|Combination Therapy (up to 4.5 Months)|Death|1|||
147333048|NCT01212757|531385642|FG004|Long-Term Safety Phase (Year 2)|Adverse Event|0|||
147333049|NCT01212757|531385643|FG005|Long-Term Safety Phase (Year 2)|Adverse Event|0|||
147333050|NCT01212757|531385644|FG006|Long-Term Safety Phase (Year 2)|Adverse Event|0|||
147600053|NCT03786718|532356295|FG000|Overall Study|Did not use the intervention|2|||
147600054|NCT03786718|532356295|FG000|Overall Study|diagnosis changed from type 2 to type 1|1|||
147600055|NCT00372411|532356300|FG000|Overall Study|Withdrawal by Subject|3|||
147600056|NCT00372411|532356301|FG001|Overall Study|Withdrawal by Subject|4|||
147600057|NCT00372411|532356302|FG002|Overall Study|Withdrawal by Subject|1|||
147600058|NCT00372411|532356300|FG000|Overall Study|Death|0|||
147600059|NCT00372411|532356301|FG001|Overall Study|Death|2|||
147600060|NCT00372411|532356302|FG002|Overall Study|Death|1|||
147600061|NCT00372411|532356300|FG000|Overall Study|Lost to Follow-up|1|||
147600062|NCT00372411|532356301|FG001|Overall Study|Lost to Follow-up|1|||
147600063|NCT00372411|532356302|FG002|Overall Study|Lost to Follow-up|1|||
147600064|NCT00372411|532356300|FG000|Overall Study|Adverse Event|1|||
147600065|NCT00372411|532356301|FG001|Overall Study|Adverse Event|1|||
147600066|NCT00372411|532356302|FG002|Overall Study|Adverse Event|0|||
147600067|NCT01398514|532356303|FG000|Overall Study|Adverse Event|1|||
147600068|NCT01398514|532356304|FG001|Overall Study|Adverse Event|0|||
147600069|NCT01398514|532356303|FG000|Overall Study|Non-compliance with study procedures|2|||
147600070|NCT01398514|532356304|FG001|Overall Study|Non-compliance with study procedures|0|||
147600071|NCT01398514|532356303|FG000|Overall Study|Physiologic non-responsiveness|1|||
147265691|NCT01218516|531147887|FG002|Combination Therapy (up to 4.5 Months)|Death|0|||
147265692|NCT01218516|531147888|FG003|Combination Therapy (up to 4.5 Months)|Death|0|||
147333051|NCT01212757|531385645|FG007|Long-Term Safety Phase (Year 2)|Adverse Event|2|||
147662285|NCT00808067|532585700|FG001|Overall Study|Excluded from analysis|19|||
147265693|NCT01218516|531147885|FG000|Combination Therapy (up to 4.5 Months)|Delay in TA Administration of >=28 days|0|||
147265694|NCT01218516|531147886|FG001|Combination Therapy (up to 4.5 Months)|Delay in TA Administration of >=28 days|3|||
147265695|NCT01218516|531147887|FG002|Combination Therapy (up to 4.5 Months)|Delay in TA Administration of >=28 days|0|||
147265696|NCT01218516|531147888|FG003|Combination Therapy (up to 4.5 Months)|Delay in TA Administration of >=28 days|0|||
147600072|NCT01398514|532356304|FG001|Overall Study|Physiologic non-responsiveness|3|||
147600073|NCT01398514|532356303|FG000|Overall Study|Failure to show a conditioned response|4|||
147600074|NCT01398514|532356304|FG001|Overall Study|Failure to show a conditioned response|3|||
147265697|NCT01218516|531147885|FG000|Combination Therapy (up to 4.5 Months)|Physician Decision|2|||
147265698|NCT01218516|531147886|FG001|Combination Therapy (up to 4.5 Months)|Physician Decision|2|||
147265699|NCT01218516|531147887|FG002|Combination Therapy (up to 4.5 Months)|Physician Decision|0|||
147265700|NCT01218516|531147888|FG003|Combination Therapy (up to 4.5 Months)|Physician Decision|0|||
147265701|NCT01218516|531147885|FG000|Combination Therapy (up to 4.5 Months)|Chemotherapy Discontinued|2|||
147265702|NCT01218516|531147886|FG001|Combination Therapy (up to 4.5 Months)|Chemotherapy Discontinued|0|||
147265703|NCT01218516|531147887|FG002|Combination Therapy (up to 4.5 Months)|Chemotherapy Discontinued|0|||
147265704|NCT01218516|531147888|FG003|Combination Therapy (up to 4.5 Months)|Chemotherapy Discontinued|0|||
147265705|NCT01218516|531147885|FG000|Combination Therapy (up to 4.5 Months)|Progressive Disease (PD) by RECIST v 1.1|17|||
147265706|NCT01218516|531147886|FG001|Combination Therapy (up to 4.5 Months)|Progressive Disease (PD) by RECIST v 1.1|15|||
147265707|NCT01218516|531147887|FG002|Combination Therapy (up to 4.5 Months)|Progressive Disease (PD) by RECIST v 1.1|0|||
147265708|NCT01218516|531147888|FG003|Combination Therapy (up to 4.5 Months)|Progressive Disease (PD) by RECIST v 1.1|0|||
147265709|NCT01218516|531147885|FG000|Combination Therapy (up to 4.5 Months)|Randomized but Not Treated|0|||
147265710|NCT01218516|531147886|FG001|Combination Therapy (up to 4.5 Months)|Randomized but Not Treated|1|||
147265711|NCT01218516|531147887|FG002|Combination Therapy (up to 4.5 Months)|Randomized but Not Treated|0|||
147265712|NCT01218516|531147888|FG003|Combination Therapy (up to 4.5 Months)|Randomized but Not Treated|0|||
147265713|NCT01218516|531147885|FG000|Combination Therapy (up to 4.5 Months)|Withdrew Consent|0|||
147265714|NCT01218516|531147886|FG001|Combination Therapy (up to 4.5 Months)|Withdrew Consent|1|||
147265715|NCT01218516|531147887|FG002|Combination Therapy (up to 4.5 Months)|Withdrew Consent|0|||
147265716|NCT01218516|531147888|FG003|Combination Therapy (up to 4.5 Months)|Withdrew Consent|0|||
147265717|NCT01218516|531147885|FG000|Combination Therapy (up to 4.5 Months)|Deterioration of Performance Status|0|||
147265718|NCT01218516|531147886|FG001|Combination Therapy (up to 4.5 Months)|Deterioration of Performance Status|3|||
147265719|NCT01218516|531147887|FG002|Combination Therapy (up to 4.5 Months)|Deterioration of Performance Status|0|||
147265720|NCT01218516|531147888|FG003|Combination Therapy (up to 4.5 Months)|Deterioration of Performance Status|0|||
147265721|NCT01218516|531147885|FG000|Combination Therapy (up to 4.5 Months)|Other|3|||
147265722|NCT01218516|531147886|FG001|Combination Therapy (up to 4.5 Months)|Other|4|||
147265723|NCT01218516|531147887|FG002|Combination Therapy (up to 4.5 Months)|Other|0|||
147265724|NCT01218516|531147888|FG003|Combination Therapy (up to 4.5 Months)|Other|0|||
147265725|NCT01218516|531147885|FG000|Combination Therapy (up to 4.5 Months)|Toxicity to TA|0|||
147265726|NCT01218516|531147886|FG001|Combination Therapy (up to 4.5 Months)|Toxicity to TA|1|||
147265727|NCT01218516|531147887|FG002|Combination Therapy (up to 4.5 Months)|Toxicity to TA|0|||
147265728|NCT01218516|531147888|FG003|Combination Therapy (up to 4.5 Months)|Toxicity to TA|0|||
147265729|NCT01218516|531147885|FG000|Combination Therapy (up to 4.5 Months)|Participant Discontinued Treatment|2|||
147265730|NCT01218516|531147886|FG001|Combination Therapy (up to 4.5 Months)|Participant Discontinued Treatment|3|||
147265731|NCT01218516|531147887|FG002|Combination Therapy (up to 4.5 Months)|Participant Discontinued Treatment|0|||
147265732|NCT01218516|531147888|FG003|Combination Therapy (up to 4.5 Months)|Participant Discontinued Treatment|0|||
147265733|NCT01218516|531147885|FG000|Combination Therapy (up to 4.5 Months)|Treatment With Items Outside Protocol|1|||
147265734|NCT01218516|531147886|FG001|Combination Therapy (up to 4.5 Months)|Treatment With Items Outside Protocol|1|||
147265735|NCT01218516|531147887|FG002|Combination Therapy (up to 4.5 Months)|Treatment With Items Outside Protocol|0|||
147265736|NCT01218516|531147888|FG003|Combination Therapy (up to 4.5 Months)|Treatment With Items Outside Protocol|0|||
147265737|NCT01539226|531147889|FG000|Overall Study|Withdrawal by Subject|24|||
147265738|NCT01539226|531147890|FG001|Overall Study|Withdrawal by Subject|54|||
147265739|NCT01539226|531147889|FG000|Overall Study|Lost to Follow-up|20|||
147265740|NCT01539226|531147890|FG001|Overall Study|Lost to Follow-up|54|||
147265741|NCT01539226|531147889|FG000|Overall Study|Death|1|||
147265742|NCT01539226|531147890|FG001|Overall Study|Death|2|||
147265743|NCT01539226|531147889|FG000|Overall Study|Adverse Event|2|||
147265744|NCT01539226|531147890|FG001|Overall Study|Adverse Event|0|||
147265745|NCT01539226|531147889|FG000|Overall Study|Pregnancy|13|||
147265746|NCT01539226|531147890|FG001|Overall Study|Pregnancy|29|||
147265747|NCT01539226|531147889|FG000|Overall Study|inappropriate enrollment|0|||
147265748|NCT01539226|531147890|FG001|Overall Study|inappropriate enrollment|1|||
147265749|NCT01539226|531147889|FG000|Overall Study|Multiple Reasons|3|||
147265750|NCT01539226|531147890|FG001|Overall Study|Multiple Reasons|1|||
147265751|NCT01539226|531147889|FG000|Overall Study|not HIV seroconversion-related|93|||
147265752|NCT01539226|531147890|FG001|Overall Study|not HIV seroconversion-related|176|||
147265753|NCT01539226|531147889|FG000|Overall Study|HIV seroconversion-related|55|||
147265754|NCT01539226|531147890|FG001|Overall Study|HIV seroconversion-related|80|||
147265755|NCT01539226|531147889|FG000|Overall Study|Non-compliance|6|||
147265756|NCT01539226|531147890|FG001|Overall Study|Non-compliance|8|||
147265757|NCT02919670|531147891|FG000|Overall Study|Only 17 participants met compliance|43|||
147265758|NCT02919670|531147892|FG001|Overall Study|Only 17 participants met compliance|39|||
147265759|NCT02118428|531147899|FG000|Overall Study|Physician Decision|0|||
147265760|NCT02118428|531147900|FG001|Overall Study|Physician Decision|1|||
147265761|NCT02118428|531147901|FG002|Overall Study|Physician Decision|0|||
147265762|NCT02118428|531147899|FG000|Overall Study|Withdrawal by Subject|2|||
147265763|NCT02118428|531147900|FG001|Overall Study|Withdrawal by Subject|2|||
147265764|NCT02118428|531147901|FG002|Overall Study|Withdrawal by Subject|0|||
147662286|NCT00735007|532585705|FG000|Overall Study|Adverse Event|4|||
147265765|NCT02118428|531147899|FG000|Overall Study|Death|7|||
147265766|NCT02118428|531147900|FG001|Overall Study|Death|5|||
147265767|NCT02118428|531147901|FG002|Overall Study|Death|0|||
147265768|NCT02118428|531147899|FG000|Overall Study|Lost to Follow-up|3|||
147265769|NCT02118428|531147900|FG001|Overall Study|Lost to Follow-up|1|||
147265770|NCT02118428|531147901|FG002|Overall Study|Lost to Follow-up|0|||
147265771|NCT02118428|531147899|FG000|Overall Study|Screen Failure or Became Inelegible|1|||
147265772|NCT02118428|531147900|FG001|Overall Study|Screen Failure or Became Inelegible|0|||
147265773|NCT02118428|531147901|FG002|Overall Study|Screen Failure or Became Inelegible|1|||
147265774|NCT01641367|531147908|FG000|Cohorts|Death|18|||
147265775|NCT01641367|531147909|FG001|Cohorts|Death|1|||
147265776|NCT01641367|531147910|FG002|Cohorts|Death|2|||
147265777|NCT01641367|531147911|FG003|Cohorts|Death|0|||
147265778|NCT01641367|531147912|FG004|Cohorts|Death|1|||
147265779|NCT01641367|531147913|FG005|Cohorts|Death|1|||
147265780|NCT01641367|531147914|FG006|Cohorts|Death|0|||
147265781|NCT01641367|531147915|FG007|Cohorts|Death|0|||
147265782|NCT01641367|531147908|FG000|Cohorts|Lost to Follow-up|16|||
147265783|NCT01641367|531147909|FG001|Cohorts|Lost to Follow-up|0|||
147265784|NCT01641367|531147910|FG002|Cohorts|Lost to Follow-up|2|||
147265785|NCT01641367|531147911|FG003|Cohorts|Lost to Follow-up|0|||
147265786|NCT01641367|531147912|FG004|Cohorts|Lost to Follow-up|2|||
147265787|NCT01641367|531147913|FG005|Cohorts|Lost to Follow-up|0|||
147265788|NCT01641367|531147914|FG006|Cohorts|Lost to Follow-up|0|||
147265789|NCT01641367|531147915|FG007|Cohorts|Lost to Follow-up|0|||
147265790|NCT01641367|531147908|FG000|Randomized Adherence Intervention|Death|0|||
147265791|NCT01641367|531147909|FG001|Randomized Adherence Intervention|Death|0|||
147265792|NCT01641367|531147910|FG002|Randomized Adherence Intervention|Death|0|||
147265793|NCT01641367|531147911|FG003|Randomized Adherence Intervention|Death|0|||
147265794|NCT01641367|531147912|FG004|Randomized Adherence Intervention|Death|0|||
147265795|NCT01641367|531147913|FG005|Randomized Adherence Intervention|Death|0|||
147265796|NCT01641367|531147914|FG006|Randomized Adherence Intervention|Death|11|||
147265797|NCT01641367|531147915|FG007|Randomized Adherence Intervention|Death|12|||
147265798|NCT01641367|531147908|FG000|Randomized Adherence Intervention|Lost to Follow-up|0|||
147265799|NCT01641367|531147909|FG001|Randomized Adherence Intervention|Lost to Follow-up|0|||
147265800|NCT01641367|531147910|FG002|Randomized Adherence Intervention|Lost to Follow-up|0|||
147265801|NCT01641367|531147911|FG003|Randomized Adherence Intervention|Lost to Follow-up|0|||
147265802|NCT01641367|531147912|FG004|Randomized Adherence Intervention|Lost to Follow-up|0|||
147265803|NCT01641367|531147913|FG005|Randomized Adherence Intervention|Lost to Follow-up|0|||
147265804|NCT01641367|531147914|FG006|Randomized Adherence Intervention|Lost to Follow-up|8|||
147265805|NCT01641367|531147915|FG007|Randomized Adherence Intervention|Lost to Follow-up|12|||
147265806|NCT00782210|531147916|FG000|Overall Study|Adverse Event|21|||
147265807|NCT00782210|531147917|FG001|Overall Study|Adverse Event|17|||
147265808|NCT00782210|531147918|FG002|Overall Study|Adverse Event|16|||
147333052|NCT01212757|531385646|FG008|Long-Term Safety Phase (Year 2)|Adverse Event|2|||
147333053|NCT01212757|531385638|FG000|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
147333054|NCT01212757|531385639|FG001|Long-Term Safety Phase (Year 2)|Lack of Efficacy|4|||
147333055|NCT01212757|531385640|FG002|Long-Term Safety Phase (Year 2)|Lack of Efficacy|2|||
147333056|NCT01212757|531385641|FG003|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
147333057|NCT01212757|531385642|FG004|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
147333058|NCT01212757|531385643|FG005|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
147333059|NCT01212757|531385644|FG006|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
147333060|NCT01212757|531385645|FG007|Long-Term Safety Phase (Year 2)|Lack of Efficacy|4|||
147333061|NCT01212757|531385646|FG008|Long-Term Safety Phase (Year 2)|Lack of Efficacy|0|||
147333062|NCT01212757|531385638|FG000|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0|||
147333063|NCT01212757|531385639|FG001|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|7|||
147333064|NCT01212757|531385640|FG002|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|9|||
147333065|NCT01212757|531385641|FG003|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0|||
147333066|NCT01212757|531385642|FG004|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0|||
147333067|NCT01212757|531385643|FG005|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0|||
147333068|NCT01212757|531385644|FG006|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|0|||
147333069|NCT01212757|531385645|FG007|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|4|||
147662287|NCT00735007|532585705|FG000|Overall Study|Protocol Violation|1|||
147333070|NCT01212757|531385646|FG008|Long-Term Safety Phase (Year 2)|Withdrawal by Subject|6|||
147265809|NCT00782210|531147916|FG000|Overall Study|Lost to Follow-up|2|||
147265810|NCT00782210|531147917|FG001|Overall Study|Lost to Follow-up|1|||
147265811|NCT00782210|531147918|FG002|Overall Study|Lost to Follow-up|2|||
147265812|NCT00782210|531147916|FG000|Overall Study|Withdrawal by Subject|11|||
147265813|NCT00782210|531147917|FG001|Overall Study|Withdrawal by Subject|8|||
147265814|NCT00782210|531147918|FG002|Overall Study|Withdrawal by Subject|11|||
147265815|NCT00782210|531147916|FG000|Overall Study|Non compliance with protocol|0|||
147265816|NCT00782210|531147917|FG001|Overall Study|Non compliance with protocol|3|||
147265817|NCT00782210|531147918|FG002|Overall Study|Non compliance with protocol|2|||
147265818|NCT00782210|531147916|FG000|Overall Study|Lack of Efficacy|13|||
147265819|NCT00782210|531147917|FG001|Overall Study|Lack of Efficacy|4|||
147265820|NCT00782210|531147918|FG002|Overall Study|Lack of Efficacy|1|||
147600075|NCT01570686|532356308|FG000|Overall Study|Abnormal test procedure result(s)|1|||
147600076|NCT01570686|532356309|FG001|Overall Study|Abnormal test procedure result(s)|1|||
147600077|NCT01570686|532356308|FG000|Overall Study|Administrative problems|0|||
147600078|NCT01570686|532356309|FG001|Overall Study|Administrative problems|1|||
147600079|NCT01570686|532356308|FG000|Overall Study|Adverse Event|8|||
147600080|NCT01570686|532356309|FG001|Overall Study|Adverse Event|6|||
147600081|NCT01570686|532356308|FG000|Overall Study|Lost to Follow-up|4|||
147600082|NCT01570686|532356309|FG001|Overall Study|Lost to Follow-up|3|||
147600083|NCT01570686|532356308|FG000|Overall Study|Protocol Deviation|3|||
147600084|NCT01570686|532356309|FG001|Overall Study|Protocol Deviation|0|||
147265821|NCT00782210|531147916|FG000|Overall Study|Other reason not described above|3|||
147265822|NCT00782210|531147917|FG001|Overall Study|Other reason not described above|2|||
147265823|NCT00782210|531147918|FG002|Overall Study|Other reason not described above|3|||
147265824|NCT00436748|531147923|FG000|Overall Study|Ineligibility Determined|1|||
147265825|NCT00436748|531147924|FG001|Overall Study|Ineligibility Determined|1|||
147265826|NCT00436748|531147923|FG000|Overall Study|Adverse Event|0|||
147265827|NCT00436748|531147924|FG001|Overall Study|Adverse Event|2|||
147265828|NCT00436748|531147923|FG000|Overall Study|Consent Withdrawn|1|||
147265829|NCT00436748|531147924|FG001|Overall Study|Consent Withdrawn|4|||
147265830|NCT00436748|531147923|FG000|Overall Study|Administrative Decision|1|||
147265831|NCT00436748|531147924|FG001|Overall Study|Administrative Decision|0|||
147265832|NCT00436748|531147923|FG000|Overall Study|Lost to Follow-up|0|||
147265833|NCT00436748|531147924|FG001|Overall Study|Lost to Follow-up|1|||
147265834|NCT00436748|531147923|FG000|Overall Study|Protocol-specified Criteria|5|||
147265835|NCT00436748|531147924|FG001|Overall Study|Protocol-specified Criteria|4|||
147265836|NCT00436748|531147923|FG000|Overall Study|Other|3|||
147265837|NCT00436748|531147924|FG001|Overall Study|Other|0|||
147265838|NCT01610791|531147925|FG000|Overall Study|Lost to Follow-up|7|||
147265839|NCT01610791|531147925|FG000|Overall Study|Adverse Event|6|||
147265840|NCT01610791|531147925|FG000|Overall Study|Physician Decision|1|||
147265841|NCT01610791|531147925|FG000|Overall Study|Adverse event and Investigator decision|1|||
147265842|NCT01610791|531147925|FG000|Overall Study|Death|1|||
147265843|NCT01610791|531147925|FG000|Overall Study|Not determined|5|||
147265844|NCT00850200|531147928|FG000|Overall Study|Physician Decision|2|||
147265845|NCT00850200|531147928|FG000|Overall Study|Did not recieve treatment|2|||
147265846|NCT00850200|531147928|FG000|Overall Study|Withdrawal by Subject|1|||
147265847|NCT02319031|531147929|FG000|Treatment Period|Death|1|||
147265848|NCT02319031|531147930|FG001|Treatment Period|Death|0|||
147265849|NCT00696137|531147938|FG000|Overall Study|Withdrawal by Subject|2|||
147265850|NCT01371656|531147939|FG000|Overall Study|Death|7|||
147265851|NCT01371656|531147940|FG001|Overall Study|Death|4|||
147265852|NCT01371656|531147939|FG000|Overall Study|Physician Decision|46|||
147265853|NCT01371656|531147940|FG001|Overall Study|Physician Decision|7|||
147265854|NCT01371656|531147939|FG000|Overall Study|Withdrawal by Subject|7|||
147265855|NCT01371656|531147940|FG001|Overall Study|Withdrawal by Subject|0|||
147265856|NCT01371656|531147939|FG000|Overall Study|Ineligible|4|||
147265857|NCT01371656|531147940|FG001|Overall Study|Ineligible|3|||
147265858|NCT01465464|531147950|FG000|Overall Study|Adverse Event|96|||
147265859|NCT01465464|531147951|FG001|Overall Study|Adverse Event|49|||
147265860|NCT01465464|531147950|FG000|Overall Study|Lack of Efficacy|139|||
147265861|NCT01465464|531147951|FG001|Overall Study|Lack of Efficacy|190|||
147265862|NCT01465464|531147950|FG000|Overall Study|Physician Decision|13|||
147265863|NCT01465464|531147951|FG001|Overall Study|Physician Decision|5|||
147265864|NCT01465464|531147950|FG000|Overall Study|Protocol Violation|1|||
147265865|NCT01465464|531147951|FG001|Overall Study|Protocol Violation|1|||
147265866|NCT01465464|531147950|FG000|Overall Study|Withdrawal by Subject|46|||
147265867|NCT01465464|531147951|FG001|Overall Study|Withdrawal by Subject|30|||
147265868|NCT01465464|531147950|FG000|Overall Study|Other|9|||
147265869|NCT01465464|531147951|FG001|Overall Study|Other|3|||
147333071|NCT01212757|531385638|FG000|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
147265870|NCT01465464|531147950|FG000|Overall Study|Ongoing treatment at cutoff date|140|||
147265871|NCT01465464|531147951|FG001|Overall Study|Ongoing treatment at cutoff date|166|||
147265872|NCT00785486|531147957|FG000|Midazolam Alone|Withdrawal by Subject|1|||
147265873|NCT00775437|531147958|FG000|Overall Study|Loss of efficacy|2|||
147265874|NCT00775437|531147958|FG000|Overall Study|Withdrawal by Subject|3|||
147662288|NCT02104895|532585706|FG000|Overall Study|Withdrawal by Subject|0|||
147265875|NCT00775437|531147958|FG000|Overall Study|Lost to Follow-up|1|||
147265876|NCT01183975|531147959|FG000|Overall Study|Lost to Follow-up|73|||
147333072|NCT01212757|531385639|FG001|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
147265877|NCT03316885|531147960|FG000|Overall Study|Adverse Event|1|||
147662289|NCT02104895|532585707|FG001|Overall Study|Withdrawal by Subject|14|||
147600085|NCT01570686|532356308|FG000|Overall Study|Withdrawal by Subject|4|||
147600086|NCT01570686|532356309|FG001|Overall Study|Withdrawal by Subject|4|||
147662290|NCT01683604|532585709|FG000|Overall Study|Adverse Event|2|||
147265878|NCT03316885|531147960|FG000|Overall Study|Death|10|||
147265879|NCT03316885|531147960|FG000|Overall Study|Lost to Follow-up|4|||
147265880|NCT03316885|531147960|FG000|Overall Study|Withdrawal by Subject|9|||
147265881|NCT03316885|531147960|FG000|Overall Study|COVID related|8|||
147265882|NCT04180020|531147963|FG000|Overall Study|missed visit|18|||
147265883|NCT04180020|531147964|FG001|Overall Study|missed visit|16|||
147265884|NCT04180020|531147963|FG000|Overall Study|Death|2|||
147265885|NCT04180020|531147964|FG001|Overall Study|Death|3|||
147265886|NCT04180020|531147963|FG000|Overall Study|Withdrawal by Subject|1|||
147265887|NCT04180020|531147964|FG001|Overall Study|Withdrawal by Subject|5|||
147265888|NCT04180020|531147963|FG000|Overall Study|incarcerated|1|||
147265889|NCT04180020|531147964|FG001|Overall Study|incarcerated|1|||
147265890|NCT04180020|531147963|FG000|Overall Study|Physician Decision|0|||
147265891|NCT04180020|531147964|FG001|Overall Study|Physician Decision|2|||
147265892|NCT02244580|531147965|FG000|Overall Study|No cancer tissues available|241|||
147265893|NCT00811577|531147968|FG000|Overall Study|Lost to Follow-up|7|||
147265894|NCT00811577|531147969|FG001|Overall Study|Lost to Follow-up|1|||
147265895|NCT00811577|531147968|FG000|Overall Study|Withdrawal by Subject|3|||
147265896|NCT00811577|531147969|FG001|Overall Study|Withdrawal by Subject|0|||
147265897|NCT04251221|531147970|FG000|Overall Study|Arterial Line Failure, unable to proceed with PET scan|2|||
147265898|NCT04251221|531147971|FG001|Overall Study|Arterial Line Failure, unable to proceed with PET scan|0|||
147265899|NCT00329407|531147972|FG000|Overall Study|Withdrawal by Subject|1|||
147265900|NCT02357940|531147973|FG000|Overall Study|Adverse Event|0|||
147265901|NCT02357940|531147974|FG001|Overall Study|Adverse Event|1|||
147265902|NCT02357940|531147973|FG000|Overall Study|Investigator's judgement|0|||
147265903|NCT02357940|531147974|FG001|Overall Study|Investigator's judgement|1|||
147265904|NCT00978068|531147975|FG000|Overall Study|Were Awaiting Initiation of ART|2|||
147265905|NCT00978068|531147976|FG001|Overall Study|Were Awaiting Initiation of ART|2|||
147265906|NCT00978068|531147975|FG000|Overall Study|Death|1|||
147265907|NCT00978068|531147976|FG001|Overall Study|Death|2|||
147265908|NCT00978068|531147975|FG000|Overall Study|Lost to Follow-up|1|||
147265909|NCT00978068|531147976|FG001|Overall Study|Lost to Follow-up|2|||
147265910|NCT00978068|531147975|FG000|Overall Study|Physician Decision|0|||
147265911|NCT00978068|531147976|FG001|Overall Study|Physician Decision|1|||
147265912|NCT00978068|531147975|FG000|Overall Study|Unable to Comply with Study|0|||
147265913|NCT00978068|531147976|FG001|Overall Study|Unable to Comply with Study|2|||
147265914|NCT02442778|531147977|FG000|Overall Study|Adverse Event|2|||
147265915|NCT02442778|531147978|FG001|Overall Study|Adverse Event|6|||
147265916|NCT02442778|531147979|FG002|Overall Study|Adverse Event|6|||
147265917|NCT02442778|531147977|FG000|Overall Study|Death|0|||
147265918|NCT02442778|531147978|FG001|Overall Study|Death|2|||
147265919|NCT02442778|531147979|FG002|Overall Study|Death|0|||
147265920|NCT02442778|531147977|FG000|Overall Study|Lack of Efficacy|1|||
147265921|NCT02442778|531147978|FG001|Overall Study|Lack of Efficacy|0|||
147265922|NCT02442778|531147979|FG002|Overall Study|Lack of Efficacy|0|||
147265923|NCT02442778|531147977|FG000|Overall Study|Lost to Follow-up|1|||
147265924|NCT02442778|531147978|FG001|Overall Study|Lost to Follow-up|1|||
147265925|NCT02442778|531147979|FG002|Overall Study|Lost to Follow-up|1|||
147265926|NCT02442778|531147977|FG000|Overall Study|Non-compliance with study drug|2|||
147265927|NCT02442778|531147978|FG001|Overall Study|Non-compliance with study drug|0|||
147265928|NCT02442778|531147979|FG002|Overall Study|Non-compliance with study drug|1|||
147265929|NCT02442778|531147977|FG000|Overall Study|Physician Decision|1|||
147265930|NCT02442778|531147978|FG001|Overall Study|Physician Decision|1|||
147265931|NCT02442778|531147979|FG002|Overall Study|Physician Decision|1|||
147265932|NCT02442778|531147977|FG000|Overall Study|Protocol Deviation|3|||
147265933|NCT02442778|531147978|FG001|Overall Study|Protocol Deviation|0|||
147265934|NCT02442778|531147979|FG002|Overall Study|Protocol Deviation|1|||
147265935|NCT02442778|531147977|FG000|Overall Study|Study participant withdrawal by parent or guardian|3|||
147600087|NCT01570686|532356308|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
147600088|NCT01570686|532356309|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
147600089|NCT02906930|532356311|FG000|Overall Study|Withdrawal by Subject|0|||
147600090|NCT02906930|532356312|FG001|Overall Study|Withdrawal by Subject|5|||
147600091|NCT02906930|532356313|FG002|Overall Study|Withdrawal by Subject|5|||
147600092|NCT02906930|532356314|FG003|Overall Study|Withdrawal by Subject|4|||
147600093|NCT02906930|532356311|FG000|Overall Study|Lost to Follow-up|5|||
147600094|NCT02906930|532356312|FG001|Overall Study|Lost to Follow-up|7|||
147600095|NCT02906930|532356313|FG002|Overall Study|Lost to Follow-up|5|||
147662291|NCT01683604|532585709|FG000|Overall Study|Lack of Efficacy|1|||
147662292|NCT01683604|532585709|FG000|Overall Study|Other|2|||
147265936|NCT02442778|531147978|FG001|Overall Study|Study participant withdrawal by parent or guardian|12|||
147265937|NCT02442778|531147979|FG002|Overall Study|Study participant withdrawal by parent or guardian|2|||
147600096|NCT02906930|532356314|FG003|Overall Study|Lost to Follow-up|2|||
147600097|NCT02906930|532356311|FG000|Overall Study|Death|0|||
147600098|NCT02906930|532356312|FG001|Overall Study|Death|0|||
147662293|NCT02481050|532587289|FG000|Overall Study|Adverse Event|1|||
147265938|NCT02442778|531147977|FG000|Overall Study|Withdrawal by Subject|4|||
147265939|NCT02442778|531147978|FG001|Overall Study|Withdrawal by Subject|4|||
147265940|NCT02442778|531147979|FG002|Overall Study|Withdrawal by Subject|3|||
147265941|NCT02442778|531147977|FG000|Overall Study|Reason not specified|1|||
147265942|NCT02442778|531147978|FG001|Overall Study|Reason not specified|4|||
147265943|NCT02442778|531147979|FG002|Overall Study|Reason not specified|0|||
147265944|NCT04964128|531147982|FG000|Phase 1 (Software Release Tag 1.0)|Withdrawal by Subject|1|||
147265945|NCT04964128|531147982|FG000|Phase 2 (Software Release Tag 2.0)|Physician Decision|1|||
147265946|NCT03913091|531147987|FG000|Overall Study|Lost to Follow-up|18|||
147265947|NCT03913091|531147988|FG001|Overall Study|Lost to Follow-up|11|||
147265948|NCT03913091|531147987|FG000|Overall Study|Required additional meds/surgery|1|||
147265949|NCT03913091|531147988|FG001|Overall Study|Required additional meds/surgery|2|||
147265950|NCT03913091|531147987|FG000|Overall Study|Chronic pain/history of substance abuse|1|||
147265951|NCT03913091|531147988|FG001|Overall Study|Chronic pain/history of substance abuse|1|||
147265952|NCT02196324|531147990|FG000|Overall Study|Withdrawal by Subject|8|||
147265953|NCT02196324|531147991|FG001|Overall Study|Withdrawal by Subject|4|||
147265954|NCT02196324|531147990|FG000|Overall Study|Adverse Event or Serious Adverse Event|6|||
147265955|NCT02196324|531147991|FG001|Overall Study|Adverse Event or Serious Adverse Event|3|||
147265956|NCT02196324|531147990|FG000|Overall Study|Occurrence of an Exclusion Criterion|0|||
147265957|NCT02196324|531147991|FG001|Overall Study|Occurrence of an Exclusion Criterion|1|||
147265958|NCT02196324|531147990|FG000|Overall Study|Other|1|||
147265959|NCT02196324|531147991|FG001|Overall Study|Other|0|||
147265960|NCT01380184|531147992|FG000|Part 1 (19 Days)|Adverse Event|1|||
147265961|NCT01380184|531147992|FG000|Part 2|Adverse Event|5|||
147265962|NCT01380184|531147992|FG000|Part 2|Disease Progression|8|||
147265963|NCT01380184|531147992|FG000|Part 2|Lost to Follow-up|1|||
147265964|NCT04243538|531147993|FG000|Overall Study|Withdrawal by Subject|0|||
147265965|NCT04243538|531147994|FG001|Overall Study|Withdrawal by Subject|2|||
147265966|NCT04243538|531147993|FG000|Overall Study|Lost to Follow-up|0|||
147265967|NCT04243538|531147994|FG001|Overall Study|Lost to Follow-up|3|||
147265968|NCT00655564|531147995|FG000|Overall Study|Adverse Event|1|||
147265969|NCT00655564|531147995|FG000|Overall Study|Lost to Follow-up|1|||
147265970|NCT00655564|531147995|FG000|Overall Study|Desired Alternate Therapy|1|||
147265971|NCT00344773|531148000|FG000|Overall Study|Adverse Event|2|||
147265972|NCT00344773|531148000|FG000|Overall Study|Objective Disease Progression|16|||
147265973|NCT00344773|531148000|FG000|Overall Study|Withdrawal by Subject|1|||
147265974|NCT00344773|531148000|FG000|Overall Study|Not Eligible for the study|2|||
147265975|NCT00500370|531148007|FG000|Overall Study|Adverse Event|9|||
147265976|NCT00500370|531148008|FG001|Overall Study|Adverse Event|3|||
147265977|NCT00500370|531148007|FG000|Overall Study|Lost to Follow-up|10|||
147265978|NCT00500370|531148008|FG001|Overall Study|Lost to Follow-up|10|||
147265979|NCT00500370|531148007|FG000|Overall Study|Protocol Violation|2|||
147265980|NCT00500370|531148008|FG001|Overall Study|Protocol Violation|4|||
147265981|NCT00500370|531148007|FG000|Overall Study|Sponsor Decision|2|||
147265982|NCT00500370|531148008|FG001|Overall Study|Sponsor Decision|0|||
147265983|NCT00500370|531148007|FG000|Overall Study|Subject Decision|10|||
147265984|NCT00500370|531148008|FG001|Overall Study|Subject Decision|17|||
147265985|NCT04804813|531148009|FG000|Overall Study|Protocol Violation|2|||
147265986|NCT04804813|531148010|FG001|Overall Study|Protocol Violation|0|||
147265987|NCT04804813|531148009|FG000|Overall Study|Withdrawal by Subject|1|||
147265988|NCT04804813|531148010|FG001|Overall Study|Withdrawal by Subject|0|||
147265989|NCT05627518|531148011|FG000|Treatment Period 1|Adverse Event|0|||
147265990|NCT05627518|531148012|FG001|Treatment Period 1|Adverse Event|0|||
147265991|NCT05627518|531148013|FG002|Treatment Period 1|Adverse Event|1|||
147265992|NCT05627518|531148014|FG003|Treatment Period 1|Adverse Event|0|||
147265993|NCT05627518|531148015|FG004|Treatment Period 1|Adverse Event|0|||
147265994|NCT05627518|531148016|FG005|Treatment Period 1|Adverse Event|0|||
147265995|NCT05627518|531148017|FG006|Treatment Period 1|Adverse Event|0|||
147265996|NCT05627518|531148018|FG007|Treatment Period 1|Adverse Event|1|||
147265997|NCT05627518|531148011|FG000|Treatment Period 1|Withdrawal by Subject|0|||
147265998|NCT05627518|531148012|FG001|Treatment Period 1|Withdrawal by Subject|0|||
147265999|NCT05627518|531148013|FG002|Treatment Period 1|Withdrawal by Subject|1|||
147266000|NCT05627518|531148014|FG003|Treatment Period 1|Withdrawal by Subject|0|||
147266001|NCT05627518|531148015|FG004|Treatment Period 1|Withdrawal by Subject|0|||
147266002|NCT05627518|531148016|FG005|Treatment Period 1|Withdrawal by Subject|1|||
147266003|NCT05627518|531148017|FG006|Treatment Period 1|Withdrawal by Subject|0|||
147266004|NCT05627518|531148018|FG007|Treatment Period 1|Withdrawal by Subject|0|||
147266005|NCT05627518|531148011|FG000|Treatment Period 1|Protocol Violation|0|||
147266006|NCT05627518|531148012|FG001|Treatment Period 1|Protocol Violation|0|||
147266007|NCT05627518|531148013|FG002|Treatment Period 1|Protocol Violation|0|||
147266008|NCT05627518|531148014|FG003|Treatment Period 1|Protocol Violation|0|||
147266009|NCT05627518|531148015|FG004|Treatment Period 1|Protocol Violation|0|||
147266010|NCT05627518|531148016|FG005|Treatment Period 1|Protocol Violation|0|||
147266011|NCT05627518|531148017|FG006|Treatment Period 1|Protocol Violation|6|||
147333073|NCT01212757|531385640|FG002|Long-Term Safety Phase (Year 2)|Lost to Follow-up|2|||
147333074|NCT01212757|531385641|FG003|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
147266012|NCT05627518|531148018|FG007|Treatment Period 1|Protocol Violation|6|||
147266013|NCT05627518|531148011|FG000|Treatment Period 2|Adverse Event|1|||
147266014|NCT05627518|531148012|FG001|Treatment Period 2|Adverse Event|0|||
147266015|NCT05627518|531148013|FG002|Treatment Period 2|Adverse Event|0|||
147266016|NCT05627518|531148014|FG003|Treatment Period 2|Adverse Event|0|||
147266017|NCT05627518|531148015|FG004|Treatment Period 2|Adverse Event|0|||
147266018|NCT05627518|531148016|FG005|Treatment Period 2|Adverse Event|0|||
147266019|NCT05627518|531148017|FG006|Treatment Period 2|Adverse Event|0|||
147266020|NCT05627518|531148018|FG007|Treatment Period 2|Adverse Event|0|||
147266021|NCT05627518|531148011|FG000|Treatment Period 2|Withdrawal by Subject|1|||
147266022|NCT05627518|531148012|FG001|Treatment Period 2|Withdrawal by Subject|0|||
147266023|NCT05627518|531148013|FG002|Treatment Period 2|Withdrawal by Subject|0|||
147266024|NCT05627518|531148014|FG003|Treatment Period 2|Withdrawal by Subject|0|||
147266025|NCT05627518|531148015|FG004|Treatment Period 2|Withdrawal by Subject|0|||
147266026|NCT05627518|531148016|FG005|Treatment Period 2|Withdrawal by Subject|0|||
147266027|NCT05627518|531148017|FG006|Treatment Period 2|Withdrawal by Subject|0|||
147266028|NCT05627518|531148018|FG007|Treatment Period 2|Withdrawal by Subject|0|||
147266029|NCT02917031|531148022|FG000|Overall Study|Reason not specified|7|||
147266030|NCT02917031|531148023|FG001|Overall Study|Reason not specified|5|||
147266031|NCT02917031|531148024|FG002|Overall Study|Reason not specified|6|||
147266032|NCT02917031|531148022|FG000|Overall Study|Development of study-specific withdrawal criteria|1|||
147266033|NCT02917031|531148023|FG001|Overall Study|Development of study-specific withdrawal criteria|1|||
147266034|NCT02917031|531148024|FG002|Overall Study|Development of study-specific withdrawal criteria|0|||
147266035|NCT02917031|531148022|FG000|Overall Study|Withdrawal by Subject|3|||
147266036|NCT02917031|531148023|FG001|Overall Study|Withdrawal by Subject|3|||
147266037|NCT02917031|531148024|FG002|Overall Study|Withdrawal by Subject|0|||
147266038|NCT02917031|531148022|FG000|Overall Study|Physician Decision|1|||
147266039|NCT02917031|531148023|FG001|Overall Study|Physician Decision|0|||
147266040|NCT02917031|531148024|FG002|Overall Study|Physician Decision|0|||
147266041|NCT02917031|531148022|FG000|Overall Study|Adverse Event|4|||
147266042|NCT02917031|531148023|FG001|Overall Study|Adverse Event|1|||
147266043|NCT02917031|531148024|FG002|Overall Study|Adverse Event|5|||
147266044|NCT02917031|531148022|FG000|Overall Study|Death|2|||
147266045|NCT02917031|531148023|FG001|Overall Study|Death|3|||
147266046|NCT02917031|531148024|FG002|Overall Study|Death|4|||
147266047|NCT01581593|531149639|FG000|Overall Study|Withdrawal by Subject|1|||
147266048|NCT03003520|531149640|FG000|Overall Study|Adverse Event|9|||
147266049|NCT03003520|531149641|FG001|Overall Study|Adverse Event|0|||
147266050|NCT03003520|531149640|FG000|Overall Study|Death|1|||
147266051|NCT03003520|531149641|FG001|Overall Study|Death|0|||
147266052|NCT03003520|531149640|FG000|Overall Study|Other reasons|4|||
147266053|NCT03003520|531149641|FG001|Overall Study|Other reasons|0|||
147266054|NCT03003520|531149640|FG000|Overall Study|Withdrawal by Subject|6|||
147266055|NCT03003520|531149641|FG001|Overall Study|Withdrawal by Subject|0|||
147266056|NCT03003520|531149640|FG000|Overall Study|Progressive disease|9|||
147266057|NCT03003520|531149641|FG001|Overall Study|Progressive disease|1|||
147266058|NCT04982029|531149642|FG000|Overall Study|Lost to Follow-up|2|||
147266059|NCT04982029|531149643|FG001|Overall Study|Lost to Follow-up|3|||
147266060|NCT03264404|531149644|FG000|Overall Study|Death|2|||
147266061|NCT03264404|531149644|FG000|Overall Study|Physician Decision|1|||
147266062|NCT03264404|531149644|FG000|Overall Study|Disease Progression|28|||
147266063|NCT03264404|531149644|FG000|Overall Study|Adverse Event|1|||
147266064|NCT03264404|531149644|FG000|Overall Study|Off study prior to treatment|2|||
147266065|NCT02586012|531149645|FG000|Overall Study|Withdrawal by Subject|1|||
147266066|NCT02586012|531149646|FG001|Overall Study|Withdrawal by Subject|1|||
147266067|NCT02586012|531149647|FG002|Overall Study|Withdrawal by Subject|0|||
147266068|NCT02586012|531149648|FG003|Overall Study|Withdrawal by Subject|1|||
147266069|NCT02586012|531149649|FG004|Overall Study|Withdrawal by Subject|0|||
147266070|NCT02586012|531149650|FG005|Overall Study|Withdrawal by Subject|2|||
147266071|NCT02586012|531149645|FG000|Overall Study|Protocol Violation|0|||
147266072|NCT02586012|531149646|FG001|Overall Study|Protocol Violation|0|||
147266073|NCT02586012|531149647|FG002|Overall Study|Protocol Violation|0|||
147266074|NCT02586012|531149648|FG003|Overall Study|Protocol Violation|0|||
147266075|NCT02586012|531149649|FG004|Overall Study|Protocol Violation|0|||
147266076|NCT02586012|531149650|FG005|Overall Study|Protocol Violation|1|||
147266077|NCT02586012|531149645|FG000|Overall Study|study terminated|0|||
147266078|NCT02586012|531149646|FG001|Overall Study|study terminated|2|||
147266079|NCT02586012|531149647|FG002|Overall Study|study terminated|1|||
147266080|NCT02586012|531149648|FG003|Overall Study|study terminated|1|||
147266081|NCT02586012|531149649|FG004|Overall Study|study terminated|1|||
147266082|NCT02586012|531149650|FG005|Overall Study|study terminated|0|||
147266083|NCT02388737|531149652|FG000|Overall Study|Pretreatment Event/Adverse Event|13|||
147266084|NCT02388737|531149653|FG001|Overall Study|Pretreatment Event/Adverse Event|11|||
147266085|NCT02388737|531149654|FG002|Overall Study|Pretreatment Event/Adverse Event|12|||
147266086|NCT02388737|531149652|FG000|Overall Study|Major Protocol Deviation|18|||
147266087|NCT02388737|531149653|FG001|Overall Study|Major Protocol Deviation|25|||
147266088|NCT02388737|531149654|FG002|Overall Study|Major Protocol Deviation|22|||
147266089|NCT02388737|531149652|FG000|Overall Study|Lost to Follow-up|5|||
147266090|NCT02388737|531149653|FG001|Overall Study|Lost to Follow-up|1|||
147266091|NCT02388737|531149654|FG002|Overall Study|Lost to Follow-up|4|||
147266092|NCT02388737|531149652|FG000|Overall Study|Voluntary Withdrawal|10|||
147266093|NCT02388737|531149653|FG001|Overall Study|Voluntary Withdrawal|18|||
147266094|NCT02388737|531149654|FG002|Overall Study|Voluntary Withdrawal|17|||
147266095|NCT02388737|531149652|FG000|Overall Study|Lack of Efficacy|3|||
147266096|NCT02388737|531149653|FG001|Overall Study|Lack of Efficacy|0|||
147266097|NCT02388737|531149654|FG002|Overall Study|Lack of Efficacy|3|||
147266098|NCT02388737|531149652|FG000|Overall Study|Reason Not Specified|5|||
147266099|NCT02388737|531149653|FG001|Overall Study|Reason Not Specified|5|||
147266100|NCT02388737|531149654|FG002|Overall Study|Reason Not Specified|4|||
147266101|NCT03252522|531149655|FG000|Phase 1: Intervention & Placebo|Adverse Event|3|||
147266102|NCT03252522|531149656|FG001|Phase 1: Intervention & Placebo|Adverse Event|1|||
147266103|NCT03252522|531149657|FG002|Phase 1: Intervention & Placebo|Adverse Event|0|||
147266104|NCT03252522|531149655|FG000|Phase 1: Intervention & Placebo|Unable to swallow pills|4|||
147266105|NCT03252522|531149656|FG001|Phase 1: Intervention & Placebo|Unable to swallow pills|1|||
147266106|NCT03252522|531149657|FG002|Phase 1: Intervention & Placebo|Unable to swallow pills|0|||
147266107|NCT03252522|531149655|FG000|Phase 1: Intervention & Placebo|Commenced stimulant medication|1|||
147266108|NCT03252522|531149656|FG001|Phase 1: Intervention & Placebo|Commenced stimulant medication|1|||
147266109|NCT03252522|531149657|FG002|Phase 1: Intervention & Placebo|Commenced stimulant medication|0|||
147266110|NCT03252522|531149655|FG000|Phase 1: Intervention & Placebo|Protocol Violation|1|||
147266111|NCT03252522|531149656|FG001|Phase 1: Intervention & Placebo|Protocol Violation|0|||
147266112|NCT03252522|531149657|FG002|Phase 1: Intervention & Placebo|Protocol Violation|0|||
147266113|NCT03252522|531149655|FG000|Phase 2: Open Label|Commenced stimulant medication|0|||
147266114|NCT03252522|531149656|FG001|Phase 2: Open Label|Commenced stimulant medication|0|||
147266115|NCT03252522|531149657|FG002|Phase 2: Open Label|Commenced stimulant medication|3|||
147266116|NCT03252522|531149655|FG000|Phase 2: Open Label|Lack of Efficacy|0|||
147266117|NCT03252522|531149656|FG001|Phase 2: Open Label|Lack of Efficacy|0|||
147266118|NCT03252522|531149657|FG002|Phase 2: Open Label|Lack of Efficacy|3|||
147266119|NCT03252522|531149655|FG000|Phase 2: Open Label|Adverse Event|0|||
147266120|NCT03252522|531149656|FG001|Phase 2: Open Label|Adverse Event|0|||
147266121|NCT03252522|531149657|FG002|Phase 2: Open Label|Adverse Event|2|||
147266122|NCT03252522|531149655|FG000|Phase 2: Open Label|Lost to Follow-up|0|||
147266123|NCT03252522|531149656|FG001|Phase 2: Open Label|Lost to Follow-up|0|||
147266124|NCT03252522|531149657|FG002|Phase 2: Open Label|Lost to Follow-up|16|||
147266125|NCT03299842|531149658|FG000|Overall Study|Caregiver withdrew consent|2|||
147266126|NCT03299842|531149658|FG000|Overall Study|Child would not keep the watch on|3|||
147266127|NCT00071812|531149659|FG000|24-Week Double-Blind Period|Adverse Event|2|||
147266128|NCT00071812|531149660|FG001|24-Week Double-Blind Period|Adverse Event|3|||
147266129|NCT00071812|531149661|FG002|24-Week Double-Blind Period|Adverse Event|4|||
147266130|NCT00071812|531149662|FG003|24-Week Double-Blind Period|Adverse Event|4|||
147266131|NCT00071812|531149659|FG000|24-Week Double-Blind Period|Lack of Efficacy|3|||
147266132|NCT00071812|531149660|FG001|24-Week Double-Blind Period|Lack of Efficacy|1|||
147266133|NCT00071812|531149661|FG002|24-Week Double-Blind Period|Lack of Efficacy|2|||
147266134|NCT00071812|531149662|FG003|24-Week Double-Blind Period|Lack of Efficacy|1|||
147266135|NCT00071812|531149659|FG000|24-Week Double-Blind Period|Lost to Follow-up|0|||
147266136|NCT00071812|531149660|FG001|24-Week Double-Blind Period|Lost to Follow-up|1|||
147266137|NCT00071812|531149661|FG002|24-Week Double-Blind Period|Lost to Follow-up|1|||
147266138|NCT00071812|531149662|FG003|24-Week Double-Blind Period|Lost to Follow-up|0|||
147266139|NCT00071812|531149659|FG000|24-Week Double-Blind Period|Withdrawal by Subject|5|||
147266140|NCT00071812|531149660|FG001|24-Week Double-Blind Period|Withdrawal by Subject|1|||
147266141|NCT00071812|531149661|FG002|24-Week Double-Blind Period|Withdrawal by Subject|1|||
147266142|NCT00071812|531149662|FG003|24-Week Double-Blind Period|Withdrawal by Subject|5|||
147266143|NCT00071812|531149659|FG000|24-Week Double-Blind Period|Protocol Violation|0|||
147266144|NCT00071812|531149660|FG001|24-Week Double-Blind Period|Protocol Violation|0|||
147266145|NCT00071812|531149661|FG002|24-Week Double-Blind Period|Protocol Violation|0|||
147266146|NCT00071812|531149662|FG003|24-Week Double-Blind Period|Protocol Violation|1|||
147266147|NCT00071812|531149659|FG000|24-Week Open-Label Extension Period|Adverse Event|0|||
147266148|NCT00071812|531149660|FG001|24-Week Open-Label Extension Period|Adverse Event|0|||
147266149|NCT00071812|531149661|FG002|24-Week Open-Label Extension Period|Adverse Event|0|||
147266150|NCT00071812|531149662|FG003|24-Week Open-Label Extension Period|Adverse Event|7|||
147266151|NCT00071812|531149659|FG000|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
147266152|NCT00071812|531149660|FG001|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
147266153|NCT00071812|531149661|FG002|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
147266154|NCT00071812|531149662|FG003|24-Week Open-Label Extension Period|Lack of Efficacy|17|||
147266155|NCT00071812|531149659|FG000|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
147266156|NCT00071812|531149660|FG001|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
147266157|NCT00071812|531149661|FG002|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
147333075|NCT01212757|531385642|FG004|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
147333076|NCT01212757|531385643|FG005|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
147333077|NCT01212757|531385644|FG006|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
147333078|NCT01212757|531385645|FG007|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
147662294|NCT02481050|532587289|FG000|Overall Study|Disease Progression|47|||
147266158|NCT00071812|531149662|FG003|24-Week Open-Label Extension Period|Lost to Follow-up|2|||
147266159|NCT00071812|531149659|FG000|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
147266160|NCT00071812|531149660|FG001|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
147266161|NCT00071812|531149661|FG002|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
147333079|NCT01212757|531385646|FG008|Long-Term Safety Phase (Year 2)|Lost to Follow-up|0|||
147266162|NCT00071812|531149662|FG003|24-Week Open-Label Extension Period|Withdrawal by Subject|12|||
147266163|NCT00071812|531149659|FG000|24-Week Open-Label Extension Period|Lack of Compliance|0|||
147266164|NCT00071812|531149660|FG001|24-Week Open-Label Extension Period|Lack of Compliance|0|||
147266165|NCT00071812|531149661|FG002|24-Week Open-Label Extension Period|Lack of Compliance|1|||
147266166|NCT00071812|531149662|FG003|24-Week Open-Label Extension Period|Lack of Compliance|2|||
147266167|NCT01816139|531149663|FG000|Overall Study|Adverse Event|6|||
147266168|NCT01816139|531149664|FG001|Overall Study|Adverse Event|8|||
147266169|NCT01816139|531149663|FG000|Overall Study|Lack of Efficacy|1|||
147266170|NCT01816139|531149664|FG001|Overall Study|Lack of Efficacy|2|||
147266171|NCT01816139|531149663|FG000|Overall Study|Lost to Follow-up|5|||
147266172|NCT01816139|531149664|FG001|Overall Study|Lost to Follow-up|3|||
147266173|NCT01816139|531149663|FG000|Overall Study|Withdrew Consent|6|||
147266174|NCT01816139|531149664|FG001|Overall Study|Withdrew Consent|4|||
147266175|NCT01816139|531149663|FG000|Overall Study|Protocol Violation|6|||
147266176|NCT01816139|531149664|FG001|Overall Study|Protocol Violation|3|||
147266177|NCT01816139|531149663|FG000|Overall Study|Reason not Specified|4|||
147266178|NCT01816139|531149664|FG001|Overall Study|Reason not Specified|2|||
147266179|NCT02554656|531149667|FG000|Overall Study|Protocol Violation|3|||
147266180|NCT00358527|531149670|FG000|Overall Study|Adverse Event|4|||
147266181|NCT00358527|531149671|FG001|Overall Study|Adverse Event|0|||
147266182|NCT00358527|531149670|FG000|Overall Study|Withdrawal by Subject|1|||
147266183|NCT00358527|531149671|FG001|Overall Study|Withdrawal by Subject|1|||
147266184|NCT00358527|531149670|FG000|Overall Study|Non-compliance with protocol|6|||
147266185|NCT00358527|531149671|FG001|Overall Study|Non-compliance with protocol|1|||
147266186|NCT00358527|531149670|FG000|Overall Study|Administrative|2|||
147266187|NCT00358527|531149671|FG001|Overall Study|Administrative|1|||
147266188|NCT00749463|531149672|FG000|Overall Study|Adverse Event|0|||
147266189|NCT00749463|531149673|FG001|Overall Study|Adverse Event|4|||
147266190|NCT00749463|531149674|FG002|Overall Study|Adverse Event|1|||
147266191|NCT00749463|531149672|FG000|Overall Study|Withdrawal by Subject|1|||
147266192|NCT00749463|531149673|FG001|Overall Study|Withdrawal by Subject|0|||
147266193|NCT00749463|531149674|FG002|Overall Study|Withdrawal by Subject|0|||
147266194|NCT00913744|531149676|FG000|Overall Study|Adverse Event|2|||
147266195|NCT00913744|531149677|FG001|Overall Study|Adverse Event|0|||
147266196|NCT00913744|531149676|FG000|Overall Study|Withdrawal by Subject|2|||
147600099|NCT02906930|532356313|FG002|Overall Study|Death|1|||
147600100|NCT02906930|532356314|FG003|Overall Study|Death|0|||
147600101|NCT02906930|532356311|FG000|Overall Study|Other|1|||
147600102|NCT02906930|532356312|FG001|Overall Study|Other|2|||
147600103|NCT02906930|532356313|FG002|Overall Study|Other|1|||
147600104|NCT02906930|532356314|FG003|Overall Study|Other|2|||
147600105|NCT00910091|532356315|FG000|Pre-assignment|Withdrawal by Subject|0|||
147600106|NCT00910091|532356316|FG001|Pre-assignment|Withdrawal by Subject|2|||
147600107|NCT00910091|532356315|FG000|Treatment and Survival|Withdrawal by Subject|3|||
147600108|NCT00910091|532356316|FG001|Treatment and Survival|Withdrawal by Subject|4|||
147600109|NCT00910091|532356315|FG000|Treatment and Survival|Adverse Event|1|||
147600110|NCT00910091|532356316|FG001|Treatment and Survival|Adverse Event|0|||
147600111|NCT01908816|532356317|FG000|Overall Study|Subject's no longer requires study drug|0|||
147600112|NCT01908816|532356318|FG001|Overall Study|Subject's no longer requires study drug|0|||
147600113|NCT01908816|532356319|FG002|Overall Study|Subject's no longer requires study drug|0|||
147600114|NCT01908816|532356320|FG003|Overall Study|Subject's no longer requires study drug|1|||
147600115|NCT01908816|532356317|FG000|Overall Study|Protocol deviation|1|||
147600116|NCT01908816|532356318|FG001|Overall Study|Protocol deviation|2|||
147600117|NCT01908816|532356319|FG002|Overall Study|Protocol deviation|1|||
147600118|NCT01908816|532356320|FG003|Overall Study|Protocol deviation|1|||
147600119|NCT01908816|532356317|FG000|Overall Study|Withdrawal by Subject|0|||
147600120|NCT01908816|532356318|FG001|Overall Study|Withdrawal by Subject|4|||
147266197|NCT00913744|531149677|FG001|Overall Study|Withdrawal by Subject|1|||
147266198|NCT00913744|531149676|FG000|Overall Study|Death|1|||
147266199|NCT00913744|531149677|FG001|Overall Study|Death|0|||
147266200|NCT01344369|531149678|FG000|Washout of 28 Days|Withdrawal by Subject|1|||
147266201|NCT01344369|531149679|FG001|Washout of 28 Days|Withdrawal by Subject|0|||
147266202|NCT01344369|531149678|FG000|Washout of 28 Days|Physician Decision|0|||
147333080|NCT01212757|531385638|FG000|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
147333081|NCT01212757|531385639|FG001|Long-Term Safety Phase (Year 3)|Adverse Event|4|||
147333082|NCT01212757|531385640|FG002|Long-Term Safety Phase (Year 3)|Adverse Event|1|||
147600121|NCT01908816|532356319|FG002|Overall Study|Withdrawal by Subject|2|||
147600122|NCT01908816|532356320|FG003|Overall Study|Withdrawal by Subject|2|||
147266203|NCT01344369|531149679|FG001|Washout of 28 Days|Physician Decision|1|||
147600123|NCT01908816|532356317|FG000|Overall Study|Lost to Follow-up|3|||
147266204|NCT01344369|531149678|FG000|Second Intervention|Emesis within 2 x Tmax|0|||
147266205|NCT01344369|531149679|FG001|Second Intervention|Emesis within 2 x Tmax|1|||
147266206|NCT02433834|531149684|FG000|Overall Study|Protocol-specified criteria|7|||
147266207|NCT02433834|531149684|FG000|Overall Study|Protocol Violation|3|||
147600124|NCT01908816|532356318|FG001|Overall Study|Lost to Follow-up|5|||
147333083|NCT01212757|531385641|FG003|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
147266208|NCT02433834|531149684|FG000|Overall Study|Lost to Follow-up|6|||
147266209|NCT02433834|531149684|FG000|Overall Study|Withdrawal by Subject|14|||
147266210|NCT02433834|531149684|FG000|Overall Study|Adverse Event|6|||
147266211|NCT02433834|531149684|FG000|Overall Study|Physician Decision|1|||
147266212|NCT00283439|531149685|FG000|Overall Study|Adverse Event|0|||
147266213|NCT00283439|531149686|FG001|Overall Study|Adverse Event|0|||
147266214|NCT00283439|531149687|FG002|Overall Study|Adverse Event|0|||
147266215|NCT00283439|531149688|FG003|Overall Study|Adverse Event|1|||
147266216|NCT00283439|531149685|FG000|Overall Study|Death|0|||
147266217|NCT00283439|531149686|FG001|Overall Study|Death|0|||
147266218|NCT00283439|531149687|FG002|Overall Study|Death|1|||
147266219|NCT00283439|531149688|FG003|Overall Study|Death|0|||
147266220|NCT00283439|531149685|FG000|Overall Study|Disease progression|0|||
147266221|NCT00283439|531149686|FG001|Overall Study|Disease progression|1|||
147266222|NCT00283439|531149687|FG002|Overall Study|Disease progression|0|||
147266223|NCT00283439|531149688|FG003|Overall Study|Disease progression|0|||
147266224|NCT00283439|531149685|FG000|Overall Study|Requirement for alternative therapy|1|||
147266225|NCT00283439|531149686|FG001|Overall Study|Requirement for alternative therapy|2|||
147266226|NCT00283439|531149687|FG002|Overall Study|Requirement for alternative therapy|5|||
147266227|NCT00283439|531149688|FG003|Overall Study|Requirement for alternative therapy|2|||
147266228|NCT00283439|531149685|FG000|Overall Study|Stem cell transplant|6|||
147266229|NCT00283439|531149686|FG001|Overall Study|Stem cell transplant|6|||
147266230|NCT00283439|531149687|FG002|Overall Study|Stem cell transplant|4|||
147266231|NCT00283439|531149688|FG003|Overall Study|Stem cell transplant|3|||
147266232|NCT00283439|531149685|FG000|Overall Study|Treatment discontinued|0|||
147266233|NCT00283439|531149686|FG001|Overall Study|Treatment discontinued|2|||
147266234|NCT00283439|531149687|FG002|Overall Study|Treatment discontinued|1|||
147266235|NCT00283439|531149688|FG003|Overall Study|Treatment discontinued|3|||
147266236|NCT00283439|531149685|FG000|Overall Study|Other|1|||
147266237|NCT00283439|531149686|FG001|Overall Study|Other|0|||
147266238|NCT00283439|531149687|FG002|Overall Study|Other|0|||
147266239|NCT00283439|531149688|FG003|Overall Study|Other|0|||
147266240|NCT01632891|531149689|FG000|Overall Study|Lost to Follow-up|0|||
147266241|NCT01632891|531149690|FG001|Overall Study|Lost to Follow-up|1|||
147266242|NCT01632891|531149689|FG000|Overall Study|Withdrawal by Subject|1|||
147266243|NCT01632891|531149690|FG001|Overall Study|Withdrawal by Subject|0|||
147266244|NCT00240071|531149692|FG000|Overall Study|Withdrawal by Subject|3|||
147266245|NCT02086110|531149706|FG000|Overall Study|Withdrawal by Subject|1|||
147266246|NCT02086110|531149707|FG001|Overall Study|Withdrawal by Subject|1|||
147266247|NCT01869192|531149708|FG000|Preoperative Chemotherapy to Surgery|patient choice|2|||
147266248|NCT01869192|531149709|FG001|Preoperative Chemotherapy to Surgery|patient choice|1|||
147266249|NCT01869192|531149708|FG000|Postoperative Chemotherapy|Physician Decision|0|||
147266250|NCT01869192|531149709|FG001|Postoperative Chemotherapy|Physician Decision|2|||
147266251|NCT01203072|531149710|FG000|Overall Study|Adverse Event|5|||
147266252|NCT01203072|531149711|FG001|Overall Study|Adverse Event|3|||
147266253|NCT01203072|531149712|FG002|Overall Study|Adverse Event|2|||
147266254|NCT01203072|531149713|FG003|Overall Study|Adverse Event|4|||
147266255|NCT01203072|531149714|FG004|Overall Study|Adverse Event|2|||
147266256|NCT01203072|531149710|FG000|Overall Study|Lack of Efficacy|1|||
147266257|NCT01203072|531149711|FG001|Overall Study|Lack of Efficacy|0|||
147266258|NCT01203072|531149712|FG002|Overall Study|Lack of Efficacy|0|||
147600125|NCT01908816|532356319|FG002|Overall Study|Lost to Follow-up|4|||
147600126|NCT01908816|532356320|FG003|Overall Study|Lost to Follow-up|2|||
147600127|NCT01908816|532356317|FG000|Overall Study|Death|1|||
147266259|NCT01203072|531149713|FG003|Overall Study|Lack of Efficacy|0|||
147266260|NCT01203072|531149714|FG004|Overall Study|Lack of Efficacy|0|||
147600128|NCT01908816|532356318|FG001|Overall Study|Death|0|||
147600129|NCT01908816|532356319|FG002|Overall Study|Death|7|||
147600130|NCT01908816|532356320|FG003|Overall Study|Death|1|||
147600131|NCT01908816|532356317|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
147600132|NCT01908816|532356318|FG001|Overall Study|Unsatisfactory therapeutic effect|13|||
147600133|NCT01908816|532356319|FG002|Overall Study|Unsatisfactory therapeutic effect|1|||
147600134|NCT01908816|532356320|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
147600135|NCT01908816|532356317|FG000|Overall Study|Early termination|87|||
147600136|NCT01908816|532356318|FG001|Overall Study|Early termination|60|||
147662295|NCT02481050|532587289|FG000|Overall Study|Withdrawal by Subject|7|||
147266261|NCT01203072|531149710|FG000|Overall Study|Lost to Follow-up|0|||
147266262|NCT01203072|531149711|FG001|Overall Study|Lost to Follow-up|1|||
147266263|NCT01203072|531149712|FG002|Overall Study|Lost to Follow-up|0|||
147266264|NCT01203072|531149713|FG003|Overall Study|Lost to Follow-up|0|||
147266265|NCT01203072|531149714|FG004|Overall Study|Lost to Follow-up|0|||
147266266|NCT01203072|531149710|FG000|Overall Study|Protocol Violation|2|||
147266267|NCT01203072|531149711|FG001|Overall Study|Protocol Violation|0|||
147266268|NCT01203072|531149712|FG002|Overall Study|Protocol Violation|0|||
147333084|NCT01212757|531385642|FG004|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
147266269|NCT01203072|531149713|FG003|Overall Study|Protocol Violation|0|||
147600137|NCT01908816|532356319|FG002|Overall Study|Early termination|43|||
147600138|NCT01908816|532356320|FG003|Overall Study|Early termination|28|||
147600139|NCT02628743|532356322|FG000|Overall Study|Other|3|||
147266270|NCT01203072|531149714|FG004|Overall Study|Protocol Violation|1|||
147266271|NCT01203072|531149710|FG000|Overall Study|Withdrawal by Subject|2|||
147266272|NCT01203072|531149711|FG001|Overall Study|Withdrawal by Subject|2|||
147266273|NCT01203072|531149712|FG002|Overall Study|Withdrawal by Subject|1|||
147266274|NCT01203072|531149713|FG003|Overall Study|Withdrawal by Subject|2|||
147266275|NCT01203072|531149714|FG004|Overall Study|Withdrawal by Subject|3|||
147266276|NCT02272413|531149716|FG000|Randomized Through Treatment Start|Not treated|3|||
147266277|NCT02272413|531149717|FG001|Randomized Through Treatment Start|Not treated|5|||
147266278|NCT02272413|531149716|FG000|Pre-switch Period|Adverse Event|38|||
147266279|NCT02272413|531149717|FG001|Pre-switch Period|Adverse Event|37|||
147266280|NCT02272413|531149716|FG000|Pre-switch Period|Death|26|||
147266281|NCT02272413|531149717|FG001|Pre-switch Period|Death|26|||
147266282|NCT02272413|531149716|FG000|Pre-switch Period|Withdrawal by Subject|27|||
147266283|NCT02272413|531149717|FG001|Pre-switch Period|Withdrawal by Subject|15|||
147266284|NCT02272413|531149716|FG000|Pre-switch Period|Physician Decision|6|||
147266285|NCT02272413|531149717|FG001|Pre-switch Period|Physician Decision|18|||
147266286|NCT02272413|531149716|FG000|Pre-switch Period|Progressive disease|185|||
147266287|NCT02272413|531149717|FG001|Pre-switch Period|Progressive disease|173|||
147266288|NCT02272413|531149716|FG000|Pre-switch Period|Lost to Follow-up|0|||
147266289|NCT02272413|531149717|FG001|Pre-switch Period|Lost to Follow-up|2|||
147266290|NCT02272413|531149716|FG000|Pre-switch Period|Protocol Violation|1|||
147266291|NCT02272413|531149717|FG001|Pre-switch Period|Protocol Violation|0|||
147266292|NCT02272413|531149716|FG000|Pre-switch Period|Other than listed|10|||
147266293|NCT02272413|531149717|FG001|Pre-switch Period|Other than listed|11|||
147266294|NCT02272413|531149716|FG000|Post-switch Period|Adverse Event|4|||
147266295|NCT02272413|531149717|FG001|Post-switch Period|Adverse Event|4|||
147266296|NCT02272413|531149716|FG000|Post-switch Period|Death|3|||
147266297|NCT02272413|531149717|FG001|Post-switch Period|Death|2|||
147266298|NCT02272413|531149716|FG000|Post-switch Period|Withdrawal by Subject|1|||
147266299|NCT02272413|531149717|FG001|Post-switch Period|Withdrawal by Subject|2|||
147266300|NCT02272413|531149716|FG000|Post-switch Period|Physician Decision|1|||
147266301|NCT02272413|531149717|FG001|Post-switch Period|Physician Decision|1|||
147266302|NCT02272413|531149716|FG000|Post-switch Period|Progressive disease|21|||
147266303|NCT02272413|531149717|FG001|Post-switch Period|Progressive disease|21|||
147266304|NCT02272413|531149716|FG000|Post-switch Period|Study terminated by sponsor|8|||
147266305|NCT02272413|531149717|FG001|Post-switch Period|Study terminated by sponsor|11|||
147266306|NCT02272413|531149716|FG000|Post-switch Period|Other than listed|4|||
147266307|NCT02272413|531149717|FG001|Post-switch Period|Other than listed|5|||
147600140|NCT02628743|532356322|FG000|Overall Study|Withdrawal by Subject|50|||
147600141|NCT02628743|532356322|FG000|Overall Study|Study Terminated by Sponsor|76|||
147600142|NCT02628743|532356322|FG000|Overall Study|Physician Decision|2|||
147600143|NCT02534844|532356323|FG000|Part B|Withdrawal by Subject|0|||
147600144|NCT02534844|532356324|FG001|Part B|Withdrawal by Subject|0|||
147600145|NCT02534844|532356325|FG002|Part B|Withdrawal by Subject|0|||
147600146|NCT02534844|532356326|FG003|Part B|Withdrawal by Subject|0|||
147600147|NCT02534844|532356327|FG004|Part B|Withdrawal by Subject|2|||
147600148|NCT02534844|532356328|FG005|Part B|Withdrawal by Subject|1|||
147600149|NCT00655876|532356329|FG000|Overall Study|Protocol Violation|9|||
147600150|NCT00655876|532356330|FG001|Overall Study|Protocol Violation|7|||
147600151|NCT01468818|532356333|FG000|Overall Study|Death during treatment|2|||
147600152|NCT00338455|532356336|FG000|Overall Study|Death|2|||
147600153|NCT00338455|532356337|FG001|Overall Study|Death|1|||
147600154|NCT00338455|532356336|FG000|Overall Study|Physician Decision|1|||
147600155|NCT00338455|532356337|FG001|Overall Study|Physician Decision|0|||
147600156|NCT01059344|532356340|FG000|Overall Study|Adverse Event|12|||
147600157|NCT01059344|532356341|FG001|Overall Study|Adverse Event|30|||
147600158|NCT01059344|532356340|FG000|Overall Study|Withdrawal by Subject|6|||
147600159|NCT01059344|532356341|FG001|Overall Study|Withdrawal by Subject|9|||
147600160|NCT01059344|532356340|FG000|Overall Study|Lost to Follow-up|1|||
147266308|NCT02286193|531149720|FG000|Overall Study|Referred: CRS unable to make contact|62|||
147266309|NCT02286193|531149720|FG000|Overall Study|Referred: unable to reach/resource sent|104|||
147266310|NCT02286193|531149720|FG000|Overall Study|Referred: Declined service|38|||
147266311|NCT00423891|531149721|FG000|Enrolled|Withdrawal by Subject|0|||
147600161|NCT01059344|532356341|FG001|Overall Study|Lost to Follow-up|1|||
147600162|NCT01059344|532356340|FG000|Overall Study|Other|3|||
147600163|NCT01059344|532356341|FG001|Overall Study|Other|6|||
147600164|NCT01739348|532356342|FG000|Part I (Base Study)|Adverse Event|41|||
147600165|NCT01739348|532356343|FG001|Part I (Base Study)|Adverse Event|52|||
147600166|NCT01739348|532356344|FG002|Part I (Base Study)|Adverse Event|8|||
147266312|NCT00423891|531149722|FG001|Enrolled|Withdrawal by Subject|0|||
147266313|NCT00423891|531149723|FG002|Enrolled|Withdrawal by Subject|1|||
147266314|NCT00423891|531149721|FG000|Enrolled|Lost to Follow-up|0|||
147266315|NCT00423891|531149722|FG001|Enrolled|Lost to Follow-up|0|||
147266316|NCT00423891|531149723|FG002|Enrolled|Lost to Follow-up|1|||
147600167|NCT01739348|532356345|FG003|Part I (Base Study)|Adverse Event|33|||
147600168|NCT01739348|532356342|FG000|Part I (Base Study)|Death|10|||
147600169|NCT01739348|532356343|FG001|Part I (Base Study)|Death|7|||
147600170|NCT01739348|532356344|FG002|Part I (Base Study)|Death|2|||
147600171|NCT01739348|532356345|FG003|Part I (Base Study)|Death|8|||
147266317|NCT00423891|531149721|FG000|Enrolled|No longer met criteria|11|||
147266318|NCT00423891|531149722|FG001|Enrolled|No longer met criteria|2|||
147266319|NCT00423891|531149723|FG002|Enrolled|No longer met criteria|1|||
147266320|NCT00423891|531149721|FG000|Treatment|Withdrawal by Subject|1|||
147266321|NCT00423891|531149722|FG001|Treatment|Withdrawal by Subject|0|||
147266322|NCT00423891|531149723|FG002|Treatment|Withdrawal by Subject|0|||
147266323|NCT00423891|531149721|FG000|Treatment|Lost to Follow-up|1|||
147266324|NCT00423891|531149722|FG001|Treatment|Lost to Follow-up|0|||
147266325|NCT00423891|531149723|FG002|Treatment|Lost to Follow-up|0|||
147266326|NCT00423891|531149721|FG000|Post-Dosing Follow Up|Withdrawal by Subject|0|||
147266327|NCT00423891|531149722|FG001|Post-Dosing Follow Up|Withdrawal by Subject|3|||
147266328|NCT00423891|531149723|FG002|Post-Dosing Follow Up|Withdrawal by Subject|2|||
147266329|NCT00423891|531149721|FG000|Post-Dosing Follow Up|Lost to Follow-up|2|||
147266330|NCT00423891|531149722|FG001|Post-Dosing Follow Up|Lost to Follow-up|0|||
147266331|NCT00423891|531149723|FG002|Post-Dosing Follow Up|Lost to Follow-up|0|||
147266332|NCT02852265|531149724|FG000|3-month Follow-up|Lost to Follow-up|1|||
147266333|NCT02852265|531149725|FG001|3-month Follow-up|Lost to Follow-up|1|||
147266334|NCT01461096|531149729|FG000|Overall Study|Death|3|||
147266335|NCT01461096|531149730|FG001|Overall Study|Death|6|||
147266336|NCT01461096|531149729|FG000|Overall Study|Severe debilitation, unable to continue|1|||
147266337|NCT01461096|531149730|FG001|Overall Study|Severe debilitation, unable to continue|1|||
147266338|NCT01461096|531149729|FG000|Overall Study|Subj not able to get to clinic|15|||
147266339|NCT01461096|531149730|FG001|Overall Study|Subj not able to get to clinic|13|||
147266340|NCT01461096|531149729|FG000|Overall Study|Site is closing|27|||
147266341|NCT01461096|531149730|FG001|Overall Study|Site is closing|30|||
147266342|NCT01461096|531149729|FG000|Overall Study|Withdrawal by Subject|5|||
147266343|NCT01461096|531149730|FG001|Overall Study|Withdrawal by Subject|3|||
147266344|NCT01461096|531149729|FG000|Overall Study|Subj not willing to adhere to reqs|3|||
147266345|NCT01461096|531149730|FG001|Overall Study|Subj not willing to adhere to reqs|4|||
147266346|NCT01461096|531149729|FG000|Overall Study|Lost to Follow-up|8|||
147266347|NCT01461096|531149730|FG001|Overall Study|Lost to Follow-up|4|||
147266348|NCT01479621|531149731|FG000|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|93|||
147266349|NCT01479621|531149732|FG001|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
147266350|NCT01479621|531149733|FG002|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
147266351|NCT01479621|531149734|FG003|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
147266352|NCT01479621|531149735|FG004|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
147266353|NCT01479621|531149736|FG005|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
147266354|NCT01479621|531149737|FG006|Pre-Assignment Period (Run-In Placebo)|Inclusion/exclusion criteria|0|||
147266355|NCT01479621|531149731|FG000|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|19|||
147266356|NCT01479621|531149732|FG001|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
147266357|NCT01479621|531149733|FG002|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
147266358|NCT01479621|531149734|FG003|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
147266359|NCT01479621|531149735|FG004|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
147266360|NCT01479621|531149736|FG005|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
147266361|NCT01479621|531149737|FG006|Pre-Assignment Period (Run-In Placebo)|Withdrawal by Subject|0|||
147266362|NCT01479621|531149731|FG000|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|153|||
147266363|NCT01479621|531149732|FG001|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
147266364|NCT01479621|531149733|FG002|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
147266365|NCT01479621|531149734|FG003|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
147266366|NCT01479621|531149735|FG004|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
147266367|NCT01479621|531149736|FG005|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
147266368|NCT01479621|531149737|FG006|Pre-Assignment Period (Run-In Placebo)|Randomization criteria not met|0|||
147266369|NCT01479621|531149731|FG000|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|7|||
147266370|NCT01479621|531149732|FG001|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
147266371|NCT01479621|531149733|FG002|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
147266372|NCT01479621|531149734|FG003|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
147333085|NCT01212757|531385643|FG005|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
147600172|NCT01739348|532356342|FG000|Part I (Base Study)|Lack of Efficacy|3|||
147600173|NCT01739348|532356343|FG001|Part I (Base Study)|Lack of Efficacy|8|||
147600174|NCT01739348|532356344|FG002|Part I (Base Study)|Lack of Efficacy|0|||
147600175|NCT01739348|532356345|FG003|Part I (Base Study)|Lack of Efficacy|7|||
147600176|NCT01739348|532356342|FG000|Part I (Base Study)|Lost to Follow-up|4|||
147600177|NCT01739348|532356343|FG001|Part I (Base Study)|Lost to Follow-up|2|||
147600178|NCT01739348|532356344|FG002|Part I (Base Study)|Lost to Follow-up|4|||
147333086|NCT01212757|531385644|FG006|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
147600179|NCT01739348|532356345|FG003|Part I (Base Study)|Lost to Follow-up|4|||
147600180|NCT01739348|532356342|FG000|Part I (Base Study)|Non-Compliance with Study Drug|3|||
147662296|NCT02481050|532587289|FG000|Overall Study|Other|3|||
147662297|NCT01228591|532587290|FG000|Baseline|Lack of Efficacy|1|||
147266373|NCT01479621|531149735|FG004|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
147266374|NCT01479621|531149736|FG005|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
147266375|NCT01479621|531149737|FG006|Pre-Assignment Period (Run-In Placebo)|Lost to Follow-up|0|||
147266376|NCT01479621|531149731|FG000|Pre-Assignment Period (Run-In Placebo)|Other|15|||
147266377|NCT01479621|531149732|FG001|Pre-Assignment Period (Run-In Placebo)|Other|0|||
147266378|NCT01479621|531149733|FG002|Pre-Assignment Period (Run-In Placebo)|Other|0|||
147266379|NCT01479621|531149734|FG003|Pre-Assignment Period (Run-In Placebo)|Other|0|||
147266380|NCT01479621|531149735|FG004|Pre-Assignment Period (Run-In Placebo)|Other|0|||
147266381|NCT01479621|531149736|FG005|Pre-Assignment Period (Run-In Placebo)|Other|0|||
147266382|NCT01479621|531149737|FG006|Pre-Assignment Period (Run-In Placebo)|Other|0|||
147266383|NCT01479621|531149731|FG000|Treatment Period|Adverse Event|0|||
147266384|NCT01479621|531149732|FG001|Treatment Period|Adverse Event|0|||
147266385|NCT01479621|531149733|FG002|Treatment Period|Adverse Event|0|||
147266386|NCT01479621|531149734|FG003|Treatment Period|Adverse Event|0|||
147266387|NCT01479621|531149735|FG004|Treatment Period|Adverse Event|1|||
147266388|NCT01479621|531149736|FG005|Treatment Period|Adverse Event|2|||
147266389|NCT01479621|531149737|FG006|Treatment Period|Adverse Event|2|||
147266390|NCT01479621|531149731|FG000|Treatment Period|Withdrawal by Subject|0|||
147266391|NCT01479621|531149732|FG001|Treatment Period|Withdrawal by Subject|4|||
147266392|NCT01479621|531149733|FG002|Treatment Period|Withdrawal by Subject|2|||
147266393|NCT01479621|531149734|FG003|Treatment Period|Withdrawal by Subject|2|||
147266394|NCT01479621|531149735|FG004|Treatment Period|Withdrawal by Subject|5|||
147266395|NCT01479621|531149736|FG005|Treatment Period|Withdrawal by Subject|5|||
147266396|NCT01479621|531149737|FG006|Treatment Period|Withdrawal by Subject|1|||
147266397|NCT01479621|531149731|FG000|Treatment Period|Physician Decision|0|||
147266398|NCT01479621|531149732|FG001|Treatment Period|Physician Decision|0|||
147266399|NCT01479621|531149733|FG002|Treatment Period|Physician Decision|0|||
147266400|NCT01479621|531149734|FG003|Treatment Period|Physician Decision|0|||
147266401|NCT01479621|531149735|FG004|Treatment Period|Physician Decision|1|||
147266402|NCT01479621|531149736|FG005|Treatment Period|Physician Decision|1|||
147266403|NCT01479621|531149737|FG006|Treatment Period|Physician Decision|0|||
147266404|NCT01479621|531149731|FG000|Treatment Period|Non-compliance to study drug|0|||
147450224|NCT02898259|531811390|FG004|Overall Study|Transformation before study began|0|||
147450225|NCT01046877|531811394|FG000|Overall Study|Exited voluntarily before tube extrusion|7|||
147600181|NCT01739348|532356343|FG001|Part I (Base Study)|Non-Compliance with Study Drug|2|||
147600182|NCT01739348|532356344|FG002|Part I (Base Study)|Non-Compliance with Study Drug|0|||
147266405|NCT01479621|531149732|FG001|Treatment Period|Non-compliance to study drug|1|||
147266406|NCT01479621|531149733|FG002|Treatment Period|Non-compliance to study drug|0|||
147266407|NCT01479621|531149734|FG003|Treatment Period|Non-compliance to study drug|0|||
147266408|NCT01479621|531149735|FG004|Treatment Period|Non-compliance to study drug|0|||
147266409|NCT01479621|531149736|FG005|Treatment Period|Non-compliance to study drug|0|||
147266410|NCT01479621|531149737|FG006|Treatment Period|Non-compliance to study drug|1|||
147266411|NCT01479621|531149731|FG000|Treatment Period|Protocol Violation|0|||
147266412|NCT01479621|531149732|FG001|Treatment Period|Protocol Violation|9|||
147266413|NCT01479621|531149733|FG002|Treatment Period|Protocol Violation|6|||
147266414|NCT01479621|531149734|FG003|Treatment Period|Protocol Violation|5|||
147266415|NCT01479621|531149735|FG004|Treatment Period|Protocol Violation|2|||
147266416|NCT01479621|531149736|FG005|Treatment Period|Protocol Violation|10|||
147266417|NCT01479621|531149737|FG006|Treatment Period|Protocol Violation|6|||
147266418|NCT01479621|531149731|FG000|Treatment Period|Pregnancy|0|||
147266419|NCT01479621|531149732|FG001|Treatment Period|Pregnancy|0|||
147266420|NCT01479621|531149733|FG002|Treatment Period|Pregnancy|2|||
147266421|NCT01479621|531149734|FG003|Treatment Period|Pregnancy|0|||
147266422|NCT01479621|531149735|FG004|Treatment Period|Pregnancy|0|||
147266423|NCT01479621|531149736|FG005|Treatment Period|Pregnancy|0|||
147266424|NCT01479621|531149737|FG006|Treatment Period|Pregnancy|0|||
147266425|NCT01479621|531149731|FG000|Treatment Period|Sponsor request subject to be withdrawn|0|||
147266426|NCT01479621|531149732|FG001|Treatment Period|Sponsor request subject to be withdrawn|2|||
147266427|NCT01479621|531149733|FG002|Treatment Period|Sponsor request subject to be withdrawn|3|||
147266428|NCT01479621|531149734|FG003|Treatment Period|Sponsor request subject to be withdrawn|1|||
147266429|NCT01479621|531149735|FG004|Treatment Period|Sponsor request subject to be withdrawn|1|||
147266430|NCT01479621|531149736|FG005|Treatment Period|Sponsor request subject to be withdrawn|1|||
147266431|NCT01479621|531149737|FG006|Treatment Period|Sponsor request subject to be withdrawn|3|||
147266432|NCT01479621|531149731|FG000|Treatment Period|Lost to Follow-up|0|||
147266433|NCT01479621|531149732|FG001|Treatment Period|Lost to Follow-up|0|||
147266434|NCT01479621|531149733|FG002|Treatment Period|Lost to Follow-up|1|||
147266435|NCT01479621|531149734|FG003|Treatment Period|Lost to Follow-up|0|||
147266436|NCT01479621|531149735|FG004|Treatment Period|Lost to Follow-up|2|||
147266437|NCT01479621|531149736|FG005|Treatment Period|Lost to Follow-up|2|||
147266438|NCT01479621|531149737|FG006|Treatment Period|Lost to Follow-up|1|||
147266439|NCT01479621|531149731|FG000|Treatment Period|Met stopping criteria|0|||
147600183|NCT01739348|532356345|FG003|Part I (Base Study)|Non-Compliance with Study Drug|0|||
147600184|NCT01739348|532356342|FG000|Part I (Base Study)|Physician Decision|10|||
147266440|NCT01479621|531149732|FG001|Treatment Period|Met stopping criteria|8|||
147266441|NCT01479621|531149733|FG002|Treatment Period|Met stopping criteria|7|||
147266442|NCT01479621|531149734|FG003|Treatment Period|Met stopping criteria|4|||
147266443|NCT01479621|531149735|FG004|Treatment Period|Met stopping criteria|9|||
147266444|NCT01479621|531149736|FG005|Treatment Period|Met stopping criteria|20|||
147266445|NCT01479621|531149737|FG006|Treatment Period|Met stopping criteria|6|||
147266446|NCT04225923|531149742|FG000|Overall Study|Protocol Violation|1|||
147266447|NCT04225923|531149743|FG001|Overall Study|Protocol Violation|0|||
147266448|NCT04225923|531149744|FG002|Overall Study|Protocol Violation|1|||
147266449|NCT04225923|531149742|FG000|Overall Study|Withdrawal by Subject|4|||
147266450|NCT04225923|531149743|FG001|Overall Study|Withdrawal by Subject|1|||
147266451|NCT04225923|531149744|FG002|Overall Study|Withdrawal by Subject|3|||
147266452|NCT04225923|531149742|FG000|Overall Study|A subject completed the study but was reported incorrectly in the report form|0|||
147266453|NCT04225923|531149743|FG001|Overall Study|A subject completed the study but was reported incorrectly in the report form|0|||
147266454|NCT04225923|531149744|FG002|Overall Study|A subject completed the study but was reported incorrectly in the report form|1|||
147266455|NCT00855309|531149745|FG000|Overall Study|patient never recieved drug|1|||
147266456|NCT00855309|531149746|FG001|Overall Study|patient never recieved drug|0|||
147266457|NCT01585766|531149747|FG000|Overall Study|Withdrawal by Subject|0|||
147266458|NCT01585766|531149748|FG001|Overall Study|Withdrawal by Subject|1|||
147266459|NCT01585766|531149749|FG002|Overall Study|Withdrawal by Subject|1|||
147266460|NCT01585766|531149750|FG003|Overall Study|Withdrawal by Subject|0|||
147266461|NCT01585766|531149751|FG004|Overall Study|Withdrawal by Subject|0|||
147266462|NCT01585766|531149752|FG005|Overall Study|Withdrawal by Subject|0|||
147266463|NCT01585766|531149747|FG000|Overall Study|Death|0|||
147266464|NCT01585766|531149748|FG001|Overall Study|Death|1|||
147266465|NCT01585766|531149749|FG002|Overall Study|Death|0|||
147266466|NCT01585766|531149750|FG003|Overall Study|Death|0|||
147266467|NCT01585766|531149751|FG004|Overall Study|Death|0|||
147266468|NCT01585766|531149752|FG005|Overall Study|Death|0|||
147266469|NCT01585766|531149747|FG000|Overall Study|Physician Decision|0|||
147266470|NCT01585766|531149748|FG001|Overall Study|Physician Decision|0|||
147266471|NCT01585766|531149749|FG002|Overall Study|Physician Decision|1|||
147266472|NCT01585766|531149750|FG003|Overall Study|Physician Decision|0|||
147266473|NCT01585766|531149751|FG004|Overall Study|Physician Decision|0|||
147266474|NCT01585766|531149752|FG005|Overall Study|Physician Decision|0|||
147266475|NCT04116710|531149753|FG000|Overall Study|Death|4|||
147266476|NCT04116710|531149754|FG001|Overall Study|Death|6|||
147266477|NCT04116710|531149755|FG002|Overall Study|Death|3|||
147266478|NCT04116710|531149756|FG003|Overall Study|Death|1|||
147266479|NCT04116710|531149753|FG000|Overall Study|Withdrawal by Subject|0|||
147266480|NCT04116710|531149754|FG001|Overall Study|Withdrawal by Subject|0|||
147266481|NCT04116710|531149755|FG002|Overall Study|Withdrawal by Subject|0|||
147266482|NCT04116710|531149756|FG003|Overall Study|Withdrawal by Subject|1|||
147266483|NCT00582933|531149757|FG000|Overall Study|Physician Decision|3|||
147266484|NCT02376166|531149762|FG000|Overall Study|Adverse Event|1|||
147266485|NCT02376166|531149762|FG000|Overall Study|Discontinued metformin early|2|||
147266486|NCT01228747|531149769|FG000|Overall Study|Adverse Event|8|||
147266487|NCT01228747|531149770|FG001|Overall Study|Adverse Event|4|||
147600185|NCT01739348|532356343|FG001|Part I (Base Study)|Physician Decision|7|||
147600186|NCT01739348|532356344|FG002|Part I (Base Study)|Physician Decision|1|||
147600187|NCT01739348|532356345|FG003|Part I (Base Study)|Physician Decision|4|||
147600188|NCT01739348|532356342|FG000|Part I (Base Study)|Protocol Violation|2|||
147600189|NCT01739348|532356343|FG001|Part I (Base Study)|Protocol Violation|0|||
147600190|NCT01739348|532356344|FG002|Part I (Base Study)|Protocol Violation|1|||
147600191|NCT01739348|532356345|FG003|Part I (Base Study)|Protocol Violation|2|||
147600192|NCT01739348|532356342|FG000|Part I (Base Study)|Screen Failure|2|||
147600193|NCT01739348|532356343|FG001|Part I (Base Study)|Screen Failure|0|||
147600194|NCT01739348|532356344|FG002|Part I (Base Study)|Screen Failure|0|||
147600195|NCT01739348|532356345|FG003|Part I (Base Study)|Screen Failure|0|||
147600196|NCT01739348|532356342|FG000|Part I (Base Study)|Site Discontinued Study Participation|1|||
147600197|NCT01739348|532356343|FG001|Part I (Base Study)|Site Discontinued Study Participation|3|||
147600198|NCT01739348|532356344|FG002|Part I (Base Study)|Site Discontinued Study Participation|0|||
147600199|NCT01739348|532356345|FG003|Part I (Base Study)|Site Discontinued Study Participation|0|||
147600200|NCT01739348|532356342|FG000|Part I (Base Study)|Study Terminated by Sponsor|72|||
147266488|NCT01228747|531149769|FG000|Overall Study|Lack of Efficacy|40|||
147266489|NCT01228747|531149770|FG001|Overall Study|Lack of Efficacy|27|||
147266490|NCT01228747|531149769|FG000|Overall Study|Protocol Violation|6|||
147266491|NCT01228747|531149770|FG001|Overall Study|Protocol Violation|5|||
147266492|NCT01228747|531149769|FG000|Overall Study|Lost to Follow-up|4|||
147266493|NCT01228747|531149770|FG001|Overall Study|Lost to Follow-up|3|||
147266494|NCT01228747|531149769|FG000|Overall Study|Withdrawal by Subject|5|||
147266495|NCT01228747|531149770|FG001|Overall Study|Withdrawal by Subject|1|||
147266496|NCT01228747|531149769|FG000|Overall Study|Other Reason|2|||
147266497|NCT01228747|531149770|FG001|Overall Study|Other Reason|5|||
147600201|NCT01739348|532356343|FG001|Part I (Base Study)|Study Terminated by Sponsor|73|||
147600202|NCT01739348|532356344|FG002|Part I (Base Study)|Study Terminated by Sponsor|0|||
147266498|NCT02036502|531149771|FG000|Part 1:Dose Determination/Escalation|Death|3|||
147266499|NCT02036502|531149772|FG001|Part 1:Dose Determination/Escalation|Death|2|||
147266500|NCT02036502|531149773|FG002|Part 1:Dose Determination/Escalation|Death|0|||
147266501|NCT02036502|531149774|FG003|Part 1:Dose Determination/Escalation|Death|0|||
147266502|NCT02036502|531149775|FG004|Part 1:Dose Determination/Escalation|Death|0|||
147266503|NCT02036502|531149776|FG005|Part 1:Dose Determination/Escalation|Death|0|||
147266504|NCT02036502|531149777|FG006|Part 1:Dose Determination/Escalation|Death|0|||
147266505|NCT02036502|531149778|FG007|Part 1:Dose Determination/Escalation|Death|0|||
147266506|NCT02036502|531149771|FG000|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|3|||
147266507|NCT02036502|531149772|FG001|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
147266508|NCT02036502|531149773|FG002|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
147266509|NCT02036502|531149774|FG003|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
147266510|NCT02036502|531149775|FG004|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
147266511|NCT02036502|531149776|FG005|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
147266512|NCT02036502|531149777|FG006|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
147266513|NCT02036502|531149778|FG007|Part 1:Dose Determination/Escalation|Study Terminated by Sponsor|0|||
147266514|NCT02036502|531149771|FG000|Part 1:Dose Determination/Escalation|Adverse Event|0|||
147266515|NCT02036502|531149772|FG001|Part 1:Dose Determination/Escalation|Adverse Event|1|||
147266516|NCT02036502|531149773|FG002|Part 1:Dose Determination/Escalation|Adverse Event|0|||
147266517|NCT02036502|531149774|FG003|Part 1:Dose Determination/Escalation|Adverse Event|0|||
147266518|NCT02036502|531149775|FG004|Part 1:Dose Determination/Escalation|Adverse Event|0|||
147266519|NCT02036502|531149776|FG005|Part 1:Dose Determination/Escalation|Adverse Event|0|||
147266520|NCT02036502|531149777|FG006|Part 1:Dose Determination/Escalation|Adverse Event|0|||
147266521|NCT02036502|531149778|FG007|Part 1:Dose Determination/Escalation|Adverse Event|0|||
147266522|NCT02036502|531149771|FG000|Part 1:Dose Determination/Escalation|Not treated|0|||
147266523|NCT02036502|531149772|FG001|Part 1:Dose Determination/Escalation|Not treated|1|||
147266524|NCT02036502|531149773|FG002|Part 1:Dose Determination/Escalation|Not treated|0|||
147266525|NCT02036502|531149774|FG003|Part 1:Dose Determination/Escalation|Not treated|0|||
147266526|NCT02036502|531149775|FG004|Part 1:Dose Determination/Escalation|Not treated|0|||
147266527|NCT02036502|531149776|FG005|Part 1:Dose Determination/Escalation|Not treated|0|||
147266528|NCT02036502|531149777|FG006|Part 1:Dose Determination/Escalation|Not treated|0|||
147333087|NCT01212757|531385645|FG007|Long-Term Safety Phase (Year 3)|Adverse Event|2|||
147333088|NCT01212757|531385646|FG008|Long-Term Safety Phase (Year 3)|Adverse Event|0|||
147333089|NCT01212757|531385638|FG000|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0|||
147333090|NCT01212757|531385639|FG001|Long-Term Safety Phase (Year 3)|Lack of Efficacy|8|||
147333091|NCT01212757|531385640|FG002|Long-Term Safety Phase (Year 3)|Lack of Efficacy|5|||
147333092|NCT01212757|531385641|FG003|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0|||
147333093|NCT01212757|531385642|FG004|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0|||
147333094|NCT01212757|531385643|FG005|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0|||
147333095|NCT01212757|531385644|FG006|Long-Term Safety Phase (Year 3)|Lack of Efficacy|0|||
147333096|NCT01212757|531385645|FG007|Long-Term Safety Phase (Year 3)|Lack of Efficacy|3|||
147333097|NCT01212757|531385646|FG008|Long-Term Safety Phase (Year 3)|Lack of Efficacy|1|||
147333098|NCT01212757|531385638|FG000|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
147333099|NCT01212757|531385639|FG001|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
147333100|NCT01212757|531385640|FG002|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|1|||
147333101|NCT01212757|531385641|FG003|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
147333102|NCT01212757|531385642|FG004|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
147333103|NCT01212757|531385643|FG005|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
147333104|NCT01212757|531385644|FG006|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
147333105|NCT01212757|531385645|FG007|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
147333106|NCT01212757|531385646|FG008|Long-Term Safety Phase (Year 3)|Non-compliance with study drug|0|||
147333107|NCT01212757|531385638|FG000|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0|||
147333108|NCT01212757|531385639|FG001|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|5|||
147333109|NCT01212757|531385640|FG002|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|1|||
147333110|NCT01212757|531385641|FG003|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0|||
147333111|NCT01212757|531385642|FG004|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0|||
147333112|NCT01212757|531385643|FG005|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0|||
147333113|NCT01212757|531385644|FG006|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|0|||
147600203|NCT01739348|532356345|FG003|Part I (Base Study)|Study Terminated by Sponsor|86|||
147600204|NCT01739348|532356342|FG000|Part I (Base Study)|Participant Moved|4|||
147333114|NCT01212757|531385645|FG007|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|1|||
147333115|NCT01212757|531385646|FG008|Long-Term Safety Phase (Year 3)|Withdrawal by Subject|1|||
147333116|NCT01212757|531385638|FG000|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
147333117|NCT01212757|531385639|FG001|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
147600205|NCT01739348|532356343|FG001|Part I (Base Study)|Participant Moved|3|||
147600206|NCT01739348|532356344|FG002|Part I (Base Study)|Participant Moved|1|||
147266529|NCT02036502|531149778|FG007|Part 1:Dose Determination/Escalation|Not treated|0|||
147600207|NCT01739348|532356345|FG003|Part I (Base Study)|Participant Moved|7|||
147600208|NCT01739348|532356342|FG000|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|27|||
147266530|NCT02036502|531149771|FG000|Part 2:Dose Confirmation|Study Terminated by Sponsor|0|||
147266531|NCT02036502|531149772|FG001|Part 2:Dose Confirmation|Study Terminated by Sponsor|0|||
147266532|NCT02036502|531149773|FG002|Part 2:Dose Confirmation|Study Terminated by Sponsor|2|||
147266533|NCT02036502|531149774|FG003|Part 2:Dose Confirmation|Study Terminated by Sponsor|1|||
147266534|NCT02036502|531149775|FG004|Part 2:Dose Confirmation|Study Terminated by Sponsor|1|||
147266535|NCT02036502|531149776|FG005|Part 2:Dose Confirmation|Study Terminated by Sponsor|0|||
147266536|NCT02036502|531149777|FG006|Part 2:Dose Confirmation|Study Terminated by Sponsor|0|||
147266537|NCT02036502|531149778|FG007|Part 2:Dose Confirmation|Study Terminated by Sponsor|0|||
147266538|NCT02036502|531149771|FG000|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
147266539|NCT02036502|531149772|FG001|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
147266540|NCT02036502|531149773|FG002|Part 2:Dose Confirmation|Withdrawal by Subject|3|||
147266541|NCT02036502|531149774|FG003|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
147266542|NCT02036502|531149775|FG004|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
147266543|NCT02036502|531149776|FG005|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
147266544|NCT02036502|531149777|FG006|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
147266545|NCT02036502|531149778|FG007|Part 2:Dose Confirmation|Withdrawal by Subject|0|||
147266546|NCT02036502|531149771|FG000|Part 2:Dose Confirmation|Death|0|||
147266547|NCT02036502|531149772|FG001|Part 2:Dose Confirmation|Death|0|||
147266548|NCT02036502|531149773|FG002|Part 2:Dose Confirmation|Death|1|||
147266549|NCT02036502|531149774|FG003|Part 2:Dose Confirmation|Death|0|||
147266550|NCT02036502|531149775|FG004|Part 2:Dose Confirmation|Death|0|||
147266551|NCT02036502|531149776|FG005|Part 2:Dose Confirmation|Death|0|||
147266552|NCT02036502|531149777|FG006|Part 2:Dose Confirmation|Death|0|||
147266553|NCT02036502|531149778|FG007|Part 2:Dose Confirmation|Death|0|||
147266554|NCT02036502|531149771|FG000|Part 2:Dose Confirmation|Not treated|0|||
147266555|NCT02036502|531149772|FG001|Part 2:Dose Confirmation|Not treated|0|||
147266556|NCT02036502|531149773|FG002|Part 2:Dose Confirmation|Not treated|0|||
147266557|NCT02036502|531149774|FG003|Part 2:Dose Confirmation|Not treated|1|||
147266558|NCT02036502|531149775|FG004|Part 2:Dose Confirmation|Not treated|0|||
147266559|NCT02036502|531149776|FG005|Part 2:Dose Confirmation|Not treated|0|||
147266560|NCT02036502|531149777|FG006|Part 2:Dose Confirmation|Not treated|0|||
147266561|NCT02036502|531149778|FG007|Part 2:Dose Confirmation|Not treated|0|||
147266562|NCT02036502|531149771|FG000|Part 3:Dose Expansion|Adverse Event|0|||
147266563|NCT02036502|531149772|FG001|Part 3:Dose Expansion|Adverse Event|0|||
147266564|NCT02036502|531149773|FG002|Part 3:Dose Expansion|Adverse Event|0|||
147266565|NCT02036502|531149774|FG003|Part 3:Dose Expansion|Adverse Event|0|||
147266566|NCT02036502|531149775|FG004|Part 3:Dose Expansion|Adverse Event|0|||
147266567|NCT02036502|531149776|FG005|Part 3:Dose Expansion|Adverse Event|4|||
147266568|NCT02036502|531149777|FG006|Part 3:Dose Expansion|Adverse Event|0|||
147266569|NCT02036502|531149778|FG007|Part 3:Dose Expansion|Adverse Event|2|||
147266570|NCT02036502|531149771|FG000|Part 3:Dose Expansion|Death|0|||
147266571|NCT02036502|531149772|FG001|Part 3:Dose Expansion|Death|0|||
147266572|NCT02036502|531149773|FG002|Part 3:Dose Expansion|Death|0|||
147266573|NCT02036502|531149774|FG003|Part 3:Dose Expansion|Death|0|||
147266574|NCT02036502|531149775|FG004|Part 3:Dose Expansion|Death|0|||
147266575|NCT02036502|531149776|FG005|Part 3:Dose Expansion|Death|24|||
147266576|NCT02036502|531149777|FG006|Part 3:Dose Expansion|Death|0|||
147266577|NCT02036502|531149778|FG007|Part 3:Dose Expansion|Death|3|||
147266578|NCT02036502|531149771|FG000|Part 3:Dose Expansion|Lost to Follow-up|0|||
147266579|NCT02036502|531149772|FG001|Part 3:Dose Expansion|Lost to Follow-up|0|||
147266580|NCT02036502|531149773|FG002|Part 3:Dose Expansion|Lost to Follow-up|0|||
147266581|NCT02036502|531149774|FG003|Part 3:Dose Expansion|Lost to Follow-up|0|||
147266582|NCT02036502|531149775|FG004|Part 3:Dose Expansion|Lost to Follow-up|0|||
147266583|NCT02036502|531149776|FG005|Part 3:Dose Expansion|Lost to Follow-up|0|||
147266584|NCT02036502|531149777|FG006|Part 3:Dose Expansion|Lost to Follow-up|0|||
147266585|NCT02036502|531149778|FG007|Part 3:Dose Expansion|Lost to Follow-up|1|||
147266586|NCT02036502|531149771|FG000|Part 3:Dose Expansion|Physician Decision|0|||
147266587|NCT02036502|531149772|FG001|Part 3:Dose Expansion|Physician Decision|0|||
147266588|NCT02036502|531149773|FG002|Part 3:Dose Expansion|Physician Decision|0|||
147266589|NCT02036502|531149774|FG003|Part 3:Dose Expansion|Physician Decision|0|||
147266590|NCT02036502|531149775|FG004|Part 3:Dose Expansion|Physician Decision|0|||
147266591|NCT02036502|531149776|FG005|Part 3:Dose Expansion|Physician Decision|1|||
147266592|NCT02036502|531149777|FG006|Part 3:Dose Expansion|Physician Decision|0|||
147266593|NCT02036502|531149778|FG007|Part 3:Dose Expansion|Physician Decision|0|||
147266594|NCT02036502|531149771|FG000|Part 3:Dose Expansion|Progressive Disease|0|||
147266595|NCT02036502|531149772|FG001|Part 3:Dose Expansion|Progressive Disease|0|||
147266596|NCT02036502|531149773|FG002|Part 3:Dose Expansion|Progressive Disease|0|||
147266597|NCT02036502|531149774|FG003|Part 3:Dose Expansion|Progressive Disease|0|||
147266598|NCT02036502|531149775|FG004|Part 3:Dose Expansion|Progressive Disease|0|||
147266599|NCT02036502|531149776|FG005|Part 3:Dose Expansion|Progressive Disease|1|||
147266600|NCT02036502|531149777|FG006|Part 3:Dose Expansion|Progressive Disease|0|||
147600209|NCT01739348|532356343|FG001|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|25|||
147266601|NCT02036502|531149778|FG007|Part 3:Dose Expansion|Progressive Disease|0|||
147266602|NCT02036502|531149771|FG000|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
147266603|NCT02036502|531149772|FG001|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
147266604|NCT02036502|531149773|FG002|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
147266605|NCT02036502|531149774|FG003|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
147266606|NCT02036502|531149775|FG004|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
147266607|NCT02036502|531149776|FG005|Part 3:Dose Expansion|Study Terminated by Sponsor|11|||
147266608|NCT02036502|531149777|FG006|Part 3:Dose Expansion|Study Terminated by Sponsor|0|||
147266609|NCT02036502|531149778|FG007|Part 3:Dose Expansion|Study Terminated by Sponsor|2|||
147266610|NCT02036502|531149771|FG000|Part 3:Dose Expansion|Withdrawal by Subject|0|||
147266611|NCT02036502|531149772|FG001|Part 3:Dose Expansion|Withdrawal by Subject|0|||
147266612|NCT02036502|531149773|FG002|Part 3:Dose Expansion|Withdrawal by Subject|0|||
147266613|NCT02036502|531149774|FG003|Part 3:Dose Expansion|Withdrawal by Subject|0|||
147266614|NCT02036502|531149775|FG004|Part 3:Dose Expansion|Withdrawal by Subject|0|||
147266615|NCT02036502|531149776|FG005|Part 3:Dose Expansion|Withdrawal by Subject|4|||
147266616|NCT02036502|531149777|FG006|Part 3:Dose Expansion|Withdrawal by Subject|1|||
147266617|NCT02036502|531149778|FG007|Part 3:Dose Expansion|Withdrawal by Subject|2|||
147266618|NCT02036502|531149771|FG000|Part 3:Dose Expansion|Not Treated|0|||
147266619|NCT02036502|531149772|FG001|Part 3:Dose Expansion|Not Treated|0|||
147266620|NCT02036502|531149773|FG002|Part 3:Dose Expansion|Not Treated|0|||
147266621|NCT02036502|531149774|FG003|Part 3:Dose Expansion|Not Treated|0|||
147266622|NCT02036502|531149775|FG004|Part 3:Dose Expansion|Not Treated|0|||
147266623|NCT02036502|531149776|FG005|Part 3:Dose Expansion|Not Treated|2|||
147266624|NCT02036502|531149777|FG006|Part 3:Dose Expansion|Not Treated|0|||
147266625|NCT02036502|531149778|FG007|Part 3:Dose Expansion|Not Treated|0|||
147266626|NCT01068509|531149781|FG000|Overall Study|Death|0|||
147266627|NCT01068509|531149782|FG001|Overall Study|Death|0|||
147266628|NCT01068509|531149783|FG002|Overall Study|Death|1|||
147266629|NCT01068509|531149781|FG000|Overall Study|Disease Progression|5|||
147266630|NCT01068509|531149782|FG001|Overall Study|Disease Progression|20|||
147266631|NCT01068509|531149783|FG002|Overall Study|Disease Progression|18|||
147266632|NCT01068509|531149781|FG000|Overall Study|Lost to Follow-up|1|||
147266633|NCT01068509|531149782|FG001|Overall Study|Lost to Follow-up|0|||
147266634|NCT01068509|531149783|FG002|Overall Study|Lost to Follow-up|0|||
147333118|NCT01212757|531385640|FG002|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
147333119|NCT01212757|531385641|FG003|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
147333120|NCT01212757|531385642|FG004|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
147333121|NCT01212757|531385643|FG005|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
147333122|NCT01212757|531385644|FG006|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
147333123|NCT01212757|531385645|FG007|Long-Term Safety Phase (Year 3)|Lost to Follow-up|0|||
147333124|NCT01212757|531385646|FG008|Long-Term Safety Phase (Year 3)|Lost to Follow-up|1|||
147333125|NCT01212757|531385638|FG000|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
147333126|NCT01212757|531385639|FG001|Long-Term Safety Phase (Year 3)|Protocol Violation|1|||
147333127|NCT01212757|531385640|FG002|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
147600210|NCT01739348|532356344|FG002|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|2|||
147600211|NCT01739348|532356345|FG003|Part I (Base Study)|Trial Partner/Caregiver Withdrew Consent|18|||
147600212|NCT01739348|532356342|FG000|Part I (Base Study)|Withdrawal by Subject|23|||
147266635|NCT01068509|531149781|FG000|Overall Study|Withdrew Consent|0|||
147266636|NCT01068509|531149782|FG001|Overall Study|Withdrew Consent|1|||
147266637|NCT01068509|531149783|FG002|Overall Study|Withdrew Consent|2|||
147266638|NCT01068509|531149781|FG000|Overall Study|Reason Not Specified|0|||
147266639|NCT01068509|531149782|FG001|Overall Study|Reason Not Specified|1|||
147266640|NCT01068509|531149783|FG002|Overall Study|Reason Not Specified|0|||
147266641|NCT02641379|531149788|FG000|Overall Study|Exclusion criterion during screening|1|||
147266642|NCT02641379|531149789|FG001|Overall Study|Exclusion criterion during screening|0|||
147266643|NCT02641379|531149790|FG002|Overall Study|Exclusion criterion during screening|0|||
147266644|NCT02641379|531149791|FG003|Overall Study|Exclusion criterion during screening|1|||
147333128|NCT01212757|531385641|FG003|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
147333129|NCT01212757|531385642|FG004|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
147333130|NCT01212757|531385643|FG005|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
147333131|NCT01212757|531385644|FG006|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
147600213|NCT01739348|532356343|FG001|Part I (Base Study)|Withdrawal by Subject|21|||
147333132|NCT01212757|531385645|FG007|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
147333133|NCT01212757|531385646|FG008|Long-Term Safety Phase (Year 3)|Protocol Violation|0|||
147333134|NCT01212757|531385638|FG000|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
147333135|NCT01212757|531385639|FG001|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
147600214|NCT01739348|532356344|FG002|Part I (Base Study)|Withdrawal by Subject|7|||
147266645|NCT02641379|531149792|FG004|Overall Study|Exclusion criterion during screening|2|||
147266646|NCT02641379|531149793|FG005|Overall Study|Exclusion criterion during screening|0|||
147266647|NCT02641379|531149794|FG006|Overall Study|Exclusion criterion during screening|0|||
147266648|NCT02641379|531149795|FG007|Overall Study|Exclusion criterion during screening|0|||
147266649|NCT02641379|531149796|FG008|Overall Study|Exclusion criterion during screening|0|||
147266650|NCT02641379|531149797|FG009|Overall Study|Exclusion criterion during screening|0|||
147266651|NCT02641379|531149798|FG010|Overall Study|Exclusion criterion during screening|0|||
147266652|NCT02641379|531149788|FG000|Overall Study|Withdrawal of informed consent|0|||
147266653|NCT02641379|531149789|FG001|Overall Study|Withdrawal of informed consent|1|||
147266654|NCT02641379|531149790|FG002|Overall Study|Withdrawal of informed consent|0|||
147266655|NCT02641379|531149791|FG003|Overall Study|Withdrawal of informed consent|0|||
147266656|NCT02641379|531149792|FG004|Overall Study|Withdrawal of informed consent|0|||
147266657|NCT02641379|531149793|FG005|Overall Study|Withdrawal of informed consent|0|||
147266658|NCT02641379|531149794|FG006|Overall Study|Withdrawal of informed consent|0|||
147266659|NCT02641379|531149795|FG007|Overall Study|Withdrawal of informed consent|1|||
147266660|NCT02641379|531149796|FG008|Overall Study|Withdrawal of informed consent|0|||
147266661|NCT02641379|531149797|FG009|Overall Study|Withdrawal of informed consent|0|||
147266662|NCT02641379|531149798|FG010|Overall Study|Withdrawal of informed consent|0|||
147266663|NCT02641379|531149788|FG000|Overall Study|Adverse Event|7|||
147266664|NCT02641379|531149789|FG001|Overall Study|Adverse Event|8|||
147266665|NCT02641379|531149790|FG002|Overall Study|Adverse Event|2|||
147266666|NCT02641379|531149791|FG003|Overall Study|Adverse Event|2|||
147266667|NCT02641379|531149792|FG004|Overall Study|Adverse Event|5|||
147266668|NCT02641379|531149793|FG005|Overall Study|Adverse Event|1|||
147266669|NCT02641379|531149794|FG006|Overall Study|Adverse Event|5|||
147266670|NCT02641379|531149795|FG007|Overall Study|Adverse Event|0|||
147266671|NCT02641379|531149796|FG008|Overall Study|Adverse Event|1|||
147266672|NCT02641379|531149797|FG009|Overall Study|Adverse Event|1|||
147266673|NCT02641379|531149798|FG010|Overall Study|Adverse Event|5|||
147266674|NCT02641379|531149788|FG000|Overall Study|Lack of Efficacy|0|||
147266675|NCT02641379|531149789|FG001|Overall Study|Lack of Efficacy|0|||
147266676|NCT02641379|531149790|FG002|Overall Study|Lack of Efficacy|2|||
147266677|NCT02641379|531149791|FG003|Overall Study|Lack of Efficacy|0|||
147266678|NCT02641379|531149792|FG004|Overall Study|Lack of Efficacy|0|||
147266679|NCT02641379|531149793|FG005|Overall Study|Lack of Efficacy|2|||
147266680|NCT02641379|531149794|FG006|Overall Study|Lack of Efficacy|0|||
147266681|NCT02641379|531149795|FG007|Overall Study|Lack of Efficacy|5|||
147266682|NCT02641379|531149796|FG008|Overall Study|Lack of Efficacy|0|||
147266683|NCT02641379|531149797|FG009|Overall Study|Lack of Efficacy|0|||
147266684|NCT02641379|531149798|FG010|Overall Study|Lack of Efficacy|0|||
147266685|NCT02641379|531149788|FG000|Overall Study|Participant unable to attend study visit|4|||
147266686|NCT02641379|531149789|FG001|Overall Study|Participant unable to attend study visit|10|||
147266687|NCT02641379|531149790|FG002|Overall Study|Participant unable to attend study visit|1|||
147266688|NCT02641379|531149791|FG003|Overall Study|Participant unable to attend study visit|2|||
147266689|NCT02641379|531149792|FG004|Overall Study|Participant unable to attend study visit|5|||
147266690|NCT02641379|531149793|FG005|Overall Study|Participant unable to attend study visit|1|||
147266691|NCT02641379|531149794|FG006|Overall Study|Participant unable to attend study visit|1|||
147266692|NCT02641379|531149795|FG007|Overall Study|Participant unable to attend study visit|1|||
147266693|NCT02641379|531149796|FG008|Overall Study|Participant unable to attend study visit|0|||
147266694|NCT02641379|531149797|FG009|Overall Study|Participant unable to attend study visit|2|||
147266695|NCT02641379|531149798|FG010|Overall Study|Participant unable to attend study visit|0|||
147266696|NCT02641379|531149788|FG000|Overall Study|Participant's compliance|0|||
147266697|NCT02641379|531149789|FG001|Overall Study|Participant's compliance|1|||
147266698|NCT02641379|531149790|FG002|Overall Study|Participant's compliance|0|||
147266699|NCT02641379|531149791|FG003|Overall Study|Participant's compliance|1|||
147266700|NCT02641379|531149792|FG004|Overall Study|Participant's compliance|0|||
147266701|NCT02641379|531149793|FG005|Overall Study|Participant's compliance|2|||
147266702|NCT02641379|531149794|FG006|Overall Study|Participant's compliance|0|||
147266703|NCT02641379|531149795|FG007|Overall Study|Participant's compliance|0|||
147266704|NCT02641379|531149796|FG008|Overall Study|Participant's compliance|1|||
147266705|NCT02641379|531149797|FG009|Overall Study|Participant's compliance|1|||
147266706|NCT02641379|531149798|FG010|Overall Study|Participant's compliance|1|||
147266707|NCT02641379|531149788|FG000|Overall Study|Participant cannot be reached|4|||
147266708|NCT02641379|531149789|FG001|Overall Study|Participant cannot be reached|4|||
147266709|NCT02641379|531149790|FG002|Overall Study|Participant cannot be reached|0|||
147266710|NCT02641379|531149791|FG003|Overall Study|Participant cannot be reached|8|||
147266711|NCT02641379|531149792|FG004|Overall Study|Participant cannot be reached|2|||
147266712|NCT02641379|531149793|FG005|Overall Study|Participant cannot be reached|1|||
147266713|NCT02641379|531149794|FG006|Overall Study|Participant cannot be reached|0|||
147266714|NCT02641379|531149795|FG007|Overall Study|Participant cannot be reached|1|||
147266715|NCT02641379|531149796|FG008|Overall Study|Participant cannot be reached|0|||
147643978|NCT01447446|532516688|FG002|Overall Study|Adverse Event|1|||
147643979|NCT01447446|532516689|FG003|Overall Study|Adverse Event|0|||
147643980|NCT01447446|532516690|FG004|Overall Study|Adverse Event|2|||
147643981|NCT01447446|532516691|FG005|Overall Study|Adverse Event|0|||
147643982|NCT01447446|532516686|FG000|Overall Study|Failure to Return/Consent Withdrawn|357|||
147643983|NCT01447446|532516687|FG001|Overall Study|Failure to Return/Consent Withdrawn|78|||
147643984|NCT01447446|532516688|FG002|Overall Study|Failure to Return/Consent Withdrawn|31|||
147266716|NCT02641379|531149797|FG009|Overall Study|Participant cannot be reached|2|||
147266717|NCT02641379|531149798|FG010|Overall Study|Participant cannot be reached|1|||
147266718|NCT02641379|531149788|FG000|Overall Study|PCR positive at Week 24|15|||
147266719|NCT02641379|531149789|FG001|Overall Study|PCR positive at Week 24|21|||
147266720|NCT02641379|531149790|FG002|Overall Study|PCR positive at Week 24|62|||
147266721|NCT02641379|531149791|FG003|Overall Study|PCR positive at Week 24|0|||
147266722|NCT02641379|531149792|FG004|Overall Study|PCR positive at Week 24|0|||
147266723|NCT02641379|531149793|FG005|Overall Study|PCR positive at Week 24|6|||
147266724|NCT02641379|531149794|FG006|Overall Study|PCR positive at Week 24|3|||
147266725|NCT02641379|531149795|FG007|Overall Study|PCR positive at Week 24|8|||
147266726|NCT02641379|531149796|FG008|Overall Study|PCR positive at Week 24|0|||
147266727|NCT02641379|531149797|FG009|Overall Study|PCR positive at Week 24|1|||
147266728|NCT02641379|531149798|FG010|Overall Study|PCR positive at Week 24|0|||
147266729|NCT02641379|531149788|FG000|Overall Study|PCR positive at follow up 2|1|||
147266730|NCT02641379|531149789|FG001|Overall Study|PCR positive at follow up 2|0|||
147266731|NCT02641379|531149790|FG002|Overall Study|PCR positive at follow up 2|0|||
147266732|NCT02641379|531149791|FG003|Overall Study|PCR positive at follow up 2|0|||
147266733|NCT02641379|531149792|FG004|Overall Study|PCR positive at follow up 2|0|||
147266734|NCT02641379|531149793|FG005|Overall Study|PCR positive at follow up 2|0|||
147266735|NCT02641379|531149794|FG006|Overall Study|PCR positive at follow up 2|0|||
147266736|NCT02641379|531149795|FG007|Overall Study|PCR positive at follow up 2|0|||
147266737|NCT02641379|531149796|FG008|Overall Study|PCR positive at follow up 2|0|||
147266738|NCT02641379|531149797|FG009|Overall Study|PCR positive at follow up 2|0|||
147266739|NCT02641379|531149798|FG010|Overall Study|PCR positive at follow up 2|0|||
147266740|NCT02641379|531149788|FG000|Overall Study|Participant showed relapse|1|||
147266741|NCT02641379|531149789|FG001|Overall Study|Participant showed relapse|0|||
147266742|NCT02641379|531149790|FG002|Overall Study|Participant showed relapse|0|||
147266743|NCT02641379|531149791|FG003|Overall Study|Participant showed relapse|0|||
147266744|NCT02641379|531149792|FG004|Overall Study|Participant showed relapse|0|||
147266745|NCT02641379|531149793|FG005|Overall Study|Participant showed relapse|0|||
147266746|NCT02641379|531149794|FG006|Overall Study|Participant showed relapse|1|||
147266747|NCT02641379|531149795|FG007|Overall Study|Participant showed relapse|0|||
147266748|NCT02641379|531149796|FG008|Overall Study|Participant showed relapse|0|||
147266749|NCT02641379|531149797|FG009|Overall Study|Participant showed relapse|0|||
147266750|NCT02641379|531149798|FG010|Overall Study|Participant showed relapse|0|||
147266751|NCT02641379|531149788|FG000|Overall Study|Participant stopped study/treatment|1|||
147266752|NCT02641379|531149789|FG001|Overall Study|Participant stopped study/treatment|3|||
147266753|NCT02641379|531149790|FG002|Overall Study|Participant stopped study/treatment|1|||
147266754|NCT02641379|531149791|FG003|Overall Study|Participant stopped study/treatment|0|||
147266755|NCT02641379|531149792|FG004|Overall Study|Participant stopped study/treatment|0|||
147266756|NCT02641379|531149793|FG005|Overall Study|Participant stopped study/treatment|1|||
147266757|NCT02641379|531149794|FG006|Overall Study|Participant stopped study/treatment|2|||
147266758|NCT02641379|531149795|FG007|Overall Study|Participant stopped study/treatment|0|||
147266759|NCT02641379|531149796|FG008|Overall Study|Participant stopped study/treatment|1|||
147266760|NCT02641379|531149797|FG009|Overall Study|Participant stopped study/treatment|0|||
147266761|NCT02641379|531149798|FG010|Overall Study|Participant stopped study/treatment|0|||
147266762|NCT02641379|531149788|FG000|Overall Study|Therapy stopped due to misunderstanding|1|||
147266763|NCT02641379|531149789|FG001|Overall Study|Therapy stopped due to misunderstanding|0|||
147266764|NCT02641379|531149790|FG002|Overall Study|Therapy stopped due to misunderstanding|0|||
147266765|NCT02641379|531149791|FG003|Overall Study|Therapy stopped due to misunderstanding|0|||
147266766|NCT02641379|531149792|FG004|Overall Study|Therapy stopped due to misunderstanding|0|||
147266767|NCT02641379|531149793|FG005|Overall Study|Therapy stopped due to misunderstanding|0|||
147266768|NCT02641379|531149794|FG006|Overall Study|Therapy stopped due to misunderstanding|0|||
147266769|NCT02641379|531149795|FG007|Overall Study|Therapy stopped due to misunderstanding|0|||
147266770|NCT02641379|531149796|FG008|Overall Study|Therapy stopped due to misunderstanding|0|||
147266771|NCT02641379|531149797|FG009|Overall Study|Therapy stopped due to misunderstanding|0|||
147266772|NCT02641379|531149798|FG010|Overall Study|Therapy stopped due to misunderstanding|0|||
147266773|NCT02641379|531149788|FG000|Overall Study|Financial problems|0|||
147266774|NCT02641379|531149789|FG001|Overall Study|Financial problems|1|||
147266775|NCT02641379|531149790|FG002|Overall Study|Financial problems|0|||
147266776|NCT02641379|531149791|FG003|Overall Study|Financial problems|0|||
147266777|NCT02641379|531149792|FG004|Overall Study|Financial problems|0|||
147266778|NCT02641379|531149793|FG005|Overall Study|Financial problems|0|||
147266779|NCT02641379|531149794|FG006|Overall Study|Financial problems|0|||
147266780|NCT02641379|531149795|FG007|Overall Study|Financial problems|0|||
147266781|NCT02641379|531149796|FG008|Overall Study|Financial problems|0|||
147266782|NCT02641379|531149797|FG009|Overall Study|Financial problems|0|||
147266783|NCT02641379|531149798|FG010|Overall Study|Financial problems|0|||
147266784|NCT02641379|531149788|FG000|Overall Study|PCR positive at Week 68|0|||
147333136|NCT01212757|531385640|FG002|Long-Term Safety Phase (Year 3)|Miscellaneous|3|||
147333137|NCT01212757|531385641|FG003|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
147266785|NCT02641379|531149789|FG001|Overall Study|PCR positive at Week 68|1|||
147266786|NCT02641379|531149790|FG002|Overall Study|PCR positive at Week 68|0|||
147266787|NCT02641379|531149791|FG003|Overall Study|PCR positive at Week 68|0|||
147266788|NCT02641379|531149792|FG004|Overall Study|PCR positive at Week 68|0|||
147266789|NCT02641379|531149793|FG005|Overall Study|PCR positive at Week 68|0|||
147266790|NCT02641379|531149794|FG006|Overall Study|PCR positive at Week 68|0|||
147266791|NCT02641379|531149795|FG007|Overall Study|PCR positive at Week 68|0|||
147266792|NCT02641379|531149796|FG008|Overall Study|PCR positive at Week 68|0|||
147266793|NCT02641379|531149797|FG009|Overall Study|PCR positive at Week 68|0|||
147266794|NCT02641379|531149798|FG010|Overall Study|PCR positive at Week 68|0|||
147266795|NCT02641379|531149788|FG000|Overall Study|PCR positive at Week 48|0|||
147266796|NCT02641379|531149789|FG001|Overall Study|PCR positive at Week 48|1|||
147266797|NCT02641379|531149790|FG002|Overall Study|PCR positive at Week 48|0|||
147266798|NCT02641379|531149791|FG003|Overall Study|PCR positive at Week 48|0|||
147266799|NCT02641379|531149792|FG004|Overall Study|PCR positive at Week 48|0|||
147266800|NCT02641379|531149793|FG005|Overall Study|PCR positive at Week 48|0|||
147266801|NCT02641379|531149794|FG006|Overall Study|PCR positive at Week 48|0|||
147266802|NCT02641379|531149795|FG007|Overall Study|PCR positive at Week 48|0|||
147266803|NCT02641379|531149796|FG008|Overall Study|PCR positive at Week 48|0|||
147266804|NCT02641379|531149797|FG009|Overall Study|PCR positive at Week 48|0|||
147266805|NCT02641379|531149798|FG010|Overall Study|PCR positive at Week 48|0|||
147266806|NCT02641379|531149788|FG000|Overall Study|PCR not performed at Week 12|0|||
147266807|NCT02641379|531149789|FG001|Overall Study|PCR not performed at Week 12|0|||
147266808|NCT02641379|531149790|FG002|Overall Study|PCR not performed at Week 12|1|||
147266809|NCT02641379|531149791|FG003|Overall Study|PCR not performed at Week 12|0|||
147266810|NCT02641379|531149792|FG004|Overall Study|PCR not performed at Week 12|0|||
147266811|NCT02641379|531149793|FG005|Overall Study|PCR not performed at Week 12|0|||
147266812|NCT02641379|531149794|FG006|Overall Study|PCR not performed at Week 12|0|||
147266813|NCT02641379|531149795|FG007|Overall Study|PCR not performed at Week 12|0|||
147266814|NCT02641379|531149796|FG008|Overall Study|PCR not performed at Week 12|0|||
147266815|NCT02641379|531149797|FG009|Overall Study|PCR not performed at Week 12|0|||
147266816|NCT02641379|531149798|FG010|Overall Study|PCR not performed at Week 12|0|||
147266817|NCT02641379|531149788|FG000|Overall Study|No PCR at baseline|0|||
147266818|NCT02641379|531149789|FG001|Overall Study|No PCR at baseline|0|||
147266819|NCT02641379|531149790|FG002|Overall Study|No PCR at baseline|1|||
147266820|NCT02641379|531149791|FG003|Overall Study|No PCR at baseline|0|||
147266821|NCT02641379|531149792|FG004|Overall Study|No PCR at baseline|0|||
147266822|NCT02641379|531149793|FG005|Overall Study|No PCR at baseline|0|||
147266823|NCT02641379|531149794|FG006|Overall Study|No PCR at baseline|0|||
147266824|NCT02641379|531149795|FG007|Overall Study|No PCR at baseline|0|||
147266825|NCT02641379|531149796|FG008|Overall Study|No PCR at baseline|0|||
147266826|NCT02641379|531149797|FG009|Overall Study|No PCR at baseline|0|||
147266827|NCT02641379|531149798|FG010|Overall Study|No PCR at baseline|0|||
147266828|NCT02641379|531149788|FG000|Overall Study|PCR positive at Week 28|0|||
147266829|NCT02641379|531149789|FG001|Overall Study|PCR positive at Week 28|0|||
147266830|NCT02641379|531149790|FG002|Overall Study|PCR positive at Week 28|1|||
147266831|NCT02641379|531149791|FG003|Overall Study|PCR positive at Week 28|0|||
147266832|NCT02641379|531149792|FG004|Overall Study|PCR positive at Week 28|0|||
147266833|NCT02641379|531149793|FG005|Overall Study|PCR positive at Week 28|0|||
147266834|NCT02641379|531149794|FG006|Overall Study|PCR positive at Week 28|0|||
147266835|NCT02641379|531149795|FG007|Overall Study|PCR positive at Week 28|0|||
147266836|NCT02641379|531149796|FG008|Overall Study|PCR positive at Week 28|0|||
147266837|NCT02641379|531149797|FG009|Overall Study|PCR positive at Week 28|0|||
147266838|NCT02641379|531149798|FG010|Overall Study|PCR positive at Week 28|0|||
147266839|NCT02641379|531149788|FG000|Overall Study|PCR sample for Week 4 not drawn|0|||
147266840|NCT02641379|531149789|FG001|Overall Study|PCR sample for Week 4 not drawn|0|||
147266841|NCT02641379|531149790|FG002|Overall Study|PCR sample for Week 4 not drawn|0|||
147266842|NCT02641379|531149791|FG003|Overall Study|PCR sample for Week 4 not drawn|1|||
147266843|NCT02641379|531149792|FG004|Overall Study|PCR sample for Week 4 not drawn|0|||
147266844|NCT02641379|531149793|FG005|Overall Study|PCR sample for Week 4 not drawn|0|||
147266845|NCT02641379|531149794|FG006|Overall Study|PCR sample for Week 4 not drawn|0|||
147266846|NCT02641379|531149795|FG007|Overall Study|PCR sample for Week 4 not drawn|0|||
147266847|NCT02641379|531149796|FG008|Overall Study|PCR sample for Week 4 not drawn|0|||
147266848|NCT02641379|531149797|FG009|Overall Study|PCR sample for Week 4 not drawn|0|||
147600215|NCT01739348|532356345|FG003|Part I (Base Study)|Withdrawal by Subject|20|||
147600216|NCT01739348|532356342|FG000|Part II (Extension Study)|Adverse Event|10|||
147600217|NCT01739348|532356343|FG001|Part II (Extension Study)|Adverse Event|11|||
147600218|NCT01739348|532356344|FG002|Part II (Extension Study)|Adverse Event|7|||
147600219|NCT01739348|532356345|FG003|Part II (Extension Study)|Adverse Event|26|||
147266849|NCT02641379|531149798|FG010|Overall Study|PCR sample for Week 4 not drawn|0|||
147266850|NCT02641379|531149788|FG000|Overall Study|Inclusion criteria not fulfilled|0|||
147266851|NCT02641379|531149789|FG001|Overall Study|Inclusion criteria not fulfilled|0|||
147266852|NCT02641379|531149790|FG002|Overall Study|Inclusion criteria not fulfilled|0|||
147266853|NCT02641379|531149791|FG003|Overall Study|Inclusion criteria not fulfilled|1|||
147266854|NCT02641379|531149792|FG004|Overall Study|Inclusion criteria not fulfilled|0|||
147266855|NCT02641379|531149793|FG005|Overall Study|Inclusion criteria not fulfilled|0|||
147450226|NCT01046877|531811394|FG000|Overall Study|Exited voluntarily after tube extrusion|11|||
147450227|NCT03016325|531811399|FG000|Treatment Period|Participant withdrew consent|0|||
147450228|NCT03016325|531811400|FG001|Treatment Period|Participant withdrew consent|1|||
147450229|NCT03016325|531811401|FG002|Treatment Period|Participant withdrew consent|0|||
147450230|NCT03016325|531811402|FG003|Treatment Period|Participant withdrew consent|0|||
147450231|NCT03016325|531811403|FG004|Treatment Period|Participant withdrew consent|0|||
147450232|NCT03016325|531811404|FG005|Treatment Period|Participant withdrew consent|0|||
147450233|NCT03016325|531811405|FG006|Treatment Period|Participant withdrew consent|0|||
147450234|NCT03016325|531811406|FG007|Treatment Period|Participant withdrew consent|0|||
147450235|NCT03016325|531811399|FG000|Treatment Period|Death|0|||
147450236|NCT03016325|531811400|FG001|Treatment Period|Death|0|||
147450237|NCT03016325|531811401|FG002|Treatment Period|Death|0|||
147450238|NCT03016325|531811402|FG003|Treatment Period|Death|0|||
147450239|NCT03016325|531811403|FG004|Treatment Period|Death|2|||
147450240|NCT03016325|531811404|FG005|Treatment Period|Death|0|||
147450241|NCT03016325|531811405|FG006|Treatment Period|Death|0|||
147450242|NCT03016325|531811406|FG007|Treatment Period|Death|0|||
147450243|NCT03016325|531811399|FG000|Treatment Period|Participant refuses assessments|0|||
147450244|NCT03016325|531811400|FG001|Treatment Period|Participant refuses assessments|0|||
147450245|NCT03016325|531811401|FG002|Treatment Period|Participant refuses assessments|1|||
147600220|NCT01739348|532356342|FG000|Part II (Extension Study)|Death|3|||
147600221|NCT01739348|532356343|FG001|Part II (Extension Study)|Death|3|||
147600222|NCT01739348|532356344|FG002|Part II (Extension Study)|Death|2|||
147450246|NCT03016325|531811402|FG003|Treatment Period|Participant refuses assessments|0|||
147450247|NCT03016325|531811403|FG004|Treatment Period|Participant refuses assessments|0|||
147450248|NCT03016325|531811404|FG005|Treatment Period|Participant refuses assessments|0|||
147450249|NCT03016325|531811405|FG006|Treatment Period|Participant refuses assessments|0|||
147450250|NCT03016325|531811406|FG007|Treatment Period|Participant refuses assessments|0|||
147450251|NCT03016325|531811399|FG000|32-Day Follow-Up Period|Death|2|||
147450252|NCT03016325|531811400|FG001|32-Day Follow-Up Period|Death|0|||
147450253|NCT03016325|531811401|FG002|32-Day Follow-Up Period|Death|5|||
147600223|NCT01739348|532356345|FG003|Part II (Extension Study)|Death|6|||
147266856|NCT02641379|531149794|FG006|Overall Study|Inclusion criteria not fulfilled|0|||
147266857|NCT02641379|531149795|FG007|Overall Study|Inclusion criteria not fulfilled|0|||
147266858|NCT02641379|531149796|FG008|Overall Study|Inclusion criteria not fulfilled|0|||
147266859|NCT02641379|531149797|FG009|Overall Study|Inclusion criteria not fulfilled|0|||
147266860|NCT02641379|531149798|FG010|Overall Study|Inclusion criteria not fulfilled|0|||
147266861|NCT02641379|531149788|FG000|Overall Study|Baseline viral load unavailable|0|||
147266862|NCT02641379|531149789|FG001|Overall Study|Baseline viral load unavailable|0|||
147266863|NCT02641379|531149790|FG002|Overall Study|Baseline viral load unavailable|0|||
147266864|NCT02641379|531149791|FG003|Overall Study|Baseline viral load unavailable|1|||
147266865|NCT02641379|531149792|FG004|Overall Study|Baseline viral load unavailable|0|||
147266866|NCT02641379|531149793|FG005|Overall Study|Baseline viral load unavailable|0|||
147266867|NCT02641379|531149794|FG006|Overall Study|Baseline viral load unavailable|0|||
147266868|NCT02641379|531149795|FG007|Overall Study|Baseline viral load unavailable|0|||
147266869|NCT02641379|531149796|FG008|Overall Study|Baseline viral load unavailable|0|||
147266870|NCT02641379|531149797|FG009|Overall Study|Baseline viral load unavailable|0|||
147266871|NCT02641379|531149798|FG010|Overall Study|Baseline viral load unavailable|0|||
147266872|NCT02641379|531149788|FG000|Overall Study|Blood could not be drawn|0|||
147266873|NCT02641379|531149789|FG001|Overall Study|Blood could not be drawn|0|||
147266874|NCT02641379|531149790|FG002|Overall Study|Blood could not be drawn|0|||
147266875|NCT02641379|531149791|FG003|Overall Study|Blood could not be drawn|0|||
147266876|NCT02641379|531149792|FG004|Overall Study|Blood could not be drawn|1|||
147266877|NCT02641379|531149793|FG005|Overall Study|Blood could not be drawn|0|||
147266878|NCT02641379|531149794|FG006|Overall Study|Blood could not be drawn|0|||
147600224|NCT01739348|532356342|FG000|Part II (Extension Study)|Lack of Efficacy|1|||
147266879|NCT02641379|531149795|FG007|Overall Study|Blood could not be drawn|0|||
147266880|NCT02641379|531149796|FG008|Overall Study|Blood could not be drawn|0|||
147450254|NCT03016325|531811402|FG003|32-Day Follow-Up Period|Death|6|||
147450255|NCT03016325|531811403|FG004|32-Day Follow-Up Period|Death|3|||
147450256|NCT03016325|531811404|FG005|32-Day Follow-Up Period|Death|0|||
147450257|NCT03016325|531811405|FG006|32-Day Follow-Up Period|Death|0|||
147600225|NCT01739348|532356343|FG001|Part II (Extension Study)|Lack of Efficacy|5|||
147450258|NCT03016325|531811406|FG007|32-Day Follow-Up Period|Death|0|||
147450259|NCT03016325|531811399|FG000|32-Day Follow-Up Period|Lost to Follow-up|1|||
147266881|NCT02641379|531149797|FG009|Overall Study|Blood could not be drawn|0|||
147266882|NCT02641379|531149798|FG010|Overall Study|Blood could not be drawn|0|||
147450260|NCT03016325|531811400|FG001|32-Day Follow-Up Period|Lost to Follow-up|0|||
147450261|NCT03016325|531811401|FG002|32-Day Follow-Up Period|Lost to Follow-up|1|||
147450262|NCT03016325|531811402|FG003|32-Day Follow-Up Period|Lost to Follow-up|1|||
147450263|NCT03016325|531811403|FG004|32-Day Follow-Up Period|Lost to Follow-up|0|||
147266883|NCT02641379|531149788|FG000|Overall Study|Protocol Violation|0|||
147266884|NCT02641379|531149789|FG001|Overall Study|Protocol Violation|0|||
147450264|NCT03016325|531811404|FG005|32-Day Follow-Up Period|Lost to Follow-up|0|||
147600226|NCT01739348|532356344|FG002|Part II (Extension Study)|Lack of Efficacy|0|||
147600227|NCT01739348|532356345|FG003|Part II (Extension Study)|Lack of Efficacy|1|||
147600228|NCT01739348|532356342|FG000|Part II (Extension Study)|Lost to Follow-up|3|||
147600229|NCT01739348|532356343|FG001|Part II (Extension Study)|Lost to Follow-up|4|||
147266885|NCT02641379|531149790|FG002|Overall Study|Protocol Violation|0|||
147266886|NCT02641379|531149791|FG003|Overall Study|Protocol Violation|0|||
147266887|NCT02641379|531149792|FG004|Overall Study|Protocol Violation|2|||
147266888|NCT02641379|531149793|FG005|Overall Study|Protocol Violation|0|||
147266889|NCT02641379|531149794|FG006|Overall Study|Protocol Violation|0|||
147266890|NCT02641379|531149795|FG007|Overall Study|Protocol Violation|0|||
147266891|NCT02641379|531149796|FG008|Overall Study|Protocol Violation|1|||
147266892|NCT02641379|531149797|FG009|Overall Study|Protocol Violation|0|||
147266893|NCT02641379|531149798|FG010|Overall Study|Protocol Violation|0|||
147266894|NCT02641379|531149788|FG000|Overall Study|Participation in sili rescue study|0|||
147266895|NCT02641379|531149789|FG001|Overall Study|Participation in sili rescue study|0|||
147266896|NCT02641379|531149790|FG002|Overall Study|Participation in sili rescue study|0|||
147266897|NCT02641379|531149791|FG003|Overall Study|Participation in sili rescue study|0|||
147266898|NCT02641379|531149792|FG004|Overall Study|Participation in sili rescue study|0|||
147266899|NCT02641379|531149793|FG005|Overall Study|Participation in sili rescue study|1|||
147266900|NCT02641379|531149794|FG006|Overall Study|Participation in sili rescue study|0|||
147266901|NCT02641379|531149795|FG007|Overall Study|Participation in sili rescue study|0|||
147266902|NCT02641379|531149796|FG008|Overall Study|Participation in sili rescue study|0|||
147266903|NCT02641379|531149797|FG009|Overall Study|Participation in sili rescue study|0|||
147266904|NCT02641379|531149798|FG010|Overall Study|Participation in sili rescue study|0|||
147266905|NCT02641379|531149788|FG000|Overall Study|Lost to Follow-up|0|||
147266906|NCT02641379|531149789|FG001|Overall Study|Lost to Follow-up|0|||
147266907|NCT02641379|531149790|FG002|Overall Study|Lost to Follow-up|0|||
147266908|NCT02641379|531149791|FG003|Overall Study|Lost to Follow-up|0|||
147266909|NCT02641379|531149792|FG004|Overall Study|Lost to Follow-up|0|||
147266910|NCT02641379|531149793|FG005|Overall Study|Lost to Follow-up|0|||
147266911|NCT02641379|531149794|FG006|Overall Study|Lost to Follow-up|0|||
147266912|NCT02641379|531149795|FG007|Overall Study|Lost to Follow-up|0|||
147266913|NCT02641379|531149796|FG008|Overall Study|Lost to Follow-up|1|||
147266914|NCT02641379|531149797|FG009|Overall Study|Lost to Follow-up|0|||
147266915|NCT02641379|531149798|FG010|Overall Study|Lost to Follow-up|0|||
147266916|NCT02641379|531149788|FG000|Overall Study|Source data not found|0|||
147266917|NCT02641379|531149789|FG001|Overall Study|Source data not found|0|||
147266918|NCT02641379|531149790|FG002|Overall Study|Source data not found|0|||
147266919|NCT02641379|531149791|FG003|Overall Study|Source data not found|0|||
147266920|NCT02641379|531149792|FG004|Overall Study|Source data not found|0|||
147266921|NCT02641379|531149793|FG005|Overall Study|Source data not found|1|||
147266922|NCT02641379|531149794|FG006|Overall Study|Source data not found|0|||
147266923|NCT02641379|531149795|FG007|Overall Study|Source data not found|0|||
147266924|NCT02641379|531149796|FG008|Overall Study|Source data not found|0|||
147266925|NCT02641379|531149797|FG009|Overall Study|Source data not found|0|||
147266926|NCT02641379|531149798|FG010|Overall Study|Source data not found|0|||
147266927|NCT02641379|531149788|FG000|Overall Study|Participant showed weight reduction|0|||
147266928|NCT02641379|531149789|FG001|Overall Study|Participant showed weight reduction|0|||
147266929|NCT02641379|531149790|FG002|Overall Study|Participant showed weight reduction|0|||
147266930|NCT02641379|531149791|FG003|Overall Study|Participant showed weight reduction|0|||
147266931|NCT02641379|531149792|FG004|Overall Study|Participant showed weight reduction|0|||
147266932|NCT02641379|531149793|FG005|Overall Study|Participant showed weight reduction|0|||
147266933|NCT02641379|531149794|FG006|Overall Study|Participant showed weight reduction|0|||
147266934|NCT02641379|531149795|FG007|Overall Study|Participant showed weight reduction|1|||
147266935|NCT02641379|531149796|FG008|Overall Study|Participant showed weight reduction|0|||
147266936|NCT02641379|531149797|FG009|Overall Study|Participant showed weight reduction|0|||
147266937|NCT02641379|531149798|FG010|Overall Study|Participant showed weight reduction|0|||
147266938|NCT02641379|531149788|FG000|Overall Study|Non-response Week 12|0|||
147266939|NCT02641379|531149789|FG001|Overall Study|Non-response Week 12|0|||
147266940|NCT02641379|531149790|FG002|Overall Study|Non-response Week 12|0|||
147266941|NCT02641379|531149791|FG003|Overall Study|Non-response Week 12|0|||
147266942|NCT02641379|531149792|FG004|Overall Study|Non-response Week 12|0|||
147266943|NCT02641379|531149793|FG005|Overall Study|Non-response Week 12|0|||
147333138|NCT01212757|531385642|FG004|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
147600230|NCT01739348|532356344|FG002|Part II (Extension Study)|Lost to Follow-up|0|||
147600231|NCT01739348|532356345|FG003|Part II (Extension Study)|Lost to Follow-up|1|||
147266944|NCT02641379|531149794|FG006|Overall Study|Non-response Week 12|0|||
147266945|NCT02641379|531149795|FG007|Overall Study|Non-response Week 12|1|||
147266946|NCT02641379|531149796|FG008|Overall Study|Non-response Week 12|0|||
147266947|NCT02641379|531149797|FG009|Overall Study|Non-response Week 12|0|||
147266948|NCT02641379|531149798|FG010|Overall Study|Non-response Week 12|0|||
147266949|NCT02641379|531149788|FG000|Overall Study|No 2 Log drop at Week 12|0|||
147266950|NCT02641379|531149789|FG001|Overall Study|No 2 Log drop at Week 12|0|||
147266951|NCT02641379|531149790|FG002|Overall Study|No 2 Log drop at Week 12|0|||
147266952|NCT02641379|531149791|FG003|Overall Study|No 2 Log drop at Week 12|0|||
147266953|NCT02641379|531149792|FG004|Overall Study|No 2 Log drop at Week 12|0|||
147266954|NCT02641379|531149793|FG005|Overall Study|No 2 Log drop at Week 12|0|||
147266955|NCT02641379|531149794|FG006|Overall Study|No 2 Log drop at Week 12|0|||
147266956|NCT02641379|531149795|FG007|Overall Study|No 2 Log drop at Week 12|0|||
147266957|NCT02641379|531149796|FG008|Overall Study|No 2 Log drop at Week 12|0|||
147266958|NCT02641379|531149797|FG009|Overall Study|No 2 Log drop at Week 12|0|||
147266959|NCT02641379|531149798|FG010|Overall Study|No 2 Log drop at Week 12|1|||
147266960|NCT02641379|531149788|FG000|Overall Study|Negative PCR result|0|||
147266961|NCT02641379|531149789|FG001|Overall Study|Negative PCR result|0|||
147266962|NCT02641379|531149790|FG002|Overall Study|Negative PCR result|0|||
147266963|NCT02641379|531149791|FG003|Overall Study|Negative PCR result|0|||
147662298|NCT01228591|532587291|FG001|Baseline|Lack of Efficacy|2|||
147662299|NCT01095835|532587292|FG000|Overall Study|Adverse Event|8|||
147662300|NCT01095835|532587293|FG001|Overall Study|Adverse Event|6|||
147662301|NCT01095835|532587294|FG002|Overall Study|Adverse Event|6|||
147662302|NCT01095835|532587292|FG000|Overall Study|Lack of Efficacy|0|||
147662303|NCT01095835|532587293|FG001|Overall Study|Lack of Efficacy|1|||
147662304|NCT01095835|532587294|FG002|Overall Study|Lack of Efficacy|0|||
147662305|NCT01095835|532587292|FG000|Overall Study|Physician Decision|0|||
147662306|NCT01095835|532587293|FG001|Overall Study|Physician Decision|0|||
147662307|NCT01095835|532587294|FG002|Overall Study|Physician Decision|1|||
147662308|NCT01095835|532587292|FG000|Overall Study|Withdrawal by Subject|1|||
147266964|NCT02641379|531149792|FG004|Overall Study|Negative PCR result|0|||
147266965|NCT02641379|531149793|FG005|Overall Study|Negative PCR result|0|||
147266966|NCT02641379|531149794|FG006|Overall Study|Negative PCR result|0|||
147266967|NCT02641379|531149795|FG007|Overall Study|Negative PCR result|0|||
147266968|NCT02641379|531149796|FG008|Overall Study|Negative PCR result|0|||
147266969|NCT02641379|531149797|FG009|Overall Study|Negative PCR result|1|||
147266970|NCT02641379|531149798|FG010|Overall Study|Negative PCR result|0|||
147266971|NCT02641379|531149788|FG000|Overall Study|Participant's PCR high|0|||
147266972|NCT02641379|531149789|FG001|Overall Study|Participant's PCR high|0|||
147266973|NCT02641379|531149790|FG002|Overall Study|Participant's PCR high|0|||
147266974|NCT02641379|531149791|FG003|Overall Study|Participant's PCR high|0|||
147266975|NCT02641379|531149792|FG004|Overall Study|Participant's PCR high|0|||
147266976|NCT02641379|531149793|FG005|Overall Study|Participant's PCR high|0|||
147266977|NCT02641379|531149794|FG006|Overall Study|Participant's PCR high|0|||
147266978|NCT02641379|531149795|FG007|Overall Study|Participant's PCR high|1|||
147266979|NCT02641379|531149796|FG008|Overall Study|Participant's PCR high|0|||
147266980|NCT02641379|531149797|FG009|Overall Study|Participant's PCR high|0|||
147266981|NCT02641379|531149798|FG010|Overall Study|Participant's PCR high|0|||
147266982|NCT02641379|531149788|FG000|Overall Study|Participant treated after Week 24|0|||
147266983|NCT02641379|531149789|FG001|Overall Study|Participant treated after Week 24|0|||
147266984|NCT02641379|531149790|FG002|Overall Study|Participant treated after Week 24|0|||
147266985|NCT02641379|531149791|FG003|Overall Study|Participant treated after Week 24|0|||
147266986|NCT02641379|531149792|FG004|Overall Study|Participant treated after Week 24|0|||
147266987|NCT02641379|531149793|FG005|Overall Study|Participant treated after Week 24|0|||
147266988|NCT02641379|531149794|FG006|Overall Study|Participant treated after Week 24|0|||
147266989|NCT02641379|531149795|FG007|Overall Study|Participant treated after Week 24|0|||
147266990|NCT02641379|531149796|FG008|Overall Study|Participant treated after Week 24|1|||
147266991|NCT02641379|531149797|FG009|Overall Study|Participant treated after Week 24|0|||
147266992|NCT02641379|531149798|FG010|Overall Study|Participant treated after Week 24|0|||
147266993|NCT02641379|531149788|FG000|Overall Study|Missing PCR result at Week 8|0|||
147266994|NCT02641379|531149789|FG001|Overall Study|Missing PCR result at Week 8|0|||
147266995|NCT02641379|531149790|FG002|Overall Study|Missing PCR result at Week 8|0|||
147266996|NCT02641379|531149791|FG003|Overall Study|Missing PCR result at Week 8|0|||
147266997|NCT02641379|531149792|FG004|Overall Study|Missing PCR result at Week 8|0|||
147266998|NCT02641379|531149793|FG005|Overall Study|Missing PCR result at Week 8|0|||
147266999|NCT02641379|531149794|FG006|Overall Study|Missing PCR result at Week 8|0|||
147267000|NCT02641379|531149795|FG007|Overall Study|Missing PCR result at Week 8|0|||
147267001|NCT02641379|531149796|FG008|Overall Study|Missing PCR result at Week 8|0|||
147267002|NCT02641379|531149797|FG009|Overall Study|Missing PCR result at Week 8|1|||
147662309|NCT01095835|532587293|FG001|Overall Study|Withdrawal by Subject|3|||
147662310|NCT01095835|532587294|FG002|Overall Study|Withdrawal by Subject|0|||
147662311|NCT01095835|532587292|FG000|Overall Study|Non study compliance|0|||
147267003|NCT02641379|531149798|FG010|Overall Study|Missing PCR result at Week 8|0|||
147267004|NCT02641379|531149788|FG000|Overall Study|PCR positive|0|||
147267005|NCT02641379|531149789|FG001|Overall Study|PCR positive|0|||
147267006|NCT02641379|531149790|FG002|Overall Study|PCR positive|0|||
147267007|NCT02641379|531149791|FG003|Overall Study|PCR positive|0|||
147267008|NCT02641379|531149792|FG004|Overall Study|PCR positive|0|||
147267009|NCT02641379|531149793|FG005|Overall Study|PCR positive|0|||
147267010|NCT02641379|531149794|FG006|Overall Study|PCR positive|1|||
147662312|NCT01095835|532587293|FG001|Overall Study|Non study compliance|0|||
147662313|NCT01095835|532587294|FG002|Overall Study|Non study compliance|1|||
147662314|NCT01095835|532587292|FG000|Overall Study|Protocol Violation|1|||
147267011|NCT02641379|531149795|FG007|Overall Study|PCR positive|0|||
147267012|NCT02641379|531149796|FG008|Overall Study|PCR positive|0|||
147267013|NCT02641379|531149797|FG009|Overall Study|PCR positive|0|||
147267014|NCT02641379|531149798|FG010|Overall Study|PCR positive|0|||
147267015|NCT01165138|531149799|FG000|Overall Study|Adverse Event|0|||
147267016|NCT01165138|531149800|FG001|Overall Study|Adverse Event|1|||
147267017|NCT01165138|531149801|FG002|Overall Study|Adverse Event|0|||
147267018|NCT01165138|531149802|FG003|Overall Study|Adverse Event|2|||
147267019|NCT01165138|531149799|FG000|Overall Study|Lack of Efficacy|0|||
147267020|NCT01165138|531149800|FG001|Overall Study|Lack of Efficacy|32|||
147267021|NCT01165138|531149801|FG002|Overall Study|Lack of Efficacy|6|||
147267022|NCT01165138|531149802|FG003|Overall Study|Lack of Efficacy|7|||
147267023|NCT01165138|531149799|FG000|Overall Study|Protocol Violation|0|||
147267024|NCT01165138|531149800|FG001|Overall Study|Protocol Violation|7|||
147267025|NCT01165138|531149801|FG002|Overall Study|Protocol Violation|0|||
147267026|NCT01165138|531149802|FG003|Overall Study|Protocol Violation|2|||
147267027|NCT01165138|531149799|FG000|Overall Study|Lost to Follow-up|0|||
147267028|NCT01165138|531149800|FG001|Overall Study|Lost to Follow-up|0|||
147267029|NCT01165138|531149801|FG002|Overall Study|Lost to Follow-up|1|||
147267030|NCT01165138|531149802|FG003|Overall Study|Lost to Follow-up|2|||
147267031|NCT01165138|531149799|FG000|Overall Study|Physician Decision|0|||
147267032|NCT01165138|531149800|FG001|Overall Study|Physician Decision|6|||
147267033|NCT01165138|531149801|FG002|Overall Study|Physician Decision|7|||
147267034|NCT01165138|531149802|FG003|Overall Study|Physician Decision|6|||
147267035|NCT01165138|531149799|FG000|Overall Study|Withdrawal by Subject|0|||
147267036|NCT01165138|531149800|FG001|Overall Study|Withdrawal by Subject|6|||
147267037|NCT01165138|531149801|FG002|Overall Study|Withdrawal by Subject|6|||
147267038|NCT01165138|531149802|FG003|Overall Study|Withdrawal by Subject|3|||
147267039|NCT03323658|531149805|FG000|Overall Study|Adverse Event|0|||
147267040|NCT03323658|531149806|FG001|Overall Study|Adverse Event|1|||
147267041|NCT03323658|531149807|FG002|Overall Study|Adverse Event|0|||
147267042|NCT00615056|531149808|FG000|Overall Study|Death|31|||
147267043|NCT00615056|531149809|FG001|Overall Study|Death|31|||
147267044|NCT00615056|531149810|FG002|Overall Study|Death|21|||
147267045|NCT00615056|531149811|FG003|Overall Study|Death|23|||
147267046|NCT00615056|531149808|FG000|Overall Study|Lost to Follow-up|1|||
147267047|NCT00615056|531149809|FG001|Overall Study|Lost to Follow-up|2|||
147267048|NCT00615056|531149810|FG002|Overall Study|Lost to Follow-up|4|||
147267049|NCT00615056|531149811|FG003|Overall Study|Lost to Follow-up|5|||
147267050|NCT00615056|531149808|FG000|Overall Study|Other|13|||
147267051|NCT00615056|531149809|FG001|Overall Study|Other|15|||
147267052|NCT00615056|531149810|FG002|Overall Study|Other|10|||
147267053|NCT00615056|531149811|FG003|Overall Study|Other|7|||
147267054|NCT00615056|531149808|FG000|Overall Study|Objective progression or relapse|0|||
147267055|NCT00615056|531149809|FG001|Overall Study|Objective progression or relapse|2|||
147267056|NCT00615056|531149810|FG002|Overall Study|Objective progression or relapse|0|||
147267057|NCT00615056|531149811|FG003|Overall Study|Objective progression or relapse|0|||
147267058|NCT00615056|531149808|FG000|Overall Study|Withdrawal by Subject|0|||
147267059|NCT00615056|531149809|FG001|Overall Study|Withdrawal by Subject|1|||
147267060|NCT00615056|531149810|FG002|Overall Study|Withdrawal by Subject|1|||
147267061|NCT00615056|531149811|FG003|Overall Study|Withdrawal by Subject|0|||
147267062|NCT00615056|531149808|FG000|Overall Study|Discontinued by Sponsor|1|||
147267063|NCT00615056|531149809|FG001|Overall Study|Discontinued by Sponsor|0|||
147267064|NCT00615056|531149810|FG002|Overall Study|Discontinued by Sponsor|0|||
147267065|NCT00615056|531149811|FG003|Overall Study|Discontinued by Sponsor|0|||
147267066|NCT00615056|531149808|FG000|Overall Study|Randomized but not treated|3|||
147267067|NCT00615056|531149809|FG001|Overall Study|Randomized but not treated|0|||
147267068|NCT00615056|531149810|FG002|Overall Study|Randomized but not treated|0|||
147267069|NCT00615056|531149811|FG003|Overall Study|Randomized but not treated|0|||
147267070|NCT04536727|531149812|FG000|Overall Study|Lost to Follow-up|1|||
147267071|NCT04536727|531149813|FG001|Overall Study|Lost to Follow-up|1|||
147267072|NCT04536727|531149812|FG000|Overall Study|Death|0|||
147267073|NCT04536727|531149813|FG001|Overall Study|Death|1|||
147267074|NCT00560950|531149816|FG000|Overall Study|Lost to Follow-up|1|||
147267075|NCT00560950|531149817|FG001|Overall Study|Lost to Follow-up|0|||
147267076|NCT02565381|531151649|FG000|Overall Study|Lost to Follow-up|1|||
147333139|NCT01212757|531385643|FG005|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
147267077|NCT02565381|531151650|FG001|Overall Study|Lost to Follow-up|0|||
147267078|NCT02565381|531151651|FG002|Overall Study|Lost to Follow-up|1|||
147267079|NCT05308901|531151656|FG000|Overall Study|Death|6|||
147267080|NCT01914666|531151660|FG000|Treatment Period|Lack of Efficacy|0|||
147267081|NCT01914666|531151661|FG001|Treatment Period|Lack of Efficacy|0|||
147267082|NCT01914666|531151662|FG002|Treatment Period|Lack of Efficacy|2|||
147267083|NCT01914666|531151660|FG000|Treatment Period|Adverse Event|10|||
147267084|NCT01914666|531151661|FG001|Treatment Period|Adverse Event|4|||
147267085|NCT01914666|531151662|FG002|Treatment Period|Adverse Event|2|||
147267086|NCT01914666|531151660|FG000|Treatment Period|Withdrawal by Subject|3|||
147267087|NCT01914666|531151661|FG001|Treatment Period|Withdrawal by Subject|2|||
147267088|NCT01914666|531151662|FG002|Treatment Period|Withdrawal by Subject|2|||
147267089|NCT01914666|531151660|FG000|Treatment Period|Physician Decision|0|||
147267090|NCT01914666|531151661|FG001|Treatment Period|Physician Decision|0|||
147662315|NCT01095835|532587293|FG001|Overall Study|Protocol Violation|2|||
147267091|NCT01914666|531151662|FG002|Treatment Period|Physician Decision|2|||
147267092|NCT01940120|531151664|FG000|Overall Study|Death|40|||
147267093|NCT01940120|531151664|FG000|Overall Study|Withdrawal by Subject|8|||
147267094|NCT03277846|531151665|FG000|Overall Study|Inpatient stay too brief|12|||
147267095|NCT03277846|531151666|FG001|Overall Study|Inpatient stay too brief|11|||
147267096|NCT03240575|531151667|FG000|Overall Study|Adverse Event|0|||
147267097|NCT03240575|531151668|FG001|Overall Study|Adverse Event|2|||
147267098|NCT03240575|531151669|FG002|Overall Study|Adverse Event|0|||
147267099|NCT03240575|531151670|FG003|Overall Study|Adverse Event|1|||
147267100|NCT03240575|531151667|FG000|Overall Study|Withdrawal by Subject|2|||
147267101|NCT03240575|531151668|FG001|Overall Study|Withdrawal by Subject|11|||
147267102|NCT03240575|531151669|FG002|Overall Study|Withdrawal by Subject|0|||
147267103|NCT03240575|531151670|FG003|Overall Study|Withdrawal by Subject|1|||
147267104|NCT03240575|531151667|FG000|Overall Study|Other|0|||
147267105|NCT03240575|531151668|FG001|Overall Study|Other|1|||
147267106|NCT03240575|531151669|FG002|Overall Study|Other|0|||
147267107|NCT03240575|531151670|FG003|Overall Study|Other|0|||
147267108|NCT03568942|531151675|FG000|Overall Study|Family emergency|1|||
147267109|NCT03568942|531151675|FG000|Overall Study|Lost to Follow-up|1|||
147267110|NCT01945489|531151676|FG000|Cycle 1|Adverse Event|2|||
147267111|NCT01945489|531151677|FG001|Cycle 1|Adverse Event|0|||
147267112|NCT01945489|531151676|FG000|Cycle 1|Lost to Follow-up|4|||
147267113|NCT01945489|531151677|FG001|Cycle 1|Lost to Follow-up|0|||
147267114|NCT01945489|531151676|FG000|Cycle 1|Personal Reasons|4|||
147267115|NCT01945489|531151677|FG001|Cycle 1|Personal Reasons|2|||
147267116|NCT01945489|531151676|FG000|Cycle 1|Protocol Violation|0|||
147267117|NCT01945489|531151677|FG001|Cycle 1|Protocol Violation|1|||
147267118|NCT01945489|531151676|FG000|Cycle 1|Other Miscellaneous Reasons|3|||
147267119|NCT01945489|531151677|FG001|Cycle 1|Other Miscellaneous Reasons|1|||
147267120|NCT01945489|531151676|FG000|Cycle 2|Adverse Event|1|||
147267121|NCT01945489|531151677|FG001|Cycle 2|Adverse Event|0|||
147267122|NCT01945489|531151676|FG000|Cycle 2|Lost to Follow-up|0|||
147267123|NCT01945489|531151677|FG001|Cycle 2|Lost to Follow-up|1|||
147267124|NCT04144166|531151679|FG000|Overall Study|Discharged before study start|1|||
147267125|NCT04144166|531151679|FG000|Overall Study|Pregnancy|1|||
147267126|NCT04144166|531151679|FG000|Overall Study|Nail polish could not be removed from finger|1|||
147267127|NCT02223767|531151684|FG000|Overall Study|Withdrawal by Subject|4|||
147267128|NCT02223767|531151685|FG001|Overall Study|Withdrawal by Subject|4|||
147267129|NCT00934544|531151687|FG000|Primary Endpoint Analysis (Interim)|Adverse Event|12|||
147267130|NCT00934544|531151688|FG001|Primary Endpoint Analysis (Interim)|Adverse Event|4|||
147267131|NCT00934544|531151689|FG002|Primary Endpoint Analysis (Interim)|Adverse Event|0|||
147267132|NCT00934544|531151687|FG000|Primary Endpoint Analysis (Interim)|Withdrawal by Subject|2|||
147267133|NCT00934544|531151688|FG001|Primary Endpoint Analysis (Interim)|Withdrawal by Subject|9|||
147267134|NCT00934544|531151689|FG002|Primary Endpoint Analysis (Interim)|Withdrawal by Subject|0|||
147267135|NCT00934544|531151687|FG000|Primary Endpoint Analysis (Interim)|Protocol Violation|2|||
147267136|NCT00934544|531151688|FG001|Primary Endpoint Analysis (Interim)|Protocol Violation|0|||
147267137|NCT00934544|531151689|FG002|Primary Endpoint Analysis (Interim)|Protocol Violation|0|||
147267138|NCT00934544|531151687|FG000|Primary Endpoint Analysis (Interim)|Disease Progression|1|||
147267139|NCT00934544|531151688|FG001|Primary Endpoint Analysis (Interim)|Disease Progression|3|||
147267140|NCT00934544|531151689|FG002|Primary Endpoint Analysis (Interim)|Disease Progression|0|||
147267141|NCT00934544|531151687|FG000|Primary Endpoint Analysis (Interim)|Non-compliance with study Medication|2|||
147267142|NCT00934544|531151688|FG001|Primary Endpoint Analysis (Interim)|Non-compliance with study Medication|0|||
147267143|NCT00934544|531151689|FG002|Primary Endpoint Analysis (Interim)|Non-compliance with study Medication|0|||
147267144|NCT00934544|531151687|FG000|Primary Endpoint Analysis (Interim)|Non-compliance with study procedures|0|||
147267145|NCT00934544|531151688|FG001|Primary Endpoint Analysis (Interim)|Non-compliance with study procedures|1|||
147267146|NCT00934544|531151689|FG002|Primary Endpoint Analysis (Interim)|Non-compliance with study procedures|0|||
147267147|NCT00934544|531151687|FG000|Primary Endpoint Analysis (Interim)|Other reasons|7|||
147267148|NCT00934544|531151688|FG001|Primary Endpoint Analysis (Interim)|Other reasons|7|||
147267149|NCT00934544|531151689|FG002|Primary Endpoint Analysis (Interim)|Other reasons|0|||
147267150|NCT00934544|531151687|FG000|Primary Endpoint Analysis (Interim)|Entered extension phase|29|||
147267151|NCT00934544|531151688|FG001|Primary Endpoint Analysis (Interim)|Entered extension phase|18|||
147267152|NCT00934544|531151689|FG002|Primary Endpoint Analysis (Interim)|Entered extension phase|0|||
147267153|NCT00934544|531151687|FG000|Overall Disposition at 5 Year Follow-up|Including stem cell transplantation|16|||
147267154|NCT00934544|531151688|FG001|Overall Disposition at 5 Year Follow-up|Including stem cell transplantation|9|||
147267155|NCT00934544|531151689|FG002|Overall Disposition at 5 Year Follow-up|Including stem cell transplantation|6|||
147333140|NCT01212757|531385644|FG006|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
147450265|NCT03016325|531811405|FG006|32-Day Follow-Up Period|Lost to Follow-up|0|||
147662316|NCT01095835|532587294|FG002|Overall Study|Protocol Violation|0|||
147267156|NCT00934544|531151687|FG000|Overall Disposition at 5 Year Follow-up|Adverse Event|35|||
147267157|NCT00934544|531151688|FG001|Overall Disposition at 5 Year Follow-up|Adverse Event|5|||
147267158|NCT00934544|531151689|FG002|Overall Disposition at 5 Year Follow-up|Adverse Event|10|||
147267159|NCT00934544|531151687|FG000|Overall Disposition at 5 Year Follow-up|Withdrawal by Subject|10|||
147267160|NCT00934544|531151688|FG001|Overall Disposition at 5 Year Follow-up|Withdrawal by Subject|9|||
147267161|NCT00934544|531151689|FG002|Overall Disposition at 5 Year Follow-up|Withdrawal by Subject|0|||
147267162|NCT00934544|531151687|FG000|Overall Disposition at 5 Year Follow-up|Protocol Violation|2|||
147662317|NCT03110354|532587295|FG000|Overall Study|Death|1|||
147267163|NCT00934544|531151688|FG001|Overall Disposition at 5 Year Follow-up|Protocol Violation|0|||
147267164|NCT00934544|531151689|FG002|Overall Disposition at 5 Year Follow-up|Protocol Violation|5|||
147267165|NCT00934544|531151687|FG000|Overall Disposition at 5 Year Follow-up|Disease progression|32|||
147267166|NCT00934544|531151688|FG001|Overall Disposition at 5 Year Follow-up|Disease progression|4|||
147267167|NCT00934544|531151689|FG002|Overall Disposition at 5 Year Follow-up|Disease progression|7|||
147267168|NCT00934544|531151687|FG000|Overall Disposition at 5 Year Follow-up|Noncompliance with study medication|4|||
147267169|NCT00934544|531151688|FG001|Overall Disposition at 5 Year Follow-up|Noncompliance with study medication|0|||
147267170|NCT00934544|531151689|FG002|Overall Disposition at 5 Year Follow-up|Noncompliance with study medication|1|||
147267171|NCT00934544|531151687|FG000|Overall Disposition at 5 Year Follow-up|Noncompliance with study procedures|0|||
147267172|NCT00934544|531151688|FG001|Overall Disposition at 5 Year Follow-up|Noncompliance with study procedures|1|||
147267173|NCT00934544|531151689|FG002|Overall Disposition at 5 Year Follow-up|Noncompliance with study procedures|0|||
147267174|NCT00934544|531151687|FG000|Overall Disposition at 5 Year Follow-up|Lack of Efficacy|8|||
147267175|NCT00934544|531151688|FG001|Overall Disposition at 5 Year Follow-up|Lack of Efficacy|0|||
147267176|NCT00934544|531151689|FG002|Overall Disposition at 5 Year Follow-up|Lack of Efficacy|5|||
147267177|NCT02643251|531151690|FG000|Overall Study|Adverse Event|3|||
147267178|NCT02643251|531151691|FG001|Overall Study|Adverse Event|1|||
147267179|NCT02643251|531151690|FG000|Overall Study|Withdrawal by Subject|2|||
147267180|NCT02643251|531151691|FG001|Overall Study|Withdrawal by Subject|0|||
147267181|NCT02643251|531151690|FG000|Overall Study|Lost to Follow-up|4|||
147267182|NCT02643251|531151691|FG001|Overall Study|Lost to Follow-up|1|||
147267183|NCT02643251|531151690|FG000|Overall Study|Protocol Violation|1|||
147267184|NCT02643251|531151691|FG001|Overall Study|Protocol Violation|0|||
147267185|NCT02643251|531151690|FG000|Overall Study|PI Decision to terminate patient|1|||
147267186|NCT02643251|531151691|FG001|Overall Study|PI Decision to terminate patient|0|||
147267187|NCT00333229|531151694|FG000|Overall Study|Lack of Efficacy|0|||
147267188|NCT00333229|531151695|FG001|Overall Study|Lack of Efficacy|1|||
147267189|NCT01466270|531151696|FG000|Overall Study|Withdrawal by Subject|4|||
147267190|NCT01466270|531151697|FG001|Overall Study|Withdrawal by Subject|1|||
147267191|NCT01466270|531151696|FG000|Overall Study|Physician Decision|1|||
147267192|NCT01466270|531151697|FG001|Overall Study|Physician Decision|0|||
147267193|NCT01466270|531151696|FG000|Overall Study|Lost to Follow-up|1|||
147267194|NCT01466270|531151697|FG001|Overall Study|Lost to Follow-up|3|||
147267195|NCT01466270|531151696|FG000|Overall Study|Progression|1|||
147267196|NCT01466270|531151697|FG001|Overall Study|Progression|0|||
147267197|NCT01466270|531151696|FG000|Overall Study|Toxicity|4|||
147267198|NCT01466270|531151697|FG001|Overall Study|Toxicity|1|||
147267199|NCT01466270|531151696|FG000|Overall Study|Multiple|1|||
147267200|NCT01466270|531151697|FG001|Overall Study|Multiple|1|||
147267201|NCT02821962|531151700|FG000|Overall Study|Lost to Follow-up|2|||
147267202|NCT02821962|531151701|FG001|Overall Study|Lost to Follow-up|0|||
147267203|NCT00654381|531151709|FG000|1st Stage|Adverse Event|3|||
147267204|NCT00654381|531151710|FG001|1st Stage|Adverse Event|3|||
147267205|NCT00654381|531151711|FG002|1st Stage|Adverse Event|3|||
147267206|NCT00654381|531151712|FG003|1st Stage|Adverse Event|3|||
147267207|NCT00654381|531151713|FG004|1st Stage|Adverse Event|2|||
147267208|NCT00654381|531151714|FG005|1st Stage|Adverse Event|1|||
147267209|NCT00654381|531151709|FG000|1st Stage|Withdrawal by Subject|0|||
147267210|NCT00654381|531151710|FG001|1st Stage|Withdrawal by Subject|0|||
147267211|NCT00654381|531151711|FG002|1st Stage|Withdrawal by Subject|0|||
147267212|NCT00654381|531151712|FG003|1st Stage|Withdrawal by Subject|1|||
147267213|NCT00654381|531151713|FG004|1st Stage|Withdrawal by Subject|0|||
147267214|NCT00654381|531151714|FG005|1st Stage|Withdrawal by Subject|1|||
147267215|NCT00654381|531151709|FG000|1st Stage|Investigator's decision|0|||
147267216|NCT00654381|531151710|FG001|1st Stage|Investigator's decision|0|||
147267217|NCT00654381|531151711|FG002|1st Stage|Investigator's decision|0|||
147267218|NCT00654381|531151712|FG003|1st Stage|Investigator's decision|1|||
147267219|NCT00654381|531151713|FG004|1st Stage|Investigator's decision|0|||
147267220|NCT00654381|531151714|FG005|1st Stage|Investigator's decision|0|||
147267221|NCT00654381|531151709|FG000|2nd Stage|Adverse Event|2|||
147267222|NCT00654381|531151710|FG001|2nd Stage|Adverse Event|0|||
147267223|NCT00654381|531151711|FG002|2nd Stage|Adverse Event|2|||
147267224|NCT00654381|531151712|FG003|2nd Stage|Adverse Event|3|||
147267225|NCT00654381|531151713|FG004|2nd Stage|Adverse Event|7|||
147267226|NCT00654381|531151714|FG005|2nd Stage|Adverse Event|2|||
147267227|NCT00654381|531151709|FG000|2nd Stage|Withdrawal by Subject|0|||
147267228|NCT00654381|531151710|FG001|2nd Stage|Withdrawal by Subject|0|||
147267229|NCT00654381|531151711|FG002|2nd Stage|Withdrawal by Subject|0|||
147267230|NCT00654381|531151712|FG003|2nd Stage|Withdrawal by Subject|0|||
147267231|NCT00654381|531151713|FG004|2nd Stage|Withdrawal by Subject|1|||
147267232|NCT00654381|531151714|FG005|2nd Stage|Withdrawal by Subject|1|||
147267233|NCT00654381|531151709|FG000|2nd Stage|Investigator's decision|0|||
147662318|NCT03110354|532587296|FG001|Overall Study|Death|0|||
147600232|NCT01739348|532356342|FG000|Part II (Extension Study)|Non-Compliance with Study Drug|0|||
147600233|NCT01739348|532356343|FG001|Part II (Extension Study)|Non-Compliance with Study Drug|0|||
147267234|NCT00654381|531151710|FG001|2nd Stage|Investigator's decision|0|||
147267235|NCT00654381|531151711|FG002|2nd Stage|Investigator's decision|1|||
147267236|NCT00654381|531151712|FG003|2nd Stage|Investigator's decision|1|||
147267237|NCT00654381|531151713|FG004|2nd Stage|Investigator's decision|0|||
147267238|NCT00654381|531151714|FG005|2nd Stage|Investigator's decision|0|||
147267239|NCT00654381|531151709|FG000|Extension Stage|Adverse Event|1|||
147267240|NCT00654381|531151710|FG001|Extension Stage|Adverse Event|2|||
147267241|NCT00654381|531151711|FG002|Extension Stage|Adverse Event|9|||
147267242|NCT00654381|531151712|FG003|Extension Stage|Adverse Event|7|||
147267243|NCT00654381|531151713|FG004|Extension Stage|Adverse Event|1|||
147267244|NCT00654381|531151714|FG005|Extension Stage|Adverse Event|1|||
147267245|NCT00654381|531151709|FG000|Extension Stage|Protocol Violation|0|||
147267246|NCT00654381|531151710|FG001|Extension Stage|Protocol Violation|0|||
147267247|NCT00654381|531151711|FG002|Extension Stage|Protocol Violation|0|||
147267248|NCT00654381|531151712|FG003|Extension Stage|Protocol Violation|1|||
147267249|NCT00654381|531151713|FG004|Extension Stage|Protocol Violation|0|||
147267250|NCT00654381|531151714|FG005|Extension Stage|Protocol Violation|0|||
147267251|NCT00654381|531151709|FG000|Extension Stage|Lack of Efficacy|0|||
147267252|NCT00654381|531151710|FG001|Extension Stage|Lack of Efficacy|0|||
147267253|NCT00654381|531151711|FG002|Extension Stage|Lack of Efficacy|1|||
147267254|NCT00654381|531151712|FG003|Extension Stage|Lack of Efficacy|0|||
147267255|NCT00654381|531151713|FG004|Extension Stage|Lack of Efficacy|0|||
147267256|NCT00654381|531151714|FG005|Extension Stage|Lack of Efficacy|0|||
147267257|NCT00654381|531151709|FG000|Extension Stage|Withdrawal by Subject|0|||
147267258|NCT00654381|531151710|FG001|Extension Stage|Withdrawal by Subject|0|||
147267259|NCT00654381|531151711|FG002|Extension Stage|Withdrawal by Subject|1|||
147267260|NCT00654381|531151712|FG003|Extension Stage|Withdrawal by Subject|1|||
147267261|NCT00654381|531151713|FG004|Extension Stage|Withdrawal by Subject|1|||
147267262|NCT00654381|531151714|FG005|Extension Stage|Withdrawal by Subject|1|||
147267263|NCT00654381|531151709|FG000|Extension Stage|Closure of the trial site|0|||
147267264|NCT00654381|531151710|FG001|Extension Stage|Closure of the trial site|0|||
147267265|NCT00654381|531151711|FG002|Extension Stage|Closure of the trial site|0|||
147267266|NCT00654381|531151712|FG003|Extension Stage|Closure of the trial site|0|||
147267267|NCT00654381|531151713|FG004|Extension Stage|Closure of the trial site|1|||
147267268|NCT00654381|531151714|FG005|Extension Stage|Closure of the trial site|1|||
147267269|NCT03100825|531151715|FG000|Overall Study|Participant/Guardian Decision|7|||
147267270|NCT03100825|531151715|FG000|Overall Study|Physician Decision|1|||
147267271|NCT00994448|531151717|FG000|Overall Study|Adverse Event|1|||
147267272|NCT00994448|531151718|FG001|Overall Study|Adverse Event|0|||
147267273|NCT00994448|531151717|FG000|Overall Study|Lost to Follow-up|5|||
147267274|NCT00994448|531151718|FG001|Overall Study|Lost to Follow-up|1|||
147267275|NCT00994448|531151717|FG000|Overall Study|Withdrawal by Subject|1|||
147267276|NCT00994448|531151718|FG001|Overall Study|Withdrawal by Subject|1|||
147267277|NCT00994448|531151717|FG000|Overall Study|Physician Decision|1|||
147267278|NCT00994448|531151718|FG001|Overall Study|Physician Decision|0|||
147267279|NCT04164901|531151721|FG000|Overall Study|Withdrawal by Subject|4|||
147267280|NCT04164901|531151722|FG001|Overall Study|Withdrawal by Subject|4|||
147267281|NCT05358821|531151725|FG000|Overall Study|Withdrawal by Subject|0|||
147267282|NCT05358821|531151726|FG001|Overall Study|Withdrawal by Subject|1|||
147267283|NCT05358821|531151727|FG002|Overall Study|Withdrawal by Subject|0|||
147267284|NCT05358821|531151725|FG000|Overall Study|Withdrawal of Consent|0|||
147267285|NCT05358821|531151726|FG001|Overall Study|Withdrawal of Consent|0|||
147267286|NCT05358821|531151727|FG002|Overall Study|Withdrawal of Consent|1|||
147267287|NCT00048542|531151729|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
147267288|NCT00048542|531151730|FG001|Double-Blind Phase|Withdrawal by Subject|1|||
147267289|NCT00048542|531151731|FG002|Double-Blind Phase|Withdrawal by Subject|0|||
147267290|NCT00048542|531151732|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
147267291|NCT00048542|531151733|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
147267292|NCT00048542|531151734|FG005|Double-Blind Phase|Withdrawal by Subject|0|||
147267293|NCT00048542|531151735|FG006|Double-Blind Phase|Withdrawal by Subject|0|||
147267294|NCT00048542|531151736|FG007|Double-Blind Phase|Withdrawal by Subject|0|||
147267295|NCT00048542|531151729|FG000|Double-Blind Phase|Protocol Violation|0|||
147267296|NCT00048542|531151730|FG001|Double-Blind Phase|Protocol Violation|0|||
147267297|NCT00048542|531151731|FG002|Double-Blind Phase|Protocol Violation|1|||
147267298|NCT00048542|531151732|FG003|Double-Blind Phase|Protocol Violation|0|||
147267299|NCT00048542|531151733|FG004|Double-Blind Phase|Protocol Violation|0|||
147267300|NCT00048542|531151734|FG005|Double-Blind Phase|Protocol Violation|0|||
147267301|NCT00048542|531151735|FG006|Double-Blind Phase|Protocol Violation|0|||
147267302|NCT00048542|531151736|FG007|Double-Blind Phase|Protocol Violation|0|||
147267303|NCT00048542|531151729|FG000|Double-Blind Phase|Sponsor request or decision|2|||
147267304|NCT00048542|531151730|FG001|Double-Blind Phase|Sponsor request or decision|0|||
147267305|NCT00048542|531151731|FG002|Double-Blind Phase|Sponsor request or decision|0|||
147267306|NCT00048542|531151732|FG003|Double-Blind Phase|Sponsor request or decision|0|||
147267307|NCT00048542|531151733|FG004|Double-Blind Phase|Sponsor request or decision|0|||
147267308|NCT00048542|531151734|FG005|Double-Blind Phase|Sponsor request or decision|0|||
147267309|NCT00048542|531151735|FG006|Double-Blind Phase|Sponsor request or decision|0|||
147267310|NCT00048542|531151736|FG007|Double-Blind Phase|Sponsor request or decision|0|||
147267311|NCT00048542|531151729|FG000|Double-Blind Phase|Randomized in error|1|||
147267312|NCT00048542|531151730|FG001|Double-Blind Phase|Randomized in error|0|||
147267313|NCT00048542|531151731|FG002|Double-Blind Phase|Randomized in error|0|||
147267314|NCT00048542|531151732|FG003|Double-Blind Phase|Randomized in error|0|||
147267315|NCT00048542|531151733|FG004|Double-Blind Phase|Randomized in error|0|||
147267316|NCT00048542|531151734|FG005|Double-Blind Phase|Randomized in error|0|||
147267317|NCT00048542|531151735|FG006|Double-Blind Phase|Randomized in error|0|||
147267318|NCT00048542|531151736|FG007|Double-Blind Phase|Randomized in error|0|||
147267319|NCT00048542|531151729|FG000|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
147267320|NCT00048542|531151730|FG001|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
147267321|NCT00048542|531151731|FG002|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
147267322|NCT00048542|531151732|FG003|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
147267323|NCT00048542|531151733|FG004|Open-Label Extension BSA Phase|Withdrawal by Subject|3|||
147267324|NCT00048542|531151734|FG005|Open-Label Extension BSA Phase|Withdrawal by Subject|6|||
147267325|NCT00048542|531151735|FG006|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
147267326|NCT00048542|531151736|FG007|Open-Label Extension BSA Phase|Withdrawal by Subject|0|||
147267327|NCT00048542|531151729|FG000|Open-Label Extension BSA Phase|Protocol Violation|0|||
147267328|NCT00048542|531151730|FG001|Open-Label Extension BSA Phase|Protocol Violation|0|||
147267329|NCT00048542|531151731|FG002|Open-Label Extension BSA Phase|Protocol Violation|0|||
147267330|NCT00048542|531151732|FG003|Open-Label Extension BSA Phase|Protocol Violation|0|||
147267331|NCT00048542|531151733|FG004|Open-Label Extension BSA Phase|Protocol Violation|0|||
147267332|NCT00048542|531151734|FG005|Open-Label Extension BSA Phase|Protocol Violation|1|||
147267333|NCT00048542|531151735|FG006|Open-Label Extension BSA Phase|Protocol Violation|0|||
147267334|NCT00048542|531151736|FG007|Open-Label Extension BSA Phase|Protocol Violation|0|||
147267335|NCT00048542|531151729|FG000|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
147267336|NCT00048542|531151730|FG001|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
147267337|NCT00048542|531151731|FG002|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
147267338|NCT00048542|531151732|FG003|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
147267339|NCT00048542|531151733|FG004|Open-Label Extension BSA Phase|Sponsor request or decision|5|||
147267340|NCT00048542|531151734|FG005|Open-Label Extension BSA Phase|Sponsor request or decision|1|||
147267341|NCT00048542|531151735|FG006|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
147267342|NCT00048542|531151736|FG007|Open-Label Extension BSA Phase|Sponsor request or decision|0|||
147267343|NCT00048542|531151729|FG000|Open-Label Extension BSA Phase|Adverse Event|0|||
147267344|NCT00048542|531151730|FG001|Open-Label Extension BSA Phase|Adverse Event|0|||
147267345|NCT00048542|531151731|FG002|Open-Label Extension BSA Phase|Adverse Event|0|||
147267346|NCT00048542|531151732|FG003|Open-Label Extension BSA Phase|Adverse Event|0|||
147267347|NCT00048542|531151733|FG004|Open-Label Extension BSA Phase|Adverse Event|1|||
147267348|NCT00048542|531151734|FG005|Open-Label Extension BSA Phase|Adverse Event|1|||
147267349|NCT00048542|531151735|FG006|Open-Label Extension BSA Phase|Adverse Event|0|||
147267350|NCT00048542|531151736|FG007|Open-Label Extension BSA Phase|Adverse Event|0|||
147267351|NCT00048542|531151729|FG000|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
147267352|NCT00048542|531151730|FG001|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
147267353|NCT00048542|531151731|FG002|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
147267354|NCT00048542|531151732|FG003|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
147267355|NCT00048542|531151733|FG004|Open-Label Extension BSA Phase|Lack of Efficacy|3|||
147267356|NCT00048542|531151734|FG005|Open-Label Extension BSA Phase|Lack of Efficacy|1|||
147267357|NCT00048542|531151735|FG006|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
147267358|NCT00048542|531151736|FG007|Open-Label Extension BSA Phase|Lack of Efficacy|0|||
147267359|NCT00048542|531151729|FG000|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
147267360|NCT00048542|531151730|FG001|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
147267361|NCT00048542|531151731|FG002|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
147267362|NCT00048542|531151732|FG003|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
147267363|NCT00048542|531151733|FG004|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
147267364|NCT00048542|531151734|FG005|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|0|||
147267365|NCT00048542|531151735|FG006|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|6|||
147267366|NCT00048542|531151736|FG007|Open-Label Extension Fixed Dose Phase|Withdrawal by Subject|3|||
147267367|NCT00048542|531151729|FG000|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
147267368|NCT00048542|531151730|FG001|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
147267369|NCT00048542|531151731|FG002|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
147267370|NCT00048542|531151732|FG003|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
147267371|NCT00048542|531151733|FG004|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
147267372|NCT00048542|531151734|FG005|Open-Label Extension Fixed Dose Phase|Protocol Violation|0|||
147267373|NCT00048542|531151735|FG006|Open-Label Extension Fixed Dose Phase|Protocol Violation|1|||
147662319|NCT03110354|532587297|FG002|Overall Study|Death|0|||
147662320|NCT03110354|532587298|FG003|Overall Study|Death|1|||
147267374|NCT00048542|531151736|FG007|Open-Label Extension Fixed Dose Phase|Protocol Violation|1|||
147267375|NCT00048542|531151729|FG000|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
147267376|NCT00048542|531151730|FG001|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
147267377|NCT00048542|531151731|FG002|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
147267378|NCT00048542|531151732|FG003|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
147267379|NCT00048542|531151733|FG004|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
147267380|NCT00048542|531151734|FG005|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|0|||
147267381|NCT00048542|531151735|FG006|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|6|||
147267382|NCT00048542|531151736|FG007|Open-Label Extension Fixed Dose Phase|Sponsor request or decision|7|||
147267383|NCT00048542|531151729|FG000|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
147267384|NCT00048542|531151730|FG001|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
147267385|NCT00048542|531151731|FG002|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
147267386|NCT00048542|531151732|FG003|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
147267387|NCT00048542|531151733|FG004|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
147267388|NCT00048542|531151734|FG005|Open-Label Extension Fixed Dose Phase|Adverse Event|0|||
147267389|NCT00048542|531151735|FG006|Open-Label Extension Fixed Dose Phase|Adverse Event|2|||
147267390|NCT00048542|531151736|FG007|Open-Label Extension Fixed Dose Phase|Adverse Event|2|||
147267391|NCT00048542|531151729|FG000|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
147267392|NCT00048542|531151730|FG001|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
147267393|NCT00048542|531151731|FG002|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
147267394|NCT00048542|531151732|FG003|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
147267395|NCT00048542|531151733|FG004|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
147267396|NCT00048542|531151734|FG005|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|0|||
147267397|NCT00048542|531151735|FG006|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|2|||
147267398|NCT00048542|531151736|FG007|Open-Label Extension Fixed Dose Phase|Lack of Efficacy|1|||
147267399|NCT00048542|531151729|FG000|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
147267400|NCT00048542|531151730|FG001|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
147267401|NCT00048542|531151731|FG002|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
147267402|NCT00048542|531151732|FG003|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
147267403|NCT00048542|531151733|FG004|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
147267404|NCT00048542|531151734|FG005|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|0|||
147267405|NCT00048542|531151735|FG006|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|5|||
147267406|NCT00048542|531151736|FG007|Open-Label Extension Fixed Dose Phase|Lost to Follow-up|8|||
147267407|NCT04476017|531151739|FG000|Part A (28 Days)|Withdrawal by Subject|1|||
147267408|NCT04476017|531151740|FG001|Part A (28 Days)|Withdrawal by Subject|0|||
147267409|NCT02704364|531151741|FG000|Overall Study|Adverse Event|1|||
147267410|NCT02704364|531151742|FG001|Overall Study|Adverse Event|1|||
147267411|NCT02704364|531151743|FG002|Overall Study|Adverse Event|0|||
147267412|NCT02704364|531151741|FG000|Overall Study|Noncompliance with study drug|1|||
147267413|NCT02704364|531151742|FG001|Overall Study|Noncompliance with study drug|1|||
147267414|NCT02704364|531151743|FG002|Overall Study|Noncompliance with study drug|0|||
147267415|NCT02704364|531151741|FG000|Overall Study|Other|0|||
147267416|NCT02704364|531151742|FG001|Overall Study|Other|1|||
147267417|NCT02704364|531151743|FG002|Overall Study|Other|1|||
147267418|NCT00846742|531151744|FG000|Overall Study|Withdrawal by Subject|1|||
147267419|NCT02775344|531151746|FG000|Overall Study|No ovarian cyst identified|3|||
147267420|NCT02775344|531151747|FG001|Overall Study|No ovarian cyst identified|2|||
147267421|NCT04627064|531151749|FG000|Overall Study|Progressive disease|8|||
147267422|NCT04627064|531151750|FG001|Overall Study|Progressive disease|0|||
147267423|NCT04627064|531151749|FG000|Overall Study|Withdrawal by Subject|2|||
147267424|NCT04627064|531151750|FG001|Overall Study|Withdrawal by Subject|0|||
147267425|NCT04627064|531151749|FG000|Overall Study|Physician Decision|1|||
147267426|NCT04627064|531151750|FG001|Overall Study|Physician Decision|0|||
147267427|NCT04098458|531151753|FG000|Overall Study|Death|1|||
147267428|NCT04098458|531151753|FG000|Overall Study|did not meet study inclusion criteria|3|||
147267429|NCT00006489|531151754|FG000|Overall Study|Adverse Event|3|||
147267430|NCT00006489|531151755|FG001|Overall Study|Adverse Event|2|||
147267431|NCT00006489|531151756|FG002|Overall Study|Adverse Event|4|||
147267432|NCT00006489|531151757|FG003|Overall Study|Adverse Event|3|||
147267433|NCT00006489|531151754|FG000|Overall Study|Withdrawal by Subject|10|||
147267434|NCT00006489|531151755|FG001|Overall Study|Withdrawal by Subject|9|||
147267435|NCT00006489|531151756|FG002|Overall Study|Withdrawal by Subject|9|||
147267436|NCT00006489|531151757|FG003|Overall Study|Withdrawal by Subject|6|||
147333141|NCT01212757|531385645|FG007|Long-Term Safety Phase (Year 3)|Miscellaneous|0|||
147333142|NCT01212757|531385646|FG008|Long-Term Safety Phase (Year 3)|Miscellaneous|2|||
147267437|NCT00006489|531151754|FG000|Overall Study|Scheduling Conflict|0|||
147267438|NCT00006489|531151755|FG001|Overall Study|Scheduling Conflict|3|||
147267439|NCT00006489|531151756|FG002|Overall Study|Scheduling Conflict|2|||
147333143|NCT01212757|531385638|FG000|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
147600234|NCT01739348|532356344|FG002|Part II (Extension Study)|Non-Compliance with Study Drug|0|||
147662321|NCT03110354|532587299|FG004|Overall Study|Death|0|||
147333144|NCT01212757|531385639|FG001|Long-Term Safety Phase (Year 4)|Miscellaneous|2|||
147333145|NCT01212757|531385640|FG002|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
147333146|NCT01212757|531385641|FG003|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
147333147|NCT01212757|531385642|FG004|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
147333148|NCT01212757|531385643|FG005|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
147333149|NCT01212757|531385644|FG006|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
147333150|NCT01212757|531385645|FG007|Long-Term Safety Phase (Year 4)|Miscellaneous|0|||
147333151|NCT01212757|531385646|FG008|Long-Term Safety Phase (Year 4)|Miscellaneous|1|||
147333152|NCT01212757|531385638|FG000|Long-Term Safety Phase (Year 4)|Adverse Event|0|||
147333153|NCT01212757|531385639|FG001|Long-Term Safety Phase (Year 4)|Adverse Event|1|||
147333154|NCT01212757|531385640|FG002|Long-Term Safety Phase (Year 4)|Adverse Event|2|||
147333155|NCT01212757|531385641|FG003|Long-Term Safety Phase (Year 4)|Adverse Event|0|||
147333156|NCT01212757|531385642|FG004|Long-Term Safety Phase (Year 4)|Adverse Event|0|||
147333157|NCT01212757|531385643|FG005|Long-Term Safety Phase (Year 4)|Adverse Event|0|||
147333158|NCT01212757|531385644|FG006|Long-Term Safety Phase (Year 4)|Adverse Event|0|||
147333159|NCT01212757|531385645|FG007|Long-Term Safety Phase (Year 4)|Adverse Event|1|||
147333160|NCT01212757|531385646|FG008|Long-Term Safety Phase (Year 4)|Adverse Event|1|||
147333161|NCT01212757|531385638|FG000|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0|||
147450266|NCT03016325|531811406|FG007|32-Day Follow-Up Period|Lost to Follow-up|0|||
147267440|NCT00006489|531151757|FG003|Overall Study|Scheduling Conflict|1|||
147267441|NCT00006489|531151754|FG000|Overall Study|Death|0|||
147267442|NCT00006489|531151755|FG001|Overall Study|Death|0|||
147267443|NCT00006489|531151756|FG002|Overall Study|Death|0|||
147267444|NCT00006489|531151757|FG003|Overall Study|Death|1|||
147267445|NCT00578175|531151758|FG000|Overall Study|Adverse Event|0|||
147267446|NCT00578175|531151759|FG001|Overall Study|Adverse Event|1|||
147267447|NCT00578175|531151760|FG002|Overall Study|Adverse Event|1|||
147267448|NCT00578175|531151758|FG000|Overall Study|Other reasons|70|||
147267449|NCT00578175|531151759|FG001|Overall Study|Other reasons|42|||
147267450|NCT00578175|531151760|FG002|Overall Study|Other reasons|23|||
147267451|NCT00235872|531151761|FG000|Overall Study|Adverse Event|34|||
147267452|NCT00235872|531151761|FG000|Overall Study|Death|1|||
147267453|NCT00235872|531151761|FG000|Overall Study|Lost to Follow-up|1|||
147267454|NCT00235872|531151761|FG000|Overall Study|Withdrawal by Subject|50|||
147267455|NCT00235872|531151761|FG000|Overall Study|Administrative reason|61|||
147267456|NCT02126969|531151762|FG000|Overall Study|Withdrawal by Subject|1|||
147267457|NCT02126969|531151763|FG001|Overall Study|Withdrawal by Subject|2|||
147267458|NCT01533246|531151771|FG000|Overall Study|Adverse Event|1|||
147267459|NCT01533246|531151771|FG000|Overall Study|Withdrawal by Subject|1|||
147267460|NCT00354172|531151772|FG000|Overall Study|Did not receive transplant|1|||
147267461|NCT01800916|531151773|FG000|Test Period 1 (1 Week)|Convex product user|0|||
147267462|NCT01800916|531151774|FG001|Test Period 1 (1 Week)|Convex product user|0|||
147267463|NCT01800916|531151775|FG002|Test Period 1 (1 Week)|Convex product user|0|||
147267464|NCT01800916|531151776|FG003|Test Period 1 (1 Week)|Convex product user|1|||
147267465|NCT01800916|531151777|FG004|Test Period 1 (1 Week)|Convex product user|0|||
147267466|NCT01800916|531151778|FG005|Test Period 1 (1 Week)|Convex product user|0|||
147267467|NCT01800916|531151779|FG006|Test Period 1 (1 Week)|Convex product user|0|||
147267468|NCT01800916|531151780|FG007|Test Period 1 (1 Week)|Convex product user|0|||
147267469|NCT01800916|531151781|FG008|Test Period 1 (1 Week)|Convex product user|0|||
147267470|NCT01800916|531151773|FG000|Test Period 1 (1 Week)|Adverse Event|0|||
147267471|NCT01800916|531151774|FG001|Test Period 1 (1 Week)|Adverse Event|0|||
147267472|NCT01800916|531151775|FG002|Test Period 1 (1 Week)|Adverse Event|0|||
147267473|NCT01800916|531151776|FG003|Test Period 1 (1 Week)|Adverse Event|0|||
147267474|NCT01800916|531151777|FG004|Test Period 1 (1 Week)|Adverse Event|1|||
147267475|NCT01800916|531151778|FG005|Test Period 1 (1 Week)|Adverse Event|0|||
147267476|NCT01800916|531151779|FG006|Test Period 1 (1 Week)|Adverse Event|0|||
147267477|NCT01800916|531151780|FG007|Test Period 1 (1 Week)|Adverse Event|0|||
147267478|NCT01800916|531151781|FG008|Test Period 1 (1 Week)|Adverse Event|0|||
147267479|NCT01232296|531151782|FG000|Overall Study|Adverse Event|24|||
147267480|NCT01232296|531151783|FG001|Overall Study|Adverse Event|12|||
147267481|NCT01232296|531151782|FG000|Overall Study|Physician Decision|1|||
147267482|NCT01232296|531151783|FG001|Overall Study|Physician Decision|1|||
147333162|NCT01212757|531385639|FG001|Long-Term Safety Phase (Year 4)|Lack of Efficacy|2|||
147333163|NCT01212757|531385640|FG002|Long-Term Safety Phase (Year 4)|Lack of Efficacy|2|||
147333164|NCT01212757|531385641|FG003|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0|||
147333165|NCT01212757|531385642|FG004|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0|||
147267483|NCT01232296|531151782|FG000|Overall Study|Progressive disease|43|||
147267484|NCT01232296|531151783|FG001|Overall Study|Progressive disease|61|||
147267485|NCT01232296|531151782|FG000|Overall Study|Study terminated by sponsor|0|||
147267486|NCT01232296|531151783|FG001|Overall Study|Study terminated by sponsor|1|||
147267487|NCT01232296|531151782|FG000|Overall Study|Technical problems|3|||
147267488|NCT01232296|531151783|FG001|Overall Study|Technical problems|0|||
147267489|NCT01232296|531151782|FG000|Overall Study|Subject/guardian decision|10|||
147267490|NCT01232296|531151783|FG001|Overall Study|Subject/guardian decision|2|||
147267491|NCT01232296|531151782|FG000|Overall Study|Death|1|||
147267492|NCT01232296|531151783|FG001|Overall Study|Death|6|||
147267493|NCT00937547|531151790|FG000|Overall Study|misdiagnosis|1|||
147267494|NCT00937547|531151791|FG001|Overall Study|misdiagnosis|6|||
147267495|NCT00937547|531151792|FG002|Overall Study|misdiagnosis|7|||
147267496|NCT01234467|531151793|FG000|Overall Study|Adverse Event|3|||
147267497|NCT01234467|531151793|FG000|Overall Study|Death|2|||
147267498|NCT01234467|531151793|FG000|Overall Study|Withdrawal by Subject|2|||
147267499|NCT01234467|531151793|FG000|Overall Study|Disease Progression|2|||
147267500|NCT01234467|531151793|FG000|Overall Study|Clinical deterioration|1|||
147267501|NCT01234467|531151793|FG000|Overall Study|Physician Decision|1|||
147267502|NCT01234467|531151793|FG000|Overall Study|Other complicating disease (stroke)|1|||
147267503|NCT04889625|531151794|FG000|Period 1|Subject did not meet eligibility criteria and was enrolled by error|2|||
147267504|NCT04889625|531151795|FG001|Period 1|Subject did not meet eligibility criteria and was enrolled by error|1|||
147267505|NCT04889625|531151794|FG000|Period 1|Subject out of window|0|||
147267506|NCT04889625|531151795|FG001|Period 1|Subject out of window|1|||
147267507|NCT04889625|531151794|FG000|Period 1|Wrong add power dispensed|0|||
147267508|NCT04889625|531151795|FG001|Period 1|Wrong add power dispensed|1|||
147267509|NCT04889625|531151794|FG000|Period 1|Discontinued due to fitting guide error|1|||
147267510|NCT04889625|531151795|FG001|Period 1|Discontinued due to fitting guide error|1|||
147267511|NCT04889625|531151794|FG000|Period 2|Test article no longer available|1|||
147267512|NCT04889625|531151795|FG001|Period 2|Test article no longer available|0|||
147267513|NCT04889625|531151794|FG000|Period 2|Incorrect lens dispensed|1|||
147267514|NCT04889625|531151795|FG001|Period 2|Incorrect lens dispensed|0|||
147267515|NCT04889625|531151794|FG000|Period 2|Wrong add power dispensed|0|||
147267516|NCT04889625|531151795|FG001|Period 2|Wrong add power dispensed|1|||
147267517|NCT00404352|531151807|FG000|Double Blind (up to 24 Month)|Adverse Event|5|||
147267518|NCT00404352|531151808|FG001|Double Blind (up to 24 Month)|Adverse Event|4|||
147267519|NCT00404352|531151809|FG002|Double Blind (up to 24 Month)|Adverse Event|6|||
147267520|NCT00404352|531151810|FG003|Double Blind (up to 24 Month)|Adverse Event|0|||
147267521|NCT00404352|531151811|FG004|Double Blind (up to 24 Month)|Adverse Event|0|||
147267522|NCT00404352|531151812|FG005|Double Blind (up to 24 Month)|Adverse Event|0|||
147267523|NCT00404352|531151813|FG006|Double Blind (up to 24 Month)|Adverse Event|0|||
147267524|NCT00404352|531151814|FG007|Double Blind (up to 24 Month)|Adverse Event|0|||
147267525|NCT00404352|531151815|FG008|Double Blind (up to 24 Month)|Adverse Event|0|||
147267526|NCT00404352|531151807|FG000|Double Blind (up to 24 Month)|Pregnancy|0|||
147267527|NCT00404352|531151808|FG001|Double Blind (up to 24 Month)|Pregnancy|0|||
147267528|NCT00404352|531151809|FG002|Double Blind (up to 24 Month)|Pregnancy|2|||
147267529|NCT00404352|531151810|FG003|Double Blind (up to 24 Month)|Pregnancy|0|||
147267530|NCT00404352|531151811|FG004|Double Blind (up to 24 Month)|Pregnancy|0|||
147267531|NCT00404352|531151812|FG005|Double Blind (up to 24 Month)|Pregnancy|0|||
147267532|NCT00404352|531151813|FG006|Double Blind (up to 24 Month)|Pregnancy|0|||
147267533|NCT00404352|531151814|FG007|Double Blind (up to 24 Month)|Pregnancy|0|||
147267534|NCT00404352|531151815|FG008|Double Blind (up to 24 Month)|Pregnancy|0|||
147267535|NCT00404352|531151807|FG000|Double Blind (up to 24 Month)|Death|0|||
147267536|NCT00404352|531151808|FG001|Double Blind (up to 24 Month)|Death|0|||
147267537|NCT00404352|531151809|FG002|Double Blind (up to 24 Month)|Death|1|||
147267538|NCT00404352|531151810|FG003|Double Blind (up to 24 Month)|Death|0|||
147267539|NCT00404352|531151811|FG004|Double Blind (up to 24 Month)|Death|0|||
147267540|NCT00404352|531151812|FG005|Double Blind (up to 24 Month)|Death|0|||
147267541|NCT00404352|531151813|FG006|Double Blind (up to 24 Month)|Death|0|||
147267542|NCT00404352|531151814|FG007|Double Blind (up to 24 Month)|Death|0|||
147267543|NCT00404352|531151815|FG008|Double Blind (up to 24 Month)|Death|0|||
147267544|NCT00404352|531151807|FG000|Double Blind (up to 24 Month)|Lost to Follow-up|1|||
147267545|NCT00404352|531151808|FG001|Double Blind (up to 24 Month)|Lost to Follow-up|2|||
147267546|NCT00404352|531151809|FG002|Double Blind (up to 24 Month)|Lost to Follow-up|1|||
147267547|NCT00404352|531151810|FG003|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
147600235|NCT01739348|532356345|FG003|Part II (Extension Study)|Non-Compliance with Study Drug|1|||
147600236|NCT01739348|532356342|FG000|Part II (Extension Study)|Physician Decision|7|||
147600237|NCT01739348|532356343|FG001|Part II (Extension Study)|Physician Decision|11|||
147600238|NCT01739348|532356344|FG002|Part II (Extension Study)|Physician Decision|6|||
147600239|NCT01739348|532356345|FG003|Part II (Extension Study)|Physician Decision|12|||
147600240|NCT01739348|532356342|FG000|Part II (Extension Study)|Study Terminated by Sponsor|329|||
147267548|NCT00404352|531151811|FG004|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
147267549|NCT00404352|531151812|FG005|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
147267550|NCT00404352|531151813|FG006|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
147267551|NCT00404352|531151814|FG007|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
147267552|NCT00404352|531151815|FG008|Double Blind (up to 24 Month)|Lost to Follow-up|0|||
147267553|NCT00404352|531151807|FG000|Double Blind (up to 24 Month)|Withdrawal by Subject|11|||
147267554|NCT00404352|531151808|FG001|Double Blind (up to 24 Month)|Withdrawal by Subject|8|||
147267555|NCT00404352|531151809|FG002|Double Blind (up to 24 Month)|Withdrawal by Subject|7|||
147600241|NCT01739348|532356343|FG001|Part II (Extension Study)|Study Terminated by Sponsor|315|||
147600242|NCT01739348|532356344|FG002|Part II (Extension Study)|Study Terminated by Sponsor|34|||
147267556|NCT00404352|531151810|FG003|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
147267557|NCT00404352|531151811|FG004|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
147267558|NCT00404352|531151812|FG005|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
147267559|NCT00404352|531151813|FG006|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
147267560|NCT00404352|531151814|FG007|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
147267561|NCT00404352|531151815|FG008|Double Blind (up to 24 Month)|Withdrawal by Subject|0|||
147267562|NCT00404352|531151807|FG000|Double Blind (up to 24 Month)|Disease progression|3|||
147267563|NCT00404352|531151808|FG001|Double Blind (up to 24 Month)|Disease progression|0|||
147267564|NCT00404352|531151809|FG002|Double Blind (up to 24 Month)|Disease progression|2|||
147267565|NCT00404352|531151810|FG003|Double Blind (up to 24 Month)|Disease progression|0|||
147267566|NCT00404352|531151811|FG004|Double Blind (up to 24 Month)|Disease progression|0|||
147267567|NCT00404352|531151812|FG005|Double Blind (up to 24 Month)|Disease progression|0|||
147267568|NCT00404352|531151813|FG006|Double Blind (up to 24 Month)|Disease progression|0|||
147267569|NCT00404352|531151814|FG007|Double Blind (up to 24 Month)|Disease progression|0|||
147267570|NCT00404352|531151815|FG008|Double Blind (up to 24 Month)|Disease progression|0|||
147267571|NCT00404352|531151807|FG000|Double Blind (up to 24 Month)|Poor compliance|1|||
147267572|NCT00404352|531151808|FG001|Double Blind (up to 24 Month)|Poor compliance|0|||
147267573|NCT00404352|531151809|FG002|Double Blind (up to 24 Month)|Poor compliance|0|||
147267574|NCT00404352|531151810|FG003|Double Blind (up to 24 Month)|Poor compliance|0|||
147267575|NCT00404352|531151811|FG004|Double Blind (up to 24 Month)|Poor compliance|0|||
147267576|NCT00404352|531151812|FG005|Double Blind (up to 24 Month)|Poor compliance|0|||
147267577|NCT00404352|531151813|FG006|Double Blind (up to 24 Month)|Poor compliance|0|||
147267578|NCT00404352|531151814|FG007|Double Blind (up to 24 Month)|Poor compliance|0|||
147267579|NCT00404352|531151815|FG008|Double Blind (up to 24 Month)|Poor compliance|0|||
147267580|NCT00404352|531151807|FG000|Double Blind (up to 24 Month)|Switched to open label phase|31|||
147267581|NCT00404352|531151808|FG001|Double Blind (up to 24 Month)|Switched to open label phase|30|||
147267582|NCT00404352|531151809|FG002|Double Blind (up to 24 Month)|Switched to open label phase|59|||
147267583|NCT00404352|531151810|FG003|Double Blind (up to 24 Month)|Switched to open label phase|0|||
147267584|NCT00404352|531151811|FG004|Double Blind (up to 24 Month)|Switched to open label phase|0|||
147267585|NCT00404352|531151812|FG005|Double Blind (up to 24 Month)|Switched to open label phase|0|||
147267586|NCT00404352|531151813|FG006|Double Blind (up to 24 Month)|Switched to open label phase|0|||
147267587|NCT00404352|531151814|FG007|Double Blind (up to 24 Month)|Switched to open label phase|0|||
147267588|NCT00404352|531151815|FG008|Double Blind (up to 24 Month)|Switched to open label phase|0|||
147267589|NCT00404352|531151807|FG000|Double Blind (up to 24 Month)|Randomized but not treated|0|||
147267590|NCT00404352|531151808|FG001|Double Blind (up to 24 Month)|Randomized but not treated|2|||
147267591|NCT00404352|531151809|FG002|Double Blind (up to 24 Month)|Randomized but not treated|0|||
147267592|NCT00404352|531151810|FG003|Double Blind (up to 24 Month)|Randomized but not treated|0|||
147267593|NCT00404352|531151811|FG004|Double Blind (up to 24 Month)|Randomized but not treated|0|||
147267594|NCT00404352|531151812|FG005|Double Blind (up to 24 Month)|Randomized but not treated|0|||
147267595|NCT00404352|531151813|FG006|Double Blind (up to 24 Month)|Randomized but not treated|0|||
147267596|NCT00404352|531151814|FG007|Double Blind (up to 24 Month)|Randomized but not treated|0|||
147267597|NCT00404352|531151815|FG008|Double Blind (up to 24 Month)|Randomized but not treated|0|||
147267598|NCT00404352|531151807|FG000|Double Blind (up to 24 Month)|Physician Decision|0|||
147267599|NCT00404352|531151808|FG001|Double Blind (up to 24 Month)|Physician Decision|0|||
147267600|NCT00404352|531151809|FG002|Double Blind (up to 24 Month)|Physician Decision|1|||
147267601|NCT00404352|531151810|FG003|Double Blind (up to 24 Month)|Physician Decision|0|||
147267602|NCT00404352|531151811|FG004|Double Blind (up to 24 Month)|Physician Decision|0|||
147267603|NCT00404352|531151812|FG005|Double Blind (up to 24 Month)|Physician Decision|0|||
147267604|NCT00404352|531151813|FG006|Double Blind (up to 24 Month)|Physician Decision|0|||
147267605|NCT00404352|531151814|FG007|Double Blind (up to 24 Month)|Physician Decision|0|||
147267606|NCT00404352|531151815|FG008|Double Blind (up to 24 Month)|Physician Decision|0|||
147267607|NCT00404352|531151807|FG000|Double Blind (up to 24 Month)|Other|0|||
147267608|NCT00404352|531151808|FG001|Double Blind (up to 24 Month)|Other|1|||
147267609|NCT00404352|531151809|FG002|Double Blind (up to 24 Month)|Other|0|||
147267610|NCT00404352|531151810|FG003|Double Blind (up to 24 Month)|Other|0|||
147267611|NCT00404352|531151811|FG004|Double Blind (up to 24 Month)|Other|0|||
147267612|NCT00404352|531151812|FG005|Double Blind (up to 24 Month)|Other|0|||
147267613|NCT00404352|531151813|FG006|Double Blind (up to 24 Month)|Other|0|||
147267614|NCT00404352|531151814|FG007|Double Blind (up to 24 Month)|Other|0|||
147267615|NCT00404352|531151815|FG008|Double Blind (up to 24 Month)|Other|0|||
147267616|NCT00404352|531151807|FG000|Open Label (up to 24 Month)|Adverse Event|0|||
147267617|NCT00404352|531151808|FG001|Open Label (up to 24 Month)|Adverse Event|0|||
147333166|NCT01212757|531385643|FG005|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0|||
147333167|NCT01212757|531385644|FG006|Long-Term Safety Phase (Year 4)|Lack of Efficacy|0|||
147267618|NCT00404352|531151809|FG002|Open Label (up to 24 Month)|Adverse Event|0|||
147267619|NCT00404352|531151810|FG003|Open Label (up to 24 Month)|Adverse Event|2|||
147267620|NCT00404352|531151811|FG004|Open Label (up to 24 Month)|Adverse Event|1|||
147267621|NCT00404352|531151812|FG005|Open Label (up to 24 Month)|Adverse Event|1|||
147267622|NCT00404352|531151813|FG006|Open Label (up to 24 Month)|Adverse Event|0|||
147267623|NCT00404352|531151814|FG007|Open Label (up to 24 Month)|Adverse Event|0|||
147267624|NCT00404352|531151815|FG008|Open Label (up to 24 Month)|Adverse Event|0|||
147267625|NCT00404352|531151807|FG000|Open Label (up to 24 Month)|Pregnancy|0|||
147267626|NCT00404352|531151808|FG001|Open Label (up to 24 Month)|Pregnancy|0|||
147267627|NCT00404352|531151809|FG002|Open Label (up to 24 Month)|Pregnancy|0|||
147267628|NCT00404352|531151810|FG003|Open Label (up to 24 Month)|Pregnancy|0|||
147267629|NCT00404352|531151811|FG004|Open Label (up to 24 Month)|Pregnancy|0|||
147267630|NCT00404352|531151812|FG005|Open Label (up to 24 Month)|Pregnancy|1|||
147267631|NCT00404352|531151813|FG006|Open Label (up to 24 Month)|Pregnancy|0|||
147267632|NCT00404352|531151814|FG007|Open Label (up to 24 Month)|Pregnancy|0|||
147267633|NCT00404352|531151815|FG008|Open Label (up to 24 Month)|Pregnancy|0|||
147267634|NCT00404352|531151807|FG000|Open Label (up to 24 Month)|Lost to Follow-up|0|||
147267635|NCT00404352|531151808|FG001|Open Label (up to 24 Month)|Lost to Follow-up|0|||
147267636|NCT00404352|531151809|FG002|Open Label (up to 24 Month)|Lost to Follow-up|0|||
147267637|NCT00404352|531151810|FG003|Open Label (up to 24 Month)|Lost to Follow-up|0|||
147267638|NCT00404352|531151811|FG004|Open Label (up to 24 Month)|Lost to Follow-up|1|||
147267639|NCT00404352|531151812|FG005|Open Label (up to 24 Month)|Lost to Follow-up|0|||
147267640|NCT00404352|531151813|FG006|Open Label (up to 24 Month)|Lost to Follow-up|0|||
147267641|NCT00404352|531151814|FG007|Open Label (up to 24 Month)|Lost to Follow-up|0|||
147267642|NCT00404352|531151815|FG008|Open Label (up to 24 Month)|Lost to Follow-up|0|||
147267643|NCT00404352|531151807|FG000|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
147267644|NCT00404352|531151808|FG001|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
147267645|NCT00404352|531151809|FG002|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
147267646|NCT00404352|531151810|FG003|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
147267647|NCT00404352|531151811|FG004|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
147267648|NCT00404352|531151812|FG005|Open Label (up to 24 Month)|Withdrawal by Subject|5|||
147267649|NCT00404352|531151813|FG006|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
147267650|NCT00404352|531151814|FG007|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
147267651|NCT00404352|531151815|FG008|Open Label (up to 24 Month)|Withdrawal by Subject|0|||
147267652|NCT00404352|531151807|FG000|Open Label (up to 24 Month)|Disease progression|0|||
147267653|NCT00404352|531151808|FG001|Open Label (up to 24 Month)|Disease progression|0|||
147267654|NCT00404352|531151809|FG002|Open Label (up to 24 Month)|Disease progression|0|||
147267655|NCT00404352|531151810|FG003|Open Label (up to 24 Month)|Disease progression|1|||
147267656|NCT00404352|531151811|FG004|Open Label (up to 24 Month)|Disease progression|0|||
147267657|NCT00404352|531151812|FG005|Open Label (up to 24 Month)|Disease progression|0|||
147267658|NCT00404352|531151813|FG006|Open Label (up to 24 Month)|Disease progression|0|||
147267659|NCT00404352|531151814|FG007|Open Label (up to 24 Month)|Disease progression|0|||
147267660|NCT00404352|531151815|FG008|Open Label (up to 24 Month)|Disease progression|0|||
147267661|NCT00404352|531151807|FG000|Open Label Extension (up to 36 Months)|Adverse Event|0|||
147267662|NCT00404352|531151808|FG001|Open Label Extension (up to 36 Months)|Adverse Event|0|||
147267663|NCT00404352|531151809|FG002|Open Label Extension (up to 36 Months)|Adverse Event|0|||
147267664|NCT00404352|531151810|FG003|Open Label Extension (up to 36 Months)|Adverse Event|0|||
147267665|NCT00404352|531151811|FG004|Open Label Extension (up to 36 Months)|Adverse Event|0|||
147267666|NCT00404352|531151812|FG005|Open Label Extension (up to 36 Months)|Adverse Event|0|||
147267667|NCT00404352|531151813|FG006|Open Label Extension (up to 36 Months)|Adverse Event|1|||
147267668|NCT00404352|531151814|FG007|Open Label Extension (up to 36 Months)|Adverse Event|1|||
147267669|NCT00404352|531151815|FG008|Open Label Extension (up to 36 Months)|Adverse Event|0|||
147267670|NCT00404352|531151807|FG000|Open Label Extension (up to 36 Months)|Other|0|||
147267671|NCT00404352|531151808|FG001|Open Label Extension (up to 36 Months)|Other|0|||
147600243|NCT01739348|532356345|FG003|Part II (Extension Study)|Study Terminated by Sponsor|323|||
147600244|NCT01739348|532356342|FG000|Part II (Extension Study)|Participant Moved|3|||
147600245|NCT01739348|532356343|FG001|Part II (Extension Study)|Participant Moved|3|||
147600246|NCT01739348|532356344|FG002|Part II (Extension Study)|Participant Moved|0|||
147600247|NCT01739348|532356345|FG003|Part II (Extension Study)|Participant Moved|3|||
147600248|NCT01739348|532356342|FG000|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|18|||
147267672|NCT00404352|531151809|FG002|Open Label Extension (up to 36 Months)|Other|0|||
147267673|NCT00404352|531151810|FG003|Open Label Extension (up to 36 Months)|Other|0|||
147267674|NCT00404352|531151811|FG004|Open Label Extension (up to 36 Months)|Other|0|||
147267675|NCT00404352|531151812|FG005|Open Label Extension (up to 36 Months)|Other|0|||
147267676|NCT00404352|531151813|FG006|Open Label Extension (up to 36 Months)|Other|0|||
147267677|NCT00404352|531151814|FG007|Open Label Extension (up to 36 Months)|Other|0|||
147267678|NCT00404352|531151815|FG008|Open Label Extension (up to 36 Months)|Other|2|||
147267679|NCT04370691|531151816|FG000|Overall Study|Pending visit|48|||
147333168|NCT01212757|531385645|FG007|Long-Term Safety Phase (Year 4)|Lack of Efficacy|1|||
147267680|NCT04370691|531151816|FG000|Overall Study|Have Not Reached Lower Window|15|||
147267681|NCT04370691|531151816|FG000|Overall Study|Termination|14|||
147267682|NCT04370691|531151816|FG000|Overall Study|Missed or Overdue|10|||
147267683|NCT00606892|531151822|FG000|First Intervention|Protocol Violation|1|||
147267684|NCT00606892|531151823|FG001|First Intervention|Protocol Violation|4|||
147333169|NCT01212757|531385646|FG008|Long-Term Safety Phase (Year 4)|Lack of Efficacy|1|||
147267685|NCT04334460|531151836|FG000|Full Analysis Set (FAS)|Patients did not receive any study drug & are therefore excluded from the FAS.|4|||
147267686|NCT04334460|531151837|FG001|Full Analysis Set (FAS)|Patients did not receive any study drug & are therefore excluded from the FAS.|1|||
147267687|NCT04334460|531151836|FG000|Safety Analysis Population|Patients did not receive any study drug & are therefore excluded from the Safety analysis set.|4|||
147267688|NCT04334460|531151837|FG001|Safety Analysis Population|Patients did not receive any study drug & are therefore excluded from the Safety analysis set.|1|||
147267689|NCT03778931|531151838|FG000|Overall Study|Withdrawal by Subject|12|||
147267690|NCT03778931|531151839|FG001|Overall Study|Withdrawal by Subject|25|||
147267691|NCT03778931|531151838|FG000|Overall Study|Physician Decision|1|||
147267692|NCT03778931|531151839|FG001|Overall Study|Physician Decision|3|||
147267693|NCT03778931|531151838|FG000|Overall Study|Participant Noncompliance|1|||
147267694|NCT03778931|531151839|FG001|Overall Study|Participant Noncompliance|1|||
147267695|NCT03778931|531151838|FG000|Overall Study|Lost to Follow-up|4|||
147267696|NCT03778931|531151839|FG001|Overall Study|Lost to Follow-up|1|||
147267697|NCT03778931|531151838|FG000|Overall Study|Death|69|||
147267698|NCT03778931|531151839|FG001|Overall Study|Death|79|||
147267699|NCT02970968|531153444|FG000|Overall Study|Withdrawal by Subject|3|||
147267700|NCT02970968|531153445|FG001|Overall Study|Withdrawal by Subject|3|||
147267701|NCT02970968|531153444|FG000|Overall Study|Adverse Event|1|||
147267702|NCT02970968|531153445|FG001|Overall Study|Adverse Event|2|||
147267703|NCT02970968|531153444|FG000|Overall Study|Lost to Follow-up|1|||
147267704|NCT02970968|531153445|FG001|Overall Study|Lost to Follow-up|1|||
147267705|NCT02970968|531153444|FG000|Overall Study|Non-Compliance|0|||
147267706|NCT02970968|531153445|FG001|Overall Study|Non-Compliance|1|||
147267707|NCT01904604|531153446|FG000|Overall Study|Withdrew before receiving dosing|0|||
147267708|NCT01904604|531153447|FG001|Overall Study|Withdrew before receiving dosing|1|||
147267709|NCT01904604|531153448|FG002|Overall Study|Withdrew before receiving dosing|0|||
147267710|NCT01904604|531153446|FG000|Overall Study|Non-compliance|1|||
147267711|NCT01904604|531153447|FG001|Overall Study|Non-compliance|0|||
147267712|NCT01904604|531153448|FG002|Overall Study|Non-compliance|0|||
147267713|NCT01904604|531153446|FG000|Overall Study|Anxiety about OFC/Refused OFC|2|||
147267714|NCT01904604|531153447|FG001|Overall Study|Anxiety about OFC/Refused OFC|0|||
147267715|NCT01904604|531153448|FG002|Overall Study|Anxiety about OFC/Refused OFC|0|||
147267716|NCT01904604|531153446|FG000|Overall Study|Patch site reactions|1|||
147267717|NCT01904604|531153447|FG001|Overall Study|Patch site reactions|1|||
147267718|NCT01904604|531153448|FG002|Overall Study|Patch site reactions|0|||
147333170|NCT01212757|531385638|FG000|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0|||
147333171|NCT01212757|531385639|FG001|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|4|||
147333172|NCT01212757|531385640|FG002|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|2|||
147333173|NCT01212757|531385641|FG003|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0|||
147333174|NCT01212757|531385642|FG004|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0|||
147333175|NCT01212757|531385643|FG005|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0|||
147333176|NCT01212757|531385644|FG006|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|0|||
147267719|NCT01904604|531153446|FG000|Overall Study|Increased syncope|0|||
147267720|NCT01904604|531153447|FG001|Overall Study|Increased syncope|1|||
147267721|NCT01904604|531153448|FG002|Overall Study|Increased syncope|0|||
147267722|NCT01904604|531153446|FG000|Overall Study|Unrelated illness|0|||
147267723|NCT01904604|531153447|FG001|Overall Study|Unrelated illness|1|||
147267724|NCT01904604|531153448|FG002|Overall Study|Unrelated illness|0|||
147267725|NCT01904604|531153446|FG000|Overall Study|Passed Week 52 OFC|1|||
147267726|NCT01904604|531153447|FG001|Overall Study|Passed Week 52 OFC|0|||
147267727|NCT01904604|531153448|FG002|Overall Study|Passed Week 52 OFC|0|||
147267728|NCT01904604|531153446|FG000|Overall Study|Withdrawal by Subject|1|||
147267729|NCT01904604|531153447|FG001|Overall Study|Withdrawal by Subject|2|||
147267730|NCT01904604|531153448|FG002|Overall Study|Withdrawal by Subject|0|||
147267731|NCT01904604|531153446|FG000|Overall Study|Participant Relocated|1|||
147267732|NCT01904604|531153447|FG001|Overall Study|Participant Relocated|1|||
147267733|NCT01904604|531153448|FG002|Overall Study|Participant Relocated|1|||
147267734|NCT01904604|531153446|FG000|Overall Study|Lost to Follow-up|0|||
147267735|NCT01904604|531153447|FG001|Overall Study|Lost to Follow-up|0|||
147267736|NCT01904604|531153448|FG002|Overall Study|Lost to Follow-up|1|||
147267737|NCT00697346|531153451|FG000|Overall Study|Adverse Event|4|||
147267738|NCT00697346|531153452|FG001|Overall Study|Adverse Event|5|||
147267739|NCT00697346|531153453|FG002|Overall Study|Adverse Event|0|||
147267740|NCT00697346|531153451|FG000|Overall Study|Progressive Disease|19|||
147267741|NCT00697346|531153452|FG001|Overall Study|Progressive Disease|18|||
147267742|NCT00697346|531153453|FG002|Overall Study|Progressive Disease|0|||
147267743|NCT00697346|531153451|FG000|Overall Study|Symptomatic Deterioration|0|||
147267744|NCT00697346|531153452|FG001|Overall Study|Symptomatic Deterioration|1|||
147267745|NCT00697346|531153453|FG002|Overall Study|Symptomatic Deterioration|0|||
147267746|NCT00697346|531153451|FG000|Overall Study|Withdrawal by Subject|2|||
147267747|NCT00697346|531153452|FG001|Overall Study|Withdrawal by Subject|2|||
147267748|NCT00697346|531153453|FG002|Overall Study|Withdrawal by Subject|0|||
147267749|NCT00697346|531153451|FG000|Overall Study|Reason not Specified|3|||
147267750|NCT00697346|531153452|FG001|Overall Study|Reason not Specified|0|||
147267751|NCT00697346|531153453|FG002|Overall Study|Reason not Specified|1|||
147267752|NCT03569371|531153454|FG000|Overall Study|Lack of Efficacy|1|||
147267753|NCT03569371|531153454|FG000|Overall Study|Lost to Follow-up|1|||
147267754|NCT03569371|531153454|FG000|Overall Study|Adverse Event|1|||
147267755|NCT03643562|531153455|FG000|Overall Study|Adverse Event|1|||
147267756|NCT03643562|531153456|FG001|Overall Study|Adverse Event|0|||
147267757|NCT03643562|531153455|FG000|Overall Study|Lack of Efficacy|0|||
147267758|NCT03643562|531153456|FG001|Overall Study|Lack of Efficacy|1|||
147267759|NCT03643562|531153455|FG000|Overall Study|Physician Decision|0|||
147267760|NCT03643562|531153456|FG001|Overall Study|Physician Decision|1|||
147267761|NCT03643562|531153455|FG000|Overall Study|Study Terminated by Sponsor|2|||
147267762|NCT03643562|531153456|FG001|Overall Study|Study Terminated by Sponsor|10|||
147267763|NCT03643562|531153455|FG000|Overall Study|Withdrawal by Subject|2|||
147267764|NCT03643562|531153456|FG001|Overall Study|Withdrawal by Subject|2|||
147267765|NCT03643562|531153455|FG000|Overall Study|Other than specified|3|||
147267766|NCT03643562|531153456|FG001|Overall Study|Other than specified|2|||
147267767|NCT04145895|531153457|FG000|Overall Study|Physician Decision|2|||
147267768|NCT04145895|531153458|FG001|Overall Study|Physician Decision|0|||
147267769|NCT04145895|531153457|FG000|Overall Study|Withdrawal by Subject|0|||
147267770|NCT04145895|531153458|FG001|Overall Study|Withdrawal by Subject|2|||
147267771|NCT01236755|531153459|FG000|Spectacles Wearing Phase|Withdrawal by Subject|8|||
147267772|NCT01236755|531153459|FG000|Spectacles Wearing Phase|Lost to Follow-up|9|||
147267773|NCT01236755|531153459|FG000|Orthokeratology Wearing Phase|Withdrawal by Subject|5|||
147267774|NCT01236755|531153459|FG000|Orthokeratology Wearing Phase|Poor Refractive Correction / Centration|3|||
147267775|NCT01481116|531153460|FG000|Overall Study|Adverse Event|26|||
147267776|NCT01481116|531153461|FG001|Overall Study|Adverse Event|26|||
147267777|NCT01481116|531153462|FG002|Overall Study|Adverse Event|42|||
147267778|NCT01481116|531153460|FG000|Overall Study|Major Protocol Deviation|3|||
147267779|NCT01481116|531153461|FG001|Overall Study|Major Protocol Deviation|7|||
147267780|NCT01481116|531153462|FG002|Overall Study|Major Protocol Deviation|1|||
147267781|NCT01481116|531153460|FG000|Overall Study|Lost to Follow-up|8|||
147267782|NCT01481116|531153461|FG001|Overall Study|Lost to Follow-up|12|||
147267783|NCT01481116|531153462|FG002|Overall Study|Lost to Follow-up|11|||
147267784|NCT01481116|531153460|FG000|Overall Study|Withdrawal by Subject|37|||
147267785|NCT01481116|531153461|FG001|Overall Study|Withdrawal by Subject|33|||
147267786|NCT01481116|531153462|FG002|Overall Study|Withdrawal by Subject|37|||
147267787|NCT01481116|531153460|FG000|Overall Study|Study Termination|730|||
147267788|NCT01481116|531153461|FG001|Overall Study|Study Termination|729|||
147267789|NCT01481116|531153462|FG002|Overall Study|Study Termination|713|||
147267790|NCT01481116|531153460|FG000|Overall Study|Pregnancy|0|||
147267791|NCT01481116|531153461|FG001|Overall Study|Pregnancy|0|||
147267792|NCT01481116|531153462|FG002|Overall Study|Pregnancy|1|||
147267793|NCT01481116|531153460|FG000|Overall Study|Lack of Efficacy|3|||
147267794|NCT01481116|531153461|FG001|Overall Study|Lack of Efficacy|3|||
147267795|NCT01481116|531153462|FG002|Overall Study|Lack of Efficacy|1|||
147267796|NCT01481116|531153460|FG000|Overall Study|Contraindications|1|||
147267797|NCT01481116|531153461|FG001|Overall Study|Contraindications|1|||
147267798|NCT01481116|531153462|FG002|Overall Study|Contraindications|0|||
147267799|NCT01481116|531153460|FG000|Overall Study|Other|1|||
147267800|NCT01481116|531153461|FG001|Overall Study|Other|1|||
147267801|NCT01481116|531153462|FG002|Overall Study|Other|0|||
147267802|NCT01481116|531153460|FG000|Overall Study|Participant Started Taking Glipizide|1|||
147267803|NCT01481116|531153461|FG001|Overall Study|Participant Started Taking Glipizide|0|||
147450267|NCT03016325|531811399|FG000|32-Day Follow-Up Period|Poor/non-compliance|1|||
147450268|NCT03016325|531811400|FG001|32-Day Follow-Up Period|Poor/non-compliance|0|||
147267804|NCT01481116|531153462|FG002|Overall Study|Participant Started Taking Glipizide|0|||
147267805|NCT01481116|531153460|FG000|Overall Study|Participant Moved Out of Area|2|||
147267806|NCT01481116|531153461|FG001|Overall Study|Participant Moved Out of Area|0|||
147267807|NCT01481116|531153462|FG002|Overall Study|Participant Moved Out of Area|1|||
147267808|NCT01481116|531153460|FG000|Overall Study|Participant Moved Out of Country|1|||
147267809|NCT01481116|531153461|FG001|Overall Study|Participant Moved Out of Country|0|||
147267810|NCT01481116|531153462|FG002|Overall Study|Participant Moved Out of Country|1|||
147450269|NCT03016325|531811401|FG002|32-Day Follow-Up Period|Poor/non-compliance|0|||
147267811|NCT01481116|531153460|FG000|Overall Study|Investigator Decision|3|||
147267812|NCT01481116|531153461|FG001|Overall Study|Investigator Decision|2|||
147267813|NCT01481116|531153462|FG002|Overall Study|Investigator Decision|1|||
147267814|NCT01481116|531153460|FG000|Overall Study|Sponsor Decision|0|||
147267815|NCT01481116|531153461|FG001|Overall Study|Sponsor Decision|1|||
147267816|NCT01481116|531153462|FG002|Overall Study|Sponsor Decision|3|||
147267817|NCT01481116|531153460|FG000|Overall Study|Non-Compliant With Study Drug|0|||
147267818|NCT01481116|531153461|FG001|Overall Study|Non-Compliant With Study Drug|1|||
147267819|NCT01481116|531153462|FG002|Overall Study|Non-Compliant With Study Drug|1|||
147267820|NCT01481116|531153460|FG000|Overall Study|Investigator's Discretion|2|||
147267821|NCT01481116|531153461|FG001|Overall Study|Investigator's Discretion|0|||
147267822|NCT01481116|531153462|FG002|Overall Study|Investigator's Discretion|0|||
147267823|NCT01481116|531153460|FG000|Overall Study|Death|2|||
147267824|NCT01481116|531153461|FG001|Overall Study|Death|1|||
147267825|NCT01481116|531153462|FG002|Overall Study|Death|0|||
147267826|NCT01481116|531153460|FG000|Overall Study|Hypoglycemic Event|4|||
147267827|NCT01481116|531153461|FG001|Overall Study|Hypoglycemic Event|0|||
147267828|NCT01481116|531153462|FG002|Overall Study|Hypoglycemic Event|0|||
147267829|NCT00805935|531153463|FG000|Overall Study|Stimulation Failure|1|||
147267830|NCT00805935|531153464|FG001|Overall Study|Stimulation Failure|5|||
147267831|NCT00805935|531153465|FG002|Overall Study|Stimulation Failure|2|||
147267832|NCT00805935|531153466|FG003|Overall Study|Stimulation Failure|2|||
147267833|NCT00805935|531153463|FG000|Overall Study|Cycle cancelled|0|||
147267834|NCT00805935|531153464|FG001|Overall Study|Cycle cancelled|0|||
147267835|NCT00805935|531153465|FG002|Overall Study|Cycle cancelled|2|||
147267836|NCT00805935|531153466|FG003|Overall Study|Cycle cancelled|0|||
147267837|NCT00805935|531153463|FG000|Overall Study|Cycle cancellation for risk of OHSS|1|||
147267838|NCT00805935|531153464|FG001|Overall Study|Cycle cancellation for risk of OHSS|0|||
147267839|NCT00805935|531153465|FG002|Overall Study|Cycle cancellation for risk of OHSS|1|||
147267840|NCT00805935|531153466|FG003|Overall Study|Cycle cancellation for risk of OHSS|0|||
147267841|NCT00805935|531153463|FG000|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|0|||
147267842|NCT00805935|531153464|FG001|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|0|||
147267843|NCT00805935|531153465|FG002|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|0|||
147267844|NCT00805935|531153466|FG003|Overall Study|Ovarian hyperstimulation syndrome(OHSS)|1|||
147267845|NCT00805935|531153463|FG000|Overall Study|Lost to Follow-up|1|||
147267846|NCT00805935|531153464|FG001|Overall Study|Lost to Follow-up|0|||
147267847|NCT00805935|531153465|FG002|Overall Study|Lost to Follow-up|0|||
147267848|NCT00805935|531153466|FG003|Overall Study|Lost to Follow-up|0|||
147267849|NCT00805935|531153463|FG000|Overall Study|No positive serum pregnancy|8|||
147267850|NCT00805935|531153464|FG001|Overall Study|No positive serum pregnancy|7|||
147267851|NCT00805935|531153465|FG002|Overall Study|No positive serum pregnancy|6|||
147267852|NCT00805935|531153466|FG003|Overall Study|No positive serum pregnancy|5|||
147267853|NCT00805935|531153463|FG000|Overall Study|Pregnancy not confirmed by ultrasound|0|||
147267854|NCT00805935|531153464|FG001|Overall Study|Pregnancy not confirmed by ultrasound|0|||
147267855|NCT00805935|531153465|FG002|Overall Study|Pregnancy not confirmed by ultrasound|0|||
147267856|NCT00805935|531153466|FG003|Overall Study|Pregnancy not confirmed by ultrasound|1|||
147267857|NCT00805935|531153463|FG000|Overall Study|Pregnancy loss/miscarriage|2|||
147267858|NCT00805935|531153464|FG001|Overall Study|Pregnancy loss/miscarriage|0|||
147267859|NCT00805935|531153465|FG002|Overall Study|Pregnancy loss/miscarriage|0|||
147267860|NCT00805935|531153466|FG003|Overall Study|Pregnancy loss/miscarriage|0|||
147267861|NCT00805935|531153463|FG000|Overall Study|Biochemical pregnancy|0|||
147267862|NCT00805935|531153464|FG001|Overall Study|Biochemical pregnancy|1|||
147267863|NCT00805935|531153465|FG002|Overall Study|Biochemical pregnancy|0|||
147267864|NCT00805935|531153466|FG003|Overall Study|Biochemical pregnancy|0|||
147267865|NCT00805935|531153463|FG000|Overall Study|Chemical pregnancy|0|||
147267866|NCT00805935|531153464|FG001|Overall Study|Chemical pregnancy|5|||
147267867|NCT00805935|531153465|FG002|Overall Study|Chemical pregnancy|3|||
147267868|NCT00805935|531153466|FG003|Overall Study|Chemical pregnancy|2|||
147267869|NCT00805935|531153463|FG000|Overall Study|Ectopic pregnancy|0|||
147267870|NCT00805935|531153464|FG001|Overall Study|Ectopic pregnancy|0|||
147267871|NCT00805935|531153465|FG002|Overall Study|Ectopic pregnancy|1|||
147267872|NCT00805935|531153466|FG003|Overall Study|Ectopic pregnancy|0|||
147267873|NCT00805935|531153463|FG000|Overall Study|Serious Adverse Event-congenital anomaly|0|||
147267874|NCT00805935|531153464|FG001|Overall Study|Serious Adverse Event-congenital anomaly|1|||
147267875|NCT00805935|531153465|FG002|Overall Study|Serious Adverse Event-congenital anomaly|0|||
147267876|NCT00805935|531153466|FG003|Overall Study|Serious Adverse Event-congenital anomaly|0|||
147267877|NCT03752619|531153474|FG000|Overall Study|Lost to Follow-up|2|||
147267878|NCT03752619|531153475|FG001|Overall Study|Lost to Follow-up|1|||
147267879|NCT03752619|531153474|FG000|Overall Study|Withdrawal by Subject|1|||
147267880|NCT03752619|531153475|FG001|Overall Study|Withdrawal by Subject|1|||
147267881|NCT03752619|531153474|FG000|Overall Study|Adverse Event|0|||
147267882|NCT03752619|531153475|FG001|Overall Study|Adverse Event|1|||
147267883|NCT05040152|531153476|FG000|Overall Study|Withdrawal by Subject|5|||
147267884|NCT05040152|531153477|FG001|Overall Study|Withdrawal by Subject|0|||
147267885|NCT05040152|531153476|FG000|Overall Study|Lost to Follow-up|0|||
147267886|NCT05040152|531153477|FG001|Overall Study|Lost to Follow-up|2|||
147267887|NCT03907683|531153478|FG000|Overall Study|Pregnancy|1|||
147267888|NCT03907683|531153478|FG000|Overall Study|Withdrawal by Subject|1|||
147267889|NCT03400332|531153479|FG000|Pre-Treatment|Other reasons|0|||
147267890|NCT03400332|531153480|FG001|Pre-Treatment|Other reasons|0|||
147267891|NCT03400332|531153481|FG002|Pre-Treatment|Other reasons|0|||
147267892|NCT03400332|531153482|FG003|Pre-Treatment|Other reasons|0|||
147267893|NCT03400332|531153483|FG004|Pre-Treatment|Other reasons|0|||
147267894|NCT03400332|531153484|FG005|Pre-Treatment|Other reasons|0|||
147267895|NCT03400332|531153485|FG006|Pre-Treatment|Other reasons|0|||
147267896|NCT03400332|531153486|FG007|Pre-Treatment|Other reasons|0|||
147267897|NCT03400332|531153487|FG008|Pre-Treatment|Other reasons|1|||
147267898|NCT03400332|531153479|FG000|Pre-Treatment|No longer met study criteria|0|||
147267899|NCT03400332|531153480|FG001|Pre-Treatment|No longer met study criteria|0|||
147333177|NCT01212757|531385645|FG007|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|1|||
147333178|NCT01212757|531385646|FG008|Long-Term Safety Phase (Year 4)|Withdrawal by Subject|3|||
147333179|NCT01212757|531385638|FG000|Long-Term Safety Phase (Year 4)|Death|0|||
147333180|NCT01212757|531385639|FG001|Long-Term Safety Phase (Year 4)|Death|0|||
147333181|NCT01212757|531385640|FG002|Long-Term Safety Phase (Year 4)|Death|1|||
147333182|NCT01212757|531385641|FG003|Long-Term Safety Phase (Year 4)|Death|0|||
147333183|NCT01212757|531385642|FG004|Long-Term Safety Phase (Year 4)|Death|0|||
147333184|NCT01212757|531385643|FG005|Long-Term Safety Phase (Year 4)|Death|0|||
147267900|NCT03400332|531153481|FG002|Pre-Treatment|No longer met study criteria|0|||
147267901|NCT03400332|531153482|FG003|Pre-Treatment|No longer met study criteria|0|||
147267902|NCT03400332|531153483|FG004|Pre-Treatment|No longer met study criteria|0|||
147267903|NCT03400332|531153484|FG005|Pre-Treatment|No longer met study criteria|0|||
147267904|NCT03400332|531153485|FG006|Pre-Treatment|No longer met study criteria|0|||
147267905|NCT03400332|531153486|FG007|Pre-Treatment|No longer met study criteria|0|||
147267906|NCT03400332|531153487|FG008|Pre-Treatment|No longer met study criteria|1|||
147267907|NCT03400332|531153479|FG000|Pre-Treatment|Withdrawal by Subject|0|||
147267908|NCT03400332|531153480|FG001|Pre-Treatment|Withdrawal by Subject|0|||
147267909|NCT03400332|531153481|FG002|Pre-Treatment|Withdrawal by Subject|0|||
147267910|NCT03400332|531153482|FG003|Pre-Treatment|Withdrawal by Subject|0|||
147267911|NCT03400332|531153483|FG004|Pre-Treatment|Withdrawal by Subject|0|||
147267912|NCT03400332|531153484|FG005|Pre-Treatment|Withdrawal by Subject|0|||
147267913|NCT03400332|531153485|FG006|Pre-Treatment|Withdrawal by Subject|0|||
147267914|NCT03400332|531153486|FG007|Pre-Treatment|Withdrawal by Subject|0|||
147267915|NCT03400332|531153487|FG008|Pre-Treatment|Withdrawal by Subject|1|||
147267916|NCT03400332|531153479|FG000|Treatment|Participant withdrew consent|2|||
147267917|NCT03400332|531153480|FG001|Treatment|Participant withdrew consent|2|||
147267918|NCT03400332|531153481|FG002|Treatment|Participant withdrew consent|0|||
147267919|NCT03400332|531153482|FG003|Treatment|Participant withdrew consent|0|||
147267920|NCT03400332|531153483|FG004|Treatment|Participant withdrew consent|3|||
147267921|NCT03400332|531153484|FG005|Treatment|Participant withdrew consent|3|||
147267922|NCT03400332|531153485|FG006|Treatment|Participant withdrew consent|1|||
147267923|NCT03400332|531153486|FG007|Treatment|Participant withdrew consent|1|||
147267924|NCT03400332|531153487|FG008|Treatment|Participant withdrew consent|1|||
147267925|NCT03400332|531153479|FG000|Treatment|Other reasons|0|||
147267926|NCT03400332|531153480|FG001|Treatment|Other reasons|1|||
147267927|NCT03400332|531153481|FG002|Treatment|Other reasons|1|||
147267928|NCT03400332|531153482|FG003|Treatment|Other reasons|0|||
147267929|NCT03400332|531153483|FG004|Treatment|Other reasons|3|||
147267930|NCT03400332|531153484|FG005|Treatment|Other reasons|1|||
147267931|NCT03400332|531153485|FG006|Treatment|Other reasons|2|||
147267932|NCT03400332|531153486|FG007|Treatment|Other reasons|0|||
147267933|NCT03400332|531153487|FG008|Treatment|Other reasons|1|||
147267934|NCT03400332|531153479|FG000|Treatment|Lost to Follow-up|0|||
147267935|NCT03400332|531153480|FG001|Treatment|Lost to Follow-up|1|||
147267936|NCT03400332|531153481|FG002|Treatment|Lost to Follow-up|0|||
147267937|NCT03400332|531153482|FG003|Treatment|Lost to Follow-up|0|||
147267938|NCT03400332|531153483|FG004|Treatment|Lost to Follow-up|0|||
147267939|NCT03400332|531153484|FG005|Treatment|Lost to Follow-up|0|||
147267940|NCT03400332|531153485|FG006|Treatment|Lost to Follow-up|0|||
147267941|NCT03400332|531153486|FG007|Treatment|Lost to Follow-up|0|||
147267942|NCT03400332|531153487|FG008|Treatment|Lost to Follow-up|0|||
147267943|NCT03400332|531153479|FG000|Treatment|Death|3|||
147267944|NCT03400332|531153480|FG001|Treatment|Death|1|||
147267945|NCT03400332|531153481|FG002|Treatment|Death|2|||
147267946|NCT03400332|531153482|FG003|Treatment|Death|3|||
147267947|NCT03400332|531153483|FG004|Treatment|Death|6|||
147267948|NCT03400332|531153484|FG005|Treatment|Death|2|||
147267949|NCT03400332|531153485|FG006|Treatment|Death|1|||
147267950|NCT03400332|531153486|FG007|Treatment|Death|3|||
147267951|NCT03400332|531153487|FG008|Treatment|Death|6|||
147267952|NCT02075840|531153490|FG000|Overall Study|Withdrawal by Subject|13|||
147267953|NCT02075840|531153491|FG001|Overall Study|Withdrawal by Subject|22|||
147267954|NCT02075840|531153490|FG000|Overall Study|Reason not specified|1|||
147267955|NCT02075840|531153491|FG001|Overall Study|Reason not specified|0|||
147267956|NCT02075840|531153490|FG000|Overall Study|Adverse Event|0|||
147267957|NCT02075840|531153491|FG001|Overall Study|Adverse Event|2|||
147267958|NCT02075840|531153490|FG000|Overall Study|Death|35|||
147267959|NCT02075840|531153491|FG001|Overall Study|Death|40|||
147267960|NCT02075840|531153490|FG000|Overall Study|Lost to Follow-up|3|||
147267961|NCT02075840|531153491|FG001|Overall Study|Lost to Follow-up|2|||
147267962|NCT02075840|531153490|FG000|Overall Study|Physician Decision|1|||
147267963|NCT02075840|531153491|FG001|Overall Study|Physician Decision|3|||
147267964|NCT02075840|531153490|FG000|Overall Study|Ongoing at CCOD|99|||
147267965|NCT02075840|531153491|FG001|Overall Study|Ongoing at CCOD|82|||
147267966|NCT03909165|531153494|FG000|Overall Study|Physician Decision|0|||
147267967|NCT03909165|531153495|FG001|Overall Study|Physician Decision|1|||
147267968|NCT03909165|531153496|FG002|Overall Study|Physician Decision|0|||
147267969|NCT03909165|531153497|FG003|Overall Study|Physician Decision|0|||
147267970|NCT03909165|531153498|FG004|Overall Study|Physician Decision|0|||
147333185|NCT01212757|531385644|FG006|Long-Term Safety Phase (Year 4)|Death|0|||
147267971|NCT03909165|531153494|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
147267972|NCT03909165|531153495|FG001|Overall Study|Randomized By Mistake Without Study Treatment|0|||
147267973|NCT03909165|531153496|FG002|Overall Study|Randomized By Mistake Without Study Treatment|0|||
147267974|NCT03909165|531153497|FG003|Overall Study|Randomized By Mistake Without Study Treatment|0|||
147267975|NCT03909165|531153498|FG004|Overall Study|Randomized By Mistake Without Study Treatment|1|||
147267976|NCT03909165|531153494|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
147267977|NCT03909165|531153495|FG001|Overall Study|Withdrawal By Parent/Guardian|2|||
147267978|NCT03909165|531153496|FG002|Overall Study|Withdrawal By Parent/Guardian|1|||
147267979|NCT03909165|531153497|FG003|Overall Study|Withdrawal By Parent/Guardian|1|||
147267980|NCT03909165|531153498|FG004|Overall Study|Withdrawal By Parent/Guardian|0|||
147267981|NCT03909165|531153494|FG000|Overall Study|Previous Drug Exposure|0|||
147267982|NCT03909165|531153495|FG001|Overall Study|Previous Drug Exposure|0|||
147267983|NCT03909165|531153496|FG002|Overall Study|Previous Drug Exposure|1|||
147267984|NCT03909165|531153497|FG003|Overall Study|Previous Drug Exposure|0|||
147267985|NCT03909165|531153498|FG004|Overall Study|Previous Drug Exposure|0|||
147267986|NCT03909165|531153494|FG000|Overall Study|Early Discharge|1|||
147267987|NCT03909165|531153495|FG001|Overall Study|Early Discharge|0|||
147267988|NCT03909165|531153496|FG002|Overall Study|Early Discharge|0|||
147267989|NCT03909165|531153497|FG003|Overall Study|Early Discharge|0|||
147267990|NCT03909165|531153498|FG004|Overall Study|Early Discharge|0|||
147267991|NCT00414661|531153499|FG000|Overall Study|Death|2|||
147267992|NCT00414661|531153500|FG001|Overall Study|Death|5|||
147267993|NCT00414661|531153501|FG002|Overall Study|Death|0|||
147267994|NCT00414661|531153502|FG003|Overall Study|Death|0|||
147267995|NCT00414661|531153499|FG000|Overall Study|Lost to Follow-up|1|||
147267996|NCT00414661|531153500|FG001|Overall Study|Lost to Follow-up|4|||
147267997|NCT00414661|531153501|FG002|Overall Study|Lost to Follow-up|0|||
147267998|NCT00414661|531153502|FG003|Overall Study|Lost to Follow-up|1|||
147267999|NCT00414661|531153499|FG000|Overall Study|Withdrawal by Subject|5|||
147268000|NCT00414661|531153500|FG001|Overall Study|Withdrawal by Subject|2|||
147268001|NCT00414661|531153501|FG002|Overall Study|Withdrawal by Subject|2|||
147268002|NCT00414661|531153502|FG003|Overall Study|Withdrawal by Subject|2|||
147268003|NCT00414661|531153499|FG000|Overall Study|Other|6|||
147268004|NCT00414661|531153500|FG001|Overall Study|Other|3|||
147268005|NCT00414661|531153501|FG002|Overall Study|Other|0|||
147268006|NCT00414661|531153502|FG003|Overall Study|Other|0|||
147268007|NCT02130765|531153506|FG000|Overall Study|Did not receive treatment|4|||
147268008|NCT02130765|531153507|FG001|Overall Study|Did not receive treatment|0|||
147268009|NCT02130765|531153508|FG002|Overall Study|Did not receive treatment|0|||
147268010|NCT02130765|531153509|FG003|Overall Study|Did not receive treatment|0|||
147268011|NCT03216850|531153519|FG000|Overall Study|Pre-analytical error|6|||
147268012|NCT01116232|531153520|FG000|Overall Study|Progressive diease|4|||
147268013|NCT03554291|531153521|FG000|Overall Study|Death|2|||
147268014|NCT03554291|531153522|FG001|Overall Study|Death|1|||
147268015|NCT03554291|531153521|FG000|Overall Study|Lost to Follow-up|1|||
147268016|NCT03554291|531153522|FG001|Overall Study|Lost to Follow-up|0|||
147268017|NCT03554291|531153521|FG000|Overall Study|Withdrawal by Subject|1|||
147600249|NCT01739348|532356343|FG001|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|12|||
147600250|NCT01739348|532356344|FG002|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|8|||
147600251|NCT01739348|532356345|FG003|Part II (Extension Study)|Trial Partner/Caregiver Withdrew Consent|16|||
147600252|NCT01739348|532356342|FG000|Part II (Extension Study)|Withdrawal by Subject|5|||
147600253|NCT01739348|532356343|FG001|Part II (Extension Study)|Withdrawal by Subject|2|||
147268018|NCT03554291|531153522|FG001|Overall Study|Withdrawal by Subject|0|||
147268019|NCT03554291|531153521|FG000|Overall Study|COVID Travel Restriction- Partial Data Collected|3|||
147268020|NCT03554291|531153522|FG001|Overall Study|COVID Travel Restriction- Partial Data Collected|0|||
147268021|NCT01398956|531153528|FG000|Overall Study|Withdrawal by Subject|4|||
147268022|NCT01398956|531153528|FG000|Overall Study|AE, non-serious non-fatal|4|||
147268023|NCT01398956|531153528|FG000|Overall Study|Withdrawal Criteria No.3|1|||
147268024|NCT01398956|531153528|FG000|Overall Study|Subject moved a long distance|1|||
147268025|NCT00451035|531153529|FG000|Overall Study|Disease progression|11|||
147333186|NCT01212757|531385645|FG007|Long-Term Safety Phase (Year 4)|Death|0|||
147268026|NCT00451035|531153529|FG000|Overall Study|Death|3|||
147268027|NCT00451035|531153529|FG000|Overall Study|New anti-neoplastic therapy|3|||
147268028|NCT03274986|531153530|FG000|Overall Study|Withdrawal by Subject|0|||
147268029|NCT03274986|531153531|FG001|Overall Study|Withdrawal by Subject|1|||
147268030|NCT03274986|531153530|FG000|Overall Study|Lost to Follow-up|0|||
147268031|NCT03274986|531153531|FG001|Overall Study|Lost to Follow-up|1|||
147268032|NCT00603746|531153532|FG000|Overall Study|Adverse Event|2|||
147268033|NCT00603746|531153533|FG001|Overall Study|Adverse Event|3|||
147268034|NCT00603746|531153534|FG002|Overall Study|Adverse Event|0|||
147268035|NCT00603746|531153535|FG003|Overall Study|Adverse Event|1|||
147268036|NCT00603746|531153536|FG004|Overall Study|Adverse Event|0|||
147268037|NCT00603746|531153537|FG005|Overall Study|Adverse Event|4|||
147268038|NCT00603746|531153532|FG000|Overall Study|Lack of Efficacy|34|||
147268039|NCT00603746|531153533|FG001|Overall Study|Lack of Efficacy|11|||
147268040|NCT00603746|531153534|FG002|Overall Study|Lack of Efficacy|6|||
147268041|NCT00603746|531153535|FG003|Overall Study|Lack of Efficacy|11|||
147268042|NCT00603746|531153536|FG004|Overall Study|Lack of Efficacy|12|||
147268043|NCT00603746|531153537|FG005|Overall Study|Lack of Efficacy|8|||
147268044|NCT00603746|531153532|FG000|Overall Study|Protocol Violation|0|||
147268045|NCT00603746|531153533|FG001|Overall Study|Protocol Violation|3|||
147268046|NCT00603746|531153534|FG002|Overall Study|Protocol Violation|1|||
147268047|NCT00603746|531153535|FG003|Overall Study|Protocol Violation|0|||
147268048|NCT00603746|531153536|FG004|Overall Study|Protocol Violation|1|||
147268049|NCT00603746|531153537|FG005|Overall Study|Protocol Violation|0|||
147268050|NCT00603746|531153532|FG000|Overall Study|Lost to Follow-up|0|||
147268051|NCT00603746|531153533|FG001|Overall Study|Lost to Follow-up|1|||
147268052|NCT00603746|531153534|FG002|Overall Study|Lost to Follow-up|1|||
147268053|NCT00603746|531153535|FG003|Overall Study|Lost to Follow-up|0|||
147268054|NCT00603746|531153536|FG004|Overall Study|Lost to Follow-up|0|||
147268055|NCT00603746|531153537|FG005|Overall Study|Lost to Follow-up|0|||
147268056|NCT00603746|531153532|FG000|Overall Study|Physician Decision|1|||
147268057|NCT00603746|531153533|FG001|Overall Study|Physician Decision|0|||
147268058|NCT00603746|531153534|FG002|Overall Study|Physician Decision|0|||
147268059|NCT00603746|531153535|FG003|Overall Study|Physician Decision|0|||
147268060|NCT00603746|531153536|FG004|Overall Study|Physician Decision|1|||
147268061|NCT00603746|531153537|FG005|Overall Study|Physician Decision|0|||
147268062|NCT00603746|531153532|FG000|Overall Study|Withdrawal by Subject|1|||
147268063|NCT00603746|531153533|FG001|Overall Study|Withdrawal by Subject|0|||
147268064|NCT00603746|531153534|FG002|Overall Study|Withdrawal by Subject|0|||
147268065|NCT00603746|531153535|FG003|Overall Study|Withdrawal by Subject|1|||
147268066|NCT00603746|531153536|FG004|Overall Study|Withdrawal by Subject|3|||
147268067|NCT00603746|531153537|FG005|Overall Study|Withdrawal by Subject|1|||
147268068|NCT01524627|531153540|FG000|Overall Study|Physician Decision|0|||
147268069|NCT01524627|531153541|FG001|Overall Study|Physician Decision|1|||
147268070|NCT01524627|531153540|FG000|Overall Study|Lost to Follow-up|1|||
147268071|NCT01524627|531153541|FG001|Overall Study|Lost to Follow-up|1|||
147268072|NCT00969553|531153542|FG000|Overall Study|Progressive disease (PD)|2|||
147268073|NCT00969553|531153543|FG001|Overall Study|Progressive disease (PD)|2|||
147268074|NCT00969553|531153544|FG002|Overall Study|Progressive disease (PD)|6|||
147268075|NCT00969553|531153545|FG003|Overall Study|Progressive disease (PD)|9|||
147268076|NCT00969553|531153546|FG004|Overall Study|Progressive disease (PD)|2|||
147268077|NCT00969553|531153547|FG005|Overall Study|Progressive disease (PD)|4|||
147268078|NCT00969553|531153548|FG006|Overall Study|Progressive disease (PD)|2|||
147268079|NCT00969553|531153549|FG007|Overall Study|Progressive disease (PD)|12|||
147268080|NCT00969553|531153550|FG008|Overall Study|Progressive disease (PD)|3|||
147268081|NCT00969553|531153542|FG000|Overall Study|Dose limiting Toxicity (DLT)|0|||
147268082|NCT00969553|531153543|FG001|Overall Study|Dose limiting Toxicity (DLT)|0|||
147268083|NCT00969553|531153544|FG002|Overall Study|Dose limiting Toxicity (DLT)|0|||
147268084|NCT00969553|531153545|FG003|Overall Study|Dose limiting Toxicity (DLT)|0|||
147268085|NCT00969553|531153546|FG004|Overall Study|Dose limiting Toxicity (DLT)|1|||
147268086|NCT00969553|531153547|FG005|Overall Study|Dose limiting Toxicity (DLT)|0|||
147268087|NCT00969553|531153548|FG006|Overall Study|Dose limiting Toxicity (DLT)|0|||
147268088|NCT00969553|531153549|FG007|Overall Study|Dose limiting Toxicity (DLT)|0|||
147268089|NCT00969553|531153550|FG008|Overall Study|Dose limiting Toxicity (DLT)|0|||
147268090|NCT00969553|531153542|FG000|Overall Study|Other Adverse Event|0|||
147268091|NCT00969553|531153543|FG001|Overall Study|Other Adverse Event|0|||
147268092|NCT00969553|531153544|FG002|Overall Study|Other Adverse Event|0|||
147268093|NCT00969553|531153545|FG003|Overall Study|Other Adverse Event|1|||
147268094|NCT00969553|531153546|FG004|Overall Study|Other Adverse Event|0|||
147268095|NCT00969553|531153547|FG005|Overall Study|Other Adverse Event|0|||
147268096|NCT00969553|531153548|FG006|Overall Study|Other Adverse Event|1|||
147268097|NCT00969553|531153549|FG007|Overall Study|Other Adverse Event|0|||
147268098|NCT00969553|531153550|FG008|Overall Study|Other Adverse Event|0|||
147268099|NCT00969553|531153542|FG000|Overall Study|Refused cont. medication|1|||
147268100|NCT00969553|531153543|FG001|Overall Study|Refused cont. medication|1|||
147268101|NCT00969553|531153544|FG002|Overall Study|Refused cont. medication|0|||
147268102|NCT00969553|531153545|FG003|Overall Study|Refused cont. medication|2|||
147268103|NCT00969553|531153546|FG004|Overall Study|Refused cont. medication|0|||
147268104|NCT00969553|531153547|FG005|Overall Study|Refused cont. medication|0|||
147268105|NCT00969553|531153548|FG006|Overall Study|Refused cont. medication|0|||
147268106|NCT00969553|531153549|FG007|Overall Study|Refused cont. medication|1|||
147268107|NCT00969553|531153550|FG008|Overall Study|Refused cont. medication|0|||
147268108|NCT00969553|531153542|FG000|Overall Study|Not specified above|0|||
147268109|NCT00969553|531153543|FG001|Overall Study|Not specified above|0|||
147268110|NCT00969553|531153544|FG002|Overall Study|Not specified above|0|||
147268111|NCT00969553|531153545|FG003|Overall Study|Not specified above|4|||
147268112|NCT00969553|531153546|FG004|Overall Study|Not specified above|0|||
147268113|NCT00969553|531153547|FG005|Overall Study|Not specified above|0|||
147268114|NCT00969553|531153548|FG006|Overall Study|Not specified above|1|||
147268115|NCT00969553|531153549|FG007|Overall Study|Not specified above|1|||
147268116|NCT00969553|531153550|FG008|Overall Study|Not specified above|0|||
147268117|NCT00717769|531153551|FG000|Overall Study|Adverse Event|9|||
147268118|NCT00717769|531153552|FG001|Overall Study|Adverse Event|6|||
147268119|NCT00717769|531153553|FG002|Overall Study|Adverse Event|1|||
147268120|NCT00717769|531153551|FG000|Overall Study|Lack of compliance|0|||
147268121|NCT00717769|531153552|FG001|Overall Study|Lack of compliance|2|||
147268122|NCT00717769|531153553|FG002|Overall Study|Lack of compliance|0|||
147268123|NCT00717769|531153551|FG000|Overall Study|Lost to Follow-up|3|||
147268124|NCT00717769|531153552|FG001|Overall Study|Lost to Follow-up|4|||
147268125|NCT00717769|531153553|FG002|Overall Study|Lost to Follow-up|0|||
147268126|NCT00717769|531153551|FG000|Overall Study|Lack of Efficacy|1|||
147268127|NCT00717769|531153552|FG001|Overall Study|Lack of Efficacy|2|||
147268128|NCT00717769|531153553|FG002|Overall Study|Lack of Efficacy|0|||
147268129|NCT00717769|531153551|FG000|Overall Study|Protocol Violation|0|||
147268130|NCT00717769|531153552|FG001|Overall Study|Protocol Violation|2|||
147268131|NCT00717769|531153553|FG002|Overall Study|Protocol Violation|0|||
147268132|NCT00717769|531153551|FG000|Overall Study|Sponsor decision|1|||
147268133|NCT00717769|531153552|FG001|Overall Study|Sponsor decision|0|||
147268134|NCT00717769|531153553|FG002|Overall Study|Sponsor decision|10|||
147268135|NCT00717769|531153551|FG000|Overall Study|Withdrew consent|2|||
147268136|NCT00717769|531153552|FG001|Overall Study|Withdrew consent|2|||
147268137|NCT00717769|531153553|FG002|Overall Study|Withdrew consent|0|||
147268138|NCT03350503|531153559|FG000|Overall Study|Adverse Event|5|||
147268139|NCT03350503|531153559|FG000|Overall Study|Withdrawal by Subject|5|||
147268140|NCT03350503|531153559|FG000|Overall Study|Continuation impossible due to move|4|||
147268141|NCT03350503|531153559|FG000|Overall Study|Physician Decision|3|||
147268142|NCT03829046|531153562|FG000|Overall Study|Withdrawal by Subject|1|||
147268143|NCT03829046|531153563|FG001|Overall Study|Withdrawal by Subject|0|||
147268144|NCT01399593|531153565|FG000|Overall Study|Physician Decision|1|||
147268145|NCT01399593|531153566|FG001|Overall Study|Physician Decision|0|||
147268146|NCT01399593|531153565|FG000|Overall Study|Adverse Event|1|||
147268147|NCT01399593|531153566|FG001|Overall Study|Adverse Event|0|||
147268148|NCT01399593|531153565|FG000|Overall Study|Death|1|||
147268149|NCT01399593|531153566|FG001|Overall Study|Death|1|||
147268150|NCT01399593|531153565|FG000|Overall Study|Transplantectomy|0|||
147268151|NCT01399593|531153566|FG001|Overall Study|Transplantectomy|1|||
147268152|NCT02357147|531153569|FG000|Combination Treatment Phase|Progressive Disease (Radiographic test)|3|||
147268153|NCT02357147|531153570|FG001|Combination Treatment Phase|Progressive Disease (Radiographic test)|3|||
147268154|NCT02357147|531153569|FG000|Combination Treatment Phase|Progressive Disease(Clinical assessment)|0|||
147268155|NCT02357147|531153570|FG001|Combination Treatment Phase|Progressive Disease(Clinical assessment)|1|||
147268156|NCT02357147|531153569|FG000|Combination Treatment Phase|Investigator Discretion|1|||
147268157|NCT02357147|531153570|FG001|Combination Treatment Phase|Investigator Discretion|1|||
147268158|NCT02357147|531153569|FG000|Combination Treatment Phase|Withdrawal by Subject|4|||
147268159|NCT02357147|531153570|FG001|Combination Treatment Phase|Withdrawal by Subject|2|||
147268160|NCT02357147|531153569|FG000|Combination Treatment Phase|Test Article Held (Greater than 21 Days)|4|||
147268161|NCT02357147|531153570|FG001|Combination Treatment Phase|Test Article Held (Greater than 21 Days)|1|||
147268162|NCT02357147|531153569|FG000|Combination Treatment Phase|Adverse Event|12|||
147268163|NCT02357147|531153570|FG001|Combination Treatment Phase|Adverse Event|4|||
147268164|NCT02357147|531153569|FG000|Combination Treatment Phase|Death|1|||
147268165|NCT02357147|531153570|FG001|Combination Treatment Phase|Death|1|||
147268166|NCT02357147|531153569|FG000|Combination Treatment Phase|Sponsor Decision|0|||
147268167|NCT02357147|531153570|FG001|Combination Treatment Phase|Sponsor Decision|12|||
147268168|NCT02357147|531153569|FG000|Combination Treatment Phase|Other|1|||
147268169|NCT02357147|531153570|FG001|Combination Treatment Phase|Other|0|||
147268170|NCT02357147|531153569|FG000|Combination Treatment Phase|Not treated|0|||
147268171|NCT02357147|531153570|FG001|Combination Treatment Phase|Not treated|2|||
147268172|NCT02357147|531153569|FG000|Maintenance Treatment Phase|Progressive Disease (Radiographic test)|15|||
147268173|NCT02357147|531153570|FG001|Maintenance Treatment Phase|Progressive Disease (Radiographic test)|10|||
147268174|NCT02357147|531153569|FG000|Maintenance Treatment Phase|Withdrawal by Subject|0|||
147600254|NCT01739348|532356344|FG002|Part II (Extension Study)|Withdrawal by Subject|4|||
147600255|NCT01739348|532356345|FG003|Part II (Extension Study)|Withdrawal by Subject|7|||
147268175|NCT02357147|531153570|FG001|Maintenance Treatment Phase|Withdrawal by Subject|1|||
147268176|NCT02357147|531153569|FG000|Maintenance Treatment Phase|Test Article Held (Greater than 21 Days)|10|||
147268177|NCT02357147|531153570|FG001|Maintenance Treatment Phase|Test Article Held (Greater than 21 Days)|0|||
147268178|NCT02357147|531153569|FG000|Maintenance Treatment Phase|Adverse Event|0|||
147268179|NCT02357147|531153570|FG001|Maintenance Treatment Phase|Adverse Event|3|||
147268180|NCT02357147|531153569|FG000|Maintenance Treatment Phase|Sponsor Decision|0|||
147268181|NCT02357147|531153570|FG001|Maintenance Treatment Phase|Sponsor Decision|15|||
147268182|NCT02357147|531153569|FG000|Maintenance Treatment Phase|Not Treated|1|||
147268183|NCT02357147|531153570|FG001|Maintenance Treatment Phase|Not Treated|0|||
147268184|NCT03962543|531153573|FG000|Treatment Phase|Death|0|||
147268185|NCT03962543|531153574|FG001|Treatment Phase|Death|1|||
147268186|NCT03962543|531153573|FG000|Treatment Phase|Withdrawal by Subject|3|||
147450270|NCT03016325|531811402|FG003|32-Day Follow-Up Period|Poor/non-compliance|1|||
147600256|NCT01085201|532356348|FG000|Overall Study|Scheduling conflict|1|||
147268187|NCT03962543|531153574|FG001|Treatment Phase|Withdrawal by Subject|0|||
147268188|NCT03962543|531153573|FG000|Treatment Phase|Adverse Event|3|||
147268189|NCT03962543|531153574|FG001|Treatment Phase|Adverse Event|12|||
147268190|NCT03962543|531153573|FG000|Treatment Phase|Lost to Follow-up|1|||
147268191|NCT03962543|531153574|FG001|Treatment Phase|Lost to Follow-up|2|||
147268192|NCT03962543|531153573|FG000|Treatment Phase|Radiographic PD|9|||
147268193|NCT03962543|531153574|FG001|Treatment Phase|Radiographic PD|3|||
147268194|NCT03962543|531153573|FG000|Treatment Phase|Participant Decision|3|||
147268195|NCT03962543|531153574|FG001|Treatment Phase|Participant Decision|8|||
147268196|NCT03962543|531153573|FG000|Treatment Phase|Received procedure not compatible with MRI|0|||
147268197|NCT03962543|531153574|FG001|Treatment Phase|Received procedure not compatible with MRI|1|||
147268198|NCT03962543|531153573|FG000|Treatment Phase|Ongoing in the Treatment Phase|4|||
147600257|NCT01085201|532356349|FG001|Overall Study|Scheduling conflict|0|||
147600258|NCT01085201|532356350|FG002|Overall Study|Scheduling conflict|1|||
147268199|NCT03962543|531153574|FG001|Treatment Phase|Ongoing in the Treatment Phase|0|||
147268200|NCT03962543|531153573|FG000|Long Term Follow-Up Phase|Withdrawal by Subject|0|||
147268201|NCT03962543|531153574|FG001|Long Term Follow-Up Phase|Withdrawal by Subject|1|||
147268202|NCT03962543|531153573|FG000|Long Term Follow-Up Phase|Adverse Event|1|||
147268203|NCT03962543|531153574|FG001|Long Term Follow-Up Phase|Adverse Event|0|||
147268204|NCT03962543|531153573|FG000|Long Term Follow-Up Phase|Physician Decision|0|||
147268205|NCT03962543|531153574|FG001|Long Term Follow-Up Phase|Physician Decision|1|||
147268206|NCT03962543|531153573|FG000|Long Term Follow-Up Phase|Radiographic PD|1|||
147268207|NCT03962543|531153574|FG001|Long Term Follow-Up Phase|Radiographic PD|0|||
147268208|NCT03962543|531153573|FG000|Long Term Follow-Up Phase|Sponsor Request|1|||
147268209|NCT03962543|531153574|FG001|Long Term Follow-Up Phase|Sponsor Request|0|||
147268210|NCT03962543|531153573|FG000|Long Term Follow-Up Phase|Participant Decision|0|||
147268211|NCT03962543|531153574|FG001|Long Term Follow-Up Phase|Participant Decision|1|||
147268212|NCT03962543|531153573|FG000|Long Term Follow-Up Phase|Positive pregnancy test|0|||
147268213|NCT03962543|531153574|FG001|Long Term Follow-Up Phase|Positive pregnancy test|1|||
147268214|NCT03962543|531153573|FG000|Long Term Follow-Up Phase|Ongoing in the Long Term Follow-Up Phase Phase|25|||
147268215|NCT03962543|531153574|FG001|Long Term Follow-Up Phase|Ongoing in the Long Term Follow-Up Phase Phase|22|||
147268216|NCT04482179|531154988|FG000|Overall Study|Death|1|||
147268217|NCT04482179|531154989|FG001|Overall Study|Death|0|||
147268218|NCT04482179|531154988|FG000|Overall Study|Withdrawal by Subject|1|||
147268219|NCT04482179|531154989|FG001|Overall Study|Withdrawal by Subject|0|||
147268220|NCT01302964|531154990|FG000|Overall Study|Adverse Event|1|||
147268221|NCT01302964|531154991|FG001|Overall Study|Adverse Event|0|||
147268222|NCT04127786|531154994|FG000|Primary Series|Adverse Event|1|||
147268223|NCT04127786|531154995|FG001|Primary Series|Adverse Event|0|||
147268224|NCT04127786|531154996|FG002|Primary Series|Adverse Event|0|||
147268225|NCT04127786|531154997|FG003|Primary Series|Adverse Event|1|||
147268226|NCT04127786|531154998|FG004|Primary Series|Adverse Event|0|||
147268227|NCT04127786|531154999|FG005|Primary Series|Adverse Event|1|||
147268228|NCT04127786|531154994|FG000|Primary Series|Protocol Violation|5|||
147268229|NCT04127786|531154995|FG001|Primary Series|Protocol Violation|3|||
147268230|NCT04127786|531154996|FG002|Primary Series|Protocol Violation|4|||
147268231|NCT04127786|531154997|FG003|Primary Series|Protocol Violation|3|||
147268232|NCT04127786|531154998|FG004|Primary Series|Protocol Violation|2|||
147268233|NCT04127786|531154999|FG005|Primary Series|Protocol Violation|0|||
147268234|NCT04127786|531154994|FG000|Primary Series|Withdrawal by Subject|0|||
147268235|NCT04127786|531154995|FG001|Primary Series|Withdrawal by Subject|0|||
147268236|NCT04127786|531154996|FG002|Primary Series|Withdrawal by Subject|0|||
147268237|NCT04127786|531154997|FG003|Primary Series|Withdrawal by Subject|1|||
147268238|NCT04127786|531154998|FG004|Primary Series|Withdrawal by Subject|0|||
147268239|NCT04127786|531154999|FG005|Primary Series|Withdrawal by Subject|0|||
147268240|NCT04127786|531154994|FG000|Primary Series|Withdrawal by Parent/Guardian|2|||
147268241|NCT04127786|531154995|FG001|Primary Series|Withdrawal by Parent/Guardian|1|||
147268242|NCT04127786|531154996|FG002|Primary Series|Withdrawal by Parent/Guardian|0|||
147268243|NCT04127786|531154997|FG003|Primary Series|Withdrawal by Parent/Guardian|0|||
147333187|NCT01212757|531385646|FG008|Long-Term Safety Phase (Year 4)|Death|1|||
147600259|NCT01085201|532356351|FG003|Overall Study|Scheduling conflict|0|||
147600260|NCT01085201|532356352|FG004|Overall Study|Scheduling conflict|0|||
147600261|NCT01085201|532356348|FG000|Overall Study|Unknown- no study drug|2|||
147268244|NCT04127786|531154998|FG004|Primary Series|Withdrawal by Parent/Guardian|0|||
147268245|NCT04127786|531154999|FG005|Primary Series|Withdrawal by Parent/Guardian|0|||
147268246|NCT04127786|531154994|FG000|Booster Phase|Withdrawal by Subject|2|||
147268247|NCT04127786|531154995|FG001|Booster Phase|Withdrawal by Subject|0|||
147268248|NCT04127786|531154996|FG002|Booster Phase|Withdrawal by Subject|0|||
147268249|NCT04127786|531154997|FG003|Booster Phase|Withdrawal by Subject|0|||
147268250|NCT04127786|531154998|FG004|Booster Phase|Withdrawal by Subject|0|||
147268251|NCT04127786|531154999|FG005|Booster Phase|Withdrawal by Subject|0|||
147268252|NCT02789176|531155008|FG000|Overall Study|Death|0|||
147600262|NCT01085201|532356349|FG001|Overall Study|Unknown- no study drug|0|||
147600263|NCT01085201|532356350|FG002|Overall Study|Unknown- no study drug|0|||
147600264|NCT01085201|532356351|FG003|Overall Study|Unknown- no study drug|0|||
147268253|NCT02789176|531155009|FG001|Overall Study|Death|0|||
147268254|NCT02789176|531155010|FG002|Overall Study|Death|3|||
147268255|NCT02789176|531155011|FG003|Overall Study|Death|0|||
147268256|NCT02789176|531155008|FG000|Overall Study|Withdrawal by Subject|0|||
147268257|NCT02789176|531155009|FG001|Overall Study|Withdrawal by Subject|0|||
147268258|NCT02789176|531155010|FG002|Overall Study|Withdrawal by Subject|1|||
147268259|NCT02789176|531155011|FG003|Overall Study|Withdrawal by Subject|0|||
147268260|NCT02789176|531155008|FG000|Overall Study|Lost to Follow-up|8|||
147268261|NCT02789176|531155009|FG001|Overall Study|Lost to Follow-up|2|||
147268262|NCT02789176|531155010|FG002|Overall Study|Lost to Follow-up|6|||
147268263|NCT02789176|531155011|FG003|Overall Study|Lost to Follow-up|1|||
147268264|NCT00596011|531155013|FG000|Overall Study|Withdrawal by Subject|2|||
147268265|NCT00596011|531155014|FG001|Overall Study|Withdrawal by Subject|3|||
147268266|NCT00596011|531155013|FG000|Overall Study|Adverse Event|11|||
147268267|NCT00596011|531155014|FG001|Overall Study|Adverse Event|7|||
147268268|NCT02347527|531155015|FG000|Overall Study|MRI not completed due to technical difficulties|1|||
147268269|NCT02347527|531155016|FG001|Overall Study|MRI not completed due to technical difficulties|0|||
147268270|NCT02347527|531155017|FG002|Overall Study|MRI not completed due to technical difficulties|0|||
147268271|NCT02347527|531155018|FG003|Overall Study|MRI not completed due to technical difficulties|0|||
147268272|NCT02347527|531155015|FG000|Overall Study|MRI stopped due to participant anxiety|0|||
147268273|NCT02347527|531155016|FG001|Overall Study|MRI stopped due to participant anxiety|1|||
147268274|NCT02347527|531155017|FG002|Overall Study|MRI stopped due to participant anxiety|0|||
147450271|NCT03016325|531811403|FG004|32-Day Follow-Up Period|Poor/non-compliance|1|||
147450272|NCT03016325|531811404|FG005|32-Day Follow-Up Period|Poor/non-compliance|0|||
147450273|NCT03016325|531811405|FG006|32-Day Follow-Up Period|Poor/non-compliance|0|||
147450274|NCT03016325|531811406|FG007|32-Day Follow-Up Period|Poor/non-compliance|0|||
147450275|NCT03016325|531811399|FG000|32-Day Follow-Up Period|Participant refused to visit|0|||
147450276|NCT03016325|531811400|FG001|32-Day Follow-Up Period|Participant refused to visit|1|||
147450277|NCT03016325|531811401|FG002|32-Day Follow-Up Period|Participant refused to visit|2|||
147450278|NCT03016325|531811402|FG003|32-Day Follow-Up Period|Participant refused to visit|0|||
147450279|NCT03016325|531811403|FG004|32-Day Follow-Up Period|Participant refused to visit|2|||
147450280|NCT03016325|531811404|FG005|32-Day Follow-Up Period|Participant refused to visit|0|||
147450281|NCT03016325|531811405|FG006|32-Day Follow-Up Period|Participant refused to visit|0|||
147450282|NCT03016325|531811406|FG007|32-Day Follow-Up Period|Participant refused to visit|0|||
147450283|NCT03016325|531811399|FG000|32-Day Follow-Up Period|Participant withdrew consent|0|||
147450284|NCT03016325|531811400|FG001|32-Day Follow-Up Period|Participant withdrew consent|0|||
147450285|NCT03016325|531811401|FG002|32-Day Follow-Up Period|Participant withdrew consent|0|||
147450286|NCT03016325|531811402|FG003|32-Day Follow-Up Period|Participant withdrew consent|0|||
147450287|NCT03016325|531811403|FG004|32-Day Follow-Up Period|Participant withdrew consent|2|||
147450288|NCT03016325|531811404|FG005|32-Day Follow-Up Period|Participant withdrew consent|0|||
147450289|NCT03016325|531811405|FG006|32-Day Follow-Up Period|Participant withdrew consent|1|||
147450290|NCT03016325|531811406|FG007|32-Day Follow-Up Period|Participant withdrew consent|0|||
147450291|NCT03016325|531811399|FG000|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
147450292|NCT03016325|531811400|FG001|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
147450293|NCT03016325|531811401|FG002|32-Day Follow-Up Period|Family doctor OK'd participant, per call|1|||
147450294|NCT03016325|531811402|FG003|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
147450295|NCT03016325|531811403|FG004|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
147450296|NCT03016325|531811404|FG005|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
147450297|NCT03016325|531811405|FG006|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
147450298|NCT03016325|531811406|FG007|32-Day Follow-Up Period|Family doctor OK'd participant, per call|0|||
147450299|NCT03016325|531811399|FG000|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
147450300|NCT03016325|531811400|FG001|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|1|||
147450301|NCT03016325|531811401|FG002|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
147450302|NCT03016325|531811402|FG003|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
147450303|NCT03016325|531811403|FG004|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
147450304|NCT03016325|531811404|FG005|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
147450305|NCT03016325|531811405|FG006|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
147450306|NCT03016325|531811406|FG007|32-Day Follow-Up Period|withdrew from Day 5, D32 form not done|0|||
147450307|NCT03016325|531811399|FG000|182-Day Follow-Up Period|Death|3|||
147450308|NCT03016325|531811400|FG001|182-Day Follow-Up Period|Death|3|||
147450309|NCT03016325|531811401|FG002|182-Day Follow-Up Period|Death|11|||
147450310|NCT03016325|531811402|FG003|182-Day Follow-Up Period|Death|12|||
147268275|NCT02347527|531155018|FG003|Overall Study|MRI stopped due to participant anxiety|0|||
147268276|NCT02347527|531155015|FG000|Overall Study|Excluded from analyses due to excess movement during MRI scan|1|||
147268277|NCT02347527|531155016|FG001|Overall Study|Excluded from analyses due to excess movement during MRI scan|1|||
147268278|NCT02347527|531155017|FG002|Overall Study|Excluded from analyses due to excess movement during MRI scan|0|||
147268279|NCT02347527|531155018|FG003|Overall Study|Excluded from analyses due to excess movement during MRI scan|0|||
147662322|NCT03110354|532587295|FG000|Overall Study|Start of new therapy|0|||
147268280|NCT02347527|531155015|FG000|Overall Study|Excluded from analyses due to technical difficulties during the study visit|1|||
147268281|NCT02347527|531155016|FG001|Overall Study|Excluded from analyses due to technical difficulties during the study visit|0|||
147268282|NCT02347527|531155017|FG002|Overall Study|Excluded from analyses due to technical difficulties during the study visit|1|||
147268283|NCT02347527|531155018|FG003|Overall Study|Excluded from analyses due to technical difficulties during the study visit|2|||
147268284|NCT02347527|531155015|FG000|Overall Study|Excluded from analyses due to non-compliance with study procedures|0|||
147268285|NCT02347527|531155016|FG001|Overall Study|Excluded from analyses due to non-compliance with study procedures|1|||
147268286|NCT02347527|531155017|FG002|Overall Study|Excluded from analyses due to non-compliance with study procedures|0|||
147268287|NCT02347527|531155018|FG003|Overall Study|Excluded from analyses due to non-compliance with study procedures|0|||
147268288|NCT00348556|531155019|FG000|Overall Study|Adverse Event|1|||
147268289|NCT00192075|531155020|FG000|Overall Study|Disease Progression|23|||
147268290|NCT00192075|531155021|FG001|Overall Study|Disease Progression|6|||
147268291|NCT00192075|531155020|FG000|Overall Study|Adverse Event|1|||
147268292|NCT00192075|531155021|FG001|Overall Study|Adverse Event|3|||
147268293|NCT00192075|531155020|FG000|Overall Study|Death|0|||
147268294|NCT00192075|531155021|FG001|Overall Study|Death|1|||
147268295|NCT00192075|531155020|FG000|Overall Study|Lack of Efficacy|0|||
147268296|NCT00192075|531155021|FG001|Overall Study|Lack of Efficacy|0|||
147268297|NCT00192075|531155020|FG000|Overall Study|Physician Decision|3|||
147268298|NCT00192075|531155021|FG001|Overall Study|Physician Decision|0|||
147268299|NCT00192075|531155020|FG000|Overall Study|Withdrawal by Subject|5|||
147268300|NCT00192075|531155021|FG001|Overall Study|Withdrawal by Subject|5|||
147268301|NCT00192075|531155020|FG000|Overall Study|Patient Non-Compliance|0|||
147268302|NCT00192075|531155021|FG001|Overall Study|Patient Non-Compliance|1|||
147268303|NCT00192075|531155020|FG000|Overall Study|Unacceptable Toxicity Exhibited by Drug|2|||
147268304|NCT00192075|531155021|FG001|Overall Study|Unacceptable Toxicity Exhibited by Drug|1|||
147268305|NCT00192075|531155020|FG000|Overall Study|Other|5|||
147268306|NCT00192075|531155021|FG001|Overall Study|Other|2|||
147268307|NCT01944059|531155022|FG000|Overall Study|Lost to Follow-up|1|||
147268308|NCT01944059|531155022|FG000|Overall Study|Physician Decision|3|||
147268309|NCT01944059|531155022|FG000|Overall Study|Withdrawal by Subject|1|||
147268310|NCT01944059|531155022|FG000|Overall Study|Adverse Event|2|||
147268311|NCT04206293|531155034|FG000|Overall Study|Consent withdrawal|1|||
147268312|NCT00430092|531155036|FG000|Overall Study|Adverse Event|0|||
147268313|NCT00430092|531155037|FG001|Overall Study|Adverse Event|0|||
147268314|NCT00430092|531155038|FG002|Overall Study|Adverse Event|1|||
147268315|NCT00430092|531155036|FG000|Overall Study|Lack of Efficacy|5|||
147268316|NCT00430092|531155037|FG001|Overall Study|Lack of Efficacy|2|||
147268317|NCT00430092|531155038|FG002|Overall Study|Lack of Efficacy|54|||
147268318|NCT00430092|531155036|FG000|Overall Study|Lost to Follow-up|1|||
147268319|NCT00430092|531155037|FG001|Overall Study|Lost to Follow-up|0|||
147268320|NCT00430092|531155038|FG002|Overall Study|Lost to Follow-up|0|||
147268321|NCT00430092|531155036|FG000|Overall Study|Protocol Violation|0|||
147268322|NCT00430092|531155037|FG001|Overall Study|Protocol Violation|1|||
147268323|NCT00430092|531155038|FG002|Overall Study|Protocol Violation|1|||
147268324|NCT00430092|531155036|FG000|Overall Study|Withdrawal by Subject|0|||
147268325|NCT00430092|531155037|FG001|Overall Study|Withdrawal by Subject|1|||
147268326|NCT00430092|531155038|FG002|Overall Study|Withdrawal by Subject|1|||
147268327|NCT00706966|531155043|FG000|Overall Study|Adverse Event|1|||
147268328|NCT01631474|531155044|FG000|Overall Study|Lost to Follow-up|8|||
147268329|NCT01631474|531155045|FG001|Overall Study|Lost to Follow-up|5|||
147268330|NCT01631474|531155046|FG002|Overall Study|Lost to Follow-up|7|||
147268331|NCT01631474|531155047|FG003|Overall Study|Lost to Follow-up|5|||
147268332|NCT01631474|531155048|FG004|Overall Study|Lost to Follow-up|5|||
147268333|NCT01631474|531155044|FG000|Overall Study|Withdrawal by Subject|4|||
147268334|NCT01631474|531155045|FG001|Overall Study|Withdrawal by Subject|4|||
147268335|NCT01631474|531155046|FG002|Overall Study|Withdrawal by Subject|2|||
147268336|NCT01631474|531155047|FG003|Overall Study|Withdrawal by Subject|6|||
147268337|NCT01631474|531155048|FG004|Overall Study|Withdrawal by Subject|5|||
147268338|NCT01631474|531155044|FG000|Overall Study|Lack of Efficacy|2|||
147268339|NCT01631474|531155045|FG001|Overall Study|Lack of Efficacy|2|||
147662323|NCT03110354|532587296|FG001|Overall Study|Start of new therapy|0|||
147268340|NCT01631474|531155046|FG002|Overall Study|Lack of Efficacy|0|||
147268341|NCT01631474|531155047|FG003|Overall Study|Lack of Efficacy|0|||
147268342|NCT01631474|531155048|FG004|Overall Study|Lack of Efficacy|2|||
147268343|NCT01631474|531155044|FG000|Overall Study|Noncompliance with Study Drug|0|||
147268344|NCT01631474|531155045|FG001|Overall Study|Noncompliance with Study Drug|0|||
147268345|NCT01631474|531155046|FG002|Overall Study|Noncompliance with Study Drug|0|||
147268346|NCT01631474|531155047|FG003|Overall Study|Noncompliance with Study Drug|0|||
147268347|NCT01631474|531155048|FG004|Overall Study|Noncompliance with Study Drug|1|||
147268348|NCT01631474|531155044|FG000|Overall Study|Adverse Event|0|||
147268349|NCT01631474|531155045|FG001|Overall Study|Adverse Event|1|||
147268350|NCT01631474|531155046|FG002|Overall Study|Adverse Event|0|||
147268351|NCT01631474|531155047|FG003|Overall Study|Adverse Event|0|||
147662324|NCT03110354|532587297|FG002|Overall Study|Start of new therapy|0|||
147268352|NCT01631474|531155048|FG004|Overall Study|Adverse Event|0|||
147268353|NCT03795610|531155049|FG000|Overall Study|Screen Failure (Did not meet inclusion/exclusion)|4|||
147268354|NCT03795610|531155049|FG000|Overall Study|Withdrawal by Subject|1|||
147268355|NCT03795610|531155049|FG000|Overall Study|Screen Failure (Unknown)|1|||
147268356|NCT00559962|531155050|FG000|Overall Study|Adverse Event|1|||
147268357|NCT00559962|531155051|FG001|Overall Study|Adverse Event|7|||
147268358|NCT00559962|531155052|FG002|Overall Study|Adverse Event|8|||
147268359|NCT00559962|531155053|FG003|Overall Study|Adverse Event|5|||
147268360|NCT00559962|531155054|FG004|Overall Study|Adverse Event|11|||
147268361|NCT00559962|531155055|FG005|Overall Study|Adverse Event|4|||
147268362|NCT00559962|531155056|FG006|Overall Study|Adverse Event|4|||
147268363|NCT00559962|531155057|FG007|Overall Study|Adverse Event|2|||
147268364|NCT00559962|531155050|FG000|Overall Study|Lost to Follow-up|0|||
147268365|NCT00559962|531155051|FG001|Overall Study|Lost to Follow-up|1|||
147268366|NCT00559962|531155052|FG002|Overall Study|Lost to Follow-up|0|||
147268367|NCT00559962|531155053|FG003|Overall Study|Lost to Follow-up|0|||
147268368|NCT00559962|531155054|FG004|Overall Study|Lost to Follow-up|0|||
147268369|NCT00559962|531155055|FG005|Overall Study|Lost to Follow-up|0|||
147268370|NCT00559962|531155056|FG006|Overall Study|Lost to Follow-up|0|||
147268371|NCT00559962|531155057|FG007|Overall Study|Lost to Follow-up|0|||
147268372|NCT00559962|531155050|FG000|Overall Study|Withdrawal by Subject|1|||
147268373|NCT00559962|531155051|FG001|Overall Study|Withdrawal by Subject|1|||
147268374|NCT00559962|531155052|FG002|Overall Study|Withdrawal by Subject|2|||
147268375|NCT00559962|531155053|FG003|Overall Study|Withdrawal by Subject|0|||
147268376|NCT00559962|531155054|FG004|Overall Study|Withdrawal by Subject|3|||
147268377|NCT00559962|531155055|FG005|Overall Study|Withdrawal by Subject|1|||
147268378|NCT00559962|531155056|FG006|Overall Study|Withdrawal by Subject|0|||
147268379|NCT00559962|531155057|FG007|Overall Study|Withdrawal by Subject|2|||
147268380|NCT00559962|531155050|FG000|Overall Study|Inclusion/exclusion criteria not met|0|||
147268381|NCT00559962|531155051|FG001|Overall Study|Inclusion/exclusion criteria not met|0|||
147268382|NCT00559962|531155052|FG002|Overall Study|Inclusion/exclusion criteria not met|0|||
147268383|NCT00559962|531155053|FG003|Overall Study|Inclusion/exclusion criteria not met|0|||
147268384|NCT00559962|531155054|FG004|Overall Study|Inclusion/exclusion criteria not met|0|||
147268385|NCT00559962|531155055|FG005|Overall Study|Inclusion/exclusion criteria not met|0|||
147268386|NCT00559962|531155056|FG006|Overall Study|Inclusion/exclusion criteria not met|1|||
147268387|NCT00559962|531155057|FG007|Overall Study|Inclusion/exclusion criteria not met|0|||
147268388|NCT03047135|531155058|FG000|Overall Study|Still being treated|3|||
147268389|NCT00323414|531155059|FG000|Overall Study|Withdrawal by Subject|0|||
147268390|NCT00323414|531155060|FG001|Overall Study|Withdrawal by Subject|1|||
147268391|NCT02659020|531155061|FG000|Overall Study|Adverse Event|0|||
147268392|NCT02659020|531155062|FG001|Overall Study|Adverse Event|0|||
147268393|NCT02659020|531155063|FG002|Overall Study|Adverse Event|0|||
147268394|NCT02659020|531155064|FG003|Overall Study|Adverse Event|2|||
147268395|NCT02659020|531155065|FG004|Overall Study|Adverse Event|0|||
147268396|NCT02659020|531155066|FG005|Overall Study|Adverse Event|0|||
147268397|NCT02659020|531155067|FG006|Overall Study|Adverse Event|2|||
147268398|NCT02659020|531155061|FG000|Overall Study|Lost to Follow-up|1|||
147268399|NCT02659020|531155062|FG001|Overall Study|Lost to Follow-up|2|||
147268400|NCT02659020|531155063|FG002|Overall Study|Lost to Follow-up|1|||
147268401|NCT02659020|531155064|FG003|Overall Study|Lost to Follow-up|6|||
147268402|NCT02659020|531155065|FG004|Overall Study|Lost to Follow-up|1|||
147268403|NCT02659020|531155066|FG005|Overall Study|Lost to Follow-up|5|||
147268404|NCT02659020|531155067|FG006|Overall Study|Lost to Follow-up|0|||
147268405|NCT02659020|531155061|FG000|Overall Study|Physician Decision|0|||
147268406|NCT02659020|531155062|FG001|Overall Study|Physician Decision|0|||
147268407|NCT02659020|531155063|FG002|Overall Study|Physician Decision|0|||
147600265|NCT01085201|532356352|FG004|Overall Study|Unknown- no study drug|0|||
147600266|NCT01085201|532356348|FG000|Overall Study|Fond ineligible after consent|0|||
147600267|NCT01085201|532356349|FG001|Overall Study|Fond ineligible after consent|1|||
147600268|NCT01085201|532356350|FG002|Overall Study|Fond ineligible after consent|1|||
147600269|NCT01085201|532356351|FG003|Overall Study|Fond ineligible after consent|0|||
147600270|NCT01085201|532356352|FG004|Overall Study|Fond ineligible after consent|0|||
147600271|NCT00528411|532356354|FG000|Overall Study|Adverse Event|4|||
147600272|NCT00528411|532356355|FG001|Overall Study|Adverse Event|0|||
147600273|NCT00528411|532356356|FG002|Overall Study|Adverse Event|1|||
147268408|NCT02659020|531155064|FG003|Overall Study|Physician Decision|1|||
147268409|NCT02659020|531155065|FG004|Overall Study|Physician Decision|1|||
147268410|NCT02659020|531155066|FG005|Overall Study|Physician Decision|0|||
147268411|NCT02659020|531155067|FG006|Overall Study|Physician Decision|1|||
147268412|NCT02659020|531155061|FG000|Overall Study|Withdrawal by Subject|2|||
147268413|NCT02659020|531155062|FG001|Overall Study|Withdrawal by Subject|1|||
147268414|NCT02659020|531155063|FG002|Overall Study|Withdrawal by Subject|0|||
147600274|NCT00528411|532356354|FG000|Overall Study|Incorrect Enrolment|1|||
147268415|NCT02659020|531155064|FG003|Overall Study|Withdrawal by Subject|3|||
147268416|NCT02659020|531155065|FG004|Overall Study|Withdrawal by Subject|3|||
147268417|NCT02659020|531155066|FG005|Overall Study|Withdrawal by Subject|6|||
147600275|NCT00528411|532356355|FG001|Overall Study|Incorrect Enrolment|1|||
147268418|NCT02659020|531155067|FG006|Overall Study|Withdrawal by Subject|3|||
147268419|NCT02659020|531155061|FG000|Overall Study|Progressive Disease|0|||
147268420|NCT02659020|531155062|FG001|Overall Study|Progressive Disease|0|||
147268421|NCT02659020|531155063|FG002|Overall Study|Progressive Disease|0|||
147268422|NCT02659020|531155064|FG003|Overall Study|Progressive Disease|4|||
147268423|NCT02659020|531155065|FG004|Overall Study|Progressive Disease|1|||
147268424|NCT02659020|531155066|FG005|Overall Study|Progressive Disease|0|||
147268425|NCT02659020|531155067|FG006|Overall Study|Progressive Disease|2|||
147268426|NCT01077960|531155068|FG000|Overall Study|Adverse Event|6|||
147268427|NCT01077960|531155068|FG000|Overall Study|Protocol Violation|3|||
147268428|NCT01077960|531155068|FG000|Overall Study|Lost to Follow-up|5|||
147268429|NCT01077960|531155068|FG000|Overall Study|Subject decision|1|||
147268430|NCT01077960|531155068|FG000|Overall Study|Reason unspecified|1|||
147268431|NCT05619692|531155069|FG000|Overall Study|Adverse Event|2|||
147268432|NCT05619692|531155070|FG001|Overall Study|Adverse Event|2|||
147268433|NCT05619692|531155069|FG000|Overall Study|Withdrawal by Participant|3|||
147268434|NCT05619692|531155070|FG001|Overall Study|Withdrawal by Participant|4|||
147268435|NCT05619692|531155069|FG000|Overall Study|Lost to Follow-up|2|||
147268436|NCT05619692|531155070|FG001|Overall Study|Lost to Follow-up|1|||
147268437|NCT05619692|531155069|FG000|Overall Study|Randomized but not treated|1|||
147268438|NCT05619692|531155070|FG001|Overall Study|Randomized but not treated|3|||
147268439|NCT04049760|531155072|FG000|Overall Study|Withdrawal by Subject|1|||
147268440|NCT02457598|531155073|FG000|Overall Study|Progressive Disease|2|||
147268441|NCT02457598|531155074|FG001|Overall Study|Progressive Disease|2|||
147268442|NCT02457598|531155075|FG002|Overall Study|Progressive Disease|1|||
147268443|NCT02457598|531155076|FG003|Overall Study|Progressive Disease|11|||
147268444|NCT02457598|531155077|FG004|Overall Study|Progressive Disease|7|||
147268445|NCT02457598|531155078|FG005|Overall Study|Progressive Disease|3|||
147268446|NCT02457598|531155079|FG006|Overall Study|Progressive Disease|2|||
147268447|NCT02457598|531155080|FG007|Overall Study|Progressive Disease|1|||
147268448|NCT02457598|531155081|FG008|Overall Study|Progressive Disease|1|||
147268449|NCT02457598|531155082|FG009|Overall Study|Progressive Disease|2|||
147268450|NCT02457598|531155083|FG010|Overall Study|Progressive Disease|45|||
147268451|NCT02457598|531155084|FG011|Overall Study|Progressive Disease|6|||
147268452|NCT02457598|531155085|FG012|Overall Study|Progressive Disease|2|||
147268453|NCT02457598|531155086|FG013|Overall Study|Progressive Disease|2|||
147268454|NCT02457598|531155087|FG014|Overall Study|Progressive Disease|10|||
147268455|NCT02457598|531155088|FG015|Overall Study|Progressive Disease|1|||
147268456|NCT02457598|531155089|FG016|Overall Study|Progressive Disease|1|||
147268457|NCT02457598|531155073|FG000|Overall Study|Investigator's Discretion|0|||
147268458|NCT02457598|531155074|FG001|Overall Study|Investigator's Discretion|2|||
147268459|NCT02457598|531155075|FG002|Overall Study|Investigator's Discretion|2|||
147268460|NCT02457598|531155076|FG003|Overall Study|Investigator's Discretion|2|||
147268461|NCT02457598|531155077|FG004|Overall Study|Investigator's Discretion|0|||
147268462|NCT02457598|531155078|FG005|Overall Study|Investigator's Discretion|0|||
147268463|NCT02457598|531155079|FG006|Overall Study|Investigator's Discretion|0|||
147268464|NCT02457598|531155080|FG007|Overall Study|Investigator's Discretion|1|||
147268465|NCT02457598|531155081|FG008|Overall Study|Investigator's Discretion|2|||
147268466|NCT02457598|531155082|FG009|Overall Study|Investigator's Discretion|0|||
147268467|NCT02457598|531155083|FG010|Overall Study|Investigator's Discretion|10|||
147268468|NCT02457598|531155084|FG011|Overall Study|Investigator's Discretion|2|||
147268469|NCT02457598|531155085|FG012|Overall Study|Investigator's Discretion|2|||
147268470|NCT02457598|531155086|FG013|Overall Study|Investigator's Discretion|1|||
147268471|NCT02457598|531155087|FG014|Overall Study|Investigator's Discretion|5|||
147268472|NCT02457598|531155088|FG015|Overall Study|Investigator's Discretion|0|||
147268473|NCT02457598|531155089|FG016|Overall Study|Investigator's Discretion|0|||
147268474|NCT02457598|531155073|FG000|Overall Study|Study Terminated by Sponsor|0|||
147268475|NCT02457598|531155074|FG001|Overall Study|Study Terminated by Sponsor|1|||
147268476|NCT02457598|531155075|FG002|Overall Study|Study Terminated by Sponsor|0|||
147268477|NCT02457598|531155076|FG003|Overall Study|Study Terminated by Sponsor|4|||
147268478|NCT02457598|531155077|FG004|Overall Study|Study Terminated by Sponsor|1|||
147600276|NCT00528411|532356356|FG002|Overall Study|Incorrect Enrolment|0|||
147600277|NCT00528411|532356354|FG000|Overall Study|Severe non-compliance to protocol|0|||
147600278|NCT00528411|532356355|FG001|Overall Study|Severe non-compliance to protocol|1|||
147600279|NCT00528411|532356356|FG002|Overall Study|Severe non-compliance to protocol|0|||
147600280|NCT00528411|532356354|FG000|Overall Study|Prior commitment medication|0|||
147600281|NCT00528411|532356355|FG001|Overall Study|Prior commitment medication|1|||
147268479|NCT02457598|531155078|FG005|Overall Study|Study Terminated by Sponsor|0|||
147268480|NCT02457598|531155079|FG006|Overall Study|Study Terminated by Sponsor|1|||
147268481|NCT02457598|531155080|FG007|Overall Study|Study Terminated by Sponsor|0|||
147268482|NCT02457598|531155081|FG008|Overall Study|Study Terminated by Sponsor|0|||
147268483|NCT02457598|531155082|FG009|Overall Study|Study Terminated by Sponsor|0|||
147268484|NCT02457598|531155083|FG010|Overall Study|Study Terminated by Sponsor|4|||
147268485|NCT02457598|531155084|FG011|Overall Study|Study Terminated by Sponsor|0|||
147268486|NCT02457598|531155085|FG012|Overall Study|Study Terminated by Sponsor|1|||
147268487|NCT02457598|531155086|FG013|Overall Study|Study Terminated by Sponsor|0|||
147268488|NCT02457598|531155087|FG014|Overall Study|Study Terminated by Sponsor|8|||
147268489|NCT02457598|531155088|FG015|Overall Study|Study Terminated by Sponsor|1|||
147268490|NCT02457598|531155089|FG016|Overall Study|Study Terminated by Sponsor|0|||
147268491|NCT02457598|531155073|FG000|Overall Study|Adverse Event|0|||
147268492|NCT02457598|531155074|FG001|Overall Study|Adverse Event|1|||
147268493|NCT02457598|531155075|FG002|Overall Study|Adverse Event|1|||
147268494|NCT02457598|531155076|FG003|Overall Study|Adverse Event|4|||
147268495|NCT02457598|531155077|FG004|Overall Study|Adverse Event|1|||
147268496|NCT02457598|531155078|FG005|Overall Study|Adverse Event|0|||
147268497|NCT02457598|531155079|FG006|Overall Study|Adverse Event|0|||
147268498|NCT02457598|531155080|FG007|Overall Study|Adverse Event|1|||
147268499|NCT02457598|531155081|FG008|Overall Study|Adverse Event|0|||
147268500|NCT02457598|531155082|FG009|Overall Study|Adverse Event|1|||
147268501|NCT02457598|531155083|FG010|Overall Study|Adverse Event|6|||
147268502|NCT02457598|531155084|FG011|Overall Study|Adverse Event|0|||
147268503|NCT02457598|531155085|FG012|Overall Study|Adverse Event|0|||
147268504|NCT02457598|531155086|FG013|Overall Study|Adverse Event|1|||
147268505|NCT02457598|531155087|FG014|Overall Study|Adverse Event|2|||
147268506|NCT02457598|531155088|FG015|Overall Study|Adverse Event|0|||
147268507|NCT02457598|531155089|FG016|Overall Study|Adverse Event|0|||
147268508|NCT02457598|531155073|FG000|Overall Study|Death|0|||
147268509|NCT02457598|531155074|FG001|Overall Study|Death|0|||
147268510|NCT02457598|531155075|FG002|Overall Study|Death|0|||
147268511|NCT02457598|531155076|FG003|Overall Study|Death|3|||
147268512|NCT02457598|531155077|FG004|Overall Study|Death|0|||
147268513|NCT02457598|531155078|FG005|Overall Study|Death|1|||
147268514|NCT02457598|531155079|FG006|Overall Study|Death|0|||
147268515|NCT02457598|531155080|FG007|Overall Study|Death|0|||
147268516|NCT02457598|531155081|FG008|Overall Study|Death|0|||
147268517|NCT02457598|531155082|FG009|Overall Study|Death|0|||
147268518|NCT02457598|531155083|FG010|Overall Study|Death|3|||
147268519|NCT02457598|531155084|FG011|Overall Study|Death|0|||
147268520|NCT02457598|531155085|FG012|Overall Study|Death|0|||
147268521|NCT02457598|531155086|FG013|Overall Study|Death|1|||
147268522|NCT02457598|531155087|FG014|Overall Study|Death|2|||
147268523|NCT02457598|531155088|FG015|Overall Study|Death|0|||
147268524|NCT02457598|531155089|FG016|Overall Study|Death|1|||
147268525|NCT02457598|531155073|FG000|Overall Study|Transition to the MHRA's Special Scheme|0|||
147268526|NCT02457598|531155074|FG001|Overall Study|Transition to the MHRA's Special Scheme|2|||
147268527|NCT02457598|531155075|FG002|Overall Study|Transition to the MHRA's Special Scheme|0|||
147268528|NCT02457598|531155076|FG003|Overall Study|Transition to the MHRA's Special Scheme|1|||
147268529|NCT02457598|531155077|FG004|Overall Study|Transition to the MHRA's Special Scheme|0|||
147268530|NCT02457598|531155078|FG005|Overall Study|Transition to the MHRA's Special Scheme|0|||
147268531|NCT02457598|531155079|FG006|Overall Study|Transition to the MHRA's Special Scheme|0|||
147268532|NCT02457598|531155080|FG007|Overall Study|Transition to the MHRA's Special Scheme|1|||
147268533|NCT02457598|531155081|FG008|Overall Study|Transition to the MHRA's Special Scheme|0|||
147268534|NCT02457598|531155082|FG009|Overall Study|Transition to the MHRA's Special Scheme|0|||
147268535|NCT02457598|531155083|FG010|Overall Study|Transition to the MHRA's Special Scheme|4|||
147268536|NCT02457598|531155084|FG011|Overall Study|Transition to the MHRA's Special Scheme|0|||
147268537|NCT02457598|531155085|FG012|Overall Study|Transition to the MHRA's Special Scheme|0|||
147268538|NCT02457598|531155086|FG013|Overall Study|Transition to the MHRA's Special Scheme|0|||
147268539|NCT02457598|531155087|FG014|Overall Study|Transition to the MHRA's Special Scheme|1|||
147268540|NCT02457598|531155088|FG015|Overall Study|Transition to the MHRA's Special Scheme|1|||
147268541|NCT02457598|531155089|FG016|Overall Study|Transition to the MHRA's Special Scheme|1|||
147268542|NCT02457598|531155073|FG000|Overall Study|Withdrew Consent|0|||
147268543|NCT02457598|531155074|FG001|Overall Study|Withdrew Consent|0|||
147268544|NCT02457598|531155075|FG002|Overall Study|Withdrew Consent|0|||
147268545|NCT02457598|531155076|FG003|Overall Study|Withdrew Consent|0|||
147268546|NCT02457598|531155077|FG004|Overall Study|Withdrew Consent|0|||
147268547|NCT02457598|531155078|FG005|Overall Study|Withdrew Consent|0|||
147268548|NCT02457598|531155079|FG006|Overall Study|Withdrew Consent|0|||
147268549|NCT02457598|531155080|FG007|Overall Study|Withdrew Consent|2|||
147268550|NCT02457598|531155081|FG008|Overall Study|Withdrew Consent|0|||
147268551|NCT02457598|531155082|FG009|Overall Study|Withdrew Consent|0|||
147268552|NCT02457598|531155083|FG010|Overall Study|Withdrew Consent|3|||
147268553|NCT02457598|531155084|FG011|Overall Study|Withdrew Consent|0|||
147268554|NCT02457598|531155085|FG012|Overall Study|Withdrew Consent|0|||
147268555|NCT02457598|531155086|FG013|Overall Study|Withdrew Consent|1|||
147268556|NCT02457598|531155087|FG014|Overall Study|Withdrew Consent|0|||
147268557|NCT02457598|531155088|FG015|Overall Study|Withdrew Consent|0|||
147268558|NCT02457598|531155089|FG016|Overall Study|Withdrew Consent|0|||
147268559|NCT02457598|531155073|FG000|Overall Study|Unacceptable Toxicity|0|||
147268560|NCT02457598|531155074|FG001|Overall Study|Unacceptable Toxicity|0|||
147268561|NCT02457598|531155075|FG002|Overall Study|Unacceptable Toxicity|0|||
147268562|NCT02457598|531155076|FG003|Overall Study|Unacceptable Toxicity|0|||
147268563|NCT02457598|531155077|FG004|Overall Study|Unacceptable Toxicity|0|||
147268564|NCT02457598|531155078|FG005|Overall Study|Unacceptable Toxicity|0|||
147268565|NCT02457598|531155079|FG006|Overall Study|Unacceptable Toxicity|0|||
147268566|NCT02457598|531155080|FG007|Overall Study|Unacceptable Toxicity|0|||
147600282|NCT00528411|532356356|FG002|Overall Study|Prior commitment medication|0|||
147600283|NCT03893565|532356357|FG000|Double-blind Induction Phase (10 Weeks)|Other|1|||
147600284|NCT03893565|532356358|FG001|Double-blind Induction Phase (10 Weeks)|Other|3|||
147600285|NCT03893565|532356359|FG002|Double-blind Induction Phase (10 Weeks)|Other|0|||
147268567|NCT02457598|531155081|FG008|Overall Study|Unacceptable Toxicity|0|||
147333188|NCT01212757|531385638|FG000|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
147333189|NCT01212757|531385639|FG001|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
147333190|NCT01212757|531385640|FG002|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
147333191|NCT01212757|531385641|FG003|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
147333192|NCT01212757|531385642|FG004|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
147333193|NCT01212757|531385643|FG005|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
147333194|NCT01212757|531385644|FG006|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
147333195|NCT01212757|531385645|FG007|Long-Term Safety Phase (Year 4)|Lost to Follow-up|1|||
147333196|NCT01212757|531385646|FG008|Long-Term Safety Phase (Year 4)|Lost to Follow-up|0|||
147333197|NCT01212757|531385638|FG000|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0|||
147333198|NCT01212757|531385639|FG001|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|3|||
147333199|NCT01212757|531385640|FG002|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|3|||
147333200|NCT01212757|531385641|FG003|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0|||
147333201|NCT01212757|531385642|FG004|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0|||
147333202|NCT01212757|531385643|FG005|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0|||
147333203|NCT01212757|531385644|FG006|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|0|||
147333204|NCT01212757|531385645|FG007|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|1|||
147333205|NCT01212757|531385646|FG008|Long-Term Safety Phase (Year 5)|Withdrawal by Subject|1|||
147333206|NCT01212757|531385638|FG000|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
147333207|NCT01212757|531385639|FG001|Long-Term Safety Phase (Year 5)|Adverse Event|2|||
147333208|NCT01212757|531385640|FG002|Long-Term Safety Phase (Year 5)|Adverse Event|2|||
147333209|NCT01212757|531385641|FG003|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
147333210|NCT01212757|531385642|FG004|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
147333211|NCT01212757|531385643|FG005|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
147333212|NCT01212757|531385644|FG006|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
147333213|NCT01212757|531385645|FG007|Long-Term Safety Phase (Year 5)|Adverse Event|2|||
147333214|NCT01212757|531385646|FG008|Long-Term Safety Phase (Year 5)|Adverse Event|0|||
147333215|NCT01212757|531385638|FG000|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0|||
147333216|NCT01212757|531385639|FG001|Long-Term Safety Phase (Year 5)|Lack of Efficacy|1|||
147333217|NCT01212757|531385640|FG002|Long-Term Safety Phase (Year 5)|Lack of Efficacy|2|||
147268568|NCT02457598|531155082|FG009|Overall Study|Unacceptable Toxicity|0|||
147268569|NCT02457598|531155083|FG010|Overall Study|Unacceptable Toxicity|1|||
147268570|NCT02457598|531155084|FG011|Overall Study|Unacceptable Toxicity|0|||
147268571|NCT02457598|531155085|FG012|Overall Study|Unacceptable Toxicity|1|||
147268572|NCT02457598|531155086|FG013|Overall Study|Unacceptable Toxicity|1|||
147268573|NCT02457598|531155087|FG014|Overall Study|Unacceptable Toxicity|1|||
147268574|NCT02457598|531155088|FG015|Overall Study|Unacceptable Toxicity|0|||
147268575|NCT02457598|531155089|FG016|Overall Study|Unacceptable Toxicity|0|||
147268576|NCT02457598|531155073|FG000|Overall Study|Intercurrent Illness|0|||
147268577|NCT02457598|531155074|FG001|Overall Study|Intercurrent Illness|0|||
147268578|NCT02457598|531155075|FG002|Overall Study|Intercurrent Illness|0|||
147268579|NCT02457598|531155076|FG003|Overall Study|Intercurrent Illness|0|||
147268580|NCT02457598|531155077|FG004|Overall Study|Intercurrent Illness|0|||
147268581|NCT02457598|531155078|FG005|Overall Study|Intercurrent Illness|0|||
147268582|NCT02457598|531155079|FG006|Overall Study|Intercurrent Illness|0|||
147268583|NCT02457598|531155080|FG007|Overall Study|Intercurrent Illness|0|||
147268584|NCT02457598|531155081|FG008|Overall Study|Intercurrent Illness|0|||
147268585|NCT02457598|531155082|FG009|Overall Study|Intercurrent Illness|0|||
147268586|NCT02457598|531155083|FG010|Overall Study|Intercurrent Illness|1|||
147268587|NCT02457598|531155084|FG011|Overall Study|Intercurrent Illness|0|||
147268588|NCT02457598|531155085|FG012|Overall Study|Intercurrent Illness|0|||
147268589|NCT02457598|531155086|FG013|Overall Study|Intercurrent Illness|0|||
147268590|NCT02457598|531155087|FG014|Overall Study|Intercurrent Illness|0|||
147268591|NCT02457598|531155088|FG015|Overall Study|Intercurrent Illness|0|||
147268592|NCT02457598|531155089|FG016|Overall Study|Intercurrent Illness|0|||
147268593|NCT02457598|531155073|FG000|Overall Study|Protocol Violation|0|||
147268594|NCT02457598|531155074|FG001|Overall Study|Protocol Violation|0|||
147268595|NCT02457598|531155075|FG002|Overall Study|Protocol Violation|0|||
147333218|NCT01212757|531385641|FG003|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0|||
147333219|NCT01212757|531385642|FG004|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0|||
147333220|NCT01212757|531385643|FG005|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0|||
147333221|NCT01212757|531385644|FG006|Long-Term Safety Phase (Year 5)|Lack of Efficacy|0|||
147600286|NCT03893565|532356360|FG003|Double-blind Induction Phase (10 Weeks)|Other|0|||
147268596|NCT02457598|531155076|FG003|Overall Study|Protocol Violation|0|||
147268597|NCT02457598|531155077|FG004|Overall Study|Protocol Violation|0|||
147268598|NCT02457598|531155078|FG005|Overall Study|Protocol Violation|0|||
147268599|NCT02457598|531155079|FG006|Overall Study|Protocol Violation|0|||
147268600|NCT02457598|531155080|FG007|Overall Study|Protocol Violation|0|||
147268601|NCT02457598|531155081|FG008|Overall Study|Protocol Violation|0|||
147268602|NCT02457598|531155082|FG009|Overall Study|Protocol Violation|0|||
147268603|NCT02457598|531155083|FG010|Overall Study|Protocol Violation|1|||
147268604|NCT02457598|531155084|FG011|Overall Study|Protocol Violation|0|||
147268605|NCT02457598|531155085|FG012|Overall Study|Protocol Violation|0|||
147268606|NCT02457598|531155086|FG013|Overall Study|Protocol Violation|0|||
147268607|NCT02457598|531155087|FG014|Overall Study|Protocol Violation|0|||
147268608|NCT02457598|531155088|FG015|Overall Study|Protocol Violation|0|||
147268609|NCT02457598|531155089|FG016|Overall Study|Protocol Violation|0|||
147268610|NCT02703636|531155091|FG000|Overall Study|Adverse Event|14|||
147268611|NCT02703636|531155091|FG000|Overall Study|Study stopped by sponsor|1|||
147268612|NCT02703636|531155091|FG000|Overall Study|Withdrawal by Subject|1|||
147268613|NCT01537783|531155103|FG000|Overall Study|Lost to Follow-up|11|||
147268614|NCT01537783|531155104|FG001|Overall Study|Lost to Follow-up|2|||
147268615|NCT02321462|531155107|FG000|Overall Study|Withdrawal by Subject|5|||
147268616|NCT02321462|531155108|FG001|Overall Study|Withdrawal by Subject|2|||
147268617|NCT02321462|531155107|FG000|Overall Study|Subject withdrawn before any treatment|1|||
147268618|NCT02321462|531155108|FG001|Overall Study|Subject withdrawn before any treatment|1|||
147333222|NCT01212757|531385645|FG007|Long-Term Safety Phase (Year 5)|Lack of Efficacy|2|||
147333223|NCT01212757|531385646|FG008|Long-Term Safety Phase (Year 5)|Lack of Efficacy|1|||
147268619|NCT00692770|531155120|FG000|Overall Study|Protocol Violation|2|||
147268620|NCT00692770|531155121|FG001|Overall Study|Protocol Violation|7|||
147268621|NCT00692770|531155120|FG000|Overall Study|Withdrawal by Subject|97|||
147268622|NCT00692770|531155121|FG001|Overall Study|Withdrawal by Subject|36|||
147268623|NCT00692770|531155120|FG000|Overall Study|Adverse Event|136|||
147268624|NCT00692770|531155121|FG001|Overall Study|Adverse Event|41|||
147268625|NCT00692770|531155120|FG000|Overall Study|Death|10|||
147268626|NCT00692770|531155121|FG001|Overall Study|Death|5|||
147268627|NCT00692770|531155120|FG000|Overall Study|Lost to Follow-up|7|||
147268628|NCT00692770|531155121|FG001|Overall Study|Lost to Follow-up|3|||
147268629|NCT00692770|531155120|FG000|Overall Study|Non-compliant with study medication|11|||
147268630|NCT00692770|531155121|FG001|Overall Study|Non-compliant with study medication|5|||
147268631|NCT00692770|531155120|FG000|Overall Study|Progression by clinical judgment|2|||
147268632|NCT00692770|531155121|FG001|Overall Study|Progression by clinical judgment|3|||
147268633|NCT00692770|531155120|FG000|Overall Study|Physician decision not protocol driven|10|||
147268634|NCT00692770|531155121|FG001|Overall Study|Physician decision not protocol driven|14|||
147268635|NCT00692770|531155120|FG000|Overall Study|Disease progression, recurrence/relapse|170|||
147268636|NCT00692770|531155121|FG001|Overall Study|Disease progression, recurrence/relapse|279|||
147268637|NCT00692770|531155120|FG000|Overall Study|Protocol driven decision point|3|||
147268638|NCT00692770|531155121|FG001|Overall Study|Protocol driven decision point|7|||
147268639|NCT00692770|531155120|FG000|Overall Study|Completed all planned assessments|79|||
147268640|NCT00692770|531155121|FG001|Overall Study|Completed all planned assessments|101|||
147268641|NCT00692770|531155120|FG000|Overall Study|Radiological and clinical progression|8|||
147268642|NCT00692770|531155121|FG001|Overall Study|Radiological and clinical progression|8|||
147268643|NCT00692770|531155120|FG000|Overall Study|Clinical endpoint reached|16|||
147268644|NCT00692770|531155121|FG001|Overall Study|Clinical endpoint reached|43|||
147268645|NCT00692770|531155120|FG000|Overall Study|Study terminated by sponsor|2|||
147268646|NCT00692770|531155121|FG001|Overall Study|Study terminated by sponsor|2|||
147268647|NCT00692770|531155120|FG000|Overall Study|Randomized but not treated|3|||
147268648|NCT00692770|531155121|FG001|Overall Study|Randomized but not treated|4|||
147268649|NCT04248816|531155122|FG000|Overall Study|Ineligible post-randomization|7|||
147268650|NCT04248816|531155123|FG001|Overall Study|Ineligible post-randomization|21|||
147268651|NCT04248816|531155124|FG002|Overall Study|Ineligible post-randomization|25|||
147268652|NCT04327986|531155125|FG000|Overall Study|Physician Decision|2|||
147268653|NCT04327986|531155126|FG001|Overall Study|Physician Decision|0|||
147268654|NCT04327986|531155127|FG002|Overall Study|Physician Decision|0|||
147268655|NCT04327986|531155125|FG000|Overall Study|Death|1|||
147333224|NCT01212757|531385638|FG000|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
147333225|NCT01212757|531385639|FG001|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|1|||
147333226|NCT01212757|531385640|FG002|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
147333227|NCT01212757|531385641|FG003|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
147333228|NCT01212757|531385642|FG004|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
147268656|NCT04327986|531155126|FG001|Overall Study|Death|0|||
147268657|NCT04327986|531155127|FG002|Overall Study|Death|0|||
147268658|NCT00834912|531155128|FG000|Treatment Period 1|Adverse Event|0|||
147333229|NCT01212757|531385643|FG005|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
147268659|NCT00834912|531155129|FG001|Treatment Period 1|Adverse Event|1|||
147268660|NCT00834912|531155130|FG002|Treatment Period 1|Adverse Event|0|||
147268661|NCT00834912|531155131|FG003|Treatment Period 1|Adverse Event|1|||
147268662|NCT00834912|531155132|FG004|Treatment Period 1|Adverse Event|0|||
147333230|NCT01212757|531385644|FG006|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
147268663|NCT00834912|531155133|FG005|Treatment Period 1|Adverse Event|0|||
147268664|NCT00834912|531155128|FG000|Treatment Period 2|Withdrawal by Subject|0|||
147333231|NCT01212757|531385645|FG007|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
147333232|NCT01212757|531385646|FG008|Long-Term Safety Phase (Year 5)|Non-compliance with study drug|0|||
147333233|NCT01212757|531385638|FG000|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
147333234|NCT01212757|531385639|FG001|Long-Term Safety Phase (Year 5)|Miscellaneous|1|||
147333235|NCT01212757|531385640|FG002|Long-Term Safety Phase (Year 5)|Miscellaneous|1|||
147268665|NCT00834912|531155129|FG001|Treatment Period 2|Withdrawal by Subject|0|||
147268666|NCT00834912|531155130|FG002|Treatment Period 2|Withdrawal by Subject|1|||
147268667|NCT00834912|531155131|FG003|Treatment Period 2|Withdrawal by Subject|0|||
147268668|NCT00834912|531155132|FG004|Treatment Period 2|Withdrawal by Subject|1|||
147268669|NCT00834912|531155133|FG005|Treatment Period 2|Withdrawal by Subject|0|||
147268670|NCT03044197|531155134|FG000|Overall Study|Withdrawal by Subject|3|||
147268671|NCT03044197|531155135|FG001|Overall Study|Withdrawal by Subject|1|||
147268672|NCT00262067|531155138|FG000|Overall Study|Death|190|||
147268673|NCT00262067|531155139|FG001|Overall Study|Death|89|||
147268674|NCT00262067|531155140|FG002|Overall Study|Death|186|||
147268675|NCT00262067|531155141|FG003|Overall Study|Death|99|||
147268676|NCT00262067|531155138|FG000|Overall Study|Lost to Follow-up|5|||
147268677|NCT00262067|531155139|FG001|Overall Study|Lost to Follow-up|4|||
147268678|NCT00262067|531155140|FG002|Overall Study|Lost to Follow-up|7|||
147268679|NCT00262067|531155141|FG003|Overall Study|Lost to Follow-up|5|||
147268680|NCT00262067|531155138|FG000|Overall Study|Sponsor's Decision to Terminate Study|1|||
147268681|NCT00262067|531155139|FG001|Overall Study|Sponsor's Decision to Terminate Study|0|||
147268682|NCT00262067|531155140|FG002|Overall Study|Sponsor's Decision to Terminate Study|0|||
147268683|NCT00262067|531155141|FG003|Overall Study|Sponsor's Decision to Terminate Study|0|||
147268684|NCT00262067|531155138|FG000|Overall Study|Patient Withdrew for Survival Follow-up|23|||
147268685|NCT00262067|531155139|FG001|Overall Study|Patient Withdrew for Survival Follow-up|7|||
147268686|NCT00262067|531155140|FG002|Overall Study|Patient Withdrew for Survival Follow-up|23|||
147268687|NCT00262067|531155141|FG003|Overall Study|Patient Withdrew for Survival Follow-up|9|||
147268688|NCT02849548|531155145|FG000|Overall Study|Lost to Follow-up|1|||
147268689|NCT02849548|531155146|FG001|Overall Study|Lost to Follow-up|2|||
147268690|NCT02849548|531155145|FG000|Overall Study|Protocol Violation|1|||
147268691|NCT02849548|531155146|FG001|Overall Study|Protocol Violation|0|||
147268692|NCT00714259|531155147|FG000|Overall Study|Death|2|||
147268693|NCT00256698|531155150|FG000|Overall Study|Withdrawal by Subject|7|||
147268694|NCT00256698|531155151|FG001|Overall Study|Withdrawal by Subject|7|||
147268695|NCT00256698|531155150|FG000|Overall Study|Adverse Event|13|||
147268696|NCT00256698|531155151|FG001|Overall Study|Adverse Event|6|||
147268697|NCT00256698|531155150|FG000|Overall Study|Protocol Violation|6|||
147268698|NCT00256698|531155151|FG001|Overall Study|Protocol Violation|5|||
147268699|NCT00256698|531155150|FG000|Overall Study|Lost to Follow-up|1|||
147268700|NCT00256698|531155151|FG001|Overall Study|Lost to Follow-up|3|||
147268701|NCT00256698|531155150|FG000|Overall Study|disease progression|97|||
147268702|NCT00256698|531155151|FG001|Overall Study|disease progression|105|||
147268703|NCT00256698|531155150|FG000|Overall Study|still ongoing at data cut-off|41|||
147268704|NCT00256698|531155151|FG001|Overall Study|still ongoing at data cut-off|46|||
147268705|NCT00256698|531155150|FG000|Overall Study|withdrawn due to osteoporosis|1|||
147268706|NCT00256698|531155151|FG001|Overall Study|withdrawn due to osteoporosis|0|||
147268707|NCT00256698|531155150|FG000|Overall Study|Prematurely Discontinued|1|||
147268708|NCT00256698|531155151|FG001|Overall Study|Prematurely Discontinued|0|||
147268709|NCT04477304|531155153|FG000|Overall Study|No valid opioid prescriptions during study timeframe|47|||
147268710|NCT04477304|531155154|FG001|Overall Study|No valid opioid prescriptions during study timeframe|26|||
147268711|NCT02777125|531155155|FG000|Overall Study|Consent form violation|14|||
147268712|NCT02777125|531155156|FG001|Overall Study|Consent form violation|12|||
147268713|NCT02777125|531155155|FG000|Overall Study|Assent form violation|21|||
147268714|NCT02777125|531155156|FG001|Overall Study|Assent form violation|23|||
147268715|NCT02777125|531155155|FG000|Overall Study|Protocol Violation|8|||
147268716|NCT02777125|531155156|FG001|Overall Study|Protocol Violation|12|||
147268717|NCT05168475|531156793|FG000|Period 1|Protocol Violation|1|||
147268718|NCT05168475|531156793|FG000|Period 1|IMP shortage|2|||
147268719|NCT05168475|531156793|FG000|Period 1|Not randomised|2|||
147268720|NCT05168475|531156793|FG000|Period 2|IMP shortage|1|||
147268721|NCT01589822|531156794|FG000|Overall Study|Withdrawal by Subject|1|||
147268722|NCT01589822|531156795|FG001|Overall Study|Withdrawal by Subject|2|||
147268723|NCT01589822|531156796|FG002|Overall Study|Withdrawal by Subject|0|||
147268724|NCT01589822|531156794|FG000|Overall Study|Death|1|||
147268725|NCT01589822|531156795|FG001|Overall Study|Death|0|||
147268726|NCT01589822|531156796|FG002|Overall Study|Death|0|||
147268727|NCT01589822|531156794|FG000|Overall Study|Missed 90 day visit|2|||
147268728|NCT01589822|531156795|FG001|Overall Study|Missed 90 day visit|1|||
147268729|NCT01589822|531156796|FG002|Overall Study|Missed 90 day visit|1|||
147268730|NCT01140477|531156797|FG000|Overall Study|Lost to Follow-up|4|||
147268731|NCT01140477|531156798|FG001|Overall Study|Lost to Follow-up|0|||
147268732|NCT01140477|531156797|FG000|Overall Study|Withdrawal by Subject|1|||
147333236|NCT01212757|531385641|FG003|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
147268733|NCT01140477|531156798|FG001|Overall Study|Withdrawal by Subject|4|||
147268734|NCT01140477|531156797|FG000|Overall Study|Surgical complication preventing implant|2|||
147268735|NCT01140477|531156798|FG001|Overall Study|Surgical complication preventing implant|0|||
147268736|NCT01140477|531156797|FG000|Overall Study|Death|1|||
147268737|NCT01140477|531156798|FG001|Overall Study|Death|1|||
147268738|NCT01140477|531156797|FG000|Overall Study|Subject explanted|0|||
147268739|NCT01140477|531156798|FG001|Overall Study|Subject explanted|1|||
147268740|NCT05723770|531156799|FG000|Overall Study|Lost to Follow-up|4|||
147268741|NCT05723770|531156799|FG000|Overall Study|Withdrawal by Subject|2|||
147268742|NCT01982253|531156801|FG000|Overall Study|Withdrawal by Subject|1|||
147268743|NCT01982253|531156802|FG001|Overall Study|Withdrawal by Subject|0|||
147268744|NCT01982253|531156803|FG002|Overall Study|Withdrawal by Subject|0|||
147268745|NCT01982253|531156801|FG000|Overall Study|Study terminated by sponsor|1|||
147268746|NCT01982253|531156802|FG001|Overall Study|Study terminated by sponsor|4|||
147268747|NCT01982253|531156803|FG002|Overall Study|Study terminated by sponsor|4|||
147268748|NCT03848845|531156804|FG000|Main Study Phase (Day 1 to Week 178)|Lost to Follow-up|0|||
147268749|NCT03848845|531156805|FG001|Main Study Phase (Day 1 to Week 178)|Lost to Follow-up|1|||
147268750|NCT03848845|531156806|FG002|Main Study Phase (Day 1 to Week 178)|Lost to Follow-up|0|||
147268751|NCT03848845|531156807|FG003|Main Study Phase (Day 1 to Week 178)|Lost to Follow-up|0|||
147268752|NCT03848845|531156804|FG000|Main Study Phase (Day 1 to Week 178)|Physician Decision|0|||
147268753|NCT03848845|531156805|FG001|Main Study Phase (Day 1 to Week 178)|Physician Decision|0|||
147268754|NCT03848845|531156806|FG002|Main Study Phase (Day 1 to Week 178)|Physician Decision|1|||
147268755|NCT03848845|531156807|FG003|Main Study Phase (Day 1 to Week 178)|Physician Decision|0|||
147268756|NCT03848845|531156804|FG000|Main Study Phase (Day 1 to Week 178)|Withdrawal by Subject|3|||
147268757|NCT03848845|531156805|FG001|Main Study Phase (Day 1 to Week 178)|Withdrawal by Subject|2|||
147268758|NCT03848845|531156806|FG002|Main Study Phase (Day 1 to Week 178)|Withdrawal by Subject|8|||
147268759|NCT03848845|531156807|FG003|Main Study Phase (Day 1 to Week 178)|Withdrawal by Subject|0|||
147268760|NCT03848845|531156804|FG000|PACT Phase (Week 178 to Week 221)|Withdrawal by Subject|0|||
147268761|NCT03848845|531156805|FG001|PACT Phase (Week 178 to Week 221)|Withdrawal by Subject|0|||
147268762|NCT03848845|531156806|FG002|PACT Phase (Week 178 to Week 221)|Withdrawal by Subject|0|||
147268763|NCT03848845|531156807|FG003|PACT Phase (Week 178 to Week 221)|Withdrawal by Subject|1|||
147268764|NCT00779675|531156808|FG000|Treatment Period|Adverse Event|87|||
147268765|NCT00779675|531156808|FG000|Treatment Period|Treatment Failure|80|||
147268766|NCT00779675|531156808|FG000|Treatment Period|Transferred to Another Study|38|||
147268767|NCT00779675|531156808|FG000|Treatment Period|Lost to Follow-up|23|||
147268768|NCT00779675|531156808|FG000|Treatment Period|Withdrawal by Subject|46|||
147268769|NCT00779675|531156808|FG000|Treatment Period|Protocol Violation|54|||
147268770|NCT00779675|531156808|FG000|Treatment Period|Did Not Meet Protocol Eligibility|1|||
147268771|NCT00779675|531156808|FG000|Treatment Period|Administrative|3|||
147268772|NCT00779675|531156808|FG000|Extended Treatment Period|Reasons unrelated to study treatment|9|||
147268773|NCT00779675|531156808|FG000|Extended Treatment Period|Protocol Violation|13|||
147268774|NCT00779675|531156808|FG000|Extended Treatment Period|Adverse Event|6|||
147268775|NCT00779675|531156808|FG000|Extended Treatment Period|Treatment Failure|11|||
147268776|NCT00779675|531156808|FG000|Extended Treatment Period|Protocol defined clinical event|1|||
147268777|NCT00779675|531156808|FG000|Extended Treatment Period|Lost to Follow-up|6|||
147268778|NCT02365636|531156812|FG000|Overall Study|Adverse Event|3|||
147268779|NCT02365636|531156813|FG001|Overall Study|Adverse Event|3|||
147268780|NCT02365636|531156814|FG002|Overall Study|Adverse Event|2|||
147268781|NCT02365636|531156812|FG000|Overall Study|Protocol Violation|1|||
147268782|NCT02365636|531156813|FG001|Overall Study|Protocol Violation|4|||
147268783|NCT02365636|531156814|FG002|Overall Study|Protocol Violation|0|||
147268784|NCT02365636|531156812|FG000|Overall Study|Lost to Follow-up|0|||
147268785|NCT02365636|531156813|FG001|Overall Study|Lost to Follow-up|0|||
147268786|NCT02365636|531156814|FG002|Overall Study|Lost to Follow-up|1|||
147268787|NCT02365636|531156812|FG000|Overall Study|Other|2|||
147268788|NCT02365636|531156813|FG001|Overall Study|Other|0|||
147268789|NCT02365636|531156814|FG002|Overall Study|Other|0|||
147268790|NCT00355238|531156821|FG000|Overall Study|Adverse event unrelated to study drug|2|||
147268791|NCT00355238|531156822|FG001|Overall Study|Adverse event unrelated to study drug|2|||
147268792|NCT00355238|531156823|FG002|Overall Study|Adverse event unrelated to study drug|0|||
147268793|NCT00355238|531156824|FG003|Overall Study|Adverse event unrelated to study drug|1|||
147268794|NCT00355238|531156821|FG000|Overall Study|Death|1|||
147268795|NCT00355238|531156822|FG001|Overall Study|Death|0|||
147268796|NCT00355238|531156823|FG002|Overall Study|Death|0|||
147268797|NCT00355238|531156824|FG003|Overall Study|Death|0|||
147268798|NCT00355238|531156821|FG000|Overall Study|Disease progression|37|||
147268799|NCT00355238|531156822|FG001|Overall Study|Disease progression|36|||
147268800|NCT00355238|531156823|FG002|Overall Study|Disease progression|16|||
147268801|NCT00355238|531156824|FG003|Overall Study|Disease progression|11|||
147268802|NCT00355238|531156821|FG000|Overall Study|Study drug toxicity|11|||
147268803|NCT00355238|531156822|FG001|Overall Study|Study drug toxicity|7|||
147268804|NCT00355238|531156823|FG002|Overall Study|Study drug toxicity|5|||
147268805|NCT00355238|531156824|FG003|Overall Study|Study drug toxicity|2|||
147268806|NCT00355238|531156821|FG000|Overall Study|Participant withdrew consent|3|||
147268807|NCT00355238|531156822|FG001|Overall Study|Participant withdrew consent|1|||
147268808|NCT00355238|531156823|FG002|Overall Study|Participant withdrew consent|0|||
147268809|NCT00355238|531156824|FG003|Overall Study|Participant withdrew consent|0|||
147268810|NCT00355238|531156821|FG000|Overall Study|Participant request to discontinue study treatment|1|||
147268811|NCT00355238|531156822|FG001|Overall Study|Participant request to discontinue study treatment|0|||
147268812|NCT00355238|531156823|FG002|Overall Study|Participant request to discontinue study treatment|1|||
147268813|NCT00355238|531156824|FG003|Overall Study|Participant request to discontinue study treatment|0|||
147268814|NCT01454934|531156825|FG000|Overall Study|Clinical progression|28|||
147268815|NCT01454934|531156826|FG001|Overall Study|Clinical progression|25|||
147268816|NCT01454934|531156825|FG000|Overall Study|Other|6|||
147268817|NCT01454934|531156826|FG001|Overall Study|Other|17|||
147268818|NCT01454934|531156825|FG000|Overall Study|Adverse Event|28|||
147268819|NCT01454934|531156826|FG001|Overall Study|Adverse Event|24|||
147268820|NCT01454934|531156825|FG000|Overall Study|Withdrawn consent|2|||
147268821|NCT01454934|531156826|FG001|Overall Study|Withdrawn consent|5|||
147268822|NCT01454934|531156825|FG000|Overall Study|Withdrawal by Subject|11|||
147268823|NCT01454934|531156826|FG001|Overall Study|Withdrawal by Subject|15|||
147268824|NCT01454934|531156825|FG000|Overall Study|Disease progression|194|||
147268825|NCT01454934|531156826|FG001|Overall Study|Disease progression|181|||
147268826|NCT01454934|531156825|FG000|Overall Study|Lost to Follow-up|0|||
147268827|NCT01454934|531156826|FG001|Overall Study|Lost to Follow-up|1|||
147268828|NCT01454934|531156825|FG000|Overall Study|Not treated|1|||
147268829|NCT01454934|531156826|FG001|Overall Study|Not treated|2|||
147268830|NCT01956110|531156827|FG000|Overall Study|Protocol Violation|25|||
147268831|NCT01956110|531156828|FG001|Overall Study|Protocol Violation|11|||
147268832|NCT01956110|531156827|FG000|Overall Study|Adverse Event|9|||
147268833|NCT01956110|531156828|FG001|Overall Study|Adverse Event|10|||
147268834|NCT01956110|531156827|FG000|Overall Study|Personal reasons|1|||
147268835|NCT01956110|531156828|FG001|Overall Study|Personal reasons|1|||
147268836|NCT03325166|531156835|FG000|Overall Study|Adverse Event|1|||
147268837|NCT01633944|531156836|FG000|Open-label Titration Phase|Adverse Event|109|||
147268838|NCT01633944|531156837|FG001|Open-label Titration Phase|Adverse Event|0|||
147268839|NCT01633944|531156838|FG002|Open-label Titration Phase|Adverse Event|0|||
147268840|NCT01633944|531156836|FG000|Open-label Titration Phase|Lack of Efficacy|33|||
147268841|NCT01633944|531156837|FG001|Open-label Titration Phase|Lack of Efficacy|0|||
147268842|NCT01633944|531156838|FG002|Open-label Titration Phase|Lack of Efficacy|0|||
147268843|NCT01633944|531156836|FG000|Open-label Titration Phase|Withdrawal by Subject|34|||
147268844|NCT01633944|531156837|FG001|Open-label Titration Phase|Withdrawal by Subject|0|||
147268845|NCT01633944|531156838|FG002|Open-label Titration Phase|Withdrawal by Subject|0|||
147268846|NCT01633944|531156836|FG000|Open-label Titration Phase|Protocol Violation|24|||
147268847|NCT01633944|531156837|FG001|Open-label Titration Phase|Protocol Violation|0|||
147268848|NCT01633944|531156838|FG002|Open-label Titration Phase|Protocol Violation|0|||
147268849|NCT01633944|531156836|FG000|Open-label Titration Phase|Lost to Follow-up|22|||
147268850|NCT01633944|531156837|FG001|Open-label Titration Phase|Lost to Follow-up|0|||
147268851|NCT01633944|531156838|FG002|Open-label Titration Phase|Lost to Follow-up|0|||
147268852|NCT01633944|531156836|FG000|Open-label Titration Phase|Other|68|||
147268853|NCT01633944|531156837|FG001|Open-label Titration Phase|Other|0|||
147268854|NCT01633944|531156838|FG002|Open-label Titration Phase|Other|0|||
147268855|NCT01633944|531156836|FG000|Double-blind Treatment Phase|Adverse Event|0|||
147268856|NCT01633944|531156837|FG001|Double-blind Treatment Phase|Adverse Event|13|||
147268857|NCT01633944|531156838|FG002|Double-blind Treatment Phase|Adverse Event|7|||
147268858|NCT01633944|531156836|FG000|Double-blind Treatment Phase|Lack of Efficacy|0|||
147268859|NCT01633944|531156837|FG001|Double-blind Treatment Phase|Lack of Efficacy|8|||
147268860|NCT01633944|531156838|FG002|Double-blind Treatment Phase|Lack of Efficacy|23|||
147268861|NCT01633944|531156836|FG000|Double-blind Treatment Phase|Withdrawal by Subject|0|||
147268862|NCT01633944|531156837|FG001|Double-blind Treatment Phase|Withdrawal by Subject|11|||
147268863|NCT01633944|531156838|FG002|Double-blind Treatment Phase|Withdrawal by Subject|8|||
147268864|NCT01633944|531156836|FG000|Double-blind Treatment Phase|Protocol Violation|0|||
147268865|NCT01633944|531156837|FG001|Double-blind Treatment Phase|Protocol Violation|7|||
147268866|NCT01633944|531156838|FG002|Double-blind Treatment Phase|Protocol Violation|10|||
147268867|NCT01633944|531156836|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
147268868|NCT01633944|531156837|FG001|Double-blind Treatment Phase|Lost to Follow-up|4|||
147268869|NCT01633944|531156838|FG002|Double-blind Treatment Phase|Lost to Follow-up|9|||
147268870|NCT01633944|531156836|FG000|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|0|||
147268871|NCT01633944|531156837|FG001|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|3|||
147268872|NCT01633944|531156838|FG002|Double-blind Treatment Phase|Withdrawal due to opioid withdrawal|1|||
147268873|NCT01633944|531156836|FG000|Double-blind Treatment Phase|Not exposed to DB study medication|0|||
147268874|NCT01633944|531156837|FG001|Double-blind Treatment Phase|Not exposed to DB study medication|1|||
147268875|NCT01633944|531156838|FG002|Double-blind Treatment Phase|Not exposed to DB study medication|0|||
147268876|NCT01633944|531156836|FG000|Double-blind Treatment Phase|Other|0|||
147268877|NCT01633944|531156837|FG001|Double-blind Treatment Phase|Other|7|||
147268878|NCT01633944|531156838|FG002|Double-blind Treatment Phase|Other|0|||
147268879|NCT00463060|531156842|FG000|Phase 1-Radiation 50Gy +Sunitinib 50mg|acute toxicity|5|||
147600287|NCT03893565|532356361|FG004|Double-blind Induction Phase (10 Weeks)|Other|1|||
147333237|NCT01212757|531385642|FG004|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
147333238|NCT01212757|531385643|FG005|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
147333239|NCT01212757|531385644|FG006|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
147333240|NCT01212757|531385645|FG007|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
147333241|NCT01212757|531385646|FG008|Long-Term Safety Phase (Year 5)|Miscellaneous|0|||
147333242|NCT00573833|531385647|FG000|Overall Study|Not Treated|2|||
147333243|NCT04493242|531385648|FG000|Overall Study|Death|10|||
147333244|NCT04493242|531385649|FG001|Overall Study|Death|14|||
147333245|NCT04493242|531385650|FG002|Overall Study|Death|16|||
147333246|NCT04493242|531385648|FG000|Overall Study|Lost to Follow-up|1|||
147268880|NCT00463060|531156842|FG000|Phase 2-Radiation 50Gy +Sunitinib 37.5mg|Withdrawal by Subject|1|||
147268881|NCT01400841|531156843|FG000|Initial Study Phase (6 Months)|Death|1|||
147268882|NCT01400841|531156843|FG000|Extended Study Phase (2 Years)|Adverse Event|2|||
147268883|NCT00701129|531156844|FG000|Overall Study|Death|2|||
147268884|NCT00910715|531156845|FG000|Overall Study|Lost to Follow-up|22|||
147268885|NCT00910715|531156846|FG001|Overall Study|Lost to Follow-up|26|||
147268886|NCT00910715|531156847|FG002|Overall Study|Lost to Follow-up|0|||
147268887|NCT02884089|531156848|FG000|Period 1|Dosing error|2|||
147268888|NCT02884089|531156849|FG001|Period 1|Dosing error|2|||
147268889|NCT02884089|531156850|FG002|Period 1|Dosing error|0|||
147268890|NCT02884089|531156851|FG003|Period 1|Dosing error|0|||
147268891|NCT02884089|531156848|FG000|Washout Period 1|Lost to Follow-up|0|||
147268892|NCT02884089|531156849|FG001|Washout Period 1|Lost to Follow-up|1|||
147268893|NCT02884089|531156850|FG002|Washout Period 1|Lost to Follow-up|0|||
147268894|NCT02884089|531156851|FG003|Washout Period 1|Lost to Follow-up|1|||
147268895|NCT02884089|531156848|FG000|Washout Period 1|Withdrawal by Subject|0|||
147268896|NCT02884089|531156849|FG001|Washout Period 1|Withdrawal by Subject|1|||
147268897|NCT02884089|531156850|FG002|Washout Period 1|Withdrawal by Subject|0|||
147268898|NCT02884089|531156851|FG003|Washout Period 1|Withdrawal by Subject|0|||
147268899|NCT02884089|531156848|FG000|Period 2|Adverse Event|1|||
147268900|NCT02884089|531156849|FG001|Period 2|Adverse Event|0|||
147268901|NCT02884089|531156850|FG002|Period 2|Adverse Event|0|||
147268902|NCT02884089|531156851|FG003|Period 2|Adverse Event|0|||
147268903|NCT02884089|531156848|FG000|Period 3|Withdrawal by Subject|0|||
147268904|NCT02884089|531156849|FG001|Period 3|Withdrawal by Subject|0|||
147268905|NCT02884089|531156850|FG002|Period 3|Withdrawal by Subject|1|||
147268906|NCT02884089|531156851|FG003|Period 3|Withdrawal by Subject|0|||
147268907|NCT02884089|531156848|FG000|Washout Period 3|Withdrawal by Subject|0|||
147268908|NCT02884089|531156849|FG001|Washout Period 3|Withdrawal by Subject|0|||
147268909|NCT02884089|531156850|FG002|Washout Period 3|Withdrawal by Subject|1|||
147268910|NCT02884089|531156851|FG003|Washout Period 3|Withdrawal by Subject|0|||
147268911|NCT02884089|531156848|FG000|Washout Period 3|Lost to Follow-up|0|||
147268912|NCT02884089|531156849|FG001|Washout Period 3|Lost to Follow-up|0|||
147268913|NCT02884089|531156850|FG002|Washout Period 3|Lost to Follow-up|0|||
147268914|NCT02884089|531156851|FG003|Washout Period 3|Lost to Follow-up|1|||
147268915|NCT02884089|531156848|FG000|Period 4|Withdrawal by Subject|0|||
147268916|NCT02884089|531156849|FG001|Period 4|Withdrawal by Subject|1|||
147268917|NCT02884089|531156850|FG002|Period 4|Withdrawal by Subject|0|||
147268918|NCT02884089|531156851|FG003|Period 4|Withdrawal by Subject|0|||
147268919|NCT02884089|531156848|FG000|Period 4|Lost to Follow-up|1|||
147268920|NCT02884089|531156849|FG001|Period 4|Lost to Follow-up|0|||
147268921|NCT02884089|531156850|FG002|Period 4|Lost to Follow-up|0|||
147268922|NCT02884089|531156851|FG003|Period 4|Lost to Follow-up|0|||
147268923|NCT02884089|531156848|FG000|Follow-up Visit|Withdrawal by Subject|1|||
147268924|NCT02884089|531156849|FG001|Follow-up Visit|Withdrawal by Subject|0|||
147268925|NCT02884089|531156850|FG002|Follow-up Visit|Withdrawal by Subject|0|||
147268926|NCT02884089|531156851|FG003|Follow-up Visit|Withdrawal by Subject|1|||
147268927|NCT01467076|531156852|FG000|Overall Study|Lost to Follow-up|1|||
147268928|NCT01467076|531156853|FG001|Overall Study|Lost to Follow-up|0|||
147268929|NCT01467076|531156854|FG002|Overall Study|Lost to Follow-up|0|||
147268930|NCT03354429|531156855|FG000|Overall Study|Withdrawal by Subject|8|||
147268931|NCT03354429|531156856|FG001|Overall Study|Withdrawal by Subject|7|||
147268932|NCT03354429|531156855|FG000|Overall Study|Lost to Follow-up|1|||
147268933|NCT03354429|531156856|FG001|Overall Study|Lost to Follow-up|0|||
147268934|NCT02624284|531156857|FG000|Overall Study|Withdrawal by Subject|3|||
147268935|NCT02624284|531156858|FG001|Overall Study|Withdrawal by Subject|6|||
147268936|NCT02624284|531156859|FG002|Overall Study|Withdrawal by Subject|3|||
147268937|NCT02624284|531156857|FG000|Overall Study|Protocol Violation|9|||
147268938|NCT02624284|531156858|FG001|Overall Study|Protocol Violation|10|||
147333247|NCT04493242|531385649|FG001|Overall Study|Lost to Follow-up|1|||
147450311|NCT03016325|531811403|FG004|182-Day Follow-Up Period|Death|9|||
147268939|NCT02624284|531156859|FG002|Overall Study|Protocol Violation|7|||
147268940|NCT02624284|531156857|FG000|Overall Study|Revealed exclusionary condition|2|||
147268941|NCT02624284|531156858|FG001|Overall Study|Revealed exclusionary condition|2|||
147268942|NCT02624284|531156859|FG002|Overall Study|Revealed exclusionary condition|0|||
147268943|NCT02624284|531156857|FG000|Overall Study|Adverse Event|0|||
147268944|NCT02624284|531156858|FG001|Overall Study|Adverse Event|0|||
147333248|NCT04493242|531385650|FG002|Overall Study|Lost to Follow-up|0|||
147268945|NCT02624284|531156859|FG002|Overall Study|Adverse Event|1|||
147268946|NCT05923229|531156860|FG000|Overall Study|Withdrawal by Subject|3|||
147268947|NCT05923229|531156861|FG001|Overall Study|Withdrawal by Subject|0|||
147268948|NCT05923229|531156860|FG000|Overall Study|Health related|2|||
147268949|NCT05923229|531156861|FG001|Overall Study|Health related|1|||
147268950|NCT03064126|531156862|FG000|Overall Study|Death|40|||
147268951|NCT03064126|531156863|FG001|Overall Study|Death|16|||
147268952|NCT03064126|531156864|FG002|Overall Study|Death|4|||
147268953|NCT03064126|531156865|FG003|Overall Study|Death|2|||
147268954|NCT03064126|531156862|FG000|Overall Study|Withdrawal by Subject|17|||
147268955|NCT03064126|531156863|FG001|Overall Study|Withdrawal by Subject|9|||
147268956|NCT03064126|531156864|FG002|Overall Study|Withdrawal by Subject|0|||
147268957|NCT03064126|531156865|FG003|Overall Study|Withdrawal by Subject|2|||
147268958|NCT03064126|531156862|FG000|Overall Study|Lost to Follow-up|7|||
147268959|NCT03064126|531156863|FG001|Overall Study|Lost to Follow-up|3|||
147268960|NCT03064126|531156864|FG002|Overall Study|Lost to Follow-up|0|||
147268961|NCT03064126|531156865|FG003|Overall Study|Lost to Follow-up|0|||
147268962|NCT03064126|531156862|FG000|Overall Study|Adverse Event|2|||
147268963|NCT03064126|531156863|FG001|Overall Study|Adverse Event|0|||
147268964|NCT03064126|531156864|FG002|Overall Study|Adverse Event|0|||
147268965|NCT03064126|531156865|FG003|Overall Study|Adverse Event|0|||
147268966|NCT03064126|531156862|FG000|Overall Study|Physician Decision|3|||
147268967|NCT03064126|531156863|FG001|Overall Study|Physician Decision|0|||
147268968|NCT03064126|531156864|FG002|Overall Study|Physician Decision|0|||
147268969|NCT03064126|531156865|FG003|Overall Study|Physician Decision|0|||
147268970|NCT03064126|531156862|FG000|Overall Study|Other reason for early termination|3|||
147268971|NCT03064126|531156863|FG001|Overall Study|Other reason for early termination|2|||
147268972|NCT03064126|531156864|FG002|Overall Study|Other reason for early termination|0|||
147268973|NCT03064126|531156865|FG003|Overall Study|Other reason for early termination|0|||
147268974|NCT03064126|531156862|FG000|Overall Study|Missed Visit|3|||
147268975|NCT03064126|531156863|FG001|Overall Study|Missed Visit|1|||
147268976|NCT03064126|531156864|FG002|Overall Study|Missed Visit|0|||
147268977|NCT03064126|531156865|FG003|Overall Study|Missed Visit|0|||
147268978|NCT05288556|531156869|FG000|Overall Study|Protocol Violation|1|||
147268979|NCT05288556|531156869|FG000|Overall Study|Withdrawal by Subject|1|||
147268980|NCT02465528|531156870|FG000|Overall Study|Progressive disease|0|||
147268981|NCT02465528|531156871|FG001|Overall Study|Progressive disease|2|||
147268982|NCT02465528|531156872|FG002|Overall Study|Progressive disease|9|||
147268983|NCT02465528|531156873|FG003|Overall Study|Progressive disease|4|||
147268984|NCT02465528|531156870|FG000|Overall Study|Study terminated by sponsor|1|||
147268985|NCT02465528|531156871|FG001|Overall Study|Study terminated by sponsor|2|||
147268986|NCT02465528|531156872|FG002|Overall Study|Study terminated by sponsor|0|||
147268987|NCT02465528|531156873|FG003|Overall Study|Study terminated by sponsor|0|||
147268988|NCT02465528|531156870|FG000|Overall Study|Withdrawal by Subject|0|||
147268989|NCT02465528|531156871|FG001|Overall Study|Withdrawal by Subject|0|||
147268990|NCT02465528|531156872|FG002|Overall Study|Withdrawal by Subject|2|||
147268991|NCT02465528|531156873|FG003|Overall Study|Withdrawal by Subject|0|||
147268992|NCT02465528|531156870|FG000|Overall Study|Adverse Event|0|||
147268993|NCT02465528|531156871|FG001|Overall Study|Adverse Event|0|||
147333249|NCT04493242|531385648|FG000|Overall Study|Withdrawal by Subject|1|||
147268994|NCT02465528|531156872|FG002|Overall Study|Adverse Event|0|||
147268995|NCT02465528|531156873|FG003|Overall Study|Adverse Event|1|||
147333250|NCT04493242|531385649|FG001|Overall Study|Withdrawal by Subject|0|||
147333251|NCT04493242|531385650|FG002|Overall Study|Withdrawal by Subject|0|||
147333252|NCT04493242|531385648|FG000|Overall Study|Subjects Discharged from Hospital Prior to End of Study|1|||
147333253|NCT04493242|531385649|FG001|Overall Study|Subjects Discharged from Hospital Prior to End of Study|1|||
147333254|NCT04493242|531385650|FG002|Overall Study|Subjects Discharged from Hospital Prior to End of Study|0|||
147333255|NCT04493242|531385648|FG000|Overall Study|Subjects Whose Status as of the End of Study Was Unknown|1|||
147333256|NCT04493242|531385649|FG001|Overall Study|Subjects Whose Status as of the End of Study Was Unknown|2|||
147268996|NCT02465528|531156870|FG000|Overall Study|Physician Decision|0|||
147268997|NCT02465528|531156871|FG001|Overall Study|Physician Decision|0|||
147268998|NCT02465528|531156872|FG002|Overall Study|Physician Decision|1|||
147268999|NCT02465528|531156873|FG003|Overall Study|Physician Decision|0|||
147269000|NCT01428193|531156884|FG000|Overall Study|Physician Decision|1|||
147269001|NCT01428193|531156884|FG000|Overall Study|Elevated screening liver enzymes|1|||
147269002|NCT03762083|531156885|FG000|Overall Study|Withdrawal by Subject|2|||
147269003|NCT03762083|531156885|FG000|Overall Study|Physician Decision|1|||
147269004|NCT02027844|531156886|FG000|Overall Study|Withdrawal by Subject|3|||
147269005|NCT02027844|531156887|FG001|Overall Study|Withdrawal by Subject|2|||
147269006|NCT02027844|531156888|FG002|Overall Study|Withdrawal by Subject|1|||
147269007|NCT02027844|531156886|FG000|Overall Study|Lost to Follow-up|0|||
147269008|NCT02027844|531156887|FG001|Overall Study|Lost to Follow-up|2|||
147450312|NCT03016325|531811404|FG005|182-Day Follow-Up Period|Death|0|||
147269009|NCT02027844|531156888|FG002|Overall Study|Lost to Follow-up|1|||
147269010|NCT02027844|531156886|FG000|Overall Study|Protocol Violation|0|||
147269011|NCT02027844|531156887|FG001|Overall Study|Protocol Violation|2|||
147269012|NCT02027844|531156888|FG002|Overall Study|Protocol Violation|0|||
147269013|NCT02027844|531156886|FG000|Overall Study|Incomlete data|2|||
147269014|NCT02027844|531156887|FG001|Overall Study|Incomlete data|0|||
147269015|NCT02027844|531156888|FG002|Overall Study|Incomlete data|0|||
147269016|NCT03837899|531156889|FG000|Overall Study|Death|6|||
147269017|NCT03837899|531156890|FG001|Overall Study|Death|8|||
147269018|NCT03837899|531156891|FG002|Overall Study|Death|3|||
147333257|NCT04493242|531385650|FG002|Overall Study|Subjects Whose Status as of the End of Study Was Unknown|1|||
147450313|NCT03016325|531811405|FG006|182-Day Follow-Up Period|Death|0|||
147450314|NCT03016325|531811406|FG007|182-Day Follow-Up Period|Death|1|||
147450315|NCT03016325|531811399|FG000|182-Day Follow-Up Period|Alive, per national insurance system|1|||
147269019|NCT03837899|531156892|FG003|Overall Study|Death|7|||
147269020|NCT03837899|531156893|FG004|Overall Study|Death|8|||
147269021|NCT03837899|531156894|FG005|Overall Study|Death|7|||
147269022|NCT03837899|531156889|FG000|Overall Study|Moved to post-trial access program|0|||
147269023|NCT03837899|531156890|FG001|Overall Study|Moved to post-trial access program|1|||
147269024|NCT03837899|531156891|FG002|Overall Study|Moved to post-trial access program|0|||
147269025|NCT03837899|531156892|FG003|Overall Study|Moved to post-trial access program|0|||
147269026|NCT03837899|531156893|FG004|Overall Study|Moved to post-trial access program|0|||
147269027|NCT03837899|531156894|FG005|Overall Study|Moved to post-trial access program|0|||
147450316|NCT03016325|531811400|FG001|182-Day Follow-Up Period|Alive, per national insurance system|0|||
147450317|NCT03016325|531811401|FG002|182-Day Follow-Up Period|Alive, per national insurance system|0|||
147450318|NCT03016325|531811402|FG003|182-Day Follow-Up Period|Alive, per national insurance system|0|||
147450319|NCT03016325|531811403|FG004|182-Day Follow-Up Period|Alive, per national insurance system|0|||
147450320|NCT03016325|531811404|FG005|182-Day Follow-Up Period|Alive, per national insurance system|0|||
147450321|NCT03016325|531811405|FG006|182-Day Follow-Up Period|Alive, per national insurance system|0|||
147450322|NCT03016325|531811406|FG007|182-Day Follow-Up Period|Alive, per national insurance system|0|||
147450323|NCT03016325|531811399|FG000|182-Day Follow-Up Period|Participant withdrew consent|0|||
147450324|NCT03016325|531811400|FG001|182-Day Follow-Up Period|Participant withdrew consent|0|||
147450325|NCT03016325|531811401|FG002|182-Day Follow-Up Period|Participant withdrew consent|0|||
147450326|NCT03016325|531811402|FG003|182-Day Follow-Up Period|Participant withdrew consent|0|||
147450327|NCT03016325|531811403|FG004|182-Day Follow-Up Period|Participant withdrew consent|1|||
147450328|NCT03016325|531811404|FG005|182-Day Follow-Up Period|Participant withdrew consent|0|||
147450329|NCT03016325|531811405|FG006|182-Day Follow-Up Period|Participant withdrew consent|1|||
147450330|NCT03016325|531811406|FG007|182-Day Follow-Up Period|Participant withdrew consent|0|||
147450331|NCT03016325|531811399|FG000|182-Day Follow-Up Period|Alive, per Family doctor|0|||
147450332|NCT03016325|531811400|FG001|182-Day Follow-Up Period|Alive, per Family doctor|0|||
147450333|NCT03016325|531811401|FG002|182-Day Follow-Up Period|Alive, per Family doctor|0|||
147450334|NCT03016325|531811402|FG003|182-Day Follow-Up Period|Alive, per Family doctor|0|||
147450335|NCT03016325|531811403|FG004|182-Day Follow-Up Period|Alive, per Family doctor|1|||
147450336|NCT03016325|531811404|FG005|182-Day Follow-Up Period|Alive, per Family doctor|0|||
147450337|NCT03016325|531811405|FG006|182-Day Follow-Up Period|Alive, per Family doctor|0|||
147450338|NCT03016325|531811406|FG007|182-Day Follow-Up Period|Alive, per Family doctor|0|||
147450339|NCT03016325|531811399|FG000|182-Day Follow-Up Period|Alive, per civil unit|0|||
147450340|NCT03016325|531811400|FG001|182-Day Follow-Up Period|Alive, per civil unit|0|||
147450341|NCT03016325|531811401|FG002|182-Day Follow-Up Period|Alive, per civil unit|0|||
147450342|NCT03016325|531811402|FG003|182-Day Follow-Up Period|Alive, per civil unit|0|||
147269028|NCT03837899|531156889|FG000|Overall Study|Other|0|||
147269029|NCT03837899|531156890|FG001|Overall Study|Other|0|||
147269030|NCT03837899|531156891|FG002|Overall Study|Other|0|||
147269031|NCT03837899|531156892|FG003|Overall Study|Other|0|||
147269032|NCT03837899|531156893|FG004|Overall Study|Other|0|||
147269033|NCT03837899|531156894|FG005|Overall Study|Other|2|||
147269034|NCT03837899|531156889|FG000|Overall Study|Lost to Follow-up|0|||
147269035|NCT03837899|531156890|FG001|Overall Study|Lost to Follow-up|1|||
147269036|NCT03837899|531156891|FG002|Overall Study|Lost to Follow-up|0|||
147269037|NCT03837899|531156892|FG003|Overall Study|Lost to Follow-up|0|||
147450343|NCT03016325|531811403|FG004|182-Day Follow-Up Period|Alive, per civil unit|1|||
147269038|NCT03837899|531156893|FG004|Overall Study|Lost to Follow-up|0|||
147269039|NCT03837899|531156894|FG005|Overall Study|Lost to Follow-up|0|||
147269040|NCT03837899|531156889|FG000|Overall Study|Withdrawal by Subject|0|||
147450344|NCT03016325|531811404|FG005|182-Day Follow-Up Period|Alive, per civil unit|0|||
147450345|NCT03016325|531811405|FG006|182-Day Follow-Up Period|Alive, per civil unit|0|||
147450346|NCT03016325|531811406|FG007|182-Day Follow-Up Period|Alive, per civil unit|0|||
147450347|NCT03016325|531811399|FG000|182-Day Follow-Up Period|Vital status collected via EMR|0|||
147450348|NCT03016325|531811400|FG001|182-Day Follow-Up Period|Vital status collected via EMR|0|||
147450349|NCT03016325|531811401|FG002|182-Day Follow-Up Period|Vital status collected via EMR|0|||
147450350|NCT03016325|531811402|FG003|182-Day Follow-Up Period|Vital status collected via EMR|1|||
147269041|NCT03837899|531156890|FG001|Overall Study|Withdrawal by Subject|0|||
147269042|NCT03837899|531156891|FG002|Overall Study|Withdrawal by Subject|0|||
147269043|NCT03837899|531156892|FG003|Overall Study|Withdrawal by Subject|1|||
147269044|NCT03837899|531156893|FG004|Overall Study|Withdrawal by Subject|0|||
147269045|NCT03837899|531156894|FG005|Overall Study|Withdrawal by Subject|0|||
147269046|NCT03837899|531156889|FG000|Overall Study|Study specific discontinuation criteria|0|||
147269047|NCT03837899|531156890|FG001|Overall Study|Study specific discontinuation criteria|1|||
147269048|NCT03837899|531156891|FG002|Overall Study|Study specific discontinuation criteria|0|||
147269049|NCT03837899|531156892|FG003|Overall Study|Study specific discontinuation criteria|0|||
147269050|NCT03837899|531156893|FG004|Overall Study|Study specific discontinuation criteria|3|||
147269051|NCT03837899|531156894|FG005|Overall Study|Study specific discontinuation criteria|1|||
147269052|NCT01554618|531156895|FG000|Randomized Through Start of Treatment|Adverse Event|1|||
147269053|NCT01554618|531156896|FG001|Randomized Through Start of Treatment|Adverse Event|0|||
147269054|NCT01554618|531156895|FG000|Controlled Assessment Period|Lost to Follow-up|2|||
147269055|NCT01554618|531156896|FG001|Controlled Assessment Period|Lost to Follow-up|1|||
147269056|NCT01554618|531156895|FG000|Controlled Assessment Period|Withdrawal by Subject|6|||
147269057|NCT01554618|531156896|FG001|Controlled Assessment Period|Withdrawal by Subject|0|||
147269058|NCT01554618|531156895|FG000|Open-Label Extension Period|Withdrawal by Subject|2|||
147269059|NCT01554618|531156896|FG001|Open-Label Extension Period|Withdrawal by Subject|3|||
147269060|NCT01554618|531156895|FG000|Open-Label Extension Period|Physician Decision|0|||
147269061|NCT01554618|531156896|FG001|Open-Label Extension Period|Physician Decision|1|||
147269062|NCT01554618|531156895|FG000|Open-Label Extension Period|Lost to Follow-up|1|||
147269063|NCT01554618|531156896|FG001|Open-Label Extension Period|Lost to Follow-up|1|||
147269064|NCT00477672|531156897|FG000|Overall Study|Adverse Event|3|||
147269065|NCT00477672|531156898|FG001|Overall Study|Adverse Event|5|||
147269066|NCT00477672|531156899|FG002|Overall Study|Adverse Event|6|||
147269067|NCT00477672|531156897|FG000|Overall Study|Death|0|||
147269068|NCT00477672|531156898|FG001|Overall Study|Death|1|||
147269069|NCT00477672|531156899|FG002|Overall Study|Death|0|||
147269070|NCT00477672|531156897|FG000|Overall Study|Disease progression|0|||
147269071|NCT00477672|531156898|FG001|Overall Study|Disease progression|1|||
147269072|NCT00477672|531156899|FG002|Overall Study|Disease progression|0|||
147269073|NCT00477672|531156897|FG000|Overall Study|Physician Decision|1|||
147269074|NCT00477672|531156898|FG001|Overall Study|Physician Decision|0|||
147269075|NCT00477672|531156899|FG002|Overall Study|Physician Decision|0|||
147269076|NCT00477672|531156897|FG000|Overall Study|Protocol noncompliance|0|||
147269077|NCT00477672|531156898|FG001|Overall Study|Protocol noncompliance|2|||
147269078|NCT00477672|531156899|FG002|Overall Study|Protocol noncompliance|0|||
147269079|NCT00477672|531156897|FG000|Overall Study|Consent withdrawn|2|||
147269080|NCT00477672|531156898|FG001|Overall Study|Consent withdrawn|5|||
147269081|NCT00477672|531156899|FG002|Overall Study|Consent withdrawn|10|||
147269082|NCT00477672|531156897|FG000|Overall Study|Discretion of Sponsor|1|||
147269083|NCT00477672|531156898|FG001|Overall Study|Discretion of Sponsor|2|||
147269084|NCT00477672|531156899|FG002|Overall Study|Discretion of Sponsor|0|||
147269085|NCT02722928|531156902|FG000|Overall Study|Standard CT was not as required per prot|5|||
147269086|NCT02722928|531156903|FG001|Overall Study|Standard CT was not as required per prot|13|||
147269087|NCT02722928|531156902|FG000|Overall Study|Required Intraoperative MRI|5|||
147269088|NCT02722928|531156903|FG001|Overall Study|Required Intraoperative MRI|7|||
147269089|NCT04011410|531156904|FG000|Overall Study|Withdrawal by Subject|1|||
147269090|NCT02275481|531156905|FG000|Overall Study|Death|2|||
147269091|NCT02275481|531156906|FG001|Overall Study|Death|1|||
147269092|NCT02275481|531156905|FG000|Overall Study|Lost to Follow-up|2|||
147269093|NCT02275481|531156906|FG001|Overall Study|Lost to Follow-up|0|||
147269094|NCT02275481|531156905|FG000|Overall Study|Withdrawal by Subject|3|||
147269095|NCT02275481|531156906|FG001|Overall Study|Withdrawal by Subject|0|||
147269096|NCT02275481|531156905|FG000|Overall Study|all other reasons combined|2|||
147269097|NCT02275481|531156906|FG001|Overall Study|all other reasons combined|1|||
147269098|NCT02275481|531156905|FG000|Overall Study|Physician Decision|0|||
147269099|NCT02275481|531156906|FG001|Overall Study|Physician Decision|1|||
147269100|NCT01838642|531156907|FG000|Overall Study|Died on study|1|||
147269101|NCT01215227|531156911|FG000|Overall Study|Adverse Event|11|||
147269102|NCT01215227|531156912|FG001|Overall Study|Adverse Event|11|||
147269103|NCT01215227|531156913|FG002|Overall Study|Adverse Event|4|||
147269104|NCT01215227|531156914|FG003|Overall Study|Adverse Event|8|||
147269105|NCT01215227|531156915|FG004|Overall Study|Adverse Event|7|||
147269106|NCT01215227|531156916|FG005|Overall Study|Adverse Event|6|||
147269107|NCT01215227|531156911|FG000|Overall Study|Treatment Failure|8|||
147269108|NCT01215227|531156912|FG001|Overall Study|Treatment Failure|4|||
147269109|NCT01215227|531156913|FG002|Overall Study|Treatment Failure|1|||
147269110|NCT01215227|531156914|FG003|Overall Study|Treatment Failure|5|||
147333258|NCT04722003|531387639|FG000|Overall Study|Lost to Follow-up|2|||
147333259|NCT04722003|531387640|FG001|Overall Study|Lost to Follow-up|0|||
147269111|NCT01215227|531156915|FG004|Overall Study|Treatment Failure|1|||
147269112|NCT01215227|531156916|FG005|Overall Study|Treatment Failure|1|||
147269113|NCT01215227|531156911|FG000|Overall Study|Lost to Follow-up|1|||
147269114|NCT01215227|531156912|FG001|Overall Study|Lost to Follow-up|4|||
147269115|NCT01215227|531156913|FG002|Overall Study|Lost to Follow-up|1|||
147269116|NCT01215227|531156914|FG003|Overall Study|Lost to Follow-up|1|||
147269117|NCT01215227|531156915|FG004|Overall Study|Lost to Follow-up|1|||
147269118|NCT01215227|531156916|FG005|Overall Study|Lost to Follow-up|2|||
147333260|NCT04722003|531387639|FG000|Overall Study|Physician Decision|1|||
147333261|NCT04722003|531387640|FG001|Overall Study|Physician Decision|0|||
147269119|NCT01215227|531156911|FG000|Overall Study|Subject Withdrew Consent|16|||
147269120|NCT01215227|531156912|FG001|Overall Study|Subject Withdrew Consent|20|||
147269121|NCT01215227|531156913|FG002|Overall Study|Subject Withdrew Consent|7|||
147269122|NCT01215227|531156914|FG003|Overall Study|Subject Withdrew Consent|10|||
147269123|NCT01215227|531156915|FG004|Overall Study|Subject Withdrew Consent|11|||
147269124|NCT01215227|531156916|FG005|Overall Study|Subject Withdrew Consent|8|||
147269125|NCT01215227|531156911|FG000|Overall Study|Non-Compliance With Protocol|2|||
147269126|NCT01215227|531156912|FG001|Overall Study|Non-Compliance With Protocol|6|||
147269127|NCT01215227|531156913|FG002|Overall Study|Non-Compliance With Protocol|1|||
147269128|NCT01215227|531156914|FG003|Overall Study|Non-Compliance With Protocol|0|||
147269129|NCT01215227|531156915|FG004|Overall Study|Non-Compliance With Protocol|0|||
147269130|NCT01215227|531156916|FG005|Overall Study|Non-Compliance With Protocol|0|||
147269131|NCT01215227|531156911|FG000|Overall Study|Administrative|83|||
147269132|NCT01215227|531156912|FG001|Overall Study|Administrative|73|||
147269133|NCT01215227|531156913|FG002|Overall Study|Administrative|42|||
147269134|NCT01215227|531156914|FG003|Overall Study|Administrative|24|||
147269135|NCT01215227|531156915|FG004|Overall Study|Administrative|28|||
147269136|NCT01215227|531156916|FG005|Overall Study|Administrative|40|||
147269137|NCT01215227|531156911|FG000|Overall Study|Missing Status|0|||
147269138|NCT01215227|531156912|FG001|Overall Study|Missing Status|1|||
147269139|NCT01215227|531156913|FG002|Overall Study|Missing Status|0|||
147269140|NCT01215227|531156914|FG003|Overall Study|Missing Status|0|||
147269141|NCT01215227|531156915|FG004|Overall Study|Missing Status|0|||
147269142|NCT01215227|531156916|FG005|Overall Study|Missing Status|0|||
147269143|NCT01215227|531156911|FG000|Overall Study|Randomized but not treated|0|||
147269144|NCT01215227|531156912|FG001|Overall Study|Randomized but not treated|0|||
147269145|NCT01215227|531156913|FG002|Overall Study|Randomized but not treated|1|||
147269146|NCT01215227|531156914|FG003|Overall Study|Randomized but not treated|1|||
147269147|NCT01215227|531156915|FG004|Overall Study|Randomized but not treated|0|||
147269148|NCT01215227|531156916|FG005|Overall Study|Randomized but not treated|1|||
147269149|NCT00291668|531156917|FG000|Overall Study|Lack of Efficacy|1|||
147269150|NCT00291668|531156918|FG001|Overall Study|Lack of Efficacy|0|||
147269151|NCT00291668|531156919|FG002|Overall Study|Lack of Efficacy|0|||
147269152|NCT00291668|531156917|FG000|Overall Study|SAE, non-fatal|1|||
147269153|NCT00291668|531156918|FG001|Overall Study|SAE, non-fatal|1|||
147269154|NCT00291668|531156919|FG002|Overall Study|SAE, non-fatal|1|||
147269155|NCT00291668|531156917|FG000|Overall Study|AE, non-serious non-fatal|1|||
147269156|NCT00291668|531156918|FG001|Overall Study|AE, non-serious non-fatal|0|||
147269157|NCT00291668|531156919|FG002|Overall Study|AE, non-serious non-fatal|0|||
147269158|NCT00291668|531156917|FG000|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|1|||
147269159|NCT00291668|531156918|FG001|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
147269160|NCT00291668|531156919|FG002|Overall Study|SAE, non-fatal+AE, non-serious non-fatal|0|||
147269161|NCT00313612|531156922|FG000|Overall Study|Patient never received treatment|0|||
147269162|NCT00313612|531156923|FG001|Overall Study|Patient never received treatment|1|||
147269163|NCT01557400|531156924|FG000|Overall Study|Transitioned to Commercial Drug Product|40|||
147269164|NCT01557400|531156924|FG000|Overall Study|Adverse Event|3|||
147269165|NCT01557400|531156924|FG000|Overall Study|Lost to Follow-up|5|||
147269166|NCT01557400|531156924|FG000|Overall Study|Withdrawal by Subject|9|||
147269167|NCT01393405|531156933|FG000|Induction Period (week1-16)|Lack of Efficacy|70|||
147269168|NCT01393405|531156934|FG001|Induction Period (week1-16)|Lack of Efficacy|0|||
147269169|NCT01393405|531156935|FG002|Induction Period (week1-16)|Lack of Efficacy|0|||
147269170|NCT01393405|531156933|FG000|Induction Period (week1-16)|Adverse Event|16|||
147269171|NCT01393405|531156934|FG001|Induction Period (week1-16)|Adverse Event|0|||
147269172|NCT01393405|531156935|FG002|Induction Period (week1-16)|Adverse Event|0|||
147269173|NCT01393405|531156933|FG000|Induction Period (week1-16)|Withdrawal by Subject|9|||
147269174|NCT01393405|531156934|FG001|Induction Period (week1-16)|Withdrawal by Subject|0|||
147269175|NCT01393405|531156935|FG002|Induction Period (week1-16)|Withdrawal by Subject|0|||
147269176|NCT01393405|531156933|FG000|Maintenance Period Week|Lack of Efficacy|0|||
147269177|NCT01393405|531156934|FG001|Maintenance Period Week|Lack of Efficacy|22|||
147269178|NCT01393405|531156935|FG002|Maintenance Period Week|Lack of Efficacy|22|||
147269179|NCT01393405|531156933|FG000|Maintenance Period Week|Adverse Event|0|||
147269180|NCT01393405|531156934|FG001|Maintenance Period Week|Adverse Event|5|||
147269181|NCT01393405|531156935|FG002|Maintenance Period Week|Adverse Event|2|||
147269182|NCT01393405|531156933|FG000|Maintenance Period Week|Withdrawal by Subject|0|||
147269183|NCT01393405|531156934|FG001|Maintenance Period Week|Withdrawal by Subject|1|||
147269184|NCT01393405|531156935|FG002|Maintenance Period Week|Withdrawal by Subject|0|||
147269185|NCT01393405|531156933|FG000|Maintenance Period Week|Lost to Follow-up|0|||
147269186|NCT01393405|531156934|FG001|Maintenance Period Week|Lost to Follow-up|1|||
147269187|NCT01393405|531156935|FG002|Maintenance Period Week|Lost to Follow-up|0|||
147333262|NCT03351075|531387641|FG000|Intensive Treatment Phase (4 mo FU)|Withdrawal by Subject|6|||
147269188|NCT01434290|531156936|FG000|Overall Study|Protocol Violation|6|||
147269189|NCT01434290|531156937|FG001|Overall Study|Protocol Violation|3|||
147269190|NCT01434290|531156936|FG000|Overall Study|No protocol treatment|2|||
147333263|NCT03351075|531387642|FG001|Intensive Treatment Phase (4 mo FU)|Withdrawal by Subject|4|||
147269191|NCT01434290|531156937|FG001|Overall Study|No protocol treatment|4|||
147269192|NCT02281552|531156938|FG000|Overall Study|Medication error|1|||
147269193|NCT02281552|531156939|FG001|Overall Study|Medication error|0|||
147269194|NCT02281552|531156938|FG000|Overall Study|Insufficient clinical response|0|||
147269195|NCT02281552|531156939|FG001|Overall Study|Insufficient clinical response|1|||
147269196|NCT02281552|531156938|FG000|Overall Study|Adverse Event|3|||
147269197|NCT02281552|531156939|FG001|Overall Study|Adverse Event|9|||
147269198|NCT01224639|531156940|FG000|Overall Study|Withdrawal by Subject|0|||
147269199|NCT01224639|531156941|FG001|Overall Study|Withdrawal by Subject|0|||
147269200|NCT01224639|531156942|FG002|Overall Study|Withdrawal by Subject|0|||
147269201|NCT01224639|531156943|FG003|Overall Study|Withdrawal by Subject|0|||
147269202|NCT01224639|531156944|FG004|Overall Study|Withdrawal by Subject|2|||
147269203|NCT01224639|531156945|FG005|Overall Study|Withdrawal by Subject|0|||
147269204|NCT01224639|531156946|FG006|Overall Study|Withdrawal by Subject|1|||
147269205|NCT01224639|531156947|FG007|Overall Study|Withdrawal by Subject|1|||
147269206|NCT01224639|531156940|FG000|Overall Study|Adverse Event|0|||
147269207|NCT01224639|531156941|FG001|Overall Study|Adverse Event|0|||
147269208|NCT01224639|531156942|FG002|Overall Study|Adverse Event|0|||
147269209|NCT01224639|531156943|FG003|Overall Study|Adverse Event|0|||
147269210|NCT01224639|531156944|FG004|Overall Study|Adverse Event|0|||
147269211|NCT01224639|531156945|FG005|Overall Study|Adverse Event|0|||
147269212|NCT01224639|531156946|FG006|Overall Study|Adverse Event|0|||
147269213|NCT01224639|531156947|FG007|Overall Study|Adverse Event|1|||
147269214|NCT04365699|531156948|FG000|Overall Study|Death|2|||
147269215|NCT04365699|531156949|FG001|Overall Study|Death|5|||
147269216|NCT04365699|531156950|FG002|Overall Study|Death|15|||
147269217|NCT03925727|531156952|FG000|Overall Study|Adverse Event|4|||
147269218|NCT03925727|531156953|FG001|Overall Study|Adverse Event|0|||
147269219|NCT03925727|531156954|FG002|Overall Study|Adverse Event|3|||
147269220|NCT03925727|531156952|FG000|Overall Study|Protocol Violation|1|||
147269221|NCT03925727|531156953|FG001|Overall Study|Protocol Violation|2|||
147269222|NCT03925727|531156954|FG002|Overall Study|Protocol Violation|2|||
147269223|NCT03925727|531156952|FG000|Overall Study|Withdrawal by Subject|3|||
147269224|NCT03925727|531156953|FG001|Overall Study|Withdrawal by Subject|2|||
147269225|NCT03925727|531156954|FG002|Overall Study|Withdrawal by Subject|4|||
147269226|NCT03925727|531156952|FG000|Overall Study|Administrative Reasons|3|||
147269227|NCT03925727|531156953|FG001|Overall Study|Administrative Reasons|1|||
147269228|NCT03925727|531156954|FG002|Overall Study|Administrative Reasons|2|||
147269229|NCT03925727|531156952|FG000|Overall Study|Randomized in error or Disqualified|8|||
147269230|NCT03925727|531156953|FG001|Overall Study|Randomized in error or Disqualified|1|||
147269231|NCT03925727|531156954|FG002|Overall Study|Randomized in error or Disqualified|7|||
147269232|NCT01574352|531156959|FG000|Overall Study|Withdrawal by Subject|6|||
147269233|NCT01574352|531156960|FG001|Overall Study|Withdrawal by Subject|13|||
147269234|NCT01574352|531156959|FG000|Overall Study|Injury in non-camp related sport|1|||
147269235|NCT01574352|531156960|FG001|Overall Study|Injury in non-camp related sport|0|||
147269236|NCT02283788|531156963|FG000|Overall Study|Adverse Event|1|||
147269237|NCT02283788|531156964|FG001|Overall Study|Adverse Event|3|||
147269238|NCT02283788|531156965|FG002|Overall Study|Adverse Event|5|||
147269239|NCT02283788|531156966|FG003|Overall Study|Adverse Event|1|||
147269240|NCT02283788|531156963|FG000|Overall Study|Withdrawal by Subject|0|||
147269241|NCT02283788|531156964|FG001|Overall Study|Withdrawal by Subject|1|||
147269242|NCT02283788|531156965|FG002|Overall Study|Withdrawal by Subject|0|||
147269243|NCT02283788|531156966|FG003|Overall Study|Withdrawal by Subject|1|||
147269244|NCT06034496|531158688|FG000|Overall Study|Did not meet minimum stimulation threshold|2|||
147269245|NCT06034496|531158689|FG001|Overall Study|Did not meet minimum stimulation threshold|1|||
147269246|NCT06034496|531158688|FG000|Overall Study|Withdrawal by Subject|5|||
147269247|NCT06034496|531158689|FG001|Overall Study|Withdrawal by Subject|4|||
147269248|NCT02018458|531158690|FG000|Overall Study|Death|4|||
147269249|NCT00116558|531158691|FG000|Overall Study|Death|11|||
147269250|NCT00116558|531158692|FG001|Overall Study|Death|5|||
147269251|NCT00116558|531158693|FG002|Overall Study|Death|3|||
147269252|NCT00116558|531158691|FG000|Overall Study|Withdrawal by Subject|17|||
147269253|NCT00116558|531158692|FG001|Overall Study|Withdrawal by Subject|3|||
147269254|NCT00116558|531158693|FG002|Overall Study|Withdrawal by Subject|12|||
147269255|NCT00116558|531158691|FG000|Overall Study|disease progression|3|||
147269256|NCT00116558|531158692|FG001|Overall Study|disease progression|7|||
147269257|NCT00116558|531158693|FG002|Overall Study|disease progression|18|||
147269258|NCT00378014|531158694|FG000|Core (Randomization to Month 11)|Adverse Event|1|||
147269259|NCT00378014|531158695|FG001|Core (Randomization to Month 11)|Adverse Event|0|||
147269260|NCT00378014|531158694|FG000|Core (Randomization to Month 11)|Graft loss|1|||
147269261|NCT00378014|531158695|FG001|Core (Randomization to Month 11)|Graft loss|2|||
147269262|NCT00378014|531158694|FG000|Core (Randomization to Month 11)|Death|5|||
147269263|NCT00378014|531158695|FG001|Core (Randomization to Month 11)|Death|3|||
147269264|NCT00378014|531158694|FG000|Core (Randomization to Month 11)|Administrative Problems|2|||
147269265|NCT00378014|531158695|FG001|Core (Randomization to Month 11)|Administrative Problems|2|||
147269266|NCT00378014|531158694|FG000|Core (Randomization to Month 11)|Lost to Follow-up|0|||
147269267|NCT00378014|531158695|FG001|Core (Randomization to Month 11)|Lost to Follow-up|1|||
147662325|NCT03110354|532587298|FG003|Overall Study|Start of new therapy|0|||
147662326|NCT03110354|532587299|FG004|Overall Study|Start of new therapy|1|||
147662327|NCT03110354|532587295|FG000|Overall Study|Failure to achieve response|2|||
147662328|NCT03110354|532587296|FG001|Overall Study|Failure to achieve response|3|||
147662329|NCT03110354|532587297|FG002|Overall Study|Failure to achieve response|0|||
147269268|NCT00378014|531158694|FG000|Core (Randomization to Month 11)|Withdrawal by Subject|5|||
147269269|NCT00378014|531158695|FG001|Core (Randomization to Month 11)|Withdrawal by Subject|2|||
147269270|NCT00378014|531158694|FG000|Core (Randomization to Month 11)|Protocol deviation|0|||
147269271|NCT00378014|531158695|FG001|Core (Randomization to Month 11)|Protocol deviation|1|||
147269272|NCT00378014|531158694|FG000|Core (Randomization to Month 11)|Lack of Efficacy|0|||
147269273|NCT00378014|531158695|FG001|Core (Randomization to Month 11)|Lack of Efficacy|1|||
147269274|NCT00378014|531158694|FG000|Extension (Month 12 to Month 59)|Adverse Event|8|||
147269275|NCT00378014|531158695|FG001|Extension (Month 12 to Month 59)|Adverse Event|7|||
147269276|NCT00378014|531158694|FG000|Extension (Month 12 to Month 59)|Death|1|||
147269277|NCT00378014|531158695|FG001|Extension (Month 12 to Month 59)|Death|2|||
147269278|NCT00378014|531158694|FG000|Extension (Month 12 to Month 59)|Administrative problems|1|||
147269279|NCT00378014|531158695|FG001|Extension (Month 12 to Month 59)|Administrative problems|0|||
147269280|NCT00378014|531158694|FG000|Extension (Month 12 to Month 59)|Lost to Follow-up|1|||
147269281|NCT00378014|531158695|FG001|Extension (Month 12 to Month 59)|Lost to Follow-up|1|||
147269282|NCT00378014|531158694|FG000|Extension (Month 12 to Month 59)|Withdrawal by Subject|0|||
147269283|NCT00378014|531158695|FG001|Extension (Month 12 to Month 59)|Withdrawal by Subject|3|||
147269284|NCT00378014|531158694|FG000|Extension (Month 12 to Month 59)|Lack of Efficacy|3|||
147269285|NCT00378014|531158695|FG001|Extension (Month 12 to Month 59)|Lack of Efficacy|1|||
147269286|NCT00357370|531158696|FG000|Cohort 2|Lack of Efficacy|0|||
147269287|NCT00357370|531158697|FG001|Cohort 2|Lack of Efficacy|2|||
147269288|NCT00357370|531158698|FG002|Cohort 2|Lack of Efficacy|1|||
147269289|NCT00357370|531158696|FG000|Cohort 2|Adverse Event|1|||
147269290|NCT00357370|531158697|FG001|Cohort 2|Adverse Event|1|||
147269291|NCT00357370|531158698|FG002|Cohort 2|Adverse Event|1|||
147269292|NCT00357370|531158696|FG000|Cohort 2|Lost to Follow-up|0|||
147269293|NCT00357370|531158697|FG001|Cohort 2|Lost to Follow-up|1|||
147269294|NCT00357370|531158698|FG002|Cohort 2|Lost to Follow-up|0|||
147269295|NCT00357370|531158696|FG000|Cohort 2|non-compliance, not met criteria, etc|1|||
147269296|NCT00357370|531158697|FG001|Cohort 2|non-compliance, not met criteria, etc|1|||
147269297|NCT00357370|531158698|FG002|Cohort 2|non-compliance, not met criteria, etc|0|||
147269298|NCT00357370|531158696|FG000|Cohort 2|Withdrawal by Subject|0|||
147269299|NCT00357370|531158697|FG001|Cohort 2|Withdrawal by Subject|2|||
147269300|NCT00357370|531158698|FG002|Cohort 2|Withdrawal by Subject|0|||
147269301|NCT01143090|531158699|FG000|Overall Study|Lack of Efficacy|2|||
147269302|NCT01143090|531158699|FG000|Overall Study|Adverse Event|17|||
147269303|NCT01143090|531158699|FG000|Overall Study|Lost to Follow-up|9|||
147269304|NCT01143090|531158699|FG000|Overall Study|Protocol Violation|2|||
147269305|NCT01143090|531158699|FG000|Overall Study|Withdrawal by Subject|18|||
147269306|NCT01143090|531158699|FG000|Overall Study|Non-compliance with study drug|1|||
147269307|NCT01143090|531158699|FG000|Overall Study|Failure to meet eligibility criteria|1|||
147269308|NCT01143090|531158699|FG000|Overall Study|Administrative|1|||
147269309|NCT03491150|531158700|FG000|Overall Study|Adverse Event|1|||
147269310|NCT03491150|531158701|FG001|Overall Study|Adverse Event|0|||
147269311|NCT03491150|531158700|FG000|Overall Study|Study Terminated by Sponsor|74|||
147269312|NCT03491150|531158701|FG001|Overall Study|Study Terminated by Sponsor|70|||
147269313|NCT03491150|531158700|FG000|Overall Study|Other|0|||
147269314|NCT03491150|531158701|FG001|Overall Study|Other|1|||
147269315|NCT03491150|531158700|FG000|Overall Study|Withdrawal by Subject|1|||
147269316|NCT03491150|531158701|FG001|Overall Study|Withdrawal by Subject|2|||
147269317|NCT00727714|531158709|FG000|Overall Study|Lost to Follow-up|2|||
147269318|NCT00325234|531158714|FG000|Overall Study|Adverse Event|10|||
147269319|NCT00325234|531158715|FG001|Overall Study|Adverse Event|7|||
147269320|NCT00325234|531158714|FG000|Overall Study|Death due to Study Disease|1|||
147269321|NCT00325234|531158715|FG001|Overall Study|Death due to Study Disease|0|||
147269322|NCT00325234|531158714|FG000|Overall Study|Entry Criteria Not Met|1|||
147269323|NCT00325234|531158715|FG001|Overall Study|Entry Criteria Not Met|2|||
147269324|NCT00325234|531158714|FG000|Overall Study|Subject Decision|6|||
147269325|NCT00325234|531158715|FG001|Overall Study|Subject Decision|8|||
147269326|NCT00325234|531158714|FG000|Overall Study|Physician Decision|17|||
147269327|NCT00325234|531158715|FG001|Overall Study|Physician Decision|12|||
147269328|NCT00325234|531158714|FG000|Overall Study|Progressive Disease|34|||
147269329|NCT00325234|531158715|FG001|Overall Study|Progressive Disease|37|||
147269330|NCT02644967|531158721|FG000|Overall Study|Death|26|||
147269331|NCT02644967|531158721|FG000|Overall Study|Physician Decision|1|||
147269332|NCT02644967|531158721|FG000|Overall Study|Withdrawal by Subject|2|||
147269333|NCT02644967|531158721|FG000|Overall Study|Protocol Violation|1|||
147269334|NCT02644967|531158721|FG000|Overall Study|Progressive Disease|1|||
147269335|NCT02644967|531158721|FG000|Overall Study|Study Terminated by Sponsor|4|||
147269336|NCT02287896|531158722|FG000|Second Injection Visit|Withdrawal by Subject|0|||
147662330|NCT03110354|532587298|FG003|Overall Study|Failure to achieve response|2|||
147269337|NCT02287896|531158723|FG001|Second Injection Visit|Withdrawal by Subject|1|||
147269338|NCT05179421|531158724|FG000|First Infusion Day|Adverse Event|1|||
147269339|NCT05179421|531158725|FG001|First Infusion Day|Adverse Event|0|||
147269340|NCT03746522|531158726|FG000|Period 1: Double-Blind (14 Weeks)|Adverse Event|0|||
147269341|NCT03746522|531158727|FG001|Period 1: Double-Blind (14 Weeks)|Adverse Event|1|||
147269342|NCT03746522|531158728|FG002|Period 1: Double-Blind (14 Weeks)|Adverse Event|0|||
147269343|NCT03746522|531158726|FG000|Period 1: Double-Blind (14 Weeks)|Withdrawal by Subject|0|||
147269344|NCT03746522|531158727|FG001|Period 1: Double-Blind (14 Weeks)|Withdrawal by Subject|1|||
147269345|NCT03746522|531158728|FG002|Period 1: Double-Blind (14 Weeks)|Withdrawal by Subject|0|||
147269346|NCT03746522|531158726|FG000|Period 2: Open-Label (38 Weeks)|Withdrawal by Subject|0|||
147269347|NCT03746522|531158727|FG001|Period 2: Open-Label (38 Weeks)|Withdrawal by Subject|0|||
147269348|NCT03746522|531158728|FG002|Period 2: Open-Label (38 Weeks)|Withdrawal by Subject|3|||
147269349|NCT03746522|531158726|FG000|Period 2: Open-Label (38 Weeks)|Adverse Event|0|||
147269350|NCT03746522|531158727|FG001|Period 2: Open-Label (38 Weeks)|Adverse Event|0|||
147269351|NCT03746522|531158728|FG002|Period 2: Open-Label (38 Weeks)|Adverse Event|4|||
147269352|NCT03746522|531158726|FG000|Period 2: Open-Label (38 Weeks)|Other than specified|0|||
147269353|NCT03746522|531158727|FG001|Period 2: Open-Label (38 Weeks)|Other than specified|0|||
147269354|NCT03746522|531158728|FG002|Period 2: Open-Label (38 Weeks)|Other than specified|2|||
147269355|NCT01639040|531158729|FG000|Overall Study|Adverse Event|1|||
147269356|NCT01639040|531158730|FG001|Overall Study|Adverse Event|0|||
147269357|NCT00486265|531158734|FG000|Overall Study|Adverse Event|1|||
147269358|NCT00486265|531158734|FG000|Overall Study|Lack of Efficacy|8|||
147269359|NCT01452412|531158735|FG000|Overall Study|Withdrawal by Subject|15|||
147269360|NCT01452412|531158736|FG001|Overall Study|Withdrawal by Subject|11|||
147269361|NCT01452412|531158735|FG000|Overall Study|Adverse Event|4|||
147269362|NCT01452412|531158736|FG001|Overall Study|Adverse Event|3|||
147269363|NCT01452412|531158735|FG000|Overall Study|Lost to Follow-up|5|||
147269364|NCT01452412|531158736|FG001|Overall Study|Lost to Follow-up|3|||
147269365|NCT01452412|531158735|FG000|Overall Study|Death|1|||
147269366|NCT01452412|531158736|FG001|Overall Study|Death|0|||
147269367|NCT01452412|531158735|FG000|Overall Study|Initiated dialysis|1|||
147269368|NCT01452412|531158736|FG001|Overall Study|Initiated dialysis|0|||
147269369|NCT01452412|531158735|FG000|Overall Study|Other|2|||
147269370|NCT01452412|531158736|FG001|Overall Study|Other|0|||
147269371|NCT05132127|531158737|FG000|Overall Study|Adverse Event|1|||
147269372|NCT03013543|531158738|FG000|Overall Study|Withdrawal by Subject|0|||
147269373|NCT03013543|531158739|FG001|Overall Study|Withdrawal by Subject|2|||
147269374|NCT03013543|531158740|FG002|Overall Study|Withdrawal by Subject|0|||
147269375|NCT03013543|531158741|FG003|Overall Study|Withdrawal by Subject|5|||
147269376|NCT03013543|531158742|FG004|Overall Study|Withdrawal by Subject|6|||
147269377|NCT03013543|531158743|FG005|Overall Study|Withdrawal by Subject|2|||
147269378|NCT03013543|531158744|FG006|Overall Study|Withdrawal by Subject|3|||
147269379|NCT03013543|531158745|FG007|Overall Study|Withdrawal by Subject|1|||
147269380|NCT03013543|531158746|FG008|Overall Study|Withdrawal by Subject|0|||
147269381|NCT03013543|531158747|FG009|Overall Study|Withdrawal by Subject|4|||
147269382|NCT03013543|531158738|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
147269383|NCT03013543|531158739|FG001|Overall Study|Withdrawal By Parent/Guardian|0|||
147269384|NCT03013543|531158740|FG002|Overall Study|Withdrawal By Parent/Guardian|1|||
147269385|NCT03013543|531158741|FG003|Overall Study|Withdrawal By Parent/Guardian|1|||
147269386|NCT03013543|531158742|FG004|Overall Study|Withdrawal By Parent/Guardian|0|||
147269387|NCT03013543|531158743|FG005|Overall Study|Withdrawal By Parent/Guardian|0|||
147269388|NCT03013543|531158744|FG006|Overall Study|Withdrawal By Parent/Guardian|0|||
147269389|NCT03013543|531158745|FG007|Overall Study|Withdrawal By Parent/Guardian|0|||
147269390|NCT03013543|531158746|FG008|Overall Study|Withdrawal By Parent/Guardian|1|||
147269391|NCT03013543|531158747|FG009|Overall Study|Withdrawal By Parent/Guardian|1|||
147269392|NCT03013543|531158738|FG000|Overall Study|Other|0|||
147269393|NCT03013543|531158739|FG001|Overall Study|Other|0|||
147269394|NCT03013543|531158740|FG002|Overall Study|Other|2|||
147269395|NCT03013543|531158741|FG003|Overall Study|Other|0|||
147269396|NCT03013543|531158742|FG004|Overall Study|Other|2|||
147269397|NCT03013543|531158743|FG005|Overall Study|Other|0|||
147269398|NCT03013543|531158744|FG006|Overall Study|Other|0|||
147269399|NCT03013543|531158745|FG007|Overall Study|Other|0|||
147662331|NCT03110354|532587299|FG004|Overall Study|Failure to achieve response|1|||
147269400|NCT03013543|531158746|FG008|Overall Study|Other|1|||
147269401|NCT03013543|531158747|FG009|Overall Study|Other|0|||
147269402|NCT03013543|531158738|FG000|Overall Study|Adverse Event|0|||
147269403|NCT03013543|531158739|FG001|Overall Study|Adverse Event|0|||
147269404|NCT03013543|531158740|FG002|Overall Study|Adverse Event|0|||
147269405|NCT03013543|531158741|FG003|Overall Study|Adverse Event|3|||
147269406|NCT03013543|531158742|FG004|Overall Study|Adverse Event|2|||
147269407|NCT03013543|531158743|FG005|Overall Study|Adverse Event|1|||
147269408|NCT03013543|531158744|FG006|Overall Study|Adverse Event|3|||
147269409|NCT03013543|531158745|FG007|Overall Study|Adverse Event|8|||
147333264|NCT03351075|531387641|FG000|Intensive Treatment Phase (4 mo FU)|Death|0|||
147662332|NCT03110354|532587295|FG000|Overall Study|Progressive disease|1|||
147269410|NCT03013543|531158746|FG008|Overall Study|Adverse Event|0|||
147269411|NCT03013543|531158747|FG009|Overall Study|Adverse Event|2|||
147269412|NCT03013543|531158738|FG000|Overall Study|Death|0|||
147333265|NCT03351075|531387642|FG001|Intensive Treatment Phase (4 mo FU)|Death|1|||
147333266|NCT03351075|531387641|FG000|Maintenance Treatment Phase (12 mo FU)|Withdrawal by Subject|1|||
147333267|NCT03351075|531387642|FG001|Maintenance Treatment Phase (12 mo FU)|Withdrawal by Subject|0|||
147333268|NCT03351075|531387641|FG000|End of Trial (18 mo FU)|Withdrawal by Subject|1|||
147333269|NCT03351075|531387642|FG001|End of Trial (18 mo FU)|Withdrawal by Subject|1|||
147269413|NCT03013543|531158739|FG001|Overall Study|Death|0|||
147269414|NCT03013543|531158740|FG002|Overall Study|Death|0|||
147269415|NCT03013543|531158741|FG003|Overall Study|Death|1|||
147269416|NCT03013543|531158742|FG004|Overall Study|Death|0|||
147269417|NCT03013543|531158743|FG005|Overall Study|Death|0|||
147269418|NCT03013543|531158744|FG006|Overall Study|Death|0|||
147269419|NCT03013543|531158745|FG007|Overall Study|Death|0|||
147269420|NCT03013543|531158746|FG008|Overall Study|Death|0|||
147269421|NCT03013543|531158747|FG009|Overall Study|Death|0|||
147269422|NCT03013543|531158738|FG000|Overall Study|Lack of Efficacy|0|||
147269423|NCT03013543|531158739|FG001|Overall Study|Lack of Efficacy|0|||
147269424|NCT03013543|531158740|FG002|Overall Study|Lack of Efficacy|0|||
147269425|NCT03013543|531158741|FG003|Overall Study|Lack of Efficacy|1|||
147269426|NCT03013543|531158742|FG004|Overall Study|Lack of Efficacy|0|||
147269427|NCT03013543|531158743|FG005|Overall Study|Lack of Efficacy|0|||
147269428|NCT03013543|531158744|FG006|Overall Study|Lack of Efficacy|0|||
147269429|NCT03013543|531158745|FG007|Overall Study|Lack of Efficacy|0|||
147269430|NCT03013543|531158746|FG008|Overall Study|Lack of Efficacy|0|||
147269431|NCT03013543|531158747|FG009|Overall Study|Lack of Efficacy|0|||
147269432|NCT03013543|531158738|FG000|Overall Study|Lost to Follow-up|0|||
147269433|NCT03013543|531158739|FG001|Overall Study|Lost to Follow-up|0|||
147269434|NCT03013543|531158740|FG002|Overall Study|Lost to Follow-up|0|||
147269435|NCT03013543|531158741|FG003|Overall Study|Lost to Follow-up|1|||
147269436|NCT03013543|531158742|FG004|Overall Study|Lost to Follow-up|0|||
147269437|NCT03013543|531158743|FG005|Overall Study|Lost to Follow-up|0|||
147269438|NCT03013543|531158744|FG006|Overall Study|Lost to Follow-up|1|||
147269439|NCT03013543|531158745|FG007|Overall Study|Lost to Follow-up|0|||
147269440|NCT03013543|531158746|FG008|Overall Study|Lost to Follow-up|0|||
147269441|NCT03013543|531158747|FG009|Overall Study|Lost to Follow-up|2|||
147269442|NCT03013543|531158738|FG000|Overall Study|Non-Compliance With Study Drug|0|||
147269443|NCT03013543|531158739|FG001|Overall Study|Non-Compliance With Study Drug|0|||
147269444|NCT03013543|531158740|FG002|Overall Study|Non-Compliance With Study Drug|0|||
147269445|NCT03013543|531158741|FG003|Overall Study|Non-Compliance With Study Drug|0|||
147269446|NCT03013543|531158742|FG004|Overall Study|Non-Compliance With Study Drug|0|||
147269447|NCT03013543|531158743|FG005|Overall Study|Non-Compliance With Study Drug|0|||
147269448|NCT03013543|531158744|FG006|Overall Study|Non-Compliance With Study Drug|0|||
147269449|NCT03013543|531158745|FG007|Overall Study|Non-Compliance With Study Drug|0|||
147269450|NCT03013543|531158746|FG008|Overall Study|Non-Compliance With Study Drug|1|||
147269451|NCT03013543|531158747|FG009|Overall Study|Non-Compliance With Study Drug|0|||
147269452|NCT03013543|531158738|FG000|Overall Study|Physician Decision|0|||
147269453|NCT03013543|531158739|FG001|Overall Study|Physician Decision|0|||
147269454|NCT03013543|531158740|FG002|Overall Study|Physician Decision|0|||
147269455|NCT03013543|531158741|FG003|Overall Study|Physician Decision|0|||
147269456|NCT03013543|531158742|FG004|Overall Study|Physician Decision|1|||
147269457|NCT03013543|531158743|FG005|Overall Study|Physician Decision|0|||
147269458|NCT03013543|531158744|FG006|Overall Study|Physician Decision|0|||
147269459|NCT03013543|531158745|FG007|Overall Study|Physician Decision|0|||
147269460|NCT03013543|531158746|FG008|Overall Study|Physician Decision|0|||
147269461|NCT03013543|531158747|FG009|Overall Study|Physician Decision|0|||
147269462|NCT03013543|531158738|FG000|Overall Study|Protocol Violation|0|||
147269463|NCT03013543|531158739|FG001|Overall Study|Protocol Violation|0|||
147269464|NCT03013543|531158740|FG002|Overall Study|Protocol Violation|0|||
147269465|NCT03013543|531158741|FG003|Overall Study|Protocol Violation|0|||
147269466|NCT03013543|531158742|FG004|Overall Study|Protocol Violation|0|||
147269467|NCT03013543|531158743|FG005|Overall Study|Protocol Violation|0|||
147333270|NCT03175172|531387643|FG000|Overall Study|Death|3|||
147269468|NCT03013543|531158744|FG006|Overall Study|Protocol Violation|0|||
147333271|NCT03175172|531387643|FG000|Overall Study|Withdrawal by Subject|3|||
147333272|NCT03175172|531387643|FG000|Overall Study|Lost to Follow-up|1|||
147269469|NCT03013543|531158745|FG007|Overall Study|Protocol Violation|0|||
147269470|NCT03013543|531158746|FG008|Overall Study|Protocol Violation|0|||
147269471|NCT03013543|531158747|FG009|Overall Study|Protocol Violation|1|||
147269472|NCT02552316|531158749|FG000|Overall Study|Withdrawal by Subject|1|||
147269473|NCT02552316|531158749|FG000|Overall Study|Withdrawal due to non-compliance|1|||
147269474|NCT04382911|531158750|FG000|Overall Study|unable to be imaged prior to surgery|2|||
147269475|NCT01120210|531158756|FG000|MAIN INFUSION|Adverse Event|1|||
147269476|NCT01120210|531158757|FG001|MAIN INFUSION|Adverse Event|0|||
147269477|NCT01120210|531158756|FG000|MAIN INFUSION|Withdrawal by Subject|0|||
147269478|NCT01120210|531158757|FG001|MAIN INFUSION|Withdrawal by Subject|1|||
147269479|NCT04697628|531158768|FG000|Overall Study|Withdrawal by Subject|17|||
147269480|NCT04697628|531158769|FG001|Overall Study|Withdrawal by Subject|23|||
147269481|NCT04697628|531158768|FG000|Overall Study|Lost to Follow-up|0|||
147269482|NCT04697628|531158769|FG001|Overall Study|Lost to Follow-up|4|||
147269483|NCT04697628|531158768|FG000|Overall Study|On-going in study|122|||
147269484|NCT04697628|531158769|FG001|Overall Study|On-going in study|91|||
147269485|NCT00974571|531158770|FG000|Overall Study|Adverse Event|31|||
147269486|NCT00974571|531158771|FG001|Overall Study|Adverse Event|4|||
147269487|NCT00974571|531158772|FG002|Overall Study|Adverse Event|27|||
147269488|NCT00974571|531158770|FG000|Overall Study|Lack of Efficacy|3|||
147269489|NCT00974571|531158771|FG001|Overall Study|Lack of Efficacy|2|||
147269490|NCT00974571|531158772|FG002|Overall Study|Lack of Efficacy|9|||
147269491|NCT00974571|531158770|FG000|Overall Study|Lost to Follow-up|2|||
147269492|NCT00974571|531158771|FG001|Overall Study|Lost to Follow-up|1|||
147269493|NCT00974571|531158772|FG002|Overall Study|Lost to Follow-up|2|||
147269494|NCT00974571|531158770|FG000|Overall Study|Protocol Violation|13|||
147269495|NCT00974571|531158771|FG001|Overall Study|Protocol Violation|4|||
147269496|NCT00974571|531158772|FG002|Overall Study|Protocol Violation|18|||
147269497|NCT00974571|531158770|FG000|Overall Study|Withdrawal by Subject|14|||
147269498|NCT00974571|531158771|FG001|Overall Study|Withdrawal by Subject|5|||
147269499|NCT00974571|531158772|FG002|Overall Study|Withdrawal by Subject|16|||
147269500|NCT00974571|531158770|FG000|Overall Study|Patient Moved|1|||
147269501|NCT00974571|531158771|FG001|Overall Study|Patient Moved|0|||
147269502|NCT00974571|531158772|FG002|Overall Study|Patient Moved|1|||
147269503|NCT00974571|531158770|FG000|Overall Study|Other|4|||
147269504|NCT00974571|531158771|FG001|Overall Study|Other|0|||
147269505|NCT00974571|531158772|FG002|Overall Study|Other|10|||
147269506|NCT00393939|531158773|FG000|Overall Study|Protocol Violation|1|||
147269507|NCT00393939|531158774|FG001|Overall Study|Protocol Violation|1|||
147269508|NCT00393939|531158773|FG000|Overall Study|Lost to Follow-up|2|||
147269509|NCT00393939|531158774|FG001|Overall Study|Lost to Follow-up|4|||
147269510|NCT00393939|531158773|FG000|Overall Study|Death|10|||
147269511|NCT00393939|531158774|FG001|Overall Study|Death|4|||
147269512|NCT00393939|531158773|FG000|Overall Study|Sponsor|5|||
147269513|NCT00393939|531158774|FG001|Overall Study|Sponsor|13|||
147269514|NCT00393939|531158773|FG000|Overall Study|Objective progression or relapse|239|||
147269515|NCT00393939|531158774|FG001|Overall Study|Objective progression or relapse|223|||
147269516|NCT00393939|531158773|FG000|Overall Study|Withdrawal by Subject|2|||
147269517|NCT00393939|531158774|FG001|Overall Study|Withdrawal by Subject|7|||
147269518|NCT00393939|531158773|FG000|Overall Study|Other|37|||
147269519|NCT00393939|531158774|FG001|Overall Study|Other|45|||
147269520|NCT02385799|531158775|FG000|Overall Study|Lost to Follow-up|1|||
147269521|NCT02385799|531158776|FG001|Overall Study|Lost to Follow-up|2|||
147269522|NCT02385799|531158775|FG000|Overall Study|Adverse Event|4|||
147269523|NCT02385799|531158776|FG001|Overall Study|Adverse Event|2|||
147269524|NCT02385799|531158775|FG000|Overall Study|Withdrawal by Subject|0|||
147269525|NCT02385799|531158776|FG001|Overall Study|Withdrawal by Subject|4|||
147269526|NCT00547703|531158777|FG000|Overall Study|Lost to Follow-up|1|||
147269527|NCT00547703|531158778|FG001|Overall Study|Lost to Follow-up|0|||
147269528|NCT02161718|531158783|FG000|Open-Label ALKS 3831 Period|Protocol Violation|2|||
147269529|NCT02161718|531158784|FG001|Open-Label ALKS 3831 Period|Protocol Violation|0|||
147269530|NCT02161718|531158785|FG002|Open-Label ALKS 3831 Period|Protocol Violation|0|||
147269531|NCT02161718|531158783|FG000|Open-Label ALKS 3831 Period|Physician Decision|1|||
147269532|NCT02161718|531158784|FG001|Open-Label ALKS 3831 Period|Physician Decision|0|||
147269533|NCT02161718|531158785|FG002|Open-Label ALKS 3831 Period|Physician Decision|0|||
147269534|NCT02161718|531158783|FG000|Open-Label ALKS 3831 Period|Non-compliance with study drug|1|||
147269535|NCT02161718|531158784|FG001|Open-Label ALKS 3831 Period|Non-compliance with study drug|0|||
147269536|NCT02161718|531158785|FG002|Open-Label ALKS 3831 Period|Non-compliance with study drug|0|||
147269537|NCT02161718|531158783|FG000|Open-Label ALKS 3831 Period|Lack of Efficacy|1|||
147269538|NCT02161718|531158784|FG001|Open-Label ALKS 3831 Period|Lack of Efficacy|0|||
147269539|NCT02161718|531158785|FG002|Open-Label ALKS 3831 Period|Lack of Efficacy|0|||
147269540|NCT02161718|531158783|FG000|Open-Label ALKS 3831 Period|Adverse Event|3|||
147269541|NCT02161718|531158784|FG001|Open-Label ALKS 3831 Period|Adverse Event|0|||
147269542|NCT02161718|531158785|FG002|Open-Label ALKS 3831 Period|Adverse Event|0|||
147269543|NCT02161718|531158783|FG000|Open-Label ALKS 3831 Period|Withdrawal by Subject|4|||
147269544|NCT02161718|531158784|FG001|Open-Label ALKS 3831 Period|Withdrawal by Subject|0|||
147269545|NCT02161718|531158785|FG002|Open-Label ALKS 3831 Period|Withdrawal by Subject|0|||
147269546|NCT02161718|531158783|FG000|Open-Label ALKS 3831 Period|Lost to Follow-up|3|||
147269547|NCT02161718|531158784|FG001|Open-Label ALKS 3831 Period|Lost to Follow-up|0|||
147269548|NCT02161718|531158785|FG002|Open-Label ALKS 3831 Period|Lost to Follow-up|0|||
147269549|NCT02161718|531158783|FG000|Open-Label ALKS 3831 Period|Failure to meet randomization criteria|6|||
147269550|NCT02161718|531158784|FG001|Open-Label ALKS 3831 Period|Failure to meet randomization criteria|0|||
147269551|NCT02161718|531158785|FG002|Open-Label ALKS 3831 Period|Failure to meet randomization criteria|0|||
147269552|NCT02161718|531158783|FG000|Post- Randomization Period|Withdrawal by Subject|0|||
147662333|NCT03110354|532587296|FG001|Overall Study|Progressive disease|1|||
147269553|NCT02161718|531158784|FG001|Post- Randomization Period|Withdrawal by Subject|23|||
147269554|NCT02161718|531158785|FG002|Post- Randomization Period|Withdrawal by Subject|18|||
147269555|NCT02161718|531158783|FG000|Post- Randomization Period|Lost to Follow-up|0|||
147269556|NCT02161718|531158784|FG001|Post- Randomization Period|Lost to Follow-up|9|||
147269557|NCT02161718|531158785|FG002|Post- Randomization Period|Lost to Follow-up|15|||
147269558|NCT02161718|531158783|FG000|Post- Randomization Period|Adverse Event|0|||
147269559|NCT02161718|531158784|FG001|Post- Randomization Period|Adverse Event|9|||
147269560|NCT02161718|531158785|FG002|Post- Randomization Period|Adverse Event|10|||
147269561|NCT02161718|531158783|FG000|Post- Randomization Period|Non- compliance with study drug|0|||
147269562|NCT02161718|531158784|FG001|Post- Randomization Period|Non- compliance with study drug|8|||
147600288|NCT03893565|532356362|FG005|Double-blind Induction Phase (10 Weeks)|Other|0|||
147600289|NCT03893565|532356363|FG006|Double-blind Induction Phase (10 Weeks)|Other|0|||
147269563|NCT02161718|531158785|FG002|Post- Randomization Period|Non- compliance with study drug|2|||
147269564|NCT02161718|531158783|FG000|Post- Randomization Period|Physician Decision|0|||
147269565|NCT02161718|531158784|FG001|Post- Randomization Period|Physician Decision|2|||
147269566|NCT02161718|531158785|FG002|Post- Randomization Period|Physician Decision|4|||
147269567|NCT02161718|531158783|FG000|Post- Randomization Period|Protocol Violation|0|||
147269568|NCT02161718|531158784|FG001|Post- Randomization Period|Protocol Violation|2|||
147269569|NCT02161718|531158785|FG002|Post- Randomization Period|Protocol Violation|3|||
147269570|NCT02161718|531158783|FG000|Post- Randomization Period|Lack of Efficacy|0|||
147269571|NCT02161718|531158784|FG001|Post- Randomization Period|Lack of Efficacy|0|||
147269572|NCT02161718|531158785|FG002|Post- Randomization Period|Lack of Efficacy|1|||
147269573|NCT02161718|531158783|FG000|Post- Randomization Period|Non-compliance with study procedures|0|||
147269574|NCT02161718|531158784|FG001|Post- Randomization Period|Non-compliance with study procedures|2|||
147269575|NCT02161718|531158785|FG002|Post- Randomization Period|Non-compliance with study procedures|4|||
147269576|NCT02161718|531158783|FG000|Post- Randomization Period|Received prohibitive treatment|0|||
147269577|NCT02161718|531158784|FG001|Post- Randomization Period|Received prohibitive treatment|1|||
147269578|NCT02161718|531158785|FG002|Post- Randomization Period|Received prohibitive treatment|2|||
147269579|NCT02161718|531158783|FG000|Post- Randomization Period|Relocation|0|||
147269580|NCT02161718|531158784|FG001|Post- Randomization Period|Relocation|3|||
147269581|NCT02161718|531158785|FG002|Post- Randomization Period|Relocation|0|||
147269582|NCT02350309|531158790|FG000|Treatment Period 1 (2 Days)|Physician Decision|0|||
147269583|NCT02350309|531158791|FG001|Treatment Period 1 (2 Days)|Physician Decision|0|||
147269584|NCT02350309|531158792|FG002|Treatment Period 1 (2 Days)|Physician Decision|1|||
147269585|NCT02350309|531158793|FG003|Treatment Period 1 (2 Days)|Physician Decision|0|||
147269586|NCT02350309|531158794|FG004|Treatment Period 1 (2 Days)|Physician Decision|0|||
147269587|NCT02350309|531158795|FG005|Treatment Period 1 (2 Days)|Physician Decision|0|||
147269588|NCT02350309|531158790|FG000|Treatment Period 4 (2 Days)|Death in the Family|0|||
147269589|NCT02350309|531158791|FG001|Treatment Period 4 (2 Days)|Death in the Family|0|||
147269590|NCT02350309|531158792|FG002|Treatment Period 4 (2 Days)|Death in the Family|0|||
147269591|NCT02350309|531158793|FG003|Treatment Period 4 (2 Days)|Death in the Family|0|||
147269592|NCT02350309|531158794|FG004|Treatment Period 4 (2 Days)|Death in the Family|0|||
147269593|NCT02350309|531158795|FG005|Treatment Period 4 (2 Days)|Death in the Family|1|||
147269594|NCT01256710|531158796|FG000|Overall Study|Death|449|||
147269595|NCT01256710|531158796|FG000|Overall Study|System Explant|67|||
147269596|NCT01256710|531158796|FG000|Overall Study|Transcatheter Aortic Valve-in-Valve Intervention|28|||
147269597|NCT01256710|531158796|FG000|Overall Study|Lost to Follow-up|67|||
147269598|NCT01256710|531158796|FG000|Overall Study|Withdrawal by Subject|29|||
147269599|NCT01256710|531158796|FG000|Overall Study|Physician Decision|9|||
147269600|NCT01256710|531158796|FG000|Overall Study|Subject Noncompliance|2|||
147269601|NCT01256710|531158796|FG000|Overall Study|Study Terminated by Sponsor|273|||
147269602|NCT01205165|531158798|FG000|Overall Study|Lost to Follow-up|2|||
147269603|NCT02681302|531158801|FG000|Overall Study|Withdrawal by Subject|1|||
147269604|NCT02681302|531158802|FG001|Overall Study|Withdrawal by Subject|1|||
147269605|NCT02681302|531158803|FG002|Overall Study|Withdrawal by Subject|0|||
147269606|NCT02681302|531158804|FG003|Overall Study|Withdrawal by Subject|0|||
147269607|NCT02681302|531158805|FG004|Overall Study|Withdrawal by Subject|1|||
147269608|NCT02681302|531158806|FG005|Overall Study|Withdrawal by Subject|0|||
147269609|NCT02681302|531158801|FG000|Overall Study|Screen Failure|2|||
147269610|NCT02681302|531158802|FG001|Overall Study|Screen Failure|4|||
147269611|NCT02681302|531158803|FG002|Overall Study|Screen Failure|2|||
147269612|NCT02681302|531158804|FG003|Overall Study|Screen Failure|0|||
147269613|NCT02681302|531158805|FG004|Overall Study|Screen Failure|1|||
147269614|NCT02681302|531158806|FG005|Overall Study|Screen Failure|1|||
147269615|NCT02681302|531158801|FG000|Overall Study|Discontinued Due to Updated FDA Risks|0|||
147269616|NCT02681302|531158802|FG001|Overall Study|Discontinued Due to Updated FDA Risks|0|||
147269617|NCT02681302|531158803|FG002|Overall Study|Discontinued Due to Updated FDA Risks|0|||
147269618|NCT02681302|531158804|FG003|Overall Study|Discontinued Due to Updated FDA Risks|0|||
147269619|NCT02681302|531158805|FG004|Overall Study|Discontinued Due to Updated FDA Risks|0|||
147269620|NCT02681302|531158806|FG005|Overall Study|Discontinued Due to Updated FDA Risks|1|||
147269621|NCT01736696|531158807|FG000|Overall Study|Withdrawal by Subject|0|||
147269622|NCT01736696|531158808|FG001|Overall Study|Withdrawal by Subject|0|||
147269623|NCT01736696|531158809|FG002|Overall Study|Withdrawal by Subject|1|||
147269624|NCT01736696|531158810|FG003|Overall Study|Withdrawal by Subject|0|||
147269625|NCT01736696|531158811|FG004|Overall Study|Withdrawal by Subject|0|||
147269626|NCT01736696|531158812|FG005|Overall Study|Withdrawal by Subject|0|||
147269627|NCT01736696|531158813|FG006|Overall Study|Withdrawal by Subject|0|||
147269628|NCT00838565|531158814|FG000|Overall Study|Withdrawal by Subject|0|||
147269629|NCT00838565|531158815|FG001|Overall Study|Withdrawal by Subject|0|||
147269630|NCT00838565|531158816|FG002|Overall Study|Withdrawal by Subject|1|||
147269631|NCT00838565|531158817|FG003|Overall Study|Withdrawal by Subject|0|||
147269632|NCT00838565|531158818|FG004|Overall Study|Withdrawal by Subject|0|||
147269633|NCT00838565|531158819|FG005|Overall Study|Withdrawal by Subject|2|||
147269634|NCT00838565|531158814|FG000|Overall Study|Other|0|||
147269635|NCT00838565|531158815|FG001|Overall Study|Other|2|||
147269636|NCT00838565|531158816|FG002|Overall Study|Other|0|||
147269637|NCT00838565|531158817|FG003|Overall Study|Other|0|||
147269638|NCT00838565|531158818|FG004|Overall Study|Other|0|||
147269639|NCT00838565|531158819|FG005|Overall Study|Other|0|||
147269640|NCT00838565|531158814|FG000|Overall Study|Randomized but not Treated|0|||
147269641|NCT00838565|531158815|FG001|Overall Study|Randomized but not Treated|1|||
147269642|NCT00838565|531158816|FG002|Overall Study|Randomized but not Treated|0|||
147269643|NCT00838565|531158817|FG003|Overall Study|Randomized but not Treated|0|||
147269644|NCT00838565|531158818|FG004|Overall Study|Randomized but not Treated|0|||
147269645|NCT00838565|531158819|FG005|Overall Study|Randomized but not Treated|0|||
147269646|NCT00458484|531158820|FG000|Overall Study|Not eligible b/c prior radiation history|0|||
147269647|NCT00458484|531158821|FG001|Overall Study|Not eligible b/c prior radiation history|0|||
147269648|NCT00458484|531158822|FG002|Overall Study|Not eligible b/c prior radiation history|0|||
147269649|NCT00458484|531158823|FG003|Overall Study|Not eligible b/c prior radiation history|0|||
147269650|NCT00458484|531158824|FG004|Overall Study|Not eligible b/c prior radiation history|0|||
147269651|NCT00458484|531158825|FG005|Overall Study|Not eligible b/c prior radiation history|1|||
147269652|NCT00458484|531158826|FG006|Overall Study|Not eligible b/c prior radiation history|0|||
147269653|NCT03571516|531158827|FG000|Overall Study|Severe diarrhea|1|||
147269654|NCT03571516|531158828|FG001|Overall Study|Severe diarrhea|0|||
147269655|NCT03571516|531158827|FG000|Overall Study|Withdrawal by Subject|0|||
147269656|NCT03571516|531158828|FG001|Overall Study|Withdrawal by Subject|1|||
147269657|NCT02741115|531158830|FG000|Overall Study|Adverse Event|1|||
147269658|NCT02741115|531158831|FG001|Overall Study|Adverse Event|0|||
147269659|NCT02741115|531158830|FG000|Overall Study|Lost to Follow-up|7|||
147269660|NCT02741115|531158831|FG001|Overall Study|Lost to Follow-up|4|||
147269661|NCT02741115|531158830|FG000|Overall Study|Withdrawal by Subject|4|||
147269662|NCT02741115|531158831|FG001|Overall Study|Withdrawal by Subject|2|||
147269663|NCT04602624|531158834|FG000|Overall Study|Protocol Deviation|1|||
147269664|NCT04602624|531158834|FG000|Overall Study|Withdrawal by Participant|1|||
147269665|NCT06425458|531158835|FG000|Overall Study|Removed by study team|2|||
147269666|NCT06425458|531158835|FG000|Overall Study|Lost to Follow-up|5|||
147269667|NCT03945981|531158838|FG000|Overall Study|Lost to Follow-up|12|||
147269668|NCT03945981|531158838|FG000|Overall Study|Physician Decision|4|||
147269669|NCT03945981|531158838|FG000|Overall Study|Withdrawal by Subject|6|||
147269670|NCT03945981|531158838|FG000|Overall Study|Protocol Violation|1|||
147269671|NCT00653224|531161051|FG000|Overall Study|Adverse Event|2|||
147269672|NCT00653224|531161052|FG001|Overall Study|Adverse Event|1|||
147269673|NCT00653224|531161051|FG000|Overall Study|Lack of Efficacy|1|||
147269674|NCT00653224|531161052|FG001|Overall Study|Lack of Efficacy|2|||
147269675|NCT00653224|531161051|FG000|Overall Study|Loss of efficacy|1|||
147269676|NCT00653224|531161052|FG001|Overall Study|Loss of efficacy|0|||
147269677|NCT00653224|531161051|FG000|Overall Study|Lost to Follow-up|1|||
147269678|NCT00653224|531161052|FG001|Overall Study|Lost to Follow-up|0|||
147269679|NCT00653224|531161051|FG000|Overall Study|Other|2|||
147269680|NCT00653224|531161052|FG001|Overall Study|Other|4|||
147269681|NCT00773175|531161053|FG000|Overall Study|Adverse Event|2|||
147269682|NCT00773175|531161054|FG001|Overall Study|Adverse Event|0|||
147269683|NCT00773175|531161053|FG000|Overall Study|Consent Withdrawn|0|||
147269684|NCT00773175|531161054|FG001|Overall Study|Consent Withdrawn|2|||
147269685|NCT00503841|531161055|FG000|Overall Study|All screen failures|44|||
147269686|NCT00326612|531161060|FG000|Overall Study|They did not have a seizure requiring tx|129|||
147269687|NCT00326612|531161061|FG001|Overall Study|They did not have a seizure requiring tx|137|||
147269688|NCT00419562|531161062|FG000|Overall Study|Lost to Follow-up|12|||
147269689|NCT00419562|531161063|FG001|Overall Study|Lost to Follow-up|13|||
147269690|NCT00419562|531161062|FG000|Overall Study|Withdrawal by Subject|20|||
147269691|NCT00419562|531161063|FG001|Overall Study|Withdrawal by Subject|18|||
147269692|NCT00419562|531161062|FG000|Overall Study|Participant Institutionalized|1|||
147269693|NCT00419562|531161063|FG001|Overall Study|Participant Institutionalized|0|||
147269694|NCT00640510|531161064|FG000|Overall Study|Lack of Efficacy|0|||
147269695|NCT00640510|531161065|FG001|Overall Study|Lack of Efficacy|1|||
147269696|NCT00640510|531161064|FG000|Overall Study|Protocol Violation|1|||
147269697|NCT00640510|531161065|FG001|Overall Study|Protocol Violation|0|||
147269698|NCT00640510|531161064|FG000|Overall Study|Physician Decision|0|||
147269699|NCT00640510|531161065|FG001|Overall Study|Physician Decision|1|||
147269700|NCT01440322|531161066|FG000|Overall Study|Discomfort|2|||
147269701|NCT01440322|531161067|FG001|Overall Study|Discomfort|0|||
147269702|NCT01440322|531161066|FG000|Overall Study|Biomicroscopy|1|||
147333273|NCT03175172|531387643|FG000|Overall Study|Study Terminated by Sponsor|3|||
147333274|NCT03169244|531387644|FG000|Overall Study|Lost to Follow-up|1|||
147333275|NCT03169244|531387645|FG001|Overall Study|Lost to Follow-up|2|||
147333276|NCT03169244|531387644|FG000|Overall Study|Adverse Event|1|||
147333277|NCT03169244|531387645|FG001|Overall Study|Adverse Event|0|||
147333278|NCT03169244|531387644|FG000|Overall Study|Withdrawal by Subject|2|||
147269703|NCT01440322|531161067|FG001|Overall Study|Biomicroscopy|0|||
147269704|NCT01440322|531161066|FG000|Overall Study|Symptoms and Problems|1|||
147269705|NCT01440322|531161067|FG001|Overall Study|Symptoms and Problems|0|||
147269706|NCT01440322|531161066|FG000|Overall Study|Unacceptable Subjective Vision|1|||
147269707|NCT01440322|531161067|FG001|Overall Study|Unacceptable Subjective Vision|0|||
147269708|NCT01440322|531161066|FG000|Overall Study|Other Product Related|1|||
147269709|NCT01440322|531161067|FG001|Overall Study|Other Product Related|0|||
147269710|NCT01440322|531161066|FG000|Overall Study|Unrelated Medical Problem|0|||
147269711|NCT01440322|531161067|FG001|Overall Study|Unrelated Medical Problem|1|||
147269712|NCT01440322|531161066|FG000|Overall Study|Other Non-Product Related|1|||
147269713|NCT01440322|531161067|FG001|Overall Study|Other Non-Product Related|0|||
147269714|NCT02412631|531161070|FG000|Overall Study|Adverse Event|1|||
147269715|NCT02412631|531161071|FG001|Overall Study|Adverse Event|2|||
147269716|NCT02412631|531161070|FG000|Overall Study|Lost to Follow-up|5|||
147269717|NCT02412631|531161071|FG001|Overall Study|Lost to Follow-up|9|||
147269718|NCT02412631|531161070|FG000|Overall Study|Withdrawal by Subject|9|||
147269719|NCT02412631|531161071|FG001|Overall Study|Withdrawal by Subject|3|||
147269720|NCT02412631|531161070|FG000|Overall Study|Early stop by FDA|5|||
147269721|NCT02412631|531161071|FG001|Overall Study|Early stop by FDA|2|||
147269722|NCT02412631|531161070|FG000|Overall Study|Unspecified reason|6|||
147269723|NCT02412631|531161071|FG001|Overall Study|Unspecified reason|8|||
147269724|NCT00770120|531161072|FG000|Overall Study|Progression|31|||
147269725|NCT00770120|531161072|FG000|Overall Study|Adverse Event|11|||
147269726|NCT00770120|531161072|FG000|Overall Study|Not Protocol Specified|11|||
147269727|NCT00770120|531161072|FG000|Overall Study|Death|3|||
147269728|NCT00770120|531161072|FG000|Overall Study|Withdrawal by Subject|2|||
147269729|NCT00770120|531161072|FG000|Overall Study|Ineligible|1|||
147269730|NCT00770120|531161072|FG000|Overall Study|Never Received Treatment/Not Analyzable|1|||
147269731|NCT00770120|531161072|FG000|Overall Study|Reason under Review|1|||
147269732|NCT01782313|531161080|FG000|Reached First Response/Completed 2 Cycle|Adverse Event|3|||
147269733|NCT01782313|531161080|FG000|Reached First Response/Completed 2 Cycle|Progressive Disease|3|||
147269734|NCT01782313|531161080|FG000|Treated Cycle 3|Progressive Disease|21|||
147269735|NCT01782313|531161080|FG000|Treated Cycle 4/Reached 16 Week Response|Progressive Disease|5|||
147269736|NCT01782313|531161080|FG000|Treated Cycle 4/Reached 16 Week Response|Adverse Event|1|||
147269737|NCT01782313|531161080|FG000|Continued Treatment After 16 Weeks|Progressive Disease|6|||
147269738|NCT01782313|531161080|FG000|Continued Treatment After 16 Weeks|Withdrawal by Subject|1|||
147269739|NCT01782313|531161080|FG000|Survival Follow up|Lost to Follow-up|1|||
147269740|NCT00958776|531161081|FG000|Overall Study|Adverse Event|0|||
147269741|NCT00958776|531161082|FG001|Overall Study|Adverse Event|1|||
147269742|NCT00958776|531161081|FG000|Overall Study|Physician Decision|1|||
147269743|NCT00958776|531161082|FG001|Overall Study|Physician Decision|0|||
147269744|NCT00958776|531161081|FG000|Overall Study|Lost to Follow-up|2|||
147269745|NCT00958776|531161082|FG001|Overall Study|Lost to Follow-up|6|||
147269746|NCT00958776|531161081|FG000|Overall Study|Withdrawal by Subject|7|||
147269747|NCT00958776|531161082|FG001|Overall Study|Withdrawal by Subject|16|||
147269748|NCT00958776|531161081|FG000|Overall Study|Protocol Violation|1|||
147269749|NCT00958776|531161082|FG001|Overall Study|Protocol Violation|1|||
147269750|NCT00958776|531161081|FG000|Overall Study|Death|2|||
147269751|NCT00958776|531161082|FG001|Overall Study|Death|1|||
147269752|NCT00958776|531161081|FG000|Overall Study|Noncompliance; Protocol Deviations|2|||
147269753|NCT00958776|531161082|FG001|Overall Study|Noncompliance; Protocol Deviations|3|||
147269754|NCT00958776|531161081|FG000|Overall Study|Missing|1|||
147269755|NCT00958776|531161082|FG001|Overall Study|Missing|1|||
147269756|NCT00480636|531161083|FG000|Overall Study|Death|12|||
147662334|NCT03110354|532587297|FG002|Overall Study|Progressive disease|3|||
147269757|NCT00480636|531161083|FG000|Overall Study|Lost to Follow-up|4|||
147269758|NCT00480636|531161083|FG000|Overall Study|Other|2|||
147269759|NCT00480636|531161083|FG000|Overall Study|Lost to follow-up; subsequently died|1|||
147333279|NCT03169244|531387645|FG001|Overall Study|Withdrawal by Subject|2|||
147269760|NCT02583256|531161084|FG000|Overall Study|Withdrawal by Subject|0|||
147269761|NCT02583256|531161085|FG001|Overall Study|Withdrawal by Subject|1|||
147269762|NCT02583256|531161086|FG002|Overall Study|Withdrawal by Subject|1|||
147269763|NCT02583256|531161087|FG003|Overall Study|Withdrawal by Subject|0|||
147269764|NCT02583256|531161084|FG000|Overall Study|Lost to Follow-up|1|||
147269765|NCT02583256|531161085|FG001|Overall Study|Lost to Follow-up|1|||
147269766|NCT02583256|531161086|FG002|Overall Study|Lost to Follow-up|0|||
147269767|NCT02583256|531161087|FG003|Overall Study|Lost to Follow-up|1|||
147269768|NCT02583256|531161084|FG000|Overall Study|Administrative/Other|2|||
147269769|NCT02583256|531161085|FG001|Overall Study|Administrative/Other|0|||
147269770|NCT02583256|531161086|FG002|Overall Study|Administrative/Other|1|||
147333280|NCT03169244|531387644|FG000|Overall Study|Physician Decision|1|||
147333281|NCT03169244|531387645|FG001|Overall Study|Physician Decision|0|||
147333282|NCT02974634|531387646|FG000|Overall Study|Advanced disease|12|||
147333283|NCT02974634|531387647|FG001|Overall Study|Advanced disease|3|||
147269771|NCT02583256|531161087|FG003|Overall Study|Administrative/Other|2|||
147269772|NCT02177266|531161094|FG000|Overall Study|Adverse Event|0|||
147269773|NCT02177266|531161095|FG001|Overall Study|Adverse Event|1|||
147269774|NCT02177266|531161094|FG000|Overall Study|Withdrawal by Subject|1|||
147269775|NCT02177266|531161095|FG001|Overall Study|Withdrawal by Subject|0|||
147269776|NCT03364049|531161097|FG000|Overall Study|Death|6|||
147269777|NCT03364049|531161098|FG001|Overall Study|Death|4|||
147269778|NCT03364049|531161099|FG002|Overall Study|Death|5|||
147269779|NCT03364049|531161100|FG003|Overall Study|Death|14|||
147269780|NCT03364049|531161097|FG000|Overall Study|In survival phase status at study closure. Participant transferred to pembrolizumab extension study|0|||
147269781|NCT03364049|531161098|FG001|Overall Study|In survival phase status at study closure. Participant transferred to pembrolizumab extension study|1|||
147269782|NCT03364049|531161099|FG002|Overall Study|In survival phase status at study closure. Participant transferred to pembrolizumab extension study|0|||
147269783|NCT03364049|531161100|FG003|Overall Study|In survival phase status at study closure. Participant transferred to pembrolizumab extension study|0|||
147269784|NCT03364049|531161097|FG000|Overall Study|Withdrawal by Subject|0|||
147333284|NCT02974634|531387646|FG000|Overall Study|Noncompliance|3|||
147269785|NCT03364049|531161098|FG001|Overall Study|Withdrawal by Subject|1|||
147269786|NCT03364049|531161099|FG002|Overall Study|Withdrawal by Subject|1|||
147269787|NCT03364049|531161100|FG003|Overall Study|Withdrawal by Subject|1|||
147269788|NCT00546715|531161101|FG000|Overall Study|Withdrawal by Subject|0|||
147269789|NCT00546715|531161102|FG001|Overall Study|Withdrawal by Subject|1|||
147269790|NCT00546715|531161103|FG002|Overall Study|Withdrawal by Subject|0|||
147269791|NCT00546715|531161104|FG003|Overall Study|Withdrawal by Subject|0|||
147269792|NCT00418691|531161105|FG000|Overall Study|Lost to Follow-up|1|||
147269793|NCT00418691|531161106|FG001|Overall Study|Lost to Follow-up|2|||
147269794|NCT00418691|531161107|FG002|Overall Study|Lost to Follow-up|3|||
147269795|NCT00418691|531161105|FG000|Overall Study|Started new medication voiding entry|0|||
147269796|NCT00418691|531161106|FG001|Overall Study|Started new medication voiding entry|0|||
147269797|NCT00418691|531161107|FG002|Overall Study|Started new medication voiding entry|1|||
147269798|NCT00418691|531161105|FG000|Overall Study|Progressive Disease|1|||
147269799|NCT00418691|531161106|FG001|Overall Study|Progressive Disease|0|||
147269800|NCT00418691|531161107|FG002|Overall Study|Progressive Disease|1|||
147269801|NCT01802775|531161108|FG000|Overall Study|Death|0|||
147269802|NCT01802775|531161109|FG001|Overall Study|Death|3|||
147269803|NCT01802775|531161108|FG000|Overall Study|Reason not provided|0|||
147269804|NCT01802775|531161109|FG001|Overall Study|Reason not provided|1|||
147269805|NCT01802775|531161108|FG000|Overall Study|Physician Decision|1|||
147269806|NCT01802775|531161109|FG001|Overall Study|Physician Decision|0|||
147269807|NCT01802775|531161108|FG000|Overall Study|Adverse Event|1|||
147269808|NCT01802775|531161109|FG001|Overall Study|Adverse Event|1|||
147269809|NCT01802775|531161108|FG000|Overall Study|Withdrawal by Subject|3|||
147269810|NCT01802775|531161109|FG001|Overall Study|Withdrawal by Subject|5|||
147269811|NCT01802775|531161108|FG000|Overall Study|Lost to Follow-up|1|||
147269812|NCT01802775|531161109|FG001|Overall Study|Lost to Follow-up|2|||
147269813|NCT01096784|531161110|FG000|Overall Study|Withdrawal by Subject|2|||
147269814|NCT01096784|531161111|FG001|Overall Study|Withdrawal by Subject|1|||
147269815|NCT01096784|531161110|FG000|Overall Study|Adverse Event|11|||
147269816|NCT01096784|531161111|FG001|Overall Study|Adverse Event|9|||
147269817|NCT01096784|531161110|FG000|Overall Study|Protocol Deviation|2|||
147269818|NCT01096784|531161111|FG001|Overall Study|Protocol Deviation|2|||
147269819|NCT01096784|531161110|FG000|Overall Study|Administrative Decision|0|||
147269820|NCT01096784|531161111|FG001|Overall Study|Administrative Decision|1|||
147269821|NCT01096784|531161110|FG000|Overall Study|Other Unspecified|0|||
147269822|NCT01096784|531161111|FG001|Overall Study|Other Unspecified|1|||
147269823|NCT03761628|531161112|FG000|Overall Study|Withdrawal by Subject|3|||
147269824|NCT03761628|531161112|FG000|Overall Study|Physician Decision|1|||
147269825|NCT03761628|531161112|FG000|Overall Study|Pregnancy|1|||
147269826|NCT03761628|531161112|FG000|Overall Study|Lost to Follow-up|1|||
147269827|NCT04649151|531161115|FG000|Overall Study|Pregnancy|0|||
147269828|NCT04649151|531161116|FG001|Overall Study|Pregnancy|0|||
147269829|NCT04649151|531161117|FG002|Overall Study|Pregnancy|0|||
147269830|NCT04649151|531161118|FG003|Overall Study|Pregnancy|0|||
147269831|NCT04649151|531161119|FG004|Overall Study|Pregnancy|3|||
147269832|NCT04649151|531161115|FG000|Overall Study|Physician Decision|10|||
147269833|NCT04649151|531161116|FG001|Overall Study|Physician Decision|0|||
147269834|NCT04649151|531161117|FG002|Overall Study|Physician Decision|0|||
147269835|NCT04649151|531161118|FG003|Overall Study|Physician Decision|1|||
147333285|NCT02974634|531387647|FG001|Overall Study|Noncompliance|7|||
147269836|NCT04649151|531161119|FG004|Overall Study|Physician Decision|1|||
147269837|NCT04649151|531161115|FG000|Overall Study|Protocol Deviation|25|||
147333286|NCT02974634|531387646|FG000|Overall Study|intervention technology related issues|5|||
147333287|NCT02974634|531387647|FG001|Overall Study|intervention technology related issues|0|||
147269838|NCT04649151|531161116|FG001|Overall Study|Protocol Deviation|3|||
147269839|NCT04649151|531161117|FG002|Overall Study|Protocol Deviation|0|||
147269840|NCT04649151|531161118|FG003|Overall Study|Protocol Deviation|0|||
147269841|NCT04649151|531161119|FG004|Overall Study|Protocol Deviation|0|||
147269842|NCT04649151|531161115|FG000|Overall Study|Received another COVID-19 vaccine under EUA|495|||
147269843|NCT04649151|531161116|FG001|Overall Study|Received another COVID-19 vaccine under EUA|730|||
147269844|NCT04649151|531161117|FG002|Overall Study|Received another COVID-19 vaccine under EUA|0|||
147269845|NCT04649151|531161118|FG003|Overall Study|Received another COVID-19 vaccine under EUA|0|||
147269846|NCT04649151|531161119|FG004|Overall Study|Received another COVID-19 vaccine under EUA|0|||
147269847|NCT04649151|531161115|FG000|Overall Study|Withdrawal by Subject|370|||
147269848|NCT04649151|531161116|FG001|Overall Study|Withdrawal by Subject|113|||
147269849|NCT04649151|531161117|FG002|Overall Study|Withdrawal by Subject|2|||
147269850|NCT04649151|531161118|FG003|Overall Study|Withdrawal by Subject|7|||
147269851|NCT04649151|531161119|FG004|Overall Study|Withdrawal by Subject|15|||
147269852|NCT04649151|531161115|FG000|Overall Study|Adverse Event|1|||
147269853|NCT04649151|531161116|FG001|Overall Study|Adverse Event|0|||
147269854|NCT04649151|531161117|FG002|Overall Study|Adverse Event|0|||
147269855|NCT04649151|531161118|FG003|Overall Study|Adverse Event|0|||
147269856|NCT04649151|531161119|FG004|Overall Study|Adverse Event|0|||
147269857|NCT04649151|531161115|FG000|Overall Study|Lost to Follow-up|256|||
147269858|NCT04649151|531161116|FG001|Overall Study|Lost to Follow-up|29|||
147269859|NCT04649151|531161117|FG002|Overall Study|Lost to Follow-up|10|||
147269860|NCT04649151|531161118|FG003|Overall Study|Lost to Follow-up|3|||
147269861|NCT04649151|531161119|FG004|Overall Study|Lost to Follow-up|6|||
147269862|NCT04649151|531161115|FG000|Overall Study|Other than specified|59|||
147269863|NCT04649151|531161116|FG001|Overall Study|Other than specified|294|||
147269864|NCT04649151|531161117|FG002|Overall Study|Other than specified|0|||
147269865|NCT04649151|531161118|FG003|Overall Study|Other than specified|0|||
147269866|NCT04649151|531161119|FG004|Overall Study|Other than specified|4|||
147269867|NCT04649151|531161115|FG000|Overall Study|Death|0|||
147333288|NCT02974634|531387646|FG000|Overall Study|Death|8|||
147662335|NCT03110354|532587298|FG003|Overall Study|Progressive disease|4|||
147269868|NCT04649151|531161116|FG001|Overall Study|Death|0|||
147269869|NCT04649151|531161117|FG002|Overall Study|Death|0|||
147269870|NCT04649151|531161118|FG003|Overall Study|Death|0|||
147269871|NCT04649151|531161119|FG004|Overall Study|Death|1|||
147269872|NCT02975934|531161120|FG000|Treatment Phase|Never initiated study drug|0|||
147269873|NCT02975934|531161121|FG001|Treatment Phase|Never initiated study drug|5|||
147269874|NCT02975934|531161122|FG002|Treatment Phase|Never initiated study drug|0|||
147269875|NCT03362502|531161123|FG000|Overall Study|Death|0|||
147269876|NCT03362502|531161124|FG001|Overall Study|Death|0|||
147269877|NCT03362502|531161125|FG002|Overall Study|Death|1|||
147269878|NCT00433654|531161128|FG000|Overall Study|Death|4|||
147269879|NCT00433654|531161129|FG001|Overall Study|Death|0|||
147269880|NCT00433654|531161128|FG000|Overall Study|Missed visit|6|||
147269881|NCT00433654|531161129|FG001|Overall Study|Missed visit|3|||
147269882|NCT00433654|531161128|FG000|Overall Study|Subject not yet due for visit|4|||
147269883|NCT00433654|531161129|FG001|Overall Study|Subject not yet due for visit|0|||
147269884|NCT00433654|531161128|FG000|Overall Study|Withdrawal by Subject|1|||
147269885|NCT00433654|531161129|FG001|Overall Study|Withdrawal by Subject|2|||
147269886|NCT03277261|531161130|FG000|Overall Study|Adverse Event|17|||
147269887|NCT03277261|531161131|FG001|Overall Study|Adverse Event|1|||
147269888|NCT03277261|531161130|FG000|Overall Study|Participant Withdrawal of Consent|6|||
147269889|NCT03277261|531161131|FG001|Overall Study|Participant Withdrawal of Consent|15|||
147269890|NCT03277261|531161130|FG000|Overall Study|Investigator / Sponsor Decision|4|||
147269891|NCT03277261|531161131|FG001|Overall Study|Investigator / Sponsor Decision|2|||
147269892|NCT03277261|531161130|FG000|Overall Study|Pregnancy|2|||
147269893|NCT03277261|531161131|FG001|Overall Study|Pregnancy|0|||
147269894|NCT03277261|531161130|FG000|Overall Study|Lost to Follow-up|2|||
147269895|NCT03277261|531161131|FG001|Overall Study|Lost to Follow-up|2|||
147269896|NCT03277261|531161130|FG000|Overall Study|Lack of Efficacy|2|||
147269897|NCT03277261|531161131|FG001|Overall Study|Lack of Efficacy|2|||
147269898|NCT03277261|531161130|FG000|Overall Study|Other-Alternative Treatment/Unspecified Reasons|1|||
147269899|NCT03277261|531161131|FG001|Overall Study|Other-Alternative Treatment/Unspecified Reasons|1|||
147269900|NCT02043015|531161132|FG000|Overall Study|Lost to Follow-up|4|||
147269901|NCT02043015|531161132|FG000|Overall Study|Withdrawal by Subject|4|||
147269902|NCT02043015|531161132|FG000|Overall Study|Removed once target enrollment reached|15|||
147269903|NCT02043015|531161132|FG000|Overall Study|Participant moved away from study city|4|||
147269904|NCT02043015|531161132|FG000|Overall Study|Incarceration|1|||
147269905|NCT01403974|531161133|FG000|Overall Study|Progressive disease according to RECIST|3|||
147269906|NCT01403974|531161134|FG001|Overall Study|Progressive disease according to RECIST|3|||
147269907|NCT01403974|531161135|FG002|Overall Study|Progressive disease according to RECIST|2|||
147269908|NCT01403974|531161136|FG003|Overall Study|Progressive disease according to RECIST|3|||
147269909|NCT01403974|531161137|FG004|Overall Study|Progressive disease according to RECIST|3|||
147269910|NCT01403974|531161138|FG005|Overall Study|Progressive disease according to RECIST|2|||
147333289|NCT02974634|531387647|FG001|Overall Study|Death|11|||
147333290|NCT04860258|531387650|FG000|Overall Study|Withdrawal by Subject|0|||
147333291|NCT04860258|531387651|FG001|Overall Study|Withdrawal by Subject|0|||
147269911|NCT01403974|531161139|FG006|Overall Study|Progressive disease according to RECIST|3|||
147269912|NCT01403974|531161140|FG007|Overall Study|Progressive disease according to RECIST|2|||
147269913|NCT01403974|531161141|FG008|Overall Study|Progressive disease according to RECIST|6|||
147269914|NCT01403974|531161142|FG009|Overall Study|Progressive disease according to RECIST|2|||
147269915|NCT01403974|531161143|FG010|Overall Study|Progressive disease according to RECIST|3|||
147269916|NCT01403974|531161144|FG011|Overall Study|Progressive disease according to RECIST|2|||
147269917|NCT01403974|531161145|FG012|Overall Study|Progressive disease according to RECIST|2|||
147269918|NCT01403974|531161146|FG013|Overall Study|Progressive disease according to RECIST|3|||
147269919|NCT01403974|531161147|FG014|Overall Study|Progressive disease according to RECIST|1|||
147269920|NCT01403974|531161148|FG015|Overall Study|Progressive disease according to RECIST|8|||
147269921|NCT01403974|531161133|FG000|Overall Study|Dose limiting toxicity (DLT)|0|||
147269922|NCT01403974|531161134|FG001|Overall Study|Dose limiting toxicity (DLT)|0|||
147269923|NCT01403974|531161135|FG002|Overall Study|Dose limiting toxicity (DLT)|0|||
147269924|NCT01403974|531161136|FG003|Overall Study|Dose limiting toxicity (DLT)|0|||
147269925|NCT01403974|531161137|FG004|Overall Study|Dose limiting toxicity (DLT)|0|||
147333292|NCT04860258|531387652|FG002|Overall Study|Withdrawal by Subject|4|||
147333293|NCT04860258|531387653|FG003|Overall Study|Withdrawal by Subject|1|||
147333294|NCT04860258|531387654|FG004|Overall Study|Withdrawal by Subject|4|||
147269926|NCT01403974|531161138|FG005|Overall Study|Dose limiting toxicity (DLT)|0|||
147269927|NCT01403974|531161139|FG006|Overall Study|Dose limiting toxicity (DLT)|0|||
147269928|NCT01403974|531161140|FG007|Overall Study|Dose limiting toxicity (DLT)|0|||
147269929|NCT01403974|531161141|FG008|Overall Study|Dose limiting toxicity (DLT)|1|||
147269930|NCT01403974|531161142|FG009|Overall Study|Dose limiting toxicity (DLT)|0|||
147269931|NCT01403974|531161143|FG010|Overall Study|Dose limiting toxicity (DLT)|0|||
147269932|NCT01403974|531161144|FG011|Overall Study|Dose limiting toxicity (DLT)|0|||
147269933|NCT01403974|531161145|FG012|Overall Study|Dose limiting toxicity (DLT)|0|||
147269934|NCT01403974|531161146|FG013|Overall Study|Dose limiting toxicity (DLT)|0|||
147269935|NCT01403974|531161147|FG014|Overall Study|Dose limiting toxicity (DLT)|0|||
147269936|NCT01403974|531161148|FG015|Overall Study|Dose limiting toxicity (DLT)|0|||
147269937|NCT01403974|531161133|FG000|Overall Study|Refused to continue study medication|0|||
147269938|NCT01403974|531161134|FG001|Overall Study|Refused to continue study medication|0|||
147269939|NCT01403974|531161135|FG002|Overall Study|Refused to continue study medication|0|||
147269940|NCT01403974|531161136|FG003|Overall Study|Refused to continue study medication|0|||
147269941|NCT01403974|531161137|FG004|Overall Study|Refused to continue study medication|0|||
147269942|NCT01403974|531161138|FG005|Overall Study|Refused to continue study medication|1|||
147269943|NCT01403974|531161139|FG006|Overall Study|Refused to continue study medication|0|||
147269944|NCT01403974|531161140|FG007|Overall Study|Refused to continue study medication|0|||
147269945|NCT01403974|531161141|FG008|Overall Study|Refused to continue study medication|1|||
147269946|NCT01403974|531161142|FG009|Overall Study|Refused to continue study medication|0|||
147269947|NCT01403974|531161143|FG010|Overall Study|Refused to continue study medication|1|||
147269948|NCT01403974|531161144|FG011|Overall Study|Refused to continue study medication|0|||
147269949|NCT01403974|531161145|FG012|Overall Study|Refused to continue study medication|0|||
147269950|NCT01403974|531161146|FG013|Overall Study|Refused to continue study medication|0|||
147269951|NCT01403974|531161147|FG014|Overall Study|Refused to continue study medication|0|||
147269952|NCT01403974|531161148|FG015|Overall Study|Refused to continue study medication|4|||
147269953|NCT01403974|531161133|FG000|Overall Study|Adverse Event|0|||
147269954|NCT01403974|531161134|FG001|Overall Study|Adverse Event|0|||
147269955|NCT01403974|531161135|FG002|Overall Study|Adverse Event|1|||
147269956|NCT01403974|531161136|FG003|Overall Study|Adverse Event|0|||
147269957|NCT01403974|531161137|FG004|Overall Study|Adverse Event|0|||
147269958|NCT01403974|531161138|FG005|Overall Study|Adverse Event|0|||
147269959|NCT01403974|531161139|FG006|Overall Study|Adverse Event|0|||
147269960|NCT01403974|531161140|FG007|Overall Study|Adverse Event|1|||
147269961|NCT01403974|531161141|FG008|Overall Study|Adverse Event|0|||
147269962|NCT01403974|531161142|FG009|Overall Study|Adverse Event|0|||
147269963|NCT01403974|531161143|FG010|Overall Study|Adverse Event|0|||
147269964|NCT01403974|531161144|FG011|Overall Study|Adverse Event|0|||
147269965|NCT01403974|531161145|FG012|Overall Study|Adverse Event|1|||
147269966|NCT01403974|531161146|FG013|Overall Study|Adverse Event|0|||
147269967|NCT01403974|531161147|FG014|Overall Study|Adverse Event|0|||
147269968|NCT01403974|531161148|FG015|Overall Study|Adverse Event|0|||
147269969|NCT01403974|531161133|FG000|Overall Study|Other than specified|0|||
147269970|NCT01403974|531161134|FG001|Overall Study|Other than specified|0|||
147269971|NCT01403974|531161135|FG002|Overall Study|Other than specified|0|||
147269972|NCT01403974|531161136|FG003|Overall Study|Other than specified|0|||
147269973|NCT01403974|531161137|FG004|Overall Study|Other than specified|0|||
147269974|NCT01403974|531161138|FG005|Overall Study|Other than specified|0|||
147269975|NCT01403974|531161139|FG006|Overall Study|Other than specified|0|||
147269976|NCT01403974|531161140|FG007|Overall Study|Other than specified|0|||
147269977|NCT01403974|531161141|FG008|Overall Study|Other than specified|0|||
147333295|NCT04860258|531387655|FG005|Overall Study|Withdrawal by Subject|1|||
147269978|NCT01403974|531161142|FG009|Overall Study|Other than specified|1|||
147269979|NCT01403974|531161143|FG010|Overall Study|Other than specified|0|||
147269980|NCT01403974|531161144|FG011|Overall Study|Other than specified|1|||
147269981|NCT01403974|531161145|FG012|Overall Study|Other than specified|0|||
147269982|NCT01403974|531161146|FG013|Overall Study|Other than specified|0|||
147269983|NCT01403974|531161147|FG014|Overall Study|Other than specified|0|||
147269984|NCT01403974|531161148|FG015|Overall Study|Other than specified|0|||
147269985|NCT01494610|531161151|FG000|Period 1|Withdrawal by Subject|1|||
147269986|NCT01494610|531161152|FG001|Period 1|Withdrawal by Subject|1|||
147269987|NCT01494610|531161151|FG000|Period 3|Adverse Event|1|||
147269988|NCT01494610|531161152|FG001|Period 3|Adverse Event|0|||
147269989|NCT01494610|531161151|FG000|Period 3|Withdrawal by Subject|1|||
147269990|NCT01494610|531161152|FG001|Period 3|Withdrawal by Subject|0|||
147269991|NCT01494610|531161151|FG000|Period 4|Protocol Violation|1|||
147269992|NCT01494610|531161152|FG001|Period 4|Protocol Violation|0|||
147269993|NCT03995953|531161153|FG000|Overall Study|Death|3|||
147269994|NCT03995953|531161154|FG001|Overall Study|Death|0|||
147269995|NCT03995953|531161155|FG002|Overall Study|Death|3|||
147269996|NCT03995953|531161156|FG003|Overall Study|Death|0|||
147269997|NCT03995953|531161157|FG004|Overall Study|Death|3|||
147269998|NCT03995953|531161158|FG005|Overall Study|Death|0|||
147269999|NCT03995953|531161159|FG006|Overall Study|Death|0|||
147270000|NCT03995953|531161160|FG007|Overall Study|Death|0|||
147270001|NCT03995953|531161161|FG008|Overall Study|Death|1|||
147333296|NCT04860258|531387656|FG006|Overall Study|Withdrawal by Subject|0|||
147333297|NCT02496702|531387657|FG000|Overall Study|Lost to Follow-up|8|||
147333298|NCT02496702|531387658|FG001|Overall Study|Lost to Follow-up|6|||
147333299|NCT02496702|531387657|FG000|Overall Study|Only partially tested|0|||
147333300|NCT02496702|531387658|FG001|Overall Study|Only partially tested|2|||
147333301|NCT01400776|531387659|FG000|Overall Study|Adverse Event|7|||
147333302|NCT01400776|531387660|FG001|Overall Study|Adverse Event|2|||
147333303|NCT01400776|531387661|FG002|Overall Study|Adverse Event|9|||
147333304|NCT01400776|531387662|FG003|Overall Study|Adverse Event|2|||
147333305|NCT01400776|531387659|FG000|Overall Study|Lost to Follow-up|1|||
147333306|NCT01400776|531387660|FG001|Overall Study|Lost to Follow-up|0|||
147333307|NCT01400776|531387661|FG002|Overall Study|Lost to Follow-up|4|||
147333308|NCT01400776|531387662|FG003|Overall Study|Lost to Follow-up|1|||
147333309|NCT01400776|531387659|FG000|Overall Study|Withdrew Consent|4|||
147333310|NCT01400776|531387660|FG001|Overall Study|Withdrew Consent|2|||
147333311|NCT01400776|531387661|FG002|Overall Study|Withdrew Consent|6|||
147333312|NCT01400776|531387662|FG003|Overall Study|Withdrew Consent|1|||
147333313|NCT01400776|531387659|FG000|Overall Study|Protocol Deviation|6|||
147333314|NCT01400776|531387660|FG001|Overall Study|Protocol Deviation|1|||
147333315|NCT01400776|531387661|FG002|Overall Study|Protocol Deviation|5|||
147333316|NCT01400776|531387662|FG003|Overall Study|Protocol Deviation|2|||
147333317|NCT01400776|531387659|FG000|Overall Study|Reason not Specified|3|||
147333318|NCT01400776|531387660|FG001|Overall Study|Reason not Specified|0|||
147333319|NCT01400776|531387661|FG002|Overall Study|Reason not Specified|4|||
147333320|NCT01400776|531387662|FG003|Overall Study|Reason not Specified|3|||
147333321|NCT04035668|531387663|FG000|Overall Study|Adverse Event|3|||
147333322|NCT04035668|531387664|FG001|Overall Study|Adverse Event|4|||
147333323|NCT04035668|531387665|FG002|Overall Study|Adverse Event|2|||
147333324|NCT04035668|531387663|FG000|Overall Study|Lost to Follow-up|0|||
147333325|NCT04035668|531387664|FG001|Overall Study|Lost to Follow-up|1|||
147333326|NCT04035668|531387665|FG002|Overall Study|Lost to Follow-up|0|||
147333327|NCT04035668|531387663|FG000|Overall Study|Physician Decision|2|||
147333328|NCT04035668|531387664|FG001|Overall Study|Physician Decision|1|||
147333329|NCT04035668|531387665|FG002|Overall Study|Physician Decision|1|||
147333330|NCT04035668|531387663|FG000|Overall Study|Subject Decision|2|||
147333331|NCT04035668|531387664|FG001|Overall Study|Subject Decision|2|||
147333332|NCT04035668|531387665|FG002|Overall Study|Subject Decision|0|||
147333333|NCT02937831|531387667|FG000|Overall Study|Protocol Violation|4|||
147333334|NCT02027558|531387670|FG000|Overall Study|Death|0|||
147333335|NCT02027558|531387671|FG001|Overall Study|Death|1|||
147333336|NCT02027558|531387670|FG000|Overall Study|Withdrawal by Subject|2|||
147333337|NCT02027558|531387671|FG001|Overall Study|Withdrawal by Subject|0|||
147333338|NCT02027558|531387670|FG000|Overall Study|Lost to Follow-up|4|||
147333339|NCT02027558|531387671|FG001|Overall Study|Lost to Follow-up|1|||
147333340|NCT02027558|531387670|FG000|Overall Study|Refused assessment|3|||
147333341|NCT02027558|531387671|FG001|Overall Study|Refused assessment|0|||
147333342|NCT00114244|531387676|FG000|Overall Study|Adverse Event|2|||
147333343|NCT00114244|531387677|FG001|Overall Study|Adverse Event|5|||
147333344|NCT00114244|531387676|FG000|Overall Study|Withdrawal by Subject|0|||
147333345|NCT00114244|531387677|FG001|Overall Study|Withdrawal by Subject|2|||
147270002|NCT03995953|531161162|FG009|Overall Study|Death|0|||
147270003|NCT03995953|531161163|FG010|Overall Study|Death|0|||
147270004|NCT03995953|531161164|FG011|Overall Study|Death|0|||
147333346|NCT02694978|531387678|FG000|Overall Study|Adverse Event|10|||
147333347|NCT02694978|531387679|FG001|Overall Study|Adverse Event|9|||
147333348|NCT02694978|531387678|FG000|Overall Study|Withdrawal by Subject|22|||
147333349|NCT02694978|531387679|FG001|Overall Study|Withdrawal by Subject|19|||
147270005|NCT03995953|531161153|FG000|Overall Study|Lost to Follow-up|6|||
147270006|NCT03995953|531161154|FG001|Overall Study|Lost to Follow-up|54|||
147270007|NCT03995953|531161155|FG002|Overall Study|Lost to Follow-up|3|||
147270008|NCT03995953|531161156|FG003|Overall Study|Lost to Follow-up|32|||
147270009|NCT03995953|531161157|FG004|Overall Study|Lost to Follow-up|5|||
147270010|NCT03995953|531161158|FG005|Overall Study|Lost to Follow-up|44|||
147270011|NCT03995953|531161159|FG006|Overall Study|Lost to Follow-up|0|||
147270012|NCT03995953|531161160|FG007|Overall Study|Lost to Follow-up|31|||
147270013|NCT03995953|531161161|FG008|Overall Study|Lost to Follow-up|8|||
147270014|NCT03995953|531161162|FG009|Overall Study|Lost to Follow-up|36|||
147270015|NCT03995953|531161163|FG010|Overall Study|Lost to Follow-up|5|||
147270016|NCT03995953|531161164|FG011|Overall Study|Lost to Follow-up|41|||
147270017|NCT03995953|531161153|FG000|Overall Study|Withdrawal by Subject|4|||
147270018|NCT03995953|531161154|FG001|Overall Study|Withdrawal by Subject|0|||
147270019|NCT03995953|531161155|FG002|Overall Study|Withdrawal by Subject|1|||
147270020|NCT03995953|531161156|FG003|Overall Study|Withdrawal by Subject|0|||
147270021|NCT03995953|531161157|FG004|Overall Study|Withdrawal by Subject|1|||
147270022|NCT03995953|531161158|FG005|Overall Study|Withdrawal by Subject|0|||
147270023|NCT03995953|531161159|FG006|Overall Study|Withdrawal by Subject|1|||
147270024|NCT03995953|531161160|FG007|Overall Study|Withdrawal by Subject|0|||
147270025|NCT03995953|531161161|FG008|Overall Study|Withdrawal by Subject|3|||
147270026|NCT03995953|531161162|FG009|Overall Study|Withdrawal by Subject|0|||
147270027|NCT03995953|531161163|FG010|Overall Study|Withdrawal by Subject|3|||
147270028|NCT03995953|531161164|FG011|Overall Study|Withdrawal by Subject|0|||
147270029|NCT03995953|531161153|FG000|Overall Study|Health Issues|0|||
147270030|NCT03995953|531161154|FG001|Overall Study|Health Issues|0|||
147270031|NCT03995953|531161155|FG002|Overall Study|Health Issues|0|||
147270032|NCT03995953|531161156|FG003|Overall Study|Health Issues|0|||
147270033|NCT03995953|531161157|FG004|Overall Study|Health Issues|1|||
147270034|NCT03995953|531161158|FG005|Overall Study|Health Issues|0|||
147270035|NCT03995953|531161159|FG006|Overall Study|Health Issues|0|||
147270036|NCT03995953|531161160|FG007|Overall Study|Health Issues|0|||
147270037|NCT03995953|531161161|FG008|Overall Study|Health Issues|4|||
147270038|NCT03995953|531161162|FG009|Overall Study|Health Issues|0|||
147270039|NCT03995953|531161163|FG010|Overall Study|Health Issues|0|||
147270040|NCT03995953|531161164|FG011|Overall Study|Health Issues|0|||
147270041|NCT03995953|531161153|FG000|Overall Study|Relocated|11|||
147270042|NCT03995953|531161154|FG001|Overall Study|Relocated|0|||
147270043|NCT03995953|531161155|FG002|Overall Study|Relocated|16|||
147270044|NCT03995953|531161156|FG003|Overall Study|Relocated|0|||
147270045|NCT03995953|531161157|FG004|Overall Study|Relocated|14|||
147270046|NCT03995953|531161158|FG005|Overall Study|Relocated|0|||
147270047|NCT03995953|531161159|FG006|Overall Study|Relocated|16|||
147270048|NCT03995953|531161160|FG007|Overall Study|Relocated|0|||
147270049|NCT03995953|531161161|FG008|Overall Study|Relocated|14|||
147270050|NCT03995953|531161162|FG009|Overall Study|Relocated|0|||
147270051|NCT03995953|531161163|FG010|Overall Study|Relocated|15|||
147270052|NCT03995953|531161164|FG011|Overall Study|Relocated|0|||
147270053|NCT02388997|531161165|FG000|Overall Study|Adverse Event|1|||
147270054|NCT02388997|531161166|FG001|Overall Study|Adverse Event|2|||
147270055|NCT02388997|531161165|FG000|Overall Study|Withdrawal by Subject|2|||
147270056|NCT02388997|531161166|FG001|Overall Study|Withdrawal by Subject|1|||
147270057|NCT02388997|531161165|FG000|Overall Study|Lung function exclusion criteria|0|||
147600290|NCT03893565|532356364|FG007|Double-blind Induction Phase (10 Weeks)|Other|0|||
147600291|NCT03893565|532356365|FG008|Double-blind Induction Phase (10 Weeks)|Other|0|||
147270058|NCT02388997|531161166|FG001|Overall Study|Lung function exclusion criteria|2|||
147270059|NCT02388997|531161165|FG000|Overall Study|Tested positive for virus during run-in|0|||
147270060|NCT02388997|531161166|FG001|Overall Study|Tested positive for virus during run-in|1|||
147270061|NCT00006184|531161167|FG000|Overall Study|Death|1|||
147270062|NCT00006184|531161168|FG001|Overall Study|Death|0|||
147270063|NCT01110915|531161175|FG000|Overall Study|Death|2|||
147270064|NCT01110915|531161176|FG001|Overall Study|Death|1|||
147270065|NCT01110915|531161175|FG000|Overall Study|Lost to Follow-up|1|||
147270066|NCT01110915|531161176|FG001|Overall Study|Lost to Follow-up|0|||
147270067|NCT01110915|531161175|FG000|Overall Study|Withdrawal by Subject|7|||
147270068|NCT01110915|531161176|FG001|Overall Study|Withdrawal by Subject|1|||
147270069|NCT02948842|531161182|FG000|Overall Study|Withdrawal by Subject|4|||
147270070|NCT00207142|531161185|FG000|Induction Phase|Adverse Event|9|||
147270071|NCT00207142|531161186|FG001|Induction Phase|Adverse Event|0|||
147270072|NCT00207142|531161187|FG002|Induction Phase|Adverse Event|0|||
147270073|NCT00207142|531161188|FG003|Induction Phase|Adverse Event|0|||
147270074|NCT00207142|531161185|FG000|Induction Phase|Death|1|||
147270075|NCT00207142|531161186|FG001|Induction Phase|Death|0|||
147270076|NCT00207142|531161187|FG002|Induction Phase|Death|0|||
147270077|NCT00207142|531161188|FG003|Induction Phase|Death|0|||
147270078|NCT00207142|531161185|FG000|Induction Phase|Lack of Efficacy|1|||
147270079|NCT00207142|531161186|FG001|Induction Phase|Lack of Efficacy|0|||
147270080|NCT00207142|531161187|FG002|Induction Phase|Lack of Efficacy|0|||
147270081|NCT00207142|531161188|FG003|Induction Phase|Lack of Efficacy|0|||
147270082|NCT00207142|531161185|FG000|Induction Phase|Lost to Follow-up|5|||
147270083|NCT00207142|531161186|FG001|Induction Phase|Lost to Follow-up|0|||
147270084|NCT00207142|531161187|FG002|Induction Phase|Lost to Follow-up|0|||
147270085|NCT00207142|531161188|FG003|Induction Phase|Lost to Follow-up|0|||
147270086|NCT00207142|531161185|FG000|Induction Phase|Physician Decision|2|||
147270087|NCT00207142|531161186|FG001|Induction Phase|Physician Decision|0|||
147270088|NCT00207142|531161187|FG002|Induction Phase|Physician Decision|0|||
147270089|NCT00207142|531161188|FG003|Induction Phase|Physician Decision|0|||
147270090|NCT00207142|531161185|FG000|Induction Phase|Poor/noncompliance|2|||
147270091|NCT00207142|531161186|FG001|Induction Phase|Poor/noncompliance|0|||
147270092|NCT00207142|531161187|FG002|Induction Phase|Poor/noncompliance|0|||
147270093|NCT00207142|531161188|FG003|Induction Phase|Poor/noncompliance|0|||
147270094|NCT00207142|531161185|FG000|Induction Phase|Pregnancy|1|||
147270095|NCT00207142|531161186|FG001|Induction Phase|Pregnancy|0|||
147270096|NCT00207142|531161187|FG002|Induction Phase|Pregnancy|0|||
147270097|NCT00207142|531161188|FG003|Induction Phase|Pregnancy|0|||
147270098|NCT00207142|531161185|FG000|Induction Phase|Subject no longer meets study criteria|3|||
147270099|NCT00207142|531161186|FG001|Induction Phase|Subject no longer meets study criteria|0|||
147270100|NCT00207142|531161187|FG002|Induction Phase|Subject no longer meets study criteria|0|||
147270101|NCT00207142|531161188|FG003|Induction Phase|Subject no longer meets study criteria|0|||
147270102|NCT00207142|531161185|FG000|Induction Phase|Withdrawal by Subject|4|||
147270103|NCT00207142|531161186|FG001|Induction Phase|Withdrawal by Subject|0|||
147270104|NCT00207142|531161187|FG002|Induction Phase|Withdrawal by Subject|0|||
147270105|NCT00207142|531161188|FG003|Induction Phase|Withdrawal by Subject|0|||
147270106|NCT00207142|531161185|FG000|Induction Phase|Incarceration|1|||
147270107|NCT00207142|531161186|FG001|Induction Phase|Incarceration|0|||
147270108|NCT00207142|531161187|FG002|Induction Phase|Incarceration|0|||
147270109|NCT00207142|531161188|FG003|Induction Phase|Incarceration|0|||
147270110|NCT00207142|531161185|FG000|Induction Phase|Missing lab data|1|||
147270111|NCT00207142|531161186|FG001|Induction Phase|Missing lab data|0|||
147270112|NCT00207142|531161187|FG002|Induction Phase|Missing lab data|0|||
147270113|NCT00207142|531161188|FG003|Induction Phase|Missing lab data|0|||
147270114|NCT00207142|531161185|FG000|Maintenance Phase/Rescue Phase|Adverse Event|0|||
147270115|NCT00207142|531161186|FG001|Maintenance Phase/Rescue Phase|Adverse Event|1|||
147270116|NCT00207142|531161187|FG002|Maintenance Phase/Rescue Phase|Adverse Event|4|||
147270117|NCT00207142|531161188|FG003|Maintenance Phase/Rescue Phase|Adverse Event|1|||
147270118|NCT00207142|531161185|FG000|Maintenance Phase/Rescue Phase|Lost to Follow-up|0|||
147270119|NCT00207142|531161186|FG001|Maintenance Phase/Rescue Phase|Lost to Follow-up|1|||
147270120|NCT00207142|531161187|FG002|Maintenance Phase/Rescue Phase|Lost to Follow-up|1|||
147270121|NCT00207142|531161188|FG003|Maintenance Phase/Rescue Phase|Lost to Follow-up|2|||
147270122|NCT00207142|531161185|FG000|Maintenance Phase/Rescue Phase|RTV intake impossible|0|||
147270123|NCT00207142|531161186|FG001|Maintenance Phase/Rescue Phase|RTV intake impossible|0|||
147270124|NCT00207142|531161187|FG002|Maintenance Phase/Rescue Phase|RTV intake impossible|1|||
147270125|NCT00207142|531161188|FG003|Maintenance Phase/Rescue Phase|RTV intake impossible|0|||
147270126|NCT00207142|531161185|FG000|Maintenance Phase/Rescue Phase|Poor/noncompliance|0|||
147270127|NCT00207142|531161186|FG001|Maintenance Phase/Rescue Phase|Poor/noncompliance|3|||
147270128|NCT00207142|531161187|FG002|Maintenance Phase/Rescue Phase|Poor/noncompliance|2|||
147270129|NCT00207142|531161188|FG003|Maintenance Phase/Rescue Phase|Poor/noncompliance|3|||
147270130|NCT00207142|531161185|FG000|Maintenance Phase/Rescue Phase|Pregnancy|0|||
147270131|NCT00207142|531161186|FG001|Maintenance Phase/Rescue Phase|Pregnancy|2|||
147270132|NCT00207142|531161187|FG002|Maintenance Phase/Rescue Phase|Pregnancy|2|||
147270133|NCT00207142|531161188|FG003|Maintenance Phase/Rescue Phase|Pregnancy|0|||
147270134|NCT00207142|531161185|FG000|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|0|||
147270135|NCT00207142|531161186|FG001|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|0|||
147270136|NCT00207142|531161187|FG002|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|1|||
147270137|NCT00207142|531161188|FG003|Maintenance Phase/Rescue Phase|Subject no longer meets study criteria|0|||
147270138|NCT00207142|531161185|FG000|Maintenance Phase/Rescue Phase|Withdrawal by Subject|0|||
147270139|NCT00207142|531161186|FG001|Maintenance Phase/Rescue Phase|Withdrawal by Subject|2|||
147270140|NCT00207142|531161187|FG002|Maintenance Phase/Rescue Phase|Withdrawal by Subject|2|||
147270141|NCT00207142|531161188|FG003|Maintenance Phase/Rescue Phase|Withdrawal by Subject|1|||
147270142|NCT00207142|531161185|FG000|Maintenance Phase/Rescue Phase|Death|0|||
147270143|NCT00207142|531161186|FG001|Maintenance Phase/Rescue Phase|Death|0|||
147270144|NCT00207142|531161187|FG002|Maintenance Phase/Rescue Phase|Death|0|||
147270145|NCT00207142|531161188|FG003|Maintenance Phase/Rescue Phase|Death|1|||
147270146|NCT00207142|531161185|FG000|Maintenance Phase/Rescue Phase|Lack of Efficacy|0|||
147270147|NCT00207142|531161186|FG001|Maintenance Phase/Rescue Phase|Lack of Efficacy|0|||
147270148|NCT00207142|531161187|FG002|Maintenance Phase/Rescue Phase|Lack of Efficacy|0|||
147270149|NCT00207142|531161188|FG003|Maintenance Phase/Rescue Phase|Lack of Efficacy|1|||
147270150|NCT01857063|531161189|FG000|Period 1 (7 Days)|Adverse Event|0|||
147270151|NCT01857063|531161190|FG001|Period 1 (7 Days)|Adverse Event|1|||
147270152|NCT01857063|531161189|FG000|Period 1 (7 Days)|Physician Decision|1|||
147270153|NCT01857063|531161190|FG001|Period 1 (7 Days)|Physician Decision|0|||
147270154|NCT01857063|531161189|FG000|Period 1 (7 Days)|Withdrawal by Subject|1|||
147270155|NCT01857063|531161190|FG001|Period 1 (7 Days)|Withdrawal by Subject|3|||
147270156|NCT01857063|531161189|FG000|Period 2 (7 Days)|Adverse Event|2|||
147270157|NCT01857063|531161190|FG001|Period 2 (7 Days)|Adverse Event|1|||
147270158|NCT01857063|531161189|FG000|Period 2 (7 Days)|Physician Decision|1|||
147270159|NCT01857063|531161190|FG001|Period 2 (7 Days)|Physician Decision|1|||
147270160|NCT01857063|531161189|FG000|Period 2 (7 Days)|Withdrawal by Subject|1|||
147270161|NCT01857063|531161190|FG001|Period 2 (7 Days)|Withdrawal by Subject|0|||
147270162|NCT04958109|531161191|FG000|Overall Study|Withdrawal by Subject|0|||
147270163|NCT04958109|531161192|FG001|Overall Study|Withdrawal by Subject|1|||
147270164|NCT04958109|531161191|FG000|Overall Study|Lost to Follow-up|0|||
147450351|NCT03016325|531811403|FG004|182-Day Follow-Up Period|Vital status collected via EMR|0|||
147450352|NCT03016325|531811404|FG005|182-Day Follow-Up Period|Vital status collected via EMR|0|||
147450353|NCT03016325|531811405|FG006|182-Day Follow-Up Period|Vital status collected via EMR|0|||
147450354|NCT03016325|531811406|FG007|182-Day Follow-Up Period|Vital status collected via EMR|0|||
147450355|NCT03016325|531811399|FG000|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
147450356|NCT03016325|531811400|FG001|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|1|||
147450357|NCT03016325|531811401|FG002|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
147450358|NCT03016325|531811402|FG003|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
147450359|NCT03016325|531811403|FG004|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
147450360|NCT03016325|531811404|FG005|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
147450361|NCT03016325|531811405|FG006|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
147450362|NCT03016325|531811406|FG007|182-Day Follow-Up Period|withdrew from D5, D32/182 forms not done|0|||
147662336|NCT03110354|532587299|FG004|Overall Study|Progressive disease|2|||
147662337|NCT03110354|532587295|FG000|Overall Study|Adverse Event|0|||
147333350|NCT02694978|531387678|FG000|Overall Study|Lost to Follow-up|14|||
147333351|NCT02694978|531387679|FG001|Overall Study|Lost to Follow-up|17|||
147270165|NCT04958109|531161192|FG001|Overall Study|Lost to Follow-up|1|||
147270166|NCT00715793|531161195|FG000|Phase 1 RP2D DAC + TMZ|secondary disease in Cycle 1|1|||
147270167|NCT00715793|531161196|FG001|Phase 1 RP2D DAC + TMZ|secondary disease in Cycle 1|0|||
147270168|NCT00715793|531161195|FG000|Phase 2 DAC (0.15 mg/kg) + TMZ|not assessable for tumor response|0|||
147270169|NCT00715793|531161196|FG001|Phase 2 DAC (0.15 mg/kg) + TMZ|not assessable for tumor response|2|||
147270170|NCT00058825|531161197|FG000|Overall Study|Relapse|9|||
147270171|NCT00058825|531161197|FG000|Overall Study|Progressive Disease|5|||
147270172|NCT00058825|531161197|FG000|Overall Study|Graft Failure|5|||
147270173|NCT00058825|531161197|FG000|Overall Study|Death|3|||
147270174|NCT04115358|531161198|FG000|Overall Study|exfoliation|0|||
147270175|NCT04115358|531161199|FG001|Overall Study|exfoliation|0|||
147270176|NCT04115358|531161200|FG002|Overall Study|exfoliation|1|||
147270177|NCT02346240|531161201|FG000|Initial Period (Baseline to Week 16)|Adverse Event|0|||
147270178|NCT02346240|531161202|FG001|Initial Period (Baseline to Week 16)|Adverse Event|4|||
147270179|NCT02346240|531161203|FG002|Initial Period (Baseline to Week 16)|Adverse Event|1|||
147270180|NCT02346240|531161204|FG003|Initial Period (Baseline to Week 16)|Adverse Event|1|||
147270181|NCT02346240|531161205|FG004|Initial Period (Baseline to Week 16)|Adverse Event|0|||
147270182|NCT02346240|531161206|FG005|Initial Period (Baseline to Week 16)|Adverse Event|0|||
147270183|NCT02346240|531161207|FG006|Initial Period (Baseline to Week 16)|Adverse Event|0|||
147270184|NCT02346240|531161208|FG007|Initial Period (Baseline to Week 16)|Adverse Event|0|||
147270185|NCT02346240|531161209|FG008|Initial Period (Baseline to Week 16)|Adverse Event|0|||
147270186|NCT02346240|531161210|FG009|Initial Period (Baseline to Week 16)|Adverse Event|0|||
147270187|NCT02346240|531161211|FG010|Initial Period (Baseline to Week 16)|Adverse Event|0|||
147270188|NCT02346240|531161212|FG011|Initial Period (Baseline to Week 16)|Adverse Event|0|||
147270189|NCT02346240|531161213|FG012|Initial Period (Baseline to Week 16)|Adverse Event|0|||
147270190|NCT02346240|531161214|FG013|Initial Period (Baseline to Week 16)|Adverse Event|0|||
147270191|NCT02346240|531161215|FG014|Initial Period (Baseline to Week 16)|Adverse Event|0|||
147270192|NCT02346240|531161216|FG015|Initial Period (Baseline to Week 16)|Adverse Event|0|||
147270193|NCT02346240|531161217|FG016|Initial Period (Baseline to Week 16)|Adverse Event|0|||
147333352|NCT02694978|531387678|FG000|Overall Study|Death|4|||
147333353|NCT02694978|531387679|FG001|Overall Study|Death|1|||
147270194|NCT02346240|531161218|FG017|Initial Period (Baseline to Week 16)|Adverse Event|0|||
147270195|NCT02346240|531161219|FG018|Initial Period (Baseline to Week 16)|Adverse Event|0|||
147270196|NCT02346240|531161220|FG019|Initial Period (Baseline to Week 16)|Adverse Event|0|||
147333354|NCT02694978|531387678|FG000|Overall Study|Other-Decision of Participant|6|||
147333355|NCT02694978|531387679|FG001|Overall Study|Other-Decision of Participant|1|||
147333356|NCT02694978|531387678|FG000|Overall Study|Other-Investigator's decision|1|||
147662338|NCT03110354|532587296|FG001|Overall Study|Adverse Event|0|||
147662339|NCT03110354|532587297|FG002|Overall Study|Adverse Event|0|||
147270197|NCT02346240|531161221|FG020|Initial Period (Baseline to Week 16)|Adverse Event|0|||
147270198|NCT02346240|531161222|FG021|Initial Period (Baseline to Week 16)|Adverse Event|0|||
147270199|NCT02346240|531161223|FG022|Initial Period (Baseline to Week 16)|Adverse Event|0|||
147270200|NCT02346240|531161224|FG023|Initial Period (Baseline to Week 16)|Adverse Event|0|||
147270201|NCT02346240|531161201|FG000|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
147333357|NCT02694978|531387679|FG001|Overall Study|Other-Investigator's decision|0|||
147333358|NCT02694978|531387678|FG000|Overall Study|Other-Unable to be reached|0|||
147270202|NCT02346240|531161202|FG001|Initial Period (Baseline to Week 16)|Lack of Efficacy|1|||
147270203|NCT02346240|531161203|FG002|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
147270204|NCT02346240|531161204|FG003|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
147270205|NCT02346240|531161205|FG004|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
147270206|NCT02346240|531161206|FG005|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
147270207|NCT02346240|531161207|FG006|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
147270208|NCT02346240|531161208|FG007|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
147270209|NCT02346240|531161209|FG008|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
147270210|NCT02346240|531161210|FG009|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
147270211|NCT02346240|531161211|FG010|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
147270212|NCT02346240|531161212|FG011|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
147270213|NCT02346240|531161213|FG012|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
147270214|NCT02346240|531161214|FG013|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
147270215|NCT02346240|531161215|FG014|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
147270216|NCT02346240|531161216|FG015|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
147270217|NCT02346240|531161217|FG016|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
147270218|NCT02346240|531161218|FG017|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
147270219|NCT02346240|531161219|FG018|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
147270220|NCT02346240|531161220|FG019|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
147270221|NCT02346240|531161221|FG020|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
147270222|NCT02346240|531161222|FG021|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
147270223|NCT02346240|531161223|FG022|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
147270224|NCT02346240|531161224|FG023|Initial Period (Baseline to Week 16)|Lack of Efficacy|0|||
147270225|NCT02346240|531161201|FG000|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
147270226|NCT02346240|531161202|FG001|Initial Period (Baseline to Week 16)|Protocol Violation|1|||
147270227|NCT02346240|531161203|FG002|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
147270228|NCT02346240|531161204|FG003|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
147270229|NCT02346240|531161205|FG004|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
147270230|NCT02346240|531161206|FG005|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
147270231|NCT02346240|531161207|FG006|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
147270232|NCT02346240|531161208|FG007|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
147270233|NCT02346240|531161209|FG008|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
147270234|NCT02346240|531161210|FG009|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
147270235|NCT02346240|531161211|FG010|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
147270236|NCT02346240|531161212|FG011|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
147270237|NCT02346240|531161213|FG012|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
147270238|NCT02346240|531161214|FG013|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
147270239|NCT02346240|531161215|FG014|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
147270240|NCT02346240|531161216|FG015|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
147270241|NCT02346240|531161217|FG016|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
147270242|NCT02346240|531161218|FG017|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
147270243|NCT02346240|531161219|FG018|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
147270244|NCT02346240|531161220|FG019|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
147270245|NCT02346240|531161221|FG020|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
147270246|NCT02346240|531161222|FG021|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
147270247|NCT02346240|531161223|FG022|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
147270248|NCT02346240|531161224|FG023|Initial Period (Baseline to Week 16)|Protocol Violation|0|||
147270249|NCT02346240|531161201|FG000|Initial Period (Baseline to Week 16)|Lost to Follow-up|1|||
147333359|NCT02694978|531387679|FG001|Overall Study|Other-Unable to be reached|1|||
147333360|NCT02694978|531387678|FG000|Overall Study|Other-Protocol noncompliant|2|||
147333361|NCT02694978|531387679|FG001|Overall Study|Other-Protocol noncompliant|1|||
147333362|NCT02694978|531387678|FG000|Overall Study|Other-Personal reasons|3|||
147333363|NCT02694978|531387679|FG001|Overall Study|Other-Personal reasons|3|||
147270250|NCT02346240|531161202|FG001|Initial Period (Baseline to Week 16)|Lost to Follow-up|2|||
147270251|NCT02346240|531161203|FG002|Initial Period (Baseline to Week 16)|Lost to Follow-up|1|||
147270252|NCT02346240|531161204|FG003|Initial Period (Baseline to Week 16)|Lost to Follow-up|3|||
147270253|NCT02346240|531161205|FG004|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
147270254|NCT02346240|531161206|FG005|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
147270255|NCT02346240|531161207|FG006|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
147270256|NCT02346240|531161208|FG007|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
147270257|NCT02346240|531161209|FG008|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
147270258|NCT02346240|531161210|FG009|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
147270259|NCT02346240|531161211|FG010|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
147270260|NCT02346240|531161212|FG011|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
147270261|NCT02346240|531161213|FG012|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
147270262|NCT02346240|531161214|FG013|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
147270263|NCT02346240|531161215|FG014|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
147270264|NCT02346240|531161216|FG015|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
147270265|NCT02346240|531161217|FG016|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
147270266|NCT02346240|531161218|FG017|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
147270267|NCT02346240|531161219|FG018|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
147270268|NCT02346240|531161220|FG019|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
147270269|NCT02346240|531161221|FG020|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
147270270|NCT02346240|531161222|FG021|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
147270271|NCT02346240|531161223|FG022|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
147270272|NCT02346240|531161224|FG023|Initial Period (Baseline to Week 16)|Lost to Follow-up|0|||
147270273|NCT02346240|531161201|FG000|Initial Period (Baseline to Week 16)|Withdrawal by Subject|1|||
147270274|NCT02346240|531161202|FG001|Initial Period (Baseline to Week 16)|Withdrawal by Subject|2|||
147270275|NCT02346240|531161203|FG002|Initial Period (Baseline to Week 16)|Withdrawal by Subject|3|||
147270276|NCT02346240|531161204|FG003|Initial Period (Baseline to Week 16)|Withdrawal by Subject|2|||
147270277|NCT02346240|531161205|FG004|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
147270278|NCT02346240|531161206|FG005|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
147270279|NCT02346240|531161207|FG006|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
147270280|NCT02346240|531161208|FG007|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
147270281|NCT02346240|531161209|FG008|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
147270282|NCT02346240|531161210|FG009|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
147270283|NCT02346240|531161211|FG010|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
147270284|NCT02346240|531161212|FG011|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
147270285|NCT02346240|531161213|FG012|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
147270286|NCT02346240|531161214|FG013|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
147270287|NCT02346240|531161215|FG014|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
147270288|NCT02346240|531161216|FG015|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
147270289|NCT02346240|531161217|FG016|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
147270290|NCT02346240|531161218|FG017|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
147270291|NCT02346240|531161219|FG018|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
147270292|NCT02346240|531161220|FG019|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
147270293|NCT02346240|531161221|FG020|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
147270294|NCT02346240|531161222|FG021|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
147270295|NCT02346240|531161223|FG022|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
147270296|NCT02346240|531161224|FG023|Initial Period (Baseline to Week 16)|Withdrawal by Subject|0|||
147270297|NCT02346240|531161201|FG000|Initial Period (Baseline to Week 16)|Non-compliance|0|||
147270298|NCT02346240|531161202|FG001|Initial Period (Baseline to Week 16)|Non-compliance|1|||
147270299|NCT02346240|531161203|FG002|Initial Period (Baseline to Week 16)|Non-compliance|0|||
147270300|NCT02346240|531161204|FG003|Initial Period (Baseline to Week 16)|Non-compliance|1|||
147270301|NCT02346240|531161205|FG004|Initial Period (Baseline to Week 16)|Non-compliance|0|||
147270302|NCT02346240|531161206|FG005|Initial Period (Baseline to Week 16)|Non-compliance|0|||
147270303|NCT02346240|531161207|FG006|Initial Period (Baseline to Week 16)|Non-compliance|0|||
147270304|NCT02346240|531161208|FG007|Initial Period (Baseline to Week 16)|Non-compliance|0|||
147270305|NCT02346240|531161209|FG008|Initial Period (Baseline to Week 16)|Non-compliance|0|||
147450363|NCT03016325|531811399|FG000|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0|||
147450364|NCT03016325|531811400|FG001|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0|||
147662340|NCT03110354|532587298|FG003|Overall Study|Adverse Event|2|||
147662341|NCT03110354|532587299|FG004|Overall Study|Adverse Event|2|||
147270306|NCT02346240|531161210|FG009|Initial Period (Baseline to Week 16)|Non-compliance|0|||
147270307|NCT02346240|531161211|FG010|Initial Period (Baseline to Week 16)|Non-compliance|0|||
147270308|NCT02346240|531161212|FG011|Initial Period (Baseline to Week 16)|Non-compliance|0|||
147270309|NCT02346240|531161213|FG012|Initial Period (Baseline to Week 16)|Non-compliance|0|||
147270310|NCT02346240|531161214|FG013|Initial Period (Baseline to Week 16)|Non-compliance|0|||
147270311|NCT02346240|531161215|FG014|Initial Period (Baseline to Week 16)|Non-compliance|0|||
147270312|NCT02346240|531161216|FG015|Initial Period (Baseline to Week 16)|Non-compliance|0|||
147270313|NCT02346240|531161217|FG016|Initial Period (Baseline to Week 16)|Non-compliance|0|||
147270314|NCT02346240|531161218|FG017|Initial Period (Baseline to Week 16)|Non-compliance|0|||
147270315|NCT02346240|531161219|FG018|Initial Period (Baseline to Week 16)|Non-compliance|0|||
147270316|NCT02346240|531161220|FG019|Initial Period (Baseline to Week 16)|Non-compliance|0|||
147270317|NCT02346240|531161221|FG020|Initial Period (Baseline to Week 16)|Non-compliance|0|||
147270318|NCT02346240|531161222|FG021|Initial Period (Baseline to Week 16)|Non-compliance|0|||
147270319|NCT02346240|531161223|FG022|Initial Period (Baseline to Week 16)|Non-compliance|0|||
147270320|NCT02346240|531161224|FG023|Initial Period (Baseline to Week 16)|Non-compliance|0|||
147450365|NCT03016325|531811401|FG002|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0|||
147270321|NCT02346240|531161201|FG000|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
147270322|NCT02346240|531161202|FG001|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
147270323|NCT02346240|531161203|FG002|Initial Period (Baseline to Week 16)|Subject missed 3 visits|1|||
147270324|NCT02346240|531161204|FG003|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
147270325|NCT02346240|531161205|FG004|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
147270326|NCT02346240|531161206|FG005|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
147270327|NCT02346240|531161207|FG006|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
147270328|NCT02346240|531161208|FG007|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
147270329|NCT02346240|531161209|FG008|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
147270330|NCT02346240|531161210|FG009|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
147270331|NCT02346240|531161211|FG010|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
147270332|NCT02346240|531161212|FG011|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
147270333|NCT02346240|531161213|FG012|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
147270334|NCT02346240|531161214|FG013|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
147270335|NCT02346240|531161215|FG014|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
147270336|NCT02346240|531161216|FG015|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
147270337|NCT02346240|531161217|FG016|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
147270338|NCT02346240|531161218|FG017|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
147270339|NCT02346240|531161219|FG018|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
147270340|NCT02346240|531161220|FG019|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
147270341|NCT02346240|531161221|FG020|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
147270342|NCT02346240|531161222|FG021|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
147270343|NCT02346240|531161223|FG022|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
147270344|NCT02346240|531161224|FG023|Initial Period (Baseline to Week 16)|Subject missed 3 visits|0|||
147270345|NCT02346240|531161201|FG000|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
147270346|NCT02346240|531161202|FG001|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
147270347|NCT02346240|531161203|FG002|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
147270348|NCT02346240|531161204|FG003|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
147270349|NCT02346240|531161205|FG004|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
147270350|NCT02346240|531161206|FG005|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
147270351|NCT02346240|531161207|FG006|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
147270352|NCT02346240|531161208|FG007|Maintenance Period (Week 16 to Week 48)|Adverse Event|1|||
147270353|NCT02346240|531161209|FG008|Maintenance Period (Week 16 to Week 48)|Adverse Event|2|||
147270354|NCT02346240|531161210|FG009|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
147270355|NCT02346240|531161211|FG010|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
147270356|NCT02346240|531161212|FG011|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
147270357|NCT02346240|531161213|FG012|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
147270358|NCT02346240|531161214|FG013|Maintenance Period (Week 16 to Week 48)|Adverse Event|1|||
147270359|NCT02346240|531161215|FG014|Maintenance Period (Week 16 to Week 48)|Adverse Event|4|||
147270360|NCT02346240|531161216|FG015|Maintenance Period (Week 16 to Week 48)|Adverse Event|1|||
147270361|NCT02346240|531161217|FG016|Maintenance Period (Week 16 to Week 48)|Adverse Event|2|||
147270362|NCT02346240|531161218|FG017|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
147270363|NCT02346240|531161219|FG018|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
147270364|NCT02346240|531161220|FG019|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
147270365|NCT02346240|531161221|FG020|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
147270366|NCT02346240|531161222|FG021|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
147270367|NCT02346240|531161223|FG022|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
147270368|NCT02346240|531161224|FG023|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
147270369|NCT02346240|531161201|FG000|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
147270370|NCT02346240|531161202|FG001|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
147270371|NCT02346240|531161203|FG002|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
147270372|NCT02346240|531161204|FG003|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
147270373|NCT02346240|531161205|FG004|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
147270374|NCT02346240|531161206|FG005|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
147270375|NCT02346240|531161207|FG006|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
147270376|NCT02346240|531161208|FG007|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
147270377|NCT02346240|531161209|FG008|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
147270378|NCT02346240|531161210|FG009|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
147270379|NCT02346240|531161211|FG010|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
147270380|NCT02346240|531161212|FG011|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
147270381|NCT02346240|531161213|FG012|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
147270382|NCT02346240|531161214|FG013|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|1|||
147270383|NCT02346240|531161215|FG014|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
147270384|NCT02346240|531161216|FG015|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|3|||
147270385|NCT02346240|531161217|FG016|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
147270386|NCT02346240|531161218|FG017|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
147270387|NCT02346240|531161219|FG018|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
147270388|NCT02346240|531161220|FG019|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
147270389|NCT02346240|531161221|FG020|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
147270390|NCT02346240|531161222|FG021|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
147270391|NCT02346240|531161223|FG022|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
147270392|NCT02346240|531161224|FG023|Maintenance Period (Week 16 to Week 48)|Lack of Efficacy|0|||
147270393|NCT02346240|531161201|FG000|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
147270394|NCT02346240|531161202|FG001|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
147270395|NCT02346240|531161203|FG002|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
147270396|NCT02346240|531161204|FG003|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
147270397|NCT02346240|531161205|FG004|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
147270398|NCT02346240|531161206|FG005|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
147270399|NCT02346240|531161207|FG006|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
147270400|NCT02346240|531161208|FG007|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
147270401|NCT02346240|531161209|FG008|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
147270402|NCT02346240|531161210|FG009|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
147270403|NCT02346240|531161211|FG010|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
147270404|NCT02346240|531161212|FG011|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
147270405|NCT02346240|531161213|FG012|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
147270406|NCT02346240|531161214|FG013|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
147270407|NCT02346240|531161215|FG014|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|1|||
147270408|NCT02346240|531161216|FG015|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
147270409|NCT02346240|531161217|FG016|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
147270410|NCT02346240|531161218|FG017|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
147270411|NCT02346240|531161219|FG018|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
147270412|NCT02346240|531161220|FG019|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
147270413|NCT02346240|531161221|FG020|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
147270414|NCT02346240|531161222|FG021|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
147270415|NCT02346240|531161223|FG022|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
147270416|NCT02346240|531161224|FG023|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
147270417|NCT02346240|531161201|FG000|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
147270418|NCT02346240|531161202|FG001|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
147270419|NCT02346240|531161203|FG002|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
147270420|NCT02346240|531161204|FG003|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
147270421|NCT02346240|531161205|FG004|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
147333364|NCT02694978|531387678|FG000|Overall Study|Other-Withdrew prior to dosing|9|||
147333365|NCT02694978|531387679|FG001|Overall Study|Other-Withdrew prior to dosing|8|||
147270422|NCT02346240|531161206|FG005|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
147270423|NCT02346240|531161207|FG006|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
147270424|NCT02346240|531161208|FG007|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
147270425|NCT02346240|531161209|FG008|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
147270426|NCT02346240|531161210|FG009|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
147270427|NCT02346240|531161211|FG010|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
147270428|NCT02346240|531161212|FG011|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|2|||
147333366|NCT01613716|531387680|FG000|Overall Study|screen failures|3|||
147333367|NCT01613716|531387680|FG000|Overall Study|Lost to Follow-up|4|||
147333368|NCT01376089|531387682|FG000|Overall Study|Patient received no contrast media|3|||
147333369|NCT01376089|531387683|FG001|Overall Study|Patient received no contrast media|4|||
147333370|NCT00419094|531387686|FG000|Overall Study|Adverse Event|3|||
147270429|NCT02346240|531161213|FG012|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
147270430|NCT02346240|531161214|FG013|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|2|||
147270431|NCT02346240|531161215|FG014|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|5|||
147333371|NCT00419094|531387687|FG001|Overall Study|Adverse Event|7|||
147333372|NCT00419094|531387686|FG000|Overall Study|Lack of Efficacy|1|||
147333373|NCT00419094|531387687|FG001|Overall Study|Lack of Efficacy|0|||
147270432|NCT02346240|531161216|FG015|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|2|||
147270433|NCT02346240|531161217|FG016|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
147270434|NCT02346240|531161218|FG017|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
147270435|NCT02346240|531161219|FG018|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
147270436|NCT02346240|531161220|FG019|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
147270437|NCT02346240|531161221|FG020|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
147270438|NCT02346240|531161222|FG021|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
147270439|NCT02346240|531161223|FG022|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
147270440|NCT02346240|531161224|FG023|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
147270441|NCT02346240|531161201|FG000|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
147270442|NCT02346240|531161202|FG001|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
147270443|NCT02346240|531161203|FG002|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
147270444|NCT02346240|531161204|FG003|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
147270445|NCT02346240|531161205|FG004|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
147270446|NCT02346240|531161206|FG005|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
147270447|NCT02346240|531161207|FG006|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
147270448|NCT02346240|531161208|FG007|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
147270449|NCT02346240|531161209|FG008|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
147270450|NCT02346240|531161210|FG009|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
147270451|NCT02346240|531161211|FG010|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
147270452|NCT02346240|531161212|FG011|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
147270453|NCT02346240|531161213|FG012|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
147270454|NCT02346240|531161214|FG013|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|3|||
147270455|NCT02346240|531161215|FG014|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|3|||
147270456|NCT02346240|531161216|FG015|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|8|||
147270457|NCT02346240|531161217|FG016|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|4|||
147270458|NCT02346240|531161218|FG017|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
147270459|NCT02346240|531161219|FG018|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
147270460|NCT02346240|531161220|FG019|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
147270461|NCT02346240|531161221|FG020|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
147270462|NCT02346240|531161222|FG021|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
147270463|NCT02346240|531161223|FG022|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
147270464|NCT02346240|531161224|FG023|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50|0|||
147270465|NCT02346240|531161201|FG000|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
147270466|NCT02346240|531161202|FG001|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
147270467|NCT02346240|531161203|FG002|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
147270468|NCT02346240|531161204|FG003|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
147270469|NCT02346240|531161205|FG004|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
147270470|NCT02346240|531161206|FG005|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
147270471|NCT02346240|531161207|FG006|Maintenance Period (Week 16 to Week 48)|Moved out of state|1|||
147270472|NCT02346240|531161208|FG007|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
147270473|NCT02346240|531161209|FG008|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
147270474|NCT02346240|531161210|FG009|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
147270475|NCT02346240|531161211|FG010|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
147270476|NCT02346240|531161212|FG011|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
147270477|NCT02346240|531161213|FG012|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
147270478|NCT02346240|531161214|FG013|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
147270479|NCT02346240|531161215|FG014|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
147270480|NCT02346240|531161216|FG015|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
147270481|NCT02346240|531161217|FG016|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
147270482|NCT02346240|531161218|FG017|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
147270483|NCT02346240|531161219|FG018|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
147270484|NCT02346240|531161220|FG019|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
147270485|NCT02346240|531161221|FG020|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
147270486|NCT02346240|531161222|FG021|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
147270487|NCT02346240|531161223|FG022|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
147270488|NCT02346240|531161224|FG023|Maintenance Period (Week 16 to Week 48)|Moved out of state|0|||
147333374|NCT00419094|531387686|FG000|Overall Study|Lost to Follow-up|0|||
147333375|NCT00419094|531387687|FG001|Overall Study|Lost to Follow-up|2|||
147333376|NCT00419094|531387686|FG000|Overall Study|Protocol Violation|1|||
147333377|NCT00419094|531387687|FG001|Overall Study|Protocol Violation|14|||
147333378|NCT00419094|531387686|FG000|Overall Study|Withdrawal of consent|1|||
147270489|NCT02346240|531161201|FG000|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
147270490|NCT02346240|531161202|FG001|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
147270491|NCT02346240|531161203|FG002|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
147270492|NCT02346240|531161204|FG003|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
147270493|NCT02346240|531161205|FG004|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
147270494|NCT02346240|531161206|FG005|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
147270495|NCT02346240|531161207|FG006|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
147270496|NCT02346240|531161208|FG007|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
147270497|NCT02346240|531161209|FG008|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|1|||
147270498|NCT02346240|531161210|FG009|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
147270499|NCT02346240|531161211|FG010|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
147270500|NCT02346240|531161212|FG011|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|1|||
147270501|NCT02346240|531161213|FG012|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
147270502|NCT02346240|531161214|FG013|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|1|||
147270503|NCT02346240|531161215|FG014|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|1|||
147270504|NCT02346240|531161216|FG015|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
147270505|NCT02346240|531161217|FG016|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
147270506|NCT02346240|531161218|FG017|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
147270507|NCT02346240|531161219|FG018|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
147270508|NCT02346240|531161220|FG019|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
147270509|NCT02346240|531161221|FG020|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
147270510|NCT02346240|531161222|FG021|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
147270511|NCT02346240|531161223|FG022|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
147270512|NCT02346240|531161224|FG023|Maintenance Period (Week 16 to Week 48)|Sponsor decision due to non-compliance|0|||
147270513|NCT02346240|531161201|FG000|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
147270514|NCT02346240|531161202|FG001|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
147270515|NCT02346240|531161203|FG002|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
147270516|NCT02346240|531161204|FG003|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
147270517|NCT02346240|531161205|FG004|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
147270518|NCT02346240|531161206|FG005|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
147270519|NCT02346240|531161207|FG006|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
147270520|NCT02346240|531161208|FG007|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
147270521|NCT02346240|531161209|FG008|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
147270522|NCT02346240|531161210|FG009|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|1|||
147270523|NCT02346240|531161211|FG010|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
147270524|NCT02346240|531161212|FG011|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
147270525|NCT02346240|531161213|FG012|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
147270526|NCT02346240|531161214|FG013|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
147270527|NCT02346240|531161215|FG014|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
147270528|NCT02346240|531161216|FG015|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
147270529|NCT02346240|531161217|FG016|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
147270530|NCT02346240|531161218|FG017|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
147270531|NCT02346240|531161219|FG018|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
147270532|NCT02346240|531161220|FG019|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
147270533|NCT02346240|531161221|FG020|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
147270534|NCT02346240|531161222|FG021|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
147270535|NCT02346240|531161223|FG022|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
147270536|NCT02346240|531161224|FG023|Maintenance Period (Week 16 to Week 48)|Adverse events and alcohol problem|0|||
147270537|NCT02346240|531161201|FG000|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
147270538|NCT02346240|531161202|FG001|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
147270539|NCT02346240|531161203|FG002|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
147270540|NCT02346240|531161204|FG003|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
147270541|NCT02346240|531161205|FG004|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
147270542|NCT02346240|531161206|FG005|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
147270543|NCT02346240|531161207|FG006|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
147270544|NCT02346240|531161208|FG007|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
147270545|NCT02346240|531161209|FG008|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
147270546|NCT02346240|531161210|FG009|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
147270547|NCT02346240|531161211|FG010|Maintenance Period (Week 16 to Week 48)|Patient's decisions|1|||
147333379|NCT00419094|531387687|FG001|Overall Study|Withdrawal of consent|5|||
147333380|NCT00419094|531387686|FG000|Overall Study|Other: Error determining exit criteria|1|||
147333381|NCT00419094|531387687|FG001|Overall Study|Other: Error determining exit criteria|0|||
147333382|NCT00419094|531387686|FG000|Overall Study|Other: Patient non-compliant|0|||
147333383|NCT00419094|531387687|FG001|Overall Study|Other: Patient non-compliant|1|||
147333384|NCT00419094|531387686|FG000|Overall Study|Other: No contact for extended period|0|||
147270548|NCT02346240|531161212|FG011|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
147270549|NCT02346240|531161213|FG012|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
147270550|NCT02346240|531161214|FG013|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
147270551|NCT02346240|531161215|FG014|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
147270552|NCT02346240|531161216|FG015|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
147270553|NCT02346240|531161217|FG016|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
147270554|NCT02346240|531161218|FG017|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
147270555|NCT02346240|531161219|FG018|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
147270556|NCT02346240|531161220|FG019|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
147270557|NCT02346240|531161221|FG020|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
147270558|NCT02346240|531161222|FG021|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
147270559|NCT02346240|531161223|FG022|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
147270560|NCT02346240|531161224|FG023|Maintenance Period (Week 16 to Week 48)|Patient's decisions|0|||
147270561|NCT02346240|531161201|FG000|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
147270562|NCT02346240|531161202|FG001|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
147270563|NCT02346240|531161203|FG002|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
147270564|NCT02346240|531161204|FG003|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
147270565|NCT02346240|531161205|FG004|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
147270566|NCT02346240|531161206|FG005|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
147270567|NCT02346240|531161207|FG006|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
147270568|NCT02346240|531161208|FG007|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
147270569|NCT02346240|531161209|FG008|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
147270570|NCT02346240|531161210|FG009|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
147270571|NCT02346240|531161211|FG010|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
147270572|NCT02346240|531161212|FG011|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
147270573|NCT02346240|531161213|FG012|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
147270574|NCT02346240|531161214|FG013|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
147270575|NCT02346240|531161215|FG014|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|1|||
147270576|NCT02346240|531161216|FG015|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
147270577|NCT02346240|531161217|FG016|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
147270578|NCT02346240|531161218|FG017|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
147270579|NCT02346240|531161219|FG018|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
147270580|NCT02346240|531161220|FG019|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
147270581|NCT02346240|531161221|FG020|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
147270582|NCT02346240|531161222|FG021|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
147270583|NCT02346240|531161223|FG022|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
147270584|NCT02346240|531161224|FG023|Maintenance Period (Week 16 to Week 48)|Unavailability due to business trip|0|||
147270585|NCT02346240|531161201|FG000|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
147270586|NCT02346240|531161202|FG001|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
147270587|NCT02346240|531161203|FG002|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
147270588|NCT02346240|531161204|FG003|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
147270589|NCT02346240|531161205|FG004|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
147270590|NCT02346240|531161206|FG005|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
147270591|NCT02346240|531161207|FG006|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
147270592|NCT02346240|531161208|FG007|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
147270593|NCT02346240|531161209|FG008|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
147270594|NCT02346240|531161210|FG009|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
147270595|NCT02346240|531161211|FG010|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
147270596|NCT02346240|531161212|FG011|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
147270597|NCT02346240|531161213|FG012|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
147270598|NCT02346240|531161214|FG013|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
147333385|NCT00419094|531387687|FG001|Overall Study|Other: No contact for extended period|1|||
147270599|NCT02346240|531161215|FG014|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|1|||
147270600|NCT02346240|531161216|FG015|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
147270601|NCT02346240|531161217|FG016|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
147270602|NCT02346240|531161218|FG017|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
147270603|NCT02346240|531161219|FG018|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
147333386|NCT03020745|531387690|FG000|Part 2 (Up to 169 Days)|Adverse Event|0|||
147333387|NCT03020745|531387691|FG001|Part 2 (Up to 169 Days)|Adverse Event|0|||
147270604|NCT02346240|531161220|FG019|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
147270605|NCT02346240|531161221|FG020|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
147270606|NCT02346240|531161222|FG021|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
147270607|NCT02346240|531161223|FG022|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
147270608|NCT02346240|531161224|FG023|Maintenance Period (Week 16 to Week 48)|Withdrawn by Sponsor|0|||
147270609|NCT02346240|531161201|FG000|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
147270610|NCT02346240|531161202|FG001|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
147270611|NCT02346240|531161203|FG002|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
147270612|NCT02346240|531161204|FG003|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
147270613|NCT02346240|531161205|FG004|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
147270614|NCT02346240|531161206|FG005|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
147270615|NCT02346240|531161207|FG006|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
147270616|NCT02346240|531161208|FG007|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
147270617|NCT02346240|531161209|FG008|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
147270618|NCT02346240|531161210|FG009|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
147270619|NCT02346240|531161211|FG010|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
147270620|NCT02346240|531161212|FG011|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
147270621|NCT02346240|531161213|FG012|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
147270622|NCT02346240|531161214|FG013|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
147270623|NCT02346240|531161215|FG014|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|1|||
147270624|NCT02346240|531161216|FG015|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
147270625|NCT02346240|531161217|FG016|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
147270626|NCT02346240|531161218|FG017|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
147270627|NCT02346240|531161219|FG018|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
147270628|NCT02346240|531161220|FG019|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
147270629|NCT02346240|531161221|FG020|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
147270630|NCT02346240|531161222|FG021|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
147270631|NCT02346240|531161223|FG022|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
147270632|NCT02346240|531161224|FG023|Maintenance Period (Week 16 to Week 48)|Patient request due to non-compliance|0|||
147270633|NCT02346240|531161201|FG000|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
147270634|NCT02346240|531161202|FG001|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
147270635|NCT02346240|531161203|FG002|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
147333388|NCT03020745|531387692|FG002|Part 2 (Up to 169 Days)|Adverse Event|0|||
147333389|NCT03020745|531387693|FG003|Part 2 (Up to 169 Days)|Adverse Event|0|||
147333390|NCT03020745|531387694|FG004|Part 2 (Up to 169 Days)|Adverse Event|0|||
147333391|NCT03020745|531387695|FG005|Part 2 (Up to 169 Days)|Adverse Event|0|||
147333392|NCT03020745|531387696|FG006|Part 2 (Up to 169 Days)|Adverse Event|0|||
147333393|NCT03020745|531387697|FG007|Part 2 (Up to 169 Days)|Adverse Event|0|||
147333394|NCT03020745|531387698|FG008|Part 2 (Up to 169 Days)|Adverse Event|1|||
147333395|NCT03020745|531387699|FG009|Part 2 (Up to 169 Days)|Adverse Event|0|||
147333396|NCT03020745|531387690|FG000|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
147333397|NCT03020745|531387691|FG001|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
147333398|NCT03020745|531387692|FG002|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
147333399|NCT03020745|531387693|FG003|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
147333400|NCT03020745|531387694|FG004|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
147333401|NCT03020745|531387695|FG005|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
147333402|NCT03020745|531387696|FG006|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
147333403|NCT03020745|531387697|FG007|Part 2 (Up to 169 Days)|Withdrawal by Subject|1|||
147333404|NCT03020745|531387698|FG008|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
147333405|NCT03020745|531387699|FG009|Part 2 (Up to 169 Days)|Withdrawal by Subject|0|||
147333406|NCT03020745|531387690|FG000|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
147333407|NCT03020745|531387691|FG001|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
147333408|NCT03020745|531387692|FG002|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
147333409|NCT03020745|531387693|FG003|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
147333410|NCT03020745|531387694|FG004|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
147333411|NCT03020745|531387695|FG005|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|1|||
147333412|NCT03020745|531387696|FG006|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
147333413|NCT03020745|531387697|FG007|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
147333414|NCT03020745|531387698|FG008|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|1|||
147333415|NCT03020745|531387699|FG009|Part 2:Optional FU (Up to 450 Days)|Lost to Follow-up|0|||
147333416|NCT03020745|531387690|FG000|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
147600292|NCT03893565|532356357|FG000|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
147270636|NCT02346240|531161204|FG003|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
147270637|NCT02346240|531161205|FG004|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
147270638|NCT02346240|531161206|FG005|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
147270639|NCT02346240|531161207|FG006|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
147270640|NCT02346240|531161208|FG007|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
147270641|NCT02346240|531161209|FG008|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
147270642|NCT02346240|531161210|FG009|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
147270643|NCT02346240|531161211|FG010|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
147270644|NCT02346240|531161212|FG011|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
147270645|NCT02346240|531161213|FG012|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
147270646|NCT02346240|531161214|FG013|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
147270647|NCT02346240|531161215|FG014|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
147270648|NCT02346240|531161216|FG015|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
147270649|NCT02346240|531161217|FG016|Open-Label Period (Week 48 to Week 144)|Adverse Event|0|||
147270650|NCT02346240|531161218|FG017|Open-Label Period (Week 48 to Week 144)|Adverse Event|1|||
147270651|NCT02346240|531161219|FG018|Open-Label Period (Week 48 to Week 144)|Adverse Event|6|||
147270652|NCT02346240|531161220|FG019|Open-Label Period (Week 48 to Week 144)|Adverse Event|2|||
147270653|NCT02346240|531161221|FG020|Open-Label Period (Week 48 to Week 144)|Adverse Event|3|||
147270654|NCT02346240|531161222|FG021|Open-Label Period (Week 48 to Week 144)|Adverse Event|13|||
147270655|NCT02346240|531161223|FG022|Open-Label Period (Week 48 to Week 144)|Adverse Event|3|||
147270656|NCT02346240|531161224|FG023|Open-Label Period (Week 48 to Week 144)|Adverse Event|3|||
147270657|NCT02346240|531161201|FG000|Open-Label Period (Week 48 to Week 144)|Death|0|||
147270658|NCT02346240|531161202|FG001|Open-Label Period (Week 48 to Week 144)|Death|0|||
147270659|NCT02346240|531161203|FG002|Open-Label Period (Week 48 to Week 144)|Death|0|||
147270660|NCT02346240|531161204|FG003|Open-Label Period (Week 48 to Week 144)|Death|0|||
147270661|NCT02346240|531161205|FG004|Open-Label Period (Week 48 to Week 144)|Death|0|||
147270662|NCT02346240|531161206|FG005|Open-Label Period (Week 48 to Week 144)|Death|0|||
147270663|NCT02346240|531161207|FG006|Open-Label Period (Week 48 to Week 144)|Death|0|||
147270664|NCT02346240|531161208|FG007|Open-Label Period (Week 48 to Week 144)|Death|0|||
147270665|NCT02346240|531161209|FG008|Open-Label Period (Week 48 to Week 144)|Death|0|||
147270666|NCT02346240|531161210|FG009|Open-Label Period (Week 48 to Week 144)|Death|0|||
147270667|NCT02346240|531161211|FG010|Open-Label Period (Week 48 to Week 144)|Death|0|||
147270668|NCT02346240|531161212|FG011|Open-Label Period (Week 48 to Week 144)|Death|0|||
147270669|NCT02346240|531161213|FG012|Open-Label Period (Week 48 to Week 144)|Death|0|||
147270670|NCT02346240|531161214|FG013|Open-Label Period (Week 48 to Week 144)|Death|0|||
147270671|NCT02346240|531161215|FG014|Open-Label Period (Week 48 to Week 144)|Death|0|||
147270672|NCT02346240|531161216|FG015|Open-Label Period (Week 48 to Week 144)|Death|0|||
147270673|NCT02346240|531161217|FG016|Open-Label Period (Week 48 to Week 144)|Death|0|||
147270674|NCT02346240|531161218|FG017|Open-Label Period (Week 48 to Week 144)|Death|0|||
147270675|NCT02346240|531161219|FG018|Open-Label Period (Week 48 to Week 144)|Death|1|||
147270676|NCT02346240|531161220|FG019|Open-Label Period (Week 48 to Week 144)|Death|1|||
147270677|NCT02346240|531161221|FG020|Open-Label Period (Week 48 to Week 144)|Death|0|||
147270678|NCT02346240|531161222|FG021|Open-Label Period (Week 48 to Week 144)|Death|1|||
147270679|NCT02346240|531161223|FG022|Open-Label Period (Week 48 to Week 144)|Death|0|||
147270680|NCT02346240|531161224|FG023|Open-Label Period (Week 48 to Week 144)|Death|0|||
147270681|NCT02346240|531161201|FG000|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
147270682|NCT02346240|531161202|FG001|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
147270683|NCT02346240|531161203|FG002|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
147270684|NCT02346240|531161204|FG003|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
147270685|NCT02346240|531161205|FG004|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
147270686|NCT02346240|531161206|FG005|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
147270687|NCT02346240|531161207|FG006|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
147270688|NCT02346240|531161208|FG007|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
147270689|NCT02346240|531161209|FG008|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
147270690|NCT02346240|531161210|FG009|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
147270691|NCT02346240|531161211|FG010|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
147270692|NCT02346240|531161212|FG011|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
147270693|NCT02346240|531161213|FG012|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
147270694|NCT02346240|531161214|FG013|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
147270695|NCT02346240|531161215|FG014|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
147270696|NCT02346240|531161216|FG015|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
147270697|NCT02346240|531161217|FG016|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
147270698|NCT02346240|531161218|FG017|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
147270699|NCT02346240|531161219|FG018|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
147270700|NCT02346240|531161220|FG019|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
147270701|NCT02346240|531161221|FG020|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
147270702|NCT02346240|531161222|FG021|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
147270703|NCT02346240|531161223|FG022|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
147270704|NCT02346240|531161224|FG023|Open-Label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
147270705|NCT02346240|531161201|FG000|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
147270706|NCT02346240|531161202|FG001|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
147270707|NCT02346240|531161203|FG002|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
147270708|NCT02346240|531161204|FG003|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
147270709|NCT02346240|531161205|FG004|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
147270710|NCT02346240|531161206|FG005|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
147270711|NCT02346240|531161207|FG006|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
147270712|NCT02346240|531161208|FG007|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
147270713|NCT02346240|531161209|FG008|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
147270714|NCT02346240|531161210|FG009|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
147270715|NCT02346240|531161211|FG010|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
147270716|NCT02346240|531161212|FG011|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
147270717|NCT02346240|531161213|FG012|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
147270718|NCT02346240|531161214|FG013|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
147270719|NCT02346240|531161215|FG014|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
147270720|NCT02346240|531161216|FG015|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
147270721|NCT02346240|531161217|FG016|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
147270722|NCT02346240|531161218|FG017|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
147270723|NCT02346240|531161219|FG018|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
147270724|NCT02346240|531161220|FG019|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
147270725|NCT02346240|531161221|FG020|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
147270726|NCT02346240|531161222|FG021|Open-Label Period (Week 48 to Week 144)|Protocol Violation|1|||
147270727|NCT02346240|531161223|FG022|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
147270728|NCT02346240|531161224|FG023|Open-Label Period (Week 48 to Week 144)|Protocol Violation|0|||
147270729|NCT02346240|531161201|FG000|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
147270730|NCT02346240|531161202|FG001|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
147270731|NCT02346240|531161203|FG002|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
147270732|NCT02346240|531161204|FG003|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
147270733|NCT02346240|531161205|FG004|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
147270734|NCT02346240|531161206|FG005|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
147270735|NCT02346240|531161207|FG006|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
147270736|NCT02346240|531161208|FG007|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
147270737|NCT02346240|531161209|FG008|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
147270738|NCT02346240|531161210|FG009|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
147270739|NCT02346240|531161211|FG010|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
147270740|NCT02346240|531161212|FG011|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
147270741|NCT02346240|531161213|FG012|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
147270742|NCT02346240|531161214|FG013|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
147270743|NCT02346240|531161215|FG014|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
147270744|NCT02346240|531161216|FG015|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
147270745|NCT02346240|531161217|FG016|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
147270746|NCT02346240|531161218|FG017|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|2|||
147270747|NCT02346240|531161219|FG018|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|2|||
147270748|NCT02346240|531161220|FG019|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|3|||
147270749|NCT02346240|531161221|FG020|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
147270750|NCT02346240|531161222|FG021|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|1|||
147270751|NCT02346240|531161223|FG022|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|1|||
147270752|NCT02346240|531161224|FG023|Open-Label Period (Week 48 to Week 144)|Lost to Follow-up|1|||
147270753|NCT02346240|531161201|FG000|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
147270754|NCT02346240|531161202|FG001|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
147270755|NCT02346240|531161203|FG002|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
147270756|NCT02346240|531161204|FG003|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
147270757|NCT02346240|531161205|FG004|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
147270758|NCT02346240|531161206|FG005|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
147270759|NCT02346240|531161207|FG006|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
147270760|NCT02346240|531161208|FG007|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
147270761|NCT02346240|531161209|FG008|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
147270762|NCT02346240|531161210|FG009|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
147270763|NCT02346240|531161211|FG010|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
147270764|NCT02346240|531161212|FG011|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
147270765|NCT02346240|531161213|FG012|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
147270766|NCT02346240|531161214|FG013|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
147270767|NCT02346240|531161215|FG014|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
147270768|NCT02346240|531161216|FG015|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
147270769|NCT02346240|531161217|FG016|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
147270770|NCT02346240|531161218|FG017|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
147270771|NCT02346240|531161219|FG018|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|4|||
147270772|NCT02346240|531161220|FG019|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|1|||
147270773|NCT02346240|531161221|FG020|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
147270774|NCT02346240|531161222|FG021|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|10|||
147270775|NCT02346240|531161223|FG022|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|1|||
147270776|NCT02346240|531161224|FG023|Open-Label Period (Week 48 to Week 144)|Withdrawal by Subject|1|||
147270777|NCT02346240|531161201|FG000|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
147270778|NCT02346240|531161202|FG001|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
147270779|NCT02346240|531161203|FG002|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
147270780|NCT02346240|531161204|FG003|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
147270781|NCT02346240|531161205|FG004|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
147270782|NCT02346240|531161206|FG005|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
147270783|NCT02346240|531161207|FG006|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
147270784|NCT02346240|531161208|FG007|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
147270785|NCT02346240|531161209|FG008|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
147270786|NCT02346240|531161210|FG009|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
147270787|NCT02346240|531161211|FG010|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
147270788|NCT02346240|531161212|FG011|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
147270789|NCT02346240|531161213|FG012|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
147270790|NCT02346240|531161214|FG013|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
147270791|NCT02346240|531161215|FG014|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
147270792|NCT02346240|531161216|FG015|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
147270793|NCT02346240|531161217|FG016|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
147270794|NCT02346240|531161218|FG017|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
147270795|NCT02346240|531161219|FG018|Open-Label Period (Week 48 to Week 144)|No PASI50 response|2|||
147270796|NCT02346240|531161220|FG019|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
147270797|NCT02346240|531161221|FG020|Open-Label Period (Week 48 to Week 144)|No PASI50 response|0|||
147270798|NCT02346240|531161222|FG021|Open-Label Period (Week 48 to Week 144)|No PASI50 response|4|||
147270799|NCT02346240|531161223|FG022|Open-Label Period (Week 48 to Week 144)|No PASI50 response|2|||
147270800|NCT02346240|531161224|FG023|Open-Label Period (Week 48 to Week 144)|No PASI50 response|3|||
147270801|NCT02346240|531161201|FG000|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
147270802|NCT02346240|531161202|FG001|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
147270803|NCT02346240|531161203|FG002|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
147270804|NCT02346240|531161204|FG003|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
147270805|NCT02346240|531161205|FG004|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
147270806|NCT02346240|531161206|FG005|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
147270807|NCT02346240|531161207|FG006|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
147270808|NCT02346240|531161208|FG007|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
147270809|NCT02346240|531161209|FG008|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
147270810|NCT02346240|531161210|FG009|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
147270811|NCT02346240|531161211|FG010|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
147270812|NCT02346240|531161212|FG011|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
147270813|NCT02346240|531161213|FG012|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
147270814|NCT02346240|531161214|FG013|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
147333417|NCT03020745|531387691|FG001|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
147333418|NCT03020745|531387692|FG002|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
147333419|NCT03020745|531387693|FG003|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
147270815|NCT02346240|531161215|FG014|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
147270816|NCT02346240|531161216|FG015|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
147270817|NCT02346240|531161217|FG016|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
147270818|NCT02346240|531161218|FG017|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
147333420|NCT03020745|531387694|FG004|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
147333421|NCT03020745|531387695|FG005|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
147333422|NCT03020745|531387696|FG006|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
147333423|NCT03020745|531387697|FG007|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
147333424|NCT03020745|531387698|FG008|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|2|||
147270819|NCT02346240|531161219|FG018|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|1|||
147270820|NCT02346240|531161220|FG019|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
147270821|NCT02346240|531161221|FG020|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
147270822|NCT02346240|531161222|FG021|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
147270823|NCT02346240|531161223|FG022|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
147270824|NCT02346240|531161224|FG023|Open-Label Period (Week 48 to Week 144)|No efficacy of study medication|0|||
147270825|NCT02942017|531161225|FG000|Overall Study|Adverse Event|0|||
147270826|NCT02942017|531161226|FG001|Overall Study|Adverse Event|1|||
147270827|NCT02942017|531161225|FG000|Overall Study|Withdrawal by Subject|0|||
147270828|NCT02942017|531161226|FG001|Overall Study|Withdrawal by Subject|1|||
147270829|NCT02942017|531161225|FG000|Overall Study|Lost to Follow-up|1|||
147270830|NCT02942017|531161226|FG001|Overall Study|Lost to Follow-up|1|||
147270831|NCT02942017|531161225|FG000|Overall Study|Randomized but not dosed|1|||
147270832|NCT02942017|531161226|FG001|Overall Study|Randomized but not dosed|3|||
147270833|NCT04399161|531161227|FG000|Overall Study|Withdrawal by Subject|1|||
147270834|NCT04399161|531161228|FG001|Overall Study|Withdrawal by Subject|0|||
147270835|NCT04399161|531161229|FG002|Overall Study|Withdrawal by Subject|2|||
147270836|NCT04399161|531161227|FG000|Overall Study|Protocol Violation|1|||
147270837|NCT04399161|531161228|FG001|Overall Study|Protocol Violation|2|||
147270838|NCT04399161|531161229|FG002|Overall Study|Protocol Violation|0|||
147270839|NCT03417141|531161230|FG000|Overall Study|Withdrawal by Subject|1|||
147270840|NCT03417141|531161230|FG000|Overall Study|Protocol Violation|3|||
147270841|NCT01455012|531161234|FG000|Overall Study|Adverse Event|0|||
147270842|NCT01455012|531161235|FG001|Overall Study|Adverse Event|2|||
147270843|NCT01455012|531161234|FG000|Overall Study|Lack of Efficacy|6|||
147270844|NCT01455012|531161235|FG001|Overall Study|Lack of Efficacy|1|||
147270845|NCT01455012|531161234|FG000|Overall Study|Withdrawal by Subject|3|||
147270846|NCT01455012|531161235|FG001|Overall Study|Withdrawal by Subject|1|||
147270847|NCT01455012|531161234|FG000|Overall Study|Unknown reason|2|||
147270848|NCT01455012|531161235|FG001|Overall Study|Unknown reason|0|||
147270849|NCT04552587|531161236|FG000|Overall Study|Lost to Follow-up|4|||
147270850|NCT02253810|531161237|FG000|Overall Study|Withdrawal by Subject|2|||
147270851|NCT02253810|531161238|FG001|Overall Study|Withdrawal by Subject|1|||
147270852|NCT02253810|531161237|FG000|Overall Study|Unknown concomitant procedure|3|||
147270853|NCT02253810|531161238|FG001|Overall Study|Unknown concomitant procedure|2|||
147270854|NCT03465878|531161242|FG000|Period 1-Part A First Intervention Day 1|Withdrawal by Subject|0|||
147270855|NCT03465878|531161243|FG001|Period 1-Part A First Intervention Day 1|Withdrawal by Subject|1|||
147270856|NCT03465878|531161244|FG002|Period 1-Part A First Intervention Day 1|Withdrawal by Subject|0|||
147270857|NCT03465878|531161245|FG003|Period 1-Part A First Intervention Day 1|Withdrawal by Subject|0|||
147270858|NCT03465878|531161242|FG000|Period 1-Part B First Intervention Day 1|Withdrawal by Subject|0|||
147270859|NCT03465878|531161243|FG001|Period 1-Part B First Intervention Day 1|Withdrawal by Subject|0|||
147270860|NCT03465878|531161244|FG002|Period 1-Part B First Intervention Day 1|Withdrawal by Subject|0|||
147270861|NCT03465878|531161245|FG003|Period 1-Part B First Intervention Day 1|Withdrawal by Subject|1|||
147270862|NCT03465878|531161242|FG000|Period 1-Part B First Intervention Day 1|Physician Decision|0|||
147270863|NCT03465878|531161243|FG001|Period 1-Part B First Intervention Day 1|Physician Decision|0|||
147270864|NCT03465878|531161244|FG002|Period 1-Part B First Intervention Day 1|Physician Decision|0|||
147270865|NCT03465878|531161245|FG003|Period 1-Part B First Intervention Day 1|Physician Decision|1|||
147270866|NCT04656132|531161246|FG000|Overall Study|Lost to Follow-up|4|||
147270867|NCT04656132|531161246|FG000|Overall Study|Lost to Follow-Up Prior to Baseline Data Collection|4|||
147270868|NCT04019041|531161247|FG000|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|3|||
147270869|NCT04019041|531161248|FG001|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|5|||
147270870|NCT04019041|531161249|FG002|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|4|||
147270871|NCT04019041|531161250|FG003|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
147270872|NCT04019041|531161251|FG004|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
147662342|NCT03110354|532587295|FG000|Overall Study|Other|0|||
147662343|NCT03110354|532587296|FG001|Overall Study|Other|0|||
147662344|NCT03110354|532587297|FG002|Overall Study|Other|0|||
147662345|NCT03110354|532587298|FG003|Overall Study|Other|1|||
147270873|NCT04019041|531161252|FG005|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
147270874|NCT04019041|531161247|FG000|Placebo Controlled Period (Weeks 0-16)|Adverse Event|0|||
147270875|NCT04019041|531161248|FG001|Placebo Controlled Period (Weeks 0-16)|Adverse Event|0|||
147270876|NCT04019041|531161249|FG002|Placebo Controlled Period (Weeks 0-16)|Adverse Event|2|||
147270877|NCT04019041|531161250|FG003|Placebo Controlled Period (Weeks 0-16)|Adverse Event|0|||
147270878|NCT04019041|531161251|FG004|Placebo Controlled Period (Weeks 0-16)|Adverse Event|0|||
147270879|NCT04019041|531161252|FG005|Placebo Controlled Period (Weeks 0-16)|Adverse Event|0|||
147270880|NCT04019041|531161247|FG000|Placebo Controlled Period (Weeks 0-16)|Other|1|||
147270881|NCT04019041|531161248|FG001|Placebo Controlled Period (Weeks 0-16)|Other|2|||
147270882|NCT04019041|531161249|FG002|Placebo Controlled Period (Weeks 0-16)|Other|1|||
147662346|NCT03110354|532587299|FG004|Overall Study|Other|1|||
147662347|NCT01298700|532587300|FG000|Overall Study|Adverse Event|50|||
147270883|NCT04019041|531161250|FG003|Placebo Controlled Period (Weeks 0-16)|Other|0|||
147270884|NCT04019041|531161251|FG004|Placebo Controlled Period (Weeks 0-16)|Other|0|||
147270885|NCT04019041|531161252|FG005|Placebo Controlled Period (Weeks 0-16)|Other|0|||
147270886|NCT04019041|531161247|FG000|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|0|||
147270887|NCT04019041|531161248|FG001|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|0|||
147270888|NCT04019041|531161249|FG002|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|1|||
147270889|NCT04019041|531161250|FG003|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|0|||
147270890|NCT04019041|531161251|FG004|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|0|||
147270891|NCT04019041|531161252|FG005|Placebo Controlled Period (Weeks 0-16)|Imprisonment/compulsory detention|0|||
147270892|NCT04019041|531161247|FG000|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
147270893|NCT04019041|531161248|FG001|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
147270894|NCT04019041|531161249|FG002|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
147270895|NCT04019041|531161250|FG003|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|4|||
147270896|NCT04019041|531161251|FG004|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|2|||
147270897|NCT04019041|531161252|FG005|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|1|||
147270898|NCT04019041|531161247|FG000|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|0|||
147270899|NCT04019041|531161248|FG001|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|0|||
147270900|NCT04019041|531161249|FG002|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|0|||
147270901|NCT04019041|531161250|FG003|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|1|||
147270902|NCT04019041|531161251|FG004|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|0|||
147270903|NCT04019041|531161252|FG005|Active Treatment+Safety F-U (Week 17-36)|Adverse Event|0|||
147270904|NCT04019041|531161247|FG000|Active Treatment+Safety F-U (Week 17-36)|Death|0|||
147270905|NCT04019041|531161248|FG001|Active Treatment+Safety F-U (Week 17-36)|Death|0|||
147270906|NCT04019041|531161249|FG002|Active Treatment+Safety F-U (Week 17-36)|Death|0|||
147270907|NCT04019041|531161250|FG003|Active Treatment+Safety F-U (Week 17-36)|Death|0|||
147270908|NCT04019041|531161251|FG004|Active Treatment+Safety F-U (Week 17-36)|Death|1|||
147270909|NCT04019041|531161252|FG005|Active Treatment+Safety F-U (Week 17-36)|Death|0|||
147270910|NCT04019041|531161247|FG000|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
147270911|NCT04019041|531161248|FG001|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
147270912|NCT04019041|531161249|FG002|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
147270913|NCT04019041|531161250|FG003|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|1|||
147270914|NCT04019041|531161251|FG004|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|2|||
147270915|NCT04019041|531161252|FG005|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|3|||
147270916|NCT04019041|531161247|FG000|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
147270917|NCT04019041|531161248|FG001|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
147270918|NCT04019041|531161249|FG002|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
147270919|NCT04019041|531161250|FG003|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
147270920|NCT04019041|531161251|FG004|Active Treatment+Safety F-U (Week 17-36)|Other|3|||
147270921|NCT04019041|531161252|FG005|Active Treatment+Safety F-U (Week 17-36)|Other|1|||
147270922|NCT02540954|531161253|FG000|Overall Study|Physician Decision|3|||
147270923|NCT02540954|531161254|FG001|Overall Study|Physician Decision|1|||
147270924|NCT02540954|531161253|FG000|Overall Study|Withdrawal by Subject|6|||
147270925|NCT02540954|531161254|FG001|Overall Study|Withdrawal by Subject|5|||
147270926|NCT02540954|531161253|FG000|Overall Study|Lost to Follow-up|1|||
147270927|NCT02540954|531161254|FG001|Overall Study|Lost to Follow-up|1|||
147270928|NCT02540954|531161253|FG000|Overall Study|Adverse Event|4|||
147270929|NCT02540954|531161254|FG001|Overall Study|Adverse Event|2|||
147270930|NCT02540954|531161253|FG000|Overall Study|Death|0|||
147270931|NCT02540954|531161254|FG001|Overall Study|Death|3|||
147270932|NCT02540954|531161253|FG000|Overall Study|Treatment failure|1|||
147270933|NCT02540954|531161254|FG001|Overall Study|Treatment failure|0|||
147270934|NCT02540954|531161253|FG000|Overall Study|Other reason|4|||
147270935|NCT02540954|531161254|FG001|Overall Study|Other reason|2|||
147270936|NCT01393743|531161255|FG000|Core Study|Adverse Event|5|||
147270937|NCT01393743|531161256|FG001|Core Study|Adverse Event|9|||
147270938|NCT01393743|531161257|FG002|Core Study|Adverse Event|0|||
147270939|NCT01393743|531161255|FG000|Core Study|Lost to Follow-up|1|||
147270940|NCT01393743|531161256|FG001|Core Study|Lost to Follow-up|1|||
147270941|NCT01393743|531161257|FG002|Core Study|Lost to Follow-up|0|||
147270942|NCT01393743|531161255|FG000|Core Study|Participant's Choice|2|||
147270943|NCT01393743|531161256|FG001|Core Study|Participant's Choice|3|||
147270944|NCT01393743|531161257|FG002|Core Study|Participant's Choice|0|||
147270945|NCT01393743|531161255|FG000|Core Study|Inadequate therapeutic effect|2|||
147270946|NCT01393743|531161256|FG001|Core Study|Inadequate therapeutic effect|0|||
147270947|NCT01393743|531161257|FG002|Core Study|Inadequate therapeutic effect|0|||
147270948|NCT01393743|531161255|FG000|Extension Phase|Adverse Event|0|||
147270949|NCT01393743|531161256|FG001|Extension Phase|Adverse Event|0|||
147333425|NCT03020745|531387699|FG009|Part 2:Optional FU (Up to 450 Days)|Withdrawal by Subject|0|||
147333426|NCT00743444|531387700|FG000|First Intervention|Catheter placement problems|0|||
147333427|NCT00743444|531387701|FG001|First Intervention|Catheter placement problems|1|||
147333428|NCT00743444|531387700|FG000|Washout Period|Adverse Event|0|||
147270950|NCT01393743|531161257|FG002|Extension Phase|Adverse Event|12|||
147270951|NCT01393743|531161255|FG000|Extension Phase|Lost to Follow-up|0|||
147270952|NCT01393743|531161256|FG001|Extension Phase|Lost to Follow-up|0|||
147270953|NCT01393743|531161257|FG002|Extension Phase|Lost to Follow-up|2|||
147270954|NCT01393743|531161255|FG000|Extension Phase|Participant choice|0|||
147270955|NCT01393743|531161256|FG001|Extension Phase|Participant choice|0|||
147270956|NCT01393743|531161257|FG002|Extension Phase|Participant choice|16|||
147270957|NCT01393743|531161255|FG000|Extension Phase|Inadequate therapeutic effect|0|||
147270958|NCT01393743|531161256|FG001|Extension Phase|Inadequate therapeutic effect|0|||
147270959|NCT01393743|531161257|FG002|Extension Phase|Inadequate therapeutic effect|7|||
147270960|NCT01393743|531161255|FG000|Extension Phase|Withdrawal by Subject|0|||
147270961|NCT01393743|531161256|FG001|Extension Phase|Withdrawal by Subject|0|||
147270962|NCT01393743|531161257|FG002|Extension Phase|Withdrawal by Subject|8|||
147270963|NCT01393743|531161255|FG000|Extension Phase|Pregnancy|0|||
147270964|NCT01393743|531161256|FG001|Extension Phase|Pregnancy|0|||
147270965|NCT01393743|531161257|FG002|Extension Phase|Pregnancy|1|||
147270966|NCT01393743|531161255|FG000|Extension Phase|Other|0|||
147270967|NCT01393743|531161256|FG001|Extension Phase|Other|0|||
147270968|NCT01393743|531161257|FG002|Extension Phase|Other|14|||
147270969|NCT00213148|531161258|FG000|Cycle 1 (1 Month)|Lost to Follow-up|1|||
147270970|NCT00213148|531161259|FG001|Cycle 1 (1 Month)|Lost to Follow-up|0|||
147270971|NCT00213148|531161260|FG002|Cycle 1 (1 Month)|Lost to Follow-up|2|||
147270972|NCT00213148|531161261|FG003|Cycle 1 (1 Month)|Lost to Follow-up|2|||
147270973|NCT00213148|531161262|FG004|Cycle 1 (1 Month)|Lost to Follow-up|1|||
147270974|NCT00213148|531161258|FG000|Cycle 1 (1 Month)|Adverse Event|0|||
147270975|NCT00213148|531161259|FG001|Cycle 1 (1 Month)|Adverse Event|0|||
147270976|NCT00213148|531161260|FG002|Cycle 1 (1 Month)|Adverse Event|1|||
147270977|NCT00213148|531161261|FG003|Cycle 1 (1 Month)|Adverse Event|0|||
147270978|NCT00213148|531161262|FG004|Cycle 1 (1 Month)|Adverse Event|0|||
147270979|NCT00213148|531161258|FG000|Cycle 1 (1 Month)|Lack of Efficacy|4|||
147270980|NCT00213148|531161259|FG001|Cycle 1 (1 Month)|Lack of Efficacy|0|||
147270981|NCT00213148|531161260|FG002|Cycle 1 (1 Month)|Lack of Efficacy|8|||
147270982|NCT00213148|531161261|FG003|Cycle 1 (1 Month)|Lack of Efficacy|5|||
147270983|NCT00213148|531161262|FG004|Cycle 1 (1 Month)|Lack of Efficacy|8|||
147270984|NCT00213148|531161258|FG000|Cycle 1 (1 Month)|Protocol Violation|1|||
147270985|NCT00213148|531161259|FG001|Cycle 1 (1 Month)|Protocol Violation|0|||
147270986|NCT00213148|531161260|FG002|Cycle 1 (1 Month)|Protocol Violation|1|||
147270987|NCT00213148|531161261|FG003|Cycle 1 (1 Month)|Protocol Violation|0|||
147270988|NCT00213148|531161262|FG004|Cycle 1 (1 Month)|Protocol Violation|0|||
147270989|NCT00213148|531161258|FG000|Cycle 1 (1 Month)|Other|3|||
147270990|NCT00213148|531161259|FG001|Cycle 1 (1 Month)|Other|0|||
147270991|NCT00213148|531161260|FG002|Cycle 1 (1 Month)|Other|2|||
147270992|NCT00213148|531161261|FG003|Cycle 1 (1 Month)|Other|2|||
147270993|NCT00213148|531161262|FG004|Cycle 1 (1 Month)|Other|7|||
147270994|NCT00213148|531161258|FG000|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0|||
147270995|NCT00213148|531161259|FG001|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0|||
147270996|NCT00213148|531161260|FG002|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0|||
147270997|NCT00213148|531161261|FG003|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|1|||
147270998|NCT00213148|531161262|FG004|Cycle 1 (1 Month)|Pregnancy Unrelated to Therapy|0|||
147270999|NCT00213148|531161258|FG000|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0|||
147271000|NCT00213148|531161259|FG001|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0|||
147271001|NCT00213148|531161260|FG002|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0|||
147271002|NCT00213148|531161261|FG003|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|0|||
147271003|NCT00213148|531161262|FG004|Cycle 1 (1 Month)|Non Resolving Cyst > 25mm|1|||
147271004|NCT00213148|531161258|FG000|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|15|||
147271005|NCT00213148|531161259|FG001|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|0|||
147271006|NCT00213148|531161260|FG002|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|5|||
147271007|NCT00213148|531161261|FG003|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|8|||
147271008|NCT00213148|531161262|FG004|Cycle 1 (1 Month)|Discontinued Before Start of Cycle 2|5|||
147271009|NCT00213148|531161258|FG000|Cycle 2 (1 Month)|Lost to Follow-up|0|||
147271010|NCT00213148|531161259|FG001|Cycle 2 (1 Month)|Lost to Follow-up|0|||
147271011|NCT00213148|531161260|FG002|Cycle 2 (1 Month)|Lost to Follow-up|2|||
147271012|NCT00213148|531161261|FG003|Cycle 2 (1 Month)|Lost to Follow-up|2|||
147271013|NCT00213148|531161262|FG004|Cycle 2 (1 Month)|Lost to Follow-up|1|||
147271014|NCT00213148|531161258|FG000|Cycle 2 (1 Month)|Lack of Efficacy|1|||
147271015|NCT00213148|531161259|FG001|Cycle 2 (1 Month)|Lack of Efficacy|3|||
147271016|NCT00213148|531161260|FG002|Cycle 2 (1 Month)|Lack of Efficacy|7|||
147333429|NCT00743444|531387701|FG001|Washout Period|Adverse Event|1|||
147333430|NCT03287622|531387706|FG000|Overall Study|Withdrawal by Subject|1|||
147271017|NCT00213148|531161261|FG003|Cycle 2 (1 Month)|Lack of Efficacy|6|||
147271018|NCT00213148|531161262|FG004|Cycle 2 (1 Month)|Lack of Efficacy|16|||
147271019|NCT00213148|531161258|FG000|Cycle 2 (1 Month)|Other|2|||
147271020|NCT00213148|531161259|FG001|Cycle 2 (1 Month)|Other|1|||
147271021|NCT00213148|531161260|FG002|Cycle 2 (1 Month)|Other|2|||
147333431|NCT03287622|531387707|FG001|Overall Study|Withdrawal by Subject|0|||
147271022|NCT00213148|531161261|FG003|Cycle 2 (1 Month)|Other|8|||
147271023|NCT00213148|531161262|FG004|Cycle 2 (1 Month)|Other|7|||
147271024|NCT00213148|531161258|FG000|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0|||
147271025|NCT00213148|531161259|FG001|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|1|||
147271026|NCT00213148|531161260|FG002|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0|||
147271027|NCT00213148|531161261|FG003|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0|||
147271028|NCT00213148|531161262|FG004|Cycle 2 (1 Month)|Pregnancy Unrelated to Therapy|0|||
147271029|NCT00213148|531161258|FG000|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|1|||
147271030|NCT00213148|531161259|FG001|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0|||
147271031|NCT00213148|531161260|FG002|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0|||
147271032|NCT00213148|531161261|FG003|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0|||
147271033|NCT00213148|531161262|FG004|Cycle 2 (1 Month)|Non Resolving Cyst > 25mm|0|||
147271034|NCT00213148|531161258|FG000|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|10|||
147271035|NCT00213148|531161259|FG001|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|1|||
147271036|NCT00213148|531161260|FG002|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|3|||
147271037|NCT00213148|531161261|FG003|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|3|||
147271038|NCT00213148|531161262|FG004|Cycle 2 (1 Month)|Discontinued Before Start of Cycle 3|6|||
147271039|NCT00213148|531161258|FG000|Cycle 3 (1 Month)|Lost to Follow-up|0|||
147271040|NCT00213148|531161259|FG001|Cycle 3 (1 Month)|Lost to Follow-up|2|||
147271041|NCT00213148|531161260|FG002|Cycle 3 (1 Month)|Lost to Follow-up|0|||
147271042|NCT00213148|531161261|FG003|Cycle 3 (1 Month)|Lost to Follow-up|0|||
147271043|NCT00213148|531161262|FG004|Cycle 3 (1 Month)|Lost to Follow-up|1|||
147271044|NCT00213148|531161258|FG000|Cycle 3 (1 Month)|Other|0|||
147271045|NCT00213148|531161259|FG001|Cycle 3 (1 Month)|Other|0|||
147271046|NCT00213148|531161260|FG002|Cycle 3 (1 Month)|Other|1|||
147271047|NCT00213148|531161261|FG003|Cycle 3 (1 Month)|Other|1|||
147271048|NCT00213148|531161262|FG004|Cycle 3 (1 Month)|Other|0|||
147271049|NCT01806896|531161264|FG000|Overall Study|Adverse Event|2|||
147271050|NCT01806896|531161265|FG001|Overall Study|Adverse Event|0|||
147271051|NCT01806896|531161264|FG000|Overall Study|Other|1|||
147271052|NCT01806896|531161265|FG001|Overall Study|Other|0|||
147271053|NCT00245765|531161266|FG000|Overall Study|Adverse Event|1|||
147271054|NCT00245765|531161267|FG001|Overall Study|Adverse Event|1|||
147271055|NCT00245765|531161268|FG002|Overall Study|Adverse Event|0|||
147271056|NCT00245765|531161266|FG000|Overall Study|Lack of Efficacy|14|||
147271057|NCT00245765|531161267|FG001|Overall Study|Lack of Efficacy|7|||
147271058|NCT00245765|531161268|FG002|Overall Study|Lack of Efficacy|0|||
147271059|NCT00245765|531161266|FG000|Overall Study|Lost to Follow-up|1|||
147271060|NCT00245765|531161267|FG001|Overall Study|Lost to Follow-up|2|||
147271061|NCT00245765|531161268|FG002|Overall Study|Lost to Follow-up|0|||
147271062|NCT00245765|531161266|FG000|Overall Study|Withdrawal by Subject|1|||
147271063|NCT00245765|531161267|FG001|Overall Study|Withdrawal by Subject|0|||
147271064|NCT00245765|531161268|FG002|Overall Study|Withdrawal by Subject|3|||
147271065|NCT00245765|531161266|FG000|Overall Study|Other reason|2|||
147271066|NCT00245765|531161267|FG001|Overall Study|Other reason|0|||
147271067|NCT00245765|531161268|FG002|Overall Study|Other reason|1|||
147271068|NCT00245765|531161266|FG000|Overall Study|Other|13|||
147271069|NCT00245765|531161267|FG001|Overall Study|Other|4|||
147271070|NCT00245765|531161268|FG002|Overall Study|Other|4|||
147271071|NCT03080961|531161269|FG000|Overall Study|Withdrawal by Subject|3|||
147271072|NCT01101841|531162655|FG000|Overall Study|Adverse Event|15|||
147271073|NCT01101841|531162656|FG001|Overall Study|Adverse Event|15|||
147271074|NCT01101841|531162655|FG000|Overall Study|Lost to Follow-up|9|||
147271075|NCT01101841|531162656|FG001|Overall Study|Lost to Follow-up|3|||
147271076|NCT01101841|531162655|FG000|Overall Study|Withdrawal by Subject|21|||
147271077|NCT01101841|531162656|FG001|Overall Study|Withdrawal by Subject|40|||
147271078|NCT01101841|531162655|FG000|Overall Study|Protocol Violation|1|||
147271079|NCT01101841|531162656|FG001|Overall Study|Protocol Violation|1|||
147333432|NCT03287622|531387706|FG000|Overall Study|Lost to Follow-up|27|||
147333433|NCT03287622|531387707|FG001|Overall Study|Lost to Follow-up|15|||
147333434|NCT03287622|531387706|FG000|Overall Study|No prescripion after surgery|28|||
147333435|NCT03287622|531387707|FG001|Overall Study|No prescripion after surgery|31|||
147333436|NCT03287622|531387706|FG000|Overall Study|prolonged Length of stay|2|||
147333437|NCT03287622|531387707|FG001|Overall Study|prolonged Length of stay|0|||
147271080|NCT01101841|531162655|FG000|Overall Study|Physician Decision|0|||
147271081|NCT01101841|531162656|FG001|Overall Study|Physician Decision|2|||
147271082|NCT01101841|531162655|FG000|Overall Study|Lack of Efficacy|0|||
147271083|NCT01101841|531162656|FG001|Overall Study|Lack of Efficacy|2|||
147271084|NCT01101841|531162655|FG000|Overall Study|Other|0|||
147271085|NCT01101841|531162656|FG001|Overall Study|Other|1|||
147333438|NCT03287622|531387706|FG000|Overall Study|surgery related|0|||
147333439|NCT03287622|531387707|FG001|Overall Study|surgery related|2|||
147271086|NCT01101841|531162655|FG000|Overall Study|Suicidality Tracking Scale|3|||
147271087|NCT01101841|531162656|FG001|Overall Study|Suicidality Tracking Scale|1|||
147271088|NCT01101841|531162655|FG000|Overall Study|Eligibility Criteria|1|||
147271089|NCT01101841|531162656|FG001|Overall Study|Eligibility Criteria|2|||
147271090|NCT03756558|531162659|FG000|Overall Study|Death|1|||
147271091|NCT03756558|531162659|FG000|Overall Study|Lost to Follow-up|2|||
147271092|NCT03756558|531162659|FG000|Overall Study|Withdrawal by Subject|2|||
147271093|NCT02896400|531162661|FG000|1 Month Follow-up|Lost to Follow-up|7|||
147333440|NCT02057692|531387708|FG000|Overall Study|Adverse Event|1|||
147333441|NCT02057692|531387709|FG001|Overall Study|Adverse Event|0|||
147333442|NCT02057692|531387710|FG002|Overall Study|Adverse Event|0|||
147333443|NCT02057692|531387711|FG003|Overall Study|Adverse Event|0|||
147333444|NCT02057692|531387708|FG000|Overall Study|Lost to Follow-up|0|||
147333445|NCT02057692|531387709|FG001|Overall Study|Lost to Follow-up|0|||
147333446|NCT02057692|531387710|FG002|Overall Study|Lost to Follow-up|0|||
147333447|NCT02057692|531387711|FG003|Overall Study|Lost to Follow-up|1|||
147333448|NCT03622580|531387720|FG000|Overall Study|Death|16|||
147271094|NCT02896400|531162662|FG001|1 Month Follow-up|Lost to Follow-up|7|||
147600293|NCT03893565|532356358|FG001|Double-blind Induction Phase (10 Weeks)|Physician Decision|1|||
147271095|NCT02896400|531162663|FG002|1 Month Follow-up|Lost to Follow-up|5|||
147271096|NCT02896400|531162664|FG003|1 Month Follow-up|Lost to Follow-up|8|||
147271097|NCT02896400|531162665|FG004|1 Month Follow-up|Lost to Follow-up|9|||
147271098|NCT02896400|531162666|FG005|1 Month Follow-up|Lost to Follow-up|6|||
147271099|NCT02896400|531162667|FG006|1 Month Follow-up|Lost to Follow-up|5|||
147271100|NCT02896400|531162668|FG007|1 Month Follow-up|Lost to Follow-up|6|||
147271101|NCT02896400|531162669|FG008|1 Month Follow-up|Lost to Follow-up|4|||
147271102|NCT02896400|531162670|FG009|1 Month Follow-up|Lost to Follow-up|7|||
147271103|NCT02896400|531162671|FG010|1 Month Follow-up|Lost to Follow-up|5|||
147271104|NCT02896400|531162672|FG011|1 Month Follow-up|Lost to Follow-up|5|||
147271105|NCT02896400|531162673|FG012|1 Month Follow-up|Lost to Follow-up|3|||
147271106|NCT02896400|531162674|FG013|1 Month Follow-up|Lost to Follow-up|4|||
147271107|NCT02896400|531162675|FG014|1 Month Follow-up|Lost to Follow-up|1|||
147271108|NCT02896400|531162676|FG015|1 Month Follow-up|Lost to Follow-up|2|||
147271109|NCT02896400|531162661|FG000|1 Month Follow-up|Death|0|||
147271110|NCT02896400|531162662|FG001|1 Month Follow-up|Death|0|||
147271111|NCT02896400|531162663|FG002|1 Month Follow-up|Death|0|||
147271112|NCT02896400|531162664|FG003|1 Month Follow-up|Death|0|||
147271113|NCT02896400|531162665|FG004|1 Month Follow-up|Death|0|||
147271114|NCT02896400|531162666|FG005|1 Month Follow-up|Death|0|||
147271115|NCT02896400|531162667|FG006|1 Month Follow-up|Death|0|||
147271116|NCT02896400|531162668|FG007|1 Month Follow-up|Death|0|||
147271117|NCT02896400|531162669|FG008|1 Month Follow-up|Death|0|||
147271118|NCT02896400|531162670|FG009|1 Month Follow-up|Death|0|||
147271119|NCT02896400|531162671|FG010|1 Month Follow-up|Death|0|||
147271120|NCT02896400|531162672|FG011|1 Month Follow-up|Death|0|||
147271121|NCT02896400|531162673|FG012|1 Month Follow-up|Death|0|||
147271122|NCT02896400|531162674|FG013|1 Month Follow-up|Death|0|||
147271123|NCT02896400|531162675|FG014|1 Month Follow-up|Death|0|||
147271124|NCT02896400|531162676|FG015|1 Month Follow-up|Death|1|||
147271125|NCT02896400|531162661|FG000|3 Month Follow-up|Lost to Follow-up|6|||
147271126|NCT02896400|531162662|FG001|3 Month Follow-up|Lost to Follow-up|3|||
147271127|NCT02896400|531162663|FG002|3 Month Follow-up|Lost to Follow-up|6|||
147271128|NCT02896400|531162664|FG003|3 Month Follow-up|Lost to Follow-up|11|||
147271129|NCT02896400|531162665|FG004|3 Month Follow-up|Lost to Follow-up|12|||
147271130|NCT02896400|531162666|FG005|3 Month Follow-up|Lost to Follow-up|6|||
147271131|NCT02896400|531162667|FG006|3 Month Follow-up|Lost to Follow-up|4|||
147271132|NCT02896400|531162668|FG007|3 Month Follow-up|Lost to Follow-up|3|||
147271133|NCT02896400|531162669|FG008|3 Month Follow-up|Lost to Follow-up|6|||
147271134|NCT02896400|531162670|FG009|3 Month Follow-up|Lost to Follow-up|5|||
147271135|NCT02896400|531162671|FG010|3 Month Follow-up|Lost to Follow-up|6|||
147271136|NCT02896400|531162672|FG011|3 Month Follow-up|Lost to Follow-up|6|||
147271137|NCT02896400|531162673|FG012|3 Month Follow-up|Lost to Follow-up|3|||
147271138|NCT02896400|531162674|FG013|3 Month Follow-up|Lost to Follow-up|5|||
147271139|NCT02896400|531162675|FG014|3 Month Follow-up|Lost to Follow-up|3|||
147271140|NCT02896400|531162676|FG015|3 Month Follow-up|Lost to Follow-up|2|||
147271141|NCT02896400|531162661|FG000|3 Month Follow-up|Death|0|||
147271142|NCT02896400|531162662|FG001|3 Month Follow-up|Death|0|||
147333449|NCT03622580|531387721|FG001|Overall Study|Death|21|||
147333450|NCT03622580|531387722|FG002|Overall Study|Death|13|||
147333451|NCT03622580|531387720|FG000|Overall Study|Adverse Event|6|||
147333452|NCT03622580|531387721|FG001|Overall Study|Adverse Event|6|||
147333453|NCT03622580|531387722|FG002|Overall Study|Adverse Event|5|||
147333454|NCT03622580|531387720|FG000|Overall Study|Withdrawal by Subject|12|||
147600294|NCT03893565|532356359|FG002|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
147600295|NCT03893565|532356360|FG003|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
147600296|NCT03893565|532356361|FG004|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
147600297|NCT03893565|532356362|FG005|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
147600298|NCT03893565|532356363|FG006|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
147600299|NCT03893565|532356364|FG007|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
147662348|NCT01298700|532587301|FG001|Overall Study|Adverse Event|51|||
147662349|NCT01298700|532587300|FG000|Overall Study|Lack of Efficacy|9|||
147271143|NCT02896400|531162663|FG002|3 Month Follow-up|Death|0|||
147271144|NCT02896400|531162664|FG003|3 Month Follow-up|Death|0|||
147271145|NCT02896400|531162665|FG004|3 Month Follow-up|Death|0|||
147271146|NCT02896400|531162666|FG005|3 Month Follow-up|Death|0|||
147333455|NCT03622580|531387721|FG001|Overall Study|Withdrawal by Subject|7|||
147271147|NCT02896400|531162667|FG006|3 Month Follow-up|Death|0|||
147271148|NCT02896400|531162668|FG007|3 Month Follow-up|Death|0|||
147271149|NCT02896400|531162669|FG008|3 Month Follow-up|Death|0|||
147271150|NCT02896400|531162670|FG009|3 Month Follow-up|Death|0|||
147271151|NCT02896400|531162671|FG010|3 Month Follow-up|Death|0|||
147271152|NCT02896400|531162672|FG011|3 Month Follow-up|Death|0|||
147271153|NCT02896400|531162673|FG012|3 Month Follow-up|Death|0|||
147271154|NCT02896400|531162674|FG013|3 Month Follow-up|Death|1|||
147271155|NCT02896400|531162675|FG014|3 Month Follow-up|Death|1|||
147271156|NCT02896400|531162676|FG015|3 Month Follow-up|Death|0|||
147271157|NCT02896400|531162661|FG000|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
147271158|NCT02896400|531162662|FG001|Biochemical Verification at 3 Months|Lost to Follow-up|0|||
147271159|NCT02896400|531162663|FG002|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
147271160|NCT02896400|531162664|FG003|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
147271161|NCT02896400|531162665|FG004|Biochemical Verification at 3 Months|Lost to Follow-up|0|||
147271162|NCT02896400|531162666|FG005|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
147271163|NCT02896400|531162667|FG006|Biochemical Verification at 3 Months|Lost to Follow-up|3|||
147271164|NCT02896400|531162668|FG007|Biochemical Verification at 3 Months|Lost to Follow-up|2|||
147271165|NCT02896400|531162669|FG008|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
147271166|NCT02896400|531162670|FG009|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
147271167|NCT02896400|531162671|FG010|Biochemical Verification at 3 Months|Lost to Follow-up|0|||
147271168|NCT02896400|531162672|FG011|Biochemical Verification at 3 Months|Lost to Follow-up|0|||
147271169|NCT02896400|531162673|FG012|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
147271170|NCT02896400|531162674|FG013|Biochemical Verification at 3 Months|Lost to Follow-up|0|||
147271171|NCT02896400|531162675|FG014|Biochemical Verification at 3 Months|Lost to Follow-up|3|||
147271172|NCT02896400|531162676|FG015|Biochemical Verification at 3 Months|Lost to Follow-up|1|||
147271173|NCT02896400|531162661|FG000|Biochemical Verification at 3 Months|participant was not eligible for biochem|45|||
147271174|NCT02896400|531162662|FG001|Biochemical Verification at 3 Months|participant was not eligible for biochem|48|||
147271175|NCT02896400|531162663|FG002|Biochemical Verification at 3 Months|participant was not eligible for biochem|46|||
147271176|NCT02896400|531162664|FG003|Biochemical Verification at 3 Months|participant was not eligible for biochem|40|||
147271177|NCT02896400|531162665|FG004|Biochemical Verification at 3 Months|participant was not eligible for biochem|45|||
147271178|NCT02896400|531162666|FG005|Biochemical Verification at 3 Months|participant was not eligible for biochem|48|||
147271179|NCT02896400|531162667|FG006|Biochemical Verification at 3 Months|participant was not eligible for biochem|48|||
147271180|NCT02896400|531162668|FG007|Biochemical Verification at 3 Months|participant was not eligible for biochem|47|||
147271181|NCT02896400|531162669|FG008|Biochemical Verification at 3 Months|participant was not eligible for biochem|44|||
147271182|NCT02896400|531162670|FG009|Biochemical Verification at 3 Months|participant was not eligible for biochem|52|||
147271183|NCT02896400|531162671|FG010|Biochemical Verification at 3 Months|participant was not eligible for biochem|55|||
147271184|NCT02896400|531162672|FG011|Biochemical Verification at 3 Months|participant was not eligible for biochem|41|||
147271185|NCT02896400|531162673|FG012|Biochemical Verification at 3 Months|participant was not eligible for biochem|52|||
147271186|NCT02896400|531162674|FG013|Biochemical Verification at 3 Months|participant was not eligible for biochem|48|||
147271187|NCT02896400|531162675|FG014|Biochemical Verification at 3 Months|participant was not eligible for biochem|52|||
147271188|NCT02896400|531162676|FG015|Biochemical Verification at 3 Months|participant was not eligible for biochem|56|||
147271189|NCT00634647|531162679|FG000|Overall Study|death on study|3|||
147271190|NCT00634647|531162679|FG000|Overall Study|refused further treatment|3|||
147271191|NCT00634647|531162679|FG000|Overall Study|declined to participate before treatment|1|||
147271192|NCT02984020|531162680|FG000|Overall Study|Experienced off-label use against Xeljanz local product document|21|||
147271193|NCT02984020|531162680|FG000|Overall Study|Not met the inclusion/exclusion criterion|9|||
147271194|NCT02984020|531162680|FG000|Overall Study|Other significant protocol violation|2|||
147271195|NCT01700179|531162681|FG000|Overall Study|Physician Decision|2|||
147271196|NCT01896895|531162682|FG000|Double-blind MP|Physician Decision|0|||
147271197|NCT01896895|531162683|FG001|Double-blind MP|Physician Decision|0|||
147271198|NCT01896895|531162684|FG002|Double-blind MP|Physician Decision|1|||
147271199|NCT01896895|531162685|FG003|Double-blind MP|Physician Decision|0|||
147271200|NCT01896895|531162682|FG000|Double-blind MP|Withdrawal by Subject|0|||
147271201|NCT01896895|531162683|FG001|Double-blind MP|Withdrawal by Subject|2|||
147271202|NCT01896895|531162684|FG002|Double-blind MP|Withdrawal by Subject|1|||
147271203|NCT01896895|531162685|FG003|Double-blind MP|Withdrawal by Subject|0|||
147271204|NCT01896895|531162682|FG000|Double-blind MP|Lost to Follow-up|1|||
147271205|NCT01896895|531162683|FG001|Double-blind MP|Lost to Follow-up|0|||
147271206|NCT01896895|531162684|FG002|Double-blind MP|Lost to Follow-up|1|||
147271207|NCT01896895|531162685|FG003|Double-blind MP|Lost to Follow-up|0|||
147271208|NCT00667342|531162686|FG000|Overall Study|Protocol Violation|1|||
147271209|NCT00667342|531162687|FG001|Overall Study|Protocol Violation|0|||
147271210|NCT00667342|531162688|FG002|Overall Study|Protocol Violation|0|||
147271211|NCT00667342|531162686|FG000|Overall Study|Withdrawal by Subject|1|||
147271212|NCT00667342|531162687|FG001|Overall Study|Withdrawal by Subject|0|||
147271213|NCT00667342|531162688|FG002|Overall Study|Withdrawal by Subject|0|||
147271214|NCT00667342|531162686|FG000|Overall Study|Physician Decision|3|||
147271215|NCT00667342|531162687|FG001|Overall Study|Physician Decision|0|||
147271216|NCT00667342|531162688|FG002|Overall Study|Physician Decision|0|||
147271217|NCT00667342|531162686|FG000|Overall Study|Relapse or tumor progression|9|||
147271218|NCT00667342|531162687|FG001|Overall Study|Relapse or tumor progression|0|||
147271219|NCT00667342|531162688|FG002|Overall Study|Relapse or tumor progression|7|||
147271220|NCT00667342|531162686|FG000|Overall Study|Adverse Event|0|||
147271221|NCT00667342|531162687|FG001|Overall Study|Adverse Event|0|||
147271222|NCT00667342|531162688|FG002|Overall Study|Adverse Event|1|||
147271223|NCT00667342|531162686|FG000|Overall Study|Ineligible|0|||
147271224|NCT00667342|531162687|FG001|Overall Study|Ineligible|0|||
147271225|NCT00667342|531162688|FG002|Overall Study|Ineligible|1|||
147271226|NCT01207778|531162689|FG000|Overall Study|Lost to Follow-up|0|||
147271227|NCT01207778|531162690|FG001|Overall Study|Lost to Follow-up|3|||
147271228|NCT01207778|531162691|FG002|Overall Study|Lost to Follow-up|3|||
147271229|NCT01433263|531162694|FG000|Overall Study|Adverse Event|3|||
147271230|NCT01433263|531162695|FG001|Overall Study|Adverse Event|1|||
147271231|NCT01433263|531162694|FG000|Overall Study|Death|5|||
147271232|NCT01433263|531162695|FG001|Overall Study|Death|3|||
147271233|NCT01433263|531162694|FG000|Overall Study|Lost to Follow-up|0|||
147271234|NCT01433263|531162695|FG001|Overall Study|Lost to Follow-up|1|||
147271235|NCT01433263|531162694|FG000|Overall Study|Protocol Deviation|1|||
147271236|NCT01433263|531162695|FG001|Overall Study|Protocol Deviation|0|||
147271237|NCT01433263|531162694|FG000|Overall Study|Withdrawal by Subject|10|||
147271238|NCT01433263|531162695|FG001|Overall Study|Withdrawal by Subject|7|||
147271239|NCT00646204|531162696|FG000|Overall Study|Adverse Event|3|||
147271240|NCT00646204|531162697|FG001|Overall Study|Adverse Event|0|||
147271241|NCT00646204|531162696|FG000|Overall Study|Withdrawal by Subject|1|||
147271242|NCT00646204|531162697|FG001|Overall Study|Withdrawal by Subject|0|||
147271243|NCT03107988|531162703|FG000|Overall Study|Adverse Event|0|||
147271244|NCT03107988|531162704|FG001|Overall Study|Adverse Event|0|||
147271245|NCT03107988|531162705|FG002|Overall Study|Adverse Event|0|||
147271246|NCT03107988|531162706|FG003|Overall Study|Adverse Event|1|||
147271247|NCT03107988|531162707|FG004|Overall Study|Adverse Event|0|||
147271248|NCT03107988|531162708|FG005|Overall Study|Adverse Event|1|||
147271249|NCT03107988|531162709|FG006|Overall Study|Adverse Event|0|||
147271250|NCT03107988|531162710|FG007|Overall Study|Adverse Event|1|||
147271251|NCT03107988|531162711|FG008|Overall Study|Adverse Event|0|||
147271252|NCT03107988|531162712|FG009|Overall Study|Adverse Event|0|||
147271253|NCT03107988|531162713|FG010|Overall Study|Adverse Event|0|||
147271254|NCT03107988|531162714|FG011|Overall Study|Adverse Event|0|||
147271255|NCT03107988|531162715|FG012|Overall Study|Adverse Event|0|||
147271256|NCT03107988|531162703|FG000|Overall Study|Disease Progression or Relapse|1|||
147271257|NCT03107988|531162704|FG001|Overall Study|Disease Progression or Relapse|2|||
147271258|NCT03107988|531162705|FG002|Overall Study|Disease Progression or Relapse|2|||
147333456|NCT03622580|531387722|FG002|Overall Study|Withdrawal by Subject|19|||
147333457|NCT03622580|531387720|FG000|Overall Study|Lost to Follow-up|12|||
147333458|NCT03622580|531387721|FG001|Overall Study|Lost to Follow-up|9|||
147333459|NCT03622580|531387722|FG002|Overall Study|Lost to Follow-up|9|||
147333460|NCT03622580|531387720|FG000|Overall Study|Protocol Violation|1|||
147333461|NCT03622580|531387721|FG001|Overall Study|Protocol Violation|0|||
147450366|NCT03016325|531811402|FG003|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0|||
147450367|NCT03016325|531811403|FG004|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|0|||
147271259|NCT03107988|531162706|FG003|Overall Study|Disease Progression or Relapse|5|||
147271260|NCT03107988|531162707|FG004|Overall Study|Disease Progression or Relapse|1|||
147271261|NCT03107988|531162708|FG005|Overall Study|Disease Progression or Relapse|1|||
147271262|NCT03107988|531162709|FG006|Overall Study|Disease Progression or Relapse|0|||
147450368|NCT03016325|531811404|FG005|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|5|||
147450369|NCT03016325|531811405|FG006|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|3|||
147450370|NCT03016325|531811406|FG007|182-Day Follow-Up Period|No cont D182 FU, Sponsor admin reason|4|||
147450371|NCT03681119|531811407|FG000|Overall Study|No specific reason|4|||
147450372|NCT03681119|531811408|FG001|Overall Study|No specific reason|0|||
147450373|NCT03681119|531811407|FG000|Overall Study|Sickness|2|||
147450374|NCT03681119|531811408|FG001|Overall Study|Sickness|0|||
147271263|NCT03107988|531162710|FG007|Overall Study|Disease Progression or Relapse|0|||
147271264|NCT03107988|531162711|FG008|Overall Study|Disease Progression or Relapse|0|||
147271265|NCT03107988|531162712|FG009|Overall Study|Disease Progression or Relapse|1|||
147271266|NCT03107988|531162713|FG010|Overall Study|Disease Progression or Relapse|4|||
147271267|NCT03107988|531162714|FG011|Overall Study|Disease Progression or Relapse|0|||
147333462|NCT03622580|531387722|FG002|Overall Study|Protocol Violation|1|||
147333463|NCT03622580|531387720|FG000|Overall Study|Physician Decision|3|||
147333464|NCT03622580|531387721|FG001|Overall Study|Physician Decision|0|||
147271268|NCT03107988|531162715|FG012|Overall Study|Disease Progression or Relapse|0|||
147450375|NCT00109707|531811413|FG000|Overall Study|Discontinued in core study without entering the extension study|215|||
147527210|NCT01004822|532084172|FG005|Overall Study|Objective progression or relapse|2|||
147271269|NCT03107988|531162703|FG000|Overall Study|Ineligible|0|||
147271270|NCT03107988|531162704|FG001|Overall Study|Ineligible|0|||
147271271|NCT03107988|531162705|FG002|Overall Study|Ineligible|0|||
147450376|NCT00109707|531811414|FG001|Overall Study|Discontinued in core study without entering the extension study|122|||
147450377|NCT00109707|531811415|FG002|Overall Study|Discontinued in core study without entering the extension study|34|||
147450378|NCT00109707|531811413|FG000|Overall Study|Abnormal laboratory values|1|||
147450379|NCT00109707|531811414|FG001|Overall Study|Abnormal laboratory values|0|||
147450380|NCT00109707|531811415|FG002|Overall Study|Abnormal laboratory values|0|||
147450381|NCT00109707|531811413|FG000|Overall Study|Administrative problems|2|||
147450382|NCT00109707|531811414|FG001|Overall Study|Administrative problems|0|||
147450383|NCT00109707|531811415|FG002|Overall Study|Administrative problems|1|||
147333465|NCT03622580|531387722|FG002|Overall Study|Physician Decision|1|||
147333466|NCT03622580|531387720|FG000|Overall Study|Pregnancy|0|||
147333467|NCT03622580|531387721|FG001|Overall Study|Pregnancy|1|||
147333468|NCT03622580|531387722|FG002|Overall Study|Pregnancy|0|||
147333469|NCT03622580|531387720|FG000|Overall Study|Lack of Efficacy|0|||
147333470|NCT03622580|531387721|FG001|Overall Study|Lack of Efficacy|0|||
147333471|NCT03622580|531387722|FG002|Overall Study|Lack of Efficacy|1|||
147333472|NCT03622580|531387720|FG000|Overall Study|Other|2|||
147333473|NCT03622580|531387721|FG001|Overall Study|Other|0|||
147333474|NCT03622580|531387722|FG002|Overall Study|Other|3|||
147271272|NCT03107988|531162706|FG003|Overall Study|Ineligible|0|||
147271273|NCT03107988|531162707|FG004|Overall Study|Ineligible|0|||
147271274|NCT03107988|531162708|FG005|Overall Study|Ineligible|0|||
147271275|NCT03107988|531162709|FG006|Overall Study|Ineligible|0|||
147271276|NCT03107988|531162710|FG007|Overall Study|Ineligible|0|||
147271277|NCT03107988|531162711|FG008|Overall Study|Ineligible|1|||
147271278|NCT03107988|531162712|FG009|Overall Study|Ineligible|0|||
147271279|NCT03107988|531162713|FG010|Overall Study|Ineligible|0|||
147271280|NCT03107988|531162714|FG011|Overall Study|Ineligible|0|||
147271281|NCT03107988|531162715|FG012|Overall Study|Ineligible|0|||
147271282|NCT04709237|531162717|FG000|Overall Study|Lost to Follow-up|1|||
147271283|NCT04709237|531162718|FG001|Overall Study|Lost to Follow-up|0|||
147271284|NCT04709237|531162719|FG002|Overall Study|Lost to Follow-up|0|||
147271285|NCT02610192|531162720|FG000|Overall Study|Received other treatment|8|||
147271286|NCT02610192|531162720|FG000|Overall Study|Physician Decision|1|||
147271287|NCT01344057|531162722|FG000|Overall Study|Premature Withdrawal|1|||
147271288|NCT00145509|531162723|FG000|Overall Study|Adverse Event|10|||
147271289|NCT00145509|531162724|FG001|Overall Study|Adverse Event|3|||
147271290|NCT00145509|531162723|FG000|Overall Study|Lack of Efficacy|3|||
147271291|NCT00145509|531162724|FG001|Overall Study|Lack of Efficacy|1|||
147271292|NCT00145509|531162723|FG000|Overall Study|Lost to Follow-up|5|||
147271293|NCT00145509|531162724|FG001|Overall Study|Lost to Follow-up|9|||
147271294|NCT00145509|531162723|FG000|Overall Study|Withdrew Consent|2|||
147271295|NCT00145509|531162724|FG001|Overall Study|Withdrew Consent|7|||
147271296|NCT00145509|531162723|FG000|Overall Study|Reason not provided|2|||
147271297|NCT00145509|531162724|FG001|Overall Study|Reason not provided|1|||
147271298|NCT01359592|531162725|FG000|Initial Registration|Adverse Event|1|||
147271299|NCT01359592|531162726|FG001|Initial Registration|Adverse Event|0|||
147271300|NCT01359592|531162727|FG002|Initial Registration|Adverse Event|0|||
147271301|NCT01359592|531162728|FG003|Initial Registration|Adverse Event|0|||
147271302|NCT01359592|531162725|FG000|Initial Registration|Death|1|||
147271303|NCT01359592|531162726|FG001|Initial Registration|Death|0|||
147271304|NCT01359592|531162727|FG002|Initial Registration|Death|0|||
147271305|NCT01359592|531162728|FG003|Initial Registration|Death|0|||
147271306|NCT01359592|531162725|FG000|Initial Registration|Other reason not protocol specified|1|||
147271307|NCT01359592|531162726|FG001|Initial Registration|Other reason not protocol specified|0|||
147271308|NCT01359592|531162727|FG002|Initial Registration|Other reason not protocol specified|0|||
147271309|NCT01359592|531162728|FG003|Initial Registration|Other reason not protocol specified|0|||
147271310|NCT01359592|531162725|FG000|Initial Registration|Ineligible|26|||
147333475|NCT01930045|531387726|FG000|Pause (up to 37 Days)|Withdrawal by Subject|0|||
147450384|NCT00109707|531811413|FG000|Overall Study|Adverse Event|10|||
147450385|NCT00109707|531811414|FG001|Overall Study|Adverse Event|2|||
147450386|NCT00109707|531811415|FG002|Overall Study|Adverse Event|3|||
147450387|NCT00109707|531811413|FG000|Overall Study|Death|4|||
147271311|NCT01359592|531162726|FG001|Initial Registration|Ineligible|0|||
147271312|NCT01359592|531162727|FG002|Initial Registration|Ineligible|0|||
147271313|NCT01359592|531162728|FG003|Initial Registration|Ineligible|0|||
147271314|NCT01359592|531162725|FG000|PET-Directed Therapy|Adverse Event|0|||
147271315|NCT01359592|531162726|FG001|PET-Directed Therapy|Adverse Event|0|||
147271316|NCT01359592|531162727|FG002|PET-Directed Therapy|Adverse Event|1|||
147271317|NCT01359592|531162728|FG003|PET-Directed Therapy|Adverse Event|0|||
147333476|NCT01930045|531387727|FG001|Pause (up to 37 Days)|Withdrawal by Subject|0|||
147333477|NCT01930045|531387728|FG002|Pause (up to 37 Days)|Withdrawal by Subject|0|||
147333478|NCT01930045|531387729|FG003|Pause (up to 37 Days)|Withdrawal by Subject|0|||
147450388|NCT00109707|531811414|FG001|Overall Study|Death|0|||
147450389|NCT00109707|531811415|FG002|Overall Study|Death|0|||
147333479|NCT01930045|531387730|FG004|Pause (up to 37 Days)|Withdrawal by Subject|0|||
147271318|NCT01359592|531162725|FG000|PET-Directed Therapy|Refusal unrelated to adverse event|0|||
147271319|NCT01359592|531162726|FG001|PET-Directed Therapy|Refusal unrelated to adverse event|0|||
147271320|NCT01359592|531162727|FG002|PET-Directed Therapy|Refusal unrelated to adverse event|1|||
147333480|NCT01930045|531387731|FG005|Pause (up to 37 Days)|Withdrawal by Subject|1|||
147333481|NCT01930045|531387726|FG000|Pause (up to 37 Days)|Protocol Violation|0|||
147333482|NCT01930045|531387727|FG001|Pause (up to 37 Days)|Protocol Violation|0|||
147333483|NCT01930045|531387728|FG002|Pause (up to 37 Days)|Protocol Violation|0|||
147333484|NCT01930045|531387729|FG003|Pause (up to 37 Days)|Protocol Violation|0|||
147271321|NCT01359592|531162728|FG003|PET-Directed Therapy|Refusal unrelated to adverse event|0|||
147271322|NCT01359592|531162725|FG000|PET-Directed Therapy|Ineligible|0|||
147271323|NCT01359592|531162726|FG001|PET-Directed Therapy|Ineligible|0|||
147271324|NCT01359592|531162727|FG002|PET-Directed Therapy|Ineligible|24|||
147271325|NCT01359592|531162728|FG003|PET-Directed Therapy|Ineligible|0|||
147271326|NCT00749775|531162735|FG000|Overall Study|Protocol Violation|24|||
147271327|NCT00749775|531162735|FG000|Overall Study|Lost to Follow-up|36|||
147271328|NCT00749775|531162735|FG000|Overall Study|No visit after first day of treatment|44|||
147333485|NCT01930045|531387730|FG004|Pause (up to 37 Days)|Protocol Violation|0|||
147271329|NCT00749775|531162735|FG000|Overall Study|No drug administration|3|||
147271330|NCT02506816|531162740|FG000|Overall Study|Adverse Event|3|||
147271331|NCT03019627|531162741|FG000|Overall Study|Adverse Event|8|||
147271332|NCT03019627|531162742|FG001|Overall Study|Adverse Event|0|||
147271333|NCT03019627|531162741|FG000|Overall Study|Unrelated to adverse event|1|||
147271334|NCT03019627|531162742|FG001|Overall Study|Unrelated to adverse event|3|||
147271335|NCT03019627|531162741|FG000|Overall Study|Lost to Follow-up|2|||
147271336|NCT03019627|531162742|FG001|Overall Study|Lost to Follow-up|1|||
147271337|NCT03019627|531162741|FG000|Overall Study|not compliance|2|||
147271338|NCT03019627|531162742|FG001|Overall Study|not compliance|2|||
147271339|NCT03019627|531162741|FG000|Overall Study|Other|2|||
147271340|NCT03019627|531162742|FG001|Overall Study|Other|2|||
147271341|NCT01340976|531162745|FG000|Overall Study|Physician Decision|2|||
147271342|NCT01340976|531162746|FG001|Overall Study|Physician Decision|0|||
147271343|NCT01340976|531162747|FG002|Overall Study|Physician Decision|1|||
147271344|NCT01340976|531162748|FG003|Overall Study|Physician Decision|1|||
147271345|NCT01340976|531162749|FG004|Overall Study|Physician Decision|1|||
147271346|NCT01340976|531162750|FG005|Overall Study|Physician Decision|0|||
147271347|NCT01340976|531162745|FG000|Overall Study|Death|0|||
147271348|NCT01340976|531162746|FG001|Overall Study|Death|1|||
147271349|NCT01340976|531162747|FG002|Overall Study|Death|0|||
147271350|NCT01340976|531162748|FG003|Overall Study|Death|0|||
147271351|NCT01340976|531162749|FG004|Overall Study|Death|0|||
147271352|NCT01340976|531162750|FG005|Overall Study|Death|0|||
147271353|NCT01340976|531162745|FG000|Overall Study|Dose Limiting Toxicity Stopping Rule|1|||
147271354|NCT01340976|531162746|FG001|Overall Study|Dose Limiting Toxicity Stopping Rule|0|||
147271355|NCT01340976|531162747|FG002|Overall Study|Dose Limiting Toxicity Stopping Rule|0|||
147271356|NCT01340976|531162748|FG003|Overall Study|Dose Limiting Toxicity Stopping Rule|0|||
147271357|NCT01340976|531162749|FG004|Overall Study|Dose Limiting Toxicity Stopping Rule|0|||
147271358|NCT01340976|531162750|FG005|Overall Study|Dose Limiting Toxicity Stopping Rule|0|||
147271359|NCT01340976|531162745|FG000|Overall Study|Withdrawal by Subject|0|||
147271360|NCT01340976|531162746|FG001|Overall Study|Withdrawal by Subject|0|||
147271361|NCT01340976|531162747|FG002|Overall Study|Withdrawal by Subject|0|||
147271362|NCT01340976|531162748|FG003|Overall Study|Withdrawal by Subject|1|||
147271363|NCT01340976|531162749|FG004|Overall Study|Withdrawal by Subject|1|||
147271364|NCT01340976|531162750|FG005|Overall Study|Withdrawal by Subject|0|||
147271365|NCT01340976|531162745|FG000|Overall Study|Other anemia treatment|1|||
147271366|NCT01340976|531162746|FG001|Overall Study|Other anemia treatment|0|||
147271367|NCT01340976|531162747|FG002|Overall Study|Other anemia treatment|2|||
147271368|NCT01340976|531162748|FG003|Overall Study|Other anemia treatment|1|||
147271369|NCT01340976|531162749|FG004|Overall Study|Other anemia treatment|0|||
147271370|NCT01340976|531162750|FG005|Overall Study|Other anemia treatment|1|||
147271371|NCT01340976|531162745|FG000|Overall Study|Adverse Event|0|||
147271372|NCT01340976|531162746|FG001|Overall Study|Adverse Event|1|||
147333486|NCT01930045|531387731|FG005|Pause (up to 37 Days)|Protocol Violation|1|||
147333487|NCT00241644|531387732|FG000|First Efficacy Period (Year 1)|Adverse Event|46|||
147333488|NCT00241644|531387733|FG001|First Efficacy Period (Year 1)|Adverse Event|45|||
147333489|NCT00241644|531387734|FG002|First Efficacy Period (Year 1)|Adverse Event|45|||
147333490|NCT00241644|531387735|FG003|First Efficacy Period (Year 1)|Adverse Event|91|||
147333491|NCT00241644|531387732|FG000|First Efficacy Period (Year 1)|Protocol Violation|3|||
147450390|NCT00109707|531811413|FG000|Overall Study|Disease progression|12|||
147271373|NCT01340976|531162747|FG002|Overall Study|Adverse Event|0|||
147271374|NCT01340976|531162748|FG003|Overall Study|Adverse Event|0|||
147271375|NCT01340976|531162749|FG004|Overall Study|Adverse Event|0|||
147271376|NCT01340976|531162750|FG005|Overall Study|Adverse Event|0|||
147271377|NCT02953821|531162751|FG000|Overall Study|Adverse Event|0|||
147271378|NCT02953821|531162752|FG001|Overall Study|Adverse Event|4|||
147271379|NCT02953821|531162751|FG000|Overall Study|Death|1|||
147271380|NCT02953821|531162752|FG001|Overall Study|Death|0|||
147271381|NCT02953821|531162751|FG000|Overall Study|Progressive Disease|5|||
147271382|NCT02953821|531162752|FG001|Overall Study|Progressive Disease|1|||
147271383|NCT02953821|531162751|FG000|Overall Study|Lost to Follow-up|2|||
147271384|NCT02953821|531162752|FG001|Overall Study|Lost to Follow-up|0|||
147271385|NCT02953821|531162751|FG000|Overall Study|Physician Decision|1|||
147271386|NCT02953821|531162752|FG001|Overall Study|Physician Decision|1|||
147271387|NCT02953821|531162751|FG000|Overall Study|Withdrawal by Subject|3|||
147271388|NCT02953821|531162752|FG001|Overall Study|Withdrawal by Subject|3|||
147271389|NCT02953821|531162751|FG000|Overall Study|Change of address|0|||
147271390|NCT02953821|531162752|FG001|Overall Study|Change of address|1|||
147271391|NCT02953821|531162751|FG000|Overall Study|Lack of Efficacy|1|||
147271392|NCT02953821|531162752|FG001|Overall Study|Lack of Efficacy|0|||
147271393|NCT02953821|531162751|FG000|Overall Study|Out of state for indeterminate time|0|||
147271394|NCT02953821|531162752|FG001|Overall Study|Out of state for indeterminate time|1|||
147271395|NCT02953821|531162751|FG000|Overall Study|No improvement|0|||
147271396|NCT02953821|531162752|FG001|Overall Study|No improvement|1|||
147271397|NCT02953821|531162751|FG000|Overall Study|Refused follow-up visit|2|||
147271398|NCT02953821|531162752|FG001|Overall Study|Refused follow-up visit|1|||
147271399|NCT01067352|531162753|FG000|Overall Study|Withdrawal by Subject|1|||
147271400|NCT01067352|531162754|FG001|Overall Study|Withdrawal by Subject|2|||
147271401|NCT01067352|531162755|FG002|Overall Study|Withdrawal by Subject|1|||
147271402|NCT01067352|531162753|FG000|Overall Study|Physician Decision|0|||
147271403|NCT01067352|531162754|FG001|Overall Study|Physician Decision|1|||
147271404|NCT01067352|531162755|FG002|Overall Study|Physician Decision|0|||
147271405|NCT02103478|531162756|FG000|Overall Study|Adverse Event|0|||
147271406|NCT02103478|531162757|FG001|Overall Study|Adverse Event|0|||
147271407|NCT02103478|531162758|FG002|Overall Study|Adverse Event|1|||
147271408|NCT02103478|531162759|FG003|Overall Study|Adverse Event|1|||
147271409|NCT02103478|531162760|FG004|Overall Study|Adverse Event|2|||
147271410|NCT02103478|531162761|FG005|Overall Study|Adverse Event|1|||
147271411|NCT02103478|531162762|FG006|Overall Study|Adverse Event|0|||
147271412|NCT02103478|531162763|FG007|Overall Study|Adverse Event|0|||
147271413|NCT02103478|531162764|FG008|Overall Study|Adverse Event|0|||
147271414|NCT02103478|531162756|FG000|Overall Study|Death|2|||
147271415|NCT02103478|531162757|FG001|Overall Study|Death|2|||
147333492|NCT00241644|531387733|FG001|First Efficacy Period (Year 1)|Protocol Violation|5|||
147333493|NCT00241644|531387734|FG002|First Efficacy Period (Year 1)|Protocol Violation|4|||
147333494|NCT00241644|531387735|FG003|First Efficacy Period (Year 1)|Protocol Violation|8|||
147333495|NCT00241644|531387732|FG000|First Efficacy Period (Year 1)|Withdrawal by Subject|59|||
147271416|NCT02103478|531162758|FG002|Overall Study|Death|1|||
147271417|NCT02103478|531162759|FG003|Overall Study|Death|1|||
147271418|NCT02103478|531162760|FG004|Overall Study|Death|5|||
147271419|NCT02103478|531162761|FG005|Overall Study|Death|15|||
147271420|NCT02103478|531162762|FG006|Overall Study|Death|14|||
147271421|NCT02103478|531162763|FG007|Overall Study|Death|10|||
147271422|NCT02103478|531162764|FG008|Overall Study|Death|11|||
147271423|NCT02103478|531162756|FG000|Overall Study|Progressive Disease|2|||
147271424|NCT02103478|531162757|FG001|Overall Study|Progressive Disease|1|||
147271425|NCT02103478|531162758|FG002|Overall Study|Progressive Disease|2|||
147271426|NCT02103478|531162759|FG003|Overall Study|Progressive Disease|0|||
147271427|NCT02103478|531162760|FG004|Overall Study|Progressive Disease|9|||
147271428|NCT02103478|531162761|FG005|Overall Study|Progressive Disease|1|||
147271429|NCT02103478|531162762|FG006|Overall Study|Progressive Disease|2|||
147271430|NCT02103478|531162763|FG007|Overall Study|Progressive Disease|0|||
147271431|NCT02103478|531162764|FG008|Overall Study|Progressive Disease|1|||
147271432|NCT02103478|531162756|FG000|Overall Study|Withdrawal by Subject|2|||
147271433|NCT02103478|531162757|FG001|Overall Study|Withdrawal by Subject|0|||
147271434|NCT02103478|531162758|FG002|Overall Study|Withdrawal by Subject|0|||
147271435|NCT02103478|531162759|FG003|Overall Study|Withdrawal by Subject|4|||
147271436|NCT02103478|531162760|FG004|Overall Study|Withdrawal by Subject|0|||
147271437|NCT02103478|531162761|FG005|Overall Study|Withdrawal by Subject|0|||
147271438|NCT02103478|531162762|FG006|Overall Study|Withdrawal by Subject|1|||
147333496|NCT00241644|531387733|FG001|First Efficacy Period (Year 1)|Withdrawal by Subject|74|||
147450391|NCT00109707|531811414|FG001|Overall Study|Disease progression|4|||
147271439|NCT02103478|531162763|FG007|Overall Study|Withdrawal by Subject|1|||
147271440|NCT02103478|531162764|FG008|Overall Study|Withdrawal by Subject|0|||
147271441|NCT02103478|531162756|FG000|Overall Study|Lost to Follow-up|0|||
147271442|NCT02103478|531162757|FG001|Overall Study|Lost to Follow-up|0|||
147271443|NCT02103478|531162758|FG002|Overall Study|Lost to Follow-up|0|||
147271444|NCT02103478|531162759|FG003|Overall Study|Lost to Follow-up|0|||
147271445|NCT02103478|531162760|FG004|Overall Study|Lost to Follow-up|0|||
147271446|NCT02103478|531162761|FG005|Overall Study|Lost to Follow-up|0|||
147271447|NCT02103478|531162762|FG006|Overall Study|Lost to Follow-up|0|||
147271448|NCT02103478|531162763|FG007|Overall Study|Lost to Follow-up|1|||
147271449|NCT02103478|531162764|FG008|Overall Study|Lost to Follow-up|0|||
147271450|NCT02103478|531162756|FG000|Overall Study|Other|1|||
147271451|NCT02103478|531162757|FG001|Overall Study|Other|3|||
147271452|NCT02103478|531162758|FG002|Overall Study|Other|2|||
147271453|NCT02103478|531162759|FG003|Overall Study|Other|0|||
147271454|NCT02103478|531162760|FG004|Overall Study|Other|3|||
147271455|NCT02103478|531162761|FG005|Overall Study|Other|8|||
147333497|NCT00241644|531387734|FG002|First Efficacy Period (Year 1)|Withdrawal by Subject|81|||
147333498|NCT00241644|531387735|FG003|First Efficacy Period (Year 1)|Withdrawal by Subject|133|||
147271456|NCT02103478|531162762|FG006|Overall Study|Other|8|||
147271457|NCT02103478|531162763|FG007|Overall Study|Other|4|||
147271458|NCT02103478|531162764|FG008|Overall Study|Other|2|||
147271459|NCT00723606|531162765|FG000|Overall Study|Adverse Event|2|||
147271460|NCT00723606|531162766|FG001|Overall Study|Adverse Event|5|||
147271461|NCT00723606|531162765|FG000|Overall Study|Other|2|||
147271462|NCT00723606|531162766|FG001|Overall Study|Other|0|||
147271463|NCT00723606|531162765|FG000|Overall Study|Withdrawal by Subject|0|||
147271464|NCT00723606|531162766|FG001|Overall Study|Withdrawal by Subject|2|||
147271465|NCT02566759|531162767|FG000|All Parts|Withdrawal by Subject|0|||
147271466|NCT02566759|531162768|FG001|All Parts|Withdrawal by Subject|1|||
147271467|NCT02566759|531162769|FG002|All Parts|Withdrawal by Subject|0|||
147271468|NCT02566759|531162770|FG003|All Parts|Withdrawal by Subject|0|||
147271469|NCT02566759|531162771|FG004|All Parts|Withdrawal by Subject|0|||
147271470|NCT02566759|531162772|FG005|All Parts|Withdrawal by Subject|0|||
147271471|NCT02566759|531162773|FG006|All Parts|Withdrawal by Subject|0|||
147271472|NCT02566759|531162774|FG007|All Parts|Withdrawal by Subject|0|||
147271473|NCT02566759|531162775|FG008|All Parts|Withdrawal by Subject|0|||
147271474|NCT02566759|531162776|FG009|All Parts|Withdrawal by Subject|0|||
147271475|NCT02566759|531162777|FG010|All Parts|Withdrawal by Subject|0|||
147271476|NCT02566759|531162778|FG011|All Parts|Withdrawal by Subject|0|||
147271477|NCT02566759|531162779|FG012|All Parts|Withdrawal by Subject|0|||
147271478|NCT02566759|531162780|FG013|All Parts|Withdrawal by Subject|0|||
147271479|NCT02566759|531162781|FG014|All Parts|Withdrawal by Subject|0|||
147271480|NCT02566759|531162782|FG015|All Parts|Withdrawal by Subject|0|||
147271481|NCT02566759|531162783|FG016|All Parts|Withdrawal by Subject|0|||
147271482|NCT02566759|531162767|FG000|All Parts|Adverse Event|0|||
147271483|NCT02566759|531162768|FG001|All Parts|Adverse Event|0|||
147271484|NCT02566759|531162769|FG002|All Parts|Adverse Event|0|||
147271485|NCT02566759|531162770|FG003|All Parts|Adverse Event|0|||
147271486|NCT02566759|531162771|FG004|All Parts|Adverse Event|0|||
147271487|NCT02566759|531162772|FG005|All Parts|Adverse Event|0|||
147271488|NCT02566759|531162773|FG006|All Parts|Adverse Event|0|||
147271489|NCT02566759|531162774|FG007|All Parts|Adverse Event|0|||
147271490|NCT02566759|531162775|FG008|All Parts|Adverse Event|0|||
147271491|NCT02566759|531162776|FG009|All Parts|Adverse Event|0|||
147271492|NCT02566759|531162777|FG010|All Parts|Adverse Event|0|||
147271493|NCT02566759|531162778|FG011|All Parts|Adverse Event|0|||
147271494|NCT02566759|531162779|FG012|All Parts|Adverse Event|1|||
147271495|NCT02566759|531162780|FG013|All Parts|Adverse Event|3|||
147271496|NCT02566759|531162781|FG014|All Parts|Adverse Event|0|||
147271497|NCT02566759|531162782|FG015|All Parts|Adverse Event|0|||
147271498|NCT02566759|531162783|FG016|All Parts|Adverse Event|0|||
147271499|NCT02566759|531162767|FG000|All Parts|Other|0|||
147271500|NCT02566759|531162768|FG001|All Parts|Other|0|||
147271501|NCT02566759|531162769|FG002|All Parts|Other|0|||
147271502|NCT02566759|531162770|FG003|All Parts|Other|0|||
147271503|NCT02566759|531162771|FG004|All Parts|Other|0|||
147271504|NCT02566759|531162772|FG005|All Parts|Other|0|||
147271505|NCT02566759|531162773|FG006|All Parts|Other|0|||
147271506|NCT02566759|531162774|FG007|All Parts|Other|0|||
147271507|NCT02566759|531162775|FG008|All Parts|Other|0|||
147271508|NCT02566759|531162776|FG009|All Parts|Other|0|||
147271509|NCT02566759|531162777|FG010|All Parts|Other|0|||
147271510|NCT02566759|531162778|FG011|All Parts|Other|0|||
147271511|NCT02566759|531162779|FG012|All Parts|Other|0|||
147271512|NCT02566759|531162780|FG013|All Parts|Other|2|||
147271513|NCT02566759|531162781|FG014|All Parts|Other|0|||
147271514|NCT02566759|531162782|FG015|All Parts|Other|0|||
147271515|NCT02566759|531162783|FG016|All Parts|Other|0|||
147271516|NCT02566759|531162767|FG000|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
147271517|NCT02566759|531162768|FG001|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
147271518|NCT02566759|531162769|FG002|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
147271519|NCT02566759|531162770|FG003|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
147271520|NCT02566759|531162771|FG004|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
147271521|NCT02566759|531162772|FG005|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
147271522|NCT02566759|531162773|FG006|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
147271523|NCT02566759|531162774|FG007|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
147271524|NCT02566759|531162775|FG008|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
147271525|NCT02566759|531162776|FG009|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
147271526|NCT02566759|531162777|FG010|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
147271527|NCT02566759|531162778|FG011|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
147271528|NCT02566759|531162779|FG012|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
147271529|NCT02566759|531162780|FG013|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
147271530|NCT02566759|531162781|FG014|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
147271531|NCT02566759|531162782|FG015|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|0|||
147271532|NCT02566759|531162783|FG016|Crossover Treatment (Part 4: 1 Day)|Withdrawal by Subject|1|||
147271533|NCT00976898|531162784|FG000|Overall Study|Protocol Violation|1|||
147271534|NCT00976898|531162784|FG000|Overall Study|Adverse Event|1|||
147271535|NCT00976898|531162784|FG000|Overall Study|Physician Decision|1|||
147271536|NCT00976898|531162784|FG000|Overall Study|Liver Transplant|1|||
147271537|NCT00976898|531162784|FG000|Overall Study|Progressive Disease|1|||
147271538|NCT05107128|531162785|FG000|Overall Study|Adverse Event|2|||
147271539|NCT05107128|531162786|FG001|Overall Study|Adverse Event|0|||
147271540|NCT05107128|531162785|FG000|Overall Study|Withdrawal by Subject|3|||
147271541|NCT05107128|531162786|FG001|Overall Study|Withdrawal by Subject|3|||
147271542|NCT05107128|531162785|FG000|Overall Study|Withdrawal of Consent|0|||
147271543|NCT05107128|531162786|FG001|Overall Study|Withdrawal of Consent|1|||
147271544|NCT05107128|531162785|FG000|Overall Study|Reason Not Specified|2|||
147271545|NCT05107128|531162786|FG001|Overall Study|Reason Not Specified|0|||
147271546|NCT01822132|531162789|FG000|Overall Study|Lost to Follow-up|4|||
147271547|NCT01822132|531162790|FG001|Overall Study|Lost to Follow-up|2|||
147271548|NCT01723228|531162792|FG000|Overall Study|Adverse Event|2|||
147271549|NCT01723228|531162793|FG001|Overall Study|Adverse Event|6|||
147271550|NCT01723228|531162792|FG000|Overall Study|Withdrawal by Subject|2|||
147271551|NCT01723228|531162793|FG001|Overall Study|Withdrawal by Subject|1|||
147271552|NCT01723228|531162792|FG000|Overall Study|Protocol Violation|0|||
147271553|NCT01723228|531162793|FG001|Overall Study|Protocol Violation|2|||
147271554|NCT01723228|531162792|FG000|Overall Study|Lost to Follow-up|2|||
147271555|NCT01723228|531162793|FG001|Overall Study|Lost to Follow-up|1|||
147271556|NCT01723228|531162792|FG000|Overall Study|Other|2|||
147271557|NCT01723228|531162793|FG001|Overall Study|Other|1|||
147271558|NCT02434770|531162794|FG000|Week 1 to Week 18|Lost to Follow-up|0|||
147271559|NCT02434770|531162795|FG001|Week 1 to Week 18|Lost to Follow-up|0|||
147271560|NCT02434770|531162796|FG002|Week 1 to Week 18|Lost to Follow-up|2|||
147271561|NCT02434770|531162794|FG000|Week 1 to Week 18|Withdrawal by Subject|6|||
147271562|NCT02434770|531162795|FG001|Week 1 to Week 18|Withdrawal by Subject|12|||
147271563|NCT02434770|531162796|FG002|Week 1 to Week 18|Withdrawal by Subject|5|||
147271564|NCT02434770|531162794|FG000|Week 1 to Week 18|Received Non-study Polio Vaccine|8|||
147271565|NCT02434770|531162795|FG001|Week 1 to Week 18|Received Non-study Polio Vaccine|10|||
147271566|NCT02434770|531162796|FG002|Week 1 to Week 18|Received Non-study Polio Vaccine|9|||
147271567|NCT02434770|531162794|FG000|Week 1 to Week 18|Relocated Out of Study Area|0|||
147271568|NCT02434770|531162795|FG001|Week 1 to Week 18|Relocated Out of Study Area|0|||
147271569|NCT02434770|531162796|FG002|Week 1 to Week 18|Relocated Out of Study Area|1|||
147271570|NCT02434770|531162794|FG000|Week 1 to Week 18|Death|1|||
147271571|NCT02434770|531162795|FG001|Week 1 to Week 18|Death|0|||
147271572|NCT02434770|531162796|FG002|Week 1 to Week 18|Death|0|||
147271573|NCT02434770|531162794|FG000|Week 18 to Week|Lost to Follow-up|2|||
147271574|NCT02434770|531162795|FG001|Week 18 to Week|Lost to Follow-up|2|||
147271575|NCT02434770|531162796|FG002|Week 18 to Week|Lost to Follow-up|1|||
147271576|NCT02434770|531162794|FG000|Week 18 to Week|Withdrawal by Subject|0|||
147271577|NCT02434770|531162795|FG001|Week 18 to Week|Withdrawal by Subject|0|||
147271578|NCT02434770|531162796|FG002|Week 18 to Week|Withdrawal by Subject|2|||
147271579|NCT02434770|531162794|FG000|Week 18 to Week|Received Non-study Polio Vaccine|6|||
147271580|NCT02434770|531162795|FG001|Week 18 to Week|Received Non-study Polio Vaccine|6|||
147271581|NCT02434770|531162796|FG002|Week 18 to Week|Received Non-study Polio Vaccine|3|||
147271582|NCT00660348|531162797|FG000|Overall Study|Withdrawal by Subject|1|||
147271583|NCT00660348|531162798|FG001|Overall Study|Withdrawal by Subject|0|||
147271584|NCT01282424|531162804|FG000|Treatment Period (TP) (81 Months)|Adverse Event|30|||
147271585|NCT01282424|531162804|FG000|Treatment Period (TP) (81 Months)|Withdrew Consent|6|||
147271586|NCT01282424|531162804|FG000|Treatment Period (TP) (81 Months)|Investigator Request|7|||
147271587|NCT01282424|531162804|FG000|Treatment Period (TP) (81 Months)|Other (Unknown)|3|||
147271588|NCT01282424|531162804|FG000|Long-term Follow-up Period (5 Years)|Withdrew Consent|2|||
147271589|NCT01282424|531162804|FG000|Long-term Follow-up Period (5 Years)|Death|40|||
147333499|NCT00241644|531387732|FG000|First Efficacy Period (Year 1)|Lost to Follow-up|116|||
147333500|NCT00241644|531387733|FG001|First Efficacy Period (Year 1)|Lost to Follow-up|142|||
147450392|NCT00109707|531811415|FG002|Overall Study|Disease progression|3|||
147271590|NCT01282424|531162804|FG000|Long-term Follow-up Period (5 Years)|Lost to Follow-up|1|||
147271591|NCT01282424|531162804|FG000|Long-term Follow-up Period (5 Years)|Other (Unknown)|21|||
147271592|NCT00528528|531162805|FG000|Overall Study|Lost to Follow-up|0|||
147271593|NCT00528528|531162806|FG001|Overall Study|Lost to Follow-up|0|||
147271594|NCT00528528|531162807|FG002|Overall Study|Lost to Follow-up|1|||
147271595|NCT00528528|531162808|FG003|Overall Study|Lost to Follow-up|1|||
147271596|NCT00528528|531162805|FG000|Overall Study|Ineligible to continue the trial|0|||
147271597|NCT00528528|531162806|FG001|Overall Study|Ineligible to continue the trial|0|||
147271598|NCT00528528|531162807|FG002|Overall Study|Ineligible to continue the trial|0|||
147271599|NCT00528528|531162808|FG003|Overall Study|Ineligible to continue the trial|1|||
147271600|NCT00528528|531162805|FG000|Overall Study|Other|0|||
147271601|NCT00528528|531162806|FG001|Overall Study|Other|1|||
147271602|NCT00528528|531162807|FG002|Overall Study|Other|0|||
147271603|NCT00528528|531162808|FG003|Overall Study|Other|0|||
147271604|NCT00528528|531162805|FG000|Overall Study|Withdrawal by Subject|3|||
147271605|NCT00528528|531162806|FG001|Overall Study|Withdrawal by Subject|2|||
147271606|NCT00528528|531162807|FG002|Overall Study|Withdrawal by Subject|1|||
147271607|NCT00528528|531162808|FG003|Overall Study|Withdrawal by Subject|1|||
147271608|NCT00528528|531162805|FG000|Overall Study|Ongoing participant|0|||
147333501|NCT00241644|531387734|FG002|First Efficacy Period (Year 1)|Lost to Follow-up|116|||
147450393|NCT00109707|531811413|FG000|Overall Study|Lost to Follow-up|3|||
147450394|NCT00109707|531811414|FG001|Overall Study|Lost to Follow-up|0|||
147450395|NCT00109707|531811415|FG002|Overall Study|Lost to Follow-up|0|||
147450396|NCT00109707|531811413|FG000|Overall Study|Protocol Violation|1|||
147450397|NCT00109707|531811414|FG001|Overall Study|Protocol Violation|0|||
147450398|NCT00109707|531811415|FG002|Overall Study|Protocol Violation|0|||
147450399|NCT00109707|531811413|FG000|Overall Study|Patient withdrew consent|6|||
147450400|NCT00109707|531811414|FG001|Overall Study|Patient withdrew consent|1|||
147450401|NCT00109707|531811415|FG002|Overall Study|Patient withdrew consent|0|||
147450402|NCT01618214|531811417|FG000|Overall Study|Adverse Event|3|||
147450403|NCT01618214|531811418|FG001|Overall Study|Adverse Event|1|||
147450404|NCT01618214|531811417|FG000|Overall Study|Lack of Efficacy|1|||
147450405|NCT01618214|531811418|FG001|Overall Study|Lack of Efficacy|1|||
147271609|NCT00528528|531162806|FG001|Overall Study|Ongoing participant|0|||
147271610|NCT00528528|531162807|FG002|Overall Study|Ongoing participant|1|||
147271611|NCT00528528|531162808|FG003|Overall Study|Ongoing participant|0|||
147271612|NCT03508219|531162809|FG000|Overall Study|Death|2|||
147271613|NCT03508219|531162809|FG000|Overall Study|Withdrawal by Subject|1|||
147271614|NCT03508219|531162809|FG000|Overall Study|Lost to Follow-up|4|||
147271615|NCT03508219|531162809|FG000|Overall Study|Missed visit|2|||
147271616|NCT04466891|531162810|FG000|Overall Study|Death|60|||
147271617|NCT04466891|531162811|FG001|Overall Study|Death|6|||
147271618|NCT04466891|531162810|FG000|Overall Study|Withdrawal by Subject|8|||
147271619|NCT04466891|531162811|FG001|Overall Study|Withdrawal by Subject|1|||
147271620|NCT04466891|531162810|FG000|Overall Study|Study terminated by sponsor|5|||
147271621|NCT04466891|531162811|FG001|Overall Study|Study terminated by sponsor|0|||
147271622|NCT04466891|531162810|FG000|Overall Study|Lost to Follow-up|2|||
147271623|NCT04466891|531162811|FG001|Overall Study|Lost to Follow-up|0|||
147271624|NCT04466891|531162810|FG000|Overall Study|Transitioned to Named Patient Supply (NPS) program|5|||
147271625|NCT04466891|531162811|FG001|Overall Study|Transitioned to Named Patient Supply (NPS) program|0|||
147450406|NCT01618214|531811417|FG000|Overall Study|Protocol Violation|1|||
147271626|NCT00445328|531162812|FG000|Overall Study|Death|0|||
147271627|NCT00445328|531162813|FG001|Overall Study|Death|1|||
147271628|NCT00445328|531162812|FG000|Overall Study|Adverse Event|0|||
147271629|NCT00445328|531162813|FG001|Overall Study|Adverse Event|3|||
147271630|NCT00445328|531162812|FG000|Overall Study|Other|0|||
147271631|NCT00445328|531162813|FG001|Overall Study|Other|2|||
147271632|NCT00445328|531162812|FG000|Overall Study|Withdrawal by Subject|2|||
147271633|NCT00445328|531162813|FG001|Overall Study|Withdrawal by Subject|0|||
147271634|NCT00445328|531162812|FG000|Overall Study|Protocol Violation|1|||
147271635|NCT00445328|531162813|FG001|Overall Study|Protocol Violation|0|||
147271636|NCT00316199|531162814|FG000|Overall Study|Adverse Event|2|||
147271637|NCT00316199|531162814|FG000|Overall Study|Death|8|||
147271638|NCT00316199|531162814|FG000|Overall Study|Lost to Follow-up|2|||
147271639|NCT00590954|531162815|FG000|Overall Study|Inevaluable|2|||
147271640|NCT02782949|531162817|FG000|Overall Study|Protocol Violation|1|||
147271641|NCT02782949|531162818|FG001|Overall Study|Protocol Violation|0|||
147271642|NCT02782949|531162817|FG000|Overall Study|Withdrawal by Subject|0|||
147271643|NCT02782949|531162818|FG001|Overall Study|Withdrawal by Subject|1|||
147271644|NCT03316872|531162819|FG000|Overall Study|Death|1|||
147271645|NCT04074317|531162822|FG000|Third Period|Withdrawal by Subject|0|||
147271646|NCT04074317|531162823|FG001|Third Period|Withdrawal by Subject|0|||
147271647|NCT04074317|531162824|FG002|Third Period|Withdrawal by Subject|0|||
147271648|NCT04074317|531162825|FG003|Third Period|Withdrawal by Subject|1|||
147271649|NCT04074317|531162826|FG004|Third Period|Withdrawal by Subject|0|||
147271650|NCT04074317|531162827|FG005|Third Period|Withdrawal by Subject|0|||
147271651|NCT06023394|531162828|FG000|Overall Study|Surgery was not performed laparoscopically|4|||
147271652|NCT06023394|531162829|FG001|Overall Study|Surgery was not performed laparoscopically|2|||
147271653|NCT06023394|531162828|FG000|Overall Study|Surgery not performed (hernia not identified on diagnostic laparoscopy)|0|||
147271654|NCT06023394|531162829|FG001|Overall Study|Surgery not performed (hernia not identified on diagnostic laparoscopy)|3|||
147271655|NCT06023394|531162828|FG000|Overall Study|Did not receive allocated intervention (Patient received ETT per surgeon)|1|||
147271656|NCT06023394|531162829|FG001|Overall Study|Did not receive allocated intervention (Patient received ETT per surgeon)|0|||
147271657|NCT06023394|531162828|FG000|Overall Study|Did not received allocated intervention (no airway device documented in EMR)|1|||
147271658|NCT06023394|531162829|FG001|Overall Study|Did not received allocated intervention (no airway device documented in EMR)|1|||
147271659|NCT03548584|531164348|FG000|Overall Study|Lost to Follow-up|0|||
147271660|NCT03548584|531164349|FG001|Overall Study|Lost to Follow-up|0|||
147271661|NCT03548584|531164350|FG002|Overall Study|Lost to Follow-up|1|||
147450407|NCT01618214|531811418|FG001|Overall Study|Protocol Violation|4|||
147450408|NCT01618214|531811417|FG000|Overall Study|Withdrawal Criteria|1|||
147450409|NCT01618214|531811418|FG001|Overall Study|Withdrawal Criteria|2|||
147271662|NCT03548584|531164348|FG000|Overall Study|Adverse Event|1|||
147271663|NCT03548584|531164349|FG001|Overall Study|Adverse Event|11|||
147271664|NCT03548584|531164350|FG002|Overall Study|Adverse Event|5|||
147271665|NCT03548584|531164348|FG000|Overall Study|Site Terminated by Sponsor|1|||
147271666|NCT03548584|531164349|FG001|Overall Study|Site Terminated by Sponsor|3|||
147271667|NCT03548584|531164350|FG002|Overall Study|Site Terminated by Sponsor|2|||
147450410|NCT01618214|531811417|FG000|Overall Study|Unclassified|4|||
147450411|NCT01618214|531811418|FG001|Overall Study|Unclassified|5|||
147450412|NCT03436862|531811420|FG000|Overall Study|Adverse Event|4|||
147450413|NCT03436862|531811420|FG000|Overall Study|Progressive Disease|2|||
147450414|NCT02937818|531811421|FG000|Overall Study|Participants decision|2|||
147450415|NCT02937818|531811422|FG001|Overall Study|Participants decision|1|||
147450416|NCT02937818|531811423|FG002|Overall Study|Participants decision|1|||
147450417|NCT02937818|531811424|FG003|Overall Study|Participants decision|1|||
147450418|NCT02937818|531811421|FG000|Overall Study|Adverse Event|2|||
147450419|NCT02937818|531811422|FG001|Overall Study|Adverse Event|4|||
147450420|NCT02937818|531811423|FG002|Overall Study|Adverse Event|1|||
147450421|NCT02937818|531811424|FG003|Overall Study|Adverse Event|1|||
147450422|NCT02937818|531811421|FG000|Overall Study|Disease progression|17|||
147450423|NCT02937818|531811422|FG001|Overall Study|Disease progression|15|||
147450424|NCT02937818|531811423|FG002|Overall Study|Disease progression|7|||
147450425|NCT02937818|531811424|FG003|Overall Study|Disease progression|19|||
147450426|NCT02937818|531811421|FG000|Overall Study|Condition under investigation worsened|0|||
147450427|NCT02937818|531811422|FG001|Overall Study|Condition under investigation worsened|0|||
147450428|NCT02937818|531811423|FG002|Overall Study|Condition under investigation worsened|1|||
147450429|NCT02937818|531811424|FG003|Overall Study|Condition under investigation worsened|0|||
147450430|NCT01929408|531811426|FG000|Overall Study|received HCT as initial treatment|8|||
147450431|NCT00391222|531811429|FG000|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|0|||
147450432|NCT00391222|531811430|FG001|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|0|||
147450433|NCT00391222|531811431|FG002|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|0|||
147450434|NCT00391222|531811432|FG003|Period II (Open-label Risperidone LAI)|Withdrawal by Subject|26|||
147450435|NCT00391222|531811429|FG000|Period II (Open-label Risperidone LAI)|Lost to Follow-up|0|||
147450436|NCT00391222|531811430|FG001|Period II (Open-label Risperidone LAI)|Lost to Follow-up|0|||
147450437|NCT00391222|531811431|FG002|Period II (Open-label Risperidone LAI)|Lost to Follow-up|0|||
147450438|NCT00391222|531811432|FG003|Period II (Open-label Risperidone LAI)|Lost to Follow-up|5|||
147450439|NCT00391222|531811429|FG000|Period II (Open-label Risperidone LAI)|Adverse Event|0|||
147450440|NCT00391222|531811430|FG001|Period II (Open-label Risperidone LAI)|Adverse Event|0|||
147450441|NCT00391222|531811431|FG002|Period II (Open-label Risperidone LAI)|Adverse Event|0|||
147450442|NCT00391222|531811432|FG003|Period II (Open-label Risperidone LAI)|Adverse Event|10|||
147450443|NCT00391222|531811429|FG000|Period II (Open-label Risperidone LAI)|Non-responder|0|||
147450444|NCT00391222|531811430|FG001|Period II (Open-label Risperidone LAI)|Non-responder|0|||
147450445|NCT00391222|531811431|FG002|Period II (Open-label Risperidone LAI)|Non-responder|0|||
147450446|NCT00391222|531811432|FG003|Period II (Open-label Risperidone LAI)|Non-responder|97|||
147450447|NCT00391222|531811429|FG000|Period II (Open-label Risperidone LAI)|Other|0|||
147450448|NCT00391222|531811430|FG001|Period II (Open-label Risperidone LAI)|Other|0|||
147450449|NCT00391222|531811431|FG002|Period II (Open-label Risperidone LAI)|Other|0|||
147450450|NCT00391222|531811432|FG003|Period II (Open-label Risperidone LAI)|Other|24|||
147450451|NCT00391222|531811429|FG000|Period III (Double-Blind Treatment)|Withdrawal by Subject|15|||
147450452|NCT00391222|531811430|FG001|Period III (Double-Blind Treatment)|Withdrawal by Subject|12|||
147450453|NCT00391222|531811431|FG002|Period III (Double-Blind Treatment)|Withdrawal by Subject|6|||
147450454|NCT00391222|531811432|FG003|Period III (Double-Blind Treatment)|Withdrawal by Subject|0|||
147450455|NCT00391222|531811429|FG000|Period III (Double-Blind Treatment)|Lost to Follow-up|2|||
147450456|NCT00391222|531811430|FG001|Period III (Double-Blind Treatment)|Lost to Follow-up|4|||
147450457|NCT00391222|531811431|FG002|Period III (Double-Blind Treatment)|Lost to Follow-up|4|||
147450458|NCT00391222|531811432|FG003|Period III (Double-Blind Treatment)|Lost to Follow-up|0|||
147450459|NCT00391222|531811429|FG000|Period III (Double-Blind Treatment)|Adverse Event|5|||
147450460|NCT00391222|531811430|FG001|Period III (Double-Blind Treatment)|Adverse Event|2|||
147450461|NCT00391222|531811431|FG002|Period III (Double-Blind Treatment)|Adverse Event|4|||
147450462|NCT00391222|531811432|FG003|Period III (Double-Blind Treatment)|Adverse Event|0|||
147450463|NCT00391222|531811429|FG000|Period III (Double-Blind Treatment)|Pregnancy|0|||
147450464|NCT00391222|531811430|FG001|Period III (Double-Blind Treatment)|Pregnancy|2|||
147450465|NCT00391222|531811431|FG002|Period III (Double-Blind Treatment)|Pregnancy|0|||
147450466|NCT00391222|531811432|FG003|Period III (Double-Blind Treatment)|Pregnancy|0|||
147450467|NCT00391222|531811429|FG000|Period III (Double-Blind Treatment)|Study Medication Non-compliant|0|||
147450468|NCT00391222|531811430|FG001|Period III (Double-Blind Treatment)|Study Medication Non-compliant|1|||
147450469|NCT00391222|531811431|FG002|Period III (Double-Blind Treatment)|Study Medication Non-compliant|3|||
147450470|NCT00391222|531811432|FG003|Period III (Double-Blind Treatment)|Study Medication Non-compliant|0|||
147450471|NCT00391222|531811429|FG000|Period III (Double-Blind Treatment)|Other|6|||
147450472|NCT00391222|531811430|FG001|Period III (Double-Blind Treatment)|Other|1|||
147450473|NCT00391222|531811431|FG002|Period III (Double-Blind Treatment)|Other|6|||
147450474|NCT00391222|531811432|FG003|Period III (Double-Blind Treatment)|Other|0|||
147662350|NCT01298700|532587301|FG001|Overall Study|Lack of Efficacy|14|||
147662351|NCT01298700|532587300|FG000|Overall Study|Lost to Follow-up|5|||
147271668|NCT03548584|531164348|FG000|Overall Study|Subject Withdrew Consent to Participate|5|||
147450475|NCT00689871|531811436|FG000|Overall Study|Lost to Follow-up|123|||
147662352|NCT01298700|532587301|FG001|Overall Study|Lost to Follow-up|2|||
147271669|NCT03548584|531164349|FG001|Overall Study|Subject Withdrew Consent to Participate|5|||
147271670|NCT03548584|531164350|FG002|Overall Study|Subject Withdrew Consent to Participate|3|||
147271671|NCT03548584|531164348|FG000|Overall Study|Lack of Efficacy|0|||
147271672|NCT03548584|531164349|FG001|Overall Study|Lack of Efficacy|1|||
147271673|NCT03548584|531164350|FG002|Overall Study|Lack of Efficacy|0|||
147271674|NCT03548584|531164348|FG000|Overall Study|Non-compliance with Study Drug|0|||
147271675|NCT03548584|531164349|FG001|Overall Study|Non-compliance with Study Drug|1|||
147271676|NCT03548584|531164350|FG002|Overall Study|Non-compliance with Study Drug|0|||
147271677|NCT03548584|531164348|FG000|Overall Study|Reason not Specified (Not Related to Coronavirus Disease 2019 [COVID-19])|0|||
147271678|NCT03548584|531164349|FG001|Overall Study|Reason not Specified (Not Related to Coronavirus Disease 2019 [COVID-19])|2|||
147271679|NCT03548584|531164350|FG002|Overall Study|Reason not Specified (Not Related to Coronavirus Disease 2019 [COVID-19])|2|||
147271680|NCT00533949|531164351|FG000|Overall Study|Protocol Violation|12|||
147271681|NCT00533949|531164352|FG001|Overall Study|Protocol Violation|12|||
147271682|NCT00533949|531164353|FG002|Overall Study|Protocol Violation|9|||
147271683|NCT00533949|531164354|FG003|Overall Study|Protocol Violation|9|||
147271684|NCT00533949|531164351|FG000|Overall Study|Withdrawal by Subject|3|||
147271685|NCT00533949|531164352|FG001|Overall Study|Withdrawal by Subject|2|||
147271686|NCT00533949|531164353|FG002|Overall Study|Withdrawal by Subject|1|||
147271687|NCT00533949|531164354|FG003|Overall Study|Withdrawal by Subject|1|||
147271688|NCT00727194|531164355|FG000|Screening Period|Low QMG scores|0|||
147271689|NCT00727194|531164356|FG001|Screening Period|Low QMG scores|0|||
147271690|NCT00727194|531164357|FG002|Screening Period|Low QMG scores|6|||
147271691|NCT00727194|531164355|FG000|Screening Period|Lacked AChR antibodies|0|||
147271692|NCT00727194|531164356|FG001|Screening Period|Lacked AChR antibodies|0|||
147271693|NCT00727194|531164357|FG002|Screening Period|Lacked AChR antibodies|5|||
147271694|NCT00727194|531164355|FG000|Screening Period|Not stable on concomitant MG therapy|0|||
147271695|NCT00727194|531164356|FG001|Screening Period|Not stable on concomitant MG therapy|0|||
147271696|NCT00727194|531164357|FG002|Screening Period|Not stable on concomitant MG therapy|2|||
147271697|NCT00727194|531164355|FG000|Screening Period|Severe infections|0|||
147271698|NCT00727194|531164356|FG001|Screening Period|Severe infections|0|||
147271699|NCT00727194|531164357|FG002|Screening Period|Severe infections|2|||
147271700|NCT00727194|531164355|FG000|Screening Period|History of thymoma|0|||
147271701|NCT00727194|531164356|FG001|Screening Period|History of thymoma|0|||
147271702|NCT00727194|531164357|FG002|Screening Period|History of thymoma|1|||
147271703|NCT00727194|531164355|FG000|Treatment Period 2|Lack of Efficacy|0|||
147271704|NCT00727194|531164356|FG001|Treatment Period 2|Lack of Efficacy|1|||
147271705|NCT00727194|531164357|FG002|Treatment Period 2|Lack of Efficacy|0|||
147271706|NCT04269161|531164358|FG000|Overall Study|Change of modality and no longer eligible|3|||
147271707|NCT04269161|531164359|FG001|Overall Study|Change of modality and no longer eligible|3|||
147271708|NCT04269161|531164358|FG000|Overall Study|Required procedure outside of NICU|1|||
147271709|NCT04269161|531164359|FG001|Overall Study|Required procedure outside of NICU|0|||
147271710|NCT04269161|531164358|FG000|Overall Study|Equipment issue|1|||
147271711|NCT04269161|531164359|FG001|Overall Study|Equipment issue|1|||
147271712|NCT01677195|531164360|FG000|Overall Study|Lost to Follow-up|14|||
147271713|NCT01677195|531164361|FG001|Overall Study|Lost to Follow-up|22|||
147271714|NCT01677195|531164362|FG002|Overall Study|Lost to Follow-up|22|||
147271715|NCT01677195|531164360|FG000|Overall Study|Withdrawal by Subject|1|||
147271716|NCT01677195|531164361|FG001|Overall Study|Withdrawal by Subject|0|||
147271717|NCT01677195|531164362|FG002|Overall Study|Withdrawal by Subject|1|||
147271718|NCT01677195|531164360|FG000|Overall Study|Adverse Event|6|||
147271719|NCT01677195|531164361|FG001|Overall Study|Adverse Event|4|||
147271720|NCT01677195|531164362|FG002|Overall Study|Adverse Event|1|||
147271721|NCT01677195|531164360|FG000|Overall Study|Physician Decision|1|||
147271722|NCT01677195|531164361|FG001|Overall Study|Physician Decision|2|||
147271723|NCT01677195|531164362|FG002|Overall Study|Physician Decision|2|||
147271724|NCT01677195|531164360|FG000|Overall Study|Pregnancy|0|||
147450476|NCT00689871|531811437|FG001|Overall Study|Lost to Follow-up|13|||
147271725|NCT01677195|531164361|FG001|Overall Study|Pregnancy|1|||
147271726|NCT01677195|531164362|FG002|Overall Study|Pregnancy|0|||
147271727|NCT01677195|531164360|FG000|Overall Study|Protocol Violation|7|||
147271728|NCT01677195|531164361|FG001|Overall Study|Protocol Violation|3|||
147271729|NCT01677195|531164362|FG002|Overall Study|Protocol Violation|4|||
147271730|NCT04368429|531164363|FG000|Overall Study|Adverse Event|1|||
147271731|NCT04368429|531164364|FG001|Overall Study|Adverse Event|0|||
147271732|NCT03633396|531164367|FG000|Overall Study|Withdrawal by Subject|4|||
147271733|NCT03633396|531164368|FG001|Overall Study|Withdrawal by Subject|4|||
147271734|NCT03633396|531164367|FG000|Overall Study|Adverse Event|1|||
147271735|NCT03633396|531164368|FG001|Overall Study|Adverse Event|1|||
147271736|NCT03633396|531164367|FG000|Overall Study|Lack of Efficacy|1|||
147271737|NCT03633396|531164368|FG001|Overall Study|Lack of Efficacy|0|||
147271738|NCT03633396|531164367|FG000|Overall Study|Coronavirus Disease 2019 (COVID-19) Restrictions|0|||
147271739|NCT03633396|531164368|FG001|Overall Study|Coronavirus Disease 2019 (COVID-19) Restrictions|1|||
147271740|NCT01012817|531164369|FG000|Overall Study|Withdrawal by Subject|0|||
147271741|NCT01012817|531164370|FG001|Overall Study|Withdrawal by Subject|0|||
147450477|NCT00689871|531811438|FG002|Overall Study|Lost to Follow-up|37|||
147333502|NCT00241644|531387735|FG003|First Efficacy Period (Year 1)|Lost to Follow-up|258|||
147333503|NCT00241644|531387732|FG000|First Efficacy Period (Year 1)|Non-compliance|2|||
147333504|NCT00241644|531387733|FG001|First Efficacy Period (Year 1)|Non-compliance|1|||
147271742|NCT01012817|531164371|FG002|Overall Study|Withdrawal by Subject|0|||
147271743|NCT01012817|531164372|FG003|Overall Study|Withdrawal by Subject|1|||
147271744|NCT01012817|531164373|FG004|Overall Study|Withdrawal by Subject|0|||
147271745|NCT01012817|531164374|FG005|Overall Study|Withdrawal by Subject|0|||
147271746|NCT01012817|531164375|FG006|Overall Study|Withdrawal by Subject|0|||
147271747|NCT01012817|531164376|FG007|Overall Study|Withdrawal by Subject|1|||
147271748|NCT01012817|531164377|FG008|Overall Study|Withdrawal by Subject|0|||
147271749|NCT01012817|531164378|FG009|Overall Study|Withdrawal by Subject|0|||
147271750|NCT01012817|531164379|FG010|Overall Study|Withdrawal by Subject|1|||
147271751|NCT01012817|531164380|FG011|Overall Study|Withdrawal by Subject|1|||
147271752|NCT01012817|531164381|FG012|Overall Study|Withdrawal by Subject|0|||
147271753|NCT01012817|531164382|FG013|Overall Study|Withdrawal by Subject|1|||
147271754|NCT01012817|531164369|FG000|Overall Study|Adverse Event|0|||
147271755|NCT01012817|531164370|FG001|Overall Study|Adverse Event|0|||
147271756|NCT01012817|531164371|FG002|Overall Study|Adverse Event|0|||
147271757|NCT01012817|531164372|FG003|Overall Study|Adverse Event|0|||
147271758|NCT01012817|531164373|FG004|Overall Study|Adverse Event|0|||
147271759|NCT01012817|531164374|FG005|Overall Study|Adverse Event|1|||
147271760|NCT01012817|531164375|FG006|Overall Study|Adverse Event|0|||
147271761|NCT01012817|531164376|FG007|Overall Study|Adverse Event|0|||
147271762|NCT01012817|531164377|FG008|Overall Study|Adverse Event|0|||
147271763|NCT01012817|531164378|FG009|Overall Study|Adverse Event|0|||
147271764|NCT01012817|531164379|FG010|Overall Study|Adverse Event|1|||
147271765|NCT01012817|531164380|FG011|Overall Study|Adverse Event|0|||
147271766|NCT01012817|531164381|FG012|Overall Study|Adverse Event|0|||
147271767|NCT01012817|531164382|FG013|Overall Study|Adverse Event|1|||
147271768|NCT02472756|531164383|FG000|Induction (Approximately 6 Months)|Adverse Event|1|||
147271769|NCT02472756|531164383|FG000|Induction (Approximately 6 Months)|Enrolled But Not Treated|1|||
147271770|NCT02472756|531164383|FG000|Maintenance (Approximately 2 Years)|Lack of Drug|7|||
147271771|NCT02472756|531164383|FG000|Maintenance (Approximately 2 Years)|Progression Disease|2|||
147271772|NCT02472756|531164383|FG000|Maintenance (Approximately 2 Years)|Adverse Event|1|||
147271773|NCT02143414|531164384|FG000|Induction|Adverse Event|1|||
147271774|NCT02143414|531164385|FG001|Induction|Adverse Event|2|||
147271775|NCT02143414|531164384|FG000|Induction|Death|1|||
147271776|NCT02143414|531164385|FG001|Induction|Death|2|||
147271777|NCT02143414|531164384|FG000|Induction|Patient refusal|1|||
147271778|NCT02143414|531164385|FG001|Induction|Patient refusal|1|||
147271779|NCT02143414|531164384|FG000|Induction|Refractory|1|||
147333505|NCT00241644|531387734|FG002|First Efficacy Period (Year 1)|Non-compliance|2|||
147662353|NCT01298700|532587300|FG000|Overall Study|Withdrawal by Subject|12|||
147662354|NCT01298700|532587301|FG001|Overall Study|Withdrawal by Subject|9|||
147662355|NCT01298700|532587300|FG000|Overall Study|Protocol Violation|6|||
147662356|NCT01298700|532587301|FG001|Overall Study|Protocol Violation|4|||
147662357|NCT01298700|532587300|FG000|Overall Study|Other Miscellaneous Reasons|16|||
147662358|NCT01298700|532587301|FG001|Overall Study|Other Miscellaneous Reasons|15|||
147662359|NCT01298700|532587300|FG000|Overall Study|Did not Receive Study Drug|3|||
147662360|NCT01298700|532587301|FG001|Overall Study|Did not Receive Study Drug|5|||
147662361|NCT04006145|532587302|FG000|Overall Study|Lost to Follow-up|0|||
147662362|NCT04006145|532587303|FG001|Overall Study|Lost to Follow-up|1|||
147662363|NCT04006145|532587302|FG000|Overall Study|Other|1|||
147662364|NCT04006145|532587303|FG001|Overall Study|Other|2|||
147662365|NCT00010257|532587306|FG000|Overall Study|Withdrawal by Subject|1|||
147662366|NCT00010257|532587307|FG001|Overall Study|Withdrawal by Subject|0|||
147662367|NCT02063672|532587308|FG000|Overall Study|Ongoing Follow-up|27|||
147662368|NCT02063672|532587309|FG001|Overall Study|Ongoing Follow-up|14|||
147662369|NCT02063672|532587308|FG000|Overall Study|Death|5|||
147662370|NCT02063672|532587309|FG001|Overall Study|Death|3|||
147271780|NCT02143414|531164385|FG001|Induction|Refractory|0|||
147333506|NCT00241644|531387735|FG003|First Efficacy Period (Year 1)|Non-compliance|3|||
147333507|NCT00241644|531387732|FG000|First Efficacy Period (Year 1)|Return dates not reliable|1|||
147662371|NCT02063672|532587308|FG000|Overall Study|Lost to Follow-up|1|||
147662372|NCT02063672|532587309|FG001|Overall Study|Lost to Follow-up|3|||
147662373|NCT02063672|532587308|FG000|Overall Study|Withdrawal by Subject|2|||
147662374|NCT02063672|532587309|FG001|Overall Study|Withdrawal by Subject|2|||
147662375|NCT01965327|532587311|FG000|Overall Study|Physician Decision|2|||
147271781|NCT02143414|531164384|FG000|Induction|Began alternative treatment|1|||
147662376|NCT02498678|532587312|FG000|Overall Study|interference from the surgical team|0|||
147271782|NCT02143414|531164385|FG001|Induction|Began alternative treatment|0|||
147271783|NCT02143414|531164384|FG000|Induction|Ineligible for postremission|5|||
147271784|NCT02143414|531164385|FG001|Induction|Ineligible for postremission|1|||
147271785|NCT02143414|531164384|FG000|Post-remission|Adverse Event|0|||
147271786|NCT02143414|531164385|FG001|Post-remission|Adverse Event|2|||
147333508|NCT00241644|531387733|FG001|First Efficacy Period (Year 1)|Return dates not reliable|0|||
147333509|NCT00241644|531387734|FG002|First Efficacy Period (Year 1)|Return dates not reliable|0|||
147271787|NCT02143414|531164384|FG000|Post-remission|Disease progression/relapse|5|||
147271788|NCT02143414|531164385|FG001|Post-remission|Disease progression/relapse|0|||
147271789|NCT02143414|531164384|FG000|Maintenance|Adverse Event|4|||
147271790|NCT02143414|531164385|FG001|Maintenance|Adverse Event|6|||
147271791|NCT02143414|531164384|FG000|Maintenance|Disease progression/relapse|3|||
147271792|NCT02143414|531164385|FG001|Maintenance|Disease progression/relapse|2|||
147271793|NCT02143414|531164384|FG000|Maintenance|Patient refusal|2|||
147271794|NCT02143414|531164385|FG001|Maintenance|Patient refusal|1|||
147271795|NCT02143414|531164384|FG000|Maintenance|Physician Decision|1|||
147271796|NCT02143414|531164385|FG001|Maintenance|Physician Decision|0|||
147271797|NCT02143414|531164384|FG000|Maintenance|Death|0|||
147271798|NCT02143414|531164385|FG001|Maintenance|Death|1|||
147271799|NCT02143414|531164384|FG000|Maintenance|On protocol treatment|0|||
147271800|NCT02143414|531164385|FG001|Maintenance|On protocol treatment|6|||
147271801|NCT00110266|531164389|FG000|Overall Study|Adverse Event|27|||
147271802|NCT00110266|531164389|FG000|Overall Study|Abnormal laboratory value|15|||
147271803|NCT00110266|531164389|FG000|Overall Study|Withdrawal by Subject|16|||
147271804|NCT00110266|531164389|FG000|Overall Study|Death|17|||
147271805|NCT00110266|531164389|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
147271806|NCT00110266|531164389|FG000|Overall Study|Participant condition no longer requires study drug|1|||
147271807|NCT00978731|531164390|FG000|Overall Study|Death|4|||
147271808|NCT00978731|531164391|FG001|Overall Study|Death|1|||
147271809|NCT00978731|531164392|FG002|Overall Study|Death|1|||
147271810|NCT00978731|531164393|FG003|Overall Study|Death|0|||
147271811|NCT00978731|531164390|FG000|Overall Study|Lost to Follow-up|0|||
147271812|NCT00978731|531164391|FG001|Overall Study|Lost to Follow-up|0|||
147271813|NCT00978731|531164392|FG002|Overall Study|Lost to Follow-up|0|||
147271814|NCT00978731|531164393|FG003|Overall Study|Lost to Follow-up|1|||
147271815|NCT00978731|531164390|FG000|Overall Study|Adverse Event|5|||
147271816|NCT00978731|531164391|FG001|Overall Study|Adverse Event|2|||
147271817|NCT00978731|531164392|FG002|Overall Study|Adverse Event|0|||
147271818|NCT00978731|531164393|FG003|Overall Study|Adverse Event|0|||
147271819|NCT00978731|531164390|FG000|Overall Study|Participant's request|1|||
147271820|NCT00978731|531164391|FG001|Overall Study|Participant's request|0|||
147271821|NCT00978731|531164392|FG002|Overall Study|Participant's request|0|||
147271822|NCT00978731|531164393|FG003|Overall Study|Participant's request|0|||
147271823|NCT00978731|531164390|FG000|Overall Study|Administrative reason|3|||
147271824|NCT00978731|531164391|FG001|Overall Study|Administrative reason|3|||
147271825|NCT00978731|531164392|FG002|Overall Study|Administrative reason|1|||
147271826|NCT00978731|531164393|FG003|Overall Study|Administrative reason|0|||
147271827|NCT00978731|531164390|FG000|Overall Study|Deterioration without progression|0|||
147271828|NCT00978731|531164391|FG001|Overall Study|Deterioration without progression|1|||
147271829|NCT00978731|531164392|FG002|Overall Study|Deterioration without progression|0|||
147333510|NCT00241644|531387735|FG003|First Efficacy Period (Year 1)|Return dates not reliable|1|||
147333511|NCT00241644|531387732|FG000|First Efficacy Period (Year 1)|Vaccinated at regular clinic|0|||
147333512|NCT00241644|531387733|FG001|First Efficacy Period (Year 1)|Vaccinated at regular clinic|0|||
147333513|NCT00241644|531387734|FG002|First Efficacy Period (Year 1)|Vaccinated at regular clinic|1|||
147333514|NCT00241644|531387735|FG003|First Efficacy Period (Year 1)|Vaccinated at regular clinic|0|||
147333515|NCT00241644|531387732|FG000|First Efficacy Period (Year 1)|Subject's parent passed away|0|||
147333516|NCT00241644|531387733|FG001|First Efficacy Period (Year 1)|Subject's parent passed away|1|||
147333517|NCT00241644|531387734|FG002|First Efficacy Period (Year 1)|Subject's parent passed away|0|||
147333518|NCT00241644|531387735|FG003|First Efficacy Period (Year 1)|Subject's parent passed away|1|||
147333519|NCT00241644|531387732|FG000|Second Efficacy Period (Year 2)|Adverse Event|11|||
147333520|NCT00241644|531387733|FG001|Second Efficacy Period (Year 2)|Adverse Event|9|||
147333521|NCT00241644|531387734|FG002|Second Efficacy Period (Year 2)|Adverse Event|12|||
147333522|NCT00241644|531387735|FG003|Second Efficacy Period (Year 2)|Adverse Event|20|||
147333523|NCT00241644|531387732|FG000|Second Efficacy Period (Year 2)|Protocol Violation|2|||
147333524|NCT00241644|531387733|FG001|Second Efficacy Period (Year 2)|Protocol Violation|1|||
147333525|NCT00241644|531387734|FG002|Second Efficacy Period (Year 2)|Protocol Violation|2|||
147333526|NCT00241644|531387735|FG003|Second Efficacy Period (Year 2)|Protocol Violation|3|||
147333527|NCT00241644|531387732|FG000|Second Efficacy Period (Year 2)|Withdrawal by Subject|4|||
147333528|NCT00241644|531387733|FG001|Second Efficacy Period (Year 2)|Withdrawal by Subject|3|||
147333529|NCT00241644|531387734|FG002|Second Efficacy Period (Year 2)|Withdrawal by Subject|2|||
147333530|NCT00241644|531387735|FG003|Second Efficacy Period (Year 2)|Withdrawal by Subject|7|||
147333531|NCT00241644|531387732|FG000|Second Efficacy Period (Year 2)|Lost to Follow-up|43|||
147271830|NCT00978731|531164393|FG003|Overall Study|Deterioration without progression|0|||
147271831|NCT00978731|531164390|FG000|Overall Study|Disease progression/relapse|5|||
147271832|NCT00978731|531164391|FG001|Overall Study|Disease progression/relapse|4|||
147271833|NCT00978731|531164392|FG002|Overall Study|Disease progression/relapse|2|||
147271834|NCT00978731|531164393|FG003|Overall Study|Disease progression/relapse|2|||
147271835|NCT00978731|531164390|FG000|Overall Study|Study closure|3|||
147271836|NCT00978731|531164391|FG001|Overall Study|Study closure|4|||
147271837|NCT00978731|531164392|FG002|Overall Study|Study closure|1|||
147271838|NCT00978731|531164393|FG003|Overall Study|Study closure|1|||
147271839|NCT00978731|531164390|FG000|Overall Study|No response|1|||
147271840|NCT00978731|531164391|FG001|Overall Study|No response|0|||
147271841|NCT00978731|531164392|FG002|Overall Study|No response|0|||
147271842|NCT00978731|531164393|FG003|Overall Study|No response|0|||
147271843|NCT00293384|531164394|FG000|Overall Study|Non-compliance|2|||
147271844|NCT00293384|531164394|FG000|Overall Study|Missed dosage/study drug|1|||
147271845|NCT00293384|531164394|FG000|Overall Study|Ineligible|2|||
147600300|NCT03893565|532356365|FG008|Double-blind Induction Phase (10 Weeks)|Physician Decision|0|||
147600301|NCT03893565|532356357|FG000|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
147600302|NCT03893565|532356358|FG001|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|2|||
147600303|NCT03893565|532356359|FG002|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
147600304|NCT03893565|532356360|FG003|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|1|||
147600305|NCT03893565|532356361|FG004|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
147600306|NCT03893565|532356362|FG005|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
147600307|NCT03893565|532356363|FG006|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
147600308|NCT03893565|532356364|FG007|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
147600309|NCT03893565|532356365|FG008|Double-blind Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
147600310|NCT03893565|532356357|FG000|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
147600311|NCT03893565|532356358|FG001|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|1|||
147271846|NCT00548808|531164398|FG000|Overall Study|Lost to Follow-up|9|||
147271847|NCT00548808|531164399|FG001|Overall Study|Lost to Follow-up|3|||
147271848|NCT00548808|531164398|FG000|Overall Study|Protocol Violation|8|||
147271849|NCT00548808|531164399|FG001|Overall Study|Protocol Violation|8|||
147271850|NCT00548808|531164398|FG000|Overall Study|Withdrawal by Subject|8|||
147271851|NCT00548808|531164399|FG001|Overall Study|Withdrawal by Subject|4|||
147271852|NCT00548808|531164398|FG000|Overall Study|Physician Decision|6|||
147271853|NCT00548808|531164399|FG001|Overall Study|Physician Decision|3|||
147271854|NCT00548808|531164398|FG000|Overall Study|Adverse Event|4|||
147271855|NCT00548808|531164399|FG001|Overall Study|Adverse Event|5|||
147271856|NCT00548808|531164398|FG000|Overall Study|Death|2|||
147271857|NCT00548808|531164399|FG001|Overall Study|Death|0|||
147271858|NCT00548808|531164398|FG000|Overall Study|Entry Criteria Not Met|2|||
147271859|NCT00548808|531164399|FG001|Overall Study|Entry Criteria Not Met|2|||
147271860|NCT00548808|531164398|FG000|Overall Study|Lack of Efficacy|2|||
147271861|NCT00548808|531164399|FG001|Overall Study|Lack of Efficacy|0|||
147271862|NCT00548808|531164398|FG000|Overall Study|Sponsor Decision|1|||
147271863|NCT00548808|531164399|FG001|Overall Study|Sponsor Decision|1|||
147271864|NCT05044234|531164400|FG000|Overall Study|Lost to Follow-up|2|||
147271865|NCT05044234|531164401|FG001|Overall Study|Lost to Follow-up|1|||
147271866|NCT05044234|531164402|FG002|Overall Study|Lost to Follow-up|1|||
147271867|NCT05044234|531164403|FG003|Overall Study|Lost to Follow-up|2|||
147600312|NCT03893565|532356359|FG002|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
147271868|NCT05044234|531164400|FG000|Overall Study|Withdrawal by Subject|6|||
147271869|NCT05044234|531164401|FG001|Overall Study|Withdrawal by Subject|4|||
147271870|NCT05044234|531164402|FG002|Overall Study|Withdrawal by Subject|5|||
147271871|NCT05044234|531164403|FG003|Overall Study|Withdrawal by Subject|8|||
147271872|NCT05044234|531164400|FG000|Overall Study|Study terminated by Sponsor|21|||
147271873|NCT05044234|531164401|FG001|Overall Study|Study terminated by Sponsor|21|||
147600313|NCT03893565|532356360|FG003|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|6|||
147600314|NCT03893565|532356361|FG004|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
147600315|NCT03893565|532356362|FG005|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
147271874|NCT05044234|531164402|FG002|Overall Study|Study terminated by Sponsor|20|||
147271875|NCT05044234|531164403|FG003|Overall Study|Study terminated by Sponsor|14|||
147271876|NCT05044234|531164400|FG000|Overall Study|Other, not specified|0|||
147271877|NCT05044234|531164401|FG001|Overall Study|Other, not specified|0|||
147271878|NCT05044234|531164402|FG002|Overall Study|Other, not specified|1|||
147271879|NCT05044234|531164403|FG003|Overall Study|Other, not specified|2|||
147271880|NCT05044234|531164400|FG000|Overall Study|Delayed data entry|0|||
147333532|NCT00241644|531387733|FG001|Second Efficacy Period (Year 2)|Lost to Follow-up|43|||
147333533|NCT00241644|531387734|FG002|Second Efficacy Period (Year 2)|Lost to Follow-up|46|||
147333534|NCT00241644|531387735|FG003|Second Efficacy Period (Year 2)|Lost to Follow-up|86|||
147333535|NCT00241644|531387732|FG000|Second Efficacy Period (Year 2)|Consenting parent passed away|1|||
147333536|NCT00241644|531387733|FG001|Second Efficacy Period (Year 2)|Consenting parent passed away|1|||
147333537|NCT00241644|531387734|FG002|Second Efficacy Period (Year 2)|Consenting parent passed away|2|||
147333538|NCT00241644|531387735|FG003|Second Efficacy Period (Year 2)|Consenting parent passed away|2|||
147333539|NCT03804918|531387736|FG000|Overall Study|Participant did not use the app|1|||
147333540|NCT01087762|531387737|FG000|Double Blind Period (Weeks 0-24)|Lack of Efficacy|2|||
147333541|NCT01087762|531387738|FG001|Double Blind Period (Weeks 0-24)|Lack of Efficacy|0|||
147333542|NCT01087762|531387739|FG002|Double Blind Period (Weeks 0-24)|Lack of Efficacy|3|||
147333543|NCT01087762|531387740|FG003|Double Blind Period (Weeks 0-24)|Lack of Efficacy|0|||
147333544|NCT01087762|531387741|FG004|Double Blind Period (Weeks 0-24)|Lack of Efficacy|0|||
147333545|NCT01087762|531387737|FG000|Double Blind Period (Weeks 0-24)|Protocol Violation|6|||
147271881|NCT05044234|531164401|FG001|Overall Study|Delayed data entry|0|||
147271882|NCT05044234|531164402|FG002|Overall Study|Delayed data entry|0|||
147271883|NCT05044234|531164403|FG003|Overall Study|Delayed data entry|1|||
147271884|NCT02940691|531164404|FG000|Overall Study|Lost to Follow-up|5|||
147271885|NCT02940691|531164404|FG000|Overall Study|Incarceration|1|||
147271886|NCT05459129|531164405|FG000|Overall Study|Death|1|||
147271887|NCT05459129|531164406|FG001|Overall Study|Death|0|||
147271888|NCT05459129|531164405|FG000|Overall Study|Study Terminated By Sponsor|5|||
147271889|NCT05459129|531164406|FG001|Overall Study|Study Terminated By Sponsor|6|||
147271890|NCT04304001|531164407|FG000|Overall Study|Lost to Follow-up|13|||
147271891|NCT04304001|531164408|FG001|Overall Study|Lost to Follow-up|9|||
147271892|NCT04033159|531164435|FG000|Washout Period|Physician Decision|0|||
147271893|NCT04033159|531164436|FG001|Washout Period|Physician Decision|1|||
147271894|NCT04033159|531164437|FG002|Washout Period|Physician Decision|0|||
147271895|NCT04033159|531164435|FG000|Washout Period|Study terminated by Sponsor|0|||
147271896|NCT04033159|531164436|FG001|Washout Period|Study terminated by Sponsor|7|||
147271897|NCT04033159|531164437|FG002|Washout Period|Study terminated by Sponsor|0|||
147271898|NCT04033159|531164435|FG000|Multiple Ascending Dose Period|Study terminated by Sponsor|6|||
147333546|NCT01087762|531387738|FG001|Double Blind Period (Weeks 0-24)|Protocol Violation|0|||
147333547|NCT01087762|531387739|FG002|Double Blind Period (Weeks 0-24)|Protocol Violation|1|||
147333548|NCT01087762|531387740|FG003|Double Blind Period (Weeks 0-24)|Protocol Violation|0|||
147333549|NCT01087762|531387741|FG004|Double Blind Period (Weeks 0-24)|Protocol Violation|0|||
147333550|NCT01087762|531387737|FG000|Double Blind Period (Weeks 0-24)|Lost to Follow-up|1|||
147333551|NCT01087762|531387738|FG001|Double Blind Period (Weeks 0-24)|Lost to Follow-up|2|||
147333552|NCT01087762|531387739|FG002|Double Blind Period (Weeks 0-24)|Lost to Follow-up|1|||
147333553|NCT01087762|531387740|FG003|Double Blind Period (Weeks 0-24)|Lost to Follow-up|0|||
147333554|NCT01087762|531387741|FG004|Double Blind Period (Weeks 0-24)|Lost to Follow-up|0|||
147333555|NCT01087762|531387737|FG000|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|1|||
147333556|NCT01087762|531387738|FG001|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|2|||
147333557|NCT01087762|531387739|FG002|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|1|||
147333558|NCT01087762|531387740|FG003|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|0|||
147333559|NCT01087762|531387741|FG004|Double Blind Period (Weeks 0-24)|Withdrawal by Subject|0|||
147333560|NCT01087762|531387737|FG000|Double Blind Period (Weeks 0-24)|SAE, non-fatal|2|||
147333561|NCT01087762|531387738|FG001|Double Blind Period (Weeks 0-24)|SAE, non-fatal|2|||
147333562|NCT01087762|531387739|FG002|Double Blind Period (Weeks 0-24)|SAE, non-fatal|3|||
147333563|NCT01087762|531387740|FG003|Double Blind Period (Weeks 0-24)|SAE, non-fatal|0|||
147333564|NCT01087762|531387741|FG004|Double Blind Period (Weeks 0-24)|SAE, non-fatal|0|||
147333565|NCT01087762|531387737|FG000|Open-Label Period (Weeks 48-204)|Lack of Efficacy|0|||
147333566|NCT01087762|531387738|FG001|Open-Label Period (Weeks 48-204)|Lack of Efficacy|0|||
147333567|NCT01087762|531387739|FG002|Open-Label Period (Weeks 48-204)|Lack of Efficacy|0|||
147333568|NCT01087762|531387740|FG003|Open-Label Period (Weeks 48-204)|Lack of Efficacy|4|||
147333569|NCT01087762|531387741|FG004|Open-Label Period (Weeks 48-204)|Lack of Efficacy|14|||
147333570|NCT01087762|531387737|FG000|Open-Label Period (Weeks 48-204)|Protocol Violation|0|||
147333571|NCT01087762|531387738|FG001|Open-Label Period (Weeks 48-204)|Protocol Violation|0|||
147333572|NCT01087762|531387739|FG002|Open-Label Period (Weeks 48-204)|Protocol Violation|0|||
147333573|NCT01087762|531387740|FG003|Open-Label Period (Weeks 48-204)|Protocol Violation|1|||
147333574|NCT01087762|531387741|FG004|Open-Label Period (Weeks 48-204)|Protocol Violation|1|||
147333575|NCT01087762|531387737|FG000|Open-Label Period (Weeks 48-204)|Lost to Follow-up|0|||
147333576|NCT01087762|531387738|FG001|Open-Label Period (Weeks 48-204)|Lost to Follow-up|0|||
147333577|NCT01087762|531387739|FG002|Open-Label Period (Weeks 48-204)|Lost to Follow-up|0|||
147333578|NCT01087762|531387740|FG003|Open-Label Period (Weeks 48-204)|Lost to Follow-up|5|||
147333579|NCT01087762|531387741|FG004|Open-Label Period (Weeks 48-204)|Lost to Follow-up|2|||
147333580|NCT01087762|531387737|FG000|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|0|||
147333581|NCT01087762|531387738|FG001|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|0|||
147333582|NCT01087762|531387739|FG002|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|0|||
147333583|NCT01087762|531387740|FG003|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|22|||
147333584|NCT01087762|531387741|FG004|Open-Label Period (Weeks 48-204)|Withdrawal by Subject|15|||
147333585|NCT01087762|531387737|FG000|Open-Label Period (Weeks 48-204)|Other|0|||
147333586|NCT01087762|531387738|FG001|Open-Label Period (Weeks 48-204)|Other|0|||
147333587|NCT01087762|531387739|FG002|Open-Label Period (Weeks 48-204)|Other|0|||
147333588|NCT01087762|531387740|FG003|Open-Label Period (Weeks 48-204)|Other|2|||
147333589|NCT01087762|531387741|FG004|Open-Label Period (Weeks 48-204)|Other|4|||
147333590|NCT01087762|531387737|FG000|Open-Label Period (Weeks 48-204)|SAE, non-fatal|0|||
147333591|NCT01087762|531387738|FG001|Open-Label Period (Weeks 48-204)|SAE, non-fatal|0|||
147333592|NCT01087762|531387739|FG002|Open-Label Period (Weeks 48-204)|SAE, non-fatal|0|||
147333593|NCT01087762|531387740|FG003|Open-Label Period (Weeks 48-204)|SAE, non-fatal|7|||
147333594|NCT01087762|531387741|FG004|Open-Label Period (Weeks 48-204)|SAE, non-fatal|4|||
147450478|NCT00689871|531811439|FG003|Overall Study|Lost to Follow-up|1|||
147271899|NCT04033159|531164436|FG001|Multiple Ascending Dose Period|Study terminated by Sponsor|0|||
147271900|NCT04033159|531164437|FG002|Multiple Ascending Dose Period|Study terminated by Sponsor|0|||
147450479|NCT00689871|531811436|FG000|Overall Study|Explanted of All Study Devices|36|||
147450480|NCT00689871|531811437|FG001|Overall Study|Explanted of All Study Devices|25|||
147450481|NCT00689871|531811438|FG002|Overall Study|Explanted of All Study Devices|29|||
147450482|NCT00689871|531811439|FG003|Overall Study|Explanted of All Study Devices|3|||
147450483|NCT00689871|531811436|FG000|Overall Study|Withdrawal by Subject|13|||
147450484|NCT00689871|531811437|FG001|Overall Study|Withdrawal by Subject|3|||
147450485|NCT00689871|531811438|FG002|Overall Study|Withdrawal by Subject|4|||
147450486|NCT00689871|531811439|FG003|Overall Study|Withdrawal by Subject|1|||
147450487|NCT00689871|531811436|FG000|Overall Study|Death|1|||
147450488|NCT00689871|531811437|FG001|Overall Study|Death|10|||
147450489|NCT00689871|531811438|FG002|Overall Study|Death|2|||
147450490|NCT00689871|531811439|FG003|Overall Study|Death|2|||
147450491|NCT00689871|531811436|FG000|Overall Study|Physician Decision|2|||
147450492|NCT00689871|531811437|FG001|Overall Study|Physician Decision|1|||
147450493|NCT00689871|531811438|FG002|Overall Study|Physician Decision|1|||
147450494|NCT00689871|531811439|FG003|Overall Study|Physician Decision|0|||
147450495|NCT02054897|531811440|FG000|Overall Study|Withdrawal by Subject|2|||
147450496|NCT02054897|531811441|FG001|Overall Study|Withdrawal by Subject|0|||
147450497|NCT02054897|531811442|FG002|Overall Study|Withdrawal by Subject|2|||
147450498|NCT02054897|531811440|FG000|Overall Study|Missing follow-up information|3|||
147450499|NCT02054897|531811441|FG001|Overall Study|Missing follow-up information|5|||
147450500|NCT02054897|531811442|FG002|Overall Study|Missing follow-up information|3|||
147450501|NCT02054897|531811440|FG000|Overall Study|Lost to Follow-up|4|||
147450502|NCT02054897|531811441|FG001|Overall Study|Lost to Follow-up|2|||
147450503|NCT02054897|531811442|FG002|Overall Study|Lost to Follow-up|7|||
147450504|NCT02054897|531811440|FG000|Overall Study|Randomized but not exposed|1|||
147450505|NCT02054897|531811441|FG001|Overall Study|Randomized but not exposed|0|||
147450506|NCT02054897|531811442|FG002|Overall Study|Randomized but not exposed|0|||
147450507|NCT00960843|531811443|FG000|Overall Study|Lost to Follow-up|2|||
147450508|NCT00960843|531811444|FG001|Overall Study|Lost to Follow-up|0|||
147450509|NCT00960843|531811443|FG000|Overall Study|Protocol Violation|0|||
147450510|NCT00960843|531811444|FG001|Overall Study|Protocol Violation|4|||
147450511|NCT00960843|531811443|FG000|Overall Study|Repeated needle dislodgment|0|||
147450512|NCT00960843|531811444|FG001|Overall Study|Repeated needle dislodgment|1|||
147450513|NCT00652366|531811445|FG000|Overall Study|Adverse Event|8|||
147450514|NCT00652366|531811446|FG001|Overall Study|Adverse Event|4|||
147450515|NCT00652366|531811447|FG002|Overall Study|Adverse Event|7|||
147450516|NCT00652366|531811448|FG003|Overall Study|Adverse Event|17|||
147450517|NCT00652366|531811449|FG004|Overall Study|Adverse Event|13|||
147450518|NCT00652366|531811445|FG000|Overall Study|Death|5|||
147450519|NCT00652366|531811446|FG001|Overall Study|Death|4|||
147450520|NCT00652366|531811447|FG002|Overall Study|Death|1|||
147450521|NCT00652366|531811448|FG003|Overall Study|Death|8|||
147450522|NCT00652366|531811449|FG004|Overall Study|Death|5|||
147450523|NCT00652366|531811445|FG000|Overall Study|Lack of Efficacy|84|||
147450524|NCT00652366|531811446|FG001|Overall Study|Lack of Efficacy|58|||
147450525|NCT00652366|531811447|FG002|Overall Study|Lack of Efficacy|53|||
147450526|NCT00652366|531811448|FG003|Overall Study|Lack of Efficacy|133|||
147450527|NCT00652366|531811449|FG004|Overall Study|Lack of Efficacy|13|||
147450528|NCT00652366|531811445|FG000|Overall Study|Violation of Selection Criteria|0|||
147450529|NCT00652366|531811446|FG001|Overall Study|Violation of Selection Criteria|0|||
147450530|NCT00652366|531811447|FG002|Overall Study|Violation of Selection Criteria|1|||
147450531|NCT00652366|531811448|FG003|Overall Study|Violation of Selection Criteria|0|||
147450532|NCT00652366|531811449|FG004|Overall Study|Violation of Selection Criteria|0|||
147450533|NCT00652366|531811445|FG000|Overall Study|Protocol Violation|1|||
147450534|NCT00652366|531811446|FG001|Overall Study|Protocol Violation|0|||
147450535|NCT00652366|531811447|FG002|Overall Study|Protocol Violation|0|||
147450536|NCT00652366|531811448|FG003|Overall Study|Protocol Violation|0|||
147450537|NCT00652366|531811449|FG004|Overall Study|Protocol Violation|0|||
147450538|NCT00652366|531811445|FG000|Overall Study|Refused treatment|3|||
147450539|NCT00652366|531811446|FG001|Overall Study|Refused treatment|7|||
147450540|NCT00652366|531811447|FG002|Overall Study|Refused treatment|6|||
147450541|NCT00652366|531811448|FG003|Overall Study|Refused treatment|17|||
147450542|NCT00652366|531811449|FG004|Overall Study|Refused treatment|5|||
147271901|NCT00499603|531164444|FG000|Overall Study|Adverse Event|0|||
147271902|NCT00499603|531164445|FG001|Overall Study|Adverse Event|1|||
147450543|NCT00652366|531811445|FG000|Overall Study|Other|5|||
147450544|NCT00652366|531811446|FG001|Overall Study|Other|2|||
147450545|NCT00652366|531811447|FG002|Overall Study|Other|3|||
147450546|NCT00652366|531811448|FG003|Overall Study|Other|4|||
147450547|NCT00652366|531811449|FG004|Overall Study|Other|0|||
147450548|NCT00889265|531811450|FG000|Overall Study|Adverse Event|1|||
147450549|NCT00889265|531811450|FG000|Overall Study|Lost to Follow-up|5|||
147450550|NCT00889265|531811450|FG000|Overall Study|Protocol Violation|1|||
147450551|NCT02069899|531811451|FG000|Overall Study|Adverse Event|6|||
147450552|NCT02069899|531811452|FG001|Overall Study|Adverse Event|0|||
147450553|NCT02069899|531811453|FG002|Overall Study|Adverse Event|1|||
147450554|NCT02069899|531811451|FG000|Overall Study|Withdrawal by Participant|2|||
147450555|NCT02069899|531811452|FG001|Overall Study|Withdrawal by Participant|0|||
147271903|NCT03323099|531164446|FG000|Overall Study|Withdrawal by Subject|6|||
147271904|NCT03323099|531164447|FG001|Overall Study|Withdrawal by Subject|12|||
147271905|NCT03323099|531164446|FG000|Overall Study|Did not complete AFEQT, or failed to start the study period|109|||
147271906|NCT03323099|531164447|FG001|Overall Study|Did not complete AFEQT, or failed to start the study period|52|||
147271907|NCT05220397|531164448|FG000|Second Janssen Vaccine Administration|Withdrawal by Subject|0|||
147271908|NCT05220397|531164449|FG001|Second Janssen Vaccine Administration|Withdrawal by Subject|0|||
147271909|NCT05220397|531164450|FG002|Second Janssen Vaccine Administration|Withdrawal by Subject|8|||
147271910|NCT05220397|531164451|FG003|Second Janssen Vaccine Administration|Withdrawal by Subject|0|||
147271911|NCT05220397|531164452|FG004|Second Janssen Vaccine Administration|Withdrawal by Subject|0|||
147271912|NCT01502644|531164453|FG000|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|1|||
147271913|NCT01502644|531164454|FG001|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|0|||
147271914|NCT01502644|531164455|FG002|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|0|||
147271915|NCT01502644|531164456|FG003|Enrolled at Visit 1 After Pre-screening|Illegal Drugs in Urine Drug Test|0|||
147271916|NCT01502644|531164453|FG000|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|2|||
147271917|NCT01502644|531164454|FG001|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|0|||
147271918|NCT01502644|531164455|FG002|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|0|||
147271919|NCT01502644|531164456|FG003|Enrolled at Visit 1 After Pre-screening|History of Opioid Substance Use Disorder|0|||
147271920|NCT01502644|531164453|FG000|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|6|||
147271921|NCT01502644|531164454|FG001|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|0|||
147271922|NCT01502644|531164455|FG002|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|0|||
147271923|NCT01502644|531164456|FG003|Enrolled at Visit 1 After Pre-screening|Declined to Participate further|0|||
147271924|NCT01502644|531164453|FG000|Assigned to NA Groups|Drop Out due to Side Effects|0|||
147271925|NCT01502644|531164454|FG001|Assigned to NA Groups|Drop Out due to Side Effects|6|||
147271926|NCT01502644|531164455|FG002|Assigned to NA Groups|Drop Out due to Side Effects|2|||
147271927|NCT01502644|531164456|FG003|Assigned to NA Groups|Drop Out due to Side Effects|7|||
147271928|NCT01502644|531164453|FG000|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|0|||
147271929|NCT01502644|531164454|FG001|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|0|||
147271930|NCT01502644|531164455|FG002|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|1|||
147271931|NCT01502644|531164456|FG003|Assigned to NA Groups|Illegal Drugs in Urine Drug Test|1|||
147271932|NCT02052739|531164459|FG000|Overall Study|Withdrew due to Adverse Event|3|||
147271933|NCT02052739|531164460|FG001|Overall Study|Withdrew due to Adverse Event|0|||
147271934|NCT02052739|531164459|FG000|Overall Study|Participant Died|2|||
147271935|NCT02052739|531164460|FG001|Overall Study|Participant Died|1|||
147271936|NCT01526889|531164461|FG000|Treatment Period|Adverse Event|2|||
147271937|NCT01526889|531164462|FG001|Treatment Period|Adverse Event|0|||
147271938|NCT01526889|531164461|FG000|Treatment Extension Period|Administrative problems|1|||
147271939|NCT01526889|531164462|FG001|Treatment Extension Period|Administrative problems|0|||
147271940|NCT01573624|531164463|FG000|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0|||
147271941|NCT01573624|531164464|FG001|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0|||
147271942|NCT01573624|531164465|FG002|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|1|||
147271943|NCT01573624|531164466|FG003|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0|||
147271944|NCT01573624|531164467|FG004|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0|||
147271945|NCT01573624|531164468|FG005|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|1|||
147271946|NCT01573624|531164469|FG006|Period 1 : Treatment Period 1 (14 Days)|Adverse Event|0|||
147271947|NCT01573624|531164463|FG000|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|4|||
147271948|NCT01573624|531164464|FG001|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|3|||
147271949|NCT01573624|531164465|FG002|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|6|||
147271950|NCT01573624|531164466|FG003|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|1|||
147271951|NCT01573624|531164467|FG004|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|2|||
147271952|NCT01573624|531164468|FG005|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|0|||
147271953|NCT01573624|531164469|FG006|Period 1 : Treatment Period 1 (14 Days)|Lack of Efficacy|1|||
147271954|NCT01573624|531164463|FG000|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|1|||
147271955|NCT01573624|531164464|FG001|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
147271956|NCT01573624|531164465|FG002|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
147271957|NCT01573624|531164466|FG003|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
147271958|NCT01573624|531164467|FG004|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
147271959|NCT01573624|531164468|FG005|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
147271960|NCT01573624|531164469|FG006|Period 1 : Treatment Period 1 (14 Days)|Protocol Violation|0|||
147271961|NCT01573624|531164463|FG000|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
147271962|NCT01573624|531164464|FG001|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
147271963|NCT01573624|531164465|FG002|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
147271964|NCT01573624|531164466|FG003|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
147333595|NCT01087762|531387737|FG000|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|0|||
147271965|NCT01573624|531164467|FG004|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
147271966|NCT01573624|531164468|FG005|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|2|||
147271967|NCT01573624|531164469|FG006|Period 1 : Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
147271968|NCT01573624|531164463|FG000|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|0|||
147271969|NCT01573624|531164464|FG001|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|0|||
147271970|NCT01573624|531164465|FG002|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1|||
147271971|NCT01573624|531164466|FG003|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1|||
147271972|NCT01573624|531164467|FG004|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|0|||
147271973|NCT01573624|531164468|FG005|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1|||
147271974|NCT01573624|531164469|FG006|Period 1 : Treatment Period 1 (14 Days)|Protocol-defined stopping criteria|1|||
147271975|NCT01573624|531164463|FG000|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
147271976|NCT01573624|531164464|FG001|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
147271977|NCT01573624|531164465|FG002|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
147271978|NCT01573624|531164466|FG003|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
147271979|NCT01573624|531164467|FG004|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
147271980|NCT01573624|531164468|FG005|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|1|||
147271981|NCT01573624|531164469|FG006|Period 2 : Washout Period 1 (12-14 Days)|Adverse Event|0|||
147271982|NCT01573624|531164463|FG000|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0|||
147271983|NCT01573624|531164464|FG001|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|1|||
147271984|NCT01573624|531164465|FG002|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0|||
147271985|NCT01573624|531164466|FG003|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|1|||
147271986|NCT01573624|531164467|FG004|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0|||
147271987|NCT01573624|531164468|FG005|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|0|||
147271988|NCT01573624|531164469|FG006|Period 2 : Washout Period 1 (12-14 Days)|Lack of Efficacy|1|||
147271989|NCT01573624|531164463|FG000|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|1|||
147271990|NCT01573624|531164464|FG001|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0|||
147271991|NCT01573624|531164465|FG002|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|2|||
147271992|NCT01573624|531164466|FG003|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|1|||
147271993|NCT01573624|531164467|FG004|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0|||
147271994|NCT01573624|531164468|FG005|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0|||
147271995|NCT01573624|531164469|FG006|Period 2 : Washout Period 1 (12-14 Days)|Protocol Violation|0|||
147271996|NCT01573624|531164463|FG000|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
147271997|NCT01573624|531164464|FG001|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
147271998|NCT01573624|531164465|FG002|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
147271999|NCT01573624|531164466|FG003|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
147272000|NCT01573624|531164467|FG004|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
147272001|NCT01573624|531164468|FG005|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|1|||
147272002|NCT01573624|531164469|FG006|Period 2 : Washout Period 1 (12-14 Days)|Physician Decision|0|||
147272003|NCT01573624|531164463|FG000|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
147333596|NCT01087762|531387738|FG001|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|0|||
147333597|NCT01087762|531387739|FG002|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|0|||
147333598|NCT01087762|531387740|FG003|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|16|||
147333599|NCT01087762|531387741|FG004|Open-Label Period (Weeks 48-204)|AE, non-serious non-fatal|13|||
147333600|NCT01087762|531387737|FG000|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|0|||
147333601|NCT01087762|531387738|FG001|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|0|||
147333602|NCT01087762|531387739|FG002|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|0|||
147333603|NCT01087762|531387740|FG003|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|2|||
147333604|NCT01087762|531387741|FG004|Open-Label Period (Weeks 48-204)|SAE, non-fatal + AE, non-serious/fatal|4|||
147333605|NCT01563354|531387744|FG000|Core Phase|Adverse Event|5|||
147333606|NCT01563354|531387745|FG001|Core Phase|Adverse Event|15|||
147333607|NCT01563354|531387746|FG002|Core Phase|Adverse Event|13|||
147333608|NCT01563354|531387744|FG000|Core Phase|Withdrawal by Subject|1|||
147333609|NCT01563354|531387745|FG001|Core Phase|Withdrawal by Subject|0|||
147333610|NCT01563354|531387746|FG002|Core Phase|Withdrawal by Subject|3|||
147333611|NCT01563354|531387744|FG000|Core Phase|Lost to Follow-up|1|||
147333612|NCT01563354|531387745|FG001|Core Phase|Lost to Follow-up|0|||
147333613|NCT01563354|531387746|FG002|Core Phase|Lost to Follow-up|0|||
147333614|NCT01563354|531387744|FG000|Core Phase|Death|1|||
147333615|NCT01563354|531387745|FG001|Core Phase|Death|5|||
147333616|NCT01563354|531387746|FG002|Core Phase|Death|2|||
147333617|NCT01563354|531387744|FG000|Core Phase|Diseasse progression|18|||
147333618|NCT01563354|531387745|FG001|Core Phase|Diseasse progression|7|||
147333619|NCT01563354|531387746|FG002|Core Phase|Diseasse progression|8|||
147333620|NCT01563354|531387744|FG000|Core Phase|Protocol deviation|2|||
147333621|NCT01563354|531387745|FG001|Core Phase|Protocol deviation|0|||
147600316|NCT03893565|532356363|FG006|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
147272004|NCT01573624|531164464|FG001|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
147272005|NCT01573624|531164465|FG002|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
147272006|NCT01573624|531164466|FG003|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|2|||
147272007|NCT01573624|531164467|FG004|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
147272008|NCT01573624|531164468|FG005|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|0|||
147272009|NCT01573624|531164469|FG006|Period 2 : Washout Period 1 (12-14 Days)|Withdrawal by Subject|1|||
147272010|NCT01573624|531164463|FG000|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0|||
147272011|NCT01573624|531164464|FG001|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0|||
147272012|NCT01573624|531164465|FG002|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|1|||
147272013|NCT01573624|531164466|FG003|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|1|||
147272014|NCT01573624|531164467|FG004|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0|||
147272015|NCT01573624|531164468|FG005|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|1|||
147272016|NCT01573624|531164469|FG006|Period 2 : Washout Period 1 (12-14 Days)|Protocol-defined stopping criteria|0|||
147272017|NCT01573624|531164463|FG000|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|5|||
147272018|NCT01573624|531164464|FG001|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|4|||
147272019|NCT01573624|531164465|FG002|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|2|||
147272020|NCT01573624|531164466|FG003|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|1|||
147272021|NCT01573624|531164467|FG004|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|3|||
147272022|NCT01573624|531164468|FG005|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|2|||
147272023|NCT01573624|531164469|FG006|Period 3 : Treatment Period 2 (14 Days)|Lack of Efficacy|0|||
147272024|NCT01573624|531164463|FG000|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0|||
147272025|NCT01573624|531164464|FG001|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|1|||
147272026|NCT01573624|531164465|FG002|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0|||
147272027|NCT01573624|531164466|FG003|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0|||
147272028|NCT01573624|531164467|FG004|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0|||
147272029|NCT01573624|531164468|FG005|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|2|||
147272030|NCT01573624|531164469|FG006|Period 3 : Treatment Period 2 (14 Days)|Protocol Violation|0|||
147272031|NCT01573624|531164463|FG000|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|1|||
147272032|NCT01573624|531164464|FG001|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
147272033|NCT01573624|531164465|FG002|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
147272034|NCT01573624|531164466|FG003|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
147272035|NCT01573624|531164467|FG004|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
147272036|NCT01573624|531164468|FG005|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
147272037|NCT01573624|531164469|FG006|Period 3 : Treatment Period 2 (14 Days)|Physician Decision|0|||
147272038|NCT01573624|531164463|FG000|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
147272039|NCT01573624|531164464|FG001|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|1|||
147272040|NCT01573624|531164465|FG002|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|1|||
147272041|NCT01573624|531164466|FG003|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
147272042|NCT01573624|531164467|FG004|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
147272043|NCT01573624|531164468|FG005|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|1|||
147272044|NCT01573624|531164469|FG006|Period 3 : Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
147272045|NCT01573624|531164463|FG000|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|1|||
147272046|NCT01573624|531164464|FG001|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
147272047|NCT01573624|531164465|FG002|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
147272048|NCT01573624|531164466|FG003|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
147272049|NCT01573624|531164467|FG004|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
147272050|NCT01573624|531164468|FG005|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
147272051|NCT01573624|531164469|FG006|Period 3 : Treatment Period 2 (14 Days)|Protocol-defined stopping criteria|0|||
147272052|NCT01573624|531164463|FG000|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|1|||
147272053|NCT01573624|531164464|FG001|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0|||
147272054|NCT01573624|531164465|FG002|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0|||
147272055|NCT01573624|531164466|FG003|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0|||
147272056|NCT01573624|531164467|FG004|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0|||
147272057|NCT01573624|531164468|FG005|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|0|||
147272058|NCT01573624|531164469|FG006|Period 4 : Washout Period 2 (12-14 Days)|Adverse Event|1|||
147272059|NCT01573624|531164463|FG000|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|0|||
147272060|NCT01573624|531164464|FG001|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1|||
147272061|NCT01573624|531164465|FG002|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1|||
147272062|NCT01573624|531164466|FG003|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1|||
147272063|NCT01573624|531164467|FG004|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1|||
147333622|NCT01563354|531387746|FG002|Core Phase|Protocol deviation|0|||
147333623|NCT01563354|531387744|FG000|Core Phase|PI decision - did not enter extension|0|||
147333624|NCT01563354|531387745|FG001|Core Phase|PI decision - did not enter extension|1|||
147333625|NCT01563354|531387746|FG002|Core Phase|PI decision - did not enter extension|0|||
147333626|NCT01563354|531387744|FG000|Core Phase|Worsening of clinical condition - did not enter extension|1|||
147333627|NCT01563354|531387745|FG001|Core Phase|Worsening of clinical condition - did not enter extension|0|||
147333628|NCT01563354|531387746|FG002|Core Phase|Worsening of clinical condition - did not enter extension|0|||
147272064|NCT01573624|531164468|FG005|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|0|||
147272065|NCT01573624|531164469|FG006|Period 4 : Washout Period 2 (12-14 Days)|Lack of Efficacy|1|||
147272066|NCT01573624|531164463|FG000|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
147272067|NCT01573624|531164464|FG001|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|1|||
147272068|NCT01573624|531164465|FG002|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
147272069|NCT01573624|531164466|FG003|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
147272070|NCT01573624|531164467|FG004|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
147272071|NCT01573624|531164468|FG005|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
147272072|NCT01573624|531164469|FG006|Period 4 : Washout Period 2 (12-14 Days)|Protocol Violation|0|||
147272073|NCT01573624|531164463|FG000|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
147272074|NCT01573624|531164464|FG001|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|1|||
147272075|NCT01573624|531164465|FG002|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
147272076|NCT01573624|531164466|FG003|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
147272077|NCT01573624|531164467|FG004|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
147272078|NCT01573624|531164468|FG005|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
147272079|NCT01573624|531164469|FG006|Period 4 : Washout Period 2 (12-14 Days)|Lost to Follow-up|0|||
147272080|NCT01573624|531164463|FG000|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
147272081|NCT01573624|531164464|FG001|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
147272082|NCT01573624|531164465|FG002|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
147272083|NCT01573624|531164466|FG003|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
147272084|NCT01573624|531164467|FG004|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|0|||
147272085|NCT01573624|531164468|FG005|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|1|||
147272086|NCT01573624|531164469|FG006|Period 4 : Washout Period 2 (12-14 Days)|Withdrawal by Subject|1|||
147272087|NCT01573624|531164463|FG000|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|0|||
147272088|NCT01573624|531164464|FG001|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1|||
147272089|NCT01573624|531164465|FG002|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1|||
147272090|NCT01573624|531164466|FG003|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1|||
147272091|NCT01573624|531164467|FG004|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|0|||
147272092|NCT01573624|531164468|FG005|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|1|||
147272093|NCT01573624|531164469|FG006|Period 4 : Washout Period 2 (12-14 Days)|Protocol-defined stopping criteria|0|||
147272094|NCT01573624|531164463|FG000|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|2|||
147272095|NCT01573624|531164464|FG001|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
147272096|NCT01573624|531164465|FG002|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
147272097|NCT01573624|531164466|FG003|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|0|||
147272098|NCT01573624|531164467|FG004|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|1|||
147272099|NCT01573624|531164468|FG005|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|1|||
147272100|NCT01573624|531164469|FG006|Period 5 : Treatment Period 3 (14 Days)|Lack of Efficacy|4|||
147272101|NCT01573624|531164463|FG000|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0|||
147272102|NCT01573624|531164464|FG001|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|1|||
147272103|NCT01573624|531164465|FG002|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0|||
147272104|NCT01573624|531164466|FG003|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0|||
147272105|NCT01573624|531164467|FG004|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0|||
147272106|NCT01573624|531164468|FG005|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|1|||
147272107|NCT01573624|531164469|FG006|Period 5 : Treatment Period 3 (14 Days)|Protocol Violation|0|||
147333629|NCT01563354|531387744|FG000|Extension Phase|Adverse Event|0|||
147333630|NCT01563354|531387745|FG001|Extension Phase|Adverse Event|3|||
147333631|NCT01563354|531387746|FG002|Extension Phase|Adverse Event|2|||
147333632|NCT01563354|531387744|FG000|Extension Phase|Withdrawal by Subject|0|||
147333633|NCT01563354|531387745|FG001|Extension Phase|Withdrawal by Subject|1|||
147333634|NCT01563354|531387746|FG002|Extension Phase|Withdrawal by Subject|0|||
147333635|NCT01563354|531387744|FG000|Extension Phase|Administration problems|3|||
147333636|NCT01563354|531387745|FG001|Extension Phase|Administration problems|2|||
147333637|NCT01563354|531387746|FG002|Extension Phase|Administration problems|3|||
147333638|NCT01563354|531387744|FG000|Extension Phase|Disease progression|9|||
147333639|NCT01563354|531387745|FG001|Extension Phase|Disease progression|8|||
147333640|NCT01563354|531387746|FG002|Extension Phase|Disease progression|10|||
147333641|NCT03621761|531387748|FG000|Overall Study|Lost to Follow-up|1|||
147333642|NCT03621761|531387749|FG001|Overall Study|Lost to Follow-up|1|||
147272108|NCT01573624|531164463|FG000|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|1|||
147272109|NCT01573624|531164464|FG001|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
147272110|NCT01573624|531164465|FG002|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
147272111|NCT01573624|531164466|FG003|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
147272112|NCT01573624|531164467|FG004|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
147272113|NCT01573624|531164468|FG005|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
147272114|NCT01573624|531164469|FG006|Period 5 : Treatment Period 3 (14 Days)|Lost to Follow-up|0|||
147272115|NCT01573624|531164463|FG000|Period 6 : Follow-up Period (7 Days)|Adverse Event|0|||
147272116|NCT01573624|531164464|FG001|Period 6 : Follow-up Period (7 Days)|Adverse Event|0|||
147272117|NCT01573624|531164465|FG002|Period 6 : Follow-up Period (7 Days)|Adverse Event|0|||
147272118|NCT01573624|531164466|FG003|Period 6 : Follow-up Period (7 Days)|Adverse Event|0|||
147272119|NCT01573624|531164467|FG004|Period 6 : Follow-up Period (7 Days)|Adverse Event|2|||
147272120|NCT01573624|531164468|FG005|Period 6 : Follow-up Period (7 Days)|Adverse Event|1|||
147272121|NCT01573624|531164469|FG006|Period 6 : Follow-up Period (7 Days)|Adverse Event|0|||
147272122|NCT01573624|531164463|FG000|Period 6 : Follow-up Period (7 Days)|Protocol Violation|1|||
147272123|NCT01573624|531164464|FG001|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
147272124|NCT01573624|531164465|FG002|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
147272125|NCT01573624|531164466|FG003|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
147272126|NCT01573624|531164467|FG004|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
147272127|NCT01573624|531164468|FG005|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
147272128|NCT01573624|531164469|FG006|Period 6 : Follow-up Period (7 Days)|Protocol Violation|0|||
147272129|NCT00613509|531164470|FG000|Cycle 1|Adverse Event|2|||
147272130|NCT00613509|531164471|FG001|Cycle 1|Adverse Event|1|||
147272131|NCT00613509|531164470|FG000|Cycle 1|Disease Progression|2|||
147272132|NCT00613509|531164471|FG001|Cycle 1|Disease Progression|6|||
147272133|NCT00613509|531164470|FG000|Cycle 1|Unacceptable Toxicity|1|||
147272134|NCT00613509|531164471|FG001|Cycle 1|Unacceptable Toxicity|0|||
147272135|NCT00613509|531164470|FG000|Cycle 1|Other administrative reason|0|||
147272136|NCT00613509|531164471|FG001|Cycle 1|Other administrative reason|1|||
147272137|NCT00677807|531164472|FG000|Overall Study|Adverse Event|4|||
147272138|NCT00677807|531164473|FG001|Overall Study|Adverse Event|1|||
147272139|NCT00677807|531164474|FG002|Overall Study|Adverse Event|6|||
147272140|NCT00677807|531164472|FG000|Overall Study|Lack of Efficacy|0|||
147272141|NCT00677807|531164473|FG001|Overall Study|Lack of Efficacy|0|||
147272142|NCT00677807|531164474|FG002|Overall Study|Lack of Efficacy|2|||
147272143|NCT00677807|531164472|FG000|Overall Study|Participant no longer needs study drug|0|||
147272144|NCT00677807|531164473|FG001|Overall Study|Participant no longer needs study drug|0|||
147272145|NCT00677807|531164474|FG002|Overall Study|Participant no longer needs study drug|1|||
147272146|NCT00677807|531164472|FG000|Overall Study|Withdrawal by Subject|10|||
147272147|NCT00677807|531164473|FG001|Overall Study|Withdrawal by Subject|3|||
147272148|NCT00677807|531164474|FG002|Overall Study|Withdrawal by Subject|6|||
147272149|NCT00677807|531164472|FG000|Overall Study|Lost to Follow-up|2|||
147272150|NCT00677807|531164473|FG001|Overall Study|Lost to Follow-up|2|||
147272151|NCT00677807|531164474|FG002|Overall Study|Lost to Follow-up|2|||
147272152|NCT00677807|531164472|FG000|Overall Study|Administrative problems|1|||
147272153|NCT00677807|531164473|FG001|Overall Study|Administrative problems|1|||
147272154|NCT00677807|531164474|FG002|Overall Study|Administrative problems|2|||
147272155|NCT00677807|531164472|FG000|Overall Study|Death|0|||
147272156|NCT00677807|531164473|FG001|Overall Study|Death|1|||
147272157|NCT00677807|531164474|FG002|Overall Study|Death|1|||
147272158|NCT00677807|531164472|FG000|Overall Study|Protocol Deviation|1|||
147272159|NCT00677807|531164473|FG001|Overall Study|Protocol Deviation|3|||
147272160|NCT00677807|531164474|FG002|Overall Study|Protocol Deviation|0|||
147272161|NCT00314366|531164479|FG000|Overall Study|not treated due to patient medical condi|1|||
147272162|NCT00314366|531164480|FG001|Overall Study|not treated due to patient medical condi|0|||
147272163|NCT03400033|531164481|FG000|Overall Study|Withdrawal by Subject|1|||
147272164|NCT03400033|531164482|FG001|Overall Study|Withdrawal by Subject|2|||
147272165|NCT01524770|531164492|FG000|First Intervention|Withdrawal by Subject|1|||
147272166|NCT01524770|531164493|FG001|First Intervention|Withdrawal by Subject|0|||
147272167|NCT01524770|531164492|FG000|First Intervention|Adverse Event|1|||
147272168|NCT01524770|531164493|FG001|First Intervention|Adverse Event|1|||
147272169|NCT01524770|531164492|FG000|First Intervention|Protocol Violation|1|||
147272170|NCT01524770|531164493|FG001|First Intervention|Protocol Violation|0|||
147272171|NCT02469610|531164495|FG000|Overall Study|Death|1|||
147272172|NCT02469610|531164496|FG001|Overall Study|Death|0|||
147272173|NCT02469610|531164495|FG000|Overall Study|Lost to Follow-up|1|||
147333643|NCT03621761|531387750|FG002|Overall Study|Lost to Follow-up|2|||
147333644|NCT03621761|531387748|FG000|Overall Study|Withdrawal by Subject|2|||
147272174|NCT02469610|531164496|FG001|Overall Study|Lost to Follow-up|0|||
147272175|NCT02469610|531164495|FG000|Overall Study|exclusion criteria|2|||
147272176|NCT02469610|531164496|FG001|Overall Study|exclusion criteria|1|||
147272177|NCT03467425|531164499|FG000|Overall Study|Adverse Event|9|||
147272178|NCT03467425|531164500|FG001|Overall Study|Adverse Event|9|||
147272179|NCT03467425|531164499|FG000|Overall Study|Lack of Efficacy|3|||
147272180|NCT03467425|531164500|FG001|Overall Study|Lack of Efficacy|1|||
147272181|NCT03467425|531164499|FG000|Overall Study|Protocol Violation|0|||
147272182|NCT03467425|531164500|FG001|Overall Study|Protocol Violation|1|||
147272183|NCT03467425|531164499|FG000|Overall Study|Lost to Follow-up|18|||
147272184|NCT03467425|531164500|FG001|Overall Study|Lost to Follow-up|25|||
147272185|NCT03467425|531164499|FG000|Overall Study|Physician Decision|2|||
147272186|NCT03467425|531164500|FG001|Overall Study|Physician Decision|1|||
147272187|NCT03467425|531164499|FG000|Overall Study|Withdrawal by Subject|15|||
147272188|NCT03467425|531164500|FG001|Overall Study|Withdrawal by Subject|17|||
147272189|NCT01864291|531164501|FG000|Overall Study|need for revision surgery|2|||
147272190|NCT01387607|531164507|FG000|Overall Study|Adverse Event|23|||
147272191|NCT01387607|531164508|FG001|Overall Study|Adverse Event|11|||
147272192|NCT01387607|531164507|FG000|Overall Study|Lack of Efficacy|8|||
147272193|NCT01387607|531164508|FG001|Overall Study|Lack of Efficacy|6|||
147272194|NCT01387607|531164507|FG000|Overall Study|Lost to Follow-up|2|||
147272195|NCT01387607|531164508|FG001|Overall Study|Lost to Follow-up|1|||
147272196|NCT01387607|531164507|FG000|Overall Study|No longer meets eligibility criteria|0|||
147272197|NCT01387607|531164508|FG001|Overall Study|No longer meets eligibility criteria|1|||
147272198|NCT01387607|531164507|FG000|Overall Study|Protocol Violation|1|||
147272199|NCT01387607|531164508|FG001|Overall Study|Protocol Violation|5|||
147272200|NCT01387607|531164507|FG000|Overall Study|Withdrawal by Subject|13|||
147272201|NCT01387607|531164508|FG001|Overall Study|Withdrawal by Subject|14|||
147272202|NCT01387607|531164507|FG000|Overall Study|Other|1|||
147272203|NCT01387607|531164508|FG001|Overall Study|Other|1|||
147272204|NCT01387607|531164507|FG000|Overall Study|Randomized, not treated|3|||
147272205|NCT01387607|531164508|FG001|Overall Study|Randomized, not treated|6|||
147272206|NCT03091192|531164515|FG000|Overall Study|Study terminated by sponsor|21|||
147272207|NCT03091192|531164516|FG001|Overall Study|Study terminated by sponsor|14|||
147272208|NCT03091192|531164515|FG000|Overall Study|Death|9|||
147272209|NCT03091192|531164516|FG001|Overall Study|Death|13|||
147272210|NCT03091192|531164515|FG000|Overall Study|Withdrawal by Subject|2|||
147272211|NCT03091192|531164516|FG001|Overall Study|Withdrawal by Subject|0|||
147272212|NCT03091192|531164515|FG000|Overall Study|Lost to Follow-up|1|||
147272213|NCT03091192|531164516|FG001|Overall Study|Lost to Follow-up|0|||
147272214|NCT03285646|531165992|FG000|Overall Study|Adverse Event|1|||
147272215|NCT03285646|531165993|FG001|Overall Study|Adverse Event|0|||
147272216|NCT03285646|531165992|FG000|Overall Study|Withdrawal by Subject|10|||
147272217|NCT03285646|531165993|FG001|Overall Study|Withdrawal by Subject|2|||
147272218|NCT03285646|531165992|FG000|Overall Study|Lost to Follow-up|2|||
147272219|NCT03285646|531165993|FG001|Overall Study|Lost to Follow-up|1|||
147272220|NCT03285646|531165992|FG000|Overall Study|Investigator/Sponsor Decision|0|||
147272221|NCT03285646|531165993|FG001|Overall Study|Investigator/Sponsor Decision|1|||
147272222|NCT04300296|531165999|FG000|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|1|||
147272223|NCT04300296|531166000|FG001|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|0|||
147272224|NCT04300296|531166001|FG002|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|0|||
147272225|NCT04300296|531166002|FG003|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|0|||
147272226|NCT04300296|531166003|FG004|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|0|||
147272227|NCT04300296|531166004|FG005|Treatment Period 1: Baseline to 16 Weeks|Progressive disease|0|||
147272228|NCT04300296|531165999|FG000|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|0|||
147272229|NCT04300296|531166000|FG001|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|0|||
147272230|NCT04300296|531166001|FG002|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|0|||
147272231|NCT04300296|531166002|FG003|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|0|||
147272232|NCT04300296|531166003|FG004|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|1|||
147272233|NCT04300296|531166004|FG005|Treatment Period 1: Baseline to 16 Weeks|Adverse Event|0|||
147272234|NCT04300296|531165999|FG000|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|1|||
147272235|NCT04300296|531166000|FG001|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|2|||
147272236|NCT04300296|531166001|FG002|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|0|||
147272237|NCT04300296|531166002|FG003|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|0|||
147272238|NCT04300296|531166003|FG004|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|0|||
147272239|NCT04300296|531166004|FG005|Treatment Period 1: Baseline to 16 Weeks|Subject/guardian decision|1|||
147272240|NCT04300296|531165999|FG000|Treatment Period 2: 16 to 32 Weeks|Adverse Event|1|||
147272241|NCT04300296|531166000|FG001|Treatment Period 2: 16 to 32 Weeks|Adverse Event|0|||
147272242|NCT04300296|531166001|FG002|Treatment Period 2: 16 to 32 Weeks|Adverse Event|2|||
147272243|NCT04300296|531166002|FG003|Treatment Period 2: 16 to 32 Weeks|Adverse Event|0|||
147272244|NCT04300296|531166003|FG004|Treatment Period 2: 16 to 32 Weeks|Adverse Event|1|||
147272245|NCT04300296|531166004|FG005|Treatment Period 2: 16 to 32 Weeks|Adverse Event|0|||
147272246|NCT04300296|531165999|FG000|Treatment Period 2: 16 to 32 Weeks|Progressive disease|2|||
147272247|NCT04300296|531166000|FG001|Treatment Period 2: 16 to 32 Weeks|Progressive disease|0|||
147272248|NCT04300296|531166001|FG002|Treatment Period 2: 16 to 32 Weeks|Progressive disease|1|||
147272249|NCT04300296|531166002|FG003|Treatment Period 2: 16 to 32 Weeks|Progressive disease|0|||
147333645|NCT03621761|531387749|FG001|Overall Study|Withdrawal by Subject|1|||
147333646|NCT03621761|531387750|FG002|Overall Study|Withdrawal by Subject|1|||
147272250|NCT04300296|531166003|FG004|Treatment Period 2: 16 to 32 Weeks|Progressive disease|2|||
147272251|NCT04300296|531166004|FG005|Treatment Period 2: 16 to 32 Weeks|Progressive disease|0|||
147272252|NCT04300296|531165999|FG000|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|0|||
147272253|NCT04300296|531166000|FG001|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|1|||
147272254|NCT04300296|531166001|FG002|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|0|||
147272255|NCT04300296|531166002|FG003|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|0|||
147272256|NCT04300296|531166003|FG004|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|0|||
147272257|NCT04300296|531166004|FG005|Treatment Period 2: 16 to 32 Weeks|Protocol deviation|0|||
147272258|NCT04300296|531165999|FG000|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|2|||
147272259|NCT04300296|531166000|FG001|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|0|||
147272260|NCT04300296|531166001|FG002|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|1|||
147272261|NCT04300296|531166002|FG003|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|1|||
147272262|NCT04300296|531166003|FG004|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|3|||
147272263|NCT04300296|531166004|FG005|Treatment Period 2: 16 to 32 Weeks|Subject/guardian decision|0|||
147272264|NCT02896127|531166005|FG000|COMPLETED WEEK 52|Adverse Event|9|||
147272265|NCT02896127|531166006|FG001|COMPLETED WEEK 52|Adverse Event|2|||
147272266|NCT02896127|531166005|FG000|COMPLETED WEEK 52|Lack of Efficacy|2|||
147272267|NCT02896127|531166006|FG001|COMPLETED WEEK 52|Lack of Efficacy|3|||
147272268|NCT02896127|531166005|FG000|COMPLETED WEEK 52|Lost to Follow-up|0|||
147272269|NCT02896127|531166006|FG001|COMPLETED WEEK 52|Lost to Follow-up|1|||
147272270|NCT02896127|531166005|FG000|COMPLETED WEEK 52|Physician Decision|1|||
147272271|NCT02896127|531166006|FG001|COMPLETED WEEK 52|Physician Decision|1|||
147272272|NCT02896127|531166005|FG000|COMPLETED WEEK 52|Pregnancy|2|||
147272273|NCT02896127|531166006|FG001|COMPLETED WEEK 52|Pregnancy|0|||
147272274|NCT02896127|531166005|FG000|COMPLETED WEEK 52|Withdrawal by Subject|12|||
147272275|NCT02896127|531166006|FG001|COMPLETED WEEK 52|Withdrawal by Subject|4|||
147272276|NCT02896127|531166005|FG000|COMPLETED WEEK 52|Technical problems|1|||
147272277|NCT02896127|531166006|FG001|COMPLETED WEEK 52|Technical problems|0|||
147272278|NCT02896127|531166005|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Withdrawal by Subject|2|||
147272279|NCT02896127|531166006|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Withdrawal by Subject|3|||
147272280|NCT02896127|531166005|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Lost to Follow-up|0|||
147272281|NCT02896127|531166006|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Lost to Follow-up|1|||
147272282|NCT02896127|531166005|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Physician Decision|1|||
147272283|NCT02896127|531166006|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Physician Decision|0|||
147272284|NCT02896127|531166005|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Pregnancy|1|||
147272285|NCT02896127|531166006|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Pregnancy|0|||
147272286|NCT02896127|531166005|FG000|COMPLETED POST-TREATMENT FOLLOW UP|Protocol Violation|0|||
147272287|NCT02896127|531166006|FG001|COMPLETED POST-TREATMENT FOLLOW UP|Protocol Violation|1|||
147272288|NCT00279708|531166007|FG000|Overall Study|Withdrawal by Subject|2|||
147272289|NCT00279708|531166008|FG001|Overall Study|Withdrawal by Subject|3|||
147272290|NCT00279708|531166007|FG000|Overall Study|Adverse Event|1|||
147272291|NCT00279708|531166008|FG001|Overall Study|Adverse Event|1|||
147272292|NCT03912233|531166009|FG000|Overall Study|Adverse Event|1|||
147272293|NCT03912233|531166010|FG001|Overall Study|Adverse Event|0|||
147272294|NCT03912233|531166011|FG002|Overall Study|Adverse Event|0|||
147272295|NCT03912233|531166012|FG003|Overall Study|Adverse Event|0|||
147272296|NCT03912233|531166013|FG004|Overall Study|Adverse Event|0|||
147272297|NCT03912233|531166014|FG005|Overall Study|Adverse Event|0|||
147333647|NCT03621761|531387748|FG000|Overall Study|Became Ineligible|0|||
147450556|NCT02069899|531811453|FG002|Overall Study|Withdrawal by Participant|0|||
147450557|NCT02069899|531811451|FG000|Overall Study|Lost to Follow-up|1|||
147272298|NCT03912233|531166009|FG000|Overall Study|Physician Decision|1|||
147272299|NCT03912233|531166010|FG001|Overall Study|Physician Decision|0|||
147272300|NCT03912233|531166011|FG002|Overall Study|Physician Decision|0|||
147272301|NCT03912233|531166012|FG003|Overall Study|Physician Decision|0|||
147272302|NCT03912233|531166013|FG004|Overall Study|Physician Decision|0|||
147272303|NCT03912233|531166014|FG005|Overall Study|Physician Decision|0|||
147272304|NCT03912233|531166009|FG000|Overall Study|Other|0|||
147272305|NCT03912233|531166010|FG001|Overall Study|Other|0|||
147272306|NCT03912233|531166011|FG002|Overall Study|Other|0|||
147272307|NCT03912233|531166012|FG003|Overall Study|Other|0|||
147272308|NCT03912233|531166013|FG004|Overall Study|Other|7|||
147272309|NCT03912233|531166014|FG005|Overall Study|Other|12|||
147272310|NCT00326911|531166015|FG000|Overall Study|Hospitalization prior to treatment|0|||
147272311|NCT00326911|531166016|FG001|Overall Study|Hospitalization prior to treatment|1|||
147272312|NCT00326911|531166015|FG000|Overall Study|Physician decision prior to treatment|1|||
147272313|NCT00326911|531166016|FG001|Overall Study|Physician decision prior to treatment|0|||
147272314|NCT00326911|531166015|FG000|Overall Study|Withdrawal by subject prior to treatment|0|||
147272315|NCT00326911|531166016|FG001|Overall Study|Withdrawal by subject prior to treatment|1|||
147272316|NCT01023659|531166020|FG000|Overall Study|Lost to Follow-up|73|||
147272317|NCT01023659|531166021|FG001|Overall Study|Lost to Follow-up|228|||
147272318|NCT01023659|531166022|FG002|Overall Study|Lost to Follow-up|99|||
147272319|NCT04537806|531166023|FG000|Overall Study|Randomized but not treated|1|||
147272320|NCT04537806|531166024|FG001|Overall Study|Randomized but not treated|0|||
147272321|NCT04537806|531166023|FG000|Overall Study|Adverse Event|1|||
147272322|NCT04537806|531166024|FG001|Overall Study|Adverse Event|1|||
147272323|NCT01434823|531166030|FG000|Overall Study|Incomplete data in medical record|4|||
147272324|NCT01434823|531166031|FG001|Overall Study|Incomplete data in medical record|7|||
147272325|NCT02477020|531166037|FG000|Overall Study|Pretreatment Event/Adverse Event|6|||
147272326|NCT02477020|531166038|FG001|Overall Study|Pretreatment Event/Adverse Event|6|||
147272327|NCT02477020|531166037|FG000|Overall Study|Voluntary Withdrawal|7|||
147272328|NCT02477020|531166038|FG001|Overall Study|Voluntary Withdrawal|16|||
147272329|NCT02477020|531166037|FG000|Overall Study|Reason not Specified|3|||
147272330|NCT02477020|531166038|FG001|Overall Study|Reason not Specified|1|||
147272331|NCT02477020|531166037|FG000|Overall Study|Lack of Efficacy|14|||
147272332|NCT02477020|531166038|FG001|Overall Study|Lack of Efficacy|5|||
147272333|NCT00501540|531166039|FG000|Overall Study|Death|5|||
147272334|NCT00519649|531166040|FG000|Overall Study|Withdrawal by Subject|1|||
147272335|NCT01465802|531166041|FG000|Overall Study|Study terminated by sponsor|1|||
147272336|NCT01465802|531166042|FG001|Overall Study|Study terminated by sponsor|0|||
147272337|NCT01465802|531166043|FG002|Overall Study|Study terminated by sponsor|0|||
147272338|NCT01465802|531166044|FG003|Overall Study|Study terminated by sponsor|1|||
147272339|NCT01465802|531166045|FG004|Overall Study|Study terminated by sponsor|7|||
147272340|NCT01465802|531166041|FG000|Overall Study|Withdrawal by Subject|7|||
147272341|NCT01465802|531166042|FG001|Overall Study|Withdrawal by Subject|7|||
147272342|NCT01465802|531166043|FG002|Overall Study|Withdrawal by Subject|0|||
147272343|NCT01465802|531166044|FG003|Overall Study|Withdrawal by Subject|8|||
147272344|NCT01465802|531166045|FG004|Overall Study|Withdrawal by Subject|1|||
147272345|NCT01465802|531166041|FG000|Overall Study|Lost to Follow-up|1|||
147272346|NCT01465802|531166042|FG001|Overall Study|Lost to Follow-up|1|||
147272347|NCT01465802|531166043|FG002|Overall Study|Lost to Follow-up|0|||
147272348|NCT01465802|531166044|FG003|Overall Study|Lost to Follow-up|0|||
147272349|NCT01465802|531166045|FG004|Overall Study|Lost to Follow-up|0|||
147272350|NCT01465802|531166041|FG000|Overall Study|Reason not specified|9|||
147272351|NCT01465802|531166042|FG001|Overall Study|Reason not specified|4|||
147272352|NCT01465802|531166043|FG002|Overall Study|Reason not specified|0|||
147272353|NCT01465802|531166044|FG003|Overall Study|Reason not specified|10|||
147272354|NCT01465802|531166045|FG004|Overall Study|Reason not specified|2|||
147272355|NCT01465802|531166041|FG000|Overall Study|Death|15|||
147272356|NCT01465802|531166042|FG001|Overall Study|Death|12|||
147272357|NCT01465802|531166043|FG002|Overall Study|Death|0|||
147272358|NCT01465802|531166044|FG003|Overall Study|Death|10|||
147272359|NCT01465802|531166045|FG004|Overall Study|Death|2|||
147272360|NCT02331446|531166046|FG000|Overall Study|Lost to Follow-up|2|||
147272361|NCT02331446|531166047|FG001|Overall Study|Lost to Follow-up|1|||
147272362|NCT02331446|531166048|FG002|Overall Study|Lost to Follow-up|0|||
147272363|NCT02331446|531166049|FG003|Overall Study|Lost to Follow-up|1|||
147272364|NCT02331446|531166046|FG000|Overall Study|Personal Problem|2|||
147272365|NCT02331446|531166047|FG001|Overall Study|Personal Problem|0|||
147272366|NCT02331446|531166048|FG002|Overall Study|Personal Problem|0|||
147272367|NCT02331446|531166049|FG003|Overall Study|Personal Problem|0|||
147272368|NCT02331446|531166046|FG000|Overall Study|Disease|0|||
147272369|NCT02331446|531166047|FG001|Overall Study|Disease|2|||
147272370|NCT02331446|531166048|FG002|Overall Study|Disease|2|||
147272371|NCT02331446|531166049|FG003|Overall Study|Disease|1|||
147272372|NCT02331446|531166046|FG000|Overall Study|Physician Decision|0|||
147272373|NCT02331446|531166047|FG001|Overall Study|Physician Decision|1|||
147272374|NCT02331446|531166048|FG002|Overall Study|Physician Decision|0|||
147272375|NCT02331446|531166049|FG003|Overall Study|Physician Decision|1|||
147272376|NCT02331446|531166046|FG000|Overall Study|Lost before baseline analysis|0|||
147272377|NCT02331446|531166047|FG001|Overall Study|Lost before baseline analysis|1|||
147272378|NCT02331446|531166048|FG002|Overall Study|Lost before baseline analysis|1|||
147272379|NCT02331446|531166049|FG003|Overall Study|Lost before baseline analysis|0|||
147272380|NCT04879745|531166050|FG000|Overall Study|Lost to Follow-up|4|||
147272381|NCT04879745|531166051|FG001|Overall Study|Lost to Follow-up|1|||
147272382|NCT00120042|531166052|FG000|Overall Study|all completed protocl|0|||
147272383|NCT00120042|531166053|FG001|Overall Study|all completed protocl|0|||
147272384|NCT00120042|531166054|FG002|Overall Study|all completed protocl|0|||
147272385|NCT03852316|531166055|FG000|Overall Study|Protocol Violation|1|||
147272386|NCT03852316|531166055|FG000|Overall Study|Withdrawal by Subject|2|||
147272387|NCT03852316|531166055|FG000|Overall Study|Enrolled but Device not Utilized|1|||
147272388|NCT04532112|531166056|FG000|Overall Study|Adverse Event|3|||
147272389|NCT04532112|531166057|FG001|Overall Study|Adverse Event|0|||
147272390|NCT03592641|531166058|FG000|Overall Study|Withdrawal by Subject|1|||
147272391|NCT03219333|531166060|FG000|Overall Study|Withdrawal by Subject|9|||
147272392|NCT03219333|531166061|FG001|Overall Study|Withdrawal by Subject|4|||
147272393|NCT03219333|531166060|FG000|Overall Study|Lost to Follow-up|1|||
147272394|NCT03219333|531166061|FG001|Overall Study|Lost to Follow-up|1|||
147272395|NCT03219333|531166060|FG000|Overall Study|Death|104|||
147272396|NCT03219333|531166061|FG001|Overall Study|Death|72|||
147333648|NCT03621761|531387749|FG001|Overall Study|Became Ineligible|2|||
147272397|NCT03219333|531166060|FG000|Overall Study|Study closed in 2023,as all milestones reached, majority of participants completed 5 years follow-up|12|||
147272398|NCT03219333|531166061|FG001|Overall Study|Study closed in 2023,as all milestones reached, majority of participants completed 5 years follow-up|12|||
147272399|NCT03219333|531166060|FG000|Overall Study|Other|2|||
147272400|NCT03219333|531166061|FG001|Overall Study|Other|2|||
147272401|NCT01126541|531166062|FG000|Overall Study|Adverse Event|0|||
147272402|NCT01126541|531166063|FG001|Overall Study|Adverse Event|2|||
147272403|NCT01126541|531166064|FG002|Overall Study|Adverse Event|4|||
147272404|NCT01126541|531166062|FG000|Overall Study|Death|0|||
147272405|NCT01126541|531166063|FG001|Overall Study|Death|1|||
147272406|NCT01126541|531166064|FG002|Overall Study|Death|0|||
147272407|NCT01126541|531166062|FG000|Overall Study|Lack of Efficacy|6|||
147272408|NCT01126541|531166063|FG001|Overall Study|Lack of Efficacy|1|||
147272409|NCT01126541|531166064|FG002|Overall Study|Lack of Efficacy|11|||
147272410|NCT01126541|531166062|FG000|Overall Study|Lost to Follow-up|1|||
147272411|NCT01126541|531166063|FG001|Overall Study|Lost to Follow-up|2|||
147272412|NCT01126541|531166064|FG002|Overall Study|Lost to Follow-up|2|||
147272413|NCT01126541|531166062|FG000|Overall Study|Withdrawal by Subject|2|||
147272414|NCT01126541|531166063|FG001|Overall Study|Withdrawal by Subject|5|||
147272415|NCT01126541|531166064|FG002|Overall Study|Withdrawal by Subject|6|||
147272416|NCT01126541|531166062|FG000|Overall Study|Protocol Violation|0|||
147272417|NCT01126541|531166063|FG001|Overall Study|Protocol Violation|0|||
147272418|NCT01126541|531166064|FG002|Overall Study|Protocol Violation|1|||
147272419|NCT01126541|531166062|FG000|Overall Study|Administrative reason or other|1|||
147272420|NCT01126541|531166063|FG001|Overall Study|Administrative reason or other|1|||
147272421|NCT01126541|531166064|FG002|Overall Study|Administrative reason or other|2|||
147272422|NCT03670810|531166065|FG000|Main Study|Adverse Event|37|||
147272423|NCT03670810|531166066|FG001|Main Study|Adverse Event|38|||
147272424|NCT03670810|531166067|FG002|Main Study|Adverse Event|3|||
147272425|NCT03670810|531166068|FG003|Main Study|Adverse Event|4|||
147272426|NCT03670810|531166069|FG004|Main Study|Adverse Event|4|||
147272427|NCT03670810|531166070|FG005|Main Study|Adverse Event|5|||
147272428|NCT03670810|531166071|FG006|Main Study|Adverse Event|0|||
147272429|NCT03670810|531166072|FG007|Main Study|Adverse Event|0|||
147272430|NCT03670810|531166073|FG008|Main Study|Adverse Event|0|||
147272431|NCT03670810|531166065|FG000|Main Study|Lack of Efficacy|8|||
147272432|NCT03670810|531166066|FG001|Main Study|Lack of Efficacy|9|||
147272433|NCT03670810|531166067|FG002|Main Study|Lack of Efficacy|3|||
147272434|NCT03670810|531166068|FG003|Main Study|Lack of Efficacy|4|||
147272435|NCT03670810|531166069|FG004|Main Study|Lack of Efficacy|0|||
147272436|NCT03670810|531166070|FG005|Main Study|Lack of Efficacy|0|||
147272437|NCT03670810|531166071|FG006|Main Study|Lack of Efficacy|0|||
147272438|NCT03670810|531166072|FG007|Main Study|Lack of Efficacy|0|||
147272439|NCT03670810|531166073|FG008|Main Study|Lack of Efficacy|0|||
147272440|NCT03670810|531166065|FG000|Main Study|Lost to Follow-up|9|||
147272441|NCT03670810|531166066|FG001|Main Study|Lost to Follow-up|7|||
147272442|NCT03670810|531166067|FG002|Main Study|Lost to Follow-up|4|||
147272443|NCT03670810|531166068|FG003|Main Study|Lost to Follow-up|6|||
147272444|NCT03670810|531166069|FG004|Main Study|Lost to Follow-up|1|||
147272445|NCT03670810|531166070|FG005|Main Study|Lost to Follow-up|0|||
147272446|NCT03670810|531166071|FG006|Main Study|Lost to Follow-up|0|||
147272447|NCT03670810|531166072|FG007|Main Study|Lost to Follow-up|0|||
147272448|NCT03670810|531166073|FG008|Main Study|Lost to Follow-up|0|||
147272449|NCT03670810|531166065|FG000|Main Study|Non-compliance with Study Drug|0|||
147272450|NCT03670810|531166066|FG001|Main Study|Non-compliance with Study Drug|2|||
147662377|NCT02498678|532587313|FG001|Overall Study|interference from the surgical team|2|||
147662378|NCT01145482|532587314|FG000|First Intervention (1 Day)|Withdrawal by Subject|0|||
147662379|NCT01145482|532587315|FG001|First Intervention (1 Day)|Withdrawal by Subject|1|||
147272451|NCT03670810|531166067|FG002|Main Study|Non-compliance with Study Drug|3|||
147272452|NCT03670810|531166068|FG003|Main Study|Non-compliance with Study Drug|0|||
147272453|NCT03670810|531166069|FG004|Main Study|Non-compliance with Study Drug|0|||
147272454|NCT03670810|531166070|FG005|Main Study|Non-compliance with Study Drug|0|||
147272455|NCT03670810|531166071|FG006|Main Study|Non-compliance with Study Drug|0|||
147272456|NCT03670810|531166072|FG007|Main Study|Non-compliance with Study Drug|1|||
147272457|NCT03670810|531166073|FG008|Main Study|Non-compliance with Study Drug|0|||
147272458|NCT03670810|531166065|FG000|Main Study|Physician Decision|3|||
147272459|NCT03670810|531166066|FG001|Main Study|Physician Decision|0|||
147272460|NCT03670810|531166067|FG002|Main Study|Physician Decision|1|||
147272461|NCT03670810|531166068|FG003|Main Study|Physician Decision|0|||
147272462|NCT03670810|531166069|FG004|Main Study|Physician Decision|0|||
147272463|NCT03670810|531166070|FG005|Main Study|Physician Decision|0|||
147272464|NCT03670810|531166071|FG006|Main Study|Physician Decision|1|||
147272465|NCT03670810|531166072|FG007|Main Study|Physician Decision|1|||
147272466|NCT03670810|531166073|FG008|Main Study|Physician Decision|0|||
147272467|NCT03670810|531166065|FG000|Main Study|Pregnancy|1|||
147272468|NCT03670810|531166066|FG001|Main Study|Pregnancy|2|||
147272469|NCT03670810|531166067|FG002|Main Study|Pregnancy|0|||
147272470|NCT03670810|531166068|FG003|Main Study|Pregnancy|0|||
147272471|NCT03670810|531166069|FG004|Main Study|Pregnancy|0|||
147272472|NCT03670810|531166070|FG005|Main Study|Pregnancy|0|||
147450558|NCT02069899|531811452|FG001|Overall Study|Lost to Follow-up|0|||
147450559|NCT02069899|531811453|FG002|Overall Study|Lost to Follow-up|1|||
147272473|NCT03670810|531166071|FG006|Main Study|Pregnancy|0|||
147272474|NCT03670810|531166072|FG007|Main Study|Pregnancy|0|||
147272475|NCT03670810|531166073|FG008|Main Study|Pregnancy|0|||
147272476|NCT03670810|531166065|FG000|Main Study|Protocol Deviation|2|||
147272477|NCT03670810|531166066|FG001|Main Study|Protocol Deviation|12|||
147272478|NCT03670810|531166067|FG002|Main Study|Protocol Deviation|8|||
147272479|NCT03670810|531166068|FG003|Main Study|Protocol Deviation|4|||
147272480|NCT03670810|531166069|FG004|Main Study|Protocol Deviation|0|||
147272481|NCT03670810|531166070|FG005|Main Study|Protocol Deviation|0|||
147272482|NCT03670810|531166071|FG006|Main Study|Protocol Deviation|0|||
147272483|NCT03670810|531166072|FG007|Main Study|Protocol Deviation|0|||
147272484|NCT03670810|531166073|FG008|Main Study|Protocol Deviation|0|||
147272485|NCT03670810|531166065|FG000|Main Study|Withdrawal by Subject|21|||
147272486|NCT03670810|531166066|FG001|Main Study|Withdrawal by Subject|21|||
147272487|NCT03670810|531166067|FG002|Main Study|Withdrawal by Subject|8|||
147272488|NCT03670810|531166068|FG003|Main Study|Withdrawal by Subject|9|||
147272489|NCT03670810|531166069|FG004|Main Study|Withdrawal by Subject|5|||
147272490|NCT03670810|531166070|FG005|Main Study|Withdrawal by Subject|2|||
147272491|NCT03670810|531166071|FG006|Main Study|Withdrawal by Subject|1|||
147272492|NCT03670810|531166072|FG007|Main Study|Withdrawal by Subject|1|||
147272493|NCT03670810|531166073|FG008|Main Study|Withdrawal by Subject|0|||
147272494|NCT03670810|531166065|FG000|Main Study|Participant did not want to take the three other treatments|1|||
147272495|NCT03670810|531166066|FG001|Main Study|Participant did not want to take the three other treatments|0|||
147272496|NCT03670810|531166067|FG002|Main Study|Participant did not want to take the three other treatments|0|||
147272497|NCT03670810|531166068|FG003|Main Study|Participant did not want to take the three other treatments|0|||
147272498|NCT03670810|531166069|FG004|Main Study|Participant did not want to take the three other treatments|0|||
147272499|NCT03670810|531166070|FG005|Main Study|Participant did not want to take the three other treatments|0|||
147272500|NCT03670810|531166071|FG006|Main Study|Participant did not want to take the three other treatments|0|||
147272501|NCT03670810|531166072|FG007|Main Study|Participant did not want to take the three other treatments|0|||
147272502|NCT03670810|531166073|FG008|Main Study|Participant did not want to take the three other treatments|0|||
147272503|NCT03670810|531166065|FG000|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
147272504|NCT03670810|531166066|FG001|Main Study|Migraines more frequent-GP advised to re-start Topiramate|1|||
147272505|NCT03670810|531166067|FG002|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
147272506|NCT03670810|531166068|FG003|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
147272507|NCT03670810|531166069|FG004|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
147272508|NCT03670810|531166070|FG005|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
147272509|NCT03670810|531166071|FG006|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
147272510|NCT03670810|531166072|FG007|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
147272511|NCT03670810|531166073|FG008|Main Study|Migraines more frequent-GP advised to re-start Topiramate|0|||
147272512|NCT03670810|531166065|FG000|Main Study|Travel and Coronavirus issues|0|||
147272513|NCT03670810|531166066|FG001|Main Study|Travel and Coronavirus issues|0|||
147272514|NCT03670810|531166067|FG002|Main Study|Travel and Coronavirus issues|0|||
147272515|NCT03670810|531166068|FG003|Main Study|Travel and Coronavirus issues|1|||
147272516|NCT03670810|531166069|FG004|Main Study|Travel and Coronavirus issues|0|||
147272517|NCT03670810|531166070|FG005|Main Study|Travel and Coronavirus issues|0|||
147272518|NCT03670810|531166071|FG006|Main Study|Travel and Coronavirus issues|0|||
147272519|NCT03670810|531166072|FG007|Main Study|Travel and Coronavirus issues|0|||
147272520|NCT03670810|531166073|FG008|Main Study|Travel and Coronavirus issues|0|||
147272521|NCT03670810|531166065|FG000|Open Label Extension|Protocol Deviation|0|||
147272522|NCT03670810|531166066|FG001|Open Label Extension|Protocol Deviation|0|||
147272523|NCT03670810|531166067|FG002|Open Label Extension|Protocol Deviation|0|||
147272524|NCT03670810|531166068|FG003|Open Label Extension|Protocol Deviation|0|||
147450560|NCT02069899|531811451|FG000|Overall Study|Other|4|||
147450561|NCT02069899|531811452|FG001|Overall Study|Other|0|||
147450562|NCT02069899|531811453|FG002|Overall Study|Other|0|||
147450563|NCT02069899|531811451|FG000|Overall Study|Participant could not travel to the study site due to Covid restrictions|0|||
147450564|NCT02069899|531811452|FG001|Overall Study|Participant could not travel to the study site due to Covid restrictions|1|||
147450565|NCT02069899|531811453|FG002|Overall Study|Participant could not travel to the study site due to Covid restrictions|0|||
147450566|NCT02069899|531811451|FG000|Overall Study|Participant was withdrawn to receive emapalumab again in CU and then subsequently died|0|||
147450567|NCT02069899|531811452|FG001|Overall Study|Participant was withdrawn to receive emapalumab again in CU and then subsequently died|0|||
147272525|NCT03670810|531166069|FG004|Open Label Extension|Protocol Deviation|0|||
147272526|NCT03670810|531166070|FG005|Open Label Extension|Protocol Deviation|0|||
147272527|NCT03670810|531166071|FG006|Open Label Extension|Protocol Deviation|0|||
147272528|NCT03670810|531166072|FG007|Open Label Extension|Protocol Deviation|0|||
147272529|NCT03670810|531166073|FG008|Open Label Extension|Protocol Deviation|5|||
147272530|NCT03670810|531166065|FG000|Open Label Extension|Death|0|||
147272531|NCT03670810|531166066|FG001|Open Label Extension|Death|0|||
147272532|NCT03670810|531166067|FG002|Open Label Extension|Death|0|||
147272533|NCT03670810|531166068|FG003|Open Label Extension|Death|0|||
147272534|NCT03670810|531166069|FG004|Open Label Extension|Death|0|||
147272535|NCT03670810|531166070|FG005|Open Label Extension|Death|0|||
147333649|NCT03621761|531387750|FG002|Overall Study|Became Ineligible|0|||
147333650|NCT01050569|531387751|FG000|Overall Study|Lost to Follow-up|20|||
147333651|NCT01050569|531387752|FG001|Overall Study|Lost to Follow-up|14|||
147333652|NCT01050569|531387753|FG002|Overall Study|Lost to Follow-up|16|||
147333653|NCT01050569|531387751|FG000|Overall Study|Withdrawal by Subject|9|||
147333654|NCT01050569|531387752|FG001|Overall Study|Withdrawal by Subject|3|||
147333655|NCT01050569|531387753|FG002|Overall Study|Withdrawal by Subject|11|||
147333656|NCT01050569|531387751|FG000|Overall Study|Lack of Efficacy|5|||
147333657|NCT01050569|531387752|FG001|Overall Study|Lack of Efficacy|4|||
147333658|NCT01050569|531387753|FG002|Overall Study|Lack of Efficacy|3|||
147333659|NCT01050569|531387751|FG000|Overall Study|Adverse Event|1|||
147333660|NCT01050569|531387752|FG001|Overall Study|Adverse Event|0|||
147333661|NCT01050569|531387753|FG002|Overall Study|Adverse Event|0|||
147333662|NCT01050569|531387751|FG000|Overall Study|Physician Decision|3|||
147333663|NCT01050569|531387752|FG001|Overall Study|Physician Decision|3|||
147333664|NCT01050569|531387753|FG002|Overall Study|Physician Decision|3|||
147333665|NCT00756730|531387758|FG000|Overall Study|discontinued due to rash prior to week 4|0|||
147333666|NCT00756730|531387759|FG001|Overall Study|discontinued due to rash prior to week 4|1|||
147333667|NCT00756730|531387758|FG000|Overall Study|persistent low-level viremmia|0|||
147333668|NCT00756730|531387759|FG001|Overall Study|persistent low-level viremmia|1|||
147333669|NCT00639002|531387760|FG000|Overall Study|Death|1|||
147333670|NCT00639002|531387760|FG000|Overall Study|Adverse Event|1|||
147333671|NCT00639002|531387760|FG000|Overall Study|Protocol Violation|1|||
147333672|NCT00639002|531387760|FG000|Overall Study|Disease progression|3|||
147333673|NCT00639002|531387760|FG000|Overall Study|Physician Decision|6|||
147333674|NCT00639002|531387760|FG000|Overall Study|Lack of Efficacy|1|||
147333675|NCT05190419|531387762|FG000|Overall Study|Lack of Efficacy|8|||
147272536|NCT03670810|531166071|FG006|Open Label Extension|Death|0|||
147272537|NCT03670810|531166072|FG007|Open Label Extension|Death|0|||
147272538|NCT03670810|531166073|FG008|Open Label Extension|Death|1|||
147272539|NCT03670810|531166065|FG000|Open Label Extension|COVID-19|0|||
147272540|NCT03670810|531166066|FG001|Open Label Extension|COVID-19|0|||
147272541|NCT03670810|531166067|FG002|Open Label Extension|COVID-19|0|||
147272542|NCT03670810|531166068|FG003|Open Label Extension|COVID-19|0|||
147272543|NCT03670810|531166069|FG004|Open Label Extension|COVID-19|0|||
147272544|NCT03670810|531166070|FG005|Open Label Extension|COVID-19|0|||
147272545|NCT03670810|531166071|FG006|Open Label Extension|COVID-19|0|||
147272546|NCT03670810|531166072|FG007|Open Label Extension|COVID-19|0|||
147272547|NCT03670810|531166073|FG008|Open Label Extension|COVID-19|1|||
147272548|NCT03670810|531166065|FG000|Open Label Extension|Lack of Efficacy|0|||
147272549|NCT03670810|531166066|FG001|Open Label Extension|Lack of Efficacy|0|||
147272550|NCT03670810|531166067|FG002|Open Label Extension|Lack of Efficacy|0|||
147272551|NCT03670810|531166068|FG003|Open Label Extension|Lack of Efficacy|0|||
147272552|NCT03670810|531166069|FG004|Open Label Extension|Lack of Efficacy|0|||
147272553|NCT03670810|531166070|FG005|Open Label Extension|Lack of Efficacy|0|||
147272554|NCT03670810|531166071|FG006|Open Label Extension|Lack of Efficacy|0|||
147272555|NCT03670810|531166072|FG007|Open Label Extension|Lack of Efficacy|0|||
147272556|NCT03670810|531166073|FG008|Open Label Extension|Lack of Efficacy|39|||
147272557|NCT03670810|531166065|FG000|Open Label Extension|Participant refused to comply with face mask use|0|||
147272558|NCT03670810|531166066|FG001|Open Label Extension|Participant refused to comply with face mask use|0|||
147272559|NCT03670810|531166067|FG002|Open Label Extension|Participant refused to comply with face mask use|0|||
147272560|NCT03670810|531166068|FG003|Open Label Extension|Participant refused to comply with face mask use|0|||
147272561|NCT03670810|531166069|FG004|Open Label Extension|Participant refused to comply with face mask use|0|||
147272562|NCT03670810|531166070|FG005|Open Label Extension|Participant refused to comply with face mask use|0|||
147272563|NCT03670810|531166071|FG006|Open Label Extension|Participant refused to comply with face mask use|0|||
147272564|NCT03670810|531166072|FG007|Open Label Extension|Participant refused to comply with face mask use|0|||
147272565|NCT03670810|531166073|FG008|Open Label Extension|Participant refused to comply with face mask use|1|||
147272566|NCT03670810|531166065|FG000|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
147333676|NCT05190419|531387763|FG001|Overall Study|Lack of Efficacy|0|||
147333677|NCT05190419|531387764|FG002|Overall Study|Lack of Efficacy|1|||
147333678|NCT05190419|531387765|FG003|Overall Study|Lack of Efficacy|0|||
147333679|NCT05190419|531387762|FG000|Overall Study|Withdrawal by Subject|7|||
147272567|NCT03670810|531166066|FG001|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
147333680|NCT05190419|531387763|FG001|Overall Study|Withdrawal by Subject|1|||
147333681|NCT05190419|531387764|FG002|Overall Study|Withdrawal by Subject|2|||
147333682|NCT05190419|531387765|FG003|Overall Study|Withdrawal by Subject|2|||
147272568|NCT03670810|531166067|FG002|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
147272569|NCT03670810|531166068|FG003|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
147272570|NCT03670810|531166069|FG004|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
147272571|NCT03670810|531166070|FG005|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
147272572|NCT03670810|531166071|FG006|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
147272573|NCT03670810|531166072|FG007|Open Label Extension|Taking medication too restrictive for lifestyle|0|||
147272574|NCT03670810|531166073|FG008|Open Label Extension|Taking medication too restrictive for lifestyle|1|||
147272575|NCT03670810|531166065|FG000|Open Label Extension|Withdrawal by Subject|0|||
147272576|NCT03670810|531166066|FG001|Open Label Extension|Withdrawal by Subject|0|||
147272577|NCT03670810|531166067|FG002|Open Label Extension|Withdrawal by Subject|0|||
147272578|NCT03670810|531166068|FG003|Open Label Extension|Withdrawal by Subject|0|||
147272579|NCT03670810|531166069|FG004|Open Label Extension|Withdrawal by Subject|0|||
147272580|NCT03670810|531166070|FG005|Open Label Extension|Withdrawal by Subject|0|||
147272581|NCT03670810|531166071|FG006|Open Label Extension|Withdrawal by Subject|0|||
147272582|NCT03670810|531166072|FG007|Open Label Extension|Withdrawal by Subject|0|||
147272583|NCT03670810|531166073|FG008|Open Label Extension|Withdrawal by Subject|46|||
147272584|NCT03670810|531166065|FG000|Open Label Extension|Participant didn't have disposition for OLE period|0|||
147272585|NCT03670810|531166066|FG001|Open Label Extension|Participant didn't have disposition for OLE period|0|||
147272586|NCT03670810|531166067|FG002|Open Label Extension|Participant didn't have disposition for OLE period|0|||
147272587|NCT03670810|531166068|FG003|Open Label Extension|Participant didn't have disposition for OLE period|0|||
147272588|NCT03670810|531166069|FG004|Open Label Extension|Participant didn't have disposition for OLE period|0|||
147272589|NCT03670810|531166070|FG005|Open Label Extension|Participant didn't have disposition for OLE period|0|||
147272590|NCT03670810|531166071|FG006|Open Label Extension|Participant didn't have disposition for OLE period|0|||
147272591|NCT03670810|531166072|FG007|Open Label Extension|Participant didn't have disposition for OLE period|0|||
147272592|NCT03670810|531166073|FG008|Open Label Extension|Participant didn't have disposition for OLE period|1|||
147272593|NCT03670810|531166065|FG000|Open Label Extension|Physician Decision|0|||
147272594|NCT03670810|531166066|FG001|Open Label Extension|Physician Decision|0|||
147272595|NCT03670810|531166067|FG002|Open Label Extension|Physician Decision|0|||
147272596|NCT03670810|531166068|FG003|Open Label Extension|Physician Decision|0|||
147272597|NCT03670810|531166069|FG004|Open Label Extension|Physician Decision|0|||
147272598|NCT03670810|531166070|FG005|Open Label Extension|Physician Decision|0|||
147272599|NCT03670810|531166071|FG006|Open Label Extension|Physician Decision|0|||
147272600|NCT03670810|531166072|FG007|Open Label Extension|Physician Decision|0|||
147272601|NCT03670810|531166073|FG008|Open Label Extension|Physician Decision|2|||
147272602|NCT03670810|531166065|FG000|Open Label Extension|Non-compliance with study drug|0|||
147272603|NCT03670810|531166066|FG001|Open Label Extension|Non-compliance with study drug|0|||
147272604|NCT03670810|531166067|FG002|Open Label Extension|Non-compliance with study drug|0|||
147272605|NCT03670810|531166068|FG003|Open Label Extension|Non-compliance with study drug|0|||
147272606|NCT03670810|531166069|FG004|Open Label Extension|Non-compliance with study drug|0|||
147272607|NCT03670810|531166070|FG005|Open Label Extension|Non-compliance with study drug|0|||
147272608|NCT03670810|531166071|FG006|Open Label Extension|Non-compliance with study drug|0|||
147272609|NCT03670810|531166072|FG007|Open Label Extension|Non-compliance with study drug|0|||
147272610|NCT03670810|531166073|FG008|Open Label Extension|Non-compliance with study drug|5|||
147272611|NCT03670810|531166065|FG000|Open Label Extension|Pregnancy|0|||
147272612|NCT03670810|531166066|FG001|Open Label Extension|Pregnancy|0|||
147272613|NCT03670810|531166067|FG002|Open Label Extension|Pregnancy|0|||
147272614|NCT03670810|531166068|FG003|Open Label Extension|Pregnancy|0|||
147272615|NCT03670810|531166069|FG004|Open Label Extension|Pregnancy|0|||
147272616|NCT03670810|531166070|FG005|Open Label Extension|Pregnancy|0|||
147272617|NCT03670810|531166071|FG006|Open Label Extension|Pregnancy|0|||
147272618|NCT03670810|531166072|FG007|Open Label Extension|Pregnancy|0|||
147272619|NCT03670810|531166073|FG008|Open Label Extension|Pregnancy|3|||
147272620|NCT03670810|531166065|FG000|Open Label Extension|Adverse Event|0|||
147272621|NCT03670810|531166066|FG001|Open Label Extension|Adverse Event|0|||
147272622|NCT03670810|531166067|FG002|Open Label Extension|Adverse Event|0|||
147272623|NCT03670810|531166068|FG003|Open Label Extension|Adverse Event|0|||
147272624|NCT03670810|531166069|FG004|Open Label Extension|Adverse Event|0|||
147272625|NCT03670810|531166070|FG005|Open Label Extension|Adverse Event|0|||
147272626|NCT03670810|531166071|FG006|Open Label Extension|Adverse Event|0|||
147272627|NCT03670810|531166072|FG007|Open Label Extension|Adverse Event|0|||
147272628|NCT03670810|531166073|FG008|Open Label Extension|Adverse Event|24|||
147272629|NCT03670810|531166065|FG000|Open Label Extension|Participant wanted to become pregnant|0|||
147272630|NCT03670810|531166066|FG001|Open Label Extension|Participant wanted to become pregnant|0|||
147272631|NCT03670810|531166067|FG002|Open Label Extension|Participant wanted to become pregnant|0|||
147272632|NCT03670810|531166068|FG003|Open Label Extension|Participant wanted to become pregnant|0|||
147272633|NCT03670810|531166069|FG004|Open Label Extension|Participant wanted to become pregnant|0|||
147272634|NCT03670810|531166070|FG005|Open Label Extension|Participant wanted to become pregnant|0|||
147272635|NCT03670810|531166071|FG006|Open Label Extension|Participant wanted to become pregnant|0|||
147272636|NCT03670810|531166072|FG007|Open Label Extension|Participant wanted to become pregnant|0|||
147272637|NCT03670810|531166073|FG008|Open Label Extension|Participant wanted to become pregnant|1|||
147272638|NCT03670810|531166065|FG000|Open Label Extension|Lost to Follow-up|0|||
147272639|NCT03670810|531166066|FG001|Open Label Extension|Lost to Follow-up|0|||
147662380|NCT02452047|532587318|FG000|Overall Study|Adverse Event|0|||
147272640|NCT03670810|531166067|FG002|Open Label Extension|Lost to Follow-up|0|||
147272641|NCT03670810|531166068|FG003|Open Label Extension|Lost to Follow-up|0|||
147272642|NCT03670810|531166069|FG004|Open Label Extension|Lost to Follow-up|0|||
147272643|NCT03670810|531166070|FG005|Open Label Extension|Lost to Follow-up|0|||
147272644|NCT03670810|531166071|FG006|Open Label Extension|Lost to Follow-up|0|||
147272645|NCT03670810|531166072|FG007|Open Label Extension|Lost to Follow-up|0|||
147272646|NCT03670810|531166073|FG008|Open Label Extension|Lost to Follow-up|23|||
147272647|NCT01470469|531166074|FG000|Overall Study|Withdrawal by Subject|4|||
147272648|NCT01470469|531166075|FG001|Overall Study|Withdrawal by Subject|6|||
147272649|NCT01470469|531166074|FG000|Overall Study|Lack of Efficacy|1|||
147272650|NCT01470469|531166075|FG001|Overall Study|Lack of Efficacy|7|||
147272651|NCT01470469|531166074|FG000|Overall Study|Adverse Event|0|||
147272652|NCT01470469|531166075|FG001|Overall Study|Adverse Event|7|||
147272653|NCT01470469|531166074|FG000|Overall Study|Lost to Follow-up|2|||
147272654|NCT01470469|531166075|FG001|Overall Study|Lost to Follow-up|2|||
147272655|NCT01470469|531166074|FG000|Overall Study|Protocol Violation|1|||
147272656|NCT01470469|531166075|FG001|Overall Study|Protocol Violation|1|||
147272657|NCT01470469|531166074|FG000|Overall Study|Other|2|||
147272658|NCT01470469|531166075|FG001|Overall Study|Other|1|||
147272659|NCT04182100|531166076|FG000|Overall Study|Adverse Event|1|||
147272660|NCT04182100|531166076|FG000|Overall Study|Withdrawal by Subject|1|||
147272661|NCT02504372|531166080|FG000|Overall Study|Death|136|||
147272662|NCT02504372|531166081|FG001|Overall Study|Death|154|||
147272663|NCT02504372|531166080|FG000|Overall Study|Lost to Follow-up|0|||
147272664|NCT02504372|531166081|FG001|Overall Study|Lost to Follow-up|2|||
147272665|NCT02504372|531166080|FG000|Overall Study|Withdrawal of consent|25|||
147272666|NCT02504372|531166081|FG001|Overall Study|Withdrawal of consent|16|||
147272667|NCT02504372|531166080|FG000|Overall Study|Participants ongoing|429|||
147272668|NCT02504372|531166081|FG001|Overall Study|Participants ongoing|415|||
147272669|NCT05059600|531166084|FG000|Overall Study|Enrolled but not Treated|10|||
147272670|NCT01365273|531166086|FG000|Overall Study|Lost to Follow-up|1|||
147272671|NCT01365273|531166087|FG001|Overall Study|Lost to Follow-up|0|||
147272672|NCT01365273|531166086|FG000|Overall Study|Protocol Violation|0|||
147272673|NCT01365273|531166087|FG001|Overall Study|Protocol Violation|1|||
147272674|NCT01365273|531166086|FG000|Overall Study|Physician Decision|1|||
147272675|NCT01365273|531166087|FG001|Overall Study|Physician Decision|0|||
147272676|NCT04907032|531166089|FG000|Overall Study|Withdrawal by Subject|7|||
147272677|NCT04907032|531166090|FG001|Overall Study|Withdrawal by Subject|1|||
147272678|NCT02519712|531166092|FG000|Overall Study|Disease Relapse|1|||
147272679|NCT02519712|531166092|FG000|Overall Study|Disease Progression|1|||
147272680|NCT02519712|531166092|FG000|Overall Study|Accruals are donors|2|||
147272681|NCT04847674|531166101|FG000|Overall Study|Withdrawal by Subject|0|||
147272682|NCT04847674|531166102|FG001|Overall Study|Withdrawal by Subject|1|||
147272683|NCT04847674|531166103|FG002|Overall Study|Withdrawal by Subject|0|||
147272684|NCT04847674|531166101|FG000|Overall Study|Lost to Follow-up|0|||
147272685|NCT04847674|531166102|FG001|Overall Study|Lost to Follow-up|0|||
147272686|NCT04847674|531166103|FG002|Overall Study|Lost to Follow-up|2|||
147272687|NCT04847674|531166101|FG000|Overall Study|Other than specified|21|||
147272688|NCT04847674|531166102|FG001|Overall Study|Other than specified|20|||
147272689|NCT04847674|531166103|FG002|Overall Study|Other than specified|20|||
147272690|NCT02705820|531166104|FG000|Overall Study|Death|2|||
147272691|NCT02705820|531166104|FG000|Overall Study|Disease Progression|34|||
147272692|NCT02705820|531166104|FG000|Overall Study|Clinical Deterioration|3|||
147272693|NCT00989833|531166107|FG000|Overall Study|Lost to Follow-up|0|||
147662381|NCT02452047|532587319|FG001|Overall Study|Adverse Event|1|||
147272694|NCT00989833|531166108|FG001|Overall Study|Lost to Follow-up|1|||
147272695|NCT00989833|531166109|FG002|Overall Study|Lost to Follow-up|0|||
147272696|NCT00989833|531166107|FG000|Overall Study|Protocol Violation|1|||
147272697|NCT00989833|531166108|FG001|Overall Study|Protocol Violation|2|||
147272698|NCT00989833|531166109|FG002|Overall Study|Protocol Violation|1|||
147272699|NCT00989833|531166107|FG000|Overall Study|Withdrawal by Subject|0|||
147272700|NCT00989833|531166108|FG001|Overall Study|Withdrawal by Subject|0|||
147333683|NCT05190419|531387762|FG000|Overall Study|Adverse Event|2|||
147333684|NCT05190419|531387763|FG001|Overall Study|Adverse Event|10|||
147333685|NCT05190419|531387764|FG002|Overall Study|Adverse Event|11|||
147272701|NCT00989833|531166109|FG002|Overall Study|Withdrawal by Subject|1|||
147272702|NCT00989833|531166107|FG000|Overall Study|Incorrectly randomized|1|||
147272703|NCT00989833|531166108|FG001|Overall Study|Incorrectly randomized|0|||
147272704|NCT00989833|531166109|FG002|Overall Study|Incorrectly randomized|0|||
147272705|NCT00308711|531166110|FG000|Overall Study|Withdrawal by Subject|1|||
147272706|NCT00308711|531166111|FG001|Overall Study|Withdrawal by Subject|0|||
147272707|NCT00308711|531166112|FG002|Overall Study|Withdrawal by Subject|1|||
147272708|NCT00308711|531166110|FG000|Overall Study|Protocol Violation|0|||
147333686|NCT05190419|531387765|FG003|Overall Study|Adverse Event|21|||
147272709|NCT00308711|531166111|FG001|Overall Study|Protocol Violation|1|||
147272710|NCT00308711|531166112|FG002|Overall Study|Protocol Violation|1|||
147272711|NCT00308711|531166110|FG000|Overall Study|Lost to Follow-up|0|||
147272712|NCT00308711|531166111|FG001|Overall Study|Lost to Follow-up|1|||
147272713|NCT00308711|531166112|FG002|Overall Study|Lost to Follow-up|0|||
147272714|NCT00308711|531166110|FG000|Overall Study|Baby not born within 7 days of treatment|1|||
147272715|NCT00308711|531166111|FG001|Overall Study|Baby not born within 7 days of treatment|2|||
147272716|NCT00308711|531166112|FG002|Overall Study|Baby not born within 7 days of treatment|2|||
147272717|NCT00308711|531166110|FG000|Overall Study|Subject incarcerated, data not allowed|0|||
147450568|NCT02069899|531811453|FG002|Overall Study|Participant was withdrawn to receive emapalumab again in CU and then subsequently died|1|||
147450569|NCT00531752|531811456|FG000|First Double-blind Intervention Period|Adverse Event|2|||
147450570|NCT00531752|531811457|FG001|First Double-blind Intervention Period|Adverse Event|0|||
147450571|NCT00531752|531811458|FG002|First Double-blind Intervention Period|Adverse Event|1|||
147450572|NCT00531752|531811459|FG003|First Double-blind Intervention Period|Adverse Event|1|||
147450573|NCT00531752|531811456|FG000|First Double-blind Intervention Period|Other|1|||
147450574|NCT00531752|531811457|FG001|First Double-blind Intervention Period|Other|4|||
147450575|NCT00531752|531811458|FG002|First Double-blind Intervention Period|Other|4|||
147450576|NCT00531752|531811459|FG003|First Double-blind Intervention Period|Other|0|||
147450577|NCT00531752|531811456|FG000|First Double-blind Intervention Period|Withdrawal by Subject|2|||
147450578|NCT00531752|531811457|FG001|First Double-blind Intervention Period|Withdrawal by Subject|0|||
147450579|NCT00531752|531811458|FG002|First Double-blind Intervention Period|Withdrawal by Subject|1|||
147450580|NCT00531752|531811459|FG003|First Double-blind Intervention Period|Withdrawal by Subject|1|||
147450581|NCT00531752|531811456|FG000|First Double-blind Intervention Period|Lost to Follow-up|0|||
147450582|NCT00531752|531811457|FG001|First Double-blind Intervention Period|Lost to Follow-up|0|||
147450583|NCT00531752|531811458|FG002|First Double-blind Intervention Period|Lost to Follow-up|1|||
147450584|NCT00531752|531811459|FG003|First Double-blind Intervention Period|Lost to Follow-up|1|||
147450585|NCT00531752|531811456|FG000|First Double-blind Intervention Period|Randomized but not treated|1|||
147450586|NCT00531752|531811457|FG001|First Double-blind Intervention Period|Randomized but not treated|0|||
147450587|NCT00531752|531811458|FG002|First Double-blind Intervention Period|Randomized but not treated|0|||
147450588|NCT00531752|531811459|FG003|First Double-blind Intervention Period|Randomized but not treated|0|||
147450589|NCT00531752|531811456|FG000|Second Double-blind Intervention Period|Adverse Event|1|||
147450590|NCT00531752|531811457|FG001|Second Double-blind Intervention Period|Adverse Event|1|||
147450591|NCT00531752|531811458|FG002|Second Double-blind Intervention Period|Adverse Event|0|||
147450592|NCT00531752|531811459|FG003|Second Double-blind Intervention Period|Adverse Event|0|||
147450593|NCT00531752|531811456|FG000|Second Double-blind Intervention Period|Other|1|||
147450594|NCT00531752|531811457|FG001|Second Double-blind Intervention Period|Other|1|||
147450595|NCT00531752|531811458|FG002|Second Double-blind Intervention Period|Other|0|||
147450596|NCT00531752|531811459|FG003|Second Double-blind Intervention Period|Other|0|||
147450597|NCT00531752|531811456|FG000|Second Double-blind Intervention Period|Withdrawal by Subject|0|||
147450598|NCT00531752|531811457|FG001|Second Double-blind Intervention Period|Withdrawal by Subject|0|||
147450599|NCT00531752|531811458|FG002|Second Double-blind Intervention Period|Withdrawal by Subject|0|||
147450600|NCT00531752|531811459|FG003|Second Double-blind Intervention Period|Withdrawal by Subject|1|||
147450601|NCT00531752|531811456|FG000|Second Double-blind Intervention Period|Lost to Follow-up|0|||
147450602|NCT00531752|531811457|FG001|Second Double-blind Intervention Period|Lost to Follow-up|0|||
147450603|NCT00531752|531811458|FG002|Second Double-blind Intervention Period|Lost to Follow-up|0|||
147450604|NCT00531752|531811459|FG003|Second Double-blind Intervention Period|Lost to Follow-up|1|||
147450605|NCT04703075|531811460|FG000|Overall Study|Adverse Event|11|||
147450606|NCT04703075|531811461|FG001|Overall Study|Adverse Event|7|||
147450607|NCT04703075|531811460|FG000|Overall Study|Lost to Follow-up|6|||
147450608|NCT04703075|531811461|FG001|Overall Study|Lost to Follow-up|12|||
147450609|NCT04703075|531811460|FG000|Overall Study|Physician Decision|3|||
147450610|NCT04703075|531811461|FG001|Overall Study|Physician Decision|0|||
147450611|NCT04703075|531811460|FG000|Overall Study|Moved|0|||
147450612|NCT04703075|531811461|FG001|Overall Study|Moved|2|||
147450613|NCT04703075|531811460|FG000|Overall Study|Index INH Resistant|0|||
147450614|NCT04703075|531811461|FG001|Overall Study|Index INH Resistant|1|||
147450615|NCT04703075|531811460|FG000|Overall Study|Lack of Efficacy|6|||
147450616|NCT04703075|531811461|FG001|Overall Study|Lack of Efficacy|18|||
147450617|NCT00550680|531811462|FG000|Overall Study|Administrative Reasons|1|||
147450618|NCT00550680|531811462|FG000|Overall Study|Adverse Event|5|||
147450619|NCT00550680|531811462|FG000|Overall Study|Death|3|||
147450620|NCT00550680|531811462|FG000|Overall Study|Early Improvement|1|||
147450621|NCT00550680|531811462|FG000|Overall Study|Lost to Follow-up|3|||
147450622|NCT00550680|531811462|FG000|Overall Study|Lack of Efficacy|1|||
147450623|NCT00550680|531811462|FG000|Overall Study|Other|10|||
147450624|NCT00550680|531811462|FG000|Overall Study|Protocol Violation|7|||
147450625|NCT00550680|531811462|FG000|Overall Study|Refused Treatment|19|||
147662382|NCT02452047|532587320|FG002|Overall Study|Adverse Event|1|||
147450626|NCT00550680|531811462|FG000|Overall Study|Screen Failure|6|||
147450627|NCT01119248|531811463|FG000|Overall Study|Physician Decision|5|||
147450628|NCT01967550|531811464|FG000|Overall Study|Withdrawal by Subject|1|||
147450629|NCT01967550|531811465|FG001|Overall Study|Withdrawal by Subject|0|||
147450630|NCT01967550|531811464|FG000|Overall Study|Adverse Event|2|||
147450631|NCT01967550|531811465|FG001|Overall Study|Adverse Event|0|||
147450632|NCT01967550|531811464|FG000|Overall Study|Protocol Violation|2|||
147450633|NCT01967550|531811465|FG001|Overall Study|Protocol Violation|1|||
147450634|NCT01967550|531811464|FG000|Overall Study|Non Compliance|0|||
147450635|NCT01967550|531811465|FG001|Overall Study|Non Compliance|1|||
147450636|NCT01100437|531811466|FG000|Titration/Stabilization|Adverse Event|0|||
147450637|NCT01100437|531811467|FG001|Titration/Stabilization|Adverse Event|0|||
147450638|NCT01100437|531811468|FG002|Titration/Stabilization|Adverse Event|4|||
147450639|NCT01100437|531811466|FG000|Titration/Stabilization|Non-compliance|0|||
147450640|NCT01100437|531811467|FG001|Titration/Stabilization|Non-compliance|0|||
147450641|NCT01100437|531811468|FG002|Titration/Stabilization|Non-compliance|1|||
147450642|NCT01100437|531811466|FG000|Titration/Stabilization|Sponsor canceled study|0|||
147450643|NCT01100437|531811467|FG001|Titration/Stabilization|Sponsor canceled study|0|||
147450644|NCT01100437|531811468|FG002|Titration/Stabilization|Sponsor canceled study|1|||
147450645|NCT01100437|531811466|FG000|Maintenance|Withdrawal by Subject|0|||
147450646|NCT01100437|531811467|FG001|Maintenance|Withdrawal by Subject|0|||
147450647|NCT01100437|531811468|FG002|Maintenance|Withdrawal by Subject|1|||
147450648|NCT01100437|531811466|FG000|Maintenance|Sponsor termination of study|0|||
147450649|NCT01100437|531811467|FG001|Maintenance|Sponsor termination of study|0|||
147450650|NCT01100437|531811468|FG002|Maintenance|Sponsor termination of study|1|||
147450651|NCT01534533|531811475|FG000|Overall Study|Lost to Follow-up|3|||
147450652|NCT01534533|531811476|FG001|Overall Study|Lost to Follow-up|0|||
147450653|NCT01534533|531811477|FG002|Overall Study|Lost to Follow-up|4|||
147450654|NCT01534533|531811478|FG003|Overall Study|Lost to Follow-up|3|||
147450655|NCT01534533|531811475|FG000|Overall Study|Withdrawal by Subject|5|||
147450656|NCT01534533|531811476|FG001|Overall Study|Withdrawal by Subject|3|||
147450657|NCT01534533|531811477|FG002|Overall Study|Withdrawal by Subject|4|||
147450658|NCT01534533|531811478|FG003|Overall Study|Withdrawal by Subject|1|||
147272718|NCT00308711|531166111|FG001|Overall Study|Subject incarcerated, data not allowed|0|||
147272719|NCT00308711|531166112|FG002|Overall Study|Subject incarcerated, data not allowed|1|||
147272720|NCT02167256|531166113|FG000|Overall Study|Adverse Event|13|||
147272721|NCT02167256|531166114|FG001|Overall Study|Adverse Event|6|||
147272722|NCT02167256|531166113|FG000|Overall Study|Withdrawal by Subject|4|||
147272723|NCT02167256|531166114|FG001|Overall Study|Withdrawal by Subject|4|||
147272724|NCT02167256|531166113|FG000|Overall Study|non-compliance|3|||
147272725|NCT02167256|531166114|FG001|Overall Study|non-compliance|0|||
147272726|NCT02167256|531166113|FG000|Overall Study|Study partner unable to participate|1|||
147272727|NCT02167256|531166114|FG001|Overall Study|Study partner unable to participate|0|||
147272728|NCT00414388|531166115|FG000|Overall Study|Adverse Event|1|||
147272729|NCT02318693|531166117|FG000|Overall Study|Protocol Violation|0|||
147272730|NCT02318693|531166118|FG001|Overall Study|Protocol Violation|1|||
147272731|NCT00689481|531166119|FG000|Overall Study|Adverse Event|7|||
147272732|NCT00689481|531166120|FG001|Overall Study|Adverse Event|1|||
147272733|NCT00689481|531166119|FG000|Overall Study|Lost to Follow-up|4|||
147272734|NCT00689481|531166120|FG001|Overall Study|Lost to Follow-up|3|||
147272735|NCT00689481|531166119|FG000|Overall Study|Lack of Efficacy|4|||
147272736|NCT00689481|531166120|FG001|Overall Study|Lack of Efficacy|3|||
147272737|NCT00689481|531166119|FG000|Overall Study|Non-compliance with study treatment|1|||
147272738|NCT00689481|531166120|FG001|Overall Study|Non-compliance with study treatment|1|||
147272739|NCT00689481|531166119|FG000|Overall Study|Withdrawal by Subject|8|||
147272740|NCT00689481|531166120|FG001|Overall Study|Withdrawal by Subject|4|||
147272741|NCT00689481|531166119|FG000|Overall Study|Excluded medication started during study|0|||
147272742|NCT00689481|531166120|FG001|Overall Study|Excluded medication started during study|1|||
147272743|NCT00689481|531166119|FG000|Overall Study|Subject early term, left on vacation|0|||
147272744|NCT00689481|531166120|FG001|Overall Study|Subject early term, left on vacation|1|||
147272745|NCT02742103|531167507|FG000|Overall Study|Protocol Violation|1|||
147272746|NCT02742103|531167508|FG001|Overall Study|Protocol Violation|0|||
147272747|NCT02742103|531167507|FG000|Overall Study|Death|2|||
147272748|NCT02742103|531167508|FG001|Overall Study|Death|2|||
147272749|NCT02742103|531167507|FG000|Overall Study|Adverse Event|1|||
147272750|NCT02742103|531167508|FG001|Overall Study|Adverse Event|0|||
147272751|NCT02742103|531167507|FG000|Overall Study|Moved to another town|0|||
147272752|NCT02742103|531167508|FG001|Overall Study|Moved to another town|1|||
147272753|NCT02742103|531167507|FG000|Overall Study|Withdrawal by Subject|5|||
147272754|NCT02742103|531167508|FG001|Overall Study|Withdrawal by Subject|2|||
147272755|NCT04346615|531167511|FG000|Overall Study|Lost to Follow-up|0|||
147272756|NCT04346615|531167512|FG001|Overall Study|Lost to Follow-up|2|||
147272757|NCT04346615|531167511|FG000|Overall Study|Withdrawal by Subject|1|||
147450659|NCT03368170|531813110|FG000|Overall Study|Adverse Event|2|||
147450660|NCT03368170|531813111|FG001|Overall Study|Adverse Event|1|||
147450661|NCT02164981|531813115|FG000|Started|Withdrawal by Subject|2|||
147450662|NCT02164981|531813116|FG001|Started|Withdrawal by Subject|1|||
147450663|NCT02164981|531813117|FG002|Started|Withdrawal by Subject|0|||
147450664|NCT02164981|531813115|FG000|Started|Protocol Violation|2|||
147450665|NCT02164981|531813116|FG001|Started|Protocol Violation|0|||
147272758|NCT04346615|531167512|FG001|Overall Study|Withdrawal by Subject|0|||
147272759|NCT04346615|531167511|FG000|Overall Study|Death|5|||
147272760|NCT04346615|531167512|FG001|Overall Study|Death|1|||
147272761|NCT04346615|531167511|FG000|Overall Study|Other|0|||
147333687|NCT05190419|531387762|FG000|Overall Study|Lost to Follow-up|1|||
147272762|NCT04346615|531167512|FG001|Overall Study|Other|2|||
147272763|NCT04346615|531167511|FG000|Overall Study|Randomized not treated|1|||
147272764|NCT04346615|531167512|FG001|Overall Study|Randomized not treated|0|||
147272765|NCT02349711|531167516|FG000|Overall Study|Withdrawal by Subject|2|||
147272766|NCT02349711|531167517|FG001|Overall Study|Withdrawal by Subject|1|||
147272767|NCT02349711|531167516|FG000|Overall Study|Lost to Follow-up|1|||
147272768|NCT02349711|531167517|FG001|Overall Study|Lost to Follow-up|1|||
147272769|NCT02096835|531167523|FG000|Overall Study|Withdrawal by Subject|1|||
147272770|NCT02096835|531167524|FG001|Overall Study|Withdrawal by Subject|0|||
147272771|NCT02096835|531167525|FG002|Overall Study|Withdrawal by Subject|0|||
147272772|NCT02096835|531167523|FG000|Overall Study|converted to open procedures|1|||
147272773|NCT02096835|531167524|FG001|Overall Study|converted to open procedures|0|||
147272774|NCT02096835|531167525|FG002|Overall Study|converted to open procedures|0|||
147272775|NCT02096835|531167523|FG000|Overall Study|Lost to Follow-up|1|||
147272776|NCT02096835|531167524|FG001|Overall Study|Lost to Follow-up|0|||
147272777|NCT02096835|531167525|FG002|Overall Study|Lost to Follow-up|1|||
147272778|NCT00023673|531167527|FG000|Overall Study|Ineligible / no protocol treatment|0|||
147272779|NCT00023673|531167528|FG001|Overall Study|Ineligible / no protocol treatment|0|||
147272780|NCT00023673|531167529|FG002|Overall Study|Ineligible / no protocol treatment|0|||
147272781|NCT00023673|531167530|FG003|Overall Study|Ineligible / no protocol treatment|1|||
147272782|NCT00023673|531167527|FG000|Overall Study|Patient withdrew consent|0|||
147272783|NCT00023673|531167528|FG001|Overall Study|Patient withdrew consent|0|||
147272784|NCT00023673|531167529|FG002|Overall Study|Patient withdrew consent|0|||
147272785|NCT00023673|531167530|FG003|Overall Study|Patient withdrew consent|1|||
147272786|NCT02453594|531167531|FG000|Overall Study|Protocol Violation|0|||
147272787|NCT02453594|531167532|FG001|Overall Study|Protocol Violation|0|||
147272788|NCT02453594|531167533|FG002|Overall Study|Protocol Violation|1|||
147272789|NCT02453594|531167531|FG000|Overall Study|Cohort Was Closed|17|||
147272790|NCT02453594|531167532|FG001|Overall Study|Cohort Was Closed|21|||
147272791|NCT02453594|531167533|FG002|Overall Study|Cohort Was Closed|14|||
147272792|NCT02453594|531167531|FG000|Overall Study|Death|20|||
147272793|NCT02453594|531167532|FG001|Overall Study|Death|24|||
147272794|NCT02453594|531167533|FG002|Overall Study|Death|16|||
147272795|NCT02453594|531167531|FG000|Overall Study|Lost to Follow-up|6|||
147272796|NCT02453594|531167532|FG001|Overall Study|Lost to Follow-up|14|||
147272797|NCT02453594|531167533|FG002|Overall Study|Lost to Follow-up|2|||
147272798|NCT02453594|531167531|FG000|Overall Study|Physician Decision|2|||
147272799|NCT02453594|531167532|FG001|Overall Study|Physician Decision|4|||
147272800|NCT02453594|531167533|FG002|Overall Study|Physician Decision|0|||
147272801|NCT02453594|531167531|FG000|Overall Study|Site Terminated by Sponsor|1|||
147272802|NCT02453594|531167532|FG001|Overall Study|Site Terminated by Sponsor|0|||
147272803|NCT02453594|531167533|FG002|Overall Study|Site Terminated by Sponsor|1|||
147272804|NCT02453594|531167531|FG000|Overall Study|Transitioned to Extension Study|16|||
147272805|NCT02453594|531167532|FG001|Overall Study|Transitioned to Extension Study|9|||
147272806|NCT02453594|531167533|FG002|Overall Study|Transitioned to Extension Study|16|||
147272807|NCT02453594|531167531|FG000|Overall Study|Withdrawal by Subject|7|||
147272808|NCT02453594|531167532|FG001|Overall Study|Withdrawal by Subject|9|||
147272809|NCT02453594|531167533|FG002|Overall Study|Withdrawal by Subject|11|||
147272810|NCT02097134|531167534|FG000|Overall Study|Physician Decision|4|||
147272811|NCT02097134|531167534|FG000|Overall Study|Non-Protocol Therapy|1|||
147272812|NCT02097134|531167534|FG000|Overall Study|Progressive Disease|3|||
147272813|NCT02097134|531167534|FG000|Overall Study|Refusal of Further Protocol Therapy|1|||
147272814|NCT00796861|531167540|FG000|Overall Study|Withdrawal by Subject|2|||
147272815|NCT00796861|531167540|FG000|Overall Study|Death|2|||
147272816|NCT00529386|531167541|FG000|Overall Study|Lost to Follow-up|1|||
147272817|NCT00813124|531167550|FG000|Overall Study|Death|2|||
147272818|NCT00813124|531167550|FG000|Overall Study|Ineligible - Participants did not received Azacytidine|9|||
147333688|NCT05190419|531387763|FG001|Overall Study|Lost to Follow-up|2|||
147333689|NCT05190419|531387764|FG002|Overall Study|Lost to Follow-up|3|||
147333690|NCT05190419|531387765|FG003|Overall Study|Lost to Follow-up|1|||
147333691|NCT05190419|531387762|FG000|Overall Study|Other|1|||
147272819|NCT00813124|531167550|FG000|Overall Study|Withdrawal by Subject|1|||
147272820|NCT00079274|531167551|FG000|Overall Study|Withdrawal by Subject|111|||
147272821|NCT00079274|531167552|FG001|Overall Study|Withdrawal by Subject|10|||
147272822|NCT00079274|531167553|FG002|Overall Study|Withdrawal by Subject|12|||
147272823|NCT00079274|531167554|FG003|Overall Study|Withdrawal by Subject|163|||
147272824|NCT00079274|531167555|FG004|Overall Study|Withdrawal by Subject|7|||
147272825|NCT00079274|531167556|FG005|Overall Study|Withdrawal by Subject|8|||
147272826|NCT00079274|531167557|FG006|Overall Study|Withdrawal by Subject|0|||
147272827|NCT00079274|531167551|FG000|Overall Study|Adverse Event|130|||
147272828|NCT00079274|531167552|FG001|Overall Study|Adverse Event|8|||
147272829|NCT00079274|531167553|FG002|Overall Study|Adverse Event|8|||
147272830|NCT00079274|531167554|FG003|Overall Study|Adverse Event|184|||
147272831|NCT00079274|531167555|FG004|Overall Study|Adverse Event|7|||
147272832|NCT00079274|531167556|FG005|Overall Study|Adverse Event|8|||
147272833|NCT00079274|531167557|FG006|Overall Study|Adverse Event|0|||
147333692|NCT05190419|531387763|FG001|Overall Study|Other|1|||
147333693|NCT05190419|531387764|FG002|Overall Study|Other|0|||
147333694|NCT05190419|531387765|FG003|Overall Study|Other|3|||
147333695|NCT03210402|531387766|FG000|Overall Study|Withdrawal by Subject|0|||
147333696|NCT03210402|531387767|FG001|Overall Study|Withdrawal by Subject|1|||
147600317|NCT03893565|532356364|FG007|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
147600318|NCT03893565|532356365|FG008|Double-blind Induction Phase (10 Weeks)|Lost to Follow-up|0|||
147600319|NCT03893565|532356357|FG000|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|5|||
147600320|NCT03893565|532356358|FG001|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|5|||
147600321|NCT03893565|532356359|FG002|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|9|||
147600322|NCT03893565|532356360|FG003|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
147600323|NCT03893565|532356361|FG004|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|6|||
147600324|NCT03893565|532356362|FG005|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
147600325|NCT03893565|532356363|FG006|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
147600326|NCT03893565|532356364|FG007|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
147600327|NCT03893565|532356365|FG008|Double-blind Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
147600328|NCT03893565|532356357|FG000|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
147600329|NCT03893565|532356358|FG001|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|2|||
147600330|NCT03893565|532356359|FG002|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
147600331|NCT03893565|532356360|FG003|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
147600332|NCT03893565|532356361|FG004|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
147600333|NCT03893565|532356362|FG005|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
147600334|NCT03893565|532356363|FG006|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
147600335|NCT03893565|532356364|FG007|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
147600336|NCT03893565|532356365|FG008|Double-blind Induction Phase (10 Weeks)|Protocol-specified withdrawal criterion met|0|||
147600337|NCT03893565|532356357|FG000|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
147600338|NCT03893565|532356358|FG001|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
147600339|NCT03893565|532356359|FG002|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
147272834|NCT00079274|531167551|FG000|Overall Study|Recurrence|21|||
147272835|NCT00079274|531167552|FG001|Overall Study|Recurrence|0|||
147272836|NCT00079274|531167553|FG002|Overall Study|Recurrence|1|||
147272837|NCT00079274|531167554|FG003|Overall Study|Recurrence|15|||
147272838|NCT00079274|531167555|FG004|Overall Study|Recurrence|0|||
147272839|NCT00079274|531167556|FG005|Overall Study|Recurrence|2|||
147272840|NCT00079274|531167557|FG006|Overall Study|Recurrence|0|||
147272841|NCT00079274|531167551|FG000|Overall Study|Alternate Treatment|6|||
147272842|NCT00079274|531167552|FG001|Overall Study|Alternate Treatment|1|||
147272843|NCT00079274|531167553|FG002|Overall Study|Alternate Treatment|0|||
147272844|NCT00079274|531167554|FG003|Overall Study|Alternate Treatment|3|||
147272845|NCT00079274|531167555|FG004|Overall Study|Alternate Treatment|0|||
147272846|NCT00079274|531167556|FG005|Overall Study|Alternate Treatment|0|||
147272847|NCT00079274|531167557|FG006|Overall Study|Alternate Treatment|0|||
147272848|NCT00079274|531167551|FG000|Overall Study|Other Medical Problems|6|||
147272849|NCT00079274|531167552|FG001|Overall Study|Other Medical Problems|1|||
147272850|NCT00079274|531167553|FG002|Overall Study|Other Medical Problems|0|||
147272851|NCT00079274|531167554|FG003|Overall Study|Other Medical Problems|7|||
147272852|NCT00079274|531167555|FG004|Overall Study|Other Medical Problems|0|||
147272853|NCT00079274|531167556|FG005|Overall Study|Other Medical Problems|0|||
147272854|NCT00079274|531167557|FG006|Overall Study|Other Medical Problems|0|||
147600340|NCT03893565|532356360|FG003|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|1|||
147600341|NCT03893565|532356361|FG004|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
147600342|NCT03893565|532356362|FG005|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
147600343|NCT03893565|532356363|FG006|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
147600344|NCT03893565|532356364|FG007|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
147600345|NCT03893565|532356365|FG008|Double-blind Induction Phase (10 Weeks)|Lack of Efficacy|0|||
147600346|NCT03893565|532356357|FG000|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
147600347|NCT03893565|532356358|FG001|Double-blind Induction Phase (10 Weeks)|Adverse Event|2|||
147600348|NCT03893565|532356359|FG002|Double-blind Induction Phase (10 Weeks)|Adverse Event|1|||
147272855|NCT00079274|531167551|FG000|Overall Study|Death|4|||
147272856|NCT00079274|531167552|FG001|Overall Study|Death|0|||
147272857|NCT00079274|531167553|FG002|Overall Study|Death|1|||
147333697|NCT02517307|531387782|FG000|Overall Study|Withdrawal by Subject|1|||
147333698|NCT02517307|531387783|FG001|Overall Study|Withdrawal by Subject|0|||
147333699|NCT02517307|531387784|FG002|Overall Study|Withdrawal by Subject|1|||
147272858|NCT00079274|531167554|FG003|Overall Study|Death|15|||
147272859|NCT00079274|531167555|FG004|Overall Study|Death|0|||
147272860|NCT00079274|531167556|FG005|Overall Study|Death|0|||
147272861|NCT00079274|531167557|FG006|Overall Study|Death|0|||
147272862|NCT00079274|531167551|FG000|Overall Study|Cytogenetic resistance|0|||
147272863|NCT00079274|531167552|FG001|Overall Study|Cytogenetic resistance|0|||
147272864|NCT00079274|531167553|FG002|Overall Study|Cytogenetic resistance|0|||
147272865|NCT00079274|531167554|FG003|Overall Study|Cytogenetic resistance|2|||
147272866|NCT00079274|531167555|FG004|Overall Study|Cytogenetic resistance|0|||
147272867|NCT00079274|531167556|FG005|Overall Study|Cytogenetic resistance|0|||
147272868|NCT00079274|531167557|FG006|Overall Study|Cytogenetic resistance|0|||
147272869|NCT00079274|531167551|FG000|Overall Study|Other|43|||
147272870|NCT00079274|531167552|FG001|Overall Study|Other|7|||
147272871|NCT00079274|531167553|FG002|Overall Study|Other|5|||
147272872|NCT00079274|531167554|FG003|Overall Study|Other|55|||
147272873|NCT00079274|531167555|FG004|Overall Study|Other|1|||
147272874|NCT00079274|531167556|FG005|Overall Study|Other|2|||
147272875|NCT00079274|531167557|FG006|Overall Study|Other|0|||
147272876|NCT00767676|531167558|FG000|Overall Study|Investigator error|54|||
147272877|NCT00617240|531167563|FG000|Overall Study|Lack of Efficacy|1|||
147272878|NCT00617240|531167564|FG001|Overall Study|Lack of Efficacy|0|||
147272879|NCT01611259|531167565|FG000|Overall Study|Physician Decision|1|||
147272880|NCT01611259|531167565|FG000|Overall Study|Lack of Efficacy|2|||
147272881|NCT01611259|531167565|FG000|Overall Study|Adverse Event|4|||
147272882|NCT01611259|531167565|FG000|Overall Study|Withdrawal by Subject|7|||
147272883|NCT03969212|531167566|FG000|Overall Study|Adverse Event|1|||
147272884|NCT03969212|531167567|FG001|Overall Study|Adverse Event|0|||
147272885|NCT03969212|531167568|FG002|Overall Study|Adverse Event|0|||
147272886|NCT03969212|531167569|FG003|Overall Study|Adverse Event|0|||
147272887|NCT03969212|531167566|FG000|Overall Study|Lost to Follow-up|2|||
147272888|NCT03969212|531167567|FG001|Overall Study|Lost to Follow-up|2|||
147272889|NCT03969212|531167568|FG002|Overall Study|Lost to Follow-up|2|||
147272890|NCT03969212|531167569|FG003|Overall Study|Lost to Follow-up|2|||
147272891|NCT03969212|531167566|FG000|Overall Study|Protocol Violation|0|||
147272892|NCT03969212|531167567|FG001|Overall Study|Protocol Violation|0|||
147272893|NCT03969212|531167568|FG002|Overall Study|Protocol Violation|0|||
147272894|NCT03969212|531167569|FG003|Overall Study|Protocol Violation|1|||
147272895|NCT03969212|531167566|FG000|Overall Study|Withdrawal by Subject|7|||
147272896|NCT03969212|531167567|FG001|Overall Study|Withdrawal by Subject|13|||
147272897|NCT03969212|531167568|FG002|Overall Study|Withdrawal by Subject|5|||
147272898|NCT03969212|531167569|FG003|Overall Study|Withdrawal by Subject|11|||
147272899|NCT03969212|531167566|FG000|Overall Study|Physician Decision|0|||
147272900|NCT03969212|531167567|FG001|Overall Study|Physician Decision|0|||
147272901|NCT03969212|531167568|FG002|Overall Study|Physician Decision|1|||
147272902|NCT03969212|531167569|FG003|Overall Study|Physician Decision|0|||
147272903|NCT03969212|531167566|FG000|Overall Study|Reason not Specified|22|||
147272904|NCT03969212|531167567|FG001|Overall Study|Reason not Specified|23|||
147272905|NCT03969212|531167568|FG002|Overall Study|Reason not Specified|28|||
147272906|NCT03969212|531167569|FG003|Overall Study|Reason not Specified|26|||
147272907|NCT01147653|531167573|FG000|Year 2|Withdrawal by Subject|2|||
147272908|NCT01147653|531167574|FG001|Year 2|Withdrawal by Subject|3|||
147272909|NCT00280566|531167575|FG000|Period 1 Open Label Ziprasidone|Lack of Efficacy|31|||
147272910|NCT00280566|531167576|FG001|Period 1 Open Label Ziprasidone|Lack of Efficacy|0|||
147272911|NCT00280566|531167577|FG002|Period 1 Open Label Ziprasidone|Lack of Efficacy|0|||
147272912|NCT00280566|531167575|FG000|Period 1 Open Label Ziprasidone|Laboratory Abnormality|3|||
147272913|NCT00280566|531167576|FG001|Period 1 Open Label Ziprasidone|Laboratory Abnormality|0|||
147272914|NCT00280566|531167577|FG002|Period 1 Open Label Ziprasidone|Laboratory Abnormality|0|||
147272915|NCT00280566|531167575|FG000|Period 1 Open Label Ziprasidone|Adverse Event|148|||
147272916|NCT00280566|531167576|FG001|Period 1 Open Label Ziprasidone|Adverse Event|0|||
147272917|NCT00280566|531167577|FG002|Period 1 Open Label Ziprasidone|Adverse Event|0|||
147272918|NCT00280566|531167575|FG000|Period 1 Open Label Ziprasidone|Lost to Follow-up|35|||
147600349|NCT03893565|532356360|FG003|Double-blind Induction Phase (10 Weeks)|Adverse Event|1|||
147600350|NCT03893565|532356361|FG004|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
147600351|NCT03893565|532356362|FG005|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
147272919|NCT00280566|531167576|FG001|Period 1 Open Label Ziprasidone|Lost to Follow-up|0|||
147272920|NCT00280566|531167577|FG002|Period 1 Open Label Ziprasidone|Lost to Follow-up|0|||
147272921|NCT00280566|531167575|FG000|Period 1 Open Label Ziprasidone|Withdrawal by Subject|76|||
147272922|NCT00280566|531167576|FG001|Period 1 Open Label Ziprasidone|Withdrawal by Subject|0|||
147272923|NCT00280566|531167577|FG002|Period 1 Open Label Ziprasidone|Withdrawal by Subject|0|||
147272924|NCT00280566|531167575|FG000|Period 1 Open Label Ziprasidone|Miscellaneous|50|||
147272925|NCT00280566|531167576|FG001|Period 1 Open Label Ziprasidone|Miscellaneous|0|||
147272926|NCT00280566|531167577|FG002|Period 1 Open Label Ziprasidone|Miscellaneous|0|||
147272927|NCT00280566|531167575|FG000|Period 2 Double Blind|Lack of Efficacy|0|||
147333700|NCT02517307|531387785|FG003|Overall Study|Withdrawal by Subject|0|||
147333701|NCT02517307|531387782|FG000|Overall Study|Protocol Violation|0|||
147600352|NCT03893565|532356363|FG006|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
147272928|NCT00280566|531167576|FG001|Period 2 Double Blind|Lack of Efficacy|9|||
147662383|NCT02452047|532587318|FG000|Overall Study|Death|1|||
147272929|NCT00280566|531167577|FG002|Period 2 Double Blind|Lack of Efficacy|22|||
147272930|NCT00280566|531167575|FG000|Period 2 Double Blind|Laboratory Abnormality|0|||
147272931|NCT00280566|531167576|FG001|Period 2 Double Blind|Laboratory Abnormality|1|||
147272932|NCT00280566|531167577|FG002|Period 2 Double Blind|Laboratory Abnormality|0|||
147272933|NCT00280566|531167575|FG000|Period 2 Double Blind|Adverse Event|0|||
147272934|NCT00280566|531167576|FG001|Period 2 Double Blind|Adverse Event|11|||
147272935|NCT00280566|531167577|FG002|Period 2 Double Blind|Adverse Event|15|||
147272936|NCT00280566|531167575|FG000|Period 2 Double Blind|Lost to Follow-up|0|||
147272937|NCT00280566|531167576|FG001|Period 2 Double Blind|Lost to Follow-up|3|||
147272938|NCT00280566|531167577|FG002|Period 2 Double Blind|Lost to Follow-up|6|||
147272939|NCT00280566|531167575|FG000|Period 2 Double Blind|Withdrawal by Subject|0|||
147272940|NCT00280566|531167576|FG001|Period 2 Double Blind|Withdrawal by Subject|9|||
147272941|NCT00280566|531167577|FG002|Period 2 Double Blind|Withdrawal by Subject|9|||
147272942|NCT00280566|531167575|FG000|Period 2 Double Blind|miscellaneous|0|||
147272943|NCT00280566|531167576|FG001|Period 2 Double Blind|miscellaneous|10|||
147272944|NCT00280566|531167577|FG002|Period 2 Double Blind|miscellaneous|5|||
147272945|NCT00353366|531167578|FG000|Overall Study|Adverse Event|8|||
147272946|NCT00353366|531167578|FG000|Overall Study|Protocol Violation|12|||
147272947|NCT00353366|531167578|FG000|Overall Study|Withdrawal by Subject|12|||
147272948|NCT00353366|531167578|FG000|Overall Study|Lost to Follow-up|92|||
147272949|NCT00353366|531167578|FG000|Overall Study|Other|19|||
147272950|NCT01302392|531167579|FG000|Overall Study|Lost to Follow-up|1|||
147272951|NCT01302392|531167580|FG001|Overall Study|Lost to Follow-up|0|||
147272952|NCT01302392|531167579|FG000|Overall Study|Withdrawal by Subject|6|||
147272953|NCT01302392|531167580|FG001|Overall Study|Withdrawal by Subject|1|||
147272954|NCT00259857|531167581|FG000|12 Months Treatment|Gr-1, lost followup; Gr-2, not compliant|1|||
147272955|NCT00259857|531167582|FG001|12 Months Treatment|Gr-1, lost followup; Gr-2, not compliant|2|||
147272956|NCT00259857|531167581|FG000|24 Months Treatment|Lost to Follow-up|0|||
147272957|NCT00259857|531167582|FG001|24 Months Treatment|Lost to Follow-up|3|||
147272958|NCT00670228|531167583|FG000|Overall Study|Adverse Event|1|||
147272959|NCT00670228|531167584|FG001|Overall Study|Adverse Event|0|||
147272960|NCT00670228|531167583|FG000|Overall Study|Death or MACE|0|||
147272961|NCT00670228|531167584|FG001|Overall Study|Death or MACE|1|||
147272962|NCT00670228|531167583|FG000|Overall Study|Not treated|2|||
147272963|NCT00670228|531167584|FG001|Overall Study|Not treated|2|||
147272964|NCT00670228|531167583|FG000|Overall Study|Not meeting the selection criteria|2|||
147272965|NCT00670228|531167584|FG001|Overall Study|Not meeting the selection criteria|0|||
147272966|NCT05267054|531167585|FG000|Overall Study|Death|13|||
147272967|NCT05267054|531167586|FG001|Overall Study|Death|14|||
147272968|NCT05267054|531167585|FG000|Overall Study|Study Ended by Sponsor|9|||
147272969|NCT05267054|531167586|FG001|Overall Study|Study Ended by Sponsor|13|||
147272970|NCT05267054|531167585|FG000|Overall Study|Lost to Follow-up|1|||
147272971|NCT05267054|531167586|FG001|Overall Study|Lost to Follow-up|1|||
147272972|NCT05267054|531167585|FG000|Overall Study|Withdrawal by Subject|1|||
147272973|NCT05267054|531167586|FG001|Overall Study|Withdrawal by Subject|1|||
147272974|NCT01552226|531167590|FG000|Overall Study|Withdrawal by Subject|4|||
147272975|NCT01552226|531167591|FG001|Overall Study|Withdrawal by Subject|4|||
147272976|NCT00376168|531167592|FG000|Overall Study|Adverse Event|1|||
147272977|NCT00376168|531167593|FG001|Overall Study|Adverse Event|1|||
147272978|NCT00376168|531167592|FG000|Overall Study|Pregnancy|1|||
147272979|NCT00376168|531167593|FG001|Overall Study|Pregnancy|0|||
147272980|NCT05091528|531167594|FG000|Overall Study|Study Termination by Sponsor|0|||
147272981|NCT05091528|531167595|FG001|Overall Study|Study Termination by Sponsor|1|||
147272982|NCT05091528|531167596|FG002|Overall Study|Study Termination by Sponsor|0|||
147272983|NCT05091528|531167597|FG003|Overall Study|Study Termination by Sponsor|1|||
147272984|NCT02214121|531167598|FG000|Part A|Patient decision|2|||
147272985|NCT02214121|531167599|FG001|Part A|Patient decision|0|||
147600353|NCT03893565|532356364|FG007|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
147600354|NCT03893565|532356365|FG008|Double-blind Induction Phase (10 Weeks)|Adverse Event|0|||
147600355|NCT03893565|532356357|FG000|Double-blind Extended Treatment(20weeks)|Other|0|||
147600356|NCT03893565|532356358|FG001|Double-blind Extended Treatment(20weeks)|Other|0|||
147600357|NCT03893565|532356359|FG002|Double-blind Extended Treatment(20weeks)|Other|0|||
147600358|NCT03893565|532356360|FG003|Double-blind Extended Treatment(20weeks)|Other|0|||
147272986|NCT02214121|531167600|FG002|Part A|Patient decision|0|||
147272987|NCT02214121|531167598|FG000|Part A|Dev. of study-specific withdrawal crit.|4|||
147272988|NCT02214121|531167599|FG001|Part A|Dev. of study-specific withdrawal crit.|0|||
147272989|NCT02214121|531167600|FG002|Part A|Dev. of study-specific withdrawal crit.|0|||
147600359|NCT03893565|532356361|FG004|Double-blind Extended Treatment(20weeks)|Other|0|||
147272990|NCT02214121|531167598|FG000|Part A|Other|1|||
147272991|NCT02214121|531167599|FG001|Part A|Other|0|||
147272992|NCT02214121|531167600|FG002|Part A|Other|0|||
147662384|NCT02452047|532587319|FG001|Overall Study|Death|3|||
147662385|NCT02452047|532587320|FG002|Overall Study|Death|1|||
147272993|NCT02214121|531167598|FG000|Part B|Patient decision|0|||
147272994|NCT02214121|531167599|FG001|Part B|Patient decision|1|||
147662386|NCT02452047|532587318|FG000|Overall Study|Physician Decision|1|||
147272995|NCT02214121|531167600|FG002|Part B|Patient decision|0|||
147272996|NCT02214121|531167598|FG000|Part B|Dev. of study-specific withdrawal crit.|0|||
147272997|NCT02214121|531167599|FG001|Part B|Dev. of study-specific withdrawal crit.|2|||
147272998|NCT02214121|531167600|FG002|Part B|Dev. of study-specific withdrawal crit.|0|||
147272999|NCT02214121|531167598|FG000|Part B|Lost to Follow-up|0|||
147273000|NCT02214121|531167599|FG001|Part B|Lost to Follow-up|0|||
147273001|NCT02214121|531167600|FG002|Part B|Lost to Follow-up|1|||
147273002|NCT02375672|531167601|FG000|Overall Study|remain on follow up|20|||
147273003|NCT02114879|531167606|FG000|Overall Study|Withdrawal by Subject|9|||
147273004|NCT02114879|531167607|FG001|Overall Study|Withdrawal by Subject|5|||
147273005|NCT02114879|531167606|FG000|Overall Study|Death|6|||
147273006|NCT02114879|531167607|FG001|Overall Study|Death|11|||
147273007|NCT02114879|531167606|FG000|Overall Study|Lost to Follow-up|4|||
147273008|NCT02114879|531167607|FG001|Overall Study|Lost to Follow-up|6|||
147273009|NCT02114879|531167606|FG000|Overall Study|Physician Decision|0|||
147273010|NCT02114879|531167607|FG001|Overall Study|Physician Decision|2|||
147273011|NCT02152995|531167608|FG000|Overall Study|Withdrawal by Subject|1|||
147273012|NCT02152995|531167609|FG001|Overall Study|Withdrawal by Subject|0|||
147273013|NCT02751983|531167611|FG000|Treatment|Stopped ACT, but Remained in study|2|||
147273014|NCT02751983|531167612|FG001|Treatment|Stopped ACT, but Remained in study|0|||
147273015|NCT02751983|531167611|FG000|Treatment|Discharged prior to beginning ACT|2|||
147273016|NCT02751983|531167612|FG001|Treatment|Discharged prior to beginning ACT|0|||
147273017|NCT02751983|531167611|FG000|Post-Treatment Assessment|Lost to Follow-up|5|||
147273018|NCT02751983|531167612|FG001|Post-Treatment Assessment|Lost to Follow-up|0|||
147273019|NCT02751983|531167611|FG000|One-Month Follow-Up Assessments|Lost to Follow-up|14|||
147273020|NCT02751983|531167612|FG001|One-Month Follow-Up Assessments|Lost to Follow-up|12|||
147273021|NCT02751983|531167611|FG000|Three-Month Follow-Up Assessments|Lost to Follow-up|12|||
147273022|NCT02751983|531167612|FG001|Three-Month Follow-Up Assessments|Lost to Follow-up|16|||
147273023|NCT03139916|531167615|FG000|Overall Study|Withdrawal by Subject|2|||
147273024|NCT03139916|531167615|FG000|Overall Study|Clinical progression prior to start of study treatment|1|||
147273025|NCT01420081|531167616|FG000|Overall Study|Death|1|||
147273026|NCT01420081|531167617|FG001|Overall Study|Death|0|||
147273027|NCT01420081|531167618|FG002|Overall Study|Death|8|||
147273028|NCT01420081|531167619|FG003|Overall Study|Death|0|||
147273029|NCT01420081|531167620|FG004|Overall Study|Death|7|||
147273030|NCT01420081|531167621|FG005|Overall Study|Death|12|||
147273031|NCT01420081|531167622|FG006|Overall Study|Death|0|||
147273032|NCT01420081|531167623|FG007|Overall Study|Death|1|||
147273033|NCT01420081|531167624|FG008|Overall Study|Death|1|||
147273034|NCT01420081|531167616|FG000|Overall Study|Lost to Follow-up|0|||
147333702|NCT02517307|531387783|FG001|Overall Study|Protocol Violation|0|||
147333703|NCT02517307|531387784|FG002|Overall Study|Protocol Violation|1|||
147333704|NCT02517307|531387785|FG003|Overall Study|Protocol Violation|1|||
147333705|NCT03863834|531387786|FG000|Overall Study|Lost to Follow-up|3|||
147333706|NCT02770248|531387788|FG000|Overall Study|Adverse Event|0|||
147333707|NCT02770248|531387789|FG001|Overall Study|Adverse Event|1|||
147333708|NCT02770248|531387788|FG000|Overall Study|Randomized in error, prior to treatment|0|||
147333709|NCT02770248|531387789|FG001|Overall Study|Randomized in error, prior to treatment|1|||
147333710|NCT01837641|531387790|FG000|Overall Study|Sponsor decision|1|||
147333711|NCT01837641|531387791|FG001|Overall Study|Sponsor decision|0|||
147333712|NCT01837641|531387792|FG002|Overall Study|Sponsor decision|0|||
147333713|NCT01837641|531387793|FG003|Overall Study|Sponsor decision|0|||
147333714|NCT01837641|531387794|FG004|Overall Study|Sponsor decision|0|||
147333715|NCT01837641|531387795|FG005|Overall Study|Sponsor decision|1|||
147333716|NCT01837641|531387796|FG006|Overall Study|Sponsor decision|0|||
147333717|NCT01837641|531387797|FG007|Overall Study|Sponsor decision|0|||
147273035|NCT01420081|531167617|FG001|Overall Study|Lost to Follow-up|0|||
147273036|NCT01420081|531167618|FG002|Overall Study|Lost to Follow-up|0|||
147273037|NCT01420081|531167619|FG003|Overall Study|Lost to Follow-up|0|||
147273038|NCT01420081|531167620|FG004|Overall Study|Lost to Follow-up|1|||
147273039|NCT01420081|531167621|FG005|Overall Study|Lost to Follow-up|1|||
147273040|NCT01420081|531167622|FG006|Overall Study|Lost to Follow-up|0|||
147273041|NCT01420081|531167623|FG007|Overall Study|Lost to Follow-up|0|||
147273042|NCT01420081|531167624|FG008|Overall Study|Lost to Follow-up|0|||
147273043|NCT01420081|531167616|FG000|Overall Study|Study Terminated by Sponsor|2|||
147273044|NCT01420081|531167617|FG001|Overall Study|Study Terminated by Sponsor|1|||
147273045|NCT01420081|531167618|FG002|Overall Study|Study Terminated by Sponsor|1|||
147273046|NCT01420081|531167619|FG003|Overall Study|Study Terminated by Sponsor|3|||
147273047|NCT01420081|531167620|FG004|Overall Study|Study Terminated by Sponsor|11|||
147273048|NCT01420081|531167621|FG005|Overall Study|Study Terminated by Sponsor|7|||
147333718|NCT01837641|531387790|FG000|Overall Study|Adverse Event|0|||
147333719|NCT01837641|531387791|FG001|Overall Study|Adverse Event|0|||
147273049|NCT01420081|531167622|FG006|Overall Study|Study Terminated by Sponsor|3|||
147273050|NCT01420081|531167623|FG007|Overall Study|Study Terminated by Sponsor|2|||
147273051|NCT01420081|531167624|FG008|Overall Study|Study Terminated by Sponsor|2|||
147333720|NCT01837641|531387792|FG002|Overall Study|Adverse Event|0|||
147333721|NCT01837641|531387793|FG003|Overall Study|Adverse Event|0|||
147333722|NCT01837641|531387794|FG004|Overall Study|Adverse Event|0|||
147273052|NCT01420081|531167616|FG000|Overall Study|Subject Refused Futher Follow-up|0|||
147273053|NCT01420081|531167617|FG001|Overall Study|Subject Refused Futher Follow-up|0|||
147333723|NCT01837641|531387795|FG005|Overall Study|Adverse Event|1|||
147333724|NCT01837641|531387796|FG006|Overall Study|Adverse Event|0|||
147273054|NCT01420081|531167618|FG002|Overall Study|Subject Refused Futher Follow-up|1|||
147273055|NCT01420081|531167619|FG003|Overall Study|Subject Refused Futher Follow-up|0|||
147273056|NCT01420081|531167620|FG004|Overall Study|Subject Refused Futher Follow-up|1|||
147273057|NCT01420081|531167621|FG005|Overall Study|Subject Refused Futher Follow-up|0|||
147273058|NCT01420081|531167622|FG006|Overall Study|Subject Refused Futher Follow-up|0|||
147273059|NCT01420081|531167623|FG007|Overall Study|Subject Refused Futher Follow-up|0|||
147273060|NCT01420081|531167624|FG008|Overall Study|Subject Refused Futher Follow-up|0|||
147273061|NCT01420081|531167616|FG000|Overall Study|Other Reasons|0|||
147273062|NCT01420081|531167617|FG001|Overall Study|Other Reasons|0|||
147273063|NCT01420081|531167618|FG002|Overall Study|Other Reasons|1|||
147273064|NCT01420081|531167619|FG003|Overall Study|Other Reasons|0|||
147273065|NCT01420081|531167620|FG004|Overall Study|Other Reasons|0|||
147273066|NCT01420081|531167621|FG005|Overall Study|Other Reasons|0|||
147273067|NCT01420081|531167622|FG006|Overall Study|Other Reasons|0|||
147273068|NCT01420081|531167623|FG007|Overall Study|Other Reasons|0|||
147273069|NCT01420081|531167624|FG008|Overall Study|Other Reasons|0|||
147273070|NCT00025883|531167625|FG000|Overall Study|had atypical progeriod lipodystrophy|4|||
147273071|NCT00025883|531167625|FG000|Overall Study|no baseline data|1|||
147273072|NCT00025883|531167625|FG000|Overall Study|Death|1|||
147273073|NCT00025883|531167625|FG000|Overall Study|Adverse Event|1|||
147273074|NCT00025883|531167625|FG000|Overall Study|didn't reach 6 months of Metreleptin|10|||
147273075|NCT00218543|531167626|FG000|Overall Study|Lost to Follow-up|8|||
147273076|NCT00218543|531167626|FG000|Overall Study|relocated|1|||
147273077|NCT00218543|531167626|FG000|Overall Study|Withdrawal by Subject|1|||
147273078|NCT00218543|531167626|FG000|Overall Study|Physician Decision|3|||
147273079|NCT00218543|531167626|FG000|Overall Study|Adverse Event|2|||
147273080|NCT02448875|531167627|FG000|Overall Study|Adverse Event|2|||
147273081|NCT02448875|531167628|FG001|Overall Study|Adverse Event|1|||
147273082|NCT02448875|531167629|FG002|Overall Study|Adverse Event|0|||
147273083|NCT02448875|531167627|FG000|Overall Study|Lost to Follow-up|1|||
147273084|NCT02448875|531167628|FG001|Overall Study|Lost to Follow-up|0|||
147273085|NCT02448875|531167629|FG002|Overall Study|Lost to Follow-up|0|||
147273086|NCT02448875|531167627|FG000|Overall Study|Investigator Decision|3|||
147273087|NCT02448875|531167628|FG001|Overall Study|Investigator Decision|0|||
147273088|NCT02448875|531167629|FG002|Overall Study|Investigator Decision|1|||
147273089|NCT02448875|531167627|FG000|Overall Study|Withdrawal by Subject|1|||
147273090|NCT02448875|531167628|FG001|Overall Study|Withdrawal by Subject|0|||
147273091|NCT02448875|531167629|FG002|Overall Study|Withdrawal by Subject|0|||
147273092|NCT01282216|531167630|FG000|Overall Study|Graft failure|0|||
147273093|NCT01282216|531167631|FG001|Overall Study|Graft failure|0|||
147273094|NCT01282216|531167632|FG002|Overall Study|Graft failure|3|||
147273095|NCT01282216|531167633|FG003|Overall Study|Graft failure|2|||
147273096|NCT01282216|531167630|FG000|Overall Study|Physician Decision|0|||
147273097|NCT01282216|531167631|FG001|Overall Study|Physician Decision|0|||
147273098|NCT01282216|531167632|FG002|Overall Study|Physician Decision|11|||
147273099|NCT01282216|531167633|FG003|Overall Study|Physician Decision|0|||
147273100|NCT01282216|531167630|FG000|Overall Study|Relapse|0|||
147273101|NCT01282216|531167631|FG001|Overall Study|Relapse|0|||
147273102|NCT01282216|531167632|FG002|Overall Study|Relapse|17|||
147273103|NCT01282216|531167633|FG003|Overall Study|Relapse|6|||
147273104|NCT01282216|531167630|FG000|Overall Study|Death|0|||
147273105|NCT01282216|531167631|FG001|Overall Study|Death|0|||
147273106|NCT01282216|531167632|FG002|Overall Study|Death|2|||
147273107|NCT01282216|531167633|FG003|Overall Study|Death|0|||
147273108|NCT03337724|531167638|FG000|Overall Study|Reason not Specified|12|||
147273109|NCT03337724|531167639|FG001|Overall Study|Reason not Specified|21|||
147273110|NCT03337724|531167640|FG002|Overall Study|Reason not Specified|9|||
147273111|NCT03337724|531167641|FG003|Overall Study|Reason not Specified|9|||
147273112|NCT03337724|531167642|FG004|Overall Study|Reason not Specified|29|||
147273113|NCT03337724|531167638|FG000|Overall Study|Withdrawal by Subject|13|||
147273114|NCT03337724|531167639|FG001|Overall Study|Withdrawal by Subject|15|||
147273115|NCT03337724|531167640|FG002|Overall Study|Withdrawal by Subject|4|||
147273116|NCT03337724|531167641|FG003|Overall Study|Withdrawal by Subject|15|||
147273117|NCT03337724|531167642|FG004|Overall Study|Withdrawal by Subject|6|||
147273118|NCT03337724|531167638|FG000|Overall Study|Protocol Deviation|0|||
147273119|NCT03337724|531167639|FG001|Overall Study|Protocol Deviation|1|||
147273120|NCT03337724|531167640|FG002|Overall Study|Protocol Deviation|1|||
147273121|NCT03337724|531167641|FG003|Overall Study|Protocol Deviation|1|||
147273122|NCT03337724|531167642|FG004|Overall Study|Protocol Deviation|0|||
147273123|NCT03337724|531167638|FG000|Overall Study|Adverse Event|1|||
147273124|NCT03337724|531167639|FG001|Overall Study|Adverse Event|1|||
147273125|NCT03337724|531167640|FG002|Overall Study|Adverse Event|0|||
147273126|NCT03337724|531167641|FG003|Overall Study|Adverse Event|1|||
147273127|NCT03337724|531167642|FG004|Overall Study|Adverse Event|0|||
147273128|NCT03337724|531167638|FG000|Overall Study|Death|40|||
147273129|NCT03337724|531167639|FG001|Overall Study|Death|89|||
147273130|NCT03337724|531167640|FG002|Overall Study|Death|43|||
147273131|NCT03337724|531167641|FG003|Overall Study|Death|76|||
147273132|NCT03337724|531167642|FG004|Overall Study|Death|50|||
147273133|NCT03337724|531167638|FG000|Overall Study|Lost to Follow-up|5|||
147273134|NCT03337724|531167639|FG001|Overall Study|Lost to Follow-up|5|||
147273135|NCT03337724|531167640|FG002|Overall Study|Lost to Follow-up|4|||
147273136|NCT03337724|531167641|FG003|Overall Study|Lost to Follow-up|7|||
147273137|NCT03337724|531167642|FG004|Overall Study|Lost to Follow-up|4|||
147273138|NCT03337724|531167638|FG000|Overall Study|Physician Decision|16|||
147273139|NCT03337724|531167639|FG001|Overall Study|Physician Decision|34|||
147273140|NCT03337724|531167640|FG002|Overall Study|Physician Decision|14|||
147273141|NCT03337724|531167641|FG003|Overall Study|Physician Decision|34|||
147273142|NCT03337724|531167642|FG004|Overall Study|Physician Decision|13|||
147273143|NCT03337724|531167638|FG000|Overall Study|Progressive Disease|0|||
147273144|NCT03337724|531167639|FG001|Overall Study|Progressive Disease|2|||
147273145|NCT03337724|531167640|FG002|Overall Study|Progressive Disease|1|||
147273146|NCT03337724|531167641|FG003|Overall Study|Progressive Disease|2|||
147273147|NCT03337724|531167642|FG004|Overall Study|Progressive Disease|0|||
147273148|NCT03337724|531167638|FG000|Overall Study|Symptomatic Deterioration|0|||
147273149|NCT03337724|531167639|FG001|Overall Study|Symptomatic Deterioration|0|||
147273150|NCT03337724|531167640|FG002|Overall Study|Symptomatic Deterioration|0|||
147273151|NCT03337724|531167641|FG003|Overall Study|Symptomatic Deterioration|1|||
147273152|NCT03337724|531167642|FG004|Overall Study|Symptomatic Deterioration|0|||
147273153|NCT00773097|531167643|FG000|Overall Study|Withdrawal by Subject|1|||
147273154|NCT00773097|531167643|FG000|Overall Study|Physician Decision|6|||
147273155|NCT03238911|531167644|FG000|Overall Study|Withdrawal by Subject|1|||
147273156|NCT03238911|531167645|FG001|Overall Study|Withdrawal by Subject|2|||
147273157|NCT03238911|531167644|FG000|Overall Study|Lost to Follow-up|2|||
147273158|NCT03238911|531167645|FG001|Overall Study|Lost to Follow-up|1|||
147273159|NCT02239536|531167646|FG000|Overall Study|Non-neoplastic polyp|23|||
147273160|NCT02239536|531167647|FG001|Overall Study|Non-neoplastic polyp|17|||
147273161|NCT05645432|531167648|FG000|Overall Study|Withdrawal by Subject|1|||
147273162|NCT03195478|531167649|FG000|Overall Study|Disease Progression|5|||
147273163|NCT03195478|531167650|FG001|Overall Study|Disease Progression|4|||
147273164|NCT03195478|531167651|FG002|Overall Study|Disease Progression|6|||
147273165|NCT03195478|531167652|FG003|Overall Study|Disease Progression|1|||
147273166|NCT03195478|531167649|FG000|Overall Study|Study Drug Toxicity|2|||
147273167|NCT03195478|531167650|FG001|Overall Study|Study Drug Toxicity|0|||
147273168|NCT03195478|531167651|FG002|Overall Study|Study Drug Toxicity|0|||
147273169|NCT03195478|531167652|FG003|Overall Study|Study Drug Toxicity|1|||
147273170|NCT03195478|531167649|FG000|Overall Study|Participant requested to discontinue study treatment|0|||
147273171|NCT03195478|531167650|FG001|Overall Study|Participant requested to discontinue study treatment|1|||
147273172|NCT03195478|531167651|FG002|Overall Study|Participant requested to discontinue study treatment|0|||
147273173|NCT03195478|531167652|FG003|Overall Study|Participant requested to discontinue study treatment|0|||
147273174|NCT03195478|531167649|FG000|Overall Study|Participant Withdrew Consent|1|||
147273175|NCT03195478|531167650|FG001|Overall Study|Participant Withdrew Consent|0|||
147273176|NCT03195478|531167651|FG002|Overall Study|Participant Withdrew Consent|0|||
147273177|NCT03195478|531167652|FG003|Overall Study|Participant Withdrew Consent|0|||
147273178|NCT03195478|531167649|FG000|Overall Study|Maximum Clinical benefit|0|||
147273179|NCT03195478|531167650|FG001|Overall Study|Maximum Clinical benefit|0|||
147273180|NCT03195478|531167651|FG002|Overall Study|Maximum Clinical benefit|1|||
147273181|NCT03195478|531167652|FG003|Overall Study|Maximum Clinical benefit|0|||
147273182|NCT03195478|531167649|FG000|Overall Study|Other Reasons|0|||
147273183|NCT03195478|531167650|FG001|Overall Study|Other Reasons|0|||
147273184|NCT03195478|531167651|FG002|Overall Study|Other Reasons|1|||
147273185|NCT03195478|531167652|FG003|Overall Study|Other Reasons|0|||
147273186|NCT01105533|531169572|FG000|Overall Study|Death|0|||
147273187|NCT01105533|531169573|FG001|Overall Study|Death|0|||
147273188|NCT01105533|531169574|FG002|Overall Study|Death|0|||
147273189|NCT01105533|531169575|FG003|Overall Study|Death|0|||
147273190|NCT01105533|531169576|FG004|Overall Study|Death|1|||
147273191|NCT01105533|531169577|FG005|Overall Study|Death|0|||
147273192|NCT01105533|531169578|FG006|Overall Study|Death|0|||
147273193|NCT01105533|531169579|FG007|Overall Study|Death|0|||
147273194|NCT01105533|531169580|FG008|Overall Study|Death|0|||
147273195|NCT01105533|531169572|FG000|Overall Study|Lack of Efficacy|1|||
147273196|NCT01105533|531169573|FG001|Overall Study|Lack of Efficacy|1|||
147273197|NCT01105533|531169574|FG002|Overall Study|Lack of Efficacy|3|||
147273198|NCT01105533|531169575|FG003|Overall Study|Lack of Efficacy|3|||
147333725|NCT01837641|531387797|FG007|Overall Study|Adverse Event|0|||
147333726|NCT01837641|531387790|FG000|Overall Study|Withdrawal by Subject|0|||
147333727|NCT01837641|531387791|FG001|Overall Study|Withdrawal by Subject|0|||
147273199|NCT01105533|531169576|FG004|Overall Study|Lack of Efficacy|4|||
147273200|NCT01105533|531169577|FG005|Overall Study|Lack of Efficacy|5|||
147273201|NCT01105533|531169578|FG006|Overall Study|Lack of Efficacy|3|||
147273202|NCT01105533|531169579|FG007|Overall Study|Lack of Efficacy|2|||
147273203|NCT01105533|531169580|FG008|Overall Study|Lack of Efficacy|9|||
147333728|NCT01837641|531387792|FG002|Overall Study|Withdrawal by Subject|0|||
147273204|NCT01105533|531169572|FG000|Overall Study|Adverse Event|0|||
147273205|NCT01105533|531169573|FG001|Overall Study|Adverse Event|0|||
147273206|NCT01105533|531169574|FG002|Overall Study|Adverse Event|0|||
147600360|NCT03893565|532356362|FG005|Double-blind Extended Treatment(20weeks)|Other|1|||
147273207|NCT01105533|531169575|FG003|Overall Study|Adverse Event|0|||
147273208|NCT01105533|531169576|FG004|Overall Study|Adverse Event|1|||
147273209|NCT01105533|531169577|FG005|Overall Study|Adverse Event|2|||
147273210|NCT01105533|531169578|FG006|Overall Study|Adverse Event|2|||
147273211|NCT01105533|531169579|FG007|Overall Study|Adverse Event|0|||
147273212|NCT01105533|531169580|FG008|Overall Study|Adverse Event|1|||
147273213|NCT01105533|531169572|FG000|Overall Study|Other|0|||
147273214|NCT01105533|531169573|FG001|Overall Study|Other|0|||
147273215|NCT01105533|531169574|FG002|Overall Study|Other|0|||
147273216|NCT01105533|531169575|FG003|Overall Study|Other|0|||
147273217|NCT01105533|531169576|FG004|Overall Study|Other|1|||
147273218|NCT01105533|531169577|FG005|Overall Study|Other|0|||
147273219|NCT01105533|531169578|FG006|Overall Study|Other|3|||
147273220|NCT01105533|531169579|FG007|Overall Study|Other|1|||
147273221|NCT01105533|531169580|FG008|Overall Study|Other|2|||
147273222|NCT01105533|531169572|FG000|Overall Study|Physician Decision|0|||
147273223|NCT01105533|531169573|FG001|Overall Study|Physician Decision|0|||
147273224|NCT01105533|531169574|FG002|Overall Study|Physician Decision|0|||
147273225|NCT01105533|531169575|FG003|Overall Study|Physician Decision|0|||
147273226|NCT01105533|531169576|FG004|Overall Study|Physician Decision|0|||
147273227|NCT01105533|531169577|FG005|Overall Study|Physician Decision|0|||
147273228|NCT01105533|531169578|FG006|Overall Study|Physician Decision|0|||
147273229|NCT01105533|531169579|FG007|Overall Study|Physician Decision|1|||
147273230|NCT01105533|531169580|FG008|Overall Study|Physician Decision|0|||
147273231|NCT00306592|531169581|FG000|Overall Study|Adverse Event|8|||
147273232|NCT00306592|531169582|FG001|Overall Study|Adverse Event|15|||
147333729|NCT01837641|531387793|FG003|Overall Study|Withdrawal by Subject|0|||
147333730|NCT01837641|531387794|FG004|Overall Study|Withdrawal by Subject|1|||
147333731|NCT01837641|531387795|FG005|Overall Study|Withdrawal by Subject|0|||
147333732|NCT01837641|531387796|FG006|Overall Study|Withdrawal by Subject|1|||
147333733|NCT01837641|531387797|FG007|Overall Study|Withdrawal by Subject|0|||
147333734|NCT01579916|531387798|FG000|Overall Study|Lost to Follow-up|6|||
147333735|NCT01579916|531387799|FG001|Overall Study|Lost to Follow-up|1|||
147333736|NCT01579916|531387798|FG000|Overall Study|Withdrawal by Subject|1|||
147333737|NCT01579916|531387799|FG001|Overall Study|Withdrawal by Subject|1|||
147333738|NCT01579916|531387798|FG000|Overall Study|Death|1|||
147333739|NCT01579916|531387799|FG001|Overall Study|Death|0|||
147333740|NCT03264456|531387800|FG000|Overall Study|Withdrawal by Subject|3|||
147333741|NCT03264456|531387800|FG000|Overall Study|Lost to Follow-up|1|||
147333742|NCT01123083|531387803|FG000|Overall Study|Investigator recommendation|1|||
147333743|NCT01123083|531387804|FG001|Overall Study|Investigator recommendation|1|||
147333744|NCT01123083|531387803|FG000|Overall Study|Administrative reasons|0|||
147333745|NCT01123083|531387804|FG001|Overall Study|Administrative reasons|4|||
147333746|NCT01123083|531387803|FG000|Overall Study|Lost to Follow-up|2|||
147333747|NCT01123083|531387804|FG001|Overall Study|Lost to Follow-up|6|||
147333748|NCT01123083|531387803|FG000|Overall Study|Adverse Event|1|||
147333749|NCT01123083|531387804|FG001|Overall Study|Adverse Event|0|||
147333750|NCT01123083|531387803|FG000|Overall Study|Withdrew for another reason not covered|0|||
147333751|NCT01123083|531387804|FG001|Overall Study|Withdrew for another reason not covered|1|||
147333752|NCT01123083|531387803|FG000|Overall Study|Participant/legal representative request|7|||
147333753|NCT01123083|531387804|FG001|Overall Study|Participant/legal representative request|3|||
147333754|NCT00961636|531387805|FG000|Overall Study|Adverse Event|35|||
147333755|NCT00961636|531387806|FG001|Overall Study|Adverse Event|54|||
147333756|NCT00961636|531387807|FG002|Overall Study|Adverse Event|13|||
147333757|NCT00961636|531387805|FG000|Overall Study|Flushing Symptoms|29|||
147333758|NCT00961636|531387806|FG001|Overall Study|Flushing Symptoms|46|||
147333759|NCT00961636|531387807|FG002|Overall Study|Flushing Symptoms|3|||
147333760|NCT00961636|531387805|FG000|Overall Study|Lost to Follow-up|2|||
147333761|NCT00961636|531387806|FG001|Overall Study|Lost to Follow-up|3|||
147333762|NCT00961636|531387807|FG002|Overall Study|Lost to Follow-up|1|||
147333763|NCT00961636|531387805|FG000|Overall Study|Physician Decision|3|||
147600361|NCT03893565|532356363|FG006|Double-blind Extended Treatment(20weeks)|Other|1|||
147600362|NCT03893565|532356364|FG007|Double-blind Extended Treatment(20weeks)|Other|0|||
147273233|NCT00306592|531169581|FG000|Overall Study|Lost to Follow-up|1|||
147273234|NCT00306592|531169582|FG001|Overall Study|Lost to Follow-up|0|||
147273235|NCT00306592|531169581|FG000|Overall Study|Noncompliance|0|||
147333764|NCT00961636|531387806|FG001|Overall Study|Physician Decision|1|||
147333765|NCT00961636|531387807|FG002|Overall Study|Physician Decision|1|||
147333766|NCT00961636|531387805|FG000|Overall Study|Protocol Violation|9|||
147333767|NCT00961636|531387806|FG001|Overall Study|Protocol Violation|5|||
147600363|NCT03893565|532356365|FG008|Double-blind Extended Treatment(20weeks)|Other|0|||
147600364|NCT03893565|532356357|FG000|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
147273236|NCT00306592|531169582|FG001|Overall Study|Noncompliance|2|||
147273237|NCT00306592|531169581|FG000|Overall Study|Persistent Antibodies|6|||
147273238|NCT00306592|531169582|FG001|Overall Study|Persistent Antibodies|3|||
147273239|NCT00306592|531169581|FG000|Overall Study|Voluntary|10|||
147273240|NCT00306592|531169582|FG001|Overall Study|Voluntary|6|||
147333768|NCT00961636|531387807|FG002|Overall Study|Protocol Violation|1|||
147273241|NCT00306592|531169581|FG000|Overall Study|Other|5|||
147273242|NCT00306592|531169582|FG001|Overall Study|Other|10|||
147273243|NCT00306592|531169581|FG000|Overall Study|Other|1|||
147273244|NCT00306592|531169582|FG001|Overall Study|Other|2|||
147273245|NCT00306592|531169581|FG000|Overall Study|48-week Treatment Period Ongoing|0|||
147273246|NCT00306592|531169582|FG001|Overall Study|48-week Treatment Period Ongoing|20|||
147273247|NCT04101526|531169583|FG000|Overall Study|Did not complete all sleep diary entries|0|||
147273248|NCT04101526|531169584|FG001|Overall Study|Did not complete all sleep diary entries|1|||
147273249|NCT02488629|531169585|FG000|Overall Study|Lack of Efficacy|3|||
147273250|NCT02488629|531169586|FG001|Overall Study|Lack of Efficacy|1|||
147273251|NCT02488629|531169587|FG002|Overall Study|Lack of Efficacy|0|||
147273252|NCT02488629|531169588|FG003|Overall Study|Lack of Efficacy|0|||
147273253|NCT02488629|531169585|FG000|Overall Study|Withdrawal by Subject|0|||
147273254|NCT02488629|531169586|FG001|Overall Study|Withdrawal by Subject|1|||
147273255|NCT02488629|531169587|FG002|Overall Study|Withdrawal by Subject|0|||
147273256|NCT02488629|531169588|FG003|Overall Study|Withdrawal by Subject|0|||
147273257|NCT02652624|531169589|FG000|Randomized Phase|Pregnancy|3|||
147273258|NCT02652624|531169590|FG001|Randomized Phase|Pregnancy|1|||
147273259|NCT02652624|531169589|FG000|Randomized Phase|Investigator's Discretion|0|||
147273260|NCT02652624|531169590|FG001|Randomized Phase|Investigator's Discretion|2|||
147273261|NCT02652624|531169589|FG000|Randomized Phase|Death|0|||
147273262|NCT02652624|531169590|FG001|Randomized Phase|Death|1|||
147273263|NCT02652624|531169589|FG000|Randomized Phase|Lost to Follow-up|0|||
147273264|NCT02652624|531169590|FG001|Randomized Phase|Lost to Follow-up|1|||
147273265|NCT02652624|531169589|FG000|Extension Phase|Lost to Follow-up|3|||
147273266|NCT02652624|531169590|FG001|Extension Phase|Lost to Follow-up|1|||
147273267|NCT02652624|531169589|FG000|Extension Phase|Pregnancy|1|||
147273268|NCT02652624|531169590|FG001|Extension Phase|Pregnancy|1|||
147273269|NCT02652624|531169589|FG000|Extension Phase|Adverse Event|0|||
147273270|NCT02652624|531169590|FG001|Extension Phase|Adverse Event|1|||
147273271|NCT02652624|531169589|FG000|Extension Phase|Withdrew Consent|0|||
147273272|NCT02652624|531169590|FG001|Extension Phase|Withdrew Consent|1|||
147273273|NCT00953329|531169591|FG000|Overall Study|Lack of Efficacy|1|||
147273274|NCT01049919|531169601|FG000|Overall Study|Met study endpoint (major amputation, death)|36|||
147273275|NCT01049919|531169602|FG001|Overall Study|Met study endpoint (major amputation, death)|16|||
147273276|NCT01049919|531169601|FG000|Overall Study|Withdrawal by Subject|5|||
147273277|NCT01049919|531169602|FG001|Overall Study|Withdrawal by Subject|0|||
147273278|NCT01049919|531169601|FG000|Overall Study|Lost to Follow-up|6|||
147273279|NCT01049919|531169602|FG001|Overall Study|Lost to Follow-up|1|||
147273280|NCT01049919|531169601|FG000|Overall Study|Physician Decision|2|||
147273281|NCT01049919|531169602|FG001|Overall Study|Physician Decision|0|||
147273282|NCT01049919|531169601|FG000|Overall Study|Received 2nd treatment via compassionate use|1|||
147273283|NCT01049919|531169602|FG001|Overall Study|Received 2nd treatment via compassionate use|0|||
147273284|NCT01049919|531169601|FG000|Overall Study|Early study termination by sponsor.|2|||
147273285|NCT01049919|531169602|FG001|Overall Study|Early study termination by sponsor.|0|||
147273286|NCT00844545|531169606|FG000|Treatment Period (26 Weeks)|Adverse Event|1|||
147273287|NCT00844545|531169606|FG000|Treatment Period (26 Weeks)|Protocol Violation|1|||
147273288|NCT00844545|531169606|FG000|Extension Treatment Period|Adverse Event|2|||
147273289|NCT00844545|531169606|FG000|Post Treatment Period|Withdrawal by Subject|1|||
147273290|NCT02039427|531169607|FG000|Overall Study|Duration of surgery > 3h|1|||
147273291|NCT02039427|531169608|FG001|Overall Study|Duration of surgery > 3h|1|||
147273292|NCT02039427|531169609|FG002|Overall Study|Duration of surgery > 3h|0|||
147273293|NCT02039427|531169610|FG003|Overall Study|Duration of surgery > 3h|0|||
147273294|NCT02039427|531169607|FG000|Overall Study|Withdrawal on concent|0|||
147273295|NCT02039427|531169608|FG001|Overall Study|Withdrawal on concent|0|||
147273296|NCT02039427|531169609|FG002|Overall Study|Withdrawal on concent|0|||
147273297|NCT02039427|531169610|FG003|Overall Study|Withdrawal on concent|1|||
147273298|NCT02039427|531169607|FG000|Overall Study|Cancellation of surgery|0|||
147273299|NCT02039427|531169608|FG001|Overall Study|Cancellation of surgery|0|||
147273300|NCT02039427|531169609|FG002|Overall Study|Cancellation of surgery|1|||
147273301|NCT02039427|531169610|FG003|Overall Study|Cancellation of surgery|0|||
147273302|NCT02039427|531169607|FG000|Overall Study|Loss of follow - up|1|||
147273303|NCT02039427|531169608|FG001|Overall Study|Loss of follow - up|0|||
147273304|NCT02039427|531169609|FG002|Overall Study|Loss of follow - up|2|||
147273305|NCT02039427|531169610|FG003|Overall Study|Loss of follow - up|4|||
147273306|NCT02039427|531169607|FG000|Overall Study|Steroid Use|1|||
147273307|NCT02039427|531169608|FG001|Overall Study|Steroid Use|0|||
147273308|NCT02039427|531169609|FG002|Overall Study|Steroid Use|0|||
147273309|NCT02039427|531169610|FG003|Overall Study|Steroid Use|0|||
147273310|NCT02984995|531169613|FG000|Overall Study|Required stem cell transplant|13|||
147273311|NCT02984995|531169614|FG001|Overall Study|Required stem cell transplant|2|||
147273312|NCT02984995|531169613|FG000|Overall Study|Progressive disease|11|||
147273313|NCT02984995|531169614|FG001|Overall Study|Progressive disease|1|||
147273314|NCT02984995|531169613|FG000|Overall Study|Adverse Event|1|||
147273315|NCT02984995|531169614|FG001|Overall Study|Adverse Event|0|||
147273316|NCT04354831|531169615|FG000|Overall Study|No blood type specific convalescent plasma was available|0|||
147450666|NCT02164981|531813117|FG002|Started|Protocol Violation|0|||
147450667|NCT02164981|531813115|FG000|Started|Adverse Event|1|||
147450668|NCT02164981|531813116|FG001|Started|Adverse Event|2|||
147450669|NCT02164981|531813117|FG002|Started|Adverse Event|0|||
147450670|NCT02164981|531813115|FG000|Phase 1 (Day 0 - Day 14)|Adverse Event|0|||
147450671|NCT02164981|531813116|FG001|Phase 1 (Day 0 - Day 14)|Adverse Event|2|||
147450672|NCT02164981|531813117|FG002|Phase 1 (Day 0 - Day 14)|Adverse Event|0|||
147450673|NCT02164981|531813115|FG000|Phase 2 (Day 14 - Day 28)|Adverse Event|2|||
147450674|NCT02164981|531813116|FG001|Phase 2 (Day 14 - Day 28)|Adverse Event|1|||
147450675|NCT02164981|531813117|FG002|Phase 2 (Day 14 - Day 28)|Adverse Event|0|||
147450676|NCT02164981|531813115|FG000|Phase 2 (Day 14 - Day 28)|Protocol Violation|0|||
147450677|NCT02164981|531813116|FG001|Phase 2 (Day 14 - Day 28)|Protocol Violation|1|||
147273317|NCT04354831|531169616|FG001|Overall Study|No blood type specific convalescent plasma was available|1|||
147273318|NCT03217136|531169618|FG000|Overall Study|Lost to Follow-up|2|||
147273319|NCT03217136|531169619|FG001|Overall Study|Lost to Follow-up|1|||
147273320|NCT03217136|531169618|FG000|Overall Study|Site Randomized Participant in Error|0|||
147273321|NCT03217136|531169619|FG001|Overall Study|Site Randomized Participant in Error|1|||
147273322|NCT03217136|531169618|FG000|Overall Study|Did Not Meet Criteria after Randomization|0|||
147273323|NCT03217136|531169619|FG001|Overall Study|Did Not Meet Criteria after Randomization|1|||
147273324|NCT03217136|531169618|FG000|Overall Study|Dispensing Error|1|||
147273325|NCT03217136|531169619|FG001|Overall Study|Dispensing Error|0|||
147273326|NCT03217136|531169618|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
147273327|NCT03217136|531169619|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
147273328|NCT01401530|531169620|FG000|Overall Study|Disease Progression|1|||
147273329|NCT01401530|531169621|FG001|Overall Study|Disease Progression|2|||
147273330|NCT01401530|531169622|FG002|Overall Study|Disease Progression|1|||
147273331|NCT01401530|531169620|FG000|Overall Study|Adverse Event|1|||
147273332|NCT01401530|531169621|FG001|Overall Study|Adverse Event|1|||
147273333|NCT01401530|531169622|FG002|Overall Study|Adverse Event|1|||
147273334|NCT01401530|531169620|FG000|Overall Study|Participant Choice|1|||
147273335|NCT01401530|531169621|FG001|Overall Study|Participant Choice|2|||
147273336|NCT01401530|531169622|FG002|Overall Study|Participant Choice|1|||
147273337|NCT01401530|531169620|FG000|Overall Study|Physician Decision|0|||
147273338|NCT01401530|531169621|FG001|Overall Study|Physician Decision|1|||
147273339|NCT01401530|531169622|FG002|Overall Study|Physician Decision|0|||
147273340|NCT02939404|531169623|FG000|Chamber at 24°C, ad Libitum Diet|Adverse Event|2|||
147273341|NCT02939404|531169624|FG001|Chamber at 24°C, ad Libitum Diet|Adverse Event|1|||
147273342|NCT02939404|531169623|FG000|Chamber at 24°C, ad Libitum Diet|Withdrawal by Subject|3|||
147273343|NCT02939404|531169624|FG001|Chamber at 24°C, ad Libitum Diet|Withdrawal by Subject|2|||
147273344|NCT06640829|531169626|FG000|Overall Study|Withdrawal by Subject|1|||
147273345|NCT06640829|531169626|FG000|Overall Study|Lost to Follow-up|1|||
147273346|NCT01350128|531169627|FG000|Overall Study|Withdrawal by Subject|3|||
147273347|NCT01350128|531169627|FG000|Overall Study|Protocol discontinuation criteria|8|||
147273348|NCT01350128|531169627|FG000|Overall Study|Physician Decision|1|||
147273349|NCT01350128|531169627|FG000|Overall Study|Lost to Follow-up|2|||
147273350|NCT01252290|531169630|FG000|Overall Study|Withdrawal by Subject|1|||
147273351|NCT02075437|531169631|FG000|Overall Study|Withdrawal by Subject|5|||
147273352|NCT02075437|531169631|FG000|Overall Study|Lost to Follow-up|1|||
147273353|NCT04439240|531169632|FG000|Overall Study|Ineligible|2|||
147273354|NCT04439240|531169632|FG000|Overall Study|Never started treatment|2|||
147273355|NCT04439240|531169632|FG000|Overall Study|Adverse Event|12|||
147273356|NCT04439240|531169632|FG000|Overall Study|Death|2|||
147273357|NCT04439240|531169632|FG000|Overall Study|Disease progression|25|||
147273358|NCT04439240|531169632|FG000|Overall Study|Other diseases|2|||
147273359|NCT04439240|531169632|FG000|Overall Study|Withdrawal by Subject|3|||
147273360|NCT04439240|531169632|FG000|Overall Study|Clinical concerns for progression and increasing tumor marker|1|||
147273361|NCT04439240|531169632|FG000|Overall Study|Symptomatic decline|1|||
147273362|NCT04439240|531169632|FG000|Overall Study|Pogression of the lymphadenopathy|1|||
147273363|NCT04439240|531169632|FG000|Overall Study|Clinical progression|1|||
147273364|NCT03604692|531169633|FG000|Overall Study|Investigator's Decision|0|||
147273365|NCT03604692|531169634|FG001|Overall Study|Investigator's Decision|0|||
147273366|NCT03604692|531169635|FG002|Overall Study|Investigator's Decision|0|||
147273367|NCT03604692|531169636|FG003|Overall Study|Investigator's Decision|1|||
147273368|NCT03604692|531169637|FG004|Overall Study|Investigator's Decision|0|||
147273369|NCT03604692|531169638|FG005|Overall Study|Investigator's Decision|7|||
147450678|NCT02164981|531813117|FG002|Phase 2 (Day 14 - Day 28)|Protocol Violation|0|||
147273370|NCT03604692|531169633|FG000|Overall Study|Withdrawal by Subject|0|||
147273371|NCT03604692|531169634|FG001|Overall Study|Withdrawal by Subject|0|||
147273372|NCT03604692|531169635|FG002|Overall Study|Withdrawal by Subject|0|||
147273373|NCT03604692|531169636|FG003|Overall Study|Withdrawal by Subject|0|||
147273374|NCT03604692|531169637|FG004|Overall Study|Withdrawal by Subject|0|||
147273375|NCT03604692|531169638|FG005|Overall Study|Withdrawal by Subject|2|||
147273376|NCT03604692|531169633|FG000|Overall Study|Progressive Disease|1|||
147273377|NCT03604692|531169634|FG001|Overall Study|Progressive Disease|0|||
147273378|NCT03604692|531169635|FG002|Overall Study|Progressive Disease|1|||
147450679|NCT01736579|531813118|FG000|Overall Study|Termination of Study by Sponsor|2|||
147450680|NCT01736579|531813119|FG001|Overall Study|Termination of Study by Sponsor|2|||
147273379|NCT03604692|531169636|FG003|Overall Study|Progressive Disease|0|||
147273380|NCT03604692|531169637|FG004|Overall Study|Progressive Disease|3|||
147273381|NCT03604692|531169638|FG005|Overall Study|Progressive Disease|4|||
147273382|NCT03604692|531169633|FG000|Overall Study|Difficulty Coming into Site|0|||
147273383|NCT03604692|531169634|FG001|Overall Study|Difficulty Coming into Site|0|||
147273384|NCT03604692|531169635|FG002|Overall Study|Difficulty Coming into Site|0|||
147273385|NCT03604692|531169636|FG003|Overall Study|Difficulty Coming into Site|0|||
147273386|NCT03604692|531169637|FG004|Overall Study|Difficulty Coming into Site|0|||
147273387|NCT03604692|531169638|FG005|Overall Study|Difficulty Coming into Site|1|||
147273388|NCT03604692|531169633|FG000|Overall Study|Death|0|||
147273389|NCT03604692|531169634|FG001|Overall Study|Death|0|||
147273390|NCT03604692|531169635|FG002|Overall Study|Death|1|||
147273391|NCT03604692|531169636|FG003|Overall Study|Death|0|||
147273392|NCT03604692|531169637|FG004|Overall Study|Death|0|||
147273393|NCT03604692|531169638|FG005|Overall Study|Death|0|||
147273394|NCT03604692|531169633|FG000|Overall Study|Drug Intolerance|0|||
147273395|NCT03604692|531169634|FG001|Overall Study|Drug Intolerance|0|||
147273396|NCT03604692|531169635|FG002|Overall Study|Drug Intolerance|0|||
147273397|NCT03604692|531169636|FG003|Overall Study|Drug Intolerance|1|||
147273398|NCT03604692|531169637|FG004|Overall Study|Drug Intolerance|0|||
147273399|NCT03604692|531169638|FG005|Overall Study|Drug Intolerance|0|||
147273400|NCT03604692|531169633|FG000|Overall Study|Noncompliance with follow-up visit|0|||
147273401|NCT03604692|531169634|FG001|Overall Study|Noncompliance with follow-up visit|0|||
147273402|NCT03604692|531169635|FG002|Overall Study|Noncompliance with follow-up visit|0|||
147273403|NCT03604692|531169636|FG003|Overall Study|Noncompliance with follow-up visit|1|||
147273404|NCT03604692|531169637|FG004|Overall Study|Noncompliance with follow-up visit|0|||
147273405|NCT03604692|531169638|FG005|Overall Study|Noncompliance with follow-up visit|0|||
147273406|NCT03604692|531169633|FG000|Overall Study|Not Treated|0|||
147273407|NCT03604692|531169634|FG001|Overall Study|Not Treated|0|||
147273408|NCT03604692|531169635|FG002|Overall Study|Not Treated|0|||
147273409|NCT03604692|531169636|FG003|Overall Study|Not Treated|0|||
147273410|NCT03604692|531169637|FG004|Overall Study|Not Treated|1|||
147273411|NCT03604692|531169638|FG005|Overall Study|Not Treated|0|||
147273412|NCT00637195|531169642|FG000|Overall Study|Lost to Follow-up|1|||
147273413|NCT00637195|531169643|FG001|Overall Study|Lost to Follow-up|0|||
147273414|NCT00637195|531169642|FG000|Overall Study|Other|2|||
147273415|NCT00637195|531169643|FG001|Overall Study|Other|0|||
147273416|NCT00637195|531169642|FG000|Overall Study|Withdrawal by Subject|0|||
147273417|NCT00637195|531169643|FG001|Overall Study|Withdrawal by Subject|1|||
147273418|NCT01469065|531169644|FG000|Overall Study|Lack of Efficacy|0|||
147273419|NCT01469065|531169645|FG001|Overall Study|Lack of Efficacy|0|||
147273420|NCT01469065|531169646|FG002|Overall Study|Lack of Efficacy|0|||
147273421|NCT01469065|531169647|FG003|Overall Study|Lack of Efficacy|0|||
147273422|NCT01469065|531169648|FG004|Overall Study|Lack of Efficacy|1|||
147273423|NCT01469065|531169644|FG000|Overall Study|Other|0|||
147273424|NCT01469065|531169645|FG001|Overall Study|Other|1|||
147273425|NCT01469065|531169646|FG002|Overall Study|Other|0|||
147273426|NCT01469065|531169647|FG003|Overall Study|Other|0|||
147273427|NCT01469065|531169648|FG004|Overall Study|Other|0|||
147273428|NCT01020019|531169654|FG000|Overall Study|Lost to Follow-up|21|||
147273429|NCT01020019|531169655|FG001|Overall Study|Lost to Follow-up|18|||
147273430|NCT01020019|531169654|FG000|Overall Study|Adverse Event|1|||
147273431|NCT01020019|531169655|FG001|Overall Study|Adverse Event|5|||
147273432|NCT01020019|531169654|FG000|Overall Study|not interested in treatment|4|||
147273433|NCT01020019|531169655|FG001|Overall Study|not interested in treatment|4|||
147273434|NCT01020019|531169654|FG000|Overall Study|moving|0|||
147273435|NCT01020019|531169655|FG001|Overall Study|moving|2|||
147273436|NCT00094653|531169658|FG000|Overall Study|Death|306|||
147273437|NCT00094653|531169659|FG001|Overall Study|Death|100|||
147273438|NCT00094653|531169660|FG002|Overall Study|Death|119|||
147273439|NCT00094653|531169658|FG000|Overall Study|Subject Withdrew Consent|10|||
147273440|NCT00094653|531169659|FG001|Overall Study|Subject Withdrew Consent|2|||
147273441|NCT00094653|531169660|FG002|Overall Study|Subject Withdrew Consent|3|||
147450681|NCT01995071|531813126|FG000|Overall Study|Adverse Event|0|||
147450682|NCT01995071|531813127|FG001|Overall Study|Adverse Event|0|||
147450683|NCT01995071|531813128|FG002|Overall Study|Adverse Event|0|||
147273442|NCT00094653|531169658|FG000|Overall Study|Other|2|||
147273443|NCT00094653|531169659|FG001|Overall Study|Other|2|||
147273444|NCT00094653|531169660|FG002|Overall Study|Other|2|||
147273445|NCT00094653|531169658|FG000|Overall Study|Lost to Follow-up|3|||
147273446|NCT00094653|531169659|FG001|Overall Study|Lost to Follow-up|2|||
147273447|NCT00094653|531169660|FG002|Overall Study|Lost to Follow-up|1|||
147273448|NCT00094653|531169658|FG000|Overall Study|Protocol Violation|0|||
147273449|NCT00094653|531169659|FG001|Overall Study|Protocol Violation|0|||
147273450|NCT00094653|531169660|FG002|Overall Study|Protocol Violation|1|||
147273451|NCT03921411|531169661|FG000|Overall Study|Withdrawal by Subject|1|||
147273452|NCT03921411|531169661|FG000|Overall Study|Protocol Deviation|2|||
147273453|NCT03921411|531169661|FG000|Overall Study|Enrolled, but never treated|2|||
147273454|NCT03120013|531169665|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
147273455|NCT03120013|531169666|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
147450684|NCT01995071|531813129|FG003|Overall Study|Adverse Event|0|||
147273456|NCT02098109|531169667|FG000|Overall Study|Protocol Violation|3|||
147273457|NCT02098109|531169668|FG001|Overall Study|Protocol Violation|0|||
147273458|NCT01541826|531169669|FG000|Overall Study|Lost to Follow-up|2|||
147273459|NCT01541826|531169670|FG001|Overall Study|Lost to Follow-up|3|||
147273460|NCT01541826|531169671|FG002|Overall Study|Lost to Follow-up|0|||
147273461|NCT01541826|531169669|FG000|Overall Study|Withdrawal by Subject|2|||
147273462|NCT01541826|531169670|FG001|Overall Study|Withdrawal by Subject|0|||
147273463|NCT01541826|531169671|FG002|Overall Study|Withdrawal by Subject|0|||
147273464|NCT01565291|531169672|FG000|Overall Study|Withdrawal by Subject|1|||
147273465|NCT01565291|531169673|FG001|Overall Study|Withdrawal by Subject|0|||
147273466|NCT00006916|531169676|FG000|Overall Study|Device not inserted|4|||
147450685|NCT01995071|531813130|FG004|Overall Study|Adverse Event|0|||
147450686|NCT01995071|531813131|FG005|Overall Study|Adverse Event|0|||
147450687|NCT01995071|531813132|FG006|Overall Study|Adverse Event|1|||
147450688|NCT01995071|531813133|FG007|Overall Study|Adverse Event|0|||
147450689|NCT01995071|531813134|FG008|Overall Study|Adverse Event|0|||
147450690|NCT01995071|531813135|FG009|Overall Study|Adverse Event|0|||
147450691|NCT01995071|531813136|FG010|Overall Study|Adverse Event|0|||
147273467|NCT00006916|531169676|FG000|Overall Study|Complication of device insertion|1|||
147273468|NCT00558103|531169677|FG000|Randomized Treatment Phase|Lost to Follow-up|2|||
147273469|NCT00558103|531169678|FG001|Randomized Treatment Phase|Lost to Follow-up|2|||
147273470|NCT00558103|531169679|FG002|Randomized Treatment Phase|Lost to Follow-up|2|||
147273471|NCT00558103|531169680|FG003|Randomized Treatment Phase|Lost to Follow-up|1|||
147273472|NCT00558103|531169681|FG004|Randomized Treatment Phase|Lost to Follow-up|3|||
147273473|NCT00558103|531169682|FG005|Randomized Treatment Phase|Lost to Follow-up|0|||
147273474|NCT00558103|531169677|FG000|Randomized Treatment Phase|Withdrawal by Subject|2|||
147273475|NCT00558103|531169678|FG001|Randomized Treatment Phase|Withdrawal by Subject|2|||
147273476|NCT00558103|531169679|FG002|Randomized Treatment Phase|Withdrawal by Subject|0|||
147450692|NCT01995071|531813137|FG011|Overall Study|Adverse Event|0|||
147450693|NCT01995071|531813126|FG000|Overall Study|Moved|0|||
147450694|NCT01995071|531813127|FG001|Overall Study|Moved|0|||
147450695|NCT01995071|531813128|FG002|Overall Study|Moved|1|||
147450696|NCT01995071|531813129|FG003|Overall Study|Moved|0|||
147450697|NCT01995071|531813130|FG004|Overall Study|Moved|1|||
147450698|NCT01995071|531813131|FG005|Overall Study|Moved|0|||
147450699|NCT01995071|531813132|FG006|Overall Study|Moved|0|||
147450700|NCT01995071|531813133|FG007|Overall Study|Moved|0|||
147450701|NCT01995071|531813134|FG008|Overall Study|Moved|0|||
147450702|NCT01995071|531813135|FG009|Overall Study|Moved|0|||
147450703|NCT01995071|531813136|FG010|Overall Study|Moved|1|||
147450704|NCT01995071|531813137|FG011|Overall Study|Moved|0|||
147450705|NCT01995071|531813126|FG000|Overall Study|Lost to Follow-up|1|||
147450706|NCT01995071|531813127|FG001|Overall Study|Lost to Follow-up|0|||
147450707|NCT01995071|531813128|FG002|Overall Study|Lost to Follow-up|0|||
147450708|NCT01995071|531813129|FG003|Overall Study|Lost to Follow-up|0|||
147450709|NCT01995071|531813130|FG004|Overall Study|Lost to Follow-up|0|||
147450710|NCT01995071|531813131|FG005|Overall Study|Lost to Follow-up|0|||
147450711|NCT01995071|531813132|FG006|Overall Study|Lost to Follow-up|0|||
147450712|NCT01995071|531813133|FG007|Overall Study|Lost to Follow-up|1|||
147450713|NCT01995071|531813134|FG008|Overall Study|Lost to Follow-up|1|||
147450714|NCT01995071|531813135|FG009|Overall Study|Lost to Follow-up|0|||
147450715|NCT01995071|531813136|FG010|Overall Study|Lost to Follow-up|0|||
147450716|NCT01995071|531813137|FG011|Overall Study|Lost to Follow-up|0|||
147450717|NCT01995071|531813126|FG000|Overall Study|Incarcerated|0|||
147450718|NCT01995071|531813127|FG001|Overall Study|Incarcerated|0|||
147450719|NCT01995071|531813128|FG002|Overall Study|Incarcerated|0|||
147450720|NCT01995071|531813129|FG003|Overall Study|Incarcerated|0|||
147450721|NCT01995071|531813130|FG004|Overall Study|Incarcerated|0|||
147450722|NCT01995071|531813131|FG005|Overall Study|Incarcerated|0|||
147450723|NCT01995071|531813132|FG006|Overall Study|Incarcerated|0|||
147450724|NCT01995071|531813133|FG007|Overall Study|Incarcerated|1|||
147450725|NCT01995071|531813134|FG008|Overall Study|Incarcerated|0|||
147662387|NCT02452047|532587319|FG001|Overall Study|Physician Decision|0|||
147662388|NCT02452047|532587320|FG002|Overall Study|Physician Decision|0|||
147273477|NCT00558103|531169680|FG003|Randomized Treatment Phase|Withdrawal by Subject|0|||
147273478|NCT00558103|531169681|FG004|Randomized Treatment Phase|Withdrawal by Subject|1|||
147273479|NCT00558103|531169682|FG005|Randomized Treatment Phase|Withdrawal by Subject|0|||
147273480|NCT00558103|531169677|FG000|Randomized Treatment Phase|Disease Progression|1|||
147273481|NCT00558103|531169678|FG001|Randomized Treatment Phase|Disease Progression|0|||
147273482|NCT00558103|531169679|FG002|Randomized Treatment Phase|Disease Progression|1|||
147273483|NCT00558103|531169680|FG003|Randomized Treatment Phase|Disease Progression|0|||
147450726|NCT01995071|531813135|FG009|Overall Study|Incarcerated|0|||
147450727|NCT01995071|531813136|FG010|Overall Study|Incarcerated|0|||
147450728|NCT01995071|531813137|FG011|Overall Study|Incarcerated|0|||
147450729|NCT01783678|531813138|FG000|Overall Study|Randomized but Not Treated|0|||
147450730|NCT01783678|531813139|FG001|Overall Study|Randomized but Not Treated|0|||
147450731|NCT01783678|531813140|FG002|Overall Study|Randomized but Not Treated|0|||
147450732|NCT01783678|531813141|FG003|Overall Study|Randomized but Not Treated|1|||
147450733|NCT01783678|531813142|FG004|Overall Study|Randomized but Not Treated|0|||
147273484|NCT00558103|531169681|FG004|Randomized Treatment Phase|Disease Progression|0|||
147273485|NCT00558103|531169682|FG005|Randomized Treatment Phase|Disease Progression|0|||
147273486|NCT00558103|531169677|FG000|Randomized Treatment Phase|Adverse Event|0|||
147273487|NCT00558103|531169678|FG001|Randomized Treatment Phase|Adverse Event|0|||
147273488|NCT00558103|531169679|FG002|Randomized Treatment Phase|Adverse Event|0|||
147273489|NCT00558103|531169680|FG003|Randomized Treatment Phase|Adverse Event|1|||
147273490|NCT00558103|531169681|FG004|Randomized Treatment Phase|Adverse Event|1|||
147273491|NCT00558103|531169682|FG005|Randomized Treatment Phase|Adverse Event|0|||
147273492|NCT00558103|531169677|FG000|Monotherapy Extension Phase|Protocol Violation|0|||
147273493|NCT00558103|531169678|FG001|Monotherapy Extension Phase|Protocol Violation|0|||
147273494|NCT00558103|531169679|FG002|Monotherapy Extension Phase|Protocol Violation|0|||
147273495|NCT00558103|531169680|FG003|Monotherapy Extension Phase|Protocol Violation|0|||
147273496|NCT00558103|531169681|FG004|Monotherapy Extension Phase|Protocol Violation|0|||
147273497|NCT00558103|531169682|FG005|Monotherapy Extension Phase|Protocol Violation|1|||
147273498|NCT00558103|531169677|FG000|Monotherapy Extension Phase|Disease Progression|0|||
147273499|NCT00558103|531169678|FG001|Monotherapy Extension Phase|Disease Progression|0|||
147273500|NCT00558103|531169679|FG002|Monotherapy Extension Phase|Disease Progression|0|||
147273501|NCT00558103|531169680|FG003|Monotherapy Extension Phase|Disease Progression|0|||
147273502|NCT00558103|531169681|FG004|Monotherapy Extension Phase|Disease Progression|0|||
147273503|NCT00558103|531169682|FG005|Monotherapy Extension Phase|Disease Progression|8|||
147273504|NCT03385239|531169685|FG000|Overall Study|Voluntary Withdrawal|2|||
147273505|NCT03385239|531169686|FG001|Overall Study|Voluntary Withdrawal|3|||
147273506|NCT03385239|531169687|FG002|Overall Study|Voluntary Withdrawal|2|||
147273507|NCT03385239|531169688|FG003|Overall Study|Voluntary Withdrawal|3|||
147273508|NCT03385239|531169689|FG004|Overall Study|Voluntary Withdrawal|0|||
147273509|NCT03385239|531169685|FG000|Overall Study|Adverse Event|0|||
147273510|NCT03385239|531169686|FG001|Overall Study|Adverse Event|0|||
147273511|NCT03385239|531169687|FG002|Overall Study|Adverse Event|1|||
147273512|NCT03385239|531169688|FG003|Overall Study|Adverse Event|0|||
147273513|NCT03385239|531169689|FG004|Overall Study|Adverse Event|0|||
147273514|NCT03385239|531169685|FG000|Overall Study|Other|0|||
147273515|NCT03385239|531169686|FG001|Overall Study|Other|0|||
147273516|NCT03385239|531169687|FG002|Overall Study|Other|0|||
147273517|NCT03385239|531169688|FG003|Overall Study|Other|1|||
147273518|NCT03385239|531169689|FG004|Overall Study|Other|0|||
147273519|NCT00700011|531169690|FG000|Overall Study|Death|0|||
147273520|NCT00700011|531169691|FG001|Overall Study|Death|1|||
147273521|NCT00678561|531169692|FG000|Overall Study|Adverse Event|0|||
147273522|NCT00678561|531169693|FG001|Overall Study|Adverse Event|1|||
147273523|NCT00678561|531169694|FG002|Overall Study|Adverse Event|1|||
147273524|NCT00678561|531169695|FG003|Overall Study|Adverse Event|0|||
147273525|NCT00678561|531169696|FG004|Overall Study|Adverse Event|1|||
147273526|NCT00678561|531169697|FG005|Overall Study|Adverse Event|0|||
147273527|NCT00678561|531169698|FG006|Overall Study|Adverse Event|0|||
147273528|NCT00678561|531169699|FG007|Overall Study|Adverse Event|0|||
147273529|NCT00678561|531169692|FG000|Overall Study|Protocol Violation|0|||
147273530|NCT00678561|531169693|FG001|Overall Study|Protocol Violation|0|||
147273531|NCT00678561|531169694|FG002|Overall Study|Protocol Violation|0|||
147273532|NCT00678561|531169695|FG003|Overall Study|Protocol Violation|0|||
147273533|NCT00678561|531169696|FG004|Overall Study|Protocol Violation|1|||
147273534|NCT00678561|531169697|FG005|Overall Study|Protocol Violation|1|||
147273535|NCT00678561|531169698|FG006|Overall Study|Protocol Violation|0|||
147273536|NCT00678561|531169699|FG007|Overall Study|Protocol Violation|0|||
147273537|NCT00678561|531169692|FG000|Overall Study|Withdrawal by Subject|0|||
147273538|NCT00678561|531169693|FG001|Overall Study|Withdrawal by Subject|0|||
147273539|NCT00678561|531169694|FG002|Overall Study|Withdrawal by Subject|0|||
147273540|NCT00678561|531169695|FG003|Overall Study|Withdrawal by Subject|0|||
147273541|NCT00678561|531169696|FG004|Overall Study|Withdrawal by Subject|0|||
147273542|NCT00678561|531169697|FG005|Overall Study|Withdrawal by Subject|0|||
147273543|NCT00678561|531169698|FG006|Overall Study|Withdrawal by Subject|0|||
147273544|NCT00678561|531169699|FG007|Overall Study|Withdrawal by Subject|1|||
147273545|NCT00004031|531169700|FG000|Overall Study|Adverse Event|5|||
147273546|NCT00004031|531169701|FG001|Overall Study|Adverse Event|0|||
147273547|NCT00004031|531169700|FG000|Overall Study|Refusal unrelated to adverse events|2|||
147273548|NCT00004031|531169701|FG001|Overall Study|Refusal unrelated to adverse events|11|||
147273549|NCT00004031|531169700|FG000|Overall Study|Progression/relapse|9|||
147273550|NCT00004031|531169701|FG001|Overall Study|Progression/relapse|4|||
147450734|NCT01783678|531813143|FG005|Overall Study|Randomized but Not Treated|0|||
147273551|NCT00004031|531169700|FG000|Overall Study|Death|3|||
147273552|NCT00004031|531169701|FG001|Overall Study|Death|1|||
147273553|NCT00004031|531169700|FG000|Overall Study|Other- not protocol specified|3|||
147273554|NCT00004031|531169701|FG001|Overall Study|Other- not protocol specified|3|||
147273555|NCT00004031|531169700|FG000|Overall Study|Reason under review|3|||
147273556|NCT00004031|531169701|FG001|Overall Study|Reason under review|2|||
147273557|NCT01451424|531169702|FG000|Overall Study|Withdrawal by Subject|1|||
147273558|NCT01451424|531169703|FG001|Overall Study|Withdrawal by Subject|1|||
147273559|NCT01451424|531169704|FG002|Overall Study|Withdrawal by Subject|0|||
147450735|NCT01783678|531813138|FG000|Overall Study|Lack of Efficacy|1|||
147450736|NCT01783678|531813139|FG001|Overall Study|Lack of Efficacy|13|||
147450737|NCT01783678|531813140|FG002|Overall Study|Lack of Efficacy|1|||
147450738|NCT01783678|531813141|FG003|Overall Study|Lack of Efficacy|3|||
147450739|NCT01783678|531813142|FG004|Overall Study|Lack of Efficacy|6|||
147450740|NCT01783678|531813143|FG005|Overall Study|Lack of Efficacy|5|||
147450741|NCT01783678|531813138|FG000|Overall Study|Lost to Follow-up|0|||
147450742|NCT01783678|531813139|FG001|Overall Study|Lost to Follow-up|4|||
147450743|NCT01783678|531813140|FG002|Overall Study|Lost to Follow-up|0|||
147450744|NCT01783678|531813141|FG003|Overall Study|Lost to Follow-up|2|||
147450745|NCT01783678|531813142|FG004|Overall Study|Lost to Follow-up|1|||
147450746|NCT01783678|531813143|FG005|Overall Study|Lost to Follow-up|0|||
147450747|NCT01783678|531813138|FG000|Overall Study|Withdrew Consent|1|||
147450748|NCT01783678|531813139|FG001|Overall Study|Withdrew Consent|1|||
147450749|NCT01783678|531813140|FG002|Overall Study|Withdrew Consent|0|||
147450750|NCT01783678|531813141|FG003|Overall Study|Withdrew Consent|2|||
147450751|NCT01783678|531813142|FG004|Overall Study|Withdrew Consent|0|||
147450752|NCT01783678|531813143|FG005|Overall Study|Withdrew Consent|0|||
147450753|NCT02404103|531813144|FG000|Overall Study|Adverse Event|1|||
147450754|NCT02404103|531813145|FG001|Overall Study|Adverse Event|0|||
147450755|NCT02404103|531813144|FG000|Overall Study|Lost to Follow-up|3|||
147450756|NCT02404103|531813145|FG001|Overall Study|Lost to Follow-up|3|||
147450757|NCT02543528|531813146|FG000|Adaptation Period|Unsatisfactory Lens Fitting|0|||
147450758|NCT02543528|531813147|FG001|Adaptation Period|Unsatisfactory Lens Fitting|0|||
147450759|NCT02543528|531813148|FG002|Adaptation Period|Unsatisfactory Lens Fitting|0|||
147450760|NCT02543528|531813149|FG003|Adaptation Period|Unsatisfactory Lens Fitting|0|||
147450761|NCT02543528|531813150|FG004|Adaptation Period|Unsatisfactory Lens Fitting|2|||
147450762|NCT02543528|531813146|FG000|Adaptation Period|Lens Handling Difficultes|0|||
147450763|NCT02543528|531813147|FG001|Adaptation Period|Lens Handling Difficultes|0|||
147450764|NCT02543528|531813148|FG002|Adaptation Period|Lens Handling Difficultes|0|||
147450765|NCT02543528|531813149|FG003|Adaptation Period|Lens Handling Difficultes|0|||
147450766|NCT02543528|531813150|FG004|Adaptation Period|Lens Handling Difficultes|8|||
147450767|NCT02543528|531813146|FG000|Adaptation Period|Lost to Follow-up|0|||
147450768|NCT02543528|531813147|FG001|Adaptation Period|Lost to Follow-up|0|||
147450769|NCT02543528|531813148|FG002|Adaptation Period|Lost to Follow-up|0|||
147600365|NCT03893565|532356358|FG001|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
147600366|NCT03893565|532356359|FG002|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
147600367|NCT03893565|532356360|FG003|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
147600368|NCT03893565|532356361|FG004|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
147600369|NCT03893565|532356362|FG005|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
147600370|NCT03893565|532356363|FG006|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|1|||
147600371|NCT03893565|532356364|FG007|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
147600372|NCT03893565|532356365|FG008|Double-blind Extended Treatment(20weeks)|Withdrawal by Subject|0|||
147273560|NCT01451424|531169705|FG003|Overall Study|Withdrawal by Subject|2|||
147273561|NCT01451424|531169702|FG000|Overall Study|Lost to Follow-up|0|||
147273562|NCT01451424|531169703|FG001|Overall Study|Lost to Follow-up|1|||
147273563|NCT01451424|531169704|FG002|Overall Study|Lost to Follow-up|0|||
147273564|NCT01451424|531169705|FG003|Overall Study|Lost to Follow-up|1|||
147273565|NCT01451424|531169702|FG000|Overall Study|Physician Decision|0|||
147273566|NCT01451424|531169703|FG001|Overall Study|Physician Decision|0|||
147273567|NCT01451424|531169704|FG002|Overall Study|Physician Decision|1|||
147273568|NCT01451424|531169705|FG003|Overall Study|Physician Decision|1|||
147273569|NCT01451424|531169702|FG000|Overall Study|Adverse Event|0|||
147273570|NCT01451424|531169703|FG001|Overall Study|Adverse Event|0|||
147273571|NCT01451424|531169704|FG002|Overall Study|Adverse Event|0|||
147273572|NCT01451424|531169705|FG003|Overall Study|Adverse Event|1|||
147273573|NCT02920983|531169706|FG000|Dispense 1|Unacceptable Lens Fit|0|||
147273574|NCT02920983|531169707|FG001|Dispense 1|Unacceptable Lens Fit|0|||
147273575|NCT02920983|531169708|FG002|Dispense 1|Unacceptable Lens Fit|0|||
147273576|NCT02920983|531169709|FG003|Dispense 1|Unacceptable Lens Fit|0|||
147273577|NCT02920983|531169710|FG004|Dispense 1|Unacceptable Lens Fit|1|||
147273578|NCT02920983|531169711|FG005|Dispense 1|Unacceptable Lens Fit|0|||
147600373|NCT03893565|532356357|FG000|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
147600374|NCT03893565|532356358|FG001|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
147273579|NCT02920983|531169706|FG000|Dispense 2|Unscceptable lens fit|1|||
147273580|NCT02920983|531169707|FG001|Dispense 2|Unscceptable lens fit|0|||
147273581|NCT02920983|531169708|FG002|Dispense 2|Unscceptable lens fit|0|||
147273582|NCT02920983|531169709|FG003|Dispense 2|Unscceptable lens fit|0|||
147273583|NCT02920983|531169710|FG004|Dispense 2|Unscceptable lens fit|1|||
147450770|NCT02543528|531813149|FG003|Adaptation Period|Lost to Follow-up|0|||
147450771|NCT02543528|531813150|FG004|Adaptation Period|Lost to Follow-up|14|||
147450772|NCT02543528|531813146|FG000|Adaptation Period|Adverse Event|0|||
147450773|NCT02543528|531813147|FG001|Adaptation Period|Adverse Event|0|||
147450774|NCT02543528|531813148|FG002|Adaptation Period|Adverse Event|0|||
147450775|NCT02543528|531813149|FG003|Adaptation Period|Adverse Event|0|||
147273584|NCT02920983|531169711|FG005|Dispense 2|Unscceptable lens fit|0|||
147662389|NCT02452047|532587318|FG000|Overall Study|Lost to Follow-up|1|||
147273585|NCT02920983|531169706|FG000|Dispense 3|Unacceptable Lens Fit|1|||
147273586|NCT02920983|531169707|FG001|Dispense 3|Unacceptable Lens Fit|1|||
147273587|NCT02920983|531169708|FG002|Dispense 3|Unacceptable Lens Fit|0|||
147273588|NCT02920983|531169709|FG003|Dispense 3|Unacceptable Lens Fit|0|||
147273589|NCT02920983|531169710|FG004|Dispense 3|Unacceptable Lens Fit|1|||
147273590|NCT02920983|531169711|FG005|Dispense 3|Unacceptable Lens Fit|0|||
147273591|NCT02908529|531169712|FG000|Overall Study|Lost to Follow-up|0|||
147273592|NCT02908529|531169713|FG001|Overall Study|Lost to Follow-up|2|||
147273593|NCT02553421|531169716|FG000|Overall Study|Lost to Follow-up|21|||
147273594|NCT02553421|531169717|FG001|Overall Study|Lost to Follow-up|1|||
147273595|NCT02553421|531169716|FG000|Overall Study|Incomplete or Insufficient Data Collecte|5|||
147273596|NCT02553421|531169717|FG001|Overall Study|Incomplete or Insufficient Data Collecte|0|||
147273597|NCT02553421|531169716|FG000|Overall Study|Improper Device Placement|3|||
147273598|NCT02553421|531169717|FG001|Overall Study|Improper Device Placement|0|||
147273599|NCT04084769|531169726|FG000|Overall Study|Protocol Violation|1|||
147273600|NCT04084769|531169727|FG001|Overall Study|Protocol Violation|3|||
147273601|NCT04084769|531169728|FG002|Overall Study|Protocol Violation|0|||
147273602|NCT04084769|531169729|FG003|Overall Study|Protocol Violation|1|||
147273603|NCT04084769|531169726|FG000|Overall Study|Withdrawal by Subject|0|||
147273604|NCT04084769|531169727|FG001|Overall Study|Withdrawal by Subject|1|||
147273605|NCT04084769|531169728|FG002|Overall Study|Withdrawal by Subject|0|||
147273606|NCT04084769|531169729|FG003|Overall Study|Withdrawal by Subject|0|||
147273607|NCT04084769|531169726|FG000|Overall Study|Withdrawal by parent/guardian|1|||
147273608|NCT04084769|531169727|FG001|Overall Study|Withdrawal by parent/guardian|0|||
147273609|NCT04084769|531169728|FG002|Overall Study|Withdrawal by parent/guardian|0|||
147273610|NCT04084769|531169729|FG003|Overall Study|Withdrawal by parent/guardian|1|||
147273611|NCT04084769|531169726|FG000|Overall Study|Lost to Follow-up|2|||
147273612|NCT04084769|531169727|FG001|Overall Study|Lost to Follow-up|0|||
147273613|NCT04084769|531169728|FG002|Overall Study|Lost to Follow-up|0|||
147273614|NCT04084769|531169729|FG003|Overall Study|Lost to Follow-up|0|||
147273615|NCT03013491|531169730|FG000|Main Study|Death|2|||
147273616|NCT03013491|531169731|FG001|Main Study|Death|2|||
147273617|NCT03013491|531169732|FG002|Main Study|Death|5|||
147273618|NCT03013491|531169733|FG003|Main Study|Death|3|||
147273619|NCT03013491|531169734|FG004|Main Study|Death|9|||
147273620|NCT03013491|531169735|FG005|Main Study|Death|12|||
147273621|NCT03013491|531169736|FG006|Main Study|Death|3|||
147273622|NCT03013491|531169737|FG007|Main Study|Death|5|||
147273623|NCT03013491|531169738|FG008|Main Study|Death|1|||
147273624|NCT03013491|531169739|FG009|Main Study|Death|2|||
147273625|NCT03013491|531169740|FG010|Main Study|Death|4|||
147273626|NCT03013491|531169741|FG011|Main Study|Death|1|||
147273627|NCT03013491|531169742|FG012|Main Study|Death|1|||
147273628|NCT03013491|531169743|FG013|Main Study|Death|4|||
147273629|NCT03013491|531169744|FG014|Main Study|Death|0|||
147273630|NCT03013491|531169745|FG015|Main Study|Death|3|||
147273631|NCT03013491|531169746|FG016|Main Study|Death|5|||
147273632|NCT03013491|531169747|FG017|Main Study|Death|1|||
147273633|NCT03013491|531169748|FG018|Main Study|Death|47|||
147273634|NCT03013491|531169730|FG000|Main Study|Lost to Follow-up|0|||
147273635|NCT03013491|531169731|FG001|Main Study|Lost to Follow-up|0|||
147662390|NCT02452047|532587319|FG001|Overall Study|Lost to Follow-up|1|||
147273636|NCT03013491|531169732|FG002|Main Study|Lost to Follow-up|1|||
147273637|NCT03013491|531169733|FG003|Main Study|Lost to Follow-up|0|||
147273638|NCT03013491|531169734|FG004|Main Study|Lost to Follow-up|1|||
147273639|NCT03013491|531169735|FG005|Main Study|Lost to Follow-up|0|||
147273640|NCT03013491|531169736|FG006|Main Study|Lost to Follow-up|0|||
147273641|NCT03013491|531169737|FG007|Main Study|Lost to Follow-up|0|||
147273642|NCT03013491|531169738|FG008|Main Study|Lost to Follow-up|0|||
147273643|NCT03013491|531169739|FG009|Main Study|Lost to Follow-up|0|||
147273644|NCT03013491|531169740|FG010|Main Study|Lost to Follow-up|0|||
147273645|NCT03013491|531169741|FG011|Main Study|Lost to Follow-up|0|||
147662391|NCT02452047|532587320|FG002|Overall Study|Lost to Follow-up|0|||
147273646|NCT03013491|531169742|FG012|Main Study|Lost to Follow-up|0|||
147273647|NCT03013491|531169743|FG013|Main Study|Lost to Follow-up|0|||
147273648|NCT03013491|531169744|FG014|Main Study|Lost to Follow-up|0|||
147662392|NCT02452047|532587318|FG000|Overall Study|Withdrawal by Subject|1|||
147662393|NCT02452047|532587319|FG001|Overall Study|Withdrawal by Subject|0|||
147273649|NCT03013491|531169745|FG015|Main Study|Lost to Follow-up|0|||
147273650|NCT03013491|531169746|FG016|Main Study|Lost to Follow-up|0|||
147273651|NCT03013491|531169747|FG017|Main Study|Lost to Follow-up|0|||
147273652|NCT03013491|531169748|FG018|Main Study|Lost to Follow-up|3|||
147273653|NCT03013491|531169730|FG000|Main Study|Termination of the study by Sponsor|0|||
147273654|NCT03013491|531169731|FG001|Main Study|Termination of the study by Sponsor|0|||
147273655|NCT03013491|531169732|FG002|Main Study|Termination of the study by Sponsor|2|||
147273656|NCT03013491|531169733|FG003|Main Study|Termination of the study by Sponsor|0|||
147273657|NCT03013491|531169734|FG004|Main Study|Termination of the study by Sponsor|1|||
147273658|NCT03013491|531169735|FG005|Main Study|Termination of the study by Sponsor|2|||
147273659|NCT03013491|531169736|FG006|Main Study|Termination of the study by Sponsor|0|||
147273660|NCT03013491|531169737|FG007|Main Study|Termination of the study by Sponsor|0|||
147273661|NCT03013491|531169738|FG008|Main Study|Termination of the study by Sponsor|1|||
147273662|NCT03013491|531169739|FG009|Main Study|Termination of the study by Sponsor|1|||
147273663|NCT03013491|531169740|FG010|Main Study|Termination of the study by Sponsor|1|||
147273664|NCT03013491|531169741|FG011|Main Study|Termination of the study by Sponsor|2|||
147333769|NCT00961636|531387805|FG000|Overall Study|Withdrawal by Subject|29|||
147333770|NCT00961636|531387806|FG001|Overall Study|Withdrawal by Subject|22|||
147333771|NCT00961636|531387807|FG002|Overall Study|Withdrawal by Subject|13|||
147333772|NCT02486588|531387810|FG000|Overall Study|Randomized in error- ineligible|738|||
147333773|NCT02486588|531387811|FG001|Overall Study|Randomized in error- ineligible|750|||
147333774|NCT02486588|531387812|FG002|Overall Study|Randomized in error- ineligible|755|||
147333775|NCT02486588|531387813|FG003|Overall Study|Randomized in error- ineligible|738|||
147333776|NCT02486588|531387814|FG004|Overall Study|Randomized in error- ineligible|746|||
147333777|NCT02486588|531387815|FG005|Overall Study|Randomized in error- ineligible|746|||
147333778|NCT02551055|531387818|FG000|Overall Study|Death|2|||
147333779|NCT02551055|531387819|FG001|Overall Study|Death|4|||
147333780|NCT02551055|531387820|FG002|Overall Study|Death|2|||
147333781|NCT02551055|531387821|FG003|Overall Study|Death|2|||
147333782|NCT02551055|531387822|FG004|Overall Study|Death|2|||
147333783|NCT02551055|531387823|FG005|Overall Study|Death|1|||
147333784|NCT02551055|531387824|FG006|Overall Study|Death|2|||
147450776|NCT02543528|531813150|FG004|Adaptation Period|Adverse Event|2|||
147450777|NCT02543528|531813146|FG000|Extended Wear Period|Adverse Event|17|||
147273665|NCT03013491|531169742|FG012|Main Study|Termination of the study by Sponsor|0|||
147273666|NCT03013491|531169743|FG013|Main Study|Termination of the study by Sponsor|0|||
147273667|NCT03013491|531169744|FG014|Main Study|Termination of the study by Sponsor|0|||
147273668|NCT03013491|531169745|FG015|Main Study|Termination of the study by Sponsor|0|||
147273669|NCT03013491|531169746|FG016|Main Study|Termination of the study by Sponsor|0|||
147273670|NCT03013491|531169747|FG017|Main Study|Termination of the study by Sponsor|1|||
147273671|NCT03013491|531169748|FG018|Main Study|Termination of the study by Sponsor|13|||
147273672|NCT03013491|531169730|FG000|Main Study|Withdrawal by Subject|0|||
147273673|NCT03013491|531169731|FG001|Main Study|Withdrawal by Subject|0|||
147273674|NCT03013491|531169732|FG002|Main Study|Withdrawal by Subject|0|||
147273675|NCT03013491|531169733|FG003|Main Study|Withdrawal by Subject|4|||
147273676|NCT03013491|531169734|FG004|Main Study|Withdrawal by Subject|2|||
147273677|NCT03013491|531169735|FG005|Main Study|Withdrawal by Subject|1|||
147273678|NCT03013491|531169736|FG006|Main Study|Withdrawal by Subject|0|||
147273679|NCT03013491|531169737|FG007|Main Study|Withdrawal by Subject|0|||
147273680|NCT03013491|531169738|FG008|Main Study|Withdrawal by Subject|0|||
147273681|NCT03013491|531169739|FG009|Main Study|Withdrawal by Subject|0|||
147273682|NCT03013491|531169740|FG010|Main Study|Withdrawal by Subject|1|||
147273683|NCT03013491|531169741|FG011|Main Study|Withdrawal by Subject|2|||
147273684|NCT03013491|531169742|FG012|Main Study|Withdrawal by Subject|0|||
147273685|NCT03013491|531169743|FG013|Main Study|Withdrawal by Subject|2|||
147273686|NCT03013491|531169744|FG014|Main Study|Withdrawal by Subject|0|||
147273687|NCT03013491|531169745|FG015|Main Study|Withdrawal by Subject|0|||
147273688|NCT03013491|531169746|FG016|Main Study|Withdrawal by Subject|0|||
147273689|NCT03013491|531169747|FG017|Main Study|Withdrawal by Subject|0|||
147273690|NCT03013491|531169748|FG018|Main Study|Withdrawal by Subject|18|||
147273691|NCT03013491|531169730|FG000|Main Study|Disease progression|0|||
147273692|NCT03013491|531169731|FG001|Main Study|Disease progression|0|||
147273693|NCT03013491|531169732|FG002|Main Study|Disease progression|0|||
147273694|NCT03013491|531169733|FG003|Main Study|Disease progression|1|||
147273695|NCT03013491|531169734|FG004|Main Study|Disease progression|0|||
147273696|NCT03013491|531169735|FG005|Main Study|Disease progression|0|||
147273697|NCT03013491|531169736|FG006|Main Study|Disease progression|0|||
147273698|NCT03013491|531169737|FG007|Main Study|Disease progression|0|||
147273699|NCT03013491|531169738|FG008|Main Study|Disease progression|1|||
147273700|NCT03013491|531169739|FG009|Main Study|Disease progression|0|||
147273701|NCT03013491|531169740|FG010|Main Study|Disease progression|1|||
147273702|NCT03013491|531169741|FG011|Main Study|Disease progression|0|||
147273703|NCT03013491|531169742|FG012|Main Study|Disease progression|0|||
147273704|NCT03013491|531169743|FG013|Main Study|Disease progression|0|||
147273705|NCT03013491|531169744|FG014|Main Study|Disease progression|0|||
147273706|NCT03013491|531169745|FG015|Main Study|Disease progression|0|||
147273707|NCT03013491|531169746|FG016|Main Study|Disease progression|0|||
147273708|NCT03013491|531169747|FG017|Main Study|Disease progression|0|||
147273709|NCT03013491|531169748|FG018|Main Study|Disease progression|4|||
147273710|NCT03013491|531169730|FG000|Main Study|Symptomatic deterioration|0|||
147333785|NCT02551055|531387825|FG007|Overall Study|Death|0|||
147333786|NCT02551055|531387818|FG000|Overall Study|Study Terminated by Sponsor|1|||
147333787|NCT02551055|531387819|FG001|Overall Study|Study Terminated by Sponsor|1|||
147450778|NCT02543528|531813147|FG001|Extended Wear Period|Adverse Event|11|||
147450779|NCT02543528|531813148|FG002|Extended Wear Period|Adverse Event|16|||
147273711|NCT03013491|531169731|FG001|Main Study|Symptomatic deterioration|0|||
147273712|NCT03013491|531169732|FG002|Main Study|Symptomatic deterioration|0|||
147273713|NCT03013491|531169733|FG003|Main Study|Symptomatic deterioration|0|||
147273714|NCT03013491|531169734|FG004|Main Study|Symptomatic deterioration|0|||
147273715|NCT03013491|531169735|FG005|Main Study|Symptomatic deterioration|1|||
147600375|NCT03893565|532356359|FG002|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
147600376|NCT03893565|532356360|FG003|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
147600377|NCT03893565|532356361|FG004|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
147600378|NCT03893565|532356362|FG005|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|2|||
147600379|NCT03893565|532356363|FG006|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|2|||
147600380|NCT03893565|532356364|FG007|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
147273716|NCT03013491|531169736|FG006|Main Study|Symptomatic deterioration|0|||
147273717|NCT03013491|531169737|FG007|Main Study|Symptomatic deterioration|0|||
147273718|NCT03013491|531169738|FG008|Main Study|Symptomatic deterioration|0|||
147273719|NCT03013491|531169739|FG009|Main Study|Symptomatic deterioration|0|||
147273720|NCT03013491|531169740|FG010|Main Study|Symptomatic deterioration|0|||
147273721|NCT03013491|531169741|FG011|Main Study|Symptomatic deterioration|0|||
147273722|NCT03013491|531169742|FG012|Main Study|Symptomatic deterioration|0|||
147273723|NCT03013491|531169743|FG013|Main Study|Symptomatic deterioration|0|||
147273724|NCT03013491|531169744|FG014|Main Study|Symptomatic deterioration|0|||
147273725|NCT03013491|531169745|FG015|Main Study|Symptomatic deterioration|0|||
147273726|NCT03013491|531169746|FG016|Main Study|Symptomatic deterioration|0|||
147273727|NCT03013491|531169747|FG017|Main Study|Symptomatic deterioration|0|||
147273728|NCT03013491|531169748|FG018|Main Study|Symptomatic deterioration|0|||
147273729|NCT03013491|531169730|FG000|Main Study|Protocol version 8.0 approval|0|||
147273730|NCT03013491|531169731|FG001|Main Study|Protocol version 8.0 approval|0|||
147273731|NCT03013491|531169732|FG002|Main Study|Protocol version 8.0 approval|0|||
147273732|NCT03013491|531169733|FG003|Main Study|Protocol version 8.0 approval|0|||
147273733|NCT03013491|531169734|FG004|Main Study|Protocol version 8.0 approval|0|||
147273734|NCT03013491|531169735|FG005|Main Study|Protocol version 8.0 approval|0|||
147273735|NCT03013491|531169736|FG006|Main Study|Protocol version 8.0 approval|0|||
147273736|NCT03013491|531169737|FG007|Main Study|Protocol version 8.0 approval|0|||
147273737|NCT03013491|531169738|FG008|Main Study|Protocol version 8.0 approval|0|||
147273738|NCT03013491|531169739|FG009|Main Study|Protocol version 8.0 approval|0|||
147273739|NCT03013491|531169740|FG010|Main Study|Protocol version 8.0 approval|1|||
147273740|NCT03013491|531169741|FG011|Main Study|Protocol version 8.0 approval|0|||
147273741|NCT03013491|531169742|FG012|Main Study|Protocol version 8.0 approval|0|||
147273742|NCT03013491|531169743|FG013|Main Study|Protocol version 8.0 approval|0|||
147273743|NCT03013491|531169744|FG014|Main Study|Protocol version 8.0 approval|0|||
147273744|NCT03013491|531169745|FG015|Main Study|Protocol version 8.0 approval|0|||
147273745|NCT03013491|531169746|FG016|Main Study|Protocol version 8.0 approval|0|||
147273746|NCT03013491|531169747|FG017|Main Study|Protocol version 8.0 approval|0|||
147273747|NCT03013491|531169748|FG018|Main Study|Protocol version 8.0 approval|0|||
147273748|NCT03013491|531169730|FG000|Main Study|Partial withdrawal with survival follow-up only|0|||
147273749|NCT03013491|531169731|FG001|Main Study|Partial withdrawal with survival follow-up only|0|||
147273750|NCT03013491|531169732|FG002|Main Study|Partial withdrawal with survival follow-up only|0|||
147273751|NCT03013491|531169733|FG003|Main Study|Partial withdrawal with survival follow-up only|0|||
147273752|NCT03013491|531169734|FG004|Main Study|Partial withdrawal with survival follow-up only|0|||
147273753|NCT03013491|531169735|FG005|Main Study|Partial withdrawal with survival follow-up only|0|||
147273754|NCT03013491|531169736|FG006|Main Study|Partial withdrawal with survival follow-up only|0|||
147273755|NCT03013491|531169737|FG007|Main Study|Partial withdrawal with survival follow-up only|0|||
147273756|NCT03013491|531169738|FG008|Main Study|Partial withdrawal with survival follow-up only|0|||
147273757|NCT03013491|531169739|FG009|Main Study|Partial withdrawal with survival follow-up only|0|||
147333788|NCT02551055|531387820|FG002|Overall Study|Study Terminated by Sponsor|0|||
147333789|NCT02551055|531387821|FG003|Overall Study|Study Terminated by Sponsor|2|||
147333790|NCT02551055|531387822|FG004|Overall Study|Study Terminated by Sponsor|2|||
147333791|NCT02551055|531387823|FG005|Overall Study|Study Terminated by Sponsor|0|||
147333792|NCT02551055|531387824|FG006|Overall Study|Study Terminated by Sponsor|0|||
147333793|NCT02551055|531387825|FG007|Overall Study|Study Terminated by Sponsor|0|||
147333794|NCT02551055|531387818|FG000|Overall Study|Withdrawal by Subject|1|||
147333795|NCT02551055|531387819|FG001|Overall Study|Withdrawal by Subject|1|||
147333796|NCT02551055|531387820|FG002|Overall Study|Withdrawal by Subject|0|||
147333797|NCT02551055|531387821|FG003|Overall Study|Withdrawal by Subject|1|||
147333798|NCT02551055|531387822|FG004|Overall Study|Withdrawal by Subject|2|||
147333799|NCT02551055|531387823|FG005|Overall Study|Withdrawal by Subject|0|||
147333800|NCT02551055|531387824|FG006|Overall Study|Withdrawal by Subject|0|||
147333801|NCT02551055|531387825|FG007|Overall Study|Withdrawal by Subject|0|||
147333802|NCT02551055|531387818|FG000|Overall Study|Reason not specified|0|||
147333803|NCT02551055|531387819|FG001|Overall Study|Reason not specified|0|||
147333804|NCT02551055|531387820|FG002|Overall Study|Reason not specified|0|||
147662394|NCT02452047|532587320|FG002|Overall Study|Withdrawal by Subject|0|||
147273758|NCT03013491|531169740|FG010|Main Study|Partial withdrawal with survival follow-up only|0|||
147333805|NCT02551055|531387821|FG003|Overall Study|Reason not specified|0|||
147333806|NCT02551055|531387822|FG004|Overall Study|Reason not specified|1|||
147333807|NCT02551055|531387823|FG005|Overall Study|Reason not specified|0|||
147333808|NCT02551055|531387824|FG006|Overall Study|Reason not specified|1|||
147273759|NCT03013491|531169741|FG011|Main Study|Partial withdrawal with survival follow-up only|1|||
147273760|NCT03013491|531169742|FG012|Main Study|Partial withdrawal with survival follow-up only|0|||
147273761|NCT03013491|531169743|FG013|Main Study|Partial withdrawal with survival follow-up only|0|||
147273762|NCT03013491|531169744|FG014|Main Study|Partial withdrawal with survival follow-up only|0|||
147273763|NCT03013491|531169745|FG015|Main Study|Partial withdrawal with survival follow-up only|0|||
147273764|NCT03013491|531169746|FG016|Main Study|Partial withdrawal with survival follow-up only|0|||
147273765|NCT03013491|531169747|FG017|Main Study|Partial withdrawal with survival follow-up only|0|||
147273766|NCT03013491|531169748|FG018|Main Study|Partial withdrawal with survival follow-up only|0|||
147273767|NCT03013491|531169730|FG000|Main Study|Start of new anticancer therapy|0|||
147273768|NCT03013491|531169731|FG001|Main Study|Start of new anticancer therapy|0|||
147273769|NCT03013491|531169732|FG002|Main Study|Start of new anticancer therapy|0|||
147273770|NCT03013491|531169733|FG003|Main Study|Start of new anticancer therapy|0|||
147273771|NCT03013491|531169734|FG004|Main Study|Start of new anticancer therapy|0|||
147273772|NCT03013491|531169735|FG005|Main Study|Start of new anticancer therapy|0|||
147273773|NCT03013491|531169736|FG006|Main Study|Start of new anticancer therapy|0|||
147273774|NCT03013491|531169737|FG007|Main Study|Start of new anticancer therapy|0|||
147273775|NCT03013491|531169738|FG008|Main Study|Start of new anticancer therapy|0|||
147273776|NCT03013491|531169739|FG009|Main Study|Start of new anticancer therapy|0|||
147273777|NCT03013491|531169740|FG010|Main Study|Start of new anticancer therapy|0|||
147273778|NCT03013491|531169741|FG011|Main Study|Start of new anticancer therapy|0|||
147273779|NCT03013491|531169742|FG012|Main Study|Start of new anticancer therapy|0|||
147273780|NCT03013491|531169743|FG013|Main Study|Start of new anticancer therapy|0|||
147450780|NCT02543528|531813149|FG003|Extended Wear Period|Adverse Event|3|||
147450781|NCT02543528|531813150|FG004|Extended Wear Period|Adverse Event|0|||
147273781|NCT03013491|531169744|FG014|Main Study|Start of new anticancer therapy|0|||
147273782|NCT03013491|531169745|FG015|Main Study|Start of new anticancer therapy|0|||
147273783|NCT03013491|531169746|FG016|Main Study|Start of new anticancer therapy|0|||
147273784|NCT03013491|531169747|FG017|Main Study|Start of new anticancer therapy|0|||
147273785|NCT03013491|531169748|FG018|Main Study|Start of new anticancer therapy|2|||
147273786|NCT03013491|531169730|FG000|Long-term Extension|Disease progression|0|||
147273787|NCT03013491|531169731|FG001|Long-term Extension|Disease progression|0|||
147273788|NCT03013491|531169732|FG002|Long-term Extension|Disease progression|0|||
147273789|NCT03013491|531169733|FG003|Long-term Extension|Disease progression|1|||
147273790|NCT03013491|531169734|FG004|Long-term Extension|Disease progression|0|||
147273791|NCT03013491|531169735|FG005|Long-term Extension|Disease progression|0|||
147273792|NCT03013491|531169736|FG006|Long-term Extension|Disease progression|0|||
147273793|NCT03013491|531169737|FG007|Long-term Extension|Disease progression|0|||
147273794|NCT03013491|531169738|FG008|Long-term Extension|Disease progression|0|||
147273795|NCT03013491|531169739|FG009|Long-term Extension|Disease progression|0|||
147273796|NCT03013491|531169740|FG010|Long-term Extension|Disease progression|0|||
147273797|NCT03013491|531169741|FG011|Long-term Extension|Disease progression|0|||
147273798|NCT03013491|531169742|FG012|Long-term Extension|Disease progression|0|||
147273799|NCT03013491|531169743|FG013|Long-term Extension|Disease progression|0|||
147273800|NCT03013491|531169744|FG014|Long-term Extension|Disease progression|0|||
147273801|NCT03013491|531169745|FG015|Long-term Extension|Disease progression|0|||
147273802|NCT03013491|531169746|FG016|Long-term Extension|Disease progression|0|||
147273803|NCT03013491|531169747|FG017|Long-term Extension|Disease progression|0|||
147273804|NCT03013491|531169748|FG018|Long-term Extension|Disease progression|1|||
147273805|NCT03013491|531169730|FG000|Long-term Extension|Withdrawal by Subject|0|||
147273806|NCT03013491|531169731|FG001|Long-term Extension|Withdrawal by Subject|0|||
147273807|NCT03013491|531169732|FG002|Long-term Extension|Withdrawal by Subject|0|||
147273808|NCT03013491|531169733|FG003|Long-term Extension|Withdrawal by Subject|0|||
147273809|NCT03013491|531169734|FG004|Long-term Extension|Withdrawal by Subject|0|||
147273810|NCT03013491|531169735|FG005|Long-term Extension|Withdrawal by Subject|0|||
147273811|NCT03013491|531169736|FG006|Long-term Extension|Withdrawal by Subject|0|||
147273812|NCT03013491|531169737|FG007|Long-term Extension|Withdrawal by Subject|1|||
147273813|NCT03013491|531169738|FG008|Long-term Extension|Withdrawal by Subject|0|||
147450782|NCT02543528|531813146|FG000|Extended Wear Period|Missed too many scheduled visits|0|||
147450783|NCT02543528|531813147|FG001|Extended Wear Period|Missed too many scheduled visits|0|||
147450784|NCT02543528|531813148|FG002|Extended Wear Period|Missed too many scheduled visits|1|||
147450785|NCT02543528|531813149|FG003|Extended Wear Period|Missed too many scheduled visits|3|||
147450786|NCT02543528|531813150|FG004|Extended Wear Period|Missed too many scheduled visits|0|||
147273814|NCT03013491|531169739|FG009|Long-term Extension|Withdrawal by Subject|0|||
147273815|NCT03013491|531169740|FG010|Long-term Extension|Withdrawal by Subject|0|||
147273816|NCT03013491|531169741|FG011|Long-term Extension|Withdrawal by Subject|0|||
147273817|NCT03013491|531169742|FG012|Long-term Extension|Withdrawal by Subject|0|||
147273818|NCT03013491|531169743|FG013|Long-term Extension|Withdrawal by Subject|0|||
147273819|NCT03013491|531169744|FG014|Long-term Extension|Withdrawal by Subject|0|||
147273820|NCT03013491|531169745|FG015|Long-term Extension|Withdrawal by Subject|0|||
147450787|NCT02543528|531813146|FG000|Extended Wear Period|Unsatisfactory Lens Fitting|1|||
147450788|NCT02543528|531813147|FG001|Extended Wear Period|Unsatisfactory Lens Fitting|0|||
147273821|NCT03013491|531169746|FG016|Long-term Extension|Withdrawal by Subject|0|||
147273822|NCT03013491|531169747|FG017|Long-term Extension|Withdrawal by Subject|0|||
147273823|NCT03013491|531169748|FG018|Long-term Extension|Withdrawal by Subject|0|||
147273824|NCT03013491|531169730|FG000|Long-term Extension|Adverse Event|0|||
147273825|NCT03013491|531169731|FG001|Long-term Extension|Adverse Event|0|||
147273826|NCT03013491|531169732|FG002|Long-term Extension|Adverse Event|0|||
147273827|NCT03013491|531169733|FG003|Long-term Extension|Adverse Event|0|||
147273828|NCT03013491|531169734|FG004|Long-term Extension|Adverse Event|0|||
147273829|NCT03013491|531169735|FG005|Long-term Extension|Adverse Event|0|||
147273830|NCT03013491|531169736|FG006|Long-term Extension|Adverse Event|0|||
147273831|NCT03013491|531169737|FG007|Long-term Extension|Adverse Event|0|||
147273832|NCT03013491|531169738|FG008|Long-term Extension|Adverse Event|0|||
147273833|NCT03013491|531169739|FG009|Long-term Extension|Adverse Event|0|||
147273834|NCT03013491|531169740|FG010|Long-term Extension|Adverse Event|0|||
147273835|NCT03013491|531169741|FG011|Long-term Extension|Adverse Event|0|||
147273836|NCT03013491|531169742|FG012|Long-term Extension|Adverse Event|0|||
147273837|NCT03013491|531169743|FG013|Long-term Extension|Adverse Event|0|||
147273838|NCT03013491|531169744|FG014|Long-term Extension|Adverse Event|0|||
147273839|NCT03013491|531169745|FG015|Long-term Extension|Adverse Event|0|||
147273840|NCT03013491|531169746|FG016|Long-term Extension|Adverse Event|0|||
147273841|NCT03013491|531169747|FG017|Long-term Extension|Adverse Event|0|||
147273842|NCT03013491|531169748|FG018|Long-term Extension|Adverse Event|1|||
147273843|NCT03013491|531169730|FG000|Long-term Extension|Death|0|||
147273844|NCT03013491|531169731|FG001|Long-term Extension|Death|0|||
147273845|NCT03013491|531169732|FG002|Long-term Extension|Death|0|||
147273846|NCT03013491|531169733|FG003|Long-term Extension|Death|0|||
147273847|NCT03013491|531169734|FG004|Long-term Extension|Death|0|||
147273848|NCT03013491|531169735|FG005|Long-term Extension|Death|0|||
147273849|NCT03013491|531169736|FG006|Long-term Extension|Death|0|||
147273850|NCT03013491|531169737|FG007|Long-term Extension|Death|0|||
147273851|NCT03013491|531169738|FG008|Long-term Extension|Death|0|||
147273852|NCT03013491|531169739|FG009|Long-term Extension|Death|0|||
147273853|NCT03013491|531169740|FG010|Long-term Extension|Death|0|||
147273854|NCT03013491|531169741|FG011|Long-term Extension|Death|0|||
147273855|NCT03013491|531169742|FG012|Long-term Extension|Death|0|||
147273856|NCT03013491|531169743|FG013|Long-term Extension|Death|0|||
147273857|NCT03013491|531169744|FG014|Long-term Extension|Death|0|||
147273858|NCT03013491|531169745|FG015|Long-term Extension|Death|0|||
147273859|NCT03013491|531169746|FG016|Long-term Extension|Death|0|||
147273860|NCT03013491|531169747|FG017|Long-term Extension|Death|0|||
147273861|NCT03013491|531169748|FG018|Long-term Extension|Death|1|||
147273862|NCT01038778|531169756|FG000|Overall Study|Withdrawal by Subject|0|||
147273863|NCT01038778|531169757|FG001|Overall Study|Withdrawal by Subject|2|||
147273864|NCT01038778|531169758|FG002|Overall Study|Withdrawal by Subject|3|||
147273865|NCT04740034|531169759|FG000|Overall Study|Death|0|||
147273866|NCT04740034|531169760|FG001|Overall Study|Death|1|||
147273867|NCT04740034|531169761|FG002|Overall Study|Death|2|||
147273868|NCT04740034|531169762|FG003|Overall Study|Death|3|||
147273869|NCT04740034|531169763|FG004|Overall Study|Death|4|||
147273870|NCT04740034|531169764|FG005|Overall Study|Death|4|||
147273871|NCT04740034|531169765|FG006|Overall Study|Death|2|||
147273872|NCT04740034|531169766|FG007|Overall Study|Death|2|||
147273873|NCT04740034|531169767|FG008|Overall Study|Death|2|||
147273874|NCT04740034|531169768|FG009|Overall Study|Death|4|||
147273875|NCT04740034|531169769|FG010|Overall Study|Death|0|||
147273876|NCT04740034|531169759|FG000|Overall Study|Lost to Follow-up|0|||
147273877|NCT04740034|531169760|FG001|Overall Study|Lost to Follow-up|0|||
147273878|NCT04740034|531169761|FG002|Overall Study|Lost to Follow-up|0|||
147273879|NCT04740034|531169762|FG003|Overall Study|Lost to Follow-up|1|||
147273880|NCT04740034|531169763|FG004|Overall Study|Lost to Follow-up|2|||
147273881|NCT04740034|531169764|FG005|Overall Study|Lost to Follow-up|2|||
147273882|NCT04740034|531169765|FG006|Overall Study|Lost to Follow-up|0|||
147273883|NCT04740034|531169766|FG007|Overall Study|Lost to Follow-up|0|||
147273884|NCT04740034|531169767|FG008|Overall Study|Lost to Follow-up|0|||
147450789|NCT02543528|531813148|FG002|Extended Wear Period|Unsatisfactory Lens Fitting|0|||
147273885|NCT04740034|531169768|FG009|Overall Study|Lost to Follow-up|1|||
147273886|NCT04740034|531169769|FG010|Overall Study|Lost to Follow-up|0|||
147273887|NCT04740034|531169759|FG000|Overall Study|Withdrawal by Subject|1|||
147273888|NCT04740034|531169760|FG001|Overall Study|Withdrawal by Subject|0|||
147273889|NCT04740034|531169761|FG002|Overall Study|Withdrawal by Subject|0|||
147273890|NCT04740034|531169762|FG003|Overall Study|Withdrawal by Subject|0|||
147273891|NCT04740034|531169763|FG004|Overall Study|Withdrawal by Subject|0|||
147273892|NCT04740034|531169764|FG005|Overall Study|Withdrawal by Subject|0|||
147273893|NCT04740034|531169765|FG006|Overall Study|Withdrawal by Subject|0|||
147450790|NCT02543528|531813149|FG003|Extended Wear Period|Unsatisfactory Lens Fitting|0|||
147273894|NCT04740034|531169766|FG007|Overall Study|Withdrawal by Subject|1|||
147273895|NCT04740034|531169767|FG008|Overall Study|Withdrawal by Subject|0|||
147273896|NCT04740034|531169768|FG009|Overall Study|Withdrawal by Subject|1|||
147273897|NCT04740034|531169769|FG010|Overall Study|Withdrawal by Subject|0|||
147273898|NCT04740034|531169759|FG000|Overall Study|Decision by sponsor|0|||
147273899|NCT04740034|531169760|FG001|Overall Study|Decision by sponsor|0|||
147273900|NCT04740034|531169761|FG002|Overall Study|Decision by sponsor|1|||
147662395|NCT01868646|532587321|FG000|Overall Study|Do not meet inclusion criteria|3|||
147662396|NCT01868646|532587322|FG001|Overall Study|Do not meet inclusion criteria|5|||
147662397|NCT02735980|532587323|FG000|Overall Study|Adverse Event|0|||
147662398|NCT02735980|532587324|FG001|Overall Study|Adverse Event|4|||
147662399|NCT02735980|532587325|FG002|Overall Study|Adverse Event|1|||
147662400|NCT02735980|532587323|FG000|Overall Study|Death|5|||
147662401|NCT02735980|532587324|FG001|Overall Study|Death|4|||
147662402|NCT02735980|532587325|FG002|Overall Study|Death|0|||
147273901|NCT04740034|531169762|FG003|Overall Study|Decision by sponsor|0|||
147273902|NCT04740034|531169763|FG004|Overall Study|Decision by sponsor|0|||
147273903|NCT04740034|531169764|FG005|Overall Study|Decision by sponsor|0|||
147273904|NCT04740034|531169765|FG006|Overall Study|Decision by sponsor|1|||
147273905|NCT04740034|531169766|FG007|Overall Study|Decision by sponsor|2|||
147273906|NCT04740034|531169767|FG008|Overall Study|Decision by sponsor|1|||
147273907|NCT04740034|531169768|FG009|Overall Study|Decision by sponsor|1|||
147273908|NCT04740034|531169769|FG010|Overall Study|Decision by sponsor|2|||
147273909|NCT00991302|531171453|FG000|Overall Study|Death|0|||
147273910|NCT00991302|531171454|FG001|Overall Study|Death|1|||
147273911|NCT00991302|531171453|FG000|Overall Study|Lost to Follow-up|14|||
147273912|NCT00991302|531171454|FG001|Overall Study|Lost to Follow-up|12|||
147273913|NCT01707004|531171455|FG000|Overall Study|Physician Decision|3|||
147273914|NCT03085927|531171458|FG000|Overall Study|Withdrawal by Subject|1|||
147273915|NCT03085927|531171459|FG001|Overall Study|Withdrawal by Subject|4|||
147273916|NCT03085927|531171458|FG000|Overall Study|Lost to Follow-up|3|||
147273917|NCT03085927|531171459|FG001|Overall Study|Lost to Follow-up|1|||
147273918|NCT03085927|531171458|FG000|Overall Study|Death|1|||
147273919|NCT03085927|531171459|FG001|Overall Study|Death|0|||
147273920|NCT03085927|531171458|FG000|Overall Study|Child Toxicity/Side Effects of Treatment|1|||
147273921|NCT03085927|531171459|FG001|Overall Study|Child Toxicity/Side Effects of Treatment|0|||
147273922|NCT03085927|531171458|FG000|Overall Study|Dyad Became Ineligible|0|||
147273923|NCT03085927|531171459|FG001|Overall Study|Dyad Became Ineligible|1|||
147273924|NCT02573324|531171460|FG000|Overall Study|Withdrawal by Subject|26|||
147273925|NCT02573324|531171461|FG001|Overall Study|Withdrawal by Subject|23|||
147273926|NCT02573324|531171462|FG002|Overall Study|Withdrawal by Subject|3|||
147273927|NCT02573324|531171460|FG000|Overall Study|Lost to Follow-up|4|||
147273928|NCT02573324|531171461|FG001|Overall Study|Lost to Follow-up|5|||
147273929|NCT02573324|531171462|FG002|Overall Study|Lost to Follow-up|0|||
147273930|NCT02573324|531171460|FG000|Overall Study|Study Terminated by Sponsor|107|||
147273931|NCT02573324|531171461|FG001|Overall Study|Study Terminated by Sponsor|89|||
147273932|NCT02573324|531171462|FG002|Overall Study|Study Terminated by Sponsor|2|||
147273933|NCT02573324|531171460|FG000|Overall Study|Death|182|||
147273934|NCT02573324|531171461|FG001|Overall Study|Death|200|||
147273935|NCT02573324|531171462|FG002|Overall Study|Death|1|||
147273936|NCT02573324|531171460|FG000|Overall Study|Other, Not Specified|20|||
147273937|NCT02573324|531171461|FG001|Overall Study|Other, Not Specified|27|||
147273938|NCT02573324|531171462|FG002|Overall Study|Other, Not Specified|0|||
147273939|NCT02573324|531171460|FG000|Overall Study|Unknown Reason|2|||
147273940|NCT02573324|531171461|FG001|Overall Study|Unknown Reason|0|||
147273941|NCT02573324|531171462|FG002|Overall Study|Unknown Reason|0|||
147273942|NCT03892889|531171463|FG000|Overall Study|Adverse Event|17|||
147273943|NCT03892889|531171463|FG000|Overall Study|Lack of Efficacy|1|||
147273944|NCT03892889|531171463|FG000|Overall Study|Lost to Follow-up|46|||
147273945|NCT03892889|531171463|FG000|Overall Study|Non-compliance with study drug|22|||
147273946|NCT03892889|531171463|FG000|Overall Study|Pregnancy|1|||
147273947|NCT03892889|531171463|FG000|Overall Study|Protocol Deviation|3|||
147273948|NCT03892889|531171463|FG000|Overall Study|Withdrawal by Subject|50|||
147273949|NCT03892889|531171463|FG000|Overall Study|Withdrawal by Caregiver|1|||
147273950|NCT03892889|531171463|FG000|Overall Study|Study Terminated by Sponsor|50|||
147273951|NCT03892889|531171463|FG000|Overall Study|Physician Decision|8|||
147273952|NCT03892889|531171463|FG000|Overall Study|Reason not Specified|5|||
147273953|NCT01610700|531171464|FG000|Overall Study|Adverse Event|3|||
147273954|NCT01610700|531171465|FG001|Overall Study|Adverse Event|1|||
147273955|NCT01610700|531171464|FG000|Overall Study|Withdrawal by Subject|0|||
147273956|NCT01610700|531171465|FG001|Overall Study|Withdrawal by Subject|1|||
147273957|NCT01610700|531171464|FG000|Overall Study|subject took one dose of street cannabis|0|||
147273958|NCT01610700|531171465|FG001|Overall Study|subject took one dose of street cannabis|1|||
147273959|NCT00679341|531171467|FG000|Overall Study|Disease progression|42|||
147273960|NCT00679341|531171468|FG001|Overall Study|Disease progression|36|||
147273961|NCT00679341|531171467|FG000|Overall Study|Adverse Event|5|||
147273962|NCT00679341|531171468|FG001|Overall Study|Adverse Event|6|||
147273963|NCT00679341|531171467|FG000|Overall Study|Subject/guardian decision to discontinue|3|||
147273964|NCT00679341|531171468|FG001|Overall Study|Subject/guardian decision to discontinue|0|||
147662403|NCT02735980|532587323|FG000|Overall Study|Physician Decision|3|||
147662404|NCT02735980|532587324|FG001|Overall Study|Physician Decision|1|||
147273965|NCT00679341|531171467|FG000|Overall Study|Death|1|||
147273966|NCT00679341|531171468|FG001|Overall Study|Death|1|||
147273967|NCT00679341|531171467|FG000|Overall Study|Other|1|||
147273968|NCT00679341|531171468|FG001|Overall Study|Other|0|||
147662405|NCT02735980|532587325|FG002|Overall Study|Physician Decision|0|||
147273969|NCT00679341|531171467|FG000|Overall Study|Physician Decision|1|||
147273970|NCT00679341|531171468|FG001|Overall Study|Physician Decision|0|||
147273971|NCT00679341|531171467|FG000|Overall Study|Not treated|0|||
147273972|NCT00679341|531171468|FG001|Overall Study|Not treated|2|||
147273973|NCT00679341|531171467|FG000|Overall Study|Physician/patient decision to withdraw|0|||
147273974|NCT00679341|531171468|FG001|Overall Study|Physician/patient decision to withdraw|6|||
147273975|NCT00654628|531171471|FG000|6-week Active Treatment Period|Adverse Event|9|||
147273976|NCT00654628|531171471|FG000|6-week Active Treatment Period|Lost to Follow-up|10|||
147273977|NCT00654628|531171471|FG000|6-week Active Treatment Period|Transferred to branch hospital|1|||
147273978|NCT00654628|531171471|FG000|6-week Active Treatment Period|Out of window period|1|||
147273979|NCT00654628|531171471|FG000|6 -Week Extension Period (Single Site)|Adverse Event|4|||
147273980|NCT00654628|531171471|FG000|6 -Week Extension Period (Single Site)|Lost to Follow-up|1|||
147273981|NCT01797536|531171472|FG000|Overall Study|Adverse Event|0|||
147273982|NCT01797536|531171473|FG001|Overall Study|Adverse Event|1|||
147273983|NCT01797536|531171474|FG002|Overall Study|Adverse Event|0|||
147273984|NCT01797536|531171475|FG003|Overall Study|Adverse Event|0|||
147273985|NCT01532687|531171480|FG000|Overall Study|Death|2|||
147273986|NCT01532687|531171481|FG001|Overall Study|Death|0|||
147273987|NCT01532687|531171480|FG000|Overall Study|Adverse Event|6|||
147273988|NCT01532687|531171481|FG001|Overall Study|Adverse Event|1|||
147273989|NCT01532687|531171480|FG000|Overall Study|Withdrawal by Subject|1|||
147273990|NCT01532687|531171481|FG001|Overall Study|Withdrawal by Subject|0|||
147273991|NCT01532687|531171480|FG000|Overall Study|Physician Decision|2|||
147273992|NCT01532687|531171481|FG001|Overall Study|Physician Decision|1|||
147273993|NCT01532687|531171480|FG000|Overall Study|Protocol-defined delay > 3 weeks|3|||
147273994|NCT01532687|531171481|FG001|Overall Study|Protocol-defined delay > 3 weeks|0|||
147273995|NCT00403455|531171482|FG000|Overall Study|Withdrawal by Subject|1|||
147273996|NCT03160703|531171483|FG000|Overall Study|Withdrawal by Subject|0|||
147273997|NCT03160703|531171484|FG001|Overall Study|Withdrawal by Subject|0|||
147273998|NCT03160703|531171485|FG002|Overall Study|Withdrawal by Subject|0|||
147273999|NCT03160703|531171486|FG003|Overall Study|Withdrawal by Subject|1|||
147274000|NCT00226941|531171493|FG000|Overall Study|Withdrawal by subject - toxicity|0|||
147274001|NCT00226941|531171494|FG001|Overall Study|Withdrawal by subject - toxicity|0|||
147274002|NCT00226941|531171495|FG002|Overall Study|Withdrawal by subject - toxicity|0|||
147274003|NCT00226941|531171496|FG003|Overall Study|Withdrawal by subject - toxicity|1|||
147274004|NCT00226941|531171493|FG000|Overall Study|Withdrawn by investigator - unrelated AE|0|||
147274005|NCT00226941|531171494|FG001|Overall Study|Withdrawn by investigator - unrelated AE|0|||
147274006|NCT00226941|531171495|FG002|Overall Study|Withdrawn by investigator - unrelated AE|0|||
147274007|NCT00226941|531171496|FG003|Overall Study|Withdrawn by investigator - unrelated AE|1|||
147274008|NCT01513291|531171497|FG000|Treatment Period|Adverse Event|8|||
147274009|NCT01513291|531171498|FG001|Treatment Period|Adverse Event|4|||
147274010|NCT01513291|531171499|FG002|Treatment Period|Adverse Event|0|||
147274011|NCT01513291|531171500|FG003|Treatment Period|Adverse Event|0|||
147274012|NCT01513291|531171501|FG004|Treatment Period|Adverse Event|0|||
147274013|NCT01513291|531171497|FG000|Treatment Period|Lack of Efficacy|3|||
147274014|NCT01513291|531171498|FG001|Treatment Period|Lack of Efficacy|0|||
147274015|NCT01513291|531171499|FG002|Treatment Period|Lack of Efficacy|0|||
147274016|NCT01513291|531171500|FG003|Treatment Period|Lack of Efficacy|0|||
147274017|NCT01513291|531171501|FG004|Treatment Period|Lack of Efficacy|0|||
147274018|NCT01513291|531171497|FG000|Treatment Period|Lost to Follow-up|2|||
147274019|NCT01513291|531171498|FG001|Treatment Period|Lost to Follow-up|3|||
147274020|NCT01513291|531171499|FG002|Treatment Period|Lost to Follow-up|0|||
147274021|NCT01513291|531171500|FG003|Treatment Period|Lost to Follow-up|0|||
147274022|NCT01513291|531171501|FG004|Treatment Period|Lost to Follow-up|0|||
147274023|NCT01513291|531171497|FG000|Treatment Period|Physician Decision|1|||
147274024|NCT01513291|531171498|FG001|Treatment Period|Physician Decision|0|||
147274025|NCT01513291|531171499|FG002|Treatment Period|Physician Decision|0|||
147274026|NCT01513291|531171500|FG003|Treatment Period|Physician Decision|0|||
147274027|NCT01513291|531171501|FG004|Treatment Period|Physician Decision|0|||
147274028|NCT01513291|531171497|FG000|Treatment Period|Protocol Violation|1|||
147274029|NCT01513291|531171498|FG001|Treatment Period|Protocol Violation|2|||
147274030|NCT01513291|531171499|FG002|Treatment Period|Protocol Violation|0|||
147274031|NCT01513291|531171500|FG003|Treatment Period|Protocol Violation|0|||
147274032|NCT01513291|531171501|FG004|Treatment Period|Protocol Violation|0|||
147274033|NCT01513291|531171497|FG000|Treatment Period|Withdrawal by Subject|8|||
147274034|NCT01513291|531171498|FG001|Treatment Period|Withdrawal by Subject|5|||
147274035|NCT01513291|531171499|FG002|Treatment Period|Withdrawal by Subject|0|||
147274036|NCT01513291|531171500|FG003|Treatment Period|Withdrawal by Subject|0|||
147274037|NCT01513291|531171501|FG004|Treatment Period|Withdrawal by Subject|0|||
147274038|NCT01513291|531171497|FG000|Treatment Period|Randomized not treated|0|||
147274039|NCT01513291|531171498|FG001|Treatment Period|Randomized not treated|2|||
147274040|NCT01513291|531171499|FG002|Treatment Period|Randomized not treated|0|||
147274041|NCT01513291|531171500|FG003|Treatment Period|Randomized not treated|0|||
147274042|NCT01513291|531171501|FG004|Treatment Period|Randomized not treated|0|||
147274043|NCT01513291|531171497|FG000|Run-out Period|Lost to Follow-up|0|||
147274044|NCT01513291|531171498|FG001|Run-out Period|Lost to Follow-up|0|||
147274045|NCT01513291|531171499|FG002|Run-out Period|Lost to Follow-up|0|||
147274046|NCT01513291|531171500|FG003|Run-out Period|Lost to Follow-up|1|||
147274047|NCT01513291|531171501|FG004|Run-out Period|Lost to Follow-up|0|||
147274048|NCT01513291|531171497|FG000|Run-out Period|Withdrawal by Subject|0|||
147274049|NCT01513291|531171498|FG001|Run-out Period|Withdrawal by Subject|0|||
147274050|NCT01513291|531171499|FG002|Run-out Period|Withdrawal by Subject|0|||
147274051|NCT01513291|531171500|FG003|Run-out Period|Withdrawal by Subject|1|||
147274052|NCT01513291|531171501|FG004|Run-out Period|Withdrawal by Subject|0|||
147274053|NCT03732638|531171502|FG000|DBT Phase (Weeks 1 to 12)|Adverse Event|5|||
147274054|NCT03732638|531171503|FG001|DBT Phase (Weeks 1 to 12)|Adverse Event|2|||
147274055|NCT03732638|531171502|FG000|DBT Phase (Weeks 1 to 12)|Eligibility failure due to baseline laboratory values|8|||
147274056|NCT03732638|531171503|FG001|DBT Phase (Weeks 1 to 12)|Eligibility failure due to baseline laboratory values|13|||
147274057|NCT03732638|531171502|FG000|DBT Phase (Weeks 1 to 12)|Lack of Efficacy|1|||
147274058|NCT03732638|531171503|FG001|DBT Phase (Weeks 1 to 12)|Lack of Efficacy|1|||
147274059|NCT03732638|531171502|FG000|DBT Phase (Weeks 1 to 12)|Lost to Follow-up|19|||
147274060|NCT03732638|531171503|FG001|DBT Phase (Weeks 1 to 12)|Lost to Follow-up|12|||
147274061|NCT03732638|531171502|FG000|DBT Phase (Weeks 1 to 12)|Non-compliance|6|||
147274062|NCT03732638|531171503|FG001|DBT Phase (Weeks 1 to 12)|Non-compliance|5|||
147274063|NCT03732638|531171502|FG000|DBT Phase (Weeks 1 to 12)|Physician Decision|0|||
147274064|NCT03732638|531171503|FG001|DBT Phase (Weeks 1 to 12)|Physician Decision|1|||
147274065|NCT03732638|531171502|FG000|DBT Phase (Weeks 1 to 12)|Protocol deviation|4|||
147274066|NCT03732638|531171503|FG001|DBT Phase (Weeks 1 to 12)|Protocol deviation|5|||
147274067|NCT03732638|531171502|FG000|DBT Phase (Weeks 1 to 12)|Withdrawal by Subject|11|||
147274068|NCT03732638|531171503|FG001|DBT Phase (Weeks 1 to 12)|Withdrawal by Subject|22|||
147274069|NCT03732638|531171502|FG000|OLE Phase (Weeks 13 to 64)|Adverse Event|10|||
147274070|NCT03732638|531171503|FG001|OLE Phase (Weeks 13 to 64)|Adverse Event|9|||
147274071|NCT03732638|531171502|FG000|OLE Phase (Weeks 13 to 64)|Death|1|||
147274072|NCT03732638|531171503|FG001|OLE Phase (Weeks 13 to 64)|Death|1|||
147274073|NCT03732638|531171502|FG000|OLE Phase (Weeks 13 to 64)|Extension phase eligibility failure due to week 12 laboratory values|2|||
147274074|NCT03732638|531171503|FG001|OLE Phase (Weeks 13 to 64)|Extension phase eligibility failure due to week 12 laboratory values|0|||
147274075|NCT03732638|531171502|FG000|OLE Phase (Weeks 13 to 64)|Lack of Efficacy|2|||
147274076|NCT03732638|531171503|FG001|OLE Phase (Weeks 13 to 64)|Lack of Efficacy|2|||
147274077|NCT03732638|531171502|FG000|OLE Phase (Weeks 13 to 64)|Lost to Follow-up|19|||
147274078|NCT03732638|531171503|FG001|OLE Phase (Weeks 13 to 64)|Lost to Follow-up|13|||
147274079|NCT03732638|531171502|FG000|OLE Phase (Weeks 13 to 64)|Non-compliance|15|||
147274080|NCT03732638|531171503|FG001|OLE Phase (Weeks 13 to 64)|Non-compliance|14|||
147274081|NCT03732638|531171502|FG000|OLE Phase (Weeks 13 to 64)|Physician Decision|9|||
147274082|NCT03732638|531171503|FG001|OLE Phase (Weeks 13 to 64)|Physician Decision|9|||
147274083|NCT03732638|531171502|FG000|OLE Phase (Weeks 13 to 64)|Pregnancy|2|||
147274084|NCT03732638|531171503|FG001|OLE Phase (Weeks 13 to 64)|Pregnancy|2|||
147274085|NCT03732638|531171502|FG000|OLE Phase (Weeks 13 to 64)|Protocol deviation|2|||
147274086|NCT03732638|531171503|FG001|OLE Phase (Weeks 13 to 64)|Protocol deviation|3|||
147274087|NCT03732638|531171502|FG000|OLE Phase (Weeks 13 to 64)|Sponsor Recommendation|1|||
147274088|NCT03732638|531171503|FG001|OLE Phase (Weeks 13 to 64)|Sponsor Recommendation|0|||
147274089|NCT03732638|531171502|FG000|OLE Phase (Weeks 13 to 64)|Withdrawal by Subject|29|||
147274090|NCT03732638|531171503|FG001|OLE Phase (Weeks 13 to 64)|Withdrawal by Subject|28|||
147274091|NCT03732638|531171502|FG000|OLE Phase (Weeks 13 to 64)|Other than specified|1|||
147274092|NCT03732638|531171503|FG001|OLE Phase (Weeks 13 to 64)|Other than specified|1|||
147274093|NCT03732638|531171502|FG000|Follow-up Phase (up to 72 Weeks)|Not reported|49|||
147274094|NCT03732638|531171503|FG001|Follow-up Phase (up to 72 Weeks)|Not reported|48|||
147274095|NCT03732638|531171502|FG000|Follow-up Phase (up to 72 Weeks)|Lost to Follow-up|10|||
147274096|NCT03732638|531171503|FG001|Follow-up Phase (up to 72 Weeks)|Lost to Follow-up|6|||
147274097|NCT03732638|531171502|FG000|Follow-up Phase (up to 72 Weeks)|Non-compliance|2|||
147274098|NCT03732638|531171503|FG001|Follow-up Phase (up to 72 Weeks)|Non-compliance|1|||
147274099|NCT03732638|531171502|FG000|Follow-up Phase (up to 72 Weeks)|Withdrawal by Subject|4|||
147274100|NCT03732638|531171503|FG001|Follow-up Phase (up to 72 Weeks)|Withdrawal by Subject|7|||
147274101|NCT01358981|531171504|FG000|Period 1|Withdrawal by Subject|0|||
147274102|NCT01358981|531171505|FG001|Period 1|Withdrawal by Subject|0|||
147274103|NCT01358981|531171506|FG002|Period 1|Withdrawal by Subject|0|||
147274104|NCT01358981|531171507|FG003|Period 1|Withdrawal by Subject|1|||
147274105|NCT01358981|531171508|FG004|Period 1|Withdrawal by Subject|0|||
147274106|NCT01358981|531171509|FG005|Period 1|Withdrawal by Subject|0|||
147274107|NCT01358981|531171510|FG006|Period 1|Withdrawal by Subject|0|||
147274108|NCT03728582|531171511|FG000|Intervention Period 1 (up to 6 Weeks)|Withdrawal by Subject|0|||
147274109|NCT03728582|531171512|FG001|Intervention Period 1 (up to 6 Weeks)|Withdrawal by Subject|1|||
147274110|NCT03728582|531171511|FG000|Washout (8 Weeks)|Withdrawal by Subject|1|||
147274111|NCT03728582|531171512|FG001|Washout (8 Weeks)|Withdrawal by Subject|0|||
147274112|NCT02732847|531171513|FG000|Overall Study|some filled early|42|||
147333809|NCT02551055|531387825|FG007|Overall Study|Reason not specified|0|||
147333810|NCT05328297|531389961|FG000|Overall Study|Adverse Event|5|||
147274113|NCT02732847|531171514|FG001|Overall Study|some filled early|42|||
147274114|NCT02738775|531171515|FG000|Overall Study|Withdrawal by Subject|0|||
147274115|NCT02738775|531171516|FG001|Overall Study|Withdrawal by Subject|1|||
147274116|NCT02738775|531171517|FG002|Overall Study|Withdrawal by Subject|0|||
147274117|NCT02738775|531171518|FG003|Overall Study|Withdrawal by Subject|0|||
147274118|NCT02738775|531171519|FG004|Overall Study|Withdrawal by Subject|0|||
147274119|NCT02738775|531171520|FG005|Overall Study|Withdrawal by Subject|0|||
147274120|NCT02738775|531171515|FG000|Overall Study|Adverse Event|0|||
147274121|NCT02738775|531171516|FG001|Overall Study|Adverse Event|0|||
147274122|NCT02738775|531171517|FG002|Overall Study|Adverse Event|0|||
147274123|NCT02738775|531171518|FG003|Overall Study|Adverse Event|1|||
147274124|NCT02738775|531171519|FG004|Overall Study|Adverse Event|0|||
147274125|NCT02738775|531171520|FG005|Overall Study|Adverse Event|0|||
147274126|NCT02738775|531171515|FG000|Overall Study|Pregnancy|0|||
147274127|NCT02738775|531171516|FG001|Overall Study|Pregnancy|1|||
147274128|NCT02738775|531171517|FG002|Overall Study|Pregnancy|0|||
147274129|NCT02738775|531171518|FG003|Overall Study|Pregnancy|0|||
147274130|NCT02738775|531171519|FG004|Overall Study|Pregnancy|0|||
147274131|NCT02738775|531171520|FG005|Overall Study|Pregnancy|0|||
147274132|NCT02738775|531171515|FG000|Overall Study|Missing|0|||
147274133|NCT02738775|531171516|FG001|Overall Study|Missing|0|||
147274134|NCT02738775|531171517|FG002|Overall Study|Missing|0|||
147274135|NCT02738775|531171518|FG003|Overall Study|Missing|0|||
147274136|NCT02738775|531171519|FG004|Overall Study|Missing|0|||
147274137|NCT02738775|531171520|FG005|Overall Study|Missing|1|||
147274138|NCT01018264|531171521|FG000|Overall Study|Withdrawal by Subject|1|||
147274139|NCT01018264|531171522|FG001|Overall Study|Withdrawal by Subject|0|||
147274140|NCT01018264|531171521|FG000|Overall Study|Lost to Follow-up|0|||
147274141|NCT01018264|531171522|FG001|Overall Study|Lost to Follow-up|1|||
147274142|NCT01785524|531171523|FG000|Overall Study|Withdrawal by Subject|2|||
147274143|NCT01785524|531171524|FG001|Overall Study|Withdrawal by Subject|2|||
147274144|NCT01060384|531171525|FG000|Overall Study|Withdrawal by Subject|0|||
147274145|NCT01060384|531171526|FG001|Overall Study|Withdrawal by Subject|1|||
147274146|NCT01060384|531171527|FG002|Overall Study|Withdrawal by Subject|0|||
147274147|NCT01060384|531171528|FG003|Overall Study|Withdrawal by Subject|0|||
147274148|NCT01060384|531171529|FG004|Overall Study|Withdrawal by Subject|0|||
147274149|NCT01060384|531171525|FG000|Overall Study|Death|0|||
147274150|NCT01060384|531171526|FG001|Overall Study|Death|0|||
147274151|NCT01060384|531171527|FG002|Overall Study|Death|0|||
147274152|NCT01060384|531171528|FG003|Overall Study|Death|0|||
147274153|NCT01060384|531171529|FG004|Overall Study|Death|1|||
147274154|NCT01060384|531171525|FG000|Overall Study|Intercurrent illness|0|||
147274155|NCT01060384|531171526|FG001|Overall Study|Intercurrent illness|0|||
147274156|NCT01060384|531171527|FG002|Overall Study|Intercurrent illness|0|||
147274157|NCT01060384|531171528|FG003|Overall Study|Intercurrent illness|0|||
147274158|NCT01060384|531171529|FG004|Overall Study|Intercurrent illness|1|||
147274159|NCT01859715|531171532|FG000|Overall Study|No 2nd VAS|16|||
147274160|NCT01859715|531171533|FG001|Overall Study|No 2nd VAS|8|||
147274161|NCT01859715|531171534|FG002|Overall Study|No 2nd VAS|23|||
147274162|NCT04936685|531171535|FG000|Overall Study|Protocol Violation|1|||
147274163|NCT04936685|531171536|FG001|Overall Study|Protocol Violation|0|||
147274164|NCT04542070|531171539|FG000|Maintenance Period (Day 1 - Month 12)|Adverse Event|10|||
147274165|NCT04542070|531171540|FG001|Maintenance Period (Day 1 - Month 12)|Adverse Event|3|||
147274166|NCT04542070|531171541|FG002|Maintenance Period (Day 1 - Month 12)|Adverse Event|1|||
147274167|NCT04542070|531171542|FG003|Maintenance Period (Day 1 - Month 12)|Adverse Event|0|||
147274168|NCT04542070|531171539|FG000|Maintenance Period (Day 1 - Month 12)|Lack of Efficacy|1|||
147274169|NCT04542070|531171540|FG001|Maintenance Period (Day 1 - Month 12)|Lack of Efficacy|2|||
147274170|NCT04542070|531171541|FG002|Maintenance Period (Day 1 - Month 12)|Lack of Efficacy|0|||
147274171|NCT04542070|531171542|FG003|Maintenance Period (Day 1 - Month 12)|Lack of Efficacy|0|||
147274172|NCT04542070|531171539|FG000|Maintenance Period (Day 1 - Month 12)|Lost to Follow-up|3|||
147274173|NCT04542070|531171540|FG001|Maintenance Period (Day 1 - Month 12)|Lost to Follow-up|4|||
147274174|NCT04542070|531171541|FG002|Maintenance Period (Day 1 - Month 12)|Lost to Follow-up|2|||
147274175|NCT04542070|531171542|FG003|Maintenance Period (Day 1 - Month 12)|Lost to Follow-up|0|||
147274176|NCT04542070|531171539|FG000|Maintenance Period (Day 1 - Month 12)|Physician Decision|1|||
147274177|NCT04542070|531171540|FG001|Maintenance Period (Day 1 - Month 12)|Physician Decision|0|||
147274178|NCT04542070|531171541|FG002|Maintenance Period (Day 1 - Month 12)|Physician Decision|1|||
147274179|NCT04542070|531171542|FG003|Maintenance Period (Day 1 - Month 12)|Physician Decision|0|||
147274180|NCT04542070|531171539|FG000|Maintenance Period (Day 1 - Month 12)|Withdrawal by Subject|5|||
147274181|NCT04542070|531171540|FG001|Maintenance Period (Day 1 - Month 12)|Withdrawal by Subject|8|||
147274182|NCT04542070|531171541|FG002|Maintenance Period (Day 1 - Month 12)|Withdrawal by Subject|9|||
147274183|NCT04542070|531171542|FG003|Maintenance Period (Day 1 - Month 12)|Withdrawal by Subject|0|||
147274184|NCT04542070|531171539|FG000|Maintenance Period (Day 1 - Month 12)|Protocol Deviation|2|||
147274185|NCT04542070|531171540|FG001|Maintenance Period (Day 1 - Month 12)|Protocol Deviation|6|||
147274186|NCT04542070|531171541|FG002|Maintenance Period (Day 1 - Month 12)|Protocol Deviation|1|||
147274187|NCT04542070|531171542|FG003|Maintenance Period (Day 1 - Month 12)|Protocol Deviation|0|||
147600381|NCT03893565|532356365|FG008|Double-blind Extended Treatment(20weeks)|Study terminated by sponsor|0|||
147600382|NCT03893565|532356357|FG000|Open-label Induction Phase (10 Weeks)|Other|0|||
147274188|NCT04542070|531171539|FG000|Maintenance Period (Day 1 - Month 12)|Protocol-Specified Withdrawal Criterion Met|1|||
147274189|NCT04542070|531171540|FG001|Maintenance Period (Day 1 - Month 12)|Protocol-Specified Withdrawal Criterion Met|1|||
147274190|NCT04542070|531171541|FG002|Maintenance Period (Day 1 - Month 12)|Protocol-Specified Withdrawal Criterion Met|0|||
147600383|NCT03893565|532356358|FG001|Open-label Induction Phase (10 Weeks)|Other|0|||
147600384|NCT03893565|532356359|FG002|Open-label Induction Phase (10 Weeks)|Other|0|||
147600385|NCT03893565|532356360|FG003|Open-label Induction Phase (10 Weeks)|Other|0|||
147600386|NCT03893565|532356361|FG004|Open-label Induction Phase (10 Weeks)|Other|0|||
147600387|NCT03893565|532356362|FG005|Open-label Induction Phase (10 Weeks)|Other|0|||
147600388|NCT03893565|532356363|FG006|Open-label Induction Phase (10 Weeks)|Other|0|||
147600389|NCT03893565|532356364|FG007|Open-label Induction Phase (10 Weeks)|Other|3|||
147600390|NCT03893565|532356365|FG008|Open-label Induction Phase (10 Weeks)|Other|0|||
147600391|NCT03893565|532356357|FG000|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
147600392|NCT03893565|532356358|FG001|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
147600393|NCT03893565|532356359|FG002|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
147600394|NCT03893565|532356360|FG003|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
147600395|NCT03893565|532356361|FG004|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
147600396|NCT03893565|532356362|FG005|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
147600397|NCT03893565|532356363|FG006|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
147600398|NCT03893565|532356364|FG007|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|5|||
147600399|NCT03893565|532356365|FG008|Open-label Induction Phase (10 Weeks)|Withdrawal by Subject|0|||
147600400|NCT03893565|532356357|FG000|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
147600401|NCT03893565|532356358|FG001|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
147600402|NCT03893565|532356359|FG002|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
147600403|NCT03893565|532356360|FG003|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
147600404|NCT03893565|532356361|FG004|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
147600405|NCT03893565|532356362|FG005|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
147600406|NCT03893565|532356363|FG006|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
147600407|NCT03893565|532356364|FG007|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|15|||
147600408|NCT03893565|532356365|FG008|Open-label Induction Phase (10 Weeks)|Study terminated by sponsor|0|||
147600409|NCT03893565|532356357|FG000|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
147600410|NCT03893565|532356358|FG001|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
147600411|NCT03893565|532356359|FG002|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
147600412|NCT03893565|532356360|FG003|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
147274191|NCT04542070|531171542|FG003|Maintenance Period (Day 1 - Month 12)|Protocol-Specified Withdrawal Criterion Met|0|||
147274192|NCT04542070|531171539|FG000|Maintenance + Extension Period|Adverse Event|10|||
147274193|NCT04542070|531171540|FG001|Maintenance + Extension Period|Adverse Event|2|||
147274194|NCT04542070|531171541|FG002|Maintenance + Extension Period|Adverse Event|0|||
147274195|NCT04542070|531171542|FG003|Maintenance + Extension Period|Adverse Event|0|||
147274196|NCT04542070|531171539|FG000|Maintenance + Extension Period|Lack of Efficacy|2|||
147274197|NCT04542070|531171540|FG001|Maintenance + Extension Period|Lack of Efficacy|2|||
147274198|NCT04542070|531171541|FG002|Maintenance + Extension Period|Lack of Efficacy|0|||
147274199|NCT04542070|531171542|FG003|Maintenance + Extension Period|Lack of Efficacy|0|||
147274200|NCT04542070|531171539|FG000|Maintenance + Extension Period|Lost to Follow-up|3|||
147450791|NCT02543528|531813150|FG004|Extended Wear Period|Unsatisfactory Lens Fitting|0|||
147450792|NCT02543528|531813146|FG000|Extended Wear Period|Lost to Follow-up|0|||
147450793|NCT02543528|531813147|FG001|Extended Wear Period|Lost to Follow-up|1|||
147450794|NCT02543528|531813148|FG002|Extended Wear Period|Lost to Follow-up|2|||
147450795|NCT02543528|531813149|FG003|Extended Wear Period|Lost to Follow-up|1|||
147274201|NCT04542070|531171540|FG001|Maintenance + Extension Period|Lost to Follow-up|4|||
147274202|NCT04542070|531171541|FG002|Maintenance + Extension Period|Lost to Follow-up|0|||
147274203|NCT04542070|531171542|FG003|Maintenance + Extension Period|Lost to Follow-up|0|||
147274204|NCT04542070|531171539|FG000|Maintenance + Extension Period|Physician Decision|1|||
147274205|NCT04542070|531171540|FG001|Maintenance + Extension Period|Physician Decision|1|||
147274206|NCT04542070|531171541|FG002|Maintenance + Extension Period|Physician Decision|0|||
147274207|NCT04542070|531171542|FG003|Maintenance + Extension Period|Physician Decision|0|||
147274208|NCT04542070|531171539|FG000|Maintenance + Extension Period|Protocol Violation|2|||
147274209|NCT04542070|531171540|FG001|Maintenance + Extension Period|Protocol Violation|5|||
147274210|NCT04542070|531171541|FG002|Maintenance + Extension Period|Protocol Violation|0|||
147274211|NCT04542070|531171542|FG003|Maintenance + Extension Period|Protocol Violation|0|||
147274212|NCT04542070|531171539|FG000|Maintenance + Extension Period|Protocol-specified withdrawal criterion met|1|||
147274213|NCT04542070|531171540|FG001|Maintenance + Extension Period|Protocol-specified withdrawal criterion met|1|||
147450796|NCT02543528|531813150|FG004|Extended Wear Period|Lost to Follow-up|0|||
147450797|NCT02543528|531813146|FG000|Extended Wear Period|Withdrawal by Subject|10|||
147600413|NCT03893565|532356361|FG004|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
147600414|NCT03893565|532356362|FG005|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
147600415|NCT03893565|532356363|FG006|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
147600416|NCT03893565|532356364|FG007|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|7|||
147600417|NCT03893565|532356365|FG008|Open-label Induction Phase (10 Weeks)|Lack of Efficacy|0|||
147600418|NCT03893565|532356357|FG000|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
147600419|NCT03893565|532356358|FG001|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
147600420|NCT03893565|532356359|FG002|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
147600421|NCT03893565|532356360|FG003|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
147600422|NCT03893565|532356361|FG004|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
147600423|NCT03893565|532356362|FG005|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
147600424|NCT03893565|532356363|FG006|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
147600425|NCT03893565|532356364|FG007|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|0|||
147600426|NCT03893565|532356365|FG008|Open-label Extended Treatment (20 Weeks)|Study terminated by sponsor|4|||
147662406|NCT02735980|532587323|FG000|Overall Study|Screen failure|1|||
147662407|NCT02735980|532587324|FG001|Overall Study|Screen failure|0|||
147274214|NCT04542070|531171541|FG002|Maintenance + Extension Period|Protocol-specified withdrawal criterion met|0|||
147274215|NCT04542070|531171542|FG003|Maintenance + Extension Period|Protocol-specified withdrawal criterion met|0|||
147274216|NCT04542070|531171539|FG000|Maintenance + Extension Period|Withdrawal by Subject|4|||
147274217|NCT04542070|531171540|FG001|Maintenance + Extension Period|Withdrawal by Subject|12|||
147274218|NCT04542070|531171541|FG002|Maintenance + Extension Period|Withdrawal by Subject|0|||
147274219|NCT04542070|531171542|FG003|Maintenance + Extension Period|Withdrawal by Subject|0|||
147274220|NCT04542070|531171539|FG000|Extension Period (Month 13 - Month 27)|Adverse Event|0|||
147274221|NCT04542070|531171540|FG001|Extension Period (Month 13 - Month 27)|Adverse Event|0|||
147274222|NCT04542070|531171541|FG002|Extension Period (Month 13 - Month 27)|Adverse Event|0|||
147274223|NCT04542070|531171542|FG003|Extension Period (Month 13 - Month 27)|Adverse Event|4|||
147274224|NCT04542070|531171539|FG000|Extension Period (Month 13 - Month 27)|Lack of Efficacy|0|||
147274225|NCT04542070|531171540|FG001|Extension Period (Month 13 - Month 27)|Lack of Efficacy|0|||
147274226|NCT04542070|531171541|FG002|Extension Period (Month 13 - Month 27)|Lack of Efficacy|0|||
147274227|NCT04542070|531171542|FG003|Extension Period (Month 13 - Month 27)|Lack of Efficacy|1|||
147274228|NCT04542070|531171539|FG000|Extension Period (Month 13 - Month 27)|Lost to Follow-up|0|||
147274229|NCT04542070|531171540|FG001|Extension Period (Month 13 - Month 27)|Lost to Follow-up|0|||
147274230|NCT04542070|531171541|FG002|Extension Period (Month 13 - Month 27)|Lost to Follow-up|0|||
147274231|NCT04542070|531171542|FG003|Extension Period (Month 13 - Month 27)|Lost to Follow-up|1|||
147274232|NCT04542070|531171539|FG000|Extension Period (Month 13 - Month 27)|Physician Decision|0|||
147274233|NCT04542070|531171540|FG001|Extension Period (Month 13 - Month 27)|Physician Decision|0|||
147274234|NCT04542070|531171541|FG002|Extension Period (Month 13 - Month 27)|Physician Decision|0|||
147274235|NCT04542070|531171542|FG003|Extension Period (Month 13 - Month 27)|Physician Decision|2|||
147274236|NCT04542070|531171539|FG000|Extension Period (Month 13 - Month 27)|Withdrawal by Subject|0|||
147274237|NCT04542070|531171540|FG001|Extension Period (Month 13 - Month 27)|Withdrawal by Subject|0|||
147274238|NCT04542070|531171541|FG002|Extension Period (Month 13 - Month 27)|Withdrawal by Subject|0|||
147274239|NCT04542070|531171542|FG003|Extension Period (Month 13 - Month 27)|Withdrawal by Subject|5|||
147274240|NCT03049813|531171545|FG000|Randomized Control Trial Phase|Participant placed in nursing home|0|||
147274241|NCT03049813|531171546|FG001|Randomized Control Trial Phase|Participant placed in nursing home|1|||
147274242|NCT03049813|531171547|FG002|Randomized Control Trial Phase|Participant placed in nursing home|0|||
147274243|NCT03049813|531171548|FG003|Randomized Control Trial Phase|Participant placed in nursing home|0|||
147274244|NCT03049813|531171545|FG000|Randomized Control Trial Phase|COVID Quarantine|2|||
147274245|NCT03049813|531171546|FG001|Randomized Control Trial Phase|COVID Quarantine|3|||
147333811|NCT05328297|531389962|FG001|Overall Study|Adverse Event|7|||
147333812|NCT05328297|531389961|FG000|Overall Study|Withdrawal by Subject|4|||
147333813|NCT05328297|531389962|FG001|Overall Study|Withdrawal by Subject|3|||
147333814|NCT05328297|531389961|FG000|Overall Study|Lack of Efficacy|1|||
147333815|NCT05328297|531389962|FG001|Overall Study|Lack of Efficacy|0|||
147333816|NCT05328297|531389961|FG000|Overall Study|Lost to Follow-up|1|||
147274246|NCT03049813|531171547|FG002|Randomized Control Trial Phase|COVID Quarantine|0|||
147274247|NCT03049813|531171548|FG003|Randomized Control Trial Phase|COVID Quarantine|0|||
147274248|NCT03049813|531171545|FG000|Randomized Control Trial Phase|Participant was in another concurrent study|0|||
147274249|NCT03049813|531171546|FG001|Randomized Control Trial Phase|Participant was in another concurrent study|1|||
147274250|NCT03049813|531171547|FG002|Randomized Control Trial Phase|Participant was in another concurrent study|0|||
147274251|NCT03049813|531171548|FG003|Randomized Control Trial Phase|Participant was in another concurrent study|0|||
147274252|NCT03049813|531171545|FG000|Randomized Control Trial Phase|Lost to Follow-up|0|||
147274253|NCT03049813|531171546|FG001|Randomized Control Trial Phase|Lost to Follow-up|2|||
147274254|NCT03049813|531171547|FG002|Randomized Control Trial Phase|Lost to Follow-up|3|||
147274255|NCT03049813|531171548|FG003|Randomized Control Trial Phase|Lost to Follow-up|0|||
147274256|NCT01813019|531171549|FG000|Overall Study|Adverse Event|0|||
147662408|NCT02735980|532587325|FG002|Overall Study|Screen failure|0|||
147274257|NCT01813019|531171550|FG001|Overall Study|Adverse Event|3|||
147274258|NCT01813019|531171549|FG000|Overall Study|Withdrawal by Subject|3|||
147274259|NCT01813019|531171550|FG001|Overall Study|Withdrawal by Subject|2|||
147274260|NCT01813019|531171549|FG000|Overall Study|administrative problems|2|||
147274261|NCT01813019|531171550|FG001|Overall Study|administrative problems|0|||
147274262|NCT01813019|531171549|FG000|Overall Study|Protocol Deviation|2|||
147274263|NCT01813019|531171550|FG001|Overall Study|Protocol Deviation|1|||
147274264|NCT01193556|531171556|FG000|Overall Study|Study termination|26|||
147274265|NCT01193556|531171557|FG001|Overall Study|Study termination|25|||
147274266|NCT01696032|531171559|FG000|Overall Study|Withdrawal by Subject|0|||
147274267|NCT01696032|531171560|FG001|Overall Study|Withdrawal by Subject|0|||
147274268|NCT01696032|531171561|FG002|Overall Study|Withdrawal by Subject|1|||
147274269|NCT01696032|531171562|FG003|Overall Study|Withdrawal by Subject|2|||
147274270|NCT01696032|531171559|FG000|Overall Study|Death|14|||
147274271|NCT01696032|531171560|FG001|Overall Study|Death|4|||
147274272|NCT01696032|531171561|FG002|Overall Study|Death|43|||
147274273|NCT01696032|531171562|FG003|Overall Study|Death|18|||
147274274|NCT01696032|531171559|FG000|Overall Study|Lost to Follow-up|0|||
147274275|NCT01696032|531171560|FG001|Overall Study|Lost to Follow-up|1|||
147274276|NCT01696032|531171561|FG002|Overall Study|Lost to Follow-up|0|||
147274277|NCT01696032|531171562|FG003|Overall Study|Lost to Follow-up|0|||
147274278|NCT01696032|531171559|FG000|Overall Study|Database lock|0|||
147274279|NCT01696032|531171560|FG001|Overall Study|Database lock|1|||
147274280|NCT01696032|531171561|FG002|Overall Study|Database lock|7|||
147274281|NCT01696032|531171562|FG003|Overall Study|Database lock|2|||
147274282|NCT03025828|531171565|FG000|Overall Study|Lost to Follow-up|1|||
147274283|NCT02203591|531171566|FG000|Overall Study|Did not meet treatment day baseline|147|||
147274284|NCT02203591|531171567|FG001|Overall Study|Did not meet treatment day baseline|141|||
147274285|NCT02203591|531171568|FG002|Overall Study|Did not meet treatment day baseline|150|||
147274286|NCT02203591|531171569|FG003|Overall Study|Did not meet treatment day baseline|45|||
147274287|NCT02203591|531171570|FG004|Overall Study|Did not meet treatment day baseline|33|||
147274288|NCT02203591|531171571|FG005|Overall Study|Did not meet treatment day baseline|35|||
147274289|NCT02203591|531171572|FG006|Overall Study|Did not meet treatment day baseline|29|||
147274290|NCT02203591|531171573|FG007|Overall Study|Did not meet treatment day baseline|12|||
147274291|NCT02203591|531171566|FG000|Overall Study|Discontinued early due to compromised test sites|0|||
147274292|NCT02203591|531171567|FG001|Overall Study|Discontinued early due to compromised test sites|1|||
147274293|NCT02203591|531171568|FG002|Overall Study|Discontinued early due to compromised test sites|1|||
147274294|NCT02203591|531171569|FG003|Overall Study|Discontinued early due to compromised test sites|0|||
147274295|NCT02203591|531171570|FG004|Overall Study|Discontinued early due to compromised test sites|1|||
147274296|NCT02203591|531171571|FG005|Overall Study|Discontinued early due to compromised test sites|0|||
147274297|NCT02203591|531171572|FG006|Overall Study|Discontinued early due to compromised test sites|0|||
147274298|NCT02203591|531171573|FG007|Overall Study|Discontinued early due to compromised test sites|1|||
147274299|NCT03306264|531171576|FG000|Overall Study|Death|33|||
147274300|NCT03306264|531171577|FG001|Overall Study|Death|25|||
147274301|NCT03306264|531171578|FG002|Overall Study|Death|34|||
147274302|NCT03306264|531171579|FG003|Overall Study|Death|34|||
147274303|NCT03306264|531171576|FG000|Overall Study|Complete Consent Withdrawal|4|||
147274304|NCT03306264|531171577|FG001|Overall Study|Complete Consent Withdrawal|4|||
147274305|NCT03306264|531171578|FG002|Overall Study|Complete Consent Withdrawal|1|||
147274306|NCT03306264|531171579|FG003|Overall Study|Complete Consent Withdrawal|8|||
147274307|NCT03306264|531171576|FG000|Overall Study|Lost to Follow-up|1|||
147274308|NCT03306264|531171577|FG001|Overall Study|Lost to Follow-up|0|||
147274309|NCT03306264|531171578|FG002|Overall Study|Lost to Follow-up|1|||
147274310|NCT03306264|531171579|FG003|Overall Study|Lost to Follow-up|0|||
147274311|NCT03306264|531171576|FG000|Overall Study|Rollover to ASTX727-06|10|||
147600427|NCT01715571|532356366|FG000|Overall Study|Lost to Follow-up|8|||
147600428|NCT04658095|532356371|FG000|Overall Study|Study terminated|5|||
147600429|NCT04658095|532356372|FG001|Overall Study|Study terminated|1|||
147600430|NCT04658095|532356373|FG002|Overall Study|Study terminated|4|||
147600431|NCT02387983|532356374|FG000|Overall Study|Adverse Event|4|||
147600432|NCT02387983|532356374|FG000|Overall Study|Protocol Violation|1|||
147600433|NCT02387983|532356374|FG000|Overall Study|Withdrawal by Subject|2|||
147600434|NCT00077857|532356375|FG000|Overall Study|Adverse Event|30|||
147274312|NCT03306264|531171577|FG001|Overall Study|Rollover to ASTX727-06|18|||
147274313|NCT03306264|531171578|FG002|Overall Study|Rollover to ASTX727-06|4|||
147274314|NCT03306264|531171579|FG003|Overall Study|Rollover to ASTX727-06|2|||
147274315|NCT03306264|531171576|FG000|Overall Study|Study Centre Terminated by Sponsor|21|||
147274316|NCT03306264|531171577|FG001|Overall Study|Study Centre Terminated by Sponsor|22|||
147274317|NCT03306264|531171578|FG002|Overall Study|Study Centre Terminated by Sponsor|4|||
147600435|NCT00077857|532356376|FG001|Overall Study|Adverse Event|32|||
147274318|NCT03306264|531171579|FG003|Overall Study|Study Centre Terminated by Sponsor|1|||
147274319|NCT02143843|531171580|FG000|Overall Study|Adverse Event|8|||
147274320|NCT02143843|531171580|FG000|Overall Study|Lack of Efficacy|2|||
147600436|NCT00077857|532356375|FG000|Overall Study|Death|7|||
147600437|NCT00077857|532356376|FG001|Overall Study|Death|3|||
147600438|NCT00077857|532356375|FG000|Overall Study|Insufficient therapeutic response|112|||
147450798|NCT02543528|531813147|FG001|Extended Wear Period|Withdrawal by Subject|9|||
147450799|NCT02543528|531813148|FG002|Extended Wear Period|Withdrawal by Subject|4|||
147450800|NCT02543528|531813149|FG003|Extended Wear Period|Withdrawal by Subject|5|||
147450801|NCT02543528|531813150|FG004|Extended Wear Period|Withdrawal by Subject|0|||
147450802|NCT01408147|531813151|FG000|Overall Study|Withdrawal by Subject|0|||
147450803|NCT01408147|531813152|FG001|Overall Study|Withdrawal by Subject|1|||
147450804|NCT01761266|531813153|FG000|Overall Study|Death|415|||
147450805|NCT01761266|531813154|FG001|Overall Study|Death|402|||
147274321|NCT02143843|531171580|FG000|Overall Study|Withdrawal by Subject|2|||
147274322|NCT02702401|531171584|FG000|Overall Study|Death|242|||
147274323|NCT02702401|531171585|FG001|Overall Study|Death|125|||
147274324|NCT02702401|531171584|FG000|Overall Study|Withdrawal by Subject|15|||
147274325|NCT02702401|531171585|FG001|Overall Study|Withdrawal by Subject|5|||
147274326|NCT02702401|531171584|FG000|Overall Study|Sponsor Decision|19|||
147274327|NCT02702401|531171585|FG001|Overall Study|Sponsor Decision|3|||
147274328|NCT02702401|531171584|FG000|Overall Study|Physician Decision|1|||
147274329|NCT02702401|531171585|FG001|Overall Study|Physician Decision|2|||
147274330|NCT02702401|531171584|FG000|Overall Study|Lost to Follow-up|1|||
147274331|NCT02702401|531171585|FG001|Overall Study|Lost to Follow-up|0|||
147274332|NCT01462357|531171590|FG000|Overall Study|Death|0|||
147274333|NCT01462357|531171591|FG001|Overall Study|Death|0|||
147274334|NCT01462357|531171592|FG002|Overall Study|Death|1|||
147274335|NCT01462357|531171590|FG000|Overall Study|Withdrawal by Subject|3|||
147274336|NCT01462357|531171591|FG001|Overall Study|Withdrawal by Subject|11|||
147274337|NCT01462357|531171592|FG002|Overall Study|Withdrawal by Subject|3|||
147274338|NCT01462357|531171590|FG000|Overall Study|Migrated/moved from study area|2|||
147274339|NCT01462357|531171591|FG001|Overall Study|Migrated/moved from study area|3|||
147274340|NCT01462357|531171592|FG002|Overall Study|Migrated/moved from study area|1|||
147274341|NCT01462357|531171590|FG000|Overall Study|Lost to Follow-up|3|||
147274342|NCT01462357|531171591|FG001|Overall Study|Lost to Follow-up|5|||
147274343|NCT01462357|531171592|FG002|Overall Study|Lost to Follow-up|7|||
147274344|NCT04292730|531171595|FG000|Overall Study|Lost to Follow-up|8|||
147274345|NCT04292730|531171596|FG001|Overall Study|Lost to Follow-up|12|||
147274346|NCT04292730|531171597|FG002|Overall Study|Lost to Follow-up|12|||
147274347|NCT04292730|531171598|FG003|Overall Study|Lost to Follow-up|48|||
147274348|NCT04292730|531171595|FG000|Overall Study|Death|2|||
147274349|NCT04292730|531171596|FG001|Overall Study|Death|2|||
147274350|NCT04292730|531171597|FG002|Overall Study|Death|4|||
147274351|NCT04292730|531171598|FG003|Overall Study|Death|12|||
147274352|NCT04292730|531171595|FG000|Overall Study|Withdrew Consent|2|||
147662409|NCT02735980|532587323|FG000|Overall Study|Withdrawal by Subject|1|||
147274353|NCT04292730|531171596|FG001|Overall Study|Withdrew Consent|2|||
147274354|NCT04292730|531171597|FG002|Overall Study|Withdrew Consent|5|||
147274355|NCT04292730|531171598|FG003|Overall Study|Withdrew Consent|6|||
147274356|NCT04292730|531171595|FG000|Overall Study|Non-Compliance with Study Drug|0|||
147274357|NCT04292730|531171596|FG001|Overall Study|Non-Compliance with Study Drug|1|||
147274358|NCT04292730|531171597|FG002|Overall Study|Non-Compliance with Study Drug|0|||
147274359|NCT04292730|531171598|FG003|Overall Study|Non-Compliance with Study Drug|0|||
147274360|NCT04292730|531171595|FG000|Overall Study|Protocol Violation|0|||
147274361|NCT04292730|531171596|FG001|Overall Study|Protocol Violation|0|||
147274362|NCT04292730|531171597|FG002|Overall Study|Protocol Violation|1|||
147274363|NCT04292730|531171598|FG003|Overall Study|Protocol Violation|0|||
147274364|NCT04292730|531171595|FG000|Overall Study|Randomized but not Treated|8|||
147274365|NCT04292730|531171596|FG001|Overall Study|Randomized but not Treated|4|||
147274366|NCT04292730|531171597|FG002|Overall Study|Randomized but not Treated|0|||
147274367|NCT04292730|531171598|FG003|Overall Study|Randomized but not Treated|14|||
147274368|NCT01527292|531171599|FG000|Overall Study|Physician Decision|0|||
147274369|NCT01527292|531171600|FG001|Overall Study|Physician Decision|3|||
147274370|NCT01482767|531171603|FG000|Overall Study|Death|1|||
147274371|NCT01482767|531171604|FG001|Overall Study|Death|1|||
147274372|NCT01482767|531171603|FG000|Overall Study|Withdrawal by Subject|7|||
147274373|NCT01482767|531171604|FG001|Overall Study|Withdrawal by Subject|5|||
147274374|NCT01482767|531171603|FG000|Overall Study|Lost to Follow-up|12|||
147274375|NCT01482767|531171604|FG001|Overall Study|Lost to Follow-up|6|||
147274376|NCT01482767|531171603|FG000|Overall Study|Adverse Event|0|||
147274377|NCT01482767|531171604|FG001|Overall Study|Adverse Event|3|||
147274378|NCT01482767|531171603|FG000|Overall Study|Site closure|22|||
147274379|NCT01482767|531171604|FG001|Overall Study|Site closure|14|||
147274380|NCT01482767|531171603|FG000|Overall Study|Non-adherence to study requirements|4|||
147274381|NCT01482767|531171604|FG001|Overall Study|Non-adherence to study requirements|7|||
147450806|NCT01761266|531813153|FG000|Overall Study|Lost to Follow-up|8|||
147450807|NCT01761266|531813154|FG001|Overall Study|Lost to Follow-up|12|||
147450808|NCT01761266|531813153|FG000|Overall Study|Withdrawal by Subject|14|||
147450809|NCT01761266|531813154|FG001|Overall Study|Withdrawal by Subject|10|||
147274382|NCT01482767|531171603|FG000|Overall Study|Alternate HCV treatment|7|||
147274383|NCT01482767|531171604|FG001|Overall Study|Alternate HCV treatment|8|||
147274384|NCT01482767|531171603|FG000|Overall Study|Ineligible|0|||
147274385|NCT01482767|531171604|FG001|Overall Study|Ineligible|5|||
147274386|NCT01482767|531171603|FG000|Overall Study|Nurse error|1|||
147274387|NCT01482767|531171604|FG001|Overall Study|Nurse error|0|||
147274388|NCT01247090|531171607|FG000|Overall Study|Physician Decision|1|||
147274389|NCT01247090|531171608|FG001|Overall Study|Physician Decision|0|||
147274390|NCT01247090|531171609|FG002|Overall Study|Physician Decision|0|||
147274391|NCT01247090|531171607|FG000|Overall Study|Withdrawal by Subject|0|||
147274392|NCT01247090|531171608|FG001|Overall Study|Withdrawal by Subject|1|||
147274393|NCT01247090|531171609|FG002|Overall Study|Withdrawal by Subject|0|||
147274394|NCT02457325|531171615|FG000|First Intervention (1 Day)|Lost to Follow-up|2|||
147274395|NCT02457325|531171616|FG001|First Intervention (1 Day)|Lost to Follow-up|2|||
147274396|NCT01574703|531171617|FG000|Overall Study|Adverse Event|0|||
147274397|NCT01574703|531171618|FG001|Overall Study|Adverse Event|2|||
147274398|NCT01574703|531171619|FG002|Overall Study|Adverse Event|1|||
147274399|NCT01574703|531171620|FG003|Overall Study|Adverse Event|1|||
147274400|NCT01574703|531171617|FG000|Overall Study|Protocol Violation|0|||
147274401|NCT01574703|531171618|FG001|Overall Study|Protocol Violation|0|||
147274402|NCT01574703|531171619|FG002|Overall Study|Protocol Violation|0|||
147274403|NCT01574703|531171620|FG003|Overall Study|Protocol Violation|1|||
147274404|NCT01574703|531171617|FG000|Overall Study|Unspecified Reason|27|||
147274405|NCT01574703|531171618|FG001|Overall Study|Unspecified Reason|15|||
147274406|NCT01574703|531171619|FG002|Overall Study|Unspecified Reason|20|||
147274407|NCT01574703|531171620|FG003|Overall Study|Unspecified Reason|16|||
147274408|NCT01574703|531171617|FG000|Overall Study|Withdrawal by Subject|53|||
147274409|NCT01574703|531171618|FG001|Overall Study|Withdrawal by Subject|52|||
147274410|NCT01574703|531171619|FG002|Overall Study|Withdrawal by Subject|36|||
147274411|NCT01574703|531171620|FG003|Overall Study|Withdrawal by Subject|61|||
147274412|NCT01574703|531171617|FG000|Overall Study|Met Withdrawal Criteria|0|||
147274413|NCT01574703|531171618|FG001|Overall Study|Met Withdrawal Criteria|1|||
147274414|NCT01574703|531171619|FG002|Overall Study|Met Withdrawal Criteria|1|||
147274415|NCT01574703|531171620|FG003|Overall Study|Met Withdrawal Criteria|0|||
147274416|NCT01574703|531171617|FG000|Overall Study|Lost to Follow-up|43|||
147274417|NCT01574703|531171618|FG001|Overall Study|Lost to Follow-up|41|||
147274418|NCT01574703|531171619|FG002|Overall Study|Lost to Follow-up|46|||
147274419|NCT01574703|531171620|FG003|Overall Study|Lost to Follow-up|35|||
147274420|NCT01574703|531171617|FG000|Overall Study|Death|2|||
147274421|NCT01574703|531171618|FG001|Overall Study|Death|1|||
147274422|NCT01574703|531171619|FG002|Overall Study|Death|1|||
147274423|NCT01574703|531171620|FG003|Overall Study|Death|0|||
147274424|NCT03591575|531171621|FG000|Overall Study|Adverse Event|2|||
147274425|NCT03591575|531171622|FG001|Overall Study|Adverse Event|0|||
147274426|NCT03591575|531171621|FG000|Overall Study|Withdrawal by Subject|4|||
147274427|NCT03591575|531171622|FG001|Overall Study|Withdrawal by Subject|1|||
147274428|NCT01660412|531171624|FG000|Overall Study|Protocol Violation|0|||
147274429|NCT01660412|531171625|FG001|Overall Study|Protocol Violation|3|||
147274430|NCT03551210|531171626|FG000|Overall Study|Adverse Event|5|||
147274431|NCT03551210|531171627|FG001|Overall Study|Adverse Event|6|||
147274432|NCT03551210|531171626|FG000|Overall Study|Withdrawal by Subject|1|||
147274433|NCT03551210|531171627|FG001|Overall Study|Withdrawal by Subject|7|||
147274434|NCT03551210|531171626|FG000|Overall Study|Needed in other antibiotic treatment|2|||
147274435|NCT03551210|531171627|FG001|Overall Study|Needed in other antibiotic treatment|5|||
147274436|NCT03551210|531171626|FG000|Overall Study|Lost to Follow-up|1|||
147274437|NCT03551210|531171627|FG001|Overall Study|Lost to Follow-up|1|||
147274438|NCT03551210|531171626|FG000|Overall Study|Absence of visit 4 and 5|1|||
147274439|NCT03551210|531171627|FG001|Overall Study|Absence of visit 4 and 5|0|||
147274440|NCT03551210|531171626|FG000|Overall Study|No drug for dispensing|0|||
147274441|NCT03551210|531171627|FG001|Overall Study|No drug for dispensing|1|||
147274442|NCT03265119|531171628|FG000|Overall Study|Adverse Event|2|||
147274443|NCT03265119|531171629|FG001|Overall Study|Adverse Event|1|||
147274444|NCT03265119|531171628|FG000|Overall Study|Lack of Efficacy|3|||
147274445|NCT03265119|531171629|FG001|Overall Study|Lack of Efficacy|0|||
147274446|NCT03265119|531171628|FG000|Overall Study|Protocol Violation|1|||
147274447|NCT03265119|531171629|FG001|Overall Study|Protocol Violation|2|||
147274448|NCT03265119|531171628|FG000|Overall Study|Withdrawal by Subject|2|||
147274449|NCT03265119|531171629|FG001|Overall Study|Withdrawal by Subject|4|||
147274450|NCT03265119|531171628|FG000|Overall Study|Lost to Follow-up|1|||
147274451|NCT03265119|531171629|FG001|Overall Study|Lost to Follow-up|0|||
147274452|NCT03265119|531171628|FG000|Overall Study|Lack of Compliance|1|||
147450810|NCT01761266|531813153|FG000|Overall Study|Sponsor Decision|41|||
147274453|NCT03265119|531171629|FG001|Overall Study|Lack of Compliance|0|||
147274454|NCT04579679|531171630|FG000|Overall Study|New Antitumor Therapy|6|||
147274455|NCT04579679|531171631|FG001|Overall Study|New Antitumor Therapy|4|||
147274456|NCT04579679|531171632|FG002|Overall Study|New Antitumor Therapy|7|||
147274457|NCT04579679|531171633|FG003|Overall Study|New Antitumor Therapy|0|||
147274458|NCT04579679|531171630|FG000|Overall Study|Withdrawal of Consent|1|||
147274459|NCT04579679|531171631|FG001|Overall Study|Withdrawal of Consent|1|||
147274460|NCT04579679|531171632|FG002|Overall Study|Withdrawal of Consent|2|||
147274461|NCT04579679|531171633|FG003|Overall Study|Withdrawal of Consent|4|||
147274462|NCT04579679|531171630|FG000|Overall Study|Death|2|||
147274463|NCT04579679|531171631|FG001|Overall Study|Death|2|||
147274464|NCT04579679|531171632|FG002|Overall Study|Death|2|||
147600439|NCT00077857|532356376|FG001|Overall Study|Insufficient therapeutic response|128|||
147274465|NCT04579679|531171633|FG003|Overall Study|Death|0|||
147274466|NCT04579679|531171630|FG000|Overall Study|Adverse Event|0|||
147274467|NCT04579679|531171631|FG001|Overall Study|Adverse Event|4|||
147274468|NCT04579679|531171632|FG002|Overall Study|Adverse Event|0|||
147274469|NCT04579679|531171633|FG003|Overall Study|Adverse Event|0|||
147274470|NCT04579679|531171630|FG000|Overall Study|Disease Progression|9|||
147274471|NCT04579679|531171631|FG001|Overall Study|Disease Progression|13|||
147274472|NCT04579679|531171632|FG002|Overall Study|Disease Progression|7|||
147274473|NCT04579679|531171633|FG003|Overall Study|Disease Progression|0|||
147274474|NCT04579679|531171630|FG000|Overall Study|Physician Decision|0|||
147600440|NCT00077857|532356375|FG000|Overall Study|Violation of selection criteria at entry|3|||
147600441|NCT00077857|532356376|FG001|Overall Study|Violation of selection criteria at entry|1|||
147600442|NCT00077857|532356375|FG000|Overall Study|Other protocol violation|0|||
147600443|NCT00077857|532356376|FG001|Overall Study|Other protocol violation|1|||
147274475|NCT04579679|531171631|FG001|Overall Study|Physician Decision|0|||
147600444|NCT00077857|532356375|FG000|Overall Study|Refused treatment|29|||
147600445|NCT00077857|532356376|FG001|Overall Study|Refused treatment|21|||
147600446|NCT00077857|532356375|FG000|Overall Study|Failure to return|5|||
147600447|NCT00077857|532356376|FG001|Overall Study|Failure to return|5|||
147600448|NCT00077857|532356375|FG000|Overall Study|Other|15|||
147600449|NCT00077857|532356376|FG001|Overall Study|Other|13|||
147600450|NCT06187909|532356379|FG000|Overall Study|Withdrawal by Subject|2|||
147600451|NCT06187909|532356380|FG001|Overall Study|Withdrawal by Subject|2|||
147600452|NCT02987959|532356382|FG000|Overall Study|Grantor stopped supply of drugs|6|||
147600453|NCT03285308|532356391|FG000|Overall Study|Adverse Event|3|||
147600454|NCT03285308|532356392|FG001|Overall Study|Adverse Event|7|||
147600455|NCT03285308|532356391|FG000|Overall Study|Withdrawal by Subject|8|||
147600456|NCT03285308|532356392|FG001|Overall Study|Withdrawal by Subject|9|||
147600457|NCT03285308|532356391|FG000|Overall Study|Lost to Follow-up|3|||
147600458|NCT03285308|532356392|FG001|Overall Study|Lost to Follow-up|1|||
147600459|NCT03285308|532356391|FG000|Overall Study|Protocol Deviation|6|||
147600460|NCT03285308|532356392|FG001|Overall Study|Protocol Deviation|5|||
147600461|NCT03285308|532356391|FG000|Overall Study|Reason not Specified|0|||
147600462|NCT03285308|532356392|FG001|Overall Study|Reason not Specified|1|||
147600463|NCT02283983|532356393|FG000|Overall Study|Inclusion criteria not met|0|||
147600464|NCT02283983|532356394|FG001|Overall Study|Inclusion criteria not met|1|||
147600465|NCT02283983|532356393|FG000|Overall Study|Withdrawal by Subject|4|||
147600466|NCT02283983|532356394|FG001|Overall Study|Withdrawal by Subject|2|||
147600467|NCT02283983|532356393|FG000|Overall Study|Protocol Violation|0|||
147600468|NCT02283983|532356394|FG001|Overall Study|Protocol Violation|4|||
147600469|NCT02283983|532356393|FG000|Overall Study|Physician Decision|2|||
147600470|NCT02283983|532356394|FG001|Overall Study|Physician Decision|4|||
147600471|NCT02283983|532356393|FG000|Overall Study|Death|1|||
147600472|NCT02283983|532356394|FG001|Overall Study|Death|0|||
147600473|NCT02283983|532356393|FG000|Overall Study|Adverse Event|1|||
147600474|NCT02283983|532356394|FG001|Overall Study|Adverse Event|0|||
147600475|NCT02283983|532356393|FG000|Overall Study|Lost to Follow-up|9|||
147600476|NCT02283983|532356394|FG001|Overall Study|Lost to Follow-up|8|||
147274476|NCT04579679|531171632|FG002|Overall Study|Physician Decision|1|||
147274477|NCT04579679|531171633|FG003|Overall Study|Physician Decision|0|||
147274478|NCT04579679|531171630|FG000|Overall Study|Study Terminated by Sponsor|2|||
147274479|NCT04579679|531171631|FG001|Overall Study|Study Terminated by Sponsor|7|||
147274480|NCT04579679|531171632|FG002|Overall Study|Study Terminated by Sponsor|1|||
147274481|NCT04579679|531171633|FG003|Overall Study|Study Terminated by Sponsor|0|||
147274482|NCT01709318|531173618|FG000|Overall Study|Adverse Event|3|||
147274483|NCT01709318|531173619|FG001|Overall Study|Adverse Event|4|||
147274484|NCT01709318|531173620|FG002|Overall Study|Adverse Event|2|||
147274485|NCT01709318|531173621|FG003|Overall Study|Adverse Event|2|||
147274486|NCT01709318|531173622|FG004|Overall Study|Adverse Event|0|||
147274487|NCT01709318|531173623|FG005|Overall Study|Adverse Event|1|||
147274488|NCT01709318|531173624|FG006|Overall Study|Adverse Event|2|||
147274489|NCT01709318|531173618|FG000|Overall Study|Lost to Follow-up|2|||
147600477|NCT02283983|532356393|FG000|Overall Study|Relapse|1|||
147600478|NCT02283983|532356394|FG001|Overall Study|Relapse|0|||
147600479|NCT03283761|532356395|FG000|Study Treatment|Patient Non-Compliance|1|||
147274490|NCT01709318|531173619|FG001|Overall Study|Lost to Follow-up|0|||
147450811|NCT01761266|531813154|FG001|Overall Study|Sponsor Decision|52|||
147600480|NCT03283761|532356395|FG000|Study Treatment|Alternative Cancer Therapy|7|||
147600481|NCT03283761|532356395|FG000|Study Treatment|Disease progression|21|||
147600482|NCT03283761|532356395|FG000|Study Treatment|Adverse Event|3|||
147600483|NCT03283761|532356395|FG000|Study Treatment|Withdrawal by Subject|4|||
147600484|NCT03283761|532356395|FG000|Study Treatment|Pre-existing GI bleed and chronic anemia from that led to hospitalization and going off trial.|1|||
147600485|NCT03283761|532356395|FG000|Study Treatment|Symptomatic Deterioration|1|||
147274491|NCT01709318|531173620|FG002|Overall Study|Lost to Follow-up|0|||
147274492|NCT01709318|531173621|FG003|Overall Study|Lost to Follow-up|0|||
147274493|NCT01709318|531173622|FG004|Overall Study|Lost to Follow-up|1|||
147600486|NCT03283761|532356395|FG000|Study Treatment|Screen Failure Before Therapy Start|1|||
147274494|NCT01709318|531173623|FG005|Overall Study|Lost to Follow-up|1|||
147274495|NCT01709318|531173624|FG006|Overall Study|Lost to Follow-up|1|||
147274496|NCT01709318|531173618|FG000|Overall Study|Non-compliance with Study Drug|0|||
147274497|NCT01709318|531173619|FG001|Overall Study|Non-compliance with Study Drug|2|||
147274498|NCT01709318|531173620|FG002|Overall Study|Non-compliance with Study Drug|1|||
147274499|NCT01709318|531173621|FG003|Overall Study|Non-compliance with Study Drug|1|||
147274500|NCT01709318|531173622|FG004|Overall Study|Non-compliance with Study Drug|0|||
147274501|NCT01709318|531173623|FG005|Overall Study|Non-compliance with Study Drug|0|||
147274502|NCT01709318|531173624|FG006|Overall Study|Non-compliance with Study Drug|2|||
147274503|NCT01709318|531173618|FG000|Overall Study|Physician Decision|0|||
147274504|NCT01709318|531173619|FG001|Overall Study|Physician Decision|0|||
147274505|NCT01709318|531173620|FG002|Overall Study|Physician Decision|0|||
147274506|NCT01709318|531173621|FG003|Overall Study|Physician Decision|0|||
147274507|NCT01709318|531173622|FG004|Overall Study|Physician Decision|0|||
147274508|NCT01709318|531173623|FG005|Overall Study|Physician Decision|0|||
147274509|NCT01709318|531173624|FG006|Overall Study|Physician Decision|1|||
147274510|NCT01709318|531173618|FG000|Overall Study|Pregnancy|0|||
147274511|NCT01709318|531173619|FG001|Overall Study|Pregnancy|0|||
147274512|NCT01709318|531173620|FG002|Overall Study|Pregnancy|0|||
147274513|NCT01709318|531173621|FG003|Overall Study|Pregnancy|0|||
147274514|NCT01709318|531173622|FG004|Overall Study|Pregnancy|1|||
147274515|NCT01709318|531173623|FG005|Overall Study|Pregnancy|0|||
147274516|NCT01709318|531173624|FG006|Overall Study|Pregnancy|0|||
147274517|NCT01709318|531173618|FG000|Overall Study|Protocol Violation|0|||
147274518|NCT01709318|531173619|FG001|Overall Study|Protocol Violation|0|||
147274519|NCT01709318|531173620|FG002|Overall Study|Protocol Violation|0|||
147274520|NCT01709318|531173621|FG003|Overall Study|Protocol Violation|0|||
147274521|NCT01709318|531173622|FG004|Overall Study|Protocol Violation|2|||
147274522|NCT01709318|531173623|FG005|Overall Study|Protocol Violation|0|||
147274523|NCT01709318|531173624|FG006|Overall Study|Protocol Violation|1|||
147274524|NCT01709318|531173618|FG000|Overall Study|Technical Problems|1|||
147274525|NCT01709318|531173619|FG001|Overall Study|Technical Problems|0|||
147274526|NCT01709318|531173620|FG002|Overall Study|Technical Problems|0|||
147274527|NCT01709318|531173621|FG003|Overall Study|Technical Problems|0|||
147274528|NCT01709318|531173622|FG004|Overall Study|Technical Problems|0|||
147274529|NCT01709318|531173623|FG005|Overall Study|Technical Problems|0|||
147274530|NCT01709318|531173624|FG006|Overall Study|Technical Problems|0|||
147274531|NCT01709318|531173618|FG000|Overall Study|Withdrawal by Subject|3|||
147274532|NCT01709318|531173619|FG001|Overall Study|Withdrawal by Subject|0|||
147274533|NCT01709318|531173620|FG002|Overall Study|Withdrawal by Subject|3|||
147274534|NCT01709318|531173621|FG003|Overall Study|Withdrawal by Subject|3|||
147274535|NCT01709318|531173622|FG004|Overall Study|Withdrawal by Subject|0|||
147274536|NCT01709318|531173623|FG005|Overall Study|Withdrawal by Subject|2|||
147274537|NCT01709318|531173624|FG006|Overall Study|Withdrawal by Subject|4|||
147274538|NCT01709318|531173618|FG000|Overall Study|Other Protocol Specified Criteria|0|||
147274539|NCT01709318|531173619|FG001|Overall Study|Other Protocol Specified Criteria|1|||
147274540|NCT01709318|531173620|FG002|Overall Study|Other Protocol Specified Criteria|0|||
147274541|NCT01709318|531173621|FG003|Overall Study|Other Protocol Specified Criteria|0|||
147274542|NCT01709318|531173622|FG004|Overall Study|Other Protocol Specified Criteria|0|||
147274543|NCT01709318|531173623|FG005|Overall Study|Other Protocol Specified Criteria|0|||
147274544|NCT01709318|531173624|FG006|Overall Study|Other Protocol Specified Criteria|0|||
147274545|NCT03370341|531173625|FG000|Overall Study|Lost to Follow-up|0|||
147274546|NCT03370341|531173626|FG001|Overall Study|Lost to Follow-up|1|||
147274547|NCT02383758|531173627|FG000|Overall Study|Withdrawal by Subject|0|||
147274548|NCT02383758|531173628|FG001|Overall Study|Withdrawal by Subject|2|||
147274549|NCT00646958|531173631|FG000|Overall Study|Lack of Efficacy|1|||
147274550|NCT00646958|531173632|FG001|Overall Study|Lack of Efficacy|0|||
147274551|NCT00646958|531173633|FG002|Overall Study|Lack of Efficacy|0|||
147274552|NCT00646958|531173631|FG000|Overall Study|Adverse Event|4|||
147274553|NCT00646958|531173632|FG001|Overall Study|Adverse Event|0|||
147274554|NCT00646958|531173633|FG002|Overall Study|Adverse Event|0|||
147274555|NCT00646958|531173631|FG000|Overall Study|Lost to Follow-up|1|||
147274556|NCT00646958|531173632|FG001|Overall Study|Lost to Follow-up|5|||
147274557|NCT00646958|531173633|FG002|Overall Study|Lost to Follow-up|7|||
147274558|NCT00646958|531173631|FG000|Overall Study|Protocol Violation|1|||
147274559|NCT00646958|531173632|FG001|Overall Study|Protocol Violation|1|||
147274560|NCT00646958|531173633|FG002|Overall Study|Protocol Violation|0|||
147274561|NCT00646958|531173631|FG000|Overall Study|Abnormal screening lab tests|1|||
147274562|NCT00646958|531173632|FG001|Overall Study|Abnormal screening lab tests|1|||
147274563|NCT00646958|531173633|FG002|Overall Study|Abnormal screening lab tests|0|||
147274564|NCT00646958|531173631|FG000|Overall Study|Withdrawal by Subject|1|||
147274565|NCT00646958|531173632|FG001|Overall Study|Withdrawal by Subject|2|||
147274566|NCT00646958|531173633|FG002|Overall Study|Withdrawal by Subject|0|||
147274567|NCT00646958|531173631|FG000|Overall Study|Did not receive study drug|2|||
147274568|NCT00646958|531173632|FG001|Overall Study|Did not receive study drug|0|||
147274569|NCT00646958|531173633|FG002|Overall Study|Did not receive study drug|2|||
147274570|NCT00600821|531173635|FG000|Overall Study|Death|45|||
147274571|NCT00600821|531173636|FG001|Overall Study|Death|46|||
147274572|NCT00600821|531173635|FG000|Overall Study|Lost to Follow-up|2|||
147274573|NCT00600821|531173636|FG001|Overall Study|Lost to Follow-up|2|||
147274574|NCT00600821|531173635|FG000|Overall Study|Withdrawal by Subject|1|||
147274575|NCT00600821|531173636|FG001|Overall Study|Withdrawal by Subject|1|||
147274576|NCT00600821|531173635|FG000|Overall Study|Terminated by sponsor|8|||
147274577|NCT00600821|531173636|FG001|Overall Study|Terminated by sponsor|6|||
147274578|NCT00600821|531173635|FG000|Overall Study|Objective progression or relapse|0|||
147274579|NCT00600821|531173636|FG001|Overall Study|Objective progression or relapse|1|||
147274580|NCT00600821|531173635|FG000|Overall Study|Randomized but not treated|0|||
147274581|NCT00600821|531173636|FG001|Overall Study|Randomized but not treated|1|||
147274582|NCT00600821|531173635|FG000|Overall Study|Other|2|||
147274583|NCT00600821|531173636|FG001|Overall Study|Other|3|||
147274584|NCT01607905|531173637|FG000|Overall Study|Withdrawal by participant|7|||
147274585|NCT01607905|531173638|FG001|Overall Study|Withdrawal by participant|2|||
147274586|NCT01607905|531173639|FG002|Overall Study|Withdrawal by participant|4|||
147274587|NCT01607905|531173640|FG003|Overall Study|Withdrawal by participant|6|||
147274588|NCT01607905|531173641|FG004|Overall Study|Withdrawal by participant|0|||
147274589|NCT01607905|531173642|FG005|Overall Study|Withdrawal by participant|4|||
147274590|NCT01607905|531173643|FG006|Overall Study|Withdrawal by participant|12|||
147274591|NCT01607905|531173637|FG000|Overall Study|Incidence or severity of AEs|5|||
147274592|NCT01607905|531173638|FG001|Overall Study|Incidence or severity of AEs|1|||
147274593|NCT01607905|531173639|FG002|Overall Study|Incidence or severity of AEs|1|||
147274594|NCT01607905|531173640|FG003|Overall Study|Incidence or severity of AEs|3|||
147274595|NCT01607905|531173641|FG004|Overall Study|Incidence or severity of AEs|0|||
147274596|NCT01607905|531173642|FG005|Overall Study|Incidence or severity of AEs|2|||
147274597|NCT01607905|531173643|FG006|Overall Study|Incidence or severity of AEs|8|||
147274598|NCT01607905|531173637|FG000|Overall Study|Disease progression|44|||
147274599|NCT01607905|531173638|FG001|Overall Study|Disease progression|16|||
147274600|NCT01607905|531173639|FG002|Overall Study|Disease progression|15|||
147274601|NCT01607905|531173640|FG003|Overall Study|Disease progression|11|||
147274602|NCT01607905|531173641|FG004|Overall Study|Disease progression|6|||
147274603|NCT01607905|531173642|FG005|Overall Study|Disease progression|7|||
147274604|NCT01607905|531173643|FG006|Overall Study|Disease progression|21|||
147274605|NCT01607905|531173637|FG000|Overall Study|Non-compliance with study procedures|0|||
147274606|NCT01607905|531173638|FG001|Overall Study|Non-compliance with study procedures|0|||
147274607|NCT01607905|531173639|FG002|Overall Study|Non-compliance with study procedures|0|||
147274608|NCT01607905|531173640|FG003|Overall Study|Non-compliance with study procedures|0|||
147274609|NCT01607905|531173641|FG004|Overall Study|Non-compliance with study procedures|0|||
147274610|NCT01607905|531173642|FG005|Overall Study|Non-compliance with study procedures|0|||
147274611|NCT01607905|531173643|FG006|Overall Study|Non-compliance with study procedures|1|||
147274612|NCT01607905|531173637|FG000|Overall Study|Death|1|||
147274613|NCT01607905|531173638|FG001|Overall Study|Death|1|||
147274614|NCT01607905|531173639|FG002|Overall Study|Death|1|||
147274615|NCT01607905|531173640|FG003|Overall Study|Death|1|||
147274616|NCT01607905|531173641|FG004|Overall Study|Death|0|||
147274617|NCT01607905|531173642|FG005|Overall Study|Death|0|||
147274618|NCT01607905|531173643|FG006|Overall Study|Death|3|||
147274619|NCT01607905|531173637|FG000|Overall Study|Other treatments become available|1|||
147274620|NCT01607905|531173638|FG001|Overall Study|Other treatments become available|0|||
147274621|NCT01607905|531173639|FG002|Overall Study|Other treatments become available|0|||
147333817|NCT05328297|531389962|FG001|Overall Study|Lost to Follow-up|0|||
147333818|NCT05328297|531389961|FG000|Overall Study|Protocol Violation|1|||
147600487|NCT03283761|532356395|FG000|Follow up|Lost to Follow-up|1|||
147600488|NCT03283761|532356395|FG000|Follow up|Symptomatic Deterioration|1|||
147600489|NCT03283761|532356395|FG000|Follow up|Death|29|||
147274622|NCT01607905|531173640|FG003|Overall Study|Other treatments become available|0|||
147274623|NCT01607905|531173641|FG004|Overall Study|Other treatments become available|0|||
147274624|NCT01607905|531173642|FG005|Overall Study|Other treatments become available|0|||
147274625|NCT01607905|531173643|FG006|Overall Study|Other treatments become available|1|||
147274626|NCT01607905|531173637|FG000|Overall Study|Investigator discretion|0|||
147274627|NCT01607905|531173638|FG001|Overall Study|Investigator discretion|0|||
147274628|NCT01607905|531173639|FG002|Overall Study|Investigator discretion|0|||
147274629|NCT01607905|531173640|FG003|Overall Study|Investigator discretion|0|||
147274630|NCT01607905|531173641|FG004|Overall Study|Investigator discretion|0|||
147274631|NCT01607905|531173642|FG005|Overall Study|Investigator discretion|1|||
147274632|NCT01607905|531173643|FG006|Overall Study|Investigator discretion|0|||
147274633|NCT01607905|531173637|FG000|Overall Study|Other|1|||
147274634|NCT01607905|531173638|FG001|Overall Study|Other|0|||
147274635|NCT01607905|531173639|FG002|Overall Study|Other|0|||
147274636|NCT01607905|531173640|FG003|Overall Study|Other|0|||
147274637|NCT01607905|531173641|FG004|Overall Study|Other|0|||
147274638|NCT01607905|531173642|FG005|Overall Study|Other|0|||
147274639|NCT01607905|531173643|FG006|Overall Study|Other|1|||
147274640|NCT01607905|531173637|FG000|Overall Study|Randomized but not treated|1|||
147274641|NCT01607905|531173638|FG001|Overall Study|Randomized but not treated|0|||
147274642|NCT01607905|531173639|FG002|Overall Study|Randomized but not treated|0|||
147600490|NCT03283761|532356395|FG000|Follow up|study terminated|4|||
147274643|NCT01607905|531173640|FG003|Overall Study|Randomized but not treated|0|||
147274644|NCT01607905|531173641|FG004|Overall Study|Randomized but not treated|1|||
147274645|NCT01607905|531173642|FG005|Overall Study|Randomized but not treated|1|||
147274646|NCT01607905|531173643|FG006|Overall Study|Randomized but not treated|0|||
147274647|NCT02602288|531173644|FG000|End of Treatment/3 Month Follow-up|Lost to Follow-up|14|||
147274648|NCT02602288|531173645|FG001|End of Treatment/3 Month Follow-up|Lost to Follow-up|10|||
147274649|NCT02602288|531173644|FG000|End of Treatment/3 Month Follow-up|Withdrawal by Subject|2|||
147274650|NCT02602288|531173645|FG001|End of Treatment/3 Month Follow-up|Withdrawal by Subject|2|||
147274651|NCT02602288|531173644|FG000|End of Treatment/3 Month Follow-up|Withdrawn - refused treatment|9|||
147274652|NCT02602288|531173645|FG001|End of Treatment/3 Month Follow-up|Withdrawn - refused treatment|6|||
147274653|NCT02602288|531173644|FG000|12 Month Follow-up|Lost to Follow-up|0|||
147274654|NCT02602288|531173645|FG001|12 Month Follow-up|Lost to Follow-up|4|||
147274655|NCT02602288|531173644|FG000|12 Month Follow-up|Withdrawal by Subject|2|||
147274656|NCT02602288|531173645|FG001|12 Month Follow-up|Withdrawal by Subject|0|||
147274657|NCT00194012|531173646|FG000|Randomized Phase|Lack of Efficacy|8|||
147274658|NCT00194012|531173647|FG001|Randomized Phase|Lack of Efficacy|18|||
147274659|NCT00194012|531173646|FG000|Randomized Phase|Study nonadherence|2|||
147274660|NCT00194012|531173647|FG001|Randomized Phase|Study nonadherence|1|||
147274661|NCT00194012|531173646|FG000|Randomized Phase|Withdrawal by Subject|3|||
147274662|NCT00194012|531173647|FG001|Randomized Phase|Withdrawal by Subject|3|||
147274663|NCT00194012|531173646|FG000|Randomized Phase|Adverse Event|2|||
147274664|NCT00194012|531173647|FG001|Randomized Phase|Adverse Event|1|||
147274665|NCT00194012|531173646|FG000|Randomized Phase|Participant reported having a rash|1|||
147274666|NCT00194012|531173647|FG001|Randomized Phase|Participant reported having a rash|0|||
147274667|NCT00194012|531173646|FG000|Randomized Phase|Emesis and enuresis|0|||
147274668|NCT00194012|531173647|FG001|Randomized Phase|Emesis and enuresis|1|||
147274669|NCT00194012|531173646|FG000|Randomized Phase|Oral/nasal twitching|0|||
147274670|NCT00194012|531173647|FG001|Randomized Phase|Oral/nasal twitching|1|||
147274671|NCT00194012|531173646|FG000|Open Label Extension (OLE)|Weight Gain|1|||
147274672|NCT00194012|531173647|FG001|Open Label Extension (OLE)|Weight Gain|0|||
147274673|NCT00194012|531173646|FG000|Open Label Extension (OLE)|Drowsiness; Jittery|0|||
147274674|NCT00194012|531173647|FG001|Open Label Extension (OLE)|Drowsiness; Jittery|1|||
147274675|NCT00194012|531173646|FG000|Open Label Extension (OLE)|Lost to Follow-up|3|||
147274676|NCT00194012|531173647|FG001|Open Label Extension (OLE)|Lost to Follow-up|5|||
147274677|NCT00194012|531173646|FG000|Open Label Extension (OLE)|Lack of Efficacy|1|||
147274678|NCT00194012|531173647|FG001|Open Label Extension (OLE)|Lack of Efficacy|0|||
147274679|NCT02066298|531173653|FG000|Overall Study|Lost to Follow-up|3|||
147274680|NCT02066298|531173654|FG001|Overall Study|Lost to Follow-up|2|||
147274681|NCT02066298|531173655|FG002|Overall Study|Lost to Follow-up|3|||
147274682|NCT02066298|531173656|FG003|Overall Study|Lost to Follow-up|2|||
147274683|NCT02066298|531173657|FG004|Overall Study|Lost to Follow-up|3|||
147274684|NCT02066298|531173658|FG005|Overall Study|Lost to Follow-up|4|||
147274685|NCT02066298|531173653|FG000|Overall Study|Withdrawal by Subject|6|||
147274686|NCT02066298|531173654|FG001|Overall Study|Withdrawal by Subject|6|||
147274687|NCT02066298|531173655|FG002|Overall Study|Withdrawal by Subject|6|||
147274688|NCT02066298|531173656|FG003|Overall Study|Withdrawal by Subject|4|||
147274689|NCT02066298|531173657|FG004|Overall Study|Withdrawal by Subject|5|||
147274690|NCT02066298|531173658|FG005|Overall Study|Withdrawal by Subject|8|||
147274691|NCT02066298|531173653|FG000|Overall Study|Physician Decision|0|||
147274692|NCT02066298|531173654|FG001|Overall Study|Physician Decision|0|||
147274693|NCT02066298|531173655|FG002|Overall Study|Physician Decision|1|||
147274694|NCT02066298|531173656|FG003|Overall Study|Physician Decision|0|||
147274695|NCT02066298|531173657|FG004|Overall Study|Physician Decision|1|||
147274696|NCT02066298|531173658|FG005|Overall Study|Physician Decision|0|||
147274697|NCT00630877|531173661|FG000|Overall Study|Adverse Event|11|||
147274698|NCT00630877|531173662|FG001|Overall Study|Adverse Event|8|||
147274699|NCT00630877|531173663|FG002|Overall Study|Adverse Event|7|||
147600491|NCT03283761|532356395|FG000|Follow up|Primary Investigator Withdrawal|1|||
147600492|NCT03283761|532356395|FG000|Follow up|Switched to alternative therapy|1|||
147274700|NCT00630877|531173661|FG000|Overall Study|Withdrawal by Subject|3|||
147274701|NCT00630877|531173662|FG001|Overall Study|Withdrawal by Subject|4|||
147274702|NCT00630877|531173663|FG002|Overall Study|Withdrawal by Subject|0|||
147274703|NCT00630877|531173661|FG000|Overall Study|Lost to Follow-up|2|||
147274704|NCT00630877|531173662|FG001|Overall Study|Lost to Follow-up|0|||
147274705|NCT00630877|531173663|FG002|Overall Study|Lost to Follow-up|0|||
147274706|NCT00630877|531173661|FG000|Overall Study|Noncompliance|2|||
147274707|NCT00630877|531173662|FG001|Overall Study|Noncompliance|3|||
147274708|NCT00630877|531173663|FG002|Overall Study|Noncompliance|1|||
147274709|NCT00630877|531173661|FG000|Overall Study|Protocol violation|1|||
147274710|NCT00630877|531173662|FG001|Overall Study|Protocol violation|0|||
147274711|NCT00630877|531173663|FG002|Overall Study|Protocol violation|1|||
147274712|NCT00630877|531173661|FG000|Overall Study|Personal reasons|0|||
147274713|NCT00630877|531173662|FG001|Overall Study|Personal reasons|0|||
147274714|NCT00630877|531173663|FG002|Overall Study|Personal reasons|1|||
147274715|NCT01639001|531173670|FG000|Overall Study|Refused further follow-up|9|||
147274716|NCT01639001|531173671|FG001|Overall Study|Refused further follow-up|12|||
147274717|NCT01639001|531173670|FG000|Overall Study|Lost to Follow-up|3|||
147274718|NCT01639001|531173671|FG001|Overall Study|Lost to Follow-up|0|||
147274719|NCT01639001|531173670|FG000|Overall Study|Death|62|||
147274720|NCT01639001|531173671|FG001|Overall Study|Death|61|||
147274721|NCT01639001|531173670|FG000|Overall Study|Randomized but not treated|0|||
147274722|NCT01639001|531173671|FG001|Overall Study|Randomized but not treated|2|||
147274723|NCT01639001|531173670|FG000|Overall Study|Long-term follow-up participants who did not respond to the contact from their study sites.|1|||
147274724|NCT01639001|531173671|FG001|Overall Study|Long-term follow-up participants who did not respond to the contact from their study sites.|2|||
147274725|NCT02649972|531173672|FG000|Overall Study|Not treated|1|||
147274726|NCT00424372|531173673|FG000|Overall Study|Death|1|||
147274727|NCT00424372|531173673|FG000|Overall Study|Adverse Event|18|||
147274728|NCT00424372|531173673|FG000|Overall Study|Lack of Efficacy|6|||
147274729|NCT00424372|531173673|FG000|Overall Study|Withdrawal by Subject|4|||
147274730|NCT00424372|531173673|FG000|Overall Study|Protocol Violation|1|||
147274731|NCT00424372|531173673|FG000|Overall Study|Health deterioration|1|||
147274732|NCT00912405|531173676|FG000|Overall Study|Lost to Follow-up|5|||
147274733|NCT00098839|531173677|FG000|Overall Study|Adverse Event|5|||
147274734|NCT00098839|531173678|FG001|Overall Study|Adverse Event|2|||
147274735|NCT00098839|531173677|FG000|Overall Study|Death|1|||
147274736|NCT00098839|531173678|FG001|Overall Study|Death|2|||
147274737|NCT00098839|531173677|FG000|Overall Study|Physician Decision|4|||
147274738|NCT00098839|531173678|FG001|Overall Study|Physician Decision|14|||
147274739|NCT00098839|531173677|FG000|Overall Study|Withdrawal by Subject|1|||
147274740|NCT00098839|531173678|FG001|Overall Study|Withdrawal by Subject|0|||
147274741|NCT00098839|531173677|FG000|Overall Study|Refusal of further protocol therapy|3|||
147450812|NCT00112905|531813155|FG000|Overall Study|Adverse Event|4|||
147450813|NCT00112905|531813155|FG000|Overall Study|Death|1|||
147450814|NCT00112905|531813155|FG000|Overall Study|Ineligibility|5|||
147450815|NCT00112905|531813155|FG000|Overall Study|Alternative treatment|1|||
147450816|NCT00112905|531813155|FG000|Overall Study|performance status was deteiorating|1|||
147450817|NCT01042600|531813156|FG000|Overall Study|Ineligible|1|||
147450818|NCT01042600|531813157|FG001|Overall Study|Ineligible|0|||
147450819|NCT02600507|531813158|FG000|Overall Study|Adverse Event|3|||
147450820|NCT02600507|531813159|FG001|Overall Study|Adverse Event|15|||
147450821|NCT02600507|531813160|FG002|Overall Study|Adverse Event|5|||
147450822|NCT02600507|531813158|FG000|Overall Study|Lack of Efficacy|3|||
147450823|NCT02600507|531813159|FG001|Overall Study|Lack of Efficacy|8|||
147450824|NCT02600507|531813160|FG002|Overall Study|Lack of Efficacy|5|||
147450825|NCT02600507|531813158|FG000|Overall Study|Lost to Follow-up|3|||
147450826|NCT02600507|531813159|FG001|Overall Study|Lost to Follow-up|5|||
147450827|NCT02600507|531813160|FG002|Overall Study|Lost to Follow-up|2|||
147450828|NCT02600507|531813158|FG000|Overall Study|Protocol Violation|12|||
147450829|NCT02600507|531813159|FG001|Overall Study|Protocol Violation|4|||
147450830|NCT02600507|531813160|FG002|Overall Study|Protocol Violation|4|||
147450831|NCT02600507|531813158|FG000|Overall Study|Physician Decision|1|||
147450832|NCT02600507|531813159|FG001|Overall Study|Physician Decision|0|||
147600493|NCT03283761|532356395|FG000|Follow up|Subject is now in Hospice|1|||
147600494|NCT04453202|532356401|FG000|Overall Study|Adverse Event|0|||
147600495|NCT04453202|532356402|FG001|Overall Study|Adverse Event|0|||
147274742|NCT00098839|531173678|FG001|Overall Study|Refusal of further protocol therapy|1|||
147274743|NCT00098839|531173677|FG000|Overall Study|Relapse|6|||
147274744|NCT00098839|531173678|FG001|Overall Study|Relapse|3|||
147274745|NCT00098839|531173677|FG000|Overall Study|M2/M3 marrow on Day 15 of Block 2|10|||
147274746|NCT00098839|531173678|FG001|Overall Study|M2/M3 marrow on Day 15 of Block 2|11|||
147274747|NCT00098839|531173677|FG000|Overall Study|Ineligible|2|||
147274748|NCT00098839|531173678|FG001|Overall Study|Ineligible|0|||
147274749|NCT02148003|531173680|FG000|Overall Study|Failed inclusion criteria|1|||
147274750|NCT02148003|531173681|FG001|Overall Study|Failed inclusion criteria|0|||
147274751|NCT02148003|531173680|FG000|Overall Study|Met exclusion criteria|0|||
147274752|NCT02148003|531173681|FG001|Overall Study|Met exclusion criteria|1|||
147274753|NCT02148003|531173680|FG000|Overall Study|Withdrawal by Subject|0|||
147274754|NCT02148003|531173681|FG001|Overall Study|Withdrawal by Subject|1|||
147450833|NCT02600507|531813160|FG002|Overall Study|Physician Decision|1|||
147450834|NCT02600507|531813158|FG000|Overall Study|Withdrawal by Subject|7|||
147450835|NCT02600507|531813159|FG001|Overall Study|Withdrawal by Subject|11|||
147450836|NCT02600507|531813160|FG002|Overall Study|Withdrawal by Subject|7|||
147450837|NCT02600507|531813158|FG000|Overall Study|Other|0|||
147450838|NCT02600507|531813159|FG001|Overall Study|Other|1|||
147450839|NCT02600507|531813160|FG002|Overall Study|Other|1|||
147450840|NCT04541004|531813165|FG000|Overall Study|Adverse Event|2|||
147450841|NCT00605085|531813166|FG000|Overall Study|Withdrawal by Subject|8|||
147450842|NCT00605085|531813167|FG001|Overall Study|Withdrawal by Subject|5|||
147450843|NCT00605085|531813166|FG000|Overall Study|Adverse Event|9|||
147450844|NCT00605085|531813167|FG001|Overall Study|Adverse Event|5|||
147450845|NCT00605085|531813166|FG000|Overall Study|Pregnancy|2|||
147600496|NCT04453202|532356403|FG002|Overall Study|Adverse Event|0|||
147274755|NCT03348904|531173684|FG000|Overall Study|Administrative reason by the sponsor|0|||
147600497|NCT04453202|532356404|FG003|Overall Study|Adverse Event|0|||
147600498|NCT04453202|532356405|FG004|Overall Study|Adverse Event|0|||
147600499|NCT04453202|532356406|FG005|Overall Study|Adverse Event|0|||
147600500|NCT04453202|532356407|FG006|Overall Study|Adverse Event|1|||
147600501|NCT04453202|532356408|FG007|Overall Study|Adverse Event|0|||
147600502|NCT04453202|532356409|FG008|Overall Study|Adverse Event|0|||
147600503|NCT04453202|532356410|FG009|Overall Study|Adverse Event|0|||
147600504|NCT04453202|532356411|FG010|Overall Study|Adverse Event|0|||
147600505|NCT04453202|532356401|FG000|Overall Study|Death|0|||
147600506|NCT04453202|532356402|FG001|Overall Study|Death|0|||
147600507|NCT04453202|532356403|FG002|Overall Study|Death|0|||
147600508|NCT04453202|532356404|FG003|Overall Study|Death|0|||
147600509|NCT04453202|532356405|FG004|Overall Study|Death|0|||
147274756|NCT03348904|531173685|FG001|Overall Study|Administrative reason by the sponsor|1|||
147274757|NCT03348904|531173686|FG002|Overall Study|Administrative reason by the sponsor|0|||
147274758|NCT00436280|531173687|FG000|Period 1: Induction|Adverse Event|8|||
147274759|NCT00436280|531173687|FG000|Period 1: Induction|Progressive Disease|12|||
147274760|NCT00436280|531173687|FG000|Period 1: Induction|Stable Disease|6|||
147274761|NCT00436280|531173687|FG000|Period 1: Induction|Withdrawal by Subject|1|||
147274762|NCT00436280|531173687|FG000|Period 1: Induction|Death|1|||
147274763|NCT00436280|531173687|FG000|Period 2: Consolidation|Adverse Event|1|||
147274764|NCT00436280|531173687|FG000|Period 2: Consolidation|Progressive Disease|10|||
147274765|NCT00436280|531173687|FG000|Period 2: Consolidation|Stable Disease|1|||
147274766|NCT00436280|531173687|FG000|Period 2: Consolidation|Physician Decision|2|||
147274767|NCT00436280|531173687|FG000|Period 2: Consolidation|Withdrawal by Subject|2|||
147274768|NCT00436280|531173687|FG000|Period 2: Consolidation|Death|1|||
147274769|NCT00436280|531173687|FG000|Period 3: Maintenance|Adverse Event|6|||
147274770|NCT00436280|531173687|FG000|Period 3: Maintenance|Progressive Disease|12|||
147274771|NCT00087568|531173689|FG000|Overall Study|Adverse Event|4|||
147274772|NCT00087568|531173690|FG001|Overall Study|Adverse Event|0|||
147274773|NCT00087568|531173689|FG000|Overall Study|Withdrawal by Subject|1|||
147274774|NCT00087568|531173690|FG001|Overall Study|Withdrawal by Subject|1|||
147274775|NCT00087568|531173689|FG000|Overall Study|Lost to Follow-up|1|||
147274776|NCT00087568|531173690|FG001|Overall Study|Lost to Follow-up|0|||
147274777|NCT00087568|531173689|FG000|Overall Study|Lack of Efficacy|24|||
147274778|NCT00087568|531173690|FG001|Overall Study|Lack of Efficacy|1|||
147274779|NCT01034397|531173691|FG000|Overall Study|Lack of compliance|0|||
147274780|NCT01034397|531173692|FG001|Overall Study|Lack of compliance|1|||
147274781|NCT01034397|531173691|FG000|Overall Study|Lack of Efficacy|3|||
147274782|NCT01034397|531173692|FG001|Overall Study|Lack of Efficacy|0|||
147274783|NCT01034397|531173691|FG000|Overall Study|Adverse Event|4|||
147274784|NCT01034397|531173692|FG001|Overall Study|Adverse Event|0|||
147274785|NCT01034397|531173691|FG000|Overall Study|Other|0|||
147274786|NCT01034397|531173692|FG001|Overall Study|Other|1|||
147274787|NCT00812929|531173695|FG000|Washout Period 1 (7 Days)|Physician Decision|0|||
147274788|NCT00812929|531173696|FG001|Washout Period 1 (7 Days)|Physician Decision|0|||
147274789|NCT00812929|531173697|FG002|Washout Period 1 (7 Days)|Physician Decision|1|||
147274790|NCT00812929|531173698|FG003|Washout Period 1 (7 Days)|Physician Decision|0|||
147333819|NCT05328297|531389962|FG001|Overall Study|Protocol Violation|0|||
147333820|NCT05328297|531389961|FG000|Overall Study|Randomized but not treated|1|||
147600510|NCT04453202|532356406|FG005|Overall Study|Death|0|||
147600511|NCT04453202|532356407|FG006|Overall Study|Death|0|||
147600512|NCT04453202|532356408|FG007|Overall Study|Death|0|||
147600513|NCT04453202|532356409|FG008|Overall Study|Death|0|||
147600514|NCT04453202|532356410|FG009|Overall Study|Death|1|||
147600515|NCT04453202|532356411|FG010|Overall Study|Death|0|||
147600516|NCT04453202|532356401|FG000|Overall Study|Lost to Follow-up|0|||
147600517|NCT04453202|532356402|FG001|Overall Study|Lost to Follow-up|1|||
147600518|NCT04453202|532356403|FG002|Overall Study|Lost to Follow-up|0|||
147600519|NCT04453202|532356404|FG003|Overall Study|Lost to Follow-up|1|||
147274791|NCT00812929|531173699|FG004|Washout Period 1 (7 Days)|Physician Decision|0|||
147274792|NCT00812929|531173700|FG005|Washout Period 1 (7 Days)|Physician Decision|0|||
147274793|NCT00812929|531173701|FG006|Washout Period 1 (7 Days)|Physician Decision|0|||
147274794|NCT00812929|531173702|FG007|Washout Period 1 (7 Days)|Physician Decision|0|||
147274795|NCT00812929|531173703|FG008|Washout Period 1 (7 Days)|Physician Decision|0|||
147274796|NCT00812929|531173704|FG009|Washout Period 1 (7 Days)|Physician Decision|0|||
147274797|NCT00812929|531173695|FG000|Washout Period 2 (7 Days)|Physician Decision|0|||
147274798|NCT00812929|531173696|FG001|Washout Period 2 (7 Days)|Physician Decision|0|||
147274799|NCT00812929|531173697|FG002|Washout Period 2 (7 Days)|Physician Decision|0|||
147274800|NCT00812929|531173698|FG003|Washout Period 2 (7 Days)|Physician Decision|0|||
147274801|NCT00812929|531173699|FG004|Washout Period 2 (7 Days)|Physician Decision|0|||
147274802|NCT00812929|531173700|FG005|Washout Period 2 (7 Days)|Physician Decision|0|||
147274803|NCT00812929|531173701|FG006|Washout Period 2 (7 Days)|Physician Decision|0|||
147600520|NCT04453202|532356405|FG004|Overall Study|Lost to Follow-up|0|||
147600521|NCT04453202|532356406|FG005|Overall Study|Lost to Follow-up|0|||
147600522|NCT04453202|532356407|FG006|Overall Study|Lost to Follow-up|0|||
147600523|NCT04453202|532356408|FG007|Overall Study|Lost to Follow-up|0|||
147600524|NCT04453202|532356409|FG008|Overall Study|Lost to Follow-up|0|||
147274804|NCT00812929|531173702|FG007|Washout Period 2 (7 Days)|Physician Decision|0|||
147274805|NCT00812929|531173703|FG008|Washout Period 2 (7 Days)|Physician Decision|0|||
147274806|NCT00812929|531173704|FG009|Washout Period 2 (7 Days)|Physician Decision|1|||
147333821|NCT05328297|531389962|FG001|Overall Study|Randomized but not treated|1|||
147333822|NCT04513522|531389963|FG000|Overall Study|Other reasons|1|||
147333823|NCT04513522|531389963|FG000|Overall Study|Adverse event unrelated to study drug|9|||
147333824|NCT04513522|531389963|FG000|Overall Study|Study drug toxicity|14|||
147333825|NCT04513522|531389963|FG000|Overall Study|Disease progression|39|||
147333826|NCT04513522|531389963|FG000|Overall Study|Participants withdrew consent|2|||
147333827|NCT05219253|531389975|FG000|Overall Study|Withdrawal by Subject|1|||
147333828|NCT05219253|531389976|FG001|Overall Study|Withdrawal by Subject|2|||
147333829|NCT03086369|531389977|FG000|Overall Study|Lost to Follow-up|1|||
147333830|NCT03086369|531389978|FG001|Overall Study|Lost to Follow-up|0|||
147333831|NCT03086369|531389979|FG002|Overall Study|Lost to Follow-up|0|||
147333832|NCT03086369|531389980|FG003|Overall Study|Lost to Follow-up|2|||
147333833|NCT03086369|531389981|FG004|Overall Study|Lost to Follow-up|1|||
147333834|NCT03086369|531389977|FG000|Overall Study|Physician Decision|0|||
147333835|NCT03086369|531389978|FG001|Overall Study|Physician Decision|0|||
147333836|NCT03086369|531389979|FG002|Overall Study|Physician Decision|0|||
147333837|NCT03086369|531389980|FG003|Overall Study|Physician Decision|1|||
147333838|NCT03086369|531389981|FG004|Overall Study|Physician Decision|2|||
147333839|NCT03086369|531389977|FG000|Overall Study|Withdrawal by Subject|0|||
147333840|NCT03086369|531389978|FG001|Overall Study|Withdrawal by Subject|0|||
147333841|NCT03086369|531389979|FG002|Overall Study|Withdrawal by Subject|0|||
147333842|NCT03086369|531389980|FG003|Overall Study|Withdrawal by Subject|5|||
147333843|NCT03086369|531389981|FG004|Overall Study|Withdrawal by Subject|3|||
147333844|NCT03086369|531389977|FG000|Overall Study|Progressive Disease|0|||
147333845|NCT03086369|531389978|FG001|Overall Study|Progressive Disease|0|||
147333846|NCT03086369|531389979|FG002|Overall Study|Progressive Disease|0|||
147333847|NCT03086369|531389980|FG003|Overall Study|Progressive Disease|1|||
147333848|NCT03086369|531389981|FG004|Overall Study|Progressive Disease|1|||
147333849|NCT04668339|531389982|FG000|Overall Study|Physician Decision|1|||
147333850|NCT04668339|531389983|FG001|Overall Study|Physician Decision|0|||
147333851|NCT04668339|531389984|FG002|Overall Study|Physician Decision|1|||
147333852|NCT04668339|531389985|FG003|Overall Study|Physician Decision|1|||
147333853|NCT04668339|531389982|FG000|Overall Study|Lost to Follow-up|14|||
147333854|NCT04668339|531389983|FG001|Overall Study|Lost to Follow-up|12|||
147333855|NCT04668339|531389984|FG002|Overall Study|Lost to Follow-up|8|||
147333856|NCT04668339|531389985|FG003|Overall Study|Lost to Follow-up|5|||
147333857|NCT04668339|531389982|FG000|Overall Study|Adverse Event|0|||
147333858|NCT04668339|531389983|FG001|Overall Study|Adverse Event|0|||
147333859|NCT04668339|531389984|FG002|Overall Study|Adverse Event|1|||
147333860|NCT04668339|531389985|FG003|Overall Study|Adverse Event|0|||
147450846|NCT00605085|531813167|FG001|Overall Study|Pregnancy|0|||
147450847|NCT00605085|531813166|FG000|Overall Study|Protocol Violation|3|||
147450848|NCT00605085|531813167|FG001|Overall Study|Protocol Violation|2|||
147450849|NCT00605085|531813166|FG000|Overall Study|Lost to Follow-up|10|||
147450850|NCT00605085|531813167|FG001|Overall Study|Lost to Follow-up|5|||
147450851|NCT00605085|531813166|FG000|Overall Study|administrative reasons|18|||
147450852|NCT00605085|531813167|FG001|Overall Study|administrative reasons|8|||
147274807|NCT00812929|531173695|FG000|Washout Period 3 (7 Days)|Adverse Event|0|||
147274808|NCT00812929|531173696|FG001|Washout Period 3 (7 Days)|Adverse Event|0|||
147274809|NCT00812929|531173697|FG002|Washout Period 3 (7 Days)|Adverse Event|0|||
147274810|NCT00812929|531173698|FG003|Washout Period 3 (7 Days)|Adverse Event|0|||
147274811|NCT00812929|531173699|FG004|Washout Period 3 (7 Days)|Adverse Event|0|||
147274812|NCT00812929|531173700|FG005|Washout Period 3 (7 Days)|Adverse Event|1|||
147274813|NCT00812929|531173701|FG006|Washout Period 3 (7 Days)|Adverse Event|0|||
147274814|NCT00812929|531173702|FG007|Washout Period 3 (7 Days)|Adverse Event|0|||
147274815|NCT00812929|531173703|FG008|Washout Period 3 (7 Days)|Adverse Event|0|||
147274816|NCT00812929|531173704|FG009|Washout Period 3 (7 Days)|Adverse Event|0|||
147274817|NCT04027686|531173707|FG000|Overall Study|Lost to Follow-up|2|||
147274818|NCT04027686|531173708|FG001|Overall Study|Lost to Follow-up|0|||
147274819|NCT04027686|531173707|FG000|Overall Study|Withdrawal by Subject|0|||
147333861|NCT04668339|531389982|FG000|Overall Study|Other than specified|3|||
147333862|NCT04668339|531389983|FG001|Overall Study|Other than specified|0|||
147450853|NCT00621504|531813168|FG000|Overall Study|Adverse Event|1|||
147450854|NCT00621504|531813169|FG001|Overall Study|Adverse Event|3|||
147450855|NCT00621504|531813168|FG000|Overall Study|At the request of sponsor/investigator|1|||
147450856|NCT00621504|531813169|FG001|Overall Study|At the request of sponsor/investigator|0|||
147274820|NCT04027686|531173708|FG001|Overall Study|Withdrawal by Subject|1|||
147274821|NCT01263873|531173709|FG000|Overall Study|One provider unable to complete numbers|1|||
147274822|NCT01263873|531173710|FG001|Overall Study|One provider unable to complete numbers|1|||
147274823|NCT00678691|531173715|FG000|Overall Study|Adverse Event|6|||
147333863|NCT04668339|531389984|FG002|Overall Study|Other than specified|1|||
147333864|NCT04668339|531389985|FG003|Overall Study|Other than specified|0|||
147333865|NCT04668339|531389982|FG000|Overall Study|Participant unblinded between Day 98 and 198|6|||
147333866|NCT04668339|531389983|FG001|Overall Study|Participant unblinded between Day 98 and 198|5|||
147274824|NCT00678691|531173716|FG001|Overall Study|Adverse Event|4|||
147274825|NCT04456699|531173732|FG000|Overall Study|Death|48|||
147274826|NCT04456699|531173733|FG001|Overall Study|Death|50|||
147274827|NCT04456699|531173734|FG002|Overall Study|Death|52|||
147274828|NCT04456699|531173732|FG000|Overall Study|Physician Decision|0|||
147274829|NCT04456699|531173733|FG001|Overall Study|Physician Decision|0|||
147274830|NCT04456699|531173734|FG002|Overall Study|Physician Decision|2|||
147274831|NCT04456699|531173732|FG000|Overall Study|Sponsor Decision|55|||
147274832|NCT04456699|531173733|FG001|Overall Study|Sponsor Decision|61|||
147274833|NCT04456699|531173734|FG002|Overall Study|Sponsor Decision|50|||
147274834|NCT04456699|531173732|FG000|Overall Study|Withdrawal by Subject|8|||
147274835|NCT04456699|531173733|FG001|Overall Study|Withdrawal by Subject|4|||
147274836|NCT04456699|531173734|FG002|Overall Study|Withdrawal by Subject|5|||
147274837|NCT02247349|531173742|FG000|Overall Study|Disease Progression|7|||
147274838|NCT02247349|531173743|FG001|Overall Study|Disease Progression|4|||
147274839|NCT02247349|531173744|FG002|Overall Study|Disease Progression|26|||
147274840|NCT02247349|531173745|FG003|Overall Study|Disease Progression|31|||
147274841|NCT02247349|531173746|FG004|Overall Study|Disease Progression|16|||
147274842|NCT02247349|531173747|FG005|Overall Study|Disease Progression|6|||
147274843|NCT02247349|531173742|FG000|Overall Study|Study drug toxicity|0|||
147274844|NCT02247349|531173743|FG001|Overall Study|Study drug toxicity|1|||
147274845|NCT02247349|531173744|FG002|Overall Study|Study drug toxicity|1|||
147274846|NCT02247349|531173745|FG003|Overall Study|Study drug toxicity|1|||
147274847|NCT02247349|531173746|FG004|Overall Study|Study drug toxicity|2|||
147274848|NCT02247349|531173747|FG005|Overall Study|Study drug toxicity|2|||
147274849|NCT02247349|531173742|FG000|Overall Study|Death|0|||
147274850|NCT02247349|531173743|FG001|Overall Study|Death|0|||
147274851|NCT02247349|531173744|FG002|Overall Study|Death|0|||
147274852|NCT02247349|531173745|FG003|Overall Study|Death|1|||
147274853|NCT02247349|531173746|FG004|Overall Study|Death|0|||
147274854|NCT02247349|531173747|FG005|Overall Study|Death|0|||
147274855|NCT02247349|531173742|FG000|Overall Study|Adverse Event unrelated to study drug|0|||
147274856|NCT02247349|531173743|FG001|Overall Study|Adverse Event unrelated to study drug|0|||
147274857|NCT02247349|531173744|FG002|Overall Study|Adverse Event unrelated to study drug|0|||
147274858|NCT02247349|531173745|FG003|Overall Study|Adverse Event unrelated to study drug|0|||
147274859|NCT02247349|531173746|FG004|Overall Study|Adverse Event unrelated to study drug|1|||
147274860|NCT02247349|531173747|FG005|Overall Study|Adverse Event unrelated to study drug|0|||
147274861|NCT02247349|531173742|FG000|Overall Study|Participant request to discontinue study treatment|0|||
147274862|NCT02247349|531173743|FG001|Overall Study|Participant request to discontinue study treatment|0|||
147274863|NCT02247349|531173744|FG002|Overall Study|Participant request to discontinue study treatment|1|||
147274864|NCT02247349|531173745|FG003|Overall Study|Participant request to discontinue study treatment|2|||
147274865|NCT02247349|531173746|FG004|Overall Study|Participant request to discontinue study treatment|1|||
147274866|NCT02247349|531173747|FG005|Overall Study|Participant request to discontinue study treatment|0|||
147274867|NCT02247349|531173742|FG000|Overall Study|Withdrawal by Subject|0|||
147662410|NCT02735980|532587324|FG001|Overall Study|Withdrawal by Subject|2|||
147662411|NCT02735980|532587325|FG002|Overall Study|Withdrawal by Subject|0|||
147662412|NCT01854697|532587326|FG000|Overall Study|Adverse Event|1|||
147662413|NCT01854697|532587327|FG001|Overall Study|Adverse Event|0|||
147662414|NCT01854697|532587328|FG002|Overall Study|Adverse Event|0|||
147662415|NCT01854697|532587329|FG003|Overall Study|Adverse Event|0|||
147662416|NCT01854697|532587330|FG004|Overall Study|Adverse Event|1|||
147662417|NCT01854697|532587326|FG000|Overall Study|Lost to Follow-up|4|||
147662418|NCT01854697|532587327|FG001|Overall Study|Lost to Follow-up|1|||
147662419|NCT01854697|532587328|FG002|Overall Study|Lost to Follow-up|1|||
147662420|NCT01854697|532587329|FG003|Overall Study|Lost to Follow-up|2|||
147662421|NCT01854697|532587330|FG004|Overall Study|Lost to Follow-up|0|||
147662422|NCT01854697|532587326|FG000|Overall Study|To enter another AbbVie study|1|||
147662423|NCT01854697|532587327|FG001|Overall Study|To enter another AbbVie study|0|||
147274868|NCT02247349|531173743|FG001|Overall Study|Withdrawal by Subject|1|||
147274869|NCT02247349|531173744|FG002|Overall Study|Withdrawal by Subject|0|||
147274870|NCT02247349|531173745|FG003|Overall Study|Withdrawal by Subject|0|||
147274871|NCT02247349|531173746|FG004|Overall Study|Withdrawal by Subject|0|||
147274872|NCT02247349|531173747|FG005|Overall Study|Withdrawal by Subject|0|||
147274873|NCT02247349|531173742|FG000|Overall Study|Administrative reason by sponsor|0|||
147274874|NCT02247349|531173743|FG001|Overall Study|Administrative reason by sponsor|0|||
147274875|NCT02247349|531173744|FG002|Overall Study|Administrative reason by sponsor|0|||
147274876|NCT02247349|531173745|FG003|Overall Study|Administrative reason by sponsor|0|||
147274877|NCT02247349|531173746|FG004|Overall Study|Administrative reason by sponsor|1|||
147274878|NCT02247349|531173747|FG005|Overall Study|Administrative reason by sponsor|0|||
147274879|NCT02247349|531173742|FG000|Overall Study|Other reasons|0|||
147274880|NCT02247349|531173743|FG001|Overall Study|Other reasons|0|||
147274881|NCT02247349|531173744|FG002|Overall Study|Other reasons|1|||
147274882|NCT02247349|531173745|FG003|Overall Study|Other reasons|0|||
147274883|NCT02247349|531173746|FG004|Overall Study|Other reasons|0|||
147274884|NCT02247349|531173747|FG005|Overall Study|Other reasons|0|||
147274885|NCT00673452|531173748|FG000|Acute Double-Blind Phase|Adverse Event|41|||
147274886|NCT00673452|531173749|FG001|Acute Double-Blind Phase|Adverse Event|24|||
147274887|NCT00673452|531173748|FG000|Acute Double-Blind Phase|Lack of Efficacy|9|||
147274888|NCT00673452|531173749|FG001|Acute Double-Blind Phase|Lack of Efficacy|14|||
147274889|NCT00673452|531173748|FG000|Acute Double-Blind Phase|Lost to Follow-up|16|||
147274890|NCT00673452|531173749|FG001|Acute Double-Blind Phase|Lost to Follow-up|19|||
147274891|NCT00673452|531173748|FG000|Acute Double-Blind Phase|Physician Decision|0|||
147274892|NCT00673452|531173749|FG001|Acute Double-Blind Phase|Physician Decision|6|||
147274893|NCT00673452|531173748|FG000|Acute Double-Blind Phase|Protocol Violation|5|||
147274894|NCT00673452|531173749|FG001|Acute Double-Blind Phase|Protocol Violation|3|||
147274895|NCT00673452|531173748|FG000|Acute Double-Blind Phase|Sponsor Decision|0|||
147274896|NCT00673452|531173749|FG001|Acute Double-Blind Phase|Sponsor Decision|1|||
147274897|NCT00673452|531173748|FG000|Acute Double-Blind Phase|Withdrawal by Subject|16|||
147274898|NCT00673452|531173749|FG001|Acute Double-Blind Phase|Withdrawal by Subject|13|||
147274899|NCT00673452|531173748|FG000|Continuation Double-Blind Phase|Adverse Event|5|||
147274900|NCT00673452|531173749|FG001|Continuation Double-Blind Phase|Adverse Event|13|||
147274901|NCT00673452|531173748|FG000|Continuation Double-Blind Phase|Withdrawal by Subject|9|||
147274902|NCT00673452|531173749|FG001|Continuation Double-Blind Phase|Withdrawal by Subject|5|||
147274903|NCT00673452|531173748|FG000|Continuation Double-Blind Phase|Lost to Follow-up|4|||
147274904|NCT00673452|531173749|FG001|Continuation Double-Blind Phase|Lost to Follow-up|5|||
147274905|NCT00673452|531173748|FG000|Continuation Double-Blind Phase|Lack of Efficacy|2|||
147274906|NCT00673452|531173749|FG001|Continuation Double-Blind Phase|Lack of Efficacy|5|||
147274907|NCT00673452|531173748|FG000|Continuation Double-Blind Phase|Protocol Violation|2|||
147274908|NCT00673452|531173749|FG001|Continuation Double-Blind Phase|Protocol Violation|3|||
147274909|NCT00673452|531173748|FG000|Continuation Double-Blind Phase|Sponsor Decision|0|||
147274910|NCT00673452|531173749|FG001|Continuation Double-Blind Phase|Sponsor Decision|3|||
147274911|NCT00673452|531173748|FG000|Continuation Double-Blind Phase|Physician Decision|2|||
147274912|NCT00673452|531173749|FG001|Continuation Double-Blind Phase|Physician Decision|0|||
147274913|NCT00673452|531173748|FG000|Continuation Double-Blind Phase|Death - Cervical vertebral fracture|1|||
147274914|NCT00673452|531173749|FG001|Continuation Double-Blind Phase|Death - Cervical vertebral fracture|0|||
147274915|NCT03495908|531173752|FG000|Overall Study|Withdrawal by Subject|3|||
147274916|NCT03495908|531173753|FG001|Overall Study|Withdrawal by Subject|1|||
147274917|NCT03495908|531173752|FG000|Overall Study|Lost to Follow-up|1|||
147274918|NCT03495908|531173753|FG001|Overall Study|Lost to Follow-up|4|||
147274919|NCT03495908|531173752|FG000|Overall Study|Adverse Event|0|||
147274920|NCT03495908|531173753|FG001|Overall Study|Adverse Event|2|||
147274921|NCT03495908|531173752|FG000|Overall Study|Death|1|||
147274922|NCT03495908|531173753|FG001|Overall Study|Death|0|||
147274923|NCT03495908|531173752|FG000|Overall Study|Physician Decision|5|||
147274924|NCT03495908|531173753|FG001|Overall Study|Physician Decision|4|||
147274925|NCT03495908|531173752|FG000|Overall Study|No documented reason|0|||
147274926|NCT03495908|531173753|FG001|Overall Study|No documented reason|2|||
147274927|NCT02410811|531173758|FG000|Overall Study|Withdrawal by Subject|0|||
147274928|NCT02410811|531173759|FG001|Overall Study|Withdrawal by Subject|0|||
147274929|NCT02410811|531173760|FG002|Overall Study|Withdrawal by Subject|1|||
147274930|NCT02410811|531173761|FG003|Overall Study|Withdrawal by Subject|0|||
147274931|NCT00480779|531173768|FG000|Overall Study|Other|2|||
147274932|NCT00480779|531173769|FG001|Overall Study|Other|0|||
147274933|NCT00480779|531173768|FG000|Overall Study|Job and Health-related|0|||
147274934|NCT00480779|531173769|FG001|Overall Study|Job and Health-related|3|||
147274935|NCT00806546|531173785|FG000|Overall Study|Enrolled, not treated|35|||
147274936|NCT00806546|531173785|FG000|Overall Study|Lost to Follow-up|32|||
147274937|NCT00806546|531173785|FG000|Overall Study|Adverse Event|74|||
147274938|NCT00806546|531173785|FG000|Overall Study|Withdrawal by Subject|75|||
147274939|NCT00806546|531173785|FG000|Overall Study|Protocol Violation|49|||
147274940|NCT00806546|531173785|FG000|Overall Study|Various|42|||
147274941|NCT01466192|531173788|FG000|Overall Study|Physician Decision|1|||
147274942|NCT01466192|531173788|FG000|Overall Study|Withdrawal by Subject|3|||
147333867|NCT04668339|531389984|FG002|Overall Study|Participant unblinded between Day 98 and 198|4|||
147333868|NCT04668339|531389985|FG003|Overall Study|Participant unblinded between Day 98 and 198|91|||
147333869|NCT04668339|531389982|FG000|Overall Study|Vaccine not Administered|0|||
147333870|NCT04668339|531389983|FG001|Overall Study|Vaccine not Administered|0|||
147333871|NCT04668339|531389984|FG002|Overall Study|Vaccine not Administered|1|||
147274943|NCT04524403|531175184|FG000|Overall Study|Withdrawal by Subject|10|||
147274944|NCT04524403|531175185|FG001|Overall Study|Withdrawal by Subject|3|||
147274945|NCT04524403|531175186|FG002|Overall Study|Withdrawal by Subject|8|||
147274946|NCT04524403|531175184|FG000|Overall Study|Lost to Follow-up|3|||
147274947|NCT04524403|531175185|FG001|Overall Study|Lost to Follow-up|4|||
147274948|NCT04524403|531175186|FG002|Overall Study|Lost to Follow-up|3|||
147274949|NCT04524403|531175184|FG000|Overall Study|Adverse Event|3|||
147450857|NCT00621504|531813168|FG000|Overall Study|Withdrew consent|9|||
147274950|NCT04524403|531175185|FG001|Overall Study|Adverse Event|1|||
147274951|NCT04524403|531175186|FG002|Overall Study|Adverse Event|4|||
147274952|NCT04524403|531175184|FG000|Overall Study|Non-compliant with study drug|1|||
147274953|NCT04524403|531175185|FG001|Overall Study|Non-compliant with study drug|2|||
147274954|NCT04524403|531175186|FG002|Overall Study|Non-compliant with study drug|3|||
147274955|NCT04524403|531175184|FG000|Overall Study|Moved|0|||
147274956|NCT04524403|531175185|FG001|Overall Study|Moved|1|||
147274957|NCT04524403|531175186|FG002|Overall Study|Moved|0|||
147274958|NCT02343458|531175190|FG000|Overall Study|Adverse Event|15|||
147274959|NCT02343458|531175191|FG001|Overall Study|Adverse Event|14|||
147274960|NCT02343458|531175192|FG002|Overall Study|Adverse Event|15|||
147274961|NCT02343458|531175193|FG003|Overall Study|Adverse Event|3|||
147274962|NCT02343458|531175190|FG000|Overall Study|Lack of Efficacy|3|||
147274963|NCT02343458|531175191|FG001|Overall Study|Lack of Efficacy|8|||
147274964|NCT02343458|531175192|FG002|Overall Study|Lack of Efficacy|4|||
147274965|NCT02343458|531175193|FG003|Overall Study|Lack of Efficacy|8|||
147274966|NCT02343458|531175190|FG000|Overall Study|Withdrawal by Subject|18|||
147274967|NCT02343458|531175191|FG001|Overall Study|Withdrawal by Subject|17|||
147274968|NCT02343458|531175192|FG002|Overall Study|Withdrawal by Subject|23|||
147274969|NCT02343458|531175193|FG003|Overall Study|Withdrawal by Subject|14|||
147274970|NCT02343458|531175190|FG000|Overall Study|Physician Decision|1|||
147274971|NCT02343458|531175191|FG001|Overall Study|Physician Decision|4|||
147333872|NCT04668339|531389985|FG003|Overall Study|Vaccine not Administered|0|||
147333873|NCT04668339|531389982|FG000|Overall Study|Protocol Violation|18|||
147333874|NCT04668339|531389983|FG001|Overall Study|Protocol Violation|23|||
147333875|NCT04668339|531389984|FG002|Overall Study|Protocol Violation|12|||
147333876|NCT04668339|531389985|FG003|Overall Study|Protocol Violation|20|||
147333877|NCT04668339|531389982|FG000|Overall Study|Withdrawal by Subject|45|||
147333878|NCT04668339|531389983|FG001|Overall Study|Withdrawal by Subject|46|||
147333879|NCT04668339|531389984|FG002|Overall Study|Withdrawal by Subject|46|||
147333880|NCT04668339|531389985|FG003|Overall Study|Withdrawal by Subject|27|||
147333881|NCT04668339|531389982|FG000|Overall Study|Study Terminated by Sponsor|59|||
147333882|NCT04668339|531389983|FG001|Overall Study|Study Terminated by Sponsor|59|||
147333883|NCT04668339|531389984|FG002|Overall Study|Study Terminated by Sponsor|71|||
147333884|NCT04668339|531389985|FG003|Overall Study|Study Terminated by Sponsor|1|||
147333885|NCT00178399|531389989|FG000|Overall Study|Physician Decision|4|||
147333886|NCT00178399|531389989|FG000|Overall Study|Withdrawal by Subject|8|||
147333887|NCT00178399|531389989|FG000|Overall Study|Lost to Follow-up|1|||
147333888|NCT00708032|531389996|FG000|Overall Study|Adverse Event|0|||
147333889|NCT00708032|531389997|FG001|Overall Study|Adverse Event|2|||
147333890|NCT00708032|531389996|FG000|Overall Study|Lost to Follow-up|1|||
147333891|NCT00708032|531389997|FG001|Overall Study|Lost to Follow-up|2|||
147333892|NCT00708032|531389996|FG000|Overall Study|Pregnancy|0|||
147333893|NCT00708032|531389997|FG001|Overall Study|Pregnancy|1|||
147333894|NCT00708032|531389996|FG000|Overall Study|Poor vision|0|||
147333895|NCT00708032|531389997|FG001|Overall Study|Poor vision|6|||
147333896|NCT00708032|531389996|FG000|Overall Study|Visit out of range at month 12|4|||
147333897|NCT00708032|531389997|FG001|Overall Study|Visit out of range at month 12|1|||
147333898|NCT00708032|531389996|FG000|Overall Study|Did not meet protocol criteria|1|||
147333899|NCT00708032|531389997|FG001|Overall Study|Did not meet protocol criteria|2|||
147333900|NCT00708032|531389996|FG000|Overall Study|Protocol Violation|4|||
147333901|NCT00708032|531389997|FG001|Overall Study|Protocol Violation|1|||
147333902|NCT00708032|531389996|FG000|Overall Study|Withdrawal by Subject|0|||
147333903|NCT00708032|531389997|FG001|Overall Study|Withdrawal by Subject|1|||
147333904|NCT02477670|531390005|FG000|Stage 1|Adverse Event|2|||
147333905|NCT02477670|531390006|FG001|Stage 1|Adverse Event|7|||
147333906|NCT02477670|531390007|FG002|Stage 1|Adverse Event|0|||
147333907|NCT02477670|531390008|FG003|Stage 1|Adverse Event|0|||
147333908|NCT02477670|531390009|FG004|Stage 1|Adverse Event|0|||
147333909|NCT02477670|531390010|FG005|Stage 1|Adverse Event|0|||
147333910|NCT02477670|531390011|FG006|Stage 1|Adverse Event|0|||
147600525|NCT04453202|532356410|FG009|Overall Study|Lost to Follow-up|1|||
147600526|NCT04453202|532356411|FG010|Overall Study|Lost to Follow-up|1|||
147600527|NCT04453202|532356401|FG000|Overall Study|Withdrawal by Subject|1|||
147333911|NCT02477670|531390005|FG000|Stage 1|Lost to Follow-up|0|||
147333912|NCT02477670|531390006|FG001|Stage 1|Lost to Follow-up|2|||
147333913|NCT02477670|531390007|FG002|Stage 1|Lost to Follow-up|0|||
147333914|NCT02477670|531390008|FG003|Stage 1|Lost to Follow-up|0|||
147333915|NCT02477670|531390009|FG004|Stage 1|Lost to Follow-up|0|||
147333916|NCT02477670|531390010|FG005|Stage 1|Lost to Follow-up|0|||
147333917|NCT02477670|531390011|FG006|Stage 1|Lost to Follow-up|0|||
147333918|NCT02477670|531390005|FG000|Stage 1|Withdrawal by Subject|1|||
147333919|NCT02477670|531390006|FG001|Stage 1|Withdrawal by Subject|2|||
147274972|NCT02343458|531175192|FG002|Overall Study|Physician Decision|2|||
147274973|NCT02343458|531175193|FG003|Overall Study|Physician Decision|2|||
147333920|NCT02477670|531390007|FG002|Stage 1|Withdrawal by Subject|0|||
147274974|NCT02343458|531175190|FG000|Overall Study|Lost to Follow-up|5|||
147274975|NCT02343458|531175191|FG001|Overall Study|Lost to Follow-up|5|||
147274976|NCT02343458|531175192|FG002|Overall Study|Lost to Follow-up|3|||
147333921|NCT02477670|531390008|FG003|Stage 1|Withdrawal by Subject|0|||
147333922|NCT02477670|531390009|FG004|Stage 1|Withdrawal by Subject|0|||
147333923|NCT02477670|531390010|FG005|Stage 1|Withdrawal by Subject|0|||
147333924|NCT02477670|531390011|FG006|Stage 1|Withdrawal by Subject|0|||
147333925|NCT02477670|531390005|FG000|Stage 1|Non-compliance with Study Drug|1|||
147333926|NCT02477670|531390006|FG001|Stage 1|Non-compliance with Study Drug|2|||
147274977|NCT02343458|531175193|FG003|Overall Study|Lost to Follow-up|1|||
147274978|NCT02343458|531175190|FG000|Overall Study|Protocol Violation|2|||
147274979|NCT02343458|531175191|FG001|Overall Study|Protocol Violation|5|||
147274980|NCT02343458|531175192|FG002|Overall Study|Protocol Violation|2|||
147274981|NCT02343458|531175193|FG003|Overall Study|Protocol Violation|2|||
147274982|NCT02343458|531175190|FG000|Overall Study|Protocol Specified Criteria|17|||
147274983|NCT02343458|531175191|FG001|Overall Study|Protocol Specified Criteria|13|||
147274984|NCT02343458|531175192|FG002|Overall Study|Protocol Specified Criteria|14|||
147274985|NCT02343458|531175193|FG003|Overall Study|Protocol Specified Criteria|8|||
147274986|NCT01913041|531175194|FG000|Overall Study|Protocol Violation|35|||
147274987|NCT01913041|531175194|FG000|Overall Study|Withdrawal by Subject|3|||
147274988|NCT01913041|531175194|FG000|Overall Study|Physician Decision|1|||
147274989|NCT01513317|531175195|FG000|Overall Study|Withdrawal by Subject|15|||
147274990|NCT01513317|531175196|FG001|Overall Study|Withdrawal by Subject|4|||
147274991|NCT01513317|531175195|FG000|Overall Study|Death|1|||
147274992|NCT01513317|531175196|FG001|Overall Study|Death|1|||
147274993|NCT01513317|531175195|FG000|Overall Study|Study terminated by sponsor|18|||
147274994|NCT01513317|531175196|FG001|Overall Study|Study terminated by sponsor|18|||
147274995|NCT01513317|531175195|FG000|Overall Study|Other|0|||
147274996|NCT01513317|531175196|FG001|Overall Study|Other|1|||
147274997|NCT02564198|531175197|FG000|Overall Study|Withdrawal by Subject|2|||
147274998|NCT02564198|531175198|FG001|Overall Study|Withdrawal by Subject|4|||
147274999|NCT02564198|531175199|FG002|Overall Study|Withdrawal by Subject|0|||
147275000|NCT02564198|531175197|FG000|Overall Study|Adverse Event|0|||
147275001|NCT02564198|531175198|FG001|Overall Study|Adverse Event|1|||
147275002|NCT02564198|531175199|FG002|Overall Study|Adverse Event|0|||
147275003|NCT02660359|531175202|FG000|Overall Study|Protocol Deviation|0|||
147275004|NCT02660359|531175203|FG001|Overall Study|Protocol Deviation|0|||
147275005|NCT02660359|531175204|FG002|Overall Study|Protocol Deviation|1|||
147275006|NCT02660359|531175202|FG000|Overall Study|Sponsor Decision to Terminate Study|73|||
147275007|NCT02660359|531175203|FG001|Overall Study|Sponsor Decision to Terminate Study|75|||
147275008|NCT02660359|531175204|FG002|Overall Study|Sponsor Decision to Terminate Study|71|||
147275009|NCT02660359|531175202|FG000|Overall Study|Lack of Efficacy|1|||
147275010|NCT02660359|531175203|FG001|Overall Study|Lack of Efficacy|1|||
147275011|NCT02660359|531175204|FG002|Overall Study|Lack of Efficacy|1|||
147275012|NCT02660359|531175202|FG000|Overall Study|Adverse Event|0|||
147275013|NCT02660359|531175203|FG001|Overall Study|Adverse Event|1|||
147275014|NCT02660359|531175204|FG002|Overall Study|Adverse Event|0|||
147275015|NCT02660359|531175202|FG000|Overall Study|Other|2|||
147275016|NCT02660359|531175203|FG001|Overall Study|Other|1|||
147275017|NCT02660359|531175204|FG002|Overall Study|Other|3|||
147275018|NCT02660359|531175202|FG000|Overall Study|Withdrawal by Subject|7|||
147275019|NCT02660359|531175203|FG001|Overall Study|Withdrawal by Subject|5|||
147275020|NCT02660359|531175204|FG002|Overall Study|Withdrawal by Subject|8|||
147275021|NCT02660359|531175202|FG000|Overall Study|Lost to Follow-up|3|||
147275022|NCT02660359|531175203|FG001|Overall Study|Lost to Follow-up|3|||
147275023|NCT02660359|531175204|FG002|Overall Study|Lost to Follow-up|0|||
147275024|NCT04622254|531175208|FG000|Main Period (Up to 22 Weeks)|Adverse Event|0|||
147275025|NCT04622254|531175209|FG001|Main Period (Up to 22 Weeks)|Adverse Event|1|||
147275026|NCT04622254|531175210|FG002|Main Period (Up to 22 Weeks)|Adverse Event|0|||
147275027|NCT04622254|531175211|FG003|Main Period (Up to 22 Weeks)|Adverse Event|0|||
147275028|NCT04622254|531175212|FG004|Main Period (Up to 22 Weeks)|Adverse Event|0|||
147275029|NCT04622254|531175213|FG005|Main Period (Up to 22 Weeks)|Adverse Event|0|||
147275030|NCT04622254|531175208|FG000|Main Period (Up to 22 Weeks)|Withdrawal by Subject|2|||
147275031|NCT04622254|531175209|FG001|Main Period (Up to 22 Weeks)|Withdrawal by Subject|1|||
147275032|NCT04622254|531175210|FG002|Main Period (Up to 22 Weeks)|Withdrawal by Subject|2|||
147275033|NCT04622254|531175211|FG003|Main Period (Up to 22 Weeks)|Withdrawal by Subject|0|||
147275034|NCT04622254|531175212|FG004|Main Period (Up to 22 Weeks)|Withdrawal by Subject|0|||
147275035|NCT04622254|531175213|FG005|Main Period (Up to 22 Weeks)|Withdrawal by Subject|0|||
147275036|NCT04622254|531175208|FG000|Main Period (Up to 22 Weeks)|Protocol Violation|1|||
147275037|NCT04622254|531175209|FG001|Main Period (Up to 22 Weeks)|Protocol Violation|0|||
147275038|NCT04622254|531175210|FG002|Main Period (Up to 22 Weeks)|Protocol Violation|0|||
147275039|NCT04622254|531175211|FG003|Main Period (Up to 22 Weeks)|Protocol Violation|0|||
147275040|NCT04622254|531175212|FG004|Main Period (Up to 22 Weeks)|Protocol Violation|0|||
147275041|NCT04622254|531175213|FG005|Main Period (Up to 22 Weeks)|Protocol Violation|0|||
147275042|NCT04622254|531175208|FG000|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
147275043|NCT04622254|531175209|FG001|Main Period (Up to 22 Weeks)|Lost to Follow-up|2|||
147275044|NCT04622254|531175210|FG002|Main Period (Up to 22 Weeks)|Lost to Follow-up|1|||
147275045|NCT04622254|531175211|FG003|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
147275046|NCT04622254|531175212|FG004|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
147275047|NCT04622254|531175213|FG005|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
147275048|NCT04622254|531175208|FG000|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
147275049|NCT04622254|531175209|FG001|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
147275050|NCT04622254|531175210|FG002|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
147275051|NCT04622254|531175211|FG003|OLEX Period (Up to 39 Weeks)|Adverse Event|1|||
147600528|NCT04453202|532356402|FG001|Overall Study|Withdrawal by Subject|2|||
147600529|NCT04453202|532356403|FG002|Overall Study|Withdrawal by Subject|1|||
147600530|NCT04453202|532356404|FG003|Overall Study|Withdrawal by Subject|2|||
147600531|NCT04453202|532356405|FG004|Overall Study|Withdrawal by Subject|1|||
147600532|NCT04453202|532356406|FG005|Overall Study|Withdrawal by Subject|1|||
147600533|NCT04453202|532356407|FG006|Overall Study|Withdrawal by Subject|0|||
147600534|NCT04453202|532356408|FG007|Overall Study|Withdrawal by Subject|0|||
147600535|NCT04453202|532356409|FG008|Overall Study|Withdrawal by Subject|0|||
147600536|NCT04453202|532356410|FG009|Overall Study|Withdrawal by Subject|1|||
147600537|NCT04453202|532356411|FG010|Overall Study|Withdrawal by Subject|0|||
147600538|NCT04453202|532356401|FG000|Overall Study|Adverse Event|0|||
147600539|NCT04453202|532356402|FG001|Overall Study|Adverse Event|0|||
147600540|NCT04453202|532356403|FG002|Overall Study|Adverse Event|0|||
147600541|NCT04453202|532356404|FG003|Overall Study|Adverse Event|0|||
147600542|NCT04453202|532356405|FG004|Overall Study|Adverse Event|0|||
147600543|NCT04453202|532356406|FG005|Overall Study|Adverse Event|1|||
147600544|NCT04453202|532356407|FG006|Overall Study|Adverse Event|0|||
147600545|NCT04453202|532356408|FG007|Overall Study|Adverse Event|0|||
147600546|NCT04453202|532356409|FG008|Overall Study|Adverse Event|0|||
147600547|NCT04453202|532356410|FG009|Overall Study|Adverse Event|0|||
147600548|NCT04453202|532356411|FG010|Overall Study|Adverse Event|0|||
147600549|NCT00669071|532356413|FG000|Overall Study|Lost to Follow-up|3|||
147600550|NCT00669071|532356413|FG000|Overall Study|Final visit 40 days out of window|1|||
147600551|NCT04305496|532356416|FG000|Global Cohort|Withdrawal by Subject|13|||
147600552|NCT04305496|532356417|FG001|Global Cohort|Withdrawal by Subject|6|||
147600553|NCT04305496|532356416|FG000|Global Cohort|Physician Decision|1|||
147275052|NCT04622254|531175212|FG004|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
147275053|NCT04622254|531175213|FG005|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
147275054|NCT04622254|531175208|FG000|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
147275055|NCT04622254|531175209|FG001|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
147275056|NCT04622254|531175210|FG002|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
147600554|NCT04305496|532356417|FG001|Global Cohort|Physician Decision|1|||
147600555|NCT04305496|532356416|FG000|Global Cohort|Subjective disease progression|16|||
147600556|NCT04305496|532356417|FG001|Global Cohort|Subjective disease progression|17|||
147600557|NCT04305496|532356416|FG000|Global Cohort|Condition under investigation worsened|209|||
147600558|NCT04305496|532356417|FG001|Global Cohort|Condition under investigation worsened|273|||
147600559|NCT04305496|532356416|FG000|Global Cohort|Protocol Violation|2|||
147600560|NCT04305496|532356417|FG001|Global Cohort|Protocol Violation|0|||
147600561|NCT04305496|532356416|FG000|Global Cohort|Adverse Event|44|||
147600562|NCT04305496|532356417|FG001|Global Cohort|Adverse Event|6|||
147600563|NCT04305496|532356416|FG000|Global Cohort|Death|3|||
147600564|NCT04305496|532356417|FG001|Global Cohort|Death|2|||
147600565|NCT04305496|532356416|FG000|Global Cohort|Any reason not specifically recorded|4|||
147600566|NCT04305496|532356417|FG001|Global Cohort|Any reason not specifically recorded|5|||
147600567|NCT04305496|532356416|FG000|China Cohort|Any reason not specifically recorded|1|||
147600568|NCT04305496|532356417|FG001|China Cohort|Any reason not specifically recorded|1|||
147600569|NCT04305496|532356416|FG000|China Cohort|Adverse Event|8|||
147600570|NCT04305496|532356417|FG001|China Cohort|Adverse Event|2|||
147275057|NCT04622254|531175211|FG003|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|3|||
147600571|NCT04305496|532356416|FG000|China Cohort|Condition under investigation worsened|40|||
147600572|NCT04305496|532356417|FG001|China Cohort|Condition under investigation worsened|47|||
147600573|NCT04305496|532356416|FG000|China Cohort|Subjective disease progression|2|||
147600574|NCT04305496|532356417|FG001|China Cohort|Subjective disease progression|2|||
147662424|NCT01854697|532587328|FG002|Overall Study|To enter another AbbVie study|0|||
147662425|NCT01854697|532587329|FG003|Overall Study|To enter another AbbVie study|0|||
147662426|NCT01854697|532587330|FG004|Overall Study|To enter another AbbVie study|1|||
147662427|NCT01854697|532587326|FG000|Overall Study|Withdrew Consent|0|||
147662428|NCT01854697|532587327|FG001|Overall Study|Withdrew Consent|1|||
147275058|NCT04622254|531175212|FG004|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
147275059|NCT04622254|531175213|FG005|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|2|||
147275060|NCT04622254|531175208|FG000|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
147275061|NCT04622254|531175209|FG001|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
147275062|NCT04622254|531175210|FG002|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
147275063|NCT04622254|531175211|FG003|OLEX Period (Up to 39 Weeks)|Pregnancy|1|||
147275064|NCT04622254|531175212|FG004|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
147275065|NCT04622254|531175213|FG005|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
147600575|NCT04305496|532356416|FG000|China Cohort|Withdrawal by Subject|2|||
147600576|NCT04305496|532356417|FG001|China Cohort|Withdrawal by Subject|1|||
147600577|NCT01157897|532356418|FG000|Overall Study|Lost to Follow-up|2|||
147600578|NCT01157897|532356419|FG001|Overall Study|Lost to Follow-up|0|||
147600579|NCT01157897|532356420|FG002|Overall Study|Lost to Follow-up|0|||
147600580|NCT01157897|532356421|FG003|Overall Study|Lost to Follow-up|1|||
147600581|NCT01157897|532356418|FG000|Overall Study|Relocated|0|||
147600582|NCT01157897|532356419|FG001|Overall Study|Relocated|2|||
147600583|NCT01157897|532356420|FG002|Overall Study|Relocated|0|||
147662429|NCT01854697|532587328|FG002|Overall Study|Withdrew Consent|0|||
147275066|NCT04622254|531175208|FG000|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
147275067|NCT04622254|531175209|FG001|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
147275068|NCT04622254|531175210|FG002|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
147275069|NCT04622254|531175211|FG003|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|1|||
147275070|NCT04622254|531175212|FG004|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
147275071|NCT04622254|531175213|FG005|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
147275072|NCT04622254|531175208|FG000|OLEX Period (Up to 39 Weeks)|No need for re-injection|0|||
147275073|NCT04622254|531175209|FG001|OLEX Period (Up to 39 Weeks)|No need for re-injection|0|||
147275074|NCT04622254|531175210|FG002|OLEX Period (Up to 39 Weeks)|No need for re-injection|0|||
147275075|NCT04622254|531175211|FG003|OLEX Period (Up to 39 Weeks)|No need for re-injection|1|||
147275076|NCT04622254|531175212|FG004|OLEX Period (Up to 39 Weeks)|No need for re-injection|9|||
147275077|NCT04622254|531175213|FG005|OLEX Period (Up to 39 Weeks)|No need for re-injection|3|||
147275078|NCT04622254|531175208|FG000|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|0|||
147275079|NCT04622254|531175209|FG001|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|0|||
147275080|NCT04622254|531175210|FG002|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|0|||
147275081|NCT04622254|531175211|FG003|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|1|||
147275082|NCT04622254|531175212|FG004|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|5|||
147275083|NCT04622254|531175213|FG005|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|4|||
147275084|NCT04622254|531175208|FG000|OLEX Period (Up to 39 Weeks)|Other|0|||
147275085|NCT04622254|531175209|FG001|OLEX Period (Up to 39 Weeks)|Other|0|||
147275086|NCT04622254|531175210|FG002|OLEX Period (Up to 39 Weeks)|Other|0|||
147275087|NCT04622254|531175211|FG003|OLEX Period (Up to 39 Weeks)|Other|0|||
147275088|NCT04622254|531175212|FG004|OLEX Period (Up to 39 Weeks)|Other|0|||
147275089|NCT04622254|531175213|FG005|OLEX Period (Up to 39 Weeks)|Other|2|||
147275090|NCT03228680|531175214|FG000|Overall Study|Adverse Event|13|||
147275091|NCT03228680|531175215|FG001|Overall Study|Adverse Event|18|||
147275092|NCT03228680|531175214|FG000|Overall Study|Randomization failure|0|||
147275093|NCT03228680|531175215|FG001|Overall Study|Randomization failure|1|||
147275094|NCT03228680|531175214|FG000|Overall Study|Withdrawal by Subject|1|||
147275095|NCT03228680|531175215|FG001|Overall Study|Withdrawal by Subject|0|||
147275096|NCT03228680|531175214|FG000|Overall Study|Other|9|||
147275097|NCT03228680|531175215|FG001|Overall Study|Other|16|||
147275098|NCT02167035|531175216|FG000|Overall Study|Adverse Event|2|||
147275099|NCT02167035|531175217|FG001|Overall Study|Adverse Event|2|||
147275100|NCT02167035|531175216|FG000|Overall Study|Lost to Follow-up|3|||
147275101|NCT02167035|531175217|FG001|Overall Study|Lost to Follow-up|3|||
147275102|NCT02167035|531175216|FG000|Overall Study|Randomized to incorrect Study Medication|0|||
147275103|NCT02167035|531175217|FG001|Overall Study|Randomized to incorrect Study Medication|1|||
147275104|NCT02489981|531175218|FG000|Overall Study|Adverse Event|21|||
147275105|NCT02489981|531175218|FG000|Overall Study|Insufficient effectiveness|16|||
147275106|NCT02489981|531175218|FG000|Overall Study|Improved|31|||
147275107|NCT02489981|531175218|FG000|Overall Study|Lost to Follow-up|31|||
147275108|NCT02489981|531175218|FG000|Overall Study|Other than listed|28|||
147275109|NCT01743092|531175219|FG000|Overall Study|Lost to Follow-up|14|||
147275110|NCT01743092|531175220|FG001|Overall Study|Lost to Follow-up|15|||
147275111|NCT03586869|531175221|FG000|Overall Study|Progressive Disease|3|||
147275112|NCT02992899|531175226|FG000|Overall Study|Withdrawal by Subject|1|||
147275113|NCT02992899|531175227|FG001|Overall Study|Withdrawal by Subject|0|||
147275114|NCT02992899|531175226|FG000|Overall Study|Lost to Follow-up|1|||
147275115|NCT02992899|531175227|FG001|Overall Study|Lost to Follow-up|3|||
147275116|NCT02370888|531175228|FG000|Overall Study|disease progression|2|||
147275117|NCT02370888|531175228|FG000|Overall Study|did not meet chimerism criteria|6|||
147275118|NCT01332305|531175229|FG000|Overall Study|Adverse Event|1|||
147275119|NCT01332305|531175230|FG001|Overall Study|Adverse Event|4|||
147275120|NCT01332305|531175231|FG002|Overall Study|Adverse Event|6|||
147275121|NCT01332305|531175232|FG003|Overall Study|Adverse Event|3|||
147275122|NCT01332305|531175233|FG004|Overall Study|Adverse Event|5|||
147275123|NCT01332305|531175229|FG000|Overall Study|Withdrawal by Subject|6|||
147275124|NCT01332305|531175230|FG001|Overall Study|Withdrawal by Subject|5|||
147275125|NCT01332305|531175231|FG002|Overall Study|Withdrawal by Subject|4|||
147275126|NCT01332305|531175232|FG003|Overall Study|Withdrawal by Subject|1|||
147275127|NCT01332305|531175233|FG004|Overall Study|Withdrawal by Subject|0|||
147275128|NCT01332305|531175229|FG000|Overall Study|Lost to Follow-up|0|||
147275129|NCT01332305|531175230|FG001|Overall Study|Lost to Follow-up|2|||
147275130|NCT01332305|531175231|FG002|Overall Study|Lost to Follow-up|3|||
147275131|NCT01332305|531175232|FG003|Overall Study|Lost to Follow-up|2|||
147275132|NCT01332305|531175233|FG004|Overall Study|Lost to Follow-up|3|||
147275133|NCT01332305|531175229|FG000|Overall Study|Protocol Violation|1|||
147333927|NCT02477670|531390007|FG002|Stage 1|Non-compliance with Study Drug|0|||
147333928|NCT02477670|531390008|FG003|Stage 1|Non-compliance with Study Drug|0|||
147275134|NCT01332305|531175230|FG001|Overall Study|Protocol Violation|2|||
147275135|NCT01332305|531175231|FG002|Overall Study|Protocol Violation|1|||
147333929|NCT02477670|531390009|FG004|Stage 1|Non-compliance with Study Drug|0|||
147275136|NCT01332305|531175232|FG003|Overall Study|Protocol Violation|0|||
147275137|NCT01332305|531175233|FG004|Overall Study|Protocol Violation|3|||
147600584|NCT01157897|532356421|FG003|Overall Study|Relocated|0|||
147600585|NCT03276221|532356422|FG000|Overall Study|Lost to Follow-up|6|||
147600586|NCT03276221|532356423|FG001|Overall Study|Lost to Follow-up|2|||
147275138|NCT01332305|531175229|FG000|Overall Study|Withdrawal by Sponsor|1|||
147275139|NCT01332305|531175230|FG001|Overall Study|Withdrawal by Sponsor|0|||
147275140|NCT01332305|531175231|FG002|Overall Study|Withdrawal by Sponsor|0|||
147275141|NCT01332305|531175232|FG003|Overall Study|Withdrawal by Sponsor|1|||
147275142|NCT01332305|531175233|FG004|Overall Study|Withdrawal by Sponsor|1|||
147275143|NCT01332305|531175229|FG000|Overall Study|Treatment Failure|1|||
147275144|NCT01332305|531175230|FG001|Overall Study|Treatment Failure|1|||
147275145|NCT01332305|531175231|FG002|Overall Study|Treatment Failure|0|||
147275146|NCT01332305|531175232|FG003|Overall Study|Treatment Failure|0|||
147275147|NCT01332305|531175233|FG004|Overall Study|Treatment Failure|0|||
147275148|NCT01332305|531175229|FG000|Overall Study|Physician Decision|0|||
147275149|NCT01332305|531175230|FG001|Overall Study|Physician Decision|0|||
147275150|NCT01332305|531175231|FG002|Overall Study|Physician Decision|0|||
147275151|NCT01332305|531175232|FG003|Overall Study|Physician Decision|1|||
147275152|NCT01332305|531175233|FG004|Overall Study|Physician Decision|0|||
147275153|NCT03192150|531175236|FG000|Overall Study|Adverse Event|14|||
147275154|NCT03192150|531175237|FG001|Overall Study|Adverse Event|12|||
147275155|NCT03192150|531175236|FG000|Overall Study|Lack of Efficacy|23|||
147275156|NCT03192150|531175237|FG001|Overall Study|Lack of Efficacy|30|||
147275157|NCT03192150|531175236|FG000|Overall Study|Lost to Follow-up|1|||
147275158|NCT03192150|531175237|FG001|Overall Study|Lost to Follow-up|1|||
147275159|NCT03192150|531175236|FG000|Overall Study|Withdrawal by Subject|4|||
147275160|NCT03192150|531175237|FG001|Overall Study|Withdrawal by Subject|2|||
147275161|NCT03192150|531175236|FG000|Overall Study|Protocol Violation|5|||
147275162|NCT03192150|531175237|FG001|Overall Study|Protocol Violation|2|||
147275163|NCT03192150|531175236|FG000|Overall Study|Surgery Canceled|6|||
147275164|NCT03192150|531175237|FG001|Overall Study|Surgery Canceled|2|||
147275165|NCT03192150|531175236|FG000|Overall Study|Other-Various Administrative Reasons|2|||
147275166|NCT03192150|531175237|FG001|Overall Study|Other-Various Administrative Reasons|5|||
147275167|NCT02579616|531175238|FG000|Overall Study|Participants did not receive treatment|3|||
147275168|NCT00482391|531175239|FG000|Overall Study|Withdrawal by Subject|1|||
147275169|NCT00482391|531175239|FG000|Overall Study|Adverse Event|1|||
147275170|NCT00482391|531175239|FG000|Overall Study|Death|1|||
147275171|NCT01448850|531175240|FG000|Overall Study|Death|3|||
147275172|NCT01448850|531175241|FG001|Overall Study|Death|6|||
147275173|NCT01448850|531175240|FG000|Overall Study|Withdrawal by Subject|13|||
147275174|NCT01448850|531175241|FG001|Overall Study|Withdrawal by Subject|21|||
147275175|NCT01448850|531175240|FG000|Overall Study|Lost to Follow-up|3|||
147275176|NCT01448850|531175241|FG001|Overall Study|Lost to Follow-up|1|||
147275177|NCT01448850|531175240|FG000|Overall Study|Other|15|||
147275178|NCT01448850|531175241|FG001|Overall Study|Other|12|||
147275179|NCT02664038|531175244|FG000|13 Week|Lost to Follow-up|7|||
147275180|NCT02664038|531175245|FG001|13 Week|Lost to Follow-up|14|||
147275181|NCT02664038|531175244|FG000|13 Week|Withdrawal by Subject|1|||
147275182|NCT02664038|531175245|FG001|13 Week|Withdrawal by Subject|0|||
147275183|NCT02664038|531175244|FG000|26 Week|Lost to Follow-up|5|||
147275184|NCT02664038|531175245|FG001|26 Week|Lost to Follow-up|4|||
147275185|NCT02606136|531175248|FG000|Main Study (104 Weeks)|Participant/Legal Guardian Decision|5|||
147275186|NCT02606136|531175248|FG000|Main Study (104 Weeks)|Withdrawal by Subject|1|||
147275187|NCT02606136|531175248|FG000|OLE (Up to 208 Weeks)|Participant/Legal Guardian Decision|1|||
147275188|NCT02606136|531175248|FG000|OLE (Up to 208 Weeks)|Sponsor Decision to Terminate Study|14|||
147275189|NCT03296696|531175249|FG000|Overall Study|Started Other Antitumor Therapy|1|||
147275190|NCT03296696|531175250|FG001|Overall Study|Started Other Antitumor Therapy|2|||
147275191|NCT03296696|531175251|FG002|Overall Study|Started Other Antitumor Therapy|1|||
147275192|NCT03296696|531175252|FG003|Overall Study|Started Other Antitumor Therapy|2|||
147275193|NCT03296696|531175253|FG004|Overall Study|Started Other Antitumor Therapy|1|||
147275194|NCT03296696|531175254|FG005|Overall Study|Started Other Antitumor Therapy|1|||
147275195|NCT03296696|531175255|FG006|Overall Study|Started Other Antitumor Therapy|2|||
147600587|NCT03276221|532356424|FG002|Overall Study|Lost to Follow-up|0|||
147600588|NCT03276221|532356422|FG000|Overall Study|Did not abstain from cannabis as per protocol|4|||
147275196|NCT03296696|531175256|FG007|Overall Study|Started Other Antitumor Therapy|3|||
147275197|NCT03296696|531175257|FG008|Overall Study|Started Other Antitumor Therapy|1|||
147275198|NCT03296696|531175258|FG009|Overall Study|Started Other Antitumor Therapy|0|||
147275199|NCT03296696|531175249|FG000|Overall Study|Death|0|||
147275200|NCT03296696|531175250|FG001|Overall Study|Death|1|||
147275201|NCT03296696|531175251|FG002|Overall Study|Death|1|||
147275202|NCT03296696|531175252|FG003|Overall Study|Death|2|||
147600589|NCT03276221|532356423|FG001|Overall Study|Did not abstain from cannabis as per protocol|0|||
147600590|NCT03276221|532356424|FG002|Overall Study|Did not abstain from cannabis as per protocol|0|||
147275203|NCT03296696|531175253|FG004|Overall Study|Death|2|||
147275204|NCT03296696|531175254|FG005|Overall Study|Death|3|||
147275205|NCT03296696|531175255|FG006|Overall Study|Death|1|||
147275206|NCT03296696|531175256|FG007|Overall Study|Death|2|||
147275207|NCT03296696|531175257|FG008|Overall Study|Death|0|||
147275208|NCT03296696|531175258|FG009|Overall Study|Death|0|||
147275209|NCT03296696|531175249|FG000|Overall Study|Withdrawal by Subject|0|||
147275210|NCT03296696|531175250|FG001|Overall Study|Withdrawal by Subject|0|||
147275211|NCT03296696|531175251|FG002|Overall Study|Withdrawal by Subject|1|||
147275212|NCT03296696|531175252|FG003|Overall Study|Withdrawal by Subject|0|||
147275213|NCT03296696|531175253|FG004|Overall Study|Withdrawal by Subject|1|||
147275214|NCT03296696|531175254|FG005|Overall Study|Withdrawal by Subject|0|||
147275215|NCT03296696|531175255|FG006|Overall Study|Withdrawal by Subject|0|||
147275216|NCT03296696|531175256|FG007|Overall Study|Withdrawal by Subject|0|||
147275217|NCT03296696|531175257|FG008|Overall Study|Withdrawal by Subject|0|||
147275218|NCT03296696|531175258|FG009|Overall Study|Withdrawal by Subject|1|||
147275219|NCT04694131|531175261|FG000|Overall Study|Withdrawal by Subject|7|||
147275220|NCT04694131|531175261|FG000|Overall Study|Screen Failure|1|||
147275221|NCT04694131|531175261|FG000|Overall Study|High stimulation threshold|3|||
147275222|NCT00086580|531175265|FG000|Treatment Period|Disease progression|9|||
147275223|NCT00086580|531175266|FG001|Treatment Period|Disease progression|8|||
147275224|NCT00086580|531175265|FG000|Treatment Period|Unable to comply with protocol|3|||
147275225|NCT00086580|531175266|FG001|Treatment Period|Unable to comply with protocol|1|||
147275226|NCT00086580|531175265|FG000|Treatment Period|Withdrawal by Subject|7|||
147275227|NCT00086580|531175266|FG001|Treatment Period|Withdrawal by Subject|8|||
147275228|NCT00086580|531175265|FG000|Treatment Period|Physician Decision|13|||
147275229|NCT00086580|531175266|FG001|Treatment Period|Physician Decision|7|||
147275230|NCT00086580|531175265|FG000|Treatment Period|AE - not treatment related|7|||
147275231|NCT00086580|531175266|FG001|Treatment Period|AE - not treatment related|7|||
147275232|NCT00086580|531175265|FG000|Treatment Period|Toxicity - treatment related|15|||
147275233|NCT00086580|531175266|FG001|Treatment Period|Toxicity - treatment related|15|||
147275234|NCT00086580|531175265|FG000|Treatment Period|Anemia or thrombocytopenia|1|||
147275235|NCT00086580|531175266|FG001|Treatment Period|Anemia or thrombocytopenia|4|||
147275236|NCT00086580|531175265|FG000|Treatment Period|Death|5|||
147275237|NCT00086580|531175266|FG001|Treatment Period|Death|7|||
147275238|NCT00086580|531175265|FG000|Treatment Period|Other|5|||
147275239|NCT00086580|531175266|FG001|Treatment Period|Other|3|||
147450858|NCT00621504|531813169|FG001|Overall Study|Withdrew consent|6|||
147450859|NCT00621504|531813168|FG000|Overall Study|Lost to Follow-up|8|||
147275240|NCT00086580|531175265|FG000|Follow-up Period|Disease progression|72|||
147275241|NCT00086580|531175266|FG001|Follow-up Period|Disease progression|99|||
147275242|NCT00086580|531175265|FG000|Follow-up Period|Unable to comply with protocol|5|||
147275243|NCT00086580|531175266|FG001|Follow-up Period|Unable to comply with protocol|0|||
147275244|NCT00086580|531175265|FG000|Follow-up Period|Withdrawal by Subject|6|||
147275245|NCT00086580|531175266|FG001|Follow-up Period|Withdrawal by Subject|6|||
147275246|NCT00086580|531175265|FG000|Follow-up Period|Physician Decision|0|||
147275247|NCT00086580|531175266|FG001|Follow-up Period|Physician Decision|1|||
147275248|NCT00086580|531175265|FG000|Follow-up Period|AE - not related|1|||
147275249|NCT00086580|531175266|FG001|Follow-up Period|AE - not related|0|||
147275250|NCT00086580|531175265|FG000|Follow-up Period|Death|13|||
147275251|NCT00086580|531175266|FG001|Follow-up Period|Death|7|||
147275252|NCT00086580|531175265|FG000|Follow-up Period|Other|7|||
147275253|NCT00086580|531175266|FG001|Follow-up Period|Other|6|||
147275254|NCT00086580|531175265|FG000|Observation Period|Unable to comply with protocol|1|||
147275255|NCT00086580|531175266|FG001|Observation Period|Unable to comply with protocol|1|||
147275256|NCT00086580|531175265|FG000|Observation Period|Withdrawal by Subject|4|||
147275257|NCT00086580|531175266|FG001|Observation Period|Withdrawal by Subject|2|||
147275258|NCT00086580|531175265|FG000|Observation Period|Death|33|||
147275259|NCT00086580|531175266|FG001|Observation Period|Death|55|||
147275260|NCT00086580|531175265|FG000|Observation Period|Other|8|||
147275261|NCT00086580|531175266|FG001|Observation Period|Other|7|||
147275262|NCT03235024|531175267|FG000|Overall Study|Adverse Event|2|||
147275263|NCT03235024|531175268|FG001|Overall Study|Adverse Event|2|||
147275264|NCT03235024|531175267|FG000|Overall Study|Death|1|||
147450860|NCT00621504|531813169|FG001|Overall Study|Lost to Follow-up|10|||
147275265|NCT03235024|531175268|FG001|Overall Study|Death|0|||
147275266|NCT03235024|531175267|FG000|Overall Study|Lost to Follow-up|2|||
147275267|NCT03235024|531175268|FG001|Overall Study|Lost to Follow-up|5|||
147275268|NCT03235024|531175267|FG000|Overall Study|Protocol Violation|1|||
147275269|NCT03235024|531175268|FG001|Overall Study|Protocol Violation|0|||
147275270|NCT03235024|531175267|FG000|Overall Study|Withdrawal by Subject|0|||
147275271|NCT03235024|531175268|FG001|Overall Study|Withdrawal by Subject|3|||
147275272|NCT02357576|531175269|FG000|Treatment Period|Withdrawal by Subject|0|||
147275273|NCT02357576|531175270|FG001|Treatment Period|Withdrawal by Subject|1|||
147275274|NCT02357576|531175269|FG000|Treatment Period|Physician Decision|0|||
147275275|NCT02357576|531175270|FG001|Treatment Period|Physician Decision|1|||
147275276|NCT02357576|531175269|FG000|Neurodevelopmental Outcome Follow Up|Scheduling error|1|||
147450861|NCT00621504|531813168|FG000|Overall Study|Other|1|||
147450862|NCT00621504|531813169|FG001|Overall Study|Other|0|||
147275277|NCT02357576|531175270|FG001|Neurodevelopmental Outcome Follow Up|Scheduling error|1|||
147275278|NCT02357576|531175269|FG000|Neurodevelopmental Outcome Follow Up|Became ineligible during follow-up|1|||
147275279|NCT02357576|531175270|FG001|Neurodevelopmental Outcome Follow Up|Became ineligible during follow-up|0|||
147275280|NCT02357576|531175269|FG000|Neurodevelopmental Outcome Follow Up|Lost to Follow-up|1|||
147275281|NCT02357576|531175270|FG001|Neurodevelopmental Outcome Follow Up|Lost to Follow-up|4|||
147275282|NCT02357576|531175269|FG000|Neurodevelopmental Outcome Follow Up|Withdrawal by Subject|2|||
147275283|NCT02357576|531175270|FG001|Neurodevelopmental Outcome Follow Up|Withdrawal by Subject|0|||
147275284|NCT00261716|531175271|FG000|Overall Study|Withdrawal by Subject|6|||
147275285|NCT00261716|531175272|FG001|Overall Study|Withdrawal by Subject|8|||
147275286|NCT00261716|531175271|FG000|Overall Study|Lost to Follow-up|0|||
147275287|NCT00261716|531175272|FG001|Overall Study|Lost to Follow-up|2|||
147275288|NCT00699699|531175275|FG000|Overall Study|Adverse Event|36|||
147275289|NCT00699699|531175275|FG000|Overall Study|Individual different reasons|21|||
147275290|NCT02047110|531175276|FG000|DB Treatment Period up to Week 24|Adverse Event|1|||
147275291|NCT02047110|531175277|FG001|DB Treatment Period up to Week 24|Adverse Event|0|||
147275292|NCT02047110|531175278|FG002|DB Treatment Period up to Week 24|Adverse Event|0|||
147275293|NCT02047110|531175279|FG003|DB Treatment Period up to Week 24|Adverse Event|0|||
147275294|NCT02047110|531175276|FG000|DB Treatment Period up to Week 24|Lost to Follow-up|1|||
147275295|NCT02047110|531175277|FG001|DB Treatment Period up to Week 24|Lost to Follow-up|0|||
147275296|NCT02047110|531175278|FG002|DB Treatment Period up to Week 24|Lost to Follow-up|0|||
147275297|NCT02047110|531175279|FG003|DB Treatment Period up to Week 24|Lost to Follow-up|0|||
147275298|NCT02047110|531175276|FG000|DB Treatment Period up to Week 24|Protocol Violation|1|||
147275299|NCT02047110|531175277|FG001|DB Treatment Period up to Week 24|Protocol Violation|0|||
147275300|NCT02047110|531175278|FG002|DB Treatment Period up to Week 24|Protocol Violation|0|||
147275301|NCT02047110|531175279|FG003|DB Treatment Period up to Week 24|Protocol Violation|0|||
147275302|NCT02047110|531175276|FG000|DB Treatment Period up to Week 24|Withdrawal by Subject|1|||
147275303|NCT02047110|531175277|FG001|DB Treatment Period up to Week 24|Withdrawal by Subject|0|||
147275304|NCT02047110|531175278|FG002|DB Treatment Period up to Week 24|Withdrawal by Subject|0|||
147275305|NCT02047110|531175279|FG003|DB Treatment Period up to Week 24|Withdrawal by Subject|1|||
147275306|NCT02047110|531175276|FG000|DB Treatment Period up to Week 24|Other than specified|1|||
147275307|NCT02047110|531175277|FG001|DB Treatment Period up to Week 24|Other than specified|2|||
147275308|NCT02047110|531175278|FG002|DB Treatment Period up to Week 24|Other than specified|3|||
147275309|NCT02047110|531175279|FG003|DB Treatment Period up to Week 24|Other than specified|1|||
147275310|NCT02047110|531175276|FG000|DB (Week 12 up to Week 24)|Withdrawal by Subject|0|||
147275311|NCT02047110|531175277|FG001|DB (Week 12 up to Week 24)|Withdrawal by Subject|1|||
147275312|NCT02047110|531175278|FG002|DB (Week 12 up to Week 24)|Withdrawal by Subject|0|||
147275313|NCT02047110|531175279|FG003|DB (Week 12 up to Week 24)|Withdrawal by Subject|0|||
147275314|NCT02047110|531175276|FG000|DB (Week 12 up to Week 24)|Other than specified|0|||
147275315|NCT02047110|531175277|FG001|DB (Week 12 up to Week 24)|Other than specified|1|||
147275316|NCT02047110|531175278|FG002|DB (Week 12 up to Week 24)|Other than specified|1|||
147275317|NCT02047110|531175279|FG003|DB (Week 12 up to Week 24)|Other than specified|0|||
147275318|NCT02047110|531175276|FG000|Escape Treatment Period|Withdrawal by Subject|1|||
147333930|NCT02477670|531390010|FG005|Stage 1|Non-compliance with Study Drug|0|||
147333931|NCT02477670|531390011|FG006|Stage 1|Non-compliance with Study Drug|0|||
147333932|NCT02477670|531390005|FG000|Stage 2|Adverse Event|0|||
147333933|NCT02477670|531390006|FG001|Stage 2|Adverse Event|0|||
147333934|NCT02477670|531390007|FG002|Stage 2|Adverse Event|1|||
147333935|NCT02477670|531390008|FG003|Stage 2|Adverse Event|0|||
147333936|NCT02477670|531390009|FG004|Stage 2|Adverse Event|0|||
147333937|NCT02477670|531390010|FG005|Stage 2|Adverse Event|0|||
147333938|NCT02477670|531390011|FG006|Stage 2|Adverse Event|0|||
147333939|NCT02477670|531390005|FG000|Stage 2|Antipsychotic Medication Changed|0|||
147333940|NCT02477670|531390006|FG001|Stage 2|Antipsychotic Medication Changed|0|||
147333941|NCT02477670|531390007|FG002|Stage 2|Antipsychotic Medication Changed|1|||
147333942|NCT02477670|531390008|FG003|Stage 2|Antipsychotic Medication Changed|0|||
147333943|NCT02477670|531390009|FG004|Stage 2|Antipsychotic Medication Changed|0|||
147333944|NCT02477670|531390010|FG005|Stage 2|Antipsychotic Medication Changed|0|||
147333945|NCT02477670|531390011|FG006|Stage 2|Antipsychotic Medication Changed|0|||
147333946|NCT02477670|531390005|FG000|Stage 2|Withdrawal by Subject|0|||
147333947|NCT02477670|531390006|FG001|Stage 2|Withdrawal by Subject|0|||
147333948|NCT02477670|531390007|FG002|Stage 2|Withdrawal by Subject|0|||
147333949|NCT02477670|531390008|FG003|Stage 2|Withdrawal by Subject|1|||
147333950|NCT02477670|531390009|FG004|Stage 2|Withdrawal by Subject|0|||
147333951|NCT02477670|531390010|FG005|Stage 2|Withdrawal by Subject|0|||
147333952|NCT02477670|531390011|FG006|Stage 2|Withdrawal by Subject|0|||
147333953|NCT01759264|531390012|FG000|Overall Study|Serious Adverse Events (SAEs)|1|||
147333954|NCT01759264|531390012|FG000|Overall Study|Adverse Event|1|||
147333955|NCT01759264|531390012|FG000|Overall Study|Other|2|||
147333956|NCT01759264|531390012|FG000|Overall Study|Lost to Follow-up|2|||
147333957|NCT01759264|531390012|FG000|Overall Study|Withdrawal by Subject|3|||
147333958|NCT01759264|531390012|FG000|Overall Study|Discontinued Humira Due to Business Trip|1|||
147333959|NCT03262935|531390015|FG000|Overall Study|Withdrawal by Subject|6|||
147333960|NCT03262935|531390016|FG001|Overall Study|Withdrawal by Subject|7|||
147333961|NCT03262935|531390015|FG000|Overall Study|End Of Follow Up By Sponsor|90|||
147333962|NCT03262935|531390016|FG001|Overall Study|End Of Follow Up By Sponsor|41|||
147275319|NCT02047110|531175277|FG001|Escape Treatment Period|Withdrawal by Subject|2|||
147275320|NCT02047110|531175278|FG002|Escape Treatment Period|Withdrawal by Subject|1|||
147275321|NCT02047110|531175279|FG003|Escape Treatment Period|Withdrawal by Subject|1|||
147275322|NCT02047110|531175276|FG000|Escape Treatment Period|Adverse Event|1|||
147275323|NCT02047110|531175277|FG001|Escape Treatment Period|Adverse Event|2|||
147275324|NCT02047110|531175278|FG002|Escape Treatment Period|Adverse Event|2|||
147275325|NCT02047110|531175279|FG003|Escape Treatment Period|Adverse Event|0|||
147275326|NCT02047110|531175276|FG000|Escape Treatment Period|Other than specified|1|||
147275327|NCT02047110|531175277|FG001|Escape Treatment Period|Other than specified|2|||
147275328|NCT02047110|531175278|FG002|Escape Treatment Period|Other than specified|0|||
147275329|NCT02047110|531175279|FG003|Escape Treatment Period|Other than specified|1|||
147275330|NCT02047110|531175276|FG000|OLE Treatment Period|Other than specified|0|||
147275331|NCT02047110|531175277|FG001|OLE Treatment Period|Other than specified|0|||
147275332|NCT02047110|531175278|FG002|OLE Treatment Period|Other than specified|1|||
147275333|NCT02047110|531175279|FG003|OLE Treatment Period|Other than specified|0|||
147275334|NCT00705575|531175280|FG000|Overall Study|Abnormal laboratory value(s)|0|||
147275335|NCT00705575|531175281|FG001|Overall Study|Abnormal laboratory value(s)|3|||
147275336|NCT00705575|531175280|FG000|Overall Study|Abnormal test procedure result(s)|2|||
147275337|NCT00705575|531175281|FG001|Overall Study|Abnormal test procedure result(s)|12|||
147275338|NCT00705575|531175280|FG000|Overall Study|Adverse Event|11|||
147275339|NCT00705575|531175281|FG001|Overall Study|Adverse Event|15|||
147275340|NCT00705575|531175280|FG000|Overall Study|Lost to Follow-up|3|||
147275341|NCT00705575|531175281|FG001|Overall Study|Lost to Follow-up|4|||
147275342|NCT00705575|531175280|FG000|Overall Study|Protocol Violation|2|||
147275343|NCT00705575|531175281|FG001|Overall Study|Protocol Violation|2|||
147275344|NCT00705575|531175280|FG000|Overall Study|Withdrawal by Subject|5|||
147275345|NCT00705575|531175281|FG001|Overall Study|Withdrawal by Subject|10|||
147275346|NCT01632800|531175284|FG000|Overall Study|Subject did not fit in apparatus|1|||
147275347|NCT01000051|531175286|FG000|Overall Study|Withdrawal by Subject|1|||
147275348|NCT01000051|531175287|FG001|Overall Study|Withdrawal by Subject|1|||
147333963|NCT03262935|531390015|FG000|Overall Study|Death|181|||
147333964|NCT03262935|531390016|FG001|Overall Study|Death|94|||
147333965|NCT03262935|531390015|FG000|Overall Study|Lost to Follow-up|9|||
147333966|NCT03262935|531390016|FG001|Overall Study|Lost to Follow-up|4|||
147333967|NCT03262935|531390015|FG000|Overall Study|Other reason|5|||
147333968|NCT03262935|531390016|FG001|Overall Study|Other reason|0|||
147333969|NCT02567656|531390017|FG000|Overall Study|Premature discontinuation due to PD|1|||
147333970|NCT02567656|531390018|FG001|Overall Study|Premature discontinuation due to PD|1|||
147333971|NCT02567656|531390019|FG002|Overall Study|Premature discontinuation due to PD|2|||
147333972|NCT02567656|531390020|FG003|Overall Study|Premature discontinuation due to PD|0|||
147333973|NCT02567656|531390021|FG004|Overall Study|Premature discontinuation due to PD|0|||
147333974|NCT02567656|531390022|FG005|Overall Study|Premature discontinuation due to PD|0|||
147333975|NCT02441036|531390025|FG000|Overall Study|No tissue resected|0|||
147333976|NCT02441036|531390026|FG001|Overall Study|No tissue resected|1|||
147333977|NCT02441036|531390027|FG002|Overall Study|No tissue resected|0|||
147333978|NCT02441036|531390028|FG003|Overall Study|No tissue resected|1|||
147333979|NCT02441036|531390029|FG004|Overall Study|No tissue resected|0|||
147333980|NCT00612586|531390030|FG000|Overall Study|Adverse Event|6|||
147333981|NCT00612586|531390031|FG001|Overall Study|Adverse Event|2|||
147333982|NCT00612586|531390030|FG000|Overall Study|Death|1|||
147333983|NCT00612586|531390031|FG001|Overall Study|Death|0|||
147333984|NCT00612586|531390030|FG000|Overall Study|Entry Criteria Not Met|0|||
147333985|NCT00612586|531390031|FG001|Overall Study|Entry Criteria Not Met|2|||
147333986|NCT00612586|531390030|FG000|Overall Study|Withdrawal by Subject|7|||
147333987|NCT00612586|531390031|FG001|Overall Study|Withdrawal by Subject|9|||
147333988|NCT00612586|531390030|FG000|Overall Study|Physician Decision|1|||
147333989|NCT00612586|531390031|FG001|Overall Study|Physician Decision|2|||
147333990|NCT00612586|531390030|FG000|Overall Study|Sponsor Decision|1|||
147333991|NCT00612586|531390031|FG001|Overall Study|Sponsor Decision|1|||
147333992|NCT00612586|531390030|FG000|Overall Study|Progressive Disease|26|||
147333993|NCT00612586|531390031|FG001|Overall Study|Progressive Disease|24|||
147333994|NCT00612586|531390030|FG000|Overall Study|Randomized and Not Treated|1|||
147333995|NCT00612586|531390031|FG001|Overall Study|Randomized and Not Treated|1|||
147333996|NCT01901276|531390032|FG000|No PPI: Week 0 to Week 4|Withdrawal by Subject|0|||
147333997|NCT01901276|531390033|FG001|No PPI: Week 0 to Week 4|Withdrawal by Subject|2|||
147275349|NCT01000051|531175286|FG000|Overall Study|Disease Progression|1|||
147275350|NCT01000051|531175287|FG001|Overall Study|Disease Progression|0|||
147275351|NCT01000051|531175286|FG000|Overall Study|Serious noncompliance|1|||
147275352|NCT01000051|531175287|FG001|Overall Study|Serious noncompliance|0|||
147333998|NCT00395018|531390034|FG000|On-Treatment|Death|4|||
147333999|NCT00395018|531390034|FG000|On-Treatment|Other Reason|2|||
147334000|NCT00395018|531390034|FG000|On-Treatment|Poor/non-compliance|2|||
147334001|NCT00395018|531390034|FG000|On-Treatment|Subject no longer meets study criteria|2|||
147334002|NCT00395018|531390034|FG000|Off-Treatment Follow-up|Followup no longer required per protocol|1|||
147334003|NCT00395018|531390034|FG000|Off-Treatment Follow-up|Lost to Follow-up|2|||
147334004|NCT00395018|531390034|FG000|Off-Treatment Follow-up|Poor/non-compliance|1|||
147275353|NCT01959581|531175290|FG000|Overall Study|Lost to Follow-up|5|||
147275354|NCT00854581|531175293|FG000|Induction (Up to Day 21)|Lack of Efficacy|4|||
147275355|NCT00854581|531175293|FG000|Induction (Up to Day 21)|Death|1|||
147275356|NCT00854581|531175293|FG000|Induction (Up to Day 21)|Physician Decision|1|||
147275357|NCT00854581|531175293|FG000|Part 2 Maintenance (Up to 12 Months)|Lack of Efficacy|3|||
147275358|NCT01339390|531175294|FG000|Overall Study|Death|32|||
147275359|NCT01339390|531175295|FG001|Overall Study|Death|29|||
147275360|NCT01339390|531175294|FG000|Overall Study|Lost to Follow-up|125|||
147275361|NCT01339390|531175295|FG001|Overall Study|Lost to Follow-up|127|||
147275362|NCT00378703|531175298|FG000|Overall Study|Disease progression|59|||
147275363|NCT00378703|531175299|FG001|Overall Study|Disease progression|43|||
147275364|NCT00378703|531175300|FG002|Overall Study|Disease progression|48|||
147275365|NCT00378703|531175301|FG003|Overall Study|Disease progression|49|||
147275366|NCT00378703|531175298|FG000|Overall Study|Adverse Event|11|||
147275367|NCT00378703|531175299|FG001|Overall Study|Adverse Event|17|||
147275368|NCT00378703|531175300|FG002|Overall Study|Adverse Event|20|||
147275369|NCT00378703|531175301|FG003|Overall Study|Adverse Event|18|||
147275370|NCT00378703|531175298|FG000|Overall Study|Death|2|||
147275371|NCT00378703|531175299|FG001|Overall Study|Death|2|||
147275372|NCT00378703|531175300|FG002|Overall Study|Death|4|||
147275373|NCT00378703|531175301|FG003|Overall Study|Death|3|||
147275374|NCT00378703|531175298|FG000|Overall Study|Withdrawal by Subject|4|||
147275375|NCT00378703|531175299|FG001|Overall Study|Withdrawal by Subject|8|||
147275376|NCT00378703|531175300|FG002|Overall Study|Withdrawal by Subject|5|||
147275377|NCT00378703|531175301|FG003|Overall Study|Withdrawal by Subject|7|||
147275378|NCT00378703|531175298|FG000|Overall Study|Physician Decision|1|||
147275379|NCT00378703|531175299|FG001|Overall Study|Physician Decision|4|||
147275380|NCT00378703|531175300|FG002|Overall Study|Physician Decision|1|||
147275381|NCT00378703|531175301|FG003|Overall Study|Physician Decision|0|||
147275382|NCT00378703|531175298|FG000|Overall Study|Alternative therapy|4|||
147275383|NCT00378703|531175299|FG001|Overall Study|Alternative therapy|2|||
147275384|NCT00378703|531175300|FG002|Overall Study|Alternative therapy|0|||
147275385|NCT00378703|531175301|FG003|Overall Study|Alternative therapy|0|||
147275386|NCT00378703|531175298|FG000|Overall Study|Other complicated disease|0|||
147275387|NCT00378703|531175299|FG001|Overall Study|Other complicated disease|2|||
147275388|NCT00378703|531175300|FG002|Overall Study|Other complicated disease|2|||
147275389|NCT00378703|531175301|FG003|Overall Study|Other complicated disease|0|||
147275390|NCT00378703|531175298|FG000|Overall Study|Symptomatic deterioration|0|||
147275391|NCT00378703|531175299|FG001|Overall Study|Symptomatic deterioration|1|||
147275392|NCT00378703|531175300|FG002|Overall Study|Symptomatic deterioration|0|||
147275393|NCT00378703|531175301|FG003|Overall Study|Symptomatic deterioration|2|||
147275394|NCT00378703|531175298|FG000|Overall Study|Surgery|1|||
147275395|NCT00378703|531175299|FG001|Overall Study|Surgery|0|||
147275396|NCT00378703|531175300|FG002|Overall Study|Surgery|0|||
147275397|NCT00378703|531175301|FG003|Overall Study|Surgery|1|||
147275398|NCT00378703|531175298|FG000|Overall Study|Joint decision of physician and patient|1|||
147275399|NCT00378703|531175299|FG001|Overall Study|Joint decision of physician and patient|0|||
147275400|NCT00378703|531175300|FG002|Overall Study|Joint decision of physician and patient|0|||
147275401|NCT00378703|531175301|FG003|Overall Study|Joint decision of physician and patient|0|||
147275402|NCT00378703|531175298|FG000|Overall Study|Adverse events and progressive disease|0|||
147275403|NCT00378703|531175299|FG001|Overall Study|Adverse events and progressive disease|0|||
147275404|NCT00378703|531175300|FG002|Overall Study|Adverse events and progressive disease|0|||
147275405|NCT00378703|531175301|FG003|Overall Study|Adverse events and progressive disease|1|||
147275406|NCT00378703|531175298|FG000|Overall Study|Relocation|0|||
147275407|NCT00378703|531175299|FG001|Overall Study|Relocation|0|||
147275408|NCT00378703|531175300|FG002|Overall Study|Relocation|1|||
147275409|NCT00378703|531175301|FG003|Overall Study|Relocation|0|||
147275410|NCT00378703|531175298|FG000|Overall Study|Ineligible|4|||
147275411|NCT00378703|531175299|FG001|Overall Study|Ineligible|7|||
147275412|NCT00378703|531175300|FG002|Overall Study|Ineligible|7|||
147275413|NCT00378703|531175301|FG003|Overall Study|Ineligible|7|||
147275414|NCT00378703|531175298|FG000|Overall Study|Never started treatment|1|||
147275415|NCT00378703|531175299|FG001|Overall Study|Never started treatment|4|||
147275416|NCT00378703|531175300|FG002|Overall Study|Never started treatment|0|||
147275417|NCT00378703|531175301|FG003|Overall Study|Never started treatment|0|||
147275418|NCT00378703|531175298|FG000|Overall Study|Other|1|||
147275419|NCT00378703|531175299|FG001|Overall Study|Other|1|||
147275420|NCT00378703|531175300|FG002|Overall Study|Other|2|||
147275421|NCT00378703|531175301|FG003|Overall Study|Other|3|||
147275422|NCT01541930|531175309|FG000|Overall Study|Withdrawal by Subject|1|||
147275423|NCT01957475|531175310|FG000|Test Period 1|Withdrawal by Subject|1|||
147275424|NCT01957475|531175311|FG001|Test Period 1|Withdrawal by Subject|0|||
147275425|NCT01957475|531175310|FG000|Test Period 1|Other|1|||
147275426|NCT01957475|531175311|FG001|Test Period 1|Other|0|||
147275427|NCT01957475|531175310|FG000|Test Period 1|Lack of Efficacy|0|||
147275428|NCT01957475|531175311|FG001|Test Period 1|Lack of Efficacy|1|||
147275429|NCT01957475|531175310|FG000|Test Period 2|Adverse Event|1|||
147275430|NCT01957475|531175311|FG001|Test Period 2|Adverse Event|0|||
147275431|NCT00813358|531175314|FG000|Overall Study|Death|32|||
147275432|NCT00813358|531175314|FG000|Overall Study|Lost to Follow-up|12|||
147275433|NCT00813358|531175314|FG000|Overall Study|other endpoints|5|||
147275434|NCT00813358|531175314|FG000|Overall Study|Withdrawal by Subject|20|||
147275435|NCT04497987|531175315|FG000|Overall Study|Adverse Event|1|||
147275436|NCT04497987|531175316|FG001|Overall Study|Adverse Event|0|||
147275437|NCT04497987|531175315|FG000|Overall Study|Death|21|||
147275438|NCT04497987|531175316|FG001|Overall Study|Death|13|||
147275439|NCT04497987|531175315|FG000|Overall Study|Lost to Follow-up|19|||
147275440|NCT04497987|531175316|FG001|Overall Study|Lost to Follow-up|17|||
147275441|NCT04497987|531175315|FG000|Overall Study|Other - as reported by the investigator|22|||
147275442|NCT04497987|531175316|FG001|Overall Study|Other - as reported by the investigator|16|||
147275443|NCT04497987|531175315|FG000|Overall Study|Physician Decision|1|||
147275444|NCT04497987|531175316|FG001|Overall Study|Physician Decision|0|||
147275445|NCT04497987|531175315|FG000|Overall Study|Withdrawal by Subject|35|||
147275446|NCT04497987|531175316|FG001|Overall Study|Withdrawal by Subject|21|||
147275447|NCT03665038|531175317|FG000|Overall Study|Lost to Follow-up|0|||
147275448|NCT03665038|531175318|FG001|Overall Study|Lost to Follow-up|0|||
147275449|NCT03665038|531175319|FG002|Overall Study|Lost to Follow-up|1|||
147275450|NCT03890367|531175324|FG000|Overall Study|Withdrawal by parent/guardian|1|||
147275451|NCT03890367|531175325|FG001|Overall Study|Withdrawal by parent/guardian|3|||
147275452|NCT03890367|531175326|FG002|Overall Study|Withdrawal by parent/guardian|0|||
147275453|NCT03890367|531175324|FG000|Overall Study|Protocol deviation|2|||
147275454|NCT03890367|531175325|FG001|Overall Study|Protocol deviation|2|||
147275455|NCT03890367|531175326|FG002|Overall Study|Protocol deviation|1|||
147275456|NCT03890367|531175324|FG000|Overall Study|Lost to Follow-up|1|||
147275457|NCT03890367|531175325|FG001|Overall Study|Lost to Follow-up|1|||
147275458|NCT03890367|531175326|FG002|Overall Study|Lost to Follow-up|0|||
147275459|NCT01310413|531177540|FG000|Day 0 to Day 385|Withdrawal by Subject|5|||
147275460|NCT01310413|531177541|FG001|Day 0 to Day 385|Withdrawal by Subject|2|||
147275461|NCT01310413|531177542|FG002|Day 0 to Day 385|Withdrawal by Subject|0|||
147275462|NCT01310413|531177543|FG003|Day 0 to Day 385|Withdrawal by Subject|2|||
147275463|NCT01310413|531177544|FG004|Day 0 to Day 385|Withdrawal by Subject|1|||
147275464|NCT01310413|531177545|FG005|Day 0 to Day 385|Withdrawal by Subject|1|||
147275465|NCT01310413|531177546|FG006|Day 0 to Day 385|Withdrawal by Subject|0|||
147275466|NCT01310413|531177540|FG000|Day 0 to Day 385|Lost to Follow-up|18|||
147275467|NCT01310413|531177541|FG001|Day 0 to Day 385|Lost to Follow-up|3|||
147275468|NCT01310413|531177542|FG002|Day 0 to Day 385|Lost to Follow-up|3|||
147275469|NCT01310413|531177543|FG003|Day 0 to Day 385|Lost to Follow-up|5|||
147275470|NCT01310413|531177544|FG004|Day 0 to Day 385|Lost to Follow-up|1|||
147275471|NCT01310413|531177545|FG005|Day 0 to Day 385|Lost to Follow-up|2|||
147275472|NCT01310413|531177546|FG006|Day 0 to Day 385|Lost to Follow-up|0|||
147275473|NCT01310413|531177540|FG000|Day 0 to Day 385|Migrated/moved from study area|3|||
147275474|NCT01310413|531177541|FG001|Day 0 to Day 385|Migrated/moved from study area|3|||
147275475|NCT01310413|531177542|FG002|Day 0 to Day 385|Migrated/moved from study area|1|||
147275476|NCT01310413|531177543|FG003|Day 0 to Day 385|Migrated/moved from study area|1|||
147275477|NCT01310413|531177544|FG004|Day 0 to Day 385|Migrated/moved from study area|1|||
147275478|NCT01310413|531177545|FG005|Day 0 to Day 385|Migrated/moved from study area|0|||
147275479|NCT01310413|531177546|FG006|Day 0 to Day 385|Migrated/moved from study area|0|||
147275480|NCT01310413|531177540|FG000|Day 0 to Day 385|Other|1|||
147275481|NCT01310413|531177541|FG001|Day 0 to Day 385|Other|0|||
147275482|NCT01310413|531177542|FG002|Day 0 to Day 385|Other|3|||
147275483|NCT01310413|531177543|FG003|Day 0 to Day 385|Other|0|||
147275484|NCT01310413|531177544|FG004|Day 0 to Day 385|Other|0|||
147334005|NCT03257813|531390038|FG000|Overall Study|Protocol Violation|6|||
147334006|NCT03257813|531390039|FG001|Overall Study|Protocol Violation|3|||
147334007|NCT03478696|531390040|FG000|Overall Study|Adverse Event|1|||
147334008|NCT03478696|531390041|FG001|Overall Study|Adverse Event|5|||
147334009|NCT03478696|531390040|FG000|Overall Study|Lost to Follow-up|1|||
147275485|NCT01310413|531177545|FG005|Day 0 to Day 385|Other|0|||
147275486|NCT01310413|531177546|FG006|Day 0 to Day 385|Other|0|||
147275487|NCT01310413|531177540|FG000|From Day U0 to Day U385|Withdrawal by Subject|0|||
147275488|NCT01310413|531177541|FG001|From Day U0 to Day U385|Withdrawal by Subject|0|||
147275489|NCT01310413|531177542|FG002|From Day U0 to Day U385|Withdrawal by Subject|0|||
147275490|NCT01310413|531177543|FG003|From Day U0 to Day U385|Withdrawal by Subject|0|||
147275491|NCT01310413|531177544|FG004|From Day U0 to Day U385|Withdrawal by Subject|0|||
147275492|NCT01310413|531177545|FG005|From Day U0 to Day U385|Withdrawal by Subject|0|||
147275493|NCT01310413|531177546|FG006|From Day U0 to Day U385|Withdrawal by Subject|1|||
147334010|NCT03478696|531390041|FG001|Overall Study|Lost to Follow-up|0|||
147334011|NCT03478696|531390040|FG000|Overall Study|Physician Decision|6|||
147275494|NCT01310413|531177540|FG000|From Day U0 to Day U385|Lost to Follow-up|0|||
147275495|NCT01310413|531177541|FG001|From Day U0 to Day U385|Lost to Follow-up|0|||
147334012|NCT03478696|531390041|FG001|Overall Study|Physician Decision|3|||
147600591|NCT00424775|532356425|FG000|Overall Study|Adverse Event|2|||
147275496|NCT01310413|531177542|FG002|From Day U0 to Day U385|Lost to Follow-up|0|||
147275497|NCT01310413|531177543|FG003|From Day U0 to Day U385|Lost to Follow-up|0|||
147275498|NCT01310413|531177544|FG004|From Day U0 to Day U385|Lost to Follow-up|0|||
147334013|NCT03478696|531390040|FG000|Overall Study|Withdrawal by Subject|9|||
147662430|NCT01854697|532587329|FG003|Overall Study|Withdrew Consent|1|||
147275499|NCT01310413|531177545|FG005|From Day U0 to Day U385|Lost to Follow-up|0|||
147275500|NCT01310413|531177546|FG006|From Day U0 to Day U385|Lost to Follow-up|2|||
147275501|NCT02564471|531177547|FG000|Overall Study|Adverse Event|1|||
147662431|NCT01854697|532587330|FG004|Overall Study|Withdrew Consent|0|||
147662432|NCT01854697|532587326|FG000|Overall Study|Other|0|||
147662433|NCT01854697|532587327|FG001|Overall Study|Other|1|||
147662434|NCT01854697|532587328|FG002|Overall Study|Other|1|||
147662435|NCT01854697|532587329|FG003|Overall Study|Other|0|||
147662436|NCT01854697|532587330|FG004|Overall Study|Other|0|||
147662437|NCT01607593|532587336|FG000|Overall Study|Adverse Event|15|||
147662438|NCT01607593|532587336|FG000|Overall Study|Lack of Efficacy|16|||
147662439|NCT01607593|532587336|FG000|Overall Study|Lost to Follow-up|25|||
147662440|NCT01607593|532587336|FG000|Overall Study|Continuation|33|||
147662441|NCT01607593|532587336|FG000|Overall Study|Other|4|||
147662442|NCT02515630|532587339|FG000|Overall Study|Withdrawal by Subject|5|||
147662443|NCT02515630|532587339|FG000|Overall Study|Adverse Event|4|||
147275502|NCT02564471|531177548|FG001|Overall Study|Adverse Event|0|||
147275503|NCT02564471|531177549|FG002|Overall Study|Adverse Event|0|||
147275504|NCT02564471|531177550|FG003|Overall Study|Adverse Event|0|||
147275505|NCT02564471|531177547|FG000|Overall Study|Withdrawal by Subject|2|||
147275506|NCT02564471|531177548|FG001|Overall Study|Withdrawal by Subject|1|||
147275507|NCT02564471|531177549|FG002|Overall Study|Withdrawal by Subject|3|||
147275508|NCT02564471|531177550|FG003|Overall Study|Withdrawal by Subject|0|||
147275509|NCT02564471|531177547|FG000|Overall Study|Lost to Follow-up|0|||
147275510|NCT02564471|531177548|FG001|Overall Study|Lost to Follow-up|2|||
147275511|NCT02564471|531177549|FG002|Overall Study|Lost to Follow-up|0|||
147275512|NCT02564471|531177550|FG003|Overall Study|Lost to Follow-up|0|||
147275513|NCT00941733|531177551|FG000|Overall Study|Death|24|||
147275514|NCT00941733|531177552|FG001|Overall Study|Death|10|||
147275515|NCT00941733|531177551|FG000|Overall Study|Withdrawal by Subject|14|||
147275516|NCT00941733|531177552|FG001|Overall Study|Withdrawal by Subject|6|||
147275517|NCT00941733|531177551|FG000|Overall Study|Adverse Event|20|||
147275518|NCT00941733|531177552|FG001|Overall Study|Adverse Event|4|||
147275519|NCT00941733|531177551|FG000|Overall Study|Lost to Follow-up|1|||
147275520|NCT00941733|531177552|FG001|Overall Study|Lost to Follow-up|2|||
147275521|NCT00941733|531177551|FG000|Overall Study|Protocol Violation|15|||
147334014|NCT03478696|531390041|FG001|Overall Study|Withdrawal by Subject|4|||
147334015|NCT03615924|531390042|FG000|Overall Study|Withdrawal by Subject|2|||
147334016|NCT03615924|531390043|FG001|Overall Study|Withdrawal by Subject|5|||
147334017|NCT03615924|531390042|FG000|Overall Study|Death|3|||
147334018|NCT03615924|531390043|FG001|Overall Study|Death|1|||
147334019|NCT03615924|531390042|FG000|Overall Study|Lost to Follow-up|1|||
147334020|NCT03615924|531390043|FG001|Overall Study|Lost to Follow-up|0|||
147334021|NCT03615924|531390042|FG000|Overall Study|Randomized in error|1|||
147334022|NCT03615924|531390043|FG001|Overall Study|Randomized in error|0|||
147334023|NCT03615924|531390042|FG000|Overall Study|Study termination by Sponsor|94|||
147450863|NCT00621504|531813168|FG000|Overall Study|Death|6|||
147450864|NCT00621504|531813169|FG001|Overall Study|Death|6|||
147450865|NCT03257267|531813174|FG000|Overall Study|Adverse Event|17|||
147600592|NCT00424775|532356426|FG001|Overall Study|Adverse Event|0|||
147600593|NCT00424775|532356425|FG000|Overall Study|Lack of Efficacy|1|||
147600594|NCT00424775|532356426|FG001|Overall Study|Lack of Efficacy|0|||
147600595|NCT00681590|532356427|FG000|Overall Study|Withdrawal by Subject|2|||
147600596|NCT00681590|532356428|FG001|Overall Study|Withdrawal by Subject|12|||
147600597|NCT02912650|532356429|FG000|Overall Study|Withdrawal by Subject|1|||
147600598|NCT02912650|532356430|FG001|Overall Study|Withdrawal by Subject|0|||
147600599|NCT02912650|532356431|FG002|Overall Study|Withdrawal by Subject|1|||
147600600|NCT02912650|532356432|FG003|Overall Study|Withdrawal by Subject|5|||
147600601|NCT02912650|532356429|FG000|Overall Study|Adverse Event|0|||
147600602|NCT02912650|532356430|FG001|Overall Study|Adverse Event|0|||
147662444|NCT02515630|532587339|FG000|Overall Study|Physician Decision|4|||
147275522|NCT00941733|531177552|FG001|Overall Study|Protocol Violation|6|||
147275523|NCT04260191|531177554|FG000|Overall Study|Decision by Sponsor|0|||
147450866|NCT03257267|531813175|FG001|Overall Study|Adverse Event|7|||
147275524|NCT04260191|531177555|FG001|Overall Study|Decision by Sponsor|1|||
147275525|NCT04260191|531177556|FG002|Overall Study|Decision by Sponsor|0|||
147275526|NCT04260191|531177554|FG000|Overall Study|Withdrawal by Subject|1|||
147275527|NCT04260191|531177555|FG001|Overall Study|Withdrawal by Subject|0|||
147275528|NCT04260191|531177556|FG002|Overall Study|Withdrawal by Subject|3|||
147334024|NCT03615924|531390043|FG001|Overall Study|Study termination by Sponsor|86|||
147334025|NCT00716144|531390044|FG000|Overall Study|Withdrawal by Subject|4|||
147450867|NCT03257267|531813174|FG000|Overall Study|Death|96|||
147450868|NCT03257267|531813175|FG001|Overall Study|Death|98|||
147600603|NCT02912650|532356431|FG002|Overall Study|Adverse Event|1|||
147662445|NCT02515630|532587339|FG000|Overall Study|Death|2|||
147662446|NCT02515630|532587339|FG000|Overall Study|Disease Progression|1|||
147662447|NCT00483652|532587340|FG000|Double-blind Treatment Period|Protocol Violation|2|||
147662448|NCT00483652|532587341|FG001|Double-blind Treatment Period|Protocol Violation|1|||
147662449|NCT00483652|532587340|FG000|Double-blind Treatment Period|Adverse Event|3|||
147600604|NCT02912650|532356432|FG003|Overall Study|Adverse Event|0|||
147600605|NCT01791153|532356435|FG000|Part 1: Blinded Period|Adverse Event|7|||
147600606|NCT01791153|532356436|FG001|Part 1: Blinded Period|Adverse Event|3|||
147600607|NCT01791153|532356437|FG002|Part 1: Blinded Period|Adverse Event|2|||
147600608|NCT01791153|532356438|FG003|Part 1: Blinded Period|Adverse Event|0|||
147600609|NCT01791153|532356439|FG004|Part 1: Blinded Period|Adverse Event|0|||
147600610|NCT01791153|532356440|FG005|Part 1: Blinded Period|Adverse Event|0|||
147600611|NCT01791153|532356441|FG006|Part 1: Blinded Period|Adverse Event|0|||
147600612|NCT01791153|532356442|FG007|Part 1: Blinded Period|Adverse Event|0|||
147600613|NCT01791153|532356435|FG000|Part 1: Blinded Period|Lack of Efficacy|1|||
147600614|NCT01791153|532356436|FG001|Part 1: Blinded Period|Lack of Efficacy|3|||
147600615|NCT01791153|532356437|FG002|Part 1: Blinded Period|Lack of Efficacy|2|||
147600616|NCT01791153|532356438|FG003|Part 1: Blinded Period|Lack of Efficacy|2|||
147600617|NCT01791153|532356439|FG004|Part 1: Blinded Period|Lack of Efficacy|0|||
147600618|NCT01791153|532356440|FG005|Part 1: Blinded Period|Lack of Efficacy|0|||
147600619|NCT01791153|532356441|FG006|Part 1: Blinded Period|Lack of Efficacy|0|||
147600620|NCT01791153|532356442|FG007|Part 1: Blinded Period|Lack of Efficacy|0|||
147600621|NCT01791153|532356435|FG000|Part 1: Blinded Period|Non-Compliance|1|||
147600622|NCT01791153|532356436|FG001|Part 1: Blinded Period|Non-Compliance|0|||
147600623|NCT01791153|532356437|FG002|Part 1: Blinded Period|Non-Compliance|0|||
147600624|NCT01791153|532356438|FG003|Part 1: Blinded Period|Non-Compliance|0|||
147275529|NCT04260191|531177554|FG000|Overall Study|Death|4|||
147275530|NCT04260191|531177555|FG001|Overall Study|Death|3|||
147275531|NCT04260191|531177556|FG002|Overall Study|Death|2|||
147275532|NCT01643473|531177557|FG000|Overall Study|Lost to Follow-up|1|||
147275533|NCT01643473|531177558|FG001|Overall Study|Lost to Follow-up|0|||
147275534|NCT01519518|531177560|FG000|Overall Study|Consent not available|7|||
147275535|NCT01519518|531177561|FG001|Overall Study|Consent not available|10|||
147275536|NCT02033889|531177562|FG000|Overall Study|Adverse Event|3|||
147600625|NCT01791153|532356439|FG004|Part 1: Blinded Period|Non-Compliance|0|||
147600626|NCT01791153|532356440|FG005|Part 1: Blinded Period|Non-Compliance|0|||
147600627|NCT01791153|532356441|FG006|Part 1: Blinded Period|Non-Compliance|0|||
147600628|NCT01791153|532356442|FG007|Part 1: Blinded Period|Non-Compliance|0|||
147600629|NCT01791153|532356435|FG000|Part 1: Blinded Period|Physician Decision|0|||
147600630|NCT01791153|532356436|FG001|Part 1: Blinded Period|Physician Decision|0|||
147600631|NCT01791153|532356437|FG002|Part 1: Blinded Period|Physician Decision|0|||
147600632|NCT01791153|532356438|FG003|Part 1: Blinded Period|Physician Decision|1|||
147600633|NCT01791153|532356439|FG004|Part 1: Blinded Period|Physician Decision|0|||
147600634|NCT01791153|532356440|FG005|Part 1: Blinded Period|Physician Decision|0|||
147600635|NCT01791153|532356441|FG006|Part 1: Blinded Period|Physician Decision|0|||
147600636|NCT01791153|532356442|FG007|Part 1: Blinded Period|Physician Decision|0|||
147600637|NCT01791153|532356435|FG000|Part 1: Blinded Period|Protocol Violation|0|||
147600638|NCT01791153|532356436|FG001|Part 1: Blinded Period|Protocol Violation|0|||
147600639|NCT01791153|532356437|FG002|Part 1: Blinded Period|Protocol Violation|0|||
147600640|NCT01791153|532356438|FG003|Part 1: Blinded Period|Protocol Violation|1|||
147600641|NCT01791153|532356439|FG004|Part 1: Blinded Period|Protocol Violation|0|||
147275537|NCT02033889|531177563|FG001|Overall Study|Adverse Event|1|||
147275538|NCT02033889|531177564|FG002|Overall Study|Adverse Event|3|||
147334026|NCT00716144|531390045|FG001|Overall Study|Withdrawal by Subject|2|||
147334027|NCT00716144|531390046|FG002|Overall Study|Withdrawal by Subject|6|||
147334028|NCT00716144|531390047|FG003|Overall Study|Withdrawal by Subject|6|||
147334029|NCT00716144|531390044|FG000|Overall Study|Lost to Follow-up|2|||
147334030|NCT00716144|531390045|FG001|Overall Study|Lost to Follow-up|2|||
147334031|NCT00716144|531390046|FG002|Overall Study|Lost to Follow-up|1|||
147334032|NCT00716144|531390047|FG003|Overall Study|Lost to Follow-up|2|||
147334033|NCT00716144|531390044|FG000|Overall Study|Adverse Event|0|||
147334034|NCT00716144|531390045|FG001|Overall Study|Adverse Event|0|||
147334035|NCT00716144|531390046|FG002|Overall Study|Adverse Event|0|||
147334036|NCT00716144|531390047|FG003|Overall Study|Adverse Event|2|||
147334037|NCT00716144|531390044|FG000|Overall Study|Non-compliance|1|||
147334038|NCT00716144|531390045|FG001|Overall Study|Non-compliance|0|||
147334039|NCT00716144|531390046|FG002|Overall Study|Non-compliance|0|||
147334040|NCT00716144|531390047|FG003|Overall Study|Non-compliance|0|||
147334041|NCT00716144|531390044|FG000|Overall Study|Protocol Violation|2|||
147334042|NCT00716144|531390045|FG001|Overall Study|Protocol Violation|0|||
147600642|NCT01791153|532356440|FG005|Part 1: Blinded Period|Protocol Violation|0|||
147600643|NCT01791153|532356441|FG006|Part 1: Blinded Period|Protocol Violation|0|||
147600644|NCT01791153|532356442|FG007|Part 1: Blinded Period|Protocol Violation|0|||
147334043|NCT00716144|531390046|FG002|Overall Study|Protocol Violation|1|||
147275539|NCT02033889|531177562|FG000|Overall Study|Death|3|||
147275540|NCT02033889|531177563|FG001|Overall Study|Death|1|||
147334044|NCT00716144|531390047|FG003|Overall Study|Protocol Violation|0|||
147600645|NCT01791153|532356435|FG000|Part 1: Blinded Period|Withdrawal by Subject|6|||
147600646|NCT01791153|532356436|FG001|Part 1: Blinded Period|Withdrawal by Subject|2|||
147334045|NCT00716144|531390044|FG000|Overall Study|Physician Decision|0|||
147334046|NCT00716144|531390045|FG001|Overall Study|Physician Decision|1|||
147334047|NCT00716144|531390046|FG002|Overall Study|Physician Decision|2|||
147275541|NCT02033889|531177564|FG002|Overall Study|Death|2|||
147275542|NCT02033889|531177562|FG000|Overall Study|Excluded Medication|1|||
147275543|NCT02033889|531177563|FG001|Overall Study|Excluded Medication|1|||
147275544|NCT02033889|531177564|FG002|Overall Study|Excluded Medication|0|||
147275545|NCT02033889|531177562|FG000|Overall Study|Lost to Follow-up|8|||
147275546|NCT02033889|531177563|FG001|Overall Study|Lost to Follow-up|5|||
147275547|NCT02033889|531177564|FG002|Overall Study|Lost to Follow-up|6|||
147275548|NCT02033889|531177562|FG000|Overall Study|Non-Compliance With Study Drug|1|||
147275549|NCT02033889|531177563|FG001|Overall Study|Non-Compliance With Study Drug|0|||
147275550|NCT02033889|531177564|FG002|Overall Study|Non-Compliance With Study Drug|0|||
147275551|NCT02033889|531177562|FG000|Overall Study|Physician Decision|0|||
147275552|NCT02033889|531177563|FG001|Overall Study|Physician Decision|1|||
147275553|NCT02033889|531177564|FG002|Overall Study|Physician Decision|1|||
147275554|NCT02033889|531177562|FG000|Overall Study|Participant moved|0|||
147275555|NCT02033889|531177563|FG001|Overall Study|Participant moved|1|||
147275556|NCT02033889|531177564|FG002|Overall Study|Participant moved|0|||
147275557|NCT02033889|531177562|FG000|Overall Study|Withdrawal by Subject|18|||
147275558|NCT02033889|531177563|FG001|Overall Study|Withdrawal by Subject|10|||
147275559|NCT02033889|531177564|FG002|Overall Study|Withdrawal by Subject|13|||
147275560|NCT03019536|531177565|FG000|Overall Study|Withdrawal by Subject|1|||
147275561|NCT03019536|531177566|FG001|Overall Study|Withdrawal by Subject|1|||
147275562|NCT03019536|531177567|FG002|Overall Study|Withdrawal by Subject|0|||
147275563|NCT03019536|531177565|FG000|Overall Study|Adverse Event|0|||
147275564|NCT03019536|531177566|FG001|Overall Study|Adverse Event|0|||
147275565|NCT03019536|531177567|FG002|Overall Study|Adverse Event|2|||
147275566|NCT01312909|531177568|FG000|Overall Study|Randomized but not treated|1|||
147275567|NCT01312909|531177569|FG001|Overall Study|Randomized but not treated|3|||
147275568|NCT01312909|531177570|FG002|Overall Study|Randomized but not treated|1|||
147275569|NCT01312909|531177568|FG000|Overall Study|Adverse Event|1|||
147275570|NCT01312909|531177569|FG001|Overall Study|Adverse Event|0|||
147275571|NCT01312909|531177570|FG002|Overall Study|Adverse Event|3|||
147275572|NCT01312909|531177568|FG000|Overall Study|Protocol Violation|2|||
147275573|NCT01312909|531177569|FG001|Overall Study|Protocol Violation|0|||
147275574|NCT01312909|531177570|FG002|Overall Study|Protocol Violation|2|||
147600647|NCT01791153|532356437|FG002|Part 1: Blinded Period|Withdrawal by Subject|2|||
147600648|NCT01791153|532356438|FG003|Part 1: Blinded Period|Withdrawal by Subject|1|||
147600649|NCT01791153|532356439|FG004|Part 1: Blinded Period|Withdrawal by Subject|0|||
147600650|NCT01791153|532356440|FG005|Part 1: Blinded Period|Withdrawal by Subject|0|||
147600651|NCT01791153|532356441|FG006|Part 1: Blinded Period|Withdrawal by Subject|0|||
147600652|NCT01791153|532356442|FG007|Part 1: Blinded Period|Withdrawal by Subject|0|||
147600653|NCT01791153|532356435|FG000|Part 2: Open-label Period|Adverse Event|0|||
147600654|NCT01791153|532356436|FG001|Part 2: Open-label Period|Adverse Event|0|||
147600655|NCT01791153|532356437|FG002|Part 2: Open-label Period|Adverse Event|0|||
147600656|NCT01791153|532356438|FG003|Part 2: Open-label Period|Adverse Event|0|||
147600657|NCT01791153|532356439|FG004|Part 2: Open-label Period|Adverse Event|0|||
147600658|NCT01791153|532356440|FG005|Part 2: Open-label Period|Adverse Event|1|||
147600659|NCT01791153|532356441|FG006|Part 2: Open-label Period|Adverse Event|1|||
147600660|NCT01791153|532356442|FG007|Part 2: Open-label Period|Adverse Event|2|||
147600661|NCT01791153|532356435|FG000|Part 2: Open-label Period|Death|0|||
147600662|NCT01791153|532356436|FG001|Part 2: Open-label Period|Death|0|||
147600663|NCT01791153|532356437|FG002|Part 2: Open-label Period|Death|0|||
147600664|NCT01791153|532356438|FG003|Part 2: Open-label Period|Death|0|||
147600665|NCT01791153|532356439|FG004|Part 2: Open-label Period|Death|0|||
147600666|NCT01791153|532356440|FG005|Part 2: Open-label Period|Death|1|||
147600667|NCT01791153|532356441|FG006|Part 2: Open-label Period|Death|1|||
147600668|NCT01791153|532356442|FG007|Part 2: Open-label Period|Death|1|||
147600669|NCT01791153|532356435|FG000|Part 2: Open-label Period|Lost to Follow-up|0|||
147600670|NCT01791153|532356436|FG001|Part 2: Open-label Period|Lost to Follow-up|0|||
147600671|NCT01791153|532356437|FG002|Part 2: Open-label Period|Lost to Follow-up|0|||
147600672|NCT01791153|532356438|FG003|Part 2: Open-label Period|Lost to Follow-up|0|||
147600673|NCT01791153|532356439|FG004|Part 2: Open-label Period|Lost to Follow-up|0|||
147662450|NCT00483652|532587341|FG001|Double-blind Treatment Period|Adverse Event|4|||
147275575|NCT01312909|531177568|FG000|Overall Study|Other|9|||
147275576|NCT01312909|531177569|FG001|Overall Study|Other|6|||
147600674|NCT01791153|532356440|FG005|Part 2: Open-label Period|Lost to Follow-up|0|||
147600675|NCT01791153|532356441|FG006|Part 2: Open-label Period|Lost to Follow-up|1|||
147600676|NCT01791153|532356442|FG007|Part 2: Open-label Period|Lost to Follow-up|0|||
147275577|NCT01312909|531177570|FG002|Overall Study|Other|11|||
147275578|NCT01312909|531177568|FG000|Overall Study|Withdrawal by Subject|8|||
147275579|NCT01312909|531177569|FG001|Overall Study|Withdrawal by Subject|10|||
147600677|NCT01791153|532356435|FG000|Part 2: Open-label Period|Lack of Efficacy|0|||
147600678|NCT01791153|532356436|FG001|Part 2: Open-label Period|Lack of Efficacy|0|||
147600679|NCT01791153|532356437|FG002|Part 2: Open-label Period|Lack of Efficacy|0|||
147275580|NCT01312909|531177570|FG002|Overall Study|Withdrawal by Subject|7|||
147275581|NCT01312909|531177568|FG000|Overall Study|Lost to Follow-up|21|||
147275582|NCT01312909|531177569|FG001|Overall Study|Lost to Follow-up|17|||
147275583|NCT01312909|531177570|FG002|Overall Study|Lost to Follow-up|20|||
147600680|NCT01791153|532356438|FG003|Part 2: Open-label Period|Lack of Efficacy|0|||
147600681|NCT01791153|532356439|FG004|Part 2: Open-label Period|Lack of Efficacy|0|||
147600682|NCT01791153|532356440|FG005|Part 2: Open-label Period|Lack of Efficacy|0|||
147600683|NCT01791153|532356441|FG006|Part 2: Open-label Period|Lack of Efficacy|0|||
147600684|NCT01791153|532356442|FG007|Part 2: Open-label Period|Lack of Efficacy|1|||
147600685|NCT01791153|532356435|FG000|Part 2: Open-label Period|Withdrawal by Subject|0|||
147600686|NCT01791153|532356436|FG001|Part 2: Open-label Period|Withdrawal by Subject|0|||
147600687|NCT01791153|532356437|FG002|Part 2: Open-label Period|Withdrawal by Subject|0|||
147600688|NCT01791153|532356438|FG003|Part 2: Open-label Period|Withdrawal by Subject|0|||
147600689|NCT01791153|532356439|FG004|Part 2: Open-label Period|Withdrawal by Subject|1|||
147600690|NCT01791153|532356440|FG005|Part 2: Open-label Period|Withdrawal by Subject|1|||
147600691|NCT01791153|532356441|FG006|Part 2: Open-label Period|Withdrawal by Subject|3|||
147600692|NCT01791153|532356442|FG007|Part 2: Open-label Period|Withdrawal by Subject|2|||
147600693|NCT01791153|532356435|FG000|Part 2: Open-label Period|Physician Decision|0|||
147600694|NCT01791153|532356436|FG001|Part 2: Open-label Period|Physician Decision|0|||
147600695|NCT01791153|532356437|FG002|Part 2: Open-label Period|Physician Decision|0|||
147600696|NCT01791153|532356438|FG003|Part 2: Open-label Period|Physician Decision|0|||
147600697|NCT01791153|532356439|FG004|Part 2: Open-label Period|Physician Decision|1|||
147600698|NCT01791153|532356440|FG005|Part 2: Open-label Period|Physician Decision|1|||
147600699|NCT01791153|532356441|FG006|Part 2: Open-label Period|Physician Decision|0|||
147600700|NCT01791153|532356442|FG007|Part 2: Open-label Period|Physician Decision|0|||
147600701|NCT02900976|532356450|FG000|Overall Study|Adverse Event|0|||
147600702|NCT02900976|532356451|FG001|Overall Study|Adverse Event|1|||
147600703|NCT02900976|532356450|FG000|Overall Study|Physician Decision|0|||
147600704|NCT02900976|532356451|FG001|Overall Study|Physician Decision|2|||
147600705|NCT02900976|532356450|FG000|Overall Study|Progressive disease|0|||
147600706|NCT02900976|532356451|FG001|Overall Study|Progressive disease|6|||
147600707|NCT01408628|532356452|FG000|Consented|Withdrawal by Subject|12|||
147600708|NCT01408628|532356452|FG000|Completed 6 Month Follow-Up|Lost to Follow-up|3|||
147600709|NCT01408628|532356452|FG000|Completed 6 Month Follow-Up|Protocol Violation|6|||
147600710|NCT01408628|532356452|FG000|Completed 6 Month Follow-Up|Withdrawal by Subject|5|||
147600711|NCT01181271|532356453|FG000|Evaluation for Allogeneic Transplant|Lack of Efficacy|6|||
147600712|NCT01181271|532356453|FG000|Evaluation for Allogeneic Transplant|Withdrawal by Subject|4|||
147600713|NCT01181271|532356453|FG000|Evaluation for Allogeneic Transplant|No suitable donor|2|||
147600714|NCT01181271|532356453|FG000|Evaluation for Allogeneic Transplant|therapy-related AML diagnosed|1|||
147600715|NCT02980874|532356454|FG000|Overall Study|Adverse Event|2|||
147600716|NCT02980874|532356455|FG001|Overall Study|Adverse Event|7|||
147275584|NCT01312909|531177568|FG000|Overall Study|Insufficient clinical response|0|||
147275585|NCT01312909|531177569|FG001|Overall Study|Insufficient clinical response|0|||
147275586|NCT01312909|531177570|FG002|Overall Study|Insufficient clinical response|1|||
147275587|NCT01312909|531177568|FG000|Overall Study|Entrance criteria not met|0|||
147275588|NCT01312909|531177569|FG001|Overall Study|Entrance criteria not met|0|||
147275589|NCT01312909|531177570|FG002|Overall Study|Entrance criteria not met|2|||
147275590|NCT00182689|531177576|FG000|Overall Study|Adverse Event|8|||
147275591|NCT00182689|531177577|FG001|Overall Study|Adverse Event|11|||
147275592|NCT00182689|531177576|FG000|Overall Study|Withdrawal by Subject|2|||
147275593|NCT00182689|531177577|FG001|Overall Study|Withdrawal by Subject|2|||
147275594|NCT00182689|531177576|FG000|Overall Study|Progression|27|||
147275595|NCT00182689|531177577|FG001|Overall Study|Progression|29|||
147275596|NCT00182689|531177576|FG000|Overall Study|Death|1|||
147275597|NCT00182689|531177577|FG001|Overall Study|Death|0|||
147275598|NCT00182689|531177576|FG000|Overall Study|not protocol specified|0|||
147275599|NCT00182689|531177577|FG001|Overall Study|not protocol specified|3|||
147275600|NCT00182689|531177576|FG000|Overall Study|Ineligible|1|||
147275601|NCT00182689|531177577|FG001|Overall Study|Ineligible|4|||
147275602|NCT00182689|531177576|FG000|Overall Study|Never received treatment|1|||
147275603|NCT00182689|531177577|FG001|Overall Study|Never received treatment|0|||
147275604|NCT01640301|531177578|FG000|Overall Study|Death|0|||
147275605|NCT01640301|531177579|FG001|Overall Study|Death|8|||
147275606|NCT00659646|531177580|FG000|Overall Study|Protocol Violation|12|||
147275607|NCT00659646|531177581|FG001|Overall Study|Protocol Violation|8|||
147275608|NCT00659646|531177580|FG000|Overall Study|Adverse Event|1|||
147275609|NCT00659646|531177581|FG001|Overall Study|Adverse Event|0|||
147450869|NCT03257267|531813174|FG000|Overall Study|Lost to Follow-up|2|||
147600717|NCT02980874|532356454|FG000|Overall Study|Withdrawal by Subject|7|||
147600718|NCT02980874|532356455|FG001|Overall Study|Withdrawal by Subject|2|||
147600719|NCT02980874|532356454|FG000|Overall Study|Lost to Follow-up|5|||
147275610|NCT00659646|531177580|FG000|Overall Study|Lost to Follow-up|1|||
147275611|NCT00659646|531177581|FG001|Overall Study|Lost to Follow-up|0|||
147275612|NCT00659646|531177580|FG000|Overall Study|protocol noncompliance after randomized|1|||
147275613|NCT00659646|531177581|FG001|Overall Study|protocol noncompliance after randomized|0|||
147275614|NCT02200042|531177584|FG000|Overall Study|Withdrawal by Subject|0|||
147275615|NCT02200042|531177585|FG001|Overall Study|Withdrawal by Subject|1|||
147334048|NCT00716144|531390047|FG003|Overall Study|Physician Decision|2|||
147334049|NCT00716144|531390044|FG000|Overall Study|Intercurrent illness|0|||
147334050|NCT00716144|531390045|FG001|Overall Study|Intercurrent illness|0|||
147334051|NCT00716144|531390046|FG002|Overall Study|Intercurrent illness|1|||
147334052|NCT00716144|531390047|FG003|Overall Study|Intercurrent illness|0|||
147334053|NCT00716144|531390044|FG000|Overall Study|Withdrew consent, allowed use of data|0|||
147334054|NCT00716144|531390045|FG001|Overall Study|Withdrew consent, allowed use of data|0|||
147334055|NCT00716144|531390046|FG002|Overall Study|Withdrew consent, allowed use of data|1|||
147334056|NCT00716144|531390047|FG003|Overall Study|Withdrew consent, allowed use of data|0|||
147334057|NCT00716144|531390044|FG000|Overall Study|Adverse event: left foot pain|0|||
147334058|NCT00716144|531390045|FG001|Overall Study|Adverse event: left foot pain|1|||
147334059|NCT00716144|531390046|FG002|Overall Study|Adverse event: left foot pain|0|||
147334060|NCT00716144|531390047|FG003|Overall Study|Adverse event: left foot pain|0|||
147334061|NCT00716144|531390044|FG000|Overall Study|Clinical Depression|0|||
147334062|NCT00716144|531390045|FG001|Overall Study|Clinical Depression|1|||
147334063|NCT00716144|531390046|FG002|Overall Study|Clinical Depression|0|||
147334064|NCT00716144|531390047|FG003|Overall Study|Clinical Depression|0|||
147334065|NCT00909363|531390048|FG000|Overall Study|Withdrawal by Subject|1|||
147334066|NCT00909363|531390049|FG001|Overall Study|Withdrawal by Subject|0|||
147334067|NCT00909363|531390050|FG002|Overall Study|Withdrawal by Subject|0|||
147334068|NCT00909363|531390048|FG000|Overall Study|Lack of Efficacy|1|||
147334069|NCT00909363|531390049|FG001|Overall Study|Lack of Efficacy|0|||
147334070|NCT00909363|531390050|FG002|Overall Study|Lack of Efficacy|0|||
147334071|NCT02954848|531390060|FG000|Overall Study|Randomized but Not Treated|0|||
147334072|NCT02954848|531390061|FG001|Overall Study|Randomized but Not Treated|1|||
147334073|NCT02954848|531390060|FG000|Overall Study|Adverse Event|2|||
147334074|NCT02954848|531390061|FG001|Overall Study|Adverse Event|3|||
147334075|NCT02954848|531390060|FG000|Overall Study|Withdrawal by Participant|0|||
147334076|NCT02954848|531390061|FG001|Overall Study|Withdrawal by Participant|1|||
147334077|NCT01802632|531390062|FG000|Overall Study|Death|28|||
147334078|NCT01802632|531390063|FG001|Overall Study|Death|1|||
147334079|NCT01802632|531390064|FG002|Overall Study|Death|38|||
147334080|NCT01802632|531390065|FG003|Overall Study|Death|0|||
147600720|NCT02980874|532356455|FG001|Overall Study|Lost to Follow-up|5|||
147600721|NCT02980874|532356454|FG000|Overall Study|Includes premature discontinuation due to study termination.|88|||
147600722|NCT02980874|532356455|FG001|Overall Study|Includes premature discontinuation due to study termination.|88|||
147600723|NCT02980874|532356454|FG000|Overall Study|Unknown study completion status|1|||
147600724|NCT02980874|532356455|FG001|Overall Study|Unknown study completion status|0|||
147600725|NCT02435836|532356456|FG000|Overall Study|Lost to Follow-up|21|||
147600726|NCT02435836|532356456|FG000|Overall Study|Lack of Efficacy|1|||
147600727|NCT02435836|532356456|FG000|Overall Study|Withdrawal by Subject|236|||
147600728|NCT02435836|532356456|FG000|Overall Study|Insufficient Clinical Response|26|||
147600729|NCT02435836|532356456|FG000|Overall Study|Adverse Event|44|||
147600730|NCT02435836|532356456|FG000|Overall Study|Sponsor discontinued trial|167|||
147600731|NCT02435836|532356456|FG000|Overall Study|Noncompliance|27|||
147600732|NCT02435836|532356456|FG000|Overall Study|Protocol Violation|6|||
147600733|NCT02435836|532356456|FG000|Overall Study|Met Withdrawal Criteria|7|||
147600734|NCT02435836|532356456|FG000|Overall Study|AE of Worsening Schizophrenia|96|||
147600735|NCT01121666|532356457|FG000|Overall Study|Protocol Violation|29|||
147600736|NCT01121666|532356458|FG001|Overall Study|Protocol Violation|10|||
147600737|NCT01629966|532356461|FG000|Overall Study|Pregnancy|0|||
147600738|NCT01629966|532356462|FG001|Overall Study|Pregnancy|1|||
147600739|NCT01629966|532356463|FG002|Overall Study|Pregnancy|0|||
147600740|NCT01629966|532356461|FG000|Overall Study|Lost to Follow-up|10|||
147600741|NCT01629966|532356462|FG001|Overall Study|Lost to Follow-up|13|||
147600742|NCT01629966|532356463|FG002|Overall Study|Lost to Follow-up|9|||
147600743|NCT01629966|532356461|FG000|Overall Study|Withdrawal by Subject|8|||
147600744|NCT01629966|532356462|FG001|Overall Study|Withdrawal by Subject|9|||
147600745|NCT01629966|532356463|FG002|Overall Study|Withdrawal by Subject|16|||
147600746|NCT01629966|532356461|FG000|Overall Study|Protocol Violation|7|||
147600747|NCT01629966|532356462|FG001|Overall Study|Protocol Violation|9|||
147600748|NCT01629966|532356463|FG002|Overall Study|Protocol Violation|7|||
147600749|NCT01629966|532356461|FG000|Overall Study|Lack of Efficacy|5|||
147600750|NCT01629966|532356462|FG001|Overall Study|Lack of Efficacy|2|||
147600751|NCT01629966|532356463|FG002|Overall Study|Lack of Efficacy|4|||
147600752|NCT01629966|532356461|FG000|Overall Study|Adverse Event|11|||
147600753|NCT01629966|532356462|FG001|Overall Study|Adverse Event|18|||
147334081|NCT01802632|531390066|FG004|Overall Study|Death|2|||
147334082|NCT01802632|531390067|FG005|Overall Study|Death|0|||
147334083|NCT01802632|531390062|FG000|Overall Study|Withdrawal by Subject|4|||
147334084|NCT01802632|531390063|FG001|Overall Study|Withdrawal by Subject|2|||
147334085|NCT01802632|531390064|FG002|Overall Study|Withdrawal by Subject|7|||
147600754|NCT01629966|532356463|FG002|Overall Study|Adverse Event|30|||
147600755|NCT02991430|532356466|FG000|Treatment Period 1|Adverse Event|1|||
147600756|NCT02991430|532356467|FG001|Treatment Period 1|Adverse Event|0|||
147334086|NCT01802632|531390065|FG003|Overall Study|Withdrawal by Subject|3|||
147600757|NCT02991430|532356468|FG002|Treatment Period 1|Adverse Event|2|||
147600758|NCT02991430|532356466|FG000|Treatment Period 1|Withdrawal by Subject|0|||
147600759|NCT02991430|532356467|FG001|Treatment Period 1|Withdrawal by Subject|4|||
147600760|NCT02991430|532356468|FG002|Treatment Period 1|Withdrawal by Subject|0|||
147600761|NCT02991430|532356466|FG000|Treatment Period 2|Study Termination|6|||
147600762|NCT02991430|532356467|FG001|Treatment Period 2|Study Termination|3|||
147600763|NCT02991430|532356468|FG002|Treatment Period 2|Study Termination|3|||
147600764|NCT02991430|532356466|FG000|Treatment Period 2|Lost to Follow-up|0|||
147600765|NCT02991430|532356467|FG001|Treatment Period 2|Lost to Follow-up|0|||
147600766|NCT02991430|532356468|FG002|Treatment Period 2|Lost to Follow-up|1|||
147600767|NCT02991430|532356466|FG000|Post-treatment Observation Period|Study Termination|3|||
147600768|NCT02991430|532356467|FG001|Post-treatment Observation Period|Study Termination|6|||
147600769|NCT02991430|532356468|FG002|Post-treatment Observation Period|Study Termination|5|||
147600770|NCT03970837|532356469|FG000|Overall Study|Adverse Event|23|||
147600771|NCT03970837|532356470|FG001|Overall Study|Adverse Event|20|||
147600772|NCT03970837|532356471|FG002|Overall Study|Adverse Event|16|||
147600773|NCT03970837|532356472|FG003|Overall Study|Adverse Event|6|||
147600774|NCT03970837|532356473|FG004|Overall Study|Adverse Event|4|||
147600775|NCT03970837|532356474|FG005|Overall Study|Adverse Event|5|||
147600776|NCT03970837|532356475|FG006|Overall Study|Adverse Event|1|||
147600777|NCT03970837|532356476|FG007|Overall Study|Adverse Event|5|||
147600778|NCT03970837|532356477|FG008|Overall Study|Adverse Event|0|||
147600779|NCT03970837|532356478|FG009|Overall Study|Adverse Event|0|||
147600780|NCT03970837|532356479|FG010|Overall Study|Adverse Event|1|||
147600781|NCT03970837|532356480|FG011|Overall Study|Adverse Event|1|||
147600782|NCT03970837|532356469|FG000|Overall Study|Lack of Efficacy|14|||
147600783|NCT03970837|532356470|FG001|Overall Study|Lack of Efficacy|12|||
147600784|NCT03970837|532356471|FG002|Overall Study|Lack of Efficacy|1|||
147600785|NCT03970837|532356472|FG003|Overall Study|Lack of Efficacy|2|||
147600786|NCT03970837|532356473|FG004|Overall Study|Lack of Efficacy|3|||
147600787|NCT03970837|532356474|FG005|Overall Study|Lack of Efficacy|4|||
147600788|NCT03970837|532356475|FG006|Overall Study|Lack of Efficacy|6|||
147600789|NCT03970837|532356476|FG007|Overall Study|Lack of Efficacy|1|||
147600790|NCT03970837|532356477|FG008|Overall Study|Lack of Efficacy|1|||
147600791|NCT03970837|532356478|FG009|Overall Study|Lack of Efficacy|0|||
147600792|NCT03970837|532356479|FG010|Overall Study|Lack of Efficacy|0|||
147600793|NCT03970837|532356480|FG011|Overall Study|Lack of Efficacy|0|||
147662451|NCT00483652|532587340|FG000|Double-blind Treatment Period|Protocol inclusion deviation|1|||
147334087|NCT01802632|531390066|FG004|Overall Study|Withdrawal by Subject|0|||
147334088|NCT01802632|531390067|FG005|Overall Study|Withdrawal by Subject|1|||
147334089|NCT01802632|531390062|FG000|Overall Study|Objective Disease Progression|1|||
147334090|NCT01802632|531390063|FG001|Overall Study|Objective Disease Progression|12|||
147334091|NCT01802632|531390064|FG002|Overall Study|Objective Disease Progression|104|||
147334092|NCT01802632|531390065|FG003|Overall Study|Objective Disease Progression|6|||
147334093|NCT01802632|531390066|FG004|Overall Study|Objective Disease Progression|4|||
147334094|NCT01802632|531390067|FG005|Overall Study|Objective Disease Progression|4|||
147334095|NCT01802632|531390062|FG000|Overall Study|Ongoing Study at Data Cut-off|168|||
147334096|NCT01802632|531390063|FG001|Overall Study|Ongoing Study at Data Cut-off|16|||
147334097|NCT01802632|531390064|FG002|Overall Study|Ongoing Study at Data Cut-off|115|||
147334098|NCT01802632|531390065|FG003|Overall Study|Ongoing Study at Data Cut-off|50|||
147334099|NCT01802632|531390066|FG004|Overall Study|Ongoing Study at Data Cut-off|6|||
147450870|NCT03257267|531813175|FG001|Overall Study|Lost to Follow-up|2|||
147600794|NCT03970837|532356469|FG000|Overall Study|Lost to Follow-up|6|||
147600795|NCT03970837|532356470|FG001|Overall Study|Lost to Follow-up|5|||
147600796|NCT03970837|532356471|FG002|Overall Study|Lost to Follow-up|5|||
147600797|NCT03970837|532356472|FG003|Overall Study|Lost to Follow-up|1|||
147600798|NCT03970837|532356473|FG004|Overall Study|Lost to Follow-up|0|||
147600799|NCT03970837|532356474|FG005|Overall Study|Lost to Follow-up|2|||
147600800|NCT03970837|532356475|FG006|Overall Study|Lost to Follow-up|0|||
147600801|NCT03970837|532356476|FG007|Overall Study|Lost to Follow-up|0|||
147600802|NCT03970837|532356477|FG008|Overall Study|Lost to Follow-up|0|||
147600803|NCT03970837|532356478|FG009|Overall Study|Lost to Follow-up|0|||
147275616|NCT01969838|531177586|FG000|Double-blind Phase|Adverse Event|10|||
147275617|NCT01969838|531177587|FG001|Double-blind Phase|Adverse Event|4|||
147275618|NCT01969838|531177588|FG002|Double-blind Phase|Adverse Event|0|||
147275619|NCT01969838|531177589|FG003|Double-blind Phase|Adverse Event|0|||
147275620|NCT01969838|531177586|FG000|Double-blind Phase|Death|5|||
147275621|NCT01969838|531177587|FG001|Double-blind Phase|Death|2|||
147275622|NCT01969838|531177588|FG002|Double-blind Phase|Death|0|||
147275623|NCT01969838|531177589|FG003|Double-blind Phase|Death|0|||
147275624|NCT01969838|531177586|FG000|Double-blind Phase|Physician Decision|5|||
147275625|NCT01969838|531177587|FG001|Double-blind Phase|Physician Decision|1|||
147275626|NCT01969838|531177588|FG002|Double-blind Phase|Physician Decision|0|||
147275627|NCT01969838|531177589|FG003|Double-blind Phase|Physician Decision|0|||
147275628|NCT01969838|531177586|FG000|Double-blind Phase|Subject Decision|4|||
147275629|NCT01969838|531177587|FG001|Double-blind Phase|Subject Decision|2|||
147275630|NCT01969838|531177588|FG002|Double-blind Phase|Subject Decision|0|||
147275631|NCT01969838|531177589|FG003|Double-blind Phase|Subject Decision|0|||
147275632|NCT01969838|531177586|FG000|Double-blind Phase|Disease Progression|2|||
147275633|NCT01969838|531177587|FG001|Double-blind Phase|Disease Progression|0|||
147275634|NCT01969838|531177588|FG002|Double-blind Phase|Disease Progression|0|||
147275635|NCT01969838|531177589|FG003|Double-blind Phase|Disease Progression|0|||
147275636|NCT01969838|531177586|FG000|Double-blind Phase|Symptomatic Spleen Growth|1|||
147275637|NCT01969838|531177587|FG001|Double-blind Phase|Symptomatic Spleen Growth|0|||
147275638|NCT01969838|531177588|FG002|Double-blind Phase|Symptomatic Spleen Growth|0|||
147275639|NCT01969838|531177589|FG003|Double-blind Phase|Symptomatic Spleen Growth|0|||
147275640|NCT01969838|531177586|FG000|Open-label Phase|Transferred to study SRA-MMB-4365|0|||
147275641|NCT01969838|531177587|FG001|Open-label Phase|Transferred to study SRA-MMB-4365|0|||
147275642|NCT01969838|531177588|FG002|Open-label Phase|Transferred to study SRA-MMB-4365|52|||
147275643|NCT01969838|531177589|FG003|Open-label Phase|Transferred to study SRA-MMB-4365|62|||
147275644|NCT01969838|531177586|FG000|Open-label Phase|Adverse Event|0|||
147275645|NCT01969838|531177587|FG001|Open-label Phase|Adverse Event|0|||
147334100|NCT01802632|531390067|FG005|Overall Study|Ongoing Study at Data Cut-off|22|||
147334101|NCT01802632|531390062|FG000|Overall Study|Other (not specified)|0|||
147334102|NCT01802632|531390063|FG001|Overall Study|Other (not specified)|0|||
147334103|NCT01802632|531390064|FG002|Overall Study|Other (not specified)|7|||
147334104|NCT01802632|531390065|FG003|Overall Study|Other (not specified)|1|||
147334105|NCT01802632|531390066|FG004|Overall Study|Other (not specified)|0|||
147334106|NCT01802632|531390067|FG005|Overall Study|Other (not specified)|1|||
147334107|NCT03383146|531390069|FG000|Overall Study|Screen Failure|1|||
147334108|NCT03383146|531390070|FG001|Overall Study|Screen Failure|0|||
147334109|NCT03383146|531390069|FG000|Overall Study|Adverse Event|6|||
147334110|NCT03383146|531390070|FG001|Overall Study|Adverse Event|18|||
147334111|NCT03383146|531390069|FG000|Overall Study|Lack of Efficacy|0|||
147334112|NCT03383146|531390070|FG001|Overall Study|Lack of Efficacy|3|||
147334113|NCT03383146|531390069|FG000|Overall Study|Withdrawal by Subject|20|||
147334114|NCT03383146|531390070|FG001|Overall Study|Withdrawal by Subject|36|||
147334115|NCT03383146|531390069|FG000|Overall Study|Lost to Follow-up|5|||
147334116|NCT03383146|531390070|FG001|Overall Study|Lost to Follow-up|15|||
147334117|NCT03383146|531390069|FG000|Overall Study|Death|0|||
147334118|NCT03383146|531390070|FG001|Overall Study|Death|2|||
147334119|NCT03383146|531390069|FG000|Overall Study|Physician Decision|0|||
147334120|NCT03383146|531390070|FG001|Overall Study|Physician Decision|1|||
147334121|NCT03383146|531390069|FG000|Overall Study|Protocol Deviation|1|||
147334122|NCT03383146|531390070|FG001|Overall Study|Protocol Deviation|8|||
147334123|NCT03383146|531390069|FG000|Overall Study|Study Terminated by the Sponsor|48|||
147334124|NCT03383146|531390070|FG001|Overall Study|Study Terminated by the Sponsor|95|||
147600804|NCT03970837|532356479|FG010|Overall Study|Lost to Follow-up|0|||
147600805|NCT03970837|532356480|FG011|Overall Study|Lost to Follow-up|0|||
147600806|NCT03970837|532356469|FG000|Overall Study|Protocol Violation|1|||
147334125|NCT03383146|531390069|FG000|Overall Study|Reason not Specified|4|||
147600807|NCT03970837|532356470|FG001|Overall Study|Protocol Violation|0|||
147600808|NCT03970837|532356471|FG002|Overall Study|Protocol Violation|0|||
147600809|NCT03970837|532356472|FG003|Overall Study|Protocol Violation|0|||
147600810|NCT03970837|532356473|FG004|Overall Study|Protocol Violation|0|||
147600811|NCT03970837|532356474|FG005|Overall Study|Protocol Violation|0|||
147600812|NCT03970837|532356475|FG006|Overall Study|Protocol Violation|0|||
147600813|NCT03970837|532356476|FG007|Overall Study|Protocol Violation|0|||
147600814|NCT03970837|532356477|FG008|Overall Study|Protocol Violation|0|||
147600815|NCT03970837|532356478|FG009|Overall Study|Protocol Violation|0|||
147600816|NCT03970837|532356479|FG010|Overall Study|Protocol Violation|0|||
147600817|NCT03970837|532356480|FG011|Overall Study|Protocol Violation|0|||
147600818|NCT03970837|532356469|FG000|Overall Study|Physician Decision|5|||
147600819|NCT03970837|532356470|FG001|Overall Study|Physician Decision|8|||
147600820|NCT03970837|532356471|FG002|Overall Study|Physician Decision|4|||
147600821|NCT03970837|532356472|FG003|Overall Study|Physician Decision|1|||
147600822|NCT03970837|532356473|FG004|Overall Study|Physician Decision|5|||
147600823|NCT03970837|532356474|FG005|Overall Study|Physician Decision|2|||
147600824|NCT03970837|532356475|FG006|Overall Study|Physician Decision|4|||
147600825|NCT03970837|532356476|FG007|Overall Study|Physician Decision|5|||
147600826|NCT03970837|532356477|FG008|Overall Study|Physician Decision|0|||
147600827|NCT03970837|532356478|FG009|Overall Study|Physician Decision|1|||
147600828|NCT03970837|532356479|FG010|Overall Study|Physician Decision|0|||
147275646|NCT01969838|531177588|FG002|Open-label Phase|Adverse Event|37|||
147334126|NCT03383146|531390070|FG001|Overall Study|Reason not Specified|6|||
147334127|NCT05382104|531390071|FG000|Period 2 (2 Days)|Adverse Event|0|||
147600829|NCT03970837|532356480|FG011|Overall Study|Physician Decision|0|||
147600830|NCT03970837|532356469|FG000|Overall Study|Withdrawal by Subject|32|||
147275647|NCT01969838|531177589|FG003|Open-label Phase|Adverse Event|49|||
147334128|NCT05382104|531390072|FG001|Period 2 (2 Days)|Adverse Event|1|||
147334129|NCT05382104|531390073|FG002|Period 2 (2 Days)|Adverse Event|0|||
147600831|NCT03970837|532356470|FG001|Overall Study|Withdrawal by Subject|35|||
147600832|NCT03970837|532356471|FG002|Overall Study|Withdrawal by Subject|12|||
147600833|NCT03970837|532356472|FG003|Overall Study|Withdrawal by Subject|8|||
147600834|NCT03970837|532356473|FG004|Overall Study|Withdrawal by Subject|6|||
147275648|NCT01969838|531177586|FG000|Open-label Phase|Disease Progression|0|||
147275649|NCT01969838|531177587|FG001|Open-label Phase|Disease Progression|0|||
147275650|NCT01969838|531177588|FG002|Open-label Phase|Disease Progression|26|||
147275651|NCT01969838|531177589|FG003|Open-label Phase|Disease Progression|27|||
147275652|NCT01969838|531177586|FG000|Open-label Phase|Lack of Efficacy|0|||
147275653|NCT01969838|531177587|FG001|Open-label Phase|Lack of Efficacy|0|||
147275654|NCT01969838|531177588|FG002|Open-label Phase|Lack of Efficacy|17|||
147275655|NCT01969838|531177589|FG003|Open-label Phase|Lack of Efficacy|19|||
147334130|NCT05382104|531390074|FG003|Period 2 (2 Days)|Adverse Event|0|||
147334131|NCT05382104|531390075|FG004|Period 2 (2 Days)|Adverse Event|0|||
147334132|NCT05382104|531390076|FG005|Period 2 (2 Days)|Adverse Event|0|||
147334133|NCT01317420|531390081|FG000|Overall Study|Progressive disease according to RECIST|2|||
147334134|NCT01317420|531390082|FG001|Overall Study|Progressive disease according to RECIST|3|||
147334135|NCT01317420|531390083|FG002|Overall Study|Progressive disease according to RECIST|3|||
147334136|NCT01317420|531390084|FG003|Overall Study|Progressive disease according to RECIST|3|||
147600835|NCT03970837|532356474|FG005|Overall Study|Withdrawal by Subject|8|||
147600836|NCT03970837|532356475|FG006|Overall Study|Withdrawal by Subject|2|||
147600837|NCT03970837|532356476|FG007|Overall Study|Withdrawal by Subject|3|||
147600838|NCT03970837|532356477|FG008|Overall Study|Withdrawal by Subject|0|||
147600839|NCT03970837|532356478|FG009|Overall Study|Withdrawal by Subject|0|||
147600840|NCT03970837|532356479|FG010|Overall Study|Withdrawal by Subject|0|||
147600841|NCT03970837|532356480|FG011|Overall Study|Withdrawal by Subject|1|||
147600842|NCT03970837|532356469|FG000|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|3|||
147600843|NCT03970837|532356470|FG001|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|12|||
147600844|NCT03970837|532356471|FG002|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|2|||
147600845|NCT03970837|532356472|FG003|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|0|||
147600846|NCT03970837|532356473|FG004|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|2|||
147600847|NCT03970837|532356474|FG005|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
147600848|NCT03970837|532356475|FG006|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
147600849|NCT03970837|532356476|FG007|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
147600850|NCT03970837|532356477|FG008|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|1|||
147600851|NCT03970837|532356478|FG009|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|0|||
147600852|NCT03970837|532356479|FG010|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|0|||
147600853|NCT03970837|532356480|FG011|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|0|||
147600854|NCT03970837|532356469|FG000|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
147600855|NCT03970837|532356470|FG001|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
147600856|NCT03970837|532356471|FG002|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
147600857|NCT03970837|532356472|FG003|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
147600858|NCT03970837|532356473|FG004|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
147600859|NCT03970837|532356474|FG005|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
147600860|NCT03970837|532356475|FG006|Overall Study|STUDY TERMINATED BY SPONSOR|8|||
147600861|NCT03970837|532356476|FG007|Overall Study|STUDY TERMINATED BY SPONSOR|11|||
147600862|NCT03970837|532356477|FG008|Overall Study|STUDY TERMINATED BY SPONSOR|2|||
147600863|NCT03970837|532356478|FG009|Overall Study|STUDY TERMINATED BY SPONSOR|1|||
147600864|NCT03970837|532356479|FG010|Overall Study|STUDY TERMINATED BY SPONSOR|2|||
147600865|NCT03970837|532356480|FG011|Overall Study|STUDY TERMINATED BY SPONSOR|3|||
147600866|NCT02132754|532356481|FG000|Overall Study|Adverse Event|0|||
147275656|NCT01969838|531177586|FG000|Open-label Phase|Subject Decision|0|||
147275657|NCT01969838|531177587|FG001|Open-label Phase|Subject Decision|0|||
147275658|NCT01969838|531177588|FG002|Open-label Phase|Subject Decision|14|||
147275659|NCT01969838|531177589|FG003|Open-label Phase|Subject Decision|15|||
147275660|NCT01969838|531177586|FG000|Open-label Phase|Death|0|||
147275661|NCT01969838|531177587|FG001|Open-label Phase|Death|0|||
147275662|NCT01969838|531177588|FG002|Open-label Phase|Death|13|||
147275663|NCT01969838|531177589|FG003|Open-label Phase|Death|11|||
147275664|NCT01969838|531177586|FG000|Open-label Phase|Physician Decision|0|||
147275665|NCT01969838|531177587|FG001|Open-label Phase|Physician Decision|0|||
147275666|NCT01969838|531177588|FG002|Open-label Phase|Physician Decision|9|||
147275667|NCT01969838|531177589|FG003|Open-label Phase|Physician Decision|14|||
147600867|NCT02132754|532356482|FG001|Overall Study|Adverse Event|0|||
147275668|NCT01969838|531177586|FG000|Open-label Phase|Non-compliance with Study Drug|0|||
147275669|NCT01969838|531177587|FG001|Open-label Phase|Non-compliance with Study Drug|0|||
147275670|NCT01969838|531177588|FG002|Open-label Phase|Non-compliance with Study Drug|2|||
147275671|NCT01969838|531177589|FG003|Open-label Phase|Non-compliance with Study Drug|0|||
147600868|NCT02132754|532356483|FG002|Overall Study|Adverse Event|0|||
147600869|NCT02132754|532356484|FG003|Overall Study|Adverse Event|0|||
147600870|NCT02132754|532356485|FG004|Overall Study|Adverse Event|0|||
147600871|NCT02132754|532356486|FG005|Overall Study|Adverse Event|0|||
147600872|NCT02132754|532356487|FG006|Overall Study|Adverse Event|0|||
147600873|NCT02132754|532356488|FG007|Overall Study|Adverse Event|0|||
147275672|NCT00408993|531177590|FG000|Overall Study|Adverse Event|15|||
147334137|NCT01317420|531390085|FG004|Overall Study|Progressive disease according to RECIST|3|||
147334138|NCT01317420|531390086|FG005|Overall Study|Progressive disease according to RECIST|3|||
147275673|NCT00408993|531177591|FG001|Overall Study|Adverse Event|4|||
147275674|NCT00408993|531177590|FG000|Overall Study|Protocol Violation|1|||
147275675|NCT00408993|531177591|FG001|Overall Study|Protocol Violation|6|||
147275676|NCT00408993|531177590|FG000|Overall Study|Lack of Efficacy|1|||
147275677|NCT00408993|531177591|FG001|Overall Study|Lack of Efficacy|4|||
147275678|NCT00408993|531177590|FG000|Overall Study|Withdrawal by Subject|2|||
147275679|NCT00408993|531177591|FG001|Overall Study|Withdrawal by Subject|3|||
147275680|NCT00298896|531177592|FG000|Overall Study|Death|3|||
147275681|NCT00298896|531177592|FG000|Overall Study|Physician Decision|2|||
147275682|NCT00298896|531177592|FG000|Overall Study|Intercurrent Illness|1|||
147275683|NCT00298896|531177592|FG000|Overall Study|Disease Progression|41|||
147275684|NCT00298896|531177592|FG000|Overall Study|Withdrawal by Subject|2|||
147275685|NCT00298896|531177592|FG000|Overall Study|Assigned to treatment in error|1|||
147275686|NCT02880371|531177593|FG000|Phase 1b|Lost to Follow-up|1|||
147275687|NCT02880371|531177594|FG001|Phase 1b|Lost to Follow-up|0|||
147275688|NCT02880371|531177595|FG002|Phase 1b|Lost to Follow-up|0|||
147275689|NCT02880371|531177596|FG003|Phase 1b|Lost to Follow-up|0|||
147275690|NCT02880371|531177597|FG004|Phase 1b|Lost to Follow-up|0|||
147275691|NCT02880371|531177598|FG005|Phase 1b|Lost to Follow-up|0|||
147275692|NCT02880371|531177599|FG006|Phase 1b|Lost to Follow-up|0|||
147275693|NCT02880371|531177600|FG007|Phase 1b|Lost to Follow-up|0|||
147275694|NCT02880371|531177593|FG000|Phase 1b|Participants terminated by Sponsor|1|||
147275695|NCT02880371|531177594|FG001|Phase 1b|Participants terminated by Sponsor|0|||
147275696|NCT02880371|531177595|FG002|Phase 1b|Participants terminated by Sponsor|0|||
147275697|NCT02880371|531177596|FG003|Phase 1b|Participants terminated by Sponsor|0|||
147275698|NCT02880371|531177597|FG004|Phase 1b|Participants terminated by Sponsor|0|||
147275699|NCT02880371|531177598|FG005|Phase 1b|Participants terminated by Sponsor|0|||
147275700|NCT02880371|531177599|FG006|Phase 1b|Participants terminated by Sponsor|0|||
147275701|NCT02880371|531177600|FG007|Phase 1b|Participants terminated by Sponsor|0|||
147275702|NCT02880371|531177593|FG000|Phase 1b|Withdrawal by Subject|0|||
147275703|NCT02880371|531177594|FG001|Phase 1b|Withdrawal by Subject|0|||
147275704|NCT02880371|531177595|FG002|Phase 1b|Withdrawal by Subject|1|||
147275705|NCT02880371|531177596|FG003|Phase 1b|Withdrawal by Subject|0|||
147275706|NCT02880371|531177597|FG004|Phase 1b|Withdrawal by Subject|0|||
147275707|NCT02880371|531177598|FG005|Phase 1b|Withdrawal by Subject|0|||
147275708|NCT02880371|531177599|FG006|Phase 1b|Withdrawal by Subject|0|||
147275709|NCT02880371|531177600|FG007|Phase 1b|Withdrawal by Subject|0|||
147275710|NCT02880371|531177593|FG000|Phase 1b|Death|4|||
147275711|NCT02880371|531177594|FG001|Phase 1b|Death|6|||
147275712|NCT02880371|531177595|FG002|Phase 1b|Death|5|||
147275713|NCT02880371|531177596|FG003|Phase 1b|Death|1|||
147275714|NCT02880371|531177597|FG004|Phase 1b|Death|0|||
147275715|NCT02880371|531177598|FG005|Phase 1b|Death|0|||
147275716|NCT02880371|531177599|FG006|Phase 1b|Death|0|||
147275717|NCT02880371|531177600|FG007|Phase 1b|Death|0|||
147275718|NCT02880371|531177593|FG000|Phase 1b|Enrolled but not Treated|0|||
147275719|NCT02880371|531177594|FG001|Phase 1b|Enrolled but not Treated|1|||
147275720|NCT02880371|531177595|FG002|Phase 1b|Enrolled but not Treated|0|||
147275721|NCT02880371|531177596|FG003|Phase 1b|Enrolled but not Treated|0|||
147275722|NCT02880371|531177597|FG004|Phase 1b|Enrolled but not Treated|0|||
147275723|NCT02880371|531177598|FG005|Phase 1b|Enrolled but not Treated|0|||
147275724|NCT02880371|531177599|FG006|Phase 1b|Enrolled but not Treated|0|||
147275725|NCT02880371|531177600|FG007|Phase 1b|Enrolled but not Treated|0|||
147275726|NCT02880371|531177593|FG000|Phase 2|Enrolled but not Treated|0|||
147275727|NCT02880371|531177594|FG001|Phase 2|Enrolled but not Treated|0|||
147275728|NCT02880371|531177595|FG002|Phase 2|Enrolled but not Treated|0|||
147275729|NCT02880371|531177596|FG003|Phase 2|Enrolled but not Treated|0|||
147275730|NCT02880371|531177597|FG004|Phase 2|Enrolled but not Treated|0|||
147275731|NCT02880371|531177598|FG005|Phase 2|Enrolled but not Treated|1|||
147275732|NCT02880371|531177599|FG006|Phase 2|Enrolled but not Treated|1|||
147275733|NCT02880371|531177600|FG007|Phase 2|Enrolled but not Treated|0|||
147275734|NCT02880371|531177593|FG000|Phase 2|Other|0|||
147275735|NCT02880371|531177594|FG001|Phase 2|Other|0|||
147275736|NCT02880371|531177595|FG002|Phase 2|Other|0|||
147275737|NCT02880371|531177596|FG003|Phase 2|Other|0|||
147275738|NCT02880371|531177597|FG004|Phase 2|Other|0|||
147275739|NCT02880371|531177598|FG005|Phase 2|Other|1|||
147275740|NCT02880371|531177599|FG006|Phase 2|Other|2|||
147275741|NCT02880371|531177600|FG007|Phase 2|Other|1|||
147275742|NCT02880371|531177593|FG000|Phase 2|Participants terminated by Sponsor|0|||
147275743|NCT02880371|531177594|FG001|Phase 2|Participants terminated by Sponsor|0|||
147275744|NCT02880371|531177595|FG002|Phase 2|Participants terminated by Sponsor|0|||
147334139|NCT01317420|531390087|FG006|Overall Study|Progressive disease according to RECIST|3|||
147275745|NCT02880371|531177596|FG003|Phase 2|Participants terminated by Sponsor|0|||
147275746|NCT02880371|531177597|FG004|Phase 2|Participants terminated by Sponsor|1|||
147275747|NCT02880371|531177598|FG005|Phase 2|Participants terminated by Sponsor|6|||
147275748|NCT02880371|531177599|FG006|Phase 2|Participants terminated by Sponsor|1|||
147275749|NCT02880371|531177600|FG007|Phase 2|Participants terminated by Sponsor|5|||
147275750|NCT02880371|531177593|FG000|Phase 2|Death|0|||
147275751|NCT02880371|531177594|FG001|Phase 2|Death|0|||
147275752|NCT02880371|531177595|FG002|Phase 2|Death|0|||
147275753|NCT02880371|531177596|FG003|Phase 2|Death|0|||
147334140|NCT01317420|531390088|FG007|Overall Study|Progressive disease according to RECIST|3|||
147334141|NCT01317420|531390089|FG008|Overall Study|Progressive disease according to RECIST|3|||
147334142|NCT01317420|531390090|FG009|Overall Study|Progressive disease according to RECIST|2|||
147334143|NCT01317420|531390091|FG010|Overall Study|Progressive disease according to RECIST|3|||
147334144|NCT01317420|531390092|FG011|Overall Study|Progressive disease according to RECIST|11|||
147334145|NCT01317420|531390093|FG012|Overall Study|Progressive disease according to RECIST|16|||
147334146|NCT01317420|531390081|FG000|Overall Study|Other adverse event|1|||
147334147|NCT01317420|531390082|FG001|Overall Study|Other adverse event|0|||
147334148|NCT01317420|531390083|FG002|Overall Study|Other adverse event|0|||
147334149|NCT01317420|531390084|FG003|Overall Study|Other adverse event|0|||
147334150|NCT01317420|531390085|FG004|Overall Study|Other adverse event|0|||
147334151|NCT01317420|531390086|FG005|Overall Study|Other adverse event|0|||
147450871|NCT03257267|531813174|FG000|Overall Study|Non-compliance with Study Drug|0|||
147450872|NCT03257267|531813175|FG001|Overall Study|Non-compliance with Study Drug|2|||
147600874|NCT02132754|532356489|FG008|Overall Study|Adverse Event|0|||
147600875|NCT02132754|532356490|FG009|Overall Study|Adverse Event|0|||
147600876|NCT02132754|532356491|FG010|Overall Study|Adverse Event|0|||
147600877|NCT02132754|532356492|FG011|Overall Study|Adverse Event|0|||
147600878|NCT02132754|532356493|FG012|Overall Study|Adverse Event|0|||
147600879|NCT02132754|532356494|FG013|Overall Study|Adverse Event|0|||
147600880|NCT02132754|532356495|FG014|Overall Study|Adverse Event|0|||
147600881|NCT02132754|532356496|FG015|Overall Study|Adverse Event|0|||
147600882|NCT02132754|532356497|FG016|Overall Study|Adverse Event|0|||
147600883|NCT02132754|532356498|FG017|Overall Study|Adverse Event|1|||
147600884|NCT02132754|532356499|FG018|Overall Study|Adverse Event|0|||
147600885|NCT02132754|532356500|FG019|Overall Study|Adverse Event|0|||
147600886|NCT02132754|532356501|FG020|Overall Study|Adverse Event|0|||
147600887|NCT02132754|532356502|FG021|Overall Study|Adverse Event|0|||
147600888|NCT02132754|532356503|FG022|Overall Study|Adverse Event|0|||
147600889|NCT02132754|532356504|FG023|Overall Study|Adverse Event|0|||
147600890|NCT02132754|532356505|FG024|Overall Study|Adverse Event|0|||
147600891|NCT02132754|532356506|FG025|Overall Study|Adverse Event|1|||
147600892|NCT02132754|532356507|FG026|Overall Study|Adverse Event|1|||
147600893|NCT02132754|532356508|FG027|Overall Study|Adverse Event|0|||
147600894|NCT02132754|532356509|FG028|Overall Study|Adverse Event|0|||
147600895|NCT02132754|532356510|FG029|Overall Study|Adverse Event|0|||
147600896|NCT02132754|532356511|FG030|Overall Study|Adverse Event|1|||
147600897|NCT02132754|532356512|FG031|Overall Study|Adverse Event|0|||
147600898|NCT02132754|532356513|FG032|Overall Study|Adverse Event|1|||
147600899|NCT02132754|532356514|FG033|Overall Study|Adverse Event|1|||
147600900|NCT02132754|532356481|FG000|Overall Study|Clinical Progression|0|||
147600901|NCT02132754|532356482|FG001|Overall Study|Clinical Progression|0|||
147600902|NCT02132754|532356483|FG002|Overall Study|Clinical Progression|0|||
147600903|NCT02132754|532356484|FG003|Overall Study|Clinical Progression|0|||
147600904|NCT02132754|532356485|FG004|Overall Study|Clinical Progression|0|||
147600905|NCT02132754|532356486|FG005|Overall Study|Clinical Progression|0|||
147600906|NCT02132754|532356487|FG006|Overall Study|Clinical Progression|0|||
147600907|NCT02132754|532356488|FG007|Overall Study|Clinical Progression|0|||
147600908|NCT02132754|532356489|FG008|Overall Study|Clinical Progression|0|||
147600909|NCT02132754|532356490|FG009|Overall Study|Clinical Progression|1|||
147600910|NCT02132754|532356491|FG010|Overall Study|Clinical Progression|0|||
147600911|NCT02132754|532356492|FG011|Overall Study|Clinical Progression|0|||
147600912|NCT02132754|532356493|FG012|Overall Study|Clinical Progression|0|||
147600913|NCT02132754|532356494|FG013|Overall Study|Clinical Progression|0|||
147334152|NCT01317420|531390087|FG006|Overall Study|Other adverse event|0|||
147334153|NCT01317420|531390088|FG007|Overall Study|Other adverse event|0|||
147334154|NCT01317420|531390089|FG008|Overall Study|Other adverse event|0|||
147334155|NCT01317420|531390090|FG009|Overall Study|Other adverse event|0|||
147334156|NCT01317420|531390091|FG010|Overall Study|Other adverse event|0|||
147334157|NCT01317420|531390092|FG011|Overall Study|Other adverse event|0|||
147334158|NCT01317420|531390093|FG012|Overall Study|Other adverse event|2|||
147334159|NCT01317420|531390081|FG000|Overall Study|Non-compliant with protocol|0|||
147334160|NCT01317420|531390082|FG001|Overall Study|Non-compliant with protocol|0|||
147450873|NCT03257267|531813174|FG000|Overall Study|Participant Decision|35|||
147450874|NCT03257267|531813175|FG001|Overall Study|Participant Decision|43|||
147600914|NCT02132754|532356495|FG014|Overall Study|Clinical Progression|0|||
147600915|NCT02132754|532356496|FG015|Overall Study|Clinical Progression|0|||
147600916|NCT02132754|532356497|FG016|Overall Study|Clinical Progression|1|||
147600917|NCT02132754|532356498|FG017|Overall Study|Clinical Progression|1|||
147600918|NCT02132754|532356499|FG018|Overall Study|Clinical Progression|0|||
147600919|NCT02132754|532356500|FG019|Overall Study|Clinical Progression|1|||
147600920|NCT02132754|532356501|FG020|Overall Study|Clinical Progression|0|||
147600921|NCT02132754|532356502|FG021|Overall Study|Clinical Progression|0|||
147334161|NCT01317420|531390083|FG002|Overall Study|Non-compliant with protocol|0|||
147334162|NCT01317420|531390084|FG003|Overall Study|Non-compliant with protocol|0|||
147450875|NCT03257267|531813174|FG000|Overall Study|Sponsor Decision|1|||
147450876|NCT03257267|531813175|FG001|Overall Study|Sponsor Decision|0|||
147275754|NCT02880371|531177597|FG004|Phase 2|Death|1|||
147275755|NCT02880371|531177598|FG005|Phase 2|Death|10|||
147275756|NCT02880371|531177599|FG006|Phase 2|Death|20|||
147275757|NCT02880371|531177600|FG007|Phase 2|Death|5|||
147275758|NCT02880371|531177593|FG000|Phase 2|Lost to Follow-up|0|||
147275759|NCT02880371|531177594|FG001|Phase 2|Lost to Follow-up|0|||
147275760|NCT02880371|531177595|FG002|Phase 2|Lost to Follow-up|0|||
147275761|NCT02880371|531177596|FG003|Phase 2|Lost to Follow-up|0|||
147275762|NCT02880371|531177597|FG004|Phase 2|Lost to Follow-up|0|||
147275763|NCT02880371|531177598|FG005|Phase 2|Lost to Follow-up|0|||
147334163|NCT01317420|531390085|FG004|Overall Study|Non-compliant with protocol|0|||
147334164|NCT01317420|531390086|FG005|Overall Study|Non-compliant with protocol|0|||
147334165|NCT01317420|531390087|FG006|Overall Study|Non-compliant with protocol|0|||
147334166|NCT01317420|531390088|FG007|Overall Study|Non-compliant with protocol|0|||
147334167|NCT01317420|531390089|FG008|Overall Study|Non-compliant with protocol|0|||
147334168|NCT01317420|531390090|FG009|Overall Study|Non-compliant with protocol|0|||
147334169|NCT01317420|531390091|FG010|Overall Study|Non-compliant with protocol|0|||
147334170|NCT01317420|531390092|FG011|Overall Study|Non-compliant with protocol|0|||
147334171|NCT01317420|531390093|FG012|Overall Study|Non-compliant with protocol|1|||
147334172|NCT01317420|531390081|FG000|Overall Study|Refused to cont. taking trial medication|0|||
147334173|NCT01317420|531390082|FG001|Overall Study|Refused to cont. taking trial medication|0|||
147334174|NCT01317420|531390083|FG002|Overall Study|Refused to cont. taking trial medication|0|||
147334175|NCT01317420|531390084|FG003|Overall Study|Refused to cont. taking trial medication|0|||
147334176|NCT01317420|531390085|FG004|Overall Study|Refused to cont. taking trial medication|0|||
147334177|NCT01317420|531390086|FG005|Overall Study|Refused to cont. taking trial medication|0|||
147334178|NCT01317420|531390087|FG006|Overall Study|Refused to cont. taking trial medication|0|||
147334179|NCT01317420|531390088|FG007|Overall Study|Refused to cont. taking trial medication|0|||
147334180|NCT01317420|531390089|FG008|Overall Study|Refused to cont. taking trial medication|0|||
147334181|NCT01317420|531390090|FG009|Overall Study|Refused to cont. taking trial medication|0|||
147334182|NCT01317420|531390091|FG010|Overall Study|Refused to cont. taking trial medication|0|||
147334183|NCT01317420|531390092|FG011|Overall Study|Refused to cont. taking trial medication|0|||
147334184|NCT01317420|531390093|FG012|Overall Study|Refused to cont. taking trial medication|1|||
147334185|NCT01317420|531390081|FG000|Overall Study|Reason other than those specified|0|||
147334186|NCT01317420|531390082|FG001|Overall Study|Reason other than those specified|0|||
147334187|NCT01317420|531390083|FG002|Overall Study|Reason other than those specified|0|||
147334188|NCT01317420|531390084|FG003|Overall Study|Reason other than those specified|0|||
147334189|NCT01317420|531390085|FG004|Overall Study|Reason other than those specified|0|||
147334190|NCT01317420|531390086|FG005|Overall Study|Reason other than those specified|0|||
147334191|NCT01317420|531390087|FG006|Overall Study|Reason other than those specified|0|||
147334192|NCT01317420|531390088|FG007|Overall Study|Reason other than those specified|0|||
147334193|NCT01317420|531390089|FG008|Overall Study|Reason other than those specified|0|||
147334194|NCT01317420|531390090|FG009|Overall Study|Reason other than those specified|1|||
147334195|NCT01317420|531390091|FG010|Overall Study|Reason other than those specified|0|||
147334196|NCT01317420|531390092|FG011|Overall Study|Reason other than those specified|0|||
147334197|NCT01317420|531390093|FG012|Overall Study|Reason other than those specified|0|||
147334198|NCT05686421|531390094|FG000|Overall Study|Screen failure|22|||
147334199|NCT05686421|531390095|FG001|Overall Study|Screen failure|0|||
147334200|NCT05686421|531390096|FG002|Overall Study|Screen failure|0|||
147334201|NCT05686421|531390097|FG003|Overall Study|Screen failure|0|||
147334202|NCT00857649|531390098|FG000|Overall Study|Adverse Event|15|||
147334203|NCT00857649|531390099|FG001|Overall Study|Adverse Event|10|||
147334204|NCT00857649|531390098|FG000|Overall Study|Non-compliance|1|||
147334205|NCT00857649|531390099|FG001|Overall Study|Non-compliance|1|||
147334206|NCT00857649|531390098|FG000|Overall Study|Protocol Violation|2|||
147334207|NCT00857649|531390099|FG001|Overall Study|Protocol Violation|2|||
147334208|NCT00857649|531390098|FG000|Overall Study|Withdrawal of Consent|10|||
147334209|NCT00857649|531390099|FG001|Overall Study|Withdrawal of Consent|7|||
147334210|NCT00857649|531390098|FG000|Overall Study|Nursing Home Placement|2|||
147334211|NCT00857649|531390099|FG001|Overall Study|Nursing Home Placement|9|||
147334212|NCT00857649|531390098|FG000|Overall Study|Other Reasons|1|||
147334213|NCT00857649|531390099|FG001|Overall Study|Other Reasons|3|||
147334214|NCT00367055|531390103|FG000|Overall Study|Adverse Event|6|||
147600922|NCT02132754|532356503|FG022|Overall Study|Clinical Progression|1|||
147600923|NCT02132754|532356504|FG023|Overall Study|Clinical Progression|0|||
147275764|NCT02880371|531177599|FG006|Phase 2|Lost to Follow-up|3|||
147334215|NCT00367055|531390104|FG001|Overall Study|Adverse Event|3|||
147334216|NCT00367055|531390103|FG000|Overall Study|Patient's Willing|3|||
147334217|NCT00367055|531390104|FG001|Overall Study|Patient's Willing|2|||
147334218|NCT00367055|531390103|FG000|Overall Study|Lack of Efficacy|1|||
147334219|NCT00367055|531390104|FG001|Overall Study|Lack of Efficacy|2|||
147275765|NCT02880371|531177600|FG007|Phase 2|Lost to Follow-up|0|||
147334220|NCT00367055|531390103|FG000|Overall Study|Lost to Follow-up|1|||
147334221|NCT00367055|531390104|FG001|Overall Study|Lost to Follow-up|1|||
147334222|NCT00367055|531390103|FG000|Overall Study|Protocol Violation|0|||
147275766|NCT02880371|531177593|FG000|Phase 2|Withdrawal by Subject|0|||
147275767|NCT02880371|531177594|FG001|Phase 2|Withdrawal by Subject|0|||
147275768|NCT02880371|531177595|FG002|Phase 2|Withdrawal by Subject|0|||
147275769|NCT02880371|531177596|FG003|Phase 2|Withdrawal by Subject|0|||
147275770|NCT02880371|531177597|FG004|Phase 2|Withdrawal by Subject|0|||
147275771|NCT02880371|531177598|FG005|Phase 2|Withdrawal by Subject|1|||
147275772|NCT02880371|531177599|FG006|Phase 2|Withdrawal by Subject|1|||
147275773|NCT02880371|531177600|FG007|Phase 2|Withdrawal by Subject|0|||
147275774|NCT02880371|531177593|FG000|Phase 2|End of Study page not completed by error|0|||
147275775|NCT02880371|531177594|FG001|Phase 2|End of Study page not completed by error|0|||
147275776|NCT02880371|531177595|FG002|Phase 2|End of Study page not completed by error|0|||
147275777|NCT02880371|531177596|FG003|Phase 2|End of Study page not completed by error|0|||
147275778|NCT02880371|531177597|FG004|Phase 2|End of Study page not completed by error|0|||
147275779|NCT02880371|531177598|FG005|Phase 2|End of Study page not completed by error|1|||
147275780|NCT02880371|531177599|FG006|Phase 2|End of Study page not completed by error|0|||
147275781|NCT02880371|531177600|FG007|Phase 2|End of Study page not completed by error|0|||
147275782|NCT03394391|531177601|FG000|Overall Study|Lost to Follow-up|1|||
147275783|NCT03394391|531177602|FG001|Overall Study|Lost to Follow-up|2|||
147275784|NCT00451282|531177605|FG000|Overall Study|Lost to Follow-up|6|||
147275785|NCT00451282|531177606|FG001|Overall Study|Lost to Follow-up|5|||
147275786|NCT01565993|531177607|FG000|Overall Study|Physician Decision|0|||
147600924|NCT02132754|532356505|FG024|Overall Study|Clinical Progression|1|||
147600925|NCT02132754|532356506|FG025|Overall Study|Clinical Progression|1|||
147600926|NCT02132754|532356507|FG026|Overall Study|Clinical Progression|0|||
147600927|NCT02132754|532356508|FG027|Overall Study|Clinical Progression|1|||
147600928|NCT02132754|532356509|FG028|Overall Study|Clinical Progression|1|||
147600929|NCT02132754|532356510|FG029|Overall Study|Clinical Progression|0|||
147600930|NCT02132754|532356511|FG030|Overall Study|Clinical Progression|1|||
147600931|NCT02132754|532356512|FG031|Overall Study|Clinical Progression|0|||
147600932|NCT02132754|532356513|FG032|Overall Study|Clinical Progression|0|||
147600933|NCT02132754|532356514|FG033|Overall Study|Clinical Progression|2|||
147600934|NCT02132754|532356481|FG000|Overall Study|Death|0|||
147600935|NCT02132754|532356482|FG001|Overall Study|Death|0|||
147600936|NCT02132754|532356483|FG002|Overall Study|Death|0|||
147600937|NCT02132754|532356484|FG003|Overall Study|Death|0|||
147600938|NCT02132754|532356485|FG004|Overall Study|Death|0|||
147600939|NCT02132754|532356486|FG005|Overall Study|Death|0|||
147600940|NCT02132754|532356487|FG006|Overall Study|Death|0|||
147600941|NCT02132754|532356488|FG007|Overall Study|Death|0|||
147600942|NCT02132754|532356489|FG008|Overall Study|Death|0|||
147600943|NCT02132754|532356490|FG009|Overall Study|Death|0|||
147600944|NCT02132754|532356491|FG010|Overall Study|Death|0|||
147600945|NCT02132754|532356492|FG011|Overall Study|Death|0|||
147600946|NCT02132754|532356493|FG012|Overall Study|Death|0|||
147600947|NCT02132754|532356494|FG013|Overall Study|Death|0|||
147600948|NCT02132754|532356495|FG014|Overall Study|Death|0|||
147600949|NCT02132754|532356496|FG015|Overall Study|Death|1|||
147600950|NCT02132754|532356497|FG016|Overall Study|Death|0|||
147600951|NCT02132754|532356498|FG017|Overall Study|Death|0|||
147600952|NCT02132754|532356499|FG018|Overall Study|Death|0|||
147600953|NCT02132754|532356500|FG019|Overall Study|Death|1|||
147600954|NCT02132754|532356501|FG020|Overall Study|Death|0|||
147600955|NCT02132754|532356502|FG021|Overall Study|Death|1|||
147600956|NCT02132754|532356503|FG022|Overall Study|Death|0|||
147600957|NCT02132754|532356504|FG023|Overall Study|Death|0|||
147600958|NCT02132754|532356505|FG024|Overall Study|Death|0|||
147600959|NCT02132754|532356506|FG025|Overall Study|Death|0|||
147600960|NCT02132754|532356507|FG026|Overall Study|Death|1|||
147600961|NCT02132754|532356508|FG027|Overall Study|Death|0|||
147600962|NCT02132754|532356509|FG028|Overall Study|Death|0|||
147600963|NCT02132754|532356510|FG029|Overall Study|Death|0|||
147600964|NCT02132754|532356511|FG030|Overall Study|Death|0|||
147600965|NCT02132754|532356512|FG031|Overall Study|Death|0|||
147600966|NCT02132754|532356513|FG032|Overall Study|Death|0|||
147600967|NCT02132754|532356514|FG033|Overall Study|Death|2|||
147600968|NCT02132754|532356481|FG000|Overall Study|Excluded Medication|0|||
147600969|NCT02132754|532356482|FG001|Overall Study|Excluded Medication|0|||
147600970|NCT02132754|532356483|FG002|Overall Study|Excluded Medication|0|||
147600971|NCT02132754|532356484|FG003|Overall Study|Excluded Medication|0|||
147600972|NCT02132754|532356485|FG004|Overall Study|Excluded Medication|0|||
147600973|NCT02132754|532356486|FG005|Overall Study|Excluded Medication|0|||
147600974|NCT02132754|532356487|FG006|Overall Study|Excluded Medication|0|||
147600975|NCT02132754|532356488|FG007|Overall Study|Excluded Medication|0|||
147600976|NCT02132754|532356489|FG008|Overall Study|Excluded Medication|0|||
147275787|NCT01565993|531177608|FG001|Overall Study|Physician Decision|3|||
147275788|NCT04086472|531177609|FG000|Overall Study|Lost to Follow-up|1|||
147275789|NCT04086472|531177610|FG001|Overall Study|Lost to Follow-up|0|||
147275790|NCT04086472|531177611|FG002|Overall Study|Lost to Follow-up|0|||
147600977|NCT02132754|532356490|FG009|Overall Study|Excluded Medication|0|||
147600978|NCT02132754|532356491|FG010|Overall Study|Excluded Medication|0|||
147600979|NCT02132754|532356492|FG011|Overall Study|Excluded Medication|0|||
147600980|NCT02132754|532356493|FG012|Overall Study|Excluded Medication|0|||
147600981|NCT02132754|532356494|FG013|Overall Study|Excluded Medication|0|||
147600982|NCT02132754|532356495|FG014|Overall Study|Excluded Medication|0|||
147662452|NCT00483652|532587341|FG001|Double-blind Treatment Period|Protocol inclusion deviation|0|||
147662453|NCT00483652|532587340|FG000|Double-blind Treatment Period|Withdrawal due to AE before study began|1|||
147662454|NCT00483652|532587341|FG001|Double-blind Treatment Period|Withdrawal due to AE before study began|0|||
147662455|NCT00891813|532587342|FG000|Overall Study|Adverse Event|3|||
147662456|NCT00891813|532587342|FG000|Overall Study|Withdrawal by Subject|1|||
147662457|NCT00891813|532587342|FG000|Overall Study|Patient Noncompliance|6|||
147662458|NCT00891813|532587342|FG000|Overall Study|Protocol Violation|2|||
147662459|NCT02513550|532587345|FG000|Double Blind Treatment Period|Withdrawal by Subject|11|||
147662460|NCT02513550|532587346|FG001|Double Blind Treatment Period|Withdrawal by Subject|11|||
147334223|NCT00367055|531390104|FG001|Overall Study|Protocol Violation|1|||
147334224|NCT00367055|531390103|FG000|Overall Study|Stopping Criterion Met|0|||
147334225|NCT00367055|531390104|FG001|Overall Study|Stopping Criterion Met|1|||
147334226|NCT00367055|531390103|FG000|Overall Study|Participant Living too Far from Hospital|0|||
147334227|NCT00367055|531390104|FG001|Overall Study|Participant Living too Far from Hospital|1|||
147334228|NCT04707313|531390105|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|4|||
147334229|NCT04707313|531390106|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|20|||
147334230|NCT04707313|531390107|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|23|||
147334231|NCT04707313|531390108|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|25|||
147334232|NCT04707313|531390109|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|15|||
147600983|NCT02132754|532356496|FG015|Overall Study|Excluded Medication|0|||
147600984|NCT02132754|532356497|FG016|Overall Study|Excluded Medication|0|||
147600985|NCT02132754|532356498|FG017|Overall Study|Excluded Medication|0|||
147600986|NCT02132754|532356499|FG018|Overall Study|Excluded Medication|0|||
147600987|NCT02132754|532356500|FG019|Overall Study|Excluded Medication|0|||
147600988|NCT02132754|532356501|FG020|Overall Study|Excluded Medication|1|||
147600989|NCT02132754|532356502|FG021|Overall Study|Excluded Medication|0|||
147600990|NCT02132754|532356503|FG022|Overall Study|Excluded Medication|0|||
147600991|NCT02132754|532356504|FG023|Overall Study|Excluded Medication|0|||
147600992|NCT02132754|532356505|FG024|Overall Study|Excluded Medication|0|||
147600993|NCT02132754|532356506|FG025|Overall Study|Excluded Medication|0|||
147600994|NCT02132754|532356507|FG026|Overall Study|Excluded Medication|0|||
147600995|NCT02132754|532356508|FG027|Overall Study|Excluded Medication|0|||
147600996|NCT02132754|532356509|FG028|Overall Study|Excluded Medication|0|||
147600997|NCT02132754|532356510|FG029|Overall Study|Excluded Medication|0|||
147600998|NCT02132754|532356511|FG030|Overall Study|Excluded Medication|0|||
147600999|NCT02132754|532356512|FG031|Overall Study|Excluded Medication|0|||
147601000|NCT02132754|532356513|FG032|Overall Study|Excluded Medication|0|||
147601001|NCT02132754|532356514|FG033|Overall Study|Excluded Medication|1|||
147601002|NCT02132754|532356481|FG000|Overall Study|Physician Decision|0|||
147601003|NCT02132754|532356482|FG001|Overall Study|Physician Decision|0|||
147601004|NCT02132754|532356483|FG002|Overall Study|Physician Decision|0|||
147601005|NCT02132754|532356484|FG003|Overall Study|Physician Decision|0|||
147601006|NCT02132754|532356485|FG004|Overall Study|Physician Decision|0|||
147601007|NCT02132754|532356486|FG005|Overall Study|Physician Decision|0|||
147601008|NCT02132754|532356487|FG006|Overall Study|Physician Decision|0|||
147601009|NCT02132754|532356488|FG007|Overall Study|Physician Decision|0|||
147601010|NCT02132754|532356489|FG008|Overall Study|Physician Decision|0|||
147601011|NCT02132754|532356490|FG009|Overall Study|Physician Decision|1|||
147601012|NCT02132754|532356491|FG010|Overall Study|Physician Decision|0|||
147601013|NCT02132754|532356492|FG011|Overall Study|Physician Decision|1|||
147601014|NCT02132754|532356493|FG012|Overall Study|Physician Decision|1|||
147601015|NCT02132754|532356494|FG013|Overall Study|Physician Decision|0|||
147601016|NCT02132754|532356495|FG014|Overall Study|Physician Decision|0|||
147601017|NCT02132754|532356496|FG015|Overall Study|Physician Decision|1|||
147334233|NCT04707313|531390110|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|38|||
147334234|NCT04707313|531390111|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|15|||
147334235|NCT04707313|531390112|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|42|||
147334236|NCT04707313|531390113|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|16|||
147334237|NCT04707313|531390114|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|0|||
147334238|NCT04707313|531390115|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|0|||
147334239|NCT04707313|531390116|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|0|||
147334240|NCT04707313|531390117|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Adverse Event|0|||
147601018|NCT02132754|532356497|FG016|Overall Study|Physician Decision|0|||
147601019|NCT02132754|532356498|FG017|Overall Study|Physician Decision|0|||
147334241|NCT04707313|531390105|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|5|||
147601020|NCT02132754|532356499|FG018|Overall Study|Physician Decision|0|||
147601021|NCT02132754|532356500|FG019|Overall Study|Physician Decision|0|||
147601022|NCT02132754|532356501|FG020|Overall Study|Physician Decision|0|||
147601023|NCT02132754|532356502|FG021|Overall Study|Physician Decision|0|||
147601024|NCT02132754|532356503|FG022|Overall Study|Physician Decision|0|||
147662461|NCT02513550|532587347|FG002|Double Blind Treatment Period|Withdrawal by Subject|25|||
147601025|NCT02132754|532356504|FG023|Overall Study|Physician Decision|0|||
147601026|NCT02132754|532356505|FG024|Overall Study|Physician Decision|1|||
147662462|NCT02513550|532587348|FG003|Double Blind Treatment Period|Withdrawal by Subject|0|||
147601027|NCT02132754|532356506|FG025|Overall Study|Physician Decision|0|||
147601028|NCT02132754|532356507|FG026|Overall Study|Physician Decision|0|||
147601029|NCT02132754|532356508|FG027|Overall Study|Physician Decision|0|||
147275791|NCT04086472|531177612|FG003|Overall Study|Lost to Follow-up|0|||
147275792|NCT04086472|531177613|FG004|Overall Study|Lost to Follow-up|1|||
147275793|NCT04086472|531177609|FG000|Overall Study|Physician Decision|0|||
147275794|NCT04086472|531177610|FG001|Overall Study|Physician Decision|1|||
147275795|NCT04086472|531177611|FG002|Overall Study|Physician Decision|1|||
147275796|NCT04086472|531177612|FG003|Overall Study|Physician Decision|0|||
147275797|NCT04086472|531177613|FG004|Overall Study|Physician Decision|0|||
147275798|NCT04086472|531177609|FG000|Overall Study|Withdrawal by Subject|1|||
147275799|NCT04086472|531177610|FG001|Overall Study|Withdrawal by Subject|1|||
147275800|NCT04086472|531177611|FG002|Overall Study|Withdrawal by Subject|1|||
147275801|NCT04086472|531177612|FG003|Overall Study|Withdrawal by Subject|0|||
147275802|NCT04086472|531177613|FG004|Overall Study|Withdrawal by Subject|0|||
147275803|NCT04086472|531177609|FG000|Overall Study|Various reasons|2|||
147275804|NCT04086472|531177610|FG001|Overall Study|Various reasons|0|||
147275805|NCT04086472|531177611|FG002|Overall Study|Various reasons|0|||
147275806|NCT04086472|531177612|FG003|Overall Study|Various reasons|3|||
147275807|NCT04086472|531177613|FG004|Overall Study|Various reasons|1|||
147275808|NCT02252081|531177619|FG000|Overall Study|Withdrawal by Subject|2|||
147275809|NCT02252081|531177620|FG001|Overall Study|Withdrawal by Subject|1|||
147275810|NCT02252081|531177619|FG000|Overall Study|Adverse Event|4|||
147275811|NCT02252081|531177620|FG001|Overall Study|Adverse Event|1|||
147275812|NCT02252081|531177619|FG000|Overall Study|non compliance & others|0|||
147275813|NCT02252081|531177620|FG001|Overall Study|non compliance & others|2|||
147275814|NCT00048724|531177621|FG000|Overall Study|Adverse Event|53|||
147275815|NCT00048724|531177622|FG001|Overall Study|Adverse Event|12|||
147275816|NCT00048724|531177621|FG000|Overall Study|Withdrawal by Subject|34|||
147275817|NCT00048724|531177622|FG001|Overall Study|Withdrawal by Subject|54|||
147275818|NCT00048724|531177621|FG000|Overall Study|Lost to Follow-up|5|||
147275819|NCT00048724|531177622|FG001|Overall Study|Lost to Follow-up|5|||
147275820|NCT00048724|531177621|FG000|Overall Study|Protocol-defined Clinical Event|17|||
147275821|NCT00048724|531177622|FG001|Overall Study|Protocol-defined Clinical Event|32|||
147275822|NCT00048724|531177621|FG000|Overall Study|Noncompliance With Protocol|4|||
147275823|NCT00048724|531177622|FG001|Overall Study|Noncompliance With Protocol|12|||
147275824|NCT00048724|531177621|FG000|Overall Study|Did Not Meet Protocol Eligibility|2|||
147275825|NCT00048724|531177622|FG001|Overall Study|Did Not Meet Protocol Eligibility|2|||
147275826|NCT00048724|531177621|FG000|Overall Study|Administrative|1|||
147275827|NCT00048724|531177622|FG001|Overall Study|Administrative|1|||
147275828|NCT04116229|531177623|FG000|Overall Study|Met exclusion criteria during screeneing on day of study visit.|2|||
147275829|NCT04116229|531177624|FG001|Overall Study|Met exclusion criteria during screeneing on day of study visit.|3|||
147275830|NCT04116229|531177623|FG000|Overall Study|Scheduling not possible.|0|||
147275831|NCT04116229|531177624|FG001|Overall Study|Scheduling not possible.|1|||
147275832|NCT04574362|531177627|FG000|Overall Study|Other|0|||
147275833|NCT04574362|531177628|FG001|Overall Study|Other|5|||
147275834|NCT04574362|531177627|FG000|Overall Study|COVID-19|0|||
147275835|NCT04574362|531177628|FG001|Overall Study|COVID-19|1|||
147275836|NCT04574362|531177627|FG000|Overall Study|Adverse Event|1|||
147275837|NCT04574362|531177628|FG001|Overall Study|Adverse Event|1|||
147275838|NCT04574362|531177627|FG000|Overall Study|Withdrawal by Subject|2|||
147275839|NCT04574362|531177628|FG001|Overall Study|Withdrawal by Subject|4|||
147275840|NCT04574362|531177627|FG000|Overall Study|Participant anxious to go to their hometown and withdrew from study|1|||
147275841|NCT04574362|531177628|FG001|Overall Study|Participant anxious to go to their hometown and withdrew from study|0|||
147275842|NCT04574362|531177627|FG000|Overall Study|Participant refused to come to the hospital|1|||
147275843|NCT04574362|531177628|FG001|Overall Study|Participant refused to come to the hospital|0|||
147275844|NCT04574362|531177627|FG000|Overall Study|Participant refused the visit|1|||
147275845|NCT04574362|531177628|FG001|Overall Study|Participant refused the visit|0|||
147275846|NCT04574362|531177627|FG000|Overall Study|Participant quit early because of business trip|1|||
147275847|NCT04574362|531177628|FG001|Overall Study|Participant quit early because of business trip|0|||
147275848|NCT00642304|531177629|FG000|Overall Study|Adverse Event|1|||
147275849|NCT00642304|531177629|FG000|Overall Study|Death|1|||
147275850|NCT00642304|531177629|FG000|Overall Study|Blood transfusion|2|||
147275851|NCT00642304|531177629|FG000|Overall Study|Erythropoiesis Stimulating Agent Use.|1|||
147275852|NCT00642304|531177629|FG000|Overall Study|Transplantation|1|||
147601030|NCT02132754|532356509|FG028|Overall Study|Physician Decision|0|||
147275853|NCT02178475|531177633|FG000|Overall Study|Withdrawal by Subject|7|||
147275854|NCT02178475|531177633|FG000|Overall Study|Lost to Follow-up|10|||
147275855|NCT02178475|531177633|FG000|Overall Study|Death|13|||
147275856|NCT02178475|531177633|FG000|Overall Study|Protocol-specified Criteria|99|||
147275857|NCT01430585|531177634|FG000|Overall Study|Death|1|||
147275858|NCT01430585|531177634|FG000|Overall Study|Objective Progression or Relapse|3|||
147275859|NCT01430585|531177634|FG000|Overall Study|Study Terminated by Sponsor|3|||
147275860|NCT01430585|531177634|FG000|Overall Study|Other|7|||
147275861|NCT00779766|531177635|FG000|Month 24|Serious Adverse Event|2|||
147601031|NCT02132754|532356510|FG029|Overall Study|Physician Decision|0|||
147275862|NCT00779766|531177636|FG001|Month 24|Serious Adverse Event|3|||
147601032|NCT02132754|532356511|FG030|Overall Study|Physician Decision|0|||
147275863|NCT00779766|531177635|FG000|Month 24|Adverse Event|3|||
147275864|NCT00779766|531177636|FG001|Month 24|Adverse Event|3|||
147275865|NCT00779766|531177635|FG000|Month 24|Protocol Violation|3|||
147275866|NCT00779766|531177636|FG001|Month 24|Protocol Violation|1|||
147275867|NCT00779766|531177635|FG000|Month 24|Withdrawal by Subject|159|||
147275868|NCT00779766|531177636|FG001|Month 24|Withdrawal by Subject|127|||
147275869|NCT00779766|531177635|FG000|Month 24|Migrated/moved from study area|138|||
147275870|NCT00779766|531177636|FG001|Month 24|Migrated/moved from study area|162|||
147275871|NCT00779766|531177635|FG000|Month 24|Lost to Follow-up|9|||
147275872|NCT00779766|531177636|FG001|Month 24|Lost to Follow-up|9|||
147275873|NCT00779766|531177635|FG000|Month 24|Other|18|||
147275874|NCT00779766|531177636|FG001|Month 24|Other|27|||
147275875|NCT00779766|531177635|FG000|Month 48|Withdrawal by Subject|68|||
147275876|NCT00779766|531177636|FG001|Month 48|Withdrawal by Subject|63|||
147275877|NCT00779766|531177635|FG000|Month 48|Migrated/moved from study area|76|||
147275878|NCT00779766|531177636|FG001|Month 48|Migrated/moved from study area|75|||
147275879|NCT00779766|531177635|FG000|Month 48|Lost to Follow-up|29|||
147275880|NCT00779766|531177636|FG001|Month 48|Lost to Follow-up|30|||
147275881|NCT00779766|531177635|FG000|Month 48|Other|1|||
147275882|NCT00779766|531177636|FG001|Month 48|Other|0|||
147275883|NCT00779766|531177635|FG000|Month 72|Withdrawal by Subject|55|||
147275884|NCT00779766|531177636|FG001|Month 72|Withdrawal by Subject|71|||
147275885|NCT00779766|531177635|FG000|Month 72|Migrated/moved from study area|124|||
147275886|NCT00779766|531177636|FG001|Month 72|Migrated/moved from study area|109|||
147275887|NCT00779766|531177635|FG000|Month 72|Lost to Follow-up|6|||
147275888|NCT00779766|531177636|FG001|Month 72|Lost to Follow-up|8|||
147275889|NCT00779766|531177635|FG000|Month 72|Other|0|||
147275890|NCT00779766|531177636|FG001|Month 72|Other|1|||
147275891|NCT01412424|531177643|FG000|Core Treatment Period|Treatment Failure|24|||
147275892|NCT01412424|531177643|FG000|Core Treatment Period|Adverse Event|21|||
147275893|NCT01412424|531177643|FG000|Core Treatment Period|Patient Request|5|||
147275894|NCT01412424|531177643|FG000|Core Treatment Period|Lost to Follow-up|2|||
147275895|NCT01412424|531177643|FG000|Core Treatment Period|Sponsor Request|1|||
147275896|NCT01412424|531177643|FG000|Extension Treatment Period|Adverse Event|2|||
147275897|NCT01412424|531177643|FG000|Extension Treatment Period|Treatment Failure|2|||
147275898|NCT01412424|531177643|FG000|Extension Treatment Period|Patient Request|2|||
147275899|NCT01274637|531177644|FG000|Overall Study|Withdrawal by Subject|0|||
147275900|NCT01274637|531177645|FG001|Overall Study|Withdrawal by Subject|1|||
147275901|NCT01274637|531177644|FG000|Overall Study|Lost to Follow-up|0|||
147275902|NCT01274637|531177645|FG001|Overall Study|Lost to Follow-up|1|||
147275903|NCT01824303|531177648|FG000|Randomized Study|Withdrawal by Subject|1|||
147275904|NCT01824303|531177649|FG001|Randomized Study|Withdrawal by Subject|1|||
147275905|NCT01824303|531177648|FG000|Randomized Study|Other Miscellaneous Reasons|1|||
147275906|NCT01824303|531177649|FG001|Randomized Study|Other Miscellaneous Reasons|0|||
147275907|NCT02075320|531177655|FG000|Overall Study|Withdrawal by Subject|2|||
147275908|NCT03773757|531177657|FG000|Overall Study|Withdrawal by Subject|2|||
147275909|NCT03773757|531177658|FG001|Overall Study|Withdrawal by Subject|4|||
147275910|NCT02985736|531177665|FG000|Overall Study|Lost to Follow-up|3|||
147275911|NCT00382733|531177666|FG000|Overall Study|Withdrawal by Subject|0|||
147275912|NCT00382733|531177667|FG001|Overall Study|Withdrawal by Subject|1|||
147275913|NCT00382733|531177668|FG002|Overall Study|Withdrawal by Subject|0|||
147275914|NCT00382733|531177669|FG003|Overall Study|Withdrawal by Subject|0|||
147275915|NCT00382733|531177670|FG004|Overall Study|Withdrawal by Subject|0|||
147275916|NCT00179413|531177671|FG000|Overall Study|Adverse Event|38|||
147275917|NCT00179413|531177672|FG001|Overall Study|Adverse Event|20|||
147275918|NCT00179413|531177671|FG000|Overall Study|Withdrawal by Subject|87|||
147275919|NCT00179413|531177672|FG001|Overall Study|Withdrawal by Subject|95|||
147275920|NCT00550836|531177673|FG000|Overall Study|Withdrawal by Subject|3|||
147275921|NCT00550836|531177674|FG001|Overall Study|Withdrawal by Subject|9|||
147275922|NCT00439140|531177677|FG000|Treatment Cycle 1|Lost to Follow-up|1|||
147275923|NCT00439140|531177678|FG001|Treatment Cycle 1|Lost to Follow-up|1|||
147275924|NCT00439140|531177679|FG002|Treatment Cycle 1|Lost to Follow-up|1|||
147275925|NCT00439140|531177677|FG000|Treatment Cycle 1|Personal reasons|0|||
147275926|NCT00439140|531177678|FG001|Treatment Cycle 1|Personal reasons|2|||
147275927|NCT00439140|531177679|FG002|Treatment Cycle 1|Personal reasons|0|||
147275928|NCT00439140|531177677|FG000|Treatment Cycle 1|Withdrawal by Subject|0|||
147275929|NCT00439140|531177678|FG001|Treatment Cycle 1|Withdrawal by Subject|1|||
147275930|NCT00439140|531177679|FG002|Treatment Cycle 1|Withdrawal by Subject|0|||
147275931|NCT00439140|531177677|FG000|Treatment Cycle 2|Withdrawal by Subject|1|||
147275932|NCT00439140|531177678|FG001|Treatment Cycle 2|Withdrawal by Subject|0|||
147275933|NCT00439140|531177679|FG002|Treatment Cycle 2|Withdrawal by Subject|0|||
147275934|NCT00439140|531177677|FG000|Treatment Cycle 2|Lost to Follow-up|1|||
147275935|NCT00439140|531177678|FG001|Treatment Cycle 2|Lost to Follow-up|1|||
147275936|NCT00439140|531177679|FG002|Treatment Cycle 2|Lost to Follow-up|0|||
147275937|NCT01458171|531177680|FG000|Overall Study|Adverse Event|1|||
147275938|NCT00578565|531177684|FG000|Overall Study|Adverse Event|3|||
147275939|NCT01192152|531177685|FG000|Period 1|left prematurely (while on treatment B)|0|||
147662463|NCT02513550|532587349|FG004|Double Blind Treatment Period|Withdrawal by Subject|0|||
147275940|NCT01192152|531177686|FG001|Period 1|left prematurely (while on treatment B)|1|||
147275941|NCT01192152|531177685|FG000|Period 3|family emergency|1|||
147275942|NCT01192152|531177686|FG001|Period 3|family emergency|0|||
147275943|NCT01559311|531177688|FG000|Overall Study|Protocol Violation|0|||
147275944|NCT01559311|531177689|FG001|Overall Study|Protocol Violation|0|||
147275945|NCT01559311|531177690|FG002|Overall Study|Protocol Violation|2|||
147275946|NCT01559311|531177688|FG000|Overall Study|Difficulty in cannulating the lateral ve|1|||
147275947|NCT01559311|531177689|FG001|Overall Study|Difficulty in cannulating the lateral ve|0|||
147275948|NCT01559311|531177690|FG002|Overall Study|Difficulty in cannulating the lateral ve|0|||
147275949|NCT01559311|531177688|FG000|Overall Study|Withdrawal by Subject|2|||
147601033|NCT02132754|532356512|FG031|Overall Study|Physician Decision|1|||
147601034|NCT02132754|532356513|FG032|Overall Study|Physician Decision|0|||
147601035|NCT02132754|532356514|FG033|Overall Study|Physician Decision|3|||
147601036|NCT02132754|532356481|FG000|Overall Study|Progressive Disease|1|||
147601037|NCT02132754|532356482|FG001|Overall Study|Progressive Disease|1|||
147601038|NCT02132754|532356483|FG002|Overall Study|Progressive Disease|1|||
147601039|NCT02132754|532356484|FG003|Overall Study|Progressive Disease|1|||
147334242|NCT04707313|531390106|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|1|||
147334243|NCT04707313|531390107|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
147334244|NCT04707313|531390108|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
147334245|NCT04707313|531390109|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|1|||
147601040|NCT02132754|532356485|FG004|Overall Study|Progressive Disease|1|||
147601041|NCT02132754|532356486|FG005|Overall Study|Progressive Disease|1|||
147275950|NCT01559311|531177689|FG001|Overall Study|Withdrawal by Subject|1|||
147275951|NCT01559311|531177690|FG002|Overall Study|Withdrawal by Subject|0|||
147275952|NCT01559311|531177688|FG000|Overall Study|Death|0|||
147275953|NCT01559311|531177689|FG001|Overall Study|Death|2|||
147275954|NCT01559311|531177690|FG002|Overall Study|Death|3|||
147275955|NCT01559311|531177688|FG000|Overall Study|Lost to Follow-up|0|||
147275956|NCT01559311|531177689|FG001|Overall Study|Lost to Follow-up|3|||
147275957|NCT01559311|531177690|FG002|Overall Study|Lost to Follow-up|2|||
147275958|NCT01559311|531177688|FG000|Overall Study|Adverse Event|0|||
147334246|NCT04707313|531390110|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
147334247|NCT04707313|531390111|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
147334248|NCT04707313|531390112|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
147334249|NCT04707313|531390113|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
147334250|NCT04707313|531390114|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
147334251|NCT04707313|531390115|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
147450877|NCT03257267|531813174|FG000|Overall Study|Physician Decision|1|||
147450878|NCT03257267|531813175|FG001|Overall Study|Physician Decision|3|||
147450879|NCT03257267|531813174|FG000|Overall Study|Disease Progression|109|||
147450880|NCT03257267|531813175|FG001|Overall Study|Disease Progression|121|||
147450881|NCT03257267|531813174|FG000|Overall Study|Withdrawal by Subject|8|||
147450882|NCT03257267|531813175|FG001|Overall Study|Withdrawal by Subject|26|||
147450883|NCT03257267|531813174|FG000|Overall Study|Other|0|||
147450884|NCT03257267|531813175|FG001|Overall Study|Other|2|||
147450885|NCT03445000|531813176|FG000|Overall Study|Disease progression|8|||
147450886|NCT03445000|531813176|FG000|Overall Study|Adverse Event|3|||
147450887|NCT03445000|531813176|FG000|Overall Study|Death|2|||
147450888|NCT03445000|531813176|FG000|Overall Study|Physician Decision|1|||
147450889|NCT03311711|531813177|FG000|Overall Study|Death|1|||
147450890|NCT03311711|531813178|FG001|Overall Study|Death|0|||
147450891|NCT03311711|531813179|FG002|Overall Study|Death|0|||
147450892|NCT03311711|531813180|FG003|Overall Study|Death|0|||
147450893|NCT03311711|531813181|FG004|Overall Study|Death|0|||
147450894|NCT03311711|531813182|FG005|Overall Study|Death|0|||
147450895|NCT03311711|531813183|FG006|Overall Study|Death|1|||
147450896|NCT03311711|531813184|FG007|Overall Study|Death|0|||
147450897|NCT03311711|531813185|FG008|Overall Study|Death|1|||
147450898|NCT03311711|531813186|FG009|Overall Study|Death|0|||
147450899|NCT03311711|531813177|FG000|Overall Study|Death of dyad partner|0|||
147450900|NCT03311711|531813178|FG001|Overall Study|Death of dyad partner|1|||
147450901|NCT03311711|531813179|FG002|Overall Study|Death of dyad partner|0|||
147601042|NCT02132754|532356487|FG006|Overall Study|Progressive Disease|1|||
147601043|NCT02132754|532356488|FG007|Overall Study|Progressive Disease|1|||
147450902|NCT03311711|531813180|FG003|Overall Study|Death of dyad partner|0|||
147450903|NCT03311711|531813181|FG004|Overall Study|Death of dyad partner|0|||
147450904|NCT03311711|531813182|FG005|Overall Study|Death of dyad partner|0|||
147450905|NCT03311711|531813183|FG006|Overall Study|Death of dyad partner|0|||
147450906|NCT03311711|531813184|FG007|Overall Study|Death of dyad partner|1|||
147450907|NCT03311711|531813185|FG008|Overall Study|Death of dyad partner|0|||
147601044|NCT02132754|532356489|FG008|Overall Study|Progressive Disease|1|||
147601045|NCT02132754|532356490|FG009|Overall Study|Progressive Disease|3|||
147601046|NCT02132754|532356491|FG010|Overall Study|Progressive Disease|3|||
147275959|NCT01559311|531177689|FG001|Overall Study|Adverse Event|0|||
147275960|NCT01559311|531177690|FG002|Overall Study|Adverse Event|1|||
147275961|NCT05013905|531177691|FG000|Overall Study|Adverse Event|1|||
147275962|NCT05013905|531177691|FG000|Overall Study|Lack of Efficacy|1|||
147275963|NCT01849588|531177692|FG000|Overall Study|Lack of Efficacy|3|||
147275964|NCT00515827|531177693|FG000|First Intervention (12 Weeks)|Unwilling to adhere to study requirement|1|||
147275965|NCT00515827|531177694|FG001|First Intervention (12 Weeks)|Unwilling to adhere to study requirement|1|||
147275966|NCT00515827|531177693|FG000|Second Intervention (12 Weeks)|Consent withdraw|1|||
147275967|NCT00515827|531177694|FG001|Second Intervention (12 Weeks)|Consent withdraw|0|||
147275968|NCT03181542|531177695|FG000|Overall Study|Subject withdrawn because research physician could not make it in time to place IV|1|||
147275969|NCT03181542|531177696|FG001|Overall Study|Subject withdrawn because research physician could not make it in time to place IV|0|||
147275970|NCT01009099|531177697|FG000|Overall Study|Lost to Follow-up|1|||
147275971|NCT01009099|531177698|FG001|Overall Study|Lost to Follow-up|0|||
147275972|NCT01009099|531177697|FG000|Overall Study|Physician Decision|3|||
147275973|NCT01009099|531177698|FG001|Overall Study|Physician Decision|2|||
147275974|NCT01009099|531177697|FG000|Overall Study|Withdrawal by Subject|1|||
147275975|NCT01009099|531177698|FG001|Overall Study|Withdrawal by Subject|1|||
147275976|NCT01009099|531177697|FG000|Overall Study|Death|0|||
147275977|NCT01009099|531177698|FG001|Overall Study|Death|1|||
147275978|NCT01856543|531177699|FG000|Overall Study|Treatment discontinued|6|||
147275979|NCT01856543|531177700|FG001|Overall Study|Treatment discontinued|3|||
147275980|NCT01856543|531177699|FG000|Overall Study|Withdrawn before start|7|||
147275981|NCT01856543|531177700|FG001|Overall Study|Withdrawn before start|3|||
147275982|NCT01712984|531177701|FG000|Overall Study|Adverse Event|0|||
147275983|NCT01712984|531177702|FG001|Overall Study|Adverse Event|0|||
147275984|NCT01712984|531177703|FG002|Overall Study|Adverse Event|1|||
147275985|NCT01712984|531177701|FG000|Overall Study|Protocol Violation|2|||
147275986|NCT01712984|531177702|FG001|Overall Study|Protocol Violation|0|||
147275987|NCT01712984|531177703|FG002|Overall Study|Protocol Violation|1|||
147275988|NCT01712984|531177701|FG000|Overall Study|Lost to Follow-up|8|||
147275989|NCT01712984|531177702|FG001|Overall Study|Lost to Follow-up|10|||
147275990|NCT01712984|531177703|FG002|Overall Study|Lost to Follow-up|1|||
147275991|NCT01712984|531177701|FG000|Overall Study|Withdrawal by Subject|6|||
147275992|NCT01712984|531177702|FG001|Overall Study|Withdrawal by Subject|6|||
147275993|NCT01712984|531177703|FG002|Overall Study|Withdrawal by Subject|7|||
147275994|NCT01265953|531179370|FG000|Overall Study|Non compliance|5|||
147275995|NCT01265953|531179371|FG001|Overall Study|Non compliance|3|||
147275996|NCT02866682|531179377|FG000|Overall Study|Death|0|||
147275997|NCT02866682|531179378|FG001|Overall Study|Death|1|||
147275998|NCT02866682|531179377|FG000|Overall Study|Lost to Follow-up|0|||
147275999|NCT02866682|531179378|FG001|Overall Study|Lost to Follow-up|4|||
147276000|NCT02866682|531179377|FG000|Overall Study|Tacrolimus Discontinued During Study|0|||
147276001|NCT02866682|531179378|FG001|Overall Study|Tacrolimus Discontinued During Study|6|||
147276002|NCT02866682|531179377|FG000|Overall Study|Other|0|||
147276003|NCT02866682|531179378|FG001|Overall Study|Other|1|||
147276004|NCT01750268|531179380|FG000|Overall Study|Lost to Follow-up|0|||
147276005|NCT01750268|531179381|FG001|Overall Study|Lost to Follow-up|2|||
147276006|NCT01750268|531179380|FG000|Overall Study|Physician Decision|0|||
147276007|NCT01750268|531179381|FG001|Overall Study|Physician Decision|3|||
147276008|NCT01750268|531179380|FG000|Overall Study|Withdrawal by Subject|2|||
147276009|NCT01750268|531179381|FG001|Overall Study|Withdrawal by Subject|0|||
147276010|NCT02086591|531179382|FG000|Overall Study|Adverse Event|1|||
147276011|NCT02086591|531179382|FG000|Overall Study|Withdrawal by Subject|1|||
147276012|NCT02086591|531179382|FG000|Overall Study|protocol terminated|3|||
147276013|NCT01923181|531179383|FG000|Overall Study|Protocol Violation|2|||
147276014|NCT01923181|531179384|FG001|Overall Study|Protocol Violation|2|||
147276015|NCT01923181|531179385|FG002|Overall Study|Protocol Violation|0|||
147276016|NCT01923181|531179386|FG003|Overall Study|Protocol Violation|2|||
147276017|NCT01923181|531179387|FG004|Overall Study|Protocol Violation|2|||
147276018|NCT01923181|531179388|FG005|Overall Study|Protocol Violation|1|||
147276019|NCT01923181|531179389|FG006|Overall Study|Protocol Violation|1|||
147276020|NCT01923181|531179390|FG007|Overall Study|Protocol Violation|2|||
147276021|NCT01923181|531179391|FG008|Overall Study|Protocol Violation|1|||
147276022|NCT01923181|531179383|FG000|Overall Study|Withdrawal by Subject|0|||
147276023|NCT01923181|531179384|FG001|Overall Study|Withdrawal by Subject|1|||
147276024|NCT01923181|531179385|FG002|Overall Study|Withdrawal by Subject|0|||
147276025|NCT01923181|531179386|FG003|Overall Study|Withdrawal by Subject|1|||
147276026|NCT01923181|531179387|FG004|Overall Study|Withdrawal by Subject|4|||
147276027|NCT01923181|531179388|FG005|Overall Study|Withdrawal by Subject|2|||
147276028|NCT01923181|531179389|FG006|Overall Study|Withdrawal by Subject|4|||
147276029|NCT01923181|531179390|FG007|Overall Study|Withdrawal by Subject|3|||
147276030|NCT01923181|531179391|FG008|Overall Study|Withdrawal by Subject|1|||
147276031|NCT01923181|531179383|FG000|Overall Study|Other|1|||
147276032|NCT01923181|531179384|FG001|Overall Study|Other|0|||
147276033|NCT01923181|531179385|FG002|Overall Study|Other|0|||
147276034|NCT01923181|531179386|FG003|Overall Study|Other|1|||
147276035|NCT01923181|531179387|FG004|Overall Study|Other|0|||
147276036|NCT01923181|531179388|FG005|Overall Study|Other|0|||
147276037|NCT01923181|531179389|FG006|Overall Study|Other|0|||
147276038|NCT01923181|531179390|FG007|Overall Study|Other|0|||
147276039|NCT01923181|531179391|FG008|Overall Study|Other|0|||
147276040|NCT01923181|531179383|FG000|Overall Study|Lost to Follow-up|0|||
147276041|NCT01923181|531179384|FG001|Overall Study|Lost to Follow-up|3|||
147276042|NCT01923181|531179385|FG002|Overall Study|Lost to Follow-up|2|||
147276043|NCT01923181|531179386|FG003|Overall Study|Lost to Follow-up|1|||
147276044|NCT01923181|531179387|FG004|Overall Study|Lost to Follow-up|2|||
147276045|NCT01923181|531179388|FG005|Overall Study|Lost to Follow-up|1|||
147276046|NCT01923181|531179389|FG006|Overall Study|Lost to Follow-up|3|||
147276047|NCT01923181|531179390|FG007|Overall Study|Lost to Follow-up|3|||
147276048|NCT01923181|531179391|FG008|Overall Study|Lost to Follow-up|1|||
147276049|NCT02944578|531179392|FG000|Overall Study|Physician Decision|1|||
147601047|NCT02132754|532356492|FG011|Overall Study|Progressive Disease|2|||
147601048|NCT02132754|532356493|FG012|Overall Study|Progressive Disease|2|||
147601049|NCT02132754|532356494|FG013|Overall Study|Progressive Disease|3|||
147601050|NCT02132754|532356495|FG014|Overall Study|Progressive Disease|2|||
147601051|NCT02132754|532356496|FG015|Overall Study|Progressive Disease|1|||
147601052|NCT02132754|532356497|FG016|Overall Study|Progressive Disease|2|||
147601053|NCT02132754|532356498|FG017|Overall Study|Progressive Disease|1|||
147601054|NCT02132754|532356499|FG018|Overall Study|Progressive Disease|3|||
147601055|NCT02132754|532356500|FG019|Overall Study|Progressive Disease|1|||
147601056|NCT02132754|532356501|FG020|Overall Study|Progressive Disease|1|||
147601057|NCT02132754|532356502|FG021|Overall Study|Progressive Disease|3|||
147601058|NCT02132754|532356503|FG022|Overall Study|Progressive Disease|2|||
147601059|NCT02132754|532356504|FG023|Overall Study|Progressive Disease|3|||
147601060|NCT02132754|532356505|FG024|Overall Study|Progressive Disease|0|||
147601061|NCT02132754|532356506|FG025|Overall Study|Progressive Disease|1|||
147601062|NCT02132754|532356507|FG026|Overall Study|Progressive Disease|2|||
147601063|NCT02132754|532356508|FG027|Overall Study|Progressive Disease|1|||
147601064|NCT02132754|532356509|FG028|Overall Study|Progressive Disease|2|||
147601065|NCT02132754|532356510|FG029|Overall Study|Progressive Disease|3|||
147601066|NCT02132754|532356511|FG030|Overall Study|Progressive Disease|1|||
147601067|NCT02132754|532356512|FG031|Overall Study|Progressive Disease|1|||
147601068|NCT02132754|532356513|FG032|Overall Study|Progressive Disease|3|||
147601069|NCT02132754|532356514|FG033|Overall Study|Progressive Disease|6|||
147601070|NCT02132754|532356481|FG000|Overall Study|Screen Failure|0|||
147601071|NCT02132754|532356482|FG001|Overall Study|Screen Failure|0|||
147601072|NCT02132754|532356483|FG002|Overall Study|Screen Failure|0|||
147601073|NCT02132754|532356484|FG003|Overall Study|Screen Failure|0|||
147601074|NCT02132754|532356485|FG004|Overall Study|Screen Failure|0|||
147601075|NCT02132754|532356486|FG005|Overall Study|Screen Failure|0|||
147601076|NCT02132754|532356487|FG006|Overall Study|Screen Failure|0|||
147601077|NCT02132754|532356488|FG007|Overall Study|Screen Failure|0|||
147601078|NCT02132754|532356489|FG008|Overall Study|Screen Failure|0|||
147601079|NCT02132754|532356490|FG009|Overall Study|Screen Failure|0|||
147601080|NCT02132754|532356491|FG010|Overall Study|Screen Failure|0|||
147601081|NCT02132754|532356492|FG011|Overall Study|Screen Failure|0|||
147601082|NCT02132754|532356493|FG012|Overall Study|Screen Failure|0|||
147601083|NCT02132754|532356494|FG013|Overall Study|Screen Failure|0|||
147601084|NCT02132754|532356495|FG014|Overall Study|Screen Failure|0|||
147601085|NCT02132754|532356496|FG015|Overall Study|Screen Failure|0|||
147601086|NCT02132754|532356497|FG016|Overall Study|Screen Failure|0|||
147601087|NCT02132754|532356498|FG017|Overall Study|Screen Failure|0|||
147601088|NCT02132754|532356499|FG018|Overall Study|Screen Failure|0|||
147601089|NCT02132754|532356500|FG019|Overall Study|Screen Failure|1|||
147601090|NCT02132754|532356501|FG020|Overall Study|Screen Failure|0|||
147601091|NCT02132754|532356502|FG021|Overall Study|Screen Failure|1|||
147601092|NCT02132754|532356503|FG022|Overall Study|Screen Failure|0|||
147601093|NCT02132754|532356504|FG023|Overall Study|Screen Failure|0|||
147601094|NCT02132754|532356505|FG024|Overall Study|Screen Failure|0|||
147601095|NCT02132754|532356506|FG025|Overall Study|Screen Failure|0|||
147601096|NCT02132754|532356507|FG026|Overall Study|Screen Failure|0|||
147601097|NCT02132754|532356508|FG027|Overall Study|Screen Failure|0|||
147601098|NCT02132754|532356509|FG028|Overall Study|Screen Failure|0|||
147601099|NCT02132754|532356510|FG029|Overall Study|Screen Failure|0|||
147276050|NCT02944578|531179393|FG001|Overall Study|Physician Decision|0|||
147276051|NCT02932891|531179395|FG000|Overall Study|Lost to Follow-up|2|||
147276052|NCT02932891|531179395|FG000|Overall Study|HPA Suppress|2|||
147601100|NCT02132754|532356511|FG030|Overall Study|Screen Failure|0|||
147601101|NCT02132754|532356512|FG031|Overall Study|Screen Failure|0|||
147601102|NCT02132754|532356513|FG032|Overall Study|Screen Failure|0|||
147601103|NCT02132754|532356514|FG033|Overall Study|Screen Failure|0|||
147601104|NCT02132754|532356481|FG000|Overall Study|Transferred to Extension Study|0|||
147601105|NCT02132754|532356482|FG001|Overall Study|Transferred to Extension Study|0|||
147601106|NCT02132754|532356483|FG002|Overall Study|Transferred to Extension Study|0|||
147601107|NCT02132754|532356484|FG003|Overall Study|Transferred to Extension Study|0|||
147601108|NCT02132754|532356485|FG004|Overall Study|Transferred to Extension Study|0|||
147601109|NCT02132754|532356486|FG005|Overall Study|Transferred to Extension Study|0|||
147276053|NCT00577122|531179398|FG000|Overall Study|Adverse Event|0|||
147601110|NCT02132754|532356487|FG006|Overall Study|Transferred to Extension Study|0|||
147601111|NCT02132754|532356488|FG007|Overall Study|Transferred to Extension Study|0|||
147601112|NCT02132754|532356489|FG008|Overall Study|Transferred to Extension Study|0|||
147601113|NCT02132754|532356490|FG009|Overall Study|Transferred to Extension Study|0|||
147601114|NCT02132754|532356491|FG010|Overall Study|Transferred to Extension Study|0|||
147601115|NCT02132754|532356492|FG011|Overall Study|Transferred to Extension Study|0|||
147601116|NCT02132754|532356493|FG012|Overall Study|Transferred to Extension Study|0|||
147601117|NCT02132754|532356494|FG013|Overall Study|Transferred to Extension Study|0|||
147601118|NCT02132754|532356495|FG014|Overall Study|Transferred to Extension Study|0|||
147601119|NCT02132754|532356496|FG015|Overall Study|Transferred to Extension Study|0|||
147601120|NCT02132754|532356497|FG016|Overall Study|Transferred to Extension Study|0|||
147601121|NCT02132754|532356498|FG017|Overall Study|Transferred to Extension Study|0|||
147601122|NCT02132754|532356499|FG018|Overall Study|Transferred to Extension Study|0|||
147601123|NCT02132754|532356500|FG019|Overall Study|Transferred to Extension Study|0|||
147601124|NCT02132754|532356501|FG020|Overall Study|Transferred to Extension Study|0|||
147601125|NCT02132754|532356502|FG021|Overall Study|Transferred to Extension Study|0|||
147601126|NCT02132754|532356503|FG022|Overall Study|Transferred to Extension Study|0|||
147601127|NCT02132754|532356504|FG023|Overall Study|Transferred to Extension Study|0|||
147601128|NCT02132754|532356505|FG024|Overall Study|Transferred to Extension Study|0|||
147601129|NCT02132754|532356506|FG025|Overall Study|Transferred to Extension Study|0|||
147601130|NCT02132754|532356507|FG026|Overall Study|Transferred to Extension Study|0|||
147601131|NCT02132754|532356508|FG027|Overall Study|Transferred to Extension Study|0|||
147601132|NCT02132754|532356509|FG028|Overall Study|Transferred to Extension Study|0|||
147601133|NCT02132754|532356510|FG029|Overall Study|Transferred to Extension Study|0|||
147601134|NCT02132754|532356511|FG030|Overall Study|Transferred to Extension Study|0|||
147601135|NCT02132754|532356512|FG031|Overall Study|Transferred to Extension Study|0|||
147601136|NCT02132754|532356513|FG032|Overall Study|Transferred to Extension Study|0|||
147601137|NCT02132754|532356514|FG033|Overall Study|Transferred to Extension Study|6|||
147601138|NCT02132754|532356481|FG000|Overall Study|Withdrawal by Subject|0|||
147601139|NCT02132754|532356482|FG001|Overall Study|Withdrawal by Subject|0|||
147601140|NCT02132754|532356483|FG002|Overall Study|Withdrawal by Subject|0|||
147601141|NCT02132754|532356484|FG003|Overall Study|Withdrawal by Subject|0|||
147601142|NCT02132754|532356485|FG004|Overall Study|Withdrawal by Subject|0|||
147601143|NCT02132754|532356486|FG005|Overall Study|Withdrawal by Subject|0|||
147601144|NCT02132754|532356487|FG006|Overall Study|Withdrawal by Subject|0|||
147601145|NCT02132754|532356488|FG007|Overall Study|Withdrawal by Subject|0|||
147601146|NCT02132754|532356489|FG008|Overall Study|Withdrawal by Subject|0|||
147601147|NCT02132754|532356490|FG009|Overall Study|Withdrawal by Subject|1|||
147601148|NCT02132754|532356491|FG010|Overall Study|Withdrawal by Subject|0|||
147601149|NCT02132754|532356492|FG011|Overall Study|Withdrawal by Subject|0|||
147276054|NCT00577122|531179399|FG001|Overall Study|Adverse Event|2|||
147276055|NCT00577122|531179398|FG000|Overall Study|Progression, relapse during active trt|6|||
147276056|NCT00577122|531179399|FG001|Overall Study|Progression, relapse during active trt|8|||
147276057|NCT00577122|531179398|FG000|Overall Study|Prog, refract disease during active trt|8|||
147276058|NCT00577122|531179399|FG001|Overall Study|Prog, refract disease during active trt|5|||
147276059|NCT00577122|531179398|FG000|Overall Study|Alternative Therapy|0|||
147276060|NCT00577122|531179399|FG001|Overall Study|Alternative Therapy|1|||
147276061|NCT00440271|531179400|FG000|Overall Study|Protocol Violation|1|||
147276062|NCT00440271|531179401|FG001|Overall Study|Protocol Violation|1|||
147276063|NCT00440271|531179400|FG000|Overall Study|Adverse Event|0|||
147276064|NCT00440271|531179401|FG001|Overall Study|Adverse Event|1|||
147276065|NCT00440271|531179400|FG000|Overall Study|Lost to Follow-up|1|||
147276066|NCT00440271|531179401|FG001|Overall Study|Lost to Follow-up|0|||
147276067|NCT00440271|531179400|FG000|Overall Study|Withdrawal by Subject|0|||
147276068|NCT00440271|531179401|FG001|Overall Study|Withdrawal by Subject|2|||
147276069|NCT00440271|531179400|FG000|Overall Study|Lack of Efficacy|0|||
147276070|NCT00440271|531179401|FG001|Overall Study|Lack of Efficacy|1|||
147276071|NCT00440271|531179400|FG000|Overall Study|Due to closure of trial|8|||
147276072|NCT00440271|531179401|FG001|Overall Study|Due to closure of trial|10|||
147276073|NCT00440271|531179400|FG000|Overall Study|Other|2|||
147276074|NCT00440271|531179401|FG001|Overall Study|Other|0|||
147276075|NCT00456092|531179402|FG000|Extension Phase|Grade 2 or Greater AE|2|||
147276076|NCT00456092|531179403|FG001|Extension Phase|Grade 2 or Greater AE|2|||
147334252|NCT04707313|531390116|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
147601150|NCT02132754|532356493|FG012|Overall Study|Withdrawal by Subject|1|||
147601151|NCT02132754|532356494|FG013|Overall Study|Withdrawal by Subject|0|||
147334253|NCT04707313|531390117|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Lack of Efficacy|0|||
147601152|NCT02132754|532356495|FG014|Overall Study|Withdrawal by Subject|1|||
147601153|NCT02132754|532356496|FG015|Overall Study|Withdrawal by Subject|2|||
147601154|NCT02132754|532356497|FG016|Overall Study|Withdrawal by Subject|1|||
147601155|NCT02132754|532356498|FG017|Overall Study|Withdrawal by Subject|0|||
147601156|NCT02132754|532356499|FG018|Overall Study|Withdrawal by Subject|0|||
147276077|NCT00456092|531179404|FG002|Extension Phase|Grade 2 or Greater AE|0|||
147276078|NCT00456092|531179405|FG003|Extension Phase|Grade 2 or Greater AE|0|||
147334254|NCT04707313|531390105|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|5|||
147276079|NCT00456092|531179406|FG004|Extension Phase|Grade 2 or Greater AE|2|||
147276080|NCT00456092|531179402|FG000|Extension Phase|Flare of Psoriatic Arthritis|1|||
147601157|NCT02132754|532356500|FG019|Overall Study|Withdrawal by Subject|0|||
147601158|NCT02132754|532356501|FG020|Overall Study|Withdrawal by Subject|1|||
147601159|NCT02132754|532356502|FG021|Overall Study|Withdrawal by Subject|0|||
147601160|NCT02132754|532356503|FG022|Overall Study|Withdrawal by Subject|0|||
147601161|NCT02132754|532356504|FG023|Overall Study|Withdrawal by Subject|0|||
147601162|NCT02132754|532356505|FG024|Overall Study|Withdrawal by Subject|1|||
147601163|NCT02132754|532356506|FG025|Overall Study|Withdrawal by Subject|0|||
147601164|NCT02132754|532356507|FG026|Overall Study|Withdrawal by Subject|0|||
147601165|NCT02132754|532356508|FG027|Overall Study|Withdrawal by Subject|1|||
147601166|NCT02132754|532356509|FG028|Overall Study|Withdrawal by Subject|0|||
147601167|NCT02132754|532356510|FG029|Overall Study|Withdrawal by Subject|0|||
147601168|NCT02132754|532356511|FG030|Overall Study|Withdrawal by Subject|0|||
147601169|NCT02132754|532356512|FG031|Overall Study|Withdrawal by Subject|1|||
147601170|NCT02132754|532356513|FG032|Overall Study|Withdrawal by Subject|0|||
147601171|NCT02132754|532356514|FG033|Overall Study|Withdrawal by Subject|2|||
147601172|NCT00754650|532358050|FG000|Overall Study|Disease Progression|2|||
147276081|NCT00456092|531179403|FG001|Extension Phase|Flare of Psoriatic Arthritis|0|||
147276082|NCT00456092|531179404|FG002|Extension Phase|Flare of Psoriatic Arthritis|0|||
147276083|NCT00456092|531179405|FG003|Extension Phase|Flare of Psoriatic Arthritis|0|||
147276084|NCT00456092|531179406|FG004|Extension Phase|Flare of Psoriatic Arthritis|1|||
147276085|NCT00456092|531179402|FG000|Extension Phase|Worsening / Not Responding to Study Drug|3|||
147276086|NCT00456092|531179403|FG001|Extension Phase|Worsening / Not Responding to Study Drug|1|||
147276087|NCT00456092|531179404|FG002|Extension Phase|Worsening / Not Responding to Study Drug|0|||
147276088|NCT00456092|531179405|FG003|Extension Phase|Worsening / Not Responding to Study Drug|0|||
147276089|NCT00456092|531179406|FG004|Extension Phase|Worsening / Not Responding to Study Drug|2|||
147276090|NCT00456092|531179402|FG000|Extension Phase|Withdrew Consent|2|||
147276091|NCT00456092|531179403|FG001|Extension Phase|Withdrew Consent|0|||
147276092|NCT00456092|531179404|FG002|Extension Phase|Withdrew Consent|0|||
147276093|NCT00456092|531179405|FG003|Extension Phase|Withdrew Consent|0|||
147276094|NCT00456092|531179406|FG004|Extension Phase|Withdrew Consent|0|||
147276095|NCT00456092|531179402|FG000|Extension Phase|Lost to Follow-up|1|||
147276096|NCT00456092|531179403|FG001|Extension Phase|Lost to Follow-up|1|||
147276097|NCT00456092|531179404|FG002|Extension Phase|Lost to Follow-up|0|||
147276098|NCT00456092|531179405|FG003|Extension Phase|Lost to Follow-up|0|||
147276099|NCT00456092|531179406|FG004|Extension Phase|Lost to Follow-up|1|||
147276100|NCT00456092|531179402|FG000|Extension Phase|Other|2|||
147276101|NCT00456092|531179403|FG001|Extension Phase|Other|0|||
147276102|NCT00456092|531179404|FG002|Extension Phase|Other|0|||
147276103|NCT00456092|531179405|FG003|Extension Phase|Other|1|||
147276104|NCT00456092|531179406|FG004|Extension Phase|Other|1|||
147276105|NCT00456092|531179402|FG000|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|3|||
147276106|NCT00456092|531179403|FG001|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|4|||
147276107|NCT00456092|531179404|FG002|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|2|||
147276108|NCT00456092|531179405|FG003|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|0|||
147276109|NCT00456092|531179406|FG004|Treatment Phase (12 Weeks)|Grade 2 or Greater Adverse Event (AE)|0|||
147276110|NCT00456092|531179402|FG000|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|1|||
147276111|NCT00456092|531179403|FG001|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|2|||
147276112|NCT00456092|531179404|FG002|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|0|||
147276113|NCT00456092|531179405|FG003|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|0|||
147276114|NCT00456092|531179406|FG004|Treatment Phase (12 Weeks)|AEs not Included in NCI Terminology|0|||
147276115|NCT00456092|531179402|FG000|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|2|||
147276116|NCT00456092|531179403|FG001|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|0|||
147276117|NCT00456092|531179404|FG002|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|0|||
147276118|NCT00456092|531179405|FG003|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|0|||
147276119|NCT00456092|531179406|FG004|Treatment Phase (12 Weeks)|Intolerability of the Study Drug|0|||
147276120|NCT00456092|531179402|FG000|Treatment Phase (12 Weeks)|Flare of Psoriasis|0|||
147276121|NCT00456092|531179403|FG001|Treatment Phase (12 Weeks)|Flare of Psoriasis|1|||
147334255|NCT04707313|531390106|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|4|||
147334256|NCT04707313|531390107|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|4|||
147334257|NCT04707313|531390108|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|5|||
147334258|NCT04707313|531390109|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|3|||
147334259|NCT04707313|531390110|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|2|||
147601173|NCT01007942|532358051|FG000|Overall Study|Adverse Event|29|||
147601174|NCT01007942|532358052|FG001|Overall Study|Adverse Event|14|||
147601175|NCT01007942|532358051|FG000|Overall Study|Abnormal test procedure|0|||
147276122|NCT00456092|531179404|FG002|Treatment Phase (12 Weeks)|Flare of Psoriasis|2|||
147276123|NCT00456092|531179405|FG003|Treatment Phase (12 Weeks)|Flare of Psoriasis|0|||
147276124|NCT00456092|531179406|FG004|Treatment Phase (12 Weeks)|Flare of Psoriasis|0|||
147276125|NCT00456092|531179402|FG000|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|0|||
147276126|NCT00456092|531179403|FG001|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|3|||
147276127|NCT00456092|531179404|FG002|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|3|||
147276128|NCT00456092|531179405|FG003|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|0|||
147276129|NCT00456092|531179406|FG004|Treatment Phase (12 Weeks)|Flare of Psoriatic Arthritis|0|||
147276130|NCT00456092|531179402|FG000|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|0|||
147276131|NCT00456092|531179403|FG001|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|2|||
147276132|NCT00456092|531179404|FG002|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|7|||
147276133|NCT00456092|531179405|FG003|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|0|||
147276134|NCT00456092|531179406|FG004|Treatment Phase (12 Weeks)|Worsening / Not Responding to Study Drug|0|||
147276135|NCT00456092|531179402|FG000|Treatment Phase (12 Weeks)|Withdrew Consent|0|||
147276136|NCT00456092|531179403|FG001|Treatment Phase (12 Weeks)|Withdrew Consent|1|||
147276137|NCT00456092|531179404|FG002|Treatment Phase (12 Weeks)|Withdrew Consent|2|||
147601176|NCT01007942|532358052|FG001|Overall Study|Abnormal test procedure|1|||
147601177|NCT01007942|532358051|FG000|Overall Study|Disease progression|217|||
147601178|NCT01007942|532358052|FG001|Overall Study|Disease progression|242|||
147601179|NCT01007942|532358051|FG000|Overall Study|New cancer therapy|5|||
147601180|NCT01007942|532358052|FG001|Overall Study|New cancer therapy|1|||
147601181|NCT01007942|532358051|FG000|Overall Study|Protocol Violation|1|||
147601182|NCT01007942|532358052|FG001|Overall Study|Protocol Violation|1|||
147601183|NCT01007942|532358051|FG000|Overall Study|Withdrawal by Subject|19|||
147601184|NCT01007942|532358052|FG001|Overall Study|Withdrawal by Subject|14|||
147601185|NCT01007942|532358051|FG000|Overall Study|Lost to Follow-up|1|||
147601186|NCT01007942|532358052|FG001|Overall Study|Lost to Follow-up|0|||
147601187|NCT01007942|532358051|FG000|Overall Study|Administrative problems|2|||
147601188|NCT01007942|532358052|FG001|Overall Study|Administrative problems|0|||
147601189|NCT01007942|532358051|FG000|Overall Study|Death|3|||
147601190|NCT01007942|532358052|FG001|Overall Study|Death|2|||
147601191|NCT01007942|532358051|FG000|Overall Study|Patients untreated|4|||
147601192|NCT01007942|532358052|FG001|Overall Study|Patients untreated|3|||
147601193|NCT03825341|532358053|FG000|Overall Study|Withdrawal by Subject|0|||
147601194|NCT03825341|532358054|FG001|Overall Study|Withdrawal by Subject|1|||
147601195|NCT00552578|532358058|FG000|Overall Study|Lost to Follow-up|1|||
147601196|NCT00552578|532358059|FG001|Overall Study|Lost to Follow-up|1|||
147601197|NCT00470067|532358060|FG000|Overall Study|Death|1|||
147601198|NCT00470067|532358060|FG000|Overall Study|Disease Progression|6|||
147601199|NCT01085734|532358068|FG000|Overall Study|Adverse Event|0|||
147601200|NCT01085734|532358069|FG001|Overall Study|Adverse Event|2|||
147601201|NCT01085734|532358068|FG000|Overall Study|Death|1|||
147601202|NCT01085734|532358069|FG001|Overall Study|Death|0|||
147601203|NCT01085734|532358068|FG000|Overall Study|Lost to Follow-up|0|||
147601204|NCT01085734|532358069|FG001|Overall Study|Lost to Follow-up|1|||
147601205|NCT01085734|532358068|FG000|Overall Study|Withdrawal by Subject|0|||
147601206|NCT01085734|532358069|FG001|Overall Study|Withdrawal by Subject|1|||
147601207|NCT03678285|532358074|FG000|Overall Study|Adverse Event|2|||
147601208|NCT03678285|532358074|FG000|Overall Study|Withdrawal by subject prior to start of workout|1|||
147601209|NCT03678285|532358074|FG000|Overall Study|Dehydrated prior to start of workout|1|||
147601210|NCT00123474|532358075|FG000|Randomized to Treatment|Randomized, never treated|1|||
147601211|NCT00123474|532358076|FG001|Randomized to Treatment|Randomized, never treated|4|||
147601212|NCT00123474|532358077|FG002|Randomized to Treatment|Randomized, never treated|2|||
147601213|NCT00123474|532358078|FG003|Randomized to Treatment|Randomized, never treated|1|||
147601214|NCT00123474|532358075|FG000|As Treated at Study Closure|not reported when site closed|1|||
147601215|NCT00123474|532358076|FG001|As Treated at Study Closure|not reported when site closed|0|||
147601216|NCT00123474|532358077|FG002|As Treated at Study Closure|not reported when site closed|1|||
147601217|NCT00123474|532358078|FG003|As Treated at Study Closure|not reported when site closed|0|||
147601218|NCT00123474|532358075|FG000|As Treated at Study Closure|Adverse Event|10|||
147601219|NCT00123474|532358076|FG001|As Treated at Study Closure|Adverse Event|4|||
147601220|NCT00123474|532358077|FG002|As Treated at Study Closure|Adverse Event|10|||
147601221|NCT00123474|532358078|FG003|As Treated at Study Closure|Adverse Event|8|||
147601222|NCT00123474|532358075|FG000|As Treated at Study Closure|Disease Progression|35|||
147601223|NCT00123474|532358076|FG001|As Treated at Study Closure|Disease Progression|42|||
147601224|NCT00123474|532358077|FG002|As Treated at Study Closure|Disease Progression|29|||
147601225|NCT00123474|532358078|FG003|As Treated at Study Closure|Disease Progression|27|||
147601226|NCT00123474|532358075|FG000|As Treated at Study Closure|Investigator Request|12|||
147601227|NCT00123474|532358076|FG001|As Treated at Study Closure|Investigator Request|6|||
147601228|NCT00123474|532358077|FG002|As Treated at Study Closure|Investigator Request|7|||
147601229|NCT00123474|532358078|FG003|As Treated at Study Closure|Investigator Request|5|||
147450908|NCT03311711|531813186|FG009|Overall Study|Death of dyad partner|1|||
147601230|NCT00123474|532358075|FG000|As Treated at Study Closure|non-specified|54|||
147601231|NCT00123474|532358076|FG001|As Treated at Study Closure|non-specified|47|||
147601232|NCT00123474|532358077|FG002|As Treated at Study Closure|non-specified|57|||
147601233|NCT00123474|532358078|FG003|As Treated at Study Closure|non-specified|60|||
147601234|NCT00123474|532358075|FG000|As Treated at Study Closure|Study Drug Toxicity|39|||
147601235|NCT00123474|532358076|FG001|As Treated at Study Closure|Study Drug Toxicity|45|||
147601236|NCT00123474|532358077|FG002|As Treated at Study Closure|Study Drug Toxicity|45|||
147662464|NCT02513550|532587350|FG005|Double Blind Treatment Period|Withdrawal by Subject|0|||
147276138|NCT00456092|531179405|FG003|Treatment Phase (12 Weeks)|Withdrew Consent|0|||
147601237|NCT00123474|532358078|FG003|As Treated at Study Closure|Study Drug Toxicity|51|||
147601238|NCT00123474|532358075|FG000|As Treated at Study Closure|Withdrawal by Subject|14|||
147601239|NCT00123474|532358076|FG001|As Treated at Study Closure|Withdrawal by Subject|19|||
147601240|NCT00123474|532358077|FG002|As Treated at Study Closure|Withdrawal by Subject|18|||
147601241|NCT00123474|532358078|FG003|As Treated at Study Closure|Withdrawal by Subject|16|||
147601242|NCT00616629|532358079|FG000|Overall Study|Protocol Violation|1|||
147601243|NCT00616629|532358080|FG001|Overall Study|Protocol Violation|2|||
147601244|NCT00616629|532358081|FG002|Overall Study|Protocol Violation|1|||
147601245|NCT00616629|532358082|FG003|Overall Study|Protocol Violation|0|||
147601246|NCT00616629|532358083|FG004|Overall Study|Protocol Violation|0|||
147601247|NCT00616629|532358079|FG000|Overall Study|AV-block|1|||
147601248|NCT00616629|532358080|FG001|Overall Study|AV-block|0|||
147601249|NCT00616629|532358081|FG002|Overall Study|AV-block|0|||
147601250|NCT00616629|532358082|FG003|Overall Study|AV-block|0|||
147601251|NCT00616629|532358083|FG004|Overall Study|AV-block|0|||
147601252|NCT00660400|532358087|FG000|Overall Study|Lack of insurance approval|1|||
147601253|NCT00660400|532358087|FG000|Overall Study|Suboptimal organ function|1|||
147601254|NCT00660400|532358087|FG000|Overall Study|Intracranial hemorrhage|1|||
147601255|NCT00660400|532358087|FG000|Overall Study|Withdrawal by Subject|1|||
147601256|NCT00085423|532358101|FG000|Overall Study|Withdrawal by Subject|1|||
147601257|NCT00085423|532358101|FG000|Overall Study|screen failure|1|||
147601258|NCT04740814|532358102|FG000|Overall Study|Adverse Event|3|||
147601259|NCT04740814|532358102|FG000|Overall Study|Protocol Violation|2|||
147601260|NCT04740814|532358102|FG000|Overall Study|Lost to Follow-up|2|||
147601261|NCT04740814|532358102|FG000|Overall Study|Withdrawal by Subject|3|||
147601262|NCT02500641|532358105|FG000|Overall Study|Adverse Event|0|||
147601263|NCT02500641|532358106|FG001|Overall Study|Adverse Event|2|||
147601264|NCT02500641|532358105|FG000|Overall Study|Withdrawal by Subject|4|||
147601265|NCT02500641|532358106|FG001|Overall Study|Withdrawal by Subject|5|||
147601266|NCT02500641|532358105|FG000|Overall Study|Unable to follow study procedures|3|||
147601267|NCT02500641|532358106|FG001|Overall Study|Unable to follow study procedures|2|||
147601268|NCT02500641|532358105|FG000|Overall Study|Protocol Violation|1|||
147601269|NCT02500641|532358106|FG001|Overall Study|Protocol Violation|2|||
147601270|NCT02500641|532358105|FG000|Overall Study|Lost to Follow-up|1|||
147601271|NCT02500641|532358106|FG001|Overall Study|Lost to Follow-up|0|||
147601272|NCT02500641|532358105|FG000|Overall Study|Sponsor decision|1|||
147601273|NCT02500641|532358106|FG001|Overall Study|Sponsor decision|0|||
147601274|NCT02500641|532358105|FG000|Overall Study|Non compliance to study drug|0|||
147601275|NCT02500641|532358106|FG001|Overall Study|Non compliance to study drug|1|||
147601276|NCT02317614|532358114|FG000|Overall Study|Lost to Follow-up|1|||
147601277|NCT02317614|532358115|FG001|Overall Study|Lost to Follow-up|1|||
147601278|NCT02317614|532358114|FG000|Overall Study|Withdrawal by Subject|1|||
147601279|NCT02317614|532358115|FG001|Overall Study|Withdrawal by Subject|0|||
147601280|NCT02317614|532358114|FG000|Overall Study|Death|1|||
147601281|NCT02317614|532358115|FG001|Overall Study|Death|1|||
147601282|NCT00750308|532358116|FG000|First Treatment|Adverse Event|0|||
147601283|NCT00750308|532358117|FG001|First Treatment|Adverse Event|1|||
147601284|NCT00750308|532358118|FG002|First Treatment|Adverse Event|0|||
147601285|NCT00750308|532358119|FG003|First Treatment|Adverse Event|0|||
147601286|NCT00750308|532358120|FG004|First Treatment|Adverse Event|0|||
147601287|NCT00750308|532358121|FG005|First Treatment|Adverse Event|0|||
147601288|NCT00750308|532358122|FG006|First Treatment|Adverse Event|0|||
147601289|NCT00750308|532358123|FG007|First Treatment|Adverse Event|0|||
147601290|NCT00750308|532358124|FG008|First Treatment|Adverse Event|0|||
147601291|NCT00750308|532358125|FG009|First Treatment|Adverse Event|0|||
147601292|NCT00750308|532358126|FG010|First Treatment|Adverse Event|1|||
147601293|NCT00750308|532358127|FG011|First Treatment|Adverse Event|1|||
147601294|NCT00750308|532358116|FG000|First Treatment|Withdrawal by Subject|0|||
147276139|NCT00456092|531179406|FG004|Treatment Phase (12 Weeks)|Withdrew Consent|0|||
147276140|NCT00456092|531179402|FG000|Treatment Phase (12 Weeks)|Lost to Follow-up|0|||
147276141|NCT00456092|531179403|FG001|Treatment Phase (12 Weeks)|Lost to Follow-up|1|||
147276142|NCT00456092|531179404|FG002|Treatment Phase (12 Weeks)|Lost to Follow-up|1|||
147276143|NCT00456092|531179405|FG003|Treatment Phase (12 Weeks)|Lost to Follow-up|0|||
147601295|NCT00750308|532358117|FG001|First Treatment|Withdrawal by Subject|0|||
147601296|NCT00750308|532358118|FG002|First Treatment|Withdrawal by Subject|0|||
147601297|NCT00750308|532358119|FG003|First Treatment|Withdrawal by Subject|1|||
147601298|NCT00750308|532358120|FG004|First Treatment|Withdrawal by Subject|0|||
147601299|NCT00750308|532358121|FG005|First Treatment|Withdrawal by Subject|0|||
147601300|NCT00750308|532358122|FG006|First Treatment|Withdrawal by Subject|0|||
147601301|NCT00750308|532358123|FG007|First Treatment|Withdrawal by Subject|1|||
147601302|NCT00750308|532358124|FG008|First Treatment|Withdrawal by Subject|0|||
147601303|NCT00750308|532358125|FG009|First Treatment|Withdrawal by Subject|0|||
147601304|NCT00750308|532358126|FG010|First Treatment|Withdrawal by Subject|0|||
147601305|NCT00750308|532358127|FG011|First Treatment|Withdrawal by Subject|0|||
147601306|NCT00750308|532358116|FG000|Second Treatment|Adverse Event|0|||
147601307|NCT00750308|532358117|FG001|Second Treatment|Adverse Event|0|||
147601308|NCT00750308|532358118|FG002|Second Treatment|Adverse Event|0|||
147276144|NCT00456092|531179406|FG004|Treatment Phase (12 Weeks)|Lost to Follow-up|0|||
147276145|NCT00456092|531179402|FG000|Treatment Phase (12 Weeks)|Other|1|||
147334260|NCT04707313|531390111|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|3|||
147334261|NCT04707313|531390112|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|2|||
147334262|NCT04707313|531390113|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|2|||
147334263|NCT04707313|531390114|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|0|||
147334264|NCT04707313|531390115|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|0|||
147334265|NCT04707313|531390116|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|0|||
147334266|NCT04707313|531390117|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Lost to Follow-up|0|||
147334267|NCT04707313|531390105|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
147334268|NCT04707313|531390106|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|1|||
147276146|NCT00456092|531179403|FG001|Treatment Phase (12 Weeks)|Other|0|||
147276147|NCT00456092|531179404|FG002|Treatment Phase (12 Weeks)|Other|1|||
147276148|NCT00456092|531179405|FG003|Treatment Phase (12 Weeks)|Other|0|||
147276149|NCT00456092|531179406|FG004|Treatment Phase (12 Weeks)|Other|0|||
147276150|NCT01600040|531179409|FG000|Overall Study|Withdrawal by Subject|1|||
147276151|NCT00113516|531179410|FG000|Part 1|Adverse Event|6|||
147276152|NCT00113516|531179411|FG001|Part 1|Adverse Event|0|||
147276153|NCT00113516|531179410|FG000|Part 1|Death|3|||
147276154|NCT00113516|531179411|FG001|Part 1|Death|0|||
147276155|NCT00113516|531179410|FG000|Part 1|Other|3|||
147276156|NCT00113516|531179411|FG001|Part 1|Other|0|||
147276157|NCT00113516|531179410|FG000|Part 1|Withdrawal by Subject|2|||
147334269|NCT04707313|531390107|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|2|||
147334270|NCT04707313|531390108|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
147334271|NCT04707313|531390109|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|1|||
147450909|NCT03311711|531813177|FG000|Overall Study|Lost to Follow-up|2|||
147450910|NCT03311711|531813178|FG001|Overall Study|Lost to Follow-up|2|||
147450911|NCT03311711|531813179|FG002|Overall Study|Lost to Follow-up|0|||
147450912|NCT03311711|531813180|FG003|Overall Study|Lost to Follow-up|0|||
147450913|NCT03311711|531813181|FG004|Overall Study|Lost to Follow-up|0|||
147450914|NCT03311711|531813182|FG005|Overall Study|Lost to Follow-up|0|||
147450915|NCT03311711|531813183|FG006|Overall Study|Lost to Follow-up|1|||
147450916|NCT03311711|531813184|FG007|Overall Study|Lost to Follow-up|1|||
147450917|NCT03311711|531813185|FG008|Overall Study|Lost to Follow-up|0|||
147450918|NCT03311711|531813186|FG009|Overall Study|Lost to Follow-up|0|||
147450919|NCT03311711|531813177|FG000|Overall Study|Withdrawal by Subject|1|||
147450920|NCT03311711|531813178|FG001|Overall Study|Withdrawal by Subject|1|||
147450921|NCT03311711|531813179|FG002|Overall Study|Withdrawal by Subject|0|||
147450922|NCT03311711|531813180|FG003|Overall Study|Withdrawal by Subject|0|||
147450923|NCT03311711|531813181|FG004|Overall Study|Withdrawal by Subject|0|||
147450924|NCT03311711|531813182|FG005|Overall Study|Withdrawal by Subject|0|||
147450925|NCT03311711|531813183|FG006|Overall Study|Withdrawal by Subject|3|||
147450926|NCT03311711|531813184|FG007|Overall Study|Withdrawal by Subject|3|||
147450927|NCT03311711|531813185|FG008|Overall Study|Withdrawal by Subject|0|||
147450928|NCT03311711|531813186|FG009|Overall Study|Withdrawal by Subject|0|||
147450929|NCT02229552|531813187|FG000|Baseline|Withdrawal by Subject|6|||
147450930|NCT02229552|531813187|FG000|1-year Follow up|Withdrawal by Subject|7|||
147450931|NCT02229552|531813187|FG000|1-year Follow up|Lost to Follow-up|18|||
147450932|NCT02229552|531813187|FG000|2-Year Follow up|Withdrawal by Subject|9|||
147450933|NCT02229552|531813187|FG000|2-Year Follow up|Lost to Follow-up|17|||
147450934|NCT00706134|531813188|FG000|Overall Study|Adverse Event|8|||
147450935|NCT00706134|531813189|FG001|Overall Study|Adverse Event|7|||
147450936|NCT00706134|531813190|FG002|Overall Study|Adverse Event|2|||
147450937|NCT00706134|531813191|FG003|Overall Study|Adverse Event|3|||
147450938|NCT00706134|531813188|FG000|Overall Study|Lost to Follow-up|0|||
147450939|NCT00706134|531813189|FG001|Overall Study|Lost to Follow-up|1|||
147450940|NCT00706134|531813190|FG002|Overall Study|Lost to Follow-up|0|||
147450941|NCT00706134|531813191|FG003|Overall Study|Lost to Follow-up|0|||
147450942|NCT00706134|531813188|FG000|Overall Study|Protocol Violation|0|||
147450943|NCT00706134|531813189|FG001|Overall Study|Protocol Violation|6|||
147276158|NCT00113516|531179411|FG001|Part 1|Withdrawal by Subject|0|||
147276159|NCT00113516|531179410|FG000|Part 1|Lack of Efficacy|2|||
147276160|NCT00113516|531179411|FG001|Part 1|Lack of Efficacy|0|||
147276161|NCT00113516|531179410|FG000|Part 1|Did Not Meet Entrance Criteria|1|||
147450944|NCT00706134|531813190|FG002|Overall Study|Protocol Violation|0|||
147450945|NCT00706134|531813191|FG003|Overall Study|Protocol Violation|3|||
147450946|NCT00706134|531813188|FG000|Overall Study|Withdrawal by Subject|1|||
147450947|NCT00706134|531813189|FG001|Overall Study|Withdrawal by Subject|2|||
147450948|NCT00706134|531813190|FG002|Overall Study|Withdrawal by Subject|1|||
147450949|NCT00706134|531813191|FG003|Overall Study|Withdrawal by Subject|0|||
147450950|NCT00706134|531813188|FG000|Overall Study|Unsatisfactory therapeutic effect|9|||
147450951|NCT00706134|531813189|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
147450952|NCT00706134|531813190|FG002|Overall Study|Unsatisfactory therapeutic effect|3|||
147276162|NCT00113516|531179411|FG001|Part 1|Did Not Meet Entrance Criteria|0|||
147276163|NCT00113516|531179410|FG000|Part 1|Laboratory Abnormality|1|||
147334272|NCT04707313|531390110|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
147334273|NCT04707313|531390111|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
147334274|NCT04707313|531390112|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
147334275|NCT04707313|531390113|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
147334276|NCT04707313|531390114|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
147334277|NCT04707313|531390115|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
147334278|NCT04707313|531390116|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
147601309|NCT00750308|532358119|FG003|Second Treatment|Adverse Event|0|||
147601310|NCT00750308|532358120|FG004|Second Treatment|Adverse Event|0|||
147601311|NCT00750308|532358121|FG005|Second Treatment|Adverse Event|1|||
147601312|NCT00750308|532358122|FG006|Second Treatment|Adverse Event|0|||
147601313|NCT00750308|532358123|FG007|Second Treatment|Adverse Event|0|||
147601314|NCT00750308|532358124|FG008|Second Treatment|Adverse Event|1|||
147601315|NCT00750308|532358125|FG009|Second Treatment|Adverse Event|0|||
147601316|NCT00750308|532358126|FG010|Second Treatment|Adverse Event|0|||
147601317|NCT00750308|532358127|FG011|Second Treatment|Adverse Event|0|||
147601318|NCT00750308|532358116|FG000|Second Treatment|Withdrawal by Subject|0|||
147601319|NCT00750308|532358117|FG001|Second Treatment|Withdrawal by Subject|0|||
147601320|NCT00750308|532358118|FG002|Second Treatment|Withdrawal by Subject|0|||
147601321|NCT00750308|532358119|FG003|Second Treatment|Withdrawal by Subject|0|||
147601322|NCT00750308|532358120|FG004|Second Treatment|Withdrawal by Subject|1|||
147601323|NCT00750308|532358121|FG005|Second Treatment|Withdrawal by Subject|0|||
147601324|NCT00750308|532358122|FG006|Second Treatment|Withdrawal by Subject|0|||
147276164|NCT00113516|531179411|FG001|Part 1|Laboratory Abnormality|0|||
147276165|NCT00113516|531179410|FG000|Part 1|Ongoing|1|||
147276166|NCT00113516|531179411|FG001|Part 1|Ongoing|0|||
147276167|NCT00113516|531179410|FG000|Part 1|Missing|65|||
147276168|NCT00113516|531179411|FG001|Part 1|Missing|0|||
147276169|NCT00113516|531179410|FG000|Part 2|Adverse Event|0|||
147276170|NCT00113516|531179411|FG001|Part 2|Adverse Event|16|||
147276171|NCT00113516|531179410|FG000|Part 2|Death|0|||
147276172|NCT00113516|531179411|FG001|Part 2|Death|5|||
147276173|NCT00113516|531179410|FG000|Part 2|Lack of Efficacy|0|||
147276174|NCT00113516|531179411|FG001|Part 2|Lack of Efficacy|37|||
147276175|NCT00113516|531179410|FG000|Part 2|Withdrawal by Subject|0|||
147276176|NCT00113516|531179411|FG001|Part 2|Withdrawal by Subject|3|||
147276177|NCT00113516|531179410|FG000|Part 2|Other|0|||
147276178|NCT00113516|531179411|FG001|Part 2|Other|3|||
147276179|NCT00113516|531179410|FG000|Part 2|Laboratory Abnormality|0|||
147276180|NCT00113516|531179411|FG001|Part 2|Laboratory Abnormality|1|||
147276181|NCT00113516|531179410|FG000|Part 2|Ongoing|0|||
147276182|NCT00113516|531179411|FG001|Part 2|Ongoing|1|||
147276183|NCT02170727|531179419|FG000|Overall Study|Lost to Follow-up|1|||
147276184|NCT02170727|531179420|FG001|Overall Study|Lost to Follow-up|0|||
147276185|NCT02170727|531179419|FG000|Overall Study|Withdrawal by Subject|2|||
147276186|NCT02170727|531179420|FG001|Overall Study|Withdrawal by Subject|0|||
147276187|NCT00414050|531179421|FG000|Overall Study|Adverse Event|1|||
147276188|NCT00414050|531179422|FG001|Overall Study|Adverse Event|1|||
147276189|NCT00414050|531179423|FG002|Overall Study|Adverse Event|1|||
147276190|NCT00414050|531179424|FG003|Overall Study|Adverse Event|1|||
147276191|NCT00414050|531179421|FG000|Overall Study|Lost to Follow-up|2|||
147276192|NCT00414050|531179422|FG001|Overall Study|Lost to Follow-up|2|||
147276193|NCT00414050|531179423|FG002|Overall Study|Lost to Follow-up|1|||
147276194|NCT00414050|531179424|FG003|Overall Study|Lost to Follow-up|1|||
147276195|NCT00414050|531179421|FG000|Overall Study|Withdrawal by Subject|5|||
147276196|NCT00414050|531179422|FG001|Overall Study|Withdrawal by Subject|3|||
147276197|NCT00414050|531179423|FG002|Overall Study|Withdrawal by Subject|2|||
147276198|NCT00414050|531179424|FG003|Overall Study|Withdrawal by Subject|4|||
147276199|NCT00414050|531179421|FG000|Overall Study|Subject discontinued for other reason|1|||
147276200|NCT00414050|531179422|FG001|Overall Study|Subject discontinued for other reason|2|||
147276201|NCT00414050|531179423|FG002|Overall Study|Subject discontinued for other reason|2|||
147276202|NCT00414050|531179424|FG003|Overall Study|Subject discontinued for other reason|1|||
147276203|NCT00414050|531179421|FG000|Overall Study|Subject Moved|0|||
147276204|NCT00414050|531179422|FG001|Overall Study|Subject Moved|0|||
147276205|NCT00414050|531179423|FG002|Overall Study|Subject Moved|0|||
147276206|NCT00414050|531179424|FG003|Overall Study|Subject Moved|1|||
147276207|NCT02802345|531179429|FG000|Overall Study|Not Treated|0|||
147276208|NCT02802345|531179430|FG001|Overall Study|Not Treated|1|||
147276209|NCT02802345|531179429|FG000|Overall Study|Adverse Event|28|||
147276210|NCT02802345|531179430|FG001|Overall Study|Adverse Event|20|||
147601325|NCT00750308|532358123|FG007|Second Treatment|Withdrawal by Subject|0|||
147601326|NCT00750308|532358124|FG008|Second Treatment|Withdrawal by Subject|0|||
147601327|NCT00750308|532358125|FG009|Second Treatment|Withdrawal by Subject|0|||
147276211|NCT02802345|531179429|FG000|Overall Study|Withdrawal by Subject|3|||
147276212|NCT02802345|531179430|FG001|Overall Study|Withdrawal by Subject|3|||
147276213|NCT02802345|531179429|FG000|Overall Study|Protocol Violation|0|||
147276214|NCT02802345|531179430|FG001|Overall Study|Protocol Violation|1|||
147276215|NCT02802345|531179429|FG000|Overall Study|Other than listed|1|||
147276216|NCT02802345|531179430|FG001|Overall Study|Other than listed|5|||
147276217|NCT00057746|531179431|FG000|Overall Study|Withdrawal by Subject|0|||
147276218|NCT00057746|531179432|FG001|Overall Study|Withdrawal by Subject|0|||
147276219|NCT00057746|531179433|FG002|Overall Study|Withdrawal by Subject|1|||
147276220|NCT01109316|531179434|FG000|Study Period 1|Adverse Event|0|||
147276221|NCT01109316|531179435|FG001|Study Period 1|Adverse Event|0|||
147276222|NCT01109316|531179436|FG002|Study Period 1|Adverse Event|1|||
147276223|NCT01109316|531179437|FG003|Study Period 1|Adverse Event|0|||
147276224|NCT01109316|531179438|FG004|Study Period 1|Adverse Event|0|||
147276225|NCT01109316|531179439|FG005|Study Period 1|Adverse Event|0|||
147276226|NCT01109316|531179434|FG000|Study Period 1|Lost to Follow-up|0|||
147276227|NCT01109316|531179435|FG001|Study Period 1|Lost to Follow-up|0|||
147276228|NCT01109316|531179436|FG002|Study Period 1|Lost to Follow-up|1|||
147276229|NCT01109316|531179437|FG003|Study Period 1|Lost to Follow-up|1|||
147276230|NCT01109316|531179438|FG004|Study Period 1|Lost to Follow-up|0|||
147276231|NCT01109316|531179439|FG005|Study Period 1|Lost to Follow-up|0|||
147276232|NCT01109316|531179434|FG000|Study Period 1|Withdrawal by Subject|0|||
147276233|NCT01109316|531179435|FG001|Study Period 1|Withdrawal by Subject|0|||
147276234|NCT01109316|531179436|FG002|Study Period 1|Withdrawal by Subject|1|||
147276235|NCT01109316|531179437|FG003|Study Period 1|Withdrawal by Subject|0|||
147276236|NCT01109316|531179438|FG004|Study Period 1|Withdrawal by Subject|2|||
147276237|NCT01109316|531179439|FG005|Study Period 1|Withdrawal by Subject|0|||
147276238|NCT01109316|531179434|FG000|Study Period 1|Sponsor Decision|0|||
147276239|NCT01109316|531179435|FG001|Study Period 1|Sponsor Decision|0|||
147276240|NCT01109316|531179436|FG002|Study Period 1|Sponsor Decision|0|||
147276241|NCT01109316|531179437|FG003|Study Period 1|Sponsor Decision|0|||
147276242|NCT01109316|531179438|FG004|Study Period 1|Sponsor Decision|0|||
147276243|NCT01109316|531179439|FG005|Study Period 1|Sponsor Decision|2|||
147276244|NCT01109316|531179434|FG000|Study Period 2|Entry Criteria Not Met|0|||
147276245|NCT01109316|531179435|FG001|Study Period 2|Entry Criteria Not Met|1|||
147276246|NCT01109316|531179436|FG002|Study Period 2|Entry Criteria Not Met|0|||
147276247|NCT01109316|531179437|FG003|Study Period 2|Entry Criteria Not Met|0|||
147276248|NCT01109316|531179438|FG004|Study Period 2|Entry Criteria Not Met|0|||
147276249|NCT01109316|531179439|FG005|Study Period 2|Entry Criteria Not Met|0|||
147276250|NCT01109316|531179434|FG000|Study Period 2|Physician Decision|0|||
147276251|NCT01109316|531179435|FG001|Study Period 2|Physician Decision|0|||
147276252|NCT01109316|531179436|FG002|Study Period 2|Physician Decision|0|||
147276253|NCT01109316|531179437|FG003|Study Period 2|Physician Decision|1|||
147601328|NCT00750308|532358126|FG010|Second Treatment|Withdrawal by Subject|0|||
147601329|NCT00750308|532358127|FG011|Second Treatment|Withdrawal by Subject|0|||
147601330|NCT00750308|532358116|FG000|Third Treatment|Withdrawal by Subject|0|||
147601331|NCT00750308|532358117|FG001|Third Treatment|Withdrawal by Subject|1|||
147601332|NCT00750308|532358118|FG002|Third Treatment|Withdrawal by Subject|0|||
147601333|NCT00750308|532358119|FG003|Third Treatment|Withdrawal by Subject|0|||
147601334|NCT00750308|532358120|FG004|Third Treatment|Withdrawal by Subject|0|||
147601335|NCT00750308|532358121|FG005|Third Treatment|Withdrawal by Subject|0|||
147601336|NCT00750308|532358122|FG006|Third Treatment|Withdrawal by Subject|0|||
147601337|NCT00750308|532358123|FG007|Third Treatment|Withdrawal by Subject|0|||
147601338|NCT00750308|532358124|FG008|Third Treatment|Withdrawal by Subject|0|||
147601339|NCT00750308|532358125|FG009|Third Treatment|Withdrawal by Subject|0|||
147601340|NCT00750308|532358126|FG010|Third Treatment|Withdrawal by Subject|0|||
147601341|NCT00750308|532358127|FG011|Third Treatment|Withdrawal by Subject|0|||
147601342|NCT00513682|532358128|FG000|Washout Phase|Adverse Event|2|||
147601343|NCT04156620|532358129|FG000|Overall Study|Adverse event - TP 1|5|||
147601344|NCT04156620|532358130|FG001|Overall Study|Adverse event - TP 1|2|||
147601345|NCT04156620|532358129|FG000|Overall Study|Lost to follow-up TP 1|1|||
147601346|NCT04156620|532358130|FG001|Overall Study|Lost to follow-up TP 1|1|||
147601347|NCT04156620|532358129|FG000|Overall Study|Progressive disease - TP 1|0|||
147601348|NCT04156620|532358130|FG001|Overall Study|Progressive disease - TP 1|1|||
147601349|NCT04156620|532358129|FG000|Overall Study|Subject decision - TP 1|3|||
147601350|NCT04156620|532358130|FG001|Overall Study|Subject decision - TP 1|5|||
147276254|NCT01109316|531179438|FG004|Study Period 2|Physician Decision|0|||
147276255|NCT01109316|531179439|FG005|Study Period 2|Physician Decision|0|||
147601351|NCT04156620|532358129|FG000|Overall Study|Adverse event - TP 2|5|||
147601352|NCT04156620|532358130|FG001|Overall Study|Adverse event - TP 2|6|||
147601353|NCT04156620|532358129|FG000|Overall Study|Death - TP 2|1|||
147276256|NCT01109316|531179434|FG000|Study Period 2|Protocol Violation|1|||
147276257|NCT01109316|531179435|FG001|Study Period 2|Protocol Violation|0|||
147276258|NCT01109316|531179436|FG002|Study Period 2|Protocol Violation|0|||
147276259|NCT01109316|531179437|FG003|Study Period 2|Protocol Violation|0|||
147276260|NCT01109316|531179438|FG004|Study Period 2|Protocol Violation|0|||
147276261|NCT01109316|531179439|FG005|Study Period 2|Protocol Violation|0|||
147334279|NCT04707313|531390117|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Non-compliance with study drug|0|||
147601354|NCT04156620|532358130|FG001|Overall Study|Death - TP 2|0|||
147601355|NCT04156620|532358129|FG000|Overall Study|Lost to follow-up - TP 2|5|||
147276262|NCT01109316|531179434|FG000|Study Period 2|Withdrawal by Subject|0|||
147276263|NCT01109316|531179435|FG001|Study Period 2|Withdrawal by Subject|0|||
147276264|NCT01109316|531179436|FG002|Study Period 2|Withdrawal by Subject|1|||
147276265|NCT01109316|531179437|FG003|Study Period 2|Withdrawal by Subject|0|||
147276266|NCT01109316|531179438|FG004|Study Period 2|Withdrawal by Subject|0|||
147276267|NCT01109316|531179439|FG005|Study Period 2|Withdrawal by Subject|1|||
147601356|NCT04156620|532358130|FG001|Overall Study|Lost to follow-up - TP 2|2|||
147601357|NCT04156620|532358129|FG000|Overall Study|Physician decision - TP 2|4|||
147601358|NCT04156620|532358130|FG001|Overall Study|Physician decision - TP 2|2|||
147601359|NCT04156620|532358129|FG000|Overall Study|Pregnancy - TP 2|1|||
147276268|NCT01109316|531179434|FG000|Study Period 3|Lost to Follow-up|0|||
147276269|NCT01109316|531179435|FG001|Study Period 3|Lost to Follow-up|0|||
147276270|NCT01109316|531179436|FG002|Study Period 3|Lost to Follow-up|0|||
147276271|NCT01109316|531179437|FG003|Study Period 3|Lost to Follow-up|0|||
147276272|NCT01109316|531179438|FG004|Study Period 3|Lost to Follow-up|1|||
147276273|NCT01109316|531179439|FG005|Study Period 3|Lost to Follow-up|0|||
147276274|NCT01109316|531179434|FG000|Study Period 3|Withdrawal by Subject|1|||
147276275|NCT01109316|531179435|FG001|Study Period 3|Withdrawal by Subject|0|||
147276276|NCT01109316|531179436|FG002|Study Period 3|Withdrawal by Subject|0|||
147276277|NCT01109316|531179437|FG003|Study Period 3|Withdrawal by Subject|0|||
147276278|NCT01109316|531179438|FG004|Study Period 3|Withdrawal by Subject|1|||
147276279|NCT01109316|531179439|FG005|Study Period 3|Withdrawal by Subject|0|||
147276280|NCT03511560|531179447|FG000|Overall Study|Death|0|||
147276281|NCT03511560|531179448|FG001|Overall Study|Death|1|||
147276282|NCT03511560|531179447|FG000|Overall Study|Adverse Event|0|||
147276283|NCT03511560|531179448|FG001|Overall Study|Adverse Event|2|||
147276284|NCT03511560|531179447|FG000|Overall Study|Transplant cancelled|0|||
147276285|NCT03511560|531179448|FG001|Overall Study|Transplant cancelled|1|||
147276286|NCT03511560|531179447|FG000|Overall Study|Patient switched to another drug|1|||
147276287|NCT03511560|531179448|FG001|Overall Study|Patient switched to another drug|0|||
147276288|NCT03075644|531179449|FG000|Overall Study|Withdrawal by Subject|1|||
147276289|NCT03075644|531179450|FG001|Overall Study|Withdrawal by Subject|1|||
147276290|NCT01706250|531179456|FG000|Overall Study|Lost to Follow-up|2|||
147276291|NCT03286140|531179457|FG000|Overall Study|Withdrawal by Subject|10|||
147276292|NCT03286140|531179458|FG001|Overall Study|Withdrawal by Subject|5|||
147276293|NCT03286140|531179457|FG000|Overall Study|Lost to Follow-up|5|||
147276294|NCT03286140|531179458|FG001|Overall Study|Lost to Follow-up|10|||
147276295|NCT03286140|531179457|FG000|Overall Study|Failure to comply|0|||
147276296|NCT03286140|531179458|FG001|Overall Study|Failure to comply|1|||
147276297|NCT01826825|531179459|FG000|Overall Study|Two patients consented and randomized to Mini-Cog did not have the Mini-Cog administered|0|||
147276298|NCT01826825|531179460|FG001|Overall Study|Two patients consented and randomized to Mini-Cog did not have the Mini-Cog administered|2|||
147276299|NCT03254134|531179461|FG000|Overall Study|Not eligible patients|599|||
147276300|NCT03254134|531179462|FG001|Overall Study|Not eligible patients|3630|||
147276301|NCT02563028|531179463|FG000|Overall Study|Lack of equipment|1|||
147276302|NCT02563028|531179463|FG000|Overall Study|Unable to elicit VEP post induction|1|||
147276303|NCT00799617|531179468|FG000|Main Testosterone Trial|Randomized in error|1|||
147276304|NCT00799617|531179469|FG001|Main Testosterone Trial|Randomized in error|1|||
147276305|NCT00799617|531179468|FG000|Main Testosterone Trial|Lost to Follow-up|18|||
147276306|NCT00799617|531179469|FG001|Main Testosterone Trial|Lost to Follow-up|20|||
147276307|NCT00799617|531179468|FG000|Sexual Funtion Trial|Lost to Follow-up|12|||
147276308|NCT00799617|531179469|FG001|Sexual Funtion Trial|Lost to Follow-up|14|||
147276309|NCT00799617|531179468|FG000|Sexual Funtion Trial|No Baseline Data|4|||
147276310|NCT00799617|531179469|FG001|Sexual Funtion Trial|No Baseline Data|7|||
147276311|NCT00799617|531179468|FG000|Physical Function Trial|Lost to Follow-up|6|||
147276312|NCT00799617|531179469|FG001|Physical Function Trial|Lost to Follow-up|11|||
147276313|NCT00799617|531179468|FG000|Vitality Trial|Lost to Follow-up|7|||
147276314|NCT00799617|531179469|FG001|Vitality Trial|Lost to Follow-up|22|||
147276315|NCT00799617|531179468|FG000|Cardiovascular Trial|Month 12 scan not available|15|||
147276316|NCT00799617|531179469|FG001|Cardiovascular Trial|Month 12 scan not available|15|||
147601360|NCT04156620|532358130|FG001|Overall Study|Pregnancy - TP 2|1|||
147601361|NCT04156620|532358129|FG000|Overall Study|Subject decision - TP 2|11|||
147601362|NCT04156620|532358130|FG001|Overall Study|Subject decision - TP 2|9|||
147601363|NCT04156620|532358129|FG000|Overall Study|New therapy for study indication - TP 2|1|||
147276317|NCT00799617|531179468|FG000|Cardiovascular Trial|Baseline scan not analyzable|0|||
147276318|NCT00799617|531179469|FG001|Cardiovascular Trial|Baseline scan not analyzable|2|||
147276319|NCT00799617|531179468|FG000|Bone Trial|Month 12 scan not available|6|||
147276320|NCT00799617|531179469|FG001|Bone Trial|Month 12 scan not available|16|||
147276321|NCT00799617|531179468|FG000|Cognitive Function Trial|Lost to Follow-up|0|||
147276322|NCT00799617|531179469|FG001|Cognitive Function Trial|Lost to Follow-up|1|||
147276323|NCT00799617|531179468|FG000|Anemia Trial|Withdrawal by Subject|3|||
147276324|NCT00799617|531179469|FG001|Anemia Trial|Withdrawal by Subject|3|||
147276325|NCT04545515|531179470|FG000|Overall Study|Adverse Event|1|||
147276326|NCT04545515|531179470|FG000|Overall Study|Withdrawal of consent (not due to AE)|2|||
147276327|NCT04545515|531179470|FG000|Overall Study|Commercial drug is available for participant|7|||
147276328|NCT02501096|531179471|FG000|Overall Study|Lost to Follow-up|0|||
147276329|NCT02501096|531179472|FG001|Overall Study|Lost to Follow-up|0|||
147276330|NCT02501096|531179473|FG002|Overall Study|Lost to Follow-up|0|||
147601364|NCT04156620|532358130|FG001|Overall Study|New therapy for study indication - TP 2|0|||
147601365|NCT02450526|532358131|FG000|DB Period (Cycle 1)|Adverse Event|0|||
147601366|NCT02450526|532358132|FG001|DB Period (Cycle 1)|Adverse Event|0|||
147601367|NCT02450526|532358133|FG002|DB Period (Cycle 1)|Adverse Event|2|||
147601368|NCT02450526|532358134|FG003|DB Period (Cycle 1)|Adverse Event|0|||
147601369|NCT02450526|532358135|FG004|DB Period (Cycle 1)|Adverse Event|0|||
147601370|NCT02450526|532358131|FG000|DB Period (Cycle 1)|Withdrawal by Subject|28|||
147601371|NCT02450526|532358132|FG001|DB Period (Cycle 1)|Withdrawal by Subject|3|||
147601372|NCT02450526|532358133|FG002|DB Period (Cycle 1)|Withdrawal by Subject|8|||
147601373|NCT02450526|532358134|FG003|DB Period (Cycle 1)|Withdrawal by Subject|1|||
147601374|NCT02450526|532358135|FG004|DB Period (Cycle 1)|Withdrawal by Subject|0|||
147601375|NCT02450526|532358131|FG000|DB Period (Cycle 1)|Lost to Follow-up|1|||
147601376|NCT02450526|532358132|FG001|DB Period (Cycle 1)|Lost to Follow-up|0|||
147601377|NCT02450526|532358133|FG002|DB Period (Cycle 1)|Lost to Follow-up|0|||
147601378|NCT02450526|532358134|FG003|DB Period (Cycle 1)|Lost to Follow-up|0|||
147601379|NCT02450526|532358135|FG004|DB Period (Cycle 1)|Lost to Follow-up|0|||
147601380|NCT02450526|532358131|FG000|DB Period (Cycle 1)|Protocol Violation|2|||
147601381|NCT02450526|532358132|FG001|DB Period (Cycle 1)|Protocol Violation|0|||
147601382|NCT02450526|532358133|FG002|DB Period (Cycle 1)|Protocol Violation|0|||
147601383|NCT02450526|532358134|FG003|DB Period (Cycle 1)|Protocol Violation|1|||
147601384|NCT02450526|532358135|FG004|DB Period (Cycle 1)|Protocol Violation|0|||
147601385|NCT02450526|532358131|FG000|OL Period (Cycles 2-5)|Adverse Event|0|||
147601386|NCT02450526|532358132|FG001|OL Period (Cycles 2-5)|Adverse Event|0|||
147601387|NCT02450526|532358133|FG002|OL Period (Cycles 2-5)|Adverse Event|0|||
147601388|NCT02450526|532358134|FG003|OL Period (Cycles 2-5)|Adverse Event|0|||
147601389|NCT02450526|532358135|FG004|OL Period (Cycles 2-5)|Adverse Event|2|||
147601390|NCT02450526|532358131|FG000|OL Period (Cycles 2-5)|Withdrawal by Subject|0|||
147276331|NCT02501096|531179474|FG003|Overall Study|Lost to Follow-up|0|||
147276332|NCT02501096|531179475|FG004|Overall Study|Lost to Follow-up|1|||
147276333|NCT02501096|531179476|FG005|Overall Study|Lost to Follow-up|1|||
147276334|NCT02501096|531179477|FG006|Overall Study|Lost to Follow-up|3|||
147276335|NCT02501096|531179478|FG007|Overall Study|Lost to Follow-up|0|||
147276336|NCT02501096|531179479|FG008|Overall Study|Lost to Follow-up|0|||
147276337|NCT02501096|531179471|FG000|Overall Study|Withdrawal by Subject|1|||
147276338|NCT02501096|531179472|FG001|Overall Study|Withdrawal by Subject|0|||
147276339|NCT02501096|531179473|FG002|Overall Study|Withdrawal by Subject|7|||
147276340|NCT02501096|531179474|FG003|Overall Study|Withdrawal by Subject|13|||
147276341|NCT02501096|531179475|FG004|Overall Study|Withdrawal by Subject|2|||
147276342|NCT02501096|531179476|FG005|Overall Study|Withdrawal by Subject|2|||
147276343|NCT02501096|531179477|FG006|Overall Study|Withdrawal by Subject|2|||
147276344|NCT02501096|531179478|FG007|Overall Study|Withdrawal by Subject|3|||
147276345|NCT02501096|531179479|FG008|Overall Study|Withdrawal by Subject|0|||
147276346|NCT02501096|531179471|FG000|Overall Study|Survival follow-up discontinued by sponsor|0|||
147276347|NCT02501096|531179472|FG001|Overall Study|Survival follow-up discontinued by sponsor|0|||
147276348|NCT02501096|531179473|FG002|Overall Study|Survival follow-up discontinued by sponsor|29|||
147276349|NCT02501096|531179474|FG003|Overall Study|Survival follow-up discontinued by sponsor|58|||
147276350|NCT02501096|531179475|FG004|Overall Study|Survival follow-up discontinued by sponsor|3|||
147276351|NCT02501096|531179476|FG005|Overall Study|Survival follow-up discontinued by sponsor|2|||
147276352|NCT02501096|531179477|FG006|Overall Study|Survival follow-up discontinued by sponsor|2|||
147276353|NCT02501096|531179478|FG007|Overall Study|Survival follow-up discontinued by sponsor|1|||
147276354|NCT02501096|531179479|FG008|Overall Study|Survival follow-up discontinued by sponsor|0|||
147276355|NCT02501096|531179471|FG000|Overall Study|Death|1|||
147276356|NCT02501096|531179472|FG001|Overall Study|Death|1|||
147276357|NCT02501096|531179473|FG002|Overall Study|Death|88|||
147276358|NCT02501096|531179474|FG003|Overall Study|Death|74|||
147276359|NCT02501096|531179475|FG004|Overall Study|Death|15|||
147276360|NCT02501096|531179476|FG005|Overall Study|Death|16|||
147276361|NCT02501096|531179477|FG006|Overall Study|Death|15|||
147276362|NCT02501096|531179478|FG007|Overall Study|Death|16|||
147276363|NCT02501096|531179479|FG008|Overall Study|Death|1|||
147276364|NCT01848990|531179480|FG000|Overall Study|Adverse Event|6|||
147276365|NCT01848990|531179481|FG001|Overall Study|Adverse Event|2|||
147276366|NCT01848990|531179482|FG002|Overall Study|Adverse Event|0|||
147276367|NCT01848990|531179480|FG000|Overall Study|Lost to Follow-up|6|||
147276368|NCT01848990|531179481|FG001|Overall Study|Lost to Follow-up|2|||
147276369|NCT01848990|531179482|FG002|Overall Study|Lost to Follow-up|2|||
147601391|NCT02450526|532358132|FG001|OL Period (Cycles 2-5)|Withdrawal by Subject|0|||
147601392|NCT02450526|532358133|FG002|OL Period (Cycles 2-5)|Withdrawal by Subject|0|||
147601393|NCT02450526|532358134|FG003|OL Period (Cycles 2-5)|Withdrawal by Subject|0|||
147276370|NCT01848990|531179480|FG000|Overall Study|Protocol Violation|1|||
147276371|NCT01848990|531179481|FG001|Overall Study|Protocol Violation|1|||
147276372|NCT01848990|531179482|FG002|Overall Study|Protocol Violation|0|||
147276373|NCT01848990|531179480|FG000|Overall Study|Withdrawal by Subject|29|||
147276374|NCT01848990|531179481|FG001|Overall Study|Withdrawal by Subject|10|||
147601394|NCT02450526|532358135|FG004|OL Period (Cycles 2-5)|Withdrawal by Subject|31|||
147662465|NCT02513550|532587345|FG000|Double Blind Treatment Period|Adverse Event|5|||
147276375|NCT01848990|531179482|FG002|Overall Study|Withdrawal by Subject|11|||
147276376|NCT01848990|531179480|FG000|Overall Study|Physician Decision|1|||
147276377|NCT01848990|531179481|FG001|Overall Study|Physician Decision|1|||
147276378|NCT01848990|531179482|FG002|Overall Study|Physician Decision|0|||
147276379|NCT01848990|531179480|FG000|Overall Study|Non Compliance|1|||
147276380|NCT01848990|531179481|FG001|Overall Study|Non Compliance|0|||
147276381|NCT01848990|531179482|FG002|Overall Study|Non Compliance|0|||
147276382|NCT01848990|531179480|FG000|Overall Study|Death|1|||
147276383|NCT01848990|531179481|FG001|Overall Study|Death|0|||
147276384|NCT01848990|531179482|FG002|Overall Study|Death|1|||
147276385|NCT01848990|531179480|FG000|Overall Study|Other|1|||
147276386|NCT01848990|531179481|FG001|Overall Study|Other|4|||
147276387|NCT01848990|531179482|FG002|Overall Study|Other|2|||
147276388|NCT00096044|531179485|FG000|Overall Study|Withdrawal by Subject|9|||
147276389|NCT00096044|531179485|FG000|Overall Study|Adverse Event|21|||
147276390|NCT00096044|531179485|FG000|Overall Study|Disease Progression|4|||
147276391|NCT02442830|531179486|FG000|Overall Study|Technical Failure|0|||
147276392|NCT02442830|531179487|FG001|Overall Study|Technical Failure|1|||
147276393|NCT01552772|531179488|FG000|Overall Study|Lost to Follow-up|2|||
147276394|NCT01552772|531179488|FG000|Overall Study|Adverse Event|1|||
147276395|NCT01552772|531179488|FG000|Overall Study|Protocol Deviation|1|||
147276396|NCT03851016|531179491|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
147276397|NCT03851016|531179492|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|2|||
147276398|NCT03878134|531179493|FG000|Overall Study|Scanner downtime or scheduling conflict|11|||
147276399|NCT00853658|531179494|FG000|Overall Study|Death|713|||
147276400|NCT00853658|531179495|FG001|Overall Study|Death|768|||
147276401|NCT00853658|531179496|FG002|Overall Study|Death|753|||
147276402|NCT00853658|531179494|FG000|Overall Study|Lost to Follow-up|11|||
147276403|NCT00853658|531179495|FG001|Overall Study|Lost to Follow-up|6|||
147276404|NCT00853658|531179496|FG002|Overall Study|Lost to Follow-up|11|||
147276405|NCT00853658|531179494|FG000|Overall Study|H.A. Request|26|||
147276406|NCT00853658|531179495|FG001|Overall Study|H.A. Request|23|||
147276407|NCT00853658|531179496|FG002|Overall Study|H.A. Request|19|||
147276408|NCT00853658|531179494|FG000|Overall Study|IRB request|0|||
147276409|NCT00853658|531179495|FG001|Overall Study|IRB request|0|||
147276410|NCT00853658|531179496|FG002|Overall Study|IRB request|2|||
147276411|NCT00853658|531179494|FG000|Overall Study|Vital Status known (alive) at study end|2|||
147276412|NCT00853658|531179495|FG001|Overall Study|Vital Status known (alive) at study end|3|||
147276413|NCT00853658|531179496|FG002|Overall Study|Vital Status known (alive) at study end|3|||
147276414|NCT00853658|531179494|FG000|Overall Study|Vital Status unknown at study end|1|||
147276415|NCT00853658|531179495|FG001|Overall Study|Vital Status unknown at study end|1|||
147276416|NCT00853658|531179496|FG002|Overall Study|Vital Status unknown at study end|0|||
147276417|NCT00853658|531179494|FG000|Overall Study|Vital Status at study end N/A|8|||
147276418|NCT00853658|531179495|FG001|Overall Study|Vital Status at study end N/A|10|||
147276419|NCT00853658|531179496|FG002|Overall Study|Vital Status at study end N/A|10|||
147276420|NCT00853658|531179494|FG000|Overall Study|Patient's request|21|||
147276421|NCT00853658|531179495|FG001|Overall Study|Patient's request|17|||
147276422|NCT00853658|531179496|FG002|Overall Study|Patient's request|11|||
147276423|NCT00853658|531179494|FG000|Overall Study|Missing study completion information|5|||
147334280|NCT04707313|531390105|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Other|1|||
147334281|NCT04707313|531390106|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Other|4|||
147334282|NCT04707313|531390107|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Other|1|||
147334283|NCT04707313|531390108|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Other|1|||
147334284|NCT04707313|531390109|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Other|2|||
147334285|NCT04707313|531390110|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
147334286|NCT04707313|531390111|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
147334287|NCT04707313|531390112|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
147334288|NCT04707313|531390113|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Other|1|||
147334289|NCT04707313|531390114|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
147334290|NCT04707313|531390115|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
147334291|NCT04707313|531390116|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
147334292|NCT04707313|531390117|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Other|0|||
147334293|NCT04707313|531390105|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|1|||
147334294|NCT04707313|531390106|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
147276424|NCT00853658|531179495|FG001|Overall Study|Missing study completion information|4|||
147276425|NCT00853658|531179496|FG002|Overall Study|Missing study completion information|6|||
147276426|NCT00586469|531179498|FG000|Overall Study|Adverse Event|0|||
147276427|NCT00586469|531179499|FG001|Overall Study|Adverse Event|1|||
147334295|NCT04707313|531390107|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
147334296|NCT04707313|531390108|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
147334297|NCT04707313|531390109|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
147276428|NCT01227512|531179502|FG000|Overall Study|Physician Decision|6|||
147276429|NCT01227512|531179503|FG001|Overall Study|Physician Decision|6|||
147276430|NCT01227512|531179502|FG000|Overall Study|Adverse Event|4|||
147276431|NCT01227512|531179503|FG001|Overall Study|Adverse Event|3|||
147276432|NCT01227512|531179502|FG000|Overall Study|Withdrawal by Subject|3|||
147601395|NCT02450526|532358131|FG000|OL Period (Cycles 2-5)|Lack of Efficacy|0|||
147601396|NCT02450526|532358132|FG001|OL Period (Cycles 2-5)|Lack of Efficacy|0|||
147601397|NCT02450526|532358133|FG002|OL Period (Cycles 2-5)|Lack of Efficacy|0|||
147601398|NCT02450526|532358134|FG003|OL Period (Cycles 2-5)|Lack of Efficacy|0|||
147601399|NCT02450526|532358135|FG004|OL Period (Cycles 2-5)|Lack of Efficacy|1|||
147601400|NCT02450526|532358131|FG000|OL Period (Cycles 2-5)|Protocol Violation|0|||
147601401|NCT02450526|532358132|FG001|OL Period (Cycles 2-5)|Protocol Violation|0|||
147276433|NCT01227512|531179503|FG001|Overall Study|Withdrawal by Subject|0|||
147276434|NCT01227512|531179502|FG000|Overall Study|Participant met withdrawal criteria|0|||
147276435|NCT01227512|531179503|FG001|Overall Study|Participant met withdrawal criteria|1|||
147276436|NCT04055116|531179504|FG000|First Intervention|Physician Decision|2|||
147276437|NCT04055116|531179505|FG001|First Intervention|Physician Decision|7|||
147276438|NCT02774681|531179512|FG000|Treatment on Study|Progressive Disease|7|||
147276439|NCT02774681|531179512|FG000|Follow-Up for 3 Years|Death|11|||
147276440|NCT02774681|531179512|FG000|Follow-Up for 3 Years|Withdrawal by Subject|1|||
147276441|NCT00512096|531179514|FG000|Overall Study|Adverse Event|2|||
147276442|NCT00512096|531179514|FG000|Overall Study|Withdrawal by Subject|2|||
147276443|NCT00512096|531179514|FG000|Overall Study|Lack of Efficacy|3|||
147276444|NCT01069289|531179521|FG000|Overall Study|Withdrawal by Subject|15|||
147276445|NCT01069289|531179522|FG001|Overall Study|Withdrawal by Subject|26|||
147276446|NCT01069289|531179521|FG000|Overall Study|Adverse Event|21|||
147276447|NCT01069289|531179522|FG001|Overall Study|Adverse Event|28|||
147276448|NCT01069289|531179521|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
147276449|NCT01069289|531179522|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
147276450|NCT01069289|531179521|FG000|Overall Study|Severe non-compliance to protocol|3|||
147276451|NCT01069289|531179522|FG001|Overall Study|Severe non-compliance to protocol|2|||
147276452|NCT01069289|531179521|FG000|Overall Study|Due to deteriorating health condition|1|||
147276453|NCT01069289|531179522|FG001|Overall Study|Due to deteriorating health condition|0|||
147276454|NCT00298038|531179523|FG000|Overall Study|Lost to Follow-up|0|||
147276455|NCT00298038|531179524|FG001|Overall Study|Lost to Follow-up|1|||
147276456|NCT00298038|531179523|FG000|Overall Study|Liver Transplant|0|||
147276457|NCT00298038|531179524|FG001|Overall Study|Liver Transplant|1|||
147276458|NCT00298038|531179523|FG000|Overall Study|Protocol Violation|1|||
147276459|NCT00298038|531179524|FG001|Overall Study|Protocol Violation|3|||
147276460|NCT00298038|531179523|FG000|Overall Study|Death|6|||
147276461|NCT00298038|531179524|FG001|Overall Study|Death|3|||
147276462|NCT00298038|531179523|FG000|Overall Study|Withdrawal by Subject|6|||
147276463|NCT00298038|531179524|FG001|Overall Study|Withdrawal by Subject|9|||
147276464|NCT00298038|531179523|FG000|Overall Study|Adverse Event|8|||
147276465|NCT00298038|531179524|FG001|Overall Study|Adverse Event|7|||
147276466|NCT00298038|531179523|FG000|Overall Study|Breakthrough overt HE episode|28|||
147276467|NCT00298038|531179524|FG001|Overall Study|Breakthrough overt HE episode|69|||
147276468|NCT00298038|531179523|FG000|Overall Study|Noncompliance|1|||
147276469|NCT00298038|531179524|FG001|Overall Study|Noncompliance|0|||
147276470|NCT00298038|531179523|FG000|Overall Study|Cocaine Abuse|1|||
147276471|NCT00298038|531179524|FG001|Overall Study|Cocaine Abuse|0|||
147276472|NCT00298038|531179523|FG000|Overall Study|Severe Gastrointestinal Bleed|1|||
147276473|NCT00298038|531179524|FG001|Overall Study|Severe Gastrointestinal Bleed|0|||
147276474|NCT02696096|531179525|FG000|Overall Study|ruled out at screening|1|||
147276475|NCT02696096|531179525|FG000|Overall Study|did not attend second fMRI|1|||
147334298|NCT04707313|531390110|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|1|||
147334299|NCT04707313|531390111|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|2|||
147334300|NCT04707313|531390112|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|1|||
147334301|NCT04707313|531390113|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
147334302|NCT04707313|531390114|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
147334303|NCT04707313|531390115|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
147334304|NCT04707313|531390116|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
147334305|NCT04707313|531390117|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Protocol Violation|0|||
147334306|NCT04707313|531390105|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|11|||
147334307|NCT04707313|531390106|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|5|||
147334308|NCT04707313|531390107|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|3|||
147334309|NCT04707313|531390108|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|7|||
147334310|NCT04707313|531390109|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|3|||
147601402|NCT02450526|532358133|FG002|OL Period (Cycles 2-5)|Protocol Violation|0|||
147334311|NCT04707313|531390110|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|4|||
147334312|NCT04707313|531390111|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|6|||
147334313|NCT04707313|531390112|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|4|||
147334314|NCT04707313|531390113|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|4|||
147334315|NCT04707313|531390114|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|0|||
147334316|NCT04707313|531390115|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|0|||
147334317|NCT04707313|531390116|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|0|||
147601403|NCT02450526|532358134|FG003|OL Period (Cycles 2-5)|Protocol Violation|0|||
147601404|NCT02450526|532358135|FG004|OL Period (Cycles 2-5)|Protocol Violation|7|||
147276476|NCT02556710|531180938|FG000|Overall Study|Surgical treatment|3|||
147276477|NCT02556710|531180939|FG001|Overall Study|Surgical treatment|0|||
147276478|NCT02556710|531180938|FG000|Overall Study|Required proscribed pain medication|2|||
147276479|NCT02556710|531180939|FG001|Overall Study|Required proscribed pain medication|1|||
147276480|NCT02556710|531180938|FG000|Overall Study|Lack of Efficacy|1|||
147276481|NCT02556710|531180939|FG001|Overall Study|Lack of Efficacy|0|||
147276482|NCT02556710|531180938|FG000|Overall Study|Worsening osteoarthritis|1|||
147276483|NCT02556710|531180939|FG001|Overall Study|Worsening osteoarthritis|0|||
147276484|NCT02556710|531180938|FG000|Overall Study|Moved out of state|1|||
147276485|NCT02556710|531180939|FG001|Overall Study|Moved out of state|0|||
147276486|NCT02556710|531180938|FG000|Overall Study|Missing reason|3|||
147276487|NCT02556710|531180939|FG001|Overall Study|Missing reason|1|||
147276488|NCT02556710|531180938|FG000|Overall Study|Pain as lack of efficacy|0|||
147276489|NCT02556710|531180939|FG001|Overall Study|Pain as lack of efficacy|4|||
147450953|NCT00706134|531813191|FG003|Overall Study|Unsatisfactory therapeutic effect|5|||
147276490|NCT00827372|531180940|FG000|Overall Study|Adverse Event|5|||
147276491|NCT00827372|531180940|FG000|Overall Study|Lack of Efficacy|3|||
147276492|NCT02139644|531180941|FG000|Run-In Period (Pre-assignment)|Randomization criteria not met|70|||
147276493|NCT02139644|531180942|FG001|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
147276494|NCT02139644|531180943|FG002|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
147276495|NCT02139644|531180944|FG003|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
147276496|NCT02139644|531180945|FG004|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
147276497|NCT02139644|531180946|FG005|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
147276498|NCT02139644|531180941|FG000|Run-In Period (Pre-assignment)|Inclusion criteria not met|30|||
147276499|NCT02139644|531180942|FG001|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
147276500|NCT02139644|531180943|FG002|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
147276501|NCT02139644|531180944|FG003|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
147276502|NCT02139644|531180945|FG004|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
147276503|NCT02139644|531180946|FG005|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
147276504|NCT02139644|531180941|FG000|Run-In Period (Pre-assignment)|Withdrawal by Subject|12|||
147276505|NCT02139644|531180942|FG001|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
147276506|NCT02139644|531180943|FG002|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
147276507|NCT02139644|531180944|FG003|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
147276508|NCT02139644|531180945|FG004|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
147276509|NCT02139644|531180946|FG005|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
147276510|NCT02139644|531180941|FG000|Run-In Period (Pre-assignment)|Exclusion criteria met|11|||
147276511|NCT02139644|531180942|FG001|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
147276512|NCT02139644|531180943|FG002|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
147276513|NCT02139644|531180944|FG003|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
147276514|NCT02139644|531180945|FG004|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
147276515|NCT02139644|531180946|FG005|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
147276516|NCT02139644|531180941|FG000|Run-In Period (Pre-assignment)|Lost to Follow-up|8|||
147276517|NCT02139644|531180942|FG001|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
147276518|NCT02139644|531180943|FG002|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
147276519|NCT02139644|531180944|FG003|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
147276520|NCT02139644|531180945|FG004|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
147276521|NCT02139644|531180946|FG005|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
147276522|NCT02139644|531180941|FG000|Run-In Period (Pre-assignment)|Adverse Event|3|||
147276523|NCT02139644|531180942|FG001|Run-In Period (Pre-assignment)|Adverse Event|0|||
147276524|NCT02139644|531180943|FG002|Run-In Period (Pre-assignment)|Adverse Event|0|||
147276525|NCT02139644|531180944|FG003|Run-In Period (Pre-assignment)|Adverse Event|0|||
147276526|NCT02139644|531180945|FG004|Run-In Period (Pre-assignment)|Adverse Event|0|||
147276527|NCT02139644|531180946|FG005|Run-In Period (Pre-assignment)|Adverse Event|0|||
147276528|NCT02139644|531180941|FG000|Run-In Period (Pre-assignment)|Other|6|||
147276529|NCT02139644|531180942|FG001|Run-In Period (Pre-assignment)|Other|0|||
147276530|NCT02139644|531180943|FG002|Run-In Period (Pre-assignment)|Other|0|||
147276531|NCT02139644|531180944|FG003|Run-In Period (Pre-assignment)|Other|0|||
147276532|NCT02139644|531180945|FG004|Run-In Period (Pre-assignment)|Other|0|||
147276533|NCT02139644|531180946|FG005|Run-In Period (Pre-assignment)|Other|0|||
147276534|NCT02139644|531180941|FG000|Treatment Period|Adverse Event|0|||
147276535|NCT02139644|531180942|FG001|Treatment Period|Adverse Event|0|||
147276536|NCT02139644|531180943|FG002|Treatment Period|Adverse Event|3|||
147276537|NCT02139644|531180944|FG003|Treatment Period|Adverse Event|2|||
147276538|NCT02139644|531180945|FG004|Treatment Period|Adverse Event|1|||
147276539|NCT02139644|531180946|FG005|Treatment Period|Adverse Event|6|||
147276540|NCT02139644|531180941|FG000|Treatment Period|Withdrawal by Subject|0|||
147276541|NCT02139644|531180942|FG001|Treatment Period|Withdrawal by Subject|0|||
147276542|NCT02139644|531180943|FG002|Treatment Period|Withdrawal by Subject|2|||
147276543|NCT02139644|531180944|FG003|Treatment Period|Withdrawal by Subject|2|||
147601405|NCT01753336|532358136|FG000|Overall Study|Patient decision|12|||
147276544|NCT02139644|531180945|FG004|Treatment Period|Withdrawal by Subject|3|||
147276545|NCT02139644|531180946|FG005|Treatment Period|Withdrawal by Subject|2|||
147276546|NCT02139644|531180941|FG000|Treatment Period|Non-compliance|0|||
147276547|NCT02139644|531180942|FG001|Treatment Period|Non-compliance|0|||
147276548|NCT02139644|531180943|FG002|Treatment Period|Non-compliance|0|||
147276549|NCT02139644|531180944|FG003|Treatment Period|Non-compliance|1|||
147276550|NCT02139644|531180945|FG004|Treatment Period|Non-compliance|0|||
147276551|NCT02139644|531180946|FG005|Treatment Period|Non-compliance|0|||
147276552|NCT02139644|531180941|FG000|Treatment Period|Protocol Violation|0|||
147276553|NCT02139644|531180942|FG001|Treatment Period|Protocol Violation|0|||
147276554|NCT02139644|531180943|FG002|Treatment Period|Protocol Violation|0|||
147276555|NCT02139644|531180944|FG003|Treatment Period|Protocol Violation|1|||
147276556|NCT02139644|531180945|FG004|Treatment Period|Protocol Violation|1|||
147276557|NCT02139644|531180946|FG005|Treatment Period|Protocol Violation|1|||
147276558|NCT02139644|531180941|FG000|Treatment Period|Disease progression|0|||
147276559|NCT02139644|531180942|FG001|Treatment Period|Disease progression|0|||
147276560|NCT02139644|531180943|FG002|Treatment Period|Disease progression|0|||
147276561|NCT02139644|531180944|FG003|Treatment Period|Disease progression|1|||
147276562|NCT02139644|531180945|FG004|Treatment Period|Disease progression|1|||
147276563|NCT02139644|531180946|FG005|Treatment Period|Disease progression|2|||
147276564|NCT02139644|531180941|FG000|Treatment Period|Lost to Follow-up|0|||
147276565|NCT02139644|531180942|FG001|Treatment Period|Lost to Follow-up|0|||
147276566|NCT02139644|531180943|FG002|Treatment Period|Lost to Follow-up|1|||
147276567|NCT02139644|531180944|FG003|Treatment Period|Lost to Follow-up|1|||
147276568|NCT02139644|531180945|FG004|Treatment Period|Lost to Follow-up|1|||
147276569|NCT02139644|531180946|FG005|Treatment Period|Lost to Follow-up|1|||
147276570|NCT02139644|531180941|FG000|Treatment Period|Lack of Efficacy|0|||
147276571|NCT02139644|531180942|FG001|Treatment Period|Lack of Efficacy|0|||
147276572|NCT02139644|531180943|FG002|Treatment Period|Lack of Efficacy|1|||
147276573|NCT02139644|531180944|FG003|Treatment Period|Lack of Efficacy|0|||
147276574|NCT02139644|531180945|FG004|Treatment Period|Lack of Efficacy|1|||
147276575|NCT02139644|531180946|FG005|Treatment Period|Lack of Efficacy|4|||
147276576|NCT02139644|531180941|FG000|Treatment Period|Other|0|||
147276577|NCT02139644|531180942|FG001|Treatment Period|Other|3|||
147276578|NCT02139644|531180943|FG002|Treatment Period|Other|1|||
147276579|NCT02139644|531180944|FG003|Treatment Period|Other|1|||
147276580|NCT02139644|531180945|FG004|Treatment Period|Other|0|||
147276581|NCT02139644|531180946|FG005|Treatment Period|Other|1|||
147276582|NCT01076400|531180948|FG000|Overall Study|Adverse Event|2|||
147276583|NCT01076400|531180949|FG001|Overall Study|Adverse Event|0|||
147276584|NCT01076400|531180950|FG002|Overall Study|Adverse Event|0|||
147276585|NCT01076400|531180948|FG000|Overall Study|Progressive Disease|5|||
147276586|NCT01076400|531180949|FG001|Overall Study|Progressive Disease|0|||
147276587|NCT01076400|531180950|FG002|Overall Study|Progressive Disease|0|||
147276588|NCT02766608|531180953|FG000|Overall Study|Adverse Event|27|||
147276589|NCT02766608|531180954|FG001|Overall Study|Adverse Event|22|||
147276590|NCT02766608|531180955|FG002|Overall Study|Adverse Event|17|||
147276591|NCT02766608|531180956|FG003|Overall Study|Adverse Event|13|||
147276592|NCT02766608|531180957|FG004|Overall Study|Adverse Event|12|||
147276593|NCT02766608|531180953|FG000|Overall Study|Withdrawal by Subject|21|||
147276594|NCT02766608|531180954|FG001|Overall Study|Withdrawal by Subject|20|||
147276595|NCT02766608|531180955|FG002|Overall Study|Withdrawal by Subject|24|||
147276596|NCT02766608|531180956|FG003|Overall Study|Withdrawal by Subject|13|||
147276597|NCT02766608|531180957|FG004|Overall Study|Withdrawal by Subject|10|||
147276598|NCT02766608|531180953|FG000|Overall Study|Lack of Efficacy|16|||
147276599|NCT02766608|531180954|FG001|Overall Study|Lack of Efficacy|15|||
147276600|NCT02766608|531180955|FG002|Overall Study|Lack of Efficacy|32|||
147276601|NCT02766608|531180956|FG003|Overall Study|Lack of Efficacy|8|||
147276602|NCT02766608|531180957|FG004|Overall Study|Lack of Efficacy|2|||
147276603|NCT02766608|531180953|FG000|Overall Study|Lost to Follow-up|6|||
147276604|NCT02766608|531180954|FG001|Overall Study|Lost to Follow-up|3|||
147276605|NCT02766608|531180955|FG002|Overall Study|Lost to Follow-up|5|||
147276606|NCT02766608|531180956|FG003|Overall Study|Lost to Follow-up|2|||
147276607|NCT02766608|531180957|FG004|Overall Study|Lost to Follow-up|2|||
147276608|NCT02766608|531180953|FG000|Overall Study|Physician Decision|3|||
147276609|NCT02766608|531180954|FG001|Overall Study|Physician Decision|2|||
147276610|NCT02766608|531180955|FG002|Overall Study|Physician Decision|3|||
147276611|NCT02766608|531180956|FG003|Overall Study|Physician Decision|1|||
147276612|NCT02766608|531180957|FG004|Overall Study|Physician Decision|2|||
147276613|NCT02766608|531180953|FG000|Overall Study|Protocol disc criteria|3|||
147276614|NCT02766608|531180954|FG001|Overall Study|Protocol disc criteria|3|||
147276615|NCT02766608|531180955|FG002|Overall Study|Protocol disc criteria|4|||
147276616|NCT02766608|531180956|FG003|Overall Study|Protocol disc criteria|0|||
147276617|NCT02766608|531180957|FG004|Overall Study|Protocol disc criteria|0|||
147276618|NCT02766608|531180953|FG000|Overall Study|Protocol Violation|0|||
147276619|NCT02766608|531180954|FG001|Overall Study|Protocol Violation|4|||
147276620|NCT02766608|531180955|FG002|Overall Study|Protocol Violation|4|||
147276621|NCT02766608|531180956|FG003|Overall Study|Protocol Violation|0|||
147276622|NCT02766608|531180957|FG004|Overall Study|Protocol Violation|1|||
147276623|NCT02766608|531180953|FG000|Overall Study|Administrative Reasons|3|||
147276624|NCT02766608|531180954|FG001|Overall Study|Administrative Reasons|1|||
147276625|NCT02766608|531180955|FG002|Overall Study|Administrative Reasons|1|||
147276626|NCT02766608|531180956|FG003|Overall Study|Administrative Reasons|0|||
147276627|NCT02766608|531180957|FG004|Overall Study|Administrative Reasons|0|||
147276628|NCT02080091|531180958|FG000|Overall Study|Study Terminated|22|||
147276629|NCT02080091|531180958|FG000|Overall Study|Death|1|||
147276630|NCT02080091|531180958|FG000|Overall Study|Withdrawal by Subject|1|||
147276631|NCT02080091|531180958|FG000|Overall Study|Other|1|||
147276632|NCT02391948|531180960|FG000|6-month Assessment|Death|0|||
147276633|NCT02391948|531180961|FG001|6-month Assessment|Death|0|||
147276634|NCT02391948|531180962|FG002|6-month Assessment|Death|0|||
147276635|NCT02391948|531180963|FG003|6-month Assessment|Death|0|||
147276636|NCT02391948|531180964|FG004|6-month Assessment|Death|1|||
147276637|NCT02391948|531180960|FG000|6-month Assessment|Withdrawal by Subject|0|||
147276638|NCT02391948|531180961|FG001|6-month Assessment|Withdrawal by Subject|0|||
147276639|NCT02391948|531180962|FG002|6-month Assessment|Withdrawal by Subject|1|||
147276640|NCT02391948|531180963|FG003|6-month Assessment|Withdrawal by Subject|2|||
147276641|NCT02391948|531180964|FG004|6-month Assessment|Withdrawal by Subject|0|||
147276642|NCT02391948|531180960|FG000|6-month Assessment|Lost to Follow-up|4|||
147276643|NCT02391948|531180961|FG001|6-month Assessment|Lost to Follow-up|5|||
147276644|NCT02391948|531180962|FG002|6-month Assessment|Lost to Follow-up|2|||
147276645|NCT02391948|531180963|FG003|6-month Assessment|Lost to Follow-up|3|||
147276646|NCT02391948|531180964|FG004|6-month Assessment|Lost to Follow-up|1|||
147276647|NCT02391948|531180960|FG000|6-month Assessment|Medical issue/illness|1|||
147276648|NCT02391948|531180961|FG001|6-month Assessment|Medical issue/illness|1|||
147276649|NCT02391948|531180962|FG002|6-month Assessment|Medical issue/illness|0|||
147276650|NCT02391948|531180963|FG003|6-month Assessment|Medical issue/illness|0|||
147276651|NCT02391948|531180964|FG004|6-month Assessment|Medical issue/illness|0|||
147276652|NCT02391948|531180960|FG000|6-month Assessment|Not able to schedule visit in timeframe|6|||
147276653|NCT02391948|531180961|FG001|6-month Assessment|Not able to schedule visit in timeframe|8|||
147276654|NCT02391948|531180962|FG002|6-month Assessment|Not able to schedule visit in timeframe|4|||
147276655|NCT02391948|531180963|FG003|6-month Assessment|Not able to schedule visit in timeframe|5|||
147276656|NCT02391948|531180964|FG004|6-month Assessment|Not able to schedule visit in timeframe|0|||
147276657|NCT02391948|531180960|FG000|6-month Assessment|In 2-visit study (6-month N/A)|68|||
147276658|NCT02391948|531180961|FG001|6-month Assessment|In 2-visit study (6-month N/A)|42|||
147276659|NCT02391948|531180962|FG002|6-month Assessment|In 2-visit study (6-month N/A)|24|||
147276660|NCT02391948|531180963|FG003|6-month Assessment|In 2-visit study (6-month N/A)|35|||
147276661|NCT02391948|531180964|FG004|6-month Assessment|In 2-visit study (6-month N/A)|24|||
147276662|NCT02391948|531180960|FG000|12-month Assessment|Death|0|||
147276663|NCT02391948|531180961|FG001|12-month Assessment|Death|0|||
147276664|NCT02391948|531180962|FG002|12-month Assessment|Death|0|||
147276665|NCT02391948|531180963|FG003|12-month Assessment|Death|1|||
147276666|NCT02391948|531180964|FG004|12-month Assessment|Death|0|||
147276667|NCT02391948|531180960|FG000|12-month Assessment|Withdrawal by Subject|1|||
147276668|NCT02391948|531180961|FG001|12-month Assessment|Withdrawal by Subject|0|||
147276669|NCT02391948|531180962|FG002|12-month Assessment|Withdrawal by Subject|0|||
147276670|NCT02391948|531180963|FG003|12-month Assessment|Withdrawal by Subject|1|||
147276671|NCT02391948|531180964|FG004|12-month Assessment|Withdrawal by Subject|0|||
147276672|NCT02391948|531180960|FG000|12-month Assessment|Lost to Follow-up|5|||
147276673|NCT02391948|531180961|FG001|12-month Assessment|Lost to Follow-up|4|||
147276674|NCT02391948|531180962|FG002|12-month Assessment|Lost to Follow-up|4|||
147276675|NCT02391948|531180963|FG003|12-month Assessment|Lost to Follow-up|4|||
147334318|NCT04707313|531390117|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Withdrawal by Subject|0|||
147334319|NCT04707313|531390105|FG000|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
147334320|NCT04707313|531390106|FG001|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
147334321|NCT04707313|531390107|FG002|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|1|||
147334322|NCT04707313|531390108|FG003|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
147601406|NCT01753336|532358136|FG000|Overall Study|Lost to Follow-up|3|||
147334323|NCT04707313|531390109|FG004|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
147334324|NCT04707313|531390110|FG005|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
147601407|NCT01753336|532358136|FG000|Overall Study|Physician Decision|2|||
147601408|NCT01753336|532358136|FG000|Overall Study|Sponsor's decision|2|||
147276676|NCT02391948|531180964|FG004|12-month Assessment|Lost to Follow-up|5|||
147276677|NCT02391948|531180960|FG000|12-month Assessment|Medical issue/illness|0|||
147276678|NCT02391948|531180961|FG001|12-month Assessment|Medical issue/illness|1|||
147276679|NCT02391948|531180962|FG002|12-month Assessment|Medical issue/illness|0|||
147276680|NCT02391948|531180963|FG003|12-month Assessment|Medical issue/illness|1|||
147276681|NCT02391948|531180964|FG004|12-month Assessment|Medical issue/illness|0|||
147276682|NCT02391948|531180960|FG000|12-month Assessment|Not able to schedule visit in timeframe|2|||
147276683|NCT02391948|531180961|FG001|12-month Assessment|Not able to schedule visit in timeframe|4|||
147276684|NCT02391948|531180962|FG002|12-month Assessment|Not able to schedule visit in timeframe|0|||
147276685|NCT02391948|531180963|FG003|12-month Assessment|Not able to schedule visit in timeframe|2|||
147334325|NCT04707313|531390111|FG006|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
147601409|NCT01753336|532358136|FG000|Overall Study|Withdrawal by Subject|1|||
147276686|NCT02391948|531180964|FG004|12-month Assessment|Not able to schedule visit in timeframe|1|||
147276687|NCT02391948|531180960|FG000|18-month Assessment|Death|0|||
147276688|NCT02391948|531180961|FG001|18-month Assessment|Death|0|||
147276689|NCT02391948|531180962|FG002|18-month Assessment|Death|0|||
147276690|NCT02391948|531180963|FG003|18-month Assessment|Death|1|||
147276691|NCT02391948|531180964|FG004|18-month Assessment|Death|1|||
147276692|NCT02391948|531180960|FG000|18-month Assessment|Withdrawal by Subject|1|||
147276693|NCT02391948|531180961|FG001|18-month Assessment|Withdrawal by Subject|0|||
147276694|NCT02391948|531180962|FG002|18-month Assessment|Withdrawal by Subject|0|||
147276695|NCT02391948|531180963|FG003|18-month Assessment|Withdrawal by Subject|1|||
147276696|NCT02391948|531180964|FG004|18-month Assessment|Withdrawal by Subject|0|||
147276697|NCT02391948|531180960|FG000|18-month Assessment|Lost to Follow-up|2|||
147276698|NCT02391948|531180961|FG001|18-month Assessment|Lost to Follow-up|6|||
147276699|NCT02391948|531180962|FG002|18-month Assessment|Lost to Follow-up|2|||
147276700|NCT02391948|531180963|FG003|18-month Assessment|Lost to Follow-up|2|||
147276701|NCT02391948|531180964|FG004|18-month Assessment|Lost to Follow-up|3|||
147276702|NCT02391948|531180960|FG000|18-month Assessment|Not able to schedule visit in timeframe|3|||
147276703|NCT02391948|531180961|FG001|18-month Assessment|Not able to schedule visit in timeframe|3|||
147276704|NCT02391948|531180962|FG002|18-month Assessment|Not able to schedule visit in timeframe|2|||
147276705|NCT02391948|531180963|FG003|18-month Assessment|Not able to schedule visit in timeframe|1|||
147276706|NCT02391948|531180964|FG004|18-month Assessment|Not able to schedule visit in timeframe|4|||
147276707|NCT02391948|531180960|FG000|18-month Assessment|In 2-visit study (18- and 24-month N/A)|66|||
147276708|NCT02391948|531180961|FG001|18-month Assessment|In 2-visit study (18- and 24-month N/A)|41|||
147276709|NCT02391948|531180962|FG002|18-month Assessment|In 2-visit study (18- and 24-month N/A)|22|||
147276710|NCT02391948|531180963|FG003|18-month Assessment|In 2-visit study (18- and 24-month N/A)|31|||
147276711|NCT02391948|531180964|FG004|18-month Assessment|In 2-visit study (18- and 24-month N/A)|22|||
147276712|NCT02391948|531180960|FG000|24-month Assessment|Death|0|||
147276713|NCT02391948|531180961|FG001|24-month Assessment|Death|0|||
147276714|NCT02391948|531180962|FG002|24-month Assessment|Death|0|||
147276715|NCT02391948|531180963|FG003|24-month Assessment|Death|0|||
147276716|NCT02391948|531180964|FG004|24-month Assessment|Death|1|||
147276717|NCT02391948|531180960|FG000|24-month Assessment|Withdrawal by Subject|1|||
147276718|NCT02391948|531180961|FG001|24-month Assessment|Withdrawal by Subject|1|||
147276719|NCT02391948|531180962|FG002|24-month Assessment|Withdrawal by Subject|0|||
147276720|NCT02391948|531180963|FG003|24-month Assessment|Withdrawal by Subject|0|||
147276721|NCT02391948|531180964|FG004|24-month Assessment|Withdrawal by Subject|1|||
147334326|NCT04707313|531390112|FG007|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|1|||
147334327|NCT04707313|531390113|FG008|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
147334328|NCT04707313|531390114|FG009|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
147334329|NCT04707313|531390115|FG010|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
147334330|NCT04707313|531390116|FG011|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
147334331|NCT04707313|531390117|FG012|Cohorts 1 and 2(Week 1 - Week 26)|Randomized not treated|0|||
147334332|NCT04707313|531390105|FG000|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
147334333|NCT04707313|531390106|FG001|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
147334334|NCT04707313|531390107|FG002|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
147334335|NCT04707313|531390108|FG003|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
147334336|NCT04707313|531390109|FG004|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
147334337|NCT04707313|531390110|FG005|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
147334338|NCT04707313|531390111|FG006|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
147334339|NCT04707313|531390112|FG007|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
147334340|NCT04707313|531390113|FG008|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
147334341|NCT04707313|531390114|FG009|Cohort 3 (Week 0 to Week 32)|Adverse Event|0|||
147334342|NCT04707313|531390115|FG010|Cohort 3 (Week 0 to Week 32)|Adverse Event|9|||
147334343|NCT04707313|531390116|FG011|Cohort 3 (Week 0 to Week 32)|Adverse Event|16|||
147334344|NCT04707313|531390117|FG012|Cohort 3 (Week 0 to Week 32)|Adverse Event|18|||
147334345|NCT04707313|531390105|FG000|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
147334346|NCT04707313|531390106|FG001|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
147334347|NCT04707313|531390107|FG002|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
147334348|NCT04707313|531390108|FG003|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
147334349|NCT04707313|531390109|FG004|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
147334350|NCT04707313|531390110|FG005|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
147334351|NCT04707313|531390111|FG006|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
147334352|NCT04707313|531390112|FG007|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
147334353|NCT04707313|531390113|FG008|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
147334354|NCT04707313|531390114|FG009|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|3|||
147334355|NCT04707313|531390115|FG010|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|1|||
147334356|NCT04707313|531390116|FG011|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|1|||
147276722|NCT02391948|531180960|FG000|24-month Assessment|Lost to Follow-up|5|||
147276723|NCT02391948|531180961|FG001|24-month Assessment|Lost to Follow-up|4|||
147276724|NCT02391948|531180962|FG002|24-month Assessment|Lost to Follow-up|0|||
147276725|NCT02391948|531180963|FG003|24-month Assessment|Lost to Follow-up|0|||
147276726|NCT02391948|531180964|FG004|24-month Assessment|Lost to Follow-up|0|||
147276727|NCT02391948|531180960|FG000|24-month Assessment|Medical issue/illness|0|||
147276728|NCT02391948|531180961|FG001|24-month Assessment|Medical issue/illness|0|||
147276729|NCT02391948|531180962|FG002|24-month Assessment|Medical issue/illness|1|||
147276730|NCT02391948|531180963|FG003|24-month Assessment|Medical issue/illness|0|||
147276731|NCT02391948|531180964|FG004|24-month Assessment|Medical issue/illness|0|||
147276732|NCT02391948|531180960|FG000|24-month Assessment|Not able to schedule visit in timeframe|8|||
147276733|NCT02391948|531180961|FG001|24-month Assessment|Not able to schedule visit in timeframe|5|||
147276734|NCT02391948|531180962|FG002|24-month Assessment|Not able to schedule visit in timeframe|2|||
147276735|NCT02391948|531180963|FG003|24-month Assessment|Not able to schedule visit in timeframe|9|||
147276736|NCT02391948|531180964|FG004|24-month Assessment|Not able to schedule visit in timeframe|8|||
147276737|NCT02348489|531180965|FG000|Overall Study|Death|336|||
147276738|NCT02348489|531180966|FG001|Overall Study|Death|335|||
147276739|NCT02348489|531180965|FG000|Overall Study|Withdrawal by Subject|14|||
147276740|NCT02348489|531180966|FG001|Overall Study|Withdrawal by Subject|27|||
147276741|NCT02348489|531180965|FG000|Overall Study|Lost to Follow-up|3|||
147276742|NCT02348489|531180966|FG001|Overall Study|Lost to Follow-up|5|||
147276743|NCT00201006|531180967|FG000|Overall Study|Withdrawal by Subject|7|||
147276744|NCT00201006|531180968|FG001|Overall Study|Withdrawal by Subject|2|||
147276745|NCT00201006|531180969|FG002|Overall Study|Withdrawal by Subject|3|||
147276746|NCT00201006|531180967|FG000|Overall Study|Adverse Event|1|||
147276747|NCT00201006|531180968|FG001|Overall Study|Adverse Event|0|||
147276748|NCT00201006|531180969|FG002|Overall Study|Adverse Event|1|||
147276749|NCT00938431|531180975|FG000|Overall Study|Adverse Event|5|||
147276750|NCT00938431|531180976|FG001|Overall Study|Adverse Event|8|||
147276751|NCT00938431|531180977|FG002|Overall Study|Adverse Event|6|||
147276752|NCT00938431|531180975|FG000|Overall Study|Lack of Efficacy|0|||
147276753|NCT00938431|531180976|FG001|Overall Study|Lack of Efficacy|1|||
147276754|NCT00938431|531180977|FG002|Overall Study|Lack of Efficacy|0|||
147276755|NCT00938431|531180975|FG000|Overall Study|Did not up titrate to 12 mg kg/day|1|||
147276756|NCT00938431|531180976|FG001|Overall Study|Did not up titrate to 12 mg kg/day|0|||
147276757|NCT00938431|531180977|FG002|Overall Study|Did not up titrate to 12 mg kg/day|0|||
147276758|NCT00938431|531180975|FG000|Overall Study|Dosing compliance issue|0|||
147276759|NCT00938431|531180976|FG001|Overall Study|Dosing compliance issue|0|||
147276760|NCT00938431|531180977|FG002|Overall Study|Dosing compliance issue|1|||
147276761|NCT00938431|531180975|FG000|Overall Study|Reached maximum dose early|0|||
147276762|NCT00938431|531180976|FG001|Overall Study|Reached maximum dose early|0|||
147276763|NCT00938431|531180977|FG002|Overall Study|Reached maximum dose early|1|||
147276764|NCT03738865|531180982|FG000|Overall Study|Withdrawal by Subject|3|||
147276765|NCT03738865|531180983|FG001|Overall Study|Withdrawal by Subject|3|||
147276766|NCT03738865|531180982|FG000|Overall Study|Adverse Event|2|||
147276767|NCT03738865|531180983|FG001|Overall Study|Adverse Event|0|||
147276768|NCT03738865|531180982|FG000|Overall Study|Physician Decision|0|||
147276769|NCT03738865|531180983|FG001|Overall Study|Physician Decision|1|||
147276770|NCT01529645|531180984|FG000|Overall Study|Lost to Follow-up|0|||
147276771|NCT01529645|531180985|FG001|Overall Study|Lost to Follow-up|1|||
147276772|NCT01529645|531180986|FG002|Overall Study|Lost to Follow-up|1|||
147276773|NCT01529645|531180987|FG003|Overall Study|Lost to Follow-up|1|||
147276774|NCT01529645|531180988|FG004|Overall Study|Lost to Follow-up|1|||
147276775|NCT01529645|531180989|FG005|Overall Study|Lost to Follow-up|0|||
147276776|NCT01529645|531180990|FG006|Overall Study|Lost to Follow-up|2|||
147276777|NCT01529645|531180991|FG007|Overall Study|Lost to Follow-up|0|||
147276778|NCT01529645|531180992|FG008|Overall Study|Lost to Follow-up|1|||
147276779|NCT01529645|531180993|FG009|Overall Study|Lost to Follow-up|0|||
147276780|NCT01529645|531180984|FG000|Overall Study|SAE - Premature contractions|0|||
147276781|NCT01529645|531180985|FG001|Overall Study|SAE - Premature contractions|0|||
147276782|NCT01529645|531180986|FG002|Overall Study|SAE - Premature contractions|1|||
147276783|NCT01529645|531180987|FG003|Overall Study|SAE - Premature contractions|0|||
147276784|NCT01529645|531180988|FG004|Overall Study|SAE - Premature contractions|0|||
147276785|NCT01529645|531180989|FG005|Overall Study|SAE - Premature contractions|0|||
147276786|NCT01529645|531180990|FG006|Overall Study|SAE - Premature contractions|0|||
147276787|NCT01529645|531180991|FG007|Overall Study|SAE - Premature contractions|0|||
147276788|NCT01529645|531180992|FG008|Overall Study|SAE - Premature contractions|0|||
147276789|NCT01529645|531180993|FG009|Overall Study|SAE - Premature contractions|0|||
147276790|NCT01529645|531180984|FG000|Overall Study|Withdrawal by Subject|2|||
147276791|NCT01529645|531180985|FG001|Overall Study|Withdrawal by Subject|0|||
147276792|NCT01529645|531180986|FG002|Overall Study|Withdrawal by Subject|0|||
147276793|NCT01529645|531180987|FG003|Overall Study|Withdrawal by Subject|1|||
147276794|NCT01529645|531180988|FG004|Overall Study|Withdrawal by Subject|1|||
147276795|NCT01529645|531180989|FG005|Overall Study|Withdrawal by Subject|1|||
147334357|NCT04707313|531390117|FG012|Cohort 3 (Week 0 to Week 32)|Lack of Efficacy|0|||
147334358|NCT04707313|531390105|FG000|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
147334359|NCT04707313|531390106|FG001|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
147334360|NCT04707313|531390107|FG002|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
147334361|NCT04707313|531390108|FG003|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
147662466|NCT02513550|532587346|FG001|Double Blind Treatment Period|Adverse Event|13|||
147662467|NCT02513550|532587347|FG002|Double Blind Treatment Period|Adverse Event|17|||
147662468|NCT02513550|532587348|FG003|Double Blind Treatment Period|Adverse Event|0|||
147662469|NCT02513550|532587349|FG004|Double Blind Treatment Period|Adverse Event|1|||
147662470|NCT02513550|532587350|FG005|Double Blind Treatment Period|Adverse Event|0|||
147662471|NCT02513550|532587345|FG000|Double Blind Treatment Period|Lost to Follow-up|9|||
147662472|NCT02513550|532587346|FG001|Double Blind Treatment Period|Lost to Follow-up|7|||
147662473|NCT02513550|532587347|FG002|Double Blind Treatment Period|Lost to Follow-up|11|||
147662474|NCT02513550|532587348|FG003|Double Blind Treatment Period|Lost to Follow-up|0|||
147662475|NCT02513550|532587349|FG004|Double Blind Treatment Period|Lost to Follow-up|0|||
147662476|NCT02513550|532587350|FG005|Double Blind Treatment Period|Lost to Follow-up|1|||
147662477|NCT02513550|532587345|FG000|Double Blind Treatment Period|Lack of Efficacy|4|||
147662478|NCT02513550|532587346|FG001|Double Blind Treatment Period|Lack of Efficacy|5|||
147662479|NCT02513550|532587347|FG002|Double Blind Treatment Period|Lack of Efficacy|6|||
147662480|NCT02513550|532587348|FG003|Double Blind Treatment Period|Lack of Efficacy|0|||
147662481|NCT02513550|532587349|FG004|Double Blind Treatment Period|Lack of Efficacy|0|||
147662482|NCT02513550|532587350|FG005|Double Blind Treatment Period|Lack of Efficacy|0|||
147662483|NCT02513550|532587345|FG000|Double Blind Treatment Period|Protocol Violation|1|||
147662484|NCT02513550|532587346|FG001|Double Blind Treatment Period|Protocol Violation|1|||
147662485|NCT02513550|532587347|FG002|Double Blind Treatment Period|Protocol Violation|4|||
147662486|NCT02513550|532587348|FG003|Double Blind Treatment Period|Protocol Violation|0|||
147662487|NCT02513550|532587349|FG004|Double Blind Treatment Period|Protocol Violation|0|||
147662488|NCT02513550|532587350|FG005|Double Blind Treatment Period|Protocol Violation|0|||
147662489|NCT02513550|532587345|FG000|Double Blind Treatment Period|Physician Decision|2|||
147662490|NCT02513550|532587346|FG001|Double Blind Treatment Period|Physician Decision|0|||
147662491|NCT02513550|532587347|FG002|Double Blind Treatment Period|Physician Decision|4|||
147276796|NCT01529645|531180990|FG006|Overall Study|Withdrawal by Subject|0|||
147276797|NCT01529645|531180991|FG007|Overall Study|Withdrawal by Subject|0|||
147276798|NCT01529645|531180992|FG008|Overall Study|Withdrawal by Subject|0|||
147276799|NCT01529645|531180993|FG009|Overall Study|Withdrawal by Subject|0|||
147276800|NCT00274716|531180994|FG000|Phase A|Other non-reported reason|4|||
147276801|NCT00274716|531180995|FG001|Phase A|Other non-reported reason|2|||
147276802|NCT00274716|531180996|FG002|Phase A|Other non-reported reason|1|||
147276803|NCT00274716|531180997|FG003|Phase A|Other non-reported reason|2|||
147276804|NCT00274716|531180998|FG004|Phase A|Other non-reported reason|0|||
147276805|NCT00274716|531180999|FG005|Phase A|Other non-reported reason|1|||
147276806|NCT00274716|531180994|FG000|Phase A|Participant moved|0|||
147276807|NCT00274716|531180995|FG001|Phase A|Participant moved|0|||
147276808|NCT00274716|531180996|FG002|Phase A|Participant moved|1|||
147276809|NCT00274716|531180997|FG003|Phase A|Participant moved|0|||
147276810|NCT00274716|531180998|FG004|Phase A|Participant moved|0|||
147276811|NCT00274716|531180999|FG005|Phase A|Participant moved|1|||
147276812|NCT00274716|531180994|FG000|Phase A|Site Terminated|0|||
147276813|NCT00274716|531180995|FG001|Phase A|Site Terminated|0|||
147276814|NCT00274716|531180996|FG002|Phase A|Site Terminated|0|||
147276815|NCT00274716|531180997|FG003|Phase A|Site Terminated|1|||
147276816|NCT00274716|531180998|FG004|Phase A|Site Terminated|0|||
147276817|NCT00274716|531180999|FG005|Phase A|Site Terminated|0|||
147276818|NCT00274716|531180994|FG000|Phase A|Protocol Violation|1|||
147276819|NCT00274716|531180995|FG001|Phase A|Protocol Violation|0|||
147276820|NCT00274716|531180996|FG002|Phase A|Protocol Violation|0|||
147276821|NCT00274716|531180997|FG003|Phase A|Protocol Violation|1|||
147276822|NCT00274716|531180998|FG004|Phase A|Protocol Violation|0|||
147276823|NCT00274716|531180999|FG005|Phase A|Protocol Violation|0|||
147276824|NCT00274716|531180994|FG000|Phase A|Met criteria for discontinuation|1|||
147276825|NCT00274716|531180995|FG001|Phase A|Met criteria for discontinuation|1|||
147276826|NCT00274716|531180996|FG002|Phase A|Met criteria for discontinuation|0|||
147276827|NCT00274716|531180997|FG003|Phase A|Met criteria for discontinuation|0|||
147276828|NCT00274716|531180998|FG004|Phase A|Met criteria for discontinuation|0|||
147276829|NCT00274716|531180999|FG005|Phase A|Met criteria for discontinuation|0|||
147276830|NCT00274716|531180994|FG000|Phase A|Withdrawal by Subject|2|||
147276831|NCT00274716|531180995|FG001|Phase A|Withdrawal by Subject|2|||
147276832|NCT00274716|531180996|FG002|Phase A|Withdrawal by Subject|1|||
147276833|NCT00274716|531180997|FG003|Phase A|Withdrawal by Subject|3|||
147276834|NCT00274716|531180998|FG004|Phase A|Withdrawal by Subject|0|||
147334362|NCT04707313|531390109|FG004|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
147334363|NCT04707313|531390110|FG005|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
147334364|NCT04707313|531390111|FG006|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
147334365|NCT04707313|531390112|FG007|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
147334366|NCT04707313|531390113|FG008|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|0|||
147334367|NCT04707313|531390114|FG009|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|3|||
147276835|NCT00274716|531180999|FG005|Phase A|Withdrawal by Subject|1|||
147276836|NCT00274716|531180994|FG000|Phase A|Adverse Event|2|||
147276837|NCT00274716|531180995|FG001|Phase A|Adverse Event|3|||
147276838|NCT00274716|531180996|FG002|Phase A|Adverse Event|3|||
147276839|NCT00274716|531180997|FG003|Phase A|Adverse Event|0|||
147276840|NCT00274716|531180998|FG004|Phase A|Adverse Event|2|||
147276841|NCT00274716|531180999|FG005|Phase A|Adverse Event|0|||
147276842|NCT00274716|531180994|FG000|Phase A|Completed but did not enter Phase B|1|||
147276843|NCT00274716|531180995|FG001|Phase A|Completed but did not enter Phase B|2|||
147276844|NCT00274716|531180996|FG002|Phase A|Completed but did not enter Phase B|2|||
147276845|NCT00274716|531180997|FG003|Phase A|Completed but did not enter Phase B|2|||
147276846|NCT00274716|531180998|FG004|Phase A|Completed but did not enter Phase B|1|||
147276847|NCT00274716|531180999|FG005|Phase A|Completed but did not enter Phase B|1|||
147276848|NCT00274716|531180994|FG000|Phase B|Adverse Event|0|||
147276849|NCT00274716|531180995|FG001|Phase B|Adverse Event|0|||
147276850|NCT00274716|531180996|FG002|Phase B|Adverse Event|2|||
147276851|NCT00274716|531180997|FG003|Phase B|Adverse Event|0|||
147276852|NCT00274716|531180998|FG004|Phase B|Adverse Event|0|||
147276853|NCT00274716|531180999|FG005|Phase B|Adverse Event|1|||
147276854|NCT00274716|531180994|FG000|Phase B|Protocol Violation|0|||
147276855|NCT00274716|531180995|FG001|Phase B|Protocol Violation|2|||
147276856|NCT00274716|531180996|FG002|Phase B|Protocol Violation|0|||
147276857|NCT00274716|531180997|FG003|Phase B|Protocol Violation|0|||
147276858|NCT00274716|531180998|FG004|Phase B|Protocol Violation|0|||
147276859|NCT00274716|531180999|FG005|Phase B|Protocol Violation|0|||
147276860|NCT00274716|531180994|FG000|Phase B|Withdrawal by Subject|0|||
147276861|NCT00274716|531180995|FG001|Phase B|Withdrawal by Subject|1|||
147276862|NCT00274716|531180996|FG002|Phase B|Withdrawal by Subject|0|||
147276863|NCT00274716|531180997|FG003|Phase B|Withdrawal by Subject|0|||
147276864|NCT00274716|531180998|FG004|Phase B|Withdrawal by Subject|0|||
147276865|NCT00274716|531180999|FG005|Phase B|Withdrawal by Subject|0|||
147276866|NCT00274716|531180994|FG000|Phase B|Participant moved|1|||
147276867|NCT00274716|531180995|FG001|Phase B|Participant moved|0|||
147276868|NCT00274716|531180996|FG002|Phase B|Participant moved|0|||
147276869|NCT00274716|531180997|FG003|Phase B|Participant moved|0|||
147276870|NCT00274716|531180998|FG004|Phase B|Participant moved|0|||
147276871|NCT00274716|531180999|FG005|Phase B|Participant moved|0|||
147276872|NCT00274716|531180994|FG000|Phase B|Other non-reported reason|0|||
147276873|NCT00274716|531180995|FG001|Phase B|Other non-reported reason|0|||
147276874|NCT00274716|531180996|FG002|Phase B|Other non-reported reason|1|||
147276875|NCT00274716|531180997|FG003|Phase B|Other non-reported reason|1|||
147276876|NCT00274716|531180998|FG004|Phase B|Other non-reported reason|0|||
147276877|NCT00274716|531180999|FG005|Phase B|Other non-reported reason|0|||
147276878|NCT00274716|531180994|FG000|Phase B|Lost to Follow-up|0|||
147276879|NCT00274716|531180995|FG001|Phase B|Lost to Follow-up|1|||
147276880|NCT00274716|531180996|FG002|Phase B|Lost to Follow-up|0|||
147276881|NCT00274716|531180997|FG003|Phase B|Lost to Follow-up|0|||
147276882|NCT00274716|531180998|FG004|Phase B|Lost to Follow-up|0|||
147276883|NCT00274716|531180999|FG005|Phase B|Lost to Follow-up|0|||
147276884|NCT04193202|531181000|FG000|Overall Study|Adverse Event|2|||
147276885|NCT04193202|531181001|FG001|Overall Study|Adverse Event|1|||
147276886|NCT04193202|531181000|FG000|Overall Study|Death|0|||
147276887|NCT04193202|531181001|FG001|Overall Study|Death|1|||
147276888|NCT04193202|531181000|FG000|Overall Study|Physician Decision|1|||
147276889|NCT04193202|531181001|FG001|Overall Study|Physician Decision|1|||
147276890|NCT04193202|531181000|FG000|Overall Study|Protocol Violation|2|||
147276891|NCT04193202|531181001|FG001|Overall Study|Protocol Violation|2|||
147276892|NCT04193202|531181000|FG000|Overall Study|Withdrawal by Subject|11|||
147276893|NCT04193202|531181001|FG001|Overall Study|Withdrawal by Subject|5|||
147276894|NCT02212730|531181002|FG000|Overall Study|Tumor not of the required cell histology|1|||
147276895|NCT02212730|531181003|FG001|Overall Study|Tumor not of the required cell histology|0|||
147276896|NCT02212730|531181002|FG000|Overall Study|Withdrawal by Subject|1|||
147276897|NCT02212730|531181003|FG001|Overall Study|Withdrawal by Subject|0|||
147276898|NCT02212730|531181002|FG000|Overall Study|Disease progression prior to RCC surgery|0|||
147276899|NCT02212730|531181003|FG001|Overall Study|Disease progression prior to RCC surgery|1|||
147276900|NCT01777997|531181006|FG000|12 Week lead-in of no ART|Severe debilitation|2|||
147276901|NCT01777997|531181006|FG000|Weeks 0 to 24/48 on ART|Participant felt treatment not working|1|||
147276902|NCT01777997|531181006|FG000|Weeks 48 to 72/96 on ART|Death|1|||
147276903|NCT01777997|531181006|FG000|Weeks 48 to 72/96 on ART|Took prohibited/precautionary meds|1|||
147276904|NCT01694706|531181007|FG000|Overall Study|Adverse Event|0|||
147276905|NCT01694706|531181008|FG001|Overall Study|Adverse Event|1|||
147276906|NCT01694706|531181009|FG002|Overall Study|Adverse Event|0|||
147276907|NCT01694706|531181007|FG000|Overall Study|other reason not defined above|1|||
147276908|NCT01694706|531181008|FG001|Overall Study|other reason not defined above|0|||
147276909|NCT01694706|531181009|FG002|Overall Study|other reason not defined above|0|||
147276910|NCT00975975|531181010|FG000|Overall Study|Death|6|||
147276911|NCT00723801|531181018|FG000|Overall Study|Lost to Follow-up|1|||
147334368|NCT04707313|531390115|FG010|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|5|||
147334369|NCT04707313|531390116|FG011|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|2|||
147276912|NCT00723801|531181019|FG001|Overall Study|Lost to Follow-up|2|||
147276913|NCT00723801|531181018|FG000|Overall Study|Protocol Violation|2|||
147276914|NCT00723801|531181019|FG001|Overall Study|Protocol Violation|1|||
147276915|NCT00047463|531181028|FG000|Overall Study|Withdrawal by Subject|0|||
147276916|NCT00047463|531181029|FG001|Overall Study|Withdrawal by Subject|3|||
147276917|NCT01490060|531181030|FG000|Cycle 1|Change of Treatment|0|||
147276918|NCT01490060|531181031|FG001|Cycle 1|Change of Treatment|1|||
147276919|NCT01490060|531181032|FG002|Cycle 1|Change of Treatment|1|||
147276920|NCT01490060|531181033|FG003|Cycle 1|Change of Treatment|1|||
147276921|NCT01490060|531181030|FG000|Cycle 1|Insurance Denied|0|||
147276922|NCT01490060|531181031|FG001|Cycle 1|Insurance Denied|0|||
147276923|NCT01490060|531181032|FG002|Cycle 1|Insurance Denied|2|||
147276924|NCT01490060|531181033|FG003|Cycle 1|Insurance Denied|0|||
147276925|NCT01490060|531181030|FG000|Cycle 1|Withdrawal by Subject|0|||
147276926|NCT01490060|531181031|FG001|Cycle 1|Withdrawal by Subject|0|||
147276927|NCT01490060|531181032|FG002|Cycle 1|Withdrawal by Subject|0|||
147276928|NCT01490060|531181033|FG003|Cycle 1|Withdrawal by Subject|1|||
147276929|NCT01490060|531181030|FG000|Cycle 1|Treatment at Another Facility|0|||
147276930|NCT01490060|531181031|FG001|Cycle 1|Treatment at Another Facility|0|||
147276931|NCT01490060|531181032|FG002|Cycle 1|Treatment at Another Facility|0|||
147276932|NCT01490060|531181033|FG003|Cycle 1|Treatment at Another Facility|1|||
147276933|NCT01490060|531181030|FG000|Cycle 2|Change of Treatment|1|||
147276934|NCT01490060|531181031|FG001|Cycle 2|Change of Treatment|1|||
147276935|NCT01490060|531181032|FG002|Cycle 2|Change of Treatment|0|||
147276936|NCT01490060|531181033|FG003|Cycle 2|Change of Treatment|0|||
147276937|NCT01490060|531181030|FG000|Cycle 2|Non-Compliance|0|||
147276938|NCT01490060|531181031|FG001|Cycle 2|Non-Compliance|0|||
147276939|NCT01490060|531181032|FG002|Cycle 2|Non-Compliance|1|||
147276940|NCT01490060|531181033|FG003|Cycle 2|Non-Compliance|0|||
147276941|NCT01490060|531181030|FG000|Cycle 2|Adverse Event Related to Chemotherapy|1|||
147276942|NCT01490060|531181031|FG001|Cycle 2|Adverse Event Related to Chemotherapy|0|||
147276943|NCT01490060|531181032|FG002|Cycle 2|Adverse Event Related to Chemotherapy|0|||
147276944|NCT01490060|531181033|FG003|Cycle 2|Adverse Event Related to Chemotherapy|0|||
147276945|NCT03698773|531181036|FG000|Overall Study|Lost to Follow-up|2|||
147276946|NCT03698773|531181037|FG001|Overall Study|Lost to Follow-up|1|||
147276947|NCT02399085|531181038|FG000|Overall Study|Adverse Event|16|||
147276948|NCT02399085|531181038|FG000|Overall Study|Death|2|||
147276949|NCT02399085|531181038|FG000|Overall Study|Withdrawal by Subject|8|||
147276950|NCT02399085|531181038|FG000|Overall Study|Progressive disease/ Disease relapse|42|||
147276951|NCT02399085|531181038|FG000|Overall Study|Physician Decision|5|||
147276952|NCT03304379|531181039|FG000|Overall Study|Protocol Violation|8|||
147276953|NCT03304379|531181040|FG001|Overall Study|Protocol Violation|10|||
147276954|NCT03304379|531181041|FG002|Overall Study|Protocol Violation|5|||
147276955|NCT03304379|531181042|FG003|Overall Study|Protocol Violation|0|||
147276956|NCT03304379|531181043|FG004|Overall Study|Protocol Violation|2|||
147276957|NCT03304379|531181039|FG000|Overall Study|Adverse Event|4|||
147276958|NCT03304379|531181040|FG001|Overall Study|Adverse Event|20|||
147276959|NCT03304379|531181041|FG002|Overall Study|Adverse Event|17|||
147276960|NCT03304379|531181042|FG003|Overall Study|Adverse Event|1|||
147276961|NCT03304379|531181043|FG004|Overall Study|Adverse Event|0|||
147276962|NCT03304379|531181039|FG000|Overall Study|Lack of Efficacy|17|||
147276963|NCT03304379|531181040|FG001|Overall Study|Lack of Efficacy|16|||
147276964|NCT03304379|531181041|FG002|Overall Study|Lack of Efficacy|20|||
147276965|NCT03304379|531181042|FG003|Overall Study|Lack of Efficacy|0|||
147276966|NCT03304379|531181043|FG004|Overall Study|Lack of Efficacy|0|||
147276967|NCT03304379|531181039|FG000|Overall Study|Physician Decision|6|||
147276968|NCT03304379|531181040|FG001|Overall Study|Physician Decision|10|||
147276969|NCT03304379|531181041|FG002|Overall Study|Physician Decision|6|||
147276970|NCT03304379|531181042|FG003|Overall Study|Physician Decision|9|||
147276971|NCT03304379|531181043|FG004|Overall Study|Physician Decision|10|||
147276972|NCT03304379|531181039|FG000|Overall Study|Withdrawal by Subject|26|||
147276973|NCT03304379|531181040|FG001|Overall Study|Withdrawal by Subject|58|||
147276974|NCT03304379|531181041|FG002|Overall Study|Withdrawal by Subject|66|||
147276975|NCT03304379|531181042|FG003|Overall Study|Withdrawal by Subject|3|||
147276976|NCT03304379|531181043|FG004|Overall Study|Withdrawal by Subject|5|||
147276977|NCT03304379|531181039|FG000|Overall Study|Lost to Follow-up|8|||
147276978|NCT03304379|531181040|FG001|Overall Study|Lost to Follow-up|24|||
147276979|NCT03304379|531181041|FG002|Overall Study|Lost to Follow-up|35|||
147276980|NCT03304379|531181042|FG003|Overall Study|Lost to Follow-up|4|||
147276981|NCT03304379|531181043|FG004|Overall Study|Lost to Follow-up|0|||
147276982|NCT03304379|531181039|FG000|Overall Study|Death|1|||
147662492|NCT02513550|532587348|FG003|Double Blind Treatment Period|Physician Decision|0|||
147276983|NCT03304379|531181040|FG001|Overall Study|Death|2|||
147276984|NCT03304379|531181041|FG002|Overall Study|Death|0|||
147276985|NCT03304379|531181042|FG003|Overall Study|Death|0|||
147276986|NCT03304379|531181043|FG004|Overall Study|Death|0|||
147276987|NCT03304379|531181039|FG000|Overall Study|Other|0|||
147276988|NCT03304379|531181040|FG001|Overall Study|Other|1|||
147276989|NCT03304379|531181041|FG002|Overall Study|Other|0|||
147276990|NCT03304379|531181042|FG003|Overall Study|Other|0|||
147276991|NCT03304379|531181043|FG004|Overall Study|Other|0|||
147276992|NCT01752933|531181053|FG000|Treatment|Disease Progression|3|||
147276993|NCT01752933|531181054|FG001|Treatment|Disease Progression|29|||
147276994|NCT01752933|531181053|FG000|Treatment|Withdrawal by Subject|0|||
147276995|NCT01752933|531181054|FG001|Treatment|Withdrawal by Subject|5|||
147276996|NCT01752933|531181053|FG000|Treatment|Adverse Event|1|||
147276997|NCT01752933|531181054|FG001|Treatment|Adverse Event|4|||
147276998|NCT01752933|531181053|FG000|Treatment|Physician Decision|0|||
147276999|NCT01752933|531181054|FG001|Treatment|Physician Decision|3|||
147277000|NCT01752933|531181053|FG000|Treatment|Death|0|||
147277001|NCT01752933|531181054|FG001|Treatment|Death|2|||
147277002|NCT01752933|531181053|FG000|Treatment|Hepatocellular carcinoma not confirmed|0|||
147277003|NCT01752933|531181054|FG001|Treatment|Hepatocellular carcinoma not confirmed|1|||
147277004|NCT01752933|531181053|FG000|Treatment|Patient noncompliant|0|||
147277005|NCT01752933|531181054|FG001|Treatment|Patient noncompliant|1|||
147277006|NCT01752933|531181053|FG000|Treatment|Patient unable to travel to appointments|0|||
147277007|NCT01752933|531181054|FG001|Treatment|Patient unable to travel to appointments|1|||
147277008|NCT01752933|531181053|FG000|Overall Study and Follow-up|Death|4|||
147277009|NCT01752933|531181054|FG001|Overall Study and Follow-up|Death|34|||
147277010|NCT01752933|531181053|FG000|Overall Study and Follow-up|Sponsor terminated study/Database lock|0|||
147277011|NCT01752933|531181054|FG001|Overall Study and Follow-up|Sponsor terminated study/Database lock|7|||
147277012|NCT01752933|531181053|FG000|Overall Study and Follow-up|Withdrawal by Subject|0|||
147277013|NCT01752933|531181054|FG001|Overall Study and Follow-up|Withdrawal by Subject|3|||
147277014|NCT01752933|531181053|FG000|Overall Study and Follow-up|Lost to Follow-up|0|||
147277015|NCT01752933|531181054|FG001|Overall Study and Follow-up|Lost to Follow-up|2|||
147277016|NCT00179647|531181059|FG000|Overall Study|Adverse Event|294|||
147277017|NCT00179647|531181059|FG000|Overall Study|Lack of Efficacy|478|||
147277018|NCT00179647|531181059|FG000|Overall Study|Withdrawal by Subject|83|||
147277019|NCT00179647|531181059|FG000|Overall Study|Lost to Follow-up|4|||
147277020|NCT00179647|531181059|FG000|Overall Study|Death|94|||
147277021|NCT00179647|531181059|FG000|Overall Study|Other|960|||
147277022|NCT00835406|531181060|FG000|Period: First Intervention|Adverse Event|0|||
147277023|NCT00835406|531181061|FG001|Period: First Intervention|Adverse Event|1|||
147277024|NCT00835406|531181060|FG000|Period: First Intervention|Withdrawal by Subject|2|||
147277025|NCT00835406|531181061|FG001|Period: First Intervention|Withdrawal by Subject|0|||
147277026|NCT00835406|531181060|FG000|Period: Washout of 7 Days|Withdrawal by Subject|0|||
147277027|NCT00835406|531181061|FG001|Period: Washout of 7 Days|Withdrawal by Subject|2|||
147277028|NCT02550652|531181066|FG000|Overall Study|Death|1|||
147277029|NCT02550652|531181067|FG001|Overall Study|Death|4|||
147277030|NCT02550652|531181066|FG000|Overall Study|Lack of Efficacy|1|||
147277031|NCT02550652|531181067|FG001|Overall Study|Lack of Efficacy|0|||
147277032|NCT02550652|531181066|FG000|Overall Study|Withdrawal by Subject|4|||
147277033|NCT02550652|531181067|FG001|Overall Study|Withdrawal by Subject|7|||
147277034|NCT02550652|531181066|FG000|Overall Study|Post Trial Access|1|||
147277035|NCT02550652|531181067|FG001|Overall Study|Post Trial Access|0|||
147277036|NCT02550652|531181066|FG000|Overall Study|Lost to Follow-up|1|||
147277037|NCT02550652|531181067|FG001|Overall Study|Lost to Follow-up|3|||
147277038|NCT02550652|531181066|FG000|Overall Study|Physician Decision|0|||
147277039|NCT02550652|531181067|FG001|Overall Study|Physician Decision|2|||
147277040|NCT02550652|531181066|FG000|Overall Study|Receipt of additional therapies that reduce peripheral B cell counts|0|||
147277041|NCT02550652|531181067|FG001|Overall Study|Receipt of additional therapies that reduce peripheral B cell counts|2|||
147277042|NCT02486406|531181068|FG000|Overall Study|Withdrew consent|1|||
147277043|NCT02486406|531181069|FG001|Overall Study|Withdrew consent|0|||
147277044|NCT02486406|531181070|FG002|Overall Study|Withdrew consent|0|||
147277045|NCT02486406|531181071|FG003|Overall Study|Withdrew consent|1|||
147277046|NCT02486406|531181068|FG000|Overall Study|Lost to Follow-up|1|||
147277047|NCT02486406|531181069|FG001|Overall Study|Lost to Follow-up|3|||
147277048|NCT02486406|531181070|FG002|Overall Study|Lost to Follow-up|1|||
147277049|NCT02486406|531181071|FG003|Overall Study|Lost to Follow-up|3|||
147277050|NCT02486406|531181068|FG000|Overall Study|Other, not specified|0|||
147277051|NCT02486406|531181069|FG001|Overall Study|Other, not specified|0|||
147277052|NCT02486406|531181070|FG002|Overall Study|Other, not specified|1|||
147277053|NCT02486406|531181071|FG003|Overall Study|Other, not specified|0|||
147277054|NCT03062891|531181077|FG000|Overall Study|Withdrawal by Subject|2|||
147277055|NCT03062891|531181078|FG001|Overall Study|Withdrawal by Subject|0|||
147277056|NCT03062891|531181077|FG000|Overall Study|Lost to Follow-up|50|||
147277057|NCT03062891|531181078|FG001|Overall Study|Lost to Follow-up|38|||
147277058|NCT03149237|531181090|FG000|Overall Study|Withdrawal by Subject|4|||
147277059|NCT03149237|531181091|FG001|Overall Study|Withdrawal by Subject|5|||
147277060|NCT04587193|531181092|FG000|Overall Study|Screen failure after consent|3|||
147277061|NCT04587193|531181093|FG001|Overall Study|Screen failure after consent|0|||
147277062|NCT04587193|531181092|FG000|Overall Study|Device broke during study|3|||
147277063|NCT04587193|531181093|FG001|Overall Study|Device broke during study|2|||
147277064|NCT02707640|531181094|FG000|Overall Study|Adverse Event|4|||
147277065|NCT02707640|531181095|FG001|Overall Study|Adverse Event|2|||
147277066|NCT02707640|531181094|FG000|Overall Study|Death|1|||
147277067|NCT02707640|531181095|FG001|Overall Study|Death|2|||
147277068|NCT02707640|531181094|FG000|Overall Study|Physician Decision|2|||
147277069|NCT02707640|531181095|FG001|Overall Study|Physician Decision|0|||
147277070|NCT02707640|531181094|FG000|Overall Study|Withdrawal by Subject|0|||
147277071|NCT02707640|531181095|FG001|Overall Study|Withdrawal by Subject|1|||
147277072|NCT02707640|531181094|FG000|Overall Study|Participant's Personal Decision|1|||
147334370|NCT04707313|531390117|FG012|Cohort 3 (Week 0 to Week 32)|Lost to Follow-up|3|||
147334371|NCT04707313|531390105|FG000|Cohort 3 (Week 0 to Week 32)|Other|0|||
147334372|NCT04707313|531390106|FG001|Cohort 3 (Week 0 to Week 32)|Other|0|||
147601410|NCT04568031|532358137|FG000|Overall Study|Lost to Follow-up|1|||
147601411|NCT04568031|532358138|FG001|Overall Study|Lost to Follow-up|0|||
147601412|NCT04568031|532358139|FG002|Overall Study|Lost to Follow-up|0|||
147601413|NCT04568031|532358140|FG003|Overall Study|Lost to Follow-up|0|||
147601414|NCT04568031|532358137|FG000|Overall Study|Physician Decision|1|||
147601415|NCT04568031|532358138|FG001|Overall Study|Physician Decision|0|||
147277073|NCT02707640|531181095|FG001|Overall Study|Participant's Personal Decision|2|||
147277074|NCT02707640|531181094|FG000|Overall Study|Sponsor Discretion|1|||
147277075|NCT02707640|531181095|FG001|Overall Study|Sponsor Discretion|0|||
147277076|NCT02648698|531182798|FG000|Overall Study|Protocol Violation|1|||
147277077|NCT02648698|531182799|FG001|Overall Study|Protocol Violation|5|||
147277078|NCT03143829|531182800|FG000|Overall Study|Withdrawal by Subject|2|||
147277079|NCT03143829|531182801|FG001|Overall Study|Withdrawal by Subject|5|||
147277080|NCT03143829|531182800|FG000|Overall Study|Lost to Follow-up|0|||
147277081|NCT03143829|531182801|FG001|Overall Study|Lost to Follow-up|2|||
147277082|NCT03143829|531182800|FG000|Overall Study|Death|1|||
147277083|NCT03143829|531182801|FG001|Overall Study|Death|1|||
147277084|NCT03143829|531182800|FG000|Overall Study|changed treatment, no longer eligible|2|||
147277085|NCT03143829|531182801|FG001|Overall Study|changed treatment, no longer eligible|2|||
147277086|NCT00966940|531182803|FG000|Period 1, First 6 Weeks|Withdrawal by Subject|2|||
147277087|NCT00966940|531182804|FG001|Period 1, First 6 Weeks|Withdrawal by Subject|0|||
147277088|NCT00966940|531182803|FG000|Period 1, First 6 Weeks|Protocol Violation|1|||
147277089|NCT00966940|531182804|FG001|Period 1, First 6 Weeks|Protocol Violation|0|||
147277090|NCT01774903|531182809|FG000|Overall Study|Adverse Event|7|||
147277091|NCT01774903|531182809|FG000|Overall Study|Withdrawal by Subject|2|||
147277092|NCT01774903|531182809|FG000|Overall Study|Lack of Efficacy|1|||
147277093|NCT01774903|531182809|FG000|Overall Study|Ineligible to continue the trial|1|||
147277094|NCT00924950|531182810|FG000|Overall Study|Lost to Follow-up|2|||
147277095|NCT01602315|531182811|FG000|Overall Study|Protocol Violation|0|||
147277096|NCT01602315|531182812|FG001|Overall Study|Protocol Violation|0|||
147277097|NCT01602315|531182813|FG002|Overall Study|Protocol Violation|0|||
147277098|NCT01602315|531182814|FG003|Overall Study|Protocol Violation|0|||
147277099|NCT01602315|531182815|FG004|Overall Study|Protocol Violation|0|||
147277100|NCT01602315|531182816|FG005|Overall Study|Protocol Violation|1|||
147277101|NCT01602315|531182817|FG006|Overall Study|Protocol Violation|0|||
147277102|NCT01602315|531182811|FG000|Overall Study|Physician Decision|2|||
147277103|NCT01602315|531182812|FG001|Overall Study|Physician Decision|0|||
147277104|NCT01602315|531182813|FG002|Overall Study|Physician Decision|0|||
147277105|NCT01602315|531182814|FG003|Overall Study|Physician Decision|0|||
147277106|NCT01602315|531182815|FG004|Overall Study|Physician Decision|2|||
147277107|NCT01602315|531182816|FG005|Overall Study|Physician Decision|1|||
147277108|NCT01602315|531182817|FG006|Overall Study|Physician Decision|1|||
147277109|NCT01602315|531182811|FG000|Overall Study|Disease progression|6|||
147277110|NCT01602315|531182812|FG001|Overall Study|Disease progression|3|||
147277111|NCT01602315|531182813|FG002|Overall Study|Disease progression|10|||
147277112|NCT01602315|531182814|FG003|Overall Study|Disease progression|1|||
147277113|NCT01602315|531182815|FG004|Overall Study|Disease progression|41|||
147277114|NCT01602315|531182816|FG005|Overall Study|Disease progression|12|||
147277115|NCT01602315|531182817|FG006|Overall Study|Disease progression|15|||
147277116|NCT01602315|531182811|FG000|Overall Study|Death|1|||
147277117|NCT01602315|531182812|FG001|Overall Study|Death|1|||
147277118|NCT01602315|531182813|FG002|Overall Study|Death|1|||
147277119|NCT01602315|531182814|FG003|Overall Study|Death|1|||
147277120|NCT01602315|531182815|FG004|Overall Study|Death|7|||
147277121|NCT01602315|531182816|FG005|Overall Study|Death|2|||
147277122|NCT01602315|531182817|FG006|Overall Study|Death|2|||
147277123|NCT01602315|531182811|FG000|Overall Study|Withdrawal by Subject|2|||
147277124|NCT01602315|531182812|FG001|Overall Study|Withdrawal by Subject|0|||
147277125|NCT01602315|531182813|FG002|Overall Study|Withdrawal by Subject|2|||
147277126|NCT01602315|531182814|FG003|Overall Study|Withdrawal by Subject|0|||
147601416|NCT04568031|532358139|FG002|Overall Study|Physician Decision|1|||
147601417|NCT04568031|532358140|FG003|Overall Study|Physician Decision|0|||
147601418|NCT04568031|532358137|FG000|Overall Study|Withdrawal by Subject|1|||
147601419|NCT04568031|532358138|FG001|Overall Study|Withdrawal by Subject|0|||
147277127|NCT01602315|531182815|FG004|Overall Study|Withdrawal by Subject|6|||
147277128|NCT01602315|531182816|FG005|Overall Study|Withdrawal by Subject|0|||
147277129|NCT01602315|531182817|FG006|Overall Study|Withdrawal by Subject|1|||
147601420|NCT04568031|532358139|FG002|Overall Study|Withdrawal by Subject|4|||
147277130|NCT01602315|531182811|FG000|Overall Study|Adverse Event|5|||
147277131|NCT01602315|531182812|FG001|Overall Study|Adverse Event|1|||
147277132|NCT01602315|531182813|FG002|Overall Study|Adverse Event|5|||
147277133|NCT01602315|531182814|FG003|Overall Study|Adverse Event|4|||
147334373|NCT04707313|531390107|FG002|Cohort 3 (Week 0 to Week 32)|Other|0|||
147601421|NCT04568031|532358140|FG003|Overall Study|Withdrawal by Subject|1|||
147601422|NCT00228423|532358143|FG000|Overall Study|Adverse Event|2|||
147601423|NCT00228423|532358144|FG001|Overall Study|Adverse Event|5|||
147277134|NCT01602315|531182815|FG004|Overall Study|Adverse Event|15|||
147277135|NCT01602315|531182816|FG005|Overall Study|Adverse Event|3|||
147277136|NCT01602315|531182817|FG006|Overall Study|Adverse Event|9|||
147277137|NCT01602315|531182811|FG000|Overall Study|Subject/guardian decision|0|||
147277138|NCT01602315|531182812|FG001|Overall Study|Subject/guardian decision|0|||
147277139|NCT01602315|531182813|FG002|Overall Study|Subject/guardian decision|0|||
147277140|NCT01602315|531182814|FG003|Overall Study|Subject/guardian decision|0|||
147277141|NCT01602315|531182815|FG004|Overall Study|Subject/guardian decision|0|||
147277142|NCT01602315|531182816|FG005|Overall Study|Subject/guardian decision|0|||
147277143|NCT01602315|531182817|FG006|Overall Study|Subject/guardian decision|1|||
147277144|NCT01602315|531182811|FG000|Overall Study|Cross-over patients to combo treatment|0|||
147277145|NCT01602315|531182812|FG001|Overall Study|Cross-over patients to combo treatment|0|||
147277146|NCT01602315|531182813|FG002|Overall Study|Cross-over patients to combo treatment|0|||
147277147|NCT01602315|531182814|FG003|Overall Study|Cross-over patients to combo treatment|0|||
147277148|NCT01602315|531182815|FG004|Overall Study|Cross-over patients to combo treatment|0|||
147277149|NCT01602315|531182816|FG005|Overall Study|Cross-over patients to combo treatment|16|||
147277150|NCT01602315|531182817|FG006|Overall Study|Cross-over patients to combo treatment|0|||
147277151|NCT00961259|531182824|FG000|Washout Period of 7 Days|due to concomitant medication used|0|||
147277152|NCT00961259|531182825|FG001|Washout Period of 7 Days|due to concomitant medication used|1|||
147277153|NCT00961259|531182826|FG002|Washout Period of 7 Days|due to concomitant medication used|0|||
147277154|NCT01252251|531182829|FG000|Overall Study|Withdrawal by Subject|1|||
147277155|NCT01324024|531182830|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|2|||
147334374|NCT04707313|531390108|FG003|Cohort 3 (Week 0 to Week 32)|Other|0|||
147334375|NCT04707313|531390109|FG004|Cohort 3 (Week 0 to Week 32)|Other|0|||
147334376|NCT04707313|531390110|FG005|Cohort 3 (Week 0 to Week 32)|Other|0|||
147334377|NCT04707313|531390111|FG006|Cohort 3 (Week 0 to Week 32)|Other|0|||
147334378|NCT04707313|531390112|FG007|Cohort 3 (Week 0 to Week 32)|Other|0|||
147334379|NCT04707313|531390113|FG008|Cohort 3 (Week 0 to Week 32)|Other|0|||
147662493|NCT02513550|532587349|FG004|Double Blind Treatment Period|Physician Decision|0|||
147662494|NCT02513550|532587350|FG005|Double Blind Treatment Period|Physician Decision|0|||
147334380|NCT04707313|531390114|FG009|Cohort 3 (Week 0 to Week 32)|Other|0|||
147334381|NCT04707313|531390115|FG010|Cohort 3 (Week 0 to Week 32)|Other|1|||
147334382|NCT04707313|531390116|FG011|Cohort 3 (Week 0 to Week 32)|Other|0|||
147334383|NCT04707313|531390117|FG012|Cohort 3 (Week 0 to Week 32)|Other|1|||
147334384|NCT04707313|531390105|FG000|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
147334385|NCT04707313|531390106|FG001|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
147601424|NCT00228423|532358143|FG000|Overall Study|Withdrawal by Subject|7|||
147601425|NCT00228423|532358144|FG001|Overall Study|Withdrawal by Subject|3|||
147601426|NCT00228423|532358143|FG000|Overall Study|Protocol Violation|1|||
147601427|NCT00228423|532358144|FG001|Overall Study|Protocol Violation|3|||
147601428|NCT00228423|532358143|FG000|Overall Study|Physician Decision|0|||
147601429|NCT00228423|532358144|FG001|Overall Study|Physician Decision|1|||
147601430|NCT03870477|532358164|FG000|Overall Study|Early Study Termination|1|||
147601431|NCT02582866|532358169|FG000|Overall Study|Death|1|||
147601432|NCT02582866|532358169|FG000|Overall Study|Lack of Efficacy|2|||
147601433|NCT02582866|532358169|FG000|Overall Study|Lost to Follow-up|2|||
147334386|NCT04707313|531390107|FG002|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
147334387|NCT04707313|531390108|FG003|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
147334388|NCT04707313|531390109|FG004|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
147334389|NCT04707313|531390110|FG005|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
147334390|NCT04707313|531390111|FG006|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
147334391|NCT04707313|531390112|FG007|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
147334392|NCT04707313|531390113|FG008|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
147334393|NCT04707313|531390114|FG009|Cohort 3 (Week 0 to Week 32)|Protocol Violation|1|||
147334394|NCT04707313|531390115|FG010|Cohort 3 (Week 0 to Week 32)|Protocol Violation|1|||
147334395|NCT04707313|531390116|FG011|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
147601434|NCT02582866|532358169|FG000|Overall Study|Withdrawal by Subject|7|||
147277156|NCT01324024|531182831|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
147277157|NCT02691455|531182834|FG000|Overall Study|Withdrawal by Subject|1|||
147277158|NCT02691455|531182835|FG001|Overall Study|Withdrawal by Subject|2|||
147277159|NCT02691455|531182834|FG000|Overall Study|Lost to Follow-up|15|||
147277160|NCT02691455|531182835|FG001|Overall Study|Lost to Follow-up|15|||
147277161|NCT01257204|531182836|FG000|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
147277162|NCT01257204|531182837|FG001|Treatment Period (up to Week 24)|Lack of Efficacy|1|||
147334396|NCT04707313|531390117|FG012|Cohort 3 (Week 0 to Week 32)|Protocol Violation|0|||
147334397|NCT04707313|531390105|FG000|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
147334398|NCT04707313|531390106|FG001|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
147334399|NCT04707313|531390107|FG002|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
147601435|NCT02582866|532358169|FG000|Overall Study|Investigator decision|5|||
147601436|NCT02582866|532358169|FG000|Overall Study|Participant wants to get pregnant|1|||
147601437|NCT02582866|532358169|FG000|Overall Study|Pregnancy|2|||
147601438|NCT02582866|532358169|FG000|Overall Study|Sponsor decision|1|||
147277163|NCT01257204|531182838|FG002|Treatment Period (up to Week 24)|Lack of Efficacy|3|||
147277164|NCT01257204|531182836|FG000|Treatment Period (up to Week 24)|Adverse Event|3|||
147277165|NCT01257204|531182837|FG001|Treatment Period (up to Week 24)|Adverse Event|1|||
147277166|NCT01257204|531182838|FG002|Treatment Period (up to Week 24)|Adverse Event|2|||
147277167|NCT01257204|531182836|FG000|Treatment Period (up to Week 24)|Withdrawal by Subject|1|||
147277168|NCT01257204|531182837|FG001|Treatment Period (up to Week 24)|Withdrawal by Subject|0|||
147277169|NCT01257204|531182838|FG002|Treatment Period (up to Week 24)|Withdrawal by Subject|1|||
147277170|NCT01257204|531182836|FG000|Treatment Period (up to Week 24)|Lost to Follow-up|0|||
147277171|NCT01257204|531182837|FG001|Treatment Period (up to Week 24)|Lost to Follow-up|2|||
147277172|NCT01257204|531182838|FG002|Treatment Period (up to Week 24)|Lost to Follow-up|0|||
147277173|NCT01257204|531182836|FG000|Treatment Period (up to Week 24)|Poor compliance/noncompliance|0|||
147277174|NCT01257204|531182837|FG001|Treatment Period (up to Week 24)|Poor compliance/noncompliance|0|||
147277175|NCT01257204|531182838|FG002|Treatment Period (up to Week 24)|Poor compliance/noncompliance|1|||
147277176|NCT01257204|531182836|FG000|Treatment Period (up to Week 24)|Participant's request to discontinue|1|||
147277177|NCT01257204|531182837|FG001|Treatment Period (up to Week 24)|Participant's request to discontinue|2|||
147277178|NCT01257204|531182838|FG002|Treatment Period (up to Week 24)|Participant's request to discontinue|2|||
147277179|NCT01257204|531182836|FG000|Follow-up Period (up to Week 48)|Withdrawal by Subject|0|||
147277180|NCT01257204|531182837|FG001|Follow-up Period (up to Week 48)|Withdrawal by Subject|2|||
147277181|NCT01257204|531182838|FG002|Follow-up Period (up to Week 48)|Withdrawal by Subject|1|||
147277182|NCT01257204|531182836|FG000|Follow-up Period (up to Week 48)|Lost to Follow-up|1|||
147277183|NCT01257204|531182837|FG001|Follow-up Period (up to Week 48)|Lost to Follow-up|4|||
147277184|NCT01257204|531182838|FG002|Follow-up Period (up to Week 48)|Lost to Follow-up|4|||
147277185|NCT01257204|531182836|FG000|Follow-up Period (up to Week 48)|Other|0|||
147277186|NCT01257204|531182837|FG001|Follow-up Period (up to Week 48)|Other|0|||
147277187|NCT01257204|531182838|FG002|Follow-up Period (up to Week 48)|Other|5|||
147277188|NCT02057757|531182839|FG000|Overall Study|Withdrawal by Subject|3|||
147277189|NCT02057757|531182840|FG001|Overall Study|Withdrawal by Subject|5|||
147277190|NCT02057757|531182839|FG000|Overall Study|Death|2|||
147277191|NCT02057757|531182840|FG001|Overall Study|Death|0|||
147277192|NCT02057757|531182839|FG000|Overall Study|Lost to Follow-up|8|||
147277193|NCT02057757|531182840|FG001|Overall Study|Lost to Follow-up|3|||
147277194|NCT02057757|531182839|FG000|Overall Study|Non-compliance|1|||
147277195|NCT02057757|531182840|FG001|Overall Study|Non-compliance|0|||
147277196|NCT00563797|531182841|FG000|Overall Study|Lost to Follow-up|7|||
147277197|NCT00563797|531182842|FG001|Overall Study|Lost to Follow-up|2|||
147277198|NCT02809976|531182843|FG000|Overall Study|Lost to Follow-up|1|||
147277199|NCT02809976|531182843|FG000|Overall Study|Withdrawal by Subject|1|||
147277200|NCT00530023|531182844|FG000|Overall Study|Withdrawal by Subject|0|||
147277201|NCT00530023|531182845|FG001|Overall Study|Withdrawal by Subject|1|||
147277202|NCT00211081|531182846|FG000|Overall Study|Withdrawal by Subject|2|||
147277203|NCT03755765|531182851|FG000|Overall Study|Withdrawal by Subject|2|||
147277204|NCT03755765|531182852|FG001|Overall Study|Withdrawal by Subject|4|||
147277205|NCT03755765|531182853|FG002|Overall Study|Withdrawal by Subject|4|||
147277206|NCT02104557|531182854|FG000|Overall Study|Adverse Event|24|||
147277207|NCT02104557|531182854|FG000|Overall Study|Lost to Follow-up|34|||
147277208|NCT02104557|531182854|FG000|Overall Study|Violated the usage and dosage|14|||
147277209|NCT02104557|531182854|FG000|Overall Study|No longer met inclusion/exclusion criteria|1|||
147277210|NCT02104557|531182854|FG000|Overall Study|Administered Sayana prior to the contract|1|||
147277211|NCT02104557|531182854|FG000|Overall Study|Other|17|||
147277212|NCT02104557|531182854|FG000|Overall Study|Change to other contraception methods|5|||
147277213|NCT02104557|531182854|FG000|Overall Study|Discontinuation due to no pain|1|||
147277214|NCT02104557|531182854|FG000|Overall Study|Withdrawal consent|2|||
147277215|NCT02104557|531182854|FG000|Overall Study|Refusal of administration due to unknown reasons|69|||
147277216|NCT02104557|531182854|FG000|Overall Study|Discontinuation of contraception|9|||
147277217|NCT01158222|531182858|FG000|Overall Study|Not eligible for intermediate phase|17|||
147277218|NCT00111228|531182861|FG000|Overall Study|Withdrawal by Subject|5|||
147277219|NCT00111228|531182862|FG001|Overall Study|Withdrawal by Subject|1|||
147277220|NCT00111228|531182863|FG002|Overall Study|Withdrawal by Subject|0|||
147277221|NCT02464969|531182866|FG000|Main Phase (Day 1 to Day 84)|Adverse Event|7|||
147277222|NCT02464969|531182867|FG001|Main Phase (Day 1 to Day 84)|Adverse Event|0|||
147277223|NCT02464969|531182866|FG000|Main Phase (Day 1 to Day 84)|Death|1|||
147277224|NCT02464969|531182867|FG001|Main Phase (Day 1 to Day 84)|Death|1|||
147277225|NCT02464969|531182866|FG000|Main Phase (Day 1 to Day 84)|Lost to Follow-up|3|||
147277226|NCT02464969|531182867|FG001|Main Phase (Day 1 to Day 84)|Lost to Follow-up|0|||
147334400|NCT04707313|531390108|FG003|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
147277227|NCT02464969|531182866|FG000|Main Phase (Day 1 to Day 84)|Withdrawal by Parent/Guardian|0|||
147277228|NCT02464969|531182867|FG001|Main Phase (Day 1 to Day 84)|Withdrawal by Parent/Guardian|4|||
147277229|NCT02464969|531182866|FG000|Main Phase (Day 1 to Day 84)|No Longer Meets Eligibility Criteria|0|||
147277230|NCT02464969|531182867|FG001|Main Phase (Day 1 to Day 84)|No Longer Meets Eligibility Criteria|1|||
147277231|NCT02464969|531182866|FG000|Main Phase (Day 1 to Day 84)|Other Reasons|4|||
147277232|NCT02464969|531182867|FG001|Main Phase (Day 1 to Day 84)|Other Reasons|2|||
147277233|NCT02464969|531182866|FG000|Main Phase (Day 1 to Day 84)|Entrance Criteria|1|||
147277234|NCT02464969|531182867|FG001|Main Phase (Day 1 to Day 84)|Entrance Criteria|1|||
147277235|NCT02464969|531182866|FG000|Main Phase (Day 1 to Day 84)|Withdrawal by Subject|1|||
147277236|NCT02464969|531182867|FG001|Main Phase (Day 1 to Day 84)|Withdrawal by Subject|0|||
147277237|NCT02464969|531182866|FG000|Extension Phase (Day 85 to Day 168)|Adverse Event|1|||
147277238|NCT02464969|531182867|FG001|Extension Phase (Day 85 to Day 168)|Adverse Event|0|||
147277239|NCT02464969|531182866|FG000|Extension Phase (Day 85 to Day 168)|Withdrawal by Parent/Guardian|1|||
147277240|NCT02464969|531182867|FG001|Extension Phase (Day 85 to Day 168)|Withdrawal by Parent/Guardian|0|||
147277241|NCT02464969|531182866|FG000|Extension Phase (Day 85 to Day 168)|Other Reasons|1|||
147277242|NCT02464969|531182867|FG001|Extension Phase (Day 85 to Day 168)|Other Reasons|0|||
147277243|NCT02863354|531182868|FG000|Year 1|Lost to Follow-up|1|||
147277244|NCT02863354|531182869|FG001|Year 1|Lost to Follow-up|1|||
147277245|NCT02863354|531182868|FG000|Year 1|Withdrawal by Subject|3|||
147277246|NCT02863354|531182869|FG001|Year 1|Withdrawal by Subject|0|||
147277247|NCT02863354|531182868|FG000|Year 1|Death|0|||
147277248|NCT02863354|531182869|FG001|Year 1|Death|1|||
147277249|NCT02863354|531182868|FG000|Year 2|Lost to Follow-up|2|||
147277250|NCT02863354|531182869|FG001|Year 2|Lost to Follow-up|2|||
147277251|NCT00724451|531182873|FG000|Overall Study|Excluded - Prior Use of Peginterferon|7|||
147277252|NCT00724451|531182873|FG000|Overall Study|Excluded - Hepatitis C Virus Negative|3|||
147277253|NCT00724451|531182873|FG000|Overall Study|Not Eligible for Treatment|431|||
147277254|NCT00724451|531182873|FG000|Overall Study|Participant Refused Treatment|89|||
147277255|NCT00724451|531182873|FG000|Overall Study|Never Started Treatment|89|||
147277256|NCT00724451|531182873|FG000|Overall Study|Unknown; No Data Sources Available|9|||
147277257|NCT00724451|531182873|FG000|Overall Study|Physician Decision|116|||
147277258|NCT00724451|531182873|FG000|Overall Study|Withdrawal by Subject|45|||
147277259|NCT00724451|531182873|FG000|Overall Study|Investigator + Participant Decision|13|||
147277260|NCT01599650|531182874|FG000|Overall Study|Administrative issue|1|||
147277261|NCT01599650|531182875|FG001|Overall Study|Administrative issue|0|||
147277262|NCT01599650|531182876|FG002|Overall Study|Administrative issue|1|||
147277263|NCT01599650|531182874|FG000|Overall Study|Physician Decision|2|||
147277264|NCT01599650|531182875|FG001|Overall Study|Physician Decision|0|||
147277265|NCT01599650|531182876|FG002|Overall Study|Physician Decision|7|||
147334401|NCT04707313|531390109|FG004|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
147334402|NCT04707313|531390110|FG005|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
147334403|NCT04707313|531390111|FG006|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
147334404|NCT04707313|531390112|FG007|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
147334405|NCT04707313|531390113|FG008|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|0|||
147334406|NCT04707313|531390114|FG009|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|1|||
147334407|NCT04707313|531390115|FG010|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|7|||
147334408|NCT04707313|531390116|FG011|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|3|||
147334409|NCT04707313|531390117|FG012|Cohort 3 (Week 0 to Week 32)|Withdrawal by Subject|3|||
147334410|NCT02459899|531390118|FG000|Overall Study|Adverse Event|1|||
147334411|NCT02459899|531390119|FG001|Overall Study|Adverse Event|1|||
147334412|NCT02459899|531390120|FG002|Overall Study|Adverse Event|0|||
147334413|NCT02459899|531390121|FG003|Overall Study|Adverse Event|0|||
147334414|NCT02459899|531390118|FG000|Overall Study|Lost to Follow-up|1|||
147334415|NCT02459899|531390119|FG001|Overall Study|Lost to Follow-up|2|||
147334416|NCT02459899|531390120|FG002|Overall Study|Lost to Follow-up|0|||
147334417|NCT02459899|531390121|FG003|Overall Study|Lost to Follow-up|1|||
147334418|NCT02459899|531390118|FG000|Overall Study|Non-compliance with the treatment|0|||
147334419|NCT02459899|531390119|FG001|Overall Study|Non-compliance with the treatment|0|||
147334420|NCT02459899|531390120|FG002|Overall Study|Non-compliance with the treatment|0|||
147334421|NCT02459899|531390121|FG003|Overall Study|Non-compliance with the treatment|1|||
147334422|NCT02459899|531390118|FG000|Overall Study|Withdrawal by Subject|1|||
147334423|NCT02459899|531390119|FG001|Overall Study|Withdrawal by Subject|3|||
147334424|NCT02459899|531390120|FG002|Overall Study|Withdrawal by Subject|0|||
147334425|NCT02459899|531390121|FG003|Overall Study|Withdrawal by Subject|0|||
147662495|NCT02513550|532587345|FG000|Double Blind Treatment Period|Site terminated by sponsor|1|||
147334426|NCT03586544|531390123|FG000|First Intervention|Adverse Event|0|||
147334427|NCT03586544|531390124|FG001|First Intervention|Adverse Event|1|||
147334428|NCT03586544|531390123|FG000|Second Intervention|Withdrawal by Subject|0|||
147334429|NCT03586544|531390124|FG001|Second Intervention|Withdrawal by Subject|1|||
147334430|NCT00539292|531390128|FG000|Overall Study|Physician Decision|1|||
147334431|NCT00539292|531390129|FG001|Overall Study|Physician Decision|0|||
147334432|NCT00324038|531390134|FG000|Overall Study|Adverse Event|38|||
147334433|NCT00324038|531390135|FG001|Overall Study|Adverse Event|23|||
147334434|NCT00324038|531390134|FG000|Overall Study|Lack of Efficacy|5|||
147334435|NCT00324038|531390135|FG001|Overall Study|Lack of Efficacy|13|||
147334436|NCT00324038|531390134|FG000|Overall Study|Lost to Follow-up|0|||
147334437|NCT00324038|531390135|FG001|Overall Study|Lost to Follow-up|2|||
147334438|NCT00324038|531390134|FG000|Overall Study|Other|6|||
147334439|NCT00324038|531390135|FG001|Overall Study|Other|13|||
147334440|NCT03070483|531390136|FG000|Overall Study|Lost to Follow-up|2|||
147277266|NCT01599650|531182874|FG000|Overall Study|Protocol Violation|0|||
147277267|NCT01599650|531182875|FG001|Overall Study|Protocol Violation|3|||
147277268|NCT01599650|531182876|FG002|Overall Study|Protocol Violation|0|||
147277269|NCT01599650|531182874|FG000|Overall Study|Death|2|||
147277270|NCT01599650|531182875|FG001|Overall Study|Death|1|||
147277271|NCT01599650|531182876|FG002|Overall Study|Death|2|||
147277272|NCT01599650|531182874|FG000|Overall Study|Lost to Follow-up|3|||
147277273|NCT01599650|531182875|FG001|Overall Study|Lost to Follow-up|3|||
147277274|NCT01599650|531182876|FG002|Overall Study|Lost to Follow-up|3|||
147277275|NCT01599650|531182874|FG000|Overall Study|Withdrawal by Subject|11|||
147277276|NCT01599650|531182875|FG001|Overall Study|Withdrawal by Subject|11|||
147277277|NCT01599650|531182876|FG002|Overall Study|Withdrawal by Subject|10|||
147277278|NCT01599650|531182874|FG000|Overall Study|Adverse Event|3|||
147277279|NCT01599650|531182875|FG001|Overall Study|Adverse Event|8|||
147277280|NCT01599650|531182876|FG002|Overall Study|Adverse Event|4|||
147277281|NCT00720876|531182877|FG000|Overall Study|found to be ineligible after starting tx|2|||
147277282|NCT00622635|531182886|FG000|Treatment Period 1|Adverse Event|0|||
147277283|NCT00622635|531182887|FG001|Treatment Period 1|Adverse Event|0|||
147277284|NCT00622635|531182888|FG002|Treatment Period 1|Adverse Event|1|||
147277285|NCT00622635|531182889|FG003|Treatment Period 1|Adverse Event|0|||
147277286|NCT00622635|531182890|FG004|Treatment Period 1|Adverse Event|0|||
147277287|NCT00622635|531182891|FG005|Treatment Period 1|Adverse Event|0|||
147277288|NCT00622635|531182886|FG000|Treatment Period 1|Withdrawal by Subject|0|||
147277289|NCT00622635|531182887|FG001|Treatment Period 1|Withdrawal by Subject|1|||
147277290|NCT00622635|531182888|FG002|Treatment Period 1|Withdrawal by Subject|0|||
147277291|NCT00622635|531182889|FG003|Treatment Period 1|Withdrawal by Subject|0|||
147277292|NCT00622635|531182890|FG004|Treatment Period 1|Withdrawal by Subject|0|||
147277293|NCT00622635|531182891|FG005|Treatment Period 1|Withdrawal by Subject|0|||
147277294|NCT00622635|531182886|FG000|Treatment Period 1|Abnormal test procedure result(s)|0|||
147277295|NCT00622635|531182887|FG001|Treatment Period 1|Abnormal test procedure result(s)|0|||
147277296|NCT00622635|531182888|FG002|Treatment Period 1|Abnormal test procedure result(s)|0|||
147277297|NCT00622635|531182889|FG003|Treatment Period 1|Abnormal test procedure result(s)|0|||
147277298|NCT00622635|531182890|FG004|Treatment Period 1|Abnormal test procedure result(s)|1|||
147277299|NCT00622635|531182891|FG005|Treatment Period 1|Abnormal test procedure result(s)|0|||
147277300|NCT00622635|531182886|FG000|Treatment Period 2|Adverse Event|1|||
147277301|NCT00622635|531182887|FG001|Treatment Period 2|Adverse Event|0|||
147334441|NCT02031471|531390137|FG000|24 Week Treatment Period|Adverse Event|6|||
147334442|NCT02031471|531390137|FG000|24 Week Treatment Period|Participant Decision to Withdraw|2|||
147334443|NCT02031471|531390137|FG000|24 Week Treatment Period|Protocol Violation|1|||
147334444|NCT02031471|531390137|FG000|24 Week Treatment Period|Insufficient Therapeutic Response|1|||
147334445|NCT02031471|531390137|FG000|24 Week Treatment Period|Hypersensitivity Reaction|1|||
147601439|NCT02582866|532358169|FG000|Overall Study|Withdrawal due to personal reasons|1|||
147601440|NCT03258853|532358170|FG000|First Intervention (14 Days)|Withdrawal by Subject|1|||
147601441|NCT03258853|532358171|FG001|First Intervention (14 Days)|Withdrawal by Subject|1|||
147601442|NCT03567382|532358174|FG000|Overall Study|Lost to Follow-up|1|||
147601443|NCT03567382|532358175|FG001|Overall Study|Lost to Follow-up|21|||
147601444|NCT03567382|532358176|FG002|Overall Study|Lost to Follow-up|1|||
147601445|NCT03567382|532358177|FG003|Overall Study|Lost to Follow-up|21|||
147277302|NCT00622635|531182888|FG002|Treatment Period 2|Adverse Event|0|||
147277303|NCT00622635|531182889|FG003|Treatment Period 2|Adverse Event|0|||
147277304|NCT00622635|531182890|FG004|Treatment Period 2|Adverse Event|0|||
147334446|NCT02031471|531390137|FG000|Long Term Extension (LTE) Period|Adverse Event|1|||
147334447|NCT02031471|531390137|FG000|Long Term Extension (LTE) Period|Insufficient Therapeutic Response|1|||
147334448|NCT00361283|531390140|FG000|Overall Study|Lost to Follow-up|27|||
147334449|NCT00430300|531390141|FG000|Overall Study|Adverse Event|0|||
147334450|NCT00430300|531390142|FG001|Overall Study|Adverse Event|2|||
147334451|NCT00430300|531390143|FG002|Overall Study|Adverse Event|1|||
147334452|NCT00430300|531390144|FG003|Overall Study|Adverse Event|1|||
147334453|NCT00430300|531390141|FG000|Overall Study|Withdrawal by Subject|1|||
147334454|NCT00430300|531390142|FG001|Overall Study|Withdrawal by Subject|0|||
147334455|NCT00430300|531390143|FG002|Overall Study|Withdrawal by Subject|5|||
147601446|NCT03567382|532358174|FG000|Overall Study|Withdrawal by Subject|2|||
147277305|NCT00622635|531182891|FG005|Treatment Period 2|Adverse Event|0|||
147277306|NCT00622635|531182886|FG000|Treatment Period 3|Adverse Event|0|||
147277307|NCT00622635|531182887|FG001|Treatment Period 3|Adverse Event|0|||
147277308|NCT00622635|531182888|FG002|Treatment Period 3|Adverse Event|0|||
147277309|NCT00622635|531182889|FG003|Treatment Period 3|Adverse Event|2|||
147334456|NCT00430300|531390144|FG003|Overall Study|Withdrawal by Subject|0|||
147334457|NCT00430300|531390141|FG000|Overall Study|Laboratory abnormality|1|||
147601447|NCT03567382|532358175|FG001|Overall Study|Withdrawal by Subject|14|||
147662496|NCT02513550|532587346|FG001|Double Blind Treatment Period|Site terminated by sponsor|1|||
147277310|NCT00622635|531182890|FG004|Treatment Period 3|Adverse Event|0|||
147277311|NCT00622635|531182891|FG005|Treatment Period 3|Adverse Event|0|||
147277312|NCT00622635|531182886|FG000|Treatment Period 3|Withdrawal by Subject|0|||
147601448|NCT03567382|532358176|FG002|Overall Study|Withdrawal by Subject|1|||
147601449|NCT03567382|532358177|FG003|Overall Study|Withdrawal by Subject|12|||
147601450|NCT02011386|532358182|FG000|Overall Study|Non-compliance|2|||
147601451|NCT02011386|532358182|FG000|Overall Study|Lack of Efficacy|3|||
147601452|NCT04555720|532358183|FG000|Overall Study|Lost to Follow-up|2|||
147277313|NCT00622635|531182887|FG001|Treatment Period 3|Withdrawal by Subject|0|||
147277314|NCT00622635|531182888|FG002|Treatment Period 3|Withdrawal by Subject|0|||
147277315|NCT00622635|531182889|FG003|Treatment Period 3|Withdrawal by Subject|1|||
147277316|NCT00622635|531182890|FG004|Treatment Period 3|Withdrawal by Subject|0|||
147277317|NCT00622635|531182891|FG005|Treatment Period 3|Withdrawal by Subject|0|||
147277318|NCT00281840|531182892|FG000|Overall Study|Adverse Event|12|||
147277319|NCT00281840|531182892|FG000|Overall Study|Physician Decision|6|||
147277320|NCT00281840|531182892|FG000|Overall Study|Withdrawal by Subject|3|||
147277321|NCT00281840|531182892|FG000|Overall Study|Disease Progression|2|||
147277322|NCT00281840|531182892|FG000|Overall Study|exceed maximum delay in treatment|1|||
147277323|NCT00281840|531182892|FG000|Overall Study|Complicating Disease|1|||
147277324|NCT02185768|531182895|FG000|Overall Study|Patients were not treated|2|||
147277325|NCT03027466|531182899|FG000|Overall Study|Opting out of the app|1869|||
147277326|NCT03027466|531182900|FG001|Overall Study|Opting out of the app|1819|||
147277327|NCT03027466|531182901|FG002|Overall Study|Opting out of the app|1743|||
147277328|NCT03027466|531182902|FG003|Overall Study|Opting out of the app|1821|||
147277329|NCT01858194|531182903|FG000|Overall Study|Total Artificial Heart Implant|0|||
147277330|NCT01858194|531182904|FG001|Overall Study|Total Artificial Heart Implant|1|||
147277331|NCT01858194|531182903|FG000|Overall Study|Lost to Follow-up|0|||
147277332|NCT01858194|531182904|FG001|Overall Study|Lost to Follow-up|1|||
147277333|NCT02158039|531182905|FG000|Overall Study|Withdrawal by Subject|1|||
147277334|NCT02158039|531182905|FG000|Overall Study|Screen Failure|9|||
147277335|NCT01079234|531182912|FG000|Main: Week 0 to 26|Adverse Event|5|||
147277336|NCT01079234|531182913|FG001|Main: Week 0 to 26|Adverse Event|4|||
147277337|NCT01079234|531182914|FG002|Main: Week 0 to 26|Adverse Event|1|||
147277338|NCT01079234|531182915|FG003|Main: Week 0 to 26|Adverse Event|0|||
147277339|NCT01079234|531182912|FG000|Main: Week 0 to 26|Lack of Efficacy|2|||
147277340|NCT01079234|531182913|FG001|Main: Week 0 to 26|Lack of Efficacy|1|||
147277341|NCT01079234|531182914|FG002|Main: Week 0 to 26|Lack of Efficacy|1|||
147277342|NCT01079234|531182915|FG003|Main: Week 0 to 26|Lack of Efficacy|0|||
147277343|NCT01079234|531182912|FG000|Main: Week 0 to 26|Protocol Violation|6|||
147277344|NCT01079234|531182913|FG001|Main: Week 0 to 26|Protocol Violation|2|||
147277345|NCT01079234|531182914|FG002|Main: Week 0 to 26|Protocol Violation|4|||
147277346|NCT01079234|531182915|FG003|Main: Week 0 to 26|Protocol Violation|0|||
147277347|NCT01079234|531182912|FG000|Main: Week 0 to 26|Withdrawal criteria|6|||
147277348|NCT01079234|531182913|FG001|Main: Week 0 to 26|Withdrawal criteria|6|||
147277349|NCT01079234|531182914|FG002|Main: Week 0 to 26|Withdrawal criteria|2|||
147277350|NCT01079234|531182915|FG003|Main: Week 0 to 26|Withdrawal criteria|0|||
147277351|NCT01079234|531182912|FG000|Main: Week 0 to 26|Unclassified|7|||
147277352|NCT01079234|531182913|FG001|Main: Week 0 to 26|Unclassified|13|||
147277353|NCT01079234|531182914|FG002|Main: Week 0 to 26|Unclassified|4|||
147277354|NCT01079234|531182915|FG003|Main: Week 0 to 26|Unclassified|0|||
147277355|NCT01079234|531182912|FG000|Extension: Week 27 to 52|Adverse Event|0|||
147277356|NCT01079234|531182913|FG001|Extension: Week 27 to 52|Adverse Event|0|||
147277357|NCT01079234|531182914|FG002|Extension: Week 27 to 52|Adverse Event|1|||
147277358|NCT01079234|531182915|FG003|Extension: Week 27 to 52|Adverse Event|0|||
147277359|NCT01079234|531182912|FG000|Extension: Week 27 to 52|Lack of Efficacy|0|||
147277360|NCT01079234|531182913|FG001|Extension: Week 27 to 52|Lack of Efficacy|0|||
147277361|NCT01079234|531182914|FG002|Extension: Week 27 to 52|Lack of Efficacy|0|||
147277362|NCT01079234|531182915|FG003|Extension: Week 27 to 52|Lack of Efficacy|2|||
147277363|NCT01079234|531182912|FG000|Extension: Week 27 to 52|Protocol Violation|0|||
147277364|NCT01079234|531182913|FG001|Extension: Week 27 to 52|Protocol Violation|0|||
147277365|NCT01079234|531182914|FG002|Extension: Week 27 to 52|Protocol Violation|2|||
147277366|NCT01079234|531182915|FG003|Extension: Week 27 to 52|Protocol Violation|5|||
147277367|NCT01079234|531182912|FG000|Extension: Week 27 to 52|Withdrawal criteria|0|||
147277368|NCT01079234|531182913|FG001|Extension: Week 27 to 52|Withdrawal criteria|0|||
147277369|NCT01079234|531182914|FG002|Extension: Week 27 to 52|Withdrawal criteria|4|||
147601453|NCT04555720|532358184|FG001|Overall Study|Lost to Follow-up|0|||
147601454|NCT04555720|532358185|FG002|Overall Study|Lost to Follow-up|0|||
147277370|NCT01079234|531182915|FG003|Extension: Week 27 to 52|Withdrawal criteria|2|||
147277371|NCT01079234|531182912|FG000|Extension: Week 27 to 52|Unclassified|0|||
147277372|NCT01079234|531182913|FG001|Extension: Week 27 to 52|Unclassified|0|||
147277373|NCT01079234|531182914|FG002|Extension: Week 27 to 52|Unclassified|4|||
147277374|NCT01079234|531182915|FG003|Extension: Week 27 to 52|Unclassified|7|||
147601455|NCT04555720|532358186|FG003|Overall Study|Lost to Follow-up|0|||
147277375|NCT03509948|531182920|FG000|Overall Study|Protocol Violation|0|||
147277376|NCT03509948|531182921|FG001|Overall Study|Protocol Violation|1|||
147277377|NCT03221257|531182922|FG000|Overall Study|Lost to Follow-up|0|||
147277378|NCT03221257|531182923|FG001|Overall Study|Lost to Follow-up|1|||
147277379|NCT03221257|531182922|FG000|Overall Study|Withdrawal by Subject|1|||
147277380|NCT03221257|531182923|FG001|Overall Study|Withdrawal by Subject|1|||
147601456|NCT04555720|532358183|FG000|Overall Study|Withdrawal by Subject|4|||
147601457|NCT04555720|532358184|FG001|Overall Study|Withdrawal by Subject|6|||
147277381|NCT05402995|531182925|FG000|Overall Study|Study terminated due to lack of enrollment and followup.|0|||
147277382|NCT05402995|531182926|FG001|Overall Study|Study terminated due to lack of enrollment and followup.|2|||
147334458|NCT00430300|531390142|FG001|Overall Study|Laboratory abnormality|0|||
147334459|NCT00430300|531390143|FG002|Overall Study|Laboratory abnormality|0|||
147334460|NCT00430300|531390144|FG003|Overall Study|Laboratory abnormality|0|||
147334461|NCT00430300|531390141|FG000|Overall Study|Other|0|||
147334462|NCT00430300|531390142|FG001|Overall Study|Other|0|||
147334463|NCT00430300|531390143|FG002|Overall Study|Other|0|||
147334464|NCT00430300|531390144|FG003|Overall Study|Other|1|||
147334465|NCT02041104|531390147|FG000|Overall Study|Lost to Follow-up|1|||
147334466|NCT02041104|531390148|FG001|Overall Study|Lost to Follow-up|4|||
147334467|NCT02041104|531390147|FG000|Overall Study|discomfort during OGTT|0|||
147334468|NCT02041104|531390148|FG001|Overall Study|discomfort during OGTT|3|||
147334469|NCT00546871|531390149|FG000|Part 1 - IV Infusions of IGIV, PK|Withdrawal by Subject|1|||
147334470|NCT00546871|531390150|FG001|Part 1 - IV Infusions of IGIV, PK|Withdrawal by Subject|0|||
147334471|NCT00546871|531390149|FG000|Part 2 - Subcutaneous (SC) IGIV, PK|Withdrawal by Subject|1|||
147334472|NCT00546871|531390150|FG001|Part 2 - Subcutaneous (SC) IGIV, PK|Withdrawal by Subject|2|||
147334473|NCT00546871|531390149|FG000|Part 2 - Subcutaneous (SC) IGIV, PK|Family Emergency|0|||
147334474|NCT00546871|531390150|FG001|Part 2 - Subcutaneous (SC) IGIV, PK|Family Emergency|1|||
147334475|NCT00546871|531390149|FG000|Study Extension Period|Protocol Violation|1|||
147334476|NCT00546871|531390150|FG001|Study Extension Period|Protocol Violation|0|||
147334477|NCT00546871|531390149|FG000|Study Extension Period|Withdrawal by Subject|0|||
147334478|NCT00546871|531390150|FG001|Study Extension Period|Withdrawal by Subject|1|||
147334479|NCT01713946|531390151|FG000|Overall Study|Death|0|||
147334480|NCT01713946|531390152|FG001|Overall Study|Death|2|||
147334481|NCT01713946|531390153|FG002|Overall Study|Death|2|||
147334482|NCT01713946|531390151|FG000|Overall Study|Adverse Event|19|||
147334483|NCT01713946|531390152|FG001|Overall Study|Adverse Event|14|||
147334484|NCT01713946|531390153|FG002|Overall Study|Adverse Event|13|||
147334485|NCT01713946|531390151|FG000|Overall Study|Withdrawal by Subject|12|||
147277383|NCT05402995|531182927|FG002|Overall Study|Study terminated due to lack of enrollment and followup.|2|||
147277384|NCT05402995|531182928|FG003|Overall Study|Study terminated due to lack of enrollment and followup.|2|||
147277385|NCT00205712|531182929|FG000|Overall Study|Lost to Follow-up|0|||
147277386|NCT00205712|531182930|FG001|Overall Study|Lost to Follow-up|1|||
147277387|NCT01071512|531182931|FG000|Overall Study|Adverse Event|1|||
147277388|NCT01071512|531182931|FG000|Overall Study|Development of antibodies to drug|2|||
147277389|NCT01071512|531182931|FG000|Overall Study|positive anti-JC virus antibody test|2|||
147277390|NCT02188485|531182932|FG000|Overall Study|Withdrawal by Subject|2|||
147277391|NCT02188485|531182933|FG001|Overall Study|Withdrawal by Subject|1|||
147277392|NCT02188485|531182932|FG000|Overall Study|PI withdrew, lack of capacity|0|||
147277393|NCT02188485|531182933|FG001|Overall Study|PI withdrew, lack of capacity|2|||
147277394|NCT00437034|531182934|FG000|Overall Study|Adverse Event|1|||
147277395|NCT00437034|531182934|FG000|Overall Study|Disease progression during treatment|5|||
147277396|NCT03146650|531182935|FG000|Registered for Study|Did not continue to meet protocol eligibility criteria after registration.|1|||
147277397|NCT03146650|531182935|FG000|Completed Cycle 1 of Treatment(Nivo+Ipi)|Adverse Event|1|||
147277398|NCT03146650|531182935|FG000|Continued to Cycle 2 and Beyond|Still on treatment|2|||
147277399|NCT03146650|531182935|FG000|Continued to Cycle 2 and Beyond|Progressive Disease|2|||
147277400|NCT03146650|531182935|FG000|2 Year Follow-up|Death|11|||
147277401|NCT03146650|531182935|FG000|2 Year Follow-up|Still in follow-up|7|||
147277402|NCT03146650|531182935|FG000|2 Year Follow-up|Lost to Follow-up|1|||
147277403|NCT02047604|531182940|FG000|Overall Study|Withdrawal by Subject|0|||
147277404|NCT02047604|531182941|FG001|Overall Study|Withdrawal by Subject|0|||
147277405|NCT02047604|531182942|FG002|Overall Study|Withdrawal by Subject|0|||
147277406|NCT02047604|531182943|FG003|Overall Study|Withdrawal by Subject|0|||
147277407|NCT02047604|531182944|FG004|Overall Study|Withdrawal by Subject|1|||
147277408|NCT02047604|531182945|FG005|Overall Study|Withdrawal by Subject|1|||
147277409|NCT00983814|531182946|FG000|Open-Label (6 Weeks)|Adverse Event|3|||
147277410|NCT00983814|531182947|FG001|Open-Label (6 Weeks)|Adverse Event|0|||
147277411|NCT00983814|531182948|FG002|Open-Label (6 Weeks)|Adverse Event|0|||
147277412|NCT00983814|531182946|FG000|Open-Label (6 Weeks)|Withdrawal by Subject|2|||
147334486|NCT01713946|531390152|FG001|Overall Study|Withdrawal by Subject|12|||
147334487|NCT01713946|531390153|FG002|Overall Study|Withdrawal by Subject|8|||
147334488|NCT01713946|531390151|FG000|Overall Study|Lack of Efficacy|8|||
147334489|NCT01713946|531390152|FG001|Overall Study|Lack of Efficacy|8|||
147334490|NCT01713946|531390153|FG002|Overall Study|Lack of Efficacy|14|||
147277413|NCT00983814|531182947|FG001|Open-Label (6 Weeks)|Withdrawal by Subject|0|||
147277414|NCT00983814|531182948|FG002|Open-Label (6 Weeks)|Withdrawal by Subject|0|||
147277415|NCT00983814|531182946|FG000|Open-Label (6 Weeks)|Physician Decision|1|||
147277416|NCT00983814|531182947|FG001|Open-Label (6 Weeks)|Physician Decision|0|||
147334491|NCT01713946|531390151|FG000|Overall Study|Protocol Violation|2|||
147334492|NCT01713946|531390152|FG001|Overall Study|Protocol Violation|4|||
147334493|NCT01713946|531390153|FG002|Overall Study|Protocol Violation|1|||
147334494|NCT01713946|531390151|FG000|Overall Study|Lost to Follow-up|0|||
147334495|NCT01713946|531390152|FG001|Overall Study|Lost to Follow-up|0|||
147277417|NCT00983814|531182948|FG002|Open-Label (6 Weeks)|Physician Decision|0|||
147277418|NCT00983814|531182946|FG000|Open-Label (6 Weeks)|Lost to Follow-up|1|||
147277419|NCT00983814|531182947|FG001|Open-Label (6 Weeks)|Lost to Follow-up|0|||
147277420|NCT00983814|531182948|FG002|Open-Label (6 Weeks)|Lost to Follow-up|0|||
147277421|NCT00983814|531182946|FG000|Double-Blind (2 Weeks)|Withdrawal by Subject|0|||
147277422|NCT00983814|531182947|FG001|Double-Blind (2 Weeks)|Withdrawal by Subject|0|||
147277423|NCT00983814|531182948|FG002|Double-Blind (2 Weeks)|Withdrawal by Subject|1|||
147277424|NCT02517905|531182949|FG000|Overall Study|Lost to Follow-up|4|||
147277425|NCT02517905|531182950|FG001|Overall Study|Lost to Follow-up|0|||
147277426|NCT02517905|531182949|FG000|Overall Study|Withdrawal by Subject|4|||
147277427|NCT02517905|531182950|FG001|Overall Study|Withdrawal by Subject|0|||
147277428|NCT02517905|531182949|FG000|Overall Study|Screen failure|2|||
147277429|NCT02517905|531182950|FG001|Overall Study|Screen failure|2|||
147277430|NCT01994395|531182956|FG000|Overall Study|Withdrawal by Subject|1|||
147277431|NCT01994395|531182957|FG001|Overall Study|Withdrawal by Subject|2|||
147277432|NCT00459134|531182958|FG000|Overall Study|Physician Decision|1|||
147277433|NCT00459134|531182959|FG001|Overall Study|Physician Decision|1|||
147277434|NCT00459134|531182958|FG000|Overall Study|Withdrawal by Subject|8|||
147277435|NCT00459134|531182959|FG001|Overall Study|Withdrawal by Subject|7|||
147277436|NCT00459134|531182958|FG000|Overall Study|Lost to Follow-up|6|||
147277437|NCT00459134|531182959|FG001|Overall Study|Lost to Follow-up|7|||
147277438|NCT00459134|531182958|FG000|Overall Study|Surgery|1|||
147277439|NCT00459134|531182959|FG001|Overall Study|Surgery|2|||
147277440|NCT00459134|531182958|FG000|Overall Study|Toxicity|4|||
147277441|NCT00459134|531182959|FG001|Overall Study|Toxicity|5|||
147277442|NCT00459134|531182958|FG000|Overall Study|Progression|1|||
147277443|NCT00459134|531182959|FG001|Overall Study|Progression|0|||
147277444|NCT00459134|531182958|FG000|Overall Study|Multiple Reasons|2|||
147277445|NCT00459134|531182959|FG001|Overall Study|Multiple Reasons|3|||
147277446|NCT00829621|531182960|FG000|Overall Study|Death|1|||
147277447|NCT00829621|531182961|FG001|Overall Study|Death|0|||
147277448|NCT00829621|531182960|FG000|Overall Study|Lost to Follow-up|3|||
147277449|NCT00829621|531182961|FG001|Overall Study|Lost to Follow-up|4|||
147277450|NCT01755416|531182964|FG000|First Intervention ( Upto 2 Days)|Withdrawal by Subject|1|||
147277451|NCT01755416|531182965|FG001|First Intervention ( Upto 2 Days)|Withdrawal by Subject|2|||
147277452|NCT01976845|531182966|FG000|Overall Study|Physician Decision|8|||
147277453|NCT01976845|531182967|FG001|Overall Study|Physician Decision|8|||
147277454|NCT01976845|531182968|FG002|Overall Study|Physician Decision|3|||
147277455|NCT00441337|531182969|FG000|Overall Study|Disease Progression|6|||
147277456|NCT00441337|531182970|FG001|Overall Study|Disease Progression|6|||
147277457|NCT00441337|531182971|FG002|Overall Study|Disease Progression|4|||
147277458|NCT00441337|531182972|FG003|Overall Study|Disease Progression|18|||
147277459|NCT00441337|531182969|FG000|Overall Study|Lost to Follow-up|0|||
147277460|NCT00441337|531182970|FG001|Overall Study|Lost to Follow-up|0|||
147277461|NCT00441337|531182971|FG002|Overall Study|Lost to Follow-up|0|||
147277462|NCT00441337|531182972|FG003|Overall Study|Lost to Follow-up|1|||
147277463|NCT00441337|531182969|FG000|Overall Study|Sponsor Decision|0|||
147277464|NCT00441337|531182970|FG001|Overall Study|Sponsor Decision|0|||
147277465|NCT00441337|531182971|FG002|Overall Study|Sponsor Decision|1|||
147277466|NCT00441337|531182972|FG003|Overall Study|Sponsor Decision|2|||
147277467|NCT00441337|531182969|FG000|Overall Study|Did not meet inclusion criteria|0|||
147277468|NCT00441337|531182970|FG001|Overall Study|Did not meet inclusion criteria|0|||
147277469|NCT00441337|531182971|FG002|Overall Study|Did not meet inclusion criteria|1|||
147277470|NCT00441337|531182972|FG003|Overall Study|Did not meet inclusion criteria|0|||
147277471|NCT03655236|531182973|FG000|Subject Disposition in Part 1 Period|Adverse Event|25|||
147277472|NCT03655236|531182974|FG001|Subject Disposition in Part 1 Period|Adverse Event|55|||
147277473|NCT03655236|531182975|FG002|Subject Disposition in Part 1 Period|Adverse Event|12|||
147277474|NCT03655236|531182973|FG000|Subject Disposition in Part 1 Period|Death|1|||
147277475|NCT03655236|531182974|FG001|Subject Disposition in Part 1 Period|Death|0|||
147277476|NCT03655236|531182975|FG002|Subject Disposition in Part 1 Period|Death|0|||
147277477|NCT03655236|531182973|FG000|Subject Disposition in Part 1 Period|Physician Decision|0|||
147277478|NCT03655236|531182974|FG001|Subject Disposition in Part 1 Period|Physician Decision|3|||
147277479|NCT03655236|531182975|FG002|Subject Disposition in Part 1 Period|Physician Decision|2|||
147277480|NCT03655236|531182973|FG000|Subject Disposition in Part 1 Period|Lost to Follow-up|1|||
147277481|NCT03655236|531182974|FG001|Subject Disposition in Part 1 Period|Lost to Follow-up|3|||
147277482|NCT03655236|531182975|FG002|Subject Disposition in Part 1 Period|Lost to Follow-up|2|||
147277483|NCT03655236|531182973|FG000|Subject Disposition in Part 1 Period|Parkinson's disease progression|2|||
147277484|NCT03655236|531182974|FG001|Subject Disposition in Part 1 Period|Parkinson's disease progression|8|||
147277485|NCT03655236|531182975|FG002|Subject Disposition in Part 1 Period|Parkinson's disease progression|5|||
147277486|NCT03655236|531182973|FG000|Subject Disposition in Part 1 Period|Poor compliance|0|||
147277487|NCT03655236|531182974|FG001|Subject Disposition in Part 1 Period|Poor compliance|2|||
147277488|NCT03655236|531182975|FG002|Subject Disposition in Part 1 Period|Poor compliance|0|||
147277489|NCT03655236|531182973|FG000|Subject Disposition in Part 1 Period|Protocol Violation|1|||
147334496|NCT01713946|531390153|FG002|Overall Study|Lost to Follow-up|1|||
147601458|NCT04555720|532358185|FG002|Overall Study|Withdrawal by Subject|0|||
147601459|NCT04555720|532358186|FG003|Overall Study|Withdrawal by Subject|0|||
147601460|NCT03753763|532358187|FG000|Overall Study|Adverse Event|2|||
147601461|NCT03753763|532358188|FG001|Overall Study|Adverse Event|0|||
147601462|NCT03753763|532358187|FG000|Overall Study|Withdrawal by Subject|3|||
147601463|NCT03753763|532358188|FG001|Overall Study|Withdrawal by Subject|1|||
147277490|NCT03655236|531182974|FG001|Subject Disposition in Part 1 Period|Protocol Violation|1|||
147277491|NCT03655236|531182975|FG002|Subject Disposition in Part 1 Period|Protocol Violation|0|||
147277492|NCT03655236|531182973|FG000|Subject Disposition in Part 1 Period|Requires prohibited medication|4|||
147277493|NCT03655236|531182974|FG001|Subject Disposition in Part 1 Period|Requires prohibited medication|5|||
147277494|NCT03655236|531182975|FG002|Subject Disposition in Part 1 Period|Requires prohibited medication|3|||
147277495|NCT03655236|531182973|FG000|Subject Disposition in Part 1 Period|Study terminated by Sponsor|12|||
147277496|NCT03655236|531182974|FG001|Subject Disposition in Part 1 Period|Study terminated by Sponsor|8|||
147277497|NCT03655236|531182975|FG002|Subject Disposition in Part 1 Period|Study terminated by Sponsor|13|||
147277498|NCT03655236|531182973|FG000|Subject Disposition in Part 1 Period|Withdrawal by Subject|0|||
147277499|NCT03655236|531182974|FG001|Subject Disposition in Part 1 Period|Withdrawal by Subject|5|||
147277500|NCT03655236|531182975|FG002|Subject Disposition in Part 1 Period|Withdrawal by Subject|3|||
147277501|NCT03655236|531182973|FG000|Subject Disposition in Part 1 Period|Withdrawal of consent|11|||
147277502|NCT03655236|531182974|FG001|Subject Disposition in Part 1 Period|Withdrawal of consent|16|||
147277503|NCT03655236|531182975|FG002|Subject Disposition in Part 1 Period|Withdrawal of consent|6|||
147277504|NCT03655236|531182973|FG000|Subject Disposition in Part 1 Period|Other|0|||
147277505|NCT03655236|531182974|FG001|Subject Disposition in Part 1 Period|Other|2|||
147277506|NCT03655236|531182975|FG002|Subject Disposition in Part 1 Period|Other|2|||
147277507|NCT03655236|531182973|FG000|Subject Disposition in Part 2 Period|Adverse Event|2|||
147277508|NCT03655236|531182974|FG001|Subject Disposition in Part 2 Period|Adverse Event|5|||
147277509|NCT03655236|531182975|FG002|Subject Disposition in Part 2 Period|Adverse Event|12|||
147277510|NCT03655236|531182973|FG000|Subject Disposition in Part 2 Period|Lost to Follow-up|1|||
147277511|NCT03655236|531182974|FG001|Subject Disposition in Part 2 Period|Lost to Follow-up|0|||
147277512|NCT03655236|531182975|FG002|Subject Disposition in Part 2 Period|Lost to Follow-up|0|||
147277513|NCT03655236|531182973|FG000|Subject Disposition in Part 2 Period|Parkinson's disease progression|4|||
147277514|NCT03655236|531182974|FG001|Subject Disposition in Part 2 Period|Parkinson's disease progression|0|||
147277515|NCT03655236|531182975|FG002|Subject Disposition in Part 2 Period|Parkinson's disease progression|2|||
147277516|NCT03655236|531182973|FG000|Subject Disposition in Part 2 Period|Protocol Violation|1|||
147277517|NCT03655236|531182974|FG001|Subject Disposition in Part 2 Period|Protocol Violation|0|||
147277518|NCT03655236|531182975|FG002|Subject Disposition in Part 2 Period|Protocol Violation|4|||
147277519|NCT03655236|531182973|FG000|Subject Disposition in Part 2 Period|Requires prohibited medication|3|||
147277520|NCT03655236|531182974|FG001|Subject Disposition in Part 2 Period|Requires prohibited medication|1|||
147277521|NCT03655236|531182975|FG002|Subject Disposition in Part 2 Period|Requires prohibited medication|5|||
147277522|NCT03655236|531182973|FG000|Subject Disposition in Part 2 Period|Study terminated by Sponsor|18|||
147277523|NCT03655236|531182974|FG001|Subject Disposition in Part 2 Period|Study terminated by Sponsor|11|||
147277524|NCT03655236|531182975|FG002|Subject Disposition in Part 2 Period|Study terminated by Sponsor|13|||
147277525|NCT03655236|531182973|FG000|Subject Disposition in Part 2 Period|Withdrawal by Subject|1|||
147277526|NCT03655236|531182974|FG001|Subject Disposition in Part 2 Period|Withdrawal by Subject|1|||
147277527|NCT03655236|531182975|FG002|Subject Disposition in Part 2 Period|Withdrawal by Subject|2|||
147277528|NCT03655236|531182973|FG000|Subject Disposition in Part 2 Period|Withdrawal of consent|5|||
147277529|NCT03655236|531182974|FG001|Subject Disposition in Part 2 Period|Withdrawal of consent|1|||
147277530|NCT03655236|531182975|FG002|Subject Disposition in Part 2 Period|Withdrawal of consent|12|||
147277531|NCT03655236|531182973|FG000|Subject Disposition in Part 2 Period|Other|1|||
147277532|NCT03655236|531182974|FG001|Subject Disposition in Part 2 Period|Other|0|||
147277533|NCT03655236|531182975|FG002|Subject Disposition in Part 2 Period|Other|0|||
147277534|NCT01818336|531184903|FG000|Overall Study|Declined retest visit|0|||
147277535|NCT01818336|531184904|FG001|Overall Study|Declined retest visit|11|||
147277536|NCT01818336|531184903|FG000|Overall Study|Lost to Follow-up|0|||
147277537|NCT01818336|531184904|FG001|Overall Study|Lost to Follow-up|1|||
147277538|NCT04258839|531184905|FG000|Overall Study|Adverse Event|2|||
147277539|NCT04258839|531184906|FG001|Overall Study|Adverse Event|4|||
147277540|NCT04258839|531184905|FG000|Overall Study|Lack of Efficacy|0|||
147277541|NCT04258839|531184906|FG001|Overall Study|Lack of Efficacy|2|||
147277542|NCT04258839|531184905|FG000|Overall Study|Lost to Follow-up|2|||
147334497|NCT01713946|531390151|FG000|Overall Study|Administrative problems|1|||
147334498|NCT01713946|531390152|FG001|Overall Study|Administrative problems|0|||
147334499|NCT01713946|531390153|FG002|Overall Study|Administrative problems|0|||
147601464|NCT03753763|532358187|FG000|Overall Study|clinical deterioration|1|||
147277543|NCT04258839|531184906|FG001|Overall Study|Lost to Follow-up|0|||
147334500|NCT01713946|531390151|FG000|Overall Study|Did not continue in Ext|0|||
147601465|NCT03753763|532358188|FG001|Overall Study|clinical deterioration|0|||
147601466|NCT00719849|532358189|FG000|Overall Study|Death|0|||
147277544|NCT04258839|531184905|FG000|Overall Study|Withdrawal by Subject|1|||
147277545|NCT04258839|531184906|FG001|Overall Study|Withdrawal by Subject|2|||
147277546|NCT04258839|531184905|FG000|Overall Study|Withdrawal by Caregiver|5|||
147277547|NCT04258839|531184906|FG001|Overall Study|Withdrawal by Caregiver|6|||
147277548|NCT04258839|531184905|FG000|Overall Study|Reason not Specified|0|||
147277549|NCT04258839|531184906|FG001|Overall Study|Reason not Specified|1|||
147277550|NCT02293005|531184907|FG000|Overall Study|Adverse Event|2|||
147277551|NCT02293005|531184907|FG000|Overall Study|Death|4|||
147277552|NCT02293005|531184907|FG000|Overall Study|Lost to Follow-up|1|||
147277553|NCT02293005|531184907|FG000|Overall Study|Withdrawal by Subject|2|||
147277554|NCT02293005|531184907|FG000|Overall Study|Progression|17|||
147277555|NCT03328897|531184908|FG000|Randomized-treatment Epoch|Adverse Event|4|||
147277556|NCT03328897|531184909|FG001|Randomized-treatment Epoch|Adverse Event|1|||
147277557|NCT03328897|531184910|FG002|Randomized-treatment Epoch|Adverse Event|1|||
147277558|NCT03328897|531184908|FG000|Randomized-treatment Epoch|Lost to Follow-up|0|||
147277559|NCT03328897|531184909|FG001|Randomized-treatment Epoch|Lost to Follow-up|1|||
147277560|NCT03328897|531184910|FG002|Randomized-treatment Epoch|Lost to Follow-up|0|||
147277561|NCT03328897|531184908|FG000|Randomized-treatment Epoch|Pregnancy|3|||
147277562|NCT03328897|531184909|FG001|Randomized-treatment Epoch|Pregnancy|0|||
147277563|NCT03328897|531184910|FG002|Randomized-treatment Epoch|Pregnancy|0|||
147277564|NCT03328897|531184908|FG000|Randomized-treatment Epoch|Patient/guardian decision|8|||
147277565|NCT03328897|531184909|FG001|Randomized-treatment Epoch|Patient/guardian decision|3|||
147277566|NCT03328897|531184910|FG002|Randomized-treatment Epoch|Patient/guardian decision|1|||
147277567|NCT03328897|531184908|FG000|Randomized-treatment Epoch|Lack of Efficacy|1|||
147277568|NCT03328897|531184909|FG001|Randomized-treatment Epoch|Lack of Efficacy|0|||
147277569|NCT03328897|531184910|FG002|Randomized-treatment Epoch|Lack of Efficacy|0|||
147277570|NCT03328897|531184908|FG000|Follow-up Epoch|Adverse Event|4|||
147277571|NCT03328897|531184909|FG001|Follow-up Epoch|Adverse Event|0|||
147277572|NCT03328897|531184910|FG002|Follow-up Epoch|Adverse Event|1|||
147277573|NCT03328897|531184908|FG000|Follow-up Epoch|Lack of Efficacy|1|||
147277574|NCT03328897|531184909|FG001|Follow-up Epoch|Lack of Efficacy|1|||
147277575|NCT03328897|531184910|FG002|Follow-up Epoch|Lack of Efficacy|1|||
147277576|NCT03328897|531184908|FG000|Follow-up Epoch|Lost to Follow-up|0|||
147277577|NCT03328897|531184909|FG001|Follow-up Epoch|Lost to Follow-up|1|||
147277578|NCT03328897|531184910|FG002|Follow-up Epoch|Lost to Follow-up|0|||
147277579|NCT03328897|531184908|FG000|Follow-up Epoch|Pregnancy|1|||
147277580|NCT03328897|531184909|FG001|Follow-up Epoch|Pregnancy|0|||
147277581|NCT03328897|531184910|FG002|Follow-up Epoch|Pregnancy|0|||
147277582|NCT03328897|531184908|FG000|Follow-up Epoch|Patient/guardian decision|2|||
147277583|NCT03328897|531184909|FG001|Follow-up Epoch|Patient/guardian decision|1|||
147277584|NCT03328897|531184910|FG002|Follow-up Epoch|Patient/guardian decision|0|||
147277585|NCT00608829|531184913|FG000|Overall Study|Death|6|||
147277586|NCT00608829|531184913|FG000|Overall Study|Withdrawal by Subject|4|||
147277587|NCT00608829|531184913|FG000|Overall Study|Subject refuses to follow up or return.|5|||
147277588|NCT00612066|531184916|FG000|Overall Study|Adverse Event|1|||
147277589|NCT00982319|531184917|FG000|Overall Study|Surgery date change|1|||
147277590|NCT00982319|531184918|FG001|Overall Study|Surgery date change|0|||
147277591|NCT00982319|531184917|FG000|Overall Study|Preop values out of acceptable range|1|||
147277592|NCT00982319|531184918|FG001|Overall Study|Preop values out of acceptable range|1|||
147277593|NCT00982319|531184917|FG000|Overall Study|Pregnancy|0|||
147277594|NCT00982319|531184918|FG001|Overall Study|Pregnancy|1|||
147277595|NCT03603964|531184921|FG000|Overall Study|Death|9|||
147277596|NCT03603964|531184921|FG000|Overall Study|Withdrawal by participant|7|||
147277597|NCT03603964|531184921|FG000|Overall Study|Study terminated by Sponsor|19|||
147277598|NCT02480621|531184936|FG000|Randomization|Withdrawal by Subject|1|||
147277599|NCT02480621|531184937|FG001|Randomization|Withdrawal by Subject|0|||
147277600|NCT02480621|531184936|FG000|Randomization|Surgeon did not give intervention|0|||
147277601|NCT02480621|531184937|FG001|Randomization|Surgeon did not give intervention|1|||
147277602|NCT02480621|531184936|FG000|Follow Up|Lost to Follow-up|4|||
147277603|NCT02480621|531184937|FG001|Follow Up|Lost to Follow-up|2|||
147277604|NCT04632940|531184940|FG000|DB Period (52 Weeks)|Participant/Legal Guardian Decision|2|||
147334501|NCT01713946|531390152|FG001|Overall Study|Did not continue in Ext|3|||
147662497|NCT02513550|532587347|FG002|Double Blind Treatment Period|Site terminated by sponsor|3|||
147662498|NCT02513550|532587348|FG003|Double Blind Treatment Period|Site terminated by sponsor|0|||
147662499|NCT02513550|532587349|FG004|Double Blind Treatment Period|Site terminated by sponsor|0|||
147662500|NCT02513550|532587350|FG005|Double Blind Treatment Period|Site terminated by sponsor|0|||
147277605|NCT04632940|531184941|FG001|DB Period (52 Weeks)|Participant/Legal Guardian Decision|0|||
147277606|NCT04632940|531184940|FG000|OLE Period (52 Weeks)|Adverse Event|1|||
147277607|NCT04632940|531184941|FG001|OLE Period (52 Weeks)|Adverse Event|0|||
147277608|NCT04632940|531184940|FG000|OLE Period (52 Weeks)|Lost to Follow-up|0|||
147277609|NCT04632940|531184941|FG001|OLE Period (52 Weeks)|Lost to Follow-up|1|||
147277610|NCT04632940|531184940|FG000|OLE Period (52 Weeks)|Physician Decision|1|||
147277611|NCT04632940|531184941|FG001|OLE Period (52 Weeks)|Physician Decision|0|||
147277612|NCT04632940|531184940|FG000|OLE Period (52 Weeks)|Participant/Legal Guardian Decision|11|||
147277613|NCT04632940|531184941|FG001|OLE Period (52 Weeks)|Participant/Legal Guardian Decision|13|||
147277614|NCT04632940|531184940|FG000|OLE Period (52 Weeks)|Sponsor Decision to Terminate Study|21|||
147277615|NCT04632940|531184941|FG001|OLE Period (52 Weeks)|Sponsor Decision to Terminate Study|19|||
147277616|NCT04632940|531184940|FG000|OLE Period (52 Weeks)|Other than specified|0|||
147277617|NCT04632940|531184941|FG001|OLE Period (52 Weeks)|Other than specified|1|||
147277618|NCT04632940|531184940|FG000|OLE Period (52 Weeks)|Entered into OLE but not treated|0|||
147277619|NCT04632940|531184941|FG001|OLE Period (52 Weeks)|Entered into OLE but not treated|1|||
147277620|NCT00684424|531184942|FG000|Overall Study|Adverse Event|1|||
147277621|NCT00684424|531184942|FG000|Overall Study|Lost to Follow-up|2|||
147277622|NCT00684424|531184942|FG000|Overall Study|Other|2|||
147277623|NCT02520531|531184945|FG000|Overall Study|Revision of study device components|2|||
147277624|NCT02520531|531184946|FG001|Overall Study|Revision of study device components|2|||
147277625|NCT02520531|531184945|FG000|Overall Study|Death|1|||
147277626|NCT02520531|531184946|FG001|Overall Study|Death|2|||
147277627|NCT02520531|531184945|FG000|Overall Study|Lost to Follow-up|1|||
147277628|NCT02520531|531184946|FG001|Overall Study|Lost to Follow-up|1|||
147277629|NCT02520531|531184945|FG000|Overall Study|Meet exclusion criterion|0|||
147277630|NCT02520531|531184946|FG001|Overall Study|Meet exclusion criterion|1|||
147277631|NCT02520531|531184945|FG000|Overall Study|Withdrawal by Subject|1|||
147277632|NCT02520531|531184946|FG001|Overall Study|Withdrawal by Subject|0|||
147277633|NCT02520531|531184945|FG000|Overall Study|Not study device|1|||
147277634|NCT02520531|531184946|FG001|Overall Study|Not study device|0|||
147277635|NCT01723904|531184949|FG000|Overall Study|Noncompliant|3|||
147277636|NCT01723904|531184949|FG000|Overall Study|Adverse Event|5|||
147277637|NCT01723904|531184949|FG000|Overall Study|Unable to follow protocol/ judged by inv|3|||
147277638|NCT00887341|531184960|FG000|Overall Study|Refused treatment|1|||
147277639|NCT00887341|531184961|FG001|Overall Study|Refused treatment|0|||
147277640|NCT00887341|531184960|FG000|Overall Study|Withdrawal by Subject|1|||
147277641|NCT00887341|531184961|FG001|Overall Study|Withdrawal by Subject|1|||
147277642|NCT00887341|531184960|FG000|Overall Study|Adverse Event|0|||
147277643|NCT00887341|531184961|FG001|Overall Study|Adverse Event|1|||
147277644|NCT00887341|531184960|FG000|Overall Study|Lost to Follow-up|0|||
147277645|NCT00887341|531184961|FG001|Overall Study|Lost to Follow-up|1|||
147277646|NCT01591681|531184964|FG000|Overall Study|Didn't meet min hypoglycemia requirement|3|||
147277647|NCT01591681|531184964|FG000|Overall Study|Failed to use system during run-in|1|||
147277648|NCT01649856|531184965|FG000|Overall Study|Withdrawal by Subject|14|||
147277649|NCT01649856|531184966|FG001|Overall Study|Withdrawal by Subject|14|||
147277650|NCT01649856|531184965|FG000|Overall Study|Protocol Violation|4|||
147277651|NCT01649856|531184966|FG001|Overall Study|Protocol Violation|4|||
147277652|NCT01649856|531184965|FG000|Overall Study|Treatment Failure|1|||
147277653|NCT01649856|531184966|FG001|Overall Study|Treatment Failure|1|||
147277654|NCT01649856|531184965|FG000|Overall Study|Death|69|||
147277655|NCT01649856|531184966|FG001|Overall Study|Death|34|||
147277656|NCT01649856|531184965|FG000|Overall Study|Stable or Progressed Disease|5|||
147277657|NCT01649856|531184966|FG001|Overall Study|Stable or Progressed Disease|3|||
147277658|NCT01649856|531184965|FG000|Overall Study|Lost to Follow-up|20|||
147277659|NCT01649856|531184966|FG001|Overall Study|Lost to Follow-up|16|||
147277660|NCT01649856|531184965|FG000|Overall Study|Lack of Compliance|6|||
147277661|NCT01649856|531184966|FG001|Overall Study|Lack of Compliance|1|||
147277662|NCT01649856|531184965|FG000|Overall Study|Other|20|||
147277663|NCT01649856|531184966|FG001|Overall Study|Other|5|||
147277664|NCT02138214|531184967|FG000|Overall Study|Withdrawal by Subject|0|||
147601467|NCT00719849|532358190|FG001|Overall Study|Death|1|||
147601468|NCT02201290|532358192|FG000|Overall Study|Withdrawal by Subject|2|||
147277665|NCT02138214|531184968|FG001|Overall Study|Withdrawal by Subject|1|||
147277666|NCT02138214|531184969|FG002|Overall Study|Withdrawal by Subject|0|||
147277667|NCT02138214|531184967|FG000|Overall Study|Lost to Follow-up|0|||
147277668|NCT02138214|531184968|FG001|Overall Study|Lost to Follow-up|2|||
147277669|NCT02138214|531184969|FG002|Overall Study|Lost to Follow-up|4|||
147277670|NCT02138214|531184967|FG000|Overall Study|Screen Failure|0|||
147601469|NCT02201290|532358192|FG000|Overall Study|Lack of Efficacy|2|||
147601470|NCT02201290|532358192|FG000|Overall Study|Adverse Event|1|||
147601471|NCT03907462|532358193|FG000|Overall Study|Physician Decision|1|||
147601472|NCT03907462|532358194|FG001|Overall Study|Physician Decision|3|||
147277671|NCT02138214|531184968|FG001|Overall Study|Screen Failure|1|||
147277672|NCT02138214|531184969|FG002|Overall Study|Screen Failure|0|||
147277673|NCT00235989|531184975|FG000|Core Treatment Period (CT)|Lost to Follow-up|0|||
147277674|NCT00235989|531184976|FG001|Core Treatment Period (CT)|Lost to Follow-up|0|||
147277675|NCT00235989|531184977|FG002|Core Treatment Period (CT)|Lost to Follow-up|0|||
147277676|NCT00235989|531184978|FG003|Core Treatment Period (CT)|Lost to Follow-up|0|||
147277677|NCT00235989|531184979|FG004|Core Treatment Period (CT)|Lost to Follow-up|0|||
147277678|NCT00235989|531184980|FG005|Core Treatment Period (CT)|Lost to Follow-up|2|||
147277679|NCT00235989|531184975|FG000|Extension Treatment Period (ET)|Adverse Event|3|||
147277680|NCT00235989|531184976|FG001|Extension Treatment Period (ET)|Adverse Event|0|||
147277681|NCT00235989|531184977|FG002|Extension Treatment Period (ET)|Adverse Event|2|||
147277682|NCT00235989|531184978|FG003|Extension Treatment Period (ET)|Adverse Event|0|||
147601473|NCT03907462|532358195|FG002|Overall Study|Physician Decision|1|||
147601474|NCT03907462|532358193|FG000|Overall Study|Withdrawal by Subject|6|||
147277683|NCT00235989|531184979|FG004|Extension Treatment Period (ET)|Adverse Event|0|||
147277684|NCT00235989|531184980|FG005|Extension Treatment Period (ET)|Adverse Event|0|||
147277685|NCT00235989|531184975|FG000|Extension Treatment Period (ET)|Lost to Follow-up|2|||
147277686|NCT00235989|531184976|FG001|Extension Treatment Period (ET)|Lost to Follow-up|0|||
147277687|NCT00235989|531184977|FG002|Extension Treatment Period (ET)|Lost to Follow-up|1|||
147277688|NCT00235989|531184978|FG003|Extension Treatment Period (ET)|Lost to Follow-up|0|||
147277689|NCT00235989|531184979|FG004|Extension Treatment Period (ET)|Lost to Follow-up|0|||
147277690|NCT00235989|531184980|FG005|Extension Treatment Period (ET)|Lost to Follow-up|0|||
147277691|NCT00235989|531184975|FG000|Extension Treatment Period (ET)|Withdrawal by Subject|1|||
147277692|NCT00235989|531184976|FG001|Extension Treatment Period (ET)|Withdrawal by Subject|1|||
147277693|NCT00235989|531184977|FG002|Extension Treatment Period (ET)|Withdrawal by Subject|1|||
147277694|NCT00235989|531184978|FG003|Extension Treatment Period (ET)|Withdrawal by Subject|4|||
147277695|NCT00235989|531184979|FG004|Extension Treatment Period (ET)|Withdrawal by Subject|0|||
147277696|NCT00235989|531184980|FG005|Extension Treatment Period (ET)|Withdrawal by Subject|0|||
147277697|NCT00235989|531184975|FG000|Extension Treatment Period (ET)|´Other´ not further itemized|2|||
147277698|NCT00235989|531184976|FG001|Extension Treatment Period (ET)|´Other´ not further itemized|3|||
147277699|NCT00235989|531184977|FG002|Extension Treatment Period (ET)|´Other´ not further itemized|1|||
147277700|NCT00235989|531184978|FG003|Extension Treatment Period (ET)|´Other´ not further itemized|2|||
147277701|NCT00235989|531184979|FG004|Extension Treatment Period (ET)|´Other´ not further itemized|0|||
147277702|NCT00235989|531184980|FG005|Extension Treatment Period (ET)|´Other´ not further itemized|0|||
147277703|NCT01334866|531184989|FG000|Overall Study|Withdrawal by Subject|10|||
147277704|NCT01334866|531184989|FG000|Overall Study|Lost to Follow-up|3|||
147277705|NCT01334866|531184989|FG000|Overall Study|Physician Decision|3|||
147277706|NCT01334866|531184989|FG000|Overall Study|medically necessary prior to procedure|2|||
147277707|NCT01334866|531184989|FG000|Overall Study|medically necessary post-procedure|1|||
147277708|NCT00958880|531185006|FG000|Overall Study|Lost to Follow-up|2|||
147277709|NCT00958880|531185007|FG001|Overall Study|Lost to Follow-up|2|||
147277710|NCT01971346|531185008|FG000|Overall Study|Protocol Violation|3|||
147277711|NCT01971346|531185008|FG000|Overall Study|Lost to Follow-up|2|||
147277712|NCT01971346|531185008|FG000|Overall Study|Withdrawal by Subject|2|||
147277713|NCT01971346|531185008|FG000|Overall Study|Physician Decision|1|||
147277714|NCT01687166|531185013|FG000|Overall Study|Attempt subject|2|||
147277715|NCT01687166|531185014|FG001|Overall Study|Attempt subject|3|||
147277716|NCT01687166|531185015|FG002|Overall Study|Attempt subject|2|||
147277717|NCT01687166|531185016|FG003|Overall Study|Attempt subject|0|||
147277718|NCT01687166|531185013|FG000|Overall Study|Did not meet eligibility criteria|4|||
147277719|NCT01687166|531185014|FG001|Overall Study|Did not meet eligibility criteria|6|||
147277720|NCT01687166|531185015|FG002|Overall Study|Did not meet eligibility criteria|1|||
147277721|NCT01687166|531185016|FG003|Overall Study|Did not meet eligibility criteria|1|||
147277722|NCT01687166|531185013|FG000|Overall Study|Adverse Event|2|||
147277723|NCT01687166|531185014|FG001|Overall Study|Adverse Event|1|||
147277724|NCT01687166|531185015|FG002|Overall Study|Adverse Event|0|||
147277725|NCT01687166|531185016|FG003|Overall Study|Adverse Event|0|||
147277726|NCT01687166|531185013|FG000|Overall Study|Physician Decision|3|||
147277727|NCT01687166|531185014|FG001|Overall Study|Physician Decision|2|||
147277728|NCT01687166|531185015|FG002|Overall Study|Physician Decision|1|||
147277729|NCT01687166|531185016|FG003|Overall Study|Physician Decision|0|||
147277730|NCT01687166|531185013|FG000|Overall Study|Withdrawal by Subject|11|||
147277731|NCT01687166|531185014|FG001|Overall Study|Withdrawal by Subject|4|||
147277732|NCT01687166|531185015|FG002|Overall Study|Withdrawal by Subject|3|||
147277733|NCT01687166|531185016|FG003|Overall Study|Withdrawal by Subject|0|||
147277734|NCT01687166|531185013|FG000|Overall Study|Lost to Follow-up|2|||
147277735|NCT01687166|531185014|FG001|Overall Study|Lost to Follow-up|5|||
147277736|NCT01687166|531185015|FG002|Overall Study|Lost to Follow-up|1|||
147277737|NCT01687166|531185016|FG003|Overall Study|Lost to Follow-up|0|||
147277738|NCT01687166|531185013|FG000|Overall Study|Equipment/Device Availability|0|||
147277739|NCT01687166|531185014|FG001|Overall Study|Equipment/Device Availability|1|||
147277740|NCT01687166|531185015|FG002|Overall Study|Equipment/Device Availability|0|||
147277741|NCT01687166|531185016|FG003|Overall Study|Equipment/Device Availability|0|||
147277742|NCT01687166|531185013|FG000|Overall Study|Death|1|||
147277743|NCT01687166|531185014|FG001|Overall Study|Death|1|||
147277744|NCT01687166|531185015|FG002|Overall Study|Death|0|||
147277745|NCT01687166|531185016|FG003|Overall Study|Death|0|||
147277746|NCT01687166|531185013|FG000|Overall Study|Protocol Violation|1|||
147277747|NCT01687166|531185014|FG001|Overall Study|Protocol Violation|1|||
147277748|NCT01687166|531185015|FG002|Overall Study|Protocol Violation|1|||
147277749|NCT01687166|531185016|FG003|Overall Study|Protocol Violation|0|||
147277750|NCT01687166|531185013|FG000|Overall Study|Subject moved out of state|0|||
147277751|NCT01687166|531185014|FG001|Overall Study|Subject moved out of state|1|||
147277752|NCT01687166|531185015|FG002|Overall Study|Subject moved out of state|0|||
147277753|NCT01687166|531185016|FG003|Overall Study|Subject moved out of state|0|||
147277754|NCT01687166|531185013|FG000|Overall Study|Patient unable to be compliant|1|||
147277755|NCT01687166|531185014|FG001|Overall Study|Patient unable to be compliant|0|||
147277756|NCT01687166|531185015|FG002|Overall Study|Patient unable to be compliant|0|||
147601475|NCT03907462|532358194|FG001|Overall Study|Withdrawal by Subject|3|||
147601476|NCT03907462|532358195|FG002|Overall Study|Withdrawal by Subject|3|||
147601477|NCT03907462|532358193|FG000|Overall Study|Pregnancy|4|||
147601478|NCT03907462|532358194|FG001|Overall Study|Pregnancy|2|||
147277757|NCT01687166|531185016|FG003|Overall Study|Patient unable to be compliant|0|||
147277758|NCT01687166|531185013|FG000|Overall Study|Physician choice to use different device|1|||
147277759|NCT01687166|531185014|FG001|Overall Study|Physician choice to use different device|2|||
147277760|NCT01687166|531185015|FG002|Overall Study|Physician choice to use different device|4|||
147277761|NCT01687166|531185016|FG003|Overall Study|Physician choice to use different device|0|||
147277762|NCT01687166|531185013|FG000|Overall Study|Insurance|0|||
147277763|NCT01687166|531185014|FG001|Overall Study|Insurance|0|||
147277764|NCT01687166|531185015|FG002|Overall Study|Insurance|1|||
147277765|NCT01687166|531185016|FG003|Overall Study|Insurance|1|||
147277766|NCT02755831|531185017|FG000|Overall Study|Lost to Follow-up|3|||
147277767|NCT02755831|531185018|FG001|Overall Study|Lost to Follow-up|3|||
147277768|NCT02296112|531185019|FG000|Overall Study|Disease progression|7|||
147277769|NCT02296112|531185019|FG000|Overall Study|Toxicity|1|||
147277770|NCT02296112|531185019|FG000|Overall Study|Began an alternate therapy|1|||
147277771|NCT02316717|531185020|FG000|Overall Study|Adverse Event|2|||
147277772|NCT02316717|531185021|FG001|Overall Study|Adverse Event|2|||
147277773|NCT02316717|531185022|FG002|Overall Study|Adverse Event|0|||
147277774|NCT02316717|531185020|FG000|Overall Study|Lost to Follow-up|1|||
147277775|NCT02316717|531185021|FG001|Overall Study|Lost to Follow-up|2|||
147277776|NCT02316717|531185022|FG002|Overall Study|Lost to Follow-up|1|||
147277777|NCT02316717|531185020|FG000|Overall Study|Non compliance|3|||
147277778|NCT02316717|531185021|FG001|Overall Study|Non compliance|1|||
147277779|NCT02316717|531185022|FG002|Overall Study|Non compliance|0|||
147277780|NCT02316717|531185020|FG000|Overall Study|Protocol Violation|2|||
147277781|NCT02316717|531185021|FG001|Overall Study|Protocol Violation|0|||
147277782|NCT02316717|531185022|FG002|Overall Study|Protocol Violation|0|||
147277783|NCT02316717|531185020|FG000|Overall Study|Withdrawal by Subject|2|||
147277784|NCT02316717|531185021|FG001|Overall Study|Withdrawal by Subject|1|||
147277785|NCT02316717|531185022|FG002|Overall Study|Withdrawal by Subject|1|||
147277786|NCT02316717|531185020|FG000|Overall Study|Death|0|||
147277787|NCT02316717|531185021|FG001|Overall Study|Death|0|||
147277788|NCT02316717|531185022|FG002|Overall Study|Death|1|||
147277789|NCT02316717|531185020|FG000|Overall Study|Physician Decision|0|||
147277790|NCT02316717|531185021|FG001|Overall Study|Physician Decision|1|||
147277791|NCT02316717|531185022|FG002|Overall Study|Physician Decision|0|||
147277792|NCT02316717|531185020|FG000|Overall Study|TBC|1|||
147277793|NCT02316717|531185021|FG001|Overall Study|TBC|0|||
147277794|NCT02316717|531185022|FG002|Overall Study|TBC|0|||
147277795|NCT00298831|531185023|FG000|Overall Study|Adverse Event|1|||
147277796|NCT00298831|531185023|FG000|Overall Study|Lost to Follow-up|3|||
147277797|NCT00298831|531185023|FG000|Overall Study|Withdrawal by Subject|1|||
147277798|NCT00298831|531185023|FG000|Overall Study|Participants did not receive treatment|27|||
147277799|NCT01516879|531185024|FG000|Overall Study|Withdrawal by Subject|9|||
147277800|NCT01516879|531185025|FG001|Overall Study|Withdrawal by Subject|11|||
147277801|NCT01516879|531185024|FG000|Overall Study|Death|0|||
147277802|NCT01516879|531185025|FG001|Overall Study|Death|2|||
147277803|NCT01516879|531185024|FG000|Overall Study|Lost to Follow-up|2|||
147277804|NCT01516879|531185025|FG001|Overall Study|Lost to Follow-up|11|||
147277805|NCT01516879|531185024|FG000|Overall Study|Other|5|||
147277806|NCT01516879|531185025|FG001|Overall Study|Other|10|||
147277807|NCT02052466|531185026|FG000|Overall Study|Withdrawal by Subject|1|||
147277808|NCT02052466|531185026|FG000|Overall Study|Acromial fracture|1|||
147277809|NCT01720069|531185027|FG000|Overall Study|Could not use e-diary correctly|0|||
147277810|NCT01720069|531185028|FG001|Overall Study|Could not use e-diary correctly|1|||
147277811|NCT01720069|531185029|FG002|Overall Study|Could not use e-diary correctly|1|||
147277812|NCT01720069|531185027|FG000|Overall Study|Randomised without baseline values|0|||
147277813|NCT01720069|531185028|FG001|Overall Study|Randomised without baseline values|0|||
147277814|NCT01720069|531185029|FG002|Overall Study|Randomised without baseline values|1|||
147277815|NCT01720069|531185027|FG000|Overall Study|Adverse Event|0|||
147277816|NCT01720069|531185028|FG001|Overall Study|Adverse Event|0|||
147277817|NCT01720069|531185029|FG002|Overall Study|Adverse Event|1|||
147277818|NCT01720069|531185027|FG000|Overall Study|Lack of Efficacy|0|||
147277819|NCT01720069|531185028|FG001|Overall Study|Lack of Efficacy|4|||
147277820|NCT01720069|531185029|FG002|Overall Study|Lack of Efficacy|0|||
147277821|NCT01720069|531185027|FG000|Overall Study|Treatment period withdrawal criteria met|4|||
147277822|NCT01720069|531185028|FG001|Overall Study|Treatment period withdrawal criteria met|8|||
147277823|NCT01720069|531185029|FG002|Overall Study|Treatment period withdrawal criteria met|9|||
147277824|NCT01720069|531185027|FG000|Overall Study|Withdrawal by Subject|0|||
147601479|NCT03907462|532358195|FG002|Overall Study|Pregnancy|6|||
147277825|NCT01720069|531185028|FG001|Overall Study|Withdrawal by Subject|2|||
147277826|NCT01720069|531185029|FG002|Overall Study|Withdrawal by Subject|1|||
147277827|NCT01720069|531185027|FG000|Overall Study|OCS bursts occured, discontinued in line|1|||
147277828|NCT01720069|531185028|FG001|Overall Study|OCS bursts occured, discontinued in line|0|||
147277829|NCT01720069|531185029|FG002|Overall Study|OCS bursts occured, discontinued in line|0|||
147277830|NCT01720069|531185027|FG000|Overall Study|Non-compliance on using e-diary|0|||
147277831|NCT01720069|531185028|FG001|Overall Study|Non-compliance on using e-diary|0|||
147277832|NCT01720069|531185029|FG002|Overall Study|Non-compliance on using e-diary|1|||
147277833|NCT01720069|531185027|FG000|Overall Study|Lost to Follow-up|0|||
147277834|NCT01720069|531185028|FG001|Overall Study|Lost to Follow-up|0|||
147277835|NCT01720069|531185029|FG002|Overall Study|Lost to Follow-up|1|||
147277836|NCT00508742|531185030|FG000|Period 1: Infant Series|Adverse Event|5|||
147277837|NCT00508742|531185031|FG001|Period 1: Infant Series|Adverse Event|4|||
147277838|NCT00508742|531185030|FG000|Period 1: Infant Series|Protocol Violation|1|||
147277839|NCT00508742|531185031|FG001|Period 1: Infant Series|Protocol Violation|0|||
147277840|NCT00508742|531185030|FG000|Period 1: Infant Series|Parent/Legal Guardian Request|31|||
147277841|NCT00508742|531185031|FG001|Period 1: Infant Series|Parent/Legal Guardian Request|40|||
147277842|NCT00508742|531185030|FG000|Period 1: Infant Series|Physician Decision|1|||
147277843|NCT00508742|531185031|FG001|Period 1: Infant Series|Physician Decision|0|||
147277844|NCT00508742|531185030|FG000|Period 1: Infant Series|Other|4|||
147277845|NCT00508742|531185031|FG001|Period 1: Infant Series|Other|1|||
147277846|NCT00508742|531185030|FG000|Period 2: After Infant Series|Adverse Event|2|||
147277847|NCT00508742|531185031|FG001|Period 2: After Infant Series|Adverse Event|6|||
147277848|NCT00508742|531185030|FG000|Period 2: After Infant Series|Lost to Follow-up|1|||
147277849|NCT00508742|531185031|FG001|Period 2: After Infant Series|Lost to Follow-up|1|||
147277850|NCT00508742|531185030|FG000|Period 2: After Infant Series|Protocol Violation|1|||
147277851|NCT00508742|531185031|FG001|Period 2: After Infant Series|Protocol Violation|0|||
147277852|NCT00508742|531185030|FG000|Period 2: After Infant Series|Parent/Legal Guardian Request|0|||
147277853|NCT00508742|531185031|FG001|Period 2: After Infant Series|Parent/Legal Guardian Request|3|||
147277854|NCT00508742|531185030|FG000|Period 2: After Infant Series|Failed to Return|1|||
147277855|NCT00508742|531185031|FG001|Period 2: After Infant Series|Failed to Return|0|||
147277856|NCT00508742|531185030|FG000|Period 2: After Infant Series|Other|2|||
147277857|NCT00508742|531185031|FG001|Period 2: After Infant Series|Other|1|||
147277858|NCT00508742|531185030|FG000|Period 3: Toddler Dose|Adverse Event|1|||
147277859|NCT00508742|531185031|FG001|Period 3: Toddler Dose|Adverse Event|0|||
147277860|NCT00508742|531185030|FG000|Period 3: Toddler Dose|Lost to Follow-up|2|||
147277861|NCT00508742|531185031|FG001|Period 3: Toddler Dose|Lost to Follow-up|3|||
147277862|NCT00508742|531185030|FG000|Period 3: Toddler Dose|Parent/Legal Guardian Request|17|||
147277863|NCT00508742|531185031|FG001|Period 3: Toddler Dose|Parent/Legal Guardian Request|8|||
147277864|NCT00508742|531185030|FG000|Period 3: Toddler Dose|Other|5|||
147277865|NCT00508742|531185031|FG001|Period 3: Toddler Dose|Other|4|||
147277866|NCT04568122|531185032|FG000|Overall Study|Lost to Follow-up|48|||
147277867|NCT04568122|531185033|FG001|Overall Study|Lost to Follow-up|44|||
147277868|NCT04568122|531185034|FG002|Overall Study|Lost to Follow-up|4|||
147277869|NCT04568122|531185035|FG003|Overall Study|Lost to Follow-up|0|||
147277870|NCT04568122|531185036|FG004|Overall Study|Lost to Follow-up|0|||
147277871|NCT02460224|531185045|FG000|Overall Study|Adverse Event|0|||
147277872|NCT02460224|531185046|FG001|Overall Study|Adverse Event|0|||
147277873|NCT02460224|531185047|FG002|Overall Study|Adverse Event|0|||
147277874|NCT02460224|531185048|FG003|Overall Study|Adverse Event|0|||
147277875|NCT02460224|531185049|FG004|Overall Study|Adverse Event|0|||
147277876|NCT02460224|531185050|FG005|Overall Study|Adverse Event|0|||
147277877|NCT02460224|531185051|FG006|Overall Study|Adverse Event|1|||
147277878|NCT02460224|531185052|FG007|Overall Study|Adverse Event|0|||
147277879|NCT02460224|531185053|FG008|Overall Study|Adverse Event|0|||
147277880|NCT02460224|531185054|FG009|Overall Study|Adverse Event|0|||
147277881|NCT02460224|531185055|FG010|Overall Study|Adverse Event|0|||
147277882|NCT02460224|531185056|FG011|Overall Study|Adverse Event|0|||
147277883|NCT02460224|531185057|FG012|Overall Study|Adverse Event|1|||
147277884|NCT02460224|531185058|FG013|Overall Study|Adverse Event|0|||
147277885|NCT02460224|531185059|FG014|Overall Study|Adverse Event|0|||
147277886|NCT02460224|531185060|FG015|Overall Study|Adverse Event|0|||
147277887|NCT02460224|531185061|FG016|Overall Study|Adverse Event|1|||
147277888|NCT02460224|531185062|FG017|Overall Study|Adverse Event|0|||
147277889|NCT02460224|531185063|FG018|Overall Study|Adverse Event|1|||
147277890|NCT02460224|531185064|FG019|Overall Study|Adverse Event|0|||
147277891|NCT02460224|531185065|FG020|Overall Study|Adverse Event|1|||
147277892|NCT02460224|531185066|FG021|Overall Study|Adverse Event|1|||
147277893|NCT02460224|531185067|FG022|Overall Study|Adverse Event|1|||
147277894|NCT02460224|531185068|FG023|Overall Study|Adverse Event|0|||
147277895|NCT02460224|531185069|FG024|Overall Study|Adverse Event|0|||
147277896|NCT02460224|531185070|FG025|Overall Study|Adverse Event|0|||
147277897|NCT02460224|531185071|FG026|Overall Study|Adverse Event|11|||
147277898|NCT02460224|531185072|FG027|Overall Study|Adverse Event|1|||
147277899|NCT02460224|531185073|FG028|Overall Study|Adverse Event|6|||
147277900|NCT02460224|531185045|FG000|Overall Study|Death|0|||
147277901|NCT02460224|531185046|FG001|Overall Study|Death|0|||
147277902|NCT02460224|531185047|FG002|Overall Study|Death|0|||
147277903|NCT02460224|531185048|FG003|Overall Study|Death|0|||
147277904|NCT02460224|531185049|FG004|Overall Study|Death|0|||
147277905|NCT02460224|531185050|FG005|Overall Study|Death|2|||
147277906|NCT02460224|531185051|FG006|Overall Study|Death|1|||
147277907|NCT02460224|531185052|FG007|Overall Study|Death|0|||
147277908|NCT02460224|531185053|FG008|Overall Study|Death|0|||
147277909|NCT02460224|531185054|FG009|Overall Study|Death|1|||
147277910|NCT02460224|531185055|FG010|Overall Study|Death|0|||
147277911|NCT02460224|531185056|FG011|Overall Study|Death|0|||
147277912|NCT02460224|531185057|FG012|Overall Study|Death|0|||
147277913|NCT02460224|531185058|FG013|Overall Study|Death|1|||
147277914|NCT02460224|531185059|FG014|Overall Study|Death|0|||
147277915|NCT02460224|531185060|FG015|Overall Study|Death|0|||
147277916|NCT02460224|531185061|FG016|Overall Study|Death|2|||
147277917|NCT02460224|531185062|FG017|Overall Study|Death|1|||
147277918|NCT02460224|531185063|FG018|Overall Study|Death|0|||
147277919|NCT02460224|531185064|FG019|Overall Study|Death|2|||
147277920|NCT02460224|531185065|FG020|Overall Study|Death|0|||
147277921|NCT02460224|531185066|FG021|Overall Study|Death|0|||
147277922|NCT02460224|531185067|FG022|Overall Study|Death|0|||
147277923|NCT02460224|531185068|FG023|Overall Study|Death|0|||
147277924|NCT02460224|531185069|FG024|Overall Study|Death|1|||
147277925|NCT02460224|531185070|FG025|Overall Study|Death|1|||
147277926|NCT02460224|531185071|FG026|Overall Study|Death|5|||
147601480|NCT03907462|532358193|FG000|Overall Study|Lost to Follow-up|16|||
147601481|NCT03907462|532358194|FG001|Overall Study|Lost to Follow-up|18|||
147277927|NCT02460224|531185072|FG027|Overall Study|Death|0|||
147277928|NCT02460224|531185073|FG028|Overall Study|Death|1|||
147277929|NCT02460224|531185045|FG000|Overall Study|Lost to Follow-up|0|||
147277930|NCT02460224|531185046|FG001|Overall Study|Lost to Follow-up|0|||
147277931|NCT02460224|531185047|FG002|Overall Study|Lost to Follow-up|0|||
147277932|NCT02460224|531185048|FG003|Overall Study|Lost to Follow-up|0|||
147277933|NCT02460224|531185049|FG004|Overall Study|Lost to Follow-up|0|||
147277934|NCT02460224|531185050|FG005|Overall Study|Lost to Follow-up|0|||
147277935|NCT02460224|531185051|FG006|Overall Study|Lost to Follow-up|0|||
147277936|NCT02460224|531185052|FG007|Overall Study|Lost to Follow-up|0|||
147277937|NCT02460224|531185053|FG008|Overall Study|Lost to Follow-up|0|||
147277938|NCT02460224|531185054|FG009|Overall Study|Lost to Follow-up|0|||
147277939|NCT02460224|531185055|FG010|Overall Study|Lost to Follow-up|0|||
147277940|NCT02460224|531185056|FG011|Overall Study|Lost to Follow-up|0|||
147334502|NCT01713946|531390153|FG002|Overall Study|Did not continue in Ext|0|||
147334503|NCT01713946|531390151|FG000|Overall Study|Did not continue in Post-Ext. Phase|1|||
147334504|NCT01713946|531390152|FG001|Overall Study|Did not continue in Post-Ext. Phase|2|||
147334505|NCT01713946|531390153|FG002|Overall Study|Did not continue in Post-Ext. Phase|0|||
147334506|NCT01713946|531390151|FG000|Overall Study|Patients never switched to everolimus|0|||
147334507|NCT01713946|531390152|FG001|Overall Study|Patients never switched to everolimus|0|||
147334508|NCT01713946|531390153|FG002|Overall Study|Patients never switched to everolimus|5|||
147334509|NCT03284957|531392011|FG000|Overall Study|Adverse Event|0|||
147334510|NCT03284957|531392012|FG001|Overall Study|Adverse Event|0|||
147334511|NCT03284957|531392013|FG002|Overall Study|Adverse Event|0|||
147334512|NCT03284957|531392014|FG003|Overall Study|Adverse Event|0|||
147334513|NCT03284957|531392015|FG004|Overall Study|Adverse Event|0|||
147334514|NCT03284957|531392016|FG005|Overall Study|Adverse Event|1|||
147334515|NCT03284957|531392017|FG006|Overall Study|Adverse Event|1|||
147334516|NCT03284957|531392018|FG007|Overall Study|Adverse Event|1|||
147334517|NCT03284957|531392019|FG008|Overall Study|Adverse Event|0|||
147334518|NCT03284957|531392020|FG009|Overall Study|Adverse Event|4|||
147334519|NCT03284957|531392021|FG010|Overall Study|Adverse Event|1|||
147334520|NCT03284957|531392022|FG011|Overall Study|Adverse Event|1|||
147334521|NCT03284957|531392023|FG012|Overall Study|Adverse Event|0|||
147334522|NCT03284957|531392024|FG013|Overall Study|Adverse Event|0|||
147334523|NCT03284957|531392025|FG014|Overall Study|Adverse Event|0|||
147334524|NCT03284957|531392026|FG015|Overall Study|Adverse Event|0|||
147334525|NCT03284957|531392011|FG000|Overall Study|Progressive Disease|3|||
147334526|NCT03284957|531392012|FG001|Overall Study|Progressive Disease|3|||
147334527|NCT03284957|531392013|FG002|Overall Study|Progressive Disease|4|||
147334528|NCT03284957|531392014|FG003|Overall Study|Progressive Disease|3|||
147334529|NCT03284957|531392015|FG004|Overall Study|Progressive Disease|3|||
147277941|NCT02460224|531185057|FG012|Overall Study|Lost to Follow-up|0|||
147277942|NCT02460224|531185058|FG013|Overall Study|Lost to Follow-up|0|||
147277943|NCT02460224|531185059|FG014|Overall Study|Lost to Follow-up|0|||
147277944|NCT02460224|531185060|FG015|Overall Study|Lost to Follow-up|0|||
147277945|NCT02460224|531185061|FG016|Overall Study|Lost to Follow-up|0|||
147334530|NCT03284957|531392016|FG005|Overall Study|Progressive Disease|5|||
147334531|NCT03284957|531392017|FG006|Overall Study|Progressive Disease|45|||
147334532|NCT03284957|531392018|FG007|Overall Study|Progressive Disease|8|||
147334533|NCT03284957|531392019|FG008|Overall Study|Progressive Disease|5|||
147277946|NCT02460224|531185062|FG017|Overall Study|Lost to Follow-up|0|||
147277947|NCT02460224|531185063|FG018|Overall Study|Lost to Follow-up|0|||
147277948|NCT02460224|531185064|FG019|Overall Study|Lost to Follow-up|0|||
147334534|NCT03284957|531392020|FG009|Overall Study|Progressive Disease|18|||
147334535|NCT03284957|531392021|FG010|Overall Study|Progressive Disease|7|||
147334536|NCT03284957|531392022|FG011|Overall Study|Progressive Disease|2|||
147334537|NCT03284957|531392023|FG012|Overall Study|Progressive Disease|3|||
147334538|NCT03284957|531392024|FG013|Overall Study|Progressive Disease|1|||
147601482|NCT03907462|532358195|FG002|Overall Study|Lost to Follow-up|22|||
147277949|NCT02460224|531185065|FG020|Overall Study|Lost to Follow-up|0|||
147277950|NCT02460224|531185066|FG021|Overall Study|Lost to Follow-up|0|||
147277951|NCT02460224|531185067|FG022|Overall Study|Lost to Follow-up|1|||
147277952|NCT02460224|531185068|FG023|Overall Study|Lost to Follow-up|0|||
147277953|NCT02460224|531185069|FG024|Overall Study|Lost to Follow-up|0|||
147277954|NCT02460224|531185070|FG025|Overall Study|Lost to Follow-up|0|||
147277955|NCT02460224|531185071|FG026|Overall Study|Lost to Follow-up|0|||
147277956|NCT02460224|531185072|FG027|Overall Study|Lost to Follow-up|0|||
147277957|NCT02460224|531185073|FG028|Overall Study|Lost to Follow-up|0|||
147277958|NCT02460224|531185045|FG000|Overall Study|Physician Decision|0|||
147277959|NCT02460224|531185046|FG001|Overall Study|Physician Decision|1|||
147277960|NCT02460224|531185047|FG002|Overall Study|Physician Decision|0|||
147277961|NCT02460224|531185048|FG003|Overall Study|Physician Decision|0|||
147277962|NCT02460224|531185049|FG004|Overall Study|Physician Decision|1|||
147277963|NCT02460224|531185050|FG005|Overall Study|Physician Decision|0|||
147277964|NCT02460224|531185051|FG006|Overall Study|Physician Decision|0|||
147277965|NCT02460224|531185052|FG007|Overall Study|Physician Decision|1|||
147277966|NCT02460224|531185053|FG008|Overall Study|Physician Decision|0|||
147450954|NCT00706134|531813188|FG000|Overall Study|Did not meet study criteria|2|||
147450955|NCT00706134|531813189|FG001|Overall Study|Did not meet study criteria|0|||
147277967|NCT02460224|531185054|FG009|Overall Study|Physician Decision|0|||
147277968|NCT02460224|531185055|FG010|Overall Study|Physician Decision|0|||
147277969|NCT02460224|531185056|FG011|Overall Study|Physician Decision|1|||
147277970|NCT02460224|531185057|FG012|Overall Study|Physician Decision|0|||
147277971|NCT02460224|531185058|FG013|Overall Study|Physician Decision|1|||
147277972|NCT02460224|531185059|FG014|Overall Study|Physician Decision|0|||
147277973|NCT02460224|531185060|FG015|Overall Study|Physician Decision|0|||
147277974|NCT02460224|531185061|FG016|Overall Study|Physician Decision|2|||
147277975|NCT02460224|531185062|FG017|Overall Study|Physician Decision|1|||
147277976|NCT02460224|531185063|FG018|Overall Study|Physician Decision|1|||
147277977|NCT02460224|531185064|FG019|Overall Study|Physician Decision|2|||
147277978|NCT02460224|531185065|FG020|Overall Study|Physician Decision|1|||
147277979|NCT02460224|531185066|FG021|Overall Study|Physician Decision|1|||
147277980|NCT02460224|531185067|FG022|Overall Study|Physician Decision|0|||
147277981|NCT02460224|531185068|FG023|Overall Study|Physician Decision|0|||
147277982|NCT02460224|531185069|FG024|Overall Study|Physician Decision|1|||
147277983|NCT02460224|531185070|FG025|Overall Study|Physician Decision|0|||
147277984|NCT02460224|531185071|FG026|Overall Study|Physician Decision|14|||
147277985|NCT02460224|531185072|FG027|Overall Study|Physician Decision|1|||
147277986|NCT02460224|531185073|FG028|Overall Study|Physician Decision|6|||
147277987|NCT02460224|531185045|FG000|Overall Study|Progressive disease|15|||
147277988|NCT02460224|531185046|FG001|Overall Study|Progressive disease|11|||
147277989|NCT02460224|531185047|FG002|Overall Study|Progressive disease|5|||
147277990|NCT02460224|531185048|FG003|Overall Study|Progressive disease|6|||
147277991|NCT02460224|531185049|FG004|Overall Study|Progressive disease|3|||
147277992|NCT02460224|531185050|FG005|Overall Study|Progressive disease|26|||
147277993|NCT02460224|531185051|FG006|Overall Study|Progressive disease|28|||
147277994|NCT02460224|531185052|FG007|Overall Study|Progressive disease|4|||
147277995|NCT02460224|531185053|FG008|Overall Study|Progressive disease|5|||
147277996|NCT02460224|531185054|FG009|Overall Study|Progressive disease|9|||
147277997|NCT02460224|531185055|FG010|Overall Study|Progressive disease|5|||
147277998|NCT02460224|531185056|FG011|Overall Study|Progressive disease|4|||
147277999|NCT02460224|531185057|FG012|Overall Study|Progressive disease|5|||
147278000|NCT02460224|531185058|FG013|Overall Study|Progressive disease|4|||
147278001|NCT02460224|531185059|FG014|Overall Study|Progressive disease|5|||
147278002|NCT02460224|531185060|FG015|Overall Study|Progressive disease|5|||
147278003|NCT02460224|531185061|FG016|Overall Study|Progressive disease|15|||
147278004|NCT02460224|531185062|FG017|Overall Study|Progressive disease|3|||
147278005|NCT02460224|531185063|FG018|Overall Study|Progressive disease|8|||
147278006|NCT02460224|531185064|FG019|Overall Study|Progressive disease|3|||
147278007|NCT02460224|531185065|FG020|Overall Study|Progressive disease|4|||
147278008|NCT02460224|531185066|FG021|Overall Study|Progressive disease|9|||
147278009|NCT02460224|531185067|FG022|Overall Study|Progressive disease|4|||
147278010|NCT02460224|531185068|FG023|Overall Study|Progressive disease|11|||
147278011|NCT02460224|531185069|FG024|Overall Study|Progressive disease|4|||
147278012|NCT02460224|531185070|FG025|Overall Study|Progressive disease|5|||
147278013|NCT02460224|531185071|FG026|Overall Study|Progressive disease|85|||
147450956|NCT00706134|531813190|FG002|Overall Study|Did not meet study criteria|0|||
147278014|NCT02460224|531185072|FG027|Overall Study|Progressive disease|17|||
147450957|NCT00706134|531813191|FG003|Overall Study|Did not meet study criteria|0|||
147278015|NCT02460224|531185073|FG028|Overall Study|Progressive disease|77|||
147278016|NCT02460224|531185045|FG000|Overall Study|Subject/guardian decision|2|||
147278017|NCT02460224|531185046|FG001|Overall Study|Subject/guardian decision|0|||
147278018|NCT02460224|531185047|FG002|Overall Study|Subject/guardian decision|1|||
147278019|NCT02460224|531185048|FG003|Overall Study|Subject/guardian decision|0|||
147278020|NCT02460224|531185049|FG004|Overall Study|Subject/guardian decision|2|||
147278021|NCT02460224|531185050|FG005|Overall Study|Subject/guardian decision|2|||
147278022|NCT02460224|531185051|FG006|Overall Study|Subject/guardian decision|0|||
147278023|NCT02460224|531185052|FG007|Overall Study|Subject/guardian decision|0|||
147278024|NCT02460224|531185053|FG008|Overall Study|Subject/guardian decision|1|||
147278025|NCT02460224|531185054|FG009|Overall Study|Subject/guardian decision|1|||
147278026|NCT02460224|531185055|FG010|Overall Study|Subject/guardian decision|0|||
147278027|NCT02460224|531185056|FG011|Overall Study|Subject/guardian decision|1|||
147278028|NCT02460224|531185057|FG012|Overall Study|Subject/guardian decision|0|||
147278029|NCT02460224|531185058|FG013|Overall Study|Subject/guardian decision|0|||
147278030|NCT02460224|531185059|FG014|Overall Study|Subject/guardian decision|0|||
147278031|NCT02460224|531185060|FG015|Overall Study|Subject/guardian decision|1|||
147278032|NCT02460224|531185061|FG016|Overall Study|Subject/guardian decision|0|||
147278033|NCT02460224|531185062|FG017|Overall Study|Subject/guardian decision|1|||
147278034|NCT02460224|531185063|FG018|Overall Study|Subject/guardian decision|2|||
147278035|NCT02460224|531185064|FG019|Overall Study|Subject/guardian decision|0|||
147278036|NCT02460224|531185065|FG020|Overall Study|Subject/guardian decision|0|||
147278037|NCT02460224|531185066|FG021|Overall Study|Subject/guardian decision|1|||
147278038|NCT02460224|531185067|FG022|Overall Study|Subject/guardian decision|0|||
147278039|NCT02460224|531185068|FG023|Overall Study|Subject/guardian decision|0|||
147278040|NCT02460224|531185069|FG024|Overall Study|Subject/guardian decision|0|||
147278041|NCT02460224|531185070|FG025|Overall Study|Subject/guardian decision|0|||
147278042|NCT02460224|531185071|FG026|Overall Study|Subject/guardian decision|6|||
147278043|NCT02460224|531185072|FG027|Overall Study|Subject/guardian decision|2|||
147278044|NCT02460224|531185073|FG028|Overall Study|Subject/guardian decision|3|||
147278045|NCT00965848|531185080|FG000|Overall Study|Protocol Violation|3|||
147278046|NCT00965848|531185081|FG001|Overall Study|Protocol Violation|0|||
147278047|NCT00965848|531185082|FG002|Overall Study|Protocol Violation|1|||
147278048|NCT00965848|531185080|FG000|Overall Study|Death|11|||
147278049|NCT00965848|531185081|FG001|Overall Study|Death|1|||
147278050|NCT00965848|531185082|FG002|Overall Study|Death|5|||
147278051|NCT00965848|531185080|FG000|Overall Study|Lost to Follow-up|0|||
147278052|NCT00965848|531185081|FG001|Overall Study|Lost to Follow-up|0|||
147278053|NCT00965848|531185082|FG002|Overall Study|Lost to Follow-up|1|||
147278054|NCT00965848|531185080|FG000|Overall Study|Withdrawal by Subject|1|||
147278055|NCT00965848|531185081|FG001|Overall Study|Withdrawal by Subject|0|||
147278056|NCT00965848|531185082|FG002|Overall Study|Withdrawal by Subject|0|||
147278057|NCT00965848|531185080|FG000|Overall Study|Indeterminate Clinical Outcome|2|||
147278058|NCT00965848|531185081|FG001|Overall Study|Indeterminate Clinical Outcome|0|||
147278059|NCT00965848|531185082|FG002|Overall Study|Indeterminate Clinical Outcome|1|||
147278060|NCT00965848|531185080|FG000|Overall Study|Not Clinically Evaluable|7|||
147278061|NCT00965848|531185081|FG001|Overall Study|Not Clinically Evaluable|1|||
147278062|NCT00965848|531185082|FG002|Overall Study|Not Clinically Evaluable|1|||
147278063|NCT00965848|531185080|FG000|Overall Study|Other|5|||
147278064|NCT00965848|531185081|FG001|Overall Study|Other|0|||
147278065|NCT00965848|531185082|FG002|Overall Study|Other|1|||
147278066|NCT00813761|531185083|FG000|Phase 1 (Baseline to 4 Weeks)|Pregnancy|2|||
147278067|NCT00813761|531185084|FG001|Phase 1 (Baseline to 4 Weeks)|Pregnancy|0|||
147278068|NCT00813761|531185085|FG002|Phase 1 (Baseline to 4 Weeks)|Pregnancy|0|||
147278069|NCT00813761|531185086|FG003|Phase 1 (Baseline to 4 Weeks)|Pregnancy|0|||
147278070|NCT00813761|531185083|FG000|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|0|||
147334539|NCT03284957|531392025|FG014|Overall Study|Progressive Disease|1|||
147334540|NCT03284957|531392026|FG015|Overall Study|Progressive Disease|2|||
147334541|NCT03284957|531392011|FG000|Overall Study|Withdrawal by Subject|0|||
147334542|NCT03284957|531392012|FG001|Overall Study|Withdrawal by Subject|0|||
147334543|NCT03284957|531392013|FG002|Overall Study|Withdrawal by Subject|0|||
147334544|NCT03284957|531392014|FG003|Overall Study|Withdrawal by Subject|0|||
147334545|NCT03284957|531392015|FG004|Overall Study|Withdrawal by Subject|0|||
147334546|NCT03284957|531392016|FG005|Overall Study|Withdrawal by Subject|0|||
147334547|NCT03284957|531392017|FG006|Overall Study|Withdrawal by Subject|0|||
147334548|NCT03284957|531392018|FG007|Overall Study|Withdrawal by Subject|0|||
147334549|NCT03284957|531392019|FG008|Overall Study|Withdrawal by Subject|0|||
147334550|NCT03284957|531392020|FG009|Overall Study|Withdrawal by Subject|2|||
147334551|NCT03284957|531392021|FG010|Overall Study|Withdrawal by Subject|0|||
147334552|NCT03284957|531392022|FG011|Overall Study|Withdrawal by Subject|0|||
147334553|NCT03284957|531392023|FG012|Overall Study|Withdrawal by Subject|0|||
147334554|NCT03284957|531392024|FG013|Overall Study|Withdrawal by Subject|0|||
147334555|NCT03284957|531392025|FG014|Overall Study|Withdrawal by Subject|0|||
147334556|NCT03284957|531392026|FG015|Overall Study|Withdrawal by Subject|0|||
147334557|NCT03284957|531392011|FG000|Overall Study|Other|0|||
147334558|NCT03284957|531392012|FG001|Overall Study|Other|0|||
147278071|NCT00813761|531185084|FG001|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|0|||
147278072|NCT00813761|531185085|FG002|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|3|||
147278073|NCT00813761|531185086|FG003|Phase 1 (Baseline to 4 Weeks)|Lost to Follow-up|1|||
147334559|NCT03284957|531392013|FG002|Overall Study|Other|0|||
147334560|NCT03284957|531392014|FG003|Overall Study|Other|0|||
147278074|NCT00813761|531185083|FG000|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|1|||
147278075|NCT00813761|531185084|FG001|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|1|||
147278076|NCT00813761|531185085|FG002|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|1|||
147334561|NCT03284957|531392015|FG004|Overall Study|Other|0|||
147334562|NCT03284957|531392016|FG005|Overall Study|Other|0|||
147334563|NCT03284957|531392017|FG006|Overall Study|Other|3|||
147278077|NCT00813761|531185086|FG003|Phase 1 (Baseline to 4 Weeks)|Protocol Violation|0|||
147278078|NCT00813761|531185083|FG000|Phase 1 (Baseline to 4 Weeks)|poor vision|0|||
147278079|NCT00813761|531185084|FG001|Phase 1 (Baseline to 4 Weeks)|poor vision|0|||
147278080|NCT00813761|531185085|FG002|Phase 1 (Baseline to 4 Weeks)|poor vision|3|||
147278081|NCT00813761|531185086|FG003|Phase 1 (Baseline to 4 Weeks)|poor vision|0|||
147278082|NCT00813761|531185083|FG000|Phase 1 (Baseline to 4 Weeks)|poor comfort|1|||
147278083|NCT00813761|531185084|FG001|Phase 1 (Baseline to 4 Weeks)|poor comfort|1|||
147278084|NCT00813761|531185085|FG002|Phase 1 (Baseline to 4 Weeks)|poor comfort|5|||
147278085|NCT00813761|531185086|FG003|Phase 1 (Baseline to 4 Weeks)|poor comfort|1|||
147278086|NCT00813761|531185083|FG000|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|0|||
147278087|NCT00813761|531185084|FG001|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|1|||
147278088|NCT00813761|531185085|FG002|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|0|||
147278089|NCT00813761|531185086|FG003|Phase 1 (Baseline to 4 Weeks)|Withdrawal by Subject|0|||
147278090|NCT00813761|531185083|FG000|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|2|||
147278091|NCT00813761|531185084|FG001|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|3|||
147278092|NCT00813761|531185085|FG002|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|0|||
147278093|NCT00813761|531185086|FG003|Phase 2 (4 Weeks to 24 Weeks)|Adverse Event|0|||
147278094|NCT00813761|531185083|FG000|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|3|||
147278095|NCT00813761|531185084|FG001|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|0|||
147278096|NCT00813761|531185085|FG002|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|2|||
147278097|NCT00813761|531185086|FG003|Phase 2 (4 Weeks to 24 Weeks)|Lost to Follow-up|1|||
147278098|NCT00813761|531185083|FG000|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|0|||
147278099|NCT00813761|531185084|FG001|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|1|||
147278100|NCT00813761|531185085|FG002|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|0|||
147278101|NCT00813761|531185086|FG003|Phase 2 (4 Weeks to 24 Weeks)|Protocol Violation|1|||
147278102|NCT00813761|531185083|FG000|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|1|||
147278103|NCT00813761|531185084|FG001|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|1|||
147278104|NCT00813761|531185085|FG002|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|1|||
147278105|NCT00813761|531185086|FG003|Phase 2 (4 Weeks to 24 Weeks)|Poor vision|0|||
147278106|NCT00813761|531185083|FG000|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|1|||
147278107|NCT00813761|531185084|FG001|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|4|||
147278108|NCT00813761|531185085|FG002|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|0|||
147278109|NCT00813761|531185086|FG003|Phase 2 (4 Weeks to 24 Weeks)|Poor comfort|3|||
147278110|NCT00813761|531185083|FG000|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|9|||
147278111|NCT00813761|531185084|FG001|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|0|||
147278112|NCT00813761|531185085|FG002|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|6|||
147278113|NCT00813761|531185086|FG003|Phase 2 (4 Weeks to 24 Weeks)|Randomization strata filled|0|||
147278114|NCT03042312|531186475|FG000|Overall Study|Administrative Reason|1|||
147278115|NCT03042312|531186476|FG001|Overall Study|Administrative Reason|1|||
147278116|NCT03042312|531186475|FG000|Overall Study|Adverse Event|0|||
147278117|NCT03042312|531186476|FG001|Overall Study|Adverse Event|1|||
147278118|NCT03042312|531186475|FG000|Overall Study|Lost to Follow-up|1|||
147278119|NCT03042312|531186476|FG001|Overall Study|Lost to Follow-up|3|||
147278120|NCT03042312|531186475|FG000|Overall Study|Any occurrence of conditions which prevented the patient's participation in the study.|4|||
147278121|NCT03042312|531186476|FG001|Overall Study|Any occurrence of conditions which prevented the patient's participation in the study.|2|||
147278122|NCT03042312|531186475|FG000|Overall Study|Withdrawal by Subject|4|||
147278123|NCT03042312|531186476|FG001|Overall Study|Withdrawal by Subject|5|||
147278124|NCT02805257|531186479|FG000|Overall Study|Lost to Follow-up|7|||
147278125|NCT02805257|531186480|FG001|Overall Study|Lost to Follow-up|6|||
147278126|NCT02805257|531186479|FG000|Overall Study|Death|0|||
147278127|NCT02805257|531186480|FG001|Overall Study|Death|1|||
147278128|NCT01043874|531186482|FG000|Overall Study|Adverse Event|3|||
147278129|NCT01043874|531186482|FG000|Overall Study|Withdrawal by Subject|1|||
147278130|NCT01043874|531186482|FG000|Overall Study|Lack of Efficacy|1|||
147278131|NCT01043874|531186482|FG000|Overall Study|Administrative Problems|1|||
147278132|NCT00672477|531186485|FG000|Overall Study|Adverse Event|10|||
147278133|NCT00672477|531186486|FG001|Overall Study|Adverse Event|7|||
147278134|NCT00672477|531186485|FG000|Overall Study|Death|7|||
147278135|NCT00672477|531186486|FG001|Overall Study|Death|11|||
147278136|NCT00672477|531186485|FG000|Overall Study|Physician Decision|2|||
147278137|NCT00672477|531186486|FG001|Overall Study|Physician Decision|0|||
147278138|NCT00672477|531186485|FG000|Overall Study|Protocol Violation|1|||
147278139|NCT00672477|531186486|FG001|Overall Study|Protocol Violation|1|||
147278140|NCT00672477|531186485|FG000|Overall Study|Withdrawal by Subject|5|||
147278141|NCT00672477|531186486|FG001|Overall Study|Withdrawal by Subject|3|||
147278142|NCT00672477|531186485|FG000|Overall Study|Lack of Efficacy|1|||
147278143|NCT00672477|531186486|FG001|Overall Study|Lack of Efficacy|1|||
147278144|NCT00672477|531186485|FG000|Overall Study|no study drug for low GFR, health cond.|1|||
147278145|NCT00672477|531186486|FG001|Overall Study|no study drug for low GFR, health cond.|3|||
147278146|NCT02886572|531186487|FG000|Overall Study|Death|8|||
147278147|NCT03087591|531186490|FG000|Overall Study|Disease progression before starting treatment, removed from study|1|||
147278148|NCT03087591|531186490|FG000|Overall Study|Withdrawal by Subject|1|||
147278149|NCT01933334|531186497|FG000|Overall Study|Adverse Event|5|||
147278150|NCT01933334|531186498|FG001|Overall Study|Adverse Event|1|||
147278151|NCT01933334|531186497|FG000|Overall Study|Withdrawal by Subject|0|||
147278152|NCT01933334|531186498|FG001|Overall Study|Withdrawal by Subject|1|||
147278153|NCT02082522|531186501|FG000|Overall Study|Sponsor termination|5|||
147278154|NCT02082522|531186502|FG001|Overall Study|Sponsor termination|3|||
147278155|NCT02082522|531186501|FG000|Overall Study|Withdrawal by Subject|2|||
147278156|NCT02082522|531186502|FG001|Overall Study|Withdrawal by Subject|4|||
147278157|NCT02082522|531186501|FG000|Overall Study|Death|1|||
147278158|NCT02082522|531186502|FG001|Overall Study|Death|0|||
147278159|NCT02082522|531186501|FG000|Overall Study|Lost to Follow-up|1|||
147278160|NCT02082522|531186502|FG001|Overall Study|Lost to Follow-up|0|||
147278161|NCT02082522|531186501|FG000|Overall Study|Physician Decision|3|||
147278162|NCT02082522|531186502|FG001|Overall Study|Physician Decision|1|||
147278163|NCT02082522|531186501|FG000|Overall Study|Disease progression|2|||
147278164|NCT02082522|531186502|FG001|Overall Study|Disease progression|2|||
147278165|NCT02082522|531186501|FG000|Overall Study|Chemotherapy change|1|||
147278166|NCT02082522|531186502|FG001|Overall Study|Chemotherapy change|3|||
147278167|NCT01863446|531186503|FG000|Overall Study|Withdrawal by Subject|1|||
147278168|NCT01863446|531186504|FG001|Overall Study|Withdrawal by Subject|0|||
147278169|NCT01863446|531186505|FG002|Overall Study|Withdrawal by Subject|1|||
147278170|NCT01863446|531186506|FG003|Overall Study|Withdrawal by Subject|2|||
147278171|NCT01863446|531186503|FG000|Overall Study|Physician Decision|0|||
147278172|NCT01863446|531186504|FG001|Overall Study|Physician Decision|0|||
147278173|NCT01863446|531186505|FG002|Overall Study|Physician Decision|1|||
147278174|NCT01863446|531186506|FG003|Overall Study|Physician Decision|0|||
147278175|NCT03095417|531186509|FG000|Overall Study|missed|1|||
147278176|NCT03095417|531186510|FG001|Overall Study|missed|2|||
147278177|NCT03095417|531186511|FG002|Overall Study|missed|0|||
147278178|NCT03095417|531186512|FG003|Overall Study|missed|1|||
147278179|NCT03095417|531186509|FG000|Overall Study|Lost to Follow-up|2|||
147278180|NCT03095417|531186510|FG001|Overall Study|Lost to Follow-up|2|||
147278181|NCT03095417|531186511|FG002|Overall Study|Lost to Follow-up|1|||
147278182|NCT03095417|531186512|FG003|Overall Study|Lost to Follow-up|0|||
147278183|NCT03095417|531186509|FG000|Overall Study|refusal|0|||
147278184|NCT03095417|531186510|FG001|Overall Study|refusal|1|||
147278185|NCT03095417|531186511|FG002|Overall Study|refusal|0|||
147278186|NCT03095417|531186512|FG003|Overall Study|refusal|1|||
147278187|NCT03095417|531186509|FG000|Overall Study|Withdrawal by Subject|8|||
147278188|NCT03095417|531186510|FG001|Overall Study|Withdrawal by Subject|2|||
147278189|NCT03095417|531186511|FG002|Overall Study|Withdrawal by Subject|5|||
147278190|NCT03095417|531186512|FG003|Overall Study|Withdrawal by Subject|4|||
147278191|NCT03095417|531186509|FG000|Overall Study|Physician Decision|1|||
147278192|NCT03095417|531186510|FG001|Overall Study|Physician Decision|2|||
147278193|NCT03095417|531186511|FG002|Overall Study|Physician Decision|2|||
147278194|NCT03095417|531186512|FG003|Overall Study|Physician Decision|2|||
147278195|NCT03095417|531186509|FG000|Overall Study|Death|1|||
147278196|NCT03095417|531186510|FG001|Overall Study|Death|2|||
147278197|NCT03095417|531186511|FG002|Overall Study|Death|1|||
147278198|NCT03095417|531186512|FG003|Overall Study|Death|3|||
147278199|NCT02571452|531186513|FG000|Overall Study Treatment|Protocol Violation|0|||
147278200|NCT02571452|531186514|FG001|Overall Study Treatment|Protocol Violation|1|||
147278201|NCT02571452|531186513|FG000|Overall Study 6-Month Follow-up|Lost to Follow-up|4|||
147278202|NCT02571452|531186514|FG001|Overall Study 6-Month Follow-up|Lost to Follow-up|0|||
147278203|NCT02571452|531186513|FG000|Overall Study 6-Month Follow-up|Protocol Violation|1|||
147278204|NCT02571452|531186514|FG001|Overall Study 6-Month Follow-up|Protocol Violation|0|||
147278205|NCT03795922|531186516|FG000|Overall Study|Adverse Event|2|||
147278206|NCT03795922|531186517|FG001|Overall Study|Adverse Event|1|||
147278207|NCT03795922|531186516|FG000|Overall Study|Withdrawal by Subject|5|||
147278208|NCT03795922|531186517|FG001|Overall Study|Withdrawal by Subject|13|||
147278209|NCT03795922|531186516|FG000|Overall Study|Lost to Follow-up|2|||
147278210|NCT03795922|531186517|FG001|Overall Study|Lost to Follow-up|3|||
147278211|NCT03795922|531186516|FG000|Overall Study|Pregnancy|0|||
147278212|NCT03795922|531186517|FG001|Overall Study|Pregnancy|1|||
147278213|NCT03795922|531186516|FG000|Overall Study|Physician Decision|1|||
147278214|NCT03795922|531186517|FG001|Overall Study|Physician Decision|2|||
147278215|NCT03795922|531186516|FG000|Overall Study|Protocol Violation|0|||
147278216|NCT03795922|531186517|FG001|Overall Study|Protocol Violation|1|||
147278217|NCT03795922|531186516|FG000|Overall Study|Other (Early termination, COVID, Family issue)|3|||
147278218|NCT03795922|531186517|FG001|Overall Study|Other (Early termination, COVID, Family issue)|4|||
147278219|NCT01416805|531186518|FG000|Overall Study|Lost to Follow-up|4|||
147278220|NCT01416805|531186519|FG001|Overall Study|Lost to Follow-up|4|||
147278221|NCT03653429|531186520|FG000|Overall Study|Physician Decision|4|||
147278222|NCT03653429|531186521|FG001|Overall Study|Physician Decision|10|||
147278223|NCT01700946|531186528|FG000|Overall Study|Lost to Follow-up|1|||
147278224|NCT01700946|531186529|FG001|Overall Study|Lost to Follow-up|0|||
147278225|NCT01700946|531186528|FG000|Overall Study|Physician Decision|7|||
147278226|NCT01700946|531186529|FG001|Overall Study|Physician Decision|12|||
147278227|NCT01700946|531186528|FG000|Overall Study|Withdrawal by Subject|0|||
147278228|NCT01700946|531186529|FG001|Overall Study|Withdrawal by Subject|2|||
147278229|NCT01700946|531186528|FG000|Overall Study|Failed to achieve Complete Remission after Induction Block III|0|||
147278230|NCT01700946|531186529|FG001|Overall Study|Failed to achieve Complete Remission after Induction Block III|2|||
147278231|NCT01700946|531186528|FG000|Overall Study|Relapse|2|||
147278232|NCT01700946|531186529|FG001|Overall Study|Relapse|1|||
147278233|NCT01700946|531186528|FG000|Overall Study|Unacceptable toxicity|1|||
147278234|NCT01700946|531186529|FG001|Overall Study|Unacceptable toxicity|0|||
147278235|NCT03056690|531186532|FG000|Overall Study|Adverse Event|3|||
147278236|NCT03056690|531186533|FG001|Overall Study|Adverse Event|2|||
147278237|NCT03056690|531186532|FG000|Overall Study|Lack of Efficacy|1|||
147278238|NCT03056690|531186533|FG001|Overall Study|Lack of Efficacy|2|||
147278239|NCT03056690|531186532|FG000|Overall Study|Lost to Follow-up|3|||
147278240|NCT03056690|531186533|FG001|Overall Study|Lost to Follow-up|2|||
147278241|NCT03056690|531186532|FG000|Overall Study|Protocol Violation|2|||
147278242|NCT03056690|531186533|FG001|Overall Study|Protocol Violation|2|||
147278243|NCT03056690|531186532|FG000|Overall Study|Withdrawal by Subject|3|||
147278244|NCT03056690|531186533|FG001|Overall Study|Withdrawal by Subject|6|||
147278245|NCT03056690|531186532|FG000|Overall Study|Non-compliance with Study Drug|1|||
147278246|NCT03056690|531186533|FG001|Overall Study|Non-compliance with Study Drug|0|||
147278247|NCT03056690|531186532|FG000|Overall Study|Miscellaneous|1|||
147278248|NCT03056690|531186533|FG001|Overall Study|Miscellaneous|2|||
147278249|NCT02617589|531186538|FG000|Randomization|Request to Discontinue Study Treatment|1|||
147278250|NCT02617589|531186539|FG001|Randomization|Request to Discontinue Study Treatment|3|||
147278251|NCT02617589|531186538|FG000|Randomization|Participant Withdrew Consent|1|||
147278252|NCT02617589|531186539|FG001|Randomization|Participant Withdrew Consent|2|||
147278253|NCT02617589|531186538|FG000|Treatment|Other Reasons|3|||
147278254|NCT02617589|531186539|FG001|Treatment|Other Reasons|3|||
147278255|NCT02617589|531186538|FG000|Treatment|Poor/Non Compliance|1|||
147278256|NCT02617589|531186539|FG001|Treatment|Poor/Non Compliance|1|||
147278257|NCT02617589|531186538|FG000|Treatment|Maximum Clinical Benefit|0|||
147278258|NCT02617589|531186539|FG001|Treatment|Maximum Clinical Benefit|2|||
147278259|NCT02617589|531186538|FG000|Treatment|Participant Withdrew Consent|2|||
147278260|NCT02617589|531186539|FG001|Treatment|Participant Withdrew Consent|6|||
147334564|NCT03284957|531392018|FG007|Overall Study|Other|0|||
147334565|NCT03284957|531392019|FG008|Overall Study|Other|1|||
147334566|NCT03284957|531392020|FG009|Overall Study|Other|6|||
147334567|NCT03284957|531392021|FG010|Overall Study|Other|0|||
147334568|NCT03284957|531392022|FG011|Overall Study|Other|0|||
147334569|NCT03284957|531392023|FG012|Overall Study|Other|0|||
147334570|NCT03284957|531392024|FG013|Overall Study|Other|0|||
147334571|NCT03284957|531392025|FG014|Overall Study|Other|2|||
147334572|NCT03284957|531392026|FG015|Overall Study|Other|0|||
147334573|NCT03544515|531392029|FG000|Overall Study|Didn't complete study follow-up due to pandemic pause in research activity|4|||
147334574|NCT03544515|531392030|FG001|Overall Study|Didn't complete study follow-up due to pandemic pause in research activity|2|||
147334575|NCT03544515|531392029|FG000|Overall Study|Lost to Follow-up|2|||
147334576|NCT03544515|531392030|FG001|Overall Study|Lost to Follow-up|0|||
147334577|NCT01393119|531392031|FG000|Overall Study|Adverse Event|1|||
147334578|NCT01393119|531392032|FG001|Overall Study|Adverse Event|1|||
147334579|NCT01393119|531392033|FG002|Overall Study|Adverse Event|0|||
147334580|NCT01393119|531392034|FG003|Overall Study|Adverse Event|1|||
147334581|NCT01393119|531392031|FG000|Overall Study|Withdrawal by Subject|0|||
147334582|NCT01393119|531392032|FG001|Overall Study|Withdrawal by Subject|1|||
147334583|NCT01393119|531392033|FG002|Overall Study|Withdrawal by Subject|1|||
147334584|NCT01393119|531392034|FG003|Overall Study|Withdrawal by Subject|0|||
147334585|NCT01393119|531392031|FG000|Overall Study|Lack of Efficacy|1|||
147334586|NCT01393119|531392032|FG001|Overall Study|Lack of Efficacy|0|||
147334587|NCT01393119|531392033|FG002|Overall Study|Lack of Efficacy|2|||
147334588|NCT01393119|531392034|FG003|Overall Study|Lack of Efficacy|1|||
147334589|NCT01393119|531392031|FG000|Overall Study|Protocol Violation|0|||
147334590|NCT01393119|531392032|FG001|Overall Study|Protocol Violation|0|||
147334591|NCT01393119|531392033|FG002|Overall Study|Protocol Violation|1|||
147334592|NCT01393119|531392034|FG003|Overall Study|Protocol Violation|0|||
147334593|NCT01393119|531392031|FG000|Overall Study|Death|0|||
147278261|NCT02617589|531186538|FG000|Treatment|Participant Request to Discontinue|12|||
147278262|NCT02617589|531186539|FG001|Treatment|Participant Request to Discontinue|21|||
147278263|NCT02617589|531186538|FG000|Treatment|Adverse Event Unrelated to Study Drug|16|||
147334594|NCT01393119|531392032|FG001|Overall Study|Death|0|||
147334595|NCT01393119|531392033|FG002|Overall Study|Death|0|||
147334596|NCT01393119|531392034|FG003|Overall Study|Death|1|||
147334597|NCT01393119|531392031|FG000|Overall Study|Randomized but Not treated|1|||
147334598|NCT01393119|531392032|FG001|Overall Study|Randomized but Not treated|0|||
147334599|NCT01393119|531392033|FG002|Overall Study|Randomized but Not treated|1|||
147450958|NCT00746252|531813194|FG000|Overall Study|weight gain >7.5 %|1|||
147278264|NCT02617589|531186539|FG001|Treatment|Adverse Event Unrelated to Study Drug|9|||
147278265|NCT02617589|531186538|FG000|Treatment|Death|1|||
147334600|NCT01393119|531392034|FG003|Overall Study|Randomized but Not treated|1|||
147334601|NCT01393119|531392031|FG000|Overall Study|Sponsor Termination of Study|11|||
147334602|NCT01393119|531392032|FG001|Overall Study|Sponsor Termination of Study|12|||
147278266|NCT02617589|531186539|FG001|Treatment|Death|1|||
147278267|NCT02617589|531186538|FG000|Treatment|Study Drug Toxicity|27|||
147278268|NCT02617589|531186539|FG001|Treatment|Study Drug Toxicity|20|||
147278269|NCT02617589|531186538|FG000|Treatment|Disease Progression|216|||
147278270|NCT02617589|531186539|FG001|Treatment|Disease Progression|136|||
147278271|NCT01975389|531186540|FG000|Overall Study|Adverse Event|10|||
147278272|NCT01975389|531186541|FG001|Overall Study|Adverse Event|6|||
147278273|NCT01975389|531186540|FG000|Overall Study|Death|61|||
147278274|NCT01975389|531186541|FG001|Overall Study|Death|54|||
147278275|NCT01975389|531186540|FG000|Overall Study|Lost to Follow-up|81|||
147278276|NCT01975389|531186541|FG001|Overall Study|Lost to Follow-up|86|||
147278277|NCT01975389|531186540|FG000|Overall Study|Withdrawal by Subject|90|||
147278278|NCT01975389|531186541|FG001|Overall Study|Withdrawal by Subject|76|||
147278279|NCT01975389|531186540|FG000|Overall Study|Other|6|||
147601483|NCT02370329|532360604|FG000|Overall Study|Alternate treatment|1|||
147278280|NCT01975389|531186541|FG001|Overall Study|Other|9|||
147278281|NCT01975389|531186540|FG000|Overall Study|Randomized, not treated|4|||
147278282|NCT01975389|531186541|FG001|Overall Study|Randomized, not treated|5|||
147278283|NCT02127307|531186542|FG000|Overall Study|Protocol Violation|36|||
147278284|NCT02127307|531186542|FG000|Overall Study|Lost to Follow-up|2|||
147278285|NCT02127307|531186542|FG000|Overall Study|Death|101|||
147278286|NCT02127307|531186542|FG000|Overall Study|Other than specified above|169|||
147278287|NCT01312961|531186544|FG000|Overall Study|Adverse Event|3|||
147278288|NCT01312961|531186545|FG001|Overall Study|Adverse Event|3|||
147278289|NCT01312961|531186544|FG000|Overall Study|Lack of Efficacy|11|||
147278290|NCT01312961|531186545|FG001|Overall Study|Lack of Efficacy|1|||
147278291|NCT01312961|531186544|FG000|Overall Study|Poor compliance to protocol|1|||
147278292|NCT01312961|531186545|FG001|Overall Study|Poor compliance to protocol|0|||
147278293|NCT01312961|531186544|FG000|Overall Study|Other than specified above|2|||
147278294|NCT01312961|531186545|FG001|Overall Study|Other than specified above|3|||
147278295|NCT04187196|531186547|FG000|Overall Study|Screen Failure|2|||
147278296|NCT04187196|531186548|FG001|Overall Study|Screen Failure|0|||
147278297|NCT00183872|531186549|FG000|Overall Study|Death|3|||
147278298|NCT00183872|531186549|FG000|Overall Study|Adverse Event|9|||
147278299|NCT00183872|531186549|FG000|Overall Study|Withdrawal by Subject|2|||
147278300|NCT00183872|531186549|FG000|Overall Study|Drug delayed more than 28 days|2|||
147334603|NCT01393119|531392033|FG002|Overall Study|Sponsor Termination of Study|9|||
147334604|NCT01393119|531392034|FG003|Overall Study|Sponsor Termination of Study|12|||
147334605|NCT01266265|531392035|FG000|Overall Study|Death|95|||
147334606|NCT01266265|531392036|FG001|Overall Study|Death|73|||
147334607|NCT01266265|531392035|FG000|Overall Study|Lost to Follow-up|23|||
147334608|NCT01266265|531392036|FG001|Overall Study|Lost to Follow-up|28|||
147334609|NCT01266265|531392035|FG000|Overall Study|Withdrawal by Subject|13|||
147334610|NCT01266265|531392036|FG001|Overall Study|Withdrawal by Subject|11|||
147334611|NCT01266265|531392035|FG000|Overall Study|Respiratory-related adverse event|2|||
147334612|NCT01266265|531392036|FG001|Overall Study|Respiratory-related adverse event|1|||
147334613|NCT01266265|531392035|FG000|Overall Study|Transferred care to another provider|22|||
147334614|NCT01266265|531392036|FG001|Overall Study|Transferred care to another provider|28|||
147334615|NCT01266265|531392035|FG000|Overall Study|Stopped/changed PAH medication(s)|16|||
147334616|NCT01266265|531392036|FG001|Overall Study|Stopped/changed PAH medication(s)|9|||
147334617|NCT01266265|531392035|FG000|Overall Study|Enrolled in another clinical study|15|||
147334618|NCT01266265|531392036|FG001|Overall Study|Enrolled in another clinical study|26|||
147334619|NCT01266265|531392035|FG000|Overall Study|Non-compliance|8|||
147334620|NCT01266265|531392036|FG001|Overall Study|Non-compliance|5|||
147334621|NCT01266265|531392035|FG000|Overall Study|Lung transplant|6|||
147334622|NCT01266265|531392036|FG001|Overall Study|Lung transplant|5|||
147334623|NCT01266265|531392035|FG000|Overall Study|Site closed early|4|||
147601484|NCT02370329|532360604|FG000|Overall Study|Adverse Event|1|||
147601485|NCT02370329|532360604|FG000|Overall Study|Disease progression|3|||
147278301|NCT00595582|531186550|FG000|Overall Study|Pilot study that PI terminated|2|||
147278302|NCT00595582|531186550|FG000|Overall Study|Lost to Follow-up|1|||
147278303|NCT00595582|531186550|FG000|Overall Study|Adverse Event|2|||
147278304|NCT00595582|531186550|FG000|Overall Study|Physician Decision|5|||
147278305|NCT02797262|531186551|FG000|Overall Study|Withdrawal by Subject|5|||
147334624|NCT01266265|531392036|FG001|Overall Study|Site closed early|3|||
147334625|NCT01266265|531392035|FG000|Overall Study|Clinical worsening|1|||
147334626|NCT01266265|531392036|FG001|Overall Study|Clinical worsening|1|||
147334627|NCT01580293|531392037|FG000|Part A_Main Trial|Adverse Event|0|||
147334628|NCT01580293|531392038|FG001|Part A_Main Trial|Adverse Event|2|||
147278306|NCT02797262|531186552|FG001|Overall Study|Withdrawal by Subject|1|||
147278307|NCT02797262|531186551|FG000|Overall Study|Lost to Follow-up|10|||
147278308|NCT02797262|531186552|FG001|Overall Study|Lost to Follow-up|7|||
147278309|NCT02797262|531186551|FG000|Overall Study|Death|1|||
147278310|NCT02797262|531186552|FG001|Overall Study|Death|2|||
147278311|NCT02797262|531186551|FG000|Overall Study|Adverse Event|1|||
147450959|NCT00746252|531813195|FG001|Overall Study|weight gain >7.5 %|2|||
147278312|NCT02797262|531186552|FG001|Overall Study|Adverse Event|0|||
147334629|NCT01580293|531392039|FG002|Part A_Main Trial|Adverse Event|0|||
147601486|NCT02370329|532360604|FG000|Overall Study|Physician Decision|2|||
147278313|NCT02797262|531186551|FG000|Overall Study|COVID-19|2|||
147278314|NCT02797262|531186552|FG001|Overall Study|COVID-19|1|||
147278315|NCT02797262|531186551|FG000|Overall Study|Out-of-country|1|||
147278316|NCT02797262|531186552|FG001|Overall Study|Out-of-country|0|||
147278317|NCT01600586|531186553|FG000|Overall Study|Physician Decision|3|||
147278318|NCT01600586|531186554|FG001|Overall Study|Physician Decision|3|||
147278319|NCT01978184|531186556|FG000|Overall Study|Progressive disease|5|||
147278320|NCT01978184|531186557|FG001|Overall Study|Progressive disease|5|||
147278321|NCT01978184|531186556|FG000|Overall Study|Other than PDA|2|||
147278322|NCT01978184|531186557|FG001|Overall Study|Other than PDA|2|||
147278323|NCT01978184|531186556|FG000|Overall Study|Physician Decision|0|||
147278324|NCT01978184|531186557|FG001|Overall Study|Physician Decision|3|||
147278325|NCT01978184|531186556|FG000|Overall Study|Noncompliance|1|||
147278326|NCT01978184|531186557|FG001|Overall Study|Noncompliance|2|||
147278327|NCT01978184|531186556|FG000|Overall Study|Death|1|||
147278328|NCT01978184|531186557|FG001|Overall Study|Death|0|||
147278329|NCT01978184|531186556|FG000|Overall Study|Withdrew- toxicities or physical decline|4|||
147278330|NCT01978184|531186557|FG001|Overall Study|Withdrew- toxicities or physical decline|8|||
147278331|NCT02460198|531186558|FG000|Overall Study|Adverse Event|1|||
147278332|NCT02460198|531186559|FG001|Overall Study|Adverse Event|3|||
147278333|NCT02460198|531186558|FG000|Overall Study|Death|36|||
147278334|NCT02460198|531186559|FG001|Overall Study|Death|28|||
147278335|NCT02460198|531186558|FG000|Overall Study|Lost to Follow-up|1|||
147278336|NCT02460198|531186559|FG001|Overall Study|Lost to Follow-up|1|||
147278337|NCT02460198|531186558|FG000|Overall Study|Transferred to Extension Study|15|||
147278338|NCT02460198|531186559|FG001|Overall Study|Transferred to Extension Study|15|||
147278339|NCT02460198|531186558|FG000|Overall Study|Withdrawal by Subject|2|||
147278340|NCT02460198|531186559|FG001|Overall Study|Withdrawal by Subject|4|||
147278341|NCT02460198|531186558|FG000|Overall Study|Site Terminated By Sponsor|0|||
147278342|NCT02460198|531186559|FG001|Overall Study|Site Terminated By Sponsor|1|||
147278343|NCT02460198|531186558|FG000|Overall Study|Did Not Continue on Extension Study|6|||
147278344|NCT02460198|531186559|FG001|Overall Study|Did Not Continue on Extension Study|11|||
147278345|NCT00931307|531186560|FG000|Overall Study|Lack of Efficacy|12|||
147278346|NCT00931307|531186560|FG000|Overall Study|Biomicroscopy|1|||
147278347|NCT00691210|531186561|FG000|Overall Study|Progression of Disease|0|||
147278348|NCT00691210|531186562|FG001|Overall Study|Progression of Disease|0|||
147278349|NCT00691210|531186563|FG002|Overall Study|Progression of Disease|0|||
147278350|NCT00691210|531186564|FG003|Overall Study|Progression of Disease|2|||
147278351|NCT00691210|531186565|FG004|Overall Study|Progression of Disease|0|||
147334630|NCT01580293|531392037|FG000|Part A_Main Trial|Withdrawal by Subject|1|||
147334631|NCT01580293|531392038|FG001|Part A_Main Trial|Withdrawal by Subject|4|||
147334632|NCT01580293|531392039|FG002|Part A_Main Trial|Withdrawal by Subject|0|||
147334633|NCT01580293|531392037|FG000|Part A_Main Trial|Non-adherence to the protocol|1|||
147334634|NCT01580293|531392038|FG001|Part A_Main Trial|Non-adherence to the protocol|0|||
147334635|NCT01580293|531392039|FG002|Part A_Main Trial|Non-adherence to the protocol|0|||
147334636|NCT01580293|531392037|FG000|Part A_Extension|Adverse Event|0|||
147334637|NCT01580293|531392038|FG001|Part A_Extension|Adverse Event|2|||
147334638|NCT01580293|531392039|FG002|Part A_Extension|Adverse Event|0|||
147334639|NCT01580293|531392037|FG000|Part A_Extension|Withdrawal by Subject|0|||
147334640|NCT01580293|531392038|FG001|Part A_Extension|Withdrawal by Subject|3|||
147334641|NCT01580293|531392039|FG002|Part A_Extension|Withdrawal by Subject|0|||
147334642|NCT01580293|531392037|FG000|Part A_Extension|Lost to Follow-up|0|||
147334643|NCT01580293|531392038|FG001|Part A_Extension|Lost to Follow-up|1|||
147334644|NCT01580293|531392039|FG002|Part A_Extension|Lost to Follow-up|0|||
147334645|NCT01580293|531392037|FG000|Part A_Extension|Other Reason|0|||
147334646|NCT01580293|531392038|FG001|Part A_Extension|Other Reason|1|||
147334647|NCT01580293|531392039|FG002|Part A_Extension|Other Reason|0|||
147334648|NCT01580293|531392037|FG000|Part A_Extension|Completed Japan only|0|||
147334649|NCT01580293|531392038|FG001|Part A_Extension|Completed Japan only|5|||
147334650|NCT01580293|531392039|FG002|Part A_Extension|Completed Japan only|0|||
147662501|NCT02513550|532587345|FG000|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0|||
147662502|NCT02513550|532587346|FG001|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0|||
147278352|NCT00691210|531186566|FG005|Overall Study|Progression of Disease|0|||
147278353|NCT00691210|531186567|FG006|Overall Study|Progression of Disease|0|||
147278354|NCT00691210|531186568|FG007|Overall Study|Progression of Disease|0|||
147278355|NCT00691210|531186561|FG000|Overall Study|Lack of Efficacy|0|||
147278356|NCT00691210|531186562|FG001|Overall Study|Lack of Efficacy|0|||
147278357|NCT00691210|531186563|FG002|Overall Study|Lack of Efficacy|0|||
147278358|NCT00691210|531186564|FG003|Overall Study|Lack of Efficacy|1|||
147278359|NCT00691210|531186565|FG004|Overall Study|Lack of Efficacy|0|||
147278360|NCT00691210|531186566|FG005|Overall Study|Lack of Efficacy|1|||
147278361|NCT00691210|531186567|FG006|Overall Study|Lack of Efficacy|0|||
147278362|NCT00691210|531186568|FG007|Overall Study|Lack of Efficacy|0|||
147334651|NCT01580293|531392037|FG000|Part B|Withdrawal by Subject|0|||
147334652|NCT01580293|531392038|FG001|Part B|Withdrawal by Subject|0|||
147334653|NCT01580293|531392039|FG002|Part B|Withdrawal by Subject|1|||
147334654|NCT01580293|531392037|FG000|Part B|Other reason|0|||
147601487|NCT02370329|532360604|FG000|Overall Study|Study closure|4|||
147601488|NCT01502410|532360609|FG000|Overall Study|Adverse Event|1|||
147601489|NCT01502410|532360610|FG001|Overall Study|Adverse Event|2|||
147601490|NCT01502410|532360611|FG002|Overall Study|Adverse Event|0|||
147601491|NCT01502410|532360612|FG003|Overall Study|Adverse Event|0|||
147601492|NCT01502410|532360609|FG000|Overall Study|Lack of Efficacy|7|||
147601493|NCT01502410|532360610|FG001|Overall Study|Lack of Efficacy|7|||
147601494|NCT01502410|532360611|FG002|Overall Study|Lack of Efficacy|0|||
147601495|NCT01502410|532360612|FG003|Overall Study|Lack of Efficacy|0|||
147601496|NCT01502410|532360609|FG000|Overall Study|Physician Decision|0|||
147601497|NCT01502410|532360610|FG001|Overall Study|Physician Decision|1|||
147601498|NCT01502410|532360611|FG002|Overall Study|Physician Decision|0|||
147601499|NCT01502410|532360612|FG003|Overall Study|Physician Decision|0|||
147601500|NCT01502410|532360609|FG000|Overall Study|Withdrawal by Subject|2|||
147601501|NCT01502410|532360610|FG001|Overall Study|Withdrawal by Subject|0|||
147601502|NCT01502410|532360611|FG002|Overall Study|Withdrawal by Subject|0|||
147601503|NCT01502410|532360612|FG003|Overall Study|Withdrawal by Subject|0|||
147601504|NCT04345601|532360613|FG000|Overall Study|Death|0|||
147601505|NCT04345601|532360614|FG001|Overall Study|Death|3|||
147601506|NCT04345601|532360615|FG002|Overall Study|Death|2|||
147601507|NCT04345601|532360613|FG000|Overall Study|Lost to Follow-up|0|||
147601508|NCT04345601|532360614|FG001|Overall Study|Lost to Follow-up|0|||
147601509|NCT04345601|532360615|FG002|Overall Study|Lost to Follow-up|2|||
147601510|NCT00699283|532360619|FG000|Overall Study|Lack of Efficacy|15|||
147601511|NCT00699283|532360620|FG001|Overall Study|Lack of Efficacy|5|||
147601512|NCT00699283|532360619|FG000|Overall Study|Lost to Follow-up|2|||
147601513|NCT00699283|532360620|FG001|Overall Study|Lost to Follow-up|0|||
147601514|NCT00699283|532360619|FG000|Overall Study|Withdrawal by Subject|1|||
147601515|NCT00699283|532360620|FG001|Overall Study|Withdrawal by Subject|0|||
147601516|NCT00699283|532360619|FG000|Overall Study|Other Reason|5|||
147601517|NCT00699283|532360620|FG001|Overall Study|Other Reason|1|||
147601518|NCT00699283|532360619|FG000|Overall Study|SAE, non-fatal|1|||
147601519|NCT00699283|532360620|FG001|Overall Study|SAE, non-fatal|1|||
147601520|NCT00699283|532360619|FG000|Overall Study|AE, non-serious non-fatal|8|||
147601521|NCT00699283|532360620|FG001|Overall Study|AE, non-serious non-fatal|1|||
147601522|NCT00699283|532360619|FG000|Overall Study|AE of unknown type|1|||
147601523|NCT00699283|532360620|FG001|Overall Study|AE of unknown type|0|||
147601524|NCT00805675|532360621|FG000|Overall Study|Adverse Event|0|||
147601525|NCT00805675|532360622|FG001|Overall Study|Adverse Event|0|||
147601526|NCT00805675|532360623|FG002|Overall Study|Adverse Event|1|||
147601527|NCT02771795|532360624|FG000|Overall Study|Withdrawal by Subject|47|||
147278363|NCT01208233|531186569|FG000|Overall Study|Adverse Event|0|||
147278364|NCT01208233|531186570|FG001|Overall Study|Adverse Event|1|||
147278365|NCT01208233|531186571|FG002|Overall Study|Adverse Event|2|||
147278366|NCT01208233|531186572|FG003|Overall Study|Adverse Event|0|||
147278367|NCT01208233|531186573|FG004|Overall Study|Adverse Event|3|||
147278368|NCT01208233|531186574|FG005|Overall Study|Adverse Event|5|||
147278369|NCT01208233|531186569|FG000|Overall Study|Death|0|||
147278370|NCT01208233|531186570|FG001|Overall Study|Death|0|||
147278371|NCT01208233|531186571|FG002|Overall Study|Death|0|||
147278372|NCT01208233|531186572|FG003|Overall Study|Death|0|||
147278373|NCT01208233|531186573|FG004|Overall Study|Death|3|||
147278374|NCT01208233|531186574|FG005|Overall Study|Death|5|||
147278375|NCT01208233|531186569|FG000|Overall Study|Did not meet entrance criteria|2|||
147278376|NCT01208233|531186570|FG001|Overall Study|Did not meet entrance criteria|1|||
147278377|NCT01208233|531186571|FG002|Overall Study|Did not meet entrance criteria|1|||
147278378|NCT01208233|531186572|FG003|Overall Study|Did not meet entrance criteria|0|||
147601528|NCT02771795|532360625|FG001|Overall Study|Withdrawal by Subject|37|||
147601529|NCT02771795|532360624|FG000|Overall Study|Termination by premature discontinuation of study|168|||
147601530|NCT02771795|532360625|FG001|Overall Study|Termination by premature discontinuation of study|185|||
147601531|NCT03929757|532360626|FG000|Main Study: Up to Day 365|Withdrawal by parent/guardian|2|||
147278379|NCT01208233|531186573|FG004|Overall Study|Did not meet entrance criteria|1|||
147601532|NCT03929757|532360627|FG001|Main Study: Up to Day 365|Withdrawal by parent/guardian|0|||
147601533|NCT03929757|532360628|FG002|Main Study: Up to Day 365|Withdrawal by parent/guardian|0|||
147601534|NCT03929757|532360626|FG000|Main Study: Up to Day 365|Other|1|||
147601535|NCT03929757|532360627|FG001|Main Study: Up to Day 365|Other|0|||
147601536|NCT03929757|532360628|FG002|Main Study: Up to Day 365|Other|0|||
147601537|NCT03929757|532360626|FG000|Extension Study: Up to Extension Day 85|Adverse Event|0|||
147601538|NCT03929757|532360627|FG001|Extension Study: Up to Extension Day 85|Adverse Event|0|||
147601539|NCT03929757|532360628|FG002|Extension Study: Up to Extension Day 85|Adverse Event|1|||
147278380|NCT01208233|531186574|FG005|Overall Study|Did not meet entrance criteria|0|||
147278381|NCT01208233|531186569|FG000|Overall Study|Medication error without adverse event|0|||
147278382|NCT01208233|531186570|FG001|Overall Study|Medication error without adverse event|0|||
147278383|NCT01208233|531186571|FG002|Overall Study|Medication error without adverse event|0|||
147278384|NCT01208233|531186572|FG003|Overall Study|Medication error without adverse event|0|||
147601540|NCT00114166|532360629|FG000|Overall Study|Wrong primary|0|||
147601541|NCT00114166|532360630|FG001|Overall Study|Wrong primary|1|||
147278385|NCT01208233|531186573|FG004|Overall Study|Medication error without adverse event|0|||
147278386|NCT01208233|531186574|FG005|Overall Study|Medication error without adverse event|1|||
147601542|NCT01154816|532360631|FG000|Overall Study|Withdrawal by Subject|1|||
147601543|NCT01154816|532360632|FG001|Overall Study|Withdrawal by Subject|0|||
147601544|NCT01154816|532360633|FG002|Overall Study|Withdrawal by Subject|0|||
147278387|NCT01208233|531186569|FG000|Overall Study|Study terminated by sponsor|0|||
147278388|NCT01208233|531186570|FG001|Overall Study|Study terminated by sponsor|0|||
147278389|NCT01208233|531186571|FG002|Overall Study|Study terminated by sponsor|0|||
147278390|NCT01208233|531186572|FG003|Overall Study|Study terminated by sponsor|0|||
147278391|NCT01208233|531186573|FG004|Overall Study|Study terminated by sponsor|10|||
147278392|NCT01208233|531186574|FG005|Overall Study|Study terminated by sponsor|7|||
147278393|NCT01208233|531186569|FG000|Overall Study|Protocol Violation|0|||
147278394|NCT01208233|531186570|FG001|Overall Study|Protocol Violation|0|||
147278395|NCT01208233|531186571|FG002|Overall Study|Protocol Violation|0|||
147278396|NCT01208233|531186572|FG003|Overall Study|Protocol Violation|0|||
147278397|NCT01208233|531186573|FG004|Overall Study|Protocol Violation|3|||
147278398|NCT01208233|531186574|FG005|Overall Study|Protocol Violation|0|||
147278399|NCT01208233|531186569|FG000|Overall Study|Other|2|||
147278400|NCT01208233|531186570|FG001|Overall Study|Other|1|||
147278401|NCT01208233|531186571|FG002|Overall Study|Other|0|||
147278402|NCT01208233|531186572|FG003|Overall Study|Other|0|||
147278403|NCT01208233|531186573|FG004|Overall Study|Other|0|||
147278404|NCT01208233|531186574|FG005|Overall Study|Other|1|||
147278405|NCT01208233|531186569|FG000|Overall Study|Withdrawal by Subject|1|||
147278406|NCT01208233|531186570|FG001|Overall Study|Withdrawal by Subject|0|||
147278407|NCT01208233|531186571|FG002|Overall Study|Withdrawal by Subject|1|||
147278408|NCT01208233|531186572|FG003|Overall Study|Withdrawal by Subject|1|||
147278409|NCT01208233|531186573|FG004|Overall Study|Withdrawal by Subject|4|||
147278410|NCT01208233|531186574|FG005|Overall Study|Withdrawal by Subject|2|||
147601545|NCT01154816|532360634|FG003|Overall Study|Withdrawal by Subject|1|||
147601546|NCT01154816|532360635|FG004|Overall Study|Withdrawal by Subject|0|||
147601547|NCT01154816|532360636|FG005|Overall Study|Withdrawal by Subject|0|||
147601548|NCT01154816|532360637|FG006|Overall Study|Withdrawal by Subject|0|||
147601549|NCT01154816|532360638|FG007|Overall Study|Withdrawal by Subject|0|||
147278411|NCT01181895|531186575|FG000|Overall Study|Adverse Event|3|||
147278412|NCT01181895|531186576|FG001|Overall Study|Adverse Event|1|||
147278413|NCT01181895|531186577|FG002|Overall Study|Adverse Event|1|||
147278414|NCT01181895|531186575|FG000|Overall Study|Lack of Efficacy|8|||
147278415|NCT01181895|531186576|FG001|Overall Study|Lack of Efficacy|9|||
147278416|NCT01181895|531186577|FG002|Overall Study|Lack of Efficacy|9|||
147278417|NCT01181895|531186575|FG000|Overall Study|Protocol Violation|2|||
147278418|NCT01181895|531186576|FG001|Overall Study|Protocol Violation|1|||
147278419|NCT01181895|531186577|FG002|Overall Study|Protocol Violation|0|||
147278420|NCT01181895|531186575|FG000|Overall Study|Lost to Follow-up|0|||
147278421|NCT01181895|531186576|FG001|Overall Study|Lost to Follow-up|1|||
147278422|NCT01181895|531186577|FG002|Overall Study|Lost to Follow-up|2|||
147278423|NCT01181895|531186575|FG000|Overall Study|Investigator Discretion|1|||
147278424|NCT01181895|531186576|FG001|Overall Study|Investigator Discretion|2|||
147278425|NCT01181895|531186577|FG002|Overall Study|Investigator Discretion|1|||
147278426|NCT01181895|531186575|FG000|Overall Study|Withdrawal by Subject|3|||
147278427|NCT01181895|531186576|FG001|Overall Study|Withdrawal by Subject|0|||
147278428|NCT01181895|531186577|FG002|Overall Study|Withdrawal by Subject|5|||
147278429|NCT00555438|531186578|FG000|10 Days Post-operative|Death|4|||
147278430|NCT00555438|531186578|FG000|Between 10 Days and 30 Days Postoperativ|Death|5|||
147601550|NCT01154816|532360639|FG008|Overall Study|Withdrawal by Subject|1|||
147278431|NCT02758236|531186581|FG000|Overall Study|Investigator discretion|43|||
147278432|NCT05789875|531186582|FG000|Overall Study|Lost to Follow-up|6|||
147278433|NCT00023452|531186583|FG000|Overall Study|Ineligible for Study|163|||
147278434|NCT00023452|531186584|FG001|Overall Study|Ineligible for Study|159|||
147278435|NCT00023452|531186583|FG000|Overall Study|Out of Window|129|||
147278436|NCT00023452|531186584|FG001|Overall Study|Out of Window|69|||
147601551|NCT01154816|532360640|FG009|Overall Study|Withdrawal by Subject|3|||
147601552|NCT01154816|532360641|FG010|Overall Study|Withdrawal by Subject|0|||
147601553|NCT01154816|532360642|FG011|Overall Study|Withdrawal by Subject|0|||
147601554|NCT01154816|532360631|FG000|Overall Study|Progressive Disease|13|||
147601555|NCT01154816|532360632|FG001|Overall Study|Progressive Disease|8|||
147278437|NCT00023452|531186583|FG000|Overall Study|Death|2|||
147278438|NCT00023452|531186584|FG001|Overall Study|Death|0|||
147278439|NCT00023452|531186583|FG000|Overall Study|Withdrawal by Subject|66|||
147278440|NCT00023452|531186584|FG001|Overall Study|Withdrawal by Subject|54|||
147278441|NCT00023452|531186583|FG000|Overall Study|Adverse Event|139|||
147278442|NCT00023452|531186584|FG001|Overall Study|Adverse Event|196|||
147601556|NCT01154816|532360633|FG002|Overall Study|Progressive Disease|9|||
147278443|NCT00023452|531186583|FG000|Overall Study|Lost to Follow-up|293|||
147278444|NCT00023452|531186584|FG001|Overall Study|Lost to Follow-up|60|||
147278445|NCT00023452|531186583|FG000|Overall Study|Physician Decision|49|||
147278446|NCT00023452|531186584|FG001|Overall Study|Physician Decision|21|||
147278447|NCT00023452|531186583|FG000|Overall Study|Refused Treatment (continued follow-up)|225|||
147278448|NCT00023452|531186584|FG001|Overall Study|Refused Treatment (continued follow-up)|224|||
147278449|NCT00023452|531186583|FG000|Overall Study|Pregnant|53|||
147278450|NCT00023452|531186584|FG001|Overall Study|Pregnant|20|||
147278451|NCT00023452|531186583|FG000|Overall Study|Other|204|||
147278452|NCT00023452|531186584|FG001|Overall Study|Other|69|||
147278453|NCT01940705|531186586|FG000|Overall Study|Lost to Follow-up|1|||
147278454|NCT01940705|531186587|FG001|Overall Study|Lost to Follow-up|3|||
147278455|NCT01940705|531186588|FG002|Overall Study|Lost to Follow-up|2|||
147278456|NCT01940705|531186589|FG003|Overall Study|Lost to Follow-up|2|||
147278457|NCT01940705|531186586|FG000|Overall Study|Withdrawal by Subject|2|||
147278458|NCT01940705|531186587|FG001|Overall Study|Withdrawal by Subject|2|||
147278459|NCT01940705|531186588|FG002|Overall Study|Withdrawal by Subject|3|||
147278460|NCT01940705|531186589|FG003|Overall Study|Withdrawal by Subject|2|||
147278461|NCT01940705|531186586|FG000|Overall Study|Intervention not given|0|||
147278462|NCT01940705|531186587|FG001|Overall Study|Intervention not given|3|||
147278463|NCT01940705|531186588|FG002|Overall Study|Intervention not given|3|||
147278464|NCT01940705|531186589|FG003|Overall Study|Intervention not given|0|||
147278465|NCT01940705|531186586|FG000|Overall Study|Withdrawal by team - hearing aid change|1|||
147278466|NCT01940705|531186587|FG001|Overall Study|Withdrawal by team - hearing aid change|0|||
147278467|NCT01940705|531186588|FG002|Overall Study|Withdrawal by team - hearing aid change|0|||
147278468|NCT01940705|531186589|FG003|Overall Study|Withdrawal by team - hearing aid change|0|||
147278469|NCT02447991|531186590|FG000|Overall Study|Withdrawn by subject - no data|0|||
147278470|NCT02447991|531186591|FG001|Overall Study|Withdrawn by subject - no data|2|||
147278471|NCT02447991|531186590|FG000|Overall Study|Withdrawn by Subject - with data|4|||
147278472|NCT02447991|531186591|FG001|Overall Study|Withdrawn by Subject - with data|4|||
147278473|NCT02447991|531186590|FG000|Overall Study|Lost to Follow-up - no data|3|||
147278474|NCT02447991|531186591|FG001|Overall Study|Lost to Follow-up - no data|6|||
147278475|NCT02447991|531186590|FG000|Overall Study|Lost to follow-up - with data|0|||
147278476|NCT02447991|531186591|FG001|Overall Study|Lost to follow-up - with data|3|||
147278477|NCT02447991|531186590|FG000|Overall Study|End of study - no treatment results|3|||
147278478|NCT02447991|531186591|FG001|Overall Study|End of study - no treatment results|6|||
147278479|NCT02447991|531186590|FG000|Overall Study|End of study - partial treatment results|0|||
147278480|NCT02447991|531186591|FG001|Overall Study|End of study - partial treatment results|9|||
147278481|NCT02770391|531186598|FG000|Overall Study|Lost to Follow-up|2|||
147278482|NCT02770391|531186598|FG000|Overall Study|Withdrawal by Subject|1|||
147278483|NCT02770391|531186598|FG000|Overall Study|Surgery delayed unevaluable|2|||
147278484|NCT02770391|531186598|FG000|Overall Study|Treatment discontinued due to treatment inturruption|1|||
147278485|NCT03333486|531186601|FG000|Overall Study|Withdrawal by Subject|1|||
147278486|NCT03333486|531186601|FG000|Overall Study|Lost to Follow-up|1|||
147278487|NCT03246529|531186606|FG000|Core Study (Until 100 d Post-transplant)|Adverse Event|0|||
147278488|NCT03246529|531186607|FG001|Core Study (Until 100 d Post-transplant)|Adverse Event|2|||
147278489|NCT03246529|531186608|FG002|Core Study (Until 100 d Post-transplant)|Adverse Event|0|||
147278490|NCT03246529|531186606|FG000|Core Study (Until 100 d Post-transplant)|Lost to Follow-up|0|||
147278491|NCT03246529|531186607|FG001|Core Study (Until 100 d Post-transplant)|Lost to Follow-up|1|||
147278492|NCT03246529|531186608|FG002|Core Study (Until 100 d Post-transplant)|Lost to Follow-up|1|||
147278493|NCT03246529|531186606|FG000|Core Study (Until 100 d Post-transplant)|Other Reasons|0|||
147278494|NCT03246529|531186607|FG001|Core Study (Until 100 d Post-transplant)|Other Reasons|2|||
147278495|NCT03246529|531186608|FG002|Core Study (Until 100 d Post-transplant)|Other Reasons|2|||
147278496|NCT03246529|531186606|FG000|Core Study (Until 100 d Post-transplant)|Physician Decision|0|||
147278497|NCT03246529|531186607|FG001|Core Study (Until 100 d Post-transplant)|Physician Decision|0|||
147278498|NCT03246529|531186608|FG002|Core Study (Until 100 d Post-transplant)|Physician Decision|1|||
147278499|NCT03246529|531186606|FG000|Core Study (Until 100 d Post-transplant)|Withdrawal by Subject|0|||
147278500|NCT03246529|531186607|FG001|Core Study (Until 100 d Post-transplant)|Withdrawal by Subject|1|||
147278501|NCT03246529|531186608|FG002|Core Study (Until 100 d Post-transplant)|Withdrawal by Subject|4|||
147278502|NCT03246529|531186606|FG000|Follow-up Period at 1 Year FU Completion|Disease progression|2|||
147278503|NCT03246529|531186607|FG001|Follow-up Period at 1 Year FU Completion|Disease progression|1|||
147278504|NCT03246529|531186608|FG002|Follow-up Period at 1 Year FU Completion|Disease progression|1|||
147450960|NCT01391000|531813196|FG000|Overall Study|Lost to Follow-up|2|||
147450961|NCT01391000|531813197|FG001|Overall Study|Lost to Follow-up|0|||
147450962|NCT00082888|531813198|FG000|Overall Study|Ineligible|1|||
147450963|NCT00082888|531813199|FG001|Overall Study|Ineligible|0|||
147450964|NCT00082888|531813200|FG002|Overall Study|Ineligible|0|||
147278505|NCT03246529|531186606|FG000|Follow-up Period at 1 Year FU Completion|Lost to Follow-up|1|||
147278506|NCT03246529|531186607|FG001|Follow-up Period at 1 Year FU Completion|Lost to Follow-up|3|||
147278507|NCT03246529|531186608|FG002|Follow-up Period at 1 Year FU Completion|Lost to Follow-up|0|||
147278508|NCT03246529|531186606|FG000|Follow-up Period at 1 Year FU Completion|Withdrawal by Subject|0|||
147450965|NCT02684981|531813203|FG000|Overall Study|Permanently discontinued the treatment|157|||
147450966|NCT02684981|531813204|FG001|Overall Study|Permanently discontinued the treatment|161|||
147450967|NCT02684981|531813205|FG002|Overall Study|Permanently discontinued the treatment|110|||
147450968|NCT02684981|531813203|FG000|Overall Study|Other|83|||
147278509|NCT03246529|531186607|FG001|Follow-up Period at 1 Year FU Completion|Withdrawal by Subject|3|||
147278510|NCT03246529|531186608|FG002|Follow-up Period at 1 Year FU Completion|Withdrawal by Subject|0|||
147278511|NCT03246529|531186606|FG000|Follow-up Period at 1 Year FU Completion|Death|0|||
147278512|NCT03246529|531186607|FG001|Follow-up Period at 1 Year FU Completion|Death|0|||
147278513|NCT03246529|531186608|FG002|Follow-up Period at 1 Year FU Completion|Death|1|||
147278514|NCT03136068|531188071|FG000|Overall Study|Lost to Follow-up|1|||
147278515|NCT03136068|531188072|FG001|Overall Study|Lost to Follow-up|1|||
147278516|NCT03136068|531188071|FG000|Overall Study|Protocol Violation|1|||
147278517|NCT03136068|531188072|FG001|Overall Study|Protocol Violation|0|||
147278518|NCT01337089|531188075|FG000|Overall Study|Adverse Event|237|||
147278519|NCT01337089|531188075|FG000|Overall Study|Withdrawal by Subject|129|||
147278520|NCT01337089|531188075|FG000|Overall Study|Withdrawal by Investigator|33|||
147278521|NCT01337089|531188075|FG000|Overall Study|Met Withdrawal Criteria|3|||
147278522|NCT01337089|531188075|FG000|Overall Study|Lost to Follow-up|2|||
147278523|NCT04419493|531188076|FG000|Wash-out After Period 1|Adverse Event|1|||
147278524|NCT04419493|531188077|FG001|Wash-out After Period 1|Adverse Event|2|||
147278525|NCT04419493|531188078|FG002|Wash-out After Period 1|Adverse Event|1|||
147278526|NCT04419493|531188079|FG003|Wash-out After Period 1|Adverse Event|0|||
147278527|NCT00524134|531188080|FG000|Overall Study|Withdrawal by Subject|1|||
147278528|NCT00524134|531188080|FG000|Overall Study|Physician Decision|1|||
147278529|NCT01782131|531188084|FG000|Overall Study|Death|93|||
147278530|NCT01782131|531188085|FG001|Overall Study|Death|96|||
147278531|NCT01782131|531188084|FG000|Overall Study|Lost to Follow-up|1|||
147278532|NCT01782131|531188085|FG001|Overall Study|Lost to Follow-up|3|||
147278533|NCT01782131|531188084|FG000|Overall Study|Withdrawal by Subject|10|||
147278534|NCT01782131|531188085|FG001|Overall Study|Withdrawal by Subject|10|||
147278535|NCT01782131|531188084|FG000|Overall Study|Randomized but not treated|5|||
147278536|NCT01782131|531188085|FG001|Overall Study|Randomized but not treated|5|||
147278537|NCT01782131|531188084|FG000|Overall Study|Reason not provided|0|||
147278538|NCT01782131|531188085|FG001|Overall Study|Reason not provided|1|||
147278539|NCT01627249|531188086|FG000|Overall Study|Death|3|||
147278540|NCT01627249|531188087|FG001|Overall Study|Death|5|||
147278541|NCT01627249|531188088|FG002|Overall Study|Death|3|||
147278542|NCT01627249|531188086|FG000|Overall Study|Withdrawal by Subject|12|||
147278543|NCT01627249|531188087|FG001|Overall Study|Withdrawal by Subject|6|||
147278544|NCT01627249|531188088|FG002|Overall Study|Withdrawal by Subject|9|||
147278545|NCT01627249|531188086|FG000|Overall Study|Missed Visit|1|||
147278546|NCT01627249|531188087|FG001|Overall Study|Missed Visit|1|||
147278547|NCT01627249|531188088|FG002|Overall Study|Missed Visit|0|||
147278548|NCT00796718|531188089|FG000|Overall Study|Adverse Event|2|||
147278549|NCT00796718|531188089|FG000|Overall Study|Exclusion Criteria|1|||
147278550|NCT00796718|531188089|FG000|Overall Study|Lost to Follow-up|5|||
147278551|NCT00796718|531188089|FG000|Overall Study|Withdrawal by Informed Consent|1|||
147278552|NCT03266588|531188090|FG000|Observational Period|Screen Failure: Eligibility Criteria|439|||
147278553|NCT03266588|531188091|FG001|Observational Period|Screen Failure: Eligibility Criteria|228|||
147278554|NCT03266588|531188092|FG002|Observational Period|Screen Failure: Eligibility Criteria|140|||
147278555|NCT03266588|531188090|FG000|Observational Period|Withdrawal by Subject|44|||
147278556|NCT03266588|531188091|FG001|Observational Period|Withdrawal by Subject|22|||
147278557|NCT03266588|531188092|FG002|Observational Period|Withdrawal by Subject|13|||
147278558|NCT03266588|531188090|FG000|Observational Period|Non-compliance|18|||
147278559|NCT03266588|531188091|FG001|Observational Period|Non-compliance|12|||
147278560|NCT03266588|531188092|FG002|Observational Period|Non-compliance|10|||
147278561|NCT03266588|531188090|FG000|Observational Period|Lost to Follow-up|8|||
147278562|NCT03266588|531188091|FG001|Observational Period|Lost to Follow-up|12|||
147278563|NCT03266588|531188092|FG002|Observational Period|Lost to Follow-up|4|||
147278564|NCT03266588|531188090|FG000|Observational Period|Eligibility Failure- Baseline Lab Values|3|||
147278565|NCT03266588|531188091|FG001|Observational Period|Eligibility Failure- Baseline Lab Values|1|||
147278566|NCT03266588|531188092|FG002|Observational Period|Eligibility Failure- Baseline Lab Values|0|||
147278567|NCT03266588|531188090|FG000|Observational Period|Protocol Deviation|1|||
147278568|NCT03266588|531188091|FG001|Observational Period|Protocol Deviation|0|||
147278569|NCT03266588|531188092|FG002|Observational Period|Protocol Deviation|0|||
147278570|NCT03266588|531188090|FG000|Observational Period|Other Reasons|3|||
147278571|NCT03266588|531188091|FG001|Observational Period|Other Reasons|0|||
147278572|NCT03266588|531188092|FG002|Observational Period|Other Reasons|1|||
147278573|NCT03266588|531188090|FG000|Long-term Treatment Period|Adverse Event|33|||
147278574|NCT03266588|531188091|FG001|Long-term Treatment Period|Adverse Event|17|||
147278575|NCT03266588|531188092|FG002|Long-term Treatment Period|Adverse Event|8|||
147278576|NCT03266588|531188090|FG000|Long-term Treatment Period|Lack of Efficacy|41|||
147278577|NCT03266588|531188091|FG001|Long-term Treatment Period|Lack of Efficacy|31|||
147278578|NCT03266588|531188092|FG002|Long-term Treatment Period|Lack of Efficacy|5|||
147278579|NCT03266588|531188090|FG000|Long-term Treatment Period|Lost to Follow-up|39|||
147278580|NCT03266588|531188091|FG001|Long-term Treatment Period|Lost to Follow-up|37|||
147278581|NCT03266588|531188092|FG002|Long-term Treatment Period|Lost to Follow-up|8|||
147278582|NCT03266588|531188090|FG000|Long-term Treatment Period|Non-Compliance|126|||
147278583|NCT03266588|531188091|FG001|Long-term Treatment Period|Non-Compliance|57|||
147278584|NCT03266588|531188092|FG002|Long-term Treatment Period|Non-Compliance|7|||
147278585|NCT03266588|531188090|FG000|Long-term Treatment Period|Pregnancy|11|||
147278586|NCT03266588|531188091|FG001|Long-term Treatment Period|Pregnancy|5|||
147278587|NCT03266588|531188092|FG002|Long-term Treatment Period|Pregnancy|0|||
147278588|NCT03266588|531188090|FG000|Long-term Treatment Period|Protocol Deviation|17|||
147278589|NCT03266588|531188091|FG001|Long-term Treatment Period|Protocol Deviation|10|||
147278590|NCT03266588|531188092|FG002|Long-term Treatment Period|Protocol Deviation|4|||
147278591|NCT03266588|531188090|FG000|Long-term Treatment Period|Screen Failure: Eligibility Criteria|33|||
147278592|NCT03266588|531188091|FG001|Long-term Treatment Period|Screen Failure: Eligibility Criteria|17|||
147278593|NCT03266588|531188092|FG002|Long-term Treatment Period|Screen Failure: Eligibility Criteria|17|||
147278594|NCT03266588|531188090|FG000|Long-term Treatment Period|Withdrawal by Subject|100|||
147278595|NCT03266588|531188091|FG001|Long-term Treatment Period|Withdrawal by Subject|63|||
147278596|NCT03266588|531188092|FG002|Long-term Treatment Period|Withdrawal by Subject|16|||
147278597|NCT03266588|531188090|FG000|Long-term Treatment Period|No Migraine Treated by Week 8 Visit|1|||
147278598|NCT03266588|531188091|FG001|Long-term Treatment Period|No Migraine Treated by Week 8 Visit|2|||
147278599|NCT03266588|531188092|FG002|Long-term Treatment Period|No Migraine Treated by Week 8 Visit|0|||
147278600|NCT03266588|531188090|FG000|Long-term Treatment Period|Other Reasons|5|||
147278601|NCT03266588|531188091|FG001|Long-term Treatment Period|Other Reasons|0|||
147278602|NCT03266588|531188092|FG002|Long-term Treatment Period|Other Reasons|0|||
147278603|NCT03266588|531188090|FG000|Long-term Treatment Period|Positive Sheehan-STS Score > 0|0|||
147278604|NCT03266588|531188091|FG001|Long-term Treatment Period|Positive Sheehan-STS Score > 0|1|||
147278605|NCT03266588|531188092|FG002|Long-term Treatment Period|Positive Sheehan-STS Score > 0|0|||
147278606|NCT02627677|531188094|FG000|Overall Study|Adverse event (not progressive disease)|1|||
147278607|NCT02627677|531188095|FG001|Overall Study|Adverse event (not progressive disease)|4|||
147278608|NCT02627677|531188096|FG002|Overall Study|Adverse event (not progressive disease)|1|||
147278609|NCT02627677|531188094|FG000|Overall Study|Progressive disease|1|||
147278610|NCT02627677|531188095|FG001|Overall Study|Progressive disease|3|||
147278611|NCT02627677|531188096|FG002|Overall Study|Progressive disease|0|||
147278612|NCT02627677|531188094|FG000|Overall Study|Lack of Efficacy|1|||
147278613|NCT02627677|531188095|FG001|Overall Study|Lack of Efficacy|2|||
147278614|NCT02627677|531188096|FG002|Overall Study|Lack of Efficacy|0|||
147278615|NCT02627677|531188094|FG000|Overall Study|Lost to Follow-up|0|||
147278616|NCT02627677|531188095|FG001|Overall Study|Lost to Follow-up|0|||
147278617|NCT02627677|531188096|FG002|Overall Study|Lost to Follow-up|1|||
147278618|NCT02627677|531188094|FG000|Overall Study|Pregnancy|0|||
147278619|NCT02627677|531188095|FG001|Overall Study|Pregnancy|1|||
147278620|NCT02627677|531188096|FG002|Overall Study|Pregnancy|0|||
147278621|NCT02627677|531188094|FG000|Overall Study|Study Terminated by Sponsor|5|||
147278622|NCT02627677|531188095|FG001|Overall Study|Study Terminated by Sponsor|10|||
147278623|NCT02627677|531188096|FG002|Overall Study|Study Terminated by Sponsor|6|||
147278624|NCT02627677|531188094|FG000|Overall Study|Physician Decision|0|||
147278625|NCT02627677|531188095|FG001|Overall Study|Physician Decision|0|||
147278626|NCT02627677|531188096|FG002|Overall Study|Physician Decision|2|||
147278627|NCT02627677|531188094|FG000|Overall Study|Withdrawal by Subject|2|||
147278628|NCT02627677|531188095|FG001|Overall Study|Withdrawal by Subject|1|||
147278629|NCT02627677|531188096|FG002|Overall Study|Withdrawal by Subject|1|||
147278630|NCT02627677|531188094|FG000|Overall Study|Reason not Specified|0|||
147278631|NCT02627677|531188095|FG001|Overall Study|Reason not Specified|0|||
147278632|NCT02627677|531188096|FG002|Overall Study|Reason not Specified|1|||
147278633|NCT02627677|531188094|FG000|Overall Study|Randomized but not Treated|1|||
147278634|NCT02627677|531188095|FG001|Overall Study|Randomized but not Treated|0|||
147278635|NCT02627677|531188096|FG002|Overall Study|Randomized but not Treated|0|||
147278636|NCT00317772|531188097|FG000|Overall Study|Adverse Event|0|||
147278637|NCT00317772|531188098|FG001|Overall Study|Adverse Event|0|||
147278638|NCT00317772|531188099|FG002|Overall Study|Adverse Event|0|||
147278639|NCT00317772|531188100|FG003|Overall Study|Adverse Event|2|||
147278640|NCT00317772|531188097|FG000|Overall Study|Disease Progression|2|||
147601557|NCT01154816|532360634|FG003|Overall Study|Progressive Disease|9|||
147601558|NCT01154816|532360635|FG004|Overall Study|Progressive Disease|8|||
147601559|NCT01154816|532360636|FG005|Overall Study|Progressive Disease|8|||
147601560|NCT01154816|532360637|FG006|Overall Study|Progressive Disease|5|||
147601561|NCT01154816|532360638|FG007|Overall Study|Progressive Disease|6|||
147601562|NCT01154816|532360639|FG008|Overall Study|Progressive Disease|8|||
147601563|NCT01154816|532360640|FG009|Overall Study|Progressive Disease|6|||
147278641|NCT00317772|531188098|FG001|Overall Study|Disease Progression|2|||
147278642|NCT00317772|531188099|FG002|Overall Study|Disease Progression|1|||
147278643|NCT00317772|531188100|FG003|Overall Study|Disease Progression|7|||
147278644|NCT01040871|531188101|FG000|Overall Study|Adverse Event|6|||
147278645|NCT01040871|531188102|FG001|Overall Study|Adverse Event|2|||
147278646|NCT01040871|531188101|FG000|Overall Study|Withdrawal by Subject|2|||
147278647|NCT01040871|531188102|FG001|Overall Study|Withdrawal by Subject|0|||
147334655|NCT01580293|531392038|FG001|Part B|Other reason|0|||
147278648|NCT01040871|531188101|FG000|Overall Study|Death|1|||
147601564|NCT01154816|532360641|FG010|Overall Study|Progressive Disease|10|||
147278649|NCT01040871|531188102|FG001|Overall Study|Death|3|||
147601565|NCT01154816|532360642|FG011|Overall Study|Progressive Disease|3|||
147278650|NCT01040871|531188101|FG000|Overall Study|Lack of Efficacy|1|||
147278651|NCT01040871|531188102|FG001|Overall Study|Lack of Efficacy|1|||
147278652|NCT01040871|531188101|FG000|Overall Study|drug supply issue|1|||
147278653|NCT01040871|531188102|FG001|Overall Study|drug supply issue|0|||
147278654|NCT01040871|531188101|FG000|Overall Study|Randomized and Not Treated|2|||
147278655|NCT01040871|531188102|FG001|Overall Study|Randomized and Not Treated|1|||
147278656|NCT01073618|531188106|FG000|Overall Study|Death|208|||
147278657|NCT01073618|531188106|FG000|Overall Study|Adverse Event|19|||
147278658|NCT01073618|531188106|FG000|Overall Study|Other|80|||
147278659|NCT02696850|531188107|FG000|Overall Study|Withdrawal by Subject|3|||
147278660|NCT02696850|531188108|FG001|Overall Study|Withdrawal by Subject|3|||
147278661|NCT02696850|531188107|FG000|Overall Study|Lost to Follow-up|8|||
147278662|NCT02696850|531188108|FG001|Overall Study|Lost to Follow-up|5|||
147278663|NCT00673049|531188111|FG000|Before Progression on Erlotinib|Randomized but not treated|3|||
147278664|NCT00673049|531188112|FG001|Before Progression on Erlotinib|Randomized but not treated|1|||
147278665|NCT00673049|531188113|FG002|Before Progression on Erlotinib|Randomized but not treated|0|||
147278666|NCT00673049|531188114|FG003|Before Progression on Erlotinib|Randomized but not treated|0|||
147278667|NCT00673049|531188111|FG000|Before Progression on Erlotinib|Death|235|||
147278668|NCT00673049|531188112|FG001|Before Progression on Erlotinib|Death|167|||
147278669|NCT00673049|531188113|FG002|Before Progression on Erlotinib|Death|1|||
147278670|NCT00673049|531188114|FG003|Before Progression on Erlotinib|Death|0|||
147278671|NCT00673049|531188111|FG000|Before Progression on Erlotinib|Lost to Follow-up|9|||
147278672|NCT00673049|531188112|FG001|Before Progression on Erlotinib|Lost to Follow-up|5|||
147278673|NCT00673049|531188113|FG002|Before Progression on Erlotinib|Lost to Follow-up|0|||
147278674|NCT00673049|531188114|FG003|Before Progression on Erlotinib|Lost to Follow-up|0|||
147278675|NCT00673049|531188111|FG000|Before Progression on Erlotinib|Withdrawal by Subject|26|||
147278676|NCT00673049|531188112|FG001|Before Progression on Erlotinib|Withdrawal by Subject|18|||
147278677|NCT00673049|531188113|FG002|Before Progression on Erlotinib|Withdrawal by Subject|0|||
147278678|NCT00673049|531188114|FG003|Before Progression on Erlotinib|Withdrawal by Subject|0|||
147278679|NCT00673049|531188111|FG000|Before Progression on Erlotinib|Other|1|||
147278680|NCT00673049|531188112|FG001|Before Progression on Erlotinib|Other|2|||
147278681|NCT00673049|531188113|FG002|Before Progression on Erlotinib|Other|0|||
147278682|NCT00673049|531188114|FG003|Before Progression on Erlotinib|Other|0|||
147278683|NCT00673049|531188111|FG000|Before Progression on Erlotinib|study terminated by sponsor|18|||
147278684|NCT00673049|531188112|FG001|Before Progression on Erlotinib|study terminated by sponsor|14|||
147278685|NCT00673049|531188113|FG002|Before Progression on Erlotinib|study terminated by sponsor|0|||
147278686|NCT00673049|531188114|FG003|Before Progression on Erlotinib|study terminated by sponsor|0|||
147278687|NCT00673049|531188111|FG000|Before Progression on Erlotinib|Switched to figitumumab|0|||
147278688|NCT00673049|531188112|FG001|Before Progression on Erlotinib|Switched to figitumumab|83|||
147278689|NCT00673049|531188113|FG002|Before Progression on Erlotinib|Switched to figitumumab|0|||
147278690|NCT00673049|531188114|FG003|Before Progression on Erlotinib|Switched to figitumumab|0|||
147278691|NCT00673049|531188111|FG000|After Progression on Erlotinib|Death|0|||
147278692|NCT00673049|531188112|FG001|After Progression on Erlotinib|Death|0|||
147278693|NCT00673049|531188113|FG002|After Progression on Erlotinib|Death|0|||
147278694|NCT00673049|531188114|FG003|After Progression on Erlotinib|Death|71|||
147278695|NCT00673049|531188111|FG000|After Progression on Erlotinib|Lost to Follow-up|0|||
147278696|NCT00673049|531188112|FG001|After Progression on Erlotinib|Lost to Follow-up|0|||
147278697|NCT00673049|531188113|FG002|After Progression on Erlotinib|Lost to Follow-up|0|||
147278698|NCT00673049|531188114|FG003|After Progression on Erlotinib|Lost to Follow-up|3|||
147278699|NCT00673049|531188111|FG000|After Progression on Erlotinib|Withdrawal by Subject|0|||
147278700|NCT00673049|531188112|FG001|After Progression on Erlotinib|Withdrawal by Subject|0|||
147278701|NCT00673049|531188113|FG002|After Progression on Erlotinib|Withdrawal by Subject|0|||
147278702|NCT00673049|531188114|FG003|After Progression on Erlotinib|Withdrawal by Subject|5|||
147278703|NCT00673049|531188111|FG000|After Progression on Erlotinib|study terminated by sponsor|0|||
147278704|NCT00673049|531188112|FG001|After Progression on Erlotinib|study terminated by sponsor|0|||
147278705|NCT00673049|531188113|FG002|After Progression on Erlotinib|study terminated by sponsor|0|||
147278706|NCT00673049|531188114|FG003|After Progression on Erlotinib|study terminated by sponsor|4|||
147278707|NCT02621606|531188115|FG000|Overall Study|Withdrawal by Subject|0|||
147278708|NCT02621606|531188116|FG001|Overall Study|Withdrawal by Subject|1|||
147278709|NCT02621606|531188117|FG002|Overall Study|Withdrawal by Subject|0|||
147278710|NCT02044510|531188118|FG000|Overall Study|Adverse Event|1|||
147278711|NCT02044510|531188119|FG001|Overall Study|Adverse Event|2|||
147278712|NCT01175824|531188120|FG000|Overall Study|Adverse Event|2|||
147278713|NCT01175824|531188121|FG001|Overall Study|Adverse Event|1|||
147278714|NCT01175824|531188120|FG000|Overall Study|Lack of Efficacy|2|||
147278715|NCT01175824|531188121|FG001|Overall Study|Lack of Efficacy|0|||
147278716|NCT01175824|531188120|FG000|Overall Study|Lost to Follow-up|0|||
147278717|NCT01175824|531188121|FG001|Overall Study|Lost to Follow-up|1|||
147278718|NCT01175824|531188120|FG000|Overall Study|Physician Decision|0|||
147278719|NCT01175824|531188121|FG001|Overall Study|Physician Decision|4|||
147278720|NCT01175824|531188120|FG000|Overall Study|Protocol Violation|2|||
147278721|NCT01175824|531188121|FG001|Overall Study|Protocol Violation|5|||
147278722|NCT01175824|531188120|FG000|Overall Study|Withdrawal by Subject|3|||
147278723|NCT01175824|531188121|FG001|Overall Study|Withdrawal by Subject|7|||
147278724|NCT01175824|531188120|FG000|Overall Study|Sponsor Decision|1|||
147278725|NCT01175824|531188121|FG001|Overall Study|Sponsor Decision|0|||
147278726|NCT01175824|531188120|FG000|Overall Study|Entry Criteria Not Met|6|||
147278727|NCT01175824|531188121|FG001|Overall Study|Entry Criteria Not Met|4|||
147278728|NCT03455855|531188122|FG000|Overall Study|Lost to Follow-up|4|||
147278729|NCT03455855|531188123|FG001|Overall Study|Lost to Follow-up|2|||
147278730|NCT02979535|531188124|FG000|Overall Study|Non compliance with the protocol|78|||
147278731|NCT02979535|531188125|FG001|Overall Study|Non compliance with the protocol|82|||
147278732|NCT02979535|531188124|FG000|Overall Study|Consent withdrawn by participant|11|||
147278733|NCT02979535|531188125|FG001|Overall Study|Consent withdrawn by participant|18|||
147278734|NCT02979535|531188124|FG000|Overall Study|Lost to Follow-up|6|||
147278735|NCT02979535|531188125|FG001|Overall Study|Lost to Follow-up|1|||
147278736|NCT04820673|531188126|FG000|Overall Study|Adverse Event|6|||
147278737|NCT04820673|531188126|FG000|Overall Study|Due to Lack of Effectiveness|1|||
147278738|NCT04820673|531188126|FG000|Overall Study|Pregnancy|1|||
147278739|NCT04820673|531188126|FG000|Overall Study|Voluntary Withdrawal|20|||
147278740|NCT04820673|531188126|FG000|Overall Study|Lost to Follow-up|10|||
147278741|NCT00587587|531188127|FG000|Overall Study|Lost to Follow-up|6|||
147278742|NCT00587587|531188128|FG001|Overall Study|Lost to Follow-up|1|||
147278743|NCT00767000|531188134|FG000|54-week Study|Adverse Event|4|||
147278744|NCT00767000|531188135|FG001|54-week Study|Adverse Event|6|||
147278745|NCT00767000|531188136|FG002|54-week Study|Adverse Event|6|||
147278746|NCT00767000|531188137|FG003|54-week Study|Adverse Event|8|||
147278747|NCT00767000|531188138|FG004|54-week Study|Adverse Event|4|||
147278748|NCT00767000|531188134|FG000|54-week Study|Creaninine/creatinine clearance|2|||
147278749|NCT00767000|531188135|FG001|54-week Study|Creaninine/creatinine clearance|1|||
147278750|NCT00767000|531188136|FG002|54-week Study|Creaninine/creatinine clearance|2|||
147278751|NCT00767000|531188137|FG003|54-week Study|Creaninine/creatinine clearance|2|||
147278752|NCT00767000|531188138|FG004|54-week Study|Creaninine/creatinine clearance|4|||
147278753|NCT00767000|531188134|FG000|54-week Study|Hyperglycemia|0|||
147278754|NCT00767000|531188135|FG001|54-week Study|Hyperglycemia|0|||
147278755|NCT00767000|531188136|FG002|54-week Study|Hyperglycemia|1|||
147278756|NCT00767000|531188137|FG003|54-week Study|Hyperglycemia|0|||
147278757|NCT00767000|531188138|FG004|54-week Study|Hyperglycemia|1|||
147278758|NCT00767000|531188134|FG000|54-week Study|Hypoglycemia|0|||
147278759|NCT00767000|531188135|FG001|54-week Study|Hypoglycemia|1|||
147278760|NCT00767000|531188136|FG002|54-week Study|Hypoglycemia|0|||
147278761|NCT00767000|531188137|FG003|54-week Study|Hypoglycemia|0|||
147278762|NCT00767000|531188138|FG004|54-week Study|Hypoglycemia|0|||
147278763|NCT00767000|531188134|FG000|54-week Study|Interruption of study medication|0|||
147278764|NCT00767000|531188135|FG001|54-week Study|Interruption of study medication|0|||
147278765|NCT00767000|531188136|FG002|54-week Study|Interruption of study medication|1|||
147278766|NCT00767000|531188137|FG003|54-week Study|Interruption of study medication|0|||
147278767|NCT00767000|531188138|FG004|54-week Study|Interruption of study medication|0|||
147278768|NCT00767000|531188134|FG000|54-week Study|Lack of Efficacy|2|||
147278769|NCT00767000|531188135|FG001|54-week Study|Lack of Efficacy|0|||
147278770|NCT00767000|531188136|FG002|54-week Study|Lack of Efficacy|1|||
147278771|NCT00767000|531188137|FG003|54-week Study|Lack of Efficacy|0|||
147278772|NCT00767000|531188138|FG004|54-week Study|Lack of Efficacy|5|||
147278773|NCT00767000|531188134|FG000|54-week Study|Lost to Follow-up|4|||
147278774|NCT00767000|531188135|FG001|54-week Study|Lost to Follow-up|0|||
147278775|NCT00767000|531188136|FG002|54-week Study|Lost to Follow-up|1|||
147334656|NCT01580293|531392039|FG002|Part B|Other reason|1|||
147601566|NCT01154816|532360631|FG000|Overall Study|Physician Decision|1|||
147601567|NCT01154816|532360632|FG001|Overall Study|Physician Decision|0|||
147601568|NCT01154816|532360633|FG002|Overall Study|Physician Decision|1|||
147601569|NCT01154816|532360634|FG003|Overall Study|Physician Decision|0|||
147601570|NCT01154816|532360635|FG004|Overall Study|Physician Decision|2|||
147601571|NCT01154816|532360636|FG005|Overall Study|Physician Decision|0|||
147601572|NCT01154816|532360637|FG006|Overall Study|Physician Decision|0|||
147601573|NCT01154816|532360638|FG007|Overall Study|Physician Decision|0|||
147278776|NCT00767000|531188137|FG003|54-week Study|Lost to Follow-up|4|||
147278777|NCT00767000|531188138|FG004|54-week Study|Lost to Follow-up|2|||
147278778|NCT00767000|531188134|FG000|54-week Study|Physician Decision|4|||
147278779|NCT00767000|531188135|FG001|54-week Study|Physician Decision|0|||
147278780|NCT00767000|531188136|FG002|54-week Study|Physician Decision|1|||
147278781|NCT00767000|531188137|FG003|54-week Study|Physician Decision|1|||
147278782|NCT00767000|531188138|FG004|54-week Study|Physician Decision|1|||
147278783|NCT00767000|531188134|FG000|54-week Study|Progressive disease|0|||
147278784|NCT00767000|531188135|FG001|54-week Study|Progressive disease|0|||
147278785|NCT00767000|531188136|FG002|54-week Study|Progressive disease|1|||
147278786|NCT00767000|531188137|FG003|54-week Study|Progressive disease|0|||
147278787|NCT00767000|531188138|FG004|54-week Study|Progressive disease|0|||
147334657|NCT01134562|531392040|FG000|Overall Study|Adverse Event|0|||
147278788|NCT00767000|531188134|FG000|54-week Study|Protocol Violation|0|||
147278789|NCT00767000|531188135|FG001|54-week Study|Protocol Violation|0|||
147601574|NCT01154816|532360639|FG008|Overall Study|Physician Decision|0|||
147278790|NCT00767000|531188136|FG002|54-week Study|Protocol Violation|1|||
147278791|NCT00767000|531188137|FG003|54-week Study|Protocol Violation|2|||
147278792|NCT00767000|531188138|FG004|54-week Study|Protocol Violation|0|||
147278793|NCT00767000|531188134|FG000|54-week Study|Withdrawal by Subject|2|||
147278794|NCT00767000|531188135|FG001|54-week Study|Withdrawal by Subject|3|||
147278795|NCT00767000|531188136|FG002|54-week Study|Withdrawal by Subject|5|||
147278796|NCT00767000|531188137|FG003|54-week Study|Withdrawal by Subject|11|||
147278797|NCT00767000|531188138|FG004|54-week Study|Withdrawal by Subject|13|||
147278798|NCT00767000|531188134|FG000|54-week Study|Study terminated by sponsor|90|||
147278799|NCT00767000|531188135|FG001|54-week Study|Study terminated by sponsor|102|||
147278800|NCT00767000|531188136|FG002|54-week Study|Study terminated by sponsor|89|||
147278801|NCT00767000|531188137|FG003|54-week Study|Study terminated by sponsor|196|||
147278802|NCT00767000|531188138|FG004|54-week Study|Study terminated by sponsor|194|||
147278803|NCT00767000|531188134|FG000|54-week Study|Reason not reported|0|||
147278804|NCT00767000|531188135|FG001|54-week Study|Reason not reported|0|||
147278805|NCT00767000|531188136|FG002|54-week Study|Reason not reported|0|||
147278806|NCT00767000|531188137|FG003|54-week Study|Reason not reported|1|||
147278807|NCT00767000|531188138|FG004|54-week Study|Reason not reported|0|||
147278808|NCT00767000|531188134|FG000|Optional 104-week Extension|Study terminated by sponsor|7|||
147278809|NCT00767000|531188135|FG001|Optional 104-week Extension|Study terminated by sponsor|3|||
147278810|NCT00767000|531188136|FG002|Optional 104-week Extension|Study terminated by sponsor|7|||
147278811|NCT00767000|531188137|FG003|Optional 104-week Extension|Study terminated by sponsor|2|||
147278812|NCT00767000|531188138|FG004|Optional 104-week Extension|Study terminated by sponsor|4|||
147278813|NCT02039505|531188140|FG000|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|2|||
147278814|NCT02039505|531188141|FG001|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|8|||
147278815|NCT02039505|531188142|FG002|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|7|||
147278816|NCT02039505|531188143|FG003|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|0|||
147278817|NCT02039505|531188144|FG004|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|0|||
147278818|NCT02039505|531188145|FG005|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|0|||
147278819|NCT02039505|531188146|FG006|Induction Phase (Week 0 to Week 14)|Pretreatment Event/Adverse Event|0|||
147278820|NCT02039505|531188140|FG000|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|1|||
147278821|NCT02039505|531188141|FG001|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|1|||
147278822|NCT02039505|531188142|FG002|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|3|||
147278823|NCT02039505|531188143|FG003|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|0|||
147278824|NCT02039505|531188144|FG004|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|0|||
147278825|NCT02039505|531188145|FG005|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|0|||
147278826|NCT02039505|531188146|FG006|Induction Phase (Week 0 to Week 14)|Lack of Efficacy|0|||
147278827|NCT02039505|531188140|FG000|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|1|||
147278828|NCT02039505|531188141|FG001|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
147278829|NCT02039505|531188142|FG002|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
147278830|NCT02039505|531188143|FG003|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
147278831|NCT02039505|531188144|FG004|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
147278832|NCT02039505|531188145|FG005|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
147278833|NCT02039505|531188146|FG006|Induction Phase (Week 0 to Week 14)|Major Protocol Deviation|0|||
147278834|NCT02039505|531188140|FG000|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|0|||
147278835|NCT02039505|531188141|FG001|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|0|||
147278836|NCT02039505|531188142|FG002|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|0|||
147278837|NCT02039505|531188143|FG003|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|13|||
147278838|NCT02039505|531188144|FG004|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|8|||
147278839|NCT02039505|531188145|FG005|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|12|||
147278840|NCT02039505|531188146|FG006|Maintenance Phase (Week 14 to Week 60)|Lack of Efficacy|0|||
147278841|NCT02039505|531188140|FG000|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|0|||
147278842|NCT02039505|531188141|FG001|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|0|||
147278843|NCT02039505|531188142|FG002|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|0|||
147278844|NCT02039505|531188143|FG003|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|6|||
147278845|NCT02039505|531188144|FG004|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|1|||
147278846|NCT02039505|531188145|FG005|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|1|||
147278847|NCT02039505|531188146|FG006|Maintenance Phase (Week 14 to Week 60)|Pretreatment Event/Adverse Event|0|||
147278848|NCT02039505|531188140|FG000|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|0|||
147278849|NCT02039505|531188141|FG001|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|0|||
147278850|NCT02039505|531188142|FG002|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|0|||
147278851|NCT02039505|531188143|FG003|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|3|||
147278852|NCT02039505|531188144|FG004|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|2|||
147278853|NCT02039505|531188145|FG005|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|1|||
147450969|NCT02684981|531813204|FG001|Overall Study|Other|49|||
147450970|NCT02684981|531813205|FG002|Overall Study|Other|17|||
147278854|NCT02039505|531188146|FG006|Maintenance Phase (Week 14 to Week 60)|Voluntary Withdrawal|0|||
147278855|NCT02039505|531188140|FG000|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
147278856|NCT02039505|531188141|FG001|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
147278857|NCT02039505|531188142|FG002|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
147278858|NCT02039505|531188143|FG003|Maintenance Phase (Week 14 to Week 60)|Pregnancy|2|||
147278859|NCT02039505|531188144|FG004|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
147278860|NCT02039505|531188145|FG005|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
147278861|NCT02039505|531188146|FG006|Maintenance Phase (Week 14 to Week 60)|Pregnancy|0|||
147278862|NCT02039505|531188140|FG000|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
147278863|NCT02039505|531188141|FG001|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
147278864|NCT02039505|531188142|FG002|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
147278865|NCT02039505|531188143|FG003|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
147278866|NCT02039505|531188144|FG004|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
147278867|NCT02039505|531188145|FG005|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|0|||
147278868|NCT02039505|531188146|FG006|Open-Label (Week 10 up to Week 154)|Lack of Efficacy|44|||
147278869|NCT02039505|531188140|FG000|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
147278870|NCT02039505|531188141|FG001|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
147278871|NCT02039505|531188142|FG002|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
147278872|NCT02039505|531188143|FG003|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
147278873|NCT02039505|531188144|FG004|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
147278874|NCT02039505|531188145|FG005|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|0|||
147278875|NCT02039505|531188146|FG006|Open-Label (Week 10 up to Week 154)|Pretreatment Event/Adverse Event|19|||
147278876|NCT02039505|531188140|FG000|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
147278877|NCT02039505|531188141|FG001|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
147278878|NCT02039505|531188142|FG002|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
147278879|NCT02039505|531188143|FG003|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
147278880|NCT02039505|531188144|FG004|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
147278881|NCT02039505|531188145|FG005|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|0|||
147278882|NCT02039505|531188146|FG006|Open-Label (Week 10 up to Week 154)|Voluntary Withdrawal|7|||
147278883|NCT02039505|531188140|FG000|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
147662503|NCT02513550|532587347|FG002|Double Blind Treatment Period|Met exclusion criteria and was not dosed|1|||
147662504|NCT02513550|532587348|FG003|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0|||
147662505|NCT02513550|532587349|FG004|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0|||
147662506|NCT02513550|532587350|FG005|Double Blind Treatment Period|Met exclusion criteria and was not dosed|0|||
147662507|NCT02513550|532587345|FG000|Double Blind Treatment Period|Due to personal business|2|||
147662508|NCT02513550|532587346|FG001|Double Blind Treatment Period|Due to personal business|0|||
147662509|NCT02513550|532587347|FG002|Double Blind Treatment Period|Due to personal business|1|||
147662510|NCT02513550|532587348|FG003|Double Blind Treatment Period|Due to personal business|0|||
147662511|NCT02513550|532587349|FG004|Double Blind Treatment Period|Due to personal business|0|||
147662512|NCT02513550|532587350|FG005|Double Blind Treatment Period|Due to personal business|0|||
147662513|NCT02513550|532587345|FG000|Double Blind Treatment Period|Death|1|||
147662514|NCT02513550|532587346|FG001|Double Blind Treatment Period|Death|0|||
147334658|NCT01134562|531392041|FG001|Overall Study|Adverse Event|1|||
147334659|NCT01134562|531392042|FG002|Overall Study|Adverse Event|0|||
147334660|NCT01134562|531392043|FG003|Overall Study|Adverse Event|0|||
147278884|NCT02039505|531188141|FG001|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
147278885|NCT02039505|531188142|FG002|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
147278886|NCT02039505|531188143|FG003|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
147278887|NCT02039505|531188144|FG004|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
147278888|NCT02039505|531188145|FG005|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|0|||
147278889|NCT02039505|531188146|FG006|Open-Label (Week 10 up to Week 154)|Major Protocol Deviation|1|||
147278890|NCT01343082|531188149|FG000|The run-in Period|Not meeting criteria|3|||
147278891|NCT01343082|531188150|FG001|The run-in Period|Not meeting criteria|4|||
147278892|NCT01343082|531188151|FG002|The run-in Period|Not meeting criteria|5|||
147278893|NCT01343082|531188149|FG000|Treatment Period , Switched to DE-111|Adverse Event|1|||
147278894|NCT01343082|531188150|FG001|Treatment Period , Switched to DE-111|Adverse Event|4|||
147278895|NCT01343082|531188151|FG002|Treatment Period , Switched to DE-111|Adverse Event|3|||
147278896|NCT01343082|531188149|FG000|Treatment Period , Switched to DE-111|Lack of Efficacy|0|||
147334661|NCT01134562|531392044|FG004|Overall Study|Adverse Event|0|||
147334662|NCT00768664|531392045|FG000|Overall Study|Death|57|||
147334663|NCT00768664|531392045|FG000|Overall Study|Lost to Follow-up|2|||
147278897|NCT01343082|531188150|FG001|Treatment Period , Switched to DE-111|Lack of Efficacy|1|||
147278898|NCT01343082|531188151|FG002|Treatment Period , Switched to DE-111|Lack of Efficacy|2|||
147334664|NCT00768664|531392045|FG000|Overall Study|Other|9|||
147334665|NCT00768664|531392045|FG000|Overall Study|Participant refused|1|||
147334666|NCT02544152|531392046|FG000|Overall Study|Adverse Event|0|||
147334667|NCT02544152|531392047|FG001|Overall Study|Adverse Event|4|||
147278899|NCT01343082|531188149|FG000|Treatment Period , Switched to DE-111|Physician Decision|0|||
147278900|NCT01343082|531188150|FG001|Treatment Period , Switched to DE-111|Physician Decision|2|||
147278901|NCT01343082|531188151|FG002|Treatment Period , Switched to DE-111|Physician Decision|2|||
147278902|NCT01343082|531188149|FG000|Treatment Period , Switched to DE-111|Withdrawal by Subject|4|||
147278903|NCT01343082|531188150|FG001|Treatment Period , Switched to DE-111|Withdrawal by Subject|2|||
147278904|NCT01343082|531188151|FG002|Treatment Period , Switched to DE-111|Withdrawal by Subject|5|||
147278905|NCT03614793|531188153|FG000|Overall Study|Lost to Follow-up|1|||
147278906|NCT03614793|531188154|FG001|Overall Study|Lost to Follow-up|2|||
147278907|NCT03614793|531188153|FG000|Overall Study|Lack of Efficacy|0|||
147278908|NCT03614793|531188154|FG001|Overall Study|Lack of Efficacy|5|||
147278909|NCT03614793|531188153|FG000|Overall Study|Withdrawal by Subject|0|||
147278910|NCT03614793|531188154|FG001|Overall Study|Withdrawal by Subject|1|||
147278911|NCT03614793|531188153|FG000|Overall Study|Insurance denied coverage of the procedure|0|||
147278912|NCT03614793|531188154|FG001|Overall Study|Insurance denied coverage of the procedure|5|||
147278913|NCT00633984|531188155|FG000|Overall Study|Lost to Follow-up|0|||
147278914|NCT00633984|531188156|FG001|Overall Study|Lost to Follow-up|6|||
147278915|NCT00633984|531188155|FG000|Overall Study|Withdrawal by Subject|8|||
147278916|NCT00633984|531188156|FG001|Overall Study|Withdrawal by Subject|7|||
147278917|NCT00633984|531188155|FG000|Overall Study|Hospitalized|1|||
147278918|NCT00633984|531188156|FG001|Overall Study|Hospitalized|0|||
147278919|NCT02554773|531188157|FG000|Original Dose Regimen (SAS 1)|Physician Decision|1|||
147278920|NCT02554773|531188158|FG001|Original Dose Regimen (SAS 1)|Physician Decision|0|||
147278921|NCT02554773|531188157|FG000|Original Dose Regimen (SAS 1)|Withdrawal by Subject|7|||
147278922|NCT02554773|531188158|FG001|Original Dose Regimen (SAS 1)|Withdrawal by Subject|0|||
147278923|NCT02554773|531188157|FG000|Original Dose Regimen (SAS 1)|Adverse Event|3|||
147278924|NCT02554773|531188158|FG001|Original Dose Regimen (SAS 1)|Adverse Event|0|||
147278925|NCT02554773|531188157|FG000|Original Dose Regimen (SAS 1)|Death|1|||
147278926|NCT02554773|531188158|FG001|Original Dose Regimen (SAS 1)|Death|0|||
147601575|NCT01154816|532360640|FG009|Overall Study|Physician Decision|1|||
147601576|NCT01154816|532360641|FG010|Overall Study|Physician Decision|1|||
147601577|NCT01154816|532360642|FG011|Overall Study|Physician Decision|1|||
147601578|NCT01154816|532360631|FG000|Overall Study|Adverse Event|5|||
147278927|NCT02554773|531188157|FG000|Original Dose Regimen (SAS 1)|Other|4|||
147278928|NCT02554773|531188158|FG001|Original Dose Regimen (SAS 1)|Other|0|||
147278929|NCT02554773|531188157|FG000|AT-Based Dose Regimen (SAS 2)|Withdrawal by Subject|0|||
147278930|NCT02554773|531188158|FG001|AT-Based Dose Regimen (SAS 2)|Withdrawal by Subject|1|||
147278931|NCT02554773|531188157|FG000|AT-Based Dose Regimen (SAS 2)|More than 1 AT measurement <15%|0|||
147278932|NCT02554773|531188158|FG001|AT-Based Dose Regimen (SAS 2)|More than 1 AT measurement <15%|1|||
147278933|NCT02554773|531188157|FG000|AT-Based Dose Regimen (SAS 2)|Adverse Event|0|||
147278934|NCT02554773|531188158|FG001|AT-Based Dose Regimen (SAS 2)|Adverse Event|1|||
147278935|NCT02554773|531188157|FG000|AT-Based Dose Regimen (SAS 2)|Other|0|||
147278936|NCT02554773|531188158|FG001|AT-Based Dose Regimen (SAS 2)|Other|3|||
147278937|NCT02496884|531188159|FG000|Overall Study|Counted twice as enrolled|2|||
147278938|NCT02496884|531188160|FG001|Overall Study|Counted twice as enrolled|0|||
147278939|NCT02496884|531188161|FG002|Overall Study|Counted twice as enrolled|0|||
147278940|NCT02496884|531188162|FG003|Overall Study|Counted twice as enrolled|0|||
147278941|NCT02496884|531188159|FG000|Overall Study|Withdrawal by Subject|0|||
147278942|NCT02496884|531188160|FG001|Overall Study|Withdrawal by Subject|3|||
147278943|NCT02496884|531188161|FG002|Overall Study|Withdrawal by Subject|0|||
147278944|NCT02496884|531188162|FG003|Overall Study|Withdrawal by Subject|0|||
147278945|NCT00097591|531188163|FG000|Overall Study|Withdrawal of consent|342|||
147278946|NCT00097591|531188164|FG001|Overall Study|Withdrawal of consent|323|||
147278947|NCT00097591|531188163|FG000|Overall Study|Less than 6 months on study drug|9|||
147278948|NCT00097591|531188164|FG001|Overall Study|Less than 6 months on study drug|7|||
147278949|NCT00097591|531188163|FG000|Overall Study|Unable to attend termination visit|53|||
147278950|NCT00097591|531188164|FG001|Overall Study|Unable to attend termination visit|51|||
147278951|NCT00097591|531188163|FG000|Overall Study|Lost to follow up|6|||
147278952|NCT00097591|531188164|FG001|Overall Study|Lost to follow up|10|||
147278953|NCT00097591|531188163|FG000|Overall Study|Other|0|||
147278954|NCT00097591|531188164|FG001|Overall Study|Other|3|||
147278955|NCT01168999|531188169|FG000|Overall Study|Lost to Follow-up|2|||
147601579|NCT01154816|532360632|FG001|Overall Study|Adverse Event|2|||
147601580|NCT01154816|532360633|FG002|Overall Study|Adverse Event|0|||
147601581|NCT01154816|532360634|FG003|Overall Study|Adverse Event|0|||
147278956|NCT01168999|531188170|FG001|Overall Study|Lost to Follow-up|1|||
147278957|NCT01168999|531188171|FG002|Overall Study|Lost to Follow-up|0|||
147278958|NCT01168999|531188172|FG003|Overall Study|Lost to Follow-up|0|||
147278959|NCT04317586|531188173|FG000|Overall Study|Participants/Hips Implanted Censored from Analysis|2|||
147278960|NCT04317586|531188173|FG000|Overall Study|Participants Terminated Early (*15 Hips Implanted)|14|||
147278961|NCT01276327|531188174|FG000|Overall Study|Adverse Event|1|||
147278962|NCT01276327|531188175|FG001|Overall Study|Adverse Event|3|||
147278963|NCT01276327|531188174|FG000|Overall Study|Withdrawal by Subject|1|||
147601582|NCT01154816|532360635|FG004|Overall Study|Adverse Event|0|||
147601583|NCT01154816|532360636|FG005|Overall Study|Adverse Event|0|||
147334668|NCT02544152|531392046|FG000|Overall Study|Withdrawal by Subject|0|||
147601584|NCT01154816|532360637|FG006|Overall Study|Adverse Event|1|||
147601585|NCT01154816|532360638|FG007|Overall Study|Adverse Event|1|||
147601586|NCT01154816|532360639|FG008|Overall Study|Adverse Event|0|||
147601587|NCT01154816|532360640|FG009|Overall Study|Adverse Event|0|||
147601588|NCT01154816|532360641|FG010|Overall Study|Adverse Event|0|||
147601589|NCT01154816|532360642|FG011|Overall Study|Adverse Event|0|||
147601590|NCT04715932|532360643|FG000|Overall Study|Lost to Follow-up|1|||
147601591|NCT04715932|532360644|FG001|Overall Study|Lost to Follow-up|0|||
147601592|NCT02393248|532360645|FG000|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
147278964|NCT01276327|531188175|FG001|Overall Study|Withdrawal by Subject|0|||
147278965|NCT00807092|531188176|FG000|Overall Study|Adverse Event|0|||
147278966|NCT00807092|531188177|FG001|Overall Study|Adverse Event|1|||
147278967|NCT00807092|531188176|FG000|Overall Study|Protocol Violation|0|||
147278968|NCT00807092|531188177|FG001|Overall Study|Protocol Violation|2|||
147278969|NCT00807092|531188176|FG000|Overall Study|Withdrawal by Subject|1|||
147278970|NCT00807092|531188177|FG001|Overall Study|Withdrawal by Subject|0|||
147278971|NCT00807092|531188176|FG000|Overall Study|CGMS data collection failed|0|||
147278972|NCT00807092|531188177|FG001|Overall Study|CGMS data collection failed|1|||
147278973|NCT01794949|531188178|FG000|Overall Study|Lost to Follow-up|1|||
147278974|NCT01794949|531188179|FG001|Overall Study|Lost to Follow-up|0|||
147278975|NCT03003676|531188180|FG000|Overall Study|Lack of Efficacy|5|||
147278976|NCT03003676|531188181|FG001|Overall Study|Lack of Efficacy|7|||
147278977|NCT03003676|531188180|FG000|Overall Study|Withdrawal by Subject|0|||
147278978|NCT03003676|531188181|FG001|Overall Study|Withdrawal by Subject|1|||
147278979|NCT03003676|531188180|FG000|Overall Study|Hepatitis B infection|1|||
147278980|NCT03003676|531188181|FG001|Overall Study|Hepatitis B infection|0|||
147278981|NCT03766646|531188185|FG000|Overall Study|Withdrawal by Subject|1|||
147278982|NCT03766646|531188186|FG001|Overall Study|Withdrawal by Subject|0|||
147278983|NCT03766646|531188185|FG000|Overall Study|Protocol Violation|0|||
147278984|NCT03766646|531188186|FG001|Overall Study|Protocol Violation|3|||
147278985|NCT00009737|531188194|FG000|Overall Study|Adverse Event|112|||
147278986|NCT00009737|531188195|FG001|Overall Study|Adverse Event|75|||
147278987|NCT00009737|531188194|FG000|Overall Study|Death|4|||
147278988|NCT00009737|531188195|FG001|Overall Study|Death|6|||
147278989|NCT00009737|531188194|FG000|Overall Study|Lack of Efficacy|17|||
147278990|NCT00009737|531188195|FG001|Overall Study|Lack of Efficacy|15|||
147278991|NCT00009737|531188194|FG000|Overall Study|Violation of Selection Criteria at Entry|13|||
147278992|NCT00009737|531188195|FG001|Overall Study|Violation of Selection Criteria at Entry|9|||
147278993|NCT00009737|531188194|FG000|Overall Study|Other Protocol Violation|1|||
147278994|NCT00009737|531188195|FG001|Overall Study|Other Protocol Violation|0|||
147278995|NCT00009737|531188194|FG000|Overall Study|Refused Treatment|15|||
147278996|NCT00009737|531188195|FG001|Overall Study|Refused Treatment|16|||
147278997|NCT00009737|531188194|FG000|Overall Study|Lost to Follow-up|1|||
147278998|NCT00009737|531188195|FG001|Overall Study|Lost to Follow-up|1|||
147278999|NCT00009737|531188194|FG000|Overall Study|Administrative/Other Reasons|7|||
147279000|NCT00009737|531188195|FG001|Overall Study|Administrative/Other Reasons|1|||
147279001|NCT01163682|531188196|FG000|Overall Study|Lost to Follow-up|6|||
147279002|NCT01163682|531188197|FG001|Overall Study|Lost to Follow-up|9|||
147279003|NCT01931839|531188201|FG000|Overall Study|Death|0|||
147279004|NCT01931839|531188202|FG001|Overall Study|Death|1|||
147279005|NCT01931839|531188203|FG002|Overall Study|Death|2|||
147279006|NCT01931839|531188204|FG003|Overall Study|Death|0|||
147279007|NCT01931839|531188205|FG004|Overall Study|Death|0|||
147279008|NCT01931839|531188206|FG005|Overall Study|Death|0|||
147279009|NCT01931839|531188207|FG006|Overall Study|Death|0|||
147279010|NCT01931839|531188201|FG000|Overall Study|Physician Decision|1|||
147279011|NCT01931839|531188202|FG001|Overall Study|Physician Decision|0|||
147279012|NCT01931839|531188203|FG002|Overall Study|Physician Decision|1|||
147601593|NCT02393248|532360646|FG001|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|1|||
147279013|NCT01931839|531188204|FG003|Overall Study|Physician Decision|0|||
147279014|NCT01931839|531188205|FG004|Overall Study|Physician Decision|0|||
147279015|NCT01931839|531188206|FG005|Overall Study|Physician Decision|0|||
147279016|NCT01931839|531188207|FG006|Overall Study|Physician Decision|1|||
147334669|NCT02544152|531392047|FG001|Overall Study|Withdrawal by Subject|3|||
147334670|NCT02544152|531392046|FG000|Overall Study|Other|1|||
147334671|NCT02544152|531392047|FG001|Overall Study|Other|0|||
147279017|NCT01931839|531188201|FG000|Overall Study|Withdrawal of consent|0|||
147334672|NCT00423098|531392048|FG000|Overall Study|Adverse Event|1|||
147334673|NCT00423098|531392049|FG001|Overall Study|Adverse Event|2|||
147601594|NCT02393248|532360647|FG002|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
147279018|NCT01931839|531188202|FG001|Overall Study|Withdrawal of consent|0|||
147279019|NCT01931839|531188203|FG002|Overall Study|Withdrawal of consent|0|||
147279020|NCT01931839|531188204|FG003|Overall Study|Withdrawal of consent|0|||
147279021|NCT01931839|531188205|FG004|Overall Study|Withdrawal of consent|1|||
147279022|NCT01931839|531188206|FG005|Overall Study|Withdrawal of consent|0|||
147279023|NCT01931839|531188207|FG006|Overall Study|Withdrawal of consent|0|||
147279024|NCT01931839|531188201|FG000|Overall Study|Adverse Event|9|||
147279025|NCT01931839|531188202|FG001|Overall Study|Adverse Event|4|||
147601595|NCT02393248|532360648|FG003|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
147601596|NCT02393248|532360649|FG004|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
147601597|NCT02393248|532360650|FG005|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|1|||
147601598|NCT02393248|532360651|FG006|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|1|||
147601599|NCT02393248|532360652|FG007|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
147601600|NCT02393248|532360653|FG008|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
147601601|NCT02393248|532360654|FG009|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
147601602|NCT02393248|532360655|FG010|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
147601603|NCT02393248|532360656|FG011|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
147601604|NCT02393248|532360657|FG012|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
147601605|NCT02393248|532360658|FG013|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
147601606|NCT02393248|532360659|FG014|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
147601607|NCT02393248|532360660|FG015|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
147601608|NCT02393248|532360661|FG016|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
147601609|NCT02393248|532360662|FG017|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
147601610|NCT02393248|532360663|FG018|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
147601611|NCT02393248|532360664|FG019|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
147601612|NCT02393248|532360665|FG020|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
147601613|NCT02393248|532360666|FG021|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
147601614|NCT02393248|532360667|FG022|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
147601615|NCT02393248|532360668|FG023|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
147601616|NCT02393248|532360669|FG024|Part 1: Monotherapy Dose Escalation|Withdrawal by Subject|0|||
147601617|NCT02393248|532360645|FG000|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
147601618|NCT02393248|532360646|FG001|Part 1: Monotherapy Dose Escalation|Disease Progression|1|||
147601619|NCT02393248|532360647|FG002|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
147601620|NCT02393248|532360648|FG003|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
147601621|NCT02393248|532360649|FG004|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
147601622|NCT02393248|532360650|FG005|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
147601623|NCT02393248|532360651|FG006|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
147601624|NCT02393248|532360652|FG007|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
147601625|NCT02393248|532360653|FG008|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
147601626|NCT02393248|532360654|FG009|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
147601627|NCT02393248|532360655|FG010|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
147601628|NCT02393248|532360656|FG011|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
147601629|NCT02393248|532360657|FG012|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
147601630|NCT02393248|532360658|FG013|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
147601631|NCT02393248|532360659|FG014|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
147601632|NCT02393248|532360660|FG015|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
147601633|NCT02393248|532360661|FG016|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
147601634|NCT02393248|532360662|FG017|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
147601635|NCT02393248|532360663|FG018|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
147601636|NCT02393248|532360664|FG019|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
147601637|NCT02393248|532360665|FG020|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
147601638|NCT02393248|532360666|FG021|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
147601639|NCT02393248|532360667|FG022|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
147601640|NCT02393248|532360668|FG023|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
147601641|NCT02393248|532360669|FG024|Part 1: Monotherapy Dose Escalation|Disease Progression|0|||
147601642|NCT02393248|532360645|FG000|Part 1: Monotherapy Dose Escalation|Death|2|||
147601643|NCT02393248|532360646|FG001|Part 1: Monotherapy Dose Escalation|Death|2|||
147601644|NCT02393248|532360647|FG002|Part 1: Monotherapy Dose Escalation|Death|3|||
147601645|NCT02393248|532360648|FG003|Part 1: Monotherapy Dose Escalation|Death|6|||
147601646|NCT02393248|532360649|FG004|Part 1: Monotherapy Dose Escalation|Death|6|||
147601647|NCT02393248|532360650|FG005|Part 1: Monotherapy Dose Escalation|Death|6|||
147601648|NCT02393248|532360651|FG006|Part 1: Monotherapy Dose Escalation|Death|5|||
147601649|NCT02393248|532360652|FG007|Part 1: Monotherapy Dose Escalation|Death|8|||
147601650|NCT02393248|532360653|FG008|Part 1: Monotherapy Dose Escalation|Death|4|||
147601651|NCT02393248|532360654|FG009|Part 1: Monotherapy Dose Escalation|Death|2|||
147601652|NCT02393248|532360655|FG010|Part 1: Monotherapy Dose Escalation|Death|0|||
147601653|NCT02393248|532360656|FG011|Part 1: Monotherapy Dose Escalation|Death|0|||
147601654|NCT02393248|532360657|FG012|Part 1: Monotherapy Dose Escalation|Death|0|||
147601655|NCT02393248|532360658|FG013|Part 1: Monotherapy Dose Escalation|Death|0|||
147601656|NCT02393248|532360659|FG014|Part 1: Monotherapy Dose Escalation|Death|0|||
147601657|NCT02393248|532360660|FG015|Part 1: Monotherapy Dose Escalation|Death|0|||
147601658|NCT02393248|532360661|FG016|Part 1: Monotherapy Dose Escalation|Death|0|||
147601659|NCT02393248|532360662|FG017|Part 1: Monotherapy Dose Escalation|Death|0|||
147601660|NCT02393248|532360663|FG018|Part 1: Monotherapy Dose Escalation|Death|0|||
147601661|NCT02393248|532360664|FG019|Part 1: Monotherapy Dose Escalation|Death|0|||
147601662|NCT02393248|532360665|FG020|Part 1: Monotherapy Dose Escalation|Death|0|||
147450971|NCT00820898|531813206|FG000|Overall Study|Inelgible - wrong primary site|1|||
147450972|NCT00452699|531813209|FG000|Overall Study|Adverse Event|10|||
147450973|NCT00452699|531813210|FG001|Overall Study|Adverse Event|3|||
147450974|NCT00452699|531813209|FG000|Overall Study|Lack of Efficacy|6|||
147450975|NCT00452699|531813210|FG001|Overall Study|Lack of Efficacy|4|||
147450976|NCT00452699|531813209|FG000|Overall Study|Lost to Follow-up|6|||
147450977|NCT00452699|531813210|FG001|Overall Study|Lost to Follow-up|9|||
147450978|NCT00452699|531813209|FG000|Overall Study|Protocol Violation|21|||
147450979|NCT00452699|531813210|FG001|Overall Study|Protocol Violation|25|||
147450980|NCT00452699|531813209|FG000|Overall Study|Withdrawal by Subject|26|||
147450981|NCT00452699|531813210|FG001|Overall Study|Withdrawal by Subject|25|||
147450982|NCT00452699|531813209|FG000|Overall Study|Other|12|||
147450983|NCT00452699|531813210|FG001|Overall Study|Other|7|||
147450984|NCT03031301|531813211|FG000|Overall Study|Protocol Violation|4|||
147450985|NCT03031301|531813212|FG001|Overall Study|Protocol Violation|8|||
147450986|NCT03031301|531813211|FG000|Overall Study|Withdrawal by Subject|7|||
147450987|NCT03031301|531813212|FG001|Overall Study|Withdrawal by Subject|4|||
147450988|NCT03031301|531813211|FG000|Overall Study|Lost to Follow-up|4|||
147450989|NCT03031301|531813212|FG001|Overall Study|Lost to Follow-up|12|||
147450990|NCT03031301|531813211|FG000|Overall Study|Noncompliance|1|||
147450991|NCT03031301|531813212|FG001|Overall Study|Noncompliance|3|||
147450992|NCT03031301|531813211|FG000|Overall Study|Technical issue|1|||
147601663|NCT02393248|532360666|FG021|Part 1: Monotherapy Dose Escalation|Death|0|||
147601664|NCT02393248|532360667|FG022|Part 1: Monotherapy Dose Escalation|Death|0|||
147279026|NCT01931839|531188203|FG002|Overall Study|Adverse Event|1|||
147279027|NCT01931839|531188204|FG003|Overall Study|Adverse Event|3|||
147279028|NCT01931839|531188205|FG004|Overall Study|Adverse Event|0|||
147279029|NCT01931839|531188206|FG005|Overall Study|Adverse Event|0|||
147279030|NCT01931839|531188207|FG006|Overall Study|Adverse Event|1|||
147279031|NCT01931839|531188201|FG000|Overall Study|Withdrawal of consent (not due to AE)|11|||
147279032|NCT01931839|531188202|FG001|Overall Study|Withdrawal of consent (not due to AE)|8|||
147279033|NCT01931839|531188203|FG002|Overall Study|Withdrawal of consent (not due to AE)|13|||
147279034|NCT01931839|531188204|FG003|Overall Study|Withdrawal of consent (not due to AE)|3|||
147279035|NCT01931839|531188205|FG004|Overall Study|Withdrawal of consent (not due to AE)|0|||
147279036|NCT01931839|531188206|FG005|Overall Study|Withdrawal of consent (not due to AE)|2|||
147279037|NCT01931839|531188207|FG006|Overall Study|Withdrawal of consent (not due to AE)|2|||
147279038|NCT01931839|531188201|FG000|Overall Study|Other non-compliance|15|||
147279039|NCT01931839|531188202|FG001|Overall Study|Other non-compliance|9|||
147279040|NCT01931839|531188203|FG002|Overall Study|Other non-compliance|12|||
147279041|NCT01931839|531188204|FG003|Overall Study|Other non-compliance|3|||
147279042|NCT01931839|531188205|FG004|Overall Study|Other non-compliance|0|||
147279043|NCT01931839|531188206|FG005|Overall Study|Other non-compliance|3|||
147279044|NCT01931839|531188207|FG006|Overall Study|Other non-compliance|0|||
147279045|NCT01931839|531188201|FG000|Overall Study|Lost to Follow-up|1|||
147279046|NCT01931839|531188202|FG001|Overall Study|Lost to Follow-up|2|||
147279047|NCT01931839|531188203|FG002|Overall Study|Lost to Follow-up|4|||
147279048|NCT01931839|531188204|FG003|Overall Study|Lost to Follow-up|5|||
147279049|NCT01931839|531188205|FG004|Overall Study|Lost to Follow-up|0|||
147279050|NCT01931839|531188206|FG005|Overall Study|Lost to Follow-up|0|||
147279051|NCT01931839|531188207|FG006|Overall Study|Lost to Follow-up|0|||
147279052|NCT01931839|531188201|FG000|Overall Study|Other|4|||
147279053|NCT01931839|531188202|FG001|Overall Study|Other|2|||
147334674|NCT00423098|531392048|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
147334675|NCT00423098|531392049|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
147334676|NCT00423098|531392048|FG000|Overall Study|Administrative problems|0|||
147334677|NCT00423098|531392049|FG001|Overall Study|Administrative problems|1|||
147334678|NCT00423098|531392048|FG000|Overall Study|Death|2|||
147334679|NCT00423098|531392049|FG001|Overall Study|Death|0|||
147334680|NCT02320123|531392050|FG000|Overall Study|Lost to Follow-up|4|||
147334681|NCT02320123|531392051|FG001|Overall Study|Lost to Follow-up|6|||
147334682|NCT02320123|531392050|FG000|Overall Study|Death|6|||
147334683|NCT02320123|531392051|FG001|Overall Study|Death|5|||
147601665|NCT02393248|532360668|FG023|Part 1: Monotherapy Dose Escalation|Death|0|||
147601666|NCT02393248|532360669|FG024|Part 1: Monotherapy Dose Escalation|Death|0|||
147601667|NCT02393248|532360645|FG000|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|1|||
147279054|NCT01931839|531188203|FG002|Overall Study|Other|6|||
147279055|NCT01931839|531188204|FG003|Overall Study|Other|0|||
147334684|NCT00941655|531392057|FG000|Overall Study|received some chemo, 4 and 9 cycles|1|||
147334685|NCT00941655|531392058|FG001|Overall Study|received some chemo, 4 and 9 cycles|0|||
147279056|NCT01931839|531188205|FG004|Overall Study|Other|0|||
147279057|NCT01931839|531188206|FG005|Overall Study|Other|0|||
147279058|NCT01931839|531188207|FG006|Overall Study|Other|0|||
147279059|NCT03224468|531188213|FG000|Overall Study|Did not obtain MM card|53|||
147279060|NCT03224468|531188214|FG001|Overall Study|Did not obtain MM card|0|||
147450993|NCT03031301|531813212|FG001|Overall Study|Technical issue|1|||
147450994|NCT03031301|531813211|FG000|Overall Study|Adverse Event|1|||
147450995|NCT03031301|531813212|FG001|Overall Study|Adverse Event|0|||
147450996|NCT02429414|531813214|FG000|Overall Study|Physician Decision|0|||
147279061|NCT03224468|531188213|FG000|Overall Study|Lost to Follow-up|4|||
147279062|NCT03224468|531188214|FG001|Overall Study|Lost to Follow-up|11|||
147279063|NCT03224468|531188213|FG000|Overall Study|Cannabis Use Disorder at Baseline|11|||
147279064|NCT03224468|531188214|FG001|Overall Study|Cannabis Use Disorder at Baseline|4|||
147279065|NCT01978119|531188215|FG000|Treatment Period 1 (12 Weeks)|Participants reached stopping criteria|1|||
147279066|NCT01978119|531188216|FG001|Treatment Period 1 (12 Weeks)|Participants reached stopping criteria|0|||
147279067|NCT01978119|531188215|FG000|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|1|||
147334686|NCT00941655|531392057|FG000|Overall Study|not meet criteria for chemo foll surgery|4|||
147334687|NCT00941655|531392058|FG001|Overall Study|not meet criteria for chemo foll surgery|0|||
147334688|NCT00941655|531392057|FG000|Overall Study|progressed while on chemo|0|||
147334689|NCT00941655|531392058|FG001|Overall Study|progressed while on chemo|2|||
147334690|NCT00941655|531392057|FG000|Overall Study|refused further treatment|0|||
147334691|NCT00941655|531392058|FG001|Overall Study|refused further treatment|1|||
147334692|NCT00941655|531392057|FG000|Overall Study|withdrew consent|0|||
147334693|NCT00941655|531392058|FG001|Overall Study|withdrew consent|1|||
147334694|NCT00941655|531392057|FG000|Overall Study|non-compliant|0|||
147334695|NCT00941655|531392058|FG001|Overall Study|non-compliant|1|||
147334696|NCT00004124|531392063|FG000|Overall Study|Received no protocol therapy|12|||
147334697|NCT00004124|531392064|FG001|Overall Study|Received no protocol therapy|20|||
147334698|NCT00446550|531392065|FG000|Overall Study|Adverse Event|1|||
147334699|NCT00446550|531392066|FG001|Overall Study|Adverse Event|0|||
147334700|NCT02698891|531392067|FG000|Overall Study|Withdrawal by Subject|2|||
147334701|NCT02698891|531392067|FG000|Overall Study|deemed ineligible|1|||
147334702|NCT02698891|531392067|FG000|Overall Study|Adverse Event|9|||
147334703|NCT00516386|531392068|FG000|Overall Study|not interested in the study|4|||
147334704|NCT00516386|531392068|FG000|Overall Study|Lost to Follow-up|2|||
147334705|NCT02383472|531392069|FG000|Overall Study|Withdrawal by Subject|1|||
147334706|NCT02383472|531392070|FG001|Overall Study|Withdrawal by Subject|1|||
147334707|NCT02013830|531392071|FG000|Overall Study|Adverse Event|3|||
147334708|NCT02013830|531392071|FG000|Overall Study|Death|1|||
147334709|NCT02013830|531392071|FG000|Overall Study|Insufficient therapeutic response|25|||
147334710|NCT02013830|531392071|FG000|Overall Study|Refused treatment|1|||
147334711|NCT01111526|531392072|FG000|Overall Study|GVHD Disease Progression|0|||
147334712|NCT01111526|531392073|FG001|Overall Study|GVHD Disease Progression|1|||
147334713|NCT01111526|531392074|FG002|Overall Study|GVHD Disease Progression|2|||
147334714|NCT04424641|531392077|FG000|Overall Study|Death|1|||
147279068|NCT01978119|531188216|FG001|Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
147279069|NCT01978119|531188215|FG000|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
147279070|NCT01978119|531188216|FG001|Treatment Period 2 (12 Weeks)|Withdrawal by Subject|2|||
147279071|NCT00812812|531188217|FG000|Overall Study|Adverse Event|2|||
147279072|NCT00812812|531188218|FG001|Overall Study|Adverse Event|1|||
147334715|NCT04424641|531392078|FG001|Overall Study|Death|2|||
147334716|NCT04424641|531392079|FG002|Overall Study|Death|3|||
147334717|NCT04424641|531392080|FG003|Overall Study|Death|0|||
147334718|NCT04424641|531392081|FG004|Overall Study|Death|3|||
147334719|NCT04424641|531392082|FG005|Overall Study|Death|0|||
147334720|NCT04424641|531392083|FG006|Overall Study|Death|1|||
147334721|NCT04424641|531392084|FG007|Overall Study|Death|2|||
147334722|NCT04424641|531392077|FG000|Overall Study|Sponsor decision|0|||
147334723|NCT04424641|531392078|FG001|Overall Study|Sponsor decision|2|||
147334724|NCT04424641|531392079|FG002|Overall Study|Sponsor decision|3|||
147334725|NCT04424641|531392080|FG003|Overall Study|Sponsor decision|7|||
147334726|NCT04424641|531392081|FG004|Overall Study|Sponsor decision|2|||
147334727|NCT04424641|531392082|FG005|Overall Study|Sponsor decision|2|||
147334728|NCT04424641|531392083|FG006|Overall Study|Sponsor decision|3|||
147334729|NCT04424641|531392084|FG007|Overall Study|Sponsor decision|4|||
147334730|NCT04424641|531392077|FG000|Overall Study|Withdrawal by Subject|0|||
147334731|NCT04424641|531392078|FG001|Overall Study|Withdrawal by Subject|0|||
147334732|NCT04424641|531392079|FG002|Overall Study|Withdrawal by Subject|0|||
147334733|NCT04424641|531392080|FG003|Overall Study|Withdrawal by Subject|0|||
147334734|NCT04424641|531392081|FG004|Overall Study|Withdrawal by Subject|1|||
147334735|NCT04424641|531392082|FG005|Overall Study|Withdrawal by Subject|0|||
147334736|NCT04424641|531392083|FG006|Overall Study|Withdrawal by Subject|0|||
147334737|NCT04424641|531392084|FG007|Overall Study|Withdrawal by Subject|0|||
147334738|NCT04424641|531392077|FG000|Overall Study|Other|0|||
147334739|NCT04424641|531392078|FG001|Overall Study|Other|0|||
147334740|NCT04424641|531392079|FG002|Overall Study|Other|1|||
147450997|NCT02429414|531813215|FG001|Overall Study|Physician Decision|1|||
147450998|NCT01784861|531813221|FG000|Overall Study|Adverse Event|0|||
147279073|NCT00812812|531188217|FG000|Overall Study|Lack of Efficacy|1|||
147334741|NCT04424641|531392080|FG003|Overall Study|Other|0|||
147334742|NCT04424641|531392081|FG004|Overall Study|Other|0|||
147334743|NCT04424641|531392082|FG005|Overall Study|Other|0|||
147334744|NCT04424641|531392083|FG006|Overall Study|Other|0|||
147334745|NCT04424641|531392084|FG007|Overall Study|Other|0|||
147334746|NCT01171625|531392091|FG000|Overall Study|On-Protocol|67|||
147334747|NCT01171625|531392091|FG000|Overall Study|Death|38|||
147279074|NCT00812812|531188218|FG001|Overall Study|Lack of Efficacy|0|||
147279075|NCT00812812|531188217|FG000|Overall Study|Lost to Follow-up|0|||
147279076|NCT00812812|531188218|FG001|Overall Study|Lost to Follow-up|1|||
147279077|NCT00812812|531188217|FG000|Overall Study|Withdrawal by Subject|0|||
147279078|NCT00812812|531188218|FG001|Overall Study|Withdrawal by Subject|2|||
147279079|NCT01877421|531188219|FG000|Phase 2|Lost to Follow-up|0|||
147279080|NCT01877421|531188220|FG001|Phase 2|Lost to Follow-up|0|||
147279081|NCT01877421|531188221|FG002|Phase 2|Lost to Follow-up|0|||
147279082|NCT01877421|531188222|FG003|Phase 2|Lost to Follow-up|0|||
147279083|NCT01877421|531188223|FG004|Phase 2|Lost to Follow-up|0|||
147279084|NCT01877421|531188224|FG005|Phase 2|Lost to Follow-up|0|||
147279085|NCT01877421|531188225|FG006|Phase 2|Lost to Follow-up|1|||
147279086|NCT01877421|531188226|FG007|Phase 2|Lost to Follow-up|0|||
147279087|NCT01877421|531188227|FG008|Phase 2|Lost to Follow-up|0|||
147279088|NCT01877421|531188228|FG009|Phase 2|Lost to Follow-up|0|||
147279089|NCT01877421|531188229|FG010|Phase 2|Lost to Follow-up|0|||
147279090|NCT01877421|531188230|FG011|Phase 2|Lost to Follow-up|0|||
147279091|NCT01877421|531188231|FG012|Phase 2|Lost to Follow-up|0|||
147279092|NCT01877421|531188232|FG013|Phase 2|Lost to Follow-up|0|||
147279093|NCT01877421|531188233|FG014|Phase 2|Lost to Follow-up|0|||
147279094|NCT01877421|531188234|FG015|Phase 2|Lost to Follow-up|0|||
147279095|NCT01877421|531188235|FG016|Phase 2|Lost to Follow-up|0|||
147279096|NCT01877421|531188236|FG017|Phase 2|Lost to Follow-up|0|||
147279097|NCT01877421|531188219|FG000|Phase 2|Withdrawal by Subject|0|||
147279098|NCT01877421|531188220|FG001|Phase 2|Withdrawal by Subject|0|||
147334748|NCT01171625|531392091|FG000|Overall Study|Withdrawal by Subject|31|||
147334749|NCT01171625|531392091|FG000|Overall Study|Explanted|10|||
147601668|NCT02393248|532360646|FG001|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
147334750|NCT01171625|531392091|FG000|Overall Study|Lost to Follow-up|5|||
147334751|NCT01171625|531392091|FG000|Overall Study|Patient received valve-in-valve|3|||
147601669|NCT02393248|532360647|FG002|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
147601670|NCT02393248|532360648|FG003|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
147601671|NCT02393248|532360649|FG004|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
147601672|NCT02393248|532360650|FG005|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
147601673|NCT02393248|532360651|FG006|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
147601674|NCT02393248|532360652|FG007|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
147601675|NCT02393248|532360653|FG008|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
147601676|NCT02393248|532360654|FG009|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
147601677|NCT02393248|532360655|FG010|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
147601678|NCT02393248|532360656|FG011|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
147601679|NCT02393248|532360657|FG012|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
147601680|NCT02393248|532360658|FG013|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
147601681|NCT02393248|532360659|FG014|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
147601682|NCT02393248|532360660|FG015|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
147601683|NCT02393248|532360661|FG016|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
147601684|NCT02393248|532360662|FG017|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
147601685|NCT02393248|532360663|FG018|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
147601686|NCT02393248|532360664|FG019|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
147601687|NCT02393248|532360665|FG020|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
147601688|NCT02393248|532360666|FG021|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
147601689|NCT02393248|532360667|FG022|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
147601690|NCT02393248|532360668|FG023|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
147601691|NCT02393248|532360669|FG024|Part 1: Monotherapy Dose Escalation|Lost to Follow-up|0|||
147601692|NCT02393248|532360645|FG000|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
147601693|NCT02393248|532360646|FG001|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
147601694|NCT02393248|532360647|FG002|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
147601695|NCT02393248|532360648|FG003|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
147601696|NCT02393248|532360649|FG004|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
147601697|NCT02393248|532360650|FG005|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|2|||
147601698|NCT02393248|532360651|FG006|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|2|||
147601699|NCT02393248|532360652|FG007|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
147662515|NCT02513550|532587347|FG002|Double Blind Treatment Period|Death|2|||
147662516|NCT02513550|532587348|FG003|Double Blind Treatment Period|Death|0|||
147279099|NCT01877421|531188221|FG002|Phase 2|Withdrawal by Subject|0|||
147279100|NCT01877421|531188222|FG003|Phase 2|Withdrawal by Subject|0|||
147279101|NCT01877421|531188223|FG004|Phase 2|Withdrawal by Subject|0|||
147279102|NCT01877421|531188224|FG005|Phase 2|Withdrawal by Subject|0|||
147279103|NCT01877421|531188225|FG006|Phase 2|Withdrawal by Subject|0|||
147279104|NCT01877421|531188226|FG007|Phase 2|Withdrawal by Subject|0|||
147279105|NCT01877421|531188227|FG008|Phase 2|Withdrawal by Subject|1|||
147279106|NCT01877421|531188228|FG009|Phase 2|Withdrawal by Subject|0|||
147279107|NCT01877421|531188229|FG010|Phase 2|Withdrawal by Subject|1|||
147279108|NCT01877421|531188230|FG011|Phase 2|Withdrawal by Subject|0|||
147279109|NCT01877421|531188231|FG012|Phase 2|Withdrawal by Subject|1|||
147279110|NCT01877421|531188232|FG013|Phase 2|Withdrawal by Subject|0|||
147279111|NCT01877421|531188233|FG014|Phase 2|Withdrawal by Subject|0|||
147279112|NCT01877421|531188234|FG015|Phase 2|Withdrawal by Subject|1|||
147279113|NCT01877421|531188235|FG016|Phase 2|Withdrawal by Subject|0|||
147279114|NCT01877421|531188236|FG017|Phase 2|Withdrawal by Subject|0|||
147279115|NCT01877421|531188219|FG000|Phase 2|Protocol Violation|0|||
147279116|NCT01877421|531188220|FG001|Phase 2|Protocol Violation|0|||
147279117|NCT01877421|531188221|FG002|Phase 2|Protocol Violation|0|||
147279118|NCT01877421|531188222|FG003|Phase 2|Protocol Violation|0|||
147279119|NCT01877421|531188223|FG004|Phase 2|Protocol Violation|0|||
147279120|NCT01877421|531188224|FG005|Phase 2|Protocol Violation|0|||
147279121|NCT01877421|531188225|FG006|Phase 2|Protocol Violation|0|||
147279122|NCT01877421|531188226|FG007|Phase 2|Protocol Violation|0|||
147279123|NCT01877421|531188227|FG008|Phase 2|Protocol Violation|0|||
147279124|NCT01877421|531188228|FG009|Phase 2|Protocol Violation|0|||
147279125|NCT01877421|531188229|FG010|Phase 2|Protocol Violation|1|||
147279126|NCT01877421|531188230|FG011|Phase 2|Protocol Violation|0|||
147279127|NCT01877421|531188231|FG012|Phase 2|Protocol Violation|0|||
147279128|NCT01877421|531188232|FG013|Phase 2|Protocol Violation|0|||
147279129|NCT01877421|531188233|FG014|Phase 2|Protocol Violation|0|||
147279130|NCT01877421|531188234|FG015|Phase 2|Protocol Violation|0|||
147279131|NCT01877421|531188235|FG016|Phase 2|Protocol Violation|0|||
147279132|NCT01877421|531188236|FG017|Phase 2|Protocol Violation|0|||
147279133|NCT00908960|531188237|FG000|Overall Study|Presence VTE dx or Absent VTE eval|1|||
147279134|NCT00908960|531188238|FG001|Overall Study|Presence VTE dx or Absent VTE eval|1|||
147279135|NCT00908960|531188239|FG002|Overall Study|Presence VTE dx or Absent VTE eval|2|||
147279136|NCT01158924|531188240|FG000|Overall Study|Withdrawal by Subject|1|||
147279137|NCT01158924|531188241|FG001|Overall Study|Withdrawal by Subject|2|||
147279138|NCT01158924|531188240|FG000|Overall Study|Lost to Follow-up|0|||
147279139|NCT01158924|531188241|FG001|Overall Study|Lost to Follow-up|1|||
147279140|NCT00432380|531190351|FG000|Overall Study|Migrated/moved from study area|3|||
147279141|NCT00432380|531190352|FG001|Overall Study|Migrated/moved from study area|4|||
147279142|NCT00432380|531190353|FG002|Overall Study|Migrated/moved from study area|1|||
147279143|NCT00432380|531190351|FG000|Overall Study|Adverse Event|1|||
147279144|NCT00432380|531190352|FG001|Overall Study|Adverse Event|0|||
147279145|NCT00432380|531190353|FG002|Overall Study|Adverse Event|0|||
147279146|NCT01071395|531190354|FG000|Overall Study|Withdrawal by Subject|2|||
147279147|NCT01071395|531190355|FG001|Overall Study|Withdrawal by Subject|1|||
147279148|NCT01071395|531190354|FG000|Overall Study|Adverse Event|3|||
147279149|NCT01071395|531190355|FG001|Overall Study|Adverse Event|1|||
147279150|NCT03422003|531190359|FG000|Baseline|Some participants skipped the survey question related to the primary outcome being analyzed.|7|||
147279151|NCT03422003|531190360|FG001|Baseline|Some participants skipped the survey question related to the primary outcome being analyzed.|2|||
147279152|NCT03422003|531190359|FG000|6-month Follow-up|Withdrawal by subject, loss to follow-up|26|||
147279153|NCT03422003|531190360|FG001|6-month Follow-up|Withdrawal by subject, loss to follow-up|33|||
147279154|NCT01404312|531190361|FG000|Overall Study|Death|21|||
147279155|NCT01404312|531190362|FG001|Overall Study|Death|27|||
147279156|NCT01404312|531190361|FG000|Overall Study|Withdrawal by Subject|15|||
147279157|NCT01404312|531190362|FG001|Overall Study|Withdrawal by Subject|18|||
147279158|NCT01404312|531190361|FG000|Overall Study|Participant Unable to get to clinic|93|||
147279159|NCT01404312|531190362|FG001|Overall Study|Participant Unable to get to clinic|103|||
147279160|NCT01404312|531190361|FG000|Overall Study|Lost to Follow-up|115|||
147279161|NCT01404312|531190362|FG001|Overall Study|Lost to Follow-up|111|||
147279162|NCT01404312|531190361|FG000|Overall Study|Site closed|22|||
147279163|NCT01404312|531190362|FG001|Overall Study|Site closed|21|||
147279164|NCT01404312|531190361|FG000|Overall Study|Participant not willing to adhere to req|31|||
147279165|NCT01404312|531190362|FG001|Overall Study|Participant not willing to adhere to req|29|||
147279166|NCT01404312|531190361|FG000|Overall Study|Severe debilitation, unable to continue|1|||
147279167|NCT01404312|531190362|FG001|Overall Study|Severe debilitation, unable to continue|2|||
147279168|NCT01722331|531190363|FG000|Part 1|Adverse Event|5|||
147279169|NCT01722331|531190364|FG001|Part 1|Adverse Event|0|||
147279170|NCT01722331|531190365|FG002|Part 1|Adverse Event|0|||
147279171|NCT01722331|531190366|FG003|Part 1|Adverse Event|0|||
147279172|NCT01722331|531190367|FG004|Part 1|Adverse Event|0|||
147279173|NCT01722331|531190368|FG005|Part 1|Adverse Event|0|||
147279174|NCT01722331|531190369|FG006|Part 1|Adverse Event|0|||
147279175|NCT01722331|531190363|FG000|Part 1|Lack of Efficacy|0|||
147279176|NCT01722331|531190364|FG001|Part 1|Lack of Efficacy|0|||
147279177|NCT01722331|531190365|FG002|Part 1|Lack of Efficacy|1|||
147279178|NCT01722331|531190366|FG003|Part 1|Lack of Efficacy|0|||
147279179|NCT01722331|531190367|FG004|Part 1|Lack of Efficacy|2|||
147279180|NCT01722331|531190368|FG005|Part 1|Lack of Efficacy|0|||
147279181|NCT01722331|531190369|FG006|Part 1|Lack of Efficacy|0|||
147279182|NCT01722331|531190363|FG000|Part 1|Lost to Follow-up|1|||
147279183|NCT01722331|531190364|FG001|Part 1|Lost to Follow-up|0|||
147450999|NCT01784861|531813222|FG001|Overall Study|Adverse Event|0|||
147279184|NCT01722331|531190365|FG002|Part 1|Lost to Follow-up|2|||
147279185|NCT01722331|531190366|FG003|Part 1|Lost to Follow-up|0|||
147279186|NCT01722331|531190367|FG004|Part 1|Lost to Follow-up|1|||
147279187|NCT01722331|531190368|FG005|Part 1|Lost to Follow-up|0|||
147451000|NCT01784861|531813223|FG002|Overall Study|Adverse Event|1|||
147451001|NCT01784861|531813224|FG003|Overall Study|Adverse Event|2|||
147451002|NCT01784861|531813225|FG004|Overall Study|Adverse Event|1|||
147451003|NCT01784861|531813226|FG005|Overall Study|Adverse Event|0|||
147451004|NCT01784861|531813221|FG000|Overall Study|Withdrawal by Subject|0|||
147451005|NCT01784861|531813222|FG001|Overall Study|Withdrawal by Subject|0|||
147451006|NCT01784861|531813223|FG002|Overall Study|Withdrawal by Subject|0|||
147279188|NCT01722331|531190369|FG006|Part 1|Lost to Follow-up|0|||
147451007|NCT01784861|531813224|FG003|Overall Study|Withdrawal by Subject|1|||
147451008|NCT01784861|531813225|FG004|Overall Study|Withdrawal by Subject|0|||
147451009|NCT01784861|531813226|FG005|Overall Study|Withdrawal by Subject|0|||
147451010|NCT01784861|531813221|FG000|Overall Study|Physician Decision|0|||
147451011|NCT01784861|531813222|FG001|Overall Study|Physician Decision|0|||
147279189|NCT01722331|531190363|FG000|Part 1|Physician Decision|0|||
147279190|NCT01722331|531190364|FG001|Part 1|Physician Decision|0|||
147279191|NCT01722331|531190365|FG002|Part 1|Physician Decision|3|||
147279192|NCT01722331|531190366|FG003|Part 1|Physician Decision|0|||
147279193|NCT01722331|531190367|FG004|Part 1|Physician Decision|1|||
147279194|NCT01722331|531190368|FG005|Part 1|Physician Decision|0|||
147279195|NCT01722331|531190369|FG006|Part 1|Physician Decision|0|||
147279196|NCT01722331|531190363|FG000|Part 1|Pregnancy|1|||
147279197|NCT01722331|531190364|FG001|Part 1|Pregnancy|0|||
147279198|NCT01722331|531190365|FG002|Part 1|Pregnancy|0|||
147279199|NCT01722331|531190366|FG003|Part 1|Pregnancy|0|||
147279200|NCT01722331|531190367|FG004|Part 1|Pregnancy|0|||
147279201|NCT01722331|531190368|FG005|Part 1|Pregnancy|0|||
147279202|NCT01722331|531190369|FG006|Part 1|Pregnancy|0|||
147279203|NCT01722331|531190363|FG000|Part 1|Progressive Disease|0|||
147451012|NCT01784861|531813223|FG002|Overall Study|Physician Decision|0|||
147451013|NCT01784861|531813224|FG003|Overall Study|Physician Decision|2|||
147451014|NCT01784861|531813225|FG004|Overall Study|Physician Decision|0|||
147451015|NCT01784861|531813226|FG005|Overall Study|Physician Decision|1|||
147451016|NCT01604265|531813227|FG000|Overall Study|Adverse Event|1|||
147451017|NCT01604265|531813228|FG001|Overall Study|Adverse Event|0|||
147451018|NCT01604265|531813227|FG000|Overall Study|Withdrawal by Subject|1|||
147451019|NCT01604265|531813228|FG001|Overall Study|Withdrawal by Subject|0|||
147451020|NCT02599961|531813229|FG000|Overall Study|Withdrawal by Subject|1|||
147451021|NCT02599961|531813229|FG000|Overall Study|Subject Non-Compliance|2|||
147451022|NCT02599961|531813229|FG000|Overall Study|Discontinuation of Study by Sponsor|9|||
147451023|NCT02599961|531813229|FG000|Overall Study|Other, Not Specified|3|||
147451024|NCT02432235|531813230|FG000|Overall Study|Death|1|||
147451025|NCT02432235|531813231|FG001|Overall Study|Death|1|||
147451026|NCT02432235|531813232|FG002|Overall Study|Death|2|||
147601700|NCT02393248|532360653|FG008|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
147601701|NCT02393248|532360654|FG009|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|1|||
147601702|NCT02393248|532360655|FG010|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
147601703|NCT02393248|532360656|FG011|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
147601704|NCT02393248|532360657|FG012|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
147601705|NCT02393248|532360658|FG013|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
147279204|NCT01722331|531190364|FG001|Part 1|Progressive Disease|0|||
147279205|NCT01722331|531190365|FG002|Part 1|Progressive Disease|0|||
147279206|NCT01722331|531190366|FG003|Part 1|Progressive Disease|0|||
147279207|NCT01722331|531190367|FG004|Part 1|Progressive Disease|1|||
147279208|NCT01722331|531190368|FG005|Part 1|Progressive Disease|0|||
147279209|NCT01722331|531190369|FG006|Part 1|Progressive Disease|0|||
147279210|NCT01722331|531190363|FG000|Part 1|Protocol Violation|1|||
147279211|NCT01722331|531190364|FG001|Part 1|Protocol Violation|0|||
147279212|NCT01722331|531190365|FG002|Part 1|Protocol Violation|0|||
147279213|NCT01722331|531190366|FG003|Part 1|Protocol Violation|0|||
147279214|NCT01722331|531190367|FG004|Part 1|Protocol Violation|1|||
147279215|NCT01722331|531190368|FG005|Part 1|Protocol Violation|0|||
147279216|NCT01722331|531190369|FG006|Part 1|Protocol Violation|0|||
147279217|NCT01722331|531190363|FG000|Part 1|Withdrawal by Subject|2|||
147451027|NCT02432235|531813233|FG003|Overall Study|Death|2|||
147451028|NCT02432235|531813234|FG004|Overall Study|Death|1|||
147279218|NCT01722331|531190364|FG001|Part 1|Withdrawal by Subject|0|||
147279219|NCT01722331|531190365|FG002|Part 1|Withdrawal by Subject|3|||
147279220|NCT01722331|531190366|FG003|Part 1|Withdrawal by Subject|0|||
147279221|NCT01722331|531190367|FG004|Part 1|Withdrawal by Subject|3|||
147279222|NCT01722331|531190368|FG005|Part 1|Withdrawal by Subject|0|||
147279223|NCT01722331|531190369|FG006|Part 1|Withdrawal by Subject|0|||
147279224|NCT01722331|531190363|FG000|Part 2|Adverse Event|3|||
147279225|NCT01722331|531190364|FG001|Part 2|Adverse Event|0|||
147279226|NCT01722331|531190365|FG002|Part 2|Adverse Event|0|||
147451029|NCT02432235|531813235|FG005|Overall Study|Death|3|||
147451030|NCT02432235|531813236|FG006|Overall Study|Death|11|||
147451031|NCT02432235|531813237|FG007|Overall Study|Death|15|||
147451032|NCT02432235|531813238|FG008|Overall Study|Death|15|||
147451033|NCT02432235|531813239|FG009|Overall Study|Death|3|||
147451034|NCT02432235|531813240|FG010|Overall Study|Death|1|||
147451035|NCT02432235|531813241|FG011|Overall Study|Death|0|||
147451036|NCT02432235|531813230|FG000|Overall Study|Withdrawal by Subject|0|||
147279227|NCT01722331|531190366|FG003|Part 2|Adverse Event|0|||
147279228|NCT01722331|531190367|FG004|Part 2|Adverse Event|0|||
147279229|NCT01722331|531190368|FG005|Part 2|Adverse Event|1|||
147279230|NCT01722331|531190369|FG006|Part 2|Adverse Event|0|||
147279231|NCT01722331|531190363|FG000|Part 2|Lack of Efficacy|3|||
147279232|NCT01722331|531190364|FG001|Part 2|Lack of Efficacy|0|||
147279233|NCT01722331|531190365|FG002|Part 2|Lack of Efficacy|11|||
147279234|NCT01722331|531190366|FG003|Part 2|Lack of Efficacy|0|||
147279235|NCT01722331|531190367|FG004|Part 2|Lack of Efficacy|0|||
147279236|NCT01722331|531190368|FG005|Part 2|Lack of Efficacy|3|||
147279237|NCT01722331|531190369|FG006|Part 2|Lack of Efficacy|3|||
147279238|NCT01722331|531190363|FG000|Part 2|Lost to Follow-up|0|||
147279239|NCT01722331|531190364|FG001|Part 2|Lost to Follow-up|0|||
147279240|NCT01722331|531190365|FG002|Part 2|Lost to Follow-up|3|||
147279241|NCT01722331|531190366|FG003|Part 2|Lost to Follow-up|0|||
147279242|NCT01722331|531190367|FG004|Part 2|Lost to Follow-up|0|||
147279243|NCT01722331|531190368|FG005|Part 2|Lost to Follow-up|1|||
147279244|NCT01722331|531190369|FG006|Part 2|Lost to Follow-up|1|||
147279245|NCT01722331|531190363|FG000|Part 2|Non-Compliance with Study Drug|1|||
147279246|NCT01722331|531190364|FG001|Part 2|Non-Compliance with Study Drug|0|||
147279247|NCT01722331|531190365|FG002|Part 2|Non-Compliance with Study Drug|1|||
147279248|NCT01722331|531190366|FG003|Part 2|Non-Compliance with Study Drug|0|||
147279249|NCT01722331|531190367|FG004|Part 2|Non-Compliance with Study Drug|0|||
147279250|NCT01722331|531190368|FG005|Part 2|Non-Compliance with Study Drug|0|||
147279251|NCT01722331|531190369|FG006|Part 2|Non-Compliance with Study Drug|0|||
147279252|NCT01722331|531190363|FG000|Part 2|Physician Decision|0|||
147279253|NCT01722331|531190364|FG001|Part 2|Physician Decision|0|||
147279254|NCT01722331|531190365|FG002|Part 2|Physician Decision|2|||
147279255|NCT01722331|531190366|FG003|Part 2|Physician Decision|0|||
147279256|NCT01722331|531190367|FG004|Part 2|Physician Decision|0|||
147279257|NCT01722331|531190368|FG005|Part 2|Physician Decision|0|||
147279258|NCT01722331|531190369|FG006|Part 2|Physician Decision|0|||
147279259|NCT01722331|531190363|FG000|Part 2|Pregnancy|0|||
147279260|NCT01722331|531190364|FG001|Part 2|Pregnancy|0|||
147279261|NCT01722331|531190365|FG002|Part 2|Pregnancy|0|||
147279262|NCT01722331|531190366|FG003|Part 2|Pregnancy|0|||
147279263|NCT01722331|531190367|FG004|Part 2|Pregnancy|0|||
147279264|NCT01722331|531190368|FG005|Part 2|Pregnancy|1|||
147279265|NCT01722331|531190369|FG006|Part 2|Pregnancy|0|||
147279266|NCT01722331|531190363|FG000|Part 2|Progressive Disease|0|||
147279267|NCT01722331|531190364|FG001|Part 2|Progressive Disease|0|||
147279268|NCT01722331|531190365|FG002|Part 2|Progressive Disease|1|||
147279269|NCT01722331|531190366|FG003|Part 2|Progressive Disease|0|||
147279270|NCT01722331|531190367|FG004|Part 2|Progressive Disease|0|||
147279271|NCT01722331|531190368|FG005|Part 2|Progressive Disease|0|||
147279272|NCT01722331|531190369|FG006|Part 2|Progressive Disease|0|||
147279273|NCT01722331|531190363|FG000|Part 2|Protocol Violation|1|||
147279274|NCT01722331|531190364|FG001|Part 2|Protocol Violation|0|||
147279275|NCT01722331|531190365|FG002|Part 2|Protocol Violation|0|||
147279276|NCT01722331|531190366|FG003|Part 2|Protocol Violation|0|||
147334752|NCT01171625|531392091|FG000|Overall Study|Other|1|||
147334753|NCT01171625|531392091|FG000|Overall Study|Consented but did not receive device|25|||
147334754|NCT03557008|531392092|FG000|Overall Study|Withdrawal by Subject|2|||
147334755|NCT03557008|531392093|FG001|Overall Study|Withdrawal by Subject|2|||
147334756|NCT03557008|531392092|FG000|Overall Study|Early termination from study|3|||
147334757|NCT03557008|531392093|FG001|Overall Study|Early termination from study|1|||
147334758|NCT00186186|531392094|FG000|Overall Study|Lack of Efficacy|3|||
147334759|NCT00186186|531392094|FG000|Overall Study|Withdrawal by Subject|3|||
147334760|NCT00186186|531392094|FG000|Overall Study|Not reported as to reason|2|||
147279277|NCT01722331|531190367|FG004|Part 2|Protocol Violation|0|||
147279278|NCT01722331|531190368|FG005|Part 2|Protocol Violation|0|||
147279279|NCT01722331|531190369|FG006|Part 2|Protocol Violation|0|||
147279280|NCT01722331|531190363|FG000|Part 2|Withdrawal by Subject|5|||
147279281|NCT01722331|531190364|FG001|Part 2|Withdrawal by Subject|0|||
147279282|NCT01722331|531190365|FG002|Part 2|Withdrawal by Subject|3|||
147279283|NCT01722331|531190366|FG003|Part 2|Withdrawal by Subject|0|||
147279284|NCT01722331|531190367|FG004|Part 2|Withdrawal by Subject|0|||
147279285|NCT01722331|531190368|FG005|Part 2|Withdrawal by Subject|2|||
147279286|NCT01722331|531190369|FG006|Part 2|Withdrawal by Subject|2|||
147334761|NCT00807144|531392095|FG000|Overall Study|Lost to Follow-up|0|||
147334762|NCT00807144|531392096|FG001|Overall Study|Lost to Follow-up|1|||
147279287|NCT01722331|531190363|FG000|Part 2|Other Protocol Specified Criteria|6|||
147279288|NCT01722331|531190364|FG001|Part 2|Other Protocol Specified Criteria|0|||
147279289|NCT01722331|531190365|FG002|Part 2|Other Protocol Specified Criteria|10|||
147279290|NCT01722331|531190366|FG003|Part 2|Other Protocol Specified Criteria|0|||
147279291|NCT01722331|531190367|FG004|Part 2|Other Protocol Specified Criteria|0|||
147279292|NCT01722331|531190368|FG005|Part 2|Other Protocol Specified Criteria|2|||
147279293|NCT01722331|531190369|FG006|Part 2|Other Protocol Specified Criteria|1|||
147279294|NCT01722331|531190363|FG000|Part 3|Adverse Event|2|||
147279295|NCT01722331|531190364|FG001|Part 3|Adverse Event|2|||
147279296|NCT01722331|531190365|FG002|Part 3|Adverse Event|0|||
147279297|NCT01722331|531190366|FG003|Part 3|Adverse Event|1|||
147279298|NCT01722331|531190367|FG004|Part 3|Adverse Event|0|||
147279299|NCT01722331|531190368|FG005|Part 3|Adverse Event|0|||
147279300|NCT01722331|531190369|FG006|Part 3|Adverse Event|0|||
147279301|NCT01722331|531190363|FG000|Part 3|Death|1|||
147279302|NCT01722331|531190364|FG001|Part 3|Death|0|||
147279303|NCT01722331|531190365|FG002|Part 3|Death|0|||
147279304|NCT01722331|531190366|FG003|Part 3|Death|0|||
147279305|NCT01722331|531190367|FG004|Part 3|Death|0|||
147279306|NCT01722331|531190368|FG005|Part 3|Death|0|||
147279307|NCT01722331|531190369|FG006|Part 3|Death|0|||
147279308|NCT01722331|531190363|FG000|Part 3|Lack of Efficacy|1|||
147279309|NCT01722331|531190364|FG001|Part 3|Lack of Efficacy|0|||
147279310|NCT01722331|531190365|FG002|Part 3|Lack of Efficacy|0|||
147279311|NCT01722331|531190366|FG003|Part 3|Lack of Efficacy|0|||
147279312|NCT01722331|531190367|FG004|Part 3|Lack of Efficacy|0|||
147279313|NCT01722331|531190368|FG005|Part 3|Lack of Efficacy|0|||
147279314|NCT01722331|531190369|FG006|Part 3|Lack of Efficacy|0|||
147279315|NCT01722331|531190363|FG000|Part 3|Lost to Follow-up|3|||
147279316|NCT01722331|531190364|FG001|Part 3|Lost to Follow-up|4|||
147279317|NCT01722331|531190365|FG002|Part 3|Lost to Follow-up|0|||
147279318|NCT01722331|531190366|FG003|Part 3|Lost to Follow-up|0|||
147279319|NCT01722331|531190367|FG004|Part 3|Lost to Follow-up|0|||
147279320|NCT01722331|531190368|FG005|Part 3|Lost to Follow-up|1|||
147279321|NCT01722331|531190369|FG006|Part 3|Lost to Follow-up|0|||
147279322|NCT01722331|531190363|FG000|Part 3|Non-Compliance with Study Drug|0|||
147279323|NCT01722331|531190364|FG001|Part 3|Non-Compliance with Study Drug|1|||
147279324|NCT01722331|531190365|FG002|Part 3|Non-Compliance with Study Drug|0|||
147279325|NCT01722331|531190366|FG003|Part 3|Non-Compliance with Study Drug|0|||
147279326|NCT01722331|531190367|FG004|Part 3|Non-Compliance with Study Drug|0|||
147279327|NCT01722331|531190368|FG005|Part 3|Non-Compliance with Study Drug|0|||
147279328|NCT01722331|531190369|FG006|Part 3|Non-Compliance with Study Drug|0|||
147279329|NCT01722331|531190363|FG000|Part 3|Physician Decision|1|||
147279330|NCT01722331|531190364|FG001|Part 3|Physician Decision|1|||
147279331|NCT01722331|531190365|FG002|Part 3|Physician Decision|0|||
147279332|NCT01722331|531190366|FG003|Part 3|Physician Decision|0|||
147279333|NCT01722331|531190367|FG004|Part 3|Physician Decision|0|||
147279334|NCT01722331|531190368|FG005|Part 3|Physician Decision|0|||
147279335|NCT01722331|531190369|FG006|Part 3|Physician Decision|1|||
147279336|NCT01722331|531190363|FG000|Part 3|Protocol Violation|2|||
147279337|NCT01722331|531190364|FG001|Part 3|Protocol Violation|1|||
147279338|NCT01722331|531190365|FG002|Part 3|Protocol Violation|0|||
147279339|NCT01722331|531190366|FG003|Part 3|Protocol Violation|0|||
147279340|NCT01722331|531190367|FG004|Part 3|Protocol Violation|0|||
147279341|NCT01722331|531190368|FG005|Part 3|Protocol Violation|0|||
147279342|NCT01722331|531190369|FG006|Part 3|Protocol Violation|0|||
147279343|NCT01722331|531190363|FG000|Part 3|Withdrawal by Subject|4|||
147279344|NCT01722331|531190364|FG001|Part 3|Withdrawal by Subject|7|||
147279345|NCT01722331|531190365|FG002|Part 3|Withdrawal by Subject|0|||
147279346|NCT01722331|531190366|FG003|Part 3|Withdrawal by Subject|0|||
147279347|NCT01722331|531190367|FG004|Part 3|Withdrawal by Subject|0|||
147279348|NCT01722331|531190368|FG005|Part 3|Withdrawal by Subject|2|||
147279349|NCT01722331|531190369|FG006|Part 3|Withdrawal by Subject|1|||
147279350|NCT01722331|531190363|FG000|Part 3|Other Protocol Specified Criteria|1|||
147279351|NCT01722331|531190364|FG001|Part 3|Other Protocol Specified Criteria|1|||
147279352|NCT01722331|531190365|FG002|Part 3|Other Protocol Specified Criteria|0|||
147279353|NCT01722331|531190366|FG003|Part 3|Other Protocol Specified Criteria|0|||
147279354|NCT01722331|531190367|FG004|Part 3|Other Protocol Specified Criteria|0|||
147279355|NCT01722331|531190368|FG005|Part 3|Other Protocol Specified Criteria|0|||
147279356|NCT01722331|531190369|FG006|Part 3|Other Protocol Specified Criteria|0|||
147279357|NCT01154166|531190370|FG000|Overall Study|Adverse Event|14|||
147279358|NCT01154166|531190371|FG001|Overall Study|Adverse Event|9|||
147279359|NCT01154166|531190370|FG000|Overall Study|Lost to Follow-up|1|||
147334763|NCT03959241|531392100|FG000|Overall Study|Withdrawal by Subject|7|||
147334764|NCT03959241|531392101|FG001|Overall Study|Withdrawal by Subject|8|||
147334765|NCT03959241|531392100|FG000|Overall Study|Lost to Follow-up|1|||
147334766|NCT03959241|531392101|FG001|Overall Study|Lost to Follow-up|0|||
147279360|NCT01154166|531190371|FG001|Overall Study|Lost to Follow-up|1|||
147279361|NCT01154166|531190370|FG000|Overall Study|Protocol Violation|4|||
147279362|NCT01154166|531190371|FG001|Overall Study|Protocol Violation|1|||
147279363|NCT01154166|531190370|FG000|Overall Study|Withdrawal by Subject|10|||
147279364|NCT01154166|531190371|FG001|Overall Study|Withdrawal by Subject|1|||
147279365|NCT01154166|531190370|FG000|Overall Study|Lack of Efficacy|3|||
147279366|NCT01154166|531190371|FG001|Overall Study|Lack of Efficacy|0|||
147279367|NCT01154166|531190370|FG000|Overall Study|Disease Progression|1|||
147279368|NCT01154166|531190371|FG001|Overall Study|Disease Progression|0|||
147279369|NCT01154166|531190370|FG000|Overall Study|Poor Compliance|1|||
147279370|NCT01154166|531190371|FG001|Overall Study|Poor Compliance|0|||
147279371|NCT04265755|531190372|FG000|Overall Study|Withdrawal by Subject|39|||
147279372|NCT04265755|531190372|FG000|Overall Study|Decision by sponsor|2|||
147279373|NCT04265755|531190372|FG000|Overall Study|Lost to Follow-up|11|||
147279374|NCT04265755|531190372|FG000|Overall Study|Death|1|||
147279375|NCT01375049|531190373|FG000|Overall Study|Adverse Event|2|||
147279376|NCT01375049|531190373|FG000|Overall Study|Lost to Follow-up|1|||
147279377|NCT01375049|531190373|FG000|Overall Study|Withdrawal by Subject|2|||
147279378|NCT01375049|531190373|FG000|Overall Study|Protocol-Specified Withdrawal Criteria|45|||
147279379|NCT01575561|531190374|FG000|Overall Study|Adverse Event|9|||
147279380|NCT01575561|531190374|FG000|Overall Study|Lack of Efficacy|8|||
147279381|NCT01575561|531190374|FG000|Overall Study|Lost to Follow-up|6|||
147279382|NCT01575561|531190374|FG000|Overall Study|Protocol Violation|4|||
147279383|NCT01575561|531190374|FG000|Overall Study|Withdrawal by Subject|11|||
147279384|NCT01575561|531190374|FG000|Overall Study|administration|1|||
147279385|NCT02840877|531190375|FG000|Baseline to 12 Weeks|Withdrawal by Subject|11|||
147279386|NCT02840877|531190375|FG000|Baseline to 12 Weeks|Moved/Transferred out|5|||
147279387|NCT02840877|531190375|FG000|Baseline to 12 Weeks|Lost to Follow-up|2|||
147279388|NCT02840877|531190375|FG000|Baseline to 12 Weeks|Death|1|||
147279389|NCT02840877|531190375|FG000|Baseline to 12 Weeks|Changed treatment regimen, no longer on first line drugs.|1|||
147279390|NCT02840877|531190375|FG000|Baseline to 12 Weeks|Treatment extended due to bacterial meningitis.|1|||
147279391|NCT02840877|531190375|FG000|12 Weeks to 6 Months|Withdrawal by Subject|4|||
147279392|NCT02840877|531190375|FG000|12 Weeks to 6 Months|Treatment failure|1|||
147279393|NCT02840877|531190375|FG000|12 Weeks to 6 Months|Moved/transferred out|1|||
147279394|NCT02840877|531190375|FG000|12 Weeks to 6 Months|Lost to Follow-up|4|||
147279395|NCT02840877|531190375|FG000|12 Weeks to 6 Months|Death|1|||
147279396|NCT02840877|531190375|FG000|6 Months to 18 Months|Withdrawal by Subject|1|||
147279397|NCT02840877|531190375|FG000|6 Months to 18 Months|Treatment failure|7|||
147279398|NCT02840877|531190375|FG000|6 Months to 18 Months|Relapse/recurrence of TB|8|||
147279399|NCT02840877|531190375|FG000|6 Months to 18 Months|Moved/transferred out|6|||
147279400|NCT02840877|531190375|FG000|6 Months to 18 Months|Lost to Follow-up|24|||
147279401|NCT02840877|531190375|FG000|6 Months to 18 Months|Death|4|||
147279402|NCT02840877|531190375|FG000|6 Months to 18 Months|Diagnosed with multi-drug resistant tuberculosis.|1|||
147279403|NCT02840877|531190375|FG000|6 Months to 18 Months|Treatment stopped due to liver injury.|1|||
147279404|NCT02840877|531190375|FG000|6 Months to 18 Months|Still in study.|14|||
147279405|NCT01172938|531190376|FG000|Placebo-controlled Phase (Week 0-24)|Adverse Event|11|||
147279406|NCT01172938|531190377|FG001|Placebo-controlled Phase (Week 0-24)|Adverse Event|8|||
147279407|NCT01172938|531190378|FG002|Placebo-controlled Phase (Week 0-24)|Adverse Event|10|||
147279408|NCT01172938|531190379|FG003|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
147279409|NCT01172938|531190380|FG004|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
147279410|NCT01172938|531190381|FG005|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
147279411|NCT01172938|531190382|FG006|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
147279412|NCT01172938|531190383|FG007|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
147279413|NCT01172938|531190384|FG008|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
147279414|NCT01172938|531190376|FG000|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|4|||
147279415|NCT01172938|531190377|FG001|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|5|||
147279416|NCT01172938|531190378|FG002|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|4|||
147279417|NCT01172938|531190379|FG003|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
147279418|NCT01172938|531190380|FG004|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
147279419|NCT01172938|531190381|FG005|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
147279420|NCT01172938|531190382|FG006|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
147279421|NCT01172938|531190383|FG007|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
147279422|NCT01172938|531190384|FG008|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
147601706|NCT02393248|532360659|FG014|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
147279423|NCT01172938|531190376|FG000|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
147279424|NCT01172938|531190377|FG001|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|1|||
147279425|NCT01172938|531190378|FG002|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|2|||
147279426|NCT01172938|531190379|FG003|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
147279427|NCT01172938|531190380|FG004|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
147279428|NCT01172938|531190381|FG005|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
147279429|NCT01172938|531190382|FG006|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
147279430|NCT01172938|531190383|FG007|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
147279431|NCT01172938|531190384|FG008|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
147279432|NCT01172938|531190376|FG000|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|2|||
147279433|NCT01172938|531190377|FG001|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|5|||
147279434|NCT01172938|531190378|FG002|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|3|||
147334767|NCT03959241|531392100|FG000|Overall Study|Move to Hospice Care|1|||
147601707|NCT02393248|532360660|FG015|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
147601708|NCT02393248|532360661|FG016|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
147601709|NCT02393248|532360662|FG017|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
147279435|NCT01172938|531190379|FG003|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
147279436|NCT01172938|531190380|FG004|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
147279437|NCT01172938|531190381|FG005|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
147334768|NCT03959241|531392101|FG001|Overall Study|Move to Hospice Care|0|||
147279438|NCT01172938|531190382|FG006|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
147279439|NCT01172938|531190383|FG007|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
147279440|NCT01172938|531190384|FG008|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
147279441|NCT01172938|531190376|FG000|Placebo-controlled Phase (Week 0-24)|Death|0|||
147279442|NCT01172938|531190377|FG001|Placebo-controlled Phase (Week 0-24)|Death|1|||
147279443|NCT01172938|531190378|FG002|Placebo-controlled Phase (Week 0-24)|Death|0|||
147279444|NCT01172938|531190379|FG003|Placebo-controlled Phase (Week 0-24)|Death|0|||
147334769|NCT03959241|531392100|FG000|Overall Study|Screen Failure|1|||
147279445|NCT01172938|531190380|FG004|Placebo-controlled Phase (Week 0-24)|Death|0|||
147279446|NCT01172938|531190381|FG005|Placebo-controlled Phase (Week 0-24)|Death|0|||
147279447|NCT01172938|531190382|FG006|Placebo-controlled Phase (Week 0-24)|Death|0|||
147279448|NCT01172938|531190383|FG007|Placebo-controlled Phase (Week 0-24)|Death|0|||
147279449|NCT01172938|531190384|FG008|Placebo-controlled Phase (Week 0-24)|Death|0|||
147279450|NCT01172938|531190376|FG000|Placebo-controlled Phase (Week 0-24)|Protocol Violation|1|||
147279451|NCT01172938|531190377|FG001|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
147334770|NCT03959241|531392101|FG001|Overall Study|Screen Failure|0|||
147334771|NCT03959241|531392100|FG000|Overall Study|Disease Relapse|0|||
147334772|NCT03959241|531392101|FG001|Overall Study|Disease Relapse|1|||
147334773|NCT03959241|531392100|FG000|Overall Study|Off Study|1|||
147334774|NCT03959241|531392101|FG001|Overall Study|Off Study|0|||
147334775|NCT03192046|531392102|FG000|Overall Study|Withdrawal by Subject|1|||
147334776|NCT03192046|531392103|FG001|Overall Study|Withdrawal by Subject|1|||
147334777|NCT01505881|531392104|FG000|Overall Study|Adverse Event|0|||
147334778|NCT01505881|531392105|FG001|Overall Study|Adverse Event|1|||
147334779|NCT01505881|531392104|FG000|Overall Study|Lost to Follow-up|2|||
147334780|NCT01505881|531392105|FG001|Overall Study|Lost to Follow-up|0|||
147334781|NCT01505881|531392104|FG000|Overall Study|Withdrawal by Subject|2|||
147334782|NCT01505881|531392105|FG001|Overall Study|Withdrawal by Subject|0|||
147334783|NCT01194154|531392106|FG000|Overall Study|Adverse Event|12|||
147334784|NCT01194154|531392107|FG001|Overall Study|Adverse Event|7|||
147334785|NCT01194154|531392106|FG000|Overall Study|Lost to Follow-up|2|||
147334786|NCT01194154|531392107|FG001|Overall Study|Lost to Follow-up|3|||
147334787|NCT01194154|531392106|FG000|Overall Study|Protocol Violation|0|||
147334788|NCT01194154|531392107|FG001|Overall Study|Protocol Violation|1|||
147334789|NCT01194154|531392106|FG000|Overall Study|Withdrawal by Subject|5|||
147334790|NCT01194154|531392107|FG001|Overall Study|Withdrawal by Subject|6|||
147334791|NCT01194154|531392106|FG000|Overall Study|Blood pressure increase|5|||
147334792|NCT01194154|531392107|FG001|Overall Study|Blood pressure increase|3|||
147334793|NCT01194154|531392106|FG000|Overall Study|Hemoglobin decrease|0|||
147334794|NCT01194154|531392107|FG001|Overall Study|Hemoglobin decrease|1|||
147334795|NCT01194154|531392106|FG000|Overall Study|Hemoglobin increase|12|||
147334796|NCT01194154|531392107|FG001|Overall Study|Hemoglobin increase|3|||
147334797|NCT01194154|531392106|FG000|Overall Study|Skipping of CERA treatment at two visits|3|||
147334798|NCT01194154|531392107|FG001|Overall Study|Skipping of CERA treatment at two visits|0|||
147334799|NCT01194154|531392106|FG000|Overall Study|Treatment with prohibited medication|4|||
147334800|NCT01194154|531392107|FG001|Overall Study|Treatment with prohibited medication|5|||
147334801|NCT01194154|531392106|FG000|Overall Study|Other|4|||
147334802|NCT01194154|531392107|FG001|Overall Study|Other|0|||
147334803|NCT01194154|531392106|FG000|Overall Study|Did not receive study medication|2|||
147334804|NCT01194154|531392107|FG001|Overall Study|Did not receive study medication|4|||
147334805|NCT00842257|531392108|FG000|Overall Study|Adverse Event|1|||
147334806|NCT01596504|531392109|FG000|Overall Study|Participant's Private Reason|0|||
147334807|NCT01596504|531392110|FG001|Overall Study|Participant's Private Reason|1|||
147334808|NCT01596504|531392111|FG002|Overall Study|Participant's Private Reason|0|||
147334809|NCT01596504|531392109|FG000|Overall Study|Adverse Event|1|||
147334810|NCT01596504|531392110|FG001|Overall Study|Adverse Event|2|||
147334811|NCT01596504|531392111|FG002|Overall Study|Adverse Event|1|||
147334812|NCT01596504|531392109|FG000|Overall Study|Withdrawal by Subject|1|||
147334813|NCT01596504|531392110|FG001|Overall Study|Withdrawal by Subject|0|||
147334814|NCT01596504|531392111|FG002|Overall Study|Withdrawal by Subject|0|||
147334815|NCT02314117|531392112|FG000|Overall Study|Lost to Follow-up|9|||
147334816|NCT02314117|531392113|FG001|Overall Study|Lost to Follow-up|14|||
147334817|NCT02314117|531392112|FG000|Overall Study|Withdrawal by Subject|3|||
147279452|NCT01172938|531190378|FG002|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
147279453|NCT01172938|531190379|FG003|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
147279454|NCT01172938|531190380|FG004|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
147334818|NCT02314117|531392113|FG001|Overall Study|Withdrawal by Subject|2|||
147334819|NCT04439799|531392114|FG000|Overall Study|Lost to Follow-up|6|||
147334820|NCT04439799|531392115|FG001|Overall Study|Lost to Follow-up|6|||
147334821|NCT04439799|531392114|FG000|Overall Study|Withdrawal by Subject|2|||
147334822|NCT04439799|531392115|FG001|Overall Study|Withdrawal by Subject|6|||
147334823|NCT04439799|531392114|FG000|Overall Study|Adverse Event|2|||
147334824|NCT04439799|531392115|FG001|Overall Study|Adverse Event|5|||
147334825|NCT00949975|531392116|FG000|Overall Study|Voluntary discontinuation|6|||
147334826|NCT00949975|531392117|FG001|Overall Study|Voluntary discontinuation|5|||
147334827|NCT00949975|531392118|FG002|Overall Study|Voluntary discontinuation|3|||
147279455|NCT01172938|531190381|FG005|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
147279456|NCT01172938|531190382|FG006|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
147279457|NCT01172938|531190383|FG007|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
147279458|NCT01172938|531190384|FG008|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
147279459|NCT01172938|531190376|FG000|Placebo-controlled Phase (Week 0-24)|Other|0|||
147279460|NCT01172938|531190377|FG001|Placebo-controlled Phase (Week 0-24)|Other|2|||
147279461|NCT01172938|531190378|FG002|Placebo-controlled Phase (Week 0-24)|Other|1|||
147279462|NCT01172938|531190379|FG003|Placebo-controlled Phase (Week 0-24)|Other|0|||
147279463|NCT01172938|531190380|FG004|Placebo-controlled Phase (Week 0-24)|Other|0|||
147279464|NCT01172938|531190381|FG005|Placebo-controlled Phase (Week 0-24)|Other|0|||
147279465|NCT01172938|531190382|FG006|Placebo-controlled Phase (Week 0-24)|Other|0|||
147279466|NCT01172938|531190383|FG007|Placebo-controlled Phase (Week 0-24)|Other|0|||
147279467|NCT01172938|531190384|FG008|Placebo-controlled Phase (Week 0-24)|Other|0|||
147279468|NCT01172938|531190376|FG000|Active Treatment Phase (Weeks 25-52)|Adverse Event|0|||
147334828|NCT00949975|531392119|FG003|Overall Study|Voluntary discontinuation|6|||
147334829|NCT00949975|531392116|FG000|Overall Study|Adverse Event|11|||
147334830|NCT00949975|531392117|FG001|Overall Study|Adverse Event|11|||
147334831|NCT00949975|531392118|FG002|Overall Study|Adverse Event|10|||
147334832|NCT00949975|531392119|FG003|Overall Study|Adverse Event|10|||
147334833|NCT00949975|531392116|FG000|Overall Study|Safety reason|0|||
147334834|NCT00949975|531392117|FG001|Overall Study|Safety reason|1|||
147334835|NCT00949975|531392118|FG002|Overall Study|Safety reason|0|||
147334836|NCT00949975|531392119|FG003|Overall Study|Safety reason|0|||
147334837|NCT00949975|531392116|FG000|Overall Study|Study-specific criteria|0|||
147334838|NCT00949975|531392117|FG001|Overall Study|Study-specific criteria|1|||
147334839|NCT00949975|531392118|FG002|Overall Study|Study-specific criteria|1|||
147334840|NCT00949975|531392119|FG003|Overall Study|Study-specific criteria|0|||
147334841|NCT00949975|531392116|FG000|Overall Study|Incorrect enrolment|5|||
147334842|NCT00949975|531392117|FG001|Overall Study|Incorrect enrolment|10|||
147334843|NCT00949975|531392118|FG002|Overall Study|Incorrect enrolment|4|||
147334844|NCT00949975|531392119|FG003|Overall Study|Incorrect enrolment|7|||
147334845|NCT00949975|531392116|FG000|Overall Study|Severe non-compliance|3|||
147334846|NCT00949975|531392117|FG001|Overall Study|Severe non-compliance|1|||
147334847|NCT00949975|531392118|FG002|Overall Study|Severe non-compliance|0|||
147334848|NCT00949975|531392119|FG003|Overall Study|Severe non-compliance|2|||
147334849|NCT00949975|531392116|FG000|Overall Study|Lost to Follow-up|1|||
147334850|NCT00949975|531392117|FG001|Overall Study|Lost to Follow-up|0|||
147334851|NCT00949975|531392118|FG002|Overall Study|Lost to Follow-up|1|||
147334852|NCT00949975|531392119|FG003|Overall Study|Lost to Follow-up|3|||
147334853|NCT00949975|531392116|FG000|Overall Study|Other|1|||
147334854|NCT00949975|531392117|FG001|Overall Study|Other|0|||
147334855|NCT00949975|531392118|FG002|Overall Study|Other|0|||
147334856|NCT00949975|531392119|FG003|Overall Study|Other|0|||
147334857|NCT04347954|531392120|FG000|Overall Study|Did not present to study site for allocated intervention|3|||
147334858|NCT04347954|531392121|FG001|Overall Study|Did not present to study site for allocated intervention|0|||
147334859|NCT04347954|531392122|FG002|Overall Study|Did not present to study site for allocated intervention|3|||
147334860|NCT04347954|531392120|FG000|Overall Study|Lost to Follow-up|0|||
147334861|NCT04347954|531392121|FG001|Overall Study|Lost to Follow-up|1|||
147334862|NCT04347954|531392122|FG002|Overall Study|Lost to Follow-up|0|||
147334863|NCT02969863|531392124|FG000|Overall Study|Physician Decision|1|||
147334864|NCT02969863|531392125|FG001|Overall Study|Physician Decision|0|||
147334865|NCT02969863|531392126|FG002|Overall Study|Physician Decision|0|||
147334866|NCT02969863|531392127|FG003|Overall Study|Physician Decision|0|||
147334867|NCT02969863|531392128|FG004|Overall Study|Physician Decision|0|||
147334868|NCT02969863|531392129|FG005|Overall Study|Physician Decision|0|||
147334869|NCT03920215|531392134|FG000|Overall Study|Lost to Follow-up|1|||
147334870|NCT03920215|531392135|FG001|Overall Study|Lost to Follow-up|2|||
147334871|NCT03920215|531392136|FG002|Overall Study|Lost to Follow-up|0|||
147334872|NCT03920215|531392137|FG003|Overall Study|Lost to Follow-up|0|||
147334873|NCT03920215|531392134|FG000|Overall Study|Death|0|||
147334874|NCT03920215|531392135|FG001|Overall Study|Death|0|||
147279469|NCT01172938|531190377|FG001|Active Treatment Phase (Weeks 25-52)|Adverse Event|2|||
147279470|NCT01172938|531190378|FG002|Active Treatment Phase (Weeks 25-52)|Adverse Event|5|||
147279471|NCT01172938|531190379|FG003|Active Treatment Phase (Weeks 25-52)|Adverse Event|1|||
147279472|NCT01172938|531190380|FG004|Active Treatment Phase (Weeks 25-52)|Adverse Event|1|||
147279473|NCT01172938|531190381|FG005|Active Treatment Phase (Weeks 25-52)|Adverse Event|2|||
147334875|NCT03920215|531392136|FG002|Overall Study|Death|0|||
147334876|NCT03920215|531392137|FG003|Overall Study|Death|1|||
147334877|NCT03024606|531392142|FG000|Overall Study|Withdrawal by Subject|9|||
147334878|NCT03024606|531392143|FG001|Overall Study|Withdrawal by Subject|10|||
147334879|NCT02547922|531392144|FG000|Overall Study|Withdrawal by Subject|9|||
147334880|NCT02547922|531392145|FG001|Overall Study|Withdrawal by Subject|6|||
147601710|NCT02393248|532360663|FG018|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
147334881|NCT02547922|531392146|FG002|Overall Study|Withdrawal by Subject|10|||
147279474|NCT01172938|531190382|FG006|Active Treatment Phase (Weeks 25-52)|Adverse Event|0|||
147279475|NCT01172938|531190383|FG007|Active Treatment Phase (Weeks 25-52)|Adverse Event|0|||
147279476|NCT01172938|531190384|FG008|Active Treatment Phase (Weeks 25-52)|Adverse Event|0|||
147279477|NCT01172938|531190376|FG000|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0|||
147279478|NCT01172938|531190377|FG001|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|4|||
147279479|NCT01172938|531190378|FG002|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|7|||
147279480|NCT01172938|531190379|FG003|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|3|||
147279481|NCT01172938|531190380|FG004|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|1|||
147279482|NCT01172938|531190381|FG005|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|3|||
147279483|NCT01172938|531190382|FG006|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0|||
147279484|NCT01172938|531190383|FG007|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0|||
147279485|NCT01172938|531190384|FG008|Active Treatment Phase (Weeks 25-52)|Lack of Efficacy|0|||
147279486|NCT01172938|531190376|FG000|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
147279487|NCT01172938|531190377|FG001|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
147279488|NCT01172938|531190378|FG002|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|1|||
147279489|NCT01172938|531190379|FG003|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
147279490|NCT01172938|531190380|FG004|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
147279491|NCT01172938|531190381|FG005|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
147279492|NCT01172938|531190382|FG006|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
147279493|NCT01172938|531190383|FG007|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
147279494|NCT01172938|531190384|FG008|Active Treatment Phase (Weeks 25-52)|Non-compliance with Study Drug|0|||
147279495|NCT01172938|531190376|FG000|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|0|||
147279496|NCT01172938|531190377|FG001|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|5|||
147279497|NCT01172938|531190378|FG002|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|1|||
147279498|NCT01172938|531190379|FG003|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|2|||
147279499|NCT01172938|531190380|FG004|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|2|||
147279500|NCT01172938|531190381|FG005|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|9|||
147279501|NCT01172938|531190382|FG006|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|1|||
147279502|NCT01172938|531190383|FG007|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|0|||
147279503|NCT01172938|531190384|FG008|Active Treatment Phase (Weeks 25-52)|Withdrawal by Subject|0|||
147279504|NCT01172938|531190376|FG000|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
147279505|NCT01172938|531190377|FG001|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|1|||
147279506|NCT01172938|531190378|FG002|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|1|||
147279507|NCT01172938|531190379|FG003|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|1|||
147279508|NCT01172938|531190380|FG004|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
147279509|NCT01172938|531190381|FG005|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
147279510|NCT01172938|531190382|FG006|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
147279511|NCT01172938|531190383|FG007|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
147279512|NCT01172938|531190384|FG008|Active Treatment Phase (Weeks 25-52)|Lost to Follow-up|0|||
147279513|NCT01172938|531190376|FG000|Active Treatment Phase (Weeks 25-52)|Other|0|||
147279514|NCT01172938|531190377|FG001|Active Treatment Phase (Weeks 25-52)|Other|0|||
147279515|NCT01172938|531190378|FG002|Active Treatment Phase (Weeks 25-52)|Other|0|||
147279516|NCT01172938|531190379|FG003|Active Treatment Phase (Weeks 25-52)|Other|0|||
147279517|NCT01172938|531190380|FG004|Active Treatment Phase (Weeks 25-52)|Other|0|||
147279518|NCT01172938|531190381|FG005|Active Treatment Phase (Weeks 25-52)|Other|1|||
147279519|NCT01172938|531190382|FG006|Active Treatment Phase (Weeks 25-52)|Other|1|||
147279520|NCT01172938|531190383|FG007|Active Treatment Phase (Weeks 25-52)|Other|0|||
147279521|NCT01172938|531190384|FG008|Active Treatment Phase (Weeks 25-52)|Other|0|||
147279522|NCT01172938|531190376|FG000|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0|||
147279523|NCT01172938|531190377|FG001|Active-Treatment Phase (Weeks 52-104)|Adverse Event|2|||
147279524|NCT01172938|531190378|FG002|Active-Treatment Phase (Weeks 52-104)|Adverse Event|1|||
147279525|NCT01172938|531190379|FG003|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0|||
147279526|NCT01172938|531190380|FG004|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0|||
147279527|NCT01172938|531190381|FG005|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0|||
147279528|NCT01172938|531190382|FG006|Active-Treatment Phase (Weeks 52-104)|Adverse Event|0|||
147279529|NCT01172938|531190383|FG007|Active-Treatment Phase (Weeks 52-104)|Adverse Event|3|||
147279530|NCT01172938|531190384|FG008|Active-Treatment Phase (Weeks 52-104)|Adverse Event|1|||
147279531|NCT01172938|531190376|FG000|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
147279532|NCT01172938|531190377|FG001|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|7|||
147279533|NCT01172938|531190378|FG002|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|8|||
147279534|NCT01172938|531190379|FG003|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
147279535|NCT01172938|531190380|FG004|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
147279536|NCT01172938|531190381|FG005|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
147279537|NCT01172938|531190382|FG006|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
147334882|NCT02547922|531392144|FG000|Overall Study|Adverse Event|3|||
147334883|NCT02547922|531392145|FG001|Overall Study|Adverse Event|1|||
147334884|NCT02547922|531392146|FG002|Overall Study|Adverse Event|2|||
147334885|NCT02547922|531392144|FG000|Overall Study|Lost to Follow-up|1|||
147334886|NCT02547922|531392145|FG001|Overall Study|Lost to Follow-up|0|||
147334887|NCT02547922|531392146|FG002|Overall Study|Lost to Follow-up|0|||
147334888|NCT02547922|531392144|FG000|Overall Study|Lack of Efficacy|5|||
147334889|NCT02547922|531392145|FG001|Overall Study|Lack of Efficacy|7|||
147279538|NCT01172938|531190383|FG007|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|4|||
147279539|NCT01172938|531190384|FG008|Active-Treatment Phase (Weeks 52-104)|Lack of Efficacy|0|||
147279540|NCT01172938|531190376|FG000|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
147279541|NCT01172938|531190377|FG001|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
147279542|NCT01172938|531190378|FG002|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|2|||
147279543|NCT01172938|531190379|FG003|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
147279544|NCT01172938|531190380|FG004|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
147279545|NCT01172938|531190381|FG005|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
147279546|NCT01172938|531190382|FG006|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
147279547|NCT01172938|531190383|FG007|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
147279548|NCT01172938|531190384|FG008|Active-Treatment Phase (Weeks 52-104)|Non-compliance with Study Drug|0|||
147279549|NCT01172938|531190376|FG000|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0|||
147279550|NCT01172938|531190377|FG001|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|10|||
147279551|NCT01172938|531190378|FG002|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|8|||
147279552|NCT01172938|531190379|FG003|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0|||
147279553|NCT01172938|531190380|FG004|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0|||
147279554|NCT01172938|531190381|FG005|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0|||
147279555|NCT01172938|531190382|FG006|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|0|||
147279556|NCT01172938|531190383|FG007|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|5|||
147279557|NCT01172938|531190384|FG008|Active-Treatment Phase (Weeks 52-104)|Withdrawal by Subject|2|||
147279558|NCT01172938|531190376|FG000|Active-Treatment Phase (Weeks 52-104)|Death|0|||
147279559|NCT01172938|531190377|FG001|Active-Treatment Phase (Weeks 52-104)|Death|0|||
147279560|NCT01172938|531190378|FG002|Active-Treatment Phase (Weeks 52-104)|Death|1|||
147279561|NCT01172938|531190379|FG003|Active-Treatment Phase (Weeks 52-104)|Death|0|||
147279562|NCT01172938|531190380|FG004|Active-Treatment Phase (Weeks 52-104)|Death|0|||
147334890|NCT02547922|531392146|FG002|Overall Study|Lack of Efficacy|4|||
147334891|NCT02547922|531392144|FG000|Overall Study|Death|1|||
147334892|NCT02547922|531392145|FG001|Overall Study|Death|0|||
147334893|NCT02547922|531392146|FG002|Overall Study|Death|0|||
147334894|NCT02547922|531392144|FG000|Overall Study|Non-responding completer, Not eligible for extension study, Use of any restricted Medications|4|||
147334895|NCT02547922|531392145|FG001|Overall Study|Non-responding completer, Not eligible for extension study, Use of any restricted Medications|8|||
147334896|NCT02547922|531392146|FG002|Overall Study|Non-responding completer, Not eligible for extension study, Use of any restricted Medications|9|||
147334897|NCT02547922|531392144|FG000|Overall Study|TECHNICAL PROBLEMS|1|||
147334898|NCT02547922|531392145|FG001|Overall Study|TECHNICAL PROBLEMS|0|||
147334899|NCT02547922|531392146|FG002|Overall Study|TECHNICAL PROBLEMS|0|||
147334900|NCT02547922|531392144|FG000|Overall Study|PROGRESSIVE DISEASE|1|||
147334901|NCT02547922|531392145|FG001|Overall Study|PROGRESSIVE DISEASE|0|||
147334902|NCT02547922|531392146|FG002|Overall Study|PROGRESSIVE DISEASE|2|||
147334903|NCT02547922|531392144|FG000|Overall Study|Physician Decision|2|||
147334904|NCT02547922|531392145|FG001|Overall Study|Physician Decision|1|||
147334905|NCT02547922|531392146|FG002|Overall Study|Physician Decision|2|||
147334906|NCT02547922|531392144|FG000|Overall Study|Patients did not receive IP|1|||
147334907|NCT02547922|531392145|FG001|Overall Study|Patients did not receive IP|1|||
147334908|NCT02547922|531392146|FG002|Overall Study|Patients did not receive IP|0|||
147334909|NCT00102063|531392149|FG000|Overall Study|Lack of Efficacy|5|||
147334910|NCT00102063|531392150|FG001|Overall Study|Lack of Efficacy|1|||
147334911|NCT00102063|531392151|FG002|Overall Study|Lack of Efficacy|1|||
147334912|NCT00102063|531392149|FG000|Overall Study|Adverse Event|7|||
147334913|NCT00102063|531392150|FG001|Overall Study|Adverse Event|4|||
147334914|NCT00102063|531392151|FG002|Overall Study|Adverse Event|2|||
147334915|NCT00102063|531392149|FG000|Overall Study|Withdrawal by Subject|4|||
147334916|NCT00102063|531392150|FG001|Overall Study|Withdrawal by Subject|12|||
147334917|NCT00102063|531392151|FG002|Overall Study|Withdrawal by Subject|5|||
147334918|NCT00102063|531392149|FG000|Overall Study|Lost to Follow-up|0|||
147279563|NCT01172938|531190381|FG005|Active-Treatment Phase (Weeks 52-104)|Death|0|||
147279564|NCT01172938|531190382|FG006|Active-Treatment Phase (Weeks 52-104)|Death|0|||
147279565|NCT01172938|531190383|FG007|Active-Treatment Phase (Weeks 52-104)|Death|0|||
147279566|NCT01172938|531190384|FG008|Active-Treatment Phase (Weeks 52-104)|Death|0|||
147334919|NCT00102063|531392150|FG001|Overall Study|Lost to Follow-up|0|||
147334920|NCT00102063|531392151|FG002|Overall Study|Lost to Follow-up|1|||
147334921|NCT00102063|531392149|FG000|Overall Study|Protocol Violation|0|||
147334922|NCT00102063|531392150|FG001|Overall Study|Protocol Violation|1|||
147279567|NCT01172938|531190376|FG000|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
147279568|NCT01172938|531190377|FG001|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|1|||
147279569|NCT01172938|531190378|FG002|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|1|||
147279570|NCT01172938|531190379|FG003|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
147279571|NCT01172938|531190380|FG004|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
147279572|NCT01172938|531190381|FG005|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
147279573|NCT01172938|531190382|FG006|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
147279574|NCT01172938|531190383|FG007|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|3|||
147279575|NCT01172938|531190384|FG008|Active-Treatment Phase (Weeks 52-104)|Lost to Follow-up|0|||
147279576|NCT01172938|531190376|FG000|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
147279577|NCT01172938|531190377|FG001|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|2|||
147279578|NCT01172938|531190378|FG002|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
147279579|NCT01172938|531190379|FG003|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
147279580|NCT01172938|531190380|FG004|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
147279581|NCT01172938|531190381|FG005|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
147279582|NCT01172938|531190382|FG006|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
147279583|NCT01172938|531190383|FG007|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|0|||
147279584|NCT01172938|531190384|FG008|Active-Treatment Phase (Weeks 52-104)|Miscellaneous|1|||
147279585|NCT01172938|531190376|FG000|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
147279586|NCT01172938|531190377|FG001|Active-Treatment Phase (Weeks 52-104)|Missing|1|||
147279587|NCT01172938|531190378|FG002|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
147279588|NCT01172938|531190379|FG003|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
147279589|NCT01172938|531190380|FG004|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
147279590|NCT01172938|531190381|FG005|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
147279591|NCT01172938|531190382|FG006|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
147279592|NCT01172938|531190383|FG007|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
147279593|NCT01172938|531190384|FG008|Active-Treatment Phase (Weeks 52-104)|Missing|0|||
147279594|NCT01172938|531190376|FG000|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
147279595|NCT01172938|531190377|FG001|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
147279596|NCT01172938|531190378|FG002|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
147279597|NCT01172938|531190379|FG003|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
147279598|NCT01172938|531190380|FG004|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
147279599|NCT01172938|531190381|FG005|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
147279600|NCT01172938|531190382|FG006|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
147279601|NCT01172938|531190383|FG007|Active-Treatment Phase Weeks (104-156)|Adverse Event|0|||
147279602|NCT01172938|531190384|FG008|Active-Treatment Phase Weeks (104-156)|Adverse Event|1|||
147279603|NCT01172938|531190376|FG000|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0|||
147279604|NCT01172938|531190377|FG001|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|4|||
147279605|NCT01172938|531190378|FG002|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|2|||
147279606|NCT01172938|531190379|FG003|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0|||
147279607|NCT01172938|531190380|FG004|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0|||
147279608|NCT01172938|531190381|FG005|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0|||
147279609|NCT01172938|531190382|FG006|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|0|||
147279610|NCT01172938|531190383|FG007|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|2|||
147279611|NCT01172938|531190384|FG008|Active-Treatment Phase Weeks (104-156)|Lack of Efficacy|2|||
147279612|NCT01172938|531190376|FG000|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0|||
147279613|NCT01172938|531190377|FG001|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|6|||
147279614|NCT01172938|531190378|FG002|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|3|||
147279615|NCT01172938|531190379|FG003|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0|||
147279616|NCT01172938|531190380|FG004|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0|||
147279617|NCT01172938|531190381|FG005|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0|||
147279618|NCT01172938|531190382|FG006|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|0|||
147279619|NCT01172938|531190383|FG007|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|2|||
147279620|NCT01172938|531190384|FG008|Active-Treatment Phase Weeks (104-156)|Withdrawal by Subject|1|||
147279621|NCT01172938|531190376|FG000|Active-Treatment Phase Weeks (104-156)|Death|0|||
147279622|NCT01172938|531190377|FG001|Active-Treatment Phase Weeks (104-156)|Death|0|||
147279623|NCT01172938|531190378|FG002|Active-Treatment Phase Weeks (104-156)|Death|0|||
147279624|NCT01172938|531190379|FG003|Active-Treatment Phase Weeks (104-156)|Death|0|||
147279625|NCT01172938|531190380|FG004|Active-Treatment Phase Weeks (104-156)|Death|0|||
147279626|NCT01172938|531190381|FG005|Active-Treatment Phase Weeks (104-156)|Death|0|||
147279627|NCT01172938|531190382|FG006|Active-Treatment Phase Weeks (104-156)|Death|0|||
147279628|NCT01172938|531190383|FG007|Active-Treatment Phase Weeks (104-156)|Death|1|||
147279629|NCT01172938|531190384|FG008|Active-Treatment Phase Weeks (104-156)|Death|0|||
147279630|NCT01172938|531190376|FG000|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
147334923|NCT00102063|531392151|FG002|Overall Study|Protocol Violation|1|||
147334924|NCT02739035|531392154|FG000|6 Weeks Post-MUA|Withdrawal by Subject|1|||
147279631|NCT01172938|531190377|FG001|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|1|||
147279632|NCT01172938|531190378|FG002|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
147279633|NCT01172938|531190379|FG003|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
147279634|NCT01172938|531190380|FG004|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
147279635|NCT01172938|531190381|FG005|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
147279636|NCT01172938|531190382|FG006|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
147279637|NCT01172938|531190383|FG007|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
147279638|NCT01172938|531190384|FG008|Active-Treatment Phase Weeks (104-156)|Lost to Follow-up|0|||
147279639|NCT01172938|531190376|FG000|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
147279640|NCT01172938|531190377|FG001|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
147279641|NCT01172938|531190378|FG002|Active-Treatment Phase Weeks (104-156)|Miscellaneious|2|||
147279642|NCT01172938|531190379|FG003|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
147279643|NCT01172938|531190380|FG004|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
147279644|NCT01172938|531190381|FG005|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
147279645|NCT01172938|531190382|FG006|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
147279646|NCT01172938|531190383|FG007|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
147279647|NCT01172938|531190384|FG008|Active-Treatment Phase Weeks (104-156)|Miscellaneious|0|||
147279648|NCT01172938|531190376|FG000|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
147279649|NCT01172938|531190377|FG001|Active-Treatment Phase (Weeks 156-208)|Adverse Event|4|||
147279650|NCT01172938|531190378|FG002|Active-Treatment Phase (Weeks 156-208)|Adverse Event|1|||
147279651|NCT01172938|531190379|FG003|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
147279652|NCT01172938|531190380|FG004|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
147279653|NCT01172938|531190381|FG005|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
147279654|NCT01172938|531190382|FG006|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
147279655|NCT01172938|531190383|FG007|Active-Treatment Phase (Weeks 156-208)|Adverse Event|3|||
147279656|NCT01172938|531190384|FG008|Active-Treatment Phase (Weeks 156-208)|Adverse Event|0|||
147279657|NCT01172938|531190376|FG000|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0|||
147279658|NCT01172938|531190377|FG001|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|1|||
147279659|NCT01172938|531190378|FG002|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|1|||
147279660|NCT01172938|531190379|FG003|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0|||
147279661|NCT01172938|531190380|FG004|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0|||
147279662|NCT01172938|531190381|FG005|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0|||
147279663|NCT01172938|531190382|FG006|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|0|||
147279664|NCT01172938|531190383|FG007|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|3|||
147279665|NCT01172938|531190384|FG008|Active-Treatment Phase (Weeks 156-208)|Lack of Efficacy|2|||
147279666|NCT01172938|531190376|FG000|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0|||
147279667|NCT01172938|531190377|FG001|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|4|||
147279668|NCT01172938|531190378|FG002|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|2|||
147279669|NCT01172938|531190379|FG003|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0|||
147279670|NCT01172938|531190380|FG004|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0|||
147279671|NCT01172938|531190381|FG005|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0|||
147279672|NCT01172938|531190382|FG006|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|0|||
147279673|NCT01172938|531190383|FG007|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|2|||
147279674|NCT01172938|531190384|FG008|Active-Treatment Phase (Weeks 156-208)|Withdrawal by Subject|4|||
147279675|NCT01172938|531190376|FG000|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
147279676|NCT01172938|531190377|FG001|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
147279677|NCT01172938|531190378|FG002|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|1|||
147279678|NCT01172938|531190379|FG003|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
147279679|NCT01172938|531190380|FG004|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
147279680|NCT01172938|531190381|FG005|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
147279681|NCT01172938|531190382|FG006|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
147279682|NCT01172938|531190383|FG007|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|0|||
147279683|NCT01172938|531190384|FG008|Active-Treatment Phase (Weeks 156-208)|Lost to Follow-up|1|||
147279684|NCT01172938|531190376|FG000|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
147334925|NCT02739035|531392155|FG001|6 Weeks Post-MUA|Withdrawal by Subject|3|||
147334926|NCT02739035|531392154|FG000|6 Weeks Post-MUA|Lost to Follow-up|1|||
147334927|NCT02739035|531392155|FG001|6 Weeks Post-MUA|Lost to Follow-up|3|||
147334928|NCT02739035|531392154|FG000|6 Weeks Post-MUA|Protocol Violation|1|||
147334929|NCT02739035|531392155|FG001|6 Weeks Post-MUA|Protocol Violation|4|||
147334930|NCT02739035|531392154|FG000|1 Year Post-MUA|Lost to Follow-up|10|||
147334931|NCT02739035|531392155|FG001|1 Year Post-MUA|Lost to Follow-up|11|||
147334932|NCT00940992|531392158|FG000|Overall Study|Adverse Event|2|||
147334933|NCT00940992|531392159|FG001|Overall Study|Adverse Event|0|||
147334934|NCT00940992|531392160|FG002|Overall Study|Adverse Event|1|||
147334935|NCT00940992|531392158|FG000|Overall Study|subject request|2|||
147334936|NCT00940992|531392159|FG001|Overall Study|subject request|1|||
147662517|NCT02513550|532587349|FG004|Double Blind Treatment Period|Death|0|||
147334937|NCT00940992|531392160|FG002|Overall Study|subject request|0|||
147334938|NCT00940992|531392158|FG000|Overall Study|Lost to Follow-up|0|||
147334939|NCT00940992|531392159|FG001|Overall Study|Lost to Follow-up|1|||
147334940|NCT00940992|531392160|FG002|Overall Study|Lost to Follow-up|1|||
147334941|NCT00630786|531392164|FG000|Overall Study|Physician Decision|0|||
147334942|NCT00630786|531392165|FG001|Overall Study|Physician Decision|0|||
147334943|NCT00630786|531392166|FG002|Overall Study|Physician Decision|1|||
147334944|NCT00630786|531392164|FG000|Overall Study|Withdrawal by Subject|0|||
147334945|NCT00630786|531392165|FG001|Overall Study|Withdrawal by Subject|1|||
147334946|NCT00630786|531392166|FG002|Overall Study|Withdrawal by Subject|1|||
147334947|NCT00630786|531392164|FG000|Overall Study|Lost to Follow-up|0|||
147334948|NCT00630786|531392165|FG001|Overall Study|Lost to Follow-up|1|||
147334949|NCT00630786|531392166|FG002|Overall Study|Lost to Follow-up|0|||
147334950|NCT00630786|531392164|FG000|Overall Study|Other|1|||
147334951|NCT00630786|531392165|FG001|Overall Study|Other|0|||
147334952|NCT00630786|531392166|FG002|Overall Study|Other|0|||
147334953|NCT02020616|531392167|FG000|Overall Study|Adverse Event|0|||
147334954|NCT02020616|531392168|FG001|Overall Study|Adverse Event|0|||
147334955|NCT02020616|531392169|FG002|Overall Study|Adverse Event|0|||
147334956|NCT02020616|531392170|FG003|Overall Study|Adverse Event|0|||
147334957|NCT02020616|531392171|FG004|Overall Study|Adverse Event|0|||
147334958|NCT02020616|531392172|FG005|Overall Study|Adverse Event|1|||
147334959|NCT02020616|531392173|FG006|Overall Study|Adverse Event|1|||
147334960|NCT02020616|531392167|FG000|Overall Study|Physician Decision|0|||
147334961|NCT02020616|531392168|FG001|Overall Study|Physician Decision|0|||
147334962|NCT02020616|531392169|FG002|Overall Study|Physician Decision|0|||
147334963|NCT02020616|531392170|FG003|Overall Study|Physician Decision|0|||
147334964|NCT02020616|531392171|FG004|Overall Study|Physician Decision|0|||
147334965|NCT02020616|531392172|FG005|Overall Study|Physician Decision|1|||
147334966|NCT02020616|531392173|FG006|Overall Study|Physician Decision|2|||
147334967|NCT02020616|531392167|FG000|Overall Study|Withdrawal by Subject|0|||
147334968|NCT02020616|531392168|FG001|Overall Study|Withdrawal by Subject|0|||
147334969|NCT02020616|531392169|FG002|Overall Study|Withdrawal by Subject|1|||
147334970|NCT02020616|531392170|FG003|Overall Study|Withdrawal by Subject|0|||
147334971|NCT02020616|531392171|FG004|Overall Study|Withdrawal by Subject|0|||
147334972|NCT02020616|531392172|FG005|Overall Study|Withdrawal by Subject|1|||
147334973|NCT02020616|531392173|FG006|Overall Study|Withdrawal by Subject|1|||
147334974|NCT02020616|531392167|FG000|Overall Study|Lost to Follow-up|0|||
147334975|NCT02020616|531392168|FG001|Overall Study|Lost to Follow-up|1|||
147334976|NCT02020616|531392169|FG002|Overall Study|Lost to Follow-up|0|||
147334977|NCT02020616|531392170|FG003|Overall Study|Lost to Follow-up|1|||
147334978|NCT02020616|531392171|FG004|Overall Study|Lost to Follow-up|1|||
147334979|NCT02020616|531392172|FG005|Overall Study|Lost to Follow-up|1|||
147334980|NCT02020616|531392173|FG006|Overall Study|Lost to Follow-up|0|||
147334981|NCT02020616|531392167|FG000|Overall Study|Early Termination Criteria Met|0|||
147334982|NCT02020616|531392168|FG001|Overall Study|Early Termination Criteria Met|0|||
147334983|NCT02020616|531392169|FG002|Overall Study|Early Termination Criteria Met|1|||
147334984|NCT02020616|531392170|FG003|Overall Study|Early Termination Criteria Met|0|||
147334985|NCT02020616|531392171|FG004|Overall Study|Early Termination Criteria Met|0|||
147334986|NCT02020616|531392172|FG005|Overall Study|Early Termination Criteria Met|1|||
147334987|NCT02020616|531392173|FG006|Overall Study|Early Termination Criteria Met|0|||
147334988|NCT02020616|531392167|FG000|Overall Study|Randomized in Error|0|||
147334989|NCT02020616|531392168|FG001|Overall Study|Randomized in Error|0|||
147334990|NCT02020616|531392169|FG002|Overall Study|Randomized in Error|0|||
147334991|NCT02020616|531392170|FG003|Overall Study|Randomized in Error|1|||
147601711|NCT02393248|532360664|FG019|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
147601712|NCT02393248|532360665|FG020|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
147601713|NCT02393248|532360666|FG021|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
147601714|NCT02393248|532360667|FG022|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
147601715|NCT02393248|532360668|FG023|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
147601716|NCT02393248|532360669|FG024|Part 1: Monotherapy Dose Escalation|Study Terminated by Sponsor|0|||
147601717|NCT02393248|532360645|FG000|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
147601718|NCT02393248|532360646|FG001|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
147643985|NCT01447446|532516689|FG003|Overall Study|Failure to Return/Consent Withdrawn|7|||
147643986|NCT01447446|532516690|FG004|Overall Study|Failure to Return/Consent Withdrawn|69|||
147334992|NCT02020616|531392171|FG004|Overall Study|Randomized in Error|0|||
147334993|NCT02020616|531392172|FG005|Overall Study|Randomized in Error|0|||
147643987|NCT01447446|532516691|FG005|Overall Study|Failure to Return/Consent Withdrawn|9|||
147643988|NCT01447446|532516686|FG000|Overall Study|Insuff. VR/TRT too Short to Expect VR|300|||
147643989|NCT01447446|532516687|FG001|Overall Study|Insuff. VR/TRT too Short to Expect VR|71|||
147643990|NCT01447446|532516688|FG002|Overall Study|Insuff. VR/TRT too Short to Expect VR|52|||
147643991|NCT01447446|532516689|FG003|Overall Study|Insuff. VR/TRT too Short to Expect VR|21|||
147643992|NCT01447446|532516690|FG004|Overall Study|Insuff. VR/TRT too Short to Expect VR|92|||
147643993|NCT01447446|532516691|FG005|Overall Study|Insuff. VR/TRT too Short to Expect VR|14|||
147334994|NCT02020616|531392173|FG006|Overall Study|Randomized in Error|0|||
147334995|NCT02020616|531392167|FG000|Overall Study|Lack of Efficacy|0|||
147334996|NCT02020616|531392168|FG001|Overall Study|Lack of Efficacy|0|||
147334997|NCT02020616|531392169|FG002|Overall Study|Lack of Efficacy|0|||
147334998|NCT02020616|531392170|FG003|Overall Study|Lack of Efficacy|0|||
147334999|NCT02020616|531392171|FG004|Overall Study|Lack of Efficacy|1|||
147335000|NCT02020616|531392172|FG005|Overall Study|Lack of Efficacy|0|||
147335001|NCT02020616|531392173|FG006|Overall Study|Lack of Efficacy|0|||
147335002|NCT00688519|531392184|FG000|Overall Study|Adverse Event|2|||
147601719|NCT02393248|532360647|FG002|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
147601720|NCT02393248|532360648|FG003|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
147601721|NCT02393248|532360649|FG004|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
147279685|NCT01172938|531190377|FG001|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
147279686|NCT01172938|531190378|FG002|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
147279687|NCT01172938|531190379|FG003|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
147279688|NCT01172938|531190380|FG004|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
147279689|NCT01172938|531190381|FG005|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
147279690|NCT01172938|531190382|FG006|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
147279691|NCT01172938|531190383|FG007|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|1|||
147279692|NCT01172938|531190384|FG008|Active-Treatment Phase (Weeks 156-208)|Miscellaneous|0|||
147279693|NCT01172938|531190376|FG000|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
147279694|NCT01172938|531190377|FG001|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
147279695|NCT01172938|531190378|FG002|Active-Treatment Phase (Weeks 208-260)|Adverse Event|1|||
147279696|NCT01172938|531190379|FG003|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
147279697|NCT01172938|531190380|FG004|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
147279698|NCT01172938|531190381|FG005|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
147279699|NCT01172938|531190382|FG006|Active-Treatment Phase (Weeks 208-260)|Adverse Event|0|||
147279700|NCT01172938|531190383|FG007|Active-Treatment Phase (Weeks 208-260)|Adverse Event|1|||
147279701|NCT01172938|531190384|FG008|Active-Treatment Phase (Weeks 208-260)|Adverse Event|1|||
147279702|NCT01172938|531190376|FG000|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
147279703|NCT01172938|531190377|FG001|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
147279704|NCT01172938|531190378|FG002|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|2|||
147279705|NCT01172938|531190379|FG003|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
147279706|NCT01172938|531190380|FG004|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
147279707|NCT01172938|531190381|FG005|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
147279708|NCT01172938|531190382|FG006|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
147279709|NCT01172938|531190383|FG007|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
147279710|NCT01172938|531190384|FG008|Active-Treatment Phase (Weeks 208-260)|Lack of Efficacy|0|||
147279711|NCT01172938|531190376|FG000|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
147279712|NCT01172938|531190377|FG001|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|1|||
147279713|NCT01172938|531190378|FG002|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
147279714|NCT01172938|531190379|FG003|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
147279715|NCT01172938|531190380|FG004|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
147279716|NCT01172938|531190381|FG005|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
147279717|NCT01172938|531190382|FG006|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
147279718|NCT01172938|531190383|FG007|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|1|||
147279719|NCT01172938|531190384|FG008|Active-Treatment Phase (Weeks 208-260)|Non-compliance with study drug|0|||
147279720|NCT01172938|531190376|FG000|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
147279721|NCT01172938|531190377|FG001|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|2|||
147279722|NCT01172938|531190378|FG002|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|3|||
147279723|NCT01172938|531190379|FG003|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
147279724|NCT01172938|531190380|FG004|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
147279725|NCT01172938|531190381|FG005|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
147279726|NCT01172938|531190382|FG006|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
147279727|NCT01172938|531190383|FG007|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|1|||
147335003|NCT00688519|531392185|FG001|Overall Study|Adverse Event|3|||
147601722|NCT02393248|532360650|FG005|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
147279728|NCT01172938|531190384|FG008|Active-Treatment Phase (Weeks 208-260)|Withdrawal by Subject|0|||
147279729|NCT01172938|531190376|FG000|Active-Treatment Phase (Weeks 208-260)|Death|0|||
147601723|NCT02393248|532360651|FG006|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|1|||
147601724|NCT02393248|532360652|FG007|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
147662518|NCT02513550|532587350|FG005|Double Blind Treatment Period|Death|0|||
147279730|NCT01172938|531190377|FG001|Active-Treatment Phase (Weeks 208-260)|Death|0|||
147335004|NCT00688519|531392184|FG000|Overall Study|Lost to Follow-up|3|||
147335005|NCT00688519|531392185|FG001|Overall Study|Lost to Follow-up|3|||
147279731|NCT01172938|531190378|FG002|Active-Treatment Phase (Weeks 208-260)|Death|1|||
147279732|NCT01172938|531190379|FG003|Active-Treatment Phase (Weeks 208-260)|Death|0|||
147279733|NCT01172938|531190380|FG004|Active-Treatment Phase (Weeks 208-260)|Death|0|||
147279734|NCT01172938|531190381|FG005|Active-Treatment Phase (Weeks 208-260)|Death|0|||
147279735|NCT01172938|531190382|FG006|Active-Treatment Phase (Weeks 208-260)|Death|0|||
147279736|NCT01172938|531190383|FG007|Active-Treatment Phase (Weeks 208-260)|Death|0|||
147279737|NCT01172938|531190384|FG008|Active-Treatment Phase (Weeks 208-260)|Death|0|||
147279738|NCT01172938|531190376|FG000|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
147279739|NCT01172938|531190377|FG001|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
147279740|NCT01172938|531190378|FG002|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|1|||
147279741|NCT01172938|531190379|FG003|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
147279742|NCT01172938|531190380|FG004|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
147279743|NCT01172938|531190381|FG005|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
147279744|NCT01172938|531190382|FG006|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
147279745|NCT01172938|531190383|FG007|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
147279746|NCT01172938|531190384|FG008|Active-Treatment Phase (Weeks 208-260)|Lost to Follow-up|0|||
147279747|NCT01172938|531190376|FG000|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
147279748|NCT01172938|531190377|FG001|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
147279749|NCT01172938|531190378|FG002|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
147279750|NCT01172938|531190379|FG003|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
147279751|NCT01172938|531190380|FG004|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
147279752|NCT01172938|531190381|FG005|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
147279753|NCT01172938|531190382|FG006|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
147279754|NCT01172938|531190383|FG007|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|0|||
147279755|NCT01172938|531190384|FG008|Active-Treatment Phase (Weeks 208-260)|Protocol Violation|1|||
147279756|NCT00003498|531190385|FG000|Overall Study|Not evaluable.|4|||
147279757|NCT02956629|531190386|FG000|Overall Study|Adverse Event|0|||
147279758|NCT02956629|531190387|FG001|Overall Study|Adverse Event|0|||
147279759|NCT02956629|531190388|FG002|Overall Study|Adverse Event|1|||
147279760|NCT02956629|531190389|FG003|Overall Study|Adverse Event|0|||
147279761|NCT02956629|531190390|FG004|Overall Study|Adverse Event|0|||
147279762|NCT02956629|531190391|FG005|Overall Study|Adverse Event|0|||
147279763|NCT02956629|531190386|FG000|Overall Study|Lost to Follow-up|2|||
147279764|NCT02956629|531190387|FG001|Overall Study|Lost to Follow-up|5|||
147279765|NCT02956629|531190388|FG002|Overall Study|Lost to Follow-up|3|||
147279766|NCT02956629|531190389|FG003|Overall Study|Lost to Follow-up|1|||
147279767|NCT02956629|531190390|FG004|Overall Study|Lost to Follow-up|0|||
147279768|NCT02956629|531190391|FG005|Overall Study|Lost to Follow-up|1|||
147279769|NCT02956629|531190386|FG000|Overall Study|Withdrawal by Subject|3|||
147279770|NCT02956629|531190387|FG001|Overall Study|Withdrawal by Subject|1|||
147279771|NCT02956629|531190388|FG002|Overall Study|Withdrawal by Subject|0|||
147279772|NCT02956629|531190389|FG003|Overall Study|Withdrawal by Subject|0|||
147279773|NCT02956629|531190390|FG004|Overall Study|Withdrawal by Subject|0|||
147279774|NCT02956629|531190391|FG005|Overall Study|Withdrawal by Subject|0|||
147279775|NCT05282004|531190399|FG000|Overall Study|Adverse Event|2|||
147279776|NCT04808609|531190400|FG000|Overall Study|Lost to Follow-up|0|||
147279777|NCT04808609|531190401|FG001|Overall Study|Lost to Follow-up|2|||
147279778|NCT04808609|531190400|FG000|Overall Study|Administrative Withdrawal|0|||
147279779|NCT04808609|531190401|FG001|Overall Study|Administrative Withdrawal|1|||
147279780|NCT01993719|531190402|FG000|First Drug Administration|Not treated|1|||
147279781|NCT01993719|531190403|FG001|First Drug Administration|Not treated|0|||
147279782|NCT01993719|531190404|FG002|First Drug Administration|Not treated|0|||
147279783|NCT01993719|531190405|FG003|First Drug Administration|Not treated|0|||
147279784|NCT01993719|531190406|FG004|First Drug Administration|Not treated|0|||
147279785|NCT02461589|531190413|FG000|Overall Study|Withdrawal by Subject|5|||
147279786|NCT02461589|531190414|FG001|Overall Study|Withdrawal by Subject|1|||
147279787|NCT02461589|531190415|FG002|Overall Study|Withdrawal by Subject|3|||
147279788|NCT02461589|531190416|FG003|Overall Study|Withdrawal by Subject|2|||
147279789|NCT02461589|531190417|FG004|Overall Study|Withdrawal by Subject|1|||
147279790|NCT02461589|531190418|FG005|Overall Study|Withdrawal by Subject|2|||
147279791|NCT02461589|531190419|FG006|Overall Study|Withdrawal by Subject|1|||
147279792|NCT02461589|531190420|FG007|Overall Study|Withdrawal by Subject|3|||
147279793|NCT02461589|531190421|FG008|Overall Study|Withdrawal by Subject|3|||
147279794|NCT02461589|531190422|FG009|Overall Study|Withdrawal by Subject|1|||
147279795|NCT02461589|531190413|FG000|Overall Study|Lost to Follow-up|0|||
147279796|NCT02461589|531190414|FG001|Overall Study|Lost to Follow-up|0|||
147279797|NCT02461589|531190415|FG002|Overall Study|Lost to Follow-up|2|||
147279798|NCT02461589|531190416|FG003|Overall Study|Lost to Follow-up|3|||
147279799|NCT02461589|531190417|FG004|Overall Study|Lost to Follow-up|1|||
147279800|NCT02461589|531190418|FG005|Overall Study|Lost to Follow-up|1|||
147279801|NCT02461589|531190419|FG006|Overall Study|Lost to Follow-up|3|||
147279802|NCT02461589|531190420|FG007|Overall Study|Lost to Follow-up|1|||
147279803|NCT02461589|531190421|FG008|Overall Study|Lost to Follow-up|3|||
147279804|NCT02461589|531190422|FG009|Overall Study|Lost to Follow-up|1|||
147601725|NCT02393248|532360653|FG008|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
147601726|NCT02393248|532360654|FG009|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
147601727|NCT02393248|532360655|FG010|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
147601728|NCT02393248|532360656|FG011|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
147601729|NCT02393248|532360657|FG012|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
147601730|NCT02393248|532360658|FG013|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
147601731|NCT02393248|532360659|FG014|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
147601732|NCT02393248|532360660|FG015|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
147601733|NCT02393248|532360661|FG016|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
147662519|NCT02513550|532587345|FG000|Post-Treatment Follow-up Period|Withdrawal by Subject|12|||
147279805|NCT02461589|531190413|FG000|Overall Study|Death|0|||
147279806|NCT02461589|531190414|FG001|Overall Study|Death|0|||
147279807|NCT02461589|531190415|FG002|Overall Study|Death|0|||
147279808|NCT02461589|531190416|FG003|Overall Study|Death|0|||
147279809|NCT02461589|531190417|FG004|Overall Study|Death|0|||
147279810|NCT02461589|531190418|FG005|Overall Study|Death|0|||
147279811|NCT02461589|531190419|FG006|Overall Study|Death|0|||
147279812|NCT02461589|531190420|FG007|Overall Study|Death|1|||
147279813|NCT02461589|531190421|FG008|Overall Study|Death|0|||
147279814|NCT02461589|531190422|FG009|Overall Study|Death|0|||
147279815|NCT02461589|531190413|FG000|Overall Study|Unclassified|0|||
147279816|NCT02461589|531190414|FG001|Overall Study|Unclassified|0|||
147279817|NCT02461589|531190415|FG002|Overall Study|Unclassified|0|||
147279818|NCT02461589|531190416|FG003|Overall Study|Unclassified|0|||
147279819|NCT02461589|531190417|FG004|Overall Study|Unclassified|0|||
147279820|NCT02461589|531190418|FG005|Overall Study|Unclassified|0|||
147279821|NCT02461589|531190419|FG006|Overall Study|Unclassified|1|||
147279822|NCT02461589|531190420|FG007|Overall Study|Unclassified|0|||
147279823|NCT02461589|531190421|FG008|Overall Study|Unclassified|0|||
147279824|NCT02461589|531190422|FG009|Overall Study|Unclassified|2|||
147279825|NCT02461589|531190413|FG000|Overall Study|Missing follow-up information|1|||
147279826|NCT02461589|531190414|FG001|Overall Study|Missing follow-up information|1|||
147279827|NCT02461589|531190415|FG002|Overall Study|Missing follow-up information|0|||
147279828|NCT02461589|531190416|FG003|Overall Study|Missing follow-up information|0|||
147279829|NCT02461589|531190417|FG004|Overall Study|Missing follow-up information|0|||
147279830|NCT02461589|531190418|FG005|Overall Study|Missing follow-up information|0|||
147279831|NCT02461589|531190419|FG006|Overall Study|Missing follow-up information|1|||
147279832|NCT02461589|531190420|FG007|Overall Study|Missing follow-up information|0|||
147279833|NCT02461589|531190421|FG008|Overall Study|Missing follow-up information|0|||
147279834|NCT02461589|531190422|FG009|Overall Study|Missing follow-up information|0|||
147279835|NCT02461589|531190413|FG000|Overall Study|Withdrawal from trial before exposure|0|||
147279836|NCT02461589|531190414|FG001|Overall Study|Withdrawal from trial before exposure|0|||
147279837|NCT02461589|531190415|FG002|Overall Study|Withdrawal from trial before exposure|0|||
147279838|NCT02461589|531190416|FG003|Overall Study|Withdrawal from trial before exposure|0|||
147279839|NCT02461589|531190417|FG004|Overall Study|Withdrawal from trial before exposure|0|||
147279840|NCT02461589|531190418|FG005|Overall Study|Withdrawal from trial before exposure|0|||
147279841|NCT02461589|531190419|FG006|Overall Study|Withdrawal from trial before exposure|0|||
147335006|NCT00688519|531392184|FG000|Overall Study|Lack of Efficacy|3|||
147335007|NCT00688519|531392185|FG001|Overall Study|Lack of Efficacy|1|||
147335008|NCT00688519|531392184|FG000|Overall Study|Withdrawal by Subject|7|||
147335009|NCT00688519|531392185|FG001|Overall Study|Withdrawal by Subject|6|||
147335010|NCT00688519|531392184|FG000|Overall Study|Prohibited medication|1|||
147335011|NCT00688519|531392185|FG001|Overall Study|Prohibited medication|0|||
147335012|NCT00688519|531392184|FG000|Overall Study|Non-compliance|0|||
147279842|NCT02461589|531190420|FG007|Overall Study|Withdrawal from trial before exposure|0|||
147279843|NCT02461589|531190421|FG008|Overall Study|Withdrawal from trial before exposure|0|||
147279844|NCT02461589|531190422|FG009|Overall Study|Withdrawal from trial before exposure|1|||
147279845|NCT04713748|531190423|FG000|Overall Study|Not enough kits allocated|35|||
147279846|NCT01557946|531190424|FG000|Overall Study|Adverse Event|3|||
147279847|NCT01557946|531190425|FG001|Overall Study|Adverse Event|0|||
147335013|NCT00688519|531392185|FG001|Overall Study|Non-compliance|1|||
147335014|NCT00688519|531392184|FG000|Overall Study|Subject moved out of state|1|||
147335015|NCT00688519|531392185|FG001|Overall Study|Subject moved out of state|0|||
147335016|NCT00688519|531392184|FG000|Overall Study|Investigator decision|1|||
147335017|NCT00688519|531392185|FG001|Overall Study|Investigator decision|0|||
147335018|NCT00688519|531392184|FG000|Overall Study|Subject moved out of area|1|||
147279848|NCT00406029|531190426|FG000|Overall Study|Adverse Event|12|||
147279849|NCT00406029|531190427|FG001|Overall Study|Adverse Event|2|||
147279850|NCT00406029|531190428|FG002|Overall Study|Adverse Event|5|||
147279851|NCT00406029|531190429|FG003|Overall Study|Adverse Event|10|||
147279852|NCT00406029|531190430|FG004|Overall Study|Adverse Event|7|||
147335019|NCT00688519|531392185|FG001|Overall Study|Subject moved out of area|0|||
147279853|NCT00406029|531190426|FG000|Overall Study|Withdrawal by Subject|3|||
147279854|NCT00406029|531190427|FG001|Overall Study|Withdrawal by Subject|4|||
147279855|NCT00406029|531190428|FG002|Overall Study|Withdrawal by Subject|2|||
147279856|NCT00406029|531190429|FG003|Overall Study|Withdrawal by Subject|2|||
147279857|NCT00406029|531190430|FG004|Overall Study|Withdrawal by Subject|0|||
147279858|NCT00406029|531190426|FG000|Overall Study|Protocol Violation|1|||
147279859|NCT00406029|531190427|FG001|Overall Study|Protocol Violation|2|||
147279860|NCT00406029|531190428|FG002|Overall Study|Protocol Violation|0|||
147279861|NCT00406029|531190429|FG003|Overall Study|Protocol Violation|2|||
147279862|NCT00406029|531190430|FG004|Overall Study|Protocol Violation|0|||
147279863|NCT00406029|531190426|FG000|Overall Study|Did Not Meet Eligibility Criteria|0|||
147279864|NCT00406029|531190427|FG001|Overall Study|Did Not Meet Eligibility Criteria|0|||
147279865|NCT00406029|531190428|FG002|Overall Study|Did Not Meet Eligibility Criteria|1|||
147279866|NCT00406029|531190429|FG003|Overall Study|Did Not Meet Eligibility Criteria|0|||
147279867|NCT00406029|531190430|FG004|Overall Study|Did Not Meet Eligibility Criteria|0|||
147279868|NCT00406029|531190426|FG000|Overall Study|Randomized in Error|0|||
147279869|NCT00406029|531190427|FG001|Overall Study|Randomized in Error|0|||
147279870|NCT00406029|531190428|FG002|Overall Study|Randomized in Error|2|||
147279871|NCT00406029|531190429|FG003|Overall Study|Randomized in Error|3|||
147279872|NCT00406029|531190430|FG004|Overall Study|Randomized in Error|1|||
147279873|NCT04067141|531190431|FG000|First Intervention|Withdrawal by Subject|0|||
147279874|NCT04067141|531190432|FG001|First Intervention|Withdrawal by Subject|1|||
147279875|NCT04067141|531190431|FG000|Second Intervention|Adverse Event|0|||
147279876|NCT04067141|531190432|FG001|Second Intervention|Adverse Event|2|||
147279877|NCT01038921|531190434|FG000|Overall Study|Withdrawal by Subject|1|||
147279878|NCT01038921|531190435|FG001|Overall Study|Withdrawal by Subject|0|||
147279879|NCT01038921|531190434|FG000|Overall Study|Physician Decision|1|||
147279880|NCT01038921|531190435|FG001|Overall Study|Physician Decision|0|||
147279881|NCT01709227|531190436|FG000|Overall Study|Physician Decision|1|||
147279882|NCT01709227|531190437|FG001|Overall Study|Physician Decision|0|||
147279883|NCT01709227|531190436|FG000|Overall Study|Pleural Peritoneal communication|0|||
147279884|NCT01709227|531190437|FG001|Overall Study|Pleural Peritoneal communication|9|||
147279885|NCT03295201|531190441|FG000|Overall Study|Lost to Follow-up|1|||
147279886|NCT03295201|531190442|FG001|Overall Study|Lost to Follow-up|1|||
147279887|NCT03295201|531190441|FG000|Overall Study|Hospital admission|0|||
147279888|NCT03295201|531190442|FG001|Overall Study|Hospital admission|1|||
147279889|NCT00572572|531190443|FG000|Overall Study|Withdrawal by Subject|3|||
147279890|NCT00572572|531190444|FG001|Overall Study|Withdrawal by Subject|6|||
147279891|NCT01831089|531190445|FG000|Cohort I: Dose Level 1|Progressive disease|3|||
147279892|NCT01831089|531190446|FG001|Cohort I: Dose Level 1|Progressive disease|0|||
147279893|NCT01831089|531190447|FG002|Cohort I: Dose Level 1|Progressive disease|0|||
147279894|NCT01831089|531190448|FG003|Cohort I: Dose Level 1|Progressive disease|0|||
147279895|NCT01831089|531190449|FG004|Cohort I: Dose Level 1|Progressive disease|0|||
147279896|NCT01831089|531190450|FG005|Cohort I: Dose Level 1|Progressive disease|0|||
147279897|NCT01831089|531190445|FG000|Cohort II: Dose Level 2|Progressive disease|0|||
147279898|NCT01831089|531190446|FG001|Cohort II: Dose Level 2|Progressive disease|2|||
147279899|NCT01831089|531190447|FG002|Cohort II: Dose Level 2|Progressive disease|0|||
147279900|NCT01831089|531190448|FG003|Cohort II: Dose Level 2|Progressive disease|0|||
147279901|NCT01831089|531190449|FG004|Cohort II: Dose Level 2|Progressive disease|0|||
147279902|NCT01831089|531190450|FG005|Cohort II: Dose Level 2|Progressive disease|0|||
147279903|NCT01831089|531190445|FG000|Cohort II: Dose Level 2|Clinical progressive disease|0|||
147279904|NCT01831089|531190446|FG001|Cohort II: Dose Level 2|Clinical progressive disease|1|||
147279905|NCT01831089|531190447|FG002|Cohort II: Dose Level 2|Clinical progressive disease|0|||
147279906|NCT01831089|531190448|FG003|Cohort II: Dose Level 2|Clinical progressive disease|0|||
147335020|NCT00688519|531392184|FG000|Overall Study|Pregnancy|0|||
147335021|NCT00688519|531392185|FG001|Overall Study|Pregnancy|1|||
147335022|NCT01063517|531392186|FG000|Overall Study|Consent withdrawal|1|||
147335023|NCT01063517|531392187|FG001|Overall Study|Consent withdrawal|0|||
147335024|NCT01063517|531392186|FG000|Overall Study|Study reached data cut-off|19|||
147279907|NCT01831089|531190449|FG004|Cohort II: Dose Level 2|Clinical progressive disease|0|||
147279908|NCT01831089|531190450|FG005|Cohort II: Dose Level 2|Clinical progressive disease|0|||
147279909|NCT01831089|531190445|FG000|Cohort III: Dose Level 3|Progressive disease|0|||
147335025|NCT01063517|531392187|FG001|Overall Study|Study reached data cut-off|7|||
147335026|NCT01063517|531392186|FG000|Overall Study|Lost to Follow-up|4|||
147279910|NCT01831089|531190446|FG001|Cohort III: Dose Level 3|Progressive disease|0|||
147279911|NCT01831089|531190447|FG002|Cohort III: Dose Level 3|Progressive disease|3|||
147279912|NCT01831089|531190448|FG003|Cohort III: Dose Level 3|Progressive disease|0|||
147279913|NCT01831089|531190449|FG004|Cohort III: Dose Level 3|Progressive disease|0|||
147279914|NCT01831089|531190450|FG005|Cohort III: Dose Level 3|Progressive disease|0|||
147279915|NCT01831089|531190445|FG000|Cohort III: Dose Level 3|Withdrawal by Subject|0|||
147279916|NCT01831089|531190446|FG001|Cohort III: Dose Level 3|Withdrawal by Subject|0|||
147279917|NCT01831089|531190447|FG002|Cohort III: Dose Level 3|Withdrawal by Subject|1|||
147279918|NCT01831089|531190448|FG003|Cohort III: Dose Level 3|Withdrawal by Subject|0|||
147335027|NCT01063517|531392187|FG001|Overall Study|Lost to Follow-up|3|||
147601734|NCT02393248|532360662|FG017|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
147601735|NCT02393248|532360663|FG018|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
147601736|NCT02393248|532360664|FG019|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
147601737|NCT02393248|532360665|FG020|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
147601738|NCT02393248|532360666|FG021|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
147601739|NCT02393248|532360667|FG022|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
147601740|NCT02393248|532360668|FG023|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
147601741|NCT02393248|532360669|FG024|Part 1: Monotherapy Dose Escalation|Clinical Decline; Withdrew by Physician|0|||
147601742|NCT02393248|532360645|FG000|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
147601743|NCT02393248|532360646|FG001|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
147601744|NCT02393248|532360647|FG002|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
147601745|NCT02393248|532360648|FG003|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
147601746|NCT02393248|532360649|FG004|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
147601747|NCT02393248|532360650|FG005|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
147601748|NCT02393248|532360651|FG006|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
147601749|NCT02393248|532360652|FG007|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
147601750|NCT02393248|532360653|FG008|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
147601751|NCT02393248|532360654|FG009|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
147601752|NCT02393248|532360655|FG010|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
147601753|NCT02393248|532360656|FG011|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|13|||
147601754|NCT02393248|532360657|FG012|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|1|||
147601755|NCT02393248|532360658|FG013|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|2|||
147601756|NCT02393248|532360659|FG014|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|3|||
147601757|NCT02393248|532360660|FG015|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
147601758|NCT02393248|532360661|FG016|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
147601759|NCT02393248|532360662|FG017|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
147601760|NCT02393248|532360663|FG018|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
147601761|NCT02393248|532360664|FG019|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
147601762|NCT02393248|532360665|FG020|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
147601763|NCT02393248|532360666|FG021|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
147601764|NCT02393248|532360667|FG022|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
147601765|NCT02393248|532360668|FG023|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
147601766|NCT02393248|532360669|FG024|Part 2: Monotherapy Dose Expansion|Withdrawal by Subject|0|||
147601767|NCT02393248|532360645|FG000|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
147601768|NCT02393248|532360646|FG001|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
147601769|NCT02393248|532360647|FG002|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
147601770|NCT02393248|532360648|FG003|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
147601771|NCT02393248|532360649|FG004|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
147601772|NCT02393248|532360650|FG005|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
147601773|NCT02393248|532360651|FG006|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
147601774|NCT02393248|532360652|FG007|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
147601775|NCT02393248|532360653|FG008|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
147601776|NCT02393248|532360654|FG009|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
147601777|NCT02393248|532360655|FG010|Part 2: Monotherapy Dose Expansion|Disease Progression|1|||
147601778|NCT02393248|532360656|FG011|Part 2: Monotherapy Dose Expansion|Disease Progression|1|||
147601779|NCT02393248|532360657|FG012|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
147601780|NCT02393248|532360658|FG013|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
147601781|NCT02393248|532360659|FG014|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
147601782|NCT02393248|532360660|FG015|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
147601783|NCT02393248|532360661|FG016|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
147601784|NCT02393248|532360662|FG017|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
147601785|NCT02393248|532360663|FG018|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
147601786|NCT02393248|532360664|FG019|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
147601787|NCT02393248|532360665|FG020|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
147601788|NCT02393248|532360666|FG021|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
147601789|NCT02393248|532360667|FG022|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
147601790|NCT02393248|532360668|FG023|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
147601791|NCT02393248|532360669|FG024|Part 2: Monotherapy Dose Expansion|Disease Progression|0|||
147601792|NCT02393248|532360645|FG000|Part 2: Monotherapy Dose Expansion|Death|0|||
147601793|NCT02393248|532360646|FG001|Part 2: Monotherapy Dose Expansion|Death|0|||
147601794|NCT02393248|532360647|FG002|Part 2: Monotherapy Dose Expansion|Death|0|||
147601795|NCT02393248|532360648|FG003|Part 2: Monotherapy Dose Expansion|Death|0|||
147601796|NCT02393248|532360649|FG004|Part 2: Monotherapy Dose Expansion|Death|0|||
147601797|NCT02393248|532360650|FG005|Part 2: Monotherapy Dose Expansion|Death|0|||
147335028|NCT01063517|531392186|FG000|Overall Study|Withdrawal by Subject|1|||
147279919|NCT01831089|531190449|FG004|Cohort III: Dose Level 3|Withdrawal by Subject|0|||
147279920|NCT01831089|531190450|FG005|Cohort III: Dose Level 3|Withdrawal by Subject|0|||
147279921|NCT01831089|531190445|FG000|Cohort III: Dose Level 3|Adverse Event|0|||
147279922|NCT01831089|531190446|FG001|Cohort III: Dose Level 3|Adverse Event|0|||
147279923|NCT01831089|531190447|FG002|Cohort III: Dose Level 3|Adverse Event|1|||
147279924|NCT01831089|531190448|FG003|Cohort III: Dose Level 3|Adverse Event|0|||
147279925|NCT01831089|531190449|FG004|Cohort III: Dose Level 3|Adverse Event|0|||
147279926|NCT01831089|531190450|FG005|Cohort III: Dose Level 3|Adverse Event|0|||
147279927|NCT01831089|531190445|FG000|Cohort III: Dose Level 3|Global end of study|0|||
147279928|NCT01831089|531190446|FG001|Cohort III: Dose Level 3|Global end of study|0|||
147279929|NCT01831089|531190447|FG002|Cohort III: Dose Level 3|Global end of study|1|||
147279930|NCT01831089|531190448|FG003|Cohort III: Dose Level 3|Global end of study|0|||
147279931|NCT01831089|531190449|FG004|Cohort III: Dose Level 3|Global end of study|0|||
147279932|NCT01831089|531190450|FG005|Cohort III: Dose Level 3|Global end of study|0|||
147279933|NCT01831089|531190445|FG000|Cohort IV: Dose Level 4|Progressive disease|0|||
147279934|NCT01831089|531190446|FG001|Cohort IV: Dose Level 4|Progressive disease|0|||
147279935|NCT01831089|531190447|FG002|Cohort IV: Dose Level 4|Progressive disease|0|||
147279936|NCT01831089|531190448|FG003|Cohort IV: Dose Level 4|Progressive disease|6|||
147279937|NCT01831089|531190449|FG004|Cohort IV: Dose Level 4|Progressive disease|0|||
147279938|NCT01831089|531190450|FG005|Cohort IV: Dose Level 4|Progressive disease|0|||
147279939|NCT01831089|531190445|FG000|Cohort V: Dose Level 5|Progressive disease|0|||
147279940|NCT01831089|531190446|FG001|Cohort V: Dose Level 5|Progressive disease|0|||
147279941|NCT01831089|531190447|FG002|Cohort V: Dose Level 5|Progressive disease|0|||
147279942|NCT01831089|531190448|FG003|Cohort V: Dose Level 5|Progressive disease|0|||
147279943|NCT01831089|531190449|FG004|Cohort V: Dose Level 5|Progressive disease|30|||
147279944|NCT01831089|531190450|FG005|Cohort V: Dose Level 5|Progressive disease|0|||
147279945|NCT01831089|531190445|FG000|Cohort V: Dose Level 5|Withdrawal by Subject|0|||
147279946|NCT01831089|531190446|FG001|Cohort V: Dose Level 5|Withdrawal by Subject|0|||
147279947|NCT01831089|531190447|FG002|Cohort V: Dose Level 5|Withdrawal by Subject|0|||
147279948|NCT01831089|531190448|FG003|Cohort V: Dose Level 5|Withdrawal by Subject|0|||
147279949|NCT01831089|531190449|FG004|Cohort V: Dose Level 5|Withdrawal by Subject|3|||
147279950|NCT01831089|531190450|FG005|Cohort V: Dose Level 5|Withdrawal by Subject|0|||
147279951|NCT01831089|531190445|FG000|Cohort V: Dose Level 5|Death|0|||
147279952|NCT01831089|531190446|FG001|Cohort V: Dose Level 5|Death|0|||
147279953|NCT01831089|531190447|FG002|Cohort V: Dose Level 5|Death|0|||
147279954|NCT01831089|531190448|FG003|Cohort V: Dose Level 5|Death|0|||
147279955|NCT01831089|531190449|FG004|Cohort V: Dose Level 5|Death|1|||
147335029|NCT01063517|531392187|FG001|Overall Study|Withdrawal by Subject|2|||
147335030|NCT01063517|531392186|FG000|Overall Study|Death|33|||
147335031|NCT01063517|531392187|FG001|Overall Study|Death|48|||
147279956|NCT01831089|531190450|FG005|Cohort V: Dose Level 5|Death|0|||
147279957|NCT01831089|531190445|FG000|Cohort V: Dose Level 5|Global end of study|0|||
147279958|NCT01831089|531190446|FG001|Cohort V: Dose Level 5|Global end of study|0|||
147279959|NCT01831089|531190447|FG002|Cohort V: Dose Level 5|Global end of study|0|||
147279960|NCT01831089|531190448|FG003|Cohort V: Dose Level 5|Global end of study|0|||
147279961|NCT01831089|531190449|FG004|Cohort V: Dose Level 5|Global end of study|2|||
147279962|NCT01831089|531190450|FG005|Cohort V: Dose Level 5|Global end of study|0|||
147279963|NCT01831089|531190445|FG000|Cohort V: Dose Level 5|Lost to Follow-up|0|||
147335032|NCT03622593|531393748|FG000|Overall Study|Withdrawal by Subject|11|||
147335033|NCT03622593|531393749|FG001|Overall Study|Withdrawal by Subject|9|||
147335034|NCT03622593|531393750|FG002|Overall Study|Withdrawal by Subject|13|||
147335035|NCT03622593|531393748|FG000|Overall Study|Death|12|||
147601798|NCT02393248|532360651|FG006|Part 2: Monotherapy Dose Expansion|Death|0|||
147601799|NCT02393248|532360652|FG007|Part 2: Monotherapy Dose Expansion|Death|0|||
147601800|NCT02393248|532360653|FG008|Part 2: Monotherapy Dose Expansion|Death|0|||
147601801|NCT02393248|532360654|FG009|Part 2: Monotherapy Dose Expansion|Death|0|||
147601802|NCT02393248|532360655|FG010|Part 2: Monotherapy Dose Expansion|Death|3|||
147601803|NCT02393248|532360656|FG011|Part 2: Monotherapy Dose Expansion|Death|29|||
147601804|NCT02393248|532360657|FG012|Part 2: Monotherapy Dose Expansion|Death|4|||
147601805|NCT02393248|532360658|FG013|Part 2: Monotherapy Dose Expansion|Death|15|||
147601806|NCT02393248|532360659|FG014|Part 2: Monotherapy Dose Expansion|Death|2|||
147601807|NCT02393248|532360660|FG015|Part 2: Monotherapy Dose Expansion|Death|0|||
147601808|NCT02393248|532360661|FG016|Part 2: Monotherapy Dose Expansion|Death|0|||
147601809|NCT02393248|532360662|FG017|Part 2: Monotherapy Dose Expansion|Death|0|||
147601810|NCT02393248|532360663|FG018|Part 2: Monotherapy Dose Expansion|Death|0|||
147601811|NCT02393248|532360664|FG019|Part 2: Monotherapy Dose Expansion|Death|0|||
147601812|NCT02393248|532360665|FG020|Part 2: Monotherapy Dose Expansion|Death|0|||
147601813|NCT02393248|532360666|FG021|Part 2: Monotherapy Dose Expansion|Death|0|||
147601814|NCT02393248|532360667|FG022|Part 2: Monotherapy Dose Expansion|Death|0|||
147601815|NCT02393248|532360668|FG023|Part 2: Monotherapy Dose Expansion|Death|0|||
147601816|NCT02393248|532360669|FG024|Part 2: Monotherapy Dose Expansion|Death|0|||
147335036|NCT03622593|531393749|FG001|Overall Study|Death|9|||
147601817|NCT02393248|532360645|FG000|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
147601818|NCT02393248|532360646|FG001|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
147601819|NCT02393248|532360647|FG002|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
147601820|NCT02393248|532360648|FG003|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
147601821|NCT02393248|532360649|FG004|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
147601822|NCT02393248|532360650|FG005|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
147601823|NCT02393248|532360651|FG006|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
147601824|NCT02393248|532360652|FG007|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
147601825|NCT02393248|532360653|FG008|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
147279964|NCT01831089|531190446|FG001|Cohort V: Dose Level 5|Lost to Follow-up|0|||
147279965|NCT01831089|531190447|FG002|Cohort V: Dose Level 5|Lost to Follow-up|0|||
147279966|NCT01831089|531190448|FG003|Cohort V: Dose Level 5|Lost to Follow-up|0|||
147279967|NCT01831089|531190449|FG004|Cohort V: Dose Level 5|Lost to Follow-up|1|||
147279968|NCT01831089|531190450|FG005|Cohort V: Dose Level 5|Lost to Follow-up|0|||
147279969|NCT01831089|531190445|FG000|Cohort B: Arm B|Progressive disease|0|||
147279970|NCT01831089|531190446|FG001|Cohort B: Arm B|Progressive disease|0|||
147279971|NCT01831089|531190447|FG002|Cohort B: Arm B|Progressive disease|0|||
147279972|NCT01831089|531190448|FG003|Cohort B: Arm B|Progressive disease|0|||
147279973|NCT01831089|531190449|FG004|Cohort B: Arm B|Progressive disease|0|||
147279974|NCT01831089|531190450|FG005|Cohort B: Arm B|Progressive disease|8|||
147279975|NCT01831089|531190445|FG000|Cohort B: Arm B|Physician Decision|0|||
147279976|NCT01831089|531190446|FG001|Cohort B: Arm B|Physician Decision|0|||
147279977|NCT01831089|531190447|FG002|Cohort B: Arm B|Physician Decision|0|||
147279978|NCT01831089|531190448|FG003|Cohort B: Arm B|Physician Decision|0|||
147279979|NCT01831089|531190449|FG004|Cohort B: Arm B|Physician Decision|0|||
147279980|NCT01831089|531190450|FG005|Cohort B: Arm B|Physician Decision|2|||
147279981|NCT01831089|531190445|FG000|Cohort B: Arm B|Never treated|0|||
147279982|NCT01831089|531190446|FG001|Cohort B: Arm B|Never treated|0|||
147279983|NCT01831089|531190447|FG002|Cohort B: Arm B|Never treated|0|||
147279984|NCT01831089|531190448|FG003|Cohort B: Arm B|Never treated|0|||
147279985|NCT01831089|531190449|FG004|Cohort B: Arm B|Never treated|0|||
147279986|NCT01831089|531190450|FG005|Cohort B: Arm B|Never treated|2|||
147279987|NCT01831089|531190445|FG000|Cohort B: Arm B|Adverse Event|0|||
147279988|NCT01831089|531190446|FG001|Cohort B: Arm B|Adverse Event|0|||
147279989|NCT01831089|531190447|FG002|Cohort B: Arm B|Adverse Event|0|||
147279990|NCT01831089|531190448|FG003|Cohort B: Arm B|Adverse Event|0|||
147279991|NCT01831089|531190449|FG004|Cohort B: Arm B|Adverse Event|0|||
147279992|NCT01831089|531190450|FG005|Cohort B: Arm B|Adverse Event|1|||
147279993|NCT01831089|531190445|FG000|Cohort B: Arm B|Global end of study|0|||
147279994|NCT01831089|531190446|FG001|Cohort B: Arm B|Global end of study|0|||
147279995|NCT01831089|531190447|FG002|Cohort B: Arm B|Global end of study|0|||
147279996|NCT01831089|531190448|FG003|Cohort B: Arm B|Global end of study|0|||
147279997|NCT01831089|531190449|FG004|Cohort B: Arm B|Global end of study|0|||
147279998|NCT01831089|531190450|FG005|Cohort B: Arm B|Global end of study|1|||
147279999|NCT00889421|531190451|FG000|Overall Study|Lack of Efficacy|3|||
147280000|NCT01958918|531190452|FG000|Overall Study|Death|1|||
147280001|NCT01958918|531190453|FG001|Overall Study|Death|3|||
147280002|NCT01958918|531190452|FG000|Overall Study|Lost to Follow-up|4|||
147280003|NCT01958918|531190453|FG001|Overall Study|Lost to Follow-up|7|||
147280004|NCT01958918|531190452|FG000|Overall Study|Withdrawal by Subject|13|||
147280005|NCT01958918|531190453|FG001|Overall Study|Withdrawal by Subject|8|||
147280006|NCT01958918|531190452|FG000|Overall Study|Lack of Efficacy|13|||
147280007|NCT01958918|531190453|FG001|Overall Study|Lack of Efficacy|10|||
147280008|NCT01958918|531190452|FG000|Overall Study|Adverse Event|12|||
147280009|NCT01958918|531190453|FG001|Overall Study|Adverse Event|12|||
147280010|NCT01958918|531190452|FG000|Overall Study|administrative problems|0|||
147280011|NCT01958918|531190453|FG001|Overall Study|administrative problems|2|||
147280012|NCT02114892|531190457|FG000|Overall Study|Lost to Follow-up|1|||
147280013|NCT02114892|531190458|FG001|Overall Study|Lost to Follow-up|2|||
147280014|NCT02013765|531190462|FG000|Overall Study|Trial was terminated by sponsor|1|||
147280015|NCT04479618|531190465|FG000|Overall Study|Agreed to randomization, but withdrew when it did not lead to assignment to Group 2|1|||
147280016|NCT04479618|531190466|FG001|Overall Study|Agreed to randomization, but withdrew when it did not lead to assignment to Group 2|0|||
147280017|NCT04479618|531190467|FG002|Overall Study|Agreed to randomization, but withdrew when it did not lead to assignment to Group 2|1|||
147280018|NCT04479618|531190465|FG000|Overall Study|Lack of Efficacy|1|||
147280019|NCT04479618|531190466|FG001|Overall Study|Lack of Efficacy|0|||
147280020|NCT04479618|531190467|FG002|Overall Study|Lack of Efficacy|0|||
147280021|NCT04479618|531190465|FG000|Overall Study|No reliable phone and unable to come in weekly|0|||
147280022|NCT04479618|531190466|FG001|Overall Study|No reliable phone and unable to come in weekly|1|||
147280023|NCT04479618|531190467|FG002|Overall Study|No reliable phone and unable to come in weekly|1|||
147280024|NCT04479618|531190465|FG000|Overall Study|Unable to comply with protocol due to physical disability plus social isolation (no assistance)|0|||
147280025|NCT04479618|531190466|FG001|Overall Study|Unable to comply with protocol due to physical disability plus social isolation (no assistance)|0|||
147601826|NCT02393248|532360654|FG009|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
147451037|NCT02432235|531813231|FG001|Overall Study|Withdrawal by Subject|1|||
147451038|NCT02432235|531813232|FG002|Overall Study|Withdrawal by Subject|0|||
147451039|NCT02432235|531813233|FG003|Overall Study|Withdrawal by Subject|0|||
147451040|NCT02432235|531813234|FG004|Overall Study|Withdrawal by Subject|0|||
147451041|NCT02432235|531813235|FG005|Overall Study|Withdrawal by Subject|2|||
147451042|NCT02432235|531813236|FG006|Overall Study|Withdrawal by Subject|5|||
147451043|NCT02432235|531813237|FG007|Overall Study|Withdrawal by Subject|3|||
147451044|NCT02432235|531813238|FG008|Overall Study|Withdrawal by Subject|1|||
147451045|NCT02432235|531813239|FG009|Overall Study|Withdrawal by Subject|0|||
147451046|NCT02432235|531813240|FG010|Overall Study|Withdrawal by Subject|0|||
147451047|NCT02432235|531813241|FG011|Overall Study|Withdrawal by Subject|0|||
147451048|NCT02432235|531813230|FG000|Overall Study|Lost to Follow-up|0|||
147451049|NCT02432235|531813231|FG001|Overall Study|Lost to Follow-up|0|||
147451050|NCT02432235|531813232|FG002|Overall Study|Lost to Follow-up|0|||
147451051|NCT02432235|531813233|FG003|Overall Study|Lost to Follow-up|0|||
147451052|NCT02432235|531813234|FG004|Overall Study|Lost to Follow-up|0|||
147451053|NCT02432235|531813235|FG005|Overall Study|Lost to Follow-up|1|||
147451054|NCT02432235|531813236|FG006|Overall Study|Lost to Follow-up|0|||
147451055|NCT02432235|531813237|FG007|Overall Study|Lost to Follow-up|0|||
147451056|NCT02432235|531813238|FG008|Overall Study|Lost to Follow-up|1|||
147451057|NCT02432235|531813239|FG009|Overall Study|Lost to Follow-up|0|||
147451058|NCT02432235|531813240|FG010|Overall Study|Lost to Follow-up|0|||
147451059|NCT02432235|531813241|FG011|Overall Study|Lost to Follow-up|0|||
147451060|NCT02432235|531813230|FG000|Overall Study|Miscellaneous|0|||
147451061|NCT02432235|531813231|FG001|Overall Study|Miscellaneous|0|||
147451062|NCT02432235|531813232|FG002|Overall Study|Miscellaneous|0|||
147451063|NCT02432235|531813233|FG003|Overall Study|Miscellaneous|0|||
147451064|NCT02432235|531813234|FG004|Overall Study|Miscellaneous|1|||
147451065|NCT02432235|531813235|FG005|Overall Study|Miscellaneous|6|||
147451066|NCT02432235|531813236|FG006|Overall Study|Miscellaneous|2|||
147451067|NCT02432235|531813237|FG007|Overall Study|Miscellaneous|2|||
147451068|NCT02432235|531813238|FG008|Overall Study|Miscellaneous|4|||
147451069|NCT02432235|531813239|FG009|Overall Study|Miscellaneous|0|||
147451070|NCT02432235|531813240|FG010|Overall Study|Miscellaneous|0|||
147451071|NCT02432235|531813241|FG011|Overall Study|Miscellaneous|1|||
147451072|NCT01895322|531813242|FG000|Overall Study|Adverse Event|1|||
147451073|NCT01895322|531813242|FG000|Overall Study|Withdrawal by Subject|2|||
147451074|NCT01895322|531813242|FG000|Overall Study|Protocol Violation|10|||
147451075|NCT00143312|531813243|FG000|Overall Study|Death|11|||
147451076|NCT00143312|531813243|FG000|Overall Study|Adverse Event|2|||
147451077|NCT00143312|531813243|FG000|Overall Study|Lost to Follow-up|1|||
147451078|NCT00143312|531813243|FG000|Overall Study|Other|1|||
147451079|NCT00143312|531813243|FG000|Overall Study|Withdrawal by Subject|1|||
147451080|NCT01834274|531813244|FG000|Overall Study|Study Termination|41|||
147451081|NCT01834274|531813245|FG001|Overall Study|Study Termination|38|||
147451082|NCT01834274|531813244|FG000|Overall Study|Withdrawal by Subject|1|||
147451083|NCT01834274|531813245|FG001|Overall Study|Withdrawal by Subject|1|||
147451084|NCT01834274|531813244|FG000|Overall Study|Lost to Follow-up|3|||
147451085|NCT01834274|531813245|FG001|Overall Study|Lost to Follow-up|1|||
147451086|NCT01834274|531813244|FG000|Overall Study|Other|2|||
147451087|NCT01834274|531813245|FG001|Overall Study|Other|1|||
147451088|NCT00606086|531813246|FG000|Overall Study|Adverse Event|1|||
147451089|NCT00606086|531813247|FG001|Overall Study|Adverse Event|1|||
147451090|NCT00606086|531813246|FG000|Overall Study|Lost to Follow-up|4|||
147451091|NCT00606086|531813247|FG001|Overall Study|Lost to Follow-up|8|||
147451092|NCT00606086|531813246|FG000|Overall Study|Protocol Violation|1|||
147451093|NCT00606086|531813247|FG001|Overall Study|Protocol Violation|0|||
147451094|NCT00606086|531813246|FG000|Overall Study|Withdrawal by Subject|5|||
147451095|NCT00606086|531813247|FG001|Overall Study|Withdrawal by Subject|3|||
147451096|NCT00606086|531813246|FG000|Overall Study|Non-compliance|0|||
147662520|NCT02513550|532587346|FG001|Post-Treatment Follow-up Period|Withdrawal by Subject|20|||
147451097|NCT00606086|531813247|FG001|Overall Study|Non-compliance|1|||
147451098|NCT00606086|531813246|FG000|Overall Study|Randomized, not treated|1|||
147451099|NCT00606086|531813247|FG001|Overall Study|Randomized, not treated|2|||
147451100|NCT03028870|531813255|FG000|Overall Study|Adverse Event|7|||
147451101|NCT03028870|531813256|FG001|Overall Study|Adverse Event|4|||
147451102|NCT03028870|531813257|FG002|Overall Study|Adverse Event|3|||
147451103|NCT03028870|531813258|FG003|Overall Study|Adverse Event|3|||
147451104|NCT03028870|531813255|FG000|Overall Study|Withdrawal by Subject|1|||
147451105|NCT03028870|531813256|FG001|Overall Study|Withdrawal by Subject|1|||
147451106|NCT03028870|531813257|FG002|Overall Study|Withdrawal by Subject|1|||
147451107|NCT03028870|531813258|FG003|Overall Study|Withdrawal by Subject|2|||
147451108|NCT03028870|531813255|FG000|Overall Study|Lost to Follow-up|1|||
147451109|NCT03028870|531813256|FG001|Overall Study|Lost to Follow-up|0|||
147451110|NCT03028870|531813257|FG002|Overall Study|Lost to Follow-up|0|||
147451111|NCT03028870|531813258|FG003|Overall Study|Lost to Follow-up|0|||
147451112|NCT03028870|531813255|FG000|Overall Study|Lack of Efficacy|3|||
147451113|NCT03028870|531813256|FG001|Overall Study|Lack of Efficacy|0|||
147451114|NCT03028870|531813257|FG002|Overall Study|Lack of Efficacy|0|||
147280026|NCT04479618|531190467|FG002|Overall Study|Unable to comply with protocol due to physical disability plus social isolation (no assistance)|1|||
147280027|NCT04479618|531190465|FG000|Overall Study|Intellectually disabled; caregivers neglected to follow protocol|0|||
147280028|NCT04479618|531190466|FG001|Overall Study|Intellectually disabled; caregivers neglected to follow protocol|0|||
147280029|NCT04479618|531190467|FG002|Overall Study|Intellectually disabled; caregivers neglected to follow protocol|1|||
147280030|NCT04479618|531190465|FG000|Overall Study|Emotionally unstable; (e.g.,data unreliable - completed four weeks' forms on day they were received)|0|||
147280031|NCT04479618|531190466|FG001|Overall Study|Emotionally unstable; (e.g.,data unreliable - completed four weeks' forms on day they were received)|0|||
147280032|NCT04479618|531190467|FG002|Overall Study|Emotionally unstable; (e.g.,data unreliable - completed four weeks' forms on day they were received)|1|||
147280033|NCT00659269|531190472|FG000|Overall Study|Physician Decision|1|||
147280034|NCT00659269|531190473|FG001|Overall Study|Physician Decision|1|||
147280035|NCT00718042|531190475|FG000|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0|||
147335037|NCT03622593|531393750|FG002|Overall Study|Death|10|||
147335038|NCT03622593|531393748|FG000|Overall Study|Lost to Follow-up|11|||
147335039|NCT03622593|531393749|FG001|Overall Study|Lost to Follow-up|5|||
147335040|NCT03622593|531393750|FG002|Overall Study|Lost to Follow-up|8|||
147335041|NCT03622593|531393748|FG000|Overall Study|Adverse Event|4|||
147335042|NCT03622593|531393749|FG001|Overall Study|Adverse Event|5|||
147335043|NCT03622593|531393750|FG002|Overall Study|Adverse Event|6|||
147335044|NCT03622593|531393748|FG000|Overall Study|Physician Decision|2|||
147335045|NCT03622593|531393749|FG001|Overall Study|Physician Decision|1|||
147335046|NCT03622593|531393750|FG002|Overall Study|Physician Decision|6|||
147335047|NCT03622593|531393748|FG000|Overall Study|Other|2|||
147335048|NCT03622593|531393749|FG001|Overall Study|Other|2|||
147335049|NCT03622593|531393750|FG002|Overall Study|Other|3|||
147335050|NCT03622593|531393748|FG000|Overall Study|Protocol Violation|0|||
147335051|NCT03622593|531393749|FG001|Overall Study|Protocol Violation|0|||
147335052|NCT03622593|531393750|FG002|Overall Study|Protocol Violation|1|||
147335053|NCT03622593|531393748|FG000|Overall Study|Pregnancy|0|||
147335054|NCT03622593|531393749|FG001|Overall Study|Pregnancy|0|||
147335055|NCT03622593|531393750|FG002|Overall Study|Pregnancy|1|||
147335056|NCT02983617|531393752|FG000|Overall Study|Adverse Event|0|||
147335057|NCT02983617|531393753|FG001|Overall Study|Adverse Event|7|||
147335058|NCT02983617|531393752|FG000|Overall Study|Death|0|||
147335059|NCT02983617|531393753|FG001|Overall Study|Death|1|||
147335060|NCT02983617|531393752|FG000|Overall Study|Investigator's Discretion|0|||
147335061|NCT02983617|531393753|FG001|Overall Study|Investigator's Discretion|1|||
147335062|NCT00711958|531393756|FG000|Overall Study|Withdrawal by Subject|6|||
147335063|NCT00711958|531393757|FG001|Overall Study|Withdrawal by Subject|8|||
147335064|NCT00711958|531393756|FG000|Overall Study|Lack of Efficacy|3|||
147335065|NCT00711958|531393757|FG001|Overall Study|Lack of Efficacy|1|||
147335066|NCT00711958|531393756|FG000|Overall Study|Clinical deterioration|1|||
147335067|NCT00711958|531393757|FG001|Overall Study|Clinical deterioration|0|||
147335068|NCT00711958|531393756|FG000|Overall Study|Adverse Event|9|||
147335069|NCT00711958|531393757|FG001|Overall Study|Adverse Event|7|||
147335070|NCT00711958|531393756|FG000|Overall Study|Protocol Violation|1|||
147335071|NCT00711958|531393757|FG001|Overall Study|Protocol Violation|0|||
147335072|NCT00711958|531393756|FG000|Overall Study|Lost to Follow-up|2|||
147335073|NCT00711958|531393757|FG001|Overall Study|Lost to Follow-up|2|||
147335074|NCT00711958|531393756|FG000|Overall Study|Death|10|||
147335075|NCT00711958|531393757|FG001|Overall Study|Death|5|||
147335076|NCT00711958|531393756|FG000|Overall Study|Progression of disease|1|||
147335077|NCT00711958|531393757|FG001|Overall Study|Progression of disease|0|||
147335078|NCT02296424|531393760|FG000|Part 1|New therapy for study indication|0|||
147335079|NCT02296424|531393761|FG001|Part 1|New therapy for study indication|1|||
147335080|NCT02296424|531393762|FG002|Part 1|New therapy for study indication|0|||
147335081|NCT02296424|531393763|FG003|Part 1|New therapy for study indication|0|||
147335082|NCT02296424|531393760|FG000|Part 1|Protocol Violation|0|||
147335083|NCT02296424|531393761|FG001|Part 1|Protocol Violation|1|||
147335084|NCT02296424|531393762|FG002|Part 1|Protocol Violation|0|||
147335085|NCT02296424|531393763|FG003|Part 1|Protocol Violation|0|||
147335086|NCT02296424|531393760|FG000|Part 1|Withdrawal by Subject|0|||
147451115|NCT03028870|531813258|FG003|Overall Study|Lack of Efficacy|0|||
147280036|NCT00718042|531190476|FG001|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0|||
147335087|NCT02296424|531393761|FG001|Part 1|Withdrawal by Subject|2|||
147335088|NCT02296424|531393762|FG002|Part 1|Withdrawal by Subject|0|||
147335089|NCT02296424|531393763|FG003|Part 1|Withdrawal by Subject|0|||
147335090|NCT02296424|531393760|FG000|Part 1|Study terminated by sponsor|0|||
147335091|NCT02296424|531393761|FG001|Part 1|Study terminated by sponsor|1|||
147335092|NCT02296424|531393762|FG002|Part 1|Study terminated by sponsor|0|||
147335093|NCT02296424|531393763|FG003|Part 1|Study terminated by sponsor|0|||
147335094|NCT02296424|531393760|FG000|Part 1|Adverse Event|2|||
147335095|NCT02296424|531393761|FG001|Part 1|Adverse Event|11|||
147335096|NCT02296424|531393762|FG002|Part 1|Adverse Event|0|||
147335097|NCT02296424|531393763|FG003|Part 1|Adverse Event|0|||
147335098|NCT02296424|531393760|FG000|Part 1|Lack of Efficacy|5|||
147335099|NCT02296424|531393761|FG001|Part 1|Lack of Efficacy|17|||
147335100|NCT02296424|531393762|FG002|Part 1|Lack of Efficacy|0|||
147601827|NCT02393248|532360655|FG010|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
147601828|NCT02393248|532360656|FG011|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|1|||
147280037|NCT00718042|531190477|FG002|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0|||
147280038|NCT00718042|531190478|FG003|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0|||
147280039|NCT00718042|531190479|FG004|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|2|||
147280040|NCT00718042|531190480|FG005|ABBOTT PRISM Chagas Testing|Withdrawal by Subject|0|||
147280041|NCT00718042|531190475|FG000|ABBOTT PRISM Chagas Testing|Protocol Violation|64|||
147280042|NCT00718042|531190476|FG001|ABBOTT PRISM Chagas Testing|Protocol Violation|0|||
147280043|NCT00718042|531190477|FG002|ABBOTT PRISM Chagas Testing|Protocol Violation|0|||
147280044|NCT00718042|531190478|FG003|ABBOTT PRISM Chagas Testing|Protocol Violation|0|||
147280045|NCT00718042|531190479|FG004|ABBOTT PRISM Chagas Testing|Protocol Violation|36|||
147280046|NCT00718042|531190480|FG005|ABBOTT PRISM Chagas Testing|Protocol Violation|0|||
147335101|NCT02296424|531393763|FG003|Part 1|Lack of Efficacy|0|||
147335102|NCT02296424|531393760|FG000|Part 1|16 directly started part II|16|||
147335103|NCT02296424|531393761|FG001|Part 1|16 directly started part II|0|||
147335104|NCT02296424|531393762|FG002|Part 1|16 directly started part II|0|||
147335105|NCT02296424|531393763|FG003|Part 1|16 directly started part II|0|||
147335106|NCT02296424|531393760|FG000|Part 2|Lack of Efficacy|0|||
147335107|NCT02296424|531393761|FG001|Part 2|Lack of Efficacy|0|||
147335108|NCT02296424|531393762|FG002|Part 2|Lack of Efficacy|1|||
147335109|NCT02296424|531393763|FG003|Part 2|Lack of Efficacy|0|||
147335110|NCT02296424|531393760|FG000|Part 2|Adverse Event|0|||
147335111|NCT02296424|531393761|FG001|Part 2|Adverse Event|0|||
147335112|NCT02296424|531393762|FG002|Part 2|Adverse Event|1|||
147335113|NCT02296424|531393763|FG003|Part 2|Adverse Event|0|||
147335114|NCT02296424|531393760|FG000|Part 2|Lost to Follow-up|0|||
147335115|NCT02296424|531393761|FG001|Part 2|Lost to Follow-up|0|||
147335116|NCT02296424|531393762|FG002|Part 2|Lost to Follow-up|1|||
147601829|NCT02393248|532360657|FG012|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
147601830|NCT02393248|532360658|FG013|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|3|||
147601831|NCT02393248|532360659|FG014|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
147601832|NCT02393248|532360660|FG015|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
147601833|NCT02393248|532360661|FG016|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
147601834|NCT02393248|532360662|FG017|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
147601835|NCT02393248|532360663|FG018|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
147601836|NCT02393248|532360664|FG019|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
147601837|NCT02393248|532360665|FG020|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
147601838|NCT02393248|532360666|FG021|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
147601839|NCT02393248|532360667|FG022|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
147601840|NCT02393248|532360668|FG023|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
147601841|NCT02393248|532360669|FG024|Part 2: Monotherapy Dose Expansion|Study Terminated by Sponsor|0|||
147601842|NCT02393248|532360645|FG000|Part 3: Combination Therapy|Withdrawal by Subject|0|||
147601843|NCT02393248|532360646|FG001|Part 3: Combination Therapy|Withdrawal by Subject|0|||
147601844|NCT02393248|532360647|FG002|Part 3: Combination Therapy|Withdrawal by Subject|0|||
147601845|NCT02393248|532360648|FG003|Part 3: Combination Therapy|Withdrawal by Subject|0|||
147601846|NCT02393248|532360649|FG004|Part 3: Combination Therapy|Withdrawal by Subject|0|||
147601847|NCT02393248|532360650|FG005|Part 3: Combination Therapy|Withdrawal by Subject|0|||
147601848|NCT02393248|532360651|FG006|Part 3: Combination Therapy|Withdrawal by Subject|0|||
147601849|NCT02393248|532360652|FG007|Part 3: Combination Therapy|Withdrawal by Subject|0|||
147601850|NCT02393248|532360653|FG008|Part 3: Combination Therapy|Withdrawal by Subject|0|||
147601851|NCT02393248|532360654|FG009|Part 3: Combination Therapy|Withdrawal by Subject|0|||
147601852|NCT02393248|532360655|FG010|Part 3: Combination Therapy|Withdrawal by Subject|0|||
147601853|NCT02393248|532360656|FG011|Part 3: Combination Therapy|Withdrawal by Subject|0|||
147601854|NCT02393248|532360657|FG012|Part 3: Combination Therapy|Withdrawal by Subject|0|||
147601855|NCT02393248|532360658|FG013|Part 3: Combination Therapy|Withdrawal by Subject|0|||
147601856|NCT02393248|532360659|FG014|Part 3: Combination Therapy|Withdrawal by Subject|0|||
147601857|NCT02393248|532360660|FG015|Part 3: Combination Therapy|Withdrawal by Subject|0|||
147601858|NCT02393248|532360661|FG016|Part 3: Combination Therapy|Withdrawal by Subject|0|||
147335117|NCT02296424|531393763|FG003|Part 2|Lost to Follow-up|0|||
147662521|NCT02513550|532587347|FG002|Post-Treatment Follow-up Period|Withdrawal by Subject|26|||
147662522|NCT02513550|532587348|FG003|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
147280047|NCT00718042|531190475|FG000|ABBOTT PRISM Chagas Testing|Insufficient sample|0|||
147335118|NCT00071799|531393764|FG000|Overall Study|Adverse Event|19|||
147335119|NCT00071799|531393765|FG001|Overall Study|Adverse Event|10|||
147335120|NCT00071799|531393764|FG000|Overall Study|Protocol Violation|1|||
147335121|NCT00071799|531393765|FG001|Overall Study|Protocol Violation|7|||
147335122|NCT00071799|531393764|FG000|Overall Study|Lost to Follow-up|1|||
147335123|NCT00071799|531393765|FG001|Overall Study|Lost to Follow-up|1|||
147335124|NCT00071799|531393764|FG000|Overall Study|Withdrawal by Subject|15|||
147335125|NCT00071799|531393765|FG001|Overall Study|Withdrawal by Subject|37|||
147335126|NCT00071799|531393764|FG000|Overall Study|Physician Decision|0|||
147335127|NCT00071799|531393765|FG001|Overall Study|Physician Decision|2|||
147280048|NCT00718042|531190476|FG001|ABBOTT PRISM Chagas Testing|Insufficient sample|1|||
147280049|NCT00718042|531190477|FG002|ABBOTT PRISM Chagas Testing|Insufficient sample|1|||
147280050|NCT00718042|531190478|FG003|ABBOTT PRISM Chagas Testing|Insufficient sample|0|||
147280051|NCT00718042|531190479|FG004|ABBOTT PRISM Chagas Testing|Insufficient sample|0|||
147280052|NCT00718042|531190480|FG005|ABBOTT PRISM Chagas Testing|Insufficient sample|0|||
147280053|NCT00718042|531190475|FG000|ABBOTT PRISM Chagas Testing|No result on comparator assay|0|||
147280054|NCT00718042|531190476|FG001|ABBOTT PRISM Chagas Testing|No result on comparator assay|1|||
147280055|NCT00718042|531190477|FG002|ABBOTT PRISM Chagas Testing|No result on comparator assay|0|||
147280056|NCT00718042|531190478|FG003|ABBOTT PRISM Chagas Testing|No result on comparator assay|0|||
147280057|NCT00718042|531190479|FG004|ABBOTT PRISM Chagas Testing|No result on comparator assay|0|||
147280058|NCT00718042|531190480|FG005|ABBOTT PRISM Chagas Testing|No result on comparator assay|0|||
147280059|NCT00718042|531190475|FG000|Donor Follow-up|Lost to Follow-up|13|||
147280060|NCT00718042|531190476|FG001|Donor Follow-up|Lost to Follow-up|0|||
147280061|NCT00718042|531190477|FG002|Donor Follow-up|Lost to Follow-up|0|||
147280062|NCT00718042|531190478|FG003|Donor Follow-up|Lost to Follow-up|0|||
147280063|NCT00718042|531190479|FG004|Donor Follow-up|Lost to Follow-up|19|||
147662523|NCT02513550|532587349|FG004|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
147280064|NCT00718042|531190480|FG005|Donor Follow-up|Lost to Follow-up|0|||
147280065|NCT04327934|531190481|FG000|Overall Study|Did not qualify|7|||
147280066|NCT04327934|531190482|FG001|Overall Study|Did not qualify|4|||
147280067|NCT04327934|531190481|FG000|Overall Study|Physician Decision|0|||
147280068|NCT04327934|531190482|FG001|Overall Study|Physician Decision|1|||
147280069|NCT02443298|531190483|FG000|Overall Study|Adverse Event|3|||
147280070|NCT02443298|531190484|FG001|Overall Study|Adverse Event|3|||
147280071|NCT02443298|531190483|FG000|Overall Study|Withdrawal by Subject|1|||
147280072|NCT02443298|531190484|FG001|Overall Study|Withdrawal by Subject|2|||
147280073|NCT01047683|531190485|FG000|Overall Study|Adverse Event|3|||
147280074|NCT01047683|531190486|FG001|Overall Study|Adverse Event|1|||
147280075|NCT01047683|531190487|FG002|Overall Study|Adverse Event|0|||
147280076|NCT01047683|531190485|FG000|Overall Study|Withdrew Consent|1|||
147280077|NCT01047683|531190486|FG001|Overall Study|Withdrew Consent|4|||
147280078|NCT01047683|531190487|FG002|Overall Study|Withdrew Consent|2|||
147280079|NCT01047683|531190485|FG000|Overall Study|Lost to Follow-up|0|||
147280080|NCT01047683|531190486|FG001|Overall Study|Lost to Follow-up|1|||
147280081|NCT01047683|531190487|FG002|Overall Study|Lost to Follow-up|0|||
147280082|NCT01047683|531190485|FG000|Overall Study|Triglycerides >2000 mg/dL|1|||
147280083|NCT01047683|531190486|FG001|Overall Study|Triglycerides >2000 mg/dL|0|||
147280084|NCT01047683|531190487|FG002|Overall Study|Triglycerides >2000 mg/dL|1|||
147280085|NCT00833924|531190502|FG000|Overall Study|Death|21|||
147280086|NCT00833924|531190502|FG000|Overall Study|Conversion|2|||
147280087|NCT00833924|531190502|FG000|Overall Study|Lost to Follow-up|2|||
147280088|NCT00833924|531190502|FG000|Overall Study|Withdrawal by Subject|13|||
147280089|NCT00833924|531190502|FG000|Overall Study|In study follow-up|71|||
147280090|NCT01485861|531190503|FG000|Phase Ib|Death|1|||
147280091|NCT01485861|531190504|FG001|Phase Ib|Death|0|||
147280092|NCT01485861|531190505|FG002|Phase Ib|Death|0|||
147280093|NCT01485861|531190506|FG003|Phase Ib|Death|0|||
147280094|NCT01485861|531190507|FG004|Phase Ib|Death|0|||
147280095|NCT01485861|531190508|FG005|Phase Ib|Death|0|||
147280096|NCT01485861|531190503|FG000|Phase Ib|Physician Decision|1|||
147280097|NCT01485861|531190504|FG001|Phase Ib|Physician Decision|1|||
147280098|NCT01485861|531190505|FG002|Phase Ib|Physician Decision|0|||
147280099|NCT01485861|531190506|FG003|Phase Ib|Physician Decision|0|||
147280100|NCT01485861|531190507|FG004|Phase Ib|Physician Decision|0|||
147280101|NCT01485861|531190508|FG005|Phase Ib|Physician Decision|0|||
147280102|NCT01485861|531190503|FG000|Phase Ib|Adverse Event|0|||
147280103|NCT01485861|531190504|FG001|Phase Ib|Adverse Event|4|||
147280104|NCT01485861|531190505|FG002|Phase Ib|Adverse Event|0|||
147280105|NCT01485861|531190506|FG003|Phase Ib|Adverse Event|0|||
147280106|NCT01485861|531190507|FG004|Phase Ib|Adverse Event|0|||
147280107|NCT01485861|531190508|FG005|Phase Ib|Adverse Event|0|||
147280108|NCT01485861|531190503|FG000|Phase Ib|Progression of disease|5|||
147280109|NCT01485861|531190504|FG001|Phase Ib|Progression of disease|0|||
147280110|NCT01485861|531190505|FG002|Phase Ib|Progression of disease|0|||
147280111|NCT01485861|531190506|FG003|Phase Ib|Progression of disease|0|||
147280112|NCT01485861|531190507|FG004|Phase Ib|Progression of disease|0|||
147280113|NCT01485861|531190508|FG005|Phase Ib|Progression of disease|0|||
147280114|NCT01485861|531190503|FG000|Phase Ib|Other|3|||
147280115|NCT01485861|531190504|FG001|Phase Ib|Other|0|||
147280116|NCT01485861|531190505|FG002|Phase Ib|Other|0|||
147280117|NCT01485861|531190506|FG003|Phase Ib|Other|0|||
147280118|NCT01485861|531190507|FG004|Phase Ib|Other|0|||
147280119|NCT01485861|531190508|FG005|Phase Ib|Other|0|||
147280120|NCT01485861|531190503|FG000|Phase Ib|Withdrawal by Subject|4|||
147280121|NCT01485861|531190504|FG001|Phase Ib|Withdrawal by Subject|1|||
147280122|NCT01485861|531190505|FG002|Phase Ib|Withdrawal by Subject|0|||
147280123|NCT01485861|531190506|FG003|Phase Ib|Withdrawal by Subject|0|||
147280124|NCT01485861|531190507|FG004|Phase Ib|Withdrawal by Subject|0|||
147280125|NCT01485861|531190508|FG005|Phase Ib|Withdrawal by Subject|0|||
147280126|NCT01485861|531190503|FG000|Phase II|Death|0|||
147280127|NCT01485861|531190504|FG001|Phase II|Death|0|||
147601859|NCT02393248|532360662|FG017|Part 3: Combination Therapy|Withdrawal by Subject|0|||
147601860|NCT02393248|532360663|FG018|Part 3: Combination Therapy|Withdrawal by Subject|1|||
147601861|NCT02393248|532360664|FG019|Part 3: Combination Therapy|Withdrawal by Subject|0|||
147601862|NCT02393248|532360665|FG020|Part 3: Combination Therapy|Withdrawal by Subject|2|||
147280128|NCT01485861|531190505|FG002|Phase II|Death|67|||
147280129|NCT01485861|531190506|FG003|Phase II|Death|71|||
147280130|NCT01485861|531190507|FG004|Phase II|Death|68|||
147280131|NCT01485861|531190508|FG005|Phase II|Death|0|||
147280132|NCT01485861|531190503|FG000|Phase II|Progression of Disease|0|||
147280133|NCT01485861|531190504|FG001|Phase II|Progression of Disease|0|||
147280134|NCT01485861|531190505|FG002|Phase II|Progression of Disease|1|||
147280135|NCT01485861|531190506|FG003|Phase II|Progression of Disease|0|||
147280136|NCT01485861|531190507|FG004|Phase II|Progression of Disease|0|||
147280137|NCT01485861|531190508|FG005|Phase II|Progression of Disease|0|||
147280138|NCT01485861|531190503|FG000|Phase II|Other|0|||
147280139|NCT01485861|531190504|FG001|Phase II|Other|0|||
147280140|NCT01485861|531190505|FG002|Phase II|Other|0|||
147280141|NCT01485861|531190506|FG003|Phase II|Other|1|||
147280142|NCT01485861|531190507|FG004|Phase II|Other|0|||
147280143|NCT01485861|531190508|FG005|Phase II|Other|0|||
147280144|NCT01485861|531190503|FG000|Phase II|Withdrawal by Subject|0|||
147280145|NCT01485861|531190504|FG001|Phase II|Withdrawal by Subject|0|||
147280146|NCT01485861|531190505|FG002|Phase II|Withdrawal by Subject|6|||
147280147|NCT01485861|531190506|FG003|Phase II|Withdrawal by Subject|3|||
147280148|NCT01485861|531190507|FG004|Phase II|Withdrawal by Subject|4|||
147280149|NCT01485861|531190508|FG005|Phase II|Withdrawal by Subject|0|||
147280150|NCT01485861|531190503|FG000|Phase II|Lost to Follow-up|0|||
147280151|NCT01485861|531190504|FG001|Phase II|Lost to Follow-up|0|||
147280152|NCT01485861|531190505|FG002|Phase II|Lost to Follow-up|2|||
147280153|NCT01485861|531190506|FG003|Phase II|Lost to Follow-up|3|||
147280154|NCT01485861|531190507|FG004|Phase II|Lost to Follow-up|5|||
147280155|NCT01485861|531190508|FG005|Phase II|Lost to Follow-up|0|||
147280156|NCT01485861|531190503|FG000|Phase II|Study Ended|0|||
147280157|NCT01485861|531190504|FG001|Phase II|Study Ended|0|||
147280158|NCT01485861|531190505|FG002|Phase II|Study Ended|7|||
147280159|NCT01485861|531190506|FG003|Phase II|Study Ended|8|||
147280160|NCT01485861|531190507|FG004|Phase II|Study Ended|6|||
147280161|NCT01485861|531190508|FG005|Phase II|Study Ended|0|||
147280162|NCT01485861|531190503|FG000|Safety Phase|Death|0|||
147280163|NCT01485861|531190504|FG001|Safety Phase|Death|0|||
147280164|NCT01485861|531190505|FG002|Safety Phase|Death|0|||
147280165|NCT01485861|531190506|FG003|Safety Phase|Death|0|||
147280166|NCT01485861|531190507|FG004|Safety Phase|Death|0|||
147280167|NCT01485861|531190508|FG005|Safety Phase|Death|2|||
147280168|NCT01485861|531190503|FG000|Safety Phase|Adverse Event|0|||
147280169|NCT01485861|531190504|FG001|Safety Phase|Adverse Event|0|||
147280170|NCT01485861|531190505|FG002|Safety Phase|Adverse Event|0|||
147280171|NCT01485861|531190506|FG003|Safety Phase|Adverse Event|0|||
147280172|NCT01485861|531190507|FG004|Safety Phase|Adverse Event|0|||
147601863|NCT02393248|532360666|FG021|Part 3: Combination Therapy|Withdrawal by Subject|1|||
147601864|NCT02393248|532360667|FG022|Part 3: Combination Therapy|Withdrawal by Subject|0|||
147280173|NCT01485861|531190508|FG005|Safety Phase|Adverse Event|1|||
147280174|NCT01485861|531190503|FG000|Safety Phase|Other|0|||
147280175|NCT01485861|531190504|FG001|Safety Phase|Other|0|||
147280176|NCT01485861|531190505|FG002|Safety Phase|Other|0|||
147280177|NCT01485861|531190506|FG003|Safety Phase|Other|0|||
147280178|NCT01485861|531190507|FG004|Safety Phase|Other|0|||
147280179|NCT01485861|531190508|FG005|Safety Phase|Other|5|||
147280180|NCT01485861|531190503|FG000|Safety Phase|Progression of Disease|0|||
147280181|NCT01485861|531190504|FG001|Safety Phase|Progression of Disease|0|||
147280182|NCT01485861|531190505|FG002|Safety Phase|Progression of Disease|0|||
147280183|NCT01485861|531190506|FG003|Safety Phase|Progression of Disease|0|||
147280184|NCT01485861|531190507|FG004|Safety Phase|Progression of Disease|0|||
147280185|NCT01485861|531190508|FG005|Safety Phase|Progression of Disease|9|||
147335128|NCT00071799|531393764|FG000|Overall Study|Lack of Efficacy|11|||
147280186|NCT01485861|531190503|FG000|Safety Phase|Withdrawal by Subject|0|||
147280187|NCT01485861|531190504|FG001|Safety Phase|Withdrawal by Subject|0|||
147280188|NCT01485861|531190505|FG002|Safety Phase|Withdrawal by Subject|0|||
147280189|NCT01485861|531190506|FG003|Safety Phase|Withdrawal by Subject|0|||
147280190|NCT01485861|531190507|FG004|Safety Phase|Withdrawal by Subject|0|||
147280191|NCT01485861|531190508|FG005|Safety Phase|Withdrawal by Subject|6|||
147280192|NCT01485861|531190503|FG000|Safety Phase|Discontinuation of Survival Follow-up|0|||
147280193|NCT01485861|531190504|FG001|Safety Phase|Discontinuation of Survival Follow-up|0|||
147280194|NCT01485861|531190505|FG002|Safety Phase|Discontinuation of Survival Follow-up|0|||
147280195|NCT01485861|531190506|FG003|Safety Phase|Discontinuation of Survival Follow-up|0|||
147280196|NCT01485861|531190507|FG004|Safety Phase|Discontinuation of Survival Follow-up|0|||
147280197|NCT01485861|531190508|FG005|Safety Phase|Discontinuation of Survival Follow-up|2|||
147280198|NCT01260922|531190510|FG000|First Intervention|Withdrawal by Subject|0|||
147280199|NCT01260922|531190511|FG001|First Intervention|Withdrawal by Subject|1|||
147335129|NCT00071799|531393765|FG001|Overall Study|Lack of Efficacy|18|||
147280200|NCT01260922|531190510|FG000|Washout of 28 Days|Withdrawal by Subject|4|||
147280201|NCT01260922|531190511|FG001|Washout of 28 Days|Withdrawal by Subject|2|||
147280202|NCT01260922|531190510|FG000|Second Intervention|Emesis|0|||
147280203|NCT01260922|531190511|FG001|Second Intervention|Emesis|2|||
147280204|NCT02822794|531190512|FG000|Overall Study|Withdrew Consent|1|||
147280205|NCT02822794|531190513|FG001|Overall Study|Withdrew Consent|0|||
147280206|NCT05101252|531190516|FG000|Overall Study|Unsatisfactory Test Article|1|||
147280207|NCT05101252|531190517|FG001|Overall Study|Unsatisfactory Test Article|0|||
147280208|NCT05101252|531190516|FG000|Overall Study|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
147280209|NCT05101252|531190517|FG001|Overall Study|Subject Withdrawn by PI due to Non Compliance to Protocol|1|||
147280210|NCT05101252|531190516|FG000|Overall Study|Withdrew Consent during study|0|||
147280211|NCT05101252|531190517|FG001|Overall Study|Withdrew Consent during study|1|||
147280212|NCT05101252|531190516|FG000|Overall Study|Subject dispensed incorrect lens in 1 eye|1|||
147280213|NCT05101252|531190517|FG001|Overall Study|Subject dispensed incorrect lens in 1 eye|1|||
147280214|NCT02266381|531190518|FG000|Overall Study|Physician Decision|3|||
147280215|NCT02266381|531190519|FG001|Overall Study|Physician Decision|5|||
147280216|NCT02266381|531190520|FG002|Overall Study|Physician Decision|4|||
147280217|NCT03732248|531190521|FG000|Overall Study|Withdrawal by Subject|1|||
147280218|NCT03732248|531190522|FG001|Overall Study|Withdrawal by Subject|0|||
147280219|NCT00733824|531190523|FG000|Phase I|Withdrawal by Subject|1|||
147280220|NCT00733824|531190524|FG001|Phase I|Withdrawal by Subject|0|||
147280221|NCT00733824|531190525|FG002|Phase I|Withdrawal by Subject|0|||
147280222|NCT00733824|531190526|FG003|Phase I|Withdrawal by Subject|0|||
147280223|NCT00733824|531190527|FG004|Phase I|Withdrawal by Subject|0|||
147280224|NCT01243944|531190529|FG000|Overall Study|Adverse Event|15|||
147280225|NCT01243944|531190530|FG001|Overall Study|Adverse Event|13|||
147280226|NCT01243944|531190529|FG000|Overall Study|Lost to Follow-up|2|||
147280227|NCT01243944|531190530|FG001|Overall Study|Lost to Follow-up|1|||
147280228|NCT01243944|531190529|FG000|Overall Study|Physician Decision|2|||
147280229|NCT01243944|531190530|FG001|Overall Study|Physician Decision|7|||
147280230|NCT01243944|531190529|FG000|Overall Study|Disease progression|12|||
147280231|NCT01243944|531190530|FG001|Overall Study|Disease progression|11|||
147280232|NCT01243944|531190529|FG000|Overall Study|Protocol deviation|1|||
147280233|NCT01243944|531190530|FG001|Overall Study|Protocol deviation|1|||
147280234|NCT01243944|531190529|FG000|Overall Study|Participant decision|10|||
147280235|NCT01243944|531190530|FG001|Overall Study|Participant decision|15|||
147280236|NCT01243944|531190529|FG000|Overall Study|Death|2|||
147280237|NCT01243944|531190530|FG001|Overall Study|Death|3|||
147280238|NCT01243944|531190529|FG000|Overall Study|Non-compliance with study treatment|1|||
147280239|NCT01243944|531190530|FG001|Overall Study|Non-compliance with study treatment|0|||
147280240|NCT01731171|531190541|FG000|Overall Study|Withdrawal by Subject|4|||
147280241|NCT01731171|531190542|FG001|Overall Study|Withdrawal by Subject|1|||
147280242|NCT01731171|531190541|FG000|Overall Study|Lost to Follow-up|3|||
147280243|NCT01731171|531190542|FG001|Overall Study|Lost to Follow-up|2|||
147280244|NCT01731171|531190541|FG000|Overall Study|Moved out of Area|0|||
147280245|NCT01731171|531190542|FG001|Overall Study|Moved out of Area|2|||
147280246|NCT01731171|531190541|FG000|Overall Study|Terminated for Lack of Adherence|0|||
147280247|NCT01731171|531190542|FG001|Overall Study|Terminated for Lack of Adherence|1|||
147280248|NCT01731171|531190541|FG000|Overall Study|Terminated for Safety Reasons|0|||
147280249|NCT01731171|531190542|FG001|Overall Study|Terminated for Safety Reasons|1|||
147280250|NCT00403546|531190545|FG000|Signed Informed Consent/Open-Label|Withdrew Consent|6|||
147280251|NCT00403546|531190546|FG001|Signed Informed Consent/Open-Label|Withdrew Consent|0|||
147280252|NCT00403546|531190547|FG002|Signed Informed Consent/Open-Label|Withdrew Consent|0|||
147335130|NCT00071799|531393764|FG000|Overall Study|Disease Progression|23|||
147335131|NCT00071799|531393765|FG001|Overall Study|Disease Progression|20|||
147335132|NCT00071799|531393764|FG000|Overall Study|Different Central+Local Pathology Review|0|||
147335133|NCT00071799|531393765|FG001|Overall Study|Different Central+Local Pathology Review|1|||
147335134|NCT00071799|531393764|FG000|Overall Study|Not Documented|0|||
147335135|NCT00071799|531393765|FG001|Overall Study|Not Documented|2|||
147335136|NCT00814346|531393766|FG000|Double-blind Phase (4 Weeks)|Adverse Event|0|||
147335137|NCT00814346|531393767|FG001|Double-blind Phase (4 Weeks)|Adverse Event|1|||
147280253|NCT00403546|531190545|FG000|Signed Informed Consent/Open-Label|Early Termination|8|||
147280254|NCT00403546|531190546|FG001|Signed Informed Consent/Open-Label|Early Termination|0|||
147280255|NCT00403546|531190547|FG002|Signed Informed Consent/Open-Label|Early Termination|0|||
147280256|NCT00403546|531190545|FG000|Signed Informed Consent/Open-Label|Terminated by Investigator|9|||
147280257|NCT00403546|531190546|FG001|Signed Informed Consent/Open-Label|Terminated by Investigator|0|||
147335138|NCT00814346|531393766|FG000|Double-blind Phase (4 Weeks)|Not otherwise specified|0|||
147280258|NCT00403546|531190547|FG002|Signed Informed Consent/Open-Label|Terminated by Investigator|0|||
147280259|NCT00403546|531190545|FG000|Signed Informed Consent/Open-Label|Adverse Event|5|||
147280260|NCT00403546|531190546|FG001|Signed Informed Consent/Open-Label|Adverse Event|0|||
147280261|NCT00403546|531190547|FG002|Signed Informed Consent/Open-Label|Adverse Event|0|||
147280262|NCT00403546|531190545|FG000|Screening Phase|Screening Failure|22|||
147335139|NCT00814346|531393767|FG001|Double-blind Phase (4 Weeks)|Not otherwise specified|2|||
147601865|NCT02393248|532360668|FG023|Part 3: Combination Therapy|Withdrawal by Subject|1|||
147601866|NCT02393248|532360669|FG024|Part 3: Combination Therapy|Withdrawal by Subject|0|||
147601867|NCT02393248|532360645|FG000|Part 3: Combination Therapy|Death|0|||
147601868|NCT02393248|532360646|FG001|Part 3: Combination Therapy|Death|0|||
147601869|NCT02393248|532360647|FG002|Part 3: Combination Therapy|Death|0|||
147601870|NCT02393248|532360648|FG003|Part 3: Combination Therapy|Death|0|||
147601871|NCT02393248|532360649|FG004|Part 3: Combination Therapy|Death|0|||
147601872|NCT02393248|532360650|FG005|Part 3: Combination Therapy|Death|0|||
147601873|NCT02393248|532360651|FG006|Part 3: Combination Therapy|Death|0|||
147601874|NCT02393248|532360652|FG007|Part 3: Combination Therapy|Death|0|||
147280263|NCT00403546|531190546|FG001|Screening Phase|Screening Failure|0|||
147601875|NCT02393248|532360653|FG008|Part 3: Combination Therapy|Death|0|||
147601876|NCT02393248|532360654|FG009|Part 3: Combination Therapy|Death|0|||
147601877|NCT02393248|532360655|FG010|Part 3: Combination Therapy|Death|0|||
147601878|NCT02393248|532360656|FG011|Part 3: Combination Therapy|Death|0|||
147601879|NCT02393248|532360657|FG012|Part 3: Combination Therapy|Death|0|||
147601880|NCT02393248|532360658|FG013|Part 3: Combination Therapy|Death|0|||
147601881|NCT02393248|532360659|FG014|Part 3: Combination Therapy|Death|0|||
147601882|NCT02393248|532360660|FG015|Part 3: Combination Therapy|Death|1|||
147601883|NCT02393248|532360661|FG016|Part 3: Combination Therapy|Death|7|||
147601884|NCT02393248|532360662|FG017|Part 3: Combination Therapy|Death|5|||
147601885|NCT02393248|532360663|FG018|Part 3: Combination Therapy|Death|5|||
147601886|NCT02393248|532360664|FG019|Part 3: Combination Therapy|Death|3|||
147601887|NCT02393248|532360665|FG020|Part 3: Combination Therapy|Death|7|||
147601888|NCT02393248|532360666|FG021|Part 3: Combination Therapy|Death|5|||
147601889|NCT02393248|532360667|FG022|Part 3: Combination Therapy|Death|6|||
147601890|NCT02393248|532360668|FG023|Part 3: Combination Therapy|Death|3|||
147601891|NCT02393248|532360669|FG024|Part 3: Combination Therapy|Death|0|||
147601892|NCT02393248|532360645|FG000|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
147601893|NCT02393248|532360646|FG001|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
147601894|NCT02393248|532360647|FG002|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
147601895|NCT02393248|532360648|FG003|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
147601896|NCT02393248|532360649|FG004|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
147601897|NCT02393248|532360650|FG005|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
147601898|NCT02393248|532360651|FG006|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
147601899|NCT02393248|532360652|FG007|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
147601900|NCT02393248|532360653|FG008|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
147601901|NCT02393248|532360654|FG009|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
147601902|NCT02393248|532360655|FG010|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
147601903|NCT02393248|532360656|FG011|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
147601904|NCT02393248|532360657|FG012|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
147601905|NCT02393248|532360658|FG013|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
147601906|NCT02393248|532360659|FG014|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
147601907|NCT02393248|532360660|FG015|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
147601908|NCT02393248|532360661|FG016|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
147280264|NCT00403546|531190547|FG002|Screening Phase|Screening Failure|0|||
147280265|NCT00403546|531190545|FG000|Screening Phase|Adverse Event|1|||
147280266|NCT00403546|531190546|FG001|Screening Phase|Adverse Event|0|||
147601909|NCT02393248|532360662|FG017|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
147280267|NCT00403546|531190547|FG002|Screening Phase|Adverse Event|0|||
147280268|NCT00403546|531190545|FG000|Screening Phase|Terminated Prior to Randomization|5|||
147280269|NCT00403546|531190546|FG001|Screening Phase|Terminated Prior to Randomization|0|||
147280270|NCT00403546|531190547|FG002|Screening Phase|Terminated Prior to Randomization|0|||
147280271|NCT00403546|531190545|FG000|Randomized Trial|Early Terminations|0|||
147280272|NCT00403546|531190546|FG001|Randomized Trial|Early Terminations|17|||
147280273|NCT00403546|531190547|FG002|Randomized Trial|Early Terminations|16|||
147280274|NCT02604589|531190548|FG000|Overall Study|catheter dislodgement|0|||
147280275|NCT02604589|531190549|FG001|Overall Study|catheter dislodgement|0|||
147280276|NCT02604589|531190550|FG002|Overall Study|catheter dislodgement|1|||
147335140|NCT00814346|531393766|FG000|Open Phase (17 Months)|Adverse Event|5|||
147335141|NCT00814346|531393767|FG001|Open Phase (17 Months)|Adverse Event|0|||
147335142|NCT00814346|531393766|FG000|Open Phase (17 Months)|Consent|2|||
147335143|NCT00814346|531393767|FG001|Open Phase (17 Months)|Consent|0|||
147280277|NCT00793910|531190551|FG000|Overall Study|discarded study pills|0|||
147280278|NCT00793910|531190552|FG001|Overall Study|discarded study pills|1|||
147335144|NCT00814346|531393766|FG000|Open Phase (17 Months)|Lost to Follow-up|2|||
147335145|NCT00814346|531393767|FG001|Open Phase (17 Months)|Lost to Follow-up|0|||
147335146|NCT00814346|531393766|FG000|Open Phase (17 Months)|Not otherwise specified|1|||
147335147|NCT00814346|531393767|FG001|Open Phase (17 Months)|Not otherwise specified|0|||
147601910|NCT02393248|532360663|FG018|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
147601911|NCT02393248|532360664|FG019|Part 3: Combination Therapy|Study Terminated by Sponsor|0|||
147601912|NCT02393248|532360665|FG020|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
147601913|NCT02393248|532360666|FG021|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
147280279|NCT00793910|531190551|FG000|Overall Study|did not pick up medications|1|||
147280280|NCT00793910|531190552|FG001|Overall Study|did not pick up medications|1|||
147280281|NCT00793910|531190551|FG000|Overall Study|ineligible based on entry criteria|2|||
147280282|NCT00793910|531190552|FG001|Overall Study|ineligible based on entry criteria|3|||
147280283|NCT00793910|531190551|FG000|Overall Study|decided to undergo LASIK instead of PRK|2|||
147280284|NCT00793910|531190552|FG001|Overall Study|decided to undergo LASIK instead of PRK|1|||
147280285|NCT00793910|531190551|FG000|Overall Study|Withdrawal by Subject|0|||
147280286|NCT00793910|531190552|FG001|Overall Study|Withdrawal by Subject|1|||
147280287|NCT02610140|531190555|FG000|Randomization and Treatment Period|Radiological progression|23|||
147280288|NCT02610140|531190556|FG001|Randomization and Treatment Period|Radiological progression|15|||
147280289|NCT02610140|531190555|FG000|Randomization and Treatment Period|Progressive disease - radiological|54|||
147280290|NCT02610140|531190556|FG001|Randomization and Treatment Period|Progressive disease - radiological|23|||
147280291|NCT02610140|531190555|FG000|Randomization and Treatment Period|Protocol Violation|1|||
147280292|NCT02610140|531190556|FG001|Randomization and Treatment Period|Protocol Violation|0|||
147601914|NCT02393248|532360667|FG022|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
147601915|NCT02393248|532360668|FG023|Part 3: Combination Therapy|Study Terminated by Sponsor|2|||
147601916|NCT02393248|532360669|FG024|Part 3: Combination Therapy|Study Terminated by Sponsor|1|||
147601917|NCT02393248|532360645|FG000|Part 3: Combination Therapy|Disease Progression|0|||
147601918|NCT02393248|532360646|FG001|Part 3: Combination Therapy|Disease Progression|0|||
147601919|NCT02393248|532360647|FG002|Part 3: Combination Therapy|Disease Progression|0|||
147601920|NCT02393248|532360648|FG003|Part 3: Combination Therapy|Disease Progression|0|||
147601921|NCT02393248|532360649|FG004|Part 3: Combination Therapy|Disease Progression|0|||
147601922|NCT02393248|532360650|FG005|Part 3: Combination Therapy|Disease Progression|0|||
147601923|NCT02393248|532360651|FG006|Part 3: Combination Therapy|Disease Progression|0|||
147601924|NCT02393248|532360652|FG007|Part 3: Combination Therapy|Disease Progression|0|||
147601925|NCT02393248|532360653|FG008|Part 3: Combination Therapy|Disease Progression|0|||
147601926|NCT02393248|532360654|FG009|Part 3: Combination Therapy|Disease Progression|0|||
147601927|NCT02393248|532360655|FG010|Part 3: Combination Therapy|Disease Progression|0|||
147601928|NCT02393248|532360656|FG011|Part 3: Combination Therapy|Disease Progression|0|||
147601929|NCT02393248|532360657|FG012|Part 3: Combination Therapy|Disease Progression|0|||
147601930|NCT02393248|532360658|FG013|Part 3: Combination Therapy|Disease Progression|0|||
147601931|NCT02393248|532360659|FG014|Part 3: Combination Therapy|Disease Progression|0|||
147601932|NCT02393248|532360660|FG015|Part 3: Combination Therapy|Disease Progression|0|||
147601933|NCT02393248|532360661|FG016|Part 3: Combination Therapy|Disease Progression|0|||
147601934|NCT02393248|532360662|FG017|Part 3: Combination Therapy|Disease Progression|0|||
147601935|NCT02393248|532360663|FG018|Part 3: Combination Therapy|Disease Progression|0|||
147601936|NCT02393248|532360664|FG019|Part 3: Combination Therapy|Disease Progression|0|||
147601937|NCT02393248|532360665|FG020|Part 3: Combination Therapy|Disease Progression|2|||
147601938|NCT02393248|532360666|FG021|Part 3: Combination Therapy|Disease Progression|1|||
147601939|NCT02393248|532360667|FG022|Part 3: Combination Therapy|Disease Progression|0|||
147601940|NCT02393248|532360668|FG023|Part 3: Combination Therapy|Disease Progression|0|||
147601941|NCT02393248|532360669|FG024|Part 3: Combination Therapy|Disease Progression|0|||
147601942|NCT02393248|532360645|FG000|Part 3: Combination Therapy|Lost to Follow-up|0|||
147601943|NCT02393248|532360646|FG001|Part 3: Combination Therapy|Lost to Follow-up|0|||
147601944|NCT02393248|532360647|FG002|Part 3: Combination Therapy|Lost to Follow-up|0|||
147601945|NCT02393248|532360648|FG003|Part 3: Combination Therapy|Lost to Follow-up|0|||
147601946|NCT02393248|532360649|FG004|Part 3: Combination Therapy|Lost to Follow-up|0|||
147601947|NCT02393248|532360650|FG005|Part 3: Combination Therapy|Lost to Follow-up|0|||
147601948|NCT02393248|532360651|FG006|Part 3: Combination Therapy|Lost to Follow-up|0|||
147601949|NCT02393248|532360652|FG007|Part 3: Combination Therapy|Lost to Follow-up|0|||
147601950|NCT02393248|532360653|FG008|Part 3: Combination Therapy|Lost to Follow-up|0|||
147601951|NCT02393248|532360654|FG009|Part 3: Combination Therapy|Lost to Follow-up|0|||
147601952|NCT02393248|532360655|FG010|Part 3: Combination Therapy|Lost to Follow-up|0|||
147280293|NCT02610140|531190555|FG000|Randomization and Treatment Period|Physician Decision|0|||
147280294|NCT02610140|531190556|FG001|Randomization and Treatment Period|Physician Decision|1|||
147280295|NCT02610140|531190555|FG000|Randomization and Treatment Period|Lack of Efficacy|1|||
147280296|NCT02610140|531190556|FG001|Randomization and Treatment Period|Lack of Efficacy|0|||
147280297|NCT02610140|531190555|FG000|Randomization and Treatment Period|Death|7|||
147280298|NCT02610140|531190556|FG001|Randomization and Treatment Period|Death|1|||
147280299|NCT02610140|531190555|FG000|Randomization and Treatment Period|Withdrawal by Subject|12|||
147280300|NCT02610140|531190556|FG001|Randomization and Treatment Period|Withdrawal by Subject|12|||
147280301|NCT02610140|531190555|FG000|Randomization and Treatment Period|Adverse Event|44|||
147280302|NCT02610140|531190556|FG001|Randomization and Treatment Period|Adverse Event|13|||
147280303|NCT02610140|531190555|FG000|Randomization and Treatment Period|Progressive disease - clinical|12|||
147280304|NCT02610140|531190556|FG001|Randomization and Treatment Period|Progressive disease - clinical|5|||
147280305|NCT02610140|531190555|FG000|Randomization and Treatment Period|Ongoing but not completed|9|||
147280306|NCT02610140|531190556|FG001|Randomization and Treatment Period|Ongoing but not completed|2|||
147280307|NCT02610140|531190555|FG000|Randomization and Treatment Period|Not treated|3|||
147451116|NCT03028870|531813255|FG000|Overall Study|Administrative|5|||
147451117|NCT03028870|531813256|FG001|Overall Study|Administrative|5|||
147451118|NCT03028870|531813257|FG002|Overall Study|Administrative|12|||
147451119|NCT03028870|531813258|FG003|Overall Study|Administrative|4|||
147451120|NCT00490451|531813259|FG000|Overall Study|Adverse Event|3|||
147451121|NCT00490451|531813260|FG001|Overall Study|Adverse Event|3|||
147451122|NCT00490451|531813259|FG000|Overall Study|Death|3|||
147451123|NCT00490451|531813260|FG001|Overall Study|Death|1|||
147451124|NCT00490451|531813259|FG000|Overall Study|Withdrawal by Subject|2|||
147451125|NCT00490451|531813260|FG001|Overall Study|Withdrawal by Subject|0|||
147451126|NCT00490451|531813259|FG000|Overall Study|Investigator Decision|1|||
147451127|NCT00490451|531813260|FG001|Overall Study|Investigator Decision|0|||
147451128|NCT00490451|531813259|FG000|Overall Study|Protocol Violation|1|||
147451129|NCT00490451|531813260|FG001|Overall Study|Protocol Violation|0|||
147451130|NCT00490451|531813259|FG000|Overall Study|Progressive Disease|53|||
147451131|NCT00490451|531813260|FG001|Overall Study|Progressive Disease|34|||
147451132|NCT01181011|531813261|FG000|Overall Study|Adverse Event|2|||
147451133|NCT01181011|531813261|FG000|Overall Study|Lost to Follow-up|1|||
147280308|NCT02610140|531190556|FG001|Randomization and Treatment Period|Not treated|10|||
147280309|NCT02610140|531190555|FG000|Safety Follow-up|Other|0|||
147280310|NCT02610140|531190556|FG001|Safety Follow-up|Other|2|||
147280311|NCT02610140|531190555|FG000|Safety Follow-up|Lost to Follow-up|1|||
147280312|NCT02610140|531190556|FG001|Safety Follow-up|Lost to Follow-up|0|||
147280313|NCT02610140|531190555|FG000|Safety Follow-up|No follow-up|5|||
147280314|NCT02610140|531190556|FG001|Safety Follow-up|No follow-up|3|||
147280315|NCT02610140|531190555|FG000|Safety Follow-up|Death|12|||
147280316|NCT02610140|531190556|FG001|Safety Follow-up|Death|2|||
147280317|NCT02610140|531190555|FG000|Safety Follow-up|Deterioration of general conditions|15|||
147280318|NCT02610140|531190556|FG001|Safety Follow-up|Deterioration of general conditions|5|||
147280319|NCT02610140|531190555|FG000|Safety Follow-up|Withdrawal by Subject|12|||
147451134|NCT00254501|531813264|FG000|Overall Study|Lost to Follow-up|1|||
147451135|NCT00254501|531813265|FG001|Overall Study|Lost to Follow-up|1|||
147280320|NCT02610140|531190556|FG001|Safety Follow-up|Withdrawal by Subject|12|||
147280321|NCT02610140|531190555|FG000|Active Follow-up|Progressive disease - radiological|30|||
147280322|NCT02610140|531190556|FG001|Active Follow-up|Progressive disease - radiological|22|||
147280323|NCT02610140|531190555|FG000|Active Follow-up|Death|8|||
147280324|NCT02610140|531190556|FG001|Active Follow-up|Death|1|||
147280325|NCT02610140|531190555|FG000|Active Follow-up|Withdrawal by Subject|4|||
147280326|NCT02610140|531190556|FG001|Active Follow-up|Withdrawal by Subject|0|||
147451136|NCT00250835|531813270|FG000|Overall Study|Withdrawal by Subject|1|||
147451137|NCT01035905|531813274|FG000|Overall Study|Lack of Efficacy|1|||
147451138|NCT01035905|531813275|FG001|Overall Study|Lack of Efficacy|1|||
147451139|NCT04942925|531813276|FG000|First Wear Period (8 -0/+3 Days)|Adverse Event|0|||
147451140|NCT04942925|531813277|FG001|First Wear Period (8 -0/+3 Days)|Adverse Event|1|||
147451141|NCT04942925|531813276|FG000|First Wear Period (8 -0/+3 Days)|Withdrawal by Subject|0|||
147451142|NCT04942925|531813277|FG001|First Wear Period (8 -0/+3 Days)|Withdrawal by Subject|1|||
147451143|NCT01452152|531813278|FG000|Overall Study|Study termination by sponsor|5|||
147451144|NCT01452152|531813279|FG001|Overall Study|Study termination by sponsor|0|||
147451145|NCT01452152|531813280|FG002|Overall Study|Study termination by sponsor|4|||
147451146|NCT02867995|531813283|FG000|Overall Study|Withdrawal by Subject|0|||
147451147|NCT02867995|531813284|FG001|Overall Study|Withdrawal by Subject|1|||
147451148|NCT02867995|531813283|FG000|Overall Study|Lost to Follow-up|0|||
147451149|NCT02867995|531813284|FG001|Overall Study|Lost to Follow-up|2|||
147451150|NCT03315871|531813285|FG000|PROSTVAC + CV301 + M7824|Withdrawal by Subject|0|||
147451151|NCT03315871|531813286|FG001|PROSTVAC + CV301 + M7824|Withdrawal by Subject|2|||
147451152|NCT03315871|531813287|FG002|PROSTVAC + CV301 + M7824|Withdrawal by Subject|0|||
147451153|NCT03315871|531813285|FG000|PROSTVAC + CV301 + M7824|Adverse Event|0|||
147451154|NCT03315871|531813286|FG001|PROSTVAC + CV301 + M7824|Adverse Event|2|||
147451155|NCT03315871|531813287|FG002|PROSTVAC + CV301 + M7824|Adverse Event|0|||
147451156|NCT03315871|531813285|FG000|PROSTVAC + CV301 + M7824|Physician Decision|0|||
147451157|NCT03315871|531813286|FG001|PROSTVAC + CV301 + M7824|Physician Decision|1|||
147451158|NCT03315871|531813287|FG002|PROSTVAC + CV301 + M7824|Physician Decision|0|||
147280327|NCT02610140|531190555|FG000|Active Follow-up|Progressive disease - clinical|1|||
147280328|NCT02610140|531190556|FG001|Active Follow-up|Progressive disease - clinical|2|||
147280329|NCT02610140|531190555|FG000|Active Follow-up|Deterioration of general conditions|1|||
147280330|NCT02610140|531190556|FG001|Active Follow-up|Deterioration of general conditions|0|||
147451159|NCT03315871|531813285|FG000|PROSTVAC + CV301 + M7824|Participant came off study for intercurrent medical illness.|0|||
147451160|NCT03315871|531813286|FG001|PROSTVAC + CV301 + M7824|Participant came off study for intercurrent medical illness.|1|||
147451161|NCT03315871|531813287|FG002|PROSTVAC + CV301 + M7824|Participant came off study for intercurrent medical illness.|0|||
147451162|NCT03315871|531813285|FG000|PROSTVAC + CV301|Progressive disease|0|||
147451163|NCT03315871|531813286|FG001|PROSTVAC + CV301|Progressive disease|0|||
147451164|NCT03315871|531813287|FG002|PROSTVAC + CV301|Progressive disease|1|||
147451165|NCT03315871|531813285|FG000|PROSTVAC + CV301|An unrelated lymphoma diagnosis requiring therapy|0|||
147451166|NCT03315871|531813286|FG001|PROSTVAC + CV301|An unrelated lymphoma diagnosis requiring therapy|0|||
147280331|NCT02610140|531190555|FG000|Active Follow-up|Ongoing but not completed|4|||
147280332|NCT02610140|531190556|FG001|Active Follow-up|Ongoing but not completed|1|||
147280333|NCT02610140|531190555|FG000|Long-term Follow-up|Death|86|||
147280334|NCT02610140|531190556|FG001|Long-term Follow-up|Death|44|||
147280335|NCT02610140|531190555|FG000|Long-term Follow-up|Withdrawal by Subject|6|||
147280336|NCT02610140|531190556|FG001|Long-term Follow-up|Withdrawal by Subject|3|||
147280337|NCT02610140|531190555|FG000|Long-term Follow-up|Lost to Follow-up|1|||
147280338|NCT02610140|531190556|FG001|Long-term Follow-up|Lost to Follow-up|2|||
147280339|NCT02610140|531190555|FG000|Long-term Follow-up|Ongoing but not completed|30|||
147280340|NCT02610140|531190556|FG001|Long-term Follow-up|Ongoing but not completed|17|||
147280341|NCT06748040|531190561|FG000|Overall Study|Death|3|||
147280342|NCT06748040|531190562|FG001|Overall Study|Death|4|||
147601953|NCT02393248|532360656|FG011|Part 3: Combination Therapy|Lost to Follow-up|0|||
147601954|NCT02393248|532360657|FG012|Part 3: Combination Therapy|Lost to Follow-up|0|||
147601955|NCT02393248|532360658|FG013|Part 3: Combination Therapy|Lost to Follow-up|0|||
147601956|NCT02393248|532360659|FG014|Part 3: Combination Therapy|Lost to Follow-up|0|||
147601957|NCT02393248|532360660|FG015|Part 3: Combination Therapy|Lost to Follow-up|0|||
147601958|NCT02393248|532360661|FG016|Part 3: Combination Therapy|Lost to Follow-up|0|||
147601959|NCT02393248|532360662|FG017|Part 3: Combination Therapy|Lost to Follow-up|0|||
147601960|NCT02393248|532360663|FG018|Part 3: Combination Therapy|Lost to Follow-up|0|||
147601961|NCT02393248|532360664|FG019|Part 3: Combination Therapy|Lost to Follow-up|0|||
147601962|NCT02393248|532360665|FG020|Part 3: Combination Therapy|Lost to Follow-up|1|||
147601963|NCT02393248|532360666|FG021|Part 3: Combination Therapy|Lost to Follow-up|1|||
147601964|NCT02393248|532360667|FG022|Part 3: Combination Therapy|Lost to Follow-up|0|||
147280343|NCT06748040|531190561|FG000|Overall Study|Lost to Follow-up|134|||
147280344|NCT06748040|531190562|FG001|Overall Study|Lost to Follow-up|132|||
147280345|NCT06748040|531190561|FG000|Overall Study|Withdrawal by Subject|3|||
147280346|NCT06748040|531190562|FG001|Overall Study|Withdrawal by Subject|5|||
147280347|NCT03794089|531192401|FG000|Overall Study|Lost to Follow-up|4|||
147280348|NCT03794089|531192402|FG001|Overall Study|Lost to Follow-up|1|||
147280349|NCT03794089|531192401|FG000|Overall Study|Withdrawal by Subject|2|||
147280350|NCT03794089|531192402|FG001|Overall Study|Withdrawal by Subject|0|||
147280351|NCT00116805|531192403|FG000|Double-blind Period Through Week 48|Lost to Follow-up|6|||
147280352|NCT00116805|531192404|FG001|Double-blind Period Through Week 48|Lost to Follow-up|2|||
147280353|NCT00116805|531192403|FG000|Double-blind Period Through Week 48|Protocol Violation|1|||
147280354|NCT00116805|531192404|FG001|Double-blind Period Through Week 48|Protocol Violation|1|||
147280355|NCT00116805|531192403|FG000|Double-blind Period Through Week 48|Withdrew Consent|4|||
147280356|NCT00116805|531192404|FG001|Double-blind Period Through Week 48|Withdrew Consent|2|||
147280357|NCT00116805|531192403|FG000|Open-label Period Weeks 49 - 96|Investigator's Discretion|1|||
147280358|NCT00116805|531192404|FG001|Open-label Period Weeks 49 - 96|Investigator's Discretion|0|||
147280359|NCT00116805|531192403|FG000|Open-label Period Weeks 49 - 96|Lost to Follow-up|2|||
147280360|NCT00116805|531192404|FG001|Open-label Period Weeks 49 - 96|Lost to Follow-up|0|||
147280361|NCT00116805|531192403|FG000|Open-label Period Weeks 49 - 96|Protocol Violation|2|||
147280362|NCT00116805|531192404|FG001|Open-label Period Weeks 49 - 96|Protocol Violation|0|||
147280363|NCT00116805|531192403|FG000|Open-label Period Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|1|||
147280364|NCT00116805|531192404|FG001|Open-label Period Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|0|||
147280365|NCT00116805|531192403|FG000|Open-label Period Weeks 49 - 96|Seroconversion|2|||
147280366|NCT00116805|531192404|FG001|Open-label Period Weeks 49 - 96|Seroconversion|0|||
147280367|NCT00116805|531192403|FG000|Open-label Period Weeks 49 - 96|Withdrew Consent|2|||
147280368|NCT00116805|531192404|FG001|Open-label Period Weeks 49 - 96|Withdrew Consent|1|||
147280369|NCT00116805|531192403|FG000|Open-label Period Weeks 97 - 144|Completed Study|1|||
147280370|NCT00116805|531192404|FG001|Open-label Period Weeks 97 - 144|Completed Study|0|||
147280371|NCT00116805|531192403|FG000|Open-label Period Weeks 97 - 144|Investigator's Discretion|2|||
147280372|NCT00116805|531192404|FG001|Open-label Period Weeks 97 - 144|Investigator's Discretion|0|||
147280373|NCT00116805|531192403|FG000|Open-label Period Weeks 97 - 144|Lost to Follow-up|5|||
147280374|NCT00116805|531192404|FG001|Open-label Period Weeks 97 - 144|Lost to Follow-up|2|||
147280375|NCT00116805|531192403|FG000|Open-label Period Weeks 97 - 144|Protocol Violation|0|||
147280376|NCT00116805|531192404|FG001|Open-label Period Weeks 97 - 144|Protocol Violation|1|||
147280377|NCT00116805|531192403|FG000|Open-label Period Weeks 97 - 144|Seroconversion|2|||
147280378|NCT00116805|531192404|FG001|Open-label Period Weeks 97 - 144|Seroconversion|3|||
147280379|NCT00116805|531192403|FG000|Open-label Period Weeks 97 - 144|Withdrew Consent|1|||
147280380|NCT00116805|531192404|FG001|Open-label Period Weeks 97 - 144|Withdrew Consent|3|||
147280381|NCT00116805|531192403|FG000|Open-label Period Weeks 145 - 192|Completed Study|1|||
147280382|NCT00116805|531192404|FG001|Open-label Period Weeks 145 - 192|Completed Study|1|||
147280383|NCT00116805|531192403|FG000|Open-label Period Weeks 145 - 192|Investigator's Discretion|2|||
147280384|NCT00116805|531192404|FG001|Open-label Period Weeks 145 - 192|Investigator's Discretion|0|||
147280385|NCT00116805|531192403|FG000|Open-label Period Weeks 145 - 192|Lost to Follow-up|3|||
147280386|NCT00116805|531192404|FG001|Open-label Period Weeks 145 - 192|Lost to Follow-up|1|||
147601965|NCT02393248|532360668|FG023|Part 3: Combination Therapy|Lost to Follow-up|0|||
147601966|NCT02393248|532360669|FG024|Part 3: Combination Therapy|Lost to Follow-up|0|||
147601967|NCT02393248|532360645|FG000|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
147601968|NCT02393248|532360646|FG001|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
147601969|NCT02393248|532360647|FG002|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
147601970|NCT02393248|532360648|FG003|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
147601971|NCT02393248|532360649|FG004|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
147601972|NCT02393248|532360650|FG005|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
147601973|NCT02393248|532360651|FG006|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
147601974|NCT02393248|532360652|FG007|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
147601975|NCT02393248|532360653|FG008|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
147601976|NCT02393248|532360654|FG009|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
147601977|NCT02393248|532360655|FG010|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
147601978|NCT02393248|532360656|FG011|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
147601979|NCT02393248|532360657|FG012|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
147601980|NCT02393248|532360658|FG013|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
147601981|NCT02393248|532360659|FG014|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
147601982|NCT02393248|532360660|FG015|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
147601983|NCT02393248|532360661|FG016|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
147601984|NCT02393248|532360662|FG017|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
147601985|NCT02393248|532360663|FG018|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
147601986|NCT02393248|532360664|FG019|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
147601987|NCT02393248|532360665|FG020|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|1|||
147601988|NCT02393248|532360666|FG021|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
147601989|NCT02393248|532360667|FG022|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
147601990|NCT02393248|532360668|FG023|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
147601991|NCT02393248|532360669|FG024|Part 3: Combination Therapy|Rolled Over to Another Protocol after Receiving Same Treatment|0|||
147601992|NCT02393248|532360645|FG000|Part 3: Combination Therapy|Adverse Event|0|||
147601993|NCT02393248|532360646|FG001|Part 3: Combination Therapy|Adverse Event|0|||
147601994|NCT02393248|532360647|FG002|Part 3: Combination Therapy|Adverse Event|0|||
147601995|NCT02393248|532360648|FG003|Part 3: Combination Therapy|Adverse Event|0|||
147601996|NCT02393248|532360649|FG004|Part 3: Combination Therapy|Adverse Event|0|||
147601997|NCT02393248|532360650|FG005|Part 3: Combination Therapy|Adverse Event|0|||
147601998|NCT02393248|532360651|FG006|Part 3: Combination Therapy|Adverse Event|0|||
147601999|NCT02393248|532360652|FG007|Part 3: Combination Therapy|Adverse Event|0|||
147602000|NCT02393248|532360653|FG008|Part 3: Combination Therapy|Adverse Event|0|||
147602001|NCT02393248|532360654|FG009|Part 3: Combination Therapy|Adverse Event|0|||
147602002|NCT02393248|532360655|FG010|Part 3: Combination Therapy|Adverse Event|0|||
147602003|NCT02393248|532360656|FG011|Part 3: Combination Therapy|Adverse Event|0|||
147602004|NCT02393248|532360657|FG012|Part 3: Combination Therapy|Adverse Event|0|||
147602005|NCT02393248|532360658|FG013|Part 3: Combination Therapy|Adverse Event|0|||
147602006|NCT02393248|532360659|FG014|Part 3: Combination Therapy|Adverse Event|0|||
147602007|NCT02393248|532360660|FG015|Part 3: Combination Therapy|Adverse Event|0|||
147602008|NCT02393248|532360661|FG016|Part 3: Combination Therapy|Adverse Event|0|||
147602009|NCT02393248|532360662|FG017|Part 3: Combination Therapy|Adverse Event|0|||
147602010|NCT02393248|532360663|FG018|Part 3: Combination Therapy|Adverse Event|0|||
147602011|NCT02393248|532360664|FG019|Part 3: Combination Therapy|Adverse Event|0|||
147602012|NCT02393248|532360665|FG020|Part 3: Combination Therapy|Adverse Event|0|||
147602013|NCT02393248|532360666|FG021|Part 3: Combination Therapy|Adverse Event|0|||
147602014|NCT02393248|532360667|FG022|Part 3: Combination Therapy|Adverse Event|0|||
147602015|NCT02393248|532360668|FG023|Part 3: Combination Therapy|Adverse Event|1|||
147602016|NCT02393248|532360669|FG024|Part 3: Combination Therapy|Adverse Event|0|||
147602017|NCT02393248|532360645|FG000|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
147602018|NCT02393248|532360646|FG001|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
147602019|NCT02393248|532360647|FG002|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
147643994|NCT01447446|532516686|FG000|Overall Study|Administrative/Other|34|||
147280387|NCT00116805|531192403|FG000|Open-label Period Weeks 145 - 192|Protocol Violation|1|||
147280388|NCT00116805|531192404|FG001|Open-label Period Weeks 145 - 192|Protocol Violation|0|||
147280389|NCT00116805|531192403|FG000|Open-label Period Weeks 145 - 192|Safety, Tolerability, or Efficacy Reason|0|||
147280390|NCT00116805|531192404|FG001|Open-label Period Weeks 145 - 192|Safety, Tolerability, or Efficacy Reason|1|||
147335148|NCT05136443|531393769|FG000|Overall Study|Lost to Follow-up|2|||
147335149|NCT05136443|531393769|FG000|Overall Study|Adverse Event|2|||
147335150|NCT00762606|531393782|FG000|Overall Study|Lost to Follow-up|18|||
147335151|NCT00762606|531393783|FG001|Overall Study|Lost to Follow-up|13|||
147335152|NCT01147341|531393786|FG000|Double Blind Period|Lack of Efficacy|1|||
147335153|NCT01147341|531393787|FG001|Double Blind Period|Lack of Efficacy|1|||
147335154|NCT01147341|531393786|FG000|Double Blind Period|Withdrawal by Subject|0|||
147335155|NCT01147341|531393787|FG001|Double Blind Period|Withdrawal by Subject|1|||
147335156|NCT01147341|531393786|FG000|Open Label Period|Lack of Efficacy|3|||
147335157|NCT01147341|531393787|FG001|Open Label Period|Lack of Efficacy|0|||
147335158|NCT01147341|531393786|FG000|Open Label Period|Subject moved|1|||
147335159|NCT01147341|531393787|FG001|Open Label Period|Subject moved|0|||
147335160|NCT05641311|531393795|FG000|Dosing Period 1|Adverse Event|1|||
147335161|NCT05641311|531393796|FG001|Dosing Period 1|Adverse Event|0|||
147335162|NCT00922207|531393801|FG000|Overall Study|Adverse Event/Intercurrent Illness|3|||
147335163|NCT00922207|531393802|FG001|Overall Study|Adverse Event/Intercurrent Illness|0|||
147335164|NCT00922207|531393803|FG002|Overall Study|Adverse Event/Intercurrent Illness|0|||
147335165|NCT00922207|531393801|FG000|Overall Study|Insufficient Therapeutic Response|0|||
147335166|NCT00922207|531393802|FG001|Overall Study|Insufficient Therapeutic Response|0|||
147335167|NCT00922207|531393803|FG002|Overall Study|Insufficient Therapeutic Response|1|||
147335168|NCT00922207|531393801|FG000|Overall Study|Violation of Selection Criteria at Entry|0|||
147335169|NCT00922207|531393802|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
147335170|NCT00922207|531393803|FG002|Overall Study|Violation of Selection Criteria at Entry|0|||
147335171|NCT00922207|531393801|FG000|Overall Study|Refused Treatment/Did Not Cooperate|1|||
147335172|NCT00922207|531393802|FG001|Overall Study|Refused Treatment/Did Not Cooperate|0|||
147335173|NCT00922207|531393803|FG002|Overall Study|Refused Treatment/Did Not Cooperate|0|||
147335174|NCT00922207|531393801|FG000|Overall Study|Withdrew Consent|2|||
147335175|NCT00922207|531393802|FG001|Overall Study|Withdrew Consent|5|||
147335176|NCT00922207|531393803|FG002|Overall Study|Withdrew Consent|2|||
147335177|NCT00922207|531393801|FG000|Overall Study|Abnormality of Laboratory Test|0|||
147335178|NCT00922207|531393802|FG001|Overall Study|Abnormality of Laboratory Test|1|||
147335179|NCT00922207|531393803|FG002|Overall Study|Abnormality of Laboratory Test|1|||
147335180|NCT03299816|531393804|FG000|Phase 1: 4-month Intervention Period|Withdrawal by Subject|1|||
147280391|NCT00116805|531192403|FG000|Open-label Period Weeks 145 - 192|Seroconversion|0|||
147335181|NCT03299816|531393805|FG001|Phase 1: 4-month Intervention Period|Withdrawal by Subject|0|||
147335182|NCT03299816|531393804|FG000|Phase 2: 12-month Follow-up Period|Withdrawal by Subject|1|||
147335183|NCT03299816|531393805|FG001|Phase 2: 12-month Follow-up Period|Withdrawal by Subject|0|||
147335184|NCT03299816|531393804|FG000|Phase 2: 12-month Follow-up Period|Lost to Follow-up|2|||
147280392|NCT00116805|531192404|FG001|Open-label Period Weeks 145 - 192|Seroconversion|1|||
147280393|NCT00116805|531192403|FG000|Open-label Period Weeks 145 - 192|Withdrew Consent|3|||
147280394|NCT00116805|531192404|FG001|Open-label Period Weeks 145 - 192|Withdrew Consent|2|||
147280395|NCT00116805|531192403|FG000|Open-label Period Weeks 193 - 240|Completed Study|0|||
147280396|NCT00116805|531192404|FG001|Open-label Period Weeks 193 - 240|Completed Study|1|||
147280397|NCT00116805|531192403|FG000|Open-label Period Weeks 193 - 240|Investigator's Discretion|1|||
147280398|NCT00116805|531192404|FG001|Open-label Period Weeks 193 - 240|Investigator's Discretion|0|||
147280399|NCT00116805|531192403|FG000|Open-label Period Weeks 193 - 240|Lost to Follow-up|3|||
147280400|NCT00116805|531192404|FG001|Open-label Period Weeks 193 - 240|Lost to Follow-up|0|||
147280401|NCT00116805|531192403|FG000|Open-label Period Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|2|||
147280402|NCT00116805|531192404|FG001|Open-label Period Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|2|||
147280403|NCT00116805|531192403|FG000|Open-label Period Weeks 193 - 240|Withdrew Consent|7|||
147335185|NCT03299816|531393805|FG001|Phase 2: 12-month Follow-up Period|Lost to Follow-up|3|||
147335186|NCT00367991|531393809|FG000|Overall Study|Withdrawal by Subject|1|||
147335187|NCT00367991|531393810|FG001|Overall Study|Withdrawal by Subject|1|||
147335188|NCT00367991|531393809|FG000|Overall Study|Adverse Event|1|||
147335189|NCT00367991|531393810|FG001|Overall Study|Adverse Event|1|||
147335190|NCT03515304|531393811|FG000|Overall Study|Lost to Follow-up|0|||
147335191|NCT03515304|531393812|FG001|Overall Study|Lost to Follow-up|3|||
147335192|NCT02705586|531393828|FG000|Overall Study|Health Issues|2|||
147335193|NCT02705586|531393828|FG000|Overall Study|Transportation Difficulties|5|||
147335194|NCT02705586|531393828|FG000|Overall Study|Vacation/Planned Absence|1|||
147335195|NCT02045836|531393829|FG000|Overall Study|Adverse Event|4|||
147335196|NCT02045836|531393830|FG001|Overall Study|Adverse Event|4|||
147335197|NCT02045836|531393829|FG000|Overall Study|Withdrawal by Subject|1|||
147335198|NCT02045836|531393830|FG001|Overall Study|Withdrawal by Subject|1|||
147335199|NCT02045836|531393829|FG000|Overall Study|Lost to Follow-up|4|||
147335200|NCT02045836|531393830|FG001|Overall Study|Lost to Follow-up|7|||
147335201|NCT02045836|531393829|FG000|Overall Study|Migrated from study area|0|||
147335202|NCT02045836|531393830|FG001|Overall Study|Migrated from study area|2|||
147335203|NCT02798835|531393833|FG000|Overall Study|Protocol Violation|0|||
147335204|NCT02798835|531393834|FG001|Overall Study|Protocol Violation|0|||
147335205|NCT02798835|531393835|FG002|Overall Study|Protocol Violation|3|||
147335206|NCT04221438|531393845|FG000|Overall Study|Adverse Event|1|||
147602020|NCT02393248|532360648|FG003|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
147602021|NCT02393248|532360649|FG004|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
147602022|NCT02393248|532360650|FG005|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
147602023|NCT02393248|532360651|FG006|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
147602024|NCT02393248|532360652|FG007|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
147602025|NCT02393248|532360653|FG008|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
147602026|NCT02393248|532360654|FG009|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
147602027|NCT02393248|532360655|FG010|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
147602028|NCT02393248|532360656|FG011|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
147602029|NCT02393248|532360657|FG012|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
147602030|NCT02393248|532360658|FG013|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
147602031|NCT02393248|532360659|FG014|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
147602032|NCT02393248|532360660|FG015|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
147602033|NCT02393248|532360661|FG016|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
147602034|NCT02393248|532360662|FG017|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
147602035|NCT02393248|532360663|FG018|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
147602036|NCT02393248|532360664|FG019|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
147602037|NCT02393248|532360665|FG020|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
147602038|NCT02393248|532360666|FG021|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
147602039|NCT02393248|532360667|FG022|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
147602040|NCT02393248|532360668|FG023|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|1|||
147602041|NCT02393248|532360669|FG024|Part 3: Combination Therapy|Placed on Hospice; Declined Further Follow-up|0|||
147602042|NCT03560986|532360670|FG000|Treatment Period A/Follow-up Period 1|Withdrawal by Subject|3|||
147602043|NCT03560986|532360671|FG001|Treatment Period A/Follow-up Period 1|Withdrawal by Subject|1|||
147602044|NCT03560986|532360670|FG000|Treatment Period A/Follow-up Period 1|Lost to Follow-up|1|||
147602045|NCT03560986|532360671|FG001|Treatment Period A/Follow-up Period 1|Lost to Follow-up|1|||
147602046|NCT03560986|532360670|FG000|Treatment Period A/Follow-up Period 1|Protocol Violation|0|||
147602047|NCT03560986|532360671|FG001|Treatment Period A/Follow-up Period 1|Protocol Violation|1|||
147602048|NCT03560986|532360670|FG000|Treatment Period A/Follow-up Period 1|Disc. before end of Follow-up Period 1|32|||
147602049|NCT03560986|532360671|FG001|Treatment Period A/Follow-up Period 1|Disc. before end of Follow-up Period 1|35|||
147602050|NCT03560986|532360670|FG000|Treatment Period B/Follow-up Period 2|Adverse Event|1|||
147602051|NCT03560986|532360671|FG001|Treatment Period B/Follow-up Period 2|Adverse Event|0|||
147602052|NCT03560986|532360670|FG000|Treatment Period B/Follow-up Period 2|Withdrawal by Subject|0|||
147602053|NCT03560986|532360671|FG001|Treatment Period B/Follow-up Period 2|Withdrawal by Subject|1|||
147602054|NCT03560986|532360670|FG000|Treatment Period B/Follow-up Period 2|Disc. before end of Follow-up Period 2|7|||
147602055|NCT03560986|532360671|FG001|Treatment Period B/Follow-up Period 2|Disc. before end of Follow-up Period 2|7|||
147602056|NCT01783548|532360684|FG000|Overall Study|Adverse Event|8|||
147662524|NCT02513550|532587350|FG005|Post-Treatment Follow-up Period|Withdrawal by Subject|0|||
147662525|NCT02513550|532587345|FG000|Post-Treatment Follow-up Period|Early terminated but completed follow-up|12|||
147662526|NCT02513550|532587346|FG001|Post-Treatment Follow-up Period|Early terminated but completed follow-up|16|||
147662527|NCT02513550|532587347|FG002|Post-Treatment Follow-up Period|Early terminated but completed follow-up|20|||
147280404|NCT00116805|531192404|FG001|Open-label Period Weeks 193 - 240|Withdrew Consent|1|||
147280405|NCT00116805|531192403|FG000|Open-label Period Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|2|||
147280406|NCT00116805|531192404|FG001|Open-label Period Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|0|||
147280407|NCT00116805|531192403|FG000|Open-label Period Weeks 241 - 288|Withdrew Consent|4|||
147280408|NCT00116805|531192404|FG001|Open-label Period Weeks 241 - 288|Withdrew Consent|0|||
147280409|NCT00116805|531192403|FG000|Open-label Period Weeks 289 - 336|Completed Study|0|||
147280410|NCT00116805|531192404|FG001|Open-label Period Weeks 289 - 336|Completed Study|1|||
147280411|NCT00116805|531192403|FG000|Open-label Period Weeks 289 - 336|Investigator's Discretion|3|||
147280412|NCT00116805|531192404|FG001|Open-label Period Weeks 289 - 336|Investigator's Discretion|2|||
147280413|NCT00116805|531192403|FG000|Open-label Period Weeks 289 - 336|Lost to Follow-up|1|||
147280414|NCT00116805|531192404|FG001|Open-label Period Weeks 289 - 336|Lost to Follow-up|1|||
147280415|NCT00116805|531192403|FG000|Open-label Period Weeks 289 - 336|Protocol Violation|0|||
147280416|NCT00116805|531192404|FG001|Open-label Period Weeks 289 - 336|Protocol Violation|1|||
147280417|NCT00116805|531192403|FG000|Open-label Period Weeks 289 - 336|Safety, Tolerability, or Efficacy Reason|0|||
147280418|NCT00116805|531192404|FG001|Open-label Period Weeks 289 - 336|Safety, Tolerability, or Efficacy Reason|1|||
147280419|NCT00116805|531192403|FG000|Open-label Period Weeks 289 - 336|Study Site Discontinued|0|||
147280420|NCT00116805|531192404|FG001|Open-label Period Weeks 289 - 336|Study Site Discontinued|1|||
147280421|NCT00116805|531192403|FG000|Open-label Period Weeks 289 - 336|Withdrew Consent|2|||
147280422|NCT00116805|531192404|FG001|Open-label Period Weeks 289 - 336|Withdrew Consent|0|||
147280423|NCT00116805|531192403|FG000|Open-label Period Weeks 337 - 384|Completed Study|1|||
147602057|NCT01783548|532360685|FG001|Overall Study|Adverse Event|4|||
147602058|NCT01783548|532360684|FG000|Overall Study|Withdrawal by Subject|11|||
147602059|NCT01783548|532360685|FG001|Overall Study|Withdrawal by Subject|8|||
147602060|NCT01783548|532360684|FG000|Overall Study|Non-compliance|4|||
147602061|NCT01783548|532360685|FG001|Overall Study|Non-compliance|0|||
147602062|NCT01783548|532360684|FG000|Overall Study|Protocol Violation|2|||
147602063|NCT01783548|532360685|FG001|Overall Study|Protocol Violation|2|||
147602064|NCT01783548|532360684|FG000|Overall Study|Lost to Follow-up|8|||
147602065|NCT01783548|532360685|FG001|Overall Study|Lost to Follow-up|3|||
147602066|NCT01783548|532360684|FG000|Overall Study|Lack of Efficacy|1|||
147602067|NCT01783548|532360685|FG001|Overall Study|Lack of Efficacy|1|||
147602068|NCT04053465|532360689|FG000|Overall Study|Withdrawal by Subject|4|||
147662528|NCT02513550|532587348|FG003|Post-Treatment Follow-up Period|Early terminated but completed follow-up|0|||
147662529|NCT02513550|532587349|FG004|Post-Treatment Follow-up Period|Early terminated but completed follow-up|0|||
147280424|NCT00116805|531192404|FG001|Open-label Period Weeks 337 - 384|Completed Study|0|||
147280425|NCT00116805|531192403|FG000|Open-label Period Weeks 337 - 384|Investigator's Discretion|1|||
147280426|NCT00116805|531192404|FG001|Open-label Period Weeks 337 - 384|Investigator's Discretion|0|||
147280427|NCT00116805|531192403|FG000|Open-label Period Weeks 337 - 384|Lost to Follow-up|2|||
147280428|NCT00116805|531192404|FG001|Open-label Period Weeks 337 - 384|Lost to Follow-up|0|||
147280429|NCT00116805|531192403|FG000|Open-label Period Weeks 337 - 384|Protocol Violation|1|||
147280430|NCT00116805|531192404|FG001|Open-label Period Weeks 337 - 384|Protocol Violation|0|||
147280431|NCT00116805|531192403|FG000|Open-label Period Weeks 337 - 384|Withdrew Consent|3|||
147280432|NCT00116805|531192404|FG001|Open-label Period Weeks 337 - 384|Withdrew Consent|1|||
147280433|NCT00116805|531192403|FG000|Open-label Period Weeks 385 - 432|Investigator's Discretion|1|||
147280434|NCT00116805|531192404|FG001|Open-label Period Weeks 385 - 432|Investigator's Discretion|0|||
147280435|NCT00116805|531192403|FG000|Open-label Period Weeks 385 - 432|Withdrew Consent|1|||
147280436|NCT00116805|531192404|FG001|Open-label Period Weeks 385 - 432|Withdrew Consent|0|||
147280437|NCT00116805|531192403|FG000|Open-label Period Weeks 433 - 480|Investigator's Discretion|1|||
147280438|NCT00116805|531192404|FG001|Open-label Period Weeks 433 - 480|Investigator's Discretion|0|||
147280439|NCT00116805|531192403|FG000|Open-label Period Weeks 433 - 480|Withdrew Consent|3|||
147280440|NCT00116805|531192404|FG001|Open-label Period Weeks 433 - 480|Withdrew Consent|0|||
147280441|NCT01760954|531192405|FG000|Treatment Period (6 Months)|Withdrawal by Subject|8|||
147280442|NCT01760954|531192406|FG001|Treatment Period (6 Months)|Withdrawal by Subject|8|||
147280443|NCT01760954|531192407|FG002|Treatment Period (6 Months)|Withdrawal by Subject|4|||
147280444|NCT01760954|531192408|FG003|Treatment Period (6 Months)|Withdrawal by Subject|5|||
147280445|NCT01760954|531192405|FG000|Treatment Period (6 Months)|Adverse Event|5|||
147280446|NCT01760954|531192406|FG001|Treatment Period (6 Months)|Adverse Event|3|||
147280447|NCT01760954|531192407|FG002|Treatment Period (6 Months)|Adverse Event|4|||
147280448|NCT01760954|531192408|FG003|Treatment Period (6 Months)|Adverse Event|10|||
147280449|NCT01760954|531192405|FG000|Treatment Period (6 Months)|Lost to Follow-up|9|||
147280450|NCT01760954|531192406|FG001|Treatment Period (6 Months)|Lost to Follow-up|1|||
147280451|NCT01760954|531192407|FG002|Treatment Period (6 Months)|Lost to Follow-up|4|||
147280452|NCT01760954|531192408|FG003|Treatment Period (6 Months)|Lost to Follow-up|3|||
147280453|NCT01760954|531192405|FG000|Treatment Period (6 Months)|Surgery or invasive intervention for end|3|||
147280454|NCT01760954|531192406|FG001|Treatment Period (6 Months)|Surgery or invasive intervention for end|3|||
147280455|NCT01760954|531192407|FG002|Treatment Period (6 Months)|Surgery or invasive intervention for end|3|||
147280456|NCT01760954|531192408|FG003|Treatment Period (6 Months)|Surgery or invasive intervention for end|2|||
147280457|NCT01760954|531192405|FG000|Treatment Period (6 Months)|Pregnancy|5|||
147280458|NCT01760954|531192406|FG001|Treatment Period (6 Months)|Pregnancy|0|||
147280459|NCT01760954|531192407|FG002|Treatment Period (6 Months)|Pregnancy|3|||
147280460|NCT01760954|531192408|FG003|Treatment Period (6 Months)|Pregnancy|2|||
147280461|NCT01760954|531192405|FG000|Treatment Period (6 Months)|Non-compliance|1|||
147280462|NCT01760954|531192406|FG001|Treatment Period (6 Months)|Non-compliance|4|||
147280463|NCT01760954|531192407|FG002|Treatment Period (6 Months)|Non-compliance|0|||
147335207|NCT04221438|531393845|FG000|Overall Study|No surgery within required timeframe due to Covid diagnosis|1|||
147335208|NCT01585558|531393848|FG000|Overall Study|Withdrawal by Subject|4|||
147335209|NCT01585558|531393849|FG001|Overall Study|Withdrawal by Subject|5|||
147335210|NCT01585558|531393850|FG002|Overall Study|Withdrawal by Subject|8|||
147335211|NCT01585558|531393848|FG000|Overall Study|Lost to Follow-up|2|||
147335212|NCT01585558|531393849|FG001|Overall Study|Lost to Follow-up|0|||
147335213|NCT01585558|531393850|FG002|Overall Study|Lost to Follow-up|3|||
147335214|NCT01585558|531393848|FG000|Overall Study|Adverse Event|3|||
147280464|NCT01760954|531192408|FG003|Treatment Period (6 Months)|Non-compliance|3|||
147280465|NCT01760954|531192405|FG000|Treatment Period (6 Months)|Other|0|||
147602069|NCT04053465|532360690|FG001|Overall Study|Withdrawal by Subject|4|||
147602070|NCT01059539|532360691|FG000|Overall Study|Adverse Event|66|||
147280466|NCT01760954|531192406|FG001|Treatment Period (6 Months)|Other|3|||
147280467|NCT01760954|531192407|FG002|Treatment Period (6 Months)|Other|3|||
147280468|NCT01760954|531192408|FG003|Treatment Period (6 Months)|Other|1|||
147335215|NCT01585558|531393849|FG001|Overall Study|Adverse Event|4|||
147602071|NCT01059539|532360691|FG000|Overall Study|Insufficient Therapeutic Response|26|||
147335216|NCT01585558|531393850|FG002|Overall Study|Adverse Event|1|||
147335217|NCT01585558|531393848|FG000|Overall Study|Protocol Violation|4|||
147335218|NCT01585558|531393849|FG001|Overall Study|Protocol Violation|3|||
147335219|NCT01585558|531393850|FG002|Overall Study|Protocol Violation|2|||
147335220|NCT01585558|531393848|FG000|Overall Study|Lack of Efficacy|0|||
147335221|NCT01585558|531393849|FG001|Overall Study|Lack of Efficacy|0|||
147335222|NCT01585558|531393850|FG002|Overall Study|Lack of Efficacy|1|||
147335223|NCT00997386|531393851|FG000|Overall Study|Death|7|||
147335224|NCT00617201|531393854|FG000|Overall Study|Lost to Follow-up|9|||
147335225|NCT00617201|531393855|FG001|Overall Study|Lost to Follow-up|13|||
147335226|NCT01350804|531393856|FG000|Core Study|Withdrawal by Subject|11|||
147335227|NCT01350804|531393857|FG001|Core Study|Withdrawal by Subject|17|||
147335228|NCT01350804|531393858|FG002|Core Study|Withdrawal by Subject|16|||
147335229|NCT01350804|531393859|FG003|Core Study|Withdrawal by Subject|7|||
147335230|NCT01350804|531393856|FG000|Core Study|Study terminated by Sponsor|0|||
147335231|NCT01350804|531393857|FG001|Core Study|Study terminated by Sponsor|0|||
147335232|NCT01350804|531393858|FG002|Core Study|Study terminated by Sponsor|0|||
147335233|NCT01350804|531393859|FG003|Core Study|Study terminated by Sponsor|2|||
147335234|NCT01350804|531393856|FG000|Core Study|Protocol deviation|1|||
147335235|NCT01350804|531393857|FG001|Core Study|Protocol deviation|0|||
147335236|NCT01350804|531393858|FG002|Core Study|Protocol deviation|1|||
147335237|NCT01350804|531393859|FG003|Core Study|Protocol deviation|0|||
147335238|NCT01350804|531393856|FG000|Core Study|Physician Decision|1|||
147335239|NCT01350804|531393857|FG001|Core Study|Physician Decision|0|||
147335240|NCT01350804|531393858|FG002|Core Study|Physician Decision|1|||
147335241|NCT01350804|531393859|FG003|Core Study|Physician Decision|3|||
147335242|NCT01350804|531393856|FG000|Core Study|Lost to Follow-up|3|||
147280469|NCT01760954|531192405|FG000|Treatment Period (6 Months)|Decrease in Bone Mineral Density (BMD)|1|||
147280470|NCT01760954|531192406|FG001|Treatment Period (6 Months)|Decrease in Bone Mineral Density (BMD)|6|||
147280471|NCT01760954|531192407|FG002|Treatment Period (6 Months)|Decrease in Bone Mineral Density (BMD)|0|||
147280472|NCT01760954|531192408|FG003|Treatment Period (6 Months)|Decrease in Bone Mineral Density (BMD)|0|||
147280473|NCT01760954|531192405|FG000|Treatment Period (6 Months)|Exclusionary Medication|1|||
147280474|NCT01760954|531192406|FG001|Treatment Period (6 Months)|Exclusionary Medication|0|||
147280475|NCT01760954|531192407|FG002|Treatment Period (6 Months)|Exclusionary Medication|0|||
147280476|NCT01760954|531192408|FG003|Treatment Period (6 Months)|Exclusionary Medication|0|||
147280477|NCT01760954|531192405|FG000|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|6|||
147280478|NCT01760954|531192406|FG001|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|6|||
147280479|NCT01760954|531192407|FG002|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|4|||
147335243|NCT01350804|531393857|FG001|Core Study|Lost to Follow-up|0|||
147335244|NCT01350804|531393858|FG002|Core Study|Lost to Follow-up|2|||
147335245|NCT01350804|531393859|FG003|Core Study|Lost to Follow-up|1|||
147335246|NCT01350804|531393856|FG000|Core Study|Lack of Efficacy|16|||
147335247|NCT01350804|531393857|FG001|Core Study|Lack of Efficacy|19|||
147602072|NCT01059539|532360691|FG000|Overall Study|Protocol Violation|55|||
147602073|NCT01059539|532360691|FG000|Overall Study|Withdrawal of Consent|80|||
147602074|NCT01059539|532360691|FG000|Overall Study|Lost to Follow-up|42|||
147602075|NCT01059539|532360691|FG000|Overall Study|Reason Not Specified|2|||
147602076|NCT02085135|532360692|FG000|Overall Study|Adverse Event|4|||
147602077|NCT02085135|532360693|FG001|Overall Study|Adverse Event|7|||
147602078|NCT02085135|532360692|FG000|Overall Study|Lost to Follow-up|2|||
147602079|NCT02085135|532360693|FG001|Overall Study|Lost to Follow-up|2|||
147602080|NCT02085135|532360692|FG000|Overall Study|Withdrawal by Subject|3|||
147602081|NCT02085135|532360693|FG001|Overall Study|Withdrawal by Subject|0|||
147602082|NCT02085135|532360692|FG000|Overall Study|Lack of Efficacy|2|||
147602083|NCT02085135|532360693|FG001|Overall Study|Lack of Efficacy|0|||
147602084|NCT04091659|532360696|FG000|Overall Study|Protocol Violation|3|||
147602085|NCT04091659|532360697|FG001|Overall Study|Protocol Violation|0|||
147602086|NCT04091659|532360696|FG000|Overall Study|Lost to Follow-up|0|||
147602087|NCT04091659|532360697|FG001|Overall Study|Lost to Follow-up|1|||
147602088|NCT04005352|532360698|FG000|Overall Study|Adverse Event|4|||
147602089|NCT04005352|532360699|FG001|Overall Study|Adverse Event|5|||
147602090|NCT04005352|532360698|FG000|Overall Study|Death|4|||
147602091|NCT04005352|532360699|FG001|Overall Study|Death|2|||
147602092|NCT04005352|532360698|FG000|Overall Study|Lost to Follow-up|6|||
147602093|NCT04005352|532360699|FG001|Overall Study|Lost to Follow-up|2|||
147335248|NCT01350804|531393858|FG002|Core Study|Lack of Efficacy|18|||
147335249|NCT01350804|531393859|FG003|Core Study|Lack of Efficacy|5|||
147335250|NCT01350804|531393856|FG000|Core Study|Death|1|||
147335251|NCT01350804|531393857|FG001|Core Study|Death|1|||
147335252|NCT01350804|531393858|FG002|Core Study|Death|1|||
147335253|NCT01350804|531393859|FG003|Core Study|Death|0|||
147335254|NCT01350804|531393856|FG000|Core Study|Adverse Event|8|||
147335255|NCT01350804|531393857|FG001|Core Study|Adverse Event|10|||
147335256|NCT01350804|531393858|FG002|Core Study|Adverse Event|8|||
147335257|NCT01350804|531393859|FG003|Core Study|Adverse Event|8|||
147335258|NCT01350804|531393856|FG000|Extension Study, Weeks 52 - 260|Withdrawal by Subject|5|||
147602094|NCT04005352|532360698|FG000|Overall Study|Physician Decision|7|||
147602095|NCT04005352|532360699|FG001|Overall Study|Physician Decision|13|||
147280480|NCT01760954|531192408|FG003|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|9|||
147280481|NCT01760954|531192405|FG000|Post-treatment Follow-up (12 Months)|Lost to Follow-up|4|||
147280482|NCT01760954|531192406|FG001|Post-treatment Follow-up (12 Months)|Lost to Follow-up|7|||
147280483|NCT01760954|531192407|FG002|Post-treatment Follow-up (12 Months)|Lost to Follow-up|2|||
147280484|NCT01760954|531192408|FG003|Post-treatment Follow-up (12 Months)|Lost to Follow-up|0|||
147280485|NCT01760954|531192405|FG000|Post-treatment Follow-up (12 Months)|Surgery or invasive intervention|6|||
147280486|NCT01760954|531192406|FG001|Post-treatment Follow-up (12 Months)|Surgery or invasive intervention|10|||
147280487|NCT01760954|531192407|FG002|Post-treatment Follow-up (12 Months)|Surgery or invasive intervention|5|||
147280488|NCT01760954|531192408|FG003|Post-treatment Follow-up (12 Months)|Surgery or invasive intervention|5|||
147280489|NCT01760954|531192405|FG000|Post-treatment Follow-up (12 Months)|Received Exclusionary Medication|1|||
147280490|NCT01760954|531192406|FG001|Post-treatment Follow-up (12 Months)|Received Exclusionary Medication|4|||
147280491|NCT01760954|531192407|FG002|Post-treatment Follow-up (12 Months)|Received Exclusionary Medication|0|||
147280492|NCT01760954|531192408|FG003|Post-treatment Follow-up (12 Months)|Received Exclusionary Medication|0|||
147280493|NCT01760954|531192405|FG000|Post-treatment Follow-up (12 Months)|Return of Menses and Acceptable BMD|0|||
147280494|NCT01760954|531192406|FG001|Post-treatment Follow-up (12 Months)|Return of Menses and Acceptable BMD|0|||
147280495|NCT01760954|531192407|FG002|Post-treatment Follow-up (12 Months)|Return of Menses and Acceptable BMD|1|||
147280496|NCT01760954|531192408|FG003|Post-treatment Follow-up (12 Months)|Return of Menses and Acceptable BMD|0|||
147280497|NCT01760954|531192405|FG000|Post-treatment Follow-up (12 Months)|Other|13|||
147280498|NCT01760954|531192406|FG001|Post-treatment Follow-up (12 Months)|Other|8|||
147280499|NCT01760954|531192407|FG002|Post-treatment Follow-up (12 Months)|Other|9|||
147280500|NCT01760954|531192408|FG003|Post-treatment Follow-up (12 Months)|Other|6|||
147280501|NCT00071487|531192414|FG000|52-Week Double-Blind Period|Adverse Event|5|||
147280502|NCT00071487|531192415|FG001|52-Week Double-Blind Period|Adverse Event|8|||
147280503|NCT00071487|531192416|FG002|52-Week Double-Blind Period|Adverse Event|4|||
147280504|NCT00071487|531192417|FG003|52-Week Double-Blind Period|Adverse Event|8|||
147280505|NCT00071487|531192414|FG000|52-Week Double-Blind Period|Lack of Efficacy|1|||
147280506|NCT00071487|531192415|FG001|52-Week Double-Blind Period|Lack of Efficacy|2|||
147280507|NCT00071487|531192416|FG002|52-Week Double-Blind Period|Lack of Efficacy|0|||
147280508|NCT00071487|531192417|FG003|52-Week Double-Blind Period|Lack of Efficacy|1|||
147280509|NCT00071487|531192414|FG000|52-Week Double-Blind Period|Withdrawal by Subject|7|||
147280510|NCT00071487|531192415|FG001|52-Week Double-Blind Period|Withdrawal by Subject|11|||
147280511|NCT00071487|531192416|FG002|52-Week Double-Blind Period|Withdrawal by Subject|7|||
147280512|NCT00071487|531192417|FG003|52-Week Double-Blind Period|Withdrawal by Subject|7|||
147280513|NCT00071487|531192414|FG000|52-Week Double-Blind Period|Physician Decision|1|||
147280514|NCT00071487|531192415|FG001|52-Week Double-Blind Period|Physician Decision|0|||
147280515|NCT00071487|531192416|FG002|52-Week Double-Blind Period|Physician Decision|0|||
147280516|NCT00071487|531192417|FG003|52-Week Double-Blind Period|Physician Decision|0|||
147280517|NCT00071487|531192414|FG000|52-Week Double-Blind Period|Lost to Follow-up|0|||
147280518|NCT00071487|531192415|FG001|52-Week Double-Blind Period|Lost to Follow-up|0|||
147280519|NCT00071487|531192416|FG002|52-Week Double-Blind Period|Lost to Follow-up|2|||
147280520|NCT00071487|531192417|FG003|52-Week Double-Blind Period|Lost to Follow-up|2|||
147280521|NCT00071487|531192414|FG000|52-Week Double-Blind Period|Pregnancy|0|||
147280522|NCT00071487|531192415|FG001|52-Week Double-Blind Period|Pregnancy|1|||
147280523|NCT00071487|531192416|FG002|52-Week Double-Blind Period|Pregnancy|0|||
147280524|NCT00071487|531192417|FG003|52-Week Double-Blind Period|Pregnancy|0|||
147280525|NCT00071487|531192414|FG000|52-Week Double-Blind Period|Protocol Violation|0|||
147280526|NCT00071487|531192415|FG001|52-Week Double-Blind Period|Protocol Violation|1|||
147280527|NCT00071487|531192416|FG002|52-Week Double-Blind Period|Protocol Violation|1|||
147280528|NCT00071487|531192417|FG003|52-Week Double-Blind Period|Protocol Violation|0|||
147280529|NCT00071487|531192414|FG000|52-Week Double-Blind Period|Death|0|||
147280530|NCT00071487|531192415|FG001|52-Week Double-Blind Period|Death|1|||
147280531|NCT00071487|531192416|FG002|52-Week Double-Blind Period|Death|0|||
147280532|NCT00071487|531192417|FG003|52-Week Double-Blind Period|Death|0|||
147280533|NCT00071487|531192414|FG000|52-Week Double-Blind Period|Lack of Compliance|6|||
147280534|NCT00071487|531192415|FG001|52-Week Double-Blind Period|Lack of Compliance|3|||
147280535|NCT00071487|531192416|FG002|52-Week Double-Blind Period|Lack of Compliance|3|||
147280536|NCT00071487|531192417|FG003|52-Week Double-Blind Period|Lack of Compliance|3|||
147280537|NCT00071487|531192414|FG000|24-Week Open-Label Extension Period|Adverse Event|0|||
147280538|NCT00071487|531192415|FG001|24-Week Open-Label Extension Period|Adverse Event|0|||
147280539|NCT00071487|531192416|FG002|24-Week Open-Label Extension Period|Adverse Event|1|||
147280540|NCT00071487|531192417|FG003|24-Week Open-Label Extension Period|Adverse Event|6|||
147280541|NCT00071487|531192414|FG000|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
147280542|NCT00071487|531192415|FG001|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
147280543|NCT00071487|531192416|FG002|24-Week Open-Label Extension Period|Lack of Efficacy|0|||
147280544|NCT00071487|531192417|FG003|24-Week Open-Label Extension Period|Lack of Efficacy|3|||
147280545|NCT00071487|531192414|FG000|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
147280546|NCT00071487|531192415|FG001|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
147280547|NCT00071487|531192416|FG002|24-Week Open-Label Extension Period|Withdrawal by Subject|0|||
147602096|NCT04005352|532360698|FG000|Overall Study|Protocol Violation|0|||
147602097|NCT04005352|532360699|FG001|Overall Study|Protocol Violation|1|||
147280548|NCT00071487|531192417|FG003|24-Week Open-Label Extension Period|Withdrawal by Subject|9|||
147280549|NCT00071487|531192414|FG000|24-Week Open-Label Extension Period|Pregnancy|0|||
147280550|NCT00071487|531192415|FG001|24-Week Open-Label Extension Period|Pregnancy|0|||
147280551|NCT00071487|531192416|FG002|24-Week Open-Label Extension Period|Pregnancy|0|||
147280552|NCT00071487|531192417|FG003|24-Week Open-Label Extension Period|Pregnancy|1|||
147280553|NCT00071487|531192414|FG000|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
147280554|NCT00071487|531192415|FG001|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
147280555|NCT00071487|531192416|FG002|24-Week Open-Label Extension Period|Lost to Follow-up|0|||
147280556|NCT00071487|531192417|FG003|24-Week Open-Label Extension Period|Lost to Follow-up|2|||
147280557|NCT00071487|531192414|FG000|24-Week Open-Label Extension Period|Lack of Compliance|0|||
147280558|NCT00071487|531192415|FG001|24-Week Open-Label Extension Period|Lack of Compliance|0|||
147280559|NCT00071487|531192416|FG002|24-Week Open-Label Extension Period|Lack of Compliance|0|||
147280560|NCT00071487|531192417|FG003|24-Week Open-Label Extension Period|Lack of Compliance|2|||
147280561|NCT02318329|531192420|FG000|Overall Study|Progressive Disease|2|||
147280562|NCT02318329|531192421|FG001|Overall Study|Progressive Disease|3|||
147280563|NCT02318329|531192422|FG002|Overall Study|Progressive Disease|2|||
147280564|NCT02318329|531192423|FG003|Overall Study|Progressive Disease|3|||
147280565|NCT02318329|531192424|FG004|Overall Study|Progressive Disease|3|||
147280566|NCT02318329|531192425|FG005|Overall Study|Progressive Disease|3|||
147280567|NCT02318329|531192426|FG006|Overall Study|Progressive Disease|1|||
147280568|NCT02318329|531192427|FG007|Overall Study|Progressive Disease|1|||
147280569|NCT02318329|531192428|FG008|Overall Study|Progressive Disease|5|||
147280570|NCT02318329|531192429|FG009|Overall Study|Progressive Disease|39|||
147280571|NCT02318329|531192420|FG000|Overall Study|Death|0|||
147280572|NCT02318329|531192421|FG001|Overall Study|Death|0|||
147280573|NCT02318329|531192422|FG002|Overall Study|Death|0|||
147280574|NCT02318329|531192423|FG003|Overall Study|Death|0|||
147280575|NCT02318329|531192424|FG004|Overall Study|Death|0|||
147280576|NCT02318329|531192425|FG005|Overall Study|Death|0|||
147280577|NCT02318329|531192426|FG006|Overall Study|Death|0|||
147280578|NCT02318329|531192427|FG007|Overall Study|Death|0|||
147280579|NCT02318329|531192428|FG008|Overall Study|Death|0|||
147280580|NCT02318329|531192429|FG009|Overall Study|Death|5|||
147280581|NCT02318329|531192420|FG000|Overall Study|Lost to Follow-up|0|||
147280582|NCT02318329|531192421|FG001|Overall Study|Lost to Follow-up|0|||
147280583|NCT02318329|531192422|FG002|Overall Study|Lost to Follow-up|0|||
147280584|NCT02318329|531192423|FG003|Overall Study|Lost to Follow-up|0|||
147280585|NCT02318329|531192424|FG004|Overall Study|Lost to Follow-up|0|||
147280586|NCT02318329|531192425|FG005|Overall Study|Lost to Follow-up|0|||
147280587|NCT02318329|531192426|FG006|Overall Study|Lost to Follow-up|0|||
147280588|NCT02318329|531192427|FG007|Overall Study|Lost to Follow-up|0|||
147280589|NCT02318329|531192428|FG008|Overall Study|Lost to Follow-up|0|||
147280590|NCT02318329|531192429|FG009|Overall Study|Lost to Follow-up|1|||
147280591|NCT02318329|531192420|FG000|Overall Study|Withdrawal by Subject|0|||
147280592|NCT02318329|531192421|FG001|Overall Study|Withdrawal by Subject|0|||
147280593|NCT02318329|531192422|FG002|Overall Study|Withdrawal by Subject|0|||
147280594|NCT02318329|531192423|FG003|Overall Study|Withdrawal by Subject|0|||
147280595|NCT02318329|531192424|FG004|Overall Study|Withdrawal by Subject|0|||
147280596|NCT02318329|531192425|FG005|Overall Study|Withdrawal by Subject|0|||
147280597|NCT02318329|531192426|FG006|Overall Study|Withdrawal by Subject|0|||
147280598|NCT02318329|531192427|FG007|Overall Study|Withdrawal by Subject|0|||
147280599|NCT02318329|531192428|FG008|Overall Study|Withdrawal by Subject|0|||
147280600|NCT02318329|531192429|FG009|Overall Study|Withdrawal by Subject|6|||
147280601|NCT02318329|531192420|FG000|Overall Study|Other|1|||
147280602|NCT02318329|531192421|FG001|Overall Study|Other|1|||
147280603|NCT02318329|531192422|FG002|Overall Study|Other|1|||
147280604|NCT02318329|531192423|FG003|Overall Study|Other|0|||
147280605|NCT02318329|531192424|FG004|Overall Study|Other|0|||
147280606|NCT02318329|531192425|FG005|Overall Study|Other|0|||
147280607|NCT02318329|531192426|FG006|Overall Study|Other|0|||
147335259|NCT01350804|531393857|FG001|Extension Study, Weeks 52 - 260|Withdrawal by Subject|6|||
147335260|NCT01350804|531393858|FG002|Extension Study, Weeks 52 - 260|Withdrawal by Subject|4|||
147335261|NCT01350804|531393859|FG003|Extension Study, Weeks 52 - 260|Withdrawal by Subject|3|||
147335262|NCT01350804|531393856|FG000|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|67|||
147335263|NCT01350804|531393857|FG001|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|67|||
147335264|NCT01350804|531393858|FG002|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|64|||
147335265|NCT01350804|531393859|FG003|Extension Study, Weeks 52 - 260|Study terminated by Sponsor|16|||
147335266|NCT01350804|531393856|FG000|Extension Study, Weeks 52 - 260|Physician Decision|1|||
147335267|NCT01350804|531393857|FG001|Extension Study, Weeks 52 - 260|Physician Decision|0|||
147335268|NCT01350804|531393858|FG002|Extension Study, Weeks 52 - 260|Physician Decision|2|||
147335269|NCT01350804|531393859|FG003|Extension Study, Weeks 52 - 260|Physician Decision|0|||
147335270|NCT01350804|531393856|FG000|Extension Study, Weeks 52 - 260|Lost to Follow-up|0|||
147280608|NCT02318329|531192427|FG007|Overall Study|Other|0|||
147280609|NCT02318329|531192428|FG008|Overall Study|Other|1|||
147280610|NCT02318329|531192429|FG009|Overall Study|Other|1|||
147280611|NCT02032901|531192432|FG000|Treatment Period (12 Weeks)|Pregnancy|1|||
147280612|NCT02032901|531192433|FG001|Treatment Period (12 Weeks)|Pregnancy|0|||
147280613|NCT02032901|531192432|FG000|Follow-Up Period (24 Weeks)|Lost to Follow-up|0|||
147280614|NCT02032901|531192433|FG001|Follow-Up Period (24 Weeks)|Lost to Follow-up|1|||
147280615|NCT00353704|531192446|FG000|Overall Study|Protocol Violation|3|||
147280616|NCT00353704|531192447|FG001|Overall Study|Protocol Violation|1|||
147280617|NCT02530619|531192457|FG000|Registered for Study|Withdrawal by Subject|2|||
147280618|NCT02530619|531192457|FG000|Continued Treatment Cycles 2 Through 6|Adverse Event|2|||
147280619|NCT02530619|531192457|FG000|Continued Treatment Cycles 2 Through 6|Withdrawal by Subject|2|||
147280620|NCT02530619|531192457|FG000|Continued Treatment Cycles 2 Through 6|Progressive Disease|4|||
147280621|NCT02530619|531192457|FG000|Continued Treatment Cycles 2 Through 6|Lack of Efficacy|2|||
147280622|NCT02530619|531192457|FG000|Follow-up Period (6 Months)|Death|4|||
147280623|NCT02530619|531192457|FG000|Follow-up Period (6 Months)|Lost to Follow-up|2|||
147280624|NCT02530619|531192457|FG000|Follow-up Period (6 Months)|Withdrawal by Subject|5|||
147280625|NCT01854554|531192468|FG000|Overall Study|Denial of Insurance Coverage|12|||
147280626|NCT01854554|531192469|FG001|Overall Study|Denial of Insurance Coverage|0|||
147280627|NCT01854554|531192468|FG000|Overall Study|Decided to get treatment locally|1|||
147280628|NCT01854554|531192469|FG001|Overall Study|Decided to get treatment locally|5|||
147280629|NCT01854554|531192468|FG000|Overall Study|Received IMR only due to insurance analysis|1|||
147280630|NCT01854554|531192469|FG001|Overall Study|Received IMR only due to insurance analysis|0|||
147280631|NCT01854554|531192468|FG000|Overall Study|Did Not Meet Eligibility Criteria|0|||
147280632|NCT01854554|531192469|FG001|Overall Study|Did Not Meet Eligibility Criteria|2|||
147280633|NCT01854554|531192468|FG000|Overall Study|Progression|0|||
147280634|NCT01854554|531192469|FG001|Overall Study|Progression|1|||
147280635|NCT01854554|531192468|FG000|Overall Study|Lost to Follow-up|0|||
147280636|NCT01854554|531192469|FG001|Overall Study|Lost to Follow-up|1|||
147280637|NCT00359762|531192472|FG000|Period II|Adverse Event|17|||
147280638|NCT00359762|531192473|FG001|Period II|Adverse Event|0|||
147280639|NCT00359762|531192474|FG002|Period II|Adverse Event|0|||
147280640|NCT00359762|531192475|FG003|Period II|Adverse Event|0|||
147280641|NCT00359762|531192476|FG004|Period II|Adverse Event|49|||
147280642|NCT00359762|531192472|FG000|Period II|Protocol Violation|18|||
147280643|NCT00359762|531192473|FG001|Period II|Protocol Violation|0|||
147280644|NCT00359762|531192474|FG002|Period II|Protocol Violation|0|||
147280645|NCT00359762|531192475|FG003|Period II|Protocol Violation|0|||
147280646|NCT00359762|531192476|FG004|Period II|Protocol Violation|11|||
147280647|NCT00359762|531192472|FG000|Period II|Physician Decision|17|||
147280648|NCT00359762|531192473|FG001|Period II|Physician Decision|0|||
147280649|NCT00359762|531192474|FG002|Period II|Physician Decision|0|||
147280650|NCT00359762|531192475|FG003|Period II|Physician Decision|0|||
147280651|NCT00359762|531192476|FG004|Period II|Physician Decision|23|||
147280652|NCT00359762|531192472|FG000|Period II|Death|2|||
147280653|NCT00359762|531192473|FG001|Period II|Death|0|||
147280654|NCT00359762|531192474|FG002|Period II|Death|0|||
147280655|NCT00359762|531192475|FG003|Period II|Death|0|||
147280656|NCT00359762|531192476|FG004|Period II|Death|4|||
147335271|NCT01350804|531393857|FG001|Extension Study, Weeks 52 - 260|Lost to Follow-up|1|||
147335272|NCT01350804|531393858|FG002|Extension Study, Weeks 52 - 260|Lost to Follow-up|0|||
147335273|NCT01350804|531393859|FG003|Extension Study, Weeks 52 - 260|Lost to Follow-up|0|||
147335274|NCT01350804|531393856|FG000|Extension Study, Weeks 52 - 260|Lack of Efficacy|4|||
147335275|NCT01350804|531393857|FG001|Extension Study, Weeks 52 - 260|Lack of Efficacy|4|||
147335276|NCT01350804|531393858|FG002|Extension Study, Weeks 52 - 260|Lack of Efficacy|0|||
147335277|NCT01350804|531393859|FG003|Extension Study, Weeks 52 - 260|Lack of Efficacy|1|||
147335278|NCT01350804|531393856|FG000|Extension Study, Weeks 52 - 260|Adverse Event|3|||
147335279|NCT01350804|531393857|FG001|Extension Study, Weeks 52 - 260|Adverse Event|1|||
147335280|NCT01350804|531393858|FG002|Extension Study, Weeks 52 - 260|Adverse Event|2|||
147335281|NCT01350804|531393859|FG003|Extension Study, Weeks 52 - 260|Adverse Event|3|||
147335282|NCT01286272|531395311|FG000|Overall Study|Ineligible after beginning treatment|1|||
147335283|NCT01286272|531395312|FG001|Overall Study|Ineligible after beginning treatment|3|||
147451167|NCT03315871|531813287|FG002|PROSTVAC + CV301|An unrelated lymphoma diagnosis requiring therapy|1|||
147451168|NCT05048719|531814814|FG000|Overall Study|Withdrawal by Subject|2|||
147451169|NCT05048719|531814815|FG001|Overall Study|Withdrawal by Subject|1|||
147280657|NCT00359762|531192472|FG000|Period II|Lack of Efficacy|11|||
147280658|NCT00359762|531192473|FG001|Period II|Lack of Efficacy|0|||
147335284|NCT04001829|531395313|FG000|Overall Study|Never start protocol therapy|5|||
147335285|NCT04001829|531395314|FG001|Overall Study|Never start protocol therapy|5|||
147335286|NCT04001829|531395313|FG000|Overall Study|Adverse Event|11|||
147335287|NCT04001829|531395314|FG001|Overall Study|Adverse Event|7|||
147335288|NCT04001829|531395313|FG000|Overall Study|Alternative therapy|1|||
147335289|NCT04001829|531395314|FG001|Overall Study|Alternative therapy|2|||
147280659|NCT00359762|531192474|FG002|Period II|Lack of Efficacy|0|||
147280660|NCT00359762|531192475|FG003|Period II|Lack of Efficacy|0|||
147280661|NCT00359762|531192476|FG004|Period II|Lack of Efficacy|8|||
147280662|NCT00359762|531192472|FG000|Period II|Lost to follow up|5|||
147280663|NCT00359762|531192473|FG001|Period II|Lost to follow up|0|||
147280664|NCT00359762|531192474|FG002|Period II|Lost to follow up|0|||
147280665|NCT00359762|531192475|FG003|Period II|Lost to follow up|0|||
147280666|NCT00359762|531192476|FG004|Period II|Lost to follow up|5|||
147280667|NCT00359762|531192472|FG000|Period II|Entry Criteria Not Met|8|||
147280668|NCT00359762|531192473|FG001|Period II|Entry Criteria Not Met|0|||
147280669|NCT00359762|531192474|FG002|Period II|Entry Criteria Not Met|0|||
147280670|NCT00359762|531192475|FG003|Period II|Entry Criteria Not Met|0|||
147280671|NCT00359762|531192476|FG004|Period II|Entry Criteria Not Met|4|||
147280672|NCT00359762|531192472|FG000|Period II|Subject Decision|50|||
147280673|NCT00359762|531192473|FG001|Period II|Subject Decision|0|||
147280674|NCT00359762|531192474|FG002|Period II|Subject Decision|0|||
147280675|NCT00359762|531192475|FG003|Period II|Subject Decision|0|||
147280676|NCT00359762|531192476|FG004|Period II|Subject Decision|70|||
147280677|NCT00359762|531192472|FG000|Period III|Protocol Violation|0|||
147280678|NCT00359762|531192473|FG001|Period III|Protocol Violation|5|||
147280679|NCT00359762|531192474|FG002|Period III|Protocol Violation|3|||
147280680|NCT00359762|531192475|FG003|Period III|Protocol Violation|8|||
147602098|NCT04005352|532360698|FG000|Overall Study|Withdrawal by Subject|28|||
147602099|NCT04005352|532360699|FG001|Overall Study|Withdrawal by Subject|38|||
147602100|NCT02695537|532360700|FG000|Overall Study|Adverse Event|3|||
147602101|NCT02695537|532360700|FG000|Overall Study|Lack of Efficacy|28|||
147602102|NCT02695537|532360700|FG000|Overall Study|Withdrawal by Subject|4|||
147602103|NCT02695537|532360700|FG000|Overall Study|Protocol Violation|3|||
147602104|NCT02256436|532360705|FG000|Overall Study|Adverse Event|9|||
147602105|NCT02256436|532360706|FG001|Overall Study|Adverse Event|14|||
147602106|NCT02256436|532360705|FG000|Overall Study|Death|216|||
147602107|NCT02256436|532360706|FG001|Overall Study|Death|208|||
147602108|NCT02256436|532360705|FG000|Overall Study|Lost to Follow-up|1|||
147602109|NCT02256436|532360706|FG001|Overall Study|Lost to Follow-up|2|||
147602110|NCT02256436|532360705|FG000|Overall Study|Physician Decision|1|||
147602111|NCT02256436|532360706|FG001|Overall Study|Physician Decision|0|||
147602112|NCT02256436|532360705|FG000|Overall Study|Protocol Violation|0|||
147602113|NCT02256436|532360706|FG001|Overall Study|Protocol Violation|1|||
147602114|NCT02256436|532360705|FG000|Overall Study|Withdrawal by Subject|26|||
147602115|NCT02256436|532360706|FG001|Overall Study|Withdrawal by Subject|10|||
147602116|NCT02256436|532360705|FG000|Overall Study|Transferred to Extension Study|11|||
147602117|NCT02256436|532360706|FG001|Overall Study|Transferred to Extension Study|23|||
147602118|NCT02256436|532360705|FG000|Overall Study|Did Not Continue on Extension Study|8|||
147602119|NCT02256436|532360706|FG001|Overall Study|Did Not Continue on Extension Study|12|||
147602120|NCT01696279|532360707|FG000|Part 1: Single Dose Lanthanum Carbonate|Kidney Transplant|1|||
147602121|NCT01696279|532360708|FG001|Part 1: Single Dose Lanthanum Carbonate|Kidney Transplant|0|||
147602122|NCT01696279|532360709|FG002|Part 1: Single Dose Lanthanum Carbonate|Kidney Transplant|0|||
147602123|NCT01696279|532360710|FG003|Part 1: Single Dose Lanthanum Carbonate|Kidney Transplant|0|||
147602124|NCT01696279|532360707|FG000|Part 2a: Calcium Carbonate + Lanthanum|Adverse Event|0|||
147602125|NCT01696279|532360708|FG001|Part 2a: Calcium Carbonate + Lanthanum|Adverse Event|5|||
147602126|NCT01696279|532360709|FG002|Part 2a: Calcium Carbonate + Lanthanum|Adverse Event|0|||
147602127|NCT01696279|532360710|FG003|Part 2a: Calcium Carbonate + Lanthanum|Adverse Event|0|||
147602128|NCT01696279|532360707|FG000|Part 2a: Calcium Carbonate + Lanthanum|Withdrawal by Subject|0|||
147602129|NCT01696279|532360708|FG001|Part 2a: Calcium Carbonate + Lanthanum|Withdrawal by Subject|1|||
147602130|NCT01696279|532360709|FG002|Part 2a: Calcium Carbonate + Lanthanum|Withdrawal by Subject|0|||
147602131|NCT01696279|532360710|FG003|Part 2a: Calcium Carbonate + Lanthanum|Withdrawal by Subject|0|||
147602132|NCT01696279|532360707|FG000|Part 2a: Calcium Carbonate + Lanthanum|Protocol Violation|0|||
147602133|NCT01696279|532360708|FG001|Part 2a: Calcium Carbonate + Lanthanum|Protocol Violation|1|||
147602134|NCT01696279|532360709|FG002|Part 2a: Calcium Carbonate + Lanthanum|Protocol Violation|0|||
147602135|NCT01696279|532360710|FG003|Part 2a: Calcium Carbonate + Lanthanum|Protocol Violation|0|||
147602136|NCT01696279|532360707|FG000|Part 2a: Calcium Carbonate + Lanthanum|Other (Unspecified)|0|||
147602137|NCT01696279|532360708|FG001|Part 2a: Calcium Carbonate + Lanthanum|Other (Unspecified)|3|||
147602138|NCT01696279|532360709|FG002|Part 2a: Calcium Carbonate + Lanthanum|Other (Unspecified)|0|||
147602139|NCT01696279|532360710|FG003|Part 2a: Calcium Carbonate + Lanthanum|Other (Unspecified)|0|||
147602140|NCT01696279|532360707|FG000|Part 2a: Calcium Carbonate + Lanthanum|Kidney Transplant|0|||
147602141|NCT01696279|532360708|FG001|Part 2a: Calcium Carbonate + Lanthanum|Kidney Transplant|7|||
147602142|NCT01696279|532360709|FG002|Part 2a: Calcium Carbonate + Lanthanum|Kidney Transplant|0|||
147602143|NCT01696279|532360710|FG003|Part 2a: Calcium Carbonate + Lanthanum|Kidney Transplant|0|||
147280681|NCT00359762|531192476|FG004|Period III|Protocol Violation|0|||
147602144|NCT01696279|532360707|FG000|Part 2a: Calcium Carbonate + Lanthanum|Non-Compliance with Study Drug|0|||
147602145|NCT01696279|532360708|FG001|Part 2a: Calcium Carbonate + Lanthanum|Non-Compliance with Study Drug|2|||
147280682|NCT00359762|531192472|FG000|Period III|Adverse Event|0|||
147602146|NCT01696279|532360709|FG002|Part 2a: Calcium Carbonate + Lanthanum|Non-Compliance with Study Drug|0|||
147602147|NCT01696279|532360710|FG003|Part 2a: Calcium Carbonate + Lanthanum|Non-Compliance with Study Drug|0|||
147280683|NCT00359762|531192473|FG001|Period III|Adverse Event|3|||
147280684|NCT00359762|531192474|FG002|Period III|Adverse Event|4|||
147280685|NCT00359762|531192475|FG003|Period III|Adverse Event|10|||
147602148|NCT01696279|532360707|FG000|Part 2b: Lanthanum Carbonate (8 Weeks)|Kidney Transplant|0|||
147602149|NCT01696279|532360708|FG001|Part 2b: Lanthanum Carbonate (8 Weeks)|Kidney Transplant|0|||
147602150|NCT01696279|532360709|FG002|Part 2b: Lanthanum Carbonate (8 Weeks)|Kidney Transplant|1|||
147602151|NCT01696279|532360710|FG003|Part 2b: Lanthanum Carbonate (8 Weeks)|Kidney Transplant|0|||
147602152|NCT01696279|532360707|FG000|Part 3: Lanthanum Carbonate (6 Months)|Kidney transplant|0|||
147602153|NCT01696279|532360708|FG001|Part 3: Lanthanum Carbonate (6 Months)|Kidney transplant|0|||
147602154|NCT01696279|532360709|FG002|Part 3: Lanthanum Carbonate (6 Months)|Kidney transplant|0|||
147602155|NCT01696279|532360710|FG003|Part 3: Lanthanum Carbonate (6 Months)|Kidney transplant|6|||
147602156|NCT01696279|532360707|FG000|Part 3: Lanthanum Carbonate (6 Months)|Other (Unspecified)|0|||
147602157|NCT01696279|532360708|FG001|Part 3: Lanthanum Carbonate (6 Months)|Other (Unspecified)|0|||
147602158|NCT01696279|532360709|FG002|Part 3: Lanthanum Carbonate (6 Months)|Other (Unspecified)|0|||
147602159|NCT01696279|532360710|FG003|Part 3: Lanthanum Carbonate (6 Months)|Other (Unspecified)|1|||
147602160|NCT01696279|532360707|FG000|Part 3: Lanthanum Carbonate (6 Months)|Missing|0|||
147602161|NCT01696279|532360708|FG001|Part 3: Lanthanum Carbonate (6 Months)|Missing|0|||
147602162|NCT01696279|532360709|FG002|Part 3: Lanthanum Carbonate (6 Months)|Missing|0|||
147602163|NCT01696279|532360710|FG003|Part 3: Lanthanum Carbonate (6 Months)|Missing|1|||
147602164|NCT05788289|532360711|FG000|Overall Study|Death|3|||
147602165|NCT02970318|532360716|FG000|Overall for Arm A & Main for Arm B|Lost to Follow-up|2|||
147602166|NCT02970318|532360717|FG001|Overall for Arm A & Main for Arm B|Lost to Follow-up|1|||
147602167|NCT02970318|532360718|FG002|Overall for Arm A & Main for Arm B|Lost to Follow-up|0|||
147602168|NCT02970318|532360719|FG003|Overall for Arm A & Main for Arm B|Lost to Follow-up|0|||
147602169|NCT02970318|532360716|FG000|Overall for Arm A & Main for Arm B|Withdrawal by Subject|13|||
147602170|NCT02970318|532360717|FG001|Overall for Arm A & Main for Arm B|Withdrawal by Subject|14|||
147602171|NCT02970318|532360718|FG002|Overall for Arm A & Main for Arm B|Withdrawal by Subject|0|||
147602172|NCT02970318|532360719|FG003|Overall for Arm A & Main for Arm B|Withdrawal by Subject|0|||
147602173|NCT02970318|532360716|FG000|Overall for Arm A & Main for Arm B|Death|41|||
147602174|NCT02970318|532360717|FG001|Overall for Arm A & Main for Arm B|Death|33|||
147602175|NCT02970318|532360718|FG002|Overall for Arm A & Main for Arm B|Death|0|||
147602176|NCT02970318|532360719|FG003|Overall for Arm A & Main for Arm B|Death|0|||
147602177|NCT02970318|532360716|FG000|Overall for Arm A & Main for Arm B|Arm B Crossed Over to Arm A Acala 100 mg Monotherapy|0|||
147602178|NCT02970318|532360717|FG001|Overall for Arm A & Main for Arm B|Arm B Crossed Over to Arm A Acala 100 mg Monotherapy|80|||
147602179|NCT02970318|532360718|FG002|Overall for Arm A & Main for Arm B|Arm B Crossed Over to Arm A Acala 100 mg Monotherapy|0|||
147602180|NCT02970318|532360719|FG003|Overall for Arm A & Main for Arm B|Arm B Crossed Over to Arm A Acala 100 mg Monotherapy|0|||
147602181|NCT02970318|532360716|FG000|ArmB: Inv.Choice Crossed Over to Acala|Lost to Follow-up|0|||
147602182|NCT02970318|532360717|FG001|ArmB: Inv.Choice Crossed Over to Acala|Lost to Follow-up|0|||
147602183|NCT02970318|532360718|FG002|ArmB: Inv.Choice Crossed Over to Acala|Lost to Follow-up|2|||
147602184|NCT02970318|532360719|FG003|ArmB: Inv.Choice Crossed Over to Acala|Lost to Follow-up|0|||
147602185|NCT02970318|532360716|FG000|ArmB: Inv.Choice Crossed Over to Acala|Withdrawal by Subject|0|||
147602186|NCT02970318|532360717|FG001|ArmB: Inv.Choice Crossed Over to Acala|Withdrawal by Subject|0|||
147602187|NCT02970318|532360718|FG002|ArmB: Inv.Choice Crossed Over to Acala|Withdrawal by Subject|1|||
147602188|NCT02970318|532360719|FG003|ArmB: Inv.Choice Crossed Over to Acala|Withdrawal by Subject|1|||
147602189|NCT02970318|532360716|FG000|ArmB: Inv.Choice Crossed Over to Acala|Death|0|||
147602190|NCT02970318|532360717|FG001|ArmB: Inv.Choice Crossed Over to Acala|Death|0|||
147602191|NCT02970318|532360718|FG002|ArmB: Inv.Choice Crossed Over to Acala|Death|18|||
147602192|NCT02970318|532360719|FG003|ArmB: Inv.Choice Crossed Over to Acala|Death|2|||
147602193|NCT03233230|532360720|FG000|Overall Study|Adverse Event|6|||
147602194|NCT03233230|532360721|FG001|Overall Study|Adverse Event|3|||
147602195|NCT03233230|532360722|FG002|Overall Study|Adverse Event|6|||
147602196|NCT03233230|532360723|FG003|Overall Study|Adverse Event|3|||
147602197|NCT03233230|532360720|FG000|Overall Study|Protocol Violation|1|||
147602198|NCT03233230|532360721|FG001|Overall Study|Protocol Violation|2|||
147602199|NCT03233230|532360722|FG002|Overall Study|Protocol Violation|1|||
147602200|NCT03233230|532360723|FG003|Overall Study|Protocol Violation|1|||
147602201|NCT03233230|532360720|FG000|Overall Study|Lack of Efficacy|1|||
147602202|NCT03233230|532360721|FG001|Overall Study|Lack of Efficacy|0|||
147602203|NCT03233230|532360722|FG002|Overall Study|Lack of Efficacy|0|||
147602204|NCT03233230|532360723|FG003|Overall Study|Lack of Efficacy|0|||
147280686|NCT00359762|531192476|FG004|Period III|Adverse Event|0|||
147280687|NCT00359762|531192472|FG000|Period III|Physician Decision|0|||
147280688|NCT00359762|531192473|FG001|Period III|Physician Decision|5|||
147280689|NCT00359762|531192474|FG002|Period III|Physician Decision|9|||
147280690|NCT00359762|531192475|FG003|Period III|Physician Decision|15|||
147280691|NCT00359762|531192476|FG004|Period III|Physician Decision|0|||
147280692|NCT00359762|531192472|FG000|Period III|Lack of Efficacy|0|||
147280693|NCT00359762|531192473|FG001|Period III|Lack of Efficacy|7|||
147280694|NCT00359762|531192474|FG002|Period III|Lack of Efficacy|5|||
147280695|NCT00359762|531192475|FG003|Period III|Lack of Efficacy|9|||
147280696|NCT00359762|531192476|FG004|Period III|Lack of Efficacy|0|||
147280697|NCT00359762|531192472|FG000|Period III|Lost to follow up|0|||
147280698|NCT00359762|531192473|FG001|Period III|Lost to follow up|1|||
147280699|NCT00359762|531192474|FG002|Period III|Lost to follow up|1|||
147280700|NCT00359762|531192475|FG003|Period III|Lost to follow up|2|||
147280701|NCT00359762|531192476|FG004|Period III|Lost to follow up|0|||
147280702|NCT00359762|531192472|FG000|Period III|Entry Criteria Not Met|0|||
147280703|NCT00359762|531192473|FG001|Period III|Entry Criteria Not Met|1|||
147280704|NCT00359762|531192474|FG002|Period III|Entry Criteria Not Met|0|||
147280705|NCT00359762|531192475|FG003|Period III|Entry Criteria Not Met|1|||
147280706|NCT00359762|531192476|FG004|Period III|Entry Criteria Not Met|0|||
147280707|NCT00359762|531192472|FG000|Period III|Subject Decision|0|||
147280708|NCT00359762|531192473|FG001|Period III|Subject Decision|7|||
147280709|NCT00359762|531192474|FG002|Period III|Subject Decision|8|||
147280710|NCT00359762|531192475|FG003|Period III|Subject Decision|20|||
147280711|NCT00359762|531192476|FG004|Period III|Subject Decision|0|||
147602205|NCT03233230|532360720|FG000|Overall Study|Other|5|||
147602206|NCT03233230|532360721|FG001|Overall Study|Other|5|||
147602207|NCT03233230|532360722|FG002|Overall Study|Other|5|||
147602208|NCT03233230|532360723|FG003|Overall Study|Other|3|||
147602209|NCT03233230|532360720|FG000|Overall Study|Withdrawal by Subject|2|||
147280712|NCT02819726|531192477|FG000|Part A (All Participants)|Lost to Follow-up|0|||
147280713|NCT02819726|531192478|FG001|Part A (All Participants)|Lost to Follow-up|1|||
147280714|NCT02819726|531192479|FG002|Part A (All Participants)|Lost to Follow-up|0|||
147280715|NCT02819726|531192480|FG003|Part A (All Participants)|Lost to Follow-up|0|||
147280716|NCT02819726|531192477|FG000|Part A (All Participants)|Withdrawal by Subject|3|||
147280717|NCT02819726|531192478|FG001|Part A (All Participants)|Withdrawal by Subject|5|||
147280718|NCT02819726|531192479|FG002|Part A (All Participants)|Withdrawal by Subject|6|||
147280719|NCT02819726|531192480|FG003|Part A (All Participants)|Withdrawal by Subject|0|||
147280720|NCT02819726|531192477|FG000|Part A (All Participants)|Protocol non-compliance|3|||
147280721|NCT02819726|531192478|FG001|Part A (All Participants)|Protocol non-compliance|4|||
147280722|NCT02819726|531192479|FG002|Part A (All Participants)|Protocol non-compliance|5|||
147280723|NCT02819726|531192480|FG003|Part A (All Participants)|Protocol non-compliance|0|||
147280724|NCT02819726|531192477|FG000|Part B (All Participants)|Lost to Follow-up|1|||
147280725|NCT02819726|531192478|FG001|Part B (All Participants)|Lost to Follow-up|1|||
147280726|NCT02819726|531192479|FG002|Part B (All Participants)|Lost to Follow-up|2|||
147280727|NCT02819726|531192480|FG003|Part B (All Participants)|Lost to Follow-up|2|||
147280728|NCT02819726|531192477|FG000|Part B (All Participants)|Withdrawal by Subject|2|||
147280729|NCT02819726|531192478|FG001|Part B (All Participants)|Withdrawal by Subject|1|||
147280730|NCT02819726|531192479|FG002|Part B (All Participants)|Withdrawal by Subject|1|||
147280731|NCT02819726|531192480|FG003|Part B (All Participants)|Withdrawal by Subject|0|||
147280732|NCT02819726|531192477|FG000|Part B (All Participants)|Protocol non-compliance|0|||
147280733|NCT02819726|531192478|FG001|Part B (All Participants)|Protocol non-compliance|0|||
147280734|NCT02819726|531192479|FG002|Part B (All Participants)|Protocol non-compliance|1|||
147280735|NCT02819726|531192480|FG003|Part B (All Participants)|Protocol non-compliance|0|||
147280736|NCT02613481|531192484|FG000|Overall Study|Lost to Follow-up|7|||
147280737|NCT02613481|531192484|FG000|Overall Study|Withdrawal by Subject|2|||
147280738|NCT01033747|531192485|FG000|Overall Study|Adverse Event|9|||
147280739|NCT01033747|531192486|FG001|Overall Study|Adverse Event|4|||
147280740|NCT01033747|531192485|FG000|Overall Study|Abnormal Laboratory Value|1|||
147280741|NCT01033747|531192486|FG001|Overall Study|Abnormal Laboratory Value|0|||
147280742|NCT01033747|531192485|FG000|Overall Study|Abnormal test procedure|0|||
147280743|NCT01033747|531192486|FG001|Overall Study|Abnormal test procedure|1|||
147280744|NCT01033747|531192485|FG000|Overall Study|Unsatisfactory therapeutic effect|14|||
147280745|NCT01033747|531192486|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
147280746|NCT01033747|531192485|FG000|Overall Study|Protocol Violation|1|||
147280747|NCT01033747|531192486|FG001|Overall Study|Protocol Violation|0|||
147280748|NCT01033747|531192485|FG000|Overall Study|Withdrawal by Subject|9|||
147280749|NCT01033747|531192486|FG001|Overall Study|Withdrawal by Subject|6|||
147280750|NCT01033747|531192485|FG000|Overall Study|Stopped at end of prolongation visit 1|1|||
147280751|NCT01033747|531192486|FG001|Overall Study|Stopped at end of prolongation visit 1|0|||
147280752|NCT01033747|531192485|FG000|Overall Study|Stopped at end of Extension 1|2|||
147280753|NCT01033747|531192486|FG001|Overall Study|Stopped at end of Extension 1|0|||
147280754|NCT02647658|531192487|FG000|Overall Study|Consent refusal|15|||
147280755|NCT02647658|531192488|FG001|Overall Study|Consent refusal|24|||
147280756|NCT00803023|531192489|FG000|Overall Study|Adverse Event|5|||
147280757|NCT00803023|531192490|FG001|Overall Study|Adverse Event|4|||
147280758|NCT00803023|531192491|FG002|Overall Study|Adverse Event|8|||
147280759|NCT00803023|531192492|FG003|Overall Study|Adverse Event|6|||
147280760|NCT00803023|531192489|FG000|Overall Study|Withdrawal by Subject|0|||
147602210|NCT03233230|532360721|FG001|Overall Study|Withdrawal by Subject|2|||
147280761|NCT00803023|531192490|FG001|Overall Study|Withdrawal by Subject|2|||
147280762|NCT00803023|531192491|FG002|Overall Study|Withdrawal by Subject|0|||
147280763|NCT00803023|531192492|FG003|Overall Study|Withdrawal by Subject|0|||
147280764|NCT00803023|531192489|FG000|Overall Study|Lost to Follow-up|0|||
147280765|NCT00803023|531192490|FG001|Overall Study|Lost to Follow-up|1|||
147280766|NCT00803023|531192491|FG002|Overall Study|Lost to Follow-up|2|||
147602211|NCT03233230|532360722|FG002|Overall Study|Withdrawal by Subject|0|||
147602212|NCT03233230|532360723|FG003|Overall Study|Withdrawal by Subject|1|||
147602213|NCT03233230|532360720|FG000|Overall Study|Lost to Follow-up|0|||
147602214|NCT03233230|532360721|FG001|Overall Study|Lost to Follow-up|3|||
147602215|NCT03233230|532360722|FG002|Overall Study|Lost to Follow-up|0|||
147602216|NCT03233230|532360723|FG003|Overall Study|Lost to Follow-up|0|||
147602217|NCT01584843|532360724|FG000|First Treatment Period|Adverse Event|0|||
147602218|NCT01584843|532360725|FG001|First Treatment Period|Adverse Event|0|||
147602219|NCT01584843|532360726|FG002|First Treatment Period|Adverse Event|1|||
147602220|NCT01584843|532360727|FG003|First Treatment Period|Adverse Event|0|||
147602221|NCT01584843|532360728|FG004|First Treatment Period|Adverse Event|0|||
147602222|NCT01584843|532360729|FG005|First Treatment Period|Adverse Event|0|||
147602223|NCT01584843|532360724|FG000|First Treatment Period|Protocol Violation|0|||
147602224|NCT01584843|532360725|FG001|First Treatment Period|Protocol Violation|0|||
147602225|NCT01584843|532360726|FG002|First Treatment Period|Protocol Violation|0|||
147602226|NCT01584843|532360727|FG003|First Treatment Period|Protocol Violation|0|||
147602227|NCT01584843|532360728|FG004|First Treatment Period|Protocol Violation|0|||
147602228|NCT01584843|532360729|FG005|First Treatment Period|Protocol Violation|1|||
147602229|NCT01584843|532360724|FG000|First Treatment Period|Met Protocol-defined Stopping Criteria|0|||
147602230|NCT01584843|532360725|FG001|First Treatment Period|Met Protocol-defined Stopping Criteria|0|||
147602231|NCT01584843|532360726|FG002|First Treatment Period|Met Protocol-defined Stopping Criteria|0|||
147602232|NCT01584843|532360727|FG003|First Treatment Period|Met Protocol-defined Stopping Criteria|0|||
147602233|NCT01584843|532360728|FG004|First Treatment Period|Met Protocol-defined Stopping Criteria|0|||
147602234|NCT01584843|532360729|FG005|First Treatment Period|Met Protocol-defined Stopping Criteria|1|||
147602235|NCT01584843|532360724|FG000|Second Treatment Period|Withdrawal by Subject|0|||
147602236|NCT01584843|532360725|FG001|Second Treatment Period|Withdrawal by Subject|0|||
147602237|NCT01584843|532360726|FG002|Second Treatment Period|Withdrawal by Subject|0|||
147280767|NCT00803023|531192492|FG003|Overall Study|Lost to Follow-up|1|||
147280768|NCT00803023|531192489|FG000|Overall Study|Lack of Efficacy|0|||
147280769|NCT00803023|531192490|FG001|Overall Study|Lack of Efficacy|1|||
147280770|NCT00803023|531192491|FG002|Overall Study|Lack of Efficacy|1|||
147451170|NCT05048719|531814816|FG002|Overall Study|Withdrawal by Subject|3|||
147451171|NCT05048719|531814817|FG003|Overall Study|Withdrawal by Subject|1|||
147451172|NCT05048719|531814818|FG004|Overall Study|Withdrawal by Subject|0|||
147451173|NCT05048719|531814819|FG005|Overall Study|Withdrawal by Subject|2|||
147451174|NCT05048719|531814820|FG006|Overall Study|Withdrawal by Subject|1|||
147451175|NCT05048719|531814821|FG007|Overall Study|Withdrawal by Subject|1|||
147451176|NCT05048719|531814822|FG008|Overall Study|Withdrawal by Subject|0|||
147451177|NCT05048719|531814814|FG000|Overall Study|Death|1|||
147451178|NCT05048719|531814815|FG001|Overall Study|Death|0|||
147280771|NCT00803023|531192492|FG003|Overall Study|Lack of Efficacy|1|||
147280772|NCT01542528|531192493|FG000|Overall Study|Lost to Follow-up|2|||
147280773|NCT01542528|531192494|FG001|Overall Study|Lost to Follow-up|1|||
147280774|NCT01542528|531192493|FG000|Overall Study|Physician Decision|1|||
147280775|NCT01542528|531192494|FG001|Overall Study|Physician Decision|0|||
147280776|NCT01542528|531192493|FG000|Overall Study|Withdrawal by Subject|9|||
147280777|NCT01542528|531192494|FG001|Overall Study|Withdrawal by Subject|6|||
147280778|NCT04382326|531192501|FG000|Overall Study|Adverse Event, not serious|1|||
147280779|NCT04382326|531192502|FG001|Overall Study|Adverse Event, not serious|2|||
147451179|NCT05048719|531814816|FG002|Overall Study|Death|0|||
147451180|NCT05048719|531814817|FG003|Overall Study|Death|0|||
147451181|NCT05048719|531814818|FG004|Overall Study|Death|0|||
147602238|NCT01584843|532360727|FG003|Second Treatment Period|Withdrawal by Subject|0|||
147602239|NCT01584843|532360728|FG004|Second Treatment Period|Withdrawal by Subject|0|||
147602240|NCT01584843|532360729|FG005|Second Treatment Period|Withdrawal by Subject|1|||
147602241|NCT04126213|532360730|FG000|Overall Study|Lost to Follow-up|9|||
147602242|NCT04126213|532360731|FG001|Overall Study|Lost to Follow-up|1|||
147602243|NCT04126213|532360732|FG002|Overall Study|Lost to Follow-up|5|||
147602244|NCT04126213|532360733|FG003|Overall Study|Lost to Follow-up|10|||
147602245|NCT04126213|532360734|FG004|Overall Study|Lost to Follow-up|4|||
147280780|NCT04382326|531192501|FG000|Overall Study|Other|1|||
147280781|NCT04382326|531192502|FG001|Overall Study|Other|0|||
147280782|NCT04382326|531192501|FG000|Overall Study|Withdrawal By Parent/Guardian|50|||
147280783|NCT04382326|531192502|FG001|Overall Study|Withdrawal By Parent/Guardian|54|||
147280784|NCT04382326|531192501|FG000|Overall Study|No Longer Meets Eligibility Criteria|50|||
147280785|NCT04382326|531192502|FG001|Overall Study|No Longer Meets Eligibility Criteria|44|||
147280786|NCT04382326|531192501|FG000|Overall Study|Protocol Violation|29|||
147280787|NCT04382326|531192502|FG001|Overall Study|Protocol Violation|23|||
147280788|NCT04382326|531192501|FG000|Overall Study|Physician Decision|0|||
147280789|NCT04382326|531192502|FG001|Overall Study|Physician Decision|1|||
147280790|NCT04382326|531192501|FG000|Overall Study|Lost to Follow-up|48|||
147280791|NCT04382326|531192502|FG001|Overall Study|Lost to Follow-up|63|||
147451182|NCT05048719|531814819|FG005|Overall Study|Death|0|||
147280792|NCT04382326|531192501|FG000|Overall Study|Adverse Event, non-fatal|1|||
147451183|NCT05048719|531814820|FG006|Overall Study|Death|0|||
147602246|NCT04126213|532360735|FG005|Overall Study|Lost to Follow-up|7|||
147602247|NCT04126213|532360730|FG000|Overall Study|Withdrawal by Subject|3|||
147335290|NCT04001829|531395313|FG000|Overall Study|Disease progression/relapse|2|||
147280793|NCT04382326|531192502|FG001|Overall Study|Adverse Event, non-fatal|1|||
147280794|NCT01762761|531192503|FG000|Overall Study|Adverse Event|15|||
147280795|NCT01762761|531192504|FG001|Overall Study|Adverse Event|17|||
147280796|NCT01762761|531192503|FG000|Overall Study|Lack of Efficacy|9|||
147280797|NCT01762761|531192504|FG001|Overall Study|Lack of Efficacy|25|||
147280798|NCT01762761|531192503|FG000|Overall Study|Protocol Violation|1|||
147280799|NCT01762761|531192504|FG001|Overall Study|Protocol Violation|1|||
147280800|NCT01762761|531192503|FG000|Overall Study|Study closed/terminated|0|||
147280801|NCT01762761|531192504|FG001|Overall Study|Study closed/terminated|2|||
147280802|NCT01762761|531192503|FG000|Overall Study|Lost to Follow-up|3|||
147280803|NCT01762761|531192504|FG001|Overall Study|Lost to Follow-up|6|||
147280804|NCT01762761|531192503|FG000|Overall Study|Physician Decision|4|||
147280805|NCT01762761|531192504|FG001|Overall Study|Physician Decision|6|||
147280806|NCT01762761|531192503|FG000|Overall Study|Withdrawal by Subject|7|||
147280807|NCT01762761|531192504|FG001|Overall Study|Withdrawal by Subject|8|||
147280808|NCT00534352|531192509|FG000|Treatment A: TMC125 + TDF/FTC|Physician Decision|1|||
147280809|NCT00534352|531192509|FG000|Treatment A: TMC125 + TDF/FTC|Lost to Follow-up|1|||
147280810|NCT00534352|531192509|FG000|Treatment C: DRV/Rtv + TDF/FTC|Physician Decision|1|||
147280811|NCT00534352|531192509|FG000|Optional Extension: DRV/Rtv + TDF/FTC|Physician Decision|1|||
147280812|NCT00534352|531192509|FG000|Optional Extension: DRV/Rtv + TDF/FTC|Lost to Follow-up|2|||
147280813|NCT00534352|531192509|FG000|Optional Extension: DRV/Rtv + TDF/FTC|Pregnancy|1|||
147280814|NCT04788147|531192510|FG000|Overall Study|Screen Failure|3|||
147280815|NCT04788147|531192511|FG001|Overall Study|Screen Failure|10|||
147280816|NCT04788147|531192510|FG000|Overall Study|Incomplete RMRS image session|2|||
147280817|NCT04788147|531192511|FG001|Overall Study|Incomplete RMRS image session|0|||
147280818|NCT00781326|531192514|FG000|Phase I|Adverse Event|1|||
147280819|NCT00781326|531192514|FG000|Phase I|Withdrawal by Subject|1|||
147280820|NCT00781326|531192514|FG000|Phase I|Physician Decision|2|||
147280821|NCT02401672|531192517|FG000|Overall Study|Withdrawal by Subject|1|||
147280822|NCT02401672|531192518|FG001|Overall Study|Withdrawal by Subject|3|||
147280823|NCT04796610|531192519|FG000|Overall Study|Withdrawal by Subject|1|||
147280824|NCT04796610|531192520|FG001|Overall Study|Withdrawal by Subject|0|||
147280825|NCT04796610|531192521|FG002|Overall Study|Withdrawal by Subject|0|||
147280826|NCT04796610|531192522|FG003|Overall Study|Withdrawal by Subject|0|||
147280827|NCT04796610|531192519|FG000|Overall Study|Lost to Follow-up|2|||
147280828|NCT04796610|531192520|FG001|Overall Study|Lost to Follow-up|0|||
147280829|NCT04796610|531192521|FG002|Overall Study|Lost to Follow-up|1|||
147280830|NCT04796610|531192522|FG003|Overall Study|Lost to Follow-up|1|||
147280831|NCT01410110|531192523|FG000|Overall Study|Withdrawal by Subject|4|||
147280832|NCT01410110|531192524|FG001|Overall Study|Withdrawal by Subject|2|||
147280833|NCT05061446|531192533|FG000|Overall Study|Adverse Event|2|||
147280834|NCT05061446|531192534|FG001|Overall Study|Adverse Event|0|||
147280835|NCT05061446|531192535|FG002|Overall Study|Adverse Event|0|||
147335291|NCT04001829|531395314|FG001|Overall Study|Disease progression/relapse|1|||
147335292|NCT04001829|531395313|FG000|Overall Study|Other complicating disease|1|||
147335293|NCT04001829|531395314|FG001|Overall Study|Other complicating disease|0|||
147335294|NCT04001829|531395313|FG000|Overall Study|Withdrawal by Subject|1|||
147335295|NCT04001829|531395314|FG001|Overall Study|Withdrawal by Subject|4|||
147335296|NCT04001829|531395313|FG000|Overall Study|Ineligible|2|||
147335297|NCT04001829|531395314|FG001|Overall Study|Ineligible|2|||
147335298|NCT04001829|531395313|FG000|Overall Study|Reason missing due to delinquent data|1|||
147335299|NCT04001829|531395314|FG001|Overall Study|Reason missing due to delinquent data|0|||
147335300|NCT05011396|531395315|FG000|Overall Study|Lost to Follow-up|3|||
147602248|NCT04126213|532360731|FG001|Overall Study|Withdrawal by Subject|2|||
147602249|NCT04126213|532360732|FG002|Overall Study|Withdrawal by Subject|1|||
147602250|NCT04126213|532360733|FG003|Overall Study|Withdrawal by Subject|1|||
147602251|NCT04126213|532360734|FG004|Overall Study|Withdrawal by Subject|1|||
147280836|NCT05061446|531192533|FG000|Overall Study|Participant no longer available due to personal reason|0|||
147280837|NCT05061446|531192534|FG001|Overall Study|Participant no longer available due to personal reason|1|||
147280838|NCT05061446|531192535|FG002|Overall Study|Participant no longer available due to personal reason|0|||
147280839|NCT02799082|531192538|FG000|Overall Study|Refused second PDT or withdraw consent|4|||
147280840|NCT02799082|531192539|FG001|Overall Study|Refused second PDT or withdraw consent|3|||
147280841|NCT02799082|531192538|FG000|Overall Study|Protocol Violation|0|||
147280842|NCT02799082|531192539|FG001|Overall Study|Protocol Violation|1|||
147280843|NCT04496258|531192540|FG000|Overall Study|Withdrawal by Subject|2|||
147280844|NCT04496258|531192541|FG001|Overall Study|Withdrawal by Subject|1|||
147280845|NCT00861341|531192544|FG000|Overall Study|Withdrawal by Subject|2|||
147335301|NCT05011396|531395316|FG001|Overall Study|Lost to Follow-up|1|||
147335302|NCT05011396|531395315|FG000|Overall Study|Withdrawal by Subject|0|||
147335303|NCT05011396|531395316|FG001|Overall Study|Withdrawal by Subject|1|||
147335304|NCT05011396|531395315|FG000|Overall Study|Positive Drug Screen|0|||
147335305|NCT05011396|531395316|FG001|Overall Study|Positive Drug Screen|1|||
147280846|NCT04382612|531192553|FG000|Overall Study|Screen failure - no attempt to use the device|1|||
147280847|NCT01328002|531192554|FG000|Open-Label Period|Inclusion/exclusion criteria not met|66|||
147662530|NCT02513550|532587350|FG005|Post-Treatment Follow-up Period|Early terminated but completed follow-up|0|||
147280848|NCT01328002|531192555|FG001|Open-Label Period|Inclusion/exclusion criteria not met|0|||
147280849|NCT01328002|531192554|FG000|Open-Label Period|Adverse Event|8|||
147280850|NCT01328002|531192555|FG001|Open-Label Period|Adverse Event|0|||
147280851|NCT01328002|531192554|FG000|Open-Label Period|Lack of Efficacy|3|||
147280852|NCT01328002|531192555|FG001|Open-Label Period|Lack of Efficacy|0|||
147280853|NCT01328002|531192554|FG000|Open-Label Period|Protocol Violation|2|||
147280854|NCT01328002|531192555|FG001|Open-Label Period|Protocol Violation|0|||
147280855|NCT01328002|531192554|FG000|Open-Label Period|Withdrawal by Subject|9|||
147280856|NCT01328002|531192555|FG001|Open-Label Period|Withdrawal by Subject|0|||
147280857|NCT01328002|531192554|FG000|Open-Label Period|Lost to Follow-up|6|||
147280858|NCT01328002|531192555|FG001|Open-Label Period|Lost to Follow-up|0|||
147280859|NCT01328002|531192554|FG000|Open-Label Period|Other Reason|2|||
147280860|NCT01328002|531192555|FG001|Open-Label Period|Other Reason|0|||
147280861|NCT01328002|531192554|FG000|Double-Blind Period|Adverse Event|1|||
147280862|NCT01328002|531192555|FG001|Double-Blind Period|Adverse Event|0|||
147280863|NCT01328002|531192554|FG000|Double-Blind Period|Lack of Efficacy|1|||
147280864|NCT01328002|531192555|FG001|Double-Blind Period|Lack of Efficacy|0|||
147280865|NCT03149328|531192556|FG000|Overall Study|Withdrawal by Subject|30|||
147280866|NCT03149328|531192557|FG001|Overall Study|Withdrawal by Subject|26|||
147280867|NCT03149328|531192556|FG000|Overall Study|Changed Dialysis Modality|18|||
147280868|NCT03149328|531192557|FG001|Overall Study|Changed Dialysis Modality|1|||
147280869|NCT03149328|531192556|FG000|Overall Study|Transplant|9|||
147280870|NCT03149328|531192557|FG001|Overall Study|Transplant|1|||
147280871|NCT03149328|531192556|FG000|Overall Study|Lost to Follow-up|25|||
147280872|NCT03149328|531192557|FG001|Overall Study|Lost to Follow-up|16|||
147280873|NCT03149328|531192556|FG000|Overall Study|Left Study Site|1|||
147280874|NCT03149328|531192557|FG001|Overall Study|Left Study Site|2|||
147280875|NCT03149328|531192556|FG000|Overall Study|Language Barrier|1|||
147280876|NCT03149328|531192557|FG001|Overall Study|Language Barrier|0|||
147280877|NCT01306617|531192561|FG000|Overall Study|Adverse Event|1|||
147280878|NCT01306617|531192562|FG001|Overall Study|Adverse Event|0|||
147280879|NCT01306617|531192563|FG002|Overall Study|Adverse Event|0|||
147280880|NCT01306617|531192561|FG000|Overall Study|Virologic Failure|0|||
147280881|NCT01306617|531192562|FG001|Overall Study|Virologic Failure|0|||
147280882|NCT01306617|531192563|FG002|Overall Study|Virologic Failure|5|||
147280883|NCT01306617|531192561|FG000|Overall Study|Non-compliance|0|||
147280884|NCT01306617|531192562|FG001|Overall Study|Non-compliance|1|||
147280885|NCT01306617|531192563|FG002|Overall Study|Non-compliance|0|||
147280886|NCT00766415|531192570|FG000|Overall Study|Withdrawal by Subject|0|||
147280887|NCT00766415|531192571|FG001|Overall Study|Withdrawal by Subject|1|||
147280888|NCT01114516|531192572|FG000|Overall Study|Lost to Follow-up|2|||
147280889|NCT01114516|531192573|FG001|Overall Study|Lost to Follow-up|1|||
147280890|NCT00061048|531192574|FG000|Overall Study|Adverse Event|2|||
147280891|NCT00061048|531192574|FG000|Overall Study|disease progression|20|||
147280892|NCT01632579|531192576|FG000|Washout Period|Adverse Event|1|||
147280893|NCT01632579|531192577|FG001|Washout Period|Adverse Event|0|||
147280894|NCT01632579|531192578|FG002|Washout Period|Adverse Event|0|||
147280895|NCT01632579|531192579|FG003|Washout Period|Adverse Event|0|||
147280896|NCT01632579|531192580|FG004|Washout Period|Adverse Event|0|||
147280897|NCT01632579|531192581|FG005|Washout Period|Adverse Event|0|||
147280898|NCT01632579|531192582|FG006|Washout Period|Adverse Event|0|||
147280899|NCT01632579|531192583|FG007|Washout Period|Adverse Event|0|||
147280900|NCT01632579|531192584|FG008|Washout Period|Adverse Event|0|||
147280901|NCT01632579|531192576|FG000|Period 2 (Second Intervention)|Adverse Event|1|||
147280902|NCT01632579|531192577|FG001|Period 2 (Second Intervention)|Adverse Event|0|||
147280903|NCT01632579|531192578|FG002|Period 2 (Second Intervention)|Adverse Event|0|||
147280904|NCT01632579|531192579|FG003|Period 2 (Second Intervention)|Adverse Event|0|||
147280905|NCT01632579|531192580|FG004|Period 2 (Second Intervention)|Adverse Event|0|||
147280906|NCT01632579|531192581|FG005|Period 2 (Second Intervention)|Adverse Event|0|||
147280907|NCT01632579|531192582|FG006|Period 2 (Second Intervention)|Adverse Event|0|||
147280908|NCT01632579|531192583|FG007|Period 2 (Second Intervention)|Adverse Event|0|||
147662531|NCT02513550|532587345|FG000|Post-Treatment Follow-up Period|Lost to Follow-up|4|||
147280909|NCT01632579|531192584|FG008|Period 2 (Second Intervention)|Adverse Event|0|||
147280910|NCT03779841|531192585|FG000|Randomized Population|Did Not Receive Treatment|3|||
147280911|NCT03779841|531192586|FG001|Randomized Population|Did Not Receive Treatment|1|||
147280912|NCT03779841|531192587|FG002|Randomized Population|Did Not Receive Treatment|0|||
147280913|NCT03779841|531192585|FG000|Treated (Safety) Population|Adverse Event|1|||
147280914|NCT03779841|531192586|FG001|Treated (Safety) Population|Adverse Event|1|||
147280915|NCT03779841|531192587|FG002|Treated (Safety) Population|Adverse Event|0|||
147280916|NCT03779841|531192585|FG000|Treated (Safety) Population|Withdrawal by Subject|4|||
147280917|NCT03779841|531192586|FG001|Treated (Safety) Population|Withdrawal by Subject|8|||
147280918|NCT03779841|531192587|FG002|Treated (Safety) Population|Withdrawal by Subject|6|||
147280919|NCT03779841|531192585|FG000|Treated (Safety) Population|Lost to Follow-up|5|||
147280920|NCT03779841|531192586|FG001|Treated (Safety) Population|Lost to Follow-up|9|||
147280921|NCT03779841|531192587|FG002|Treated (Safety) Population|Lost to Follow-up|8|||
147280922|NCT03779841|531192585|FG000|Treated (Safety) Population|Death|1|||
147280923|NCT03779841|531192586|FG001|Treated (Safety) Population|Death|0|||
147280924|NCT03779841|531192587|FG002|Treated (Safety) Population|Death|2|||
147280925|NCT00898677|531192588|FG000|Overall Study|Adverse Event|0|||
147280926|NCT00898677|531192589|FG001|Overall Study|Adverse Event|0|||
147280927|NCT00898677|531192590|FG002|Overall Study|Adverse Event|1|||
147280928|NCT00898677|531192591|FG003|Overall Study|Adverse Event|0|||
147280929|NCT00898677|531192588|FG000|Overall Study|Lost to Follow-up|0|||
147280930|NCT00898677|531192589|FG001|Overall Study|Lost to Follow-up|0|||
147280931|NCT00898677|531192590|FG002|Overall Study|Lost to Follow-up|2|||
147280932|NCT00898677|531192591|FG003|Overall Study|Lost to Follow-up|0|||
147280933|NCT00898677|531192588|FG000|Overall Study|Protocol Violation|1|||
147280934|NCT00898677|531192589|FG001|Overall Study|Protocol Violation|1|||
147280935|NCT00898677|531192590|FG002|Overall Study|Protocol Violation|2|||
147280936|NCT00898677|531192591|FG003|Overall Study|Protocol Violation|0|||
147280937|NCT00898677|531192588|FG000|Overall Study|Withdrawal by Subject|0|||
147280938|NCT00898677|531192589|FG001|Overall Study|Withdrawal by Subject|0|||
147280939|NCT00898677|531192590|FG002|Overall Study|Withdrawal by Subject|0|||
147280940|NCT00898677|531192591|FG003|Overall Study|Withdrawal by Subject|1|||
147280941|NCT00898677|531192588|FG000|Overall Study|Not Treated: Adverse Event|0|||
147280942|NCT00898677|531192589|FG001|Overall Study|Not Treated: Adverse Event|2|||
147280943|NCT00898677|531192590|FG002|Overall Study|Not Treated: Adverse Event|1|||
147280944|NCT00898677|531192591|FG003|Overall Study|Not Treated: Adverse Event|0|||
147280945|NCT00898677|531192588|FG000|Overall Study|Not Treated: Lost to Follow-Up|0|||
147280946|NCT00898677|531192589|FG001|Overall Study|Not Treated: Lost to Follow-Up|5|||
147280947|NCT00898677|531192590|FG002|Overall Study|Not Treated: Lost to Follow-Up|5|||
147280948|NCT00898677|531192591|FG003|Overall Study|Not Treated: Lost to Follow-Up|2|||
147280949|NCT00898677|531192588|FG000|Overall Study|Not Treated: Pregnancy|0|||
147280950|NCT00898677|531192589|FG001|Overall Study|Not Treated: Pregnancy|0|||
147280951|NCT00898677|531192590|FG002|Overall Study|Not Treated: Pregnancy|1|||
147280952|NCT00898677|531192591|FG003|Overall Study|Not Treated: Pregnancy|0|||
147280953|NCT00898677|531192588|FG000|Overall Study|Not Treated: Protocol Violation|2|||
147280954|NCT00898677|531192589|FG001|Overall Study|Not Treated: Protocol Violation|0|||
147280955|NCT00898677|531192590|FG002|Overall Study|Not Treated: Protocol Violation|2|||
147280956|NCT00898677|531192591|FG003|Overall Study|Not Treated: Protocol Violation|0|||
147335306|NCT03253848|531395317|FG000|Overall Study|Adverse Event|7|||
147335307|NCT03253848|531395317|FG000|Overall Study|Death|5|||
147335308|NCT03253848|531395317|FG000|Overall Study|initiation of other treatments|3|||
147335309|NCT03253848|531395317|FG000|Overall Study|Other complicating disease|1|||
147335310|NCT03253848|531395317|FG000|Overall Study|Withdrawal by Subject|1|||
147335311|NCT03253848|531395317|FG000|Overall Study|Declining health|1|||
147335312|NCT04480827|531395319|FG000|Overall Study|Adverse Event|0|||
147335313|NCT04480827|531395320|FG001|Overall Study|Adverse Event|0|||
147335314|NCT04480827|531395321|FG002|Overall Study|Adverse Event|0|||
147335315|NCT04480827|531395322|FG003|Overall Study|Adverse Event|0|||
147335316|NCT04480827|531395323|FG004|Overall Study|Adverse Event|0|||
147451184|NCT05048719|531814821|FG007|Overall Study|Death|0|||
147451185|NCT05048719|531814822|FG008|Overall Study|Death|0|||
147602252|NCT04126213|532360735|FG005|Overall Study|Withdrawal by Subject|1|||
147602253|NCT04126213|532360730|FG000|Overall Study|Other|0|||
147602254|NCT04126213|532360731|FG001|Overall Study|Other|0|||
147602255|NCT04126213|532360732|FG002|Overall Study|Other|2|||
147602256|NCT04126213|532360733|FG003|Overall Study|Other|2|||
147602257|NCT04126213|532360734|FG004|Overall Study|Other|0|||
147602258|NCT04126213|532360735|FG005|Overall Study|Other|1|||
147602259|NCT04126213|532360730|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
147602260|NCT04126213|532360731|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
147602261|NCT04126213|532360732|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
147602262|NCT04126213|532360733|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
147602263|NCT04126213|532360734|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
147602264|NCT04126213|532360735|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
147602265|NCT02853370|532360738|FG000|Overall Study|Physician Decision|1|||
147335317|NCT04480827|531395324|FG005|Overall Study|Adverse Event|1|||
147335318|NCT04480827|531395325|FG006|Overall Study|Adverse Event|0|||
147662532|NCT02513550|532587346|FG001|Post-Treatment Follow-up Period|Lost to Follow-up|2|||
147662533|NCT02513550|532587347|FG002|Post-Treatment Follow-up Period|Lost to Follow-up|7|||
147280957|NCT00898677|531192588|FG000|Overall Study|Not Treated: Withdraw by Subject|2|||
147335319|NCT04218110|531395326|FG000|Overall Study|Withdrawal by Subject|0|||
147602266|NCT02853370|532360738|FG000|Overall Study|Lack of Efficacy|2|||
147602267|NCT02853370|532360738|FG000|Overall Study|Death|1|||
147602268|NCT02853370|532360738|FG000|Overall Study|Adverse Event|4|||
147602269|NCT02853370|532360738|FG000|Overall Study|Withdrawal by Subject|3|||
147280958|NCT00898677|531192589|FG001|Overall Study|Not Treated: Withdraw by Subject|16|||
147280959|NCT00898677|531192590|FG002|Overall Study|Not Treated: Withdraw by Subject|11|||
147280960|NCT00898677|531192591|FG003|Overall Study|Not Treated: Withdraw by Subject|3|||
147280961|NCT00898677|531192588|FG000|Overall Study|Not Treated: Patient uncooperative|2|||
147280962|NCT00898677|531192589|FG001|Overall Study|Not Treated: Patient uncooperative|3|||
147280963|NCT00898677|531192590|FG002|Overall Study|Not Treated: Patient uncooperative|1|||
147280964|NCT00898677|531192591|FG003|Overall Study|Not Treated: Patient uncooperative|0|||
147280965|NCT00898677|531192588|FG000|Overall Study|Not Treated: Abnormal Prestudy Labs|0|||
147451186|NCT05048719|531814814|FG000|Overall Study|Adverse Event|0|||
147451187|NCT05048719|531814815|FG001|Overall Study|Adverse Event|1|||
147451188|NCT05048719|531814816|FG002|Overall Study|Adverse Event|2|||
147451189|NCT05048719|531814817|FG003|Overall Study|Adverse Event|0|||
147451190|NCT05048719|531814818|FG004|Overall Study|Adverse Event|1|||
147451191|NCT05048719|531814819|FG005|Overall Study|Adverse Event|0|||
147451192|NCT05048719|531814820|FG006|Overall Study|Adverse Event|0|||
147451193|NCT05048719|531814821|FG007|Overall Study|Adverse Event|0|||
147451194|NCT05048719|531814822|FG008|Overall Study|Adverse Event|0|||
147451195|NCT05048719|531814814|FG000|Overall Study|Lost to Follow-up|0|||
147451196|NCT05048719|531814815|FG001|Overall Study|Lost to Follow-up|0|||
147451197|NCT05048719|531814816|FG002|Overall Study|Lost to Follow-up|1|||
147451198|NCT05048719|531814817|FG003|Overall Study|Lost to Follow-up|3|||
147451199|NCT05048719|531814818|FG004|Overall Study|Lost to Follow-up|1|||
147451200|NCT05048719|531814819|FG005|Overall Study|Lost to Follow-up|1|||
147451201|NCT05048719|531814820|FG006|Overall Study|Lost to Follow-up|1|||
147451202|NCT05048719|531814821|FG007|Overall Study|Lost to Follow-up|1|||
147451203|NCT05048719|531814822|FG008|Overall Study|Lost to Follow-up|0|||
147451204|NCT05048719|531814814|FG000|Overall Study|Physician Decision|0|||
147451205|NCT05048719|531814815|FG001|Overall Study|Physician Decision|0|||
147451206|NCT05048719|531814816|FG002|Overall Study|Physician Decision|0|||
147451207|NCT05048719|531814817|FG003|Overall Study|Physician Decision|0|||
147451208|NCT05048719|531814818|FG004|Overall Study|Physician Decision|0|||
147451209|NCT05048719|531814819|FG005|Overall Study|Physician Decision|0|||
147451210|NCT05048719|531814820|FG006|Overall Study|Physician Decision|0|||
147451211|NCT05048719|531814821|FG007|Overall Study|Physician Decision|1|||
147451212|NCT05048719|531814822|FG008|Overall Study|Physician Decision|1|||
147451213|NCT05048719|531814814|FG000|Overall Study|Patient Decision due To Changes in Personal Life|1|||
147451214|NCT05048719|531814815|FG001|Overall Study|Patient Decision due To Changes in Personal Life|0|||
147451215|NCT05048719|531814816|FG002|Overall Study|Patient Decision due To Changes in Personal Life|0|||
147451216|NCT05048719|531814817|FG003|Overall Study|Patient Decision due To Changes in Personal Life|0|||
147451217|NCT05048719|531814818|FG004|Overall Study|Patient Decision due To Changes in Personal Life|0|||
147451218|NCT05048719|531814819|FG005|Overall Study|Patient Decision due To Changes in Personal Life|0|||
147451219|NCT05048719|531814820|FG006|Overall Study|Patient Decision due To Changes in Personal Life|0|||
147451220|NCT05048719|531814821|FG007|Overall Study|Patient Decision due To Changes in Personal Life|0|||
147451221|NCT05048719|531814822|FG008|Overall Study|Patient Decision due To Changes in Personal Life|0|||
147451222|NCT05048719|531814814|FG000|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
147451223|NCT05048719|531814815|FG001|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|1|||
147451224|NCT05048719|531814816|FG002|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
147451225|NCT05048719|531814817|FG003|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
147451226|NCT05048719|531814818|FG004|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
147602270|NCT02196701|532360739|FG000|Overall Study|Adverse Event|1|||
147602271|NCT02196701|532360739|FG000|Overall Study|Lost to Follow-up|1|||
147602272|NCT02196701|532360739|FG000|Overall Study|Non-adherence to Protocol|1|||
147602273|NCT03275064|532360740|FG000|Treatment Period Part A and Part B|PI decision based on poor veins for blood sampling|0|||
147602274|NCT03275064|532360741|FG001|Treatment Period Part A and Part B|PI decision based on poor veins for blood sampling|0|||
147602275|NCT03275064|532360742|FG002|Treatment Period Part A and Part B|PI decision based on poor veins for blood sampling|0|||
147602276|NCT03275064|532360743|FG003|Treatment Period Part A and Part B|PI decision based on poor veins for blood sampling|1|||
147602277|NCT03275064|532360744|FG004|Treatment Period Part A and Part B|PI decision based on poor veins for blood sampling|0|||
147602278|NCT03275064|532360740|FG000|Treatment Period Part A and Part B|Patient discontinued treatment and entered follow-up|1|||
147602279|NCT03275064|532360741|FG001|Treatment Period Part A and Part B|Patient discontinued treatment and entered follow-up|0|||
147602280|NCT03275064|532360742|FG002|Treatment Period Part A and Part B|Patient discontinued treatment and entered follow-up|0|||
147602281|NCT03275064|532360743|FG003|Treatment Period Part A and Part B|Patient discontinued treatment and entered follow-up|0|||
147602282|NCT03275064|532360744|FG004|Treatment Period Part A and Part B|Patient discontinued treatment and entered follow-up|0|||
147602283|NCT03275064|532360740|FG000|Post-treatment Follow-up Parts A and B|Lost to Follow-up|1|||
147602284|NCT03275064|532360741|FG001|Post-treatment Follow-up Parts A and B|Lost to Follow-up|0|||
147602285|NCT03275064|532360742|FG002|Post-treatment Follow-up Parts A and B|Lost to Follow-up|2|||
147602286|NCT03275064|532360743|FG003|Post-treatment Follow-up Parts A and B|Lost to Follow-up|0|||
147602287|NCT03275064|532360744|FG004|Post-treatment Follow-up Parts A and B|Lost to Follow-up|1|||
147602288|NCT03275064|532360740|FG000|Post-treatment Follow-up Parts A and B|No longer required treatment|0|||
147280966|NCT00898677|531192589|FG001|Overall Study|Not Treated: Abnormal Prestudy Labs|0|||
147451227|NCT05048719|531814819|FG005|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
147602289|NCT03275064|532360741|FG001|Post-treatment Follow-up Parts A and B|No longer required treatment|0|||
147602290|NCT03275064|532360742|FG002|Post-treatment Follow-up Parts A and B|No longer required treatment|0|||
147602291|NCT03275064|532360743|FG003|Post-treatment Follow-up Parts A and B|No longer required treatment|1|||
147602292|NCT03275064|532360744|FG004|Post-treatment Follow-up Parts A and B|No longer required treatment|0|||
147602293|NCT03275064|532360740|FG000|Post-treatment Follow-up Parts A and B|Subject/guardian decision|1|||
147602294|NCT03275064|532360741|FG001|Post-treatment Follow-up Parts A and B|Subject/guardian decision|0|||
147602295|NCT03275064|532360742|FG002|Post-treatment Follow-up Parts A and B|Subject/guardian decision|1|||
147602296|NCT03275064|532360743|FG003|Post-treatment Follow-up Parts A and B|Subject/guardian decision|0|||
147602297|NCT03275064|532360744|FG004|Post-treatment Follow-up Parts A and B|Subject/guardian decision|0|||
147602298|NCT00827632|532360745|FG000|Overall Study|Lost to Follow-up|8|||
147602299|NCT00827632|532360746|FG001|Overall Study|Lost to Follow-up|12|||
147602300|NCT00827632|532360745|FG000|Overall Study|Early withdrawal|14|||
147602301|NCT00827632|532360746|FG001|Overall Study|Early withdrawal|11|||
147602302|NCT01898650|532360749|FG000|Overall Study|the subject would not lie still for imaging|1|||
147602303|NCT03923530|532360750|FG000|Overall Study|Withdrawal by Subject|1|||
147335320|NCT04218110|531395327|FG001|Overall Study|Withdrawal by Subject|0|||
147335321|NCT04218110|531395328|FG002|Overall Study|Withdrawal by Subject|0|||
147335322|NCT04218110|531395329|FG003|Overall Study|Withdrawal by Subject|1|||
147335323|NCT00002842|531395330|FG000|Overall Study|ineligible for surgical resection|27|||
147335324|NCT02015546|531395331|FG000|Overall Study|Withdrawal by Subject|1|||
147335325|NCT02015546|531395332|FG001|Overall Study|Withdrawal by Subject|1|||
147602304|NCT03923530|532360750|FG000|Overall Study|screen failure|3|||
147602305|NCT00407758|532360751|FG000|Overall Study|ineligible -improper prior treatment|1|||
147602306|NCT02722148|532360762|FG000|Overall Study|Lost to Follow-up|2|||
147602307|NCT02722148|532360762|FG000|Overall Study|Non compliant with treatment regimen|3|||
147602308|NCT00855803|532360764|FG000|Overall Study|Death|2|||
147602309|NCT00855803|532360764|FG000|Overall Study|Lost to Follow-up|2|||
147602310|NCT00855803|532360764|FG000|Overall Study|Technical inability to undergo procedure|2|||
147602311|NCT00855803|532360764|FG000|Overall Study|Not evaluable at 3 month timepoint|2|||
147335326|NCT02015546|531395333|FG002|Overall Study|Withdrawal by Subject|1|||
147335327|NCT02015546|531395331|FG000|Overall Study|Screem Failure|2|||
147335328|NCT02015546|531395332|FG001|Overall Study|Screem Failure|1|||
147335329|NCT02015546|531395333|FG002|Overall Study|Screem Failure|3|||
147335330|NCT05855655|531395334|FG000|Overall Study|Withdrawal by Subject|0|||
147335331|NCT05855655|531395335|FG001|Overall Study|Withdrawal by Subject|1|||
147335332|NCT05855655|531395334|FG000|Overall Study|Lost to Follow-up|4|||
147335333|NCT05855655|531395335|FG001|Overall Study|Lost to Follow-up|0|||
147335334|NCT01337635|531395337|FG000|Overall Study|Lost to Follow-up|0|||
147335335|NCT01337635|531395338|FG001|Overall Study|Lost to Follow-up|1|||
147335336|NCT01113931|531395339|FG000|Overall Study|Adverse Event|2|||
147335337|NCT01113931|531395340|FG001|Overall Study|Adverse Event|2|||
147335338|NCT01113931|531395339|FG000|Overall Study|Physician Decision|0|||
147335339|NCT01113931|531395340|FG001|Overall Study|Physician Decision|2|||
147335340|NCT01113931|531395339|FG000|Overall Study|Lost to Follow-up|12|||
147335341|NCT01113931|531395340|FG001|Overall Study|Lost to Follow-up|9|||
147335342|NCT01113931|531395339|FG000|Overall Study|Various|2|||
147335343|NCT01113931|531395340|FG001|Overall Study|Various|4|||
147335344|NCT01113931|531395339|FG000|Overall Study|Withdrawal by Subject|3|||
147335345|NCT01113931|531395340|FG001|Overall Study|Withdrawal by Subject|0|||
147335346|NCT01307267|531395343|FG000|Overall Study|Death|4|||
147335347|NCT01307267|531395344|FG001|Overall Study|Death|3|||
147335348|NCT01307267|531395345|FG002|Overall Study|Death|5|||
147335349|NCT01307267|531395346|FG003|Overall Study|Death|3|||
147335350|NCT01307267|531395347|FG004|Overall Study|Death|1|||
147335351|NCT01307267|531395348|FG005|Overall Study|Death|26|||
147335352|NCT01307267|531395349|FG006|Overall Study|Death|2|||
147335353|NCT01307267|531395350|FG007|Overall Study|Death|2|||
147335354|NCT01307267|531395351|FG008|Overall Study|Death|21|||
147335355|NCT01307267|531395352|FG009|Overall Study|Death|2|||
147335356|NCT01307267|531395353|FG010|Overall Study|Death|3|||
147335357|NCT01307267|531395354|FG011|Overall Study|Death|9|||
147335358|NCT01307267|531395355|FG012|Overall Study|Death|0|||
147451228|NCT05048719|531814820|FG006|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
147602312|NCT00855803|532360764|FG000|Overall Study|Withdrawal by Subject|3|||
147602313|NCT00855803|532360764|FG000|Overall Study|Physician Decision|3|||
147602314|NCT00809159|532360765|FG000|Part 1|Adverse Event|1|||
147335359|NCT01307267|531395356|FG013|Overall Study|Death|0|||
147335360|NCT01307267|531395357|FG014|Overall Study|Death|0|||
147335361|NCT01307267|531395358|FG015|Overall Study|Death|0|||
147335362|NCT01307267|531395359|FG016|Overall Study|Death|1|||
147335363|NCT01307267|531395360|FG017|Overall Study|Death|1|||
147335364|NCT01307267|531395361|FG018|Overall Study|Death|2|||
147335365|NCT01307267|531395362|FG019|Overall Study|Death|8|||
147335366|NCT01307267|531395363|FG020|Overall Study|Death|1|||
147335367|NCT01307267|531395364|FG021|Overall Study|Death|2|||
147335368|NCT01307267|531395365|FG022|Overall Study|Death|2|||
147335369|NCT01307267|531395343|FG000|Overall Study|Lost to Follow-up|0|||
147335370|NCT01307267|531395344|FG001|Overall Study|Lost to Follow-up|0|||
147335371|NCT01307267|531395345|FG002|Overall Study|Lost to Follow-up|0|||
147335372|NCT01307267|531395346|FG003|Overall Study|Lost to Follow-up|0|||
147335373|NCT01307267|531395347|FG004|Overall Study|Lost to Follow-up|0|||
147335374|NCT01307267|531395348|FG005|Overall Study|Lost to Follow-up|7|||
147335375|NCT01307267|531395349|FG006|Overall Study|Lost to Follow-up|0|||
147335376|NCT01307267|531395350|FG007|Overall Study|Lost to Follow-up|0|||
147335377|NCT01307267|531395351|FG008|Overall Study|Lost to Follow-up|1|||
147335378|NCT01307267|531395352|FG009|Overall Study|Lost to Follow-up|2|||
147335379|NCT01307267|531395353|FG010|Overall Study|Lost to Follow-up|1|||
147335380|NCT01307267|531395354|FG011|Overall Study|Lost to Follow-up|0|||
147335381|NCT01307267|531395355|FG012|Overall Study|Lost to Follow-up|0|||
147335382|NCT01307267|531395356|FG013|Overall Study|Lost to Follow-up|0|||
147335383|NCT01307267|531395357|FG014|Overall Study|Lost to Follow-up|0|||
147335384|NCT01307267|531395358|FG015|Overall Study|Lost to Follow-up|0|||
147335385|NCT01307267|531395359|FG016|Overall Study|Lost to Follow-up|0|||
147335386|NCT01307267|531395360|FG017|Overall Study|Lost to Follow-up|0|||
147335387|NCT01307267|531395361|FG018|Overall Study|Lost to Follow-up|0|||
147335388|NCT01307267|531395362|FG019|Overall Study|Lost to Follow-up|2|||
147335389|NCT01307267|531395363|FG020|Overall Study|Lost to Follow-up|0|||
147335390|NCT01307267|531395364|FG021|Overall Study|Lost to Follow-up|0|||
147335391|NCT01307267|531395365|FG022|Overall Study|Lost to Follow-up|0|||
147335392|NCT01307267|531395343|FG000|Overall Study|Withdrawal by Subject|0|||
147335393|NCT01307267|531395344|FG001|Overall Study|Withdrawal by Subject|0|||
147335394|NCT01307267|531395345|FG002|Overall Study|Withdrawal by Subject|0|||
147335395|NCT01307267|531395346|FG003|Overall Study|Withdrawal by Subject|0|||
147335396|NCT01307267|531395347|FG004|Overall Study|Withdrawal by Subject|0|||
147335397|NCT01307267|531395348|FG005|Overall Study|Withdrawal by Subject|1|||
147335398|NCT01307267|531395349|FG006|Overall Study|Withdrawal by Subject|0|||
147335399|NCT01307267|531395350|FG007|Overall Study|Withdrawal by Subject|1|||
147335400|NCT01307267|531395351|FG008|Overall Study|Withdrawal by Subject|5|||
147335401|NCT01307267|531395352|FG009|Overall Study|Withdrawal by Subject|1|||
147335402|NCT01307267|531395353|FG010|Overall Study|Withdrawal by Subject|1|||
147602315|NCT00809159|532360766|FG001|Part 1|Adverse Event|1|||
147602316|NCT00809159|532360767|FG002|Part 1|Adverse Event|0|||
147602317|NCT00809159|532360768|FG003|Part 1|Adverse Event|0|||
147602318|NCT00809159|532360769|FG004|Part 1|Adverse Event|0|||
147602319|NCT00809159|532360770|FG005|Part 1|Adverse Event|0|||
147602320|NCT00809159|532360765|FG000|Part 1|Lost to Follow-up|1|||
147602321|NCT00809159|532360766|FG001|Part 1|Lost to Follow-up|0|||
147602322|NCT00809159|532360767|FG002|Part 1|Lost to Follow-up|0|||
147602323|NCT00809159|532360768|FG003|Part 1|Lost to Follow-up|0|||
147602324|NCT00809159|532360769|FG004|Part 1|Lost to Follow-up|0|||
147602325|NCT00809159|532360770|FG005|Part 1|Lost to Follow-up|0|||
147602326|NCT00809159|532360765|FG000|Part 1|Withdrawal by Subject|3|||
147602327|NCT00809159|532360766|FG001|Part 1|Withdrawal by Subject|1|||
147602328|NCT00809159|532360767|FG002|Part 1|Withdrawal by Subject|0|||
147602329|NCT00809159|532360768|FG003|Part 1|Withdrawal by Subject|0|||
147602330|NCT00809159|532360769|FG004|Part 1|Withdrawal by Subject|0|||
147602331|NCT00809159|532360770|FG005|Part 1|Withdrawal by Subject|0|||
147602332|NCT00809159|532360765|FG000|Part 1|Unsatisfactory therapeutic effect|3|||
147602333|NCT00809159|532360766|FG001|Part 1|Unsatisfactory therapeutic effect|1|||
147602334|NCT00809159|532360767|FG002|Part 1|Unsatisfactory therapeutic effect|0|||
147602335|NCT00809159|532360768|FG003|Part 1|Unsatisfactory therapeutic effect|0|||
147602336|NCT00809159|532360769|FG004|Part 1|Unsatisfactory therapeutic effect|0|||
147602337|NCT00809159|532360770|FG005|Part 1|Unsatisfactory therapeutic effect|0|||
147602338|NCT00809159|532360765|FG000|Part 1 and 2|Unsatisfactory therapeutic effect|0|||
147602339|NCT00809159|532360766|FG001|Part 1 and 2|Unsatisfactory therapeutic effect|0|||
147602340|NCT00809159|532360767|FG002|Part 1 and 2|Unsatisfactory therapeutic effect|4|||
147602341|NCT00809159|532360768|FG003|Part 1 and 2|Unsatisfactory therapeutic effect|3|||
147335403|NCT01307267|531395354|FG011|Overall Study|Withdrawal by Subject|1|||
147335404|NCT01307267|531395355|FG012|Overall Study|Withdrawal by Subject|0|||
147335405|NCT01307267|531395356|FG013|Overall Study|Withdrawal by Subject|0|||
147335406|NCT01307267|531395357|FG014|Overall Study|Withdrawal by Subject|0|||
147335407|NCT01307267|531395358|FG015|Overall Study|Withdrawal by Subject|0|||
147335408|NCT01307267|531395359|FG016|Overall Study|Withdrawal by Subject|0|||
147335409|NCT01307267|531395360|FG017|Overall Study|Withdrawal by Subject|0|||
147335410|NCT01307267|531395361|FG018|Overall Study|Withdrawal by Subject|0|||
147335411|NCT01307267|531395362|FG019|Overall Study|Withdrawal by Subject|3|||
147335412|NCT01307267|531395363|FG020|Overall Study|Withdrawal by Subject|0|||
147335413|NCT01307267|531395364|FG021|Overall Study|Withdrawal by Subject|0|||
147335414|NCT01307267|531395365|FG022|Overall Study|Withdrawal by Subject|0|||
147335415|NCT01307267|531395343|FG000|Overall Study|Other|0|||
147335416|NCT01307267|531395344|FG001|Overall Study|Other|0|||
147335417|NCT01307267|531395345|FG002|Overall Study|Other|0|||
147335418|NCT01307267|531395346|FG003|Overall Study|Other|0|||
147602342|NCT00809159|532360769|FG004|Part 1 and 2|Unsatisfactory therapeutic effect|5|||
147602343|NCT00809159|532360770|FG005|Part 1 and 2|Unsatisfactory therapeutic effect|1|||
147602344|NCT00809159|532360765|FG000|Part 1 and 2|Administrative problems|0|||
147280967|NCT00898677|531192590|FG002|Overall Study|Not Treated: Abnormal Prestudy Labs|0|||
147280968|NCT00898677|531192591|FG003|Overall Study|Not Treated: Abnormal Prestudy Labs|1|||
147280969|NCT00898677|531192588|FG000|Overall Study|Not Treated: Abnormal Baseline ECG|1|||
147280970|NCT00898677|531192589|FG001|Overall Study|Not Treated: Abnormal Baseline ECG|0|||
147280971|NCT00898677|531192590|FG002|Overall Study|Not Treated: Abnormal Baseline ECG|0|||
147280972|NCT00898677|531192591|FG003|Overall Study|Not Treated: Abnormal Baseline ECG|0|||
147280973|NCT00898677|531192588|FG000|Overall Study|Not Treated: No Longer Met Inc Criteria|0|||
147280974|NCT00898677|531192589|FG001|Overall Study|Not Treated: No Longer Met Inc Criteria|3|||
147280975|NCT00898677|531192590|FG002|Overall Study|Not Treated: No Longer Met Inc Criteria|1|||
147280976|NCT00898677|531192591|FG003|Overall Study|Not Treated: No Longer Met Inc Criteria|0|||
147335419|NCT01307267|531395347|FG004|Overall Study|Other|0|||
147335420|NCT01307267|531395348|FG005|Overall Study|Other|7|||
147335421|NCT01307267|531395349|FG006|Overall Study|Other|0|||
147335422|NCT01307267|531395350|FG007|Overall Study|Other|1|||
147335423|NCT01307267|531395351|FG008|Overall Study|Other|3|||
147335424|NCT01307267|531395352|FG009|Overall Study|Other|0|||
147335425|NCT01307267|531395353|FG010|Overall Study|Other|1|||
147335426|NCT01307267|531395354|FG011|Overall Study|Other|1|||
147451229|NCT05048719|531814821|FG007|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
147602345|NCT00809159|532360766|FG001|Part 1 and 2|Administrative problems|0|||
147602346|NCT00809159|532360767|FG002|Part 1 and 2|Administrative problems|0|||
147602347|NCT00809159|532360768|FG003|Part 1 and 2|Administrative problems|1|||
147602348|NCT00809159|532360769|FG004|Part 1 and 2|Administrative problems|0|||
147602349|NCT00809159|532360770|FG005|Part 1 and 2|Administrative problems|0|||
147602350|NCT00809159|532360765|FG000|Part 1 and 2|Adverse Event|0|||
147602351|NCT00809159|532360766|FG001|Part 1 and 2|Adverse Event|0|||
147602352|NCT00809159|532360767|FG002|Part 1 and 2|Adverse Event|1|||
147602353|NCT00809159|532360768|FG003|Part 1 and 2|Adverse Event|0|||
147602354|NCT00809159|532360769|FG004|Part 1 and 2|Adverse Event|1|||
147602355|NCT00809159|532360770|FG005|Part 1 and 2|Adverse Event|1|||
147602356|NCT00809159|532360765|FG000|Part 1 and 2|Lost to Follow-up|0|||
147602357|NCT00809159|532360766|FG001|Part 1 and 2|Lost to Follow-up|0|||
147602358|NCT00809159|532360767|FG002|Part 1 and 2|Lost to Follow-up|1|||
147602359|NCT00809159|532360768|FG003|Part 1 and 2|Lost to Follow-up|1|||
147602360|NCT00809159|532360769|FG004|Part 1 and 2|Lost to Follow-up|0|||
147602361|NCT00809159|532360770|FG005|Part 1 and 2|Lost to Follow-up|0|||
147602362|NCT00809159|532360765|FG000|Part 1 and 2|Withdrawal by Subject|0|||
147602363|NCT00809159|532360766|FG001|Part 1 and 2|Withdrawal by Subject|0|||
147602364|NCT00809159|532360767|FG002|Part 1 and 2|Withdrawal by Subject|4|||
147602365|NCT00809159|532360768|FG003|Part 1 and 2|Withdrawal by Subject|0|||
147602366|NCT00809159|532360769|FG004|Part 1 and 2|Withdrawal by Subject|0|||
147602367|NCT00809159|532360770|FG005|Part 1 and 2|Withdrawal by Subject|1|||
147602368|NCT01672970|532360774|FG000|Overall Study|Lack of Efficacy|12|||
147602369|NCT01672970|532360774|FG000|Overall Study|Adverse Event|18|||
147602370|NCT01672970|532360774|FG000|Overall Study|Withdrawal by Subject|2|||
147602371|NCT01672970|532360774|FG000|Overall Study|Lost to Follow-up|5|||
147602372|NCT01672970|532360774|FG000|Overall Study|Other|9|||
147602373|NCT01672970|532360774|FG000|Overall Study|Enrolled but not treated|1|||
147602374|NCT04874636|532360775|FG000|Overall Study|Adverse Event|17|||
147602375|NCT04874636|532360776|FG001|Overall Study|Adverse Event|7|||
147602376|NCT04874636|532360775|FG000|Overall Study|Lost to Follow-up|1|||
147602377|NCT04874636|532360776|FG001|Overall Study|Lost to Follow-up|0|||
147602378|NCT04874636|532360775|FG000|Overall Study|Non-Compliance with Study Drug|2|||
147602379|NCT04874636|532360776|FG001|Overall Study|Non-Compliance with Study Drug|0|||
147602380|NCT04874636|532360775|FG000|Overall Study|Physician Decision|1|||
147602381|NCT04874636|532360776|FG001|Overall Study|Physician Decision|0|||
147602382|NCT04874636|532360775|FG000|Overall Study|Withdrawal by Subject|6|||
147602383|NCT04874636|532360776|FG001|Overall Study|Withdrawal by Subject|5|||
147602384|NCT01770392|532360777|FG000|Washout Period of at Least 14 Days|Adverse Event|1|||
147602385|NCT04188301|532360778|FG000|Month 3|Lost to Follow-up|0|||
147602386|NCT04188301|532360779|FG001|Month 3|Lost to Follow-up|0|||
147602387|NCT04188301|532360780|FG002|Month 3|Lost to Follow-up|1|||
147602388|NCT04188301|532360778|FG000|Month 12|Lost to Follow-up|0|||
147602389|NCT04188301|532360779|FG001|Month 12|Lost to Follow-up|0|||
147602390|NCT04188301|532360780|FG002|Month 12|Lost to Follow-up|2|||
147602391|NCT04188301|532360778|FG000|Month 12|Death|1|||
147280977|NCT00898677|531192588|FG000|Overall Study|Not Treated: Lack of Migraine Attack|9|||
147602392|NCT04188301|532360779|FG001|Month 12|Death|1|||
147602393|NCT04188301|532360780|FG002|Month 12|Death|0|||
147602394|NCT04188301|532360778|FG000|Month 18|Lost to Follow-up|6|||
147280978|NCT00898677|531192589|FG001|Overall Study|Not Treated: Lack of Migraine Attack|39|||
147335427|NCT01307267|531395355|FG012|Overall Study|Other|1|||
147335428|NCT01307267|531395356|FG013|Overall Study|Other|0|||
147602395|NCT04188301|532360779|FG001|Month 18|Lost to Follow-up|0|||
147602396|NCT04188301|532360780|FG002|Month 18|Lost to Follow-up|0|||
147602397|NCT03401450|532360781|FG000|Overall Study|Lost to Follow-up|4|||
147602398|NCT03401450|532360782|FG001|Overall Study|Lost to Follow-up|6|||
147602399|NCT03401450|532360781|FG000|Overall Study|Anesthesia plan changed|2|||
147280979|NCT00898677|531192590|FG002|Overall Study|Not Treated: Lack of Migraine Attack|43|||
147280980|NCT00898677|531192591|FG003|Overall Study|Not Treated: Lack of Migraine Attack|12|||
147280981|NCT00898677|531192588|FG000|Overall Study|Not Treated: Other (Not Specified)|0|||
147280982|NCT00898677|531192589|FG001|Overall Study|Not Treated: Other (Not Specified)|0|||
147280983|NCT00898677|531192590|FG002|Overall Study|Not Treated: Other (Not Specified)|2|||
147280984|NCT00898677|531192591|FG003|Overall Study|Not Treated: Other (Not Specified)|0|||
147280985|NCT00836875|531192594|FG000|Overall Study|Death|3|||
147280986|NCT00836875|531192595|FG001|Overall Study|Death|2|||
147280987|NCT00836875|531192594|FG000|Overall Study|Withdrawal by Subject|0|||
147280988|NCT00836875|531192595|FG001|Overall Study|Withdrawal by Subject|1|||
147280989|NCT00129987|531194514|FG000|1st Educational Session|Withdrawal by Subject|141|||
147280990|NCT00129987|531194515|FG001|1st Educational Session|Withdrawal by Subject|109|||
147280991|NCT00129987|531194514|FG000|1 Year|Withdrawal by Subject|32|||
147280992|NCT00129987|531194515|FG001|1 Year|Withdrawal by Subject|21|||
147280993|NCT01159938|531194516|FG000|First Study Period|Protocol Violation (Microalbuminuria)|0|||
147280994|NCT01159938|531194517|FG001|First Study Period|Protocol Violation (Microalbuminuria)|0|||
147280995|NCT01159938|531194518|FG002|First Study Period|Protocol Violation (Microalbuminuria)|1|||
147280996|NCT01159938|531194519|FG003|First Study Period|Protocol Violation (Microalbuminuria)|0|||
147280997|NCT01159938|531194520|FG004|First Study Period|Protocol Violation (Microalbuminuria)|0|||
147280998|NCT00581945|531194521|FG000|Overall Study|Adverse Event|4|||
147280999|NCT00581945|531194522|FG001|Overall Study|Adverse Event|4|||
147281000|NCT00581945|531194521|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
147281001|NCT00581945|531194522|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
147281002|NCT00581945|531194521|FG000|Overall Study|Withdrawal by Subject|2|||
147281003|NCT00581945|531194522|FG001|Overall Study|Withdrawal by Subject|6|||
147281004|NCT00581945|531194521|FG000|Overall Study|Death|1|||
147281005|NCT00581945|531194522|FG001|Overall Study|Death|0|||
147281006|NCT00982020|531194529|FG000|Overall Study|Adverse Event|19|||
147281007|NCT00982020|531194530|FG001|Overall Study|Adverse Event|15|||
147281008|NCT00982020|531194529|FG000|Overall Study|Withdrawal by Subject|11|||
147281009|NCT00982020|531194530|FG001|Overall Study|Withdrawal by Subject|14|||
147281010|NCT00982020|531194529|FG000|Overall Study|Lost to Follow-up|5|||
147281011|NCT00982020|531194530|FG001|Overall Study|Lost to Follow-up|11|||
147281012|NCT00982020|531194529|FG000|Overall Study|Lack of Efficacy|10|||
147281013|NCT00982020|531194530|FG001|Overall Study|Lack of Efficacy|4|||
147281014|NCT00982020|531194529|FG000|Overall Study|Parent/Caregiver Decision|5|||
147281015|NCT00982020|531194530|FG001|Overall Study|Parent/Caregiver Decision|5|||
147281016|NCT00982020|531194529|FG000|Overall Study|Treatment Non-compliance|3|||
147281017|NCT00982020|531194530|FG001|Overall Study|Treatment Non-compliance|6|||
147281018|NCT00982020|531194529|FG000|Overall Study|Physician Decision|2|||
147281019|NCT00982020|531194530|FG001|Overall Study|Physician Decision|5|||
147281020|NCT00982020|531194529|FG000|Overall Study|Entry Criteria Not Met|2|||
147281021|NCT00982020|531194530|FG001|Overall Study|Entry Criteria Not Met|1|||
147281022|NCT00982020|531194529|FG000|Overall Study|Protocol Violation|0|||
147281023|NCT00982020|531194530|FG001|Overall Study|Protocol Violation|2|||
147281024|NCT00982020|531194529|FG000|Overall Study|Clinical Relapse|0|||
147281025|NCT00982020|531194530|FG001|Overall Study|Clinical Relapse|1|||
147281026|NCT00466193|531194531|FG000|Overall Study|Adverse Event|0|||
147281027|NCT00466193|531194532|FG001|Overall Study|Adverse Event|1|||
147281028|NCT00466193|531194531|FG000|Overall Study|Lost to Follow-up|2|||
147281029|NCT00466193|531194532|FG001|Overall Study|Lost to Follow-up|4|||
147281030|NCT00466193|531194531|FG000|Overall Study|Physician Decision|1|||
147281031|NCT00466193|531194532|FG001|Overall Study|Physician Decision|0|||
147281032|NCT00466193|531194531|FG000|Overall Study|Protocol Violation|1|||
147281033|NCT00466193|531194532|FG001|Overall Study|Protocol Violation|1|||
147281034|NCT00466193|531194531|FG000|Overall Study|Withdrawal by Subject|7|||
147451230|NCT05048719|531814822|FG008|Overall Study|Participant was Unresponsive and Too Far Out of Window to Resume Treatment|0|||
147281035|NCT00466193|531194532|FG001|Overall Study|Withdrawal by Subject|2|||
147281036|NCT00466193|531194531|FG000|Overall Study|Patient refused Visit 4 procedures|1|||
147281037|NCT00466193|531194532|FG001|Overall Study|Patient refused Visit 4 procedures|0|||
147281038|NCT02525133|531194533|FG000|Overall Study|Adverse Event|0|||
147281039|NCT02525133|531194534|FG001|Overall Study|Adverse Event|1|||
147281040|NCT02525133|531194533|FG000|Overall Study|Death|0|||
147281041|NCT02525133|531194534|FG001|Overall Study|Death|1|||
147451231|NCT05048719|531814814|FG000|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
147281042|NCT02525133|531194533|FG000|Overall Study|did not meet randomization criteria|1|||
147281043|NCT02525133|531194534|FG001|Overall Study|did not meet randomization criteria|0|||
147281044|NCT02525133|531194533|FG000|Overall Study|Lost to Follow-up|5|||
147281045|NCT02525133|531194534|FG001|Overall Study|Lost to Follow-up|1|||
147281046|NCT02525133|531194533|FG000|Overall Study|randomized not enrolled|3|||
147281047|NCT02525133|531194534|FG001|Overall Study|randomized not enrolled|0|||
147281048|NCT02525133|531194533|FG000|Overall Study|Withdrawal by Subject|1|||
147281049|NCT02525133|531194534|FG001|Overall Study|Withdrawal by Subject|0|||
147281050|NCT01181921|531194536|FG000|Overall Study|Lost to Follow-up|1|||
147281051|NCT02317575|531194537|FG000|Period 1|Difficulty with venous cannulation|0|||
147281052|NCT02317575|531194538|FG001|Period 1|Difficulty with venous cannulation|1|||
147281053|NCT02317575|531194539|FG002|Period 1|Difficulty with venous cannulation|0|||
147281054|NCT02317575|531194540|FG003|Period 1|Difficulty with venous cannulation|0|||
147281055|NCT02317575|531194541|FG004|Period 1|Difficulty with venous cannulation|0|||
147281056|NCT02317575|531194537|FG000|Period 1|Withdrawal by Subject|1|||
147281057|NCT02317575|531194538|FG001|Period 1|Withdrawal by Subject|0|||
147281058|NCT02317575|531194539|FG002|Period 1|Withdrawal by Subject|0|||
147602400|NCT03401450|532360782|FG001|Overall Study|Anesthesia plan changed|2|||
147602401|NCT03401450|532360781|FG000|Overall Study|Did not complete medication diary|4|||
147602402|NCT03401450|532360782|FG001|Overall Study|Did not complete medication diary|2|||
147602403|NCT03401450|532360781|FG000|Overall Study|post surgery medication change|2|||
147602404|NCT03401450|532360782|FG001|Overall Study|post surgery medication change|1|||
147602405|NCT03401450|532360781|FG000|Overall Study|Cancelled surgery|0|||
147602406|NCT03401450|532360782|FG001|Overall Study|Cancelled surgery|2|||
147602407|NCT00620659|532360787|FG000|Treatment Period 1|Adverse Event|1|||
147602408|NCT00620659|532360788|FG001|Treatment Period 1|Adverse Event|0|||
147602409|NCT00620659|532360789|FG002|Treatment Period 1|Adverse Event|0|||
147602410|NCT00620659|532360790|FG003|Treatment Period 1|Adverse Event|3|||
147602411|NCT00620659|532360791|FG004|Treatment Period 1|Adverse Event|0|||
147602412|NCT00620659|532360792|FG005|Treatment Period 1|Adverse Event|0|||
147602413|NCT00620659|532360787|FG000|Treatment Period 1|Protocol Violation|1|||
147602414|NCT00620659|532360788|FG001|Treatment Period 1|Protocol Violation|0|||
147602415|NCT00620659|532360789|FG002|Treatment Period 1|Protocol Violation|0|||
147602416|NCT00620659|532360790|FG003|Treatment Period 1|Protocol Violation|0|||
147602417|NCT00620659|532360791|FG004|Treatment Period 1|Protocol Violation|0|||
147602418|NCT00620659|532360792|FG005|Treatment Period 1|Protocol Violation|0|||
147602419|NCT00620659|532360787|FG000|Treatment Period 1|Withdrawal by Subject|1|||
147602420|NCT00620659|532360788|FG001|Treatment Period 1|Withdrawal by Subject|0|||
147602421|NCT00620659|532360789|FG002|Treatment Period 1|Withdrawal by Subject|1|||
147602422|NCT00620659|532360790|FG003|Treatment Period 1|Withdrawal by Subject|0|||
147602423|NCT00620659|532360791|FG004|Treatment Period 1|Withdrawal by Subject|1|||
147602424|NCT00620659|532360792|FG005|Treatment Period 1|Withdrawal by Subject|0|||
147602425|NCT00620659|532360787|FG000|Placebo Washout Period 1|Withdrawal by Subject|0|||
147602426|NCT00620659|532360788|FG001|Placebo Washout Period 1|Withdrawal by Subject|0|||
147602427|NCT00620659|532360789|FG002|Placebo Washout Period 1|Withdrawal by Subject|0|||
147602428|NCT00620659|532360790|FG003|Placebo Washout Period 1|Withdrawal by Subject|1|||
147602429|NCT00620659|532360791|FG004|Placebo Washout Period 1|Withdrawal by Subject|0|||
147602430|NCT00620659|532360792|FG005|Placebo Washout Period 1|Withdrawal by Subject|0|||
147602431|NCT00620659|532360787|FG000|Treatment Period 2|Adverse Event|0|||
147602432|NCT00620659|532360788|FG001|Treatment Period 2|Adverse Event|3|||
147602433|NCT00620659|532360789|FG002|Treatment Period 2|Adverse Event|0|||
147602434|NCT00620659|532360790|FG003|Treatment Period 2|Adverse Event|0|||
147602435|NCT00620659|532360791|FG004|Treatment Period 2|Adverse Event|2|||
147602436|NCT00620659|532360792|FG005|Treatment Period 2|Adverse Event|0|||
147602437|NCT00620659|532360787|FG000|Treatment Period 2|Withdrawal by Subject|0|||
147602438|NCT00620659|532360788|FG001|Treatment Period 2|Withdrawal by Subject|0|||
147602439|NCT00620659|532360789|FG002|Treatment Period 2|Withdrawal by Subject|1|||
147602440|NCT00620659|532360790|FG003|Treatment Period 2|Withdrawal by Subject|0|||
147602441|NCT00620659|532360791|FG004|Treatment Period 2|Withdrawal by Subject|3|||
147602442|NCT00620659|532360792|FG005|Treatment Period 2|Withdrawal by Subject|0|||
147602443|NCT00620659|532360787|FG000|Placebo Washout Period 2|Adverse Event|2|||
147602444|NCT00620659|532360788|FG001|Placebo Washout Period 2|Adverse Event|0|||
147602445|NCT00620659|532360789|FG002|Placebo Washout Period 2|Adverse Event|0|||
147602446|NCT00620659|532360790|FG003|Placebo Washout Period 2|Adverse Event|0|||
147602447|NCT00620659|532360791|FG004|Placebo Washout Period 2|Adverse Event|0|||
147602448|NCT00620659|532360792|FG005|Placebo Washout Period 2|Adverse Event|0|||
147602449|NCT00620659|532360787|FG000|Treatment Period 3|Adverse Event|0|||
147602450|NCT00620659|532360788|FG001|Treatment Period 3|Adverse Event|2|||
147602451|NCT00620659|532360789|FG002|Treatment Period 3|Adverse Event|0|||
147602452|NCT00620659|532360790|FG003|Treatment Period 3|Adverse Event|0|||
147602453|NCT00620659|532360791|FG004|Treatment Period 3|Adverse Event|0|||
147602454|NCT00620659|532360792|FG005|Treatment Period 3|Adverse Event|0|||
147602455|NCT00620659|532360787|FG000|Treatment Period 3|Withdrawal by Subject|0|||
147662534|NCT02513550|532587348|FG003|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
147602456|NCT00620659|532360788|FG001|Treatment Period 3|Withdrawal by Subject|0|||
147602457|NCT00620659|532360789|FG002|Treatment Period 3|Withdrawal by Subject|0|||
147602458|NCT00620659|532360790|FG003|Treatment Period 3|Withdrawal by Subject|1|||
147602459|NCT00620659|532360791|FG004|Treatment Period 3|Withdrawal by Subject|0|||
147602460|NCT00620659|532360792|FG005|Treatment Period 3|Withdrawal by Subject|0|||
147602461|NCT01709838|532360793|FG000|Overall Study|Withdrawal by Subject|21|||
147602462|NCT01709838|532360793|FG000|Overall Study|Lost to Follow-up|16|||
147602463|NCT01709838|532360793|FG000|Overall Study|Pregnancy|10|||
147602464|NCT01709838|532360793|FG000|Overall Study|Subject/guardian decision|8|||
147281059|NCT02317575|531194540|FG003|Period 1|Withdrawal by Subject|0|||
147281060|NCT02317575|531194541|FG004|Period 1|Withdrawal by Subject|0|||
147335429|NCT01307267|531395357|FG014|Overall Study|Other|2|||
147281061|NCT02548962|531194544|FG000|Overall Study|Withdrawal by Subject|1|||
147281062|NCT02548962|531194545|FG001|Overall Study|Withdrawal by Subject|0|||
147281063|NCT04831736|531194546|FG000|Overall Study|Withdrawal by Subject|0|||
147281064|NCT04831736|531194547|FG001|Overall Study|Withdrawal by Subject|1|||
147281065|NCT02159482|531194550|FG000|Overall Study|Withdrawal by Subject|2|||
147281066|NCT02159482|531194550|FG000|Overall Study|Physician Decision|3|||
147281067|NCT02828111|531194553|FG000|Overall Study|Withdrawal by Subject|0|||
147281068|NCT02828111|531194554|FG001|Overall Study|Withdrawal by Subject|0|||
147281069|NCT02828111|531194555|FG002|Overall Study|Withdrawal by Subject|2|||
147281070|NCT02828111|531194556|FG003|Overall Study|Withdrawal by Subject|0|||
147281071|NCT02828111|531194557|FG004|Overall Study|Withdrawal by Subject|0|||
147281072|NCT02828111|531194553|FG000|Overall Study|Lost to Follow-up|0|||
147281073|NCT02828111|531194554|FG001|Overall Study|Lost to Follow-up|0|||
147281074|NCT02828111|531194555|FG002|Overall Study|Lost to Follow-up|0|||
147281075|NCT02828111|531194556|FG003|Overall Study|Lost to Follow-up|1|||
147281076|NCT02828111|531194557|FG004|Overall Study|Lost to Follow-up|1|||
147281077|NCT04096560|531194558|FG000|Overall Study|Reason not Specified|1|||
147281078|NCT04096560|531194559|FG001|Overall Study|Reason not Specified|0|||
147281079|NCT04096560|531194560|FG002|Overall Study|Reason not Specified|0|||
147281080|NCT04096560|531194561|FG003|Overall Study|Reason not Specified|0|||
147281081|NCT04096560|531194562|FG004|Overall Study|Reason not Specified|1|||
147281082|NCT04096560|531194563|FG005|Overall Study|Reason not Specified|1|||
147602465|NCT01709838|532360793|FG000|Overall Study|Adverse Event|4|||
147281083|NCT04096560|531194564|FG006|Overall Study|Reason not Specified|1|||
147281084|NCT04096560|531194565|FG007|Overall Study|Reason not Specified|0|||
147281085|NCT04096560|531194558|FG000|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|0|||
147281086|NCT04096560|531194559|FG001|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|0|||
147281087|NCT04096560|531194560|FG002|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|0|||
147281088|NCT04096560|531194561|FG003|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|0|||
147281089|NCT04096560|531194562|FG004|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|0|||
147281090|NCT04096560|531194563|FG005|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|3|||
147602466|NCT01709838|532360793|FG000|Overall Study|Physician Decision|4|||
147281091|NCT04096560|531194564|FG006|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|3|||
147281092|NCT04096560|531194565|FG007|Overall Study|Pretreatment Event, Serious Adverse Event, or Adverse Event|0|||
147281093|NCT04096560|531194558|FG000|Overall Study|Study Terminated by Sponsor|0|||
147281094|NCT04096560|531194559|FG001|Overall Study|Study Terminated by Sponsor|0|||
147281095|NCT04096560|531194560|FG002|Overall Study|Study Terminated by Sponsor|0|||
147281096|NCT04096560|531194561|FG003|Overall Study|Study Terminated by Sponsor|5|||
147281097|NCT04096560|531194562|FG004|Overall Study|Study Terminated by Sponsor|6|||
147602467|NCT01709838|532360793|FG000|Overall Study|Death|3|||
147602468|NCT01709838|532360793|FG000|Overall Study|Protocol Violation|1|||
147602469|NCT01193127|532360796|FG000|Randomized|Surgery Cancelled|0|||
147602470|NCT01193127|532360797|FG001|Randomized|Surgery Cancelled|0|||
147602471|NCT01193127|532360798|FG002|Randomized|Surgery Cancelled|0|||
147602472|NCT01193127|532360799|FG003|Randomized|Surgery Cancelled|1|||
147602473|NCT01193127|532360796|FG000|Treated|Withdrawal by Subject|0|||
147602474|NCT01193127|532360797|FG001|Treated|Withdrawal by Subject|0|||
147602475|NCT01193127|532360798|FG002|Treated|Withdrawal by Subject|0|||
147602476|NCT01193127|532360799|FG003|Treated|Withdrawal by Subject|1|||
147602477|NCT03246646|532360802|FG000|Overall Study|deemed ineligible and administratively withdrawn|1|||
147602478|NCT03246646|532360803|FG001|Overall Study|deemed ineligible and administratively withdrawn|0|||
147602479|NCT03246646|532360802|FG000|Overall Study|Withdrawal by Subject|3|||
147602480|NCT03246646|532360803|FG001|Overall Study|Withdrawal by Subject|0|||
147602481|NCT03246646|532360802|FG000|Overall Study|Lost to Follow-up|7|||
147602482|NCT03246646|532360803|FG001|Overall Study|Lost to Follow-up|0|||
147602483|NCT02352779|532360806|FG000|Overall Study|Personal Issues|1|||
147602484|NCT02352779|532360807|FG001|Overall Study|Personal Issues|1|||
147602485|NCT02352779|532360808|FG002|Overall Study|Personal Issues|0|||
147602486|NCT02352779|532360806|FG000|Overall Study|Too Many Forms|2|||
147602487|NCT02352779|532360807|FG001|Overall Study|Too Many Forms|0|||
147602488|NCT02352779|532360808|FG002|Overall Study|Too Many Forms|0|||
147602489|NCT02352779|532360806|FG000|Overall Study|Feeling Overwhelmed|1|||
147602490|NCT02352779|532360807|FG001|Overall Study|Feeling Overwhelmed|0|||
147602491|NCT02352779|532360808|FG002|Overall Study|Feeling Overwhelmed|0|||
147602492|NCT02352779|532360806|FG000|Overall Study|Disliked Intervention|1|||
147281098|NCT04096560|531194563|FG005|Overall Study|Study Terminated by Sponsor|4|||
147281099|NCT04096560|531194564|FG006|Overall Study|Study Terminated by Sponsor|6|||
147281100|NCT04096560|531194565|FG007|Overall Study|Study Terminated by Sponsor|1|||
147281101|NCT04096560|531194558|FG000|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
147281102|NCT04096560|531194559|FG001|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
147281103|NCT04096560|531194560|FG002|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
147281104|NCT04096560|531194561|FG003|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
147602493|NCT02352779|532360807|FG001|Overall Study|Disliked Intervention|0|||
147602494|NCT02352779|532360808|FG002|Overall Study|Disliked Intervention|0|||
147281105|NCT04096560|531194562|FG004|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
147281106|NCT04096560|531194563|FG005|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
147281107|NCT04096560|531194564|FG006|Overall Study|Met the Discontinuation Criteria of the Protocol|0|||
147281108|NCT04096560|531194565|FG007|Overall Study|Met the Discontinuation Criteria of the Protocol|1|||
147281109|NCT01459796|531194568|FG000|Overall Study|Non compliance with protocol|2|||
147281110|NCT01459796|531194569|FG001|Overall Study|Non compliance with protocol|4|||
147281111|NCT01459796|531194568|FG000|Overall Study|Adverse Event|5|||
147281112|NCT01459796|531194569|FG001|Overall Study|Adverse Event|5|||
147281113|NCT01459796|531194568|FG000|Overall Study|Withdrawal by Subject|6|||
147281114|NCT01459796|531194569|FG001|Overall Study|Withdrawal by Subject|3|||
147281115|NCT01459796|531194568|FG000|Overall Study|Lost to Follow-up|5|||
147281116|NCT01459796|531194569|FG001|Overall Study|Lost to Follow-up|4|||
147281117|NCT01459796|531194568|FG000|Overall Study|Reason unspecified|1|||
147281118|NCT01459796|531194569|FG001|Overall Study|Reason unspecified|2|||
147281119|NCT01459796|531194568|FG000|Overall Study|Decision by the sponsor|75|||
147281120|NCT01459796|531194569|FG001|Overall Study|Decision by the sponsor|108|||
147281121|NCT00701051|531194570|FG000|Screening|Failed Screening|40|||
147281122|NCT00701051|531194571|FG001|Screening|Failed Screening|0|||
147281123|NCT00701051|531194572|FG002|Screening|Failed Screening|0|||
147281124|NCT00701051|531194570|FG000|Screening|Time conflicts|19|||
147281125|NCT00701051|531194571|FG001|Screening|Time conflicts|0|||
147281126|NCT00701051|531194572|FG002|Screening|Time conflicts|0|||
147281127|NCT00701051|531194570|FG000|Exercise Intervention|time conflict; non-study related illness|0|||
147281128|NCT00701051|531194571|FG001|Exercise Intervention|time conflict; non-study related illness|5|||
147281129|NCT00701051|531194572|FG002|Exercise Intervention|time conflict; non-study related illness|3|||
147602495|NCT02352779|532360806|FG000|Overall Study|Changed Mind|1|||
147602496|NCT02352779|532360807|FG001|Overall Study|Changed Mind|0|||
147602497|NCT02352779|532360808|FG002|Overall Study|Changed Mind|0|||
147602498|NCT02352779|532360806|FG000|Overall Study|Study Related Symptoms|1|||
147602499|NCT02352779|532360807|FG001|Overall Study|Study Related Symptoms|0|||
147602500|NCT02352779|532360808|FG002|Overall Study|Study Related Symptoms|0|||
147602501|NCT02352779|532360806|FG000|Overall Study|Absence of Symptoms|1|||
147602502|NCT02352779|532360807|FG001|Overall Study|Absence of Symptoms|0|||
147602503|NCT02352779|532360808|FG002|Overall Study|Absence of Symptoms|0|||
147602504|NCT02352779|532360806|FG000|Overall Study|Other Medical Reason|0|||
147602505|NCT02352779|532360807|FG001|Overall Study|Other Medical Reason|0|||
147602506|NCT02352779|532360808|FG002|Overall Study|Other Medical Reason|1|||
147602507|NCT02352779|532360806|FG000|Overall Study|No Reason|0|||
147602508|NCT02352779|532360807|FG001|Overall Study|No Reason|0|||
147602509|NCT02352779|532360808|FG002|Overall Study|No Reason|1|||
147602510|NCT00968799|532360811|FG000|Overall Study|Advanced disease, HIPEC not applicable|2|||
147602511|NCT01104779|532360814|FG000|Overall Study|Protocol Violation|1|||
147602512|NCT01104779|532360815|FG001|Overall Study|Protocol Violation|2|||
147602513|NCT01104779|532360816|FG002|Overall Study|Protocol Violation|2|||
147602514|NCT01104779|532360814|FG000|Overall Study|Lack of Efficacy|26|||
147602515|NCT01104779|532360815|FG001|Overall Study|Lack of Efficacy|12|||
147602516|NCT01104779|532360816|FG002|Overall Study|Lack of Efficacy|13|||
147602517|NCT01104779|532360814|FG000|Overall Study|Adverse Event|13|||
147602518|NCT01104779|532360815|FG001|Overall Study|Adverse Event|14|||
147602519|NCT01104779|532360816|FG002|Overall Study|Adverse Event|13|||
147602520|NCT01104779|532360814|FG000|Overall Study|Did not meet inc/exc criteria|1|||
147602521|NCT01104779|532360815|FG001|Overall Study|Did not meet inc/exc criteria|1|||
147602522|NCT01104779|532360816|FG002|Overall Study|Did not meet inc/exc criteria|1|||
147602523|NCT01104779|532360814|FG000|Overall Study|Other reasons|0|||
147602524|NCT01104779|532360815|FG001|Overall Study|Other reasons|1|||
147602525|NCT01104779|532360816|FG002|Overall Study|Other reasons|0|||
147602526|NCT01104779|532360814|FG000|Overall Study|Lost to Follow-up|2|||
147281130|NCT03634579|531194573|FG000|Overall Study|study termination|9|||
147281131|NCT05857527|531194574|FG000|Overall Study|Withdrawal by Subject|0|||
147281132|NCT05857527|531194575|FG001|Overall Study|Withdrawal by Subject|1|||
147281133|NCT02543346|531194576|FG000|Second Priming Visit|Withdrawal by Subject|0|||
147281134|NCT02543346|531194577|FG001|Second Priming Visit|Withdrawal by Subject|2|||
147281135|NCT02543346|531194578|FG002|Second Priming Visit|Withdrawal by Subject|2|||
147281136|NCT02543346|531194579|FG003|Second Priming Visit|Withdrawal by Subject|2|||
147281137|NCT02543346|531194576|FG000|Second Priming Visit|Adverse Event|1|||
147281138|NCT02543346|531194577|FG001|Second Priming Visit|Adverse Event|0|||
147602527|NCT01104779|532360815|FG001|Overall Study|Lost to Follow-up|0|||
147602528|NCT01104779|532360816|FG002|Overall Study|Lost to Follow-up|1|||
147602529|NCT01104779|532360814|FG000|Overall Study|Withdrawal by Subject|16|||
147602530|NCT01104779|532360815|FG001|Overall Study|Withdrawal by Subject|25|||
147602531|NCT01104779|532360816|FG002|Overall Study|Withdrawal by Subject|32|||
147281139|NCT02543346|531194578|FG002|Second Priming Visit|Adverse Event|0|||
147335430|NCT01307267|531395358|FG015|Overall Study|Other|1|||
147602532|NCT01372774|532360819|FG000|Overall Study|Withdrawal prior to treatment|4|||
147602533|NCT01372774|532360820|FG001|Overall Study|Withdrawal prior to treatment|5|||
147602534|NCT00389831|532360821|FG000|Overall Study|Lack of Efficacy|0|||
147602535|NCT00389831|532360822|FG001|Overall Study|Lack of Efficacy|2|||
147602536|NCT00389831|532360821|FG000|Overall Study|Did not receive treatment.|0|||
147602537|NCT00389831|532360822|FG001|Overall Study|Did not receive treatment.|2|||
147602538|NCT00389831|532360821|FG000|Overall Study|Other reasons|0|||
147602539|NCT00389831|532360822|FG001|Overall Study|Other reasons|2|||
147602540|NCT00389831|532360821|FG000|Overall Study|Lost to Follow-up|0|||
147602541|NCT00389831|532360822|FG001|Overall Study|Lost to Follow-up|1|||
147602542|NCT04639713|532360827|FG000|Overall Study|Protocol Noncompliance|2|||
147602543|NCT04639713|532360827|FG000|Overall Study|Withdrawal by Subject|1|||
147602544|NCT03190330|532363534|FG000|Overall Study|Adverse Event|2|||
147602545|NCT03190330|532363534|FG000|Overall Study|Death|10|||
147602546|NCT03190330|532363534|FG000|Overall Study|Lost to Follow-up|1|||
147602547|NCT03190330|532363534|FG000|Overall Study|Withdrawal by Subject|6|||
147602548|NCT03190330|532363534|FG000|Overall Study|Progressive Disease|1|||
147602549|NCT02081209|532363535|FG000|Overall Study|Withdrawal by Subject|1|||
147602550|NCT00633243|532363539|FG000|Overall Study|Withdrawal by Subject|0|||
147602551|NCT00633243|532363540|FG001|Overall Study|Withdrawal by Subject|1|||
147602552|NCT00633243|532363539|FG000|Overall Study|incarceration|0|||
147602553|NCT00633243|532363540|FG001|Overall Study|incarceration|2|||
147602554|NCT00633243|532363539|FG000|Overall Study|Homeless--no refrigeration for meds|0|||
147602555|NCT00633243|532363540|FG001|Overall Study|Homeless--no refrigeration for meds|1|||
147602556|NCT00633243|532363539|FG000|Overall Study|Not comfortable with self-injecting|0|||
147602557|NCT00633243|532363540|FG001|Overall Study|Not comfortable with self-injecting|1|||
147602558|NCT00633243|532363539|FG000|Overall Study|Mental Health--Depression|0|||
147602559|NCT00633243|532363540|FG001|Overall Study|Mental Health--Depression|1|||
147602560|NCT00633243|532363539|FG000|Overall Study|Couldn't tolerate side-effects|1|||
147602561|NCT00633243|532363540|FG001|Overall Study|Couldn't tolerate side-effects|1|||
147602562|NCT02022748|532363541|FG000|Overall Study|Adverse Event|1|||
147602563|NCT02022748|532363542|FG001|Overall Study|Adverse Event|1|||
147602564|NCT02022748|532363543|FG002|Overall Study|Adverse Event|0|||
147602565|NCT02022748|532363541|FG000|Overall Study|Withdrawal by Subject|0|||
147602566|NCT02022748|532363542|FG001|Overall Study|Withdrawal by Subject|1|||
147602567|NCT02022748|532363543|FG002|Overall Study|Withdrawal by Subject|0|||
147602568|NCT00379340|532363545|FG000|Overall Study|Death|0|||
147602569|NCT00379340|532363546|FG001|Overall Study|Death|0|||
147602570|NCT00379340|532363547|FG002|Overall Study|Death|0|||
147602571|NCT00379340|532363548|FG003|Overall Study|Death|2|||
147602572|NCT00379340|532363549|FG004|Overall Study|Death|0|||
147602573|NCT00379340|532363545|FG000|Overall Study|Lack of Efficacy|6|||
147602574|NCT00379340|532363546|FG001|Overall Study|Lack of Efficacy|1|||
147602575|NCT00379340|532363547|FG002|Overall Study|Lack of Efficacy|0|||
147602576|NCT00379340|532363548|FG003|Overall Study|Lack of Efficacy|4|||
147602577|NCT00379340|532363549|FG004|Overall Study|Lack of Efficacy|3|||
147602578|NCT00379340|532363545|FG000|Overall Study|Physician Decision|6|||
147602579|NCT00379340|532363546|FG001|Overall Study|Physician Decision|2|||
147602580|NCT00379340|532363547|FG002|Overall Study|Physician Decision|1|||
147602581|NCT00379340|532363548|FG003|Overall Study|Physician Decision|2|||
147602582|NCT00379340|532363549|FG004|Overall Study|Physician Decision|3|||
147602583|NCT00379340|532363545|FG000|Overall Study|Withdrawal by Subject|0|||
147602584|NCT00379340|532363546|FG001|Overall Study|Withdrawal by Subject|0|||
147602585|NCT00379340|532363547|FG002|Overall Study|Withdrawal by Subject|0|||
147602586|NCT00379340|532363548|FG003|Overall Study|Withdrawal by Subject|1|||
147602587|NCT00379340|532363549|FG004|Overall Study|Withdrawal by Subject|0|||
147602588|NCT00379340|532363545|FG000|Overall Study|Refusal of further protocol therapy|1|||
147602589|NCT00379340|532363546|FG001|Overall Study|Refusal of further protocol therapy|0|||
147602590|NCT00379340|532363547|FG002|Overall Study|Refusal of further protocol therapy|1|||
147602591|NCT00379340|532363548|FG003|Overall Study|Refusal of further protocol therapy|1|||
147602592|NCT00379340|532363549|FG004|Overall Study|Refusal of further protocol therapy|7|||
147602593|NCT00379340|532363545|FG000|Overall Study|On more than 1 tumor therapeutic study|0|||
147602594|NCT00379340|532363546|FG001|Overall Study|On more than 1 tumor therapeutic study|0|||
147602595|NCT00379340|532363547|FG002|Overall Study|On more than 1 tumor therapeutic study|0|||
147602596|NCT00379340|532363548|FG003|Overall Study|On more than 1 tumor therapeutic study|2|||
147602597|NCT00379340|532363549|FG004|Overall Study|On more than 1 tumor therapeutic study|0|||
147602598|NCT00379340|532363545|FG000|Overall Study|Delayed nephrectomy and anaplasia|0|||
147602599|NCT00379340|532363546|FG001|Overall Study|Delayed nephrectomy and anaplasia|0|||
147602600|NCT00379340|532363547|FG002|Overall Study|Delayed nephrectomy and anaplasia|0|||
147602601|NCT00379340|532363548|FG003|Overall Study|Delayed nephrectomy and anaplasia|1|||
147602602|NCT00379340|532363549|FG004|Overall Study|Delayed nephrectomy and anaplasia|1|||
147602603|NCT04347122|532363550|FG000|Overall Study|Physician Decision|0|||
147602604|NCT04347122|532363551|FG001|Overall Study|Physician Decision|3|||
147602605|NCT04347122|532363552|FG002|Overall Study|Physician Decision|3|||
147602606|NCT04347122|532363553|FG003|Overall Study|Physician Decision|6|||
147602607|NCT04994483|532363557|FG000|Overall Study|Adverse Event|26|||
147602608|NCT04994483|532363558|FG001|Overall Study|Adverse Event|17|||
147602609|NCT04994483|532363557|FG000|Overall Study|Lost to Follow-up|6|||
147602610|NCT04994483|532363558|FG001|Overall Study|Lost to Follow-up|10|||
147335431|NCT01307267|531395359|FG016|Overall Study|Other|0|||
147335432|NCT01307267|531395360|FG017|Overall Study|Other|0|||
147335433|NCT01307267|531395361|FG018|Overall Study|Other|0|||
147335434|NCT01307267|531395362|FG019|Overall Study|Other|19|||
147335435|NCT01307267|531395363|FG020|Overall Study|Other|2|||
147335436|NCT01307267|531395364|FG021|Overall Study|Other|3|||
147335437|NCT01307267|531395365|FG022|Overall Study|Other|2|||
147335438|NCT04956575|531395369|FG000|Overall Study|Death|1|||
147335439|NCT04956575|531395370|FG001|Overall Study|Death|0|||
147335440|NCT04956575|531395371|FG002|Overall Study|Death|0|||
147335441|NCT04956575|531395372|FG003|Overall Study|Death|0|||
147335442|NCT04956575|531395373|FG004|Overall Study|Death|0|||
147335443|NCT04956575|531395374|FG005|Overall Study|Death|0|||
147335444|NCT04956575|531395375|FG006|Overall Study|Death|0|||
147335445|NCT04956575|531395376|FG007|Overall Study|Death|1|||
147335446|NCT04956575|531395377|FG008|Overall Study|Death|0|||
147335447|NCT04956575|531395378|FG009|Overall Study|Death|1|||
147335448|NCT04956575|531395379|FG010|Overall Study|Death|0|||
147335449|NCT04956575|531395380|FG011|Overall Study|Death|0|||
147335450|NCT04956575|531395369|FG000|Overall Study|Lost to Follow-up|3|||
147335451|NCT04956575|531395370|FG001|Overall Study|Lost to Follow-up|4|||
147335452|NCT04956575|531395371|FG002|Overall Study|Lost to Follow-up|2|||
147335453|NCT04956575|531395372|FG003|Overall Study|Lost to Follow-up|3|||
147335454|NCT04956575|531395373|FG004|Overall Study|Lost to Follow-up|1|||
147335455|NCT04956575|531395374|FG005|Overall Study|Lost to Follow-up|10|||
147335456|NCT04956575|531395375|FG006|Overall Study|Lost to Follow-up|11|||
147335457|NCT04956575|531395376|FG007|Overall Study|Lost to Follow-up|7|||
147335458|NCT04956575|531395377|FG008|Overall Study|Lost to Follow-up|4|||
147335459|NCT04956575|531395378|FG009|Overall Study|Lost to Follow-up|2|||
147335460|NCT04956575|531395379|FG010|Overall Study|Lost to Follow-up|3|||
147335461|NCT04956575|531395380|FG011|Overall Study|Lost to Follow-up|8|||
147335462|NCT04956575|531395369|FG000|Overall Study|Withdrawal by Subject|1|||
147335463|NCT04956575|531395370|FG001|Overall Study|Withdrawal by Subject|2|||
147335464|NCT04956575|531395371|FG002|Overall Study|Withdrawal by Subject|1|||
147335465|NCT04956575|531395372|FG003|Overall Study|Withdrawal by Subject|4|||
147335466|NCT04956575|531395373|FG004|Overall Study|Withdrawal by Subject|2|||
147335467|NCT04956575|531395374|FG005|Overall Study|Withdrawal by Subject|8|||
147335468|NCT04956575|531395375|FG006|Overall Study|Withdrawal by Subject|5|||
147335469|NCT04956575|531395376|FG007|Overall Study|Withdrawal by Subject|1|||
147335470|NCT04956575|531395377|FG008|Overall Study|Withdrawal by Subject|1|||
147335471|NCT04956575|531395378|FG009|Overall Study|Withdrawal by Subject|0|||
147335472|NCT04956575|531395379|FG010|Overall Study|Withdrawal by Subject|3|||
147335473|NCT04956575|531395380|FG011|Overall Study|Withdrawal by Subject|1|||
147335474|NCT03593876|531395381|FG000|Overall Study|Withdrawal by Subject|1|||
147335475|NCT03593876|531395381|FG000|Overall Study|Discharged home before intervention completion|2|||
147335476|NCT00854906|531395384|FG000|Overall Study|One person had no ocular history|1|||
147335477|NCT04527549|531395387|FG000|Overall Study|Withdrawal by Subject|1|||
147335478|NCT04527549|531395388|FG001|Overall Study|Withdrawal by Subject|1|||
147335479|NCT03718767|531395389|FG000|Overall Study|Declined to participate (before treatment started)|0|||
147335480|NCT03718767|531395390|FG001|Overall Study|Declined to participate (before treatment started)|0|||
147335481|NCT03718767|531395391|FG002|Overall Study|Declined to participate (before treatment started)|7|||
147335482|NCT03718767|531395389|FG000|Overall Study|Ineligible|0|||
147335483|NCT03718767|531395390|FG001|Overall Study|Ineligible|0|||
147335484|NCT03718767|531395391|FG002|Overall Study|Ineligible|17|||
147335485|NCT01290224|531395392|FG000|Overall Study|Adverse Event|1|||
147335486|NCT01290224|531395392|FG000|Overall Study|Refused Further Treatment|4|||
147335487|NCT00346333|531395393|FG000|Overall Study|Death|1|||
147335488|NCT00346333|531395394|FG001|Overall Study|Death|0|||
147335489|NCT00346333|531395393|FG000|Overall Study|unwilling or unable to continue|4|||
147335490|NCT00346333|531395394|FG001|Overall Study|unwilling or unable to continue|8|||
147662535|NCT02513550|532587349|FG004|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
147662536|NCT02513550|532587350|FG005|Post-Treatment Follow-up Period|Lost to Follow-up|0|||
147335491|NCT03460756|531395395|FG000|Overall Study|Adverse Event|0|||
147335492|NCT03460756|531395396|FG001|Overall Study|Adverse Event|0|||
147335493|NCT03460756|531395397|FG002|Overall Study|Adverse Event|0|||
147335494|NCT03460756|531395398|FG003|Overall Study|Adverse Event|1|||
147335495|NCT03460756|531395395|FG000|Overall Study|Lack of Efficacy|0|||
147335496|NCT03460756|531395396|FG001|Overall Study|Lack of Efficacy|0|||
147335497|NCT03460756|531395397|FG002|Overall Study|Lack of Efficacy|0|||
147335498|NCT03460756|531395398|FG003|Overall Study|Lack of Efficacy|2|||
147335499|NCT03460756|531395395|FG000|Overall Study|Lost to Follow-up|0|||
147335500|NCT03460756|531395396|FG001|Overall Study|Lost to Follow-up|1|||
147335501|NCT03460756|531395397|FG002|Overall Study|Lost to Follow-up|2|||
147335502|NCT03460756|531395398|FG003|Overall Study|Lost to Follow-up|1|||
147335503|NCT03460756|531395395|FG000|Overall Study|Pregnancy|0|||
147335504|NCT03460756|531395396|FG001|Overall Study|Pregnancy|0|||
147335505|NCT03460756|531395397|FG002|Overall Study|Pregnancy|0|||
147335506|NCT03460756|531395398|FG003|Overall Study|Pregnancy|1|||
147335507|NCT03460756|531395395|FG000|Overall Study|Protocol Violation|0|||
147662537|NCT02513550|532587345|FG000|Post-Treatment Follow-up Period|Adverse Event|1|||
147281140|NCT02543346|531194579|FG003|Second Priming Visit|Adverse Event|0|||
147281141|NCT01748994|531194580|FG000|Overall Study|Lost to Follow-up|8|||
147281142|NCT01748994|531194581|FG001|Overall Study|Lost to Follow-up|6|||
147281143|NCT02141516|531194582|FG000|Overall Study|Adverse Event|0|||
147281144|NCT02141516|531194583|FG001|Overall Study|Adverse Event|1|||
147281145|NCT02141516|531194584|FG002|Overall Study|Adverse Event|0|||
147281146|NCT02141516|531194582|FG000|Overall Study|Lost to Follow-up|0|||
147281147|NCT02141516|531194583|FG001|Overall Study|Lost to Follow-up|1|||
147281148|NCT02141516|531194584|FG002|Overall Study|Lost to Follow-up|0|||
147281149|NCT02141516|531194582|FG000|Overall Study|Other|0|||
147281150|NCT02141516|531194583|FG001|Overall Study|Other|3|||
147281151|NCT02141516|531194584|FG002|Overall Study|Other|0|||
147281152|NCT03251924|531194585|FG000|Overall Study|Disease Progression|6|||
147281153|NCT03251924|531194586|FG001|Overall Study|Disease Progression|6|||
147281154|NCT03251924|531194587|FG002|Overall Study|Disease Progression|7|||
147281155|NCT03251924|531194588|FG003|Overall Study|Disease Progression|8|||
147281156|NCT03251924|531194589|FG004|Overall Study|Disease Progression|8|||
147281157|NCT03251924|531194590|FG005|Overall Study|Disease Progression|7|||
147281158|NCT03251924|531194591|FG006|Overall Study|Disease Progression|6|||
147281159|NCT03251924|531194592|FG007|Overall Study|Disease Progression|10|||
147281160|NCT03251924|531194593|FG008|Overall Study|Disease Progression|6|||
147602611|NCT04994483|532363557|FG000|Overall Study|Noncompliance with study drug|8|||
147602612|NCT04994483|532363558|FG001|Overall Study|Noncompliance with study drug|5|||
147602613|NCT04994483|532363557|FG000|Overall Study|Physician Decision|5|||
147602614|NCT04994483|532363558|FG001|Overall Study|Physician Decision|0|||
147602615|NCT04994483|532363557|FG000|Overall Study|Withdrawal by Subject|41|||
147602616|NCT04994483|532363558|FG001|Overall Study|Withdrawal by Subject|38|||
147602617|NCT04994483|532363557|FG000|Overall Study|Sponsor requests subject to be withdrawn|2|||
147602618|NCT04994483|532363558|FG001|Overall Study|Sponsor requests subject to be withdrawn|1|||
147602619|NCT04994483|532363557|FG000|Overall Study|Met stopping criteria|1|||
147602620|NCT04994483|532363558|FG001|Overall Study|Met stopping criteria|0|||
147602621|NCT04994483|532363557|FG000|Overall Study|Randomized in error, not treated|4|||
147602622|NCT04994483|532363558|FG001|Overall Study|Randomized in error, not treated|3|||
147602623|NCT04994483|532363557|FG000|Overall Study|Lack of a reliable study partner|0|||
147602624|NCT04994483|532363558|FG001|Overall Study|Lack of a reliable study partner|1|||
147602625|NCT04994483|532363557|FG000|Overall Study|Met MRI exclusion criteria|0|||
147602626|NCT04994483|532363558|FG001|Overall Study|Met MRI exclusion criteria|1|||
147602627|NCT00112866|532363559|FG000|Overall Study|Protocol Violation|1|||
147602628|NCT00112866|532363560|FG001|Overall Study|Protocol Violation|0|||
147602629|NCT00112866|532363559|FG000|Overall Study|did not start treatment post-op|1|||
147602630|NCT00112866|532363560|FG001|Overall Study|did not start treatment post-op|2|||
147602631|NCT00554190|532363561|FG000|Overall Study|Termination forms not completed|10|||
147602632|NCT02903030|532363562|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|2|||
147602633|NCT02903030|532363563|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|1|||
147602634|NCT00977379|532363564|FG000|Overall Study|Withdrawal by Subject|1|||
147602635|NCT00977379|532363565|FG001|Overall Study|Withdrawal by Subject|1|||
147602636|NCT00977379|532363564|FG000|Overall Study|Death|7|||
147602637|NCT00977379|532363565|FG001|Overall Study|Death|9|||
147602638|NCT00977379|532363564|FG000|Overall Study|Premature Study Termination|4|||
147602639|NCT00977379|532363565|FG001|Overall Study|Premature Study Termination|0|||
147602640|NCT00977379|532363564|FG000|Overall Study|Participant Moving House|0|||
147602641|NCT00977379|532363565|FG001|Overall Study|Participant Moving House|1|||
147602642|NCT00977379|532363564|FG000|Overall Study|Randomization Error|0|||
147602643|NCT00977379|532363565|FG001|Overall Study|Randomization Error|1|||
147602644|NCT02603393|532363566|FG000|Overall Study|Patient/guardian decision|32|||
147602645|NCT02603393|532363567|FG001|Overall Study|Patient/guardian decision|18|||
147602646|NCT02603393|532363566|FG000|Overall Study|Adverse Event|17|||
147602647|NCT02603393|532363567|FG001|Overall Study|Adverse Event|15|||
147602648|NCT02603393|532363566|FG000|Overall Study|Technical problems|4|||
147602649|NCT02603393|532363567|FG001|Overall Study|Technical problems|7|||
147602650|NCT02603393|532363566|FG000|Overall Study|Lack of Efficacy|7|||
147602651|NCT02603393|532363567|FG001|Overall Study|Lack of Efficacy|2|||
147602652|NCT02603393|532363566|FG000|Overall Study|Death|3|||
147602653|NCT02603393|532363567|FG001|Overall Study|Death|4|||
147602654|NCT02603393|532363566|FG000|Overall Study|Physician Decision|3|||
147602655|NCT02603393|532363567|FG001|Overall Study|Physician Decision|3|||
147602656|NCT02603393|532363566|FG000|Overall Study|Protocol deviation|2|||
147602657|NCT02603393|532363567|FG001|Overall Study|Protocol deviation|3|||
147602658|NCT02603393|532363566|FG000|Overall Study|Lost to Follow-up|1|||
147602659|NCT02603393|532363567|FG001|Overall Study|Lost to Follow-up|2|||
147602660|NCT02603393|532363566|FG000|Overall Study|Non-compliance with study treatment|1|||
147281161|NCT03251924|531194585|FG000|Overall Study|Adverse Event unrelated to study drug|0|||
147335508|NCT03460756|531395396|FG001|Overall Study|Protocol Violation|0|||
147602661|NCT02603393|532363567|FG001|Overall Study|Non-compliance with study treatment|0|||
147602662|NCT02603393|532363566|FG000|Overall Study|Sponsor decision|1|||
147602663|NCT02603393|532363567|FG001|Overall Study|Sponsor decision|0|||
147602664|NCT00699374|532363568|FG000|Overall Study|Death|93|||
147602665|NCT00699374|532363569|FG001|Overall Study|Death|83|||
147335509|NCT03460756|531395397|FG002|Overall Study|Protocol Violation|0|||
147335510|NCT03460756|531395398|FG003|Overall Study|Protocol Violation|1|||
147335511|NCT03460756|531395395|FG000|Overall Study|Withdrawal by Subject|0|||
147335512|NCT03460756|531395396|FG001|Overall Study|Withdrawal by Subject|4|||
147335513|NCT03460756|531395397|FG002|Overall Study|Withdrawal by Subject|7|||
147335514|NCT03460756|531395398|FG003|Overall Study|Withdrawal by Subject|3|||
147335515|NCT03946670|531395402|FG000|Overall Study|Progressive Disease|34|||
147335516|NCT03946670|531395403|FG001|Overall Study|Progressive Disease|27|||
147335517|NCT03946670|531395402|FG000|Overall Study|Adverse Event|7|||
147335518|NCT03946670|531395403|FG001|Overall Study|Adverse Event|10|||
147335519|NCT03946670|531395402|FG000|Overall Study|Physician Decision|6|||
147335520|NCT03946670|531395403|FG001|Overall Study|Physician Decision|5|||
147335521|NCT03946670|531395402|FG000|Overall Study|Death|5|||
147335522|NCT03946670|531395403|FG001|Overall Study|Death|8|||
147335523|NCT03946670|531395402|FG000|Overall Study|Hematopoietic stem cell transplantation (HSCT) Planned|5|||
147335524|NCT03946670|531395403|FG001|Overall Study|Hematopoietic stem cell transplantation (HSCT) Planned|6|||
147602666|NCT00699374|532363568|FG000|Overall Study|Adverse Event|70|||
147602667|NCT00699374|532363569|FG001|Overall Study|Adverse Event|67|||
147602668|NCT00699374|532363568|FG000|Overall Study|Global deterioration of health status|7|||
147602669|NCT00699374|532363569|FG001|Overall Study|Global deterioration of health status|8|||
147602670|NCT00699374|532363568|FG000|Overall Study|Lost to Follow-up|3|||
147602671|NCT00699374|532363569|FG001|Overall Study|Lost to Follow-up|5|||
147602672|NCT00699374|532363568|FG000|Overall Study|Withdrawal by Subject|34|||
147602673|NCT00699374|532363569|FG001|Overall Study|Withdrawal by Subject|44|||
147602674|NCT00699374|532363568|FG000|Overall Study|Objective progression or relapse|281|||
147602675|NCT00699374|532363569|FG001|Overall Study|Objective progression or relapse|277|||
147602676|NCT00699374|532363568|FG000|Overall Study|Other|18|||
147602677|NCT00699374|532363569|FG001|Overall Study|Other|15|||
147602678|NCT00699374|532363568|FG000|Overall Study|Protocol Violation|2|||
147602679|NCT00699374|532363569|FG001|Overall Study|Protocol Violation|6|||
147602680|NCT00699374|532363568|FG000|Overall Study|Study terminated by sponsor|13|||
147602681|NCT00699374|532363569|FG001|Overall Study|Study terminated by sponsor|28|||
147602682|NCT00699374|532363568|FG000|Overall Study|Randomized but not treated|4|||
147602683|NCT00699374|532363569|FG001|Overall Study|Randomized but not treated|2|||
147602684|NCT00699374|532363568|FG000|Overall Study|Died 28 days after last dose|5|||
147602685|NCT00699374|532363569|FG001|Overall Study|Died 28 days after last dose|9|||
147602686|NCT01359969|532363573|FG000|Overall Study|Study continued until at least 20 patients had been treated for at least one treatment.|37|||
147602687|NCT00593736|532363577|FG000|Screening Period and Placebo Run-in|Adverse Event|0|||
147602688|NCT00593736|532363578|FG001|Screening Period and Placebo Run-in|Adverse Event|0|||
147602689|NCT00593736|532363579|FG002|Screening Period and Placebo Run-in|Adverse Event|0|||
147602690|NCT00593736|532363580|FG003|Screening Period and Placebo Run-in|Adverse Event|3|||
147602691|NCT00593736|532363577|FG000|Screening Period and Placebo Run-in|Lost to Follow-up|0|||
147602692|NCT00593736|532363578|FG001|Screening Period and Placebo Run-in|Lost to Follow-up|0|||
147602693|NCT00593736|532363579|FG002|Screening Period and Placebo Run-in|Lost to Follow-up|0|||
147602694|NCT00593736|532363580|FG003|Screening Period and Placebo Run-in|Lost to Follow-up|9|||
147602695|NCT00593736|532363577|FG000|Screening Period and Placebo Run-in|Withdrawal by Subject|0|||
147602696|NCT00593736|532363578|FG001|Screening Period and Placebo Run-in|Withdrawal by Subject|0|||
147602697|NCT00593736|532363579|FG002|Screening Period and Placebo Run-in|Withdrawal by Subject|0|||
147602698|NCT00593736|532363580|FG003|Screening Period and Placebo Run-in|Withdrawal by Subject|43|||
147602699|NCT00593736|532363577|FG000|Screening Period and Placebo Run-in|Study Termination|0|||
147602700|NCT00593736|532363578|FG001|Screening Period and Placebo Run-in|Study Termination|0|||
147602701|NCT00593736|532363579|FG002|Screening Period and Placebo Run-in|Study Termination|0|||
147602702|NCT00593736|532363580|FG003|Screening Period and Placebo Run-in|Study Termination|15|||
147602703|NCT00593736|532363577|FG000|Screening Period and Placebo Run-in|Did Not Meet Criteria|0|||
147602704|NCT00593736|532363578|FG001|Screening Period and Placebo Run-in|Did Not Meet Criteria|0|||
147602705|NCT00593736|532363579|FG002|Screening Period and Placebo Run-in|Did Not Meet Criteria|0|||
147602706|NCT00593736|532363580|FG003|Screening Period and Placebo Run-in|Did Not Meet Criteria|322|||
147602707|NCT00593736|532363577|FG000|Screening Period and Placebo Run-in|Various|0|||
147602708|NCT00593736|532363578|FG001|Screening Period and Placebo Run-in|Various|0|||
147602709|NCT00593736|532363579|FG002|Screening Period and Placebo Run-in|Various|0|||
147602710|NCT00593736|532363580|FG003|Screening Period and Placebo Run-in|Various|25|||
147602711|NCT00593736|532363577|FG000|Treatment Period and Placebo Run-out|Lost to Follow-up|2|||
147662538|NCT02513550|532587346|FG001|Post-Treatment Follow-up Period|Adverse Event|1|||
147662539|NCT02513550|532587347|FG002|Post-Treatment Follow-up Period|Adverse Event|4|||
147662540|NCT02513550|532587348|FG003|Post-Treatment Follow-up Period|Adverse Event|0|||
147335525|NCT03946670|531395402|FG000|Overall Study|Subject Decision|4|||
147602712|NCT00593736|532363578|FG001|Treatment Period and Placebo Run-out|Lost to Follow-up|1|||
147602713|NCT00593736|532363579|FG002|Treatment Period and Placebo Run-out|Lost to Follow-up|2|||
147662541|NCT02513550|532587349|FG004|Post-Treatment Follow-up Period|Adverse Event|0|||
147335526|NCT03946670|531395403|FG001|Overall Study|Subject Decision|5|||
147335527|NCT03946670|531395402|FG000|Overall Study|Study Terminated By Sponsor|2|||
147335528|NCT03946670|531395403|FG001|Overall Study|Study Terminated By Sponsor|0|||
147335529|NCT03946670|531395402|FG000|Overall Study|New Therapy For Study Indication|1|||
147335530|NCT03946670|531395403|FG001|Overall Study|New Therapy For Study Indication|0|||
147335531|NCT03946670|531395402|FG000|Overall Study|Not Treated|1|||
147335532|NCT03946670|531395403|FG001|Overall Study|Not Treated|1|||
147335533|NCT02425111|531395404|FG000|Part A: Treatment Period|Pretreatment Event/Adverse Event|2|||
147335534|NCT02425111|531395404|FG000|Part A: Treatment Period|Lack of Efficacy|15|||
147335535|NCT02425111|531395404|FG000|Part A: Treatment Period|Voluntary Withdrawal|4|||
147335536|NCT02425111|531395404|FG000|Part A: Treatment Period|Lost to Follow-up|2|||
147335537|NCT02425111|531395404|FG000|Part B: Treatment Extension Period|Pretreatment Event/Adverse Event(s)|3|||
147335538|NCT02425111|531395404|FG000|Part B: Treatment Extension Period|Lack of Efficacy|7|||
147335539|NCT00588770|531395408|FG000|Overall Study|Disease progression|85|||
147335540|NCT00588770|531395409|FG001|Overall Study|Disease progression|68|||
147335541|NCT00588770|531395408|FG000|Overall Study|Adverse Event|29|||
147335542|NCT00588770|531395409|FG001|Overall Study|Adverse Event|58|||
147335543|NCT00588770|531395408|FG000|Overall Study|Death|13|||
147335544|NCT00588770|531395409|FG001|Overall Study|Death|22|||
147335545|NCT00588770|531395408|FG000|Overall Study|Withdrawal by Subject|15|||
147335546|NCT00588770|531395409|FG001|Overall Study|Withdrawal by Subject|25|||
147335547|NCT00588770|531395408|FG000|Overall Study|Alternative therapy|2|||
147335548|NCT00588770|531395409|FG001|Overall Study|Alternative therapy|4|||
147335549|NCT00588770|531395408|FG000|Overall Study|Other complicating disease|3|||
147335550|NCT00588770|531395409|FG001|Overall Study|Other complicating disease|2|||
147335551|NCT00588770|531395408|FG000|Overall Study|Not start protocol therapy|0|||
147335552|NCT00588770|531395409|FG001|Overall Study|Not start protocol therapy|9|||
147335553|NCT00588770|531395408|FG000|Overall Study|Lack of Efficacy|8|||
147335554|NCT00588770|531395409|FG001|Overall Study|Lack of Efficacy|10|||
147335555|NCT00588770|531395408|FG000|Overall Study|Physician discretion|2|||
147335556|NCT00588770|531395409|FG001|Overall Study|Physician discretion|0|||
147335557|NCT00588770|531395408|FG000|Overall Study|Patient non-compliance|2|||
147335558|NCT00588770|531395409|FG001|Overall Study|Patient non-compliance|2|||
147335559|NCT00843882|531395410|FG000|Step 1|Lack of Efficacy|14|||
147335560|NCT00843882|531395411|FG001|Step 1|Lack of Efficacy|10|||
147335561|NCT00843882|531395412|FG002|Step 1|Lack of Efficacy|21|||
147335562|NCT00843882|531395410|FG000|Step 1|Adverse Event|8|||
147335563|NCT00843882|531395411|FG001|Step 1|Adverse Event|17|||
147335564|NCT00843882|531395412|FG002|Step 1|Adverse Event|20|||
147335565|NCT00843882|531395410|FG000|Step 1|Death|1|||
147335566|NCT00843882|531395411|FG001|Step 1|Death|2|||
147335567|NCT00843882|531395412|FG002|Step 1|Death|4|||
147335568|NCT00843882|531395410|FG000|Step 1|Withdrawal by Subject|6|||
147335569|NCT00843882|531395411|FG001|Step 1|Withdrawal by Subject|12|||
147335570|NCT00843882|531395412|FG002|Step 1|Withdrawal by Subject|9|||
147335571|NCT00843882|531395410|FG000|Step 1|Physician Decision|0|||
147335572|NCT00843882|531395411|FG001|Step 1|Physician Decision|5|||
147335573|NCT00843882|531395412|FG002|Step 1|Physician Decision|1|||
147335574|NCT00843882|531395410|FG000|Step 1|Patient and physician's decision|0|||
147335575|NCT00843882|531395411|FG001|Step 1|Patient and physician's decision|0|||
147335576|NCT00843882|531395412|FG002|Step 1|Patient and physician's decision|1|||
147602714|NCT00593736|532363580|FG003|Treatment Period and Placebo Run-out|Lost to Follow-up|0|||
147602715|NCT00593736|532363577|FG000|Treatment Period and Placebo Run-out|Protocol Violation|0|||
147602716|NCT00593736|532363578|FG001|Treatment Period and Placebo Run-out|Protocol Violation|0|||
147602717|NCT00593736|532363579|FG002|Treatment Period and Placebo Run-out|Protocol Violation|1|||
147602718|NCT00593736|532363580|FG003|Treatment Period and Placebo Run-out|Protocol Violation|1|||
147602719|NCT00593736|532363577|FG000|Treatment Period and Placebo Run-out|Withdrawal by Subject|0|||
147602720|NCT00593736|532363578|FG001|Treatment Period and Placebo Run-out|Withdrawal by Subject|0|||
147602721|NCT00593736|532363579|FG002|Treatment Period and Placebo Run-out|Withdrawal by Subject|1|||
147602722|NCT00593736|532363580|FG003|Treatment Period and Placebo Run-out|Withdrawal by Subject|3|||
147602723|NCT00593736|532363577|FG000|Treatment Period and Placebo Run-out|Various|1|||
147602724|NCT00593736|532363578|FG001|Treatment Period and Placebo Run-out|Various|1|||
147602725|NCT00593736|532363579|FG002|Treatment Period and Placebo Run-out|Various|1|||
147602726|NCT00593736|532363580|FG003|Treatment Period and Placebo Run-out|Various|0|||
147602727|NCT01868893|532363581|FG000|Overall Study|Adverse Event|2|||
147335577|NCT00843882|531395410|FG000|Step 1|Other complicating disease|1|||
147335578|NCT00843882|531395411|FG001|Step 1|Other complicating disease|3|||
147335579|NCT00843882|531395412|FG002|Step 1|Other complicating disease|4|||
147335580|NCT00843882|531395410|FG000|Step 1|Alternative therapy|0|||
147335581|NCT00843882|531395411|FG001|Step 1|Alternative therapy|1|||
147335582|NCT00843882|531395412|FG002|Step 1|Alternative therapy|1|||
147335583|NCT00843882|531395410|FG000|Step 1|Patient switched treatment early due to DSMC announcement|0|||
147335584|NCT00843882|531395411|FG001|Step 1|Patient switched treatment early due to DSMC announcement|4|||
147335585|NCT00843882|531395412|FG002|Step 1|Patient switched treatment early due to DSMC announcement|0|||
147335586|NCT00843882|531395410|FG000|Step 1|Off treatment reason unknown|0|||
147335587|NCT00843882|531395411|FG001|Step 1|Off treatment reason unknown|1|||
147335588|NCT00843882|531395412|FG002|Step 1|Off treatment reason unknown|4|||
147335589|NCT00843882|531395410|FG000|Step 1|Never started treatment|2|||
147602728|NCT01868893|532363581|FG000|Overall Study|Commercial availability of study drug|17|||
147602729|NCT01868893|532363581|FG000|Overall Study|Neutropenia|1|||
147602730|NCT01857271|532363582|FG000|Overall Study|Lost to Follow-up|1|||
147602731|NCT04283500|532363587|FG000|Overall Study|Lost to Follow-up|8|||
147602732|NCT04283500|532363587|FG000|Overall Study|Withdrawn by study team prior to intervention for not meeting post-enrollment inclusion criteria|1|||
147602733|NCT02006693|532363591|FG000|Overall Study|No Reason Specified|6|||
147602734|NCT02006693|532363592|FG001|Overall Study|No Reason Specified|8|||
147602735|NCT02006693|532363591|FG000|Overall Study|Another Glaucoma-related Surgery|12|||
147602736|NCT02006693|532363592|FG001|Overall Study|Another Glaucoma-related Surgery|1|||
147602737|NCT02006693|532363591|FG000|Overall Study|XEN Implant Explantation|0|||
147602738|NCT02006693|532363592|FG001|Overall Study|XEN Implant Explantation|1|||
147602739|NCT02006693|532363591|FG000|Overall Study|Death|2|||
147602740|NCT02006693|532363592|FG001|Overall Study|Death|2|||
147602741|NCT02006693|532363591|FG000|Overall Study|Lost to Follow-up|4|||
147602742|NCT02006693|532363592|FG001|Overall Study|Lost to Follow-up|1|||
147602743|NCT02006693|532363591|FG000|Overall Study|Patient Decision|4|||
147602744|NCT02006693|532363592|FG001|Overall Study|Patient Decision|0|||
147602745|NCT01119508|532363595|FG000|Overall Study|Adverse Event|56|||
147602746|NCT01119508|532363595|FG000|Overall Study|Withdrawal by Subject|2|||
147602747|NCT01119508|532363595|FG000|Overall Study|Died before tumor response evaluation|1|||
147602748|NCT00265395|532363596|FG000|Overall Study|Adverse Event|3|||
147602749|NCT00265395|532363597|FG001|Overall Study|Adverse Event|6|||
147602750|NCT00265395|532363596|FG000|Overall Study|Lost to Follow-up|2|||
147602751|NCT00265395|532363597|FG001|Overall Study|Lost to Follow-up|1|||
147602752|NCT00265395|532363596|FG000|Overall Study|Withdrawal by Subject|1|||
147602753|NCT00265395|532363597|FG001|Overall Study|Withdrawal by Subject|6|||
147602754|NCT00265395|532363596|FG000|Overall Study|Protocol Violation|2|||
147602755|NCT00265395|532363597|FG001|Overall Study|Protocol Violation|2|||
147602756|NCT00265395|532363596|FG000|Overall Study|Lack of Efficacy|0|||
147602757|NCT00265395|532363597|FG001|Overall Study|Lack of Efficacy|1|||
147602758|NCT00265395|532363596|FG000|Overall Study|Administrative|0|||
147602759|NCT00265395|532363597|FG001|Overall Study|Administrative|1|||
147602760|NCT02563106|532363602|FG000|Overall Study|Withdrawal by Subject|7|||
147602761|NCT02563106|532363603|FG001|Overall Study|Withdrawal by Subject|8|||
147602762|NCT02563106|532363602|FG000|Overall Study|Adverse Event|17|||
147602763|NCT02563106|532363603|FG001|Overall Study|Adverse Event|15|||
147602764|NCT02563106|532363602|FG000|Overall Study|Protocol Violation|1|||
147602765|NCT02563106|532363603|FG001|Overall Study|Protocol Violation|0|||
147602766|NCT02563106|532363602|FG000|Overall Study|Use of non-permitted concurrent therapy|1|||
147602767|NCT02563106|532363603|FG001|Overall Study|Use of non-permitted concurrent therapy|2|||
147602768|NCT02563106|532363602|FG000|Overall Study|Lost to Follow-up|3|||
147602769|NCT02563106|532363603|FG001|Overall Study|Lost to Follow-up|2|||
147602770|NCT02563106|532363602|FG000|Overall Study|Physician Decision|3|||
147602771|NCT02563106|532363603|FG001|Overall Study|Physician Decision|1|||
147602772|NCT02563106|532363602|FG000|Overall Study|Other reason - not specified|2|||
147602773|NCT02563106|532363603|FG001|Overall Study|Other reason - not specified|1|||
147602774|NCT04729309|532363604|FG000|Period 1|Subject unable to return for Period 2|3|||
147602775|NCT04729309|532363605|FG001|Period 1|Subject unable to return for Period 2|0|||
147602776|NCT04729309|532363604|FG000|Period 1|Lost to Follow-up|1|||
147602777|NCT04729309|532363605|FG001|Period 1|Lost to Follow-up|0|||
147602778|NCT01212588|532363606|FG000|Overall Study|Physician Decision|0|||
147602779|NCT01212588|532363607|FG001|Overall Study|Physician Decision|1|||
147602780|NCT01212588|532363606|FG000|Overall Study|Protocol Violation|1|||
147602781|NCT01212588|532363607|FG001|Overall Study|Protocol Violation|1|||
147602782|NCT02338193|532363608|FG000|Overall Study|Withdrawal by Subject|0|||
147602783|NCT02338193|532363609|FG001|Overall Study|Withdrawal by Subject|0|||
147602784|NCT02338193|532363610|FG002|Overall Study|Withdrawal by Subject|2|||
147602785|NCT02338193|532363608|FG000|Overall Study|Pregnancy|0|||
147281162|NCT03251924|531194586|FG001|Overall Study|Adverse Event unrelated to study drug|0|||
147281163|NCT03251924|531194587|FG002|Overall Study|Adverse Event unrelated to study drug|0|||
147281164|NCT03251924|531194588|FG003|Overall Study|Adverse Event unrelated to study drug|1|||
147602786|NCT02338193|532363609|FG001|Overall Study|Pregnancy|1|||
147602787|NCT02338193|532363610|FG002|Overall Study|Pregnancy|1|||
147602788|NCT02338193|532363608|FG000|Overall Study|Noncompliant with visits|2|||
147602789|NCT02338193|532363609|FG001|Overall Study|Noncompliant with visits|2|||
147602790|NCT02338193|532363610|FG002|Overall Study|Noncompliant with visits|7|||
147602791|NCT02338193|532363608|FG000|Overall Study|moved out of state|0|||
147602792|NCT02338193|532363609|FG001|Overall Study|moved out of state|1|||
147662542|NCT02513550|532587350|FG005|Post-Treatment Follow-up Period|Adverse Event|0|||
147602793|NCT02338193|532363610|FG002|Overall Study|moved out of state|0|||
147602794|NCT02338193|532363608|FG000|Overall Study|intolerant of side effects|1|||
147602795|NCT02338193|532363609|FG001|Overall Study|intolerant of side effects|0|||
147602796|NCT02338193|532363610|FG002|Overall Study|intolerant of side effects|0|||
147602797|NCT01136967|532363611|FG000|Overall Study|Adverse Event|9|||
147602798|NCT01136967|532363612|FG001|Overall Study|Adverse Event|12|||
147602799|NCT01136967|532363611|FG000|Overall Study|Participant Choice|8|||
147602800|NCT01136967|532363612|FG001|Overall Study|Participant Choice|3|||
147335590|NCT00843882|531395411|FG001|Step 1|Never started treatment|0|||
147335591|NCT00843882|531395412|FG002|Step 1|Never started treatment|0|||
147335592|NCT00843882|531395410|FG000|Step 2 (Cross-over to Arm B)|Lack of Efficacy|1|||
147335593|NCT00843882|531395411|FG001|Step 2 (Cross-over to Arm B)|Lack of Efficacy|9|||
147335594|NCT00843882|531395412|FG002|Step 2 (Cross-over to Arm B)|Lack of Efficacy|0|||
147335595|NCT00843882|531395410|FG000|Step 2 (Cross-over to Arm B)|Adverse Event|0|||
147335596|NCT00843882|531395411|FG001|Step 2 (Cross-over to Arm B)|Adverse Event|6|||
147335597|NCT00843882|531395412|FG002|Step 2 (Cross-over to Arm B)|Adverse Event|0|||
147335598|NCT00843882|531395410|FG000|Step 2 (Cross-over to Arm B)|Death|0|||
147335599|NCT00843882|531395411|FG001|Step 2 (Cross-over to Arm B)|Death|3|||
147602801|NCT01136967|532363611|FG000|Overall Study|Lost to Follow-up|0|||
147602802|NCT01136967|532363612|FG001|Overall Study|Lost to Follow-up|1|||
147602803|NCT01136967|532363611|FG000|Overall Study|Withdrawal by Subject|1|||
147602804|NCT01136967|532363612|FG001|Overall Study|Withdrawal by Subject|2|||
147602805|NCT01136967|532363611|FG000|Overall Study|Clinical Progression|3|||
147602806|NCT01136967|532363612|FG001|Overall Study|Clinical Progression|5|||
147602807|NCT01136967|532363611|FG000|Overall Study|Radiation|1|||
147602808|NCT01136967|532363612|FG001|Overall Study|Radiation|0|||
147602809|NCT01136967|532363611|FG000|Overall Study|Non-compliance|1|||
147602810|NCT01136967|532363612|FG001|Overall Study|Non-compliance|0|||
147602811|NCT01136967|532363611|FG000|Overall Study|Investigator's Choice|1|||
147602812|NCT01136967|532363612|FG001|Overall Study|Investigator's Choice|1|||
147602813|NCT01136967|532363611|FG000|Overall Study|Increase in Lesion Size|0|||
147602814|NCT01136967|532363612|FG001|Overall Study|Increase in Lesion Size|2|||
147602815|NCT01136967|532363611|FG000|Overall Study|Diagnosis of Second Primary Cancer|0|||
147602816|NCT01136967|532363612|FG001|Overall Study|Diagnosis of Second Primary Cancer|1|||
147602817|NCT01735955|532363614|FG000|Overall Study|Administrative problems|1|||
147602818|NCT01735955|532363614|FG000|Overall Study|Patient/guardian decision|1|||
147602819|NCT01735955|532363614|FG000|Overall Study|Patient withdrew consent|2|||
147602820|NCT01735955|532363614|FG000|Overall Study|Physician Decision|4|||
147602821|NCT01735955|532363614|FG000|Overall Study|Disease progression|24|||
147602822|NCT01735955|532363614|FG000|Overall Study|Adverse Event|5|||
147602823|NCT02885181|532363615|FG000|Overall Study|Investigator's Discretion|0|||
147602824|NCT02885181|532363616|FG001|Overall Study|Investigator's Discretion|1|||
147602825|NCT02885181|532363617|FG002|Overall Study|Investigator's Discretion|0|||
147602826|NCT02885181|532363618|FG003|Overall Study|Investigator's Discretion|1|||
147602827|NCT02885181|532363615|FG000|Overall Study|Adverse Event|0|||
147602828|NCT02885181|532363616|FG001|Overall Study|Adverse Event|0|||
147602829|NCT02885181|532363617|FG002|Overall Study|Adverse Event|0|||
147602830|NCT02885181|532363618|FG003|Overall Study|Adverse Event|1|||
147602831|NCT02885181|532363615|FG000|Overall Study|Withdrawal by Subject|0|||
147602832|NCT02885181|532363616|FG001|Overall Study|Withdrawal by Subject|0|||
147602833|NCT02885181|532363617|FG002|Overall Study|Withdrawal by Subject|0|||
147602834|NCT02885181|532363618|FG003|Overall Study|Withdrawal by Subject|1|||
147602835|NCT03317834|532363619|FG000|Overall Study|Death|2|||
147602836|NCT03317834|532363619|FG000|Overall Study|Device Revision|5|||
147602837|NCT03317834|532363619|FG000|Overall Study|Withdrawal by Subject|13|||
147602838|NCT03317834|532363619|FG000|Overall Study|Lost to Follow-up|13|||
147602839|NCT04228783|532363623|FG000|Overall Study|Adverse Event|1|||
147602840|NCT04228783|532363624|FG001|Overall Study|Adverse Event|0|||
147602841|NCT04228783|532363625|FG002|Overall Study|Adverse Event|2|||
147602842|NCT04228783|532363626|FG003|Overall Study|Adverse Event|0|||
147602843|NCT04228783|532363627|FG004|Overall Study|Adverse Event|0|||
147602844|NCT04228783|532363628|FG005|Overall Study|Adverse Event|1|||
147602845|NCT04228783|532363623|FG000|Overall Study|Death|0|||
147602846|NCT04228783|532363624|FG001|Overall Study|Death|0|||
147335600|NCT00843882|531395412|FG002|Step 2 (Cross-over to Arm B)|Death|0|||
147451232|NCT05048719|531814815|FG001|Overall Study|Sponsor decision due To inadvertent Enrollment|1|||
147602847|NCT04228783|532363625|FG002|Overall Study|Death|0|||
147602848|NCT04228783|532363626|FG003|Overall Study|Death|0|||
147602849|NCT04228783|532363627|FG004|Overall Study|Death|1|||
147602850|NCT04228783|532363628|FG005|Overall Study|Death|0|||
147602851|NCT04228783|532363623|FG000|Overall Study|Lost to Follow-up|36|||
147602852|NCT04228783|532363624|FG001|Overall Study|Lost to Follow-up|36|||
147662543|NCT02513550|532587345|FG000|Post-Treatment Follow-up Period|Physician Decision|2|||
147602853|NCT04228783|532363625|FG002|Overall Study|Lost to Follow-up|28|||
147602854|NCT04228783|532363626|FG003|Overall Study|Lost to Follow-up|6|||
147602855|NCT04228783|532363627|FG004|Overall Study|Lost to Follow-up|14|||
147602856|NCT04228783|532363628|FG005|Overall Study|Lost to Follow-up|3|||
147335601|NCT00843882|531395410|FG000|Step 2 (Cross-over to Arm B)|Withdrawal by Subject|2|||
147335602|NCT00843882|531395411|FG001|Step 2 (Cross-over to Arm B)|Withdrawal by Subject|5|||
147602857|NCT04228783|532363623|FG000|Overall Study|Physician Decision|1|||
147602858|NCT04228783|532363624|FG001|Overall Study|Physician Decision|2|||
147602859|NCT04228783|532363625|FG002|Overall Study|Physician Decision|0|||
147602860|NCT04228783|532363626|FG003|Overall Study|Physician Decision|0|||
147602861|NCT04228783|532363627|FG004|Overall Study|Physician Decision|0|||
147602862|NCT04228783|532363628|FG005|Overall Study|Physician Decision|0|||
147281165|NCT03251924|531194589|FG004|Overall Study|Adverse Event unrelated to study drug|0|||
147281166|NCT03251924|531194590|FG005|Overall Study|Adverse Event unrelated to study drug|1|||
147281167|NCT03251924|531194591|FG006|Overall Study|Adverse Event unrelated to study drug|1|||
147281168|NCT03251924|531194592|FG007|Overall Study|Adverse Event unrelated to study drug|0|||
147451233|NCT05048719|531814816|FG002|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
147451234|NCT05048719|531814817|FG003|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
147451235|NCT05048719|531814818|FG004|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
147602863|NCT04228783|532363623|FG000|Overall Study|Protocol Violation|0|||
147281169|NCT03251924|531194593|FG008|Overall Study|Adverse Event unrelated to study drug|0|||
147281170|NCT03251924|531194585|FG000|Overall Study|Death|0|||
147281171|NCT03251924|531194586|FG001|Overall Study|Death|1|||
147281172|NCT03251924|531194587|FG002|Overall Study|Death|0|||
147281173|NCT03251924|531194588|FG003|Overall Study|Death|1|||
147281174|NCT03251924|531194589|FG004|Overall Study|Death|1|||
147281175|NCT03251924|531194590|FG005|Overall Study|Death|1|||
147281176|NCT03251924|531194591|FG006|Overall Study|Death|0|||
147281177|NCT03251924|531194592|FG007|Overall Study|Death|0|||
147281178|NCT03251924|531194593|FG008|Overall Study|Death|0|||
147281179|NCT03251924|531194585|FG000|Overall Study|Study Drug Toxicity|0|||
147281180|NCT03251924|531194586|FG001|Overall Study|Study Drug Toxicity|0|||
147281181|NCT03251924|531194587|FG002|Overall Study|Study Drug Toxicity|0|||
147281182|NCT03251924|531194588|FG003|Overall Study|Study Drug Toxicity|1|||
147281183|NCT03251924|531194589|FG004|Overall Study|Study Drug Toxicity|0|||
147281184|NCT03251924|531194590|FG005|Overall Study|Study Drug Toxicity|0|||
147281185|NCT03251924|531194591|FG006|Overall Study|Study Drug Toxicity|0|||
147281186|NCT03251924|531194592|FG007|Overall Study|Study Drug Toxicity|0|||
147281187|NCT03251924|531194593|FG008|Overall Study|Study Drug Toxicity|1|||
147281188|NCT03251924|531194585|FG000|Overall Study|Other Reasons|0|||
147281189|NCT03251924|531194586|FG001|Overall Study|Other Reasons|0|||
147281190|NCT03251924|531194587|FG002|Overall Study|Other Reasons|0|||
147281191|NCT03251924|531194588|FG003|Overall Study|Other Reasons|0|||
147281192|NCT03251924|531194589|FG004|Overall Study|Other Reasons|0|||
147281193|NCT03251924|531194590|FG005|Overall Study|Other Reasons|0|||
147281194|NCT03251924|531194591|FG006|Overall Study|Other Reasons|0|||
147281195|NCT03251924|531194592|FG007|Overall Study|Other Reasons|0|||
147281196|NCT03251924|531194593|FG008|Overall Study|Other Reasons|1|||
147281197|NCT03251924|531194585|FG000|Overall Study|Participant request to discontinue study treatment|0|||
147281198|NCT03251924|531194586|FG001|Overall Study|Participant request to discontinue study treatment|0|||
147281199|NCT03251924|531194587|FG002|Overall Study|Participant request to discontinue study treatment|0|||
147281200|NCT03251924|531194588|FG003|Overall Study|Participant request to discontinue study treatment|0|||
147281201|NCT03251924|531194589|FG004|Overall Study|Participant request to discontinue study treatment|0|||
147281202|NCT03251924|531194590|FG005|Overall Study|Participant request to discontinue study treatment|0|||
147281203|NCT03251924|531194591|FG006|Overall Study|Participant request to discontinue study treatment|0|||
147281204|NCT03251924|531194592|FG007|Overall Study|Participant request to discontinue study treatment|1|||
147281205|NCT03251924|531194593|FG008|Overall Study|Participant request to discontinue study treatment|0|||
147281206|NCT00153101|531194594|FG000|Overall Study|Lost to Follow-up|14|||
147281207|NCT00153101|531194595|FG001|Overall Study|Lost to Follow-up|14|||
147281208|NCT00153101|531194596|FG002|Overall Study|Lost to Follow-up|12|||
147281209|NCT00153101|531194597|FG003|Overall Study|Lost to Follow-up|5|||
147281210|NCT00153101|531194598|FG004|Overall Study|Lost to Follow-up|5|||
147451236|NCT05048719|531814819|FG005|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
147451237|NCT05048719|531814820|FG006|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
147602864|NCT04228783|532363624|FG001|Overall Study|Protocol Violation|0|||
147602865|NCT04228783|532363625|FG002|Overall Study|Protocol Violation|0|||
147602866|NCT04228783|532363626|FG003|Overall Study|Protocol Violation|1|||
147602867|NCT04228783|532363627|FG004|Overall Study|Protocol Violation|0|||
147602868|NCT04228783|532363628|FG005|Overall Study|Protocol Violation|0|||
147602869|NCT04228783|532363623|FG000|Overall Study|Withdrawal by Subject|6|||
147602870|NCT04228783|532363624|FG001|Overall Study|Withdrawal by Subject|10|||
147602871|NCT04228783|532363625|FG002|Overall Study|Withdrawal by Subject|19|||
147602872|NCT04228783|532363626|FG003|Overall Study|Withdrawal by Subject|1|||
147602873|NCT04228783|532363627|FG004|Overall Study|Withdrawal by Subject|2|||
147602874|NCT04228783|532363628|FG005|Overall Study|Withdrawal by Subject|0|||
147602875|NCT04228783|532363623|FG000|Overall Study|Other|4|||
147602876|NCT04228783|532363624|FG001|Overall Study|Other|3|||
147602877|NCT04228783|532363625|FG002|Overall Study|Other|2|||
147602878|NCT04228783|532363626|FG003|Overall Study|Other|1|||
147602879|NCT04228783|532363627|FG004|Overall Study|Other|0|||
147602880|NCT04228783|532363628|FG005|Overall Study|Other|0|||
147281211|NCT00153101|531194594|FG000|Overall Study|Withdrawal by Subject|3|||
147281212|NCT00153101|531194595|FG001|Overall Study|Withdrawal by Subject|4|||
147281213|NCT00153101|531194596|FG002|Overall Study|Withdrawal by Subject|3|||
147281214|NCT00153101|531194597|FG003|Overall Study|Withdrawal by Subject|3|||
147281215|NCT00153101|531194598|FG004|Overall Study|Withdrawal by Subject|5|||
147281216|NCT03169153|531194599|FG000|Period 1, First 30 Days of Wear|Lost to Follow-up|1|||
147602881|NCT00626392|532363629|FG000|Run-in Period|Adverse Event|0|||
147451238|NCT05048719|531814821|FG007|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
147451239|NCT05048719|531814822|FG008|Overall Study|Sponsor decision due To inadvertent Enrollment|0|||
147451240|NCT05048719|531814814|FG000|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
147451241|NCT05048719|531814815|FG001|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
147451242|NCT05048719|531814816|FG002|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
147451243|NCT05048719|531814817|FG003|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|1|||
147451244|NCT05048719|531814818|FG004|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
147451245|NCT05048719|531814819|FG005|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
147451246|NCT05048719|531814820|FG006|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
147281217|NCT03169153|531194600|FG001|Period 1, First 30 Days of Wear|Lost to Follow-up|1|||
147281218|NCT03169153|531194599|FG000|Period 1, First 30 Days of Wear|Withdrawal by Subject|2|||
147281219|NCT03169153|531194600|FG001|Period 1, First 30 Days of Wear|Withdrawal by Subject|3|||
147281220|NCT03169153|531194599|FG000|Period 2, Second 30 Days of Wear|Adverse Event|1|||
147281221|NCT03169153|531194600|FG001|Period 2, Second 30 Days of Wear|Adverse Event|2|||
147281222|NCT03169153|531194599|FG000|Period 2, Second 30 Days of Wear|Could not attend visit|1|||
147281223|NCT03169153|531194600|FG001|Period 2, Second 30 Days of Wear|Could not attend visit|0|||
147281224|NCT01440946|531194601|FG000|Overall Study|Lost to Follow-up|1|||
147281225|NCT01440946|531194602|FG001|Overall Study|Lost to Follow-up|1|||
147281226|NCT01440946|531194601|FG000|Overall Study|Physician Decision|1|||
147281227|NCT01440946|531194602|FG001|Overall Study|Physician Decision|0|||
147281228|NCT03299192|531194603|FG000|Overall Study|Fell before classes started|1|||
147281229|NCT03299192|531194604|FG001|Overall Study|Fell before classes started|0|||
147451247|NCT05048719|531814821|FG007|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
147451248|NCT05048719|531814822|FG008|Overall Study|Participant decided to Discontinue Treatment and only Return for Single Final Visit|0|||
147451249|NCT05048719|531814814|FG000|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
147451250|NCT05048719|531814815|FG001|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
147451251|NCT05048719|531814816|FG002|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
147451252|NCT05048719|531814817|FG003|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
147662544|NCT02513550|532587346|FG001|Post-Treatment Follow-up Period|Physician Decision|0|||
147281230|NCT03299192|531194605|FG002|Overall Study|Fell before classes started|0|||
147281231|NCT03299192|531194603|FG000|Overall Study|Other|0|||
147281232|NCT03299192|531194604|FG001|Overall Study|Other|2|||
147281233|NCT03299192|531194605|FG002|Overall Study|Other|1|||
147281234|NCT00983580|531194608|FG000|Overall Study|Cancel Prior to treatment|1|||
147281235|NCT00983580|531194609|FG001|Overall Study|Cancel Prior to treatment|3|||
147281236|NCT00983580|531194608|FG000|Overall Study|Protocol Violation|1|||
147281237|NCT00983580|531194609|FG001|Overall Study|Protocol Violation|1|||
147281238|NCT00983580|531194608|FG000|Overall Study|Ineligible|3|||
147281239|NCT00983580|531194609|FG001|Overall Study|Ineligible|0|||
147281240|NCT01603875|531194612|FG000|Overall Study|Preexisting rabies antibody|3|||
147281241|NCT01603875|531194613|FG001|Overall Study|Preexisting rabies antibody|4|||
147281242|NCT01603875|531194614|FG002|Overall Study|Preexisting rabies antibody|3|||
147281243|NCT01603875|531194612|FG000|Overall Study|Lost to Follow-up|4|||
147281244|NCT01603875|531194613|FG001|Overall Study|Lost to Follow-up|3|||
147281245|NCT01603875|531194614|FG002|Overall Study|Lost to Follow-up|6|||
147281246|NCT01603875|531194612|FG000|Overall Study|Protocol Violation|0|||
147281247|NCT01603875|531194613|FG001|Overall Study|Protocol Violation|1|||
147281248|NCT01603875|531194614|FG002|Overall Study|Protocol Violation|0|||
147281249|NCT01652716|531194618|FG000|Overall Study|Loss of glucose control|1|||
147281250|NCT01652716|531194619|FG001|Overall Study|Loss of glucose control|0|||
147281251|NCT01652716|531194618|FG000|Overall Study|Administrative|0|||
147281252|NCT01652716|531194619|FG001|Overall Study|Administrative|2|||
147281253|NCT01652716|531194618|FG000|Overall Study|Investigator decision|1|||
147281254|NCT01652716|531194619|FG001|Overall Study|Investigator decision|4|||
147281255|NCT01652716|531194618|FG000|Overall Study|Lost to Follow-up|12|||
147281256|NCT01652716|531194619|FG001|Overall Study|Lost to Follow-up|11|||
147281257|NCT01652716|531194618|FG000|Overall Study|Protocol Violation|2|||
147281258|NCT01652716|531194619|FG001|Overall Study|Protocol Violation|1|||
147281259|NCT01652716|531194618|FG000|Overall Study|Adverse Event|7|||
147281260|NCT01652716|531194619|FG001|Overall Study|Adverse Event|10|||
147281261|NCT01652716|531194618|FG000|Overall Study|Withdrawal by Subject|33|||
147281262|NCT01652716|531194619|FG001|Overall Study|Withdrawal by Subject|18|||
147281263|NCT01337297|531194622|FG000|Overall Study|They entered to single anodal tDCS|4|||
147281264|NCT01337297|531194623|FG001|Overall Study|They entered to single anodal tDCS|3|||
147281265|NCT01337297|531194622|FG000|Overall Study|Lost to Follow-up|1|||
147281266|NCT01337297|531194623|FG001|Overall Study|Lost to Follow-up|3|||
147281267|NCT02778204|531194624|FG000|Overall Study|Adverse Event|1|||
147281268|NCT02778204|531194625|FG001|Overall Study|Adverse Event|0|||
147281269|NCT02778204|531194626|FG002|Overall Study|Adverse Event|0|||
147281270|NCT02778204|531194627|FG003|Overall Study|Adverse Event|0|||
147602882|NCT00626392|532363630|FG001|Run-in Period|Adverse Event|0|||
147602883|NCT00626392|532363631|FG002|Run-in Period|Adverse Event|1|||
147602884|NCT00626392|532363632|FG003|Run-in Period|Adverse Event|0|||
147602885|NCT00626392|532363633|FG004|Run-in Period|Adverse Event|1|||
147602886|NCT00626392|532363634|FG005|Run-in Period|Adverse Event|0|||
147602887|NCT00626392|532363629|FG000|Run-in Period|Withdrawal by Subject|0|||
147602888|NCT00626392|532363630|FG001|Run-in Period|Withdrawal by Subject|1|||
147602889|NCT00626392|532363631|FG002|Run-in Period|Withdrawal by Subject|1|||
147602890|NCT00626392|532363632|FG003|Run-in Period|Withdrawal by Subject|1|||
147602891|NCT00626392|532363633|FG004|Run-in Period|Withdrawal by Subject|3|||
147602892|NCT00626392|532363634|FG005|Run-in Period|Withdrawal by Subject|1|||
147602893|NCT00626392|532363629|FG000|Run-in Period|Noncompliance|1|||
147602894|NCT00626392|532363630|FG001|Run-in Period|Noncompliance|0|||
147602895|NCT00626392|532363631|FG002|Run-in Period|Noncompliance|1|||
147602896|NCT00626392|532363632|FG003|Run-in Period|Noncompliance|0|||
147602897|NCT00626392|532363633|FG004|Run-in Period|Noncompliance|0|||
147602898|NCT00626392|532363634|FG005|Run-in Period|Noncompliance|0|||
147602899|NCT00626392|532363629|FG000|Coadministration Period|Adverse Event|3|||
147602900|NCT00626392|532363630|FG001|Coadministration Period|Adverse Event|1|||
147602901|NCT00626392|532363631|FG002|Coadministration Period|Adverse Event|7|||
147602902|NCT00626392|532363632|FG003|Coadministration Period|Adverse Event|4|||
147602903|NCT00626392|532363633|FG004|Coadministration Period|Adverse Event|3|||
147602904|NCT00626392|532363634|FG005|Coadministration Period|Adverse Event|4|||
147602905|NCT00626392|532363629|FG000|Coadministration Period|Withdrawal by Subject|1|||
147602906|NCT00626392|532363630|FG001|Coadministration Period|Withdrawal by Subject|1|||
147602907|NCT00626392|532363631|FG002|Coadministration Period|Withdrawal by Subject|0|||
147602908|NCT00626392|532363632|FG003|Coadministration Period|Withdrawal by Subject|1|||
147602909|NCT00626392|532363633|FG004|Coadministration Period|Withdrawal by Subject|0|||
147281271|NCT02778204|531194624|FG000|Overall Study|Withdrawal by Subject|0|||
147281272|NCT02778204|531194625|FG001|Overall Study|Withdrawal by Subject|0|||
147281273|NCT02778204|531194626|FG002|Overall Study|Withdrawal by Subject|1|||
147281274|NCT02778204|531194627|FG003|Overall Study|Withdrawal by Subject|2|||
147281275|NCT02778204|531194624|FG000|Overall Study|Lost to Follow-up|1|||
147281276|NCT02778204|531194625|FG001|Overall Study|Lost to Follow-up|0|||
147281277|NCT02778204|531194626|FG002|Overall Study|Lost to Follow-up|2|||
147281278|NCT02778204|531194627|FG003|Overall Study|Lost to Follow-up|1|||
147281279|NCT02778204|531194624|FG000|Overall Study|Protocol Violation|0|||
147281280|NCT02778204|531194625|FG001|Overall Study|Protocol Violation|0|||
147281281|NCT02778204|531194626|FG002|Overall Study|Protocol Violation|1|||
147281282|NCT02778204|531194627|FG003|Overall Study|Protocol Violation|0|||
147281283|NCT02778204|531194624|FG000|Overall Study|Eligibility Violation|0|||
147281284|NCT02778204|531194625|FG001|Overall Study|Eligibility Violation|0|||
147281285|NCT02778204|531194626|FG002|Overall Study|Eligibility Violation|0|||
147281286|NCT02778204|531194627|FG003|Overall Study|Eligibility Violation|1|||
147281287|NCT04122443|531194628|FG000|Stage 1 - Open Label|Satisfactory relief after ibuprofen administration. Exited study|0|||
147281288|NCT04122443|531194629|FG001|Stage 1 - Open Label|Satisfactory relief after ibuprofen administration. Exited study|0|||
147281289|NCT04122443|531194630|FG002|Stage 1 - Open Label|Satisfactory relief after ibuprofen administration. Exited study|234|||
147281290|NCT04122443|531194628|FG000|Stage 1 - Open Label|Withdrawal by Subject|0|||
147281291|NCT04122443|531194629|FG001|Stage 1 - Open Label|Withdrawal by Subject|0|||
147281292|NCT04122443|531194630|FG002|Stage 1 - Open Label|Withdrawal by Subject|5|||
147281293|NCT01072201|531194631|FG000|Overall Study|Lost to Follow-up|0|||
147281294|NCT01072201|531194632|FG001|Overall Study|Lost to Follow-up|1|||
147281295|NCT00360334|531194633|FG000|Overall Study|Adverse Event|7|||
147281296|NCT00360334|531194634|FG001|Overall Study|Adverse Event|4|||
147281297|NCT00360334|531194633|FG000|Overall Study|Protocol Violation|1|||
147335603|NCT00843882|531395412|FG002|Step 2 (Cross-over to Arm B)|Withdrawal by Subject|0|||
147335604|NCT00843882|531395410|FG000|Step 2 (Cross-over to Arm B)|Physician Decision|1|||
147335605|NCT00843882|531395411|FG001|Step 2 (Cross-over to Arm B)|Physician Decision|1|||
147335606|NCT00843882|531395412|FG002|Step 2 (Cross-over to Arm B)|Physician Decision|0|||
147335607|NCT00843882|531395410|FG000|Step 2 (Cross-over to Arm B)|Alternative treatment|0|||
147335608|NCT00843882|531395411|FG001|Step 2 (Cross-over to Arm B)|Alternative treatment|1|||
147602910|NCT00626392|532363634|FG005|Coadministration Period|Withdrawal by Subject|1|||
147602911|NCT00626392|532363629|FG000|Coadministration Period|Protocol Violation|0|||
147602912|NCT00626392|532363630|FG001|Coadministration Period|Protocol Violation|1|||
147602913|NCT00626392|532363631|FG002|Coadministration Period|Protocol Violation|0|||
147602914|NCT00626392|532363632|FG003|Coadministration Period|Protocol Violation|1|||
147281298|NCT00360334|531194634|FG001|Overall Study|Protocol Violation|1|||
147281299|NCT00360334|531194633|FG000|Overall Study|Physician Decision|2|||
147281300|NCT00360334|531194634|FG001|Overall Study|Physician Decision|3|||
147281301|NCT00360334|531194633|FG000|Overall Study|Lack of Efficacy|0|||
147281302|NCT00360334|531194634|FG001|Overall Study|Lack of Efficacy|1|||
147281303|NCT00360334|531194633|FG000|Overall Study|Entry criterion not met|1|||
147281304|NCT00360334|531194634|FG001|Overall Study|Entry criterion not met|2|||
147281305|NCT00360334|531194633|FG000|Overall Study|Subject decision|8|||
147335609|NCT00843882|531395412|FG002|Step 2 (Cross-over to Arm B)|Alternative treatment|0|||
147335610|NCT00843882|531395410|FG000|Step 2 (Cross-over to Arm B)|Prolonged wound healing|0|||
147335611|NCT00843882|531395411|FG001|Step 2 (Cross-over to Arm B)|Prolonged wound healing|1|||
147335612|NCT00843882|531395412|FG002|Step 2 (Cross-over to Arm B)|Prolonged wound healing|0|||
147335613|NCT00256243|531395413|FG000|Overall Study|Lost to Follow-up|2|||
147335614|NCT00256243|531395413|FG000|Overall Study|Death|7|||
147335615|NCT00256243|531395413|FG000|Overall Study|Not treated|1|||
147335616|NCT00792948|531395414|FG000|Overall Study|Adverse Event|6|||
147335617|NCT00792948|531395414|FG000|Overall Study|Death|4|||
147335618|NCT00792948|531395414|FG000|Overall Study|Withdrawal by Subject|3|||
147335619|NCT00792948|531395414|FG000|Overall Study|Ineligible|2|||
147335620|NCT00792948|531395414|FG000|Overall Study|Insurance denial - not treated|1|||
147335621|NCT00792948|531395414|FG000|Overall Study|Physician Decision|11|||
147335622|NCT00792948|531395414|FG000|Overall Study|Protocol Violation|1|||
147335623|NCT06129045|531395415|FG000|Overall Study|Lost to Follow-up|1|||
147335624|NCT06129045|531395416|FG001|Overall Study|Lost to Follow-up|1|||
147335625|NCT06129045|531395417|FG002|Overall Study|Lost to Follow-up|4|||
147335626|NCT01582269|531395418|FG000|Overall Study|Withdrawal by Subject|1|||
147335627|NCT01582269|531395419|FG001|Overall Study|Withdrawal by Subject|0|||
147335628|NCT01582269|531395420|FG002|Overall Study|Withdrawal by Subject|0|||
147335629|NCT05076266|531395421|FG000|Overall Study|Survey not complete - Participant refusal|2|||
147335630|NCT05076266|531395422|FG001|Overall Study|Survey not complete - Participant refusal|0|||
147335631|NCT03516942|531395425|FG000|Registration through baseline survey com|Withdrawal by Subject|36|||
147335632|NCT03516942|531395425|FG000|Registration through baseline survey com|Death|8|||
147335633|NCT03516942|531395425|FG000|Registration through baseline survey com|Could not contact patient after enrollment|58|||
147335634|NCT03516942|531395425|FG000|T0: Baseline|LOST|13|||
147335635|NCT03516942|531395425|FG000|T1: 3 Months Survey|Withdrawal by Subject|13|||
147335636|NCT03516942|531395425|FG000|T1: 3 Months Survey|Death|10|||
147335637|NCT03516942|531395425|FG000|T1: 3 Months Survey|Lost|163|||
147335638|NCT03516942|531395425|FG000|T2: 6 Month Survey|Withdrawal by Subject|15|||
147335639|NCT03516942|531395425|FG000|T2: 6 Month Survey|Death|14|||
147335640|NCT03516942|531395425|FG000|T2: 6 Month Survey|Lost|180|||
147335641|NCT03516942|531395425|FG000|T3: 12 Month Survey|Withdrawal by Subject|15|||
147335642|NCT03516942|531395425|FG000|T3: 12 Month Survey|Death|19|||
147335643|NCT03516942|531395425|FG000|T3: 12 Month Survey|Lost|209|||
147335644|NCT01426269|531396374|FG000|Period 1: 12 Weeks|Adverse Event|5|||
147335645|NCT01426269|531396375|FG001|Period 1: 12 Weeks|Adverse Event|0|||
147335646|NCT01426269|531396376|FG002|Period 1: 12 Weeks|Adverse Event|0|||
147335647|NCT01426269|531396374|FG000|Period 1: 12 Weeks|Withdrawal by Subject|22|||
147335648|NCT01426269|531396375|FG001|Period 1: 12 Weeks|Withdrawal by Subject|0|||
147335649|NCT01426269|531396376|FG002|Period 1: 12 Weeks|Withdrawal by Subject|0|||
147335650|NCT01426269|531396374|FG000|Period 1: 12 Weeks|Protocol Violation|5|||
147335651|NCT01426269|531396375|FG001|Period 1: 12 Weeks|Protocol Violation|0|||
147335652|NCT01426269|531396376|FG002|Period 1: 12 Weeks|Protocol Violation|0|||
147335653|NCT01426269|531396374|FG000|Period 1: 12 Weeks|Lost to Follow-up|22|||
147335654|NCT01426269|531396375|FG001|Period 1: 12 Weeks|Lost to Follow-up|0|||
147335655|NCT01426269|531396376|FG002|Period 1: 12 Weeks|Lost to Follow-up|0|||
147335656|NCT01426269|531396374|FG000|Period 1: 12 Weeks|Pregnancy|1|||
147335657|NCT01426269|531396375|FG001|Period 1: 12 Weeks|Pregnancy|0|||
147335658|NCT01426269|531396376|FG002|Period 1: 12 Weeks|Pregnancy|0|||
147335659|NCT01426269|531396374|FG000|Eligibility for Period 2, Randomization|Did not qualify|42|||
147335660|NCT01426269|531396375|FG001|Eligibility for Period 2, Randomization|Did not qualify|0|||
147335661|NCT01426269|531396376|FG002|Eligibility for Period 2, Randomization|Did not qualify|0|||
147335662|NCT01426269|531396374|FG000|Eligibility for Period 2, Randomization|Qualified, opted out|8|||
147335663|NCT01426269|531396375|FG001|Eligibility for Period 2, Randomization|Qualified, opted out|0|||
147335664|NCT01426269|531396376|FG002|Eligibility for Period 2, Randomization|Qualified, opted out|0|||
147335665|NCT01426269|531396374|FG000|Period 2: 40 Weeks|Adverse Event|0|||
147335666|NCT01426269|531396375|FG001|Period 2: 40 Weeks|Adverse Event|1|||
147335667|NCT01426269|531396376|FG002|Period 2: 40 Weeks|Adverse Event|2|||
147335668|NCT01426269|531396374|FG000|Period 2: 40 Weeks|Withdrawal by Subject|0|||
147335669|NCT01426269|531396375|FG001|Period 2: 40 Weeks|Withdrawal by Subject|9|||
147335670|NCT01426269|531396376|FG002|Period 2: 40 Weeks|Withdrawal by Subject|11|||
147335671|NCT01426269|531396374|FG000|Period 2: 40 Weeks|Protocol Violation|0|||
147335672|NCT01426269|531396375|FG001|Period 2: 40 Weeks|Protocol Violation|5|||
147335673|NCT01426269|531396376|FG002|Period 2: 40 Weeks|Protocol Violation|5|||
147335674|NCT01426269|531396374|FG000|Period 2: 40 Weeks|Lost to Follow-up|0|||
147335675|NCT01426269|531396375|FG001|Period 2: 40 Weeks|Lost to Follow-up|8|||
147335676|NCT01426269|531396376|FG002|Period 2: 40 Weeks|Lost to Follow-up|6|||
147335677|NCT01426269|531396374|FG000|Period 2: 40 Weeks|Site closed|0|||
147335678|NCT01426269|531396375|FG001|Period 2: 40 Weeks|Site closed|6|||
147335679|NCT01426269|531396376|FG002|Period 2: 40 Weeks|Site closed|5|||
147335680|NCT01426269|531396374|FG000|Period 2: 40 Weeks|Relapsed|0|||
147335681|NCT01426269|531396375|FG001|Period 2: 40 Weeks|Relapsed|9|||
147335682|NCT01426269|531396376|FG002|Period 2: 40 Weeks|Relapsed|18|||
147335683|NCT00799396|531396378|FG000|Clopidogrel Treatment|Adverse Event|6|||
147281306|NCT00360334|531194634|FG001|Overall Study|Subject decision|2|||
147281307|NCT01916304|531194635|FG000|Overall Study|Screening failure|17|||
147281308|NCT01898793|531194636|FG000|Overall Study|Death|2|||
147281309|NCT01898793|531194637|FG001|Overall Study|Death|1|||
147281310|NCT01898793|531194638|FG002|Overall Study|Death|4|||
147281311|NCT01898793|531194639|FG003|Overall Study|Death|0|||
147281312|NCT01898793|531194640|FG004|Overall Study|Death|0|||
147281313|NCT01898793|531194641|FG005|Overall Study|Death|0|||
147281314|NCT01898793|531194642|FG006|Overall Study|Death|0|||
147281315|NCT04666441|531194643|FG000|Overall Study|Lost to Follow-up|1|||
147335684|NCT00799396|531396378|FG000|Clopidogrel Treatment|Physician Decision|5|||
147335685|NCT00799396|531396378|FG000|Clopidogrel Treatment|Withdrawal by Subject|2|||
147335686|NCT00799396|531396378|FG000|Clopidogrel Plus Aspirin|Adverse Event|2|||
147602915|NCT00626392|532363633|FG004|Coadministration Period|Protocol Violation|1|||
147602916|NCT00626392|532363634|FG005|Coadministration Period|Protocol Violation|0|||
147602917|NCT00626392|532363629|FG000|Coadministration Period|Other|0|||
147602918|NCT00626392|532363630|FG001|Coadministration Period|Other|2|||
147602919|NCT00626392|532363631|FG002|Coadministration Period|Other|3|||
147602920|NCT00626392|532363632|FG003|Coadministration Period|Other|1|||
147602921|NCT00626392|532363633|FG004|Coadministration Period|Other|1|||
147602922|NCT00626392|532363634|FG005|Coadministration Period|Other|1|||
147602923|NCT03151811|532363638|FG000|Overall Study|Randomized But Not Treated|18|||
147602924|NCT03151811|532363639|FG001|Overall Study|Randomized But Not Treated|3|||
147602925|NCT03151811|532363638|FG000|Overall Study|Progressive Disease|130|||
147602926|NCT03151811|532363639|FG001|Overall Study|Progressive Disease|170|||
147602927|NCT03151811|532363638|FG000|Overall Study|Adverse Event|49|||
147602928|NCT03151811|532363639|FG001|Overall Study|Adverse Event|40|||
147602929|NCT03151811|532363638|FG000|Overall Study|Lack of Efficacy|6|||
147602930|NCT03151811|532363639|FG001|Overall Study|Lack of Efficacy|8|||
147602931|NCT03151811|532363638|FG000|Overall Study|Physician Decision|21|||
147602932|NCT03151811|532363639|FG001|Overall Study|Physician Decision|9|||
147602933|NCT03151811|532363638|FG000|Overall Study|Withdrawal by Subject|17|||
147602934|NCT03151811|532363639|FG001|Overall Study|Withdrawal by Subject|7|||
147602935|NCT03151811|532363638|FG000|Overall Study|Lost to Follow-up|0|||
147602936|NCT03151811|532363639|FG001|Overall Study|Lost to Follow-up|1|||
147602937|NCT03151811|532363638|FG000|Overall Study|Study Terminated by Sponsor|5|||
147602938|NCT03151811|532363639|FG001|Overall Study|Study Terminated by Sponsor|11|||
147602939|NCT01517373|532363640|FG000|Run-in Period|Death|1|||
147602940|NCT01517373|532363641|FG001|Run-in Period|Death|0|||
147602941|NCT01517373|532363642|FG002|Run-in Period|Death|0|||
147602942|NCT01517373|532363643|FG003|Run-in Period|Death|0|||
147602943|NCT01517373|532363644|FG004|Run-in Period|Death|0|||
147602944|NCT01517373|532363645|FG005|Run-in Period|Death|0|||
147602945|NCT01517373|532363640|FG000|Run-in Period|Adverse Event|5|||
147602946|NCT01517373|532363641|FG001|Run-in Period|Adverse Event|0|||
147602947|NCT01517373|532363642|FG002|Run-in Period|Adverse Event|0|||
147602948|NCT01517373|532363643|FG003|Run-in Period|Adverse Event|0|||
147602949|NCT01517373|532363644|FG004|Run-in Period|Adverse Event|0|||
147602950|NCT01517373|532363645|FG005|Run-in Period|Adverse Event|0|||
147602951|NCT01517373|532363640|FG000|Run-in Period|Did not meet eligibility criteria|34|||
147602952|NCT01517373|532363641|FG001|Run-in Period|Did not meet eligibility criteria|0|||
147602953|NCT01517373|532363642|FG002|Run-in Period|Did not meet eligibility criteria|0|||
147602954|NCT01517373|532363643|FG003|Run-in Period|Did not meet eligibility criteria|0|||
147602955|NCT01517373|532363644|FG004|Run-in Period|Did not meet eligibility criteria|0|||
147602956|NCT01517373|532363645|FG005|Run-in Period|Did not meet eligibility criteria|0|||
147602957|NCT01517373|532363640|FG000|Run-in Period|Lost to Follow-up|1|||
147602958|NCT01517373|532363641|FG001|Run-in Period|Lost to Follow-up|0|||
147602959|NCT01517373|532363642|FG002|Run-in Period|Lost to Follow-up|0|||
147602960|NCT01517373|532363643|FG003|Run-in Period|Lost to Follow-up|0|||
147602961|NCT01517373|532363644|FG004|Run-in Period|Lost to Follow-up|0|||
147281316|NCT04666441|531194644|FG001|Overall Study|Lost to Follow-up|4|||
147281317|NCT04666441|531194645|FG002|Overall Study|Lost to Follow-up|1|||
147281318|NCT04666441|531194646|FG003|Overall Study|Lost to Follow-up|3|||
147281319|NCT04666441|531194647|FG004|Overall Study|Lost to Follow-up|0|||
147281320|NCT04666441|531194648|FG005|Overall Study|Lost to Follow-up|2|||
147602962|NCT01517373|532363645|FG005|Run-in Period|Lost to Follow-up|0|||
147602963|NCT01517373|532363640|FG000|Run-in Period|Withdrawal by Subject|12|||
147602964|NCT01517373|532363641|FG001|Run-in Period|Withdrawal by Subject|0|||
147602965|NCT01517373|532363642|FG002|Run-in Period|Withdrawal by Subject|0|||
147281321|NCT04666441|531194649|FG006|Overall Study|Lost to Follow-up|2|||
147602966|NCT01517373|532363643|FG003|Run-in Period|Withdrawal by Subject|0|||
147602967|NCT01517373|532363644|FG004|Run-in Period|Withdrawal by Subject|0|||
147602968|NCT01517373|532363645|FG005|Run-in Period|Withdrawal by Subject|0|||
147602969|NCT01517373|532363640|FG000|Run-in Period|Sponsor Decision|3|||
147602970|NCT01517373|532363641|FG001|Run-in Period|Sponsor Decision|0|||
147281322|NCT04666441|531194650|FG007|Overall Study|Lost to Follow-up|2|||
147281323|NCT04666441|531194643|FG000|Overall Study|Subject Decision|1|||
147281324|NCT04666441|531194644|FG001|Overall Study|Subject Decision|1|||
147281325|NCT04666441|531194645|FG002|Overall Study|Subject Decision|3|||
147281326|NCT04666441|531194646|FG003|Overall Study|Subject Decision|1|||
147335687|NCT00799396|531396378|FG000|Clopidogrel Plus Aspirin|Physician Decision|4|||
147335688|NCT01867216|531396379|FG000|Overall Study|Withdrawal by Subject|2|||
147335689|NCT01867216|531396380|FG001|Overall Study|Withdrawal by Subject|0|||
147335690|NCT01867216|531396381|FG002|Overall Study|Withdrawal by Subject|0|||
147335691|NCT01867216|531396382|FG003|Overall Study|Withdrawal by Subject|0|||
147335692|NCT01867216|531396383|FG004|Overall Study|Withdrawal by Subject|1|||
147335693|NCT01867216|531396384|FG005|Overall Study|Withdrawal by Subject|0|||
147335694|NCT01867216|531396385|FG006|Overall Study|Withdrawal by Subject|1|||
147335695|NCT01867216|531396379|FG000|Overall Study|Physician Decision|1|||
147335696|NCT01867216|531396380|FG001|Overall Study|Physician Decision|0|||
147335697|NCT01867216|531396381|FG002|Overall Study|Physician Decision|0|||
147335698|NCT01867216|531396382|FG003|Overall Study|Physician Decision|0|||
147335699|NCT01867216|531396383|FG004|Overall Study|Physician Decision|0|||
147335700|NCT01867216|531396384|FG005|Overall Study|Physician Decision|0|||
147335701|NCT01867216|531396385|FG006|Overall Study|Physician Decision|0|||
147335702|NCT01867216|531396379|FG000|Overall Study|Unable to Place Catheter for Blood Draws|1|||
147335703|NCT01867216|531396380|FG001|Overall Study|Unable to Place Catheter for Blood Draws|0|||
147335704|NCT01867216|531396381|FG002|Overall Study|Unable to Place Catheter for Blood Draws|0|||
147335705|NCT01867216|531396382|FG003|Overall Study|Unable to Place Catheter for Blood Draws|0|||
147335706|NCT01867216|531396383|FG004|Overall Study|Unable to Place Catheter for Blood Draws|0|||
147335707|NCT01867216|531396384|FG005|Overall Study|Unable to Place Catheter for Blood Draws|0|||
147335708|NCT01867216|531396385|FG006|Overall Study|Unable to Place Catheter for Blood Draws|0|||
147335709|NCT03454529|531396386|FG000|Overall Study|Did not receive treatment|6|||
147335710|NCT03454529|531396386|FG000|Overall Study|Received < 80% doses|1|||
147335711|NCT05764161|531396390|FG000|12-week DBVC Period|Lack of Efficacy|2|||
147335712|NCT05764161|531396391|FG001|12-week DBVC Period|Lack of Efficacy|1|||
147335713|NCT05764161|531396390|FG000|12-week DBVC Period|Lost to Follow-up|0|||
147335714|NCT05764161|531396391|FG001|12-week DBVC Period|Lost to Follow-up|2|||
147335715|NCT05764161|531396390|FG000|12-week DBVC Period|Protocol Violation|2|||
147335716|NCT05764161|531396391|FG001|12-week DBVC Period|Protocol Violation|4|||
147335717|NCT05764161|531396390|FG000|12-week DBVC Period|Withdrawal by Subject|7|||
147335718|NCT05764161|531396391|FG001|12-week DBVC Period|Withdrawal by Subject|6|||
147335719|NCT05764161|531396390|FG000|40-week OLE Period|Lack of Efficacy|0|||
147335720|NCT05764161|531396391|FG001|40-week OLE Period|Lack of Efficacy|1|||
147335721|NCT05764161|531396390|FG000|40-week OLE Period|Lost to Follow-up|1|||
147335722|NCT05764161|531396391|FG001|40-week OLE Period|Lost to Follow-up|4|||
147335723|NCT05764161|531396390|FG000|40-week OLE Period|Withdrawal by Subject|2|||
147335724|NCT05764161|531396391|FG001|40-week OLE Period|Withdrawal by Subject|7|||
147335725|NCT05764161|531396390|FG000|40-week OLE Period|Extended Travel|0|||
147335726|NCT05764161|531396391|FG001|40-week OLE Period|Extended Travel|1|||
147335727|NCT05764161|531396390|FG000|40-week OLE Period|Ongoing|66|||
147335728|NCT05764161|531396391|FG001|40-week OLE Period|Ongoing|59|||
147335729|NCT00831415|531396392|FG000|Overall Study|Adverse Event|14|||
147335730|NCT00831415|531396392|FG000|Overall Study|Failed to return|3|||
147281327|NCT04666441|531194647|FG004|Overall Study|Subject Decision|0|||
147281328|NCT04666441|531194648|FG005|Overall Study|Subject Decision|1|||
147281329|NCT04666441|531194649|FG006|Overall Study|Subject Decision|3|||
147281330|NCT04666441|531194650|FG007|Overall Study|Subject Decision|2|||
147281331|NCT01578551|531194652|FG000|Overall Study|Adverse Event|1|||
147281332|NCT01578551|531194653|FG001|Overall Study|Adverse Event|0|||
147281333|NCT04028388|531194655|FG000|Overall Study|Evaluations missing|3|||
147281334|NCT04028388|531194656|FG001|Overall Study|Evaluations missing|6|||
147281335|NCT04028388|531194655|FG000|Overall Study|Not started|2|||
147281336|NCT04028388|531194656|FG001|Overall Study|Not started|0|||
147281337|NCT00818441|531194664|FG000|Overall Study|Death|69|||
147281338|NCT00818441|531194665|FG001|Overall Study|Death|26|||
147335731|NCT00831415|531396392|FG000|Overall Study|Physician Decision|6|||
147451253|NCT05048719|531814818|FG004|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
147281339|NCT00818441|531194664|FG000|Overall Study|Other|5|||
147335732|NCT00831415|531396392|FG000|Overall Study|Lost to Follow-up|9|||
147335733|NCT00831415|531396392|FG000|Overall Study|Protocol Violation|3|||
147335734|NCT00831415|531396392|FG000|Overall Study|Withdrawal by Subject|35|||
147335735|NCT00831415|531396392|FG000|Overall Study|Unsatisfactory response - Efficacy|4|||
147335736|NCT00831415|531396392|FG000|Overall Study|Death|1|||
147335737|NCT05694065|531396393|FG000|Overall Study|Intravascular ultrasound (IVUS) pullback fails to cover the complete target lesion|3|||
147335738|NCT05694065|531396393|FG000|Overall Study|Ineligible for diagnostic intervention (IVUS or FFR examination)|2|||
147335739|NCT05694065|531396393|FG000|Overall Study|Target vessel with severe myocardial bridge|1|||
147451254|NCT05048719|531814819|FG005|Overall Study|Site Terminated Participant due to Sponsor Directions|1|||
147451255|NCT05048719|531814820|FG006|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
147451256|NCT05048719|531814821|FG007|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
147451257|NCT05048719|531814822|FG008|Overall Study|Site Terminated Participant due to Sponsor Directions|0|||
147281340|NCT00818441|531194665|FG001|Overall Study|Other|0|||
147281341|NCT00818441|531194664|FG000|Overall Study|Lost to Follow-up|2|||
147281342|NCT00818441|531194665|FG001|Overall Study|Lost to Follow-up|1|||
147281343|NCT00818441|531194664|FG000|Overall Study|Withdrawal by Subject|2|||
147281344|NCT00818441|531194665|FG001|Overall Study|Withdrawal by Subject|0|||
147281345|NCT00818441|531194664|FG000|Overall Study|Adverse Event|0|||
147281346|NCT00818441|531194665|FG001|Overall Study|Adverse Event|1|||
147281347|NCT00818441|531194664|FG000|Overall Study|Study terminated by sponsor|11|||
147281348|NCT00818441|531194665|FG001|Overall Study|Study terminated by sponsor|2|||
147281349|NCT02199691|531194666|FG000|Overall Study|Protocol Violation|3|||
147281350|NCT02199691|531194667|FG001|Overall Study|Protocol Violation|3|||
147281351|NCT02199691|531194668|FG002|Overall Study|Protocol Violation|6|||
147281352|NCT02199691|531194669|FG003|Overall Study|Protocol Violation|7|||
147281353|NCT02199691|531194666|FG000|Overall Study|Withdrawal by Subject|5|||
147281354|NCT02199691|531194667|FG001|Overall Study|Withdrawal by Subject|3|||
147281355|NCT02199691|531194668|FG002|Overall Study|Withdrawal by Subject|12|||
147281356|NCT02199691|531194669|FG003|Overall Study|Withdrawal by Subject|13|||
147281357|NCT02199691|531194666|FG000|Overall Study|Lost to Follow-up|2|||
147281358|NCT02199691|531194667|FG001|Overall Study|Lost to Follow-up|1|||
147281359|NCT02199691|531194668|FG002|Overall Study|Lost to Follow-up|9|||
147281360|NCT02199691|531194669|FG003|Overall Study|Lost to Follow-up|10|||
147281361|NCT01209624|531194678|FG000|Overall Study|Death|2|||
147281362|NCT01209624|531194678|FG000|Overall Study|Adverse Event|13|||
147281363|NCT01209624|531194678|FG000|Overall Study|Lack of Efficacy|17|||
147281364|NCT01209624|531194678|FG000|Overall Study|Lost to Follow-up|290|||
147281365|NCT01209624|531194678|FG000|Overall Study|Other|4|||
147281366|NCT03403634|531194679|FG000|Overall Study|Disease progression|3|||
147281367|NCT03403634|531194679|FG000|Overall Study|Did not meet eligibility criteria|4|||
147281368|NCT03964454|531194680|FG000|Overall Study|Lost to Follow-up|13|||
147281369|NCT03964454|531194681|FG001|Overall Study|Lost to Follow-up|7|||
147281370|NCT03964454|531194680|FG000|Overall Study|Withdrawal by Subject|4|||
147281371|NCT03964454|531194681|FG001|Overall Study|Withdrawal by Subject|11|||
147281372|NCT01539291|531196518|FG000|Study GS-US-312-0116|Adverse Event|9|||
147281373|NCT01539291|531196519|FG001|Study GS-US-312-0116|Adverse Event|0|||
147281374|NCT01539291|531196520|FG002|Study GS-US-312-0116|Adverse Event|0|||
147281375|NCT01539291|531196521|FG003|Study GS-US-312-0116|Adverse Event|0|||
147281376|NCT01539291|531196518|FG000|Study GS-US-312-0116|Physician Decision|1|||
147281377|NCT01539291|531196519|FG001|Study GS-US-312-0116|Physician Decision|0|||
147281378|NCT01539291|531196520|FG002|Study GS-US-312-0116|Physician Decision|0|||
147281379|NCT01539291|531196521|FG003|Study GS-US-312-0116|Physician Decision|0|||
147281380|NCT01539291|531196518|FG000|Study GS-US-312-0116|Withdrawal by Subject|12|||
147281381|NCT01539291|531196519|FG001|Study GS-US-312-0116|Withdrawal by Subject|0|||
147281382|NCT01539291|531196520|FG002|Study GS-US-312-0116|Withdrawal by Subject|0|||
147281383|NCT01539291|531196521|FG003|Study GS-US-312-0116|Withdrawal by Subject|0|||
147281384|NCT01539291|531196518|FG000|Study GS-US-312-0116|Study Terminated by Sponsor|2|||
147281385|NCT01539291|531196519|FG001|Study GS-US-312-0116|Study Terminated by Sponsor|0|||
147281386|NCT01539291|531196520|FG002|Study GS-US-312-0116|Study Terminated by Sponsor|0|||
147281387|NCT01539291|531196521|FG003|Study GS-US-312-0116|Study Terminated by Sponsor|0|||
147281388|NCT01539291|531196518|FG000|Study GS-US-312-0116|Other|1|||
147281389|NCT01539291|531196519|FG001|Study GS-US-312-0116|Other|0|||
147281390|NCT01539291|531196520|FG002|Study GS-US-312-0116|Other|0|||
147281391|NCT01539291|531196521|FG003|Study GS-US-312-0116|Other|0|||
147281392|NCT01539291|531196518|FG000|Study GS-US-312-0117|Adverse Event|22|||
147281393|NCT01539291|531196519|FG001|Study GS-US-312-0117|Adverse Event|1|||
147281394|NCT01539291|531196520|FG002|Study GS-US-312-0117|Adverse Event|9|||
147281395|NCT01539291|531196521|FG003|Study GS-US-312-0117|Adverse Event|12|||
147281396|NCT01539291|531196518|FG000|Study GS-US-312-0117|Physician Decision|9|||
147281397|NCT01539291|531196519|FG001|Study GS-US-312-0117|Physician Decision|0|||
147281398|NCT01539291|531196520|FG002|Study GS-US-312-0117|Physician Decision|6|||
147281399|NCT01539291|531196521|FG003|Study GS-US-312-0117|Physician Decision|4|||
147335740|NCT03861767|531396394|FG000|Overall Study|Withdrawal by Subject|2|||
147335741|NCT03861767|531396395|FG001|Overall Study|Withdrawal by Subject|1|||
147335742|NCT03861767|531396396|FG002|Overall Study|Withdrawal by Subject|0|||
147335743|NCT03861767|531396397|FG003|Overall Study|Withdrawal by Subject|5|||
147335744|NCT03861767|531396398|FG004|Overall Study|Withdrawal by Subject|2|||
147335745|NCT03861767|531396399|FG005|Overall Study|Withdrawal by Subject|1|||
147335746|NCT03861767|531396400|FG006|Overall Study|Withdrawal by Subject|3|||
147281400|NCT01539291|531196518|FG000|Study GS-US-312-0117|Withdrawal by Subject|5|||
147281401|NCT01539291|531196519|FG001|Study GS-US-312-0117|Withdrawal by Subject|0|||
147281402|NCT01539291|531196520|FG002|Study GS-US-312-0117|Withdrawal by Subject|6|||
147335747|NCT03861767|531396401|FG007|Overall Study|Withdrawal by Subject|1|||
147335748|NCT03861767|531396402|FG008|Overall Study|Withdrawal by Subject|0|||
147335749|NCT03861767|531396403|FG009|Overall Study|Withdrawal by Subject|5|||
147335750|NCT01145885|531396404|FG000|Overall Study|Progressive Disease|7|||
147281403|NCT01539291|531196521|FG003|Study GS-US-312-0117|Withdrawal by Subject|4|||
147281404|NCT01539291|531196518|FG000|Study GS-US-312-0117|Study Terminated by Sponsor|3|||
147281405|NCT01539291|531196519|FG001|Study GS-US-312-0117|Study Terminated by Sponsor|0|||
147281406|NCT01539291|531196520|FG002|Study GS-US-312-0117|Study Terminated by Sponsor|0|||
147335751|NCT03184558|531396405|FG000|Overall Study|Withdrawal by Subject|2|||
147281407|NCT01539291|531196521|FG003|Study GS-US-312-0117|Study Terminated by Sponsor|5|||
147281408|NCT01539291|531196518|FG000|Study GS-US-312-0117|Other|2|||
147281409|NCT01539291|531196519|FG001|Study GS-US-312-0117|Other|1|||
147281410|NCT01539291|531196520|FG002|Study GS-US-312-0117|Other|1|||
147281411|NCT01539291|531196521|FG003|Study GS-US-312-0117|Other|1|||
147281412|NCT04450264|531196522|FG000|Overall Study|Incomplete survey|13|||
147281413|NCT04450264|531196523|FG001|Overall Study|Incomplete survey|19|||
147281414|NCT03985423|531196526|FG000|Overall Study|Adverse Event|1|||
147281415|NCT03985423|531196526|FG000|Overall Study|Death|2|||
147281416|NCT03985423|531196526|FG000|Overall Study|Physician Decision|1|||
147281417|NCT03985423|531196526|FG000|Overall Study|Withdrawal by Subject|2|||
147281418|NCT03985423|531196526|FG000|Overall Study|Lack of insurance and citizenship|1|||
147281419|NCT01045447|531196527|FG000|Overall Study|Adverse Event|0|||
147281420|NCT01045447|531196528|FG001|Overall Study|Adverse Event|1|||
147281421|NCT01045447|531196527|FG000|Overall Study|Lack of Efficacy|3|||
147281422|NCT01045447|531196528|FG001|Overall Study|Lack of Efficacy|1|||
147281423|NCT01045447|531196527|FG000|Overall Study|Protocol Violation|6|||
147281424|NCT01045447|531196528|FG001|Overall Study|Protocol Violation|3|||
147281425|NCT01045447|531196527|FG000|Overall Study|Withdrawal Criteria|10|||
147281426|NCT01045447|531196528|FG001|Overall Study|Withdrawal Criteria|10|||
147281427|NCT01045447|531196527|FG000|Overall Study|Unclassified|17|||
147281428|NCT01045447|531196528|FG001|Overall Study|Unclassified|13|||
147281429|NCT03320070|531196529|FG000|DBT Phase (Week 1 to Week 24)|Adverse Event|1|||
147281430|NCT03320070|531196530|FG001|DBT Phase (Week 1 to Week 24)|Adverse Event|1|||
147281431|NCT03320070|531196529|FG000|DBT Phase (Week 1 to Week 24)|Withdrawal by Subject|2|||
147281432|NCT03320070|531196530|FG001|DBT Phase (Week 1 to Week 24)|Withdrawal by Subject|2|||
147281433|NCT03320070|531196529|FG000|OLE Phase (Week 25 to Week 48)|Adverse Event|3|||
147281434|NCT03320070|531196530|FG001|OLE Phase (Week 25 to Week 48)|Adverse Event|0|||
147281435|NCT03320070|531196529|FG000|OLE Phase (Week 25 to Week 48)|Lost to Follow-up|0|||
147281436|NCT03320070|531196530|FG001|OLE Phase (Week 25 to Week 48)|Lost to Follow-up|1|||
147281437|NCT03320070|531196529|FG000|OLE Phase (Week 25 to Week 48)|Non-compliance with Study Drug|1|||
147281438|NCT03320070|531196530|FG001|OLE Phase (Week 25 to Week 48)|Non-compliance with Study Drug|0|||
147281439|NCT03320070|531196529|FG000|OLE Phase (Week 25 to Week 48)|Withdrawal by Subject|1|||
147281440|NCT03320070|531196530|FG001|OLE Phase (Week 25 to Week 48)|Withdrawal by Subject|1|||
147281441|NCT01075321|531196533|FG000|Overall Study|Withdrawal by Subject|0|||
147335752|NCT03184558|531396405|FG000|Overall Study|Death|16|||
147335753|NCT03184558|531396405|FG000|Overall Study|Lost to Follow-up|2|||
147335754|NCT03184558|531396405|FG000|Overall Study|Other|9|||
147335755|NCT05299606|531396406|FG000|Overall Study|Death|1|||
147602971|NCT01517373|532363642|FG002|Run-in Period|Sponsor Decision|0|||
147602972|NCT01517373|532363643|FG003|Run-in Period|Sponsor Decision|0|||
147602973|NCT01517373|532363644|FG004|Run-in Period|Sponsor Decision|0|||
147602974|NCT01517373|532363645|FG005|Run-in Period|Sponsor Decision|0|||
147662545|NCT02513550|532587347|FG002|Post-Treatment Follow-up Period|Physician Decision|0|||
147662546|NCT02513550|532587348|FG003|Post-Treatment Follow-up Period|Physician Decision|0|||
147662547|NCT02513550|532587349|FG004|Post-Treatment Follow-up Period|Physician Decision|0|||
147281442|NCT01075321|531196534|FG001|Overall Study|Withdrawal by Subject|0|||
147602975|NCT01517373|532363640|FG000|Run-in Period|Other|1|||
147602976|NCT01517373|532363641|FG001|Run-in Period|Other|0|||
147602977|NCT01517373|532363642|FG002|Run-in Period|Other|0|||
147602978|NCT01517373|532363643|FG003|Run-in Period|Other|0|||
147602979|NCT01517373|532363644|FG004|Run-in Period|Other|0|||
147602980|NCT01517373|532363645|FG005|Run-in Period|Other|0|||
147602981|NCT01517373|532363640|FG000|Treatment Period|Adverse Event|0|||
147602982|NCT01517373|532363641|FG001|Treatment Period|Adverse Event|0|||
147602983|NCT01517373|532363642|FG002|Treatment Period|Adverse Event|0|||
147602984|NCT01517373|532363643|FG003|Treatment Period|Adverse Event|0|||
147602985|NCT01517373|532363644|FG004|Treatment Period|Adverse Event|0|||
147602986|NCT01517373|532363645|FG005|Treatment Period|Adverse Event|2|||
147602987|NCT01517373|532363640|FG000|Treatment Period|Lost to Follow-up|0|||
147602988|NCT01517373|532363641|FG001|Treatment Period|Lost to Follow-up|0|||
147602989|NCT01517373|532363642|FG002|Treatment Period|Lost to Follow-up|1|||
147281443|NCT01075321|531196535|FG002|Overall Study|Withdrawal by Subject|1|||
147281444|NCT01075321|531196536|FG003|Overall Study|Withdrawal by Subject|1|||
147281445|NCT01075321|531196533|FG000|Overall Study|Protocol Violation|0|||
147281446|NCT01075321|531196534|FG001|Overall Study|Protocol Violation|0|||
147281447|NCT01075321|531196535|FG002|Overall Study|Protocol Violation|1|||
147281448|NCT01075321|531196536|FG003|Overall Study|Protocol Violation|0|||
147281449|NCT01075321|531196533|FG000|Overall Study|Treatment Incomplete due to progression|1|||
147281450|NCT01075321|531196534|FG001|Overall Study|Treatment Incomplete due to progression|0|||
147281451|NCT01075321|531196535|FG002|Overall Study|Treatment Incomplete due to progression|0|||
147335756|NCT02880241|531396407|FG000|Overall Study|Lack of Efficacy|1|||
147335757|NCT02880241|531396408|FG001|Overall Study|Lack of Efficacy|0|||
147602990|NCT01517373|532363643|FG003|Treatment Period|Lost to Follow-up|1|||
147602991|NCT01517373|532363644|FG004|Treatment Period|Lost to Follow-up|0|||
147602992|NCT01517373|532363645|FG005|Treatment Period|Lost to Follow-up|0|||
147602993|NCT01517373|532363640|FG000|Treatment Period|Withdrawal by Subject|0|||
147281452|NCT01075321|531196536|FG003|Overall Study|Treatment Incomplete due to progression|0|||
147281453|NCT01075321|531196533|FG000|Overall Study|Ineligible (miscalculated lab value)|0|||
147281454|NCT01075321|531196534|FG001|Overall Study|Ineligible (miscalculated lab value)|0|||
147281455|NCT01075321|531196535|FG002|Overall Study|Ineligible (miscalculated lab value)|0|||
147281456|NCT01075321|531196536|FG003|Overall Study|Ineligible (miscalculated lab value)|1|||
147281457|NCT00003457|531196539|FG000|Overall Study|Not evaluable|9|||
147281458|NCT02246998|531196540|FG000|Overall Study|Adverse Event|0|||
147281459|NCT02246998|531196541|FG001|Overall Study|Adverse Event|1|||
147281460|NCT02246998|531196542|FG002|Overall Study|Adverse Event|1|||
147281461|NCT02246998|531196543|FG003|Overall Study|Adverse Event|0|||
147281462|NCT02246998|531196540|FG000|Overall Study|Lost to Follow-up|1|||
147281463|NCT02246998|531196541|FG001|Overall Study|Lost to Follow-up|0|||
147281464|NCT02246998|531196542|FG002|Overall Study|Lost to Follow-up|0|||
147281465|NCT02246998|531196543|FG003|Overall Study|Lost to Follow-up|1|||
147281466|NCT02246998|531196540|FG000|Overall Study|Randomized but Never Dosed|1|||
147281467|NCT02246998|531196541|FG001|Overall Study|Randomized but Never Dosed|2|||
147281468|NCT02246998|531196542|FG002|Overall Study|Randomized but Never Dosed|2|||
147281469|NCT02246998|531196543|FG003|Overall Study|Randomized but Never Dosed|1|||
147281470|NCT02473614|531196544|FG000|First Intervention (3 Weeks)|Job duties/lack of transportation|1|||
147281471|NCT02473614|531196545|FG001|First Intervention (3 Weeks)|Job duties/lack of transportation|0|||
147281472|NCT01075074|531196546|FG000|Overall Study|Surgeon changed to open incisional case|1|||
147281473|NCT01075074|531196547|FG001|Overall Study|Surgeon changed to open incisional case|2|||
147281474|NCT01075074|531196548|FG002|Overall Study|Surgeon changed to open incisional case|2|||
147281475|NCT02416791|531196549|FG000|6 Months|Lost to Follow-up|0|||
147281476|NCT02416791|531196550|FG001|6 Months|Lost to Follow-up|0|||
147281477|NCT02416791|531196551|FG002|6 Months|Lost to Follow-up|1|||
147281478|NCT00562159|531196552|FG000|Overall Study|Adverse Event|11|||
147281479|NCT00562159|531196553|FG001|Overall Study|Adverse Event|8|||
147281480|NCT00562159|531196552|FG000|Overall Study|Lost to Follow-up|5|||
147281481|NCT00562159|531196553|FG001|Overall Study|Lost to Follow-up|4|||
147281482|NCT00562159|531196552|FG000|Overall Study|Withdrawal by Subject|9|||
147335758|NCT02880241|531396409|FG002|Overall Study|Lack of Efficacy|0|||
147602994|NCT01517373|532363641|FG001|Treatment Period|Withdrawal by Subject|3|||
147602995|NCT01517373|532363642|FG002|Treatment Period|Withdrawal by Subject|2|||
147602996|NCT01517373|532363643|FG003|Treatment Period|Withdrawal by Subject|2|||
147602997|NCT01517373|532363644|FG004|Treatment Period|Withdrawal by Subject|2|||
147602998|NCT01517373|532363645|FG005|Treatment Period|Withdrawal by Subject|3|||
147602999|NCT01517373|532363640|FG000|Treatment Period|Other|0|||
147603000|NCT01517373|532363641|FG001|Treatment Period|Other|0|||
147603001|NCT01517373|532363642|FG002|Treatment Period|Other|0|||
147603002|NCT01517373|532363643|FG003|Treatment Period|Other|0|||
147603003|NCT01517373|532363644|FG004|Treatment Period|Other|1|||
147603004|NCT01517373|532363645|FG005|Treatment Period|Other|0|||
147603005|NCT01517373|532363640|FG000|Treatment Period|Protocol Violation|0|||
147603006|NCT01517373|532363641|FG001|Treatment Period|Protocol Violation|0|||
147603007|NCT01517373|532363642|FG002|Treatment Period|Protocol Violation|0|||
147603008|NCT01517373|532363643|FG003|Treatment Period|Protocol Violation|0|||
147603009|NCT01517373|532363644|FG004|Treatment Period|Protocol Violation|1|||
147603010|NCT01517373|532363645|FG005|Treatment Period|Protocol Violation|0|||
147603011|NCT01517373|532363640|FG000|Treatment Period|Lack of Efficacy|0|||
147603012|NCT01517373|532363641|FG001|Treatment Period|Lack of Efficacy|1|||
147603013|NCT01517373|532363642|FG002|Treatment Period|Lack of Efficacy|1|||
147603014|NCT01517373|532363643|FG003|Treatment Period|Lack of Efficacy|3|||
147603015|NCT01517373|532363644|FG004|Treatment Period|Lack of Efficacy|2|||
147603016|NCT01517373|532363645|FG005|Treatment Period|Lack of Efficacy|0|||
147603017|NCT01517373|532363640|FG000|Treatment Period|Medication error without AEs|0|||
147603018|NCT01517373|532363641|FG001|Treatment Period|Medication error without AEs|0|||
147603019|NCT01517373|532363642|FG002|Treatment Period|Medication error without AEs|2|||
147603020|NCT01517373|532363643|FG003|Treatment Period|Medication error without AEs|1|||
147603021|NCT01517373|532363644|FG004|Treatment Period|Medication error without AEs|0|||
147603022|NCT01517373|532363645|FG005|Treatment Period|Medication error without AEs|2|||
147603023|NCT01081834|532363650|FG000|Core Period: Baseline to Week 26|Pregnancy|1|||
147603024|NCT01081834|532363651|FG001|Core Period: Baseline to Week 26|Pregnancy|0|||
147603025|NCT01081834|532363652|FG002|Core Period: Baseline to Week 26|Pregnancy|0|||
147603026|NCT01081834|532363653|FG003|Core Period: Baseline to Week 26|Pregnancy|0|||
147281483|NCT00562159|531196553|FG001|Overall Study|Withdrawal by Subject|8|||
147281484|NCT00562159|531196552|FG000|Overall Study|Protocol Violation|12|||
147281485|NCT00562159|531196553|FG001|Overall Study|Protocol Violation|12|||
147281486|NCT00562159|531196552|FG000|Overall Study|Did not meet protocol eligibility|1|||
147335759|NCT02880241|531396410|FG003|Overall Study|Lack of Efficacy|0|||
147335760|NCT02880241|531396411|FG004|Overall Study|Lack of Efficacy|0|||
147335761|NCT02880241|531396412|FG005|Overall Study|Lack of Efficacy|0|||
147603027|NCT01081834|532363654|FG004|Core Period: Baseline to Week 26|Pregnancy|0|||
147603028|NCT01081834|532363650|FG000|Core Period: Baseline to Week 26|Adverse Event|2|||
147603029|NCT01081834|532363651|FG001|Core Period: Baseline to Week 26|Adverse Event|5|||
147281487|NCT00562159|531196553|FG001|Overall Study|Did not meet protocol eligibility|1|||
147281488|NCT01992536|531196554|FG000|Overall Study|Administrative Reason|0|||
147281489|NCT01992536|531196555|FG001|Overall Study|Administrative Reason|0|||
147281490|NCT01992536|531196556|FG002|Overall Study|Administrative Reason|0|||
147281491|NCT01992536|531196557|FG003|Overall Study|Administrative Reason|0|||
147281492|NCT01992536|531196558|FG004|Overall Study|Administrative Reason|0|||
147281493|NCT01992536|531196559|FG005|Overall Study|Administrative Reason|0|||
147281494|NCT01992536|531196560|FG006|Overall Study|Administrative Reason|7|||
147281495|NCT01992536|531196561|FG007|Overall Study|Administrative Reason|0|||
147281496|NCT01992536|531196562|FG008|Overall Study|Administrative Reason|0|||
147281497|NCT01992536|531196563|FG009|Overall Study|Administrative Reason|0|||
147281498|NCT01992536|531196554|FG000|Overall Study|Lost to Follow-up|4|||
147281499|NCT01992536|531196555|FG001|Overall Study|Lost to Follow-up|2|||
147281500|NCT01992536|531196556|FG002|Overall Study|Lost to Follow-up|1|||
147281501|NCT01992536|531196557|FG003|Overall Study|Lost to Follow-up|0|||
147281502|NCT01992536|531196558|FG004|Overall Study|Lost to Follow-up|0|||
147281503|NCT01992536|531196559|FG005|Overall Study|Lost to Follow-up|1|||
147281504|NCT01992536|531196560|FG006|Overall Study|Lost to Follow-up|0|||
147281505|NCT01992536|531196561|FG007|Overall Study|Lost to Follow-up|0|||
147281506|NCT01992536|531196562|FG008|Overall Study|Lost to Follow-up|1|||
147281507|NCT01992536|531196563|FG009|Overall Study|Lost to Follow-up|1|||
147281508|NCT01992536|531196554|FG000|Overall Study|Withdrawal by Subject|0|||
147281509|NCT01992536|531196555|FG001|Overall Study|Withdrawal by Subject|1|||
147281510|NCT01992536|531196556|FG002|Overall Study|Withdrawal by Subject|0|||
147281511|NCT01992536|531196557|FG003|Overall Study|Withdrawal by Subject|2|||
147281512|NCT01992536|531196558|FG004|Overall Study|Withdrawal by Subject|0|||
147451258|NCT02921971|531814827|FG000|Overall Study|Adverse Event|1|||
147451259|NCT02921971|531814828|FG001|Overall Study|Adverse Event|2|||
147451260|NCT02921971|531814827|FG000|Overall Study|Lack of Efficacy|3|||
147451261|NCT02921971|531814828|FG001|Overall Study|Lack of Efficacy|1|||
147451262|NCT02921971|531814827|FG000|Overall Study|Other than specified above|2|||
147451263|NCT02921971|531814828|FG001|Overall Study|Other than specified above|1|||
147451264|NCT01903837|531814836|FG000|Part A|Withdrawal by Subject|4|||
147451265|NCT01903837|531814837|FG001|Part A|Withdrawal by Subject|9|||
147451266|NCT01903837|531814838|FG002|Part A|Withdrawal by Subject|8|||
147451267|NCT01903837|531814839|FG003|Part A|Withdrawal by Subject|5|||
147451268|NCT01903837|531814836|FG000|Part A|Adverse Event|3|||
147451269|NCT01903837|531814837|FG001|Part A|Adverse Event|6|||
147281513|NCT01992536|531196559|FG005|Overall Study|Withdrawal by Subject|0|||
147451270|NCT01903837|531814838|FG002|Part A|Adverse Event|9|||
147451271|NCT01903837|531814839|FG003|Part A|Adverse Event|6|||
147451272|NCT01903837|531814836|FG000|Part A|Lost to Follow-up|9|||
147451273|NCT01903837|531814837|FG001|Part A|Lost to Follow-up|7|||
147451274|NCT01903837|531814838|FG002|Part A|Lost to Follow-up|7|||
147451275|NCT01903837|531814839|FG003|Part A|Lost to Follow-up|2|||
147451276|NCT01903837|531814836|FG000|Part A|Non-compliance with study drug|1|||
147451277|NCT01903837|531814837|FG001|Part A|Non-compliance with study drug|4|||
147451278|NCT01903837|531814838|FG002|Part A|Non-compliance with study drug|4|||
147451279|NCT01903837|531814839|FG003|Part A|Non-compliance with study drug|0|||
147451280|NCT01903837|531814836|FG000|Part A|Physician Decision|1|||
147451281|NCT01903837|531814837|FG001|Part A|Physician Decision|1|||
147451282|NCT01903837|531814838|FG002|Part A|Physician Decision|0|||
147451283|NCT01903837|531814839|FG003|Part A|Physician Decision|0|||
147451284|NCT01903837|531814836|FG000|Part A|Protocol Violation|1|||
147451285|NCT01903837|531814837|FG001|Part A|Protocol Violation|1|||
147451286|NCT01903837|531814838|FG002|Part A|Protocol Violation|0|||
147451287|NCT01903837|531814839|FG003|Part A|Protocol Violation|0|||
147451288|NCT01903837|531814836|FG000|Part B|Lost to Follow-up|0|||
147451289|NCT01903837|531814837|FG001|Part B|Lost to Follow-up|3|||
147451290|NCT01903837|531814838|FG002|Part B|Lost to Follow-up|3|||
147451291|NCT01903837|531814839|FG003|Part B|Lost to Follow-up|4|||
147603030|NCT01081834|532363652|FG002|Core Period: Baseline to Week 26|Adverse Event|3|||
147603031|NCT01081834|532363653|FG003|Core Period: Baseline to Week 26|Adverse Event|1|||
147603032|NCT01081834|532363654|FG004|Core Period: Baseline to Week 26|Adverse Event|1|||
147603033|NCT01081834|532363650|FG000|Core Period: Baseline to Week 26|Death|1|||
147281514|NCT01992536|531196560|FG006|Overall Study|Withdrawal by Subject|0|||
147281515|NCT01992536|531196561|FG007|Overall Study|Withdrawal by Subject|0|||
147281516|NCT01992536|531196562|FG008|Overall Study|Withdrawal by Subject|0|||
147281517|NCT01992536|531196563|FG009|Overall Study|Withdrawal by Subject|0|||
147281518|NCT03669081|531196564|FG000|Overall Study|Data could not be validated|1|||
147281519|NCT03669081|531196565|FG001|Overall Study|Data could not be validated|1|||
147451292|NCT01903837|531814836|FG000|Part B|Withdrawal by Subject|1|||
147451293|NCT01903837|531814837|FG001|Part B|Withdrawal by Subject|2|||
147451294|NCT01903837|531814838|FG002|Part B|Withdrawal by Subject|0|||
147451295|NCT01903837|531814839|FG003|Part B|Withdrawal by Subject|3|||
147451296|NCT01903837|531814836|FG000|Part B|Adverse Event|3|||
147451297|NCT01903837|531814837|FG001|Part B|Adverse Event|0|||
147451298|NCT01903837|531814838|FG002|Part B|Adverse Event|2|||
147451299|NCT01903837|531814839|FG003|Part B|Adverse Event|0|||
147451300|NCT01903837|531814836|FG000|Part B|Non-compliance with study drug|2|||
147603034|NCT01081834|532363651|FG001|Core Period: Baseline to Week 26|Death|0|||
147603035|NCT01081834|532363652|FG002|Core Period: Baseline to Week 26|Death|0|||
147603036|NCT01081834|532363653|FG003|Core Period: Baseline to Week 26|Death|0|||
147603037|NCT01081834|532363654|FG004|Core Period: Baseline to Week 26|Death|0|||
147603038|NCT01081834|532363650|FG000|Core Period: Baseline to Week 26|Lost to Follow-up|2|||
147603039|NCT01081834|532363651|FG001|Core Period: Baseline to Week 26|Lost to Follow-up|2|||
147603040|NCT01081834|532363652|FG002|Core Period: Baseline to Week 26|Lost to Follow-up|5|||
147603041|NCT01081834|532363653|FG003|Core Period: Baseline to Week 26|Lost to Follow-up|0|||
147603042|NCT01081834|532363654|FG004|Core Period: Baseline to Week 26|Lost to Follow-up|0|||
147603043|NCT01081834|532363650|FG000|Core Period: Baseline to Week 26|Protocol Violation|0|||
147603044|NCT01081834|532363651|FG001|Core Period: Baseline to Week 26|Protocol Violation|4|||
147603045|NCT01081834|532363652|FG002|Core Period: Baseline to Week 26|Protocol Violation|0|||
147603046|NCT01081834|532363653|FG003|Core Period: Baseline to Week 26|Protocol Violation|0|||
147603047|NCT01081834|532363654|FG004|Core Period: Baseline to Week 26|Protocol Violation|2|||
147603048|NCT01081834|532363650|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|15|||
147603049|NCT01081834|532363651|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|3|||
147603050|NCT01081834|532363652|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|9|||
147281520|NCT00389324|531196566|FG000|Run-In Phase|Adverse Event|1|||
147281521|NCT00389324|531196566|FG000|Run-In Phase|Lost to Follow-up|1|||
147281522|NCT00389324|531196566|FG000|Run-In Phase|Withdrawal by Subject|1|||
147281523|NCT00389324|531196566|FG000|Subcutaneous Phase|Adverse Event|2|||
147281524|NCT00389324|531196566|FG000|Subcutaneous Phase|Non-compliance with study medication|2|||
147603051|NCT01081834|532363653|FG003|Core Period: Baseline to Week 26|Withdrawal by Subject|3|||
147603052|NCT01081834|532363654|FG004|Core Period: Baseline to Week 26|Withdrawal by Subject|1|||
147603053|NCT01081834|532363650|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|3|||
147603054|NCT01081834|532363651|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|4|||
147603055|NCT01081834|532363652|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|2|||
147603056|NCT01081834|532363653|FG003|Core Period: Baseline to Week 26|Noncompliance with study drug|2|||
147603057|NCT01081834|532363654|FG004|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
147603058|NCT01081834|532363650|FG000|Core Period: Baseline to Week 26|Unable to take rescue therapy|1|||
147603059|NCT01081834|532363651|FG001|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
147281525|NCT00389324|531196566|FG000|Subcutaneous Phase|Withdrawal by Subject|2|||
147281526|NCT00389324|531196566|FG000|Subcutaneous Phase|Lost to Follow-up|1|||
147281527|NCT02519504|531196567|FG000|Overall Study|Protocol Violation|6|||
147281528|NCT02519504|531196568|FG001|Overall Study|Protocol Violation|5|||
147281529|NCT02519504|531196567|FG000|Overall Study|Ineligible for direct testing|12|||
147281530|NCT02519504|531196568|FG001|Overall Study|Ineligible for direct testing|12|||
147281531|NCT02519504|531196567|FG000|Overall Study|Did not participate in direct testing|95|||
147281532|NCT02519504|531196568|FG001|Overall Study|Did not participate in direct testing|86|||
147281533|NCT03936244|531196569|FG000|Overall Study|Lost to Follow-up|5|||
147281534|NCT03936244|531196570|FG001|Overall Study|Lost to Follow-up|1|||
147281535|NCT03936244|531196569|FG000|Overall Study|Physician Decision|7|||
147281536|NCT03936244|531196570|FG001|Overall Study|Physician Decision|3|||
147281537|NCT03551938|531196571|FG000|3-Month Follow Up|Lost to Follow-up|39|||
147281538|NCT03551938|531196572|FG001|3-Month Follow Up|Lost to Follow-up|38|||
147281539|NCT03551938|531196571|FG000|6-Month Follow Up|Lost to Follow-up|46|||
147281540|NCT03551938|531196572|FG001|6-Month Follow Up|Lost to Follow-up|42|||
147335762|NCT00057837|531396413|FG000|Overall Study|Progression/relapse|12|||
147335763|NCT00057837|531396414|FG001|Overall Study|Progression/relapse|14|||
147335764|NCT00057837|531396413|FG000|Overall Study|Adverse Event|2|||
147335765|NCT00057837|531396414|FG001|Overall Study|Adverse Event|12|||
147335766|NCT00057837|531396413|FG000|Overall Study|Death|5|||
147335767|NCT00057837|531396414|FG001|Overall Study|Death|4|||
147335768|NCT00057837|531396413|FG000|Overall Study|Withdrawal by Subject|5|||
147335769|NCT00057837|531396414|FG001|Overall Study|Withdrawal by Subject|3|||
147281541|NCT03551938|531196571|FG000|9-Month Follow Up|Lost to Follow-up|44|||
147281542|NCT03551938|531196572|FG001|9-Month Follow Up|Lost to Follow-up|43|||
147281543|NCT01925183|531196573|FG000|Overall Study|Adverse Event|1|||
147281544|NCT01925183|531196574|FG001|Overall Study|Adverse Event|0|||
147281545|NCT01114646|531196575|FG000|Overall Study|Withdrawal by Subject|3|||
147281546|NCT01114646|531196576|FG001|Overall Study|Withdrawal by Subject|2|||
147281547|NCT01046110|531196577|FG000|Overall Study|Adverse Event|9|||
147281548|NCT01046110|531196578|FG001|Overall Study|Adverse Event|2|||
147281549|NCT01046110|531196577|FG000|Overall Study|Lack of Efficacy|0|||
147335770|NCT00057837|531396413|FG000|Overall Study|Alternative therapy|0|||
147335771|NCT00057837|531396414|FG001|Overall Study|Alternative therapy|1|||
147335772|NCT00057837|531396413|FG000|Overall Study|Other complicating disease|2|||
147281550|NCT01046110|531196578|FG001|Overall Study|Lack of Efficacy|1|||
147281551|NCT01046110|531196577|FG000|Overall Study|Protocol Violation|7|||
147281552|NCT01046110|531196578|FG001|Overall Study|Protocol Violation|12|||
147335773|NCT00057837|531396414|FG001|Overall Study|Other complicating disease|1|||
147281553|NCT01046110|531196577|FG000|Overall Study|Withdrawal Criteria|3|||
147603060|NCT01081834|532363652|FG002|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
147603061|NCT01081834|532363653|FG003|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
147603062|NCT01081834|532363654|FG004|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
147603063|NCT01081834|532363650|FG000|Core Period: Baseline to Week 26|Other|4|||
147603064|NCT01081834|532363651|FG001|Core Period: Baseline to Week 26|Other|4|||
147603065|NCT01081834|532363652|FG002|Core Period: Baseline to Week 26|Other|3|||
147603066|NCT01081834|532363653|FG003|Core Period: Baseline to Week 26|Other|1|||
147603067|NCT01081834|532363654|FG004|Core Period: Baseline to Week 26|Other|0|||
147603068|NCT01081834|532363650|FG000|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|3|||
147603069|NCT01081834|532363651|FG001|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|1|||
147603070|NCT01081834|532363652|FG002|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0|||
147603071|NCT01081834|532363653|FG003|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0|||
147603072|NCT01081834|532363654|FG004|Core Period: Baseline to Week 26|Lack of efficacy on rescue therapy|0|||
147603073|NCT01081834|532363650|FG000|Extension Period: Week 26 to Week 52|Adverse Event|1|||
147603074|NCT01081834|532363651|FG001|Extension Period: Week 26 to Week 52|Adverse Event|0|||
147603075|NCT01081834|532363652|FG002|Extension Period: Week 26 to Week 52|Adverse Event|0|||
147603076|NCT01081834|532363653|FG003|Extension Period: Week 26 to Week 52|Adverse Event|0|||
147603077|NCT01081834|532363654|FG004|Extension Period: Week 26 to Week 52|Adverse Event|0|||
147603078|NCT01081834|532363650|FG000|Extension Period: Week 26 to Week 52|Death|1|||
147603079|NCT01081834|532363651|FG001|Extension Period: Week 26 to Week 52|Death|0|||
147603080|NCT01081834|532363652|FG002|Extension Period: Week 26 to Week 52|Death|0|||
147603081|NCT01081834|532363653|FG003|Extension Period: Week 26 to Week 52|Death|0|||
147603082|NCT01081834|532363654|FG004|Extension Period: Week 26 to Week 52|Death|0|||
147603083|NCT01081834|532363650|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|4|||
147603084|NCT01081834|532363651|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|4|||
147603085|NCT01081834|532363652|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
147603086|NCT01081834|532363653|FG003|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
147603087|NCT01081834|532363654|FG004|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
147603088|NCT01081834|532363650|FG000|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
147603089|NCT01081834|532363651|FG001|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
147603090|NCT01081834|532363652|FG002|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
147603091|NCT01081834|532363653|FG003|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
147603092|NCT01081834|532363654|FG004|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
147603093|NCT01081834|532363650|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
147281554|NCT01046110|531196578|FG001|Overall Study|Withdrawal Criteria|5|||
147281555|NCT01046110|531196577|FG000|Overall Study|Unclassified|36|||
147281556|NCT01046110|531196578|FG001|Overall Study|Unclassified|35|||
147281557|NCT01233817|531196581|FG000|Overall Study|Lost to Follow-up|1|||
147281558|NCT01233817|531196581|FG000|Overall Study|Withdrawal by Subject|2|||
147281559|NCT01202773|531196582|FG000|Overall Study|Adverse Event|4|||
147281560|NCT01202773|531196583|FG001|Overall Study|Adverse Event|5|||
147281561|NCT01202773|531196584|FG002|Overall Study|Adverse Event|5|||
147281562|NCT01202773|531196582|FG000|Overall Study|Lack of Efficacy|5|||
147281563|NCT01202773|531196583|FG001|Overall Study|Lack of Efficacy|4|||
147281564|NCT01202773|531196584|FG002|Overall Study|Lack of Efficacy|9|||
147281565|NCT01202773|531196582|FG000|Overall Study|Entry Criteria Not Met|2|||
147281566|NCT01202773|531196583|FG001|Overall Study|Entry Criteria Not Met|0|||
147281567|NCT01202773|531196584|FG002|Overall Study|Entry Criteria Not Met|1|||
147281568|NCT01202773|531196582|FG000|Overall Study|Lost to Follow-up|1|||
147281569|NCT01202773|531196583|FG001|Overall Study|Lost to Follow-up|2|||
147281570|NCT01202773|531196584|FG002|Overall Study|Lost to Follow-up|2|||
147281571|NCT01202773|531196582|FG000|Overall Study|Withdrawal by Subject|13|||
147281572|NCT01202773|531196583|FG001|Overall Study|Withdrawal by Subject|6|||
147281573|NCT01202773|531196584|FG002|Overall Study|Withdrawal by Subject|5|||
147281574|NCT01202773|531196582|FG000|Overall Study|Physician Decision|2|||
147281575|NCT01202773|531196583|FG001|Overall Study|Physician Decision|0|||
147281576|NCT01202773|531196584|FG002|Overall Study|Physician Decision|0|||
147281577|NCT01202773|531196582|FG000|Overall Study|Protocol Violation|11|||
147281578|NCT01202773|531196583|FG001|Overall Study|Protocol Violation|6|||
147281579|NCT01202773|531196584|FG002|Overall Study|Protocol Violation|10|||
147281580|NCT01202773|531196582|FG000|Overall Study|Sponsor Decision|19|||
147281581|NCT01202773|531196583|FG001|Overall Study|Sponsor Decision|20|||
147281582|NCT01202773|531196584|FG002|Overall Study|Sponsor Decision|23|||
147281583|NCT01430130|531196585|FG000|Overall Study|Lost to Follow-up|1|||
147281584|NCT01430130|531196585|FG000|Overall Study|Infection on Control Side of Incision|1|||
147281585|NCT03525834|531196586|FG000|Overall Study|Progressive disease|1|||
147281586|NCT00614939|531196592|FG000|Overall Study|Withdrawal by Subject|10|||
147281587|NCT00614939|531196593|FG001|Overall Study|Withdrawal by Subject|17|||
147281588|NCT00614939|531196592|FG000|Overall Study|Study specific discontinuation criteris|13|||
147281589|NCT00614939|531196593|FG001|Overall Study|Study specific discontinuation criteris|16|||
147281590|NCT00614939|531196592|FG000|Overall Study|Adverse Event|2|||
147603094|NCT01081834|532363651|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|2|||
147603095|NCT01081834|532363652|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
147603096|NCT01081834|532363653|FG003|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
147662548|NCT02513550|532587350|FG005|Post-Treatment Follow-up Period|Physician Decision|0|||
147662549|NCT02513550|532587345|FG000|Post-Treatment Follow-up Period|Death|0|||
147662550|NCT02513550|532587346|FG001|Post-Treatment Follow-up Period|Death|0|||
147662551|NCT02513550|532587347|FG002|Post-Treatment Follow-up Period|Death|1|||
147662552|NCT02513550|532587348|FG003|Post-Treatment Follow-up Period|Death|0|||
147662553|NCT02513550|532587349|FG004|Post-Treatment Follow-up Period|Death|0|||
147662554|NCT02513550|532587350|FG005|Post-Treatment Follow-up Period|Death|0|||
147662555|NCT02513550|532587345|FG000|Post-Treatment Follow-up Period|Subject move out of town|0|||
147662556|NCT02513550|532587346|FG001|Post-Treatment Follow-up Period|Subject move out of town|0|||
147662557|NCT02513550|532587347|FG002|Post-Treatment Follow-up Period|Subject move out of town|1|||
147662558|NCT02513550|532587348|FG003|Post-Treatment Follow-up Period|Subject move out of town|0|||
147662559|NCT02513550|532587349|FG004|Post-Treatment Follow-up Period|Subject move out of town|0|||
147662560|NCT02513550|532587350|FG005|Post-Treatment Follow-up Period|Subject move out of town|0|||
147662561|NCT02513550|532587345|FG000|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0|||
147662562|NCT02513550|532587346|FG001|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0|||
147662563|NCT02513550|532587347|FG002|Post-Treatment Follow-up Period|Subject did not come for Visit-802|3|||
147662564|NCT02513550|532587348|FG003|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0|||
147662565|NCT02513550|532587349|FG004|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0|||
147662566|NCT02513550|532587350|FG005|Post-Treatment Follow-up Period|Subject did not come for Visit-802|0|||
147662567|NCT02513550|532587345|FG000|Post-Treatment Follow-up Period|Labor Reasons|0|||
147662568|NCT02513550|532587346|FG001|Post-Treatment Follow-up Period|Labor Reasons|0|||
147603097|NCT01081834|532363654|FG004|Extension Period: Week 26 to Week 52|Withdrawal by Subject|0|||
147603098|NCT01081834|532363650|FG000|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1|||
147603099|NCT01081834|532363651|FG001|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
147603100|NCT01081834|532363652|FG002|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1|||
147603101|NCT01081834|532363653|FG003|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
147603102|NCT01081834|532363654|FG004|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
147603103|NCT01081834|532363650|FG000|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|1|||
147603104|NCT01081834|532363651|FG001|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|4|||
147603105|NCT01081834|532363652|FG002|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|0|||
147603106|NCT01081834|532363653|FG003|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|0|||
147603107|NCT01081834|532363654|FG004|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|0|||
147603108|NCT01081834|532363650|FG000|Extension Period: Week 26 to Week 52|Other|4|||
147603109|NCT01081834|532363651|FG001|Extension Period: Week 26 to Week 52|Other|5|||
147603110|NCT01081834|532363652|FG002|Extension Period: Week 26 to Week 52|Other|4|||
147603111|NCT01081834|532363653|FG003|Extension Period: Week 26 to Week 52|Other|0|||
147603112|NCT01081834|532363654|FG004|Extension Period: Week 26 to Week 52|Other|0|||
147603113|NCT01081834|532363650|FG000|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|7|||
147603114|NCT01081834|532363651|FG001|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|1|||
147603115|NCT01081834|532363652|FG002|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|0|||
147603116|NCT01081834|532363653|FG003|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|0|||
147603117|NCT01081834|532363654|FG004|Extension Period: Week 26 to Week 52|Lack of efficacy on rescue therapy|0|||
147603118|NCT01081834|532363650|FG000|Extension Period: Week 26 to Week 52|Physician Decision|0|||
147603119|NCT01081834|532363651|FG001|Extension Period: Week 26 to Week 52|Physician Decision|1|||
147603120|NCT01081834|532363652|FG002|Extension Period: Week 26 to Week 52|Physician Decision|0|||
147603121|NCT01081834|532363653|FG003|Extension Period: Week 26 to Week 52|Physician Decision|0|||
147603122|NCT01081834|532363654|FG004|Extension Period: Week 26 to Week 52|Physician Decision|0|||
147603123|NCT00742924|532363655|FG000|Overall Study|Adverse Event|0|||
147603124|NCT00742924|532363656|FG001|Overall Study|Adverse Event|0|||
147603125|NCT00742924|532363657|FG002|Overall Study|Adverse Event|1|||
147603126|NCT00742924|532363658|FG003|Overall Study|Adverse Event|1|||
147603127|NCT00742924|532363655|FG000|Overall Study|Lack of Efficacy|5|||
147603128|NCT00742924|532363656|FG001|Overall Study|Lack of Efficacy|1|||
147603129|NCT00742924|532363657|FG002|Overall Study|Lack of Efficacy|2|||
147603130|NCT00742924|532363658|FG003|Overall Study|Lack of Efficacy|4|||
147603131|NCT00742924|532363655|FG000|Overall Study|Physician Decision|0|||
147662569|NCT02513550|532587347|FG002|Post-Treatment Follow-up Period|Labor Reasons|1|||
147662570|NCT02513550|532587348|FG003|Post-Treatment Follow-up Period|Labor Reasons|0|||
147662571|NCT02513550|532587349|FG004|Post-Treatment Follow-up Period|Labor Reasons|0|||
147451301|NCT01903837|531814837|FG001|Part B|Non-compliance with study drug|0|||
147662572|NCT02513550|532587350|FG005|Post-Treatment Follow-up Period|Labor Reasons|0|||
147662573|NCT02869789|532587358|FG000|Overall Study|Disease progression|184|||
147662574|NCT02869789|532587359|FG001|Overall Study|Disease progression|109|||
147603132|NCT00742924|532363656|FG001|Overall Study|Physician Decision|0|||
147603133|NCT00742924|532363657|FG002|Overall Study|Physician Decision|0|||
147603134|NCT00742924|532363658|FG003|Overall Study|Physician Decision|1|||
147603135|NCT00742924|532363655|FG000|Overall Study|Withdrawal by Subject|0|||
147603136|NCT00742924|532363656|FG001|Overall Study|Withdrawal by Subject|1|||
147603137|NCT00742924|532363657|FG002|Overall Study|Withdrawal by Subject|1|||
147281591|NCT00614939|531196593|FG001|Overall Study|Adverse Event|5|||
147281592|NCT00614939|531196592|FG000|Overall Study|Incorrect enrollment|1|||
147281593|NCT00614939|531196593|FG001|Overall Study|Incorrect enrollment|2|||
147281594|NCT00614939|531196592|FG000|Overall Study|Death|4|||
147281595|NCT00614939|531196593|FG001|Overall Study|Death|3|||
147281596|NCT00614939|531196592|FG000|Overall Study|Poor/non-compliance|4|||
147603138|NCT00742924|532363658|FG003|Overall Study|Withdrawal by Subject|0|||
147603139|NCT01777620|532363659|FG000|Overall Study|Subject Withdrawal|1|||
147603140|NCT01777620|532363660|FG001|Overall Study|Subject Withdrawal|0|||
147603141|NCT00936897|532363682|FG000|Overall Study|Withdrawal by Subject|9|||
147603142|NCT00936897|532363683|FG001|Overall Study|Withdrawal by Subject|19|||
147603143|NCT00936897|532363682|FG000|Overall Study|Adverse Event|4|||
147603144|NCT00936897|532363683|FG001|Overall Study|Adverse Event|13|||
147603145|NCT00936897|532363682|FG000|Overall Study|Other|3|||
147603146|NCT00936897|532363683|FG001|Overall Study|Other|9|||
147603147|NCT00936897|532363682|FG000|Overall Study|Lost to Follow-up|1|||
147603148|NCT00936897|532363683|FG001|Overall Study|Lost to Follow-up|10|||
147603149|NCT00936897|532363682|FG000|Overall Study|Administrative Decision|1|||
147603150|NCT00936897|532363683|FG001|Overall Study|Administrative Decision|2|||
147603151|NCT00936897|532363682|FG000|Overall Study|Protocol Violation|1|||
147603152|NCT00936897|532363683|FG001|Overall Study|Protocol Violation|1|||
147603153|NCT00936897|532363682|FG000|Overall Study|Ineligibility Determined|0|||
147603154|NCT00936897|532363683|FG001|Overall Study|Ineligibility Determined|3|||
147603155|NCT00936897|532363682|FG000|Overall Study|Noncompliance|0|||
147603156|NCT00936897|532363683|FG001|Overall Study|Noncompliance|2|||
147603157|NCT00936897|532363682|FG000|Overall Study|Death|0|||
147603158|NCT00936897|532363683|FG001|Overall Study|Death|1|||
147603159|NCT04058067|532363684|FG000|Overall Study|Adverse Event|2|||
147603160|NCT04058067|532363685|FG001|Overall Study|Adverse Event|0|||
147603161|NCT04058067|532363684|FG000|Overall Study|Death|0|||
147603162|NCT04058067|532363685|FG001|Overall Study|Death|1|||
147603163|NCT04058067|532363684|FG000|Overall Study|Physician Decision|3|||
147603164|NCT04058067|532363685|FG001|Overall Study|Physician Decision|1|||
147603165|NCT04058067|532363684|FG000|Overall Study|Protocol Violation|0|||
147603166|NCT04058067|532363685|FG001|Overall Study|Protocol Violation|1|||
147603167|NCT04058067|532363684|FG000|Overall Study|Withdrawal by Subject|7|||
147603168|NCT04058067|532363685|FG001|Overall Study|Withdrawal by Subject|8|||
147603169|NCT05005312|532363686|FG000|Overall Study|Enrolled, but not treated|0|||
147603170|NCT05005312|532363687|FG001|Overall Study|Enrolled, but not treated|1|||
147603171|NCT01283035|532363688|FG000|Overall Study|Subject later found ineligible|1|||
147603172|NCT02792699|532363694|FG000|Overall Study|Adverse Event|1|||
147603173|NCT02792699|532363695|FG001|Overall Study|Adverse Event|2|||
147603174|NCT02792699|532363696|FG002|Overall Study|Adverse Event|4|||
147603175|NCT02792699|532363694|FG000|Overall Study|Withdrawal by Subject|4|||
147603176|NCT02792699|532363695|FG001|Overall Study|Withdrawal by Subject|4|||
147603177|NCT02792699|532363696|FG002|Overall Study|Withdrawal by Subject|3|||
147603178|NCT02792699|532363694|FG000|Overall Study|Lost to Follow-up|0|||
147603179|NCT02792699|532363695|FG001|Overall Study|Lost to Follow-up|1|||
147603180|NCT02792699|532363696|FG002|Overall Study|Lost to Follow-up|2|||
147603181|NCT02792699|532363694|FG000|Overall Study|Physician Decision|2|||
147603182|NCT02792699|532363695|FG001|Overall Study|Physician Decision|0|||
147603183|NCT02792699|532363696|FG002|Overall Study|Physician Decision|0|||
147603184|NCT02792699|532363694|FG000|Overall Study|Dissatisfaction with Treatment Efficacy|1|||
147281597|NCT00614939|531196593|FG001|Overall Study|Poor/non-compliance|0|||
147281598|NCT00614939|531196592|FG000|Overall Study|Hospitalized due to kidney transplant|1|||
147603185|NCT02792699|532363695|FG001|Overall Study|Dissatisfaction with Treatment Efficacy|3|||
147603186|NCT02792699|532363696|FG002|Overall Study|Dissatisfaction with Treatment Efficacy|1|||
147603187|NCT02792699|532363694|FG000|Overall Study|Other|1|||
147603188|NCT02792699|532363695|FG001|Overall Study|Other|0|||
147603189|NCT02792699|532363696|FG002|Overall Study|Other|0|||
147603190|NCT04524364|532363697|FG000|Overall Study|Physician Decision|3|||
147603191|NCT04524364|532363698|FG001|Overall Study|Physician Decision|6|||
147603192|NCT04524364|532363697|FG000|Overall Study|Adverse Event|0|||
147603193|NCT04524364|532363698|FG001|Overall Study|Adverse Event|1|||
147603194|NCT04524364|532363697|FG000|Overall Study|Investigational device deficiency|0|||
147603195|NCT04524364|532363698|FG001|Overall Study|Investigational device deficiency|1|||
147603196|NCT04524364|532363697|FG000|Overall Study|Implantable cardioverter device (ICD) discovered|0|||
147603197|NCT04524364|532363698|FG001|Overall Study|Implantable cardioverter device (ICD) discovered|1|||
147281599|NCT00614939|531196593|FG001|Overall Study|Hospitalized due to kidney transplant|0|||
147603198|NCT04524364|532363697|FG000|Overall Study|Device unavailability|0|||
147603199|NCT04524364|532363698|FG001|Overall Study|Device unavailability|2|||
147603200|NCT04524364|532363697|FG000|Overall Study|Atrio-ventricular Paroxysmal tachycardia requiring ablation outside PV|1|||
147603201|NCT04524364|532363698|FG001|Overall Study|Atrio-ventricular Paroxysmal tachycardia requiring ablation outside PV|0|||
147281600|NCT00840970|531196594|FG000|Overall Study|Adverse Event|0|||
147281601|NCT00840970|531196595|FG001|Overall Study|Adverse Event|0|||
147281602|NCT00840970|531196596|FG002|Overall Study|Adverse Event|1|||
147281603|NCT03465540|531196597|FG000|Overall Study|Withdrawal by Subject|0|||
147281604|NCT03465540|531196598|FG001|Overall Study|Withdrawal by Subject|0|||
147281605|NCT03465540|531196599|FG002|Overall Study|Withdrawal by Subject|1|||
147281606|NCT03465540|531196600|FG003|Overall Study|Withdrawal by Subject|1|||
147281607|NCT03465540|531196601|FG004|Overall Study|Withdrawal by Subject|1|||
147451302|NCT01903837|531814838|FG002|Part B|Non-compliance with study drug|0|||
147603202|NCT04524364|532363697|FG000|Overall Study|Low International normalized ratio (INR)|1|||
147603203|NCT04524364|532363698|FG001|Overall Study|Low International normalized ratio (INR)|0|||
147603204|NCT02865460|532363699|FG000|Overall Study|Adverse Event|1|||
147603205|NCT02865460|532363700|FG001|Overall Study|Adverse Event|0|||
147603206|NCT02865460|532363699|FG000|Overall Study|Withdrawal by Subject|1|||
147603207|NCT02865460|532363700|FG001|Overall Study|Withdrawal by Subject|1|||
147603208|NCT02865460|532363699|FG000|Overall Study|Lost to Follow-up|7|||
147603209|NCT02865460|532363700|FG001|Overall Study|Lost to Follow-up|4|||
147603210|NCT02865460|532363699|FG000|Overall Study|Ubiquinol group -not deployed to Gulf; Placebo group- ill with COVID|1|||
147603211|NCT02865460|532363700|FG001|Overall Study|Ubiquinol group -not deployed to Gulf; Placebo group- ill with COVID|1|||
147603212|NCT00380744|532363701|FG000|Overall Study|Death|0|||
147603213|NCT00380744|532363702|FG001|Overall Study|Death|0|||
147603214|NCT00380744|532363703|FG002|Overall Study|Death|0|||
147603215|NCT00380744|532363704|FG003|Overall Study|Death|0|||
147603216|NCT00380744|532363705|FG004|Overall Study|Death|0|||
147603217|NCT00380744|532363706|FG005|Overall Study|Death|0|||
147603218|NCT00380744|532363707|FG006|Overall Study|Death|1|||
147603219|NCT00380744|532363701|FG000|Overall Study|Withdrawal by Subject|1|||
147603220|NCT00380744|532363702|FG001|Overall Study|Withdrawal by Subject|0|||
147603221|NCT00380744|532363703|FG002|Overall Study|Withdrawal by Subject|0|||
147603222|NCT00380744|532363704|FG003|Overall Study|Withdrawal by Subject|0|||
147603223|NCT00380744|532363705|FG004|Overall Study|Withdrawal by Subject|0|||
147603224|NCT00380744|532363706|FG005|Overall Study|Withdrawal by Subject|0|||
147603225|NCT00380744|532363707|FG006|Overall Study|Withdrawal by Subject|0|||
147603226|NCT00620555|532363713|FG000|Overall Study|Adverse Event|4|||
147603227|NCT00620555|532363713|FG000|Overall Study|Protocol Violation|2|||
147603228|NCT00620555|532363713|FG000|Overall Study|Lack of Efficacy|12|||
147603229|NCT00620555|532363713|FG000|Overall Study|Withdrawal by Subject|1|||
147603230|NCT00620555|532363713|FG000|Overall Study|Choice of other treatment|1|||
147603231|NCT00620555|532363713|FG000|Overall Study|Visit failure against planned|1|||
147603232|NCT03796039|532363714|FG000|Overall Study|Death|2|||
147603233|NCT03796039|532363715|FG001|Overall Study|Death|1|||
147603234|NCT03796039|532363714|FG000|Overall Study|Withdrawal by Subject|7|||
147603235|NCT03796039|532363715|FG001|Overall Study|Withdrawal by Subject|4|||
147603236|NCT01140503|532363716|FG000|Overall Study|Withdrawal by Subject|1|||
147603237|NCT02927366|532363717|FG000|Overall Study|Adverse Event|1|||
147603238|NCT02927366|532363718|FG001|Overall Study|Adverse Event|0|||
147603239|NCT02927366|532363717|FG000|Overall Study|Patient schedule|1|||
147603240|NCT02927366|532363718|FG001|Overall Study|Patient schedule|0|||
147603241|NCT00587990|532363719|FG000|Overall Study|Death|0|||
147603242|NCT00587990|532363720|FG001|Overall Study|Death|0|||
147603243|NCT00587990|532363721|FG002|Overall Study|Death|1|||
147603244|NCT00206323|532363722|FG000|Overall Study|Lack of Efficacy|4|||
147603245|NCT00206323|532363723|FG001|Overall Study|Lack of Efficacy|1|||
147603246|NCT00206323|532363722|FG000|Overall Study|Adverse Event|1|||
147603247|NCT00206323|532363723|FG001|Overall Study|Adverse Event|1|||
147603248|NCT00206323|532363722|FG000|Overall Study|Lost to Follow-up|1|||
147603249|NCT00206323|532363723|FG001|Overall Study|Lost to Follow-up|1|||
147603250|NCT03334617|532363724|FG000|Overall Study|Adverse Event|0|||
147603251|NCT03334617|532363725|FG001|Overall Study|Adverse Event|0|||
147603252|NCT03334617|532363726|FG002|Overall Study|Adverse Event|0|||
147603253|NCT03334617|532363727|FG003|Overall Study|Adverse Event|0|||
147603254|NCT03334617|532363728|FG004|Overall Study|Adverse Event|0|||
147603255|NCT03334617|532363729|FG005|Overall Study|Adverse Event|0|||
147603256|NCT03334617|532363730|FG006|Overall Study|Adverse Event|0|||
147603257|NCT03334617|532363731|FG007|Overall Study|Adverse Event|0|||
147603258|NCT03334617|532363732|FG008|Overall Study|Adverse Event|1|||
147603259|NCT03334617|532363733|FG009|Overall Study|Adverse Event|0|||
147603260|NCT03334617|532363734|FG010|Overall Study|Adverse Event|0|||
147603261|NCT03334617|532363735|FG011|Overall Study|Adverse Event|0|||
147603262|NCT03334617|532363736|FG012|Overall Study|Adverse Event|1|||
147603263|NCT03334617|532363737|FG013|Overall Study|Adverse Event|0|||
147603264|NCT03334617|532363738|FG014|Overall Study|Adverse Event|0|||
147603265|NCT03334617|532363739|FG015|Overall Study|Adverse Event|0|||
147603266|NCT03334617|532363740|FG016|Overall Study|Adverse Event|0|||
147662575|NCT02869789|532587360|FG002|Overall Study|Disease progression|260|||
147281608|NCT03465540|531196602|FG005|Overall Study|Withdrawal by Subject|0|||
147281609|NCT03465540|531196597|FG000|Overall Study|Lost to Follow-up|0|||
147451303|NCT01903837|531814839|FG003|Part B|Non-compliance with study drug|1|||
147451304|NCT01903837|531814836|FG000|Part B|Incarceration|2|||
147281610|NCT03465540|531196598|FG001|Overall Study|Lost to Follow-up|1|||
147281611|NCT03465540|531196599|FG002|Overall Study|Lost to Follow-up|0|||
147281612|NCT03465540|531196600|FG003|Overall Study|Lost to Follow-up|0|||
147281613|NCT03465540|531196601|FG004|Overall Study|Lost to Follow-up|1|||
147281614|NCT03465540|531196602|FG005|Overall Study|Lost to Follow-up|0|||
147281615|NCT03465540|531196597|FG000|Overall Study|Death|1|||
147281616|NCT03465540|531196598|FG001|Overall Study|Death|1|||
147281617|NCT03465540|531196599|FG002|Overall Study|Death|0|||
147281618|NCT03465540|531196600|FG003|Overall Study|Death|2|||
147281619|NCT03465540|531196601|FG004|Overall Study|Death|0|||
147281620|NCT03465540|531196602|FG005|Overall Study|Death|2|||
147281621|NCT03465540|531196597|FG000|Overall Study|Protocol specified criteria|0|||
147281622|NCT03465540|531196598|FG001|Overall Study|Protocol specified criteria|2|||
147281623|NCT03465540|531196599|FG002|Overall Study|Protocol specified criteria|2|||
147281624|NCT03465540|531196600|FG003|Overall Study|Protocol specified criteria|0|||
147281625|NCT03465540|531196601|FG004|Overall Study|Protocol specified criteria|2|||
147281626|NCT03465540|531196602|FG005|Overall Study|Protocol specified criteria|0|||
147281627|NCT00504829|531196603|FG000|Overall Study|Protocol Violation|6|||
147281628|NCT00504829|531196604|FG001|Overall Study|Protocol Violation|4|||
147451305|NCT01903837|531814837|FG001|Part B|Incarceration|0|||
147451306|NCT01903837|531814838|FG002|Part B|Incarceration|0|||
147603267|NCT03334617|532363741|FG017|Overall Study|Adverse Event|0|||
147603268|NCT03334617|532363742|FG018|Overall Study|Adverse Event|0|||
147603269|NCT03334617|532363743|FG019|Overall Study|Adverse Event|0|||
147603270|NCT03334617|532363744|FG020|Overall Study|Adverse Event|0|||
147603271|NCT03334617|532363745|FG021|Overall Study|Adverse Event|0|||
147603272|NCT03334617|532363724|FG000|Overall Study|Death|18|||
147603273|NCT03334617|532363725|FG001|Overall Study|Death|18|||
147603274|NCT03334617|532363726|FG002|Overall Study|Death|20|||
147603275|NCT03334617|532363727|FG003|Overall Study|Death|21|||
147603276|NCT03334617|532363728|FG004|Overall Study|Death|20|||
147603277|NCT03334617|532363729|FG005|Overall Study|Death|16|||
147603278|NCT03334617|532363730|FG006|Overall Study|Death|28|||
147603279|NCT03334617|532363731|FG007|Overall Study|Death|35|||
147603280|NCT03334617|532363732|FG008|Overall Study|Death|47|||
147603281|NCT03334617|532363733|FG009|Overall Study|Death|0|||
147603282|NCT03334617|532363734|FG010|Overall Study|Death|19|||
147603283|NCT03334617|532363735|FG011|Overall Study|Death|6|||
147603284|NCT03334617|532363736|FG012|Overall Study|Death|20|||
147603285|NCT03334617|532363737|FG013|Overall Study|Death|22|||
147603286|NCT03334617|532363738|FG014|Overall Study|Death|17|||
147603287|NCT03334617|532363739|FG015|Overall Study|Death|18|||
147281629|NCT00504829|531196605|FG002|Overall Study|Protocol Violation|10|||
147281630|NCT01854827|531196606|FG000|Overall Study|Death|1|||
147281631|NCT04443218|531196607|FG000|Overall Study|Exited study for other reasons|9|||
147603288|NCT03334617|532363740|FG016|Overall Study|Death|12|||
147603289|NCT03334617|532363741|FG017|Overall Study|Death|15|||
147603290|NCT03334617|532363742|FG018|Overall Study|Death|16|||
147603291|NCT03334617|532363743|FG019|Overall Study|Death|27|||
147603292|NCT03334617|532363744|FG020|Overall Study|Death|14|||
147603293|NCT03334617|532363745|FG021|Overall Study|Death|27|||
147603294|NCT03334617|532363724|FG000|Overall Study|Lost to Follow-up|0|||
147603295|NCT03334617|532363725|FG001|Overall Study|Lost to Follow-up|0|||
147603296|NCT03334617|532363726|FG002|Overall Study|Lost to Follow-up|0|||
147603297|NCT03334617|532363727|FG003|Overall Study|Lost to Follow-up|1|||
147603298|NCT03334617|532363728|FG004|Overall Study|Lost to Follow-up|0|||
147603299|NCT03334617|532363729|FG005|Overall Study|Lost to Follow-up|1|||
147603300|NCT03334617|532363730|FG006|Overall Study|Lost to Follow-up|0|||
147603301|NCT03334617|532363731|FG007|Overall Study|Lost to Follow-up|0|||
147603302|NCT03334617|532363732|FG008|Overall Study|Lost to Follow-up|1|||
147603303|NCT03334617|532363733|FG009|Overall Study|Lost to Follow-up|0|||
147603304|NCT03334617|532363734|FG010|Overall Study|Lost to Follow-up|0|||
147603305|NCT03334617|532363735|FG011|Overall Study|Lost to Follow-up|0|||
147603306|NCT03334617|532363736|FG012|Overall Study|Lost to Follow-up|0|||
147451307|NCT01903837|531814839|FG003|Part B|Incarceration|1|||
147603307|NCT03334617|532363737|FG013|Overall Study|Lost to Follow-up|0|||
147281632|NCT04443218|531196607|FG000|Overall Study|Withdrawal by Subject|1|||
147281633|NCT04443218|531196607|FG000|Overall Study|Lost to Follow-up|4|||
147281634|NCT04443218|531196607|FG000|Overall Study|Death|19|||
147281635|NCT02660944|531196608|FG000|Overall Study|Adverse Event|3|||
147281636|NCT02660944|531196609|FG001|Overall Study|Adverse Event|4|||
147451308|NCT01903837|531814836|FG000|Part B|Physician Decision|1|||
147603308|NCT03334617|532363738|FG014|Overall Study|Lost to Follow-up|0|||
147603309|NCT03334617|532363739|FG015|Overall Study|Lost to Follow-up|0|||
147603310|NCT03334617|532363740|FG016|Overall Study|Lost to Follow-up|0|||
147603311|NCT03334617|532363741|FG017|Overall Study|Lost to Follow-up|0|||
147603312|NCT03334617|532363742|FG018|Overall Study|Lost to Follow-up|0|||
147603313|NCT03334617|532363743|FG019|Overall Study|Lost to Follow-up|0|||
147603314|NCT03334617|532363744|FG020|Overall Study|Lost to Follow-up|0|||
147603315|NCT03334617|532363745|FG021|Overall Study|Lost to Follow-up|0|||
147603316|NCT03334617|532363724|FG000|Overall Study|Withdrawal by Subject|0|||
147281637|NCT02660944|531196608|FG000|Overall Study|Physician Decision|3|||
147281638|NCT02660944|531196609|FG001|Overall Study|Physician Decision|1|||
147281639|NCT02660944|531196608|FG000|Overall Study|Withdrawal by Subject|5|||
147281640|NCT02660944|531196609|FG001|Overall Study|Withdrawal by Subject|3|||
147281641|NCT02660944|531196608|FG000|Overall Study|Lost to Follow-up|4|||
147281642|NCT02660944|531196609|FG001|Overall Study|Lost to Follow-up|1|||
147281643|NCT02660944|531196608|FG000|Overall Study|Subject schedule|0|||
147281644|NCT02660944|531196609|FG001|Overall Study|Subject schedule|1|||
147281645|NCT02660944|531196608|FG000|Overall Study|Exclusion criteria met|2|||
147335774|NCT00057837|531396413|FG000|Overall Study|Physician Decision|1|||
147335775|NCT00057837|531396414|FG001|Overall Study|Physician Decision|0|||
147335776|NCT00057837|531396413|FG000|Overall Study|Ineligible|3|||
147335777|NCT00057837|531396414|FG001|Overall Study|Ineligible|3|||
147603317|NCT03334617|532363725|FG001|Overall Study|Withdrawal by Subject|1|||
147603318|NCT03334617|532363726|FG002|Overall Study|Withdrawal by Subject|0|||
147603319|NCT03334617|532363727|FG003|Overall Study|Withdrawal by Subject|0|||
147603320|NCT03334617|532363728|FG004|Overall Study|Withdrawal by Subject|1|||
147603321|NCT03334617|532363729|FG005|Overall Study|Withdrawal by Subject|1|||
147603322|NCT03334617|532363730|FG006|Overall Study|Withdrawal by Subject|1|||
147603323|NCT03334617|532363731|FG007|Overall Study|Withdrawal by Subject|2|||
147603324|NCT03334617|532363732|FG008|Overall Study|Withdrawal by Subject|0|||
147603325|NCT03334617|532363733|FG009|Overall Study|Withdrawal by Subject|0|||
147603326|NCT03334617|532363734|FG010|Overall Study|Withdrawal by Subject|0|||
147603327|NCT03334617|532363735|FG011|Overall Study|Withdrawal by Subject|1|||
147603328|NCT03334617|532363736|FG012|Overall Study|Withdrawal by Subject|1|||
147603329|NCT03334617|532363737|FG013|Overall Study|Withdrawal by Subject|0|||
147603330|NCT03334617|532363738|FG014|Overall Study|Withdrawal by Subject|2|||
147603331|NCT03334617|532363739|FG015|Overall Study|Withdrawal by Subject|1|||
147603332|NCT03334617|532363740|FG016|Overall Study|Withdrawal by Subject|0|||
147603333|NCT03334617|532363741|FG017|Overall Study|Withdrawal by Subject|1|||
147603334|NCT03334617|532363742|FG018|Overall Study|Withdrawal by Subject|1|||
147603335|NCT03334617|532363743|FG019|Overall Study|Withdrawal by Subject|1|||
147603336|NCT03334617|532363744|FG020|Overall Study|Withdrawal by Subject|0|||
147603337|NCT03334617|532363745|FG021|Overall Study|Withdrawal by Subject|1|||
147603338|NCT03334617|532363724|FG000|Overall Study|Other|1|||
147603339|NCT03334617|532363725|FG001|Overall Study|Other|2|||
147603340|NCT03334617|532363726|FG002|Overall Study|Other|0|||
147603341|NCT03334617|532363727|FG003|Overall Study|Other|1|||
147603342|NCT03334617|532363728|FG004|Overall Study|Other|1|||
147603343|NCT03334617|532363729|FG005|Overall Study|Other|0|||
147603344|NCT03334617|532363730|FG006|Overall Study|Other|2|||
147281646|NCT02660944|531196609|FG001|Overall Study|Exclusion criteria met|0|||
147335778|NCT00057837|531396413|FG000|Overall Study|Never started treatment|1|||
147335779|NCT00057837|531396414|FG001|Overall Study|Never started treatment|1|||
147335780|NCT02537522|531396415|FG000|Phase I - Contralateral|Subject no longer eligible|15|||
147335781|NCT02537522|531396416|FG001|Phase I - Contralateral|Subject no longer eligible|7|||
147335782|NCT02537522|531396417|FG002|Phase I - Contralateral|Subject no longer eligible|0|||
147335783|NCT02537522|531396418|FG003|Phase I - Contralateral|Subject no longer eligible|0|||
147335784|NCT02537522|531396415|FG000|Phase I - Contralateral|Withdrawal by Subject|0|||
147335785|NCT02537522|531396416|FG001|Phase I - Contralateral|Withdrawal by Subject|1|||
147335786|NCT02537522|531396417|FG002|Phase I - Contralateral|Withdrawal by Subject|0|||
147335787|NCT02537522|531396418|FG003|Phase I - Contralateral|Withdrawal by Subject|0|||
147335788|NCT02537522|531396415|FG000|Phase I - Contralateral|incorrect randomization|0|||
147335789|NCT02537522|531396416|FG001|Phase I - Contralateral|incorrect randomization|1|||
147335790|NCT02537522|531396417|FG002|Phase I - Contralateral|incorrect randomization|0|||
147335791|NCT02537522|531396418|FG003|Phase I - Contralateral|incorrect randomization|0|||
147335792|NCT02537522|531396415|FG000|Phase I - Contralateral|unsatisfactory lens fitting|0|||
147335793|NCT02537522|531396416|FG001|Phase I - Contralateral|unsatisfactory lens fitting|1|||
147335794|NCT02537522|531396417|FG002|Phase I - Contralateral|unsatisfactory lens fitting|0|||
147335795|NCT02537522|531396418|FG003|Phase I - Contralateral|unsatisfactory lens fitting|0|||
147335796|NCT02537522|531396415|FG000|Phase II - Period 1 Bilateral|Adverse Event|0|||
147662576|NCT02869789|532587361|FG003|Overall Study|Disease progression|19|||
147662577|NCT02869789|532587358|FG000|Overall Study|Study drug toxicity|90|||
147335797|NCT02537522|531396416|FG001|Phase II - Period 1 Bilateral|Adverse Event|0|||
147335798|NCT02537522|531396417|FG002|Phase II - Period 1 Bilateral|Adverse Event|0|||
147335799|NCT02537522|531396418|FG003|Phase II - Period 1 Bilateral|Adverse Event|1|||
147335800|NCT02570711|531396421|FG000|Overall Study|Death|1|||
147603345|NCT03334617|532363731|FG007|Overall Study|Other|1|||
147603346|NCT03334617|532363732|FG008|Overall Study|Other|8|||
147603347|NCT03334617|532363733|FG009|Overall Study|Other|0|||
147603348|NCT03334617|532363734|FG010|Overall Study|Other|3|||
147603349|NCT03334617|532363735|FG011|Overall Study|Other|1|||
147603350|NCT03334617|532363736|FG012|Overall Study|Other|3|||
147662578|NCT02869789|532587359|FG001|Overall Study|Study drug toxicity|32|||
147281647|NCT02843568|531196610|FG000|Overall Study|Excluded from Primary Population due to change in treatment|4|||
147281648|NCT02843568|531196611|FG001|Overall Study|Excluded from Primary Population due to change in treatment|2|||
147281649|NCT02843568|531196610|FG000|Overall Study|Death|3|||
147281650|NCT02843568|531196611|FG001|Overall Study|Death|3|||
147281651|NCT02843568|531196610|FG000|Overall Study|Withdrawal by Subject|1|||
147281652|NCT02843568|531196611|FG001|Overall Study|Withdrawal by Subject|1|||
147281653|NCT02843568|531196610|FG000|Overall Study|Lost to Follow-up|2|||
147281654|NCT02843568|531196611|FG001|Overall Study|Lost to Follow-up|0|||
147281655|NCT03586999|531196612|FG000|Overall Study|Lack of Efficacy|2|||
147281656|NCT00096941|531196621|FG000|Overall Study|disease progression|3|||
147281657|NCT01525082|531196625|FG000|Overall Study|Death|1|||
147281658|NCT04111497|531196626|FG000|Overall Study|relapse of primary disease|1|||
147281659|NCT04111497|531196626|FG000|Overall Study|toxicity and/or lack of efficacy|13|||
147281660|NCT03880578|531196627|FG000|Overall Study|Withdrawal by Subject|0|||
147281661|NCT03880578|531196628|FG001|Overall Study|Withdrawal by Subject|3|||
147281662|NCT03880578|531196629|FG002|Overall Study|Withdrawal by Subject|1|||
147281663|NCT03880578|531196627|FG000|Overall Study|Death|0|||
147281664|NCT03880578|531196628|FG001|Overall Study|Death|1|||
147281665|NCT03880578|531196629|FG002|Overall Study|Death|0|||
147281666|NCT02328326|531196631|FG000|Overall Study|Withdrawal by Subject|10|||
147281667|NCT02328326|531196632|FG001|Overall Study|Withdrawal by Subject|3|||
147281668|NCT02328326|531196631|FG000|Overall Study|Death|2|||
147281669|NCT02328326|531196632|FG001|Overall Study|Death|1|||
147281670|NCT02328326|531196631|FG000|Overall Study|Lost to Follow-up|10|||
147281671|NCT02328326|531196632|FG001|Overall Study|Lost to Follow-up|4|||
147281672|NCT02209324|531196633|FG000|Overall Study|Adverse Event|2|||
147281673|NCT02209324|531196633|FG000|Overall Study|Lack of Efficacy|1|||
147281674|NCT02209324|531196633|FG000|Overall Study|Lost to Follow-up|1|||
147281675|NCT02209324|531196633|FG000|Overall Study|Physician Decision|3|||
147281676|NCT02209324|531196633|FG000|Overall Study|Protocol Violation|14|||
147281677|NCT02209324|531196633|FG000|Overall Study|Withdrawal by Subject|8|||
147281678|NCT02209324|531196633|FG000|Overall Study|Clinical laboratory value is ineligible on day 1|4|||
147281679|NCT02209324|531196633|FG000|Overall Study|Platelet count < LLN in Laboratory test|7|||
147281680|NCT02209324|531196633|FG000|Overall Study|QT interval >-450 ms on measurement of an ECG|5|||
147281681|NCT03105362|531196634|FG000|Overall Study|Withdrawal by Subject|1|||
147281682|NCT03105362|531196634|FG000|Overall Study|Lost to Follow-up|1|||
147281683|NCT01785602|531196635|FG000|Overall Study|Withdrawal by Subject|2|||
147281684|NCT01785602|531196636|FG001|Overall Study|Withdrawal by Subject|0|||
147281685|NCT01785602|531196635|FG000|Overall Study|Lost to Follow-up|1|||
147281686|NCT01785602|531196636|FG001|Overall Study|Lost to Follow-up|1|||
147281687|NCT01785602|531196635|FG000|Overall Study|Adverse Event|3|||
147281688|NCT01785602|531196636|FG001|Overall Study|Adverse Event|5|||
147335801|NCT02570711|531396422|FG001|Overall Study|Death|0|||
147335802|NCT02570711|531396421|FG000|Overall Study|Early Termination of Study by Sponsor|0|||
147335803|NCT02570711|531396422|FG001|Overall Study|Early Termination of Study by Sponsor|2|||
147335804|NCT05001945|531396423|FG000|Overall Study|Adverse Event|0|||
147335805|NCT05001945|531396424|FG001|Overall Study|Adverse Event|0|||
147335806|NCT05001945|531396425|FG002|Overall Study|Adverse Event|0|||
147603351|NCT03334617|532363737|FG013|Overall Study|Other|1|||
147603352|NCT03334617|532363738|FG014|Overall Study|Other|1|||
147603353|NCT03334617|532363739|FG015|Overall Study|Other|3|||
147603354|NCT03334617|532363740|FG016|Overall Study|Other|3|||
147603355|NCT03334617|532363741|FG017|Overall Study|Other|3|||
147603356|NCT03334617|532363742|FG018|Overall Study|Other|7|||
147603357|NCT03334617|532363743|FG019|Overall Study|Other|4|||
147603358|NCT03334617|532363744|FG020|Overall Study|Other|1|||
147603359|NCT03334617|532363745|FG021|Overall Study|Other|4|||
147603360|NCT03334617|532363724|FG000|Overall Study|Continuing study off treatment at data cut-off|0|||
147603361|NCT03334617|532363725|FG001|Overall Study|Continuing study off treatment at data cut-off|0|||
147603362|NCT03334617|532363726|FG002|Overall Study|Continuing study off treatment at data cut-off|0|||
147603363|NCT03334617|532363727|FG003|Overall Study|Continuing study off treatment at data cut-off|0|||
147603364|NCT03334617|532363728|FG004|Overall Study|Continuing study off treatment at data cut-off|0|||
147603365|NCT03334617|532363729|FG005|Overall Study|Continuing study off treatment at data cut-off|2|||
147603366|NCT03334617|532363730|FG006|Overall Study|Continuing study off treatment at data cut-off|0|||
147603367|NCT03334617|532363731|FG007|Overall Study|Continuing study off treatment at data cut-off|0|||
147603368|NCT03334617|532363732|FG008|Overall Study|Continuing study off treatment at data cut-off|0|||
147603369|NCT03334617|532363733|FG009|Overall Study|Continuing study off treatment at data cut-off|0|||
147281689|NCT01785602|531196635|FG000|Overall Study|Administrative problems|7|||
147281690|NCT01785602|531196636|FG001|Overall Study|Administrative problems|3|||
147335807|NCT05001945|531396426|FG003|Overall Study|Adverse Event|1|||
147335808|NCT05001945|531396427|FG004|Overall Study|Adverse Event|0|||
147603370|NCT03334617|532363734|FG010|Overall Study|Continuing study off treatment at data cut-off|1|||
147603371|NCT03334617|532363735|FG011|Overall Study|Continuing study off treatment at data cut-off|0|||
147281691|NCT02041429|531196640|FG000|Overall Study|Progressive Disease|2|||
147281692|NCT02041429|531196641|FG001|Overall Study|Progressive Disease|2|||
147281693|NCT02041429|531196642|FG002|Overall Study|Progressive Disease|3|||
147335809|NCT05001945|531396428|FG005|Overall Study|Adverse Event|0|||
147281694|NCT02041429|531196643|FG003|Overall Study|Progressive Disease|2|||
147603372|NCT03334617|532363736|FG012|Overall Study|Continuing study off treatment at data cut-off|0|||
147603373|NCT03334617|532363737|FG013|Overall Study|Continuing study off treatment at data cut-off|0|||
147603374|NCT03334617|532363738|FG014|Overall Study|Continuing study off treatment at data cut-off|0|||
147603375|NCT03334617|532363739|FG015|Overall Study|Continuing study off treatment at data cut-off|0|||
147603376|NCT03334617|532363740|FG016|Overall Study|Continuing study off treatment at data cut-off|0|||
147603377|NCT03334617|532363741|FG017|Overall Study|Continuing study off treatment at data cut-off|0|||
147603378|NCT03334617|532363742|FG018|Overall Study|Continuing study off treatment at data cut-off|0|||
147603379|NCT03334617|532363743|FG019|Overall Study|Continuing study off treatment at data cut-off|1|||
147603380|NCT03334617|532363744|FG020|Overall Study|Continuing study off treatment at data cut-off|2|||
147603381|NCT03334617|532363745|FG021|Overall Study|Continuing study off treatment at data cut-off|4|||
147603382|NCT03657342|532363746|FG000|Overall Study|Adverse Event, including SAE/Death|6|||
147603383|NCT03657342|532363747|FG001|Overall Study|Adverse Event, including SAE/Death|3|||
147603384|NCT03657342|532363746|FG000|Overall Study|Withdrawal by Subject|4|||
147603385|NCT03657342|532363747|FG001|Overall Study|Withdrawal by Subject|4|||
147603386|NCT03657342|532363746|FG000|Overall Study|PATIENT WITHDRAWN BY THE SPONSOR DUE TO USE OF CYCLOSPORINE A DURING TRIAL (NOT ALLOWED)|1|||
147603387|NCT03657342|532363747|FG001|Overall Study|PATIENT WITHDRAWN BY THE SPONSOR DUE TO USE OF CYCLOSPORINE A DURING TRIAL (NOT ALLOWED)|0|||
147281695|NCT02041429|531196640|FG000|Overall Study|Toxicity|0|||
147281696|NCT02041429|531196641|FG001|Overall Study|Toxicity|1|||
147281697|NCT02041429|531196642|FG002|Overall Study|Toxicity|4|||
147281698|NCT02041429|531196643|FG003|Overall Study|Toxicity|2|||
147281699|NCT02041429|531196640|FG000|Overall Study|Withdrawal by Subject|0|||
147281700|NCT02041429|531196641|FG001|Overall Study|Withdrawal by Subject|1|||
147281701|NCT02041429|531196642|FG002|Overall Study|Withdrawal by Subject|0|||
147281702|NCT02041429|531196643|FG003|Overall Study|Withdrawal by Subject|0|||
147281703|NCT02041429|531196640|FG000|Overall Study|On Maintenance Therapy|1|||
147281704|NCT02041429|531196641|FG001|Overall Study|On Maintenance Therapy|0|||
147281705|NCT02041429|531196642|FG002|Overall Study|On Maintenance Therapy|0|||
147281706|NCT02041429|531196643|FG003|Overall Study|On Maintenance Therapy|2|||
147281707|NCT05204134|531196648|FG000|Overall Study|Withdrawal by Subject|3|||
147281708|NCT05204134|531196648|FG000|Overall Study|Physician Decision|1|||
147281709|NCT01312467|531196650|FG000|Overall Study|Adverse Event|4|||
147281710|NCT01312467|531196650|FG000|Overall Study|Lost to Follow-up|1|||
147281711|NCT01312467|531196650|FG000|Overall Study|Withdrawal by Subject|2|||
147281712|NCT01312467|531196650|FG000|Overall Study|Deported to country of origin|1|||
147281713|NCT01312467|531196650|FG000|Overall Study|Another medical condition|1|||
147281714|NCT01312467|531196650|FG000|Overall Study|Ineligible|4|||
147281715|NCT02752048|531196651|FG000|Overall Study|Withdrawal by Subject|0|||
147281716|NCT02752048|531196652|FG001|Overall Study|Withdrawal by Subject|0|||
147281717|NCT02752048|531196653|FG002|Overall Study|Withdrawal by Subject|3|||
147281718|NCT01431508|531196654|FG000|Overall Study|Lack of Efficacy|1|||
147281719|NCT01431508|531196654|FG000|Overall Study|Unable to Follow Protocol Procedures|1|||
147281720|NCT00132769|531196655|FG000|Overall Study|Withdrawal by Subject|1|||
147281721|NCT00132769|531196656|FG001|Overall Study|Withdrawal by Subject|3|||
147281722|NCT00132769|531196655|FG000|Overall Study|Lack of Efficacy|7|||
147281723|NCT00132769|531196656|FG001|Overall Study|Lack of Efficacy|6|||
147281724|NCT00132769|531196655|FG000|Overall Study|Adverse Event|2|||
147281725|NCT00132769|531196656|FG001|Overall Study|Adverse Event|1|||
147281726|NCT00132769|531196655|FG000|Overall Study|Protocol Violation|1|||
147281727|NCT00132769|531196656|FG001|Overall Study|Protocol Violation|1|||
147281728|NCT00129259|531196657|FG000|Overall Study|Lost to Follow-up|1|||
147281729|NCT00129259|531196658|FG001|Overall Study|Lost to Follow-up|1|||
147281730|NCT00129259|531196657|FG000|Overall Study|Withdrawal by Subject|2|||
147281731|NCT00129259|531196658|FG001|Overall Study|Withdrawal by Subject|1|||
147281732|NCT00129259|531196657|FG000|Overall Study|Only available minimal phone assessments|0|||
147281733|NCT00129259|531196658|FG001|Overall Study|Only available minimal phone assessments|1|||
147281734|NCT01609556|531196662|FG000|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
147281735|NCT01609556|531196663|FG001|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
147281736|NCT01609556|531196664|FG002|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
147281737|NCT01609556|531196665|FG003|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
147281738|NCT01609556|531196666|FG004|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1|||
147281739|NCT01609556|531196667|FG005|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
147281740|NCT01609556|531196668|FG006|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
147603388|NCT03657342|532363746|FG000|Overall Study|PI WITHDREW PATIENT DUE TO THE HIS/HER UNSTABLE CLINICAL CONDITION|1|||
147281741|NCT01609556|531196669|FG007|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1|||
147281742|NCT01609556|531196670|FG008|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1|||
147603389|NCT03657342|532363747|FG001|Overall Study|PI WITHDREW PATIENT DUE TO THE HIS/HER UNSTABLE CLINICAL CONDITION|0|||
147281743|NCT01609556|531196671|FG009|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
147281744|NCT01609556|531196672|FG010|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1|||
147281745|NCT01609556|531196673|FG011|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|1|||
147281746|NCT01609556|531196674|FG012|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
147603390|NCT03734666|532363749|FG000|Overall Study|Other|7|||
147603391|NCT03734666|532363750|FG001|Overall Study|Other|4|||
147603392|NCT03734666|532363749|FG000|Overall Study|Lost to Follow-up|12|||
147603393|NCT03734666|532363750|FG001|Overall Study|Lost to Follow-up|12|||
147603394|NCT01910389|532363752|FG000|Overall Study|Withdrawal by Subject|2|||
147603395|NCT01910389|532363753|FG001|Overall Study|Withdrawal by Subject|0|||
147603396|NCT01910389|532363752|FG000|Overall Study|Study Closed|13|||
147603397|NCT01910389|532363753|FG001|Overall Study|Study Closed|8|||
147603398|NCT05896202|532363754|FG000|Overall Study|Lost to Follow-up|2|||
147603399|NCT05896202|532363755|FG001|Overall Study|Lost to Follow-up|2|||
147603400|NCT04669691|532363756|FG000|Overall Study|Death|0|||
147603401|NCT04669691|532363757|FG001|Overall Study|Death|1|||
147603402|NCT04669691|532363758|FG002|Overall Study|Death|0|||
147603403|NCT04669691|532363759|FG003|Overall Study|Death|0|||
147281747|NCT01609556|531196675|FG013|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
147281748|NCT01609556|531196676|FG014|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
147281749|NCT01609556|531196677|FG015|Dose Escalation: Maximum 101.3 Weeks|Adverse Event|0|||
147281750|NCT01609556|531196662|FG000|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0|||
147281751|NCT01609556|531196663|FG001|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|1|||
147281752|NCT01609556|531196664|FG002|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|1|||
147281753|NCT01609556|531196665|FG003|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|1|||
147281754|NCT01609556|531196666|FG004|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|8|||
147281755|NCT01609556|531196667|FG005|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|13|||
147281756|NCT01609556|531196668|FG006|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|5|||
147281757|NCT01609556|531196669|FG007|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|4|||
147281758|NCT01609556|531196670|FG008|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|3|||
147281759|NCT01609556|531196671|FG009|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|3|||
147281760|NCT01609556|531196672|FG010|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|6|||
147281761|NCT01609556|531196673|FG011|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|3|||
147281762|NCT01609556|531196674|FG012|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0|||
147281763|NCT01609556|531196675|FG013|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0|||
147281764|NCT01609556|531196676|FG014|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0|||
147281765|NCT01609556|531196677|FG015|Dose Escalation: Maximum 101.3 Weeks|Disease Progression|0|||
147281766|NCT01609556|531196662|FG000|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
147281767|NCT01609556|531196663|FG001|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
147281768|NCT01609556|531196664|FG002|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
147281769|NCT01609556|531196665|FG003|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
147281770|NCT01609556|531196666|FG004|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
147281771|NCT01609556|531196667|FG005|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|2|||
147281772|NCT01609556|531196668|FG006|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|2|||
147281773|NCT01609556|531196669|FG007|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
147281774|NCT01609556|531196670|FG008|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
147281775|NCT01609556|531196671|FG009|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|1|||
147281776|NCT01609556|531196672|FG010|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|1|||
147281777|NCT01609556|531196673|FG011|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|2|||
147281778|NCT01609556|531196674|FG012|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
147281779|NCT01609556|531196675|FG013|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
147281780|NCT01609556|531196676|FG014|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
147281781|NCT01609556|531196677|FG015|Dose Escalation: Maximum 101.3 Weeks|Clinical Progression|0|||
147281782|NCT01609556|531196662|FG000|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
147281783|NCT01609556|531196663|FG001|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
147281784|NCT01609556|531196664|FG002|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
147281785|NCT01609556|531196665|FG003|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
147281786|NCT01609556|531196666|FG004|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
147281787|NCT01609556|531196667|FG005|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|1|||
147281788|NCT01609556|531196668|FG006|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
147281789|NCT01609556|531196669|FG007|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
147281790|NCT01609556|531196670|FG008|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
147281791|NCT01609556|531196671|FG009|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
147281792|NCT01609556|531196672|FG010|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
147281793|NCT01609556|531196673|FG011|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|1|||
147281794|NCT01609556|531196674|FG012|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
147603404|NCT04669691|532363760|FG004|Overall Study|Death|0|||
147603405|NCT04669691|532363761|FG005|Overall Study|Death|0|||
147603406|NCT01822275|532363762|FG000|Overall Study|Withdrawal by Subject|3|||
147603407|NCT01822275|532363762|FG000|Overall Study|Adverse Event|3|||
147603408|NCT01822275|532363762|FG000|Overall Study|Progression|14|||
147603409|NCT01822275|532363762|FG000|Overall Study|Physician Decision|2|||
147603410|NCT00911807|532363763|FG000|Overall Study|Adverse Event|2|||
147281795|NCT01609556|531196675|FG013|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
147281796|NCT01609556|531196676|FG014|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
147603411|NCT00911807|532363764|FG001|Overall Study|Adverse Event|1|||
147603412|NCT00911807|532363765|FG002|Overall Study|Adverse Event|5|||
147603413|NCT00911807|532363763|FG000|Overall Study|Death|0|||
147603414|NCT00911807|532363764|FG001|Overall Study|Death|0|||
147603415|NCT00911807|532363765|FG002|Overall Study|Death|1|||
147603416|NCT00911807|532363763|FG000|Overall Study|Protocol Violation|6|||
147603417|NCT00911807|532363764|FG001|Overall Study|Protocol Violation|4|||
147603418|NCT00911807|532363765|FG002|Overall Study|Protocol Violation|9|||
147603419|NCT00911807|532363763|FG000|Overall Study|Withdrawal by Subject|8|||
147603420|NCT00911807|532363764|FG001|Overall Study|Withdrawal by Subject|10|||
147603421|NCT00911807|532363765|FG002|Overall Study|Withdrawal by Subject|7|||
147603422|NCT00911807|532363763|FG000|Overall Study|Organizational reasons|1|||
147603423|NCT00911807|532363764|FG001|Overall Study|Organizational reasons|3|||
147603424|NCT00911807|532363765|FG002|Overall Study|Organizational reasons|1|||
147603425|NCT03918109|532363769|FG000|Overall Study|Withdrawal by Subject|0|||
147603426|NCT03918109|532363770|FG001|Overall Study|Withdrawal by Subject|0|||
147603427|NCT03918109|532363771|FG002|Overall Study|Withdrawal by Subject|2|||
147603428|NCT03918109|532363772|FG003|Overall Study|Withdrawal by Subject|1|||
147603429|NCT03918109|532363769|FG000|Overall Study|Lost to Follow-up|0|||
147603430|NCT03918109|532363770|FG001|Overall Study|Lost to Follow-up|0|||
147603431|NCT03918109|532363771|FG002|Overall Study|Lost to Follow-up|0|||
147603432|NCT03918109|532363772|FG003|Overall Study|Lost to Follow-up|1|||
147603433|NCT04430855|532363773|FG000|Period 1 (Weeks 1-12)|Adverse Event|1|||
147603434|NCT04430855|532363774|FG001|Period 1 (Weeks 1-12)|Adverse Event|0|||
147603435|NCT04430855|532363773|FG000|Period 1 (Weeks 1-12)|Withdrawal by Subject|1|||
147603436|NCT04430855|532363774|FG001|Period 1 (Weeks 1-12)|Withdrawal by Subject|2|||
147603437|NCT04430855|532363773|FG000|Period 1 (Weeks 1-12)|Lost to Follow-up|0|||
147603438|NCT04430855|532363774|FG001|Period 1 (Weeks 1-12)|Lost to Follow-up|2|||
147603439|NCT04430855|532363773|FG000|Period 1 (Weeks 1-12)|Lack of Efficacy|0|||
147281797|NCT01609556|531196677|FG015|Dose Escalation: Maximum 101.3 Weeks|Began New Anticancer Therapy|0|||
147281798|NCT01609556|531196662|FG000|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
147281799|NCT01609556|531196663|FG001|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
147281800|NCT01609556|531196664|FG002|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
147281801|NCT01609556|531196665|FG003|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
147281802|NCT01609556|531196666|FG004|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
147281803|NCT01609556|531196667|FG005|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|1|||
147281804|NCT01609556|531196668|FG006|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
147281805|NCT01609556|531196669|FG007|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
147281806|NCT01609556|531196670|FG008|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
147281807|NCT01609556|531196671|FG009|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
147281808|NCT01609556|531196672|FG010|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
147281809|NCT01609556|531196673|FG011|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
147281810|NCT01609556|531196674|FG012|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
147281811|NCT01609556|531196675|FG013|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
147281812|NCT01609556|531196676|FG014|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
147281813|NCT01609556|531196677|FG015|Dose Escalation: Maximum 101.3 Weeks|Withdrawal by Subject|0|||
147281814|NCT01609556|531196662|FG000|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
147281815|NCT01609556|531196663|FG001|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
147281816|NCT01609556|531196664|FG002|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
147281817|NCT01609556|531196665|FG003|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
147281818|NCT01609556|531196666|FG004|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
147281819|NCT01609556|531196667|FG005|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
147281820|NCT01609556|531196668|FG006|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
147335810|NCT05001945|531396429|FG006|Overall Study|Adverse Event|0|||
147335811|NCT05001945|531396430|FG007|Overall Study|Adverse Event|0|||
147335812|NCT05001945|531396423|FG000|Overall Study|Lost to Follow-up|0|||
147335813|NCT05001945|531396424|FG001|Overall Study|Lost to Follow-up|1|||
147335814|NCT05001945|531396425|FG002|Overall Study|Lost to Follow-up|1|||
147603440|NCT04430855|532363774|FG001|Period 1 (Weeks 1-12)|Lack of Efficacy|1|||
147603441|NCT04430855|532363773|FG000|Period 1 (Weeks 1-12)|Other|0|||
147603442|NCT04430855|532363774|FG001|Period 1 (Weeks 1-12)|Other|1|||
147335815|NCT05001945|531396426|FG003|Overall Study|Lost to Follow-up|2|||
147335816|NCT05001945|531396427|FG004|Overall Study|Lost to Follow-up|0|||
147335817|NCT05001945|531396428|FG005|Overall Study|Lost to Follow-up|1|||
147603443|NCT04430855|532363773|FG000|Period 2 (Weeks 12-48)|Withdrawal by Subject|2|||
147603444|NCT04430855|532363774|FG001|Period 2 (Weeks 12-48)|Withdrawal by Subject|5|||
147603445|NCT04430855|532363773|FG000|Period 2 (Weeks 12-48)|Lost to Follow-up|1|||
147603446|NCT04430855|532363774|FG001|Period 2 (Weeks 12-48)|Lost to Follow-up|2|||
147603447|NCT04430855|532363773|FG000|Period 2 (Weeks 12-48)|Lack of Efficacy|2|||
147603448|NCT04430855|532363774|FG001|Period 2 (Weeks 12-48)|Lack of Efficacy|3|||
147603449|NCT01425723|532363775|FG000|Overall Study|Lack of Efficacy|0|||
147603450|NCT01425723|532363776|FG001|Overall Study|Lack of Efficacy|1|||
147603451|NCT01425723|532363775|FG000|Overall Study|Withdrawal by Subject|1|||
147603452|NCT01425723|532363776|FG001|Overall Study|Withdrawal by Subject|4|||
147603453|NCT01425723|532363775|FG000|Overall Study|Lost to Follow-up|0|||
147603454|NCT01425723|532363776|FG001|Overall Study|Lost to Follow-up|3|||
147603455|NCT01425723|532363775|FG000|Overall Study|Physician Decision|2|||
147603456|NCT01425723|532363776|FG001|Overall Study|Physician Decision|0|||
147603457|NCT01425723|532363775|FG000|Overall Study|Other|1|||
147603458|NCT01425723|532363776|FG001|Overall Study|Other|10|||
147603459|NCT00186043|532363777|FG000|Overall Study|Lack of Efficacy|1|||
147603460|NCT00186043|532363778|FG001|Overall Study|Lack of Efficacy|3|||
147603461|NCT00186043|532363777|FG000|Overall Study|Lost to Follow-up|4|||
147603462|NCT00186043|532363778|FG001|Overall Study|Lost to Follow-up|6|||
147603463|NCT00186043|532363777|FG000|Overall Study|Withdrawal by Subject|1|||
147603464|NCT00186043|532363778|FG001|Overall Study|Withdrawal by Subject|0|||
147603465|NCT00186043|532363777|FG000|Overall Study|Adverse Event|7|||
147603466|NCT00186043|532363778|FG001|Overall Study|Adverse Event|3|||
147603467|NCT00186043|532363777|FG000|Overall Study|Protocol Violation|2|||
147603468|NCT00186043|532363778|FG001|Overall Study|Protocol Violation|1|||
147603469|NCT00871741|532363779|FG000|Overall Study|Premature study termination|9|||
147603470|NCT00871741|532363780|FG001|Overall Study|Premature study termination|7|||
147603471|NCT04663295|532365606|FG000|Run-in Period|Withdrawal by Subject|3|||
147603472|NCT04663295|532365606|FG000|Overall Study Period|Pregnancy|1|||
147603473|NCT04663295|532365606|FG000|Overall Study Period|Withdrawn by Parent/Guardian|1|||
147603474|NCT03610516|532365607|FG000|Treatment Epoch|Adverse Event|3|||
147603475|NCT03610516|532365608|FG001|Treatment Epoch|Adverse Event|1|||
147603476|NCT03610516|532365607|FG000|Treatment Epoch|Death|1|||
147603477|NCT03610516|532365608|FG001|Treatment Epoch|Death|0|||
147603478|NCT03610516|532365607|FG000|Treatment Epoch|Lack of Efficacy|0|||
147603479|NCT03610516|532365608|FG001|Treatment Epoch|Lack of Efficacy|1|||
147603480|NCT03610516|532365607|FG000|Treatment Epoch|No longer requires treatment|1|||
147603481|NCT03610516|532365608|FG001|Treatment Epoch|No longer requires treatment|0|||
147603482|NCT03610516|532365607|FG000|Treatment Epoch|Non-Compliance with study treatment|1|||
147603483|NCT03610516|532365608|FG001|Treatment Epoch|Non-Compliance with study treatment|0|||
147603484|NCT03610516|532365607|FG000|Treatment Epoch|Physician Decision|8|||
147603485|NCT03610516|532365608|FG001|Treatment Epoch|Physician Decision|5|||
147603486|NCT03610516|532365607|FG000|Treatment Epoch|Protocol Deviation|1|||
147603487|NCT03610516|532365608|FG001|Treatment Epoch|Protocol Deviation|0|||
147603488|NCT03610516|532365607|FG000|Treatment Epoch|Withdrawal by Subject|3|||
147603489|NCT03610516|532365608|FG001|Treatment Epoch|Withdrawal by Subject|1|||
147603490|NCT03610516|532365607|FG000|Post-Treatment Follow-up|Subject/Guardian Decision|1|||
147603491|NCT03610516|532365608|FG001|Post-Treatment Follow-up|Subject/Guardian Decision|0|||
147603492|NCT03610516|532365607|FG000|Post-Treatment Follow-up|Death|1|||
147603493|NCT03610516|532365608|FG001|Post-Treatment Follow-up|Death|0|||
147603494|NCT03700385|532365610|FG000|Overall Study|Lost to Follow-up|1|||
147603495|NCT04241315|532365611|FG000|Overall Study|Withdrawal by Subject|0|||
147603496|NCT04241315|532365612|FG001|Overall Study|Withdrawal by Subject|1|||
147603497|NCT01555671|532365616|FG000|Overall Study|Physician Decision|20|||
147603498|NCT01555671|532365617|FG001|Overall Study|Physician Decision|25|||
147603499|NCT04590040|532365620|FG000|Treatment Period|Lost to Follow-up|2|||
147603500|NCT04590040|532365621|FG001|Treatment Period|Lost to Follow-up|5|||
147603501|NCT04590040|532365622|FG002|Treatment Period|Lost to Follow-up|0|||
147603502|NCT04590040|532365620|FG000|Treatment Period|Physician Decision|0|||
147662579|NCT02869789|532587360|FG002|Overall Study|Study drug toxicity|55|||
147662580|NCT02869789|532587361|FG003|Overall Study|Study drug toxicity|14|||
147662581|NCT02869789|532587358|FG000|Overall Study|Death|7|||
147662582|NCT02869789|532587359|FG001|Overall Study|Death|3|||
147281821|NCT01609556|531196669|FG007|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
147281822|NCT01609556|531196670|FG008|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|1|||
147281823|NCT01609556|531196671|FG009|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
147281824|NCT01609556|531196672|FG010|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
147603503|NCT04590040|532365621|FG001|Treatment Period|Physician Decision|0|||
147603504|NCT04590040|532365622|FG002|Treatment Period|Physician Decision|2|||
147603505|NCT00631657|532365630|FG000|6-Month Treatment Period|Adverse Event|47|||
147603506|NCT00631657|532365631|FG001|6-Month Treatment Period|Adverse Event|0|||
147603507|NCT00631657|532365632|FG002|6-Month Treatment Period|Adverse Event|7|||
147603508|NCT00631657|532365630|FG000|6-Month Treatment Period|Withdrawal by Subject|14|||
147603509|NCT00631657|532365631|FG001|6-Month Treatment Period|Withdrawal by Subject|0|||
147603510|NCT00631657|532365632|FG002|6-Month Treatment Period|Withdrawal by Subject|5|||
147603511|NCT00631657|532365630|FG000|6-Month Treatment Period|Lack of Efficacy|34|||
147603512|NCT00631657|532365631|FG001|6-Month Treatment Period|Lack of Efficacy|0|||
147603513|NCT00631657|532365632|FG002|6-Month Treatment Period|Lack of Efficacy|25|||
147603514|NCT00631657|532365630|FG000|6-Month Treatment Period|Lost to Follow-up|7|||
147662583|NCT02869789|532587360|FG002|Overall Study|Death|5|||
147662584|NCT02869789|532587361|FG003|Overall Study|Death|1|||
147662585|NCT02869789|532587358|FG000|Overall Study|Adverse Event unrelated to study drug|30|||
147662586|NCT02869789|532587359|FG001|Overall Study|Adverse Event unrelated to study drug|18|||
147662587|NCT02869789|532587360|FG002|Overall Study|Adverse Event unrelated to study drug|21|||
147662588|NCT02869789|532587361|FG003|Overall Study|Adverse Event unrelated to study drug|6|||
147662589|NCT02869789|532587358|FG000|Overall Study|Participant request to discontinue study treatment|10|||
147662590|NCT02869789|532587359|FG001|Overall Study|Participant request to discontinue study treatment|5|||
147662591|NCT02869789|532587360|FG002|Overall Study|Participant request to discontinue study treatment|5|||
147662592|NCT02869789|532587361|FG003|Overall Study|Participant request to discontinue study treatment|3|||
147662593|NCT02869789|532587358|FG000|Overall Study|Withdrawal by Subject|5|||
147662594|NCT02869789|532587359|FG001|Overall Study|Withdrawal by Subject|2|||
147662595|NCT02869789|532587360|FG002|Overall Study|Withdrawal by Subject|7|||
147662596|NCT02869789|532587361|FG003|Overall Study|Withdrawal by Subject|2|||
147662597|NCT02869789|532587358|FG000|Overall Study|Lost to Follow-up|0|||
147662598|NCT02869789|532587359|FG001|Overall Study|Lost to Follow-up|0|||
147281825|NCT01609556|531196673|FG011|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
147281826|NCT01609556|531196674|FG012|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
147281827|NCT01609556|531196675|FG013|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
147281828|NCT01609556|531196676|FG014|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
147281829|NCT01609556|531196677|FG015|Dose Escalation: Maximum 101.3 Weeks|Investigator Decision|0|||
147281830|NCT01609556|531196662|FG000|Dose Escalation: Maximum 101.3 Weeks|Death|2|||
147281831|NCT01609556|531196663|FG001|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
147281832|NCT01609556|531196664|FG002|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
147281833|NCT01609556|531196665|FG003|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
147281834|NCT01609556|531196666|FG004|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
147281835|NCT01609556|531196667|FG005|Dose Escalation: Maximum 101.3 Weeks|Death|1|||
147281836|NCT01609556|531196668|FG006|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
147281837|NCT01609556|531196669|FG007|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
147281838|NCT01609556|531196670|FG008|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
147281839|NCT01609556|531196671|FG009|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
147281840|NCT01609556|531196672|FG010|Dose Escalation: Maximum 101.3 Weeks|Death|1|||
147281841|NCT01609556|531196673|FG011|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
147281842|NCT01609556|531196674|FG012|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
147281843|NCT01609556|531196675|FG013|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
147281844|NCT01609556|531196676|FG014|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
147281845|NCT01609556|531196677|FG015|Dose Escalation: Maximum 101.3 Weeks|Death|0|||
147281846|NCT01609556|531196662|FG000|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
147281847|NCT01609556|531196663|FG001|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
147281848|NCT01609556|531196664|FG002|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
147281849|NCT01609556|531196665|FG003|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
147281850|NCT01609556|531196666|FG004|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
147281851|NCT01609556|531196667|FG005|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
147662599|NCT02869789|532587360|FG002|Overall Study|Lost to Follow-up|2|||
147281852|NCT01609556|531196668|FG006|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
147281853|NCT01609556|531196669|FG007|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
147281854|NCT01609556|531196670|FG008|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
147281855|NCT01609556|531196671|FG009|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
147281856|NCT01609556|531196672|FG010|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
147281857|NCT01609556|531196673|FG011|Dose Expansion: Maximum 124 Weeks|Adverse Event|0|||
147281858|NCT01609556|531196674|FG012|Dose Expansion: Maximum 124 Weeks|Adverse Event|4|||
147281859|NCT01609556|531196675|FG013|Dose Expansion: Maximum 124 Weeks|Adverse Event|2|||
147281860|NCT01609556|531196676|FG014|Dose Expansion: Maximum 124 Weeks|Adverse Event|2|||
147281861|NCT01609556|531196677|FG015|Dose Expansion: Maximum 124 Weeks|Adverse Event|2|||
147281862|NCT01609556|531196662|FG000|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
147281863|NCT01609556|531196663|FG001|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
147281864|NCT01609556|531196664|FG002|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
147281865|NCT01609556|531196665|FG003|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
147281866|NCT01609556|531196666|FG004|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
147281867|NCT01609556|531196667|FG005|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
147281868|NCT01609556|531196668|FG006|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
147281869|NCT01609556|531196669|FG007|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
147281870|NCT01609556|531196670|FG008|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
147281871|NCT01609556|531196671|FG009|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
147281872|NCT01609556|531196672|FG010|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
147281873|NCT01609556|531196673|FG011|Dose Expansion: Maximum 124 Weeks|Disease Progression|0|||
147451309|NCT01903837|531814837|FG001|Part B|Physician Decision|0|||
147662600|NCT02869789|532587361|FG003|Overall Study|Lost to Follow-up|0|||
147451310|NCT01903837|531814838|FG002|Part B|Physician Decision|0|||
147451311|NCT01903837|531814839|FG003|Part B|Physician Decision|2|||
147281874|NCT01609556|531196674|FG012|Dose Expansion: Maximum 124 Weeks|Disease Progression|32|||
147281875|NCT01609556|531196675|FG013|Dose Expansion: Maximum 124 Weeks|Disease Progression|13|||
147281876|NCT01609556|531196676|FG014|Dose Expansion: Maximum 124 Weeks|Disease Progression|20|||
147281877|NCT01609556|531196677|FG015|Dose Expansion: Maximum 124 Weeks|Disease Progression|27|||
147281878|NCT01609556|531196662|FG000|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
147281879|NCT01609556|531196663|FG001|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
147281880|NCT01609556|531196664|FG002|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
147281881|NCT01609556|531196665|FG003|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
147281882|NCT01609556|531196666|FG004|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
147281883|NCT01609556|531196667|FG005|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
147281884|NCT01609556|531196668|FG006|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
147281885|NCT01609556|531196669|FG007|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
147281886|NCT01609556|531196670|FG008|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
147281887|NCT01609556|531196671|FG009|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
147281888|NCT01609556|531196672|FG010|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
147281889|NCT01609556|531196673|FG011|Dose Expansion: Maximum 124 Weeks|Clinical Progression|0|||
147281890|NCT01609556|531196674|FG012|Dose Expansion: Maximum 124 Weeks|Clinical Progression|3|||
147281891|NCT01609556|531196675|FG013|Dose Expansion: Maximum 124 Weeks|Clinical Progression|3|||
147281892|NCT01609556|531196676|FG014|Dose Expansion: Maximum 124 Weeks|Clinical Progression|3|||
147281893|NCT01609556|531196677|FG015|Dose Expansion: Maximum 124 Weeks|Clinical Progression|2|||
147281894|NCT01609556|531196662|FG000|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
147281895|NCT01609556|531196663|FG001|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
147281896|NCT01609556|531196664|FG002|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
147281897|NCT01609556|531196665|FG003|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
147281898|NCT01609556|531196666|FG004|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
147281899|NCT01609556|531196667|FG005|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
147281900|NCT01609556|531196668|FG006|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
147281901|NCT01609556|531196669|FG007|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
147281902|NCT01609556|531196670|FG008|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
147281903|NCT01609556|531196671|FG009|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
147281904|NCT01609556|531196672|FG010|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
147281905|NCT01609556|531196673|FG011|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
147281906|NCT01609556|531196674|FG012|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|1|||
147281907|NCT01609556|531196675|FG013|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
147281908|NCT01609556|531196676|FG014|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
147281909|NCT01609556|531196677|FG015|Dose Expansion: Maximum 124 Weeks|Began New Anticancer Therapy|0|||
147281910|NCT01609556|531196662|FG000|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
147281911|NCT01609556|531196663|FG001|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
147281912|NCT01609556|531196664|FG002|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
147281913|NCT01609556|531196665|FG003|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
147281914|NCT01609556|531196666|FG004|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
147281915|NCT01609556|531196667|FG005|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
147281916|NCT01609556|531196668|FG006|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
147281917|NCT01609556|531196669|FG007|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
147281918|NCT01609556|531196670|FG008|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
147281919|NCT01609556|531196671|FG009|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
147281920|NCT01609556|531196672|FG010|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
147281921|NCT01609556|531196673|FG011|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|0|||
147281922|NCT01609556|531196674|FG012|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|1|||
147281923|NCT01609556|531196675|FG013|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|4|||
147281924|NCT01609556|531196676|FG014|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|2|||
147603515|NCT00631657|532365631|FG001|6-Month Treatment Period|Lost to Follow-up|0|||
147603516|NCT00631657|532365632|FG002|6-Month Treatment Period|Lost to Follow-up|2|||
147603517|NCT00631657|532365630|FG000|6-Month Treatment Period|Uncooperative Reasons Unrelated to Trial|21|||
147281925|NCT01609556|531196677|FG015|Dose Expansion: Maximum 124 Weeks|Withdrawal by Subject|5|||
147281926|NCT01609556|531196662|FG000|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
147281927|NCT01609556|531196663|FG001|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
147281928|NCT01609556|531196664|FG002|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
147281929|NCT01609556|531196665|FG003|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
147281930|NCT01609556|531196666|FG004|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
147281931|NCT01609556|531196667|FG005|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
147603518|NCT00631657|532365631|FG001|6-Month Treatment Period|Uncooperative Reasons Unrelated to Trial|0|||
147603519|NCT00631657|532365632|FG002|6-Month Treatment Period|Uncooperative Reasons Unrelated to Trial|6|||
147603520|NCT00631657|532365630|FG000|6-Month Treatment Period|Other|16|||
147603521|NCT00631657|532365631|FG001|6-Month Treatment Period|Other|0|||
147603522|NCT00631657|532365632|FG002|6-Month Treatment Period|Other|4|||
147603523|NCT00631657|532365630|FG000|6-Month Treatment Period|Not Treated|2|||
147603524|NCT00631657|532365631|FG001|6-Month Treatment Period|Not Treated|0|||
147603525|NCT00631657|532365632|FG002|6-Month Treatment Period|Not Treated|1|||
147603526|NCT00631657|532365630|FG000|7-Day Discontinuation Period|Not Treated|1|||
147603527|NCT00631657|532365631|FG001|7-Day Discontinuation Period|Not Treated|1|||
147603528|NCT00631657|532365632|FG002|7-Day Discontinuation Period|Not Treated|1|||
147603529|NCT00631657|532365630|FG000|7-Day Discontinuation Period|Other|1|||
147603530|NCT00631657|532365631|FG001|7-Day Discontinuation Period|Other|0|||
147603531|NCT00631657|532365632|FG002|7-Day Discontinuation Period|Other|0|||
147603532|NCT01284361|532365638|FG000|Overall Study|Withdrawal by Subject|1|||
147603533|NCT01284361|532365638|FG000|Overall Study|Protocol Violation|5|||
147281932|NCT01609556|531196668|FG006|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
147281933|NCT01609556|531196669|FG007|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
147281934|NCT01609556|531196670|FG008|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
147281935|NCT01609556|531196671|FG009|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
147281936|NCT01609556|531196672|FG010|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
147281937|NCT01609556|531196673|FG011|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
147281938|NCT01609556|531196674|FG012|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
147281939|NCT01609556|531196675|FG013|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
147281940|NCT01609556|531196676|FG014|Dose Expansion: Maximum 124 Weeks|Investigator Decision|0|||
147281941|NCT01609556|531196677|FG015|Dose Expansion: Maximum 124 Weeks|Investigator Decision|1|||
147281942|NCT01609556|531196662|FG000|Dose Expansion: Maximum 124 Weeks|Death|0|||
147281943|NCT01609556|531196663|FG001|Dose Expansion: Maximum 124 Weeks|Death|0|||
147281944|NCT01609556|531196664|FG002|Dose Expansion: Maximum 124 Weeks|Death|0|||
147281945|NCT01609556|531196665|FG003|Dose Expansion: Maximum 124 Weeks|Death|0|||
147281946|NCT01609556|531196666|FG004|Dose Expansion: Maximum 124 Weeks|Death|0|||
147281947|NCT01609556|531196667|FG005|Dose Expansion: Maximum 124 Weeks|Death|0|||
147281948|NCT01609556|531196668|FG006|Dose Expansion: Maximum 124 Weeks|Death|0|||
147281949|NCT01609556|531196669|FG007|Dose Expansion: Maximum 124 Weeks|Death|0|||
147281950|NCT01609556|531196670|FG008|Dose Expansion: Maximum 124 Weeks|Death|0|||
147281951|NCT01609556|531196671|FG009|Dose Expansion: Maximum 124 Weeks|Death|0|||
147281952|NCT01609556|531196672|FG010|Dose Expansion: Maximum 124 Weeks|Death|0|||
147281953|NCT01609556|531196673|FG011|Dose Expansion: Maximum 124 Weeks|Death|0|||
147281954|NCT01609556|531196674|FG012|Dose Expansion: Maximum 124 Weeks|Death|4|||
147281955|NCT01609556|531196675|FG013|Dose Expansion: Maximum 124 Weeks|Death|2|||
147281956|NCT01609556|531196676|FG014|Dose Expansion: Maximum 124 Weeks|Death|0|||
147281957|NCT01609556|531196677|FG015|Dose Expansion: Maximum 124 Weeks|Death|3|||
147281958|NCT01609556|531196662|FG000|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
147281959|NCT01609556|531196663|FG001|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
147281960|NCT01609556|531196664|FG002|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
147603534|NCT01284361|532365638|FG000|Overall Study|Adverse Event|1|||
147603535|NCT01284361|532365638|FG000|Overall Study|Lost to Follow-up|2|||
147603536|NCT01957397|532365645|FG000|Test Period 1|sudden leakage/small bag|1|||
147603537|NCT01957397|532365646|FG001|Test Period 1|sudden leakage/small bag|1|||
147603538|NCT01957397|532365645|FG000|Test Period 1|Withdrawal by Subject|1|||
147603539|NCT01957397|532365646|FG001|Test Period 1|Withdrawal by Subject|0|||
147603540|NCT01957397|532365645|FG000|Test Period 2|Adverse Event|0|||
147603541|NCT01957397|532365646|FG001|Test Period 2|Adverse Event|1|||
147603542|NCT01957397|532365645|FG000|Test Period 3|Adverse Event|1|||
147603543|NCT01957397|532365646|FG001|Test Period 3|Adverse Event|2|||
147603544|NCT01957397|532365645|FG000|Test Period 3|the adhesive did not work|1|||
147281961|NCT01609556|531196665|FG003|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
147281962|NCT01609556|531196666|FG004|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
147281963|NCT01609556|531196667|FG005|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
147281964|NCT01609556|531196668|FG006|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
147281965|NCT01609556|531196669|FG007|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
147281966|NCT01609556|531196670|FG008|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
147281967|NCT01609556|531196671|FG009|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
147281968|NCT01609556|531196672|FG010|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
147281969|NCT01609556|531196673|FG011|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
147281970|NCT01609556|531196674|FG012|Dose Expansion: Maximum 124 Weeks|Other Than Specified|1|||
147281971|NCT01609556|531196675|FG013|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
147281972|NCT01609556|531196676|FG014|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
147603545|NCT01957397|532365646|FG001|Test Period 3|the adhesive did not work|0|||
147451312|NCT01903837|531814836|FG000|Part B|Lack of Efficacy|0|||
147451313|NCT01903837|531814837|FG001|Part B|Lack of Efficacy|1|||
147603546|NCT00540293|532365647|FG000|Overall Study|Adverse event related to study drug|10|||
147603547|NCT00540293|532365647|FG000|Overall Study|Adverse event not related to study drug|7|||
147603548|NCT00540293|532365647|FG000|Overall Study|Withdrawal by Subject|6|||
147603549|NCT00540293|532365647|FG000|Overall Study|Protocol violation, & subject schedule|12|||
147603550|NCT03537599|532365648|FG000|Overall Study|Disease Progression|2|||
147281973|NCT01609556|531196677|FG015|Dose Expansion: Maximum 124 Weeks|Other Than Specified|0|||
147281974|NCT02788175|531196680|FG000|Overall Study|Protocol Violation|3|||
147281975|NCT02788175|531196680|FG000|Overall Study|Withdrawal by Subject|4|||
147281976|NCT02788175|531196680|FG000|Overall Study|Ineligible prior to study agent|6|||
147281977|NCT00162136|531196681|FG000|Overall Study|Adverse Event|1|||
147281978|NCT00162136|531196681|FG000|Overall Study|Death|1|||
147281979|NCT00162136|531196681|FG000|Overall Study|Disease Progression/Relapse|23|||
147281980|NCT00162136|531196681|FG000|Overall Study|Investigator Request|5|||
147281981|NCT00162136|531196681|FG000|Overall Study|Study Drug Toxicity|4|||
147281982|NCT00162136|531196681|FG000|Overall Study|Withdrawal by Subject|1|||
147281983|NCT00774995|531196682|FG000|Overall Study|Protocol Violation|0|||
147281984|NCT00774995|531196683|FG001|Overall Study|Protocol Violation|0|||
147281985|NCT00774995|531196684|FG002|Overall Study|Protocol Violation|1|||
147281986|NCT00774995|531196685|FG003|Overall Study|Protocol Violation|0|||
147281987|NCT00428610|531196690|FG000|Overall Study|Death Due to Adverse Event|3|||
147281988|NCT00428610|531196691|FG001|Overall Study|Death Due to Adverse Event|0|||
147281989|NCT00428610|531196692|FG002|Overall Study|Death Due to Adverse Event|5|||
147281990|NCT00428610|531196690|FG000|Overall Study|Death Due to Progressive Disease|0|||
147281991|NCT00428610|531196691|FG001|Overall Study|Death Due to Progressive Disease|0|||
147281992|NCT00428610|531196692|FG002|Overall Study|Death Due to Progressive Disease|2|||
147281993|NCT00428610|531196690|FG000|Overall Study|Adverse Event|2|||
147281994|NCT00428610|531196691|FG001|Overall Study|Adverse Event|3|||
147281995|NCT00428610|531196692|FG002|Overall Study|Adverse Event|2|||
147281996|NCT00428610|531196690|FG000|Overall Study|Investigator Decision|2|||
147281997|NCT00428610|531196691|FG001|Overall Study|Investigator Decision|1|||
147281998|NCT00428610|531196692|FG002|Overall Study|Investigator Decision|1|||
147281999|NCT00428610|531196690|FG000|Overall Study|Progressive Disease|42|||
147282000|NCT00428610|531196691|FG001|Overall Study|Progressive Disease|14|||
147282001|NCT00428610|531196692|FG002|Overall Study|Progressive Disease|22|||
147282002|NCT00428610|531196690|FG000|Overall Study|Withdrawal by Subject|4|||
147282003|NCT00428610|531196691|FG001|Overall Study|Withdrawal by Subject|0|||
147282004|NCT00428610|531196692|FG002|Overall Study|Withdrawal by Subject|0|||
147282005|NCT00262834|531198937|FG000|Overall Study|Surgery delayed/tissue not collected|1|||
147282006|NCT00262834|531198938|FG001|Overall Study|Surgery delayed/tissue not collected|4|||
147282007|NCT01054729|531198939|FG000|Overall Study|Randomized but Not Treated|0|||
147282008|NCT01054729|531198940|FG001|Overall Study|Randomized but Not Treated|1|||
147282009|NCT01054729|531198941|FG002|Overall Study|Randomized but Not Treated|0|||
147282010|NCT01054729|531198942|FG003|Overall Study|Randomized but Not Treated|0|||
147282011|NCT01054729|531198939|FG000|Overall Study|Adverse Event|1|||
147282012|NCT01054729|531198940|FG001|Overall Study|Adverse Event|1|||
147282013|NCT01054729|531198941|FG002|Overall Study|Adverse Event|2|||
147282014|NCT01054729|531198942|FG003|Overall Study|Adverse Event|1|||
147282015|NCT01054729|531198939|FG000|Overall Study|Withdrawal by Subject|1|||
147282016|NCT01054729|531198940|FG001|Overall Study|Withdrawal by Subject|0|||
147282017|NCT01054729|531198941|FG002|Overall Study|Withdrawal by Subject|1|||
147282018|NCT01054729|531198942|FG003|Overall Study|Withdrawal by Subject|0|||
147282019|NCT01054729|531198939|FG000|Overall Study|Lost to Follow-up|0|||
147282020|NCT01054729|531198940|FG001|Overall Study|Lost to Follow-up|1|||
147282021|NCT01054729|531198941|FG002|Overall Study|Lost to Follow-up|0|||
147282022|NCT01054729|531198942|FG003|Overall Study|Lost to Follow-up|0|||
147282023|NCT01054729|531198939|FG000|Overall Study|Lost to Follow-up, Later Contacted Site|0|||
147282024|NCT01054729|531198940|FG001|Overall Study|Lost to Follow-up, Later Contacted Site|1|||
147282025|NCT01054729|531198941|FG002|Overall Study|Lost to Follow-up, Later Contacted Site|0|||
147282026|NCT01054729|531198942|FG003|Overall Study|Lost to Follow-up, Later Contacted Site|0|||
147282027|NCT01054729|531198939|FG000|Overall Study|Non-responder|1|||
147282028|NCT01054729|531198940|FG001|Overall Study|Non-responder|0|||
147282029|NCT01054729|531198941|FG002|Overall Study|Non-responder|1|||
147282030|NCT01054729|531198942|FG003|Overall Study|Non-responder|1|||
147282031|NCT01054729|531198939|FG000|Overall Study|PEG/RBV Non-responder|1|||
147335818|NCT05001945|531396429|FG006|Overall Study|Lost to Follow-up|0|||
147335819|NCT05001945|531396430|FG007|Overall Study|Lost to Follow-up|0|||
147335820|NCT05001945|531396423|FG000|Overall Study|Protocol Violation|1|||
147335821|NCT05001945|531396424|FG001|Overall Study|Protocol Violation|0|||
147335822|NCT05001945|531396425|FG002|Overall Study|Protocol Violation|1|||
147335823|NCT05001945|531396426|FG003|Overall Study|Protocol Violation|1|||
147335824|NCT05001945|531396427|FG004|Overall Study|Protocol Violation|0|||
147335825|NCT05001945|531396428|FG005|Overall Study|Protocol Violation|1|||
147335826|NCT05001945|531396429|FG006|Overall Study|Protocol Violation|0|||
147451314|NCT01903837|531814838|FG002|Part B|Lack of Efficacy|0|||
147451315|NCT01903837|531814839|FG003|Part B|Lack of Efficacy|0|||
147282032|NCT01054729|531198940|FG001|Overall Study|PEG/RBV Non-responder|0|||
147282033|NCT01054729|531198941|FG002|Overall Study|PEG/RBV Non-responder|1|||
147282034|NCT01054729|531198942|FG003|Overall Study|PEG/RBV Non-responder|0|||
147282035|NCT01054729|531198939|FG000|Overall Study|Personal/Obligations|0|||
147282036|NCT01054729|531198940|FG001|Overall Study|Personal/Obligations|1|||
147335827|NCT05001945|531396430|FG007|Overall Study|Protocol Violation|0|||
147335828|NCT05001945|531396423|FG000|Overall Study|Withdrawal by Subject|0|||
147451316|NCT01857869|531814843|FG000|Primary/Challenge Phase|Lost to Follow-up|2|||
147282037|NCT01054729|531198941|FG002|Overall Study|Personal/Obligations|0|||
147282038|NCT01054729|531198942|FG003|Overall Study|Personal/Obligations|0|||
147282039|NCT01054729|531198939|FG000|Overall Study|Subject moved|0|||
147282040|NCT01054729|531198940|FG001|Overall Study|Subject moved|0|||
147282041|NCT01054729|531198941|FG002|Overall Study|Subject moved|1|||
147282042|NCT01054729|531198942|FG003|Overall Study|Subject moved|0|||
147282043|NCT01054729|531198939|FG000|Overall Study|Lack of Efficacy|0|||
147282044|NCT01054729|531198940|FG001|Overall Study|Lack of Efficacy|0|||
147282045|NCT01054729|531198941|FG002|Overall Study|Lack of Efficacy|0|||
147282046|NCT01054729|531198942|FG003|Overall Study|Lack of Efficacy|1|||
147282047|NCT02352493|531198946|FG000|Overall Study|Pregnancy|0|||
147282048|NCT02352493|531198947|FG001|Overall Study|Pregnancy|0|||
147282049|NCT02352493|531198948|FG002|Overall Study|Pregnancy|0|||
147282050|NCT02352493|531198949|FG003|Overall Study|Pregnancy|0|||
147282051|NCT02352493|531198950|FG004|Overall Study|Pregnancy|0|||
147282052|NCT02352493|531198951|FG005|Overall Study|Pregnancy|0|||
147282053|NCT02352493|531198952|FG006|Overall Study|Pregnancy|1|||
147282054|NCT02352493|531198953|FG007|Overall Study|Pregnancy|0|||
147282055|NCT02352493|531198954|FG008|Overall Study|Pregnancy|1|||
147282056|NCT02352493|531198955|FG009|Overall Study|Pregnancy|0|||
147282057|NCT02352493|531198956|FG010|Overall Study|Pregnancy|0|||
147282058|NCT02352493|531198957|FG011|Overall Study|Pregnancy|0|||
147282059|NCT02352493|531198958|FG012|Overall Study|Pregnancy|0|||
147282060|NCT02352493|531198959|FG013|Overall Study|Pregnancy|0|||
147282061|NCT02352493|531198960|FG014|Overall Study|Pregnancy|0|||
147282062|NCT02352493|531198961|FG015|Overall Study|Pregnancy|0|||
147282063|NCT02352493|531198962|FG016|Overall Study|Pregnancy|0|||
147282064|NCT02352493|531198963|FG017|Overall Study|Pregnancy|0|||
147282065|NCT02352493|531198946|FG000|Overall Study|Withdrawal by Subject|0|||
147282066|NCT02352493|531198947|FG001|Overall Study|Withdrawal by Subject|0|||
147282067|NCT02352493|531198948|FG002|Overall Study|Withdrawal by Subject|0|||
147282068|NCT02352493|531198949|FG003|Overall Study|Withdrawal by Subject|0|||
147282069|NCT02352493|531198950|FG004|Overall Study|Withdrawal by Subject|0|||
147282070|NCT02352493|531198951|FG005|Overall Study|Withdrawal by Subject|0|||
147282071|NCT02352493|531198952|FG006|Overall Study|Withdrawal by Subject|0|||
147282072|NCT02352493|531198953|FG007|Overall Study|Withdrawal by Subject|0|||
147282073|NCT02352493|531198954|FG008|Overall Study|Withdrawal by Subject|1|||
147282074|NCT02352493|531198955|FG009|Overall Study|Withdrawal by Subject|0|||
147282075|NCT02352493|531198956|FG010|Overall Study|Withdrawal by Subject|0|||
147282076|NCT02352493|531198957|FG011|Overall Study|Withdrawal by Subject|0|||
147282077|NCT02352493|531198958|FG012|Overall Study|Withdrawal by Subject|0|||
147282078|NCT02352493|531198959|FG013|Overall Study|Withdrawal by Subject|0|||
147282079|NCT02352493|531198960|FG014|Overall Study|Withdrawal by Subject|1|||
147282080|NCT02352493|531198961|FG015|Overall Study|Withdrawal by Subject|0|||
147282081|NCT02352493|531198962|FG016|Overall Study|Withdrawal by Subject|0|||
147282082|NCT02352493|531198963|FG017|Overall Study|Withdrawal by Subject|0|||
147282083|NCT02352493|531198946|FG000|Overall Study|Lost to Follow-up|0|||
147282084|NCT02352493|531198947|FG001|Overall Study|Lost to Follow-up|0|||
147282085|NCT02352493|531198948|FG002|Overall Study|Lost to Follow-up|0|||
147282086|NCT02352493|531198949|FG003|Overall Study|Lost to Follow-up|0|||
147282087|NCT02352493|531198950|FG004|Overall Study|Lost to Follow-up|0|||
147282088|NCT02352493|531198951|FG005|Overall Study|Lost to Follow-up|0|||
147282089|NCT02352493|531198952|FG006|Overall Study|Lost to Follow-up|0|||
147282090|NCT02352493|531198953|FG007|Overall Study|Lost to Follow-up|0|||
147282091|NCT02352493|531198954|FG008|Overall Study|Lost to Follow-up|0|||
147282092|NCT02352493|531198955|FG009|Overall Study|Lost to Follow-up|1|||
147282093|NCT02352493|531198956|FG010|Overall Study|Lost to Follow-up|0|||
147282094|NCT02352493|531198957|FG011|Overall Study|Lost to Follow-up|0|||
147282095|NCT02352493|531198958|FG012|Overall Study|Lost to Follow-up|1|||
147282096|NCT02352493|531198959|FG013|Overall Study|Lost to Follow-up|2|||
147282097|NCT02352493|531198960|FG014|Overall Study|Lost to Follow-up|0|||
147282098|NCT02352493|531198961|FG015|Overall Study|Lost to Follow-up|0|||
147282099|NCT02352493|531198962|FG016|Overall Study|Lost to Follow-up|0|||
147282100|NCT02352493|531198963|FG017|Overall Study|Lost to Follow-up|0|||
147282101|NCT02162810|531198964|FG000|Overall Study|Protocol Violation|1|||
147282102|NCT02162810|531198965|FG001|Overall Study|Protocol Violation|0|||
147282103|NCT02162810|531198964|FG000|Overall Study|patients did not report compliance|4|||
147282104|NCT02162810|531198965|FG001|Overall Study|patients did not report compliance|1|||
147282105|NCT02546544|531198970|FG000|Overall Study|Disease Progression|14|||
147282106|NCT02546544|531198970|FG000|Overall Study|Adverse Event|1|||
147282107|NCT02546544|531198970|FG000|Overall Study|Withdrawal by Subject|1|||
147282108|NCT01921348|531198971|FG000|Overall Study|Withdrawal by Subject|1|||
147282109|NCT01921348|531198972|FG001|Overall Study|Withdrawal by Subject|0|||
147282110|NCT01921348|531198971|FG000|Overall Study|Lost to Follow-up|0|||
147282111|NCT01921348|531198972|FG001|Overall Study|Lost to Follow-up|2|||
147282112|NCT02223390|531198973|FG000|Overall Study|Lost to Follow-up|9|||
147282113|NCT02223390|531198974|FG001|Overall Study|Lost to Follow-up|4|||
147282114|NCT01465334|531198975|FG000|Overall Study|Disease Progression|1|||
147282115|NCT01465334|531198976|FG001|Overall Study|Disease Progression|0|||
147282116|NCT01465334|531198975|FG000|Overall Study|Adverse Event|1|||
147282117|NCT01465334|531198976|FG001|Overall Study|Adverse Event|0|||
147282118|NCT01465334|531198975|FG000|Overall Study|Richter's transformation|0|||
147282119|NCT01465334|531198976|FG001|Overall Study|Richter's transformation|3|||
147282120|NCT01465334|531198975|FG000|Overall Study|Refractory Disease|0|||
147282121|NCT01465334|531198976|FG001|Overall Study|Refractory Disease|3|||
147282122|NCT00795600|531198981|FG000|Overall Study|Adverse Event|1|||
147335829|NCT05001945|531396424|FG001|Overall Study|Withdrawal by Subject|0|||
147335830|NCT05001945|531396425|FG002|Overall Study|Withdrawal by Subject|0|||
147335831|NCT05001945|531396426|FG003|Overall Study|Withdrawal by Subject|1|||
147335832|NCT05001945|531396427|FG004|Overall Study|Withdrawal by Subject|1|||
147335833|NCT05001945|531396428|FG005|Overall Study|Withdrawal by Subject|1|||
147335834|NCT05001945|531396429|FG006|Overall Study|Withdrawal by Subject|0|||
147335835|NCT05001945|531396430|FG007|Overall Study|Withdrawal by Subject|1|||
147335836|NCT05001945|531396423|FG000|Overall Study|Not specified by Investigator|0|||
147335837|NCT05001945|531396424|FG001|Overall Study|Not specified by Investigator|3|||
147335838|NCT05001945|531396425|FG002|Overall Study|Not specified by Investigator|0|||
147335839|NCT05001945|531396426|FG003|Overall Study|Not specified by Investigator|0|||
147335840|NCT05001945|531396427|FG004|Overall Study|Not specified by Investigator|1|||
147335841|NCT05001945|531396428|FG005|Overall Study|Not specified by Investigator|0|||
147335842|NCT05001945|531396429|FG006|Overall Study|Not specified by Investigator|0|||
147335843|NCT05001945|531396430|FG007|Overall Study|Not specified by Investigator|0|||
147335844|NCT00585533|531396431|FG000|Overall Study|objective or symptomatic progression|9|||
147335845|NCT03482011|531396432|FG000|Induction Period (16 Weeks)|Adverse Event|1|||
147335846|NCT03482011|531396433|FG001|Induction Period (16 Weeks)|Adverse Event|3|||
147335847|NCT03482011|531396434|FG002|Induction Period (16 Weeks)|Adverse Event|0|||
147335848|NCT03482011|531396435|FG003|Induction Period (16 Weeks)|Adverse Event|0|||
147335849|NCT03482011|531396436|FG004|Induction Period (16 Weeks)|Adverse Event|0|||
147335850|NCT03482011|531396437|FG005|Induction Period (16 Weeks)|Adverse Event|0|||
147335851|NCT03482011|531396438|FG006|Induction Period (16 Weeks)|Adverse Event|0|||
147335852|NCT03482011|531396439|FG007|Induction Period (16 Weeks)|Adverse Event|0|||
147335853|NCT03482011|531396432|FG000|Induction Period (16 Weeks)|Lack of Efficacy|3|||
147335854|NCT03482011|531396433|FG001|Induction Period (16 Weeks)|Lack of Efficacy|1|||
147335855|NCT03482011|531396434|FG002|Induction Period (16 Weeks)|Lack of Efficacy|0|||
147335856|NCT03482011|531396435|FG003|Induction Period (16 Weeks)|Lack of Efficacy|0|||
147335857|NCT03482011|531396436|FG004|Induction Period (16 Weeks)|Lack of Efficacy|0|||
147335858|NCT03482011|531396437|FG005|Induction Period (16 Weeks)|Lack of Efficacy|0|||
147335859|NCT03482011|531396438|FG006|Induction Period (16 Weeks)|Lack of Efficacy|0|||
147335860|NCT03482011|531396439|FG007|Induction Period (16 Weeks)|Lack of Efficacy|0|||
147335861|NCT03482011|531396432|FG000|Induction Period (16 Weeks)|Lost to Follow-up|0|||
147335862|NCT03482011|531396433|FG001|Induction Period (16 Weeks)|Lost to Follow-up|1|||
147335863|NCT03482011|531396434|FG002|Induction Period (16 Weeks)|Lost to Follow-up|0|||
147335864|NCT03482011|531396435|FG003|Induction Period (16 Weeks)|Lost to Follow-up|0|||
147335865|NCT03482011|531396436|FG004|Induction Period (16 Weeks)|Lost to Follow-up|0|||
147335866|NCT03482011|531396437|FG005|Induction Period (16 Weeks)|Lost to Follow-up|0|||
147335867|NCT03482011|531396438|FG006|Induction Period (16 Weeks)|Lost to Follow-up|0|||
147335868|NCT03482011|531396439|FG007|Induction Period (16 Weeks)|Lost to Follow-up|0|||
147335869|NCT03482011|531396432|FG000|Induction Period (16 Weeks)|Screen Failure|0|||
147282123|NCT00795600|531198982|FG001|Overall Study|Adverse Event|1|||
147335870|NCT03482011|531396433|FG001|Induction Period (16 Weeks)|Screen Failure|1|||
147335871|NCT03482011|531396434|FG002|Induction Period (16 Weeks)|Screen Failure|0|||
147335872|NCT03482011|531396435|FG003|Induction Period (16 Weeks)|Screen Failure|0|||
147335873|NCT03482011|531396436|FG004|Induction Period (16 Weeks)|Screen Failure|0|||
147335874|NCT03482011|531396437|FG005|Induction Period (16 Weeks)|Screen Failure|0|||
147335875|NCT03482011|531396438|FG006|Induction Period (16 Weeks)|Screen Failure|0|||
147335876|NCT03482011|531396439|FG007|Induction Period (16 Weeks)|Screen Failure|0|||
147335877|NCT03482011|531396432|FG000|Induction Period (16 Weeks)|Withdrawal by Subject|2|||
147335878|NCT03482011|531396433|FG001|Induction Period (16 Weeks)|Withdrawal by Subject|5|||
147335879|NCT03482011|531396434|FG002|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
147335880|NCT03482011|531396435|FG003|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
147335881|NCT03482011|531396436|FG004|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
147335882|NCT03482011|531396437|FG005|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
147282124|NCT00795600|531198981|FG000|Overall Study|Protocol Violation|1|||
147335883|NCT03482011|531396438|FG006|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
147335884|NCT03482011|531396439|FG007|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
147335885|NCT03482011|531396432|FG000|Maintenance Period (36 Weeks)|Adverse Event|0|||
147335886|NCT03482011|531396433|FG001|Maintenance Period (36 Weeks)|Adverse Event|0|||
147335887|NCT03482011|531396434|FG002|Maintenance Period (36 Weeks)|Adverse Event|0|||
147282125|NCT00795600|531198982|FG001|Overall Study|Protocol Violation|2|||
147282126|NCT00795600|531198981|FG000|Overall Study|Withdrawal by Subject|1|||
147335888|NCT03482011|531396435|FG003|Maintenance Period (36 Weeks)|Adverse Event|0|||
147282127|NCT00795600|531198982|FG001|Overall Study|Withdrawal by Subject|0|||
147335889|NCT03482011|531396436|FG004|Maintenance Period (36 Weeks)|Adverse Event|0|||
147335890|NCT03482011|531396437|FG005|Maintenance Period (36 Weeks)|Adverse Event|1|||
147335891|NCT03482011|531396438|FG006|Maintenance Period (36 Weeks)|Adverse Event|1|||
147335892|NCT03482011|531396439|FG007|Maintenance Period (36 Weeks)|Adverse Event|4|||
147335893|NCT03482011|531396432|FG000|Maintenance Period (36 Weeks)|Lack of Efficacy|0|||
147335894|NCT03482011|531396433|FG001|Maintenance Period (36 Weeks)|Lack of Efficacy|0|||
147335895|NCT03482011|531396434|FG002|Maintenance Period (36 Weeks)|Lack of Efficacy|1|||
147335896|NCT03482011|531396435|FG003|Maintenance Period (36 Weeks)|Lack of Efficacy|2|||
147335897|NCT03482011|531396436|FG004|Maintenance Period (36 Weeks)|Lack of Efficacy|1|||
147335898|NCT03482011|531396437|FG005|Maintenance Period (36 Weeks)|Lack of Efficacy|1|||
147451317|NCT01857869|531814844|FG001|Primary/Challenge Phase|Lost to Follow-up|0|||
147451318|NCT01857869|531814845|FG002|Primary/Challenge Phase|Lost to Follow-up|0|||
147451319|NCT01857869|531814846|FG003|Primary/Challenge Phase|Lost to Follow-up|0|||
147451320|NCT01857869|531814847|FG004|Primary/Challenge Phase|Lost to Follow-up|0|||
147451321|NCT01857869|531814848|FG005|Primary/Challenge Phase|Lost to Follow-up|0|||
147451322|NCT01857869|531814849|FG006|Primary/Challenge Phase|Lost to Follow-up|0|||
147451323|NCT01857869|531814850|FG007|Primary/Challenge Phase|Lost to Follow-up|0|||
147451324|NCT01857869|531814851|FG008|Primary/Challenge Phase|Lost to Follow-up|0|||
147451325|NCT01857869|531814852|FG009|Primary/Challenge Phase|Lost to Follow-up|0|||
147451326|NCT01857869|531814843|FG000|Primary/Challenge Phase|Pregnancy|1|||
147451327|NCT01857869|531814844|FG001|Primary/Challenge Phase|Pregnancy|0|||
147451328|NCT01857869|531814845|FG002|Primary/Challenge Phase|Pregnancy|0|||
147451329|NCT01857869|531814846|FG003|Primary/Challenge Phase|Pregnancy|0|||
147451330|NCT01857869|531814847|FG004|Primary/Challenge Phase|Pregnancy|0|||
147451331|NCT01857869|531814848|FG005|Primary/Challenge Phase|Pregnancy|0|||
147282128|NCT00795600|531198981|FG000|Overall Study|Unclassified|1|||
147335899|NCT03482011|531396438|FG006|Maintenance Period (36 Weeks)|Lack of Efficacy|0|||
147335900|NCT03482011|531396439|FG007|Maintenance Period (36 Weeks)|Lack of Efficacy|9|||
147335901|NCT03482011|531396432|FG000|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
147335902|NCT03482011|531396433|FG001|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
147335903|NCT03482011|531396434|FG002|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
147335904|NCT03482011|531396435|FG003|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
147335905|NCT03482011|531396436|FG004|Maintenance Period (36 Weeks)|Lost to Follow-up|2|||
147335906|NCT03482011|531396437|FG005|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
147335907|NCT03482011|531396438|FG006|Maintenance Period (36 Weeks)|Lost to Follow-up|0|||
147335908|NCT03482011|531396439|FG007|Maintenance Period (36 Weeks)|Lost to Follow-up|1|||
147335909|NCT03482011|531396432|FG000|Maintenance Period (36 Weeks)|Physician Decision|0|||
147335910|NCT03482011|531396433|FG001|Maintenance Period (36 Weeks)|Physician Decision|0|||
147335911|NCT03482011|531396434|FG002|Maintenance Period (36 Weeks)|Physician Decision|0|||
147335912|NCT03482011|531396435|FG003|Maintenance Period (36 Weeks)|Physician Decision|1|||
147335913|NCT03482011|531396436|FG004|Maintenance Period (36 Weeks)|Physician Decision|0|||
147335914|NCT03482011|531396437|FG005|Maintenance Period (36 Weeks)|Physician Decision|1|||
147335915|NCT03482011|531396438|FG006|Maintenance Period (36 Weeks)|Physician Decision|1|||
147335916|NCT03482011|531396439|FG007|Maintenance Period (36 Weeks)|Physician Decision|1|||
147282129|NCT00795600|531198982|FG001|Overall Study|Unclassified|1|||
147282130|NCT01248884|531198988|FG000|Overall Study|Withdrawal by Subject|1|||
147282131|NCT01248884|531198989|FG001|Overall Study|Withdrawal by Subject|3|||
147282132|NCT01248884|531198990|FG002|Overall Study|Withdrawal by Subject|1|||
147282133|NCT01248884|531198988|FG000|Overall Study|Adverse Event|1|||
147282134|NCT01248884|531198989|FG001|Overall Study|Adverse Event|0|||
147282135|NCT01248884|531198990|FG002|Overall Study|Adverse Event|0|||
147282136|NCT00575588|531198995|FG000|Overall Study|Adverse Event|11|||
147282137|NCT00575588|531198996|FG001|Overall Study|Adverse Event|13|||
147282138|NCT00575588|531198995|FG000|Overall Study|Withdrawal by Subject|27|||
147282139|NCT00575588|531198996|FG001|Overall Study|Withdrawal by Subject|31|||
147282140|NCT00575588|531198995|FG000|Overall Study|Lost to Follow-up|1|||
147282141|NCT00575588|531198996|FG001|Overall Study|Lost to Follow-up|3|||
147282142|NCT00575588|531198995|FG000|Overall Study|Death|4|||
147282143|NCT00575588|531198996|FG001|Overall Study|Death|2|||
147282144|NCT00575588|531198995|FG000|Overall Study|Incorrect enrollment|8|||
147335917|NCT03482011|531396432|FG000|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
147335918|NCT03482011|531396433|FG001|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
147335919|NCT03482011|531396434|FG002|Maintenance Period (36 Weeks)|Withdrawal by Subject|0|||
147335920|NCT03482011|531396435|FG003|Maintenance Period (36 Weeks)|Withdrawal by Subject|1|||
147335921|NCT03482011|531396436|FG004|Maintenance Period (36 Weeks)|Withdrawal by Subject|2|||
147335922|NCT03482011|531396437|FG005|Maintenance Period (36 Weeks)|Withdrawal by Subject|1|||
147282145|NCT00575588|531198996|FG001|Overall Study|Incorrect enrollment|4|||
147335923|NCT03482011|531396438|FG006|Maintenance Period (36 Weeks)|Withdrawal by Subject|2|||
147451332|NCT01857869|531814849|FG006|Primary/Challenge Phase|Pregnancy|0|||
147451333|NCT01857869|531814850|FG007|Primary/Challenge Phase|Pregnancy|0|||
147451334|NCT01857869|531814851|FG008|Primary/Challenge Phase|Pregnancy|0|||
147451335|NCT01857869|531814852|FG009|Primary/Challenge Phase|Pregnancy|0|||
147282146|NCT00575588|531198995|FG000|Overall Study|Study specific discontinuation criteria|203|||
147603551|NCT03537599|532365649|FG001|Overall Study|Disease Progression|1|||
147603552|NCT03537599|532365648|FG000|Overall Study|Death|0|||
147603553|NCT03537599|532365649|FG001|Overall Study|Death|1|||
147603554|NCT00325195|532365652|FG000|Randomized|Not dosed|5|||
147603555|NCT00325195|532365653|FG001|Randomized|Not dosed|5|||
147603556|NCT00325195|532365654|FG002|Randomized|Not dosed|3|||
147603557|NCT00325195|532365652|FG000|Received Intervention: ITT Population|Adverse Event|15|||
147603558|NCT00325195|532365653|FG001|Received Intervention: ITT Population|Adverse Event|17|||
147603559|NCT00325195|532365654|FG002|Received Intervention: ITT Population|Adverse Event|1|||
147603560|NCT00325195|532365652|FG000|Received Intervention: ITT Population|Death|3|||
147603561|NCT00325195|532365653|FG001|Received Intervention: ITT Population|Death|1|||
147603562|NCT00325195|532365654|FG002|Received Intervention: ITT Population|Death|0|||
147603563|NCT00325195|532365652|FG000|Received Intervention: ITT Population|Withdrawal by Subject|7|||
147603564|NCT00325195|532365653|FG001|Received Intervention: ITT Population|Withdrawal by Subject|6|||
147603565|NCT00325195|532365654|FG002|Received Intervention: ITT Population|Withdrawal by Subject|1|||
147603566|NCT00325195|532365652|FG000|Received Intervention: ITT Population|Lost to Follow-up|0|||
147603567|NCT00325195|532365653|FG001|Received Intervention: ITT Population|Lost to Follow-up|0|||
147603568|NCT00325195|532365654|FG002|Received Intervention: ITT Population|Lost to Follow-up|2|||
147603569|NCT00325195|532365652|FG000|Received Intervention: ITT Population|Protocol violation/non-compliance|1|||
147603570|NCT00325195|532365653|FG001|Received Intervention: ITT Population|Protocol violation/non-compliance|1|||
147603571|NCT00325195|532365654|FG002|Received Intervention: ITT Population|Protocol violation/non-compliance|0|||
147603572|NCT05083585|532365655|FG000|Overall Study|Death|1|||
147603573|NCT05083585|532365656|FG001|Overall Study|Death|1|||
147603574|NCT05083585|532365655|FG000|Overall Study|Lost to Follow-up|1|||
147603575|NCT05083585|532365656|FG001|Overall Study|Lost to Follow-up|1|||
147603576|NCT05083585|532365655|FG000|Overall Study|Withdrawal by Subject|2|||
147603577|NCT05083585|532365656|FG001|Overall Study|Withdrawal by Subject|0|||
147603578|NCT05083585|532365655|FG000|Overall Study|Randomized but not vaccinated|2|||
147603579|NCT05083585|532365656|FG001|Overall Study|Randomized but not vaccinated|0|||
147603580|NCT00806286|532365657|FG000|Overall Study|Adverse Event|5|||
147603581|NCT00806286|532365658|FG001|Overall Study|Adverse Event|2|||
147603582|NCT00806286|532365659|FG002|Overall Study|Adverse Event|0|||
147603583|NCT00806286|532365657|FG000|Overall Study|Disease progression|31|||
147603584|NCT00806286|532365658|FG001|Overall Study|Disease progression|38|||
147603585|NCT00806286|532365659|FG002|Overall Study|Disease progression|1|||
147603586|NCT00806286|532365657|FG000|Overall Study|Death|1|||
147603587|NCT00806286|532365658|FG001|Overall Study|Death|6|||
147603588|NCT00806286|532365659|FG002|Overall Study|Death|0|||
147603589|NCT00806286|532365657|FG000|Overall Study|Lost to Follow-up|0|||
147603590|NCT00806286|532365658|FG001|Overall Study|Lost to Follow-up|1|||
147603591|NCT00806286|532365659|FG002|Overall Study|Lost to Follow-up|0|||
147603592|NCT00806286|532365657|FG000|Overall Study|Withdrawal by Subject|8|||
147603593|NCT00806286|532365658|FG001|Overall Study|Withdrawal by Subject|3|||
147603594|NCT00806286|532365659|FG002|Overall Study|Withdrawal by Subject|1|||
147603595|NCT00806286|532365657|FG000|Overall Study|Physician Decision|2|||
147603596|NCT00806286|532365658|FG001|Overall Study|Physician Decision|2|||
147282147|NCT00575588|531198996|FG001|Overall Study|Study specific discontinuation criteria|218|||
147282148|NCT00575588|531198995|FG000|Overall Study|Severe non-compliance to protocol|5|||
147282149|NCT00575588|531198996|FG001|Overall Study|Severe non-compliance to protocol|7|||
147282150|NCT00575588|531198995|FG000|Overall Study|Safety reasons|2|||
147282151|NCT00575588|531198996|FG001|Overall Study|Safety reasons|1|||
147282152|NCT00575588|531198995|FG000|Overall Study|Elevated triglyceride|1|||
147282153|NCT00575588|531198996|FG001|Overall Study|Elevated triglyceride|0|||
147282154|NCT00575588|531198995|FG000|Overall Study|Patient moved|1|||
147282155|NCT00575588|531198996|FG001|Overall Study|Patient moved|3|||
147282156|NCT00575588|531198995|FG000|Overall Study|Impossible to determine HbA1c|0|||
147282157|NCT00575588|531198996|FG001|Overall Study|Impossible to determine HbA1c|1|||
147282158|NCT00736996|531198997|FG000|Overall Study|Lost to Follow-up|1|||
147282159|NCT00736996|531198998|FG001|Overall Study|Lost to Follow-up|9|||
147603597|NCT00806286|532365659|FG002|Overall Study|Physician Decision|0|||
147662601|NCT02869789|532587358|FG000|Overall Study|Maximum clinical benefit|5|||
147282160|NCT00736996|531198999|FG002|Overall Study|Lost to Follow-up|2|||
147282161|NCT02667912|531199000|FG000|Overall Study|Death|3|||
147282162|NCT02667912|531199001|FG001|Overall Study|Death|1|||
147603598|NCT00806286|532365657|FG000|Overall Study|Due to a variety of reasons|7|||
147603599|NCT00806286|532365658|FG001|Overall Study|Due to a variety of reasons|2|||
147603600|NCT00806286|532365659|FG002|Overall Study|Due to a variety of reasons|1|||
147603601|NCT03469336|532365660|FG000|Overall Study|Adverse Event|1|||
147603602|NCT00686075|532365662|FG000|Overall Study|Withdrawal by Subject|4|||
147603603|NCT00686075|532365663|FG001|Overall Study|Withdrawal by Subject|3|||
147603604|NCT00686075|532365664|FG002|Overall Study|Withdrawal by Subject|3|||
147603605|NCT00686075|532365665|FG003|Overall Study|Withdrawal by Subject|7|||
147603606|NCT00686075|532365666|FG004|Overall Study|Withdrawal by Subject|1|||
147603607|NCT00686075|532365667|FG005|Overall Study|Withdrawal by Subject|0|||
147603608|NCT00686075|532365668|FG006|Overall Study|Withdrawal by Subject|0|||
147282163|NCT02667912|531199000|FG000|Overall Study|Withdrawal by Subject|1|||
147282164|NCT02667912|531199001|FG001|Overall Study|Withdrawal by Subject|2|||
147282165|NCT02667912|531199000|FG000|Overall Study|Withdrawal by Subject|1|||
147282166|NCT02667912|531199001|FG001|Overall Study|Withdrawal by Subject|0|||
147282167|NCT01343407|531199014|FG000|Second Treatment Period (Part 2)|Adverse Event|0|||
147282168|NCT01343407|531199015|FG001|Second Treatment Period (Part 2)|Adverse Event|0|||
147282169|NCT01343407|531199016|FG002|Second Treatment Period (Part 2)|Adverse Event|1|||
147282170|NCT01343407|531199017|FG003|Second Treatment Period (Part 2)|Adverse Event|0|||
147282171|NCT01343407|531199018|FG004|Second Treatment Period (Part 2)|Adverse Event|0|||
147282172|NCT01343407|531199019|FG005|Second Treatment Period (Part 2)|Adverse Event|0|||
147282173|NCT01343407|531199014|FG000|Second Washout (Part 2)|Withdrawal by Subject|0|||
147282174|NCT01343407|531199015|FG001|Second Washout (Part 2)|Withdrawal by Subject|0|||
147282175|NCT01343407|531199016|FG002|Second Washout (Part 2)|Withdrawal by Subject|1|||
147282176|NCT01343407|531199017|FG003|Second Washout (Part 2)|Withdrawal by Subject|0|||
147282177|NCT01343407|531199018|FG004|Second Washout (Part 2)|Withdrawal by Subject|0|||
147282178|NCT01343407|531199019|FG005|Second Washout (Part 2)|Withdrawal by Subject|0|||
147282179|NCT04079933|531199020|FG000|Overall Study|Withdrawal by Subject|3|||
147282180|NCT04079933|531199021|FG001|Overall Study|Withdrawal by Subject|4|||
147282181|NCT04079933|531199020|FG000|Overall Study|Lost to Follow-up|0|||
147282182|NCT04079933|531199021|FG001|Overall Study|Lost to Follow-up|1|||
147282183|NCT01986829|531199026|FG000|Overall Study|Death|1|||
147282184|NCT02504866|531199027|FG000|6-Month Follow up (CON Group Only)|Adverse Event|1|||
147282185|NCT02504866|531199028|FG001|6-Month Follow up (CON Group Only)|Adverse Event|0|||
147282186|NCT02504866|531199029|FG002|6-Month Follow up (CON Group Only)|Adverse Event|0|||
147282187|NCT01229436|531199030|FG000|Overall Study|Withdrawal by Subject|2|||
147282188|NCT01229436|531199030|FG000|Overall Study|Lost to Follow-up|3|||
147282189|NCT01775137|531199031|FG000|Overall Study|Death|1|||
147282190|NCT01775137|531199031|FG000|Overall Study|Protocol deviation|2|||
147282191|NCT01775137|531199031|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
147282192|NCT01775137|531199031|FG000|Overall Study|Adverse Event|1|||
147282193|NCT01775137|531199031|FG000|Overall Study|Withdrawal by participants|5|||
147282194|NCT02059148|531199032|FG000|Treatment 1|Protocol Violation|0|||
147282195|NCT02059148|531199033|FG001|Treatment 1|Protocol Violation|0|||
147282196|NCT02059148|531199034|FG002|Treatment 1|Protocol Violation|0|||
147282197|NCT02059148|531199035|FG003|Treatment 1|Protocol Violation|0|||
147603609|NCT00686075|532365669|FG007|Overall Study|Withdrawal by Subject|2|||
147603610|NCT00686075|532365670|FG008|Overall Study|Withdrawal by Subject|4|||
147603611|NCT00686075|532365671|FG009|Overall Study|Withdrawal by Subject|6|||
147603612|NCT00686075|532365662|FG000|Overall Study|Lost to Follow-up|3|||
147603613|NCT00686075|532365663|FG001|Overall Study|Lost to Follow-up|6|||
147603614|NCT00686075|532365664|FG002|Overall Study|Lost to Follow-up|3|||
147603615|NCT00686075|532365665|FG003|Overall Study|Lost to Follow-up|2|||
147603616|NCT00686075|532365666|FG004|Overall Study|Lost to Follow-up|3|||
147603617|NCT00686075|532365667|FG005|Overall Study|Lost to Follow-up|3|||
147603618|NCT00686075|532365668|FG006|Overall Study|Lost to Follow-up|0|||
147603619|NCT00686075|532365669|FG007|Overall Study|Lost to Follow-up|0|||
147603620|NCT00686075|532365670|FG008|Overall Study|Lost to Follow-up|2|||
147603621|NCT00686075|532365671|FG009|Overall Study|Lost to Follow-up|3|||
147603622|NCT00686075|532365662|FG000|Overall Study|Other|1|||
147603623|NCT00686075|532365663|FG001|Overall Study|Other|1|||
147603624|NCT00686075|532365664|FG002|Overall Study|Other|0|||
147603625|NCT00686075|532365665|FG003|Overall Study|Other|0|||
147603626|NCT00686075|532365666|FG004|Overall Study|Other|0|||
147603627|NCT00686075|532365667|FG005|Overall Study|Other|0|||
147603628|NCT00686075|532365668|FG006|Overall Study|Other|0|||
147282198|NCT02059148|531199036|FG004|Treatment 1|Protocol Violation|0|||
147282199|NCT02059148|531199037|FG005|Treatment 1|Protocol Violation|1|||
147282200|NCT03231371|531199038|FG000|Overall Study|Withdrawal by Subject|1|||
147282201|NCT03231371|531199038|FG000|Overall Study|chose or were ineligible to have MRI|12|||
147282202|NCT00437489|531199041|FG000|Overall Study|Study terminated by sponsor|23|||
147282203|NCT00437489|531199042|FG001|Overall Study|Study terminated by sponsor|21|||
147282204|NCT00437489|531199041|FG000|Overall Study|Lost to Follow-up|0|||
147282205|NCT00437489|531199042|FG001|Overall Study|Lost to Follow-up|1|||
147282206|NCT03321981|531199044|FG000|Overall Study|Progressive Disease (PD)|15|||
147282207|NCT03321981|531199045|FG001|Overall Study|Progressive Disease (PD)|30|||
147282208|NCT03321981|531199046|FG002|Overall Study|Progressive Disease (PD)|47|||
147282209|NCT03321981|531199044|FG000|Overall Study|Subject withdrawal of all treatment and follow-up with agreement for contact|0|||
147282210|NCT03321981|531199045|FG001|Overall Study|Subject withdrawal of all treatment and follow-up with agreement for contact|2|||
147603629|NCT00686075|532365669|FG007|Overall Study|Other|0|||
147603630|NCT00686075|532365670|FG008|Overall Study|Other|0|||
147603631|NCT00686075|532365671|FG009|Overall Study|Other|1|||
147603632|NCT02740699|532365673|FG000|Overall Study|Lost to Follow-up|5|||
147603633|NCT02740699|532365673|FG000|Overall Study|Withdrawal by Subject|14|||
147603634|NCT02740699|532365673|FG000|Overall Study|Physician Decision|5|||
147603635|NCT02585934|532365674|FG000|Overall Study|Lost to Follow-up|2|||
147603636|NCT02585934|532365675|FG001|Overall Study|Lost to Follow-up|2|||
147603637|NCT02585934|532365674|FG000|Overall Study|Protocol Violation|14|||
147603638|NCT02585934|532365675|FG001|Overall Study|Protocol Violation|11|||
147603639|NCT02585934|532365674|FG000|Overall Study|Adverse Event|21|||
147603640|NCT02585934|532365675|FG001|Overall Study|Adverse Event|22|||
147603641|NCT02585934|532365674|FG000|Overall Study|Physician Decision|3|||
147603642|NCT02585934|532365675|FG001|Overall Study|Physician Decision|2|||
147603643|NCT02585934|532365674|FG000|Overall Study|Withdrawal by Subject|7|||
147603644|NCT02585934|532365675|FG001|Overall Study|Withdrawal by Subject|21|||
147603645|NCT02585934|532365674|FG000|Overall Study|Lack of Efficacy|2|||
147603646|NCT02585934|532365675|FG001|Overall Study|Lack of Efficacy|1|||
147603647|NCT02585934|532365674|FG000|Overall Study|Death|2|||
147603648|NCT02585934|532365675|FG001|Overall Study|Death|0|||
147603649|NCT02585934|532365674|FG000|Overall Study|Caregiver Withdrew Consent|7|||
147603650|NCT02585934|532365675|FG001|Overall Study|Caregiver Withdrew Consent|7|||
147603651|NCT02585934|532365674|FG000|Overall Study|Sponsor Termination|1|||
147603652|NCT02585934|532365675|FG001|Overall Study|Sponsor Termination|2|||
147603653|NCT02585934|532365674|FG000|Overall Study|Another Reason|10|||
147603654|NCT02585934|532365675|FG001|Overall Study|Another Reason|5|||
147603655|NCT04713553|532365676|FG000|Primary Study (2 Months)|Withdrawal by Subject|2|||
147603656|NCT04713553|532365677|FG001|Primary Study (2 Months)|Withdrawal by Subject|3|||
147603657|NCT04713553|532365678|FG002|Primary Study (2 Months)|Withdrawal by Subject|0|||
147603658|NCT04713553|532365679|FG003|Primary Study (2 Months)|Withdrawal by Subject|0|||
147603659|NCT04713553|532365680|FG004|Primary Study (2 Months)|Withdrawal by Subject|1|||
147603660|NCT04713553|532365681|FG005|Primary Study (2 Months)|Withdrawal by Subject|0|||
147603661|NCT04713553|532365682|FG006|Primary Study (2 Months)|Withdrawal by Subject|0|||
147603662|NCT04713553|532365676|FG000|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
147603663|NCT04713553|532365677|FG001|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
147603664|NCT04713553|532365678|FG002|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
147603665|NCT04713553|532365679|FG003|Primary Study (2 Months)|Withdrawal by parent/guardian|1|||
147603666|NCT04713553|532365680|FG004|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
147603667|NCT04713553|532365681|FG005|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
147282211|NCT03321981|531199046|FG002|Overall Study|Subject withdrawal of all treatment and follow-up with agreement for contact|0|||
147282212|NCT03321981|531199044|FG000|Overall Study|Adverse Event|0|||
147282213|NCT03321981|531199045|FG001|Overall Study|Adverse Event|0|||
147282214|NCT03321981|531199046|FG002|Overall Study|Adverse Event|2|||
147282215|NCT03321981|531199044|FG000|Overall Study|symptomatic deterioration|0|||
147282216|NCT03321981|531199045|FG001|Overall Study|symptomatic deterioration|1|||
147282217|NCT03321981|531199046|FG002|Overall Study|symptomatic deterioration|1|||
147282218|NCT03321981|531199044|FG000|Overall Study|Lack of compliance|0|||
147282219|NCT03321981|531199045|FG001|Overall Study|Lack of compliance|1|||
147282220|NCT03321981|531199046|FG002|Overall Study|Lack of compliance|0|||
147282221|NCT03321981|531199044|FG000|Overall Study|Subject withdrawal of all treatment and follow-up with disagreement for contact|0|||
147282222|NCT03321981|531199045|FG001|Overall Study|Subject withdrawal of all treatment and follow-up with disagreement for contact|1|||
147282223|NCT03321981|531199046|FG002|Overall Study|Subject withdrawal of all treatment and follow-up with disagreement for contact|0|||
147282224|NCT03321981|531199044|FG000|Overall Study|Death|0|||
147282225|NCT03321981|531199045|FG001|Overall Study|Death|1|||
147282226|NCT03321981|531199046|FG002|Overall Study|Death|0|||
147282227|NCT03321981|531199044|FG000|Overall Study|Subject withdrawal of investigational product|0|||
147282228|NCT03321981|531199045|FG001|Overall Study|Subject withdrawal of investigational product|1|||
147282229|NCT03321981|531199046|FG002|Overall Study|Subject withdrawal of investigational product|0|||
147282230|NCT03321981|531199044|FG000|Overall Study|Treating physician decision due to lack of clinical benefit for patient|0|||
147282231|NCT03321981|531199045|FG001|Overall Study|Treating physician decision due to lack of clinical benefit for patient|1|||
147603668|NCT04713553|532365682|FG006|Primary Study (2 Months)|Withdrawal by parent/guardian|0|||
147603669|NCT04713553|532365676|FG000|Primary Study (2 Months)|Other|1|||
147603670|NCT04713553|532365677|FG001|Primary Study (2 Months)|Other|2|||
147603671|NCT04713553|532365678|FG002|Primary Study (2 Months)|Other|0|||
147603672|NCT04713553|532365679|FG003|Primary Study (2 Months)|Other|0|||
147603673|NCT04713553|532365680|FG004|Primary Study (2 Months)|Other|1|||
147603674|NCT04713553|532365681|FG005|Primary Study (2 Months)|Other|0|||
147603675|NCT04713553|532365682|FG006|Primary Study (2 Months)|Other|0|||
147282232|NCT03321981|531199046|FG002|Overall Study|Treating physician decision due to lack of clinical benefit for patient|0|||
147282233|NCT03321981|531199044|FG000|Overall Study|Scans showed PD 01JUL2019 (but the PT has received radiation and since TA05 the assessments are NE)|0|||
147282234|NCT03321981|531199045|FG001|Overall Study|Scans showed PD 01JUL2019 (but the PT has received radiation and since TA05 the assessments are NE)|1|||
147335924|NCT03482011|531396439|FG007|Maintenance Period (36 Weeks)|Withdrawal by Subject|2|||
147603676|NCT04713553|532365676|FG000|Primary Study (2 Months)|Lost to Follow-up|1|||
147603677|NCT04713553|532365677|FG001|Primary Study (2 Months)|Lost to Follow-up|1|||
147603678|NCT04713553|532365678|FG002|Primary Study (2 Months)|Lost to Follow-up|2|||
147603679|NCT04713553|532365679|FG003|Primary Study (2 Months)|Lost to Follow-up|1|||
147603680|NCT04713553|532365680|FG004|Primary Study (2 Months)|Lost to Follow-up|0|||
147603681|NCT04713553|532365681|FG005|Primary Study (2 Months)|Lost to Follow-up|0|||
147603682|NCT04713553|532365682|FG006|Primary Study (2 Months)|Lost to Follow-up|0|||
147282235|NCT03321981|531199046|FG002|Overall Study|Scans showed PD 01JUL2019 (but the PT has received radiation and since TA05 the assessments are NE)|0|||
147282236|NCT00022516|531199056|FG000|Overall Study|Adverse Event|0|||
147282237|NCT00022516|531199057|FG001|Overall Study|Adverse Event|59|||
147282238|NCT00022516|531199056|FG000|Overall Study|Lack of Efficacy|0|||
147282239|NCT00022516|531199057|FG001|Overall Study|Lack of Efficacy|27|||
147282240|NCT00022516|531199056|FG000|Overall Study|Physician Decision|0|||
147282241|NCT00022516|531199057|FG001|Overall Study|Physician Decision|1|||
147282242|NCT00022516|531199056|FG000|Overall Study|Protocol Violation|1|||
147282243|NCT00022516|531199057|FG001|Overall Study|Protocol Violation|3|||
147282244|NCT00022516|531199056|FG000|Overall Study|Withdrawal by Subject|2|||
147282245|NCT00022516|531199057|FG001|Overall Study|Withdrawal by Subject|113|||
147282246|NCT00022516|531199056|FG000|Overall Study|Incomplete documentation|0|||
147282247|NCT00022516|531199057|FG001|Overall Study|Incomplete documentation|27|||
147282248|NCT03321019|531199059|FG000|Overall Study|Withdrawal by Subject|0|||
147282249|NCT03321019|531199060|FG001|Overall Study|Withdrawal by Subject|6|||
147282250|NCT03321019|531199059|FG000|Overall Study|Lost to Follow-up|0|||
147282251|NCT03321019|531199060|FG001|Overall Study|Lost to Follow-up|22|||
147282252|NCT04934670|531199061|FG000|Overall Study|Death|4|||
147282253|NCT04934670|531199062|FG001|Overall Study|Death|0|||
147282254|NCT04934670|531199061|FG000|Overall Study|Lost to Follow-up|1|||
147282255|NCT04934670|531199062|FG001|Overall Study|Lost to Follow-up|4|||
147282256|NCT03067441|531199065|FG000|Overall Study|Withdrawal by Subject|16|||
147282257|NCT03067441|531199066|FG001|Overall Study|Withdrawal by Subject|34|||
147282258|NCT03067441|531199065|FG000|Overall Study|Lost to Follow-up|7|||
147282259|NCT03067441|531199066|FG001|Overall Study|Lost to Follow-up|5|||
147282260|NCT03067441|531199065|FG000|Overall Study|Adverse Event|7|||
147282261|NCT03067441|531199066|FG001|Overall Study|Adverse Event|14|||
147282262|NCT03067441|531199065|FG000|Overall Study|Study Terminated by Sponsor or Investigator|1|||
147282263|NCT03067441|531199066|FG001|Overall Study|Study Terminated by Sponsor or Investigator|0|||
147282264|NCT03067441|531199065|FG000|Overall Study|Physician Decision|1|||
147282265|NCT03067441|531199066|FG001|Overall Study|Physician Decision|3|||
147282266|NCT03067441|531199065|FG000|Overall Study|Other|1|||
147282267|NCT03067441|531199066|FG001|Overall Study|Other|1|||
147282268|NCT01592708|531199067|FG000|Overall Study|Protocol Violation|3|||
147282269|NCT01592708|531199068|FG001|Overall Study|Protocol Violation|0|||
147282270|NCT02056301|531199072|FG000|Overall Study|Protocol Violation|1|||
147282271|NCT02056301|531199073|FG001|Overall Study|Protocol Violation|2|||
147282272|NCT02056301|531199072|FG000|Overall Study|Surgical complications req. 2nd surgery|1|||
147282273|NCT02056301|531199073|FG001|Overall Study|Surgical complications req. 2nd surgery|0|||
147282274|NCT02056301|531199072|FG000|Overall Study|Withdrawal by Subject|0|||
147282275|NCT02056301|531199073|FG001|Overall Study|Withdrawal by Subject|1|||
147282276|NCT02056301|531199072|FG000|Overall Study|Issues with epidural|0|||
147282277|NCT02056301|531199073|FG001|Overall Study|Issues with epidural|3|||
147282278|NCT03433456|531199078|FG000|Overall Study|Death|1|||
147282279|NCT03433456|531199079|FG001|Overall Study|Death|1|||
147282280|NCT03433456|531199078|FG000|Overall Study|Lost to Follow-up|14|||
147282281|NCT03433456|531199079|FG001|Overall Study|Lost to Follow-up|11|||
147282282|NCT03433456|531199078|FG000|Overall Study|Pt in ICU and unable to complete follow-up visit|1|||
147282283|NCT03433456|531199079|FG001|Overall Study|Pt in ICU and unable to complete follow-up visit|0|||
147282284|NCT01198600|531199087|FG000|Phase 1: Period One, 30 Days of Wear|Inconvenience|1|||
147282285|NCT01198600|531199088|FG001|Phase 1: Period One, 30 Days of Wear|Inconvenience|0|||
147603683|NCT04713553|532365676|FG000|Primary Study (2 Months)|Inclusion criteria not met|0|||
147603684|NCT04713553|532365677|FG001|Primary Study (2 Months)|Inclusion criteria not met|0|||
147603685|NCT04713553|532365678|FG002|Primary Study (2 Months)|Inclusion criteria not met|1|||
147603686|NCT04713553|532365679|FG003|Primary Study (2 Months)|Inclusion criteria not met|0|||
147282286|NCT01198600|531199089|FG002|Phase 1: Period One, 30 Days of Wear|Inconvenience|0|||
147282287|NCT01198600|531199090|FG003|Phase 1: Period One, 30 Days of Wear|Inconvenience|0|||
147282288|NCT01198600|531199087|FG000|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|1|||
147282289|NCT01198600|531199088|FG001|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|0|||
147603687|NCT04713553|532365680|FG004|Primary Study (2 Months)|Inclusion criteria not met|0|||
147603688|NCT04713553|532365681|FG005|Primary Study (2 Months)|Inclusion criteria not met|0|||
147282290|NCT01198600|531199089|FG002|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|0|||
147282291|NCT01198600|531199090|FG003|Phase 1: Period One, 30 Days of Wear|Asymptomatic infiltrates|0|||
147282292|NCT01198600|531199087|FG000|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|0|||
147282293|NCT01198600|531199088|FG001|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|1|||
147282294|NCT01198600|531199089|FG002|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|0|||
147282295|NCT01198600|531199090|FG003|Phase 1: Period One, 30 Days of Wear|Unable to achieve acceptable comfort|0|||
147282296|NCT01198600|531199087|FG000|Phase 1: Period Two, 30 Days of Wear|Inconvenience|0|||
147282297|NCT01198600|531199088|FG001|Phase 1: Period Two, 30 Days of Wear|Inconvenience|1|||
147282298|NCT01198600|531199089|FG002|Phase 1: Period Two, 30 Days of Wear|Inconvenience|0|||
147282299|NCT01198600|531199090|FG003|Phase 1: Period Two, 30 Days of Wear|Inconvenience|0|||
147282300|NCT01198600|531199087|FG000|Phase 2: 56 Days of Wear|Inconvenience|0|||
147282301|NCT01198600|531199088|FG001|Phase 2: 56 Days of Wear|Inconvenience|0|||
147282302|NCT01198600|531199089|FG002|Phase 2: 56 Days of Wear|Inconvenience|2|||
147282303|NCT01198600|531199090|FG003|Phase 2: 56 Days of Wear|Inconvenience|0|||
147282304|NCT01198600|531199087|FG000|Phase 2: 56 Days of Wear|Relocation|0|||
147282305|NCT01198600|531199088|FG001|Phase 2: 56 Days of Wear|Relocation|0|||
147282306|NCT01198600|531199089|FG002|Phase 2: 56 Days of Wear|Relocation|2|||
147282307|NCT01198600|531199090|FG003|Phase 2: 56 Days of Wear|Relocation|0|||
147282308|NCT01198600|531199087|FG000|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|0|||
147282309|NCT01198600|531199088|FG001|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|0|||
147282310|NCT01198600|531199089|FG002|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|1|||
147282311|NCT01198600|531199090|FG003|Phase 2: 56 Days of Wear|Unable to achieve satisfactory comfort|0|||
147282312|NCT04177108|531199091|FG000|Overall Study|Withdrawal by Subject|4|||
147282313|NCT04177108|531199092|FG001|Overall Study|Withdrawal by Subject|8|||
147282314|NCT04177108|531199093|FG002|Overall Study|Withdrawal by Subject|9|||
147282315|NCT04177108|531199094|FG003|Overall Study|Withdrawal by Subject|11|||
147282316|NCT04177108|531199095|FG004|Overall Study|Withdrawal by Subject|13|||
147282317|NCT04177108|531199091|FG000|Overall Study|Physician Decision|23|||
147282318|NCT04177108|531199092|FG001|Overall Study|Physician Decision|15|||
147282319|NCT04177108|531199093|FG002|Overall Study|Physician Decision|18|||
147282320|NCT04177108|531199094|FG003|Overall Study|Physician Decision|29|||
147282321|NCT04177108|531199095|FG004|Overall Study|Physician Decision|23|||
147282322|NCT04177108|531199091|FG000|Overall Study|Reason Not Specified|0|||
147282323|NCT04177108|531199092|FG001|Overall Study|Reason Not Specified|1|||
147282324|NCT04177108|531199093|FG002|Overall Study|Reason Not Specified|0|||
147282325|NCT04177108|531199094|FG003|Overall Study|Reason Not Specified|0|||
147282326|NCT04177108|531199095|FG004|Overall Study|Reason Not Specified|2|||
147282327|NCT04177108|531199091|FG000|Overall Study|Lost to Follow-up|0|||
147282328|NCT04177108|531199092|FG001|Overall Study|Lost to Follow-up|0|||
147282329|NCT04177108|531199093|FG002|Overall Study|Lost to Follow-up|1|||
147282330|NCT04177108|531199094|FG003|Overall Study|Lost to Follow-up|1|||
147282331|NCT04177108|531199095|FG004|Overall Study|Lost to Follow-up|1|||
147282332|NCT04177108|531199091|FG000|Overall Study|Death|16|||
147282333|NCT04177108|531199092|FG001|Overall Study|Death|19|||
147282334|NCT04177108|531199093|FG002|Overall Study|Death|13|||
147282335|NCT04177108|531199094|FG003|Overall Study|Death|17|||
147282336|NCT04177108|531199095|FG004|Overall Study|Death|18|||
147282337|NCT01427712|531199096|FG000|Overall Study|Transfer to a different hospital|2|||
147282338|NCT01427712|531199096|FG000|Overall Study|Lost to Follow-up|1|||
147282339|NCT01427712|531199096|FG000|Overall Study|Aggravation of cystic fibrosis|3|||
147282340|NCT01427712|531199096|FG000|Overall Study|Failure to visit|1|||
147282341|NCT00784043|531199097|FG000|Overall Study|Withdrawal by Subject|8|||
147282342|NCT00784043|531199098|FG001|Overall Study|Withdrawal by Subject|5|||
147282343|NCT00784043|531199097|FG000|Overall Study|Protocol Terminated|23|||
147282344|NCT00784043|531199098|FG001|Overall Study|Protocol Terminated|1|||
147282345|NCT01143259|531199099|FG000|Overall Study|Withdrawal by Subject|3|||
147282346|NCT01143259|531199100|FG001|Overall Study|Withdrawal by Subject|2|||
147282347|NCT01143259|531199099|FG000|Overall Study|Protocol Violation|13|||
147282348|NCT01143259|531199100|FG001|Overall Study|Protocol Violation|9|||
147282349|NCT01143259|531199099|FG000|Overall Study|Screen Failure|7|||
147282350|NCT01143259|531199100|FG001|Overall Study|Screen Failure|9|||
147282351|NCT00099983|531199101|FG000|Overall Study|Lost to Follow-up|2|||
147282352|NCT00099983|531199102|FG001|Overall Study|Lost to Follow-up|3|||
147282353|NCT00099983|531199101|FG000|Overall Study|Missing Source Documents|14|||
147451336|NCT01857869|531814843|FG000|Primary/Challenge Phase|Protocol Violation|1|||
147451337|NCT01857869|531814844|FG001|Primary/Challenge Phase|Protocol Violation|0|||
147451338|NCT01857869|531814845|FG002|Primary/Challenge Phase|Protocol Violation|0|||
147451339|NCT01857869|531814846|FG003|Primary/Challenge Phase|Protocol Violation|0|||
147451340|NCT01857869|531814847|FG004|Primary/Challenge Phase|Protocol Violation|0|||
147282354|NCT00099983|531199102|FG001|Overall Study|Missing Source Documents|15|||
147282355|NCT00099983|531199101|FG000|Overall Study|Withdrawal by Subject|3|||
147282356|NCT00099983|531199102|FG001|Overall Study|Withdrawal by Subject|2|||
147282357|NCT00099983|531199101|FG000|Overall Study|Adverse Event|1|||
147282358|NCT00099983|531199102|FG001|Overall Study|Adverse Event|1|||
147282359|NCT00099983|531199101|FG000|Overall Study|Lack of Efficacy|0|||
147282360|NCT00099983|531199102|FG001|Overall Study|Lack of Efficacy|1|||
147282361|NCT00099983|531199101|FG000|Overall Study|Unable to return for appointments|1|||
147282362|NCT00099983|531199102|FG001|Overall Study|Unable to return for appointments|1|||
147282363|NCT00099983|531199101|FG000|Overall Study|Moved|1|||
147282364|NCT00099983|531199102|FG001|Overall Study|Moved|0|||
147282365|NCT00099983|531199101|FG000|Overall Study|Other psychiatric problem|1|||
147282366|NCT00099983|531199102|FG001|Overall Study|Other psychiatric problem|0|||
147282367|NCT00099983|531199101|FG000|Overall Study|Incarcerated|0|||
147282368|NCT00099983|531199102|FG001|Overall Study|Incarcerated|1|||
147282369|NCT00099983|531199101|FG000|Overall Study|Intolerant of burden of visits|0|||
147282370|NCT00099983|531199102|FG001|Overall Study|Intolerant of burden of visits|1|||
147282371|NCT00099983|531199101|FG000|Overall Study|Other issue|1|||
147282372|NCT00099983|531199102|FG001|Overall Study|Other issue|0|||
147282373|NCT02641080|531199103|FG000|Overall Study|Physician Decision|2|||
147282374|NCT02641080|531199104|FG001|Overall Study|Physician Decision|0|||
147282375|NCT02641080|531199103|FG000|Overall Study|Withdrawal by Subject|0|||
147282376|NCT02641080|531199104|FG001|Overall Study|Withdrawal by Subject|1|||
147282377|NCT02641080|531199103|FG000|Overall Study|Rehab Center denied use of pumps|0|||
147282378|NCT02641080|531199104|FG001|Overall Study|Rehab Center denied use of pumps|3|||
147282379|NCT02641080|531199103|FG000|Overall Study|Lost to Follow-up|0|||
147282380|NCT02641080|531199104|FG001|Overall Study|Lost to Follow-up|3|||
147282381|NCT00803634|531199105|FG000|Overall Study|Withdrew Consent|1|||
147282382|NCT00803634|531199106|FG001|Overall Study|Withdrew Consent|0|||
147282383|NCT00803634|531199105|FG000|Overall Study|Lost to Follow-up|2|||
147282384|NCT00803634|531199106|FG001|Overall Study|Lost to Follow-up|3|||
147282385|NCT00803634|531199105|FG000|Overall Study|Death|3|||
147282386|NCT00803634|531199106|FG001|Overall Study|Death|2|||
147282387|NCT04307186|531199107|FG000|Period 1 - Gadobutrol|Withdrawal by Subject|1|||
147282388|NCT04307186|531199107|FG000|Washout 3-14 Days|Withdrawal by Subject|1|||
147282389|NCT04307186|531199107|FG000|Washout 3-14 Days|Progressive disease|1|||
147282390|NCT04307186|531199107|FG000|Washout 3-14 Days|Pre-specified withdrawal criterion met|1|||
147282391|NCT04307186|531199107|FG000|Period 2 - Gadoquatrane|Protocol Violation|1|||
147282392|NCT03835533|531199109|FG000|Overall Study|Death|5|||
147282393|NCT03835533|531199110|FG001|Overall Study|Death|10|||
147282394|NCT03835533|531199111|FG002|Overall Study|Death|9|||
147282395|NCT03835533|531199109|FG000|Overall Study|Withdrawal by Subject|2|||
147282396|NCT03835533|531199110|FG001|Overall Study|Withdrawal by Subject|2|||
147282397|NCT03835533|531199111|FG002|Overall Study|Withdrawal by Subject|2|||
147282398|NCT03835533|531199109|FG000|Overall Study|Lost to Follow-up|1|||
147282399|NCT03835533|531199110|FG001|Overall Study|Lost to Follow-up|0|||
147282400|NCT03835533|531199111|FG002|Overall Study|Lost to Follow-up|0|||
147282401|NCT03238001|531199112|FG000|Visit 1 (Primary Endpoint Cohort)|Protocol Violation|2|||
147282402|NCT03238001|531199112|FG000|Visit 1 (Primary Endpoint Cohort)|Unanalyzable test result|2|||
147282403|NCT03238001|531199112|FG000|Visit 2 (Secondary Endpoint Cohort)|Lost to Follow-up|16|||
147282404|NCT03238001|531199112|FG000|Visit 2 (Secondary Endpoint Cohort)|Unanalyzable test result|2|||
147282405|NCT03238001|531199112|FG000|Visit 2 (Secondary Endpoint Cohort)|Withdrawal by Subject|3|||
147282406|NCT03238001|531199112|FG000|Visit 2 (Secondary Endpoint Cohort)|Met exclusion criteria at visit 2|3|||
147282407|NCT03238001|531199112|FG000|Visit 2 (Secondary Endpoint Cohort)|Study completion|1|||
147282408|NCT03238001|531199112|FG000|Visit 2 (Secondary Endpoint Cohort)|Protocol Violation|4|||
147282409|NCT03791398|531199116|FG000|Overall Study|Progression of Disease Under Study|2|||
147282410|NCT03791398|531199117|FG001|Overall Study|Progression of Disease Under Study|0|||
147282411|NCT03791398|531199118|FG002|Overall Study|Progression of Disease Under Study|0|||
147282412|NCT02207829|531199121|FG000|Overall Study|Adverse Event|10|||
147282413|NCT02207829|531199122|FG001|Overall Study|Adverse Event|9|||
147282414|NCT02207829|531199121|FG000|Overall Study|Lack of Efficacy|7|||
147282415|NCT02207829|531199122|FG001|Overall Study|Lack of Efficacy|5|||
147282416|NCT02207829|531199121|FG000|Overall Study|Lost to Follow-up|2|||
147282417|NCT02207829|531199122|FG001|Overall Study|Lost to Follow-up|2|||
147282418|NCT02207829|531199121|FG000|Overall Study|Protocol deviation|5|||
147282419|NCT02207829|531199122|FG001|Overall Study|Protocol deviation|4|||
147282420|NCT02207829|531199121|FG000|Overall Study|Withdrew consent|18|||
147282421|NCT02207829|531199122|FG001|Overall Study|Withdrew consent|14|||
147282422|NCT00766376|531199123|FG000|Overall Study|Withdrawal by Subject|27|||
147282423|NCT01418209|531199124|FG000|Overall Study|Withdrawal by Subject|1|||
147282424|NCT01418209|531199125|FG001|Overall Study|Withdrawal by Subject|0|||
147335925|NCT03482011|531396432|FG000|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
147603689|NCT04713553|532365682|FG006|Primary Study (2 Months)|Inclusion criteria not met|0|||
147603690|NCT01716715|532365687|FG000|Overall Study|Never Treated|2|||
147603691|NCT01716715|532365688|FG001|Overall Study|Never Treated|4|||
147603692|NCT00849186|532365689|FG000|Overall Study|Adverse Event|2|||
147603693|NCT00849186|532365689|FG000|Overall Study|Withdrawal by Subject|1|||
147603694|NCT00849186|532365689|FG000|Overall Study|not treated|6|||
147282425|NCT01418209|531199126|FG002|Overall Study|Withdrawal by Subject|1|||
147282426|NCT01418209|531199124|FG000|Overall Study|Did not provide hot flash diary data|1|||
147282427|NCT01418209|531199125|FG001|Overall Study|Did not provide hot flash diary data|3|||
147282428|NCT01418209|531199126|FG002|Overall Study|Did not provide hot flash diary data|3|||
147282429|NCT00101101|531199127|FG000|Overall Study|never received vaccine|20|||
147282430|NCT01800903|531199128|FG000|Second Test Period|unable to catheterise|1|||
147282431|NCT01800903|531199129|FG001|Second Test Period|unable to catheterise|0|||
147282432|NCT01800903|531199130|FG002|Second Test Period|unable to catheterise|0|||
147282433|NCT01800903|531199131|FG003|Second Test Period|unable to catheterise|0|||
147282434|NCT01800903|531199132|FG004|Second Test Period|unable to catheterise|0|||
147282435|NCT01800903|531199133|FG005|Second Test Period|unable to catheterise|0|||
147282436|NCT01110239|531199136|FG000|Sham Preconditioning|Withdrawal by Subject|0|||
147282437|NCT01110239|531199137|FG001|Sham Preconditioning|Withdrawal by Subject|0|||
147282438|NCT01110239|531199138|FG002|Sham Preconditioning|Withdrawal by Subject|1|||
147603695|NCT00849186|532365689|FG000|Overall Study|Other|1|||
147282439|NCT01110239|531199139|FG003|Sham Preconditioning|Withdrawal by Subject|0|||
147282440|NCT01110239|531199136|FG000|7.5 Min Ischemia|Withdrawal by Subject|0|||
147282441|NCT01110239|531199137|FG001|7.5 Min Ischemia|Withdrawal by Subject|0|||
147282442|NCT01110239|531199138|FG002|7.5 Min Ischemia|Withdrawal by Subject|1|||
147282443|NCT01110239|531199139|FG003|7.5 Min Ischemia|Withdrawal by Subject|0|||
147282444|NCT00080223|531199140|FG000|Overall Study|Adverse Event|23|||
147282445|NCT00080223|531199140|FG000|Overall Study|Death|21|||
147282446|NCT00080223|531199140|FG000|Overall Study|Withdrawal by Subject|13|||
147282447|NCT00080223|531199140|FG000|Overall Study|Lung Transplantation|9|||
147282448|NCT00080223|531199140|FG000|Overall Study|Non-compliance With Study Treatment|7|||
147282449|NCT00080223|531199140|FG000|Overall Study|Participant unwilling to continue|2|||
147282450|NCT00080223|531199140|FG000|Overall Study|Physician Decision|1|||
147282451|NCT04452344|531199147|FG000|Overall Study|Withdrawal by Subject|3|||
147282452|NCT04452344|531199148|FG001|Overall Study|Withdrawal by Subject|6|||
147282453|NCT04452344|531199147|FG000|Overall Study|Adverse Event|1|||
147282454|NCT04452344|531199148|FG001|Overall Study|Adverse Event|2|||
147282455|NCT04452344|531199147|FG000|Overall Study|Lost to Follow-up|2|||
147282456|NCT04452344|531199148|FG001|Overall Study|Lost to Follow-up|2|||
147282457|NCT04452344|531199147|FG000|Overall Study|No Post-Op Visit|6|||
147282458|NCT04452344|531199148|FG001|Overall Study|No Post-Op Visit|7|||
147282459|NCT01968434|531199154|FG000|Overall Study|Lost to Follow-up|3|||
147282460|NCT01968434|531199155|FG001|Overall Study|Lost to Follow-up|6|||
147282461|NCT01438411|531200959|FG000|Overall Study|Adverse Event|8|||
147282462|NCT01438411|531200959|FG000|Overall Study|Lost to Follow-up|1|||
147282463|NCT01438411|531200959|FG000|Overall Study|Lack of Efficacy|1|||
147282464|NCT01438411|531200959|FG000|Overall Study|Withdrawal by Subject|3|||
147282465|NCT02280044|531200962|FG000|Overall Study|Planned alternate|0|||
147282466|NCT02280044|531200963|FG001|Overall Study|Planned alternate|2|||
147282467|NCT02105116|531200964|FG000|Overall Study|not eligible for step 2 of trial|5|||
147282468|NCT02105116|531200964|FG000|Overall Study|Death|1|||
147282469|NCT04837482|531200965|FG000|Period 2|Withdrawal by Subject|0|||
147282470|NCT04837482|531200966|FG001|Period 2|Withdrawal by Subject|1|||
147282471|NCT01175382|531200967|FG000|Overall Study|Lost to Follow-up|4|||
147282472|NCT01175382|531200968|FG001|Overall Study|Lost to Follow-up|3|||
147282473|NCT01175382|531200969|FG002|Overall Study|Lost to Follow-up|1|||
147282474|NCT01175382|531200967|FG000|Overall Study|Physician Decision|0|||
147282475|NCT01175382|531200968|FG001|Overall Study|Physician Decision|1|||
147282476|NCT01175382|531200969|FG002|Overall Study|Physician Decision|0|||
147282477|NCT01175382|531200967|FG000|Overall Study|Withdrawal by Subject|0|||
147282478|NCT01175382|531200968|FG001|Overall Study|Withdrawal by Subject|0|||
147282479|NCT01175382|531200969|FG002|Overall Study|Withdrawal by Subject|1|||
147282480|NCT01175382|531200967|FG000|Overall Study|No longer having problem|1|||
147282481|NCT01175382|531200968|FG001|Overall Study|No longer having problem|0|||
147282482|NCT01175382|531200969|FG002|Overall Study|No longer having problem|1|||
147282483|NCT01175382|531200967|FG000|Overall Study|Unable/unwilling to attend visits|3|||
147282484|NCT01175382|531200968|FG001|Overall Study|Unable/unwilling to attend visits|1|||
147603696|NCT00417170|532365690|FG000|Overall Study|Adverse Event|1|||
147282485|NCT01175382|531200969|FG002|Overall Study|Unable/unwilling to attend visits|2|||
147282486|NCT01175382|531200967|FG000|Overall Study|Unwilling to follow protocol|0|||
147282487|NCT01175382|531200968|FG001|Overall Study|Unwilling to follow protocol|1|||
147282488|NCT01175382|531200969|FG002|Overall Study|Unwilling to follow protocol|0|||
147282489|NCT01175382|531200967|FG000|Overall Study|Unable to tolerate study meds|0|||
147335926|NCT03482011|531396433|FG001|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
147603697|NCT00417170|532365691|FG001|Overall Study|Adverse Event|1|||
147603698|NCT00417170|532365690|FG000|Overall Study|Withdrawal by Subject|1|||
147603699|NCT00417170|532365691|FG001|Overall Study|Withdrawal by Subject|1|||
147282490|NCT01175382|531200968|FG001|Overall Study|Unable to tolerate study meds|1|||
147282491|NCT01175382|531200969|FG002|Overall Study|Unable to tolerate study meds|1|||
147282492|NCT00844194|531200970|FG000|Overall Study|Adverse Event|17|||
147282493|NCT00844194|531200971|FG001|Overall Study|Adverse Event|5|||
147282494|NCT00844194|531200970|FG000|Overall Study|Protocol Violation|1|||
147282495|NCT00844194|531200971|FG001|Overall Study|Protocol Violation|1|||
147282496|NCT00844194|531200970|FG000|Overall Study|Lost to Follow-up|1|||
147282497|NCT00844194|531200971|FG001|Overall Study|Lost to Follow-up|1|||
147282498|NCT00844194|531200970|FG000|Overall Study|Withdrawal by Subject|2|||
147282499|NCT00844194|531200971|FG001|Overall Study|Withdrawal by Subject|1|||
147282500|NCT00844194|531200970|FG000|Overall Study|Lack of Efficacy|3|||
147282501|NCT00844194|531200971|FG001|Overall Study|Lack of Efficacy|0|||
147282502|NCT00844194|531200970|FG000|Overall Study|Other reason (not specified)|1|||
147282503|NCT00844194|531200971|FG001|Overall Study|Other reason (not specified)|0|||
147282504|NCT01659021|531200978|FG000|Main Study|Adverse Event|2|||
147282505|NCT01659021|531200979|FG001|Main Study|Adverse Event|3|||
147282506|NCT01659021|531200978|FG000|Main Study|Lost to Follow-up|1|||
147282507|NCT01659021|531200979|FG001|Main Study|Lost to Follow-up|0|||
147282508|NCT01659021|531200978|FG000|Main Study|Unknown Reasons|2|||
147282509|NCT01659021|531200979|FG001|Main Study|Unknown Reasons|1|||
147603700|NCT00417170|532365690|FG000|Overall Study|Lost to Follow-up|0|||
147282510|NCT01659021|531200978|FG000|Main Study|Physician Decision|34|||
147282511|NCT01659021|531200979|FG001|Main Study|Physician Decision|16|||
147282512|NCT01659021|531200978|FG000|Main Study|Withdrawal by Subject|19|||
147282513|NCT01659021|531200979|FG001|Main Study|Withdrawal by Subject|16|||
147282514|NCT01659021|531200978|FG000|Main Study|Study Terminated by Sponsor|16|||
147282515|NCT01659021|531200979|FG001|Main Study|Study Terminated by Sponsor|1|||
147282516|NCT01659021|531200978|FG000|Long-Term Follow Up|Lost to Follow-up|3|||
147282517|NCT01659021|531200979|FG001|Long-Term Follow Up|Lost to Follow-up|3|||
147282518|NCT01659021|531200978|FG000|Long-Term Follow Up|Withdrawal by Subject|2|||
147282519|NCT01659021|531200979|FG001|Long-Term Follow Up|Withdrawal by Subject|1|||
147282520|NCT01751568|531200982|FG000|Overall Study|Participant never started treatment of raltegravir, was taken off-study.|1|||
147282521|NCT01751568|531200983|FG001|Overall Study|Participant never started treatment of raltegravir, was taken off-study.|0|||
147282522|NCT01751568|531200984|FG002|Overall Study|Participant never started treatment of raltegravir, was taken off-study.|0|||
147282523|NCT03447769|531200985|FG000|Overall Study|Progressive disease|138|||
147282524|NCT03447769|531200986|FG001|Overall Study|Progressive disease|148|||
147282525|NCT03447769|531200985|FG000|Overall Study|Study terminated by Sponsor|60|||
147282526|NCT03447769|531200986|FG001|Overall Study|Study terminated by Sponsor|44|||
147282527|NCT03447769|531200985|FG000|Overall Study|Adverse Event|34|||
147282528|NCT03447769|531200986|FG001|Overall Study|Adverse Event|31|||
147282529|NCT03447769|531200985|FG000|Overall Study|Patient decision|27|||
147282530|NCT03447769|531200986|FG001|Overall Study|Patient decision|27|||
147282531|NCT03447769|531200985|FG000|Overall Study|Protocol deviation|4|||
147282532|NCT03447769|531200986|FG001|Overall Study|Protocol deviation|6|||
147282533|NCT03447769|531200985|FG000|Overall Study|Death|2|||
147282534|NCT03447769|531200986|FG001|Overall Study|Death|7|||
147282535|NCT03447769|531200985|FG000|Overall Study|Technical problems|1|||
147282536|NCT03447769|531200986|FG001|Overall Study|Technical problems|0|||
147282537|NCT03447769|531200985|FG000|Overall Study|Lost to Follow-up|0|||
147282538|NCT03447769|531200986|FG001|Overall Study|Lost to Follow-up|1|||
147282539|NCT03447769|531200985|FG000|Overall Study|Physician Decision|13|||
147282540|NCT03447769|531200986|FG001|Overall Study|Physician Decision|5|||
147282541|NCT00797667|531200987|FG000|Overall Study|Lack of Efficacy|0|||
147282542|NCT00797667|531200988|FG001|Overall Study|Lack of Efficacy|1|||
147282543|NCT00797667|531200989|FG002|Overall Study|Lack of Efficacy|0|||
147282544|NCT00797667|531200987|FG000|Overall Study|Lost to Follow-up|8|||
147282545|NCT00797667|531200988|FG001|Overall Study|Lost to Follow-up|12|||
147282546|NCT00797667|531200989|FG002|Overall Study|Lost to Follow-up|2|||
147282547|NCT00797667|531200987|FG000|Overall Study|Physician Decision|3|||
147282548|NCT00797667|531200988|FG001|Overall Study|Physician Decision|1|||
147282549|NCT00797667|531200989|FG002|Overall Study|Physician Decision|0|||
147282550|NCT00797667|531200987|FG000|Overall Study|Pregnancy|2|||
147282551|NCT00797667|531200988|FG001|Overall Study|Pregnancy|0|||
147282552|NCT00797667|531200989|FG002|Overall Study|Pregnancy|0|||
147282553|NCT00797667|531200987|FG000|Overall Study|Protocol Violation|2|||
147282554|NCT00797667|531200988|FG001|Overall Study|Protocol Violation|7|||
147282555|NCT00797667|531200989|FG002|Overall Study|Protocol Violation|0|||
147282556|NCT00797667|531200987|FG000|Overall Study|Study Terminated by Sponsor|217|||
147282557|NCT00797667|531200988|FG001|Overall Study|Study Terminated by Sponsor|216|||
147282558|NCT00797667|531200989|FG002|Overall Study|Study Terminated by Sponsor|115|||
147282559|NCT00797667|531200987|FG000|Overall Study|Withdrawal by Subject|9|||
147282560|NCT00797667|531200988|FG001|Overall Study|Withdrawal by Subject|14|||
147282561|NCT00797667|531200989|FG002|Overall Study|Withdrawal by Subject|2|||
147282562|NCT00797667|531200987|FG000|Overall Study|Adverse Event|19|||
147282563|NCT00797667|531200988|FG001|Overall Study|Adverse Event|8|||
147282564|NCT00797667|531200989|FG002|Overall Study|Adverse Event|8|||
147282565|NCT02673697|531200990|FG000|Overall Study|Adverse Event|2|||
147282566|NCT02673697|531200991|FG001|Overall Study|Adverse Event|0|||
147282567|NCT02673697|531200990|FG000|Overall Study|Death|32|||
147282568|NCT02673697|531200991|FG001|Overall Study|Death|24|||
147282569|NCT02673697|531200990|FG000|Overall Study|Lost to Follow-up|5|||
147282570|NCT02673697|531200991|FG001|Overall Study|Lost to Follow-up|2|||
147282571|NCT02673697|531200990|FG000|Overall Study|Physician Decision|2|||
147282572|NCT02673697|531200991|FG001|Overall Study|Physician Decision|1|||
147603701|NCT00417170|532365691|FG001|Overall Study|Lost to Follow-up|1|||
147603702|NCT02704403|532365692|FG000|Overall Study|Randomized and not treated (due to non-compliance with protocol)|4|||
147603703|NCT02704403|532365693|FG001|Overall Study|Randomized and not treated (due to non-compliance with protocol)|3|||
147282573|NCT02673697|531200990|FG000|Overall Study|Withdrawal by Subject|10|||
147282574|NCT02673697|531200991|FG001|Overall Study|Withdrawal by Subject|7|||
147282575|NCT02673697|531200990|FG000|Overall Study|Change subj medical status|1|||
147282576|NCT02673697|531200991|FG001|Overall Study|Change subj medical status|2|||
147282577|NCT02673697|531200990|FG000|Overall Study|Explant|10|||
147282578|NCT02673697|531200991|FG001|Overall Study|Explant|5|||
147282579|NCT02673697|531200990|FG000|Overall Study|Sponsor Decision to stop follow up|391|||
147282580|NCT02673697|531200991|FG001|Overall Study|Sponsor Decision to stop follow up|416|||
147282581|NCT00817089|531200998|FG000|First Alcohol Challenge|Lost to Follow-up|0|||
147282582|NCT00817089|531200999|FG001|First Alcohol Challenge|Lost to Follow-up|0|||
147282583|NCT00817089|531201000|FG002|First Alcohol Challenge|Lost to Follow-up|0|||
147451341|NCT01857869|531814848|FG005|Primary/Challenge Phase|Protocol Violation|0|||
147451342|NCT01857869|531814849|FG006|Primary/Challenge Phase|Protocol Violation|0|||
147282584|NCT00817089|531201001|FG003|First Alcohol Challenge|Lost to Follow-up|1|||
147282585|NCT00817089|531200998|FG000|Second Alcohol Challenge|Lost to Follow-up|0|||
147282586|NCT00817089|531200999|FG001|Second Alcohol Challenge|Lost to Follow-up|1|||
147282587|NCT00817089|531201000|FG002|Second Alcohol Challenge|Lost to Follow-up|0|||
147282588|NCT00817089|531201001|FG003|Second Alcohol Challenge|Lost to Follow-up|0|||
147282589|NCT03783923|531201002|FG000|Placebo-Controlled Period (26 Weeks)|Study Terminated|3|||
147282590|NCT03783923|531201003|FG001|Placebo-Controlled Period (26 Weeks)|Study Terminated|2|||
147282591|NCT03783923|531201002|FG000|Placebo-Controlled Period (26 Weeks)|Adverse Event|1|||
147282592|NCT03783923|531201003|FG001|Placebo-Controlled Period (26 Weeks)|Adverse Event|0|||
147282593|NCT03783923|531201002|FG000|Placebo-Controlled Period (26 Weeks)|Withdrawal by Subject|0|||
147282594|NCT03783923|531201003|FG001|Placebo-Controlled Period (26 Weeks)|Withdrawal by Subject|2|||
147282595|NCT03783923|531201002|FG000|Open-Label Extension (26 Weeks)|Withdrawal by Subject|1|||
147282596|NCT03783923|531201003|FG001|Open-Label Extension (26 Weeks)|Withdrawal by Subject|1|||
147282597|NCT03783923|531201002|FG000|Open-Label Extension (26 Weeks)|Study Terminated|0|||
147282598|NCT03783923|531201003|FG001|Open-Label Extension (26 Weeks)|Study Terminated|1|||
147282599|NCT01767116|531201012|FG000|Overall Study|Lost to Follow-up|2|||
147282600|NCT01767116|531201013|FG001|Overall Study|Lost to Follow-up|2|||
147282601|NCT05799495|531201018|FG000|Treatment (Up to 5 Days)|Adverse Event|0|||
147282602|NCT05799495|531201019|FG001|Treatment (Up to 5 Days)|Adverse Event|1|||
147282603|NCT05799495|531201020|FG002|Treatment (Up to 5 Days)|Adverse Event|1|||
147282604|NCT05799495|531201021|FG003|Treatment (Up to 5 Days)|Adverse Event|0|||
147282605|NCT05799495|531201018|FG000|Treatment (Up to 5 Days)|Non-compliance with study drug|0|||
147282606|NCT05799495|531201019|FG001|Treatment (Up to 5 Days)|Non-compliance with study drug|0|||
147282607|NCT05799495|531201020|FG002|Treatment (Up to 5 Days)|Non-compliance with study drug|0|||
147282608|NCT05799495|531201021|FG003|Treatment (Up to 5 Days)|Non-compliance with study drug|1|||
147282609|NCT05799495|531201018|FG000|Treatment (Up to 5 Days)|Other|0|||
147282610|NCT05799495|531201019|FG001|Treatment (Up to 5 Days)|Other|1|||
147282611|NCT05799495|531201020|FG002|Treatment (Up to 5 Days)|Other|0|||
147282612|NCT05799495|531201021|FG003|Treatment (Up to 5 Days)|Other|0|||
147282613|NCT05799495|531201018|FG000|Treatment (Up to 5 Days)|Withdrawal by Subject|1|||
147282614|NCT05799495|531201019|FG001|Treatment (Up to 5 Days)|Withdrawal by Subject|1|||
147282615|NCT05799495|531201020|FG002|Treatment (Up to 5 Days)|Withdrawal by Subject|1|||
147282616|NCT05799495|531201021|FG003|Treatment (Up to 5 Days)|Withdrawal by Subject|3|||
147282617|NCT05799495|531201018|FG000|Treatment (Up to 5 Days)|Randomized not treated|0|||
147282618|NCT05799495|531201019|FG001|Treatment (Up to 5 Days)|Randomized not treated|1|||
147282619|NCT05799495|531201020|FG002|Treatment (Up to 5 Days)|Randomized not treated|1|||
147282620|NCT05799495|531201021|FG003|Treatment (Up to 5 Days)|Randomized not treated|1|||
147282621|NCT05799495|531201018|FG000|Follow Up (Up to 4 Weeks)|Withdrawal by Subject|0|||
147282622|NCT05799495|531201019|FG001|Follow Up (Up to 4 Weeks)|Withdrawal by Subject|0|||
147282623|NCT05799495|531201020|FG002|Follow Up (Up to 4 Weeks)|Withdrawal by Subject|1|||
147282624|NCT05799495|531201021|FG003|Follow Up (Up to 4 Weeks)|Withdrawal by Subject|0|||
147282625|NCT03694548|531201022|FG000|Part A Survey|Protocol Violation|3|||
147282626|NCT03694548|531201023|FG001|Part A Survey|Protocol Violation|3|||
147282627|NCT03694548|531201024|FG002|Part A Survey|Protocol Violation|0|||
147282628|NCT03694548|531201022|FG000|Part B Yoga Program|Protocol Violation|0|||
147282629|NCT03694548|531201023|FG001|Part B Yoga Program|Protocol Violation|0|||
147282630|NCT03694548|531201024|FG002|Part B Yoga Program|Protocol Violation|3|||
147282631|NCT03694548|531201022|FG000|Part B Yoga Program|Did not attend intervention|0|||
147282632|NCT03694548|531201023|FG001|Part B Yoga Program|Did not attend intervention|0|||
147282633|NCT03694548|531201024|FG002|Part B Yoga Program|Did not attend intervention|8|||
147282634|NCT00305058|531201025|FG000|Overall Study|Participant too young|1|||
147282635|NCT00305058|531201026|FG001|Overall Study|Participant too young|0|||
147282636|NCT00305058|531201025|FG000|Overall Study|Missing data collection instrument|3|||
147282637|NCT00305058|531201026|FG001|Overall Study|Missing data collection instrument|2|||
147282638|NCT00305058|531201025|FG000|Overall Study|Missing outcome data|3|||
147282639|NCT00305058|531201026|FG001|Overall Study|Missing outcome data|2|||
147282640|NCT04102501|531201027|FG000|Overall Study|Withdrawal by Subject|7|||
147282641|NCT04102501|531201028|FG001|Overall Study|Withdrawal by Subject|9|||
147282642|NCT04102501|531201027|FG000|Overall Study|Adverse Event|1|||
147282643|NCT04102501|531201028|FG001|Overall Study|Adverse Event|3|||
147282644|NCT02338362|531201029|FG000|Overall Study|Withdrawal by Subject|1|||
147282645|NCT02338362|531201030|FG001|Overall Study|Withdrawal by Subject|1|||
147282646|NCT01669343|531201031|FG000|Part A: All Patients|Withdrawal by Subject|7|||
147282647|NCT01669343|531201031|FG000|Part A: All Patients|Ineligibility discovered after enrollment|2|||
147282648|NCT01669343|531201031|FG000|Part B: Patients With BMI>=25|Withdrawal by Subject|13|||
147282649|NCT01669343|531201031|FG000|Part B: Patients With BMI>=25|Recruited during interim analysis|3|||
147451343|NCT01857869|531814850|FG007|Primary/Challenge Phase|Protocol Violation|0|||
147282650|NCT01669343|531201031|FG000|Part B: Patients With BMI>=25|Ineligibility discovered after enrollment|1|||
147451344|NCT01857869|531814851|FG008|Primary/Challenge Phase|Protocol Violation|0|||
147282651|NCT00439777|531201032|FG000|Treatment Period|Death|29|||
147282652|NCT00439777|531201033|FG001|Treatment Period|Death|21|||
147282653|NCT00439777|531201032|FG000|Treatment Period|Study terminated by sponsor|125|||
147282654|NCT00439777|531201033|FG001|Treatment Period|Study terminated by sponsor|132|||
147282655|NCT00439777|531201032|FG000|Treatment Period|Site closed by investigator|0|||
147282656|NCT00439777|531201033|FG001|Treatment Period|Site closed by investigator|1|||
147282657|NCT00439777|531201032|FG000|Treatment Period|Did not take study treatment|7|||
147282658|NCT00439777|531201033|FG001|Treatment Period|Did not take study treatment|8|||
147282659|NCT00439777|531201032|FG000|Treatment Period|Adverse Event|111|||
147282660|NCT00439777|531201033|FG001|Treatment Period|Adverse Event|92|||
147282661|NCT00439777|531201032|FG000|Treatment Period|Protocol Violation|23|||
147282662|NCT00439777|531201033|FG001|Treatment Period|Protocol Violation|30|||
147282663|NCT00439777|531201032|FG000|Treatment Period|Withdrawal by Subject|66|||
147282664|NCT00439777|531201033|FG001|Treatment Period|Withdrawal by Subject|118|||
147282665|NCT00439777|531201032|FG000|Treatment Period|Lack of Efficacy|1|||
147282666|NCT00439777|531201033|FG001|Treatment Period|Lack of Efficacy|4|||
147282667|NCT00439777|531201032|FG000|Treatment Period|Lost to Follow-up|8|||
147282668|NCT00439777|531201033|FG001|Treatment Period|Lost to Follow-up|10|||
147282669|NCT00439777|531201032|FG000|Treatment Period|Protocol driven decision point|1|||
147282670|NCT00439777|531201033|FG001|Treatment Period|Protocol driven decision point|3|||
147282671|NCT00439777|531201032|FG000|Treatment Period|Physician Decision|7|||
147282672|NCT00439777|531201033|FG001|Treatment Period|Physician Decision|18|||
147282673|NCT00439777|531201032|FG000|Treatment Period|Clinical endpoint reached|26|||
147282674|NCT00439777|531201033|FG001|Treatment Period|Clinical endpoint reached|13|||
147282675|NCT00439777|531201032|FG000|Treatment Period|Technical problems|3|||
147282676|NCT00439777|531201033|FG001|Treatment Period|Technical problems|1|||
147282677|NCT00439777|531201032|FG000|Treatment Period|Participant convenience|12|||
147282678|NCT00439777|531201033|FG001|Treatment Period|Participant convenience|8|||
147282679|NCT00439777|531201032|FG000|Observational Period|Protocol Violation|0|||
147282680|NCT00439777|531201033|FG001|Observational Period|Protocol Violation|2|||
147282681|NCT00439777|531201032|FG000|Observational Period|Withdrawal by Subject|9|||
147335927|NCT03482011|531396434|FG002|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
147335928|NCT03482011|531396435|FG003|Follow-up Period (12 Weeks)|Withdrawal by Subject|2|||
147335929|NCT03482011|531396436|FG004|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
147335930|NCT03482011|531396437|FG005|Follow-up Period (12 Weeks)|Withdrawal by Subject|1|||
147335931|NCT03482011|531396438|FG006|Follow-up Period (12 Weeks)|Withdrawal by Subject|1|||
147335932|NCT03482011|531396439|FG007|Follow-up Period (12 Weeks)|Withdrawal by Subject|5|||
147335933|NCT03482011|531396432|FG000|Follow-up Period (12 Weeks)|Adverse Event|0|||
147335934|NCT03482011|531396433|FG001|Follow-up Period (12 Weeks)|Adverse Event|0|||
147335935|NCT03482011|531396434|FG002|Follow-up Period (12 Weeks)|Adverse Event|0|||
147335936|NCT03482011|531396435|FG003|Follow-up Period (12 Weeks)|Adverse Event|0|||
147335937|NCT03482011|531396436|FG004|Follow-up Period (12 Weeks)|Adverse Event|0|||
147335938|NCT03482011|531396437|FG005|Follow-up Period (12 Weeks)|Adverse Event|0|||
147335939|NCT03482011|531396438|FG006|Follow-up Period (12 Weeks)|Adverse Event|1|||
147335940|NCT03482011|531396439|FG007|Follow-up Period (12 Weeks)|Adverse Event|4|||
147335941|NCT03482011|531396432|FG000|Follow-up Period (12 Weeks)|Lack of Efficacy|0|||
147335942|NCT03482011|531396433|FG001|Follow-up Period (12 Weeks)|Lack of Efficacy|0|||
147335943|NCT03482011|531396434|FG002|Follow-up Period (12 Weeks)|Lack of Efficacy|1|||
147335944|NCT03482011|531396435|FG003|Follow-up Period (12 Weeks)|Lack of Efficacy|3|||
147335945|NCT03482011|531396436|FG004|Follow-up Period (12 Weeks)|Lack of Efficacy|0|||
147335946|NCT03482011|531396437|FG005|Follow-up Period (12 Weeks)|Lack of Efficacy|0|||
147335947|NCT03482011|531396438|FG006|Follow-up Period (12 Weeks)|Lack of Efficacy|0|||
147335948|NCT03482011|531396439|FG007|Follow-up Period (12 Weeks)|Lack of Efficacy|6|||
147335949|NCT03482011|531396432|FG000|Follow-up Period (12 Weeks)|Physician Decision|0|||
147335950|NCT03482011|531396433|FG001|Follow-up Period (12 Weeks)|Physician Decision|0|||
147335951|NCT03482011|531396434|FG002|Follow-up Period (12 Weeks)|Physician Decision|0|||
147335952|NCT03482011|531396435|FG003|Follow-up Period (12 Weeks)|Physician Decision|0|||
147335953|NCT03482011|531396436|FG004|Follow-up Period (12 Weeks)|Physician Decision|0|||
147335954|NCT03482011|531396437|FG005|Follow-up Period (12 Weeks)|Physician Decision|0|||
147335955|NCT03482011|531396438|FG006|Follow-up Period (12 Weeks)|Physician Decision|0|||
147335956|NCT03482011|531396439|FG007|Follow-up Period (12 Weeks)|Physician Decision|1|||
147335957|NCT03482011|531396432|FG000|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
147282682|NCT00439777|531201033|FG001|Observational Period|Withdrawal by Subject|5|||
147282683|NCT00439777|531201032|FG000|Observational Period|Lost to Follow-up|1|||
147335958|NCT03482011|531396433|FG001|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
147335959|NCT03482011|531396434|FG002|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
147335960|NCT03482011|531396435|FG003|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
147603704|NCT02704403|532365692|FG000|Overall Study|Administrative reasons by sponsor|1251|||
147335961|NCT03482011|531396436|FG004|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
147335962|NCT03482011|531396437|FG005|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
147335963|NCT03482011|531396438|FG006|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
147335964|NCT03482011|531396439|FG007|Follow-up Period (12 Weeks)|Lost to Follow-up|1|||
147335965|NCT00468052|531396440|FG000|Overall Study|Protocol Violation|7|||
147335966|NCT00468052|531396441|FG001|Overall Study|Protocol Violation|8|||
147335967|NCT02709655|531396442|FG000|Single-Blind Phase (4 Weeks)|Adverse Event|2|||
147335968|NCT02709655|531396443|FG001|Single-Blind Phase (4 Weeks)|Adverse Event|0|||
147335969|NCT02709655|531396444|FG002|Single-Blind Phase (4 Weeks)|Adverse Event|0|||
147335970|NCT02709655|531396445|FG003|Single-Blind Phase (4 Weeks)|Adverse Event|0|||
147335971|NCT02709655|531396446|FG004|Single-Blind Phase (4 Weeks)|Adverse Event|0|||
147335972|NCT02709655|531396442|FG000|Single-Blind Phase (4 Weeks)|Lack of Efficacy|8|||
147335973|NCT02709655|531396443|FG001|Single-Blind Phase (4 Weeks)|Lack of Efficacy|0|||
147335974|NCT02709655|531396444|FG002|Single-Blind Phase (4 Weeks)|Lack of Efficacy|0|||
147335975|NCT02709655|531396445|FG003|Single-Blind Phase (4 Weeks)|Lack of Efficacy|0|||
147335976|NCT02709655|531396446|FG004|Single-Blind Phase (4 Weeks)|Lack of Efficacy|0|||
147335977|NCT02709655|531396442|FG000|Single-Blind Phase (4 Weeks)|Non-compliance with study drug|3|||
147335978|NCT02709655|531396443|FG001|Single-Blind Phase (4 Weeks)|Non-compliance with study drug|0|||
147335979|NCT02709655|531396444|FG002|Single-Blind Phase (4 Weeks)|Non-compliance with study drug|0|||
147335980|NCT02709655|531396445|FG003|Single-Blind Phase (4 Weeks)|Non-compliance with study drug|0|||
147335981|NCT02709655|531396446|FG004|Single-Blind Phase (4 Weeks)|Non-compliance with study drug|0|||
147335982|NCT02709655|531396442|FG000|Single-Blind Phase (4 Weeks)|Protocol Violation|3|||
147335983|NCT02709655|531396443|FG001|Single-Blind Phase (4 Weeks)|Protocol Violation|0|||
147335984|NCT02709655|531396444|FG002|Single-Blind Phase (4 Weeks)|Protocol Violation|0|||
147335985|NCT02709655|531396445|FG003|Single-Blind Phase (4 Weeks)|Protocol Violation|0|||
147335986|NCT02709655|531396446|FG004|Single-Blind Phase (4 Weeks)|Protocol Violation|0|||
147335987|NCT02709655|531396442|FG000|Single-Blind Phase (4 Weeks)|Withdrawal by Subject|15|||
147335988|NCT02709655|531396443|FG001|Single-Blind Phase (4 Weeks)|Withdrawal by Subject|0|||
147335989|NCT02709655|531396444|FG002|Single-Blind Phase (4 Weeks)|Withdrawal by Subject|0|||
147335990|NCT02709655|531396445|FG003|Single-Blind Phase (4 Weeks)|Withdrawal by Subject|0|||
147335991|NCT02709655|531396446|FG004|Single-Blind Phase (4 Weeks)|Withdrawal by Subject|0|||
147335992|NCT02709655|531396442|FG000|Single-Blind Phase (4 Weeks)|Lost to Follow-up|1|||
147335993|NCT02709655|531396443|FG001|Single-Blind Phase (4 Weeks)|Lost to Follow-up|0|||
147335994|NCT02709655|531396444|FG002|Single-Blind Phase (4 Weeks)|Lost to Follow-up|0|||
147335995|NCT02709655|531396445|FG003|Single-Blind Phase (4 Weeks)|Lost to Follow-up|0|||
147335996|NCT02709655|531396446|FG004|Single-Blind Phase (4 Weeks)|Lost to Follow-up|0|||
147335997|NCT02709655|531396442|FG000|Single-Blind Phase (4 Weeks)|Failure to meet randomization criteria|85|||
147335998|NCT02709655|531396443|FG001|Single-Blind Phase (4 Weeks)|Failure to meet randomization criteria|0|||
147335999|NCT02709655|531396444|FG002|Single-Blind Phase (4 Weeks)|Failure to meet randomization criteria|0|||
147336000|NCT02709655|531396445|FG003|Single-Blind Phase (4 Weeks)|Failure to meet randomization criteria|0|||
147336001|NCT02709655|531396446|FG004|Single-Blind Phase (4 Weeks)|Failure to meet randomization criteria|0|||
147336002|NCT02709655|531396442|FG000|Single-Blind Phase (4 Weeks)|Other than specified|20|||
147336003|NCT02709655|531396443|FG001|Single-Blind Phase (4 Weeks)|Other than specified|0|||
147336004|NCT02709655|531396444|FG002|Single-Blind Phase (4 Weeks)|Other than specified|0|||
147336005|NCT02709655|531396445|FG003|Single-Blind Phase (4 Weeks)|Other than specified|0|||
147336006|NCT02709655|531396446|FG004|Single-Blind Phase (4 Weeks)|Other than specified|0|||
147336007|NCT02709655|531396442|FG000|Single-Blind Phase (4 Weeks)|Enrolled but not treated|6|||
147336008|NCT02709655|531396443|FG001|Single-Blind Phase (4 Weeks)|Enrolled but not treated|0|||
147336009|NCT02709655|531396444|FG002|Single-Blind Phase (4 Weeks)|Enrolled but not treated|0|||
147336010|NCT02709655|531396445|FG003|Single-Blind Phase (4 Weeks)|Enrolled but not treated|0|||
147336011|NCT02709655|531396446|FG004|Single-Blind Phase (4 Weeks)|Enrolled but not treated|0|||
147336012|NCT02709655|531396442|FG000|Double-Blind Phase (8 Weeks)|Adverse Event|0|||
147336013|NCT02709655|531396443|FG001|Double-Blind Phase (8 Weeks)|Adverse Event|1|||
147336014|NCT02709655|531396444|FG002|Double-Blind Phase (8 Weeks)|Adverse Event|2|||
147336015|NCT02709655|531396445|FG003|Double-Blind Phase (8 Weeks)|Adverse Event|3|||
147336016|NCT02709655|531396446|FG004|Double-Blind Phase (8 Weeks)|Adverse Event|0|||
147336017|NCT02709655|531396442|FG000|Double-Blind Phase (8 Weeks)|Lack of Efficacy|0|||
147336018|NCT02709655|531396443|FG001|Double-Blind Phase (8 Weeks)|Lack of Efficacy|2|||
147336019|NCT02709655|531396444|FG002|Double-Blind Phase (8 Weeks)|Lack of Efficacy|0|||
147336020|NCT02709655|531396445|FG003|Double-Blind Phase (8 Weeks)|Lack of Efficacy|0|||
147336021|NCT02709655|531396446|FG004|Double-Blind Phase (8 Weeks)|Lack of Efficacy|1|||
147336022|NCT02709655|531396442|FG000|Double-Blind Phase (8 Weeks)|Non-compliance with study drug|0|||
147336023|NCT02709655|531396443|FG001|Double-Blind Phase (8 Weeks)|Non-compliance with study drug|1|||
147336024|NCT02709655|531396444|FG002|Double-Blind Phase (8 Weeks)|Non-compliance with study drug|3|||
147603705|NCT02704403|532365693|FG001|Overall Study|Administrative reasons by sponsor|616|||
147603706|NCT02704403|532365692|FG000|Overall Study|Death|4|||
147336025|NCT02709655|531396445|FG003|Double-Blind Phase (8 Weeks)|Non-compliance with study drug|6|||
147336026|NCT02709655|531396446|FG004|Double-Blind Phase (8 Weeks)|Non-compliance with study drug|1|||
147336027|NCT02709655|531396442|FG000|Double-Blind Phase (8 Weeks)|Protocol Violation|0|||
147603707|NCT02704403|532365693|FG001|Overall Study|Death|3|||
147603708|NCT02704403|532365692|FG000|Overall Study|Endpoint event|52|||
147603709|NCT02704403|532365693|FG001|Overall Study|Endpoint event|24|||
147282684|NCT00439777|531201033|FG001|Observational Period|Lost to Follow-up|11|||
147282685|NCT00439777|531201032|FG000|Observational Period|Death|27|||
147282686|NCT00439777|531201033|FG001|Observational Period|Death|20|||
147282687|NCT00439777|531201032|FG000|Observational Period|Study terminated by sponsor|3|||
147282688|NCT00439777|531201033|FG001|Observational Period|Study terminated by sponsor|1|||
147282689|NCT00439777|531201032|FG000|Observational Period|Protocol driven decision point|0|||
147282690|NCT00439777|531201033|FG001|Observational Period|Protocol driven decision point|1|||
147282691|NCT00439777|531201032|FG000|Observational Period|Lack of Efficacy|1|||
147282692|NCT00439777|531201033|FG001|Observational Period|Lack of Efficacy|0|||
147282693|NCT00439777|531201032|FG000|Observational Period|Technical problems|0|||
147282694|NCT00439777|531201033|FG001|Observational Period|Technical problems|1|||
147282695|NCT00661492|531201034|FG000|Overall Study|Adverse Event|16|||
147282696|NCT00661492|531201035|FG001|Overall Study|Adverse Event|13|||
147282697|NCT00661492|531201034|FG000|Overall Study|Disease Progression|44|||
147282698|NCT00661492|531201035|FG001|Overall Study|Disease Progression|14|||
147282699|NCT00661492|531201034|FG000|Overall Study|Patient Request|6|||
147603710|NCT02704403|532365692|FG000|Overall Study|Lost to Follow-up|22|||
147603711|NCT02704403|532365693|FG001|Overall Study|Lost to Follow-up|11|||
147603712|NCT02704403|532365692|FG000|Overall Study|Protocol Violation|15|||
147603713|NCT02704403|532365693|FG001|Overall Study|Protocol Violation|15|||
147282700|NCT00661492|531201035|FG001|Overall Study|Patient Request|1|||
147282701|NCT00661492|531201034|FG000|Overall Study|Investigator Request|1|||
147282702|NCT00661492|531201035|FG001|Overall Study|Investigator Request|0|||
147282703|NCT00661492|531201034|FG000|Overall Study|Lost to Follow-up|0|||
147603714|NCT02704403|532365692|FG000|Overall Study|Adverse Event|2|||
147603715|NCT02704403|532365693|FG001|Overall Study|Adverse Event|0|||
147603716|NCT02704403|532365692|FG000|Overall Study|Withdrawal by Subject|85|||
147603717|NCT02704403|532365693|FG001|Overall Study|Withdrawal by Subject|45|||
147603718|NCT02704403|532365692|FG000|Overall Study|Investigator decision|1|||
147603719|NCT02704403|532365693|FG001|Overall Study|Investigator decision|1|||
147603720|NCT02704403|532365692|FG000|Overall Study|Follow-up not possible|1|||
147662602|NCT02869789|532587359|FG001|Overall Study|Maximum clinical benefit|2|||
147662603|NCT02869789|532587360|FG002|Overall Study|Maximum clinical benefit|1|||
147282704|NCT00661492|531201035|FG001|Overall Study|Lost to Follow-up|1|||
147282705|NCT00661492|531201034|FG000|Overall Study|Other|1|||
147282706|NCT00661492|531201035|FG001|Overall Study|Other|0|||
147282707|NCT01024387|531201036|FG000|Overall Study|Radiographic Progression|29|||
147282708|NCT01024387|531201036|FG000|Overall Study|Symptomatic Progression|10|||
147282709|NCT01024387|531201036|FG000|Overall Study|Physician Decision|5|||
147282710|NCT01024387|531201036|FG000|Overall Study|Withdrawal by Subject|5|||
147282711|NCT01024387|531201036|FG000|Overall Study|Death|2|||
147282712|NCT01024387|531201036|FG000|Overall Study|Prolonged Treatment Delay|1|||
147282713|NCT01024387|531201036|FG000|Overall Study|Adverse Event|3|||
147282714|NCT01024387|531201036|FG000|Overall Study|Other|5|||
147282715|NCT03855189|531201037|FG000|Overall Study|Adverse Event|5|||
147282716|NCT03855189|531201038|FG001|Overall Study|Adverse Event|2|||
147282717|NCT03855189|531201039|FG002|Overall Study|Adverse Event|4|||
147282718|NCT03855189|531201037|FG000|Overall Study|Treatment Failure|1|||
147282719|NCT03855189|531201038|FG001|Overall Study|Treatment Failure|1|||
147282720|NCT03855189|531201039|FG002|Overall Study|Treatment Failure|2|||
147282721|NCT03855189|531201037|FG000|Overall Study|Noncompliance with Protocol|0|||
147282722|NCT03855189|531201038|FG001|Overall Study|Noncompliance with Protocol|1|||
147282723|NCT03855189|531201039|FG002|Overall Study|Noncompliance with Protocol|0|||
147282724|NCT03855189|531201037|FG000|Overall Study|Did Not Return|4|||
147282725|NCT03855189|531201038|FG001|Overall Study|Did Not Return|3|||
147282726|NCT03855189|531201039|FG002|Overall Study|Did Not Return|0|||
147282727|NCT06281548|531201040|FG000|Overall Study|Lost to Follow-up|3|||
147282728|NCT00586105|531201041|FG000|Overall Study|Adverse Event|4|||
147282729|NCT00586105|531201041|FG000|Overall Study|Death|2|||
147282730|NCT00586105|531201041|FG000|Overall Study|Protocol Violation|1|||
147282731|NCT00586105|531201041|FG000|Overall Study|Withdrawal by Subject|3|||
147282732|NCT00586105|531201041|FG000|Overall Study|Disease progression|19|||
147282733|NCT00586105|531201041|FG000|Overall Study|Switched to commercial drug|9|||
147282734|NCT00586105|531201041|FG000|Overall Study|Reason not reported|1|||
147282735|NCT00503685|531201044|FG000|Overall Study|Adverse Event|0|||
147282736|NCT00503685|531201045|FG001|Overall Study|Adverse Event|0|||
147282737|NCT00503685|531201046|FG002|Overall Study|Adverse Event|2|||
147282738|NCT00503685|531201044|FG000|Overall Study|Withdrawal by Subject|0|||
147336028|NCT02709655|531396443|FG001|Double-Blind Phase (8 Weeks)|Protocol Violation|1|||
147282739|NCT00503685|531201045|FG001|Overall Study|Withdrawal by Subject|1|||
147282740|NCT00503685|531201046|FG002|Overall Study|Withdrawal by Subject|0|||
147282741|NCT00503685|531201044|FG000|Overall Study|Protocol Violation|0|||
147282742|NCT00503685|531201045|FG001|Overall Study|Protocol Violation|1|||
147282743|NCT00503685|531201046|FG002|Overall Study|Protocol Violation|0|||
147603721|NCT02704403|532365693|FG001|Overall Study|Follow-up not possible|2|||
147603722|NCT01756079|532365696|FG000|Treatment / Follow-up: Week 4 to Week 72|Withdrawal by Subject|4|||
147603723|NCT01756079|532365696|FG000|Treatment / Follow-up: Week 4 to Week 72|Adverse Event|5|||
147662604|NCT02869789|532587361|FG003|Overall Study|Maximum clinical benefit|0|||
147451345|NCT01857869|531814852|FG009|Primary/Challenge Phase|Protocol Violation|0|||
147451346|NCT01857869|531814843|FG000|Primary/Challenge Phase|Other|1|||
147451347|NCT01857869|531814844|FG001|Primary/Challenge Phase|Other|1|||
147451348|NCT01857869|531814845|FG002|Primary/Challenge Phase|Other|0|||
147451349|NCT01857869|531814846|FG003|Primary/Challenge Phase|Other|0|||
147451350|NCT01857869|531814847|FG004|Primary/Challenge Phase|Other|0|||
147451351|NCT01857869|531814848|FG005|Primary/Challenge Phase|Other|0|||
147451352|NCT01857869|531814849|FG006|Primary/Challenge Phase|Other|0|||
147451353|NCT01857869|531814850|FG007|Primary/Challenge Phase|Other|0|||
147451354|NCT01857869|531814851|FG008|Primary/Challenge Phase|Other|0|||
147451355|NCT01857869|531814852|FG009|Primary/Challenge Phase|Other|0|||
147451356|NCT01857869|531814843|FG000|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
147282744|NCT00503685|531201044|FG000|Overall Study|Eligibility Criteria Not Met|0|||
147282745|NCT00503685|531201045|FG001|Overall Study|Eligibility Criteria Not Met|1|||
147282746|NCT00503685|531201046|FG002|Overall Study|Eligibility Criteria Not Met|0|||
147282747|NCT03099382|531201047|FG000|Overall Study|Protocol Violation|2|||
147282748|NCT03099382|531201048|FG001|Overall Study|Protocol Violation|3|||
147282749|NCT01802411|531201049|FG000|Overall Study|Death|2|||
147451357|NCT01857869|531814844|FG001|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
147451358|NCT01857869|531814845|FG002|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
147451359|NCT01857869|531814846|FG003|Booster/Rechallenge Phase|Withdrawal by Subject|1|||
147451360|NCT01857869|531814847|FG004|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
147451361|NCT01857869|531814848|FG005|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
147451362|NCT01857869|531814849|FG006|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
147451363|NCT01857869|531814850|FG007|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
147451364|NCT01857869|531814851|FG008|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
147451365|NCT01857869|531814852|FG009|Booster/Rechallenge Phase|Withdrawal by Subject|0|||
147451366|NCT01857869|531814843|FG000|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
147451367|NCT01857869|531814844|FG001|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
147451368|NCT01857869|531814845|FG002|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
147451369|NCT01857869|531814846|FG003|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|1|||
147451370|NCT01857869|531814847|FG004|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
147451371|NCT01857869|531814848|FG005|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
147451372|NCT01857869|531814849|FG006|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
147451373|NCT01857869|531814850|FG007|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
147451374|NCT01857869|531814851|FG008|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
147451375|NCT01857869|531814852|FG009|Booster/Rechallenge Phase|Volunteer took antibiotic pre-challenge|0|||
147451376|NCT03603496|531814864|FG000|Overall Study|Death|19|||
147451377|NCT03603496|531814865|FG001|Overall Study|Death|24|||
147451378|NCT03603496|531814864|FG000|Overall Study|Lost to Follow-up|141|||
147451379|NCT03603496|531814865|FG001|Overall Study|Lost to Follow-up|141|||
147451380|NCT03603496|531814864|FG000|Overall Study|Withdrawal by Subject|26|||
147451381|NCT03603496|531814865|FG001|Overall Study|Withdrawal by Subject|20|||
147451382|NCT03594227|531814866|FG000|Overall Study|Adverse Event|2|||
147451383|NCT03594227|531814867|FG001|Overall Study|Adverse Event|1|||
147451384|NCT03594227|531814868|FG002|Overall Study|Adverse Event|0|||
147451385|NCT03594227|531814869|FG003|Overall Study|Adverse Event|2|||
147451386|NCT03594227|531814866|FG000|Overall Study|Lost to Follow-up|1|||
147451387|NCT03594227|531814867|FG001|Overall Study|Lost to Follow-up|1|||
147451388|NCT03594227|531814868|FG002|Overall Study|Lost to Follow-up|1|||
147451389|NCT03594227|531814869|FG003|Overall Study|Lost to Follow-up|0|||
147603724|NCT01756079|532365696|FG000|Treatment / Follow-up: Week 4 to Week 72|No information available|2|||
147603725|NCT01756079|532365696|FG000|Treatment / Follow-up: Week 4 to Week 72|Lack of Efficacy|20|||
147282750|NCT01802411|531201050|FG001|Overall Study|Death|1|||
147282751|NCT01802411|531201049|FG000|Overall Study|Adverse Event|2|||
147282752|NCT01802411|531201050|FG001|Overall Study|Adverse Event|7|||
147282753|NCT01802411|531201049|FG000|Overall Study|Lack of Efficacy|8|||
147282754|NCT01802411|531201050|FG001|Overall Study|Lack of Efficacy|10|||
147282755|NCT01802411|531201049|FG000|Overall Study|Withdrawal by Subject|0|||
147282756|NCT01802411|531201050|FG001|Overall Study|Withdrawal by Subject|2|||
147282757|NCT01802411|531201049|FG000|Overall Study|Planned pleurodesis as part of the proc|1|||
147282758|NCT01802411|531201050|FG001|Overall Study|Planned pleurodesis as part of the proc|0|||
147282759|NCT01802411|531201049|FG000|Overall Study|Surgery aborted after bronchoscopy|1|||
147282760|NCT01802411|531201050|FG001|Overall Study|Surgery aborted after bronchoscopy|0|||
147282761|NCT01802411|531201049|FG000|Overall Study|Proc changed to video-asst thorascopic|0|||
147282762|NCT01802411|531201050|FG001|Overall Study|Proc changed to video-asst thorascopic|1|||
147282763|NCT01337245|531201051|FG000|Overall Study|Lost to Follow-up|1|||
147282764|NCT03930745|531201052|FG000|Overall Study|Lost to Follow-up|10|||
147282765|NCT03930745|531201053|FG001|Overall Study|Lost to Follow-up|5|||
147282766|NCT03930745|531201052|FG000|Overall Study|Withdrawal by Subject|1|||
147282767|NCT03930745|531201053|FG001|Overall Study|Withdrawal by Subject|2|||
147282768|NCT03930745|531201052|FG000|Overall Study|Protocol Violation|2|||
147282769|NCT03930745|531201053|FG001|Overall Study|Protocol Violation|2|||
147603726|NCT01756079|532365696|FG000|Treatment / Follow-up: Week 4 to Week 72|No boceprevir during Treatment Period|4|||
147603727|NCT03597529|532365697|FG000|Overall Study|Lost to Follow-up|10|||
147603728|NCT03597529|532365698|FG001|Overall Study|Lost to Follow-up|12|||
147603729|NCT03597529|532365697|FG000|Overall Study|Physician Decision|3|||
147603730|NCT03597529|532365698|FG001|Overall Study|Physician Decision|1|||
147603731|NCT03597529|532365697|FG000|Overall Study|Withdrawal by Subject|6|||
147603732|NCT03597529|532365698|FG001|Overall Study|Withdrawal by Subject|3|||
147603733|NCT03597529|532365697|FG000|Overall Study|Non-compliant with study activities|1|||
147603734|NCT03597529|532365698|FG001|Overall Study|Non-compliant with study activities|2|||
147603735|NCT04015908|532365699|FG000|Overall Study|Lost to Follow-up|0|||
147603736|NCT04015908|532365700|FG001|Overall Study|Lost to Follow-up|1|||
147603737|NCT03464630|532365703|FG000|Overall Study|Lost to Follow-up|62|||
147603738|NCT03464630|532365704|FG001|Overall Study|Lost to Follow-up|52|||
147603739|NCT03464630|532365703|FG000|Overall Study|Withdrawal by Subject|16|||
147603740|NCT03464630|532365704|FG001|Overall Study|Withdrawal by Subject|10|||
147603741|NCT03464630|532365703|FG000|Overall Study|Passive Disengagement|8|||
147603742|NCT03464630|532365704|FG001|Overall Study|Passive Disengagement|4|||
147603743|NCT00998309|532365707|FG000|Overall Study|Protocol Violation|4|||
147603744|NCT00735397|532365711|FG000|Overall Study|Adverse Event|194|||
147603745|NCT00735397|532365711|FG000|Overall Study|Lost to Follow-up|33|||
147603746|NCT00735397|532365711|FG000|Overall Study|Participant choice|252|||
147603747|NCT00735397|532365711|FG000|Overall Study|Inadequate therapeutic effect|202|||
147603748|NCT00735397|532365711|FG000|Overall Study|Administrative/Other|502|||
147603749|NCT06077149|532365712|FG000|Overall Study|Death|1|||
147603750|NCT06077149|532365713|FG001|Overall Study|Death|0|||
147603751|NCT06077149|532365712|FG000|Overall Study|Withdrawal by Subject|2|||
147603752|NCT06077149|532365713|FG001|Overall Study|Withdrawal by Subject|0|||
147603753|NCT06077149|532365712|FG000|Overall Study|RSV infection before vaccination|3|||
147603754|NCT06077149|532365713|FG001|Overall Study|RSV infection before vaccination|0|||
147603755|NCT04154631|532365715|FG000|Overall Study|Patients lost to post or 6-month follow-up|42|||
147603756|NCT04154631|532365716|FG001|Overall Study|Patients lost to post or 6-month follow-up|53|||
147603757|NCT01441947|532365717|FG000|Overall Study|Withdrawal by Subject|3|||
147603758|NCT01441947|532365718|FG001|Overall Study|Withdrawal by Subject|0|||
147603759|NCT02238795|532365719|FG000|Overall Study|Patient without purpura fulminans|1|||
147603760|NCT03384654|532365721|FG000|Overall Study|Withdrawal by Subject|0|||
147603761|NCT03384654|532365722|FG001|Overall Study|Withdrawal by Subject|0|||
147603762|NCT03384654|532365723|FG002|Overall Study|Withdrawal by Subject|1|||
147603763|NCT03384654|532365724|FG003|Overall Study|Withdrawal by Subject|0|||
147603764|NCT04159935|532365727|FG000|Overall Study|Study terminated due to COVID-19|1|||
147603765|NCT04159935|532365728|FG001|Overall Study|Study terminated due to COVID-19|3|||
147603766|NCT01341782|532365729|FG000|Overall Study|Adverse Event|1|||
147603767|NCT01341782|532365730|FG001|Overall Study|Adverse Event|1|||
147603768|NCT01341782|532365729|FG000|Overall Study|Withdrawal by Subject|6|||
147603769|NCT01341782|532365730|FG001|Overall Study|Withdrawal by Subject|5|||
147603770|NCT01341782|532365729|FG000|Overall Study|Missed 3 consecutive doses|0|||
147603771|NCT01341782|532365730|FG001|Overall Study|Missed 3 consecutive doses|4|||
147603772|NCT01341782|532365729|FG000|Overall Study|2 consecutive calcium values >11.5 mg/dL|0|||
147603773|NCT01341782|532365730|FG001|Overall Study|2 consecutive calcium values >11.5 mg/dL|1|||
147603774|NCT01341782|532365729|FG000|Overall Study|2 consecutive calcium values < 8.4 mg/dL|3|||
147603775|NCT01341782|532365730|FG001|Overall Study|2 consecutive calcium values < 8.4 mg/dL|3|||
147603776|NCT01341782|532365729|FG000|Overall Study|Other|5|||
147603777|NCT01341782|532365730|FG001|Overall Study|Other|0|||
147603778|NCT02036775|532365731|FG000|Treatment Period 2 (6 Days)|Withdrawal by Subject|0|||
147603779|NCT02036775|532365732|FG001|Treatment Period 2 (6 Days)|Withdrawal by Subject|0|||
147603780|NCT02036775|532365733|FG002|Treatment Period 2 (6 Days)|Withdrawal by Subject|0|||
147603781|NCT02036775|532365734|FG003|Treatment Period 2 (6 Days)|Withdrawal by Subject|0|||
147603782|NCT02036775|532365735|FG004|Treatment Period 2 (6 Days)|Withdrawal by Subject|0|||
147603783|NCT02036775|532365736|FG005|Treatment Period 2 (6 Days)|Withdrawal by Subject|1|||
147603784|NCT00477295|532365744|FG000|Overall Study|Adverse Event|31|||
147603785|NCT00477295|532365745|FG001|Overall Study|Adverse Event|35|||
147603786|NCT00477295|532365744|FG000|Overall Study|Withdrawal by Subject|35|||
147603787|NCT00477295|532365745|FG001|Overall Study|Withdrawal by Subject|24|||
147603788|NCT00477295|532365744|FG000|Overall Study|Lack of Efficacy|23|||
147603789|NCT00477295|532365745|FG001|Overall Study|Lack of Efficacy|23|||
147603790|NCT00477295|532365744|FG000|Overall Study|Protocol Violation|3|||
147603791|NCT00477295|532365745|FG001|Overall Study|Protocol Violation|8|||
147662605|NCT02869789|532587358|FG000|Overall Study|Poor/Non-compliance|0|||
147603792|NCT00477295|532365744|FG000|Overall Study|Physician Decision|4|||
147603793|NCT00477295|532365745|FG001|Overall Study|Physician Decision|5|||
147603794|NCT00477295|532365744|FG000|Overall Study|Lost to Follow-up|21|||
147603795|NCT00477295|532365745|FG001|Overall Study|Lost to Follow-up|11|||
147603796|NCT00477295|532365744|FG000|Overall Study|Other|4|||
147603797|NCT00477295|532365745|FG001|Overall Study|Other|3|||
147603798|NCT03276780|532365748|FG000|Overall Study|Withdrawal by Subject|5|||
147603799|NCT03276780|532365749|FG001|Overall Study|Withdrawal by Subject|3|||
147662606|NCT02869789|532587359|FG001|Overall Study|Poor/Non-compliance|2|||
147603800|NCT03276780|532365748|FG000|Overall Study|Lost to Follow-up|3|||
147603801|NCT03276780|532365749|FG001|Overall Study|Lost to Follow-up|5|||
147603802|NCT03276780|532365748|FG000|Overall Study|Moved out of state|1|||
147603803|NCT03276780|532365749|FG001|Overall Study|Moved out of state|1|||
147603804|NCT03276780|532365748|FG000|Overall Study|Already enrolled in another smoking cessation study providing NRT|1|||
147603805|NCT03276780|532365749|FG001|Overall Study|Already enrolled in another smoking cessation study providing NRT|0|||
147603806|NCT03276780|532365748|FG000|Overall Study|No show to appointments after baseline through Week 5|8|||
147603807|NCT03276780|532365749|FG001|Overall Study|No show to appointments after baseline through Week 5|1|||
147282770|NCT03930745|531201052|FG000|Overall Study|COVID-19 Shelter in Place Order|3|||
147282771|NCT03930745|531201053|FG001|Overall Study|COVID-19 Shelter in Place Order|5|||
147282772|NCT03930745|531201052|FG000|Overall Study|Adverse Event|0|||
147282773|NCT03930745|531201053|FG001|Overall Study|Adverse Event|1|||
147282774|NCT03930745|531201052|FG000|Overall Study|Pregnancy|0|||
147282775|NCT03930745|531201053|FG001|Overall Study|Pregnancy|1|||
147282776|NCT04095858|531201056|FG000|Overall Study|Death|1|||
147282777|NCT04095858|531201057|FG001|Overall Study|Death|0|||
147282778|NCT04095858|531201056|FG000|Overall Study|Study terminated by Sponsor|2|||
147603808|NCT02304458|532365750|FG000|Overall Study|Adverse Event|0|||
147603809|NCT02304458|532365751|FG001|Overall Study|Adverse Event|0|||
147603810|NCT02304458|532365752|FG002|Overall Study|Adverse Event|7|||
147603811|NCT02304458|532365753|FG003|Overall Study|Adverse Event|0|||
147603812|NCT02304458|532365754|FG004|Overall Study|Adverse Event|0|||
147603813|NCT02304458|532365755|FG005|Overall Study|Adverse Event|0|||
147603814|NCT02304458|532365756|FG006|Overall Study|Adverse Event|3|||
147603815|NCT02304458|532365757|FG007|Overall Study|Adverse Event|4|||
147603816|NCT02304458|532365750|FG000|Overall Study|Death|0|||
147603817|NCT02304458|532365751|FG001|Overall Study|Death|0|||
147603818|NCT02304458|532365752|FG002|Overall Study|Death|2|||
147603819|NCT02304458|532365753|FG003|Overall Study|Death|0|||
147282779|NCT04095858|531201057|FG001|Overall Study|Study terminated by Sponsor|4|||
147282780|NCT01344460|531201058|FG000|Overall Study|Withdrawal by Subject|1|||
147282781|NCT01344460|531201058|FG000|Overall Study|Lost to Follow-up|2|||
147282782|NCT03285477|531201059|FG000|Treatment and Response Assessment Period|Death|1|||
147282783|NCT03285477|531201060|FG001|Treatment and Response Assessment Period|Death|0|||
147282784|NCT03285477|531201059|FG000|Treatment and Response Assessment Period|Withdrawn of Consent|1|||
147282785|NCT03285477|531201060|FG001|Treatment and Response Assessment Period|Withdrawn of Consent|0|||
147282786|NCT03285477|531201059|FG000|Recurrence Follow-up Period|Lost to Follow-up|0|||
147282787|NCT03285477|531201060|FG001|Recurrence Follow-up Period|Lost to Follow-up|1|||
147282788|NCT03285477|531201059|FG000|Recurrence Follow-up Period|Withdrawal of consent|1|||
147282789|NCT03285477|531201060|FG001|Recurrence Follow-up Period|Withdrawal of consent|3|||
147282790|NCT03285477|531201059|FG000|Recurrence Follow-up Period|AK recurrence during the Recurrence Follow-Up Period|5|||
147603820|NCT02304458|532365754|FG004|Overall Study|Death|0|||
147603821|NCT02304458|532365755|FG005|Overall Study|Death|0|||
147603822|NCT02304458|532365756|FG006|Overall Study|Death|1|||
147603823|NCT02304458|532365757|FG007|Overall Study|Death|0|||
147603824|NCT02304458|532365750|FG000|Overall Study|Lack of Efficacy|4|||
147603825|NCT02304458|532365751|FG001|Overall Study|Lack of Efficacy|6|||
147603826|NCT02304458|532365752|FG002|Overall Study|Lack of Efficacy|38|||
147603827|NCT02304458|532365753|FG003|Overall Study|Lack of Efficacy|5|||
147603828|NCT02304458|532365754|FG004|Overall Study|Lack of Efficacy|6|||
147603829|NCT02304458|532365755|FG005|Overall Study|Lack of Efficacy|6|||
147603830|NCT02304458|532365756|FG006|Overall Study|Lack of Efficacy|21|||
147603831|NCT02304458|532365757|FG007|Overall Study|Lack of Efficacy|4|||
147603832|NCT02304458|532365750|FG000|Overall Study|Physician Decision|2|||
147603833|NCT02304458|532365751|FG001|Overall Study|Physician Decision|0|||
147603834|NCT02304458|532365752|FG002|Overall Study|Physician Decision|16|||
147603835|NCT02304458|532365753|FG003|Overall Study|Physician Decision|1|||
147603836|NCT02304458|532365754|FG004|Overall Study|Physician Decision|0|||
147282791|NCT03285477|531201060|FG001|Recurrence Follow-up Period|AK recurrence during the Recurrence Follow-Up Period|51|||
147282792|NCT03483623|531201073|FG000|Overall Study|43 complete sets achieved|1|||
147282793|NCT00560833|531201074|FG000|Overall Study|Adverse Event|16|||
147282794|NCT00560833|531201075|FG001|Overall Study|Adverse Event|10|||
147282795|NCT00560833|531201076|FG002|Overall Study|Adverse Event|25|||
147603837|NCT02304458|532365755|FG005|Overall Study|Physician Decision|0|||
147603838|NCT02304458|532365756|FG006|Overall Study|Physician Decision|3|||
147603839|NCT02304458|532365757|FG007|Overall Study|Physician Decision|0|||
147603840|NCT02304458|532365750|FG000|Overall Study|Protocol Violation|0|||
147282796|NCT00560833|531201077|FG003|Overall Study|Adverse Event|23|||
147282797|NCT00560833|531201078|FG004|Overall Study|Adverse Event|35|||
147603841|NCT02304458|532365751|FG001|Overall Study|Protocol Violation|0|||
147603842|NCT02304458|532365752|FG002|Overall Study|Protocol Violation|1|||
147603843|NCT02304458|532365753|FG003|Overall Study|Protocol Violation|0|||
147603844|NCT02304458|532365754|FG004|Overall Study|Protocol Violation|0|||
147603845|NCT02304458|532365755|FG005|Overall Study|Protocol Violation|0|||
147603846|NCT02304458|532365756|FG006|Overall Study|Protocol Violation|0|||
147603847|NCT02304458|532365757|FG007|Overall Study|Protocol Violation|0|||
147603848|NCT02304458|532365750|FG000|Overall Study|Withdrawal by Subject|1|||
147662607|NCT02869789|532587360|FG002|Overall Study|Poor/Non-compliance|1|||
147662608|NCT02869789|532587361|FG003|Overall Study|Poor/Non-compliance|0|||
147662609|NCT02869789|532587358|FG000|Overall Study|Participant no longer meets study criteria|0|||
147662610|NCT02869789|532587359|FG001|Overall Study|Participant no longer meets study criteria|1|||
147662611|NCT02869789|532587360|FG002|Overall Study|Participant no longer meets study criteria|1|||
147662612|NCT02869789|532587361|FG003|Overall Study|Participant no longer meets study criteria|0|||
147662613|NCT02869789|532587358|FG000|Overall Study|Administrative reason by sponsor|0|||
147282798|NCT00560833|531201074|FG000|Overall Study|Lost to Follow-up|0|||
147282799|NCT00560833|531201075|FG001|Overall Study|Lost to Follow-up|0|||
147282800|NCT00560833|531201076|FG002|Overall Study|Lost to Follow-up|1|||
147282801|NCT00560833|531201077|FG003|Overall Study|Lost to Follow-up|0|||
147282802|NCT00560833|531201078|FG004|Overall Study|Lost to Follow-up|0|||
147282803|NCT00560833|531201074|FG000|Overall Study|Lack of Efficacy|22|||
147282804|NCT00560833|531201075|FG001|Overall Study|Lack of Efficacy|9|||
147282805|NCT00560833|531201076|FG002|Overall Study|Lack of Efficacy|6|||
147282806|NCT00560833|531201077|FG003|Overall Study|Lack of Efficacy|4|||
147282807|NCT00560833|531201078|FG004|Overall Study|Lack of Efficacy|4|||
147282808|NCT00560833|531201074|FG000|Overall Study|Participant uncooperative|5|||
147282809|NCT00560833|531201075|FG001|Overall Study|Participant uncooperative|5|||
147282810|NCT00560833|531201076|FG002|Overall Study|Participant uncooperative|4|||
147282811|NCT00560833|531201077|FG003|Overall Study|Participant uncooperative|4|||
147282812|NCT00560833|531201078|FG004|Overall Study|Participant uncooperative|2|||
147282813|NCT00560833|531201074|FG000|Overall Study|Other|1|||
147282814|NCT00560833|531201075|FG001|Overall Study|Other|1|||
147282815|NCT00560833|531201076|FG002|Overall Study|Other|3|||
147282816|NCT00560833|531201077|FG003|Overall Study|Other|0|||
147282817|NCT00560833|531201078|FG004|Overall Study|Other|0|||
147282818|NCT00560833|531201074|FG000|Overall Study|Never received drug|0|||
147282819|NCT00560833|531201075|FG001|Overall Study|Never received drug|1|||
147282820|NCT00560833|531201076|FG002|Overall Study|Never received drug|0|||
147282821|NCT00560833|531201077|FG003|Overall Study|Never received drug|0|||
147282822|NCT00560833|531201078|FG004|Overall Study|Never received drug|1|||
147282823|NCT01059617|531201081|FG000|Overall Study|Other|7|||
147282824|NCT01059617|531201082|FG001|Overall Study|Other|1|||
147282825|NCT01059617|531201083|FG002|Overall Study|Other|8|||
147282826|NCT01059617|531201084|FG003|Overall Study|Other|6|||
147282827|NCT00852397|531201086|FG000|Overall Study|Adverse Event|4|||
147282828|NCT00852397|531201087|FG001|Overall Study|Adverse Event|6|||
147282829|NCT00852397|531201088|FG002|Overall Study|Adverse Event|4|||
147282830|NCT00852397|531201086|FG000|Overall Study|Death|0|||
147282831|NCT00852397|531201087|FG001|Overall Study|Death|0|||
147282832|NCT00852397|531201088|FG002|Overall Study|Death|1|||
147282833|NCT00852397|531201086|FG000|Overall Study|Withdrawal by Subject|4|||
147282834|NCT00852397|531201087|FG001|Overall Study|Withdrawal by Subject|1|||
147282835|NCT00852397|531201088|FG002|Overall Study|Withdrawal by Subject|2|||
147282836|NCT00852397|531201086|FG000|Overall Study|Study terminated by sponsor|2|||
147282837|NCT00852397|531201087|FG001|Overall Study|Study terminated by sponsor|1|||
147282838|NCT00852397|531201088|FG002|Overall Study|Study terminated by sponsor|6|||
147282839|NCT00852397|531201086|FG000|Overall Study|Difficulty in study site visit|1|||
147282840|NCT00852397|531201087|FG001|Overall Study|Difficulty in study site visit|0|||
147282841|NCT00852397|531201088|FG002|Overall Study|Difficulty in study site visit|0|||
147282842|NCT00852397|531201086|FG000|Overall Study|Protocol Violation|0|||
147282843|NCT00852397|531201087|FG001|Overall Study|Protocol Violation|0|||
147282844|NCT00852397|531201088|FG002|Overall Study|Protocol Violation|1|||
147282845|NCT03864614|531201094|FG000|Overall Study|Participant Did Not Meet 50% Reduction in HAMD-17|116|||
147282846|NCT03864614|531201095|FG001|Overall Study|Participant Did Not Meet 50% Reduction in HAMD-17|173|||
147282847|NCT03864614|531201096|FG002|Overall Study|Participant Did Not Meet 50% Reduction in HAMD-17|0|||
147282848|NCT03864614|531201097|FG003|Overall Study|Participant Did Not Meet 50% Reduction in HAMD-17|0|||
147282849|NCT03864614|531201094|FG000|Overall Study|Withdrawal by Subject|72|||
147282850|NCT03864614|531201095|FG001|Overall Study|Withdrawal by Subject|100|||
147282851|NCT03864614|531201096|FG002|Overall Study|Withdrawal by Subject|1|||
147282852|NCT03864614|531201097|FG003|Overall Study|Withdrawal by Subject|21|||
147282853|NCT03864614|531201094|FG000|Overall Study|Lost to Follow-up|45|||
147282854|NCT03864614|531201095|FG001|Overall Study|Lost to Follow-up|54|||
147662614|NCT02869789|532587359|FG001|Overall Study|Administrative reason by sponsor|0|||
147282855|NCT03864614|531201096|FG002|Overall Study|Lost to Follow-up|0|||
147282856|NCT03864614|531201097|FG003|Overall Study|Lost to Follow-up|9|||
147282857|NCT03864614|531201094|FG000|Overall Study|Adverse Event|42|||
147282858|NCT03864614|531201095|FG001|Overall Study|Adverse Event|30|||
147282859|NCT03864614|531201096|FG002|Overall Study|Adverse Event|1|||
147282860|NCT03864614|531201097|FG003|Overall Study|Adverse Event|9|||
147662615|NCT02869789|532587360|FG002|Overall Study|Administrative reason by sponsor|1|||
147662616|NCT02869789|532587361|FG003|Overall Study|Administrative reason by sponsor|0|||
147282861|NCT03864614|531201094|FG000|Overall Study|Protocol Deviation|6|||
147282862|NCT03864614|531201095|FG001|Overall Study|Protocol Deviation|26|||
147282863|NCT03864614|531201096|FG002|Overall Study|Protocol Deviation|0|||
147282864|NCT03864614|531201097|FG003|Overall Study|Protocol Deviation|1|||
147662617|NCT02869789|532587358|FG000|Overall Study|Other reasons|4|||
147603849|NCT02304458|532365751|FG001|Overall Study|Withdrawal by Subject|0|||
147603850|NCT02304458|532365752|FG002|Overall Study|Withdrawal by Subject|7|||
147603851|NCT02304458|532365753|FG003|Overall Study|Withdrawal by Subject|0|||
147603852|NCT02304458|532365754|FG004|Overall Study|Withdrawal by Subject|0|||
147603853|NCT02304458|532365755|FG005|Overall Study|Withdrawal by Subject|0|||
147603854|NCT02304458|532365756|FG006|Overall Study|Withdrawal by Subject|1|||
147603855|NCT02304458|532365757|FG007|Overall Study|Withdrawal by Subject|0|||
147603856|NCT00390221|532365758|FG000|Overall Study|Lost to Follow-up|0|||
147603857|NCT00390221|532365759|FG001|Overall Study|Lost to Follow-up|3|||
147603858|NCT00390221|532365760|FG002|Overall Study|Lost to Follow-up|0|||
147603859|NCT00390221|532365758|FG000|Overall Study|Adverse Event|1|||
147603860|NCT00390221|532365759|FG001|Overall Study|Adverse Event|4|||
147603861|NCT00390221|532365760|FG002|Overall Study|Adverse Event|3|||
147603862|NCT00390221|532365758|FG000|Overall Study|Investigator Decision|0|||
147603863|NCT00390221|532365759|FG001|Overall Study|Investigator Decision|0|||
147603864|NCT00390221|532365760|FG002|Overall Study|Investigator Decision|1|||
147603865|NCT00390221|532365758|FG000|Overall Study|Withdrawal by Subject|13|||
147603866|NCT00390221|532365759|FG001|Overall Study|Withdrawal by Subject|9|||
147603867|NCT00390221|532365760|FG002|Overall Study|Withdrawal by Subject|7|||
147603868|NCT00390221|532365758|FG000|Overall Study|Subject Non-compliance|1|||
147603869|NCT00390221|532365759|FG001|Overall Study|Subject Non-compliance|0|||
147603870|NCT00390221|532365760|FG002|Overall Study|Subject Non-compliance|2|||
147603871|NCT00390221|532365758|FG000|Overall Study|Other|3|||
147603872|NCT00390221|532365759|FG001|Overall Study|Other|4|||
147603873|NCT00390221|532365760|FG002|Overall Study|Other|2|||
147603874|NCT03582826|532365765|FG000|Overall Study|Lost to Follow-up|39|||
147603875|NCT03582826|532365766|FG001|Overall Study|Lost to Follow-up|0|||
147603876|NCT03582826|532365765|FG000|Overall Study|Withdrawal by Subject|2|||
147603877|NCT03582826|532365766|FG001|Overall Study|Withdrawal by Subject|0|||
147603878|NCT01565850|532365769|FG000|Overall Study|Adverse Event|0|||
147282865|NCT03864614|531201094|FG000|Overall Study|Physician Decision|7|||
147282866|NCT03864614|531201095|FG001|Overall Study|Physician Decision|10|||
147282867|NCT03864614|531201096|FG002|Overall Study|Physician Decision|1|||
147282868|NCT03864614|531201097|FG003|Overall Study|Physician Decision|5|||
147282869|NCT03864614|531201094|FG000|Overall Study|Non-compliance With Investigational Drug|4|||
147282870|NCT03864614|531201095|FG001|Overall Study|Non-compliance With Investigational Drug|4|||
147282871|NCT03864614|531201096|FG002|Overall Study|Non-compliance With Investigational Drug|0|||
147282872|NCT03864614|531201097|FG003|Overall Study|Non-compliance With Investigational Drug|0|||
147282873|NCT03864614|531201094|FG000|Overall Study|Sponsor Decision|1|||
147282874|NCT03864614|531201095|FG001|Overall Study|Sponsor Decision|2|||
147282875|NCT03864614|531201096|FG002|Overall Study|Sponsor Decision|0|||
147282876|NCT03864614|531201097|FG003|Overall Study|Sponsor Decision|0|||
147282877|NCT03864614|531201094|FG000|Overall Study|Pregnancy|0|||
147282878|NCT03864614|531201095|FG001|Overall Study|Pregnancy|1|||
147282879|NCT03864614|531201096|FG002|Overall Study|Pregnancy|0|||
147282880|NCT03864614|531201097|FG003|Overall Study|Pregnancy|0|||
147282881|NCT03864614|531201094|FG000|Overall Study|Other|7|||
147282882|NCT03864614|531201095|FG001|Overall Study|Other|9|||
147282883|NCT03864614|531201096|FG002|Overall Study|Other|1|||
147282884|NCT03864614|531201097|FG003|Overall Study|Other|4|||
147282885|NCT03864614|531201094|FG000|Overall Study|Enrolled but did not receive SAGE-217|0|||
147282886|NCT03864614|531201095|FG001|Overall Study|Enrolled but did not receive SAGE-217|0|||
147282887|NCT03864614|531201096|FG002|Overall Study|Enrolled but did not receive SAGE-217|0|||
147282888|NCT03864614|531201097|FG003|Overall Study|Enrolled but did not receive SAGE-217|159|||
147282889|NCT00136955|531202749|FG000|Overall Study|Adverse Event|8|||
147282890|NCT00136955|531202749|FG000|Overall Study|Lost to Follow-up|1|||
147282891|NCT00136955|531202749|FG000|Overall Study|Withdrawal by Subject|2|||
147282892|NCT00136955|531202749|FG000|Overall Study|Incl. prog. disease, protocol violation|12|||
147282893|NCT02239510|531202750|FG000|Overall Study|Lost to Follow-up|2|||
147282894|NCT02239510|531202751|FG001|Overall Study|Lost to Follow-up|1|||
147282895|NCT00074282|531202754|FG000|Step 1|Adverse Event|32|||
147282896|NCT00074282|531202755|FG001|Step 1|Adverse Event|0|||
147282897|NCT00074282|531202756|FG002|Step 1|Adverse Event|0|||
147282898|NCT00074282|531202754|FG000|Step 1|Death|6|||
147282899|NCT00074282|531202755|FG001|Step 1|Death|0|||
147282900|NCT00074282|531202756|FG002|Step 1|Death|0|||
147282901|NCT00074282|531202754|FG000|Step 1|Withdrawal by Subject|7|||
147282902|NCT00074282|531202755|FG001|Step 1|Withdrawal by Subject|0|||
147282903|NCT00074282|531202756|FG002|Step 1|Withdrawal by Subject|0|||
147282904|NCT00074282|531202754|FG000|Step 1|Disease progression|2|||
147282905|NCT00074282|531202755|FG001|Step 1|Disease progression|0|||
147603879|NCT01565850|532365770|FG001|Overall Study|Adverse Event|1|||
147603880|NCT01565850|532365769|FG000|Overall Study|Lost to Follow-up|12|||
147603881|NCT01565850|532365770|FG001|Overall Study|Lost to Follow-up|4|||
147603882|NCT01565850|532365769|FG000|Overall Study|Investigator's Discretion|2|||
147603883|NCT01565850|532365770|FG001|Overall Study|Investigator's Discretion|1|||
147603884|NCT01565850|532365769|FG000|Overall Study|Participant noncompliance|2|||
147603885|NCT01565850|532365770|FG001|Overall Study|Participant noncompliance|0|||
147603886|NCT01565850|532365769|FG000|Overall Study|Withdrew Consent|4|||
147336029|NCT02709655|531396444|FG002|Double-Blind Phase (8 Weeks)|Protocol Violation|0|||
147336030|NCT02709655|531396445|FG003|Double-Blind Phase (8 Weeks)|Protocol Violation|0|||
147336031|NCT02709655|531396446|FG004|Double-Blind Phase (8 Weeks)|Protocol Violation|0|||
147336032|NCT02709655|531396442|FG000|Double-Blind Phase (8 Weeks)|Withdrawal by Subject|0|||
147336033|NCT02709655|531396443|FG001|Double-Blind Phase (8 Weeks)|Withdrawal by Subject|4|||
147336034|NCT02709655|531396444|FG002|Double-Blind Phase (8 Weeks)|Withdrawal by Subject|4|||
147603887|NCT01565850|532365770|FG001|Overall Study|Withdrew Consent|2|||
147603888|NCT05323123|532365771|FG000|Overall Study|Withdrawal by Subject|2|||
147603889|NCT05323123|532365772|FG001|Overall Study|Withdrawal by Subject|1|||
147603890|NCT05323123|532365771|FG000|Overall Study|Lost to Follow-up|4|||
147603891|NCT05323123|532365772|FG001|Overall Study|Lost to Follow-up|2|||
147603892|NCT05323123|532365771|FG000|Overall Study|Removed by research staff due to no longer fulfilling eligibility requirements|1|||
147603893|NCT05323123|532365772|FG001|Overall Study|Removed by research staff due to no longer fulfilling eligibility requirements|0|||
147603894|NCT05529472|532365773|FG000|Overall Study|Withdrawal by Subject|1|||
147603895|NCT05529472|532365774|FG001|Overall Study|Withdrawal by Subject|1|||
147603896|NCT03589768|532367746|FG000|Overall Study|Death|1|||
147603897|NCT03589768|532367747|FG001|Overall Study|Death|0|||
147603898|NCT03589768|532367748|FG002|Overall Study|Death|8|||
147603899|NCT03589768|532367749|FG003|Overall Study|Death|3|||
147603900|NCT03589768|532367746|FG000|Overall Study|Withdrawal by Subject|2|||
147603901|NCT03589768|532367747|FG001|Overall Study|Withdrawal by Subject|0|||
147603902|NCT03589768|532367748|FG002|Overall Study|Withdrawal by Subject|0|||
147603903|NCT03589768|532367749|FG003|Overall Study|Withdrawal by Subject|0|||
147603904|NCT03589768|532367746|FG000|Overall Study|Protocol Violation|1|||
147603905|NCT03589768|532367747|FG001|Overall Study|Protocol Violation|0|||
147603906|NCT03589768|532367748|FG002|Overall Study|Protocol Violation|0|||
147603907|NCT03589768|532367749|FG003|Overall Study|Protocol Violation|0|||
147603908|NCT03047330|532367750|FG000|Sleep Block 1|Withdrawal by Subject|3|||
147603909|NCT00000378|532367751|FG000|Overall Study|Lack of Efficacy|16|||
147603910|NCT00000378|532367752|FG001|Overall Study|Lack of Efficacy|14|||
147603911|NCT00663026|532367765|FG000|Overall Study|Lost to Follow-up|1|||
147603912|NCT00663026|532367766|FG001|Overall Study|Lost to Follow-up|0|||
147603913|NCT00663026|532367767|FG002|Overall Study|Lost to Follow-up|0|||
147603914|NCT00663026|532367765|FG000|Overall Study|Other|1|||
147603915|NCT00663026|532367766|FG001|Overall Study|Other|2|||
147603916|NCT00663026|532367767|FG002|Overall Study|Other|0|||
147603917|NCT00663026|532367765|FG000|Overall Study|Adverse Event|0|||
147603918|NCT00663026|532367766|FG001|Overall Study|Adverse Event|2|||
147603919|NCT00663026|532367767|FG002|Overall Study|Adverse Event|3|||
147603920|NCT00663026|532367765|FG000|Overall Study|Caregiver Request|0|||
147603921|NCT00663026|532367766|FG001|Overall Study|Caregiver Request|2|||
147603922|NCT00663026|532367767|FG002|Overall Study|Caregiver Request|0|||
147603923|NCT00663026|532367765|FG000|Overall Study|Withdrawal by Subject|0|||
147603924|NCT00663026|532367766|FG001|Overall Study|Withdrawal by Subject|0|||
147603925|NCT00663026|532367767|FG002|Overall Study|Withdrawal by Subject|1|||
147603926|NCT03783039|532367778|FG000|Overall Study|Death|2|||
147603927|NCT03783039|532367779|FG001|Overall Study|Death|1|||
147603928|NCT00918138|532367780|FG000|Overall Study|Subject withdrew consent|1|||
147603929|NCT00918138|532367781|FG001|Overall Study|Subject withdrew consent|1|||
147603930|NCT00918138|532367780|FG000|Overall Study|Death|1|||
147603931|NCT00918138|532367781|FG001|Overall Study|Death|0|||
147603932|NCT03972163|532367782|FG000|Overall Study|Death|0|||
147603933|NCT03972163|532367783|FG001|Overall Study|Death|1|||
147603934|NCT02315196|532367784|FG000|Overall Study|Withdrew consent|9|||
147603935|NCT03400943|532367785|FG000|Treatment Period 1|Adverse Event|0|||
147603936|NCT03400943|532367786|FG001|Treatment Period 1|Adverse Event|0|||
147603937|NCT03400943|532367787|FG002|Treatment Period 1|Adverse Event|0|||
147603938|NCT03400943|532367788|FG003|Treatment Period 1|Adverse Event|1|||
147603939|NCT03400943|532367785|FG000|Treatment Period 1|Lost to Follow-up|1|||
147603940|NCT03400943|532367786|FG001|Treatment Period 1|Lost to Follow-up|0|||
147603941|NCT03400943|532367787|FG002|Treatment Period 1|Lost to Follow-up|0|||
147603942|NCT03400943|532367788|FG003|Treatment Period 1|Lost to Follow-up|0|||
147603943|NCT03400943|532367785|FG000|Treatment Period 1|Protocol Violation|0|||
147603944|NCT03400943|532367786|FG001|Treatment Period 1|Protocol Violation|1|||
147603945|NCT03400943|532367787|FG002|Treatment Period 1|Protocol Violation|1|||
147603946|NCT03400943|532367788|FG003|Treatment Period 1|Protocol Violation|0|||
147603947|NCT03400943|532367785|FG000|Treatment Period 1|Study terminated by sponsor|2|||
147603948|NCT03400943|532367786|FG001|Treatment Period 1|Study terminated by sponsor|0|||
147662618|NCT02869789|532587359|FG001|Overall Study|Other reasons|8|||
147603949|NCT03400943|532367787|FG002|Treatment Period 1|Study terminated by sponsor|0|||
147603950|NCT03400943|532367788|FG003|Treatment Period 1|Study terminated by sponsor|1|||
147603951|NCT03400943|532367785|FG000|Treatment Period 1|Withdrawal by Subject|0|||
147603952|NCT03400943|532367786|FG001|Treatment Period 1|Withdrawal by Subject|0|||
147603953|NCT03400943|532367787|FG002|Treatment Period 1|Withdrawal by Subject|3|||
147603954|NCT03400943|532367788|FG003|Treatment Period 1|Withdrawal by Subject|1|||
147603955|NCT03400943|532367785|FG000|Treatment Period 1|Other|2|||
147603956|NCT03400943|532367786|FG001|Treatment Period 1|Other|1|||
147282906|NCT00074282|531202756|FG002|Step 1|Disease progression|0|||
147282907|NCT00074282|531202754|FG000|Step 1|Alternative therapy|2|||
147282908|NCT00074282|531202755|FG001|Step 1|Alternative therapy|0|||
147282909|NCT00074282|531202756|FG002|Step 1|Alternative therapy|0|||
147282910|NCT00074282|531202754|FG000|Step 1|Other complicating disease|2|||
147282911|NCT00074282|531202755|FG001|Step 1|Other complicating disease|0|||
147282912|NCT00074282|531202756|FG002|Step 1|Other complicating disease|0|||
147282913|NCT00074282|531202754|FG000|Step 1|Physician Decision|1|||
147282914|NCT00074282|531202755|FG001|Step 1|Physician Decision|0|||
147282915|NCT00074282|531202756|FG002|Step 1|Physician Decision|0|||
147282916|NCT00074282|531202754|FG000|Step 1|Ineligible|4|||
147282917|NCT00074282|531202755|FG001|Step 1|Ineligible|0|||
147282918|NCT00074282|531202756|FG002|Step 1|Ineligible|0|||
147282919|NCT00074282|531202754|FG000|Step 1|Never started treatment|2|||
147282920|NCT00074282|531202755|FG001|Step 1|Never started treatment|0|||
147282921|NCT00074282|531202756|FG002|Step 1|Never started treatment|0|||
147336035|NCT02709655|531396445|FG003|Double-Blind Phase (8 Weeks)|Withdrawal by Subject|4|||
147336036|NCT02709655|531396446|FG004|Double-Blind Phase (8 Weeks)|Withdrawal by Subject|1|||
147336037|NCT02709655|531396442|FG000|Double-Blind Phase (8 Weeks)|Lost to Follow-up|0|||
147336038|NCT02709655|531396443|FG001|Double-Blind Phase (8 Weeks)|Lost to Follow-up|1|||
147336039|NCT02709655|531396444|FG002|Double-Blind Phase (8 Weeks)|Lost to Follow-up|0|||
147336040|NCT02709655|531396445|FG003|Double-Blind Phase (8 Weeks)|Lost to Follow-up|2|||
147336041|NCT02709655|531396446|FG004|Double-Blind Phase (8 Weeks)|Lost to Follow-up|0|||
147336042|NCT02709655|531396442|FG000|Double-Blind Phase (8 Weeks)|Other than specified|0|||
147336043|NCT02709655|531396443|FG001|Double-Blind Phase (8 Weeks)|Other than specified|5|||
147336044|NCT02709655|531396444|FG002|Double-Blind Phase (8 Weeks)|Other than specified|7|||
147336045|NCT02709655|531396445|FG003|Double-Blind Phase (8 Weeks)|Other than specified|5|||
147336046|NCT02709655|531396446|FG004|Double-Blind Phase (8 Weeks)|Other than specified|2|||
147336047|NCT02248480|531396447|FG000|Overall Study|Lack of Efficacy|4|||
147336048|NCT02248480|531396448|FG001|Overall Study|Lack of Efficacy|6|||
147336049|NCT02248480|531396447|FG000|Overall Study|Adverse Event|11|||
147336050|NCT02248480|531396448|FG001|Overall Study|Adverse Event|2|||
147336051|NCT02248480|531396447|FG000|Overall Study|Withdrawal by Subject|2|||
147336052|NCT02248480|531396448|FG001|Overall Study|Withdrawal by Subject|4|||
147336053|NCT02248480|531396447|FG000|Overall Study|Entry Criteria Not Met|0|||
147336054|NCT02248480|531396448|FG001|Overall Study|Entry Criteria Not Met|1|||
147336055|NCT02248480|531396447|FG000|Overall Study|Other:Physician Decision|0|||
147336056|NCT02248480|531396448|FG001|Overall Study|Other:Physician Decision|1|||
147336057|NCT04795752|531396449|FG000|Primary Endpoint Phase|Withdrawal by Subject|7|||
147336058|NCT04795752|531396450|FG001|Primary Endpoint Phase|Withdrawal by Subject|7|||
147336059|NCT04795752|531396449|FG000|Primary Endpoint Phase|Lost to Follow-up|3|||
147336060|NCT04795752|531396450|FG001|Primary Endpoint Phase|Lost to Follow-up|2|||
147336061|NCT04795752|531396449|FG000|Primary Endpoint Phase|Physician Decision|2|||
147336062|NCT04795752|531396450|FG001|Primary Endpoint Phase|Physician Decision|0|||
147336063|NCT04795752|531396449|FG000|Primary Endpoint Phase|Other|4|||
147336064|NCT04795752|531396450|FG001|Primary Endpoint Phase|Other|1|||
147336065|NCT04795752|531396449|FG000|Primary Endpoint Phase|Protocol Violation|1|||
147336066|NCT04795752|531396450|FG001|Primary Endpoint Phase|Protocol Violation|0|||
147336067|NCT04795752|531396449|FG000|X-over-Restasis arm; Durability-TC arm|Lost to Follow-up|7|||
147336068|NCT04795752|531396450|FG001|X-over-Restasis arm; Durability-TC arm|Lost to Follow-up|0|||
147336069|NCT04795752|531396449|FG000|X-over-Restasis arm; Durability-TC arm|Withdrawal by Subject|1|||
147282922|NCT00074282|531202754|FG000|Step 2|Adverse Event|0|||
147336070|NCT04795752|531396450|FG001|X-over-Restasis arm; Durability-TC arm|Withdrawal by Subject|1|||
147336071|NCT04795752|531396449|FG000|X-over-Restasis arm; Durability-TC arm|Physician Decision|1|||
147282923|NCT00074282|531202755|FG001|Step 2|Adverse Event|2|||
147282924|NCT00074282|531202756|FG002|Step 2|Adverse Event|12|||
147282925|NCT00074282|531202754|FG000|Step 2|Disease progression|0|||
147282926|NCT00074282|531202755|FG001|Step 2|Disease progression|0|||
147282927|NCT00074282|531202756|FG002|Step 2|Disease progression|5|||
147336072|NCT04795752|531396450|FG001|X-over-Restasis arm; Durability-TC arm|Physician Decision|0|||
147336073|NCT04795752|531396449|FG000|X-over-Restasis arm; Durability-TC arm|Death|1|||
147336074|NCT04795752|531396450|FG001|X-over-Restasis arm; Durability-TC arm|Death|0|||
147336075|NCT04795752|531396449|FG000|X-over-Restasis arm; Durability-TC arm|Other|3|||
147603957|NCT03400943|532367787|FG002|Treatment Period 1|Other|2|||
147282928|NCT00074282|531202754|FG000|Step 2|Death|0|||
147282929|NCT00074282|531202755|FG001|Step 2|Death|0|||
147282930|NCT00074282|531202756|FG002|Step 2|Death|3|||
147336076|NCT04795752|531396450|FG001|X-over-Restasis arm; Durability-TC arm|Other|1|||
147336077|NCT06218251|531396453|FG000|Overall Study|Lost to Follow-up|4|||
147336078|NCT05797155|531396454|FG000|Overall Study|Lost to Follow-up|33|||
147336079|NCT05797155|531396455|FG001|Overall Study|Lost to Follow-up|12|||
147282931|NCT00074282|531202754|FG000|Step 2|Withdrawal by Subject|0|||
147282932|NCT00074282|531202755|FG001|Step 2|Withdrawal by Subject|0|||
147282933|NCT00074282|531202756|FG002|Step 2|Withdrawal by Subject|2|||
147282934|NCT00074282|531202754|FG000|Step 2|Physician Decision|0|||
147282935|NCT00074282|531202755|FG001|Step 2|Physician Decision|0|||
147282936|NCT00074282|531202756|FG002|Step 2|Physician Decision|1|||
147662619|NCT02869789|532587360|FG002|Overall Study|Other reasons|6|||
147336080|NCT00026312|531396456|FG000|Overall Study|Adverse Event|0|||
147336081|NCT00026312|531396457|FG001|Overall Study|Adverse Event|32|||
147336082|NCT00026312|531396456|FG000|Overall Study|Death|1|||
147336083|NCT00026312|531396457|FG001|Overall Study|Death|7|||
147336084|NCT00026312|531396456|FG000|Overall Study|Lack of Efficacy|19|||
147336085|NCT00026312|531396457|FG001|Overall Study|Lack of Efficacy|114|||
147336086|NCT00026312|531396456|FG000|Overall Study|Lost to Follow-up|0|||
147336087|NCT00026312|531396457|FG001|Overall Study|Lost to Follow-up|5|||
147336088|NCT00026312|531396456|FG000|Overall Study|Physician Decision|1|||
147336089|NCT00026312|531396457|FG001|Overall Study|Physician Decision|37|||
147336090|NCT00026312|531396456|FG000|Overall Study|Protocol Violation|0|||
147336091|NCT00026312|531396457|FG001|Overall Study|Protocol Violation|3|||
147336092|NCT00026312|531396456|FG000|Overall Study|Withdrawal by Subject|1|||
147336093|NCT00026312|531396457|FG001|Overall Study|Withdrawal by Subject|6|||
147336094|NCT00026312|531396456|FG000|Overall Study|Ineligible|4|||
147336095|NCT00026312|531396457|FG001|Overall Study|Ineligible|5|||
147336096|NCT00026312|531396456|FG000|Overall Study|Entry onto another COG study|0|||
147336097|NCT00026312|531396457|FG001|Overall Study|Entry onto another COG study|1|||
147336098|NCT00026312|531396456|FG000|Overall Study|Refusal by patient/parent/guardian|8|||
147336099|NCT00026312|531396457|FG001|Overall Study|Refusal by patient/parent/guardian|59|||
147336100|NCT02445391|531396458|FG000|Overall Study|No active protocol treatment|3|||
147336101|NCT02445391|531396459|FG001|Overall Study|No active protocol treatment|0|||
147336102|NCT02445391|531396460|FG002|Overall Study|No active protocol treatment|0|||
147336103|NCT02445391|531396458|FG000|Overall Study|Adverse Event|0|||
147336104|NCT02445391|531396459|FG001|Overall Study|Adverse Event|21|||
147336105|NCT02445391|531396460|FG002|Overall Study|Adverse Event|12|||
147336106|NCT02445391|531396458|FG000|Overall Study|Alternative therapy|0|||
147336107|NCT02445391|531396459|FG001|Overall Study|Alternative therapy|0|||
147336108|NCT02445391|531396460|FG002|Overall Study|Alternative therapy|1|||
147336109|NCT02445391|531396458|FG000|Overall Study|Disease progression|0|||
147336110|NCT02445391|531396459|FG001|Overall Study|Disease progression|7|||
147336111|NCT02445391|531396460|FG002|Overall Study|Disease progression|22|||
147336112|NCT02445391|531396458|FG000|Overall Study|Complicating disease|0|||
147336113|NCT02445391|531396459|FG001|Overall Study|Complicating disease|2|||
147336114|NCT02445391|531396460|FG002|Overall Study|Complicating disease|1|||
147336115|NCT02445391|531396458|FG000|Overall Study|Withdrawal by Subject|0|||
147336116|NCT02445391|531396459|FG001|Overall Study|Withdrawal by Subject|4|||
147336117|NCT02445391|531396460|FG002|Overall Study|Withdrawal by Subject|9|||
147336118|NCT02445391|531396458|FG000|Overall Study|Financial issue|0|||
147336119|NCT02445391|531396459|FG001|Overall Study|Financial issue|0|||
147282937|NCT00074282|531202754|FG000|Step 2|Ineligible|0|||
147282938|NCT00074282|531202755|FG001|Step 2|Ineligible|0|||
147282939|NCT00074282|531202756|FG002|Step 2|Ineligible|1|||
147282940|NCT00464542|531202757|FG000|Pre-treatment|Withdrawal by Subject|2|||
147282941|NCT03859323|531202759|FG000|Overall Study|Lost to Follow-up|0|||
147282942|NCT03859323|531202760|FG001|Overall Study|Lost to Follow-up|0|||
147282943|NCT03859323|531202761|FG002|Overall Study|Lost to Follow-up|0|||
147282944|NCT03859323|531202762|FG003|Overall Study|Lost to Follow-up|0|||
147282945|NCT03859323|531202763|FG004|Overall Study|Lost to Follow-up|0|||
147282946|NCT03859323|531202764|FG005|Overall Study|Lost to Follow-up|0|||
147282947|NCT03859323|531202765|FG006|Overall Study|Lost to Follow-up|1|||
147282948|NCT03859323|531202766|FG007|Overall Study|Lost to Follow-up|0|||
147282949|NCT03859323|531202767|FG008|Overall Study|Lost to Follow-up|0|||
147282950|NCT03859323|531202768|FG009|Overall Study|Lost to Follow-up|0|||
147282951|NCT03859323|531202769|FG010|Overall Study|Lost to Follow-up|0|||
147336120|NCT02445391|531396460|FG002|Overall Study|Financial issue|2|||
147282952|NCT03859323|531202770|FG011|Overall Study|Lost to Follow-up|0|||
147336121|NCT02445391|531396458|FG000|Overall Study|Still on treatment|0|||
147336122|NCT02445391|531396459|FG001|Overall Study|Still on treatment|7|||
147336123|NCT02445391|531396460|FG002|Overall Study|Still on treatment|16|||
147336124|NCT02445391|531396458|FG000|Overall Study|Not start protocol therapy|0|||
147336125|NCT02445391|531396459|FG001|Overall Study|Not start protocol therapy|12|||
147336126|NCT02445391|531396460|FG002|Overall Study|Not start protocol therapy|9|||
147282953|NCT03859323|531202771|FG012|Overall Study|Lost to Follow-up|0|||
147282954|NCT03859323|531202759|FG000|Overall Study|Withdrawal by Subject|0|||
147603958|NCT03400943|532367788|FG003|Treatment Period 1|Other|2|||
147603959|NCT03400943|532367785|FG000|Post-treatment Period 1|Adverse Event|2|||
147603960|NCT03400943|532367786|FG001|Post-treatment Period 1|Adverse Event|0|||
147603961|NCT03400943|532367787|FG002|Post-treatment Period 1|Adverse Event|0|||
147603962|NCT03400943|532367788|FG003|Post-treatment Period 1|Adverse Event|0|||
147603963|NCT03400943|532367785|FG000|Post-treatment Period 1|Protocol Violation|1|||
147603964|NCT03400943|532367786|FG001|Post-treatment Period 1|Protocol Violation|0|||
147603965|NCT03400943|532367787|FG002|Post-treatment Period 1|Protocol Violation|0|||
147603966|NCT03400943|532367788|FG003|Post-treatment Period 1|Protocol Violation|0|||
147603967|NCT03400943|532367785|FG000|Post-treatment Period 1|Study terminated by sponsor|5|||
147603968|NCT03400943|532367786|FG001|Post-treatment Period 1|Study terminated by sponsor|0|||
147603969|NCT03400943|532367787|FG002|Post-treatment Period 1|Study terminated by sponsor|5|||
147451390|NCT03594227|531814866|FG000|Overall Study|Withdrawal by Subject|1|||
147451391|NCT03594227|531814867|FG001|Overall Study|Withdrawal by Subject|1|||
147451392|NCT03594227|531814868|FG002|Overall Study|Withdrawal by Subject|1|||
147451393|NCT03594227|531814869|FG003|Overall Study|Withdrawal by Subject|1|||
147451394|NCT03594227|531814866|FG000|Overall Study|Pregnancy|0|||
147451395|NCT03594227|531814867|FG001|Overall Study|Pregnancy|1|||
147451396|NCT03594227|531814868|FG002|Overall Study|Pregnancy|0|||
147451397|NCT03594227|531814869|FG003|Overall Study|Pregnancy|0|||
147451398|NCT03594227|531814866|FG000|Overall Study|Sponsor Decision|0|||
147451399|NCT03594227|531814867|FG001|Overall Study|Sponsor Decision|0|||
147451400|NCT03594227|531814868|FG002|Overall Study|Sponsor Decision|0|||
147451401|NCT03594227|531814869|FG003|Overall Study|Sponsor Decision|1|||
147451402|NCT03594227|531814866|FG000|Overall Study|Programmatic Analysis Non-completer|1|||
147451403|NCT03594227|531814867|FG001|Overall Study|Programmatic Analysis Non-completer|0|||
147451404|NCT03594227|531814868|FG002|Overall Study|Programmatic Analysis Non-completer|1|||
147451405|NCT03594227|531814869|FG003|Overall Study|Programmatic Analysis Non-completer|1|||
147451406|NCT00790907|531814870|FG000|Overall Study|Adverse Event|9|||
147451407|NCT00790907|531814871|FG001|Overall Study|Adverse Event|7|||
147451408|NCT00790907|531814872|FG002|Overall Study|Adverse Event|6|||
147451409|NCT00790907|531814870|FG000|Overall Study|Physician Decision|304|||
147451410|NCT00790907|531814871|FG001|Overall Study|Physician Decision|271|||
147451411|NCT00790907|531814872|FG002|Overall Study|Physician Decision|255|||
147451412|NCT00790907|531814870|FG000|Overall Study|Withdrawal by Subject|1|||
147451413|NCT00790907|531814871|FG001|Overall Study|Withdrawal by Subject|7|||
147451414|NCT00790907|531814872|FG002|Overall Study|Withdrawal by Subject|5|||
147451415|NCT00790907|531814870|FG000|Overall Study|Bleeding Event|11|||
147451416|NCT00790907|531814871|FG001|Overall Study|Bleeding Event|16|||
147451417|NCT00790907|531814872|FG002|Overall Study|Bleeding Event|21|||
147451418|NCT00790907|531814870|FG000|Overall Study|Required Protocol-prohibited Therapy|17|||
147451419|NCT00790907|531814871|FG001|Overall Study|Required Protocol-prohibited Therapy|5|||
147451420|NCT00790907|531814872|FG002|Overall Study|Required Protocol-prohibited Therapy|7|||
147451421|NCT00790907|531814870|FG000|Overall Study|Qualifying Condition Not Present|29|||
147451422|NCT00790907|531814871|FG001|Overall Study|Qualifying Condition Not Present|14|||
147451423|NCT00790907|531814872|FG002|Overall Study|Qualifying Condition Not Present|16|||
147451424|NCT00790907|531814870|FG000|Overall Study|Verbatim Reason on the Case Report Form|74|||
147451425|NCT00790907|531814871|FG001|Overall Study|Verbatim Reason on the Case Report Form|20|||
147451426|NCT00790907|531814872|FG002|Overall Study|Verbatim Reason on the Case Report Form|29|||
147451427|NCT00790907|531814870|FG000|Overall Study|Did Not Receive Study Drug|10|||
147451428|NCT00790907|531814871|FG001|Overall Study|Did Not Receive Study Drug|0|||
147451429|NCT00790907|531814872|FG002|Overall Study|Did Not Receive Study Drug|0|||
147451430|NCT01888640|531814873|FG000|Overall Study|Lost to Follow-up|1|||
147451431|NCT01888640|531814874|FG001|Overall Study|Lost to Follow-up|2|||
147451432|NCT01888640|531814875|FG002|Overall Study|Lost to Follow-up|0|||
147451433|NCT01888640|531814873|FG000|Overall Study|Withdrawal by Subject|15|||
147451434|NCT01888640|531814874|FG001|Overall Study|Withdrawal by Subject|11|||
147451435|NCT01888640|531814875|FG002|Overall Study|Withdrawal by Subject|4|||
147451436|NCT01888640|531814873|FG000|Overall Study|Minimum dose not met|10|||
147451437|NCT01888640|531814874|FG001|Overall Study|Minimum dose not met|16|||
147451438|NCT01888640|531814875|FG002|Overall Study|Minimum dose not met|0|||
147451439|NCT01888640|531814873|FG000|Overall Study|Given wrong unit (placebo)|1|||
147451440|NCT01888640|531814874|FG001|Overall Study|Given wrong unit (placebo)|0|||
147451441|NCT01888640|531814875|FG002|Overall Study|Given wrong unit (placebo)|0|||
147451442|NCT01888640|531814873|FG000|Overall Study|Excluded for prior TENS|0|||
147451443|NCT01888640|531814874|FG001|Overall Study|Excluded for prior TENS|1|||
147451444|NCT01888640|531814875|FG002|Overall Study|Excluded for prior TENS|0|||
147451445|NCT01888640|531814873|FG000|Overall Study|Researcher Termination of Participant|0|||
147451446|NCT01888640|531814874|FG001|Overall Study|Researcher Termination of Participant|1|||
147451447|NCT01888640|531814875|FG002|Overall Study|Researcher Termination of Participant|1|||
147451448|NCT00774345|531814876|FG000|Pre-treatment|Other reasons|2|||
147451449|NCT00774345|531814877|FG001|Pre-treatment|Other reasons|0|||
147451450|NCT00774345|531814876|FG000|Treatment|Adverse Event|61|||
147451451|NCT00774345|531814877|FG001|Treatment|Adverse Event|15|||
147451452|NCT00774345|531814876|FG000|Treatment|Progressive Disease without histologic transformation|51|||
147451453|NCT00774345|531814877|FG001|Treatment|Progressive Disease without histologic transformation|111|||
147603970|NCT03400943|532367788|FG003|Post-treatment Period 1|Study terminated by sponsor|6|||
147603971|NCT03400943|532367785|FG000|Post-treatment Period 1|Withdrawal by Subject|1|||
147603972|NCT03400943|532367786|FG001|Post-treatment Period 1|Withdrawal by Subject|0|||
147603973|NCT03400943|532367787|FG002|Post-treatment Period 1|Withdrawal by Subject|2|||
147451454|NCT00774345|531814876|FG000|Treatment|Progressive Disease with histologic transformation|4|||
147451455|NCT00774345|531814877|FG001|Treatment|Progressive Disease with histologic transformation|2|||
147451456|NCT00774345|531814876|FG000|Treatment|Withdrawal by Subject|5|||
147451457|NCT00774345|531814877|FG001|Treatment|Withdrawal by Subject|2|||
147451458|NCT00774345|531814876|FG000|Treatment|Lost to Follow-up|1|||
147603974|NCT03400943|532367788|FG003|Post-treatment Period 1|Withdrawal by Subject|2|||
147336127|NCT03215927|531397546|FG000|Randomized, Placebo-controlled|Lack of Efficacy|0|||
147336128|NCT03215927|531397547|FG001|Randomized, Placebo-controlled|Lack of Efficacy|1|||
147336129|NCT03215927|531397546|FG000|Open Label Extension|Adverse Event|1|||
147336130|NCT03215927|531397547|FG001|Open Label Extension|Adverse Event|0|||
147336131|NCT03215927|531397546|FG000|Open Label Extension|Lack of Efficacy|1|||
147336132|NCT03215927|531397547|FG001|Open Label Extension|Lack of Efficacy|0|||
147336133|NCT03215927|531397546|FG000|Open Label Extension|Death|0|||
147336134|NCT03215927|531397547|FG001|Open Label Extension|Death|1|||
147336135|NCT03779048|531397548|FG000|Phase 1: 4-week Non-randomized BT run-in|Lost to Follow-up|8|||
147336136|NCT03779048|531397549|FG001|Phase 1: 4-week Non-randomized BT run-in|Lost to Follow-up|0|||
147336137|NCT03779048|531397550|FG002|Phase 1: 4-week Non-randomized BT run-in|Lost to Follow-up|0|||
147336138|NCT03779048|531397548|FG000|Phase 1: 4-week Non-randomized BT run-in|Could not complete visit due to COVID-19|5|||
147336139|NCT03779048|531397549|FG001|Phase 1: 4-week Non-randomized BT run-in|Could not complete visit due to COVID-19|0|||
147336140|NCT03779048|531397550|FG002|Phase 1: 4-week Non-randomized BT run-in|Could not complete visit due to COVID-19|0|||
147336141|NCT03779048|531397548|FG000|Phase 2: Randomized Trial|Lost to Follow-up|0|||
147336142|NCT03779048|531397549|FG001|Phase 2: Randomized Trial|Lost to Follow-up|2|||
147336143|NCT03779048|531397550|FG002|Phase 2: Randomized Trial|Lost to Follow-up|2|||
147336144|NCT00465816|531397551|FG000|Overall Study|Lost to Follow-up|0|||
147336145|NCT00465816|531397552|FG001|Overall Study|Lost to Follow-up|0|||
147336146|NCT00465816|531397553|FG002|Overall Study|Lost to Follow-up|2|||
147336147|NCT00818454|531397556|FG000|Treatment Period 1|Adverse Event|0|||
147336148|NCT00818454|531397557|FG001|Treatment Period 1|Adverse Event|1|||
147336149|NCT00818454|531397558|FG002|Treatment Period 1|Adverse Event|0|||
147336150|NCT00818454|531397559|FG003|Treatment Period 1|Adverse Event|0|||
147336151|NCT00818454|531397556|FG000|Treatment Period 1|Other|3|||
147336152|NCT00818454|531397557|FG001|Treatment Period 1|Other|0|||
147336153|NCT00818454|531397558|FG002|Treatment Period 1|Other|0|||
147336154|NCT00818454|531397559|FG003|Treatment Period 1|Other|0|||
147336155|NCT00818454|531397556|FG000|Washout Period of 1 Week|Adverse Event|1|||
147336156|NCT00818454|531397557|FG001|Washout Period of 1 Week|Adverse Event|1|||
147336157|NCT00818454|531397558|FG002|Washout Period of 1 Week|Adverse Event|0|||
147336158|NCT00818454|531397559|FG003|Washout Period of 1 Week|Adverse Event|0|||
147336159|NCT00818454|531397556|FG000|Washout Period of 1 Week|Protocol Violation|2|||
147336160|NCT00818454|531397557|FG001|Washout Period of 1 Week|Protocol Violation|0|||
147336161|NCT00818454|531397558|FG002|Washout Period of 1 Week|Protocol Violation|0|||
147336162|NCT00818454|531397559|FG003|Washout Period of 1 Week|Protocol Violation|0|||
147336163|NCT00818454|531397556|FG000|Washout Period of 1 Week|Other|1|||
147336164|NCT00818454|531397557|FG001|Washout Period of 1 Week|Other|2|||
147336165|NCT00818454|531397558|FG002|Washout Period of 1 Week|Other|0|||
147336166|NCT00818454|531397559|FG003|Washout Period of 1 Week|Other|0|||
147336167|NCT00818454|531397556|FG000|Treatment Period 2|Other|2|||
147336168|NCT00818454|531397557|FG001|Treatment Period 2|Other|1|||
147336169|NCT00818454|531397558|FG002|Treatment Period 2|Other|0|||
147336170|NCT00818454|531397559|FG003|Treatment Period 2|Other|0|||
147336171|NCT00818454|531397556|FG000|Treatment Period 3|Adverse Event|0|||
147282955|NCT03859323|531202760|FG001|Overall Study|Withdrawal by Subject|0|||
147282956|NCT03859323|531202761|FG002|Overall Study|Withdrawal by Subject|1|||
147282957|NCT03859323|531202762|FG003|Overall Study|Withdrawal by Subject|0|||
147282958|NCT03859323|531202763|FG004|Overall Study|Withdrawal by Subject|0|||
147282959|NCT03859323|531202764|FG005|Overall Study|Withdrawal by Subject|1|||
147282960|NCT03859323|531202765|FG006|Overall Study|Withdrawal by Subject|0|||
147282961|NCT03859323|531202766|FG007|Overall Study|Withdrawal by Subject|0|||
147282962|NCT03859323|531202767|FG008|Overall Study|Withdrawal by Subject|0|||
147282963|NCT03859323|531202768|FG009|Overall Study|Withdrawal by Subject|1|||
147282964|NCT03859323|531202769|FG010|Overall Study|Withdrawal by Subject|1|||
147282965|NCT03859323|531202770|FG011|Overall Study|Withdrawal by Subject|2|||
147282966|NCT03859323|531202771|FG012|Overall Study|Withdrawal by Subject|1|||
147282967|NCT03859323|531202759|FG000|Overall Study|Pregnancy|0|||
147282968|NCT03859323|531202760|FG001|Overall Study|Pregnancy|0|||
147282969|NCT03859323|531202761|FG002|Overall Study|Pregnancy|0|||
147282970|NCT03859323|531202762|FG003|Overall Study|Pregnancy|0|||
147282971|NCT03859323|531202763|FG004|Overall Study|Pregnancy|0|||
147282972|NCT03859323|531202764|FG005|Overall Study|Pregnancy|0|||
147282973|NCT03859323|531202765|FG006|Overall Study|Pregnancy|0|||
147282974|NCT03859323|531202766|FG007|Overall Study|Pregnancy|0|||
147282975|NCT03859323|531202767|FG008|Overall Study|Pregnancy|0|||
147282976|NCT03859323|531202768|FG009|Overall Study|Pregnancy|1|||
147282977|NCT03859323|531202769|FG010|Overall Study|Pregnancy|0|||
147282978|NCT03859323|531202770|FG011|Overall Study|Pregnancy|0|||
147282979|NCT03859323|531202771|FG012|Overall Study|Pregnancy|0|||
147282980|NCT01682460|531202772|FG000|Overall Study|Withdrawal by Subject|2|||
147336172|NCT00818454|531397557|FG001|Treatment Period 3|Adverse Event|0|||
147336173|NCT00818454|531397558|FG002|Treatment Period 3|Adverse Event|0|||
147336174|NCT00818454|531397559|FG003|Treatment Period 3|Adverse Event|1|||
147336175|NCT01765543|531397570|FG000|Overall Study|Death|1|||
147336176|NCT01765543|531397570|FG000|Overall Study|Withdrawal by Subject|2|||
147336177|NCT00507689|531397571|FG000|Pre-Randomization Period|Adverse Event|1|||
147336178|NCT00507689|531397572|FG001|Pre-Randomization Period|Adverse Event|0|||
147336179|NCT00507689|531397571|FG000|Pre-Randomization Period|Physician Decision|1|||
147336180|NCT00507689|531397572|FG001|Pre-Randomization Period|Physician Decision|0|||
147336181|NCT00507689|531397571|FG000|Pre-Randomization Period|Withdrawal by Subject|1|||
147336182|NCT00507689|531397572|FG001|Pre-Randomization Period|Withdrawal by Subject|0|||
147336183|NCT00507689|531397571|FG000|Randomized Period|Adverse Event|1|||
147336184|NCT00507689|531397572|FG001|Randomized Period|Adverse Event|1|||
147336185|NCT00507689|531397571|FG000|Randomized Period|Withdrawal by Subject|0|||
147336186|NCT00507689|531397572|FG001|Randomized Period|Withdrawal by Subject|1|||
147336187|NCT00424762|531397580|FG000|Overall Study|Withdrawal by Subject|18|||
147336188|NCT00424762|531397581|FG001|Overall Study|Withdrawal by Subject|19|||
147336189|NCT00424762|531397580|FG000|Overall Study|Lost to Follow-up|2|||
147336190|NCT00424762|531397581|FG001|Overall Study|Lost to Follow-up|3|||
147336191|NCT00723450|531397582|FG000|Open-Label Phase|Adverse Event|26|||
147336192|NCT00723450|531397583|FG001|Open-Label Phase|Adverse Event|0|||
147336193|NCT00723450|531397584|FG002|Open-Label Phase|Adverse Event|0|||
147336194|NCT00723450|531397582|FG000|Open-Label Phase|Lack of Efficacy|18|||
147336195|NCT00723450|531397583|FG001|Open-Label Phase|Lack of Efficacy|0|||
147336196|NCT00723450|531397584|FG002|Open-Label Phase|Lack of Efficacy|0|||
147336197|NCT00723450|531397582|FG000|Open-Label Phase|Protocol Violation|35|||
147336198|NCT00723450|531397583|FG001|Open-Label Phase|Protocol Violation|0|||
147336199|NCT00723450|531397584|FG002|Open-Label Phase|Protocol Violation|0|||
147336200|NCT00723450|531397582|FG000|Open-Label Phase|Lost to Follow-up|7|||
147336201|NCT00723450|531397583|FG001|Open-Label Phase|Lost to Follow-up|0|||
147336202|NCT00723450|531397584|FG002|Open-Label Phase|Lost to Follow-up|0|||
147336203|NCT00723450|531397582|FG000|Open-Label Phase|Physician Decision|2|||
147336204|NCT00723450|531397583|FG001|Open-Label Phase|Physician Decision|0|||
147336205|NCT00723450|531397584|FG002|Open-Label Phase|Physician Decision|0|||
147336206|NCT00723450|531397582|FG000|Open-Label Phase|Withdrawal by Subject|37|||
147336207|NCT00723450|531397583|FG001|Open-Label Phase|Withdrawal by Subject|0|||
147336208|NCT00723450|531397584|FG002|Open-Label Phase|Withdrawal by Subject|0|||
147336209|NCT00723450|531397582|FG000|Randomized Phase|Adverse Event|0|||
147336210|NCT00723450|531397583|FG001|Randomized Phase|Adverse Event|26|||
147336211|NCT00723450|531397584|FG002|Randomized Phase|Adverse Event|17|||
147336212|NCT00723450|531397582|FG000|Randomized Phase|Lack of Efficacy|0|||
147336213|NCT00723450|531397583|FG001|Randomized Phase|Lack of Efficacy|11|||
147336214|NCT00723450|531397584|FG002|Randomized Phase|Lack of Efficacy|11|||
147336215|NCT00723450|531397582|FG000|Randomized Phase|Protocol Violation|0|||
147336216|NCT00723450|531397583|FG001|Randomized Phase|Protocol Violation|9|||
147336217|NCT00723450|531397584|FG002|Randomized Phase|Protocol Violation|13|||
147336218|NCT00723450|531397582|FG000|Randomized Phase|Lost to Follow-up|0|||
147336219|NCT00723450|531397583|FG001|Randomized Phase|Lost to Follow-up|2|||
147336220|NCT00723450|531397584|FG002|Randomized Phase|Lost to Follow-up|3|||
147336221|NCT00723450|531397582|FG000|Randomized Phase|Physician Decision|0|||
147336222|NCT00723450|531397583|FG001|Randomized Phase|Physician Decision|3|||
147336223|NCT00723450|531397584|FG002|Randomized Phase|Physician Decision|1|||
147336224|NCT00723450|531397582|FG000|Randomized Phase|Withdrawal by Subject|0|||
147336225|NCT00723450|531397583|FG001|Randomized Phase|Withdrawal by Subject|14|||
147336226|NCT00723450|531397584|FG002|Randomized Phase|Withdrawal by Subject|22|||
147336227|NCT01135511|531397585|FG000|Overall Study|Adverse Event|0|||
147451459|NCT00774345|531814877|FG001|Treatment|Lost to Follow-up|1|||
147451460|NCT00774345|531814876|FG000|Treatment|Death|4|||
147603975|NCT03400943|532367785|FG000|Post-treatment Period 1|Other|2|||
147603976|NCT03400943|532367786|FG001|Post-treatment Period 1|Other|0|||
147603977|NCT03400943|532367787|FG002|Post-treatment Period 1|Other|4|||
147336228|NCT01135511|531397586|FG001|Overall Study|Adverse Event|1|||
147336229|NCT01135511|531397587|FG002|Overall Study|Adverse Event|2|||
147336230|NCT01135511|531397588|FG003|Overall Study|Adverse Event|0|||
147603978|NCT03400943|532367788|FG003|Post-treatment Period 1|Other|5|||
147603979|NCT03400943|532367785|FG000|Treatment Period 2|Study terminated by sponsor|0|||
147603980|NCT03400943|532367786|FG001|Treatment Period 2|Study terminated by sponsor|1|||
147603981|NCT03400943|532367787|FG002|Treatment Period 2|Study terminated by sponsor|0|||
147336231|NCT01135511|531397589|FG004|Overall Study|Adverse Event|0|||
147336232|NCT01135511|531397590|FG005|Overall Study|Adverse Event|1|||
147336233|NCT01135511|531397591|FG006|Overall Study|Adverse Event|0|||
147336234|NCT01135511|531397592|FG007|Overall Study|Adverse Event|1|||
147336235|NCT01135511|531397593|FG008|Overall Study|Adverse Event|0|||
147336236|NCT01135511|531397585|FG000|Overall Study|Lack of Efficacy|0|||
147336237|NCT01135511|531397586|FG001|Overall Study|Lack of Efficacy|1|||
147336238|NCT01135511|531397587|FG002|Overall Study|Lack of Efficacy|1|||
147336239|NCT01135511|531397588|FG003|Overall Study|Lack of Efficacy|2|||
147336240|NCT01135511|531397589|FG004|Overall Study|Lack of Efficacy|0|||
147336241|NCT01135511|531397590|FG005|Overall Study|Lack of Efficacy|0|||
147336242|NCT01135511|531397591|FG006|Overall Study|Lack of Efficacy|0|||
147603982|NCT03400943|532367788|FG003|Treatment Period 2|Study terminated by sponsor|0|||
147336243|NCT01135511|531397592|FG007|Overall Study|Lack of Efficacy|0|||
147336244|NCT01135511|531397593|FG008|Overall Study|Lack of Efficacy|0|||
147603983|NCT03400943|532367785|FG000|Treatment Period 2|Withdrawal by Subject|0|||
147336245|NCT01135511|531397585|FG000|Overall Study|Protocol Violation|0|||
147336246|NCT01135511|531397586|FG001|Overall Study|Protocol Violation|0|||
147336247|NCT01135511|531397587|FG002|Overall Study|Protocol Violation|3|||
147336248|NCT01135511|531397588|FG003|Overall Study|Protocol Violation|0|||
147336249|NCT01135511|531397589|FG004|Overall Study|Protocol Violation|0|||
147336250|NCT01135511|531397590|FG005|Overall Study|Protocol Violation|0|||
147282981|NCT01682460|531202772|FG000|Overall Study|Did not meet inclusion criteria|2|||
147282982|NCT02055352|531202776|FG000|Overall Study|Adverse Event|0|||
147282983|NCT02055352|531202777|FG001|Overall Study|Adverse Event|1|||
147282984|NCT02055352|531202776|FG000|Overall Study|Non-eligible|0|||
147282985|NCT02055352|531202777|FG001|Overall Study|Non-eligible|1|||
147282986|NCT02055352|531202776|FG000|Overall Study|Poor compliance|1|||
147282987|NCT02055352|531202777|FG001|Overall Study|Poor compliance|1|||
147282988|NCT02055352|531202776|FG000|Overall Study|Death|1|||
147336251|NCT01135511|531397591|FG006|Overall Study|Protocol Violation|0|||
147336252|NCT01135511|531397592|FG007|Overall Study|Protocol Violation|0|||
147336253|NCT01135511|531397593|FG008|Overall Study|Protocol Violation|0|||
147336254|NCT01135511|531397585|FG000|Overall Study|Pregnancy|0|||
147336255|NCT01135511|531397586|FG001|Overall Study|Pregnancy|0|||
147336256|NCT01135511|531397587|FG002|Overall Study|Pregnancy|0|||
147336257|NCT01135511|531397588|FG003|Overall Study|Pregnancy|1|||
147336258|NCT01135511|531397589|FG004|Overall Study|Pregnancy|0|||
147336259|NCT01135511|531397590|FG005|Overall Study|Pregnancy|0|||
147336260|NCT01135511|531397591|FG006|Overall Study|Pregnancy|0|||
147336261|NCT01135511|531397592|FG007|Overall Study|Pregnancy|0|||
147336262|NCT01135511|531397593|FG008|Overall Study|Pregnancy|0|||
147336263|NCT01135511|531397585|FG000|Overall Study|could not visit the clinic|0|||
147336264|NCT01135511|531397586|FG001|Overall Study|could not visit the clinic|1|||
147336265|NCT01135511|531397587|FG002|Overall Study|could not visit the clinic|2|||
147336266|NCT01135511|531397588|FG003|Overall Study|could not visit the clinic|0|||
147336267|NCT01135511|531397589|FG004|Overall Study|could not visit the clinic|0|||
147336268|NCT01135511|531397590|FG005|Overall Study|could not visit the clinic|0|||
147336269|NCT01135511|531397591|FG006|Overall Study|could not visit the clinic|0|||
147336270|NCT01135511|531397592|FG007|Overall Study|could not visit the clinic|0|||
147336271|NCT01135511|531397593|FG008|Overall Study|could not visit the clinic|0|||
147336272|NCT01135511|531397585|FG000|Overall Study|noncompliance with study drug taken|0|||
147336273|NCT01135511|531397586|FG001|Overall Study|noncompliance with study drug taken|0|||
147336274|NCT01135511|531397587|FG002|Overall Study|noncompliance with study drug taken|0|||
147336275|NCT01135511|531397588|FG003|Overall Study|noncompliance with study drug taken|0|||
147336276|NCT01135511|531397589|FG004|Overall Study|noncompliance with study drug taken|1|||
147336277|NCT01135511|531397590|FG005|Overall Study|noncompliance with study drug taken|0|||
147336278|NCT01135511|531397591|FG006|Overall Study|noncompliance with study drug taken|0|||
147336279|NCT01135511|531397592|FG007|Overall Study|noncompliance with study drug taken|0|||
147336280|NCT01135511|531397593|FG008|Overall Study|noncompliance with study drug taken|0|||
147336281|NCT01135511|531397585|FG000|Overall Study|Withdrawal by Subject|0|||
147336282|NCT01135511|531397586|FG001|Overall Study|Withdrawal by Subject|0|||
147336283|NCT01135511|531397587|FG002|Overall Study|Withdrawal by Subject|0|||
147336284|NCT01135511|531397588|FG003|Overall Study|Withdrawal by Subject|0|||
147336285|NCT01135511|531397589|FG004|Overall Study|Withdrawal by Subject|0|||
147336286|NCT01135511|531397590|FG005|Overall Study|Withdrawal by Subject|0|||
147336287|NCT01135511|531397591|FG006|Overall Study|Withdrawal by Subject|1|||
147336288|NCT01135511|531397592|FG007|Overall Study|Withdrawal by Subject|0|||
147336289|NCT01135511|531397593|FG008|Overall Study|Withdrawal by Subject|1|||
147336290|NCT00545077|531397595|FG000|Overall Study|Treatment not received|5|||
147336291|NCT00545077|531397596|FG001|Overall Study|Treatment not received|1|||
147336292|NCT00545077|531397595|FG000|Overall Study|Disease Progression|131|||
147336293|NCT00545077|531397596|FG001|Overall Study|Disease Progression|98|||
147336294|NCT00545077|531397595|FG000|Overall Study|Withdrawal by Subject|3|||
147336295|NCT00545077|531397596|FG001|Overall Study|Withdrawal by Subject|14|||
147336296|NCT00545077|531397595|FG000|Overall Study|Physician Decision|6|||
147336297|NCT00545077|531397596|FG001|Overall Study|Physician Decision|3|||
147336298|NCT00545077|531397595|FG000|Overall Study|Lost to Follow-up|2|||
147336299|NCT00545077|531397596|FG001|Overall Study|Lost to Follow-up|0|||
147336300|NCT00545077|531397595|FG000|Overall Study|Protocol Violation|1|||
147336301|NCT00545077|531397596|FG001|Overall Study|Protocol Violation|0|||
147336302|NCT00545077|531397595|FG000|Overall Study|Adverse Event|0|||
147336303|NCT00545077|531397596|FG001|Overall Study|Adverse Event|31|||
147336304|NCT00545077|531397595|FG000|Overall Study|Death|0|||
147336305|NCT00545077|531397596|FG001|Overall Study|Death|8|||
147336306|NCT03260140|531397597|FG000|Overall Study|Death|4|||
147336307|NCT03260140|531397598|FG001|Overall Study|Death|1|||
147336308|NCT03260140|531397597|FG000|Overall Study|Withdrawal by Subject|1|||
147336309|NCT03260140|531397598|FG001|Overall Study|Withdrawal by Subject|4|||
147336310|NCT05283395|531397601|FG000|Overall Study|Adverse Event|4|||
147336311|NCT05283395|531397602|FG001|Overall Study|Adverse Event|4|||
147336312|NCT05283395|531397603|FG002|Overall Study|Adverse Event|0|||
147336313|NCT05283395|531397601|FG000|Overall Study|Patient Lost to Follow-Up|0|||
147336314|NCT05283395|531397602|FG001|Overall Study|Patient Lost to Follow-Up|0|||
147282989|NCT02055352|531202777|FG001|Overall Study|Death|2|||
147282990|NCT02055352|531202776|FG000|Overall Study|Patient decision|1|||
147282991|NCT02055352|531202777|FG001|Overall Study|Patient decision|1|||
147282992|NCT02055352|531202776|FG000|Overall Study|Use of prohibited treatment|0|||
147282993|NCT02055352|531202777|FG001|Overall Study|Use of prohibited treatment|3|||
147282994|NCT02055352|531202776|FG000|Overall Study|AE, study drug would be detrimental|1|||
147282995|NCT02055352|531202777|FG001|Overall Study|AE, study drug would be detrimental|3|||
147282996|NCT02055352|531202776|FG000|Overall Study|Withdrawal of informed consent|1|||
147282997|NCT02055352|531202777|FG001|Overall Study|Withdrawal of informed consent|0|||
147282998|NCT02055352|531202776|FG000|Overall Study|Reason unknown|1|||
147282999|NCT02055352|531202777|FG001|Overall Study|Reason unknown|5|||
147336315|NCT05283395|531397603|FG002|Overall Study|Patient Lost to Follow-Up|1|||
147336316|NCT05283395|531397601|FG000|Overall Study|Patient Withdrawal|2|||
147336317|NCT05283395|531397602|FG001|Overall Study|Patient Withdrawal|4|||
147336318|NCT05283395|531397603|FG002|Overall Study|Patient Withdrawal|2|||
147336319|NCT05283395|531397601|FG000|Overall Study|Investigator Decision|1|||
147336320|NCT05283395|531397602|FG001|Overall Study|Investigator Decision|0|||
147336321|NCT05283395|531397603|FG002|Overall Study|Investigator Decision|1|||
147336322|NCT05283395|531397601|FG000|Overall Study|Enrolled in error|0|||
147336323|NCT05283395|531397602|FG001|Overall Study|Enrolled in error|0|||
147336324|NCT05283395|531397603|FG002|Overall Study|Enrolled in error|1|||
147336325|NCT01063972|531397604|FG000|Overall Study|Death|12|||
147336326|NCT01063972|531397605|FG001|Overall Study|Death|11|||
147336327|NCT01063972|531397604|FG000|Overall Study|Incarcerated|2|||
147336328|NCT01063972|531397605|FG001|Overall Study|Incarcerated|1|||
147336329|NCT00712335|531397606|FG000|Overall Study|Withdrawal by Subject|0|||
147336330|NCT00712335|531397607|FG001|Overall Study|Withdrawal by Subject|7|||
147336331|NCT00712335|531397608|FG002|Overall Study|Withdrawal by Subject|2|||
147336332|NCT00712335|531397609|FG003|Overall Study|Withdrawal by Subject|3|||
147336333|NCT00712335|531397610|FG004|Overall Study|Withdrawal by Subject|0|||
147336334|NCT00712335|531397606|FG000|Overall Study|Lost to Follow-up|2|||
147336335|NCT00712335|531397607|FG001|Overall Study|Lost to Follow-up|5|||
147336336|NCT00712335|531397608|FG002|Overall Study|Lost to Follow-up|0|||
147336337|NCT00712335|531397609|FG003|Overall Study|Lost to Follow-up|1|||
147336338|NCT00712335|531397610|FG004|Overall Study|Lost to Follow-up|0|||
147336339|NCT00712335|531397606|FG000|Overall Study|Protocol Violation|1|||
147336340|NCT00712335|531397607|FG001|Overall Study|Protocol Violation|2|||
147336341|NCT00712335|531397608|FG002|Overall Study|Protocol Violation|1|||
147336342|NCT00712335|531397609|FG003|Overall Study|Protocol Violation|0|||
147336343|NCT00712335|531397610|FG004|Overall Study|Protocol Violation|0|||
147336344|NCT00712335|531397606|FG000|Overall Study|Lack of Efficacy|0|||
147336345|NCT00712335|531397607|FG001|Overall Study|Lack of Efficacy|0|||
147336346|NCT00712335|531397608|FG002|Overall Study|Lack of Efficacy|1|||
147336347|NCT00712335|531397609|FG003|Overall Study|Lack of Efficacy|1|||
147336348|NCT00712335|531397610|FG004|Overall Study|Lack of Efficacy|0|||
147336349|NCT00712335|531397606|FG000|Overall Study|Other Reason|0|||
147336350|NCT00712335|531397607|FG001|Overall Study|Other Reason|3|||
147336351|NCT00712335|531397608|FG002|Overall Study|Other Reason|1|||
147336352|NCT00712335|531397609|FG003|Overall Study|Other Reason|0|||
147336353|NCT00712335|531397610|FG004|Overall Study|Other Reason|0|||
147336354|NCT03401112|531397611|FG000|Overall Study|Adverse Event|1|||
147336355|NCT03401112|531397612|FG001|Overall Study|Adverse Event|2|||
147336356|NCT03401112|531397613|FG002|Overall Study|Adverse Event|3|||
147336357|NCT03401112|531397614|FG003|Overall Study|Adverse Event|2|||
147336358|NCT03401112|531397615|FG004|Overall Study|Adverse Event|0|||
147336359|NCT03401112|531397611|FG000|Overall Study|Lost to Follow-up|1|||
147336360|NCT03401112|531397612|FG001|Overall Study|Lost to Follow-up|0|||
147336361|NCT03401112|531397613|FG002|Overall Study|Lost to Follow-up|0|||
147336362|NCT03401112|531397614|FG003|Overall Study|Lost to Follow-up|0|||
147336363|NCT03401112|531397615|FG004|Overall Study|Lost to Follow-up|0|||
147336364|NCT03401112|531397611|FG000|Overall Study|Noncompliance|1|||
147451461|NCT00774345|531814877|FG001|Treatment|Death|0|||
147283000|NCT05349617|531202778|FG000|Overall Study|Death|1|||
147283001|NCT05349617|531202779|FG001|Overall Study|Death|1|||
147336365|NCT03401112|531397612|FG001|Overall Study|Noncompliance|2|||
147336366|NCT03401112|531397613|FG002|Overall Study|Noncompliance|3|||
147336367|NCT03401112|531397614|FG003|Overall Study|Noncompliance|0|||
147336368|NCT03401112|531397615|FG004|Overall Study|Noncompliance|0|||
147336369|NCT03401112|531397611|FG000|Overall Study|Did not Meet Inclusion Criteria|1|||
147336370|NCT03401112|531397612|FG001|Overall Study|Did not Meet Inclusion Criteria|0|||
147336371|NCT03401112|531397613|FG002|Overall Study|Did not Meet Inclusion Criteria|0|||
147336372|NCT03401112|531397614|FG003|Overall Study|Did not Meet Inclusion Criteria|0|||
147283002|NCT05349617|531202778|FG000|Overall Study|Lost to Follow-up|3|||
147336373|NCT03401112|531397615|FG004|Overall Study|Did not Meet Inclusion Criteria|0|||
147336374|NCT03401112|531397611|FG000|Overall Study|Withdrawal by Subject|0|||
147336375|NCT03401112|531397612|FG001|Overall Study|Withdrawal by Subject|3|||
147336376|NCT03401112|531397613|FG002|Overall Study|Withdrawal by Subject|2|||
147283003|NCT05349617|531202779|FG001|Overall Study|Lost to Follow-up|8|||
147336377|NCT03401112|531397614|FG003|Overall Study|Withdrawal by Subject|1|||
147336378|NCT03401112|531397615|FG004|Overall Study|Withdrawal by Subject|0|||
147336379|NCT03401112|531397611|FG000|Overall Study|Physician Decision|0|||
147336380|NCT03401112|531397612|FG001|Overall Study|Physician Decision|0|||
147336381|NCT03401112|531397613|FG002|Overall Study|Physician Decision|0|||
147336382|NCT03401112|531397614|FG003|Overall Study|Physician Decision|2|||
147336383|NCT03401112|531397615|FG004|Overall Study|Physician Decision|0|||
147336384|NCT03401112|531397611|FG000|Overall Study|Study was Terminated by Sponsor|0|||
147336385|NCT03401112|531397612|FG001|Overall Study|Study was Terminated by Sponsor|0|||
147336386|NCT03401112|531397613|FG002|Overall Study|Study was Terminated by Sponsor|0|||
147336387|NCT03401112|531397614|FG003|Overall Study|Study was Terminated by Sponsor|1|||
147336388|NCT03401112|531397615|FG004|Overall Study|Study was Terminated by Sponsor|0|||
147336389|NCT03401112|531397611|FG000|Overall Study|Day 1 Assessment not Done|1|||
147336390|NCT03401112|531397612|FG001|Overall Study|Day 1 Assessment not Done|0|||
147336391|NCT03401112|531397613|FG002|Overall Study|Day 1 Assessment not Done|0|||
147336392|NCT03401112|531397614|FG003|Overall Study|Day 1 Assessment not Done|0|||
147336393|NCT03401112|531397615|FG004|Overall Study|Day 1 Assessment not Done|0|||
147336394|NCT03401112|531397611|FG000|Overall Study|Not Dosed|0|||
147336395|NCT03401112|531397612|FG001|Overall Study|Not Dosed|0|||
147336396|NCT03401112|531397613|FG002|Overall Study|Not Dosed|1|||
147336397|NCT03401112|531397614|FG003|Overall Study|Not Dosed|0|||
147336398|NCT03401112|531397615|FG004|Overall Study|Not Dosed|0|||
147336399|NCT03401112|531397611|FG000|Overall Study|Missed Clinical Visit|0|||
147336400|NCT03401112|531397612|FG001|Overall Study|Missed Clinical Visit|0|||
147336401|NCT03401112|531397613|FG002|Overall Study|Missed Clinical Visit|1|||
147336402|NCT03401112|531397614|FG003|Overall Study|Missed Clinical Visit|0|||
147336403|NCT03401112|531397615|FG004|Overall Study|Missed Clinical Visit|0|||
147336404|NCT03401112|531397611|FG000|Overall Study|Missed Doses|0|||
147336405|NCT03401112|531397612|FG001|Overall Study|Missed Doses|0|||
147336406|NCT03401112|531397613|FG002|Overall Study|Missed Doses|1|||
147336407|NCT03401112|531397614|FG003|Overall Study|Missed Doses|0|||
147336408|NCT03401112|531397615|FG004|Overall Study|Missed Doses|0|||
147336409|NCT01264679|531397616|FG000|Overall Study|Participation in Another Clinical Trial|1|||
147336410|NCT01264679|531397616|FG000|Overall Study|Physician Decision|1|||
147336411|NCT01264679|531397616|FG000|Overall Study|Sponsor's Suspension of Dosing|2|||
147336412|NCT01264679|531397616|FG000|Overall Study|Withdrawal by Subject|1|||
147336413|NCT03475316|531397617|FG000|6 Month Intervention|Adverse Event|2|||
147336414|NCT03475316|531397618|FG001|6 Month Intervention|Adverse Event|1|||
147336415|NCT03475316|531397617|FG000|6 Month Intervention|Withdrawal by Subject|2|||
147336416|NCT03475316|531397618|FG001|6 Month Intervention|Withdrawal by Subject|0|||
147336417|NCT03475316|531397617|FG000|6 Month Intervention|Study stopped due to COVID pandemic|1|||
147336418|NCT03475316|531397618|FG001|6 Month Intervention|Study stopped due to COVID pandemic|3|||
147336419|NCT03475316|531397617|FG000|9 Months|Study stopped due to COVID pandemic|3|||
147336420|NCT03475316|531397618|FG001|9 Months|Study stopped due to COVID pandemic|4|||
147336421|NCT00424645|531397619|FG000|Overall Study|Death|1|||
147336422|NCT00424645|531397620|FG001|Overall Study|Death|0|||
147283004|NCT05349617|531202778|FG000|Overall Study|Withdrawal by Subject|2|||
147283005|NCT05349617|531202779|FG001|Overall Study|Withdrawal by Subject|10|||
147283006|NCT03811912|531202781|FG000|Overall Study|Withdrew Consent|4|||
147283007|NCT03811912|531202782|FG001|Overall Study|Withdrew Consent|2|||
147283008|NCT04401579|531202783|FG000|Overall Study|Death|23|||
147283009|NCT04401579|531202784|FG001|Overall Study|Death|36|||
147283010|NCT04401579|531202783|FG000|Overall Study|Lost to Follow-up|40|||
147283011|NCT04401579|531202784|FG001|Overall Study|Lost to Follow-up|41|||
147283012|NCT04401579|531202783|FG000|Overall Study|Withdrawal by Subject|8|||
147283013|NCT04401579|531202784|FG001|Overall Study|Withdrawal by Subject|16|||
147283014|NCT04401579|531202783|FG000|Overall Study|Physician Decision|1|||
147283015|NCT04401579|531202784|FG001|Overall Study|Physician Decision|2|||
147283016|NCT04401579|531202783|FG000|Overall Study|Became ineligible after enrollment|1|||
147336423|NCT01179334|531397621|FG000|Treatment Period|Adverse Event|1|||
147336424|NCT01179334|531397622|FG001|Treatment Period|Adverse Event|0|||
147336425|NCT01179334|531397621|FG000|Long-term Extension (LTE) Period|Study terminated by sponsor|6|||
147283017|NCT04401579|531202784|FG001|Overall Study|Became ineligible after enrollment|1|||
147283018|NCT04401579|531202783|FG000|Overall Study|Enrolled but treatment not administered|7|||
147283019|NCT04401579|531202784|FG001|Overall Study|Enrolled but treatment not administered|9|||
147283020|NCT04401579|531202783|FG000|Overall Study|Adverse Event|2|||
147336426|NCT01179334|531397622|FG001|Long-term Extension (LTE) Period|Study terminated by sponsor|2|||
147336427|NCT01179334|531397621|FG000|Long-term Extension (LTE) Period|Death|3|||
147336428|NCT01179334|531397622|FG001|Long-term Extension (LTE) Period|Death|0|||
147336429|NCT01179334|531397621|FG000|Long-term Extension (LTE) Period|Adverse Event|2|||
147336430|NCT01179334|531397622|FG001|Long-term Extension (LTE) Period|Adverse Event|4|||
147336431|NCT04177394|531397623|FG000|Overall Study|Death|16|||
147336432|NCT04177394|531397623|FG000|Overall Study|Withdrawal by Subject|19|||
147336433|NCT04177394|531397623|FG000|Overall Study|Missed visits|61|||
147336434|NCT04177394|531397623|FG000|Overall Study|Expected Visits|15|||
147283021|NCT04401579|531202784|FG001|Overall Study|Adverse Event|1|||
147283022|NCT04401579|531202783|FG000|Overall Study|Scheduling error|1|||
147283023|NCT04401579|531202784|FG001|Overall Study|Scheduling error|2|||
147283024|NCT04401579|531202783|FG000|Overall Study|Transferred to another hospital|1|||
147283025|NCT04401579|531202784|FG001|Overall Study|Transferred to another hospital|2|||
147283026|NCT00489970|531202785|FG000|Persistence Year 9|Lost to Follow-up|2|||
147283027|NCT00489970|531202786|FG001|Persistence Year 9|Lost to Follow-up|2|||
147283028|NCT00489970|531202787|FG002|Persistence Year 9|Lost to Follow-up|3|||
147283029|NCT00489970|531202785|FG000|Persistence Year 9|Other|1|||
147283030|NCT00489970|531202786|FG001|Persistence Year 9|Other|0|||
147336435|NCT00258895|531397624|FG000|Overall Study|Lost to Follow-up|3|||
147336436|NCT00258895|531397625|FG001|Overall Study|Lost to Follow-up|1|||
147336437|NCT00258895|531397624|FG000|Overall Study|Protocol Violation|6|||
147336438|NCT00258895|531397625|FG001|Overall Study|Protocol Violation|2|||
147336439|NCT00258895|531397624|FG000|Overall Study|Withdrawal by Subject|1|||
147336440|NCT00258895|531397625|FG001|Overall Study|Withdrawal by Subject|0|||
147336441|NCT00547118|531397626|FG000|Overall Study|Did not qualify prior to starting drug|1|||
147336442|NCT00547118|531397627|FG001|Overall Study|Did not qualify prior to starting drug|1|||
147336443|NCT00547118|531397626|FG000|Overall Study|Study suspended|7|||
147336444|NCT00547118|531397627|FG001|Overall Study|Study suspended|8|||
147336445|NCT01595321|531397630|FG000|Overall Study|Adverse Event|1|||
147336446|NCT01595321|531397631|FG001|Overall Study|Adverse Event|1|||
147336447|NCT01595321|531397632|FG002|Overall Study|Adverse Event|1|||
147336448|NCT01595321|531397630|FG000|Overall Study|Lack of Efficacy|0|||
147336449|NCT01595321|531397631|FG001|Overall Study|Lack of Efficacy|0|||
147336450|NCT01595321|531397632|FG002|Overall Study|Lack of Efficacy|4|||
147336451|NCT01390402|531397633|FG000|Overall Study|Death|1|||
147336452|NCT01390402|531397633|FG000|Overall Study|Disease Progression|4|||
147336453|NCT04789408|531397634|FG000|Overall Study|Death|4|||
147336454|NCT04789408|531397635|FG001|Overall Study|Death|3|||
147336455|NCT04789408|531397636|FG002|Overall Study|Death|6|||
147336456|NCT04789408|531397634|FG000|Overall Study|Did not meet eligibility criteria|1|||
147336457|NCT04789408|531397635|FG001|Overall Study|Did not meet eligibility criteria|0|||
147336458|NCT04789408|531397636|FG002|Overall Study|Did not meet eligibility criteria|0|||
147336459|NCT04789408|531397634|FG000|Overall Study|Participant withdrawal of consent from further follow-up|0|||
147336460|NCT04789408|531397635|FG001|Overall Study|Participant withdrawal of consent from further follow-up|0|||
147336461|NCT04789408|531397636|FG002|Overall Study|Participant withdrawal of consent from further follow-up|1|||
147336462|NCT01170026|531398649|FG000|Overall Study|Lost to Follow-up|4|||
147336463|NCT01170026|531398650|FG001|Overall Study|Lost to Follow-up|2|||
147336464|NCT03785782|531398662|FG000|Overall Study|their lesions' were not suitable for the study criteria|2|||
147336465|NCT03785782|531398663|FG001|Overall Study|their lesions' were not suitable for the study criteria|0|||
147336466|NCT03785782|531398662|FG000|Overall Study|Withdrawal by Subject|1|||
147336467|NCT03785782|531398663|FG001|Overall Study|Withdrawal by Subject|1|||
147336468|NCT03785782|531398662|FG000|Overall Study|insufficient image quality.|3|||
147336469|NCT03785782|531398663|FG001|Overall Study|insufficient image quality.|0|||
147336470|NCT03889925|531398664|FG000|Overall Study|Lost to Follow-up|11|||
147336471|NCT03889925|531398665|FG001|Overall Study|Lost to Follow-up|10|||
147336472|NCT03762668|531398666|FG000|Period 1, First Week of Wear|Withdrawal by Subject|0|||
147336473|NCT03762668|531398667|FG001|Period 1, First Week of Wear|Withdrawal by Subject|1|||
147336474|NCT02613871|531398674|FG000|Overall Study|Death|2|||
147336475|NCT02613871|531398674|FG000|Overall Study|Withdrew Consent|1|||
147336476|NCT01786564|531398675|FG000|Overall Study|Lost to Follow-up|47|||
147336477|NCT01786564|531398675|FG000|Overall Study|Ineligible|17|||
147336478|NCT00494442|531398676|FG000|Overall Study|Death|1|||
147336479|NCT00494442|531398677|FG001|Overall Study|Death|1|||
147336480|NCT00494442|531398676|FG000|Overall Study|Lack of Efficacy|16|||
147336481|NCT00494442|531398677|FG001|Overall Study|Lack of Efficacy|10|||
147336482|NCT00494442|531398676|FG000|Overall Study|Adverse Event|0|||
147336483|NCT00494442|531398677|FG001|Overall Study|Adverse Event|2|||
147336484|NCT00494442|531398676|FG000|Overall Study|Physician Decision|0|||
147336485|NCT00494442|531398677|FG001|Overall Study|Physician Decision|1|||
147336486|NCT00494442|531398676|FG000|Overall Study|Non-compliance|0|||
147336487|NCT00494442|531398677|FG001|Overall Study|Non-compliance|1|||
147336488|NCT00494442|531398676|FG000|Overall Study|Intercurrent illness|0|||
147336489|NCT00494442|531398677|FG001|Overall Study|Intercurrent illness|1|||
147451462|NCT00774345|531814876|FG000|Treatment|Other Reasons|32|||
147451463|NCT00774345|531814877|FG001|Treatment|Other Reasons|26|||
147451464|NCT01277549|531814878|FG000|Overall Study|Failed to meet eligibility criteria|13|||
147283031|NCT00489970|531202787|FG002|Persistence Year 9|Other|2|||
147283032|NCT01863680|531202788|FG000|Overall Study|Adverse Event|17|||
147283033|NCT01863680|531202788|FG000|Overall Study|Risk of OHSS|17|||
147336490|NCT01241292|531398680|FG000|Overall Study|Administrative Reason by Sponsor|1|||
147336491|NCT01241292|531398681|FG001|Overall Study|Administrative Reason by Sponsor|0|||
147336492|NCT01241292|531398680|FG000|Overall Study|Disease Progression|2|||
147336493|NCT01241292|531398681|FG001|Overall Study|Disease Progression|0|||
147336494|NCT01241292|531398680|FG000|Overall Study|Study Drug Toxicity|0|||
147336495|NCT01241292|531398681|FG001|Overall Study|Study Drug Toxicity|1|||
147336496|NCT01241292|531398680|FG000|Overall Study|Participant Discontinued Treatment|0|||
147451465|NCT01277549|531814879|FG001|Overall Study|Failed to meet eligibility criteria|9|||
147283034|NCT01863680|531202788|FG000|Overall Study|Spontaneous pregnancy|2|||
147451466|NCT01277549|531814878|FG000|Overall Study|Withdrawal by Subject|1|||
147451467|NCT01277549|531814879|FG001|Overall Study|Withdrawal by Subject|3|||
147451468|NCT01277549|531814878|FG000|Overall Study|Protocol Violation|10|||
147451469|NCT01277549|531814879|FG001|Overall Study|Protocol Violation|1|||
147451470|NCT01277549|531814878|FG000|Overall Study|Physician Decision|2|||
147451471|NCT01277549|531814879|FG001|Overall Study|Physician Decision|1|||
147451472|NCT00075504|531814880|FG000|Overall Study|Withdrawal by Subject|9|||
147451473|NCT00075504|531814881|FG001|Overall Study|Withdrawal by Subject|7|||
147451474|NCT02228590|531814882|FG000|Overall Study|Withdrawal by Subject|1|||
147451475|NCT02109484|531814883|FG000|Overall Study|Lost to Follow-up|0|||
147451476|NCT02109484|531814884|FG001|Overall Study|Lost to Follow-up|0|||
147451477|NCT02109484|531814885|FG002|Overall Study|Lost to Follow-up|0|||
147451478|NCT02109484|531814886|FG003|Overall Study|Lost to Follow-up|1|||
147451479|NCT02109484|531814887|FG004|Overall Study|Lost to Follow-up|1|||
147451480|NCT02109484|531814888|FG005|Overall Study|Lost to Follow-up|0|||
147451481|NCT02109484|531814889|FG006|Overall Study|Lost to Follow-up|1|||
147451482|NCT02109484|531814890|FG007|Overall Study|Lost to Follow-up|0|||
147451483|NCT02109484|531814883|FG000|Overall Study|Withdrawal by Subject|0|||
147451484|NCT02109484|531814884|FG001|Overall Study|Withdrawal by Subject|0|||
147451485|NCT02109484|531814885|FG002|Overall Study|Withdrawal by Subject|0|||
147451486|NCT02109484|531814886|FG003|Overall Study|Withdrawal by Subject|0|||
147451487|NCT02109484|531814887|FG004|Overall Study|Withdrawal by Subject|1|||
147451488|NCT02109484|531814888|FG005|Overall Study|Withdrawal by Subject|1|||
147451489|NCT02109484|531814889|FG006|Overall Study|Withdrawal by Subject|1|||
147451490|NCT02109484|531814890|FG007|Overall Study|Withdrawal by Subject|0|||
147451491|NCT02109484|531814883|FG000|Overall Study|Physician Decision|0|||
147451492|NCT02109484|531814884|FG001|Overall Study|Physician Decision|0|||
147451493|NCT02109484|531814885|FG002|Overall Study|Physician Decision|0|||
147451494|NCT02109484|531814886|FG003|Overall Study|Physician Decision|0|||
147451495|NCT02109484|531814887|FG004|Overall Study|Physician Decision|2|||
147451496|NCT02109484|531814888|FG005|Overall Study|Physician Decision|0|||
147451497|NCT02109484|531814889|FG006|Overall Study|Physician Decision|0|||
147451498|NCT02109484|531814890|FG007|Overall Study|Physician Decision|0|||
147451499|NCT02109484|531814883|FG000|Overall Study|Death|0|||
147451500|NCT02109484|531814884|FG001|Overall Study|Death|0|||
147451501|NCT02109484|531814885|FG002|Overall Study|Death|0|||
147451502|NCT02109484|531814886|FG003|Overall Study|Death|0|||
147451503|NCT02109484|531814887|FG004|Overall Study|Death|0|||
147451504|NCT02109484|531814888|FG005|Overall Study|Death|0|||
147451505|NCT02109484|531814889|FG006|Overall Study|Death|0|||
147451506|NCT02109484|531814890|FG007|Overall Study|Death|2|||
147451507|NCT02109484|531814883|FG000|Overall Study|Moved away from study area|0|||
147451508|NCT02109484|531814884|FG001|Overall Study|Moved away from study area|0|||
147451509|NCT02109484|531814885|FG002|Overall Study|Moved away from study area|0|||
147451510|NCT02109484|531814886|FG003|Overall Study|Moved away from study area|0|||
147451511|NCT02109484|531814887|FG004|Overall Study|Moved away from study area|0|||
147451512|NCT02109484|531814888|FG005|Overall Study|Moved away from study area|0|||
147451513|NCT02109484|531814889|FG006|Overall Study|Moved away from study area|1|||
147451514|NCT02109484|531814890|FG007|Overall Study|Moved away from study area|1|||
147451515|NCT02111993|531814891|FG000|Overall Study|Physician Decision|5|||
147451516|NCT02111993|531814892|FG001|Overall Study|Physician Decision|4|||
147451517|NCT01097863|531814893|FG000|Overall Study|Discomfort|1|||
147451518|NCT01097863|531814894|FG001|Overall Study|Discomfort|0|||
147451519|NCT01097863|531814895|FG002|Overall Study|Discomfort|1|||
147451520|NCT01097863|531814893|FG000|Overall Study|Did not return for final visit|0|||
147451521|NCT01097863|531814894|FG001|Overall Study|Did not return for final visit|0|||
147451522|NCT01097863|531814895|FG002|Overall Study|Did not return for final visit|1|||
147451523|NCT00796315|531814896|FG000|Overall Study|Protocol Violation|0|||
147451524|NCT00796315|531814897|FG001|Overall Study|Protocol Violation|1|||
147451525|NCT00796315|531814898|FG002|Overall Study|Protocol Violation|0|||
147451526|NCT01400451|531814911|FG000|Combination Treatment (or Intended)|Withdrawal by Subject|2|||
147451527|NCT01400451|531814912|FG001|Combination Treatment (or Intended)|Withdrawal by Subject|1|||
147451528|NCT01400451|531814913|FG002|Combination Treatment (or Intended)|Withdrawal by Subject|1|||
147451529|NCT01400451|531814911|FG000|Combination Treatment (or Intended)|Drug Toxicity|0|||
147451530|NCT01400451|531814912|FG001|Combination Treatment (or Intended)|Drug Toxicity|1|||
147451531|NCT01400451|531814913|FG002|Combination Treatment (or Intended)|Drug Toxicity|0|||
147451532|NCT01400451|531814911|FG000|Combination Treatment (or Intended)|Adverse Event|1|||
147662620|NCT02869789|532587361|FG003|Overall Study|Other reasons|0|||
147451533|NCT01400451|531814912|FG001|Combination Treatment (or Intended)|Adverse Event|0|||
147451534|NCT01400451|531814913|FG002|Combination Treatment (or Intended)|Adverse Event|0|||
147451535|NCT01400451|531814911|FG000|Combination Treatment (or Intended)|Disease Progression|3|||
147451536|NCT01400451|531814912|FG001|Combination Treatment (or Intended)|Disease Progression|1|||
147451537|NCT01400451|531814913|FG002|Combination Treatment (or Intended)|Disease Progression|1|||
147451538|NCT01400451|531814911|FG000|Combination Treatment (or Intended)|Dose-limiting toxicity|0|||
147451539|NCT01400451|531814912|FG001|Combination Treatment (or Intended)|Dose-limiting toxicity|1|||
147451540|NCT01400451|531814913|FG002|Combination Treatment (or Intended)|Dose-limiting toxicity|0|||
147662621|NCT01529606|532587363|FG000|Overall Study|Lost to Follow-up|21|||
147283035|NCT01863680|531202788|FG000|Overall Study|Withdrawal by Subject|1|||
147283036|NCT01863680|531202788|FG000|Overall Study|Did not undergo IVF/ET|14|||
147283037|NCT01863680|531202788|FG000|Overall Study|Other|6|||
147283038|NCT00618514|531202789|FG000|Overall Study|Lost to Follow-up|11|||
147283039|NCT00618514|531202790|FG001|Overall Study|Lost to Follow-up|12|||
147283040|NCT00618514|531202791|FG002|Overall Study|Lost to Follow-up|4|||
147283041|NCT00566228|531202796|FG000|Overall Study|Withdrawal by Subject|1|||
147283042|NCT00566228|531202797|FG001|Overall Study|Withdrawal by Subject|0|||
147283043|NCT00566228|531202796|FG000|Overall Study|Attempt to mobilize stem cells failed|2|||
147283044|NCT00566228|531202797|FG001|Overall Study|Attempt to mobilize stem cells failed|2|||
147283045|NCT00566228|531202796|FG000|Overall Study|Unable to collect sufficient CD34 cells|3|||
147283046|NCT00566228|531202797|FG001|Overall Study|Unable to collect sufficient CD34 cells|2|||
147283047|NCT00566228|531202796|FG000|Overall Study|progressed before infusion could occur|0|||
147283048|NCT00566228|531202797|FG001|Overall Study|progressed before infusion could occur|1|||
147283049|NCT02707055|531202800|FG000|Phase 1|Withdrawal by Subject|1|||
147283050|NCT02707055|531202801|FG001|Phase 1|Withdrawal by Subject|2|||
147283051|NCT02707055|531202800|FG000|Phase 1|Physician Decision|0|||
147283052|NCT02707055|531202801|FG001|Phase 1|Physician Decision|1|||
147283053|NCT02707055|531202800|FG000|Phase 2|Adverse Event|1|||
147283054|NCT02707055|531202801|FG001|Phase 2|Adverse Event|2|||
147283055|NCT00902304|531202804|FG000|Overall Study|Adverse Event|4|||
147283056|NCT00902304|531202805|FG001|Overall Study|Adverse Event|10|||
147283057|NCT00902304|531202806|FG002|Overall Study|Adverse Event|25|||
147283058|NCT00902304|531202804|FG000|Overall Study|Investigator discretion|3|||
147283059|NCT00902304|531202805|FG001|Overall Study|Investigator discretion|5|||
147283060|NCT00902304|531202806|FG002|Overall Study|Investigator discretion|13|||
147283061|NCT00902304|531202804|FG000|Overall Study|Lost to Follow-up|7|||
147283062|NCT00902304|531202805|FG001|Overall Study|Lost to Follow-up|7|||
147283063|NCT00902304|531202806|FG002|Overall Study|Lost to Follow-up|7|||
147283064|NCT00902304|531202804|FG000|Overall Study|Protocol Violation|9|||
147283065|NCT00902304|531202805|FG001|Overall Study|Protocol Violation|18|||
147283066|NCT00902304|531202806|FG002|Overall Study|Protocol Violation|20|||
147283067|NCT00902304|531202804|FG000|Overall Study|Withdrawal by Subject|32|||
147283068|NCT00902304|531202805|FG001|Overall Study|Withdrawal by Subject|22|||
147283069|NCT00902304|531202806|FG002|Overall Study|Withdrawal by Subject|43|||
147283070|NCT00902304|531202804|FG000|Overall Study|includes pregnancy|3|||
147283071|NCT00902304|531202805|FG001|Overall Study|includes pregnancy|9|||
147283072|NCT00902304|531202806|FG002|Overall Study|includes pregnancy|2|||
147283073|NCT02492100|531202807|FG000|Overall Study|Death|1|||
147283074|NCT05706506|531202808|FG000|Overall Study|Adverse Event|1|||
147283075|NCT05706506|531202808|FG000|Overall Study|Withdrawal by Subject|4|||
147283076|NCT05706506|531202808|FG000|Overall Study|Lost to Follow-up|2|||
147283077|NCT05706506|531202808|FG000|Overall Study|Inadvertent Enrolment|12|||
147283078|NCT05706506|531202808|FG000|Overall Study|Early Discontinuation Due to Hyperglycemia|1|||
147283079|NCT05706506|531202808|FG000|Overall Study|Participant Moved Out of State|1|||
147283080|NCT03832010|531202809|FG000|Overall Study|Withdrawal by Subject|2|||
147283081|NCT03832010|531202810|FG001|Overall Study|Withdrawal by Subject|1|||
147283082|NCT03832010|531202811|FG002|Overall Study|Withdrawal by Subject|0|||
147283083|NCT03832010|531202809|FG000|Overall Study|Lost to Follow-up|2|||
147283084|NCT03832010|531202810|FG001|Overall Study|Lost to Follow-up|1|||
147283085|NCT03832010|531202811|FG002|Overall Study|Lost to Follow-up|1|||
147283086|NCT00987467|531202812|FG000|Overall Study|Lost to Follow-up|2|||
147283087|NCT02646423|531202813|FG000|Overall Study|Adverse Event|5|||
147283088|NCT02646423|531202814|FG001|Overall Study|Adverse Event|7|||
147283089|NCT02646423|531202813|FG000|Overall Study|Ineligible|2|||
147283090|NCT02646423|531202814|FG001|Overall Study|Ineligible|1|||
147283091|NCT00086346|531202818|FG000|Randomization|Did not receive test article|4|||
147283092|NCT00086346|531202819|FG001|Randomization|Did not receive test article|4|||
147283093|NCT00086346|531202818|FG000|Patients Dosed With Test Article|Adverse Event|94|||
147283094|NCT00086346|531202819|FG001|Patients Dosed With Test Article|Adverse Event|11|||
147283095|NCT00086346|531202818|FG000|Patients Dosed With Test Article|Lost to Follow-up|1|||
147283096|NCT00086346|531202819|FG001|Patients Dosed With Test Article|Lost to Follow-up|3|||
147283097|NCT00086346|531202818|FG000|Patients Dosed With Test Article|Nonmedical event|7|||
147283098|NCT00086346|531202819|FG001|Patients Dosed With Test Article|Nonmedical event|3|||
147283099|NCT00086346|531202818|FG000|Patients Dosed With Test Article|Withdrawal by Subject|16|||
147283100|NCT00086346|531202819|FG001|Patients Dosed With Test Article|Withdrawal by Subject|3|||
147283101|NCT00086346|531202818|FG000|Patients Dosed With Test Article|Protocol Violation|11|||
147283102|NCT00086346|531202819|FG001|Patients Dosed With Test Article|Protocol Violation|3|||
147283103|NCT00086346|531202818|FG000|Patients Dosed With Test Article|Lack of Efficacy|11|||
147283104|NCT00086346|531202819|FG001|Patients Dosed With Test Article|Lack of Efficacy|0|||
147283105|NCT02807948|531202820|FG000|Overall Study|Physician Decision|1|||
147283106|NCT02807948|531202821|FG001|Overall Study|Physician Decision|0|||
147283107|NCT01303627|531202825|FG000|Overall Study|the failure while performing URS|0|||
147283108|NCT01303627|531202826|FG001|Overall Study|the failure while performing URS|1|||
147283109|NCT02511431|531202835|FG000|Treatment|Lost to Follow-up|0|||
147283110|NCT02511431|531202836|FG001|Treatment|Lost to Follow-up|0|||
147603984|NCT03400943|532367786|FG001|Treatment Period 2|Withdrawal by Subject|1|||
147283111|NCT02511431|531202837|FG002|Treatment|Lost to Follow-up|1|||
147283112|NCT02511431|531202838|FG003|Treatment|Lost to Follow-up|0|||
147283113|NCT02511431|531202839|FG004|Treatment|Lost to Follow-up|0|||
147283114|NCT02511431|531202840|FG005|Treatment|Lost to Follow-up|1|||
147283115|NCT00462384|531202841|FG000|Overall Study|Adverse Event|2|||
147283116|NCT00462384|531202841|FG000|Overall Study|Death|2|||
147283117|NCT00462384|531202841|FG000|Overall Study|Withdrawal by Subject|1|||
147283118|NCT00462384|531202841|FG000|Overall Study|Other|4|||
147283119|NCT01131312|531202842|FG000|Overall Study|Lost to Follow-up|425|||
147283120|NCT01131312|531202843|FG001|Overall Study|Lost to Follow-up|229|||
147283121|NCT01131312|531202844|FG002|Overall Study|Lost to Follow-up|351|||
147283122|NCT03879798|531202846|FG000|Overall Study|Adverse Event|0|||
147283123|NCT03879798|531202847|FG001|Overall Study|Adverse Event|0|||
147283124|NCT03879798|531202848|FG002|Overall Study|Adverse Event|0|||
147283125|NCT03879798|531202849|FG003|Overall Study|Adverse Event|0|||
147283126|NCT03879798|531202850|FG004|Overall Study|Adverse Event|0|||
147283127|NCT03879798|531202851|FG005|Overall Study|Adverse Event|1|||
147283128|NCT03879798|531202846|FG000|Overall Study|Lack of Efficacy|0|||
147283129|NCT03879798|531202847|FG001|Overall Study|Lack of Efficacy|0|||
147283130|NCT03879798|531202848|FG002|Overall Study|Lack of Efficacy|0|||
147283131|NCT03879798|531202849|FG003|Overall Study|Lack of Efficacy|0|||
147283132|NCT03879798|531202850|FG004|Overall Study|Lack of Efficacy|0|||
147283133|NCT03879798|531202851|FG005|Overall Study|Lack of Efficacy|1|||
147283134|NCT03879798|531202846|FG000|Overall Study|Withdrawal by Subject|0|||
147283135|NCT03879798|531202847|FG001|Overall Study|Withdrawal by Subject|0|||
147283136|NCT03879798|531202848|FG002|Overall Study|Withdrawal by Subject|0|||
147283137|NCT03879798|531202849|FG003|Overall Study|Withdrawal by Subject|0|||
147283138|NCT03879798|531202850|FG004|Overall Study|Withdrawal by Subject|0|||
147283139|NCT03879798|531202851|FG005|Overall Study|Withdrawal by Subject|1|||
147283140|NCT03893448|531202853|FG000|Overall Study|Withdrawal by Parent/Guardian|59|||
147283141|NCT03893448|531202854|FG001|Overall Study|Withdrawal by Parent/Guardian|85|||
147283142|NCT03893448|531202853|FG000|Overall Study|Physician Decision|8|||
147283143|NCT03893448|531202854|FG001|Overall Study|Physician Decision|14|||
147283144|NCT03893448|531202853|FG000|Overall Study|Lost to Follow-up|34|||
147283145|NCT03893448|531202854|FG001|Overall Study|Lost to Follow-up|27|||
147283146|NCT03893448|531202853|FG000|Overall Study|Death|1|||
147283147|NCT03893448|531202854|FG001|Overall Study|Death|0|||
147283148|NCT00856583|531202859|FG000|Overall Study|Lack of Efficacy|389|||
147603985|NCT03400943|532367787|FG002|Treatment Period 2|Withdrawal by Subject|0|||
147283149|NCT00856583|531202860|FG001|Overall Study|Lack of Efficacy|377|||
147283150|NCT00856583|531202859|FG000|Overall Study|Serious Adverse Event (SAE)|99|||
147283151|NCT00856583|531202860|FG001|Overall Study|Serious Adverse Event (SAE)|65|||
147283152|NCT00856583|531202859|FG000|Overall Study|Non-SAE: Mostly Asymptomatic ECGs|393|||
147283153|NCT00856583|531202860|FG001|Overall Study|Non-SAE: Mostly Asymptomatic ECGs|179|||
147283154|NCT00856583|531202859|FG000|Overall Study|Non-compliance|305|||
147283155|NCT00856583|531202860|FG001|Overall Study|Non-compliance|262|||
147283156|NCT00856583|531202859|FG000|Overall Study|Withdrawal by Subject|1092|||
147283157|NCT00856583|531202860|FG001|Overall Study|Withdrawal by Subject|919|||
147283158|NCT00856583|531202859|FG000|Overall Study|Physician Decision|59|||
147283159|NCT00856583|531202860|FG001|Overall Study|Physician Decision|82|||
147283160|NCT00856583|531202859|FG000|Overall Study|Pregnancy|14|||
147283161|NCT00856583|531202860|FG001|Overall Study|Pregnancy|5|||
147283162|NCT00856583|531202859|FG000|Overall Study|Other|92|||
147283163|NCT00856583|531202860|FG001|Overall Study|Other|104|||
147283164|NCT00856583|531202859|FG000|Overall Study|Non-evaluable: Patient on Polytherapy|694|||
147283165|NCT00856583|531202860|FG001|Overall Study|Non-evaluable: Patient on Polytherapy|604|||
147283166|NCT01944046|531202861|FG000|Randomized to DB|Adverse Event|5|||
147283167|NCT01944046|531202862|FG001|Randomized to DB|Adverse Event|2|||
147283168|NCT01944046|531202861|FG000|Randomized to DB|Clinical Worsening|3|||
147283169|NCT01944046|531202862|FG001|Randomized to DB|Clinical Worsening|2|||
147283170|NCT01944046|531202861|FG000|Randomized to DB|Lost to Follow-up|3|||
147283171|NCT01944046|531202862|FG001|Randomized to DB|Lost to Follow-up|3|||
147283172|NCT01944046|531202861|FG000|Randomized to DB|Withdrawal by Subject|2|||
147283173|NCT01944046|531202862|FG001|Randomized to DB|Withdrawal by Subject|4|||
147283174|NCT01944046|531202861|FG000|Randomized to DB|Physician Decision|1|||
147283175|NCT01944046|531202862|FG001|Randomized to DB|Physician Decision|2|||
147283176|NCT01944046|531202861|FG000|Randomized to DB|Did not have baseline ABC-SW|2|||
147283177|NCT01944046|531202862|FG001|Randomized to DB|Did not have baseline ABC-SW|0|||
147283178|NCT01944046|531202861|FG000|Randomized to DB|Did not have a postbaseline ABC SW|5|||
147283179|NCT01944046|531202862|FG001|Randomized to DB|Did not have a postbaseline ABC SW|6|||
147283180|NCT01944046|531202861|FG000|Open Label Eligible and Consented|Lost to Follow-up|3|||
147283181|NCT01944046|531202862|FG001|Open Label Eligible and Consented|Lost to Follow-up|5|||
147336497|NCT01241292|531398681|FG001|Overall Study|Participant Discontinued Treatment|2|||
147283182|NCT01944046|531202861|FG000|Open Label Eligible and Consented|Adverse Event|6|||
147283183|NCT01944046|531202862|FG001|Open Label Eligible and Consented|Adverse Event|1|||
147283184|NCT01944046|531202861|FG000|Open Label Eligible and Consented|Clinical Worsening|4|||
147451541|NCT04417894|531814919|FG000|Overall Study|Lost to Follow-up|3|||
147451542|NCT04417894|531814920|FG001|Overall Study|Lost to Follow-up|0|||
147451543|NCT04417894|531814919|FG000|Overall Study|Withdrawal by Subject|7|||
147283185|NCT01944046|531202862|FG001|Open Label Eligible and Consented|Clinical Worsening|2|||
147283186|NCT01944046|531202861|FG000|Open Label Eligible and Consented|Withdrawal by Subject|1|||
147283187|NCT01944046|531202862|FG001|Open Label Eligible and Consented|Withdrawal by Subject|0|||
147283188|NCT01985126|531202866|FG000|Overall Study|Death|15|||
147283189|NCT01985126|531202867|FG001|Overall Study|Death|69|||
147451544|NCT04417894|531814920|FG001|Overall Study|Withdrawal by Subject|6|||
147451545|NCT04417894|531814919|FG000|Overall Study|Lack of Efficacy|3|||
147451546|NCT04417894|531814920|FG001|Overall Study|Lack of Efficacy|1|||
147451547|NCT01836783|531814931|FG000|Overall Study|Withdrawal by Subject|0|||
147451548|NCT01836783|531814932|FG001|Overall Study|Withdrawal by Subject|2|||
147451549|NCT01273883|531814934|FG000|First Intervention|Adverse Event|2|||
147451550|NCT01273883|531814935|FG001|First Intervention|Adverse Event|1|||
147451551|NCT01273883|531814934|FG000|Second Intervention|Lost to Follow-up|1|||
147451552|NCT01273883|531814935|FG001|Second Intervention|Lost to Follow-up|1|||
147451553|NCT01273883|531814934|FG000|Second Intervention|Lack of Efficacy|1|||
147451554|NCT01273883|531814935|FG001|Second Intervention|Lack of Efficacy|0|||
147451555|NCT02124564|531814938|FG000|Treatment Period|Adverse Event|2|||
147451556|NCT02124564|531814938|FG000|Treatment Period|Lack of Efficacy|3|||
147451557|NCT02124564|531814938|FG000|Treatment Period|Withdrawal by Subject|2|||
147451558|NCT04489888|531814939|FG000|Overall Study|Death|75|||
147451559|NCT04489888|531814939|FG000|Overall Study|Sponsor Decision|26|||
147451560|NCT02043548|531814942|FG000|Overall Study|Lack of Efficacy|1|||
147451561|NCT02043548|531814943|FG001|Overall Study|Lack of Efficacy|0|||
147451562|NCT02043548|531814942|FG000|Overall Study|Adverse Event|0|||
147451563|NCT02043548|531814943|FG001|Overall Study|Adverse Event|1|||
147451564|NCT01430455|531814950|FG000|Overall Study|Withdrawal by Subject|1|||
147451565|NCT01430455|531814950|FG000|Overall Study|Switched to follow-up phase|1|||
147451566|NCT03829657|531814954|FG000|OL Treatment Period (Week 1 to Week 16)|Adverse Event|12|||
147451567|NCT03829657|531814955|FG001|OL Treatment Period (Week 1 to Week 16)|Adverse Event|4|||
147451568|NCT03829657|531814956|FG002|OL Treatment Period (Week 1 to Week 16)|Adverse Event|2|||
147451569|NCT03829657|531814957|FG003|OL Treatment Period (Week 1 to Week 16)|Adverse Event|0|||
147451570|NCT03829657|531814958|FG004|OL Treatment Period (Week 1 to Week 16)|Adverse Event|0|||
147451571|NCT03829657|531814954|FG000|OL Treatment Period (Week 1 to Week 16)|Physician Decision|1|||
147451572|NCT03829657|531814955|FG001|OL Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
147451573|NCT03829657|531814956|FG002|OL Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
147451574|NCT03829657|531814957|FG003|OL Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
147451575|NCT03829657|531814958|FG004|OL Treatment Period (Week 1 to Week 16)|Physician Decision|0|||
147451576|NCT03829657|531814954|FG000|OL Treatment Period (Week 1 to Week 16)|Study Terminated by Sponsor|1|||
147451577|NCT03829657|531814955|FG001|OL Treatment Period (Week 1 to Week 16)|Study Terminated by Sponsor|3|||
147451578|NCT03829657|531814956|FG002|OL Treatment Period (Week 1 to Week 16)|Study Terminated by Sponsor|9|||
147451579|NCT03829657|531814957|FG003|OL Treatment Period (Week 1 to Week 16)|Study Terminated by Sponsor|0|||
147451580|NCT03829657|531814958|FG004|OL Treatment Period (Week 1 to Week 16)|Study Terminated by Sponsor|0|||
147451581|NCT03829657|531814954|FG000|OL Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|6|||
147451582|NCT03829657|531814955|FG001|OL Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|7|||
147451583|NCT03829657|531814956|FG002|OL Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|5|||
147451584|NCT03829657|531814957|FG003|OL Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|0|||
147451585|NCT03829657|531814958|FG004|OL Treatment Period (Week 1 to Week 16)|Withdrawal by Subject|0|||
147451586|NCT03829657|531814954|FG000|OL Treatment Period (Week 1 to Week 16)|Failure to Meet Day 29 Continuation Criterion|10|||
147451587|NCT03829657|531814955|FG001|OL Treatment Period (Week 1 to Week 16)|Failure to Meet Day 29 Continuation Criterion|6|||
147451588|NCT03829657|531814956|FG002|OL Treatment Period (Week 1 to Week 16)|Failure to Meet Day 29 Continuation Criterion|4|||
147451589|NCT03829657|531814957|FG003|OL Treatment Period (Week 1 to Week 16)|Failure to Meet Day 29 Continuation Criterion|0|||
147451590|NCT03829657|531814958|FG004|OL Treatment Period (Week 1 to Week 16)|Failure to Meet Day 29 Continuation Criterion|0|||
147451591|NCT03829657|531814954|FG000|OL Treatment Period (Week 1 to Week 16)|Miscellaneous|3|||
147451592|NCT03829657|531814955|FG001|OL Treatment Period (Week 1 to Week 16)|Miscellaneous|1|||
147451593|NCT03829657|531814956|FG002|OL Treatment Period (Week 1 to Week 16)|Miscellaneous|1|||
147451594|NCT03829657|531814957|FG003|OL Treatment Period (Week 1 to Week 16)|Miscellaneous|0|||
147451595|NCT03829657|531814958|FG004|OL Treatment Period (Week 1 to Week 16)|Miscellaneous|0|||
147451596|NCT03829657|531814954|FG000|RW Treatment Period (Week 16 to Week 24)|Adverse Event|0|||
147451597|NCT03829657|531814955|FG001|RW Treatment Period (Week 16 to Week 24)|Adverse Event|0|||
147451598|NCT03829657|531814956|FG002|RW Treatment Period (Week 16 to Week 24)|Adverse Event|0|||
147451599|NCT03829657|531814957|FG003|RW Treatment Period (Week 16 to Week 24)|Adverse Event|0|||
147451600|NCT03829657|531814958|FG004|RW Treatment Period (Week 16 to Week 24)|Adverse Event|1|||
147283190|NCT01985126|531202866|FG000|Overall Study|Lost to Follow-up|0|||
147451601|NCT03829657|531814954|FG000|RW Treatment Period (Week 16 to Week 24)|Study Terminated by Sponsor|0|||
147283191|NCT01985126|531202867|FG001|Overall Study|Lost to Follow-up|8|||
147283192|NCT01985126|531202866|FG000|Overall Study|Study Terminated By Sponsor|1|||
147283193|NCT01985126|531202867|FG001|Overall Study|Study Terminated By Sponsor|22|||
147603986|NCT03400943|532367788|FG003|Treatment Period 2|Withdrawal by Subject|0|||
147603987|NCT03400943|532367785|FG000|Treatment Period 2|Other|1|||
147603988|NCT03400943|532367786|FG001|Treatment Period 2|Other|6|||
147283194|NCT01985126|531202866|FG000|Overall Study|Withdrawal by Subject|2|||
147283195|NCT01985126|531202867|FG001|Overall Study|Withdrawal by Subject|7|||
147283196|NCT02371369|531202870|FG000|Part 1|Physician Decision|0|||
147283197|NCT02371369|531202871|FG001|Part 1|Physician Decision|3|||
147283198|NCT02371369|531202870|FG000|Part 1|Adverse Event|8|||
147336498|NCT03034915|531398684|FG000|Overall Study|Adverse Event|29|||
147336499|NCT03034915|531398685|FG001|Overall Study|Adverse Event|32|||
147336500|NCT03034915|531398686|FG002|Overall Study|Adverse Event|22|||
147336501|NCT03034915|531398684|FG000|Overall Study|Lost to Follow-up|5|||
147336502|NCT03034915|531398685|FG001|Overall Study|Lost to Follow-up|13|||
147336503|NCT03034915|531398686|FG002|Overall Study|Lost to Follow-up|3|||
147662622|NCT01529606|532587364|FG001|Overall Study|Lost to Follow-up|18|||
147336504|NCT03034915|531398684|FG000|Overall Study|Withdrawal by Subject|29|||
147603989|NCT03400943|532367787|FG002|Treatment Period 2|Other|0|||
147603990|NCT03400943|532367788|FG003|Treatment Period 2|Other|0|||
147603991|NCT03400943|532367785|FG000|Follow-up Period|Withdrawal by Subject|1|||
147603992|NCT03400943|532367786|FG001|Follow-up Period|Withdrawal by Subject|0|||
147603993|NCT03400943|532367787|FG002|Follow-up Period|Withdrawal by Subject|0|||
147603994|NCT03400943|532367788|FG003|Follow-up Period|Withdrawal by Subject|0|||
147603995|NCT00537303|532367789|FG000|Overall Study|Adverse Event|1|||
147603996|NCT00537303|532367790|FG001|Overall Study|Adverse Event|4|||
147603997|NCT00537303|532367789|FG000|Overall Study|Lack of Efficacy|6|||
147603998|NCT00537303|532367790|FG001|Overall Study|Lack of Efficacy|7|||
147603999|NCT00537303|532367789|FG000|Overall Study|Protocol Violation|8|||
147604000|NCT00537303|532367790|FG001|Overall Study|Protocol Violation|4|||
147604001|NCT00537303|532367789|FG000|Overall Study|Withdrawal criteria|3|||
147604002|NCT00537303|532367790|FG001|Overall Study|Withdrawal criteria|3|||
147604003|NCT00537303|532367789|FG000|Overall Study|Unclassified|8|||
147662623|NCT01746862|532587365|FG000|Overall Study|Withdrawal by Subject|1|||
147662624|NCT01746862|532587366|FG001|Overall Study|Withdrawal by Subject|1|||
147662625|NCT01746862|532587365|FG000|Overall Study|Protocol Violation|1|||
147662626|NCT01746862|532587366|FG001|Overall Study|Protocol Violation|0|||
147662627|NCT01746862|532587365|FG000|Overall Study|Consent withdrawal by parent's guardian|5|||
147336505|NCT03034915|531398685|FG001|Overall Study|Withdrawal by Subject|46|||
147336506|NCT03034915|531398686|FG002|Overall Study|Withdrawal by Subject|41|||
147336507|NCT03034915|531398684|FG000|Overall Study|Protocol Deviation|2|||
147336508|NCT03034915|531398685|FG001|Overall Study|Protocol Deviation|14|||
147336509|NCT03034915|531398686|FG002|Overall Study|Protocol Deviation|7|||
147336510|NCT03034915|531398684|FG000|Overall Study|Lack of Efficacy|8|||
147336511|NCT03034915|531398685|FG001|Overall Study|Lack of Efficacy|16|||
147336512|NCT03034915|531398686|FG002|Overall Study|Lack of Efficacy|18|||
147336513|NCT03034915|531398684|FG000|Overall Study|Site closed|2|||
147336514|NCT03034915|531398685|FG001|Overall Study|Site closed|2|||
147336515|NCT03034915|531398686|FG002|Overall Study|Site closed|4|||
147336516|NCT03034915|531398684|FG000|Overall Study|Protocol-defined withdrawal criteria met|19|||
147336517|NCT03034915|531398685|FG001|Overall Study|Protocol-defined withdrawal criteria met|26|||
147336518|NCT03034915|531398686|FG002|Overall Study|Protocol-defined withdrawal criteria met|29|||
147336519|NCT03034915|531398684|FG000|Overall Study|Physician Decision|1|||
147336520|NCT03034915|531398685|FG001|Overall Study|Physician Decision|5|||
147336521|NCT03034915|531398686|FG002|Overall Study|Physician Decision|2|||
147336522|NCT03593213|531398687|FG000|Open-label Treatment Period (18 Weeks)|Adverse Event|39|||
147336523|NCT03593213|531398688|FG001|Open-label Treatment Period (18 Weeks)|Adverse Event|0|||
147336524|NCT03593213|531398689|FG002|Open-label Treatment Period (18 Weeks)|Adverse Event|0|||
147336525|NCT03593213|531398690|FG003|Open-label Treatment Period (18 Weeks)|Adverse Event|0|||
147336526|NCT03593213|531398687|FG000|Open-label Treatment Period (18 Weeks)|Lack of Efficacy|14|||
147336527|NCT03593213|531398688|FG001|Open-label Treatment Period (18 Weeks)|Lack of Efficacy|0|||
147336528|NCT03593213|531398689|FG002|Open-label Treatment Period (18 Weeks)|Lack of Efficacy|0|||
147336529|NCT03593213|531398690|FG003|Open-label Treatment Period (18 Weeks)|Lack of Efficacy|0|||
147336530|NCT03593213|531398687|FG000|Open-label Treatment Period (18 Weeks)|Withdrawal by Subject|85|||
147336531|NCT03593213|531398688|FG001|Open-label Treatment Period (18 Weeks)|Withdrawal by Subject|0|||
147336532|NCT03593213|531398689|FG002|Open-label Treatment Period (18 Weeks)|Withdrawal by Subject|0|||
147336533|NCT03593213|531398690|FG003|Open-label Treatment Period (18 Weeks)|Withdrawal by Subject|0|||
147604004|NCT00537303|532367790|FG001|Overall Study|Unclassified|7|||
147604005|NCT03839823|532367791|FG000|Overall Study|Adverse Event|8|||
147283199|NCT02371369|531202871|FG001|Part 1|Adverse Event|0|||
147283200|NCT02371369|531202870|FG000|Part 1|Withdrawal by Subject|1|||
147283201|NCT02371369|531202871|FG001|Part 1|Withdrawal by Subject|6|||
147283202|NCT02371369|531202870|FG000|Part 1|Disease progression|0|||
147283203|NCT02371369|531202871|FG001|Part 1|Disease progression|1|||
147283204|NCT02371369|531202870|FG000|Part 1|Protocol Violation|0|||
147283205|NCT02371369|531202871|FG001|Part 1|Protocol Violation|1|||
147604006|NCT03839823|532367792|FG001|Overall Study|Adverse Event|4|||
147283206|NCT02371369|531202870|FG000|Part 2|Adverse Event|6|||
147283207|NCT02371369|531202871|FG001|Part 2|Adverse Event|5|||
147283208|NCT02371369|531202870|FG000|Part 2|Withdrawal by Subject|16|||
147283209|NCT02371369|531202871|FG001|Part 2|Withdrawal by Subject|6|||
147283210|NCT02371369|531202870|FG000|Part 2|Investigator decision|1|||
147283211|NCT02371369|531202871|FG001|Part 2|Investigator decision|2|||
147283212|NCT02371369|531202870|FG000|Part 2|Death|0|||
147283213|NCT02371369|531202871|FG001|Part 2|Death|1|||
147283214|NCT02371369|531202870|FG000|Part 2|Disease progression|1|||
147283215|NCT02371369|531202871|FG001|Part 2|Disease progression|0|||
147283216|NCT02371369|531202870|FG000|Part 2|Subject Noncompliance|1|||
147283217|NCT02371369|531202871|FG001|Part 2|Subject Noncompliance|0|||
147283218|NCT02371369|531202870|FG000|Part 2|Lost to Follow-up|1|||
147283219|NCT02371369|531202871|FG001|Part 2|Lost to Follow-up|1|||
147283220|NCT02371369|531202870|FG000|Part 2|Subject transitioned to commercial supply|6|||
147283221|NCT02371369|531202871|FG001|Part 2|Subject transitioned to commercial supply|4|||
147283222|NCT02371369|531202870|FG000|Part 2|Subject transitioned to another DS pexidartinib protocol|15|||
147283223|NCT02371369|531202871|FG001|Part 2|Subject transitioned to another DS pexidartinib protocol|9|||
147283224|NCT02371369|531202870|FG000|Part 2|Surgical resection of tumor|1|||
147283225|NCT02371369|531202871|FG001|Part 2|Surgical resection of tumor|1|||
147283226|NCT02371369|531202870|FG000|Part 2|Other|0|||
147283227|NCT02371369|531202871|FG001|Part 2|Other|1|||
147283228|NCT01587651|531202874|FG000|Overall Study|Adverse Event|0|||
147283229|NCT01587651|531202875|FG001|Overall Study|Adverse Event|1|||
147283230|NCT01587651|531202876|FG002|Overall Study|Adverse Event|0|||
147283231|NCT01587651|531202874|FG000|Overall Study|Protocol Violation|0|||
147283232|NCT01587651|531202875|FG001|Overall Study|Protocol Violation|1|||
147283233|NCT01587651|531202876|FG002|Overall Study|Protocol Violation|1|||
147283234|NCT01587651|531202874|FG000|Overall Study|Withdrawal by Subject|0|||
147283235|NCT01587651|531202875|FG001|Overall Study|Withdrawal by Subject|1|||
147283236|NCT01587651|531202876|FG002|Overall Study|Withdrawal by Subject|0|||
147283237|NCT03864900|531202883|FG000|Overall Study|Withdrawal by Subject|1|||
147283238|NCT03864900|531202884|FG001|Overall Study|Withdrawal by Subject|1|||
147283239|NCT03864900|531202883|FG000|Overall Study|medical reason: change anticoagulation drug, Hemorrhage, operation|2|||
147283240|NCT03864900|531202884|FG001|Overall Study|medical reason: change anticoagulation drug, Hemorrhage, operation|5|||
147283241|NCT01866709|531202885|FG000|Overall Study|Adverse Event|1|||
147283242|NCT01866709|531202886|FG001|Overall Study|Adverse Event|0|||
147283243|NCT03191903|531202890|FG000|Overall Study|Withdrawal by Subject|6|||
147283244|NCT03191903|531202891|FG001|Overall Study|Withdrawal by Subject|5|||
147283245|NCT03191903|531202892|FG002|Overall Study|Withdrawal by Subject|4|||
147283246|NCT03191903|531202890|FG000|Overall Study|Adverse Event|1|||
147283247|NCT03191903|531202891|FG001|Overall Study|Adverse Event|0|||
147283248|NCT03191903|531202892|FG002|Overall Study|Adverse Event|0|||
147283249|NCT00927927|531202898|FG000|Overall Study|Withdrawal by Subject|0|||
147283250|NCT00927927|531202899|FG001|Overall Study|Withdrawal by Subject|0|||
147283251|NCT00927927|531202900|FG002|Overall Study|Withdrawal by Subject|0|||
147283252|NCT00927927|531202901|FG003|Overall Study|Withdrawal by Subject|0|||
147283253|NCT00927927|531202902|FG004|Overall Study|Withdrawal by Subject|0|||
147283254|NCT00927927|531202903|FG005|Overall Study|Withdrawal by Subject|0|||
147283255|NCT00927927|531202904|FG006|Overall Study|Withdrawal by Subject|0|||
147283256|NCT00927927|531202905|FG007|Overall Study|Withdrawal by Subject|2|||
147283257|NCT00927927|531202906|FG008|Overall Study|Withdrawal by Subject|0|||
147283258|NCT00927927|531202907|FG009|Overall Study|Withdrawal by Subject|0|||
147283259|NCT00927927|531202908|FG010|Overall Study|Withdrawal by Subject|0|||
147283260|NCT00927927|531202909|FG011|Overall Study|Withdrawal by Subject|2|||
147283261|NCT00927927|531202910|FG012|Overall Study|Withdrawal by Subject|0|||
147283262|NCT00927927|531202911|FG013|Overall Study|Withdrawal by Subject|0|||
147283263|NCT00927927|531202912|FG014|Overall Study|Withdrawal by Subject|0|||
147336534|NCT03593213|531398687|FG000|Open-label Treatment Period (18 Weeks)|Lost to Follow-up|51|||
147283264|NCT03135522|531202919|FG000|Overall Study|Adverse Event|1|||
147283265|NCT03135522|531202920|FG001|Overall Study|Adverse Event|0|||
147283266|NCT00499369|531202921|FG000|Overall Study|Adverse Event|2|||
147283267|NCT00499369|531202922|FG001|Overall Study|Adverse Event|2|||
147283268|NCT00499369|531202923|FG002|Overall Study|Adverse Event|3|||
147283269|NCT00499369|531202924|FG003|Overall Study|Adverse Event|1|||
147283270|NCT00499369|531202925|FG004|Overall Study|Adverse Event|2|||
147283271|NCT00499369|531202921|FG000|Overall Study|Withdrawal by Subject|0|||
147283272|NCT00499369|531202922|FG001|Overall Study|Withdrawal by Subject|1|||
147283273|NCT00499369|531202923|FG002|Overall Study|Withdrawal by Subject|1|||
147283274|NCT00499369|531202924|FG003|Overall Study|Withdrawal by Subject|0|||
147283275|NCT00499369|531202925|FG004|Overall Study|Withdrawal by Subject|0|||
147283276|NCT00499369|531202921|FG000|Overall Study|Progression|10|||
147283277|NCT00499369|531202922|FG001|Overall Study|Progression|12|||
147283278|NCT00499369|531202923|FG002|Overall Study|Progression|9|||
147283279|NCT00499369|531202924|FG003|Overall Study|Progression|6|||
147283280|NCT00499369|531202925|FG004|Overall Study|Progression|10|||
147283281|NCT00499369|531202921|FG000|Overall Study|Death|0|||
147283282|NCT00499369|531202922|FG001|Overall Study|Death|1|||
147283283|NCT00499369|531202923|FG002|Overall Study|Death|0|||
147283284|NCT00499369|531202924|FG003|Overall Study|Death|0|||
147283285|NCT00499369|531202925|FG004|Overall Study|Death|0|||
147283286|NCT00499369|531202921|FG000|Overall Study|Not protocol specified|2|||
147283287|NCT00499369|531202922|FG001|Overall Study|Not protocol specified|0|||
147283288|NCT00499369|531202923|FG002|Overall Study|Not protocol specified|3|||
147283289|NCT00499369|531202924|FG003|Overall Study|Not protocol specified|1|||
147283290|NCT00499369|531202925|FG004|Overall Study|Not protocol specified|0|||
147283291|NCT00499369|531202921|FG000|Overall Study|Ineligible|2|||
147336535|NCT03593213|531398688|FG001|Open-label Treatment Period (18 Weeks)|Lost to Follow-up|0|||
147336536|NCT03593213|531398689|FG002|Open-label Treatment Period (18 Weeks)|Lost to Follow-up|0|||
147336537|NCT03593213|531398690|FG003|Open-label Treatment Period (18 Weeks)|Lost to Follow-up|0|||
147336538|NCT03593213|531398687|FG000|Open-label Treatment Period (18 Weeks)|Death|1|||
147336539|NCT03593213|531398688|FG001|Open-label Treatment Period (18 Weeks)|Death|0|||
147336540|NCT03593213|531398689|FG002|Open-label Treatment Period (18 Weeks)|Death|0|||
147336541|NCT03593213|531398690|FG003|Open-label Treatment Period (18 Weeks)|Death|0|||
147336542|NCT03593213|531398687|FG000|Open-label Treatment Period (18 Weeks)|Protocol Deviation|5|||
147336543|NCT03593213|531398688|FG001|Open-label Treatment Period (18 Weeks)|Protocol Deviation|0|||
147336544|NCT03593213|531398689|FG002|Open-label Treatment Period (18 Weeks)|Protocol Deviation|0|||
147336545|NCT03593213|531398690|FG003|Open-label Treatment Period (18 Weeks)|Protocol Deviation|0|||
147336546|NCT03593213|531398687|FG000|Open-label Treatment Period (18 Weeks)|Non-compliance with Study Drug|23|||
147527211|NCT01004822|532084173|FG006|Overall Study|Objective progression or relapse|1|||
147527212|NCT01004822|532084174|FG007|Overall Study|Objective progression or relapse|4|||
147527213|NCT01004822|532084167|FG000|Overall Study|Global deterioration of health status|0|||
147527214|NCT01004822|532084168|FG001|Overall Study|Global deterioration of health status|0|||
147283292|NCT00499369|531202922|FG001|Overall Study|Ineligible|2|||
147283293|NCT00499369|531202923|FG002|Overall Study|Ineligible|1|||
147527215|NCT01004822|532084169|FG002|Overall Study|Global deterioration of health status|0|||
147527216|NCT01004822|532084170|FG003|Overall Study|Global deterioration of health status|1|||
147527217|NCT01004822|532084171|FG004|Overall Study|Global deterioration of health status|0|||
147527218|NCT01004822|532084172|FG005|Overall Study|Global deterioration of health status|0|||
147527219|NCT01004822|532084173|FG006|Overall Study|Global deterioration of health status|1|||
147527220|NCT01004822|532084174|FG007|Overall Study|Global deterioration of health status|0|||
147527221|NCT01004822|532084167|FG000|Overall Study|No longer willing to continue|0|||
147527222|NCT01004822|532084168|FG001|Overall Study|No longer willing to continue|0|||
147527223|NCT01004822|532084169|FG002|Overall Study|No longer willing to continue|0|||
147527224|NCT01004822|532084170|FG003|Overall Study|No longer willing to continue|1|||
147527225|NCT01004822|532084171|FG004|Overall Study|No longer willing to continue|2|||
147527226|NCT01004822|532084172|FG005|Overall Study|No longer willing to continue|1|||
147527227|NCT01004822|532084173|FG006|Overall Study|No longer willing to continue|1|||
147527228|NCT01004822|532084174|FG007|Overall Study|No longer willing to continue|0|||
147527229|NCT01004822|532084167|FG000|Overall Study|Adverse Event|0|||
147527230|NCT01004822|532084168|FG001|Overall Study|Adverse Event|0|||
147527231|NCT01004822|532084169|FG002|Overall Study|Adverse Event|0|||
147527232|NCT01004822|532084170|FG003|Overall Study|Adverse Event|0|||
147527233|NCT01004822|532084171|FG004|Overall Study|Adverse Event|0|||
147527234|NCT01004822|532084172|FG005|Overall Study|Adverse Event|0|||
147527235|NCT01004822|532084173|FG006|Overall Study|Adverse Event|1|||
147527236|NCT01004822|532084174|FG007|Overall Study|Adverse Event|1|||
147527237|NCT01004822|532084167|FG000|Overall Study|Other|0|||
147527238|NCT01004822|532084168|FG001|Overall Study|Other|0|||
147527239|NCT01004822|532084169|FG002|Overall Study|Other|4|||
147527240|NCT01004822|532084170|FG003|Overall Study|Other|1|||
147527241|NCT01004822|532084171|FG004|Overall Study|Other|0|||
147527242|NCT01004822|532084172|FG005|Overall Study|Other|1|||
147527243|NCT01004822|532084173|FG006|Overall Study|Other|0|||
147527244|NCT01004822|532084174|FG007|Overall Study|Other|0|||
147527245|NCT01858701|532084175|FG000|Period 1, First 30 Days of Wear|Withdrawal by Subject|0|||
147527246|NCT01858701|532084176|FG001|Period 1, First 30 Days of Wear|Withdrawal by Subject|1|||
147527247|NCT01858701|532084175|FG000|Washout Period, 1-13 Days|Inclusion/Exclusion Criteria Not Met|1|||
147527248|NCT01858701|532084176|FG001|Washout Period, 1-13 Days|Inclusion/Exclusion Criteria Not Met|0|||
147527249|NCT01858701|532084175|FG000|Washout Period, 1-13 Days|Withdrawal by Subject|1|||
147527250|NCT01858701|532084176|FG001|Washout Period, 1-13 Days|Withdrawal by Subject|2|||
147527251|NCT01858701|532084175|FG000|Period 2, Second 30 Days of Wear|Comfort|0|||
147527252|NCT01858701|532084176|FG001|Period 2, Second 30 Days of Wear|Comfort|1|||
147527253|NCT01801475|532084179|FG000|Overall Study|Withdrawal by Subject|0|||
147527254|NCT01801475|532084180|FG001|Overall Study|Withdrawal by Subject|0|||
147527255|NCT01801475|532084181|FG002|Overall Study|Withdrawal by Subject|0|||
147527256|NCT01801475|532084182|FG003|Overall Study|Withdrawal by Subject|0|||
147527257|NCT01801475|532084183|FG004|Overall Study|Withdrawal by Subject|1|||
147527258|NCT01786707|532084184|FG000|Overall Study|Lost to Follow-up|1|||
147527259|NCT01786707|532084185|FG001|Overall Study|Lost to Follow-up|1|||
147283294|NCT00499369|531202924|FG003|Overall Study|Ineligible|1|||
147283295|NCT00499369|531202925|FG004|Overall Study|Ineligible|0|||
147283296|NCT01898195|531202926|FG000|Smoking Abstinence|Did not have good measurements|35|||
147283297|NCT01898195|531202927|FG001|Smoking Abstinence|Did not have good measurements|38|||
147283298|NCT01898195|531202928|FG002|Smoking Abstinence|Did not have good measurements|36|||
147283299|NCT03283670|531202929|FG000|Placebo Gas|Withdrawal by Subject|2|||
147283300|NCT03283670|531202929|FG000|25% Nitrous Oxide|Withdrawal by Subject|4|||
147283301|NCT03283670|531202929|FG000|50% Nitrous Oxide|Withdrawal by Subject|1|||
147283302|NCT00612313|531202933|FG000|Overall Study|Withdrawal by Subject|6|||
147283303|NCT00612313|531202934|FG001|Overall Study|Withdrawal by Subject|9|||
147283304|NCT00612313|531202933|FG000|Overall Study|Lost to Follow-up|11|||
147283305|NCT00612313|531202934|FG001|Overall Study|Lost to Follow-up|4|||
147283306|NCT01773226|531204950|FG000|Overall Study|Withdrawal by Subject|1|||
147283307|NCT00993447|531204955|FG000|Overall Study|Withdrawal by Subject|23|||
147283308|NCT00993447|531204956|FG001|Overall Study|Withdrawal by Subject|8|||
147283309|NCT00993447|531204955|FG000|Overall Study|Protocol Violation|12|||
147283310|NCT00993447|531204956|FG001|Overall Study|Protocol Violation|8|||
147283311|NCT00993447|531204955|FG000|Overall Study|Lost to Follow-up|1|||
147283312|NCT00993447|531204956|FG001|Overall Study|Lost to Follow-up|3|||
147283313|NCT00993447|531204955|FG000|Overall Study|Adverse Event|1|||
147283314|NCT00993447|531204956|FG001|Overall Study|Adverse Event|0|||
147283315|NCT00970502|531204957|FG000|Overall Study|Withdrawal by Subject|1|||
147283316|NCT02041195|531204958|FG000|Overall Study|Adverse Event|1|||
147283317|NCT02041195|531204959|FG001|Overall Study|Adverse Event|2|||
147283318|NCT02041195|531204960|FG002|Overall Study|Adverse Event|0|||
147283319|NCT02041195|531204961|FG003|Overall Study|Adverse Event|0|||
147283320|NCT02041195|531204962|FG004|Overall Study|Adverse Event|0|||
147283321|NCT02041195|531204963|FG005|Overall Study|Adverse Event|0|||
147283322|NCT02041195|531204964|FG006|Overall Study|Adverse Event|3|||
147283323|NCT02041195|531204965|FG007|Overall Study|Adverse Event|0|||
147336547|NCT03593213|531398688|FG001|Open-label Treatment Period (18 Weeks)|Non-compliance with Study Drug|0|||
147336548|NCT03593213|531398689|FG002|Open-label Treatment Period (18 Weeks)|Non-compliance with Study Drug|0|||
147336549|NCT03593213|531398690|FG003|Open-label Treatment Period (18 Weeks)|Non-compliance with Study Drug|0|||
147336550|NCT03593213|531398687|FG000|Open-label Treatment Period (18 Weeks)|Study Terminated by the Sponsor|90|||
147336551|NCT03593213|531398688|FG001|Open-label Treatment Period (18 Weeks)|Study Terminated by the Sponsor|0|||
147336552|NCT03593213|531398689|FG002|Open-label Treatment Period (18 Weeks)|Study Terminated by the Sponsor|0|||
147336553|NCT03593213|531398690|FG003|Open-label Treatment Period (18 Weeks)|Study Terminated by the Sponsor|0|||
147336554|NCT03593213|531398687|FG000|Open-label Treatment Period (18 Weeks)|Reason not Specified|13|||
147336555|NCT03593213|531398688|FG001|Open-label Treatment Period (18 Weeks)|Reason not Specified|0|||
147336556|NCT03593213|531398689|FG002|Open-label Treatment Period (18 Weeks)|Reason not Specified|0|||
147336557|NCT03593213|531398690|FG003|Open-label Treatment Period (18 Weeks)|Reason not Specified|0|||
147336558|NCT03593213|531398687|FG000|Open-label Treatment Period (18 Weeks)|Failure to Meet Randomization Criteria|104|||
147336559|NCT03593213|531398688|FG001|Open-label Treatment Period (18 Weeks)|Failure to Meet Randomization Criteria|0|||
147336560|NCT03593213|531398689|FG002|Open-label Treatment Period (18 Weeks)|Failure to Meet Randomization Criteria|0|||
147336561|NCT03593213|531398690|FG003|Open-label Treatment Period (18 Weeks)|Failure to Meet Randomization Criteria|0|||
147336562|NCT03593213|531398687|FG000|Double-blind Treatment Period (26 Weeks)|Number of Participants with Relapse Event|0|||
147336563|NCT03593213|531398688|FG001|Double-blind Treatment Period (26 Weeks)|Number of Participants with Relapse Event|15|||
147336564|NCT03593213|531398689|FG002|Double-blind Treatment Period (26 Weeks)|Number of Participants with Relapse Event|9|||
147336565|NCT03593213|531398690|FG003|Double-blind Treatment Period (26 Weeks)|Number of Participants with Relapse Event|8|||
147336566|NCT03593213|531398687|FG000|Double-blind Treatment Period (26 Weeks)|Adverse Event|0|||
147336567|NCT03593213|531398688|FG001|Double-blind Treatment Period (26 Weeks)|Adverse Event|2|||
147336568|NCT03593213|531398689|FG002|Double-blind Treatment Period (26 Weeks)|Adverse Event|0|||
147336569|NCT03593213|531398690|FG003|Double-blind Treatment Period (26 Weeks)|Adverse Event|4|||
147336570|NCT03593213|531398687|FG000|Double-blind Treatment Period (26 Weeks)|Withdrawal by Subject|0|||
147336571|NCT03593213|531398688|FG001|Double-blind Treatment Period (26 Weeks)|Withdrawal by Subject|4|||
147527260|NCT00421928|532084186|FG000|Overall Study|Adverse Event|61|||
147527261|NCT00421928|532084187|FG001|Overall Study|Adverse Event|140|||
147283324|NCT02041195|531204958|FG000|Overall Study|Withdrawal by Subject|1|||
147283325|NCT02041195|531204959|FG001|Overall Study|Withdrawal by Subject|0|||
147283326|NCT02041195|531204960|FG002|Overall Study|Withdrawal by Subject|0|||
147283327|NCT02041195|531204961|FG003|Overall Study|Withdrawal by Subject|0|||
147527262|NCT00421928|532084188|FG002|Overall Study|Adverse Event|22|||
147527263|NCT00421928|532084186|FG000|Overall Study|Lost to Follow-up|5|||
147527264|NCT00421928|532084187|FG001|Overall Study|Lost to Follow-up|0|||
147283328|NCT02041195|531204962|FG004|Overall Study|Withdrawal by Subject|0|||
147283329|NCT02041195|531204963|FG005|Overall Study|Withdrawal by Subject|0|||
147283330|NCT02041195|531204964|FG006|Overall Study|Withdrawal by Subject|4|||
147283331|NCT02041195|531204965|FG007|Overall Study|Withdrawal by Subject|3|||
147283332|NCT02041195|531204958|FG000|Overall Study|Unable to comply with study visits|0|||
147451602|NCT03829657|531814955|FG001|RW Treatment Period (Week 16 to Week 24)|Study Terminated by Sponsor|0|||
147451603|NCT03829657|531814956|FG002|RW Treatment Period (Week 16 to Week 24)|Study Terminated by Sponsor|0|||
147451604|NCT03829657|531814957|FG003|RW Treatment Period (Week 16 to Week 24)|Study Terminated by Sponsor|2|||
147451605|NCT03829657|531814958|FG004|RW Treatment Period (Week 16 to Week 24)|Study Terminated by Sponsor|3|||
147451606|NCT03829657|531814954|FG000|RW Treatment Period (Week 16 to Week 24)|Withdrawal by Subject|0|||
147451607|NCT03829657|531814955|FG001|RW Treatment Period (Week 16 to Week 24)|Withdrawal by Subject|0|||
147451608|NCT03829657|531814956|FG002|RW Treatment Period (Week 16 to Week 24)|Withdrawal by Subject|0|||
147451609|NCT03829657|531814957|FG003|RW Treatment Period (Week 16 to Week 24)|Withdrawal by Subject|1|||
147451610|NCT03829657|531814958|FG004|RW Treatment Period (Week 16 to Week 24)|Withdrawal by Subject|1|||
147451611|NCT03829657|531814954|FG000|RW Treatment Period (Week 16 to Week 24)|Miscellaneous|0|||
147451612|NCT03829657|531814955|FG001|RW Treatment Period (Week 16 to Week 24)|Miscellaneous|0|||
147451613|NCT03829657|531814956|FG002|RW Treatment Period (Week 16 to Week 24)|Miscellaneous|0|||
147451614|NCT03829657|531814957|FG003|RW Treatment Period (Week 16 to Week 24)|Miscellaneous|0|||
147451615|NCT03829657|531814958|FG004|RW Treatment Period (Week 16 to Week 24)|Miscellaneous|1|||
147451616|NCT04418076|531814960|FG000|Overall Study|Death|1|||
147451617|NCT04418076|531814961|FG001|Overall Study|Death|0|||
147451618|NCT04418076|531814962|FG002|Overall Study|Death|0|||
147451619|NCT04418076|531814963|FG003|Overall Study|Death|0|||
147451620|NCT04418076|531814960|FG000|Overall Study|Lost to Follow-up|2|||
147451621|NCT04418076|531814961|FG001|Overall Study|Lost to Follow-up|5|||
147451622|NCT04418076|531814962|FG002|Overall Study|Lost to Follow-up|1|||
147451623|NCT04418076|531814963|FG003|Overall Study|Lost to Follow-up|2|||
147451624|NCT04418076|531814960|FG000|Overall Study|Withdrawal by Subject|1|||
147451625|NCT04418076|531814961|FG001|Overall Study|Withdrawal by Subject|0|||
147451626|NCT04418076|531814962|FG002|Overall Study|Withdrawal by Subject|1|||
147451627|NCT04418076|531814963|FG003|Overall Study|Withdrawal by Subject|1|||
147451628|NCT04418076|531814960|FG000|Overall Study|Dropped out after receiving pillbox and phone|2|||
147451629|NCT04418076|531814961|FG001|Overall Study|Dropped out after receiving pillbox and phone|0|||
147451630|NCT04418076|531814962|FG002|Overall Study|Dropped out after receiving pillbox and phone|2|||
147451631|NCT04418076|531814963|FG003|Overall Study|Dropped out after receiving pillbox and phone|3|||
147451632|NCT01425008|531814965|FG000|Dose Escalation Phase|Progressive Disease|2|||
147451633|NCT01425008|531814966|FG001|Dose Escalation Phase|Progressive Disease|3|||
147451634|NCT01425008|531814967|FG002|Dose Escalation Phase|Progressive Disease|2|||
147451635|NCT01425008|531814968|FG003|Dose Escalation Phase|Progressive Disease|3|||
147451636|NCT01425008|531814969|FG004|Dose Escalation Phase|Progressive Disease|5|||
147451637|NCT01425008|531814970|FG005|Dose Escalation Phase|Progressive Disease|4|||
147451638|NCT01425008|531814971|FG006|Dose Escalation Phase|Progressive Disease|0|||
147451639|NCT01425008|531814972|FG007|Dose Escalation Phase|Progressive Disease|2|||
147451640|NCT01425008|531814973|FG008|Dose Escalation Phase|Progressive Disease|6|||
147451641|NCT01425008|531814974|FG009|Dose Escalation Phase|Progressive Disease|2|||
147451642|NCT01425008|531814975|FG010|Dose Escalation Phase|Progressive Disease|0|||
147451643|NCT01425008|531814976|FG011|Dose Escalation Phase|Progressive Disease|0|||
147451644|NCT01425008|531814977|FG012|Dose Escalation Phase|Progressive Disease|0|||
147451645|NCT01425008|531814978|FG013|Dose Escalation Phase|Progressive Disease|0|||
147451646|NCT01425008|531814979|FG014|Dose Escalation Phase|Progressive Disease|0|||
147451647|NCT01425008|531814980|FG015|Dose Escalation Phase|Progressive Disease|0|||
147451648|NCT01425008|531814981|FG016|Dose Escalation Phase|Progressive Disease|0|||
147451649|NCT01425008|531814982|FG017|Dose Escalation Phase|Progressive Disease|0|||
147451650|NCT01425008|531814983|FG018|Dose Escalation Phase|Progressive Disease|0|||
147451651|NCT01425008|531814965|FG000|Dose Escalation Phase|Adverse Event|2|||
147451652|NCT01425008|531814966|FG001|Dose Escalation Phase|Adverse Event|0|||
147451653|NCT01425008|531814967|FG002|Dose Escalation Phase|Adverse Event|0|||
147451654|NCT01425008|531814968|FG003|Dose Escalation Phase|Adverse Event|0|||
147451655|NCT01425008|531814969|FG004|Dose Escalation Phase|Adverse Event|0|||
147451656|NCT01425008|531814970|FG005|Dose Escalation Phase|Adverse Event|2|||
147451657|NCT01425008|531814971|FG006|Dose Escalation Phase|Adverse Event|0|||
147451658|NCT01425008|531814972|FG007|Dose Escalation Phase|Adverse Event|0|||
147451659|NCT01425008|531814973|FG008|Dose Escalation Phase|Adverse Event|2|||
147451660|NCT01425008|531814974|FG009|Dose Escalation Phase|Adverse Event|0|||
147451661|NCT01425008|531814975|FG010|Dose Escalation Phase|Adverse Event|0|||
147604007|NCT03839823|532367791|FG000|Overall Study|Death|1|||
147451662|NCT01425008|531814976|FG011|Dose Escalation Phase|Adverse Event|0|||
147451663|NCT01425008|531814977|FG012|Dose Escalation Phase|Adverse Event|0|||
147451664|NCT01425008|531814978|FG013|Dose Escalation Phase|Adverse Event|0|||
147451665|NCT01425008|531814979|FG014|Dose Escalation Phase|Adverse Event|0|||
147451666|NCT01425008|531814980|FG015|Dose Escalation Phase|Adverse Event|0|||
147604008|NCT03839823|532367792|FG001|Overall Study|Death|0|||
147604009|NCT03839823|532367791|FG000|Overall Study|Physician Decision|1|||
147451667|NCT01425008|531814981|FG016|Dose Escalation Phase|Adverse Event|0|||
147451668|NCT01425008|531814982|FG017|Dose Escalation Phase|Adverse Event|0|||
147451669|NCT01425008|531814983|FG018|Dose Escalation Phase|Adverse Event|0|||
147451670|NCT01425008|531814965|FG000|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
147451671|NCT01425008|531814966|FG001|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
147451672|NCT01425008|531814967|FG002|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
147451673|NCT01425008|531814968|FG003|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
147451674|NCT01425008|531814969|FG004|Dose Escalation Phase|Unsatisfactory Therapeutic Response|1|||
147451675|NCT01425008|531814970|FG005|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
147451676|NCT01425008|531814971|FG006|Dose Escalation Phase|Unsatisfactory Therapeutic Response|2|||
147451677|NCT01425008|531814972|FG007|Dose Escalation Phase|Unsatisfactory Therapeutic Response|1|||
147451678|NCT01425008|531814973|FG008|Dose Escalation Phase|Unsatisfactory Therapeutic Response|1|||
147451679|NCT01425008|531814974|FG009|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
147451680|NCT01425008|531814975|FG010|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
147451681|NCT01425008|531814976|FG011|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
147451682|NCT01425008|531814977|FG012|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
147451683|NCT01425008|531814978|FG013|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
147451684|NCT01425008|531814979|FG014|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
147451685|NCT01425008|531814980|FG015|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
147451686|NCT01425008|531814981|FG016|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
147451687|NCT01425008|531814982|FG017|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
147451688|NCT01425008|531814983|FG018|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
147451689|NCT01425008|531814965|FG000|Dose Escalation Phase|Withdrawal by Subject|0|||
147451690|NCT01425008|531814966|FG001|Dose Escalation Phase|Withdrawal by Subject|0|||
147451691|NCT01425008|531814967|FG002|Dose Escalation Phase|Withdrawal by Subject|0|||
147451692|NCT01425008|531814968|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
147451693|NCT01425008|531814969|FG004|Dose Escalation Phase|Withdrawal by Subject|1|||
147451694|NCT01425008|531814970|FG005|Dose Escalation Phase|Withdrawal by Subject|1|||
147451695|NCT01425008|531814971|FG006|Dose Escalation Phase|Withdrawal by Subject|1|||
147451696|NCT01425008|531814972|FG007|Dose Escalation Phase|Withdrawal by Subject|0|||
147451697|NCT01425008|531814973|FG008|Dose Escalation Phase|Withdrawal by Subject|1|||
147451698|NCT01425008|531814974|FG009|Dose Escalation Phase|Withdrawal by Subject|0|||
147451699|NCT01425008|531814975|FG010|Dose Escalation Phase|Withdrawal by Subject|0|||
147451700|NCT01425008|531814976|FG011|Dose Escalation Phase|Withdrawal by Subject|0|||
147451701|NCT01425008|531814977|FG012|Dose Escalation Phase|Withdrawal by Subject|0|||
147451702|NCT01425008|531814978|FG013|Dose Escalation Phase|Withdrawal by Subject|0|||
147451703|NCT01425008|531814979|FG014|Dose Escalation Phase|Withdrawal by Subject|0|||
147451704|NCT01425008|531814980|FG015|Dose Escalation Phase|Withdrawal by Subject|0|||
147451705|NCT01425008|531814981|FG016|Dose Escalation Phase|Withdrawal by Subject|0|||
147451706|NCT01425008|531814982|FG017|Dose Escalation Phase|Withdrawal by Subject|0|||
147451707|NCT01425008|531814983|FG018|Dose Escalation Phase|Withdrawal by Subject|0|||
147451708|NCT01425008|531814965|FG000|Dose Escalation Phase|Symptomatic Deterioration|0|||
147451709|NCT01425008|531814966|FG001|Dose Escalation Phase|Symptomatic Deterioration|0|||
147451710|NCT01425008|531814967|FG002|Dose Escalation Phase|Symptomatic Deterioration|1|||
147451711|NCT01425008|531814968|FG003|Dose Escalation Phase|Symptomatic Deterioration|0|||
147451712|NCT01425008|531814969|FG004|Dose Escalation Phase|Symptomatic Deterioration|0|||
147451713|NCT01425008|531814970|FG005|Dose Escalation Phase|Symptomatic Deterioration|0|||
147451714|NCT01425008|531814971|FG006|Dose Escalation Phase|Symptomatic Deterioration|0|||
147451715|NCT01425008|531814972|FG007|Dose Escalation Phase|Symptomatic Deterioration|0|||
147451716|NCT01425008|531814973|FG008|Dose Escalation Phase|Symptomatic Deterioration|2|||
147451717|NCT01425008|531814974|FG009|Dose Escalation Phase|Symptomatic Deterioration|2|||
147451718|NCT01425008|531814975|FG010|Dose Escalation Phase|Symptomatic Deterioration|0|||
147451719|NCT01425008|531814976|FG011|Dose Escalation Phase|Symptomatic Deterioration|0|||
147451720|NCT01425008|531814977|FG012|Dose Escalation Phase|Symptomatic Deterioration|0|||
147451721|NCT01425008|531814978|FG013|Dose Escalation Phase|Symptomatic Deterioration|0|||
147451722|NCT01425008|531814979|FG014|Dose Escalation Phase|Symptomatic Deterioration|0|||
147451723|NCT01425008|531814980|FG015|Dose Escalation Phase|Symptomatic Deterioration|0|||
147451724|NCT01425008|531814981|FG016|Dose Escalation Phase|Symptomatic Deterioration|0|||
147451725|NCT01425008|531814982|FG017|Dose Escalation Phase|Symptomatic Deterioration|0|||
147451726|NCT01425008|531814983|FG018|Dose Escalation Phase|Symptomatic Deterioration|0|||
147451727|NCT01425008|531814965|FG000|Dose Escalation Phase|Other|0|||
147451728|NCT01425008|531814966|FG001|Dose Escalation Phase|Other|0|||
147451729|NCT01425008|531814967|FG002|Dose Escalation Phase|Other|0|||
147451730|NCT01425008|531814968|FG003|Dose Escalation Phase|Other|0|||
147451731|NCT01425008|531814969|FG004|Dose Escalation Phase|Other|0|||
147451732|NCT01425008|531814970|FG005|Dose Escalation Phase|Other|0|||
147451733|NCT01425008|531814971|FG006|Dose Escalation Phase|Other|0|||
147451734|NCT01425008|531814972|FG007|Dose Escalation Phase|Other|0|||
147451735|NCT01425008|531814973|FG008|Dose Escalation Phase|Other|1|||
147451736|NCT01425008|531814974|FG009|Dose Escalation Phase|Other|0|||
147451737|NCT01425008|531814975|FG010|Dose Escalation Phase|Other|0|||
147451738|NCT01425008|531814976|FG011|Dose Escalation Phase|Other|0|||
147451739|NCT01425008|531814977|FG012|Dose Escalation Phase|Other|0|||
147451740|NCT01425008|531814978|FG013|Dose Escalation Phase|Other|0|||
147451741|NCT01425008|531814979|FG014|Dose Escalation Phase|Other|0|||
147283333|NCT02041195|531204959|FG001|Overall Study|Unable to comply with study visits|1|||
147283334|NCT02041195|531204960|FG002|Overall Study|Unable to comply with study visits|0|||
147283335|NCT02041195|531204961|FG003|Overall Study|Unable to comply with study visits|0|||
147283336|NCT02041195|531204962|FG004|Overall Study|Unable to comply with study visits|1|||
147283337|NCT02041195|531204963|FG005|Overall Study|Unable to comply with study visits|0|||
147283338|NCT02041195|531204964|FG006|Overall Study|Unable to comply with study visits|0|||
147283339|NCT02041195|531204965|FG007|Overall Study|Unable to comply with study visits|0|||
147283340|NCT03564496|531204966|FG000|Overall Study|Withdrawal by Subject|1|||
147283341|NCT03564496|531204967|FG001|Overall Study|Withdrawal by Subject|1|||
147283342|NCT03564496|531204968|FG002|Overall Study|Withdrawal by Subject|0|||
147283343|NCT03564496|531204966|FG000|Overall Study|Screen failure|0|||
147283344|NCT03564496|531204967|FG001|Overall Study|Screen failure|3|||
147283345|NCT03564496|531204968|FG002|Overall Study|Screen failure|0|||
147283346|NCT00674986|531204969|FG000|Overall Study|Adverse Event|2|||
147283347|NCT00674986|531204970|FG001|Overall Study|Adverse Event|1|||
147336572|NCT03593213|531398689|FG002|Double-blind Treatment Period (26 Weeks)|Withdrawal by Subject|2|||
147336573|NCT03593213|531398690|FG003|Double-blind Treatment Period (26 Weeks)|Withdrawal by Subject|3|||
147336574|NCT03593213|531398687|FG000|Double-blind Treatment Period (26 Weeks)|Lost to Follow-up|0|||
147336575|NCT03593213|531398688|FG001|Double-blind Treatment Period (26 Weeks)|Lost to Follow-up|5|||
147336576|NCT03593213|531398689|FG002|Double-blind Treatment Period (26 Weeks)|Lost to Follow-up|4|||
147336577|NCT03593213|531398690|FG003|Double-blind Treatment Period (26 Weeks)|Lost to Follow-up|1|||
147336578|NCT03593213|531398687|FG000|Double-blind Treatment Period (26 Weeks)|Pregnancy|0|||
147336579|NCT03593213|531398688|FG001|Double-blind Treatment Period (26 Weeks)|Pregnancy|0|||
147336580|NCT03593213|531398689|FG002|Double-blind Treatment Period (26 Weeks)|Pregnancy|0|||
147336581|NCT03593213|531398690|FG003|Double-blind Treatment Period (26 Weeks)|Pregnancy|1|||
147336582|NCT03593213|531398687|FG000|Double-blind Treatment Period (26 Weeks)|Protocol Deviation|0|||
147336583|NCT03593213|531398688|FG001|Double-blind Treatment Period (26 Weeks)|Protocol Deviation|3|||
147336584|NCT03593213|531398689|FG002|Double-blind Treatment Period (26 Weeks)|Protocol Deviation|2|||
147336585|NCT03593213|531398690|FG003|Double-blind Treatment Period (26 Weeks)|Protocol Deviation|5|||
147336586|NCT03593213|531398687|FG000|Double-blind Treatment Period (26 Weeks)|Non-compliance with Study Drug|0|||
147336587|NCT03593213|531398688|FG001|Double-blind Treatment Period (26 Weeks)|Non-compliance with Study Drug|1|||
147336588|NCT03593213|531398689|FG002|Double-blind Treatment Period (26 Weeks)|Non-compliance with Study Drug|2|||
147336589|NCT03593213|531398690|FG003|Double-blind Treatment Period (26 Weeks)|Non-compliance with Study Drug|0|||
147336590|NCT03593213|531398687|FG000|Double-blind Treatment Period (26 Weeks)|Study Terminated by Sponsor|0|||
147336591|NCT03593213|531398688|FG001|Double-blind Treatment Period (26 Weeks)|Study Terminated by Sponsor|9|||
147336592|NCT03593213|531398689|FG002|Double-blind Treatment Period (26 Weeks)|Study Terminated by Sponsor|11|||
147336593|NCT03593213|531398690|FG003|Double-blind Treatment Period (26 Weeks)|Study Terminated by Sponsor|13|||
147336594|NCT03593213|531398687|FG000|Double-blind Treatment Period (26 Weeks)|Reason not Specified|0|||
147336595|NCT03593213|531398688|FG001|Double-blind Treatment Period (26 Weeks)|Reason not Specified|1|||
147336596|NCT03593213|531398689|FG002|Double-blind Treatment Period (26 Weeks)|Reason not Specified|3|||
147336597|NCT03593213|531398690|FG003|Double-blind Treatment Period (26 Weeks)|Reason not Specified|0|||
147336598|NCT01831791|531398691|FG000|Overall Study|Withdrawal by Subject|10|||
147336599|NCT00494780|531398692|FG000|Overall Study|Adverse Event|1|||
147336600|NCT00494780|531398693|FG001|Overall Study|Adverse Event|0|||
147336601|NCT00494780|531398692|FG000|Overall Study|Withdrew before Dosed|0|||
147336602|NCT00494780|531398693|FG001|Overall Study|Withdrew before Dosed|1|||
147336603|NCT00494780|531398692|FG000|Overall Study|Progression of Study Disease|7|||
147336604|NCT00494780|531398693|FG001|Overall Study|Progression of Study Disease|8|||
147336605|NCT00494780|531398692|FG000|Overall Study|New Treatment|2|||
147336606|NCT00494780|531398693|FG001|Overall Study|New Treatment|2|||
147336607|NCT00494780|531398692|FG000|Overall Study|Non-compliance|1|||
147336608|NCT00494780|531398693|FG001|Overall Study|Non-compliance|0|||
147336609|NCT00494780|531398692|FG000|Overall Study|Residual Tumour Mass|0|||
147336610|NCT00494780|531398693|FG001|Overall Study|Residual Tumour Mass|1|||
147336611|NCT00494780|531398692|FG000|Overall Study|Insurance Issues|0|||
147336612|NCT00494780|531398693|FG001|Overall Study|Insurance Issues|1|||
147336613|NCT01190007|531398694|FG000|Overall Study|Withdrawal by Subject|4|||
147336614|NCT01190007|531398694|FG000|Overall Study|Adverse Event|8|||
147283348|NCT00674986|531204969|FG000|Overall Study|Subject withdrew consent|12|||
147283349|NCT00674986|531204970|FG001|Overall Study|Subject withdrew consent|19|||
147283350|NCT00674986|531204969|FG000|Overall Study|Lost to Follow-up|25|||
147336615|NCT01190007|531398694|FG000|Overall Study|Difficulty of visit for complications|1|||
147336616|NCT01190007|531398694|FG000|Overall Study|Participant was arrested|1|||
147336617|NCT01254019|531398695|FG000|Overall Study|Adverse Event|0|||
147336618|NCT01254019|531398696|FG001|Overall Study|Adverse Event|2|||
147336619|NCT01254019|531398695|FG000|Overall Study|Protocol Violation|1|||
147283351|NCT00674986|531204970|FG001|Overall Study|Lost to Follow-up|53|||
147283352|NCT00674986|531204969|FG000|Overall Study|Other reasons|4|||
147283353|NCT00674986|531204970|FG001|Overall Study|Other reasons|8|||
147283354|NCT01880424|531204971|FG000|Overall Study|Adverse Event|7|||
147451742|NCT01425008|531814980|FG015|Dose Escalation Phase|Other|0|||
147662628|NCT01746862|532587366|FG001|Overall Study|Consent withdrawal by parent's guardian|2|||
147662629|NCT01746862|532587365|FG000|Overall Study|Entered puberty during the study|1|||
147283355|NCT01880424|531204972|FG001|Overall Study|Adverse Event|6|||
147283356|NCT01880424|531204971|FG000|Overall Study|Lack of Efficacy|1|||
147283357|NCT01880424|531204972|FG001|Overall Study|Lack of Efficacy|4|||
147283358|NCT01880424|531204971|FG000|Overall Study|Lost to Follow-up|3|||
147283359|NCT01880424|531204972|FG001|Overall Study|Lost to Follow-up|2|||
147283360|NCT01880424|531204971|FG000|Overall Study|Protocol Violation|11|||
147283361|NCT01880424|531204972|FG001|Overall Study|Protocol Violation|13|||
147283362|NCT01880424|531204971|FG000|Overall Study|Withdrawal by Subject|10|||
147283363|NCT01880424|531204972|FG001|Overall Study|Withdrawal by Subject|30|||
147283364|NCT01880424|531204971|FG000|Overall Study|Other|1|||
147283365|NCT01880424|531204972|FG001|Overall Study|Other|0|||
147283366|NCT03521635|531204975|FG000|Overall Study|Adverse Event|1|||
147283367|NCT03521635|531204976|FG001|Overall Study|Adverse Event|1|||
147336620|NCT01254019|531398696|FG001|Overall Study|Protocol Violation|0|||
147336621|NCT01254019|531398695|FG000|Overall Study|Withdrawal by Subject|0|||
147336622|NCT01254019|531398696|FG001|Overall Study|Withdrawal by Subject|2|||
147336623|NCT03061474|531398697|FG000|Overall Study|Adverse Event|2|||
147336624|NCT03061474|531398698|FG001|Overall Study|Adverse Event|0|||
147336625|NCT03061474|531398697|FG000|Overall Study|Safety Risk|0|||
147336626|NCT03061474|531398698|FG001|Overall Study|Safety Risk|1|||
147336627|NCT03061474|531398697|FG000|Overall Study|Participant unwilling or unable to participate|0|||
147336628|NCT03061474|531398698|FG001|Overall Study|Participant unwilling or unable to participate|2|||
147336629|NCT03061474|531398697|FG000|Overall Study|Lost to Follow-up|0|||
147336630|NCT03061474|531398698|FG001|Overall Study|Lost to Follow-up|1|||
147336631|NCT00845832|531398701|FG000|Treatment Period|Adverse Event|0|||
147336632|NCT00845832|531398702|FG001|Treatment Period|Adverse Event|2|||
147336633|NCT00845832|531398703|FG002|Treatment Period|Adverse Event|0|||
147336634|NCT00845832|531398701|FG000|Treatment Period|Protocol Violation|1|||
147336635|NCT00845832|531398702|FG001|Treatment Period|Protocol Violation|1|||
147336636|NCT00845832|531398703|FG002|Treatment Period|Protocol Violation|0|||
147336637|NCT00845832|531398701|FG000|Safety Follow-Up|Withdrawal by Subject|1|||
147336638|NCT00845832|531398702|FG001|Safety Follow-Up|Withdrawal by Subject|0|||
147336639|NCT00845832|531398703|FG002|Safety Follow-Up|Withdrawal by Subject|0|||
147336640|NCT00845832|531398701|FG000|Extended Safety Follow-Up|Withdrawal by Subject|0|||
147336641|NCT00845832|531398702|FG001|Extended Safety Follow-Up|Withdrawal by Subject|0|||
147336642|NCT00845832|531398703|FG002|Extended Safety Follow-Up|Withdrawal by Subject|7|||
147336643|NCT01391130|531398704|FG000|Overall Study|Withdrawal by Subject|3|||
147336644|NCT01391130|531398705|FG001|Overall Study|Withdrawal by Subject|2|||
147336645|NCT01391130|531398704|FG000|Overall Study|Physician Decision|2|||
147336646|NCT01391130|531398705|FG001|Overall Study|Physician Decision|3|||
147336647|NCT01391130|531398704|FG000|Overall Study|Did not Receive Drug|1|||
147336648|NCT01391130|531398705|FG001|Overall Study|Did not Receive Drug|1|||
147336649|NCT00189202|531398706|FG000|Overall Study|Physician Decision|5|||
147336650|NCT00668863|531398707|FG000|Overall Study|Objective Progression or Relapse|42|||
147336651|NCT00668863|531398707|FG000|Overall Study|Adverse Event|13|||
147336652|NCT00668863|531398707|FG000|Overall Study|Study Terminated by Sponsor|8|||
147336653|NCT00668863|531398707|FG000|Overall Study|Global Deterioration of Health Status|4|||
147336654|NCT00668863|531398707|FG000|Overall Study|Withdrawal by Subject|1|||
147336655|NCT00668863|531398707|FG000|Overall Study|Surgery|1|||
147336656|NCT00668863|531398707|FG000|Overall Study|Subject's work scheduling problem|1|||
147336657|NCT00668863|531398707|FG000|Overall Study|Physician Decision|1|||
147336658|NCT00869323|531398710|FG000|Maintenance Therapy|concurrent illness|1|||
147336659|NCT01068743|531398713|FG000|Period 3|Adverse Event|0|||
147336660|NCT01068743|531398714|FG001|Period 3|Adverse Event|1|||
147336661|NCT01068743|531398715|FG002|Period 3|Adverse Event|0|||
147336662|NCT01068743|531398716|FG003|Period 3|Adverse Event|0|||
147336663|NCT00638963|531398717|FG000|Overall Study|Withdrawal by Subject|1|||
147336664|NCT00638963|531398718|FG001|Overall Study|Withdrawal by Subject|0|||
147336665|NCT00834834|531398732|FG000|Overall Study|Withdrawal by Subject|4|||
147336666|NCT00834834|531398733|FG001|Overall Study|Withdrawal by Subject|3|||
147336667|NCT00373529|531398734|FG000|Overall Study|Physician Decision|19|||
147336668|NCT00373529|531398734|FG000|Overall Study|Withdrawal by Subject|7|||
147336669|NCT00373529|531398734|FG000|Overall Study|Adverse Event|7|||
147336670|NCT00373529|531398734|FG000|Overall Study|Treatment failure|36|||
147336671|NCT00373529|531398734|FG000|Overall Study|Disease recurrence|10|||
147336672|NCT00373529|531398734|FG000|Overall Study|Death|16|||
147336673|NCT00373529|531398734|FG000|Overall Study|Need for treatment prohibited by study|1|||
147283368|NCT03521635|531204975|FG000|Overall Study|Refused to complete study visit|1|||
147283369|NCT03521635|531204976|FG001|Overall Study|Refused to complete study visit|0|||
147336674|NCT00373529|531398734|FG000|Overall Study|Other|8|||
147336675|NCT00373529|531398734|FG000|Overall Study|Failed independent confirmation of AML|3|||
147336676|NCT00373529|531398734|FG000|Overall Study|Consent violation|1|||
147336677|NCT00442117|531398735|FG000|Overall Study|Adverse Event|3|||
147451743|NCT01425008|531814981|FG016|Dose Escalation Phase|Other|0|||
147283370|NCT03521635|531204975|FG000|Overall Study|Refused to continue trial medication|2|||
147283371|NCT03521635|531204976|FG001|Overall Study|Refused to continue trial medication|2|||
147283372|NCT03521635|531204975|FG000|Overall Study|Lost to Follow-up|0|||
147283373|NCT03521635|531204976|FG001|Overall Study|Lost to Follow-up|1|||
147283374|NCT03521635|531204975|FG000|Overall Study|Meet exclusion criteria|0|||
147283375|NCT03521635|531204976|FG001|Overall Study|Meet exclusion criteria|1|||
147283376|NCT03521635|531204975|FG000|Overall Study|Patient not taken study medicine|0|||
147283377|NCT03521635|531204976|FG001|Overall Study|Patient not taken study medicine|1|||
147283378|NCT04495374|531204980|FG000|Overall Study|Protocol Violation|2|||
147283379|NCT04495374|531204981|FG001|Overall Study|Protocol Violation|1|||
147283380|NCT03727750|531204982|FG000|Overall Study|Death|45|||
147283381|NCT03727750|531204982|FG000|Overall Study|Withdrawal by Subject|2|||
147283382|NCT03727750|531204982|FG000|Overall Study|Lost to Follow-up|1|||
147283383|NCT03727750|531204982|FG000|Overall Study|Other|1|||
147283384|NCT01054820|531204984|FG000|Overall Study|Withdrawal by Subject|2|||
147283385|NCT00321919|531204985|FG000|Overall Study|Adverse Event|17|||
147283386|NCT00321919|531204986|FG001|Overall Study|Adverse Event|10|||
147283387|NCT00321919|531204985|FG000|Overall Study|Death|21|||
147283388|NCT00321919|531204986|FG001|Overall Study|Death|17|||
147283389|NCT00321919|531204985|FG000|Overall Study|Insufficient Therapeutic Response|1|||
147283390|NCT00321919|531204986|FG001|Overall Study|Insufficient Therapeutic Response|0|||
147283391|NCT00321919|531204985|FG000|Overall Study|Violation of Selection Criteria at Entry|1|||
147283392|NCT00321919|531204986|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
147283393|NCT00321919|531204985|FG000|Overall Study|Refused Treatment|23|||
147283394|NCT00321919|531204986|FG001|Overall Study|Refused Treatment|14|||
147283395|NCT00321919|531204985|FG000|Overall Study|Other Protocol Violation|2|||
147283396|NCT00321919|531204986|FG001|Overall Study|Other Protocol Violation|3|||
147283397|NCT00321919|531204985|FG000|Overall Study|Failure to Return|3|||
147283398|NCT00321919|531204986|FG001|Overall Study|Failure to Return|1|||
147283399|NCT00321919|531204985|FG000|Overall Study|Other withdrawal reason|7|||
147283400|NCT00321919|531204986|FG001|Overall Study|Other withdrawal reason|6|||
147283401|NCT02624804|531204987|FG000|Overall Study|Screen Failure|5|||
147283402|NCT02590354|531204988|FG000|Phase 1|Active hepatitis B or C infection|1|||
147283403|NCT02590354|531204988|FG000|Phase 1|Confirmed neutrophil count <1200/µl|1|||
147283404|NCT02590354|531204988|FG000|Phase 1|Detectable level of HIV DNA or caRNA|75|||
147283405|NCT02590354|531204988|FG000|Phase 1|Subject does not want to participate|20|||
147283406|NCT02590354|531204988|FG000|Phase 1|Lost to Follow-up|1|||
147283407|NCT02590354|531204988|FG000|Phase 2 - Treatment Interruption|Lost to Follow-up|2|||
147283408|NCT00996996|531204989|FG000|Overall Study|Progressive Disease|10|||
147283409|NCT00996996|531204989|FG000|Overall Study|Non-compliance|8|||
147283410|NCT00996996|531204989|FG000|Overall Study|Lost to Follow-up|9|||
147283411|NCT00996996|531204989|FG000|Overall Study|Death|5|||
147283412|NCT00996996|531204989|FG000|Overall Study|Did Not Receive Study Medications|1|||
147283413|NCT00760929|531204990|FG000|Overall Study|Adverse Event|2|||
147283414|NCT00760929|531204991|FG001|Overall Study|Adverse Event|0|||
147283415|NCT00760929|531204992|FG002|Overall Study|Adverse Event|6|||
147283416|NCT00760929|531204993|FG003|Overall Study|Adverse Event|10|||
147283417|NCT00760929|531204990|FG000|Overall Study|Lack of Efficacy|0|||
147283418|NCT00760929|531204991|FG001|Overall Study|Lack of Efficacy|2|||
147283419|NCT00760929|531204992|FG002|Overall Study|Lack of Efficacy|1|||
147283420|NCT00760929|531204993|FG003|Overall Study|Lack of Efficacy|0|||
147283421|NCT00760929|531204990|FG000|Overall Study|Withdrawal by Subject|1|||
147283422|NCT00760929|531204991|FG001|Overall Study|Withdrawal by Subject|0|||
147283423|NCT00760929|531204992|FG002|Overall Study|Withdrawal by Subject|9|||
147283424|NCT00760929|531204993|FG003|Overall Study|Withdrawal by Subject|1|||
147283425|NCT00760929|531204990|FG000|Overall Study|Lost to Follow-up|0|||
147283426|NCT00760929|531204991|FG001|Overall Study|Lost to Follow-up|0|||
147283427|NCT00760929|531204992|FG002|Overall Study|Lost to Follow-up|1|||
147283428|NCT00760929|531204993|FG003|Overall Study|Lost to Follow-up|0|||
147283429|NCT00760929|531204990|FG000|Overall Study|Progression of Disease|21|||
147283430|NCT00760929|531204991|FG001|Overall Study|Progression of Disease|26|||
147283431|NCT00760929|531204992|FG002|Overall Study|Progression of Disease|38|||
147283432|NCT00760929|531204993|FG003|Overall Study|Progression of Disease|42|||
147283433|NCT00760929|531204990|FG000|Overall Study|Other|2|||
147283434|NCT00760929|531204991|FG001|Overall Study|Other|0|||
147283435|NCT00760929|531204992|FG002|Overall Study|Other|2|||
147283436|NCT00760929|531204993|FG003|Overall Study|Other|1|||
147283437|NCT00760929|531204990|FG000|Overall Study|Death|0|||
147283438|NCT00760929|531204991|FG001|Overall Study|Death|0|||
147283439|NCT00760929|531204992|FG002|Overall Study|Death|1|||
147283440|NCT00760929|531204993|FG003|Overall Study|Death|0|||
147283441|NCT00760929|531204990|FG000|Overall Study|Violation of Selection Criteria at Entry|0|||
147283442|NCT00760929|531204991|FG001|Overall Study|Violation of Selection Criteria at Entry|0|||
147283443|NCT00760929|531204992|FG002|Overall Study|Violation of Selection Criteria at Entry|0|||
147283444|NCT00760929|531204993|FG003|Overall Study|Violation of Selection Criteria at Entry|1|||
147283445|NCT02099838|531204994|FG000|Overall Study|Death|1|||
147283446|NCT02099838|531204995|FG001|Overall Study|Death|0|||
147604010|NCT03839823|532367792|FG001|Overall Study|Physician Decision|5|||
147604011|NCT03839823|532367791|FG000|Overall Study|Progressive Disease (PD)|65|||
147283447|NCT02099838|531204994|FG000|Overall Study|Lost to Follow-up|3|||
147283448|NCT02099838|531204995|FG001|Overall Study|Lost to Follow-up|1|||
147283449|NCT02099838|531204994|FG000|Overall Study|Withdrawal by Subject|0|||
147283450|NCT02099838|531204995|FG001|Overall Study|Withdrawal by Subject|1|||
147283451|NCT01227889|531204996|FG000|Randomized Phase (RP)|Adverse Event|13|||
147283452|NCT01227889|531204997|FG001|Randomized Phase (RP)|Adverse Event|0|||
147283453|NCT01227889|531204996|FG000|Randomized Phase (RP)|Physician Decision|13|||
147283454|NCT01227889|531204997|FG001|Randomized Phase (RP)|Physician Decision|5|||
147283455|NCT01227889|531204996|FG000|Randomized Phase (RP)|Progressive Disease|135|||
147283456|NCT01227889|531204997|FG001|Randomized Phase (RP)|Progressive Disease|52|||
147283457|NCT01227889|531204996|FG000|Randomized Phase (RP)|Study terminated by sponsor|10|||
147283458|NCT01227889|531204997|FG001|Randomized Phase (RP)|Study terminated by sponsor|0|||
147283459|NCT01227889|531204996|FG000|Randomized Phase (RP)|Missing|1|||
147283460|NCT01227889|531204997|FG001|Randomized Phase (RP)|Missing|3|||
147283461|NCT01227889|531204996|FG000|Randomized Phase (RP)|Withdrawal by Subject|15|||
147283462|NCT01227889|531204997|FG001|Randomized Phase (RP)|Withdrawal by Subject|3|||
147283463|NCT01227889|531204996|FG000|Crossover Phase|Adverse Event|0|||
147283464|NCT01227889|531204997|FG001|Crossover Phase|Adverse Event|1|||
147283465|NCT01227889|531204996|FG000|Crossover Phase|Physician Decision|0|||
147283466|NCT01227889|531204997|FG001|Crossover Phase|Physician Decision|3|||
147283467|NCT01227889|531204996|FG000|Crossover Phase|Progressive Disease|0|||
147283468|NCT01227889|531204997|FG001|Crossover Phase|Progressive Disease|31|||
147283469|NCT01227889|531204996|FG000|Crossover Phase|Study Terminated By Sponsor|0|||
147283470|NCT01227889|531204997|FG001|Crossover Phase|Study Terminated By Sponsor|1|||
147283471|NCT01227889|531204996|FG000|Crossover Phase|Withdrawal by Subject|0|||
147283472|NCT01227889|531204997|FG001|Crossover Phase|Withdrawal by Subject|1|||
147283473|NCT04121962|531204998|FG000|Overall Study|Lost to Follow-up|42|||
147283474|NCT04121962|531204999|FG001|Overall Study|Lost to Follow-up|39|||
147283475|NCT00774787|531205000|FG000|Overall Study|Lost to Follow-up|1|||
147283476|NCT02019719|531205001|FG000|Overall Study|Adverse Event|1|||
147283477|NCT02019719|531205002|FG001|Overall Study|Adverse Event|0|||
147283478|NCT02019719|531205003|FG002|Overall Study|Adverse Event|0|||
147283479|NCT02019719|531205004|FG003|Overall Study|Adverse Event|1|||
147283480|NCT02019719|531205005|FG004|Overall Study|Adverse Event|1|||
147283481|NCT02019719|531205001|FG000|Overall Study|Protocol Violation|1|||
147283482|NCT02019719|531205002|FG001|Overall Study|Protocol Violation|1|||
147283483|NCT02019719|531205003|FG002|Overall Study|Protocol Violation|0|||
147336678|NCT00442117|531398736|FG001|Overall Study|Adverse Event|2|||
147336679|NCT00442117|531398735|FG000|Overall Study|Lack of Efficacy|2|||
147336680|NCT00442117|531398736|FG001|Overall Study|Lack of Efficacy|6|||
147336681|NCT00442117|531398735|FG000|Overall Study|Lost to Follow-up|1|||
147336682|NCT00442117|531398736|FG001|Overall Study|Lost to Follow-up|2|||
147336683|NCT00442117|531398735|FG000|Overall Study|Withdrawal by Subject|2|||
147336684|NCT00442117|531398736|FG001|Overall Study|Withdrawal by Subject|2|||
147336685|NCT00442117|531398735|FG000|Overall Study|Major Deviation|25|||
147336686|NCT00442117|531398736|FG001|Overall Study|Major Deviation|20|||
147336687|NCT00442117|531398735|FG000|Overall Study|Non compliance with protocol|3|||
147336688|NCT00442117|531398736|FG001|Overall Study|Non compliance with protocol|5|||
147336689|NCT00442117|531398735|FG000|Overall Study|Met Withdrawal Criteria|2|||
147336690|NCT00442117|531398736|FG001|Overall Study|Met Withdrawal Criteria|1|||
147336691|NCT04009577|531398737|FG000|Core Study|Adverse Event|1|||
147336692|NCT04009577|531398738|FG001|Core Study|Adverse Event|0|||
147336693|NCT04009577|531398739|FG002|Core Study|Adverse Event|2|||
147336694|NCT04009577|531398740|FG003|Core Study|Adverse Event|4|||
147336695|NCT04009577|531398737|FG000|Core Study|Withdrawal by Subject|0|||
147336696|NCT04009577|531398738|FG001|Core Study|Withdrawal by Subject|0|||
147336697|NCT04009577|531398739|FG002|Core Study|Withdrawal by Subject|2|||
147336698|NCT04009577|531398740|FG003|Core Study|Withdrawal by Subject|0|||
147336699|NCT04009577|531398737|FG000|Core Study|Other|0|||
147336700|NCT04009577|531398738|FG001|Core Study|Other|0|||
147336701|NCT04009577|531398739|FG002|Core Study|Other|0|||
147336702|NCT04009577|531398740|FG003|Core Study|Other|1|||
147336703|NCT04009577|531398737|FG000|Extension Phase|Adverse Event|0|||
147336704|NCT04009577|531398738|FG001|Extension Phase|Adverse Event|0|||
147336705|NCT04009577|531398739|FG002|Extension Phase|Adverse Event|0|||
147451744|NCT01425008|531814982|FG017|Dose Escalation Phase|Other|0|||
147604012|NCT03839823|532367792|FG001|Overall Study|Progressive Disease (PD)|65|||
147604013|NCT03839823|532367791|FG000|Overall Study|Subject Decision|2|||
147283484|NCT02019719|531205004|FG003|Overall Study|Protocol Violation|0|||
147283485|NCT02019719|531205005|FG004|Overall Study|Protocol Violation|0|||
147283486|NCT02019719|531205001|FG000|Overall Study|Protocol defined stopping criteria|2|||
147283487|NCT02019719|531205002|FG001|Overall Study|Protocol defined stopping criteria|0|||
147283488|NCT02019719|531205003|FG002|Overall Study|Protocol defined stopping criteria|0|||
147283489|NCT02019719|531205004|FG003|Overall Study|Protocol defined stopping criteria|1|||
147283490|NCT02019719|531205005|FG004|Overall Study|Protocol defined stopping criteria|1|||
147336706|NCT04009577|531398740|FG003|Extension Phase|Adverse Event|1|||
147604014|NCT03839823|532367792|FG001|Overall Study|Subject Decision|9|||
147604015|NCT03839823|532367791|FG000|Overall Study|Not Treated|0|||
147604016|NCT03839823|532367792|FG001|Overall Study|Not Treated|10|||
147604017|NCT03327792|532367793|FG000|Overall Study|Adverse Event|4|||
147604018|NCT03327792|532367794|FG001|Overall Study|Adverse Event|0|||
147604019|NCT03327792|532367793|FG000|Overall Study|Family/Personal issues|3|||
147604020|NCT03327792|532367794|FG001|Overall Study|Family/Personal issues|2|||
147604021|NCT03327792|532367793|FG000|Overall Study|Lost to Follow-up|0|||
147604022|NCT03327792|532367794|FG001|Overall Study|Lost to Follow-up|1|||
147604023|NCT01161407|532367797|FG000|Overall Study|Protocol Violation|3|||
147662630|NCT01746862|532587366|FG001|Overall Study|Entered puberty during the study|0|||
147662631|NCT00385918|532587379|FG000|Feasibility & Baseline Measurement Phase|outside of inclusion criteria|0|||
147283491|NCT02019719|531205001|FG000|Overall Study|Physician Decision|2|||
147283492|NCT02019719|531205002|FG001|Overall Study|Physician Decision|0|||
147283493|NCT02019719|531205003|FG002|Overall Study|Physician Decision|0|||
147283494|NCT02019719|531205004|FG003|Overall Study|Physician Decision|0|||
147283495|NCT02019719|531205005|FG004|Overall Study|Physician Decision|0|||
147283496|NCT04535037|531205006|FG000|Overall Study|Protocol Violation|1|||
147283497|NCT04535037|531205007|FG001|Overall Study|Protocol Violation|0|||
147283498|NCT04535037|531205006|FG000|Overall Study|Withdrawal by Subject|8|||
147283499|NCT04535037|531205007|FG001|Overall Study|Withdrawal by Subject|9|||
147283500|NCT04535037|531205006|FG000|Overall Study|Migrated / moved from the study area|1|||
147283501|NCT04535037|531205007|FG001|Overall Study|Migrated / moved from the study area|4|||
147283502|NCT04535037|531205006|FG000|Overall Study|Other|2|||
147283503|NCT04535037|531205007|FG001|Overall Study|Other|5|||
147283504|NCT02731131|531205009|FG000|Overall Study|Psychiatric Disorder|0|||
147283505|NCT02731131|531205010|FG001|Overall Study|Psychiatric Disorder|1|||
147283506|NCT02731131|531205009|FG000|Overall Study|Refused Therapy|0|||
147283507|NCT02731131|531205010|FG001|Overall Study|Refused Therapy|1|||
147283508|NCT02348216|531205015|FG000|Overall Study|Death|5|||
147283509|NCT02348216|531205016|FG001|Overall Study|Death|53|||
147283510|NCT02348216|531205017|FG002|Overall Study|Death|11|||
147283511|NCT02348216|531205018|FG003|Overall Study|Death|20|||
147283512|NCT02348216|531205019|FG004|Overall Study|Death|16|||
147283513|NCT02348216|531205020|FG005|Overall Study|Death|32|||
147283514|NCT02348216|531205021|FG006|Overall Study|Death|17|||
147283515|NCT02348216|531205015|FG000|Overall Study|Full consent withdrawal|0|||
147283516|NCT02348216|531205016|FG001|Overall Study|Full consent withdrawal|0|||
147336707|NCT04009577|531398737|FG000|Extension Phase|Inadequate therapeutic effect|0|||
147336708|NCT04009577|531398738|FG001|Extension Phase|Inadequate therapeutic effect|0|||
147336709|NCT04009577|531398739|FG002|Extension Phase|Inadequate therapeutic effect|1|||
147336710|NCT04009577|531398740|FG003|Extension Phase|Inadequate therapeutic effect|0|||
147336711|NCT04009577|531398737|FG000|Extension Phase|Withdrawal by Subject|0|||
147336712|NCT04009577|531398738|FG001|Extension Phase|Withdrawal by Subject|0|||
147336713|NCT04009577|531398739|FG002|Extension Phase|Withdrawal by Subject|1|||
147336714|NCT04009577|531398740|FG003|Extension Phase|Withdrawal by Subject|0|||
147336715|NCT04009577|531398737|FG000|Extension Phase|Not Treated|0|||
147336716|NCT04009577|531398738|FG001|Extension Phase|Not Treated|0|||
147336717|NCT04009577|531398739|FG002|Extension Phase|Not Treated|2|||
147336718|NCT04009577|531398740|FG003|Extension Phase|Not Treated|0|||
147336719|NCT00305695|531398746|FG000|Overall Study|Withdrawal by subject prior to 18 month|40|||
147336720|NCT00305695|531398747|FG001|Overall Study|Withdrawal by subject prior to 18 month|26|||
147336721|NCT00305695|531398746|FG000|Overall Study|Did not have baseline scan|1|||
147336722|NCT00305695|531398747|FG001|Overall Study|Did not have baseline scan|1|||
147336723|NCT00841035|531398749|FG000|Phase 1 Overall Study|Physician Decision|13|||
147336724|NCT01810263|531398770|FG000|Overall Study|Lost to Follow-up|8|||
147336725|NCT01810263|531398771|FG001|Overall Study|Lost to Follow-up|7|||
147336726|NCT01121549|531398772|FG000|Overall Study|Adverse Event|10|||
147336727|NCT01121549|531398772|FG000|Overall Study|Lack of Efficacy|11|||
147451745|NCT01425008|531814983|FG018|Dose Escalation Phase|Other|0|||
147604024|NCT01161407|532367798|FG001|Overall Study|Protocol Violation|1|||
147283517|NCT02348216|531205017|FG002|Overall Study|Full consent withdrawal|0|||
147283518|NCT02348216|531205018|FG003|Overall Study|Full consent withdrawal|1|||
147604025|NCT01475097|532367802|FG000|Overall Study|Protocol Violation|1|||
147604026|NCT01475097|532367803|FG001|Overall Study|Protocol Violation|1|||
147283519|NCT02348216|531205019|FG004|Overall Study|Full consent withdrawal|3|||
147283520|NCT02348216|531205020|FG005|Overall Study|Full consent withdrawal|0|||
147283521|NCT02348216|531205021|FG006|Overall Study|Full consent withdrawal|3|||
147283522|NCT02348216|531205015|FG000|Overall Study|Lost to Follow-up|0|||
147283523|NCT02348216|531205016|FG001|Overall Study|Lost to Follow-up|5|||
147283524|NCT02348216|531205017|FG002|Overall Study|Lost to Follow-up|2|||
147283525|NCT02348216|531205018|FG003|Overall Study|Lost to Follow-up|0|||
147283526|NCT02348216|531205019|FG004|Overall Study|Lost to Follow-up|1|||
147336728|NCT01121549|531398772|FG000|Overall Study|Lost to Follow-up|12|||
147336729|NCT01121549|531398772|FG000|Overall Study|Did not meet entrance criteria|9|||
147336730|NCT01121549|531398772|FG000|Overall Study|Study terminated by sponsor|197|||
147336731|NCT01121549|531398772|FG000|Overall Study|Pregnancy|1|||
147336732|NCT01121549|531398772|FG000|Overall Study|Protocol Violation|33|||
147451746|NCT01425008|531814965|FG000|Dose Expansion Phase|Progressive Disease|0|||
147451747|NCT01425008|531814966|FG001|Dose Expansion Phase|Progressive Disease|0|||
147451748|NCT01425008|531814967|FG002|Dose Expansion Phase|Progressive Disease|0|||
147451749|NCT01425008|531814968|FG003|Dose Expansion Phase|Progressive Disease|0|||
147451750|NCT01425008|531814969|FG004|Dose Expansion Phase|Progressive Disease|0|||
147451751|NCT01425008|531814970|FG005|Dose Expansion Phase|Progressive Disease|0|||
147451752|NCT01425008|531814971|FG006|Dose Expansion Phase|Progressive Disease|0|||
147451753|NCT01425008|531814972|FG007|Dose Expansion Phase|Progressive Disease|0|||
147451754|NCT01425008|531814973|FG008|Dose Expansion Phase|Progressive Disease|0|||
147451755|NCT01425008|531814974|FG009|Dose Expansion Phase|Progressive Disease|0|||
147451756|NCT01425008|531814975|FG010|Dose Expansion Phase|Progressive Disease|10|||
147451757|NCT01425008|531814976|FG011|Dose Expansion Phase|Progressive Disease|4|||
147451758|NCT01425008|531814977|FG012|Dose Expansion Phase|Progressive Disease|12|||
147604027|NCT04516759|532367805|FG000|Overall Study|Withdrawal by Subject|1|||
147604028|NCT04516759|532367806|FG001|Overall Study|Withdrawal by Subject|1|||
147283527|NCT02348216|531205020|FG005|Overall Study|Lost to Follow-up|1|||
147283528|NCT02348216|531205021|FG006|Overall Study|Lost to Follow-up|1|||
147283529|NCT02348216|531205015|FG000|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|1|||
147283530|NCT02348216|531205016|FG001|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|4|||
147283531|NCT02348216|531205017|FG002|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|6|||
147283532|NCT02348216|531205018|FG003|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|4|||
147283533|NCT02348216|531205019|FG004|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|5|||
147283534|NCT02348216|531205020|FG005|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|8|||
147283535|NCT02348216|531205021|FG006|Overall Study|Enrolled but did not initiate axicabtagene ciloleucel|2|||
147283536|NCT02348216|531205015|FG000|Overall Study|Reason not specified|2|||
147283537|NCT02348216|531205016|FG001|Overall Study|Reason not specified|19|||
147283538|NCT02348216|531205017|FG002|Overall Study|Reason not specified|11|||
147283539|NCT02348216|531205018|FG003|Overall Study|Reason not specified|17|||
147283540|NCT02348216|531205019|FG004|Overall Study|Reason not specified|21|||
147283541|NCT02348216|531205020|FG005|Overall Study|Reason not specified|17|||
147283542|NCT02348216|531205021|FG006|Overall Study|Reason not specified|19|||
147283543|NCT01055639|531205022|FG000|Overall Study|Adverse Event|0|||
147283544|NCT01055639|531205023|FG001|Overall Study|Adverse Event|1|||
147283545|NCT01055639|531205022|FG000|Overall Study|Lack of Efficacy|0|||
147283546|NCT01055639|531205023|FG001|Overall Study|Lack of Efficacy|1|||
147283547|NCT01055639|531205022|FG000|Overall Study|Lost to Follow-up|8|||
147283548|NCT01055639|531205023|FG001|Overall Study|Lost to Follow-up|11|||
147283549|NCT01055639|531205022|FG000|Overall Study|Protocol Violation|5|||
147283550|NCT01055639|531205023|FG001|Overall Study|Protocol Violation|5|||
147283551|NCT01055639|531205022|FG000|Overall Study|Withdrawal by Subject|8|||
147283552|NCT01055639|531205023|FG001|Overall Study|Withdrawal by Subject|11|||
147283553|NCT00765245|531205024|FG000|Overall Study|disease progression|3|||
147283554|NCT00765245|531205025|FG001|Overall Study|disease progression|2|||
147283555|NCT00765245|531205024|FG000|Overall Study|Withdrawal by Subject|3|||
147283556|NCT00765245|531205025|FG001|Overall Study|Withdrawal by Subject|0|||
147283557|NCT00765245|531205024|FG000|Overall Study|Adverse Event|5|||
147283558|NCT00765245|531205025|FG001|Overall Study|Adverse Event|0|||
147283559|NCT00765245|531205024|FG000|Overall Study|Physician Decision|1|||
147283560|NCT00765245|531205025|FG001|Overall Study|Physician Decision|0|||
147283561|NCT00765245|531205024|FG000|Overall Study|Death|1|||
147283562|NCT00765245|531205025|FG001|Overall Study|Death|0|||
147283563|NCT01197950|531205027|FG000|Overall Study|Women's request (31), high workload (8), returned home (4), partus in one hour (1), other (6)|16|||
147283564|NCT01197950|531205028|FG001|Overall Study|Women's request (31), high workload (8), returned home (4), partus in one hour (1), other (6)|16|||
147283565|NCT01197950|531205029|FG002|Overall Study|Women's request (31), high workload (8), returned home (4), partus in one hour (1), other (6)|18|||
147283566|NCT02553330|531205030|FG000|Overall Study|Study Terminated by Sponsor|2|||
147283567|NCT02553330|531205031|FG001|Overall Study|Study Terminated by Sponsor|13|||
147283568|NCT02553330|531205032|FG002|Overall Study|Study Terminated by Sponsor|12|||
147283569|NCT02553330|531205030|FG000|Overall Study|Withdrawal by Subject|3|||
147283570|NCT02553330|531205031|FG001|Overall Study|Withdrawal by Subject|19|||
147283571|NCT02553330|531205032|FG002|Overall Study|Withdrawal by Subject|21|||
147451759|NCT01425008|531814978|FG013|Dose Expansion Phase|Progressive Disease|1|||
147604029|NCT04516759|532367805|FG000|Overall Study|Other|0|||
147604030|NCT04516759|532367806|FG001|Overall Study|Other|1|||
147283572|NCT02553330|531205030|FG000|Overall Study|Other|0|||
147283573|NCT02553330|531205031|FG001|Overall Study|Other|1|||
147283574|NCT02553330|531205032|FG002|Overall Study|Other|0|||
147283575|NCT02553330|531205030|FG000|Overall Study|Non compliance to study treatment|0|||
147283576|NCT02553330|531205031|FG001|Overall Study|Non compliance to study treatment|1|||
147283577|NCT02553330|531205032|FG002|Overall Study|Non compliance to study treatment|0|||
147283578|NCT02553330|531205030|FG000|Overall Study|Adverse Event|0|||
147451760|NCT01425008|531814979|FG014|Dose Expansion Phase|Progressive Disease|5|||
147451761|NCT01425008|531814980|FG015|Dose Expansion Phase|Progressive Disease|8|||
147451762|NCT01425008|531814981|FG016|Dose Expansion Phase|Progressive Disease|9|||
147336733|NCT01121549|531398772|FG000|Overall Study|Withdrawal by Subject|16|||
147336734|NCT01121549|531398772|FG000|Overall Study|Other|58|||
147336735|NCT00304031|531399981|FG000|Concomitant RT+TMZ (Pre-randomization)|Ineligible due to insufficient tissue|144|||
147336736|NCT00304031|531399982|FG001|Concomitant RT+TMZ (Pre-randomization)|Ineligible due to insufficient tissue|0|||
147336737|NCT00304031|531399983|FG002|Concomitant RT+TMZ (Pre-randomization)|Ineligible due to insufficient tissue|0|||
147336738|NCT00304031|531399981|FG000|Concomitant RT+TMZ (Pre-randomization)|Disease progression|48|||
147336739|NCT00304031|531399982|FG001|Concomitant RT+TMZ (Pre-randomization)|Disease progression|0|||
147336740|NCT00304031|531399983|FG002|Concomitant RT+TMZ (Pre-randomization)|Disease progression|0|||
147336741|NCT00304031|531399981|FG000|Concomitant RT+TMZ (Pre-randomization)|Patient refusal|19|||
147336742|NCT00304031|531399982|FG001|Concomitant RT+TMZ (Pre-randomization)|Patient refusal|0|||
147336743|NCT00304031|531399983|FG002|Concomitant RT+TMZ (Pre-randomization)|Patient refusal|0|||
147336744|NCT00304031|531399981|FG000|Concomitant RT+TMZ (Pre-randomization)|Death|18|||
147336745|NCT00304031|531399982|FG001|Concomitant RT+TMZ (Pre-randomization)|Death|0|||
147336746|NCT00304031|531399983|FG002|Concomitant RT+TMZ (Pre-randomization)|Death|0|||
147336747|NCT00304031|531399981|FG000|Concomitant RT+TMZ (Pre-randomization)|Physician preference|15|||
147336748|NCT00304031|531399982|FG001|Concomitant RT+TMZ (Pre-randomization)|Physician preference|0|||
147336749|NCT00304031|531399983|FG002|Concomitant RT+TMZ (Pre-randomization)|Physician preference|0|||
147336750|NCT00304031|531399981|FG000|Concomitant RT+TMZ (Pre-randomization)|Toxicity|10|||
147336751|NCT00304031|531399982|FG001|Concomitant RT+TMZ (Pre-randomization)|Toxicity|0|||
147336752|NCT00304031|531399983|FG002|Concomitant RT+TMZ (Pre-randomization)|Toxicity|0|||
147336753|NCT00304031|531399981|FG000|Concomitant RT+TMZ (Pre-randomization)|Other complicating disease|1|||
147336754|NCT00304031|531399982|FG001|Concomitant RT+TMZ (Pre-randomization)|Other complicating disease|0|||
147336755|NCT00304031|531399983|FG002|Concomitant RT+TMZ (Pre-randomization)|Other complicating disease|0|||
147336756|NCT00304031|531399981|FG000|Concomitant RT+TMZ (Pre-randomization)|Other, not otherwise specified|37|||
147336757|NCT00304031|531399982|FG001|Concomitant RT+TMZ (Pre-randomization)|Other, not otherwise specified|0|||
147336758|NCT00304031|531399983|FG002|Concomitant RT+TMZ (Pre-randomization)|Other, not otherwise specified|0|||
147336759|NCT00304031|531399981|FG000|Randomization to Adjuvant TMZ Arm|No follow-up collected|0|||
147336760|NCT00304031|531399982|FG001|Randomization to Adjuvant TMZ Arm|No follow-up collected|0|||
147336761|NCT00304031|531399983|FG002|Randomization to Adjuvant TMZ Arm|No follow-up collected|2|||
147336762|NCT00493649|531399984|FG000|Overall Study|Adverse Event|44|||
147336763|NCT00493649|531399984|FG000|Overall Study|Patient Request|21|||
147336764|NCT00493649|531399984|FG000|Overall Study|Investigator Request|2|||
147336765|NCT00493649|531399984|FG000|Overall Study|Disease Progression|1|||
147336766|NCT00493649|531399984|FG000|Overall Study|Lost to Follow-up|1|||
147336767|NCT00493649|531399984|FG000|Overall Study|Other|13|||
147451763|NCT01425008|531814982|FG017|Dose Expansion Phase|Progressive Disease|2|||
147451764|NCT01425008|531814983|FG018|Dose Expansion Phase|Progressive Disease|10|||
147283579|NCT02553330|531205031|FG001|Overall Study|Adverse Event|1|||
147283580|NCT02553330|531205032|FG002|Overall Study|Adverse Event|0|||
147283581|NCT02553330|531205030|FG000|Overall Study|Lost to Follow-up|0|||
147283582|NCT02553330|531205031|FG001|Overall Study|Lost to Follow-up|4|||
147283583|NCT02553330|531205032|FG002|Overall Study|Lost to Follow-up|4|||
147283584|NCT02896855|531205033|FG000|Overall Study|Death|50|||
147283585|NCT02896855|531205034|FG001|Overall Study|Death|40|||
147283586|NCT02896855|531205033|FG000|Overall Study|Lost to Follow-up|15|||
147283587|NCT02896855|531205034|FG001|Overall Study|Lost to Follow-up|9|||
147283588|NCT02896855|531205033|FG000|Overall Study|Withdrawal by Subject|7|||
147283589|NCT02896855|531205034|FG001|Overall Study|Withdrawal by Subject|4|||
147283590|NCT01205685|531205035|FG000|Overall Study|Disease Progression|10|||
147283591|NCT01205685|531205035|FG000|Overall Study|Withdrawal by Subject|1|||
147283592|NCT02169674|531205036|FG000|Overall Study|Withdrawal by Subject|2|||
147283593|NCT02169674|531205037|FG001|Overall Study|Withdrawal by Subject|1|||
147283594|NCT02169674|531205036|FG000|Overall Study|Seroprotected|30|||
147283595|NCT02169674|531205037|FG001|Overall Study|Seroprotected|76|||
147283596|NCT02169674|531205036|FG000|Overall Study|Lost to Follow-up|0|||
147283597|NCT02169674|531205037|FG001|Overall Study|Lost to Follow-up|1|||
147283598|NCT01666002|531205038|FG000|Overall Study|Lost to Follow-up|5|||
147283599|NCT01666002|531205039|FG001|Overall Study|Lost to Follow-up|0|||
147283600|NCT02265705|531205061|FG000|Treatment Period Week 0-24|Adverse Event|3|||
147283601|NCT02265705|531205062|FG001|Treatment Period Week 0-24|Adverse Event|2|||
147283602|NCT02265705|531205063|FG002|Treatment Period Week 0-24|Adverse Event|0|||
147283603|NCT02265705|531205064|FG003|Treatment Period Week 0-24|Adverse Event|0|||
147283604|NCT02265705|531205065|FG004|Treatment Period Week 0-24|Adverse Event|0|||
147283605|NCT02265705|531205066|FG005|Treatment Period Week 0-24|Adverse Event|0|||
147283606|NCT02265705|531205067|FG006|Treatment Period Week 0-24|Adverse Event|0|||
147283607|NCT02265705|531205061|FG000|Treatment Period Week 0-24|Entry Criteria Not Met|1|||
147336768|NCT01662336|531399985|FG000|Overall Study|Adverse Event|1|||
147336769|NCT01662336|531399985|FG000|Overall Study|No longer on LPV/r|30|||
147336770|NCT01662336|531399985|FG000|Overall Study|Other|29|||
147336771|NCT01662336|531399985|FG000|Overall Study|Withdrawal by Subject|6|||
147283608|NCT02265705|531205062|FG001|Treatment Period Week 0-24|Entry Criteria Not Met|1|||
147283609|NCT02265705|531205063|FG002|Treatment Period Week 0-24|Entry Criteria Not Met|0|||
147336772|NCT02189252|531399986|FG000|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|0|||
147336773|NCT02189252|531399987|FG001|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|1|||
147336774|NCT02189252|531399988|FG002|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|0|||
147336775|NCT02189252|531399989|FG003|Period 1 (Visit 4b, Week 4)|Withdrawal by Subject|0|||
147336776|NCT02189252|531399986|FG000|Period 1 (Visit 4b, Week 4)|Adverse Event|0|||
147336777|NCT02189252|531399987|FG001|Period 1 (Visit 4b, Week 4)|Adverse Event|1|||
147336778|NCT02189252|531399988|FG002|Period 1 (Visit 4b, Week 4)|Adverse Event|0|||
147336779|NCT02189252|531399989|FG003|Period 1 (Visit 4b, Week 4)|Adverse Event|0|||
147336780|NCT00566735|531399990|FG000|Overall Study|Withdrawal by Subject|0|||
147336781|NCT00566735|531399991|FG001|Overall Study|Withdrawal by Subject|1|||
147336782|NCT00566735|531399990|FG000|Overall Study|Refused neuropsychological testing|2|||
147336783|NCT00566735|531399991|FG001|Overall Study|Refused neuropsychological testing|5|||
147336784|NCT00566735|531399990|FG000|Overall Study|Switched into a manic episode|0|||
147336785|NCT00566735|531399991|FG001|Overall Study|Switched into a manic episode|1|||
147336786|NCT04603924|531399992|FG000|Overall Study|Not Dosed|2|||
147336787|NCT04603924|531399993|FG001|Overall Study|Not Dosed|1|||
147336788|NCT04603924|531399992|FG000|Overall Study|Withdrawal by Subject|6|||
147336789|NCT04603924|531399993|FG001|Overall Study|Withdrawal by Subject|6|||
147336790|NCT04603924|531399992|FG000|Overall Study|Adverse Event|2|||
147336791|NCT04603924|531399993|FG001|Overall Study|Adverse Event|2|||
147336792|NCT00686855|531399999|FG000|Overall Study|Lost to Follow-up|1|||
147336793|NCT00686855|531400000|FG001|Overall Study|Lost to Follow-up|0|||
147336794|NCT00686855|531399999|FG000|Overall Study|Progressive GVHD|0|||
147336795|NCT00686855|531400000|FG001|Overall Study|Progressive GVHD|1|||
147336796|NCT02731755|531400007|FG000|First Intervention|Withdrawal by Subject|0|||
147336797|NCT02731755|531400008|FG001|First Intervention|Withdrawal by Subject|2|||
147336798|NCT01460446|531400009|FG000|Overall Study|Non-compliance|2|||
147336799|NCT01460446|531400010|FG001|Overall Study|Non-compliance|9|||
147336800|NCT01460446|531400009|FG000|Overall Study|Consent Withdrawn|0|||
147336801|NCT01460446|531400010|FG001|Overall Study|Consent Withdrawn|4|||
147336802|NCT01460446|531400009|FG000|Overall Study|Non-compliance & Consent Withdrawn|1|||
147336803|NCT01460446|531400010|FG001|Overall Study|Non-compliance & Consent Withdrawn|3|||
147336804|NCT01460446|531400009|FG000|Overall Study|Surgery/Illness|1|||
147336805|NCT01460446|531400010|FG001|Overall Study|Surgery/Illness|1|||
147336806|NCT01460446|531400009|FG000|Overall Study|Pregnancy|1|||
147336807|NCT01460446|531400010|FG001|Overall Study|Pregnancy|0|||
147336808|NCT01460446|531400009|FG000|Overall Study|Other Reasons Incl. Lost for Follow-Up|0|||
147336809|NCT01460446|531400010|FG001|Overall Study|Other Reasons Incl. Lost for Follow-Up|3|||
147336810|NCT00516321|531400011|FG000|Open-label (OL) Pre-Antiviral Treatment|Lack of Efficacy|11|||
147336811|NCT00516321|531400012|FG001|Open-label (OL) Pre-Antiviral Treatment|Lack of Efficacy|0|||
147336812|NCT00516321|531400013|FG002|Open-label (OL) Pre-Antiviral Treatment|Lack of Efficacy|0|||
147336813|NCT00516321|531400011|FG000|Open-label (OL) Pre-Antiviral Treatment|Adverse Event|9|||
147336814|NCT00516321|531400012|FG001|Open-label (OL) Pre-Antiviral Treatment|Adverse Event|0|||
147336815|NCT00516321|531400013|FG002|Open-label (OL) Pre-Antiviral Treatment|Adverse Event|0|||
147336816|NCT00516321|531400011|FG000|Open-label (OL) Pre-Antiviral Treatment|Protocol Violation|1|||
147336817|NCT00516321|531400012|FG001|Open-label (OL) Pre-Antiviral Treatment|Protocol Violation|0|||
147336818|NCT00516321|531400013|FG002|Open-label (OL) Pre-Antiviral Treatment|Protocol Violation|0|||
147336819|NCT00516321|531400011|FG000|Open-label (OL) Pre-Antiviral Treatment|Lost to Follow-up|2|||
147336820|NCT00516321|531400012|FG001|Open-label (OL) Pre-Antiviral Treatment|Lost to Follow-up|0|||
147336821|NCT00516321|531400013|FG002|Open-label (OL) Pre-Antiviral Treatment|Lost to Follow-up|0|||
147336822|NCT00516321|531400011|FG000|Open-label (OL) Pre-Antiviral Treatment|Investigator Discretion|7|||
147336823|NCT00516321|531400012|FG001|Open-label (OL) Pre-Antiviral Treatment|Investigator Discretion|0|||
147336824|NCT00516321|531400013|FG002|Open-label (OL) Pre-Antiviral Treatment|Investigator Discretion|0|||
147336825|NCT00516321|531400011|FG000|Open-label (OL) Pre-Antiviral Treatment|Withdrawal by Subject|3|||
147336826|NCT00516321|531400012|FG001|Open-label (OL) Pre-Antiviral Treatment|Withdrawal by Subject|0|||
147336827|NCT00516321|531400013|FG002|Open-label (OL) Pre-Antiviral Treatment|Withdrawal by Subject|0|||
147336828|NCT00516321|531400011|FG000|Double-blind (DB) Antiviral Treatment|Lost to Follow-up|0|||
147336829|NCT00516321|531400012|FG001|Double-blind (DB) Antiviral Treatment|Lost to Follow-up|12|||
147336830|NCT00516321|531400013|FG002|Double-blind (DB) Antiviral Treatment|Lost to Follow-up|22|||
147336831|NCT00516321|531400011|FG000|Double-blind (DB) Antiviral Treatment|Withdrawal by Subject|0|||
147336832|NCT00516321|531400012|FG001|Double-blind (DB) Antiviral Treatment|Withdrawal by Subject|13|||
147336833|NCT00516321|531400013|FG002|Double-blind (DB) Antiviral Treatment|Withdrawal by Subject|18|||
147336834|NCT00516321|531400011|FG000|Double-blind (DB) Antiviral Treatment|Adverse Event|0|||
147336835|NCT00516321|531400012|FG001|Double-blind (DB) Antiviral Treatment|Adverse Event|8|||
147336836|NCT00516321|531400013|FG002|Double-blind (DB) Antiviral Treatment|Adverse Event|13|||
147336837|NCT00516321|531400011|FG000|Double-blind (DB) Antiviral Treatment|Protocol Violation|0|||
147336838|NCT00516321|531400012|FG001|Double-blind (DB) Antiviral Treatment|Protocol Violation|0|||
147336839|NCT00516321|531400013|FG002|Double-blind (DB) Antiviral Treatment|Protocol Violation|1|||
147336840|NCT00516321|531400011|FG000|Double-blind (DB) Antiviral Treatment|Physician Decision|0|||
147336841|NCT00516321|531400012|FG001|Double-blind (DB) Antiviral Treatment|Physician Decision|2|||
147283610|NCT02265705|531205064|FG003|Treatment Period Week 0-24|Entry Criteria Not Met|0|||
147283611|NCT02265705|531205065|FG004|Treatment Period Week 0-24|Entry Criteria Not Met|0|||
147283612|NCT02265705|531205066|FG005|Treatment Period Week 0-24|Entry Criteria Not Met|0|||
147283613|NCT02265705|531205067|FG006|Treatment Period Week 0-24|Entry Criteria Not Met|0|||
147283614|NCT02265705|531205061|FG000|Treatment Period Week 0-24|Physician Decision|1|||
147283615|NCT02265705|531205062|FG001|Treatment Period Week 0-24|Physician Decision|0|||
147283616|NCT02265705|531205063|FG002|Treatment Period Week 0-24|Physician Decision|0|||
147283617|NCT02265705|531205064|FG003|Treatment Period Week 0-24|Physician Decision|0|||
147283618|NCT02265705|531205065|FG004|Treatment Period Week 0-24|Physician Decision|0|||
147283619|NCT02265705|531205066|FG005|Treatment Period Week 0-24|Physician Decision|0|||
147283620|NCT02265705|531205067|FG006|Treatment Period Week 0-24|Physician Decision|0|||
147283621|NCT02265705|531205061|FG000|Treatment Period Week 0-24|Withdrawal by Subject|7|||
147283622|NCT02265705|531205062|FG001|Treatment Period Week 0-24|Withdrawal by Subject|5|||
147283623|NCT02265705|531205063|FG002|Treatment Period Week 0-24|Withdrawal by Subject|0|||
147283624|NCT02265705|531205064|FG003|Treatment Period Week 0-24|Withdrawal by Subject|0|||
147283625|NCT02265705|531205065|FG004|Treatment Period Week 0-24|Withdrawal by Subject|0|||
147283626|NCT02265705|531205066|FG005|Treatment Period Week 0-24|Withdrawal by Subject|0|||
147283627|NCT02265705|531205067|FG006|Treatment Period Week 0-24|Withdrawal by Subject|0|||
147283628|NCT02265705|531205061|FG000|Treatment Period Week 0-24|Lack of Efficacy|0|||
147283629|NCT02265705|531205062|FG001|Treatment Period Week 0-24|Lack of Efficacy|1|||
147283630|NCT02265705|531205063|FG002|Treatment Period Week 0-24|Lack of Efficacy|0|||
147283631|NCT02265705|531205064|FG003|Treatment Period Week 0-24|Lack of Efficacy|0|||
147283632|NCT02265705|531205065|FG004|Treatment Period Week 0-24|Lack of Efficacy|0|||
147283633|NCT02265705|531205066|FG005|Treatment Period Week 0-24|Lack of Efficacy|0|||
147283634|NCT02265705|531205067|FG006|Treatment Period Week 0-24|Lack of Efficacy|0|||
147283635|NCT02265705|531205061|FG000|Rescue Period|Withdrawal by Subject|0|||
147283636|NCT02265705|531205062|FG001|Rescue Period|Withdrawal by Subject|0|||
147283637|NCT02265705|531205063|FG002|Rescue Period|Withdrawal by Subject|1|||
147283638|NCT02265705|531205064|FG003|Rescue Period|Withdrawal by Subject|0|||
147283639|NCT02265705|531205065|FG004|Rescue Period|Withdrawal by Subject|0|||
147283640|NCT02265705|531205066|FG005|Rescue Period|Withdrawal by Subject|0|||
147283641|NCT02265705|531205067|FG006|Rescue Period|Withdrawal by Subject|0|||
147283642|NCT02265705|531205061|FG000|Rescue Period|Death|0|||
147283643|NCT02265705|531205062|FG001|Rescue Period|Death|0|||
147283644|NCT02265705|531205063|FG002|Rescue Period|Death|1|||
147283645|NCT02265705|531205064|FG003|Rescue Period|Death|0|||
147283646|NCT02265705|531205065|FG004|Rescue Period|Death|0|||
147283647|NCT02265705|531205066|FG005|Rescue Period|Death|0|||
147604031|NCT03511326|532367807|FG000|Overall Study|Withdrawal by Subject|1|||
147604032|NCT00867503|532367810|FG000|Overall Study|Withdrawal by Subject|1|||
147604033|NCT01001988|532367813|FG000|Overall Study|Protocol Violation|84|||
147283648|NCT02265705|531205067|FG006|Rescue Period|Death|0|||
147283649|NCT02265705|531205061|FG000|Rescue Period|Lack of Efficacy|0|||
147283650|NCT02265705|531205062|FG001|Rescue Period|Lack of Efficacy|0|||
147283651|NCT02265705|531205063|FG002|Rescue Period|Lack of Efficacy|1|||
147283652|NCT02265705|531205064|FG003|Rescue Period|Lack of Efficacy|0|||
147283653|NCT02265705|531205065|FG004|Rescue Period|Lack of Efficacy|0|||
147283654|NCT02265705|531205066|FG005|Rescue Period|Lack of Efficacy|0|||
147283655|NCT02265705|531205067|FG006|Rescue Period|Lack of Efficacy|0|||
147283656|NCT02265705|531205061|FG000|Open Label Period|Adverse Event|0|||
147283657|NCT02265705|531205062|FG001|Open Label Period|Adverse Event|0|||
147283658|NCT02265705|531205063|FG002|Open Label Period|Adverse Event|0|||
147283659|NCT02265705|531205064|FG003|Open Label Period|Adverse Event|2|||
147283660|NCT02265705|531205065|FG004|Open Label Period|Adverse Event|2|||
147283661|NCT02265705|531205066|FG005|Open Label Period|Adverse Event|0|||
147283662|NCT02265705|531205067|FG006|Open Label Period|Adverse Event|0|||
147283663|NCT02265705|531205061|FG000|Open Label Period|Physician Decision|0|||
147283664|NCT02265705|531205062|FG001|Open Label Period|Physician Decision|0|||
147283665|NCT02265705|531205063|FG002|Open Label Period|Physician Decision|0|||
147283666|NCT02265705|531205064|FG003|Open Label Period|Physician Decision|0|||
147283667|NCT02265705|531205065|FG004|Open Label Period|Physician Decision|1|||
147283668|NCT02265705|531205066|FG005|Open Label Period|Physician Decision|0|||
147283669|NCT02265705|531205067|FG006|Open Label Period|Physician Decision|0|||
147283670|NCT02265705|531205061|FG000|Open Label Period|Withdrawal by Subject|0|||
147283671|NCT02265705|531205062|FG001|Open Label Period|Withdrawal by Subject|0|||
147283672|NCT02265705|531205063|FG002|Open Label Period|Withdrawal by Subject|0|||
147283673|NCT02265705|531205064|FG003|Open Label Period|Withdrawal by Subject|0|||
147283674|NCT02265705|531205065|FG004|Open Label Period|Withdrawal by Subject|2|||
147283675|NCT02265705|531205066|FG005|Open Label Period|Withdrawal by Subject|0|||
147336842|NCT00516321|531400013|FG002|Double-blind (DB) Antiviral Treatment|Physician Decision|0|||
147336843|NCT02139046|531400014|FG000|Overall Study|Pretreatment Event/Adverse Event|9|||
147283676|NCT02265705|531205067|FG006|Open Label Period|Withdrawal by Subject|0|||
147283677|NCT02265705|531205061|FG000|Follow-up Period|Sponsor Decision|0|||
147283678|NCT02265705|531205062|FG001|Follow-up Period|Sponsor Decision|0|||
147283679|NCT02265705|531205063|FG002|Follow-up Period|Sponsor Decision|0|||
147451765|NCT01425008|531814965|FG000|Dose Expansion Phase|Withdrawal by Subject|0|||
147451766|NCT01425008|531814966|FG001|Dose Expansion Phase|Withdrawal by Subject|0|||
147451767|NCT01425008|531814967|FG002|Dose Expansion Phase|Withdrawal by Subject|0|||
147451768|NCT01425008|531814968|FG003|Dose Expansion Phase|Withdrawal by Subject|0|||
147451769|NCT01425008|531814969|FG004|Dose Expansion Phase|Withdrawal by Subject|0|||
147451770|NCT01425008|531814970|FG005|Dose Expansion Phase|Withdrawal by Subject|0|||
147451771|NCT01425008|531814971|FG006|Dose Expansion Phase|Withdrawal by Subject|0|||
147451772|NCT01425008|531814972|FG007|Dose Expansion Phase|Withdrawal by Subject|0|||
147451773|NCT01425008|531814973|FG008|Dose Expansion Phase|Withdrawal by Subject|0|||
147451774|NCT01425008|531814974|FG009|Dose Expansion Phase|Withdrawal by Subject|0|||
147451775|NCT01425008|531814975|FG010|Dose Expansion Phase|Withdrawal by Subject|1|||
147451776|NCT01425008|531814976|FG011|Dose Expansion Phase|Withdrawal by Subject|0|||
147451777|NCT01425008|531814977|FG012|Dose Expansion Phase|Withdrawal by Subject|0|||
147451778|NCT01425008|531814978|FG013|Dose Expansion Phase|Withdrawal by Subject|0|||
147451779|NCT01425008|531814979|FG014|Dose Expansion Phase|Withdrawal by Subject|0|||
147336844|NCT02139046|531400015|FG001|Overall Study|Pretreatment Event/Adverse Event|9|||
147336845|NCT02139046|531400016|FG002|Overall Study|Pretreatment Event/Adverse Event|10|||
147336846|NCT02139046|531400017|FG003|Overall Study|Pretreatment Event/Adverse Event|13|||
147336847|NCT02139046|531400018|FG004|Overall Study|Pretreatment Event/Adverse Event|7|||
147336848|NCT02139046|531400014|FG000|Overall Study|Major Protocol Deviation|9|||
147336849|NCT02139046|531400015|FG001|Overall Study|Major Protocol Deviation|10|||
147604034|NCT01001988|532367813|FG000|Overall Study|Withdrawal by Subject|18|||
147336850|NCT02139046|531400016|FG002|Overall Study|Major Protocol Deviation|16|||
147336851|NCT02139046|531400017|FG003|Overall Study|Major Protocol Deviation|12|||
147336852|NCT02139046|531400018|FG004|Overall Study|Major Protocol Deviation|6|||
147336853|NCT02139046|531400014|FG000|Overall Study|Lost to Follow-up|13|||
147336854|NCT02139046|531400015|FG001|Overall Study|Lost to Follow-up|16|||
147336855|NCT02139046|531400016|FG002|Overall Study|Lost to Follow-up|16|||
147336856|NCT02139046|531400017|FG003|Overall Study|Lost to Follow-up|18|||
147336857|NCT02139046|531400018|FG004|Overall Study|Lost to Follow-up|13|||
147336858|NCT02139046|531400014|FG000|Overall Study|Voluntary Withdrawal|20|||
147336859|NCT02139046|531400015|FG001|Overall Study|Voluntary Withdrawal|8|||
147336860|NCT02139046|531400016|FG002|Overall Study|Voluntary Withdrawal|10|||
147336861|NCT02139046|531400017|FG003|Overall Study|Voluntary Withdrawal|15|||
147336862|NCT02139046|531400018|FG004|Overall Study|Voluntary Withdrawal|16|||
147336863|NCT02139046|531400014|FG000|Overall Study|Lack of Efficacy|0|||
147336864|NCT02139046|531400015|FG001|Overall Study|Lack of Efficacy|1|||
147336865|NCT02139046|531400016|FG002|Overall Study|Lack of Efficacy|2|||
147336866|NCT02139046|531400017|FG003|Overall Study|Lack of Efficacy|1|||
147336867|NCT02139046|531400018|FG004|Overall Study|Lack of Efficacy|2|||
147336868|NCT02139046|531400014|FG000|Overall Study|Withdrawal due to a Gout Flare|1|||
147451780|NCT01425008|531814980|FG015|Dose Expansion Phase|Withdrawal by Subject|1|||
147451781|NCT01425008|531814981|FG016|Dose Expansion Phase|Withdrawal by Subject|1|||
147451782|NCT01425008|531814982|FG017|Dose Expansion Phase|Withdrawal by Subject|0|||
147451783|NCT01425008|531814983|FG018|Dose Expansion Phase|Withdrawal by Subject|0|||
147451784|NCT01425008|531814965|FG000|Dose Expansion Phase|Other|0|||
147451785|NCT01425008|531814966|FG001|Dose Expansion Phase|Other|0|||
147604035|NCT01001988|532367813|FG000|Overall Study|Lost to Follow-up|15|||
147604036|NCT01844856|532367814|FG000|Overall Study|Lost to Follow-up|15|||
147604037|NCT01844856|532367815|FG001|Overall Study|Lost to Follow-up|3|||
147283680|NCT02265705|531205064|FG003|Follow-up Period|Sponsor Decision|0|||
147283681|NCT02265705|531205065|FG004|Follow-up Period|Sponsor Decision|0|||
147283682|NCT02265705|531205066|FG005|Follow-up Period|Sponsor Decision|1|||
147283683|NCT02265705|531205067|FG006|Follow-up Period|Sponsor Decision|6|||
147283684|NCT02265705|531205061|FG000|Follow-up Period|Adverse Event|0|||
147283685|NCT02265705|531205062|FG001|Follow-up Period|Adverse Event|0|||
147283686|NCT02265705|531205063|FG002|Follow-up Period|Adverse Event|0|||
147283687|NCT02265705|531205064|FG003|Follow-up Period|Adverse Event|0|||
147283688|NCT02265705|531205065|FG004|Follow-up Period|Adverse Event|0|||
147283689|NCT02265705|531205066|FG005|Follow-up Period|Adverse Event|0|||
147283690|NCT02265705|531205067|FG006|Follow-up Period|Adverse Event|3|||
147283691|NCT02265705|531205061|FG000|Follow-up Period|Physician Decision|0|||
147283692|NCT02265705|531205062|FG001|Follow-up Period|Physician Decision|0|||
147283693|NCT02265705|531205063|FG002|Follow-up Period|Physician Decision|0|||
147283694|NCT02265705|531205064|FG003|Follow-up Period|Physician Decision|0|||
147451786|NCT01425008|531814967|FG002|Dose Expansion Phase|Other|0|||
147283695|NCT02265705|531205065|FG004|Follow-up Period|Physician Decision|0|||
147283696|NCT02265705|531205066|FG005|Follow-up Period|Physician Decision|0|||
147336869|NCT02139046|531400015|FG001|Overall Study|Withdrawal due to a Gout Flare|1|||
147336870|NCT02139046|531400016|FG002|Overall Study|Withdrawal due to a Gout Flare|1|||
147336871|NCT02139046|531400017|FG003|Overall Study|Withdrawal due to a Gout Flare|0|||
147336872|NCT02139046|531400018|FG004|Overall Study|Withdrawal due to a Gout Flare|1|||
147336873|NCT02139046|531400014|FG000|Overall Study|Other Miscellaneous Reasons|10|||
147451787|NCT01425008|531814968|FG003|Dose Expansion Phase|Other|0|||
147604038|NCT01844856|532367814|FG000|Overall Study|Adverse Event|3|||
147283697|NCT02265705|531205067|FG006|Follow-up Period|Physician Decision|1|||
147283698|NCT02265705|531205061|FG000|Follow-up Period|Withdrawal by Subject|0|||
147283699|NCT02265705|531205062|FG001|Follow-up Period|Withdrawal by Subject|0|||
147283700|NCT02265705|531205063|FG002|Follow-up Period|Withdrawal by Subject|0|||
147283701|NCT02265705|531205064|FG003|Follow-up Period|Withdrawal by Subject|0|||
147283702|NCT02265705|531205065|FG004|Follow-up Period|Withdrawal by Subject|0|||
147283703|NCT02265705|531205066|FG005|Follow-up Period|Withdrawal by Subject|0|||
147283704|NCT02265705|531205067|FG006|Follow-up Period|Withdrawal by Subject|1|||
147283705|NCT00346034|531205069|FG000|Overall Study|Adverse Event|34|||
147283706|NCT00346034|531205069|FG000|Overall Study|Lack of Efficacy|8|||
147283707|NCT00346034|531205069|FG000|Overall Study|Withdrawal by Subject|13|||
147283708|NCT00346034|531205069|FG000|Overall Study|Patient Stopped Taking Study Drug|1|||
147283709|NCT00346034|531205069|FG000|Overall Study|Not Willing to Follow Dosing Regimen|1|||
147283710|NCT04000165|531205070|FG000|Overall Study|Physician Decision|1|||
147283711|NCT04000165|531205070|FG000|Overall Study|Withdrawal by Subject|1|||
147283712|NCT00941603|531205074|FG000|Overall Study|Adverse Event|10|||
147283713|NCT00941603|531205075|FG001|Overall Study|Adverse Event|15|||
147336874|NCT02139046|531400015|FG001|Overall Study|Other Miscellaneous Reasons|9|||
147336875|NCT02139046|531400016|FG002|Overall Study|Other Miscellaneous Reasons|4|||
147336876|NCT02139046|531400017|FG003|Overall Study|Other Miscellaneous Reasons|9|||
147336877|NCT02139046|531400018|FG004|Overall Study|Other Miscellaneous Reasons|12|||
147336878|NCT01582100|531400027|FG000|Overall Study|Adverse Event|1|||
147336879|NCT01582100|531400027|FG000|Overall Study|Withdrawal by Subject|1|||
147336880|NCT01040689|531400028|FG000|Overall Study|Adverse Event|0|||
147336881|NCT01040689|531400029|FG001|Overall Study|Adverse Event|0|||
147336882|NCT01040689|531400030|FG002|Overall Study|Adverse Event|2|||
147336883|NCT01040689|531400031|FG003|Overall Study|Adverse Event|4|||
147336884|NCT01040689|531400028|FG000|Overall Study|Lack of Efficacy|0|||
147336885|NCT01040689|531400029|FG001|Overall Study|Lack of Efficacy|0|||
147336886|NCT01040689|531400030|FG002|Overall Study|Lack of Efficacy|1|||
147336887|NCT01040689|531400031|FG003|Overall Study|Lack of Efficacy|0|||
147336888|NCT01040689|531400028|FG000|Overall Study|Lost to Follow-up|1|||
147336889|NCT01040689|531400029|FG001|Overall Study|Lost to Follow-up|0|||
147336890|NCT01040689|531400030|FG002|Overall Study|Lost to Follow-up|0|||
147336891|NCT01040689|531400031|FG003|Overall Study|Lost to Follow-up|0|||
147336892|NCT01040689|531400028|FG000|Overall Study|Withdrawal by Subject|2|||
147336893|NCT01040689|531400029|FG001|Overall Study|Withdrawal by Subject|1|||
147336894|NCT01040689|531400030|FG002|Overall Study|Withdrawal by Subject|1|||
147336895|NCT01040689|531400031|FG003|Overall Study|Withdrawal by Subject|0|||
147336896|NCT01040689|531400028|FG000|Overall Study|Other reasons not listed above|0|||
147336897|NCT01040689|531400029|FG001|Overall Study|Other reasons not listed above|1|||
147336898|NCT01040689|531400030|FG002|Overall Study|Other reasons not listed above|0|||
147336899|NCT01040689|531400031|FG003|Overall Study|Other reasons not listed above|0|||
147336900|NCT05876949|531400032|FG000|Overall Study|Withdrawal by Subject|1|||
147336901|NCT05876949|531400033|FG001|Overall Study|Withdrawal by Subject|3|||
147336902|NCT05876949|531400032|FG000|Overall Study|Physician Decision|0|||
147336903|NCT05876949|531400033|FG001|Overall Study|Physician Decision|2|||
147336904|NCT05876949|531400032|FG000|Overall Study|Death|0|||
147336905|NCT05876949|531400033|FG001|Overall Study|Death|1|||
147336906|NCT00463788|531400044|FG000|Overall Study|Progressive Disease|86|||
147336907|NCT00463788|531400045|FG001|Overall Study|Progressive Disease|42|||
147336908|NCT00463788|531400044|FG000|Overall Study|Adverse Event|6|||
147336909|NCT00463788|531400045|FG001|Overall Study|Adverse Event|2|||
147336910|NCT00463788|531400044|FG000|Overall Study|Withdrawal by Subject|6|||
147336911|NCT00463788|531400045|FG001|Overall Study|Withdrawal by Subject|2|||
147336912|NCT00463788|531400044|FG000|Overall Study|Death|4|||
147336913|NCT00463788|531400045|FG001|Overall Study|Death|3|||
147336914|NCT00463788|531400044|FG000|Overall Study|Symptomatic Deterioration|2|||
147336915|NCT00463788|531400045|FG001|Overall Study|Symptomatic Deterioration|3|||
147336916|NCT00463788|531400044|FG000|Overall Study|Lost to Follow-up|1|||
147336917|NCT00463788|531400045|FG001|Overall Study|Lost to Follow-up|0|||
147336918|NCT00463788|531400044|FG000|Overall Study|Protocol Violation|0|||
147336919|NCT00463788|531400045|FG001|Overall Study|Protocol Violation|1|||
147336920|NCT00463788|531400044|FG000|Overall Study|Other|3|||
147336921|NCT00463788|531400045|FG001|Overall Study|Other|0|||
147283714|NCT00941603|531205076|FG002|Overall Study|Adverse Event|5|||
147336922|NCT00463788|531400044|FG000|Overall Study|Randomized but not treated|1|||
147336923|NCT00463788|531400045|FG001|Overall Study|Randomized but not treated|1|||
147336924|NCT00360698|531400046|FG000|Run-In|Physician Decision|0|||
147336925|NCT00360698|531400047|FG001|Run-In|Physician Decision|1|||
147336926|NCT00360698|531400046|FG000|Run-In|Withdrawal by Subject|0|||
147336927|NCT00360698|531400047|FG001|Run-In|Withdrawal by Subject|2|||
147336928|NCT00360698|531400046|FG000|Run-In|Non compliance with treatment procedure|0|||
147336929|NCT00360698|531400047|FG001|Run-In|Non compliance with treatment procedure|1|||
147336930|NCT00360698|531400046|FG000|Run-In|Sponsor request|0|||
147336931|NCT00360698|531400047|FG001|Run-In|Sponsor request|2|||
147336932|NCT00360698|531400046|FG000|Run-In|Patient did not meet inclusion criteria|0|||
147451788|NCT01425008|531814969|FG004|Dose Expansion Phase|Other|0|||
147283715|NCT00941603|531205077|FG003|Overall Study|Adverse Event|1|||
147283716|NCT00941603|531205078|FG004|Overall Study|Adverse Event|4|||
147283717|NCT00941603|531205079|FG005|Overall Study|Adverse Event|0|||
147283718|NCT00941603|531205074|FG000|Overall Study|Lost to Follow-up|0|||
147283719|NCT00941603|531205075|FG001|Overall Study|Lost to Follow-up|0|||
147283720|NCT00941603|531205076|FG002|Overall Study|Lost to Follow-up|0|||
147283721|NCT00941603|531205077|FG003|Overall Study|Lost to Follow-up|1|||
147283722|NCT00941603|531205078|FG004|Overall Study|Lost to Follow-up|0|||
147283723|NCT00941603|531205079|FG005|Overall Study|Lost to Follow-up|2|||
147283724|NCT00941603|531205074|FG000|Overall Study|Withdrawal by Subject|0|||
147283725|NCT00941603|531205075|FG001|Overall Study|Withdrawal by Subject|0|||
147283726|NCT00941603|531205076|FG002|Overall Study|Withdrawal by Subject|0|||
147283727|NCT00941603|531205077|FG003|Overall Study|Withdrawal by Subject|2|||
147283728|NCT00941603|531205078|FG004|Overall Study|Withdrawal by Subject|0|||
147283729|NCT00941603|531205079|FG005|Overall Study|Withdrawal by Subject|1|||
147283730|NCT00941603|531205074|FG000|Overall Study|Protocol Violation|0|||
147283731|NCT00941603|531205075|FG001|Overall Study|Protocol Violation|1|||
147283732|NCT00941603|531205076|FG002|Overall Study|Protocol Violation|0|||
147283733|NCT00941603|531205077|FG003|Overall Study|Protocol Violation|0|||
147283734|NCT00941603|531205078|FG004|Overall Study|Protocol Violation|0|||
147283735|NCT00941603|531205079|FG005|Overall Study|Protocol Violation|0|||
147283736|NCT00941603|531205074|FG000|Overall Study|Did not meet protocol eligibility|1|||
147283737|NCT00941603|531205075|FG001|Overall Study|Did not meet protocol eligibility|0|||
147283738|NCT00941603|531205076|FG002|Overall Study|Did not meet protocol eligibility|0|||
147283739|NCT00941603|531205077|FG003|Overall Study|Did not meet protocol eligibility|0|||
147283740|NCT00941603|531205078|FG004|Overall Study|Did not meet protocol eligibility|0|||
147283741|NCT00941603|531205079|FG005|Overall Study|Did not meet protocol eligibility|0|||
147283742|NCT02079805|531205080|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
147283743|NCT02079805|531205081|FG001|Overall Study|Pretreatment Event/Adverse Event|1|||
147283744|NCT02079805|531205080|FG000|Overall Study|Voluntary Withdrawal|0|||
147283745|NCT02079805|531205081|FG001|Overall Study|Voluntary Withdrawal|1|||
147283746|NCT00383435|531205082|FG000|26-Week Double-Blind Treatment Period|Adverse Event|10|||
147283747|NCT00383435|531205083|FG001|26-Week Double-Blind Treatment Period|Adverse Event|2|||
147283748|NCT00383435|531205084|FG002|26-Week Double-Blind Treatment Period|Adverse Event|8|||
147283749|NCT00383435|531205085|FG003|26-Week Double-Blind Treatment Period|Adverse Event|6|||
147283750|NCT00383435|531205086|FG004|26-Week Double-Blind Treatment Period|Adverse Event|8|||
147283751|NCT00383435|531205082|FG000|26-Week Double-Blind Treatment Period|Lack of Efficacy|3|||
147283752|NCT00383435|531205083|FG001|26-Week Double-Blind Treatment Period|Lack of Efficacy|2|||
147283753|NCT00383435|531205084|FG002|26-Week Double-Blind Treatment Period|Lack of Efficacy|3|||
147283754|NCT00383435|531205085|FG003|26-Week Double-Blind Treatment Period|Lack of Efficacy|5|||
147283755|NCT00383435|531205086|FG004|26-Week Double-Blind Treatment Period|Lack of Efficacy|8|||
147283756|NCT00383435|531205082|FG000|26-Week Double-Blind Treatment Period|Lost to Follow-up|3|||
147283757|NCT00383435|531205083|FG001|26-Week Double-Blind Treatment Period|Lost to Follow-up|3|||
147283758|NCT00383435|531205084|FG002|26-Week Double-Blind Treatment Period|Lost to Follow-up|1|||
147283759|NCT00383435|531205085|FG003|26-Week Double-Blind Treatment Period|Lost to Follow-up|2|||
147283760|NCT00383435|531205086|FG004|26-Week Double-Blind Treatment Period|Lost to Follow-up|2|||
147283761|NCT00383435|531205082|FG000|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|7|||
147283762|NCT00383435|531205083|FG001|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|12|||
147283763|NCT00383435|531205084|FG002|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|14|||
147283764|NCT00383435|531205085|FG003|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|10|||
147283765|NCT00383435|531205086|FG004|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|17|||
147283766|NCT00383435|531205082|FG000|26-Week Double-Blind Treatment Period|Participant withdrawal related|2|||
147283767|NCT00383435|531205083|FG001|26-Week Double-Blind Treatment Period|Participant withdrawal related|3|||
147283768|NCT00383435|531205084|FG002|26-Week Double-Blind Treatment Period|Participant withdrawal related|7|||
147283769|NCT00383435|531205085|FG003|26-Week Double-Blind Treatment Period|Participant withdrawal related|3|||
147283770|NCT00383435|531205086|FG004|26-Week Double-Blind Treatment Period|Participant withdrawal related|7|||
147283771|NCT00383435|531205082|FG000|26-Week Double-Blind Treatment Period|Non-compliance with protocol|1|||
147283772|NCT00383435|531205083|FG001|26-Week Double-Blind Treatment Period|Non-compliance with protocol|5|||
147283773|NCT00383435|531205084|FG002|26-Week Double-Blind Treatment Period|Non-compliance with protocol|3|||
147283774|NCT00383435|531205085|FG003|26-Week Double-Blind Treatment Period|Non-compliance with protocol|5|||
147283775|NCT00383435|531205086|FG004|26-Week Double-Blind Treatment Period|Non-compliance with protocol|4|||
147283776|NCT00383435|531205082|FG000|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|10|||
147283777|NCT00383435|531205083|FG001|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|8|||
147283778|NCT00383435|531205084|FG002|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|9|||
147283779|NCT00383435|531205085|FG003|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|5|||
147604039|NCT01844856|532367815|FG001|Overall Study|Adverse Event|6|||
147283780|NCT00383435|531205086|FG004|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|6|||
147604040|NCT01844856|532367814|FG000|Overall Study|Withdrawal by Subject|3|||
147336933|NCT00360698|531400047|FG001|Run-In|Patient did not meet inclusion criteria|1|||
147336934|NCT00360698|531400046|FG000|Run-In|Patient personal reasons|0|||
147336935|NCT00360698|531400047|FG001|Run-In|Patient personal reasons|2|||
147336936|NCT00360698|531400046|FG000|Run-In|Need of insulin with meals|0|||
147336937|NCT00360698|531400047|FG001|Run-In|Need of insulin with meals|1|||
147283781|NCT00383435|531205082|FG000|26-Week Double-Blind Treatment Period|Administrative|5|||
147283782|NCT00383435|531205083|FG001|26-Week Double-Blind Treatment Period|Administrative|3|||
147336938|NCT00360698|531400046|FG000|Treatment Period|Non compliance with treatment procedure|1|||
147336939|NCT00360698|531400047|FG001|Treatment Period|Non compliance with treatment procedure|0|||
147336940|NCT00360698|531400046|FG000|Treatment Period|Early termination by error|0|||
147336941|NCT00360698|531400047|FG001|Treatment Period|Early termination by error|1|||
147336942|NCT01692938|531400048|FG000|Overall Study|Protocol Deviation|1|||
147336943|NCT01692938|531400049|FG001|Overall Study|Protocol Deviation|1|||
147283783|NCT00383435|531205084|FG002|26-Week Double-Blind Treatment Period|Administrative|1|||
147283784|NCT00383435|531205085|FG003|26-Week Double-Blind Treatment Period|Administrative|1|||
147283785|NCT00383435|531205086|FG004|26-Week Double-Blind Treatment Period|Administrative|1|||
147283786|NCT00383435|531205082|FG000|26-Week Treatment Safety Extension|Adverse Event|4|||
147283787|NCT00383435|531205083|FG001|26-Week Treatment Safety Extension|Adverse Event|2|||
147283788|NCT00383435|531205084|FG002|26-Week Treatment Safety Extension|Adverse Event|5|||
147283789|NCT00383435|531205085|FG003|26-Week Treatment Safety Extension|Adverse Event|5|||
147283790|NCT00383435|531205086|FG004|26-Week Treatment Safety Extension|Adverse Event|1|||
147283791|NCT00383435|531205082|FG000|26-Week Treatment Safety Extension|Lack of Efficacy|1|||
147283792|NCT00383435|531205083|FG001|26-Week Treatment Safety Extension|Lack of Efficacy|1|||
147283793|NCT00383435|531205084|FG002|26-Week Treatment Safety Extension|Lack of Efficacy|1|||
147283794|NCT00383435|531205085|FG003|26-Week Treatment Safety Extension|Lack of Efficacy|1|||
147283795|NCT00383435|531205086|FG004|26-Week Treatment Safety Extension|Lack of Efficacy|0|||
147283796|NCT00383435|531205082|FG000|26-Week Treatment Safety Extension|Lost to Follow-up|0|||
147283797|NCT00383435|531205083|FG001|26-Week Treatment Safety Extension|Lost to Follow-up|2|||
147283798|NCT00383435|531205084|FG002|26-Week Treatment Safety Extension|Lost to Follow-up|1|||
147283799|NCT00383435|531205085|FG003|26-Week Treatment Safety Extension|Lost to Follow-up|0|||
147283800|NCT00383435|531205086|FG004|26-Week Treatment Safety Extension|Lost to Follow-up|1|||
147283801|NCT00383435|531205082|FG000|26-Week Treatment Safety Extension|Participant withdrawal unrelated|2|||
147283802|NCT00383435|531205083|FG001|26-Week Treatment Safety Extension|Participant withdrawal unrelated|2|||
147283803|NCT00383435|531205084|FG002|26-Week Treatment Safety Extension|Participant withdrawal unrelated|6|||
147283804|NCT00383435|531205085|FG003|26-Week Treatment Safety Extension|Participant withdrawal unrelated|6|||
147283805|NCT00383435|531205086|FG004|26-Week Treatment Safety Extension|Participant withdrawal unrelated|0|||
147283806|NCT00383435|531205082|FG000|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
147283807|NCT00383435|531205083|FG001|26-Week Treatment Safety Extension|Participant withdrawal related|0|||
147283808|NCT00383435|531205084|FG002|26-Week Treatment Safety Extension|Participant withdrawal related|2|||
147283809|NCT00383435|531205085|FG003|26-Week Treatment Safety Extension|Participant withdrawal related|0|||
147283810|NCT00383435|531205086|FG004|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
147283811|NCT00383435|531205082|FG000|26-Week Treatment Safety Extension|Non-compliance with protocol|4|||
147283812|NCT00383435|531205083|FG001|26-Week Treatment Safety Extension|Non-compliance with protocol|1|||
147283813|NCT00383435|531205084|FG002|26-Week Treatment Safety Extension|Non-compliance with protocol|1|||
147283814|NCT00383435|531205085|FG003|26-Week Treatment Safety Extension|Non-compliance with protocol|1|||
147283815|NCT00383435|531205086|FG004|26-Week Treatment Safety Extension|Non-compliance with protocol|0|||
147283816|NCT00383435|531205082|FG000|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1|||
147283817|NCT00383435|531205083|FG001|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0|||
147283818|NCT00383435|531205084|FG002|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0|||
147283819|NCT00383435|531205085|FG003|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1|||
147283820|NCT00383435|531205086|FG004|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0|||
147283821|NCT00383435|531205082|FG000|26-Week Treatment Safety Extension|Administrative|1|||
147283822|NCT00383435|531205083|FG001|26-Week Treatment Safety Extension|Administrative|1|||
147283823|NCT00383435|531205084|FG002|26-Week Treatment Safety Extension|Administrative|0|||
147283824|NCT00383435|531205085|FG003|26-Week Treatment Safety Extension|Administrative|1|||
147283825|NCT00383435|531205086|FG004|26-Week Treatment Safety Extension|Administrative|0|||
147283826|NCT01753193|531205087|FG000|Overall Study|Withdrawal by Subject|23|||
147336944|NCT01692938|531400048|FG000|Overall Study|Study completed prior to site completion|3|||
147336945|NCT01692938|531400049|FG001|Overall Study|Study completed prior to site completion|3|||
147336946|NCT02755116|531400051|FG000|Overall Study|surgery converted to open, pt admitted|3|||
147336947|NCT02755116|531400052|FG001|Overall Study|surgery converted to open, pt admitted|1|||
147336948|NCT02423291|531400053|FG000|Overall Study|Lack of Efficacy|14|||
147336949|NCT02423291|531400053|FG000|Overall Study|Adverse Event|1|||
147336950|NCT01510717|531400054|FG000|Overall Study|Adverse Event|1|||
147451789|NCT01425008|531814970|FG005|Dose Expansion Phase|Other|0|||
147451790|NCT01425008|531814971|FG006|Dose Expansion Phase|Other|0|||
147451791|NCT01425008|531814972|FG007|Dose Expansion Phase|Other|0|||
147283827|NCT01753193|531205087|FG000|Overall Study|Lost to Follow-up|6|||
147283828|NCT01753193|531205087|FG000|Overall Study|Death|1|||
147283829|NCT01753193|531205087|FG000|Overall Study|Other|16|||
147283830|NCT00583557|531205088|FG000|Overall Study|Withdrawal by Subject|18|||
147283831|NCT00583557|531205088|FG000|Overall Study|Adverse Event|9|||
147283832|NCT00583557|531205088|FG000|Overall Study|Lack of Efficacy|31|||
147283833|NCT00583557|531205088|FG000|Overall Study|Lack of Compliance|5|||
147283834|NCT00583557|531205088|FG000|Overall Study|Other|5|||
147283835|NCT00583557|531205088|FG000|Overall Study|Did not receive belimumab in LBRA99|2|||
147283836|NCT02682264|531205089|FG000|Overall Study|Withdrawal by Subject|56|||
147283837|NCT02682264|531205090|FG001|Overall Study|Withdrawal by Subject|45|||
147283838|NCT02682264|531205089|FG000|Overall Study|Lost to Follow-up|49|||
147283839|NCT02682264|531205090|FG001|Overall Study|Lost to Follow-up|41|||
147283840|NCT02682264|531205089|FG000|Overall Study|Lack of Efficacy|14|||
147283841|NCT02682264|531205090|FG001|Overall Study|Lack of Efficacy|16|||
147283842|NCT02682264|531205089|FG000|Overall Study|Withdrawal by Parent|6|||
147283843|NCT02682264|531205090|FG001|Overall Study|Withdrawal by Parent|7|||
147283844|NCT02682264|531205089|FG000|Overall Study|Adverse Event|9|||
147283845|NCT02682264|531205090|FG001|Overall Study|Adverse Event|0|||
147283846|NCT02682264|531205089|FG000|Overall Study|Noncompliance with study drug|1|||
147283847|NCT02682264|531205090|FG001|Overall Study|Noncompliance with study drug|4|||
147283848|NCT02682264|531205089|FG000|Overall Study|Pregnancy|1|||
147283849|NCT02682264|531205090|FG001|Overall Study|Pregnancy|2|||
147283850|NCT02682264|531205089|FG000|Overall Study|Recovery|1|||
147283851|NCT02682264|531205090|FG001|Overall Study|Recovery|2|||
147283852|NCT02682264|531205089|FG000|Overall Study|Progressive Disease|1|||
147283853|NCT02682264|531205090|FG001|Overall Study|Progressive Disease|0|||
147283854|NCT02682264|531205089|FG000|Overall Study|Technical Problems|0|||
147283855|NCT02682264|531205090|FG001|Overall Study|Technical Problems|1|||
147283856|NCT02682264|531205089|FG000|Overall Study|Moved abroad and unable to continue|0|||
147283857|NCT02682264|531205090|FG001|Overall Study|Moved abroad and unable to continue|3|||
147283858|NCT02682264|531205089|FG000|Overall Study|Stopped test article application|0|||
147283859|NCT02682264|531205090|FG001|Overall Study|Stopped test article application|1|||
147283860|NCT02347761|531205091|FG000|All Collected|Death|1|||
147283861|NCT02347761|531205092|FG001|All Collected|Death|0|||
147283862|NCT02347761|531205093|FG002|All Collected|Death|0|||
147283863|NCT02347761|531205091|FG000|All Collected|Lost to Follow-up|3|||
147283864|NCT02347761|531205092|FG001|All Collected|Lost to Follow-up|2|||
147283865|NCT02347761|531205093|FG002|All Collected|Lost to Follow-up|3|||
147283866|NCT02347761|531205091|FG000|All Collected|Withdrawal by Subject|11|||
147283867|NCT02347761|531205092|FG001|All Collected|Withdrawal by Subject|11|||
147283868|NCT02347761|531205093|FG002|All Collected|Withdrawal by Subject|22|||
147283869|NCT02347761|531205091|FG000|All Collected|invetigator disretion|2|||
147283870|NCT02347761|531205092|FG001|All Collected|invetigator disretion|0|||
147283871|NCT02347761|531205093|FG002|All Collected|invetigator disretion|0|||
147283872|NCT02347761|531205091|FG000|All Collected|instillation site pain|0|||
147283873|NCT02347761|531205092|FG001|All Collected|instillation site pain|0|||
147283874|NCT02347761|531205093|FG002|All Collected|instillation site pain|1|||
147283875|NCT02347761|531205091|FG000|All Collected|exacerbation of COPD|0|||
147283876|NCT02347761|531205092|FG001|All Collected|exacerbation of COPD|0|||
147283877|NCT02347761|531205093|FG002|All Collected|exacerbation of COPD|1|||
147283878|NCT02347761|531205091|FG000|All Collected|moved/travel|0|||
147283879|NCT02347761|531205092|FG001|All Collected|moved/travel|1|||
147283880|NCT02347761|531205093|FG002|All Collected|moved/travel|0|||
147283881|NCT02347761|531205091|FG000|On Study Treatment|Lack of Efficacy|2|||
147283882|NCT02347761|531205092|FG001|On Study Treatment|Lack of Efficacy|3|||
147283883|NCT02347761|531205093|FG002|On Study Treatment|Lack of Efficacy|4|||
147283884|NCT02347761|531205091|FG000|On Study Treatment|non-compliance with study medication|0|||
147283885|NCT02347761|531205092|FG001|On Study Treatment|non-compliance with study medication|0|||
147283886|NCT02347761|531205093|FG002|On Study Treatment|non-compliance with study medication|2|||
147283887|NCT02347761|531205091|FG000|On Study Treatment|Withdrawal by Subject|7|||
147283888|NCT02347761|531205092|FG001|On Study Treatment|Withdrawal by Subject|3|||
147283889|NCT02347761|531205093|FG002|On Study Treatment|Withdrawal by Subject|5|||
147283890|NCT02347761|531205091|FG000|On Study Treatment|move/travel|2|||
147283891|NCT02347761|531205092|FG001|On Study Treatment|move/travel|6|||
147283892|NCT02347761|531205093|FG002|On Study Treatment|move/travel|5|||
147604041|NCT01844856|532367815|FG001|Overall Study|Withdrawal by Subject|2|||
147283893|NCT02347761|531205091|FG000|On Study Treatment|dissastisfaction with device|2|||
147283894|NCT02347761|531205092|FG001|On Study Treatment|dissastisfaction with device|1|||
147283895|NCT02347761|531205093|FG002|On Study Treatment|dissastisfaction with device|4|||
147283896|NCT02347761|531205091|FG000|On Study Treatment|Lost to Follow-up|2|||
147283897|NCT02347761|531205092|FG001|On Study Treatment|Lost to Follow-up|1|||
147283898|NCT02347761|531205093|FG002|On Study Treatment|Lost to Follow-up|1|||
147283899|NCT02347761|531205091|FG000|On Study Treatment|investigator discretion|2|||
147283900|NCT02347761|531205092|FG001|On Study Treatment|investigator discretion|0|||
147283901|NCT02347761|531205093|FG002|On Study Treatment|investigator discretion|0|||
147604042|NCT01844856|532367814|FG000|Overall Study|Noncompliance|2|||
147451792|NCT01425008|531814973|FG008|Dose Expansion Phase|Other|0|||
147451793|NCT01425008|531814974|FG009|Dose Expansion Phase|Other|0|||
147451794|NCT01425008|531814975|FG010|Dose Expansion Phase|Other|0|||
147451795|NCT01425008|531814976|FG011|Dose Expansion Phase|Other|0|||
147451796|NCT01425008|531814977|FG012|Dose Expansion Phase|Other|1|||
147451797|NCT01425008|531814978|FG013|Dose Expansion Phase|Other|0|||
147451798|NCT01425008|531814979|FG014|Dose Expansion Phase|Other|0|||
147451799|NCT01425008|531814980|FG015|Dose Expansion Phase|Other|0|||
147451800|NCT01425008|531814981|FG016|Dose Expansion Phase|Other|2|||
147451801|NCT01425008|531814982|FG017|Dose Expansion Phase|Other|0|||
147451802|NCT01425008|531814983|FG018|Dose Expansion Phase|Other|4|||
147451803|NCT01425008|531814965|FG000|Dose Expansion Phase|Symptomatic Deterioration|0|||
147451804|NCT01425008|531814966|FG001|Dose Expansion Phase|Symptomatic Deterioration|0|||
147451805|NCT01425008|531814967|FG002|Dose Expansion Phase|Symptomatic Deterioration|0|||
147451806|NCT01425008|531814968|FG003|Dose Expansion Phase|Symptomatic Deterioration|0|||
147451807|NCT01425008|531814969|FG004|Dose Expansion Phase|Symptomatic Deterioration|0|||
147451808|NCT01425008|531814970|FG005|Dose Expansion Phase|Symptomatic Deterioration|0|||
147451809|NCT01425008|531814971|FG006|Dose Expansion Phase|Symptomatic Deterioration|0|||
147451810|NCT01425008|531814972|FG007|Dose Expansion Phase|Symptomatic Deterioration|0|||
147451811|NCT01425008|531814973|FG008|Dose Expansion Phase|Symptomatic Deterioration|0|||
147451812|NCT01425008|531814974|FG009|Dose Expansion Phase|Symptomatic Deterioration|0|||
147283902|NCT02347761|531205091|FG000|On Study Treatment|durg not working|0|||
147283903|NCT02347761|531205092|FG001|On Study Treatment|durg not working|1|||
147283904|NCT02347761|531205093|FG002|On Study Treatment|durg not working|1|||
147283905|NCT02347761|531205091|FG000|On Study Treatment|Adverse Event|10|||
147283906|NCT02347761|531205092|FG001|On Study Treatment|Adverse Event|8|||
147283907|NCT02347761|531205093|FG002|On Study Treatment|Adverse Event|20|||
147283908|NCT01255358|531205095|FG000|Overall Study|Adverse Event|2|||
147283909|NCT01255358|531205095|FG000|Overall Study|Protocol Violation|2|||
147283910|NCT03950739|531205096|FG000|Treatment Phase|Adverse Event|2|||
147283911|NCT03950739|531205096|FG000|Optional Extension Phase|Death|1|||
147283912|NCT03950739|531205096|FG000|Optional Extension Phase|Progressive Disease|5|||
147283913|NCT03950739|531205096|FG000|Optional Extension Phase|Adverse Event|7|||
147283914|NCT03950739|531205096|FG000|Optional Extension Phase|Lost to Follow-up|2|||
147283915|NCT03950739|531205096|FG000|Optional Extension Phase|Site Closure|2|||
147283916|NCT03950739|531205096|FG000|Optional Extension Phase|Pregnancy|1|||
147283917|NCT03625570|531205097|FG000|Primary Endpoint - Immediate Post|Withdrawal by Subject|2|||
147283918|NCT03625570|531205098|FG001|Primary Endpoint - Immediate Post|Withdrawal by Subject|1|||
147283919|NCT03625570|531205097|FG000|Primary Endpoint - Immediate Post|PI decision; unable to perform exercises|1|||
147283920|NCT03625570|531205098|FG001|Primary Endpoint - Immediate Post|PI decision; unable to perform exercises|0|||
147283921|NCT03625570|531205097|FG000|Primary Endpoint - Immediate Post|Withdrawn; COVID-19 shut down|0|||
147283922|NCT03625570|531205098|FG001|Primary Endpoint - Immediate Post|Withdrawn; COVID-19 shut down|1|||
147283923|NCT03264989|531205099|FG000|Overall Study|Lost to Follow-up|1|||
147283924|NCT03264989|531205100|FG001|Overall Study|Lost to Follow-up|0|||
147283925|NCT03264989|531205099|FG000|Overall Study|New Therapy for study Indication|1|||
147283926|NCT03264989|531205100|FG001|Overall Study|New Therapy for study Indication|0|||
147283927|NCT03264989|531205099|FG000|Overall Study|Protocol Violation|0|||
147283928|NCT03264989|531205100|FG001|Overall Study|Protocol Violation|1|||
147283929|NCT03264989|531205099|FG000|Overall Study|Patient decision|13|||
147283930|NCT03264989|531205100|FG001|Overall Study|Patient decision|0|||
147283931|NCT03264989|531205099|FG000|Overall Study|Physician Decision|6|||
147283932|NCT03264989|531205100|FG001|Overall Study|Physician Decision|4|||
147283933|NCT03264989|531205099|FG000|Overall Study|Adverse Event|2|||
147283934|NCT03264989|531205100|FG001|Overall Study|Adverse Event|1|||
147283935|NCT03264989|531205099|FG000|Overall Study|Death|1|||
147283936|NCT03264989|531205100|FG001|Overall Study|Death|1|||
147283937|NCT03264989|531205099|FG000|Overall Study|Pregnancy|2|||
147283938|NCT03264989|531205100|FG001|Overall Study|Pregnancy|0|||
147283939|NCT03264989|531205099|FG000|Overall Study|End of Study|19|||
147283940|NCT03264989|531205100|FG001|Overall Study|End of Study|5|||
147283941|NCT01343056|531205103|FG000|Overall Study|Lost to Follow-up|7|||
147283942|NCT01343056|531205104|FG001|Overall Study|Lost to Follow-up|5|||
147283943|NCT01343056|531205105|FG002|Overall Study|Lost to Follow-up|3|||
147283944|NCT01343056|531205106|FG003|Overall Study|Lost to Follow-up|9|||
147283945|NCT00345579|531205107|FG000|Overall Study|Adverse Event|9|||
147283946|NCT00345579|531205108|FG001|Overall Study|Adverse Event|6|||
147283947|NCT00345579|531205107|FG000|Overall Study|Protocol Violation|14|||
147283948|NCT00345579|531205108|FG001|Overall Study|Protocol Violation|5|||
147283949|NCT00345579|531205107|FG000|Overall Study|Withdrawal by Subject|50|||
147283950|NCT00345579|531205108|FG001|Overall Study|Withdrawal by Subject|17|||
147283951|NCT00345579|531205107|FG000|Overall Study|Lost to Follow-up|82|||
147283952|NCT00345579|531205108|FG001|Overall Study|Lost to Follow-up|36|||
147283953|NCT00345579|531205107|FG000|Overall Study|Other|9|||
147451813|NCT01425008|531814975|FG010|Dose Expansion Phase|Symptomatic Deterioration|2|||
147451814|NCT01425008|531814976|FG011|Dose Expansion Phase|Symptomatic Deterioration|1|||
147451815|NCT01425008|531814977|FG012|Dose Expansion Phase|Symptomatic Deterioration|0|||
147283954|NCT00345579|531205108|FG001|Overall Study|Other|1|||
147283955|NCT03029208|531205109|FG000|Overall Study|Withdrawal by Subject|2|||
147283956|NCT03029208|531205110|FG001|Overall Study|Withdrawal by Subject|3|||
147283957|NCT03029208|531205109|FG000|Overall Study|Lost to Follow-up|0|||
147283958|NCT03029208|531205110|FG001|Overall Study|Lost to Follow-up|1|||
147283959|NCT01732835|531205113|FG000|6-month Primary Endpoint|Did not receive device|19|||
147283960|NCT01732835|531205113|FG000|6-month Primary Endpoint|Withdrawal by Subject|2|||
147283961|NCT01732835|531205113|FG000|6-month Primary Endpoint|Adverse Event|3|||
147283962|NCT01732835|531205113|FG000|2-year Extended Follow-up|Withdrawal by Subject|1|||
147283963|NCT01732835|531205113|FG000|2-year Extended Follow-up|Adverse Event|3|||
147283964|NCT01732835|531205113|FG000|2-year Extended Follow-up|Death|1|||
147283965|NCT03207750|531205114|FG000|Overall Study|Adverse Event|3|||
147283966|NCT03207750|531205115|FG001|Overall Study|Adverse Event|2|||
147283967|NCT03207750|531205114|FG000|Overall Study|Lost to Follow-up|21|||
147283968|NCT03207750|531205115|FG001|Overall Study|Lost to Follow-up|29|||
147283969|NCT03207750|531205114|FG000|Overall Study|Protocol Violation|0|||
147283970|NCT03207750|531205115|FG001|Overall Study|Protocol Violation|1|||
147283971|NCT03207750|531205114|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN AE|11|||
147283972|NCT03207750|531205115|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN AE|13|||
147283973|NCT03207750|531205114|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|7|||
147283974|NCT03207750|531205115|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|10|||
147283975|NCT03207750|531205114|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|10|||
147283976|NCT03207750|531205115|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|5|||
147283977|NCT03207750|531205114|FG000|Overall Study|NOT WILLING / NOT ABLE TO BE CONTACTED|1|||
147283978|NCT03207750|531205115|FG001|Overall Study|NOT WILLING / NOT ABLE TO BE CONTACTED|2|||
147283979|NCT03207750|531205114|FG000|Overall Study|OTHER, NOT SPECIFIED|5|||
147283980|NCT03207750|531205115|FG001|Overall Study|OTHER, NOT SPECIFIED|4|||
147283981|NCT02334748|531205116|FG000|Overall Study|Adverse Event|1|||
147283982|NCT02334748|531205116|FG000|Overall Study|Inclusion in the CACZ8852306 study|1|||
147283983|NCT02334748|531205116|FG000|Overall Study|Patient no longer required study drug|2|||
147283984|NCT02334748|531205116|FG000|Overall Study|Lack of Efficacy|4|||
147283985|NCT02493361|531205117|FG000|Overall Study|Withdrawal by Subject|3|||
147283986|NCT01568047|531205122|FG000|Overall Study|Ineligibility|1|||
147283987|NCT01568047|531205123|FG001|Overall Study|Ineligibility|0|||
147283988|NCT01568047|531205124|FG002|Overall Study|Ineligibility|0|||
147283989|NCT01568047|531205125|FG003|Overall Study|Ineligibility|0|||
147283990|NCT01568047|531205122|FG000|Overall Study|Withdrawal by Subject|0|||
147283991|NCT01568047|531205123|FG001|Overall Study|Withdrawal by Subject|1|||
147283992|NCT01568047|531205124|FG002|Overall Study|Withdrawal by Subject|0|||
147283993|NCT01568047|531205125|FG003|Overall Study|Withdrawal by Subject|0|||
147283994|NCT01568047|531205122|FG000|Overall Study|Adverse Event|0|||
147283995|NCT01568047|531205123|FG001|Overall Study|Adverse Event|0|||
147283996|NCT01568047|531205124|FG002|Overall Study|Adverse Event|1|||
147283997|NCT01568047|531205125|FG003|Overall Study|Adverse Event|1|||
147283998|NCT01618838|531205128|FG000|Overall Study|slow accrual, trial closed prematurely.|4|||
147283999|NCT02308033|531205131|FG000|Overall Study|Normal Gram stain at Baseline|13|||
147284000|NCT02308033|531205132|FG001|Overall Study|Normal Gram stain at Baseline|10|||
147284001|NCT02308033|531205131|FG000|Overall Study|Positive for STD at Baseline|7|||
147284002|NCT02308033|531205132|FG001|Overall Study|Positive for STD at Baseline|4|||
147284003|NCT02308033|531205131|FG000|Overall Study|Lost to Follow-up|6|||
147284004|NCT02308033|531205132|FG001|Overall Study|Lost to Follow-up|5|||
147284005|NCT00499889|531205136|FG000|Overall Study|Infection prior to treatment|1|||
147284006|NCT00345397|531205137|FG000|Overall Study|Death|1|||
147284007|NCT03325712|531205138|FG000|Overall Study|Protocol Violation|0|||
147284008|NCT03325712|531205139|FG001|Overall Study|Protocol Violation|0|||
147284009|NCT03325712|531205140|FG002|Overall Study|Protocol Violation|0|||
147284010|NCT03325712|531205141|FG003|Overall Study|Protocol Violation|0|||
147336951|NCT01510717|531400055|FG001|Overall Study|Adverse Event|2|||
147336952|NCT01510717|531400054|FG000|Overall Study|Death|1|||
147336953|NCT01510717|531400055|FG001|Overall Study|Death|0|||
147284011|NCT03325712|531205142|FG004|Overall Study|Protocol Violation|1|||
147284012|NCT03325712|531205143|FG005|Overall Study|Protocol Violation|0|||
147284013|NCT03325712|531205144|FG006|Overall Study|Protocol Violation|0|||
147284014|NCT03325712|531205145|FG007|Overall Study|Protocol Violation|0|||
147284015|NCT03325712|531205138|FG000|Overall Study|Adverse Event|0|||
147284016|NCT03325712|531205139|FG001|Overall Study|Adverse Event|0|||
147284017|NCT03325712|531205140|FG002|Overall Study|Adverse Event|0|||
147284018|NCT03325712|531205141|FG003|Overall Study|Adverse Event|0|||
147284019|NCT03325712|531205142|FG004|Overall Study|Adverse Event|1|||
147284020|NCT03325712|531205143|FG005|Overall Study|Adverse Event|0|||
147284021|NCT03325712|531205144|FG006|Overall Study|Adverse Event|0|||
147284022|NCT03325712|531205145|FG007|Overall Study|Adverse Event|0|||
147284023|NCT01297062|531205146|FG000|Overall Study|Adverse Event|2|||
147284024|NCT01297062|531205147|FG001|Overall Study|Adverse Event|0|||
147284025|NCT01297062|531205148|FG002|Overall Study|Adverse Event|1|||
147284026|NCT01297062|531205149|FG003|Overall Study|Adverse Event|0|||
147336954|NCT01510717|531400054|FG000|Overall Study|Lost to Follow-up|0|||
147336955|NCT01510717|531400055|FG001|Overall Study|Lost to Follow-up|1|||
147284027|NCT01297062|531205150|FG004|Overall Study|Adverse Event|0|||
147284028|NCT01297062|531205151|FG005|Overall Study|Adverse Event|0|||
147284029|NCT01297062|531205152|FG006|Overall Study|Adverse Event|0|||
147284030|NCT01297062|531205146|FG000|Overall Study|Physician Decision|1|||
147284031|NCT01297062|531205147|FG001|Overall Study|Physician Decision|0|||
147284032|NCT01297062|531205148|FG002|Overall Study|Physician Decision|1|||
147284033|NCT01297062|531205149|FG003|Overall Study|Physician Decision|0|||
147284034|NCT01297062|531205150|FG004|Overall Study|Physician Decision|0|||
147284035|NCT01297062|531205151|FG005|Overall Study|Physician Decision|0|||
147284036|NCT01297062|531205152|FG006|Overall Study|Physician Decision|6|||
147284037|NCT01297062|531205146|FG000|Overall Study|Protocol Violation|0|||
147284038|NCT01297062|531205147|FG001|Overall Study|Protocol Violation|0|||
147284039|NCT01297062|531205148|FG002|Overall Study|Protocol Violation|0|||
147284040|NCT01297062|531205149|FG003|Overall Study|Protocol Violation|0|||
147284041|NCT01297062|531205150|FG004|Overall Study|Protocol Violation|1|||
147284042|NCT01297062|531205151|FG005|Overall Study|Protocol Violation|0|||
147284043|NCT01297062|531205152|FG006|Overall Study|Protocol Violation|0|||
147284044|NCT01297062|531205146|FG000|Overall Study|Subject Decision|1|||
147284045|NCT01297062|531205147|FG001|Overall Study|Subject Decision|1|||
147284046|NCT01297062|531205148|FG002|Overall Study|Subject Decision|0|||
147284047|NCT01297062|531205149|FG003|Overall Study|Subject Decision|1|||
147284048|NCT01297062|531205150|FG004|Overall Study|Subject Decision|1|||
147284049|NCT01297062|531205151|FG005|Overall Study|Subject Decision|1|||
147284050|NCT01297062|531205152|FG006|Overall Study|Subject Decision|2|||
147284051|NCT03823651|531205153|FG000|Overall Study|Death|5|||
147284052|NCT03823651|531205154|FG001|Overall Study|Death|0|||
147284053|NCT03823651|531205153|FG000|Overall Study|Physician Decision|1|||
147284054|NCT03823651|531205154|FG001|Overall Study|Physician Decision|0|||
147284055|NCT03823651|531205153|FG000|Overall Study|Caregiver to patient who died|0|||
147284056|NCT03823651|531205154|FG001|Overall Study|Caregiver to patient who died|5|||
147284057|NCT03823651|531205153|FG000|Overall Study|Caregiver to patient who was withdrawn due to physician decision|0|||
147284058|NCT03823651|531205154|FG001|Overall Study|Caregiver to patient who was withdrawn due to physician decision|1|||
147284059|NCT01850004|531205155|FG000|Overall Study|Poor/Non-compliance|1|||
147284060|NCT01850004|531205155|FG000|Overall Study|Participant Withdrew Consent|9|||
147284061|NCT01850004|531205155|FG000|Overall Study|Participant Request to Discontinue Treatment|2|||
147284062|NCT01850004|531205155|FG000|Overall Study|Adverse Event Unrelated to Study Drug|1|||
147284063|NCT01850004|531205155|FG000|Overall Study|Adverse Event Related to Study Drug|4|||
147284064|NCT01850004|531205155|FG000|Overall Study|Other Reasons|2|||
147284065|NCT01850004|531205155|FG000|Overall Study|Participant No Longer Meets Study Criteria|1|||
147284066|NCT01850004|531205155|FG000|Overall Study|Maximum Clinical Benefit|4|||
147284067|NCT05350449|531205156|FG000|Overall Study|Withdrawal by Subject|4|||
147284068|NCT05350449|531205157|FG001|Overall Study|Withdrawal by Subject|8|||
147284069|NCT01046643|531207255|FG000|First Period Treatment or Placebo|Withdrawal by Subject|0|||
147284070|NCT01046643|531207256|FG001|First Period Treatment or Placebo|Withdrawal by Subject|1|||
147284071|NCT01046643|531207257|FG002|First Period Treatment or Placebo|Withdrawal by Subject|0|||
147284072|NCT01046643|531207258|FG003|First Period Treatment or Placebo|Withdrawal by Subject|0|||
147284073|NCT01175668|531207261|FG000|Overall Study|Withdrawal by Subject|2|||
147284074|NCT01175668|531207262|FG001|Overall Study|Withdrawal by Subject|0|||
147284075|NCT00874029|531207263|FG000|Overall Study|Withdrawal by Subject|10|||
147284076|NCT00874029|531207263|FG000|Overall Study|Pregnancy|4|||
147284077|NCT00874029|531207263|FG000|Overall Study|Physician Decision|1|||
147284078|NCT00874029|531207263|FG000|Overall Study|Adverse Event|1|||
147284079|NCT00874029|531207263|FG000|Overall Study|Lost to Follow-up|5|||
147284080|NCT02937545|531207270|FG000|Overall Study|Withdrawal by Subject|1|||
147284081|NCT02937545|531207271|FG001|Overall Study|Withdrawal by Subject|2|||
147284082|NCT02937545|531207272|FG002|Overall Study|Withdrawal by Subject|6|||
147284083|NCT02937545|531207273|FG003|Overall Study|Withdrawal by Subject|7|||
147284084|NCT02937545|531207270|FG000|Overall Study|Lost to Follow-up|1|||
147284085|NCT02937545|531207271|FG001|Overall Study|Lost to Follow-up|0|||
147284086|NCT02937545|531207272|FG002|Overall Study|Lost to Follow-up|0|||
147284087|NCT02937545|531207273|FG003|Overall Study|Lost to Follow-up|0|||
147284088|NCT02007577|531207274|FG000|Overall Study|Adverse Event|1|||
147284089|NCT02007577|531207275|FG001|Overall Study|Adverse Event|0|||
147284090|NCT02007577|531207274|FG000|Overall Study|Withdrawal by Subject|0|||
147284091|NCT02007577|531207275|FG001|Overall Study|Withdrawal by Subject|1|||
147336956|NCT01510717|531400054|FG000|Overall Study|Withdrawal by Subject|0|||
147284092|NCT02504294|531207278|FG000|Overall Study|Adverse Event|15|||
147284093|NCT02504294|531207279|FG001|Overall Study|Adverse Event|12|||
147284094|NCT02504294|531207278|FG000|Overall Study|Withdrawal by Subject|7|||
147284095|NCT02504294|531207279|FG001|Overall Study|Withdrawal by Subject|1|||
147284096|NCT02504294|531207278|FG000|Overall Study|Protocol Violation|27|||
147284097|NCT02504294|531207279|FG001|Overall Study|Protocol Violation|26|||
147284098|NCT02504294|531207278|FG000|Overall Study|Physician Decision|1|||
147284099|NCT02504294|531207279|FG001|Overall Study|Physician Decision|2|||
147527265|NCT00421928|532084188|FG002|Overall Study|Lost to Follow-up|3|||
147336957|NCT01510717|531400055|FG001|Overall Study|Withdrawal by Subject|2|||
147604043|NCT01844856|532367815|FG001|Overall Study|Noncompliance|3|||
147284100|NCT02504294|531207278|FG000|Overall Study|Lost to Follow-up|6|||
147284101|NCT02504294|531207279|FG001|Overall Study|Lost to Follow-up|7|||
147284102|NCT02252211|531207285|FG000|Overall Study|Adverse Event|0|||
147284103|NCT02252211|531207286|FG001|Overall Study|Adverse Event|1|||
147284104|NCT02252211|531207287|FG002|Overall Study|Adverse Event|0|||
147284105|NCT02252211|531207285|FG000|Overall Study|Progressive disease|3|||
147284106|NCT02252211|531207286|FG001|Overall Study|Progressive disease|2|||
147284107|NCT02252211|531207287|FG002|Overall Study|Progressive disease|0|||
147284108|NCT02252211|531207285|FG000|Overall Study|Withdrawal by Subject|1|||
147284109|NCT02252211|531207286|FG001|Overall Study|Withdrawal by Subject|0|||
147284110|NCT02252211|531207287|FG002|Overall Study|Withdrawal by Subject|0|||
147284111|NCT02252211|531207285|FG000|Overall Study|Serious Adverse Event During Screening|1|||
147284112|NCT02252211|531207286|FG001|Overall Study|Serious Adverse Event During Screening|0|||
147284113|NCT02252211|531207287|FG002|Overall Study|Serious Adverse Event During Screening|1|||
147284114|NCT00968669|531207289|FG000|Overall Study|Lost to Follow-up|5|||
147284115|NCT00968669|531207290|FG001|Overall Study|Lost to Follow-up|2|||
147284116|NCT00968669|531207291|FG002|Overall Study|Lost to Follow-up|1|||
147284117|NCT00968669|531207292|FG003|Overall Study|Lost to Follow-up|4|||
147284118|NCT00968669|531207289|FG000|Overall Study|Withdrawal by Subject|9|||
147284119|NCT00968669|531207290|FG001|Overall Study|Withdrawal by Subject|7|||
147336958|NCT02555215|531400058|FG000|Overall Study|Other|1|||
147336959|NCT02555215|531400058|FG000|Overall Study|Investigator Decision|2|||
147336960|NCT01595061|531400059|FG000|Overall Study|Never Treated|3|||
147336961|NCT01595061|531400059|FG000|Overall Study|Inadequate Pathology|1|||
147336962|NCT00529789|531400060|FG000|Study Period II/III|Parent/Caregiver Decision|9|||
147336963|NCT00529789|531400060|FG000|Study Period II/III|Adverse Event|3|||
147336964|NCT00529789|531400060|FG000|Study Period II/III|Lack of Efficacy|2|||
147336965|NCT00529789|531400060|FG000|Study Period II/III|Withdrawal by Subject|1|||
147336966|NCT00529789|531400060|FG000|Study Period II/III|Protocol Violation|3|||
147336967|NCT00529789|531400060|FG000|Study Period II/III|Physician Decision|3|||
147336968|NCT00529789|531400060|FG000|Study Period II/III|Lost to Follow-up|3|||
147336969|NCT00529789|531400060|FG000|Study Period IV|Parent/Caregiver Decision|1|||
147336970|NCT00529789|531400060|FG000|Study Period IV|Adverse Event|1|||
147336971|NCT00529789|531400060|FG000|Study Period IV|Lack of Efficacy|1|||
147336972|NCT00529789|531400060|FG000|Study Period IV|Lost to Follow-up|3|||
147336973|NCT03194958|531400063|FG000|Overall Study|Death|0|||
147336974|NCT03194958|531400064|FG001|Overall Study|Death|1|||
147336975|NCT03194958|531400065|FG002|Overall Study|Death|1|||
147336976|NCT03194958|531400066|FG003|Overall Study|Death|1|||
147336977|NCT03194958|531400063|FG000|Overall Study|Withdrawal by Subject|24|||
147336978|NCT03194958|531400064|FG001|Overall Study|Withdrawal by Subject|27|||
147336979|NCT03194958|531400065|FG002|Overall Study|Withdrawal by Subject|7|||
147336980|NCT03194958|531400066|FG003|Overall Study|Withdrawal by Subject|22|||
147336981|NCT03194958|531400063|FG000|Overall Study|Lost to Follow-up|168|||
147336982|NCT03194958|531400064|FG001|Overall Study|Lost to Follow-up|196|||
147336983|NCT03194958|531400065|FG002|Overall Study|Lost to Follow-up|174|||
147336984|NCT03194958|531400066|FG003|Overall Study|Lost to Follow-up|186|||
147336985|NCT00959946|531400068|FG000|Overall Study|Adverse Event|0|||
147336986|NCT00959946|531400069|FG001|Overall Study|Adverse Event|0|||
147336987|NCT00959946|531400070|FG002|Overall Study|Adverse Event|2|||
147336988|NCT00959946|531400071|FG003|Overall Study|Adverse Event|1|||
147336989|NCT00959946|531400072|FG004|Overall Study|Adverse Event|0|||
147336990|NCT00959946|531400073|FG005|Overall Study|Adverse Event|1|||
147336991|NCT00959946|531400074|FG006|Overall Study|Adverse Event|0|||
147336992|NCT00959946|531400075|FG007|Overall Study|Adverse Event|0|||
147336993|NCT00959946|531400068|FG000|Overall Study|Death|0|||
147336994|NCT00959946|531400069|FG001|Overall Study|Death|0|||
147336995|NCT00959946|531400070|FG002|Overall Study|Death|0|||
147336996|NCT00959946|531400071|FG003|Overall Study|Death|0|||
147336997|NCT00959946|531400072|FG004|Overall Study|Death|0|||
147336998|NCT00959946|531400073|FG005|Overall Study|Death|1|||
147604044|NCT01844856|532367814|FG000|Overall Study|Enterococcus Resistant|0|||
147604045|NCT01844856|532367815|FG001|Overall Study|Enterococcus Resistant|1|||
147604046|NCT01844856|532367814|FG000|Overall Study|Inadvertently Not Scheduled|1|||
147604047|NCT01844856|532367815|FG001|Overall Study|Inadvertently Not Scheduled|0|||
147604048|NCT01844856|532367814|FG000|Overall Study|Randomized but was a Screen Failure|0|||
147284120|NCT00968669|531207291|FG002|Overall Study|Withdrawal by Subject|5|||
147284121|NCT00968669|531207292|FG003|Overall Study|Withdrawal by Subject|3|||
147284122|NCT00968669|531207289|FG000|Overall Study|Pregnancy|0|||
147284123|NCT00968669|531207290|FG001|Overall Study|Pregnancy|0|||
147284124|NCT00968669|531207291|FG002|Overall Study|Pregnancy|2|||
147336999|NCT00959946|531400074|FG006|Overall Study|Death|0|||
147337000|NCT00959946|531400075|FG007|Overall Study|Death|0|||
147337001|NCT00959946|531400068|FG000|Overall Study|Disease Progression|2|||
147337002|NCT00959946|531400069|FG001|Overall Study|Disease Progression|4|||
147337003|NCT00959946|531400070|FG002|Overall Study|Disease Progression|2|||
147337004|NCT00959946|531400071|FG003|Overall Study|Disease Progression|4|||
147337005|NCT00959946|531400072|FG004|Overall Study|Disease Progression|4|||
147337006|NCT00959946|531400073|FG005|Overall Study|Disease Progression|6|||
147451816|NCT01425008|531814978|FG013|Dose Expansion Phase|Symptomatic Deterioration|0|||
147451817|NCT01425008|531814979|FG014|Dose Expansion Phase|Symptomatic Deterioration|0|||
147451818|NCT01425008|531814980|FG015|Dose Expansion Phase|Symptomatic Deterioration|1|||
147451819|NCT01425008|531814981|FG016|Dose Expansion Phase|Symptomatic Deterioration|2|||
147451820|NCT01425008|531814982|FG017|Dose Expansion Phase|Symptomatic Deterioration|0|||
147451821|NCT01425008|531814983|FG018|Dose Expansion Phase|Symptomatic Deterioration|1|||
147451822|NCT01425008|531814965|FG000|Dose Expansion Phase|Adverse Event|0|||
147451823|NCT01425008|531814966|FG001|Dose Expansion Phase|Adverse Event|0|||
147451824|NCT01425008|531814967|FG002|Dose Expansion Phase|Adverse Event|0|||
147451825|NCT01425008|531814968|FG003|Dose Expansion Phase|Adverse Event|0|||
147451826|NCT01425008|531814969|FG004|Dose Expansion Phase|Adverse Event|0|||
147451827|NCT01425008|531814970|FG005|Dose Expansion Phase|Adverse Event|0|||
147451828|NCT01425008|531814971|FG006|Dose Expansion Phase|Adverse Event|0|||
147451829|NCT01425008|531814972|FG007|Dose Expansion Phase|Adverse Event|0|||
147451830|NCT01425008|531814973|FG008|Dose Expansion Phase|Adverse Event|0|||
147451831|NCT01425008|531814974|FG009|Dose Expansion Phase|Adverse Event|0|||
147451832|NCT01425008|531814975|FG010|Dose Expansion Phase|Adverse Event|2|||
147451833|NCT01425008|531814976|FG011|Dose Expansion Phase|Adverse Event|3|||
147451834|NCT01425008|531814977|FG012|Dose Expansion Phase|Adverse Event|3|||
147451835|NCT01425008|531814978|FG013|Dose Expansion Phase|Adverse Event|0|||
147451836|NCT01425008|531814979|FG014|Dose Expansion Phase|Adverse Event|1|||
147451837|NCT01425008|531814980|FG015|Dose Expansion Phase|Adverse Event|1|||
147451838|NCT01425008|531814981|FG016|Dose Expansion Phase|Adverse Event|5|||
147451839|NCT01425008|531814982|FG017|Dose Expansion Phase|Adverse Event|0|||
147451840|NCT01425008|531814983|FG018|Dose Expansion Phase|Adverse Event|3|||
147451841|NCT01425008|531814965|FG000|Dose Expansion Phase|Lost to Follow-up|0|||
147451842|NCT01425008|531814966|FG001|Dose Expansion Phase|Lost to Follow-up|0|||
147451843|NCT01425008|531814967|FG002|Dose Expansion Phase|Lost to Follow-up|0|||
147451844|NCT01425008|531814968|FG003|Dose Expansion Phase|Lost to Follow-up|0|||
147451845|NCT01425008|531814969|FG004|Dose Expansion Phase|Lost to Follow-up|0|||
147451846|NCT01425008|531814970|FG005|Dose Expansion Phase|Lost to Follow-up|0|||
147451847|NCT01425008|531814971|FG006|Dose Expansion Phase|Lost to Follow-up|0|||
147451848|NCT01425008|531814972|FG007|Dose Expansion Phase|Lost to Follow-up|0|||
147451849|NCT01425008|531814973|FG008|Dose Expansion Phase|Lost to Follow-up|0|||
147451850|NCT01425008|531814974|FG009|Dose Expansion Phase|Lost to Follow-up|0|||
147451851|NCT01425008|531814975|FG010|Dose Expansion Phase|Lost to Follow-up|0|||
147451852|NCT01425008|531814976|FG011|Dose Expansion Phase|Lost to Follow-up|0|||
147451853|NCT01425008|531814977|FG012|Dose Expansion Phase|Lost to Follow-up|0|||
147451854|NCT01425008|531814978|FG013|Dose Expansion Phase|Lost to Follow-up|0|||
147451855|NCT01425008|531814979|FG014|Dose Expansion Phase|Lost to Follow-up|0|||
147451856|NCT01425008|531814980|FG015|Dose Expansion Phase|Lost to Follow-up|0|||
147451857|NCT01425008|531814981|FG016|Dose Expansion Phase|Lost to Follow-up|1|||
147451858|NCT01425008|531814982|FG017|Dose Expansion Phase|Lost to Follow-up|0|||
147451859|NCT01425008|531814983|FG018|Dose Expansion Phase|Lost to Follow-up|0|||
147451860|NCT01425008|531814965|FG000|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
147451861|NCT01425008|531814966|FG001|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
147451862|NCT01425008|531814967|FG002|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
147451863|NCT01425008|531814968|FG003|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
147451864|NCT01425008|531814969|FG004|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
147451865|NCT01425008|531814970|FG005|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
147451866|NCT01425008|531814971|FG006|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
147451867|NCT01425008|531814972|FG007|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
147451868|NCT01425008|531814973|FG008|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
147451869|NCT01425008|531814974|FG009|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
147451870|NCT01425008|531814975|FG010|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
147451871|NCT01425008|531814976|FG011|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
147451872|NCT01425008|531814977|FG012|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
147451873|NCT01425008|531814978|FG013|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
147451874|NCT01425008|531814979|FG014|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
147451875|NCT01425008|531814980|FG015|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
147451876|NCT01425008|531814981|FG016|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
147451877|NCT01425008|531814982|FG017|Dose Expansion Phase|Unsatisfactory Therapeutic Response|0|||
147451878|NCT01425008|531814983|FG018|Dose Expansion Phase|Unsatisfactory Therapeutic Response|1|||
147451879|NCT00264238|531814984|FG000|Overall Study|Protocol Violation|1|||
147451880|NCT00562588|531814987|FG000|Overall Study|Adverse Event|40|||
147451881|NCT00562588|531814988|FG001|Overall Study|Adverse Event|58|||
147451882|NCT00562588|531814987|FG000|Overall Study|Protocol Violation|30|||
147451883|NCT00562588|531814988|FG001|Overall Study|Protocol Violation|26|||
147451884|NCT00562588|531814987|FG000|Overall Study|Lost to Follow-up|12|||
147451885|NCT00562588|531814988|FG001|Overall Study|Lost to Follow-up|4|||
147451886|NCT00562588|531814987|FG000|Overall Study|Withdrawal by Subject|10|||
147451887|NCT00562588|531814988|FG001|Overall Study|Withdrawal by Subject|9|||
147451888|NCT00562588|531814987|FG000|Overall Study|Other|0|||
147284125|NCT00968669|531207292|FG003|Overall Study|Pregnancy|0|||
147284126|NCT00968669|531207289|FG000|Overall Study|AE|1|||
147284127|NCT00968669|531207290|FG001|Overall Study|AE|0|||
147284128|NCT00968669|531207291|FG002|Overall Study|AE|0|||
147284129|NCT00968669|531207292|FG003|Overall Study|AE|0|||
147284130|NCT00968669|531207289|FG000|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|0|||
147284131|NCT00968669|531207290|FG001|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|0|||
147284132|NCT00968669|531207291|FG002|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|0|||
147284133|NCT00968669|531207292|FG003|Overall Study|AE-TRANSITIONAL CELL TUMOR IN BLADDER|1|||
147284134|NCT00968669|531207289|FG000|Overall Study|DID NOT MEET EXCLUSION CRITERIA|1|||
147284135|NCT00968669|531207290|FG001|Overall Study|DID NOT MEET EXCLUSION CRITERIA|0|||
147284136|NCT00968669|531207291|FG002|Overall Study|DID NOT MEET EXCLUSION CRITERIA|0|||
147284137|NCT00968669|531207292|FG003|Overall Study|DID NOT MEET EXCLUSION CRITERIA|0|||
147284138|NCT00968669|531207289|FG000|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|1|||
147284139|NCT00968669|531207290|FG001|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|0|||
147284140|NCT00968669|531207291|FG002|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|0|||
147284141|NCT00968669|531207292|FG003|Overall Study|DUE TO REPEATED ASTHMA EXACERBATIONS|0|||
147284142|NCT00968669|531207289|FG000|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|0|||
147284143|NCT00968669|531207290|FG001|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|0|||
147284144|NCT00968669|531207291|FG002|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|1|||
147284145|NCT00968669|531207292|FG003|Overall Study|EARLY DISCONTINUED ON 10-DEC-2010|0|||
147284146|NCT00968669|531207289|FG000|Overall Study|EARLY WITHDRAWAL|0|||
147284147|NCT00968669|531207290|FG001|Overall Study|EARLY WITHDRAWAL|1|||
147284148|NCT00968669|531207291|FG002|Overall Study|EARLY WITHDRAWAL|0|||
147284149|NCT00968669|531207292|FG003|Overall Study|EARLY WITHDRAWAL|0|||
147284150|NCT00968669|531207289|FG000|Overall Study|ERROR IN HADS ADMINISTRATION|0|||
147284151|NCT00968669|531207290|FG001|Overall Study|ERROR IN HADS ADMINISTRATION|0|||
147284152|NCT00968669|531207291|FG002|Overall Study|ERROR IN HADS ADMINISTRATION|1|||
147284153|NCT00968669|531207292|FG003|Overall Study|ERROR IN HADS ADMINISTRATION|0|||
147284154|NCT00968669|531207289|FG000|Overall Study|INEGIBILITY TO PERFORM VISIT|1|||
147284155|NCT00968669|531207290|FG001|Overall Study|INEGIBILITY TO PERFORM VISIT|0|||
147284156|NCT00968669|531207291|FG002|Overall Study|INEGIBILITY TO PERFORM VISIT|0|||
147284157|NCT00968669|531207292|FG003|Overall Study|INEGIBILITY TO PERFORM VISIT|0|||
147284158|NCT00968669|531207289|FG000|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|0|||
147284159|NCT00968669|531207290|FG001|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|1|||
147284160|NCT00968669|531207291|FG002|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|0|||
147284161|NCT00968669|531207292|FG003|Overall Study|PATIENT RECEIVE ORAL PREDNISONE|0|||
147284162|NCT00968669|531207289|FG000|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|0|||
147284163|NCT00968669|531207290|FG001|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|1|||
147284164|NCT00968669|531207291|FG002|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|0|||
147284165|NCT00968669|531207292|FG003|Overall Study|PATIENT WAS ENROLLED BY MISTAKE|0|||
147284166|NCT00968669|531207289|FG000|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|0|||
147284167|NCT00968669|531207290|FG001|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|1|||
147284168|NCT00968669|531207291|FG002|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|0|||
147284169|NCT00968669|531207292|FG003|Overall Study|PATIENT WAS RANDOMIZED BY MISTAKE|0|||
147284170|NCT00968669|531207289|FG000|Overall Study|PATIENT WILL BE WORKING ABROAD|0|||
147284171|NCT00968669|531207290|FG001|Overall Study|PATIENT WILL BE WORKING ABROAD|1|||
147284172|NCT00968669|531207291|FG002|Overall Study|PATIENT WILL BE WORKING ABROAD|0|||
147284173|NCT00968669|531207292|FG003|Overall Study|PATIENT WILL BE WORKING ABROAD|0|||
147284174|NCT00968669|531207289|FG000|Overall Study|SPONSOR DECISION|0|||
147284175|NCT00968669|531207290|FG001|Overall Study|SPONSOR DECISION|1|||
147284176|NCT00968669|531207291|FG002|Overall Study|SPONSOR DECISION|0|||
147284177|NCT00968669|531207292|FG003|Overall Study|SPONSOR DECISION|0|||
147284178|NCT00968669|531207289|FG000|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|0|||
147284179|NCT00968669|531207290|FG001|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|0|||
147284180|NCT00968669|531207291|FG002|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|1|||
147284181|NCT00968669|531207292|FG003|Overall Study|SUBJECT COMPLETED SAFETY FOLLOW-UP|0|||
147284182|NCT00968669|531207289|FG000|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|0|||
147284183|NCT00968669|531207290|FG001|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|1|||
147284184|NCT00968669|531207291|FG002|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|0|||
147284185|NCT00968669|531207292|FG003|Overall Study|SUBJECT DID NOT MEET ACQ REQUIREMENT|0|||
147284186|NCT00968669|531207289|FG000|Overall Study|SUBJECT INCARCERATED|0|||
147284187|NCT00968669|531207290|FG001|Overall Study|SUBJECT INCARCERATED|1|||
147284188|NCT00968669|531207291|FG002|Overall Study|SUBJECT INCARCERATED|0|||
147284189|NCT00968669|531207292|FG003|Overall Study|SUBJECT INCARCERATED|0|||
147284190|NCT00968669|531207289|FG000|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|0|||
147284191|NCT00968669|531207290|FG001|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|1|||
147284192|NCT00968669|531207291|FG002|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|0|||
147337007|NCT00959946|531400074|FG006|Overall Study|Disease Progression|2|||
147337008|NCT00959946|531400075|FG007|Overall Study|Disease Progression|2|||
147337009|NCT00959946|531400068|FG000|Overall Study|Withdrawal by Subject|0|||
147451889|NCT00562588|531814988|FG001|Overall Study|Other|2|||
147451890|NCT00264004|531816403|FG000|Overall Study|Adverse Event|2|||
147451891|NCT00264004|531816404|FG001|Overall Study|Adverse Event|3|||
147451892|NCT00264004|531816405|FG002|Overall Study|Adverse Event|6|||
147451893|NCT00264004|531816406|FG003|Overall Study|Adverse Event|4|||
147451894|NCT00264004|531816403|FG000|Overall Study|Withdrawal by Subject|0|||
147451895|NCT00264004|531816404|FG001|Overall Study|Withdrawal by Subject|1|||
147451896|NCT00264004|531816405|FG002|Overall Study|Withdrawal by Subject|2|||
147451897|NCT00264004|531816406|FG003|Overall Study|Withdrawal by Subject|2|||
147451898|NCT00264004|531816403|FG000|Overall Study|Other|2|||
147451899|NCT00264004|531816404|FG001|Overall Study|Other|2|||
147451900|NCT00264004|531816405|FG002|Overall Study|Other|0|||
147451901|NCT00264004|531816406|FG003|Overall Study|Other|3|||
147451902|NCT00264004|531816403|FG000|Overall Study|Development study specific disc. crit.|1|||
147451903|NCT00264004|531816404|FG001|Overall Study|Development study specific disc. crit.|0|||
147451904|NCT00264004|531816405|FG002|Overall Study|Development study specific disc. crit.|1|||
147451905|NCT00264004|531816406|FG003|Overall Study|Development study specific disc. crit.|0|||
147451906|NCT00264004|531816403|FG000|Overall Study|Cond. under inv. worsened|9|||
147451907|NCT00264004|531816404|FG001|Overall Study|Cond. under inv. worsened|5|||
147451908|NCT00264004|531816405|FG002|Overall Study|Cond. under inv. worsened|3|||
147451909|NCT00264004|531816406|FG003|Overall Study|Cond. under inv. worsened|4|||
147451910|NCT00264004|531816403|FG000|Overall Study|Not treated|3|||
147451911|NCT00264004|531816404|FG001|Overall Study|Not treated|0|||
147451912|NCT00264004|531816405|FG002|Overall Study|Not treated|2|||
147451913|NCT00264004|531816406|FG003|Overall Study|Not treated|2|||
147451914|NCT03691974|531816407|FG000|Overall Study|Physician Decision|1|||
147451915|NCT03691974|531816408|FG001|Overall Study|Physician Decision|0|||
147451916|NCT03691974|531816407|FG000|Overall Study|Adverse Event|1|||
147451917|NCT03691974|531816408|FG001|Overall Study|Adverse Event|0|||
147451918|NCT03691974|531816407|FG000|Overall Study|Withdrawal by Subject|11|||
147451919|NCT03691974|531816408|FG001|Overall Study|Withdrawal by Subject|9|||
147451920|NCT03691974|531816407|FG000|Overall Study|Protocol Violation|1|||
147451921|NCT03691974|531816408|FG001|Overall Study|Protocol Violation|0|||
147451922|NCT03691974|531816407|FG000|Overall Study|Lost to Follow-up|8|||
147451923|NCT03691974|531816408|FG001|Overall Study|Lost to Follow-up|7|||
147451924|NCT00691483|531816409|FG000|Overall Study|Adverse Event|14|||
147451925|NCT00691483|531816410|FG001|Overall Study|Adverse Event|6|||
147451926|NCT00691483|531816409|FG000|Overall Study|Lost to Follow-up|17|||
147451927|NCT00691483|531816410|FG001|Overall Study|Lost to Follow-up|10|||
147451928|NCT00691483|531816409|FG000|Overall Study|Withdrawal by Subject|24|||
147451929|NCT00691483|531816410|FG001|Overall Study|Withdrawal by Subject|7|||
147451930|NCT00691483|531816409|FG000|Overall Study|Other known cause|6|||
147451931|NCT00691483|531816410|FG001|Overall Study|Other known cause|1|||
147451932|NCT00691483|531816409|FG000|Overall Study|Randomized by not treated|7|||
147451933|NCT00691483|531816410|FG001|Overall Study|Randomized by not treated|1|||
147451934|NCT03860961|531816412|FG000|Overall Study|Withdrawal by Subject|6|||
147451935|NCT03860961|531816413|FG001|Overall Study|Withdrawal by Subject|11|||
147451936|NCT03860961|531816412|FG000|Overall Study|Death|10|||
147451937|NCT03860961|531816413|FG001|Overall Study|Death|6|||
147451938|NCT03860961|531816412|FG000|Overall Study|Incomplete two-year data|4|||
147451939|NCT03860961|531816413|FG001|Overall Study|Incomplete two-year data|0|||
147451940|NCT02105454|531816414|FG000|Overall Study|Withdrawal by Subject|1|||
147451941|NCT00493870|531816415|FG000|Overall Study|Lost to Follow-up|12|||
147451942|NCT00493870|531816416|FG001|Overall Study|Lost to Follow-up|15|||
147451943|NCT00272038|531816417|FG000|Overall Study|withdrew before they received 2 cycles|7|||
147451944|NCT02721355|531816418|FG000|Overall Study|Lost to Follow-up|6|||
147451945|NCT02721355|531816419|FG001|Overall Study|Lost to Follow-up|1|||
147451946|NCT00356278|531816420|FG000|Overall Study|Withdrawal by Subject|25|||
147451947|NCT00356278|531816421|FG001|Overall Study|Withdrawal by Subject|15|||
147604049|NCT01844856|532367815|FG001|Overall Study|Randomized but was a Screen Failure|1|||
147604050|NCT00927394|532367818|FG000|Overall Study|Adverse Event|14|||
147604051|NCT00927394|532367819|FG001|Overall Study|Adverse Event|9|||
147604052|NCT00927394|532367818|FG000|Overall Study|Unsatisfactory therapeutic effect|17|||
147604053|NCT00927394|532367819|FG001|Overall Study|Unsatisfactory therapeutic effect|23|||
147604054|NCT00927394|532367818|FG000|Overall Study|Withdrawal by Subject|20|||
147604055|NCT00927394|532367819|FG001|Overall Study|Withdrawal by Subject|24|||
147604056|NCT00927394|532367818|FG000|Overall Study|Lost to Follow-up|8|||
147451948|NCT00356278|531816422|FG002|Overall Study|Withdrawal by Subject|19|||
147451949|NCT00883337|531816425|FG000|Core Treatment Period|Adverse Event|9|||
147451950|NCT00883337|531816426|FG001|Core Treatment Period|Adverse Event|12|||
147451951|NCT00883337|531816427|FG002|Core Treatment Period|Adverse Event|22|||
147451952|NCT00883337|531816425|FG000|Core Treatment Period|Lack of Efficacy|7|||
147451953|NCT00883337|531816426|FG001|Core Treatment Period|Lack of Efficacy|4|||
147451954|NCT00883337|531816427|FG002|Core Treatment Period|Lack of Efficacy|2|||
147451955|NCT00883337|531816425|FG000|Core Treatment Period|Lost to Follow-up|1|||
147451956|NCT00883337|531816426|FG001|Core Treatment Period|Lost to Follow-up|1|||
147451957|NCT00883337|531816427|FG002|Core Treatment Period|Lost to Follow-up|0|||
147451958|NCT00883337|531816425|FG000|Core Treatment Period|Withdrawal by Subject|2|||
147604057|NCT00927394|532367819|FG001|Overall Study|Lost to Follow-up|14|||
147451959|NCT00883337|531816426|FG001|Core Treatment Period|Withdrawal by Subject|2|||
147451960|NCT00883337|531816427|FG002|Core Treatment Period|Withdrawal by Subject|6|||
147451961|NCT00883337|531816425|FG000|Core Treatment Period|Wish to be pregnant|1|||
147451962|NCT00883337|531816426|FG001|Core Treatment Period|Wish to be pregnant|2|||
147451963|NCT00883337|531816427|FG002|Core Treatment Period|Wish to be pregnant|1|||
147451964|NCT00883337|531816425|FG000|Core Treatment Period|Poor compliance to protocol|0|||
147451965|NCT00883337|531816426|FG001|Core Treatment Period|Poor compliance to protocol|0|||
147451966|NCT00883337|531816427|FG002|Core Treatment Period|Poor compliance to protocol|1|||
147451967|NCT00883337|531816425|FG000|Core Treatment Period|Other than above|0|||
147451968|NCT00883337|531816426|FG001|Core Treatment Period|Other than above|1|||
147451969|NCT00883337|531816427|FG002|Core Treatment Period|Other than above|1|||
147451970|NCT00883337|531816425|FG000|Extension Treatment Period|Adverse Event|8|||
147451971|NCT00883337|531816426|FG001|Extension Treatment Period|Adverse Event|5|||
147451972|NCT00883337|531816427|FG002|Extension Treatment Period|Adverse Event|5|||
147451973|NCT00883337|531816425|FG000|Extension Treatment Period|Lack of Efficacy|8|||
147451974|NCT00883337|531816426|FG001|Extension Treatment Period|Lack of Efficacy|8|||
147451975|NCT00883337|531816427|FG002|Extension Treatment Period|Lack of Efficacy|8|||
147451976|NCT00883337|531816425|FG000|Extension Treatment Period|Poor compliance to protocol|1|||
147451977|NCT00883337|531816426|FG001|Extension Treatment Period|Poor compliance to protocol|1|||
147451978|NCT00883337|531816427|FG002|Extension Treatment Period|Poor compliance to protocol|1|||
147451979|NCT00883337|531816425|FG000|Extension Treatment Period|Lost to Follow-up|1|||
147451980|NCT00883337|531816426|FG001|Extension Treatment Period|Lost to Follow-up|0|||
147451981|NCT00883337|531816427|FG002|Extension Treatment Period|Lost to Follow-up|0|||
147451982|NCT00883337|531816425|FG000|Extension Treatment Period|Other than above|10|||
147604058|NCT00927394|532367818|FG000|Overall Study|Administrative Problem|1|||
147604059|NCT00927394|532367819|FG001|Overall Study|Administrative Problem|0|||
147604060|NCT00927394|532367818|FG000|Overall Study|Death|1|||
147604061|NCT00927394|532367819|FG001|Overall Study|Death|1|||
147604062|NCT00927394|532367818|FG000|Overall Study|Protocol deviation|16|||
147604063|NCT00927394|532367819|FG001|Overall Study|Protocol deviation|13|||
147604064|NCT00927394|532367818|FG000|Overall Study|Randomized in error|0|||
147604065|NCT00927394|532367819|FG001|Overall Study|Randomized in error|1|||
147451983|NCT00883337|531816426|FG001|Extension Treatment Period|Other than above|9|||
147451984|NCT00883337|531816427|FG002|Extension Treatment Period|Other than above|5|||
147451985|NCT01652287|531816428|FG000|Overall Study|Withdrawal by Subject|2|||
147451986|NCT01652287|531816429|FG001|Overall Study|Withdrawal by Subject|0|||
147451987|NCT00527605|531816431|FG000|Overall Study|Adverse Event|3|||
147451988|NCT00527605|531816432|FG001|Overall Study|Adverse Event|0|||
147451989|NCT00527605|531816431|FG000|Overall Study|Withdrawal by Subject|3|||
147451990|NCT00527605|531816432|FG001|Overall Study|Withdrawal by Subject|7|||
147451991|NCT00527605|531816431|FG000|Overall Study|Lost to Follow-up|6|||
147451992|NCT00527605|531816432|FG001|Overall Study|Lost to Follow-up|2|||
147451993|NCT00527605|531816431|FG000|Overall Study|Protocol Violation|1|||
147451994|NCT00527605|531816432|FG001|Overall Study|Protocol Violation|2|||
147451995|NCT00763139|531816438|FG000|Overall Study|Adverse Event|4|||
147451996|NCT00763139|531816439|FG001|Overall Study|Adverse Event|2|||
147451997|NCT00763139|531816438|FG000|Overall Study|Withdrawal by Subject|0|||
147451998|NCT00763139|531816439|FG001|Overall Study|Withdrawal by Subject|1|||
147451999|NCT00763139|531816438|FG000|Overall Study|med change not allowed by protocol|1|||
147452000|NCT00763139|531816439|FG001|Overall Study|med change not allowed by protocol|0|||
147452001|NCT01592760|531816440|FG000|24-hour Follow-Up|Lost to Follow-up|4|||
147452002|NCT01592760|531816441|FG001|24-hour Follow-Up|Lost to Follow-up|3|||
147452003|NCT01592760|531816442|FG002|24-hour Follow-Up|Lost to Follow-up|2|||
147452004|NCT04312009|531816443|FG000|Overall Study|Withdrawal by Subject|2|||
147452005|NCT04312009|531816444|FG001|Overall Study|Withdrawal by Subject|1|||
147452006|NCT01363986|531816447|FG000|Overall Study|Disease progression|1|||
147452007|NCT01637142|531816448|FG000|Washout Period (at Least 3 Days)|Physician Decision|1|||
147452008|NCT03468309|531816449|FG000|Overall Study|Lost to Follow-up|4|||
147452009|NCT03468309|531816449|FG000|Overall Study|Withdrawal by Subject|2|||
147452010|NCT00179309|531816452|FG000|Treatment|Toxicity|2|||
147604066|NCT01221363|532367820|FG000|Overall Study|Pregnancy|1|||
147604067|NCT01221363|532367821|FG001|Overall Study|Pregnancy|0|||
147604068|NCT01221363|532367820|FG000|Overall Study|Withdrawal by Subject|11|||
147662632|NCT00385918|532587380|FG001|Feasibility & Baseline Measurement Phase|outside of inclusion criteria|0|||
147662633|NCT00385918|532587381|FG002|Feasibility & Baseline Measurement Phase|outside of inclusion criteria|8|||
147452011|NCT00179309|531816453|FG001|Treatment|Toxicity|3|||
147452012|NCT00179309|531816452|FG000|Treatment|Withdrawal by Subject|1|||
147452013|NCT00179309|531816453|FG001|Treatment|Withdrawal by Subject|2|||
147604069|NCT01221363|532367821|FG001|Overall Study|Withdrawal by Subject|5|||
147604070|NCT01329549|532367826|FG000|Overall Study|Withdrawal by Subject|1|||
147452014|NCT00179309|531816452|FG000|Treatment|Allergy|1|||
147452015|NCT00179309|531816453|FG001|Treatment|Allergy|0|||
147452016|NCT00488982|531816454|FG000|Course 1|Physician Decision|0|||
147452017|NCT00488982|531816455|FG001|Course 1|Physician Decision|2|||
147452018|NCT00488982|531816456|FG002|Course 1|Physician Decision|4|||
147452019|NCT00488982|531816454|FG000|Course 1|Withdrawal by Subject|0|||
147452020|NCT00488982|531816455|FG001|Course 1|Withdrawal by Subject|8|||
147452021|NCT00488982|531816456|FG002|Course 1|Withdrawal by Subject|2|||
147452022|NCT00488982|531816454|FG000|Course 1|nonprotocol therapy|0|||
147452023|NCT00488982|531816455|FG001|Course 1|nonprotocol therapy|2|||
147452024|NCT00488982|531816456|FG002|Course 1|nonprotocol therapy|2|||
147452025|NCT00488982|531816454|FG000|Course 1|Adverse Event|0|||
147452026|NCT00488982|531816455|FG001|Course 1|Adverse Event|0|||
147452027|NCT00488982|531816456|FG002|Course 1|Adverse Event|6|||
147452028|NCT01777152|531816459|FG000|Overall Study|Withdrawal by Subject|22|||
147452029|NCT01777152|531816460|FG001|Overall Study|Withdrawal by Subject|16|||
147452030|NCT01777152|531816459|FG000|Overall Study|Lost to Follow-up|3|||
147452031|NCT01777152|531816460|FG001|Overall Study|Lost to Follow-up|5|||
147452032|NCT01777152|531816459|FG000|Overall Study|Death|68|||
147452033|NCT01777152|531816460|FG001|Overall Study|Death|89|||
147452034|NCT01777152|531816459|FG000|Overall Study|Not eligible, no study drug received|1|||
147452035|NCT01777152|531816460|FG001|Overall Study|Not eligible, no study drug received|0|||
147452036|NCT01777152|531816459|FG000|Overall Study|Change of diagnosis|1|||
147452037|NCT01777152|531816460|FG001|Overall Study|Change of diagnosis|0|||
147452038|NCT03548558|531816461|FG000|Phase 1: 16 Total Fortnightly Sessions|Death|2|||
147452039|NCT03548558|531816462|FG001|Phase 1: 16 Total Fortnightly Sessions|Death|1|||
147452040|NCT03548558|531816463|FG002|Phase 1: 16 Total Fortnightly Sessions|Death|0|||
147452041|NCT03548558|531816464|FG003|Phase 1: 16 Total Fortnightly Sessions|Death|1|||
147452042|NCT03548558|531816465|FG004|Phase 1: 16 Total Fortnightly Sessions|Death|0|||
147452043|NCT03548558|531816466|FG005|Phase 1: 16 Total Fortnightly Sessions|Death|0|||
147452044|NCT03548558|531816467|FG006|Phase 1: 16 Total Fortnightly Sessions|Death|0|||
147452045|NCT03548558|531816461|FG000|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|3|||
147452046|NCT03548558|531816462|FG001|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|1|||
147452047|NCT03548558|531816463|FG002|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|1|||
147452048|NCT03548558|531816464|FG003|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|3|||
147452049|NCT03548558|531816465|FG004|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|2|||
147452050|NCT03548558|531816466|FG005|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|0|||
147452051|NCT03548558|531816467|FG006|Phase 1: 16 Total Fortnightly Sessions|Withdrawal by Subject|0|||
147452052|NCT03548558|531816461|FG000|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|7|||
147452053|NCT03548558|531816462|FG001|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|15|||
147452054|NCT03548558|531816463|FG002|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|9|||
147452055|NCT03548558|531816464|FG003|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|13|||
147452056|NCT03548558|531816465|FG004|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|24|||
147452057|NCT03548558|531816466|FG005|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|0|||
147452058|NCT03548558|531816467|FG006|Phase 1: 16 Total Fortnightly Sessions|Lost to Follow-up|0|||
147452059|NCT03548558|531816461|FG000|Phase 2: Booster Sessions Every 2 Months|Death|0|||
147452060|NCT03548558|531816462|FG001|Phase 2: Booster Sessions Every 2 Months|Death|0|||
147452061|NCT03548558|531816463|FG002|Phase 2: Booster Sessions Every 2 Months|Death|0|||
147452062|NCT03548558|531816464|FG003|Phase 2: Booster Sessions Every 2 Months|Death|0|||
147452063|NCT03548558|531816465|FG004|Phase 2: Booster Sessions Every 2 Months|Death|3|||
147452064|NCT03548558|531816466|FG005|Phase 2: Booster Sessions Every 2 Months|Death|1|||
147452065|NCT03548558|531816467|FG006|Phase 2: Booster Sessions Every 2 Months|Death|1|||
147604071|NCT01329549|532367826|FG000|Overall Study|Adverse Event|1|||
147604072|NCT01775189|532367827|FG000|Drug Discrimination Phase: Day 1|Adverse Event|0|||
147604073|NCT01775189|532367828|FG001|Drug Discrimination Phase: Day 1|Adverse Event|3|||
147604074|NCT01775189|532367829|FG002|Drug Discrimination Phase: Day 1|Adverse Event|0|||
147604075|NCT01775189|532367830|FG003|Drug Discrimination Phase: Day 1|Adverse Event|0|||
147604076|NCT01775189|532367831|FG004|Drug Discrimination Phase: Day 1|Adverse Event|0|||
147604077|NCT01775189|532367832|FG005|Drug Discrimination Phase: Day 1|Adverse Event|0|||
147604078|NCT01775189|532367833|FG006|Drug Discrimination Phase: Day 1|Adverse Event|0|||
147604079|NCT01775189|532367827|FG000|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
147604080|NCT01775189|532367828|FG001|Drug Discrimination Phase: Day 2|Protocol Violation|1|||
147604081|NCT01775189|532367829|FG002|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
147604082|NCT01775189|532367830|FG003|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
147604083|NCT01775189|532367831|FG004|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
147604084|NCT01775189|532367832|FG005|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
147604085|NCT01775189|532367833|FG006|Drug Discrimination Phase: Day 2|Protocol Violation|0|||
147452066|NCT03548558|531816461|FG000|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|0|||
147452067|NCT03548558|531816462|FG001|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|0|||
147452068|NCT03548558|531816463|FG002|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|0|||
147452069|NCT03548558|531816464|FG003|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|0|||
147452070|NCT03548558|531816465|FG004|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|4|||
147452071|NCT03548558|531816466|FG005|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|3|||
147452072|NCT03548558|531816467|FG006|Phase 2: Booster Sessions Every 2 Months|Withdrawal by Subject|3|||
147284193|NCT00968669|531207292|FG003|Overall Study|SUBJECT WAS RANDOMIZED IN ERROR|0|||
147284194|NCT00968669|531207289|FG000|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|0|||
147284195|NCT00968669|531207290|FG001|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|0|||
147284196|NCT00968669|531207291|FG002|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|0|||
147284197|NCT00968669|531207292|FG003|Overall Study|WITHDRAWN DUE TO PREDNISONE USE|1|||
147284198|NCT01953926|531207293|FG000|Overall Study|Withdrawal by Subject|23|||
147284199|NCT01953926|531207294|FG001|Overall Study|Withdrawal by Subject|3|||
147284200|NCT01953926|531207295|FG002|Overall Study|Withdrawal by Subject|3|||
147284201|NCT01953926|531207296|FG003|Overall Study|Withdrawal by Subject|5|||
147284202|NCT01953926|531207297|FG004|Overall Study|Withdrawal by Subject|6|||
147284203|NCT01953926|531207298|FG005|Overall Study|Withdrawal by Subject|0|||
147284204|NCT01953926|531207299|FG006|Overall Study|Withdrawal by Subject|1|||
147284205|NCT01953926|531207293|FG000|Overall Study|Physician Decision|1|||
147284206|NCT01953926|531207294|FG001|Overall Study|Physician Decision|0|||
147284207|NCT01953926|531207295|FG002|Overall Study|Physician Decision|0|||
147284208|NCT01953926|531207296|FG003|Overall Study|Physician Decision|0|||
147284209|NCT01953926|531207297|FG004|Overall Study|Physician Decision|2|||
147284210|NCT01953926|531207298|FG005|Overall Study|Physician Decision|0|||
147284211|NCT01953926|531207299|FG006|Overall Study|Physician Decision|0|||
147284212|NCT01953926|531207293|FG000|Overall Study|Lost to Follow-up|18|||
147284213|NCT01953926|531207294|FG001|Overall Study|Lost to Follow-up|3|||
147284214|NCT01953926|531207295|FG002|Overall Study|Lost to Follow-up|0|||
147284215|NCT01953926|531207296|FG003|Overall Study|Lost to Follow-up|5|||
147284216|NCT01953926|531207297|FG004|Overall Study|Lost to Follow-up|3|||
147284217|NCT01953926|531207298|FG005|Overall Study|Lost to Follow-up|0|||
147284218|NCT01953926|531207299|FG006|Overall Study|Lost to Follow-up|0|||
147284219|NCT01953926|531207293|FG000|Overall Study|Protocol Violation|1|||
147284220|NCT01953926|531207294|FG001|Overall Study|Protocol Violation|0|||
147284221|NCT01953926|531207295|FG002|Overall Study|Protocol Violation|0|||
147284222|NCT01953926|531207296|FG003|Overall Study|Protocol Violation|0|||
147337010|NCT00959946|531400069|FG001|Overall Study|Withdrawal by Subject|0|||
147337011|NCT00959946|531400070|FG002|Overall Study|Withdrawal by Subject|0|||
147284223|NCT01953926|531207297|FG004|Overall Study|Protocol Violation|0|||
147284224|NCT01953926|531207298|FG005|Overall Study|Protocol Violation|0|||
147284225|NCT01953926|531207299|FG006|Overall Study|Protocol Violation|0|||
147284226|NCT01953926|531207293|FG000|Overall Study|Other, Disease progression|2|||
147284227|NCT01953926|531207294|FG001|Overall Study|Other, Disease progression|1|||
147284228|NCT01953926|531207295|FG002|Overall Study|Other, Disease progression|0|||
147284229|NCT01953926|531207296|FG003|Overall Study|Other, Disease progression|0|||
147284230|NCT01953926|531207297|FG004|Overall Study|Other, Disease progression|1|||
147284231|NCT01953926|531207298|FG005|Overall Study|Other, Disease progression|0|||
147284232|NCT01953926|531207299|FG006|Overall Study|Other, Disease progression|0|||
147284233|NCT01953926|531207293|FG000|Overall Study|Discontinuation of study by sponsor|41|||
147337012|NCT00959946|531400071|FG003|Overall Study|Withdrawal by Subject|0|||
147337013|NCT00959946|531400072|FG004|Overall Study|Withdrawal by Subject|0|||
147337014|NCT00959946|531400073|FG005|Overall Study|Withdrawal by Subject|1|||
147337015|NCT00959946|531400074|FG006|Overall Study|Withdrawal by Subject|0|||
147337016|NCT00959946|531400075|FG007|Overall Study|Withdrawal by Subject|0|||
147337017|NCT00356265|531400076|FG000|Overall Study|Withdrawal by Subject|0|||
147337018|NCT00356265|531400077|FG001|Overall Study|Withdrawal by Subject|0|||
147337019|NCT00356265|531400078|FG002|Overall Study|Withdrawal by Subject|1|||
147337020|NCT00159783|531400087|FG000|Overall Study|Adverse Event|5|||
147337021|NCT00159783|531400088|FG001|Overall Study|Adverse Event|7|||
147337022|NCT00159783|531400089|FG002|Overall Study|Adverse Event|9|||
147337023|NCT00159783|531400087|FG000|Overall Study|Lack of Efficacy|1|||
147337024|NCT00159783|531400088|FG001|Overall Study|Lack of Efficacy|2|||
147337025|NCT00159783|531400089|FG002|Overall Study|Lack of Efficacy|3|||
147337026|NCT00159783|531400087|FG000|Overall Study|Withdrawal by Subject|7|||
147337027|NCT00159783|531400088|FG001|Overall Study|Withdrawal by Subject|11|||
147337028|NCT00159783|531400089|FG002|Overall Study|Withdrawal by Subject|12|||
147337029|NCT00159783|531400087|FG000|Overall Study|Lost to Follow-up|6|||
147337030|NCT00159783|531400088|FG001|Overall Study|Lost to Follow-up|5|||
147337031|NCT00159783|531400089|FG002|Overall Study|Lost to Follow-up|11|||
147337032|NCT00159783|531400087|FG000|Overall Study|Other|0|||
147337033|NCT00159783|531400088|FG001|Overall Study|Other|2|||
147337034|NCT00159783|531400089|FG002|Overall Study|Other|4|||
147337035|NCT04975308|531400090|FG000|Overall Study|Withdrawal by Subject|6|||
147284234|NCT01953926|531207294|FG001|Overall Study|Discontinuation of study by sponsor|7|||
147284235|NCT01953926|531207295|FG002|Overall Study|Discontinuation of study by sponsor|5|||
147284236|NCT01953926|531207296|FG003|Overall Study|Discontinuation of study by sponsor|12|||
147337036|NCT04975308|531400091|FG001|Overall Study|Withdrawal by Subject|16|||
147337037|NCT04975308|531400092|FG002|Overall Study|Withdrawal by Subject|6|||
147337038|NCT04975308|531400090|FG000|Overall Study|Physician Decision|0|||
147337039|NCT04975308|531400091|FG001|Overall Study|Physician Decision|3|||
147337040|NCT04975308|531400092|FG002|Overall Study|Physician Decision|1|||
147337041|NCT04975308|531400090|FG000|Overall Study|Adverse Event|10|||
147337042|NCT04975308|531400091|FG001|Overall Study|Adverse Event|1|||
147337043|NCT04975308|531400092|FG002|Overall Study|Adverse Event|12|||
147337044|NCT04975308|531400090|FG000|Overall Study|On study treatment (Ongoing)|65|||
147337045|NCT04975308|531400091|FG001|Overall Study|On study treatment (Ongoing)|43|||
147337046|NCT04975308|531400092|FG002|Overall Study|On study treatment (Ongoing)|75|||
147337047|NCT04975308|531400090|FG000|Overall Study|Protocol Deviation|4|||
147337048|NCT04975308|531400091|FG001|Overall Study|Protocol Deviation|3|||
147337049|NCT04975308|531400092|FG002|Overall Study|Protocol Deviation|2|||
147337050|NCT02538107|531400093|FG000|Overall Study|Did not receive any Mircera dose|11|||
147337051|NCT02538107|531400093|FG000|Overall Study|Missing|5|||
147337052|NCT02538107|531400093|FG000|Overall Study|Necessity of dialysis|20|||
147337053|NCT02538107|531400093|FG000|Overall Study|Administration of other ESA|11|||
147337054|NCT02538107|531400093|FG000|Overall Study|No further treatment necessary|18|||
147337055|NCT02538107|531400093|FG000|Overall Study|Withdrawal by Subject|17|||
147284237|NCT01953926|531207297|FG004|Overall Study|Discontinuation of study by sponsor|46|||
147284238|NCT01953926|531207298|FG005|Overall Study|Discontinuation of study by sponsor|5|||
147284239|NCT01953926|531207299|FG006|Overall Study|Discontinuation of study by sponsor|6|||
147284240|NCT01953926|531207293|FG000|Overall Study|Not Treated|1|||
147284241|NCT01953926|531207294|FG001|Overall Study|Not Treated|0|||
147284242|NCT01953926|531207295|FG002|Overall Study|Not Treated|1|||
147284243|NCT01953926|531207296|FG003|Overall Study|Not Treated|0|||
147284244|NCT01953926|531207297|FG004|Overall Study|Not Treated|0|||
147284245|NCT01953926|531207298|FG005|Overall Study|Not Treated|0|||
147284246|NCT01953926|531207299|FG006|Overall Study|Not Treated|0|||
147284247|NCT01949480|531207305|FG000|Overall Study|Physician Decision|5|||
147284248|NCT01949480|531207306|FG001|Overall Study|Physician Decision|8|||
147284249|NCT00144339|531207307|FG000|Overall Study|Adverse Event|746|||
147284250|NCT00144339|531207308|FG001|Overall Study|Adverse Event|627|||
147337056|NCT02538107|531400093|FG000|Overall Study|Death|4|||
147337057|NCT02538107|531400093|FG000|Overall Study|Administrative reason|5|||
147337058|NCT02538107|531400093|FG000|Overall Study|Adverse Event|4|||
147337059|NCT02538107|531400093|FG000|Overall Study|Surgery|1|||
147337060|NCT02538107|531400093|FG000|Overall Study|Other|7|||
147337061|NCT02538107|531400093|FG000|Overall Study|Not recorded|7|||
147337062|NCT01278394|531400094|FG000|Overall Study|Lost to Follow-up|1|||
147337063|NCT01236560|531400097|FG000|Overall Study|Adverse Event|0|||
147337064|NCT01236560|531400098|FG001|Overall Study|Adverse Event|2|||
147337065|NCT01236560|531400099|FG002|Overall Study|Adverse Event|1|||
147337066|NCT01236560|531400100|FG003|Overall Study|Adverse Event|3|||
147337067|NCT01236560|531400101|FG004|Overall Study|Adverse Event|0|||
147337068|NCT01236560|531400102|FG005|Overall Study|Adverse Event|0|||
147337069|NCT01236560|531400097|FG000|Overall Study|Death|0|||
147337070|NCT01236560|531400098|FG001|Overall Study|Death|1|||
147337071|NCT01236560|531400099|FG002|Overall Study|Death|0|||
147337072|NCT01236560|531400100|FG003|Overall Study|Death|1|||
147337073|NCT01236560|531400101|FG004|Overall Study|Death|0|||
147337074|NCT01236560|531400102|FG005|Overall Study|Death|0|||
147337075|NCT01236560|531400097|FG000|Overall Study|Lost to Follow-up|0|||
147337076|NCT01236560|531400098|FG001|Overall Study|Lost to Follow-up|1|||
147337077|NCT01236560|531400099|FG002|Overall Study|Lost to Follow-up|1|||
147337078|NCT01236560|531400100|FG003|Overall Study|Lost to Follow-up|0|||
147337079|NCT01236560|531400101|FG004|Overall Study|Lost to Follow-up|0|||
147337080|NCT01236560|531400102|FG005|Overall Study|Lost to Follow-up|0|||
147337081|NCT01236560|531400097|FG000|Overall Study|Physician Decision|0|||
147337082|NCT01236560|531400098|FG001|Overall Study|Physician Decision|1|||
147337083|NCT01236560|531400099|FG002|Overall Study|Physician Decision|8|||
147337084|NCT01236560|531400100|FG003|Overall Study|Physician Decision|0|||
147337085|NCT01236560|531400101|FG004|Overall Study|Physician Decision|0|||
147337086|NCT01236560|531400102|FG005|Overall Study|Physician Decision|0|||
147337087|NCT01236560|531400097|FG000|Overall Study|Withdrawal by Subject|0|||
147452073|NCT03548558|531816461|FG000|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|0|||
147604086|NCT01775189|532367827|FG000|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0|||
147284251|NCT00144339|531207307|FG000|Overall Study|Protocol Violation|75|||
147284252|NCT00144339|531207308|FG001|Overall Study|Protocol Violation|48|||
147284253|NCT00144339|531207307|FG000|Overall Study|Withdrawal by Subject|403|||
147284254|NCT00144339|531207308|FG001|Overall Study|Withdrawal by Subject|300|||
147284255|NCT00144339|531207307|FG000|Overall Study|Lost to Follow-up|76|||
147284256|NCT00144339|531207308|FG001|Overall Study|Lost to Follow-up|64|||
147284257|NCT00144339|531207307|FG000|Overall Study|Other|58|||
147337088|NCT01236560|531400098|FG001|Overall Study|Withdrawal by Subject|0|||
147337089|NCT01236560|531400099|FG002|Overall Study|Withdrawal by Subject|1|||
147337090|NCT01236560|531400100|FG003|Overall Study|Withdrawal by Subject|2|||
147337091|NCT01236560|531400101|FG004|Overall Study|Withdrawal by Subject|0|||
147337092|NCT01236560|531400102|FG005|Overall Study|Withdrawal by Subject|0|||
147284258|NCT00144339|531207308|FG001|Overall Study|Other|60|||
147284259|NCT04798586|531207313|FG000|Overall Study|Death|2|||
147284260|NCT00968617|531207314|FG000|Overall Study|Study terminated by sponsor|6|||
147284261|NCT04433767|531207315|FG000|Overall Study|Adverse Event|1|||
147337093|NCT01236560|531400097|FG000|Overall Study|Progressive disease|5|||
147337094|NCT01236560|531400098|FG001|Overall Study|Progressive disease|19|||
147337095|NCT01236560|531400099|FG002|Overall Study|Progressive disease|9|||
147337096|NCT01236560|531400100|FG003|Overall Study|Progressive disease|16|||
147337097|NCT01236560|531400101|FG004|Overall Study|Progressive disease|0|||
147337098|NCT01236560|531400102|FG005|Overall Study|Progressive disease|0|||
147337099|NCT02471755|531400103|FG000|Overall Study|Withdrawal by Subject|1|||
147337100|NCT02471755|531400104|FG001|Overall Study|Withdrawal by Subject|0|||
147337101|NCT02471755|531400103|FG000|Overall Study|Lost to Follow-up|0|||
147337102|NCT02471755|531400104|FG001|Overall Study|Lost to Follow-up|1|||
147337103|NCT05323734|531400108|FG000|Overall Study|Adverse Event|5|||
147337104|NCT05323734|531400109|FG001|Overall Study|Adverse Event|2|||
147337105|NCT05323734|531400108|FG000|Overall Study|Physician Decision|1|||
147337106|NCT05323734|531400109|FG001|Overall Study|Physician Decision|0|||
147337107|NCT05323734|531400108|FG000|Overall Study|Lack of Efficacy|1|||
147337108|NCT05323734|531400109|FG001|Overall Study|Lack of Efficacy|2|||
147337109|NCT05323734|531400108|FG000|Overall Study|Withdrawal by Subject|2|||
147337110|NCT05323734|531400109|FG001|Overall Study|Withdrawal by Subject|0|||
147337111|NCT05323734|531400108|FG000|Overall Study|Participant Withdrawn Due|0|||
147337112|NCT05323734|531400109|FG001|Overall Study|Participant Withdrawn Due|1|||
147337113|NCT05061693|531400110|FG000|16-week Placebo-controlled (PC) Period|Adverse Event|1|||
147337114|NCT05061693|531400111|FG001|16-week Placebo-controlled (PC) Period|Adverse Event|1|||
147337115|NCT05061693|531400112|FG002|16-week Placebo-controlled (PC) Period|Adverse Event|1|||
147337116|NCT05061693|531400113|FG003|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
147337117|NCT05061693|531400114|FG004|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
147337118|NCT05061693|531400115|FG005|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
147337119|NCT05061693|531400116|FG006|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
147337120|NCT05061693|531400117|FG007|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
147337121|NCT05061693|531400118|FG008|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
147337122|NCT05061693|531400119|FG009|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
147337123|NCT05061693|531400120|FG010|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
147337124|NCT05061693|531400121|FG011|16-week Placebo-controlled (PC) Period|Adverse Event|0|||
147337125|NCT05061693|531400110|FG000|16-week Placebo-controlled (PC) Period|Death|0|||
147337126|NCT05061693|531400111|FG001|16-week Placebo-controlled (PC) Period|Death|1|||
147337127|NCT05061693|531400112|FG002|16-week Placebo-controlled (PC) Period|Death|0|||
147337128|NCT05061693|531400113|FG003|16-week Placebo-controlled (PC) Period|Death|0|||
147337129|NCT05061693|531400114|FG004|16-week Placebo-controlled (PC) Period|Death|0|||
147337130|NCT05061693|531400115|FG005|16-week Placebo-controlled (PC) Period|Death|0|||
147337131|NCT05061693|531400116|FG006|16-week Placebo-controlled (PC) Period|Death|0|||
147337132|NCT05061693|531400117|FG007|16-week Placebo-controlled (PC) Period|Death|0|||
147337133|NCT05061693|531400118|FG008|16-week Placebo-controlled (PC) Period|Death|0|||
147337134|NCT05061693|531400119|FG009|16-week Placebo-controlled (PC) Period|Death|0|||
147337135|NCT05061693|531400120|FG010|16-week Placebo-controlled (PC) Period|Death|0|||
147337136|NCT05061693|531400121|FG011|16-week Placebo-controlled (PC) Period|Death|0|||
147337137|NCT05061693|531400110|FG000|16-week Placebo-controlled (PC) Period|Lack of Efficacy|1|||
147337138|NCT05061693|531400111|FG001|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
147337139|NCT05061693|531400112|FG002|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
147337140|NCT05061693|531400113|FG003|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
147337141|NCT05061693|531400114|FG004|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
147337142|NCT05061693|531400115|FG005|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
147337143|NCT05061693|531400116|FG006|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
147337144|NCT05061693|531400117|FG007|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
147337145|NCT05061693|531400118|FG008|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
147337146|NCT05061693|531400119|FG009|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
147337147|NCT05061693|531400120|FG010|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
147337148|NCT05061693|531400121|FG011|16-week Placebo-controlled (PC) Period|Lack of Efficacy|0|||
147337149|NCT05061693|531400110|FG000|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
147337150|NCT05061693|531400111|FG001|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
147337151|NCT05061693|531400112|FG002|16-week Placebo-controlled (PC) Period|Lost to Follow-up|1|||
147337152|NCT05061693|531400113|FG003|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
147337153|NCT05061693|531400114|FG004|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
147337154|NCT05061693|531400115|FG005|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
147337155|NCT05061693|531400116|FG006|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
147337156|NCT05061693|531400117|FG007|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
147337157|NCT05061693|531400118|FG008|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
147337158|NCT05061693|531400119|FG009|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
147337159|NCT05061693|531400120|FG010|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
147337160|NCT05061693|531400121|FG011|16-week Placebo-controlled (PC) Period|Lost to Follow-up|0|||
147337161|NCT05061693|531400110|FG000|16-week Placebo-controlled (PC) Period|Protocol Violation|1|||
147337162|NCT05061693|531400111|FG001|16-week Placebo-controlled (PC) Period|Protocol Violation|1|||
147337163|NCT05061693|531400112|FG002|16-week Placebo-controlled (PC) Period|Protocol Violation|1|||
147337164|NCT05061693|531400113|FG003|16-week Placebo-controlled (PC) Period|Protocol Violation|2|||
147452074|NCT03548558|531816462|FG001|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|0|||
147452075|NCT03548558|531816463|FG002|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|0|||
147452076|NCT03548558|531816464|FG003|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|0|||
147452077|NCT03548558|531816465|FG004|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|62|||
147452078|NCT03548558|531816466|FG005|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|67|||
147452079|NCT03548558|531816467|FG006|Phase 2: Booster Sessions Every 2 Months|Lost to Follow-up|61|||
147452080|NCT05980299|531816476|FG000|Overall Study|Death|28|||
147452081|NCT05980299|531816477|FG001|Overall Study|Death|0|||
147452082|NCT05980299|531816476|FG000|Overall Study|Discharged from Nursing Home|9|||
147452083|NCT05980299|531816477|FG001|Overall Study|Discharged from Nursing Home|0|||
147452084|NCT05980299|531816476|FG000|Overall Study|Lost to Follow-up|0|||
147452085|NCT05980299|531816477|FG001|Overall Study|Lost to Follow-up|10|||
147452086|NCT00290433|531816480|FG000|Overall Study|Disease Progression|13|||
147452087|NCT00290433|531816480|FG000|Overall Study|Adverse Event|14|||
147452088|NCT00290433|531816480|FG000|Overall Study|Withdrawal by Subject|1|||
147452089|NCT00290433|531816480|FG000|Overall Study|Non-Compliance|1|||
147452090|NCT00290433|531816480|FG000|Overall Study|Congestive Heart Failure|1|||
147452091|NCT00290433|531816480|FG000|Overall Study|Transplant in CR|5|||
147452092|NCT00290433|531816480|FG000|Overall Study|Unrelated Infection/Death|1|||
147452093|NCT02264990|531816485|FG000|Overall Study|Death|255|||
147452094|NCT02264990|531816486|FG001|Overall Study|Death|250|||
147452095|NCT02264990|531816485|FG000|Overall Study|Withdrawal by Subject|4|||
147452096|NCT02264990|531816486|FG001|Overall Study|Withdrawal by Subject|5|||
147452097|NCT02264990|531816485|FG000|Overall Study|Lost to Follow-up|1|||
147452098|NCT02264990|531816486|FG001|Overall Study|Lost to Follow-up|3|||
147452099|NCT02264990|531816485|FG000|Overall Study|Other|0|||
147452100|NCT02264990|531816486|FG001|Overall Study|Other|1|||
147452101|NCT01098071|531816495|FG000|Overall Study|Surgery (adenoidectomy)|2|||
147452102|NCT01098071|531816495|FG000|Overall Study|Lost to Follow-up|13|||
147452103|NCT00797732|531816499|FG000|Overall Study|Withdrawal by Subject|3|||
147452104|NCT00797732|531816500|FG001|Overall Study|Withdrawal by Subject|3|||
147452105|NCT00797732|531816501|FG002|Overall Study|Withdrawal by Subject|0|||
147452106|NCT00797732|531816499|FG000|Overall Study|Lost to Follow-up|1|||
147452107|NCT00797732|531816500|FG001|Overall Study|Lost to Follow-up|0|||
147284262|NCT00288587|531207325|FG000|Overall Study|Death|4|||
147284263|NCT00288587|531207326|FG001|Overall Study|Death|4|||
147284264|NCT00288587|531207325|FG000|Overall Study|Transplant|0|||
147452108|NCT00797732|531816501|FG002|Overall Study|Lost to Follow-up|0|||
147452109|NCT00797732|531816499|FG000|Overall Study|Death|1|||
147452110|NCT00797732|531816500|FG001|Overall Study|Death|0|||
147452111|NCT00797732|531816501|FG002|Overall Study|Death|0|||
147452112|NCT00797732|531816499|FG000|Overall Study|Not meet inclusion criteria|0|||
147452113|NCT00797732|531816500|FG001|Overall Study|Not meet inclusion criteria|0|||
147452114|NCT00797732|531816501|FG002|Overall Study|Not meet inclusion criteria|7|||
147452115|NCT00797732|531816499|FG000|Overall Study|Excluded due to time constraints|0|||
147452116|NCT00797732|531816500|FG001|Overall Study|Excluded due to time constraints|0|||
147452117|NCT00797732|531816501|FG002|Overall Study|Excluded due to time constraints|24|||
147452118|NCT00797732|531816499|FG000|Overall Study|Refused to Participate|0|||
147452119|NCT00797732|531816500|FG001|Overall Study|Refused to Participate|0|||
147452120|NCT00797732|531816501|FG002|Overall Study|Refused to Participate|123|||
147452121|NCT04607733|531816511|FG000|Overall Study|Lost to Follow-up|1|||
147452122|NCT04607733|531816512|FG001|Overall Study|Lost to Follow-up|0|||
147452123|NCT04607733|531816513|FG002|Overall Study|Lost to Follow-up|0|||
147452124|NCT04607733|531816514|FG003|Overall Study|Lost to Follow-up|1|||
147452125|NCT04607733|531816515|FG004|Overall Study|Lost to Follow-up|1|||
147452126|NCT04607733|531816516|FG005|Overall Study|Lost to Follow-up|0|||
147452127|NCT04607733|531816511|FG000|Overall Study|Withdrawal by Subject|0|||
147452128|NCT04607733|531816512|FG001|Overall Study|Withdrawal by Subject|0|||
147604087|NCT01775189|532367828|FG001|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|2|||
147604088|NCT01775189|532367829|FG002|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|7|||
147604089|NCT01775189|532367830|FG003|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0|||
147284265|NCT00288587|531207326|FG001|Overall Study|Transplant|3|||
147284266|NCT00288587|531207325|FG000|Overall Study|Adverse Event|0|||
147452129|NCT04607733|531816513|FG002|Overall Study|Withdrawal by Subject|0|||
147452130|NCT04607733|531816514|FG003|Overall Study|Withdrawal by Subject|0|||
147452131|NCT04607733|531816515|FG004|Overall Study|Withdrawal by Subject|1|||
147452132|NCT04607733|531816516|FG005|Overall Study|Withdrawal by Subject|0|||
147452133|NCT01665807|531816517|FG000|Overall Study|Withdrawal by Subject|2|||
147452134|NCT01665807|531816518|FG001|Overall Study|Withdrawal by Subject|0|||
147452135|NCT01665807|531816519|FG002|Overall Study|Withdrawal by Subject|1|||
147452136|NCT03504397|531816520|FG000|Overall Study|Progressive Disease|151|||
147452137|NCT03504397|531816521|FG001|Overall Study|Progressive Disease|199|||
147452138|NCT03504397|531816520|FG000|Overall Study|Withdrawal by Subject|29|||
147604090|NCT01775189|532367831|FG004|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0|||
147284267|NCT00288587|531207326|FG001|Overall Study|Adverse Event|1|||
147284268|NCT00288587|531207325|FG000|Overall Study|Physician Decision|0|||
147604091|NCT01775189|532367832|FG005|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0|||
147604092|NCT01775189|532367833|FG006|Drug Discrimination Phase: Day 2|Did Not Meet Entrance Criteria|0|||
147284269|NCT00288587|531207326|FG001|Overall Study|Physician Decision|2|||
147284270|NCT00288587|531207325|FG000|Overall Study|Severe Aortic Stenosis|1|||
147284271|NCT00288587|531207326|FG001|Overall Study|Severe Aortic Stenosis|0|||
147284272|NCT01434602|531207327|FG000|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|0|||
147284273|NCT01434602|531207328|FG001|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|1|||
147284274|NCT01434602|531207329|FG002|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|0|||
147284275|NCT01434602|531207330|FG003|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|0|||
147284276|NCT01434602|531207331|FG004|Phase I Dose Escalation|Participant was underdosed (i.e., was taking incorrect dose at home)/Not evaluable|0|||
147284277|NCT01434602|531207327|FG000|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|0|||
147284278|NCT01434602|531207328|FG001|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|0|||
147284279|NCT01434602|531207329|FG002|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|0|||
147284280|NCT01434602|531207330|FG003|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|1|||
147284281|NCT01434602|531207331|FG004|Phase II Recommended Phase 2 Dose|Active progression before start of treatment|0|||
147284282|NCT01434602|531207327|FG000|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|0|||
147284283|NCT01434602|531207328|FG001|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|0|||
147284284|NCT01434602|531207329|FG002|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|0|||
147284285|NCT01434602|531207330|FG003|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|1|||
147284286|NCT01434602|531207331|FG004|Phase II Recommended Phase 2 Dose|Bilateral large pulmonary embolisms in the right and left main pulmonary arteries|0|||
147284287|NCT01434602|531207327|FG000|Phase II Recommended Phase 2 Dose|Started new therapy|0|||
147284288|NCT01434602|531207328|FG001|Phase II Recommended Phase 2 Dose|Started new therapy|0|||
147284289|NCT01434602|531207329|FG002|Phase II Recommended Phase 2 Dose|Started new therapy|0|||
147284290|NCT01434602|531207330|FG003|Phase II Recommended Phase 2 Dose|Started new therapy|1|||
147284291|NCT01434602|531207331|FG004|Phase II Recommended Phase 2 Dose|Started new therapy|0|||
147284292|NCT01434602|531207327|FG000|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|0|||
147284293|NCT01434602|531207328|FG001|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|0|||
147284294|NCT01434602|531207329|FG002|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|0|||
147284295|NCT01434602|531207330|FG003|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|1|||
147284296|NCT01434602|531207331|FG004|Phase II Recommended Phase 2 Dose|Decline in patient condition/health/ADL's|0|||
147284297|NCT01434602|531207327|FG000|Phase II Recommended Phase 2 Dose|Transfer of care|0|||
147284298|NCT01434602|531207328|FG001|Phase II Recommended Phase 2 Dose|Transfer of care|0|||
147284299|NCT01434602|531207329|FG002|Phase II Recommended Phase 2 Dose|Transfer of care|0|||
147284300|NCT01434602|531207330|FG003|Phase II Recommended Phase 2 Dose|Transfer of care|1|||
147284301|NCT01434602|531207331|FG004|Phase II Recommended Phase 2 Dose|Transfer of care|0|||
147284302|NCT01434602|531207327|FG000|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|0|||
147284303|NCT01434602|531207328|FG001|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|0|||
147284304|NCT01434602|531207329|FG002|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|0|||
147284305|NCT01434602|531207330|FG003|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|0|||
147284306|NCT01434602|531207331|FG004|Phase II Recommended Phase 2 Dose|Withdrawal by Subject|1|||
147284307|NCT01434602|531207327|FG000|Phase II Recommended Phase 2 Dose|Physician Decision|0|||
147284308|NCT01434602|531207328|FG001|Phase II Recommended Phase 2 Dose|Physician Decision|0|||
147284309|NCT01434602|531207329|FG002|Phase II Recommended Phase 2 Dose|Physician Decision|0|||
147284310|NCT01434602|531207330|FG003|Phase II Recommended Phase 2 Dose|Physician Decision|1|||
147284311|NCT01434602|531207331|FG004|Phase II Recommended Phase 2 Dose|Physician Decision|1|||
147284312|NCT01434602|531207327|FG000|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|0|||
147284313|NCT01434602|531207328|FG001|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|0|||
147284314|NCT01434602|531207329|FG002|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|0|||
147284315|NCT01434602|531207330|FG003|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|1|||
147284316|NCT01434602|531207331|FG004|Phase II Recommended Phase 2 Dose|Switched to alternative treatment|0|||
147284317|NCT01434602|531207327|FG000|Phase II Recommended Phase 2 Dose|Refused further treatment|0|||
147284318|NCT01434602|531207328|FG001|Phase II Recommended Phase 2 Dose|Refused further treatment|0|||
147284319|NCT01434602|531207329|FG002|Phase II Recommended Phase 2 Dose|Refused further treatment|0|||
147284320|NCT01434602|531207330|FG003|Phase II Recommended Phase 2 Dose|Refused further treatment|2|||
147337165|NCT05061693|531400114|FG004|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
147337166|NCT05061693|531400115|FG005|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
147337167|NCT05061693|531400116|FG006|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
147452139|NCT03504397|531816521|FG001|Overall Study|Withdrawal by Subject|17|||
147452140|NCT03504397|531816520|FG000|Overall Study|Lost to Follow-up|1|||
147452141|NCT03504397|531816521|FG001|Overall Study|Lost to Follow-up|0|||
147452142|NCT03504397|531816520|FG000|Overall Study|Death|14|||
147452143|NCT03504397|531816521|FG001|Overall Study|Death|16|||
147452144|NCT03504397|531816520|FG000|Overall Study|Adverse Event|40|||
147452145|NCT03504397|531816521|FG001|Overall Study|Adverse Event|14|||
147452146|NCT03504397|531816520|FG000|Overall Study|miscellaneous|17|||
147604093|NCT01775189|532367827|FG000|Treatment Phase: Washout Period 1|Protocol Violation|0|||
147604094|NCT01775189|532367828|FG001|Treatment Phase: Washout Period 1|Protocol Violation|0|||
147284321|NCT01434602|531207331|FG004|Phase II Recommended Phase 2 Dose|Refused further treatment|0|||
147284322|NCT01764945|531207337|FG000|Overall Study|Adverse Event|0|||
147452147|NCT03504397|531816521|FG001|Overall Study|miscellaneous|15|||
147452148|NCT03504397|531816520|FG000|Overall Study|Protocol deviation|1|||
147452149|NCT03504397|531816521|FG001|Overall Study|Protocol deviation|0|||
147452150|NCT03504397|531816520|FG000|Overall Study|Participants who did not take the study drug|4|||
147452151|NCT03504397|531816521|FG001|Overall Study|Participants who did not take the study drug|4|||
147452152|NCT03215771|531816524|FG000|Overall Study|Withdrawal by Subject|2|||
147452153|NCT03215771|531816524|FG000|Overall Study|Physician Decision|1|||
147452154|NCT00574275|531816529|FG000|Overall Study|Randomized but not treated|2|||
147452155|NCT00574275|531816530|FG001|Overall Study|Randomized but not treated|3|||
147452156|NCT00574275|531816529|FG000|Overall Study|Adverse Event|32|||
147452157|NCT00574275|531816530|FG001|Overall Study|Adverse Event|76|||
147452158|NCT00574275|531816529|FG000|Overall Study|Disease progression|160|||
147452159|NCT00574275|531816530|FG001|Overall Study|Disease progression|146|||
147452160|NCT00574275|531816529|FG000|Overall Study|Lost to Follow-up|2|||
147452161|NCT00574275|531816530|FG001|Overall Study|Lost to Follow-up|1|||
147452162|NCT00574275|531816529|FG000|Overall Study|Study stopped based on DMC decision|62|||
147452163|NCT00574275|531816530|FG001|Overall Study|Study stopped based on DMC decision|23|||
147452164|NCT00574275|531816529|FG000|Overall Study|Withdrawal by Subject|15|||
147452165|NCT00574275|531816530|FG001|Overall Study|Withdrawal by Subject|17|||
147452166|NCT00574275|531816529|FG000|Overall Study|Error calculating tumor measurement|1|||
147452167|NCT00574275|531816530|FG001|Overall Study|Error calculating tumor measurement|0|||
147452168|NCT00574275|531816529|FG000|Overall Study|Physician Decision|1|||
147452169|NCT00574275|531816530|FG001|Overall Study|Physician Decision|1|||
147452170|NCT00574275|531816529|FG000|Overall Study|Protocol Violation|0|||
147452171|NCT00574275|531816530|FG001|Overall Study|Protocol Violation|1|||
147452172|NCT00574275|531816529|FG000|Overall Study|Patient and Investigator decision|0|||
147452173|NCT00574275|531816530|FG001|Overall Study|Patient and Investigator decision|1|||
147452174|NCT00574275|531816529|FG000|Overall Study|Insurance change|0|||
147452175|NCT00574275|531816530|FG001|Overall Study|Insurance change|1|||
147452176|NCT00574275|531816529|FG000|Overall Study|Operation for curative intent|0|||
147452177|NCT00574275|531816530|FG001|Overall Study|Operation for curative intent|1|||
147452178|NCT02703311|531816531|FG000|Overall Study|Death|5|||
147452179|NCT02703311|531816531|FG000|Overall Study|Withdrawal by Subject|3|||
147452180|NCT01967537|531816534|FG000|Overall Study|Withdrawal by Subject|52|||
147452181|NCT01967537|531816534|FG000|Overall Study|Refuse treatment|2|||
147452182|NCT01967537|531816534|FG000|Overall Study|Lost to Follow-up|6|||
147452183|NCT00137111|531816535|FG000|Total Therapy|Death|35|||
147452184|NCT00137111|531816536|FG001|Total Therapy|Death|0|||
147452185|NCT00137111|531816537|FG002|Total Therapy|Death|0|||
147452186|NCT00137111|531816538|FG003|Total Therapy|Death|0|||
147452187|NCT00137111|531816535|FG000|Total Therapy|Non Compliance|5|||
147452188|NCT00137111|531816536|FG001|Total Therapy|Non Compliance|0|||
147452189|NCT00137111|531816537|FG002|Total Therapy|Non Compliance|0|||
147452190|NCT00137111|531816538|FG003|Total Therapy|Non Compliance|0|||
147452191|NCT02788747|531816539|FG000|Overall Study|Adverse Event|1|||
147452192|NCT02788747|531816540|FG001|Overall Study|Adverse Event|0|||
147452193|NCT02788747|531816541|FG002|Overall Study|Adverse Event|0|||
147284323|NCT01764945|531207338|FG001|Overall Study|Adverse Event|1|||
147284324|NCT01764945|531207339|FG002|Overall Study|Adverse Event|0|||
147284325|NCT01764945|531207340|FG003|Overall Study|Adverse Event|0|||
147284326|NCT01764945|531207341|FG004|Overall Study|Adverse Event|0|||
147284327|NCT01764945|531207342|FG005|Overall Study|Adverse Event|0|||
147284328|NCT01764945|531207343|FG006|Overall Study|Adverse Event|1|||
147452194|NCT00562354|531816542|FG000|Overall Study|Physician Decision|0|||
147284329|NCT01764945|531207344|FG007|Overall Study|Adverse Event|0|||
147284330|NCT05077267|531207346|FG000|Treatment Period|Lost to Follow-up|0|||
147284331|NCT05077267|531207347|FG001|Treatment Period|Lost to Follow-up|1|||
147452195|NCT00562354|531816543|FG001|Overall Study|Physician Decision|1|||
147452196|NCT00562354|531816542|FG000|Overall Study|Lost to Follow-up|0|||
147452197|NCT00562354|531816543|FG001|Overall Study|Lost to Follow-up|1|||
147452198|NCT00317109|531816544|FG000|Overall Study|Withdrawal by Subject|2|||
147452199|NCT00317109|531816545|FG001|Overall Study|Withdrawal by Subject|0|||
147452200|NCT00317109|531816544|FG000|Overall Study|Migated/moved from study area|1|||
147284332|NCT05077267|531207348|FG002|Treatment Period|Lost to Follow-up|0|||
147284333|NCT05077267|531207346|FG000|Treatment Period|Withdrawal by Subject|0|||
147284334|NCT05077267|531207347|FG001|Treatment Period|Withdrawal by Subject|1|||
147284335|NCT05077267|531207348|FG002|Treatment Period|Withdrawal by Subject|0|||
147284336|NCT05077267|531207346|FG000|Follow-up Period|Lost to Follow-up|0|||
147284337|NCT05077267|531207347|FG001|Follow-up Period|Lost to Follow-up|5|||
147284338|NCT05077267|531207348|FG002|Follow-up Period|Lost to Follow-up|7|||
147284339|NCT05077267|531207346|FG000|Follow-up Period|Withdrawal by Subject|0|||
147284340|NCT05077267|531207347|FG001|Follow-up Period|Withdrawal by Subject|2|||
147284341|NCT05077267|531207348|FG002|Follow-up Period|Withdrawal by Subject|5|||
147284342|NCT05077267|531207346|FG000|Follow-up Period|Study terminated by sponsor|0|||
147284343|NCT05077267|531207347|FG001|Follow-up Period|Study terminated by sponsor|27|||
147284344|NCT05077267|531207348|FG002|Follow-up Period|Study terminated by sponsor|23|||
147284345|NCT05077267|531207346|FG000|Follow-up Period|Received COVID-19 booster outside of trial|0|||
147284346|NCT05077267|531207347|FG001|Follow-up Period|Received COVID-19 booster outside of trial|66|||
147284347|NCT05077267|531207348|FG002|Follow-up Period|Received COVID-19 booster outside of trial|30|||
147284348|NCT05077267|531207346|FG000|Follow-up Period|Patient is busy at work and withdraws the IC|0|||
147284349|NCT05077267|531207347|FG001|Follow-up Period|Patient is busy at work and withdraws the IC|0|||
147284350|NCT05077267|531207348|FG002|Follow-up Period|Patient is busy at work and withdraws the IC|1|||
147284351|NCT01136291|531207357|FG000|Overall Study|Lost to Follow-up|1|||
147284352|NCT01136291|531207358|FG001|Overall Study|Lost to Follow-up|1|||
147284353|NCT03165045|531207363|FG000|Visit 1|No registration after visit 1|9|||
147284354|NCT03165045|531207363|FG000|Visit 1|No treatment documented|10|||
147284355|NCT03165045|531207363|FG000|Visit 1|No visit 1|10|||
147284356|NCT03165045|531207363|FG000|Visit 2|Available CCQ score at visit 1 only|109|||
147284357|NCT03165045|531207363|FG000|Visit 2|No available total CCQ score at all|29|||
147284358|NCT03165045|531207363|FG000|Visit 2|Available total CCQ score at vist 2 only|44|||
147284359|NCT01827904|531207364|FG000|Main Study|Withdrawal by Subject|1|||
147284360|NCT01827904|531207365|FG001|Main Study|Withdrawal by Subject|0|||
147284361|NCT01827904|531207366|FG002|Main Study|Withdrawal by Subject|0|||
147284362|NCT01827904|531207364|FG000|Main Study|Adverse Event|1|||
147284363|NCT01827904|531207365|FG001|Main Study|Adverse Event|0|||
147284364|NCT01827904|531207366|FG002|Main Study|Adverse Event|0|||
147284365|NCT01827904|531207364|FG000|Main Continuation / Crossover Phase|Alternative treatment|1|||
147284366|NCT01827904|531207365|FG001|Main Continuation / Crossover Phase|Alternative treatment|0|||
147284367|NCT01827904|531207366|FG002|Main Continuation / Crossover Phase|Alternative treatment|0|||
147284368|NCT01827904|531207364|FG000|Main Continuation / Crossover Phase|Withdrawal by Subject|1|||
147284369|NCT01827904|531207365|FG001|Main Continuation / Crossover Phase|Withdrawal by Subject|0|||
147284370|NCT01827904|531207366|FG002|Main Continuation / Crossover Phase|Withdrawal by Subject|0|||
147284371|NCT01827904|531207364|FG000|Main Continuation / Crossover Phase|Health reasons unrelated to study|1|||
147284372|NCT01827904|531207365|FG001|Main Continuation / Crossover Phase|Health reasons unrelated to study|0|||
147284373|NCT01827904|531207366|FG002|Main Continuation / Crossover Phase|Health reasons unrelated to study|0|||
147284374|NCT01827904|531207364|FG000|Long-term Annual Follow-up|Withdrawal by Subject|11|||
147284375|NCT01827904|531207365|FG001|Long-term Annual Follow-up|Withdrawal by Subject|0|||
147284376|NCT01827904|531207366|FG002|Long-term Annual Follow-up|Withdrawal by Subject|5|||
147284377|NCT01827904|531207364|FG000|Long-term Annual Follow-up|Alternative Treatment|4|||
147284378|NCT01827904|531207365|FG001|Long-term Annual Follow-up|Alternative Treatment|0|||
147284379|NCT01827904|531207366|FG002|Long-term Annual Follow-up|Alternative Treatment|1|||
147284380|NCT01827904|531207364|FG000|Long-term Annual Follow-up|Unrelated Health Reason|2|||
147284381|NCT01827904|531207365|FG001|Long-term Annual Follow-up|Unrelated Health Reason|0|||
147284382|NCT01827904|531207366|FG002|Long-term Annual Follow-up|Unrelated Health Reason|1|||
147284383|NCT01827904|531207364|FG000|Long-term Annual Follow-up|Lost to Follow-up|2|||
147284384|NCT01827904|531207365|FG001|Long-term Annual Follow-up|Lost to Follow-up|0|||
147284385|NCT01827904|531207366|FG002|Long-term Annual Follow-up|Lost to Follow-up|0|||
147284386|NCT01827904|531207364|FG000|Long-term Annual Follow-up|Physician Decision|1|||
147284387|NCT01827904|531207365|FG001|Long-term Annual Follow-up|Physician Decision|0|||
147284388|NCT01827904|531207366|FG002|Long-term Annual Follow-up|Physician Decision|0|||
147284389|NCT01827904|531207364|FG000|Long-term Annual Follow-up|Lack of Efficacy|1|||
147284390|NCT01827904|531207365|FG001|Long-term Annual Follow-up|Lack of Efficacy|0|||
147284391|NCT01827904|531207366|FG002|Long-term Annual Follow-up|Lack of Efficacy|0|||
147284392|NCT01827904|531207364|FG000|Long-term Annual Follow-up|Suboptimal Treatment|1|||
147284393|NCT01827904|531207365|FG001|Long-term Annual Follow-up|Suboptimal Treatment|0|||
147284394|NCT01827904|531207366|FG002|Long-term Annual Follow-up|Suboptimal Treatment|0|||
147284395|NCT00142909|531207372|FG000|Randomization|Various Reasons|7|||
147284396|NCT00142909|531207373|FG001|Randomization|Various Reasons|10|||
147284397|NCT00142909|531207372|FG000|Medications Begin|Protocol Violation|2|||
147337168|NCT05061693|531400117|FG007|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
147337169|NCT05061693|531400118|FG008|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
147337170|NCT05061693|531400119|FG009|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
147284398|NCT00142909|531207373|FG001|Medications Begin|Protocol Violation|0|||
147284399|NCT00142909|531207372|FG000|Medications Begin|Withdrawal by Subject|5|||
147284400|NCT00142909|531207373|FG001|Medications Begin|Withdrawal by Subject|3|||
147284401|NCT00142909|531207372|FG000|Medications Begin|Withdrawal by Subject|2|||
147284402|NCT00142909|531207373|FG001|Medications Begin|Withdrawal by Subject|0|||
147284403|NCT01870843|531207377|FG000|Overall Study|Adverse Event|10|||
147284404|NCT01870843|531207377|FG000|Overall Study|Lost to Follow-up|24|||
147284405|NCT01870843|531207377|FG000|Overall Study|Death|1|||
147284406|NCT01870843|531207377|FG000|Overall Study|Withdrawal by Subject|18|||
147284407|NCT02265237|531207378|FG000|As Treated (Overall Study)|Adverse Event|1|||
147284408|NCT02265237|531207379|FG001|As Treated (Overall Study)|Adverse Event|1|||
147284409|NCT02265237|531207380|FG002|As Treated (Overall Study)|Adverse Event|0|||
147452201|NCT00317109|531816545|FG001|Overall Study|Migated/moved from study area|0|||
147452202|NCT01026831|531816546|FG000|Overall Study|Adverse Event|4|||
147452203|NCT01026831|531816547|FG001|Overall Study|Adverse Event|3|||
147452204|NCT01026831|531816546|FG000|Overall Study|Lost to Follow-up|2|||
147452205|NCT01026831|531816547|FG001|Overall Study|Lost to Follow-up|0|||
147452206|NCT01026831|531816546|FG000|Overall Study|Physician Decision|1|||
147452207|NCT01026831|531816547|FG001|Overall Study|Physician Decision|1|||
147452208|NCT01026831|531816546|FG000|Overall Study|Protocol Violation|0|||
147452209|NCT01026831|531816547|FG001|Overall Study|Protocol Violation|2|||
147452210|NCT01026831|531816546|FG000|Overall Study|Withdrawal by Subject|7|||
147452211|NCT01026831|531816547|FG001|Overall Study|Withdrawal by Subject|5|||
147452212|NCT01079182|531816549|FG000|Overall Study|Lost to Follow-up|1634|||
147452213|NCT01079182|531816549|FG000|Overall Study|Adverse Drug Reaction (ADR)|261|||
147452214|NCT01079182|531816549|FG000|Overall Study|Lack of Efficacy|514|||
147452215|NCT01079182|531816549|FG000|Overall Study|ADR and Lack of Effectiveness|39|||
147452216|NCT01079182|531816549|FG000|Overall Study|Reasons not Evaluated|271|||
147452217|NCT01508702|531816550|FG000|Overall Study|Adverse Event|7|||
147452218|NCT01508702|531816551|FG001|Overall Study|Adverse Event|3|||
147452219|NCT01508702|531816550|FG000|Overall Study|Gout flare|2|||
147452220|NCT01508702|531816551|FG001|Overall Study|Gout flare|0|||
147452221|NCT01508702|531816550|FG000|Overall Study|Protocol Violation|2|||
147452222|NCT01508702|531816551|FG001|Overall Study|Protocol Violation|1|||
147452223|NCT01508702|531816550|FG000|Overall Study|Lost to Follow-up|1|||
147452224|NCT01508702|531816551|FG001|Overall Study|Lost to Follow-up|2|||
147452225|NCT01508702|531816550|FG000|Overall Study|Withdrawal by Subject|11|||
147452226|NCT01508702|531816551|FG001|Overall Study|Withdrawal by Subject|7|||
147452227|NCT00879697|531816552|FG000|Overall Study|Physician Decision|2|||
147452228|NCT00879697|531816553|FG001|Overall Study|Physician Decision|2|||
147452229|NCT02500121|531816554|FG000|Overall Study|Lost to Follow-up|0|||
147452230|NCT02500121|531816555|FG001|Overall Study|Lost to Follow-up|1|||
147452231|NCT02500121|531816554|FG000|Overall Study|Withdrawal by Subject|1|||
147452232|NCT02500121|531816555|FG001|Overall Study|Withdrawal by Subject|1|||
147452233|NCT02500121|531816554|FG000|Overall Study|Death|26|||
147452234|NCT02500121|531816555|FG001|Overall Study|Death|24|||
147452235|NCT01437397|531816557|FG000|Overall Study|Lost to Follow-up|9|||
147452236|NCT01437397|531816558|FG001|Overall Study|Lost to Follow-up|4|||
147452237|NCT01437397|531816559|FG002|Overall Study|Lost to Follow-up|2|||
147452238|NCT01437397|531816560|FG003|Overall Study|Lost to Follow-up|4|||
147452239|NCT01437397|531816561|FG004|Overall Study|Lost to Follow-up|5|||
147452240|NCT01437397|531816557|FG000|Overall Study|Withdrawal by Subject|11|||
147452241|NCT01437397|531816558|FG001|Overall Study|Withdrawal by Subject|12|||
147452242|NCT01437397|531816559|FG002|Overall Study|Withdrawal by Subject|24|||
147452243|NCT01437397|531816560|FG003|Overall Study|Withdrawal by Subject|11|||
147452244|NCT01437397|531816561|FG004|Overall Study|Withdrawal by Subject|22|||
147452245|NCT01437397|531816557|FG000|Overall Study|Protocol Violation|10|||
147452246|NCT01437397|531816558|FG001|Overall Study|Protocol Violation|12|||
147452247|NCT01437397|531816559|FG002|Overall Study|Protocol Violation|13|||
147452248|NCT01437397|531816560|FG003|Overall Study|Protocol Violation|21|||
147452249|NCT01437397|531816561|FG004|Overall Study|Protocol Violation|19|||
147452250|NCT01437397|531816557|FG000|Overall Study|Lack of Efficacy|5|||
147452251|NCT01437397|531816558|FG001|Overall Study|Lack of Efficacy|4|||
147452252|NCT01437397|531816559|FG002|Overall Study|Lack of Efficacy|8|||
147452253|NCT01437397|531816560|FG003|Overall Study|Lack of Efficacy|10|||
147452254|NCT01437397|531816561|FG004|Overall Study|Lack of Efficacy|20|||
147452255|NCT01437397|531816557|FG000|Overall Study|Adverse Event|21|||
147452256|NCT01437397|531816558|FG001|Overall Study|Adverse Event|22|||
147452257|NCT01437397|531816559|FG002|Overall Study|Adverse Event|16|||
147452258|NCT01437397|531816560|FG003|Overall Study|Adverse Event|14|||
147452259|NCT01437397|531816561|FG004|Overall Study|Adverse Event|21|||
147452260|NCT01437397|531816557|FG000|Overall Study|Site termination/COPD exacerbation/other|10|||
147452261|NCT01437397|531816558|FG001|Overall Study|Site termination/COPD exacerbation/other|8|||
147452262|NCT01437397|531816559|FG002|Overall Study|Site termination/COPD exacerbation/other|9|||
147452263|NCT01437397|531816560|FG003|Overall Study|Site termination/COPD exacerbation/other|9|||
147284410|NCT02265237|531207381|FG003|As Treated (Overall Study)|Adverse Event|0|||
147452264|NCT01437397|531816561|FG004|Overall Study|Site termination/COPD exacerbation/other|14|||
147452265|NCT00903175|531816562|FG000|Period 1 - First Line|Adverse Event|36|||
147452266|NCT00903175|531816563|FG001|Period 1 - First Line|Adverse Event|50|||
147452267|NCT00903175|531816562|FG000|Period 1 - First Line|Abnormal lab value(s)|0|||
147452268|NCT00903175|531816563|FG001|Period 1 - First Line|Abnormal lab value(s)|1|||
147452269|NCT00903175|531816562|FG000|Period 1 - First Line|Abnormal test procedure result(s)|1|||
147337171|NCT05061693|531400120|FG010|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
147337172|NCT05061693|531400121|FG011|16-week Placebo-controlled (PC) Period|Protocol Violation|0|||
147337173|NCT05061693|531400110|FG000|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|2|||
147337174|NCT05061693|531400111|FG001|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|4|||
147337175|NCT05061693|531400112|FG002|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|2|||
147337176|NCT05061693|531400113|FG003|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|2|||
147337177|NCT05061693|531400114|FG004|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
147337178|NCT05061693|531400115|FG005|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
147337179|NCT05061693|531400116|FG006|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
147337180|NCT05061693|531400117|FG007|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
147337181|NCT05061693|531400118|FG008|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
147337182|NCT05061693|531400119|FG009|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
147337183|NCT05061693|531400120|FG010|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
147337184|NCT05061693|531400121|FG011|16-week Placebo-controlled (PC) Period|Withdrawal by Subject|0|||
147337185|NCT05061693|531400110|FG000|24-week Extension Period|Adverse Event|0|||
147337186|NCT05061693|531400111|FG001|24-week Extension Period|Adverse Event|0|||
147337187|NCT05061693|531400112|FG002|24-week Extension Period|Adverse Event|0|||
147337188|NCT05061693|531400113|FG003|24-week Extension Period|Adverse Event|0|||
147337189|NCT05061693|531400114|FG004|24-week Extension Period|Adverse Event|0|||
147337190|NCT05061693|531400115|FG005|24-week Extension Period|Adverse Event|0|||
147337191|NCT05061693|531400116|FG006|24-week Extension Period|Adverse Event|0|||
147337192|NCT05061693|531400117|FG007|24-week Extension Period|Adverse Event|2|||
147337193|NCT05061693|531400118|FG008|24-week Extension Period|Adverse Event|2|||
147337194|NCT05061693|531400119|FG009|24-week Extension Period|Adverse Event|0|||
147337195|NCT05061693|531400120|FG010|24-week Extension Period|Adverse Event|1|||
147337196|NCT05061693|531400121|FG011|24-week Extension Period|Adverse Event|3|||
147337197|NCT05061693|531400110|FG000|24-week Extension Period|Lack of Efficacy|0|||
147452270|NCT00903175|531816563|FG001|Period 1 - First Line|Abnormal test procedure result(s)|0|||
147452271|NCT00903175|531816562|FG000|Period 1 - First Line|Protocol Violation|3|||
147452272|NCT00903175|531816563|FG001|Period 1 - First Line|Protocol Violation|3|||
147337198|NCT05061693|531400111|FG001|24-week Extension Period|Lack of Efficacy|0|||
147337199|NCT05061693|531400112|FG002|24-week Extension Period|Lack of Efficacy|0|||
147337200|NCT05061693|531400113|FG003|24-week Extension Period|Lack of Efficacy|0|||
147337201|NCT05061693|531400114|FG004|24-week Extension Period|Lack of Efficacy|0|||
147337202|NCT05061693|531400115|FG005|24-week Extension Period|Lack of Efficacy|0|||
147337203|NCT05061693|531400116|FG006|24-week Extension Period|Lack of Efficacy|0|||
147337204|NCT05061693|531400117|FG007|24-week Extension Period|Lack of Efficacy|0|||
147337205|NCT05061693|531400118|FG008|24-week Extension Period|Lack of Efficacy|0|||
147337206|NCT05061693|531400119|FG009|24-week Extension Period|Lack of Efficacy|0|||
147337207|NCT05061693|531400120|FG010|24-week Extension Period|Lack of Efficacy|2|||
147337208|NCT05061693|531400121|FG011|24-week Extension Period|Lack of Efficacy|0|||
147452273|NCT00903175|531816562|FG000|Period 1 - First Line|Withdrawal by Subject|8|||
147452274|NCT00903175|531816563|FG001|Period 1 - First Line|Withdrawal by Subject|12|||
147452275|NCT00903175|531816562|FG000|Period 1 - First Line|Administrative problems|12|||
147452276|NCT00903175|531816563|FG001|Period 1 - First Line|Administrative problems|13|||
147452277|NCT00903175|531816562|FG000|Period 1 - First Line|Death|17|||
147452278|NCT00903175|531816563|FG001|Period 1 - First Line|Death|10|||
147452279|NCT00903175|531816562|FG000|Period 2 - Second Line|Missing|1|||
147452280|NCT00903175|531816563|FG001|Period 2 - Second Line|Missing|0|||
147452281|NCT00903175|531816562|FG000|Period 2 - Second Line|Adverse Event|16|||
147452282|NCT00903175|531816563|FG001|Period 2 - Second Line|Adverse Event|20|||
147452283|NCT00903175|531816562|FG000|Period 2 - Second Line|Withdrawal by Subject|7|||
147452284|NCT00903175|531816563|FG001|Period 2 - Second Line|Withdrawal by Subject|5|||
147452285|NCT00903175|531816562|FG000|Period 2 - Second Line|Lost to Follow-up|1|||
147452286|NCT00903175|531816563|FG001|Period 2 - Second Line|Lost to Follow-up|0|||
147337209|NCT05061693|531400110|FG000|24-week Extension Period|Lost to Follow-up|0|||
147337210|NCT05061693|531400111|FG001|24-week Extension Period|Lost to Follow-up|0|||
147337211|NCT05061693|531400112|FG002|24-week Extension Period|Lost to Follow-up|0|||
147337212|NCT05061693|531400113|FG003|24-week Extension Period|Lost to Follow-up|0|||
147337213|NCT05061693|531400114|FG004|24-week Extension Period|Lost to Follow-up|0|||
147337214|NCT05061693|531400115|FG005|24-week Extension Period|Lost to Follow-up|0|||
147337215|NCT05061693|531400116|FG006|24-week Extension Period|Lost to Follow-up|1|||
147337216|NCT05061693|531400117|FG007|24-week Extension Period|Lost to Follow-up|0|||
147337217|NCT05061693|531400118|FG008|24-week Extension Period|Lost to Follow-up|1|||
147337218|NCT05061693|531400119|FG009|24-week Extension Period|Lost to Follow-up|1|||
147337219|NCT05061693|531400120|FG010|24-week Extension Period|Lost to Follow-up|0|||
147452287|NCT00903175|531816562|FG000|Period 2 - Second Line|Administrative problems|19|||
147452288|NCT00903175|531816563|FG001|Period 2 - Second Line|Administrative problems|9|||
147452289|NCT00903175|531816562|FG000|Period 2 - Second Line|Death|5|||
147452290|NCT00903175|531816563|FG001|Period 2 - Second Line|Death|2|||
147452291|NCT03074474|531816564|FG000|Overall Study|Lost to Follow-up|10|||
147604095|NCT01775189|532367829|FG002|Treatment Phase: Washout Period 1|Protocol Violation|0|||
147604096|NCT01775189|532367830|FG003|Treatment Phase: Washout Period 1|Protocol Violation|0|||
147604097|NCT01775189|532367831|FG004|Treatment Phase: Washout Period 1|Protocol Violation|0|||
147604098|NCT01775189|532367832|FG005|Treatment Phase: Washout Period 1|Protocol Violation|1|||
147604099|NCT01775189|532367833|FG006|Treatment Phase: Washout Period 1|Protocol Violation|0|||
147284411|NCT02265237|531207378|FG000|As Treated (Overall Study)|Withdrawal by Subject|1|||
147284412|NCT02265237|531207379|FG001|As Treated (Overall Study)|Withdrawal by Subject|0|||
147284413|NCT02265237|531207380|FG002|As Treated (Overall Study)|Withdrawal by Subject|1|||
147284414|NCT02265237|531207381|FG003|As Treated (Overall Study)|Withdrawal by Subject|0|||
147284415|NCT02265237|531207378|FG000|As Treated (Overall Study)|Lost to Follow-up|1|||
147284416|NCT02265237|531207379|FG001|As Treated (Overall Study)|Lost to Follow-up|2|||
147284417|NCT02265237|531207380|FG002|As Treated (Overall Study)|Lost to Follow-up|6|||
147284418|NCT02265237|531207381|FG003|As Treated (Overall Study)|Lost to Follow-up|0|||
147284419|NCT02265237|531207378|FG000|As Treated (Overall Study)|Other|2|||
147284420|NCT02265237|531207379|FG001|As Treated (Overall Study)|Other|0|||
147284421|NCT02265237|531207380|FG002|As Treated (Overall Study)|Other|3|||
147284422|NCT02265237|531207381|FG003|As Treated (Overall Study)|Other|1|||
147284423|NCT01178853|531207383|FG000|Period 1 (Warfarin Titration)|INR Out of Range|1|||
147284424|NCT01178853|531207384|FG001|Period 1 (Warfarin Titration)|INR Out of Range|2|||
147284425|NCT01178853|531207383|FG000|Period 2 (Warfarin + Study Drug)|Withdrawal by Subject|1|||
147284426|NCT01178853|531207384|FG001|Period 2 (Warfarin + Study Drug)|Withdrawal by Subject|0|||
147284427|NCT01178853|531207383|FG000|Period 3 (Warfarin Titration)|Adverse Event|1|||
147604100|NCT01775189|532367827|FG000|Treatment Phase: Washout Period 2|Protocol Violation|0|||
147604101|NCT01775189|532367828|FG001|Treatment Phase: Washout Period 2|Protocol Violation|0|||
147604102|NCT01775189|532367829|FG002|Treatment Phase: Washout Period 2|Protocol Violation|0|||
147284428|NCT01178853|531207384|FG001|Period 3 (Warfarin Titration)|Adverse Event|0|||
147284429|NCT01178853|531207383|FG000|Period 4 (Warfarin + Study Drug)|Adverse Event|0|||
147284430|NCT01178853|531207384|FG001|Period 4 (Warfarin + Study Drug)|Adverse Event|2|||
147284431|NCT01178853|531207383|FG000|Period 4 (Warfarin + Study Drug)|Withdrawal by Subject|0|||
147284432|NCT01178853|531207384|FG001|Period 4 (Warfarin + Study Drug)|Withdrawal by Subject|1|||
147284433|NCT03550313|531207385|FG000|Overall Study|Adverse Event|0|||
147284434|NCT03550313|531207386|FG001|Overall Study|Adverse Event|1|||
147284435|NCT03550313|531207387|FG002|Overall Study|Adverse Event|0|||
147284436|NCT03550313|531207385|FG000|Overall Study|Lost to Follow-up|5|||
147284437|NCT03550313|531207386|FG001|Overall Study|Lost to Follow-up|7|||
147284438|NCT03550313|531207387|FG002|Overall Study|Lost to Follow-up|12|||
147284439|NCT03550313|531207385|FG000|Overall Study|Study terminated by sponsor|44|||
147284440|NCT03550313|531207386|FG001|Overall Study|Study terminated by sponsor|37|||
147284441|NCT03550313|531207387|FG002|Overall Study|Study terminated by sponsor|48|||
147284442|NCT03550313|531207385|FG000|Overall Study|No longer met eligibility criteria|3|||
147284443|NCT03550313|531207386|FG001|Overall Study|No longer met eligibility criteria|5|||
147284444|NCT03550313|531207387|FG002|Overall Study|No longer met eligibility criteria|6|||
147284445|NCT03550313|531207385|FG000|Overall Study|Withdrawal by parent/guardian|20|||
147284446|NCT03550313|531207386|FG001|Overall Study|Withdrawal by parent/guardian|18|||
147284447|NCT03550313|531207387|FG002|Overall Study|Withdrawal by parent/guardian|26|||
147284448|NCT03550313|531207385|FG000|Overall Study|Other|4|||
147284449|NCT03550313|531207386|FG001|Overall Study|Other|2|||
147284450|NCT03550313|531207387|FG002|Overall Study|Other|2|||
147284451|NCT03550313|531207385|FG000|Overall Study|Randomized but not vaccinated|3|||
147284452|NCT03550313|531207386|FG001|Overall Study|Randomized but not vaccinated|23|||
147284453|NCT03550313|531207387|FG002|Overall Study|Randomized but not vaccinated|2|||
147284454|NCT03550313|531207385|FG000|Overall Study|Sites terminated due to quality issues|18|||
147284455|NCT03550313|531207386|FG001|Overall Study|Sites terminated due to quality issues|17|||
147284456|NCT03550313|531207387|FG002|Overall Study|Sites terminated due to quality issues|18|||
147284457|NCT00839072|531207388|FG000|First Intervention Period|Withdrawal by Subject|1|||
147284458|NCT00839072|531207389|FG001|First Intervention Period|Withdrawal by Subject|0|||
147284459|NCT00839072|531207388|FG000|First Intervention Period|Adverse Event|1|||
147284460|NCT00839072|531207389|FG001|First Intervention Period|Adverse Event|1|||
147284461|NCT00839072|531207388|FG000|Second Intervention Period|Withdrawal by Subject|1|||
147284462|NCT00839072|531207389|FG001|Second Intervention Period|Withdrawal by Subject|0|||
147284463|NCT01682837|531207390|FG000|Baseline|Withdrawal by Subject|5|||
147284464|NCT04782323|531207391|FG000|Overall Study|Death|1|||
147284465|NCT04782323|531207392|FG001|Overall Study|Death|0|||
147284466|NCT04782323|531207393|FG002|Overall Study|Death|0|||
147284467|NCT04782323|531207394|FG003|Overall Study|Death|0|||
147284468|NCT04782323|531207395|FG004|Overall Study|Death|1|||
147284469|NCT04782323|531207396|FG005|Overall Study|Death|1|||
147284470|NCT04782323|531207397|FG006|Overall Study|Death|1|||
147284471|NCT04782323|531207398|FG007|Overall Study|Death|0|||
147284472|NCT04782323|531207391|FG000|Overall Study|Withdrawal by Subject|0|||
147284473|NCT04782323|531207392|FG001|Overall Study|Withdrawal by Subject|0|||
147284474|NCT04782323|531207393|FG002|Overall Study|Withdrawal by Subject|1|||
147284475|NCT04782323|531207394|FG003|Overall Study|Withdrawal by Subject|0|||
147284476|NCT04782323|531207395|FG004|Overall Study|Withdrawal by Subject|0|||
147284477|NCT04782323|531207396|FG005|Overall Study|Withdrawal by Subject|1|||
147284478|NCT04782323|531207397|FG006|Overall Study|Withdrawal by Subject|0|||
147284479|NCT04782323|531207398|FG007|Overall Study|Withdrawal by Subject|1|||
147284480|NCT04782323|531207391|FG000|Overall Study|Lost to Follow-up|0|||
147284481|NCT04782323|531207392|FG001|Overall Study|Lost to Follow-up|1|||
147284482|NCT04782323|531207393|FG002|Overall Study|Lost to Follow-up|1|||
147284483|NCT04782323|531207394|FG003|Overall Study|Lost to Follow-up|0|||
147284484|NCT04782323|531207395|FG004|Overall Study|Lost to Follow-up|0|||
147284485|NCT04782323|531207396|FG005|Overall Study|Lost to Follow-up|1|||
147284486|NCT04782323|531207397|FG006|Overall Study|Lost to Follow-up|1|||
147284487|NCT04782323|531207398|FG007|Overall Study|Lost to Follow-up|2|||
147284488|NCT04782323|531207391|FG000|Overall Study|randomization in error|1|||
147284489|NCT04782323|531207392|FG001|Overall Study|randomization in error|0|||
147284490|NCT04782323|531207393|FG002|Overall Study|randomization in error|0|||
147284491|NCT04782323|531207394|FG003|Overall Study|randomization in error|0|||
147284492|NCT04782323|531207395|FG004|Overall Study|randomization in error|0|||
147284493|NCT04782323|531207396|FG005|Overall Study|randomization in error|0|||
147337220|NCT05061693|531400121|FG011|24-week Extension Period|Lost to Follow-up|0|||
147337221|NCT05061693|531400110|FG000|24-week Extension Period|Withdrawal by Subject|0|||
147337222|NCT05061693|531400111|FG001|24-week Extension Period|Withdrawal by Subject|0|||
147337223|NCT05061693|531400112|FG002|24-week Extension Period|Withdrawal by Subject|0|||
147284494|NCT04782323|531207397|FG006|Overall Study|randomization in error|0|||
147284495|NCT04782323|531207398|FG007|Overall Study|randomization in error|0|||
147284496|NCT04369469|531207399|FG000|Overall Study|Lost to Follow-up|2|||
147284497|NCT04369469|531207400|FG001|Overall Study|Lost to Follow-up|4|||
147284498|NCT04369469|531207399|FG000|Overall Study|Physician Decision|2|||
147284499|NCT04369469|531207400|FG001|Overall Study|Physician Decision|1|||
147284500|NCT04369469|531207399|FG000|Overall Study|Withdrawal by Subject|2|||
147284501|NCT04369469|531207400|FG001|Overall Study|Withdrawal by Subject|3|||
147284502|NCT04369469|531207399|FG000|Overall Study|Adverse Event|1|||
147284503|NCT04369469|531207400|FG001|Overall Study|Adverse Event|0|||
147284504|NCT04369469|531207399|FG000|Overall Study|Did Not Meet Inclusion/Exclusion Criteria|2|||
147284505|NCT04369469|531207400|FG001|Overall Study|Did Not Meet Inclusion/Exclusion Criteria|0|||
147284506|NCT04369469|531207399|FG000|Overall Study|Not Qualified due to History of Anaphylaxis|1|||
147284507|NCT04369469|531207400|FG001|Overall Study|Not Qualified due to History of Anaphylaxis|0|||
147284508|NCT04369469|531207399|FG000|Overall Study|Unable to Provide Consent|0|||
147284509|NCT04369469|531207400|FG001|Overall Study|Unable to Provide Consent|1|||
147284510|NCT01165281|531207401|FG000|Overall Study|Adverse Event|12|||
147284511|NCT01165281|531207402|FG001|Overall Study|Adverse Event|14|||
147284512|NCT01165281|531207401|FG000|Overall Study|Death|3|||
147284513|NCT01165281|531207402|FG001|Overall Study|Death|4|||
147284514|NCT01165281|531207401|FG000|Overall Study|Lack of Efficacy|4|||
147284515|NCT01165281|531207402|FG001|Overall Study|Lack of Efficacy|1|||
147284516|NCT01165281|531207401|FG000|Overall Study|Lost to Follow-up|0|||
147284517|NCT01165281|531207402|FG001|Overall Study|Lost to Follow-up|1|||
147284518|NCT01165281|531207401|FG000|Overall Study|Physician Decision|8|||
147337224|NCT05061693|531400113|FG003|24-week Extension Period|Withdrawal by Subject|0|||
147337225|NCT05061693|531400114|FG004|24-week Extension Period|Withdrawal by Subject|0|||
147337226|NCT05061693|531400115|FG005|24-week Extension Period|Withdrawal by Subject|0|||
147337227|NCT05061693|531400116|FG006|24-week Extension Period|Withdrawal by Subject|0|||
147337228|NCT05061693|531400117|FG007|24-week Extension Period|Withdrawal by Subject|0|||
147337229|NCT05061693|531400118|FG008|24-week Extension Period|Withdrawal by Subject|1|||
147337230|NCT05061693|531400119|FG009|24-week Extension Period|Withdrawal by Subject|2|||
147337231|NCT05061693|531400120|FG010|24-week Extension Period|Withdrawal by Subject|2|||
147337232|NCT05061693|531400121|FG011|24-week Extension Period|Withdrawal by Subject|1|||
147337233|NCT05061693|531400110|FG000|24-week Extension Period|Sponsor Decision|0|||
147337234|NCT05061693|531400111|FG001|24-week Extension Period|Sponsor Decision|0|||
147337235|NCT05061693|531400112|FG002|24-week Extension Period|Sponsor Decision|0|||
147337236|NCT05061693|531400113|FG003|24-week Extension Period|Sponsor Decision|0|||
147337237|NCT05061693|531400114|FG004|24-week Extension Period|Sponsor Decision|0|||
147337238|NCT05061693|531400115|FG005|24-week Extension Period|Sponsor Decision|0|||
147337239|NCT05061693|531400116|FG006|24-week Extension Period|Sponsor Decision|0|||
147337240|NCT05061693|531400117|FG007|24-week Extension Period|Sponsor Decision|1|||
147337241|NCT05061693|531400118|FG008|24-week Extension Period|Sponsor Decision|0|||
147284519|NCT01165281|531207402|FG001|Overall Study|Physician Decision|1|||
147284520|NCT01165281|531207401|FG000|Overall Study|Protocol Violation|6|||
147284521|NCT01165281|531207402|FG001|Overall Study|Protocol Violation|5|||
147284522|NCT01165281|531207401|FG000|Overall Study|Withdrawal by Subject|8|||
147337242|NCT05061693|531400119|FG009|24-week Extension Period|Sponsor Decision|0|||
147284523|NCT01165281|531207402|FG001|Overall Study|Withdrawal by Subject|7|||
147284524|NCT01165281|531207401|FG000|Overall Study|Noncompliance with Study Drug|1|||
147284525|NCT01165281|531207402|FG001|Overall Study|Noncompliance with Study Drug|4|||
147284526|NCT01165281|531207401|FG000|Overall Study|Progressive Disease|10|||
147284527|NCT01165281|531207402|FG001|Overall Study|Progressive Disease|14|||
147337243|NCT05061693|531400120|FG010|24-week Extension Period|Sponsor Decision|0|||
147284528|NCT01165281|531207401|FG000|Overall Study|Other|6|||
147284529|NCT01165281|531207402|FG001|Overall Study|Other|0|||
147284530|NCT02863991|531207403|FG000|Overall Study|Death|0|||
147284531|NCT02863991|531207404|FG001|Overall Study|Death|3|||
147284532|NCT02863991|531207403|FG000|Overall Study|Lack of Efficacy|0|||
147284533|NCT02863991|531207404|FG001|Overall Study|Lack of Efficacy|1|||
147284534|NCT02863991|531207403|FG000|Overall Study|Study Terminated|2|||
147284535|NCT02863991|531207404|FG001|Overall Study|Study Terminated|8|||
147337244|NCT05061693|531400121|FG011|24-week Extension Period|Sponsor Decision|0|||
147337245|NCT05061693|531400110|FG000|24-week Extension Period|Site Closure|0|||
147337246|NCT05061693|531400111|FG001|24-week Extension Period|Site Closure|0|||
147337247|NCT05061693|531400112|FG002|24-week Extension Period|Site Closure|0|||
147337248|NCT05061693|531400113|FG003|24-week Extension Period|Site Closure|0|||
147337249|NCT05061693|531400114|FG004|24-week Extension Period|Site Closure|0|||
147337250|NCT05061693|531400115|FG005|24-week Extension Period|Site Closure|0|||
147337251|NCT05061693|531400116|FG006|24-week Extension Period|Site Closure|0|||
147337252|NCT05061693|531400117|FG007|24-week Extension Period|Site Closure|0|||
147337253|NCT05061693|531400118|FG008|24-week Extension Period|Site Closure|1|||
147337254|NCT05061693|531400119|FG009|24-week Extension Period|Site Closure|0|||
147337255|NCT05061693|531400120|FG010|24-week Extension Period|Site Closure|0|||
147337256|NCT05061693|531400121|FG011|24-week Extension Period|Site Closure|1|||
147337257|NCT00658996|531400128|FG000|First Intervention|Positive slit lamp finding|1|||
147337258|NCT00658996|531400129|FG001|First Intervention|Positive slit lamp finding|0|||
147337259|NCT00658996|531400128|FG000|First Intervention|Lack of lenses|0|||
147337260|NCT00658996|531400129|FG001|First Intervention|Lack of lenses|1|||
147337261|NCT00658996|531400128|FG000|Crossover Period|Physician Decision|1|||
147337262|NCT00658996|531400129|FG001|Crossover Period|Physician Decision|0|||
147337263|NCT00658996|531400128|FG000|Crossover Period|Ineligible|1|||
147337264|NCT00658996|531400129|FG001|Crossover Period|Ineligible|1|||
147337265|NCT00658996|531400128|FG000|Second Intervention|Developed a stye on upper lid|1|||
147337266|NCT00658996|531400129|FG001|Second Intervention|Developed a stye on upper lid|0|||
147337267|NCT00658996|531400128|FG000|Second Intervention|Positive slit lamp finding|0|||
147337268|NCT00658996|531400129|FG001|Second Intervention|Positive slit lamp finding|1|||
147337269|NCT02994654|531400130|FG000|Overall Study|Lost to Follow-up|1|||
147337270|NCT03603717|531400133|FG000|Overall Study|Lost to Follow-up|20|||
147337271|NCT03603717|531400134|FG001|Overall Study|Lost to Follow-up|20|||
147337272|NCT03603717|531400133|FG000|Overall Study|Withdrawal by Subject|16|||
147337273|NCT03603717|531400134|FG001|Overall Study|Withdrawal by Subject|10|||
147337274|NCT01353963|531400135|FG000|Overall Study|Adverse Event|2|||
147337275|NCT05777785|531401411|FG000|Overall Study|Withdrawal by Subject|5|||
147337276|NCT05777785|531401411|FG000|Overall Study|Lost to Follow-up|1|||
147337277|NCT05644444|531401416|FG000|Tolerance Phase|Adverse Event|0|||
147337278|NCT05644444|531401417|FG001|Tolerance Phase|Adverse Event|2|||
147337279|NCT05644444|531401416|FG000|Treatment Phase|Adverse Event|0|||
147337280|NCT05644444|531401417|FG001|Treatment Phase|Adverse Event|2|||
147337281|NCT04817670|531401418|FG000|Overall Study|Withdrawal by Subject|1|||
147337282|NCT04817670|531401419|FG001|Overall Study|Withdrawal by Subject|0|||
147337283|NCT04817670|531401420|FG002|Overall Study|Withdrawal by Subject|0|||
147337284|NCT04817670|531401421|FG003|Overall Study|Withdrawal by Subject|0|||
147337285|NCT04817670|531401422|FG004|Overall Study|Withdrawal by Subject|0|||
147337286|NCT04817670|531401418|FG000|Overall Study|Lost to Follow-up|0|||
147337287|NCT04817670|531401419|FG001|Overall Study|Lost to Follow-up|0|||
147337288|NCT04817670|531401420|FG002|Overall Study|Lost to Follow-up|1|||
147337289|NCT04817670|531401421|FG003|Overall Study|Lost to Follow-up|0|||
147337290|NCT04817670|531401422|FG004|Overall Study|Lost to Follow-up|0|||
147337291|NCT02396316|531401425|FG000|Overall Study|Physician Decision|1|||
147337292|NCT02396316|531401426|FG001|Overall Study|Physician Decision|0|||
147337293|NCT02396316|531401425|FG000|Overall Study|Progressive disease|6|||
147337294|NCT02396316|531401426|FG001|Overall Study|Progressive disease|3|||
147337295|NCT02396316|531401425|FG000|Overall Study|Protocol Violation|0|||
147337296|NCT02396316|531401426|FG001|Overall Study|Protocol Violation|1|||
147337297|NCT02396316|531401425|FG000|Overall Study|Treatment unblinded|0|||
147337298|NCT02396316|531401426|FG001|Overall Study|Treatment unblinded|1|||
147337299|NCT00714714|531401438|FG000|Overall Study|Adverse Event|1|||
147337300|NCT01185561|531401439|FG000|Overall Study|Lost to Follow-up|0|||
147337301|NCT01185561|531401440|FG001|Overall Study|Lost to Follow-up|4|||
147337302|NCT01185561|531401439|FG000|Overall Study|Withdrawal by Subject|2|||
147337303|NCT01185561|531401440|FG001|Overall Study|Withdrawal by Subject|8|||
147337304|NCT01078116|531401441|FG000|Overall Study|Lost to Follow-up|17|||
147337305|NCT01078116|531401441|FG000|Overall Study|Adverse Event|5|||
147337306|NCT01078116|531401441|FG000|Overall Study|Withdrawal by Subject|8|||
147337307|NCT01078116|531401441|FG000|Overall Study|Lack of effectiveness|15|||
147337308|NCT01078116|531401441|FG000|Overall Study|Case report form not completed|3|||
147337309|NCT02616900|531401442|FG000|Overall Study|Lack of Efficacy|7|||
147337310|NCT02616900|531401442|FG000|Overall Study|Lost to Follow-up|2|||
147337311|NCT02616900|531401442|FG000|Overall Study|Protocol Violation|5|||
147337312|NCT02616900|531401442|FG000|Overall Study|Withdrawal by Subject|3|||
147337313|NCT02616900|531401442|FG000|Overall Study|Incomplete data|6|||
147284536|NCT00364858|531207409|FG000|Overall Study|Adverse Event|1|||
147284537|NCT00364858|531207410|FG001|Overall Study|Adverse Event|5|||
147284538|NCT00364858|531207409|FG000|Overall Study|Withdrawal by Subject|1|||
147284539|NCT00364858|531207410|FG001|Overall Study|Withdrawal by Subject|1|||
147284540|NCT00364858|531207409|FG000|Overall Study|Pregnancy|1|||
147284541|NCT00364858|531207410|FG001|Overall Study|Pregnancy|1|||
147284542|NCT00364858|531207409|FG000|Overall Study|Clinical failure|2|||
147284543|NCT00364858|531207410|FG001|Overall Study|Clinical failure|13|||
147284544|NCT00364858|531207409|FG000|Overall Study|Discontinuation at baseline|1|||
147284545|NCT00364858|531207410|FG001|Overall Study|Discontinuation at baseline|0|||
147284546|NCT00364858|531207409|FG000|Overall Study|Non-compliant|1|||
147284547|NCT00364858|531207410|FG001|Overall Study|Non-compliant|0|||
147284548|NCT00364858|531207409|FG000|Overall Study|Return to Q2 regimen|0|||
147284549|NCT00364858|531207410|FG001|Overall Study|Return to Q2 regimen|1|||
147284550|NCT00364858|531207409|FG000|Overall Study|Clinical baseline issue|0|||
147284551|NCT00364858|531207410|FG001|Overall Study|Clinical baseline issue|1|||
147284552|NCT01307501|531207411|FG000|Overall Study|Treatment Failure|1|||
147284553|NCT01307501|531207411|FG000|Overall Study|Death|20|||
147284554|NCT01307501|531207411|FG000|Overall Study|Lost to Follow-up|1|||
147284555|NCT01307501|531207411|FG000|Overall Study|Starting Hospice|1|||
147284556|NCT00363766|531207412|FG000|Overall Study|Progressive Disease|15|||
147284557|NCT00363766|531207413|FG001|Overall Study|Progressive Disease|9|||
147284558|NCT00363766|531207412|FG000|Overall Study|Adverse Event|10|||
147284559|NCT00363766|531207413|FG001|Overall Study|Adverse Event|2|||
147284560|NCT00363766|531207412|FG000|Overall Study|Disease Related Death|1|||
147284561|NCT00363766|531207413|FG001|Overall Study|Disease Related Death|3|||
147284562|NCT00363766|531207412|FG000|Overall Study|Not Disease Related Death|3|||
147284563|NCT00363766|531207413|FG001|Overall Study|Not Disease Related Death|4|||
147284564|NCT00363766|531207412|FG000|Overall Study|Withdrawal by Subject|2|||
147284565|NCT00363766|531207413|FG001|Overall Study|Withdrawal by Subject|0|||
147284566|NCT00363766|531207412|FG000|Overall Study|Physician Decision|1|||
147284567|NCT00363766|531207413|FG001|Overall Study|Physician Decision|2|||
147284568|NCT00558285|531207414|FG000|Overall Study|Adverse Event|1|||
147284569|NCT00558285|531207415|FG001|Overall Study|Adverse Event|1|||
147284570|NCT00558285|531207416|FG002|Overall Study|Adverse Event|4|||
147284571|NCT00558285|531207417|FG003|Overall Study|Adverse Event|1|||
147284572|NCT00558285|531207418|FG004|Overall Study|Adverse Event|2|||
147284573|NCT00558285|531207414|FG000|Overall Study|Abnormal test procedure result(s)|1|||
147284574|NCT00558285|531207415|FG001|Overall Study|Abnormal test procedure result(s)|0|||
147284575|NCT00558285|531207416|FG002|Overall Study|Abnormal test procedure result(s)|0|||
147284576|NCT00558285|531207417|FG003|Overall Study|Abnormal test procedure result(s)|0|||
147284577|NCT00558285|531207418|FG004|Overall Study|Abnormal test procedure result(s)|0|||
147284578|NCT00558285|531207414|FG000|Overall Study|Subject withdrew consent|2|||
147284579|NCT00558285|531207415|FG001|Overall Study|Subject withdrew consent|0|||
147284580|NCT00558285|531207416|FG002|Overall Study|Subject withdrew consent|1|||
147284581|NCT00558285|531207417|FG003|Overall Study|Subject withdrew consent|1|||
147284582|NCT00558285|531207418|FG004|Overall Study|Subject withdrew consent|1|||
147284583|NCT00558285|531207414|FG000|Overall Study|Lost to Follow-up|1|||
147284584|NCT00558285|531207415|FG001|Overall Study|Lost to Follow-up|1|||
147284585|NCT00558285|531207416|FG002|Overall Study|Lost to Follow-up|0|||
147284586|NCT00558285|531207417|FG003|Overall Study|Lost to Follow-up|0|||
147284587|NCT00558285|531207418|FG004|Overall Study|Lost to Follow-up|0|||
147284588|NCT00558285|531207414|FG000|Overall Study|Administrative problems|0|||
147284589|NCT00558285|531207415|FG001|Overall Study|Administrative problems|0|||
147284590|NCT00558285|531207416|FG002|Overall Study|Administrative problems|0|||
147284591|NCT00558285|531207417|FG003|Overall Study|Administrative problems|1|||
147284592|NCT00558285|531207418|FG004|Overall Study|Administrative problems|1|||
147284593|NCT00558285|531207414|FG000|Overall Study|Protocol deviation|1|||
147284594|NCT00558285|531207415|FG001|Overall Study|Protocol deviation|1|||
147284595|NCT00558285|531207416|FG002|Overall Study|Protocol deviation|0|||
147284596|NCT00558285|531207417|FG003|Overall Study|Protocol deviation|1|||
147284597|NCT00558285|531207418|FG004|Overall Study|Protocol deviation|0|||
147284598|NCT02345512|531207425|FG000|Overall Study|Adverse Event|1|||
147284599|NCT02345512|531207425|FG000|Overall Study|Withdrawal by Subject|1|||
147284600|NCT01660906|531207426|FG000|Overall Study|Discontinued due to study drug toxicity|3|||
147284601|NCT03478891|531207429|FG000|Overall Study|Enrolled, but product never administered|0|||
147284602|NCT03478891|531207430|FG001|Overall Study|Enrolled, but product never administered|0|||
147284603|NCT03478891|531207431|FG002|Overall Study|Enrolled, but product never administered|1|||
147284604|NCT03478891|531207429|FG000|Overall Study|Moved from area|0|||
147284605|NCT03478891|531207430|FG001|Overall Study|Moved from area|0|||
147284606|NCT03478891|531207431|FG002|Overall Study|Moved from area|1|||
147284607|NCT03478891|531207429|FG000|Overall Study|Lost to Follow-up|1|||
147284608|NCT03478891|531207430|FG001|Overall Study|Lost to Follow-up|0|||
147284609|NCT03478891|531207431|FG002|Overall Study|Lost to Follow-up|1|||
147284610|NCT04827576|531209287|FG000|Overall Study|Death|5|||
147284611|NCT04827576|531209288|FG001|Overall Study|Death|17|||
147284612|NCT04827576|531209289|FG002|Overall Study|Death|17|||
147284613|NCT04827576|531209290|FG003|Overall Study|Death|32|||
147284614|NCT04827576|531209287|FG000|Overall Study|Study Terminated by Sponsor|2|||
147284615|NCT04827576|531209288|FG001|Overall Study|Study Terminated by Sponsor|9|||
147284616|NCT04827576|531209289|FG002|Overall Study|Study Terminated by Sponsor|7|||
147284617|NCT04827576|531209290|FG003|Overall Study|Study Terminated by Sponsor|5|||
147284618|NCT04827576|531209287|FG000|Overall Study|Investigator's Discretion|1|||
147284619|NCT04827576|531209288|FG001|Overall Study|Investigator's Discretion|0|||
147284620|NCT04827576|531209289|FG002|Overall Study|Investigator's Discretion|2|||
147284621|NCT04827576|531209290|FG003|Overall Study|Investigator's Discretion|5|||
147284622|NCT04827576|531209287|FG000|Overall Study|Withdrew Consent|0|||
147284623|NCT04827576|531209288|FG001|Overall Study|Withdrew Consent|3|||
147284624|NCT04827576|531209289|FG002|Overall Study|Withdrew Consent|0|||
147284625|NCT04827576|531209290|FG003|Overall Study|Withdrew Consent|0|||
147284626|NCT04827576|531209287|FG000|Overall Study|Lost to Follow-up|1|||
147284627|NCT04827576|531209288|FG001|Overall Study|Lost to Follow-up|0|||
147284628|NCT04827576|531209289|FG002|Overall Study|Lost to Follow-up|0|||
147284629|NCT04827576|531209290|FG003|Overall Study|Lost to Follow-up|0|||
147284630|NCT04295564|531209291|FG000|Overall Study|Withdrawn by PI after discharge due to diagnosis of a rare chromosomal mutation.|1|||
147284631|NCT04295564|531209292|FG001|Overall Study|Withdrawn by PI after discharge due to diagnosis of a rare chromosomal mutation.|0|||
147284632|NCT02527798|531209293|FG000|Overall Study|Physician Decision|1|||
147284633|NCT02527798|531209294|FG001|Overall Study|Physician Decision|0|||
147284634|NCT02527798|531209295|FG002|Overall Study|Physician Decision|1|||
147284635|NCT02527798|531209296|FG003|Overall Study|Physician Decision|1|||
147284636|NCT02527798|531209297|FG004|Overall Study|Physician Decision|0|||
147284637|NCT02527798|531209298|FG005|Overall Study|Physician Decision|0|||
147284638|NCT02527798|531209293|FG000|Overall Study|Death|0|||
147284639|NCT02527798|531209294|FG001|Overall Study|Death|0|||
147284640|NCT02527798|531209295|FG002|Overall Study|Death|1|||
147284641|NCT02527798|531209296|FG003|Overall Study|Death|0|||
147284642|NCT02527798|531209297|FG004|Overall Study|Death|0|||
147284643|NCT02527798|531209298|FG005|Overall Study|Death|0|||
147284644|NCT02527798|531209293|FG000|Overall Study|Withdrawal by Subject|0|||
147284645|NCT02527798|531209294|FG001|Overall Study|Withdrawal by Subject|1|||
147284646|NCT02527798|531209295|FG002|Overall Study|Withdrawal by Subject|2|||
147284647|NCT02527798|531209296|FG003|Overall Study|Withdrawal by Subject|0|||
147284648|NCT02527798|531209297|FG004|Overall Study|Withdrawal by Subject|0|||
147284649|NCT02527798|531209298|FG005|Overall Study|Withdrawal by Subject|0|||
147284650|NCT02527798|531209293|FG000|Overall Study|Reason undisclosed|1|||
147284651|NCT02527798|531209294|FG001|Overall Study|Reason undisclosed|0|||
147284652|NCT02527798|531209295|FG002|Overall Study|Reason undisclosed|1|||
147284653|NCT02527798|531209296|FG003|Overall Study|Reason undisclosed|0|||
147284654|NCT02527798|531209297|FG004|Overall Study|Reason undisclosed|0|||
147284655|NCT02527798|531209298|FG005|Overall Study|Reason undisclosed|0|||
147284656|NCT02527798|531209293|FG000|Overall Study|Did not receive intervention|1|||
147284657|NCT02527798|531209294|FG001|Overall Study|Did not receive intervention|1|||
147284658|NCT02527798|531209295|FG002|Overall Study|Did not receive intervention|0|||
147284659|NCT02527798|531209296|FG003|Overall Study|Did not receive intervention|0|||
147284660|NCT02527798|531209297|FG004|Overall Study|Did not receive intervention|0|||
147284661|NCT02527798|531209298|FG005|Overall Study|Did not receive intervention|0|||
147284662|NCT04745169|531209299|FG000|Overall Study|Kidney transplantation|1|||
147284663|NCT04745169|531209299|FG000|Overall Study|Participant health problems|3|||
147337314|NCT02242487|531401443|FG000|Overall Study|Adverse Event|13|||
147337315|NCT02242487|531401444|FG001|Overall Study|Adverse Event|15|||
147337316|NCT02242487|531401443|FG000|Overall Study|Lack of Efficacy|4|||
147337317|NCT02242487|531401444|FG001|Overall Study|Lack of Efficacy|6|||
147337318|NCT02242487|531401443|FG000|Overall Study|Protocol Violation|2|||
147284664|NCT04745169|531209299|FG000|Overall Study|Physician Decision|2|||
147284665|NCT00724282|531209303|FG000|Overall Study|Withdrawal by Subject|3|||
147284666|NCT00724282|531209303|FG000|Overall Study|Physician Decision|1|||
147284667|NCT01808690|531209304|FG000|Overall Study|Withdrawal by Subject|1|||
147284668|NCT01808690|531209305|FG001|Overall Study|Withdrawal by Subject|2|||
147284669|NCT02053350|531209310|FG000|Overall Study|Withdrawal by Subject|1|||
147284670|NCT02053350|531209310|FG000|Overall Study|Adverse Event|4|||
147284671|NCT01747772|531209311|FG000|Overall Study|SWE Data Not Obtainable Prior to Biopsy|9|||
147284672|NCT02244944|531209312|FG000|Overall Study|Withdrawal by Subject|1|||
147284673|NCT02244944|531209312|FG000|Overall Study|Study Terminated|1|||
147662634|NCT00385918|532587379|FG000|Feasibility & Baseline Measurement Phase|Withdrawal by Subject|0|||
147284674|NCT01928719|531209315|FG000|Overall Study|Lost to Follow-up|26|||
147284675|NCT01928719|531209316|FG001|Overall Study|Lost to Follow-up|11|||
147284676|NCT01928719|531209315|FG000|Overall Study|Withdrawal by Subject|22|||
147337319|NCT02242487|531401444|FG001|Overall Study|Protocol Violation|0|||
147284677|NCT01928719|531209316|FG001|Overall Study|Withdrawal by Subject|7|||
147284678|NCT01928719|531209315|FG000|Overall Study|Protocol Violation|3|||
147284679|NCT01928719|531209316|FG001|Overall Study|Protocol Violation|1|||
147284680|NCT01928719|531209315|FG000|Overall Study|Adverse Event|1|||
147284681|NCT01928719|531209316|FG001|Overall Study|Adverse Event|0|||
147284682|NCT02367911|531209317|FG000|Overall Study|Withdrawal by Subject|3|||
147284683|NCT02367911|531209318|FG001|Overall Study|Withdrawal by Subject|2|||
147284684|NCT02367911|531209317|FG000|Overall Study|Lost to Follow-up|2|||
147284685|NCT02367911|531209318|FG001|Overall Study|Lost to Follow-up|2|||
147284686|NCT00263666|531209319|FG000|Overall Study|Adverse Event|6|||
147284687|NCT00263666|531209320|FG001|Overall Study|Adverse Event|8|||
147284688|NCT00263666|531209319|FG000|Overall Study|Lost to Follow-up|1|||
147284689|NCT00263666|531209320|FG001|Overall Study|Lost to Follow-up|2|||
147284690|NCT00263666|531209319|FG000|Overall Study|Withdrawal by Subject|0|||
147284691|NCT00263666|531209320|FG001|Overall Study|Withdrawal by Subject|1|||
147284692|NCT00896168|531209321|FG000|Overall Study|Adverse Event|4|||
147284693|NCT00896168|531209322|FG001|Overall Study|Adverse Event|7|||
147284694|NCT00896168|531209321|FG000|Overall Study|Treatment failure|8|||
147284695|NCT00896168|531209322|FG001|Overall Study|Treatment failure|10|||
147284696|NCT00896168|531209321|FG000|Overall Study|Lost to Follow-up|1|||
147284697|NCT00896168|531209322|FG001|Overall Study|Lost to Follow-up|1|||
147284698|NCT00896168|531209321|FG000|Overall Study|Other|1|||
147284699|NCT00896168|531209322|FG001|Overall Study|Other|1|||
147284700|NCT01490632|531209323|FG000|Part A: Initial Treatment Period|Adverse Event|0|||
147284701|NCT01490632|531209324|FG001|Part A: Initial Treatment Period|Adverse Event|0|||
147284702|NCT01490632|531209325|FG002|Part A: Initial Treatment Period|Adverse Event|2|||
147284703|NCT01490632|531209326|FG003|Part A: Initial Treatment Period|Adverse Event|4|||
147284704|NCT01490632|531209327|FG004|Part A: Initial Treatment Period|Adverse Event|4|||
147284705|NCT01490632|531209328|FG005|Part A: Initial Treatment Period|Adverse Event|0|||
147284706|NCT01490632|531209329|FG006|Part A: Initial Treatment Period|Adverse Event|0|||
147284707|NCT01490632|531209330|FG007|Part A: Initial Treatment Period|Adverse Event|0|||
147284708|NCT01490632|531209331|FG008|Part A: Initial Treatment Period|Adverse Event|0|||
147284709|NCT01490632|531209332|FG009|Part A: Initial Treatment Period|Adverse Event|0|||
147284710|NCT01490632|531209333|FG010|Part A: Initial Treatment Period|Adverse Event|0|||
147284711|NCT01490632|531209334|FG011|Part A: Initial Treatment Period|Adverse Event|0|||
147284712|NCT01490632|531209335|FG012|Part A: Initial Treatment Period|Adverse Event|0|||
147284713|NCT01490632|531209336|FG013|Part A: Initial Treatment Period|Adverse Event|0|||
147284714|NCT01490632|531209337|FG014|Part A: Initial Treatment Period|Adverse Event|0|||
147284715|NCT01490632|531209338|FG015|Part A: Initial Treatment Period|Adverse Event|0|||
147284716|NCT01490632|531209339|FG016|Part A: Initial Treatment Period|Adverse Event|0|||
147284717|NCT01490632|531209340|FG017|Part A: Initial Treatment Period|Adverse Event|0|||
147284718|NCT01490632|531209341|FG018|Part A: Initial Treatment Period|Adverse Event|0|||
147284719|NCT01490632|531209342|FG019|Part A: Initial Treatment Period|Adverse Event|0|||
147284720|NCT01490632|531209323|FG000|Part A: Initial Treatment Period|Lack of Efficacy|3|||
147284721|NCT01490632|531209324|FG001|Part A: Initial Treatment Period|Lack of Efficacy|1|||
147284722|NCT01490632|531209325|FG002|Part A: Initial Treatment Period|Lack of Efficacy|2|||
147284723|NCT01490632|531209326|FG003|Part A: Initial Treatment Period|Lack of Efficacy|2|||
147284724|NCT01490632|531209327|FG004|Part A: Initial Treatment Period|Lack of Efficacy|0|||
147284725|NCT01490632|531209328|FG005|Part A: Initial Treatment Period|Lack of Efficacy|0|||
147284726|NCT01490632|531209329|FG006|Part A: Initial Treatment Period|Lack of Efficacy|0|||
147284727|NCT01490632|531209330|FG007|Part A: Initial Treatment Period|Lack of Efficacy|0|||
147284728|NCT01490632|531209331|FG008|Part A: Initial Treatment Period|Lack of Efficacy|0|||
147284729|NCT01490632|531209332|FG009|Part A: Initial Treatment Period|Lack of Efficacy|0|||
147284730|NCT01490632|531209333|FG010|Part A: Initial Treatment Period|Lack of Efficacy|0|||
147284731|NCT01490632|531209334|FG011|Part A: Initial Treatment Period|Lack of Efficacy|0|||
147284732|NCT01490632|531209335|FG012|Part A: Initial Treatment Period|Lack of Efficacy|0|||
147284733|NCT01490632|531209336|FG013|Part A: Initial Treatment Period|Lack of Efficacy|0|||
147284734|NCT01490632|531209337|FG014|Part A: Initial Treatment Period|Lack of Efficacy|0|||
147284735|NCT01490632|531209338|FG015|Part A: Initial Treatment Period|Lack of Efficacy|0|||
147284736|NCT01490632|531209339|FG016|Part A: Initial Treatment Period|Lack of Efficacy|0|||
147284737|NCT01490632|531209340|FG017|Part A: Initial Treatment Period|Lack of Efficacy|0|||
147284738|NCT01490632|531209341|FG018|Part A: Initial Treatment Period|Lack of Efficacy|0|||
147284739|NCT01490632|531209342|FG019|Part A: Initial Treatment Period|Lack of Efficacy|0|||
147284740|NCT01490632|531209323|FG000|Part A: Initial Treatment Period|Lost to Follow-up|0|||
147284741|NCT01490632|531209324|FG001|Part A: Initial Treatment Period|Lost to Follow-up|0|||
147284742|NCT01490632|531209325|FG002|Part A: Initial Treatment Period|Lost to Follow-up|1|||
147284743|NCT01490632|531209326|FG003|Part A: Initial Treatment Period|Lost to Follow-up|1|||
147284744|NCT01490632|531209327|FG004|Part A: Initial Treatment Period|Lost to Follow-up|2|||
147284745|NCT01490632|531209328|FG005|Part A: Initial Treatment Period|Lost to Follow-up|0|||
147337320|NCT02242487|531401443|FG000|Overall Study|Lost to Follow-up|2|||
147337321|NCT02242487|531401444|FG001|Overall Study|Lost to Follow-up|1|||
147337322|NCT02242487|531401443|FG000|Overall Study|Other - Miscellaneous|4|||
147604103|NCT01775189|532367830|FG003|Treatment Phase: Washout Period 2|Protocol Violation|1|||
147604104|NCT01775189|532367831|FG004|Treatment Phase: Washout Period 2|Protocol Violation|0|||
147604105|NCT01775189|532367832|FG005|Treatment Phase: Washout Period 2|Protocol Violation|0|||
147284746|NCT01490632|531209329|FG006|Part A: Initial Treatment Period|Lost to Follow-up|0|||
147284747|NCT01490632|531209330|FG007|Part A: Initial Treatment Period|Lost to Follow-up|0|||
147284748|NCT01490632|531209331|FG008|Part A: Initial Treatment Period|Lost to Follow-up|0|||
147337323|NCT02242487|531401444|FG001|Overall Study|Other - Miscellaneous|6|||
147284749|NCT01490632|531209332|FG009|Part A: Initial Treatment Period|Lost to Follow-up|0|||
147284750|NCT01490632|531209333|FG010|Part A: Initial Treatment Period|Lost to Follow-up|0|||
147284751|NCT01490632|531209334|FG011|Part A: Initial Treatment Period|Lost to Follow-up|0|||
147284752|NCT01490632|531209335|FG012|Part A: Initial Treatment Period|Lost to Follow-up|0|||
147284753|NCT01490632|531209336|FG013|Part A: Initial Treatment Period|Lost to Follow-up|0|||
147284754|NCT01490632|531209337|FG014|Part A: Initial Treatment Period|Lost to Follow-up|0|||
147284755|NCT01490632|531209338|FG015|Part A: Initial Treatment Period|Lost to Follow-up|0|||
147284756|NCT01490632|531209339|FG016|Part A: Initial Treatment Period|Lost to Follow-up|0|||
147284757|NCT01490632|531209340|FG017|Part A: Initial Treatment Period|Lost to Follow-up|0|||
147284758|NCT01490632|531209341|FG018|Part A: Initial Treatment Period|Lost to Follow-up|0|||
147284759|NCT01490632|531209342|FG019|Part A: Initial Treatment Period|Lost to Follow-up|0|||
147284760|NCT01490632|531209323|FG000|Part A: Initial Treatment Period|Physician Decision|0|||
147284761|NCT01490632|531209324|FG001|Part A: Initial Treatment Period|Physician Decision|1|||
147284762|NCT01490632|531209325|FG002|Part A: Initial Treatment Period|Physician Decision|0|||
147284763|NCT01490632|531209326|FG003|Part A: Initial Treatment Period|Physician Decision|1|||
147284764|NCT01490632|531209327|FG004|Part A: Initial Treatment Period|Physician Decision|0|||
147284765|NCT01490632|531209328|FG005|Part A: Initial Treatment Period|Physician Decision|0|||
147284766|NCT01490632|531209329|FG006|Part A: Initial Treatment Period|Physician Decision|0|||
147284767|NCT01490632|531209330|FG007|Part A: Initial Treatment Period|Physician Decision|0|||
147284768|NCT01490632|531209331|FG008|Part A: Initial Treatment Period|Physician Decision|0|||
147284769|NCT01490632|531209332|FG009|Part A: Initial Treatment Period|Physician Decision|0|||
147284770|NCT01490632|531209333|FG010|Part A: Initial Treatment Period|Physician Decision|0|||
147284771|NCT01490632|531209334|FG011|Part A: Initial Treatment Period|Physician Decision|0|||
147284772|NCT01490632|531209335|FG012|Part A: Initial Treatment Period|Physician Decision|0|||
147284773|NCT01490632|531209336|FG013|Part A: Initial Treatment Period|Physician Decision|0|||
147284774|NCT01490632|531209337|FG014|Part A: Initial Treatment Period|Physician Decision|0|||
147284775|NCT01490632|531209338|FG015|Part A: Initial Treatment Period|Physician Decision|0|||
147284776|NCT01490632|531209339|FG016|Part A: Initial Treatment Period|Physician Decision|0|||
147284777|NCT01490632|531209340|FG017|Part A: Initial Treatment Period|Physician Decision|0|||
147284778|NCT01490632|531209341|FG018|Part A: Initial Treatment Period|Physician Decision|0|||
147284779|NCT01490632|531209342|FG019|Part A: Initial Treatment Period|Physician Decision|0|||
147284780|NCT01490632|531209323|FG000|Part A: Initial Treatment Period|Sponsor Decision|2|||
147284781|NCT01490632|531209324|FG001|Part A: Initial Treatment Period|Sponsor Decision|0|||
147284782|NCT01490632|531209325|FG002|Part A: Initial Treatment Period|Sponsor Decision|0|||
147284783|NCT01490632|531209326|FG003|Part A: Initial Treatment Period|Sponsor Decision|0|||
147284784|NCT01490632|531209327|FG004|Part A: Initial Treatment Period|Sponsor Decision|0|||
147284785|NCT01490632|531209328|FG005|Part A: Initial Treatment Period|Sponsor Decision|0|||
147284786|NCT01490632|531209329|FG006|Part A: Initial Treatment Period|Sponsor Decision|0|||
147284787|NCT01490632|531209330|FG007|Part A: Initial Treatment Period|Sponsor Decision|0|||
147284788|NCT01490632|531209331|FG008|Part A: Initial Treatment Period|Sponsor Decision|0|||
147284789|NCT01490632|531209332|FG009|Part A: Initial Treatment Period|Sponsor Decision|0|||
147284790|NCT01490632|531209333|FG010|Part A: Initial Treatment Period|Sponsor Decision|0|||
147284791|NCT01490632|531209334|FG011|Part A: Initial Treatment Period|Sponsor Decision|0|||
147284792|NCT01490632|531209335|FG012|Part A: Initial Treatment Period|Sponsor Decision|0|||
147284793|NCT01490632|531209336|FG013|Part A: Initial Treatment Period|Sponsor Decision|0|||
147284794|NCT01490632|531209337|FG014|Part A: Initial Treatment Period|Sponsor Decision|0|||
147284795|NCT01490632|531209338|FG015|Part A: Initial Treatment Period|Sponsor Decision|0|||
147284796|NCT01490632|531209339|FG016|Part A: Initial Treatment Period|Sponsor Decision|0|||
147284797|NCT01490632|531209340|FG017|Part A: Initial Treatment Period|Sponsor Decision|0|||
147284798|NCT01490632|531209341|FG018|Part A: Initial Treatment Period|Sponsor Decision|0|||
147284799|NCT01490632|531209342|FG019|Part A: Initial Treatment Period|Sponsor Decision|0|||
147284800|NCT01490632|531209323|FG000|Part A: Initial Treatment Period|Withdrawal by Subject|2|||
147284801|NCT01490632|531209324|FG001|Part A: Initial Treatment Period|Withdrawal by Subject|2|||
147284802|NCT01490632|531209325|FG002|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
147284803|NCT01490632|531209326|FG003|Part A: Initial Treatment Period|Withdrawal by Subject|1|||
147284804|NCT01490632|531209327|FG004|Part A: Initial Treatment Period|Withdrawal by Subject|2|||
147284805|NCT01490632|531209328|FG005|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
147284806|NCT01490632|531209329|FG006|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
147284807|NCT01490632|531209330|FG007|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
147284808|NCT01490632|531209331|FG008|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
147284809|NCT01490632|531209332|FG009|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
147284810|NCT01490632|531209333|FG010|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
147284811|NCT01490632|531209334|FG011|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
147284812|NCT01490632|531209335|FG012|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
147284813|NCT01490632|531209336|FG013|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
147337324|NCT02242487|531401443|FG000|Overall Study|Withdrawal by Subject|37|||
147337325|NCT02242487|531401444|FG001|Overall Study|Withdrawal by Subject|19|||
147337326|NCT00508924|531401447|FG000|Overall Study|Protocol Violation|0|||
147337327|NCT00508924|531401448|FG001|Overall Study|Protocol Violation|0|||
147337328|NCT00508924|531401449|FG002|Overall Study|Protocol Violation|1|||
147337329|NCT00508924|531401450|FG003|Overall Study|Protocol Violation|1|||
147337330|NCT02252042|531401453|FG000|Overall Study|Adverse Event|9|||
147337331|NCT02252042|531401454|FG001|Overall Study|Adverse Event|6|||
147337332|NCT02252042|531401453|FG000|Overall Study|Death|209|||
147337333|NCT02252042|531401454|FG001|Overall Study|Death|217|||
147337334|NCT02252042|531401453|FG000|Overall Study|Physician Decision|0|||
147337335|NCT02252042|531401454|FG001|Overall Study|Physician Decision|2|||
147337336|NCT02252042|531401453|FG000|Overall Study|Transferred to Extension Study|7|||
147452292|NCT03074474|531816564|FG000|Overall Study|Withdrawal by Subject|10|||
147284814|NCT01490632|531209337|FG014|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
147284815|NCT01490632|531209338|FG015|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
147284816|NCT01490632|531209339|FG016|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
147284817|NCT01490632|531209340|FG017|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
147284818|NCT01490632|531209341|FG018|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
147284819|NCT01490632|531209342|FG019|Part A: Initial Treatment Period|Withdrawal by Subject|0|||
147284820|NCT01490632|531209323|FG000|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
147284821|NCT01490632|531209324|FG001|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
147284822|NCT01490632|531209325|FG002|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
147284823|NCT01490632|531209326|FG003|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
147284824|NCT01490632|531209327|FG004|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|9|||
147284825|NCT01490632|531209328|FG005|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
147284826|NCT01490632|531209329|FG006|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
147284827|NCT01490632|531209330|FG007|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
147284828|NCT01490632|531209331|FG008|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
147284829|NCT01490632|531209332|FG009|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
147284830|NCT01490632|531209333|FG010|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
147284831|NCT01490632|531209334|FG011|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
147284832|NCT01490632|531209335|FG012|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
147284833|NCT01490632|531209336|FG013|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
147284834|NCT01490632|531209337|FG014|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
147284835|NCT01490632|531209338|FG015|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
147284836|NCT01490632|531209339|FG016|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
147284837|NCT01490632|531209340|FG017|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
147284838|NCT01490632|531209341|FG018|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
147284839|NCT01490632|531209342|FG019|Part A: Initial Treatment Period|Discontinued at Week 12 per protocol|0|||
147284840|NCT01490632|531209323|FG000|Part B: Extension or Step-Up Period|Adverse Event|0|||
147284841|NCT01490632|531209324|FG001|Part B: Extension or Step-Up Period|Adverse Event|0|||
147284842|NCT01490632|531209325|FG002|Part B: Extension or Step-Up Period|Adverse Event|0|||
147337337|NCT02252042|531401454|FG001|Overall Study|Transferred to Extension Study|1|||
147337338|NCT02252042|531401453|FG000|Overall Study|Did Not Continue on Extension Study|7|||
147337339|NCT02252042|531401454|FG001|Overall Study|Did Not Continue on Extension Study|2|||
147337340|NCT02252042|531401453|FG000|Overall Study|Withdrawal by Subject|15|||
147452293|NCT03074474|531816564|FG000|Overall Study|Death|4|||
147452294|NCT03074474|531816564|FG000|Overall Study|1 exited due to recurrence and 2 exited due to mesh removal.|3|||
147452295|NCT00328627|531819894|FG000|Overall Study|Hyperglycemic Rescue|41|||
147452296|NCT00328627|531819895|FG001|Overall Study|Hyperglycemic Rescue|18|||
147452297|NCT00328627|531819896|FG002|Overall Study|Hyperglycemic Rescue|16|||
147452298|NCT00328627|531819897|FG003|Overall Study|Hyperglycemic Rescue|13|||
147452299|NCT00328627|531819898|FG004|Overall Study|Hyperglycemic Rescue|6|||
147452300|NCT00328627|531819899|FG005|Overall Study|Hyperglycemic Rescue|5|||
147452301|NCT00328627|531819900|FG006|Overall Study|Hyperglycemic Rescue|19|||
147452302|NCT00328627|531819901|FG007|Overall Study|Hyperglycemic Rescue|6|||
147452303|NCT00328627|531819902|FG008|Overall Study|Hyperglycemic Rescue|6|||
147452304|NCT00328627|531819903|FG009|Overall Study|Hyperglycemic Rescue|11|||
147452305|NCT00328627|531819904|FG010|Overall Study|Hyperglycemic Rescue|3|||
147604106|NCT01775189|532367833|FG006|Treatment Phase: Washout Period 2|Protocol Violation|0|||
147604107|NCT01775189|532367827|FG000|Treatment Phase: Washout Period 3|Protocol Violation|0|||
147604108|NCT01775189|532367828|FG001|Treatment Phase: Washout Period 3|Protocol Violation|0|||
147604109|NCT01775189|532367829|FG002|Treatment Phase: Washout Period 3|Protocol Violation|0|||
147337341|NCT02252042|531401454|FG001|Overall Study|Withdrawal by Subject|20|||
147337342|NCT00979992|531401455|FG000|Overall Study|Ineligible - inadequate pathology|1|||
147337343|NCT00979992|531401455|FG000|Overall Study|Ineligible - wrong cell type|2|||
147337344|NCT00979992|531401455|FG000|Overall Study|Refused - Never Treated|2|||
147452306|NCT00328627|531819905|FG011|Overall Study|Hyperglycemic Rescue|2|||
147452307|NCT00328627|531819894|FG000|Overall Study|Adverse Event|3|||
147284843|NCT01490632|531209326|FG003|Part B: Extension or Step-Up Period|Adverse Event|0|||
147284844|NCT01490632|531209327|FG004|Part B: Extension or Step-Up Period|Adverse Event|0|||
147284845|NCT01490632|531209328|FG005|Part B: Extension or Step-Up Period|Adverse Event|2|||
147284846|NCT01490632|531209329|FG006|Part B: Extension or Step-Up Period|Adverse Event|2|||
147284847|NCT01490632|531209330|FG007|Part B: Extension or Step-Up Period|Adverse Event|0|||
147284848|NCT01490632|531209331|FG008|Part B: Extension or Step-Up Period|Adverse Event|0|||
147284849|NCT01490632|531209332|FG009|Part B: Extension or Step-Up Period|Adverse Event|2|||
147284850|NCT01490632|531209333|FG010|Part B: Extension or Step-Up Period|Adverse Event|3|||
147284851|NCT01490632|531209334|FG011|Part B: Extension or Step-Up Period|Adverse Event|1|||
147284852|NCT01490632|531209335|FG012|Part B: Extension or Step-Up Period|Adverse Event|0|||
147284853|NCT01490632|531209336|FG013|Part B: Extension or Step-Up Period|Adverse Event|0|||
147284854|NCT01490632|531209337|FG014|Part B: Extension or Step-Up Period|Adverse Event|0|||
147284855|NCT01490632|531209338|FG015|Part B: Extension or Step-Up Period|Adverse Event|0|||
147284856|NCT01490632|531209339|FG016|Part B: Extension or Step-Up Period|Adverse Event|0|||
147284857|NCT01490632|531209340|FG017|Part B: Extension or Step-Up Period|Adverse Event|0|||
147284858|NCT01490632|531209341|FG018|Part B: Extension or Step-Up Period|Adverse Event|0|||
147284859|NCT01490632|531209342|FG019|Part B: Extension or Step-Up Period|Adverse Event|0|||
147284860|NCT01490632|531209323|FG000|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
147284861|NCT01490632|531209324|FG001|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
147284862|NCT01490632|531209325|FG002|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
147284863|NCT01490632|531209326|FG003|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
147284864|NCT01490632|531209327|FG004|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
147284865|NCT01490632|531209328|FG005|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
147284866|NCT01490632|531209329|FG006|Part B: Extension or Step-Up Period|Lack of Efficacy|1|||
147284867|NCT01490632|531209330|FG007|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
147284868|NCT01490632|531209331|FG008|Part B: Extension or Step-Up Period|Lack of Efficacy|1|||
147284869|NCT01490632|531209332|FG009|Part B: Extension or Step-Up Period|Lack of Efficacy|3|||
147284870|NCT01490632|531209333|FG010|Part B: Extension or Step-Up Period|Lack of Efficacy|1|||
147284871|NCT01490632|531209334|FG011|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
147284872|NCT01490632|531209335|FG012|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
147284873|NCT01490632|531209336|FG013|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
147337345|NCT04532528|531401456|FG000|Overall Study|Adverse Event|12|||
147337346|NCT04532528|531401457|FG001|Overall Study|Adverse Event|17|||
147337347|NCT04532528|531401456|FG000|Overall Study|Withdrawal of consent|16|||
147337348|NCT04532528|531401457|FG001|Overall Study|Withdrawal of consent|17|||
147337349|NCT04532528|531401456|FG000|Overall Study|Participant stop Dabigatran during the 12-month study period|22|||
147337350|NCT04532528|531401457|FG001|Overall Study|Participant stop Dabigatran during the 12-month study period|24|||
147337351|NCT04532528|531401456|FG000|Overall Study|Lost to Follow-up|69|||
147337352|NCT04532528|531401457|FG001|Overall Study|Lost to Follow-up|68|||
147337353|NCT04532528|531401456|FG000|Overall Study|Administrative problems|12|||
147337354|NCT04532528|531401457|FG001|Overall Study|Administrative problems|14|||
147337355|NCT04532528|531401456|FG000|Overall Study|Death|3|||
147337356|NCT04532528|531401457|FG001|Overall Study|Death|3|||
147337357|NCT04532528|531401456|FG000|Overall Study|Other|38|||
147337358|NCT04532528|531401457|FG001|Overall Study|Other|46|||
147337359|NCT03691428|531401460|FG000|Overall Study|Withdrawal by Subject|6|||
147337360|NCT03691428|531401461|FG001|Overall Study|Withdrawal by Subject|8|||
147337361|NCT01460290|531401462|FG000|Overall Study|Adverse Event|3|||
147337362|NCT01460290|531401462|FG000|Overall Study|Elevated liver function|1|||
147337363|NCT02527148|531401463|FG000|Overall Study|Did not receive study intervention|1|||
147452308|NCT00328627|531819895|FG001|Overall Study|Adverse Event|1|||
147452309|NCT00328627|531819896|FG002|Overall Study|Adverse Event|2|||
147452310|NCT00328627|531819897|FG003|Overall Study|Adverse Event|3|||
147452311|NCT00328627|531819898|FG004|Overall Study|Adverse Event|1|||
147452312|NCT00328627|531819899|FG005|Overall Study|Adverse Event|2|||
147452313|NCT00328627|531819900|FG006|Overall Study|Adverse Event|1|||
147452314|NCT00328627|531819901|FG007|Overall Study|Adverse Event|2|||
147452315|NCT00328627|531819902|FG008|Overall Study|Adverse Event|0|||
147452316|NCT00328627|531819903|FG009|Overall Study|Adverse Event|7|||
147452317|NCT00328627|531819904|FG010|Overall Study|Adverse Event|5|||
147452318|NCT00328627|531819905|FG011|Overall Study|Adverse Event|4|||
147452319|NCT00328627|531819894|FG000|Overall Study|Protocol Violation|2|||
147604110|NCT01775189|532367830|FG003|Treatment Phase: Washout Period 3|Protocol Violation|1|||
147284874|NCT01490632|531209337|FG014|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
147284875|NCT01490632|531209338|FG015|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
147284876|NCT01490632|531209339|FG016|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
147284877|NCT01490632|531209340|FG017|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
147284878|NCT01490632|531209341|FG018|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
147337364|NCT02527148|531401464|FG001|Overall Study|Did not receive study intervention|0|||
147337365|NCT02448446|531401467|FG000|Overall Study|Withdrawal by Subject|1|||
147337366|NCT02448446|531401468|FG001|Overall Study|Withdrawal by Subject|0|||
147337367|NCT01254188|531401469|FG000|Overall Study|Disease Progression|6|||
147604111|NCT01775189|532367831|FG004|Treatment Phase: Washout Period 3|Protocol Violation|0|||
147284879|NCT01490632|531209342|FG019|Part B: Extension or Step-Up Period|Lack of Efficacy|0|||
147284880|NCT01490632|531209323|FG000|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
147284881|NCT01490632|531209324|FG001|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
147284882|NCT01490632|531209325|FG002|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
147284883|NCT01490632|531209326|FG003|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
147284884|NCT01490632|531209327|FG004|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
147284885|NCT01490632|531209328|FG005|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
147284886|NCT01490632|531209329|FG006|Part B: Extension or Step-Up Period|Lost to Follow-up|2|||
147284887|NCT01490632|531209330|FG007|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
147284888|NCT01490632|531209331|FG008|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
147284889|NCT01490632|531209332|FG009|Part B: Extension or Step-Up Period|Lost to Follow-up|1|||
147284890|NCT01490632|531209333|FG010|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
147284891|NCT01490632|531209334|FG011|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
147284892|NCT01490632|531209335|FG012|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
147284893|NCT01490632|531209336|FG013|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
147284894|NCT01490632|531209337|FG014|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
147284895|NCT01490632|531209338|FG015|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
147284896|NCT01490632|531209339|FG016|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
147284897|NCT01490632|531209340|FG017|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
147284898|NCT01490632|531209341|FG018|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
147284899|NCT01490632|531209342|FG019|Part B: Extension or Step-Up Period|Lost to Follow-up|0|||
147284900|NCT01490632|531209323|FG000|Part B: Extension or Step-Up Period|Physician Decision|0|||
147284901|NCT01490632|531209324|FG001|Part B: Extension or Step-Up Period|Physician Decision|0|||
147284902|NCT01490632|531209325|FG002|Part B: Extension or Step-Up Period|Physician Decision|0|||
147284903|NCT01490632|531209326|FG003|Part B: Extension or Step-Up Period|Physician Decision|0|||
147284904|NCT01490632|531209327|FG004|Part B: Extension or Step-Up Period|Physician Decision|0|||
147284905|NCT01490632|531209328|FG005|Part B: Extension or Step-Up Period|Physician Decision|0|||
147284906|NCT01490632|531209329|FG006|Part B: Extension or Step-Up Period|Physician Decision|1|||
147284907|NCT01490632|531209330|FG007|Part B: Extension or Step-Up Period|Physician Decision|0|||
147284908|NCT01490632|531209331|FG008|Part B: Extension or Step-Up Period|Physician Decision|0|||
147284909|NCT01490632|531209332|FG009|Part B: Extension or Step-Up Period|Physician Decision|0|||
147337368|NCT01254188|531401469|FG000|Overall Study|Protocol Violation|6|||
147337369|NCT01254188|531401469|FG000|Overall Study|Pregnancy|2|||
147337370|NCT01254188|531401469|FG000|Overall Study|Death|4|||
147337371|NCT01254188|531401469|FG000|Overall Study|Lost to Follow-up|5|||
147337372|NCT01254188|531401469|FG000|Overall Study|Withdrawal by Subject|7|||
147337373|NCT01254188|531401469|FG000|Overall Study|Adverse Event|43|||
147337374|NCT01254188|531401469|FG000|Overall Study|per investigator discretion|20|||
147337375|NCT02202499|531401474|FG000|Overall Study|Cancer diagnosis|0|||
147337376|NCT02202499|531401475|FG001|Overall Study|Cancer diagnosis|0|||
147337377|NCT02202499|531401476|FG002|Overall Study|Cancer diagnosis|1|||
147337378|NCT02202499|531401474|FG000|Overall Study|Moved from area|0|||
147337379|NCT02202499|531401475|FG001|Overall Study|Moved from area|0|||
147337380|NCT02202499|531401476|FG002|Overall Study|Moved from area|1|||
147337381|NCT02202499|531401474|FG000|Overall Study|Declined before randomization|1|||
147337382|NCT02202499|531401475|FG001|Overall Study|Declined before randomization|0|||
147337383|NCT02202499|531401476|FG002|Overall Study|Declined before randomization|0|||
147337384|NCT02202499|531401474|FG000|Overall Study|Auto accident|1|||
147337385|NCT02202499|531401475|FG001|Overall Study|Auto accident|0|||
147337386|NCT02202499|531401476|FG002|Overall Study|Auto accident|0|||
147337387|NCT02957136|531401482|FG000|Overall Study|Withdrawal by Subject|2|||
147337388|NCT02957136|531401483|FG001|Overall Study|Withdrawal by Subject|1|||
147337389|NCT02200770|531401487|FG000|Randomized-controlled Period (RCP)|Adverse Event|0|||
147337390|NCT02200770|531401488|FG001|Randomized-controlled Period (RCP)|Adverse Event|2|||
147337391|NCT02200770|531401487|FG000|Randomized-controlled Period (RCP)|Withdrawal by Subject|1|||
147337392|NCT02200770|531401488|FG001|Randomized-controlled Period (RCP)|Withdrawal by Subject|1|||
147337393|NCT02200770|531401487|FG000|Randomized-controlled Period (RCP)|Participants randomized, but not treated|0|||
147337394|NCT02200770|531401488|FG001|Randomized-controlled Period (RCP)|Participants randomized, but not treated|1|||
147337395|NCT02200770|531401487|FG000|Randomized-controlled Period (RCP)|Other|1|||
147337396|NCT02200770|531401488|FG001|Randomized-controlled Period (RCP)|Other|2|||
147337397|NCT02200770|531401487|FG000|Open-label Period (OLP)|Adverse Event|1|||
147337398|NCT02200770|531401488|FG001|Open-label Period (OLP)|Adverse Event|2|||
147337399|NCT02200770|531401487|FG000|Open-label Period (OLP)|Death|1|||
147604112|NCT01775189|532367832|FG005|Treatment Phase: Washout Period 3|Protocol Violation|0|||
147284910|NCT01490632|531209333|FG010|Part B: Extension or Step-Up Period|Physician Decision|0|||
147284911|NCT01490632|531209334|FG011|Part B: Extension or Step-Up Period|Physician Decision|0|||
147337400|NCT02200770|531401488|FG001|Open-label Period (OLP)|Death|2|||
147337401|NCT02200770|531401487|FG000|Open-label Period (OLP)|Lost to Follow-up|0|||
147337402|NCT02200770|531401488|FG001|Open-label Period (OLP)|Lost to Follow-up|1|||
147284912|NCT01490632|531209335|FG012|Part B: Extension or Step-Up Period|Physician Decision|0|||
147284913|NCT01490632|531209336|FG013|Part B: Extension or Step-Up Period|Physician Decision|0|||
147284914|NCT01490632|531209337|FG014|Part B: Extension or Step-Up Period|Physician Decision|0|||
147284915|NCT01490632|531209338|FG015|Part B: Extension or Step-Up Period|Physician Decision|0|||
147284916|NCT01490632|531209339|FG016|Part B: Extension or Step-Up Period|Physician Decision|0|||
147284917|NCT01490632|531209340|FG017|Part B: Extension or Step-Up Period|Physician Decision|0|||
147284918|NCT01490632|531209341|FG018|Part B: Extension or Step-Up Period|Physician Decision|0|||
147284919|NCT01490632|531209342|FG019|Part B: Extension or Step-Up Period|Physician Decision|0|||
147284920|NCT01490632|531209323|FG000|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
147284921|NCT01490632|531209324|FG001|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
147284922|NCT01490632|531209325|FG002|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
147284923|NCT01490632|531209326|FG003|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
147284924|NCT01490632|531209327|FG004|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
147284925|NCT01490632|531209328|FG005|Part B: Extension or Step-Up Period|Sponsor Decision|1|||
147284926|NCT01490632|531209329|FG006|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
147284927|NCT01490632|531209330|FG007|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
147284928|NCT01490632|531209331|FG008|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
147284929|NCT01490632|531209332|FG009|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
147284930|NCT01490632|531209333|FG010|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
147284931|NCT01490632|531209334|FG011|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
147284932|NCT01490632|531209335|FG012|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
147284933|NCT01490632|531209336|FG013|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
147284934|NCT01490632|531209337|FG014|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
147284935|NCT01490632|531209338|FG015|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
147284936|NCT01490632|531209339|FG016|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
147284937|NCT01490632|531209340|FG017|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
147284938|NCT01490632|531209341|FG018|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
147284939|NCT01490632|531209342|FG019|Part B: Extension or Step-Up Period|Sponsor Decision|0|||
147284940|NCT01490632|531209323|FG000|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
147284941|NCT01490632|531209324|FG001|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
147284942|NCT01490632|531209325|FG002|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
147284943|NCT01490632|531209326|FG003|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
147284944|NCT01490632|531209327|FG004|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
147284945|NCT01490632|531209328|FG005|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
147284946|NCT01490632|531209329|FG006|Part B: Extension or Step-Up Period|Withdrawal by Subject|1|||
147284947|NCT01490632|531209330|FG007|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
147284948|NCT01490632|531209331|FG008|Part B: Extension or Step-Up Period|Withdrawal by Subject|1|||
147284949|NCT01490632|531209332|FG009|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
147284950|NCT01490632|531209333|FG010|Part B: Extension or Step-Up Period|Withdrawal by Subject|1|||
147284951|NCT01490632|531209334|FG011|Part B: Extension or Step-Up Period|Withdrawal by Subject|2|||
147284952|NCT01490632|531209335|FG012|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
147284953|NCT01490632|531209336|FG013|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
147284954|NCT01490632|531209337|FG014|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
147337403|NCT02200770|531401487|FG000|Open-label Period (OLP)|Withdrawal by Subject|0|||
147337404|NCT02200770|531401488|FG001|Open-label Period (OLP)|Withdrawal by Subject|14|||
147337405|NCT02200770|531401487|FG000|Open-label Period (OLP)|Other|6|||
147337406|NCT02200770|531401488|FG001|Open-label Period (OLP)|Other|15|||
147337407|NCT01124734|531401489|FG000|Overall Study|Disease progression|13|||
147337408|NCT01124734|531401489|FG000|Overall Study|Adverse Event|1|||
147284955|NCT01490632|531209338|FG015|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
147337409|NCT01124734|531401489|FG000|Overall Study|Withdrawal by Subject|1|||
147337410|NCT01124734|531401489|FG000|Overall Study|Elected for alternative treatment|2|||
147337411|NCT01837966|531401492|FG000|Overall Study|Withdrawal by Subject|2|||
147337412|NCT01837966|531401493|FG001|Overall Study|Withdrawal by Subject|1|||
147337413|NCT01202955|531401494|FG000|Period 1: 10 Days|Withdrawal by Subject|0|||
147337414|NCT01202955|531401495|FG001|Period 1: 10 Days|Withdrawal by Subject|2|||
147337415|NCT02928224|531401498|FG000|Overall Study|Lost to Follow-up|1|||
147337416|NCT02928224|531401499|FG001|Overall Study|Lost to Follow-up|1|||
147337417|NCT02928224|531401500|FG002|Overall Study|Lost to Follow-up|3|||
147337418|NCT02928224|531401501|FG003|Overall Study|Lost to Follow-up|0|||
147337419|NCT02928224|531401498|FG000|Overall Study|Death|30|||
147337420|NCT02928224|531401499|FG001|Overall Study|Death|209|||
147337421|NCT02928224|531401500|FG002|Overall Study|Death|193|||
147337422|NCT02928224|531401501|FG003|Overall Study|Death|198|||
147337423|NCT02928224|531401498|FG000|Overall Study|Withdrawal by Subject|0|||
147337424|NCT02928224|531401499|FG001|Overall Study|Withdrawal by Subject|3|||
147337425|NCT02928224|531401500|FG002|Overall Study|Withdrawal by Subject|7|||
147284956|NCT01490632|531209339|FG016|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
147337426|NCT02928224|531401501|FG003|Overall Study|Withdrawal by Subject|20|||
147452320|NCT00328627|531819895|FG001|Overall Study|Protocol Violation|2|||
147284957|NCT01490632|531209340|FG017|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
147284958|NCT01490632|531209341|FG018|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
147284959|NCT01490632|531209342|FG019|Part B: Extension or Step-Up Period|Withdrawal by Subject|0|||
147284960|NCT01490632|531209323|FG000|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
147284961|NCT01490632|531209324|FG001|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
147284962|NCT01490632|531209325|FG002|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
147284963|NCT01490632|531209326|FG003|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
147284964|NCT01490632|531209327|FG004|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
147284965|NCT01490632|531209328|FG005|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|1|||
147284966|NCT01490632|531209329|FG006|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|6|||
147284967|NCT01490632|531209330|FG007|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|6|||
147284968|NCT01490632|531209331|FG008|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|8|||
147284969|NCT01490632|531209332|FG009|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|19|||
147284970|NCT01490632|531209333|FG010|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|16|||
147284971|NCT01490632|531209334|FG011|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|5|||
147284972|NCT01490632|531209335|FG012|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
147284973|NCT01490632|531209336|FG013|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
147284974|NCT01490632|531209337|FG014|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
147284975|NCT01490632|531209338|FG015|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
147284976|NCT01490632|531209339|FG016|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
147284977|NCT01490632|531209340|FG017|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
147284978|NCT01490632|531209341|FG018|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
147284979|NCT01490632|531209342|FG019|Part B: Extension or Step-Up Period|Completed Part B and Not Moving to PartC|0|||
147284980|NCT01490632|531209323|FG000|Part C: Washout or Step-Down Period|Adverse Event|0|||
147284981|NCT01490632|531209324|FG001|Part C: Washout or Step-Down Period|Adverse Event|0|||
147284982|NCT01490632|531209325|FG002|Part C: Washout or Step-Down Period|Adverse Event|0|||
147284983|NCT01490632|531209326|FG003|Part C: Washout or Step-Down Period|Adverse Event|0|||
147284984|NCT01490632|531209327|FG004|Part C: Washout or Step-Down Period|Adverse Event|0|||
147284985|NCT01490632|531209328|FG005|Part C: Washout or Step-Down Period|Adverse Event|0|||
147284986|NCT01490632|531209329|FG006|Part C: Washout or Step-Down Period|Adverse Event|0|||
147284987|NCT01490632|531209330|FG007|Part C: Washout or Step-Down Period|Adverse Event|0|||
147284988|NCT01490632|531209331|FG008|Part C: Washout or Step-Down Period|Adverse Event|0|||
147284989|NCT01490632|531209332|FG009|Part C: Washout or Step-Down Period|Adverse Event|0|||
147284990|NCT01490632|531209333|FG010|Part C: Washout or Step-Down Period|Adverse Event|0|||
147284991|NCT01490632|531209334|FG011|Part C: Washout or Step-Down Period|Adverse Event|0|||
147284992|NCT01490632|531209335|FG012|Part C: Washout or Step-Down Period|Adverse Event|0|||
147284993|NCT01490632|531209336|FG013|Part C: Washout or Step-Down Period|Adverse Event|0|||
147284994|NCT01490632|531209337|FG014|Part C: Washout or Step-Down Period|Adverse Event|2|||
147284995|NCT01490632|531209338|FG015|Part C: Washout or Step-Down Period|Adverse Event|2|||
147284996|NCT01490632|531209339|FG016|Part C: Washout or Step-Down Period|Adverse Event|0|||
147284997|NCT01490632|531209340|FG017|Part C: Washout or Step-Down Period|Adverse Event|0|||
147284998|NCT01490632|531209341|FG018|Part C: Washout or Step-Down Period|Adverse Event|0|||
147284999|NCT01490632|531209342|FG019|Part C: Washout or Step-Down Period|Adverse Event|0|||
147285000|NCT01490632|531209323|FG000|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
147285001|NCT01490632|531209324|FG001|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
147285002|NCT01490632|531209325|FG002|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
147285003|NCT01490632|531209326|FG003|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
147285004|NCT01490632|531209327|FG004|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
147285005|NCT01490632|531209328|FG005|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
147285006|NCT01490632|531209329|FG006|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
147285007|NCT01490632|531209330|FG007|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
147285008|NCT01490632|531209331|FG008|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
147285009|NCT01490632|531209332|FG009|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
147285010|NCT01490632|531209333|FG010|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
147285011|NCT01490632|531209334|FG011|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
147285012|NCT01490632|531209335|FG012|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
147285013|NCT01490632|531209336|FG013|Part C: Washout or Step-Down Period|Lost to Follow-up|1|||
147285014|NCT01490632|531209337|FG014|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
147285015|NCT01490632|531209338|FG015|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
147285016|NCT01490632|531209339|FG016|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
147285017|NCT01490632|531209340|FG017|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
147337427|NCT02928224|531401498|FG000|Overall Study|Study participation terminated by sponsor|3|||
147337428|NCT02928224|531401499|FG001|Overall Study|Study participation terminated by sponsor|8|||
147285018|NCT01490632|531209341|FG018|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
147285019|NCT01490632|531209342|FG019|Part C: Washout or Step-Down Period|Lost to Follow-up|0|||
147285020|NCT01490632|531209323|FG000|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
147285021|NCT01490632|531209324|FG001|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
147285022|NCT01490632|531209325|FG002|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
147285023|NCT01490632|531209326|FG003|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
147285024|NCT01490632|531209327|FG004|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
147285025|NCT01490632|531209328|FG005|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
147285026|NCT01490632|531209329|FG006|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
147285027|NCT01490632|531209330|FG007|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
147285028|NCT01490632|531209331|FG008|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
147285029|NCT01490632|531209332|FG009|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
147285030|NCT01490632|531209333|FG010|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
147285031|NCT01490632|531209334|FG011|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
147285032|NCT01490632|531209335|FG012|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
147285033|NCT01490632|531209336|FG013|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
147285034|NCT01490632|531209337|FG014|Part C: Washout or Step-Down Period|Withdrawal by Subject|2|||
147285035|NCT01490632|531209338|FG015|Part C: Washout or Step-Down Period|Withdrawal by Subject|1|||
147285036|NCT01490632|531209339|FG016|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
147285037|NCT01490632|531209340|FG017|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
147285038|NCT01490632|531209341|FG018|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
147285039|NCT01490632|531209342|FG019|Part C: Washout or Step-Down Period|Withdrawal by Subject|0|||
147285040|NCT01490632|531209323|FG000|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
147285041|NCT01490632|531209324|FG001|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
147285042|NCT01490632|531209325|FG002|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
147285043|NCT01490632|531209326|FG003|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
147285044|NCT01490632|531209327|FG004|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
147285045|NCT01490632|531209328|FG005|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
147285046|NCT01490632|531209329|FG006|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
147285047|NCT01490632|531209330|FG007|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
147285048|NCT01490632|531209331|FG008|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
147285049|NCT01490632|531209332|FG009|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
147285050|NCT01490632|531209333|FG010|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
147285051|NCT01490632|531209334|FG011|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
147285052|NCT01490632|531209335|FG012|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|5|||
147285053|NCT01490632|531209336|FG013|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|9|||
147285054|NCT01490632|531209337|FG014|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|14|||
147285055|NCT01490632|531209338|FG015|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|34|||
147285056|NCT01490632|531209339|FG016|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
147285057|NCT01490632|531209340|FG017|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
147285058|NCT01490632|531209341|FG018|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
147285059|NCT01490632|531209342|FG019|Part C: Washout or Step-Down Period|Did Not Qualify for Part D Per Protocol|0|||
147285060|NCT01490632|531209323|FG000|Part D: Re-Treatment Period|Adverse Event|0|||
147285061|NCT01490632|531209324|FG001|Part D: Re-Treatment Period|Adverse Event|0|||
147285062|NCT01490632|531209325|FG002|Part D: Re-Treatment Period|Adverse Event|0|||
147285063|NCT01490632|531209326|FG003|Part D: Re-Treatment Period|Adverse Event|0|||
147285064|NCT01490632|531209327|FG004|Part D: Re-Treatment Period|Adverse Event|0|||
147285065|NCT01490632|531209328|FG005|Part D: Re-Treatment Period|Adverse Event|0|||
147285066|NCT01490632|531209329|FG006|Part D: Re-Treatment Period|Adverse Event|0|||
147285067|NCT01490632|531209330|FG007|Part D: Re-Treatment Period|Adverse Event|0|||
147285068|NCT01490632|531209331|FG008|Part D: Re-Treatment Period|Adverse Event|0|||
147285069|NCT01490632|531209332|FG009|Part D: Re-Treatment Period|Adverse Event|0|||
147285070|NCT01490632|531209333|FG010|Part D: Re-Treatment Period|Adverse Event|0|||
147285071|NCT01490632|531209334|FG011|Part D: Re-Treatment Period|Adverse Event|0|||
147285072|NCT01490632|531209335|FG012|Part D: Re-Treatment Period|Adverse Event|0|||
147285073|NCT01490632|531209336|FG013|Part D: Re-Treatment Period|Adverse Event|0|||
147285074|NCT01490632|531209337|FG014|Part D: Re-Treatment Period|Adverse Event|0|||
147285075|NCT01490632|531209338|FG015|Part D: Re-Treatment Period|Adverse Event|0|||
147285076|NCT01490632|531209339|FG016|Part D: Re-Treatment Period|Adverse Event|0|||
147337429|NCT02928224|531401500|FG002|Overall Study|Study participation terminated by sponsor|12|||
147604113|NCT01775189|532367833|FG006|Treatment Phase: Washout Period 3|Protocol Violation|1|||
147604114|NCT01755767|532367834|FG000|Overall Study|Progressive Disease|8|||
147604115|NCT01755767|532367835|FG001|Overall Study|Progressive Disease|7|||
147604116|NCT01755767|532367836|FG002|Overall Study|Progressive Disease|91|||
147285077|NCT01490632|531209340|FG017|Part D: Re-Treatment Period|Adverse Event|1|||
147285078|NCT01490632|531209341|FG018|Part D: Re-Treatment Period|Adverse Event|1|||
147285079|NCT01490632|531209342|FG019|Part D: Re-Treatment Period|Adverse Event|3|||
147285080|NCT01490632|531209323|FG000|Part D: Re-Treatment Period|Death|0|||
147285081|NCT01490632|531209324|FG001|Part D: Re-Treatment Period|Death|0|||
147285082|NCT01490632|531209325|FG002|Part D: Re-Treatment Period|Death|0|||
147285083|NCT01490632|531209326|FG003|Part D: Re-Treatment Period|Death|0|||
147285084|NCT01490632|531209327|FG004|Part D: Re-Treatment Period|Death|0|||
147285085|NCT01490632|531209328|FG005|Part D: Re-Treatment Period|Death|0|||
147285086|NCT01490632|531209329|FG006|Part D: Re-Treatment Period|Death|0|||
147285087|NCT01490632|531209330|FG007|Part D: Re-Treatment Period|Death|0|||
147285088|NCT01490632|531209331|FG008|Part D: Re-Treatment Period|Death|0|||
147285089|NCT01490632|531209332|FG009|Part D: Re-Treatment Period|Death|0|||
147285090|NCT01490632|531209333|FG010|Part D: Re-Treatment Period|Death|0|||
147285091|NCT01490632|531209334|FG011|Part D: Re-Treatment Period|Death|0|||
147285092|NCT01490632|531209335|FG012|Part D: Re-Treatment Period|Death|0|||
147285093|NCT01490632|531209336|FG013|Part D: Re-Treatment Period|Death|0|||
147285094|NCT01490632|531209337|FG014|Part D: Re-Treatment Period|Death|0|||
147285095|NCT01490632|531209338|FG015|Part D: Re-Treatment Period|Death|0|||
147285096|NCT01490632|531209339|FG016|Part D: Re-Treatment Period|Death|0|||
147285097|NCT01490632|531209340|FG017|Part D: Re-Treatment Period|Death|0|||
147285098|NCT01490632|531209341|FG018|Part D: Re-Treatment Period|Death|1|||
147285099|NCT01490632|531209342|FG019|Part D: Re-Treatment Period|Death|0|||
147285100|NCT01490632|531209323|FG000|Part D: Re-Treatment Period|Lack of Efficacy|0|||
147285101|NCT01490632|531209324|FG001|Part D: Re-Treatment Period|Lack of Efficacy|0|||
147285102|NCT01490632|531209325|FG002|Part D: Re-Treatment Period|Lack of Efficacy|0|||
147285103|NCT01490632|531209326|FG003|Part D: Re-Treatment Period|Lack of Efficacy|0|||
147285104|NCT01490632|531209327|FG004|Part D: Re-Treatment Period|Lack of Efficacy|0|||
147285105|NCT01490632|531209328|FG005|Part D: Re-Treatment Period|Lack of Efficacy|0|||
147285106|NCT01490632|531209329|FG006|Part D: Re-Treatment Period|Lack of Efficacy|0|||
147285107|NCT01490632|531209330|FG007|Part D: Re-Treatment Period|Lack of Efficacy|0|||
147285108|NCT01490632|531209331|FG008|Part D: Re-Treatment Period|Lack of Efficacy|0|||
147285109|NCT01490632|531209332|FG009|Part D: Re-Treatment Period|Lack of Efficacy|0|||
147285110|NCT01490632|531209333|FG010|Part D: Re-Treatment Period|Lack of Efficacy|0|||
147285111|NCT01490632|531209334|FG011|Part D: Re-Treatment Period|Lack of Efficacy|0|||
147285112|NCT01490632|531209335|FG012|Part D: Re-Treatment Period|Lack of Efficacy|0|||
147285113|NCT01490632|531209336|FG013|Part D: Re-Treatment Period|Lack of Efficacy|0|||
147285114|NCT01490632|531209337|FG014|Part D: Re-Treatment Period|Lack of Efficacy|0|||
147285115|NCT01490632|531209338|FG015|Part D: Re-Treatment Period|Lack of Efficacy|0|||
147285116|NCT01490632|531209339|FG016|Part D: Re-Treatment Period|Lack of Efficacy|0|||
147285117|NCT01490632|531209340|FG017|Part D: Re-Treatment Period|Lack of Efficacy|3|||
147285118|NCT01490632|531209341|FG018|Part D: Re-Treatment Period|Lack of Efficacy|1|||
147285119|NCT01490632|531209342|FG019|Part D: Re-Treatment Period|Lack of Efficacy|2|||
147285120|NCT01490632|531209323|FG000|Part D: Re-Treatment Period|Lost to Follow-up|0|||
147285121|NCT01490632|531209324|FG001|Part D: Re-Treatment Period|Lost to Follow-up|0|||
147285122|NCT01490632|531209325|FG002|Part D: Re-Treatment Period|Lost to Follow-up|0|||
147285123|NCT01490632|531209326|FG003|Part D: Re-Treatment Period|Lost to Follow-up|0|||
147285124|NCT01490632|531209327|FG004|Part D: Re-Treatment Period|Lost to Follow-up|0|||
147285125|NCT01490632|531209328|FG005|Part D: Re-Treatment Period|Lost to Follow-up|0|||
147285126|NCT01490632|531209329|FG006|Part D: Re-Treatment Period|Lost to Follow-up|0|||
147285127|NCT01490632|531209330|FG007|Part D: Re-Treatment Period|Lost to Follow-up|0|||
147285128|NCT01490632|531209331|FG008|Part D: Re-Treatment Period|Lost to Follow-up|0|||
147337430|NCT02928224|531401501|FG003|Overall Study|Study participation terminated by sponsor|3|||
147337431|NCT02928224|531401498|FG000|Overall Study|Other|3|||
147337432|NCT02928224|531401499|FG001|Overall Study|Other|3|||
147337433|NCT02928224|531401500|FG002|Overall Study|Other|5|||
147337434|NCT02928224|531401501|FG003|Overall Study|Other|0|||
147337435|NCT02115139|531401502|FG000|Overall Study|Protocol Violation|1|||
147337436|NCT02115139|531401502|FG000|Overall Study|treatment discontinuation|6|||
147337437|NCT00468910|531401503|FG000|Overall Study|Lost to Follow-up|2|||
147337438|NCT00468910|531401504|FG001|Overall Study|Lost to Follow-up|1|||
147452321|NCT00328627|531819896|FG002|Overall Study|Protocol Violation|2|||
147285129|NCT01490632|531209332|FG009|Part D: Re-Treatment Period|Lost to Follow-up|0|||
147337439|NCT00468910|531401503|FG000|Overall Study|Withdrawal by Subject|2|||
147285130|NCT01490632|531209333|FG010|Part D: Re-Treatment Period|Lost to Follow-up|0|||
147285131|NCT01490632|531209334|FG011|Part D: Re-Treatment Period|Lost to Follow-up|0|||
147285132|NCT01490632|531209335|FG012|Part D: Re-Treatment Period|Lost to Follow-up|0|||
147285133|NCT01490632|531209336|FG013|Part D: Re-Treatment Period|Lost to Follow-up|0|||
147452322|NCT00328627|531819897|FG003|Overall Study|Protocol Violation|8|||
147285134|NCT01490632|531209337|FG014|Part D: Re-Treatment Period|Lost to Follow-up|0|||
147285135|NCT01490632|531209338|FG015|Part D: Re-Treatment Period|Lost to Follow-up|0|||
147285136|NCT01490632|531209339|FG016|Part D: Re-Treatment Period|Lost to Follow-up|0|||
147337440|NCT00468910|531401504|FG001|Overall Study|Withdrawal by Subject|1|||
147337441|NCT00468910|531401503|FG000|Overall Study|Medical Contraindication|0|||
147452323|NCT00328627|531819898|FG004|Overall Study|Protocol Violation|5|||
147285137|NCT01490632|531209340|FG017|Part D: Re-Treatment Period|Lost to Follow-up|0|||
147285138|NCT01490632|531209341|FG018|Part D: Re-Treatment Period|Lost to Follow-up|1|||
147285139|NCT01490632|531209342|FG019|Part D: Re-Treatment Period|Lost to Follow-up|0|||
147285140|NCT01490632|531209323|FG000|Part D: Re-Treatment Period|Physician Decision|0|||
147285141|NCT01490632|531209324|FG001|Part D: Re-Treatment Period|Physician Decision|0|||
147285142|NCT01490632|531209325|FG002|Part D: Re-Treatment Period|Physician Decision|0|||
147285143|NCT01490632|531209326|FG003|Part D: Re-Treatment Period|Physician Decision|0|||
147285144|NCT01490632|531209327|FG004|Part D: Re-Treatment Period|Physician Decision|0|||
147285145|NCT01490632|531209328|FG005|Part D: Re-Treatment Period|Physician Decision|0|||
147285146|NCT01490632|531209329|FG006|Part D: Re-Treatment Period|Physician Decision|0|||
147285147|NCT01490632|531209330|FG007|Part D: Re-Treatment Period|Physician Decision|0|||
147285148|NCT01490632|531209331|FG008|Part D: Re-Treatment Period|Physician Decision|0|||
147285149|NCT01490632|531209332|FG009|Part D: Re-Treatment Period|Physician Decision|0|||
147285150|NCT01490632|531209333|FG010|Part D: Re-Treatment Period|Physician Decision|0|||
147285151|NCT01490632|531209334|FG011|Part D: Re-Treatment Period|Physician Decision|0|||
147285152|NCT01490632|531209335|FG012|Part D: Re-Treatment Period|Physician Decision|0|||
147285153|NCT01490632|531209336|FG013|Part D: Re-Treatment Period|Physician Decision|0|||
147285154|NCT01490632|531209337|FG014|Part D: Re-Treatment Period|Physician Decision|0|||
147285155|NCT01490632|531209338|FG015|Part D: Re-Treatment Period|Physician Decision|0|||
147285156|NCT01490632|531209339|FG016|Part D: Re-Treatment Period|Physician Decision|0|||
147285157|NCT01490632|531209340|FG017|Part D: Re-Treatment Period|Physician Decision|0|||
147285158|NCT01490632|531209341|FG018|Part D: Re-Treatment Period|Physician Decision|1|||
147285159|NCT01490632|531209342|FG019|Part D: Re-Treatment Period|Physician Decision|1|||
147285160|NCT01490632|531209323|FG000|Part D: Re-Treatment Period|Protocol Violation|0|||
147285161|NCT01490632|531209324|FG001|Part D: Re-Treatment Period|Protocol Violation|0|||
147285162|NCT01490632|531209325|FG002|Part D: Re-Treatment Period|Protocol Violation|0|||
147285163|NCT01490632|531209326|FG003|Part D: Re-Treatment Period|Protocol Violation|0|||
147285164|NCT01490632|531209327|FG004|Part D: Re-Treatment Period|Protocol Violation|0|||
147285165|NCT01490632|531209328|FG005|Part D: Re-Treatment Period|Protocol Violation|0|||
147285166|NCT01490632|531209329|FG006|Part D: Re-Treatment Period|Protocol Violation|0|||
147285167|NCT01490632|531209330|FG007|Part D: Re-Treatment Period|Protocol Violation|0|||
147285168|NCT01490632|531209331|FG008|Part D: Re-Treatment Period|Protocol Violation|0|||
147285169|NCT01490632|531209332|FG009|Part D: Re-Treatment Period|Protocol Violation|0|||
147285170|NCT01490632|531209333|FG010|Part D: Re-Treatment Period|Protocol Violation|0|||
147285171|NCT01490632|531209334|FG011|Part D: Re-Treatment Period|Protocol Violation|0|||
147285172|NCT01490632|531209335|FG012|Part D: Re-Treatment Period|Protocol Violation|0|||
147285173|NCT01490632|531209336|FG013|Part D: Re-Treatment Period|Protocol Violation|0|||
147285174|NCT01490632|531209337|FG014|Part D: Re-Treatment Period|Protocol Violation|0|||
147285175|NCT01490632|531209338|FG015|Part D: Re-Treatment Period|Protocol Violation|0|||
147285176|NCT01490632|531209339|FG016|Part D: Re-Treatment Period|Protocol Violation|0|||
147285177|NCT01490632|531209340|FG017|Part D: Re-Treatment Period|Protocol Violation|0|||
147285178|NCT01490632|531209341|FG018|Part D: Re-Treatment Period|Protocol Violation|1|||
147285179|NCT01490632|531209342|FG019|Part D: Re-Treatment Period|Protocol Violation|0|||
147285180|NCT01490632|531209323|FG000|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
147285181|NCT01490632|531209324|FG001|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
147285182|NCT01490632|531209325|FG002|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
147285183|NCT01490632|531209326|FG003|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
147285184|NCT01490632|531209327|FG004|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
147285185|NCT01490632|531209328|FG005|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
147285186|NCT01490632|531209329|FG006|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
147285187|NCT01490632|531209330|FG007|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
147285188|NCT01490632|531209331|FG008|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
147337442|NCT00468910|531401504|FG001|Overall Study|Medical Contraindication|1|||
147337443|NCT01909778|531401505|FG000|Overall Study|failed screening|1|||
147337444|NCT00919763|531401506|FG000|Overall Study|Adverse Event|7|||
147337445|NCT00919763|531401507|FG001|Overall Study|Adverse Event|1|||
147337446|NCT00919763|531401506|FG000|Overall Study|Lost to Follow-up|1|||
147337447|NCT00919763|531401507|FG001|Overall Study|Lost to Follow-up|0|||
147337448|NCT00919763|531401506|FG000|Overall Study|Protocol Violation|1|||
147337449|NCT00919763|531401507|FG001|Overall Study|Protocol Violation|1|||
147337450|NCT00919763|531401506|FG000|Overall Study|Withdrawal by Subject|3|||
147337451|NCT00919763|531401507|FG001|Overall Study|Withdrawal by Subject|1|||
147337452|NCT00919763|531401506|FG000|Overall Study|Non-compliance|0|||
147337453|NCT00919763|531401507|FG001|Overall Study|Non-compliance|1|||
147337454|NCT04740164|531401509|FG000|Overall Study|Lack of Efficacy|4|||
147337455|NCT04740164|531401510|FG001|Overall Study|Lack of Efficacy|0|||
147337456|NCT04740164|531401509|FG000|Overall Study|Physician Decision|3|||
147285189|NCT01490632|531209332|FG009|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
147285190|NCT01490632|531209333|FG010|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
147285191|NCT01490632|531209334|FG011|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
147337457|NCT04740164|531401510|FG001|Overall Study|Physician Decision|3|||
147337458|NCT01152190|531401511|FG000|Overall Study|Adverse Event|2|||
147285192|NCT01490632|531209335|FG012|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
147285193|NCT01490632|531209336|FG013|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
147285194|NCT01490632|531209337|FG014|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
147285195|NCT01490632|531209338|FG015|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
147285196|NCT01490632|531209339|FG016|Part D: Re-Treatment Period|Withdrawal by Subject|0|||
147452324|NCT00328627|531819899|FG005|Overall Study|Protocol Violation|5|||
147285197|NCT01490632|531209340|FG017|Part D: Re-Treatment Period|Withdrawal by Subject|1|||
147285198|NCT01490632|531209341|FG018|Part D: Re-Treatment Period|Withdrawal by Subject|1|||
147285199|NCT01490632|531209342|FG019|Part D: Re-Treatment Period|Withdrawal by Subject|1|||
147285200|NCT05732454|531209344|FG000|Part 1: DB Period|Withdrawal by Subject|1|||
147285201|NCT05732454|531209345|FG001|Part 1: DB Period|Withdrawal by Subject|2|||
147285202|NCT05732454|531209344|FG000|Part 1: DB Period|Adverse Event|1|||
147285203|NCT05732454|531209345|FG001|Part 1: DB Period|Adverse Event|0|||
147285204|NCT05732454|531209344|FG000|Part 1: DB Period|Lost to Follow-up|1|||
147285205|NCT05732454|531209345|FG001|Part 1: DB Period|Lost to Follow-up|0|||
147285206|NCT05732454|531209344|FG000|Part 1: DB Period|Protocol Violation|0|||
147285207|NCT05732454|531209345|FG001|Part 1: DB Period|Protocol Violation|1|||
147285208|NCT05732454|531209344|FG000|Part 1: OLE Period|Study Terminated by Sponsor|25|||
147285209|NCT05732454|531209345|FG001|Part 1: OLE Period|Study Terminated by Sponsor|19|||
147285210|NCT05732454|531209344|FG000|Part 1: OLE Period|Withdrawal by Subject|2|||
147285211|NCT05732454|531209345|FG001|Part 1: OLE Period|Withdrawal by Subject|3|||
147285212|NCT05732454|531209344|FG000|Part 1: OLE Period|Adverse Event|0|||
147285213|NCT05732454|531209345|FG001|Part 1: OLE Period|Adverse Event|1|||
147285214|NCT05732454|531209344|FG000|Part 1: OLE Period|Lack of Efficacy|0|||
147285215|NCT05732454|531209345|FG001|Part 1: OLE Period|Lack of Efficacy|1|||
147285216|NCT01153633|531209346|FG000|Overall Study|Protocol Violation|1|||
147285217|NCT01153633|531209347|FG001|Overall Study|Protocol Violation|1|||
147285218|NCT01153633|531209346|FG000|Overall Study|Therapeutic failure|3|||
147285219|NCT01153633|531209347|FG001|Overall Study|Therapeutic failure|3|||
147285220|NCT00384085|531209348|FG000|Overall Study|Adverse Event|5|||
147285221|NCT00384085|531209349|FG001|Overall Study|Adverse Event|5|||
147285222|NCT00384085|531209350|FG002|Overall Study|Adverse Event|4|||
147285223|NCT00384085|531209348|FG000|Overall Study|Lack of Efficacy|0|||
147285224|NCT00384085|531209349|FG001|Overall Study|Lack of Efficacy|3|||
147285225|NCT00384085|531209350|FG002|Overall Study|Lack of Efficacy|2|||
147285226|NCT00384085|531209348|FG000|Overall Study|No longer Requires Study Treatment|1|||
147452325|NCT00328627|531819900|FG006|Overall Study|Protocol Violation|6|||
147452326|NCT00328627|531819901|FG007|Overall Study|Protocol Violation|2|||
147452327|NCT00328627|531819902|FG008|Overall Study|Protocol Violation|1|||
147452328|NCT00328627|531819903|FG009|Overall Study|Protocol Violation|4|||
147452329|NCT00328627|531819904|FG010|Overall Study|Protocol Violation|6|||
147604117|NCT01755767|532367837|FG003|Overall Study|Progressive Disease|43|||
147604118|NCT01755767|532367834|FG000|Overall Study|Clinical Disease Progression|4|||
147604119|NCT01755767|532367835|FG001|Overall Study|Clinical Disease Progression|2|||
147285227|NCT00384085|531209349|FG001|Overall Study|No longer Requires Study Treatment|0|||
147285228|NCT00384085|531209350|FG002|Overall Study|No longer Requires Study Treatment|1|||
147285229|NCT00384085|531209348|FG000|Overall Study|Protocol Violation|2|||
147285230|NCT00384085|531209349|FG001|Overall Study|Protocol Violation|2|||
147285231|NCT00384085|531209350|FG002|Overall Study|Protocol Violation|2|||
147285232|NCT00384085|531209348|FG000|Overall Study|Lost to Follow-up|9|||
147285233|NCT00384085|531209349|FG001|Overall Study|Lost to Follow-up|9|||
147285234|NCT00384085|531209350|FG002|Overall Study|Lost to Follow-up|10|||
147285235|NCT00384085|531209348|FG000|Overall Study|Progressive Disease|0|||
147285236|NCT00384085|531209349|FG001|Overall Study|Progressive Disease|1|||
147285237|NCT00384085|531209350|FG002|Overall Study|Progressive Disease|0|||
147285238|NCT00384085|531209348|FG000|Overall Study|Withdrawal by Subject|14|||
147285239|NCT00384085|531209349|FG001|Overall Study|Withdrawal by Subject|19|||
147285240|NCT00384085|531209350|FG002|Overall Study|Withdrawal by Subject|29|||
147285241|NCT00384085|531209348|FG000|Overall Study|Patient non-compliant|4|||
147285242|NCT00384085|531209349|FG001|Overall Study|Patient non-compliant|4|||
147285243|NCT00384085|531209350|FG002|Overall Study|Patient non-compliant|5|||
147285244|NCT00384085|531209348|FG000|Overall Study|Physician Decision|1|||
147285245|NCT00384085|531209349|FG001|Overall Study|Physician Decision|0|||
147285246|NCT00384085|531209350|FG002|Overall Study|Physician Decision|0|||
147285247|NCT00384085|531209348|FG000|Overall Study|Loss of site personnel|1|||
147285248|NCT00384085|531209349|FG001|Overall Study|Loss of site personnel|0|||
147285249|NCT00384085|531209350|FG002|Overall Study|Loss of site personnel|1|||
147604120|NCT01755767|532367836|FG002|Overall Study|Clinical Disease Progression|29|||
147285250|NCT00384085|531209348|FG000|Overall Study|Sponsor decision|1|||
147285251|NCT00384085|531209349|FG001|Overall Study|Sponsor decision|2|||
147285252|NCT00384085|531209350|FG002|Overall Study|Sponsor decision|1|||
147285253|NCT00384085|531209348|FG000|Overall Study|Patient moved|1|||
147285254|NCT00384085|531209349|FG001|Overall Study|Patient moved|0|||
147285255|NCT00384085|531209350|FG002|Overall Study|Patient moved|1|||
147285256|NCT00384085|531209348|FG000|Overall Study|Patient required surgery|0|||
147285257|NCT00384085|531209349|FG001|Overall Study|Patient required surgery|1|||
147285258|NCT00384085|531209350|FG002|Overall Study|Patient required surgery|0|||
147337459|NCT01152190|531401512|FG001|Overall Study|Adverse Event|4|||
147337460|NCT01152190|531401511|FG000|Overall Study|Death|1|||
147337461|NCT01152190|531401512|FG001|Overall Study|Death|0|||
147337462|NCT01152190|531401511|FG000|Overall Study|Protocol Violation|1|||
147337463|NCT01152190|531401512|FG001|Overall Study|Protocol Violation|1|||
147337464|NCT01152190|531401511|FG000|Overall Study|Withdrawal by Subject|1|||
147337465|NCT01152190|531401512|FG001|Overall Study|Withdrawal by Subject|3|||
147337466|NCT00433199|531401517|FG000|Double-Blind Period|Adverse Event|0|||
147337467|NCT00433199|531401518|FG001|Double-Blind Period|Adverse Event|25|||
147285259|NCT03725982|531209353|FG000|First Intervention|Withdrawal by Subject|0|||
147285260|NCT03725982|531209354|FG001|First Intervention|Withdrawal by Subject|1|||
147285261|NCT03725982|531209353|FG000|First Intervention|Physician Decision|1|||
147285262|NCT03725982|531209354|FG001|First Intervention|Physician Decision|1|||
147285263|NCT01944631|531209358|FG000|Overall Study|Adverse Event|1|||
147285264|NCT01944631|531209359|FG001|Overall Study|Adverse Event|0|||
147285265|NCT01944631|531209358|FG000|Overall Study|Lost to Follow-up|3|||
147285266|NCT01944631|531209359|FG001|Overall Study|Lost to Follow-up|1|||
147285267|NCT01944631|531209358|FG000|Overall Study|Withdrawal by Subject|0|||
147285268|NCT01944631|531209359|FG001|Overall Study|Withdrawal by Subject|1|||
147285269|NCT00838110|531209360|FG000|Overall Study|Death|0|||
147285270|NCT00838110|531209361|FG001|Overall Study|Death|0|||
147285271|NCT00838110|531209362|FG002|Overall Study|Death|1|||
147285272|NCT00838110|531209363|FG003|Overall Study|Death|2|||
147285273|NCT00838110|531209360|FG000|Overall Study|Adverse Event|11|||
147285274|NCT00838110|531209361|FG001|Overall Study|Adverse Event|10|||
147285275|NCT00838110|531209362|FG002|Overall Study|Adverse Event|8|||
147285276|NCT00838110|531209363|FG003|Overall Study|Adverse Event|7|||
147285277|NCT00838110|531209360|FG000|Overall Study|Withdrawal by Subject|5|||
147285278|NCT00838110|531209361|FG001|Overall Study|Withdrawal by Subject|6|||
147285279|NCT00838110|531209362|FG002|Overall Study|Withdrawal by Subject|3|||
147285280|NCT00838110|531209363|FG003|Overall Study|Withdrawal by Subject|4|||
147285281|NCT00838110|531209360|FG000|Overall Study|Other|3|||
147285282|NCT00838110|531209361|FG001|Overall Study|Other|3|||
147285283|NCT00838110|531209362|FG002|Overall Study|Other|3|||
147285284|NCT00838110|531209363|FG003|Overall Study|Other|2|||
147285285|NCT00838110|531209360|FG000|Overall Study|Protocol Violation|0|||
147285286|NCT00838110|531209361|FG001|Overall Study|Protocol Violation|2|||
147285287|NCT00838110|531209362|FG002|Overall Study|Protocol Violation|1|||
147285288|NCT00838110|531209363|FG003|Overall Study|Protocol Violation|1|||
147285289|NCT00838110|531209360|FG000|Overall Study|Lost to Follow-up|3|||
147285290|NCT00838110|531209361|FG001|Overall Study|Lost to Follow-up|0|||
147285291|NCT00838110|531209362|FG002|Overall Study|Lost to Follow-up|0|||
147285292|NCT00838110|531209363|FG003|Overall Study|Lost to Follow-up|0|||
147285293|NCT00838110|531209360|FG000|Overall Study|Did not meet eligibility criteria|0|||
147285294|NCT00838110|531209361|FG001|Overall Study|Did not meet eligibility criteria|0|||
147285295|NCT00838110|531209362|FG002|Overall Study|Did not meet eligibility criteria|1|||
147285296|NCT00838110|531209363|FG003|Overall Study|Did not meet eligibility criteria|2|||
147285297|NCT00838110|531209360|FG000|Overall Study|Randomized but not treated|0|||
147285298|NCT00838110|531209361|FG001|Overall Study|Randomized but not treated|1|||
147604121|NCT01755767|532367837|FG003|Overall Study|Clinical Disease Progression|20|||
147604122|NCT01755767|532367834|FG000|Overall Study|Radiographic Disease Progression|9|||
147604123|NCT01755767|532367835|FG001|Overall Study|Radiographic Disease Progression|4|||
147604124|NCT01755767|532367836|FG002|Overall Study|Radiographic Disease Progression|44|||
147604125|NCT01755767|532367837|FG003|Overall Study|Radiographic Disease Progression|27|||
147604126|NCT01755767|532367834|FG000|Overall Study|Adverse Event|6|||
147604127|NCT01755767|532367835|FG001|Overall Study|Adverse Event|0|||
147604128|NCT01755767|532367836|FG002|Overall Study|Adverse Event|28|||
147604129|NCT01755767|532367837|FG003|Overall Study|Adverse Event|11|||
147604130|NCT01755767|532367834|FG000|Overall Study|Death|1|||
147604131|NCT01755767|532367835|FG001|Overall Study|Death|2|||
147285299|NCT00838110|531209362|FG002|Overall Study|Randomized but not treated|0|||
147285300|NCT00838110|531209363|FG003|Overall Study|Randomized but not treated|0|||
147285301|NCT01003899|531209364|FG000|Overall Study|Other Adverse Event|8|||
147285302|NCT01003899|531209364|FG000|Overall Study|Not entered|4|||
147285303|NCT01003899|531209364|FG000|Overall Study|Not treated|1|||
147285304|NCT01003899|531209364|FG000|Overall Study|Progressive disease|34|||
147285305|NCT00352365|531209365|FG000|Induction Therapy|Adverse Event|7|||
147337468|NCT00433199|531401517|FG000|Double-Blind Period|Lack of Efficacy|0|||
147337469|NCT00433199|531401518|FG001|Double-Blind Period|Lack of Efficacy|2|||
147337470|NCT00433199|531401517|FG000|Double-Blind Period|Lost to Follow-up|2|||
147337471|NCT00433199|531401518|FG001|Double-Blind Period|Lost to Follow-up|5|||
147604132|NCT01755767|532367836|FG002|Overall Study|Death|15|||
147604133|NCT01755767|532367837|FG003|Overall Study|Death|4|||
147604134|NCT01755767|532367834|FG000|Overall Study|Subject Decision|0|||
147285306|NCT00352365|531209365|FG000|Induction Therapy|Progression/Relapse|8|||
147285307|NCT00352365|531209365|FG000|Induction Therapy|Death|7|||
147285308|NCT00352365|531209365|FG000|Induction Therapy|Not protocol specified|1|||
147285309|NCT00352365|531209365|FG000|Induction Therapy|Not eligible|3|||
147337472|NCT00433199|531401517|FG000|Double-Blind Period|Withdrawal by Subject|8|||
147604135|NCT01755767|532367835|FG001|Overall Study|Subject Decision|0|||
147604136|NCT01755767|532367836|FG002|Overall Study|Subject Decision|10|||
147604137|NCT01755767|532367837|FG003|Overall Study|Subject Decision|3|||
147604138|NCT01755767|532367834|FG000|Overall Study|Withdrawal by Subject|0|||
147604139|NCT01755767|532367835|FG001|Overall Study|Withdrawal by Subject|0|||
147604140|NCT01755767|532367836|FG002|Overall Study|Withdrawal by Subject|2|||
147604141|NCT01755767|532367837|FG003|Overall Study|Withdrawal by Subject|1|||
147604142|NCT01755767|532367834|FG000|Overall Study|Other|0|||
147604143|NCT01755767|532367835|FG001|Overall Study|Other|0|||
147285310|NCT00352365|531209365|FG000|Induction Therapy|Death before starting protocol therapy|1|||
147285311|NCT00352365|531209365|FG000|Maintenance Therapy|Progression/Relapse|3|||
147285312|NCT00352365|531209365|FG000|Maintenance Therapy|Death|2|||
147285313|NCT00352365|531209365|FG000|Maintenance Therapy|Not protocol specified|3|||
147285314|NCT00352365|531209365|FG000|Maintenance Therapy|Not eligible|4|||
147285315|NCT01262651|531209366|FG000|Overall Study|Adverse Event|40|||
147285316|NCT01262651|531209367|FG001|Overall Study|Adverse Event|35|||
147285317|NCT01262651|531209366|FG000|Overall Study|Withdrawal by Subject|15|||
147285318|NCT01262651|531209367|FG001|Overall Study|Withdrawal by Subject|11|||
147285319|NCT01262651|531209366|FG000|Overall Study|Withdrawal by Investigator|2|||
147285320|NCT01262651|531209367|FG001|Overall Study|Withdrawal by Investigator|2|||
147285321|NCT01262651|531209366|FG000|Overall Study|Met Withdrawal Criteria|1|||
147285322|NCT01262651|531209367|FG001|Overall Study|Met Withdrawal Criteria|0|||
147285323|NCT02811861|531209368|FG000|Overall Study|Radiological Disease Progression|123|||
147285324|NCT02811861|531209369|FG001|Overall Study|Radiological Disease Progression|97|||
147285325|NCT02811861|531209370|FG002|Overall Study|Radiological Disease Progression|174|||
147285326|NCT02811861|531209368|FG000|Overall Study|Clinical Disease Progression|20|||
147285327|NCT02811861|531209369|FG001|Overall Study|Clinical Disease Progression|19|||
147285328|NCT02811861|531209370|FG002|Overall Study|Clinical Disease Progression|22|||
147285329|NCT02811861|531209368|FG000|Overall Study|Adverse Event|63|||
147285330|NCT02811861|531209369|FG001|Overall Study|Adverse Event|60|||
147285331|NCT02811861|531209370|FG002|Overall Study|Adverse Event|41|||
147285332|NCT02811861|531209368|FG000|Overall Study|Lost to Follow-up|0|||
147285333|NCT02811861|531209369|FG001|Overall Study|Lost to Follow-up|0|||
147285334|NCT02811861|531209370|FG002|Overall Study|Lost to Follow-up|1|||
147285335|NCT02811861|531209368|FG000|Overall Study|Subject Choice|29|||
147285336|NCT02811861|531209369|FG001|Overall Study|Subject Choice|17|||
147285337|NCT02811861|531209370|FG002|Overall Study|Subject Choice|23|||
147285338|NCT02811861|531209368|FG000|Overall Study|Withdrawal by Subject|4|||
147285339|NCT02811861|531209369|FG001|Overall Study|Withdrawal by Subject|4|||
147285340|NCT02811861|531209370|FG002|Overall Study|Withdrawal by Subject|9|||
147285341|NCT02811861|531209368|FG000|Overall Study|Other|4|||
147285342|NCT02811861|531209369|FG001|Overall Study|Other|13|||
147285343|NCT02811861|531209370|FG002|Overall Study|Other|3|||
147285344|NCT02811861|531209368|FG000|Overall Study|Treatment Ongoing at Cutoff Date|112|||
147285345|NCT02811861|531209369|FG001|Overall Study|Treatment Ongoing at Cutoff Date|142|||
147285346|NCT02811861|531209370|FG002|Overall Study|Treatment Ongoing at Cutoff Date|67|||
147285347|NCT02811861|531209368|FG000|Overall Study|Randomized but not treated|2|||
147285348|NCT02811861|531209369|FG001|Overall Study|Randomized but not treated|3|||
147285349|NCT02811861|531209370|FG002|Overall Study|Randomized but not treated|17|||
147285350|NCT04743908|531209371|FG000|Overall Study|Death|1|||
147285351|NCT04743908|531209372|FG001|Overall Study|Death|0|||
147285352|NCT04743908|531209371|FG000|Overall Study|Lost to Follow-up|181|||
147285353|NCT04743908|531209372|FG001|Overall Study|Lost to Follow-up|180|||
147285354|NCT04743908|531209371|FG000|Overall Study|Withdrawal by Subject|1|||
147285355|NCT04743908|531209372|FG001|Overall Study|Withdrawal by Subject|2|||
147285356|NCT04969783|531209376|FG000|Overall Study|Lost to Follow-up|2|||
147285357|NCT04969783|531209377|FG001|Overall Study|Lost to Follow-up|0|||
147285358|NCT04969783|531209376|FG000|Overall Study|Withdrawal by Subject|4|||
147285359|NCT04969783|531209377|FG001|Overall Study|Withdrawal by Subject|0|||
147285360|NCT04969783|531209376|FG000|Overall Study|Physician Decision|6|||
147285361|NCT04969783|531209377|FG001|Overall Study|Physician Decision|0|||
147285362|NCT00512135|531209378|FG000|Overall Study|Not Treated|5|||
147285363|NCT00512135|531209378|FG000|Overall Study|Lack of Efficacy|2|||
147285364|NCT00512135|531209378|FG000|Overall Study|Adverse Event|6|||
147285365|NCT00512135|531209378|FG000|Overall Study|Withdrawal by Subject|22|||
147285366|NCT00512135|531209378|FG000|Overall Study|Lost to Follow-up|27|||
147285367|NCT00512135|531209378|FG000|Overall Study|Other|22|||
147285368|NCT03422250|531209379|FG000|Intervention|Adverse Event|0|||
147285369|NCT03422250|531209380|FG001|Intervention|Adverse Event|1|||
147285370|NCT03422250|531209381|FG002|Intervention|Adverse Event|0|||
147285371|NCT03422250|531209382|FG003|Intervention|Adverse Event|1|||
147604144|NCT01755767|532367836|FG002|Overall Study|Other|2|||
147604145|NCT01755767|532367837|FG003|Overall Study|Other|3|||
147604146|NCT01755767|532367834|FG000|Overall Study|Ongoing Treatment as of 06 Jan 2017|0|||
147285372|NCT03422250|531209379|FG000|Intervention|safety (psoriasis, cortical vascular lesions on MRI)|1|||
147285373|NCT03422250|531209380|FG001|Intervention|safety (psoriasis, cortical vascular lesions on MRI)|0|||
147285374|NCT03422250|531209381|FG002|Intervention|safety (psoriasis, cortical vascular lesions on MRI)|2|||
147285375|NCT03422250|531209382|FG003|Intervention|safety (psoriasis, cortical vascular lesions on MRI)|0|||
147285376|NCT03422250|531209379|FG000|Follow-up|Withdrawal by Subject|0|||
147285377|NCT03422250|531209380|FG001|Follow-up|Withdrawal by Subject|0|||
147285378|NCT03422250|531209381|FG002|Follow-up|Withdrawal by Subject|0|||
147285379|NCT03422250|531209382|FG003|Follow-up|Withdrawal by Subject|1|||
147285380|NCT03422250|531209379|FG000|Follow-up|Adverse Event|0|||
147285381|NCT03422250|531209380|FG001|Follow-up|Adverse Event|0|||
147285382|NCT03422250|531209381|FG002|Follow-up|Adverse Event|0|||
147285383|NCT03422250|531209382|FG003|Follow-up|Adverse Event|1|||
147285384|NCT00377819|531209385|FG000|Overall Study|Adverse Event|2|||
147285385|NCT00377819|531209386|FG001|Overall Study|Adverse Event|3|||
147285386|NCT00377819|531209385|FG000|Overall Study|Withdrawal by Subject|10|||
147285387|NCT00377819|531209386|FG001|Overall Study|Withdrawal by Subject|4|||
147285388|NCT00377819|531209385|FG000|Overall Study|Death|0|||
147285389|NCT00377819|531209386|FG001|Overall Study|Death|1|||
147285390|NCT00377819|531209385|FG000|Overall Study|Lost to Follow-up|0|||
147285391|NCT00377819|531209386|FG001|Overall Study|Lost to Follow-up|1|||
147285392|NCT00377819|531209385|FG000|Overall Study|Protocol Violation|1|||
147285393|NCT00377819|531209386|FG001|Overall Study|Protocol Violation|1|||
147285394|NCT00467870|531209393|FG000|Overall Study|Adverse Event|13|||
147285395|NCT00467870|531209394|FG001|Overall Study|Adverse Event|9|||
147285396|NCT00467870|531209395|FG002|Overall Study|Adverse Event|1|||
147285397|NCT00467870|531209396|FG003|Overall Study|Adverse Event|15|||
147285398|NCT00467870|531209397|FG004|Overall Study|Adverse Event|15|||
147285399|NCT00467870|531209398|FG005|Overall Study|Adverse Event|1|||
147285400|NCT00467870|531209393|FG000|Overall Study|Protocol Violation|2|||
147285401|NCT00467870|531209394|FG001|Overall Study|Protocol Violation|1|||
147285402|NCT00467870|531209395|FG002|Overall Study|Protocol Violation|1|||
147285403|NCT00467870|531209396|FG003|Overall Study|Protocol Violation|2|||
147285404|NCT00467870|531209397|FG004|Overall Study|Protocol Violation|0|||
147285405|NCT00467870|531209398|FG005|Overall Study|Protocol Violation|0|||
147285406|NCT00467870|531209393|FG000|Overall Study|Withdrawal by Subject|14|||
147285407|NCT00467870|531209394|FG001|Overall Study|Withdrawal by Subject|21|||
147285408|NCT00467870|531209395|FG002|Overall Study|Withdrawal by Subject|0|||
147285409|NCT00467870|531209396|FG003|Overall Study|Withdrawal by Subject|9|||
147285410|NCT00467870|531209397|FG004|Overall Study|Withdrawal by Subject|10|||
147285411|NCT00467870|531209398|FG005|Overall Study|Withdrawal by Subject|1|||
147285412|NCT00467870|531209393|FG000|Overall Study|Lost to Follow-up|5|||
147285413|NCT00467870|531209394|FG001|Overall Study|Lost to Follow-up|3|||
147285414|NCT00467870|531209395|FG002|Overall Study|Lost to Follow-up|1|||
147285415|NCT00467870|531209396|FG003|Overall Study|Lost to Follow-up|1|||
147285416|NCT00467870|531209397|FG004|Overall Study|Lost to Follow-up|3|||
147285417|NCT00467870|531209398|FG005|Overall Study|Lost to Follow-up|0|||
147285418|NCT00467870|531209393|FG000|Overall Study|Subject Non-compliance|3|||
147285419|NCT00467870|531209394|FG001|Overall Study|Subject Non-compliance|4|||
147285420|NCT00467870|531209395|FG002|Overall Study|Subject Non-compliance|0|||
147285421|NCT00467870|531209396|FG003|Overall Study|Subject Non-compliance|1|||
147285422|NCT00467870|531209397|FG004|Overall Study|Subject Non-compliance|5|||
147285423|NCT00467870|531209398|FG005|Overall Study|Subject Non-compliance|0|||
147285424|NCT00467870|531209393|FG000|Overall Study|Other/Unknown|8|||
147285425|NCT00467870|531209394|FG001|Overall Study|Other/Unknown|5|||
147285426|NCT00467870|531209395|FG002|Overall Study|Other/Unknown|1|||
147285427|NCT00467870|531209396|FG003|Overall Study|Other/Unknown|5|||
147285428|NCT00467870|531209397|FG004|Overall Study|Other/Unknown|4|||
147285429|NCT00467870|531209398|FG005|Overall Study|Other/Unknown|0|||
147285430|NCT01917526|531209399|FG000|Overall Study|Protocol Violation|1|||
147285431|NCT01917526|531209400|FG001|Overall Study|Protocol Violation|1|||
147285432|NCT02261363|531209401|FG000|Overall Study|Lost to Follow-up|21|||
147285433|NCT01517802|531209402|FG000|Overall Study|Death|1|||
147285434|NCT03268811|531209410|FG000|Overall Study|Adverse Event|0|||
147285435|NCT03268811|531209411|FG001|Overall Study|Adverse Event|1|||
147285436|NCT02031276|531209412|FG000|Period 1 Double-blind IV|Adverse Event|6|||
147285437|NCT02031276|531209413|FG001|Period 1 Double-blind IV|Adverse Event|5|||
147285438|NCT02031276|531209414|FG002|Period 1 Double-blind IV|Adverse Event|1|||
147285439|NCT02031276|531209412|FG000|Period 1 Double-blind IV|Other|0|||
147285440|NCT02031276|531209413|FG001|Period 1 Double-blind IV|Other|1|||
147285441|NCT02031276|531209414|FG002|Period 1 Double-blind IV|Other|0|||
147285442|NCT02031276|531209412|FG000|Period 2 Open-label Risankizumab IV|Adverse Event|1|||
147285443|NCT02031276|531209413|FG001|Period 2 Open-label Risankizumab IV|Adverse Event|0|||
147285444|NCT02031276|531209414|FG002|Period 2 Open-label Risankizumab IV|Adverse Event|0|||
147285445|NCT02031276|531209412|FG000|Period 2 Open-label Risankizumab IV|Withdrawal by Subject|3|||
147285446|NCT02031276|531209413|FG001|Period 2 Open-label Risankizumab IV|Withdrawal by Subject|0|||
147285447|NCT02031276|531209414|FG002|Period 2 Open-label Risankizumab IV|Withdrawal by Subject|0|||
147285448|NCT02031276|531209412|FG000|Period 2 Open-label Risankizumab IV|Other|0|||
147285449|NCT02031276|531209413|FG001|Period 2 Open-label Risankizumab IV|Other|2|||
147285450|NCT02031276|531209414|FG002|Period 2 Open-label Risankizumab IV|Other|1|||
147285451|NCT02031276|531209412|FG000|Period 3 Open-label Risankizumab SC|Adverse Event|0|||
147285452|NCT02031276|531209413|FG001|Period 3 Open-label Risankizumab SC|Adverse Event|2|||
147285453|NCT02031276|531209414|FG002|Period 3 Open-label Risankizumab SC|Adverse Event|0|||
147285454|NCT02031276|531209412|FG000|Period 3 Open-label Risankizumab SC|Protocol Violation|2|||
147285455|NCT02031276|531209413|FG001|Period 3 Open-label Risankizumab SC|Protocol Violation|0|||
147285456|NCT02031276|531209414|FG002|Period 3 Open-label Risankizumab SC|Protocol Violation|0|||
147285457|NCT02031276|531209412|FG000|Period 3 Open-label Risankizumab SC|Withdrawal by Subject|1|||
147285458|NCT02031276|531209413|FG001|Period 3 Open-label Risankizumab SC|Withdrawal by Subject|1|||
147285459|NCT02031276|531209414|FG002|Period 3 Open-label Risankizumab SC|Withdrawal by Subject|1|||
147285460|NCT02031276|531209412|FG000|Period 3 Open-label Risankizumab SC|Other|0|||
147285461|NCT02031276|531209413|FG001|Period 3 Open-label Risankizumab SC|Other|0|||
147285462|NCT02031276|531209414|FG002|Period 3 Open-label Risankizumab SC|Other|1|||
147285463|NCT01148810|531209415|FG000|Overall Study|Adverse Event|0|||
147285464|NCT01148810|531209416|FG001|Overall Study|Adverse Event|2|||
147285465|NCT01148810|531209415|FG000|Overall Study|Lack of Efficacy|0|||
147285466|NCT01148810|531209416|FG001|Overall Study|Lack of Efficacy|1|||
147285467|NCT01148810|531209415|FG000|Overall Study|Withdrawal by Subject|0|||
147285468|NCT01148810|531209416|FG001|Overall Study|Withdrawal by Subject|2|||
147285469|NCT01148810|531209415|FG000|Overall Study|Protocol Violation|1|||
147285470|NCT01148810|531209416|FG001|Overall Study|Protocol Violation|0|||
147285471|NCT02417246|531209424|FG000|Phase 1 Brand Name Metoprolol ER|Lost to Follow-up|1|||
147285472|NCT02417246|531209425|FG001|Phase 1 Brand Name Metoprolol ER|Lost to Follow-up|1|||
147285473|NCT02417246|531209424|FG000|Phase 1 Brand Name Metoprolol ER|Physician Decision|1|||
147285474|NCT02417246|531209425|FG001|Phase 1 Brand Name Metoprolol ER|Physician Decision|0|||
147285475|NCT02417246|531209424|FG000|Phase 1 Brand Name Metoprolol ER|Withdrawal by Subject|2|||
147285476|NCT02417246|531209425|FG001|Phase 1 Brand Name Metoprolol ER|Withdrawal by Subject|3|||
147285477|NCT02417246|531209424|FG000|Phase 2 1st Generic Administered|Physician Decision|1|||
147285478|NCT02417246|531209425|FG001|Phase 2 1st Generic Administered|Physician Decision|0|||
147285479|NCT04408469|531209429|FG000|Overall Study|Lost to Follow-up|6|||
147285480|NCT04408469|531209430|FG001|Overall Study|Lost to Follow-up|9|||
147285481|NCT04408469|531209429|FG000|Overall Study|Withdrawal by Subject|6|||
147285482|NCT04408469|531209430|FG001|Overall Study|Withdrawal by Subject|1|||
147285483|NCT04408469|531209429|FG000|Overall Study|Dismissal due to ineligibility|0|||
147285484|NCT04408469|531209430|FG001|Overall Study|Dismissal due to ineligibility|1|||
147285485|NCT04321460|531209431|FG000|Overall Study|Participants who had no defecation or no data about it|1|||
147285486|NCT04321460|531209432|FG001|Overall Study|Participants who had no defecation or no data about it|1|||
147285487|NCT01308749|531209433|FG000|Period 1: Double Blind Treatment|Adverse Event|1|||
147285488|NCT01308749|531209434|FG001|Period 1: Double Blind Treatment|Adverse Event|0|||
147285489|NCT01308749|531209433|FG000|Period 2: Open Label Treatment|Adverse Event|0|||
147285490|NCT01308749|531209434|FG001|Period 2: Open Label Treatment|Adverse Event|1|||
147285491|NCT01308749|531209433|FG000|Period 2: Open Label Treatment|Lost to Follow-up|0|||
147285492|NCT01308749|531209434|FG001|Period 2: Open Label Treatment|Lost to Follow-up|1|||
147285493|NCT03058679|531209439|FG000|Baseline to Week 6|Lost to Follow-up|3|||
147285494|NCT03058679|531209440|FG001|Baseline to Week 6|Lost to Follow-up|2|||
147285495|NCT03058679|531209439|FG000|Baseline to Week 6|Change in Crohn's disease medication|4|||
147285496|NCT03058679|531209440|FG001|Baseline to Week 6|Change in Crohn's disease medication|2|||
147285497|NCT03058679|531209439|FG000|Baseline to Week 6|Adverse Event|6|||
147285498|NCT03058679|531209440|FG001|Baseline to Week 6|Adverse Event|6|||
147285499|NCT03058679|531209439|FG000|Baseline to Week 6|Withdrawal by Subject|4|||
147285500|NCT03058679|531209440|FG001|Baseline to Week 6|Withdrawal by Subject|3|||
147285501|NCT03058679|531209439|FG000|Baseline to Week 6|Difficulty following the diet|0|||
147285502|NCT03058679|531209440|FG001|Baseline to Week 6|Difficulty following the diet|2|||
147285503|NCT03058679|531209439|FG000|Baseline to Week 6|Physician Decision|1|||
147285504|NCT03058679|531209440|FG001|Baseline to Week 6|Physician Decision|0|||
147285505|NCT03058679|531209439|FG000|Week 6 to Week 12|Change in medication|5|||
147285506|NCT03058679|531209440|FG001|Week 6 to Week 12|Change in medication|7|||
147285507|NCT03058679|531209439|FG000|Week 6 to Week 12|Adverse Event|4|||
147285508|NCT03058679|531209440|FG001|Week 6 to Week 12|Adverse Event|3|||
147285509|NCT03058679|531209439|FG000|Week 6 to Week 12|Withdrawal by Subject|9|||
147285510|NCT03058679|531209440|FG001|Week 6 to Week 12|Withdrawal by Subject|4|||
147285511|NCT03058679|531209439|FG000|Week 6 to Week 12|Difficulty following the assigned diet|2|||
147285512|NCT03058679|531209440|FG001|Week 6 to Week 12|Difficulty following the assigned diet|3|||
147285513|NCT00599326|531209445|FG000|Overall Study|Lost to Follow-up|1|||
147285514|NCT00599326|531209445|FG000|Overall Study|Noncompliant|1|||
147285515|NCT00784810|531209446|FG000|Overall Study|Adverse Event|32|||
147285516|NCT00784810|531209447|FG001|Overall Study|Adverse Event|20|||
147285517|NCT00784810|531209446|FG000|Overall Study|Lack of Efficacy|14|||
147285518|NCT00784810|531209447|FG001|Overall Study|Lack of Efficacy|11|||
147285519|NCT00784810|531209446|FG000|Overall Study|Withdrawal by Subject|11|||
147285520|NCT00784810|531209447|FG001|Overall Study|Withdrawal by Subject|9|||
147285521|NCT00784810|531209446|FG000|Overall Study|Administrative|5|||
147285522|NCT00784810|531209447|FG001|Overall Study|Administrative|8|||
147285523|NCT00784810|531209446|FG000|Overall Study|Lost to Follow-up|1|||
147285524|NCT00784810|531209447|FG001|Overall Study|Lost to Follow-up|1|||
147285525|NCT04137380|531209448|FG000|Overall Study|Physician Decision|0|||
147285526|NCT04137380|531209449|FG001|Overall Study|Physician Decision|0|||
147285527|NCT04137380|531209450|FG002|Overall Study|Physician Decision|0|||
147285528|NCT04137380|531209451|FG003|Overall Study|Physician Decision|1|||
147285529|NCT04137380|531209452|FG004|Overall Study|Physician Decision|0|||
147285530|NCT04137380|531209453|FG005|Overall Study|Physician Decision|0|||
147285531|NCT04137380|531209454|FG006|Overall Study|Physician Decision|0|||
147285532|NCT00779246|531209455|FG000|Overall Study|Missing sufficient data for analysis|33|||
147285533|NCT00779246|531209456|FG001|Overall Study|Missing sufficient data for analysis|53|||
147285534|NCT03579459|531209457|FG000|Overall Study|Adverse Event|7|||
147285535|NCT03579459|531209458|FG001|Overall Study|Adverse Event|6|||
147285536|NCT03579459|531209459|FG002|Overall Study|Adverse Event|2|||
147285537|NCT03579459|531209460|FG003|Overall Study|Adverse Event|6|||
147285538|NCT03579459|531209457|FG000|Overall Study|Death|1|||
147285539|NCT03579459|531209458|FG001|Overall Study|Death|0|||
147285540|NCT03579459|531209459|FG002|Overall Study|Death|1|||
147285541|NCT03579459|531209460|FG003|Overall Study|Death|2|||
147285542|NCT03579459|531209457|FG000|Overall Study|Lost to Follow-up|6|||
147285543|NCT03579459|531209458|FG001|Overall Study|Lost to Follow-up|2|||
147285544|NCT03579459|531209459|FG002|Overall Study|Lost to Follow-up|4|||
147285545|NCT03579459|531209460|FG003|Overall Study|Lost to Follow-up|1|||
147285546|NCT03579459|531209457|FG000|Overall Study|Physician Decision|0|||
147285547|NCT03579459|531209458|FG001|Overall Study|Physician Decision|1|||
147285548|NCT03579459|531209459|FG002|Overall Study|Physician Decision|0|||
147285549|NCT03579459|531209460|FG003|Overall Study|Physician Decision|1|||
147285550|NCT03579459|531209457|FG000|Overall Study|Protocol Violation|1|||
147285551|NCT03579459|531209458|FG001|Overall Study|Protocol Violation|2|||
147285552|NCT03579459|531209459|FG002|Overall Study|Protocol Violation|3|||
147285553|NCT03579459|531209460|FG003|Overall Study|Protocol Violation|5|||
147285554|NCT03579459|531209457|FG000|Overall Study|Withdrawal by Subject|12|||
147285555|NCT03579459|531209458|FG001|Overall Study|Withdrawal by Subject|8|||
147285556|NCT03579459|531209459|FG002|Overall Study|Withdrawal by Subject|11|||
147285557|NCT03579459|531209460|FG003|Overall Study|Withdrawal by Subject|8|||
147285558|NCT03579459|531209457|FG000|Overall Study|Medication error without associated adverse event|2|||
147285559|NCT03579459|531209458|FG001|Overall Study|Medication error without associated adverse event|1|||
147285560|NCT03579459|531209459|FG002|Overall Study|Medication error without associated adverse event|1|||
147285561|NCT03579459|531209460|FG003|Overall Study|Medication error without associated adverse event|0|||
147285562|NCT03579459|531209457|FG000|Overall Study|Other|0|||
147285563|NCT03579459|531209458|FG001|Overall Study|Other|1|||
147285564|NCT03579459|531209459|FG002|Overall Study|Other|1|||
147285565|NCT03579459|531209460|FG003|Overall Study|Other|0|||
147285566|NCT03579459|531209457|FG000|Overall Study|Randomized not vaccinated|0|||
147285567|NCT03579459|531209458|FG001|Overall Study|Randomized not vaccinated|2|||
147285568|NCT03579459|531209459|FG002|Overall Study|Randomized not vaccinated|0|||
147285569|NCT03579459|531209460|FG003|Overall Study|Randomized not vaccinated|1|||
147285570|NCT02844946|531209462|FG000|Overall Study|Lost to Follow-up|7|||
147285571|NCT02844946|531209463|FG001|Overall Study|Lost to Follow-up|0|||
147285572|NCT02806986|531209464|FG000|Treatment Stage 1|Adverse Event|1|||
147285573|NCT02806986|531209464|FG000|Treatment Stage 2|Adverse Event|3|||
147285574|NCT02806986|531209464|FG000|Treatment Stage 2|Withdrawal by Subject|2|||
147285575|NCT00407537|531209465|FG000|Overall Study|Death|5|||
147285576|NCT00407537|531209466|FG001|Overall Study|Death|2|||
147285577|NCT00407537|531209465|FG000|Overall Study|Adverse Event|36|||
147285578|NCT00407537|531209466|FG001|Overall Study|Adverse Event|0|||
147285579|NCT00407537|531209465|FG000|Overall Study|Lost to Follow-up|12|||
147337473|NCT00433199|531401518|FG001|Double-Blind Period|Withdrawal by Subject|19|||
147337474|NCT00433199|531401517|FG000|Double-Blind Period|Protocol Violation|1|||
147337475|NCT00433199|531401518|FG001|Double-Blind Period|Protocol Violation|10|||
147285580|NCT00407537|531209466|FG001|Overall Study|Lost to Follow-up|19|||
147285581|NCT00407537|531209465|FG000|Overall Study|Other|6|||
147285582|NCT00407537|531209466|FG001|Overall Study|Other|7|||
147285583|NCT00407537|531209465|FG000|Overall Study|Withdrawal by Subject|34|||
147285584|NCT00407537|531209466|FG001|Overall Study|Withdrawal by Subject|16|||
147285585|NCT06027216|531209467|FG000|Overall Study|Did not qualify|8|||
147285586|NCT00413413|531209471|FG000|Single-Blind|Adverse Event|0|||
147337476|NCT00433199|531401517|FG000|Double-Blind Period|Administrative|1|||
147337477|NCT00433199|531401518|FG001|Double-Blind Period|Administrative|5|||
147337478|NCT00433199|531401517|FG000|Open-Label Period|Adverse Event|0|||
147285587|NCT00413413|531209472|FG001|Single-Blind|Adverse Event|9|||
147285588|NCT00413413|531209473|FG002|Single-Blind|Adverse Event|0|||
147285589|NCT00413413|531209471|FG000|Single-Blind|Lack of Efficacy|0|||
147285590|NCT00413413|531209472|FG001|Single-Blind|Lack of Efficacy|5|||
147337479|NCT00433199|531401518|FG001|Open-Label Period|Adverse Event|19|||
147337480|NCT00433199|531401517|FG000|Open-Label Period|Lack of Efficacy|0|||
147337481|NCT00433199|531401518|FG001|Open-Label Period|Lack of Efficacy|2|||
147337482|NCT00433199|531401517|FG000|Open-Label Period|Lost to Follow-up|0|||
147285591|NCT00413413|531209473|FG002|Single-Blind|Lack of Efficacy|0|||
147285592|NCT00413413|531209471|FG000|Single-Blind|Subject no longer requires study drug|0|||
147285593|NCT00413413|531209472|FG001|Single-Blind|Subject no longer requires study drug|151|||
147285594|NCT00413413|531209473|FG002|Single-Blind|Subject no longer requires study drug|0|||
147285595|NCT00413413|531209471|FG000|Single-Blind|Protocol Violation|0|||
147285596|NCT00413413|531209472|FG001|Single-Blind|Protocol Violation|16|||
147285597|NCT00413413|531209473|FG002|Single-Blind|Protocol Violation|0|||
147285598|NCT00413413|531209471|FG000|Single-Blind|Withdrawal by Subject|0|||
147285599|NCT00413413|531209472|FG001|Single-Blind|Withdrawal by Subject|27|||
147285600|NCT00413413|531209473|FG002|Single-Blind|Withdrawal by Subject|0|||
147285601|NCT00413413|531209471|FG000|Single-Blind|Lost to Follow-up|0|||
147285602|NCT00413413|531209472|FG001|Single-Blind|Lost to Follow-up|8|||
147285603|NCT00413413|531209473|FG002|Single-Blind|Lost to Follow-up|0|||
147285604|NCT00413413|531209471|FG000|Double-Blind|Adverse Event|6|||
147285605|NCT00413413|531209472|FG001|Double-Blind|Adverse Event|0|||
147285606|NCT00413413|531209473|FG002|Double-Blind|Adverse Event|5|||
147285607|NCT00413413|531209471|FG000|Double-Blind|Unsatisfactory therapeutic effect|1|||
147285608|NCT00413413|531209472|FG001|Double-Blind|Unsatisfactory therapeutic effect|2|||
147285609|NCT00413413|531209473|FG002|Double-Blind|Unsatisfactory therapeutic effect|1|||
147285610|NCT00413413|531209471|FG000|Double-Blind|Protocol deviation|1|||
147285611|NCT00413413|531209472|FG001|Double-Blind|Protocol deviation|2|||
147285612|NCT00413413|531209473|FG002|Double-Blind|Protocol deviation|1|||
147285613|NCT00413413|531209471|FG000|Double-Blind|Subject withdrew consent|4|||
147285614|NCT00413413|531209472|FG001|Double-Blind|Subject withdrew consent|6|||
147285615|NCT00413413|531209473|FG002|Double-Blind|Subject withdrew consent|9|||
147285616|NCT00413413|531209471|FG000|Double-Blind|Lost to Follow-up|3|||
147285617|NCT00413413|531209472|FG001|Double-Blind|Lost to Follow-up|4|||
147285618|NCT00413413|531209473|FG002|Double-Blind|Lost to Follow-up|2|||
147285619|NCT01040130|531209474|FG000|Overall Study|Adverse Event|1|||
147285620|NCT01040130|531209475|FG001|Overall Study|Adverse Event|1|||
147285621|NCT01040130|531209476|FG002|Overall Study|Adverse Event|0|||
147285622|NCT01040130|531209477|FG003|Overall Study|Adverse Event|5|||
147285623|NCT01040130|531209478|FG004|Overall Study|Adverse Event|0|||
147285624|NCT01040130|531209479|FG005|Overall Study|Adverse Event|3|||
147285625|NCT01040130|531209474|FG000|Overall Study|Protocol Violation|0|||
147285626|NCT01040130|531209475|FG001|Overall Study|Protocol Violation|0|||
147285627|NCT01040130|531209476|FG002|Overall Study|Protocol Violation|2|||
147285628|NCT01040130|531209477|FG003|Overall Study|Protocol Violation|0|||
147285629|NCT01040130|531209478|FG004|Overall Study|Protocol Violation|0|||
147285630|NCT01040130|531209479|FG005|Overall Study|Protocol Violation|0|||
147285631|NCT01040130|531209474|FG000|Overall Study|Withdrawal by Subject|0|||
147285632|NCT01040130|531209475|FG001|Overall Study|Withdrawal by Subject|2|||
147285633|NCT01040130|531209476|FG002|Overall Study|Withdrawal by Subject|0|||
147337483|NCT00433199|531401518|FG001|Open-Label Period|Lost to Follow-up|3|||
147337484|NCT00433199|531401517|FG000|Open-Label Period|Withdrawal by Subject|0|||
147337485|NCT00433199|531401518|FG001|Open-Label Period|Withdrawal by Subject|7|||
147337486|NCT00433199|531401517|FG000|Open-Label Period|Protocol Violation|0|||
147337487|NCT00433199|531401518|FG001|Open-Label Period|Protocol Violation|2|||
147337488|NCT00433199|531401517|FG000|Open-Label Period|Administrative|0|||
147337489|NCT00433199|531401518|FG001|Open-Label Period|Administrative|1|||
147337490|NCT00357097|531401519|FG000|Overall Study|Did not meet inclusion criteria|5|||
147337491|NCT00357097|531401520|FG001|Overall Study|Did not meet inclusion criteria|3|||
147337492|NCT00357097|531401519|FG000|Overall Study|Adverse Event|34|||
147337493|NCT00357097|531401520|FG001|Overall Study|Adverse Event|6|||
147337494|NCT00357097|531401519|FG000|Overall Study|Withdrawal by Subject|8|||
147337495|NCT00357097|531401520|FG001|Overall Study|Withdrawal by Subject|7|||
147337496|NCT00357097|531401519|FG000|Overall Study|Non-compliance|1|||
147337497|NCT00357097|531401520|FG001|Overall Study|Non-compliance|2|||
147337498|NCT00357097|531401519|FG000|Overall Study|Lack of Efficacy|2|||
147337499|NCT00357097|531401520|FG001|Overall Study|Lack of Efficacy|8|||
147337500|NCT00357097|531401519|FG000|Overall Study|Met Exclusion Criteria|3|||
147337501|NCT00357097|531401520|FG001|Overall Study|Met Exclusion Criteria|1|||
147337502|NCT00357097|531401519|FG000|Overall Study|Other|1|||
147337503|NCT00357097|531401520|FG001|Overall Study|Other|1|||
147285634|NCT01040130|531209477|FG003|Overall Study|Withdrawal by Subject|0|||
147285635|NCT01040130|531209478|FG004|Overall Study|Withdrawal by Subject|0|||
147285636|NCT01040130|531209479|FG005|Overall Study|Withdrawal by Subject|1|||
147337504|NCT00357097|531401519|FG000|Overall Study|Increase of RLS Symptoms|0|||
147285637|NCT01040130|531209474|FG000|Overall Study|Other reasons not listed above|2|||
147285638|NCT01040130|531209475|FG001|Overall Study|Other reasons not listed above|0|||
147285639|NCT01040130|531209476|FG002|Overall Study|Other reasons not listed above|0|||
147337505|NCT00357097|531401520|FG001|Overall Study|Increase of RLS Symptoms|1|||
147337506|NCT00732381|531401523|FG000|Overall Study|Adverse Event|1|||
147337507|NCT00732381|531401524|FG001|Overall Study|Adverse Event|0|||
147337508|NCT00732381|531401523|FG000|Overall Study|Treatment Failure|1|||
147337509|NCT00732381|531401524|FG001|Overall Study|Treatment Failure|1|||
147337510|NCT00457691|531401525|FG000|Overall Study|Adverse Event|4|||
147285640|NCT01040130|531209477|FG003|Overall Study|Other reasons not listed above|0|||
147285641|NCT01040130|531209478|FG004|Overall Study|Other reasons not listed above|0|||
147285642|NCT01040130|531209479|FG005|Overall Study|Other reasons not listed above|0|||
147337511|NCT00457691|531401526|FG001|Overall Study|Adverse Event|1|||
147285643|NCT00096135|531209480|FG000|Overall Study|Physician Decision|20|||
147337512|NCT00457691|531401525|FG000|Overall Study|Death|163|||
147337513|NCT00457691|531401526|FG001|Overall Study|Death|148|||
147337514|NCT00457691|531401525|FG000|Overall Study|Protocol Violation|1|||
147337515|NCT00457691|531401526|FG001|Overall Study|Protocol Violation|3|||
147337516|NCT00457691|531401525|FG000|Overall Study|Lost to Follow-up|23|||
147337517|NCT00457691|531401526|FG001|Overall Study|Lost to Follow-up|14|||
147337518|NCT00457691|531401525|FG000|Overall Study|Study terminated by Sponsor|1|||
147337519|NCT00457691|531401526|FG001|Overall Study|Study terminated by Sponsor|1|||
147337520|NCT00457691|531401525|FG000|Overall Study|Subject refused (reason other than AE)|14|||
147337521|NCT00457691|531401526|FG001|Overall Study|Subject refused (reason other than AE)|19|||
147337522|NCT00457691|531401525|FG000|Overall Study|Disease progression, study terminated|180|||
147337523|NCT00457691|531401526|FG001|Overall Study|Disease progression, study terminated|196|||
147337524|NCT01420549|531401527|FG000|Overall Study|Adverse Event|1|||
147337525|NCT01420549|531401528|FG001|Overall Study|Adverse Event|1|||
147337526|NCT01420549|531401527|FG000|Overall Study|Lost to Follow-up|2|||
147337527|NCT01420549|531401528|FG001|Overall Study|Lost to Follow-up|2|||
147337528|NCT01420549|531401527|FG000|Overall Study|Protocol Violation|0|||
147337529|NCT01420549|531401528|FG001|Overall Study|Protocol Violation|1|||
147337530|NCT01420549|531401527|FG000|Overall Study|Non-adherence to medication|4|||
147337531|NCT01420549|531401528|FG001|Overall Study|Non-adherence to medication|1|||
147337532|NCT03073941|531402847|FG000|Overall Study|Received non-study device intraoperatively|0|||
147337533|NCT03073941|531402848|FG001|Overall Study|Received non-study device intraoperatively|2|||
147337534|NCT03073941|531402847|FG000|Overall Study|Death|1|||
147337535|NCT03073941|531402848|FG001|Overall Study|Death|0|||
147337536|NCT03073941|531402847|FG000|Overall Study|Withdrawal by Subject|1|||
147337537|NCT03073941|531402848|FG001|Overall Study|Withdrawal by Subject|3|||
147337538|NCT03073941|531402847|FG000|Overall Study|Lost to Follow-up|5|||
147337539|NCT03073941|531402848|FG001|Overall Study|Lost to Follow-up|4|||
147337540|NCT03073941|531402847|FG000|Overall Study|Adverse Event|4|||
147337541|NCT03073941|531402848|FG001|Overall Study|Adverse Event|2|||
147337542|NCT03073941|531402847|FG000|Overall Study|Met an exclusion criterion|0|||
147337543|NCT03073941|531402848|FG001|Overall Study|Met an exclusion criterion|1|||
147337544|NCT01188655|531402852|FG000|Overall Study|Lack of Efficacy|1|||
147337545|NCT01188655|531402852|FG000|Overall Study|Lost to Follow-up|1|||
147337546|NCT01188655|531402852|FG000|Overall Study|Other|11|||
147285644|NCT00096135|531209481|FG001|Overall Study|Physician Decision|4|||
147285645|NCT00096135|531209480|FG000|Overall Study|Refusal of further protocol therapy|4|||
147285646|NCT00096135|531209481|FG001|Overall Study|Refusal of further protocol therapy|1|||
147285647|NCT00096135|531209480|FG000|Overall Study|Progressive disease, Marrow,CNS, Relapse|22|||
147285648|NCT00096135|531209481|FG001|Overall Study|Progressive disease, Marrow,CNS, Relapse|7|||
147285649|NCT00096135|531209480|FG000|Overall Study|Other, specify|15|||
147285650|NCT00096135|531209481|FG001|Overall Study|Other, specify|3|||
147285651|NCT00096135|531209480|FG000|Overall Study|Ineligible|2|||
147285652|NCT00096135|531209481|FG001|Overall Study|Ineligible|0|||
147285653|NCT04537923|531211017|FG000|Overall Study|Adverse Event|2|||
147285654|NCT04537923|531211018|FG001|Overall Study|Adverse Event|1|||
147285655|NCT04537923|531211019|FG002|Overall Study|Adverse Event|2|||
147285656|NCT04537923|531211020|FG003|Overall Study|Adverse Event|4|||
147285657|NCT04537923|531211017|FG000|Overall Study|Death|3|||
147285658|NCT04537923|531211018|FG001|Overall Study|Death|3|||
147285659|NCT04537923|531211019|FG002|Overall Study|Death|1|||
147285660|NCT04537923|531211020|FG003|Overall Study|Death|11|||
147337547|NCT00925899|531402853|FG000|Part 1|Death|1|||
147285661|NCT04537923|531211017|FG000|Overall Study|Lost to Follow-up|1|||
147285662|NCT04537923|531211018|FG001|Overall Study|Lost to Follow-up|2|||
147285663|NCT04537923|531211019|FG002|Overall Study|Lost to Follow-up|1|||
147285664|NCT04537923|531211020|FG003|Overall Study|Lost to Follow-up|6|||
147285665|NCT04537923|531211017|FG000|Overall Study|Physician Decision|1|||
147285666|NCT04537923|531211018|FG001|Overall Study|Physician Decision|0|||
147285667|NCT04537923|531211019|FG002|Overall Study|Physician Decision|2|||
147285668|NCT04537923|531211020|FG003|Overall Study|Physician Decision|5|||
147285669|NCT04537923|531211017|FG000|Overall Study|Pregnancy|1|||
147285670|NCT04537923|531211018|FG001|Overall Study|Pregnancy|0|||
147285671|NCT04537923|531211019|FG002|Overall Study|Pregnancy|0|||
147285672|NCT04537923|531211020|FG003|Overall Study|Pregnancy|0|||
147285673|NCT04537923|531211017|FG000|Overall Study|Withdrawal by Subject|4|||
147285674|NCT04537923|531211018|FG001|Overall Study|Withdrawal by Subject|4|||
147285675|NCT04537923|531211019|FG002|Overall Study|Withdrawal by Subject|4|||
147285676|NCT04537923|531211020|FG003|Overall Study|Withdrawal by Subject|58|||
147285677|NCT04537923|531211017|FG000|Overall Study|Missed study visits|2|||
147285678|NCT04537923|531211018|FG001|Overall Study|Missed study visits|0|||
147337548|NCT00925899|531402854|FG001|Part 1|Death|2|||
147337549|NCT00925899|531402853|FG000|Part 1|Withdrawal by Subject|10|||
147337550|NCT00925899|531402854|FG001|Part 1|Withdrawal by Subject|9|||
147337551|NCT00683696|531402855|FG000|Overall Study|Withdrawn due to study closure|337|||
147337552|NCT00683696|531402856|FG001|Overall Study|Withdrawn due to study closure|338|||
147337553|NCT00683696|531402855|FG000|Overall Study|Withdrawn prior to study closure|13|||
147337554|NCT00683696|531402856|FG001|Overall Study|Withdrawn prior to study closure|28|||
147285679|NCT04537923|531211019|FG002|Overall Study|Missed study visits|0|||
147285680|NCT04537923|531211020|FG003|Overall Study|Missed study visits|3|||
147285681|NCT04537923|531211017|FG000|Overall Study|Sponsor's decision|0|||
147285682|NCT04537923|531211018|FG001|Overall Study|Sponsor's decision|0|||
147285683|NCT04537923|531211019|FG002|Overall Study|Sponsor's decision|1|||
147285684|NCT04537923|531211020|FG003|Overall Study|Sponsor's decision|1|||
147285685|NCT04537923|531211017|FG000|Overall Study|Safety reasons|1|||
147285686|NCT04537923|531211018|FG001|Overall Study|Safety reasons|0|||
147285687|NCT04537923|531211019|FG002|Overall Study|Safety reasons|0|||
147285688|NCT04537923|531211020|FG003|Overall Study|Safety reasons|0|||
147285689|NCT01261611|531211021|FG000|Treatment Cycle 1|Withdrawal by Subject|3|||
147285690|NCT01261611|531211022|FG001|Treatment Cycle 1|Withdrawal by Subject|2|||
147285691|NCT01261611|531211023|FG002|Treatment Cycle 1|Withdrawal by Subject|0|||
147285692|NCT01261611|531211021|FG000|Treatment Cycle 1|Lost to Follow-up|1|||
147285693|NCT01261611|531211022|FG001|Treatment Cycle 1|Lost to Follow-up|0|||
147285694|NCT01261611|531211023|FG002|Treatment Cycle 1|Lost to Follow-up|0|||
147285695|NCT01261611|531211021|FG000|Treatment Cycle 1|Adverse Event|0|||
147285696|NCT01261611|531211022|FG001|Treatment Cycle 1|Adverse Event|1|||
147285697|NCT01261611|531211023|FG002|Treatment Cycle 1|Adverse Event|0|||
147285698|NCT01261611|531211021|FG000|Treatment Cycle 1|Protocol Violation|0|||
147285699|NCT01261611|531211022|FG001|Treatment Cycle 1|Protocol Violation|0|||
147285700|NCT01261611|531211023|FG002|Treatment Cycle 1|Protocol Violation|2|||
147285701|NCT01261611|531211021|FG000|Treatment Cycle 2|Completed study|4|||
147285702|NCT01261611|531211022|FG001|Treatment Cycle 2|Completed study|0|||
147285703|NCT01261611|531211023|FG002|Treatment Cycle 2|Completed study|0|||
147285704|NCT01261611|531211021|FG000|Treatment Cycle 2|Withdrawal by Subject|4|||
147285705|NCT01261611|531211022|FG001|Treatment Cycle 2|Withdrawal by Subject|0|||
147285706|NCT01261611|531211023|FG002|Treatment Cycle 2|Withdrawal by Subject|0|||
147285707|NCT01261611|531211021|FG000|Treatment Cycle 2|Adverse Event|1|||
147285708|NCT01261611|531211022|FG001|Treatment Cycle 2|Adverse Event|0|||
147285709|NCT01261611|531211023|FG002|Treatment Cycle 2|Adverse Event|0|||
147285710|NCT01261611|531211021|FG000|Treatment Cycle 2|Protocol Violation|2|||
147285711|NCT01261611|531211022|FG001|Treatment Cycle 2|Protocol Violation|0|||
147285712|NCT01261611|531211023|FG002|Treatment Cycle 2|Protocol Violation|0|||
147285713|NCT01261611|531211021|FG000|Treatment Cycle 2|Not otherwise specified|2|||
147285714|NCT01261611|531211022|FG001|Treatment Cycle 2|Not otherwise specified|0|||
147285715|NCT01261611|531211023|FG002|Treatment Cycle 2|Not otherwise specified|0|||
147285716|NCT01261611|531211021|FG000|Treatment Cycle 3|Completed study|24|||
147285717|NCT01261611|531211022|FG001|Treatment Cycle 3|Completed study|0|||
147285718|NCT01261611|531211023|FG002|Treatment Cycle 3|Completed study|0|||
147285719|NCT01261611|531211021|FG000|Treatment Cycle 3|Withdrawal by Subject|4|||
147285720|NCT01261611|531211022|FG001|Treatment Cycle 3|Withdrawal by Subject|0|||
147285721|NCT01261611|531211023|FG002|Treatment Cycle 3|Withdrawal by Subject|0|||
147285722|NCT01261611|531211021|FG000|Treatment Cycle 3|Adverse Event|1|||
147285723|NCT01261611|531211022|FG001|Treatment Cycle 3|Adverse Event|0|||
147285724|NCT01261611|531211023|FG002|Treatment Cycle 3|Adverse Event|0|||
147285725|NCT01261611|531211021|FG000|Treatment Cycle 3|Lost to Follow-up|1|||
147285726|NCT01261611|531211022|FG001|Treatment Cycle 3|Lost to Follow-up|0|||
147285727|NCT01261611|531211023|FG002|Treatment Cycle 3|Lost to Follow-up|0|||
147285728|NCT01261611|531211021|FG000|Treatment Cycle 4|Completed study|87|||
147285729|NCT01261611|531211022|FG001|Treatment Cycle 4|Completed study|0|||
147285730|NCT01261611|531211023|FG002|Treatment Cycle 4|Completed study|0|||
147285731|NCT01261611|531211021|FG000|Treatment Cycle 4|Withdrawal by Subject|3|||
147285732|NCT01261611|531211022|FG001|Treatment Cycle 4|Withdrawal by Subject|0|||
147604147|NCT01755767|532367835|FG001|Overall Study|Ongoing Treatment as of 06 Jan 2017|0|||
147285733|NCT01261611|531211023|FG002|Treatment Cycle 4|Withdrawal by Subject|0|||
147285734|NCT01261611|531211021|FG000|Treatment Cycle 4|Adverse Event|1|||
147285735|NCT01261611|531211022|FG001|Treatment Cycle 4|Adverse Event|0|||
147285736|NCT01261611|531211023|FG002|Treatment Cycle 4|Adverse Event|0|||
147285737|NCT01261611|531211021|FG000|Treatment Cycle 4|Lost to Follow-up|2|||
147285738|NCT01261611|531211022|FG001|Treatment Cycle 4|Lost to Follow-up|0|||
147285739|NCT01261611|531211023|FG002|Treatment Cycle 4|Lost to Follow-up|0|||
147285740|NCT01261611|531211021|FG000|Treatment Cycle 4|Not otherwise specified|3|||
147285741|NCT01261611|531211022|FG001|Treatment Cycle 4|Not otherwise specified|0|||
147285742|NCT01261611|531211023|FG002|Treatment Cycle 4|Not otherwise specified|0|||
147285743|NCT01261611|531211021|FG000|Treatment Cycle 5|Withdrawal by Subject|1|||
147285744|NCT01261611|531211022|FG001|Treatment Cycle 5|Withdrawal by Subject|0|||
147604148|NCT01755767|532367836|FG002|Overall Study|Ongoing Treatment as of 06 Jan 2017|5|||
147604149|NCT01755767|532367837|FG003|Overall Study|Ongoing Treatment as of 06 Jan 2017|2|||
147285745|NCT01261611|531211023|FG002|Treatment Cycle 5|Withdrawal by Subject|0|||
147285746|NCT01261611|531211021|FG000|Treatment Cycle 5|Adverse Event|1|||
147604150|NCT04623086|532367838|FG000|Overall Study|Withdrawal by Subject|0|||
147285747|NCT01261611|531211022|FG001|Treatment Cycle 5|Adverse Event|0|||
147285748|NCT01261611|531211023|FG002|Treatment Cycle 5|Adverse Event|0|||
147285749|NCT01261611|531211021|FG000|Treatment Cycle 5|Lost to Follow-up|1|||
147285750|NCT01261611|531211022|FG001|Treatment Cycle 5|Lost to Follow-up|0|||
147285751|NCT01261611|531211023|FG002|Treatment Cycle 5|Lost to Follow-up|0|||
147285752|NCT03586648|531211027|FG000|Period 1|Withdrawal by Subject|0|||
147452330|NCT00328627|531819905|FG011|Overall Study|Protocol Violation|2|||
147285753|NCT03586648|531211028|FG001|Period 1|Withdrawal by Subject|1|||
147285754|NCT03586648|531211027|FG000|Period 1|Lost to Follow-up|1|||
147285755|NCT03586648|531211028|FG001|Period 1|Lost to Follow-up|1|||
147285756|NCT03586648|531211027|FG000|Period 1|Adverse Event|1|||
147285757|NCT03586648|531211028|FG001|Period 1|Adverse Event|0|||
147285758|NCT03586648|531211027|FG000|Period 1|Study related symptoms or complaints|2|||
147285759|NCT03586648|531211028|FG001|Period 1|Study related symptoms or complaints|1|||
147285760|NCT03586648|531211027|FG000|Period 1|Physician Decision|0|||
147285761|NCT03586648|531211028|FG001|Period 1|Physician Decision|1|||
147285762|NCT03586648|531211027|FG000|Period 2|Adverse Event|1|||
147285763|NCT03586648|531211028|FG001|Period 2|Adverse Event|0|||
147285764|NCT02395120|531211029|FG000|Overall Study|Missed follow-up dental exam|57|||
147285765|NCT02395120|531211030|FG001|Overall Study|Missed follow-up dental exam|62|||
147285766|NCT02395120|531211031|FG002|Overall Study|Missed follow-up dental exam|6|||
147285767|NCT02395120|531211032|FG003|Overall Study|Missed follow-up dental exam|6|||
147285768|NCT02395120|531211033|FG004|Overall Study|Missed follow-up dental exam|51|||
147285769|NCT00377234|531211034|FG000|Overall Study|Adverse Event|14|||
147285770|NCT00377234|531211035|FG001|Overall Study|Adverse Event|17|||
147285771|NCT00377234|531211034|FG000|Overall Study|Withdrawal by Subject|11|||
147285772|NCT00377234|531211035|FG001|Overall Study|Withdrawal by Subject|9|||
147285773|NCT00377234|531211034|FG000|Overall Study|Lost to Follow-up|4|||
147285774|NCT00377234|531211035|FG001|Overall Study|Lost to Follow-up|2|||
147285775|NCT00377234|531211034|FG000|Overall Study|Administrative|2|||
147285776|NCT00377234|531211035|FG001|Overall Study|Administrative|1|||
147285777|NCT00377234|531211034|FG000|Overall Study|Not assigned|3|||
147285778|NCT00377234|531211035|FG001|Overall Study|Not assigned|2|||
147285779|NCT01159691|531211037|FG000|Overall Study|Lost to Follow-up|2|||
147285780|NCT01159691|531211037|FG000|Overall Study|Unknown reasons|1|||
147285781|NCT01159691|531211037|FG000|Overall Study|Discontinued Neupro due to Adverse Event|6|||
147285782|NCT01159691|531211037|FG000|Overall Study|Discontinued Neupro due to other reasons|1|||
147285783|NCT01159691|531211037|FG000|Overall Study|Disc. Neupro other & lost to follow-up|2|||
147285784|NCT01159691|531211037|FG000|Overall Study|Disc. Neupro other & unknown reasons|7|||
147285785|NCT01159691|531211037|FG000|Overall Study|Disc. Neupro due to AE & unknown reasons|2|||
147285786|NCT01159691|531211037|FG000|Overall Study|Disc. Neupro lack of efficacy & unknown|1|||
147285787|NCT03822533|531211038|FG000|3 Month Follow-up|Withdrawal by Subject|3|||
147285788|NCT03822533|531211039|FG001|3 Month Follow-up|Withdrawal by Subject|4|||
147285789|NCT03822533|531211038|FG000|3 Month Follow-up|Lost to Follow-up|2|||
147285790|NCT03822533|531211039|FG001|3 Month Follow-up|Lost to Follow-up|2|||
147285791|NCT03822533|531211038|FG000|6 Month Follow-up|Lost to Follow-up|3|||
147452331|NCT00328627|531819894|FG000|Overall Study|Lost to Follow-up|4|||
147452332|NCT00328627|531819895|FG001|Overall Study|Lost to Follow-up|2|||
147452333|NCT00328627|531819896|FG002|Overall Study|Lost to Follow-up|2|||
147452334|NCT00328627|531819897|FG003|Overall Study|Lost to Follow-up|4|||
147452335|NCT00328627|531819898|FG004|Overall Study|Lost to Follow-up|0|||
147285792|NCT03822533|531211039|FG001|6 Month Follow-up|Lost to Follow-up|0|||
147285793|NCT03822533|531211038|FG000|12 Month Follow-up|Lost to Follow-up|2|||
147452336|NCT00328627|531819899|FG005|Overall Study|Lost to Follow-up|2|||
147285794|NCT03822533|531211039|FG001|12 Month Follow-up|Lost to Follow-up|3|||
147285795|NCT03822533|531211038|FG000|12 Month Follow-up|Pregnancy|0|||
147285796|NCT03822533|531211039|FG001|12 Month Follow-up|Pregnancy|1|||
147285797|NCT03822533|531211038|FG000|12 Month Follow-up|Surgery|2|||
147285798|NCT03822533|531211039|FG001|12 Month Follow-up|Surgery|0|||
147285799|NCT03822533|531211038|FG000|12 Month Follow-up|Wrong address|1|||
147285800|NCT03822533|531211039|FG001|12 Month Follow-up|Wrong address|0|||
147285801|NCT03822533|531211038|FG000|12 Month Follow-up|No symptoms|1|||
147285802|NCT03822533|531211039|FG001|12 Month Follow-up|No symptoms|0|||
147285803|NCT03822533|531211038|FG000|12 Month Follow-up|Changed primary care center|0|||
147452337|NCT00328627|531819900|FG006|Overall Study|Lost to Follow-up|3|||
147285804|NCT03822533|531211039|FG001|12 Month Follow-up|Changed primary care center|1|||
147285805|NCT02489500|531211040|FG000|Overall Study|Death|1|||
147285806|NCT02489500|531211041|FG001|Overall Study|Death|1|||
147285807|NCT02863926|531211042|FG000|Overall Study|Physician Decision|1|||
147285808|NCT02863926|531211043|FG001|Overall Study|Physician Decision|0|||
147285809|NCT02863926|531211042|FG000|Overall Study|Lost to Follow-up|1|||
147285810|NCT02863926|531211043|FG001|Overall Study|Lost to Follow-up|1|||
147285811|NCT04726709|531211047|FG000|Overall Study|Withdrawal by Subject|2|||
147452338|NCT00328627|531819901|FG007|Overall Study|Lost to Follow-up|0|||
147452339|NCT00328627|531819902|FG008|Overall Study|Lost to Follow-up|3|||
147285812|NCT04726709|531211048|FG001|Overall Study|Withdrawal by Subject|2|||
147452340|NCT00328627|531819903|FG009|Overall Study|Lost to Follow-up|2|||
147452341|NCT00328627|531819904|FG010|Overall Study|Lost to Follow-up|0|||
147285813|NCT03073603|531211050|FG000|Overall Study|Noncompliance|3|||
147285814|NCT03073603|531211051|FG001|Overall Study|Noncompliance|1|||
147285815|NCT03073603|531211050|FG000|Overall Study|Adverse Event|5|||
147452342|NCT00328627|531819905|FG011|Overall Study|Lost to Follow-up|1|||
147452343|NCT00328627|531819894|FG000|Overall Study|Withdrawal by Subject|5|||
147285816|NCT03073603|531211051|FG001|Overall Study|Adverse Event|3|||
147285817|NCT03073603|531211050|FG000|Overall Study|Physician Decision|1|||
147285818|NCT03073603|531211051|FG001|Overall Study|Physician Decision|2|||
147285819|NCT03073603|531211050|FG000|Overall Study|Required treatment not allowed by protocol|1|||
147285820|NCT03073603|531211051|FG001|Overall Study|Required treatment not allowed by protocol|0|||
147285821|NCT03073603|531211050|FG000|Overall Study|Financial or insurance-related|8|||
147285822|NCT03073603|531211051|FG001|Overall Study|Financial or insurance-related|0|||
147285823|NCT03073603|531211050|FG000|Overall Study|Withdrawal by Subject|0|||
147285824|NCT03073603|531211051|FG001|Overall Study|Withdrawal by Subject|1|||
147285825|NCT03073603|531211050|FG000|Overall Study|Discontinued DMT|4|||
147285826|NCT03073603|531211051|FG001|Overall Study|Discontinued DMT|0|||
147285827|NCT03073603|531211050|FG000|Overall Study|Restarted DMT|0|||
147285828|NCT03073603|531211051|FG001|Overall Study|Restarted DMT|1|||
147285829|NCT00823719|531211054|FG000|Overall Study|Adverse Event|1|||
147285830|NCT00823719|531211055|FG001|Overall Study|Adverse Event|2|||
147285831|NCT00823719|531211054|FG000|Overall Study|Physician Decision|1|||
147285832|NCT00823719|531211055|FG001|Overall Study|Physician Decision|4|||
147285833|NCT00823719|531211054|FG000|Overall Study|Withdrawal by Subject|0|||
147285834|NCT00823719|531211055|FG001|Overall Study|Withdrawal by Subject|1|||
147285835|NCT00823719|531211054|FG000|Overall Study|Disease Progression|4|||
147285836|NCT00823719|531211055|FG001|Overall Study|Disease Progression|4|||
147285837|NCT04757649|531211057|FG000|Overall Study|Withdrawal by Subject|1|||
147285838|NCT04757649|531211057|FG000|Overall Study|Adverse Event|1|||
147285839|NCT04827212|531211062|FG000|Baseline to 16 Weeks|Lost to Follow-up|2|||
147285840|NCT04827212|531211063|FG001|Baseline to 16 Weeks|Lost to Follow-up|2|||
147285841|NCT04827212|531211062|FG000|16 to 24 Weeks|Lost to Follow-up|3|||
147285842|NCT04827212|531211063|FG001|16 to 24 Weeks|Lost to Follow-up|4|||
147285843|NCT00574080|531211064|FG000|Overall Study|Death|10|||
147285844|NCT00574080|531211065|FG001|Overall Study|Death|10|||
147285845|NCT00563784|531211068|FG000|Overall Study|Withdrawal by Subject|2|||
147285846|NCT00563784|531211068|FG000|Overall Study|Screen Failures|20|||
147285847|NCT03434119|531211069|FG000|Overall Study|Randomized but not treated|1|||
147285848|NCT03434119|531211070|FG001|Overall Study|Randomized but not treated|0|||
147285849|NCT03434119|531211069|FG000|Overall Study|Adverse Event|1|||
147285850|NCT03434119|531211070|FG001|Overall Study|Adverse Event|0|||
147285851|NCT03434119|531211069|FG000|Overall Study|Poor Compliance to Protocol|0|||
147285852|NCT03434119|531211070|FG001|Overall Study|Poor Compliance to Protocol|1|||
147285853|NCT03434119|531211069|FG000|Overall Study|Study Terminated by Sponsor|91|||
147285854|NCT03434119|531211070|FG001|Overall Study|Study Terminated by Sponsor|102|||
147285855|NCT03434119|531211069|FG000|Overall Study|Withdrawal by Subject|7|||
147285856|NCT03434119|531211070|FG001|Overall Study|Withdrawal by Subject|5|||
147285857|NCT03434119|531211069|FG000|Overall Study|Other than specified|7|||
147285858|NCT03434119|531211070|FG001|Overall Study|Other than specified|5|||
147285859|NCT04360824|531211071|FG000|Overall Study|Withdrawal by Subject|2|||
147285860|NCT04360824|531211072|FG001|Overall Study|Withdrawal by Subject|1|||
147285861|NCT04360824|531211071|FG000|Overall Study|Did not receive assigned treatment|1|||
147285862|NCT04360824|531211072|FG001|Overall Study|Did not receive assigned treatment|3|||
147285863|NCT00304070|531211073|FG000|Overall Study|Death|0|||
147285864|NCT00304070|531211074|FG001|Overall Study|Death|0|||
147285865|NCT00304070|531211075|FG002|Overall Study|Death|3|||
147285866|NCT00304070|531211073|FG000|Overall Study|Lost to Follow-up|0|||
147285867|NCT00304070|531211074|FG001|Overall Study|Lost to Follow-up|0|||
147285868|NCT00304070|531211075|FG002|Overall Study|Lost to Follow-up|1|||
147285869|NCT00304070|531211073|FG000|Overall Study|Physician Decision|0|||
147285870|NCT00304070|531211074|FG001|Overall Study|Physician Decision|0|||
147285871|NCT00304070|531211075|FG002|Overall Study|Physician Decision|3|||
147285872|NCT00304070|531211073|FG000|Overall Study|Withdrawal by Subject|0|||
147285873|NCT00304070|531211074|FG001|Overall Study|Withdrawal by Subject|0|||
147285874|NCT00304070|531211075|FG002|Overall Study|Withdrawal by Subject|1|||
147285875|NCT00304070|531211073|FG000|Overall Study|Progressive Disease|3|||
147285876|NCT00304070|531211074|FG001|Overall Study|Progressive Disease|7|||
147285877|NCT00304070|531211075|FG002|Overall Study|Progressive Disease|4|||
147285878|NCT00320216|531211076|FG000|Overall Study|Adverse Event|0|||
147285879|NCT00320216|531211077|FG001|Overall Study|Adverse Event|6|||
147285880|NCT00320216|531211078|FG002|Overall Study|Adverse Event|0|||
147285881|NCT00320216|531211079|FG003|Overall Study|Adverse Event|2|||
147285882|NCT00320216|531211080|FG004|Overall Study|Adverse Event|2|||
147285883|NCT00320216|531211076|FG000|Overall Study|Lack of Efficacy|6|||
147285884|NCT00320216|531211077|FG001|Overall Study|Lack of Efficacy|2|||
147285885|NCT00320216|531211078|FG002|Overall Study|Lack of Efficacy|1|||
147285886|NCT00320216|531211079|FG003|Overall Study|Lack of Efficacy|0|||
147285887|NCT00320216|531211080|FG004|Overall Study|Lack of Efficacy|1|||
147285888|NCT00320216|531211076|FG000|Overall Study|Lost to Follow-up|3|||
147285889|NCT00320216|531211077|FG001|Overall Study|Lost to Follow-up|0|||
147285890|NCT00320216|531211078|FG002|Overall Study|Lost to Follow-up|0|||
147285891|NCT00320216|531211079|FG003|Overall Study|Lost to Follow-up|0|||
147285892|NCT00320216|531211080|FG004|Overall Study|Lost to Follow-up|0|||
147285893|NCT00320216|531211076|FG000|Overall Study|Other|7|||
147285894|NCT00320216|531211077|FG001|Overall Study|Other|2|||
147285895|NCT00320216|531211078|FG002|Overall Study|Other|5|||
147285896|NCT00320216|531211079|FG003|Overall Study|Other|1|||
147285897|NCT00320216|531211080|FG004|Overall Study|Other|3|||
147285898|NCT00148343|531211085|FG000|Overall Study|Withdrawal by Subject|12|||
147285899|NCT00148343|531211086|FG001|Overall Study|Withdrawal by Subject|7|||
147285900|NCT00148343|531211085|FG000|Overall Study|Physician Decision|3|||
147285901|NCT00148343|531211086|FG001|Overall Study|Physician Decision|4|||
147285902|NCT02528214|531211089|FG000|Overall Study|Protocol Violation|0|||
147285903|NCT02528214|531211090|FG001|Overall Study|Protocol Violation|1|||
147285904|NCT02528214|531211089|FG000|Overall Study|Adverse Event|0|||
147285905|NCT02528214|531211090|FG001|Overall Study|Adverse Event|1|||
147285906|NCT02528214|531211089|FG000|Overall Study|Other than specified above|0|||
147285907|NCT02528214|531211090|FG001|Overall Study|Other than specified above|1|||
147285908|NCT01380327|531211091|FG000|Overall Study|Lost to Follow-up|0|||
147285909|NCT01380327|531211092|FG001|Overall Study|Lost to Follow-up|1|||
147285910|NCT01380327|531211093|FG002|Overall Study|Lost to Follow-up|1|||
147285911|NCT01380327|531211091|FG000|Overall Study|Protocol Violation|3|||
147285912|NCT01380327|531211092|FG001|Overall Study|Protocol Violation|2|||
147285913|NCT01380327|531211093|FG002|Overall Study|Protocol Violation|3|||
147285914|NCT01380327|531211091|FG000|Overall Study|Withdrawal by Subject|0|||
147285915|NCT01380327|531211092|FG001|Overall Study|Withdrawal by Subject|0|||
147285916|NCT01380327|531211093|FG002|Overall Study|Withdrawal by Subject|1|||
147285917|NCT01380327|531211091|FG000|Overall Study|Housing situation precluded ability to k|0|||
147285918|NCT01380327|531211092|FG001|Overall Study|Housing situation precluded ability to k|0|||
147285919|NCT01380327|531211093|FG002|Overall Study|Housing situation precluded ability to k|1|||
147285920|NCT01380327|531211091|FG000|Overall Study|Questionable onset of epilepsy|0|||
147285921|NCT01380327|531211092|FG001|Overall Study|Questionable onset of epilepsy|0|||
147285922|NCT01380327|531211093|FG002|Overall Study|Questionable onset of epilepsy|1|||
147285923|NCT05046795|531211094|FG000|Overall Study|Adverse Event|13|||
147285924|NCT05046795|531211095|FG001|Overall Study|Adverse Event|15|||
147285925|NCT05046795|531211094|FG000|Overall Study|Withdrawal by Subject|4|||
147285926|NCT05046795|531211095|FG001|Overall Study|Withdrawal by Subject|7|||
147285927|NCT05046795|531211094|FG000|Overall Study|Physician Decision|1|||
147285928|NCT05046795|531211095|FG001|Overall Study|Physician Decision|2|||
147285929|NCT05046795|531211094|FG000|Overall Study|Protocol Violation|1|||
147285930|NCT05046795|531211095|FG001|Overall Study|Protocol Violation|2|||
147285931|NCT05046795|531211094|FG000|Overall Study|Death|1|||
147285932|NCT05046795|531211095|FG001|Overall Study|Death|0|||
147285933|NCT05046795|531211094|FG000|Overall Study|Public health emergency (COVID-19) restrictions|2|||
147285934|NCT05046795|531211095|FG001|Overall Study|Public health emergency (COVID-19) restrictions|3|||
147285935|NCT01127178|531211096|FG000|Dose Escalation: Treatment Phase|Adverse Event|1|||
147285936|NCT01127178|531211097|FG001|Dose Escalation: Treatment Phase|Adverse Event|0|||
147285937|NCT01127178|531211096|FG000|Dose Escalation: Treatment Phase|Withdrawal by Subject|1|||
147285938|NCT01127178|531211097|FG001|Dose Escalation: Treatment Phase|Withdrawal by Subject|0|||
147285939|NCT01127178|531211096|FG000|Dose Escalation: Treatment Phase|Other|2|||
147285940|NCT01127178|531211097|FG001|Dose Escalation: Treatment Phase|Other|0|||
147285941|NCT01127178|531211096|FG000|Dose Escalation: Extension Phase|Adverse Event|0|||
147285942|NCT01127178|531211097|FG001|Dose Escalation: Extension Phase|Adverse Event|1|||
147285943|NCT01127178|531211096|FG000|Dose Escalation: Extension Phase|Withdrawal by Subject|1|||
147285944|NCT01127178|531211097|FG001|Dose Escalation: Extension Phase|Withdrawal by Subject|0|||
147285945|NCT01127178|531211096|FG000|Dose Escalation: Extension Phase|Other|1|||
147285946|NCT01127178|531211097|FG001|Dose Escalation: Extension Phase|Other|0|||
147285947|NCT05348681|531211098|FG000|Overall Study|Study terminated by Sponsor|8|||
147285948|NCT05348681|531211099|FG001|Overall Study|Study terminated by Sponsor|3|||
147285949|NCT05348681|531211098|FG000|Overall Study|Withdrawal by Subject|1|||
147285950|NCT05348681|531211099|FG001|Overall Study|Withdrawal by Subject|1|||
147285951|NCT05348681|531211098|FG000|Overall Study|Lost to Follow-up|1|||
147285952|NCT05348681|531211099|FG001|Overall Study|Lost to Follow-up|1|||
147285953|NCT05348681|531211098|FG000|Overall Study|Adverse Event|1|||
147285954|NCT05348681|531211099|FG001|Overall Study|Adverse Event|0|||
147285955|NCT05348681|531211098|FG000|Overall Study|Other|2|||
147285956|NCT05348681|531211099|FG001|Overall Study|Other|1|||
147285957|NCT03646513|531211103|FG000|Overall Study|Premature study termination|4|||
147285958|NCT00782340|531211104|FG000|Open Label Titration|Adverse Event|12|||
147285959|NCT00782340|531211105|FG001|Open Label Titration|Adverse Event|0|||
147285960|NCT00782340|531211106|FG002|Open Label Titration|Adverse Event|0|||
147285961|NCT00782340|531211104|FG000|Open Label Titration|Treatment failure|50|||
147285962|NCT00782340|531211105|FG001|Open Label Titration|Treatment failure|0|||
147285963|NCT00782340|531211106|FG002|Open Label Titration|Treatment failure|0|||
147285964|NCT00782340|531211104|FG000|Open Label Titration|Protocol Violation|5|||
147285965|NCT00782340|531211105|FG001|Open Label Titration|Protocol Violation|0|||
147285966|NCT00782340|531211106|FG002|Open Label Titration|Protocol Violation|0|||
147285967|NCT00782340|531211104|FG000|Open Label Titration|Withdrawal by Subject|5|||
147285968|NCT00782340|531211105|FG001|Open Label Titration|Withdrawal by Subject|0|||
147285969|NCT00782340|531211106|FG002|Open Label Titration|Withdrawal by Subject|0|||
147285970|NCT00782340|531211104|FG000|Open Label Titration|Enrollment capped|16|||
147285971|NCT00782340|531211105|FG001|Open Label Titration|Enrollment capped|0|||
147285972|NCT00782340|531211106|FG002|Open Label Titration|Enrollment capped|0|||
147285973|NCT00782340|531211104|FG000|Open Label Titration|Did not meet responder criteria|2|||
147285974|NCT00782340|531211105|FG001|Open Label Titration|Did not meet responder criteria|0|||
147285975|NCT00782340|531211106|FG002|Open Label Titration|Did not meet responder criteria|0|||
147285976|NCT00782340|531211104|FG000|Open Label Titration|Lost to Follow-up|5|||
147285977|NCT00782340|531211105|FG001|Open Label Titration|Lost to Follow-up|0|||
147285978|NCT00782340|531211106|FG002|Open Label Titration|Lost to Follow-up|0|||
147285979|NCT00782340|531211104|FG000|Open Label Titration|Randomized in error|6|||
147285980|NCT00782340|531211105|FG001|Open Label Titration|Randomized in error|0|||
147285981|NCT00782340|531211106|FG002|Open Label Titration|Randomized in error|0|||
147285982|NCT00759109|531211109|FG000|Overall Study|Adverse Event|17|||
147285983|NCT00759109|531211110|FG001|Overall Study|Adverse Event|12|||
147285984|NCT00759109|531211109|FG000|Overall Study|Inability to comply|1|||
147285985|NCT00759109|531211110|FG001|Overall Study|Inability to comply|1|||
147285986|NCT00759109|531211109|FG000|Overall Study|Withdrawal by Subject|9|||
147285987|NCT00759109|531211110|FG001|Overall Study|Withdrawal by Subject|5|||
147285988|NCT00759109|531211109|FG000|Overall Study|Death|4|||
147285989|NCT00759109|531211110|FG001|Overall Study|Death|3|||
147285990|NCT00759109|531211109|FG000|Overall Study|Lost to Follow-up|4|||
147285991|NCT00759109|531211110|FG001|Overall Study|Lost to Follow-up|6|||
147285992|NCT00759109|531211109|FG000|Overall Study|Started new therapy|2|||
147285993|NCT00759109|531211110|FG001|Overall Study|Started new therapy|6|||
147285994|NCT00759109|531211109|FG000|Overall Study|HCV RNA negative|1|||
147285995|NCT00759109|531211110|FG001|Overall Study|HCV RNA negative|0|||
147285996|NCT00759109|531211109|FG000|Overall Study|Participant moved to a different city|0|||
147285997|NCT00759109|531211110|FG001|Overall Study|Participant moved to a different city|1|||
147285998|NCT00759109|531211109|FG000|Overall Study|Participant had a liver transplant|0|||
147285999|NCT00759109|531211110|FG001|Overall Study|Participant had a liver transplant|1|||
147286000|NCT00759109|531211109|FG000|Overall Study|Lost during study|1|||
147286001|NCT00759109|531211110|FG001|Overall Study|Lost during study|0|||
147286002|NCT01660763|531211113|FG000|Overall Study|Lack of Efficacy|45|||
147286003|NCT01660763|531211114|FG001|Overall Study|Lack of Efficacy|50|||
147286004|NCT01660763|531211113|FG000|Overall Study|Adverse Event|22|||
147286005|NCT01660763|531211114|FG001|Overall Study|Adverse Event|7|||
147286006|NCT01660763|531211113|FG000|Overall Study|Protocol Violation|1|||
147286007|NCT01660763|531211114|FG001|Overall Study|Protocol Violation|0|||
147286008|NCT01660763|531211113|FG000|Overall Study|Withdrawal by Subject|4|||
147286009|NCT01660763|531211114|FG001|Overall Study|Withdrawal by Subject|0|||
147286010|NCT01660763|531211113|FG000|Overall Study|Patient ready for early discharge|28|||
147286011|NCT01660763|531211114|FG001|Overall Study|Patient ready for early discharge|4|||
147286012|NCT01910519|531211115|FG000|Overall Study|Withdrawal by Subject|2|||
147286013|NCT01910519|531211116|FG001|Overall Study|Withdrawal by Subject|0|||
147286014|NCT01910519|531211115|FG000|Overall Study|Adverse Event|2|||
147286015|NCT01910519|531211116|FG001|Overall Study|Adverse Event|0|||
147286016|NCT04266028|531211117|FG000|Overall Study|Adverse Event|0|||
147286017|NCT04266028|531211118|FG001|Overall Study|Adverse Event|0|||
147286018|NCT04266028|531211119|FG002|Overall Study|Adverse Event|1|||
147286019|NCT04266028|531211120|FG003|Overall Study|Adverse Event|0|||
147286020|NCT04266028|531211121|FG004|Overall Study|Adverse Event|1|||
147286021|NCT04266028|531211122|FG005|Overall Study|Adverse Event|0|||
147286022|NCT04266028|531211123|FG006|Overall Study|Adverse Event|2|||
147286023|NCT04266028|531211124|FG007|Overall Study|Adverse Event|0|||
147286024|NCT04266028|531211117|FG000|Overall Study|temporary halt of the study|0|||
147286025|NCT04266028|531211118|FG001|Overall Study|temporary halt of the study|0|||
147286026|NCT04266028|531211119|FG002|Overall Study|temporary halt of the study|0|||
147286027|NCT04266028|531211120|FG003|Overall Study|temporary halt of the study|0|||
147286028|NCT04266028|531211121|FG004|Overall Study|temporary halt of the study|0|||
147286029|NCT04266028|531211122|FG005|Overall Study|temporary halt of the study|0|||
147286030|NCT04266028|531211123|FG006|Overall Study|temporary halt of the study|2|||
147286031|NCT04266028|531211124|FG007|Overall Study|temporary halt of the study|1|||
147286032|NCT04266028|531211117|FG000|Overall Study|Onset of birch pollen season|0|||
147286033|NCT04266028|531211118|FG001|Overall Study|Onset of birch pollen season|0|||
147286034|NCT04266028|531211119|FG002|Overall Study|Onset of birch pollen season|0|||
147286035|NCT04266028|531211120|FG003|Overall Study|Onset of birch pollen season|0|||
147286036|NCT04266028|531211121|FG004|Overall Study|Onset of birch pollen season|1|||
147286037|NCT04266028|531211122|FG005|Overall Study|Onset of birch pollen season|0|||
147286038|NCT04266028|531211123|FG006|Overall Study|Onset of birch pollen season|0|||
147286039|NCT04266028|531211124|FG007|Overall Study|Onset of birch pollen season|0|||
147286040|NCT00380068|531211126|FG000|Overall Study|Adverse Event|40|||
147337555|NCT00683696|531402855|FG000|Overall Study|Lost to Follow-up|5|||
147337556|NCT00683696|531402856|FG001|Overall Study|Lost to Follow-up|6|||
147337557|NCT00683696|531402855|FG000|Overall Study|Vital status follow-up only|3|||
147604151|NCT04623086|532367839|FG001|Overall Study|Withdrawal by Subject|0|||
147286041|NCT00380068|531211126|FG000|Overall Study|Withdrawal by Subject|10|||
147286042|NCT00380068|531211126|FG000|Overall Study|Not compliant|6|||
147286043|NCT00380068|531211126|FG000|Overall Study|Lost to Follow-up|1|||
147286044|NCT00380068|531211126|FG000|Overall Study|Addition of other PAH therapeutic agent|1|||
147286045|NCT00380068|531211126|FG000|Overall Study|Lung transplant|3|||
147286046|NCT00380068|531211126|FG000|Overall Study|Physician Decision|2|||
147286047|NCT00380068|531211126|FG000|Overall Study|Partipant moved away|1|||
147286048|NCT00380068|531211126|FG000|Overall Study|Lack of Efficacy|5|||
147286049|NCT01458574|531211127|FG000|Overall Study|Adverse Event|5|||
147286050|NCT01458574|531211128|FG001|Overall Study|Adverse Event|9|||
147286051|NCT01458574|531211129|FG002|Overall Study|Adverse Event|7|||
147286052|NCT01458574|531211127|FG000|Overall Study|Lack of Efficacy|70|||
147286053|NCT01458574|531211128|FG001|Overall Study|Lack of Efficacy|53|||
147286054|NCT01458574|531211129|FG002|Overall Study|Lack of Efficacy|132|||
147286055|NCT01458574|531211127|FG000|Overall Study|Lost to Follow-up|3|||
147286056|NCT01458574|531211128|FG001|Overall Study|Lost to Follow-up|2|||
147286057|NCT01458574|531211129|FG002|Overall Study|Lost to Follow-up|1|||
147286058|NCT01458574|531211127|FG000|Overall Study|Pregnancy|1|||
147286059|NCT01458574|531211128|FG001|Overall Study|Pregnancy|1|||
147286060|NCT01458574|531211129|FG002|Overall Study|Pregnancy|0|||
147286061|NCT01458574|531211127|FG000|Overall Study|Protocol Violation|0|||
147286062|NCT01458574|531211128|FG001|Overall Study|Protocol Violation|1|||
147286063|NCT01458574|531211129|FG002|Overall Study|Protocol Violation|0|||
147286064|NCT01458574|531211127|FG000|Overall Study|Withdrawal by Subject|6|||
147286065|NCT01458574|531211128|FG001|Overall Study|Withdrawal by Subject|3|||
147286066|NCT01458574|531211129|FG002|Overall Study|Withdrawal by Subject|5|||
147286067|NCT01458574|531211127|FG000|Overall Study|Other|2|||
147286068|NCT01458574|531211128|FG001|Overall Study|Other|1|||
147286069|NCT01458574|531211129|FG002|Overall Study|Other|0|||
147286070|NCT01458574|531211127|FG000|Overall Study|Randomized but not treated|0|||
147286071|NCT01458574|531211128|FG001|Overall Study|Randomized but not treated|1|||
147286072|NCT01458574|531211129|FG002|Overall Study|Randomized but not treated|0|||
147286073|NCT02125786|531211130|FG000|Overall Study|Still in Follow-up|3|||
147286074|NCT02125786|531211130|FG000|Overall Study|Screen Failure|2|||
147286075|NCT02125786|531211130|FG000|Overall Study|Withdrawal by Family before Start of RT|2|||
147286076|NCT02125786|531211130|FG000|Overall Study|Progressive Disease|44|||
147286077|NCT02125786|531211130|FG000|Overall Study|Death|8|||
147286078|NCT04964089|531211133|FG000|Overall Study|Adverse Event|8|||
147286079|NCT04964089|531211134|FG001|Overall Study|Adverse Event|6|||
147286080|NCT04964089|531211133|FG000|Overall Study|Non-compliance with study schedule|1|||
147286081|NCT04964089|531211134|FG001|Overall Study|Non-compliance with study schedule|0|||
147286082|NCT04964089|531211133|FG000|Overall Study|Withdrawal by Subject|6|||
147286083|NCT04964089|531211134|FG001|Overall Study|Withdrawal by Subject|5|||
147286084|NCT04964089|531211133|FG000|Overall Study|Lost to Follow-up|1|||
147286085|NCT04964089|531211134|FG001|Overall Study|Lost to Follow-up|1|||
147286086|NCT04964089|531211133|FG000|Overall Study|Progressive disease|4|||
147286087|NCT04964089|531211134|FG001|Overall Study|Progressive disease|0|||
147286088|NCT04964089|531211133|FG000|Overall Study|Physician Decision|1|||
147286089|NCT04964089|531211134|FG001|Overall Study|Physician Decision|0|||
147286090|NCT04964089|531211133|FG000|Overall Study|Participant did not want to continue study treatment|1|||
147286091|NCT04964089|531211134|FG001|Overall Study|Participant did not want to continue study treatment|0|||
147286092|NCT04964089|531211133|FG000|Overall Study|Participant moved to different state|1|||
147286093|NCT04964089|531211134|FG001|Overall Study|Participant moved to different state|0|||
147286094|NCT04964089|531211133|FG000|Overall Study|Participant decided to discontinue|0|||
147286095|NCT04964089|531211134|FG001|Overall Study|Participant decided to discontinue|1|||
147286096|NCT01664078|531211137|FG000|Overall Study|Death|9|||
147286097|NCT01664078|531211137|FG000|Overall Study|Withdrawal by Subject|4|||
147286098|NCT01664078|531211137|FG000|Overall Study|Lost to Follow-up|2|||
147286099|NCT01664078|531211137|FG000|Overall Study|missed 5 year visit|1|||
147286100|NCT01664078|531211137|FG000|Overall Study|Other|53|||
147286101|NCT02720484|531211146|FG000|Treatment on Study|Adverse Event|1|||
147286102|NCT02720484|531211146|FG000|Treatment on Study|Withdrawal by Subject|1|||
147286103|NCT02720484|531211146|FG000|Treatment on Study|Progressive Disease|4|||
147286104|NCT02720484|531211146|FG000|Follow Up for 2 Years|Withdrawal by Subject|1|||
147286105|NCT02720484|531211146|FG000|Follow Up for 2 Years|Death|3|||
147286106|NCT02720484|531211146|FG000|Follow Up for 2 Years|Lost to Follow-up|2|||
147286107|NCT05070897|531211147|FG000|Overall Study|Protocol Violation|123|||
147286108|NCT05070897|531211148|FG001|Overall Study|Protocol Violation|68|||
147286109|NCT01617629|531211151|FG000|Overall Study|Death|2|||
147286110|NCT01617629|531211151|FG000|Overall Study|Investigator's Clinical Judgement|1|||
147452344|NCT00328627|531819895|FG001|Overall Study|Withdrawal by Subject|4|||
147662635|NCT00385918|532587380|FG001|Feasibility & Baseline Measurement Phase|Withdrawal by Subject|0|||
147662636|NCT00385918|532587381|FG002|Feasibility & Baseline Measurement Phase|Withdrawal by Subject|5|||
147286111|NCT01617629|531211151|FG000|Overall Study|Reason Not Specified|1|||
147286112|NCT01617629|531211151|FG000|Overall Study|Participant Withdrew Consent|2|||
147286113|NCT01663636|531211152|FG000|Infant SMS Reminder Feasibility Study|Lost to Follow-up|25|||
147286114|NCT01663636|531211153|FG001|Infant SMS Reminder Feasibility Study|Lost to Follow-up|31|||
147286115|NCT03832946|531211154|FG000|Overall Study|Adverse Event|3|||
147286116|NCT03832946|531211155|FG001|Overall Study|Adverse Event|1|||
147286117|NCT03832946|531211154|FG000|Overall Study|Lost to Follow-up|1|||
147286118|NCT03832946|531211155|FG001|Overall Study|Lost to Follow-up|0|||
147286119|NCT03832946|531211154|FG000|Overall Study|Change in Protocol forbidding use of Nintedanib / Pirfenidone|30|||
147286120|NCT03832946|531211155|FG001|Overall Study|Change in Protocol forbidding use of Nintedanib / Pirfenidone|22|||
147286121|NCT03832946|531211154|FG000|Overall Study|Lack of Efficacy|1|||
147286122|NCT03832946|531211155|FG001|Overall Study|Lack of Efficacy|0|||
147286123|NCT03832946|531211154|FG000|Overall Study|Withdrawal by Subject|12|||
147286124|NCT03832946|531211155|FG001|Overall Study|Withdrawal by Subject|9|||
147286125|NCT02715765|531211156|FG000|Overall Study|Study Termination|3|||
147286126|NCT02715765|531211157|FG001|Overall Study|Study Termination|0|||
147286127|NCT02715765|531211158|FG002|Overall Study|Study Termination|0|||
147286128|NCT02838017|531211160|FG000|Overall Study|Lost to Follow-up|14|||
147286129|NCT02838017|531211161|FG001|Overall Study|Lost to Follow-up|11|||
147286130|NCT01692197|531211162|FG000|Overall Study|Failed Screening|3|||
147286131|NCT02120924|531211163|FG000|Overall Study|Lack of Efficacy|1|||
147286132|NCT02120924|531211164|FG001|Overall Study|Lack of Efficacy|2|||
147286133|NCT02120924|531211165|FG002|Overall Study|Lack of Efficacy|3|||
147286134|NCT02120924|531211163|FG000|Overall Study|Adverse Event|0|||
147286135|NCT02120924|531211164|FG001|Overall Study|Adverse Event|1|||
147286136|NCT02120924|531211165|FG002|Overall Study|Adverse Event|3|||
147286137|NCT02120924|531211163|FG000|Overall Study|Withdrawal by Subject|16|||
147286138|NCT02120924|531211164|FG001|Overall Study|Withdrawal by Subject|20|||
147286139|NCT02120924|531211165|FG002|Overall Study|Withdrawal by Subject|8|||
147286140|NCT02120924|531211163|FG000|Overall Study|Lost to Follow-up|14|||
147286141|NCT02120924|531211164|FG001|Overall Study|Lost to Follow-up|14|||
147286142|NCT02120924|531211165|FG002|Overall Study|Lost to Follow-up|11|||
147286143|NCT02120924|531211163|FG000|Overall Study|Pregnancy|2|||
147286144|NCT02120924|531211164|FG001|Overall Study|Pregnancy|0|||
147286145|NCT02120924|531211165|FG002|Overall Study|Pregnancy|0|||
147286146|NCT02120924|531211163|FG000|Overall Study|Protocol Violation|3|||
147286147|NCT02120924|531211164|FG001|Overall Study|Protocol Violation|7|||
147286148|NCT02120924|531211165|FG002|Overall Study|Protocol Violation|2|||
147286149|NCT02120924|531211163|FG000|Overall Study|Physician Decision|0|||
147286150|NCT02120924|531211164|FG001|Overall Study|Physician Decision|1|||
147286151|NCT02120924|531211165|FG002|Overall Study|Physician Decision|1|||
147286152|NCT02120924|531211163|FG000|Overall Study|Death|1|||
147286153|NCT02120924|531211164|FG001|Overall Study|Death|0|||
147286154|NCT02120924|531211165|FG002|Overall Study|Death|0|||
147286155|NCT02120924|531211163|FG000|Overall Study|Compliance with IP|5|||
147286156|NCT02120924|531211164|FG001|Overall Study|Compliance with IP|1|||
147286157|NCT02120924|531211165|FG002|Overall Study|Compliance with IP|1|||
147286158|NCT01884350|531211166|FG000|Primary Efficacy Analysis Set (24 Weeks)|Subject Withdrew Consent|17|||
147286159|NCT01884350|531211167|FG001|Primary Efficacy Analysis Set (24 Weeks)|Subject Withdrew Consent|20|||
147286160|NCT01884350|531211168|FG002|Primary Efficacy Analysis Set (24 Weeks)|Subject Withdrew Consent|0|||
147286161|NCT01884350|531211166|FG000|Primary Efficacy Analysis Set (24 Weeks)|Death|6|||
147286162|NCT01884350|531211167|FG001|Primary Efficacy Analysis Set (24 Weeks)|Death|4|||
147286163|NCT01884350|531211168|FG002|Primary Efficacy Analysis Set (24 Weeks)|Death|0|||
147286164|NCT01884350|531211166|FG000|Primary Efficacy Analysis Set (24 Weeks)|Lost to Follow-up|0|||
147286165|NCT01884350|531211167|FG001|Primary Efficacy Analysis Set (24 Weeks)|Lost to Follow-up|1|||
147286166|NCT01884350|531211168|FG002|Primary Efficacy Analysis Set (24 Weeks)|Lost to Follow-up|0|||
147286167|NCT01884350|531211166|FG000|Primary Efficacy Analysis Set (24 Weeks)|Serious Adverse Event|7|||
147337558|NCT00683696|531402856|FG001|Overall Study|Vital status follow-up only|3|||
147337559|NCT00683696|531402855|FG000|Overall Study|Death|46|||
147337560|NCT00683696|531402856|FG001|Overall Study|Death|30|||
147337561|NCT00089544|531402857|FG000|Overall Study|Ineligible|1|||
147337562|NCT00089544|531402858|FG001|Overall Study|Ineligible|0|||
147337563|NCT01823536|531402861|FG000|Overall Study|Lost to Follow-up|1|||
147337564|NCT01823536|531402862|FG001|Overall Study|Lost to Follow-up|0|||
147337565|NCT01823536|531402863|FG002|Overall Study|Lost to Follow-up|0|||
147337566|NCT01823536|531402864|FG003|Overall Study|Lost to Follow-up|1|||
147337567|NCT01823536|531402865|FG004|Overall Study|Lost to Follow-up|1|||
147452345|NCT00328627|531819896|FG002|Overall Study|Withdrawal by Subject|5|||
147452346|NCT00328627|531819897|FG003|Overall Study|Withdrawal by Subject|6|||
147286168|NCT01884350|531211167|FG001|Primary Efficacy Analysis Set (24 Weeks)|Serious Adverse Event|6|||
147286169|NCT01884350|531211168|FG002|Primary Efficacy Analysis Set (24 Weeks)|Serious Adverse Event|0|||
147286170|NCT01884350|531211166|FG000|Primary Efficacy Analysis Set (24 Weeks)|Adverse Event|15|||
147286171|NCT01884350|531211167|FG001|Primary Efficacy Analysis Set (24 Weeks)|Adverse Event|11|||
147286172|NCT01884350|531211168|FG002|Primary Efficacy Analysis Set (24 Weeks)|Adverse Event|0|||
147337568|NCT01823536|531402866|FG005|Overall Study|Lost to Follow-up|0|||
147286173|NCT01884350|531211166|FG000|Primary Efficacy Analysis Set (24 Weeks)|Drug Interruption >30 Consecutive Days|0|||
147286174|NCT01884350|531211167|FG001|Primary Efficacy Analysis Set (24 Weeks)|Drug Interruption >30 Consecutive Days|2|||
147286175|NCT01884350|531211168|FG002|Primary Efficacy Analysis Set (24 Weeks)|Drug Interruption >30 Consecutive Days|0|||
147286176|NCT01884350|531211166|FG000|Primary Efficacy Analysis Set (24 Weeks)|Inclusion/exclusion criterion|2|||
147337569|NCT01823536|531402861|FG000|Overall Study|Protocol Violation|0|||
147286177|NCT01884350|531211167|FG001|Primary Efficacy Analysis Set (24 Weeks)|Inclusion/exclusion criterion|5|||
147286178|NCT01884350|531211168|FG002|Primary Efficacy Analysis Set (24 Weeks)|Inclusion/exclusion criterion|0|||
147286179|NCT01884350|531211166|FG000|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used|2|||
147286180|NCT01884350|531211167|FG001|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used|0|||
147286181|NCT01884350|531211168|FG002|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used|0|||
147286182|NCT01884350|531211166|FG000|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used, treatment taken|1|||
147286183|NCT01884350|531211167|FG001|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used, treatment taken|1|||
147286184|NCT01884350|531211168|FG002|Primary Efficacy Analysis Set (24 Weeks)|Helping Hand not used, treatment taken|0|||
147286185|NCT01884350|531211166|FG000|Primary Efficacy Analysis Set (24 Weeks)|Withdrawal by Subject|1|||
147286186|NCT01884350|531211167|FG001|Primary Efficacy Analysis Set (24 Weeks)|Withdrawal by Subject|1|||
147286187|NCT01884350|531211168|FG002|Primary Efficacy Analysis Set (24 Weeks)|Withdrawal by Subject|0|||
147286188|NCT01884350|531211166|FG000|Primary Efficacy Analysis Set (24 Weeks)|Medical reason|3|||
147286189|NCT01884350|531211167|FG001|Primary Efficacy Analysis Set (24 Weeks)|Medical reason|3|||
147286190|NCT01884350|531211168|FG002|Primary Efficacy Analysis Set (24 Weeks)|Medical reason|0|||
147286191|NCT01884350|531211166|FG000|Primary Efficacy Analysis Set (48 Weeks)|Subject Withdrew Consent|21|||
147286192|NCT01884350|531211167|FG001|Primary Efficacy Analysis Set (48 Weeks)|Subject Withdrew Consent|0|||
147286193|NCT01884350|531211168|FG002|Primary Efficacy Analysis Set (48 Weeks)|Subject Withdrew Consent|2|||
147286194|NCT01884350|531211166|FG000|Primary Efficacy Analysis Set (48 Weeks)|Death|7|||
147286195|NCT01884350|531211167|FG001|Primary Efficacy Analysis Set (48 Weeks)|Death|3|||
147286196|NCT01884350|531211168|FG002|Primary Efficacy Analysis Set (48 Weeks)|Death|3|||
147286197|NCT01884350|531211166|FG000|Primary Efficacy Analysis Set (48 Weeks)|Lost to Follow-up|1|||
147286198|NCT01884350|531211167|FG001|Primary Efficacy Analysis Set (48 Weeks)|Lost to Follow-up|0|||
147286199|NCT01884350|531211168|FG002|Primary Efficacy Analysis Set (48 Weeks)|Lost to Follow-up|1|||
147286200|NCT01884350|531211166|FG000|Primary Efficacy Analysis Set (48 Weeks)|Serious Adverse Event|17|||
147286201|NCT01884350|531211167|FG001|Primary Efficacy Analysis Set (48 Weeks)|Serious Adverse Event|6|||
147286202|NCT01884350|531211168|FG002|Primary Efficacy Analysis Set (48 Weeks)|Serious Adverse Event|3|||
147286203|NCT01884350|531211166|FG000|Primary Efficacy Analysis Set (48 Weeks)|Adverse Event|17|||
147286204|NCT01884350|531211167|FG001|Primary Efficacy Analysis Set (48 Weeks)|Adverse Event|3|||
147286205|NCT01884350|531211168|FG002|Primary Efficacy Analysis Set (48 Weeks)|Adverse Event|0|||
147286206|NCT01884350|531211166|FG000|Primary Efficacy Analysis Set (48 Weeks)|Drug Interruption >30 Consecutive Days|3|||
147286207|NCT01884350|531211167|FG001|Primary Efficacy Analysis Set (48 Weeks)|Drug Interruption >30 Consecutive Days|0|||
147286208|NCT01884350|531211168|FG002|Primary Efficacy Analysis Set (48 Weeks)|Drug Interruption >30 Consecutive Days|2|||
147286209|NCT01884350|531211166|FG000|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used|4|||
147286210|NCT01884350|531211167|FG001|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used|0|||
147286211|NCT01884350|531211168|FG002|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used|0|||
147286212|NCT01884350|531211166|FG000|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used, treatment taken|3|||
147286213|NCT01884350|531211167|FG001|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used, treatment taken|0|||
147286214|NCT01884350|531211168|FG002|Primary Efficacy Analysis Set (48 Weeks)|Helping Hand not used, treatment taken|0|||
147286215|NCT01884350|531211166|FG000|Primary Efficacy Analysis Set (48 Weeks)|Medical reason|4|||
147286216|NCT01884350|531211167|FG001|Primary Efficacy Analysis Set (48 Weeks)|Medical reason|1|||
147286217|NCT01884350|531211168|FG002|Primary Efficacy Analysis Set (48 Weeks)|Medical reason|0|||
147286218|NCT01884350|531211166|FG000|Primary Efficacy Analysis Set (48 Weeks)|Subject decision|1|||
147286219|NCT01884350|531211167|FG001|Primary Efficacy Analysis Set (48 Weeks)|Subject decision|0|||
147286220|NCT01884350|531211168|FG002|Primary Efficacy Analysis Set (48 Weeks)|Subject decision|0|||
147286221|NCT01884350|531211166|FG000|Primary Efficacy Analysis Set (48 Weeks)|Inclusion / Exclusion Criterion|2|||
147286222|NCT01884350|531211167|FG001|Primary Efficacy Analysis Set (48 Weeks)|Inclusion / Exclusion Criterion|0|||
147286223|NCT01884350|531211168|FG002|Primary Efficacy Analysis Set (48 Weeks)|Inclusion / Exclusion Criterion|0|||
147286224|NCT03588572|531211175|FG000|Visitation 1|Lack of Efficacy|1|||
147286225|NCT03588572|531211176|FG001|Visitation 1|Lack of Efficacy|1|||
147286226|NCT03588572|531211175|FG000|Visitation 2|Lost to Follow-up|1|||
147286227|NCT03588572|531211176|FG001|Visitation 2|Lost to Follow-up|1|||
147286228|NCT03588572|531211175|FG000|Visitation 2|Lack of Efficacy|0|||
147286229|NCT03588572|531211176|FG001|Visitation 2|Lack of Efficacy|1|||
147286230|NCT03588572|531211175|FG000|Visitation 2|Withdrawal by Subject|1|||
147286231|NCT03588572|531211176|FG001|Visitation 2|Withdrawal by Subject|0|||
147604152|NCT04623086|532367840|FG002|Overall Study|Withdrawal by Subject|10|||
147286232|NCT03588572|531211175|FG000|Visitation 3|Lost to Follow-up|1|||
147286233|NCT03588572|531211176|FG001|Visitation 3|Lost to Follow-up|1|||
147286234|NCT03588572|531211175|FG000|Visitation 3|Physician Decision|1|||
147286235|NCT03588572|531211176|FG001|Visitation 3|Physician Decision|1|||
147286236|NCT03588572|531211175|FG000|Visitation 3|Withdrawal by Subject|1|||
147286237|NCT03588572|531211176|FG001|Visitation 3|Withdrawal by Subject|0|||
147286238|NCT02663817|531211177|FG000|Overall Study|Screen failure|2|||
147604153|NCT00191165|532367841|FG000|Overall Study|Adverse Event|2|||
147604154|NCT00191165|532367842|FG001|Overall Study|Adverse Event|0|||
147286239|NCT01308580|531211179|FG000|Overall Study|Lost to Follow-up|12|||
147286240|NCT01308580|531211180|FG001|Overall Study|Lost to Follow-up|7|||
147286241|NCT03712917|531211181|FG000|Overall Study|Pregnancy|0|||
147286242|NCT03712917|531211182|FG001|Overall Study|Pregnancy|0|||
147286243|NCT03712917|531211183|FG002|Overall Study|Pregnancy|1|||
147286244|NCT03712917|531211181|FG000|Overall Study|Adverse Event|0|||
147286245|NCT03712917|531211182|FG001|Overall Study|Adverse Event|4|||
147286246|NCT03712917|531211183|FG002|Overall Study|Adverse Event|3|||
147286247|NCT03712917|531211181|FG000|Overall Study|Lost to Follow-up|9|||
147286248|NCT03712917|531211182|FG001|Overall Study|Lost to Follow-up|4|||
147286249|NCT03712917|531211183|FG002|Overall Study|Lost to Follow-up|5|||
147286250|NCT01438541|531211184|FG000|Overall Study|Physician Decision|1|||
147286251|NCT01438541|531211184|FG000|Overall Study|Withdrawal by Subject|1|||
147286252|NCT01438541|531211184|FG000|Overall Study|discharge from the hospital|5|||
147286253|NCT02091167|531211185|FG000|Overall Study|Lost to Follow-up|0|||
147286254|NCT02091167|531211186|FG001|Overall Study|Lost to Follow-up|2|||
147286255|NCT03096782|531211187|FG000|Overall Study|Death|1|||
147286256|NCT03096782|531211187|FG000|Overall Study|Participant Relapsed|1|||
147286257|NCT01286779|531213183|FG000|Overall Study|Withdrawal by Subject|9|||
147286258|NCT01286779|531213183|FG000|Overall Study|Protocol Violation|5|||
147286259|NCT01286779|531213183|FG000|Overall Study|Physician Decision|2|||
147286260|NCT01286779|531213183|FG000|Overall Study|Participant had scheduled surgery|1|||
147286261|NCT01286779|531213183|FG000|Overall Study|Participant moved to another country|1|||
147286262|NCT01286779|531213183|FG000|Overall Study|Discontinued by sponsor|1|||
147286263|NCT02862106|531213184|FG000|Overall Study|Adverse Event|4|||
147286264|NCT02862106|531213185|FG001|Overall Study|Adverse Event|0|||
147286265|NCT02862106|531213184|FG000|Overall Study|Protocol Violation|16|||
147286266|NCT02862106|531213185|FG001|Overall Study|Protocol Violation|1|||
147286267|NCT02862106|531213184|FG000|Overall Study|Lost to Follow-up|15|||
147286268|NCT02862106|531213185|FG001|Overall Study|Lost to Follow-up|5|||
147286269|NCT02862106|531213184|FG000|Overall Study|Withdrawal by Subject|2|||
147286270|NCT02862106|531213185|FG001|Overall Study|Withdrawal by Subject|0|||
147286271|NCT02862106|531213184|FG000|Overall Study|Subjects moved to other city|1|||
147286272|NCT02862106|531213185|FG001|Overall Study|Subjects moved to other city|0|||
147286273|NCT00377676|531213186|FG000|Overall Study|Adverse Event|498|||
147286274|NCT00377676|531213187|FG001|Overall Study|Adverse Event|107|||
147286275|NCT00377676|531213186|FG000|Overall Study|Protocol Violation|33|||
147286276|NCT00377676|531213187|FG001|Overall Study|Protocol Violation|27|||
147286277|NCT00377676|531213186|FG000|Overall Study|Death|5|||
147286278|NCT00377676|531213187|FG001|Overall Study|Death|2|||
147286279|NCT00377676|531213186|FG000|Overall Study|Withdrawal by Subject|187|||
147286280|NCT00377676|531213187|FG001|Overall Study|Withdrawal by Subject|72|||
147286281|NCT00377676|531213186|FG000|Overall Study|Lost to Follow-up|120|||
147286282|NCT00377676|531213187|FG001|Overall Study|Lost to Follow-up|56|||
147286283|NCT00377676|531213186|FG000|Overall Study|Other|118|||
147286284|NCT00377676|531213187|FG001|Overall Study|Other|58|||
147286285|NCT00093145|531213201|FG000|Overall Study|Unacceptable Toxicity Only|2|||
147286286|NCT00093145|531213201|FG000|Overall Study|Physician Decision|5|||
147286287|NCT00093145|531213201|FG000|Overall Study|Withdrawal by Subject|9|||
147286288|NCT00093145|531213201|FG000|Overall Study|Other|1|||
147286289|NCT01310036|531213202|FG000|Overall Study|Administrative/other|10|||
147286290|NCT01310036|531213202|FG000|Overall Study|Withdrew Consent|11|||
147286291|NCT01310036|531213202|FG000|Overall Study|Refused Treatment/Did not Cooperate|4|||
147286292|NCT01310036|531213202|FG000|Overall Study|Progression of Disease|164|||
147286293|NCT01310036|531213202|FG000|Overall Study|Death|1|||
147286294|NCT01310036|531213202|FG000|Overall Study|Adverse event or intercurrent illness|12|||
147286295|NCT00553267|531213203|FG000|Overall Study|Adverse Event|8|||
147286296|NCT00553267|531213204|FG001|Overall Study|Adverse Event|10|||
147286297|NCT00553267|531213205|FG002|Overall Study|Adverse Event|5|||
147286298|NCT00553267|531213203|FG000|Overall Study|Non compliant with protocol|3|||
147337570|NCT01823536|531402862|FG001|Overall Study|Protocol Violation|1|||
147337571|NCT01823536|531402863|FG002|Overall Study|Protocol Violation|0|||
147286299|NCT00553267|531213204|FG001|Overall Study|Non compliant with protocol|3|||
147286300|NCT00553267|531213205|FG002|Overall Study|Non compliant with protocol|2|||
147286301|NCT00553267|531213203|FG000|Overall Study|Lost to Follow-up|0|||
147286302|NCT00553267|531213204|FG001|Overall Study|Lost to Follow-up|0|||
147286303|NCT00553267|531213205|FG002|Overall Study|Lost to Follow-up|1|||
147286304|NCT00553267|531213203|FG000|Overall Study|Consent withdrawn|2|||
147286305|NCT00553267|531213204|FG001|Overall Study|Consent withdrawn|3|||
147286306|NCT00553267|531213205|FG002|Overall Study|Consent withdrawn|1|||
147286307|NCT00553267|531213203|FG000|Overall Study|Specified category|1|||
147286308|NCT00553267|531213204|FG001|Overall Study|Specified category|2|||
147286309|NCT00553267|531213205|FG002|Overall Study|Specified category|1|||
147286310|NCT04389840|531213206|FG000|Overall Study|Adverse Event|0|||
147286311|NCT04389840|531213207|FG001|Overall Study|Adverse Event|0|||
147286312|NCT04389840|531213208|FG002|Overall Study|Adverse Event|0|||
147286313|NCT04389840|531213209|FG003|Overall Study|Adverse Event|1|||
147286314|NCT04389840|531213210|FG004|Overall Study|Adverse Event|0|||
147286315|NCT04389840|531213211|FG005|Overall Study|Adverse Event|0|||
147337572|NCT01823536|531402864|FG003|Overall Study|Protocol Violation|0|||
147286316|NCT04389840|531213206|FG000|Overall Study|Subject request and prohibited concomitant medication|2|||
147286317|NCT04389840|531213207|FG001|Overall Study|Subject request and prohibited concomitant medication|0|||
147286318|NCT04389840|531213208|FG002|Overall Study|Subject request and prohibited concomitant medication|0|||
147286319|NCT04389840|531213209|FG003|Overall Study|Subject request and prohibited concomitant medication|0|||
147286320|NCT04389840|531213210|FG004|Overall Study|Subject request and prohibited concomitant medication|1|||
147286321|NCT04389840|531213211|FG005|Overall Study|Subject request and prohibited concomitant medication|0|||
147286322|NCT04389840|531213206|FG000|Overall Study|Death|0|||
147286323|NCT04389840|531213207|FG001|Overall Study|Death|1|||
147286324|NCT04389840|531213208|FG002|Overall Study|Death|0|||
147286325|NCT04389840|531213209|FG003|Overall Study|Death|0|||
147286326|NCT04389840|531213210|FG004|Overall Study|Death|0|||
147286327|NCT04389840|531213211|FG005|Overall Study|Death|0|||
147286328|NCT02365467|531213217|FG000|Overall Study|Death|3|||
147286329|NCT02043782|531213218|FG000|Period 1|Adverse Event|0|||
147286330|NCT02043782|531213219|FG001|Period 1|Adverse Event|0|||
147286331|NCT02043782|531213220|FG002|Period 1|Adverse Event|1|||
147286332|NCT02043782|531213221|FG003|Period 1|Adverse Event|0|||
147286333|NCT02043782|531213222|FG004|Period 1|Adverse Event|0|||
147286334|NCT02043782|531213223|FG005|Period 1|Adverse Event|0|||
147286335|NCT00709722|531213224|FG000|Overall Study|Adverse Event|1|||
147286336|NCT04667117|531213225|FG000|Investigational Period|Lost to Follow-up|0|||
147286337|NCT04667117|531213226|FG001|Investigational Period|Lost to Follow-up|0|||
147286338|NCT04667117|531213227|FG002|Investigational Period|Lost to Follow-up|1|||
147286339|NCT04667117|531213225|FG000|Investigational Period|Protocol Deviation|0|||
147286340|NCT04667117|531213226|FG001|Investigational Period|Protocol Deviation|1|||
147286341|NCT04667117|531213227|FG002|Investigational Period|Protocol Deviation|0|||
147286342|NCT04667117|531213225|FG000|Extension Period|Lost to Follow-up|1|||
147286343|NCT04667117|531213226|FG001|Extension Period|Lost to Follow-up|0|||
147286344|NCT04667117|531213227|FG002|Extension Period|Lost to Follow-up|0|||
147286345|NCT03359096|531213228|FG000|HGNS Washout (1 Week)|Withdrawal by Subject|0|||
147286346|NCT03359096|531213229|FG001|HGNS Washout (1 Week)|Withdrawal by Subject|1|||
147286347|NCT03359096|531213228|FG000|First Intervention (4 Weeks)|Death|1|||
147286348|NCT03359096|531213229|FG001|First Intervention (4 Weeks)|Death|0|||
147286349|NCT03359096|531213228|FG000|First Intervention (4 Weeks)|Physician Decision|1|||
147286350|NCT03359096|531213229|FG001|First Intervention (4 Weeks)|Physician Decision|0|||
147286351|NCT01306162|531213230|FG000|Period 1|Adverse Event|0|||
147286352|NCT01306162|531213231|FG001|Period 1|Adverse Event|0|||
147286353|NCT01306162|531213232|FG002|Period 1|Adverse Event|0|||
147286354|NCT01306162|531213233|FG003|Period 1|Adverse Event|1|||
147286355|NCT01306162|531213230|FG000|Washout 1|Non-compliance to protocol|0|||
147286356|NCT01306162|531213231|FG001|Washout 1|Non-compliance to protocol|1|||
147286357|NCT01306162|531213232|FG002|Washout 1|Non-compliance to protocol|0|||
147286358|NCT01306162|531213233|FG003|Washout 1|Non-compliance to protocol|0|||
147286359|NCT00833989|531213237|FG000|Overall Study|Physician Decision|0|||
147286360|NCT00833989|531213238|FG001|Overall Study|Physician Decision|0|||
147286361|NCT00833989|531213239|FG002|Overall Study|Physician Decision|0|||
147286362|NCT00833989|531213240|FG003|Overall Study|Physician Decision|1|||
147286363|NCT00833989|531213237|FG000|Overall Study|Withdrawal by Subject|3|||
147286364|NCT00833989|531213238|FG001|Overall Study|Withdrawal by Subject|0|||
147286365|NCT00833989|531213239|FG002|Overall Study|Withdrawal by Subject|1|||
147286366|NCT00833989|531213240|FG003|Overall Study|Withdrawal by Subject|1|||
147286367|NCT02952924|531213243|FG000|Overall Study|Protocol Violation|0|||
147286368|NCT02952924|531213244|FG001|Overall Study|Protocol Violation|0|||
147286369|NCT02952924|531213245|FG002|Overall Study|Protocol Violation|0|||
147286370|NCT02952924|531213246|FG003|Overall Study|Protocol Violation|0|||
147286371|NCT02952924|531213247|FG004|Overall Study|Protocol Violation|0|||
147286372|NCT02952924|531213248|FG005|Overall Study|Protocol Violation|0|||
147286373|NCT02952924|531213249|FG006|Overall Study|Protocol Violation|0|||
147286374|NCT02952924|531213250|FG007|Overall Study|Protocol Violation|0|||
147286375|NCT02952924|531213251|FG008|Overall Study|Protocol Violation|0|||
147286376|NCT02952924|531213252|FG009|Overall Study|Protocol Violation|0|||
147337573|NCT01823536|531402865|FG004|Overall Study|Protocol Violation|0|||
147337574|NCT01823536|531402866|FG005|Overall Study|Protocol Violation|0|||
147286377|NCT02952924|531213253|FG010|Overall Study|Protocol Violation|0|||
147286378|NCT02952924|531213254|FG011|Overall Study|Protocol Violation|0|||
147286379|NCT02952924|531213255|FG012|Overall Study|Protocol Violation|0|||
147286380|NCT02952924|531213256|FG013|Overall Study|Protocol Violation|0|||
147286381|NCT02952924|531213257|FG014|Overall Study|Protocol Violation|0|||
147286382|NCT02952924|531213258|FG015|Overall Study|Protocol Violation|0|||
147286383|NCT02952924|531213259|FG016|Overall Study|Protocol Violation|0|||
147286384|NCT02952924|531213260|FG017|Overall Study|Protocol Violation|0|||
147286385|NCT02952924|531213261|FG018|Overall Study|Protocol Violation|0|||
147286386|NCT02952924|531213262|FG019|Overall Study|Protocol Violation|1|||
147286387|NCT02952924|531213263|FG020|Overall Study|Protocol Violation|0|||
147286388|NCT02952924|531213264|FG021|Overall Study|Protocol Violation|0|||
147286389|NCT02952924|531213243|FG000|Overall Study|Participant refused to adhere to study protocol|0|||
147286390|NCT02952924|531213244|FG001|Overall Study|Participant refused to adhere to study protocol|0|||
147286391|NCT02952924|531213245|FG002|Overall Study|Participant refused to adhere to study protocol|0|||
147286392|NCT02952924|531213246|FG003|Overall Study|Participant refused to adhere to study protocol|0|||
147286393|NCT02952924|531213247|FG004|Overall Study|Participant refused to adhere to study protocol|0|||
147286394|NCT02952924|531213248|FG005|Overall Study|Participant refused to adhere to study protocol|0|||
147286395|NCT02952924|531213249|FG006|Overall Study|Participant refused to adhere to study protocol|0|||
147286396|NCT02952924|531213250|FG007|Overall Study|Participant refused to adhere to study protocol|0|||
147286397|NCT02952924|531213251|FG008|Overall Study|Participant refused to adhere to study protocol|0|||
147286398|NCT02952924|531213252|FG009|Overall Study|Participant refused to adhere to study protocol|0|||
147286399|NCT02952924|531213253|FG010|Overall Study|Participant refused to adhere to study protocol|0|||
147286400|NCT02952924|531213254|FG011|Overall Study|Participant refused to adhere to study protocol|0|||
147286401|NCT02952924|531213255|FG012|Overall Study|Participant refused to adhere to study protocol|0|||
147286402|NCT02952924|531213256|FG013|Overall Study|Participant refused to adhere to study protocol|0|||
147286403|NCT02952924|531213257|FG014|Overall Study|Participant refused to adhere to study protocol|0|||
147286404|NCT02952924|531213258|FG015|Overall Study|Participant refused to adhere to study protocol|0|||
147286405|NCT02952924|531213259|FG016|Overall Study|Participant refused to adhere to study protocol|0|||
147286406|NCT02952924|531213260|FG017|Overall Study|Participant refused to adhere to study protocol|1|||
147286407|NCT02952924|531213261|FG018|Overall Study|Participant refused to adhere to study protocol|0|||
147286408|NCT02952924|531213262|FG019|Overall Study|Participant refused to adhere to study protocol|0|||
147286409|NCT02952924|531213263|FG020|Overall Study|Participant refused to adhere to study protocol|0|||
147286410|NCT02952924|531213264|FG021|Overall Study|Participant refused to adhere to study protocol|0|||
147286411|NCT02952924|531213243|FG000|Overall Study|Participant unable to adhere to study visit schedule|0|||
147286412|NCT02952924|531213244|FG001|Overall Study|Participant unable to adhere to study visit schedule|0|||
147286413|NCT02952924|531213245|FG002|Overall Study|Participant unable to adhere to study visit schedule|0|||
147286414|NCT02952924|531213246|FG003|Overall Study|Participant unable to adhere to study visit schedule|0|||
147286415|NCT02952924|531213247|FG004|Overall Study|Participant unable to adhere to study visit schedule|0|||
147286416|NCT02952924|531213248|FG005|Overall Study|Participant unable to adhere to study visit schedule|0|||
147286417|NCT02952924|531213249|FG006|Overall Study|Participant unable to adhere to study visit schedule|0|||
147286418|NCT02952924|531213250|FG007|Overall Study|Participant unable to adhere to study visit schedule|0|||
147286419|NCT02952924|531213251|FG008|Overall Study|Participant unable to adhere to study visit schedule|0|||
147286420|NCT02952924|531213252|FG009|Overall Study|Participant unable to adhere to study visit schedule|0|||
147286421|NCT02952924|531213253|FG010|Overall Study|Participant unable to adhere to study visit schedule|0|||
147286422|NCT02952924|531213254|FG011|Overall Study|Participant unable to adhere to study visit schedule|0|||
147286423|NCT02952924|531213255|FG012|Overall Study|Participant unable to adhere to study visit schedule|0|||
147286424|NCT02952924|531213256|FG013|Overall Study|Participant unable to adhere to study visit schedule|0|||
147286425|NCT02952924|531213257|FG014|Overall Study|Participant unable to adhere to study visit schedule|0|||
147286426|NCT02952924|531213258|FG015|Overall Study|Participant unable to adhere to study visit schedule|0|||
147286427|NCT02952924|531213259|FG016|Overall Study|Participant unable to adhere to study visit schedule|0|||
147286428|NCT02952924|531213260|FG017|Overall Study|Participant unable to adhere to study visit schedule|0|||
147286429|NCT02952924|531213261|FG018|Overall Study|Participant unable to adhere to study visit schedule|0|||
147286430|NCT02952924|531213262|FG019|Overall Study|Participant unable to adhere to study visit schedule|0|||
147286431|NCT02952924|531213263|FG020|Overall Study|Participant unable to adhere to study visit schedule|0|||
147286432|NCT02952924|531213264|FG021|Overall Study|Participant unable to adhere to study visit schedule|1|||
147286433|NCT02952924|531213243|FG000|Overall Study|Noncompliance with study drug|0|||
147286434|NCT02952924|531213244|FG001|Overall Study|Noncompliance with study drug|0|||
147286435|NCT02952924|531213245|FG002|Overall Study|Noncompliance with study drug|0|||
147286436|NCT02952924|531213246|FG003|Overall Study|Noncompliance with study drug|0|||
147286437|NCT02952924|531213247|FG004|Overall Study|Noncompliance with study drug|0|||
147286438|NCT02952924|531213248|FG005|Overall Study|Noncompliance with study drug|0|||
147286439|NCT02952924|531213249|FG006|Overall Study|Noncompliance with study drug|0|||
147286440|NCT02952924|531213250|FG007|Overall Study|Noncompliance with study drug|0|||
147286441|NCT02952924|531213251|FG008|Overall Study|Noncompliance with study drug|0|||
147286442|NCT02952924|531213252|FG009|Overall Study|Noncompliance with study drug|0|||
147286443|NCT02952924|531213253|FG010|Overall Study|Noncompliance with study drug|0|||
147286444|NCT02952924|531213254|FG011|Overall Study|Noncompliance with study drug|0|||
147286445|NCT02952924|531213255|FG012|Overall Study|Noncompliance with study drug|0|||
147286446|NCT02952924|531213256|FG013|Overall Study|Noncompliance with study drug|0|||
147286447|NCT02952924|531213257|FG014|Overall Study|Noncompliance with study drug|0|||
147286448|NCT02952924|531213258|FG015|Overall Study|Noncompliance with study drug|0|||
147286449|NCT02952924|531213259|FG016|Overall Study|Noncompliance with study drug|0|||
147286450|NCT02952924|531213260|FG017|Overall Study|Noncompliance with study drug|0|||
147286451|NCT02952924|531213261|FG018|Overall Study|Noncompliance with study drug|0|||
147452347|NCT00328627|531819898|FG004|Overall Study|Withdrawal by Subject|2|||
147452348|NCT00328627|531819899|FG005|Overall Study|Withdrawal by Subject|5|||
147286452|NCT02952924|531213262|FG019|Overall Study|Noncompliance with study drug|0|||
147286453|NCT02952924|531213263|FG020|Overall Study|Noncompliance with study drug|0|||
147286454|NCT02952924|531213264|FG021|Overall Study|Noncompliance with study drug|1|||
147286455|NCT01226745|531213265|FG000|Overall Study|Did not complete schedule of assessments|8|||
147286456|NCT01226745|531213266|FG001|Overall Study|Did not complete schedule of assessments|3|||
147286457|NCT01226745|531213267|FG002|Overall Study|Did not complete schedule of assessments|6|||
147286458|NCT01226745|531213268|FG003|Overall Study|Did not complete schedule of assessments|0|||
147286459|NCT01226745|531213269|FG004|Overall Study|Did not complete schedule of assessments|0|||
147286460|NCT01226745|531213270|FG005|Overall Study|Did not complete schedule of assessments|1|||
147286461|NCT01226745|531213265|FG000|Overall Study|Lost to Follow-up|2|||
147286462|NCT01226745|531213266|FG001|Overall Study|Lost to Follow-up|6|||
147286463|NCT01226745|531213267|FG002|Overall Study|Lost to Follow-up|6|||
147286464|NCT01226745|531213268|FG003|Overall Study|Lost to Follow-up|1|||
147286465|NCT01226745|531213269|FG004|Overall Study|Lost to Follow-up|1|||
147286466|NCT01226745|531213270|FG005|Overall Study|Lost to Follow-up|2|||
147286467|NCT01226745|531213265|FG000|Overall Study|Death|1|||
147286468|NCT01226745|531213266|FG001|Overall Study|Death|0|||
147286469|NCT01226745|531213267|FG002|Overall Study|Death|0|||
147286470|NCT01226745|531213268|FG003|Overall Study|Death|0|||
147286471|NCT01226745|531213269|FG004|Overall Study|Death|0|||
147286472|NCT01226745|531213270|FG005|Overall Study|Death|1|||
147286473|NCT01226745|531213265|FG000|Overall Study|Other|6|||
147286474|NCT01226745|531213266|FG001|Overall Study|Other|7|||
147286475|NCT01226745|531213267|FG002|Overall Study|Other|8|||
147286476|NCT01226745|531213268|FG003|Overall Study|Other|4|||
147286477|NCT01226745|531213269|FG004|Overall Study|Other|3|||
147286478|NCT01226745|531213270|FG005|Overall Study|Other|1|||
147286479|NCT01435577|531213271|FG000|Overall Study|Adverse Event|10|||
147286480|NCT01435577|531213272|FG001|Overall Study|Adverse Event|0|||
147286481|NCT01435577|531213271|FG000|Overall Study|Lack of Efficacy|7|||
147286482|NCT01435577|531213272|FG001|Overall Study|Lack of Efficacy|51|||
147286483|NCT01435577|531213271|FG000|Overall Study|Alternative treatment started|0|||
147286484|NCT01435577|531213272|FG001|Overall Study|Alternative treatment started|1|||
147286485|NCT02232893|531213278|FG000|Overall Study|Withdrawal by Subject|4|||
147286486|NCT02232893|531213279|FG001|Overall Study|Withdrawal by Subject|1|||
147286487|NCT02232893|531213278|FG000|Overall Study|Adverse Event|0|||
147286488|NCT02232893|531213279|FG001|Overall Study|Adverse Event|1|||
147286489|NCT02232893|531213278|FG000|Overall Study|Sponsor request early termination|0|||
147286490|NCT02232893|531213279|FG001|Overall Study|Sponsor request early termination|1|||
147286491|NCT02232893|531213278|FG000|Overall Study|Developed exclusion criteria|0|||
147286492|NCT02232893|531213279|FG001|Overall Study|Developed exclusion criteria|1|||
147286493|NCT02232893|531213278|FG000|Overall Study|Other|0|||
147286494|NCT02232893|531213279|FG001|Overall Study|Other|3|||
147286495|NCT01090453|531213282|FG000|Overall Study|Withdrawal by Subject|1|||
147286496|NCT01090453|531213283|FG001|Overall Study|Withdrawal by Subject|2|||
147286497|NCT01090453|531213282|FG000|Overall Study|Lost to Follow-up|7|||
147286498|NCT01090453|531213283|FG001|Overall Study|Lost to Follow-up|7|||
147286499|NCT01090453|531213282|FG000|Overall Study|Non serious AEs|1|||
147286500|NCT01090453|531213283|FG001|Overall Study|Non serious AEs|0|||
147286501|NCT01090453|531213282|FG000|Overall Study|Protocol Violation|2|||
147286502|NCT01090453|531213283|FG001|Overall Study|Protocol Violation|0|||
147286503|NCT01090453|531213282|FG000|Overall Study|Other|2|||
147286504|NCT01090453|531213283|FG001|Overall Study|Other|4|||
147286505|NCT01090453|531213282|FG000|Overall Study|Eligibility Criteria|0|||
147286506|NCT01090453|531213283|FG001|Overall Study|Eligibility Criteria|1|||
147286507|NCT00522275|531213284|FG000|Overall Study|Adverse Event|35|||
147337575|NCT01823536|531402861|FG000|Overall Study|Withdrawal by Subject|1|||
147337576|NCT01823536|531402862|FG001|Overall Study|Withdrawal by Subject|1|||
147337577|NCT01823536|531402863|FG002|Overall Study|Withdrawal by Subject|0|||
147337578|NCT01823536|531402864|FG003|Overall Study|Withdrawal by Subject|0|||
147337579|NCT01823536|531402865|FG004|Overall Study|Withdrawal by Subject|0|||
147337580|NCT01823536|531402866|FG005|Overall Study|Withdrawal by Subject|0|||
147286508|NCT00522275|531213284|FG000|Overall Study|Lack of Efficacy|80|||
147337581|NCT01823536|531402861|FG000|Overall Study|Visit 1 delayed, unable to reschedule|0|||
147337582|NCT01823536|531402862|FG001|Overall Study|Visit 1 delayed, unable to reschedule|0|||
147337583|NCT01823536|531402863|FG002|Overall Study|Visit 1 delayed, unable to reschedule|1|||
147286509|NCT00522275|531213284|FG000|Overall Study|Subject withdrew consent|16|||
147286510|NCT00522275|531213284|FG000|Overall Study|Protocol deviation|1|||
147286511|NCT00522275|531213284|FG000|Overall Study|Unsatisfactory compliance|11|||
147286512|NCT00522275|531213284|FG000|Overall Study|Lost to Follow-up|8|||
147286513|NCT00522275|531213284|FG000|Overall Study|Other: Subject wants to become pregnant|2|||
147286514|NCT00522275|531213284|FG000|Overall Study|Other: Subject is pregnant|2|||
147286515|NCT00522275|531213284|FG000|Overall Study|Other: Subject relocated|2|||
147337584|NCT01823536|531402864|FG003|Overall Study|Visit 1 delayed, unable to reschedule|0|||
147662637|NCT00385918|532587379|FG000|Feasibility & Baseline Measurement Phase|Physician Decision|0|||
147286516|NCT00522275|531213284|FG000|Overall Study|Other: Subject arrested|1|||
147286517|NCT00522275|531213284|FG000|Overall Study|Other: Site / clinic closed|4|||
147604155|NCT00191165|532367841|FG000|Overall Study|Protocol Violation|0|||
147286518|NCT00522275|531213284|FG000|Overall Study|Other: Travel to / from site difficulty|3|||
147286519|NCT00522275|531213284|FG000|Overall Study|Other: Sponsor request|2|||
147286520|NCT00522275|531213284|FG000|Overall Study|Other: Subject ran out of medication|1|||
147286521|NCT00522275|531213284|FG000|Overall Study|Other: Subject had surgery for epilepsy|2|||
147286522|NCT03867734|531213286|FG000|Overall Study|Lost to Follow-up|2|||
147286523|NCT03965052|531213287|FG000|Overall Study|Protocol Violation|1|||
147286524|NCT03965052|531213288|FG001|Overall Study|Protocol Violation|0|||
147286525|NCT04323436|531213294|FG000|Overall Study|Adverse Event|7|||
147286526|NCT04323436|531213295|FG001|Overall Study|Adverse Event|0|||
147286527|NCT04323436|531213296|FG002|Overall Study|Adverse Event|0|||
147286528|NCT04323436|531213294|FG000|Overall Study|Transfer to another clinical study or to other alternative treatment option|8|||
147286529|NCT04323436|531213295|FG001|Overall Study|Transfer to another clinical study or to other alternative treatment option|0|||
147286530|NCT04323436|531213296|FG002|Overall Study|Transfer to another clinical study or to other alternative treatment option|0|||
147286531|NCT04323436|531213294|FG000|Overall Study|Death|1|||
147286532|NCT04323436|531213295|FG001|Overall Study|Death|0|||
147286533|NCT04323436|531213296|FG002|Overall Study|Death|0|||
147286534|NCT04323436|531213294|FG000|Overall Study|Physician Decision|2|||
147286535|NCT04323436|531213295|FG001|Overall Study|Physician Decision|0|||
147286536|NCT04323436|531213296|FG002|Overall Study|Physician Decision|0|||
147286537|NCT04323436|531213294|FG000|Overall Study|Progressive disease|10|||
147286538|NCT04323436|531213295|FG001|Overall Study|Progressive disease|0|||
147286539|NCT04323436|531213296|FG002|Overall Study|Progressive disease|0|||
147286540|NCT04323436|531213294|FG000|Overall Study|Subject decision|3|||
147286541|NCT04323436|531213295|FG001|Overall Study|Subject decision|0|||
147286542|NCT04323436|531213296|FG002|Overall Study|Subject decision|0|||
147286543|NCT01365494|531213297|FG000|Overall Study|Adverse Event|1|||
147286544|NCT01365494|531213298|FG001|Overall Study|Adverse Event|0|||
147286545|NCT01365494|531213297|FG000|Overall Study|Withdrawal by Subject|0|||
147286546|NCT01365494|531213298|FG001|Overall Study|Withdrawal by Subject|1|||
147286547|NCT01365494|531213297|FG000|Overall Study|Lost to Follow-up|1|||
147286548|NCT01365494|531213298|FG001|Overall Study|Lost to Follow-up|2|||
147286549|NCT03351049|531213299|FG000|Overall Study|Withdrawal|26|||
147286550|NCT03351049|531213300|FG001|Overall Study|Withdrawal|22|||
147286551|NCT03832192|531213303|FG000|Overall Study|Participants are disenrolled upon hospital discharge.|152|||
147286552|NCT03832192|531213304|FG001|Overall Study|Participants are disenrolled upon hospital discharge.|149|||
147286553|NCT02663128|531213305|FG000|Period 2|Physician Decision|0|||
147286554|NCT02663128|531213306|FG001|Period 2|Physician Decision|0|||
147286555|NCT02663128|531213307|FG002|Period 2|Physician Decision|0|||
147286556|NCT02663128|531213308|FG003|Period 2|Physician Decision|0|||
147286557|NCT02663128|531213309|FG004|Period 2|Physician Decision|1|||
147286558|NCT02663128|531213310|FG005|Period 2|Physician Decision|0|||
147286559|NCT02730819|531213322|FG000|Overall Study|Lost to Follow-up|9|||
147286560|NCT02121847|531213323|FG000|Overall Study|Administrative Reasons|1|||
147286561|NCT02121847|531213323|FG000|Overall Study|Adverse Event|2|||
147286562|NCT01410448|531213329|FG000|Overall Study|No conversion to everolimus|0|||
147286563|NCT01410448|531213330|FG001|Overall Study|No conversion to everolimus|24|||
147286564|NCT01410448|531213329|FG000|Overall Study|Graft loss|4|||
147286565|NCT01410448|531213330|FG001|Overall Study|Graft loss|1|||
147286566|NCT01410448|531213329|FG000|Overall Study|Administrative issues|2|||
147286567|NCT01410448|531213330|FG001|Overall Study|Administrative issues|1|||
147286568|NCT01410448|531213329|FG000|Overall Study|Lost to Follow-up|1|||
147286569|NCT01410448|531213330|FG001|Overall Study|Lost to Follow-up|0|||
147286570|NCT01410448|531213329|FG000|Overall Study|Withdrawal by Subject|3|||
147286571|NCT01410448|531213330|FG001|Overall Study|Withdrawal by Subject|2|||
147286572|NCT01410448|531213329|FG000|Overall Study|Protocol Violation|0|||
147286573|NCT01410448|531213330|FG001|Overall Study|Protocol Violation|4|||
147286574|NCT01410448|531213329|FG000|Overall Study|Death|2|||
147286575|NCT01410448|531213330|FG001|Overall Study|Death|3|||
147286576|NCT02535065|531213331|FG000|Overall Study|Death|13|||
147286577|NCT02535065|531213331|FG000|Overall Study|Lost to Follow-up|1|||
147286578|NCT02535065|531213331|FG000|Overall Study|Withdrawal by Subject|6|||
147286579|NCT01781572|531213332|FG000|MEK162 45mg BID+LEE011 200mg|Adverse Event|7|||
147286580|NCT01781572|531213333|FG001|MEK162 45mg BID+LEE011 200mg|Adverse Event|0|||
147286581|NCT01781572|531213334|FG002|MEK162 45mg BID+LEE011 200mg|Adverse Event|11|||
147286582|NCT01781572|531213332|FG000|MEK162 45mg BID+LEE011 200mg|Progressive disease|8|||
147286583|NCT01781572|531213333|FG001|MEK162 45mg BID+LEE011 200mg|Progressive disease|6|||
147286584|NCT01781572|531213334|FG002|MEK162 45mg BID+LEE011 200mg|Progressive disease|23|||
147286585|NCT01781572|531213332|FG000|MEK162 45mg BID+LEE011 200mg|Withdrawal by Subject|1|||
147286586|NCT01781572|531213333|FG001|MEK162 45mg BID+LEE011 200mg|Withdrawal by Subject|0|||
147286587|NCT01781572|531213334|FG002|MEK162 45mg BID+LEE011 200mg|Withdrawal by Subject|2|||
147286588|NCT01781572|531213332|FG000|MEK162 45mg BID+LEE011 200mg|Physician Decision|0|||
147286589|NCT01781572|531213333|FG001|MEK162 45mg BID+LEE011 200mg|Physician Decision|0|||
147286590|NCT01781572|531213334|FG002|MEK162 45mg BID+LEE011 200mg|Physician Decision|4|||
147286591|NCT01781572|531213332|FG000|MEK162 45mg BID+LEE011 200mg|Death|0|||
147604156|NCT00191165|532367842|FG001|Overall Study|Protocol Violation|1|||
147286592|NCT01781572|531213333|FG001|MEK162 45mg BID+LEE011 200mg|Death|0|||
147286593|NCT01781572|531213334|FG002|MEK162 45mg BID+LEE011 200mg|Death|1|||
147286594|NCT01781572|531213332|FG000|MEK162 45mg BID+LEE011 250mg|Progressive Disease|2|||
147286595|NCT01781572|531213333|FG001|MEK162 45mg BID+LEE011 250mg|Progressive Disease|0|||
147286596|NCT01781572|531213334|FG002|MEK162 45mg BID+LEE011 250mg|Progressive Disease|0|||
147286597|NCT01781572|531213332|FG000|MEK162 45mg BID+LEE011 250mg|Withdrawal by Subject|1|||
147286598|NCT01781572|531213333|FG001|MEK162 45mg BID+LEE011 250mg|Withdrawal by Subject|0|||
147286599|NCT01781572|531213334|FG002|MEK162 45mg BID+LEE011 250mg|Withdrawal by Subject|0|||
147286600|NCT01781572|531213332|FG000|MEK162 30mg BID+LEE011 300mg|Adverse Event|1|||
147286601|NCT01781572|531213333|FG001|MEK162 30mg BID+LEE011 300mg|Adverse Event|0|||
147286602|NCT01781572|531213334|FG002|MEK162 30mg BID+LEE011 300mg|Adverse Event|0|||
147286603|NCT01781572|531213332|FG000|MEK162 30mg BID+LEE011 300mg|Progressive Disease|3|||
147286604|NCT01781572|531213333|FG001|MEK162 30mg BID+LEE011 300mg|Progressive Disease|2|||
147286605|NCT01781572|531213334|FG002|MEK162 30mg BID+LEE011 300mg|Progressive Disease|0|||
147286606|NCT01781572|531213332|FG000|MEK162 45mg BID+LEE011 300mg|Adverse Event|1|||
147286607|NCT01781572|531213333|FG001|MEK162 45mg BID+LEE011 300mg|Adverse Event|1|||
147286608|NCT01781572|531213334|FG002|MEK162 45mg BID+LEE011 300mg|Adverse Event|0|||
147286609|NCT01781572|531213332|FG000|MEK162 45mg BID+LEE011 300mg|Progressive Disease|4|||
147286610|NCT01781572|531213333|FG001|MEK162 45mg BID+LEE011 300mg|Progressive Disease|3|||
147286611|NCT01781572|531213334|FG002|MEK162 45mg BID+LEE011 300mg|Progressive Disease|0|||
147286612|NCT01781572|531213332|FG000|MEK162 45mg BID+LEE011 300mg|Death|1|||
147286613|NCT01781572|531213333|FG001|MEK162 45mg BID+LEE011 300mg|Death|0|||
147286614|NCT01781572|531213334|FG002|MEK162 45mg BID+LEE011 300mg|Death|0|||
147286615|NCT01781572|531213332|FG000|MEK162 30mg LEE011 200mg|Progressive Disease|0|||
147286616|NCT01781572|531213333|FG001|MEK162 30mg LEE011 200mg|Progressive Disease|5|||
147286617|NCT01781572|531213334|FG002|MEK162 30mg LEE011 200mg|Progressive Disease|0|||
147286618|NCT01781572|531213332|FG000|MEK162 45mg LEE011 450mg|Adverse Event|0|||
147286619|NCT01781572|531213333|FG001|MEK162 45mg LEE011 450mg|Adverse Event|1|||
147286620|NCT01781572|531213334|FG002|MEK162 45mg LEE011 450mg|Adverse Event|0|||
147286621|NCT01781572|531213332|FG000|MEK162 45mg LEE011 450mg|Physician Decision|0|||
147286622|NCT01781572|531213333|FG001|MEK162 45mg LEE011 450mg|Physician Decision|2|||
147286623|NCT01781572|531213334|FG002|MEK162 45mg LEE011 450mg|Physician Decision|0|||
147286624|NCT01781572|531213332|FG000|MEK162 45mg LEE011 450mg|Progressive Disease|0|||
147286625|NCT01781572|531213333|FG001|MEK162 45mg LEE011 450mg|Progressive Disease|6|||
147286626|NCT01781572|531213334|FG002|MEK162 45mg LEE011 450mg|Progressive Disease|0|||
147286627|NCT01781572|531213332|FG000|MEK162 45mg LEE011 600mg|Adverse Event|0|||
147286628|NCT01781572|531213333|FG001|MEK162 45mg LEE011 600mg|Adverse Event|1|||
147286629|NCT01781572|531213334|FG002|MEK162 45mg LEE011 600mg|Adverse Event|0|||
147286630|NCT01781572|531213332|FG000|MEK162 45mg LEE011 600mg|Progressive Disease|0|||
147286631|NCT01781572|531213333|FG001|MEK162 45mg LEE011 600mg|Progressive Disease|5|||
147286632|NCT01781572|531213334|FG002|MEK162 45mg LEE011 600mg|Progressive Disease|0|||
147286633|NCT03156023|531213337|FG000|Overall Study|Withdrawal by Subject|1|||
147286634|NCT03156023|531213338|FG001|Overall Study|Withdrawal by Subject|0|||
147286635|NCT03156023|531213339|FG002|Overall Study|Withdrawal by Subject|2|||
147286636|NCT03156023|531213340|FG003|Overall Study|Withdrawal by Subject|1|||
147286637|NCT03156023|531213341|FG004|Overall Study|Withdrawal by Subject|1|||
147286638|NCT03156023|531213337|FG000|Overall Study|Lost to Follow-up|0|||
147662638|NCT00385918|532587380|FG001|Feasibility & Baseline Measurement Phase|Physician Decision|0|||
147662639|NCT00385918|532587381|FG002|Feasibility & Baseline Measurement Phase|Physician Decision|1|||
147286639|NCT03156023|531213338|FG001|Overall Study|Lost to Follow-up|0|||
147286640|NCT03156023|531213339|FG002|Overall Study|Lost to Follow-up|0|||
147286641|NCT03156023|531213340|FG003|Overall Study|Lost to Follow-up|0|||
147286642|NCT03156023|531213341|FG004|Overall Study|Lost to Follow-up|1|||
147286643|NCT00932893|531213342|FG000|Overall Study|Death|115|||
147286644|NCT00932893|531213343|FG001|Overall Study|Death|24|||
147286645|NCT00932893|531213342|FG000|Overall Study|Lost to Follow-up|8|||
147286646|NCT00932893|531213343|FG001|Overall Study|Lost to Follow-up|0|||
147286647|NCT00932893|531213342|FG000|Overall Study|Withdrawal by Subject|5|||
147286648|NCT00932893|531213343|FG001|Overall Study|Withdrawal by Subject|2|||
147286649|NCT00932893|531213342|FG000|Overall Study|Other|5|||
147286650|NCT00932893|531213343|FG001|Overall Study|Other|144|||
147286651|NCT02526693|531215531|FG000|Overall Study|Physician Decision|3|||
147286652|NCT02526693|531215532|FG001|Overall Study|Physician Decision|1|||
147286653|NCT01585103|531215534|FG000|Overall Study|Unable to swallow Cytosponge|6|||
147286654|NCT01349569|531215535|FG000|Overall Study|Lack of Efficacy|4|||
147286655|NCT03581305|531215536|FG000|Dopaminergic Study|Withdrawal by Subject|1|||
147286656|NCT03581305|531215537|FG001|Dopaminergic Study|Withdrawal by Subject|1|||
147286657|NCT03581305|531215536|FG000|Dopaminergic Study|could not finish FDOPA scan|2|||
147286658|NCT03581305|531215537|FG001|Dopaminergic Study|could not finish FDOPA scan|0|||
147286659|NCT03581305|531215536|FG000|Serotonergic Study|Withdrawal by Subject|5|||
147286660|NCT03581305|531215537|FG001|Serotonergic Study|Withdrawal by Subject|1|||
147286661|NCT01798927|531215538|FG000|Overall Study|Withdrawal by Subject|1|||
147286662|NCT00626522|531215539|FG000|Overall Study|Protocol Violation|0|||
147286663|NCT00626522|531215540|FG001|Overall Study|Protocol Violation|0|||
147286664|NCT00626522|531215541|FG002|Overall Study|Protocol Violation|0|||
147286665|NCT00626522|531215542|FG003|Overall Study|Protocol Violation|0|||
147286666|NCT00626522|531215543|FG004|Overall Study|Protocol Violation|1|||
147286667|NCT00626522|531215544|FG005|Overall Study|Protocol Violation|0|||
147286668|NCT00626522|531215539|FG000|Overall Study|Adverse Event|2|||
147286669|NCT00626522|531215540|FG001|Overall Study|Adverse Event|1|||
147286670|NCT00626522|531215541|FG002|Overall Study|Adverse Event|2|||
147286671|NCT00626522|531215542|FG003|Overall Study|Adverse Event|0|||
147286672|NCT00626522|531215543|FG004|Overall Study|Adverse Event|1|||
147286673|NCT00626522|531215544|FG005|Overall Study|Adverse Event|1|||
147286674|NCT00626522|531215539|FG000|Overall Study|Withdrawal by Subject|2|||
147286675|NCT00626522|531215540|FG001|Overall Study|Withdrawal by Subject|5|||
147286676|NCT00626522|531215541|FG002|Overall Study|Withdrawal by Subject|5|||
147286677|NCT00626522|531215542|FG003|Overall Study|Withdrawal by Subject|0|||
147286678|NCT00626522|531215543|FG004|Overall Study|Withdrawal by Subject|4|||
147286679|NCT00626522|531215544|FG005|Overall Study|Withdrawal by Subject|1|||
147286680|NCT00626522|531215539|FG000|Overall Study|COPD exacerbation|0|||
147286681|NCT00626522|531215540|FG001|Overall Study|COPD exacerbation|0|||
147286682|NCT00626522|531215541|FG002|Overall Study|COPD exacerbation|0|||
147286683|NCT00626522|531215542|FG003|Overall Study|COPD exacerbation|1|||
147286684|NCT00626522|531215543|FG004|Overall Study|COPD exacerbation|1|||
147286685|NCT00626522|531215544|FG005|Overall Study|COPD exacerbation|0|||
147286686|NCT00626522|531215539|FG000|Overall Study|Lost to Follow-up|0|||
147286687|NCT00626522|531215540|FG001|Overall Study|Lost to Follow-up|1|||
147286688|NCT00626522|531215541|FG002|Overall Study|Lost to Follow-up|0|||
147286689|NCT00626522|531215542|FG003|Overall Study|Lost to Follow-up|0|||
147286690|NCT00626522|531215543|FG004|Overall Study|Lost to Follow-up|0|||
147286691|NCT00626522|531215544|FG005|Overall Study|Lost to Follow-up|0|||
147286692|NCT00626522|531215539|FG000|Overall Study|Inconsistent reason reported|1|||
147286693|NCT00626522|531215540|FG001|Overall Study|Inconsistent reason reported|0|||
147286694|NCT00626522|531215541|FG002|Overall Study|Inconsistent reason reported|0|||
147286695|NCT00626522|531215542|FG003|Overall Study|Inconsistent reason reported|0|||
147286696|NCT00626522|531215543|FG004|Overall Study|Inconsistent reason reported|0|||
147286697|NCT00626522|531215544|FG005|Overall Study|Inconsistent reason reported|0|||
147286698|NCT00626522|531215539|FG000|Overall Study|Non-fulfilment of in/exclusion criteria|1|||
147286699|NCT00626522|531215540|FG001|Overall Study|Non-fulfilment of in/exclusion criteria|0|||
147286700|NCT00626522|531215541|FG002|Overall Study|Non-fulfilment of in/exclusion criteria|1|||
147286701|NCT00626522|531215542|FG003|Overall Study|Non-fulfilment of in/exclusion criteria|1|||
147286702|NCT00626522|531215543|FG004|Overall Study|Non-fulfilment of in/exclusion criteria|0|||
147286703|NCT00626522|531215544|FG005|Overall Study|Non-fulfilment of in/exclusion criteria|0|||
147286704|NCT00328510|531215548|FG000|Overall Study|Gag disorder, could not use frame|4|||
147286705|NCT00328510|531215549|FG001|Overall Study|Gag disorder, could not use frame|0|||
147286706|NCT00328510|531215548|FG000|Overall Study|Dentition problems, could not use frame|1|||
147286707|NCT00328510|531215549|FG001|Overall Study|Dentition problems, could not use frame|0|||
147286708|NCT00328510|531215548|FG000|Overall Study|Withdrawal by Subject|4|||
147286709|NCT00328510|531215549|FG001|Overall Study|Withdrawal by Subject|2|||
147286710|NCT00328510|531215548|FG000|Overall Study|Severe kyphosis, could not use mask|0|||
147286711|NCT00328510|531215549|FG001|Overall Study|Severe kyphosis, could not use mask|1|||
147286712|NCT00328510|531215548|FG000|Overall Study|Treatment changed to a single fraction|1|||
147286713|NCT00328510|531215549|FG001|Overall Study|Treatment changed to a single fraction|1|||
147286714|NCT01412944|531215551|FG000|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0|||
147286715|NCT01412944|531215552|FG001|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0|||
147286716|NCT01412944|531215553|FG002|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|1|||
147286717|NCT01412944|531215554|FG003|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0|||
147286718|NCT01412944|531215555|FG004|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0|||
147286719|NCT01412944|531215556|FG005|IV: Per Previous CAIN457A2304 Treatment|Withdrawal by Subject|0|||
147286720|NCT01412944|531215551|FG000|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0|||
147286721|NCT01412944|531215552|FG001|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0|||
147286722|NCT01412944|531215553|FG002|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0|||
147286723|NCT01412944|531215554|FG003|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0|||
147286724|NCT01412944|531215555|FG004|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|0|||
147286725|NCT01412944|531215556|FG005|IV: Per Previous CAIN457A2304 Treatment|Protocol deviation|1|||
147286726|NCT01412944|531215551|FG000|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0|||
147286727|NCT01412944|531215552|FG001|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0|||
147286728|NCT01412944|531215553|FG002|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0|||
147662640|NCT00385918|532587379|FG000|Intervention Phase After Randomization|Withdrawal by Subject|1|||
147286729|NCT01412944|531215554|FG003|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0|||
147286730|NCT01412944|531215555|FG004|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|0|||
147286731|NCT01412944|531215556|FG005|IV: Per Previous CAIN457A2304 Treatment|Lost to Follow-up|1|||
147286732|NCT01412944|531215551|FG000|IV: Per CAIN457A2307|Withdrawal by Subject|1|||
147286733|NCT01412944|531215552|FG001|IV: Per CAIN457A2307|Withdrawal by Subject|0|||
147286734|NCT01412944|531215553|FG002|IV: Per CAIN457A2307|Withdrawal by Subject|0|||
147286735|NCT01412944|531215554|FG003|IV: Per CAIN457A2307|Withdrawal by Subject|0|||
147286736|NCT01412944|531215555|FG004|IV: Per CAIN457A2307|Withdrawal by Subject|0|||
147286737|NCT01412944|531215556|FG005|IV: Per CAIN457A2307|Withdrawal by Subject|0|||
147286738|NCT01412944|531215551|FG000|IV: Per CAIN457A2307|Protocol deviation|0|||
147286739|NCT01412944|531215552|FG001|IV: Per CAIN457A2307|Protocol deviation|1|||
147286740|NCT01412944|531215553|FG002|IV: Per CAIN457A2307|Protocol deviation|0|||
147286741|NCT01412944|531215554|FG003|IV: Per CAIN457A2307|Protocol deviation|0|||
147286742|NCT01412944|531215555|FG004|IV: Per CAIN457A2307|Protocol deviation|0|||
147337585|NCT01823536|531402865|FG004|Overall Study|Visit 1 delayed, unable to reschedule|0|||
147337586|NCT01823536|531402866|FG005|Overall Study|Visit 1 delayed, unable to reschedule|0|||
147337587|NCT01823536|531402861|FG000|Overall Study|Met exclusion criterion No 6|0|||
147337588|NCT01823536|531402862|FG001|Overall Study|Met exclusion criterion No 6|0|||
147337589|NCT01823536|531402863|FG002|Overall Study|Met exclusion criterion No 6|0|||
147337590|NCT01823536|531402864|FG003|Overall Study|Met exclusion criterion No 6|1|||
147337591|NCT01823536|531402865|FG004|Overall Study|Met exclusion criterion No 6|0|||
147337592|NCT01823536|531402866|FG005|Overall Study|Met exclusion criterion No 6|0|||
147337593|NCT01823536|531402861|FG000|Overall Study|Subject moved out of the state|0|||
147337594|NCT01823536|531402862|FG001|Overall Study|Subject moved out of the state|0|||
147286743|NCT01412944|531215556|FG005|IV: Per CAIN457A2307|Protocol deviation|0|||
147286744|NCT01412944|531215551|FG000|IV: Per CAIN457A2307|Lost to Follow-up|0|||
147286745|NCT01412944|531215552|FG001|IV: Per CAIN457A2307|Lost to Follow-up|1|||
147286746|NCT01412944|531215553|FG002|IV: Per CAIN457A2307|Lost to Follow-up|0|||
147286747|NCT01412944|531215554|FG003|IV: Per CAIN457A2307|Lost to Follow-up|0|||
147286748|NCT01412944|531215555|FG004|IV: Per CAIN457A2307|Lost to Follow-up|0|||
147286749|NCT01412944|531215556|FG005|IV: Per CAIN457A2307|Lost to Follow-up|0|||
147286750|NCT01412944|531215551|FG000|Entire: IV + Maintenance|Withdrawal by Subject|0|||
147286751|NCT01412944|531215552|FG001|Entire: IV + Maintenance|Withdrawal by Subject|0|||
147286752|NCT01412944|531215553|FG002|Entire: IV + Maintenance|Withdrawal by Subject|1|||
147286753|NCT01412944|531215554|FG003|Entire: IV + Maintenance|Withdrawal by Subject|1|||
147286754|NCT01412944|531215555|FG004|Entire: IV + Maintenance|Withdrawal by Subject|1|||
147286755|NCT01412944|531215556|FG005|Entire: IV + Maintenance|Withdrawal by Subject|0|||
147452349|NCT00328627|531819900|FG006|Overall Study|Withdrawal by Subject|4|||
147452350|NCT00328627|531819901|FG007|Overall Study|Withdrawal by Subject|4|||
147452351|NCT00328627|531819902|FG008|Overall Study|Withdrawal by Subject|4|||
147452352|NCT00328627|531819903|FG009|Overall Study|Withdrawal by Subject|5|||
147452353|NCT00328627|531819904|FG010|Overall Study|Withdrawal by Subject|2|||
147286756|NCT01412944|531215551|FG000|Entire: IV + Maintenance|Adverse Event|0|||
147286757|NCT01412944|531215552|FG001|Entire: IV + Maintenance|Adverse Event|0|||
147286758|NCT01412944|531215553|FG002|Entire: IV + Maintenance|Adverse Event|0|||
147286759|NCT01412944|531215554|FG003|Entire: IV + Maintenance|Adverse Event|0|||
147286760|NCT01412944|531215555|FG004|Entire: IV + Maintenance|Adverse Event|1|||
147286761|NCT01412944|531215556|FG005|Entire: IV + Maintenance|Adverse Event|0|||
147286762|NCT01412944|531215551|FG000|Entire: IV + Maintenance|Protocol deviation|0|||
147286763|NCT01412944|531215552|FG001|Entire: IV + Maintenance|Protocol deviation|0|||
147286764|NCT01412944|531215553|FG002|Entire: IV + Maintenance|Protocol deviation|0|||
147286765|NCT01412944|531215554|FG003|Entire: IV + Maintenance|Protocol deviation|0|||
147286766|NCT01412944|531215555|FG004|Entire: IV + Maintenance|Protocol deviation|0|||
147286767|NCT01412944|531215556|FG005|Entire: IV + Maintenance|Protocol deviation|1|||
147286768|NCT01412944|531215551|FG000|Entire: IV + Maintenance|Lost to Follow-up|0|||
147286769|NCT01412944|531215552|FG001|Entire: IV + Maintenance|Lost to Follow-up|0|||
147286770|NCT01412944|531215553|FG002|Entire: IV + Maintenance|Lost to Follow-up|0|||
147286771|NCT01412944|531215554|FG003|Entire: IV + Maintenance|Lost to Follow-up|0|||
147286772|NCT01412944|531215555|FG004|Entire: IV + Maintenance|Lost to Follow-up|0|||
147286773|NCT01412944|531215556|FG005|Entire: IV + Maintenance|Lost to Follow-up|1|||
147286774|NCT01412944|531215551|FG000|Entire: IV + Maintenance|Lack of Efficacy|0|||
147286775|NCT01412944|531215552|FG001|Entire: IV + Maintenance|Lack of Efficacy|0|||
147286776|NCT01412944|531215553|FG002|Entire: IV + Maintenance|Lack of Efficacy|0|||
147337595|NCT01823536|531402863|FG002|Overall Study|Subject moved out of the state|0|||
147337596|NCT01823536|531402864|FG003|Overall Study|Subject moved out of the state|0|||
147337597|NCT01823536|531402865|FG004|Overall Study|Subject moved out of the state|1|||
147286777|NCT01412944|531215554|FG003|Entire: IV + Maintenance|Lack of Efficacy|0|||
147337598|NCT01823536|531402866|FG005|Overall Study|Subject moved out of the state|0|||
147452354|NCT00328627|531819905|FG011|Overall Study|Withdrawal by Subject|7|||
147286778|NCT01412944|531215555|FG004|Entire: IV + Maintenance|Lack of Efficacy|1|||
147452355|NCT00328627|531819894|FG000|Overall Study|Pregnancy|0|||
147286779|NCT01412944|531215556|FG005|Entire: IV + Maintenance|Lack of Efficacy|0|||
147286780|NCT01412944|531215551|FG000|Entire: IV + Maintenance|Withdrawal by Subject|2|||
147286781|NCT01412944|531215552|FG001|Entire: IV + Maintenance|Withdrawal by Subject|1|||
147286782|NCT01412944|531215553|FG002|Entire: IV + Maintenance|Withdrawal by Subject|0|||
147286783|NCT01412944|531215554|FG003|Entire: IV + Maintenance|Withdrawal by Subject|0|||
147286784|NCT01412944|531215555|FG004|Entire: IV + Maintenance|Withdrawal by Subject|0|||
147286785|NCT01412944|531215556|FG005|Entire: IV + Maintenance|Withdrawal by Subject|0|||
147286786|NCT01412944|531215551|FG000|Entire: IV + Maintenance|Protocol deviation|0|||
147286787|NCT01412944|531215552|FG001|Entire: IV + Maintenance|Protocol deviation|1|||
147286788|NCT01412944|531215553|FG002|Entire: IV + Maintenance|Protocol deviation|0|||
147286789|NCT01412944|531215554|FG003|Entire: IV + Maintenance|Protocol deviation|0|||
147286790|NCT01412944|531215555|FG004|Entire: IV + Maintenance|Protocol deviation|0|||
147286791|NCT01412944|531215556|FG005|Entire: IV + Maintenance|Protocol deviation|0|||
147286792|NCT01412944|531215551|FG000|Entire: IV + Maintenance|Lost to Follow-up|0|||
147286793|NCT01412944|531215552|FG001|Entire: IV + Maintenance|Lost to Follow-up|1|||
147286794|NCT01412944|531215553|FG002|Entire: IV + Maintenance|Lost to Follow-up|0|||
147286795|NCT01412944|531215554|FG003|Entire: IV + Maintenance|Lost to Follow-up|0|||
147286796|NCT01412944|531215555|FG004|Entire: IV + Maintenance|Lost to Follow-up|0|||
147286797|NCT01412944|531215556|FG005|Entire: IV + Maintenance|Lost to Follow-up|0|||
147286798|NCT01412944|531215551|FG000|Entire: IV + Maintenance|Lack of Efficacy|0|||
147286799|NCT01412944|531215552|FG001|Entire: IV + Maintenance|Lack of Efficacy|1|||
147286800|NCT01412944|531215553|FG002|Entire: IV + Maintenance|Lack of Efficacy|0|||
147286801|NCT01412944|531215554|FG003|Entire: IV + Maintenance|Lack of Efficacy|0|||
147286802|NCT01412944|531215555|FG004|Entire: IV + Maintenance|Lack of Efficacy|0|||
147286803|NCT01412944|531215556|FG005|Entire: IV + Maintenance|Lack of Efficacy|0|||
147286804|NCT01412944|531215551|FG000|Entire: IV + Maintenance|Adverse Event|0|||
147286805|NCT01412944|531215552|FG001|Entire: IV + Maintenance|Adverse Event|1|||
147286806|NCT01412944|531215553|FG002|Entire: IV + Maintenance|Adverse Event|0|||
147286807|NCT01412944|531215554|FG003|Entire: IV + Maintenance|Adverse Event|0|||
147286808|NCT01412944|531215555|FG004|Entire: IV + Maintenance|Adverse Event|0|||
147286809|NCT01412944|531215556|FG005|Entire: IV + Maintenance|Adverse Event|0|||
147286810|NCT01990950|531215557|FG000|Overall Study|Death|3|||
147286811|NCT01990950|531215557|FG000|Overall Study|Lost to Follow-up|2|||
147286812|NCT01990950|531215557|FG000|Overall Study|Withdrawal by Subject|6|||
147286813|NCT02349295|531215558|FG000|Double Blind Treatment (Week 0-24)|Adverse Event|7|||
147286814|NCT02349295|531215559|FG001|Double Blind Treatment (Week 0-24)|Adverse Event|5|||
147452356|NCT00328627|531819895|FG001|Overall Study|Pregnancy|1|||
147452357|NCT00328627|531819896|FG002|Overall Study|Pregnancy|0|||
147452358|NCT00328627|531819897|FG003|Overall Study|Pregnancy|0|||
147286815|NCT02349295|531215560|FG002|Double Blind Treatment (Week 0-24)|Adverse Event|5|||
147286816|NCT02349295|531215561|FG003|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
147286817|NCT02349295|531215562|FG004|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
147286818|NCT02349295|531215563|FG005|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
147286819|NCT02349295|531215564|FG006|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
147286820|NCT02349295|531215565|FG007|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
147286821|NCT02349295|531215566|FG008|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
147286822|NCT02349295|531215567|FG009|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
147286823|NCT02349295|531215568|FG010|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
147286824|NCT02349295|531215569|FG011|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
147286825|NCT02349295|531215570|FG012|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
147286826|NCT02349295|531215571|FG013|Double Blind Treatment (Week 0-24)|Adverse Event|0|||
147286827|NCT02349295|531215558|FG000|Double Blind Treatment (Week 0-24)|Lack of Efficacy|4|||
147286828|NCT02349295|531215559|FG001|Double Blind Treatment (Week 0-24)|Lack of Efficacy|2|||
147286829|NCT02349295|531215560|FG002|Double Blind Treatment (Week 0-24)|Lack of Efficacy|9|||
147286830|NCT02349295|531215561|FG003|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
147286831|NCT02349295|531215562|FG004|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
147286832|NCT02349295|531215563|FG005|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
147452359|NCT00328627|531819898|FG004|Overall Study|Pregnancy|0|||
147286833|NCT02349295|531215564|FG006|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
147286834|NCT02349295|531215565|FG007|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
147286835|NCT02349295|531215566|FG008|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
147286836|NCT02349295|531215567|FG009|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
147286837|NCT02349295|531215568|FG010|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
147286838|NCT02349295|531215569|FG011|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
147286839|NCT02349295|531215570|FG012|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
147286840|NCT02349295|531215571|FG013|Double Blind Treatment (Week 0-24)|Lack of Efficacy|0|||
147286841|NCT02349295|531215558|FG000|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|2|||
147286842|NCT02349295|531215559|FG001|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|2|||
147286843|NCT02349295|531215560|FG002|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|7|||
147286844|NCT02349295|531215561|FG003|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
147452360|NCT00328627|531819899|FG005|Overall Study|Pregnancy|0|||
147286845|NCT02349295|531215562|FG004|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
147286846|NCT02349295|531215563|FG005|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
147452361|NCT00328627|531819900|FG006|Overall Study|Pregnancy|0|||
147452362|NCT00328627|531819901|FG007|Overall Study|Pregnancy|0|||
147452363|NCT00328627|531819902|FG008|Overall Study|Pregnancy|0|||
147452364|NCT00328627|531819903|FG009|Overall Study|Pregnancy|0|||
147286847|NCT02349295|531215564|FG006|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
147286848|NCT02349295|531215565|FG007|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
147286849|NCT02349295|531215566|FG008|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
147286850|NCT02349295|531215567|FG009|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
147286851|NCT02349295|531215568|FG010|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
147286852|NCT02349295|531215569|FG011|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
147286853|NCT02349295|531215570|FG012|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
147286854|NCT02349295|531215571|FG013|Double Blind Treatment (Week 0-24)|Withdrawal by Subject|0|||
147286855|NCT02349295|531215558|FG000|Double Blind Treatment (Week 0-24)|Lost to Follow-up|1|||
147286856|NCT02349295|531215559|FG001|Double Blind Treatment (Week 0-24)|Lost to Follow-up|1|||
147286857|NCT02349295|531215560|FG002|Double Blind Treatment (Week 0-24)|Lost to Follow-up|2|||
147286858|NCT02349295|531215561|FG003|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
147286859|NCT02349295|531215562|FG004|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
147286860|NCT02349295|531215563|FG005|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
147286861|NCT02349295|531215564|FG006|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
147286862|NCT02349295|531215565|FG007|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
147286863|NCT02349295|531215566|FG008|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
147286864|NCT02349295|531215567|FG009|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
147286865|NCT02349295|531215568|FG010|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
147286866|NCT02349295|531215569|FG011|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
147286867|NCT02349295|531215570|FG012|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
147286868|NCT02349295|531215571|FG013|Double Blind Treatment (Week 0-24)|Lost to Follow-up|0|||
147286869|NCT02349295|531215558|FG000|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
147286870|NCT02349295|531215559|FG001|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|1|||
147286871|NCT02349295|531215560|FG002|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|1|||
147286872|NCT02349295|531215561|FG003|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
147286873|NCT02349295|531215562|FG004|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
147286874|NCT02349295|531215563|FG005|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
147286875|NCT02349295|531215564|FG006|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
147286876|NCT02349295|531215565|FG007|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
147286877|NCT02349295|531215566|FG008|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
147286878|NCT02349295|531215567|FG009|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
147286879|NCT02349295|531215568|FG010|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
147286880|NCT02349295|531215569|FG011|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
147286881|NCT02349295|531215570|FG012|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
147286882|NCT02349295|531215571|FG013|Double Blind Treatment (Week 0-24)|Failure To Meet Randomization|0|||
147286883|NCT02349295|531215558|FG000|IR (Week 16-24)|Lack of Efficacy|0|||
147286884|NCT02349295|531215559|FG001|IR (Week 16-24)|Lack of Efficacy|0|||
147286885|NCT02349295|531215560|FG002|IR (Week 16-24)|Lack of Efficacy|0|||
147286886|NCT02349295|531215561|FG003|IR (Week 16-24)|Lack of Efficacy|1|||
147286887|NCT02349295|531215562|FG004|IR (Week 16-24)|Lack of Efficacy|0|||
147286888|NCT02349295|531215563|FG005|IR (Week 16-24)|Lack of Efficacy|0|||
147286889|NCT02349295|531215564|FG006|IR (Week 16-24)|Lack of Efficacy|0|||
147286890|NCT02349295|531215565|FG007|IR (Week 16-24)|Lack of Efficacy|0|||
147604157|NCT00191165|532367841|FG000|Overall Study|Participant Moved Away|0|||
147604158|NCT00191165|532367842|FG001|Overall Study|Participant Moved Away|1|||
147604159|NCT00715624|532367843|FG000|Overall Study|Adverse Event|12|||
147604160|NCT00715624|532367844|FG001|Overall Study|Adverse Event|37|||
147604161|NCT00715624|532367843|FG000|Overall Study|Lack of Efficacy|11|||
147604162|NCT00715624|532367844|FG001|Overall Study|Lack of Efficacy|11|||
147604163|NCT00715624|532367843|FG000|Overall Study|Lost to Follow-up|1|||
147604164|NCT00715624|532367844|FG001|Overall Study|Lost to Follow-up|2|||
147604165|NCT00715624|532367843|FG000|Overall Study|Protocol Violation|1|||
147604166|NCT00715624|532367844|FG001|Overall Study|Protocol Violation|0|||
147286891|NCT02349295|531215566|FG008|IR (Week 16-24)|Lack of Efficacy|0|||
147286892|NCT02349295|531215567|FG009|IR (Week 16-24)|Lack of Efficacy|0|||
147286893|NCT02349295|531215568|FG010|IR (Week 16-24)|Lack of Efficacy|0|||
147286894|NCT02349295|531215569|FG011|IR (Week 16-24)|Lack of Efficacy|0|||
147286895|NCT02349295|531215570|FG012|IR (Week 16-24)|Lack of Efficacy|0|||
147286896|NCT02349295|531215571|FG013|IR (Week 16-24)|Lack of Efficacy|0|||
147286897|NCT02349295|531215558|FG000|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
147286898|NCT02349295|531215559|FG001|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
147286899|NCT02349295|531215560|FG002|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
147286900|NCT02349295|531215561|FG003|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
147286901|NCT02349295|531215562|FG004|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
147286902|NCT02349295|531215563|FG005|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
147604167|NCT00715624|532367843|FG000|Overall Study|Withdrawal by Subject|11|||
147604168|NCT00715624|532367844|FG001|Overall Study|Withdrawal by Subject|25|||
147604169|NCT00715624|532367843|FG000|Overall Study|Familial and personal reasons|10|||
147604170|NCT00715624|532367844|FG001|Overall Study|Familial and personal reasons|22|||
147604171|NCT00715624|532367843|FG000|Overall Study|Poor compliance|6|||
147604172|NCT00715624|532367844|FG001|Overall Study|Poor compliance|13|||
147604173|NCT00715624|532367843|FG000|Overall Study|Sponsor decision|0|||
147604174|NCT00715624|532367844|FG001|Overall Study|Sponsor decision|4|||
147604175|NCT00715624|532367843|FG000|Overall Study|Incorrect randomization (not treated)|0|||
147604176|NCT00715624|532367844|FG001|Overall Study|Incorrect randomization (not treated)|1|||
147604177|NCT00715624|532367843|FG000|Overall Study|Other|0|||
147604178|NCT00715624|532367844|FG001|Overall Study|Other|1|||
147604179|NCT03200912|532367845|FG000|Overall Study|Adverse Event|3|||
147604180|NCT03200912|532367846|FG001|Overall Study|Adverse Event|0|||
147604181|NCT03200912|532367847|FG002|Overall Study|Adverse Event|0|||
147604182|NCT03200912|532367845|FG000|Overall Study|Withdrawal by Subject|1|||
147604183|NCT03200912|532367846|FG001|Overall Study|Withdrawal by Subject|2|||
147604184|NCT03200912|532367847|FG002|Overall Study|Withdrawal by Subject|4|||
147604185|NCT03200912|532367845|FG000|Overall Study|Non-compliance with study drug|0|||
147604186|NCT03200912|532367846|FG001|Overall Study|Non-compliance with study drug|1|||
147604187|NCT03200912|532367847|FG002|Overall Study|Non-compliance with study drug|0|||
147286903|NCT02349295|531215564|FG006|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
147286904|NCT02349295|531215565|FG007|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|32|||
147286905|NCT02349295|531215566|FG008|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|25|||
147286906|NCT02349295|531215567|FG009|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|19|||
147286907|NCT02349295|531215568|FG010|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|18|||
147286908|NCT02349295|531215569|FG011|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
147286909|NCT02349295|531215570|FG012|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
147286910|NCT02349295|531215571|FG013|Long-Term Extension Period (Week 24-156)|Lack of Efficacy|0|||
147286911|NCT02349295|531215558|FG000|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
147286912|NCT02349295|531215559|FG001|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
147286913|NCT02349295|531215560|FG002|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
147286914|NCT02349295|531215561|FG003|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
147286915|NCT02349295|531215562|FG004|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
147286916|NCT02349295|531215563|FG005|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
147286917|NCT02349295|531215564|FG006|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
147286918|NCT02349295|531215565|FG007|Long-Term Extension Period (Week 24-156)|Adverse Event|9|||
147286919|NCT02349295|531215566|FG008|Long-Term Extension Period (Week 24-156)|Adverse Event|9|||
147286920|NCT02349295|531215567|FG009|Long-Term Extension Period (Week 24-156)|Adverse Event|2|||
147286921|NCT02349295|531215568|FG010|Long-Term Extension Period (Week 24-156)|Adverse Event|2|||
147286922|NCT02349295|531215569|FG011|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
147286923|NCT02349295|531215570|FG012|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
147286924|NCT02349295|531215571|FG013|Long-Term Extension Period (Week 24-156)|Adverse Event|0|||
147286925|NCT02349295|531215558|FG000|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
147286926|NCT02349295|531215559|FG001|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
147286927|NCT02349295|531215560|FG002|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
147286928|NCT02349295|531215561|FG003|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
147286929|NCT02349295|531215562|FG004|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
147286930|NCT02349295|531215563|FG005|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
147286931|NCT02349295|531215564|FG006|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
147286932|NCT02349295|531215565|FG007|Long-Term Extension Period (Week 24-156)|Unknown/Missing|2|||
147286933|NCT02349295|531215566|FG008|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
147286934|NCT02349295|531215567|FG009|Long-Term Extension Period (Week 24-156)|Unknown/Missing|3|||
147286935|NCT02349295|531215568|FG010|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
147286936|NCT02349295|531215569|FG011|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
147286937|NCT02349295|531215570|FG012|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
147286938|NCT02349295|531215571|FG013|Long-Term Extension Period (Week 24-156)|Unknown/Missing|0|||
147337599|NCT03648762|531402867|FG000|Overall Study|Lost to Follow-up|1|||
147337600|NCT03648762|531402868|FG001|Overall Study|Lost to Follow-up|2|||
147337601|NCT03648762|531402869|FG002|Overall Study|Lost to Follow-up|0|||
147337602|NCT03648762|531402867|FG000|Overall Study|Withdrawal by Subject|5|||
147337603|NCT03648762|531402868|FG001|Overall Study|Withdrawal by Subject|2|||
147286939|NCT02349295|531215558|FG000|Long-Term Extension Period (Week 24-156)|Death|0|||
147337604|NCT03648762|531402869|FG002|Overall Study|Withdrawal by Subject|1|||
147604188|NCT03196635|532367849|FG000|Overall Study|Withdrawal by Subject|1|||
147604189|NCT00229723|532367852|FG000|Concomitant Phase|Adverse Event|4|||
147604190|NCT00229723|532367853|FG001|Concomitant Phase|Adverse Event|2|||
147286940|NCT02349295|531215559|FG001|Long-Term Extension Period (Week 24-156)|Death|0|||
147286941|NCT02349295|531215560|FG002|Long-Term Extension Period (Week 24-156)|Death|0|||
147286942|NCT02349295|531215561|FG003|Long-Term Extension Period (Week 24-156)|Death|0|||
147337605|NCT01391832|531402872|FG000|Overall Study|Withdrawal by Subject|21|||
147337606|NCT01391832|531402873|FG001|Overall Study|Withdrawal by Subject|22|||
147604191|NCT00229723|532367854|FG002|Concomitant Phase|Adverse Event|5|||
147286943|NCT02349295|531215562|FG004|Long-Term Extension Period (Week 24-156)|Death|0|||
147286944|NCT02349295|531215563|FG005|Long-Term Extension Period (Week 24-156)|Death|0|||
147286945|NCT02349295|531215564|FG006|Long-Term Extension Period (Week 24-156)|Death|0|||
147286946|NCT02349295|531215565|FG007|Long-Term Extension Period (Week 24-156)|Death|1|||
147286947|NCT02349295|531215566|FG008|Long-Term Extension Period (Week 24-156)|Death|1|||
147286948|NCT02349295|531215567|FG009|Long-Term Extension Period (Week 24-156)|Death|1|||
147286949|NCT02349295|531215568|FG010|Long-Term Extension Period (Week 24-156)|Death|0|||
147286950|NCT02349295|531215569|FG011|Long-Term Extension Period (Week 24-156)|Death|0|||
147286951|NCT02349295|531215570|FG012|Long-Term Extension Period (Week 24-156)|Death|0|||
147286952|NCT02349295|531215571|FG013|Long-Term Extension Period (Week 24-156)|Death|0|||
147286953|NCT02349295|531215558|FG000|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
147286954|NCT02349295|531215559|FG001|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
147286955|NCT02349295|531215560|FG002|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
147286956|NCT02349295|531215561|FG003|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
147286957|NCT02349295|531215562|FG004|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
147286958|NCT02349295|531215563|FG005|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
147286959|NCT02349295|531215564|FG006|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
147286960|NCT02349295|531215565|FG007|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|4|||
147286961|NCT02349295|531215566|FG008|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|2|||
147286962|NCT02349295|531215567|FG009|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|1|||
147286963|NCT02349295|531215568|FG010|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|3|||
147286964|NCT02349295|531215569|FG011|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
147286965|NCT02349295|531215570|FG012|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
147286966|NCT02349295|531215571|FG013|Long-Term Extension Period (Week 24-156)|Withdrawal by Subject|0|||
147286967|NCT02349295|531215558|FG000|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
147286968|NCT02349295|531215559|FG001|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
147286969|NCT02349295|531215560|FG002|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
147286970|NCT02349295|531215561|FG003|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
147286971|NCT02349295|531215562|FG004|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
147286972|NCT02349295|531215563|FG005|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
147286973|NCT02349295|531215564|FG006|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
147286974|NCT02349295|531215565|FG007|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|2|||
147286975|NCT02349295|531215566|FG008|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|2|||
147286976|NCT02349295|531215567|FG009|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
147286977|NCT02349295|531215568|FG010|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
147286978|NCT02349295|531215569|FG011|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
147286979|NCT02349295|531215570|FG012|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
147286980|NCT02349295|531215571|FG013|Long-Term Extension Period (Week 24-156)|Lost to Follow-up|0|||
147286981|NCT02349295|531215558|FG000|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
147286982|NCT02349295|531215559|FG001|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
147286983|NCT02349295|531215560|FG002|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
147337607|NCT01391832|531402872|FG000|Overall Study|Lost to Follow-up|0|||
147337608|NCT01391832|531402873|FG001|Overall Study|Lost to Follow-up|1|||
147337609|NCT03345901|531402879|FG000|Overall Study|The study was terminated|18|||
147337610|NCT00722046|531402880|FG000|Overall Study|Adverse Event|0|||
147337611|NCT00722046|531402881|FG001|Overall Study|Adverse Event|1|||
147337612|NCT00722046|531402882|FG002|Overall Study|Adverse Event|2|||
147337613|NCT00722046|531402883|FG003|Overall Study|Adverse Event|1|||
147337614|NCT00722046|531402884|FG004|Overall Study|Adverse Event|2|||
147337615|NCT00722046|531402885|FG005|Overall Study|Adverse Event|1|||
147337616|NCT00722046|531402886|FG006|Overall Study|Adverse Event|0|||
147337617|NCT00722046|531402880|FG000|Overall Study|Death|0|||
147337618|NCT00722046|531402881|FG001|Overall Study|Death|1|||
147604192|NCT00229723|532367855|FG003|Concomitant Phase|Adverse Event|2|||
147604193|NCT00229723|532367856|FG004|Concomitant Phase|Adverse Event|0|||
147604194|NCT00229723|532367857|FG005|Concomitant Phase|Adverse Event|1|||
147604195|NCT00229723|532367858|FG006|Concomitant Phase|Adverse Event|2|||
147604196|NCT00229723|532367852|FG000|Concomitant Phase|Objective disease progression|0|||
147604197|NCT00229723|532367853|FG001|Concomitant Phase|Objective disease progression|0|||
147604198|NCT00229723|532367854|FG002|Concomitant Phase|Objective disease progression|0|||
147604199|NCT00229723|532367855|FG003|Concomitant Phase|Objective disease progression|0|||
147604200|NCT00229723|532367856|FG004|Concomitant Phase|Objective disease progression|0|||
147604201|NCT00229723|532367857|FG005|Concomitant Phase|Objective disease progression|0|||
147604202|NCT00229723|532367858|FG006|Concomitant Phase|Objective disease progression|0|||
147604203|NCT00229723|532367852|FG000|Concomitant Phase|Clinical progression|0|||
147604204|NCT00229723|532367853|FG001|Concomitant Phase|Clinical progression|0|||
147604205|NCT00229723|532367854|FG002|Concomitant Phase|Clinical progression|0|||
147604206|NCT00229723|532367855|FG003|Concomitant Phase|Clinical progression|0|||
147286984|NCT02349295|531215561|FG003|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
147286985|NCT02349295|531215562|FG004|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
147286986|NCT02349295|531215563|FG005|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
147286987|NCT02349295|531215564|FG006|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
147286988|NCT02349295|531215565|FG007|Long-Term Extension Period (Week 24-156)|Physician Decision|2|||
147286989|NCT02349295|531215566|FG008|Long-Term Extension Period (Week 24-156)|Physician Decision|2|||
147286990|NCT02349295|531215567|FG009|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
147286991|NCT02349295|531215568|FG010|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
147286992|NCT02349295|531215569|FG011|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
147286993|NCT02349295|531215570|FG012|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
147286994|NCT02349295|531215571|FG013|Long-Term Extension Period (Week 24-156)|Physician Decision|0|||
147286995|NCT02349295|531215558|FG000|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
147286996|NCT02349295|531215559|FG001|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
147286997|NCT02349295|531215560|FG002|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
147286998|NCT02349295|531215561|FG003|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
147286999|NCT02349295|531215562|FG004|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
147287000|NCT02349295|531215563|FG005|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
147287001|NCT02349295|531215564|FG006|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
147287002|NCT02349295|531215565|FG007|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
147287003|NCT02349295|531215566|FG008|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
147287004|NCT02349295|531215567|FG009|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
147287005|NCT02349295|531215568|FG010|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|0|||
147287006|NCT02349295|531215569|FG011|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|1|||
147287007|NCT02349295|531215570|FG012|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|5|||
147287008|NCT02349295|531215571|FG013|Follow-Up Period (Up to 12-24 Weeks)|Withdrawal by Subject|1|||
147287009|NCT02349295|531215558|FG000|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
147287010|NCT02349295|531215559|FG001|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
147287011|NCT02349295|531215560|FG002|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
147287012|NCT02349295|531215561|FG003|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
147287013|NCT02349295|531215562|FG004|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
147287014|NCT02349295|531215563|FG005|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
147287015|NCT02349295|531215564|FG006|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
147287016|NCT02349295|531215565|FG007|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
147287017|NCT02349295|531215566|FG008|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
147287018|NCT02349295|531215567|FG009|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
147287019|NCT02349295|531215568|FG010|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
147287020|NCT02349295|531215569|FG011|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|1|||
147287021|NCT02349295|531215570|FG012|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|2|||
147287022|NCT02349295|531215571|FG013|Follow-Up Period (Up to 12-24 Weeks)|Lost to Follow-up|0|||
147287023|NCT02349295|531215558|FG000|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
147287024|NCT02349295|531215559|FG001|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
147287025|NCT02349295|531215560|FG002|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
147287026|NCT02349295|531215561|FG003|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
147287027|NCT02349295|531215562|FG004|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
147287028|NCT02349295|531215563|FG005|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
147287029|NCT02349295|531215564|FG006|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
147287030|NCT02349295|531215565|FG007|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
147287031|NCT02349295|531215566|FG008|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
147287032|NCT02349295|531215567|FG009|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
147287033|NCT02349295|531215568|FG010|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
147287034|NCT02349295|531215569|FG011|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|1|||
147287035|NCT02349295|531215570|FG012|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|1|||
147287036|NCT02349295|531215571|FG013|Follow-Up Period (Up to 12-24 Weeks)|Adverse Event|0|||
147287037|NCT02349295|531215558|FG000|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
147287038|NCT02349295|531215559|FG001|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
147287039|NCT02349295|531215560|FG002|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
147604207|NCT00229723|532367856|FG004|Concomitant Phase|Clinical progression|0|||
147604208|NCT00229723|532367857|FG005|Concomitant Phase|Clinical progression|0|||
147604209|NCT00229723|532367858|FG006|Concomitant Phase|Clinical progression|1|||
147604210|NCT00229723|532367852|FG000|Concomitant Phase|Lost to Follow-up|0|||
147604211|NCT00229723|532367853|FG001|Concomitant Phase|Lost to Follow-up|0|||
147287040|NCT02349295|531215561|FG003|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
147287041|NCT02349295|531215562|FG004|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
147604212|NCT00229723|532367854|FG002|Concomitant Phase|Lost to Follow-up|0|||
147604213|NCT00229723|532367855|FG003|Concomitant Phase|Lost to Follow-up|0|||
147452365|NCT00328627|531819904|FG010|Overall Study|Pregnancy|0|||
147452366|NCT00328627|531819905|FG011|Overall Study|Pregnancy|0|||
147452367|NCT00328627|531819894|FG000|Overall Study|Physician Decision|4|||
147452368|NCT00328627|531819895|FG001|Overall Study|Physician Decision|3|||
147452369|NCT00328627|531819896|FG002|Overall Study|Physician Decision|1|||
147452370|NCT00328627|531819897|FG003|Overall Study|Physician Decision|2|||
147452371|NCT00328627|531819898|FG004|Overall Study|Physician Decision|1|||
147452372|NCT00328627|531819899|FG005|Overall Study|Physician Decision|1|||
147452373|NCT00328627|531819900|FG006|Overall Study|Physician Decision|1|||
147452374|NCT00328627|531819901|FG007|Overall Study|Physician Decision|0|||
147452375|NCT00328627|531819902|FG008|Overall Study|Physician Decision|3|||
147452376|NCT00328627|531819903|FG009|Overall Study|Physician Decision|2|||
147452377|NCT00328627|531819904|FG010|Overall Study|Physician Decision|1|||
147452378|NCT00328627|531819905|FG011|Overall Study|Physician Decision|0|||
147452379|NCT00328627|531819894|FG000|Overall Study|Other|0|||
147452380|NCT00328627|531819895|FG001|Overall Study|Other|0|||
147452381|NCT00328627|531819896|FG002|Overall Study|Other|0|||
147604214|NCT00229723|532367856|FG004|Concomitant Phase|Lost to Follow-up|1|||
147287042|NCT02349295|531215563|FG005|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
147287043|NCT02349295|531215564|FG006|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
147287044|NCT02349295|531215565|FG007|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
147287045|NCT02349295|531215566|FG008|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
147287046|NCT02349295|531215567|FG009|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
147287047|NCT02349295|531215568|FG010|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
147287048|NCT02349295|531215569|FG011|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|2|||
147287049|NCT02349295|531215570|FG012|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
147287050|NCT02349295|531215571|FG013|Follow-Up Period (Up to 12-24 Weeks)|Physician Decision|0|||
147287051|NCT02349295|531215558|FG000|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
147287052|NCT02349295|531215559|FG001|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
147287053|NCT02349295|531215560|FG002|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
147287054|NCT02349295|531215561|FG003|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
147287055|NCT02349295|531215562|FG004|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
147287056|NCT02349295|531215563|FG005|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
147287057|NCT02349295|531215564|FG006|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
147287058|NCT02349295|531215565|FG007|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
147287059|NCT02349295|531215566|FG008|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
147287060|NCT02349295|531215567|FG009|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
147287061|NCT02349295|531215568|FG010|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
147287062|NCT02349295|531215569|FG011|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|4|||
147287063|NCT02349295|531215570|FG012|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
147287064|NCT02349295|531215571|FG013|Follow-Up Period (Up to 12-24 Weeks)|Unknown/Missing|0|||
147287065|NCT06111742|531215574|FG000|Overall Study|Did not receive intervention|1|||
147287066|NCT06111742|531215575|FG001|Overall Study|Did not receive intervention|0|||
147287067|NCT06111742|531215576|FG002|Overall Study|Did not receive intervention|0|||
147287068|NCT06111742|531215574|FG000|Overall Study|Withdrawal by Subject|2|||
147287069|NCT06111742|531215575|FG001|Overall Study|Withdrawal by Subject|0|||
147287070|NCT06111742|531215576|FG002|Overall Study|Withdrawal by Subject|0|||
147287071|NCT01914926|531215577|FG000|Overall Study|Adverse Event|1|||
147287072|NCT01914926|531215578|FG001|Overall Study|Adverse Event|0|||
147287073|NCT01914926|531215577|FG000|Overall Study|uncooperative, agitated and removed|0|||
147287074|NCT01914926|531215578|FG001|Overall Study|uncooperative, agitated and removed|1|||
147287075|NCT03489304|531215579|FG000|Overall Study|Lost to Follow-up|4|||
147287076|NCT02239679|531215580|FG000|Overall Study|Lost to Follow-up|1|||
147287077|NCT02239679|531215581|FG001|Overall Study|Lost to Follow-up|0|||
147287078|NCT02239679|531215582|FG002|Overall Study|Lost to Follow-up|0|||
147287079|NCT02239679|531215580|FG000|Overall Study|Withdrawal by Subject|2|||
147287080|NCT02239679|531215581|FG001|Overall Study|Withdrawal by Subject|3|||
147287081|NCT02239679|531215582|FG002|Overall Study|Withdrawal by Subject|1|||
147287082|NCT02605954|531215584|FG000|Overall Study|Adverse Event|5|||
147452382|NCT00328627|531819897|FG003|Overall Study|Other|1|||
147452383|NCT00328627|531819898|FG004|Overall Study|Other|0|||
147452384|NCT00328627|531819899|FG005|Overall Study|Other|0|||
147452385|NCT00328627|531819900|FG006|Overall Study|Other|1|||
147452386|NCT00328627|531819901|FG007|Overall Study|Other|0|||
147452387|NCT00328627|531819902|FG008|Overall Study|Other|0|||
147287083|NCT02605954|531215585|FG001|Overall Study|Adverse Event|1|||
147287084|NCT02605954|531215584|FG000|Overall Study|Investigator's Discretion|1|||
147452388|NCT00328627|531819903|FG009|Overall Study|Other|1|||
147452389|NCT00328627|531819904|FG010|Overall Study|Other|1|||
147604215|NCT00229723|532367857|FG005|Concomitant Phase|Lost to Follow-up|0|||
147287085|NCT02605954|531215585|FG001|Overall Study|Investigator's Discretion|0|||
147452390|NCT00328627|531819905|FG011|Overall Study|Other|0|||
147452391|NCT02049944|531819906|FG000|Overall Study|Protocol Violation|2|||
147452392|NCT01662440|531819907|FG000|Overall Study|Adverse Event|1|||
147452393|NCT01662440|531819908|FG001|Overall Study|Adverse Event|0|||
147287086|NCT02605954|531215584|FG000|Overall Study|Non-Compliance with Study Drug|1|||
147287087|NCT02605954|531215585|FG001|Overall Study|Non-Compliance with Study Drug|0|||
147287088|NCT02605954|531215584|FG000|Overall Study|Withdrew Consent|2|||
147287089|NCT02605954|531215585|FG001|Overall Study|Withdrew Consent|2|||
147287090|NCT02605954|531215584|FG000|Overall Study|Lost to Follow-up|3|||
147287091|NCT02605954|531215585|FG001|Overall Study|Lost to Follow-up|0|||
147287092|NCT02605954|531215584|FG000|Overall Study|Randomized but not treated|0|||
147287093|NCT02605954|531215585|FG001|Overall Study|Randomized but not treated|1|||
147287094|NCT02301143|531215586|FG000|Induction Period|Enrolled But Not Treated|1|||
147287095|NCT02301143|531215587|FG001|Induction Period|Enrolled But Not Treated|0|||
147287096|NCT02301143|531215586|FG000|Induction Period|Death|1|||
147287097|NCT02301143|531215587|FG001|Induction Period|Death|0|||
147287098|NCT02301143|531215586|FG000|Induction Period|Adverse Event|22|||
147287099|NCT02301143|531215587|FG001|Induction Period|Adverse Event|0|||
147287100|NCT02301143|531215586|FG000|Induction Period|Progressive Disease|8|||
147287101|NCT02301143|531215587|FG001|Induction Period|Progressive Disease|0|||
147287102|NCT02301143|531215586|FG000|Induction Period|Withdrawal by Subject|3|||
147287103|NCT02301143|531215587|FG001|Induction Period|Withdrawal by Subject|0|||
147287104|NCT02301143|531215586|FG000|Induction Period|Noncompliance with Study Drug|1|||
147287105|NCT02301143|531215587|FG001|Induction Period|Noncompliance with Study Drug|0|||
147287106|NCT02301143|531215586|FG000|Induction Period|Physician Decision|4|||
147287107|NCT02301143|531215587|FG001|Induction Period|Physician Decision|0|||
147287108|NCT02301143|531215586|FG000|Induction Period|Symptomatic Deterioration|2|||
147287109|NCT02301143|531215587|FG001|Induction Period|Symptomatic Deterioration|0|||
147287110|NCT02301143|531215586|FG000|Induction Period|Protocol Violation|2|||
147287111|NCT02301143|531215587|FG001|Induction Period|Protocol Violation|0|||
147287112|NCT02301143|531215586|FG000|Induction Period|Other|1|||
147287113|NCT02301143|531215587|FG001|Induction Period|Other|0|||
147287114|NCT02301143|531215586|FG000|Investigator's Choice|Adverse Event|0|||
147287115|NCT02301143|531215587|FG001|Investigator's Choice|Adverse Event|3|||
147287116|NCT02301143|531215586|FG000|Investigator's Choice|Progressive Disease|0|||
147287117|NCT02301143|531215587|FG001|Investigator's Choice|Progressive Disease|3|||
147287118|NCT02301143|531215586|FG000|Investigator's Choice|Noncompliance With Study Drug|0|||
147287119|NCT02301143|531215587|FG001|Investigator's Choice|Noncompliance With Study Drug|1|||
147287120|NCT02301143|531215586|FG000|Investigator's Choice|Symptomatic Deterioration|0|||
147287121|NCT02301143|531215587|FG001|Investigator's Choice|Symptomatic Deterioration|1|||
147287122|NCT02301143|531215586|FG000|Investigator's Choice|Other|0|||
147287123|NCT02301143|531215587|FG001|Investigator's Choice|Other|1|||
147287124|NCT02301143|531215586|FG000|Investigator's Choice|Unresectable Surgery|0|||
147287125|NCT02301143|531215587|FG001|Investigator's Choice|Unresectable Surgery|1|||
147287126|NCT03214367|531215588|FG000|Lead-in Period|Withdrawal by Subject|50|||
147287127|NCT03214367|531215589|FG001|Lead-in Period|Withdrawal by Subject|0|||
147287128|NCT03214367|531215590|FG002|Lead-in Period|Withdrawal by Subject|0|||
147287129|NCT03214367|531215591|FG003|Lead-in Period|Withdrawal by Subject|0|||
147287130|NCT03214367|531215592|FG004|Lead-in Period|Withdrawal by Subject|2|||
147287131|NCT03214367|531215593|FG005|Lead-in Period|Withdrawal by Subject|0|||
147287132|NCT03214367|531215594|FG006|Lead-in Period|Withdrawal by Subject|0|||
147287133|NCT03214367|531215595|FG007|Lead-in Period|Withdrawal by Subject|0|||
147287134|NCT03214367|531215588|FG000|Lead-in Period|Adverse Event|3|||
147287135|NCT03214367|531215589|FG001|Lead-in Period|Adverse Event|0|||
147287136|NCT03214367|531215590|FG002|Lead-in Period|Adverse Event|0|||
147604216|NCT00229723|532367858|FG006|Concomitant Phase|Lost to Follow-up|0|||
147604217|NCT00229723|532367852|FG000|Concomitant Phase|Informed consent withdrawn|3|||
147604218|NCT00229723|532367853|FG001|Concomitant Phase|Informed consent withdrawn|2|||
147604219|NCT00229723|532367854|FG002|Concomitant Phase|Informed consent withdrawn|0|||
147604220|NCT00229723|532367855|FG003|Concomitant Phase|Informed consent withdrawn|2|||
147604221|NCT00229723|532367856|FG004|Concomitant Phase|Informed consent withdrawn|0|||
147604222|NCT00229723|532367857|FG005|Concomitant Phase|Informed consent withdrawn|0|||
147604223|NCT00229723|532367858|FG006|Concomitant Phase|Informed consent withdrawn|0|||
147604224|NCT00229723|532367852|FG000|Concomitant Phase|Severe non-compliance|0|||
147287137|NCT03214367|531215591|FG003|Lead-in Period|Adverse Event|0|||
147287138|NCT03214367|531215592|FG004|Lead-in Period|Adverse Event|0|||
147287139|NCT03214367|531215593|FG005|Lead-in Period|Adverse Event|0|||
147287140|NCT03214367|531215594|FG006|Lead-in Period|Adverse Event|0|||
147287141|NCT03214367|531215595|FG007|Lead-in Period|Adverse Event|0|||
147287142|NCT03214367|531215588|FG000|Lead-in Period|Lost to Follow-up|12|||
147287143|NCT03214367|531215589|FG001|Lead-in Period|Lost to Follow-up|0|||
147287144|NCT03214367|531215590|FG002|Lead-in Period|Lost to Follow-up|0|||
147287145|NCT03214367|531215591|FG003|Lead-in Period|Lost to Follow-up|0|||
147287146|NCT03214367|531215592|FG004|Lead-in Period|Lost to Follow-up|0|||
147337619|NCT00722046|531402882|FG002|Overall Study|Death|0|||
147337620|NCT00722046|531402883|FG003|Overall Study|Death|0|||
147337621|NCT00722046|531402884|FG004|Overall Study|Death|0|||
147287147|NCT03214367|531215593|FG005|Lead-in Period|Lost to Follow-up|0|||
147287148|NCT03214367|531215594|FG006|Lead-in Period|Lost to Follow-up|0|||
147287149|NCT03214367|531215595|FG007|Lead-in Period|Lost to Follow-up|0|||
147337622|NCT00722046|531402885|FG005|Overall Study|Death|0|||
147337623|NCT00722046|531402886|FG006|Overall Study|Death|2|||
147337624|NCT00722046|531402880|FG000|Overall Study|Protocol Violation|1|||
147337625|NCT00722046|531402881|FG001|Overall Study|Protocol Violation|0|||
147337626|NCT00722046|531402882|FG002|Overall Study|Protocol Violation|0|||
147337627|NCT00722046|531402883|FG003|Overall Study|Protocol Violation|0|||
147337628|NCT00722046|531402884|FG004|Overall Study|Protocol Violation|0|||
147337629|NCT00722046|531402885|FG005|Overall Study|Protocol Violation|1|||
147452394|NCT01662440|531819909|FG002|Overall Study|Adverse Event|0|||
147452395|NCT01662440|531819910|FG003|Overall Study|Adverse Event|1|||
147452396|NCT01662440|531819907|FG000|Overall Study|Death|0|||
147452397|NCT01662440|531819908|FG001|Overall Study|Death|1|||
147452398|NCT01662440|531819909|FG002|Overall Study|Death|0|||
147452399|NCT01662440|531819910|FG003|Overall Study|Death|0|||
147452400|NCT01662440|531819907|FG000|Overall Study|Lost to Follow-up|2|||
147452401|NCT01662440|531819908|FG001|Overall Study|Lost to Follow-up|2|||
147452402|NCT01662440|531819909|FG002|Overall Study|Lost to Follow-up|4|||
147452403|NCT01662440|531819910|FG003|Overall Study|Lost to Follow-up|1|||
147452404|NCT01662440|531819907|FG000|Overall Study|Subject moved to another country.|0|||
147452405|NCT01662440|531819908|FG001|Overall Study|Subject moved to another country.|1|||
147452406|NCT01662440|531819909|FG002|Overall Study|Subject moved to another country.|0|||
147287150|NCT03214367|531215588|FG000|Lead-in Period|Sponsor Decision|11|||
147452407|NCT01662440|531819910|FG003|Overall Study|Subject moved to another country.|0|||
147452408|NCT01662440|531819907|FG000|Overall Study|Protocol Violation|1|||
147452409|NCT01662440|531819908|FG001|Overall Study|Protocol Violation|0|||
147452410|NCT01662440|531819909|FG002|Overall Study|Protocol Violation|0|||
147452411|NCT01662440|531819910|FG003|Overall Study|Protocol Violation|0|||
147452412|NCT01662440|531819907|FG000|Overall Study|Withdrawal by Subject|5|||
147452413|NCT01662440|531819908|FG001|Overall Study|Withdrawal by Subject|2|||
147452414|NCT01662440|531819909|FG002|Overall Study|Withdrawal by Subject|2|||
147452415|NCT01662440|531819910|FG003|Overall Study|Withdrawal by Subject|2|||
147452416|NCT01765673|531819911|FG000|Overall Study|No transportation for 2nd/3rd visits|1|||
147452417|NCT01284114|531819912|FG000|Overall Study|viral infection|1|||
147452418|NCT01284114|531819912|FG000|Overall Study|From the results of ALLTITUDE study|1|||
147452419|NCT01284114|531819912|FG000|Overall Study|Symptomatic hypotension|1|||
147452420|NCT01284114|531819912|FG000|Overall Study|dizziness|1|||
147452421|NCT03409744|531819913|FG000|Overall Study|Death|2|||
147452422|NCT03409744|531819913|FG000|Overall Study|Physician Decision|5|||
147452423|NCT03409744|531819913|FG000|Overall Study|Pregnancy|1|||
147452424|NCT03409744|531819913|FG000|Overall Study|Lost to Follow-up|1|||
147452425|NCT03409744|531819913|FG000|Overall Study|Protocol Violation|1|||
147604225|NCT00229723|532367853|FG001|Concomitant Phase|Severe non-compliance|1|||
147604226|NCT00229723|532367854|FG002|Concomitant Phase|Severe non-compliance|0|||
147287151|NCT03214367|531215589|FG001|Lead-in Period|Sponsor Decision|0|||
147287152|NCT03214367|531215590|FG002|Lead-in Period|Sponsor Decision|0|||
147287153|NCT03214367|531215591|FG003|Lead-in Period|Sponsor Decision|0|||
147287154|NCT03214367|531215592|FG004|Lead-in Period|Sponsor Decision|0|||
147287155|NCT03214367|531215593|FG005|Lead-in Period|Sponsor Decision|0|||
147287156|NCT03214367|531215594|FG006|Lead-in Period|Sponsor Decision|0|||
147287157|NCT03214367|531215595|FG007|Lead-in Period|Sponsor Decision|0|||
147287158|NCT03214367|531215588|FG000|Lead-in Period|Physician Decision|12|||
147287159|NCT03214367|531215589|FG001|Lead-in Period|Physician Decision|0|||
147287160|NCT03214367|531215590|FG002|Lead-in Period|Physician Decision|0|||
147287161|NCT03214367|531215591|FG003|Lead-in Period|Physician Decision|0|||
147287162|NCT03214367|531215592|FG004|Lead-in Period|Physician Decision|0|||
147337630|NCT00722046|531402886|FG006|Overall Study|Protocol Violation|0|||
147337631|NCT00722046|531402880|FG000|Overall Study|Withdrawal by Subject|3|||
147337632|NCT00722046|531402881|FG001|Overall Study|Withdrawal by Subject|3|||
147337633|NCT00722046|531402882|FG002|Overall Study|Withdrawal by Subject|4|||
147452426|NCT04872101|531819914|FG000|Overall Study|Withdrawal by Subject|10|||
147452427|NCT04872101|531819915|FG001|Overall Study|Withdrawal by Subject|16|||
147452428|NCT04872101|531819914|FG000|Overall Study|Lack of Efficacy|6|||
147452429|NCT04872101|531819915|FG001|Overall Study|Lack of Efficacy|14|||
147604227|NCT00229723|532367855|FG003|Concomitant Phase|Severe non-compliance|0|||
147604228|NCT00229723|532367856|FG004|Concomitant Phase|Severe non-compliance|1|||
147604229|NCT00229723|532367857|FG005|Concomitant Phase|Severe non-compliance|0|||
147287163|NCT03214367|531215593|FG005|Lead-in Period|Physician Decision|0|||
147287164|NCT03214367|531215594|FG006|Lead-in Period|Physician Decision|0|||
147452430|NCT04872101|531819914|FG000|Overall Study|Adverse Event|1|||
147452431|NCT04872101|531819915|FG001|Overall Study|Adverse Event|6|||
147452432|NCT04872101|531819914|FG000|Overall Study|Lost to Follow-up|2|||
147452433|NCT04872101|531819915|FG001|Overall Study|Lost to Follow-up|1|||
147287165|NCT03214367|531215595|FG007|Lead-in Period|Physician Decision|0|||
147337634|NCT00722046|531402883|FG003|Overall Study|Withdrawal by Subject|4|||
147337635|NCT00722046|531402884|FG004|Overall Study|Withdrawal by Subject|4|||
147452434|NCT04872101|531819914|FG000|Overall Study|Pregnancy|2|||
147452435|NCT04872101|531819915|FG001|Overall Study|Pregnancy|0|||
147452436|NCT04872101|531819914|FG000|Overall Study|Prohibited Medication|1|||
147452437|NCT04872101|531819915|FG001|Overall Study|Prohibited Medication|0|||
147452438|NCT04872101|531819914|FG000|Overall Study|Not dosed|1|||
147452439|NCT04872101|531819915|FG001|Overall Study|Not dosed|0|||
147452440|NCT02475681|531819916|FG000|Overall Study|Death|16|||
147452441|NCT02475681|531819917|FG001|Overall Study|Death|6|||
147452442|NCT02475681|531819918|FG002|Overall Study|Death|9|||
147287166|NCT03214367|531215588|FG000|Lead-in Period|Protocol Violation|5|||
147287167|NCT03214367|531215589|FG001|Lead-in Period|Protocol Violation|0|||
147287168|NCT03214367|531215590|FG002|Lead-in Period|Protocol Violation|0|||
147287169|NCT03214367|531215591|FG003|Lead-in Period|Protocol Violation|0|||
147287170|NCT03214367|531215592|FG004|Lead-in Period|Protocol Violation|0|||
147287171|NCT03214367|531215593|FG005|Lead-in Period|Protocol Violation|0|||
147287172|NCT03214367|531215594|FG006|Lead-in Period|Protocol Violation|0|||
147287173|NCT03214367|531215595|FG007|Lead-in Period|Protocol Violation|0|||
147287174|NCT03214367|531215588|FG000|Lead-in Period|Treatment Interruption|1|||
147287175|NCT03214367|531215589|FG001|Lead-in Period|Treatment Interruption|0|||
147287176|NCT03214367|531215590|FG002|Lead-in Period|Treatment Interruption|0|||
147287177|NCT03214367|531215591|FG003|Lead-in Period|Treatment Interruption|0|||
147287178|NCT03214367|531215592|FG004|Lead-in Period|Treatment Interruption|0|||
147287179|NCT03214367|531215593|FG005|Lead-in Period|Treatment Interruption|0|||
147287180|NCT03214367|531215594|FG006|Lead-in Period|Treatment Interruption|0|||
147287181|NCT03214367|531215595|FG007|Lead-in Period|Treatment Interruption|0|||
147287182|NCT03214367|531215588|FG000|Treatment Period|Adverse Event|0|||
147287183|NCT03214367|531215589|FG001|Treatment Period|Adverse Event|1|||
147287184|NCT03214367|531215590|FG002|Treatment Period|Adverse Event|4|||
147287185|NCT03214367|531215591|FG003|Treatment Period|Adverse Event|2|||
147452443|NCT02475681|531819916|FG000|Overall Study|Physician Decision|0|||
147452444|NCT02475681|531819917|FG001|Overall Study|Physician Decision|3|||
147452445|NCT02475681|531819918|FG002|Overall Study|Physician Decision|1|||
147452446|NCT02475681|531819916|FG000|Overall Study|Withdrawal by Subject|12|||
147604230|NCT00229723|532367858|FG006|Concomitant Phase|Severe non-compliance|0|||
147604231|NCT00229723|532367852|FG000|Concomitant Phase|Other|3|||
147604232|NCT00229723|532367853|FG001|Concomitant Phase|Other|0|||
147604233|NCT00229723|532367854|FG002|Concomitant Phase|Other|1|||
147604234|NCT00229723|532367855|FG003|Concomitant Phase|Other|1|||
147604235|NCT00229723|532367856|FG004|Concomitant Phase|Other|0|||
147604236|NCT00229723|532367857|FG005|Concomitant Phase|Other|2|||
147604237|NCT00229723|532367858|FG006|Concomitant Phase|Other|0|||
147604238|NCT00229723|532367852|FG000|Maintenance Phase|Adverse Event|7|||
147604239|NCT00229723|532367853|FG001|Maintenance Phase|Adverse Event|2|||
147604240|NCT00229723|532367854|FG002|Maintenance Phase|Adverse Event|1|||
147604241|NCT00229723|532367855|FG003|Maintenance Phase|Adverse Event|4|||
147604242|NCT00229723|532367856|FG004|Maintenance Phase|Adverse Event|7|||
147604243|NCT00229723|532367857|FG005|Maintenance Phase|Adverse Event|5|||
147604244|NCT00229723|532367858|FG006|Maintenance Phase|Adverse Event|2|||
147604245|NCT00229723|532367852|FG000|Maintenance Phase|Objective disease progression|5|||
147604246|NCT00229723|532367853|FG001|Maintenance Phase|Objective disease progression|5|||
147604247|NCT00229723|532367854|FG002|Maintenance Phase|Objective disease progression|3|||
147604248|NCT00229723|532367855|FG003|Maintenance Phase|Objective disease progression|6|||
147604249|NCT00229723|532367856|FG004|Maintenance Phase|Objective disease progression|2|||
147604250|NCT00229723|532367857|FG005|Maintenance Phase|Objective disease progression|9|||
147604251|NCT00229723|532367858|FG006|Maintenance Phase|Objective disease progression|5|||
147604252|NCT00229723|532367852|FG000|Maintenance Phase|Clinical progression|4|||
147604253|NCT00229723|532367853|FG001|Maintenance Phase|Clinical progression|1|||
147604254|NCT00229723|532367854|FG002|Maintenance Phase|Clinical progression|2|||
147604255|NCT00229723|532367855|FG003|Maintenance Phase|Clinical progression|2|||
147604256|NCT00229723|532367856|FG004|Maintenance Phase|Clinical progression|1|||
147604257|NCT00229723|532367857|FG005|Maintenance Phase|Clinical progression|1|||
147604258|NCT00229723|532367858|FG006|Maintenance Phase|Clinical progression|1|||
147604259|NCT00229723|532367852|FG000|Maintenance Phase|Lost to Follow-up|0|||
147604260|NCT00229723|532367853|FG001|Maintenance Phase|Lost to Follow-up|1|||
147604261|NCT00229723|532367854|FG002|Maintenance Phase|Lost to Follow-up|2|||
147604262|NCT00229723|532367855|FG003|Maintenance Phase|Lost to Follow-up|2|||
147604263|NCT00229723|532367856|FG004|Maintenance Phase|Lost to Follow-up|0|||
147604264|NCT00229723|532367857|FG005|Maintenance Phase|Lost to Follow-up|0|||
147604265|NCT00229723|532367858|FG006|Maintenance Phase|Lost to Follow-up|1|||
147287186|NCT03214367|531215592|FG004|Treatment Period|Adverse Event|0|||
147287187|NCT03214367|531215593|FG005|Treatment Period|Adverse Event|0|||
147287188|NCT03214367|531215594|FG006|Treatment Period|Adverse Event|0|||
147287189|NCT03214367|531215595|FG007|Treatment Period|Adverse Event|0|||
147287190|NCT03214367|531215588|FG000|Treatment Period|Death|0|||
147287191|NCT03214367|531215589|FG001|Treatment Period|Death|1|||
147287192|NCT03214367|531215590|FG002|Treatment Period|Death|1|||
147452447|NCT02475681|531819917|FG001|Overall Study|Withdrawal by Subject|6|||
147604266|NCT00229723|532367852|FG000|Maintenance Phase|Informed consent withdrawn|1|||
147604267|NCT00229723|532367853|FG001|Maintenance Phase|Informed consent withdrawn|0|||
147287193|NCT03214367|531215591|FG003|Treatment Period|Death|1|||
147604268|NCT00229723|532367854|FG002|Maintenance Phase|Informed consent withdrawn|0|||
147287194|NCT03214367|531215592|FG004|Treatment Period|Death|0|||
147452448|NCT02475681|531819918|FG002|Overall Study|Withdrawal by Subject|9|||
147287195|NCT03214367|531215593|FG005|Treatment Period|Death|0|||
147287196|NCT03214367|531215594|FG006|Treatment Period|Death|0|||
147287197|NCT03214367|531215595|FG007|Treatment Period|Death|0|||
147287198|NCT03214367|531215588|FG000|Treatment Period|Lost to Follow-up|0|||
147287199|NCT03214367|531215589|FG001|Treatment Period|Lost to Follow-up|5|||
147287200|NCT03214367|531215590|FG002|Treatment Period|Lost to Follow-up|3|||
147287201|NCT03214367|531215591|FG003|Treatment Period|Lost to Follow-up|2|||
147287202|NCT03214367|531215592|FG004|Treatment Period|Lost to Follow-up|0|||
147287203|NCT03214367|531215593|FG005|Treatment Period|Lost to Follow-up|2|||
147287204|NCT03214367|531215594|FG006|Treatment Period|Lost to Follow-up|1|||
147287205|NCT03214367|531215595|FG007|Treatment Period|Lost to Follow-up|0|||
147287206|NCT03214367|531215588|FG000|Treatment Period|Sponsor Decision|0|||
147287207|NCT03214367|531215589|FG001|Treatment Period|Sponsor Decision|3|||
147287208|NCT03214367|531215590|FG002|Treatment Period|Sponsor Decision|0|||
147287209|NCT03214367|531215591|FG003|Treatment Period|Sponsor Decision|0|||
147287210|NCT03214367|531215592|FG004|Treatment Period|Sponsor Decision|0|||
147287211|NCT03214367|531215593|FG005|Treatment Period|Sponsor Decision|0|||
147287212|NCT03214367|531215594|FG006|Treatment Period|Sponsor Decision|0|||
147287213|NCT03214367|531215595|FG007|Treatment Period|Sponsor Decision|0|||
147287214|NCT03214367|531215588|FG000|Treatment Period|Physician Decision|0|||
147287215|NCT03214367|531215589|FG001|Treatment Period|Physician Decision|1|||
147287216|NCT03214367|531215590|FG002|Treatment Period|Physician Decision|2|||
147287217|NCT03214367|531215591|FG003|Treatment Period|Physician Decision|0|||
147287218|NCT03214367|531215592|FG004|Treatment Period|Physician Decision|0|||
147287219|NCT03214367|531215593|FG005|Treatment Period|Physician Decision|0|||
147287220|NCT03214367|531215594|FG006|Treatment Period|Physician Decision|0|||
147287221|NCT03214367|531215595|FG007|Treatment Period|Physician Decision|0|||
147287222|NCT03214367|531215588|FG000|Treatment Period|Protocol Violation|0|||
147287223|NCT03214367|531215589|FG001|Treatment Period|Protocol Violation|3|||
147287224|NCT03214367|531215590|FG002|Treatment Period|Protocol Violation|0|||
147337636|NCT00722046|531402885|FG005|Overall Study|Withdrawal by Subject|7|||
147337637|NCT00722046|531402886|FG006|Overall Study|Withdrawal by Subject|3|||
147337638|NCT00722046|531402880|FG000|Overall Study|Randomized, but not treated|1|||
147337639|NCT00722046|531402881|FG001|Overall Study|Randomized, but not treated|1|||
147337640|NCT00722046|531402882|FG002|Overall Study|Randomized, but not treated|0|||
147337641|NCT00722046|531402883|FG003|Overall Study|Randomized, but not treated|2|||
147337642|NCT00722046|531402884|FG004|Overall Study|Randomized, but not treated|0|||
147337643|NCT00722046|531402885|FG005|Overall Study|Randomized, but not treated|0|||
147337644|NCT00722046|531402886|FG006|Overall Study|Randomized, but not treated|0|||
147337645|NCT00722046|531402880|FG000|Overall Study|Other|0|||
147337646|NCT00722046|531402881|FG001|Overall Study|Other|0|||
147337647|NCT00722046|531402882|FG002|Overall Study|Other|1|||
147337648|NCT00722046|531402883|FG003|Overall Study|Other|1|||
147337649|NCT00722046|531402884|FG004|Overall Study|Other|3|||
147337650|NCT00722046|531402885|FG005|Overall Study|Other|2|||
147337651|NCT00722046|531402886|FG006|Overall Study|Other|1|||
147337652|NCT00925587|531402887|FG000|Overall Study|Protocol Specified Criteria|6|||
147337653|NCT00925587|531402888|FG001|Overall Study|Protocol Specified Criteria|6|||
147337654|NCT00925587|531402887|FG000|Overall Study|Physician Decision|4|||
147337655|NCT00925587|531402888|FG001|Overall Study|Physician Decision|1|||
147337656|NCT00925587|531402887|FG000|Overall Study|Protocol Violation|6|||
147337657|NCT00925587|531402888|FG001|Overall Study|Protocol Violation|4|||
147337658|NCT00925587|531402887|FG000|Overall Study|Withdrawal by Subject|9|||
147337659|NCT00925587|531402888|FG001|Overall Study|Withdrawal by Subject|6|||
147337660|NCT00925587|531402887|FG000|Overall Study|Death|5|||
147337661|NCT00925587|531402888|FG001|Overall Study|Death|5|||
147337662|NCT00925587|531402887|FG000|Overall Study|Adverse Event|6|||
147337663|NCT00925587|531402888|FG001|Overall Study|Adverse Event|2|||
147337664|NCT00925587|531402887|FG000|Overall Study|Lost to Follow-up|0|||
147337665|NCT00925587|531402888|FG001|Overall Study|Lost to Follow-up|1|||
147604269|NCT00229723|532367855|FG003|Maintenance Phase|Informed consent withdrawn|1|||
147287225|NCT03214367|531215591|FG003|Treatment Period|Protocol Violation|0|||
147287226|NCT03214367|531215592|FG004|Treatment Period|Protocol Violation|0|||
147337666|NCT01149369|531402893|FG000|Overall Study|Adverse Event|6|||
147337667|NCT01149369|531402894|FG001|Overall Study|Adverse Event|3|||
147337668|NCT03644849|531402895|FG000|Overall Study|Lost to Follow-up|1|||
147337669|NCT03644849|531402896|FG001|Overall Study|Lost to Follow-up|3|||
147337670|NCT02755805|531402897|FG000|Overall Study|Lost to Follow-up|1|||
147337671|NCT02755805|531402898|FG001|Overall Study|Lost to Follow-up|2|||
147287227|NCT03214367|531215593|FG005|Treatment Period|Protocol Violation|0|||
147287228|NCT03214367|531215594|FG006|Treatment Period|Protocol Violation|0|||
147287229|NCT03214367|531215595|FG007|Treatment Period|Protocol Violation|0|||
147287230|NCT03214367|531215588|FG000|Treatment Period|Withdrawal by Subject|0|||
147287231|NCT03214367|531215589|FG001|Treatment Period|Withdrawal by Subject|20|||
147287232|NCT03214367|531215590|FG002|Treatment Period|Withdrawal by Subject|23|||
147604270|NCT00229723|532367856|FG004|Maintenance Phase|Informed consent withdrawn|1|||
147337672|NCT02755805|531402897|FG000|Overall Study|Refused assessments|1|||
147337673|NCT02755805|531402898|FG001|Overall Study|Refused assessments|0|||
147337674|NCT02755805|531402897|FG000|Overall Study|Withdrawal by Subject|0|||
147287233|NCT03214367|531215591|FG003|Treatment Period|Withdrawal by Subject|14|||
147287234|NCT03214367|531215592|FG004|Treatment Period|Withdrawal by Subject|0|||
147287235|NCT03214367|531215593|FG005|Treatment Period|Withdrawal by Subject|1|||
147287236|NCT03214367|531215594|FG006|Treatment Period|Withdrawal by Subject|1|||
147287237|NCT03214367|531215595|FG007|Treatment Period|Withdrawal by Subject|1|||
147287238|NCT03508843|531215596|FG000|Overall Study|Withdrawal by Subject|1|||
147287239|NCT03508843|531215596|FG000|Overall Study|technical difficulties|2|||
147287240|NCT04717596|531215597|FG000|Overall Study|Withdrawal by Subject|4|||
147287241|NCT03555396|531215598|FG000|Overall Study|Death|3|||
147287242|NCT03555396|531215599|FG001|Overall Study|Death|1|||
147287243|NCT03555396|531215598|FG000|Overall Study|Lost to Follow-up|0|||
147287244|NCT03555396|531215599|FG001|Overall Study|Lost to Follow-up|2|||
147287245|NCT02536508|531215600|FG000|Overall Study|Withdrawal by Subject|18|||
147287246|NCT02536508|531215601|FG001|Overall Study|Withdrawal by Subject|13|||
147287247|NCT02536508|531215602|FG002|Overall Study|Withdrawal by Subject|7|||
147287248|NCT02536508|531215600|FG000|Overall Study|Adverse Event|14|||
147287249|NCT02536508|531215601|FG001|Overall Study|Adverse Event|13|||
147287250|NCT02536508|531215602|FG002|Overall Study|Adverse Event|6|||
147287251|NCT02536508|531215600|FG000|Overall Study|Lost to Follow-up|12|||
147287252|NCT02536508|531215601|FG001|Overall Study|Lost to Follow-up|4|||
147287253|NCT02536508|531215602|FG002|Overall Study|Lost to Follow-up|0|||
147287254|NCT02536508|531215600|FG000|Overall Study|Lack of Efficacy|3|||
147287255|NCT02536508|531215601|FG001|Overall Study|Lack of Efficacy|5|||
147287256|NCT02536508|531215602|FG002|Overall Study|Lack of Efficacy|4|||
147287257|NCT02536508|531215600|FG000|Overall Study|Protocol Discontinuation Criteria|3|||
147287258|NCT02536508|531215601|FG001|Overall Study|Protocol Discontinuation Criteria|2|||
147287259|NCT02536508|531215602|FG002|Overall Study|Protocol Discontinuation Criteria|2|||
147287260|NCT02536508|531215600|FG000|Overall Study|Physician Decision|0|||
147287261|NCT02536508|531215601|FG001|Overall Study|Physician Decision|4|||
147287262|NCT02536508|531215602|FG002|Overall Study|Physician Decision|2|||
147287263|NCT02536508|531215600|FG000|Overall Study|Major Protocol Deviation|2|||
147287264|NCT02536508|531215601|FG001|Overall Study|Major Protocol Deviation|2|||
147287265|NCT02536508|531215602|FG002|Overall Study|Major Protocol Deviation|2|||
147287266|NCT02536508|531215600|FG000|Overall Study|Administrative Reasons|0|||
147287267|NCT02536508|531215601|FG001|Overall Study|Administrative Reasons|1|||
147287268|NCT02536508|531215602|FG002|Overall Study|Administrative Reasons|0|||
147287269|NCT00130533|531215604|FG000|Overall Study|Withdrawal by Subject|33|||
147287270|NCT00130533|531215605|FG001|Overall Study|Withdrawal by Subject|6|||
147287271|NCT00130533|531215604|FG000|Overall Study|Adverse Event|34|||
147287272|NCT00130533|531215605|FG001|Overall Study|Adverse Event|1|||
147287273|NCT00130533|531215604|FG000|Overall Study|Disease relapse|9|||
147287274|NCT00130533|531215605|FG001|Overall Study|Disease relapse|13|||
147287275|NCT00130533|531215604|FG000|Overall Study|Interruption of treatment > 3 weeks|11|||
147287276|NCT00130533|531215605|FG001|Overall Study|Interruption of treatment > 3 weeks|0|||
147287277|NCT00130533|531215604|FG000|Overall Study|Death|4|||
147287278|NCT00130533|531215605|FG001|Overall Study|Death|2|||
147287279|NCT00130533|531215604|FG000|Overall Study|Protocol Violation|5|||
147287280|NCT00130533|531215605|FG001|Overall Study|Protocol Violation|1|||
147287281|NCT00130533|531215604|FG000|Overall Study|Lost to Follow-up|1|||
147287282|NCT00130533|531215605|FG001|Overall Study|Lost to Follow-up|1|||
147287283|NCT00130533|531215604|FG000|Overall Study|Sponsor´s decision|2|||
147287284|NCT00130533|531215605|FG001|Overall Study|Sponsor´s decision|0|||
147287285|NCT00130533|531215604|FG000|Overall Study|Second Primary Malignancy|0|||
147287286|NCT00130533|531215605|FG001|Overall Study|Second Primary Malignancy|1|||
147287287|NCT00130533|531215604|FG000|Overall Study|Other|12|||
147287288|NCT00130533|531215605|FG001|Overall Study|Other|5|||
147287289|NCT02384759|531215612|FG000|Overall Study|Patients not treated|3|||
147287290|NCT02384759|531215613|FG001|Overall Study|Patients not treated|2|||
147287291|NCT01605617|531215614|FG000|First Intervention|Adverse Event|0|||
147287292|NCT01605617|531215615|FG001|First Intervention|Adverse Event|1|||
147287293|NCT01605617|531215614|FG000|Washout Period of 4 Weeks|Study Terminated|2|||
147287294|NCT01605617|531215615|FG001|Washout Period of 4 Weeks|Study Terminated|1|||
147287295|NCT02014116|531215617|FG000|Overall Study|Progressive Disease|3|||
147604271|NCT00229723|532367857|FG005|Maintenance Phase|Informed consent withdrawn|1|||
147604272|NCT00229723|532367858|FG006|Maintenance Phase|Informed consent withdrawn|0|||
147604273|NCT00229723|532367852|FG000|Maintenance Phase|Severe non-compliance|3|||
147604274|NCT00229723|532367853|FG001|Maintenance Phase|Severe non-compliance|1|||
147287296|NCT02014116|531215618|FG001|Overall Study|Progressive Disease|4|||
147287297|NCT02014116|531215619|FG002|Overall Study|Progressive Disease|2|||
147287298|NCT02014116|531215620|FG003|Overall Study|Progressive Disease|6|||
147287299|NCT02014116|531215621|FG004|Overall Study|Progressive Disease|1|||
147287300|NCT02014116|531215622|FG005|Overall Study|Progressive Disease|13|||
147287301|NCT02014116|531215623|FG006|Overall Study|Progressive Disease|1|||
147287302|NCT02014116|531215624|FG007|Overall Study|Progressive Disease|3|||
147287303|NCT02014116|531215625|FG008|Overall Study|Progressive Disease|7|||
147287304|NCT02014116|531215617|FG000|Overall Study|Adverse Event|0|||
147287305|NCT02014116|531215618|FG001|Overall Study|Adverse Event|0|||
147287306|NCT02014116|531215619|FG002|Overall Study|Adverse Event|0|||
147452449|NCT02475681|531819916|FG000|Overall Study|Lost to Follow-up|2|||
147452450|NCT02475681|531819917|FG001|Overall Study|Lost to Follow-up|1|||
147452451|NCT02475681|531819918|FG002|Overall Study|Lost to Follow-up|3|||
147452452|NCT02475681|531819916|FG000|Overall Study|Ongoing in Study|0|||
147452453|NCT02475681|531819917|FG001|Overall Study|Ongoing in Study|163|||
147452454|NCT02475681|531819918|FG002|Overall Study|Ongoing in Study|157|||
147452455|NCT02475681|531819916|FG000|Overall Study|Reasons other than above listed|2|||
147452456|NCT02475681|531819917|FG001|Overall Study|Reasons other than above listed|0|||
147604275|NCT00229723|532367854|FG002|Maintenance Phase|Severe non-compliance|0|||
147287307|NCT02014116|531215620|FG003|Overall Study|Adverse Event|0|||
147287308|NCT02014116|531215621|FG004|Overall Study|Adverse Event|1|||
147287309|NCT02014116|531215622|FG005|Overall Study|Adverse Event|0|||
147287310|NCT02014116|531215623|FG006|Overall Study|Adverse Event|0|||
147287311|NCT02014116|531215624|FG007|Overall Study|Adverse Event|1|||
147287312|NCT02014116|531215625|FG008|Overall Study|Adverse Event|0|||
147287313|NCT02014116|531215617|FG000|Overall Study|Lost to Follow-up|0|||
147287314|NCT02014116|531215618|FG001|Overall Study|Lost to Follow-up|0|||
147287315|NCT02014116|531215619|FG002|Overall Study|Lost to Follow-up|0|||
147287316|NCT02014116|531215620|FG003|Overall Study|Lost to Follow-up|0|||
147287317|NCT02014116|531215621|FG004|Overall Study|Lost to Follow-up|0|||
147287318|NCT02014116|531215622|FG005|Overall Study|Lost to Follow-up|1|||
147287319|NCT02014116|531215623|FG006|Overall Study|Lost to Follow-up|0|||
147287320|NCT02014116|531215624|FG007|Overall Study|Lost to Follow-up|0|||
147287321|NCT02014116|531215625|FG008|Overall Study|Lost to Follow-up|1|||
147287322|NCT02014116|531215617|FG000|Overall Study|Death|0|||
147287323|NCT02014116|531215618|FG001|Overall Study|Death|0|||
147287324|NCT02014116|531215619|FG002|Overall Study|Death|0|||
147287325|NCT02014116|531215620|FG003|Overall Study|Death|0|||
147287326|NCT02014116|531215621|FG004|Overall Study|Death|0|||
147287327|NCT02014116|531215622|FG005|Overall Study|Death|0|||
147287328|NCT02014116|531215623|FG006|Overall Study|Death|0|||
147287329|NCT02014116|531215624|FG007|Overall Study|Death|1|||
147287330|NCT02014116|531215625|FG008|Overall Study|Death|1|||
147287331|NCT02014116|531215617|FG000|Overall Study|Withdrawal by Subject|0|||
147287332|NCT02014116|531215618|FG001|Overall Study|Withdrawal by Subject|0|||
147287333|NCT02014116|531215619|FG002|Overall Study|Withdrawal by Subject|1|||
147287334|NCT02014116|531215620|FG003|Overall Study|Withdrawal by Subject|1|||
147287335|NCT02014116|531215621|FG004|Overall Study|Withdrawal by Subject|0|||
147287336|NCT02014116|531215622|FG005|Overall Study|Withdrawal by Subject|1|||
147287337|NCT02014116|531215623|FG006|Overall Study|Withdrawal by Subject|0|||
147287338|NCT02014116|531215624|FG007|Overall Study|Withdrawal by Subject|0|||
147287339|NCT02014116|531215625|FG008|Overall Study|Withdrawal by Subject|0|||
147287340|NCT02014116|531215617|FG000|Overall Study|Withdrawal Caregiver Decision|0|||
147287341|NCT02014116|531215618|FG001|Overall Study|Withdrawal Caregiver Decision|0|||
147287342|NCT02014116|531215619|FG002|Overall Study|Withdrawal Caregiver Decision|0|||
147287343|NCT02014116|531215620|FG003|Overall Study|Withdrawal Caregiver Decision|0|||
147287344|NCT02014116|531215621|FG004|Overall Study|Withdrawal Caregiver Decision|0|||
147287345|NCT02014116|531215622|FG005|Overall Study|Withdrawal Caregiver Decision|1|||
147287346|NCT02014116|531215623|FG006|Overall Study|Withdrawal Caregiver Decision|0|||
147287347|NCT02014116|531215624|FG007|Overall Study|Withdrawal Caregiver Decision|0|||
147287348|NCT02014116|531215625|FG008|Overall Study|Withdrawal Caregiver Decision|0|||
147287349|NCT02014116|531215617|FG000|Overall Study|Physician Decision|0|||
147287350|NCT02014116|531215618|FG001|Overall Study|Physician Decision|0|||
147287351|NCT02014116|531215619|FG002|Overall Study|Physician Decision|0|||
147287352|NCT02014116|531215620|FG003|Overall Study|Physician Decision|0|||
147287353|NCT02014116|531215621|FG004|Overall Study|Physician Decision|0|||
147287354|NCT02014116|531215622|FG005|Overall Study|Physician Decision|0|||
147287355|NCT02014116|531215623|FG006|Overall Study|Physician Decision|0|||
147287356|NCT02014116|531215624|FG007|Overall Study|Physician Decision|0|||
147287357|NCT02014116|531215625|FG008|Overall Study|Physician Decision|1|||
147287358|NCT00121238|531215626|FG000|Overall Study|disease progression before intervention|1|||
147287359|NCT00121238|531215626|FG000|Overall Study|Protocol Violation|2|||
147287360|NCT03043664|531215627|FG000|Overall Study|Lost to Follow-up|1|||
147287361|NCT01540851|531215628|FG000|Overall Study|Lost to Follow-up|14|||
147287362|NCT01540851|531215629|FG001|Overall Study|Lost to Follow-up|15|||
147287363|NCT01540851|531215628|FG000|Overall Study|Withdrawal by Subject|7|||
147604276|NCT00229723|532367855|FG003|Maintenance Phase|Severe non-compliance|0|||
147287364|NCT01540851|531215629|FG001|Overall Study|Withdrawal by Subject|3|||
147287365|NCT00325468|531215630|FG000|Overall Study|Adverse Event|1|||
147287366|NCT00325468|531215631|FG001|Overall Study|Adverse Event|1|||
147287367|NCT00325468|531215632|FG002|Overall Study|Adverse Event|0|||
147287368|NCT00325468|531215633|FG003|Overall Study|Adverse Event|5|||
147287369|NCT00325468|531215634|FG004|Overall Study|Adverse Event|1|||
147287370|NCT00325468|531215630|FG000|Overall Study|Death|2|||
147287371|NCT00325468|531215631|FG001|Overall Study|Death|0|||
147287372|NCT00325468|531215632|FG002|Overall Study|Death|2|||
147287373|NCT00325468|531215633|FG003|Overall Study|Death|4|||
147287374|NCT00325468|531215634|FG004|Overall Study|Death|0|||
147452457|NCT02475681|531819918|FG002|Overall Study|Reasons other than above listed|0|||
147287375|NCT00325468|531215630|FG000|Overall Study|Lost to Follow-up|0|||
147287376|NCT00325468|531215631|FG001|Overall Study|Lost to Follow-up|0|||
147287377|NCT00325468|531215632|FG002|Overall Study|Lost to Follow-up|1|||
147287378|NCT00325468|531215633|FG003|Overall Study|Lost to Follow-up|2|||
147287379|NCT00325468|531215634|FG004|Overall Study|Lost to Follow-up|2|||
147287380|NCT00325468|531215630|FG000|Overall Study|Physician Decision|1|||
147287381|NCT00325468|531215631|FG001|Overall Study|Physician Decision|1|||
147287382|NCT00325468|531215632|FG002|Overall Study|Physician Decision|0|||
147287383|NCT00325468|531215633|FG003|Overall Study|Physician Decision|1|||
147287384|NCT00325468|531215634|FG004|Overall Study|Physician Decision|0|||
147287385|NCT00325468|531215630|FG000|Overall Study|Withdrawal by Subject|3|||
147287386|NCT00325468|531215631|FG001|Overall Study|Withdrawal by Subject|1|||
147287387|NCT00325468|531215632|FG002|Overall Study|Withdrawal by Subject|0|||
147287388|NCT00325468|531215633|FG003|Overall Study|Withdrawal by Subject|14|||
147287389|NCT00325468|531215634|FG004|Overall Study|Withdrawal by Subject|4|||
147287390|NCT00325468|531215630|FG000|Overall Study|site closure etc|4|||
147287391|NCT00325468|531215631|FG001|Overall Study|site closure etc|2|||
147287392|NCT00325468|531215632|FG002|Overall Study|site closure etc|1|||
147287393|NCT00325468|531215633|FG003|Overall Study|site closure etc|8|||
147287394|NCT00325468|531215634|FG004|Overall Study|site closure etc|1|||
147287395|NCT03593655|531215635|FG000|First Product Use Period|Withdrawal by Subject|1|||
147287396|NCT03593655|531215636|FG001|First Product Use Period|Withdrawal by Subject|1|||
147287397|NCT03593655|531215635|FG000|First Product Use Period|Lost to Follow-up|1|||
147287398|NCT03593655|531215636|FG001|First Product Use Period|Lost to Follow-up|3|||
147287399|NCT03593655|531215635|FG000|Second Product Use Period|Withdrawal by Subject|1|||
147287400|NCT03593655|531215636|FG001|Second Product Use Period|Withdrawal by Subject|1|||
147287401|NCT03593655|531215635|FG000|Second Product Use Period|Lost to Follow-up|1|||
147287402|NCT03593655|531215636|FG001|Second Product Use Period|Lost to Follow-up|0|||
147287403|NCT03593655|531215635|FG000|Third Product Use Period|Lost to Follow-up|1|||
147287404|NCT03593655|531215636|FG001|Third Product Use Period|Lost to Follow-up|2|||
147287405|NCT03593655|531215635|FG000|Third Product Use Period|Physician Decision|0|||
147287406|NCT03593655|531215636|FG001|Third Product Use Period|Physician Decision|1|||
147287407|NCT03593655|531215635|FG000|Third Product Use Period|Withdrawal by Subject|0|||
147287408|NCT03593655|531215636|FG001|Third Product Use Period|Withdrawal by Subject|1|||
147287409|NCT03732209|531215637|FG000|Overall Study|Lost to Follow-up|4|||
147287410|NCT03732209|531215638|FG001|Overall Study|Lost to Follow-up|4|||
147287411|NCT03732209|531215637|FG000|Overall Study|Withdrawal by Subject|8|||
147287412|NCT03732209|531215638|FG001|Overall Study|Withdrawal by Subject|9|||
147287413|NCT02864082|531215639|FG000|Overall Study|Adverse Event|1|||
147287414|NCT02864082|531215640|FG001|Overall Study|Adverse Event|1|||
147287415|NCT02864082|531215639|FG000|Overall Study|Lost to Follow-up|0|||
147287416|NCT02864082|531215640|FG001|Overall Study|Lost to Follow-up|1|||
147287417|NCT02864082|531215639|FG000|Overall Study|Withdrawal by Subject|2|||
147287418|NCT02864082|531215640|FG001|Overall Study|Withdrawal by Subject|2|||
147287419|NCT04139317|531215641|FG000|Overall Study|Adverse Event|10|||
147287420|NCT04139317|531215642|FG001|Overall Study|Adverse Event|2|||
147287421|NCT04139317|531215641|FG000|Overall Study|Death|6|||
147287422|NCT04139317|531215642|FG001|Overall Study|Death|4|||
147287423|NCT04139317|531215641|FG000|Overall Study|Lost to Follow-up|1|||
147287424|NCT04139317|531215642|FG001|Overall Study|Lost to Follow-up|0|||
147287425|NCT04139317|531215641|FG000|Overall Study|Physician Decision|3|||
147287426|NCT04139317|531215642|FG001|Overall Study|Physician Decision|1|||
147287427|NCT04139317|531215641|FG000|Overall Study|Progressive Disease|19|||
147287428|NCT04139317|531215642|FG001|Overall Study|Progressive Disease|9|||
147287429|NCT04139317|531215641|FG000|Overall Study|Subject Decision|2|||
147287430|NCT04139317|531215642|FG001|Overall Study|Subject Decision|2|||
147287431|NCT03621696|531215643|FG000|Overall Study|Not eligible|0|||
147287432|NCT03621696|531215644|FG001|Overall Study|Not eligible|0|||
147287433|NCT03621696|531215645|FG002|Overall Study|Not eligible|0|||
147287434|NCT03621696|531215646|FG003|Overall Study|Not eligible|5|||
147287435|NCT03621696|531215643|FG000|Overall Study|Withdrawal by Subject|1|||
147287436|NCT03621696|531215644|FG001|Overall Study|Withdrawal by Subject|1|||
147287437|NCT03621696|531215645|FG002|Overall Study|Withdrawal by Subject|1|||
147287438|NCT03621696|531215646|FG003|Overall Study|Withdrawal by Subject|0|||
147287439|NCT03621696|531215643|FG000|Overall Study|Physician Decision|0|||
147287440|NCT03621696|531215644|FG001|Overall Study|Physician Decision|0|||
147287441|NCT03621696|531215645|FG002|Overall Study|Physician Decision|1|||
147287442|NCT03621696|531215646|FG003|Overall Study|Physician Decision|0|||
147287443|NCT01109992|531215649|FG000|Overall Study|Withdrawal by Subject|0|||
147287444|NCT01109992|531215650|FG001|Overall Study|Withdrawal by Subject|1|||
147287445|NCT01109992|531215649|FG000|Overall Study|Movement during rest scan.|0|||
147287446|NCT01109992|531215650|FG001|Overall Study|Movement during rest scan.|1|||
147287447|NCT00690755|531215651|FG000|Overall Study|Physician Decision|2|||
147287448|NCT00690755|531215652|FG001|Overall Study|Physician Decision|0|||
147287449|NCT00690755|531215653|FG002|Overall Study|Physician Decision|46|||
147287450|NCT00690755|531215654|FG003|Overall Study|Physician Decision|5|||
147287451|NCT00690755|531215655|FG004|Overall Study|Physician Decision|0|||
147287452|NCT00690755|531215656|FG005|Overall Study|Physician Decision|4|||
147287453|NCT00690755|531215657|FG006|Overall Study|Physician Decision|0|||
147287454|NCT00214136|531215660|FG000|Overall Study|Death|5|||
147287455|NCT04287920|531215661|FG000|Overall Study|Lost to Follow-up|1|||
147287456|NCT04287920|531215662|FG001|Overall Study|Lost to Follow-up|1|||
147287457|NCT04287920|531215661|FG000|Overall Study|Withdrawal by Subject|0|||
147287458|NCT04287920|531215662|FG001|Overall Study|Withdrawal by Subject|3|||
147287459|NCT02310750|531215663|FG000|HP Period 1|Lost to Follow-up|0|||
147287460|NCT02310750|531215664|FG001|HP Period 1|Lost to Follow-up|0|||
147287461|NCT02310750|531215665|FG002|HP Period 1|Lost to Follow-up|0|||
147287462|NCT02310750|531215666|FG003|HP Period 1|Lost to Follow-up|0|||
147287463|NCT02310750|531215667|FG004|HP Period 1|Lost to Follow-up|0|||
147287464|NCT02310750|531215668|FG005|HP Period 1|Lost to Follow-up|0|||
147287465|NCT02310750|531215669|FG006|HP Period 1|Lost to Follow-up|1|||
147287466|NCT02310750|531215670|FG007|HP Period 1|Lost to Follow-up|0|||
147287467|NCT02310750|531215671|FG008|HP Period 1|Lost to Follow-up|0|||
147287468|NCT02310750|531215672|FG009|HP Period 1|Lost to Follow-up|0|||
147287469|NCT02310750|531215673|FG010|HP Period 1|Lost to Follow-up|0|||
147287470|NCT02310750|531215674|FG011|HP Period 1|Lost to Follow-up|0|||
147287471|NCT02310750|531215675|FG012|HP Period 1|Lost to Follow-up|0|||
147287472|NCT02310750|531215676|FG013|HP Period 1|Lost to Follow-up|0|||
147287473|NCT02310750|531215677|FG014|HP Period 1|Lost to Follow-up|0|||
147287474|NCT02310750|531215678|FG015|HP Period 1|Lost to Follow-up|0|||
147287475|NCT02310750|531215663|FG000|HP Period 1|Withdrawal by Subject|1|||
147287476|NCT02310750|531215664|FG001|HP Period 1|Withdrawal by Subject|0|||
147287477|NCT02310750|531215665|FG002|HP Period 1|Withdrawal by Subject|0|||
147287478|NCT02310750|531215666|FG003|HP Period 1|Withdrawal by Subject|1|||
147287479|NCT02310750|531215667|FG004|HP Period 1|Withdrawal by Subject|0|||
147287480|NCT02310750|531215668|FG005|HP Period 1|Withdrawal by Subject|0|||
147287481|NCT02310750|531215669|FG006|HP Period 1|Withdrawal by Subject|0|||
147287482|NCT02310750|531215670|FG007|HP Period 1|Withdrawal by Subject|0|||
147287483|NCT02310750|531215671|FG008|HP Period 1|Withdrawal by Subject|0|||
147287484|NCT02310750|531215672|FG009|HP Period 1|Withdrawal by Subject|0|||
147287485|NCT02310750|531215673|FG010|HP Period 1|Withdrawal by Subject|0|||
147287486|NCT02310750|531215674|FG011|HP Period 1|Withdrawal by Subject|0|||
147287487|NCT02310750|531215675|FG012|HP Period 1|Withdrawal by Subject|0|||
147287488|NCT02310750|531215676|FG013|HP Period 1|Withdrawal by Subject|0|||
147287489|NCT02310750|531215677|FG014|HP Period 1|Withdrawal by Subject|0|||
147287490|NCT02310750|531215678|FG015|HP Period 1|Withdrawal by Subject|0|||
147287491|NCT02310750|531215663|FG000|HP Washout 1|Lost to Follow-up|0|||
147287492|NCT02310750|531215664|FG001|HP Washout 1|Lost to Follow-up|0|||
147287493|NCT02310750|531215665|FG002|HP Washout 1|Lost to Follow-up|1|||
147287494|NCT02310750|531215666|FG003|HP Washout 1|Lost to Follow-up|1|||
147287495|NCT02310750|531215667|FG004|HP Washout 1|Lost to Follow-up|2|||
147287496|NCT02310750|531215668|FG005|HP Washout 1|Lost to Follow-up|2|||
147287497|NCT02310750|531215669|FG006|HP Washout 1|Lost to Follow-up|3|||
147287498|NCT02310750|531215670|FG007|HP Washout 1|Lost to Follow-up|0|||
147287499|NCT02310750|531215671|FG008|HP Washout 1|Lost to Follow-up|0|||
147287500|NCT02310750|531215672|FG009|HP Washout 1|Lost to Follow-up|0|||
147287501|NCT02310750|531215673|FG010|HP Washout 1|Lost to Follow-up|0|||
147287502|NCT02310750|531215674|FG011|HP Washout 1|Lost to Follow-up|0|||
147287503|NCT02310750|531215675|FG012|HP Washout 1|Lost to Follow-up|0|||
147287504|NCT02310750|531215676|FG013|HP Washout 1|Lost to Follow-up|0|||
147287505|NCT02310750|531215677|FG014|HP Washout 1|Lost to Follow-up|0|||
147287506|NCT02310750|531215678|FG015|HP Washout 1|Lost to Follow-up|0|||
147287507|NCT02310750|531215663|FG000|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
147287508|NCT02310750|531215664|FG001|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
147287509|NCT02310750|531215665|FG002|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
147287510|NCT02310750|531215666|FG003|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|1|||
147287511|NCT02310750|531215667|FG004|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
147287512|NCT02310750|531215668|FG005|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|2|||
147287513|NCT02310750|531215669|FG006|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
147287514|NCT02310750|531215670|FG007|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
147287515|NCT02310750|531215671|FG008|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|6|||
147287516|NCT02310750|531215672|FG009|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|1|||
147287517|NCT02310750|531215673|FG010|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
147287518|NCT02310750|531215674|FG011|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
147287519|NCT02310750|531215675|FG012|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
147287520|NCT02310750|531215676|FG013|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
147287521|NCT02310750|531215677|FG014|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
147287522|NCT02310750|531215678|FG015|HP MAD, Psoriasis MD, HP Fasted/Fed|Adverse Event|0|||
147287523|NCT02310750|531215663|FG000|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
147287524|NCT02310750|531215664|FG001|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
147287525|NCT02310750|531215665|FG002|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
147287526|NCT02310750|531215666|FG003|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
147287527|NCT02310750|531215667|FG004|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
147287528|NCT02310750|531215668|FG005|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
147287529|NCT02310750|531215669|FG006|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
147287530|NCT02310750|531215670|FG007|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
147287531|NCT02310750|531215671|FG008|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
147287532|NCT02310750|531215672|FG009|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|1|||
147287533|NCT02310750|531215673|FG010|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
147287534|NCT02310750|531215674|FG011|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
147287535|NCT02310750|531215675|FG012|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
147287536|NCT02310750|531215676|FG013|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
147287537|NCT02310750|531215677|FG014|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
147287538|NCT02310750|531215678|FG015|HP MAD, Psoriasis MD, HP Fasted/Fed|Non-Compliance|0|||
147287539|NCT02310750|531215663|FG000|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
147287540|NCT02310750|531215664|FG001|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
147287541|NCT02310750|531215665|FG002|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
147287542|NCT02310750|531215666|FG003|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
147287543|NCT02310750|531215667|FG004|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
147287544|NCT02310750|531215668|FG005|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
147287545|NCT02310750|531215669|FG006|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
147287546|NCT02310750|531215670|FG007|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|1|||
147287547|NCT02310750|531215671|FG008|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|1|||
147287548|NCT02310750|531215672|FG009|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|1|||
147287549|NCT02310750|531215673|FG010|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
147287550|NCT02310750|531215674|FG011|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
147287551|NCT02310750|531215675|FG012|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
147287552|NCT02310750|531215676|FG013|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
147287553|NCT02310750|531215677|FG014|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
147287554|NCT02310750|531215678|FG015|HP MAD, Psoriasis MD, HP Fasted/Fed|Withdrawal by Subject|0|||
147287555|NCT02310750|531215663|FG000|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
147287556|NCT02310750|531215664|FG001|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
147287557|NCT02310750|531215665|FG002|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
147287558|NCT02310750|531215666|FG003|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
147287559|NCT02310750|531215667|FG004|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
147287560|NCT02310750|531215668|FG005|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
147287561|NCT02310750|531215669|FG006|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
147287562|NCT02310750|531215670|FG007|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|1|||
147287563|NCT02310750|531215671|FG008|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|1|||
147287564|NCT02310750|531215672|FG009|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
147287565|NCT02310750|531215673|FG010|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
147287566|NCT02310750|531215674|FG011|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
147287567|NCT02310750|531215675|FG012|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
147287568|NCT02310750|531215676|FG013|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
147287569|NCT02310750|531215677|FG014|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
147287570|NCT02310750|531215678|FG015|HP MAD, Psoriasis MD, HP Fasted/Fed|Lost to Follow-up|0|||
147287571|NCT02310750|531215663|FG000|HP Washout 2|Lost to Follow-up|0|||
147287572|NCT02310750|531215664|FG001|HP Washout 2|Lost to Follow-up|0|||
147287573|NCT02310750|531215665|FG002|HP Washout 2|Lost to Follow-up|0|||
147287574|NCT02310750|531215666|FG003|HP Washout 2|Lost to Follow-up|0|||
147287575|NCT02310750|531215667|FG004|HP Washout 2|Lost to Follow-up|1|||
147287576|NCT02310750|531215668|FG005|HP Washout 2|Lost to Follow-up|0|||
147287577|NCT02310750|531215669|FG006|HP Washout 2|Lost to Follow-up|7|||
147287578|NCT02310750|531215670|FG007|HP Washout 2|Lost to Follow-up|0|||
147287579|NCT02310750|531215671|FG008|HP Washout 2|Lost to Follow-up|0|||
147337675|NCT02755805|531402898|FG001|Overall Study|Withdrawal by Subject|2|||
147337676|NCT02593149|531402899|FG000|Run-In|Didn't use CVC for at least 21 days|36|||
147337677|NCT02593149|531402900|FG001|Run-In|Didn't use CVC for at least 21 days|38|||
147337678|NCT02593149|531402899|FG000|Intervention|Didn't use CVC for at least 21 day|116|||
147337679|NCT02593149|531402900|FG001|Intervention|Didn't use CVC for at least 21 day|115|||
147337680|NCT01140048|531402901|FG000|Overall Study|Physician Decision|1|||
147337681|NCT01140048|531402901|FG000|Overall Study|Withdrawal by Subject|13|||
147337682|NCT01140048|531402901|FG000|Overall Study|Lost to Follow-up|31|||
147337683|NCT03520413|531402902|FG000|Overall Study|Lost to Follow-up|1|||
147337684|NCT03520413|531402903|FG001|Overall Study|Lost to Follow-up|1|||
147337685|NCT03520413|531402902|FG000|Overall Study|Withdrawal by Subject|1|||
147287580|NCT02310750|531215672|FG009|HP Washout 2|Lost to Follow-up|0|||
147337686|NCT03520413|531402903|FG001|Overall Study|Withdrawal by Subject|2|||
147287581|NCT02310750|531215673|FG010|HP Washout 2|Lost to Follow-up|0|||
147287582|NCT02310750|531215674|FG011|HP Washout 2|Lost to Follow-up|0|||
147287583|NCT02310750|531215675|FG012|HP Washout 2|Lost to Follow-up|0|||
147337687|NCT03520413|531402902|FG000|Overall Study|Death|0|||
147337688|NCT03520413|531402903|FG001|Overall Study|Death|1|||
147337689|NCT03520413|531402902|FG000|Overall Study|Physician Decision|3|||
147287584|NCT02310750|531215676|FG013|HP Washout 2|Lost to Follow-up|0|||
147287585|NCT02310750|531215677|FG014|HP Washout 2|Lost to Follow-up|0|||
147287586|NCT02310750|531215678|FG015|HP Washout 2|Lost to Follow-up|0|||
147287587|NCT01934218|531215682|FG000|Double-blind Phase|Adverse Event|8|||
147287588|NCT01934218|531215683|FG001|Double-blind Phase|Adverse Event|8|||
147287589|NCT01934218|531215682|FG000|Double-blind Phase|Lack of Efficacy|6|||
147287590|NCT01934218|531215683|FG001|Double-blind Phase|Lack of Efficacy|7|||
147287591|NCT01934218|531215682|FG000|Double-blind Phase|Lost to Follow-up|7|||
147287592|NCT01934218|531215683|FG001|Double-blind Phase|Lost to Follow-up|14|||
147287593|NCT01934218|531215682|FG000|Double-blind Phase|Physician Decision|1|||
147287594|NCT01934218|531215683|FG001|Double-blind Phase|Physician Decision|2|||
147287595|NCT01934218|531215682|FG000|Double-blind Phase|Protocol Violation|4|||
147287596|NCT01934218|531215683|FG001|Double-blind Phase|Protocol Violation|0|||
147287597|NCT01934218|531215682|FG000|Double-blind Phase|Withdrawal by Subject|16|||
147287598|NCT01934218|531215683|FG001|Double-blind Phase|Withdrawal by Subject|13|||
147287599|NCT01934218|531215682|FG000|Double-blind Phase|Noncompliance with Study Protocol|5|||
147287600|NCT01934218|531215683|FG001|Double-blind Phase|Noncompliance with Study Protocol|8|||
147287601|NCT01934218|531215682|FG000|Double-blind Phase|Protocol Violation of Study Eligibility|1|||
147287602|NCT01934218|531215683|FG001|Double-blind Phase|Protocol Violation of Study Eligibility|2|||
147287603|NCT01934218|531215682|FG000|Open-Label Phase|Adverse Event|2|||
147287604|NCT01934218|531215683|FG001|Open-Label Phase|Adverse Event|4|||
147287605|NCT01934218|531215682|FG000|Open-Label Phase|Lack of Efficacy|1|||
147287606|NCT01934218|531215683|FG001|Open-Label Phase|Lack of Efficacy|4|||
147287607|NCT01934218|531215682|FG000|Open-Label Phase|Lost to Follow-up|4|||
147287608|NCT01934218|531215683|FG001|Open-Label Phase|Lost to Follow-up|2|||
147287609|NCT01934218|531215682|FG000|Open-Label Phase|Physician Decision|1|||
147287610|NCT01934218|531215683|FG001|Open-Label Phase|Physician Decision|0|||
147287611|NCT01934218|531215682|FG000|Open-Label Phase|Protocol Violation|1|||
147287612|NCT01934218|531215683|FG001|Open-Label Phase|Protocol Violation|0|||
147287613|NCT01934218|531215682|FG000|Open-Label Phase|Withdrawal by Subject|13|||
147287614|NCT01934218|531215683|FG001|Open-Label Phase|Withdrawal by Subject|11|||
147287615|NCT01934218|531215682|FG000|Open-Label Phase|Noncompliance with Study Protocol|4|||
147287616|NCT01934218|531215683|FG001|Open-Label Phase|Noncompliance with Study Protocol|2|||
147287617|NCT01934218|531215682|FG000|Open-Label Phase|Failure to Exam Primary Evaluation|0|||
147287618|NCT01934218|531215683|FG001|Open-Label Phase|Failure to Exam Primary Evaluation|1|||
147287619|NCT03538626|531215684|FG000|Overall Study|Withdrawal by Subject|0|||
147287620|NCT03538626|531215685|FG001|Overall Study|Withdrawal by Subject|1|||
147287621|NCT03538626|531215686|FG002|Overall Study|Withdrawal by Subject|0|||
147287622|NCT03538626|531215687|FG003|Overall Study|Withdrawal by Subject|0|||
147287623|NCT03538626|531215688|FG004|Overall Study|Withdrawal by Subject|0|||
147287624|NCT03538626|531215689|FG005|Overall Study|Withdrawal by Subject|0|||
147287625|NCT03538626|531215690|FG006|Overall Study|Withdrawal by Subject|0|||
147287626|NCT03538626|531215691|FG007|Overall Study|Withdrawal by Subject|0|||
147287627|NCT03538626|531215684|FG000|Overall Study|Lost to Follow-up|0|||
147287628|NCT03538626|531215685|FG001|Overall Study|Lost to Follow-up|0|||
147287629|NCT03538626|531215686|FG002|Overall Study|Lost to Follow-up|0|||
147287630|NCT03538626|531215687|FG003|Overall Study|Lost to Follow-up|0|||
147287631|NCT03538626|531215688|FG004|Overall Study|Lost to Follow-up|0|||
147287632|NCT03538626|531215689|FG005|Overall Study|Lost to Follow-up|0|||
147287633|NCT03538626|531215690|FG006|Overall Study|Lost to Follow-up|1|||
147287634|NCT03538626|531215691|FG007|Overall Study|Lost to Follow-up|0|||
147287635|NCT02911948|531215693|FG000|Overall Study|Protocol Violation|0|||
147287636|NCT02911948|531215694|FG001|Overall Study|Protocol Violation|1|||
147287637|NCT02911948|531215693|FG000|Overall Study|Withdrawal by Subject|0|||
147287638|NCT02911948|531215694|FG001|Overall Study|Withdrawal by Subject|2|||
147287639|NCT02911948|531215693|FG000|Overall Study|Lack of Efficacy|0|||
147287640|NCT02911948|531215694|FG001|Overall Study|Lack of Efficacy|1|||
147287641|NCT02911948|531215693|FG000|Overall Study|Unclassified|0|||
147287642|NCT02911948|531215694|FG001|Overall Study|Unclassified|3|||
147287643|NCT03021187|531215695|FG000|Overall Study|Death|0|||
147287644|NCT03021187|531215696|FG001|Overall Study|Death|0|||
147287645|NCT03021187|531215697|FG002|Overall Study|Death|3|||
147287646|NCT03021187|531215698|FG003|Overall Study|Death|0|||
147287647|NCT03021187|531215695|FG000|Overall Study|Withdrawal by Subject|0|||
147287648|NCT03021187|531215696|FG001|Overall Study|Withdrawal by Subject|6|||
147287649|NCT03021187|531215697|FG002|Overall Study|Withdrawal by Subject|2|||
147287650|NCT03021187|531215698|FG003|Overall Study|Withdrawal by Subject|5|||
147287651|NCT03021187|531215695|FG000|Overall Study|Lost to Follow-up|10|||
147287652|NCT03021187|531215696|FG001|Overall Study|Lost to Follow-up|3|||
147287653|NCT03021187|531215697|FG002|Overall Study|Lost to Follow-up|1|||
147287654|NCT03021187|531215698|FG003|Overall Study|Lost to Follow-up|4|||
147287655|NCT00718718|531215699|FG000|Prior to Week 12|Adverse Event|0|||
147287656|NCT00718718|531215700|FG001|Prior to Week 12|Adverse Event|0|||
147287657|NCT00718718|531215701|FG002|Prior to Week 12|Adverse Event|0|||
147287658|NCT00718718|531215702|FG003|Prior to Week 12|Adverse Event|0|||
147287659|NCT00718718|531215703|FG004|Prior to Week 12|Adverse Event|0|||
147287660|NCT00718718|531215704|FG005|Prior to Week 12|Adverse Event|0|||
147287661|NCT00718718|531215705|FG006|Prior to Week 12|Adverse Event|0|||
147287662|NCT00718718|531215706|FG007|Prior to Week 12|Adverse Event|1|||
147287663|NCT00718718|531215707|FG008|Prior to Week 12|Adverse Event|1|||
147287664|NCT00718718|531215708|FG009|Prior to Week 12|Adverse Event|0|||
147287665|NCT00718718|531215699|FG000|Prior to Week 12|Withdrawal by Subject|0|||
147287666|NCT00718718|531215700|FG001|Prior to Week 12|Withdrawal by Subject|0|||
147287667|NCT00718718|531215701|FG002|Prior to Week 12|Withdrawal by Subject|0|||
147287668|NCT00718718|531215702|FG003|Prior to Week 12|Withdrawal by Subject|0|||
147287669|NCT00718718|531215703|FG004|Prior to Week 12|Withdrawal by Subject|3|||
147287670|NCT00718718|531215704|FG005|Prior to Week 12|Withdrawal by Subject|0|||
147287671|NCT00718718|531215705|FG006|Prior to Week 12|Withdrawal by Subject|1|||
147287672|NCT00718718|531215706|FG007|Prior to Week 12|Withdrawal by Subject|1|||
147287673|NCT00718718|531215707|FG008|Prior to Week 12|Withdrawal by Subject|1|||
147287674|NCT00718718|531215708|FG009|Prior to Week 12|Withdrawal by Subject|0|||
147287675|NCT00718718|531215699|FG000|Prior to Week 12|Other|1|||
147287676|NCT00718718|531215700|FG001|Prior to Week 12|Other|0|||
147287677|NCT00718718|531215701|FG002|Prior to Week 12|Other|1|||
147287678|NCT00718718|531215702|FG003|Prior to Week 12|Other|0|||
147287679|NCT00718718|531215703|FG004|Prior to Week 12|Other|0|||
147287680|NCT00718718|531215704|FG005|Prior to Week 12|Other|0|||
147287681|NCT00718718|531215705|FG006|Prior to Week 12|Other|0|||
147287682|NCT00718718|531215706|FG007|Prior to Week 12|Other|0|||
147287683|NCT00718718|531215707|FG008|Prior to Week 12|Other|0|||
147287684|NCT00718718|531215708|FG009|Prior to Week 12|Other|0|||
147287685|NCT00718718|531215699|FG000|Week 12 to End of Study|Adverse Event|0|||
147287686|NCT00718718|531215700|FG001|Week 12 to End of Study|Adverse Event|0|||
147287687|NCT00718718|531215701|FG002|Week 12 to End of Study|Adverse Event|0|||
147287688|NCT00718718|531215702|FG003|Week 12 to End of Study|Adverse Event|0|||
147287689|NCT00718718|531215703|FG004|Week 12 to End of Study|Adverse Event|0|||
147287690|NCT00718718|531215704|FG005|Week 12 to End of Study|Adverse Event|0|||
147287691|NCT00718718|531215705|FG006|Week 12 to End of Study|Adverse Event|0|||
147287692|NCT00718718|531215706|FG007|Week 12 to End of Study|Adverse Event|1|||
147287693|NCT00718718|531215707|FG008|Week 12 to End of Study|Adverse Event|0|||
147287694|NCT00718718|531215708|FG009|Week 12 to End of Study|Adverse Event|0|||
147287695|NCT00718718|531215699|FG000|Week 12 to End of Study|Death|0|||
147287696|NCT00718718|531215700|FG001|Week 12 to End of Study|Death|0|||
147287697|NCT00718718|531215701|FG002|Week 12 to End of Study|Death|0|||
147287698|NCT00718718|531215702|FG003|Week 12 to End of Study|Death|0|||
147287699|NCT00718718|531215703|FG004|Week 12 to End of Study|Death|0|||
147287700|NCT00718718|531215704|FG005|Week 12 to End of Study|Death|1|||
147287701|NCT00718718|531215705|FG006|Week 12 to End of Study|Death|0|||
147287702|NCT00718718|531215706|FG007|Week 12 to End of Study|Death|0|||
147287703|NCT00718718|531215707|FG008|Week 12 to End of Study|Death|0|||
147287704|NCT00718718|531215708|FG009|Week 12 to End of Study|Death|0|||
147287705|NCT00718718|531215699|FG000|Week 12 to End of Study|Withdrawal by Subject|0|||
147287706|NCT00718718|531215700|FG001|Week 12 to End of Study|Withdrawal by Subject|0|||
147287707|NCT00718718|531215701|FG002|Week 12 to End of Study|Withdrawal by Subject|0|||
147287708|NCT00718718|531215702|FG003|Week 12 to End of Study|Withdrawal by Subject|0|||
147287709|NCT00718718|531215703|FG004|Week 12 to End of Study|Withdrawal by Subject|0|||
147287710|NCT00718718|531215704|FG005|Week 12 to End of Study|Withdrawal by Subject|2|||
147287711|NCT00718718|531215705|FG006|Week 12 to End of Study|Withdrawal by Subject|1|||
147287712|NCT00718718|531215706|FG007|Week 12 to End of Study|Withdrawal by Subject|0|||
147287713|NCT00718718|531215707|FG008|Week 12 to End of Study|Withdrawal by Subject|0|||
147287714|NCT00718718|531215708|FG009|Week 12 to End of Study|Withdrawal by Subject|0|||
147287715|NCT00718718|531215699|FG000|Week 12 to End of Study|Lost to Follow-up|0|||
147287716|NCT00718718|531215700|FG001|Week 12 to End of Study|Lost to Follow-up|0|||
147287717|NCT00718718|531215701|FG002|Week 12 to End of Study|Lost to Follow-up|0|||
147287718|NCT00718718|531215702|FG003|Week 12 to End of Study|Lost to Follow-up|0|||
147287719|NCT00718718|531215703|FG004|Week 12 to End of Study|Lost to Follow-up|0|||
147287720|NCT00718718|531215704|FG005|Week 12 to End of Study|Lost to Follow-up|0|||
147287721|NCT00718718|531215705|FG006|Week 12 to End of Study|Lost to Follow-up|0|||
147287722|NCT00718718|531215706|FG007|Week 12 to End of Study|Lost to Follow-up|0|||
147287723|NCT00718718|531215707|FG008|Week 12 to End of Study|Lost to Follow-up|1|||
147287724|NCT00718718|531215708|FG009|Week 12 to End of Study|Lost to Follow-up|0|||
147287725|NCT00718718|531215699|FG000|Week 12 to End of Study|Other|0|||
147287726|NCT00718718|531215700|FG001|Week 12 to End of Study|Other|1|||
147287727|NCT00718718|531215701|FG002|Week 12 to End of Study|Other|0|||
147287728|NCT00718718|531215702|FG003|Week 12 to End of Study|Other|1|||
147287729|NCT00718718|531215703|FG004|Week 12 to End of Study|Other|0|||
147287730|NCT00718718|531215704|FG005|Week 12 to End of Study|Other|0|||
147287731|NCT00718718|531215705|FG006|Week 12 to End of Study|Other|1|||
147287732|NCT00718718|531215706|FG007|Week 12 to End of Study|Other|0|||
147287733|NCT00718718|531215707|FG008|Week 12 to End of Study|Other|0|||
147287734|NCT00718718|531215708|FG009|Week 12 to End of Study|Other|0|||
147287735|NCT03394924|531215711|FG000|Overall Study|Adverse Event|0|||
147287736|NCT03394924|531215712|FG001|Overall Study|Adverse Event|5|||
147287737|NCT03394924|531215713|FG002|Overall Study|Adverse Event|0|||
147287738|NCT03394924|531215711|FG000|Overall Study|Withdrawal by Subject|2|||
147337690|NCT03520413|531402903|FG001|Overall Study|Physician Decision|3|||
147337691|NCT03520413|531402902|FG000|Overall Study|Completed a study interview but did not obtain HbA1c data|19|||
147337692|NCT03520413|531402903|FG001|Overall Study|Completed a study interview but did not obtain HbA1c data|19|||
147337693|NCT04054635|531402904|FG000|Second Visit (First Follow-up)|Lost to Follow-up|0|||
147287739|NCT03394924|531215712|FG001|Overall Study|Withdrawal by Subject|0|||
147287740|NCT03394924|531215713|FG002|Overall Study|Withdrawal by Subject|0|||
147287741|NCT03394924|531215711|FG000|Overall Study|Lost to Follow-up|0|||
147287742|NCT03394924|531215712|FG001|Overall Study|Lost to Follow-up|1|||
147287743|NCT03394924|531215713|FG002|Overall Study|Lost to Follow-up|0|||
147287744|NCT03394924|531215711|FG000|Overall Study|Did not meet all inclusion criteria|1|||
147287745|NCT03394924|531215712|FG001|Overall Study|Did not meet all inclusion criteria|0|||
147287746|NCT03394924|531215713|FG002|Overall Study|Did not meet all inclusion criteria|0|||
147287747|NCT02276482|531215714|FG000|Overall Study|Adverse Event|1|||
147287748|NCT02276482|531215715|FG001|Overall Study|Adverse Event|0|||
147287749|NCT02276482|531215714|FG000|Overall Study|Withdrawal by Subject|1|||
147287750|NCT02276482|531215715|FG001|Overall Study|Withdrawal by Subject|0|||
147287751|NCT02276482|531215714|FG000|Overall Study|Gram-negative infection|1|||
147287752|NCT02276482|531215715|FG001|Overall Study|Gram-negative infection|0|||
147287753|NCT02276482|531215714|FG000|Overall Study|Reason not specified|0|||
147287754|NCT02276482|531215715|FG001|Overall Study|Reason not specified|1|||
147287755|NCT03277313|531215716|FG000|Epoch 1 (Six-week Ramp-up Period)|Adverse Event|1|||
147287756|NCT03277313|531215717|FG001|Epoch 1 (Six-week Ramp-up Period)|Adverse Event|0|||
147287757|NCT03277313|531215716|FG000|Epoch 2 (36 Months After Epoch 1)|Adverse Event|0|||
147287758|NCT03277313|531215717|FG001|Epoch 2 (36 Months After Epoch 1)|Adverse Event|1|||
147287759|NCT03277313|531215716|FG000|Epoch 2 (36 Months After Epoch 1)|Physician Decision|0|||
147287760|NCT03277313|531215717|FG001|Epoch 2 (36 Months After Epoch 1)|Physician Decision|1|||
147287761|NCT03277313|531215716|FG000|Epoch 2 (36 Months After Epoch 1)|Withdrawal by Subject|0|||
147287762|NCT03277313|531215717|FG001|Epoch 2 (36 Months After Epoch 1)|Withdrawal by Subject|6|||
147287763|NCT03277313|531215716|FG000|Epoch 2 (36 Months After Epoch 1)|Reason not Specified|0|||
147287764|NCT03277313|531215717|FG001|Epoch 2 (36 Months After Epoch 1)|Reason not Specified|1|||
147287765|NCT02005471|531215720|FG000|Main Study|Adverse Event|0|||
147287766|NCT02005471|531215721|FG001|Main Study|Adverse Event|1|||
147287767|NCT02005471|531215722|FG002|Main Study|Adverse Event|0|||
147287768|NCT02005471|531215723|FG003|Main Study|Adverse Event|0|||
147287769|NCT02005471|531215720|FG000|Main Study|Death|83|||
147287770|NCT02005471|531215721|FG001|Main Study|Death|52|||
147287771|NCT02005471|531215722|FG002|Main Study|Death|0|||
147287772|NCT02005471|531215723|FG003|Main Study|Death|0|||
147287773|NCT02005471|531215720|FG000|Main Study|Lost to Follow-up|4|||
147287774|NCT02005471|531215721|FG001|Main Study|Lost to Follow-up|5|||
147287775|NCT02005471|531215722|FG002|Main Study|Lost to Follow-up|0|||
147287776|NCT02005471|531215723|FG003|Main Study|Lost to Follow-up|0|||
147287777|NCT02005471|531215720|FG000|Main Study|Physician Decision|3|||
147287778|NCT02005471|531215721|FG001|Main Study|Physician Decision|1|||
147287779|NCT02005471|531215722|FG002|Main Study|Physician Decision|0|||
147287780|NCT02005471|531215723|FG003|Main Study|Physician Decision|0|||
147287781|NCT02005471|531215720|FG000|Main Study|Withdrawal by Subject|26|||
147287782|NCT02005471|531215721|FG001|Main Study|Withdrawal by Subject|11|||
147287783|NCT02005471|531215722|FG002|Main Study|Withdrawal by Subject|0|||
147337694|NCT04054635|531402905|FG001|Second Visit (First Follow-up)|Lost to Follow-up|1|||
147337695|NCT04054635|531402906|FG002|Second Visit (First Follow-up)|Lost to Follow-up|0|||
147287784|NCT02005471|531215723|FG003|Main Study|Withdrawal by Subject|0|||
147287785|NCT02005471|531215720|FG000|Main Study|Reason not Specified|0|||
147287786|NCT02005471|531215721|FG001|Main Study|Reason not Specified|6|||
147287787|NCT02005471|531215722|FG002|Main Study|Reason not Specified|0|||
147287788|NCT02005471|531215723|FG003|Main Study|Reason not Specified|0|||
147287789|NCT02005471|531215720|FG000|Main Study|Randomized but not Dosed|8|||
147287790|NCT02005471|531215721|FG001|Main Study|Randomized but not Dosed|0|||
147287791|NCT02005471|531215722|FG002|Main Study|Randomized but not Dosed|0|||
147287792|NCT02005471|531215723|FG003|Main Study|Randomized but not Dosed|0|||
147287793|NCT02005471|531215720|FG000|Re-Treatment/Crossover (R/C) Substudy|Withdrawal by Subject|0|||
147287794|NCT02005471|531215721|FG001|Re-Treatment/Crossover (R/C) Substudy|Withdrawal by Subject|0|||
147287795|NCT02005471|531215722|FG002|Re-Treatment/Crossover (R/C) Substudy|Withdrawal by Subject|0|||
147287796|NCT02005471|531215723|FG003|Re-Treatment/Crossover (R/C) Substudy|Withdrawal by Subject|1|||
147287797|NCT02005471|531215720|FG000|Re-Treatment/Crossover (R/C) Substudy|Lost to Follow-up|0|||
147287798|NCT02005471|531215721|FG001|Re-Treatment/Crossover (R/C) Substudy|Lost to Follow-up|0|||
147287799|NCT02005471|531215722|FG002|Re-Treatment/Crossover (R/C) Substudy|Lost to Follow-up|1|||
147287800|NCT02005471|531215723|FG003|Re-Treatment/Crossover (R/C) Substudy|Lost to Follow-up|1|||
147287801|NCT02005471|531215720|FG000|Re-Treatment/Crossover (R/C) Substudy|Death|0|||
147287802|NCT02005471|531215721|FG001|Re-Treatment/Crossover (R/C) Substudy|Death|0|||
147337696|NCT04054635|531402904|FG000|Third Visit (Second Follow-up)|Lost to Follow-up|1|||
147287803|NCT02005471|531215722|FG002|Re-Treatment/Crossover (R/C) Substudy|Death|1|||
147287804|NCT02005471|531215723|FG003|Re-Treatment/Crossover (R/C) Substudy|Death|8|||
147287805|NCT00627705|531215725|FG000|Overall Study|Unwilling to take the compound (taste)|1|||
147287806|NCT00627705|531215726|FG001|Overall Study|Unwilling to take the compound (taste)|3|||
147287807|NCT00627705|531215725|FG000|Overall Study|Adverse Event|1|||
147287808|NCT00627705|531215726|FG001|Overall Study|Adverse Event|0|||
147287809|NCT00627705|531215725|FG000|Overall Study|Withdrawal by Subject|0|||
147287810|NCT00627705|531215726|FG001|Overall Study|Withdrawal by Subject|2|||
147287811|NCT00627705|531215725|FG000|Overall Study|Lost to Follow-up|0|||
147287812|NCT00627705|531215726|FG001|Overall Study|Lost to Follow-up|1|||
147287813|NCT00253864|531215729|FG000|Overall Study|Lost to Follow-up|5|||
147287814|NCT00253864|531215730|FG001|Overall Study|Lost to Follow-up|8|||
147287815|NCT00360529|531215734|FG000|Overall Study|Adverse Event|10|||
147287816|NCT00360529|531215735|FG001|Overall Study|Adverse Event|23|||
147287817|NCT00360529|531215736|FG002|Overall Study|Adverse Event|33|||
147287818|NCT00360529|531215734|FG000|Overall Study|Protocol Violation|3|||
147287819|NCT00360529|531215735|FG001|Overall Study|Protocol Violation|3|||
147287820|NCT00360529|531215736|FG002|Overall Study|Protocol Violation|11|||
147287821|NCT00360529|531215734|FG000|Overall Study|Lost to Follow-up|14|||
147287822|NCT00360529|531215735|FG001|Overall Study|Lost to Follow-up|10|||
147287823|NCT00360529|531215736|FG002|Overall Study|Lost to Follow-up|13|||
147287824|NCT00360529|531215734|FG000|Overall Study|Withdrawal by Subject|22|||
147287825|NCT00360529|531215735|FG001|Overall Study|Withdrawal by Subject|14|||
147287826|NCT00360529|531215736|FG002|Overall Study|Withdrawal by Subject|18|||
147287827|NCT00360529|531215734|FG000|Overall Study|Lack of Efficacy|8|||
147287828|NCT00360529|531215735|FG001|Overall Study|Lack of Efficacy|6|||
147287829|NCT00360529|531215736|FG002|Overall Study|Lack of Efficacy|5|||
147287830|NCT00360529|531215734|FG000|Overall Study|Reason discontinued not explained above|4|||
147287831|NCT00360529|531215735|FG001|Overall Study|Reason discontinued not explained above|9|||
147287832|NCT00360529|531215736|FG002|Overall Study|Reason discontinued not explained above|11|||
147287833|NCT00791765|531217309|FG000|Weeks 1 to 12|Adverse Event|0|||
147287834|NCT00791765|531217310|FG001|Weeks 1 to 12|Adverse Event|1|||
147287835|NCT00791765|531217309|FG000|Weeks 1 to 12|Lost to Follow-up|1|||
147287836|NCT00791765|531217310|FG001|Weeks 1 to 12|Lost to Follow-up|0|||
147287837|NCT00791765|531217309|FG000|Weeks 1 to 12|Withdrawal by Subject|3|||
147287838|NCT00791765|531217310|FG001|Weeks 1 to 12|Withdrawal by Subject|0|||
147287839|NCT00791765|531217309|FG000|Weeks 1 to 12|Physician Decision|1|||
147287840|NCT00791765|531217310|FG001|Weeks 1 to 12|Physician Decision|0|||
147287841|NCT00791765|531217309|FG000|Weeks 1 to 12|Disease progression|3|||
147287842|NCT00791765|531217310|FG001|Weeks 1 to 12|Disease progression|0|||
147287843|NCT00791765|531217309|FG000|Weeks 1 to 12|Ineligibility determined|0|||
147287844|NCT00791765|531217310|FG001|Weeks 1 to 12|Ineligibility determined|3|||
147287845|NCT00791765|531217309|FG000|Weeks 13 to 24|Protocol deviation|2|||
147287846|NCT00791765|531217310|FG001|Weeks 13 to 24|Protocol deviation|0|||
147287847|NCT00791765|531217309|FG000|Weeks 13 to 24|Adverse Event|0|||
147287848|NCT00791765|531217310|FG001|Weeks 13 to 24|Adverse Event|3|||
147287849|NCT00791765|531217309|FG000|Weeks 13 to 24|Withdrawal by Subject|2|||
147287850|NCT00791765|531217310|FG001|Weeks 13 to 24|Withdrawal by Subject|1|||
147287851|NCT00791765|531217309|FG000|Weeks 13 to 24|Disease progression|0|||
147287852|NCT00791765|531217310|FG001|Weeks 13 to 24|Disease progression|1|||
147287853|NCT00791765|531217309|FG000|Weeks 13 to 24|Lost to Follow-up|1|||
147287854|NCT00791765|531217310|FG001|Weeks 13 to 24|Lost to Follow-up|2|||
147287855|NCT00791765|531217309|FG000|Weeks 13 to 24|Other|0|||
147287856|NCT00791765|531217310|FG001|Weeks 13 to 24|Other|1|||
147287857|NCT00924287|531217312|FG000|Overall Study|Death|1|||
147287858|NCT01625897|531217319|FG000|Overall Study|Adverse Event|27|||
147287859|NCT01625897|531217320|FG001|Overall Study|Adverse Event|10|||
147287860|NCT01625897|531217319|FG000|Overall Study|Physician Decision|0|||
147287861|NCT01625897|531217320|FG001|Overall Study|Physician Decision|1|||
147287862|NCT01625897|531217319|FG000|Overall Study|Withdrawal by Subject|25|||
147287863|NCT01625897|531217320|FG001|Overall Study|Withdrawal by Subject|3|||
147287864|NCT00156065|531217321|FG000|Overall Study|Enrolled But Never Received Treatment|1|||
147287865|NCT00156065|531217322|FG001|Overall Study|Enrolled But Never Received Treatment|1|||
147287866|NCT00156065|531217323|FG002|Overall Study|Enrolled But Never Received Treatment|0|||
147287867|NCT00156065|531217321|FG000|Overall Study|Adverse Event|8|||
147287868|NCT00156065|531217322|FG001|Overall Study|Adverse Event|11|||
147287869|NCT00156065|531217323|FG002|Overall Study|Adverse Event|4|||
147604277|NCT00229723|532367856|FG004|Maintenance Phase|Severe non-compliance|1|||
147604278|NCT00229723|532367857|FG005|Maintenance Phase|Severe non-compliance|0|||
147604279|NCT00229723|532367858|FG006|Maintenance Phase|Severe non-compliance|0|||
147604280|NCT00229723|532367852|FG000|Maintenance Phase|Other|5|||
147287870|NCT00156065|531217321|FG000|Overall Study|Lack of Efficacy|2|||
147287871|NCT00156065|531217322|FG001|Overall Study|Lack of Efficacy|9|||
147287872|NCT00156065|531217323|FG002|Overall Study|Lack of Efficacy|3|||
147287873|NCT00156065|531217321|FG000|Overall Study|Withdrawal by Subject|13|||
147287874|NCT00156065|531217322|FG001|Overall Study|Withdrawal by Subject|26|||
147287875|NCT00156065|531217323|FG002|Overall Study|Withdrawal by Subject|16|||
147604281|NCT00229723|532367853|FG001|Maintenance Phase|Other|4|||
147604282|NCT00229723|532367854|FG002|Maintenance Phase|Other|1|||
147287876|NCT00156065|531217321|FG000|Overall Study|Lost to Follow-up|5|||
147287877|NCT00156065|531217322|FG001|Overall Study|Lost to Follow-up|7|||
147287878|NCT00156065|531217323|FG002|Overall Study|Lost to Follow-up|1|||
147287879|NCT00156065|531217321|FG000|Overall Study|Other|2|||
147287880|NCT00156065|531217322|FG001|Overall Study|Other|9|||
147287881|NCT00156065|531217323|FG002|Overall Study|Other|3|||
147287882|NCT01432366|531217324|FG000|Overall Study|Non-Responder|7|||
147287883|NCT01432366|531217324|FG000|Overall Study|Adverse Event|8|||
147287884|NCT01432366|531217324|FG000|Overall Study|Withdrawal Due to Non-Compliance|3|||
147287885|NCT01432366|531217324|FG000|Overall Study|Pregnancy|1|||
147287886|NCT01432366|531217324|FG000|Overall Study|Lost to Follow-up|13|||
147287887|NCT01432366|531217324|FG000|Overall Study|Lack of Efficacy|1|||
147287888|NCT01432366|531217324|FG000|Overall Study|Site Closed|20|||
147287889|NCT01432366|531217324|FG000|Overall Study|Investigator Forget to Complete Visits|1|||
147287890|NCT01432366|531217324|FG000|Overall Study|Other|14|||
147287891|NCT02891187|531217325|FG000|Overall Study|Lost to Follow-up|1|||
147287892|NCT02891187|531217326|FG001|Overall Study|Lost to Follow-up|2|||
147287893|NCT04546581|531217327|FG000|Overall Study|Adverse Event|9|||
147287894|NCT04546581|531217328|FG001|Overall Study|Adverse Event|3|||
147287895|NCT04546581|531217327|FG000|Overall Study|Physician Decision|0|||
147287896|NCT04546581|531217328|FG001|Overall Study|Physician Decision|1|||
147287897|NCT04546581|531217327|FG000|Overall Study|Protocol Violation|1|||
147287898|NCT04546581|531217328|FG001|Overall Study|Protocol Violation|2|||
147287899|NCT04546581|531217327|FG000|Overall Study|Withdrawal by Subject|3|||
147287900|NCT04546581|531217328|FG001|Overall Study|Withdrawal by Subject|7|||
147287901|NCT01275625|531217329|FG000|Overall Study|Death|1|||
147287902|NCT01275625|531217329|FG000|Overall Study|Lack of Efficacy|2|||
147287903|NCT01275625|531217329|FG000|Overall Study|Lost to Follow-up|1|||
147287904|NCT01275625|531217329|FG000|Overall Study|Withdrawal by Subject|3|||
147287905|NCT01275625|531217329|FG000|Overall Study|Protocol Violation|1|||
147287906|NCT01275625|531217329|FG000|Overall Study|Adverse Event|4|||
147287907|NCT01275625|531217329|FG000|Overall Study|Other|1|||
147287908|NCT04579757|531217332|FG000|Overall Study|Adverse Event|0|||
147287909|NCT04579757|531217333|FG001|Overall Study|Adverse Event|0|||
147287910|NCT04579757|531217334|FG002|Overall Study|Adverse Event|0|||
147287911|NCT04579757|531217335|FG003|Overall Study|Adverse Event|2|||
147287912|NCT04579757|531217336|FG004|Overall Study|Adverse Event|1|||
147287913|NCT04579757|531217337|FG005|Overall Study|Adverse Event|1|||
147287914|NCT04579757|531217338|FG006|Overall Study|Adverse Event|0|||
147287915|NCT04579757|531217339|FG007|Overall Study|Adverse Event|0|||
147287916|NCT04579757|531217340|FG008|Overall Study|Adverse Event|0|||
147287917|NCT04579757|531217332|FG000|Overall Study|Death|4|||
147287918|NCT04579757|531217333|FG001|Overall Study|Death|1|||
147287919|NCT04579757|531217334|FG002|Overall Study|Death|14|||
147287920|NCT04579757|531217335|FG003|Overall Study|Death|3|||
147287921|NCT04579757|531217336|FG004|Overall Study|Death|2|||
147287922|NCT04579757|531217337|FG005|Overall Study|Death|7|||
147287923|NCT04579757|531217338|FG006|Overall Study|Death|0|||
147287924|NCT04579757|531217339|FG007|Overall Study|Death|1|||
147337697|NCT04054635|531402905|FG001|Third Visit (Second Follow-up)|Lost to Follow-up|0|||
147337698|NCT04054635|531402906|FG002|Third Visit (Second Follow-up)|Lost to Follow-up|0|||
147287925|NCT04579757|531217340|FG008|Overall Study|Death|3|||
147287926|NCT04579757|531217332|FG000|Overall Study|Physician Decision|0|||
147287927|NCT04579757|531217333|FG001|Overall Study|Physician Decision|0|||
147287928|NCT04579757|531217334|FG002|Overall Study|Physician Decision|0|||
147287929|NCT04579757|531217335|FG003|Overall Study|Physician Decision|2|||
147287930|NCT04579757|531217336|FG004|Overall Study|Physician Decision|1|||
147287931|NCT04579757|531217337|FG005|Overall Study|Physician Decision|1|||
147287932|NCT04579757|531217338|FG006|Overall Study|Physician Decision|1|||
147287933|NCT04579757|531217339|FG007|Overall Study|Physician Decision|0|||
147337699|NCT00891930|531402907|FG000|Part 1 Panitumumab + Irinotecan|Full Consent Withdrawn|2|||
147337700|NCT00891930|531402907|FG000|Part 1 Panitumumab + Irinotecan|Death|66|||
147337701|NCT00891930|531402907|FG000|Part 1 Panitumumab + Irinotecan|Lost to Follow-up|1|||
147337702|NCT00891930|531402907|FG000|Part 2 Panitumumab + AMG479|Full Consent Withdrawn|1|||
147287934|NCT04579757|531217340|FG008|Overall Study|Physician Decision|0|||
147337703|NCT00891930|531402907|FG000|Part 2 Panitumumab + AMG479|Death|30|||
147337704|NCT00439569|531402910|FG000|Cohort 1 (500 mg/kg/Day)|Allergic reaction|1|||
147287935|NCT04579757|531217332|FG000|Overall Study|Study Terminated By Sponsor|0|||
147337705|NCT00439569|531402910|FG000|Cohort 1 (500 mg/kg/Day)|Less than 80% study drug compliance|3|||
147287936|NCT04579757|531217333|FG001|Overall Study|Study Terminated By Sponsor|0|||
147604283|NCT00229723|532367855|FG003|Maintenance Phase|Other|2|||
147287937|NCT04579757|531217334|FG002|Overall Study|Study Terminated By Sponsor|0|||
147287938|NCT04579757|531217335|FG003|Overall Study|Study Terminated By Sponsor|0|||
147287939|NCT04579757|531217336|FG004|Overall Study|Study Terminated By Sponsor|2|||
147287940|NCT04579757|531217337|FG005|Overall Study|Study Terminated By Sponsor|0|||
147287941|NCT04579757|531217338|FG006|Overall Study|Study Terminated By Sponsor|0|||
147604284|NCT00229723|532367856|FG004|Maintenance Phase|Other|3|||
147287942|NCT04579757|531217339|FG007|Overall Study|Study Terminated By Sponsor|2|||
147287943|NCT04579757|531217340|FG008|Overall Study|Study Terminated By Sponsor|0|||
147287944|NCT04579757|531217332|FG000|Overall Study|Withdrawal by Subject|1|||
147287945|NCT04579757|531217333|FG001|Overall Study|Withdrawal by Subject|1|||
147287946|NCT04579757|531217334|FG002|Overall Study|Withdrawal by Subject|0|||
147287947|NCT04579757|531217335|FG003|Overall Study|Withdrawal by Subject|0|||
147287948|NCT04579757|531217336|FG004|Overall Study|Withdrawal by Subject|2|||
147287949|NCT04579757|531217337|FG005|Overall Study|Withdrawal by Subject|1|||
147287950|NCT04579757|531217338|FG006|Overall Study|Withdrawal by Subject|0|||
147287951|NCT04579757|531217339|FG007|Overall Study|Withdrawal by Subject|3|||
147287952|NCT04579757|531217340|FG008|Overall Study|Withdrawal by Subject|0|||
147287953|NCT04579757|531217332|FG000|Overall Study|Radiological or Clinical PD|1|||
147287954|NCT04579757|531217333|FG001|Overall Study|Radiological or Clinical PD|4|||
147287955|NCT04579757|531217334|FG002|Overall Study|Radiological or Clinical PD|1|||
147287956|NCT04579757|531217335|FG003|Overall Study|Radiological or Clinical PD|3|||
147287957|NCT04579757|531217336|FG004|Overall Study|Radiological or Clinical PD|9|||
147287958|NCT04579757|531217337|FG005|Overall Study|Radiological or Clinical PD|4|||
147287959|NCT04579757|531217338|FG006|Overall Study|Radiological or Clinical PD|2|||
147287960|NCT04579757|531217339|FG007|Overall Study|Radiological or Clinical PD|2|||
147287961|NCT04579757|531217340|FG008|Overall Study|Radiological or Clinical PD|0|||
147287962|NCT04579757|531217332|FG000|Overall Study|Start of New Therapy|0|||
147287963|NCT04579757|531217333|FG001|Overall Study|Start of New Therapy|0|||
147287964|NCT04579757|531217334|FG002|Overall Study|Start of New Therapy|0|||
147287965|NCT04579757|531217335|FG003|Overall Study|Start of New Therapy|0|||
147287966|NCT04579757|531217336|FG004|Overall Study|Start of New Therapy|2|||
147287967|NCT04579757|531217337|FG005|Overall Study|Start of New Therapy|1|||
147287968|NCT04579757|531217338|FG006|Overall Study|Start of New Therapy|0|||
147287969|NCT04579757|531217339|FG007|Overall Study|Start of New Therapy|0|||
147287970|NCT04579757|531217340|FG008|Overall Study|Start of New Therapy|0|||
147287971|NCT02207816|531217341|FG000|Overall Study|Serious Adverse Event|0|||
147287972|NCT02207816|531217342|FG001|Overall Study|Serious Adverse Event|5|||
147287973|NCT02207816|531217343|FG002|Overall Study|Serious Adverse Event|2|||
147287974|NCT02207816|531217341|FG000|Overall Study|Eligibility Criteria Not Fulfilled|2|||
147287975|NCT02207816|531217342|FG001|Overall Study|Eligibility Criteria Not Fulfilled|1|||
147287976|NCT02207816|531217343|FG002|Overall Study|Eligibility Criteria Not Fulfilled|2|||
147287977|NCT02207816|531217341|FG000|Overall Study|Withdrawal by Subject|4|||
147287978|NCT02207816|531217342|FG001|Overall Study|Withdrawal by Subject|9|||
147287979|NCT02207816|531217343|FG002|Overall Study|Withdrawal by Subject|7|||
147287980|NCT02207816|531217341|FG000|Overall Study|Migrated/Moved From Study Area|41|||
147287981|NCT02207816|531217342|FG001|Overall Study|Migrated/Moved From Study Area|60|||
147287982|NCT02207816|531217343|FG002|Overall Study|Migrated/Moved From Study Area|51|||
147287983|NCT02207816|531217341|FG000|Overall Study|Lost to Follow-up|3|||
147287984|NCT02207816|531217342|FG001|Overall Study|Lost to Follow-up|9|||
147287985|NCT02207816|531217343|FG002|Overall Study|Lost to Follow-up|1|||
147287986|NCT02207816|531217341|FG000|Overall Study|Other|1|||
147287987|NCT02207816|531217342|FG001|Overall Study|Other|2|||
147287988|NCT02207816|531217343|FG002|Overall Study|Other|4|||
147287989|NCT02473952|531217350|FG000|Overall Study|Adverse Event|2|||
147287990|NCT02473952|531217351|FG001|Overall Study|Adverse Event|2|||
147287991|NCT02473952|531217350|FG000|Overall Study|Withdrawal by Subject|0|||
147287992|NCT02473952|531217351|FG001|Overall Study|Withdrawal by Subject|6|||
147287993|NCT00237744|531217355|FG000|Overall Study|Withdrawal by Subject|3|||
147287994|NCT00237744|531217356|FG001|Overall Study|Withdrawal by Subject|1|||
147287995|NCT00237744|531217357|FG002|Overall Study|Withdrawal by Subject|0|||
147287996|NCT04955639|531217358|FG000|Overall Study|Withdrawal by Subject|2|||
147287997|NCT04955639|531217359|FG001|Overall Study|Withdrawal by Subject|2|||
147604285|NCT00229723|532367857|FG005|Maintenance Phase|Other|3|||
147287998|NCT04955639|531217358|FG000|Overall Study|Week 26 survey not completed|2|||
147287999|NCT04955639|531217359|FG001|Overall Study|Week 26 survey not completed|2|||
147288000|NCT01369342|531217360|FG000|Overall Study|Withdrawal by Subject|7|||
147288001|NCT01369342|531217361|FG001|Overall Study|Withdrawal by Subject|7|||
147288002|NCT01369342|531217362|FG002|Overall Study|Withdrawal by Subject|2|||
147288003|NCT01369342|531217360|FG000|Overall Study|Lost to Follow-up|5|||
147288004|NCT01369342|531217361|FG001|Overall Study|Lost to Follow-up|2|||
147288005|NCT01369342|531217362|FG002|Overall Study|Lost to Follow-up|1|||
147288006|NCT01369342|531217360|FG000|Overall Study|Not Treated|1|||
147288007|NCT01369342|531217361|FG001|Overall Study|Not Treated|0|||
147288008|NCT01369342|531217362|FG002|Overall Study|Not Treated|0|||
147288009|NCT03204279|531217366|FG000|Overall Study|Withdrawal by Subject|0|||
147288010|NCT03204279|531217367|FG001|Overall Study|Withdrawal by Subject|1|||
147288011|NCT04969250|531217372|FG000|Overall Study|Protocol Violation|0|||
147288012|NCT04969250|531217373|FG001|Overall Study|Protocol Violation|2|||
147288013|NCT04969250|531217374|FG002|Overall Study|Protocol Violation|3|||
147288014|NCT04969250|531217375|FG003|Overall Study|Protocol Violation|8|||
147288015|NCT04969250|531217372|FG000|Overall Study|Withdrawal by Subject|0|||
147288016|NCT04969250|531217373|FG001|Overall Study|Withdrawal by Subject|1|||
147288017|NCT04969250|531217374|FG002|Overall Study|Withdrawal by Subject|0|||
147288018|NCT04969250|531217375|FG003|Overall Study|Withdrawal by Subject|0|||
147288019|NCT03305016|531217376|FG000|Overall Study|Withdrawal by Subject|2|||
147288020|NCT02119416|531217377|FG000|Overall Study|Protocol Violation|1|||
147288021|NCT02119416|531217378|FG001|Overall Study|Protocol Violation|1|||
147288022|NCT02119416|531217379|FG002|Overall Study|Protocol Violation|1|||
147288023|NCT02119416|531217377|FG000|Overall Study|wrong pubertal stage|1|||
147288024|NCT02119416|531217378|FG001|Overall Study|wrong pubertal stage|0|||
147288025|NCT02119416|531217379|FG002|Overall Study|wrong pubertal stage|1|||
147288026|NCT02278328|531217380|FG000|Neuropsych Screening|found ineligible on neuropsych|1|||
147288027|NCT02278328|531217381|FG001|Neuropsych Screening|found ineligible on neuropsych|0|||
147288028|NCT02278328|531217382|FG002|Neuropsych Screening|found ineligible on neuropsych|0|||
147288029|NCT02278328|531217380|FG000|Neuropsych Screening|Withdrawal by Subject|0|||
147288030|NCT02278328|531217381|FG001|Neuropsych Screening|Withdrawal by Subject|1|||
147288031|NCT02278328|531217382|FG002|Neuropsych Screening|Withdrawal by Subject|0|||
147288032|NCT02278328|531217380|FG000|Neuropsych Screening|incomplete consent|0|||
147288033|NCT02278328|531217381|FG001|Neuropsych Screening|incomplete consent|0|||
147288034|NCT02278328|531217382|FG002|Neuropsych Screening|incomplete consent|2|||
147288035|NCT01059565|531217383|FG000|24-Week Randomized Phase|Randomized but not treated|1|||
147288036|NCT01059565|531217384|FG001|24-Week Randomized Phase|Randomized but not treated|0|||
147288037|NCT01059565|531217383|FG000|24-Week Randomized Phase|Adverse Event|5|||
147288038|NCT01059565|531217384|FG001|24-Week Randomized Phase|Adverse Event|0|||
147288039|NCT01059565|531217383|FG000|24-Week Randomized Phase|Withdrawal by Subject|3|||
147288040|NCT01059565|531217384|FG001|24-Week Randomized Phase|Withdrawal by Subject|1|||
147288041|NCT01059565|531217383|FG000|24-Week Randomized Phase|Lost to Follow-up|0|||
147288042|NCT01059565|531217384|FG001|24-Week Randomized Phase|Lost to Follow-up|1|||
147288043|NCT01059565|531217383|FG000|24-Week Randomized Phase|Noncompliance with Study Drug Regimen|1|||
147288044|NCT01059565|531217384|FG001|24-Week Randomized Phase|Noncompliance with Study Drug Regimen|5|||
147288045|NCT01059565|531217383|FG000|24-Week Open-Label Phase|Adverse Event|2|||
147288046|NCT01059565|531217384|FG001|24-Week Open-Label Phase|Adverse Event|0|||
147288047|NCT01059565|531217383|FG000|24-Week Open-Label Phase|Worsening health (physician decision)|1|||
147288048|NCT01059565|531217384|FG001|24-Week Open-Label Phase|Worsening health (physician decision)|1|||
147288049|NCT01059565|531217383|FG000|24-Week Open-Label Phase|Withdrawal by Subject|1|||
147288050|NCT01059565|531217384|FG001|24-Week Open-Label Phase|Withdrawal by Subject|0|||
147288051|NCT01059565|531217383|FG000|24-Week Open-Label Phase|Subject noncompliance|1|||
147288052|NCT01059565|531217384|FG001|24-Week Open-Label Phase|Subject noncompliance|0|||
147288053|NCT01059565|531217383|FG000|24-Week Open-Label Phase|Unable to clean device (hospitalization)|0|||
147288054|NCT01059565|531217384|FG001|24-Week Open-Label Phase|Unable to clean device (hospitalization)|1|||
147288055|NCT01059565|531217383|FG000|24-Week Open-Label Phase|Pulmonologist/participant decision|0|||
147288056|NCT01059565|531217384|FG001|24-Week Open-Label Phase|Pulmonologist/participant decision|1|||
147288057|NCT03927950|531217385|FG000|Overall Study|Adverse Event|9|||
147288058|NCT03263429|531217386|FG000|Overall Study|Withdrawal by Subject|0|||
147288059|NCT03263429|531217387|FG001|Overall Study|Withdrawal by Subject|1|||
147288060|NCT03263429|531217388|FG002|Overall Study|Withdrawal by Subject|0|||
147288061|NCT03263429|531217386|FG000|Overall Study|Follow-Up Period Completed|0|||
147288062|NCT03263429|531217387|FG001|Overall Study|Follow-Up Period Completed|2|||
147288063|NCT03263429|531217388|FG002|Overall Study|Follow-Up Period Completed|0|||
147288064|NCT03263429|531217386|FG000|Overall Study|Death|3|||
147288065|NCT03263429|531217387|FG001|Overall Study|Death|5|||
147288066|NCT03263429|531217388|FG002|Overall Study|Death|16|||
147288067|NCT03263429|531217386|FG000|Overall Study|Participant unable to return|0|||
147288068|NCT03263429|531217387|FG001|Overall Study|Participant unable to return|0|||
147288069|NCT03263429|531217388|FG002|Overall Study|Participant unable to return|1|||
147288070|NCT03263429|531217386|FG000|Overall Study|Study Closed|0|||
147288071|NCT03263429|531217387|FG001|Overall Study|Study Closed|0|||
147288072|NCT03263429|531217388|FG002|Overall Study|Study Closed|1|||
147288073|NCT01618864|531217389|FG000|Overall Study|Withdrawal by Subject|2|||
147288074|NCT01618864|531217389|FG000|Overall Study|Lost to Follow-up|2|||
147288075|NCT05177770|531217390|FG000|Overall Study|Death|4|||
147288076|NCT05177770|531217390|FG000|Overall Study|Withdrawal by Subject|1|||
147288077|NCT05177770|531217390|FG000|Overall Study|Adverse Event prior to dosing|1|||
147288078|NCT03585244|531217393|FG000|Overall Study|Withdrawal by Subject|15|||
147288079|NCT02105948|531217394|FG000|Overall Study|Adverse Event|10|||
147337706|NCT00439569|531402910|FG000|Cohort 2 (500 mg/kg/Day)|Less than 80% study drug compliance|1|||
147337707|NCT01943916|531402916|FG000|Overall Study|Technically invalid images|10|||
147337708|NCT01943916|531402916|FG000|Overall Study|Enrollment Failure|23|||
147337709|NCT01943916|531402916|FG000|Overall Study|Pilot Phase exclusion|100|||
147337710|NCT01943916|531402916|FG000|Overall Study|Quality Assurance Reader Fail|130|||
147288080|NCT02105948|531217395|FG001|Overall Study|Adverse Event|7|||
147288081|NCT02105948|531217396|FG002|Overall Study|Adverse Event|11|||
147662641|NCT00385918|532587380|FG001|Intervention Phase After Randomization|Withdrawal by Subject|0|||
147288082|NCT02105948|531217397|FG003|Overall Study|Adverse Event|11|||
147288083|NCT02105948|531217394|FG000|Overall Study|Lack of Efficacy|0|||
147288084|NCT02105948|531217395|FG001|Overall Study|Lack of Efficacy|1|||
147337711|NCT01943916|531402916|FG000|Overall Study|Technical Failure|39|||
147288085|NCT02105948|531217396|FG002|Overall Study|Lack of Efficacy|3|||
147288086|NCT02105948|531217397|FG003|Overall Study|Lack of Efficacy|2|||
147288087|NCT02105948|531217394|FG000|Overall Study|Lost to Follow-up|0|||
147288088|NCT02105948|531217395|FG001|Overall Study|Lost to Follow-up|0|||
147288089|NCT02105948|531217396|FG002|Overall Study|Lost to Follow-up|2|||
147288090|NCT02105948|531217397|FG003|Overall Study|Lost to Follow-up|1|||
147288091|NCT02105948|531217394|FG000|Overall Study|Physician Decision|2|||
147288092|NCT02105948|531217395|FG001|Overall Study|Physician Decision|2|||
147288093|NCT02105948|531217396|FG002|Overall Study|Physician Decision|2|||
147288094|NCT02105948|531217397|FG003|Overall Study|Physician Decision|2|||
147288095|NCT02105948|531217394|FG000|Overall Study|Withdrawal by Subject|15|||
147288096|NCT02105948|531217395|FG001|Overall Study|Withdrawal by Subject|10|||
147288097|NCT02105948|531217396|FG002|Overall Study|Withdrawal by Subject|10|||
147288098|NCT02105948|531217397|FG003|Overall Study|Withdrawal by Subject|11|||
147288099|NCT03273946|531217402|FG000|Overall Study|Withdrawal by Subject|5|||
147288100|NCT03273946|531217402|FG000|Overall Study|Unwillingness of the guardian|1|||
147288101|NCT03273946|531217402|FG000|Overall Study|Participant refused to use the drug|2|||
147288102|NCT03273946|531217402|FG000|Overall Study|Participant relative refused to use drug|1|||
147288103|NCT01220557|531217404|FG000|Overall Study|Lost to Follow-up|5|||
147288104|NCT01220557|531217405|FG001|Overall Study|Lost to Follow-up|3|||
147288105|NCT01220557|531217404|FG000|Overall Study|attended less than 6 lessons|1|||
147288106|NCT01220557|531217405|FG001|Overall Study|attended less than 6 lessons|2|||
147288107|NCT02199028|531217412|FG000|Week 1|Adverse Event|1|||
147288108|NCT02199028|531217413|FG001|Week 1|Adverse Event|0|||
147288109|NCT02199028|531217412|FG000|Week 3|Adverse Event|1|||
147288110|NCT02199028|531217413|FG001|Week 3|Adverse Event|0|||
147288111|NCT01881126|531217414|FG000|Overall Study|Non-compliance|1|||
147288112|NCT01881126|531217415|FG001|Overall Study|Non-compliance|1|||
147288113|NCT01881126|531217414|FG000|Overall Study|Adverse Event|0|||
147288114|NCT01881126|531217415|FG001|Overall Study|Adverse Event|1|||
147288115|NCT04072159|531217418|FG000|Overall Study|Lost to Follow-up|6|||
147288116|NCT04072159|531217419|FG001|Overall Study|Lost to Follow-up|6|||
147288117|NCT04072159|531217418|FG000|Overall Study|Withdrawal by Subject|2|||
147288118|NCT04072159|531217419|FG001|Overall Study|Withdrawal by Subject|0|||
147337712|NCT01943916|531402916|FG000|Overall Study|Protocol Deviation No Biopsy|25|||
147337713|NCT01943916|531402916|FG000|Overall Study|No Truth Panel Review|38|||
147337714|NCT01943916|531402916|FG000|Overall Study|Protocol Deviation|1|||
147337715|NCT01576484|531402917|FG000|Overall Study|Adverse Event|1|||
147337716|NCT01576484|531402918|FG001|Overall Study|Adverse Event|1|||
147337717|NCT01576484|531402917|FG000|Overall Study|Protocol Violation|0|||
147337718|NCT01576484|531402918|FG001|Overall Study|Protocol Violation|2|||
147337719|NCT01576484|531402917|FG000|Overall Study|Sponsor Decision|2|||
147337720|NCT01576484|531402918|FG001|Overall Study|Sponsor Decision|8|||
147337721|NCT01576484|531402917|FG000|Overall Study|Withdrawal by Subject|0|||
147337722|NCT01576484|531402918|FG001|Overall Study|Withdrawal by Subject|3|||
147337723|NCT01576484|531402917|FG000|Overall Study|Other|2|||
147337724|NCT01576484|531402918|FG001|Overall Study|Other|5|||
147337725|NCT03823911|531402922|FG000|Overall Study|Lost to Follow-up|1|||
147337726|NCT03823911|531402923|FG001|Overall Study|Lost to Follow-up|5|||
147337727|NCT03823911|531402924|FG002|Overall Study|Lost to Follow-up|2|||
147337728|NCT03823911|531402922|FG000|Overall Study|Did not meet eligibility criteria|13|||
147337729|NCT03823911|531402923|FG001|Overall Study|Did not meet eligibility criteria|7|||
147337730|NCT03823911|531402924|FG002|Overall Study|Did not meet eligibility criteria|4|||
147337731|NCT03823911|531402922|FG000|Overall Study|Death|0|||
147337732|NCT03823911|531402923|FG001|Overall Study|Death|1|||
147337733|NCT03823911|531402924|FG002|Overall Study|Death|0|||
147337734|NCT00958633|531402929|FG000|Open-Label (up to 16 Weeks)|Lost to Follow-up|0|||
147337735|NCT00958633|531402930|FG001|Open-Label (up to 16 Weeks)|Lost to Follow-up|0|||
147337736|NCT00958633|531402931|FG002|Open-Label (up to 16 Weeks)|Lost to Follow-up|14|||
147337737|NCT00958633|531402929|FG000|Open-Label (up to 16 Weeks)|Withdrawal by Subject|0|||
147337738|NCT00958633|531402930|FG001|Open-Label (up to 16 Weeks)|Withdrawal by Subject|0|||
147337739|NCT00958633|531402931|FG002|Open-Label (up to 16 Weeks)|Withdrawal by Subject|18|||
147604286|NCT00229723|532367858|FG006|Maintenance Phase|Other|1|||
147604287|NCT02677714|532367861|FG000|Overall Study|Withdrawal by Subject|2|||
147604288|NCT02677714|532367862|FG001|Overall Study|Withdrawal by Subject|0|||
147337740|NCT00958633|531402929|FG000|Open-Label (up to 16 Weeks)|Worsening of symptoms|0|||
147337741|NCT00958633|531402930|FG001|Open-Label (up to 16 Weeks)|Worsening of symptoms|0|||
147337742|NCT00958633|531402931|FG002|Open-Label (up to 16 Weeks)|Worsening of symptoms|13|||
147337743|NCT00958633|531402929|FG000|Open-Label (up to 16 Weeks)|Lack of Efficacy|0|||
147337744|NCT00958633|531402930|FG001|Open-Label (up to 16 Weeks)|Lack of Efficacy|0|||
147337745|NCT00958633|531402931|FG002|Open-Label (up to 16 Weeks)|Lack of Efficacy|8|||
147604289|NCT00901576|532367863|FG000|Second Intervention|Withdrawal by Subject|0|||
147288119|NCT00695669|531217422|FG000|Overall Study|Adverse Event|0|||
147288120|NCT00695669|531217423|FG001|Overall Study|Adverse Event|0|||
147288121|NCT00695669|531217424|FG002|Overall Study|Adverse Event|2|||
147288122|NCT00695669|531217425|FG003|Overall Study|Adverse Event|0|||
147288123|NCT00695669|531217422|FG000|Overall Study|Lost to Follow-up|4|||
147288124|NCT00695669|531217423|FG001|Overall Study|Lost to Follow-up|4|||
147288125|NCT00695669|531217424|FG002|Overall Study|Lost to Follow-up|1|||
147288126|NCT00695669|531217425|FG003|Overall Study|Lost to Follow-up|4|||
147288127|NCT05045625|531217426|FG000|Overall Study|Lost to Follow-up|3|||
147452458|NCT01745146|531819929|FG000|Overall Study|Withdrawal by Subject|1|||
147288128|NCT00047879|531217428|FG000|Overall Study|Progressive disease|4|||
147288129|NCT00047879|531217429|FG001|Overall Study|Progressive disease|3|||
147288130|NCT01196975|531217431|FG000|Overall Study|Adverse Event|2|||
147288131|NCT01196975|531217432|FG001|Overall Study|Adverse Event|2|||
147288132|NCT01196975|531217433|FG002|Overall Study|Adverse Event|0|||
147288133|NCT01196975|531217434|FG003|Overall Study|Adverse Event|0|||
147288134|NCT01196975|531217435|FG004|Overall Study|Adverse Event|2|||
147288135|NCT01196975|531217431|FG000|Overall Study|Withdrawal by Subject|2|||
147288136|NCT01196975|531217432|FG001|Overall Study|Withdrawal by Subject|1|||
147288137|NCT01196975|531217433|FG002|Overall Study|Withdrawal by Subject|0|||
147288138|NCT01196975|531217434|FG003|Overall Study|Withdrawal by Subject|1|||
147288139|NCT01196975|531217435|FG004|Overall Study|Withdrawal by Subject|0|||
147288140|NCT01196975|531217431|FG000|Overall Study|Lost to Follow-up|11|||
147288141|NCT01196975|531217432|FG001|Overall Study|Lost to Follow-up|6|||
147288142|NCT01196975|531217433|FG002|Overall Study|Lost to Follow-up|5|||
147288143|NCT01196975|531217434|FG003|Overall Study|Lost to Follow-up|5|||
147288144|NCT01196975|531217435|FG004|Overall Study|Lost to Follow-up|11|||
147288145|NCT03738150|531217436|FG000|Base Study|Withdrawal by Subject|1|||
147288146|NCT03738150|531217436|FG000|Extension Study|Withdrawal by Subject|1|||
147288147|NCT00110617|531217453|FG000|Overall Study|Adverse Event|2|||
147288148|NCT00110617|531217454|FG001|Overall Study|Adverse Event|4|||
147288149|NCT00110617|531217453|FG000|Overall Study|Abnormal Laboratory Value|4|||
147288150|NCT00110617|531217454|FG001|Overall Study|Abnormal Laboratory Value|2|||
147288151|NCT00110617|531217453|FG000|Overall Study|Lack of Efficacy|1|||
147288152|NCT00110617|531217454|FG001|Overall Study|Lack of Efficacy|0|||
147288153|NCT00110617|531217453|FG000|Overall Study|Patient no longer requires study drug|1|||
147288154|NCT00110617|531217454|FG001|Overall Study|Patient no longer requires study drug|0|||
147288155|NCT00110617|531217453|FG000|Overall Study|Protocol Violation|5|||
147288156|NCT00110617|531217454|FG001|Overall Study|Protocol Violation|0|||
147288157|NCT00110617|531217453|FG000|Overall Study|Withdrawal by Subject|10|||
147288158|NCT00110617|531217454|FG001|Overall Study|Withdrawal by Subject|4|||
147288159|NCT00110617|531217453|FG000|Overall Study|Lost to Follow-up|9|||
147288160|NCT00110617|531217454|FG001|Overall Study|Lost to Follow-up|1|||
147288161|NCT00110617|531217453|FG000|Overall Study|Administrative problems|6|||
147288162|NCT00110617|531217454|FG001|Overall Study|Administrative problems|5|||
147288163|NCT00110617|531217453|FG000|Overall Study|Death|1|||
147288164|NCT00110617|531217454|FG001|Overall Study|Death|1|||
147288165|NCT00110617|531217453|FG000|Overall Study|Did not receive study drug|0|||
147288166|NCT00110617|531217454|FG001|Overall Study|Did not receive study drug|12|||
147288167|NCT00045110|531217457|FG000|100mg Phase 1 Dose Escalalation|did not initiate treatment|0|||
147288168|NCT00045110|531217458|FG001|100mg Phase 1 Dose Escalalation|did not initiate treatment|2|||
147288169|NCT00045110|531217459|FG002|100mg Phase 1 Dose Escalalation|did not initiate treatment|1|||
147288170|NCT00045110|531217457|FG000|100mg Phase 1 Dose Escalalation|prior treatment history|0|||
147288171|NCT00045110|531217458|FG001|100mg Phase 1 Dose Escalalation|prior treatment history|4|||
147288172|NCT00045110|531217459|FG002|100mg Phase 1 Dose Escalalation|prior treatment history|0|||
147288173|NCT00045110|531217457|FG000|100mg Phase 1 Dose Escalalation|ineligible histology|0|||
147288174|NCT00045110|531217458|FG001|100mg Phase 1 Dose Escalalation|ineligible histology|0|||
147288175|NCT00045110|531217459|FG002|100mg Phase 1 Dose Escalalation|ineligible histology|1|||
147288176|NCT03662750|531217464|FG000|Overall Study|Withdrawal by Subject|1|||
147288177|NCT03069482|531220302|FG000|Overall Study|Lost to Follow-up|0|||
147288178|NCT03069482|531220303|FG001|Overall Study|Lost to Follow-up|1|||
147288179|NCT03069482|531220302|FG000|Overall Study|Physician Decision|1|||
147604290|NCT00901576|532367864|FG001|Second Intervention|Withdrawal by Subject|0|||
147288180|NCT03069482|531220303|FG001|Overall Study|Physician Decision|0|||
147288181|NCT01983293|531220309|FG000|Overall Study|Withdrawal by Subject|29|||
147288182|NCT01983293|531220310|FG001|Overall Study|Withdrawal by Subject|15|||
147288183|NCT01983293|531220309|FG000|Overall Study|Missing 12-month visit|3|||
147288184|NCT01983293|531220310|FG001|Overall Study|Missing 12-month visit|3|||
147288185|NCT01983293|531220309|FG000|Overall Study|Missing NYHA/Patient Global Assessment|1|||
147288186|NCT01983293|531220310|FG001|Overall Study|Missing NYHA/Patient Global Assessment|1|||
147288187|NCT03147248|531220312|FG000|Overall Study|Adverse Event|0|||
147288188|NCT03147248|531220313|FG001|Overall Study|Adverse Event|2|||
147288189|NCT03147248|531220314|FG002|Overall Study|Adverse Event|2|||
147288190|NCT03147248|531220315|FG003|Overall Study|Adverse Event|2|||
147288191|NCT03147248|531220316|FG004|Overall Study|Adverse Event|6|||
147288192|NCT03147248|531220317|FG005|Overall Study|Adverse Event|11|||
147288193|NCT03147248|531220312|FG000|Overall Study|Disease progression|1|||
147288194|NCT03147248|531220313|FG001|Overall Study|Disease progression|0|||
147288195|NCT03147248|531220314|FG002|Overall Study|Disease progression|0|||
147288196|NCT03147248|531220315|FG003|Overall Study|Disease progression|0|||
147288197|NCT03147248|531220316|FG004|Overall Study|Disease progression|0|||
147288198|NCT03147248|531220317|FG005|Overall Study|Disease progression|2|||
147288199|NCT03147248|531220312|FG000|Overall Study|Withdrawal by Subject|0|||
147288200|NCT03147248|531220313|FG001|Overall Study|Withdrawal by Subject|0|||
147604291|NCT00901576|532367865|FG002|Second Intervention|Withdrawal by Subject|0|||
147288201|NCT03147248|531220314|FG002|Overall Study|Withdrawal by Subject|0|||
147288202|NCT03147248|531220315|FG003|Overall Study|Withdrawal by Subject|0|||
147288203|NCT03147248|531220316|FG004|Overall Study|Withdrawal by Subject|12|||
147288204|NCT03147248|531220317|FG005|Overall Study|Withdrawal by Subject|9|||
147288205|NCT03147248|531220312|FG000|Overall Study|Protocol Violation|0|||
147288206|NCT03147248|531220313|FG001|Overall Study|Protocol Violation|0|||
147288207|NCT03147248|531220314|FG002|Overall Study|Protocol Violation|0|||
147288208|NCT03147248|531220315|FG003|Overall Study|Protocol Violation|0|||
147288209|NCT03147248|531220316|FG004|Overall Study|Protocol Violation|2|||
147288210|NCT03147248|531220317|FG005|Overall Study|Protocol Violation|0|||
147288211|NCT03147248|531220312|FG000|Overall Study|Lost to Follow-up|0|||
147288212|NCT03147248|531220313|FG001|Overall Study|Lost to Follow-up|0|||
147288213|NCT03147248|531220314|FG002|Overall Study|Lost to Follow-up|0|||
147288214|NCT03147248|531220315|FG003|Overall Study|Lost to Follow-up|0|||
147288215|NCT03147248|531220316|FG004|Overall Study|Lost to Follow-up|2|||
147288216|NCT03147248|531220317|FG005|Overall Study|Lost to Follow-up|0|||
147288217|NCT03147248|531220312|FG000|Overall Study|Pregnancy|0|||
147288218|NCT03147248|531220313|FG001|Overall Study|Pregnancy|0|||
147288219|NCT03147248|531220314|FG002|Overall Study|Pregnancy|0|||
147288220|NCT03147248|531220315|FG003|Overall Study|Pregnancy|0|||
147288221|NCT03147248|531220316|FG004|Overall Study|Pregnancy|1|||
147288222|NCT03147248|531220317|FG005|Overall Study|Pregnancy|0|||
147288223|NCT03147248|531220312|FG000|Overall Study|Death|0|||
147288224|NCT03147248|531220313|FG001|Overall Study|Death|0|||
147288225|NCT03147248|531220314|FG002|Overall Study|Death|0|||
147288226|NCT03147248|531220315|FG003|Overall Study|Death|0|||
147288227|NCT03147248|531220316|FG004|Overall Study|Death|0|||
147288228|NCT03147248|531220317|FG005|Overall Study|Death|4|||
147288229|NCT03147248|531220312|FG000|Overall Study|Physician Decision|0|||
147288230|NCT03147248|531220313|FG001|Overall Study|Physician Decision|0|||
147288231|NCT03147248|531220314|FG002|Overall Study|Physician Decision|0|||
147288232|NCT03147248|531220315|FG003|Overall Study|Physician Decision|0|||
147288233|NCT03147248|531220316|FG004|Overall Study|Physician Decision|2|||
147288234|NCT03147248|531220317|FG005|Overall Study|Physician Decision|4|||
147288235|NCT03147248|531220312|FG000|Overall Study|Prolonged Dosing Interval|0|||
147288236|NCT03147248|531220313|FG001|Overall Study|Prolonged Dosing Interval|0|||
147288237|NCT03147248|531220314|FG002|Overall Study|Prolonged Dosing Interval|0|||
147288238|NCT03147248|531220315|FG003|Overall Study|Prolonged Dosing Interval|0|||
147288239|NCT03147248|531220316|FG004|Overall Study|Prolonged Dosing Interval|1|||
147288240|NCT03147248|531220317|FG005|Overall Study|Prolonged Dosing Interval|1|||
147288241|NCT03750552|531220318|FG000|Overall Study|Adverse Event|5|||
147288242|NCT03750552|531220319|FG001|Overall Study|Adverse Event|1|||
147288243|NCT03750552|531220318|FG000|Overall Study|Withdrawal by Subject|1|||
147288244|NCT03750552|531220319|FG001|Overall Study|Withdrawal by Subject|1|||
147288245|NCT03750552|531220318|FG000|Overall Study|Other|2|||
147288246|NCT03750552|531220319|FG001|Overall Study|Other|0|||
147288247|NCT02062632|531220320|FG000|Overall Study|No treatment data|1|||
147288248|NCT00773968|531220323|FG000|Overall Study|Adverse Event|2|||
147288249|NCT00773968|531220323|FG000|Overall Study|Death|1|||
147288250|NCT00773968|531220323|FG000|Overall Study|Failure to Return|2|||
147288251|NCT00773968|531220323|FG000|Overall Study|Lack of Efficacy|3|||
147288252|NCT00773968|531220323|FG000|Overall Study|Protocol Violation|1|||
147288253|NCT00773968|531220323|FG000|Overall Study|Withdrawal by Subject|11|||
147288254|NCT00773968|531220323|FG000|Overall Study|Screen Failure|17|||
147288255|NCT00773968|531220323|FG000|Overall Study|Other|8|||
147288256|NCT02008890|531220331|FG000|Period 1|Withdrawal by Subject|7|||
147288257|NCT02008890|531220332|FG001|Period 1|Withdrawal by Subject|7|||
147288258|NCT02008890|531220333|FG002|Period 1|Withdrawal by Subject|5|||
147288259|NCT02008890|531220334|FG003|Period 1|Withdrawal by Subject|0|||
147337746|NCT00958633|531402929|FG000|Open-Label (up to 16 Weeks)|Non-adherence|0|||
147337747|NCT00958633|531402930|FG001|Open-Label (up to 16 Weeks)|Non-adherence|0|||
147337748|NCT00958633|531402931|FG002|Open-Label (up to 16 Weeks)|Non-adherence|2|||
147337749|NCT00958633|531402929|FG000|Open-Label (up to 16 Weeks)|Physician Decision|0|||
147288260|NCT02008890|531220335|FG004|Period 1|Withdrawal by Subject|0|||
147288261|NCT02008890|531220331|FG000|Period 1|Pregnancy|1|||
147288262|NCT02008890|531220332|FG001|Period 1|Pregnancy|0|||
147288263|NCT02008890|531220333|FG002|Period 1|Pregnancy|0|||
147288264|NCT02008890|531220334|FG003|Period 1|Pregnancy|0|||
147662642|NCT00385918|532587381|FG002|Intervention Phase After Randomization|Withdrawal by Subject|0|||
147288265|NCT02008890|531220335|FG004|Period 1|Pregnancy|0|||
147288266|NCT02008890|531220331|FG000|Period 1|Physician Decision|1|||
147288267|NCT02008890|531220332|FG001|Period 1|Physician Decision|0|||
147288268|NCT02008890|531220333|FG002|Period 1|Physician Decision|1|||
147288269|NCT02008890|531220334|FG003|Period 1|Physician Decision|0|||
147288270|NCT02008890|531220335|FG004|Period 1|Physician Decision|0|||
147288271|NCT02008890|531220331|FG000|Period 1|Adverse Event|6|||
147288272|NCT02008890|531220332|FG001|Period 1|Adverse Event|8|||
147288273|NCT02008890|531220333|FG002|Period 1|Adverse Event|6|||
147288274|NCT02008890|531220334|FG003|Period 1|Adverse Event|0|||
147288275|NCT02008890|531220335|FG004|Period 1|Adverse Event|0|||
147288276|NCT02008890|531220331|FG000|Period 2|Adverse Event|12|||
147288277|NCT02008890|531220332|FG001|Period 2|Adverse Event|7|||
147288278|NCT02008890|531220333|FG002|Period 2|Adverse Event|0|||
147288279|NCT02008890|531220334|FG003|Period 2|Adverse Event|5|||
147288280|NCT02008890|531220335|FG004|Period 2|Adverse Event|5|||
147288281|NCT02008890|531220331|FG000|Period 2|Withdrawal by Subject|11|||
147288282|NCT02008890|531220332|FG001|Period 2|Withdrawal by Subject|8|||
147288283|NCT02008890|531220333|FG002|Period 2|Withdrawal by Subject|0|||
147288284|NCT02008890|531220334|FG003|Period 2|Withdrawal by Subject|7|||
147288285|NCT02008890|531220335|FG004|Period 2|Withdrawal by Subject|2|||
147288286|NCT02008890|531220331|FG000|Period 2|Physician Decision|4|||
147288287|NCT02008890|531220332|FG001|Period 2|Physician Decision|0|||
147288288|NCT02008890|531220333|FG002|Period 2|Physician Decision|0|||
147288289|NCT02008890|531220334|FG003|Period 2|Physician Decision|2|||
147288290|NCT02008890|531220335|FG004|Period 2|Physician Decision|1|||
147288291|NCT02008890|531220331|FG000|Period 2|Lost to Follow-up|0|||
147288292|NCT02008890|531220332|FG001|Period 2|Lost to Follow-up|0|||
147288293|NCT02008890|531220333|FG002|Period 2|Lost to Follow-up|1|||
147288294|NCT02008890|531220334|FG003|Period 2|Lost to Follow-up|0|||
147288295|NCT02008890|531220335|FG004|Period 2|Lost to Follow-up|0|||
147288296|NCT02008890|531220331|FG000|Extension Period|Withdrawal by Subject|3|||
147288297|NCT02008890|531220332|FG001|Extension Period|Withdrawal by Subject|2|||
147288298|NCT02008890|531220333|FG002|Extension Period|Withdrawal by Subject|0|||
147288299|NCT02008890|531220334|FG003|Extension Period|Withdrawal by Subject|4|||
147288300|NCT02008890|531220335|FG004|Extension Period|Withdrawal by Subject|2|||
147288301|NCT02008890|531220331|FG000|Extension Period|Lost to Follow-up|1|||
147288302|NCT02008890|531220332|FG001|Extension Period|Lost to Follow-up|0|||
147288303|NCT02008890|531220333|FG002|Extension Period|Lost to Follow-up|0|||
147288304|NCT02008890|531220334|FG003|Extension Period|Lost to Follow-up|0|||
147288305|NCT02008890|531220335|FG004|Extension Period|Lost to Follow-up|0|||
147288306|NCT02008890|531220331|FG000|Extension Period|Adverse Event|1|||
147288307|NCT02008890|531220332|FG001|Extension Period|Adverse Event|3|||
147288308|NCT02008890|531220333|FG002|Extension Period|Adverse Event|0|||
147288309|NCT02008890|531220334|FG003|Extension Period|Adverse Event|0|||
147288310|NCT02008890|531220335|FG004|Extension Period|Adverse Event|2|||
147288311|NCT02332720|531220336|FG000|Part A and Part B|Lost to Follow-up|1|||
147288312|NCT02332720|531220337|FG001|Part A and Part B|Lost to Follow-up|0|||
147288313|NCT02332720|531220338|FG002|Part A and Part B|Lost to Follow-up|0|||
147288314|NCT02332720|531220339|FG003|Part A and Part B|Lost to Follow-up|0|||
147288315|NCT02332720|531220340|FG004|Part A and Part B|Lost to Follow-up|0|||
147288316|NCT02332720|531220341|FG005|Part A and Part B|Lost to Follow-up|2|||
147288317|NCT02332720|531220342|FG006|Part A and Part B|Lost to Follow-up|1|||
147288318|NCT02332720|531220343|FG007|Part A and Part B|Lost to Follow-up|1|||
147288319|NCT02332720|531220344|FG008|Part A and Part B|Lost to Follow-up|0|||
147288320|NCT02332720|531220345|FG009|Part A and Part B|Lost to Follow-up|0|||
147288321|NCT02332720|531220346|FG010|Part A and Part B|Lost to Follow-up|0|||
147288322|NCT02332720|531220347|FG011|Part A and Part B|Lost to Follow-up|0|||
147288323|NCT02332720|531220348|FG012|Part A and Part B|Lost to Follow-up|0|||
147288324|NCT02332720|531220349|FG013|Part A and Part B|Lost to Follow-up|0|||
147288325|NCT02332720|531220350|FG014|Part A and Part B|Lost to Follow-up|0|||
147288326|NCT02332720|531220351|FG015|Part A and Part B|Lost to Follow-up|1|||
147288327|NCT02332720|531220352|FG016|Part A and Part B|Lost to Follow-up|0|||
147288328|NCT02332720|531220353|FG017|Part A and Part B|Lost to Follow-up|0|||
147288329|NCT02332720|531220354|FG018|Part A and Part B|Lost to Follow-up|0|||
147288330|NCT02332720|531220355|FG019|Part A and Part B|Lost to Follow-up|0|||
147288331|NCT02332720|531220356|FG020|Part A and Part B|Lost to Follow-up|0|||
147288332|NCT02332720|531220357|FG021|Part A and Part B|Lost to Follow-up|0|||
147288333|NCT02332720|531220358|FG022|Part A and Part B|Lost to Follow-up|0|||
147288334|NCT02332720|531220336|FG000|Part A and Part B|Adverse Event|0|||
147288335|NCT02332720|531220337|FG001|Part A and Part B|Adverse Event|0|||
147288336|NCT02332720|531220338|FG002|Part A and Part B|Adverse Event|0|||
147288337|NCT02332720|531220339|FG003|Part A and Part B|Adverse Event|0|||
147288338|NCT02332720|531220340|FG004|Part A and Part B|Adverse Event|0|||
147288339|NCT02332720|531220341|FG005|Part A and Part B|Adverse Event|0|||
147337750|NCT00958633|531402930|FG001|Open-Label (up to 16 Weeks)|Physician Decision|0|||
147337751|NCT00958633|531402931|FG002|Open-Label (up to 16 Weeks)|Physician Decision|4|||
147337752|NCT00958633|531402929|FG000|Double-Blind Phase (up to 52 Weeks)|Excluded due to missing baseline and follow-up data.|1|||
147604292|NCT00901576|532367866|FG003|Second Intervention|Withdrawal by Subject|1|||
147604293|NCT00901576|532367867|FG004|Second Intervention|Withdrawal by Subject|0|||
147604294|NCT00901576|532367868|FG005|Second Intervention|Withdrawal by Subject|1|||
147604295|NCT00901576|532367863|FG000|Second Intervention|Physician Decision|1|||
147288340|NCT02332720|531220342|FG006|Part A and Part B|Adverse Event|0|||
147288341|NCT02332720|531220343|FG007|Part A and Part B|Adverse Event|0|||
147288342|NCT02332720|531220344|FG008|Part A and Part B|Adverse Event|0|||
147288343|NCT02332720|531220345|FG009|Part A and Part B|Adverse Event|0|||
147288344|NCT02332720|531220346|FG010|Part A and Part B|Adverse Event|0|||
147288345|NCT02332720|531220347|FG011|Part A and Part B|Adverse Event|0|||
147288346|NCT02332720|531220348|FG012|Part A and Part B|Adverse Event|0|||
147288347|NCT02332720|531220349|FG013|Part A and Part B|Adverse Event|0|||
147288348|NCT02332720|531220350|FG014|Part A and Part B|Adverse Event|0|||
147288349|NCT02332720|531220351|FG015|Part A and Part B|Adverse Event|0|||
147288350|NCT02332720|531220352|FG016|Part A and Part B|Adverse Event|0|||
147288351|NCT02332720|531220353|FG017|Part A and Part B|Adverse Event|1|||
147288352|NCT02332720|531220354|FG018|Part A and Part B|Adverse Event|0|||
147288353|NCT02332720|531220355|FG019|Part A and Part B|Adverse Event|0|||
147288354|NCT02332720|531220356|FG020|Part A and Part B|Adverse Event|0|||
147288355|NCT02332720|531220357|FG021|Part A and Part B|Adverse Event|0|||
147288356|NCT02332720|531220358|FG022|Part A and Part B|Adverse Event|0|||
147288357|NCT02332720|531220336|FG000|Part A and Part B|Physician Decision|0|||
147288358|NCT02332720|531220337|FG001|Part A and Part B|Physician Decision|0|||
147288359|NCT02332720|531220338|FG002|Part A and Part B|Physician Decision|0|||
147288360|NCT02332720|531220339|FG003|Part A and Part B|Physician Decision|0|||
147288361|NCT02332720|531220340|FG004|Part A and Part B|Physician Decision|0|||
147288362|NCT02332720|531220341|FG005|Part A and Part B|Physician Decision|0|||
147288363|NCT02332720|531220342|FG006|Part A and Part B|Physician Decision|0|||
147288364|NCT02332720|531220343|FG007|Part A and Part B|Physician Decision|0|||
147288365|NCT02332720|531220344|FG008|Part A and Part B|Physician Decision|0|||
147288366|NCT02332720|531220345|FG009|Part A and Part B|Physician Decision|0|||
147288367|NCT02332720|531220346|FG010|Part A and Part B|Physician Decision|0|||
147288368|NCT02332720|531220347|FG011|Part A and Part B|Physician Decision|0|||
147288369|NCT02332720|531220348|FG012|Part A and Part B|Physician Decision|0|||
147288370|NCT02332720|531220349|FG013|Part A and Part B|Physician Decision|0|||
147288371|NCT02332720|531220350|FG014|Part A and Part B|Physician Decision|0|||
147288372|NCT02332720|531220351|FG015|Part A and Part B|Physician Decision|0|||
147288373|NCT02332720|531220352|FG016|Part A and Part B|Physician Decision|0|||
147288374|NCT02332720|531220353|FG017|Part A and Part B|Physician Decision|0|||
147288375|NCT02332720|531220354|FG018|Part A and Part B|Physician Decision|1|||
147288376|NCT02332720|531220355|FG019|Part A and Part B|Physician Decision|0|||
147288377|NCT02332720|531220356|FG020|Part A and Part B|Physician Decision|0|||
147288378|NCT02332720|531220357|FG021|Part A and Part B|Physician Decision|0|||
147288379|NCT02332720|531220358|FG022|Part A and Part B|Physician Decision|0|||
147288380|NCT02332720|531220336|FG000|Part A and Part B|Withdrawal by Subject|0|||
147288381|NCT02332720|531220337|FG001|Part A and Part B|Withdrawal by Subject|0|||
147288382|NCT02332720|531220338|FG002|Part A and Part B|Withdrawal by Subject|0|||
147288383|NCT02332720|531220339|FG003|Part A and Part B|Withdrawal by Subject|0|||
147288384|NCT02332720|531220340|FG004|Part A and Part B|Withdrawal by Subject|0|||
147288385|NCT02332720|531220341|FG005|Part A and Part B|Withdrawal by Subject|1|||
147288386|NCT02332720|531220342|FG006|Part A and Part B|Withdrawal by Subject|0|||
147288387|NCT02332720|531220343|FG007|Part A and Part B|Withdrawal by Subject|0|||
147288388|NCT02332720|531220344|FG008|Part A and Part B|Withdrawal by Subject|0|||
147288389|NCT02332720|531220345|FG009|Part A and Part B|Withdrawal by Subject|0|||
147288390|NCT02332720|531220346|FG010|Part A and Part B|Withdrawal by Subject|0|||
147288391|NCT02332720|531220347|FG011|Part A and Part B|Withdrawal by Subject|0|||
147288392|NCT02332720|531220348|FG012|Part A and Part B|Withdrawal by Subject|0|||
147288393|NCT02332720|531220349|FG013|Part A and Part B|Withdrawal by Subject|0|||
147288394|NCT02332720|531220350|FG014|Part A and Part B|Withdrawal by Subject|0|||
147288395|NCT02332720|531220351|FG015|Part A and Part B|Withdrawal by Subject|0|||
147288396|NCT02332720|531220352|FG016|Part A and Part B|Withdrawal by Subject|0|||
147288397|NCT02332720|531220353|FG017|Part A and Part B|Withdrawal by Subject|0|||
147288398|NCT02332720|531220354|FG018|Part A and Part B|Withdrawal by Subject|0|||
147288399|NCT02332720|531220355|FG019|Part A and Part B|Withdrawal by Subject|1|||
147452459|NCT01745146|531819930|FG001|Overall Study|Withdrawal by Subject|3|||
147288400|NCT02332720|531220356|FG020|Part A and Part B|Withdrawal by Subject|0|||
147288401|NCT02332720|531220357|FG021|Part A and Part B|Withdrawal by Subject|0|||
147288402|NCT02332720|531220358|FG022|Part A and Part B|Withdrawal by Subject|0|||
147288403|NCT03240588|531220359|FG000|Overall Study|Death|3|||
147288404|NCT03240588|531220360|FG001|Overall Study|Death|0|||
147288405|NCT03240588|531220361|FG002|Overall Study|Death|0|||
147288406|NCT03240588|531220359|FG000|Overall Study|Adverse Event|5|||
147288407|NCT03240588|531220360|FG001|Overall Study|Adverse Event|4|||
147288408|NCT03240588|531220361|FG002|Overall Study|Adverse Event|0|||
147288409|NCT03240588|531220359|FG000|Overall Study|Lost to Follow-up|9|||
147288410|NCT03240588|531220360|FG001|Overall Study|Lost to Follow-up|4|||
147288411|NCT03240588|531220361|FG002|Overall Study|Lost to Follow-up|0|||
147288412|NCT03240588|531220359|FG000|Overall Study|Physician Decision|3|||
147288413|NCT03240588|531220360|FG001|Overall Study|Physician Decision|2|||
147288414|NCT03240588|531220361|FG002|Overall Study|Physician Decision|0|||
147288415|NCT03240588|531220359|FG000|Overall Study|Did not meet eligibility criteria|0|||
147288416|NCT03240588|531220360|FG001|Overall Study|Did not meet eligibility criteria|6|||
147288417|NCT03240588|531220361|FG002|Overall Study|Did not meet eligibility criteria|0|||
147288418|NCT03240588|531220359|FG000|Overall Study|No longer meets protocol criteria|12|||
147288419|NCT03240588|531220360|FG001|Overall Study|No longer meets protocol criteria|7|||
147288420|NCT03240588|531220361|FG002|Overall Study|No longer meets protocol criteria|0|||
147288421|NCT03240588|531220359|FG000|Overall Study|Withdrawal by Subject|60|||
147288422|NCT03240588|531220360|FG001|Overall Study|Withdrawal by Subject|52|||
147288423|NCT03240588|531220361|FG002|Overall Study|Withdrawal by Subject|7|||
147288424|NCT03240588|531220359|FG000|Overall Study|Other, additional details not available.|0|||
147288425|NCT03240588|531220360|FG001|Overall Study|Other, additional details not available.|12|||
147288426|NCT03240588|531220361|FG002|Overall Study|Other, additional details not available.|1|||
147288427|NCT03240588|531220359|FG000|Overall Study|Attempted to implant study device but unable to do so/unsuccessful neurostimulation trial procedure|14|||
147288428|NCT03240588|531220360|FG001|Overall Study|Attempted to implant study device but unable to do so/unsuccessful neurostimulation trial procedure|3|||
147288429|NCT03240588|531220361|FG002|Overall Study|Attempted to implant study device but unable to do so/unsuccessful neurostimulation trial procedure|0|||
147288430|NCT03240588|531220359|FG000|Overall Study|Closure of study|55|||
147288431|NCT03240588|531220360|FG001|Overall Study|Closure of study|3|||
147288432|NCT03240588|531220361|FG002|Overall Study|Closure of study|0|||
147288433|NCT03240588|531220359|FG000|Overall Study|Subject non-compliance|23|||
147288434|NCT03240588|531220360|FG001|Overall Study|Subject non-compliance|2|||
147337753|NCT00958633|531402930|FG001|Double-Blind Phase (up to 52 Weeks)|Excluded due to missing baseline and follow-up data.|0|||
147337754|NCT00958633|531402931|FG002|Double-Blind Phase (up to 52 Weeks)|Excluded due to missing baseline and follow-up data.|0|||
147337755|NCT00094575|531402935|FG000|Overall Study|Death|146|||
147337756|NCT00094575|531402936|FG001|Overall Study|Death|146|||
147337757|NCT04305405|531402937|FG000|Overall Study|Withdrawal by parent/guardian|0|||
147337758|NCT04305405|531402938|FG001|Overall Study|Withdrawal by parent/guardian|1|||
147337759|NCT00206375|531402940|FG000|Overall Study|Lost to Follow-up|1|||
147452460|NCT01745146|531819929|FG000|Overall Study|Lost to Follow-up|2|||
147452461|NCT01745146|531819930|FG001|Overall Study|Lost to Follow-up|0|||
147452462|NCT04623242|531819931|FG000|Overall Study|Withdrawal by Subject|7|||
147452463|NCT04623242|531819932|FG001|Overall Study|Withdrawal by Subject|12|||
147452464|NCT04623242|531819933|FG002|Overall Study|Withdrawal by Subject|5|||
147452465|NCT04623242|531819934|FG003|Overall Study|Withdrawal by Subject|7|||
147452466|NCT04623242|531819935|FG004|Overall Study|Withdrawal by Subject|0|||
147452467|NCT04623242|531819931|FG000|Overall Study|Reason Not Disclosed to protect treatment and genetic unblinding|6|||
147452468|NCT04623242|531819932|FG001|Overall Study|Reason Not Disclosed to protect treatment and genetic unblinding|4|||
147452469|NCT04623242|531819933|FG002|Overall Study|Reason Not Disclosed to protect treatment and genetic unblinding|5|||
147452470|NCT04623242|531819934|FG003|Overall Study|Reason Not Disclosed to protect treatment and genetic unblinding|3|||
147452471|NCT04623242|531819935|FG004|Overall Study|Reason Not Disclosed to protect treatment and genetic unblinding|0|||
147452472|NCT04623242|531819931|FG000|Overall Study|Subject unblinded to mutation status|0|||
147452473|NCT04623242|531819932|FG001|Overall Study|Subject unblinded to mutation status|0|||
147452474|NCT04623242|531819933|FG002|Overall Study|Subject unblinded to mutation status|0|||
147452475|NCT04623242|531819934|FG003|Overall Study|Subject unblinded to mutation status|13|||
147452476|NCT04623242|531819935|FG004|Overall Study|Subject unblinded to mutation status|0|||
147452477|NCT00326898|531819938|FG000|Overall Study|Disease progression|52|||
147452478|NCT00326898|531819939|FG001|Overall Study|Disease progression|54|||
147452479|NCT00326898|531819940|FG002|Overall Study|Disease progression|102|||
147452480|NCT00326898|531819938|FG000|Overall Study|Adverse Event|124|||
147452481|NCT00326898|531819939|FG001|Overall Study|Adverse Event|128|||
147452482|NCT00326898|531819940|FG002|Overall Study|Adverse Event|33|||
147452483|NCT00326898|531819938|FG000|Overall Study|Death|2|||
147452484|NCT00326898|531819939|FG001|Overall Study|Death|0|||
147452485|NCT00326898|531819940|FG002|Overall Study|Death|0|||
147452486|NCT00326898|531819938|FG000|Overall Study|Withdrawal by Subject|134|||
147452487|NCT00326898|531819939|FG001|Overall Study|Withdrawal by Subject|128|||
147452488|NCT00326898|531819940|FG002|Overall Study|Withdrawal by Subject|32|||
147452489|NCT00326898|531819938|FG000|Overall Study|Alternative therapy|1|||
147452490|NCT00326898|531819939|FG001|Overall Study|Alternative therapy|0|||
147452491|NCT00326898|531819940|FG002|Overall Study|Alternative therapy|0|||
147452492|NCT00326898|531819938|FG000|Overall Study|Other complicating disease|5|||
147452493|NCT00326898|531819939|FG001|Overall Study|Other complicating disease|5|||
147452494|NCT00326898|531819940|FG002|Overall Study|Other complicating disease|4|||
147452495|NCT00326898|531819938|FG000|Overall Study|Other/Missing/Unknown|33|||
147452496|NCT00326898|531819939|FG001|Overall Study|Other/Missing/Unknown|28|||
147452497|NCT00326898|531819940|FG002|Overall Study|Other/Missing/Unknown|32|||
147337760|NCT00206375|531402941|FG001|Overall Study|Lost to Follow-up|0|||
147337761|NCT00206375|531402942|FG002|Overall Study|Lost to Follow-up|0|||
147337762|NCT00206375|531402940|FG000|Overall Study|Withdrawal by Subject|2|||
147337763|NCT00206375|531402941|FG001|Overall Study|Withdrawal by Subject|1|||
147337764|NCT00206375|531402942|FG002|Overall Study|Withdrawal by Subject|3|||
147337765|NCT00206375|531402940|FG000|Overall Study|Study terminated due to lack of funds|0|||
147337766|NCT00206375|531402941|FG001|Overall Study|Study terminated due to lack of funds|1|||
147452498|NCT03847987|531819941|FG000|Overall Study|Lost to Follow-up|1|||
147452499|NCT03847987|531819942|FG001|Overall Study|Lost to Follow-up|0|||
147452500|NCT03847987|531819941|FG000|Overall Study|Adverse Event|2|||
147452501|NCT03847987|531819942|FG001|Overall Study|Adverse Event|0|||
147604296|NCT00901576|532367864|FG001|Second Intervention|Physician Decision|0|||
147604297|NCT00901576|532367865|FG002|Second Intervention|Physician Decision|0|||
147452502|NCT02605642|531819946|FG000|Overall Study|Other|11|||
147452503|NCT02605642|531819947|FG001|Overall Study|Other|1|||
147288435|NCT03240588|531220361|FG002|Overall Study|Subject non-compliance|1|||
147288436|NCT03240588|531220359|FG000|Overall Study|Device Deficiency|1|||
147288437|NCT03240588|531220360|FG001|Overall Study|Device Deficiency|0|||
147288438|NCT03240588|531220361|FG002|Overall Study|Device Deficiency|0|||
147288439|NCT03240588|531220359|FG000|Overall Study|End of study information not provided to determine reason for withdrawal.|0|||
147288440|NCT03240588|531220360|FG001|Overall Study|End of study information not provided to determine reason for withdrawal.|1|||
147288441|NCT03240588|531220361|FG002|Overall Study|End of study information not provided to determine reason for withdrawal.|1|||
147288442|NCT02091726|531220363|FG000|Overall Study|Lost to Follow-up|6|||
147288443|NCT02047045|531220367|FG000|Baseline|Withdrawal by Subject|3|||
147288444|NCT02047045|531220368|FG001|Baseline|Withdrawal by Subject|2|||
147288445|NCT02047045|531220367|FG000|Treatment Period (8 Weeks )|Adverse Event|3|||
147288446|NCT02047045|531220368|FG001|Treatment Period (8 Weeks )|Adverse Event|1|||
147288447|NCT02047045|531220367|FG000|Treatment Period (8 Weeks )|Lost to Follow-up|1|||
147288448|NCT02047045|531220368|FG001|Treatment Period (8 Weeks )|Lost to Follow-up|3|||
147288449|NCT02047045|531220367|FG000|Treatment Period (8 Weeks )|Withdrawal by Subject|3|||
147288450|NCT02047045|531220368|FG001|Treatment Period (8 Weeks )|Withdrawal by Subject|5|||
147288451|NCT02047045|531220367|FG000|Treatment Period (8 Weeks )|moved far away out of work|3|||
147288452|NCT02047045|531220368|FG001|Treatment Period (8 Weeks )|moved far away out of work|0|||
147288453|NCT02047045|531220367|FG000|Treatment Period (8 Weeks )|no reason was given|1|||
147288454|NCT02047045|531220368|FG001|Treatment Period (8 Weeks )|no reason was given|0|||
147288455|NCT02047045|531220367|FG000|Treatment Period (8 Weeks )|refused to take drugs|0|||
147288456|NCT02047045|531220368|FG001|Treatment Period (8 Weeks )|refused to take drugs|5|||
147288457|NCT02047045|531220367|FG000|Treatment Period (8 Weeks )|for safety considerations|0|||
147288458|NCT02047045|531220368|FG001|Treatment Period (8 Weeks )|for safety considerations|1|||
147288459|NCT02047045|531220367|FG000|Follow-up Period (24 Weeks)|Adverse Event|1|||
147288460|NCT02047045|531220368|FG001|Follow-up Period (24 Weeks)|Adverse Event|1|||
147288461|NCT04066114|531220369|FG000|Overall Study|Adverse Event|1|||
147288462|NCT04066114|531220370|FG001|Overall Study|Adverse Event|0|||
147288463|NCT04066114|531220371|FG002|Overall Study|Adverse Event|0|||
147288464|NCT04066114|531220369|FG000|Overall Study|Withdrawal by Subject|1|||
147288465|NCT04066114|531220370|FG001|Overall Study|Withdrawal by Subject|0|||
147288466|NCT04066114|531220371|FG002|Overall Study|Withdrawal by Subject|0|||
147288467|NCT04066114|531220369|FG000|Overall Study|Did Not Meet Eligibility Criteria|0|||
147288468|NCT04066114|531220370|FG001|Overall Study|Did Not Meet Eligibility Criteria|7|||
147452504|NCT02605642|531819946|FG000|Overall Study|Participant non-compliance|2|||
147452505|NCT02605642|531819947|FG001|Overall Study|Participant non-compliance|4|||
147452506|NCT02605642|531819946|FG000|Overall Study|Physician Decision|10|||
147452507|NCT02605642|531819947|FG001|Overall Study|Physician Decision|0|||
147452508|NCT02605642|531819946|FG000|Overall Study|Lost to Follow-up|12|||
147452509|NCT02605642|531819947|FG001|Overall Study|Lost to Follow-up|1|||
147452510|NCT02605642|531819946|FG000|Overall Study|Adverse Event|14|||
147452511|NCT02605642|531819947|FG001|Overall Study|Adverse Event|2|||
147452512|NCT02605642|531819946|FG000|Overall Study|Withdrawal by Subject|23|||
147288469|NCT04066114|531220371|FG002|Overall Study|Did Not Meet Eligibility Criteria|0|||
147288470|NCT00856856|531220373|FG000|2-year Clinical Follow-up|Lost to Follow-up|1|||
147337767|NCT00206375|531402942|FG002|Overall Study|Study terminated due to lack of funds|1|||
147337768|NCT00837616|531402945|FG000|Overall Study|Withdrawal by Subject|0|||
147337769|NCT00837616|531402946|FG001|Overall Study|Withdrawal by Subject|1|||
147337770|NCT02674750|531402947|FG000|Overall Study|Death|4|||
147337771|NCT02674750|531402948|FG001|Overall Study|Death|5|||
147337772|NCT02674750|531402949|FG002|Overall Study|Death|8|||
147337773|NCT02674750|531402947|FG000|Overall Study|Lost to Follow-up|0|||
147337774|NCT02674750|531402948|FG001|Overall Study|Lost to Follow-up|8|||
147337775|NCT02674750|531402949|FG002|Overall Study|Lost to Follow-up|0|||
147337776|NCT02674750|531402947|FG000|Overall Study|Lack of Efficacy|1|||
147337777|NCT02674750|531402948|FG001|Overall Study|Lack of Efficacy|17|||
147337778|NCT02674750|531402949|FG002|Overall Study|Lack of Efficacy|3|||
147337779|NCT02674750|531402947|FG000|Overall Study|Withdrawal by Subject|0|||
147337780|NCT02674750|531402948|FG001|Overall Study|Withdrawal by Subject|7|||
147337781|NCT02674750|531402949|FG002|Overall Study|Withdrawal by Subject|1|||
147337782|NCT02674750|531402947|FG000|Overall Study|Other|0|||
147288471|NCT00856856|531220373|FG000|4-year Clinical Follow-up|Missed visit|1|||
147337783|NCT02674750|531402948|FG001|Overall Study|Other|8|||
147337784|NCT02674750|531402949|FG002|Overall Study|Other|0|||
147337785|NCT01685606|531402950|FG000|Overall Study|Withdrawal by Subject|1|||
147452513|NCT02605642|531819947|FG001|Overall Study|Withdrawal by Subject|2|||
147288472|NCT00434057|531220376|FG000|Overall Study|Withdrawal by Subject|1|||
147288473|NCT00455195|531220379|FG000|Double-blind Study AGLU02704|Adverse Event|2|||
147288474|NCT00455195|531220380|FG001|Double-blind Study AGLU02704|Adverse Event|1|||
147288475|NCT00455195|531220379|FG000|Double-blind Study AGLU02704|Death|1|||
147452514|NCT02605642|531819946|FG000|Overall Study|Lack of response|24|||
147452515|NCT02605642|531819947|FG001|Overall Study|Lack of response|11|||
147337786|NCT01787760|531402951|FG000|Overall Study|Anisometropia > -1.00D in spherical equi|1|||
147337787|NCT01787760|531402952|FG001|Overall Study|Anisometropia > -1.00D in spherical equi|0|||
147452516|NCT02111564|531819956|FG000|Overall Study|Death|109|||
147452517|NCT02111564|531819957|FG001|Overall Study|Death|120|||
147452518|NCT02111564|531819956|FG000|Overall Study|Lost to Follow-up|2|||
147452519|NCT02111564|531819957|FG001|Overall Study|Lost to Follow-up|3|||
147452520|NCT02111564|531819956|FG000|Overall Study|Withdrawal by Subject|20|||
147452521|NCT02111564|531819957|FG001|Overall Study|Withdrawal by Subject|20|||
147288476|NCT00455195|531220380|FG001|Double-blind Study AGLU02704|Death|0|||
147288477|NCT00455195|531220379|FG000|Double-blind Study AGLU02704|Withdrawal by Subject|2|||
147288478|NCT00455195|531220380|FG001|Double-blind Study AGLU02704|Withdrawal by Subject|2|||
147288479|NCT00455195|531220379|FG000|Double-blind Study AGLU02704|Unable to commit time to study|0|||
147288480|NCT00455195|531220380|FG001|Double-blind Study AGLU02704|Unable to commit time to study|1|||
147288481|NCT02117570|531220383|FG000|Stage 1 Participants Aged 50 to 64 Years|Withdrawal by Subject|0|||
147288482|NCT02117570|531220384|FG001|Stage 1 Participants Aged 50 to 64 Years|Withdrawal by Subject|2|||
147288483|NCT02117570|531220385|FG002|Stage 1 Participants Aged 50 to 64 Years|Withdrawal by Subject|1|||
147288484|NCT02117570|531220383|FG000|Stage 1 Participants Aged 50 to 64 Years|Lost to Follow-up|1|||
147288485|NCT02117570|531220384|FG001|Stage 1 Participants Aged 50 to 64 Years|Lost to Follow-up|1|||
147288486|NCT02117570|531220385|FG002|Stage 1 Participants Aged 50 to 64 Years|Lost to Follow-up|0|||
147288487|NCT02117570|531220383|FG000|Stage 2 Participants Aged 65 to 85 Years|Withdrawal by Subject|0|||
147288488|NCT02117570|531220384|FG001|Stage 2 Participants Aged 65 to 85 Years|Withdrawal by Subject|0|||
147288489|NCT02117570|531220385|FG002|Stage 2 Participants Aged 65 to 85 Years|Withdrawal by Subject|2|||
147288490|NCT02117570|531220383|FG000|Stage 2 Participants Aged 65 to 85 Years|Death|0|||
147288491|NCT02117570|531220384|FG001|Stage 2 Participants Aged 65 to 85 Years|Death|0|||
147288492|NCT02117570|531220385|FG002|Stage 2 Participants Aged 65 to 85 Years|Death|1|||
147288493|NCT02117570|531220383|FG000|Stage 2 Participants Aged 65 to 85 Years|Protocol Violation|0|||
147288494|NCT02117570|531220384|FG001|Stage 2 Participants Aged 65 to 85 Years|Protocol Violation|0|||
147288495|NCT02117570|531220385|FG002|Stage 2 Participants Aged 65 to 85 Years|Protocol Violation|1|||
147288496|NCT02117570|531220383|FG000|Stage 2 Participants Aged 65 to 85 Years|Lost to Follow-up|1|||
147288497|NCT02117570|531220384|FG001|Stage 2 Participants Aged 65 to 85 Years|Lost to Follow-up|2|||
147288498|NCT02117570|531220385|FG002|Stage 2 Participants Aged 65 to 85 Years|Lost to Follow-up|2|||
147288499|NCT02117570|531220383|FG000|Stage 2 Participants Aged 65 to 85 Years|Withdrew before vaccination|0|||
147288500|NCT02117570|531220384|FG001|Stage 2 Participants Aged 65 to 85 Years|Withdrew before vaccination|1|||
147288501|NCT02117570|531220385|FG002|Stage 2 Participants Aged 65 to 85 Years|Withdrew before vaccination|0|||
147288502|NCT02148250|531220386|FG000|Screening|Withdrawal by Subject|5|||
147288503|NCT02148250|531220387|FG001|Screening|Withdrawal by Subject|0|||
147288504|NCT00922428|531220388|FG000|Overall Study|retrospective/extremely implausible data|2|||
147288505|NCT00922428|531220388|FG000|Overall Study|no medication use or questionable use|13|||
147288506|NCT03701555|531220400|FG000|Part 2 (Day 1)|Lost to Follow-up|0|||
147288507|NCT03701555|531220401|FG001|Part 2 (Day 1)|Lost to Follow-up|0|||
147288508|NCT03701555|531220402|FG002|Part 2 (Day 1)|Lost to Follow-up|0|||
147288509|NCT03701555|531220403|FG003|Part 2 (Day 1)|Lost to Follow-up|0|||
147288510|NCT03701555|531220404|FG004|Part 2 (Day 1)|Lost to Follow-up|0|||
147288511|NCT03701555|531220405|FG005|Part 2 (Day 1)|Lost to Follow-up|0|||
147288512|NCT03701555|531220406|FG006|Part 2 (Day 1)|Lost to Follow-up|0|||
147288513|NCT03701555|531220407|FG007|Part 2 (Day 1)|Lost to Follow-up|0|||
147288514|NCT03701555|531220408|FG008|Part 2 (Day 1)|Lost to Follow-up|0|||
147288515|NCT03701555|531220409|FG009|Part 2 (Day 1)|Lost to Follow-up|0|||
147288516|NCT03701555|531220410|FG010|Part 2 (Day 1)|Lost to Follow-up|0|||
147288517|NCT03701555|531220411|FG011|Part 2 (Day 1)|Lost to Follow-up|0|||
147288518|NCT03701555|531220412|FG012|Part 2 (Day 1)|Lost to Follow-up|0|||
147288519|NCT03701555|531220413|FG013|Part 2 (Day 1)|Lost to Follow-up|0|||
147288520|NCT03701555|531220414|FG014|Part 2 (Day 1)|Lost to Follow-up|0|||
147288521|NCT03701555|531220415|FG015|Part 2 (Day 1)|Lost to Follow-up|0|||
147288522|NCT03701555|531220416|FG016|Part 2 (Day 1)|Lost to Follow-up|0|||
147288523|NCT03701555|531220417|FG017|Part 2 (Day 1)|Lost to Follow-up|0|||
147288524|NCT03701555|531220418|FG018|Part 2 (Day 1)|Lost to Follow-up|0|||
147288525|NCT03701555|531220419|FG019|Part 2 (Day 1)|Lost to Follow-up|0|||
147288526|NCT03701555|531220420|FG020|Part 2 (Day 1)|Lost to Follow-up|0|||
147288527|NCT03701555|531220421|FG021|Part 2 (Day 1)|Lost to Follow-up|1|||
147288528|NCT03701555|531220422|FG022|Part 2 (Day 1)|Lost to Follow-up|0|||
147288529|NCT03701555|531220423|FG023|Part 2 (Day 1)|Lost to Follow-up|0|||
147288530|NCT03701555|531220424|FG024|Part 2 (Day 1)|Lost to Follow-up|0|||
147288531|NCT03701555|531220425|FG025|Part 2 (Day 1)|Lost to Follow-up|0|||
147288532|NCT03701555|531220426|FG026|Part 2 (Day 1)|Lost to Follow-up|0|||
147288533|NCT03701555|531220427|FG027|Part 2 (Day 1)|Lost to Follow-up|0|||
147288534|NCT03701555|531220428|FG028|Part 2 (Day 1)|Lost to Follow-up|0|||
147452522|NCT00687362|531819958|FG000|Overall Study|Protocol Violation|2|||
147452523|NCT00687362|531819958|FG000|Overall Study|Withdrawal by Subject|1|||
147452524|NCT02354703|531819959|FG000|Overall Study|Withdrawal by Subject|1|||
147288535|NCT03701555|531220429|FG029|Part 2 (Day 1)|Lost to Follow-up|0|||
147288536|NCT03701555|531220430|FG030|Part 2 (Day 1)|Lost to Follow-up|0|||
147288537|NCT03701555|531220431|FG031|Part 2 (Day 1)|Lost to Follow-up|0|||
147452525|NCT02354703|531819960|FG001|Overall Study|Withdrawal by Subject|1|||
147452526|NCT02354703|531819961|FG002|Overall Study|Withdrawal by Subject|1|||
147288538|NCT03701555|531220432|FG032|Part 2 (Day 1)|Lost to Follow-up|0|||
147288539|NCT03701555|531220433|FG033|Part 2 (Day 1)|Lost to Follow-up|0|||
147288540|NCT03701555|531220434|FG034|Part 2 (Day 1)|Lost to Follow-up|0|||
147288541|NCT03701555|531220435|FG035|Part 2 (Day 1)|Lost to Follow-up|0|||
147288542|NCT03701555|531220400|FG000|Part 2 (Day 1)|Subject Non-compliance|0|||
147288543|NCT03701555|531220401|FG001|Part 2 (Day 1)|Subject Non-compliance|0|||
147288544|NCT03701555|531220402|FG002|Part 2 (Day 1)|Subject Non-compliance|0|||
147288545|NCT03701555|531220403|FG003|Part 2 (Day 1)|Subject Non-compliance|0|||
147288546|NCT03701555|531220404|FG004|Part 2 (Day 1)|Subject Non-compliance|0|||
147288547|NCT03701555|531220405|FG005|Part 2 (Day 1)|Subject Non-compliance|0|||
147288548|NCT03701555|531220406|FG006|Part 2 (Day 1)|Subject Non-compliance|0|||
147288549|NCT03701555|531220407|FG007|Part 2 (Day 1)|Subject Non-compliance|0|||
147288550|NCT03701555|531220408|FG008|Part 2 (Day 1)|Subject Non-compliance|0|||
147288551|NCT03701555|531220409|FG009|Part 2 (Day 1)|Subject Non-compliance|0|||
147288552|NCT03701555|531220410|FG010|Part 2 (Day 1)|Subject Non-compliance|0|||
147288553|NCT03701555|531220411|FG011|Part 2 (Day 1)|Subject Non-compliance|0|||
147337788|NCT01787760|531402953|FG002|Overall Study|Anisometropia > -1.00D in spherical equi|0|||
147337789|NCT01787760|531402951|FG000|Overall Study|Decompensated on left exotropia|0|||
147337790|NCT01787760|531402952|FG001|Overall Study|Decompensated on left exotropia|0|||
147337791|NCT01787760|531402953|FG002|Overall Study|Decompensated on left exotropia|1|||
147604298|NCT00901576|532367866|FG003|Second Intervention|Physician Decision|0|||
147604299|NCT00901576|532367867|FG004|Second Intervention|Physician Decision|0|||
147604300|NCT00901576|532367868|FG005|Second Intervention|Physician Decision|0|||
147604301|NCT00171951|532367871|FG000|Overall Study|Adverse Event|1|||
147604302|NCT00171951|532367871|FG000|Overall Study|Abnormal Laboratory Values|2|||
147604303|NCT00171951|532367871|FG000|Overall Study|Unsatisfactory Therapeutic Effect|3|||
147604304|NCT00171951|532367871|FG000|Overall Study|Participants Withdrew Consent|3|||
147604305|NCT00171951|532367871|FG000|Overall Study|New Cancer Therapy|5|||
147604306|NCT00171951|532367871|FG000|Overall Study|Reason not Specified|2|||
147288554|NCT03701555|531220412|FG012|Part 2 (Day 1)|Subject Non-compliance|0|||
147288555|NCT03701555|531220413|FG013|Part 2 (Day 1)|Subject Non-compliance|1|||
147288556|NCT03701555|531220414|FG014|Part 2 (Day 1)|Subject Non-compliance|0|||
147288557|NCT03701555|531220415|FG015|Part 2 (Day 1)|Subject Non-compliance|0|||
147337792|NCT01787760|531402951|FG000|Overall Study|Dryness|0|||
147337793|NCT01787760|531402952|FG001|Overall Study|Dryness|1|||
147337794|NCT01787760|531402953|FG002|Overall Study|Dryness|0|||
147337795|NCT01787760|531402951|FG000|Overall Study|Relocation|1|||
147337796|NCT01787760|531402952|FG001|Overall Study|Relocation|1|||
147337797|NCT01787760|531402953|FG002|Overall Study|Relocation|0|||
147337798|NCT01787760|531402951|FG000|Overall Study|Lens discomfort|3|||
147337799|NCT01787760|531402952|FG001|Overall Study|Lens discomfort|0|||
147337800|NCT01787760|531402953|FG002|Overall Study|Lens discomfort|0|||
147337801|NCT01787760|531402951|FG000|Overall Study|Lens handling difficulty|1|||
147337802|NCT01787760|531402952|FG001|Overall Study|Lens handling difficulty|2|||
147337803|NCT01787760|531402953|FG002|Overall Study|Lens handling difficulty|0|||
147337804|NCT01787760|531402951|FG000|Overall Study|Protocol Violation|6|||
147337805|NCT01787760|531402952|FG001|Overall Study|Protocol Violation|0|||
147337806|NCT01787760|531402953|FG002|Overall Study|Protocol Violation|1|||
147337807|NCT01787760|531402951|FG000|Overall Study|Withdrawal by Subject|5|||
147337808|NCT01787760|531402952|FG001|Overall Study|Withdrawal by Subject|1|||
147337809|NCT01787760|531402953|FG002|Overall Study|Withdrawal by Subject|2|||
147337810|NCT01787760|531402951|FG000|Overall Study|Lost to Follow-up|1|||
147337811|NCT01787760|531402952|FG001|Overall Study|Lost to Follow-up|0|||
147337812|NCT01787760|531402953|FG002|Overall Study|Lost to Follow-up|1|||
147337813|NCT01787760|531402951|FG000|Overall Study|Stroke|1|||
147337814|NCT01787760|531402952|FG001|Overall Study|Stroke|0|||
147337815|NCT01787760|531402953|FG002|Overall Study|Stroke|0|||
147337816|NCT01787760|531402951|FG000|Overall Study|Unsatisfactory lens fitting performance|3|||
147337817|NCT01787760|531402952|FG001|Overall Study|Unsatisfactory lens fitting performance|6|||
147337818|NCT01787760|531402953|FG002|Overall Study|Unsatisfactory lens fitting performance|0|||
147337819|NCT01787760|531402951|FG000|Overall Study|Unsatisfactory physiological response|2|||
147337820|NCT01787760|531402952|FG001|Overall Study|Unsatisfactory physiological response|4|||
147337821|NCT01787760|531402953|FG002|Overall Study|Unsatisfactory physiological response|0|||
147337822|NCT01787760|531402951|FG000|Overall Study|Unsatisfactory visual response|1|||
147337823|NCT01787760|531402952|FG001|Overall Study|Unsatisfactory visual response|1|||
147337824|NCT01787760|531402953|FG002|Overall Study|Unsatisfactory visual response|0|||
147604307|NCT00724048|532367872|FG000|Overall Study|Adverse Event|1|||
147604308|NCT00724048|532367873|FG001|Overall Study|Adverse Event|1|||
147604309|NCT00724048|532367874|FG002|Overall Study|Adverse Event|1|||
147288558|NCT03701555|531220416|FG016|Part 2 (Day 1)|Subject Non-compliance|1|||
147288559|NCT03701555|531220417|FG017|Part 2 (Day 1)|Subject Non-compliance|2|||
147288560|NCT03701555|531220418|FG018|Part 2 (Day 1)|Subject Non-compliance|0|||
147337825|NCT01787760|531402951|FG000|Overall Study|Near vision blur|1|||
147337826|NCT01787760|531402952|FG001|Overall Study|Near vision blur|0|||
147337827|NCT01787760|531402953|FG002|Overall Study|Near vision blur|0|||
147337828|NCT03512756|531402954|FG000|Part 1|Death|23|||
147604310|NCT00724048|532367875|FG003|Overall Study|Adverse Event|0|||
147288561|NCT03701555|531220419|FG019|Part 2 (Day 1)|Subject Non-compliance|0|||
147288562|NCT03701555|531220420|FG020|Part 2 (Day 1)|Subject Non-compliance|0|||
147288563|NCT03701555|531220421|FG021|Part 2 (Day 1)|Subject Non-compliance|0|||
147288564|NCT03701555|531220422|FG022|Part 2 (Day 1)|Subject Non-compliance|0|||
147288565|NCT03701555|531220423|FG023|Part 2 (Day 1)|Subject Non-compliance|1|||
147288566|NCT03701555|531220424|FG024|Part 2 (Day 1)|Subject Non-compliance|0|||
147288567|NCT03701555|531220425|FG025|Part 2 (Day 1)|Subject Non-compliance|0|||
147288568|NCT03701555|531220426|FG026|Part 2 (Day 1)|Subject Non-compliance|0|||
147288569|NCT03701555|531220427|FG027|Part 2 (Day 1)|Subject Non-compliance|0|||
147288570|NCT03701555|531220428|FG028|Part 2 (Day 1)|Subject Non-compliance|0|||
147288571|NCT03701555|531220429|FG029|Part 2 (Day 1)|Subject Non-compliance|0|||
147288572|NCT03701555|531220430|FG030|Part 2 (Day 1)|Subject Non-compliance|0|||
147288573|NCT03701555|531220431|FG031|Part 2 (Day 1)|Subject Non-compliance|0|||
147288574|NCT03701555|531220432|FG032|Part 2 (Day 1)|Subject Non-compliance|0|||
147288575|NCT03701555|531220433|FG033|Part 2 (Day 1)|Subject Non-compliance|0|||
147288576|NCT03701555|531220434|FG034|Part 2 (Day 1)|Subject Non-compliance|0|||
147288577|NCT03701555|531220435|FG035|Part 2 (Day 1)|Subject Non-compliance|0|||
147288578|NCT03701555|531220400|FG000|Part 2 (Day 1)|Other|0|||
147288579|NCT03701555|531220401|FG001|Part 2 (Day 1)|Other|0|||
147288580|NCT03701555|531220402|FG002|Part 2 (Day 1)|Other|0|||
147288581|NCT03701555|531220403|FG003|Part 2 (Day 1)|Other|0|||
147288582|NCT03701555|531220404|FG004|Part 2 (Day 1)|Other|0|||
147288583|NCT03701555|531220405|FG005|Part 2 (Day 1)|Other|0|||
147288584|NCT03701555|531220406|FG006|Part 2 (Day 1)|Other|0|||
147288585|NCT03701555|531220407|FG007|Part 2 (Day 1)|Other|0|||
147288586|NCT03701555|531220408|FG008|Part 2 (Day 1)|Other|0|||
147288587|NCT03701555|531220409|FG009|Part 2 (Day 1)|Other|0|||
147288588|NCT03701555|531220410|FG010|Part 2 (Day 1)|Other|3|||
147288589|NCT03701555|531220411|FG011|Part 2 (Day 1)|Other|1|||
147288590|NCT03701555|531220412|FG012|Part 2 (Day 1)|Other|0|||
147288591|NCT03701555|531220413|FG013|Part 2 (Day 1)|Other|1|||
147288592|NCT03701555|531220414|FG014|Part 2 (Day 1)|Other|0|||
147288593|NCT03701555|531220415|FG015|Part 2 (Day 1)|Other|2|||
147288594|NCT03701555|531220416|FG016|Part 2 (Day 1)|Other|2|||
147288595|NCT03701555|531220417|FG017|Part 2 (Day 1)|Other|0|||
147288596|NCT03701555|531220418|FG018|Part 2 (Day 1)|Other|0|||
147288597|NCT03701555|531220419|FG019|Part 2 (Day 1)|Other|0|||
147288598|NCT03701555|531220420|FG020|Part 2 (Day 1)|Other|0|||
147288599|NCT03701555|531220421|FG021|Part 2 (Day 1)|Other|0|||
147288600|NCT03701555|531220422|FG022|Part 2 (Day 1)|Other|0|||
147288601|NCT03701555|531220423|FG023|Part 2 (Day 1)|Other|0|||
147288602|NCT03701555|531220424|FG024|Part 2 (Day 1)|Other|0|||
147288603|NCT03701555|531220425|FG025|Part 2 (Day 1)|Other|0|||
147288604|NCT03701555|531220426|FG026|Part 2 (Day 1)|Other|0|||
147288605|NCT03701555|531220427|FG027|Part 2 (Day 1)|Other|0|||
147288606|NCT03701555|531220428|FG028|Part 2 (Day 1)|Other|0|||
147288607|NCT03701555|531220429|FG029|Part 2 (Day 1)|Other|0|||
147288608|NCT03701555|531220430|FG030|Part 2 (Day 1)|Other|0|||
147288609|NCT03701555|531220431|FG031|Part 2 (Day 1)|Other|0|||
147288610|NCT03701555|531220432|FG032|Part 2 (Day 1)|Other|0|||
147288611|NCT03701555|531220433|FG033|Part 2 (Day 1)|Other|0|||
147288612|NCT03701555|531220434|FG034|Part 2 (Day 1)|Other|0|||
147288613|NCT03701555|531220435|FG035|Part 2 (Day 1)|Other|0|||
147288614|NCT03701555|531220400|FG000|Part 3 (Day 1)|Subject Non-compliance|0|||
147288615|NCT03701555|531220401|FG001|Part 3 (Day 1)|Subject Non-compliance|0|||
147288616|NCT03701555|531220402|FG002|Part 3 (Day 1)|Subject Non-compliance|0|||
147288617|NCT03701555|531220403|FG003|Part 3 (Day 1)|Subject Non-compliance|0|||
147288618|NCT03701555|531220404|FG004|Part 3 (Day 1)|Subject Non-compliance|0|||
147288619|NCT03701555|531220405|FG005|Part 3 (Day 1)|Subject Non-compliance|0|||
147288620|NCT03701555|531220406|FG006|Part 3 (Day 1)|Subject Non-compliance|0|||
147288621|NCT03701555|531220407|FG007|Part 3 (Day 1)|Subject Non-compliance|0|||
147288622|NCT03701555|531220408|FG008|Part 3 (Day 1)|Subject Non-compliance|0|||
147288623|NCT03701555|531220409|FG009|Part 3 (Day 1)|Subject Non-compliance|0|||
147288624|NCT03701555|531220410|FG010|Part 3 (Day 1)|Subject Non-compliance|0|||
147288625|NCT03701555|531220411|FG011|Part 3 (Day 1)|Subject Non-compliance|0|||
147288626|NCT03701555|531220412|FG012|Part 3 (Day 1)|Subject Non-compliance|0|||
147288627|NCT03701555|531220413|FG013|Part 3 (Day 1)|Subject Non-compliance|0|||
147288628|NCT03701555|531220414|FG014|Part 3 (Day 1)|Subject Non-compliance|0|||
147288629|NCT03701555|531220415|FG015|Part 3 (Day 1)|Subject Non-compliance|0|||
147288630|NCT03701555|531220416|FG016|Part 3 (Day 1)|Subject Non-compliance|0|||
147288631|NCT03701555|531220417|FG017|Part 3 (Day 1)|Subject Non-compliance|0|||
147288632|NCT03701555|531220418|FG018|Part 3 (Day 1)|Subject Non-compliance|0|||
147288633|NCT03701555|531220419|FG019|Part 3 (Day 1)|Subject Non-compliance|0|||
147288634|NCT03701555|531220420|FG020|Part 3 (Day 1)|Subject Non-compliance|0|||
147288635|NCT03701555|531220421|FG021|Part 3 (Day 1)|Subject Non-compliance|0|||
147288636|NCT03701555|531220422|FG022|Part 3 (Day 1)|Subject Non-compliance|0|||
147288637|NCT03701555|531220423|FG023|Part 3 (Day 1)|Subject Non-compliance|0|||
147288638|NCT03701555|531220424|FG024|Part 3 (Day 1)|Subject Non-compliance|0|||
147288639|NCT03701555|531220425|FG025|Part 3 (Day 1)|Subject Non-compliance|0|||
147288640|NCT03701555|531220426|FG026|Part 3 (Day 1)|Subject Non-compliance|0|||
147337829|NCT03512756|531402955|FG001|Part 1|Death|18|||
147288641|NCT03701555|531220427|FG027|Part 3 (Day 1)|Subject Non-compliance|0|||
147288642|NCT03701555|531220428|FG028|Part 3 (Day 1)|Subject Non-compliance|0|||
147288643|NCT03701555|531220429|FG029|Part 3 (Day 1)|Subject Non-compliance|1|||
147288644|NCT03701555|531220430|FG030|Part 3 (Day 1)|Subject Non-compliance|0|||
147288645|NCT03701555|531220431|FG031|Part 3 (Day 1)|Subject Non-compliance|1|||
147288646|NCT03701555|531220432|FG032|Part 3 (Day 1)|Subject Non-compliance|0|||
147288647|NCT03701555|531220433|FG033|Part 3 (Day 1)|Subject Non-compliance|0|||
147288648|NCT03701555|531220434|FG034|Part 3 (Day 1)|Subject Non-compliance|0|||
147288649|NCT03701555|531220435|FG035|Part 3 (Day 1)|Subject Non-compliance|0|||
147288650|NCT03701555|531220400|FG000|Part 3 (Day 1)|Subject Decision|0|||
147288651|NCT03701555|531220401|FG001|Part 3 (Day 1)|Subject Decision|0|||
147288652|NCT03701555|531220402|FG002|Part 3 (Day 1)|Subject Decision|0|||
147288653|NCT03701555|531220403|FG003|Part 3 (Day 1)|Subject Decision|0|||
147288654|NCT03701555|531220404|FG004|Part 3 (Day 1)|Subject Decision|0|||
147288655|NCT03701555|531220405|FG005|Part 3 (Day 1)|Subject Decision|0|||
147288656|NCT03701555|531220406|FG006|Part 3 (Day 1)|Subject Decision|0|||
147288657|NCT03701555|531220407|FG007|Part 3 (Day 1)|Subject Decision|0|||
147288658|NCT03701555|531220408|FG008|Part 3 (Day 1)|Subject Decision|0|||
147288659|NCT03701555|531220409|FG009|Part 3 (Day 1)|Subject Decision|0|||
147288660|NCT03701555|531220410|FG010|Part 3 (Day 1)|Subject Decision|0|||
147288661|NCT03701555|531220411|FG011|Part 3 (Day 1)|Subject Decision|0|||
147288662|NCT03701555|531220412|FG012|Part 3 (Day 1)|Subject Decision|0|||
147288663|NCT03701555|531220413|FG013|Part 3 (Day 1)|Subject Decision|0|||
147288664|NCT03701555|531220414|FG014|Part 3 (Day 1)|Subject Decision|0|||
147288665|NCT03701555|531220415|FG015|Part 3 (Day 1)|Subject Decision|0|||
147288666|NCT03701555|531220416|FG016|Part 3 (Day 1)|Subject Decision|0|||
147288667|NCT03701555|531220417|FG017|Part 3 (Day 1)|Subject Decision|0|||
147288668|NCT03701555|531220418|FG018|Part 3 (Day 1)|Subject Decision|0|||
147288669|NCT03701555|531220419|FG019|Part 3 (Day 1)|Subject Decision|0|||
147288670|NCT03701555|531220420|FG020|Part 3 (Day 1)|Subject Decision|0|||
147288671|NCT03701555|531220421|FG021|Part 3 (Day 1)|Subject Decision|0|||
147288672|NCT03701555|531220422|FG022|Part 3 (Day 1)|Subject Decision|0|||
147288673|NCT03701555|531220423|FG023|Part 3 (Day 1)|Subject Decision|0|||
147288674|NCT03701555|531220424|FG024|Part 3 (Day 1)|Subject Decision|0|||
147288675|NCT03701555|531220425|FG025|Part 3 (Day 1)|Subject Decision|0|||
147288676|NCT03701555|531220426|FG026|Part 3 (Day 1)|Subject Decision|1|||
147288677|NCT03701555|531220427|FG027|Part 3 (Day 1)|Subject Decision|0|||
147288678|NCT03701555|531220428|FG028|Part 3 (Day 1)|Subject Decision|0|||
147288679|NCT03701555|531220429|FG029|Part 3 (Day 1)|Subject Decision|0|||
147288680|NCT03701555|531220430|FG030|Part 3 (Day 1)|Subject Decision|0|||
147288681|NCT03701555|531220431|FG031|Part 3 (Day 1)|Subject Decision|2|||
147288682|NCT03701555|531220432|FG032|Part 3 (Day 1)|Subject Decision|1|||
147288683|NCT03701555|531220433|FG033|Part 3 (Day 1)|Subject Decision|1|||
147288684|NCT03701555|531220434|FG034|Part 3 (Day 1)|Subject Decision|0|||
147288685|NCT03701555|531220435|FG035|Part 3 (Day 1)|Subject Decision|0|||
147337830|NCT03512756|531402956|FG002|Part 1|Death|0|||
147337831|NCT03512756|531402957|FG003|Part 1|Death|0|||
147337832|NCT03512756|531402954|FG000|Part 1|Lost to Follow-up|0|||
147337833|NCT03512756|531402955|FG001|Part 1|Lost to Follow-up|3|||
147337834|NCT03512756|531402956|FG002|Part 1|Lost to Follow-up|0|||
147337835|NCT03512756|531402957|FG003|Part 1|Lost to Follow-up|0|||
147337836|NCT03512756|531402954|FG000|Part 1|Physician Decision|0|||
147337837|NCT03512756|531402955|FG001|Part 1|Physician Decision|1|||
147337838|NCT03512756|531402956|FG002|Part 1|Physician Decision|0|||
147337839|NCT03512756|531402957|FG003|Part 1|Physician Decision|0|||
147337840|NCT03512756|531402954|FG000|Part 1|Withdrawal by Subject|2|||
147337841|NCT03512756|531402955|FG001|Part 1|Withdrawal by Subject|2|||
147337842|NCT03512756|531402956|FG002|Part 1|Withdrawal by Subject|0|||
147337843|NCT03512756|531402957|FG003|Part 1|Withdrawal by Subject|0|||
147337844|NCT03512756|531402954|FG000|Part 2|Death|0|||
147337845|NCT03512756|531402955|FG001|Part 2|Death|0|||
147337846|NCT03512756|531402956|FG002|Part 2|Death|32|||
147337847|NCT03512756|531402957|FG003|Part 2|Death|21|||
147337848|NCT03512756|531402954|FG000|Part 2|Lost to Follow-up|0|||
147288686|NCT03701555|531220400|FG000|Part 3 (Day 1)|Other|0|||
147288687|NCT03701555|531220401|FG001|Part 3 (Day 1)|Other|0|||
147288688|NCT03701555|531220402|FG002|Part 3 (Day 1)|Other|0|||
147288689|NCT03701555|531220403|FG003|Part 3 (Day 1)|Other|0|||
147337849|NCT03512756|531402955|FG001|Part 2|Lost to Follow-up|0|||
147337850|NCT03512756|531402956|FG002|Part 2|Lost to Follow-up|1|||
147337851|NCT03512756|531402957|FG003|Part 2|Lost to Follow-up|0|||
147337852|NCT03512756|531402954|FG000|Part 2|Physician Decision|0|||
147337853|NCT03512756|531402955|FG001|Part 2|Physician Decision|0|||
147288690|NCT03701555|531220404|FG004|Part 3 (Day 1)|Other|0|||
147288691|NCT03701555|531220405|FG005|Part 3 (Day 1)|Other|0|||
147288692|NCT03701555|531220406|FG006|Part 3 (Day 1)|Other|0|||
147288693|NCT03701555|531220407|FG007|Part 3 (Day 1)|Other|0|||
147288694|NCT03701555|531220408|FG008|Part 3 (Day 1)|Other|0|||
147288695|NCT03701555|531220409|FG009|Part 3 (Day 1)|Other|0|||
147288696|NCT03701555|531220410|FG010|Part 3 (Day 1)|Other|0|||
147337854|NCT03512756|531402956|FG002|Part 2|Physician Decision|2|||
147337855|NCT03512756|531402957|FG003|Part 2|Physician Decision|4|||
147337856|NCT03512756|531402954|FG000|Part 2|Study Terminated by Sponsor|0|||
147604311|NCT00724048|532367872|FG000|Overall Study|Lost to Follow-up|0|||
147288697|NCT03701555|531220411|FG011|Part 3 (Day 1)|Other|0|||
147288698|NCT03701555|531220412|FG012|Part 3 (Day 1)|Other|0|||
147288699|NCT03701555|531220413|FG013|Part 3 (Day 1)|Other|0|||
147288700|NCT03701555|531220414|FG014|Part 3 (Day 1)|Other|0|||
147288701|NCT03701555|531220415|FG015|Part 3 (Day 1)|Other|0|||
147288702|NCT03701555|531220416|FG016|Part 3 (Day 1)|Other|0|||
147288703|NCT03701555|531220417|FG017|Part 3 (Day 1)|Other|0|||
147288704|NCT03701555|531220418|FG018|Part 3 (Day 1)|Other|0|||
147288705|NCT03701555|531220419|FG019|Part 3 (Day 1)|Other|0|||
147288706|NCT03701555|531220420|FG020|Part 3 (Day 1)|Other|0|||
147288707|NCT03701555|531220421|FG021|Part 3 (Day 1)|Other|0|||
147288708|NCT03701555|531220422|FG022|Part 3 (Day 1)|Other|0|||
147288709|NCT03701555|531220423|FG023|Part 3 (Day 1)|Other|0|||
147288710|NCT03701555|531220424|FG024|Part 3 (Day 1)|Other|1|||
147288711|NCT03701555|531220425|FG025|Part 3 (Day 1)|Other|1|||
147288712|NCT03701555|531220426|FG026|Part 3 (Day 1)|Other|0|||
147288713|NCT03701555|531220427|FG027|Part 3 (Day 1)|Other|0|||
147288714|NCT03701555|531220428|FG028|Part 3 (Day 1)|Other|0|||
147288715|NCT03701555|531220429|FG029|Part 3 (Day 1)|Other|1|||
147288716|NCT03701555|531220430|FG030|Part 3 (Day 1)|Other|1|||
147288717|NCT03701555|531220431|FG031|Part 3 (Day 1)|Other|0|||
147288718|NCT03701555|531220432|FG032|Part 3 (Day 1)|Other|1|||
147288719|NCT03701555|531220433|FG033|Part 3 (Day 1)|Other|1|||
147288720|NCT03701555|531220434|FG034|Part 3 (Day 1)|Other|0|||
147288721|NCT03701555|531220435|FG035|Part 3 (Day 1)|Other|0|||
147288722|NCT04447404|531220443|FG000|Overall Study|Death|2|||
147337857|NCT03512756|531402955|FG001|Part 2|Study Terminated by Sponsor|0|||
147337858|NCT03512756|531402956|FG002|Part 2|Study Terminated by Sponsor|2|||
147337859|NCT03512756|531402957|FG003|Part 2|Study Terminated by Sponsor|6|||
147288723|NCT04447404|531220444|FG001|Overall Study|Death|0|||
147288724|NCT04723576|531220445|FG000|Overall Study|Withdrawal by Subject|2133|||
147288725|NCT04723576|531220446|FG001|Overall Study|Withdrawal by Subject|3234|||
147288726|NCT01064739|531220447|FG000|Fixed Sodium Diet + Fava Beans|Adverse Event|1|||
147288727|NCT04258020|531220450|FG000|Overall Study|Withdrawal by Subject|1|||
147288728|NCT04258020|531220451|FG001|Overall Study|Withdrawal by Subject|0|||
147288729|NCT02097472|531220452|FG000|Received Vaccination 2|Adverse Event|0|||
147288730|NCT02097472|531220453|FG001|Received Vaccination 2|Adverse Event|0|||
147288731|NCT02097472|531220454|FG002|Received Vaccination 2|Adverse Event|0|||
147288732|NCT02097472|531220455|FG003|Received Vaccination 2|Adverse Event|0|||
147288733|NCT02097472|531220456|FG004|Received Vaccination 2|Adverse Event|0|||
147288734|NCT02097472|531220457|FG005|Received Vaccination 2|Adverse Event|0|||
147288735|NCT02097472|531220458|FG006|Received Vaccination 2|Adverse Event|1|||
147288736|NCT02097472|531220459|FG007|Received Vaccination 2|Adverse Event|0|||
147288737|NCT04004611|531220460|FG000|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
147288738|NCT04004611|531220461|FG001|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
147288739|NCT04004611|531220462|FG002|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
147288740|NCT04004611|531220463|FG003|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
147288741|NCT04004611|531220464|FG004|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
147288742|NCT04004611|531220465|FG005|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
147288743|NCT04004611|531220466|FG006|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
147288744|NCT04004611|531220467|FG007|OL Maintenance Period (Wk 12-52)|Adverse Event|0|||
147288745|NCT04004611|531220468|FG008|OL Maintenance Period (Wk 12-52)|Adverse Event|1|||
147288746|NCT04004611|531220460|FG000|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|0|||
147288747|NCT04004611|531220461|FG001|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|0|||
147337860|NCT03512756|531402954|FG000|Part 2|Protocol Violation|0|||
147337861|NCT03512756|531402955|FG001|Part 2|Protocol Violation|0|||
147337862|NCT03512756|531402956|FG002|Part 2|Protocol Violation|1|||
147337863|NCT03512756|531402957|FG003|Part 2|Protocol Violation|0|||
147337864|NCT03512756|531402954|FG000|Part 2|Withdrawal by Subject|0|||
147337865|NCT03512756|531402955|FG001|Part 2|Withdrawal by Subject|0|||
147337866|NCT03512756|531402956|FG002|Part 2|Withdrawal by Subject|3|||
147337867|NCT03512756|531402957|FG003|Part 2|Withdrawal by Subject|9|||
147337868|NCT04250883|531404740|FG000|Overall Study|Lost to Follow-up|1|||
147337869|NCT04250883|531404741|FG001|Overall Study|Lost to Follow-up|0|||
147452527|NCT02354703|531819962|FG003|Overall Study|Withdrawal by Subject|1|||
147452528|NCT02354703|531819959|FG000|Overall Study|Lost to Follow-up|2|||
147452529|NCT02354703|531819960|FG001|Overall Study|Lost to Follow-up|7|||
147288748|NCT04004611|531220462|FG002|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|0|||
147288749|NCT04004611|531220463|FG003|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|0|||
147288750|NCT04004611|531220464|FG004|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|0|||
147288751|NCT04004611|531220465|FG005|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|1|||
147288752|NCT04004611|531220466|FG006|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|1|||
147288753|NCT04004611|531220467|FG007|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|0|||
147288754|NCT04004611|531220468|FG008|OL Maintenance Period (Wk 12-52)|Lack of Efficacy|3|||
147288755|NCT04004611|531220460|FG000|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
147288756|NCT04004611|531220461|FG001|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
147337870|NCT01318382|531404743|FG000|Overall Study|Physician Decision|2|||
147337871|NCT01318382|531404743|FG000|Overall Study|Device Malfunction|10|||
147337872|NCT01318382|531404743|FG000|Overall Study|Protocol Violation|1|||
147452530|NCT02354703|531819961|FG002|Overall Study|Lost to Follow-up|9|||
147452531|NCT02354703|531819962|FG003|Overall Study|Lost to Follow-up|2|||
147452532|NCT02354703|531819959|FG000|Overall Study|Adverse Event|0|||
147452533|NCT02354703|531819960|FG001|Overall Study|Adverse Event|0|||
147452534|NCT02354703|531819961|FG002|Overall Study|Adverse Event|1|||
147452535|NCT02354703|531819962|FG003|Overall Study|Adverse Event|0|||
147452536|NCT01268293|531819967|FG000|Overall Study|Disease progression|7|||
147452537|NCT01268293|531819967|FG000|Overall Study|Adverse Event|1|||
147288757|NCT04004611|531220462|FG002|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
147288758|NCT04004611|531220463|FG003|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
147288759|NCT04004611|531220464|FG004|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|1|||
147288760|NCT04004611|531220465|FG005|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
147288761|NCT04004611|531220466|FG006|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
147288762|NCT04004611|531220467|FG007|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
147288763|NCT04004611|531220468|FG008|OL Maintenance Period (Wk 12-52)|Withdrawal by Parent or Guardian|0|||
147288764|NCT04004611|531220460|FG000|OL Induction and Maintenance Period|Adverse Event|0|||
147288765|NCT04004611|531220461|FG001|OL Induction and Maintenance Period|Adverse Event|0|||
147288766|NCT04004611|531220462|FG002|OL Induction and Maintenance Period|Adverse Event|1|||
147288767|NCT04004611|531220463|FG003|OL Induction and Maintenance Period|Adverse Event|0|||
147288768|NCT04004611|531220464|FG004|OL Induction and Maintenance Period|Adverse Event|0|||
147288769|NCT04004611|531220465|FG005|OL Induction and Maintenance Period|Adverse Event|0|||
147288770|NCT04004611|531220466|FG006|OL Induction and Maintenance Period|Adverse Event|0|||
147288771|NCT04004611|531220467|FG007|OL Induction and Maintenance Period|Adverse Event|0|||
147288772|NCT04004611|531220468|FG008|OL Induction and Maintenance Period|Adverse Event|0|||
147288773|NCT04004611|531220460|FG000|OL Induction and Maintenance Period|Lack of Efficacy|1|||
147288774|NCT04004611|531220461|FG001|OL Induction and Maintenance Period|Lack of Efficacy|0|||
147288775|NCT04004611|531220462|FG002|OL Induction and Maintenance Period|Lack of Efficacy|4|||
147288776|NCT04004611|531220463|FG003|OL Induction and Maintenance Period|Lack of Efficacy|0|||
147288777|NCT04004611|531220464|FG004|OL Induction and Maintenance Period|Lack of Efficacy|0|||
147288778|NCT04004611|531220465|FG005|OL Induction and Maintenance Period|Lack of Efficacy|0|||
147288779|NCT04004611|531220466|FG006|OL Induction and Maintenance Period|Lack of Efficacy|0|||
147288780|NCT04004611|531220467|FG007|OL Induction and Maintenance Period|Lack of Efficacy|0|||
147288781|NCT04004611|531220468|FG008|OL Induction and Maintenance Period|Lack of Efficacy|0|||
147288782|NCT04004611|531220460|FG000|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
147288783|NCT04004611|531220461|FG001|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|1|||
147288784|NCT04004611|531220462|FG002|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
147288785|NCT04004611|531220463|FG003|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
147288786|NCT04004611|531220464|FG004|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
147288787|NCT04004611|531220465|FG005|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
147288788|NCT04004611|531220466|FG006|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
147288789|NCT04004611|531220467|FG007|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
147288790|NCT04004611|531220468|FG008|OL Induction and Maintenance Period|Withdrawal by Parent or Guardian|0|||
147288791|NCT03834779|531220474|FG000|Overall Study|Death|1|||
147288792|NCT03834779|531220475|FG001|Overall Study|Death|2|||
147288793|NCT03834779|531220474|FG000|Overall Study|Lost to Follow-up|6|||
147288794|NCT03834779|531220475|FG001|Overall Study|Lost to Follow-up|4|||
147288795|NCT01519206|531220480|FG000|Overall Study|Lost to Follow-up|3|||
147288796|NCT01519206|531220480|FG000|Overall Study|Missed Visit|2|||
147288797|NCT03579563|531220484|FG000|Overall Study|Lost to Follow-up|0|||
147288798|NCT03579563|531220485|FG001|Overall Study|Lost to Follow-up|0|||
147288799|NCT03579563|531220486|FG002|Overall Study|Lost to Follow-up|0|||
147337873|NCT01599104|531404744|FG000|Overall Study|Withdrawal by Subject|1|||
147337874|NCT01599104|531404745|FG001|Overall Study|Withdrawal by Subject|1|||
147337875|NCT01599104|531404746|FG002|Overall Study|Withdrawal by Subject|2|||
147337876|NCT01599104|531404744|FG000|Overall Study|Technical Problems|1|||
147337877|NCT01599104|531404745|FG001|Overall Study|Technical Problems|0|||
147337878|NCT01599104|531404746|FG002|Overall Study|Technical Problems|0|||
147337879|NCT01599104|531404744|FG000|Overall Study|Physician Decision|3|||
147337880|NCT01599104|531404745|FG001|Overall Study|Physician Decision|2|||
147337881|NCT01599104|531404746|FG002|Overall Study|Physician Decision|2|||
147452538|NCT01268293|531819967|FG000|Overall Study|Subject choice|1|||
147452539|NCT00699348|531819968|FG000|Overall Study|Death|6|||
147452540|NCT00699348|531819968|FG000|Overall Study|Adverse Event|15|||
147604312|NCT00724048|532367873|FG001|Overall Study|Lost to Follow-up|1|||
147337882|NCT01599104|531404744|FG000|Overall Study|Non-compliance with study treatment|0|||
147337883|NCT01599104|531404745|FG001|Overall Study|Non-compliance with study treatment|1|||
147337884|NCT01599104|531404746|FG002|Overall Study|Non-compliance with study treatment|0|||
147452541|NCT00699348|531819968|FG000|Overall Study|Withdrawal by Subject|11|||
147452542|NCT00699348|531819968|FG000|Overall Study|Protocol Violation|10|||
147452543|NCT00699348|531819968|FG000|Overall Study|Lack of Efficacy|8|||
147604313|NCT00724048|532367874|FG002|Overall Study|Lost to Follow-up|0|||
147288800|NCT03579563|531220487|FG003|Overall Study|Lost to Follow-up|0|||
147288801|NCT03579563|531220488|FG004|Overall Study|Lost to Follow-up|1|||
147288802|NCT03579563|531220489|FG005|Overall Study|Lost to Follow-up|0|||
147288803|NCT03579563|531220484|FG000|Overall Study|Lack of Efficacy|1|||
147288804|NCT03579563|531220485|FG001|Overall Study|Lack of Efficacy|1|||
147288805|NCT03579563|531220486|FG002|Overall Study|Lack of Efficacy|4|||
147288806|NCT03579563|531220487|FG003|Overall Study|Lack of Efficacy|1|||
147452544|NCT00699348|531819968|FG000|Overall Study|Failure to return|1|||
147452545|NCT00699348|531819968|FG000|Overall Study|Blood transfusion|24|||
147452546|NCT00699348|531819968|FG000|Overall Study|Renal transplantation|10|||
147452547|NCT00699348|531819968|FG000|Overall Study|Other|5|||
147452548|NCT02597855|531819971|FG000|Overall Study|Lost to Follow-up|2|||
147452549|NCT02597855|531819972|FG001|Overall Study|Lost to Follow-up|1|||
147452550|NCT03704194|531819978|FG000|Overall Study|Withdrawal by Subject|0|||
147452551|NCT03704194|531819979|FG001|Overall Study|Withdrawal by Subject|1|||
147452552|NCT00925015|531819980|FG000|Overall Study|Adverse Event|1|||
147452553|NCT00925015|531819981|FG001|Overall Study|Adverse Event|2|||
147452554|NCT00925015|531819982|FG002|Overall Study|Adverse Event|1|||
147452555|NCT00925015|531819980|FG000|Overall Study|Physician Decision|0|||
147452556|NCT00925015|531819981|FG001|Overall Study|Physician Decision|1|||
147452557|NCT00925015|531819982|FG002|Overall Study|Physician Decision|0|||
147452558|NCT00925015|531819980|FG000|Overall Study|Progressive Disease|7|||
147452559|NCT00925015|531819981|FG001|Overall Study|Progressive Disease|3|||
147452560|NCT00925015|531819982|FG002|Overall Study|Progressive Disease|4|||
147452561|NCT00925015|531819980|FG000|Overall Study|Withdrawal by Subject|0|||
147288807|NCT03579563|531220488|FG004|Overall Study|Lack of Efficacy|2|||
147288808|NCT03579563|531220489|FG005|Overall Study|Lack of Efficacy|3|||
147452562|NCT00925015|531819981|FG001|Overall Study|Withdrawal by Subject|0|||
147288809|NCT03579563|531220484|FG000|Overall Study|Health concern (unrelated to the intervention of the study)|2|||
147288810|NCT03579563|531220485|FG001|Overall Study|Health concern (unrelated to the intervention of the study)|0|||
147288811|NCT03579563|531220486|FG002|Overall Study|Health concern (unrelated to the intervention of the study)|0|||
147288812|NCT03579563|531220487|FG003|Overall Study|Health concern (unrelated to the intervention of the study)|1|||
147288813|NCT03579563|531220488|FG004|Overall Study|Health concern (unrelated to the intervention of the study)|2|||
147288814|NCT03579563|531220489|FG005|Overall Study|Health concern (unrelated to the intervention of the study)|2|||
147288815|NCT03579563|531220484|FG000|Overall Study|Time/distance concern|0|||
147288816|NCT03579563|531220485|FG001|Overall Study|Time/distance concern|0|||
147288817|NCT03579563|531220486|FG002|Overall Study|Time/distance concern|1|||
147288818|NCT03579563|531220487|FG003|Overall Study|Time/distance concern|0|||
147288819|NCT03579563|531220488|FG004|Overall Study|Time/distance concern|0|||
147288820|NCT03579563|531220489|FG005|Overall Study|Time/distance concern|1|||
147288821|NCT03579563|531220484|FG000|Overall Study|COVID shutdown|2|||
147288822|NCT03579563|531220485|FG001|Overall Study|COVID shutdown|3|||
147288823|NCT03579563|531220486|FG002|Overall Study|COVID shutdown|4|||
147288824|NCT03579563|531220487|FG003|Overall Study|COVID shutdown|3|||
147288825|NCT03579563|531220488|FG004|Overall Study|COVID shutdown|1|||
147288826|NCT03579563|531220489|FG005|Overall Study|COVID shutdown|2|||
147288827|NCT03579563|531220484|FG000|Overall Study|Protocol administration error|1|||
147288828|NCT03579563|531220485|FG001|Overall Study|Protocol administration error|0|||
147288829|NCT03579563|531220486|FG002|Overall Study|Protocol administration error|1|||
147288830|NCT03579563|531220487|FG003|Overall Study|Protocol administration error|0|||
147288831|NCT03579563|531220488|FG004|Overall Study|Protocol administration error|1|||
147288832|NCT03579563|531220489|FG005|Overall Study|Protocol administration error|5|||
147288833|NCT04349553|531220493|FG000|Overall Study|Withdrawal by Subject|1|||
147288834|NCT04349553|531220494|FG001|Overall Study|Withdrawal by Subject|0|||
147288835|NCT04349553|531220495|FG002|Overall Study|Withdrawal by Subject|1|||
147288836|NCT04349553|531220496|FG003|Overall Study|Withdrawal by Subject|0|||
147288837|NCT03526250|531220497|FG000|Overall Study|Adverse Event|4|||
147288838|NCT03526250|531220497|FG000|Overall Study|Progressive Disease|16|||
147288839|NCT03526250|531220497|FG000|Overall Study|No Treatment|3|||
147452563|NCT00925015|531819982|FG002|Overall Study|Withdrawal by Subject|1|||
147452564|NCT04681170|531819987|FG000|Stratified Enrolment & run-in|Death|1|||
147452565|NCT04681170|531819988|FG001|Stratified Enrolment & run-in|Death|0|||
147288840|NCT04420221|531220498|FG000|Overall Study|Withdrawal by Subject|0|||
147288841|NCT04420221|531220499|FG001|Overall Study|Withdrawal by Subject|0|||
147288842|NCT04420221|531220500|FG002|Overall Study|Withdrawal by Subject|0|||
147288843|NCT04420221|531220501|FG003|Overall Study|Withdrawal by Subject|0|||
147288844|NCT04420221|531220502|FG004|Overall Study|Withdrawal by Subject|0|||
147288845|NCT04420221|531220503|FG005|Overall Study|Withdrawal by Subject|20|||
147288846|NCT04420221|531220504|FG006|Overall Study|Withdrawal by Subject|5|||
147288847|NCT04420221|531220498|FG000|Overall Study|Other|0|||
147288848|NCT04420221|531220499|FG001|Overall Study|Other|0|||
147288849|NCT04420221|531220500|FG002|Overall Study|Other|0|||
147288850|NCT04420221|531220501|FG003|Overall Study|Other|0|||
147452566|NCT04681170|531819987|FG000|Stratified Enrolment & run-in|Withdrawal by Subject|0|||
147452567|NCT04681170|531819988|FG001|Stratified Enrolment & run-in|Withdrawal by Subject|1|||
147452568|NCT04681170|531819987|FG000|Stratified Enrolment & run-in|Protocol Violation|0|||
147288851|NCT04420221|531220502|FG004|Overall Study|Other|0|||
147288852|NCT04420221|531220503|FG005|Overall Study|Other|1|||
147288853|NCT04420221|531220504|FG006|Overall Study|Other|1|||
147288854|NCT04420221|531220498|FG000|Overall Study|Lost to Follow-up|0|||
147288855|NCT04420221|531220499|FG001|Overall Study|Lost to Follow-up|0|||
147288856|NCT04420221|531220500|FG002|Overall Study|Lost to Follow-up|0|||
147288857|NCT04420221|531220501|FG003|Overall Study|Lost to Follow-up|0|||
147288858|NCT04420221|531220502|FG004|Overall Study|Lost to Follow-up|0|||
147288859|NCT04420221|531220503|FG005|Overall Study|Lost to Follow-up|3|||
147288860|NCT04420221|531220504|FG006|Overall Study|Lost to Follow-up|2|||
147288861|NCT04420221|531220498|FG000|Overall Study|Migrated / Moved from the Study Area|0|||
147288862|NCT04420221|531220499|FG001|Overall Study|Migrated / Moved from the Study Area|0|||
147288863|NCT04420221|531220500|FG002|Overall Study|Migrated / Moved from the Study Area|0|||
147288864|NCT04420221|531220501|FG003|Overall Study|Migrated / Moved from the Study Area|0|||
147288865|NCT04420221|531220502|FG004|Overall Study|Migrated / Moved from the Study Area|0|||
147288866|NCT04420221|531220503|FG005|Overall Study|Migrated / Moved from the Study Area|1|||
147288867|NCT04420221|531220504|FG006|Overall Study|Migrated / Moved from the Study Area|2|||
147288868|NCT02219932|531220505|FG000|Overall Study|Other|5|||
147288869|NCT02219932|531220506|FG001|Overall Study|Other|11|||
147288870|NCT02219932|531220505|FG000|Overall Study|Death|1|||
147288871|NCT02219932|531220506|FG001|Overall Study|Death|1|||
147288872|NCT02219932|531220505|FG000|Overall Study|Investigator Decision|0|||
147288873|NCT02219932|531220506|FG001|Overall Study|Investigator Decision|1|||
147288874|NCT02219932|531220505|FG000|Overall Study|Consent Withdrawn|11|||
147288875|NCT02219932|531220506|FG001|Overall Study|Consent Withdrawn|7|||
147288876|NCT02219932|531220505|FG000|Overall Study|Lack of Efficacy (Subject Perception)|10|||
147288877|NCT02219932|531220506|FG001|Overall Study|Lack of Efficacy (Subject Perception)|2|||
147288878|NCT02219932|531220505|FG000|Overall Study|Protocol Violation|10|||
147288879|NCT02219932|531220506|FG001|Overall Study|Protocol Violation|6|||
147288880|NCT02219932|531220505|FG000|Overall Study|Pregnancy|1|||
147288881|NCT02219932|531220506|FG001|Overall Study|Pregnancy|0|||
147288882|NCT02219932|531220505|FG000|Overall Study|Lost to Follow-up|4|||
147288883|NCT02219932|531220506|FG001|Overall Study|Lost to Follow-up|2|||
147288884|NCT02219932|531220505|FG000|Overall Study|Adverse Event|23|||
147288885|NCT02219932|531220506|FG001|Overall Study|Adverse Event|21|||
147288886|NCT00990652|531220507|FG000|Pre-surgical Bortezomib|Adverse Event|1|||
147288887|NCT00990652|531220507|FG000|Post-sugery Bortezomib + Temozolomide|Withdrawal by Subject|1|||
147288888|NCT01272934|531220513|FG000|Overall Study|Adverse Event|0|||
147288889|NCT01272934|531220514|FG001|Overall Study|Adverse Event|1|||
147288890|NCT01272934|531220513|FG000|Overall Study|Abnormal Laboratory Value|0|||
147288891|NCT01272934|531220514|FG001|Overall Study|Abnormal Laboratory Value|1|||
147288892|NCT01358526|531220519|FG000|Open-label Titration Period|Adverse Event|95|||
147288893|NCT01358526|531220520|FG001|Open-label Titration Period|Adverse Event|0|||
147288894|NCT01358526|531220521|FG002|Open-label Titration Period|Adverse Event|0|||
147288895|NCT01358526|531220519|FG000|Open-label Titration Period|Withdrawal by Subject|65|||
147288896|NCT01358526|531220520|FG001|Open-label Titration Period|Withdrawal by Subject|0|||
147288897|NCT01358526|531220521|FG002|Open-label Titration Period|Withdrawal by Subject|0|||
147288898|NCT01358526|531220519|FG000|Open-label Titration Period|Lost to Follow-up|25|||
147288899|NCT01358526|531220520|FG001|Open-label Titration Period|Lost to Follow-up|0|||
147288900|NCT01358526|531220521|FG002|Open-label Titration Period|Lost to Follow-up|0|||
147288901|NCT01358526|531220519|FG000|Open-label Titration Period|Lack of Efficacy|107|||
147288902|NCT01358526|531220520|FG001|Open-label Titration Period|Lack of Efficacy|0|||
147288903|NCT01358526|531220521|FG002|Open-label Titration Period|Lack of Efficacy|0|||
147288904|NCT01358526|531220519|FG000|Open-label Titration Period|Confirmed or suspected diversion|16|||
147288905|NCT01358526|531220520|FG001|Open-label Titration Period|Confirmed or suspected diversion|0|||
147288906|NCT01358526|531220521|FG002|Open-label Titration Period|Confirmed or suspected diversion|0|||
147288907|NCT01358526|531220519|FG000|Open-label Titration Period|Administrative|8|||
147288908|NCT01358526|531220520|FG001|Open-label Titration Period|Administrative|0|||
147288909|NCT01358526|531220521|FG002|Open-label Titration Period|Administrative|0|||
147288910|NCT01358526|531220519|FG000|Open-label Titration Period|Did not qualify|178|||
147288911|NCT01358526|531220520|FG001|Open-label Titration Period|Did not qualify|0|||
147288912|NCT01358526|531220521|FG002|Open-label Titration Period|Did not qualify|0|||
147288913|NCT01358526|531220519|FG000|Double-blind Phase|Adverse Event|0|||
147288914|NCT01358526|531220520|FG001|Double-blind Phase|Adverse Event|24|||
147288915|NCT01358526|531220521|FG002|Double-blind Phase|Adverse Event|23|||
147288916|NCT01358526|531220519|FG000|Double-blind Phase|Withdrawal by Subject|0|||
147288917|NCT01358526|531220520|FG001|Double-blind Phase|Withdrawal by Subject|10|||
147288918|NCT01358526|531220521|FG002|Double-blind Phase|Withdrawal by Subject|8|||
147288919|NCT01358526|531220519|FG000|Double-blind Phase|Lost to Follow-up|0|||
147288920|NCT01358526|531220520|FG001|Double-blind Phase|Lost to Follow-up|4|||
147288921|NCT01358526|531220521|FG002|Double-blind Phase|Lost to Follow-up|1|||
147288922|NCT01358526|531220519|FG000|Double-blind Phase|Lack of Efficacy|0|||
147288923|NCT01358526|531220520|FG001|Double-blind Phase|Lack of Efficacy|31|||
147288924|NCT01358526|531220521|FG002|Double-blind Phase|Lack of Efficacy|73|||
147337885|NCT01599104|531404744|FG000|Overall Study|Lack of Efficacy|4|||
147288925|NCT01358526|531220519|FG000|Double-blind Phase|Confirmed or suspected diversion|0|||
147288926|NCT01358526|531220520|FG001|Double-blind Phase|Confirmed or suspected diversion|5|||
147288927|NCT01358526|531220521|FG002|Double-blind Phase|Confirmed or suspected diversion|6|||
147288928|NCT01358526|531220519|FG000|Double-blind Phase|Administrative|0|||
147288929|NCT01358526|531220520|FG001|Double-blind Phase|Administrative|6|||
147288930|NCT01358526|531220521|FG002|Double-blind Phase|Administrative|10|||
147288931|NCT04558346|531220522|FG000|Overall Study|Withdrawal by Subject|2|||
147288932|NCT04558346|531220523|FG001|Overall Study|Withdrawal by Subject|0|||
147288933|NCT04558346|531220522|FG000|Overall Study|Lost to Follow-up|0|||
147288934|NCT04558346|531220523|FG001|Overall Study|Lost to Follow-up|1|||
147288935|NCT04558346|531220522|FG000|Overall Study|Adverse Event|0|||
147288936|NCT04558346|531220523|FG001|Overall Study|Adverse Event|1|||
147288937|NCT01462344|531220524|FG000|Overall Study|Withdrawal by Subject|245|||
147288938|NCT01462344|531220525|FG001|Overall Study|Withdrawal by Subject|226|||
147288939|NCT01462344|531220524|FG000|Overall Study|Adverse Event|24|||
147288940|NCT01462344|531220525|FG001|Overall Study|Adverse Event|23|||
147288941|NCT01462344|531220524|FG000|Overall Study|Asthma Exacerbation|34|||
147288942|NCT01462344|531220525|FG001|Overall Study|Asthma Exacerbation|35|||
147288943|NCT01462344|531220524|FG000|Overall Study|Lack of Efficacy|5|||
147288944|NCT01462344|531220525|FG001|Overall Study|Lack of Efficacy|6|||
147288945|NCT01462344|531220524|FG000|Overall Study|Protocol Violation|68|||
147288946|NCT01462344|531220525|FG001|Overall Study|Protocol Violation|53|||
147288947|NCT01462344|531220524|FG000|Overall Study|Lost to Follow-up|7|||
147288948|NCT01462344|531220525|FG001|Overall Study|Lost to Follow-up|7|||
147288949|NCT01962974|531220526|FG000|Overall Study|Study termination|7|||
147288950|NCT03086447|531220527|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
147288951|NCT03086447|531220528|FG001|Overall Study|No Longer Meets Eligibility Criteria|1|||
147288952|NCT03086447|531220527|FG000|Overall Study|Lost Lens|2|||
147288953|NCT03086447|531220528|FG001|Overall Study|Lost Lens|5|||
147288954|NCT03086447|531220527|FG000|Overall Study|Product quality complaint|0|||
147288955|NCT03086447|531220528|FG001|Overall Study|Product quality complaint|1|||
147288956|NCT03086447|531220527|FG000|Overall Study|Lens Damage|1|||
147288957|NCT03086447|531220528|FG001|Overall Study|Lens Damage|6|||
147288958|NCT03086447|531220527|FG000|Overall Study|Unsatisfactory Lens Fitting|0|||
147288959|NCT03086447|531220528|FG001|Overall Study|Unsatisfactory Lens Fitting|1|||
147288960|NCT03086447|531220527|FG000|Overall Study|Test Article No Longer Available|1|||
147288961|NCT03086447|531220528|FG001|Overall Study|Test Article No Longer Available|0|||
147288962|NCT03086447|531220527|FG000|Overall Study|Protocol Violation|2|||
147288963|NCT03086447|531220528|FG001|Overall Study|Protocol Violation|4|||
147288964|NCT03086447|531220527|FG000|Overall Study|Lost to Follow-up|0|||
147288965|NCT03086447|531220528|FG001|Overall Study|Lost to Follow-up|1|||
147288966|NCT03086447|531220527|FG000|Overall Study|Adverse Event|3|||
147288967|NCT03086447|531220528|FG001|Overall Study|Adverse Event|0|||
147288968|NCT03086447|531220527|FG000|Overall Study|Lens Discomfort|2|||
147288969|NCT03086447|531220528|FG001|Overall Study|Lens Discomfort|1|||
147288970|NCT00809757|531220530|FG000|Overall Study|Adverse Event|2|||
147288971|NCT00809757|531220531|FG001|Overall Study|Adverse Event|3|||
147288972|NCT00809757|531220532|FG002|Overall Study|Adverse Event|3|||
147288973|NCT00809757|531220530|FG000|Overall Study|Lost to Follow-up|0|||
147288974|NCT00809757|531220531|FG001|Overall Study|Lost to Follow-up|0|||
147288975|NCT00809757|531220532|FG002|Overall Study|Lost to Follow-up|1|||
147288976|NCT00809757|531220530|FG000|Overall Study|Protocol Violation|1|||
147288977|NCT00809757|531220531|FG001|Overall Study|Protocol Violation|1|||
147288978|NCT00809757|531220532|FG002|Overall Study|Protocol Violation|1|||
147288979|NCT00809757|531220530|FG000|Overall Study|Withdrawal by Subject|2|||
147288980|NCT00809757|531220531|FG001|Overall Study|Withdrawal by Subject|1|||
147288981|NCT00809757|531220532|FG002|Overall Study|Withdrawal by Subject|3|||
147288982|NCT00809757|531220530|FG000|Overall Study|Subject Uncooperative|1|||
147288983|NCT00809757|531220531|FG001|Overall Study|Subject Uncooperative|0|||
147288984|NCT00809757|531220532|FG002|Overall Study|Subject Uncooperative|2|||
147288985|NCT00809757|531220530|FG000|Overall Study|Noncompliance with Medication|0|||
147288986|NCT00809757|531220531|FG001|Overall Study|Noncompliance with Medication|0|||
147288987|NCT00809757|531220532|FG002|Overall Study|Noncompliance with Medication|1|||
147288988|NCT00659334|531220533|FG000|Overall Study|Screen Failure|8|||
147288989|NCT00659334|531220534|FG001|Overall Study|Screen Failure|5|||
147288990|NCT00659334|531220535|FG002|Overall Study|Screen Failure|0|||
147288991|NCT00659334|531220536|FG003|Overall Study|Screen Failure|0|||
147288992|NCT00659334|531220537|FG004|Overall Study|Screen Failure|0|||
147288993|NCT00659334|531220538|FG005|Overall Study|Screen Failure|0|||
147288994|NCT00659334|531220539|FG006|Overall Study|Screen Failure|1|||
147288995|NCT01174342|531220540|FG000|Overall Study|Conversion to cesarean section|4|||
147288996|NCT01218438|531220544|FG000|Epoch 1|Physician Decision|2|||
147288997|NCT01218438|531220544|FG000|Epoch 1|Adverse Event|1|||
147288998|NCT01218438|531220544|FG000|Epoch 3|Withdrawal by Subject|3|||
147288999|NCT01218438|531220544|FG000|Epoch 3|Adverse Event|1|||
147289000|NCT01218438|531220544|FG000|Epoch 4|Physician Decision|1|||
147289001|NCT01218438|531220544|FG000|Epoch 4|Withdrawal by Subject|2|||
147289002|NCT05819749|531220545|FG000|Overall Study|Lost to Follow-up|1|||
147289003|NCT05912400|531222640|FG000|Overall Study|Lost to Follow-up|1|||
147289004|NCT05912400|531222641|FG001|Overall Study|Lost to Follow-up|0|||
147289005|NCT05912400|531222640|FG000|Overall Study|Physician Decision|6|||
147289006|NCT05912400|531222641|FG001|Overall Study|Physician Decision|0|||
147289007|NCT05912400|531222640|FG000|Overall Study|Withdrawal by Subject|1|||
147289008|NCT05912400|531222641|FG001|Overall Study|Withdrawal by Subject|0|||
147289009|NCT02522494|531222644|FG000|Overall Study|Lost to Follow-up|6|||
147289010|NCT02522494|531222645|FG001|Overall Study|Lost to Follow-up|2|||
147289011|NCT02522494|531222644|FG000|Overall Study|Withdrawal by Subject|1|||
147289012|NCT02522494|531222645|FG001|Overall Study|Withdrawal by Subject|0|||
147289013|NCT02522494|531222644|FG000|Overall Study|CVT visit cancelled or no-show for CVT visit|6|||
147289014|NCT02522494|531222645|FG001|Overall Study|CVT visit cancelled or no-show for CVT visit|2|||
147289015|NCT02522494|531222644|FG000|Overall Study|Participant did not watch the video|1|||
147289016|NCT02522494|531222645|FG001|Overall Study|Participant did not watch the video|0|||
147289017|NCT02522494|531222644|FG000|Overall Study|Death|0|||
147289018|NCT02522494|531222645|FG001|Overall Study|Death|1|||
147289019|NCT03461003|531222650|FG000|Overall Study|Lost to Follow-up|2|||
147289020|NCT03461003|531222651|FG001|Overall Study|Lost to Follow-up|2|||
147289021|NCT03461003|531222650|FG000|Overall Study|Withdrawal by Subject|3|||
147289022|NCT03461003|531222651|FG001|Overall Study|Withdrawal by Subject|1|||
147289023|NCT00765843|531222655|FG000|Overall Study|Lost to Follow-up|1|||
147289024|NCT00765843|531222656|FG001|Overall Study|Lost to Follow-up|3|||
147289025|NCT00765843|531222657|FG002|Overall Study|Lost to Follow-up|2|||
147289026|NCT00765843|531222655|FG000|Overall Study|did not return to receive intervention|0|||
147289027|NCT00765843|531222656|FG001|Overall Study|did not return to receive intervention|1|||
147289028|NCT00765843|531222657|FG002|Overall Study|did not return to receive intervention|0|||
147289029|NCT00765843|531222655|FG000|Overall Study|Adverse Event|0|||
147289030|NCT00765843|531222656|FG001|Overall Study|Adverse Event|0|||
147289031|NCT00765843|531222657|FG002|Overall Study|Adverse Event|1|||
147289032|NCT02508311|531222658|FG000|Overall Study|Withdrawal by Subject|1|||
147289033|NCT02508311|531222659|FG001|Overall Study|Withdrawal by Subject|0|||
147289034|NCT00448539|531222660|FG000|Overall Study|Medication non-compliance|4|||
147289035|NCT00448539|531222661|FG001|Overall Study|Medication non-compliance|1|||
147289036|NCT00448539|531222660|FG000|Overall Study|Protocol Violation|1|||
147289037|NCT00448539|531222661|FG001|Overall Study|Protocol Violation|0|||
147289038|NCT00448539|531222660|FG000|Overall Study|Request of the investigator or sponsor|67|||
147289039|NCT00448539|531222661|FG001|Overall Study|Request of the investigator or sponsor|54|||
147289040|NCT00448539|531222660|FG000|Overall Study|Withdrawal by Subject|20|||
147289041|NCT00448539|531222661|FG001|Overall Study|Withdrawal by Subject|24|||
147289042|NCT00448539|531222660|FG000|Overall Study|Diary non-compliance|1|||
147289043|NCT00448539|531222661|FG001|Overall Study|Diary non-compliance|0|||
147289044|NCT00448539|531222660|FG000|Overall Study|Adverse Event|9|||
147289045|NCT00448539|531222661|FG001|Overall Study|Adverse Event|26|||
147289046|NCT00448539|531222660|FG000|Overall Study|Lack of Efficacy|27|||
147289047|NCT00448539|531222661|FG001|Overall Study|Lack of Efficacy|40|||
147289048|NCT00448539|531222660|FG000|Overall Study|Miscellaneous|2|||
147289049|NCT00448539|531222661|FG001|Overall Study|Miscellaneous|1|||
147289050|NCT00448539|531222660|FG000|Overall Study|Change of meds|2|||
147289051|NCT00448539|531222661|FG001|Overall Study|Change of meds|3|||
147289052|NCT00448539|531222660|FG000|Overall Study|Lost to Follow-up|1|||
147289053|NCT00448539|531222661|FG001|Overall Study|Lost to Follow-up|3|||
147289054|NCT04862143|531222662|FG000|Overall Study|Adverse Event|1|||
147289055|NCT04862143|531222662|FG000|Overall Study|Study terminated by sponsor|1|||
147289056|NCT02370602|531222663|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
147289057|NCT02370602|531222664|FG001|Overall Study|Pretreatment Event/Adverse Event|0|||
147289058|NCT02370602|531222665|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
147289059|NCT02370602|531222666|FG003|Overall Study|Pretreatment Event/Adverse Event|0|||
147289060|NCT02370602|531222667|FG004|Overall Study|Pretreatment Event/Adverse Event|0|||
147289061|NCT02370602|531222668|FG005|Overall Study|Pretreatment Event/Adverse Event|0|||
147289062|NCT02103439|531222669|FG000|Overall Study|Adverse Event|0|||
147289063|NCT02103439|531222670|FG001|Overall Study|Adverse Event|2|||
147289064|NCT02103439|531222669|FG000|Overall Study|Withdrawal by Subject|3|||
147289065|NCT02103439|531222670|FG001|Overall Study|Withdrawal by Subject|1|||
147289066|NCT03349710|531222671|FG000|Treatment Period|Death|0|||
147289067|NCT03349710|531222672|FG001|Treatment Period|Death|0|||
147289068|NCT03349710|531222673|FG002|Treatment Period|Death|1|||
147289069|NCT03349710|531222674|FG003|Treatment Period|Death|0|||
147289070|NCT03349710|531222671|FG000|Treatment Period|Disease Progression|0|||
147289071|NCT03349710|531222672|FG001|Treatment Period|Disease Progression|2|||
147289072|NCT03349710|531222673|FG002|Treatment Period|Disease Progression|0|||
147289073|NCT03349710|531222674|FG003|Treatment Period|Disease Progression|1|||
147289074|NCT03349710|531222671|FG000|Treatment Period|Study Drug Toxicity|1|||
147289075|NCT03349710|531222672|FG001|Treatment Period|Study Drug Toxicity|0|||
147289076|NCT03349710|531222673|FG002|Treatment Period|Study Drug Toxicity|1|||
147289077|NCT03349710|531222674|FG003|Treatment Period|Study Drug Toxicity|1|||
147289078|NCT03349710|531222671|FG000|Treatment Period|Adverse event unrelated to Study Drug|2|||
147337886|NCT01599104|531404745|FG001|Overall Study|Lack of Efficacy|4|||
147337887|NCT01599104|531404746|FG002|Overall Study|Lack of Efficacy|10|||
147337888|NCT01599104|531404744|FG000|Overall Study|Adverse Event|7|||
147337889|NCT01599104|531404745|FG001|Overall Study|Adverse Event|6|||
147337890|NCT01599104|531404746|FG002|Overall Study|Adverse Event|12|||
147337891|NCT02271854|531404751|FG000|Overall Study|Withdrawal by Subject|2|||
147337892|NCT02271854|531404751|FG000|Overall Study|Unable or unwilling to cooperate with st|1|||
147337893|NCT02271854|531404751|FG000|Overall Study|Lost to Follow-up|1|||
147337894|NCT01308567|531404752|FG000|Overall Study|Lost to Follow-up|2|||
147289079|NCT03349710|531222672|FG001|Treatment Period|Adverse event unrelated to Study Drug|1|||
147289080|NCT03349710|531222673|FG002|Treatment Period|Adverse event unrelated to Study Drug|1|||
147289081|NCT03349710|531222674|FG003|Treatment Period|Adverse event unrelated to Study Drug|1|||
147289082|NCT03349710|531222671|FG000|Treatment Period|admin reason by sponsor|0|||
147289083|NCT03349710|531222672|FG001|Treatment Period|admin reason by sponsor|7|||
147289084|NCT03349710|531222673|FG002|Treatment Period|admin reason by sponsor|0|||
147289085|NCT03349710|531222674|FG003|Treatment Period|admin reason by sponsor|19|||
147289086|NCT03349710|531222671|FG000|Treatment Period|Other Reason|2|||
147289087|NCT03349710|531222672|FG001|Treatment Period|Other Reason|0|||
147289088|NCT03349710|531222673|FG002|Treatment Period|Other Reason|2|||
147289089|NCT03349710|531222674|FG003|Treatment Period|Other Reason|1|||
147289090|NCT03349710|531222671|FG000|Treatment Period|completed|6|||
147289091|NCT03349710|531222672|FG001|Treatment Period|completed|0|||
147289092|NCT03349710|531222673|FG002|Treatment Period|completed|18|||
147289093|NCT03349710|531222674|FG003|Treatment Period|completed|1|||
147289094|NCT03349710|531222671|FG000|Treatment Period|participant request to discontinue|0|||
147289095|NCT03349710|531222672|FG001|Treatment Period|participant request to discontinue|0|||
147289096|NCT03349710|531222673|FG002|Treatment Period|participant request to discontinue|4|||
147289097|NCT03349710|531222674|FG003|Treatment Period|participant request to discontinue|0|||
147289098|NCT03349710|531222671|FG000|Treatment Period|participant withdrew consent|1|||
147289099|NCT03349710|531222672|FG001|Treatment Period|participant withdrew consent|0|||
147289100|NCT03349710|531222673|FG002|Treatment Period|participant withdrew consent|0|||
147289101|NCT03349710|531222674|FG003|Treatment Period|participant withdrew consent|0|||
147289102|NCT00695903|531222675|FG000|Had End of Therapy (EOT) Assessment|Randomized not treated|0|||
147289103|NCT00695903|531222676|FG001|Had End of Therapy (EOT) Assessment|Randomized not treated|2|||
147289104|NCT00695903|531222675|FG000|Had End of Therapy (EOT) Assessment|No confirmed MRSA|9|||
147289105|NCT00695903|531222676|FG001|Had End of Therapy (EOT) Assessment|No confirmed MRSA|9|||
147289106|NCT00695903|531222675|FG000|Had End of Therapy (EOT) Assessment|Adverse Event|1|||
147289107|NCT00695903|531222676|FG001|Had End of Therapy (EOT) Assessment|Adverse Event|0|||
147289108|NCT00695903|531222675|FG000|Had End of Therapy (EOT) Assessment|Withdrawal by Subject|1|||
147289109|NCT00695903|531222676|FG001|Had End of Therapy (EOT) Assessment|Withdrawal by Subject|1|||
147289110|NCT00695903|531222675|FG000|Had End of Therapy (EOT) Assessment|Physician Decision|0|||
147289111|NCT00695903|531222676|FG001|Had End of Therapy (EOT) Assessment|Physician Decision|1|||
147289112|NCT00695903|531222675|FG000|Had End of Therapy (EOT) Assessment|Protocol Violation|1|||
147289113|NCT00695903|531222676|FG001|Had End of Therapy (EOT) Assessment|Protocol Violation|2|||
147289114|NCT00695903|531222675|FG000|Had Test of Cure (TOC) Assessment|Lack of Efficacy|1|||
147289115|NCT00695903|531222676|FG001|Had Test of Cure (TOC) Assessment|Lack of Efficacy|0|||
147289116|NCT00695903|531222675|FG000|Had Test of Cure (TOC) Assessment|Lost to Follow-up|1|||
147289117|NCT00695903|531222676|FG001|Had Test of Cure (TOC) Assessment|Lost to Follow-up|0|||
147289118|NCT00695903|531222675|FG000|Had Test of Cure (TOC) Assessment|Adverse Event|0|||
147289119|NCT00695903|531222676|FG001|Had Test of Cure (TOC) Assessment|Adverse Event|1|||
147289120|NCT02696317|531222677|FG000|Habitual, 10 Days of Wear|Withdrawal by Subject|2|||
147289121|NCT02696317|531222678|FG001|Habitual, 10 Days of Wear|Withdrawal by Subject|4|||
147289122|NCT02696317|531222677|FG000|Period 2, 10 Days of Wear|Withdrawal by Subject|1|||
147289123|NCT02696317|531222678|FG001|Period 2, 10 Days of Wear|Withdrawal by Subject|0|||
147289124|NCT01343368|531222679|FG000|Overall Study|Death|1|||
147289125|NCT01343368|531222680|FG001|Overall Study|Death|0|||
147289126|NCT01343368|531222679|FG000|Overall Study|Lost to Follow-up|1|||
147289127|NCT01343368|531222680|FG001|Overall Study|Lost to Follow-up|0|||
147289128|NCT01296568|531222686|FG000|Continued Access Phase|Lost to Follow-up|1|||
147289129|NCT01296568|531222686|FG000|Continued Access Phase|Withdrawal by Subject|1|||
147289130|NCT01296568|531222686|FG000|Continued Access Phase|Disease Progression|1|||
147289131|NCT00321854|531222687|FG000|Overall Study|Adverse Event|41|||
147289132|NCT00321854|531222688|FG001|Overall Study|Adverse Event|43|||
147289133|NCT00321854|531222687|FG000|Overall Study|Lack of Efficacy|9|||
147289134|NCT00321854|531222688|FG001|Overall Study|Lack of Efficacy|14|||
147289135|NCT00321854|531222687|FG000|Overall Study|Protocol Violation|6|||
147289136|NCT00321854|531222688|FG001|Overall Study|Protocol Violation|5|||
147289137|NCT00321854|531222687|FG000|Overall Study|Lost to Follow-up|0|||
147289138|NCT00321854|531222688|FG001|Overall Study|Lost to Follow-up|2|||
147289139|NCT00321854|531222687|FG000|Overall Study|Withdrawal by Subject|6|||
147337895|NCT01308567|531404753|FG001|Overall Study|Lost to Follow-up|4|||
147337896|NCT01308567|531404754|FG002|Overall Study|Lost to Follow-up|4|||
147337897|NCT01571596|531404757|FG000|Overall Study|Adverse Event|2|||
147289140|NCT00321854|531222688|FG001|Overall Study|Withdrawal by Subject|17|||
147289141|NCT00321854|531222687|FG000|Overall Study|Other|1|||
147289142|NCT00321854|531222688|FG001|Overall Study|Other|1|||
147289143|NCT01816594|531222689|FG000|Overall Study|Local Progress|0|||
147289144|NCT01816594|531222690|FG001|Overall Study|Local Progress|2|||
147289145|NCT01816594|531222689|FG000|Overall Study|Adverse Event|9|||
147289146|NCT01816594|531222690|FG001|Overall Study|Adverse Event|0|||
147289147|NCT01816594|531222689|FG000|Overall Study|Withdrawal by Subject|1|||
147289148|NCT01816594|531222690|FG001|Overall Study|Withdrawal by Subject|0|||
147289149|NCT01816594|531222689|FG000|Overall Study|Physician Decision|1|||
147289150|NCT01816594|531222690|FG001|Overall Study|Physician Decision|0|||
147289151|NCT00413153|531222691|FG000|Overall Study|Withdrawal by Subject|1|||
147289152|NCT00413153|531222692|FG001|Overall Study|Withdrawal by Subject|1|||
147289153|NCT00413153|531222691|FG000|Overall Study|Adverse Event|1|||
147289154|NCT00413153|531222692|FG001|Overall Study|Adverse Event|0|||
147289155|NCT00454051|531222693|FG000|Overall Study|Adverse Event|1|||
147289156|NCT00454051|531222694|FG001|Overall Study|Adverse Event|2|||
147289157|NCT00454051|531222693|FG000|Overall Study|Withdrawal by Subject|1|||
147289158|NCT00454051|531222694|FG001|Overall Study|Withdrawal by Subject|0|||
147289159|NCT00454051|531222693|FG000|Overall Study|Protocol Violation|1|||
147289160|NCT00454051|531222694|FG001|Overall Study|Protocol Violation|1|||
147289161|NCT01571362|531222695|FG000|Open-Label Conversion + Titration Period|Withdrawal by Subject|11|||
147289162|NCT01571362|531222696|FG001|Open-Label Conversion + Titration Period|Withdrawal by Subject|0|||
147289163|NCT01571362|531222697|FG002|Open-Label Conversion + Titration Period|Withdrawal by Subject|0|||
147337898|NCT01571596|531404758|FG001|Overall Study|Adverse Event|0|||
147337899|NCT01571596|531404759|FG002|Overall Study|Adverse Event|0|||
147337900|NCT01571596|531404757|FG000|Overall Study|Study Terminated by the Sponsor|0|||
147337901|NCT01571596|531404758|FG001|Overall Study|Study Terminated by the Sponsor|1|||
147337902|NCT01571596|531404759|FG002|Overall Study|Study Terminated by the Sponsor|1|||
147337903|NCT00434304|531404762|FG000|Overall Study|Adverse Event|14|||
147337904|NCT00434304|531404762|FG000|Overall Study|Lack of Efficacy|2|||
147337905|NCT00434304|531404762|FG000|Overall Study|Withdrawal by Subject|4|||
147337906|NCT01636687|531404766|FG000|Induction Period|Withdrawal by Subject|1|||
147337907|NCT01636687|531404767|FG001|Induction Period|Withdrawal by Subject|0|||
147337908|NCT01636687|531404768|FG002|Induction Period|Withdrawal by Subject|0|||
147337909|NCT01636687|531404769|FG003|Induction Period|Withdrawal by Subject|0|||
147337910|NCT01636687|531404770|FG004|Induction Period|Withdrawal by Subject|0|||
147337911|NCT01636687|531404766|FG000|Induction Period|Adverse Event|1|||
147337912|NCT01636687|531404767|FG001|Induction Period|Adverse Event|0|||
147337913|NCT01636687|531404768|FG002|Induction Period|Adverse Event|0|||
147337914|NCT01636687|531404769|FG003|Induction Period|Adverse Event|0|||
147337915|NCT01636687|531404770|FG004|Induction Period|Adverse Event|1|||
147337916|NCT01636687|531404766|FG000|Induction Period|Lack of Efficacy|0|||
147337917|NCT01636687|531404767|FG001|Induction Period|Lack of Efficacy|0|||
147337918|NCT01636687|531404768|FG002|Induction Period|Lack of Efficacy|0|||
147337919|NCT01636687|531404769|FG003|Induction Period|Lack of Efficacy|0|||
147337920|NCT01636687|531404770|FG004|Induction Period|Lack of Efficacy|1|||
147337921|NCT01636687|531404766|FG000|Induction Period|Physician Decision|1|||
147337922|NCT01636687|531404767|FG001|Induction Period|Physician Decision|0|||
147337923|NCT01636687|531404768|FG002|Induction Period|Physician Decision|0|||
147337924|NCT01636687|531404769|FG003|Induction Period|Physician Decision|0|||
147337925|NCT01636687|531404770|FG004|Induction Period|Physician Decision|0|||
147337926|NCT01636687|531404766|FG000|Maintenance Period|Withdrawal by Subject|2|||
147337927|NCT01636687|531404767|FG001|Maintenance Period|Withdrawal by Subject|0|||
147337928|NCT01636687|531404768|FG002|Maintenance Period|Withdrawal by Subject|2|||
147337929|NCT01636687|531404769|FG003|Maintenance Period|Withdrawal by Subject|0|||
147337930|NCT01636687|531404770|FG004|Maintenance Period|Withdrawal by Subject|0|||
147337931|NCT01636687|531404766|FG000|Maintenance Period|Adverse Event|1|||
147337932|NCT01636687|531404767|FG001|Maintenance Period|Adverse Event|0|||
147337933|NCT01636687|531404768|FG002|Maintenance Period|Adverse Event|0|||
147604314|NCT00724048|532367875|FG003|Overall Study|Lost to Follow-up|0|||
147289164|NCT01571362|531222695|FG000|Open-Label Conversion + Titration Period|Protocol Violation|7|||
147289165|NCT01571362|531222696|FG001|Open-Label Conversion + Titration Period|Protocol Violation|0|||
147289166|NCT01571362|531222697|FG002|Open-Label Conversion + Titration Period|Protocol Violation|0|||
147289167|NCT01571362|531222695|FG000|Open-Label Conversion + Titration Period|Adverse Event|57|||
147289168|NCT01571362|531222696|FG001|Open-Label Conversion + Titration Period|Adverse Event|0|||
147337934|NCT01636687|531404769|FG003|Maintenance Period|Adverse Event|0|||
147337935|NCT01636687|531404770|FG004|Maintenance Period|Adverse Event|0|||
147337936|NCT01636687|531404766|FG000|Maintenance Period|Lack of Efficacy|4|||
147337937|NCT01636687|531404767|FG001|Maintenance Period|Lack of Efficacy|1|||
147337938|NCT01636687|531404768|FG002|Maintenance Period|Lack of Efficacy|0|||
147337939|NCT01636687|531404769|FG003|Maintenance Period|Lack of Efficacy|0|||
147337940|NCT01636687|531404770|FG004|Maintenance Period|Lack of Efficacy|0|||
147604315|NCT00724048|532367872|FG000|Overall Study|Withdrawal by Subject|1|||
147289169|NCT01571362|531222697|FG002|Open-Label Conversion + Titration Period|Adverse Event|0|||
147337941|NCT01636687|531404766|FG000|Maintenance Period|Lost to Follow-up|1|||
147337942|NCT01636687|531404767|FG001|Maintenance Period|Lost to Follow-up|1|||
147289170|NCT01571362|531222695|FG000|Open-Label Conversion + Titration Period|Lost to Follow-up|10|||
147289171|NCT01571362|531222696|FG001|Open-Label Conversion + Titration Period|Lost to Follow-up|0|||
147289172|NCT01571362|531222697|FG002|Open-Label Conversion + Titration Period|Lost to Follow-up|0|||
147289173|NCT01571362|531222695|FG000|Open-Label Conversion + Titration Period|Does not meet entrance criteria|41|||
147289174|NCT01571362|531222696|FG001|Open-Label Conversion + Titration Period|Does not meet entrance criteria|0|||
147289175|NCT01571362|531222697|FG002|Open-Label Conversion + Titration Period|Does not meet entrance criteria|0|||
147289176|NCT01571362|531222695|FG000|Open-Label Conversion + Titration Period|Other - unspecified|3|||
147289177|NCT01571362|531222696|FG001|Open-Label Conversion + Titration Period|Other - unspecified|0|||
147289178|NCT01571362|531222697|FG002|Open-Label Conversion + Titration Period|Other - unspecified|0|||
147289179|NCT01571362|531222695|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
147289180|NCT01571362|531222696|FG001|Double-Blind Treatment Period|Withdrawal by Subject|11|||
147289181|NCT01571362|531222697|FG002|Double-Blind Treatment Period|Withdrawal by Subject|5|||
147289182|NCT01571362|531222695|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
147289183|NCT01571362|531222696|FG001|Double-Blind Treatment Period|Protocol Violation|8|||
147289184|NCT01571362|531222697|FG002|Double-Blind Treatment Period|Protocol Violation|9|||
147289185|NCT01571362|531222695|FG000|Double-Blind Treatment Period|Adverse Event|0|||
147289186|NCT01571362|531222696|FG001|Double-Blind Treatment Period|Adverse Event|9|||
147289187|NCT01571362|531222697|FG002|Double-Blind Treatment Period|Adverse Event|14|||
147289188|NCT01571362|531222695|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
147289189|NCT01571362|531222696|FG001|Double-Blind Treatment Period|Lost to Follow-up|3|||
147289190|NCT01571362|531222697|FG002|Double-Blind Treatment Period|Lost to Follow-up|6|||
147289191|NCT01571362|531222695|FG000|Double-Blind Treatment Period|Insufficient clinical response|0|||
147289192|NCT01571362|531222696|FG001|Double-Blind Treatment Period|Insufficient clinical response|16|||
147289193|NCT01571362|531222697|FG002|Double-Blind Treatment Period|Insufficient clinical response|4|||
147289194|NCT01571362|531222695|FG000|Double-Blind Treatment Period|Other - unspecified|0|||
147289195|NCT01571362|531222696|FG001|Double-Blind Treatment Period|Other - unspecified|6|||
147289196|NCT01571362|531222697|FG002|Double-Blind Treatment Period|Other - unspecified|1|||
147289197|NCT03117738|531222698|FG000|Overall Study|Withdrawal by Subject|3|||
147289198|NCT03117738|531222699|FG001|Overall Study|Withdrawal by Subject|1|||
147289199|NCT03117738|531222698|FG000|Overall Study|Lost to Follow-up|1|||
147289200|NCT03117738|531222699|FG001|Overall Study|Lost to Follow-up|4|||
147289201|NCT03966157|531222700|FG000|Overall Study|Physician Decision|1|||
147289202|NCT03966157|531222701|FG001|Overall Study|Physician Decision|0|||
147289203|NCT01669629|531222702|FG000|Period 1|protocol deviation|1|||
147337943|NCT01636687|531404768|FG002|Maintenance Period|Lost to Follow-up|0|||
147337944|NCT01636687|531404769|FG003|Maintenance Period|Lost to Follow-up|0|||
147337945|NCT01636687|531404770|FG004|Maintenance Period|Lost to Follow-up|1|||
147337946|NCT01636687|531404766|FG000|Maintenance Period|Physician Decision|0|||
147337947|NCT01636687|531404767|FG001|Maintenance Period|Physician Decision|0|||
147337948|NCT01636687|531404768|FG002|Maintenance Period|Physician Decision|0|||
147337949|NCT01636687|531404769|FG003|Maintenance Period|Physician Decision|0|||
147337950|NCT01636687|531404770|FG004|Maintenance Period|Physician Decision|1|||
147337951|NCT01636687|531404766|FG000|Extension Period|technical problems|0|||
147337952|NCT01636687|531404767|FG001|Extension Period|technical problems|1|||
147337953|NCT01636687|531404768|FG002|Extension Period|technical problems|2|||
147337954|NCT01636687|531404769|FG003|Extension Period|technical problems|1|||
147337955|NCT01636687|531404770|FG004|Extension Period|technical problems|0|||
147337956|NCT01636687|531404766|FG000|Extension Period|Adverse Event|4|||
147337957|NCT01636687|531404767|FG001|Extension Period|Adverse Event|3|||
147337958|NCT01636687|531404768|FG002|Extension Period|Adverse Event|2|||
147337959|NCT01636687|531404769|FG003|Extension Period|Adverse Event|1|||
147337960|NCT01636687|531404770|FG004|Extension Period|Adverse Event|0|||
147337961|NCT01636687|531404766|FG000|Extension Period|Lack of Efficacy|7|||
147337962|NCT01636687|531404767|FG001|Extension Period|Lack of Efficacy|0|||
147337963|NCT01636687|531404768|FG002|Extension Period|Lack of Efficacy|2|||
147337964|NCT01636687|531404769|FG003|Extension Period|Lack of Efficacy|1|||
147337965|NCT01636687|531404770|FG004|Extension Period|Lack of Efficacy|0|||
147452569|NCT04681170|531819988|FG001|Stratified Enrolment & run-in|Protocol Violation|1|||
147452570|NCT04681170|531819987|FG000|Open Label Efficacy Phase|Adverse Event|0|||
147452571|NCT04681170|531819988|FG001|Open Label Efficacy Phase|Adverse Event|2|||
147452572|NCT04681170|531819987|FG000|Open Label Safety Phase|Withdrawal by Subject|0|||
147452573|NCT04681170|531819988|FG001|Open Label Safety Phase|Withdrawal by Subject|1|||
147289204|NCT01669629|531222703|FG001|Period 1|protocol deviation|2|||
147337966|NCT01636687|531404766|FG000|Extension Period|Lost to Follow-up|1|||
147337967|NCT01636687|531404767|FG001|Extension Period|Lost to Follow-up|0|||
147452574|NCT04681170|531819987|FG000|Open Label Safety Phase|AEs and none compliance|0|||
147452575|NCT04681170|531819988|FG001|Open Label Safety Phase|AEs and none compliance|1|||
147337968|NCT01636687|531404768|FG002|Extension Period|Lost to Follow-up|1|||
147337969|NCT01636687|531404769|FG003|Extension Period|Lost to Follow-up|0|||
147452576|NCT04986202|531819989|FG000|Overall Study|Death|10|||
147452577|NCT04986202|531819990|FG001|Overall Study|Death|3|||
147289205|NCT01221597|531222704|FG000|Overall Study|Adverse Event|4|||
147289206|NCT01221597|531222705|FG001|Overall Study|Adverse Event|1|||
147289207|NCT01221597|531222704|FG000|Overall Study|Withdrawal by Subject|20|||
147289208|NCT01221597|531222705|FG001|Overall Study|Withdrawal by Subject|6|||
147289209|NCT01221597|531222704|FG000|Overall Study|Lost to Follow-up|6|||
147289210|NCT01221597|531222705|FG001|Overall Study|Lost to Follow-up|5|||
147289211|NCT01221597|531222704|FG000|Overall Study|Protocol Violation|1|||
147289212|NCT01221597|531222705|FG001|Overall Study|Protocol Violation|0|||
147289213|NCT01221597|531222704|FG000|Overall Study|Other|3|||
147289214|NCT01221597|531222705|FG001|Overall Study|Other|4|||
147289215|NCT01221597|531222704|FG000|Overall Study|Death|2|||
147289216|NCT01221597|531222705|FG001|Overall Study|Death|0|||
147289217|NCT04420689|531222707|FG000|Overall Study|COVID-19 related hospitalization|0|||
147289218|NCT04420689|531222708|FG001|Overall Study|COVID-19 related hospitalization|0|||
147289219|NCT04420689|531222709|FG002|Overall Study|COVID-19 related hospitalization|0|||
147289220|NCT04420689|531222710|FG003|Overall Study|COVID-19 related hospitalization|0|||
147289221|NCT04420689|531222711|FG004|Overall Study|COVID-19 related hospitalization|1|||
147289222|NCT04420689|531222712|FG005|Overall Study|COVID-19 related hospitalization|0|||
147289223|NCT04420689|531222713|FG006|Overall Study|COVID-19 related hospitalization|0|||
147289224|NCT04420689|531222707|FG000|Overall Study|Physician Decision|0|||
147289225|NCT04420689|531222708|FG001|Overall Study|Physician Decision|0|||
147289226|NCT04420689|531222709|FG002|Overall Study|Physician Decision|0|||
147289227|NCT04420689|531222710|FG003|Overall Study|Physician Decision|0|||
147289228|NCT04420689|531222711|FG004|Overall Study|Physician Decision|0|||
147289229|NCT04420689|531222712|FG005|Overall Study|Physician Decision|1|||
147289230|NCT04420689|531222713|FG006|Overall Study|Physician Decision|0|||
147289231|NCT01292928|531222720|FG000|Overall Study|Death|8|||
147289232|NCT01292928|531222720|FG000|Overall Study|Withdrawal by Subject|8|||
147289233|NCT01292928|531222720|FG000|Overall Study|Lost to Follow-up|6|||
147289234|NCT01292928|531222720|FG000|Overall Study|Physician Decision|2|||
147289235|NCT04530448|531222721|FG000|Overall Study|Physician Decision|3|||
147289236|NCT04530448|531222722|FG001|Overall Study|Physician Decision|0|||
147289237|NCT01491854|531222723|FG000|Overall Study|mainly due to premature termination|93|||
147289238|NCT01491854|531222723|FG000|Overall Study|Death|1|||
147289239|NCT01491854|531222723|FG000|Overall Study|Withdrawal by Subject|3|||
147289240|NCT01491854|531222723|FG000|Overall Study|Lost to Follow-up|33|||
147289241|NCT01026974|531222735|FG000|Overall Study|Withdrawal by Subject|0|||
147289242|NCT01026974|531222736|FG001|Overall Study|Withdrawal by Subject|1|||
147289243|NCT01026974|531222737|FG002|Overall Study|Withdrawal by Subject|7|||
147289244|NCT01026974|531222738|FG003|Overall Study|Withdrawal by Subject|2|||
147289245|NCT01026974|531222735|FG000|Overall Study|Lost to Follow-up|1|||
147289246|NCT01026974|531222736|FG001|Overall Study|Lost to Follow-up|1|||
147289247|NCT01026974|531222737|FG002|Overall Study|Lost to Follow-up|4|||
147289248|NCT01026974|531222738|FG003|Overall Study|Lost to Follow-up|0|||
147289249|NCT01026974|531222735|FG000|Overall Study|Adverse Event|0|||
147289250|NCT01026974|531222736|FG001|Overall Study|Adverse Event|0|||
147289251|NCT01026974|531222737|FG002|Overall Study|Adverse Event|0|||
147289252|NCT01026974|531222738|FG003|Overall Study|Adverse Event|1|||
147289253|NCT01026974|531222735|FG000|Overall Study|Inappropriate enrollment|0|||
147289254|NCT01026974|531222736|FG001|Overall Study|Inappropriate enrollment|0|||
147289255|NCT01026974|531222737|FG002|Overall Study|Inappropriate enrollment|1|||
147289256|NCT01026974|531222738|FG003|Overall Study|Inappropriate enrollment|0|||
147289257|NCT01715805|531222740|FG000|Placebo + ADT Lead-in Period|Adverse Event|41|||
147289258|NCT01715805|531222741|FG001|Placebo + ADT Lead-in Period|Adverse Event|0|||
147289259|NCT01715805|531222742|FG002|Placebo + ADT Lead-in Period|Adverse Event|0|||
147289260|NCT01715805|531222743|FG003|Placebo + ADT Lead-in Period|Adverse Event|0|||
147289261|NCT01715805|531222740|FG000|Placebo + ADT Lead-in Period|Insufficient therapeutic response|6|||
147289262|NCT01715805|531222741|FG001|Placebo + ADT Lead-in Period|Insufficient therapeutic response|0|||
147289263|NCT01715805|531222742|FG002|Placebo + ADT Lead-in Period|Insufficient therapeutic response|0|||
147289264|NCT01715805|531222743|FG003|Placebo + ADT Lead-in Period|Insufficient therapeutic response|0|||
147289265|NCT01715805|531222740|FG000|Placebo + ADT Lead-in Period|Protocol Violation|74|||
147289266|NCT01715805|531222741|FG001|Placebo + ADT Lead-in Period|Protocol Violation|0|||
147289267|NCT01715805|531222742|FG002|Placebo + ADT Lead-in Period|Protocol Violation|0|||
147604316|NCT00724048|532367873|FG001|Overall Study|Withdrawal by Subject|2|||
147604317|NCT00724048|532367874|FG002|Overall Study|Withdrawal by Subject|1|||
147604318|NCT00724048|532367875|FG003|Overall Study|Withdrawal by Subject|2|||
147289268|NCT01715805|531222743|FG003|Placebo + ADT Lead-in Period|Protocol Violation|0|||
147289269|NCT01715805|531222740|FG000|Placebo + ADT Lead-in Period|Withdrawal of Consent|49|||
147289270|NCT01715805|531222741|FG001|Placebo + ADT Lead-in Period|Withdrawal of Consent|0|||
147289271|NCT01715805|531222742|FG002|Placebo + ADT Lead-in Period|Withdrawal of Consent|0|||
147289272|NCT01715805|531222743|FG003|Placebo + ADT Lead-in Period|Withdrawal of Consent|0|||
147289273|NCT01715805|531222740|FG000|Placebo + ADT Lead-in Period|Lost to Follow-up|34|||
147289274|NCT01715805|531222741|FG001|Placebo + ADT Lead-in Period|Lost to Follow-up|0|||
147289275|NCT01715805|531222742|FG002|Placebo + ADT Lead-in Period|Lost to Follow-up|0|||
147289276|NCT01715805|531222743|FG003|Placebo + ADT Lead-in Period|Lost to Follow-up|0|||
147289277|NCT01715805|531222740|FG000|Placebo + ADT Lead-in Period|Site Terminated by Sponsor|1|||
147289278|NCT01715805|531222741|FG001|Placebo + ADT Lead-in Period|Site Terminated by Sponsor|0|||
147289279|NCT01715805|531222742|FG002|Placebo + ADT Lead-in Period|Site Terminated by Sponsor|0|||
147289280|NCT01715805|531222743|FG003|Placebo + ADT Lead-in Period|Site Terminated by Sponsor|0|||
147289281|NCT01715805|531222740|FG000|Placebo + ADT Lead-in Period|Other Reason Not Specified|10|||
147289282|NCT01715805|531222741|FG001|Placebo + ADT Lead-in Period|Other Reason Not Specified|0|||
147289283|NCT01715805|531222742|FG002|Placebo + ADT Lead-in Period|Other Reason Not Specified|0|||
147289284|NCT01715805|531222743|FG003|Placebo + ADT Lead-in Period|Other Reason Not Specified|0|||
147289285|NCT01715805|531222740|FG000|Double-Blind or Continued Treatment|Study or Site Terminated by Sponsor|0|||
147289286|NCT01715805|531222741|FG001|Double-Blind or Continued Treatment|Study or Site Terminated by Sponsor|0|||
147289287|NCT01715805|531222742|FG002|Double-Blind or Continued Treatment|Study or Site Terminated by Sponsor|0|||
147289288|NCT01715805|531222743|FG003|Double-Blind or Continued Treatment|Study or Site Terminated by Sponsor|1|||
147289289|NCT01715805|531222740|FG000|Double-Blind or Continued Treatment|Adverse Event|0|||
147289290|NCT01715805|531222741|FG001|Double-Blind or Continued Treatment|Adverse Event|3|||
147289291|NCT01715805|531222742|FG002|Double-Blind or Continued Treatment|Adverse Event|23|||
147289292|NCT01715805|531222743|FG003|Double-Blind or Continued Treatment|Adverse Event|2|||
147289293|NCT01715805|531222740|FG000|Double-Blind or Continued Treatment|Protocol Violation|0|||
147289294|NCT01715805|531222741|FG001|Double-Blind or Continued Treatment|Protocol Violation|14|||
147289295|NCT01715805|531222742|FG002|Double-Blind or Continued Treatment|Protocol Violation|12|||
147289296|NCT01715805|531222743|FG003|Double-Blind or Continued Treatment|Protocol Violation|19|||
147289297|NCT01715805|531222740|FG000|Double-Blind or Continued Treatment|Withdrawal of consent|0|||
147289298|NCT01715805|531222741|FG001|Double-Blind or Continued Treatment|Withdrawal of consent|11|||
147289299|NCT01715805|531222742|FG002|Double-Blind or Continued Treatment|Withdrawal of consent|11|||
147289300|NCT01715805|531222743|FG003|Double-Blind or Continued Treatment|Withdrawal of consent|13|||
147289301|NCT01715805|531222740|FG000|Double-Blind or Continued Treatment|Lost to Follow-up|0|||
147289302|NCT01715805|531222741|FG001|Double-Blind or Continued Treatment|Lost to Follow-up|7|||
147289303|NCT01715805|531222742|FG002|Double-Blind or Continued Treatment|Lost to Follow-up|10|||
147289304|NCT01715805|531222743|FG003|Double-Blind or Continued Treatment|Lost to Follow-up|10|||
147289305|NCT01715805|531222740|FG000|Double-Blind or Continued Treatment|Other Reason Not Specified|0|||
147289306|NCT01715805|531222741|FG001|Double-Blind or Continued Treatment|Other Reason Not Specified|1|||
147289307|NCT01715805|531222742|FG002|Double-Blind or Continued Treatment|Other Reason Not Specified|0|||
147289308|NCT01715805|531222743|FG003|Double-Blind or Continued Treatment|Other Reason Not Specified|3|||
147289309|NCT01715805|531222740|FG000|Double-Blind or Continued Treatment|Did not ingest Double-Blind Treatment|0|||
147289310|NCT01715805|531222741|FG001|Double-Blind or Continued Treatment|Did not ingest Double-Blind Treatment|3|||
147289311|NCT01715805|531222742|FG002|Double-Blind or Continued Treatment|Did not ingest Double-Blind Treatment|0|||
147289312|NCT01715805|531222743|FG003|Double-Blind or Continued Treatment|Did not ingest Double-Blind Treatment|0|||
147289313|NCT02647359|531222746|FG000|Stage 1: Double-Masked Period (48 Weeks)|Non-compliance with study drug|0|||
147289314|NCT02647359|531222747|FG001|Stage 1: Double-Masked Period (48 Weeks)|Non-compliance with study drug|1|||
147289315|NCT02647359|531222746|FG000|Stage 1: Double-Masked Period (48 Weeks)|Other than specified|4|||
147289316|NCT02647359|531222747|FG001|Stage 1: Double-Masked Period (48 Weeks)|Other than specified|0|||
147289317|NCT02647359|531222746|FG000|Stage 2: Open-Label Extension (96 Weeks)|Adverse Event|2|||
147289318|NCT02647359|531222747|FG001|Stage 2: Open-Label Extension (96 Weeks)|Adverse Event|1|||
147289319|NCT02647359|531222746|FG000|Stage 2: Open-Label Extension (96 Weeks)|Other than specified|8|||
147289320|NCT02647359|531222747|FG001|Stage 2: Open-Label Extension (96 Weeks)|Other than specified|3|||
147289321|NCT02647359|531222746|FG000|Open-Label Sub-Study (96 Weeks)|Lost to Follow-up|1|||
147289322|NCT02647359|531222747|FG001|Open-Label Sub-Study (96 Weeks)|Lost to Follow-up|0|||
147289323|NCT02647359|531222746|FG000|Open-Label Sub-Study (96 Weeks)|Other than specified|7|||
147289324|NCT02647359|531222747|FG001|Open-Label Sub-Study (96 Weeks)|Other than specified|4|||
147289325|NCT04642638|531222748|FG000|Overall Study|Withdrawal by Subject|23|||
147289326|NCT04642638|531222749|FG001|Overall Study|Withdrawal by Subject|29|||
147289327|NCT04642638|531222750|FG002|Overall Study|Withdrawal by Subject|9|||
147289328|NCT04642638|531222751|FG003|Overall Study|Withdrawal by Subject|7|||
147289329|NCT04642638|531222752|FG004|Overall Study|Withdrawal by Subject|61|||
147289330|NCT04642638|531222753|FG005|Overall Study|Withdrawal by Subject|27|||
147289331|NCT04642638|531222748|FG000|Overall Study|Lost to Follow-up|17|||
147289332|NCT04642638|531222749|FG001|Overall Study|Lost to Follow-up|18|||
147289333|NCT04642638|531222750|FG002|Overall Study|Lost to Follow-up|5|||
147289334|NCT04642638|531222751|FG003|Overall Study|Lost to Follow-up|5|||
147289335|NCT04642638|531222752|FG004|Overall Study|Lost to Follow-up|6|||
147289336|NCT04642638|531222753|FG005|Overall Study|Lost to Follow-up|3|||
147289337|NCT04642638|531222748|FG000|Overall Study|Adverse Event|0|||
147289338|NCT04642638|531222749|FG001|Overall Study|Adverse Event|0|||
147289339|NCT04642638|531222750|FG002|Overall Study|Adverse Event|1|||
147289340|NCT04642638|531222751|FG003|Overall Study|Adverse Event|0|||
147289341|NCT04642638|531222752|FG004|Overall Study|Adverse Event|10|||
147289342|NCT04642638|531222753|FG005|Overall Study|Adverse Event|3|||
147337970|NCT01636687|531404770|FG004|Extension Period|Lost to Follow-up|0|||
147289343|NCT04642638|531222748|FG000|Overall Study|Reason Not Specified|1|||
147289344|NCT04642638|531222749|FG001|Overall Study|Reason Not Specified|4|||
147289345|NCT04642638|531222750|FG002|Overall Study|Reason Not Specified|0|||
147289346|NCT04642638|531222751|FG003|Overall Study|Reason Not Specified|0|||
147289347|NCT04642638|531222752|FG004|Overall Study|Reason Not Specified|38|||
147289348|NCT04642638|531222753|FG005|Overall Study|Reason Not Specified|16|||
147289349|NCT04642638|531222748|FG000|Overall Study|Physician Decision|0|||
147289350|NCT04642638|531222749|FG001|Overall Study|Physician Decision|0|||
147289351|NCT04642638|531222750|FG002|Overall Study|Physician Decision|0|||
147289352|NCT04642638|531222751|FG003|Overall Study|Physician Decision|0|||
147289353|NCT04642638|531222752|FG004|Overall Study|Physician Decision|2|||
147289354|NCT04642638|531222753|FG005|Overall Study|Physician Decision|1|||
147289355|NCT04642638|531222748|FG000|Overall Study|Protocol Deviation|0|||
147289356|NCT04642638|531222749|FG001|Overall Study|Protocol Deviation|0|||
147289357|NCT04642638|531222750|FG002|Overall Study|Protocol Deviation|0|||
147289358|NCT04642638|531222751|FG003|Overall Study|Protocol Deviation|0|||
147289359|NCT04642638|531222752|FG004|Overall Study|Protocol Deviation|1|||
147289360|NCT04642638|531222753|FG005|Overall Study|Protocol Deviation|3|||
147289361|NCT04642638|531222748|FG000|Overall Study|Study Terminated|0|||
147289362|NCT04642638|531222749|FG001|Overall Study|Study Terminated|0|||
147289363|NCT04642638|531222750|FG002|Overall Study|Study Terminated|0|||
147289364|NCT04642638|531222751|FG003|Overall Study|Study Terminated|0|||
147289365|NCT04642638|531222752|FG004|Overall Study|Study Terminated|484|||
147289366|NCT04642638|531222753|FG005|Overall Study|Study Terminated|250|||
147289367|NCT04642638|531222748|FG000|Overall Study|Pregnancy|0|||
147289368|NCT04642638|531222749|FG001|Overall Study|Pregnancy|0|||
147289369|NCT04642638|531222750|FG002|Overall Study|Pregnancy|0|||
147289370|NCT04642638|531222751|FG003|Overall Study|Pregnancy|0|||
147289371|NCT04642638|531222752|FG004|Overall Study|Pregnancy|1|||
147289372|NCT04642638|531222753|FG005|Overall Study|Pregnancy|0|||
147289373|NCT00511004|531222754|FG000|Overall Study|Lost to Follow-up|0|||
147289374|NCT00511004|531222755|FG001|Overall Study|Lost to Follow-up|0|||
147289375|NCT00511004|531222756|FG002|Overall Study|Lost to Follow-up|4|||
147289376|NCT01672801|531222758|FG000|Overall Study|Screen Failure|0|||
147289377|NCT01672801|531222759|FG001|Overall Study|Screen Failure|1|||
147289378|NCT02384954|531222764|FG000|Phase 1|Progressive Disease|2|||
147289379|NCT02384954|531222765|FG001|Phase 1|Progressive Disease|0|||
147289380|NCT02384954|531222766|FG002|Phase 1|Progressive Disease|1|||
147289381|NCT02384954|531222767|FG003|Phase 1|Progressive Disease|1|||
147289382|NCT02384954|531222768|FG004|Phase 1|Progressive Disease|0|||
147289383|NCT02384954|531222769|FG005|Phase 1|Progressive Disease|0|||
147289384|NCT02384954|531222770|FG006|Phase 1|Progressive Disease|0|||
147289385|NCT02384954|531222771|FG007|Phase 1|Progressive Disease|0|||
147289386|NCT02384954|531222772|FG008|Phase 1|Progressive Disease|0|||
147289387|NCT02384954|531222764|FG000|Phase 1|Adverse Event|0|||
147289388|NCT02384954|531222765|FG001|Phase 1|Adverse Event|0|||
147289389|NCT02384954|531222766|FG002|Phase 1|Adverse Event|1|||
147289390|NCT02384954|531222767|FG003|Phase 1|Adverse Event|0|||
147289391|NCT02384954|531222768|FG004|Phase 1|Adverse Event|0|||
147289392|NCT02384954|531222769|FG005|Phase 1|Adverse Event|0|||
147289393|NCT02384954|531222770|FG006|Phase 1|Adverse Event|0|||
147289394|NCT02384954|531222771|FG007|Phase 1|Adverse Event|0|||
147289395|NCT02384954|531222772|FG008|Phase 1|Adverse Event|0|||
147289396|NCT02384954|531222764|FG000|Phase 2|Progressive Disease|0|||
147289397|NCT02384954|531222765|FG001|Phase 2|Progressive Disease|0|||
147289398|NCT02384954|531222766|FG002|Phase 2|Progressive Disease|0|||
147289399|NCT02384954|531222767|FG003|Phase 2|Progressive Disease|0|||
147289400|NCT02384954|531222768|FG004|Phase 2|Progressive Disease|0|||
147289401|NCT02384954|531222769|FG005|Phase 2|Progressive Disease|0|||
147289402|NCT02384954|531222770|FG006|Phase 2|Progressive Disease|0|||
147289403|NCT02384954|531222771|FG007|Phase 2|Progressive Disease|1|||
147289404|NCT02384954|531222772|FG008|Phase 2|Progressive Disease|2|||
147289405|NCT02384954|531222764|FG000|Phase 2|Adverse Event|0|||
147289406|NCT02384954|531222765|FG001|Phase 2|Adverse Event|0|||
147289407|NCT02384954|531222766|FG002|Phase 2|Adverse Event|0|||
147289408|NCT02384954|531222767|FG003|Phase 2|Adverse Event|0|||
147289409|NCT02384954|531222768|FG004|Phase 2|Adverse Event|0|||
147289410|NCT02384954|531222769|FG005|Phase 2|Adverse Event|0|||
147289411|NCT02384954|531222770|FG006|Phase 2|Adverse Event|0|||
147289412|NCT02384954|531222771|FG007|Phase 2|Adverse Event|1|||
147289413|NCT02384954|531222772|FG008|Phase 2|Adverse Event|1|||
147289414|NCT02384954|531222764|FG000|Phase 2|Failure to meet continuation criteria|0|||
147289415|NCT02384954|531222765|FG001|Phase 2|Failure to meet continuation criteria|0|||
147289416|NCT02384954|531222766|FG002|Phase 2|Failure to meet continuation criteria|0|||
147289417|NCT02384954|531222767|FG003|Phase 2|Failure to meet continuation criteria|0|||
147289418|NCT02384954|531222768|FG004|Phase 2|Failure to meet continuation criteria|0|||
147289419|NCT02384954|531222769|FG005|Phase 2|Failure to meet continuation criteria|0|||
147289420|NCT02384954|531222770|FG006|Phase 2|Failure to meet continuation criteria|0|||
147289421|NCT02384954|531222771|FG007|Phase 2|Failure to meet continuation criteria|1|||
147289422|NCT02384954|531222772|FG008|Phase 2|Failure to meet continuation criteria|0|||
147289423|NCT02372396|531222783|FG000|Overall Study|Lost to Follow-up|7|||
147289424|NCT02372396|531222784|FG001|Overall Study|Lost to Follow-up|9|||
147289425|NCT04313634|531222787|FG000|Overall Study|Adverse Event|2|||
147289426|NCT04313634|531222788|FG001|Overall Study|Adverse Event|2|||
147289427|NCT04313634|531222789|FG002|Overall Study|Adverse Event|0|||
147289428|NCT04313634|531222787|FG000|Overall Study|Withdrawal by Subject|1|||
147289429|NCT04313634|531222788|FG001|Overall Study|Withdrawal by Subject|0|||
147289430|NCT04313634|531222789|FG002|Overall Study|Withdrawal by Subject|1|||
147289431|NCT04313634|531222787|FG000|Overall Study|Protocol Violation|0|||
147289432|NCT04313634|531222788|FG001|Overall Study|Protocol Violation|0|||
147289433|NCT04313634|531222789|FG002|Overall Study|Protocol Violation|1|||
147289434|NCT03595904|531222795|FG000|Overall Study|Protocol Violation|3|||
147289435|NCT03595904|531222796|FG001|Overall Study|Protocol Violation|1|||
147289436|NCT03595904|531222795|FG000|Overall Study|Deemed medically ineligible for direct access colonoscopy|4|||
147289437|NCT03595904|531222796|FG001|Overall Study|Deemed medically ineligible for direct access colonoscopy|3|||
147289438|NCT03595904|531222795|FG000|Overall Study|Insurance complications|1|||
147289439|NCT03595904|531222796|FG001|Overall Study|Insurance complications|0|||
147289440|NCT03595904|531222795|FG000|Overall Study|COVID-19 halt in non-essential appointments during 6 month follow up|2|||
147289441|NCT03595904|531222796|FG001|Overall Study|COVID-19 halt in non-essential appointments during 6 month follow up|1|||
147289442|NCT01581281|531222797|FG000|Overall Study|Early Study Closure|15|||
147289443|NCT01581281|531222798|FG001|Overall Study|Early Study Closure|6|||
147289444|NCT01581281|531222799|FG002|Overall Study|Early Study Closure|12|||
147289445|NCT02298192|531222801|FG000|Overall Study|Unclassified|3|||
147289446|NCT02298192|531222802|FG001|Overall Study|Unclassified|2|||
147289447|NCT02298192|531222801|FG000|Overall Study|Withdrawal criteria|2|||
147289448|NCT02298192|531222802|FG001|Overall Study|Withdrawal criteria|0|||
147289449|NCT02298192|531222801|FG000|Overall Study|Withdrawal by Subject|6|||
147289450|NCT02298192|531222802|FG001|Overall Study|Withdrawal by Subject|1|||
147289451|NCT02298192|531222801|FG000|Overall Study|Lost to Follow-up|2|||
147289452|NCT02298192|531222802|FG001|Overall Study|Lost to Follow-up|1|||
147289453|NCT02298192|531222801|FG000|Overall Study|Adverse Event|6|||
147289454|NCT02298192|531222802|FG001|Overall Study|Adverse Event|2|||
147289455|NCT04764396|531222805|FG000|Overall Study|Physician Decision|1|||
147289456|NCT04764396|531222806|FG001|Overall Study|Physician Decision|0|||
147289457|NCT03230916|531222807|FG000|Overall Study|Withdrawal by Subject|0|||
147289458|NCT03230916|531222808|FG001|Overall Study|Withdrawal by Subject|0|||
147289459|NCT03230916|531222809|FG002|Overall Study|Withdrawal by Subject|0|||
147289460|NCT03230916|531222810|FG003|Overall Study|Withdrawal by Subject|0|||
147289461|NCT03230916|531222811|FG004|Overall Study|Withdrawal by Subject|0|||
147289462|NCT03230916|531222812|FG005|Overall Study|Withdrawal by Subject|1|||
147289463|NCT03230916|531222813|FG006|Overall Study|Withdrawal by Subject|0|||
147289464|NCT03230916|531222814|FG007|Overall Study|Withdrawal by Subject|0|||
147289465|NCT03230916|531222815|FG008|Overall Study|Withdrawal by Subject|0|||
147289466|NCT03230916|531222816|FG009|Overall Study|Withdrawal by Subject|0|||
147289467|NCT03230916|531222817|FG010|Overall Study|Withdrawal by Subject|0|||
147289468|NCT01128413|531222819|FG000|Overall Study|Withdrawal by Subject|1|||
147289469|NCT01128413|531222820|FG001|Overall Study|Withdrawal by Subject|0|||
147289470|NCT01128413|531222819|FG000|Overall Study|NICOM Monitor Problems|2|||
147289471|NCT01128413|531222820|FG001|Overall Study|NICOM Monitor Problems|1|||
147289472|NCT01128413|531222819|FG000|Overall Study|Pt made DNR|1|||
147289473|NCT01128413|531222820|FG001|Overall Study|Pt made DNR|0|||
147289474|NCT01218646|531222823|FG000|Overall Study|Adverse Event|0|||
147289475|NCT01218646|531222824|FG001|Overall Study|Adverse Event|0|||
147289476|NCT01218646|531222825|FG002|Overall Study|Adverse Event|1|||
147289477|NCT01218646|531222826|FG003|Overall Study|Adverse Event|0|||
147289478|NCT01218646|531222823|FG000|Overall Study|Lost to Follow-up|1|||
147289479|NCT01218646|531222824|FG001|Overall Study|Lost to Follow-up|0|||
147289480|NCT01218646|531222825|FG002|Overall Study|Lost to Follow-up|0|||
147289481|NCT01218646|531222826|FG003|Overall Study|Lost to Follow-up|0|||
147289482|NCT01218646|531222823|FG000|Overall Study|Protocol Violation|0|||
147289483|NCT01218646|531222824|FG001|Overall Study|Protocol Violation|0|||
147289484|NCT01218646|531222825|FG002|Overall Study|Protocol Violation|1|||
147289485|NCT01218646|531222826|FG003|Overall Study|Protocol Violation|1|||
147289486|NCT00722761|531222827|FG000|Overall Study|Lost to Follow-up|1|||
147289487|NCT00722761|531222828|FG001|Overall Study|Lost to Follow-up|4|||
147289488|NCT00722761|531222827|FG000|Overall Study|Withdrawal by Subject|5|||
147289489|NCT00722761|531222828|FG001|Overall Study|Withdrawal by Subject|2|||
147289490|NCT02693665|531222829|FG000|Overall Study|Death|3|||
147289491|NCT02693665|531222830|FG001|Overall Study|Death|2|||
147289492|NCT02693665|531222829|FG000|Overall Study|Lost to Follow-up|7|||
147289493|NCT02693665|531222830|FG001|Overall Study|Lost to Follow-up|3|||
147289494|NCT02693665|531222829|FG000|Overall Study|Protocol Violation|1|||
147289495|NCT02693665|531222830|FG001|Overall Study|Protocol Violation|0|||
147289496|NCT02693665|531222829|FG000|Overall Study|Withdrawal by Subject|2|||
147289497|NCT02693665|531222830|FG001|Overall Study|Withdrawal by Subject|0|||
147289498|NCT02693665|531222829|FG000|Overall Study|patient wanted to leave it behind|1|||
147289499|NCT02693665|531222830|FG001|Overall Study|patient wanted to leave it behind|0|||
147289500|NCT02693665|531222829|FG000|Overall Study|anxiety|1|||
147289501|NCT02693665|531222830|FG001|Overall Study|anxiety|0|||
147289502|NCT02693665|531222829|FG000|Overall Study|family issues|1|||
147289503|NCT02693665|531222830|FG001|Overall Study|family issues|0|||
147289504|NCT02693665|531222829|FG000|Overall Study|no reason given|1|||
147289505|NCT02693665|531222830|FG001|Overall Study|no reason given|0|||
147289506|NCT02075593|531222831|FG000|Overall Study|Withdrawal by Subject|1|||
147289507|NCT02010060|531222834|FG000|Overall Study|Lost to Follow-up|1|||
147289508|NCT02010060|531222835|FG001|Overall Study|Lost to Follow-up|2|||
147289509|NCT02010060|531222836|FG002|Overall Study|Lost to Follow-up|2|||
147289510|NCT02010060|531222834|FG000|Overall Study|Injury|0|||
147289511|NCT02010060|531222835|FG001|Overall Study|Injury|1|||
147289512|NCT02010060|531222836|FG002|Overall Study|Injury|0|||
147289513|NCT04414696|531222837|FG000|3-month Follow up|Withdrawal by Subject|1|||
147289514|NCT04414696|531222838|FG001|3-month Follow up|Withdrawal by Subject|0|||
147289515|NCT04414696|531222837|FG000|3-month Follow up|Lost to Follow-up|22|||
147289516|NCT04414696|531222838|FG001|3-month Follow up|Lost to Follow-up|23|||
147289517|NCT04414696|531222837|FG000|6-month Follow up|Withdrawal by Subject|1|||
147289518|NCT04414696|531222838|FG001|6-month Follow up|Withdrawal by Subject|2|||
147289519|NCT04414696|531222837|FG000|6-month Follow up|Lost to Follow-up|5|||
147289520|NCT04414696|531222838|FG001|6-month Follow up|Lost to Follow-up|2|||
147289521|NCT00660010|531222839|FG000|Overall Study|Withdrawal by Subject|2|||
147289522|NCT00660010|531222839|FG000|Overall Study|Lost to Follow-up|3|||
147289523|NCT00660010|531222839|FG000|Overall Study|Adverse Event|1|||
147289524|NCT00660010|531222839|FG000|Overall Study|Noncompliance with visit schedule|3|||
147289525|NCT00726752|531222840|FG000|Overall Study|Lack of Efficacy|6|||
147289526|NCT06167031|531222843|FG000|Overall Study|Lost to Follow-up|5|||
147289527|NCT06167031|531222844|FG001|Overall Study|Lost to Follow-up|1|||
147289528|NCT03870763|531225588|FG000|Overall Study|Study terminated by sponsor|0|||
147289529|NCT03870763|531225589|FG001|Overall Study|Study terminated by sponsor|2|||
147289530|NCT03870763|531225590|FG002|Overall Study|Study terminated by sponsor|0|||
147289531|NCT03870763|531225588|FG000|Overall Study|Withdrawal by Subject|0|||
147289532|NCT03870763|531225589|FG001|Overall Study|Withdrawal by Subject|1|||
147289533|NCT03870763|531225590|FG002|Overall Study|Withdrawal by Subject|0|||
147289534|NCT03870763|531225588|FG000|Overall Study|Worsening of multiple sclerosis attack|0|||
147289535|NCT03870763|531225589|FG001|Overall Study|Worsening of multiple sclerosis attack|0|||
147289536|NCT03870763|531225590|FG002|Overall Study|Worsening of multiple sclerosis attack|1|||
147289537|NCT02120027|531225593|FG000|Overall Study|Adverse Event|4|||
147289538|NCT02120027|531225594|FG001|Overall Study|Adverse Event|5|||
147289539|NCT02120027|531225593|FG000|Overall Study|Lack of Efficacy|3|||
147289540|NCT02120027|531225594|FG001|Overall Study|Lack of Efficacy|5|||
147289541|NCT02120027|531225593|FG000|Overall Study|Lost to Follow-up|5|||
147289542|NCT02120027|531225594|FG001|Overall Study|Lost to Follow-up|13|||
147289543|NCT02120027|531225593|FG000|Overall Study|Other|4|||
147289544|NCT02120027|531225594|FG001|Overall Study|Other|0|||
147289545|NCT02120027|531225593|FG000|Overall Study|Physician Decision|4|||
147289546|NCT02120027|531225594|FG001|Overall Study|Physician Decision|3|||
147289547|NCT02120027|531225593|FG000|Overall Study|Protocol Violation|18|||
147289548|NCT02120027|531225594|FG001|Overall Study|Protocol Violation|21|||
147289549|NCT02120027|531225593|FG000|Overall Study|Study terminated by Sponsor|45|||
147289550|NCT02120027|531225594|FG001|Overall Study|Study terminated by Sponsor|47|||
147289551|NCT02120027|531225593|FG000|Overall Study|Withdrawal by Subject|33|||
147289552|NCT02120027|531225594|FG001|Overall Study|Withdrawal by Subject|25|||
147289553|NCT03393000|531225597|FG000|Overall Study|Death|11|||
147289554|NCT03393000|531225597|FG000|Overall Study|Withdrawal by Subject|2|||
147289555|NCT03393000|531225597|FG000|Overall Study|Physician Decision|1|||
147289556|NCT01773070|531225598|FG000|Overall Study|Withdrawal by Subject|24|||
147289557|NCT01773070|531225598|FG000|Overall Study|Lost to Follow-up|39|||
147289558|NCT01773070|531225598|FG000|Overall Study|Other|15|||
147289559|NCT01773070|531225598|FG000|Overall Study|Death (unrelated to study procedures)|3|||
147289560|NCT01471054|531225599|FG000|Overall Study|Study terminated prematurely|4|||
147289561|NCT01471054|531225600|FG001|Overall Study|Study terminated prematurely|0|||
147289562|NCT01843192|531225601|FG000|Overall Study|Intra-operative exclusions per protocol|2|||
147289563|NCT01843192|531225602|FG001|Overall Study|Intra-operative exclusions per protocol|6|||
147289564|NCT01843192|531225603|FG002|Overall Study|Intra-operative exclusions per protocol|2|||
147289565|NCT01559844|531225604|FG000|Overall Study|Consent Withdrawn|7|||
147289566|NCT01559844|531225604|FG000|Overall Study|Death|5|||
147289567|NCT01559844|531225604|FG000|Overall Study|Efficacy Failure|10|||
147289568|NCT01559844|531225604|FG000|Overall Study|No Longer A Transplant Candidate|3|||
147289569|NCT02181803|531225605|FG000|Overall Study|Withdrawal by Subject|0|||
147289570|NCT02181803|531225606|FG001|Overall Study|Withdrawal by Subject|2|||
147289571|NCT02181803|531225607|FG002|Overall Study|Withdrawal by Subject|0|||
147289572|NCT02181803|531225608|FG003|Overall Study|Withdrawal by Subject|0|||
147289573|NCT02181803|531225609|FG004|Overall Study|Withdrawal by Subject|0|||
147289574|NCT02181803|531225610|FG005|Overall Study|Withdrawal by Subject|0|||
147289575|NCT02181803|531225611|FG006|Overall Study|Withdrawal by Subject|0|||
147289576|NCT02181803|531225612|FG007|Overall Study|Withdrawal by Subject|0|||
147289577|NCT02181803|531225613|FG008|Overall Study|Withdrawal by Subject|0|||
147289578|NCT02181803|531225605|FG000|Overall Study|Physician Decision|0|||
147289579|NCT02181803|531225606|FG001|Overall Study|Physician Decision|0|||
147289580|NCT02181803|531225607|FG002|Overall Study|Physician Decision|0|||
147289581|NCT02181803|531225608|FG003|Overall Study|Physician Decision|1|||
147289582|NCT02181803|531225609|FG004|Overall Study|Physician Decision|0|||
147289583|NCT02181803|531225610|FG005|Overall Study|Physician Decision|0|||
147289584|NCT02181803|531225611|FG006|Overall Study|Physician Decision|0|||
147289585|NCT02181803|531225612|FG007|Overall Study|Physician Decision|1|||
147289586|NCT02181803|531225613|FG008|Overall Study|Physician Decision|0|||
147289587|NCT02181803|531225605|FG000|Overall Study|Adverse Event|0|||
147289588|NCT02181803|531225606|FG001|Overall Study|Adverse Event|2|||
147289589|NCT02181803|531225607|FG002|Overall Study|Adverse Event|0|||
147289590|NCT02181803|531225608|FG003|Overall Study|Adverse Event|1|||
147289591|NCT02181803|531225609|FG004|Overall Study|Adverse Event|0|||
147289592|NCT02181803|531225610|FG005|Overall Study|Adverse Event|0|||
147289593|NCT02181803|531225611|FG006|Overall Study|Adverse Event|1|||
147289594|NCT02181803|531225612|FG007|Overall Study|Adverse Event|0|||
147289595|NCT02181803|531225613|FG008|Overall Study|Adverse Event|0|||
147289596|NCT00951041|531225614|FG000|Overall Study|Withdrawal by Subject|1|||
147289597|NCT00951041|531225615|FG001|Overall Study|Withdrawal by Subject|1|||
147289598|NCT00951041|531225614|FG000|Overall Study|Lost to Follow-up|1|||
147289599|NCT00951041|531225615|FG001|Overall Study|Lost to Follow-up|0|||
147289600|NCT00951041|531225614|FG000|Overall Study|Other|3|||
147289601|NCT00951041|531225615|FG001|Overall Study|Other|0|||
147289602|NCT01259713|531225616|FG000|Overall Study|Adverse Event|54|||
147289603|NCT01259713|531225617|FG001|Overall Study|Adverse Event|23|||
147289604|NCT01259713|531225616|FG000|Overall Study|Death Not Related to IFI|8|||
147289605|NCT01259713|531225617|FG001|Overall Study|Death Not Related to IFI|1|||
147289606|NCT01259713|531225616|FG000|Overall Study|Investigators Discretion|14|||
147289607|NCT01259713|531225617|FG001|Overall Study|Investigators Discretion|6|||
147289608|NCT01259713|531225616|FG000|Overall Study|Lack of Efficacy|2|||
147289609|NCT01259713|531225617|FG001|Overall Study|Lack of Efficacy|0|||
147289610|NCT01259713|531225616|FG000|Overall Study|Protocol Violation|5|||
147289611|NCT01259713|531225617|FG001|Overall Study|Protocol Violation|4|||
147289612|NCT01259713|531225616|FG000|Overall Study|Subject Withdrew Consent|12|||
147289613|NCT01259713|531225617|FG001|Overall Study|Subject Withdrew Consent|7|||
147289614|NCT02388724|531225619|FG000|Overall Study|Reason not Specified|0|||
147289615|NCT02388724|531225620|FG001|Overall Study|Reason not Specified|1|||
147289616|NCT02388724|531225619|FG000|Overall Study|Major Protocol Deviation|3|||
147289617|NCT02388724|531225620|FG001|Overall Study|Major Protocol Deviation|3|||
147289618|NCT02388724|531225619|FG000|Overall Study|Pretreatment Event/Adverse Event|3|||
147289619|NCT02388724|531225620|FG001|Overall Study|Pretreatment Event/Adverse Event|2|||
147289620|NCT02388724|531225619|FG000|Overall Study|Voluntary Withdrawal|6|||
147289621|NCT02388724|531225620|FG001|Overall Study|Voluntary Withdrawal|5|||
147289622|NCT02388724|531225619|FG000|Overall Study|Randomized but not Treated|0|||
147289623|NCT02388724|531225620|FG001|Overall Study|Randomized but not Treated|2|||
147289624|NCT01217073|531225621|FG000|Base Period|Adverse Event|1|||
147289625|NCT01217073|531225622|FG001|Base Period|Adverse Event|0|||
147289626|NCT01217073|531225623|FG002|Base Period|Adverse Event|1|||
147289627|NCT01217073|531225624|FG003|Base Period|Adverse Event|0|||
147289628|NCT01217073|531225625|FG004|Base Period|Adverse Event|4|||
147289629|NCT01217073|531225626|FG005|Base Period|Adverse Event|1|||
147289630|NCT01217073|531225627|FG006|Base Period|Adverse Event|0|||
147289631|NCT01217073|531225628|FG007|Base Period|Adverse Event|0|||
147289632|NCT01217073|531225621|FG000|Base Period|Alanine aminotransferase (ALT)/AST|1|||
147289633|NCT01217073|531225622|FG001|Base Period|Alanine aminotransferase (ALT)/AST|0|||
147289634|NCT01217073|531225623|FG002|Base Period|Alanine aminotransferase (ALT)/AST|0|||
147289635|NCT01217073|531225624|FG003|Base Period|Alanine aminotransferase (ALT)/AST|0|||
147289636|NCT01217073|531225625|FG004|Base Period|Alanine aminotransferase (ALT)/AST|0|||
147289637|NCT01217073|531225626|FG005|Base Period|Alanine aminotransferase (ALT)/AST|0|||
147289638|NCT01217073|531225627|FG006|Base Period|Alanine aminotransferase (ALT)/AST|0|||
147289639|NCT01217073|531225628|FG007|Base Period|Alanine aminotransferase (ALT)/AST|0|||
147289640|NCT01217073|531225621|FG000|Base Period|Excluded medication|0|||
147289641|NCT01217073|531225622|FG001|Base Period|Excluded medication|0|||
147289642|NCT01217073|531225623|FG002|Base Period|Excluded medication|0|||
147289643|NCT01217073|531225624|FG003|Base Period|Excluded medication|0|||
147289644|NCT01217073|531225625|FG004|Base Period|Excluded medication|1|||
147289645|NCT01217073|531225626|FG005|Base Period|Excluded medication|0|||
147289646|NCT01217073|531225627|FG006|Base Period|Excluded medication|0|||
147289647|NCT01217073|531225628|FG007|Base Period|Excluded medication|0|||
147289648|NCT01217073|531225621|FG000|Base Period|Lack of Efficacy|0|||
147289649|NCT01217073|531225622|FG001|Base Period|Lack of Efficacy|0|||
147289650|NCT01217073|531225623|FG002|Base Period|Lack of Efficacy|0|||
147289651|NCT01217073|531225624|FG003|Base Period|Lack of Efficacy|0|||
147289652|NCT01217073|531225625|FG004|Base Period|Lack of Efficacy|0|||
147289653|NCT01217073|531225626|FG005|Base Period|Lack of Efficacy|1|||
147289654|NCT01217073|531225627|FG006|Base Period|Lack of Efficacy|0|||
147289655|NCT01217073|531225628|FG007|Base Period|Lack of Efficacy|0|||
147289656|NCT01217073|531225621|FG000|Base Period|Lost to Follow-up|0|||
147289657|NCT01217073|531225622|FG001|Base Period|Lost to Follow-up|0|||
147289658|NCT01217073|531225623|FG002|Base Period|Lost to Follow-up|1|||
147289659|NCT01217073|531225624|FG003|Base Period|Lost to Follow-up|1|||
147289660|NCT01217073|531225625|FG004|Base Period|Lost to Follow-up|3|||
147289661|NCT01217073|531225626|FG005|Base Period|Lost to Follow-up|0|||
147289662|NCT01217073|531225627|FG006|Base Period|Lost to Follow-up|0|||
147289663|NCT01217073|531225628|FG007|Base Period|Lost to Follow-up|0|||
147289664|NCT01217073|531225621|FG000|Base Period|Physician Decision|0|||
147289665|NCT01217073|531225622|FG001|Base Period|Physician Decision|0|||
147289666|NCT01217073|531225623|FG002|Base Period|Physician Decision|0|||
147289667|NCT01217073|531225624|FG003|Base Period|Physician Decision|0|||
147289668|NCT01217073|531225625|FG004|Base Period|Physician Decision|1|||
147289669|NCT01217073|531225626|FG005|Base Period|Physician Decision|0|||
147289670|NCT01217073|531225627|FG006|Base Period|Physician Decision|0|||
147289671|NCT01217073|531225628|FG007|Base Period|Physician Decision|0|||
147289672|NCT01217073|531225621|FG000|Base Period|Protocol Violation|1|||
147289673|NCT01217073|531225622|FG001|Base Period|Protocol Violation|0|||
147289674|NCT01217073|531225623|FG002|Base Period|Protocol Violation|0|||
147289675|NCT01217073|531225624|FG003|Base Period|Protocol Violation|0|||
147289676|NCT01217073|531225625|FG004|Base Period|Protocol Violation|1|||
147289677|NCT01217073|531225626|FG005|Base Period|Protocol Violation|2|||
147289678|NCT01217073|531225627|FG006|Base Period|Protocol Violation|0|||
147289679|NCT01217073|531225628|FG007|Base Period|Protocol Violation|0|||
147289680|NCT01217073|531225621|FG000|Base Period|Withdrawal by Subject|4|||
147289681|NCT01217073|531225622|FG001|Base Period|Withdrawal by Subject|5|||
147289682|NCT01217073|531225623|FG002|Base Period|Withdrawal by Subject|5|||
147289683|NCT01217073|531225624|FG003|Base Period|Withdrawal by Subject|1|||
147289684|NCT01217073|531225625|FG004|Base Period|Withdrawal by Subject|5|||
147289685|NCT01217073|531225626|FG005|Base Period|Withdrawal by Subject|5|||
147289686|NCT01217073|531225627|FG006|Base Period|Withdrawal by Subject|0|||
147604319|NCT00724048|532367872|FG000|Overall Study|Investigator decision|0|||
147604320|NCT00724048|532367873|FG001|Overall Study|Investigator decision|0|||
147289687|NCT01217073|531225628|FG007|Base Period|Withdrawal by Subject|0|||
147289688|NCT01217073|531225621|FG000|Extension Period|Adverse Event|0|||
147289689|NCT01217073|531225622|FG001|Extension Period|Adverse Event|0|||
147289690|NCT01217073|531225623|FG002|Extension Period|Adverse Event|0|||
147289691|NCT01217073|531225624|FG003|Extension Period|Adverse Event|0|||
147289692|NCT01217073|531225625|FG004|Extension Period|Adverse Event|0|||
147289693|NCT01217073|531225626|FG005|Extension Period|Adverse Event|0|||
147289694|NCT01217073|531225627|FG006|Extension Period|Adverse Event|19|||
147289695|NCT01217073|531225628|FG007|Extension Period|Adverse Event|5|||
147289696|NCT01217073|531225621|FG000|Extension Period|ALT/AST|0|||
147289697|NCT01217073|531225622|FG001|Extension Period|ALT/AST|0|||
147289698|NCT01217073|531225623|FG002|Extension Period|ALT/AST|0|||
147289699|NCT01217073|531225624|FG003|Extension Period|ALT/AST|0|||
147289700|NCT01217073|531225625|FG004|Extension Period|ALT/AST|0|||
147289701|NCT01217073|531225626|FG005|Extension Period|ALT/AST|0|||
147289702|NCT01217073|531225627|FG006|Extension Period|ALT/AST|2|||
147289703|NCT01217073|531225628|FG007|Extension Period|ALT/AST|0|||
147289704|NCT01217073|531225621|FG000|Extension Period|Contraindication to study medication|0|||
147289705|NCT01217073|531225622|FG001|Extension Period|Contraindication to study medication|0|||
147289706|NCT01217073|531225623|FG002|Extension Period|Contraindication to study medication|0|||
147289707|NCT01217073|531225624|FG003|Extension Period|Contraindication to study medication|0|||
147289708|NCT01217073|531225625|FG004|Extension Period|Contraindication to study medication|0|||
147289709|NCT01217073|531225626|FG005|Extension Period|Contraindication to study medication|0|||
147289710|NCT01217073|531225627|FG006|Extension Period|Contraindication to study medication|1|||
147289711|NCT01217073|531225628|FG007|Extension Period|Contraindication to study medication|0|||
147289712|NCT01217073|531225621|FG000|Extension Period|Creatinine/eGFR|0|||
147289713|NCT01217073|531225622|FG001|Extension Period|Creatinine/eGFR|0|||
147289714|NCT01217073|531225623|FG002|Extension Period|Creatinine/eGFR|0|||
147289715|NCT01217073|531225624|FG003|Extension Period|Creatinine/eGFR|0|||
147289716|NCT01217073|531225625|FG004|Extension Period|Creatinine/eGFR|0|||
147289717|NCT01217073|531225626|FG005|Extension Period|Creatinine/eGFR|0|||
147289718|NCT01217073|531225627|FG006|Extension Period|Creatinine/eGFR|11|||
147289719|NCT01217073|531225628|FG007|Extension Period|Creatinine/eGFR|1|||
147289720|NCT01217073|531225621|FG000|Extension Period|Death|0|||
147289721|NCT01217073|531225622|FG001|Extension Period|Death|0|||
147289722|NCT01217073|531225623|FG002|Extension Period|Death|0|||
147289723|NCT01217073|531225624|FG003|Extension Period|Death|0|||
147289724|NCT01217073|531225625|FG004|Extension Period|Death|0|||
147289725|NCT01217073|531225626|FG005|Extension Period|Death|0|||
147289726|NCT01217073|531225627|FG006|Extension Period|Death|1|||
147289727|NCT01217073|531225628|FG007|Extension Period|Death|0|||
147289728|NCT01217073|531225621|FG000|Extension Period|Excluded medication|0|||
147289729|NCT01217073|531225622|FG001|Extension Period|Excluded medication|0|||
147289730|NCT01217073|531225623|FG002|Extension Period|Excluded medication|0|||
147289731|NCT01217073|531225624|FG003|Extension Period|Excluded medication|0|||
147289732|NCT01217073|531225625|FG004|Extension Period|Excluded medication|0|||
147289733|NCT01217073|531225626|FG005|Extension Period|Excluded medication|0|||
147289734|NCT01217073|531225627|FG006|Extension Period|Excluded medication|2|||
147289735|NCT01217073|531225628|FG007|Extension Period|Excluded medication|0|||
147289736|NCT01217073|531225621|FG000|Extension Period|Lack of Efficacy|0|||
147289737|NCT01217073|531225622|FG001|Extension Period|Lack of Efficacy|0|||
147289738|NCT01217073|531225623|FG002|Extension Period|Lack of Efficacy|0|||
147289739|NCT01217073|531225624|FG003|Extension Period|Lack of Efficacy|0|||
147289740|NCT01217073|531225625|FG004|Extension Period|Lack of Efficacy|0|||
147289741|NCT01217073|531225626|FG005|Extension Period|Lack of Efficacy|0|||
147289742|NCT01217073|531225627|FG006|Extension Period|Lack of Efficacy|3|||
147289743|NCT01217073|531225628|FG007|Extension Period|Lack of Efficacy|0|||
147289744|NCT01217073|531225621|FG000|Extension Period|Lost to Follow-up|0|||
147289745|NCT01217073|531225622|FG001|Extension Period|Lost to Follow-up|0|||
147289746|NCT01217073|531225623|FG002|Extension Period|Lost to Follow-up|0|||
147289747|NCT01217073|531225624|FG003|Extension Period|Lost to Follow-up|0|||
147289748|NCT01217073|531225625|FG004|Extension Period|Lost to Follow-up|0|||
147337971|NCT01636687|531404766|FG000|Extension Period|Physician Decision|1|||
147289749|NCT01217073|531225626|FG005|Extension Period|Lost to Follow-up|0|||
147289750|NCT01217073|531225627|FG006|Extension Period|Lost to Follow-up|9|||
147289751|NCT01217073|531225628|FG007|Extension Period|Lost to Follow-up|1|||
147289752|NCT01217073|531225621|FG000|Extension Period|Non-compliance with study drug|0|||
147289753|NCT01217073|531225622|FG001|Extension Period|Non-compliance with study drug|0|||
147289754|NCT01217073|531225623|FG002|Extension Period|Non-compliance with study drug|0|||
147289755|NCT01217073|531225624|FG003|Extension Period|Non-compliance with study drug|0|||
147289756|NCT01217073|531225625|FG004|Extension Period|Non-compliance with study drug|0|||
147289757|NCT01217073|531225626|FG005|Extension Period|Non-compliance with study drug|0|||
147289758|NCT01217073|531225627|FG006|Extension Period|Non-compliance with study drug|0|||
147289759|NCT01217073|531225628|FG007|Extension Period|Non-compliance with study drug|1|||
147289760|NCT01217073|531225621|FG000|Extension Period|Physician Decision|0|||
147289761|NCT01217073|531225622|FG001|Extension Period|Physician Decision|0|||
147289762|NCT01217073|531225623|FG002|Extension Period|Physician Decision|0|||
147289763|NCT01217073|531225624|FG003|Extension Period|Physician Decision|0|||
147289764|NCT01217073|531225625|FG004|Extension Period|Physician Decision|0|||
147289765|NCT01217073|531225626|FG005|Extension Period|Physician Decision|0|||
147289766|NCT01217073|531225627|FG006|Extension Period|Physician Decision|4|||
147289767|NCT01217073|531225628|FG007|Extension Period|Physician Decision|1|||
147289768|NCT01217073|531225621|FG000|Extension Period|Protocol Violation|0|||
147289769|NCT01217073|531225622|FG001|Extension Period|Protocol Violation|0|||
147289770|NCT01217073|531225623|FG002|Extension Period|Protocol Violation|0|||
147289771|NCT01217073|531225624|FG003|Extension Period|Protocol Violation|0|||
147289772|NCT01217073|531225625|FG004|Extension Period|Protocol Violation|0|||
147289773|NCT01217073|531225626|FG005|Extension Period|Protocol Violation|0|||
147289774|NCT01217073|531225627|FG006|Extension Period|Protocol Violation|2|||
147289775|NCT01217073|531225628|FG007|Extension Period|Protocol Violation|1|||
147289776|NCT01217073|531225621|FG000|Extension Period|Site discontinued study participation|0|||
147289777|NCT01217073|531225622|FG001|Extension Period|Site discontinued study participation|0|||
147289778|NCT01217073|531225623|FG002|Extension Period|Site discontinued study participation|0|||
147289779|NCT01217073|531225624|FG003|Extension Period|Site discontinued study participation|0|||
147289780|NCT01217073|531225625|FG004|Extension Period|Site discontinued study participation|0|||
147289781|NCT01217073|531225626|FG005|Extension Period|Site discontinued study participation|0|||
147289782|NCT01217073|531225627|FG006|Extension Period|Site discontinued study participation|7|||
147289783|NCT01217073|531225628|FG007|Extension Period|Site discontinued study participation|2|||
147337972|NCT01636687|531404767|FG001|Extension Period|Physician Decision|0|||
147337973|NCT01636687|531404768|FG002|Extension Period|Physician Decision|0|||
147337974|NCT01636687|531404769|FG003|Extension Period|Physician Decision|1|||
147337975|NCT01636687|531404770|FG004|Extension Period|Physician Decision|0|||
147337976|NCT01636687|531404766|FG000|Extension Period|study terminated by sponsor|33|||
147337977|NCT01636687|531404767|FG001|Extension Period|study terminated by sponsor|50|||
147337978|NCT01636687|531404768|FG002|Extension Period|study terminated by sponsor|17|||
147289784|NCT01217073|531225621|FG000|Extension Period|Withdrawal by Subject|0|||
147289785|NCT01217073|531225622|FG001|Extension Period|Withdrawal by Subject|0|||
147289786|NCT01217073|531225623|FG002|Extension Period|Withdrawal by Subject|0|||
147289787|NCT01217073|531225624|FG003|Extension Period|Withdrawal by Subject|0|||
147337979|NCT01636687|531404769|FG003|Extension Period|study terminated by sponsor|23|||
147337980|NCT01636687|531404770|FG004|Extension Period|study terminated by sponsor|0|||
147337981|NCT01636687|531404766|FG000|Extension Period|Withdrawal by Subject|1|||
147337982|NCT01636687|531404767|FG001|Extension Period|Withdrawal by Subject|0|||
147337983|NCT01636687|531404768|FG002|Extension Period|Withdrawal by Subject|1|||
147289788|NCT01217073|531225625|FG004|Extension Period|Withdrawal by Subject|0|||
147289789|NCT01217073|531225626|FG005|Extension Period|Withdrawal by Subject|0|||
147289790|NCT01217073|531225627|FG006|Extension Period|Withdrawal by Subject|30|||
147289791|NCT01217073|531225628|FG007|Extension Period|Withdrawal by Subject|8|||
147289792|NCT00620750|531225629|FG000|Overall Study|Lost to Follow-up|25|||
147289793|NCT04477187|531225630|FG000|Overall Study|Lost to Follow-up|2|||
147289794|NCT02564523|531225631|FG000|Overall Study|Withdrawal by Subject|3|||
147289795|NCT02564523|531225632|FG001|Overall Study|Withdrawal by Subject|0|||
147662643|NCT00385918|532587379|FG000|Intervention Phase After Randomization|Physician Decision|1|||
147662644|NCT00385918|532587380|FG001|Intervention Phase After Randomization|Physician Decision|0|||
147662645|NCT00385918|532587381|FG002|Intervention Phase After Randomization|Physician Decision|0|||
147662646|NCT00385918|532587379|FG000|Intervention Phase After Randomization|Lost to Follow-up|1|||
147662647|NCT00385918|532587380|FG001|Intervention Phase After Randomization|Lost to Follow-up|0|||
147289796|NCT02564523|531225633|FG002|Overall Study|Withdrawal by Subject|1|||
147289797|NCT02564523|531225634|FG003|Overall Study|Withdrawal by Subject|0|||
147289798|NCT02564523|531225635|FG004|Overall Study|Withdrawal by Subject|1|||
147289799|NCT02564523|531225636|FG005|Overall Study|Withdrawal by Subject|0|||
147289800|NCT02564523|531225637|FG006|Overall Study|Withdrawal by Subject|1|||
147289801|NCT02564523|531225638|FG007|Overall Study|Withdrawal by Subject|0|||
147289802|NCT02564523|531225639|FG008|Overall Study|Withdrawal by Subject|0|||
147289803|NCT02564523|531225640|FG009|Overall Study|Withdrawal by Subject|0|||
147289804|NCT02564523|531225641|FG010|Overall Study|Withdrawal by Subject|1|||
147289805|NCT02564523|531225642|FG011|Overall Study|Withdrawal by Subject|0|||
147289806|NCT02564523|531225643|FG012|Overall Study|Withdrawal by Subject|1|||
147289807|NCT02564523|531225644|FG013|Overall Study|Withdrawal by Subject|0|||
147289808|NCT02564523|531225645|FG014|Overall Study|Withdrawal by Subject|0|||
147289809|NCT02564523|531225646|FG015|Overall Study|Withdrawal by Subject|0|||
147289810|NCT02564523|531225647|FG016|Overall Study|Withdrawal by Subject|0|||
147289811|NCT02564523|531225648|FG017|Overall Study|Withdrawal by Subject|0|||
147289812|NCT02564523|531225631|FG000|Overall Study|Adverse Event|0|||
147289813|NCT02564523|531225632|FG001|Overall Study|Adverse Event|0|||
147289814|NCT02564523|531225633|FG002|Overall Study|Adverse Event|0|||
147289815|NCT02564523|531225634|FG003|Overall Study|Adverse Event|0|||
147289816|NCT02564523|531225635|FG004|Overall Study|Adverse Event|0|||
147289817|NCT02564523|531225636|FG005|Overall Study|Adverse Event|0|||
147289818|NCT02564523|531225637|FG006|Overall Study|Adverse Event|0|||
147289819|NCT02564523|531225638|FG007|Overall Study|Adverse Event|0|||
147289820|NCT02564523|531225639|FG008|Overall Study|Adverse Event|0|||
147289821|NCT02564523|531225640|FG009|Overall Study|Adverse Event|0|||
147289822|NCT02564523|531225641|FG010|Overall Study|Adverse Event|0|||
147289823|NCT02564523|531225642|FG011|Overall Study|Adverse Event|0|||
147289824|NCT02564523|531225643|FG012|Overall Study|Adverse Event|0|||
147289825|NCT02564523|531225644|FG013|Overall Study|Adverse Event|0|||
147289826|NCT02564523|531225645|FG014|Overall Study|Adverse Event|0|||
147289827|NCT02564523|531225646|FG015|Overall Study|Adverse Event|0|||
147289828|NCT02564523|531225647|FG016|Overall Study|Adverse Event|0|||
147289829|NCT02564523|531225648|FG017|Overall Study|Adverse Event|1|||
147289830|NCT02564523|531225631|FG000|Overall Study|Death|0|||
147289831|NCT02564523|531225632|FG001|Overall Study|Death|0|||
147289832|NCT02564523|531225633|FG002|Overall Study|Death|0|||
147289833|NCT02564523|531225634|FG003|Overall Study|Death|0|||
147289834|NCT02564523|531225635|FG004|Overall Study|Death|0|||
147289835|NCT02564523|531225636|FG005|Overall Study|Death|0|||
147289836|NCT02564523|531225637|FG006|Overall Study|Death|1|||
147289837|NCT02564523|531225638|FG007|Overall Study|Death|0|||
147289838|NCT02564523|531225639|FG008|Overall Study|Death|0|||
147289839|NCT02564523|531225640|FG009|Overall Study|Death|0|||
147289840|NCT02564523|531225641|FG010|Overall Study|Death|1|||
147289841|NCT02564523|531225642|FG011|Overall Study|Death|0|||
147289842|NCT02564523|531225643|FG012|Overall Study|Death|0|||
147289843|NCT02564523|531225644|FG013|Overall Study|Death|0|||
147289844|NCT02564523|531225645|FG014|Overall Study|Death|0|||
147289845|NCT02564523|531225646|FG015|Overall Study|Death|0|||
147289846|NCT02564523|531225647|FG016|Overall Study|Death|0|||
147289847|NCT02564523|531225648|FG017|Overall Study|Death|0|||
147289848|NCT02564523|531225631|FG000|Overall Study|Lost to Follow-up|2|||
147289849|NCT02564523|531225632|FG001|Overall Study|Lost to Follow-up|1|||
147289850|NCT02564523|531225633|FG002|Overall Study|Lost to Follow-up|4|||
147289851|NCT02564523|531225634|FG003|Overall Study|Lost to Follow-up|0|||
147289852|NCT02564523|531225635|FG004|Overall Study|Lost to Follow-up|1|||
147289853|NCT02564523|531225636|FG005|Overall Study|Lost to Follow-up|0|||
147289854|NCT02564523|531225637|FG006|Overall Study|Lost to Follow-up|1|||
147289855|NCT02564523|531225638|FG007|Overall Study|Lost to Follow-up|0|||
147289856|NCT02564523|531225639|FG008|Overall Study|Lost to Follow-up|0|||
147289857|NCT02564523|531225640|FG009|Overall Study|Lost to Follow-up|0|||
147289858|NCT02564523|531225641|FG010|Overall Study|Lost to Follow-up|0|||
147289859|NCT02564523|531225642|FG011|Overall Study|Lost to Follow-up|1|||
147289860|NCT02564523|531225643|FG012|Overall Study|Lost to Follow-up|1|||
147289861|NCT02564523|531225644|FG013|Overall Study|Lost to Follow-up|0|||
147662648|NCT00385918|532587381|FG002|Intervention Phase After Randomization|Lost to Follow-up|0|||
147289862|NCT02564523|531225645|FG014|Overall Study|Lost to Follow-up|0|||
147289863|NCT02564523|531225646|FG015|Overall Study|Lost to Follow-up|0|||
147289864|NCT02564523|531225647|FG016|Overall Study|Lost to Follow-up|0|||
147289865|NCT02564523|531225648|FG017|Overall Study|Lost to Follow-up|0|||
147289866|NCT02564523|531225631|FG000|Overall Study|Physician Decision|0|||
147289867|NCT02564523|531225632|FG001|Overall Study|Physician Decision|0|||
147289868|NCT02564523|531225633|FG002|Overall Study|Physician Decision|0|||
147289869|NCT02564523|531225634|FG003|Overall Study|Physician Decision|0|||
147289870|NCT02564523|531225635|FG004|Overall Study|Physician Decision|1|||
147289871|NCT02564523|531225636|FG005|Overall Study|Physician Decision|0|||
147289872|NCT02564523|531225637|FG006|Overall Study|Physician Decision|0|||
147289873|NCT02564523|531225638|FG007|Overall Study|Physician Decision|0|||
147289874|NCT02564523|531225639|FG008|Overall Study|Physician Decision|0|||
147289875|NCT02564523|531225640|FG009|Overall Study|Physician Decision|0|||
147289876|NCT02564523|531225641|FG010|Overall Study|Physician Decision|1|||
147289877|NCT02564523|531225642|FG011|Overall Study|Physician Decision|0|||
147289878|NCT02564523|531225643|FG012|Overall Study|Physician Decision|0|||
147289879|NCT02564523|531225644|FG013|Overall Study|Physician Decision|0|||
147289880|NCT02564523|531225645|FG014|Overall Study|Physician Decision|0|||
147289881|NCT02564523|531225646|FG015|Overall Study|Physician Decision|0|||
147289882|NCT02564523|531225647|FG016|Overall Study|Physician Decision|0|||
147289883|NCT02564523|531225648|FG017|Overall Study|Physician Decision|0|||
147289884|NCT02564523|531225631|FG000|Overall Study|Protocol Violation|2|||
147289885|NCT02564523|531225632|FG001|Overall Study|Protocol Violation|2|||
147289886|NCT02564523|531225633|FG002|Overall Study|Protocol Violation|5|||
147289887|NCT02564523|531225634|FG003|Overall Study|Protocol Violation|0|||
147289888|NCT02564523|531225635|FG004|Overall Study|Protocol Violation|1|||
147289889|NCT02564523|531225636|FG005|Overall Study|Protocol Violation|0|||
147289890|NCT02564523|531225637|FG006|Overall Study|Protocol Violation|0|||
147289891|NCT02564523|531225638|FG007|Overall Study|Protocol Violation|0|||
147289892|NCT02564523|531225639|FG008|Overall Study|Protocol Violation|0|||
147289893|NCT02564523|531225640|FG009|Overall Study|Protocol Violation|0|||
147289894|NCT02564523|531225641|FG010|Overall Study|Protocol Violation|0|||
147289895|NCT02564523|531225642|FG011|Overall Study|Protocol Violation|0|||
147289896|NCT02564523|531225643|FG012|Overall Study|Protocol Violation|0|||
147289897|NCT02564523|531225644|FG013|Overall Study|Protocol Violation|0|||
147289898|NCT02564523|531225645|FG014|Overall Study|Protocol Violation|0|||
147289899|NCT02564523|531225646|FG015|Overall Study|Protocol Violation|0|||
147289900|NCT02564523|531225647|FG016|Overall Study|Protocol Violation|0|||
147289901|NCT02564523|531225648|FG017|Overall Study|Protocol Violation|0|||
147289902|NCT02564523|531225631|FG000|Overall Study|Other|3|||
147289903|NCT02564523|531225632|FG001|Overall Study|Other|0|||
147289904|NCT02564523|531225633|FG002|Overall Study|Other|0|||
147289905|NCT02564523|531225634|FG003|Overall Study|Other|1|||
147289906|NCT02564523|531225635|FG004|Overall Study|Other|0|||
147289907|NCT02564523|531225636|FG005|Overall Study|Other|0|||
147289908|NCT02564523|531225637|FG006|Overall Study|Other|0|||
147337984|NCT01636687|531404769|FG003|Extension Period|Withdrawal by Subject|1|||
147337985|NCT01636687|531404770|FG004|Extension Period|Withdrawal by Subject|0|||
147337986|NCT01636687|531404766|FG000|Follow-up Period|Withdrawal by Subject|1|||
147337987|NCT01636687|531404767|FG001|Follow-up Period|Withdrawal by Subject|0|||
147337988|NCT01636687|531404768|FG002|Follow-up Period|Withdrawal by Subject|0|||
147337989|NCT01636687|531404769|FG003|Follow-up Period|Withdrawal by Subject|0|||
147337990|NCT01636687|531404770|FG004|Follow-up Period|Withdrawal by Subject|1|||
147337991|NCT02918279|531404778|FG000|Overall Study|Lost to Follow-up|3|||
147337992|NCT02918279|531404779|FG001|Overall Study|Lost to Follow-up|6|||
147337993|NCT02918279|531404778|FG000|Overall Study|Withdrawal by Subject|5|||
147337994|NCT02918279|531404779|FG001|Overall Study|Withdrawal by Subject|15|||
147337995|NCT02918279|531404778|FG000|Overall Study|Withdrawal by parent/guardian|2|||
147337996|NCT02918279|531404779|FG001|Overall Study|Withdrawal by parent/guardian|1|||
147337997|NCT02918279|531404778|FG000|Overall Study|Other|3|||
147337998|NCT02918279|531404779|FG001|Overall Study|Other|1|||
147337999|NCT00636207|531404780|FG000|Overall Study|Adverse Event|1|||
147338000|NCT00636207|531404781|FG001|Overall Study|Adverse Event|0|||
147338001|NCT00636207|531404782|FG002|Overall Study|Adverse Event|0|||
147338002|NCT00636207|531404783|FG003|Overall Study|Adverse Event|0|||
147338003|NCT00636207|531404784|FG004|Overall Study|Adverse Event|0|||
147604321|NCT00724048|532367874|FG002|Overall Study|Investigator decision|1|||
147604322|NCT00724048|532367875|FG003|Overall Study|Investigator decision|0|||
147604323|NCT00724048|532367872|FG000|Overall Study|Did not tolerate study drug|0|||
147604324|NCT00724048|532367873|FG001|Overall Study|Did not tolerate study drug|0|||
147289909|NCT02564523|531225638|FG007|Overall Study|Other|0|||
147289910|NCT02564523|531225639|FG008|Overall Study|Other|0|||
147289911|NCT02564523|531225640|FG009|Overall Study|Other|0|||
147289912|NCT02564523|531225641|FG010|Overall Study|Other|0|||
147338004|NCT00636207|531404785|FG005|Overall Study|Adverse Event|0|||
147338005|NCT00636207|531404786|FG006|Overall Study|Adverse Event|0|||
147338006|NCT00636207|531404780|FG000|Overall Study|Withdrawal by Subject|0|||
147289913|NCT02564523|531225642|FG011|Overall Study|Other|0|||
147289914|NCT02564523|531225643|FG012|Overall Study|Other|0|||
147289915|NCT02564523|531225644|FG013|Overall Study|Other|0|||
147338007|NCT00636207|531404781|FG001|Overall Study|Withdrawal by Subject|1|||
147604325|NCT00724048|532367874|FG002|Overall Study|Did not tolerate study drug|0|||
147289916|NCT02564523|531225645|FG014|Overall Study|Other|0|||
147289917|NCT02564523|531225646|FG015|Overall Study|Other|0|||
147604326|NCT00724048|532367875|FG003|Overall Study|Did not tolerate study drug|1|||
147289918|NCT02564523|531225647|FG016|Overall Study|Other|0|||
147289919|NCT02564523|531225648|FG017|Overall Study|Other|0|||
147338008|NCT00636207|531404782|FG002|Overall Study|Withdrawal by Subject|0|||
147289920|NCT03905655|531225651|FG000|Overall Study|Adverse Event|1|||
147289921|NCT03905655|531225652|FG001|Overall Study|Adverse Event|0|||
147289922|NCT03905655|531225653|FG002|Overall Study|Adverse Event|1|||
147289923|NCT03905655|531225654|FG003|Overall Study|Adverse Event|1|||
147289924|NCT02566031|531225655|FG000|Overall Study|Patient/guardian decision|14|||
147289925|NCT02566031|531225656|FG001|Overall Study|Patient/guardian decision|7|||
147289926|NCT02566031|531225655|FG000|Overall Study|Protocol deviation|2|||
147289927|NCT02566031|531225656|FG001|Overall Study|Protocol deviation|3|||
147289928|NCT02566031|531225655|FG000|Overall Study|Adverse Event|3|||
147289929|NCT02566031|531225656|FG001|Overall Study|Adverse Event|1|||
147289930|NCT02566031|531225655|FG000|Overall Study|Lost to Follow-up|1|||
147289931|NCT02566031|531225656|FG001|Overall Study|Lost to Follow-up|1|||
147289932|NCT03031938|531225657|FG000|Overall Study|Death|1|||
147289933|NCT03031938|531225658|FG001|Overall Study|Death|0|||
147289934|NCT02479412|531225659|FG000|Overall Study|Adverse Event|0|||
147289935|NCT02479412|531225660|FG001|Overall Study|Adverse Event|0|||
147289936|NCT02479412|531225661|FG002|Overall Study|Adverse Event|1|||
147289937|NCT02479412|531225662|FG003|Overall Study|Adverse Event|0|||
147289938|NCT02479412|531225663|FG004|Overall Study|Adverse Event|0|||
147289939|NCT02479412|531225664|FG005|Overall Study|Adverse Event|0|||
147289940|NCT02479412|531225665|FG006|Overall Study|Adverse Event|0|||
147289941|NCT02479412|531225666|FG007|Overall Study|Adverse Event|0|||
147289942|NCT02479412|531225667|FG008|Overall Study|Adverse Event|0|||
147289943|NCT02479412|531225659|FG000|Overall Study|Study-specific withdrawal criteria|0|||
147289944|NCT02479412|531225660|FG001|Overall Study|Study-specific withdrawal criteria|0|||
147289945|NCT02479412|531225661|FG002|Overall Study|Study-specific withdrawal criteria|1|||
147289946|NCT02479412|531225662|FG003|Overall Study|Study-specific withdrawal criteria|1|||
147289947|NCT02479412|531225663|FG004|Overall Study|Study-specific withdrawal criteria|0|||
147289948|NCT02479412|531225664|FG005|Overall Study|Study-specific withdrawal criteria|0|||
147289949|NCT02479412|531225665|FG006|Overall Study|Study-specific withdrawal criteria|0|||
147289950|NCT02479412|531225666|FG007|Overall Study|Study-specific withdrawal criteria|1|||
147289951|NCT02479412|531225667|FG008|Overall Study|Study-specific withdrawal criteria|1|||
147289952|NCT02479412|531225659|FG000|Overall Study|Randomization to wrong PK sampling group|0|||
147289953|NCT02479412|531225660|FG001|Overall Study|Randomization to wrong PK sampling group|0|||
147289954|NCT02479412|531225661|FG002|Overall Study|Randomization to wrong PK sampling group|0|||
147289955|NCT02479412|531225662|FG003|Overall Study|Randomization to wrong PK sampling group|0|||
147289956|NCT02479412|531225663|FG004|Overall Study|Randomization to wrong PK sampling group|1|||
147289957|NCT02479412|531225664|FG005|Overall Study|Randomization to wrong PK sampling group|0|||
147289958|NCT02479412|531225665|FG006|Overall Study|Randomization to wrong PK sampling group|0|||
147289959|NCT02479412|531225666|FG007|Overall Study|Randomization to wrong PK sampling group|0|||
147289960|NCT02479412|531225667|FG008|Overall Study|Randomization to wrong PK sampling group|0|||
147289961|NCT02732938|531225671|FG000|Overall Study|Death|0|||
147289962|NCT02732938|531225672|FG001|Overall Study|Death|11|||
147289963|NCT02732938|531225673|FG002|Overall Study|Death|0|||
147289964|NCT02732938|531225671|FG000|Overall Study|Randomized but did not receive treatment|0|||
147289965|NCT02732938|531225672|FG001|Overall Study|Randomized but did not receive treatment|1|||
147289966|NCT02732938|531225673|FG002|Overall Study|Randomized but did not receive treatment|0|||
147289967|NCT02732938|531225671|FG000|Overall Study|Refused further follow-up|1|||
147289968|NCT02732938|531225672|FG001|Overall Study|Refused further follow-up|0|||
147289969|NCT02732938|531225673|FG002|Overall Study|Refused further follow-up|0|||
147289970|NCT02732938|531225671|FG000|Overall Study|Study terminated by sponsor|3|||
147289971|NCT02732938|531225672|FG001|Overall Study|Study terminated by sponsor|6|||
147289972|NCT02732938|531225673|FG002|Overall Study|Study terminated by sponsor|0|||
147289973|NCT01613248|531225674|FG000|Overall Study|Adverse Event|0|||
147289974|NCT01613248|531225675|FG001|Overall Study|Adverse Event|0|||
147289975|NCT01613248|531225676|FG002|Overall Study|Adverse Event|0|||
147289976|NCT01613248|531225677|FG003|Overall Study|Adverse Event|1|||
147289977|NCT01613248|531225678|FG004|Overall Study|Adverse Event|0|||
147289978|NCT01613248|531225679|FG005|Overall Study|Adverse Event|0|||
147289979|NCT01613248|531225674|FG000|Overall Study|Withdrawal by Subject|3|||
147289980|NCT01613248|531225675|FG001|Overall Study|Withdrawal by Subject|2|||
147662649|NCT00128661|532587382|FG000|Overall Study|Adverse Event|14|||
147289981|NCT01613248|531225676|FG002|Overall Study|Withdrawal by Subject|2|||
147289982|NCT01613248|531225677|FG003|Overall Study|Withdrawal by Subject|5|||
147289983|NCT01613248|531225678|FG004|Overall Study|Withdrawal by Subject|0|||
147289984|NCT01613248|531225679|FG005|Overall Study|Withdrawal by Subject|1|||
147289985|NCT01613248|531225674|FG000|Overall Study|Lost to Follow-up|5|||
147289986|NCT01613248|531225675|FG001|Overall Study|Lost to Follow-up|7|||
147289987|NCT01613248|531225676|FG002|Overall Study|Lost to Follow-up|4|||
147289988|NCT01613248|531225677|FG003|Overall Study|Lost to Follow-up|8|||
147289989|NCT01613248|531225678|FG004|Overall Study|Lost to Follow-up|4|||
147289990|NCT01613248|531225679|FG005|Overall Study|Lost to Follow-up|2|||
147289991|NCT01613248|531225674|FG000|Overall Study|Study Terminated by Sponsor|4|||
147289992|NCT01613248|531225675|FG001|Overall Study|Study Terminated by Sponsor|6|||
147289993|NCT01613248|531225676|FG002|Overall Study|Study Terminated by Sponsor|8|||
147289994|NCT01613248|531225677|FG003|Overall Study|Study Terminated by Sponsor|8|||
147289995|NCT01613248|531225678|FG004|Overall Study|Study Terminated by Sponsor|9|||
147338009|NCT00636207|531404783|FG003|Overall Study|Withdrawal by Subject|0|||
147338010|NCT00636207|531404784|FG004|Overall Study|Withdrawal by Subject|1|||
147338011|NCT00636207|531404785|FG005|Overall Study|Withdrawal by Subject|0|||
147338012|NCT00636207|531404786|FG006|Overall Study|Withdrawal by Subject|0|||
147338013|NCT02888080|531404787|FG000|Overall Study|Subject / Guardian decision|1|||
147338014|NCT02888080|531404788|FG001|Overall Study|Subject / Guardian decision|3|||
147289996|NCT01613248|531225679|FG005|Overall Study|Study Terminated by Sponsor|11|||
147289997|NCT01613248|531225674|FG000|Overall Study|Physician Decision|8|||
147289998|NCT01613248|531225675|FG001|Overall Study|Physician Decision|8|||
147289999|NCT01613248|531225676|FG002|Overall Study|Physician Decision|9|||
147290000|NCT01613248|531225677|FG003|Overall Study|Physician Decision|4|||
147290001|NCT01613248|531225678|FG004|Overall Study|Physician Decision|7|||
147290002|NCT01613248|531225679|FG005|Overall Study|Physician Decision|6|||
147290003|NCT01613248|531225674|FG000|Overall Study|Lack of Qualifying Event|9|||
147290004|NCT01613248|531225675|FG001|Overall Study|Lack of Qualifying Event|11|||
147290005|NCT01613248|531225676|FG002|Overall Study|Lack of Qualifying Event|10|||
147290006|NCT01613248|531225677|FG003|Overall Study|Lack of Qualifying Event|11|||
147290007|NCT01613248|531225678|FG004|Overall Study|Lack of Qualifying Event|15|||
147290008|NCT01613248|531225679|FG005|Overall Study|Lack of Qualifying Event|18|||
147290009|NCT01613248|531225674|FG000|Overall Study|Pregnancy|0|||
147290010|NCT01613248|531225675|FG001|Overall Study|Pregnancy|0|||
147290011|NCT01613248|531225676|FG002|Overall Study|Pregnancy|0|||
147290012|NCT01613248|531225677|FG003|Overall Study|Pregnancy|1|||
147290013|NCT01613248|531225678|FG004|Overall Study|Pregnancy|0|||
147290014|NCT01613248|531225679|FG005|Overall Study|Pregnancy|0|||
147290015|NCT03280121|531225681|FG000|Overall Study|Physician Decision|1|||
147290016|NCT03280121|531225681|FG000|Overall Study|Lost to Follow-up|1|||
147338015|NCT02888080|531404787|FG000|Overall Study|New Therapy for study indication|1|||
147338016|NCT02888080|531404788|FG001|Overall Study|New Therapy for study indication|0|||
147338017|NCT02888080|531404787|FG000|Overall Study|Lack of Efficacy|0|||
147338018|NCT02888080|531404788|FG001|Overall Study|Lack of Efficacy|1|||
147338019|NCT02888080|531404787|FG000|Overall Study|Adverse Event|0|||
147338020|NCT02888080|531404788|FG001|Overall Study|Adverse Event|1|||
147338021|NCT01641198|531404789|FG000|After 12 Months of Function|Lost to Follow-up|3|||
147338022|NCT01641198|531404790|FG001|After 12 Months of Function|Lost to Follow-up|2|||
147338023|NCT01641198|531404791|FG002|After 12 Months of Function|Lost to Follow-up|2|||
147338024|NCT01641198|531404789|FG000|After 12 Months of Function|Protocol Violation|1|||
147338025|NCT01641198|531404790|FG001|After 12 Months of Function|Protocol Violation|0|||
147338026|NCT01641198|531404791|FG002|After 12 Months of Function|Protocol Violation|0|||
147338027|NCT01641198|531404789|FG000|After 12 Months of Function|Adverse Event|0|||
147338028|NCT01641198|531404790|FG001|After 12 Months of Function|Adverse Event|1|||
147338029|NCT01641198|531404791|FG002|After 12 Months of Function|Adverse Event|0|||
147338030|NCT01641198|531404789|FG000|After 24 Months of Function|Lost to Follow-up|4|||
147338031|NCT01641198|531404790|FG001|After 24 Months of Function|Lost to Follow-up|9|||
147338032|NCT01641198|531404791|FG002|After 24 Months of Function|Lost to Follow-up|6|||
147338033|NCT01641198|531404789|FG000|At 15-20 Years of Function|Lost to Follow-up|5|||
147338034|NCT01641198|531404790|FG001|At 15-20 Years of Function|Lost to Follow-up|1|||
147338035|NCT01641198|531404791|FG002|At 15-20 Years of Function|Lost to Follow-up|1|||
147338036|NCT01641198|531404789|FG000|At 15-20 Years of Function|Death|1|||
147338037|NCT01641198|531404790|FG001|At 15-20 Years of Function|Death|0|||
147338038|NCT01641198|531404791|FG002|At 15-20 Years of Function|Death|1|||
147338039|NCT00980330|531404792|FG000|Overall Study|Adverse Event|0|||
147338040|NCT00980330|531404793|FG001|Overall Study|Adverse Event|0|||
147338041|NCT00980330|531404794|FG002|Overall Study|Adverse Event|0|||
147338042|NCT00980330|531404795|FG003|Overall Study|Adverse Event|1|||
147338043|NCT00980330|531404796|FG004|Overall Study|Adverse Event|0|||
147338044|NCT00980330|531404797|FG005|Overall Study|Adverse Event|0|||
147338045|NCT00980330|531404798|FG006|Overall Study|Adverse Event|0|||
147338046|NCT00980330|531404792|FG000|Overall Study|Lost to Follow-up|1|||
147338047|NCT00980330|531404793|FG001|Overall Study|Lost to Follow-up|1|||
147338048|NCT00980330|531404794|FG002|Overall Study|Lost to Follow-up|4|||
147338049|NCT00980330|531404795|FG003|Overall Study|Lost to Follow-up|2|||
147338050|NCT00980330|531404796|FG004|Overall Study|Lost to Follow-up|1|||
147338051|NCT00980330|531404797|FG005|Overall Study|Lost to Follow-up|1|||
147338052|NCT00980330|531404798|FG006|Overall Study|Lost to Follow-up|2|||
147338053|NCT00980330|531404792|FG000|Overall Study|Withdrawal by Subject|2|||
147338054|NCT00980330|531404793|FG001|Overall Study|Withdrawal by Subject|4|||
147338055|NCT00980330|531404794|FG002|Overall Study|Withdrawal by Subject|4|||
147338056|NCT00980330|531404795|FG003|Overall Study|Withdrawal by Subject|1|||
147452578|NCT04986202|531819991|FG002|Overall Study|Death|10|||
147290017|NCT03280121|531225681|FG000|Overall Study|screen failure - 3 hernia too small and 1 pH too low|4|||
147290018|NCT03638141|531225691|FG000|Overall Study|1 subject was removed from the study due to non compliance and was never treated.|1|||
147290019|NCT03996473|531225692|FG000|Treatment Assignment|Withdrawal by Subject|1|||
147338057|NCT00980330|531404796|FG004|Overall Study|Withdrawal by Subject|3|||
147338058|NCT00980330|531404797|FG005|Overall Study|Withdrawal by Subject|2|||
147290020|NCT03996473|531225692|FG000|Treatment Assignment|Progressive disease|6|||
147290021|NCT03996473|531225692|FG000|Treatment Assignment|Study drug never administered|1|||
147290022|NCT03996473|531225692|FG000|Active Follow-up|Death|1|||
147290023|NCT03996473|531225692|FG000|Long-term Follow-up|Death|5|||
147290024|NCT03759873|531225693|FG000|Overall Study|Not appropriate for cardiac rehab|4|||
147290025|NCT03759873|531225694|FG001|Overall Study|Not appropriate for cardiac rehab|4|||
147290026|NCT03759873|531225695|FG002|Overall Study|Not appropriate for cardiac rehab|4|||
147290027|NCT03759873|531225696|FG003|Overall Study|Not appropriate for cardiac rehab|2|||
147290028|NCT03759873|531225693|FG000|Overall Study|Moved outside eligible area|0|||
147290029|NCT03759873|531225694|FG001|Overall Study|Moved outside eligible area|2|||
147290030|NCT03759873|531225695|FG002|Overall Study|Moved outside eligible area|0|||
147290031|NCT03759873|531225696|FG003|Overall Study|Moved outside eligible area|0|||
147290032|NCT03759873|531225693|FG000|Overall Study|Withdrawal by Subject|0|||
147290033|NCT03759873|531225694|FG001|Overall Study|Withdrawal by Subject|0|||
147290034|NCT03759873|531225695|FG002|Overall Study|Withdrawal by Subject|1|||
147290035|NCT03759873|531225696|FG003|Overall Study|Withdrawal by Subject|0|||
147290036|NCT06116591|531225699|FG000|Overall Study|No longer met eligibility criteria|0|||
147290037|NCT06116591|531225700|FG001|Overall Study|No longer met eligibility criteria|1|||
147290038|NCT06116591|531225699|FG000|Overall Study|Other: Change in life situation|0|||
147290039|NCT06116591|531225700|FG001|Overall Study|Other: Change in life situation|1|||
147290040|NCT05585307|531225701|FG000|Overall Study|Lost to Follow-up|0|||
147290041|NCT05585307|531225702|FG001|Overall Study|Lost to Follow-up|0|||
147290042|NCT05585307|531225703|FG002|Overall Study|Lost to Follow-up|0|||
147290043|NCT05585307|531225704|FG003|Overall Study|Lost to Follow-up|0|||
147452579|NCT04986202|531819989|FG000|Overall Study|Physician Decision|3|||
147452580|NCT04986202|531819990|FG001|Overall Study|Physician Decision|1|||
147452581|NCT04986202|531819991|FG002|Overall Study|Physician Decision|2|||
147452582|NCT04986202|531819989|FG000|Overall Study|Withdrawal by Subject|4|||
147452583|NCT04986202|531819990|FG001|Overall Study|Withdrawal by Subject|2|||
147452584|NCT04986202|531819991|FG002|Overall Study|Withdrawal by Subject|4|||
147452585|NCT02118792|531819992|FG000|Overall Study|Withdrawal by Subject|6|||
147452586|NCT02118792|531819993|FG001|Overall Study|Withdrawal by Subject|3|||
147452587|NCT02118792|531819992|FG000|Overall Study|Lost to Follow-up|4|||
147452588|NCT02118792|531819993|FG001|Overall Study|Lost to Follow-up|4|||
147452589|NCT02118792|531819992|FG000|Overall Study|Adverse Event|5|||
147452590|NCT02118792|531819993|FG001|Overall Study|Adverse Event|4|||
147452591|NCT02118792|531819992|FG000|Overall Study|Withdrawal by parent/guardian|14|||
147452592|NCT02118792|531819993|FG001|Overall Study|Withdrawal by parent/guardian|20|||
147452593|NCT02118792|531819992|FG000|Overall Study|Other|1|||
147452594|NCT02118792|531819993|FG001|Overall Study|Other|6|||
147452595|NCT02118792|531819992|FG000|Overall Study|Randomised but not treated|1|||
147452596|NCT02118792|531819993|FG001|Overall Study|Randomised but not treated|0|||
147290044|NCT05585307|531225705|FG004|Overall Study|Lost to Follow-up|0|||
147290045|NCT05585307|531225706|FG005|Overall Study|Lost to Follow-up|0|||
147290046|NCT05585307|531225707|FG006|Overall Study|Lost to Follow-up|1|||
147290047|NCT05585307|531225708|FG007|Overall Study|Lost to Follow-up|0|||
147290048|NCT06476366|531225715|FG000|Overall Study|Lost to Follow-up|1|||
147290049|NCT06476366|531225716|FG001|Overall Study|Lost to Follow-up|3|||
147290050|NCT06476366|531225715|FG000|Overall Study|Adverse Event|1|||
147290051|NCT06476366|531225716|FG001|Overall Study|Adverse Event|0|||
147290052|NCT03449030|531225720|FG000|Overall Study|Withdrawal by Subject|0|||
147290053|NCT03449030|531225721|FG001|Overall Study|Withdrawal by Subject|0|||
147290054|NCT03449030|531225722|FG002|Overall Study|Withdrawal by Subject|0|||
147290055|NCT03449030|531225723|FG003|Overall Study|Withdrawal by Subject|1|||
147290056|NCT03449030|531225724|FG004|Overall Study|Withdrawal by Subject|1|||
147290057|NCT03449030|531225725|FG005|Overall Study|Withdrawal by Subject|1|||
147290058|NCT03449030|531225726|FG006|Overall Study|Withdrawal by Subject|1|||
147290059|NCT03449030|531225727|FG007|Overall Study|Withdrawal by Subject|2|||
147290060|NCT03449030|531225728|FG008|Overall Study|Withdrawal by Subject|0|||
147290061|NCT03449030|531225729|FG009|Overall Study|Withdrawal by Subject|0|||
147290062|NCT03449030|531225720|FG000|Overall Study|Symptomatic Deterioration|0|||
147290063|NCT03449030|531225721|FG001|Overall Study|Symptomatic Deterioration|1|||
147290064|NCT03449030|531225722|FG002|Overall Study|Symptomatic Deterioration|0|||
147290065|NCT03449030|531225723|FG003|Overall Study|Symptomatic Deterioration|0|||
147452597|NCT05131204|531819994|FG000|Overall Study|Sponsor request|2|||
147452598|NCT05131204|531819995|FG001|Overall Study|Sponsor request|1|||
147452599|NCT02363686|531819997|FG000|Overall Study|Withdrawal by Subject|22|||
147452600|NCT02363686|531819997|FG000|Overall Study|incomplete FEES examinations|13|||
147452601|NCT02469090|531820005|FG000|Period 1: Dose Titration Phase|Adverse Event|12|||
147452602|NCT02469090|531820006|FG001|Period 1: Dose Titration Phase|Adverse Event|0|||
147290066|NCT03449030|531225724|FG004|Overall Study|Symptomatic Deterioration|0|||
147290067|NCT03449030|531225725|FG005|Overall Study|Symptomatic Deterioration|1|||
147290068|NCT03449030|531225726|FG006|Overall Study|Symptomatic Deterioration|1|||
147290069|NCT03449030|531225727|FG007|Overall Study|Symptomatic Deterioration|0|||
147290070|NCT03449030|531225728|FG008|Overall Study|Symptomatic Deterioration|2|||
147290071|NCT03449030|531225729|FG009|Overall Study|Symptomatic Deterioration|0|||
147290072|NCT03449030|531225720|FG000|Overall Study|Progressive Disease|1|||
147290073|NCT03449030|531225721|FG001|Overall Study|Progressive Disease|0|||
147290074|NCT03449030|531225722|FG002|Overall Study|Progressive Disease|1|||
147290075|NCT03449030|531225723|FG003|Overall Study|Progressive Disease|4|||
147290076|NCT03449030|531225724|FG004|Overall Study|Progressive Disease|5|||
147290077|NCT03449030|531225725|FG005|Overall Study|Progressive Disease|3|||
147290078|NCT03449030|531225726|FG006|Overall Study|Progressive Disease|0|||
147290079|NCT03449030|531225727|FG007|Overall Study|Progressive Disease|1|||
147290080|NCT03449030|531225728|FG008|Overall Study|Progressive Disease|1|||
147290081|NCT03449030|531225729|FG009|Overall Study|Progressive Disease|1|||
147290082|NCT03449030|531225720|FG000|Overall Study|Adverse Event|0|||
147290083|NCT03449030|531225721|FG001|Overall Study|Adverse Event|0|||
147290084|NCT03449030|531225722|FG002|Overall Study|Adverse Event|0|||
147290085|NCT03449030|531225723|FG003|Overall Study|Adverse Event|0|||
147290086|NCT03449030|531225724|FG004|Overall Study|Adverse Event|0|||
147290087|NCT03449030|531225725|FG005|Overall Study|Adverse Event|2|||
147290088|NCT03449030|531225726|FG006|Overall Study|Adverse Event|0|||
147290089|NCT03449030|531225727|FG007|Overall Study|Adverse Event|0|||
147290090|NCT03449030|531225728|FG008|Overall Study|Adverse Event|0|||
147290091|NCT03449030|531225729|FG009|Overall Study|Adverse Event|0|||
147290092|NCT03449030|531225720|FG000|Overall Study|Death|0|||
147290093|NCT03449030|531225721|FG001|Overall Study|Death|0|||
147290094|NCT03449030|531225722|FG002|Overall Study|Death|0|||
147290095|NCT03449030|531225723|FG003|Overall Study|Death|0|||
147290096|NCT03449030|531225724|FG004|Overall Study|Death|1|||
147290097|NCT03449030|531225725|FG005|Overall Study|Death|0|||
147290098|NCT03449030|531225726|FG006|Overall Study|Death|0|||
147290099|NCT03449030|531225727|FG007|Overall Study|Death|0|||
147290100|NCT03449030|531225728|FG008|Overall Study|Death|0|||
147290101|NCT03449030|531225729|FG009|Overall Study|Death|0|||
147290102|NCT00700401|531225737|FG000|Overall Study|Detectable HCV RNA after Week 4|82|||
147290103|NCT00700401|531225737|FG000|Overall Study|Adverse Event|5|||
147290104|NCT00700401|531225737|FG000|Overall Study|Refused Treatment|2|||
147290105|NCT00700401|531225737|FG000|Overall Study|Lost to Follow-up|1|||
147290106|NCT00700401|531225737|FG000|Overall Study|Treatment never started|1|||
147290107|NCT00700401|531225737|FG000|Overall Study|HCV RNA not detected at baseline and SAE|1|||
147290108|NCT00700401|531225737|FG000|Overall Study|Withdrawal by Subject|2|||
147290109|NCT00295750|531225741|FG000|Overall Study|Adverse Event|19|||
147290110|NCT00295750|531225742|FG001|Overall Study|Adverse Event|15|||
147290111|NCT00295750|531225743|FG002|Overall Study|Adverse Event|12|||
147290112|NCT00295750|531225741|FG000|Overall Study|Lack of Efficacy|1|||
147290113|NCT00295750|531225742|FG001|Overall Study|Lack of Efficacy|1|||
147290114|NCT00295750|531225743|FG002|Overall Study|Lack of Efficacy|0|||
147290115|NCT00295750|531225741|FG000|Overall Study|Lost to Follow-up|1|||
147290116|NCT00295750|531225742|FG001|Overall Study|Lost to Follow-up|4|||
147290117|NCT00295750|531225743|FG002|Overall Study|Lost to Follow-up|1|||
147290118|NCT00295750|531225741|FG000|Overall Study|Taking prohibited therapy|2|||
147290119|NCT00295750|531225742|FG001|Overall Study|Taking prohibited therapy|3|||
147290120|NCT00295750|531225743|FG002|Overall Study|Taking prohibited therapy|2|||
147290121|NCT00295750|531225741|FG000|Overall Study|Administrative errors|2|||
147290122|NCT00295750|531225742|FG001|Overall Study|Administrative errors|4|||
147290123|NCT00295750|531225743|FG002|Overall Study|Administrative errors|5|||
147290124|NCT00295750|531225741|FG000|Overall Study|Trial drug errors|1|||
147290125|NCT00295750|531225742|FG001|Overall Study|Trial drug errors|1|||
147290126|NCT00295750|531225743|FG002|Overall Study|Trial drug errors|0|||
147290127|NCT00295750|531225741|FG000|Overall Study|Disease progression|2|||
147290128|NCT00295750|531225742|FG001|Overall Study|Disease progression|1|||
147290129|NCT00295750|531225743|FG002|Overall Study|Disease progression|0|||
147290130|NCT00295750|531225741|FG000|Overall Study|Personal reasons|0|||
147290131|NCT00295750|531225742|FG001|Overall Study|Personal reasons|1|||
147290132|NCT00295750|531225743|FG002|Overall Study|Personal reasons|0|||
147290133|NCT00295750|531225741|FG000|Overall Study|Randomized but never received trial drug|4|||
147290134|NCT00295750|531225742|FG001|Overall Study|Randomized but never received trial drug|3|||
147290135|NCT00295750|531225743|FG002|Overall Study|Randomized but never received trial drug|3|||
147290136|NCT00295750|531225741|FG000|Overall Study|Withdrawal by Subject|9|||
147290137|NCT00295750|531225742|FG001|Overall Study|Withdrawal by Subject|4|||
147290138|NCT00295750|531225743|FG002|Overall Study|Withdrawal by Subject|7|||
147290139|NCT00295750|531225741|FG000|Overall Study|Protocol Violation|2|||
147290140|NCT00295750|531225742|FG001|Overall Study|Protocol Violation|4|||
147290141|NCT00295750|531225743|FG002|Overall Study|Protocol Violation|2|||
147290142|NCT01650259|531225744|FG000|Overall Study|Improvement|105|||
147290143|NCT01650259|531225745|FG001|Overall Study|Improvement|0|||
147290144|NCT01650259|531225744|FG000|Overall Study|Adverse Event|127|||
147290145|NCT01650259|531225745|FG001|Overall Study|Adverse Event|0|||
147662650|NCT00128661|532587383|FG001|Overall Study|Adverse Event|11|||
147290146|NCT01650259|531225744|FG000|Overall Study|Lack of Efficacy|143|||
147290147|NCT01650259|531225745|FG001|Overall Study|Lack of Efficacy|0|||
147290148|NCT01650259|531225744|FG000|Overall Study|Lost to Follow-up|435|||
147290149|NCT01650259|531225745|FG001|Overall Study|Lost to Follow-up|0|||
147290150|NCT01650259|531225744|FG000|Overall Study|Patients had no visit after entry|70|||
147290151|NCT01650259|531225745|FG001|Overall Study|Patients had no visit after entry|0|||
147290152|NCT01650259|531225744|FG000|Overall Study|CRF not collected|98|||
147290153|NCT01650259|531225745|FG001|Overall Study|CRF not collected|82|||
147290154|NCT01650259|531225744|FG000|Overall Study|Not treated|1|||
147290155|NCT01650259|531225745|FG001|Overall Study|Not treated|7|||
147290156|NCT01650259|531225744|FG000|Overall Study|Other than listed|64|||
147290157|NCT01650259|531225745|FG001|Overall Study|Other than listed|146|||
147290158|NCT00355082|531225751|FG000|Double-Blind (DB) Treatment Phase|Adverse Event|4|||
147290159|NCT00355082|531225752|FG001|Double-Blind (DB) Treatment Phase|Adverse Event|10|||
147290160|NCT00355082|531225753|FG002|Double-Blind (DB) Treatment Phase|Adverse Event|0|||
147290161|NCT00355082|531225751|FG000|Double-Blind (DB) Treatment Phase|Withdrawal by Subject|9|||
147290162|NCT00355082|531225752|FG001|Double-Blind (DB) Treatment Phase|Withdrawal by Subject|8|||
147290163|NCT00355082|531225753|FG002|Double-Blind (DB) Treatment Phase|Withdrawal by Subject|0|||
147290164|NCT00355082|531225751|FG000|Double-Blind (DB) Treatment Phase|Lack of Efficacy|6|||
147290165|NCT00355082|531225752|FG001|Double-Blind (DB) Treatment Phase|Lack of Efficacy|7|||
147290166|NCT00355082|531225753|FG002|Double-Blind (DB) Treatment Phase|Lack of Efficacy|0|||
147290167|NCT00355082|531225751|FG000|Double-Blind (DB) Treatment Phase|Lost to Follow-up|0|||
147290168|NCT00355082|531225752|FG001|Double-Blind (DB) Treatment Phase|Lost to Follow-up|4|||
147290169|NCT00355082|531225753|FG002|Double-Blind (DB) Treatment Phase|Lost to Follow-up|0|||
147290170|NCT00355082|531225751|FG000|Double-Blind (DB) Treatment Phase|Protocol Violation|0|||
147290171|NCT00355082|531225752|FG001|Double-Blind (DB) Treatment Phase|Protocol Violation|4|||
147290172|NCT00355082|531225753|FG002|Double-Blind (DB) Treatment Phase|Protocol Violation|0|||
147290173|NCT00355082|531225751|FG000|Double-Blind (DB) Treatment Phase|Pregnancy|0|||
147290174|NCT00355082|531225752|FG001|Double-Blind (DB) Treatment Phase|Pregnancy|1|||
147290175|NCT00355082|531225753|FG002|Double-Blind (DB) Treatment Phase|Pregnancy|0|||
147290176|NCT00355082|531225751|FG000|Continuation Phase|Adverse Event|2|||
147290177|NCT00355082|531225752|FG001|Continuation Phase|Adverse Event|0|||
147290178|NCT00355082|531225753|FG002|Continuation Phase|Adverse Event|1|||
147290179|NCT00355082|531225751|FG000|Continuation Phase|Lost to Follow-up|2|||
147290180|NCT00355082|531225752|FG001|Continuation Phase|Lost to Follow-up|0|||
147290181|NCT00355082|531225753|FG002|Continuation Phase|Lost to Follow-up|1|||
147290182|NCT00355082|531225751|FG000|Continuation Phase|Protocol Violation|1|||
147290183|NCT00355082|531225752|FG001|Continuation Phase|Protocol Violation|0|||
147290184|NCT00355082|531225753|FG002|Continuation Phase|Protocol Violation|1|||
147290185|NCT00355082|531225751|FG000|Continuation Phase|Withdrawal by Subject|4|||
147290186|NCT00355082|531225752|FG001|Continuation Phase|Withdrawal by Subject|0|||
147290187|NCT00355082|531225753|FG002|Continuation Phase|Withdrawal by Subject|0|||
147290188|NCT00355082|531225751|FG000|Continuation Phase|Lack of Efficacy|5|||
147290189|NCT00355082|531225752|FG001|Continuation Phase|Lack of Efficacy|0|||
147290190|NCT00355082|531225753|FG002|Continuation Phase|Lack of Efficacy|0|||
147290191|NCT00355082|531225751|FG000|Continuation Phase|Site Closed by Sponsor|8|||
147290192|NCT00355082|531225752|FG001|Continuation Phase|Site Closed by Sponsor|0|||
147290193|NCT00355082|531225753|FG002|Continuation Phase|Site Closed by Sponsor|0|||
147290194|NCT00355082|531225751|FG000|Continuation Phase|Scheduling Error|1|||
147290195|NCT00355082|531225752|FG001|Continuation Phase|Scheduling Error|0|||
147290196|NCT00355082|531225753|FG002|Continuation Phase|Scheduling Error|0|||
147290197|NCT00355082|531225751|FG000|Continuation Phase|Ran Out of Drug Due to Travel|1|||
147290198|NCT00355082|531225752|FG001|Continuation Phase|Ran Out of Drug Due to Travel|0|||
147290199|NCT00355082|531225753|FG002|Continuation Phase|Ran Out of Drug Due to Travel|0|||
147290200|NCT00724971|531225763|FG000|Overall Study|Adverse Event|5|||
147290201|NCT00724971|531225763|FG000|Overall Study|Withdrawal by Subject|1|||
147290202|NCT01003249|531225764|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
147290203|NCT01003249|531225765|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
147290204|NCT01003249|531225764|FG000|First Intervention (4 Weeks)|Non-Serious Event|1|||
147290205|NCT01003249|531225765|FG001|First Intervention (4 Weeks)|Non-Serious Event|1|||
147290206|NCT01003249|531225764|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
147290207|NCT01003249|531225765|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
147290208|NCT01003249|531225764|FG000|Second Intervention (4 Weeks)|Adverse Event|1|||
147290209|NCT01003249|531225765|FG001|Second Intervention (4 Weeks)|Adverse Event|0|||
147290210|NCT02132611|531225770|FG000|Overall Study|Death|2|||
147290211|NCT03943095|531225771|FG000|Overall Study|Incorrectly dispensed wrong box kit|0|||
147338059|NCT00980330|531404798|FG006|Overall Study|Withdrawal by Subject|5|||
147338060|NCT00980330|531404792|FG000|Overall Study|(not specified)|2|||
147338061|NCT00980330|531404793|FG001|Overall Study|(not specified)|0|||
147338062|NCT00980330|531404794|FG002|Overall Study|(not specified)|0|||
147290212|NCT03943095|531225772|FG001|Overall Study|Incorrectly dispensed wrong box kit|1|||
147290213|NCT03943095|531225771|FG000|Overall Study|Withdrawal by Subject|1|||
147290214|NCT03943095|531225772|FG001|Overall Study|Withdrawal by Subject|0|||
147290215|NCT03387852|531225773|FG000|Overall Study|Adverse event (AE)|3|||
147290216|NCT03387852|531225774|FG001|Overall Study|Adverse event (AE)|0|||
147290217|NCT03387852|531225775|FG002|Overall Study|Adverse event (AE)|2|||
147338063|NCT00980330|531404795|FG003|Overall Study|(not specified)|1|||
147338064|NCT00980330|531404796|FG004|Overall Study|(not specified)|1|||
147338065|NCT00980330|531404797|FG005|Overall Study|(not specified)|1|||
147338066|NCT00980330|531404798|FG006|Overall Study|(not specified)|0|||
147338067|NCT00666276|531404801|FG000|Overall Study|Protocol Violation|34|||
147338068|NCT01039688|531404802|FG000|Overall Study|Adverse Event|38|||
147338069|NCT01039688|531404803|FG001|Overall Study|Adverse Event|39|||
147338070|NCT01039688|531404804|FG002|Overall Study|Adverse Event|24|||
147338071|NCT01039688|531404802|FG000|Overall Study|Lack of Efficacy|20|||
147338072|NCT01039688|531404803|FG001|Overall Study|Lack of Efficacy|11|||
147338073|NCT01039688|531404804|FG002|Overall Study|Lack of Efficacy|26|||
147290218|NCT03387852|531225776|FG003|Overall Study|Adverse event (AE)|0|||
147290219|NCT03387852|531225773|FG000|Overall Study|Loss of asthma control (LOAC)|28|||
147290220|NCT03387852|531225774|FG001|Overall Study|Loss of asthma control (LOAC)|16|||
147290221|NCT03387852|531225775|FG002|Overall Study|Loss of asthma control (LOAC)|20|||
147290222|NCT03387852|531225776|FG003|Overall Study|Loss of asthma control (LOAC)|14|||
147290223|NCT03387852|531225773|FG000|Overall Study|Withdrawal by participant|1|||
147290224|NCT03387852|531225774|FG001|Overall Study|Withdrawal by participant|1|||
147290225|NCT03387852|531225775|FG002|Overall Study|Withdrawal by participant|3|||
147290226|NCT03387852|531225776|FG003|Overall Study|Withdrawal by participant|2|||
147290227|NCT03387852|531225773|FG000|Overall Study|Other- Unspecified|1|||
147290228|NCT03387852|531225774|FG001|Overall Study|Other- Unspecified|1|||
147290229|NCT03387852|531225775|FG002|Overall Study|Other- Unspecified|2|||
147290230|NCT03387852|531225776|FG003|Overall Study|Other- Unspecified|1|||
147290231|NCT03387852|531225773|FG000|Overall Study|Poor compliance to protocol|0|||
147290232|NCT03387852|531225774|FG001|Overall Study|Poor compliance to protocol|0|||
147290233|NCT03387852|531225775|FG002|Overall Study|Poor compliance to protocol|0|||
147290234|NCT03387852|531225776|FG003|Overall Study|Poor compliance to protocol|1|||
147290235|NCT03387852|531225773|FG000|Overall Study|Randomized and not treated|0|||
147290236|NCT03387852|531225774|FG001|Overall Study|Randomized and not treated|0|||
147290237|NCT03387852|531225775|FG002|Overall Study|Randomized and not treated|0|||
147290238|NCT03387852|531225776|FG003|Overall Study|Randomized and not treated|1|||
147290239|NCT02194621|531225777|FG000|Overall Study|6 withdrew prior to randomization|2|||
147290240|NCT02194621|531225778|FG001|Overall Study|6 withdrew prior to randomization|2|||
147290241|NCT02194621|531225779|FG002|Overall Study|6 withdrew prior to randomization|2|||
147290242|NCT02194621|531225777|FG000|Overall Study|Withdrawal by Subject|4|||
147290243|NCT02194621|531225778|FG001|Overall Study|Withdrawal by Subject|4|||
147290244|NCT02194621|531225779|FG002|Overall Study|Withdrawal by Subject|7|||
147290245|NCT02763384|531225787|FG000|Overall Study|Physician Decision|1|||
147290246|NCT02763384|531225787|FG000|Overall Study|Rapid decline - went on hospice|1|||
147290247|NCT02493127|531225788|FG000|Overall Study|Lost to Follow-up|1|||
147290248|NCT02493127|531225789|FG001|Overall Study|Lost to Follow-up|1|||
147290249|NCT02096900|531225791|FG000|Overall Study|Did not receive medication|3|||
147290250|NCT02096900|531225792|FG001|Overall Study|Did not receive medication|1|||
147290251|NCT02096900|531225791|FG000|Overall Study|Surgery cancelled- medication received|1|||
147290252|NCT02096900|531225792|FG001|Overall Study|Surgery cancelled- medication received|1|||
147290253|NCT03034577|531225802|FG000|Overall Study|Withdrawal by Subject|6|||
147290254|NCT03034577|531225803|FG001|Overall Study|Withdrawal by Subject|9|||
147290255|NCT03034577|531225802|FG000|Overall Study|Lost to Follow-up|25|||
147290256|NCT03034577|531225803|FG001|Overall Study|Lost to Follow-up|26|||
147290257|NCT04177758|531225804|FG000|Overall Study|Lost to Follow-up|19|||
147290258|NCT04177758|531225805|FG001|Overall Study|Lost to Follow-up|11|||
147290259|NCT00808808|531225809|FG000|Overall Study|Vaccinated; survey not completed|131|||
147290260|NCT00808808|531225810|FG001|Overall Study|Vaccinated; survey not completed|169|||
147290261|NCT00808808|531225811|FG002|Overall Study|Vaccinated; survey not completed|302|||
147290262|NCT00808808|531225809|FG000|Overall Study|Employee was not vaccinated.|2686|||
147338074|NCT01039688|531404802|FG000|Overall Study|Lost to Follow-up|11|||
147338075|NCT01039688|531404803|FG001|Overall Study|Lost to Follow-up|9|||
147338076|NCT01039688|531404804|FG002|Overall Study|Lost to Follow-up|5|||
147338077|NCT01039688|531404802|FG000|Overall Study|Other|13|||
147338078|NCT01039688|531404803|FG001|Overall Study|Other|25|||
147338079|NCT01039688|531404804|FG002|Overall Study|Other|12|||
147290263|NCT00808808|531225810|FG001|Overall Study|Employee was not vaccinated.|2268|||
147290264|NCT00808808|531225811|FG002|Overall Study|Employee was not vaccinated.|2255|||
147290265|NCT02653482|531225813|FG000|Overall Study|Death|1|||
147290266|NCT02653482|531225814|FG001|Overall Study|Death|1|||
147290267|NCT04657211|531225815|FG000|Overall Study|Withdrawal by Subject|21|||
147290268|NCT04657211|531225815|FG000|Overall Study|Lost to Follow-up|113|||
147338080|NCT01039688|531404802|FG000|Overall Study|Withdrawal by Subject|23|||
147290269|NCT04657211|531225815|FG000|Overall Study|Death|47|||
147290270|NCT04657211|531225815|FG000|Overall Study|Transfer to another institution|21|||
147290271|NCT04657211|531225815|FG000|Overall Study|Other|29|||
147338081|NCT01039688|531404803|FG001|Overall Study|Withdrawal by Subject|27|||
147338082|NCT01039688|531404804|FG002|Overall Study|Withdrawal by Subject|13|||
147604327|NCT00724048|532367872|FG000|Overall Study|Other than specified|1|||
147604328|NCT00724048|532367873|FG001|Overall Study|Other than specified|1|||
147604329|NCT00724048|532367874|FG002|Overall Study|Other than specified|0|||
147604330|NCT00724048|532367875|FG003|Overall Study|Other than specified|0|||
147338083|NCT01039688|531404802|FG000|Overall Study|Death|2|||
147290272|NCT06273774|531225817|FG000|Overall Study|Participant was out of state.|0|||
147290273|NCT06273774|531225818|FG001|Overall Study|Participant was out of state.|0|||
147290274|NCT06273774|531225819|FG002|Overall Study|Participant was out of state.|0|||
147290275|NCT06273774|531225820|FG003|Overall Study|Participant was out of state.|0|||
147290276|NCT06273774|531225821|FG004|Overall Study|Participant was out of state.|0|||
147290277|NCT06273774|531225822|FG005|Overall Study|Participant was out of state.|1|||
147290278|NCT06273774|531225817|FG000|Overall Study|Lost to Follow-up|0|||
147290279|NCT06273774|531225818|FG001|Overall Study|Lost to Follow-up|0|||
147290280|NCT06273774|531225819|FG002|Overall Study|Lost to Follow-up|0|||
147290281|NCT06273774|531225820|FG003|Overall Study|Lost to Follow-up|0|||
147290282|NCT06273774|531225821|FG004|Overall Study|Lost to Follow-up|1|||
147290283|NCT06273774|531225822|FG005|Overall Study|Lost to Follow-up|0|||
147290284|NCT00844857|531228049|FG000|Overall Study|Adverse Event|24|||
147290285|NCT00844857|531228050|FG001|Overall Study|Adverse Event|5|||
147290286|NCT00844857|531228049|FG000|Overall Study|Sponsor Decision|1|||
147290287|NCT00844857|531228050|FG001|Overall Study|Sponsor Decision|1|||
147290288|NCT00844857|531228049|FG000|Overall Study|Physician Decision|2|||
147290289|NCT00844857|531228050|FG001|Overall Study|Physician Decision|0|||
147290290|NCT00844857|531228049|FG000|Overall Study|Parent/Caregiver Decision|6|||
147290291|NCT00844857|531228050|FG001|Overall Study|Parent/Caregiver Decision|2|||
147290292|NCT00844857|531228049|FG000|Overall Study|Withdrawal by Subject|8|||
147290293|NCT00844857|531228050|FG001|Overall Study|Withdrawal by Subject|7|||
147290294|NCT00844857|531228049|FG000|Overall Study|Protocol Violation|6|||
147290295|NCT00844857|531228050|FG001|Overall Study|Protocol Violation|0|||
147290296|NCT00844857|531228049|FG000|Overall Study|Lack of Efficacy|5|||
147290297|NCT00844857|531228050|FG001|Overall Study|Lack of Efficacy|5|||
147290298|NCT00844857|531228049|FG000|Overall Study|Clinical Relapse|0|||
147290299|NCT00844857|531228050|FG001|Overall Study|Clinical Relapse|1|||
147290300|NCT00844857|531228049|FG000|Overall Study|Entry Criteria Not Met|0|||
147290301|NCT00844857|531228050|FG001|Overall Study|Entry Criteria Not Met|1|||
147290302|NCT00844857|531228049|FG000|Overall Study|Lost to Follow-up|2|||
147290303|NCT00844857|531228050|FG001|Overall Study|Lost to Follow-up|3|||
147290304|NCT00844857|531228049|FG000|Overall Study|Did Not Take Study Drug|3|||
147290305|NCT00844857|531228050|FG001|Overall Study|Did Not Take Study Drug|1|||
147290306|NCT00844857|531228049|FG000|Overall Study|Good Clinical Practice Violations|21|||
147290307|NCT00844857|531228050|FG001|Overall Study|Good Clinical Practice Violations|11|||
147290308|NCT00570674|531228051|FG000|Overall Study|Withdrawal by Subject|0|||
147290309|NCT00570674|531228052|FG001|Overall Study|Withdrawal by Subject|0|||
147290310|NCT00570674|531228053|FG002|Overall Study|Withdrawal by Subject|1|||
147290311|NCT00570674|531228054|FG003|Overall Study|Withdrawal by Subject|0|||
147290312|NCT00570674|531228055|FG004|Overall Study|Withdrawal by Subject|0|||
147290313|NCT00570674|531228056|FG005|Overall Study|Withdrawal by Subject|0|||
147338084|NCT01039688|531404803|FG001|Overall Study|Death|0|||
147338085|NCT01039688|531404804|FG002|Overall Study|Death|0|||
147338086|NCT02594735|531404805|FG000|Overall Study|Adverse Event|1|||
147338087|NCT03844269|531404809|FG000|Overall Study|Withdrawal pre-intervention|1|||
147338088|NCT03844269|531404809|FG000|Overall Study|Did not complete the intervention|2|||
147338089|NCT00665444|531404810|FG000|Overall Study|Physician Decision|1|||
147338090|NCT00665444|531404810|FG000|Overall Study|Study Terminated by Study Sponsor|1|||
147338091|NCT00101010|531404814|FG000|Overall Study|Physician Decision|1|||
147338092|NCT00346151|531404815|FG000|Overall Study|Withdrawal by Subject|3|||
147338093|NCT03737240|531404820|FG000|Overall Study|Lost to Follow-up|16|||
147338094|NCT03737240|531404821|FG001|Overall Study|Lost to Follow-up|15|||
147338095|NCT01369498|531404822|FG000|Overall Study|Lack of Efficacy|9|||
147338096|NCT01369498|531404823|FG001|Overall Study|Lack of Efficacy|9|||
147338097|NCT01369498|531404824|FG002|Overall Study|Lack of Efficacy|1|||
147338098|NCT01369498|531404825|FG003|Overall Study|Lack of Efficacy|3|||
147338099|NCT01369498|531404822|FG000|Overall Study|Adverse Event|1|||
147338100|NCT01369498|531404823|FG001|Overall Study|Adverse Event|2|||
147338101|NCT01369498|531404824|FG002|Overall Study|Adverse Event|0|||
147452603|NCT02469090|531820007|FG002|Period 1: Dose Titration Phase|Adverse Event|0|||
147338102|NCT01369498|531404825|FG003|Overall Study|Adverse Event|1|||
147452604|NCT02469090|531820005|FG000|Period 1: Dose Titration Phase|Withdrawal by Subject|8|||
147338103|NCT01369498|531404822|FG000|Overall Study|Withdrawal of Consent|0|||
147290314|NCT00570674|531228057|FG006|Overall Study|Withdrawal by Subject|0|||
147290315|NCT01877408|531228058|FG000|Overall Study|Lost to Follow-up|0|||
147338104|NCT01369498|531404823|FG001|Overall Study|Withdrawal of Consent|1|||
147338105|NCT01369498|531404824|FG002|Overall Study|Withdrawal of Consent|1|||
147338106|NCT01369498|531404825|FG003|Overall Study|Withdrawal of Consent|1|||
147338107|NCT01369498|531404822|FG000|Overall Study|Death|0|||
147290316|NCT01877408|531228059|FG001|Overall Study|Lost to Follow-up|2|||
147290317|NCT02621931|531228060|FG000|Overall Study|Death|0|||
147290318|NCT02621931|531228061|FG001|Overall Study|Death|1|||
147290319|NCT02621931|531228062|FG002|Overall Study|Death|0|||
147290320|NCT02621931|531228060|FG000|Overall Study|Adverse Event|8|||
147290321|NCT02621931|531228061|FG001|Overall Study|Adverse Event|5|||
147290322|NCT02621931|531228062|FG002|Overall Study|Adverse Event|7|||
147290323|NCT02621931|531228060|FG000|Overall Study|Withdrawal by Subject|12|||
147290324|NCT02621931|531228061|FG001|Overall Study|Withdrawal by Subject|10|||
147290325|NCT02621931|531228062|FG002|Overall Study|Withdrawal by Subject|11|||
147290326|NCT02621931|531228060|FG000|Overall Study|Protocol Violation|2|||
147290327|NCT02621931|531228061|FG001|Overall Study|Protocol Violation|2|||
147290328|NCT02621931|531228062|FG002|Overall Study|Protocol Violation|2|||
147290329|NCT02621931|531228060|FG000|Overall Study|Pregnancy|2|||
147290330|NCT02621931|531228061|FG001|Overall Study|Pregnancy|0|||
147290331|NCT02621931|531228062|FG002|Overall Study|Pregnancy|0|||
147290332|NCT02621931|531228060|FG000|Overall Study|Noncompliance to study procedures|0|||
147290333|NCT02621931|531228061|FG001|Overall Study|Noncompliance to study procedures|1|||
147290334|NCT02621931|531228062|FG002|Overall Study|Noncompliance to study procedures|2|||
147290335|NCT02621931|531228060|FG000|Overall Study|Lost to Follow-up|8|||
147290336|NCT02621931|531228061|FG001|Overall Study|Lost to Follow-up|7|||
147604331|NCT02329847|532367876|FG000|Overall Study|Death|4|||
147604332|NCT02329847|532367877|FG001|Overall Study|Death|4|||
147604333|NCT02329847|532367878|FG002|Overall Study|Death|22|||
147290337|NCT02621931|531228062|FG002|Overall Study|Lost to Follow-up|10|||
147290338|NCT02621931|531228060|FG000|Overall Study|Lack of Efficacy|0|||
147290339|NCT02621931|531228061|FG001|Overall Study|Lack of Efficacy|0|||
147290340|NCT02621931|531228062|FG002|Overall Study|Lack of Efficacy|1|||
147290341|NCT02621931|531228060|FG000|Overall Study|Other|1|||
147290342|NCT02621931|531228061|FG001|Overall Study|Other|1|||
147290343|NCT02621931|531228062|FG002|Overall Study|Other|3|||
147290344|NCT00920426|531228063|FG000|ITZ111451|Adverse Event|1|||
147290345|NCT00920426|531228064|FG001|ITZ111451|Adverse Event|0|||
147290346|NCT00920426|531228065|FG002|ITZ111451|Adverse Event|0|||
147290347|NCT00920426|531228066|FG003|ITZ111451|Adverse Event|0|||
147290348|NCT01292603|531228067|FG000|Part 1: Pilot Dose Selection Period|Adverse Event|0|||
147290349|NCT01292603|531228068|FG001|Part 1: Pilot Dose Selection Period|Adverse Event|0|||
147290350|NCT01292603|531228069|FG002|Part 1: Pilot Dose Selection Period|Adverse Event|0|||
147290351|NCT01292603|531228070|FG003|Part 1: Pilot Dose Selection Period|Adverse Event|4|||
147290352|NCT01292603|531228071|FG004|Part 1: Pilot Dose Selection Period|Adverse Event|0|||
147290353|NCT01292603|531228072|FG005|Part 1: Pilot Dose Selection Period|Adverse Event|0|||
147290354|NCT01292603|531228067|FG000|Part 1: Pilot Dose Selection Period|Death|0|||
147290355|NCT01292603|531228068|FG001|Part 1: Pilot Dose Selection Period|Death|0|||
147290356|NCT01292603|531228069|FG002|Part 1: Pilot Dose Selection Period|Death|0|||
147290357|NCT01292603|531228070|FG003|Part 1: Pilot Dose Selection Period|Death|1|||
147290358|NCT01292603|531228071|FG004|Part 1: Pilot Dose Selection Period|Death|0|||
147290359|NCT01292603|531228072|FG005|Part 1: Pilot Dose Selection Period|Death|0|||
147290360|NCT01292603|531228067|FG000|Part 1: Pilot Dose Selection Period|Protocol Violation|0|||
147290361|NCT01292603|531228068|FG001|Part 1: Pilot Dose Selection Period|Protocol Violation|0|||
147290362|NCT01292603|531228069|FG002|Part 1: Pilot Dose Selection Period|Protocol Violation|0|||
147290363|NCT01292603|531228070|FG003|Part 1: Pilot Dose Selection Period|Protocol Violation|2|||
147290364|NCT01292603|531228071|FG004|Part 1: Pilot Dose Selection Period|Protocol Violation|0|||
147290365|NCT01292603|531228072|FG005|Part 1: Pilot Dose Selection Period|Protocol Violation|0|||
147290366|NCT01292603|531228067|FG000|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0|||
147290367|NCT01292603|531228068|FG001|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0|||
147290368|NCT01292603|531228069|FG002|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0|||
147290369|NCT01292603|531228070|FG003|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|1|||
147290370|NCT01292603|531228071|FG004|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0|||
147290371|NCT01292603|531228072|FG005|Part 1: Pilot Dose Selection Period|Withdrawal by Subject|0|||
147290372|NCT01292603|531228067|FG000|Part 1: Regular Follow-Up Period|Death|3|||
147290373|NCT01292603|531228068|FG001|Part 1: Regular Follow-Up Period|Death|1|||
147290374|NCT01292603|531228069|FG002|Part 1: Regular Follow-Up Period|Death|3|||
147290375|NCT01292603|531228070|FG003|Part 1: Regular Follow-Up Period|Death|1|||
147290376|NCT01292603|531228071|FG004|Part 1: Regular Follow-Up Period|Death|0|||
147290377|NCT01292603|531228072|FG005|Part 1: Regular Follow-Up Period|Death|0|||
147290378|NCT01292603|531228067|FG000|Part 1: Regular Follow-Up Period|Disease Progression|3|||
147290379|NCT01292603|531228068|FG001|Part 1: Regular Follow-Up Period|Disease Progression|6|||
147604334|NCT02329847|532367879|FG003|Overall Study|Death|12|||
147604335|NCT02329847|532367880|FG004|Overall Study|Death|20|||
147290380|NCT01292603|531228069|FG002|Part 1: Regular Follow-Up Period|Disease Progression|3|||
147290381|NCT01292603|531228070|FG003|Part 1: Regular Follow-Up Period|Disease Progression|0|||
147290382|NCT01292603|531228071|FG004|Part 1: Regular Follow-Up Period|Disease Progression|0|||
147290383|NCT01292603|531228072|FG005|Part 1: Regular Follow-Up Period|Disease Progression|0|||
147290384|NCT01292603|531228067|FG000|Part 2: Dose Confirmation Period|Death|0|||
147290385|NCT01292603|531228068|FG001|Part 2: Dose Confirmation Period|Death|0|||
147290386|NCT01292603|531228069|FG002|Part 2: Dose Confirmation Period|Death|0|||
147338108|NCT01369498|531404823|FG001|Overall Study|Death|0|||
147338109|NCT01369498|531404824|FG002|Overall Study|Death|1|||
147290387|NCT01292603|531228070|FG003|Part 2: Dose Confirmation Period|Death|0|||
147338110|NCT01369498|531404825|FG003|Overall Study|Death|0|||
147338111|NCT01369498|531404822|FG000|Overall Study|Investigator's Discretion|1|||
147604336|NCT02329847|532367881|FG005|Overall Study|Death|13|||
147604337|NCT02329847|532367876|FG000|Overall Study|Lost to Follow-up|0|||
147338112|NCT01369498|531404823|FG001|Overall Study|Investigator's Discretion|0|||
147290388|NCT01292603|531228071|FG004|Part 2: Dose Confirmation Period|Death|1|||
147290389|NCT01292603|531228072|FG005|Part 2: Dose Confirmation Period|Death|0|||
147290390|NCT01292603|531228067|FG000|Part 2: Dose Confirmation Period|Physician Decision|0|||
147290391|NCT01292603|531228068|FG001|Part 2: Dose Confirmation Period|Physician Decision|0|||
147290392|NCT01292603|531228069|FG002|Part 2: Dose Confirmation Period|Physician Decision|0|||
147290393|NCT01292603|531228070|FG003|Part 2: Dose Confirmation Period|Physician Decision|0|||
147290394|NCT01292603|531228071|FG004|Part 2: Dose Confirmation Period|Physician Decision|2|||
147290395|NCT01292603|531228072|FG005|Part 2: Dose Confirmation Period|Physician Decision|0|||
147290396|NCT01292603|531228067|FG000|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0|||
147290397|NCT01292603|531228068|FG001|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0|||
147290398|NCT01292603|531228069|FG002|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0|||
147290399|NCT01292603|531228070|FG003|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|0|||
147290400|NCT01292603|531228071|FG004|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|1|||
147290401|NCT01292603|531228072|FG005|Part 2: Dose Confirmation Period|Withdrawn Prior to Treatment|1|||
147290402|NCT01292603|531228067|FG000|Part 2: Dose Confirmation Period|Adverse Event|0|||
147290403|NCT01292603|531228068|FG001|Part 2: Dose Confirmation Period|Adverse Event|0|||
147290404|NCT01292603|531228069|FG002|Part 2: Dose Confirmation Period|Adverse Event|0|||
147290405|NCT01292603|531228070|FG003|Part 2: Dose Confirmation Period|Adverse Event|0|||
147290406|NCT01292603|531228071|FG004|Part 2: Dose Confirmation Period|Adverse Event|7|||
147290407|NCT01292603|531228072|FG005|Part 2: Dose Confirmation Period|Adverse Event|9|||
147290408|NCT01292603|531228067|FG000|Part 2: Dose Confirmation Period|Protocol Violation|0|||
147290409|NCT01292603|531228068|FG001|Part 2: Dose Confirmation Period|Protocol Violation|0|||
147290410|NCT01292603|531228069|FG002|Part 2: Dose Confirmation Period|Protocol Violation|0|||
147290411|NCT01292603|531228070|FG003|Part 2: Dose Confirmation Period|Protocol Violation|0|||
147290412|NCT01292603|531228071|FG004|Part 2: Dose Confirmation Period|Protocol Violation|5|||
147290413|NCT01292603|531228072|FG005|Part 2: Dose Confirmation Period|Protocol Violation|3|||
147290414|NCT01292603|531228067|FG000|Part 2: Dose Confirmation Period|Withdrawal by Subject|0|||
147290415|NCT01292603|531228068|FG001|Part 2: Dose Confirmation Period|Withdrawal by Subject|0|||
147290416|NCT01292603|531228069|FG002|Part 2: Dose Confirmation Period|Withdrawal by Subject|0|||
147290417|NCT01292603|531228070|FG003|Part 2: Dose Confirmation Period|Withdrawal by Subject|0|||
147290418|NCT01292603|531228071|FG004|Part 2: Dose Confirmation Period|Withdrawal by Subject|0|||
147290419|NCT01292603|531228072|FG005|Part 2: Dose Confirmation Period|Withdrawal by Subject|2|||
147290420|NCT01292603|531228067|FG000|Part 2: Regular Follow-Up|Death|0|||
147290421|NCT01292603|531228068|FG001|Part 2: Regular Follow-Up|Death|0|||
147290422|NCT01292603|531228069|FG002|Part 2: Regular Follow-Up|Death|0|||
147338113|NCT01369498|531404824|FG002|Overall Study|Investigator's Discretion|1|||
147338114|NCT01369498|531404825|FG003|Overall Study|Investigator's Discretion|3|||
147338115|NCT01369498|531404822|FG000|Overall Study|Unknown Reason|1|||
147338116|NCT01369498|531404823|FG001|Overall Study|Unknown Reason|0|||
147338117|NCT01369498|531404824|FG002|Overall Study|Unknown Reason|11|||
147338118|NCT01369498|531404825|FG003|Overall Study|Unknown Reason|6|||
147338119|NCT01369498|531404822|FG000|Overall Study|Disease Progression|0|||
147338120|NCT01369498|531404823|FG001|Overall Study|Disease Progression|0|||
147338121|NCT01369498|531404824|FG002|Overall Study|Disease Progression|0|||
147338122|NCT01369498|531404825|FG003|Overall Study|Disease Progression|1|||
147338123|NCT00535145|531404832|FG000|Phase I|Adverse Event|3|||
147338124|NCT00535145|531404832|FG000|Phase I|Lost to Follow-up|7|||
147338125|NCT00535145|531404832|FG000|Phase I|Withdrawal by Subject|6|||
147338126|NCT00535145|531404832|FG000|Phase I|(eligibility)|8|||
147338127|NCT00535145|531404832|FG000|Phase I|(protocol violation)|1|||
147338128|NCT00535145|531404832|FG000|Phase I|(PI decision)|1|||
147338129|NCT00535145|531404832|FG000|Phase I|(diagnosis)|3|||
147338130|NCT00535145|531404832|FG000|Phase II|Adverse Event|2|||
147338131|NCT00535145|531404832|FG000|Phase II|Lack of Efficacy|1|||
147338132|NCT00535145|531404832|FG000|Phase II|Lost to Follow-up|5|||
147338133|NCT00535145|531404832|FG000|Phase II|Withdrawal by Subject|5|||
147338134|NCT00535145|531404832|FG000|Phase II|Subject non-compliance|2|||
147338135|NCT01444417|531404833|FG000|Overall Study|Ineligibility Determined|0|||
147338136|NCT01444417|531404834|FG001|Overall Study|Ineligibility Determined|1|||
147290423|NCT01292603|531228070|FG003|Part 2: Regular Follow-Up|Death|0|||
147290424|NCT01292603|531228071|FG004|Part 2: Regular Follow-Up|Death|6|||
147338137|NCT01444417|531404833|FG000|Overall Study|Withdrawal by Subject|2|||
147338138|NCT01444417|531404834|FG001|Overall Study|Withdrawal by Subject|0|||
147338139|NCT02214160|531404836|FG000|Overall Study|Withdrawal by Subject|1|||
147338140|NCT02214160|531404837|FG001|Overall Study|Withdrawal by Subject|0|||
147290425|NCT01292603|531228072|FG005|Part 2: Regular Follow-Up|Death|3|||
147338141|NCT02214160|531404838|FG002|Overall Study|Withdrawal by Subject|6|||
147604338|NCT02329847|532367877|FG001|Overall Study|Lost to Follow-up|0|||
147338142|NCT02214160|531404836|FG000|Overall Study|Death|2|||
147338143|NCT02214160|531404837|FG001|Overall Study|Death|2|||
147338144|NCT02214160|531404838|FG002|Overall Study|Death|1|||
147338145|NCT02214160|531404836|FG000|Overall Study|Subject Non-Compliance|0|||
147338146|NCT02214160|531404837|FG001|Overall Study|Subject Non-Compliance|3|||
147290426|NCT01292603|531228067|FG000|Part 2: Regular Follow-Up|Disease Progression|0|||
147290427|NCT01292603|531228068|FG001|Part 2: Regular Follow-Up|Disease Progression|0|||
147290428|NCT01292603|531228069|FG002|Part 2: Regular Follow-Up|Disease Progression|0|||
147290429|NCT01292603|531228070|FG003|Part 2: Regular Follow-Up|Disease Progression|0|||
147290430|NCT01292603|531228071|FG004|Part 2: Regular Follow-Up|Disease Progression|5|||
147290431|NCT01292603|531228072|FG005|Part 2: Regular Follow-Up|Disease Progression|5|||
147290432|NCT01292603|531228067|FG000|Part 2: Regular Follow-Up|Noncompliance|0|||
147290433|NCT01292603|531228068|FG001|Part 2: Regular Follow-Up|Noncompliance|0|||
147290434|NCT01292603|531228069|FG002|Part 2: Regular Follow-Up|Noncompliance|0|||
147290435|NCT01292603|531228070|FG003|Part 2: Regular Follow-Up|Noncompliance|0|||
147290436|NCT01292603|531228071|FG004|Part 2: Regular Follow-Up|Noncompliance|1|||
147290437|NCT01292603|531228072|FG005|Part 2: Regular Follow-Up|Noncompliance|0|||
147290438|NCT01292603|531228067|FG000|Part 2: Regular Follow-Up|Withdrawal by Subject|0|||
147290439|NCT01292603|531228068|FG001|Part 2: Regular Follow-Up|Withdrawal by Subject|0|||
147290440|NCT01292603|531228069|FG002|Part 2: Regular Follow-Up|Withdrawal by Subject|0|||
147290441|NCT01292603|531228070|FG003|Part 2: Regular Follow-Up|Withdrawal by Subject|0|||
147290442|NCT01292603|531228071|FG004|Part 2: Regular Follow-Up|Withdrawal by Subject|0|||
147290443|NCT01292603|531228072|FG005|Part 2: Regular Follow-Up|Withdrawal by Subject|1|||
147290444|NCT01292603|531228067|FG000|Part 2: Regular Follow-Up|Protocol Violation|0|||
147290445|NCT01292603|531228068|FG001|Part 2: Regular Follow-Up|Protocol Violation|0|||
147290446|NCT01292603|531228069|FG002|Part 2: Regular Follow-Up|Protocol Violation|0|||
147290447|NCT01292603|531228070|FG003|Part 2: Regular Follow-Up|Protocol Violation|0|||
147290448|NCT01292603|531228071|FG004|Part 2: Regular Follow-Up|Protocol Violation|2|||
147290449|NCT01292603|531228072|FG005|Part 2: Regular Follow-Up|Protocol Violation|0|||
147290450|NCT01292603|531228067|FG000|Part 2: Regular Follow-Up|Physician Decision|0|||
147290451|NCT01292603|531228068|FG001|Part 2: Regular Follow-Up|Physician Decision|0|||
147290452|NCT01292603|531228069|FG002|Part 2: Regular Follow-Up|Physician Decision|0|||
147290453|NCT01292603|531228070|FG003|Part 2: Regular Follow-Up|Physician Decision|0|||
147290454|NCT01292603|531228071|FG004|Part 2: Regular Follow-Up|Physician Decision|2|||
147290455|NCT01292603|531228072|FG005|Part 2: Regular Follow-Up|Physician Decision|0|||
147290456|NCT01292603|531228067|FG000|Part 2: Regular Follow-Up|Lost to Follow-up|0|||
147290457|NCT01292603|531228068|FG001|Part 2: Regular Follow-Up|Lost to Follow-up|0|||
147290458|NCT01292603|531228069|FG002|Part 2: Regular Follow-Up|Lost to Follow-up|0|||
147290459|NCT01292603|531228070|FG003|Part 2: Regular Follow-Up|Lost to Follow-up|0|||
147290460|NCT01292603|531228071|FG004|Part 2: Regular Follow-Up|Lost to Follow-up|1|||
147290461|NCT01292603|531228072|FG005|Part 2: Regular Follow-Up|Lost to Follow-up|1|||
147290462|NCT01292603|531228067|FG000|Part 2: Regular Follow-Up|Adverse Event|0|||
147290463|NCT01292603|531228068|FG001|Part 2: Regular Follow-Up|Adverse Event|0|||
147290464|NCT01292603|531228069|FG002|Part 2: Regular Follow-Up|Adverse Event|0|||
147290465|NCT01292603|531228070|FG003|Part 2: Regular Follow-Up|Adverse Event|0|||
147290466|NCT01292603|531228071|FG004|Part 2: Regular Follow-Up|Adverse Event|2|||
147290467|NCT01292603|531228072|FG005|Part 2: Regular Follow-Up|Adverse Event|2|||
147290468|NCT01292603|531228067|FG000|Overall Survival Status|Death|3|||
147290469|NCT01292603|531228068|FG001|Overall Survival Status|Death|1|||
147290470|NCT01292603|531228069|FG002|Overall Survival Status|Death|3|||
147290471|NCT01292603|531228070|FG003|Overall Survival Status|Death|1|||
147290472|NCT01292603|531228071|FG004|Overall Survival Status|Death|16|||
147290473|NCT01292603|531228072|FG005|Overall Survival Status|Death|10|||
147290474|NCT01912612|531228083|FG000|Overall Study|Adverse Event|4|||
147290475|NCT01912612|531228084|FG001|Overall Study|Adverse Event|0|||
147290476|NCT01912612|531228085|FG002|Overall Study|Adverse Event|0|||
147290477|NCT01912612|531228083|FG000|Overall Study|Withdrew consent|1|||
147290478|NCT01912612|531228084|FG001|Overall Study|Withdrew consent|0|||
147290479|NCT01912612|531228085|FG002|Overall Study|Withdrew consent|0|||
147290480|NCT01912612|531228083|FG000|Overall Study|Study design change|0|||
147290481|NCT01912612|531228084|FG001|Overall Study|Study design change|0|||
147290482|NCT01912612|531228085|FG002|Overall Study|Study design change|3|||
147290483|NCT01588184|531228086|FG000|Overall Study|Death|1|||
147290484|NCT01588184|531228087|FG001|Overall Study|Death|0|||
147290485|NCT01588184|531228088|FG002|Overall Study|Death|0|||
147290486|NCT01588184|531228089|FG003|Overall Study|Death|1|||
147290487|NCT01588184|531228090|FG004|Overall Study|Death|1|||
147290488|NCT01588184|531228091|FG005|Overall Study|Death|1|||
147604339|NCT02329847|532367878|FG002|Overall Study|Lost to Follow-up|2|||
147290489|NCT01588184|531228086|FG000|Overall Study|Withdrawal by Subject|2|||
147290490|NCT01588184|531228087|FG001|Overall Study|Withdrawal by Subject|4|||
147290491|NCT01588184|531228088|FG002|Overall Study|Withdrawal by Subject|0|||
147290492|NCT01588184|531228089|FG003|Overall Study|Withdrawal by Subject|1|||
147290493|NCT01588184|531228090|FG004|Overall Study|Withdrawal by Subject|0|||
147290494|NCT01588184|531228091|FG005|Overall Study|Withdrawal by Subject|0|||
147290495|NCT01588184|531228086|FG000|Overall Study|Bevacizumab treatment provision changed|0|||
147290496|NCT01588184|531228087|FG001|Overall Study|Bevacizumab treatment provision changed|6|||
147290497|NCT01588184|531228088|FG002|Overall Study|Bevacizumab treatment provision changed|2|||
147290498|NCT01588184|531228089|FG003|Overall Study|Bevacizumab treatment provision changed|0|||
147290499|NCT01588184|531228090|FG004|Overall Study|Bevacizumab treatment provision changed|1|||
147290500|NCT01588184|531228091|FG005|Overall Study|Bevacizumab treatment provision changed|3|||
147290501|NCT01588184|531228086|FG000|Overall Study|multiple reasons|0|||
147290502|NCT01588184|531228087|FG001|Overall Study|multiple reasons|3|||
147290503|NCT01588184|531228088|FG002|Overall Study|multiple reasons|0|||
147290504|NCT01588184|531228089|FG003|Overall Study|multiple reasons|1|||
147290505|NCT01588184|531228090|FG004|Overall Study|multiple reasons|0|||
147290506|NCT01588184|531228091|FG005|Overall Study|multiple reasons|0|||
147290507|NCT00907153|531228092|FG000|Overall Study|Lost to Follow-up|1|||
147290508|NCT00907153|531228093|FG001|Overall Study|Lost to Follow-up|1|||
147290509|NCT00907153|531228092|FG000|Overall Study|Withdrawal by Subject|1|||
147290510|NCT00907153|531228093|FG001|Overall Study|Withdrawal by Subject|3|||
147290511|NCT02460991|531228094|FG000|Overall Study|Withdrawal by Subject|0|||
147290512|NCT02460991|531228095|FG001|Overall Study|Withdrawal by Subject|2|||
147290513|NCT02277106|531228096|FG000|Stage 2|Adverse Event|0|||
147290514|NCT02277106|531228097|FG001|Stage 2|Adverse Event|0|||
147290515|NCT02277106|531228098|FG002|Stage 2|Adverse Event|1|||
147290516|NCT03667053|531228102|FG000|Overall Study|Withdrawal by Subject|1|||
147290517|NCT03667053|531228103|FG001|Overall Study|Withdrawal by Subject|0|||
147290518|NCT03667053|531228104|FG002|Overall Study|Withdrawal by Subject|0|||
147290519|NCT00515502|531228105|FG000|Treatment Period 1|Adverse Event|0|||
147290520|NCT00515502|531228106|FG001|Treatment Period 1|Adverse Event|0|||
147290521|NCT00515502|531228107|FG002|Treatment Period 1|Adverse Event|0|||
147290522|NCT00515502|531228108|FG003|Treatment Period 1|Adverse Event|0|||
147290523|NCT00515502|531228109|FG004|Treatment Period 1|Adverse Event|0|||
147290524|NCT00515502|531228110|FG005|Treatment Period 1|Adverse Event|0|||
147290525|NCT00515502|531228111|FG006|Treatment Period 1|Adverse Event|1|||
147290526|NCT00515502|531228112|FG007|Treatment Period 1|Adverse Event|0|||
147290527|NCT00515502|531228113|FG008|Treatment Period 1|Adverse Event|1|||
147290528|NCT00515502|531228114|FG009|Treatment Period 1|Adverse Event|0|||
147290529|NCT00515502|531228115|FG010|Treatment Period 1|Adverse Event|0|||
147290530|NCT00515502|531228116|FG011|Treatment Period 1|Adverse Event|1|||
147290531|NCT00515502|531228105|FG000|Treatment Period 2|Adverse Event|0|||
147290532|NCT00515502|531228106|FG001|Treatment Period 2|Adverse Event|1|||
147290533|NCT00515502|531228107|FG002|Treatment Period 2|Adverse Event|0|||
147290534|NCT00515502|531228108|FG003|Treatment Period 2|Adverse Event|0|||
147290535|NCT00515502|531228109|FG004|Treatment Period 2|Adverse Event|0|||
147290536|NCT00515502|531228110|FG005|Treatment Period 2|Adverse Event|0|||
147290537|NCT00515502|531228111|FG006|Treatment Period 2|Adverse Event|0|||
147290538|NCT00515502|531228112|FG007|Treatment Period 2|Adverse Event|0|||
147290539|NCT00515502|531228113|FG008|Treatment Period 2|Adverse Event|0|||
147290540|NCT00515502|531228114|FG009|Treatment Period 2|Adverse Event|0|||
147290541|NCT00515502|531228115|FG010|Treatment Period 2|Adverse Event|0|||
147290542|NCT00515502|531228116|FG011|Treatment Period 2|Adverse Event|0|||
147290543|NCT01869491|531228117|FG000|Overall Study|Adverse Event|3|||
147290544|NCT01869491|531228118|FG001|Overall Study|Adverse Event|5|||
147290545|NCT01869491|531228117|FG000|Overall Study|Lack of Efficacy|0|||
147290546|NCT01869491|531228118|FG001|Overall Study|Lack of Efficacy|3|||
147290547|NCT01869491|531228117|FG000|Overall Study|Withdrawal by Subject|6|||
147290548|NCT01869491|531228118|FG001|Overall Study|Withdrawal by Subject|7|||
147290549|NCT01869491|531228117|FG000|Overall Study|Lost to Follow-up|11|||
147290550|NCT01869491|531228118|FG001|Overall Study|Lost to Follow-up|9|||
147290551|NCT01869491|531228117|FG000|Overall Study|No further need of investigational product|1|||
147290552|NCT01869491|531228118|FG001|Overall Study|No further need of investigational product|0|||
147290553|NCT01910129|531228119|FG000|Randomized Phase 2|Withdrawal by Subject|2|||
147290554|NCT01910129|531228120|FG001|Randomized Phase 2|Withdrawal by Subject|1|||
147290555|NCT01910129|531228121|FG002|Randomized Phase 2|Withdrawal by Subject|0|||
147290556|NCT01910129|531228119|FG000|Randomized Phase 3|Withdrawal by Subject|0|||
147290557|NCT01910129|531228120|FG001|Randomized Phase 3|Withdrawal by Subject|1|||
147290558|NCT01910129|531228121|FG002|Randomized Phase 3|Withdrawal by Subject|0|||
147290559|NCT00965523|531228122|FG000|Study 221|Progressive Disease|4|||
147290560|NCT00965523|531228122|FG000|Study 221|Physician Decision|3|||
147290561|NCT00965523|531228122|FG000|Study 224|Progressive Disease|5|||
147290562|NCT00965523|531228122|FG000|Study 224|Physician Decision|1|||
147290563|NCT02363738|531228123|FG000|Overall Study|Adverse Event|5|||
147290564|NCT02363738|531228124|FG001|Overall Study|Adverse Event|2|||
147290565|NCT02363738|531228123|FG000|Overall Study|Lack of Efficacy|1|||
147290566|NCT02363738|531228124|FG001|Overall Study|Lack of Efficacy|2|||
147290567|NCT02363738|531228123|FG000|Overall Study|Lost to Follow-up|2|||
147290568|NCT02363738|531228124|FG001|Overall Study|Lost to Follow-up|1|||
147290569|NCT02187991|531228125|FG000|Overall Study|Adverse Event|13|||
147290570|NCT02187991|531228126|FG001|Overall Study|Adverse Event|14|||
147290571|NCT02187991|531228127|FG002|Overall Study|Adverse Event|3|||
147290572|NCT02187991|531228128|FG003|Overall Study|Adverse Event|2|||
147290573|NCT02187991|531228125|FG000|Overall Study|Withdrawal by Subject|9|||
147290574|NCT02187991|531228126|FG001|Overall Study|Withdrawal by Subject|6|||
147290575|NCT02187991|531228127|FG002|Overall Study|Withdrawal by Subject|3|||
147290576|NCT02187991|531228128|FG003|Overall Study|Withdrawal by Subject|2|||
147290577|NCT02187991|531228125|FG000|Overall Study|Physician Decision|4|||
147290578|NCT02187991|531228126|FG001|Overall Study|Physician Decision|4|||
147290579|NCT02187991|531228127|FG002|Overall Study|Physician Decision|0|||
147290580|NCT02187991|531228128|FG003|Overall Study|Physician Decision|2|||
147290581|NCT02187991|531228125|FG000|Overall Study|Other, unrelated complication|7|||
147290582|NCT02187991|531228126|FG001|Overall Study|Other, unrelated complication|1|||
147290583|NCT02187991|531228127|FG002|Overall Study|Other, unrelated complication|1|||
147290584|NCT02187991|531228128|FG003|Overall Study|Other, unrelated complication|2|||
147290585|NCT02187991|531228125|FG000|Overall Study|Death|1|||
147290586|NCT02187991|531228126|FG001|Overall Study|Death|3|||
147290587|NCT02187991|531228127|FG002|Overall Study|Death|0|||
147290588|NCT02187991|531228128|FG003|Overall Study|Death|0|||
147290589|NCT01939028|531228129|FG000|Overall Study|Withdrawal by Subject|5|||
147290590|NCT01939028|531228129|FG000|Overall Study|Physician Decision|7|||
147290591|NCT00322348|531228132|FG000|Overall Study|Adverse Event|0|||
147290592|NCT00322348|531228133|FG001|Overall Study|Adverse Event|1|||
147290593|NCT00322348|531228132|FG000|Overall Study|Withdrawal by Subject|1|||
147290594|NCT00322348|531228133|FG001|Overall Study|Withdrawal by Subject|4|||
147290595|NCT00322348|531228132|FG000|Overall Study|Lost to Follow-up|1|||
147290596|NCT00322348|531228133|FG001|Overall Study|Lost to Follow-up|0|||
147290597|NCT00322348|531228132|FG000|Overall Study|Death|0|||
147290598|NCT00322348|531228133|FG001|Overall Study|Death|2|||
147290599|NCT00322348|531228132|FG000|Overall Study|Disease Progression|30|||
147290600|NCT00322348|531228133|FG001|Overall Study|Disease Progression|25|||
147290601|NCT00322348|531228132|FG000|Overall Study|Reasons not specified|5|||
147290602|NCT00322348|531228133|FG001|Overall Study|Reasons not specified|1|||
147290603|NCT00989287|531228138|FG000|Overall Study|Adverse Event|1|||
147290604|NCT00989287|531228139|FG001|Overall Study|Adverse Event|0|||
147290605|NCT00989287|531228138|FG000|Overall Study|Lost to Follow-up|0|||
147290606|NCT00989287|531228139|FG001|Overall Study|Lost to Follow-up|1|||
147290607|NCT01857531|531228153|FG000|Overall Study|Withdrawal by Subject|4|||
147290608|NCT02576067|531228154|FG000|Overall Study|Death|0|||
147290609|NCT02576067|531228155|FG001|Overall Study|Death|1|||
147290610|NCT02576067|531228154|FG000|Overall Study|Lack of Efficacy|1|||
147290611|NCT02576067|531228155|FG001|Overall Study|Lack of Efficacy|0|||
147290612|NCT02576067|531228154|FG000|Overall Study|Lost to Follow-up|11|||
147290613|NCT02576067|531228155|FG001|Overall Study|Lost to Follow-up|0|||
147290614|NCT02576067|531228154|FG000|Overall Study|Withdrawal by Subject|11|||
147290615|NCT02576067|531228155|FG001|Overall Study|Withdrawal by Subject|2|||
147290616|NCT02576067|531228154|FG000|Overall Study|study closure of main CIRT trial)|0|||
147290617|NCT02576067|531228155|FG001|Overall Study|study closure of main CIRT trial)|8|||
147290618|NCT02576067|531228154|FG000|Overall Study|not randomized, failed run-in|7|||
147290619|NCT02576067|531228155|FG001|Overall Study|not randomized, failed run-in|0|||
147290620|NCT02576067|531228154|FG000|Overall Study|screen failure/ re-enrolled|0|||
147290621|NCT02576067|531228155|FG001|Overall Study|screen failure/ re-enrolled|25|||
147290622|NCT02576067|531228154|FG000|Overall Study|Physician Decision|4|||
147290623|NCT02576067|531228155|FG001|Overall Study|Physician Decision|0|||
147290624|NCT03570619|531228158|FG000|Overall Study|Adverse Event|2|||
147290625|NCT03570619|531228159|FG001|Overall Study|Adverse Event|0|||
147290626|NCT03570619|531228160|FG002|Overall Study|Adverse Event|1|||
147290627|NCT03570619|531228158|FG000|Overall Study|new diagnosis of new malignancy|1|||
147290628|NCT03570619|531228159|FG001|Overall Study|new diagnosis of new malignancy|0|||
147290629|NCT03570619|531228160|FG002|Overall Study|new diagnosis of new malignancy|0|||
147290630|NCT03570619|531228158|FG000|Overall Study|Physician Decision|1|||
147290631|NCT03570619|531228159|FG001|Overall Study|Physician Decision|1|||
147290632|NCT03570619|531228160|FG002|Overall Study|Physician Decision|0|||
147290633|NCT03570619|531228158|FG000|Overall Study|Withdrawal by Subject|0|||
147290634|NCT03570619|531228159|FG001|Overall Study|Withdrawal by Subject|2|||
147290635|NCT03570619|531228160|FG002|Overall Study|Withdrawal by Subject|0|||
147290636|NCT04773587|531228161|FG000|Overall Study|Lost to Follow-up|11|||
147290637|NCT04773587|531228162|FG001|Overall Study|Lost to Follow-up|3|||
147338147|NCT02214160|531404838|FG002|Overall Study|Subject Non-Compliance|1|||
147338148|NCT02214160|531404836|FG000|Overall Study|Adverse Event|0|||
147290638|NCT04773587|531228161|FG000|Overall Study|Adverse Event|6|||
147338149|NCT02214160|531404837|FG001|Overall Study|Adverse Event|1|||
147338150|NCT02214160|531404838|FG002|Overall Study|Adverse Event|1|||
147338151|NCT02214160|531404836|FG000|Overall Study|Sponsor Decision|0|||
147290639|NCT04773587|531228162|FG001|Overall Study|Adverse Event|3|||
147290640|NCT04773587|531228161|FG000|Overall Study|Lack of Efficacy|5|||
147290641|NCT04773587|531228162|FG001|Overall Study|Lack of Efficacy|2|||
147290642|NCT04773587|531228161|FG000|Overall Study|Withdrawal by Subject|4|||
147290643|NCT04773587|531228162|FG001|Overall Study|Withdrawal by Subject|5|||
147290644|NCT04773587|531228161|FG000|Overall Study|Noncompliance|1|||
147290645|NCT04773587|531228162|FG001|Overall Study|Noncompliance|0|||
147290646|NCT04773587|531228161|FG000|Overall Study|Protocol Violation|1|||
147290647|NCT04773587|531228162|FG001|Overall Study|Protocol Violation|0|||
147290648|NCT04773587|531228161|FG000|Overall Study|Consent withdrawn due to AEs of nausea, headaches, dizziness, and brain fog|1|||
147290649|NCT04773587|531228162|FG001|Overall Study|Consent withdrawn due to AEs of nausea, headaches, dizziness, and brain fog|0|||
147338152|NCT02214160|531404837|FG001|Overall Study|Sponsor Decision|2|||
147290650|NCT02372409|531228163|FG000|Overall Study|Lost to Follow-up|1|||
147290651|NCT02372409|531228164|FG001|Overall Study|Lost to Follow-up|0|||
147290652|NCT02372409|531228163|FG000|Overall Study|Disease progression|1|||
147290653|NCT02372409|531228164|FG001|Overall Study|Disease progression|1|||
147290654|NCT01808313|531228165|FG000|Overall Study|Adverse Event|5|||
147290655|NCT01808313|531228165|FG000|Overall Study|Protocol Violation|2|||
147290656|NCT01808313|531228165|FG000|Overall Study|Met Protocol-defined Stopping Criteria|1|||
147290657|NCT01808313|531228165|FG000|Overall Study|Lost to Follow-up|1|||
147290658|NCT01808313|531228165|FG000|Overall Study|Physician Decision|1|||
147290659|NCT04656847|531228168|FG000|3 Month After Inclusion|lack of data on myocardial infarction and/or data by visits|23|||
147290660|NCT03301051|531228169|FG000|Overall Study|Adverse Event|0|||
147290661|NCT03301051|531228170|FG001|Overall Study|Adverse Event|4|||
147290662|NCT03301051|531228169|FG000|Overall Study|Withdrawal by Subject|59|||
147290663|NCT03301051|531228170|FG001|Overall Study|Withdrawal by Subject|65|||
147290664|NCT03301051|531228169|FG000|Overall Study|Lost to Follow-up|263|||
147290665|NCT03301051|531228170|FG001|Overall Study|Lost to Follow-up|282|||
147290666|NCT03301051|531228169|FG000|Overall Study|Protocol Violation|1|||
147290667|NCT03301051|531228170|FG001|Overall Study|Protocol Violation|3|||
147290668|NCT03301051|531228169|FG000|Overall Study|Physician Decision|1|||
147290669|NCT03301051|531228170|FG001|Overall Study|Physician Decision|3|||
147290670|NCT03301051|531228169|FG000|Overall Study|Death|1|||
147290671|NCT03301051|531228170|FG001|Overall Study|Death|1|||
147290672|NCT03301051|531228169|FG000|Overall Study|Miscellaneous|8|||
147290673|NCT03301051|531228170|FG001|Overall Study|Miscellaneous|4|||
147290674|NCT03301051|531228169|FG000|Overall Study|Randomized, not vaccinated|13|||
147290675|NCT03301051|531228170|FG001|Overall Study|Randomized, not vaccinated|10|||
147290676|NCT00622167|531228171|FG000|Overall Study|Did not meet angiographic criteria|20|||
147290677|NCT00435370|531228176|FG000|Overall Study|Adverse Event|8|||
147290678|NCT00435370|531228177|FG001|Overall Study|Adverse Event|8|||
147290679|NCT00435370|531228176|FG000|Overall Study|Withdrawal by Subject|10|||
147290680|NCT00435370|531228177|FG001|Overall Study|Withdrawal by Subject|10|||
147290681|NCT00435370|531228176|FG000|Overall Study|Antipsychotic medication changed|4|||
147290682|NCT00435370|531228177|FG001|Overall Study|Antipsychotic medication changed|2|||
147290683|NCT01965834|531228179|FG000|Overall Study|Lack of Efficacy|4|||
147290684|NCT02352948|531228185|FG000|Overall Study|Death|47|||
147290685|NCT02352948|531228186|FG001|Overall Study|Death|48|||
147290686|NCT02352948|531228187|FG002|Overall Study|Death|114|||
147290687|NCT02352948|531228188|FG003|Overall Study|Death|74|||
147290688|NCT02352948|531228189|FG004|Overall Study|Death|77|||
147290689|NCT02352948|531228190|FG005|Overall Study|Death|44|||
147290690|NCT02352948|531228185|FG000|Overall Study|Lost to Follow-up|1|||
147290691|NCT02352948|531228186|FG001|Overall Study|Lost to Follow-up|0|||
147290692|NCT02352948|531228187|FG002|Overall Study|Lost to Follow-up|2|||
147290693|NCT02352948|531228188|FG003|Overall Study|Lost to Follow-up|1|||
147290694|NCT02352948|531228189|FG004|Overall Study|Lost to Follow-up|2|||
147290695|NCT02352948|531228190|FG005|Overall Study|Lost to Follow-up|1|||
147290696|NCT02352948|531228185|FG000|Overall Study|Withdrawal by Subject|1|||
147290697|NCT02352948|531228186|FG001|Overall Study|Withdrawal by Subject|10|||
147290698|NCT02352948|531228187|FG002|Overall Study|Withdrawal by Subject|11|||
147290699|NCT02352948|531228188|FG003|Overall Study|Withdrawal by Subject|23|||
147290700|NCT02352948|531228189|FG004|Overall Study|Withdrawal by Subject|9|||
147290701|NCT02352948|531228190|FG005|Overall Study|Withdrawal by Subject|4|||
147290702|NCT02352948|531228185|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
147290703|NCT02352948|531228186|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
147338153|NCT02214160|531404838|FG002|Overall Study|Sponsor Decision|0|||
147338154|NCT02214160|531404836|FG000|Overall Study|Protocol Violation|1|||
147338155|NCT02214160|531404837|FG001|Overall Study|Protocol Violation|0|||
147338156|NCT02214160|531404838|FG002|Overall Study|Protocol Violation|0|||
147338157|NCT02214160|531404836|FG000|Overall Study|Physician Decision|0|||
147338158|NCT02214160|531404837|FG001|Overall Study|Physician Decision|0|||
147338159|NCT02214160|531404838|FG002|Overall Study|Physician Decision|1|||
147338160|NCT02423798|531404839|FG000|Overall Study|Withdrawal by Subject|3|||
147338161|NCT01430611|531404843|FG000|Overall Study|Adverse Event|0|||
147338162|NCT01430611|531404844|FG001|Overall Study|Adverse Event|1|||
147290704|NCT02352948|531228187|FG002|Overall Study|Eligibility criteria not fulfilled|0|||
147290705|NCT02352948|531228188|FG003|Overall Study|Eligibility criteria not fulfilled|1|||
147290706|NCT02352948|531228189|FG004|Overall Study|Eligibility criteria not fulfilled|0|||
147290707|NCT02352948|531228190|FG005|Overall Study|Eligibility criteria not fulfilled|0|||
147338163|NCT01430611|531404843|FG000|Overall Study|Protocol Violation|1|||
147290708|NCT02352948|531228185|FG000|Overall Study|Other|0|||
147290709|NCT02352948|531228186|FG001|Overall Study|Other|0|||
147290710|NCT02352948|531228187|FG002|Overall Study|Other|2|||
147290711|NCT02352948|531228188|FG003|Overall Study|Other|0|||
147290712|NCT02352948|531228189|FG004|Overall Study|Other|0|||
147290713|NCT02352948|531228190|FG005|Overall Study|Other|0|||
147290714|NCT00679939|531228191|FG000|52-Week Double-Blind (DB) Period|Withdrew Consent|17|||
147338164|NCT01430611|531404844|FG001|Overall Study|Protocol Violation|0|||
147338165|NCT01430611|531404843|FG000|Overall Study|Lost to Follow-up|1|||
147338166|NCT01430611|531404844|FG001|Overall Study|Lost to Follow-up|0|||
147290715|NCT00679939|531228192|FG001|52-Week Double-Blind (DB) Period|Withdrew Consent|13|||
147290716|NCT00679939|531228191|FG000|52-Week Double-Blind (DB) Period|Adverse Event|14|||
147290717|NCT00679939|531228192|FG001|52-Week Double-Blind (DB) Period|Adverse Event|12|||
147290718|NCT00679939|531228191|FG000|52-Week Double-Blind (DB) Period|Investigator Discretion|5|||
147290719|NCT00679939|531228192|FG001|52-Week Double-Blind (DB) Period|Investigator Discretion|0|||
147290720|NCT00679939|531228191|FG000|52-Week Double-Blind (DB) Period|Protocol Violation|1|||
147290721|NCT00679939|531228192|FG001|52-Week Double-Blind (DB) Period|Protocol Violation|0|||
147290722|NCT00679939|531228191|FG000|52-Week Double-Blind (DB) Period|Lost to Follow-up|0|||
147290723|NCT00679939|531228192|FG001|52-Week Double-Blind (DB) Period|Lost to Follow-up|2|||
147290724|NCT00679939|531228191|FG000|24-Week Open-Label (OL) Period|Adverse Event|0|||
147290725|NCT00679939|531228192|FG001|24-Week Open-Label (OL) Period|Adverse Event|1|||
147290726|NCT00679939|531228191|FG000|24-Week Open-Label (OL) Period|Protocol Violation|1|||
147290727|NCT00679939|531228192|FG001|24-Week Open-Label (OL) Period|Protocol Violation|1|||
147290728|NCT00679939|531228191|FG000|24-Week Open-Label (OL) Period|Met Stopping Criteria|3|||
147290729|NCT00679939|531228192|FG001|24-Week Open-Label (OL) Period|Met Stopping Criteria|1|||
147290730|NCT00679939|531228191|FG000|24-Week Open-Label (OL) Period|Physician Decision|1|||
147290731|NCT00679939|531228192|FG001|24-Week Open-Label (OL) Period|Physician Decision|0|||
147290732|NCT00679939|531228191|FG000|24-Week Open-Label (OL) Period|Withdrawal by Subject|2|||
147290733|NCT00679939|531228192|FG001|24-Week Open-Label (OL) Period|Withdrawal by Subject|1|||
147290734|NCT02269670|531228195|FG000|Overall Study|All subjects have not completed all research related interventions|3|||
147290735|NCT05374421|531228196|FG000|Overall Study|Withdrawal by Subject|3|||
147290736|NCT05374421|531228197|FG001|Overall Study|Withdrawal by Subject|4|||
147290737|NCT04370054|531228200|FG000|Treatment Phase|Lost to Follow-up|1|||
147290738|NCT04370054|531228200|FG000|Treatment Phase|Withdrawal by Subject|1|||
147290739|NCT04370054|531228200|FG000|Follow-Up Phase|Ongoing|75|||
147290740|NCT01962493|531228202|FG000|Overall Study|Adverse Event|1|||
147290741|NCT01962493|531228203|FG001|Overall Study|Adverse Event|2|||
147290742|NCT01962493|531228202|FG000|Overall Study|Protocol Violation|0|||
147290743|NCT01962493|531228203|FG001|Overall Study|Protocol Violation|1|||
147290744|NCT01962493|531228202|FG000|Overall Study|Withdrawal by Subject|4|||
147290745|NCT01962493|531228203|FG001|Overall Study|Withdrawal by Subject|2|||
147290746|NCT02979639|531229753|FG000|Overall Study|Withdrawal based on medical judgement|1|||
147290747|NCT02979639|531229753|FG000|Overall Study|Lost to Follow-up|8|||
147290748|NCT02979639|531229753|FG000|Overall Study|Withdrawal by Subject|3|||
147290749|NCT02979639|531229753|FG000|Overall Study|Adverse Event|2|||
147290750|NCT02985866|531229766|FG000|Overall Study|Poor CGM data|1|||
147290751|NCT02985866|531229767|FG001|Overall Study|Poor CGM data|1|||
147290752|NCT04402866|531229774|FG000|Overall Study|Discontinued Prior to Treatment|0|||
147290753|NCT04402866|531229775|FG001|Overall Study|Discontinued Prior to Treatment|0|||
147290754|NCT04402866|531229776|FG002|Overall Study|Discontinued Prior to Treatment|0|||
147290755|NCT04402866|531229777|FG003|Overall Study|Discontinued Prior to Treatment|0|||
147290756|NCT04402866|531229778|FG004|Overall Study|Discontinued Prior to Treatment|2|||
147290757|NCT04402866|531229779|FG005|Overall Study|Discontinued Prior to Treatment|3|||
147290758|NCT04402866|531229774|FG000|Overall Study|Adverse Event|2|||
147290759|NCT04402866|531229775|FG001|Overall Study|Adverse Event|1|||
147290760|NCT04402866|531229776|FG002|Overall Study|Adverse Event|0|||
147290761|NCT04402866|531229777|FG003|Overall Study|Adverse Event|0|||
147290762|NCT04402866|531229778|FG004|Overall Study|Adverse Event|13|||
147290763|NCT04402866|531229779|FG005|Overall Study|Adverse Event|8|||
147290764|NCT04402866|531229774|FG000|Overall Study|Miscellaneous|0|||
147290765|NCT04402866|531229775|FG001|Overall Study|Miscellaneous|0|||
147290766|NCT04402866|531229776|FG002|Overall Study|Miscellaneous|1|||
147290767|NCT04402866|531229777|FG003|Overall Study|Miscellaneous|0|||
147290768|NCT04402866|531229778|FG004|Overall Study|Miscellaneous|0|||
147290769|NCT04402866|531229779|FG005|Overall Study|Miscellaneous|0|||
147338167|NCT01430611|531404843|FG000|Overall Study|Withdrawal by Subject|15|||
147338168|NCT01430611|531404844|FG001|Overall Study|Withdrawal by Subject|14|||
147338169|NCT02204982|531404845|FG000|Overall Study|Patient ineligible-medical monitor|1|||
147338170|NCT02204982|531404846|FG001|Overall Study|Patient ineligible-medical monitor|0|||
147290770|NCT04402866|531229774|FG000|Overall Study|Lost to Follow-up|0|||
147290771|NCT04402866|531229775|FG001|Overall Study|Lost to Follow-up|0|||
147290772|NCT04402866|531229776|FG002|Overall Study|Lost to Follow-up|0|||
147290773|NCT04402866|531229777|FG003|Overall Study|Lost to Follow-up|0|||
147290774|NCT04402866|531229778|FG004|Overall Study|Lost to Follow-up|0|||
147290775|NCT04402866|531229779|FG005|Overall Study|Lost to Follow-up|1|||
147290776|NCT04402866|531229774|FG000|Overall Study|Withdrawal by Subject|0|||
147290777|NCT04402866|531229775|FG001|Overall Study|Withdrawal by Subject|0|||
147290778|NCT04402866|531229776|FG002|Overall Study|Withdrawal by Subject|0|||
147290779|NCT04402866|531229777|FG003|Overall Study|Withdrawal by Subject|0|||
147338171|NCT02204982|531404845|FG000|Overall Study|Withdrawal by Subject|1|||
147338172|NCT02204982|531404846|FG001|Overall Study|Withdrawal by Subject|0|||
147290780|NCT04402866|531229778|FG004|Overall Study|Withdrawal by Subject|0|||
147290781|NCT04402866|531229779|FG005|Overall Study|Withdrawal by Subject|2|||
147290782|NCT03647501|531229780|FG000|Overall Study|Lost to Follow-up|1|||
147290783|NCT03647501|531229781|FG001|Overall Study|Lost to Follow-up|1|||
147290784|NCT03647501|531229780|FG000|Overall Study|Withdrawal by Subject|0|||
147290785|NCT03647501|531229781|FG001|Overall Study|Withdrawal by Subject|1|||
147290786|NCT01362140|531229790|FG000|Overall Study|Noncompliance|1|||
147290787|NCT01362140|531229791|FG001|Overall Study|Noncompliance|0|||
147290788|NCT01362140|531229790|FG000|Overall Study|Adverse Event|2|||
147290789|NCT01362140|531229791|FG001|Overall Study|Adverse Event|2|||
147290790|NCT01362140|531229790|FG000|Overall Study|Withdrawal by Subject|3|||
147290791|NCT01362140|531229791|FG001|Overall Study|Withdrawal by Subject|3|||
147290792|NCT01362140|531229790|FG000|Overall Study|Administrative Decision|0|||
147290793|NCT01362140|531229791|FG001|Overall Study|Administrative Decision|1|||
147290794|NCT01362140|531229790|FG000|Overall Study|Death|2|||
147290795|NCT01362140|531229791|FG001|Overall Study|Death|1|||
147290796|NCT01362140|531229790|FG000|Overall Study|Other|1|||
147290797|NCT01362140|531229791|FG001|Overall Study|Other|1|||
147290798|NCT01362140|531229790|FG000|Overall Study|Protocol-specified Criteria|1|||
147290799|NCT01362140|531229791|FG001|Overall Study|Protocol-specified Criteria|2|||
147290800|NCT01362140|531229790|FG000|Overall Study|Discontinued Without Receiving Treatment|0|||
147290801|NCT01362140|531229791|FG001|Overall Study|Discontinued Without Receiving Treatment|1|||
147290802|NCT00492284|531229792|FG000|Overall Study|Adverse Event|0|||
147290803|NCT00492284|531229793|FG001|Overall Study|Adverse Event|1|||
147290804|NCT00492284|531229794|FG002|Overall Study|Adverse Event|1|||
147290805|NCT00492284|531229795|FG003|Overall Study|Adverse Event|2|||
147290806|NCT00492284|531229792|FG000|Overall Study|Lost to Follow-up|0|||
147290807|NCT00492284|531229793|FG001|Overall Study|Lost to Follow-up|0|||
147290808|NCT00492284|531229794|FG002|Overall Study|Lost to Follow-up|3|||
147290809|NCT00492284|531229795|FG003|Overall Study|Lost to Follow-up|1|||
147290810|NCT00492284|531229792|FG000|Overall Study|Death|0|||
147290811|NCT00492284|531229793|FG001|Overall Study|Death|3|||
147290812|NCT00492284|531229794|FG002|Overall Study|Death|2|||
147290813|NCT00492284|531229795|FG003|Overall Study|Death|5|||
147290814|NCT00492284|531229792|FG000|Overall Study|Withdrawal by Subject|1|||
147290815|NCT00492284|531229793|FG001|Overall Study|Withdrawal by Subject|0|||
147290816|NCT00492284|531229794|FG002|Overall Study|Withdrawal by Subject|0|||
147290817|NCT00492284|531229795|FG003|Overall Study|Withdrawal by Subject|2|||
147290818|NCT01474681|531229796|FG000|Overall Study|Death|0|||
147290819|NCT01474681|531229797|FG001|Overall Study|Death|3|||
147290820|NCT01474681|531229798|FG002|Overall Study|Death|2|||
147290821|NCT01474681|531229799|FG003|Overall Study|Death|6|||
147290822|NCT02195986|531229802|FG000|Overall Study|Adverse Event|3|||
147290823|NCT02195986|531229803|FG001|Overall Study|Adverse Event|0|||
147290824|NCT02195986|531229804|FG002|Overall Study|Adverse Event|0|||
147290825|NCT02195986|531229802|FG000|Overall Study|Withdrawal by Subject|0|||
147290826|NCT02195986|531229803|FG001|Overall Study|Withdrawal by Subject|3|||
147290827|NCT02195986|531229804|FG002|Overall Study|Withdrawal by Subject|0|||
147290828|NCT02195986|531229802|FG000|Overall Study|Family Emergency|0|||
147290829|NCT02195986|531229803|FG001|Overall Study|Family Emergency|0|||
147338173|NCT02204982|531404845|FG000|Overall Study|Adverse Event|1|||
147338174|NCT02204982|531404846|FG001|Overall Study|Adverse Event|0|||
147338175|NCT02204982|531404845|FG000|Overall Study|Adverse Event and Investigator decision|1|||
147338176|NCT02204982|531404846|FG001|Overall Study|Adverse Event and Investigator decision|0|||
147338177|NCT02204982|531404845|FG000|Overall Study|Physician Decision|0|||
147338178|NCT02204982|531404846|FG001|Overall Study|Physician Decision|2|||
147338179|NCT02204982|531404845|FG000|Overall Study|Protocol-Specified Disease Progression|0|||
147338180|NCT02204982|531404846|FG001|Overall Study|Protocol-Specified Disease Progression|4|||
147338181|NCT02204982|531404845|FG000|Overall Study|Termination of Study bySponsor|0|||
147338182|NCT02204982|531404846|FG001|Overall Study|Termination of Study bySponsor|1|||
147338183|NCT01968226|531404847|FG000|Overall Study|[F-18] RDG-K5 was not available|2|||
147338184|NCT00566527|531404848|FG000|Overall Study|Reason not provided|3|||
147338185|NCT00566527|531404849|FG001|Overall Study|Reason not provided|11|||
147338186|NCT00566527|531404850|FG002|Overall Study|Reason not provided|10|||
147290830|NCT02195986|531229804|FG002|Overall Study|Family Emergency|1|||
147290831|NCT02195986|531229802|FG000|Overall Study|Protocol Violation|0|||
147290832|NCT02195986|531229803|FG001|Overall Study|Protocol Violation|1|||
147290833|NCT02195986|531229804|FG002|Overall Study|Protocol Violation|1|||
147290834|NCT02195986|531229802|FG000|Overall Study|Non-compliance|0|||
147338187|NCT00566527|531404848|FG000|Overall Study|Adverse Event|2|||
147338188|NCT00566527|531404849|FG001|Overall Study|Adverse Event|0|||
147338189|NCT00566527|531404850|FG002|Overall Study|Adverse Event|1|||
147290835|NCT02195986|531229803|FG001|Overall Study|Non-compliance|1|||
147290836|NCT02195986|531229804|FG002|Overall Study|Non-compliance|0|||
147290837|NCT00319098|531229807|FG000|Overall Study|Serious adverse event|3|||
147290838|NCT00319098|531229808|FG001|Overall Study|Serious adverse event|0|||
147290839|NCT00319098|531229807|FG000|Overall Study|Adverse Event|20|||
147290840|NCT00319098|531229808|FG001|Overall Study|Adverse Event|1|||
147338190|NCT00566527|531404848|FG000|Overall Study|Physician Decision|3|||
147338191|NCT00566527|531404849|FG001|Overall Study|Physician Decision|8|||
147338192|NCT00566527|531404850|FG002|Overall Study|Physician Decision|20|||
147290841|NCT00319098|531229807|FG000|Overall Study|Withdrawal by Subject|37|||
147290842|NCT00319098|531229808|FG001|Overall Study|Withdrawal by Subject|8|||
147290843|NCT00319098|531229807|FG000|Overall Study|Migrated/moved from study area|2|||
147290844|NCT00319098|531229808|FG001|Overall Study|Migrated/moved from study area|1|||
147290845|NCT00319098|531229807|FG000|Overall Study|Lost to Follow-up|37|||
147290846|NCT00319098|531229808|FG001|Overall Study|Lost to Follow-up|13|||
147290847|NCT00319098|531229807|FG000|Overall Study|Others|33|||
147290848|NCT00319098|531229808|FG001|Overall Study|Others|8|||
147290849|NCT00319098|531229807|FG000|Overall Study|Protocol Violation|3|||
147290850|NCT00319098|531229808|FG001|Overall Study|Protocol Violation|1|||
147290851|NCT02834780|531229809|FG000|Overall Study|Disease Progression -Radiologically Confirmed|1|||
147290852|NCT02834780|531229810|FG001|Overall Study|Disease Progression -Radiologically Confirmed|3|||
147290853|NCT02834780|531229811|FG002|Overall Study|Disease Progression -Radiologically Confirmed|2|||
147290854|NCT02834780|531229812|FG003|Overall Study|Disease Progression -Radiologically Confirmed|7|||
147290855|NCT02834780|531229813|FG004|Overall Study|Disease Progression -Radiologically Confirmed|1|||
147290856|NCT02834780|531229814|FG005|Overall Study|Disease Progression -Radiologically Confirmed|6|||
147290857|NCT02834780|531229815|FG006|Overall Study|Disease Progression -Radiologically Confirmed|2|||
147290858|NCT02834780|531229816|FG007|Overall Study|Disease Progression -Radiologically Confirmed|4|||
147290859|NCT02834780|531229817|FG008|Overall Study|Disease Progression -Radiologically Confirmed|3|||
147290860|NCT02834780|531229818|FG009|Overall Study|Disease Progression -Radiologically Confirmed|6|||
147290861|NCT02834780|531229819|FG010|Overall Study|Disease Progression -Radiologically Confirmed|3|||
147290862|NCT02834780|531229820|FG011|Overall Study|Disease Progression -Radiologically Confirmed|24|||
147290863|NCT02834780|531229821|FG012|Overall Study|Disease Progression -Radiologically Confirmed|32|||
147290864|NCT02834780|531229809|FG000|Overall Study|Withdrawal by Subject|0|||
147290865|NCT02834780|531229810|FG001|Overall Study|Withdrawal by Subject|0|||
147290866|NCT02834780|531229811|FG002|Overall Study|Withdrawal by Subject|1|||
147290867|NCT02834780|531229812|FG003|Overall Study|Withdrawal by Subject|0|||
147290868|NCT02834780|531229813|FG004|Overall Study|Withdrawal by Subject|0|||
147290869|NCT02834780|531229814|FG005|Overall Study|Withdrawal by Subject|0|||
147290870|NCT02834780|531229815|FG006|Overall Study|Withdrawal by Subject|0|||
147290871|NCT02834780|531229816|FG007|Overall Study|Withdrawal by Subject|0|||
147290872|NCT02834780|531229817|FG008|Overall Study|Withdrawal by Subject|0|||
147290873|NCT02834780|531229818|FG009|Overall Study|Withdrawal by Subject|0|||
147290874|NCT02834780|531229819|FG010|Overall Study|Withdrawal by Subject|1|||
147290875|NCT02834780|531229820|FG011|Overall Study|Withdrawal by Subject|0|||
147290876|NCT02834780|531229821|FG012|Overall Study|Withdrawal by Subject|0|||
147290877|NCT02834780|531229809|FG000|Overall Study|Adverse Event|0|||
147290878|NCT02834780|531229810|FG001|Overall Study|Adverse Event|0|||
147290879|NCT02834780|531229811|FG002|Overall Study|Adverse Event|0|||
147290880|NCT02834780|531229812|FG003|Overall Study|Adverse Event|0|||
147290881|NCT02834780|531229813|FG004|Overall Study|Adverse Event|1|||
147290882|NCT02834780|531229814|FG005|Overall Study|Adverse Event|0|||
147290883|NCT02834780|531229815|FG006|Overall Study|Adverse Event|1|||
147290884|NCT02834780|531229816|FG007|Overall Study|Adverse Event|1|||
147290885|NCT02834780|531229817|FG008|Overall Study|Adverse Event|0|||
147290886|NCT02834780|531229818|FG009|Overall Study|Adverse Event|2|||
147290887|NCT02834780|531229819|FG010|Overall Study|Adverse Event|0|||
147290888|NCT02834780|531229820|FG011|Overall Study|Adverse Event|3|||
147290889|NCT02834780|531229821|FG012|Overall Study|Adverse Event|2|||
147290890|NCT02834780|531229809|FG000|Overall Study|Disease Progression - Clinically Confirmed|1|||
147290891|NCT02834780|531229810|FG001|Overall Study|Disease Progression - Clinically Confirmed|0|||
147290892|NCT02834780|531229811|FG002|Overall Study|Disease Progression - Clinically Confirmed|0|||
147290893|NCT02834780|531229812|FG003|Overall Study|Disease Progression - Clinically Confirmed|1|||
147290894|NCT02834780|531229813|FG004|Overall Study|Disease Progression - Clinically Confirmed|1|||
147290895|NCT02834780|531229814|FG005|Overall Study|Disease Progression - Clinically Confirmed|1|||
147290896|NCT02834780|531229815|FG006|Overall Study|Disease Progression - Clinically Confirmed|1|||
147290897|NCT02834780|531229816|FG007|Overall Study|Disease Progression - Clinically Confirmed|2|||
147290898|NCT02834780|531229817|FG008|Overall Study|Disease Progression - Clinically Confirmed|0|||
147290899|NCT02834780|531229818|FG009|Overall Study|Disease Progression - Clinically Confirmed|2|||
147290900|NCT02834780|531229819|FG010|Overall Study|Disease Progression - Clinically Confirmed|1|||
147290901|NCT02834780|531229820|FG011|Overall Study|Disease Progression - Clinically Confirmed|2|||
147290902|NCT02834780|531229821|FG012|Overall Study|Disease Progression - Clinically Confirmed|5|||
147290903|NCT02834780|531229809|FG000|Overall Study|Other|1|||
147290904|NCT02834780|531229810|FG001|Overall Study|Other|0|||
147290905|NCT02834780|531229811|FG002|Overall Study|Other|1|||
147290906|NCT02834780|531229812|FG003|Overall Study|Other|2|||
147290907|NCT02834780|531229813|FG004|Overall Study|Other|0|||
147290908|NCT02834780|531229814|FG005|Overall Study|Other|0|||
147290909|NCT02834780|531229815|FG006|Overall Study|Other|0|||
147290910|NCT02834780|531229816|FG007|Overall Study|Other|0|||
147290911|NCT02834780|531229817|FG008|Overall Study|Other|0|||
147290912|NCT02834780|531229818|FG009|Overall Study|Other|0|||
147290913|NCT02834780|531229819|FG010|Overall Study|Other|0|||
147290914|NCT02834780|531229820|FG011|Overall Study|Other|0|||
147290915|NCT02834780|531229821|FG012|Overall Study|Other|1|||
147290916|NCT03150056|531229822|FG000|Overall Study|Withdrawal by Subject|0|||
147290917|NCT03150056|531229823|FG001|Overall Study|Withdrawal by Subject|0|||
147290918|NCT03150056|531229824|FG002|Overall Study|Withdrawal by Subject|0|||
147290919|NCT03150056|531229825|FG003|Overall Study|Withdrawal by Subject|0|||
147290920|NCT03150056|531229826|FG004|Overall Study|Withdrawal by Subject|0|||
147290921|NCT03150056|531229827|FG005|Overall Study|Withdrawal by Subject|2|||
147290922|NCT03150056|531229822|FG000|Overall Study|Study terminated by Sponsor|1|||
147290923|NCT03150056|531229823|FG001|Overall Study|Study terminated by Sponsor|3|||
147290924|NCT03150056|531229824|FG002|Overall Study|Study terminated by Sponsor|1|||
147290925|NCT03150056|531229825|FG003|Overall Study|Study terminated by Sponsor|1|||
147290926|NCT03150056|531229826|FG004|Overall Study|Study terminated by Sponsor|5|||
147290927|NCT03150056|531229827|FG005|Overall Study|Study terminated by Sponsor|6|||
147290928|NCT03150056|531229822|FG000|Overall Study|Death|9|||
147290929|NCT03150056|531229823|FG001|Overall Study|Death|2|||
147290930|NCT03150056|531229824|FG002|Overall Study|Death|2|||
147290931|NCT03150056|531229825|FG003|Overall Study|Death|7|||
147290932|NCT03150056|531229826|FG004|Overall Study|Death|8|||
147290933|NCT03150056|531229827|FG005|Overall Study|Death|10|||
147290934|NCT02415400|531229828|FG000|Overall Study|Adverse Event|0|||
147290935|NCT02415400|531229829|FG001|Overall Study|Adverse Event|1|||
147290936|NCT02415400|531229830|FG002|Overall Study|Adverse Event|1|||
147290937|NCT02415400|531229831|FG003|Overall Study|Adverse Event|2|||
147290938|NCT02415400|531229828|FG000|Overall Study|Participant request to stop therapy|4|||
147290939|NCT02415400|531229829|FG001|Overall Study|Participant request to stop therapy|3|||
147290940|NCT02415400|531229830|FG002|Overall Study|Participant request to stop therapy|8|||
147290941|NCT02415400|531229831|FG003|Overall Study|Participant request to stop therapy|6|||
147290942|NCT02415400|531229828|FG000|Overall Study|Participant withdrew consent|14|||
147452605|NCT02469090|531820006|FG001|Period 1: Dose Titration Phase|Withdrawal by Subject|0|||
147452606|NCT02469090|531820007|FG002|Period 1: Dose Titration Phase|Withdrawal by Subject|0|||
147452607|NCT02469090|531820005|FG000|Period 1: Dose Titration Phase|Lost to Follow-up|1|||
147452608|NCT02469090|531820006|FG001|Period 1: Dose Titration Phase|Lost to Follow-up|0|||
147452609|NCT02469090|531820007|FG002|Period 1: Dose Titration Phase|Lost to Follow-up|0|||
147452610|NCT02469090|531820005|FG000|Period 1: Dose Titration Phase|Lack of Efficacy|11|||
147452611|NCT02469090|531820006|FG001|Period 1: Dose Titration Phase|Lack of Efficacy|0|||
147452612|NCT02469090|531820007|FG002|Period 1: Dose Titration Phase|Lack of Efficacy|0|||
147452613|NCT02469090|531820005|FG000|Period 2: Maintenance Treatment Phase|Adverse Event|0|||
147452614|NCT02469090|531820006|FG001|Period 2: Maintenance Treatment Phase|Adverse Event|5|||
147452615|NCT02469090|531820007|FG002|Period 2: Maintenance Treatment Phase|Adverse Event|15|||
147452616|NCT02469090|531820005|FG000|Period 2: Maintenance Treatment Phase|Withdrawal by Subject|0|||
147452617|NCT02469090|531820006|FG001|Period 2: Maintenance Treatment Phase|Withdrawal by Subject|3|||
147452618|NCT02469090|531820007|FG002|Period 2: Maintenance Treatment Phase|Withdrawal by Subject|4|||
147452619|NCT02469090|531820005|FG000|Period 2: Maintenance Treatment Phase|Lack of Efficacy|0|||
147452620|NCT02469090|531820006|FG001|Period 2: Maintenance Treatment Phase|Lack of Efficacy|1|||
147452621|NCT02469090|531820007|FG002|Period 2: Maintenance Treatment Phase|Lack of Efficacy|0|||
147452622|NCT02469090|531820005|FG000|Period 2: Maintenance Treatment Phase|Death|0|||
147452623|NCT02469090|531820006|FG001|Period 2: Maintenance Treatment Phase|Death|0|||
147452624|NCT02469090|531820007|FG002|Period 2: Maintenance Treatment Phase|Death|1|||
147452625|NCT03823391|531820011|FG000|Period 2: Weeks 12 to Week 24|Adverse Event|1|||
147452626|NCT03823391|531820012|FG001|Period 2: Weeks 12 to Week 24|Adverse Event|1|||
147452627|NCT03823391|531820011|FG000|Period 2: Weeks 12 to Week 24|Withdrawal by Subject|1|||
147452628|NCT03823391|531820012|FG001|Period 2: Weeks 12 to Week 24|Withdrawal by Subject|0|||
147452629|NCT05882318|531820018|FG000|Overall Study|Withdrawal by Subject|1|||
147452630|NCT05882318|531820019|FG001|Overall Study|Withdrawal by Subject|0|||
147452631|NCT05882318|531820018|FG000|Overall Study|Protocol Violation|0|||
147452632|NCT05882318|531820019|FG001|Overall Study|Protocol Violation|1|||
147452633|NCT05030311|531820022|FG000|Overall Study|Technical problems|0|||
147452634|NCT05030311|531820023|FG001|Overall Study|Technical problems|1|||
147452635|NCT05030311|531820022|FG000|Overall Study|Withdrawal by Subject|31|||
147290943|NCT02415400|531229829|FG001|Overall Study|Participant withdrew consent|12|||
147290944|NCT02415400|531229830|FG002|Overall Study|Participant withdrew consent|30|||
147290945|NCT02415400|531229831|FG003|Overall Study|Participant withdrew consent|21|||
147290946|NCT02415400|531229828|FG000|Overall Study|Death|39|||
147290947|NCT02415400|531229829|FG001|Overall Study|Death|41|||
147290948|NCT02415400|531229830|FG002|Overall Study|Death|35|||
147290949|NCT02415400|531229831|FG003|Overall Study|Death|42|||
147452636|NCT05030311|531820023|FG001|Overall Study|Withdrawal by Subject|17|||
147290950|NCT02415400|531229828|FG000|Overall Study|Lost to Follow-up|3|||
147290951|NCT02415400|531229829|FG001|Overall Study|Lost to Follow-up|3|||
147452637|NCT05030311|531820022|FG000|Overall Study|Adverse Event|13|||
147452638|NCT05030311|531820023|FG001|Overall Study|Adverse Event|5|||
147452639|NCT05030311|531820022|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
147290952|NCT02415400|531229830|FG002|Overall Study|Lost to Follow-up|2|||
147290953|NCT02415400|531229831|FG003|Overall Study|Lost to Follow-up|5|||
147290954|NCT02415400|531229828|FG000|Overall Study|Poor/Non-Compliance|0|||
147290955|NCT02415400|531229829|FG001|Overall Study|Poor/Non-Compliance|1|||
147290956|NCT02415400|531229830|FG002|Overall Study|Poor/Non-Compliance|3|||
147290957|NCT02415400|531229831|FG003|Overall Study|Poor/Non-Compliance|4|||
147290958|NCT02415400|531229828|FG000|Overall Study|Participant no longer meets criteria|2|||
147290959|NCT02415400|531229829|FG001|Overall Study|Participant no longer meets criteria|0|||
147290960|NCT02415400|531229830|FG002|Overall Study|Participant no longer meets criteria|0|||
147290961|NCT02415400|531229831|FG003|Overall Study|Participant no longer meets criteria|1|||
147290962|NCT02415400|531229828|FG000|Overall Study|Participant doesn't answer phone|1|||
147290963|NCT02415400|531229829|FG001|Overall Study|Participant doesn't answer phone|0|||
147290964|NCT02415400|531229830|FG002|Overall Study|Participant doesn't answer phone|0|||
147290965|NCT02415400|531229831|FG003|Overall Study|Participant doesn't answer phone|0|||
147290966|NCT02415400|531229828|FG000|Overall Study|Participant wanted home visits|1|||
147290967|NCT02415400|531229829|FG001|Overall Study|Participant wanted home visits|0|||
147290968|NCT02415400|531229830|FG002|Overall Study|Participant wanted home visits|0|||
147290969|NCT02415400|531229831|FG003|Overall Study|Participant wanted home visits|0|||
147290970|NCT02415400|531229828|FG000|Overall Study|Randomized in error|2|||
147290971|NCT02415400|531229829|FG001|Overall Study|Randomized in error|0|||
147290972|NCT02415400|531229830|FG002|Overall Study|Randomized in error|0|||
147290973|NCT02415400|531229831|FG003|Overall Study|Randomized in error|0|||
147290974|NCT02415400|531229828|FG000|Overall Study|No study drug on site|0|||
147290975|NCT02415400|531229829|FG001|Overall Study|No study drug on site|1|||
147290976|NCT02415400|531229830|FG002|Overall Study|No study drug on site|0|||
147290977|NCT02415400|531229831|FG003|Overall Study|No study drug on site|0|||
147290978|NCT02415400|531229828|FG000|Overall Study|Stroke and stroke rehabilitation|0|||
147290979|NCT02415400|531229829|FG001|Overall Study|Stroke and stroke rehabilitation|0|||
147290980|NCT02415400|531229830|FG002|Overall Study|Stroke and stroke rehabilitation|1|||
147290981|NCT02415400|531229831|FG003|Overall Study|Stroke and stroke rehabilitation|0|||
147290982|NCT02415400|531229828|FG000|Overall Study|Coagulation values cannot be set|0|||
147290983|NCT02415400|531229829|FG001|Overall Study|Coagulation values cannot be set|0|||
147290984|NCT02415400|531229830|FG002|Overall Study|Coagulation values cannot be set|1|||
147290985|NCT02415400|531229831|FG003|Overall Study|Coagulation values cannot be set|0|||
147290986|NCT02415400|531229828|FG000|Overall Study|State regulations prevent participation|0|||
147290987|NCT02415400|531229829|FG001|Overall Study|State regulations prevent participation|0|||
147290988|NCT02415400|531229830|FG002|Overall Study|State regulations prevent participation|1|||
147290989|NCT02415400|531229831|FG003|Overall Study|State regulations prevent participation|0|||
147290990|NCT02415400|531229828|FG000|Overall Study|Poor treatment monitoring|0|||
147290991|NCT02415400|531229829|FG001|Overall Study|Poor treatment monitoring|0|||
147290992|NCT02415400|531229830|FG002|Overall Study|Poor treatment monitoring|1|||
147290993|NCT02415400|531229831|FG003|Overall Study|Poor treatment monitoring|0|||
147290994|NCT02415400|531229828|FG000|Overall Study|Participant in jail|0|||
147290995|NCT02415400|531229829|FG001|Overall Study|Participant in jail|0|||
147290996|NCT02415400|531229830|FG002|Overall Study|Participant in jail|1|||
147338193|NCT00566527|531404848|FG000|Overall Study|Lost to Follow-up|3|||
147338194|NCT00566527|531404849|FG001|Overall Study|Lost to Follow-up|4|||
147338195|NCT00566527|531404850|FG002|Overall Study|Lost to Follow-up|4|||
147338196|NCT00566527|531404848|FG000|Overall Study|Withdrawal by Subject|6|||
147338197|NCT00566527|531404849|FG001|Overall Study|Withdrawal by Subject|43|||
147338198|NCT00566527|531404850|FG002|Overall Study|Withdrawal by Subject|43|||
147338199|NCT00457743|531404851|FG000|Overall Study|Adverse Event|0|||
147338200|NCT00457743|531404852|FG001|Overall Study|Adverse Event|4|||
147338201|NCT00457743|531404853|FG002|Overall Study|Adverse Event|0|||
147338202|NCT00457743|531404851|FG000|Overall Study|Lack of Efficacy|3|||
147338203|NCT00457743|531404852|FG001|Overall Study|Lack of Efficacy|23|||
147338204|NCT00457743|531404853|FG002|Overall Study|Lack of Efficacy|3|||
147338205|NCT02261467|531404854|FG000|Overall Study|Enrolled in Error|1|||
147338206|NCT02261467|531404855|FG001|Overall Study|Enrolled in Error|0|||
147338207|NCT02261467|531404854|FG000|Overall Study|Protocol Violation|0|||
147338208|NCT02261467|531404855|FG001|Overall Study|Protocol Violation|1|||
147338209|NCT02261467|531404854|FG000|Overall Study|Personal Reasons|17|||
147338210|NCT02261467|531404855|FG001|Overall Study|Personal Reasons|22|||
147290997|NCT02415400|531229831|FG003|Overall Study|Participant in jail|0|||
147290998|NCT02415400|531229828|FG000|Overall Study|Investigator decision|0|||
147290999|NCT02415400|531229829|FG001|Overall Study|Investigator decision|0|||
147291000|NCT02415400|531229830|FG002|Overall Study|Investigator decision|1|||
147291001|NCT02415400|531229831|FG003|Overall Study|Investigator decision|1|||
147291002|NCT02415400|531229828|FG000|Overall Study|Site closure; participant won't transfer|0|||
147291003|NCT02415400|531229829|FG001|Overall Study|Site closure; participant won't transfer|0|||
147291004|NCT02415400|531229830|FG002|Overall Study|Site closure; participant won't transfer|0|||
147291005|NCT02415400|531229831|FG003|Overall Study|Site closure; participant won't transfer|1|||
147291006|NCT02270450|531229836|FG000|Overall Study|Refusal unrelated to adverse event|3|||
147338211|NCT02261467|531404854|FG000|Overall Study|Lost to Follow-up|2|||
147338212|NCT02261467|531404855|FG001|Overall Study|Lost to Follow-up|13|||
147338213|NCT02261467|531404854|FG000|Overall Study|Adverse Event|1|||
147338214|NCT02261467|531404855|FG001|Overall Study|Adverse Event|1|||
147452640|NCT05030311|531820023|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
147452641|NCT05030311|531820022|FG000|Overall Study|Physician Decision|5|||
147452642|NCT05030311|531820023|FG001|Overall Study|Physician Decision|2|||
147452643|NCT05030311|531820022|FG000|Overall Study|Lost to Follow-up|5|||
147452644|NCT05030311|531820023|FG001|Overall Study|Lost to Follow-up|1|||
147452645|NCT05030311|531820022|FG000|Overall Study|Protocol Violation|4|||
147452646|NCT05030311|531820023|FG001|Overall Study|Protocol Violation|4|||
147452647|NCT03042468|531820024|FG000|Overall Study|Death|0|||
147604340|NCT02329847|532367879|FG003|Overall Study|Lost to Follow-up|3|||
147604341|NCT02329847|532367880|FG004|Overall Study|Lost to Follow-up|0|||
147604342|NCT02329847|532367881|FG005|Overall Study|Lost to Follow-up|1|||
147604343|NCT02329847|532367876|FG000|Overall Study|Physician Decision|0|||
147291007|NCT02270450|531229837|FG001|Overall Study|Refusal unrelated to adverse event|1|||
147291008|NCT02270450|531229838|FG002|Overall Study|Refusal unrelated to adverse event|5|||
147291009|NCT02270450|531229839|FG003|Overall Study|Refusal unrelated to adverse event|14|||
147291010|NCT02270450|531229836|FG000|Overall Study|Progression/relapse|1|||
147291011|NCT02270450|531229837|FG001|Overall Study|Progression/relapse|2|||
147291012|NCT02270450|531229838|FG002|Overall Study|Progression/relapse|4|||
147291013|NCT02270450|531229839|FG003|Overall Study|Progression/relapse|9|||
147291014|NCT02270450|531229836|FG000|Overall Study|Death|19|||
147291015|NCT02270450|531229837|FG001|Overall Study|Death|19|||
147291016|NCT02270450|531229838|FG002|Overall Study|Death|31|||
147291017|NCT02270450|531229839|FG003|Overall Study|Death|59|||
147291018|NCT01392560|531229844|FG000|Overall Study|Adverse Event|2|||
147291019|NCT01392560|531229844|FG000|Overall Study|not entered|8|||
147291020|NCT01392560|531229844|FG000|Overall Study|discontinued during placebo run-in|2|||
147291021|NCT02081846|531229845|FG000|Overall Study|Withdrawal by Subject|1|||
147291022|NCT02081846|531229846|FG001|Overall Study|Withdrawal by Subject|0|||
147604344|NCT02329847|532367877|FG001|Overall Study|Physician Decision|0|||
147604345|NCT02329847|532367878|FG002|Overall Study|Physician Decision|0|||
147291023|NCT02081846|531229845|FG000|Overall Study|invalid consent|1|||
147291024|NCT02081846|531229846|FG001|Overall Study|invalid consent|0|||
147291025|NCT03282227|531229847|FG000|Overall Study|Exposure Goals Achieved|60|||
147291026|NCT03282227|531229847|FG000|Overall Study|Non-compliance w/ protocol requirements|79|||
147291027|NCT03282227|531229847|FG000|Overall Study|Adverse Event|15|||
147291028|NCT03282227|531229847|FG000|Overall Study|Lost to Follow-up|21|||
147291029|NCT03282227|531229847|FG000|Overall Study|Withdrawal by Subject|20|||
147291030|NCT03282227|531229847|FG000|Overall Study|Lack of Efficacy|12|||
147291031|NCT03282227|531229847|FG000|Overall Study|Sponsor decision|3|||
147291032|NCT03282227|531229847|FG000|Overall Study|Physician Decision|2|||
147291033|NCT03282227|531229847|FG000|Overall Study|Pregnancy|2|||
147291034|NCT03282227|531229847|FG000|Overall Study|Other|1|||
147291035|NCT02491671|531229853|FG000|Overall Study|Adverse Event|6|||
147291036|NCT02491671|531229854|FG001|Overall Study|Adverse Event|8|||
147291037|NCT02491671|531229853|FG000|Overall Study|Death|0|||
147291038|NCT02491671|531229854|FG001|Overall Study|Death|2|||
147291039|NCT02491671|531229853|FG000|Overall Study|Use of sealants other than Hemopatch|5|||
147291040|NCT02491671|531229854|FG001|Overall Study|Use of sealants other than Hemopatch|3|||
147291041|NCT02251990|531229855|FG000|Period 1 (Double-blind [DB])|Adverse Event|1|||
147291042|NCT02251990|531229856|FG001|Period 1 (Double-blind [DB])|Adverse Event|1|||
147291043|NCT02251990|531229855|FG000|Period 1 (Double-blind [DB])|Lack of Efficacy|5|||
147291044|NCT02251990|531229856|FG001|Period 1 (Double-blind [DB])|Lack of Efficacy|0|||
147291045|NCT02251990|531229855|FG000|Period 1 (Double-blind [DB])|Withdrawal by Subject|1|||
147291046|NCT02251990|531229856|FG001|Period 1 (Double-blind [DB])|Withdrawal by Subject|0|||
147291047|NCT02251990|531229855|FG000|Period 1 (Double-blind [DB])|Not Treated|1|||
147604346|NCT02329847|532367879|FG003|Overall Study|Physician Decision|0|||
147604347|NCT02329847|532367880|FG004|Overall Study|Physician Decision|1|||
147604348|NCT02329847|532367881|FG005|Overall Study|Physician Decision|0|||
147291048|NCT02251990|531229856|FG001|Period 1 (Double-blind [DB])|Not Treated|0|||
147291049|NCT02251990|531229855|FG000|Period 2 (ITG Follow-up/DTG Open Label)|Lack of Efficacy|0|||
147291050|NCT02251990|531229856|FG001|Period 2 (ITG Follow-up/DTG Open Label)|Lack of Efficacy|1|||
147291051|NCT02251990|531229855|FG000|Period 2 (ITG Follow-up/DTG Open Label)|Adverse Event|0|||
147291052|NCT02251990|531229856|FG001|Period 2 (ITG Follow-up/DTG Open Label)|Adverse Event|2|||
147291053|NCT03265600|531229857|FG000|Overall Study|Lost to Follow-up|17|||
147291054|NCT03265600|531229858|FG001|Overall Study|Lost to Follow-up|5|||
147452648|NCT03042468|531820025|FG001|Overall Study|Death|1|||
147604349|NCT02329847|532367876|FG000|Overall Study|Withdrawal by Subject|2|||
147291055|NCT03265600|531229857|FG000|Overall Study|Withdrawal by Subject|4|||
147291056|NCT03265600|531229858|FG001|Overall Study|Withdrawal by Subject|2|||
147291057|NCT03265600|531229857|FG000|Overall Study|Partially completed 8 wk or 24 wk survey|3|||
147291058|NCT03265600|531229858|FG001|Overall Study|Partially completed 8 wk or 24 wk survey|5|||
147291059|NCT00535730|531229859|FG000|Overall Study|Adverse Event|1|||
147291060|NCT00535730|531229860|FG001|Overall Study|Adverse Event|1|||
147452649|NCT03042468|531820026|FG002|Overall Study|Death|1|||
147291061|NCT00535730|531229859|FG000|Overall Study|Lost to Follow-up|0|||
147452650|NCT03042468|531820027|FG003|Overall Study|Death|0|||
147604350|NCT02329847|532367877|FG001|Overall Study|Withdrawal by Subject|1|||
147604351|NCT02329847|532367878|FG002|Overall Study|Withdrawal by Subject|5|||
147604352|NCT02329847|532367879|FG003|Overall Study|Withdrawal by Subject|7|||
147604353|NCT02329847|532367880|FG004|Overall Study|Withdrawal by Subject|8|||
147604354|NCT02329847|532367881|FG005|Overall Study|Withdrawal by Subject|3|||
147604355|NCT02329847|532367876|FG000|Overall Study|Other|1|||
147604356|NCT02329847|532367877|FG001|Overall Study|Other|2|||
147291062|NCT00535730|531229860|FG001|Overall Study|Lost to Follow-up|1|||
147291063|NCT00535730|531229859|FG000|Overall Study|Physician Decision|0|||
147291064|NCT00535730|531229860|FG001|Overall Study|Physician Decision|1|||
147291065|NCT00535730|531229859|FG000|Overall Study|Protocol Violation|1|||
147291066|NCT00535730|531229860|FG001|Overall Study|Protocol Violation|0|||
147291067|NCT00535730|531229859|FG000|Overall Study|Withdrawal by Subject|0|||
147291068|NCT00535730|531229860|FG001|Overall Study|Withdrawal by Subject|4|||
147291069|NCT02293538|531229861|FG000|Overall Study|Adverse Event|0|||
147291070|NCT02293538|531229862|FG001|Overall Study|Adverse Event|1|||
147291071|NCT02293538|531229861|FG000|Overall Study|Lost to Follow-up|1|||
147291072|NCT02293538|531229862|FG001|Overall Study|Lost to Follow-up|0|||
147291073|NCT02293538|531229861|FG000|Overall Study|Withdrawal by Subject|0|||
147291074|NCT02293538|531229862|FG001|Overall Study|Withdrawal by Subject|1|||
147291075|NCT00936858|531229865|FG000|Overall Study|Death|3|||
147291076|NCT00936858|531229865|FG000|Overall Study|Progression|29|||
147291077|NCT00936858|531229865|FG000|Overall Study|Withdrawal by Subject|5|||
147291078|NCT00936858|531229865|FG000|Overall Study|Adverse Event|1|||
147291079|NCT00936858|531229865|FG000|Overall Study|Physician Decision|7|||
147291080|NCT00936858|531229865|FG000|Overall Study|Still on protocol treatment/ No documentation to say off protocol treatment|4|||
147291081|NCT00936858|531229865|FG000|Overall Study|Lost to Follow-up|1|||
147291082|NCT00584727|531229873|FG000|First Intervention|Discontinuation|0|||
147291083|NCT00584727|531229874|FG001|First Intervention|Discontinuation|0|||
147291084|NCT00584727|531229875|FG002|First Intervention|Discontinuation|1|||
147291085|NCT00584727|531229876|FG003|First Intervention|Discontinuation|0|||
147291086|NCT00584727|531229877|FG004|First Intervention|Discontinuation|0|||
147291087|NCT00584727|531229878|FG005|First Intervention|Discontinuation|0|||
147291088|NCT00584727|531229873|FG000|Third Intervention|Protocol Violation|0|||
147291089|NCT00584727|531229874|FG001|Third Intervention|Protocol Violation|0|||
147291090|NCT00584727|531229875|FG002|Third Intervention|Protocol Violation|1|||
147291091|NCT00584727|531229876|FG003|Third Intervention|Protocol Violation|0|||
147291092|NCT00584727|531229877|FG004|Third Intervention|Protocol Violation|4|||
147291093|NCT00584727|531229878|FG005|Third Intervention|Protocol Violation|2|||
147291094|NCT00729833|531229881|FG000|Overall Study|Death|5|||
147291095|NCT00729833|531229882|FG001|Overall Study|Death|1|||
147291096|NCT00729833|531229883|FG002|Overall Study|Death|3|||
147291097|NCT00729833|531229884|FG003|Overall Study|Death|5|||
147291098|NCT00729833|531229881|FG000|Overall Study|Study Terminated by Sponsor|0|||
147291099|NCT00729833|531229882|FG001|Overall Study|Study Terminated by Sponsor|0|||
147291100|NCT00729833|531229883|FG002|Overall Study|Study Terminated by Sponsor|1|||
147291101|NCT00729833|531229884|FG003|Overall Study|Study Terminated by Sponsor|0|||
147291102|NCT00729833|531229881|FG000|Overall Study|Lost to Follow-up|1|||
147291103|NCT00729833|531229882|FG001|Overall Study|Lost to Follow-up|0|||
147291104|NCT00729833|531229883|FG002|Overall Study|Lost to Follow-up|0|||
147291105|NCT00729833|531229884|FG003|Overall Study|Lost to Follow-up|0|||
147291106|NCT00729833|531229881|FG000|Overall Study|Withdrawal by Subject|3|||
147291107|NCT00729833|531229882|FG001|Overall Study|Withdrawal by Subject|1|||
147291108|NCT00729833|531229883|FG002|Overall Study|Withdrawal by Subject|3|||
147291109|NCT00729833|531229884|FG003|Overall Study|Withdrawal by Subject|0|||
147291110|NCT00729833|531229881|FG000|Overall Study|Unspecified Reasons|11|||
147291111|NCT00729833|531229882|FG001|Overall Study|Unspecified Reasons|5|||
147291112|NCT00729833|531229883|FG002|Overall Study|Unspecified Reasons|5|||
147291113|NCT00729833|531229884|FG003|Overall Study|Unspecified Reasons|1|||
147291114|NCT00092131|531229885|FG000|Treatment Period I|Adverse Event|1|||
147291115|NCT00092131|531229886|FG001|Treatment Period I|Adverse Event|0|||
147291116|NCT00092131|531229885|FG000|Treatment Period II|Adverse Event|0|||
147291117|NCT00092131|531229886|FG001|Treatment Period II|Adverse Event|1|||
147291118|NCT02341417|531229887|FG000|Overall Study|Withdrawal by Subject|0|||
147291119|NCT02341417|531229888|FG001|Overall Study|Withdrawal by Subject|2|||
147291120|NCT02341417|531229889|FG002|Overall Study|Withdrawal by Subject|0|||
147291121|NCT02341417|531229887|FG000|Overall Study|Decision by sponsor|2|||
147291122|NCT02341417|531229888|FG001|Overall Study|Decision by sponsor|0|||
147291123|NCT02341417|531229889|FG002|Overall Study|Decision by sponsor|0|||
147291124|NCT02341417|531229887|FG000|Overall Study|Death|0|||
147291125|NCT02341417|531229888|FG001|Overall Study|Death|0|||
147291126|NCT02341417|531229889|FG002|Overall Study|Death|1|||
147291127|NCT02820623|531229890|FG000|Overall Study|Withdrawal by Subject|1|||
147291128|NCT02820623|531229891|FG001|Overall Study|Withdrawal by Subject|3|||
147291129|NCT02820623|531229892|FG002|Overall Study|Withdrawal by Subject|3|||
147291130|NCT02820623|531229890|FG000|Overall Study|Participation interrupted due to COVID-19|3|||
147291131|NCT02820623|531229891|FG001|Overall Study|Participation interrupted due to COVID-19|3|||
147452651|NCT03042468|531820028|FG004|Overall Study|Death|0|||
147604357|NCT02329847|532367878|FG002|Overall Study|Other|6|||
147291132|NCT02820623|531229892|FG002|Overall Study|Participation interrupted due to COVID-19|2|||
147291133|NCT02820623|531229890|FG000|Overall Study|Therapist unable to enroll clients|1|||
147291134|NCT02820623|531229891|FG001|Overall Study|Therapist unable to enroll clients|1|||
147291135|NCT02820623|531229892|FG002|Overall Study|Therapist unable to enroll clients|3|||
147291136|NCT02820623|531229890|FG000|Overall Study|Clients declined, piloting condition, or only telehealth|0|||
147291137|NCT02820623|531229891|FG001|Overall Study|Clients declined, piloting condition, or only telehealth|0|||
147291138|NCT02820623|531229892|FG002|Overall Study|Clients declined, piloting condition, or only telehealth|3|||
147291139|NCT04598152|531229902|FG000|Overall Study|Lost to Follow-up|0|||
147291140|NCT04598152|531229903|FG001|Overall Study|Lost to Follow-up|1|||
147291141|NCT03674177|531229904|FG000|Overall Study|Lost to Follow-up|2|||
147291142|NCT03674177|531229905|FG001|Overall Study|Lost to Follow-up|1|||
147338215|NCT00794118|531404858|FG000|Overall Study|Lost to Follow-up|16|||
147338216|NCT00794118|531404858|FG000|Overall Study|Withdrawal by Subject|9|||
147338217|NCT00794118|531404858|FG000|Overall Study|Changed hospital center|2|||
147338218|NCT01597258|531404864|FG000|Overall Study|No Drug Administration|1|||
147338219|NCT00933400|531404865|FG000|Overall Study|Withdrawal by Subject|21|||
147338220|NCT00933400|531404866|FG001|Overall Study|Withdrawal by Subject|1|||
147338221|NCT01415349|531404867|FG000|Treatment Period 1|Adverse Event|0|||
147338222|NCT01415349|531404868|FG001|Treatment Period 1|Adverse Event|1|||
147338223|NCT01415349|531404867|FG000|Treatment Period 1|Withdrawal by Subject|0|||
147338224|NCT01415349|531404868|FG001|Treatment Period 1|Withdrawal by Subject|1|||
147338225|NCT01764464|531404869|FG000|First Intervention|Withdrawal by Subject|1|||
147338226|NCT01764464|531404870|FG001|First Intervention|Withdrawal by Subject|0|||
147338227|NCT01764464|531404869|FG000|First Intervention|Lost to Follow-up|1|||
147338228|NCT01764464|531404870|FG001|First Intervention|Lost to Follow-up|0|||
147338229|NCT01764464|531404869|FG000|First Intervention|Adverse Event|0|||
147338230|NCT01764464|531404870|FG001|First Intervention|Adverse Event|2|||
147338231|NCT01764464|531404869|FG000|First Intervention|did not receive study drug|0|||
147338232|NCT01764464|531404870|FG001|First Intervention|did not receive study drug|1|||
147338233|NCT01764464|531404869|FG000|Second Intervention (Cross-over)|Adverse Event|2|||
147338234|NCT01764464|531404870|FG001|Second Intervention (Cross-over)|Adverse Event|0|||
147338235|NCT02079844|531404871|FG000|Treatment Period 1|Voluntary Withdrawal|0|||
147338236|NCT02079844|531404872|FG001|Treatment Period 1|Voluntary Withdrawal|0|||
147338237|NCT02079844|531404873|FG002|Treatment Period 1|Voluntary Withdrawal|2|||
147338238|NCT02079844|531404871|FG000|Treatment Period 2|Voluntary Withdrawal|0|||
147338239|NCT02079844|531404872|FG001|Treatment Period 2|Voluntary Withdrawal|1|||
147338240|NCT02079844|531404873|FG002|Treatment Period 2|Voluntary Withdrawal|0|||
147338241|NCT02531113|531404878|FG000|Induction Period: Week 0 to 12|Adverse Event|4|||
147338242|NCT02531113|531404878|FG000|Induction Period: Week 0 to 12|Lack of Efficacy|4|||
147338243|NCT02531113|531404878|FG000|Induction Period: Week 0 to 12|Withdrawal by Subject|3|||
147338244|NCT02531113|531404878|FG000|Extension Period: Week 12 up to Week 160|Physician Decision|2|||
147338245|NCT02531113|531404878|FG000|Extension Period: Week 12 up to Week 160|Adverse Event|5|||
147338246|NCT02531113|531404878|FG000|Extension Period: Week 12 up to Week 160|Lack of Efficacy|19|||
147338247|NCT02531113|531404878|FG000|Extension Period: Week 12 up to Week 160|Withdrawal by Subject|11|||
147338248|NCT02531113|531404878|FG000|Extension Period: Week 12 up to Week 160|Pregnancy|1|||
147338249|NCT05262738|531406984|FG000|Overall Study|Withdrawal by Subject|1|||
147338250|NCT05262738|531406985|FG001|Overall Study|Withdrawal by Subject|0|||
147338251|NCT02374463|531406986|FG000|Overall Study|Withdrawal by Subject|3|||
147338252|NCT02374463|531406987|FG001|Overall Study|Withdrawal by Subject|3|||
147338253|NCT00774397|531406995|FG000|Overall Study|Adverse Event|1|||
147338254|NCT00774397|531406996|FG001|Overall Study|Adverse Event|3|||
147338255|NCT00774397|531406997|FG002|Overall Study|Adverse Event|16|||
147338256|NCT00774397|531406998|FG003|Overall Study|Adverse Event|8|||
147338257|NCT00774397|531406999|FG004|Overall Study|Adverse Event|8|||
147338258|NCT00774397|531407000|FG005|Overall Study|Adverse Event|3|||
147338259|NCT00774397|531407001|FG006|Overall Study|Adverse Event|16|||
147338260|NCT00774397|531406995|FG000|Overall Study|Lack of Efficacy|11|||
147452652|NCT03042468|531820029|FG005|Overall Study|Death|0|||
147452653|NCT03042468|531820024|FG000|Overall Study|Withdrawal by Subject|0|||
147452654|NCT03042468|531820025|FG001|Overall Study|Withdrawal by Subject|0|||
147452655|NCT03042468|531820026|FG002|Overall Study|Withdrawal by Subject|0|||
147452656|NCT03042468|531820027|FG003|Overall Study|Withdrawal by Subject|0|||
147452657|NCT03042468|531820028|FG004|Overall Study|Withdrawal by Subject|0|||
147291143|NCT03674177|531229906|FG002|Overall Study|Lost to Follow-up|0|||
147338261|NCT00774397|531406996|FG001|Overall Study|Lack of Efficacy|4|||
147338262|NCT00774397|531406997|FG002|Overall Study|Lack of Efficacy|5|||
147338263|NCT00774397|531406998|FG003|Overall Study|Lack of Efficacy|3|||
147338264|NCT00774397|531406999|FG004|Overall Study|Lack of Efficacy|27|||
147338265|NCT00774397|531407000|FG005|Overall Study|Lack of Efficacy|15|||
147338266|NCT00774397|531407001|FG006|Overall Study|Lack of Efficacy|9|||
147338267|NCT00774397|531406995|FG000|Overall Study|Protocol Violation|0|||
147338268|NCT00774397|531406996|FG001|Overall Study|Protocol Violation|1|||
147452658|NCT03042468|531820029|FG005|Overall Study|Withdrawal by Subject|1|||
147291144|NCT03674177|531229907|FG003|Overall Study|Lost to Follow-up|2|||
147291145|NCT00714168|531229908|FG000|Overall Study|Pregnancy|5|||
147291146|NCT00714168|531229909|FG001|Overall Study|Pregnancy|4|||
147291147|NCT00714168|531229908|FG000|Overall Study|Lost to Follow-up|32|||
147291148|NCT00714168|531229909|FG001|Overall Study|Lost to Follow-up|50|||
147291149|NCT00714168|531229908|FG000|Overall Study|Relocation|4|||
147291150|NCT00714168|531229909|FG001|Overall Study|Relocation|3|||
147291151|NCT00714168|531229908|FG000|Overall Study|Non-study medical condition|3|||
147291152|NCT00714168|531229909|FG001|Overall Study|Non-study medical condition|2|||
147291153|NCT04988308|531229910|FG000|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|2|||
147291154|NCT04988308|531229911|FG001|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|4|||
147291155|NCT04988308|531229912|FG002|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|4|||
147291156|NCT04988308|531229913|FG003|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
147291157|NCT04988308|531229914|FG004|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
147291158|NCT04988308|531229915|FG005|Placebo Controlled Period (Weeks 0-16)|Withdrawal by Subject|0|||
147291159|NCT04988308|531229910|FG000|Placebo Controlled Period (Weeks 0-16)|Death|0|||
147291160|NCT04988308|531229911|FG001|Placebo Controlled Period (Weeks 0-16)|Death|0|||
147291161|NCT04988308|531229912|FG002|Placebo Controlled Period (Weeks 0-16)|Death|1|||
147291162|NCT04988308|531229913|FG003|Placebo Controlled Period (Weeks 0-16)|Death|0|||
147291163|NCT04988308|531229914|FG004|Placebo Controlled Period (Weeks 0-16)|Death|0|||
147291164|NCT04988308|531229915|FG005|Placebo Controlled Period (Weeks 0-16)|Death|0|||
147291165|NCT04988308|531229910|FG000|Placebo Controlled Period (Weeks 0-16)|Lost to Follow-up|4|||
147291166|NCT04988308|531229911|FG001|Placebo Controlled Period (Weeks 0-16)|Lost to Follow-up|4|||
147291167|NCT04988308|531229912|FG002|Placebo Controlled Period (Weeks 0-16)|Lost to Follow-up|0|||
147291168|NCT04988308|531229913|FG003|Placebo Controlled Period (Weeks 0-16)|Lost to Follow-up|0|||
147291169|NCT04988308|531229914|FG004|Placebo Controlled Period (Weeks 0-16)|Lost to Follow-up|0|||
147291170|NCT04988308|531229915|FG005|Placebo Controlled Period (Weeks 0-16)|Lost to Follow-up|0|||
147291171|NCT04988308|531229910|FG000|Placebo Controlled Period (Weeks 0-16)|Other|10|||
147291172|NCT04988308|531229911|FG001|Placebo Controlled Period (Weeks 0-16)|Other|9|||
147291173|NCT04988308|531229912|FG002|Placebo Controlled Period (Weeks 0-16)|Other|14|||
147291174|NCT04988308|531229913|FG003|Placebo Controlled Period (Weeks 0-16)|Other|0|||
147291175|NCT04988308|531229914|FG004|Placebo Controlled Period (Weeks 0-16)|Other|0|||
147291176|NCT04988308|531229915|FG005|Placebo Controlled Period (Weeks 0-16)|Other|0|||
147291177|NCT04988308|531229910|FG000|Placebo Controlled Period (Weeks 0-16)|Study terminated by sponsor|6|||
147291178|NCT04988308|531229911|FG001|Placebo Controlled Period (Weeks 0-16)|Study terminated by sponsor|4|||
147291179|NCT04988308|531229912|FG002|Placebo Controlled Period (Weeks 0-16)|Study terminated by sponsor|3|||
147291180|NCT04988308|531229913|FG003|Placebo Controlled Period (Weeks 0-16)|Study terminated by sponsor|0|||
147291181|NCT04988308|531229914|FG004|Placebo Controlled Period (Weeks 0-16)|Study terminated by sponsor|0|||
147291182|NCT04988308|531229915|FG005|Placebo Controlled Period (Weeks 0-16)|Study terminated by sponsor|0|||
147291183|NCT04988308|531229910|FG000|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
147291184|NCT04988308|531229911|FG001|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
147291185|NCT04988308|531229912|FG002|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|0|||
147291186|NCT04988308|531229913|FG003|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|3|||
147291187|NCT04988308|531229914|FG004|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|2|||
147291188|NCT04988308|531229915|FG005|Active Treatment+Safety F-U (Week 17-36)|Withdrawal by Subject|1|||
147291189|NCT04988308|531229910|FG000|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
147291190|NCT04988308|531229911|FG001|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
147291191|NCT04988308|531229912|FG002|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|0|||
147291192|NCT04988308|531229913|FG003|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|3|||
147291193|NCT04988308|531229914|FG004|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|3|||
147291194|NCT04988308|531229915|FG005|Active Treatment+Safety F-U (Week 17-36)|Lost to Follow-up|1|||
147291195|NCT04988308|531229910|FG000|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
147291196|NCT04988308|531229911|FG001|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
147291197|NCT04988308|531229912|FG002|Active Treatment+Safety F-U (Week 17-36)|Other|0|||
147291198|NCT04988308|531229913|FG003|Active Treatment+Safety F-U (Week 17-36)|Other|10|||
147291199|NCT04988308|531229914|FG004|Active Treatment+Safety F-U (Week 17-36)|Other|10|||
147291200|NCT04988308|531229915|FG005|Active Treatment+Safety F-U (Week 17-36)|Other|14|||
147291201|NCT04988308|531229910|FG000|Active Treatment+Safety F-U (Week 17-36)|Study terminated by sponsor|0|||
147291202|NCT04988308|531229911|FG001|Active Treatment+Safety F-U (Week 17-36)|Study terminated by sponsor|0|||
147291203|NCT04988308|531229912|FG002|Active Treatment+Safety F-U (Week 17-36)|Study terminated by sponsor|0|||
147291204|NCT04988308|531229913|FG003|Active Treatment+Safety F-U (Week 17-36)|Study terminated by sponsor|5|||
147291205|NCT04988308|531229914|FG004|Active Treatment+Safety F-U (Week 17-36)|Study terminated by sponsor|6|||
147291206|NCT04988308|531229915|FG005|Active Treatment+Safety F-U (Week 17-36)|Study terminated by sponsor|2|||
147338269|NCT00774397|531406997|FG002|Overall Study|Protocol Violation|3|||
147338270|NCT00774397|531406998|FG003|Overall Study|Protocol Violation|1|||
147338271|NCT00774397|531406999|FG004|Overall Study|Protocol Violation|2|||
147338272|NCT00774397|531407000|FG005|Overall Study|Protocol Violation|1|||
147338273|NCT00774397|531407001|FG006|Overall Study|Protocol Violation|0|||
147291207|NCT02625623|531229920|FG000|Overall Study|Participants randomized but not treated|9|||
147291208|NCT02625623|531229921|FG001|Overall Study|Participants randomized but not treated|1|||
147291209|NCT00744653|531229922|FG000|Overall Study|antineoplastic treatment|11|||
147291210|NCT00744653|531229922|FG000|Overall Study|Death|1|||
147291211|NCT00744653|531229922|FG000|Overall Study|Lost to Follow-up|1|||
147291212|NCT00744653|531229922|FG000|Overall Study|Physician Decision|3|||
147291213|NCT03826667|531229923|FG000|Overall Study|Protocol deviation|21|||
147291214|NCT03077724|531229926|FG000|Overall Study|Lost to Follow-up|5|||
147291215|NCT03077724|531229927|FG001|Overall Study|Lost to Follow-up|1|||
147291216|NCT03077724|531229926|FG000|Overall Study|Withdrawal by Subject|3|||
147291217|NCT03077724|531229927|FG001|Overall Study|Withdrawal by Subject|1|||
147291218|NCT02313428|531229928|FG000|Overall Study|Lost to Follow-up|1|||
147291219|NCT02313428|531229929|FG001|Overall Study|Lost to Follow-up|1|||
147291220|NCT01738984|531232112|FG000|Overall Study|Pregnancy|4|||
147291221|NCT01738984|531232113|FG001|Overall Study|Pregnancy|0|||
147291222|NCT01738984|531232112|FG000|Overall Study|Withdrawal by Subject|1|||
147291223|NCT01738984|531232113|FG001|Overall Study|Withdrawal by Subject|0|||
147291224|NCT01738984|531232112|FG000|Overall Study|Lost to Follow-up|59|||
147291225|NCT01738984|531232113|FG001|Overall Study|Lost to Follow-up|39|||
147291226|NCT00955357|531232117|FG000|Titration Phase|Adverse Event|9|||
147291227|NCT00955357|531232118|FG001|Titration Phase|Adverse Event|46|||
147291228|NCT00955357|531232117|FG000|Titration Phase|Lack of Efficacy|0|||
147291229|NCT00955357|531232118|FG001|Titration Phase|Lack of Efficacy|2|||
147291230|NCT00955357|531232117|FG000|Titration Phase|Protocol Violation|3|||
147291231|NCT00955357|531232118|FG001|Titration Phase|Protocol Violation|7|||
147291232|NCT00955357|531232117|FG000|Titration Phase|Lost to Follow-up|1|||
147291233|NCT00955357|531232118|FG001|Titration Phase|Lost to Follow-up|3|||
147291234|NCT00955357|531232117|FG000|Titration Phase|Withdrawal by Subject|3|||
147291235|NCT00955357|531232118|FG001|Titration Phase|Withdrawal by Subject|5|||
147291236|NCT00955357|531232117|FG000|Titration Phase|Prohibited Antiepileptic Drug change|0|||
147291237|NCT00955357|531232118|FG001|Titration Phase|Prohibited Antiepileptic Drug change|1|||
147291238|NCT00955357|531232117|FG000|Titration Phase|Study medication not tolerated|0|||
147291239|NCT00955357|531232118|FG001|Titration Phase|Study medication not tolerated|1|||
147291240|NCT00955357|531232117|FG000|Titration Phase|Non compliance to study procedures|0|||
147291241|NCT00955357|531232118|FG001|Titration Phase|Non compliance to study procedures|1|||
147291242|NCT00955357|531232117|FG000|Maintenance Phase|Adverse Event|3|||
147291243|NCT00955357|531232118|FG001|Maintenance Phase|Adverse Event|23|||
147291244|NCT00955357|531232117|FG000|Maintenance Phase|Lack of Efficacy|0|||
147291245|NCT00955357|531232118|FG001|Maintenance Phase|Lack of Efficacy|4|||
147291246|NCT00955357|531232117|FG000|Maintenance Phase|Protocol Violation|2|||
147291247|NCT00955357|531232118|FG001|Maintenance Phase|Protocol Violation|6|||
147291248|NCT00955357|531232117|FG000|Maintenance Phase|Lost to Follow-up|2|||
147291249|NCT00955357|531232118|FG001|Maintenance Phase|Lost to Follow-up|7|||
147291250|NCT00955357|531232117|FG000|Maintenance Phase|Withdrawal by Subject|4|||
147291251|NCT00955357|531232118|FG001|Maintenance Phase|Withdrawal by Subject|4|||
147291252|NCT00955357|531232117|FG000|Maintenance Phase|Patient moving out of area|0|||
147291253|NCT00955357|531232118|FG001|Maintenance Phase|Patient moving out of area|1|||
147291254|NCT00955357|531232117|FG000|Maintenance Phase|Non compliance to study procedures|1|||
147291255|NCT00955357|531232118|FG001|Maintenance Phase|Non compliance to study procedures|0|||
147291256|NCT01258608|531232119|FG000|Overall Study|Metastatic Hepatocellular Carcinoma|1|||
147291257|NCT01258608|531232120|FG001|Overall Study|Metastatic Hepatocellular Carcinoma|0|||
147291258|NCT01258608|531232119|FG000|Overall Study|Clinical progression|1|||
147291259|NCT01258608|531232120|FG001|Overall Study|Clinical progression|0|||
147291260|NCT01258608|531232119|FG000|Overall Study|Sponsor decision|0|||
147291261|NCT01258608|531232120|FG001|Overall Study|Sponsor decision|1|||
147291262|NCT01258608|531232119|FG000|Overall Study|Physician Decision|6|||
147291263|NCT01258608|531232120|FG001|Overall Study|Physician Decision|1|||
147291264|NCT01258608|531232119|FG000|Overall Study|Lost to Follow-up|0|||
147452659|NCT03042468|531820024|FG000|Overall Study|Lost to Follow-up|0|||
147452660|NCT03042468|531820025|FG001|Overall Study|Lost to Follow-up|0|||
147291265|NCT01258608|531232120|FG001|Overall Study|Lost to Follow-up|1|||
147291266|NCT01258608|531232119|FG000|Overall Study|Lack of compliance|1|||
147291267|NCT01258608|531232120|FG001|Overall Study|Lack of compliance|0|||
147291268|NCT01258608|531232119|FG000|Overall Study|Lack of Efficacy|0|||
147291269|NCT01258608|531232120|FG001|Overall Study|Lack of Efficacy|1|||
147291270|NCT01258608|531232119|FG000|Overall Study|Adverse Event|6|||
147291271|NCT01258608|531232120|FG001|Overall Study|Adverse Event|10|||
147291272|NCT01258608|531232119|FG000|Overall Study|Withdrawal by Subject|6|||
147291273|NCT01258608|531232120|FG001|Overall Study|Withdrawal by Subject|5|||
147291274|NCT02943408|531232126|FG000|Overall Study|Lost to Follow-up|7|||
147452661|NCT03042468|531820026|FG002|Overall Study|Lost to Follow-up|0|||
147291275|NCT02943408|531232127|FG001|Overall Study|Lost to Follow-up|1|||
147291276|NCT02943408|531232126|FG000|Overall Study|Withdrawal by Subject|0|||
147291277|NCT02943408|531232127|FG001|Overall Study|Withdrawal by Subject|1|||
147291278|NCT01621126|531232132|FG000|Overall Study|Physician Decision|6|||
147291279|NCT01949311|531232133|FG000|Overall Study|Lost to Follow-up|73|||
147452662|NCT03042468|531820027|FG003|Overall Study|Lost to Follow-up|0|||
147338274|NCT00774397|531406995|FG000|Overall Study|Lost to Follow-up|0|||
147338275|NCT00774397|531406996|FG001|Overall Study|Lost to Follow-up|1|||
147338276|NCT00774397|531406997|FG002|Overall Study|Lost to Follow-up|1|||
147338277|NCT00774397|531406998|FG003|Overall Study|Lost to Follow-up|1|||
147338278|NCT00774397|531406999|FG004|Overall Study|Lost to Follow-up|0|||
147338279|NCT00774397|531407000|FG005|Overall Study|Lost to Follow-up|1|||
147338280|NCT00774397|531407001|FG006|Overall Study|Lost to Follow-up|0|||
147338281|NCT00774397|531406995|FG000|Overall Study|Refused to continue trial medication|1|||
147338282|NCT00774397|531406996|FG001|Overall Study|Refused to continue trial medication|3|||
147338283|NCT00774397|531406997|FG002|Overall Study|Refused to continue trial medication|2|||
147338284|NCT00774397|531406998|FG003|Overall Study|Refused to continue trial medication|2|||
147338285|NCT00774397|531406999|FG004|Overall Study|Refused to continue trial medication|6|||
147338286|NCT00774397|531407000|FG005|Overall Study|Refused to continue trial medication|2|||
147338287|NCT00774397|531407001|FG006|Overall Study|Refused to continue trial medication|3|||
147338288|NCT00774397|531406995|FG000|Overall Study|Not treated|0|||
147338289|NCT00774397|531406996|FG001|Overall Study|Not treated|0|||
147338290|NCT00774397|531406997|FG002|Overall Study|Not treated|0|||
147338291|NCT00774397|531406998|FG003|Overall Study|Not treated|0|||
147338292|NCT00774397|531406999|FG004|Overall Study|Not treated|1|||
147338293|NCT00774397|531407000|FG005|Overall Study|Not treated|0|||
147338294|NCT00774397|531407001|FG006|Overall Study|Not treated|1|||
147338295|NCT00774397|531406995|FG000|Overall Study|Other than those stated above|1|||
147338296|NCT00774397|531406996|FG001|Overall Study|Other than those stated above|1|||
147338297|NCT00774397|531406997|FG002|Overall Study|Other than those stated above|3|||
147338298|NCT00774397|531406998|FG003|Overall Study|Other than those stated above|2|||
147338299|NCT00774397|531406999|FG004|Overall Study|Other than those stated above|2|||
147338300|NCT00774397|531407000|FG005|Overall Study|Other than those stated above|0|||
147338301|NCT00774397|531407001|FG006|Overall Study|Other than those stated above|1|||
147338302|NCT00077675|531407002|FG000|Overall Study|Adverse Event|1|||
147338303|NCT00077675|531407003|FG001|Overall Study|Adverse Event|2|||
147338304|NCT00077675|531407002|FG000|Overall Study|Lost to Follow-up|6|||
147338305|NCT00077675|531407003|FG001|Overall Study|Lost to Follow-up|3|||
147338306|NCT00077675|531407002|FG000|Overall Study|Withdrawal by Subject|1|||
147338307|NCT00077675|531407003|FG001|Overall Study|Withdrawal by Subject|0|||
147338308|NCT00077675|531407002|FG000|Overall Study|Other|0|||
147338309|NCT00077675|531407003|FG001|Overall Study|Other|1|||
147452663|NCT03042468|531820028|FG004|Overall Study|Lost to Follow-up|1|||
147452664|NCT03042468|531820029|FG005|Overall Study|Lost to Follow-up|1|||
147452665|NCT03557359|531820032|FG000|Dose 1: 240 mg|Adverse Event|1|||
147452666|NCT03557359|531820033|FG001|Dose 1: 240 mg|Adverse Event|0|||
147452667|NCT03092726|531820034|FG000|Overall Study|Adverse Event|3|||
147452668|NCT03092726|531820035|FG001|Overall Study|Adverse Event|10|||
147452669|NCT03092726|531820034|FG000|Overall Study|Lack of Efficacy|0|||
147452670|NCT03092726|531820035|FG001|Overall Study|Lack of Efficacy|1|||
147452671|NCT03092726|531820034|FG000|Overall Study|Lost to Follow-up|1|||
147452672|NCT03092726|531820035|FG001|Overall Study|Lost to Follow-up|0|||
147291280|NCT01949311|531232133|FG000|Overall Study|Terminated by Sponsor|708|||
147291281|NCT01949311|531232133|FG000|Overall Study|Withdrawal by Subject|375|||
147291282|NCT01949311|531232133|FG000|Overall Study|Lack of Efficacy|50|||
147291283|NCT01949311|531232133|FG000|Overall Study|Protocol Deviation|34|||
147291284|NCT01949311|531232133|FG000|Overall Study|Pregnancy|20|||
147291285|NCT01949311|531232133|FG000|Overall Study|Physician Decision|9|||
147291286|NCT01949311|531232133|FG000|Overall Study|Other|4|||
147291287|NCT01949311|531232133|FG000|Overall Study|Adverse Event|107|||
147291288|NCT02338154|531232134|FG000|Overall Study|Death|46|||
147291289|NCT02338154|531232134|FG000|Overall Study|Valve Implant Failure|17|||
147452673|NCT03092726|531820034|FG000|Overall Study|Withdrawal by Subject|5|||
147291290|NCT02338154|531232134|FG000|Overall Study|Valve Explant|11|||
147338310|NCT00077675|531407002|FG000|Overall Study|Never received study treatment|3|||
147338311|NCT00077675|531407003|FG001|Overall Study|Never received study treatment|3|||
147338312|NCT02499159|531407004|FG000|Randomization|Protocol Violation|1|||
147338313|NCT02499159|531407005|FG001|Randomization|Protocol Violation|1|||
147338314|NCT02499159|531407004|FG000|30-Day Follow-Up Phone Call|Withdrawal by Subject|1|||
147452674|NCT03092726|531820035|FG001|Overall Study|Withdrawal by Subject|3|||
147604358|NCT02329847|532367879|FG003|Overall Study|Other|13|||
147338315|NCT02499159|531407005|FG001|30-Day Follow-Up Phone Call|Withdrawal by Subject|1|||
147604359|NCT02329847|532367880|FG004|Overall Study|Other|10|||
147338316|NCT02499159|531407004|FG000|30-Day Follow-Up Phone Call|Lost to Follow-up|3|||
147338317|NCT02499159|531407005|FG001|30-Day Follow-Up Phone Call|Lost to Follow-up|1|||
147452675|NCT01662895|531820040|FG000|Overall Study|Lost to Follow-up|0|||
147604360|NCT02329847|532367881|FG005|Overall Study|Other|3|||
147452676|NCT01662895|531820041|FG001|Overall Study|Lost to Follow-up|1|||
147291291|NCT02338154|531232134|FG000|Overall Study|Withdrawal by Subject or by Investigator|10|||
147291292|NCT02338154|531232134|FG000|Overall Study|Lost to Follow-up|8|||
147338318|NCT02499159|531407004|FG000|30-Day Follow-Up Phone Call|Withdrawal due to ineligibility|2|||
147452677|NCT00705939|531820042|FG000|Overall Study|Protocol Violation|0|||
147604361|NCT03365011|532367883|FG000|Overall Study|Withdrawal by Subject|1|||
147291293|NCT02338154|531232134|FG000|Overall Study|Other Reason|3|||
147291294|NCT02338154|531232134|FG000|Overall Study|Patients Without Exit Form|47|||
147291295|NCT02338154|531232134|FG000|Overall Study|Missing Exit Reason on Exit Form|1|||
147291296|NCT04279314|531232135|FG000|Overall Study|Adverse Event|55|||
147291297|NCT04279314|531232135|FG000|Overall Study|Withdrawal by Subject|5|||
147291298|NCT04279314|531232135|FG000|Overall Study|Lack of Efficacy|5|||
147291299|NCT04279314|531232135|FG000|Overall Study|Protocol Violation|3|||
147291300|NCT04279314|531232135|FG000|Overall Study|Other (not COVID-19 related)|2|||
147291301|NCT03166618|531232140|FG000|Overall Study|Study was Terminated|0|||
147291302|NCT03166618|531232141|FG001|Overall Study|Study was Terminated|1|||
147291303|NCT01925950|531232142|FG000|Part 2|Withdrawal by Subject|1|||
147291304|NCT01925950|531232143|FG001|Part 2|Withdrawal by Subject|0|||
147291305|NCT03137303|531232145|FG000|T1: 3-month Follow-up|Withdrawal by Subject|1|||
147291306|NCT03137303|531232146|FG001|T1: 3-month Follow-up|Withdrawal by Subject|4|||
147291307|NCT03137303|531232145|FG000|T1: 3-month Follow-up|Lost to Follow-up|5|||
147291308|NCT03137303|531232146|FG001|T1: 3-month Follow-up|Lost to Follow-up|6|||
147291309|NCT03137303|531232145|FG000|T2: 6-month Follow-up|Lost to Follow-up|5|||
147291310|NCT03137303|531232146|FG001|T2: 6-month Follow-up|Lost to Follow-up|5|||
147291311|NCT03137303|531232145|FG000|T3: 9-month Follow-up|Death|1|||
147291312|NCT03137303|531232146|FG001|T3: 9-month Follow-up|Death|0|||
147291313|NCT03137303|531232145|FG000|T3: 9-month Follow-up|Lost to Follow-up|4|||
147291314|NCT03137303|531232146|FG001|T3: 9-month Follow-up|Lost to Follow-up|4|||
147291315|NCT03137303|531232145|FG000|T4: 12-month Follow-up|Withdrawal by Subject|0|||
147291316|NCT03137303|531232146|FG001|T4: 12-month Follow-up|Withdrawal by Subject|1|||
147291317|NCT03137303|531232145|FG000|T4: 12-month Follow-up|Lost to Follow-up|7|||
147291318|NCT03137303|531232146|FG001|T4: 12-month Follow-up|Lost to Follow-up|4|||
147291319|NCT03561090|531232147|FG000|Overall Study|Adverse Event|11|||
147291320|NCT03561090|531232148|FG001|Overall Study|Adverse Event|7|||
147291321|NCT03561090|531232147|FG000|Overall Study|Non-Compliance With Study Drug|2|||
147291322|NCT03561090|531232148|FG001|Overall Study|Non-Compliance With Study Drug|0|||
147291323|NCT03561090|531232147|FG000|Overall Study|Protocol Violation|2|||
147291324|NCT03561090|531232148|FG001|Overall Study|Protocol Violation|2|||
147291325|NCT03561090|531232147|FG000|Overall Study|Withdrawal by Subject|7|||
147291326|NCT03561090|531232148|FG001|Overall Study|Withdrawal by Subject|7|||
147291327|NCT03561090|531232147|FG000|Overall Study|Lost to Follow-up|7|||
147291328|NCT03561090|531232148|FG001|Overall Study|Lost to Follow-up|2|||
147291329|NCT03561090|531232147|FG000|Overall Study|Study Terminated by Sponsor|10|||
147291330|NCT03561090|531232148|FG001|Overall Study|Study Terminated by Sponsor|15|||
147291331|NCT03561090|531232147|FG000|Overall Study|Randomized by Mistake|1|||
147291332|NCT03561090|531232148|FG001|Overall Study|Randomized by Mistake|1|||
147291333|NCT03561090|531232147|FG000|Overall Study|Other Not Specified|0|||
147291334|NCT03561090|531232148|FG001|Overall Study|Other Not Specified|2|||
147291335|NCT01433354|531232159|FG000|Overall Study|Adverse Event|6|||
147291336|NCT01433354|531232159|FG000|Overall Study|Lost to Follow-up|1|||
147291337|NCT01433354|531232159|FG000|Overall Study|Administrative problems|90|||
147291338|NCT01433354|531232159|FG000|Overall Study|Protocol Violation|2|||
147291339|NCT01433354|531232159|FG000|Overall Study|Lack of Efficacy|17|||
147291340|NCT01433354|531232159|FG000|Overall Study|Subject Withdrew Consent|3|||
147291341|NCT02015676|531232164|FG000|Overall Study|Adverse Event|2|||
147291342|NCT02015676|531232165|FG001|Overall Study|Adverse Event|18|||
147291343|NCT02015676|531232166|FG002|Overall Study|Adverse Event|0|||
147291344|NCT02015676|531232164|FG000|Overall Study|Lack of Efficacy|2|||
147291345|NCT02015676|531232165|FG001|Overall Study|Lack of Efficacy|4|||
147291346|NCT02015676|531232166|FG002|Overall Study|Lack of Efficacy|0|||
147291347|NCT02015676|531232164|FG000|Overall Study|Protocol Violation|1|||
147291348|NCT02015676|531232165|FG001|Overall Study|Protocol Violation|0|||
147291349|NCT02015676|531232166|FG002|Overall Study|Protocol Violation|0|||
147291350|NCT02015676|531232164|FG000|Overall Study|Withdrawal by Subject|1|||
147291351|NCT02015676|531232165|FG001|Overall Study|Withdrawal by Subject|7|||
147291352|NCT02015676|531232166|FG002|Overall Study|Withdrawal by Subject|1|||
147291353|NCT02015676|531232164|FG000|Overall Study|Administrative reasons|0|||
147291354|NCT02015676|531232165|FG001|Overall Study|Administrative reasons|3|||
147291355|NCT02015676|531232166|FG002|Overall Study|Administrative reasons|1|||
147291356|NCT02015676|531232164|FG000|Overall Study|Death|0|||
147291357|NCT02015676|531232165|FG001|Overall Study|Death|1|||
147291358|NCT02015676|531232166|FG002|Overall Study|Death|0|||
147291359|NCT02015676|531232164|FG000|Overall Study|Disease progression|3|||
147291360|NCT02015676|531232165|FG001|Overall Study|Disease progression|1|||
147291361|NCT02015676|531232166|FG002|Overall Study|Disease progression|1|||
147291362|NCT01618162|531232167|FG000|Overall Study|Protocol Violation|13|||
147291363|NCT01618162|531232168|FG001|Overall Study|Protocol Violation|10|||
147291364|NCT01618162|531232167|FG000|Overall Study|Adverse Event|9|||
147604362|NCT03365011|532367884|FG001|Overall Study|Withdrawal by Subject|2|||
147291365|NCT01618162|531232168|FG001|Overall Study|Adverse Event|2|||
147291366|NCT01618162|531232167|FG000|Overall Study|Withdrawal Criteria|2|||
147291367|NCT01618162|531232168|FG001|Overall Study|Withdrawal Criteria|10|||
147291368|NCT01618162|531232167|FG000|Overall Study|Unclassified|14|||
147291369|NCT01618162|531232168|FG001|Overall Study|Unclassified|13|||
147291370|NCT00476476|531232169|FG000|Overall Study|Adverse Event|2|||
147291371|NCT00476476|531232170|FG001|Overall Study|Adverse Event|7|||
147291372|NCT00476476|531232169|FG000|Overall Study|Progressive Disease|0|||
147291373|NCT00476476|531232170|FG001|Overall Study|Progressive Disease|17|||
147291374|NCT04794803|531232171|FG000|Overall Study|Death|1|||
147291375|NCT04794803|531232172|FG001|Overall Study|Death|3|||
147291376|NCT04794803|531232171|FG000|Overall Study|Lost to Follow-up|2|||
147291377|NCT04794803|531232172|FG001|Overall Study|Lost to Follow-up|2|||
147291378|NCT04794803|531232171|FG000|Overall Study|Withdrawal by Subject|1|||
147291379|NCT04794803|531232172|FG001|Overall Study|Withdrawal by Subject|0|||
147291380|NCT04794803|531232171|FG000|Overall Study|Physician Decision|1|||
147291381|NCT04794803|531232172|FG001|Overall Study|Physician Decision|1|||
147291382|NCT04794803|531232171|FG000|Overall Study|Patient transferred to another centre for oxygen rehabilitation|4|||
147291383|NCT04794803|531232172|FG001|Overall Study|Patient transferred to another centre for oxygen rehabilitation|1|||
147291384|NCT04794803|531232171|FG000|Overall Study|Refused to continue the treatment|1|||
147291385|NCT04794803|531232172|FG001|Overall Study|Refused to continue the treatment|0|||
147291386|NCT04794803|531232171|FG000|Overall Study|Patient admitted to ICU|0|||
147291387|NCT04794803|531232172|FG001|Overall Study|Patient admitted to ICU|1|||
147291388|NCT00971048|531232174|FG000|Overall Study|Protocol Violation|1|||
147291389|NCT00971048|531232175|FG001|Overall Study|Protocol Violation|2|||
147291390|NCT00971048|531232176|FG002|Overall Study|Protocol Violation|0|||
147291391|NCT00971048|531232177|FG003|Overall Study|Protocol Violation|1|||
147291392|NCT00971048|531232174|FG000|Overall Study|Adverse Event|0|||
147291393|NCT00971048|531232175|FG001|Overall Study|Adverse Event|0|||
147291394|NCT00971048|531232176|FG002|Overall Study|Adverse Event|1|||
147291395|NCT00971048|531232177|FG003|Overall Study|Adverse Event|0|||
147291396|NCT00971048|531232174|FG000|Overall Study|Physician Decision|0|||
147291397|NCT00971048|531232175|FG001|Overall Study|Physician Decision|0|||
147291398|NCT00971048|531232176|FG002|Overall Study|Physician Decision|0|||
147291399|NCT00971048|531232177|FG003|Overall Study|Physician Decision|1|||
147291400|NCT03321396|531232181|FG000|Overall Study|Physician Decision|1|||
147291401|NCT01654549|531232184|FG000|Overall Study|H.pylori eradication not successful|0|||
147291402|NCT01654549|531232185|FG001|Overall Study|H.pylori eradication not successful|1|||
147291403|NCT00937924|531232188|FG000|Overall Study|Lost to Follow-up|44|||
147291404|NCT00937924|531232189|FG001|Overall Study|Lost to Follow-up|44|||
147291405|NCT00937924|531232190|FG002|Overall Study|Lost to Follow-up|41|||
147291406|NCT02633137|531232209|FG000|Overall Study|Adverse Event|1|||
147291407|NCT02633137|531232209|FG000|Overall Study|Lack of Efficacy|2|||
147291408|NCT02633137|531232209|FG000|Overall Study|Withdrawal by Subject|1|||
147291409|NCT03152526|531232210|FG000|Overall Study|Withdrawal by Subject|0|||
147291410|NCT03152526|531232211|FG001|Overall Study|Withdrawal by Subject|1|||
147291411|NCT04307004|531232212|FG000|Randomization 1|Withdrawal by Subject|25|||
147291412|NCT04307004|531232213|FG001|Randomization 1|Withdrawal by Subject|26|||
147291413|NCT04307004|531232214|FG002|Randomization 1|Withdrawal by Subject|0|||
147291414|NCT04307004|531232215|FG003|Randomization 1|Withdrawal by Subject|0|||
147291415|NCT04307004|531232212|FG000|Randomization 2|Withdrawal by Subject|0|||
147291416|NCT04307004|531232213|FG001|Randomization 2|Withdrawal by Subject|0|||
147291417|NCT04307004|531232214|FG002|Randomization 2|Withdrawal by Subject|28|||
147291418|NCT04307004|531232215|FG003|Randomization 2|Withdrawal by Subject|23|||
147291419|NCT05545072|531232216|FG000|Overall Study|Lost to Follow-up|1|||
147291420|NCT05545072|531232217|FG001|Overall Study|Lost to Follow-up|0|||
147291421|NCT05545072|531232216|FG000|Overall Study|Study ended prematurely due to funding|2|||
147291422|NCT05545072|531232217|FG001|Overall Study|Study ended prematurely due to funding|2|||
147291423|NCT02395042|531232218|FG000|Treatment 1 Period|Adverse Event|1|||
147291424|NCT02395042|531232219|FG001|Treatment 1 Period|Adverse Event|3|||
147291425|NCT02395042|531232220|FG002|Treatment 1 Period|Adverse Event|1|||
147291426|NCT02395042|531232218|FG000|Treatment 1 Period|Lack of Efficacy|1|||
147291427|NCT02395042|531232219|FG001|Treatment 1 Period|Lack of Efficacy|1|||
147291428|NCT02395042|531232220|FG002|Treatment 1 Period|Lack of Efficacy|0|||
147291429|NCT02395042|531232218|FG000|Treatment 1 Period|Lost to Follow-up|1|||
147291430|NCT02395042|531232219|FG001|Treatment 1 Period|Lost to Follow-up|0|||
147291431|NCT02395042|531232220|FG002|Treatment 1 Period|Lost to Follow-up|0|||
147291432|NCT02395042|531232218|FG000|Treatment 1 Period|Other Miscellaneous Reasons|0|||
147291433|NCT02395042|531232219|FG001|Treatment 1 Period|Other Miscellaneous Reasons|2|||
147291434|NCT02395042|531232220|FG002|Treatment 1 Period|Other Miscellaneous Reasons|1|||
147291435|NCT02395042|531232218|FG000|Treatment 2 Period|Lack of Efficacy|1|||
147291436|NCT02395042|531232219|FG001|Treatment 2 Period|Lack of Efficacy|1|||
147291437|NCT02395042|531232220|FG002|Treatment 2 Period|Lack of Efficacy|0|||
147291438|NCT01324271|531232221|FG000|Overall Study|Lost to Follow-up|3|||
147291439|NCT01324271|531232222|FG001|Overall Study|Lost to Follow-up|0|||
147291440|NCT01324271|531232221|FG000|Overall Study|Physician Decision|1|||
147291441|NCT01324271|531232222|FG001|Overall Study|Physician Decision|0|||
147291442|NCT02807558|531232223|FG000|Overall Study|Consent withdrawn by participant|4|||
147291443|NCT02807558|531232224|FG001|Overall Study|Consent withdrawn by participant|0|||
147291444|NCT02807558|531232225|FG002|Overall Study|Consent withdrawn by participant|4|||
147291445|NCT02807558|531232226|FG003|Overall Study|Consent withdrawn by participant|2|||
147338319|NCT02499159|531407005|FG001|30-Day Follow-Up Phone Call|Withdrawal due to ineligibility|0|||
147338320|NCT02499159|531407004|FG000|30-Day Follow-Up Phone Call|Other|1|||
147338321|NCT02499159|531407005|FG001|30-Day Follow-Up Phone Call|Other|0|||
147338322|NCT04425863|531407006|FG000|Overall Study|Death|0|||
147338323|NCT04425863|531407007|FG001|Overall Study|Death|0|||
147338324|NCT04425863|531407008|FG002|Overall Study|Death|1|||
147338325|NCT02601820|531407009|FG000|Early On-Treatment (T2)|Missing T2 Record|51|||
147338326|NCT02601820|531407009|FG000|Late On-Treatment (T3)|missing T3 Record|49|||
147338327|NCT02601820|531407009|FG000|12 Weeks Post-Treatment (T4)|Missing T4 record|3|||
147338328|NCT02601820|531407009|FG000|1-Yr Post-Treatment (T5)|Missing T5 Record|88|||
147338329|NCT01599793|531407010|FG000|Overall Study|Adverse Event|2|||
147338330|NCT02564744|531407013|FG000|Overall Study|Investigator decision|0|||
147338331|NCT02564744|531407014|FG001|Overall Study|Investigator decision|0|||
147338332|NCT02564744|531407015|FG002|Overall Study|Investigator decision|0|||
147338333|NCT02564744|531407016|FG003|Overall Study|Investigator decision|0|||
147338334|NCT02564744|531407017|FG004|Overall Study|Investigator decision|1|||
147338335|NCT02564744|531407013|FG000|Overall Study|Death|10|||
147338336|NCT02564744|531407014|FG001|Overall Study|Death|5|||
147338337|NCT02564744|531407015|FG002|Overall Study|Death|4|||
147338338|NCT02564744|531407016|FG003|Overall Study|Death|16|||
147338339|NCT02564744|531407017|FG004|Overall Study|Death|16|||
147338340|NCT02564744|531407013|FG000|Overall Study|End of study Page Missing|0|||
147338341|NCT02564744|531407014|FG001|Overall Study|End of study Page Missing|0|||
147338342|NCT02564744|531407015|FG002|Overall Study|End of study Page Missing|3|||
147291446|NCT02807558|531232227|FG004|Overall Study|Consent withdrawn by participant|1|||
147291447|NCT02807558|531232228|FG005|Overall Study|Consent withdrawn by participant|0|||
147291448|NCT02807558|531232223|FG000|Overall Study|Non-compliance with Study Drug|0|||
147291449|NCT02807558|531232224|FG001|Overall Study|Non-compliance with Study Drug|0|||
147291450|NCT02807558|531232225|FG002|Overall Study|Non-compliance with Study Drug|1|||
147291451|NCT02807558|531232226|FG003|Overall Study|Non-compliance with Study Drug|0|||
147291452|NCT02807558|531232227|FG004|Overall Study|Non-compliance with Study Drug|0|||
147291453|NCT02807558|531232228|FG005|Overall Study|Non-compliance with Study Drug|0|||
147291454|NCT02807558|531232223|FG000|Overall Study|Adverse Event|0|||
147291455|NCT02807558|531232224|FG001|Overall Study|Adverse Event|0|||
147291456|NCT02807558|531232225|FG002|Overall Study|Adverse Event|9|||
147291457|NCT02807558|531232226|FG003|Overall Study|Adverse Event|0|||
147291458|NCT02807558|531232227|FG004|Overall Study|Adverse Event|0|||
147291459|NCT02807558|531232228|FG005|Overall Study|Adverse Event|0|||
147291460|NCT02807558|531232223|FG000|Overall Study|Death|23|||
147291461|NCT02807558|531232224|FG001|Overall Study|Death|2|||
147291462|NCT02807558|531232225|FG002|Overall Study|Death|3|||
147291463|NCT02807558|531232226|FG003|Overall Study|Death|43|||
147291464|NCT02807558|531232227|FG004|Overall Study|Death|24|||
147291465|NCT02807558|531232228|FG005|Overall Study|Death|15|||
147291466|NCT02807558|531232223|FG000|Overall Study|Progressive Disease|0|||
147291467|NCT02807558|531232224|FG001|Overall Study|Progressive Disease|0|||
147291468|NCT02807558|531232225|FG002|Overall Study|Progressive Disease|1|||
147291469|NCT02807558|531232226|FG003|Overall Study|Progressive Disease|0|||
147291470|NCT02807558|531232227|FG004|Overall Study|Progressive Disease|0|||
147291471|NCT02807558|531232228|FG005|Overall Study|Progressive Disease|0|||
147291472|NCT02807558|531232223|FG000|Overall Study|Other than specified|1|||
147291473|NCT02807558|531232224|FG001|Overall Study|Other than specified|0|||
147291474|NCT02807558|531232225|FG002|Overall Study|Other than specified|2|||
147291475|NCT02807558|531232226|FG003|Overall Study|Other than specified|0|||
147291476|NCT02807558|531232227|FG004|Overall Study|Other than specified|1|||
147291477|NCT02807558|531232228|FG005|Overall Study|Other than specified|1|||
147338343|NCT02564744|531407016|FG003|Overall Study|End of study Page Missing|3|||
147338344|NCT02564744|531407017|FG004|Overall Study|End of study Page Missing|0|||
147338345|NCT02564744|531407013|FG000|Overall Study|Subject Withdrew Consent|1|||
147338346|NCT02564744|531407014|FG001|Overall Study|Subject Withdrew Consent|1|||
147338347|NCT02564744|531407015|FG002|Overall Study|Subject Withdrew Consent|1|||
147338348|NCT02564744|531407016|FG003|Overall Study|Subject Withdrew Consent|0|||
147338349|NCT02564744|531407017|FG004|Overall Study|Subject Withdrew Consent|2|||
147338350|NCT02564744|531407013|FG000|Overall Study|Lost to Follow-up|0|||
147291478|NCT02807558|531232223|FG000|Overall Study|Lack of Efficacy|0|||
147338351|NCT02564744|531407014|FG001|Overall Study|Lost to Follow-up|1|||
147338352|NCT02564744|531407015|FG002|Overall Study|Lost to Follow-up|0|||
147338353|NCT02564744|531407016|FG003|Overall Study|Lost to Follow-up|0|||
147338354|NCT02564744|531407017|FG004|Overall Study|Lost to Follow-up|1|||
147338355|NCT02564744|531407013|FG000|Overall Study|Reason not specified|1|||
147338356|NCT02564744|531407014|FG001|Overall Study|Reason not specified|0|||
147291479|NCT02807558|531232224|FG001|Overall Study|Lack of Efficacy|0|||
147291480|NCT02807558|531232225|FG002|Overall Study|Lack of Efficacy|9|||
147291481|NCT02807558|531232226|FG003|Overall Study|Lack of Efficacy|0|||
147291482|NCT02807558|531232227|FG004|Overall Study|Lack of Efficacy|0|||
147291483|NCT02807558|531232228|FG005|Overall Study|Lack of Efficacy|0|||
147338357|NCT02564744|531407015|FG002|Overall Study|Reason not specified|0|||
147338358|NCT02564744|531407016|FG003|Overall Study|Reason not specified|0|||
147291484|NCT01972841|531232229|FG000|Overall Study|Randomized but Never Received Treatment|2|||
147291485|NCT01972841|531232230|FG001|Overall Study|Randomized but Never Received Treatment|5|||
147291486|NCT01972841|531232231|FG002|Overall Study|Randomized but Never Received Treatment|4|||
147291487|NCT01972841|531232232|FG003|Overall Study|Randomized but Never Received Treatment|2|||
147291488|NCT01972841|531232233|FG004|Overall Study|Randomized but Never Received Treatment|6|||
147291489|NCT01972841|531232234|FG005|Overall Study|Randomized but Never Received Treatment|13|||
147291490|NCT01972841|531232229|FG000|Overall Study|Adverse Event|13|||
147291491|NCT01972841|531232230|FG001|Overall Study|Adverse Event|8|||
147291492|NCT01972841|531232231|FG002|Overall Study|Adverse Event|12|||
147291493|NCT01972841|531232232|FG003|Overall Study|Adverse Event|9|||
147291494|NCT01972841|531232233|FG004|Overall Study|Adverse Event|21|||
147291495|NCT01972841|531232234|FG005|Overall Study|Adverse Event|26|||
147291496|NCT01972841|531232229|FG000|Overall Study|Lack of Efficacy|1|||
147291497|NCT01972841|531232230|FG001|Overall Study|Lack of Efficacy|0|||
147291498|NCT01972841|531232231|FG002|Overall Study|Lack of Efficacy|0|||
147291499|NCT01972841|531232232|FG003|Overall Study|Lack of Efficacy|2|||
147291500|NCT01972841|531232233|FG004|Overall Study|Lack of Efficacy|4|||
147291501|NCT01972841|531232234|FG005|Overall Study|Lack of Efficacy|1|||
147291502|NCT01972841|531232229|FG000|Overall Study|Lost to Follow-up|4|||
147291503|NCT01972841|531232230|FG001|Overall Study|Lost to Follow-up|2|||
147291504|NCT01972841|531232231|FG002|Overall Study|Lost to Follow-up|4|||
147291505|NCT01972841|531232232|FG003|Overall Study|Lost to Follow-up|2|||
147291506|NCT01972841|531232233|FG004|Overall Study|Lost to Follow-up|9|||
147291507|NCT01972841|531232234|FG005|Overall Study|Lost to Follow-up|3|||
147291508|NCT01972841|531232229|FG000|Overall Study|Protocol Violation|2|||
147291509|NCT01972841|531232230|FG001|Overall Study|Protocol Violation|2|||
147291510|NCT01972841|531232231|FG002|Overall Study|Protocol Violation|3|||
147291511|NCT01972841|531232232|FG003|Overall Study|Protocol Violation|5|||
147291512|NCT01972841|531232233|FG004|Overall Study|Protocol Violation|9|||
147291513|NCT01972841|531232234|FG005|Overall Study|Protocol Violation|4|||
147291514|NCT01972841|531232229|FG000|Overall Study|Withdrawal by participants|21|||
147291515|NCT01972841|531232230|FG001|Overall Study|Withdrawal by participants|27|||
147291516|NCT01972841|531232231|FG002|Overall Study|Withdrawal by participants|23|||
147291517|NCT01972841|531232232|FG003|Overall Study|Withdrawal by participants|16|||
147291518|NCT01972841|531232233|FG004|Overall Study|Withdrawal by participants|33|||
147291519|NCT01972841|531232234|FG005|Overall Study|Withdrawal by participants|34|||
147291520|NCT01972841|531232229|FG000|Overall Study|Miscellaneous|0|||
147291521|NCT01972841|531232230|FG001|Overall Study|Miscellaneous|0|||
147291522|NCT01972841|531232231|FG002|Overall Study|Miscellaneous|4|||
147291523|NCT01972841|531232232|FG003|Overall Study|Miscellaneous|1|||
147291524|NCT01972841|531232233|FG004|Overall Study|Miscellaneous|0|||
147291525|NCT01972841|531232234|FG005|Overall Study|Miscellaneous|4|||
147291526|NCT01972841|531232229|FG000|Overall Study|Did not have end of treatment page|0|||
147291527|NCT01972841|531232230|FG001|Overall Study|Did not have end of treatment page|0|||
147291528|NCT01972841|531232231|FG002|Overall Study|Did not have end of treatment page|0|||
147291529|NCT01972841|531232232|FG003|Overall Study|Did not have end of treatment page|0|||
147291530|NCT01972841|531232233|FG004|Overall Study|Did not have end of treatment page|1|||
147291531|NCT01972841|531232234|FG005|Overall Study|Did not have end of treatment page|0|||
147291532|NCT04818346|531232237|FG000|24-Week Placebo-controlled Period|Adverse Event|1|||
147291533|NCT04818346|531232238|FG001|24-Week Placebo-controlled Period|Adverse Event|2|||
147291534|NCT04818346|531232239|FG002|24-Week Placebo-controlled Period|Adverse Event|0|||
147291535|NCT04818346|531232240|FG003|24-Week Placebo-controlled Period|Adverse Event|3|||
147291536|NCT04818346|531232237|FG000|24-Week Placebo-controlled Period|Lost to Follow-up|3|||
147291537|NCT04818346|531232238|FG001|24-Week Placebo-controlled Period|Lost to Follow-up|2|||
147291538|NCT04818346|531232239|FG002|24-Week Placebo-controlled Period|Lost to Follow-up|3|||
147291539|NCT04818346|531232240|FG003|24-Week Placebo-controlled Period|Lost to Follow-up|1|||
147291540|NCT04818346|531232237|FG000|24-Week Placebo-controlled Period|Physician Decision|1|||
147291541|NCT04818346|531232238|FG001|24-Week Placebo-controlled Period|Physician Decision|0|||
147291542|NCT04818346|531232239|FG002|24-Week Placebo-controlled Period|Physician Decision|0|||
147291543|NCT04818346|531232240|FG003|24-Week Placebo-controlled Period|Physician Decision|0|||
147291544|NCT04818346|531232237|FG000|24-Week Placebo-controlled Period|Protocol Violation|0|||
147291545|NCT04818346|531232238|FG001|24-Week Placebo-controlled Period|Protocol Violation|0|||
147291546|NCT04818346|531232239|FG002|24-Week Placebo-controlled Period|Protocol Violation|1|||
147291547|NCT04818346|531232240|FG003|24-Week Placebo-controlled Period|Protocol Violation|1|||
147291548|NCT04818346|531232237|FG000|24-Week Placebo-controlled Period|Withdrawal by Subject|1|||
147291549|NCT04818346|531232238|FG001|24-Week Placebo-controlled Period|Withdrawal by Subject|1|||
147291550|NCT04818346|531232239|FG002|24-Week Placebo-controlled Period|Withdrawal by Subject|6|||
147291551|NCT04818346|531232240|FG003|24-Week Placebo-controlled Period|Withdrawal by Subject|2|||
147291552|NCT04818346|531232237|FG000|24-Week Placebo-controlled Period|Subject Terminated by Sponsor|1|||
147291553|NCT04818346|531232238|FG001|24-Week Placebo-controlled Period|Subject Terminated by Sponsor|0|||
147291554|NCT04818346|531232239|FG002|24-Week Placebo-controlled Period|Subject Terminated by Sponsor|0|||
147338359|NCT02564744|531407017|FG004|Overall Study|Reason not specified|0|||
147338360|NCT00277355|531407026|FG000|Overall Study|Withdrawal by Subject|3|||
147291555|NCT04818346|531232240|FG003|24-Week Placebo-controlled Period|Subject Terminated by Sponsor|0|||
147291556|NCT04818346|531232237|FG000|24-Week Placebo-controlled Period|Latent Tuberculosis; Unable to Provide Proof of Treatment|1|||
147291557|NCT04818346|531232238|FG001|24-Week Placebo-controlled Period|Latent Tuberculosis; Unable to Provide Proof of Treatment|0|||
147291558|NCT04818346|531232239|FG002|24-Week Placebo-controlled Period|Latent Tuberculosis; Unable to Provide Proof of Treatment|0|||
147291559|NCT04818346|531232240|FG003|24-Week Placebo-controlled Period|Latent Tuberculosis; Unable to Provide Proof of Treatment|0|||
147291560|NCT04818346|531232237|FG000|24-Week Placebo-controlled Period|Use of Prohibited Concomitant Medication|0|||
147291561|NCT04818346|531232238|FG001|24-Week Placebo-controlled Period|Use of Prohibited Concomitant Medication|0|||
147291562|NCT04818346|531232239|FG002|24-Week Placebo-controlled Period|Use of Prohibited Concomitant Medication|1|||
147291563|NCT04818346|531232240|FG003|24-Week Placebo-controlled Period|Use of Prohibited Concomitant Medication|0|||
147291564|NCT04818346|531232237|FG000|24-Week Placebo-controlled Period|Ineligible to Be Included in the Study Due to Abnormal Coagulation Profile|0|||
147291565|NCT04818346|531232238|FG001|24-Week Placebo-controlled Period|Ineligible to Be Included in the Study Due to Abnormal Coagulation Profile|0|||
147291566|NCT04818346|531232239|FG002|24-Week Placebo-controlled Period|Ineligible to Be Included in the Study Due to Abnormal Coagulation Profile|0|||
147291567|NCT04818346|531232240|FG003|24-Week Placebo-controlled Period|Ineligible to Be Included in the Study Due to Abnormal Coagulation Profile|1|||
147291568|NCT04818346|531232237|FG000|28-Week Double-blind Extension Period|Adverse Event|1|||
147291569|NCT04818346|531232238|FG001|28-Week Double-blind Extension Period|Adverse Event|0|||
147291570|NCT04818346|531232239|FG002|28-Week Double-blind Extension Period|Adverse Event|1|||
147291571|NCT04818346|531232240|FG003|28-Week Double-blind Extension Period|Adverse Event|1|||
147291572|NCT04818346|531232237|FG000|28-Week Double-blind Extension Period|Lost to Follow-up|1|||
147291573|NCT04818346|531232238|FG001|28-Week Double-blind Extension Period|Lost to Follow-up|2|||
147291574|NCT04818346|531232239|FG002|28-Week Double-blind Extension Period|Lost to Follow-up|1|||
147291575|NCT04818346|531232240|FG003|28-Week Double-blind Extension Period|Lost to Follow-up|1|||
147291576|NCT04818346|531232237|FG000|28-Week Double-blind Extension Period|Withdrawal by Subject|0|||
147291577|NCT04818346|531232238|FG001|28-Week Double-blind Extension Period|Withdrawal by Subject|3|||
147291578|NCT04818346|531232239|FG002|28-Week Double-blind Extension Period|Withdrawal by Subject|4|||
147291579|NCT04818346|531232240|FG003|28-Week Double-blind Extension Period|Withdrawal by Subject|3|||
147291580|NCT04818346|531232237|FG000|28-Week Double-blind Extension Period|Non-compliance|0|||
147291581|NCT04818346|531232238|FG001|28-Week Double-blind Extension Period|Non-compliance|1|||
147291582|NCT04818346|531232239|FG002|28-Week Double-blind Extension Period|Non-compliance|0|||
147291583|NCT04818346|531232240|FG003|28-Week Double-blind Extension Period|Non-compliance|0|||
147291584|NCT04818346|531232237|FG000|28-Week Double-blind Extension Period|Non-compliance with Study Drug|0|||
147291585|NCT04818346|531232238|FG001|28-Week Double-blind Extension Period|Non-compliance with Study Drug|1|||
147291586|NCT04818346|531232239|FG002|28-Week Double-blind Extension Period|Non-compliance with Study Drug|0|||
147291587|NCT04818346|531232240|FG003|28-Week Double-blind Extension Period|Non-compliance with Study Drug|0|||
147291588|NCT04818346|531232237|FG000|28-Week Double-blind Extension Period|Scheduling Conflicts|0|||
147291589|NCT04818346|531232238|FG001|28-Week Double-blind Extension Period|Scheduling Conflicts|0|||
147291590|NCT04818346|531232239|FG002|28-Week Double-blind Extension Period|Scheduling Conflicts|0|||
147291591|NCT04818346|531232240|FG003|28-Week Double-blind Extension Period|Scheduling Conflicts|1|||
147291592|NCT03695172|531232241|FG000|Overall Study|Withdrawal by Subject|1|||
147291593|NCT03695172|531232242|FG001|Overall Study|Withdrawal by Subject|1|||
147291594|NCT03695172|531232243|FG002|Overall Study|Withdrawal by Subject|0|||
147291595|NCT02734212|531232244|FG000|Overall Study|Lost to Follow-up|5|||
147291596|NCT02734212|531232245|FG001|Overall Study|Lost to Follow-up|10|||
147291597|NCT04313881|531232248|FG000|Overall Study|Death|138|||
147291598|NCT04313881|531232249|FG001|Overall Study|Death|126|||
147291599|NCT04313881|531232248|FG000|Overall Study|Study terminated by sponsor|108|||
147291600|NCT04313881|531232249|FG001|Overall Study|Study terminated by sponsor|129|||
147291601|NCT04313881|531232248|FG000|Overall Study|Consent withdrawn|19|||
147291602|NCT04313881|531232249|FG001|Overall Study|Consent withdrawn|15|||
147291603|NCT04313881|531232248|FG000|Overall Study|Reason not Specified|3|||
147291604|NCT04313881|531232249|FG001|Overall Study|Reason not Specified|1|||
147291605|NCT00727272|531232250|FG000|Washout Period A|Adverse Event|0|||
147291606|NCT00727272|531232251|FG001|Washout Period A|Adverse Event|0|||
147291607|NCT00727272|531232252|FG002|Washout Period A|Adverse Event|1|||
147291608|NCT00727272|531232250|FG000|Washout Period B|Withdrawal by Subject|0|||
147291609|NCT00727272|531232251|FG001|Washout Period B|Withdrawal by Subject|0|||
147291610|NCT00727272|531232252|FG002|Washout Period B|Withdrawal by Subject|1|||
147291611|NCT00651664|531232253|FG000|Overall Study|Occurrence of Adverse Event(s)|0|||
147291612|NCT00651664|531232254|FG001|Overall Study|Occurrence of Adverse Event(s)|0|||
147291613|NCT00651664|531232255|FG002|Overall Study|Occurrence of Adverse Event(s)|0|||
147291614|NCT00651664|531232256|FG003|Overall Study|Occurrence of Adverse Event(s)|0|||
147291615|NCT00651664|531232257|FG004|Overall Study|Occurrence of Adverse Event(s)|0|||
147291616|NCT00651664|531232258|FG005|Overall Study|Occurrence of Adverse Event(s)|0|||
147291617|NCT00651664|531232259|FG006|Overall Study|Occurrence of Adverse Event(s)|1|||
147291618|NCT00651664|531232260|FG007|Overall Study|Occurrence of Adverse Event(s)|0|||
147291619|NCT00651664|531232261|FG008|Overall Study|Occurrence of Adverse Event(s)|1|||
147291620|NCT00651664|531232262|FG009|Overall Study|Occurrence of Adverse Event(s)|0|||
147291621|NCT00651664|531232253|FG000|Overall Study|Unsatisfactory Therapeutic Response|0|||
147291622|NCT00651664|531232254|FG001|Overall Study|Unsatisfactory Therapeutic Response|0|||
147291623|NCT00651664|531232255|FG002|Overall Study|Unsatisfactory Therapeutic Response|0|||
147291624|NCT00651664|531232256|FG003|Overall Study|Unsatisfactory Therapeutic Response|0|||
147291625|NCT00651664|531232257|FG004|Overall Study|Unsatisfactory Therapeutic Response|1|||
147291626|NCT00651664|531232258|FG005|Overall Study|Unsatisfactory Therapeutic Response|1|||
147291627|NCT00651664|531232259|FG006|Overall Study|Unsatisfactory Therapeutic Response|0|||
147291628|NCT00651664|531232260|FG007|Overall Study|Unsatisfactory Therapeutic Response|1|||
147291629|NCT00651664|531232261|FG008|Overall Study|Unsatisfactory Therapeutic Response|0|||
147291630|NCT00651664|531232262|FG009|Overall Study|Unsatisfactory Therapeutic Response|1|||
147291631|NCT00651664|531232253|FG000|Overall Study|Progressive Disease|3|||
147291632|NCT00651664|531232254|FG001|Overall Study|Progressive Disease|3|||
147291633|NCT00651664|531232255|FG002|Overall Study|Progressive Disease|3|||
147291634|NCT00651664|531232256|FG003|Overall Study|Progressive Disease|12|||
147291635|NCT00651664|531232257|FG004|Overall Study|Progressive Disease|4|||
147291636|NCT00651664|531232258|FG005|Overall Study|Progressive Disease|1|||
147291637|NCT00651664|531232259|FG006|Overall Study|Progressive Disease|3|||
147291638|NCT00651664|531232260|FG007|Overall Study|Progressive Disease|6|||
147291639|NCT00651664|531232261|FG008|Overall Study|Progressive Disease|5|||
147291640|NCT00651664|531232262|FG009|Overall Study|Progressive Disease|5|||
147291641|NCT00651664|531232253|FG000|Overall Study|Patient Declined Further Treatment|0|||
147291642|NCT00651664|531232254|FG001|Overall Study|Patient Declined Further Treatment|0|||
147291643|NCT00651664|531232255|FG002|Overall Study|Patient Declined Further Treatment|0|||
147291644|NCT00651664|531232256|FG003|Overall Study|Patient Declined Further Treatment|1|||
147291645|NCT00651664|531232257|FG004|Overall Study|Patient Declined Further Treatment|1|||
147291646|NCT00651664|531232258|FG005|Overall Study|Patient Declined Further Treatment|1|||
147291647|NCT00651664|531232259|FG006|Overall Study|Patient Declined Further Treatment|0|||
147291648|NCT00651664|531232260|FG007|Overall Study|Patient Declined Further Treatment|0|||
147291649|NCT00651664|531232261|FG008|Overall Study|Patient Declined Further Treatment|0|||
147291650|NCT00651664|531232262|FG009|Overall Study|Patient Declined Further Treatment|1|||
147291651|NCT00651664|531232253|FG000|Overall Study|Symptomatic Deterioration|0|||
147291652|NCT00651664|531232254|FG001|Overall Study|Symptomatic Deterioration|0|||
147291653|NCT00651664|531232255|FG002|Overall Study|Symptomatic Deterioration|0|||
147291654|NCT00651664|531232256|FG003|Overall Study|Symptomatic Deterioration|1|||
147291655|NCT00651664|531232257|FG004|Overall Study|Symptomatic Deterioration|0|||
147291656|NCT00651664|531232258|FG005|Overall Study|Symptomatic Deterioration|0|||
147291657|NCT00651664|531232259|FG006|Overall Study|Symptomatic Deterioration|1|||
147291658|NCT00651664|531232260|FG007|Overall Study|Symptomatic Deterioration|0|||
147291659|NCT00651664|531232261|FG008|Overall Study|Symptomatic Deterioration|1|||
147291660|NCT00651664|531232262|FG009|Overall Study|Symptomatic Deterioration|0|||
147291661|NCT00651664|531232253|FG000|Overall Study|Reason not Specified|0|||
147291662|NCT00651664|531232254|FG001|Overall Study|Reason not Specified|0|||
147291663|NCT00651664|531232255|FG002|Overall Study|Reason not Specified|0|||
147291664|NCT00651664|531232256|FG003|Overall Study|Reason not Specified|0|||
147291665|NCT00651664|531232257|FG004|Overall Study|Reason not Specified|0|||
147291666|NCT00651664|531232258|FG005|Overall Study|Reason not Specified|0|||
147291667|NCT00651664|531232259|FG006|Overall Study|Reason not Specified|1|||
147291668|NCT00651664|531232260|FG007|Overall Study|Reason not Specified|0|||
147291669|NCT00651664|531232261|FG008|Overall Study|Reason not Specified|0|||
147291670|NCT00651664|531232262|FG009|Overall Study|Reason not Specified|0|||
147291671|NCT00688636|531232263|FG000|Overall Study|Adverse Event|2|||
147291672|NCT00688636|531232264|FG001|Overall Study|Adverse Event|1|||
147291673|NCT01572727|531232265|FG000|Overall Study|Adverse Event|43|||
147291674|NCT01572727|531232266|FG001|Overall Study|Adverse Event|15|||
147291675|NCT01572727|531232265|FG000|Overall Study|Lost to Follow-up|1|||
147291676|NCT01572727|531232266|FG001|Overall Study|Lost to Follow-up|1|||
147291677|NCT01572727|531232265|FG000|Overall Study|Physician Decision|23|||
147291678|NCT01572727|531232266|FG001|Overall Study|Physician Decision|9|||
147338361|NCT00277355|531407027|FG001|Overall Study|Withdrawal by Subject|3|||
147338362|NCT00277355|531407026|FG000|Overall Study|Lost to Follow-up|2|||
147291679|NCT01572727|531232265|FG000|Overall Study|Progressive disease|59|||
147291680|NCT01572727|531232266|FG001|Overall Study|Progressive disease|82|||
147291681|NCT01572727|531232265|FG000|Overall Study|Protocol Violation|0|||
147291682|NCT01572727|531232266|FG001|Overall Study|Protocol Violation|1|||
147291683|NCT01572727|531232265|FG000|Overall Study|Study terminated by sponsor|61|||
147291684|NCT01572727|531232266|FG001|Overall Study|Study terminated by sponsor|83|||
147291685|NCT01572727|531232265|FG000|Overall Study|Parent/guardian decision|14|||
147291686|NCT01572727|531232266|FG001|Overall Study|Parent/guardian decision|9|||
147291687|NCT01572727|531232265|FG000|Overall Study|Death|2|||
147291688|NCT01572727|531232266|FG001|Overall Study|Death|2|||
147291689|NCT01572727|531232265|FG000|Overall Study|Untreated|4|||
147291690|NCT01572727|531232266|FG001|Overall Study|Untreated|7|||
147291691|NCT04053764|531232267|FG000|Overall Study|Withdrawal by Subject|6|||
147291692|NCT04053764|531232268|FG001|Overall Study|Withdrawal by Subject|2|||
147291693|NCT04053764|531232267|FG000|Overall Study|Physician Decision|2|||
147291694|NCT04053764|531232268|FG001|Overall Study|Physician Decision|1|||
147291695|NCT04053764|531232267|FG000|Overall Study|Adverse Event|1|||
147291696|NCT04053764|531232268|FG001|Overall Study|Adverse Event|0|||
147291697|NCT04053764|531232267|FG000|Overall Study|Pregnancy|1|||
147291698|NCT04053764|531232268|FG001|Overall Study|Pregnancy|0|||
147291699|NCT04732286|531232269|FG000|Overall Study|Progressive Disease|2|||
147291700|NCT04732286|531232269|FG000|Overall Study|Physician Decision|1|||
147291701|NCT04732286|531232269|FG000|Overall Study|Study Terminated by Sponsor|31|||
147291702|NCT04732286|531232269|FG000|Overall Study|Withdrawal by Subject|10|||
147291703|NCT04732286|531232269|FG000|Overall Study|Non-compliance With Study Drug|1|||
147291704|NCT04732286|531232269|FG000|Overall Study|Lost to Follow-up|4|||
147291705|NCT04732286|531232269|FG000|Overall Study|Death|51|||
147291706|NCT01954017|531232270|FG000|Overall Study|Adverse Event|0|||
147291707|NCT01954017|531232271|FG001|Overall Study|Adverse Event|0|||
147291708|NCT01954017|531232272|FG002|Overall Study|Adverse Event|1|||
147291709|NCT01954017|531232270|FG000|Overall Study|Death|2|||
147291710|NCT01954017|531232271|FG001|Overall Study|Death|1|||
147291711|NCT01954017|531232272|FG002|Overall Study|Death|1|||
147291712|NCT01954017|531232270|FG000|Overall Study|Withdrawal by Subject|0|||
147291713|NCT01954017|531232271|FG001|Overall Study|Withdrawal by Subject|1|||
147291714|NCT01954017|531232272|FG002|Overall Study|Withdrawal by Subject|0|||
147291715|NCT01954017|531232270|FG000|Overall Study|Protocol Violation|0|||
147291716|NCT01954017|531232271|FG001|Overall Study|Protocol Violation|3|||
147291717|NCT01954017|531232272|FG002|Overall Study|Protocol Violation|2|||
147291718|NCT01954017|531232270|FG000|Overall Study|Necrotizing enterocolitis|1|||
147604363|NCT04730349|532367886|FG000|Overall Study|Participant withdrew consent|1|||
147291719|NCT01954017|531232271|FG001|Overall Study|Necrotizing enterocolitis|0|||
147291720|NCT01954017|531232272|FG002|Overall Study|Necrotizing enterocolitis|1|||
147291721|NCT01954017|531232270|FG000|Overall Study|Enteral intake stopped >7 days|0|||
147291722|NCT01954017|531232271|FG001|Overall Study|Enteral intake stopped >7 days|1|||
147291723|NCT01954017|531232272|FG002|Overall Study|Enteral intake stopped >7 days|1|||
147291724|NCT01954017|531232270|FG000|Overall Study|All other reasons|2|||
147291725|NCT01954017|531232271|FG001|Overall Study|All other reasons|2|||
147291726|NCT01954017|531232272|FG002|Overall Study|All other reasons|7|||
147291727|NCT03346759|531232273|FG000|Enrollment to Baseline Data Collected|Lost to Follow-up|2|||
147291728|NCT03346759|531232274|FG001|Enrollment to Baseline Data Collected|Lost to Follow-up|3|||
147291729|NCT03346759|531232273|FG000|First Menstrual Cycle|Withdrawal by Subject|1|||
147291730|NCT03346759|531232274|FG001|First Menstrual Cycle|Withdrawal by Subject|0|||
147291731|NCT03346759|531232273|FG000|Second Menstrual Cycle|Lost to Follow-up|1|||
147291732|NCT03346759|531232274|FG001|Second Menstrual Cycle|Lost to Follow-up|0|||
147291733|NCT01453595|531232276|FG000|Overall Study|Dose Limiting Toxicity (DLT)|2|||
147291734|NCT01453595|531232277|FG001|Overall Study|Dose Limiting Toxicity (DLT)|1|||
147291735|NCT01453595|531232278|FG002|Overall Study|Dose Limiting Toxicity (DLT)|2|||
147291736|NCT01864564|531232284|FG000|Overall Study|Lost to Follow-up|17|||
147291737|NCT01864564|531232285|FG001|Overall Study|Lost to Follow-up|23|||
147291738|NCT01864564|531232284|FG000|Overall Study|Withdrawal by Subject|20|||
147291739|NCT01864564|531232285|FG001|Overall Study|Withdrawal by Subject|11|||
147291740|NCT01864564|531232284|FG000|Overall Study|Protocol Violation|0|||
147291741|NCT01864564|531232285|FG001|Overall Study|Protocol Violation|27|||
147291742|NCT01864564|531232284|FG000|Overall Study|not reported|0|||
147291743|NCT01864564|531232285|FG001|Overall Study|not reported|34|||
147291744|NCT00710424|531232288|FG000|Overall Study|Adverse Event|30|||
147291745|NCT00710424|531232289|FG001|Overall Study|Adverse Event|12|||
147291746|NCT00710424|531232288|FG000|Overall Study|Lack of Efficacy|4|||
147291747|NCT00710424|531232289|FG001|Overall Study|Lack of Efficacy|5|||
147338363|NCT00277355|531407027|FG001|Overall Study|Lost to Follow-up|2|||
147338364|NCT00277355|531407026|FG000|Overall Study|Adverse Event|5|||
147338365|NCT00277355|531407027|FG001|Overall Study|Adverse Event|0|||
147338366|NCT00277355|531407026|FG000|Overall Study|Death|3|||
147338367|NCT00277355|531407027|FG001|Overall Study|Death|0|||
147338368|NCT00277355|531407026|FG000|Overall Study|Physician Decision|1|||
147338369|NCT00277355|531407027|FG001|Overall Study|Physician Decision|0|||
147452678|NCT00705939|531820043|FG001|Overall Study|Protocol Violation|0|||
147604364|NCT04730349|532367887|FG001|Overall Study|Participant withdrew consent|0|||
147291748|NCT00710424|531232288|FG000|Overall Study|Withdrawal by Subject|5|||
147291749|NCT00710424|531232289|FG001|Overall Study|Withdrawal by Subject|3|||
147291750|NCT00710424|531232288|FG000|Overall Study|Lost to Follow-up|0|||
147291751|NCT00710424|531232289|FG001|Overall Study|Lost to Follow-up|1|||
147291752|NCT00710424|531232288|FG000|Overall Study|Refused medication, no side effects|1|||
147291753|NCT00710424|531232289|FG001|Overall Study|Refused medication, no side effects|0|||
147291754|NCT00710424|531232288|FG000|Overall Study|Non-compliance with stable analgesia|1|||
147291755|NCT00710424|531232289|FG001|Overall Study|Non-compliance with stable analgesia|0|||
147291756|NCT00710424|531232288|FG000|Overall Study|Did not meet entry criteria at visit 1|1|||
147291757|NCT00710424|531232289|FG001|Overall Study|Did not meet entry criteria at visit 1|0|||
147291758|NCT00710424|531232288|FG000|Overall Study|Subject thought medication changed|1|||
147338370|NCT02765100|531407028|FG000|Overall Study|subject found ineligible after baseline|1|||
147291759|NCT00710424|531232289|FG001|Overall Study|Subject thought medication changed|0|||
147291760|NCT00710424|531232288|FG000|Overall Study|Ceased treatment due to travel|1|||
147291761|NCT00710424|531232289|FG001|Overall Study|Ceased treatment due to travel|0|||
147291762|NCT00710424|531232288|FG000|Overall Study|Subject preferred paracetamol|0|||
147291763|NCT00710424|531232289|FG001|Overall Study|Subject preferred paracetamol|1|||
147291764|NCT00710424|531232288|FG000|Overall Study|Felt good so stopped treatment|0|||
147291765|NCT00710424|531232289|FG001|Overall Study|Felt good so stopped treatment|1|||
147291766|NCT00003508|531234159|FG000|Overall Study|Not evaluable|5|||
147291767|NCT02160314|531234160|FG000|Overall Study|Adverse Event|0|||
147291768|NCT02160314|531234161|FG001|Overall Study|Adverse Event|6|||
147291769|NCT02160314|531234160|FG000|Overall Study|Protocol Violation|0|||
147291770|NCT02160314|531234161|FG001|Overall Study|Protocol Violation|4|||
147291771|NCT02160314|531234160|FG000|Overall Study|Withdrawal by Subject|1|||
147291772|NCT02160314|531234161|FG001|Overall Study|Withdrawal by Subject|2|||
147291773|NCT02160314|531234160|FG000|Overall Study|Lost to Follow-up|0|||
147291774|NCT02160314|531234161|FG001|Overall Study|Lost to Follow-up|1|||
147291775|NCT00593567|531234162|FG000|Overall Study|Adverse Event|2|||
147291776|NCT00593567|531234163|FG001|Overall Study|Adverse Event|0|||
147291777|NCT00593567|531234162|FG000|Overall Study|Physician Decision|2|||
147291778|NCT00593567|531234163|FG001|Overall Study|Physician Decision|0|||
147291779|NCT00593567|531234162|FG000|Overall Study|Protocol Violation|13|||
147291780|NCT00593567|531234163|FG001|Overall Study|Protocol Violation|7|||
147291781|NCT00593567|531234162|FG000|Overall Study|Lack of Efficacy|2|||
147291782|NCT00593567|531234163|FG001|Overall Study|Lack of Efficacy|1|||
147291783|NCT00593567|531234162|FG000|Overall Study|Withdrawal by Subject|1|||
147291784|NCT00593567|531234163|FG001|Overall Study|Withdrawal by Subject|2|||
147291785|NCT00590902|531234169|FG000|Overall Study|Death|1|||
147291786|NCT00785291|531234170|FG000|Overall Study|Never began treatment|8|||
147291787|NCT00785291|531234171|FG001|Overall Study|Never began treatment|4|||
147291788|NCT00785291|531234172|FG002|Overall Study|Never began treatment|4|||
147291789|NCT00785291|531234170|FG000|Overall Study|Adverse Event|39|||
147291790|NCT00785291|531234171|FG001|Overall Study|Adverse Event|70|||
147291791|NCT00785291|531234172|FG002|Overall Study|Adverse Event|56|||
147291792|NCT00785291|531234170|FG000|Overall Study|Death|7|||
147291793|NCT00785291|531234171|FG001|Overall Study|Death|4|||
147291794|NCT00785291|531234172|FG002|Overall Study|Death|3|||
147291795|NCT00785291|531234170|FG000|Overall Study|Withdrawal by Subject|35|||
147291796|NCT00785291|531234171|FG001|Overall Study|Withdrawal by Subject|36|||
147291797|NCT00785291|531234172|FG002|Overall Study|Withdrawal by Subject|17|||
147291798|NCT00785291|531234170|FG000|Overall Study|Alternative Therapy|12|||
147291799|NCT00785291|531234171|FG001|Overall Study|Alternative Therapy|6|||
147291800|NCT00785291|531234172|FG002|Overall Study|Alternative Therapy|7|||
147291801|NCT00785291|531234170|FG000|Overall Study|Complicating illness|6|||
147291802|NCT00785291|531234171|FG001|Overall Study|Complicating illness|4|||
147291803|NCT00785291|531234172|FG002|Overall Study|Complicating illness|4|||
147291804|NCT00785291|531234170|FG000|Overall Study|Other Medical Reasons|29|||
147291805|NCT00785291|531234171|FG001|Overall Study|Other Medical Reasons|25|||
147291806|NCT00785291|531234172|FG002|Overall Study|Other Medical Reasons|15|||
147291807|NCT02119260|531234173|FG000|Overall Study|Adverse Event|1|||
147291808|NCT02119260|531234174|FG001|Overall Study|Adverse Event|0|||
147291809|NCT02119260|531234175|FG002|Overall Study|Adverse Event|0|||
147291810|NCT02119260|531234176|FG003|Overall Study|Adverse Event|0|||
147291811|NCT02119260|531234177|FG004|Overall Study|Adverse Event|0|||
147291812|NCT02119260|531234178|FG005|Overall Study|Adverse Event|0|||
147291813|NCT02119260|531234179|FG006|Overall Study|Adverse Event|0|||
147291814|NCT02119260|531234173|FG000|Overall Study|Withdrew consent|0|||
147291815|NCT02119260|531234174|FG001|Overall Study|Withdrew consent|1|||
147291816|NCT02119260|531234175|FG002|Overall Study|Withdrew consent|1|||
147291817|NCT02119260|531234176|FG003|Overall Study|Withdrew consent|0|||
147338371|NCT02765100|531407029|FG001|Overall Study|subject found ineligible after baseline|1|||
147338372|NCT02765100|531407028|FG000|Overall Study|Lost to Follow-up|0|||
147338373|NCT02765100|531407029|FG001|Overall Study|Lost to Follow-up|1|||
147338374|NCT02675244|531407039|FG000|Overall Study|Death|9|||
147338375|NCT02675244|531407040|FG001|Overall Study|Death|6|||
147291818|NCT02119260|531234177|FG004|Overall Study|Withdrew consent|0|||
147291819|NCT02119260|531234178|FG005|Overall Study|Withdrew consent|0|||
147291820|NCT02119260|531234179|FG006|Overall Study|Withdrew consent|0|||
147291821|NCT01986881|531234180|FG000|Overall Study|Death|228|||
147291822|NCT01986881|531234181|FG001|Overall Study|Death|233|||
147291823|NCT01986881|531234182|FG002|Overall Study|Death|247|||
147291824|NCT01986881|531234180|FG000|Overall Study|Lost to Follow-up|51|||
147291825|NCT01986881|531234181|FG001|Overall Study|Lost to Follow-up|44|||
147291826|NCT01986881|531234182|FG002|Overall Study|Lost to Follow-up|55|||
147291827|NCT01986881|531234180|FG000|Overall Study|Physician Decision|7|||
147291828|NCT01986881|531234181|FG001|Overall Study|Physician Decision|4|||
147338376|NCT02675244|531407039|FG000|Overall Study|Withdrawal by Subject|3|||
147338377|NCT02675244|531407040|FG001|Overall Study|Withdrawal by Subject|6|||
147291829|NCT01986881|531234182|FG002|Overall Study|Physician Decision|6|||
147291830|NCT01986881|531234180|FG000|Overall Study|Study Site Terminated by Sponsor|2|||
147452679|NCT00705939|531820044|FG002|Overall Study|Protocol Violation|1|||
147452680|NCT00705939|531820042|FG000|Overall Study|Withdrawal by Subject|0|||
147452681|NCT00705939|531820043|FG001|Overall Study|Withdrawal by Subject|1|||
147452682|NCT00705939|531820044|FG002|Overall Study|Withdrawal by Subject|3|||
147452683|NCT00705939|531820042|FG000|Overall Study|Physician Decision|0|||
147452684|NCT00705939|531820043|FG001|Overall Study|Physician Decision|1|||
147452685|NCT00705939|531820044|FG002|Overall Study|Physician Decision|0|||
147452686|NCT05048342|531820045|FG000|Overall Study|Adverse Event|1|||
147452687|NCT05048342|531820045|FG000|Overall Study|Subject decision|2|||
147452688|NCT01441063|531820046|FG000|Tocilizumab Alone|Required AZT/VGC addition|3|||
147452689|NCT01441063|531820046|FG000|Tocilizumab + Zidovudine /Valganciclovir|Worsening KSHV-MCD symptoms|1|||
147452690|NCT02275338|531820047|FG000|Overall Study|Adverse Event|15|||
147452691|NCT02275338|531820047|FG000|Overall Study|Lack of Efficacy|3|||
147452692|NCT02275338|531820047|FG000|Overall Study|Withdrawal by Subject|4|||
147452693|NCT02275338|531820047|FG000|Overall Study|Disease progression (death)|1|||
147452694|NCT02275338|531820047|FG000|Overall Study|Ineligible to start Phase 2|4|||
147452695|NCT02275338|531820047|FG000|Overall Study|Reason not specified|5|||
147452696|NCT02275338|531820047|FG000|Overall Study|Does not meet entry criteria|1|||
147452697|NCT00784654|531820050|FG000|Open-Label Period (Non-Randomized)|Adverse Event|44|||
147452698|NCT00784654|531820051|FG001|Open-Label Period (Non-Randomized)|Adverse Event|0|||
147452699|NCT00784654|531820052|FG002|Open-Label Period (Non-Randomized)|Adverse Event|0|||
147452700|NCT00784654|531820050|FG000|Open-Label Period (Non-Randomized)|Withdrawal by Subject|22|||
147452701|NCT00784654|531820051|FG001|Open-Label Period (Non-Randomized)|Withdrawal by Subject|0|||
147452702|NCT00784654|531820052|FG002|Open-Label Period (Non-Randomized)|Withdrawal by Subject|0|||
147452703|NCT00784654|531820050|FG000|Open-Label Period (Non-Randomized)|Lack of Efficacy|21|||
147452704|NCT00784654|531820051|FG001|Open-Label Period (Non-Randomized)|Lack of Efficacy|0|||
147452705|NCT00784654|531820052|FG002|Open-Label Period (Non-Randomized)|Lack of Efficacy|0|||
147452706|NCT00784654|531820050|FG000|Open-Label Period (Non-Randomized)|Lost to Follow-up|11|||
147452707|NCT00784654|531820051|FG001|Open-Label Period (Non-Randomized)|Lost to Follow-up|0|||
147452708|NCT00784654|531820052|FG002|Open-Label Period (Non-Randomized)|Lost to Follow-up|0|||
147452709|NCT00784654|531820050|FG000|Open-Label Period (Non-Randomized)|Protocol Violation|7|||
147452710|NCT00784654|531820051|FG001|Open-Label Period (Non-Randomized)|Protocol Violation|0|||
147452711|NCT00784654|531820052|FG002|Open-Label Period (Non-Randomized)|Protocol Violation|0|||
147452712|NCT00784654|531820050|FG000|Open-Label Period (Non-Randomized)|Mother is a drug addict|1|||
147452713|NCT00784654|531820051|FG001|Open-Label Period (Non-Randomized)|Mother is a drug addict|0|||
147452714|NCT00784654|531820052|FG002|Open-Label Period (Non-Randomized)|Mother is a drug addict|0|||
147452715|NCT00784654|531820050|FG000|Open-Label Period (Non-Randomized)|Decision of medical monitor|1|||
147452716|NCT00784654|531820051|FG001|Open-Label Period (Non-Randomized)|Decision of medical monitor|0|||
147452717|NCT00784654|531820052|FG002|Open-Label Period (Non-Randomized)|Decision of medical monitor|0|||
147452718|NCT00784654|531820050|FG000|Open-Label Period (Non-Randomized)|Home situation intolerable|1|||
147452719|NCT00784654|531820051|FG001|Open-Label Period (Non-Randomized)|Home situation intolerable|0|||
147452720|NCT00784654|531820052|FG002|Open-Label Period (Non-Randomized)|Home situation intolerable|0|||
147452721|NCT00784654|531820050|FG000|Open-Label Period (Non-Randomized)|ADHD-RS score too high for Random Phase|1|||
147452722|NCT00784654|531820051|FG001|Open-Label Period (Non-Randomized)|ADHD-RS score too high for Random Phase|0|||
147452723|NCT00784654|531820052|FG002|Open-Label Period (Non-Randomized)|ADHD-RS score too high for Random Phase|0|||
147291831|NCT01986881|531234181|FG001|Overall Study|Study Site Terminated by Sponsor|2|||
147291832|NCT01986881|531234182|FG002|Overall Study|Study Site Terminated by Sponsor|3|||
147291833|NCT01986881|531234180|FG000|Overall Study|Withdrawal by Subject|41|||
147291834|NCT01986881|531234181|FG001|Overall Study|Withdrawal by Subject|60|||
147291835|NCT01986881|531234182|FG002|Overall Study|Withdrawal by Subject|45|||
147291836|NCT01986881|531234180|FG000|Overall Study|Subject Moved|0|||
147291837|NCT01986881|531234181|FG001|Overall Study|Subject Moved|1|||
147291838|NCT01986881|531234182|FG002|Overall Study|Subject Moved|0|||
147291839|NCT01986881|531234180|FG000|Overall Study|Other|1|||
147291840|NCT01986881|531234181|FG001|Overall Study|Other|2|||
147291841|NCT01986881|531234182|FG002|Overall Study|Other|2|||
147291842|NCT02057874|531234183|FG000|Overall Study|participant did not return for scan|1|||
147452724|NCT00784654|531820050|FG000|Open-Label Period (Non-Randomized)|Met stopping criteria for CGI-S score|1|||
147452725|NCT00784654|531820051|FG001|Open-Label Period (Non-Randomized)|Met stopping criteria for CGI-S score|0|||
147452726|NCT00784654|531820052|FG002|Open-Label Period (Non-Randomized)|Met stopping criteria for CGI-S score|0|||
147604365|NCT04730349|532367886|FG000|Overall Study|Disease progression|6|||
147291843|NCT04205630|531234184|FG000|Overall Study|Disease progression per RECIST 1.1|37|||
147291844|NCT04205630|531234184|FG000|Overall Study|Disease clinical progression|7|||
147291845|NCT04205630|531234184|FG000|Overall Study|Withdrawal by Subject|2|||
147452727|NCT00784654|531820050|FG000|Open-Label Period (Non-Randomized)|Did not provide end of study page|1|||
147291846|NCT04205630|531234184|FG000|Overall Study|Adverse Event|17|||
147291847|NCT04205630|531234184|FG000|Overall Study|Other|1|||
147291848|NCT00886340|531234185|FG000|Overall Study|Withdrawal by Subject|0|||
147291849|NCT00886340|531234186|FG001|Overall Study|Withdrawal by Subject|7|||
147291850|NCT03224182|531234187|FG000|Overall Study|Study Drug Not Instilled|6|||
147291851|NCT03224182|531234188|FG001|Overall Study|Study Drug Not Instilled|1|||
147291852|NCT03224182|531234187|FG000|Overall Study|Histology Other than Low- to Intermediate-Risk NMIBC|22|||
147291853|NCT03224182|531234188|FG001|Overall Study|Histology Other than Low- to Intermediate-Risk NMIBC|11|||
147291854|NCT03224182|531234187|FG000|Overall Study|Withdrew of Consent|4|||
147291855|NCT03224182|531234188|FG001|Overall Study|Withdrew of Consent|2|||
147291856|NCT03224182|531234187|FG000|Overall Study|Investigator Decision|3|||
147291857|NCT03224182|531234188|FG001|Overall Study|Investigator Decision|1|||
147291858|NCT03224182|531234187|FG000|Overall Study|Sponsor Decision|26|||
147291859|NCT03224182|531234188|FG001|Overall Study|Sponsor Decision|12|||
147291860|NCT03224182|531234187|FG000|Overall Study|Participant Refused Follow-up Procedures/Cystoscopy|4|||
147291861|NCT03224182|531234188|FG001|Overall Study|Participant Refused Follow-up Procedures/Cystoscopy|0|||
147291862|NCT03224182|531234187|FG000|Overall Study|Lost to Follow-up|1|||
147291863|NCT03224182|531234188|FG001|Overall Study|Lost to Follow-up|0|||
147291864|NCT03224182|531234187|FG000|Overall Study|Participant Had Recurrence|11|||
147291865|NCT03224182|531234188|FG001|Overall Study|Participant Had Recurrence|5|||
147291866|NCT03224182|531234187|FG000|Overall Study|Death|0|||
147291867|NCT03224182|531234188|FG001|Overall Study|Death|1|||
147291868|NCT03224182|531234187|FG000|Overall Study|Reason not Specified|3|||
147291869|NCT03224182|531234188|FG001|Overall Study|Reason not Specified|3|||
147291870|NCT03224182|531234187|FG000|Overall Study|Other|1|||
147291871|NCT03224182|531234188|FG001|Overall Study|Other|0|||
147291872|NCT02481310|531234189|FG000|Follow up|Still in follow up|0|||
147291873|NCT02481310|531234190|FG001|Follow up|Still in follow up|3|||
147291874|NCT02481310|531234191|FG002|Follow up|Still in follow up|0|||
147291875|NCT02925455|531234196|FG000|Overall Study|Withdrawal by Subject|2|||
147291876|NCT02925455|531234197|FG001|Overall Study|Withdrawal by Subject|0|||
147291877|NCT00686166|531234198|FG000|Overall Study|Adverse Event|7|||
147291878|NCT00686166|531234198|FG000|Overall Study|Withdrawal by Subject|1|||
147291879|NCT00686166|531234198|FG000|Overall Study|Progression/Relapse|1|||
147291880|NCT00686166|531234198|FG000|Overall Study|Death|1|||
147291881|NCT00686166|531234198|FG000|Overall Study|Not Protocol Specified|1|||
147291882|NCT00686166|531234198|FG000|Overall Study|Ineligible|5|||
147291883|NCT00686166|531234198|FG000|Overall Study|Did not begin protocol therapy|4|||
147291884|NCT01514448|531234199|FG000|Overall Study|Death|7|||
147291885|NCT01514448|531234200|FG001|Overall Study|Death|8|||
147291886|NCT01514448|531234199|FG000|Overall Study|Withdrawal by Subject|2|||
147291887|NCT01514448|531234200|FG001|Overall Study|Withdrawal by Subject|0|||
147291888|NCT01514448|531234199|FG000|Overall Study|Lost to Follow-up|2|||
147291889|NCT01514448|531234200|FG001|Overall Study|Lost to Follow-up|0|||
147291890|NCT01514448|531234199|FG000|Overall Study|New Cancer Therapy|1|||
147291891|NCT01514448|531234200|FG001|Overall Study|New Cancer Therapy|0|||
147291892|NCT02314624|531234201|FG000|Overall Study|No participating patient|16|||
147291893|NCT02314624|531234202|FG001|Overall Study|No participating patient|13|||
147291894|NCT02314624|531234201|FG000|Overall Study|Participant withdrew|7|||
147291895|NCT02314624|531234202|FG001|Overall Study|Participant withdrew|2|||
147291896|NCT02314624|531234201|FG000|Overall Study|Lost to Follow-up|2|||
147291897|NCT02314624|531234202|FG001|Overall Study|Lost to Follow-up|5|||
147291898|NCT02314624|531234201|FG000|Overall Study|Dropped/Excluded by PI|6|||
147291899|NCT02314624|531234202|FG001|Overall Study|Dropped/Excluded by PI|6|||
147291900|NCT03912259|531234205|FG000|Overall Study|Adverse Event (AE)|2|||
147291901|NCT03912259|531234206|FG001|Overall Study|Adverse Event (AE)|4|||
147291902|NCT03912259|531234205|FG000|Overall Study|Lack of Efficacy|4|||
147291903|NCT03912259|531234206|FG001|Overall Study|Lack of Efficacy|1|||
147291904|NCT03912259|531234205|FG000|Overall Study|Withdrawal by Subject|11|||
147291905|NCT03912259|531234206|FG001|Overall Study|Withdrawal by Subject|1|||
147291906|NCT00360308|531234207|FG000|Overall Study|Adverse Event|15|||
147291907|NCT00360308|531234208|FG001|Overall Study|Adverse Event|14|||
147291908|NCT00360308|531234209|FG002|Overall Study|Adverse Event|25|||
147291909|NCT00360308|531234207|FG000|Overall Study|Abnormal Laboratory Value(s)|0|||
147291910|NCT00360308|531234208|FG001|Overall Study|Abnormal Laboratory Value(s)|1|||
147291911|NCT00360308|531234209|FG002|Overall Study|Abnormal Laboratory Value(s)|0|||
147291912|NCT00360308|531234207|FG000|Overall Study|Protocol Violation|2|||
147291913|NCT00360308|531234208|FG001|Overall Study|Protocol Violation|1|||
147291914|NCT00360308|531234209|FG002|Overall Study|Protocol Violation|2|||
147291915|NCT00360308|531234207|FG000|Overall Study|Withdrawal by Subject|11|||
147291916|NCT00360308|531234208|FG001|Overall Study|Withdrawal by Subject|7|||
147291917|NCT00360308|531234209|FG002|Overall Study|Withdrawal by Subject|14|||
147291918|NCT00360308|531234207|FG000|Overall Study|Lack of Efficacy|3|||
147291919|NCT00360308|531234208|FG001|Overall Study|Lack of Efficacy|0|||
147291920|NCT00360308|531234209|FG002|Overall Study|Lack of Efficacy|2|||
147291921|NCT00360308|531234207|FG000|Overall Study|Other|2|||
147291922|NCT00360308|531234208|FG001|Overall Study|Other|1|||
147291923|NCT00360308|531234209|FG002|Overall Study|Other|1|||
147291924|NCT00360308|531234207|FG000|Overall Study|Study termination by sponsor|43|||
147291925|NCT00360308|531234208|FG001|Overall Study|Study termination by sponsor|55|||
147291926|NCT00360308|531234209|FG002|Overall Study|Study termination by sponsor|44|||
147291927|NCT04786444|531234210|FG000|Overall Study|Withdrawal by Subject|4|||
147291928|NCT04786444|531234211|FG001|Overall Study|Withdrawal by Subject|7|||
147291929|NCT04786444|531234212|FG002|Overall Study|Withdrawal by Subject|2|||
147291930|NCT04786444|531234210|FG000|Overall Study|Lost to Follow-up|11|||
147291931|NCT04786444|531234211|FG001|Overall Study|Lost to Follow-up|9|||
147291932|NCT04786444|531234212|FG002|Overall Study|Lost to Follow-up|10|||
147291933|NCT04786444|531234210|FG000|Overall Study|Subject would like to become pregnant|0|||
147291934|NCT04786444|531234211|FG001|Overall Study|Subject would like to become pregnant|1|||
147291935|NCT04786444|531234212|FG002|Overall Study|Subject would like to become pregnant|0|||
147291936|NCT04969198|531234219|FG000|Overall Study|Withdrawal by Subject|20|||
147291937|NCT04969198|531234219|FG000|Overall Study|Withdrawn by PI for Participant Non-Compliance|16|||
147291938|NCT04969198|531234219|FG000|Overall Study|Lost to Follow-up|20|||
147291939|NCT04391023|531234220|FG000|Overall Study|Withdrawal by Subject|2|||
147291940|NCT04391023|531234221|FG001|Overall Study|Withdrawal by Subject|2|||
147291941|NCT04009291|531234225|FG000|Open-Label Period (Weeks 4 to 266)|Withdrawal by Subject|0|||
147291942|NCT04009291|531234226|FG001|Open-Label Period (Weeks 4 to 266)|Withdrawal by Subject|0|||
147291943|NCT04009291|531234227|FG002|Open-Label Period (Weeks 4 to 266)|Withdrawal by Subject|0|||
147291944|NCT04009291|531234228|FG003|Open-Label Period (Weeks 4 to 266)|Withdrawal by Subject|0|||
147291945|NCT04009291|531234229|FG004|Open-Label Period (Weeks 4 to 266)|Withdrawal by Subject|1|||
147291946|NCT04009291|531234225|FG000|Open-Label Period (Weeks 4 to 266)|Study Ongoing|0|||
147291947|NCT04009291|531234226|FG001|Open-Label Period (Weeks 4 to 266)|Study Ongoing|0|||
147291948|NCT04009291|531234227|FG002|Open-Label Period (Weeks 4 to 266)|Study Ongoing|0|||
147291949|NCT04009291|531234228|FG003|Open-Label Period (Weeks 4 to 266)|Study Ongoing|0|||
147291950|NCT04009291|531234229|FG004|Open-Label Period (Weeks 4 to 266)|Study Ongoing|58|||
147291951|NCT01270347|531234230|FG000|Core Phase|Adverse Event|1|||
147291952|NCT01270347|531234231|FG001|Core Phase|Adverse Event|6|||
147291953|NCT01270347|531234230|FG000|Core Phase|Withdrawal by Subject|1|||
147291954|NCT01270347|531234231|FG001|Core Phase|Withdrawal by Subject|2|||
147291955|NCT01270347|531234230|FG000|Core Phase|Lost to Follow-up|0|||
147291956|NCT01270347|531234231|FG001|Core Phase|Lost to Follow-up|1|||
147291957|NCT01270347|531234230|FG000|Core Phase|Miscellaneous|8|||
147291958|NCT01270347|531234231|FG001|Core Phase|Miscellaneous|14|||
147291959|NCT01270347|531234230|FG000|Extension Phase|Adverse Event|1|||
147291960|NCT01270347|531234231|FG001|Extension Phase|Adverse Event|3|||
147291961|NCT01270347|531234230|FG000|Extension Phase|Withdrawal by Subject|3|||
147291962|NCT01270347|531234231|FG001|Extension Phase|Withdrawal by Subject|4|||
147291963|NCT01270347|531234230|FG000|Extension Phase|Miscellaneous|2|||
147291964|NCT01270347|531234231|FG001|Extension Phase|Miscellaneous|2|||
147291965|NCT02085408|531234232|FG000|Step 1: Induction|Disease Progression|19|||
147291966|NCT02085408|531234233|FG001|Step 1: Induction|Disease Progression|19|||
147291967|NCT02085408|531234232|FG000|Step 1: Induction|Adverse Event|18|||
147291968|NCT02085408|531234233|FG001|Step 1: Induction|Adverse Event|17|||
147291969|NCT02085408|531234232|FG000|Step 1: Induction|Death|33|||
147291970|NCT02085408|531234233|FG001|Step 1: Induction|Death|30|||
147291971|NCT02085408|531234232|FG000|Step 1: Induction|Withdrawal by Subject|16|||
147291972|NCT02085408|531234233|FG001|Step 1: Induction|Withdrawal by Subject|8|||
147291973|NCT02085408|531234232|FG000|Step 1: Induction|Alternative Therapy|15|||
147291974|NCT02085408|531234233|FG001|Step 1: Induction|Alternative Therapy|19|||
147291975|NCT02085408|531234232|FG000|Step 1: Induction|Complicating Disease|2|||
147291976|NCT02085408|531234233|FG001|Step 1: Induction|Complicating Disease|3|||
147291977|NCT02085408|531234232|FG000|Step 1: Induction|Other|27|||
147452728|NCT00784654|531820051|FG001|Open-Label Period (Non-Randomized)|Did not provide end of study page|0|||
147452729|NCT00784654|531820052|FG002|Open-Label Period (Non-Randomized)|Did not provide end of study page|0|||
147452730|NCT00784654|531820050|FG000|Randomized Withdrawal Period|Met relapse criteria per investigator|0|||
147452731|NCT00784654|531820051|FG001|Randomized Withdrawal Period|Met relapse criteria per investigator|8|||
147452732|NCT00784654|531820052|FG002|Randomized Withdrawal Period|Met relapse criteria per investigator|35|||
147291978|NCT02085408|531234233|FG001|Step 1: Induction|Other|39|||
147604366|NCT04730349|532367887|FG001|Overall Study|Disease progression|4|||
147291979|NCT02085408|531234232|FG000|Step 1: Induction|Never started treatment|6|||
147291980|NCT02085408|531234233|FG001|Step 1: Induction|Never started treatment|4|||
147291981|NCT02085408|531234232|FG000|Step 2: Consolidation|Disease Progression|5|||
147291982|NCT02085408|531234233|FG001|Step 2: Consolidation|Disease Progression|20|||
147291983|NCT02085408|531234232|FG000|Step 2: Consolidation|Adverse Event|9|||
147291984|NCT02085408|531234233|FG001|Step 2: Consolidation|Adverse Event|8|||
147291985|NCT02085408|531234232|FG000|Step 2: Consolidation|Death|4|||
147291986|NCT02085408|531234233|FG001|Step 2: Consolidation|Death|3|||
147291987|NCT02085408|531234232|FG000|Step 2: Consolidation|Withdrawal by Subject|8|||
147291988|NCT02085408|531234233|FG001|Step 2: Consolidation|Withdrawal by Subject|5|||
147291989|NCT02085408|531234232|FG000|Step 2: Consolidation|Alternative Therapy|9|||
147291990|NCT02085408|531234233|FG001|Step 2: Consolidation|Alternative Therapy|3|||
147291991|NCT02085408|531234232|FG000|Step 2: Consolidation|Complicating Disease|0|||
147291992|NCT02085408|531234233|FG001|Step 2: Consolidation|Complicating Disease|2|||
147291993|NCT02085408|531234232|FG000|Step 2: Consolidation|Other|6|||
147291994|NCT02085408|531234233|FG001|Step 2: Consolidation|Other|6|||
147291995|NCT02085408|531234232|FG000|Step 2: Consolidation|Never started treatment|4|||
147291996|NCT02085408|531234233|FG001|Step 2: Consolidation|Never started treatment|3|||
147291997|NCT02085408|531234232|FG000|Step 3: Maintenance|Disease Progression|13|||
147291998|NCT02085408|531234233|FG001|Step 3: Maintenance|Disease Progression|11|||
147291999|NCT02085408|531234232|FG000|Step 3: Maintenance|Adverse Event|2|||
147292000|NCT02085408|531234233|FG001|Step 3: Maintenance|Adverse Event|4|||
147292001|NCT02085408|531234232|FG000|Step 3: Maintenance|Death|1|||
147292002|NCT02085408|531234233|FG001|Step 3: Maintenance|Death|2|||
147292003|NCT02085408|531234232|FG000|Step 3: Maintenance|Alternative Therapy|1|||
147292004|NCT02085408|531234233|FG001|Step 3: Maintenance|Alternative Therapy|1|||
147292005|NCT02085408|531234232|FG000|Step 3: Maintenance|Complicating Disease|0|||
147292006|NCT02085408|531234233|FG001|Step 3: Maintenance|Complicating Disease|1|||
147292007|NCT02085408|531234232|FG000|Step 3: Maintenance|Other|3|||
147292008|NCT02085408|531234233|FG001|Step 3: Maintenance|Other|2|||
147292009|NCT02085408|531234232|FG000|Step 3: Maintenance|Never started treatment|5|||
147292010|NCT02085408|531234233|FG001|Step 3: Maintenance|Never started treatment|1|||
147292011|NCT02189798|531234234|FG000|Extended Use Phase|Withdrawal by Subject|0|||
147292012|NCT02189798|531234235|FG001|Extended Use Phase|Withdrawal by Subject|4|||
147292013|NCT02189798|531234234|FG000|Extended Use Phase|Physician Decision|1|||
147292014|NCT02189798|531234235|FG001|Extended Use Phase|Physician Decision|0|||
147292015|NCT02189798|531234234|FG000|Extended Use Phase|Desire to explore other commercial technology/Processor Upgrade|11|||
147292016|NCT02189798|531234235|FG001|Extended Use Phase|Desire to explore other commercial technology/Processor Upgrade|1|||
147292017|NCT02189798|531234234|FG000|Extended Use Phase|Explanted prior to 24 month visit|1|||
147292018|NCT02189798|531234235|FG001|Extended Use Phase|Explanted prior to 24 month visit|0|||
147292019|NCT02189798|531234234|FG000|Extended Use Phase|Travel Issues|2|||
147292020|NCT02189798|531234235|FG001|Extended Use Phase|Travel Issues|1|||
147292021|NCT02189798|531234234|FG000|Extended Use Phase|No longer perceiving a benefit from acoustic component|0|||
147292022|NCT02189798|531234235|FG001|Extended Use Phase|No longer perceiving a benefit from acoustic component|3|||
147292023|NCT05553808|531234238|FG000|Overall Study|Death|25|||
147292024|NCT05553808|531234239|FG001|Overall Study|Death|62|||
147292025|NCT05553808|531234238|FG000|Overall Study|Site Closed|6|||
147292026|NCT05553808|531234239|FG001|Overall Study|Site Closed|6|||
147292027|NCT05553808|531234238|FG000|Overall Study|Lost to Follow-up|1|||
147292028|NCT05553808|531234239|FG001|Overall Study|Lost to Follow-up|0|||
147292029|NCT05553808|531234238|FG000|Overall Study|Withdrawal by Subject|3|||
147292030|NCT05553808|531234239|FG001|Overall Study|Withdrawal by Subject|2|||
147292031|NCT02273141|531234242|FG000|Overall Study|Adverse Event|0|||
147292032|NCT02273141|531234243|FG001|Overall Study|Adverse Event|1|||
147292033|NCT02273141|531234242|FG000|Overall Study|Lost to Follow-up|1|||
147292034|NCT02273141|531234243|FG001|Overall Study|Lost to Follow-up|3|||
147292035|NCT02273141|531234242|FG000|Overall Study|Withdrawal by Subject|10|||
147292036|NCT02273141|531234243|FG001|Overall Study|Withdrawal by Subject|15|||
147292037|NCT02273141|531234242|FG000|Overall Study|Various|6|||
147292038|NCT02273141|531234243|FG001|Overall Study|Various|6|||
147292039|NCT01556438|531234244|FG000|Overall Study|Adverse Event|4|||
147292040|NCT01556438|531234245|FG001|Overall Study|Adverse Event|2|||
147292041|NCT01556438|531234244|FG000|Overall Study|Sponsor Decision|0|||
147292042|NCT01556438|531234245|FG001|Overall Study|Sponsor Decision|2|||
147292043|NCT01556438|531234244|FG000|Overall Study|Progressive Disease|0|||
147292044|NCT01556438|531234245|FG001|Overall Study|Progressive Disease|6|||
147292045|NCT01556438|531234244|FG000|Overall Study|Death|0|||
147292046|NCT01556438|531234245|FG001|Overall Study|Death|1|||
147292047|NCT00529399|531234246|FG000|Overall Study|Lost to Follow-up|1|||
147292048|NCT00529399|531234247|FG001|Overall Study|Lost to Follow-up|0|||
147292049|NCT00529399|531234248|FG002|Overall Study|Lost to Follow-up|1|||
147292050|NCT00529399|531234246|FG000|Overall Study|Withdrawal by Subject|1|||
147292051|NCT00529399|531234247|FG001|Overall Study|Withdrawal by Subject|0|||
147292052|NCT00529399|531234248|FG002|Overall Study|Withdrawal by Subject|1|||
147292053|NCT00529399|531234246|FG000|Overall Study|Non-compliant|0|||
147292054|NCT00529399|531234247|FG001|Overall Study|Non-compliant|1|||
147292055|NCT00529399|531234248|FG002|Overall Study|Non-compliant|0|||
147292056|NCT03206203|531234265|FG000|Treatment|Death|38|||
147292057|NCT03206203|531234266|FG001|Treatment|Death|26|||
147292058|NCT03206203|531234267|FG002|Treatment|Death|0|||
147292059|NCT03206203|531234265|FG000|Treatment|Withdrawal by Subject|1|||
147292060|NCT03206203|531234266|FG001|Treatment|Withdrawal by Subject|0|||
147452733|NCT00784654|531820050|FG000|Randomized Withdrawal Period|Lack of Efficacy|0|||
147452734|NCT00784654|531820051|FG001|Randomized Withdrawal Period|Lack of Efficacy|5|||
147292061|NCT03206203|531234267|FG002|Treatment|Withdrawal by Subject|0|||
147292062|NCT03206203|531234265|FG000|Treatment|Lost to Follow-up|4|||
147292063|NCT03206203|531234266|FG001|Treatment|Lost to Follow-up|0|||
147292064|NCT03206203|531234267|FG002|Treatment|Lost to Follow-up|0|||
147292065|NCT03206203|531234265|FG000|Treatment|N/A in Follow-Up|8|||
147292066|NCT03206203|531234266|FG001|Treatment|N/A in Follow-Up|1|||
147292067|NCT03206203|531234267|FG002|Treatment|N/A in Follow-Up|0|||
147292068|NCT03206203|531234265|FG000|Treatment|Disease progression|0|||
147292069|NCT03206203|531234266|FG001|Treatment|Disease progression|1|||
147292070|NCT03206203|531234267|FG002|Treatment|Disease progression|0|||
147292071|NCT03206203|531234265|FG000|Treatment|Refused follow-up|0|||
147292072|NCT03206203|531234266|FG001|Treatment|Refused follow-up|1|||
147292073|NCT03206203|531234267|FG002|Treatment|Refused follow-up|0|||
147292074|NCT03206203|531234265|FG000|Treatment|Cross over to Arm 1|0|||
147292075|NCT03206203|531234266|FG001|Treatment|Cross over to Arm 1|19|||
147292076|NCT03206203|531234267|FG002|Treatment|Cross over to Arm 1|0|||
147292077|NCT03206203|531234265|FG000|Optional Cross-Over|Death|0|||
147292078|NCT03206203|531234266|FG001|Optional Cross-Over|Death|0|||
147292079|NCT03206203|531234267|FG002|Optional Cross-Over|Death|14|||
147292080|NCT03206203|531234265|FG000|Optional Cross-Over|Refused follow-up|0|||
147292081|NCT03206203|531234266|FG001|Optional Cross-Over|Refused follow-up|0|||
147292082|NCT03206203|531234267|FG002|Optional Cross-Over|Refused follow-up|2|||
147292083|NCT03998618|531234268|FG000|Overall Study|Death|7|||
147292084|NCT03998618|531234269|FG001|Overall Study|Death|11|||
147292085|NCT03998618|531234268|FG000|Overall Study|hospice enrollment|3|||
147292086|NCT03998618|531234269|FG001|Overall Study|hospice enrollment|3|||
147292087|NCT03998618|531234268|FG000|Overall Study|Not feeling well/health problems|3|||
147292088|NCT03998618|531234269|FG001|Overall Study|Not feeling well/health problems|5|||
147292089|NCT03998618|531234268|FG000|Overall Study|Lost to Follow-up|6|||
147292090|NCT03998618|531234269|FG001|Overall Study|Lost to Follow-up|6|||
147292091|NCT03998618|531234268|FG000|Overall Study|Withdrawal by Subject|0|||
147292092|NCT03998618|531234269|FG001|Overall Study|Withdrawal by Subject|4|||
147292093|NCT01483924|531234270|FG000|Overall Study|Withdrawal by Subject|2|||
147292094|NCT01483924|531234271|FG001|Overall Study|Withdrawal by Subject|0|||
147292095|NCT01483924|531234272|FG002|Overall Study|Withdrawal by Subject|0|||
147292096|NCT01483924|531234273|FG003|Overall Study|Withdrawal by Subject|1|||
147292097|NCT01483924|531234274|FG004|Overall Study|Withdrawal by Subject|1|||
147292098|NCT01483924|531234270|FG000|Overall Study|Adverse Event|0|||
147292099|NCT01483924|531234271|FG001|Overall Study|Adverse Event|0|||
147292100|NCT01483924|531234272|FG002|Overall Study|Adverse Event|1|||
147292101|NCT01483924|531234273|FG003|Overall Study|Adverse Event|1|||
147292102|NCT01483924|531234274|FG004|Overall Study|Adverse Event|0|||
147292103|NCT01483924|531234270|FG000|Overall Study|Non-compliance|0|||
147292104|NCT01483924|531234271|FG001|Overall Study|Non-compliance|0|||
147292105|NCT01483924|531234272|FG002|Overall Study|Non-compliance|0|||
147292106|NCT01483924|531234273|FG003|Overall Study|Non-compliance|1|||
147292107|NCT01483924|531234274|FG004|Overall Study|Non-compliance|1|||
147292108|NCT01483924|531234270|FG000|Overall Study|Sponsor concern over ECG result|0|||
147292109|NCT01483924|531234271|FG001|Overall Study|Sponsor concern over ECG result|0|||
147292110|NCT01483924|531234272|FG002|Overall Study|Sponsor concern over ECG result|0|||
147292111|NCT01483924|531234273|FG003|Overall Study|Sponsor concern over ECG result|1|||
147292112|NCT01483924|531234274|FG004|Overall Study|Sponsor concern over ECG result|0|||
147292113|NCT00003298|531234275|FG000|Step 1 (Neoadjuvant Therapy)|Ineligible for step 1|1|||
147292114|NCT00003298|531234275|FG000|Step 1 (Neoadjuvant Therapy)|Adverse Event|3|||
147292115|NCT00003298|531234275|FG000|Surgery|Unresectable at surgery|3|||
147292116|NCT00003298|531234275|FG000|Surgery|Progression before surgery|2|||
147292117|NCT00003298|531234275|FG000|Surgery|Unevaluable and off study|2|||
147292118|NCT00003298|531234275|FG000|Re-register to Step 2 After Surgery|Less than 15 nodes examined|7|||
147292119|NCT00003298|531234275|FG000|Re-register to Step 2 After Surgery|Positive margins|5|||
147292120|NCT00003298|531234275|FG000|Re-register to Step 2 After Surgery|Other complications|2|||
147292121|NCT00003298|531234275|FG000|Re-register to Step 2 After Surgery|Reason unknown|1|||
147292122|NCT00003298|531234275|FG000|Re-register to Step 2 After Surgery|Ineligible due to tumor staging|3|||
147292123|NCT00003298|531234275|FG000|Step 2 (Adjuvant Therapy)|Ineligible|1|||
147292124|NCT00003298|531234275|FG000|Step 2 (Adjuvant Therapy)|Death|1|||
147292125|NCT00003298|531234275|FG000|Step 2 (Adjuvant Therapy)|Progression before starting treatment|1|||
147292126|NCT00003298|531234275|FG000|Step 2 (Adjuvant Therapy)|Excessive complication|1|||
147292127|NCT00003298|531234275|FG000|Step 2 (Adjuvant Therapy)|Withdrawal by Subject|2|||
147292128|NCT00335322|531234277|FG000|Overall Study|Randomised but withdrew prior to ART sta|1|||
147292129|NCT00335322|531234278|FG001|Overall Study|Randomised but withdrew prior to ART sta|2|||
147292130|NCT00335322|531234279|FG002|Overall Study|Randomised but withdrew prior to ART sta|2|||
147292131|NCT04330638|531234284|FG000|Overall Study|Adverse Event|9|||
147338378|NCT02675244|531407039|FG000|Overall Study|Lost to Follow-up|1|||
147338379|NCT02675244|531407040|FG001|Overall Study|Lost to Follow-up|1|||
147292132|NCT04330638|531234285|FG001|Overall Study|Adverse Event|10|||
147292133|NCT04330638|531234286|FG002|Overall Study|Adverse Event|15|||
147292134|NCT04330638|531234287|FG003|Overall Study|Adverse Event|6|||
147292135|NCT04330638|531234288|FG004|Overall Study|Adverse Event|10|||
147292136|NCT04330638|531234289|FG005|Overall Study|Adverse Event|5|||
147292137|NCT04330638|531234284|FG000|Overall Study|Other|2|||
147292138|NCT04330638|531234285|FG001|Overall Study|Other|2|||
147292139|NCT04330638|531234286|FG002|Overall Study|Other|5|||
147292140|NCT04330638|531234287|FG003|Overall Study|Other|1|||
147292141|NCT04330638|531234288|FG004|Overall Study|Other|3|||
147292142|NCT04330638|531234289|FG005|Overall Study|Other|2|||
147292143|NCT04330638|531234284|FG000|Overall Study|Withdrawal by Subject|4|||
147292144|NCT04330638|531234285|FG001|Overall Study|Withdrawal by Subject|0|||
147292145|NCT04330638|531234286|FG002|Overall Study|Withdrawal by Subject|0|||
147452735|NCT00784654|531820052|FG002|Randomized Withdrawal Period|Lack of Efficacy|18|||
147452736|NCT00784654|531820050|FG000|Randomized Withdrawal Period|Withdrawal by Subject|0|||
147452737|NCT00784654|531820051|FG001|Randomized Withdrawal Period|Withdrawal by Subject|1|||
147452738|NCT00784654|531820052|FG002|Randomized Withdrawal Period|Withdrawal by Subject|7|||
147452739|NCT00784654|531820050|FG000|Randomized Withdrawal Period|Protocol Violation|0|||
147292146|NCT04330638|531234287|FG003|Overall Study|Withdrawal by Subject|0|||
147292147|NCT04330638|531234288|FG004|Overall Study|Withdrawal by Subject|0|||
147292148|NCT04330638|531234289|FG005|Overall Study|Withdrawal by Subject|0|||
147292149|NCT04330638|531234284|FG000|Overall Study|Lost to Follow-up|3|||
147292150|NCT04330638|531234285|FG001|Overall Study|Lost to Follow-up|2|||
147292151|NCT04330638|531234286|FG002|Overall Study|Lost to Follow-up|3|||
147292152|NCT04330638|531234287|FG003|Overall Study|Lost to Follow-up|2|||
147292153|NCT04330638|531234288|FG004|Overall Study|Lost to Follow-up|3|||
147292154|NCT04330638|531234289|FG005|Overall Study|Lost to Follow-up|0|||
147292155|NCT01041638|531234291|FG000|Overall Study|Adverse Event|4|||
147292156|NCT01041638|531234291|FG000|Overall Study|Death|1|||
147292157|NCT01041638|531234291|FG000|Overall Study|Lack of Efficacy|7|||
147292158|NCT01041638|531234291|FG000|Overall Study|Physician Decision|4|||
147292159|NCT01041638|531234291|FG000|Overall Study|Withdrawal by Subject|11|||
147292160|NCT03152552|531234292|FG000|Treatment Period 1 (12 Weeks)|Death|0|||
147292161|NCT03152552|531234293|FG001|Treatment Period 1 (12 Weeks)|Death|1|||
147292162|NCT03152552|531234294|FG002|Treatment Period 1 (12 Weeks)|Death|0|||
147292163|NCT03152552|531234295|FG003|Treatment Period 1 (12 Weeks)|Death|0|||
147292164|NCT03152552|531234296|FG004|Treatment Period 1 (12 Weeks)|Death|1|||
147292165|NCT03152552|531234292|FG000|Treatment Period 1 (12 Weeks)|Protocol deviation|0|||
147292166|NCT03152552|531234293|FG001|Treatment Period 1 (12 Weeks)|Protocol deviation|1|||
147292167|NCT03152552|531234294|FG002|Treatment Period 1 (12 Weeks)|Protocol deviation|0|||
147292168|NCT03152552|531234295|FG003|Treatment Period 1 (12 Weeks)|Protocol deviation|0|||
147292169|NCT03152552|531234296|FG004|Treatment Period 1 (12 Weeks)|Protocol deviation|0|||
147292170|NCT03152552|531234292|FG000|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|8|||
147292171|NCT03152552|531234293|FG001|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|9|||
147292172|NCT03152552|531234294|FG002|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|19|||
147292173|NCT03152552|531234295|FG003|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|19|||
147292174|NCT03152552|531234296|FG004|Treatment Period 1 (12 Weeks)|Study terminated by sponsor|20|||
147292175|NCT03152552|531234292|FG000|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
147292176|NCT03152552|531234293|FG001|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
147292177|NCT03152552|531234294|FG002|Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
147292178|NCT03152552|531234295|FG003|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
147292179|NCT03152552|531234296|FG004|Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
147292180|NCT03152552|531234292|FG000|Treatment Period 1 (12 Weeks)|Technical problems|0|||
147292181|NCT03152552|531234293|FG001|Treatment Period 1 (12 Weeks)|Technical problems|0|||
147292182|NCT03152552|531234294|FG002|Treatment Period 1 (12 Weeks)|Technical problems|1|||
147292183|NCT03152552|531234295|FG003|Treatment Period 1 (12 Weeks)|Technical problems|0|||
147292184|NCT03152552|531234296|FG004|Treatment Period 1 (12 Weeks)|Technical problems|0|||
147292185|NCT03152552|531234292|FG000|Treatment Period 1 (12 Weeks)|Subject/guardian decision|0|||
147292186|NCT03152552|531234293|FG001|Treatment Period 1 (12 Weeks)|Subject/guardian decision|0|||
147292187|NCT03152552|531234294|FG002|Treatment Period 1 (12 Weeks)|Subject/guardian decision|0|||
147292188|NCT03152552|531234295|FG003|Treatment Period 1 (12 Weeks)|Subject/guardian decision|1|||
147292189|NCT03152552|531234296|FG004|Treatment Period 1 (12 Weeks)|Subject/guardian decision|0|||
147292190|NCT03152552|531234292|FG000|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|6|||
147292191|NCT03152552|531234293|FG001|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|5|||
147292192|NCT03152552|531234294|FG002|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|9|||
147292193|NCT03152552|531234295|FG003|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|9|||
147292194|NCT03152552|531234296|FG004|Treatment Period 2 (24 Weeks)|Study terminated by sponsor|11|||
147292195|NCT04084314|531234299|FG000|Overall Study|Subject/guardian decision|91|||
147292196|NCT04084314|531234299|FG000|Overall Study|Adverse Event|24|||
147292197|NCT04084314|531234299|FG000|Overall Study|Lost to Follow-up|19|||
147292198|NCT04084314|531234299|FG000|Overall Study|New therapy for study indication|9|||
147452740|NCT00784654|531820051|FG001|Randomized Withdrawal Period|Protocol Violation|2|||
147452741|NCT00784654|531820052|FG002|Randomized Withdrawal Period|Protocol Violation|1|||
147452742|NCT00784654|531820050|FG000|Randomized Withdrawal Period|Adverse Event|0|||
147452743|NCT00784654|531820051|FG001|Randomized Withdrawal Period|Adverse Event|1|||
147292199|NCT04084314|531234299|FG000|Overall Study|Pregnancy|9|||
147292200|NCT04084314|531234299|FG000|Overall Study|Withdrawal of informed consent|8|||
147292201|NCT04084314|531234299|FG000|Overall Study|Physician Decision|4|||
147292202|NCT04084314|531234299|FG000|Overall Study|Protocol Deviation|3|||
147292203|NCT03336619|531234300|FG000|Overall Study|Completed Study, but not positive for influenza by RT-PCR (not included in ITTI population)|192|||
147292204|NCT03336619|531234301|FG001|Overall Study|Completed Study, but not positive for influenza by RT-PCR (not included in ITTI population)|204|||
147292205|NCT03336619|531234300|FG000|Overall Study|Withdrawal by Subject|17|||
147292206|NCT03336619|531234301|FG001|Overall Study|Withdrawal by Subject|16|||
147452744|NCT00784654|531820052|FG002|Randomized Withdrawal Period|Adverse Event|1|||
147292207|NCT03336619|531234300|FG000|Overall Study|Adverse Event|2|||
147292208|NCT03336619|531234301|FG001|Overall Study|Adverse Event|5|||
147292209|NCT03336619|531234300|FG000|Overall Study|Physician Decision|3|||
147292210|NCT03336619|531234301|FG001|Overall Study|Physician Decision|0|||
147292211|NCT01300546|531234302|FG000|Overall Study|Withdrawal by Subject|1|||
147292212|NCT01300546|531234303|FG001|Overall Study|Withdrawal by Subject|0|||
147292213|NCT01300546|531234302|FG000|Overall Study|Lost to Follow-up|0|||
147292214|NCT01300546|531234303|FG001|Overall Study|Lost to Follow-up|2|||
147292215|NCT01300546|531234302|FG000|Overall Study|Lack of Efficacy|0|||
147292216|NCT01300546|531234303|FG001|Overall Study|Lack of Efficacy|3|||
147292217|NCT01300546|531234302|FG000|Overall Study|Adverse Event|0|||
147292218|NCT01300546|531234303|FG001|Overall Study|Adverse Event|1|||
147292219|NCT00983073|531234311|FG000|Titration and Optimal Dose Period|Adverse Event|19|||
147292220|NCT00983073|531234311|FG000|Titration and Optimal Dose Period|Withdrawal by Subject|11|||
147292221|NCT00983073|531234311|FG000|Titration and Optimal Dose Period|Lack of Efficacy|5|||
147292222|NCT00983073|531234311|FG000|Titration and Optimal Dose Period|Non-Compliance|1|||
147292223|NCT00983073|531234311|FG000|Titration and Optimal Dose Period|Other reason|4|||
147292224|NCT00983073|531234311|FG000|Maintenance Period|Adverse Event|5|||
147292225|NCT00983073|531234311|FG000|Maintenance Period|Withdrawal by Subject|2|||
147292226|NCT00983073|531234311|FG000|Maintenance Period|Lack of Efficacy|2|||
147292227|NCT00983073|531234311|FG000|Maintenance Period|Other Reason|7|||
147292228|NCT00234065|531234312|FG000|Overall Study|Adverse Event|268|||
147292229|NCT00234065|531234313|FG001|Overall Study|Adverse Event|166|||
147292230|NCT00234065|531234312|FG000|Overall Study|Withdrawal by Subject|73|||
147292231|NCT00234065|531234313|FG001|Overall Study|Withdrawal by Subject|56|||
147292232|NCT00234065|531234312|FG000|Overall Study|Physician Decision|23|||
147292233|NCT00234065|531234313|FG001|Overall Study|Physician Decision|22|||
147292234|NCT00234065|531234312|FG000|Overall Study|Not Classified|111|||
147292235|NCT00234065|531234313|FG001|Overall Study|Not Classified|112|||
147292236|NCT05557942|531234314|FG000|Overall Study|Death|0|||
147292237|NCT05557942|531234315|FG001|Overall Study|Death|0|||
147292238|NCT05557942|531234316|FG002|Overall Study|Death|0|||
147292239|NCT05557942|531234317|FG003|Overall Study|Death|2|||
147292240|NCT05557942|531234318|FG004|Overall Study|Death|1|||
147292241|NCT05557942|531234319|FG005|Overall Study|Death|1|||
147292242|NCT05557942|531234314|FG000|Overall Study|Physician Decision|1|||
147292243|NCT05557942|531234315|FG001|Overall Study|Physician Decision|1|||
147292244|NCT05557942|531234316|FG002|Overall Study|Physician Decision|2|||
147292245|NCT05557942|531234317|FG003|Overall Study|Physician Decision|3|||
147292246|NCT05557942|531234318|FG004|Overall Study|Physician Decision|0|||
147292247|NCT05557942|531234319|FG005|Overall Study|Physician Decision|2|||
147292248|NCT05557942|531234314|FG000|Overall Study|Study terminated by sponsor|17|||
147292249|NCT05557942|531234315|FG001|Overall Study|Study terminated by sponsor|17|||
147292250|NCT05557942|531234316|FG002|Overall Study|Study terminated by sponsor|14|||
147292251|NCT05557942|531234317|FG003|Overall Study|Study terminated by sponsor|40|||
147292252|NCT05557942|531234318|FG004|Overall Study|Study terminated by sponsor|45|||
147292253|NCT05557942|531234319|FG005|Overall Study|Study terminated by sponsor|37|||
147292254|NCT05557942|531234314|FG000|Overall Study|Protocol Violation|0|||
147292255|NCT05557942|531234315|FG001|Overall Study|Protocol Violation|0|||
147292256|NCT05557942|531234316|FG002|Overall Study|Protocol Violation|0|||
147292257|NCT05557942|531234317|FG003|Overall Study|Protocol Violation|0|||
147292258|NCT05557942|531234318|FG004|Overall Study|Protocol Violation|0|||
147292259|NCT05557942|531234319|FG005|Overall Study|Protocol Violation|1|||
147292260|NCT05557942|531234314|FG000|Overall Study|Withdrawal by Subject|0|||
147292261|NCT05557942|531234315|FG001|Overall Study|Withdrawal by Subject|0|||
147292262|NCT05557942|531234316|FG002|Overall Study|Withdrawal by Subject|0|||
147292263|NCT05557942|531234317|FG003|Overall Study|Withdrawal by Subject|0|||
147292264|NCT05557942|531234318|FG004|Overall Study|Withdrawal by Subject|2|||
147292265|NCT05557942|531234319|FG005|Overall Study|Withdrawal by Subject|0|||
147292266|NCT03776136|531234320|FG000|Overall Study|Death|85|||
147292267|NCT03776136|531234320|FG000|Overall Study|Withdrawal by Subject|3|||
147292268|NCT03776136|531234320|FG000|Overall Study|Sponsor Decision|15|||
147292269|NCT05245864|531234327|FG000|Overall Study|Withdrawal by Subject|1|||
147292270|NCT05245864|531234328|FG001|Overall Study|Withdrawal by Subject|1|||
147292271|NCT03576768|531235952|FG000|Overall Study|Lost to Follow-up|3|||
147292272|NCT03576768|531235953|FG001|Overall Study|Lost to Follow-up|3|||
147292273|NCT03576768|531235954|FG002|Overall Study|Lost to Follow-up|0|||
147292274|NCT03576768|531235955|FG003|Overall Study|Lost to Follow-up|0|||
147292275|NCT01549613|531235967|FG000|Overall Study|Lost to Follow-up|11|||
147292276|NCT01549613|531235968|FG001|Overall Study|Lost to Follow-up|11|||
147292277|NCT02216123|531235969|FG000|Overall Study|Lost to Follow-up|4|||
147292278|NCT02216123|531235970|FG001|Overall Study|Lost to Follow-up|2|||
147292279|NCT02216123|531235969|FG000|Overall Study|Withdrawal by Subject|2|||
147292280|NCT02216123|531235970|FG001|Overall Study|Withdrawal by Subject|0|||
147292281|NCT02131272|531235971|FG000|Overall Study|Withdrawal by parent|0|||
147292282|NCT02131272|531235972|FG001|Overall Study|Withdrawal by parent|1|||
147292283|NCT02131272|531235971|FG000|Overall Study|Withdrawal by Subject|0|||
147292284|NCT02131272|531235972|FG001|Overall Study|Withdrawal by Subject|1|||
147292285|NCT02131272|531235971|FG000|Overall Study|Withdrawal Criteria|1|||
147604367|NCT04730349|532367886|FG000|Overall Study|Study drug toxicity|0|||
147604368|NCT04730349|532367887|FG001|Overall Study|Study drug toxicity|1|||
147292286|NCT02131272|531235972|FG001|Overall Study|Withdrawal Criteria|0|||
147292287|NCT00381940|531235973|FG000|Overall Study|Lack of Efficacy|3|||
147292288|NCT00381940|531235973|FG000|Overall Study|Protocol Violation|1|||
147292289|NCT00381940|531235973|FG000|Overall Study|Ineligible|1|||
147292290|NCT03162224|531235974|FG000|Overall Study|Death|4|||
147292291|NCT03162224|531235975|FG001|Overall Study|Death|5|||
147292292|NCT03162224|531235976|FG002|Overall Study|Death|8|||
147292293|NCT03162224|531235974|FG000|Overall Study|Withdrawal by Subject|1|||
147292294|NCT03162224|531235975|FG001|Overall Study|Withdrawal by Subject|0|||
147292295|NCT03162224|531235976|FG002|Overall Study|Withdrawal by Subject|1|||
147292296|NCT03162224|531235974|FG000|Overall Study|Lost to Follow-up|0|||
147292297|NCT03162224|531235975|FG001|Overall Study|Lost to Follow-up|1|||
147292298|NCT03162224|531235976|FG002|Overall Study|Lost to Follow-up|0|||
147292299|NCT03162224|531235974|FG000|Overall Study|Other|6|||
147292300|NCT03162224|531235975|FG001|Overall Study|Other|2|||
147292301|NCT03162224|531235976|FG002|Overall Study|Other|1|||
147292302|NCT05159622|531235977|FG000|Overall Study|Lost to Follow-up|4|||
147292303|NCT05159622|531235978|FG001|Overall Study|Lost to Follow-up|5|||
147292304|NCT04162769|531235979|FG000|Double-blind Treatment (12-Week)|Adverse Event|2|||
147292305|NCT04162769|531235980|FG001|Double-blind Treatment (12-Week)|Adverse Event|5|||
147292306|NCT04162769|531235981|FG002|Double-blind Treatment (12-Week)|Adverse Event|0|||
147292307|NCT04162769|531235982|FG003|Double-blind Treatment (12-Week)|Adverse Event|0|||
147292308|NCT04162769|531235979|FG000|Double-blind Treatment (12-Week)|Withdrawal by Subject|4|||
147338380|NCT02675244|531407039|FG000|Overall Study|Ongoing at 2 Years|190|||
147338381|NCT02675244|531407040|FG001|Overall Study|Ongoing at 2 Years|185|||
147338382|NCT02652442|531407044|FG000|Centrifugation - Distance|Lost to Follow-up|1|||
147338383|NCT01177670|531407046|FG000|Overall Study|Study Terminated|115|||
147338384|NCT01177670|531407046|FG000|Overall Study|Physician Decision|50|||
147338385|NCT01177670|531407046|FG000|Overall Study|Withdrawal by Subject|4|||
147338386|NCT00391898|531407047|FG000|Overall Study|Adverse Event|3|||
147338387|NCT00391898|531407048|FG001|Overall Study|Adverse Event|0|||
147338388|NCT00391898|531407047|FG000|Overall Study|Other|8|||
147338389|NCT00391898|531407048|FG001|Overall Study|Other|10|||
147338390|NCT00309907|531407055|FG000|Overall Study|Death|4|||
147338391|NCT00309907|531407055|FG000|Overall Study|Physician Decision|1|||
147338392|NCT00309907|531407055|FG000|Overall Study|Ineligible|11|||
147338393|NCT00309907|531407055|FG000|Overall Study|Major infectious event|4|||
147338394|NCT00244855|531407056|FG000|Overall Study|Withdrawal by Subject|0|||
147338395|NCT00244855|531407057|FG001|Overall Study|Withdrawal by Subject|1|||
147338396|NCT00869258|531407058|FG000|Overall Study|Physician Decision|1|||
147338397|NCT02529995|531407060|FG000|Part A|Ongoing Study at Data Cut-off|14|||
147338398|NCT02529995|531407061|FG001|Part A|Ongoing Study at Data Cut-off|16|||
147338399|NCT02529995|531407060|FG000|Part A|Discontinued Study|1|||
147338400|NCT02529995|531407061|FG001|Part A|Discontinued Study|0|||
147338401|NCT02529995|531407060|FG000|Part B|Ongoing Study at Data Cut-off|0|||
147338402|NCT02529995|531407061|FG001|Part B|Ongoing Study at Data Cut-off|7|||
147338403|NCT02529995|531407060|FG000|Part B|Discontinued Study|6|||
147338404|NCT02529995|531407061|FG001|Part B|Discontinued Study|5|||
147338405|NCT01075217|531407066|FG000|Overall Study|Adverse Event|1|||
147338406|NCT01075217|531407067|FG001|Overall Study|Adverse Event|1|||
147338407|NCT01075217|531407066|FG000|Overall Study|Physician Decision|1|||
147338408|NCT01075217|531407067|FG001|Overall Study|Physician Decision|0|||
147338409|NCT00364013|531407070|FG000|Overall Study|Ineligibility determined|4|||
147338410|NCT00364013|531407071|FG001|Overall Study|Ineligibility determined|2|||
147338411|NCT00364013|531407070|FG000|Overall Study|Adverse Event|4|||
147338412|NCT00364013|531407071|FG001|Overall Study|Adverse Event|3|||
147338413|NCT00364013|531407070|FG000|Overall Study|Withdrawal by Subject|13|||
147338414|NCT00364013|531407071|FG001|Overall Study|Withdrawal by Subject|18|||
147338415|NCT00364013|531407070|FG000|Overall Study|Physician Decision|3|||
147338416|NCT00364013|531407071|FG001|Overall Study|Physician Decision|3|||
147338417|NCT00364013|531407070|FG000|Overall Study|Lost to Follow-up|10|||
147338418|NCT00364013|531407071|FG001|Overall Study|Lost to Follow-up|3|||
147604369|NCT03155945|532367896|FG000|Overall Study|Lost to Follow-up|0|||
147604370|NCT03155945|532367897|FG001|Overall Study|Lost to Follow-up|1|||
147292309|NCT04162769|531235980|FG001|Double-blind Treatment (12-Week)|Withdrawal by Subject|3|||
147338419|NCT00364013|531407070|FG000|Overall Study|Protocol-specified criteria|6|||
147604371|NCT03155945|532367896|FG000|Overall Study|Withdrawal by Subject|0|||
147292310|NCT04162769|531235981|FG002|Double-blind Treatment (12-Week)|Withdrawal by Subject|2|||
147338420|NCT00364013|531407071|FG001|Overall Study|Protocol-specified criteria|6|||
147338421|NCT00364013|531407070|FG000|Overall Study|Other|41|||
147292311|NCT04162769|531235982|FG003|Double-blind Treatment (12-Week)|Withdrawal by Subject|0|||
147292312|NCT04162769|531235979|FG000|Double-blind Treatment (12-Week)|Physician Decision|1|||
147338422|NCT00364013|531407071|FG001|Overall Study|Other|47|||
147604372|NCT03155945|532367897|FG001|Overall Study|Withdrawal by Subject|1|||
147604373|NCT03155945|532367896|FG000|Overall Study|Other Reason|0|||
147292313|NCT04162769|531235980|FG001|Double-blind Treatment (12-Week)|Physician Decision|0|||
147338423|NCT00364013|531407070|FG000|Overall Study|Ongoing|20|||
147292314|NCT04162769|531235981|FG002|Double-blind Treatment (12-Week)|Physician Decision|0|||
147292315|NCT04162769|531235982|FG003|Double-blind Treatment (12-Week)|Physician Decision|0|||
147292316|NCT04162769|531235979|FG000|Double-blind Treatment (12-Week)|Lost to Follow-up|5|||
147292317|NCT04162769|531235980|FG001|Double-blind Treatment (12-Week)|Lost to Follow-up|1|||
147292318|NCT04162769|531235981|FG002|Double-blind Treatment (12-Week)|Lost to Follow-up|6|||
147292319|NCT04162769|531235982|FG003|Double-blind Treatment (12-Week)|Lost to Follow-up|0|||
147292320|NCT04162769|531235979|FG000|Double-blind Treatment (12-Week)|Protocol deviation|1|||
147292321|NCT04162769|531235980|FG001|Double-blind Treatment (12-Week)|Protocol deviation|1|||
147292322|NCT04162769|531235981|FG002|Double-blind Treatment (12-Week)|Protocol deviation|0|||
147292323|NCT04162769|531235982|FG003|Double-blind Treatment (12-Week)|Protocol deviation|0|||
147292324|NCT04162769|531235979|FG000|Double-blind Treatment (12-Week)|Other|0|||
147292325|NCT04162769|531235980|FG001|Double-blind Treatment (12-Week)|Other|1|||
147292326|NCT04162769|531235981|FG002|Double-blind Treatment (12-Week)|Other|1|||
147292327|NCT04162769|531235982|FG003|Double-blind Treatment (12-Week)|Other|0|||
147292328|NCT04162769|531235979|FG000|OLE Period (52-Week)|Adverse Event|0|||
147292329|NCT04162769|531235980|FG001|OLE Period (52-Week)|Adverse Event|0|||
147292330|NCT04162769|531235981|FG002|OLE Period (52-Week)|Adverse Event|0|||
147292331|NCT04162769|531235982|FG003|OLE Period (52-Week)|Adverse Event|5|||
147292332|NCT04162769|531235979|FG000|OLE Period (52-Week)|Withdrawal by Subject|0|||
147292333|NCT04162769|531235980|FG001|OLE Period (52-Week)|Withdrawal by Subject|0|||
147292334|NCT04162769|531235981|FG002|OLE Period (52-Week)|Withdrawal by Subject|0|||
147292335|NCT04162769|531235982|FG003|OLE Period (52-Week)|Withdrawal by Subject|10|||
147292336|NCT04162769|531235979|FG000|OLE Period (52-Week)|Physician Decision|0|||
147292337|NCT04162769|531235980|FG001|OLE Period (52-Week)|Physician Decision|0|||
147292338|NCT04162769|531235981|FG002|OLE Period (52-Week)|Physician Decision|0|||
147292339|NCT04162769|531235982|FG003|OLE Period (52-Week)|Physician Decision|1|||
147292340|NCT04162769|531235979|FG000|OLE Period (52-Week)|Lost to Follow-up|0|||
147292341|NCT04162769|531235980|FG001|OLE Period (52-Week)|Lost to Follow-up|0|||
147292342|NCT04162769|531235981|FG002|OLE Period (52-Week)|Lost to Follow-up|0|||
147292343|NCT04162769|531235982|FG003|OLE Period (52-Week)|Lost to Follow-up|9|||
147292344|NCT04162769|531235979|FG000|OLE Period (52-Week)|Protocol deviation|0|||
147292345|NCT04162769|531235980|FG001|OLE Period (52-Week)|Protocol deviation|0|||
147292346|NCT04162769|531235981|FG002|OLE Period (52-Week)|Protocol deviation|0|||
147292347|NCT04162769|531235982|FG003|OLE Period (52-Week)|Protocol deviation|2|||
147292348|NCT00725452|531235984|FG000|Overall Study|Adverse Event|3|||
147292349|NCT00725452|531235984|FG000|Overall Study|Lack of Efficacy|2|||
147292350|NCT00725452|531235984|FG000|Overall Study|Reason not specified|1|||
147292351|NCT00725452|531235984|FG000|Overall Study|Physician Decision|1|||
147292352|NCT00725452|531235984|FG000|Overall Study|Withdrawal by Subject|3|||
147292353|NCT00725452|531235984|FG000|Overall Study|Lost to Follow-up|1|||
147292354|NCT02163733|531235985|FG000|Part B: Day 15 to End Part B (AZD9291)|Death|0|||
147292355|NCT02163733|531235986|FG001|Part B: Day 15 to End Part B (AZD9291)|Death|0|||
147292356|NCT02163733|531235987|FG002|Part B: Day 15 to End Part B (AZD9291)|Death|5|||
147292357|NCT02163733|531235985|FG000|Part B: Day 15 to End Part B (AZD9291)|Disease progression|0|||
147292358|NCT02163733|531235986|FG001|Part B: Day 15 to End Part B (AZD9291)|Disease progression|0|||
147292359|NCT02163733|531235987|FG002|Part B: Day 15 to End Part B (AZD9291)|Disease progression|19|||
147292360|NCT02723864|531235988|FG000|Overall Study|Refused further treatment|1|||
147292361|NCT02723864|531235989|FG001|Overall Study|Refused further treatment|0|||
147292362|NCT02723864|531235990|FG002|Overall Study|Refused further treatment|0|||
147292363|NCT02723864|531235991|FG003|Overall Study|Refused further treatment|0|||
147292364|NCT02723864|531235992|FG004|Overall Study|Refused further treatment|1|||
147292365|NCT02723864|531235993|FG005|Overall Study|Refused further treatment|2|||
147292366|NCT02723864|531235994|FG006|Overall Study|Refused further treatment|0|||
147292367|NCT02723864|531235988|FG000|Overall Study|Exceed treatment hold time|0|||
147292368|NCT02723864|531235989|FG001|Overall Study|Exceed treatment hold time|1|||
147292369|NCT02723864|531235990|FG002|Overall Study|Exceed treatment hold time|0|||
147292370|NCT02723864|531235991|FG003|Overall Study|Exceed treatment hold time|0|||
147292371|NCT02723864|531235992|FG004|Overall Study|Exceed treatment hold time|0|||
147292372|NCT02723864|531235993|FG005|Overall Study|Exceed treatment hold time|0|||
147292373|NCT02723864|531235994|FG006|Overall Study|Exceed treatment hold time|0|||
147292374|NCT02723864|531235988|FG000|Overall Study|Clinical progression|0|||
147292375|NCT02723864|531235989|FG001|Overall Study|Clinical progression|0|||
147292376|NCT02723864|531235990|FG002|Overall Study|Clinical progression|1|||
147292377|NCT02723864|531235991|FG003|Overall Study|Clinical progression|0|||
147292378|NCT02723864|531235992|FG004|Overall Study|Clinical progression|0|||
147292379|NCT02723864|531235993|FG005|Overall Study|Clinical progression|3|||
147292380|NCT02723864|531235994|FG006|Overall Study|Clinical progression|1|||
147452745|NCT00784654|531820050|FG000|Randomized Withdrawal Period|Did not complete a visit|0|||
147292381|NCT02723864|531235988|FG000|Overall Study|Physician Decision|0|||
147292382|NCT02723864|531235989|FG001|Overall Study|Physician Decision|0|||
147292383|NCT02723864|531235990|FG002|Overall Study|Physician Decision|0|||
147292384|NCT02723864|531235991|FG003|Overall Study|Physician Decision|0|||
147292385|NCT02723864|531235992|FG004|Overall Study|Physician Decision|0|||
147292386|NCT02723864|531235993|FG005|Overall Study|Physician Decision|0|||
147292387|NCT02723864|531235994|FG006|Overall Study|Physician Decision|1|||
147292388|NCT02723864|531235988|FG000|Overall Study|Changes in patient condition|0|||
147292389|NCT02723864|531235989|FG001|Overall Study|Changes in patient condition|0|||
147292390|NCT02723864|531235990|FG002|Overall Study|Changes in patient condition|0|||
147292391|NCT02723864|531235991|FG003|Overall Study|Changes in patient condition|0|||
147292392|NCT02723864|531235992|FG004|Overall Study|Changes in patient condition|0|||
147292393|NCT02723864|531235993|FG005|Overall Study|Changes in patient condition|1|||
147292394|NCT02723864|531235994|FG006|Overall Study|Changes in patient condition|0|||
147292395|NCT02723864|531235988|FG000|Overall Study|Patient choice|0|||
147292396|NCT02723864|531235989|FG001|Overall Study|Patient choice|0|||
147292397|NCT02723864|531235990|FG002|Overall Study|Patient choice|0|||
147292398|NCT02723864|531235991|FG003|Overall Study|Patient choice|0|||
147292399|NCT02723864|531235992|FG004|Overall Study|Patient choice|0|||
147292400|NCT02723864|531235993|FG005|Overall Study|Patient choice|1|||
147292401|NCT02723864|531235994|FG006|Overall Study|Patient choice|0|||
147292402|NCT02723864|531235988|FG000|Overall Study|Adverse Event|0|||
147292403|NCT02723864|531235989|FG001|Overall Study|Adverse Event|0|||
147292404|NCT02723864|531235990|FG002|Overall Study|Adverse Event|0|||
147292405|NCT02723864|531235991|FG003|Overall Study|Adverse Event|0|||
147292406|NCT02723864|531235992|FG004|Overall Study|Adverse Event|0|||
147292407|NCT02723864|531235993|FG005|Overall Study|Adverse Event|1|||
147292408|NCT02723864|531235994|FG006|Overall Study|Adverse Event|0|||
147292409|NCT02723864|531235988|FG000|Overall Study|Started new treatment|0|||
147292410|NCT02723864|531235989|FG001|Overall Study|Started new treatment|0|||
147292411|NCT02723864|531235990|FG002|Overall Study|Started new treatment|0|||
147292412|NCT02723864|531235991|FG003|Overall Study|Started new treatment|0|||
147292413|NCT02723864|531235992|FG004|Overall Study|Started new treatment|0|||
147292414|NCT02723864|531235993|FG005|Overall Study|Started new treatment|1|||
147292415|NCT02723864|531235994|FG006|Overall Study|Started new treatment|0|||
147292416|NCT02723864|531235988|FG000|Overall Study|Switched to alternative treatment|0|||
147292417|NCT02723864|531235989|FG001|Overall Study|Switched to alternative treatment|0|||
147292418|NCT02723864|531235990|FG002|Overall Study|Switched to alternative treatment|0|||
147292419|NCT02723864|531235991|FG003|Overall Study|Switched to alternative treatment|0|||
147292420|NCT02723864|531235992|FG004|Overall Study|Switched to alternative treatment|0|||
147292421|NCT02723864|531235993|FG005|Overall Study|Switched to alternative treatment|1|||
147292422|NCT02723864|531235994|FG006|Overall Study|Switched to alternative treatment|0|||
147292423|NCT02723864|531235988|FG000|Overall Study|Late determination of ineligibility|0|||
147292424|NCT02723864|531235989|FG001|Overall Study|Late determination of ineligibility|0|||
147292425|NCT02723864|531235990|FG002|Overall Study|Late determination of ineligibility|0|||
147292426|NCT02723864|531235991|FG003|Overall Study|Late determination of ineligibility|0|||
147292427|NCT02723864|531235992|FG004|Overall Study|Late determination of ineligibility|0|||
147292428|NCT02723864|531235993|FG005|Overall Study|Late determination of ineligibility|1|||
147292429|NCT02723864|531235994|FG006|Overall Study|Late determination of ineligibility|0|||
147292430|NCT00713648|531235997|FG000|Overall Study|Adverse Event|1|||
147292431|NCT00713648|531235997|FG000|Overall Study|Unclassified|2|||
147292432|NCT00713648|531235997|FG000|Overall Study|According to Protocol|2|||
147292433|NCT00713648|531235997|FG000|Overall Study|Development of antibodies|3|||
147292434|NCT00082173|531235998|FG000|Overall Study|Withdrawal by Subject|3|||
147292435|NCT00082173|531235999|FG001|Overall Study|Withdrawal by Subject|5|||
147292436|NCT00082173|531235998|FG000|Overall Study|Lost to Follow-up|1|||
147292437|NCT00082173|531235999|FG001|Overall Study|Lost to Follow-up|0|||
147292438|NCT00082173|531235998|FG000|Overall Study|Adverse Event|1|||
147292439|NCT00082173|531235999|FG001|Overall Study|Adverse Event|0|||
147292440|NCT00082173|531235998|FG000|Overall Study|Culture negative or resistant at baselin|5|||
147292441|NCT00082173|531235999|FG001|Overall Study|Culture negative or resistant at baselin|6|||
147292442|NCT01733732|531236000|FG000|Overall Study|Adverse Event|1|||
147292443|NCT01733732|531236001|FG001|Overall Study|Adverse Event|0|||
147604374|NCT03155945|532367897|FG001|Overall Study|Other Reason|1|||
147292444|NCT01733732|531236000|FG000|Overall Study|Did not attend all study visits|1|||
147292445|NCT01733732|531236001|FG001|Overall Study|Did not attend all study visits|0|||
147292446|NCT00746590|531236002|FG000|Overall Study|Death|1|||
147292447|NCT00464815|531236005|FG000|Overall Study|Withdrawal by Subject|6|||
147292448|NCT00464815|531236006|FG001|Overall Study|Withdrawal by Subject|3|||
147292449|NCT02633800|531236011|FG000|Overall Study|Death|3|||
147292450|NCT02633800|531236012|FG001|Overall Study|Death|3|||
147292451|NCT02633800|531236011|FG000|Overall Study|Reason not provided|1|||
147292452|NCT02633800|531236012|FG001|Overall Study|Reason not provided|0|||
147292453|NCT02633800|531236011|FG000|Overall Study|Radiologic(al) progression|23|||
147292454|NCT02633800|531236012|FG001|Overall Study|Radiologic(al) progression|23|||
147292455|NCT02633800|531236011|FG000|Overall Study|Clinical progression|3|||
147604375|NCT02013674|532367899|FG000|Overall Study|Death|0|||
147604376|NCT02013674|532367900|FG001|Overall Study|Death|1|||
147292456|NCT02633800|531236012|FG001|Overall Study|Clinical progression|6|||
147292457|NCT02633800|531236011|FG000|Overall Study|Study terminated by sponsor|6|||
147292458|NCT02633800|531236012|FG001|Overall Study|Study terminated by sponsor|5|||
147292459|NCT02633800|531236011|FG000|Overall Study|Adverse event, non-fatal|7|||
147292460|NCT02633800|531236012|FG001|Overall Study|Adverse event, non-fatal|2|||
147292461|NCT02633800|531236011|FG000|Overall Study|Withdrawal by Subject|0|||
147292462|NCT02633800|531236012|FG001|Overall Study|Withdrawal by Subject|3|||
147292463|NCT02633800|531236011|FG000|Overall Study|Patient Request|1|||
147292464|NCT02633800|531236012|FG001|Overall Study|Patient Request|1|||
147292465|NCT00254982|531236015|FG000|Overall Study|Other|2|||
147292466|NCT00254982|531236016|FG001|Overall Study|Other|1|||
147292467|NCT00254982|531236015|FG000|Overall Study|Lack of Efficacy|5|||
147292468|NCT00254982|531236016|FG001|Overall Study|Lack of Efficacy|3|||
147292469|NCT00254982|531236015|FG000|Overall Study|Lost to Follow-up|5|||
147292470|NCT00254982|531236016|FG001|Overall Study|Lost to Follow-up|3|||
147292471|NCT00254982|531236015|FG000|Overall Study|Adverse Event|18|||
147292472|NCT00254982|531236016|FG001|Overall Study|Adverse Event|16|||
147292473|NCT00254982|531236015|FG000|Overall Study|Withdrawal by Subject|1|||
147292474|NCT00254982|531236016|FG001|Overall Study|Withdrawal by Subject|1|||
147292475|NCT00254982|531236015|FG000|Overall Study|Inclusion/exclusion criteria violation|0|||
147292476|NCT00254982|531236016|FG001|Overall Study|Inclusion/exclusion criteria violation|2|||
147292477|NCT00254982|531236015|FG000|Overall Study|Protocol deviation|1|||
147292478|NCT00254982|531236016|FG001|Overall Study|Protocol deviation|1|||
147292479|NCT00254982|531236015|FG000|Overall Study|Diagnosis of Tuberculosis|1|||
147292480|NCT00254982|531236016|FG001|Overall Study|Diagnosis of Tuberculosis|1|||
147292481|NCT00254982|531236015|FG000|Overall Study|Malignancy|0|||
147292482|NCT00254982|531236016|FG001|Overall Study|Malignancy|2|||
147292483|NCT00254982|531236015|FG000|Overall Study|Opportunistic infection|1|||
147292484|NCT00254982|531236016|FG001|Overall Study|Opportunistic infection|0|||
147292485|NCT00254982|531236015|FG000|Overall Study|Abnormal liver function tests|2|||
147292486|NCT00254982|531236016|FG001|Overall Study|Abnormal liver function tests|1|||
147292487|NCT03643952|531236020|FG000|Overall Study|Lack of Efficacy|1|||
147292488|NCT01358968|531236021|FG000|Period 2|Adverse Event|0|||
147292489|NCT01358968|531236022|FG001|Period 2|Adverse Event|1|||
147292490|NCT01358968|531236023|FG002|Period 2|Adverse Event|0|||
147292491|NCT01358968|531236024|FG003|Period 2|Adverse Event|0|||
147292492|NCT01358968|531236021|FG000|Continued Access Phase|Progression of Disease|0|||
147292493|NCT01358968|531236022|FG001|Continued Access Phase|Progression of Disease|0|||
147292494|NCT01358968|531236023|FG002|Continued Access Phase|Progression of Disease|8|||
147292495|NCT01358968|531236024|FG003|Continued Access Phase|Progression of Disease|4|||
147292496|NCT01358968|531236021|FG000|Continued Access Phase|Protocol Violation|0|||
147292497|NCT01358968|531236022|FG001|Continued Access Phase|Protocol Violation|0|||
147292498|NCT01358968|531236023|FG002|Continued Access Phase|Protocol Violation|0|||
147292499|NCT01358968|531236024|FG003|Continued Access Phase|Protocol Violation|2|||
147292500|NCT01358968|531236021|FG000|Continued Access Phase|Withdrawal by Subject|0|||
147292501|NCT01358968|531236022|FG001|Continued Access Phase|Withdrawal by Subject|0|||
147292502|NCT01358968|531236023|FG002|Continued Access Phase|Withdrawal by Subject|3|||
147292503|NCT01358968|531236024|FG003|Continued Access Phase|Withdrawal by Subject|0|||
147292504|NCT01358968|531236021|FG000|Continued Access Phase|Death|0|||
147292505|NCT01358968|531236022|FG001|Continued Access Phase|Death|0|||
147292506|NCT01358968|531236023|FG002|Continued Access Phase|Death|1|||
147292507|NCT01358968|531236024|FG003|Continued Access Phase|Death|1|||
147292508|NCT00487162|531236027|FG000|Overall Study|Adverse Event|0|||
147292509|NCT00487162|531236028|FG001|Overall Study|Adverse Event|1|||
147292510|NCT00487162|531236027|FG000|Overall Study|Physician Decision|0|||
147292511|NCT00487162|531236028|FG001|Overall Study|Physician Decision|1|||
147292512|NCT00487162|531236027|FG000|Overall Study|Withdrawal by Subject|2|||
147292513|NCT00487162|531236028|FG001|Overall Study|Withdrawal by Subject|3|||
147292514|NCT00815295|531236029|FG000|Overall Study|Cetuximab hypersensitivity reaction|0|||
147292515|NCT00815295|531236030|FG001|Overall Study|Cetuximab hypersensitivity reaction|1|||
147292516|NCT00815295|531236031|FG002|Overall Study|Cetuximab hypersensitivity reaction|3|||
147292517|NCT04052204|531236032|FG000|Overall Study|Death|1|||
147292518|NCT04052204|531236033|FG001|Overall Study|Death|0|||
147292519|NCT04052204|531236034|FG002|Overall Study|Death|0|||
147292520|NCT04052204|531236032|FG000|Overall Study|Progressive disease|1|||
147292521|NCT04052204|531236033|FG001|Overall Study|Progressive disease|0|||
147292522|NCT04052204|531236034|FG002|Overall Study|Progressive disease|0|||
147292523|NCT04052204|531236032|FG000|Overall Study|Other|1|||
147292524|NCT04052204|531236033|FG001|Overall Study|Other|0|||
147292525|NCT04052204|531236034|FG002|Overall Study|Other|0|||
147292526|NCT03644186|531236053|FG000|Overall Study|Withdrawal by Subject|1|||
147292527|NCT03644186|531236054|FG001|Overall Study|Withdrawal by Subject|1|||
147292528|NCT02701985|531236057|FG000|Overall Study|Withdrawal by Subject|1|||
147292529|NCT02701985|531236058|FG001|Overall Study|Withdrawal by Subject|1|||
147292530|NCT02701985|531236057|FG000|Overall Study|Lost to Follow-up|1|||
147292531|NCT02701985|531236058|FG001|Overall Study|Lost to Follow-up|0|||
147292532|NCT02701985|531236057|FG000|Overall Study|Death|1|||
147292533|NCT02701985|531236058|FG001|Overall Study|Death|0|||
147292534|NCT02701985|531236057|FG000|Overall Study|Adverse Event|0|||
147292535|NCT02701985|531236058|FG001|Overall Study|Adverse Event|5|||
147292536|NCT01988779|531236062|FG000|Overall Study|Withdrawal by Subject|2|||
147292537|NCT01988779|531236063|FG001|Overall Study|Withdrawal by Subject|2|||
147292538|NCT01988779|531236062|FG000|Overall Study|Protocol Violation|1|||
147292539|NCT01988779|531236063|FG001|Overall Study|Protocol Violation|0|||
147292540|NCT00377403|531236064|FG000|Overall Study|Unable to contact for telephone intervie|4|||
147292541|NCT00377403|531236065|FG001|Overall Study|Unable to contact for telephone intervie|7|||
147292542|NCT00417079|531236067|FG000|Overall Study|Disease progression|267|||
147292543|NCT00417079|531236068|FG001|Overall Study|Disease progression|180|||
147292544|NCT00417079|531236067|FG000|Overall Study|Adverse Event|32|||
147292545|NCT00417079|531236068|FG001|Overall Study|Adverse Event|67|||
147292546|NCT00417079|531236067|FG000|Overall Study|Non-compliance to protocol|0|||
147292547|NCT00417079|531236068|FG001|Overall Study|Non-compliance to protocol|1|||
147292548|NCT00417079|531236067|FG000|Overall Study|Lost to Follow-up|2|||
147292549|NCT00417079|531236068|FG001|Overall Study|Lost to Follow-up|0|||
147292550|NCT00417079|531236067|FG000|Overall Study|Withdrawal by Subject|17|||
147292551|NCT00417079|531236068|FG001|Overall Study|Withdrawal by Subject|8|||
147292552|NCT00417079|531236067|FG000|Overall Study|Not treated|6|||
147292553|NCT00417079|531236068|FG001|Overall Study|Not treated|7|||
147292554|NCT00417079|531236067|FG000|Overall Study|Screened failure|2|||
147292555|NCT00417079|531236068|FG001|Overall Study|Screened failure|1|||
147292556|NCT00417079|531236067|FG000|Overall Study|Investigator's decision|1|||
147292557|NCT00417079|531236068|FG001|Overall Study|Investigator's decision|4|||
147292558|NCT00417079|531236067|FG000|Overall Study|Non-confirmed Disease progression|1|||
147292559|NCT00417079|531236068|FG001|Overall Study|Non-confirmed Disease progression|1|||
147292560|NCT00417079|531236067|FG000|Overall Study|Clinical deterioration|1|||
147292561|NCT00417079|531236068|FG001|Overall Study|Clinical deterioration|0|||
147292562|NCT00417079|531236067|FG000|Overall Study|Screening error|2|||
147292563|NCT00417079|531236068|FG001|Overall Study|Screening error|1|||
147292564|NCT00417079|531236067|FG000|Overall Study|Withdrawal by subject's family|0|||
147292565|NCT00417079|531236068|FG001|Overall Study|Withdrawal by subject's family|1|||
147292566|NCT00417079|531236067|FG000|Overall Study|Patient unable to come to the clinic|0|||
147292567|NCT00417079|531236068|FG001|Overall Study|Patient unable to come to the clinic|1|||
147292568|NCT00417079|531236067|FG000|Overall Study|abnormal liver function tests|0|||
147292569|NCT00417079|531236068|FG001|Overall Study|abnormal liver function tests|1|||
147292570|NCT01922076|531236071|FG000|Overall Study|Adverse Event|0|||
147292571|NCT01922076|531236072|FG001|Overall Study|Adverse Event|0|||
147292572|NCT01922076|531236073|FG002|Overall Study|Adverse Event|0|||
147292573|NCT01922076|531236074|FG003|Overall Study|Adverse Event|0|||
147292574|NCT01922076|531236075|FG004|Overall Study|Adverse Event|1|||
147292575|NCT01922076|531236076|FG005|Overall Study|Adverse Event|0|||
147292576|NCT01922076|531236077|FG006|Overall Study|Adverse Event|0|||
147292577|NCT01922076|531236071|FG000|Overall Study|Physician Decision|0|||
147292578|NCT01922076|531236072|FG001|Overall Study|Physician Decision|0|||
147292579|NCT01922076|531236073|FG002|Overall Study|Physician Decision|1|||
147292580|NCT01922076|531236074|FG003|Overall Study|Physician Decision|0|||
147292581|NCT01922076|531236075|FG004|Overall Study|Physician Decision|0|||
147292582|NCT01922076|531236076|FG005|Overall Study|Physician Decision|0|||
147292583|NCT01922076|531236077|FG006|Overall Study|Physician Decision|0|||
147292584|NCT01922076|531236071|FG000|Overall Study|Withdrawal by Subject|0|||
147292585|NCT01922076|531236072|FG001|Overall Study|Withdrawal by Subject|0|||
147292586|NCT01922076|531236073|FG002|Overall Study|Withdrawal by Subject|0|||
147292587|NCT01922076|531236074|FG003|Overall Study|Withdrawal by Subject|1|||
147292588|NCT01922076|531236075|FG004|Overall Study|Withdrawal by Subject|0|||
147292589|NCT01922076|531236076|FG005|Overall Study|Withdrawal by Subject|1|||
147292590|NCT01922076|531236077|FG006|Overall Study|Withdrawal by Subject|1|||
147292591|NCT01022762|531236078|FG000|Overall Study|Adverse Event|3|||
147292592|NCT01022762|531236079|FG001|Overall Study|Adverse Event|1|||
147292593|NCT01022762|531236078|FG000|Overall Study|Lack of Efficacy|0|||
147292594|NCT01022762|531236079|FG001|Overall Study|Lack of Efficacy|1|||
147292595|NCT01022762|531236078|FG000|Overall Study|Protocol Violation|7|||
147604377|NCT02013674|532367899|FG000|Overall Study|Lost to Follow-up|1|||
147292596|NCT01022762|531236079|FG001|Overall Study|Protocol Violation|6|||
147292597|NCT01022762|531236078|FG000|Overall Study|Unclassified|12|||
147292598|NCT01022762|531236079|FG001|Overall Study|Unclassified|20|||
147292599|NCT00802074|531236080|FG000|Overall Study|Adverse Event|1|||
147292600|NCT00802074|531236081|FG001|Overall Study|Adverse Event|1|||
147292601|NCT00802074|531236082|FG002|Overall Study|Adverse Event|1|||
147292602|NCT00802074|531236083|FG003|Overall Study|Adverse Event|0|||
147292603|NCT00802074|531236084|FG004|Overall Study|Adverse Event|0|||
147292604|NCT00802074|531236085|FG005|Overall Study|Adverse Event|0|||
147292605|NCT00802074|531236080|FG000|Overall Study|Withdrawal by Subject|1|||
147292606|NCT00802074|531236081|FG001|Overall Study|Withdrawal by Subject|0|||
147292607|NCT00802074|531236082|FG002|Overall Study|Withdrawal by Subject|0|||
147292608|NCT00802074|531236083|FG003|Overall Study|Withdrawal by Subject|0|||
147292609|NCT00802074|531236084|FG004|Overall Study|Withdrawal by Subject|0|||
147292610|NCT00802074|531236085|FG005|Overall Study|Withdrawal by Subject|0|||
147292611|NCT00827918|531236086|FG000|Overall Study|Adverse Event|4|||
147292612|NCT00827918|531236087|FG001|Overall Study|Adverse Event|0|||
147292613|NCT00827918|531236088|FG002|Overall Study|Adverse Event|0|||
147452746|NCT00784654|531820051|FG001|Randomized Withdrawal Period|Did not complete a visit|1|||
147452747|NCT00784654|531820052|FG002|Randomized Withdrawal Period|Did not complete a visit|0|||
147452748|NCT00784654|531820050|FG000|Randomized Withdrawal Period|Family reasons|0|||
147452749|NCT00784654|531820051|FG001|Randomized Withdrawal Period|Family reasons|0|||
147452750|NCT00784654|531820052|FG002|Randomized Withdrawal Period|Family reasons|1|||
147452751|NCT03461757|531820053|FG000|Overall Study|Adverse Event|1|||
147292614|NCT00827918|531236086|FG000|Overall Study|Lack of Efficacy|16|||
147292615|NCT00827918|531236087|FG001|Overall Study|Lack of Efficacy|4|||
147292616|NCT00827918|531236088|FG002|Overall Study|Lack of Efficacy|15|||
147292617|NCT00827918|531236086|FG000|Overall Study|Physician Decision|1|||
147292618|NCT00827918|531236087|FG001|Overall Study|Physician Decision|0|||
147292619|NCT00827918|531236088|FG002|Overall Study|Physician Decision|0|||
147292620|NCT00827918|531236086|FG000|Overall Study|Pregnancy|0|||
147292621|NCT00827918|531236087|FG001|Overall Study|Pregnancy|1|||
147292622|NCT00827918|531236088|FG002|Overall Study|Pregnancy|0|||
147292623|NCT00827918|531236086|FG000|Overall Study|Progressive Disease|1|||
147292624|NCT00827918|531236087|FG001|Overall Study|Progressive Disease|1|||
147292625|NCT00827918|531236088|FG002|Overall Study|Progressive Disease|0|||
147292626|NCT00827918|531236086|FG000|Overall Study|Protocol Violation|0|||
147292627|NCT00827918|531236087|FG001|Overall Study|Protocol Violation|1|||
147292628|NCT00827918|531236088|FG002|Overall Study|Protocol Violation|0|||
147292629|NCT00827918|531236086|FG000|Overall Study|Withdrawal by Subject|6|||
147292630|NCT00827918|531236087|FG001|Overall Study|Withdrawal by Subject|2|||
147292631|NCT00827918|531236088|FG002|Overall Study|Withdrawal by Subject|6|||
147292632|NCT03743038|531236091|FG000|Overall Study|Physician Decision|1|||
147292633|NCT01565707|531236092|FG000|Overall Study|Adverse Event|1|||
147292634|NCT01565707|531236093|FG001|Overall Study|Adverse Event|6|||
147292635|NCT01565707|531236094|FG002|Overall Study|Adverse Event|2|||
147292636|NCT01565707|531236095|FG003|Overall Study|Adverse Event|1|||
147292637|NCT01565707|531236092|FG000|Overall Study|Lost to Follow-up|1|||
147292638|NCT01565707|531236093|FG001|Overall Study|Lost to Follow-up|0|||
147292639|NCT01565707|531236094|FG002|Overall Study|Lost to Follow-up|0|||
147292640|NCT01565707|531236095|FG003|Overall Study|Lost to Follow-up|0|||
147292641|NCT01565707|531236092|FG000|Overall Study|Protocol Violation|1|||
147292642|NCT01565707|531236093|FG001|Overall Study|Protocol Violation|0|||
147292643|NCT01565707|531236094|FG002|Overall Study|Protocol Violation|0|||
147292644|NCT01565707|531236095|FG003|Overall Study|Protocol Violation|1|||
147292645|NCT01565707|531236092|FG000|Overall Study|Withdrawal by Subject|3|||
147338424|NCT00364013|531407071|FG001|Overall Study|Ongoing|13|||
147338425|NCT00293293|531407072|FG000|Overall Study|Withdrawal by Subject|1|||
147338426|NCT00293293|531407073|FG001|Overall Study|Withdrawal by Subject|1|||
147338427|NCT00293293|531407072|FG000|Overall Study|"Patient too anxious to complete trial"|1|||
147338428|NCT00293293|531407073|FG001|Overall Study|"Patient too anxious to complete trial"|0|||
147338429|NCT00293293|531407072|FG000|Overall Study|Patient discontinued chemotherapy|0|||
147338430|NCT00293293|531407073|FG001|Overall Study|Patient discontinued chemotherapy|1|||
147338431|NCT02512965|531407078|FG000|Overall Study|Withdrawal by Subject|0|||
147338432|NCT02512965|531407079|FG001|Overall Study|Withdrawal by Subject|4|||
147338433|NCT00835770|531407080|FG000|Overall Study|MS Relapse|17|||
147338434|NCT00835770|531407081|FG001|Overall Study|MS Relapse|23|||
147338435|NCT00835770|531407080|FG000|Overall Study|MS Progression|14|||
147338436|NCT00835770|531407081|FG001|Overall Study|MS Progression|9|||
147338437|NCT00835770|531407080|FG000|Overall Study|Adverse Event|113|||
147338438|NCT00835770|531407081|FG001|Overall Study|Adverse Event|124|||
147452752|NCT03461757|531820054|FG001|Overall Study|Adverse Event|0|||
147292646|NCT01565707|531236093|FG001|Overall Study|Withdrawal by Subject|1|||
147292647|NCT01565707|531236094|FG002|Overall Study|Withdrawal by Subject|1|||
147292648|NCT01565707|531236095|FG003|Overall Study|Withdrawal by Subject|1|||
147292649|NCT01565707|531236092|FG000|Overall Study|Randomized but not evaluable|2|||
147292650|NCT01565707|531236093|FG001|Overall Study|Randomized but not evaluable|0|||
147292651|NCT01565707|531236094|FG002|Overall Study|Randomized but not evaluable|0|||
147292652|NCT01565707|531236095|FG003|Overall Study|Randomized but not evaluable|0|||
147292653|NCT01565707|531236092|FG000|Overall Study|Miscellaneous|1|||
147292654|NCT01565707|531236093|FG001|Overall Study|Miscellaneous|1|||
147338439|NCT00835770|531407080|FG000|Overall Study|Lost to Follow-up|22|||
147452753|NCT03461757|531820053|FG000|Overall Study|Lost to Follow-up|13|||
147452754|NCT03461757|531820054|FG001|Overall Study|Lost to Follow-up|7|||
147452755|NCT03461757|531820053|FG000|Overall Study|Not Experienced Moderate/Severe Migraine|28|||
147452756|NCT03461757|531820054|FG001|Overall Study|Not Experienced Moderate/Severe Migraine|25|||
147452757|NCT03461757|531820053|FG000|Overall Study|Non-compliance with study treatment|0|||
147452758|NCT03461757|531820054|FG001|Overall Study|Non-compliance with study treatment|1|||
147452759|NCT03461757|531820053|FG000|Overall Study|Pregnancy|2|||
147452760|NCT03461757|531820054|FG001|Overall Study|Pregnancy|0|||
147452761|NCT03461757|531820053|FG000|Overall Study|Protocol Violation|1|||
147452762|NCT03461757|531820054|FG001|Overall Study|Protocol Violation|1|||
147452763|NCT03461757|531820053|FG000|Overall Study|Withdrawal by Subject|7|||
147452764|NCT03461757|531820054|FG001|Overall Study|Withdrawal by Subject|7|||
147452765|NCT03461757|531820053|FG000|Overall Study|Other Reasons|1|||
147452766|NCT03461757|531820054|FG001|Overall Study|Other Reasons|4|||
147292655|NCT01565707|531236094|FG002|Overall Study|Miscellaneous|0|||
147292656|NCT01565707|531236095|FG003|Overall Study|Miscellaneous|2|||
147292657|NCT05207813|531236096|FG000|Overall Study|Lost to Follow-up|2|||
147292658|NCT00617344|531236097|FG000|Overall Study|Serious adverse event|1|||
147292659|NCT00617344|531236098|FG001|Overall Study|Serious adverse event|0|||
147292660|NCT00617344|531236099|FG002|Overall Study|Serious adverse event|0|||
147292661|NCT00617344|531236097|FG000|Overall Study|Other Adverse Event|1|||
147292662|NCT00617344|531236098|FG001|Overall Study|Other Adverse Event|1|||
147292663|NCT00617344|531236099|FG002|Overall Study|Other Adverse Event|0|||
147292664|NCT00617344|531236097|FG000|Overall Study|Protocol Violation|10|||
147292665|NCT00617344|531236098|FG001|Overall Study|Protocol Violation|8|||
147292666|NCT00617344|531236099|FG002|Overall Study|Protocol Violation|5|||
147292667|NCT00617344|531236097|FG000|Overall Study|Lost to Follow-up|5|||
147292668|NCT00617344|531236098|FG001|Overall Study|Lost to Follow-up|4|||
147292669|NCT00617344|531236099|FG002|Overall Study|Lost to Follow-up|1|||
147292670|NCT00617344|531236097|FG000|Overall Study|Withdrawal by Subject|8|||
147292671|NCT00617344|531236098|FG001|Overall Study|Withdrawal by Subject|9|||
147292672|NCT00617344|531236099|FG002|Overall Study|Withdrawal by Subject|2|||
147292673|NCT01261338|531236105|FG000|Overall Study|Withdrawal by Subject|3|||
147292674|NCT01261338|531236106|FG001|Overall Study|Withdrawal by Subject|2|||
147292675|NCT01329029|531236107|FG000|Overall Study|Withdrawal by Subject|117|||
147292676|NCT01329029|531236108|FG001|Overall Study|Withdrawal by Subject|87|||
147292677|NCT01329029|531236107|FG000|Overall Study|Adverse Event|82|||
147292678|NCT01329029|531236108|FG001|Overall Study|Adverse Event|29|||
147292679|NCT01329029|531236107|FG000|Overall Study|Death|16|||
147292680|NCT01329029|531236108|FG001|Overall Study|Death|19|||
147292681|NCT01329029|531236107|FG000|Overall Study|Other|14|||
147292682|NCT01329029|531236108|FG001|Overall Study|Other|20|||
147292683|NCT01329029|531236107|FG000|Overall Study|COPD Exacerbation|11|||
147292684|NCT01329029|531236108|FG001|Overall Study|COPD Exacerbation|18|||
147292685|NCT01329029|531236107|FG000|Overall Study|Physician Decision|16|||
147292686|NCT01329029|531236108|FG001|Overall Study|Physician Decision|13|||
147292687|NCT01329029|531236107|FG000|Overall Study|Lost to Follow-up|8|||
147292688|NCT01329029|531236108|FG001|Overall Study|Lost to Follow-up|5|||
147292689|NCT01329029|531236107|FG000|Overall Study|Met Pre-defined Discontinuation Criteria|5|||
147292690|NCT01329029|531236108|FG001|Overall Study|Met Pre-defined Discontinuation Criteria|1|||
147292691|NCT02794285|531237459|FG000|Overall Study|Adverse Event|11|||
147292692|NCT02794285|531237460|FG001|Overall Study|Adverse Event|4|||
147292693|NCT02794285|531237461|FG002|Overall Study|Adverse Event|5|||
147292694|NCT02794285|531237462|FG003|Overall Study|Adverse Event|8|||
147292695|NCT02794285|531237459|FG000|Overall Study|Condition Under Investigation Improved|1|||
147292696|NCT02794285|531237460|FG001|Overall Study|Condition Under Investigation Improved|0|||
147292697|NCT02794285|531237461|FG002|Overall Study|Condition Under Investigation Improved|0|||
147292698|NCT02794285|531237462|FG003|Overall Study|Condition Under Investigation Improved|0|||
147292699|NCT02794285|531237459|FG000|Overall Study|Condition Under Investigation Worsened|0|||
147292700|NCT02794285|531237460|FG001|Overall Study|Condition Under Investigation Worsened|2|||
147292701|NCT02794285|531237461|FG002|Overall Study|Condition Under Investigation Worsened|1|||
147292702|NCT02794285|531237462|FG003|Overall Study|Condition Under Investigation Worsened|0|||
147292703|NCT02794285|531237459|FG000|Overall Study|Death|2|||
147292704|NCT02794285|531237460|FG001|Overall Study|Death|1|||
147338440|NCT00835770|531407081|FG001|Overall Study|Lost to Follow-up|19|||
147338441|NCT00835770|531407080|FG000|Overall Study|Consent Withdrawn|144|||
147338442|NCT00835770|531407081|FG001|Overall Study|Consent Withdrawn|156|||
147338443|NCT00835770|531407080|FG000|Overall Study|Investigator Decision|42|||
147338444|NCT00835770|531407081|FG001|Overall Study|Investigator Decision|42|||
147338445|NCT00835770|531407080|FG000|Overall Study|Participant Non-Compliance|11|||
147338446|NCT00835770|531407081|FG001|Overall Study|Participant Non-Compliance|9|||
147338447|NCT00835770|531407080|FG000|Overall Study|Death|4|||
147338448|NCT00835770|531407081|FG001|Overall Study|Death|6|||
147338449|NCT00835770|531407080|FG000|Overall Study|Other|115|||
147604378|NCT02013674|532367900|FG001|Overall Study|Lost to Follow-up|0|||
147604379|NCT03433755|532367904|FG000|Overall Study|Lost to Follow-up|1|||
147604380|NCT03433755|532367905|FG001|Overall Study|Lost to Follow-up|0|||
147604381|NCT03433755|532367906|FG002|Overall Study|Lost to Follow-up|0|||
147292705|NCT02794285|531237461|FG002|Overall Study|Death|2|||
147292706|NCT02794285|531237462|FG003|Overall Study|Death|0|||
147292707|NCT02794285|531237459|FG000|Overall Study|Development of Study-specific Withdrawal Criteria|1|||
147292708|NCT02794285|531237460|FG001|Overall Study|Development of Study-specific Withdrawal Criteria|0|||
147292709|NCT02794285|531237461|FG002|Overall Study|Development of Study-specific Withdrawal Criteria|0|||
147292710|NCT02794285|531237462|FG003|Overall Study|Development of Study-specific Withdrawal Criteria|1|||
147292711|NCT02794285|531237459|FG000|Overall Study|Failure to Meet Randomisation Criteria|0|||
147292712|NCT02794285|531237460|FG001|Overall Study|Failure to Meet Randomisation Criteria|0|||
147338450|NCT00835770|531407081|FG001|Overall Study|Other|104|||
147338451|NCT00835770|531407080|FG000|Overall Study|Other|2|||
147292713|NCT02794285|531237461|FG002|Overall Study|Failure to Meet Randomisation Criteria|1|||
147338452|NCT00835770|531407081|FG001|Overall Study|Other|1|||
147338453|NCT01185782|531407082|FG000|Overall Study|Adverse Event|0|||
147452767|NCT02425826|531820055|FG000|Placebo-controlled Phase (Week 0 - 16)|Adverse Event|5|||
147452768|NCT02425826|531820056|FG001|Placebo-controlled Phase (Week 0 - 16)|Adverse Event|2|||
147452769|NCT02425826|531820057|FG002|Placebo-controlled Phase (Week 0 - 16)|Adverse Event|0|||
147452770|NCT02425826|531820055|FG000|Placebo-controlled Phase (Week 0 - 16)|Lack of Efficacy|0|||
147452771|NCT02425826|531820056|FG001|Placebo-controlled Phase (Week 0 - 16)|Lack of Efficacy|1|||
147452772|NCT02425826|531820057|FG002|Placebo-controlled Phase (Week 0 - 16)|Lack of Efficacy|0|||
147452773|NCT02425826|531820055|FG000|Placebo-controlled Phase (Week 0 - 16)|Withdrawal by Subject|9|||
147452774|NCT02425826|531820056|FG001|Placebo-controlled Phase (Week 0 - 16)|Withdrawal by Subject|1|||
147452775|NCT02425826|531820057|FG002|Placebo-controlled Phase (Week 0 - 16)|Withdrawal by Subject|0|||
147452776|NCT02425826|531820055|FG000|Placebo-controlled Phase (Week 0 - 16)|Lost to Follow-up|10|||
147292714|NCT02794285|531237462|FG003|Overall Study|Failure to Meet Randomisation Criteria|0|||
147292715|NCT02794285|531237459|FG000|Overall Study|Lack of Efficacy|10|||
147292716|NCT02794285|531237460|FG001|Overall Study|Lack of Efficacy|6|||
147292717|NCT02794285|531237461|FG002|Overall Study|Lack of Efficacy|3|||
147292718|NCT02794285|531237462|FG003|Overall Study|Lack of Efficacy|3|||
147292719|NCT02794285|531237459|FG000|Overall Study|Lost to Follow-up|5|||
147292720|NCT02794285|531237460|FG001|Overall Study|Lost to Follow-up|6|||
147292721|NCT02794285|531237461|FG002|Overall Study|Lost to Follow-up|3|||
147292722|NCT02794285|531237462|FG003|Overall Study|Lost to Follow-up|1|||
147292723|NCT02794285|531237459|FG000|Overall Study|Severe Non-compliance to Protocol|1|||
147292724|NCT02794285|531237460|FG001|Overall Study|Severe Non-compliance to Protocol|2|||
147292725|NCT02794285|531237461|FG002|Overall Study|Severe Non-compliance to Protocol|1|||
147292726|NCT02794285|531237462|FG003|Overall Study|Severe Non-compliance to Protocol|0|||
147292727|NCT02794285|531237459|FG000|Overall Study|Withdrawal by Subject|38|||
147292728|NCT02794285|531237460|FG001|Overall Study|Withdrawal by Subject|29|||
147292729|NCT02794285|531237461|FG002|Overall Study|Withdrawal by Subject|20|||
147292730|NCT02794285|531237462|FG003|Overall Study|Withdrawal by Subject|12|||
147292731|NCT02794285|531237459|FG000|Overall Study|Missing|1|||
147292732|NCT02794285|531237460|FG001|Overall Study|Missing|0|||
147292733|NCT02794285|531237461|FG002|Overall Study|Missing|0|||
147292734|NCT02794285|531237462|FG003|Overall Study|Missing|0|||
147292735|NCT02794285|531237459|FG000|Overall Study|Due to COVID-19 Pandemic|7|||
147292736|NCT02794285|531237460|FG001|Overall Study|Due to COVID-19 Pandemic|2|||
147292737|NCT02794285|531237461|FG002|Overall Study|Due to COVID-19 Pandemic|4|||
147292738|NCT02794285|531237462|FG003|Overall Study|Due to COVID-19 Pandemic|0|||
147292739|NCT02794285|531237459|FG000|Overall Study|Other - Not Due to COVID-19 Pandemic|2|||
147292740|NCT02794285|531237460|FG001|Overall Study|Other - Not Due to COVID-19 Pandemic|6|||
147292741|NCT02794285|531237461|FG002|Overall Study|Other - Not Due to COVID-19 Pandemic|2|||
147292742|NCT02794285|531237462|FG003|Overall Study|Other - Not Due to COVID-19 Pandemic|1|||
147292743|NCT03252587|531237463|FG000|Overall Study|Adverse Event|3|||
147292744|NCT03252587|531237464|FG001|Overall Study|Adverse Event|8|||
147292745|NCT03252587|531237465|FG002|Overall Study|Adverse Event|6|||
147292746|NCT03252587|531237466|FG003|Overall Study|Adverse Event|12|||
147292747|NCT03252587|531237463|FG000|Overall Study|Lack of Efficacy|7|||
147292748|NCT03252587|531237464|FG001|Overall Study|Lack of Efficacy|2|||
147292749|NCT03252587|531237465|FG002|Overall Study|Lack of Efficacy|2|||
147292750|NCT03252587|531237466|FG003|Overall Study|Lack of Efficacy|4|||
147292751|NCT03252587|531237463|FG000|Overall Study|Lost to Follow-up|2|||
147292752|NCT03252587|531237464|FG001|Overall Study|Lost to Follow-up|0|||
147292753|NCT03252587|531237465|FG002|Overall Study|Lost to Follow-up|0|||
147292754|NCT03252587|531237466|FG003|Overall Study|Lost to Follow-up|2|||
147292755|NCT03252587|531237463|FG000|Overall Study|Pregnancy|2|||
147292756|NCT03252587|531237464|FG001|Overall Study|Pregnancy|1|||
147292757|NCT03252587|531237465|FG002|Overall Study|Pregnancy|0|||
147292758|NCT03252587|531237466|FG003|Overall Study|Pregnancy|1|||
147292759|NCT03252587|531237463|FG000|Overall Study|Withdrawal by Subject|8|||
147292760|NCT03252587|531237464|FG001|Overall Study|Withdrawal by Subject|4|||
147452777|NCT02425826|531820056|FG001|Placebo-controlled Phase (Week 0 - 16)|Lost to Follow-up|4|||
147452778|NCT02425826|531820057|FG002|Placebo-controlled Phase (Week 0 - 16)|Lost to Follow-up|0|||
147452779|NCT02425826|531820055|FG000|Placebo-controlled Phase (Week 0 - 16)|Other|3|||
147452780|NCT02425826|531820056|FG001|Placebo-controlled Phase (Week 0 - 16)|Other|1|||
147604382|NCT03433755|532367907|FG003|Overall Study|Lost to Follow-up|0|||
147604383|NCT03433755|532367904|FG000|Overall Study|Decision by Sponsor|1|||
147604384|NCT03433755|532367905|FG001|Overall Study|Decision by Sponsor|0|||
147292761|NCT03252587|531237465|FG002|Overall Study|Withdrawal by Subject|4|||
147604385|NCT03433755|532367906|FG002|Overall Study|Decision by Sponsor|0|||
147292762|NCT03252587|531237466|FG003|Overall Study|Withdrawal by Subject|4|||
147292763|NCT03252587|531237463|FG000|Overall Study|Other Reasons|2|||
147292764|NCT03252587|531237464|FG001|Overall Study|Other Reasons|5|||
147292765|NCT03252587|531237465|FG002|Overall Study|Other Reasons|5|||
147452781|NCT02425826|531820057|FG002|Placebo-controlled Phase (Week 0 - 16)|Other|0|||
147604386|NCT03433755|532367907|FG003|Overall Study|Decision by Sponsor|0|||
147604387|NCT05065567|532367911|FG000|Overall Study|Lost to Follow-up|10|||
147292766|NCT03252587|531237466|FG003|Overall Study|Other Reasons|4|||
147292767|NCT04124926|531237467|FG000|Healing Phase|Pretreatment Event, Adverse Event (AE), or Serious AE (SAE)|3|||
147292768|NCT04124926|531237468|FG001|Healing Phase|Pretreatment Event, Adverse Event (AE), or Serious AE (SAE)|7|||
147292769|NCT04124926|531237469|FG002|Healing Phase|Pretreatment Event, Adverse Event (AE), or Serious AE (SAE)|0|||
147292770|NCT04124926|531237470|FG003|Healing Phase|Pretreatment Event, Adverse Event (AE), or Serious AE (SAE)|0|||
147292771|NCT04124926|531237471|FG004|Healing Phase|Pretreatment Event, Adverse Event (AE), or Serious AE (SAE)|0|||
147292772|NCT04124926|531237467|FG000|Healing Phase|Protocol Violation|0|||
147292773|NCT04124926|531237468|FG001|Healing Phase|Protocol Violation|1|||
147292774|NCT04124926|531237469|FG002|Healing Phase|Protocol Violation|0|||
147292775|NCT04124926|531237470|FG003|Healing Phase|Protocol Violation|0|||
147292776|NCT04124926|531237471|FG004|Healing Phase|Protocol Violation|0|||
147292777|NCT04124926|531237467|FG000|Healing Phase|Lost to Follow-up|5|||
147292778|NCT04124926|531237468|FG001|Healing Phase|Lost to Follow-up|4|||
147292779|NCT04124926|531237469|FG002|Healing Phase|Lost to Follow-up|0|||
147604388|NCT05065567|532367912|FG001|Overall Study|Lost to Follow-up|9|||
147604389|NCT05065567|532367913|FG002|Overall Study|Lost to Follow-up|6|||
147604390|NCT03510598|532369673|FG000|Overall Study|Withdrawal by Subject|1|||
147604391|NCT04240392|532369674|FG000|Overall Study|Withdrawal by Subject|13|||
147604392|NCT04240392|532369675|FG001|Overall Study|Withdrawal by Subject|4|||
147604393|NCT04240392|532369674|FG000|Overall Study|Lost to Follow-up|11|||
147604394|NCT04240392|532369675|FG001|Overall Study|Lost to Follow-up|12|||
147604395|NCT03665441|532369683|FG000|Overall Study|survival follow up ongoing|23|||
147604396|NCT03665441|532369684|FG001|Overall Study|survival follow up ongoing|0|||
147604397|NCT03665441|532369683|FG000|Overall Study|Patients ongoing on treatment|9|||
147604398|NCT03665441|532369684|FG001|Overall Study|Patients ongoing on treatment|6|||
147604399|NCT03665441|532369683|FG000|Overall Study|Randomized but not treated|7|||
147604400|NCT03665441|532369684|FG001|Overall Study|Randomized but not treated|11|||
147604401|NCT00191113|532369685|FG000|Core Study|Withdrawal by Subject|25|||
147604402|NCT00191113|532369686|FG001|Core Study|Withdrawal by Subject|9|||
147604403|NCT00191113|532369685|FG000|Core Study|Protocol Violation|6|||
147604404|NCT00191113|532369686|FG001|Core Study|Protocol Violation|2|||
147604405|NCT00191113|532369685|FG000|Core Study|Lost to Follow-up|3|||
147604406|NCT00191113|532369686|FG001|Core Study|Lost to Follow-up|0|||
147604407|NCT00191113|532369685|FG000|Core Study|Adverse Event|0|||
147604408|NCT00191113|532369686|FG001|Core Study|Adverse Event|2|||
147604409|NCT00191113|532369685|FG000|Core Study|Lack of Efficacy|0|||
147604410|NCT00191113|532369686|FG001|Core Study|Lack of Efficacy|2|||
147604411|NCT00191113|532369685|FG000|Core Study|Death|1|||
147604412|NCT00191113|532369686|FG001|Core Study|Death|0|||
147604413|NCT05307510|532369687|FG000|Overall Study|Lost to Follow-up|3|||
147604414|NCT05307510|532369688|FG001|Overall Study|Lost to Follow-up|6|||
147604415|NCT05307510|532369687|FG000|Overall Study|Withdrawal by Subject|0|||
147604416|NCT05307510|532369688|FG001|Overall Study|Withdrawal by Subject|1|||
147604417|NCT04003896|532369692|FG000|Overall Study|Withdrawal by Subject|3|||
147604418|NCT04003896|532369692|FG000|Overall Study|Physician Decision|1|||
147604419|NCT01682863|532369693|FG000|Overall Study|Subject/guardian decision|19|||
147604420|NCT01682863|532369694|FG001|Overall Study|Subject/guardian decision|12|||
147604421|NCT01682863|532369695|FG002|Overall Study|Subject/guardian decision|10|||
147604422|NCT01682863|532369693|FG000|Overall Study|Lost to Follow-up|5|||
147604423|NCT01682863|532369694|FG001|Overall Study|Lost to Follow-up|1|||
147604424|NCT01682863|532369695|FG002|Overall Study|Lost to Follow-up|6|||
147604425|NCT01682863|532369693|FG000|Overall Study|Death|1|||
147604426|NCT01682863|532369694|FG001|Overall Study|Death|3|||
147604427|NCT01682863|532369695|FG002|Overall Study|Death|4|||
147604428|NCT01682863|532369693|FG000|Overall Study|Protocol deviation|1|||
147292780|NCT04124926|531237470|FG003|Healing Phase|Lost to Follow-up|0|||
147292781|NCT04124926|531237471|FG004|Healing Phase|Lost to Follow-up|0|||
147292782|NCT04124926|531237467|FG000|Healing Phase|Voluntary Withdrawal|10|||
147292783|NCT04124926|531237468|FG001|Healing Phase|Voluntary Withdrawal|7|||
147292784|NCT04124926|531237469|FG002|Healing Phase|Voluntary Withdrawal|0|||
147292785|NCT04124926|531237470|FG003|Healing Phase|Voluntary Withdrawal|0|||
147292786|NCT04124926|531237471|FG004|Healing Phase|Voluntary Withdrawal|0|||
147292787|NCT04124926|531237467|FG000|Healing Phase|Withdrawal of Consent|5|||
147292788|NCT04124926|531237468|FG001|Healing Phase|Withdrawal of Consent|3|||
147292789|NCT04124926|531237469|FG002|Healing Phase|Withdrawal of Consent|0|||
147292790|NCT04124926|531237470|FG003|Healing Phase|Withdrawal of Consent|0|||
147292791|NCT04124926|531237471|FG004|Healing Phase|Withdrawal of Consent|0|||
147292792|NCT04124926|531237467|FG000|Healing Phase|Miscellaneous|8|||
147604429|NCT01682863|532369694|FG001|Overall Study|Protocol deviation|0|||
147292793|NCT04124926|531237468|FG001|Healing Phase|Miscellaneous|7|||
147604430|NCT01682863|532369695|FG002|Overall Study|Protocol deviation|1|||
147604431|NCT01682863|532369693|FG000|Overall Study|Technical problems|1|||
147604432|NCT01682863|532369694|FG001|Overall Study|Technical problems|0|||
147604433|NCT01682863|532369695|FG002|Overall Study|Technical problems|0|||
147604434|NCT01682863|532369693|FG000|Overall Study|Adverse Event|0|||
147604435|NCT01682863|532369694|FG001|Overall Study|Adverse Event|1|||
147604436|NCT01682863|532369695|FG002|Overall Study|Adverse Event|2|||
147604437|NCT01682863|532369693|FG000|Overall Study|Physician Decision|0|||
147604438|NCT01682863|532369694|FG001|Overall Study|Physician Decision|0|||
147604439|NCT01682863|532369695|FG002|Overall Study|Physician Decision|1|||
147292794|NCT04124926|531237469|FG002|Healing Phase|Miscellaneous|0|||
147292795|NCT04124926|531237470|FG003|Healing Phase|Miscellaneous|0|||
147292796|NCT04124926|531237471|FG004|Healing Phase|Miscellaneous|0|||
147292797|NCT04124926|531237467|FG000|Healing Phase|Randomized but not Treated|0|||
147292798|NCT04124926|531237468|FG001|Healing Phase|Randomized but not Treated|3|||
147292799|NCT04124926|531237469|FG002|Healing Phase|Randomized but not Treated|0|||
147292800|NCT04124926|531237470|FG003|Healing Phase|Randomized but not Treated|0|||
147292801|NCT04124926|531237471|FG004|Healing Phase|Randomized but not Treated|0|||
147338454|NCT01185782|531407083|FG001|Overall Study|Adverse Event|1|||
147604440|NCT00837473|532369696|FG000|Overall Study|Lost to Follow-up|1|||
147604441|NCT00837473|532369696|FG000|Overall Study|Withdrawal by Subject|2|||
147604442|NCT01635218|532369697|FG000|Overall Study|Lost to Follow-up|3|||
147604443|NCT01635218|532369698|FG001|Overall Study|Lost to Follow-up|7|||
147604444|NCT01635218|532369699|FG002|Overall Study|Lost to Follow-up|6|||
147604445|NCT04576923|532369700|FG000|Overall Study|15 had scans that were determined to be invalid and these are not reported within the results.|15|||
147604446|NCT01635283|532369701|FG000|Overall Study|Tumor Progression|3|||
147604447|NCT01635283|532369701|FG000|Overall Study|Lost to Follow-up|1|||
147604448|NCT01305044|532369704|FG000|Overall Study|Withdrawal by Subject|3|||
147604449|NCT01305044|532369705|FG001|Overall Study|Withdrawal by Subject|6|||
147604450|NCT00492024|532369708|FG000|Treatment|Adverse Event|3|||
147604451|NCT00492024|532369709|FG001|Treatment|Adverse Event|1|||
147604452|NCT00492024|532369708|FG000|Treatment|Lack of Efficacy|21|||
147604453|NCT00492024|532369709|FG001|Treatment|Lack of Efficacy|20|||
147604454|NCT00492024|532369708|FG000|Treatment|Lost to Follow-up|3|||
147604455|NCT00492024|532369709|FG001|Treatment|Lost to Follow-up|1|||
147604456|NCT00492024|532369708|FG000|Treatment|Withdrawal by Subject|2|||
147604457|NCT00492024|532369709|FG001|Treatment|Withdrawal by Subject|0|||
147604458|NCT00492024|532369708|FG000|Follow up|Lack of Efficacy|0|||
147604459|NCT00492024|532369709|FG001|Follow up|Lack of Efficacy|1|||
147604460|NCT00492024|532369708|FG000|Follow up|Lost to Follow-up|1|||
147604461|NCT00492024|532369709|FG001|Follow up|Lost to Follow-up|1|||
147604462|NCT04628793|532369722|FG000|Overall Study|Study terminated by sponsor|0|||
147604463|NCT04628793|532369723|FG001|Overall Study|Study terminated by sponsor|0|||
147604464|NCT04628793|532369724|FG002|Overall Study|Study terminated by sponsor|8|||
147604465|NCT04628793|532369722|FG000|Overall Study|Withdrawal by Subject|2|||
147604466|NCT04628793|532369723|FG001|Overall Study|Withdrawal by Subject|3|||
147604467|NCT04628793|532369724|FG002|Overall Study|Withdrawal by Subject|0|||
147604468|NCT04628793|532369722|FG000|Overall Study|Lost to Follow-up|0|||
147604469|NCT04628793|532369723|FG001|Overall Study|Lost to Follow-up|1|||
147604470|NCT04628793|532369724|FG002|Overall Study|Lost to Follow-up|0|||
147604471|NCT02309138|532369725|FG000|Overall Study|Withdrawal by Subject|44|||
147604472|NCT02309138|532369726|FG001|Overall Study|Withdrawal by Subject|15|||
147604473|NCT02309138|532369725|FG000|Overall Study|Protocol Violation|4|||
147604474|NCT02309138|532369726|FG001|Overall Study|Protocol Violation|2|||
147604475|NCT02309138|532369725|FG000|Overall Study|delivered before visit 2|0|||
147604476|NCT02309138|532369726|FG001|Overall Study|delivered before visit 2|1|||
147604477|NCT03421730|532369730|FG000|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
147604478|NCT03421730|532369731|FG001|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|2|||
147604479|NCT03421730|532369732|FG002|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
147604480|NCT03421730|532369733|FG003|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
147604481|NCT03421730|532369734|FG004|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
147604482|NCT03421730|532369735|FG005|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
147604483|NCT03421730|532369736|FG006|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
147604484|NCT03421730|532369737|FG007|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
147604485|NCT03421730|532369738|FG008|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
147604486|NCT03421730|532369739|FG009|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
147604487|NCT03421730|532369740|FG010|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
147604488|NCT03421730|532369741|FG011|First Intervention (Day 1, Visit 2)|Withdrawal by subject or legal guardian|0|||
147604489|NCT03421730|532369730|FG000|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
147604490|NCT03421730|532369731|FG001|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
147604491|NCT03421730|532369732|FG002|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
147604492|NCT03421730|532369733|FG003|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
147604493|NCT03421730|532369734|FG004|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|2|||
147604494|NCT03421730|532369735|FG005|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
147604495|NCT03421730|532369736|FG006|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
147292802|NCT04124926|531237467|FG000|Maintenance Phase|Pretreatment Event, AE, or SAE|0|||
147292803|NCT04124926|531237468|FG001|Maintenance Phase|Pretreatment Event, AE, or SAE|0|||
147338455|NCT01185782|531407082|FG000|Overall Study|Protocol Violation|1|||
147338456|NCT01185782|531407083|FG001|Overall Study|Protocol Violation|0|||
147292804|NCT04124926|531237469|FG002|Maintenance Phase|Pretreatment Event, AE, or SAE|3|||
147604496|NCT03421730|532369737|FG007|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
147604497|NCT03421730|532369738|FG008|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
147604498|NCT03421730|532369739|FG009|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
147604499|NCT03421730|532369740|FG010|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
147604500|NCT03421730|532369741|FG011|Washout (Days 4 to 10)|Withdrawal by subject or legal guardian|0|||
147604501|NCT01338870|532369744|FG000|Overall Study|Lost to Follow-up|0|||
147604502|NCT01338870|532369745|FG001|Overall Study|Lost to Follow-up|0|||
147604503|NCT01338870|532369746|FG002|Overall Study|Lost to Follow-up|1|||
147604504|NCT01338870|532369747|FG003|Overall Study|Lost to Follow-up|0|||
147604505|NCT01338870|532369748|FG004|Overall Study|Lost to Follow-up|1|||
147604506|NCT01338870|532369749|FG005|Overall Study|Lost to Follow-up|0|||
147604507|NCT01338870|532369744|FG000|Overall Study|Withdrawal by Subject|2|||
147604508|NCT01338870|532369745|FG001|Overall Study|Withdrawal by Subject|3|||
147604509|NCT01338870|532369746|FG002|Overall Study|Withdrawal by Subject|4|||
147604510|NCT01338870|532369747|FG003|Overall Study|Withdrawal by Subject|0|||
147604511|NCT01338870|532369748|FG004|Overall Study|Withdrawal by Subject|0|||
147604512|NCT01338870|532369749|FG005|Overall Study|Withdrawal by Subject|2|||
147604513|NCT01338870|532369744|FG000|Overall Study|Other|3|||
147604514|NCT01338870|532369745|FG001|Overall Study|Other|3|||
147604515|NCT01338870|532369746|FG002|Overall Study|Other|3|||
147604516|NCT01338870|532369747|FG003|Overall Study|Other|2|||
147292805|NCT04124926|531237470|FG003|Maintenance Phase|Pretreatment Event, AE, or SAE|5|||
147292806|NCT04124926|531237471|FG004|Maintenance Phase|Pretreatment Event, AE, or SAE|4|||
147292807|NCT04124926|531237467|FG000|Maintenance Phase|Protocol Violation|0|||
147292808|NCT04124926|531237468|FG001|Maintenance Phase|Protocol Violation|0|||
147604517|NCT01338870|532369748|FG004|Overall Study|Other|0|||
147604518|NCT01338870|532369749|FG005|Overall Study|Other|2|||
147604519|NCT01338870|532369744|FG000|Overall Study|Protocol Violation|0|||
147292809|NCT04124926|531237469|FG002|Maintenance Phase|Protocol Violation|3|||
147604520|NCT01338870|532369745|FG001|Overall Study|Protocol Violation|2|||
147604521|NCT01338870|532369746|FG002|Overall Study|Protocol Violation|2|||
147604522|NCT01338870|532369747|FG003|Overall Study|Protocol Violation|2|||
147604523|NCT01338870|532369748|FG004|Overall Study|Protocol Violation|1|||
147604524|NCT01338870|532369749|FG005|Overall Study|Protocol Violation|1|||
147604525|NCT01338870|532369744|FG000|Overall Study|Adverse Event|4|||
147604526|NCT01338870|532369745|FG001|Overall Study|Adverse Event|4|||
147604527|NCT01338870|532369746|FG002|Overall Study|Adverse Event|1|||
147604528|NCT01338870|532369747|FG003|Overall Study|Adverse Event|5|||
147604529|NCT01338870|532369748|FG004|Overall Study|Adverse Event|4|||
147604530|NCT01338870|532369749|FG005|Overall Study|Adverse Event|1|||
147604531|NCT01955083|532369750|FG000|Overall Study|Lost to Follow-up|1|||
147604532|NCT01955083|532369751|FG001|Overall Study|Lost to Follow-up|1|||
147604533|NCT01559389|532369760|FG000|Overall Study|Withdrawal by Subject|20|||
147604534|NCT01559389|532369761|FG001|Overall Study|Withdrawal by Subject|20|||
147604535|NCT02871492|532369762|FG000|Overall Study|Lost to Follow-up|6|||
147604536|NCT02871492|532369763|FG001|Overall Study|Lost to Follow-up|3|||
147604537|NCT02871492|532369764|FG002|Overall Study|Lost to Follow-up|5|||
147604538|NCT02871492|532369762|FG000|Overall Study|Withdrawal by Subject|0|||
147604539|NCT02871492|532369763|FG001|Overall Study|Withdrawal by Subject|0|||
147604540|NCT02871492|532369764|FG002|Overall Study|Withdrawal by Subject|1|||
147604541|NCT04546724|532369765|FG000|Overall Study|Withdrawal by Subject|145|||
147604542|NCT04546724|532369766|FG001|Overall Study|Withdrawal by Subject|41|||
147604543|NCT04546724|532369765|FG000|Overall Study|Adverse Event|1|||
147604544|NCT04546724|532369766|FG001|Overall Study|Adverse Event|1|||
147604545|NCT04546724|532369765|FG000|Overall Study|Lost to Follow-up|186|||
147604546|NCT04546724|532369766|FG001|Overall Study|Lost to Follow-up|63|||
147604547|NCT04546724|532369765|FG000|Overall Study|Physician Decision|8|||
147604548|NCT04546724|532369766|FG001|Overall Study|Physician Decision|2|||
147604549|NCT04546724|532369765|FG000|Overall Study|Death|2|||
147604550|NCT04546724|532369766|FG001|Overall Study|Death|1|||
147604551|NCT04546724|532369765|FG000|Overall Study|subject has been out of town|1|||
147604552|NCT04546724|532369766|FG001|Overall Study|subject has been out of town|0|||
147292810|NCT04124926|531237470|FG003|Maintenance Phase|Protocol Violation|0|||
147292811|NCT04124926|531237471|FG004|Maintenance Phase|Protocol Violation|0|||
147604553|NCT04546724|532369765|FG000|Overall Study|subject is incarcerated|2|||
147604554|NCT04546724|532369766|FG001|Overall Study|subject is incarcerated|0|||
147604555|NCT04546724|532369765|FG000|Overall Study|subject is relocating|12|||
147604556|NCT04546724|532369766|FG001|Overall Study|subject is relocating|4|||
147604557|NCT04546724|532369765|FG000|Overall Study|Subject in another study|1|||
147604558|NCT04546724|532369766|FG001|Overall Study|Subject in another study|1|||
147604559|NCT03583086|532369767|FG000|Overall Study|Death|2|||
147604560|NCT03583086|532369768|FG001|Overall Study|Death|6|||
147604561|NCT03583086|532369769|FG002|Overall Study|Death|12|||
147292812|NCT04124926|531237467|FG000|Maintenance Phase|Lost to Follow-up|0|||
147292813|NCT04124926|531237468|FG001|Maintenance Phase|Lost to Follow-up|0|||
147292814|NCT04124926|531237469|FG002|Maintenance Phase|Lost to Follow-up|7|||
147604562|NCT03583086|532369770|FG003|Overall Study|Death|10|||
147604563|NCT03583086|532369771|FG004|Overall Study|Death|14|||
147604564|NCT03583086|532369772|FG005|Overall Study|Death|14|||
147604565|NCT03583086|532369773|FG006|Overall Study|Death|4|||
147604566|NCT03583086|532369767|FG000|Overall Study|Withdrawal by Subject|0|||
147604567|NCT03583086|532369768|FG001|Overall Study|Withdrawal by Subject|0|||
147604568|NCT03583086|532369769|FG002|Overall Study|Withdrawal by Subject|1|||
147604569|NCT03583086|532369770|FG003|Overall Study|Withdrawal by Subject|0|||
147604570|NCT03583086|532369771|FG004|Overall Study|Withdrawal by Subject|0|||
147604571|NCT03583086|532369772|FG005|Overall Study|Withdrawal by Subject|0|||
147604572|NCT03583086|532369773|FG006|Overall Study|Withdrawal by Subject|1|||
147604573|NCT03583086|532369767|FG000|Overall Study|Refused follow-up|0|||
147604574|NCT03583086|532369768|FG001|Overall Study|Refused follow-up|0|||
147604575|NCT03583086|532369769|FG002|Overall Study|Refused follow-up|1|||
147604576|NCT03583086|532369770|FG003|Overall Study|Refused follow-up|0|||
147604577|NCT03583086|532369771|FG004|Overall Study|Refused follow-up|1|||
147604578|NCT03583086|532369772|FG005|Overall Study|Refused follow-up|0|||
147604579|NCT03583086|532369773|FG006|Overall Study|Refused follow-up|0|||
147604580|NCT03583086|532369767|FG000|Overall Study|Declining Performance Status|0|||
147604581|NCT03583086|532369768|FG001|Overall Study|Declining Performance Status|0|||
147604582|NCT03583086|532369769|FG002|Overall Study|Declining Performance Status|1|||
147604583|NCT03583086|532369770|FG003|Overall Study|Declining Performance Status|0|||
147604584|NCT03583086|532369771|FG004|Overall Study|Declining Performance Status|0|||
147604585|NCT03583086|532369772|FG005|Overall Study|Declining Performance Status|0|||
147604586|NCT03583086|532369773|FG006|Overall Study|Declining Performance Status|0|||
147604587|NCT03583086|532369767|FG000|Overall Study|Still on study|0|||
147604588|NCT03583086|532369768|FG001|Overall Study|Still on study|0|||
147604589|NCT03583086|532369769|FG002|Overall Study|Still on study|0|||
147604590|NCT03583086|532369770|FG003|Overall Study|Still on study|1|||
147604591|NCT03583086|532369771|FG004|Overall Study|Still on study|0|||
147604592|NCT03583086|532369772|FG005|Overall Study|Still on study|0|||
147604593|NCT03583086|532369773|FG006|Overall Study|Still on study|1|||
147604594|NCT03583086|532369767|FG000|Overall Study|Disease progression|0|||
147604595|NCT03583086|532369768|FG001|Overall Study|Disease progression|0|||
147604596|NCT03583086|532369769|FG002|Overall Study|Disease progression|0|||
147604597|NCT03583086|532369770|FG003|Overall Study|Disease progression|0|||
147604598|NCT03583086|532369771|FG004|Overall Study|Disease progression|0|||
147604599|NCT03583086|532369772|FG005|Overall Study|Disease progression|0|||
147292815|NCT04124926|531237470|FG003|Maintenance Phase|Lost to Follow-up|8|||
147292816|NCT04124926|531237471|FG004|Maintenance Phase|Lost to Follow-up|9|||
147292817|NCT04124926|531237467|FG000|Maintenance Phase|Voluntary Withdrawal|0|||
147292818|NCT04124926|531237468|FG001|Maintenance Phase|Voluntary Withdrawal|0|||
147292819|NCT04124926|531237469|FG002|Maintenance Phase|Voluntary Withdrawal|3|||
147292820|NCT04124926|531237470|FG003|Maintenance Phase|Voluntary Withdrawal|6|||
147292821|NCT04124926|531237471|FG004|Maintenance Phase|Voluntary Withdrawal|5|||
147292822|NCT04124926|531237467|FG000|Maintenance Phase|Pregnancy|0|||
147292823|NCT04124926|531237468|FG001|Maintenance Phase|Pregnancy|0|||
147292824|NCT04124926|531237469|FG002|Maintenance Phase|Pregnancy|0|||
147292825|NCT04124926|531237470|FG003|Maintenance Phase|Pregnancy|1|||
147292826|NCT04124926|531237471|FG004|Maintenance Phase|Pregnancy|0|||
147292827|NCT04124926|531237467|FG000|Maintenance Phase|Lack of Efficacy|0|||
147292828|NCT04124926|531237468|FG001|Maintenance Phase|Lack of Efficacy|0|||
147292829|NCT04124926|531237469|FG002|Maintenance Phase|Lack of Efficacy|0|||
147292830|NCT04124926|531237470|FG003|Maintenance Phase|Lack of Efficacy|0|||
147292831|NCT04124926|531237471|FG004|Maintenance Phase|Lack of Efficacy|1|||
147292832|NCT04124926|531237467|FG000|Maintenance Phase|Withdrawal of Consent|0|||
147292833|NCT04124926|531237468|FG001|Maintenance Phase|Withdrawal of Consent|0|||
147292834|NCT04124926|531237469|FG002|Maintenance Phase|Withdrawal of Consent|5|||
147292835|NCT04124926|531237470|FG003|Maintenance Phase|Withdrawal of Consent|5|||
147292836|NCT04124926|531237471|FG004|Maintenance Phase|Withdrawal of Consent|5|||
147292837|NCT04124926|531237467|FG000|Maintenance Phase|Miscellaneous|0|||
147292838|NCT04124926|531237468|FG001|Maintenance Phase|Miscellaneous|0|||
147292839|NCT04124926|531237469|FG002|Maintenance Phase|Miscellaneous|1|||
147292840|NCT04124926|531237470|FG003|Maintenance Phase|Miscellaneous|2|||
147292841|NCT04124926|531237471|FG004|Maintenance Phase|Miscellaneous|4|||
147292842|NCT04124926|531237467|FG000|Maintenance Phase|Randomized but not Treated|0|||
147292843|NCT04124926|531237468|FG001|Maintenance Phase|Randomized but not Treated|0|||
147292844|NCT04124926|531237469|FG002|Maintenance Phase|Randomized but not Treated|2|||
147292845|NCT04124926|531237470|FG003|Maintenance Phase|Randomized but not Treated|2|||
147338457|NCT01185782|531407082|FG000|Overall Study|Poor Response to Treatment|3|||
147338458|NCT01185782|531407083|FG001|Overall Study|Poor Response to Treatment|1|||
147292846|NCT04124926|531237471|FG004|Maintenance Phase|Randomized but not Treated|0|||
147338459|NCT01185782|531407082|FG000|Overall Study|Other|2|||
147604600|NCT03583086|532369773|FG006|Overall Study|Disease progression|1|||
147604601|NCT03583086|532369767|FG000|Overall Study|Undergoing radiation therapy|0|||
147604602|NCT03583086|532369768|FG001|Overall Study|Undergoing radiation therapy|0|||
147604603|NCT03583086|532369769|FG002|Overall Study|Undergoing radiation therapy|0|||
147604604|NCT03583086|532369770|FG003|Overall Study|Undergoing radiation therapy|0|||
147604605|NCT03583086|532369771|FG004|Overall Study|Undergoing radiation therapy|0|||
147604606|NCT03583086|532369772|FG005|Overall Study|Undergoing radiation therapy|0|||
147604607|NCT03583086|532369773|FG006|Overall Study|Undergoing radiation therapy|1|||
147604608|NCT03583086|532369767|FG000|Overall Study|Lost to Follow-up|0|||
147604609|NCT03583086|532369768|FG001|Overall Study|Lost to Follow-up|0|||
147604610|NCT03583086|532369769|FG002|Overall Study|Lost to Follow-up|0|||
147604611|NCT03583086|532369770|FG003|Overall Study|Lost to Follow-up|0|||
147292847|NCT02013622|531237477|FG000|Overall Study|Lost to Follow-up|10|||
147292848|NCT02013622|531237477|FG000|Overall Study|Adverse Event|3|||
147292849|NCT02013622|531237477|FG000|Overall Study|Met Withdrawal Criteria|3|||
147292850|NCT02013622|531237477|FG000|Overall Study|Withdrawal by Subject|6|||
147292851|NCT02013622|531237477|FG000|Overall Study|Protocol Deviation|1|||
147292852|NCT02013622|531237477|FG000|Overall Study|Lack of Efficacy|1|||
147292853|NCT05130970|531237480|FG000|Overall Study|Adverse Event|1|||
147292854|NCT05130970|531237481|FG001|Overall Study|Adverse Event|1|||
147292855|NCT05130970|531237480|FG000|Overall Study|Death|0|||
147292856|NCT05130970|531237481|FG001|Overall Study|Death|1|||
147292857|NCT05130970|531237480|FG000|Overall Study|Lost to Follow-up|0|||
147292858|NCT05130970|531237481|FG001|Overall Study|Lost to Follow-up|1|||
147292859|NCT05130970|531237480|FG000|Overall Study|Physician Decision|0|||
147292860|NCT05130970|531237481|FG001|Overall Study|Physician Decision|1|||
147292861|NCT05130970|531237480|FG000|Overall Study|Withdrawal by Subject|1|||
147292862|NCT05130970|531237481|FG001|Overall Study|Withdrawal by Subject|1|||
147292863|NCT01640808|531237483|FG000|Overall Study|Unable to continue dynamic CT|14|||
147292864|NCT01640808|531237484|FG001|Overall Study|Unable to continue dynamic CT|4|||
147292865|NCT01640808|531237483|FG000|Overall Study|Withdrawal by Subject|12|||
147292866|NCT01640808|531237484|FG001|Overall Study|Withdrawal by Subject|4|||
147292867|NCT01640808|531237483|FG000|Overall Study|Lost to Follow-up|4|||
147292868|NCT01640808|531237484|FG001|Overall Study|Lost to Follow-up|0|||
147292869|NCT01640808|531237483|FG000|Overall Study|Start an antiviral therapy using IFN|3|||
147292870|NCT01640808|531237484|FG001|Overall Study|Start an antiviral therapy using IFN|0|||
147292871|NCT01640808|531237483|FG000|Overall Study|Administration of anticancer drugs|2|||
147292872|NCT01640808|531237484|FG001|Overall Study|Administration of anticancer drugs|1|||
147292873|NCT01640808|531237483|FG000|Overall Study|Physician Decision|19|||
147292874|NCT01640808|531237484|FG001|Overall Study|Physician Decision|5|||
147292875|NCT01640808|531237483|FG000|Overall Study|Randomized but not treated|4|||
147292876|NCT01640808|531237484|FG001|Overall Study|Randomized but not treated|2|||
147292877|NCT02192502|531237486|FG000|Overall Study|Did not receive intervention due to euvolemia|4|||
147292878|NCT02192502|531237487|FG001|Overall Study|Did not receive intervention due to euvolemia|1|||
147292879|NCT02192502|531237486|FG000|Overall Study|did not receive intervention due to circulatory arrest|2|||
147292880|NCT02192502|531237487|FG001|Overall Study|did not receive intervention due to circulatory arrest|0|||
147604612|NCT03583086|532369771|FG004|Overall Study|Lost to Follow-up|0|||
147604613|NCT03583086|532369772|FG005|Overall Study|Lost to Follow-up|1|||
147604614|NCT03583086|532369773|FG006|Overall Study|Lost to Follow-up|0|||
147604615|NCT03583086|532369767|FG000|Overall Study|Adverse Event|0|||
147604616|NCT03583086|532369768|FG001|Overall Study|Adverse Event|0|||
147604617|NCT03583086|532369769|FG002|Overall Study|Adverse Event|0|||
147604618|NCT03583086|532369770|FG003|Overall Study|Adverse Event|0|||
147604619|NCT03583086|532369771|FG004|Overall Study|Adverse Event|0|||
147604620|NCT03583086|532369772|FG005|Overall Study|Adverse Event|1|||
147604621|NCT03583086|532369773|FG006|Overall Study|Adverse Event|0|||
147604622|NCT00396812|532369775|FG000|Overall Study|Physician Decision|1|||
147604623|NCT03201445|532369779|FG000|Part A DB Phase (Through Week 13)|Lost to Follow-up|1|||
147604624|NCT03201445|532369780|FG001|Part A DB Phase (Through Week 13)|Lost to Follow-up|0|||
147604625|NCT03201445|532369779|FG000|Part A DB Phase (Through Week 13)|Protocol Violation|0|||
147604626|NCT03201445|532369780|FG001|Part A DB Phase (Through Week 13)|Protocol Violation|1|||
147604627|NCT03201445|532369779|FG000|Part A DB Phase (Through Week 13)|Withdrawal by Subject|0|||
147604628|NCT03201445|532369780|FG001|Part A DB Phase (Through Week 13)|Withdrawal by Subject|2|||
147604629|NCT03201445|532369779|FG000|Part B DB Phase (Week 13 to 26)|Adverse Event|1|||
147604630|NCT03201445|532369780|FG001|Part B DB Phase (Week 13 to 26)|Adverse Event|0|||
147604631|NCT03201445|532369779|FG000|Part B DB Phase (Week 13 to 26)|Progressive Disease|2|||
147604632|NCT03201445|532369780|FG001|Part B DB Phase (Week 13 to 26)|Progressive Disease|0|||
147604633|NCT03201445|532369779|FG000|OL Phase (13 Weeks)|Adverse Event|0|||
147604634|NCT03201445|532369780|FG001|OL Phase (13 Weeks)|Adverse Event|2|||
147604635|NCT03201445|532369779|FG000|OL Phase (13 Weeks)|Withdrawal by Subject|2|||
147292881|NCT02192502|531237486|FG000|Overall Study|did not receive intervention due to logistic reasons|1|||
147292882|NCT02192502|531237487|FG001|Overall Study|did not receive intervention due to logistic reasons|0|||
147292883|NCT01381692|531237488|FG000|Overall Study|Adverse Event|1|||
147292884|NCT01381692|531237489|FG001|Overall Study|Adverse Event|0|||
147292885|NCT01381692|531237490|FG002|Overall Study|Adverse Event|0|||
147292886|NCT01381692|531237491|FG003|Overall Study|Adverse Event|0|||
147292887|NCT01381692|531237492|FG004|Overall Study|Adverse Event|0|||
147604636|NCT03201445|532369780|FG001|OL Phase (13 Weeks)|Withdrawal by Subject|1|||
147604637|NCT03201445|532369779|FG000|LTE: DB Study Drug (up to Week 195)|Adverse Event|9|||
147604638|NCT03201445|532369780|FG001|LTE: DB Study Drug (up to Week 195)|Adverse Event|10|||
147604639|NCT03201445|532369779|FG000|LTE: DB Study Drug (up to Week 195)|Lost to Follow-up|0|||
147604640|NCT03201445|532369780|FG001|LTE: DB Study Drug (up to Week 195)|Lost to Follow-up|1|||
147604641|NCT03201445|532369779|FG000|LTE: DB Study Drug (up to Week 195)|Physician Decision|0|||
147604642|NCT03201445|532369780|FG001|LTE: DB Study Drug (up to Week 195)|Physician Decision|2|||
147604643|NCT03201445|532369779|FG000|LTE: DB Study Drug (up to Week 195)|Withdrawal by Subject|4|||
147604644|NCT03201445|532369780|FG001|LTE: DB Study Drug (up to Week 195)|Withdrawal by Subject|4|||
147604645|NCT03201445|532369779|FG000|LTE: DB Study Drug (up to Week 195)|Pre-Specified Decrease In Sperm Parameters (Switched to MP)|6|||
147604646|NCT03201445|532369780|FG001|LTE: DB Study Drug (up to Week 195)|Pre-Specified Decrease In Sperm Parameters (Switched to MP)|7|||
147604647|NCT03201445|532369779|FG000|LTE: DB Study Drug (up to Week 195)|Study Terminated By Sponsor|11|||
147604648|NCT03201445|532369780|FG001|LTE: DB Study Drug (up to Week 195)|Study Terminated By Sponsor|5|||
147604649|NCT03201445|532369779|FG000|LTE: OL Study Drug (Up to Week 195)|Adverse Event|3|||
147604650|NCT03201445|532369780|FG001|LTE: OL Study Drug (Up to Week 195)|Adverse Event|2|||
147604651|NCT03201445|532369779|FG000|LTE: OL Study Drug (Up to Week 195)|Physician Decision|1|||
147604652|NCT03201445|532369780|FG001|LTE: OL Study Drug (Up to Week 195)|Physician Decision|2|||
147604653|NCT03201445|532369779|FG000|LTE: OL Study Drug (Up to Week 195)|Withdrawal by Subject|1|||
147604654|NCT03201445|532369780|FG001|LTE: OL Study Drug (Up to Week 195)|Withdrawal by Subject|1|||
147604655|NCT03201445|532369779|FG000|LTE: OL Study Drug (Up to Week 195)|Pre-Specified Decrease In Sperm Parameters (Switched to MP)|5|||
147604656|NCT03201445|532369780|FG001|LTE: OL Study Drug (Up to Week 195)|Pre-Specified Decrease In Sperm Parameters (Switched to MP)|3|||
147604657|NCT03201445|532369779|FG000|LTE: OL Study Drug (Up to Week 195)|Progressive Disease|2|||
147604658|NCT03201445|532369780|FG001|LTE: OL Study Drug (Up to Week 195)|Progressive Disease|0|||
147604659|NCT03201445|532369779|FG000|LTE: OL Study Drug (Up to Week 195)|Study Terminated By Sponsor|6|||
147604660|NCT03201445|532369780|FG001|LTE: OL Study Drug (Up to Week 195)|Study Terminated By Sponsor|6|||
147604661|NCT03201445|532369779|FG000|Monitoring Phase (Up to Week 52)|Withdrawal by Subject|1|||
147604662|NCT03201445|532369780|FG001|Monitoring Phase (Up to Week 52)|Withdrawal by Subject|1|||
147604663|NCT03201445|532369779|FG000|Monitoring Phase (Up to Week 52)|Study Terminated By Sponsor|0|||
147604664|NCT03201445|532369780|FG001|Monitoring Phase (Up to Week 52)|Study Terminated By Sponsor|1|||
147604665|NCT01346293|532369783|FG000|Overall Study|Protocol Violation|30|||
147604666|NCT01346293|532369784|FG001|Overall Study|Protocol Violation|9|||
147604667|NCT01346293|532369783|FG000|Overall Study|Lost to Follow-up|21|||
147604668|NCT01346293|532369784|FG001|Overall Study|Lost to Follow-up|8|||
147604669|NCT01346293|532369783|FG000|Overall Study|Withdrawal by Subject|15|||
147604670|NCT01346293|532369784|FG001|Overall Study|Withdrawal by Subject|4|||
147604671|NCT01346293|532369783|FG000|Overall Study|Other|1|||
147604672|NCT01346293|532369784|FG001|Overall Study|Other|0|||
147604673|NCT01844505|532369787|FG000|Treatment Period|SUBJECT WITHDREW CONSENT|9|||
147604674|NCT01844505|532369788|FG001|Treatment Period|SUBJECT WITHDREW CONSENT|12|||
147604675|NCT01844505|532369789|FG002|Treatment Period|SUBJECT WITHDREW CONSENT|19|||
147604676|NCT01844505|532369787|FG000|Treatment Period|Other Reasons|120|||
147604677|NCT01844505|532369788|FG001|Treatment Period|Other Reasons|136|||
147604678|NCT01844505|532369789|FG002|Treatment Period|Other Reasons|58|||
147604679|NCT01844505|532369787|FG000|Treatment Period|Lost to Follow-up|9|||
147604680|NCT01844505|532369788|FG001|Treatment Period|Lost to Follow-up|11|||
147604681|NCT01844505|532369789|FG002|Treatment Period|Lost to Follow-up|6|||
147604682|NCT01844505|532369787|FG000|Treatment Period|Death|175|||
147604683|NCT01844505|532369788|FG001|Treatment Period|Death|154|||
147604684|NCT01844505|532369789|FG002|Treatment Period|Death|228|||
147604685|NCT00128830|532369790|FG000|Overall Study|Adverse Event|10|||
147604686|NCT00128830|532369790|FG000|Overall Study|Withdrawal by Subject|14|||
147604687|NCT00128830|532369790|FG000|Overall Study|Lost to Follow-up|4|||
147604688|NCT00128830|532369790|FG000|Overall Study|Reached a virologic endpoint|29|||
147604689|NCT00128830|532369790|FG000|Overall Study|Non-compliant|4|||
147604690|NCT00128830|532369790|FG000|Overall Study|Discontinued or ineligible for study|2|||
147604691|NCT00128830|532369790|FG000|Overall Study|Other|9|||
147604692|NCT02730351|532369791|FG000|Treatment Period 1 (2 Weeks)|Adverse Event|1|||
147604693|NCT02730351|532369792|FG001|Treatment Period 1 (2 Weeks)|Adverse Event|0|||
147604694|NCT02730351|532369791|FG000|Wash-out Period (2 Weeks)|Protocol Violation|0|||
147604695|NCT02730351|532369792|FG001|Wash-out Period (2 Weeks)|Protocol Violation|1|||
147604696|NCT02730351|532369791|FG000|Wash-out Period (2 Weeks)|Withdrawal by Subject|1|||
147604697|NCT02730351|532369792|FG001|Wash-out Period (2 Weeks)|Withdrawal by Subject|0|||
147604698|NCT02730351|532369791|FG000|Treatment Period 2 (2 Weeks)|Adverse Event|1|||
147662651|NCT00128661|532587382|FG000|Overall Study|Lost to Follow-up|10|||
147662652|NCT00128661|532587383|FG001|Overall Study|Lost to Follow-up|7|||
147338460|NCT01185782|531407083|FG001|Overall Study|Other|5|||
147338461|NCT01185782|531407082|FG000|Overall Study|Randomized but not treated|0|||
147338462|NCT01185782|531407083|FG001|Overall Study|Randomized but not treated|4|||
147338463|NCT02507752|531407084|FG000|Overall Study|Adverse Event|1|||
147604699|NCT02730351|532369792|FG001|Treatment Period 2 (2 Weeks)|Adverse Event|0|||
147662653|NCT00128661|532587382|FG000|Overall Study|Withdrawal by Subject|243|||
147662654|NCT00128661|532587383|FG001|Overall Study|Withdrawal by Subject|232|||
147662655|NCT00128661|532587382|FG000|Overall Study|Other|7|||
147662656|NCT00128661|532587383|FG001|Overall Study|Other|8|||
147452782|NCT02425826|531820055|FG000|Apremilast Extension Phase (Weeks 16-52)|Adverse Event|7|||
147452783|NCT02425826|531820056|FG001|Apremilast Extension Phase (Weeks 16-52)|Adverse Event|0|||
147452784|NCT02425826|531820057|FG002|Apremilast Extension Phase (Weeks 16-52)|Adverse Event|2|||
147452785|NCT02425826|531820055|FG000|Apremilast Extension Phase (Weeks 16-52)|Lost to Follow-up|8|||
147604700|NCT02730351|532369791|FG000|Treatment Period 2 (2 Weeks)|Lack of Efficacy|1|||
147604701|NCT02730351|532369792|FG001|Treatment Period 2 (2 Weeks)|Lack of Efficacy|0|||
147604702|NCT00311402|532369793|FG000|Overall Study|Adverse Event|118|||
147604703|NCT00311402|532369794|FG001|Overall Study|Adverse Event|105|||
147604704|NCT00311402|532369793|FG000|Overall Study|Lost to Follow-up|0|||
147604705|NCT00311402|532369794|FG001|Overall Study|Lost to Follow-up|3|||
147604706|NCT00311402|532369793|FG000|Overall Study|Withdrawal by Subject|17|||
147604707|NCT00311402|532369794|FG001|Overall Study|Withdrawal by Subject|18|||
147604708|NCT00311402|532369793|FG000|Overall Study|Lack of Efficacy|58|||
147604709|NCT00311402|532369794|FG001|Overall Study|Lack of Efficacy|42|||
147604710|NCT00311402|532369793|FG000|Overall Study|Protocol Violation|7|||
147604711|NCT00311402|532369794|FG001|Overall Study|Protocol Violation|6|||
147604712|NCT00311402|532369793|FG000|Overall Study|IRB's rejection etc.|10|||
147604713|NCT00311402|532369794|FG001|Overall Study|IRB's rejection etc.|3|||
147604714|NCT00838435|532369795|FG000|PK Sub-Study 2 (4 Weeks)|no postdose blood sample|1|||
147604715|NCT00838435|532369795|FG000|Safety/Efficacy Sub-Study 1 (6 Months)|Adverse Event|2|||
147604716|NCT00838435|532369795|FG000|Part 2 (7 Years)|Adverse Event|2|||
147604717|NCT00838435|532369795|FG000|Part 2 (7 Years)|Lost to Follow-up|2|||
147604718|NCT00838435|532369795|FG000|Part 2 (7 Years)|Physician Decision|1|||
147604719|NCT00838435|532369795|FG000|Part 2 (7 Years)|Sponsor Decision|6|||
147604720|NCT00838435|532369795|FG000|Part 2 (7 Years)|Withdrawal by Subject|5|||
147604721|NCT02754856|532369801|FG000|Overall Study|Withdrawal by Subject|1|||
147604722|NCT04874155|532369804|FG000|Overall Study|Lost to Follow-up|1|||
147604723|NCT04874155|532369805|FG001|Overall Study|Lost to Follow-up|1|||
147452786|NCT02425826|531820056|FG001|Apremilast Extension Phase (Weeks 16-52)|Lost to Follow-up|0|||
147452787|NCT02425826|531820057|FG002|Apremilast Extension Phase (Weeks 16-52)|Lost to Follow-up|6|||
147452788|NCT02425826|531820055|FG000|Apremilast Extension Phase (Weeks 16-52)|Withdrawal by Subject|12|||
147452789|NCT02425826|531820056|FG001|Apremilast Extension Phase (Weeks 16-52)|Withdrawal by Subject|0|||
147452790|NCT02425826|531820057|FG002|Apremilast Extension Phase (Weeks 16-52)|Withdrawal by Subject|4|||
147452791|NCT02425826|531820055|FG000|Apremilast Extension Phase (Weeks 16-52)|Lack of Efficacy|8|||
147452792|NCT02425826|531820056|FG001|Apremilast Extension Phase (Weeks 16-52)|Lack of Efficacy|0|||
147452793|NCT02425826|531820057|FG002|Apremilast Extension Phase (Weeks 16-52)|Lack of Efficacy|1|||
147452794|NCT02425826|531820055|FG000|Apremilast Extension Phase (Weeks 16-52)|miscellaneous|0|||
147452795|NCT02425826|531820056|FG001|Apremilast Extension Phase (Weeks 16-52)|miscellaneous|0|||
147452796|NCT02425826|531820057|FG002|Apremilast Extension Phase (Weeks 16-52)|miscellaneous|1|||
147452797|NCT03861559|531820058|FG000|Overall Study|Adverse Event|0|||
147452798|NCT03861559|531820059|FG001|Overall Study|Adverse Event|2|||
147452799|NCT03861559|531820058|FG000|Overall Study|Treatment failure|0|||
147604724|NCT04874155|532369804|FG000|Overall Study|Withdrawal by Subject|2|||
147604725|NCT04874155|532369805|FG001|Overall Study|Withdrawal by Subject|2|||
147604726|NCT00530218|532369806|FG000|Overall Study|CMV Not Detected|13|||
147452800|NCT03861559|531820059|FG001|Overall Study|Treatment failure|2|||
147452801|NCT03861559|531820058|FG000|Overall Study|Noncompliance|1|||
147452802|NCT03861559|531820059|FG001|Overall Study|Noncompliance|1|||
147452803|NCT03861559|531820058|FG000|Overall Study|Did not meet eligibility requirements|1|||
147452804|NCT03861559|531820059|FG001|Overall Study|Did not meet eligibility requirements|0|||
147452805|NCT01344876|531820062|FG000|Overall Study|Adverse Event|0|||
147452806|NCT01344876|531820063|FG001|Overall Study|Adverse Event|0|||
147452807|NCT01344876|531820064|FG002|Overall Study|Adverse Event|0|||
147452808|NCT01344876|531820065|FG003|Overall Study|Adverse Event|0|||
147452809|NCT01344876|531820066|FG004|Overall Study|Adverse Event|1|||
147452810|NCT01344876|531820062|FG000|Overall Study|Withdrawal by Subject|0|||
147452811|NCT01344876|531820063|FG001|Overall Study|Withdrawal by Subject|0|||
147452812|NCT01344876|531820064|FG002|Overall Study|Withdrawal by Subject|1|||
147452813|NCT01344876|531820065|FG003|Overall Study|Withdrawal by Subject|0|||
147452814|NCT01344876|531820066|FG004|Overall Study|Withdrawal by Subject|0|||
147452815|NCT01344876|531820062|FG000|Overall Study|Definite progression of primary disease|1|||
147604727|NCT00530218|532369806|FG000|Overall Study|Death|12|||
147604728|NCT00678886|532369809|FG000|Overall Study|Withdrawal by Subject|0|||
147604729|NCT00678886|532369810|FG001|Overall Study|Withdrawal by Subject|0|||
147604730|NCT00678886|532369811|FG002|Overall Study|Withdrawal by Subject|4|||
147604731|NCT00678886|532369812|FG003|Overall Study|Withdrawal by Subject|6|||
147604732|NCT00678886|532369809|FG000|Overall Study|Physician Decision|0|||
147604733|NCT00678886|532369810|FG001|Overall Study|Physician Decision|0|||
147604734|NCT00678886|532369811|FG002|Overall Study|Physician Decision|1|||
147604735|NCT00678886|532369812|FG003|Overall Study|Physician Decision|1|||
147452816|NCT01344876|531820063|FG001|Overall Study|Definite progression of primary disease|0|||
147452817|NCT01344876|531820064|FG002|Overall Study|Definite progression of primary disease|0|||
147452818|NCT01344876|531820065|FG003|Overall Study|Definite progression of primary disease|3|||
147604736|NCT00678886|532369809|FG000|Overall Study|Lost to Follow-up|0|||
147604737|NCT00678886|532369810|FG001|Overall Study|Lost to Follow-up|0|||
147292888|NCT01381692|531237493|FG005|Overall Study|Adverse Event|0|||
147292889|NCT03896035|531237495|FG000|Overall Study|Lost to Follow-up|2|||
147292890|NCT03896035|531237496|FG001|Overall Study|Lost to Follow-up|6|||
147292891|NCT03896035|531237495|FG000|Overall Study|Withdrawal by Subject|0|||
147292892|NCT03896035|531237496|FG001|Overall Study|Withdrawal by Subject|1|||
147292893|NCT03896035|531237495|FG000|Overall Study|Health/family health issues during COVID|0|||
147292894|NCT03896035|531237496|FG001|Overall Study|Health/family health issues during COVID|4|||
147292895|NCT01506193|531237499|FG000|Overall Study|Protocol Violation|1|||
147292896|NCT01506193|531237500|FG001|Overall Study|Protocol Violation|0|||
147292897|NCT01506193|531237501|FG002|Overall Study|Protocol Violation|1|||
147292898|NCT01506193|531237499|FG000|Overall Study|Migrated/moved from study area|0|||
147292899|NCT01506193|531237500|FG001|Overall Study|Migrated/moved from study area|0|||
147292900|NCT01506193|531237501|FG002|Overall Study|Migrated/moved from study area|1|||
147292901|NCT01506193|531237499|FG000|Overall Study|Adverse event, non-fatal|0|||
147292902|NCT01506193|531237500|FG001|Overall Study|Adverse event, non-fatal|0|||
147292903|NCT01506193|531237501|FG002|Overall Study|Adverse event, non-fatal|1|||
147292904|NCT01506193|531237499|FG000|Overall Study|Withdrawal by Subject|5|||
147292905|NCT01506193|531237500|FG001|Overall Study|Withdrawal by Subject|1|||
147292906|NCT01506193|531237501|FG002|Overall Study|Withdrawal by Subject|8|||
147292907|NCT01506193|531237499|FG000|Overall Study|Lost to Follow-up|8|||
147292908|NCT01506193|531237500|FG001|Overall Study|Lost to Follow-up|3|||
147292909|NCT01506193|531237501|FG002|Overall Study|Lost to Follow-up|3|||
147292910|NCT01388816|531237502|FG000|Overall Study|Adverse Event|0|||
147292911|NCT01388816|531237503|FG001|Overall Study|Adverse Event|2|||
147292912|NCT01388816|531237504|FG002|Overall Study|Adverse Event|0|||
147292913|NCT01388816|531237505|FG003|Overall Study|Adverse Event|0|||
147292914|NCT01388816|531237502|FG000|Overall Study|Lost to Follow-up|0|||
147292915|NCT01388816|531237503|FG001|Overall Study|Lost to Follow-up|1|||
147292916|NCT01388816|531237504|FG002|Overall Study|Lost to Follow-up|0|||
147292917|NCT01388816|531237505|FG003|Overall Study|Lost to Follow-up|0|||
147292918|NCT01388816|531237502|FG000|Overall Study|Withdrawal by Subject|2|||
147292919|NCT01388816|531237503|FG001|Overall Study|Withdrawal by Subject|1|||
147292920|NCT01388816|531237504|FG002|Overall Study|Withdrawal by Subject|1|||
147292921|NCT01388816|531237505|FG003|Overall Study|Withdrawal by Subject|0|||
147292922|NCT01388816|531237502|FG000|Overall Study|Protocol Violation|0|||
147292923|NCT01388816|531237503|FG001|Overall Study|Protocol Violation|0|||
147292924|NCT01388816|531237504|FG002|Overall Study|Protocol Violation|2|||
147292925|NCT01388816|531237505|FG003|Overall Study|Protocol Violation|0|||
147292926|NCT00743366|531237506|FG000|Intervention 1 (8 Days)|Withdrawal by Subject|3|||
147292927|NCT00743366|531237507|FG001|Intervention 1 (8 Days)|Withdrawal by Subject|3|||
147292928|NCT02308748|531237514|FG000|Period 1|Withdrawal by Subject|0|||
147292929|NCT02308748|531237515|FG001|Period 1|Withdrawal by Subject|0|||
147292930|NCT02308748|531237516|FG002|Period 1|Withdrawal by Subject|1|||
147292931|NCT02308748|531237517|FG003|Period 1|Withdrawal by Subject|0|||
147292932|NCT02308748|531237518|FG004|Period 1|Withdrawal by Subject|0|||
147292933|NCT02308748|531237519|FG005|Period 1|Withdrawal by Subject|0|||
147292934|NCT02308748|531237520|FG006|Period 1|Withdrawal by Subject|0|||
147292935|NCT02308748|531237521|FG007|Period 1|Withdrawal by Subject|0|||
147292936|NCT02308748|531237522|FG008|Period 1|Withdrawal by Subject|0|||
147292937|NCT02308748|531237523|FG009|Period 1|Withdrawal by Subject|0|||
147292938|NCT02308748|531237514|FG000|Period 2|Adverse Event|0|||
147292939|NCT02308748|531237515|FG001|Period 2|Adverse Event|0|||
147292940|NCT02308748|531237516|FG002|Period 2|Adverse Event|0|||
147292941|NCT02308748|531237517|FG003|Period 2|Adverse Event|0|||
147292942|NCT02308748|531237518|FG004|Period 2|Adverse Event|0|||
147292943|NCT02308748|531237519|FG005|Period 2|Adverse Event|0|||
147292944|NCT02308748|531237520|FG006|Period 2|Adverse Event|0|||
147292945|NCT02308748|531237521|FG007|Period 2|Adverse Event|1|||
147292946|NCT02308748|531237522|FG008|Period 2|Adverse Event|0|||
147292947|NCT02308748|531237523|FG009|Period 2|Adverse Event|0|||
147292948|NCT02308748|531237514|FG000|Period 3|Protocol Violation|0|||
147292949|NCT02308748|531237515|FG001|Period 3|Protocol Violation|0|||
147292950|NCT02308748|531237516|FG002|Period 3|Protocol Violation|0|||
147292951|NCT02308748|531237517|FG003|Period 3|Protocol Violation|0|||
147292952|NCT02308748|531237518|FG004|Period 3|Protocol Violation|0|||
147292953|NCT02308748|531237519|FG005|Period 3|Protocol Violation|0|||
147292954|NCT02308748|531237520|FG006|Period 3|Protocol Violation|0|||
147292955|NCT02308748|531237521|FG007|Period 3|Protocol Violation|0|||
147292956|NCT02308748|531237522|FG008|Period 3|Protocol Violation|0|||
147292957|NCT02308748|531237523|FG009|Period 3|Protocol Violation|1|||
147292958|NCT02308748|531237514|FG000|Period 5|Adverse Event|1|||
147292959|NCT02308748|531237515|FG001|Period 5|Adverse Event|0|||
147292960|NCT02308748|531237516|FG002|Period 5|Adverse Event|0|||
147292961|NCT02308748|531237517|FG003|Period 5|Adverse Event|0|||
147604738|NCT00678886|532369811|FG002|Overall Study|Lost to Follow-up|3|||
147604739|NCT00678886|532369812|FG003|Overall Study|Lost to Follow-up|2|||
147292962|NCT02308748|531237518|FG004|Period 5|Adverse Event|0|||
147292963|NCT02308748|531237519|FG005|Period 5|Adverse Event|0|||
147292964|NCT02308748|531237520|FG006|Period 5|Adverse Event|0|||
147338464|NCT02507752|531407084|FG000|Overall Study|Protocol Violation|6|||
147338465|NCT02507752|531407084|FG000|Overall Study|Lost to Follow-up|7|||
147338466|NCT02507752|531407084|FG000|Overall Study|Infusion reaction at first infusion|1|||
147338467|NCT02507752|531407084|FG000|Overall Study|Participant didn't perform visit Week 12|1|||
147338468|NCT02507752|531407084|FG000|Overall Study|Participant didn't perform visit Week 24|1|||
147338469|NCT01061151|531407089|FG000|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|2|||
147338470|NCT01061151|531407090|FG001|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|0|||
147338471|NCT01061151|531407091|FG002|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|0|||
147338472|NCT01061151|531407092|FG003|Protocol Version 2.0: 04/2011-09/2012|Protocol Violation|1|||
147338473|NCT01061151|531407089|FG000|Protocol Version 2.0: 04/2011-09/2012|Death|6|||
147338474|NCT01061151|531407090|FG001|Protocol Version 2.0: 04/2011-09/2012|Death|9|||
147338475|NCT01061151|531407091|FG002|Protocol Version 2.0: 04/2011-09/2012|Death|1|||
147338476|NCT01061151|531407092|FG003|Protocol Version 2.0: 04/2011-09/2012|Death|2|||
147338477|NCT01061151|531407089|FG000|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|89|||
147338478|NCT01061151|531407090|FG001|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|82|||
147338479|NCT01061151|531407091|FG002|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|2|||
147338480|NCT01061151|531407092|FG003|Protocol Version 2.0: 04/2011-09/2012|Withdrawal by Subject|10|||
147338481|NCT01061151|531407089|FG000|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|73|||
147338482|NCT01061151|531407090|FG001|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|65|||
147338483|NCT01061151|531407091|FG002|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|2|||
147338484|NCT01061151|531407092|FG003|Protocol Version 2.0: 04/2011-09/2012|Lost to Follow-up|10|||
147338485|NCT01061151|531407089|FG000|Protocol Version 2.0: 04/2011-09/2012|Site Closure|15|||
147338486|NCT01061151|531407090|FG001|Protocol Version 2.0: 04/2011-09/2012|Site Closure|19|||
147338487|NCT01061151|531407091|FG002|Protocol Version 2.0: 04/2011-09/2012|Site Closure|1|||
147338488|NCT01061151|531407092|FG003|Protocol Version 2.0: 04/2011-09/2012|Site Closure|0|||
147338489|NCT01061151|531407089|FG000|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|44|||
147338490|NCT01061151|531407090|FG001|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|61|||
147338491|NCT01061151|531407091|FG002|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|2|||
147338492|NCT01061151|531407092|FG003|Protocol Version 2.0: 04/2011-09/2012|Subject Unable to Get to Clinic|5|||
147338493|NCT01061151|531407089|FG000|Protocol Version 2.0: 04/2011-09/2012|Other Reason|3|||
147338494|NCT01061151|531407090|FG001|Protocol Version 2.0: 04/2011-09/2012|Other Reason|5|||
147338495|NCT01061151|531407091|FG002|Protocol Version 2.0: 04/2011-09/2012|Other Reason|1|||
147338496|NCT01061151|531407092|FG003|Protocol Version 2.0: 04/2011-09/2012|Other Reason|0|||
147338497|NCT01061151|531407089|FG000|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|0|||
147338498|NCT01061151|531407090|FG001|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|0|||
147338499|NCT01061151|531407091|FG002|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|2|||
147338500|NCT01061151|531407092|FG003|Protocol Version 3.0: 10/2012-10/2014|Protocol Violation|4|||
147338501|NCT01061151|531407089|FG000|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|1|||
147338502|NCT01061151|531407090|FG001|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|0|||
147338503|NCT01061151|531407091|FG002|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|0|||
147338504|NCT01061151|531407092|FG003|Protocol Version 3.0: 10/2012-10/2014|Adverse Event|0|||
147338505|NCT01061151|531407089|FG000|Protocol Version 3.0: 10/2012-10/2014|Death|3|||
147338506|NCT01061151|531407090|FG001|Protocol Version 3.0: 10/2012-10/2014|Death|5|||
147338507|NCT01061151|531407091|FG002|Protocol Version 3.0: 10/2012-10/2014|Death|1|||
147338508|NCT01061151|531407092|FG003|Protocol Version 3.0: 10/2012-10/2014|Death|1|||
147338509|NCT01061151|531407089|FG000|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|54|||
147338510|NCT01061151|531407090|FG001|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|52|||
147338511|NCT01061151|531407091|FG002|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|31|||
147338512|NCT01061151|531407092|FG003|Protocol Version 3.0: 10/2012-10/2014|Withdrawal by Subject|3|||
147338513|NCT01061151|531407089|FG000|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|49|||
147338514|NCT01061151|531407090|FG001|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|36|||
147338515|NCT01061151|531407091|FG002|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|25|||
147338516|NCT01061151|531407092|FG003|Protocol Version 3.0: 10/2012-10/2014|Lost to Follow-up|4|||
147338517|NCT01061151|531407089|FG000|Protocol Version 3.0: 10/2012-10/2014|Site Closure|12|||
147338518|NCT01061151|531407090|FG001|Protocol Version 3.0: 10/2012-10/2014|Site Closure|11|||
147338519|NCT01061151|531407091|FG002|Protocol Version 3.0: 10/2012-10/2014|Site Closure|2|||
147338520|NCT01061151|531407092|FG003|Protocol Version 3.0: 10/2012-10/2014|Site Closure|0|||
147338521|NCT01061151|531407089|FG000|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|28|||
147338522|NCT01061151|531407090|FG001|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|26|||
147338523|NCT01061151|531407091|FG002|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|15|||
147338524|NCT01061151|531407092|FG003|Protocol Version 3.0: 10/2012-10/2014|Subject Unable to Get to Clinic|5|||
147338525|NCT01061151|531407089|FG000|Protocol Version 3.0: 10/2012-10/2014|Other Reason|5|||
147338526|NCT01061151|531407090|FG001|Protocol Version 3.0: 10/2012-10/2014|Other Reason|8|||
147338527|NCT01061151|531407091|FG002|Protocol Version 3.0: 10/2012-10/2014|Other Reason|1|||
147338528|NCT01061151|531407092|FG003|Protocol Version 3.0: 10/2012-10/2014|Other Reason|3|||
147604740|NCT00678886|532369809|FG000|Overall Study|Other|0|||
147604741|NCT00678886|532369810|FG001|Overall Study|Other|0|||
147604742|NCT00678886|532369811|FG002|Overall Study|Other|1|||
147604743|NCT00678886|532369812|FG003|Overall Study|Other|0|||
147604744|NCT03477903|532369813|FG000|Overall Study|Study Terminated by Sponsor|1|||
147604745|NCT01147107|532369814|FG000|Overall Study|Lack of Efficacy|5|||
147604746|NCT01147107|532369815|FG001|Overall Study|Lack of Efficacy|0|||
147604747|NCT01147107|532369814|FG000|Overall Study|Withdrawal by Subject|1|||
147604748|NCT01147107|532369815|FG001|Overall Study|Withdrawal by Subject|1|||
147604749|NCT03496610|532369816|FG000|Overall Study|Lost to Follow-up|3|||
147604750|NCT03496610|532369817|FG001|Overall Study|Lost to Follow-up|2|||
147604751|NCT03496610|532369816|FG000|Overall Study|Physician Decision|1|||
147604752|NCT03496610|532369817|FG001|Overall Study|Physician Decision|0|||
147604753|NCT03496610|532369816|FG000|Overall Study|Withdrawal by Subject|1|||
147604754|NCT03496610|532369817|FG001|Overall Study|Withdrawal by Subject|0|||
147604755|NCT05330468|532369818|FG000|Overall Study|Death|6|||
147604756|NCT05330468|532369818|FG000|Overall Study|Withdrawal by Subject|4|||
147604757|NCT05330468|532369818|FG000|Overall Study|Lost to Follow-up|4|||
147604758|NCT00369317|532369819|FG000|Overall Study|Adverse Event|3|||
147292965|NCT02308748|531237521|FG007|Period 5|Adverse Event|0|||
147292966|NCT02308748|531237522|FG008|Period 5|Adverse Event|1|||
147292967|NCT02308748|531237523|FG009|Period 5|Adverse Event|0|||
147292968|NCT01994954|531237524|FG000|Overall Study|Death|1|||
147292969|NCT01994954|531237525|FG001|Overall Study|Death|0|||
147292970|NCT01994954|531237524|FG000|Overall Study|Withdrawal by Subject|9|||
147292971|NCT01994954|531237525|FG001|Overall Study|Withdrawal by Subject|14|||
147604759|NCT00369317|532369819|FG000|Overall Study|Death|1|||
147604760|NCT00369317|532369819|FG000|Overall Study|Lack of Efficacy|5|||
147604761|NCT00369317|532369819|FG000|Overall Study|Physician Decision|2|||
147604762|NCT00369317|532369819|FG000|Overall Study|Withdrawal by Subject|8|||
147604763|NCT00369317|532369819|FG000|Overall Study|Ineligible|1|||
147604764|NCT02365558|532369820|FG000|Period 1 (Day 1 Through Day 7)|Adverse Event|1|||
147604765|NCT02365558|532369821|FG001|Period 1 (Day 1 Through Day 7)|Adverse Event|0|||
147604766|NCT02365558|532369820|FG000|Period 2 (Day 8 Through Day 20)|Withdrawal by Subject|0|||
147604767|NCT02365558|532369821|FG001|Period 2 (Day 8 Through Day 20)|Withdrawal by Subject|1|||
147604768|NCT06281171|532369825|FG000|Timepoint 2|Lost to Follow-up|6|||
147604769|NCT06281171|532369826|FG001|Timepoint 2|Lost to Follow-up|4|||
147604770|NCT06281171|532369825|FG000|Timepoint 3|Lost to Follow-up|0|||
147604771|NCT06281171|532369826|FG001|Timepoint 3|Lost to Follow-up|5|||
147604772|NCT01458106|532369831|FG000|Overall Study|Withdrawal by Subject|2|||
147604773|NCT01458106|532369832|FG001|Overall Study|Withdrawal by Subject|0|||
147604774|NCT01458106|532369831|FG000|Overall Study|Pre-rFVIIIFc Adverse Event|1|||
147604775|NCT01458106|532369832|FG001|Overall Study|Pre-rFVIIIFc Adverse Event|0|||
147604776|NCT01458106|532369831|FG000|Overall Study|Withdrawn Per Protocol|0|||
147604777|NCT01458106|532369832|FG001|Overall Study|Withdrawn Per Protocol|1|||
147604778|NCT00073021|532369833|FG000|Overall Study|Protocol Violation|2|||
147604779|NCT00073021|532369834|FG001|Overall Study|Protocol Violation|1|||
147604780|NCT00073021|532369833|FG000|Overall Study|Adverse Event|4|||
147604781|NCT00073021|532369834|FG001|Overall Study|Adverse Event|4|||
147604782|NCT00073021|532369833|FG000|Overall Study|Withdrawal by Subject|6|||
147604783|NCT00073021|532369834|FG001|Overall Study|Withdrawal by Subject|5|||
147604784|NCT00073021|532369833|FG000|Overall Study|Physician Decision|3|||
147604785|NCT00073021|532369834|FG001|Overall Study|Physician Decision|1|||
147604786|NCT00073021|532369833|FG000|Overall Study|Lack of Efficacy|11|||
147604787|NCT00073021|532369834|FG001|Overall Study|Lack of Efficacy|5|||
147604788|NCT03835221|532369835|FG000|Methafilcon A|Withdrawal by Subject|1|||
147604789|NCT01197755|532369839|FG000|Overall Study|Adverse Event|8|||
147604790|NCT01197755|532369840|FG001|Overall Study|Adverse Event|10|||
147604791|NCT01197755|532369841|FG002|Overall Study|Adverse Event|10|||
147604792|NCT01197755|532369839|FG000|Overall Study|Study-specific discontinuation criteria|2|||
147604793|NCT01197755|532369840|FG001|Overall Study|Study-specific discontinuation criteria|1|||
147604794|NCT01197755|532369841|FG002|Overall Study|Study-specific discontinuation criteria|0|||
147292972|NCT01994954|531237524|FG000|Overall Study|Physician Decision|2|||
147292973|NCT01994954|531237525|FG001|Overall Study|Physician Decision|2|||
147292974|NCT01994954|531237524|FG000|Overall Study|Lost to Follow-up|8|||
147292975|NCT01994954|531237525|FG001|Overall Study|Lost to Follow-up|10|||
147292976|NCT01994954|531237524|FG000|Overall Study|6 Month Follow-up Not Complete|5|||
147604795|NCT01197755|532369839|FG000|Overall Study|Entered the long-term extension study|18|||
147604796|NCT01197755|532369840|FG001|Overall Study|Entered the long-term extension study|21|||
147604797|NCT01197755|532369841|FG002|Overall Study|Entered the long-term extension study|35|||
147292977|NCT01994954|531237525|FG001|Overall Study|6 Month Follow-up Not Complete|4|||
147292978|NCT00449176|531237526|FG000|Overall Study|Withdrawal by Subject|39|||
147292979|NCT00449176|531237527|FG001|Overall Study|Withdrawal by Subject|43|||
147604798|NCT01197755|532369839|FG000|Overall Study|Lack of therapeutic response|0|||
147604799|NCT01197755|532369840|FG001|Overall Study|Lack of therapeutic response|7|||
147604800|NCT01197755|532369841|FG002|Overall Study|Lack of therapeutic response|4|||
147604801|NCT01197755|532369839|FG000|Overall Study|Severe non-compliance to the protocol|2|||
147292980|NCT00449176|531237528|FG002|Overall Study|Withdrawal by Subject|59|||
147292981|NCT00449176|531237526|FG000|Overall Study|Lost to Follow-up|13|||
147292982|NCT00449176|531237527|FG001|Overall Study|Lost to Follow-up|8|||
147292983|NCT00449176|531237528|FG002|Overall Study|Lost to Follow-up|12|||
147292984|NCT00449176|531237526|FG000|Overall Study|Adverse Event|51|||
147292985|NCT00449176|531237527|FG001|Overall Study|Adverse Event|107|||
147292986|NCT00449176|531237528|FG002|Overall Study|Adverse Event|15|||
147292987|NCT00449176|531237526|FG000|Overall Study|Lack of Efficacy|13|||
147292988|NCT00449176|531237527|FG001|Overall Study|Lack of Efficacy|7|||
147292989|NCT00449176|531237528|FG002|Overall Study|Lack of Efficacy|50|||
147292990|NCT00449176|531237526|FG000|Overall Study|Study drug non-compliant|14|||
147292991|NCT00449176|531237527|FG001|Overall Study|Study drug non-compliant|11|||
147338529|NCT00939510|531407096|FG000|Overall Study|Withdrawal by Subject|1|||
147338530|NCT03903822|531407097|FG000|Treatment Phase (6 Weeks)|Adverse Event|3|||
147338531|NCT03903822|531407098|FG001|Treatment Phase (6 Weeks)|Adverse Event|3|||
147338532|NCT03903822|531407099|FG002|Treatment Phase (6 Weeks)|Adverse Event|1|||
147338533|NCT03903822|531407100|FG003|Treatment Phase (6 Weeks)|Adverse Event|1|||
147338534|NCT03903822|531407101|FG004|Treatment Phase (6 Weeks)|Adverse Event|1|||
147338535|NCT03903822|531407102|FG005|Treatment Phase (6 Weeks)|Adverse Event|6|||
147338536|NCT03903822|531407103|FG006|Treatment Phase (6 Weeks)|Adverse Event|1|||
147338537|NCT03903822|531407104|FG007|Treatment Phase (6 Weeks)|Adverse Event|0|||
147338538|NCT03903822|531407097|FG000|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
147338539|NCT03903822|531407098|FG001|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
147338540|NCT03903822|531407099|FG002|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
147338541|NCT03903822|531407100|FG003|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
147338542|NCT03903822|531407101|FG004|Treatment Phase (6 Weeks)|Lack of Efficacy|1|||
147338543|NCT03903822|531407102|FG005|Treatment Phase (6 Weeks)|Lack of Efficacy|1|||
147338544|NCT03903822|531407103|FG006|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
147338545|NCT03903822|531407104|FG007|Treatment Phase (6 Weeks)|Lack of Efficacy|0|||
147338546|NCT03903822|531407097|FG000|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
147338547|NCT03903822|531407098|FG001|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
147338548|NCT03903822|531407099|FG002|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
147338549|NCT03903822|531407100|FG003|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
147338550|NCT03903822|531407101|FG004|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
147338551|NCT03903822|531407102|FG005|Treatment Phase (6 Weeks)|Lost to Follow-up|0|||
147338552|NCT03903822|531407103|FG006|Treatment Phase (6 Weeks)|Lost to Follow-up|1|||
147338553|NCT03903822|531407104|FG007|Treatment Phase (6 Weeks)|Lost to Follow-up|1|||
147338554|NCT03903822|531407097|FG000|Treatment Phase (6 Weeks)|Physician Decision|0|||
147338555|NCT03903822|531407098|FG001|Treatment Phase (6 Weeks)|Physician Decision|2|||
147338556|NCT03903822|531407099|FG002|Treatment Phase (6 Weeks)|Physician Decision|0|||
147338557|NCT03903822|531407100|FG003|Treatment Phase (6 Weeks)|Physician Decision|0|||
147338558|NCT03903822|531407101|FG004|Treatment Phase (6 Weeks)|Physician Decision|0|||
147338559|NCT03903822|531407102|FG005|Treatment Phase (6 Weeks)|Physician Decision|0|||
147338560|NCT03903822|531407103|FG006|Treatment Phase (6 Weeks)|Physician Decision|0|||
147338561|NCT03903822|531407104|FG007|Treatment Phase (6 Weeks)|Physician Decision|0|||
147338562|NCT03903822|531407097|FG000|Treatment Phase (6 Weeks)|Pregnancy|0|||
147338563|NCT03903822|531407098|FG001|Treatment Phase (6 Weeks)|Pregnancy|0|||
147338564|NCT03903822|531407099|FG002|Treatment Phase (6 Weeks)|Pregnancy|0|||
147338565|NCT03903822|531407100|FG003|Treatment Phase (6 Weeks)|Pregnancy|1|||
147338566|NCT03903822|531407101|FG004|Treatment Phase (6 Weeks)|Pregnancy|1|||
147338567|NCT03903822|531407102|FG005|Treatment Phase (6 Weeks)|Pregnancy|0|||
147338568|NCT03903822|531407103|FG006|Treatment Phase (6 Weeks)|Pregnancy|0|||
147338569|NCT03903822|531407104|FG007|Treatment Phase (6 Weeks)|Pregnancy|0|||
147338570|NCT03903822|531407097|FG000|Treatment Phase (6 Weeks)|Protocol Violation|0|||
147338571|NCT03903822|531407098|FG001|Treatment Phase (6 Weeks)|Protocol Violation|0|||
147338572|NCT03903822|531407099|FG002|Treatment Phase (6 Weeks)|Protocol Violation|0|||
147338573|NCT03903822|531407100|FG003|Treatment Phase (6 Weeks)|Protocol Violation|1|||
147338574|NCT03903822|531407101|FG004|Treatment Phase (6 Weeks)|Protocol Violation|0|||
147338575|NCT03903822|531407102|FG005|Treatment Phase (6 Weeks)|Protocol Violation|0|||
147338576|NCT03903822|531407103|FG006|Treatment Phase (6 Weeks)|Protocol Violation|0|||
147338577|NCT03903822|531407104|FG007|Treatment Phase (6 Weeks)|Protocol Violation|0|||
147338578|NCT03903822|531407097|FG000|Treatment Phase (6 Weeks)|Withdrawal by Subject|2|||
147338579|NCT03903822|531407098|FG001|Treatment Phase (6 Weeks)|Withdrawal by Subject|4|||
147338580|NCT03903822|531407099|FG002|Treatment Phase (6 Weeks)|Withdrawal by Subject|2|||
147338581|NCT03903822|531407100|FG003|Treatment Phase (6 Weeks)|Withdrawal by Subject|2|||
147338582|NCT03903822|531407101|FG004|Treatment Phase (6 Weeks)|Withdrawal by Subject|1|||
147292992|NCT00449176|531237528|FG002|Overall Study|Study drug non-compliant|11|||
147292993|NCT00449176|531237526|FG000|Overall Study|all other|22|||
147292994|NCT00449176|531237527|FG001|Overall Study|all other|19|||
147292995|NCT00449176|531237528|FG002|Overall Study|all other|20|||
147292996|NCT00675766|531237529|FG000|Overall Study|Lost to Follow-up|6|||
147292997|NCT00675766|531237530|FG001|Overall Study|Lost to Follow-up|5|||
147292998|NCT00675766|531237531|FG002|Overall Study|Lost to Follow-up|21|||
147338583|NCT03903822|531407102|FG005|Treatment Phase (6 Weeks)|Withdrawal by Subject|2|||
147604802|NCT01197755|532369840|FG001|Overall Study|Severe non-compliance to the protocol|1|||
147604803|NCT01197755|532369841|FG002|Overall Study|Severe non-compliance to the protocol|2|||
147604804|NCT01197755|532369839|FG000|Overall Study|Withdrawal by Subject|1|||
147604805|NCT01197755|532369840|FG001|Overall Study|Withdrawal by Subject|0|||
147604806|NCT01197755|532369841|FG002|Overall Study|Withdrawal by Subject|0|||
147604807|NCT01197755|532369839|FG000|Overall Study|Lost to Follow-up|0|||
147604808|NCT01197755|532369840|FG001|Overall Study|Lost to Follow-up|0|||
147604809|NCT01197755|532369841|FG002|Overall Study|Lost to Follow-up|1|||
147604810|NCT01197755|532369839|FG000|Overall Study|eg, change in circumstances|7|||
147604811|NCT01197755|532369840|FG001|Overall Study|eg, change in circumstances|3|||
147604812|NCT01197755|532369841|FG002|Overall Study|eg, change in circumstances|2|||
147604813|NCT00499174|532369842|FG000|Overall Study|Physician Decision|78|||
147604814|NCT00499174|532369843|FG001|Overall Study|Physician Decision|9|||
147604815|NCT01214915|532369844|FG000|Overall Study|Adverse Event|8|||
147338584|NCT03903822|531407103|FG006|Treatment Phase (6 Weeks)|Withdrawal by Subject|3|||
147338585|NCT03903822|531407104|FG007|Treatment Phase (6 Weeks)|Withdrawal by Subject|3|||
147338586|NCT03903822|531407097|FG000|Treatment Phase (6 Weeks)|Refused Further Treatment|2|||
147338587|NCT03903822|531407098|FG001|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
147338588|NCT03903822|531407099|FG002|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
147338589|NCT03903822|531407100|FG003|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
147338590|NCT03903822|531407101|FG004|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
147338591|NCT03903822|531407102|FG005|Treatment Phase (6 Weeks)|Refused Further Treatment|1|||
147338592|NCT03903822|531407103|FG006|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
147338593|NCT03903822|531407104|FG007|Treatment Phase (6 Weeks)|Refused Further Treatment|0|||
147338594|NCT03903822|531407097|FG000|Treatment Phase (6 Weeks)|Other|2|||
147338595|NCT03903822|531407098|FG001|Treatment Phase (6 Weeks)|Other|1|||
147338596|NCT03903822|531407099|FG002|Treatment Phase (6 Weeks)|Other|0|||
147338597|NCT03903822|531407100|FG003|Treatment Phase (6 Weeks)|Other|0|||
147338598|NCT03903822|531407101|FG004|Treatment Phase (6 Weeks)|Other|1|||
147338599|NCT03903822|531407102|FG005|Treatment Phase (6 Weeks)|Other|1|||
147338600|NCT03903822|531407103|FG006|Treatment Phase (6 Weeks)|Other|0|||
147338601|NCT03903822|531407104|FG007|Treatment Phase (6 Weeks)|Other|0|||
147338602|NCT03903822|531407097|FG000|Follow up Phase (4 Weeks)|Adverse Event|3|||
147338603|NCT03903822|531407098|FG001|Follow up Phase (4 Weeks)|Adverse Event|2|||
147338604|NCT03903822|531407099|FG002|Follow up Phase (4 Weeks)|Adverse Event|1|||
147338605|NCT03903822|531407100|FG003|Follow up Phase (4 Weeks)|Adverse Event|1|||
147338606|NCT03903822|531407101|FG004|Follow up Phase (4 Weeks)|Adverse Event|0|||
147338607|NCT03903822|531407102|FG005|Follow up Phase (4 Weeks)|Adverse Event|5|||
147338608|NCT03903822|531407103|FG006|Follow up Phase (4 Weeks)|Adverse Event|1|||
147338609|NCT03903822|531407104|FG007|Follow up Phase (4 Weeks)|Adverse Event|0|||
147338610|NCT03903822|531407097|FG000|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
147338611|NCT03903822|531407098|FG001|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
147338612|NCT03903822|531407099|FG002|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
147338613|NCT03903822|531407100|FG003|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
147338614|NCT03903822|531407101|FG004|Follow up Phase (4 Weeks)|Lack of Efficacy|1|||
147338615|NCT03903822|531407102|FG005|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
147338616|NCT03903822|531407103|FG006|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
147338617|NCT03903822|531407104|FG007|Follow up Phase (4 Weeks)|Lack of Efficacy|0|||
147338618|NCT03903822|531407097|FG000|Follow up Phase (4 Weeks)|Lost to Follow-up|2|||
147338619|NCT03903822|531407098|FG001|Follow up Phase (4 Weeks)|Lost to Follow-up|0|||
147338620|NCT03903822|531407099|FG002|Follow up Phase (4 Weeks)|Lost to Follow-up|0|||
147338621|NCT03903822|531407100|FG003|Follow up Phase (4 Weeks)|Lost to Follow-up|0|||
147338622|NCT03903822|531407101|FG004|Follow up Phase (4 Weeks)|Lost to Follow-up|0|||
147338623|NCT03903822|531407102|FG005|Follow up Phase (4 Weeks)|Lost to Follow-up|0|||
147338624|NCT03903822|531407103|FG006|Follow up Phase (4 Weeks)|Lost to Follow-up|1|||
147338625|NCT03903822|531407104|FG007|Follow up Phase (4 Weeks)|Lost to Follow-up|3|||
147338626|NCT03903822|531407097|FG000|Follow up Phase (4 Weeks)|Pregnancy|0|||
147338627|NCT03903822|531407098|FG001|Follow up Phase (4 Weeks)|Pregnancy|0|||
147338628|NCT03903822|531407099|FG002|Follow up Phase (4 Weeks)|Pregnancy|0|||
147338629|NCT03903822|531407100|FG003|Follow up Phase (4 Weeks)|Pregnancy|1|||
147338630|NCT03903822|531407101|FG004|Follow up Phase (4 Weeks)|Pregnancy|1|||
147338631|NCT03903822|531407102|FG005|Follow up Phase (4 Weeks)|Pregnancy|0|||
147338632|NCT03903822|531407103|FG006|Follow up Phase (4 Weeks)|Pregnancy|0|||
147338633|NCT03903822|531407104|FG007|Follow up Phase (4 Weeks)|Pregnancy|0|||
147338634|NCT03903822|531407097|FG000|Follow up Phase (4 Weeks)|Withdrawal by Subject|2|||
147338635|NCT03903822|531407098|FG001|Follow up Phase (4 Weeks)|Withdrawal by Subject|5|||
147338636|NCT03903822|531407099|FG002|Follow up Phase (4 Weeks)|Withdrawal by Subject|3|||
147338637|NCT03903822|531407100|FG003|Follow up Phase (4 Weeks)|Withdrawal by Subject|2|||
147338638|NCT03903822|531407101|FG004|Follow up Phase (4 Weeks)|Withdrawal by Subject|2|||
147604816|NCT01214915|532369844|FG000|Overall Study|Lack of Efficacy|3|||
147604817|NCT00761865|532369845|FG000|Overall Study|Lost to Follow-up|8|||
147338639|NCT03903822|531407102|FG005|Follow up Phase (4 Weeks)|Withdrawal by Subject|2|||
147338640|NCT03903822|531407103|FG006|Follow up Phase (4 Weeks)|Withdrawal by Subject|3|||
147292999|NCT00675766|531237532|FG003|Overall Study|Lost to Follow-up|26|||
147293000|NCT02576678|531237533|FG000|Overall Study|Adverse Event|0|||
147293001|NCT02576678|531237534|FG001|Overall Study|Adverse Event|0|||
147293002|NCT02576678|531237535|FG002|Overall Study|Adverse Event|2|||
147293003|NCT02576678|531237533|FG000|Overall Study|Withdrawal by Subject|3|||
147293004|NCT02576678|531237534|FG001|Overall Study|Withdrawal by Subject|1|||
147293005|NCT02576678|531237535|FG002|Overall Study|Withdrawal by Subject|2|||
147293006|NCT02576678|531237533|FG000|Overall Study|Lost to Follow-up|0|||
147293007|NCT02576678|531237534|FG001|Overall Study|Lost to Follow-up|0|||
147338641|NCT03903822|531407104|FG007|Follow up Phase (4 Weeks)|Withdrawal by Subject|3|||
147338642|NCT03903822|531407097|FG000|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
147338643|NCT03903822|531407098|FG001|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
147338644|NCT03903822|531407099|FG002|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
147338645|NCT03903822|531407100|FG003|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
147604818|NCT00761865|532369846|FG001|Overall Study|Lost to Follow-up|7|||
147604819|NCT03866902|532369847|FG000|Overall Study|Lost to Follow-up|98|||
147604820|NCT03866902|532369848|FG001|Overall Study|Lost to Follow-up|82|||
147604821|NCT03866902|532369847|FG000|Overall Study|Pregnancy|18|||
147604822|NCT03866902|532369848|FG001|Overall Study|Pregnancy|24|||
147604823|NCT03982199|532369853|FG000|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|152|||
147604824|NCT03982199|532369854|FG001|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|159|||
147604825|NCT03982199|532369855|FG002|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
147604826|NCT03982199|532369856|FG003|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
147604827|NCT03982199|532369857|FG004|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
147604828|NCT03982199|532369858|FG005|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
147604829|NCT03982199|532369859|FG006|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
147604830|NCT03982199|532369860|FG007|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
147604831|NCT03982199|532369861|FG008|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
147604832|NCT03982199|532369862|FG009|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
147604833|NCT03982199|532369863|FG010|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
147604834|NCT03982199|532369864|FG011|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
147604835|NCT03982199|532369865|FG012|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
147604836|NCT03982199|532369866|FG013|Main Cohorts (Day 1 up to Day 1095)|Lost to Follow-up|0|||
147604837|NCT03982199|532369853|FG000|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|39|||
147604838|NCT03982199|532369854|FG001|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|33|||
147604839|NCT03982199|532369855|FG002|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
147604840|NCT03982199|532369856|FG003|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
147604841|NCT03982199|532369857|FG004|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
147604842|NCT03982199|532369858|FG005|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
147604843|NCT03982199|532369859|FG006|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
147604844|NCT03982199|532369860|FG007|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
147604845|NCT03982199|532369861|FG008|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
147604846|NCT03982199|532369862|FG009|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
147604847|NCT03982199|532369863|FG010|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
147604848|NCT03982199|532369864|FG011|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
147604849|NCT03982199|532369865|FG012|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
147604850|NCT03982199|532369866|FG013|Main Cohorts (Day 1 up to Day 1095)|Physician Decision|0|||
147604851|NCT03982199|532369853|FG000|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|514|||
147604852|NCT03982199|532369854|FG001|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|503|||
147604853|NCT03982199|532369855|FG002|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
147604854|NCT03982199|532369856|FG003|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
147604855|NCT03982199|532369857|FG004|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
147604856|NCT03982199|532369858|FG005|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
147604857|NCT03982199|532369859|FG006|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
147604858|NCT03982199|532369860|FG007|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
147604859|NCT03982199|532369861|FG008|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
147604860|NCT03982199|532369862|FG009|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
147604861|NCT03982199|532369863|FG010|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
147604862|NCT03982199|532369864|FG011|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
147604863|NCT03982199|532369865|FG012|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
147604864|NCT03982199|532369866|FG013|Main Cohorts (Day 1 up to Day 1095)|Withdrawal by Subject|0|||
147604865|NCT03982199|532369853|FG000|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|12|||
147604866|NCT03982199|532369854|FG001|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|14|||
147604867|NCT03982199|532369855|FG002|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
147293008|NCT02576678|531237535|FG002|Overall Study|Lost to Follow-up|1|||
147293009|NCT02576678|531237533|FG000|Overall Study|Miscellaneous|2|||
147293010|NCT02576678|531237534|FG001|Overall Study|Miscellaneous|0|||
147293011|NCT02576678|531237535|FG002|Overall Study|Miscellaneous|0|||
147338646|NCT03903822|531407101|FG004|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
147604868|NCT03982199|532369856|FG003|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
147604869|NCT03982199|532369857|FG004|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
147604870|NCT03982199|532369858|FG005|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
147604871|NCT03982199|532369859|FG006|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
147604872|NCT03982199|532369860|FG007|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
147338647|NCT03903822|531407102|FG005|Follow up Phase (4 Weeks)|Refused Further Study Procedures|1|||
147338648|NCT03903822|531407103|FG006|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
147338649|NCT03903822|531407104|FG007|Follow up Phase (4 Weeks)|Refused Further Study Procedures|0|||
147338650|NCT03903822|531407097|FG000|Follow up Phase (4 Weeks)|Other|1|||
147338651|NCT03903822|531407098|FG001|Follow up Phase (4 Weeks)|Other|1|||
147338652|NCT03903822|531407099|FG002|Follow up Phase (4 Weeks)|Other|0|||
147338653|NCT03903822|531407100|FG003|Follow up Phase (4 Weeks)|Other|0|||
147338654|NCT03903822|531407101|FG004|Follow up Phase (4 Weeks)|Other|0|||
147338655|NCT03903822|531407102|FG005|Follow up Phase (4 Weeks)|Other|0|||
147338656|NCT03903822|531407103|FG006|Follow up Phase (4 Weeks)|Other|0|||
147338657|NCT03903822|531407104|FG007|Follow up Phase (4 Weeks)|Other|0|||
147338658|NCT04594759|531407120|FG000|Overall Study|Lost to Follow-up|3|||
147338659|NCT01395758|531407127|FG000|Open-label Treatment Period|Withdrawal by Subject|4|||
147338660|NCT01395758|531407128|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
147338661|NCT01395758|531407129|FG002|Open-label Treatment Period|Withdrawal by Subject|0|||
147338662|NCT01041417|531407136|FG000|Overall Study|Adverse Event|5|||
147338663|NCT01041417|531407137|FG001|Overall Study|Adverse Event|2|||
147338664|NCT01041417|531407136|FG000|Overall Study|Lost to Follow-up|1|||
147338665|NCT01041417|531407137|FG001|Overall Study|Lost to Follow-up|1|||
147338666|NCT01041417|531407136|FG000|Overall Study|Death|1|||
147338667|NCT01041417|531407137|FG001|Overall Study|Death|0|||
147338668|NCT03473340|531407138|FG000|Overall Study|Follow up not possible due to COVID restrictions|3|||
147338669|NCT03473340|531407139|FG001|Overall Study|Follow up not possible due to COVID restrictions|0|||
147338670|NCT03473340|531407138|FG000|Overall Study|Withdrawal by Subject|1|||
147338671|NCT03473340|531407139|FG001|Overall Study|Withdrawal by Subject|0|||
147338672|NCT03473340|531407138|FG000|Overall Study|Lost to Follow-up|1|||
147338673|NCT03473340|531407139|FG001|Overall Study|Lost to Follow-up|2|||
147338674|NCT00203411|531407140|FG000|Follow-up|Progressive Disease|4|||
147338675|NCT01212991|531407145|FG000|Double-blind|Lost to Follow-up|8|||
147338676|NCT01212991|531407146|FG001|Double-blind|Lost to Follow-up|4|||
147338677|NCT01212991|531407147|FG002|Double-blind|Lost to Follow-up|0|||
147338678|NCT01212991|531407145|FG000|Double-blind|Death|699|||
147338679|NCT01212991|531407146|FG001|Double-blind|Death|550|||
147338680|NCT01212991|531407147|FG002|Double-blind|Death|0|||
147338681|NCT01212991|531407145|FG000|Double-blind|Withdrawal by Subject|16|||
147338682|NCT01212991|531407146|FG001|Double-blind|Withdrawal by Subject|19|||
147338683|NCT01212991|531407147|FG002|Double-blind|Withdrawal by Subject|0|||
147338684|NCT01212991|531407145|FG000|Double-blind|Other|7|||
147338685|NCT01212991|531407146|FG001|Double-blind|Other|0|||
147338686|NCT01212991|531407147|FG002|Double-blind|Other|0|||
147338687|NCT01212991|531407145|FG000|Double-blind|Sponsor decision|142|||
147338688|NCT01212991|531407146|FG001|Double-blind|Sponsor decision|38|||
147338689|NCT01212991|531407147|FG002|Double-blind|Sponsor decision|0|||
147338690|NCT01212991|531407145|FG000|Open-label|Death|0|||
147338691|NCT01212991|531407146|FG001|Open-label|Death|0|||
147338692|NCT01212991|531407147|FG002|Open-label|Death|166|||
147338693|NCT01212991|531407145|FG000|Open-label|Lost to Follow-up|0|||
147338694|NCT01212991|531407146|FG001|Open-label|Lost to Follow-up|0|||
147338695|NCT01212991|531407147|FG002|Open-label|Lost to Follow-up|5|||
147338696|NCT01212991|531407145|FG000|Open-label|Withdrawal by Subject|0|||
147338697|NCT01212991|531407146|FG001|Open-label|Withdrawal by Subject|0|||
147338698|NCT01212991|531407147|FG002|Open-label|Withdrawal by Subject|7|||
147338699|NCT01212991|531407145|FG000|Open-label|Sponsor decision|0|||
147338700|NCT01212991|531407146|FG001|Open-label|Sponsor decision|0|||
147338701|NCT01212991|531407147|FG002|Open-label|Sponsor decision|53|||
147604873|NCT03982199|532369861|FG008|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
147604874|NCT03982199|532369862|FG009|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
147338702|NCT01212991|531407145|FG000|Open-label|Other|0|||
147338703|NCT01212991|531407146|FG001|Open-label|Other|0|||
147338704|NCT01212991|531407147|FG002|Open-label|Other|3|||
147338705|NCT00632424|531407148|FG000|Overall Study|Disease Progression|17|||
147338706|NCT00632424|531407148|FG000|Overall Study|Study Drug Toxicity|1|||
147338707|NCT05135000|531407149|FG000|Overall Study|Adverse Event|2|||
147338708|NCT05135000|531407150|FG001|Overall Study|Adverse Event|0|||
147338709|NCT05135000|531407149|FG000|Overall Study|Lost to Follow-up|1|||
147338710|NCT05135000|531407150|FG001|Overall Study|Lost to Follow-up|0|||
147338711|NCT05135000|531407149|FG000|Overall Study|Study Terminated by Sponsor|6|||
147338712|NCT05135000|531407150|FG001|Overall Study|Study Terminated by Sponsor|3|||
147338713|NCT04623008|531408231|FG000|Baseline to T2|Withdrawal by Subject|4|||
147338714|NCT04623008|531408232|FG001|Baseline to T2|Withdrawal by Subject|2|||
147338715|NCT04623008|531408231|FG000|Baseline to T3|Withdrawal by Subject|4|||
147338716|NCT04623008|531408232|FG001|Baseline to T3|Withdrawal by Subject|2|||
147338717|NCT02763319|531408242|FG000|Overall Study|Adverse Event|12|||
147604875|NCT03982199|532369863|FG010|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
147604876|NCT03982199|532369864|FG011|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
147604877|NCT03982199|532369865|FG012|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
147604878|NCT03982199|532369866|FG013|Main Cohorts (Day 1 up to Day 1095)|Adverse Event|0|||
147604879|NCT03982199|532369853|FG000|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|10|||
147604880|NCT03982199|532369854|FG001|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|8|||
147604881|NCT03982199|532369855|FG002|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
147604882|NCT03982199|532369856|FG003|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
147604883|NCT03982199|532369857|FG004|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
147604884|NCT03982199|532369858|FG005|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
147604885|NCT03982199|532369859|FG006|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
147604886|NCT03982199|532369860|FG007|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
147604887|NCT03982199|532369861|FG008|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
147604888|NCT03982199|532369862|FG009|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
147604889|NCT03982199|532369863|FG010|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
147604890|NCT03982199|532369864|FG011|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
147604891|NCT03982199|532369865|FG012|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
147604892|NCT03982199|532369866|FG013|Main Cohorts (Day 1 up to Day 1095)|Technical Problems|0|||
147604893|NCT03982199|532369853|FG000|Main Cohorts (Day 1 up to Day 1095)|Death|39|||
147293012|NCT02472964|531237536|FG000|Part 1 (up to Week 24)|Adverse Event|2|||
147604894|NCT03982199|532369854|FG001|Main Cohorts (Day 1 up to Day 1095)|Death|38|||
147604895|NCT03982199|532369855|FG002|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
147604896|NCT03982199|532369856|FG003|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
147604897|NCT03982199|532369857|FG004|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
147604898|NCT03982199|532369858|FG005|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
147604899|NCT03982199|532369859|FG006|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
147604900|NCT03982199|532369860|FG007|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
147604901|NCT03982199|532369861|FG008|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
147604902|NCT03982199|532369862|FG009|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
147604903|NCT03982199|532369863|FG010|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
147604904|NCT03982199|532369864|FG011|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
147604905|NCT03982199|532369865|FG012|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
147604906|NCT03982199|532369866|FG013|Main Cohorts (Day 1 up to Day 1095)|Death|0|||
147604907|NCT03982199|532369853|FG000|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|26|||
147604908|NCT03982199|532369854|FG001|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|21|||
147604909|NCT03982199|532369855|FG002|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
147604910|NCT03982199|532369856|FG003|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
147604911|NCT03982199|532369857|FG004|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
147604912|NCT03982199|532369858|FG005|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
147604913|NCT03982199|532369859|FG006|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
147604914|NCT03982199|532369860|FG007|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
147604915|NCT03982199|532369861|FG008|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
147604916|NCT03982199|532369862|FG009|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
147604917|NCT03982199|532369863|FG010|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
147604918|NCT03982199|532369864|FG011|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
147604919|NCT03982199|532369865|FG012|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
147604920|NCT03982199|532369866|FG013|Main Cohorts (Day 1 up to Day 1095)|Site terminated by Sponsor|0|||
147604921|NCT03982199|532369853|FG000|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|129|||
147604922|NCT03982199|532369854|FG001|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|117|||
147604923|NCT03982199|532369855|FG002|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
147604924|NCT03982199|532369856|FG003|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
147604925|NCT03982199|532369857|FG004|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
147604926|NCT03982199|532369858|FG005|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
147604927|NCT03982199|532369859|FG006|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
147604928|NCT03982199|532369860|FG007|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
147604929|NCT03982199|532369861|FG008|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
147604930|NCT03982199|532369862|FG009|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
147604931|NCT03982199|532369863|FG010|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
147604932|NCT03982199|532369864|FG011|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
147604933|NCT03982199|532369865|FG012|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
147604934|NCT03982199|532369866|FG013|Main Cohorts (Day 1 up to Day 1095)|Study Terminated by Sponsor|0|||
147604935|NCT03982199|532369853|FG000|Main Cohorts (Day 1 up to Day 1095)|Other|80|||
147604936|NCT03982199|532369854|FG001|Main Cohorts (Day 1 up to Day 1095)|Other|83|||
147604937|NCT03982199|532369855|FG002|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
147293013|NCT02472964|531237537|FG001|Part 1 (up to Week 24)|Adverse Event|4|||
147293014|NCT02472964|531237536|FG000|Part 1 (up to Week 24)|disease progression|58|||
147293015|NCT02472964|531237537|FG001|Part 1 (up to Week 24)|disease progression|47|||
147452819|NCT01344876|531820066|FG004|Overall Study|Definite progression of primary disease|0|||
147604938|NCT03982199|532369856|FG003|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
147293016|NCT02472964|531237536|FG000|Part 1 (up to Week 24)|Death|3|||
147293017|NCT02472964|531237537|FG001|Part 1 (up to Week 24)|Death|6|||
147293018|NCT02472964|531237536|FG000|Part 1 (up to Week 24)|Physician Decision|3|||
147293019|NCT02472964|531237537|FG001|Part 1 (up to Week 24)|Physician Decision|1|||
147293020|NCT02472964|531237536|FG000|Part 1 (up to Week 24)|Lost to Follow-up|0|||
147293021|NCT02472964|531237537|FG001|Part 1 (up to Week 24)|Lost to Follow-up|1|||
147293022|NCT02472964|531237536|FG000|Part 1 (up to Week 24)|Withdrawal by Subject|7|||
147293023|NCT02472964|531237537|FG001|Part 1 (up to Week 24)|Withdrawal by Subject|2|||
147293024|NCT02472964|531237536|FG000|Part 1 (up to Week 24)|Other|2|||
147293025|NCT02472964|531237537|FG001|Part 1 (up to Week 24)|Other|1|||
147604939|NCT03982199|532369857|FG004|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
147604940|NCT03982199|532369858|FG005|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
147604941|NCT03982199|532369859|FG006|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
147604942|NCT03982199|532369860|FG007|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
147604943|NCT03982199|532369861|FG008|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
147604944|NCT03982199|532369862|FG009|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
147604945|NCT03982199|532369863|FG010|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
147604946|NCT03982199|532369864|FG011|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
147604947|NCT03982199|532369865|FG012|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
147604948|NCT03982199|532369866|FG013|Main Cohorts (Day 1 up to Day 1095)|Other|0|||
147604949|NCT03982199|532369853|FG000|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|18|||
147604950|NCT03982199|532369854|FG001|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|15|||
147604951|NCT03982199|532369855|FG002|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
147604952|NCT03982199|532369856|FG003|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
147604953|NCT03982199|532369857|FG004|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
147604954|NCT03982199|532369858|FG005|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
147604955|NCT03982199|532369859|FG006|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
147604956|NCT03982199|532369860|FG007|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
147604957|NCT03982199|532369861|FG008|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
147604958|NCT03982199|532369862|FG009|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
147604959|NCT03982199|532369863|FG010|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
147604960|NCT03982199|532369864|FG011|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
147604961|NCT03982199|532369865|FG012|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
147604962|NCT03982199|532369866|FG013|Main Cohorts (Day 1 up to Day 1095)|Randomized but not vaccinated|0|||
147604963|NCT03982199|532369853|FG000|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|4|||
147604964|NCT03982199|532369854|FG001|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|7|||
147604965|NCT03982199|532369855|FG002|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
147604966|NCT03982199|532369856|FG003|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
147293026|NCT02472964|531237536|FG000|Part 2 (Week 24-week 48)|Adverse Event|4|||
147293027|NCT02472964|531237537|FG001|Part 2 (Week 24-week 48)|Adverse Event|2|||
147293028|NCT02472964|531237536|FG000|Part 2 (Week 24-week 48)|Disease Progression|52|||
147293029|NCT02472964|531237537|FG001|Part 2 (Week 24-week 48)|Disease Progression|56|||
147293030|NCT02472964|531237536|FG000|Part 2 (Week 24-week 48)|Death|0|||
147293031|NCT02472964|531237537|FG001|Part 2 (Week 24-week 48)|Death|1|||
147293032|NCT02472964|531237536|FG000|Part 2 (Week 24-week 48)|Physician Decision|1|||
147293033|NCT02472964|531237537|FG001|Part 2 (Week 24-week 48)|Physician Decision|1|||
147293034|NCT02472964|531237536|FG000|Part 2 (Week 24-week 48)|Lost to Follow-up|2|||
147293035|NCT02472964|531237537|FG001|Part 2 (Week 24-week 48)|Lost to Follow-up|1|||
147293036|NCT02472964|531237536|FG000|Part 2 (Week 24-week 48)|Withdrawal by Subject|3|||
147293037|NCT02472964|531237537|FG001|Part 2 (Week 24-week 48)|Withdrawal by Subject|1|||
147293038|NCT02472964|531237536|FG000|Part 2 (Week 24-week 48)|Protocol Violation|3|||
147293039|NCT02472964|531237537|FG001|Part 2 (Week 24-week 48)|Protocol Violation|1|||
147452820|NCT05107765|531820067|FG000|Overall Study|Lost to Follow-up|4|||
147452821|NCT05107765|531820068|FG001|Overall Study|Lost to Follow-up|1|||
147293040|NCT01454583|531237540|FG000|1st Year|Lost to Follow-up|1057|||
147293041|NCT01454583|531237541|FG001|1st Year|Lost to Follow-up|318|||
147293042|NCT01454583|531237542|FG002|1st Year|Lost to Follow-up|180|||
147293043|NCT01454583|531237540|FG000|2nd Year|Lost to Follow-up|3965|||
147293044|NCT01454583|531237541|FG001|2nd Year|Lost to Follow-up|1049|||
147293045|NCT01454583|531237542|FG002|2nd Year|Lost to Follow-up|737|||
147293046|NCT01454583|531237540|FG000|3rd Year|Lost to Follow-up|1959|||
147293047|NCT01454583|531237541|FG001|3rd Year|Lost to Follow-up|512|||
147293048|NCT01454583|531237542|FG002|3rd Year|Lost to Follow-up|297|||
147293049|NCT01749982|531237545|FG000|Overall Study|Physician Decision|0|||
147293050|NCT01749982|531237546|FG001|Overall Study|Physician Decision|0|||
147293051|NCT01749982|531237547|FG002|Overall Study|Physician Decision|0|||
147293052|NCT01749982|531237548|FG003|Overall Study|Physician Decision|1|||
147293053|NCT01749982|531237545|FG000|Overall Study|Lost to Follow-up|0|||
147293054|NCT01749982|531237546|FG001|Overall Study|Lost to Follow-up|0|||
147452822|NCT05107765|531820067|FG000|Overall Study|Withdrawn by investigator due to non-compliance|1|||
147293055|NCT01749982|531237547|FG002|Overall Study|Lost to Follow-up|0|||
147293056|NCT01749982|531237548|FG003|Overall Study|Lost to Follow-up|1|||
147293057|NCT01749982|531237545|FG000|Overall Study|Withdrawal by Subject|0|||
147293058|NCT01749982|531237546|FG001|Overall Study|Withdrawal by Subject|0|||
147604967|NCT03982199|532369857|FG004|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
147604968|NCT03982199|532369858|FG005|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
147604969|NCT03982199|532369859|FG006|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
147604970|NCT03982199|532369860|FG007|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
147604971|NCT03982199|532369861|FG008|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
147604972|NCT03982199|532369862|FG009|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
147604973|NCT03982199|532369863|FG010|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
147604974|NCT03982199|532369864|FG011|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
147604975|NCT03982199|532369865|FG012|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
147604976|NCT03982199|532369866|FG013|Main Cohorts (Day 1 up to Day 1095)|Protocol Violation|0|||
147604977|NCT03982199|532369853|FG000|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|11|||
147604978|NCT03982199|532369854|FG001|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|11|||
147604979|NCT03982199|532369855|FG002|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
147604980|NCT03982199|532369856|FG003|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
147604981|NCT03982199|532369857|FG004|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
147604982|NCT03982199|532369858|FG005|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
147604983|NCT03982199|532369859|FG006|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
147604984|NCT03982199|532369860|FG007|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
147604985|NCT03982199|532369861|FG008|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
147604986|NCT03982199|532369862|FG009|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
147604987|NCT03982199|532369863|FG010|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
147604988|NCT03982199|532369864|FG011|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
147604989|NCT03982199|532369865|FG012|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
147604990|NCT03982199|532369866|FG013|Main Cohorts (Day 1 up to Day 1095)|Initiated prohibited medication|0|||
147604991|NCT03982199|532369853|FG000|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
147452823|NCT05107765|531820068|FG001|Overall Study|Withdrawn by investigator due to non-compliance|0|||
147452824|NCT05107765|531820067|FG000|Overall Study|Withdrawal by Subjects due to scheduling issues|6|||
147604992|NCT03982199|532369854|FG001|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
147604993|NCT03982199|532369855|FG002|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
147604994|NCT03982199|532369856|FG003|Revacc Subcohorts (From Day 365 to 730)|Other|3|||
147604995|NCT03982199|532369857|FG004|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
147604996|NCT03982199|532369858|FG005|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
147604997|NCT03982199|532369859|FG006|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
147604998|NCT03982199|532369860|FG007|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
147604999|NCT03982199|532369861|FG008|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
147605000|NCT03982199|532369862|FG009|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
147605001|NCT03982199|532369863|FG010|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
147605002|NCT03982199|532369864|FG011|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
147605003|NCT03982199|532369865|FG012|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
147605004|NCT03982199|532369866|FG013|Revacc Subcohorts (From Day 365 to 730)|Other|0|||
147605005|NCT03982199|532369853|FG000|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
147605006|NCT03982199|532369854|FG001|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
147605007|NCT03982199|532369855|FG002|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|1|||
147605008|NCT03982199|532369856|FG003|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
147605009|NCT03982199|532369857|FG004|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
147662657|NCT02782741|532587386|FG000|Blinded Treatment Period: up to Week 49|Adverse Event|0|||
147662658|NCT02782741|532587387|FG001|Blinded Treatment Period: up to Week 49|Adverse Event|4|||
147662659|NCT02782741|532587388|FG002|Blinded Treatment Period: up to Week 49|Adverse Event|0|||
147293059|NCT01749982|531237547|FG002|Overall Study|Withdrawal by Subject|0|||
147293060|NCT01749982|531237548|FG003|Overall Study|Withdrawal by Subject|1|||
147293061|NCT01967732|531237549|FG000|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|0|||
147293062|NCT01967732|531237550|FG001|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|1|||
147293063|NCT01967732|531237551|FG002|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|0|||
147293064|NCT01967732|531237552|FG003|Washout Period of 1 Day (Day 0)|Dropped due to personal reasons|0|||
147293065|NCT01967732|531237549|FG000|First Intervention (Day 1)|Poor venous access|0|||
147293066|NCT01967732|531237550|FG001|First Intervention (Day 1)|Poor venous access|1|||
147293067|NCT01967732|531237551|FG002|First Intervention (Day 1)|Poor venous access|0|||
147293068|NCT01967732|531237552|FG003|First Intervention (Day 1)|Poor venous access|0|||
147662660|NCT02782741|532587386|FG000|Blinded Treatment Period: up to Week 49|Other|0|||
147293069|NCT01687257|531237560|FG000|Overall Study|Efficacy Failure|6|||
147293070|NCT01687257|531237561|FG001|Overall Study|Efficacy Failure|0|||
147605010|NCT03982199|532369858|FG005|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
147605011|NCT03982199|532369859|FG006|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
147605012|NCT03982199|532369860|FG007|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
147293071|NCT01687257|531237562|FG002|Overall Study|Efficacy Failure|5|||
147293072|NCT01687257|531237560|FG000|Overall Study|Subject Withdrew Consent|1|||
147605013|NCT03982199|532369861|FG008|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
147605014|NCT03982199|532369862|FG009|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
147605015|NCT03982199|532369863|FG010|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
147605016|NCT03982199|532369864|FG011|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
147605017|NCT03982199|532369865|FG012|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
147605018|NCT03982199|532369866|FG013|Revacc Subcohorts (From Day 365 to 730)|Site terminated by Sponsor|0|||
147605019|NCT03982199|532369853|FG000|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
147605020|NCT03982199|532369854|FG001|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
147605021|NCT03982199|532369855|FG002|Revacc Subcohorts (From Day 365 to 730)|Death|1|||
147605022|NCT03982199|532369856|FG003|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
147605023|NCT03982199|532369857|FG004|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
147605024|NCT03982199|532369858|FG005|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
147605025|NCT03982199|532369859|FG006|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
147605026|NCT03982199|532369860|FG007|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
147605027|NCT03982199|532369861|FG008|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
147293073|NCT01687257|531237561|FG001|Overall Study|Subject Withdrew Consent|1|||
147293074|NCT01687257|531237562|FG002|Overall Study|Subject Withdrew Consent|1|||
147293075|NCT01687257|531237560|FG000|Overall Study|Adverse Event|1|||
147293076|NCT01687257|531237561|FG001|Overall Study|Adverse Event|0|||
147293077|NCT01687257|531237562|FG002|Overall Study|Adverse Event|0|||
147293078|NCT01687257|531237560|FG000|Overall Study|Investigator's Discretion|0|||
147293079|NCT01687257|531237561|FG001|Overall Study|Investigator's Discretion|3|||
147293080|NCT01687257|531237562|FG002|Overall Study|Investigator's Discretion|0|||
147605028|NCT03982199|532369862|FG009|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
147605029|NCT03982199|532369863|FG010|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
147605030|NCT03982199|532369864|FG011|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
147605031|NCT03982199|532369865|FG012|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
147605032|NCT03982199|532369866|FG013|Revacc Subcohorts (From Day 365 to 730)|Death|0|||
147605033|NCT03982199|532369853|FG000|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
147605034|NCT03982199|532369854|FG001|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
147605035|NCT03982199|532369855|FG002|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|21|||
147605036|NCT03982199|532369856|FG003|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|18|||
147605037|NCT03982199|532369857|FG004|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
147605038|NCT03982199|532369858|FG005|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
147605039|NCT03982199|532369859|FG006|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
147605040|NCT03982199|532369860|FG007|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
147605041|NCT03982199|532369861|FG008|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
147605042|NCT03982199|532369862|FG009|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
147605043|NCT03982199|532369863|FG010|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
147605044|NCT03982199|532369864|FG011|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
147605045|NCT03982199|532369865|FG012|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
147605046|NCT03982199|532369866|FG013|Revacc Subcohorts (From Day 365 to 730)|Withdrawal by Subject|0|||
147605047|NCT03982199|532369853|FG000|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
147605048|NCT03982199|532369854|FG001|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
147605049|NCT03982199|532369855|FG002|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
147605050|NCT03982199|532369856|FG003|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|1|||
147605051|NCT03982199|532369857|FG004|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
147605052|NCT03982199|532369858|FG005|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
147605053|NCT03982199|532369859|FG006|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
147293081|NCT03085485|531237563|FG000|Overall Study|Death|1|||
147293082|NCT03085485|531237564|FG001|Overall Study|Death|0|||
147293083|NCT03085485|531237563|FG000|Overall Study|Lost to Follow-up|1|||
147293084|NCT03085485|531237564|FG001|Overall Study|Lost to Follow-up|0|||
147293085|NCT01302119|531237565|FG000|Overall Study|Withdrawal by Subject|30|||
147293086|NCT01302119|531237566|FG001|Overall Study|Withdrawal by Subject|20|||
147338718|NCT02763319|531408243|FG001|Overall Study|Adverse Event|3|||
147293087|NCT01302119|531237565|FG000|Overall Study|Lost to Follow-up|10|||
147338719|NCT02763319|531408242|FG000|Overall Study|Death|123|||
147452825|NCT05107765|531820068|FG001|Overall Study|Withdrawal by Subjects due to scheduling issues|3|||
147452826|NCT01407926|531821438|FG000|Overall Study|Lost to Follow-up|55|||
147293088|NCT01302119|531237566|FG001|Overall Study|Lost to Follow-up|4|||
147293089|NCT01302119|531237565|FG000|Overall Study|Adverse Event|2|||
147293090|NCT01302119|531237566|FG001|Overall Study|Adverse Event|1|||
147293091|NCT01302119|531237565|FG000|Overall Study|Non-compliance|4|||
147293092|NCT01302119|531237566|FG001|Overall Study|Non-compliance|2|||
147293093|NCT01302119|531237565|FG000|Overall Study|Non-specific|4|||
147293094|NCT01302119|531237566|FG001|Overall Study|Non-specific|1|||
147293095|NCT01775904|531237570|FG000|LY2886721 Capsule (Water, Fasting)|Adverse Event|1|||
147293096|NCT01775904|531237570|FG000|LY2886721 ODT (Water, Fasting)|Adverse Event|1|||
147293097|NCT04891419|531237571|FG000|Overall Study|Withdrawal by Subject|4|||
147293098|NCT04891419|531237572|FG001|Overall Study|Withdrawal by Subject|0|||
147452827|NCT02814565|531821439|FG000|Overall Study|Lack of Efficacy|0|||
147452828|NCT02814565|531821440|FG001|Overall Study|Lack of Efficacy|1|||
147452829|NCT02814565|531821439|FG000|Overall Study|Subject decision, caused by AE Influenza|1|||
147452830|NCT02814565|531821440|FG001|Overall Study|Subject decision, caused by AE Influenza|1|||
147452831|NCT02468648|531821441|FG000|Overall Study|Death|1|||
147452832|NCT04232696|531821442|FG000|Overall Study|Implant attempted but not completed|5|||
147452833|NCT04232696|531821443|FG001|Overall Study|Implant attempted but not completed|2|||
147452834|NCT04232696|531821442|FG000|Overall Study|Not satisfied with therapy outcome|0|||
147293099|NCT04891419|531237571|FG000|Overall Study|Lost to Follow-up|1|||
147293100|NCT04891419|531237572|FG001|Overall Study|Lost to Follow-up|3|||
147293101|NCT00490646|531237576|FG000|Overall Study|Still on trastuzumab monotherapy|1|||
147293102|NCT00490646|531237577|FG001|Overall Study|Still on trastuzumab monotherapy|1|||
147293103|NCT00490646|531237576|FG000|Overall Study|Never Treated (had an adverse event)|1|||
147293104|NCT00490646|531237577|FG001|Overall Study|Never Treated (had an adverse event)|0|||
147293105|NCT00490646|531237576|FG000|Overall Study|Never Treated (withdrew consent)|0|||
147293106|NCT00490646|531237577|FG001|Overall Study|Never Treated (withdrew consent)|1|||
147293107|NCT01178086|531237578|FG000|Overall Study|Participant refusal|7|||
147293108|NCT01178086|531237578|FG000|Overall Study|Physician Decision|44|||
147293109|NCT01178086|531237578|FG000|Overall Study|Switch to other CLL therapy|113|||
147293110|NCT01178086|531237578|FG000|Overall Study|Death|59|||
147293111|NCT01178086|531237578|FG000|Overall Study|Other unspecified|89|||
147293112|NCT01178086|531237578|FG000|Overall Study|Excluded from EAS|20|||
147293113|NCT02137369|531237579|FG000|Overall Study|Withdrawal by Subject|3|||
147293114|NCT02137369|531237580|FG001|Overall Study|Withdrawal by Subject|2|||
147293115|NCT02137369|531237579|FG000|Overall Study|Adverse Event|2|||
147293116|NCT02137369|531237580|FG001|Overall Study|Adverse Event|0|||
147293117|NCT02137369|531237579|FG000|Overall Study|Lost to Follow-up|1|||
147293118|NCT02137369|531237580|FG001|Overall Study|Lost to Follow-up|0|||
147293119|NCT02137369|531237579|FG000|Overall Study|Moved away|2|||
147293120|NCT02137369|531237580|FG001|Overall Study|Moved away|0|||
147293121|NCT00126438|531237582|FG000|Overall Study|Withdrawal due to adverse event|1|||
147293122|NCT00126438|531237583|FG001|Overall Study|Withdrawal due to adverse event|0|||
147293123|NCT00126438|531237582|FG000|Overall Study|Lost to Follow-up|22|||
147293124|NCT00126438|531237583|FG001|Overall Study|Lost to Follow-up|0|||
147293125|NCT00126438|531237582|FG000|Overall Study|Protocol Violation|8|||
147293126|NCT00126438|531237583|FG001|Overall Study|Protocol Violation|8|||
147293127|NCT00126438|531237582|FG000|Overall Study|Withdrawal by Subject|3|||
147293128|NCT00126438|531237583|FG001|Overall Study|Withdrawal by Subject|2|||
147293129|NCT02899728|531237587|FG000|Overall Study|Withdrawal by Subject|1|||
147293130|NCT02899728|531237588|FG001|Overall Study|Withdrawal by Subject|1|||
147293131|NCT02626780|531237590|FG000|Overall Study|Withdrawal by Subject|3|||
147293132|NCT04304833|531237591|FG000|Overall Study|Due to the pandemic in person visits were not allowed|4|||
147293133|NCT04304833|531237592|FG001|Overall Study|Due to the pandemic in person visits were not allowed|2|||
147293134|NCT00613951|531237595|FG000|Overall Study|Adverse Event|1|||
147293135|NCT00613951|531237596|FG001|Overall Study|Adverse Event|0|||
147293136|NCT00613951|531237597|FG002|Overall Study|Adverse Event|1|||
147293137|NCT00613951|531237595|FG000|Overall Study|Lack of Efficacy|0|||
147293138|NCT00613951|531237596|FG001|Overall Study|Lack of Efficacy|1|||
147293139|NCT00613951|531237597|FG002|Overall Study|Lack of Efficacy|1|||
147293140|NCT00613951|531237595|FG000|Overall Study|Protocol Violation|1|||
147293141|NCT00613951|531237596|FG001|Overall Study|Protocol Violation|1|||
147293142|NCT00613951|531237597|FG002|Overall Study|Protocol Violation|1|||
147293143|NCT00613951|531237595|FG000|Overall Study|Unclassified|5|||
147293144|NCT00613951|531237596|FG001|Overall Study|Unclassified|3|||
147293145|NCT00613951|531237597|FG002|Overall Study|Unclassified|2|||
147293146|NCT05540522|531237599|FG000|Overall Study|Adverse Event|1|||
147293147|NCT05540522|531237600|FG001|Overall Study|Adverse Event|0|||
147293148|NCT05540522|531237601|FG002|Overall Study|Adverse Event|2|||
147293149|NCT05540522|531237602|FG003|Overall Study|Adverse Event|5|||
147293150|NCT05540522|531237599|FG000|Overall Study|Lost to Follow-up|487|||
147293151|NCT05540522|531237600|FG001|Overall Study|Lost to Follow-up|427|||
147293152|NCT05540522|531237601|FG002|Overall Study|Lost to Follow-up|146|||
147452835|NCT04232696|531821443|FG001|Overall Study|Not satisfied with therapy outcome|8|||
147293153|NCT05540522|531237602|FG003|Overall Study|Lost to Follow-up|166|||
147293154|NCT05540522|531237599|FG000|Overall Study|Physician Decision|11|||
147293155|NCT05540522|531237600|FG001|Overall Study|Physician Decision|19|||
147293156|NCT05540522|531237601|FG002|Overall Study|Physician Decision|8|||
147293157|NCT05540522|531237602|FG003|Overall Study|Physician Decision|13|||
147293158|NCT05540522|531237599|FG000|Overall Study|Pregnancy|1|||
147293159|NCT05540522|531237600|FG001|Overall Study|Pregnancy|0|||
147293160|NCT05540522|531237601|FG002|Overall Study|Pregnancy|0|||
147293161|NCT05540522|531237602|FG003|Overall Study|Pregnancy|0|||
147293162|NCT05540522|531237599|FG000|Overall Study|Protocol Violation|3|||
147293163|NCT05540522|531237600|FG001|Overall Study|Protocol Violation|1|||
147293164|NCT05540522|531237601|FG002|Overall Study|Protocol Violation|9|||
147293165|NCT05540522|531237602|FG003|Overall Study|Protocol Violation|7|||
147293166|NCT05540522|531237599|FG000|Overall Study|Withdrawal by Subject|168|||
147293167|NCT05540522|531237600|FG001|Overall Study|Withdrawal by Subject|134|||
147293168|NCT05540522|531237601|FG002|Overall Study|Withdrawal by Subject|331|||
147293169|NCT05540522|531237602|FG003|Overall Study|Withdrawal by Subject|322|||
147293170|NCT05540522|531237599|FG000|Overall Study|Death|7|||
147293171|NCT05540522|531237600|FG001|Overall Study|Death|9|||
147293172|NCT05540522|531237601|FG002|Overall Study|Death|49|||
147293173|NCT05540522|531237602|FG003|Overall Study|Death|46|||
147293174|NCT05540522|531237599|FG000|Overall Study|Not vaccinated|34|||
147293175|NCT05540522|531237600|FG001|Overall Study|Not vaccinated|53|||
147293176|NCT05540522|531237601|FG002|Overall Study|Not vaccinated|57|||
147293177|NCT05540522|531237602|FG003|Overall Study|Not vaccinated|50|||
147293178|NCT05540522|531237599|FG000|Overall Study|No longer meets eligibility criteria|0|||
147293179|NCT05540522|531237600|FG001|Overall Study|No longer meets eligibility criteria|0|||
147293180|NCT05540522|531237601|FG002|Overall Study|No longer meets eligibility criteria|3|||
147293181|NCT05540522|531237602|FG003|Overall Study|No longer meets eligibility criteria|2|||
147293182|NCT05540522|531237599|FG000|Overall Study|Other (Unspecified)|8|||
147293183|NCT05540522|531237600|FG001|Overall Study|Other (Unspecified)|10|||
147293184|NCT05540522|531237601|FG002|Overall Study|Other (Unspecified)|4|||
147293185|NCT05540522|531237602|FG003|Overall Study|Other (Unspecified)|2|||
147293186|NCT03754803|531237603|FG000|Overall Study|Withdrawal by Subject|2|||
147293187|NCT04348604|531237606|FG000|Week 8|Withdrawal by Subject|1|||
147293188|NCT04348604|531237607|FG001|Week 8|Withdrawal by Subject|1|||
147293189|NCT04348604|531237606|FG000|Week 8|Lost to Follow-up|1|||
147293190|NCT04348604|531237607|FG001|Week 8|Lost to Follow-up|2|||
147293191|NCT04348604|531237606|FG000|Week 8|Suspended|0|||
147293192|NCT04348604|531237607|FG001|Week 8|Suspended|1|||
147293193|NCT04348604|531237606|FG000|Week 12|Lost to Follow-up|1|||
147293194|NCT04348604|531237607|FG001|Week 12|Lost to Follow-up|2|||
147293195|NCT04348604|531237606|FG000|Week 12|Withdrawal by Subject|1|||
147293196|NCT04348604|531237607|FG001|Week 12|Withdrawal by Subject|0|||
147293197|NCT04348604|531237606|FG000|Week 24|Lost to Follow-up|2|||
147293198|NCT04348604|531237607|FG001|Week 24|Lost to Follow-up|1|||
147452836|NCT04232696|531821442|FG000|Overall Study|Adverse Event|0|||
147293199|NCT02097108|531237608|FG000|Overall Study|Adverse Event|1|||
147293200|NCT02097108|531237608|FG000|Overall Study|patient was abroad for 6 months|1|||
147293201|NCT00127608|531237611|FG000|Overall Study|VZV DNA negative|1|||
147293202|NCT00680407|531237619|FG000|Overall Study|Lost to Follow-up|3|||
147293203|NCT00680407|531237620|FG001|Overall Study|Lost to Follow-up|3|||
147293204|NCT00680407|531237621|FG002|Overall Study|Lost to Follow-up|1|||
147293205|NCT00680407|531237619|FG000|Overall Study|Withdrawal by Subject|5|||
147293206|NCT00680407|531237620|FG001|Overall Study|Withdrawal by Subject|2|||
147293207|NCT00680407|531237621|FG002|Overall Study|Withdrawal by Subject|2|||
147293208|NCT00506493|531237622|FG000|Overall Study|Death|6|||
147293209|NCT00506493|531237622|FG000|Overall Study|Withdrawal by Subject|5|||
147293210|NCT04050865|531239798|FG000|Overall Study|Adverse Event|1|||
147293211|NCT04050865|531239799|FG001|Overall Study|Adverse Event|0|||
147293212|NCT04050865|531239798|FG000|Overall Study|no insert|1|||
147293213|NCT04050865|531239799|FG001|Overall Study|no insert|0|||
147293214|NCT04050865|531239798|FG000|Overall Study|Only 1 insert|2|||
147293215|NCT04050865|531239799|FG001|Overall Study|Only 1 insert|3|||
147293216|NCT04050865|531239798|FG000|Overall Study|Physician Decision|0|||
147293217|NCT04050865|531239799|FG001|Overall Study|Physician Decision|1|||
147293218|NCT04050865|531239798|FG000|Overall Study|Withdrawal by Subject|0|||
147293219|NCT04050865|531239799|FG001|Overall Study|Withdrawal by Subject|1|||
147293220|NCT00857207|531239804|FG000|Overall Study|Withdrawal by Subject|13|||
147293221|NCT00857207|531239805|FG001|Overall Study|Withdrawal by Subject|0|||
147293222|NCT00857207|531239804|FG000|Overall Study|did not meet inclusion criteria for deficit in inhibition or failed the TOMM|18|||
147293223|NCT00857207|531239805|FG001|Overall Study|did not meet inclusion criteria for deficit in inhibition or failed the TOMM|0|||
147293224|NCT00857207|531239804|FG000|Overall Study|Subject chose not to participate after signing consent|3|||
147293225|NCT00857207|531239805|FG001|Overall Study|Subject chose not to participate after signing consent|0|||
147293226|NCT00643916|531239809|FG000|Overall Study|Protocol Violation|0|||
147293227|NCT00643916|531239810|FG001|Overall Study|Protocol Violation|1|||
147293228|NCT00643916|531239811|FG002|Overall Study|Protocol Violation|1|||
147293229|NCT00643916|531239812|FG003|Overall Study|Protocol Violation|1|||
147293230|NCT00643916|531239813|FG004|Overall Study|Protocol Violation|0|||
147293231|NCT00643916|531239814|FG005|Overall Study|Protocol Violation|0|||
147293232|NCT00643916|531239809|FG000|Overall Study|Lost to Follow-up|0|||
147293233|NCT00643916|531239810|FG001|Overall Study|Lost to Follow-up|1|||
147293234|NCT00643916|531239811|FG002|Overall Study|Lost to Follow-up|0|||
147293235|NCT00643916|531239812|FG003|Overall Study|Lost to Follow-up|0|||
147293236|NCT00643916|531239813|FG004|Overall Study|Lost to Follow-up|0|||
147293237|NCT00643916|531239814|FG005|Overall Study|Lost to Follow-up|0|||
147293238|NCT00643916|531239809|FG000|Overall Study|Withdrawal by Subject|2|||
147293239|NCT00643916|531239810|FG001|Overall Study|Withdrawal by Subject|2|||
147293240|NCT00643916|531239811|FG002|Overall Study|Withdrawal by Subject|2|||
147293241|NCT00643916|531239812|FG003|Overall Study|Withdrawal by Subject|1|||
147293242|NCT00643916|531239813|FG004|Overall Study|Withdrawal by Subject|0|||
147293243|NCT00643916|531239814|FG005|Overall Study|Withdrawal by Subject|1|||
147293244|NCT00643916|531239809|FG000|Overall Study|Not Vaccinated|2|||
147293245|NCT00643916|531239810|FG001|Overall Study|Not Vaccinated|2|||
147293246|NCT00643916|531239811|FG002|Overall Study|Not Vaccinated|3|||
147293247|NCT00643916|531239812|FG003|Overall Study|Not Vaccinated|0|||
147293248|NCT00643916|531239813|FG004|Overall Study|Not Vaccinated|2|||
147293249|NCT00643916|531239814|FG005|Overall Study|Not Vaccinated|0|||
147293250|NCT00447057|531239818|FG000|Overall Study|Adverse Event|4|||
147293251|NCT00447057|531239819|FG001|Overall Study|Adverse Event|10|||
147293252|NCT00447057|531239820|FG002|Overall Study|Adverse Event|0|||
147293253|NCT00447057|531239821|FG003|Overall Study|Adverse Event|3|||
147293254|NCT00447057|531239818|FG000|Overall Study|Death due to study disease|6|||
147293255|NCT00447057|531239819|FG001|Overall Study|Death due to study disease|4|||
147293256|NCT00447057|531239820|FG002|Overall Study|Death due to study disease|1|||
147293257|NCT00447057|531239821|FG003|Overall Study|Death due to study disease|1|||
147293258|NCT00447057|531239818|FG000|Overall Study|Lost to Follow-up|0|||
147293259|NCT00447057|531239819|FG001|Overall Study|Lost to Follow-up|1|||
147293260|NCT00447057|531239820|FG002|Overall Study|Lost to Follow-up|0|||
147293261|NCT00447057|531239821|FG003|Overall Study|Lost to Follow-up|0|||
147293262|NCT00447057|531239818|FG000|Overall Study|Entry criteria not met|1|||
147293263|NCT00447057|531239819|FG001|Overall Study|Entry criteria not met|1|||
147293264|NCT00447057|531239820|FG002|Overall Study|Entry criteria not met|0|||
147293265|NCT00447057|531239821|FG003|Overall Study|Entry criteria not met|0|||
147293266|NCT00447057|531239818|FG000|Overall Study|Protocol Violation|0|||
147293267|NCT00447057|531239819|FG001|Overall Study|Protocol Violation|1|||
147293268|NCT00447057|531239820|FG002|Overall Study|Protocol Violation|0|||
147293269|NCT00447057|531239821|FG003|Overall Study|Protocol Violation|0|||
147293270|NCT00447057|531239818|FG000|Overall Study|Withdrawal by Subject|4|||
147293271|NCT00447057|531239819|FG001|Overall Study|Withdrawal by Subject|5|||
147293272|NCT00447057|531239820|FG002|Overall Study|Withdrawal by Subject|1|||
147293273|NCT00447057|531239821|FG003|Overall Study|Withdrawal by Subject|1|||
147293274|NCT00447057|531239818|FG000|Overall Study|Physician Decision|9|||
147293275|NCT00447057|531239819|FG001|Overall Study|Physician Decision|6|||
147293276|NCT00447057|531239820|FG002|Overall Study|Physician Decision|3|||
147293277|NCT00447057|531239821|FG003|Overall Study|Physician Decision|1|||
147293278|NCT00447057|531239818|FG000|Overall Study|Sponsor decision|1|||
147293279|NCT00447057|531239819|FG001|Overall Study|Sponsor decision|1|||
147293280|NCT00447057|531239820|FG002|Overall Study|Sponsor decision|0|||
147293281|NCT00447057|531239821|FG003|Overall Study|Sponsor decision|0|||
147293282|NCT00447057|531239818|FG000|Overall Study|Progressive disease|58|||
147293283|NCT00447057|531239819|FG001|Overall Study|Progressive disease|43|||
147293284|NCT00447057|531239820|FG002|Overall Study|Progressive disease|13|||
147293285|NCT00447057|531239821|FG003|Overall Study|Progressive disease|18|||
147293286|NCT00447057|531239818|FG000|Overall Study|Death due to adverse event|0|||
147293287|NCT00447057|531239819|FG001|Overall Study|Death due to adverse event|0|||
147293288|NCT00447057|531239820|FG002|Overall Study|Death due to adverse event|1|||
147293289|NCT00447057|531239821|FG003|Overall Study|Death due to adverse event|2|||
147293290|NCT00447057|531239818|FG000|Overall Study|Death, study drug related|0|||
147293291|NCT00447057|531239819|FG001|Overall Study|Death, study drug related|1|||
147293292|NCT00447057|531239820|FG002|Overall Study|Death, study drug related|0|||
147293293|NCT00447057|531239821|FG003|Overall Study|Death, study drug related|0|||
147293294|NCT00440531|531239822|FG000|Overall Study|Adverse Event|1|||
147293295|NCT00440531|531239823|FG001|Overall Study|Adverse Event|0|||
147293296|NCT00440531|531239824|FG002|Overall Study|Adverse Event|2|||
147452837|NCT04232696|531821443|FG001|Overall Study|Adverse Event|3|||
147452838|NCT04232696|531821442|FG000|Overall Study|Withdrawal by Subject|0|||
147452839|NCT04232696|531821443|FG001|Overall Study|Withdrawal by Subject|3|||
147452840|NCT04232696|531821442|FG000|Overall Study|Missed Visit|0|||
147452841|NCT04232696|531821443|FG001|Overall Study|Missed Visit|2|||
147452842|NCT04232696|531821442|FG000|Overall Study|Other reason|0|||
147452843|NCT04232696|531821443|FG001|Overall Study|Other reason|1|||
147452844|NCT02787863|531821444|FG000|Overall Study|Death|1|||
147452845|NCT02787863|531821445|FG001|Overall Study|Death|0|||
147452846|NCT02787863|531821446|FG002|Overall Study|Death|1|||
147452847|NCT02787863|531821447|FG003|Overall Study|Death|0|||
147452848|NCT02787863|531821448|FG004|Overall Study|Death|0|||
147452849|NCT02787863|531821449|FG005|Overall Study|Death|0|||
147452850|NCT02787863|531821450|FG006|Overall Study|Death|0|||
147452851|NCT02787863|531821451|FG007|Overall Study|Death|0|||
147452852|NCT02787863|531821444|FG000|Overall Study|Withdrawal by Subject|0|||
147452853|NCT02787863|531821445|FG001|Overall Study|Withdrawal by Subject|1|||
147452854|NCT02787863|531821446|FG002|Overall Study|Withdrawal by Subject|1|||
147605054|NCT03982199|532369860|FG007|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
147605055|NCT03982199|532369861|FG008|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
147605056|NCT03982199|532369862|FG009|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
147605057|NCT03982199|532369863|FG010|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
147605058|NCT03982199|532369864|FG011|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
147605059|NCT03982199|532369865|FG012|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
147605060|NCT03982199|532369866|FG013|Revacc Subcohorts (From Day 365 to 730)|Physician Decision|0|||
147605061|NCT03982199|532369853|FG000|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
147605062|NCT03982199|532369854|FG001|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
147605063|NCT03982199|532369855|FG002|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|3|||
147605064|NCT03982199|532369856|FG003|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|2|||
147605065|NCT03982199|532369857|FG004|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
147605066|NCT03982199|532369858|FG005|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
147605067|NCT03982199|532369859|FG006|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
147605068|NCT03982199|532369860|FG007|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
147605069|NCT03982199|532369861|FG008|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
147605070|NCT03982199|532369862|FG009|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
147605071|NCT03982199|532369863|FG010|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
147605072|NCT03982199|532369864|FG011|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
147605073|NCT03982199|532369865|FG012|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
147605074|NCT03982199|532369866|FG013|Revacc Subcohorts (From Day 365 to 730)|Lost to Follow-up|0|||
147605075|NCT03982199|532369853|FG000|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
147605076|NCT03982199|532369854|FG001|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
147605077|NCT03982199|532369855|FG002|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
147605078|NCT03982199|532369856|FG003|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
147605079|NCT03982199|532369857|FG004|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
147605080|NCT03982199|532369858|FG005|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
147605081|NCT03982199|532369859|FG006|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
147605082|NCT03982199|532369860|FG007|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
147605083|NCT03982199|532369861|FG008|Revacc Subcohorts (From Day 730 to 1095)|Other|5|||
147605084|NCT03982199|532369862|FG009|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
147293297|NCT00440531|531239822|FG000|Overall Study|Withdrawal by Subject|2|||
147293298|NCT00440531|531239823|FG001|Overall Study|Withdrawal by Subject|0|||
147293299|NCT00440531|531239824|FG002|Overall Study|Withdrawal by Subject|0|||
147293300|NCT00440531|531239822|FG000|Overall Study|Protocol Violation|1|||
147293301|NCT00440531|531239823|FG001|Overall Study|Protocol Violation|2|||
147293302|NCT00440531|531239824|FG002|Overall Study|Protocol Violation|0|||
147293303|NCT00440531|531239822|FG000|Overall Study|Lost to Follow-up|4|||
147293304|NCT00440531|531239823|FG001|Overall Study|Lost to Follow-up|3|||
147605085|NCT03982199|532369863|FG010|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
147605086|NCT03982199|532369864|FG011|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
147605087|NCT03982199|532369865|FG012|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
147605088|NCT03982199|532369866|FG013|Revacc Subcohorts (From Day 730 to 1095)|Other|0|||
147605089|NCT03982199|532369853|FG000|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
147605090|NCT03982199|532369854|FG001|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
147605091|NCT03982199|532369855|FG002|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
147605092|NCT03982199|532369856|FG003|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
147605093|NCT03982199|532369857|FG004|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
147605094|NCT03982199|532369858|FG005|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
147605095|NCT03982199|532369859|FG006|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
147605096|NCT03982199|532369860|FG007|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
147605097|NCT03982199|532369861|FG008|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|107|||
147605098|NCT03982199|532369862|FG009|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
147605099|NCT03982199|532369863|FG010|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
147605100|NCT03982199|532369864|FG011|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
147605101|NCT03982199|532369865|FG012|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
147605102|NCT03982199|532369866|FG013|Revacc Subcohorts (From Day 730 to 1095)|Study Terminated by Sponsor|0|||
147338720|NCT02763319|531408243|FG001|Overall Study|Death|123|||
147338721|NCT02763319|531408242|FG000|Overall Study|Lost to Follow-up|6|||
147338722|NCT02763319|531408243|FG001|Overall Study|Lost to Follow-up|7|||
147338723|NCT02763319|531408242|FG000|Overall Study|Noncompliance with Study Drug|2|||
147338724|NCT02763319|531408243|FG001|Overall Study|Noncompliance with Study Drug|0|||
147338725|NCT02763319|531408242|FG000|Overall Study|"Captured as Other in Database"|29|||
147338726|NCT02763319|531408243|FG001|Overall Study|"Captured as Other in Database"|34|||
147293305|NCT00440531|531239824|FG002|Overall Study|Lost to Follow-up|5|||
147293306|NCT00440531|531239822|FG000|Overall Study|see pre-assignment details|2|||
147452855|NCT02787863|531821447|FG003|Overall Study|Withdrawal by Subject|0|||
147452856|NCT02787863|531821448|FG004|Overall Study|Withdrawal by Subject|0|||
147452857|NCT02787863|531821449|FG005|Overall Study|Withdrawal by Subject|0|||
147452858|NCT02787863|531821450|FG006|Overall Study|Withdrawal by Subject|0|||
147452859|NCT02787863|531821451|FG007|Overall Study|Withdrawal by Subject|0|||
147452860|NCT01368835|531821452|FG000|Overall Study|Inclusion criteria/photography quality|22|||
147452861|NCT01368835|531821452|FG000|Overall Study|Lost to Follow-up|11|||
147605103|NCT03982199|532369853|FG000|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
147605104|NCT03982199|532369854|FG001|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
147605105|NCT03982199|532369855|FG002|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
147605106|NCT03982199|532369856|FG003|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
147605107|NCT03982199|532369857|FG004|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
147605108|NCT03982199|532369858|FG005|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
147605109|NCT03982199|532369859|FG006|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
147605110|NCT03982199|532369860|FG007|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
147605111|NCT03982199|532369861|FG008|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|3|||
147605112|NCT03982199|532369862|FG009|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
147605113|NCT03982199|532369863|FG010|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
147605114|NCT03982199|532369864|FG011|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
147605115|NCT03982199|532369865|FG012|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
147605116|NCT03982199|532369866|FG013|Revacc Subcohorts (From Day 730 to 1095)|Site terminated by Sponsor|0|||
147605117|NCT03982199|532369853|FG000|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
147605118|NCT03982199|532369854|FG001|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
147605119|NCT03982199|532369855|FG002|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
147293307|NCT00440531|531239823|FG001|Overall Study|see pre-assignment details|0|||
147293308|NCT00440531|531239824|FG002|Overall Study|see pre-assignment details|0|||
147293309|NCT00677833|531239827|FG000|Overall Study|Withdrawal by Subject|4|||
147293310|NCT00677833|531239828|FG001|Overall Study|Withdrawal by Subject|0|||
147293311|NCT00677833|531239829|FG002|Overall Study|Withdrawal by Subject|1|||
147293312|NCT00677833|531239830|FG003|Overall Study|Withdrawal by Subject|3|||
147293313|NCT00677833|531239827|FG000|Overall Study|Lost to Follow-up|0|||
147293314|NCT00677833|531239828|FG001|Overall Study|Lost to Follow-up|0|||
147293315|NCT00677833|531239829|FG002|Overall Study|Lost to Follow-up|1|||
147293316|NCT00677833|531239830|FG003|Overall Study|Lost to Follow-up|0|||
147293317|NCT02606279|531239831|FG000|Overall Study|Lost to Follow-up|0|||
147293318|NCT02606279|531239832|FG001|Overall Study|Lost to Follow-up|1|||
147605120|NCT03982199|532369856|FG003|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
147605121|NCT03982199|532369857|FG004|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
147452862|NCT01678144|531821453|FG000|Stage 1: MAR Classic|Adverse Event|1|||
147452863|NCT03118297|531821454|FG000|Overall Study|Lost to Follow-up|0|||
147452864|NCT03118297|531821455|FG001|Overall Study|Lost to Follow-up|2|||
147452865|NCT02754726|531821456|FG000|Overall Study|Progressive Disease by RECIST|13|||
147452866|NCT02754726|531821456|FG000|Overall Study|Achieved Best Response and converted to maintenance treatment off study|12|||
147452867|NCT02754726|531821456|FG000|Overall Study|Clinical Disease Progression|5|||
147452868|NCT02754726|531821456|FG000|Overall Study|Adverse Event|3|||
147452869|NCT02754726|531821456|FG000|Overall Study|Withdrawal by Subject|1|||
147452870|NCT02754726|531821456|FG000|Overall Study|Tolerability|1|||
147452871|NCT01885000|531821457|FG000|Overall Study|Adverse Event|1|||
147452872|NCT01885000|531821458|FG001|Overall Study|Adverse Event|0|||
147452873|NCT01885000|531821457|FG000|Overall Study|Withdrawal by Subject|1|||
147605122|NCT03982199|532369858|FG005|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
147605123|NCT03982199|532369859|FG006|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
147605124|NCT03982199|532369860|FG007|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
147605125|NCT03982199|532369861|FG008|Revacc Subcohorts (From Day 730 to 1095)|Death|2|||
147605126|NCT03982199|532369862|FG009|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
147605127|NCT03982199|532369863|FG010|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
147605128|NCT03982199|532369864|FG011|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
147605129|NCT03982199|532369865|FG012|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
147605130|NCT03982199|532369866|FG013|Revacc Subcohorts (From Day 730 to 1095)|Death|0|||
147605131|NCT03982199|532369853|FG000|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
147293319|NCT04493216|531239833|FG000|Overall Study|Study terminated by sponsor|30|||
147293320|NCT04493216|531239834|FG001|Overall Study|Study terminated by sponsor|33|||
147293321|NCT04493216|531239835|FG002|Overall Study|Study terminated by sponsor|28|||
147293322|NCT04493216|531239836|FG003|Overall Study|Study terminated by sponsor|27|||
147452874|NCT01885000|531821458|FG001|Overall Study|Withdrawal by Subject|1|||
147605132|NCT03982199|532369854|FG001|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
147605133|NCT03982199|532369855|FG002|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
147293323|NCT04493216|531239833|FG000|Overall Study|Withdrawal by Subject|2|||
147293324|NCT04493216|531239834|FG001|Overall Study|Withdrawal by Subject|1|||
147338727|NCT02763319|531408242|FG000|Overall Study|Physician Decision|1|||
147293325|NCT04493216|531239835|FG002|Overall Study|Withdrawal by Subject|1|||
147293326|NCT04493216|531239836|FG003|Overall Study|Withdrawal by Subject|2|||
147293327|NCT04493216|531239833|FG000|Overall Study|Protocol Violation|1|||
147605134|NCT03982199|532369856|FG003|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
147605135|NCT03982199|532369857|FG004|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
147605136|NCT03982199|532369858|FG005|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
147605137|NCT03982199|532369859|FG006|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
147605138|NCT03982199|532369860|FG007|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
147605139|NCT03982199|532369861|FG008|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|2|||
147605140|NCT03982199|532369862|FG009|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
147605141|NCT03982199|532369863|FG010|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
147605142|NCT03982199|532369864|FG011|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
147605143|NCT03982199|532369865|FG012|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
147605144|NCT03982199|532369866|FG013|Revacc Subcohorts (From Day 730 to 1095)|Adverse Event|0|||
147605145|NCT03982199|532369853|FG000|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
147605146|NCT03982199|532369854|FG001|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
147605147|NCT03982199|532369855|FG002|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
147605148|NCT03982199|532369856|FG003|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
147605149|NCT03982199|532369857|FG004|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
147605150|NCT03982199|532369858|FG005|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|3|||
147605151|NCT03982199|532369859|FG006|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
147605152|NCT03982199|532369860|FG007|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|7|||
147605153|NCT03982199|532369861|FG008|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|20|||
147605154|NCT03982199|532369862|FG009|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
147605155|NCT03982199|532369863|FG010|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
147605156|NCT03982199|532369864|FG011|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
147605157|NCT03982199|532369865|FG012|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
147605158|NCT03982199|532369866|FG013|Revacc Subcohorts (From Day 730 to 1095)|Withdrawal by Subject|0|||
147605159|NCT03982199|532369853|FG000|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
147605160|NCT03982199|532369854|FG001|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
147605161|NCT03982199|532369855|FG002|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
147605162|NCT03982199|532369856|FG003|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
147605163|NCT03982199|532369857|FG004|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
147605164|NCT03982199|532369858|FG005|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
147605165|NCT03982199|532369859|FG006|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
147605166|NCT03982199|532369860|FG007|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
147605167|NCT03982199|532369861|FG008|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|3|||
147605168|NCT03982199|532369862|FG009|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
147605169|NCT03982199|532369863|FG010|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
147605170|NCT03982199|532369864|FG011|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
147605171|NCT03982199|532369865|FG012|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
147605172|NCT03982199|532369866|FG013|Revacc Subcohorts (From Day 730 to 1095)|Physician Decision|0|||
147605173|NCT03982199|532369853|FG000|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
147605174|NCT03982199|532369854|FG001|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
147605175|NCT03982199|532369855|FG002|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
147605176|NCT03982199|532369856|FG003|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
147605177|NCT03982199|532369857|FG004|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
147605178|NCT03982199|532369858|FG005|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|1|||
147605179|NCT03982199|532369859|FG006|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
147605180|NCT03982199|532369860|FG007|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|3|||
147605181|NCT03982199|532369861|FG008|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|4|||
147605182|NCT03982199|532369862|FG009|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
147605183|NCT03982199|532369863|FG010|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
147605184|NCT03982199|532369864|FG011|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
147605185|NCT03982199|532369865|FG012|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
147605186|NCT03982199|532369866|FG013|Revacc Subcohorts (From Day 730 to 1095)|Lost to Follow-up|0|||
147293328|NCT04493216|531239834|FG001|Overall Study|Protocol Violation|2|||
147293329|NCT04493216|531239835|FG002|Overall Study|Protocol Violation|0|||
147452875|NCT01885000|531821457|FG000|Overall Study|Protocol Violation|0|||
147605187|NCT03982199|532369853|FG000|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
147452876|NCT01885000|531821458|FG001|Overall Study|Protocol Violation|1|||
147452877|NCT02162732|531821460|FG000|Overall Study|Biopsy not performed.|18|||
147293330|NCT04493216|531239836|FG003|Overall Study|Protocol Violation|2|||
147293331|NCT04493216|531239833|FG000|Overall Study|Physician Decision|0|||
147605188|NCT03982199|532369854|FG001|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
147293332|NCT04493216|531239834|FG001|Overall Study|Physician Decision|0|||
147293333|NCT04493216|531239835|FG002|Overall Study|Physician Decision|1|||
147605189|NCT03982199|532369855|FG002|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
147605190|NCT03982199|532369856|FG003|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
147605191|NCT03982199|532369857|FG004|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
147605192|NCT03982199|532369858|FG005|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
147293334|NCT04493216|531239836|FG003|Overall Study|Physician Decision|0|||
147293335|NCT04493216|531239833|FG000|Overall Study|Lost to Follow-up|2|||
147293336|NCT04493216|531239834|FG001|Overall Study|Lost to Follow-up|1|||
147293337|NCT04493216|531239835|FG002|Overall Study|Lost to Follow-up|0|||
147293338|NCT04493216|531239836|FG003|Overall Study|Lost to Follow-up|1|||
147293339|NCT04493216|531239833|FG000|Overall Study|Adverse Event|1|||
147293340|NCT04493216|531239834|FG001|Overall Study|Adverse Event|4|||
147293341|NCT04493216|531239835|FG002|Overall Study|Adverse Event|5|||
147293342|NCT04493216|531239836|FG003|Overall Study|Adverse Event|2|||
147293343|NCT04493216|531239833|FG000|Overall Study|Subject reached protocol-defined stopping criteria|4|||
147293344|NCT04493216|531239834|FG001|Overall Study|Subject reached protocol-defined stopping criteria|2|||
147293345|NCT04493216|531239835|FG002|Overall Study|Subject reached protocol-defined stopping criteria|7|||
147293346|NCT04493216|531239836|FG003|Overall Study|Subject reached protocol-defined stopping criteria|2|||
147293347|NCT00985725|531239839|FG000|Overall Study|Adverse Event|4|||
147293348|NCT00985725|531239840|FG001|Overall Study|Adverse Event|1|||
147293349|NCT00985725|531239839|FG000|Overall Study|Protocol Violation|1|||
147293350|NCT00985725|531239840|FG001|Overall Study|Protocol Violation|3|||
147293351|NCT00985725|531239839|FG000|Overall Study|Withdrawal by Subject|4|||
147293352|NCT00985725|531239840|FG001|Overall Study|Withdrawal by Subject|4|||
147293353|NCT00985725|531239839|FG000|Overall Study|Lost to Follow-up|1|||
147293354|NCT00985725|531239840|FG001|Overall Study|Lost to Follow-up|1|||
147293355|NCT00985725|531239839|FG000|Overall Study|Lack of Efficacy|0|||
147293356|NCT00985725|531239840|FG001|Overall Study|Lack of Efficacy|1|||
147293357|NCT00985725|531239839|FG000|Overall Study|Non-compliance|1|||
147293358|NCT00985725|531239840|FG001|Overall Study|Non-compliance|2|||
147293359|NCT00985725|531239839|FG000|Overall Study|Out-of-window visits|0|||
147293360|NCT00985725|531239840|FG001|Overall Study|Out-of-window visits|1|||
147293361|NCT03151005|531239844|FG000|Overall Study|Lost to Follow-up|5|||
147293362|NCT03151005|531239845|FG001|Overall Study|Lost to Follow-up|5|||
147293363|NCT03318523|531239850|FG000|PC Period: Up to Year 1|Adverse Event|1|||
147293364|NCT03318523|531239851|FG001|PC Period: Up to Year 1|Adverse Event|0|||
147293365|NCT03318523|531239852|FG002|PC Period: Up to Year 1|Adverse Event|2|||
147293366|NCT03318523|531239853|FG003|PC Period: Up to Year 1|Adverse Event|0|||
147293367|NCT03318523|531239854|FG004|PC Period: Up to Year 1|Adverse Event|0|||
147293368|NCT03318523|531239855|FG005|PC Period: Up to Year 1|Adverse Event|0|||
147293369|NCT03318523|531239856|FG006|PC Period: Up to Year 1|Adverse Event|0|||
147293370|NCT03318523|531239857|FG007|PC Period: Up to Year 1|Adverse Event|0|||
147293371|NCT03318523|531239858|FG008|PC Period: Up to Year 1|Adverse Event|0|||
147293372|NCT03318523|531239859|FG009|PC Period: Up to Year 1|Adverse Event|0|||
147293373|NCT03318523|531239850|FG000|PC Period: Up to Year 1|Consent Withdrawn|3|||
147293374|NCT03318523|531239851|FG001|PC Period: Up to Year 1|Consent Withdrawn|2|||
147293375|NCT03318523|531239852|FG002|PC Period: Up to Year 1|Consent Withdrawn|0|||
147293376|NCT03318523|531239853|FG003|PC Period: Up to Year 1|Consent Withdrawn|4|||
147293377|NCT03318523|531239854|FG004|PC Period: Up to Year 1|Consent Withdrawn|0|||
147293378|NCT03318523|531239855|FG005|PC Period: Up to Year 1|Consent Withdrawn|0|||
147293379|NCT03318523|531239856|FG006|PC Period: Up to Year 1|Consent Withdrawn|0|||
147605193|NCT03982199|532369859|FG006|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
147605194|NCT03982199|532369860|FG007|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
147605195|NCT03982199|532369861|FG008|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|0|||
147605196|NCT03982199|532369862|FG009|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|36|||
147605197|NCT03982199|532369863|FG010|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|36|||
147293380|NCT03318523|531239857|FG007|PC Period: Up to Year 1|Consent Withdrawn|0|||
147452878|NCT03446885|531821464|FG000|Overall Study|Lost to Follow-up|1|||
147293381|NCT03318523|531239858|FG008|PC Period: Up to Year 1|Consent Withdrawn|0|||
147293382|NCT03318523|531239859|FG009|PC Period: Up to Year 1|Consent Withdrawn|0|||
147293383|NCT03318523|531239850|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
147293384|NCT03318523|531239851|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
147293385|NCT03318523|531239852|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
147293386|NCT03318523|531239853|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
147293387|NCT03318523|531239854|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|1|||
147293388|NCT03318523|531239855|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
147293389|NCT03318523|531239856|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
147293390|NCT03318523|531239857|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|1|||
147293391|NCT03318523|531239858|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|0|||
147293392|NCT03318523|531239859|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Adverse Event|2|||
147293393|NCT03318523|531239850|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
147293394|NCT03318523|531239851|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
147293395|NCT03318523|531239852|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
147293396|NCT03318523|531239853|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
147293397|NCT03318523|531239854|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|1|||
147293398|NCT03318523|531239855|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
147293399|NCT03318523|531239856|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|0|||
147293400|NCT03318523|531239857|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|1|||
147293401|NCT03318523|531239858|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|3|||
147293402|NCT03318523|531239859|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Consent Withdrawn|2|||
147293403|NCT03318523|531239850|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
147293404|NCT03318523|531239851|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
147293405|NCT03318523|531239852|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
147293406|NCT03318523|531239853|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
147293407|NCT03318523|531239854|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
147293408|NCT03318523|531239855|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|1|||
147293409|NCT03318523|531239856|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
147293410|NCT03318523|531239857|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
147293411|NCT03318523|531239858|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
147293412|NCT03318523|531239859|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Investigator Decision|0|||
147338728|NCT02763319|531408243|FG001|Overall Study|Physician Decision|7|||
147338729|NCT02763319|531408242|FG000|Overall Study|Progressive Disease|24|||
147338730|NCT02763319|531408243|FG001|Overall Study|Progressive Disease|27|||
147338731|NCT02763319|531408242|FG000|Overall Study|Completed the Maximum per Protocol Treatment Period|1|||
147338732|NCT02763319|531408243|FG001|Overall Study|Completed the Maximum per Protocol Treatment Period|0|||
147338733|NCT02763319|531408242|FG000|Overall Study|Diagnosed with COVID-19 and/or Tested Positive for Coronavirus SARS-CoV-2|2|||
147338734|NCT02763319|531408243|FG001|Overall Study|Diagnosed with COVID-19 and/or Tested Positive for Coronavirus SARS-CoV-2|1|||
147338735|NCT02763319|531408242|FG000|Overall Study|Withdrawal by Subject|26|||
147338736|NCT02763319|531408243|FG001|Overall Study|Withdrawal by Subject|25|||
147338737|NCT03936660|531408245|FG000|Overall Study|Missing medication data at 6 and 12 months.|2|||
147338738|NCT03936660|531408246|FG001|Overall Study|Missing medication data at 6 and 12 months.|2|||
147338739|NCT01875848|531408250|FG000|Overall Study|Withdrawal by Subject|2|||
147338740|NCT01875848|531408251|FG001|Overall Study|Withdrawal by Subject|0|||
147338741|NCT00840177|531408252|FG000|Overall Study|Adverse Event|5|||
147338742|NCT00840177|531408253|FG001|Overall Study|Adverse Event|1|||
147338743|NCT00840177|531408254|FG002|Overall Study|Adverse Event|1|||
147338744|NCT00840177|531408252|FG000|Overall Study|Refusal unrelated to adverse events|1|||
147338745|NCT00840177|531408253|FG001|Overall Study|Refusal unrelated to adverse events|0|||
147338746|NCT00840177|531408254|FG002|Overall Study|Refusal unrelated to adverse events|1|||
147338747|NCT00840177|531408252|FG000|Overall Study|Progression/relapse|2|||
147338748|NCT00840177|531408253|FG001|Overall Study|Progression/relapse|0|||
147338749|NCT00840177|531408254|FG002|Overall Study|Progression/relapse|0|||
147338750|NCT00840177|531408252|FG000|Overall Study|Death|4|||
147338751|NCT00840177|531408253|FG001|Overall Study|Death|5|||
147338752|NCT00840177|531408254|FG002|Overall Study|Death|5|||
147338753|NCT00840177|531408252|FG000|Overall Study|not protocol specified|6|||
147338754|NCT00840177|531408253|FG001|Overall Study|not protocol specified|3|||
147338755|NCT00840177|531408254|FG002|Overall Study|not protocol specified|0|||
147338756|NCT00840177|531408252|FG000|Overall Study|Ineligible|0|||
147338757|NCT00840177|531408253|FG001|Overall Study|Ineligible|0|||
147338758|NCT00840177|531408254|FG002|Overall Study|Ineligible|3|||
147338759|NCT00840177|531408252|FG000|Overall Study|Did not start treatment|0|||
147338760|NCT00840177|531408253|FG001|Overall Study|Did not start treatment|0|||
147338761|NCT00840177|531408254|FG002|Overall Study|Did not start treatment|1|||
147338762|NCT02407249|531408255|FG000|Overall Study|Did not complete 12-month follow-up|13|||
147338763|NCT02407249|531408255|FG000|Overall Study|Not treated|13|||
147338764|NCT01622868|531408256|FG000|Overall Study|Protocol Violation|7|||
147338765|NCT01622868|531408257|FG001|Overall Study|Protocol Violation|0|||
147338766|NCT00542789|531408258|FG000|Overall Study|Adverse Event|18|||
147338767|NCT00542789|531408259|FG001|Overall Study|Adverse Event|17|||
147338768|NCT00542789|531408258|FG000|Overall Study|Withdrawal by Subject|7|||
147338769|NCT00542789|531408259|FG001|Overall Study|Withdrawal by Subject|3|||
147452879|NCT03446885|531821465|FG001|Overall Study|Lost to Follow-up|0|||
147338770|NCT00542789|531408258|FG000|Overall Study|Protocol Violation|8|||
147338771|NCT00542789|531408259|FG001|Overall Study|Protocol Violation|1|||
147452880|NCT03446885|531821464|FG000|Overall Study|Did not complete entire visit|1|||
147605198|NCT03982199|532369864|FG011|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|35|||
147605199|NCT03982199|532369865|FG012|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|125|||
147605200|NCT03982199|532369866|FG013|Revacc Subcohort (From Day 1095 to 1460)|Study Terminated by Sponsor|114|||
147293413|NCT03318523|531239850|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
147293414|NCT03318523|531239851|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
147293415|NCT03318523|531239852|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
147293416|NCT03318523|531239853|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
147293417|NCT03318523|531239854|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
147293418|NCT03318523|531239855|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
147293419|NCT03318523|531239856|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
147293420|NCT03318523|531239857|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
147293421|NCT03318523|531239858|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|0|||
147293422|NCT03318523|531239859|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Death|1|||
147293423|NCT03318523|531239850|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|0|||
147293424|NCT03318523|531239851|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|0|||
147293425|NCT03318523|531239852|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|0|||
147293426|NCT03318523|531239853|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|0|||
147293427|NCT03318523|531239854|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|17|||
147293428|NCT03318523|531239855|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|36|||
147293429|NCT03318523|531239856|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|39|||
147293430|NCT03318523|531239857|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|48|||
147293431|NCT03318523|531239858|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|94|||
147293432|NCT03318523|531239859|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Study Terminated by Sponsor|91|||
147293433|NCT03318523|531239850|FG000|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
147293434|NCT03318523|531239851|FG001|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
147293435|NCT03318523|531239852|FG002|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
147293436|NCT03318523|531239853|FG003|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
147293437|NCT03318523|531239854|FG004|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|1|||
147338772|NCT00542789|531408258|FG000|Overall Study|Recurrence of Gastric Ulcer|8|||
147338773|NCT00542789|531408259|FG001|Overall Study|Recurrence of Gastric Ulcer|57|||
147605201|NCT03982199|532369853|FG000|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
147605202|NCT03982199|532369854|FG001|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
147338774|NCT02584829|531408260|FG000|Overall Study|Physician Decision|1|||
147338775|NCT02584829|531408261|FG001|Overall Study|Physician Decision|0|||
147338776|NCT02584829|531408260|FG000|Overall Study|Withdrawal by Subject|0|||
147338777|NCT02584829|531408261|FG001|Overall Study|Withdrawal by Subject|1|||
147338778|NCT02584829|531408260|FG000|Overall Study|Progressive Disease|0|||
147338779|NCT02584829|531408261|FG001|Overall Study|Progressive Disease|3|||
147338780|NCT01424397|531408265|FG000|Period-2 (8 Days)|Withdrawal by Subject|0|||
147338781|NCT01424397|531408266|FG001|Period-2 (8 Days)|Withdrawal by Subject|0|||
147338782|NCT01424397|531408267|FG002|Period-2 (8 Days)|Withdrawal by Subject|1|||
147338783|NCT01424397|531408268|FG003|Period-2 (8 Days)|Withdrawal by Subject|0|||
147338784|NCT01424397|531408269|FG004|Period-2 (8 Days)|Withdrawal by Subject|0|||
147338785|NCT01424397|531408270|FG005|Period-2 (8 Days)|Withdrawal by Subject|0|||
147338786|NCT01424397|531408271|FG006|Period-2 (8 Days)|Withdrawal by Subject|0|||
147338787|NCT01424397|531408272|FG007|Period-2 (8 Days)|Withdrawal by Subject|0|||
147338788|NCT01424397|531408273|FG008|Period-2 (8 Days)|Withdrawal by Subject|0|||
147338789|NCT01424397|531408274|FG009|Period-2 (8 Days)|Withdrawal by Subject|0|||
147338790|NCT01424397|531408275|FG010|Period-2 (8 Days)|Withdrawal by Subject|0|||
147338791|NCT01424397|531408276|FG011|Period-2 (8 Days)|Withdrawal by Subject|0|||
147338792|NCT02767765|531408277|FG000|Overall Study|Adverse Event|4|||
147338793|NCT02767765|531408277|FG000|Overall Study|Death|1|||
147605203|NCT03982199|532369855|FG002|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
147605204|NCT03982199|532369856|FG003|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
147605205|NCT03982199|532369857|FG004|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
147293438|NCT03318523|531239855|FG005|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
147293439|NCT03318523|531239856|FG006|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
147338794|NCT02767765|531408277|FG000|Overall Study|Insufficient response|1|||
147338795|NCT02767765|531408277|FG000|Overall Study|Lost to Follow-up|2|||
147338796|NCT02767765|531408277|FG000|Overall Study|Investigator decision|1|||
147338797|NCT02767765|531408277|FG000|Overall Study|Non-Compliance|1|||
147338798|NCT02767765|531408277|FG000|Overall Study|Withdrawal by Subject|1|||
147338799|NCT01951170|531408278|FG000|Overall Study|Investigator decision|1|||
147338800|NCT00585052|531408289|FG000|Overall Study|Withdrawal by Subject|1|||
147338801|NCT00446459|531408292|FG000|8 Months|Protocol Violation|12|||
147338802|NCT00446459|531408292|FG000|12 Months|Protocol Violation|4|||
147338803|NCT00446459|531408292|FG000|12 Months|14 subjects to MMF + Rituximab Study|14|||
147338804|NCT00858117|531408294|FG000|Treatment on Study|Adverse Event|2|||
147338805|NCT00858117|531408294|FG000|Follow up for 5 Years|Death|4|||
147338806|NCT00858117|531408294|FG000|Follow up for 5 Years|No further data collected for study|9|||
147338807|NCT03531840|531408299|FG000|Overall Study|Death on study|3|||
147338808|NCT03531840|531408300|FG001|Overall Study|Death on study|2|||
147605206|NCT03982199|532369858|FG005|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
147293440|NCT03318523|531239857|FG007|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|2|||
147293441|NCT03318523|531239858|FG008|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|3|||
147293442|NCT03318523|531239859|FG009|DBE Period:Year 2 to EOS (Up to 3 Years)|Other|0|||
147293443|NCT00863655|531239862|FG000|Overall Study|Protocol Violation|4|||
147293444|NCT00863655|531239863|FG001|Overall Study|Protocol Violation|0|||
147293445|NCT00863655|531239862|FG000|Overall Study|Adverse Event|52|||
147293446|NCT00863655|531239863|FG001|Overall Study|Adverse Event|8|||
147293447|NCT00863655|531239862|FG000|Overall Study|Withdrawal by Subject|47|||
147293448|NCT00863655|531239863|FG001|Overall Study|Withdrawal by Subject|7|||
147293449|NCT00863655|531239862|FG000|Overall Study|Administrative problems|1|||
147293450|NCT00863655|531239863|FG001|Overall Study|Administrative problems|0|||
147293451|NCT00863655|531239862|FG000|Overall Study|Death|7|||
147293452|NCT00863655|531239863|FG001|Overall Study|Death|1|||
147293453|NCT00863655|531239862|FG000|Overall Study|New cancer therapy|5|||
147293454|NCT00863655|531239863|FG001|Overall Study|New cancer therapy|1|||
147293455|NCT00863655|531239862|FG000|Overall Study|Disease progression|364|||
147293456|NCT00863655|531239863|FG001|Overall Study|Disease progression|221|||
147293457|NCT00863655|531239862|FG000|Overall Study|Treatment completed as per protocol|5|||
147293458|NCT00863655|531239863|FG001|Overall Study|Treatment completed as per protocol|1|||
147293459|NCT02261493|531239864|FG000|Overall Study|Noncompliance|0|||
147293460|NCT02261493|531239865|FG001|Overall Study|Noncompliance|0|||
147293461|NCT02261493|531239866|FG002|Overall Study|Noncompliance|2|||
147293462|NCT02261493|531239864|FG000|Overall Study|Physician Decision|0|||
147293463|NCT02261493|531239865|FG001|Overall Study|Physician Decision|1|||
147293464|NCT02261493|531239866|FG002|Overall Study|Physician Decision|0|||
147293465|NCT02261493|531239864|FG000|Overall Study|Undisclosed alcohol abuse|0|||
147293466|NCT02261493|531239865|FG001|Overall Study|Undisclosed alcohol abuse|1|||
147293467|NCT02261493|531239866|FG002|Overall Study|Undisclosed alcohol abuse|0|||
147293468|NCT02261493|531239864|FG000|Overall Study|Protocol Violation|1|||
147293469|NCT02261493|531239865|FG001|Overall Study|Protocol Violation|0|||
147293470|NCT02261493|531239866|FG002|Overall Study|Protocol Violation|0|||
147293471|NCT02261493|531239864|FG000|Overall Study|Personal Reasons|14|||
147293472|NCT02261493|531239865|FG001|Overall Study|Personal Reasons|14|||
147293473|NCT02261493|531239866|FG002|Overall Study|Personal Reasons|16|||
147293474|NCT02261493|531239864|FG000|Overall Study|Lost to Follow-up|14|||
147293475|NCT02261493|531239865|FG001|Overall Study|Lost to Follow-up|27|||
147293476|NCT02261493|531239866|FG002|Overall Study|Lost to Follow-up|8|||
147293477|NCT02261493|531239864|FG000|Overall Study|Pregnancy|1|||
147293478|NCT02261493|531239865|FG001|Overall Study|Pregnancy|2|||
147293479|NCT02261493|531239866|FG002|Overall Study|Pregnancy|0|||
147293480|NCT02261493|531239864|FG000|Overall Study|Lack of Efficacy|0|||
147293481|NCT02261493|531239865|FG001|Overall Study|Lack of Efficacy|1|||
147293482|NCT02261493|531239866|FG002|Overall Study|Lack of Efficacy|0|||
147293483|NCT02261493|531239864|FG000|Overall Study|Adverse Event|0|||
147293484|NCT02261493|531239865|FG001|Overall Study|Adverse Event|1|||
147293485|NCT02261493|531239866|FG002|Overall Study|Adverse Event|0|||
147293486|NCT01597050|531239867|FG000|Overall Study|Withdrawal by Subject|1|||
147293487|NCT01597050|531239868|FG001|Overall Study|Withdrawal by Subject|0|||
147293488|NCT00483184|531239869|FG000|Overall Study|Withdrawal by Subject|2|||
147293489|NCT00483184|531239870|FG001|Overall Study|Withdrawal by Subject|2|||
147293490|NCT00483184|531239871|FG002|Overall Study|Withdrawal by Subject|0|||
147293491|NCT00483184|531239869|FG000|Overall Study|Lost to Follow-up|1|||
147293492|NCT00483184|531239870|FG001|Overall Study|Lost to Follow-up|0|||
147293493|NCT00483184|531239871|FG002|Overall Study|Lost to Follow-up|0|||
147293494|NCT00483184|531239869|FG000|Overall Study|Adverse Event|1|||
147293495|NCT00483184|531239870|FG001|Overall Study|Adverse Event|2|||
147293496|NCT00483184|531239871|FG002|Overall Study|Adverse Event|2|||
147293497|NCT00483184|531239869|FG000|Overall Study|Protocol Violation|1|||
147293498|NCT00483184|531239870|FG001|Overall Study|Protocol Violation|0|||
147293499|NCT00483184|531239871|FG002|Overall Study|Protocol Violation|1|||
147293500|NCT02065336|531239872|FG000|Extension Phase|Study Terminated by Sponsor|0|||
147293501|NCT02065336|531239873|FG001|Extension Phase|Study Terminated by Sponsor|0|||
147293502|NCT02065336|531239874|FG002|Extension Phase|Study Terminated by Sponsor|0|||
147293503|NCT02065336|531239875|FG003|Extension Phase|Study Terminated by Sponsor|0|||
147338809|NCT03531840|531408301|FG002|Overall Study|Death on study|1|||
147605207|NCT03982199|532369859|FG006|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
147605208|NCT03982199|532369860|FG007|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
147293504|NCT02065336|531239876|FG004|Extension Phase|Study Terminated by Sponsor|0|||
147293505|NCT02065336|531239877|FG005|Extension Phase|Study Terminated by Sponsor|0|||
147293506|NCT02065336|531239878|FG006|Extension Phase|Study Terminated by Sponsor|0|||
147293507|NCT02065336|531239879|FG007|Extension Phase|Study Terminated by Sponsor|0|||
147293508|NCT02065336|531239880|FG008|Extension Phase|Study Terminated by Sponsor|2|||
147293509|NCT02065336|531239881|FG009|Extension Phase|Study Terminated by Sponsor|8|||
147338810|NCT03531840|531408302|FG003|Overall Study|Death on study|2|||
147293510|NCT00530855|531239882|FG000|Overall Study|Lack of Efficacy|20|||
147293511|NCT00530855|531239882|FG000|Overall Study|Withdrawal by Subject|30|||
147293512|NCT00530855|531239882|FG000|Overall Study|Fatal Serious AE|3|||
147293513|NCT00530855|531239882|FG000|Overall Study|Non Fatal Serious AE|7|||
147293514|NCT00530855|531239882|FG000|Overall Study|Non Fatal Non Serious AE|12|||
147293515|NCT00530855|531239882|FG000|Overall Study|Protocol Violation|3|||
147293516|NCT00530855|531239882|FG000|Overall Study|Unsatisfactory compliance of subject|11|||
147293517|NCT00530855|531239882|FG000|Overall Study|Lost to Follow-up|9|||
147293518|NCT00530855|531239882|FG000|Overall Study|Other reason for premature termination|17|||
147293519|NCT01627327|531239883|FG000|Overall Study|Adverse Event|6|||
147293520|NCT01627327|531239884|FG001|Overall Study|Adverse Event|12|||
147293521|NCT01627327|531239883|FG000|Overall Study|Lack of Efficacy-No Sub-Reason|0|||
147293522|NCT01627327|531239884|FG001|Overall Study|Lack of Efficacy-No Sub-Reason|2|||
147293523|NCT01627327|531239883|FG000|Overall Study|Lack of Efficacy-Sub-Reason Exacerbation|4|||
147293524|NCT01627327|531239884|FG001|Overall Study|Lack of Efficacy-Sub-Reason Exacerbation|9|||
147293525|NCT01627327|531239883|FG000|Overall Study|Protocol Violation|4|||
147293526|NCT01627327|531239884|FG001|Overall Study|Protocol Violation|10|||
147293527|NCT01627327|531239883|FG000|Overall Study|Lost to Follow-up|1|||
147293528|NCT01627327|531239884|FG001|Overall Study|Lost to Follow-up|3|||
147293529|NCT01627327|531239883|FG000|Overall Study|Physician Decision|1|||
147293530|NCT01627327|531239884|FG001|Overall Study|Physician Decision|0|||
147293531|NCT01627327|531239883|FG000|Overall Study|Withdrawal by Subject|3|||
147293532|NCT01627327|531239884|FG001|Overall Study|Withdrawal by Subject|3|||
147293533|NCT00868439|531239892|FG000|Overall Study|Adverse Event|4|||
147293534|NCT00868439|531239893|FG001|Overall Study|Adverse Event|3|||
147293535|NCT00868439|531239892|FG000|Overall Study|Prot-Specified W/D Criteria (Serum K+)|2|||
147293536|NCT00868439|531239893|FG001|Overall Study|Prot-Specified W/D Criteria (Serum K+)|3|||
147293537|NCT00868439|531239892|FG000|Overall Study|Death|0|||
147293538|NCT00868439|531239893|FG001|Overall Study|Death|1|||
147293539|NCT00868439|531239892|FG000|Overall Study|Protocol Violation|1|||
147293540|NCT00868439|531239893|FG001|Overall Study|Protocol Violation|1|||
147293541|NCT00868439|531239892|FG000|Overall Study|Physician Decision|1|||
147293542|NCT00868439|531239893|FG001|Overall Study|Physician Decision|0|||
147293543|NCT00868439|531239892|FG000|Overall Study|Withdrawal by Subject|0|||
147293544|NCT00868439|531239893|FG001|Overall Study|Withdrawal by Subject|1|||
147293545|NCT00423176|531239894|FG000|Overall Study|Adverse Event|4|||
147293546|NCT00423176|531239895|FG001|Overall Study|Adverse Event|6|||
147293547|NCT00423176|531239894|FG000|Overall Study|Treatment Failure|1|||
147293548|NCT00423176|531239895|FG001|Overall Study|Treatment Failure|6|||
147293549|NCT00423176|531239894|FG000|Overall Study|Lost to Follow-up|4|||
147293550|NCT00423176|531239895|FG001|Overall Study|Lost to Follow-up|7|||
147293551|NCT00423176|531239894|FG000|Overall Study|Withdrawal by Subject|4|||
147293552|NCT00423176|531239895|FG001|Overall Study|Withdrawal by Subject|3|||
147293553|NCT00423176|531239894|FG000|Overall Study|Protocol Violation|1|||
147293554|NCT00423176|531239895|FG001|Overall Study|Protocol Violation|3|||
147293555|NCT00423176|531239894|FG000|Overall Study|Did not meet protocol eligibility|2|||
147293556|NCT00423176|531239895|FG001|Overall Study|Did not meet protocol eligibility|4|||
147338811|NCT03531840|531408299|FG000|Overall Study|Death during follow up|2|||
147338812|NCT03531840|531408300|FG001|Overall Study|Death during follow up|3|||
147338813|NCT03531840|531408301|FG002|Overall Study|Death during follow up|4|||
147338814|NCT03531840|531408302|FG003|Overall Study|Death during follow up|1|||
147338815|NCT02267824|531408303|FG000|Overall Study|Pregnancy|1|||
147338816|NCT02267824|531408304|FG001|Overall Study|Pregnancy|1|||
147338817|NCT02267824|531408303|FG000|Overall Study|Lost to Follow-up|4|||
147338818|NCT02267824|531408304|FG001|Overall Study|Lost to Follow-up|0|||
147338819|NCT02267824|531408303|FG000|Overall Study|Protocol Violation|3|||
147338820|NCT02267824|531408304|FG001|Overall Study|Protocol Violation|0|||
147338821|NCT02267824|531408303|FG000|Overall Study|Did Not Meet Initial Dental Criteria|2|||
147338822|NCT02267824|531408304|FG001|Overall Study|Did Not Meet Initial Dental Criteria|0|||
147338823|NCT03074331|531408305|FG000|Overall Study|Enrolled but Not Treated|1|||
147338824|NCT03074331|531408305|FG000|Overall Study|Lost to Follow-up|5|||
147338825|NCT03074331|531408305|FG000|Overall Study|Withdrew Consent|1|||
147338826|NCT03451721|531408306|FG000|Overall Study|Death|1|||
147338827|NCT00960141|531408307|FG000|Overall Study|Adverse Event|4|||
147662661|NCT02782741|532587387|FG001|Blinded Treatment Period: up to Week 49|Other|1|||
147293557|NCT00224874|531239898|FG000|Overall Study|Withdrawal by Subject|0|||
147293558|NCT00224874|531239899|FG001|Overall Study|Withdrawal by Subject|0|||
147293559|NCT00224874|531239900|FG002|Overall Study|Withdrawal by Subject|1|||
147293560|NCT00224874|531239901|FG003|Overall Study|Withdrawal by Subject|0|||
147293561|NCT00911534|531239902|FG000|Overall Study|Adverse Event|4|||
147293562|NCT00911534|531239903|FG001|Overall Study|Adverse Event|4|||
147293563|NCT00911534|531239902|FG000|Overall Study|Lost to Follow-up|2|||
147293564|NCT00911534|531239903|FG001|Overall Study|Lost to Follow-up|4|||
147293565|NCT00911534|531239902|FG000|Overall Study|Withdrawal by Subject|2|||
147293566|NCT00911534|531239903|FG001|Overall Study|Withdrawal by Subject|1|||
147293567|NCT00911534|531239902|FG000|Overall Study|Lack of Efficacy|4|||
147293568|NCT00911534|531239903|FG001|Overall Study|Lack of Efficacy|1|||
147293569|NCT00911534|531239902|FG000|Overall Study|Withdrawal of consent|1|||
147293570|NCT00911534|531239903|FG001|Overall Study|Withdrawal of consent|4|||
147338828|NCT00960141|531408308|FG001|Overall Study|Adverse Event|8|||
147605209|NCT03982199|532369861|FG008|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
147605210|NCT03982199|532369862|FG009|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|1|||
147605211|NCT03982199|532369863|FG010|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
147605212|NCT03982199|532369864|FG011|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
147605213|NCT03982199|532369865|FG012|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
147605214|NCT03982199|532369866|FG013|Revacc Subcohort (From Day 1095 to 1460)|Site terminated by Sponsor|0|||
147605215|NCT03982199|532369853|FG000|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
147605216|NCT03982199|532369854|FG001|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
147605217|NCT03982199|532369855|FG002|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
147605218|NCT03982199|532369856|FG003|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
147605219|NCT03982199|532369857|FG004|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
147605220|NCT03982199|532369858|FG005|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
147605221|NCT03982199|532369859|FG006|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
147605222|NCT03982199|532369860|FG007|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
147605223|NCT03982199|532369861|FG008|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
147605224|NCT03982199|532369862|FG009|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
147293571|NCT00911534|531239902|FG000|Overall Study|Other|2|||
147293572|NCT00911534|531239903|FG001|Overall Study|Other|2|||
147293573|NCT02477111|531239904|FG000|Overall Study|Death|28|||
147293574|NCT02477111|531239904|FG000|Overall Study|Withdrawal by Subject|19|||
147293575|NCT02477111|531239904|FG000|Overall Study|Lost to Follow-up|4|||
147293576|NCT01328574|531239905|FG000|Overall Study|Refused further treatment|1|||
147293577|NCT00113568|531239910|FG000|Overall Study|Adverse Event|97|||
147293578|NCT00113568|531239910|FG000|Overall Study|Death|1|||
147293579|NCT00113568|531239910|FG000|Overall Study|Lack of Efficacy|30|||
147293580|NCT00113568|531239910|FG000|Overall Study|Lost to Follow-up|156|||
147293581|NCT00113568|531239910|FG000|Overall Study|Protocol Violation|32|||
147293582|NCT00113568|531239910|FG000|Overall Study|Withdrawal by Subject|117|||
147293583|NCT00113568|531239910|FG000|Overall Study|Other|112|||
147293584|NCT00736645|531239912|FG000|Overall Study|Adverse Event|0|||
147293585|NCT00736645|531239913|FG001|Overall Study|Adverse Event|2|||
147293586|NCT00736645|531239914|FG002|Overall Study|Adverse Event|0|||
147293587|NCT00736645|531239915|FG003|Overall Study|Adverse Event|0|||
147293588|NCT04403698|531239916|FG000|Overall Study|Adverse Event|1|||
147293589|NCT04403698|531239917|FG001|Overall Study|Adverse Event|1|||
147293590|NCT04403698|531239916|FG000|Overall Study|Lost to Follow-up|1|||
147293591|NCT04403698|531239917|FG001|Overall Study|Lost to Follow-up|0|||
147293592|NCT04403698|531239916|FG000|Overall Study|Protocol Violation|0|||
147293593|NCT04403698|531239917|FG001|Overall Study|Protocol Violation|1|||
147293594|NCT04899349|531239920|FG000|Overall Study|Study terminated by Sponsor|2|||
147293595|NCT04899349|531239921|FG001|Overall Study|Study terminated by Sponsor|0|||
147293596|NCT01018394|531239922|FG000|Overall Study|Withdrawal by Subject|5|||
147293597|NCT01018394|531239923|FG001|Overall Study|Withdrawal by Subject|5|||
147293598|NCT01018394|531239922|FG000|Overall Study|Lost to Follow-up|4|||
147293599|NCT01018394|531239923|FG001|Overall Study|Lost to Follow-up|3|||
147293600|NCT03792126|531239924|FG000|Overall Study|Adverse Event|1|||
147293601|NCT03792126|531239925|FG001|Overall Study|Adverse Event|2|||
147293602|NCT03792126|531239924|FG000|Overall Study|Death|0|||
147293603|NCT03792126|531239925|FG001|Overall Study|Death|1|||
147293604|NCT03792126|531239924|FG000|Overall Study|Lost to Follow-up|1|||
147293605|NCT03792126|531239925|FG001|Overall Study|Lost to Follow-up|0|||
147293606|NCT03792126|531239924|FG000|Overall Study|Withdrawal by Subject|0|||
147293607|NCT03792126|531239925|FG001|Overall Study|Withdrawal by Subject|1|||
147293608|NCT03792126|531239924|FG000|Overall Study|COVID-19 Restrictions|1|||
147338829|NCT00960141|531408309|FG002|Overall Study|Adverse Event|2|||
147338830|NCT00960141|531408307|FG000|Overall Study|Lack of Efficacy|3|||
147338831|NCT00960141|531408308|FG001|Overall Study|Lack of Efficacy|4|||
147293609|NCT03792126|531239925|FG001|Overall Study|COVID-19 Restrictions|3|||
147293610|NCT03792126|531239924|FG000|Overall Study|Symptoms resolved|0|||
147293611|NCT03792126|531239925|FG001|Overall Study|Symptoms resolved|3|||
147338832|NCT00960141|531408309|FG002|Overall Study|Lack of Efficacy|2|||
147338833|NCT00960141|531408307|FG000|Overall Study|Lost to Follow-up|1|||
147338834|NCT00960141|531408308|FG001|Overall Study|Lost to Follow-up|0|||
147338835|NCT00960141|531408309|FG002|Overall Study|Lost to Follow-up|0|||
147605225|NCT03982199|532369863|FG010|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
147605226|NCT03982199|532369864|FG011|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
147293612|NCT00683644|531239926|FG000|Overall Study|Withdrawal by Subject|4|||
147293613|NCT00683644|531239927|FG001|Overall Study|Withdrawal by Subject|2|||
147338836|NCT00960141|531408307|FG000|Overall Study|Protocol Violation|1|||
147293614|NCT00683644|531239926|FG000|Overall Study|Lost to Follow-up|1|||
147293615|NCT00683644|531239927|FG001|Overall Study|Lost to Follow-up|4|||
147293616|NCT00683644|531239926|FG000|Overall Study|Adverse Event|1|||
147293617|NCT00683644|531239927|FG001|Overall Study|Adverse Event|2|||
147293618|NCT00683644|531239926|FG000|Overall Study|Low copper, other health problems,|7|||
147293619|NCT00683644|531239927|FG001|Overall Study|Low copper, other health problems,|6|||
147338837|NCT00960141|531408308|FG001|Overall Study|Protocol Violation|3|||
147605227|NCT03982199|532369865|FG012|Revacc Subcohort (From Day 1095 to 1460)|Death|0|||
147293620|NCT04322682|531239928|FG000|Overall Study|Withdrawal by Subject|33|||
147293621|NCT04322682|531239929|FG001|Overall Study|Withdrawal by Subject|47|||
147293622|NCT04322682|531239928|FG000|Overall Study|Death|5|||
147293623|NCT04322682|531239929|FG001|Overall Study|Death|9|||
147293624|NCT04322682|531239928|FG000|Overall Study|Lost to Follow-up|4|||
147293625|NCT04322682|531239929|FG001|Overall Study|Lost to Follow-up|8|||
147293626|NCT04322682|531239928|FG000|Overall Study|Admitted to Hospital and Intubated|1|||
147293627|NCT04322682|531239929|FG001|Overall Study|Admitted to Hospital and Intubated|0|||
147293628|NCT02238379|531239931|FG000|Overall Study|Lost to Follow-up|1|||
147293629|NCT02238379|531239932|FG001|Overall Study|Lost to Follow-up|0|||
147293630|NCT04123067|531239933|FG000|Overall Study|Lost to Follow-up|0|||
147293631|NCT04123067|531239934|FG001|Overall Study|Lost to Follow-up|1|||
147293632|NCT00441090|531239935|FG000|Overall Study|Adverse Event|0|||
147293633|NCT00441090|531239936|FG001|Overall Study|Adverse Event|1|||
147293634|NCT00441090|531239937|FG002|Overall Study|Adverse Event|1|||
147293635|NCT00441090|531239938|FG003|Overall Study|Adverse Event|0|||
147293636|NCT00441090|531239939|FG004|Overall Study|Adverse Event|0|||
147293637|NCT00441090|531239935|FG000|Overall Study|Platelet increase;more than 500,000 mm^3|0|||
147293638|NCT00441090|531239936|FG001|Overall Study|Platelet increase;more than 500,000 mm^3|0|||
147293639|NCT00441090|531239937|FG002|Overall Study|Platelet increase;more than 500,000 mm^3|0|||
147293640|NCT00441090|531239938|FG003|Overall Study|Platelet increase;more than 500,000 mm^3|2|||
147293641|NCT00441090|531239939|FG004|Overall Study|Platelet increase;more than 500,000 mm^3|0|||
147293642|NCT00441090|531239935|FG000|Overall Study|Withdrawal by Subject|1|||
147293643|NCT00441090|531239936|FG001|Overall Study|Withdrawal by Subject|0|||
147293644|NCT00441090|531239937|FG002|Overall Study|Withdrawal by Subject|1|||
147293645|NCT00441090|531239938|FG003|Overall Study|Withdrawal by Subject|0|||
147293646|NCT00441090|531239939|FG004|Overall Study|Withdrawal by Subject|0|||
147293647|NCT00441090|531239935|FG000|Overall Study|Lack of Efficacy|1|||
147293648|NCT00441090|531239936|FG001|Overall Study|Lack of Efficacy|0|||
147293649|NCT00441090|531239937|FG002|Overall Study|Lack of Efficacy|0|||
147293650|NCT00441090|531239938|FG003|Overall Study|Lack of Efficacy|0|||
147293651|NCT00441090|531239939|FG004|Overall Study|Lack of Efficacy|0|||
147293652|NCT01441102|531239940|FG000|Overall Study|Adverse Event|1|||
147293653|NCT01441102|531239940|FG000|Overall Study|Withdrawal by Subject|2|||
147293654|NCT00605280|531239941|FG000|Year 1|Protocol Violation|0|||
147293655|NCT00605280|531239942|FG001|Year 1|Protocol Violation|0|||
147293656|NCT00605280|531239943|FG002|Year 1|Protocol Violation|0|||
147293657|NCT00605280|531239944|FG003|Year 1|Protocol Violation|1|||
147293658|NCT00605280|531239941|FG000|Year 1|Adverse Event|3|||
147293659|NCT00605280|531239942|FG001|Year 1|Adverse Event|1|||
147293660|NCT00605280|531239943|FG002|Year 1|Adverse Event|1|||
147293661|NCT00605280|531239944|FG003|Year 1|Adverse Event|5|||
147293662|NCT00605280|531239941|FG000|Year 1|Physician Decision|7|||
147293663|NCT00605280|531239942|FG001|Year 1|Physician Decision|4|||
147293664|NCT00605280|531239943|FG002|Year 1|Physician Decision|0|||
147293665|NCT00605280|531239944|FG003|Year 1|Physician Decision|6|||
147293666|NCT00605280|531239941|FG000|Year 1|Withdrawal by Subject|2|||
147293667|NCT00605280|531239942|FG001|Year 1|Withdrawal by Subject|4|||
147293668|NCT00605280|531239943|FG002|Year 1|Withdrawal by Subject|0|||
147293669|NCT00605280|531239944|FG003|Year 1|Withdrawal by Subject|4|||
147293670|NCT00605280|531239941|FG000|Year 1|Other|2|||
147293671|NCT00605280|531239942|FG001|Year 1|Other|1|||
147293672|NCT00605280|531239943|FG002|Year 1|Other|0|||
147605228|NCT03982199|532369866|FG013|Revacc Subcohort (From Day 1095 to 1460)|Death|1|||
147605229|NCT03982199|532369853|FG000|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
147605230|NCT03982199|532369854|FG001|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
147605231|NCT03982199|532369855|FG002|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
147605232|NCT03982199|532369856|FG003|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
147605233|NCT03982199|532369857|FG004|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
147605234|NCT03982199|532369858|FG005|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
147293673|NCT00605280|531239944|FG003|Year 1|Other|1|||
147293674|NCT00605280|531239941|FG000|Year 1|Lost to Follow-up or Patient non-comply|5|||
147293675|NCT00605280|531239942|FG001|Year 1|Lost to Follow-up or Patient non-comply|1|||
147293676|NCT00605280|531239943|FG002|Year 1|Lost to Follow-up or Patient non-comply|0|||
147293677|NCT00605280|531239944|FG003|Year 1|Lost to Follow-up or Patient non-comply|2|||
147293678|NCT00605280|531239941|FG000|Year 2|Adverse Event|4|||
147293679|NCT00605280|531239942|FG001|Year 2|Adverse Event|0|||
147293680|NCT00605280|531239943|FG002|Year 2|Adverse Event|2|||
147293681|NCT00605280|531239944|FG003|Year 2|Adverse Event|4|||
147293682|NCT00605280|531239941|FG000|Year 2|Physician Decision|11|||
147293683|NCT00605280|531239942|FG001|Year 2|Physician Decision|6|||
147293684|NCT00605280|531239943|FG002|Year 2|Physician Decision|4|||
147293685|NCT00605280|531239944|FG003|Year 2|Physician Decision|11|||
147293686|NCT00605280|531239941|FG000|Year 2|Withdrawal by Subject|4|||
147293687|NCT00605280|531239942|FG001|Year 2|Withdrawal by Subject|0|||
147293688|NCT00605280|531239943|FG002|Year 2|Withdrawal by Subject|0|||
147293689|NCT00605280|531239944|FG003|Year 2|Withdrawal by Subject|4|||
147605235|NCT03982199|532369859|FG006|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
147605236|NCT03982199|532369860|FG007|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
147605237|NCT03982199|532369861|FG008|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
147605238|NCT03982199|532369862|FG009|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
147605239|NCT03982199|532369863|FG010|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|1|||
147605240|NCT03982199|532369864|FG011|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|2|||
147605241|NCT03982199|532369865|FG012|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|4|||
147605242|NCT03982199|532369866|FG013|Revacc Subcohort (From Day 1095 to 1460)|Withdrawal by Subject|0|||
147605243|NCT03982199|532369853|FG000|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
147605244|NCT03982199|532369854|FG001|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
147605245|NCT03982199|532369855|FG002|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
147605246|NCT03982199|532369856|FG003|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
147605247|NCT03982199|532369857|FG004|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
147605248|NCT03982199|532369858|FG005|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
147605249|NCT03982199|532369859|FG006|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
147605250|NCT03982199|532369860|FG007|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
147605251|NCT03982199|532369861|FG008|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
147605252|NCT03982199|532369862|FG009|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
147605253|NCT03982199|532369863|FG010|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
147605254|NCT03982199|532369864|FG011|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
147605255|NCT03982199|532369865|FG012|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|0|||
147605256|NCT03982199|532369866|FG013|Revacc Subcohort (From Day 1095 to 1460)|Physician Decision|1|||
147605257|NCT03982199|532369853|FG000|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
147605258|NCT03982199|532369854|FG001|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
147605259|NCT03982199|532369855|FG002|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
147605260|NCT03982199|532369856|FG003|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
147605261|NCT03982199|532369857|FG004|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
147605262|NCT03982199|532369858|FG005|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
147605263|NCT03982199|532369859|FG006|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
147605264|NCT03982199|532369860|FG007|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
147605265|NCT03982199|532369861|FG008|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
147605266|NCT03982199|532369862|FG009|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
147605267|NCT03982199|532369863|FG010|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
147605268|NCT03982199|532369864|FG011|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|0|||
147605269|NCT03982199|532369865|FG012|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|1|||
147605270|NCT03982199|532369866|FG013|Revacc Subcohort (From Day 1095 to 1460)|Lost to Follow-up|3|||
147605271|NCT03982199|532369853|FG000|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
147605272|NCT03982199|532369854|FG001|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
147605273|NCT03982199|532369855|FG002|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
147605274|NCT03982199|532369856|FG003|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
147605275|NCT03982199|532369857|FG004|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
147605276|NCT03982199|532369858|FG005|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
147605277|NCT03982199|532369859|FG006|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
147605278|NCT03982199|532369860|FG007|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
147338838|NCT00960141|531408309|FG002|Overall Study|Protocol Violation|2|||
147338839|NCT00960141|531408307|FG000|Overall Study|Withdrawal by Subject|1|||
147605279|NCT03982199|532369861|FG008|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
147605280|NCT03982199|532369862|FG009|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
147605281|NCT03982199|532369863|FG010|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
147605282|NCT03982199|532369864|FG011|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
147605283|NCT03982199|532369865|FG012|Revacc Subcohort (From Day 1095 to 1460)|Other|1|||
147605284|NCT03982199|532369866|FG013|Revacc Subcohort (From Day 1095 to 1460)|Other|0|||
147605285|NCT02278055|532371532|FG000|Overall Study|Adverse Event|1|||
147605286|NCT02278055|532371532|FG000|Overall Study|Lost to Follow-up|1|||
147605287|NCT02278055|532371532|FG000|Overall Study|Withdrawal by Subject|2|||
147605288|NCT02278055|532371532|FG000|Overall Study|Progressive Disease|4|||
147605289|NCT04040192|532371533|FG000|Open Label Run-in Period (up to 8 Weeks)|Adverse Event|18|||
147605290|NCT04040192|532371534|FG001|Open Label Run-in Period (up to 8 Weeks)|Adverse Event|0|||
147605291|NCT04040192|532371535|FG002|Open Label Run-in Period (up to 8 Weeks)|Adverse Event|0|||
147605292|NCT04040192|532371533|FG000|Open Label Run-in Period (up to 8 Weeks)|Lost to Follow-up|14|||
147605293|NCT04040192|532371534|FG001|Open Label Run-in Period (up to 8 Weeks)|Lost to Follow-up|0|||
147605294|NCT04040192|532371535|FG002|Open Label Run-in Period (up to 8 Weeks)|Lost to Follow-up|0|||
147605295|NCT04040192|532371533|FG000|Open Label Run-in Period (up to 8 Weeks)|Physician Decision|3|||
147338840|NCT00960141|531408308|FG001|Overall Study|Withdrawal by Subject|2|||
147338841|NCT00960141|531408309|FG002|Overall Study|Withdrawal by Subject|1|||
147605296|NCT04040192|532371534|FG001|Open Label Run-in Period (up to 8 Weeks)|Physician Decision|0|||
147605297|NCT04040192|532371535|FG002|Open Label Run-in Period (up to 8 Weeks)|Physician Decision|0|||
147605298|NCT04040192|532371533|FG000|Open Label Run-in Period (up to 8 Weeks)|Protocol Violation|3|||
147605299|NCT04040192|532371534|FG001|Open Label Run-in Period (up to 8 Weeks)|Protocol Violation|0|||
147605300|NCT04040192|532371535|FG002|Open Label Run-in Period (up to 8 Weeks)|Protocol Violation|0|||
147605301|NCT04040192|532371533|FG000|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by Subject|8|||
147605302|NCT04040192|532371534|FG001|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by Subject|0|||
147605303|NCT04040192|532371535|FG002|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by Subject|0|||
147605304|NCT04040192|532371533|FG000|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by parent/guardian|18|||
147605305|NCT04040192|532371534|FG001|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by parent/guardian|0|||
147605306|NCT04040192|532371535|FG002|Open Label Run-in Period (up to 8 Weeks)|Withdrawal by parent/guardian|0|||
147605307|NCT04040192|532371533|FG000|Open Label Run-in Period (up to 8 Weeks)|Failure to meet randomization criteria|152|||
147605308|NCT04040192|532371534|FG001|Open Label Run-in Period (up to 8 Weeks)|Failure to meet randomization criteria|0|||
147605309|NCT04040192|532371535|FG002|Open Label Run-in Period (up to 8 Weeks)|Failure to meet randomization criteria|0|||
147605310|NCT04040192|532371533|FG000|Open Label Run-in Period (up to 8 Weeks)|Other|11|||
147605311|NCT04040192|532371534|FG001|Open Label Run-in Period (up to 8 Weeks)|Other|0|||
147605312|NCT04040192|532371535|FG002|Open Label Run-in Period (up to 8 Weeks)|Other|0|||
147605313|NCT04040192|532371533|FG000|Double Blind Period (up to 52 Weeks)|Adverse Event|0|||
147605314|NCT04040192|532371534|FG001|Double Blind Period (up to 52 Weeks)|Adverse Event|3|||
147605315|NCT04040192|532371535|FG002|Double Blind Period (up to 52 Weeks)|Adverse Event|1|||
147605316|NCT04040192|532371533|FG000|Double Blind Period (up to 52 Weeks)|Lost to Follow-up|0|||
147605317|NCT04040192|532371534|FG001|Double Blind Period (up to 52 Weeks)|Lost to Follow-up|6|||
147605318|NCT04040192|532371535|FG002|Double Blind Period (up to 52 Weeks)|Lost to Follow-up|10|||
147605319|NCT04040192|532371533|FG000|Double Blind Period (up to 52 Weeks)|Physician Decision|0|||
147605320|NCT04040192|532371534|FG001|Double Blind Period (up to 52 Weeks)|Physician Decision|0|||
147605321|NCT04040192|532371535|FG002|Double Blind Period (up to 52 Weeks)|Physician Decision|2|||
147605322|NCT04040192|532371533|FG000|Double Blind Period (up to 52 Weeks)|Protocol Violation|0|||
147605323|NCT04040192|532371534|FG001|Double Blind Period (up to 52 Weeks)|Protocol Violation|1|||
147605324|NCT04040192|532371535|FG002|Double Blind Period (up to 52 Weeks)|Protocol Violation|3|||
147605325|NCT04040192|532371533|FG000|Double Blind Period (up to 52 Weeks)|Withdrawal by Subject|0|||
147605326|NCT04040192|532371534|FG001|Double Blind Period (up to 52 Weeks)|Withdrawal by Subject|6|||
147605327|NCT04040192|532371535|FG002|Double Blind Period (up to 52 Weeks)|Withdrawal by Subject|11|||
147605328|NCT04040192|532371533|FG000|Double Blind Period (up to 52 Weeks)|Withdrawal by parent/guardian|0|||
147605329|NCT04040192|532371534|FG001|Double Blind Period (up to 52 Weeks)|Withdrawal by parent/guardian|8|||
147605330|NCT04040192|532371535|FG002|Double Blind Period (up to 52 Weeks)|Withdrawal by parent/guardian|7|||
147605331|NCT04040192|532371533|FG000|Double Blind Period (up to 52 Weeks)|Other|0|||
147605332|NCT04040192|532371534|FG001|Double Blind Period (up to 52 Weeks)|Other|29|||
147605333|NCT04040192|532371535|FG002|Double Blind Period (up to 52 Weeks)|Other|18|||
147605334|NCT04040192|532371533|FG000|Double Blind Period (up to 52 Weeks)|Pregnancy|0|||
147605335|NCT04040192|532371534|FG001|Double Blind Period (up to 52 Weeks)|Pregnancy|2|||
147605336|NCT04040192|532371535|FG002|Double Blind Period (up to 52 Weeks)|Pregnancy|0|||
147605337|NCT04040192|532371533|FG000|Double Blind Period (up to 52 Weeks)|Missing|0|||
147605338|NCT04040192|532371534|FG001|Double Blind Period (up to 52 Weeks)|Missing|2|||
147605339|NCT04040192|532371535|FG002|Double Blind Period (up to 52 Weeks)|Missing|5|||
147605340|NCT00469144|532371536|FG000|Overall Study|Death|0|||
147605341|NCT00469144|532371537|FG001|Overall Study|Death|1|||
147605342|NCT00469144|532371536|FG000|Overall Study|No Response|5|||
147605343|NCT00469144|532371537|FG001|Overall Study|No Response|5|||
147605344|NCT00469144|532371536|FG000|Overall Study|Progressive Disease|1|||
147605345|NCT00469144|532371537|FG001|Overall Study|Progressive Disease|0|||
147605346|NCT01994291|532371538|FG000|Overall Study|Adverse Event|4|||
147605347|NCT01994291|532371539|FG001|Overall Study|Adverse Event|1|||
147605348|NCT01994291|532371540|FG002|Overall Study|Adverse Event|3|||
147605349|NCT01994291|532371538|FG000|Overall Study|Lost to Follow-up|1|||
147605350|NCT01994291|532371539|FG001|Overall Study|Lost to Follow-up|1|||
147605351|NCT01994291|532371540|FG002|Overall Study|Lost to Follow-up|0|||
147605352|NCT01994291|532371538|FG000|Overall Study|Does not meet entrance criteria|1|||
147605353|NCT01994291|532371539|FG001|Overall Study|Does not meet entrance criteria|0|||
147605354|NCT01994291|532371540|FG002|Overall Study|Does not meet entrance criteria|0|||
147605355|NCT01994291|532371538|FG000|Overall Study|Medication error without associated AE|1|||
147605356|NCT01994291|532371539|FG001|Overall Study|Medication error without associated AE|0|||
147605357|NCT01994291|532371540|FG002|Overall Study|Medication error without associated AE|1|||
147605358|NCT01994291|532371538|FG000|Overall Study|Protocol Violation|1|||
147605359|NCT01994291|532371539|FG001|Overall Study|Protocol Violation|0|||
147338842|NCT05274217|531408318|FG000|Overall Study|Study terminated.|11|||
147338843|NCT05274217|531408319|FG001|Overall Study|Study terminated.|0|||
147338844|NCT03144674|531408322|FG000|Overall Study|Participant Transferred to Rollover Study|1|||
147338845|NCT03144674|531408323|FG001|Overall Study|Participant Transferred to Rollover Study|1|||
147605360|NCT01994291|532371540|FG002|Overall Study|Protocol Violation|0|||
147605361|NCT01994291|532371538|FG000|Overall Study|Withdrawal by Subject|6|||
147605362|NCT01994291|532371539|FG001|Overall Study|Withdrawal by Subject|3|||
147605363|NCT01994291|532371540|FG002|Overall Study|Withdrawal by Subject|5|||
147605364|NCT01994291|532371538|FG000|Overall Study|Other|1|||
147605365|NCT01994291|532371539|FG001|Overall Study|Other|2|||
147605366|NCT01994291|532371540|FG002|Overall Study|Other|0|||
147605367|NCT00856375|532371541|FG000|Overall Study|Other|0|||
147605368|NCT00856375|532371542|FG001|Overall Study|Other|1|||
147605369|NCT00856375|532371541|FG000|Overall Study|Death|32|||
147605370|NCT00856375|532371542|FG001|Overall Study|Death|30|||
147605371|NCT00856375|532371541|FG000|Overall Study|Sponsor Terminated Study|7|||
147605372|NCT00856375|532371542|FG001|Overall Study|Sponsor Terminated Study|7|||
147605373|NCT00856375|532371541|FG000|Overall Study|Withdrawal by Subject|2|||
147605374|NCT00856375|532371542|FG001|Overall Study|Withdrawal by Subject|1|||
147605375|NCT00856375|532371541|FG000|Overall Study|Lost to Follow-up|1|||
147605376|NCT00856375|532371542|FG001|Overall Study|Lost to Follow-up|2|||
147605377|NCT02227446|532371543|FG000|Overall Study|not eligible post randomization|18|||
147605378|NCT02227446|532371544|FG001|Overall Study|not eligible post randomization|29|||
147605379|NCT02227446|532371543|FG000|Overall Study|Withdrawal by Subject|4|||
147605380|NCT02227446|532371544|FG001|Overall Study|Withdrawal by Subject|5|||
147605381|NCT02121392|532371545|FG000|Prior to Intervention|Protocol Violation|40|||
147605382|NCT02121392|532371546|FG001|Prior to Intervention|Protocol Violation|35|||
147605383|NCT02121392|532371545|FG000|Prior to Intervention|Withdrawal by Subject|8|||
147605384|NCT02121392|532371546|FG001|Prior to Intervention|Withdrawal by Subject|6|||
147605385|NCT02121392|532371545|FG000|After Placement of AC Block vs Sham|Protocol Violation|3|||
147605386|NCT02121392|532371546|FG001|After Placement of AC Block vs Sham|Protocol Violation|2|||
147605387|NCT02121392|532371545|FG000|After Placement of AC Block vs Sham|Lost to Follow-up|0|||
147605388|NCT02121392|532371546|FG001|After Placement of AC Block vs Sham|Lost to Follow-up|1|||
147605389|NCT01352416|532371547|FG000|Overall Study|Physician Decision|1|||
147605390|NCT01352416|532371548|FG001|Overall Study|Physician Decision|2|||
147605391|NCT01352416|532371549|FG002|Overall Study|Physician Decision|2|||
147605392|NCT01352416|532371550|FG003|Overall Study|Physician Decision|1|||
147605393|NCT03016975|532371559|FG000|At 30 Days Follow-up|Subject is a Screen failure|1|||
147605394|NCT03016975|532371560|FG001|At 30 Days Follow-up|Subject is a Screen failure|0|||
147605395|NCT03016975|532371561|FG002|At 30 Days Follow-up|Subject is a Screen failure|0|||
147605396|NCT03016975|532371559|FG000|At 6 Months Follow-up|Death|2|||
147605397|NCT03016975|532371560|FG001|At 6 Months Follow-up|Death|0|||
147605398|NCT03016975|532371561|FG002|At 6 Months Follow-up|Death|0|||
147605399|NCT03016975|532371559|FG000|At 6 Months Follow-up|Subject withdrawn by investigator|1|||
147605400|NCT03016975|532371560|FG001|At 6 Months Follow-up|Subject withdrawn by investigator|0|||
147605401|NCT03016975|532371561|FG002|At 6 Months Follow-up|Subject withdrawn by investigator|0|||
147605402|NCT03016975|532371559|FG000|At 6 Months Follow-up|Re-attempt procedure|1|||
147605403|NCT03016975|532371560|FG001|At 6 Months Follow-up|Re-attempt procedure|0|||
147605404|NCT03016975|532371561|FG002|At 6 Months Follow-up|Re-attempt procedure|0|||
147605405|NCT03016975|532371559|FG000|At 6 Months Follow-up|Aborted implant|1|||
147605406|NCT03016975|532371560|FG001|At 6 Months Follow-up|Aborted implant|0|||
147605407|NCT03016975|532371561|FG002|At 6 Months Follow-up|Aborted implant|0|||
147605408|NCT03016975|532371559|FG000|At 2 Year Follow-up|Death|1|||
147605409|NCT03016975|532371560|FG001|At 2 Year Follow-up|Death|0|||
147605410|NCT03016975|532371561|FG002|At 2 Year Follow-up|Death|0|||
147605411|NCT03016975|532371559|FG000|At 3 Year Follow-up|Death|1|||
147605412|NCT03016975|532371560|FG001|At 3 Year Follow-up|Death|0|||
147605413|NCT03016975|532371561|FG002|At 3 Year Follow-up|Death|0|||
147605414|NCT03016975|532371559|FG000|At 3 Year Follow-up|Withdrawal by Subject|1|||
147605415|NCT03016975|532371560|FG001|At 3 Year Follow-up|Withdrawal by Subject|0|||
147605416|NCT03016975|532371561|FG002|At 3 Year Follow-up|Withdrawal by Subject|0|||
147605417|NCT03016975|532371559|FG000|At 4-year Follow-up|Exited Study for other reasons|1|||
147605418|NCT03016975|532371560|FG001|At 4-year Follow-up|Exited Study for other reasons|0|||
147338846|NCT03144674|531408324|FG002|Overall Study|Participant Transferred to Rollover Study|5|||
147338847|NCT03144674|531408325|FG003|Overall Study|Participant Transferred to Rollover Study|6|||
147338848|NCT03144674|531408322|FG000|Overall Study|Death|3|||
147338849|NCT03144674|531408323|FG001|Overall Study|Death|2|||
147338850|NCT03144674|531408324|FG002|Overall Study|Death|6|||
147338851|NCT03144674|531408325|FG003|Overall Study|Death|24|||
147605419|NCT03016975|532371561|FG002|At 4-year Follow-up|Exited Study for other reasons|0|||
147338852|NCT03144674|531408322|FG000|Overall Study|Lost to Follow-up|0|||
147338853|NCT03144674|531408323|FG001|Overall Study|Lost to Follow-up|1|||
147338854|NCT03144674|531408324|FG002|Overall Study|Lost to Follow-up|0|||
147605420|NCT02901548|532371562|FG000|Overall Study|Withdrew after month 3 biopsy showed persistent cancer|4|||
147605421|NCT01228019|532371574|FG000|Overall Study|Dose Violation|70|||
147605422|NCT01228019|532371574|FG000|Overall Study|Duplicate enrollment|1|||
147605423|NCT01228019|532371574|FG000|Overall Study|Missing pre-treatment data|72|||
147605424|NCT01228019|532371574|FG000|Overall Study|Triglyceride Entry Criteria Not Met|152|||
147605425|NCT01228019|532371574|FG000|Overall Study|Violation of Entry Criterion|9|||
147605426|NCT02640053|532371576|FG000|Overall Study|Withdrawal by Subject|2|||
147605427|NCT02640053|532371577|FG001|Overall Study|Withdrawal by Subject|1|||
147605428|NCT02640053|532371576|FG000|Overall Study|Adverse Event|1|||
147605429|NCT02640053|532371577|FG001|Overall Study|Adverse Event|1|||
147605430|NCT02640053|532371576|FG000|Overall Study|Alternative Therapy|1|||
147605431|NCT02640053|532371577|FG001|Overall Study|Alternative Therapy|1|||
147605432|NCT02640053|532371576|FG000|Overall Study|Chemo regimen changed after 1st Rx|0|||
147605433|NCT02640053|532371577|FG001|Overall Study|Chemo regimen changed after 1st Rx|1|||
147605434|NCT02348723|532371579|FG000|Overall Study|No ablation|21|||
147605435|NCT02348723|532371580|FG001|Overall Study|No ablation|20|||
147605436|NCT02348723|532371579|FG000|Overall Study|Non-compliant with Protocol|1|||
147605437|NCT02348723|532371580|FG001|Overall Study|Non-compliant with Protocol|0|||
147605438|NCT02348723|532371579|FG000|Overall Study|Lost to Follow-up|1|||
147605439|NCT02348723|532371580|FG001|Overall Study|Lost to Follow-up|1|||
147605440|NCT02348723|532371579|FG000|Overall Study|Consent withdrawn|1|||
147605441|NCT02348723|532371580|FG001|Overall Study|Consent withdrawn|3|||
147605442|NCT02348723|532371579|FG000|Overall Study|Reason other than specified|1|||
147605443|NCT02348723|532371580|FG001|Overall Study|Reason other than specified|1|||
147605444|NCT02348723|532371579|FG000|Overall Study|Adverse Event|3|||
147605445|NCT02348723|532371580|FG001|Overall Study|Adverse Event|1|||
147605446|NCT01268501|532371581|FG000|Overall Study|Lost to Follow-up|1|||
147605447|NCT01268501|532371581|FG000|Overall Study|Withdrawal by Subject|3|||
147605448|NCT01268501|532371581|FG000|Overall Study|Unacceptable Subjective Vision|3|||
147605449|NCT01268501|532371581|FG000|Overall Study|Handling Difficulties|2|||
147605450|NCT02910063|532371582|FG000|Phase 2|Withdrawal by Subject|3|||
147605451|NCT02910063|532371583|FG001|Phase 2|Withdrawal by Subject|0|||
147605452|NCT02910063|532371584|FG002|Phase 2|Withdrawal by Subject|0|||
147605453|NCT02910063|532371582|FG000|Phase 2|Lost to Follow-up|1|||
147605454|NCT02910063|532371583|FG001|Phase 2|Lost to Follow-up|0|||
147293690|NCT00605280|531239941|FG000|Year 2|Other|1|||
147293691|NCT00605280|531239942|FG001|Year 2|Other|0|||
147293692|NCT00605280|531239943|FG002|Year 2|Other|0|||
147293693|NCT00605280|531239944|FG003|Year 2|Other|1|||
147293694|NCT00605280|531239941|FG000|Year 2|Lost to Follow-up or Patient non-comply|4|||
147293695|NCT00605280|531239942|FG001|Year 2|Lost to Follow-up or Patient non-comply|0|||
147293696|NCT00605280|531239943|FG002|Year 2|Lost to Follow-up or Patient non-comply|0|||
147293697|NCT00605280|531239944|FG003|Year 2|Lost to Follow-up or Patient non-comply|2|||
147293698|NCT00605280|531239941|FG000|Year 3 Extension|Adverse Event|2|||
147293699|NCT00605280|531239942|FG001|Year 3 Extension|Adverse Event|0|||
147293700|NCT00605280|531239943|FG002|Year 3 Extension|Adverse Event|0|||
147293701|NCT00605280|531239944|FG003|Year 3 Extension|Adverse Event|2|||
147293702|NCT00605280|531239941|FG000|Year 3 Extension|Physician Decision|0|||
147293703|NCT00605280|531239942|FG001|Year 3 Extension|Physician Decision|0|||
147293704|NCT00605280|531239943|FG002|Year 3 Extension|Physician Decision|0|||
147293705|NCT00605280|531239944|FG003|Year 3 Extension|Physician Decision|2|||
147293706|NCT00605280|531239941|FG000|Year 3 Extension|Withdrawal by Subject|2|||
147293707|NCT00605280|531239942|FG001|Year 3 Extension|Withdrawal by Subject|0|||
147293708|NCT00605280|531239943|FG002|Year 3 Extension|Withdrawal by Subject|0|||
147293709|NCT00605280|531239944|FG003|Year 3 Extension|Withdrawal by Subject|5|||
147338855|NCT03144674|531408325|FG003|Overall Study|Lost to Follow-up|4|||
147338856|NCT03144674|531408322|FG000|Overall Study|Withdrawal by Participant|0|||
147338857|NCT03144674|531408323|FG001|Overall Study|Withdrawal by Participant|0|||
147338858|NCT03144674|531408324|FG002|Overall Study|Withdrawal by Participant|2|||
147605455|NCT02910063|532371584|FG002|Phase 2|Lost to Follow-up|0|||
147605456|NCT02910063|532371582|FG000|Phase 2|Death|24|||
147605457|NCT02910063|532371583|FG001|Phase 2|Death|0|||
147605458|NCT02910063|532371584|FG002|Phase 2|Death|0|||
147605459|NCT04435184|532371585|FG000|Overall Study|follow-up blood draws missing|3|||
147605460|NCT04435184|532371586|FG001|Overall Study|follow-up blood draws missing|5|||
147293710|NCT00605280|531239941|FG000|Year 3 Extension|Other|2|||
147293711|NCT00605280|531239942|FG001|Year 3 Extension|Other|0|||
147338859|NCT03144674|531408325|FG003|Overall Study|Withdrawal by Participant|6|||
147338860|NCT03144674|531408322|FG000|Overall Study|Discharged from the Trust|0|||
147338861|NCT03144674|531408323|FG001|Overall Study|Discharged from the Trust|0|||
147338862|NCT03144674|531408324|FG002|Overall Study|Discharged from the Trust|1|||
147338863|NCT03144674|531408325|FG003|Overall Study|Discharged from the Trust|0|||
147338864|NCT03144674|531408322|FG000|Overall Study|Exclusion Criteria Met|0|||
147338865|NCT03144674|531408323|FG001|Overall Study|Exclusion Criteria Met|0|||
147338866|NCT03144674|531408324|FG002|Overall Study|Exclusion Criteria Met|1|||
147452881|NCT03446885|531821465|FG001|Overall Study|Did not complete entire visit|0|||
147338867|NCT03144674|531408325|FG003|Overall Study|Exclusion Criteria Met|0|||
147452882|NCT04735653|531821470|FG000|Overall Study|Lost to Follow-up|17|||
147452883|NCT04735653|531821471|FG001|Overall Study|Lost to Follow-up|7|||
147605461|NCT04693416|532371587|FG000|Overall Study|Lost to Follow-up|13|||
147605462|NCT04693416|532371588|FG001|Overall Study|Lost to Follow-up|0|||
147605463|NCT00474266|532371591|FG000|Overall Study|Withdrawal by Subject|7|||
147293712|NCT00605280|531239943|FG002|Year 3 Extension|Other|0|||
147293713|NCT00605280|531239944|FG003|Year 3 Extension|Other|0|||
147293714|NCT00605280|531239941|FG000|Year 3 Extension|Lost to Follow-up or Patient non-comply|2|||
147338868|NCT03144674|531408322|FG000|Overall Study|Changed Physicians|0|||
147605464|NCT00474266|532371592|FG001|Overall Study|Withdrawal by Subject|20|||
147605465|NCT00474266|532371593|FG002|Overall Study|Withdrawal by Subject|4|||
147605466|NCT00474266|532371594|FG003|Overall Study|Withdrawal by Subject|7|||
147605467|NCT02774642|532371596|FG000|Overall Study|Lost to Follow-up|9|||
147605468|NCT02774642|532371597|FG001|Overall Study|Lost to Follow-up|7|||
147605469|NCT00426361|532371606|FG000|Overall Study|Lost to Follow-up|3|||
147605470|NCT00426361|532371607|FG001|Overall Study|Lost to Follow-up|2|||
147605471|NCT00426361|532371608|FG002|Overall Study|Lost to Follow-up|5|||
147605472|NCT00426361|532371606|FG000|Overall Study|Withdrawal by Subject|1|||
147605473|NCT00426361|532371607|FG001|Overall Study|Withdrawal by Subject|3|||
147605474|NCT00426361|532371608|FG002|Overall Study|Withdrawal by Subject|0|||
147605475|NCT02828241|532371610|FG000|Overall Study|Adverse Event|7|||
147605476|NCT02828241|532371611|FG001|Overall Study|Adverse Event|2|||
147605477|NCT02828241|532371610|FG000|Overall Study|Protocol Violation|1|||
147605478|NCT02828241|532371611|FG001|Overall Study|Protocol Violation|0|||
147605479|NCT03050060|532371625|FG000|Overall Study|Adverse Event|7|||
147605480|NCT03050060|532371625|FG000|Overall Study|Withdrawal by Subject|1|||
147605481|NCT03050060|532371625|FG000|Overall Study|Progression|7|||
147605482|NCT00510289|532371626|FG000|Overall Study|Withdrawal by Subject|7|||
147605483|NCT00510289|532371626|FG000|Overall Study|Refused bone marrow biopsy|2|||
147605484|NCT00510289|532371626|FG000|Overall Study|Lost to Follow-up|1|||
147605485|NCT00510289|532371626|FG000|Overall Study|Progressed prior to starting drug|2|||
147605486|NCT00861198|532371630|FG000|Overall Study|SpyGlass Failed|5|||
147605487|NCT02288182|532371631|FG000|Overall Study|Adverse Event|0|||
147605488|NCT02288182|532371632|FG001|Overall Study|Adverse Event|1|||
147605489|NCT02288182|532371631|FG000|Overall Study|Lost to Follow-up|0|||
147605490|NCT02288182|532371632|FG001|Overall Study|Lost to Follow-up|1|||
147605491|NCT02823652|532371633|FG000|Step 1: On-line Genetic Education Study|Baseline survey not done|58|||
147605492|NCT02823652|532371634|FG001|Step 1: On-line Genetic Education Study|Baseline survey not done|64|||
147605493|NCT02823652|532371635|FG002|Step 1: On-line Genetic Education Study|Baseline survey not done|7|||
147605494|NCT02823652|532371633|FG000|Step 2: Genetic Counseling Substudy|Ineligible|2|||
147605495|NCT02823652|532371634|FG001|Step 2: Genetic Counseling Substudy|Ineligible|0|||
147605496|NCT02823652|532371635|FG002|Step 2: Genetic Counseling Substudy|Ineligible|0|||
147605497|NCT02823652|532371633|FG000|Step 2: Genetic Counseling Substudy|Withdrawal by Subject|2|||
147605498|NCT02823652|532371634|FG001|Step 2: Genetic Counseling Substudy|Withdrawal by Subject|0|||
147605499|NCT02823652|532371635|FG002|Step 2: Genetic Counseling Substudy|Withdrawal by Subject|1|||
147605500|NCT02823652|532371633|FG000|Step 2: Genetic Counseling Substudy|Other|2|||
147605501|NCT02823652|532371634|FG001|Step 2: Genetic Counseling Substudy|Other|2|||
147605502|NCT02823652|532371635|FG002|Step 2: Genetic Counseling Substudy|Other|1|||
147605503|NCT04619992|532371636|FG000|Overall Study|Withdrawal by Subject|1|||
147605504|NCT04619992|532371637|FG001|Overall Study|Withdrawal by Subject|0|||
147605505|NCT04428333|532371638|FG000|Overall Study|Physician Decision|5|||
147605506|NCT04428333|532371639|FG001|Overall Study|Physician Decision|6|||
147605507|NCT04428333|532371638|FG000|Overall Study|Withdrawal by Subject|1|||
147605508|NCT04428333|532371639|FG001|Overall Study|Withdrawal by Subject|3|||
147605509|NCT04428333|532371638|FG000|Overall Study|Study Terminated By Sponsor|14|||
147605510|NCT04428333|532371639|FG001|Overall Study|Study Terminated By Sponsor|16|||
147605511|NCT02269163|532371640|FG000|Overall Study|Lost to Follow-up|1|||
147605512|NCT02269163|532371641|FG001|Overall Study|Lost to Follow-up|0|||
147605513|NCT02269163|532371640|FG000|Overall Study|Major protocol violation|0|||
147605514|NCT02269163|532371641|FG001|Overall Study|Major protocol violation|1|||
147605515|NCT02269163|532371640|FG000|Overall Study|Other|2|||
147605516|NCT02269163|532371641|FG001|Overall Study|Other|2|||
147605517|NCT02269163|532371640|FG000|Overall Study|Withdrawal by Subject|0|||
147605518|NCT02269163|532371641|FG001|Overall Study|Withdrawal by Subject|3|||
147605519|NCT02269163|532371640|FG000|Overall Study|Physician Decision|0|||
147605520|NCT02269163|532371641|FG001|Overall Study|Physician Decision|1|||
147605521|NCT00758680|532371645|FG000|Overall Study|Adverse Event|0|||
147605522|NCT00758680|532371646|FG001|Overall Study|Adverse Event|0|||
147293715|NCT00605280|531239942|FG001|Year 3 Extension|Lost to Follow-up or Patient non-comply|0|||
147293716|NCT00605280|531239943|FG002|Year 3 Extension|Lost to Follow-up or Patient non-comply|0|||
147293717|NCT00605280|531239944|FG003|Year 3 Extension|Lost to Follow-up or Patient non-comply|0|||
147605523|NCT00758680|532371647|FG002|Overall Study|Adverse Event|0|||
147605524|NCT00758680|532371648|FG003|Overall Study|Adverse Event|0|||
147605525|NCT00758680|532371649|FG004|Overall Study|Adverse Event|0|||
147605526|NCT00758680|532371650|FG005|Overall Study|Adverse Event|0|||
147605527|NCT00758680|532371651|FG006|Overall Study|Adverse Event|0|||
147605528|NCT00758680|532371652|FG007|Overall Study|Adverse Event|1|||
147605529|NCT00758680|532371653|FG008|Overall Study|Adverse Event|0|||
147293718|NCT00518115|531239945|FG000|Overall Study|Adverse Event|6|||
147293719|NCT00518115|531239946|FG001|Overall Study|Adverse Event|1|||
147605530|NCT00758680|532371654|FG009|Overall Study|Adverse Event|1|||
147605531|NCT00758680|532371645|FG000|Overall Study|Laboratory Adverse Event|0|||
147605532|NCT00758680|532371646|FG001|Overall Study|Laboratory Adverse Event|0|||
147605533|NCT00758680|532371647|FG002|Overall Study|Laboratory Adverse Event|0|||
147605534|NCT00758680|532371648|FG003|Overall Study|Laboratory Adverse Event|0|||
147293720|NCT00518115|531239947|FG002|Overall Study|Adverse Event|5|||
147293721|NCT00518115|531239948|FG003|Overall Study|Adverse Event|6|||
147293722|NCT00518115|531239949|FG004|Overall Study|Adverse Event|5|||
147293723|NCT00518115|531239950|FG005|Overall Study|Adverse Event|5|||
147293724|NCT00518115|531239951|FG006|Overall Study|Adverse Event|5|||
147293725|NCT00518115|531239952|FG007|Overall Study|Adverse Event|10|||
147293726|NCT00518115|531239953|FG008|Overall Study|Adverse Event|2|||
147293727|NCT00518115|531239954|FG009|Overall Study|Adverse Event|9|||
147293728|NCT00518115|531239945|FG000|Overall Study|Lost to Follow-up|0|||
147293729|NCT00518115|531239946|FG001|Overall Study|Lost to Follow-up|0|||
147293730|NCT00518115|531239947|FG002|Overall Study|Lost to Follow-up|2|||
147293731|NCT00518115|531239948|FG003|Overall Study|Lost to Follow-up|3|||
147293732|NCT00518115|531239949|FG004|Overall Study|Lost to Follow-up|1|||
147293733|NCT00518115|531239950|FG005|Overall Study|Lost to Follow-up|3|||
147293734|NCT00518115|531239951|FG006|Overall Study|Lost to Follow-up|0|||
147293735|NCT00518115|531239952|FG007|Overall Study|Lost to Follow-up|1|||
147293736|NCT00518115|531239953|FG008|Overall Study|Lost to Follow-up|1|||
147293737|NCT00518115|531239954|FG009|Overall Study|Lost to Follow-up|1|||
147293738|NCT00518115|531239945|FG000|Overall Study|Protocol Violation|1|||
147293739|NCT00518115|531239946|FG001|Overall Study|Protocol Violation|3|||
147293740|NCT00518115|531239947|FG002|Overall Study|Protocol Violation|1|||
147293741|NCT00518115|531239948|FG003|Overall Study|Protocol Violation|0|||
147293742|NCT00518115|531239949|FG004|Overall Study|Protocol Violation|0|||
147293743|NCT00518115|531239950|FG005|Overall Study|Protocol Violation|0|||
147293744|NCT00518115|531239951|FG006|Overall Study|Protocol Violation|0|||
147293745|NCT00518115|531239952|FG007|Overall Study|Protocol Violation|0|||
147293746|NCT00518115|531239953|FG008|Overall Study|Protocol Violation|0|||
147293747|NCT00518115|531239954|FG009|Overall Study|Protocol Violation|0|||
147293748|NCT00518115|531239945|FG000|Overall Study|Withdrawal by Subject|1|||
147293749|NCT00518115|531239946|FG001|Overall Study|Withdrawal by Subject|1|||
147293750|NCT00518115|531239947|FG002|Overall Study|Withdrawal by Subject|5|||
147293751|NCT00518115|531239948|FG003|Overall Study|Withdrawal by Subject|0|||
147293752|NCT00518115|531239949|FG004|Overall Study|Withdrawal by Subject|2|||
147293753|NCT00518115|531239950|FG005|Overall Study|Withdrawal by Subject|1|||
147293754|NCT00518115|531239951|FG006|Overall Study|Withdrawal by Subject|0|||
147293755|NCT00518115|531239952|FG007|Overall Study|Withdrawal by Subject|2|||
147293756|NCT00518115|531239953|FG008|Overall Study|Withdrawal by Subject|1|||
147293757|NCT00518115|531239954|FG009|Overall Study|Withdrawal by Subject|3|||
147293758|NCT00518115|531239945|FG000|Overall Study|Lack of Efficacy|1|||
147605535|NCT00758680|532371649|FG004|Overall Study|Laboratory Adverse Event|0|||
147605536|NCT00758680|532371650|FG005|Overall Study|Laboratory Adverse Event|0|||
147605537|NCT00758680|532371651|FG006|Overall Study|Laboratory Adverse Event|0|||
147605538|NCT00758680|532371652|FG007|Overall Study|Laboratory Adverse Event|0|||
147605539|NCT00758680|532371653|FG008|Overall Study|Laboratory Adverse Event|1|||
147605540|NCT00758680|532371654|FG009|Overall Study|Laboratory Adverse Event|0|||
147605541|NCT00758680|532371645|FG000|Overall Study|Withdrawal by Subject|0|||
147605542|NCT00758680|532371646|FG001|Overall Study|Withdrawal by Subject|0|||
147605543|NCT00758680|532371647|FG002|Overall Study|Withdrawal by Subject|0|||
147605544|NCT00758680|532371648|FG003|Overall Study|Withdrawal by Subject|0|||
147605545|NCT00758680|532371649|FG004|Overall Study|Withdrawal by Subject|0|||
147605546|NCT00758680|532371650|FG005|Overall Study|Withdrawal by Subject|0|||
147605547|NCT00758680|532371651|FG006|Overall Study|Withdrawal by Subject|1|||
147605548|NCT00758680|532371652|FG007|Overall Study|Withdrawal by Subject|0|||
147293759|NCT00518115|531239946|FG001|Overall Study|Lack of Efficacy|0|||
147293760|NCT00518115|531239947|FG002|Overall Study|Lack of Efficacy|1|||
147293761|NCT00518115|531239948|FG003|Overall Study|Lack of Efficacy|1|||
147293762|NCT00518115|531239949|FG004|Overall Study|Lack of Efficacy|0|||
147293763|NCT00518115|531239950|FG005|Overall Study|Lack of Efficacy|0|||
147293764|NCT00518115|531239951|FG006|Overall Study|Lack of Efficacy|0|||
147293765|NCT00518115|531239952|FG007|Overall Study|Lack of Efficacy|1|||
147293766|NCT00518115|531239953|FG008|Overall Study|Lack of Efficacy|0|||
147338869|NCT03144674|531408323|FG001|Overall Study|Changed Physicians|0|||
147338870|NCT03144674|531408324|FG002|Overall Study|Changed Physicians|0|||
147338871|NCT03144674|531408325|FG003|Overall Study|Changed Physicians|1|||
147605549|NCT00758680|532371653|FG008|Overall Study|Withdrawal by Subject|1|||
147605550|NCT00758680|532371654|FG009|Overall Study|Withdrawal by Subject|0|||
147605551|NCT00319982|532371655|FG000|Overall Study|Withdrawal by Subject|1|||
147293767|NCT00518115|531239954|FG009|Overall Study|Lack of Efficacy|0|||
147293768|NCT00518115|531239945|FG000|Overall Study|Non-Compliance|1|||
147293769|NCT00518115|531239946|FG001|Overall Study|Non-Compliance|0|||
147293770|NCT00518115|531239947|FG002|Overall Study|Non-Compliance|1|||
147293771|NCT00518115|531239948|FG003|Overall Study|Non-Compliance|0|||
147293772|NCT00518115|531239949|FG004|Overall Study|Non-Compliance|1|||
147293773|NCT00518115|531239950|FG005|Overall Study|Non-Compliance|1|||
147293774|NCT00518115|531239951|FG006|Overall Study|Non-Compliance|1|||
147293775|NCT00518115|531239952|FG007|Overall Study|Non-Compliance|1|||
147293776|NCT00518115|531239953|FG008|Overall Study|Non-Compliance|0|||
147338872|NCT03144674|531408322|FG000|Overall Study|Removed for Safety|0|||
147605552|NCT00319982|532371656|FG001|Overall Study|Withdrawal by Subject|0|||
147605553|NCT01094886|532371657|FG000|Overall Study|Adverse Event|2|||
147605554|NCT01094886|532371657|FG000|Overall Study|Withdrawal by Subject|5|||
147605555|NCT03480386|532371658|FG000|Overall Study|Did not complete measures at 3-months|17|||
147605556|NCT03480386|532371659|FG001|Overall Study|Did not complete measures at 3-months|14|||
147605557|NCT03480386|532371658|FG000|Overall Study|No baseline measures|11|||
147605558|NCT03480386|532371659|FG001|Overall Study|No baseline measures|14|||
147605559|NCT03480386|532371658|FG000|Overall Study|Death|0|||
147605560|NCT03480386|532371659|FG001|Overall Study|Death|5|||
147605561|NCT03480386|532371658|FG000|Overall Study|Withdrawal by Subject|12|||
147605562|NCT03480386|532371659|FG001|Overall Study|Withdrawal by Subject|8|||
147605563|NCT03480386|532371658|FG000|Overall Study|Lost to Follow-up|2|||
147605564|NCT03480386|532371659|FG001|Overall Study|Lost to Follow-up|1|||
147605565|NCT03480386|532371658|FG000|Overall Study|Complicating disease|0|||
147605566|NCT03480386|532371659|FG001|Overall Study|Complicating disease|1|||
147605567|NCT03480386|532371658|FG000|Overall Study|Disease progression|3|||
147605568|NCT03480386|532371659|FG001|Overall Study|Disease progression|0|||
147605569|NCT03480386|532371658|FG000|Overall Study|Became ineligible|0|||
147605570|NCT03480386|532371659|FG001|Overall Study|Became ineligible|2|||
147605571|NCT00574912|532371660|FG000|Overall Study|Could not place IV lines.|3|||
147605572|NCT00574912|532371660|FG000|Overall Study|scheduling conflicts|3|||
147605573|NCT00574912|532371660|FG000|Overall Study|Physician Decision|2|||
147605574|NCT00371397|532371665|FG000|Session 1|Withdrawal by Subject|1|||
147605575|NCT00371397|532371666|FG001|Session 1|Withdrawal by Subject|0|||
147605576|NCT00371397|532371667|FG002|Session 1|Withdrawal by Subject|0|||
147293777|NCT00518115|531239954|FG009|Overall Study|Non-Compliance|1|||
147293778|NCT00518115|531239945|FG000|Overall Study|Treatment Eligibility Criteria Not Met|1|||
147293779|NCT00518115|531239946|FG001|Overall Study|Treatment Eligibility Criteria Not Met|1|||
147293780|NCT00518115|531239947|FG002|Overall Study|Treatment Eligibility Criteria Not Met|0|||
147293781|NCT00518115|531239948|FG003|Overall Study|Treatment Eligibility Criteria Not Met|0|||
147293782|NCT00518115|531239949|FG004|Overall Study|Treatment Eligibility Criteria Not Met|0|||
147293783|NCT00518115|531239950|FG005|Overall Study|Treatment Eligibility Criteria Not Met|4|||
147605577|NCT00371397|532371668|FG003|Session 1|Withdrawal by Subject|0|||
147605578|NCT00371397|532371669|FG004|Session 1|Withdrawal by Subject|0|||
147605579|NCT00371397|532371670|FG005|Session 1|Withdrawal by Subject|0|||
147605580|NCT00371397|532371671|FG006|Session 1|Withdrawal by Subject|0|||
147605581|NCT00371397|532371672|FG007|Session 1|Withdrawal by Subject|1|||
147605582|NCT00371397|532371673|FG008|Session 1|Withdrawal by Subject|0|||
147605583|NCT00371397|532371674|FG009|Session 1|Withdrawal by Subject|0|||
147293784|NCT00518115|531239951|FG006|Overall Study|Treatment Eligibility Criteria Not Met|0|||
147293785|NCT00518115|531239952|FG007|Overall Study|Treatment Eligibility Criteria Not Met|0|||
147293786|NCT00518115|531239953|FG008|Overall Study|Treatment Eligibility Criteria Not Met|0|||
147293787|NCT00518115|531239954|FG009|Overall Study|Treatment Eligibility Criteria Not Met|0|||
147293788|NCT00518115|531239945|FG000|Overall Study|Physician Prescribed Antidiabetic Drug|1|||
147293789|NCT00518115|531239946|FG001|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
147293790|NCT00518115|531239947|FG002|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
147293791|NCT00518115|531239948|FG003|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
147293792|NCT00518115|531239949|FG004|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
147293793|NCT00518115|531239950|FG005|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
147293794|NCT00518115|531239951|FG006|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
147293795|NCT00518115|531239952|FG007|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
147293796|NCT00518115|531239953|FG008|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
147293797|NCT00518115|531239954|FG009|Overall Study|Physician Prescribed Antidiabetic Drug|0|||
147293798|NCT00518115|531239945|FG000|Overall Study|Different Monotherapy Diabetic Drug|0|||
147293799|NCT00518115|531239946|FG001|Overall Study|Different Monotherapy Diabetic Drug|0|||
147293800|NCT00518115|531239947|FG002|Overall Study|Different Monotherapy Diabetic Drug|1|||
147293801|NCT00518115|531239948|FG003|Overall Study|Different Monotherapy Diabetic Drug|0|||
147293802|NCT00518115|531239949|FG004|Overall Study|Different Monotherapy Diabetic Drug|0|||
147293803|NCT00518115|531239950|FG005|Overall Study|Different Monotherapy Diabetic Drug|0|||
147293804|NCT00518115|531239951|FG006|Overall Study|Different Monotherapy Diabetic Drug|0|||
147293805|NCT00518115|531239952|FG007|Overall Study|Different Monotherapy Diabetic Drug|0|||
147293806|NCT00518115|531239953|FG008|Overall Study|Different Monotherapy Diabetic Drug|1|||
147293807|NCT00518115|531239954|FG009|Overall Study|Different Monotherapy Diabetic Drug|0|||
147293808|NCT00518115|531239945|FG000|Overall Study|Wrong Monotherapy Administered|0|||
147293809|NCT00518115|531239946|FG001|Overall Study|Wrong Monotherapy Administered|0|||
147293810|NCT00518115|531239947|FG002|Overall Study|Wrong Monotherapy Administered|1|||
147293811|NCT00518115|531239948|FG003|Overall Study|Wrong Monotherapy Administered|0|||
147293812|NCT00518115|531239949|FG004|Overall Study|Wrong Monotherapy Administered|0|||
147293813|NCT00518115|531239950|FG005|Overall Study|Wrong Monotherapy Administered|0|||
147293814|NCT00518115|531239951|FG006|Overall Study|Wrong Monotherapy Administered|1|||
147293815|NCT00518115|531239952|FG007|Overall Study|Wrong Monotherapy Administered|0|||
147293816|NCT00518115|531239953|FG008|Overall Study|Wrong Monotherapy Administered|0|||
147293817|NCT00518115|531239954|FG009|Overall Study|Wrong Monotherapy Administered|0|||
147293818|NCT00518115|531239945|FG000|Overall Study|Violation of Exclusion Criteria|0|||
147605584|NCT00371397|532371675|FG010|Session 1|Withdrawal by Subject|0|||
147605585|NCT00371397|532371676|FG011|Session 1|Withdrawal by Subject|0|||
147605586|NCT02377427|532371677|FG000|Part A (Up to Week 20)|Physician Decision|1|||
147605587|NCT02377427|532371678|FG001|Part A (Up to Week 20)|Physician Decision|0|||
147605588|NCT02377427|532371679|FG002|Part A (Up to Week 20)|Physician Decision|0|||
147605589|NCT02377427|532371680|FG003|Part A (Up to Week 20)|Physician Decision|0|||
147605590|NCT02377427|532371681|FG004|Part A (Up to Week 20)|Physician Decision|0|||
147605591|NCT02377427|532371677|FG000|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|1|||
147605592|NCT02377427|532371678|FG001|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0|||
147605593|NCT02377427|532371679|FG002|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0|||
147605594|NCT02377427|532371680|FG003|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0|||
147605595|NCT02377427|532371681|FG004|Part A (Up to Week 20)|Other: AE of Asthma Exacerbation|0|||
147605596|NCT02377427|532371677|FG000|Part A (Up to Week 20)|Withdrawal by Subject|2|||
147605597|NCT02377427|532371678|FG001|Part A (Up to Week 20)|Withdrawal by Subject|0|||
147605598|NCT02377427|532371679|FG002|Part A (Up to Week 20)|Withdrawal by Subject|0|||
147605599|NCT02377427|532371680|FG003|Part A (Up to Week 20)|Withdrawal by Subject|0|||
147605600|NCT02377427|532371681|FG004|Part A (Up to Week 20)|Withdrawal by Subject|0|||
147605601|NCT02377427|532371677|FG000|Part B (From Week 20 and up to Week 80)|Protocol Violation|0|||
147605602|NCT02377427|532371678|FG001|Part B (From Week 20 and up to Week 80)|Protocol Violation|0|||
147605603|NCT02377427|532371679|FG002|Part B (From Week 20 and up to Week 80)|Protocol Violation|1|||
147605604|NCT02377427|532371680|FG003|Part B (From Week 20 and up to Week 80)|Protocol Violation|0|||
147605605|NCT02377427|532371681|FG004|Part B (From Week 20 and up to Week 80)|Protocol Violation|0|||
147605606|NCT02293863|532371682|FG000|Overall Study|Death|4|||
147605607|NCT02293863|532371683|FG001|Overall Study|Death|6|||
147605608|NCT02293863|532371684|FG002|Overall Study|Death|4|||
147605609|NCT02293863|532371682|FG000|Overall Study|Lost to Follow-up|2|||
147605610|NCT02293863|532371683|FG001|Overall Study|Lost to Follow-up|2|||
147605611|NCT02293863|532371684|FG002|Overall Study|Lost to Follow-up|2|||
147605612|NCT02293863|532371682|FG000|Overall Study|Withdrawal by Subject|3|||
147605613|NCT02293863|532371683|FG001|Overall Study|Withdrawal by Subject|3|||
147605614|NCT02293863|532371684|FG002|Overall Study|Withdrawal by Subject|1|||
147605615|NCT02293863|532371682|FG000|Overall Study|Reason Not Specified|0|||
147605616|NCT02293863|532371683|FG001|Overall Study|Reason Not Specified|2|||
147605617|NCT02293863|532371684|FG002|Overall Study|Reason Not Specified|2|||
147605618|NCT02342639|532371685|FG000|Overall Study|Acute illness, unrelated to study drug|2|||
147293819|NCT00518115|531239946|FG001|Overall Study|Violation of Exclusion Criteria|0|||
147293820|NCT00518115|531239947|FG002|Overall Study|Violation of Exclusion Criteria|0|||
147293821|NCT00518115|531239948|FG003|Overall Study|Violation of Exclusion Criteria|1|||
147293822|NCT00518115|531239949|FG004|Overall Study|Violation of Exclusion Criteria|0|||
147293823|NCT00518115|531239950|FG005|Overall Study|Violation of Exclusion Criteria|0|||
147293824|NCT00518115|531239951|FG006|Overall Study|Violation of Exclusion Criteria|1|||
147293825|NCT00518115|531239952|FG007|Overall Study|Violation of Exclusion Criteria|0|||
147293826|NCT00518115|531239953|FG008|Overall Study|Violation of Exclusion Criteria|0|||
147293827|NCT00518115|531239954|FG009|Overall Study|Violation of Exclusion Criteria|0|||
147293828|NCT00518115|531239945|FG000|Overall Study|Family Emergency; Had to Go to England|0|||
147293829|NCT00518115|531239946|FG001|Overall Study|Family Emergency; Had to Go to England|0|||
147293830|NCT00518115|531239947|FG002|Overall Study|Family Emergency; Had to Go to England|0|||
147293831|NCT00518115|531239948|FG003|Overall Study|Family Emergency; Had to Go to England|0|||
147293832|NCT00518115|531239949|FG004|Overall Study|Family Emergency; Had to Go to England|1|||
147293833|NCT00518115|531239950|FG005|Overall Study|Family Emergency; Had to Go to England|0|||
147293834|NCT00518115|531239951|FG006|Overall Study|Family Emergency; Had to Go to England|0|||
147293835|NCT00518115|531239952|FG007|Overall Study|Family Emergency; Had to Go to England|0|||
147293836|NCT00518115|531239953|FG008|Overall Study|Family Emergency; Had to Go to England|0|||
147293837|NCT00518115|531239954|FG009|Overall Study|Family Emergency; Had to Go to England|0|||
147293838|NCT00518115|531239945|FG000|Overall Study|Withdrew Consent|0|||
147293839|NCT00518115|531239946|FG001|Overall Study|Withdrew Consent|0|||
147293840|NCT00518115|531239947|FG002|Overall Study|Withdrew Consent|0|||
147293841|NCT00518115|531239948|FG003|Overall Study|Withdrew Consent|0|||
147293842|NCT00518115|531239949|FG004|Overall Study|Withdrew Consent|0|||
147293843|NCT00518115|531239950|FG005|Overall Study|Withdrew Consent|1|||
147605619|NCT02342639|532371686|FG001|Overall Study|Acute illness, unrelated to study drug|3|||
147293844|NCT00518115|531239951|FG006|Overall Study|Withdrew Consent|0|||
147293845|NCT00518115|531239952|FG007|Overall Study|Withdrew Consent|0|||
147293846|NCT00518115|531239953|FG008|Overall Study|Withdrew Consent|0|||
147293847|NCT00518115|531239954|FG009|Overall Study|Withdrew Consent|0|||
147293848|NCT00518115|531239945|FG000|Overall Study|Moved Out of State|0|||
147293849|NCT00518115|531239946|FG001|Overall Study|Moved Out of State|0|||
147293850|NCT00518115|531239947|FG002|Overall Study|Moved Out of State|0|||
147452884|NCT04735653|531821470|FG000|Overall Study|Withdrawal by Subject|8|||
147605620|NCT02342639|532371685|FG000|Overall Study|Protocol Violation|0|||
147605621|NCT02342639|532371686|FG001|Overall Study|Protocol Violation|2|||
147605622|NCT00416884|532371689|FG000|Overall Study|Study terminated due to low accrual|1|||
147605623|NCT00213135|532373051|FG000|Overall Study|Adverse Event|9|||
147605624|NCT00213135|532373052|FG001|Overall Study|Adverse Event|5|||
147605625|NCT00213135|532373053|FG002|Overall Study|Adverse Event|5|||
147605626|NCT00213135|532373051|FG000|Overall Study|Lost to Follow-up|11|||
147605627|NCT00213135|532373052|FG001|Overall Study|Lost to Follow-up|8|||
147605628|NCT00213135|532373053|FG002|Overall Study|Lost to Follow-up|4|||
147605629|NCT00213135|532373051|FG000|Overall Study|Protocol Violation|4|||
147605630|NCT00213135|532373052|FG001|Overall Study|Protocol Violation|4|||
147605631|NCT00213135|532373053|FG002|Overall Study|Protocol Violation|10|||
147605632|NCT00213135|532373051|FG000|Overall Study|Death|1|||
147605633|NCT00213135|532373052|FG001|Overall Study|Death|1|||
147605634|NCT00213135|532373053|FG002|Overall Study|Death|2|||
147605635|NCT00213135|532373051|FG000|Overall Study|Disease progression|4|||
147605636|NCT00213135|532373052|FG001|Overall Study|Disease progression|5|||
147605637|NCT00213135|532373053|FG002|Overall Study|Disease progression|21|||
147605638|NCT00213135|532373051|FG000|Overall Study|Other|21|||
147605639|NCT00213135|532373052|FG001|Overall Study|Other|12|||
147605640|NCT00213135|532373053|FG002|Overall Study|Other|15|||
147605641|NCT02886624|532373057|FG000|12-week Post Treatment Follow-up|Death|1|||
147605642|NCT02886624|532373057|FG000|48-week Post Treatment Follow-up|Lost to Follow-up|1|||
147605643|NCT02929056|532373061|FG000|Overall Study|Lost to Follow-up|0|||
147605644|NCT02929056|532373062|FG001|Overall Study|Lost to Follow-up|1|||
147605645|NCT00402116|532373063|FG000|Overall Study|Jaw infection after surgery-other|1|||
147605646|NCT00402116|532373064|FG001|Overall Study|Jaw infection after surgery-other|0|||
147605647|NCT00402116|532373065|FG002|Overall Study|Jaw infection after surgery-other|0|||
147605648|NCT00402116|532373063|FG000|Overall Study|Withdrawal by Subject|1|||
147605649|NCT00402116|532373064|FG001|Overall Study|Withdrawal by Subject|0|||
147338873|NCT03144674|531408323|FG001|Overall Study|Removed for Safety|0|||
147338874|NCT03144674|531408324|FG002|Overall Study|Removed for Safety|0|||
147338875|NCT03144674|531408325|FG003|Overall Study|Removed for Safety|1|||
147338876|NCT03144674|531408322|FG000|Overall Study|Site Closed|0|||
147338877|NCT03144674|531408323|FG001|Overall Study|Site Closed|0|||
147338878|NCT03144674|531408324|FG002|Overall Study|Site Closed|0|||
147338879|NCT03144674|531408325|FG003|Overall Study|Site Closed|1|||
147338880|NCT03144674|531408322|FG000|Overall Study|Histological Criteria Not Met|0|||
147338881|NCT03144674|531408323|FG001|Overall Study|Histological Criteria Not Met|0|||
147338882|NCT03144674|531408324|FG002|Overall Study|Histological Criteria Not Met|0|||
147338883|NCT03144674|531408325|FG003|Overall Study|Histological Criteria Not Met|1|||
147338884|NCT03144674|531408322|FG000|Overall Study|Multifactorial Cognitive Decline|0|||
147338885|NCT03144674|531408323|FG001|Overall Study|Multifactorial Cognitive Decline|0|||
147452885|NCT04735653|531821471|FG001|Overall Study|Withdrawal by Subject|2|||
147452886|NCT04735653|531821470|FG000|Overall Study|Death|0|||
147605650|NCT00402116|532373065|FG002|Overall Study|Withdrawal by Subject|5|||
147605651|NCT00402116|532373063|FG000|Overall Study|Treatment completed per protocol|1|||
147605652|NCT00402116|532373064|FG001|Overall Study|Treatment completed per protocol|1|||
147605653|NCT00402116|532373065|FG002|Overall Study|Treatment completed per protocol|2|||
147605654|NCT00402116|532373063|FG000|Overall Study|other complicating disease|0|||
147605655|NCT00402116|532373064|FG001|Overall Study|other complicating disease|0|||
147605656|NCT00402116|532373065|FG002|Overall Study|other complicating disease|2|||
147605657|NCT00402116|532373063|FG000|Overall Study|Disease Progression|0|||
147605658|NCT00402116|532373064|FG001|Overall Study|Disease Progression|4|||
147605659|NCT00402116|532373065|FG002|Overall Study|Disease Progression|38|||
147605660|NCT00402116|532373063|FG000|Overall Study|mistaken thrombocytopenia|0|||
147605661|NCT00402116|532373064|FG001|Overall Study|mistaken thrombocytopenia|0|||
147605662|NCT00402116|532373065|FG002|Overall Study|mistaken thrombocytopenia|1|||
147605663|NCT00402116|532373063|FG000|Overall Study|decline related hyponatremia/tumor|0|||
147605664|NCT00402116|532373064|FG001|Overall Study|decline related hyponatremia/tumor|0|||
147605665|NCT00402116|532373065|FG002|Overall Study|decline related hyponatremia/tumor|1|||
147452887|NCT04735653|531821471|FG001|Overall Study|Death|2|||
147452888|NCT04735653|531821470|FG000|Overall Study|Removed due to determination of participant noncompliance|2|||
147605666|NCT00402116|532373063|FG000|Overall Study|Adverse Event|0|||
147605667|NCT00402116|532373064|FG001|Overall Study|Adverse Event|1|||
147605668|NCT00402116|532373065|FG002|Overall Study|Adverse Event|6|||
147605669|NCT05048329|532373066|FG000|Overall Study|Withdrawal by Subject|1|||
147605670|NCT05048329|532373066|FG000|Overall Study|Screenfail|1|||
147338886|NCT03144674|531408324|FG002|Overall Study|Multifactorial Cognitive Decline|0|||
147452889|NCT04735653|531821471|FG001|Overall Study|Removed due to determination of participant noncompliance|0|||
147452890|NCT00252057|531821475|FG000|Overall Study|Withdrawal by Subject|2|||
147605671|NCT00324649|532373067|FG000|Overall Study|Adverse Event|1|||
147605672|NCT00324649|532373068|FG001|Overall Study|Adverse Event|4|||
147605673|NCT00324649|532373067|FG000|Overall Study|Withdrawal by Subject|0|||
147605674|NCT00324649|532373068|FG001|Overall Study|Withdrawal by Subject|1|||
147605675|NCT00324649|532373067|FG000|Overall Study|Noncompliance|1|||
147605676|NCT00324649|532373068|FG001|Overall Study|Noncompliance|0|||
147605677|NCT01564537|532373069|FG000|Overall Study|Site Terminated by Sponsor|1|||
147662662|NCT02782741|532587388|FG002|Blinded Treatment Period: up to Week 49|Other|0|||
147605678|NCT01564537|532373070|FG001|Overall Study|Site Terminated by Sponsor|0|||
147605679|NCT01564537|532373069|FG000|Overall Study|Withdrawal by Subject|12|||
147605680|NCT01564537|532373070|FG001|Overall Study|Withdrawal by Subject|14|||
147605681|NCT01564537|532373069|FG000|Overall Study|Lost to Follow-up|7|||
147605682|NCT01564537|532373070|FG001|Overall Study|Lost to Follow-up|3|||
147605683|NCT01564537|532373069|FG000|Overall Study|Reason not specified|81|||
147605684|NCT01564537|532373070|FG001|Overall Study|Reason not specified|82|||
147605685|NCT05776862|532373071|FG000|Overall Study|Adverse Event|0|||
147605686|NCT05776862|532373072|FG001|Overall Study|Adverse Event|1|||
147605687|NCT05776862|532373071|FG000|Overall Study|non-compliance|1|||
147605688|NCT05776862|532373072|FG001|Overall Study|non-compliance|0|||
147605689|NCT02448706|532373073|FG000|Overall Study|Withdrawal by Subject|4|||
147605690|NCT02448706|532373074|FG001|Overall Study|Withdrawal by Subject|3|||
147605691|NCT02448706|532373073|FG000|Overall Study|Protocol Violation|1|||
147338887|NCT03144674|531408325|FG003|Overall Study|Multifactorial Cognitive Decline|1|||
147338888|NCT03144674|531408322|FG000|Overall Study|Progression of Chronic Lymphocytic Leukemia|0|||
147338889|NCT03144674|531408323|FG001|Overall Study|Progression of Chronic Lymphocytic Leukemia|0|||
147338890|NCT03144674|531408324|FG002|Overall Study|Progression of Chronic Lymphocytic Leukemia|0|||
147338891|NCT03144674|531408325|FG003|Overall Study|Progression of Chronic Lymphocytic Leukemia|1|||
147338892|NCT00736853|531408326|FG000|Open-Label Period|Physician Decision|2|||
147338893|NCT00736853|531408327|FG001|Open-Label Period|Physician Decision|0|||
147338894|NCT00736853|531408328|FG002|Open-Label Period|Physician Decision|0|||
147338895|NCT00736853|531408326|FG000|Open-Label Period|Adverse Event|31|||
147338896|NCT00736853|531408327|FG001|Open-Label Period|Adverse Event|0|||
147338897|NCT00736853|531408328|FG002|Open-Label Period|Adverse Event|0|||
147338898|NCT00736853|531408326|FG000|Open-Label Period|Withdrawal by Subject|16|||
147338899|NCT00736853|531408327|FG001|Open-Label Period|Withdrawal by Subject|0|||
147338900|NCT00736853|531408328|FG002|Open-Label Period|Withdrawal by Subject|0|||
147338901|NCT00736853|531408326|FG000|Open-Label Period|Started but not treated|42|||
147338902|NCT00736853|531408327|FG001|Open-Label Period|Started but not treated|0|||
147338903|NCT00736853|531408328|FG002|Open-Label Period|Started but not treated|0|||
147338904|NCT00736853|531408326|FG000|Open-Label Period|Failed to meet the transfer criteria|40|||
147338905|NCT00736853|531408327|FG001|Open-Label Period|Failed to meet the transfer criteria|0|||
147338906|NCT00736853|531408328|FG002|Open-Label Period|Failed to meet the transfer criteria|0|||
147338907|NCT00736853|531408326|FG000|Open-Label Period|Unable to attend hospital appointments|1|||
147338908|NCT00736853|531408327|FG001|Open-Label Period|Unable to attend hospital appointments|0|||
147338909|NCT00736853|531408328|FG002|Open-Label Period|Unable to attend hospital appointments|0|||
147338910|NCT00736853|531408326|FG000|Double-Blind Period|Lack of Efficacy|0|||
147338911|NCT00736853|531408327|FG001|Double-Blind Period|Lack of Efficacy|19|||
147338912|NCT00736853|531408328|FG002|Double-Blind Period|Lack of Efficacy|42|||
147338913|NCT00736853|531408326|FG000|Double-Blind Period|Adverse Event|0|||
147338914|NCT00736853|531408327|FG001|Double-Blind Period|Adverse Event|3|||
147338915|NCT00736853|531408328|FG002|Double-Blind Period|Adverse Event|2|||
147338916|NCT00736853|531408326|FG000|Double-Blind Period|Withdrawal by Subject|0|||
147338917|NCT00736853|531408327|FG001|Double-Blind Period|Withdrawal by Subject|1|||
147338918|NCT00736853|531408328|FG002|Double-Blind Period|Withdrawal by Subject|4|||
147338919|NCT00736853|531408326|FG000|Double-Blind Period|Ineligible to participate the study|0|||
147338920|NCT00736853|531408327|FG001|Double-Blind Period|Ineligible to participate the study|1|||
147338921|NCT00736853|531408328|FG002|Double-Blind Period|Ineligible to participate the study|0|||
147338922|NCT01199705|531408329|FG000|SCIG Treatment (Wash-in/Wash-out)|Transfer of Residence|1|||
147338923|NCT01616459|531408330|FG000|Overall Study|Adverse Event|1|||
147338924|NCT01616459|531408331|FG001|Overall Study|Adverse Event|1|||
147338925|NCT01616459|531408332|FG002|Overall Study|Adverse Event|2|||
147338926|NCT01616459|531408333|FG003|Overall Study|Adverse Event|0|||
147338927|NCT01616459|531408330|FG000|Overall Study|Lost to Follow-up|1|||
147338928|NCT01616459|531408331|FG001|Overall Study|Lost to Follow-up|11|||
147338929|NCT01616459|531408332|FG002|Overall Study|Lost to Follow-up|3|||
147338930|NCT01616459|531408333|FG003|Overall Study|Lost to Follow-up|2|||
147338931|NCT01616459|531408330|FG000|Overall Study|Protocol Violation|0|||
147452891|NCT00252057|531821476|FG001|Overall Study|Withdrawal by Subject|5|||
147338932|NCT01616459|531408331|FG001|Overall Study|Protocol Violation|0|||
147338933|NCT01616459|531408332|FG002|Overall Study|Protocol Violation|0|||
147338934|NCT01616459|531408333|FG003|Overall Study|Protocol Violation|2|||
147338935|NCT01616459|531408330|FG000|Overall Study|Withdrawal by Subject|2|||
147338936|NCT01616459|531408331|FG001|Overall Study|Withdrawal by Subject|4|||
147338937|NCT01616459|531408332|FG002|Overall Study|Withdrawal by Subject|4|||
147452892|NCT00252057|531821475|FG000|Overall Study|Death|1|||
147605692|NCT02448706|532373074|FG001|Overall Study|Protocol Violation|1|||
147605693|NCT01199471|532373075|FG000|Overall Study|Protocol Violation|4|||
147605694|NCT01199471|532373075|FG000|Overall Study|Withdrawal by Subject|1|||
147338938|NCT01616459|531408333|FG003|Overall Study|Withdrawal by Subject|4|||
147605695|NCT01199471|532373075|FG000|Overall Study|Physician Decision|1|||
147338939|NCT01616459|531408330|FG000|Overall Study|Other reason|0|||
147338940|NCT01616459|531408331|FG001|Overall Study|Other reason|1|||
147338941|NCT01616459|531408332|FG002|Overall Study|Other reason|1|||
147605696|NCT02065700|532373076|FG000|Overall Study|Adverse Event|165|||
147605697|NCT02065700|532373077|FG001|Overall Study|Adverse Event|101|||
147605698|NCT02065700|532373076|FG000|Overall Study|Withdrawal by Subject|90|||
147605699|NCT02065700|532373077|FG001|Overall Study|Withdrawal by Subject|29|||
147605700|NCT02065700|532373076|FG000|Overall Study|Lost to Follow-up|12|||
147605701|NCT02065700|532373077|FG001|Overall Study|Lost to Follow-up|9|||
147605702|NCT02065700|532373076|FG000|Overall Study|Physician Decision|2|||
147605703|NCT02065700|532373077|FG001|Overall Study|Physician Decision|0|||
147605704|NCT02065700|532373076|FG000|Overall Study|Sponsor Request|38|||
147605705|NCT02065700|532373077|FG001|Overall Study|Sponsor Request|15|||
147605706|NCT02065700|532373076|FG000|Overall Study|Treatment Failure|3|||
147605707|NCT02065700|532373077|FG001|Overall Study|Treatment Failure|2|||
147605708|NCT02065700|532373076|FG000|Overall Study|Use of Non-permitted Concurrent Therapy|3|||
147605709|NCT02065700|532373077|FG001|Overall Study|Use of Non-permitted Concurrent Therapy|0|||
147605710|NCT02065700|532373076|FG000|Overall Study|Adverse Event and Treatment Failure|0|||
147605711|NCT02065700|532373077|FG001|Overall Study|Adverse Event and Treatment Failure|2|||
147605712|NCT02065700|532373076|FG000|Overall Study|Non-compliance with Study Procedures|2|||
147605713|NCT02065700|532373077|FG001|Overall Study|Non-compliance with Study Procedures|0|||
147605714|NCT02065700|532373076|FG000|Overall Study|Not Defined|21|||
147605715|NCT02065700|532373077|FG001|Overall Study|Not Defined|3|||
147605716|NCT03151408|532373078|FG000|Overall Study|Adverse Event|24|||
147605717|NCT03151408|532373079|FG001|Overall Study|Adverse Event|23|||
147605718|NCT03151408|532373078|FG000|Overall Study|Death|46|||
147605719|NCT03151408|532373079|FG001|Overall Study|Death|26|||
147605720|NCT03151408|532373078|FG000|Overall Study|Physician Decision|13|||
147605721|NCT03151408|532373079|FG001|Overall Study|Physician Decision|19|||
147605722|NCT03151408|532373078|FG000|Overall Study|Withdrawal by Subject|16|||
147605723|NCT03151408|532373079|FG001|Overall Study|Withdrawal by Subject|20|||
147605724|NCT03151408|532373078|FG000|Overall Study|Progressive disease|45|||
147605725|NCT03151408|532373079|FG001|Overall Study|Progressive disease|61|||
147605726|NCT03151408|532373078|FG000|Overall Study|non-compliance by patient|1|||
147605727|NCT03151408|532373079|FG001|Overall Study|non-compliance by patient|0|||
147605728|NCT03151408|532373078|FG000|Overall Study|other reasons|56|||
147605729|NCT03151408|532373079|FG001|Overall Study|other reasons|52|||
147605730|NCT03151408|532373078|FG000|Overall Study|randomized and not treated|2|||
147605731|NCT03151408|532373079|FG001|Overall Study|randomized and not treated|2|||
147605732|NCT03262038|532373084|FG000|Overall Study|Withdrawal by Subject|0|||
147605733|NCT03262038|532373085|FG001|Overall Study|Withdrawal by Subject|1|||
147605734|NCT04933968|532373086|FG000|Overall Study|Adverse Event|0|||
147605735|NCT04933968|532373087|FG001|Overall Study|Adverse Event|0|||
147605736|NCT04933968|532373088|FG002|Overall Study|Adverse Event|1|||
147605737|NCT04933968|532373089|FG003|Overall Study|Adverse Event|1|||
147605738|NCT04933968|532373090|FG004|Overall Study|Adverse Event|0|||
147605739|NCT04933968|532373091|FG005|Overall Study|Adverse Event|0|||
147605740|NCT04933968|532373086|FG000|Overall Study|Lost to Follow-up|1|||
147605741|NCT04933968|532373087|FG001|Overall Study|Lost to Follow-up|0|||
147605742|NCT04933968|532373088|FG002|Overall Study|Lost to Follow-up|1|||
147605743|NCT04933968|532373089|FG003|Overall Study|Lost to Follow-up|0|||
147605744|NCT04933968|532373090|FG004|Overall Study|Lost to Follow-up|0|||
147605745|NCT04933968|532373091|FG005|Overall Study|Lost to Follow-up|0|||
147605746|NCT04933968|532373086|FG000|Overall Study|Randomized not treated|1|||
147605747|NCT04933968|532373087|FG001|Overall Study|Randomized not treated|0|||
147605748|NCT04933968|532373088|FG002|Overall Study|Randomized not treated|0|||
147605749|NCT04933968|532373089|FG003|Overall Study|Randomized not treated|0|||
147605750|NCT04933968|532373090|FG004|Overall Study|Randomized not treated|0|||
147605751|NCT04933968|532373091|FG005|Overall Study|Randomized not treated|0|||
147605752|NCT04933968|532373086|FG000|Overall Study|Sponsor terminated study|0|||
147293851|NCT00518115|531239948|FG003|Overall Study|Moved Out of State|0|||
147293852|NCT00518115|531239949|FG004|Overall Study|Moved Out of State|0|||
147293853|NCT00518115|531239950|FG005|Overall Study|Moved Out of State|0|||
147293854|NCT00518115|531239951|FG006|Overall Study|Moved Out of State|0|||
147293855|NCT00518115|531239952|FG007|Overall Study|Moved Out of State|0|||
147293856|NCT00518115|531239953|FG008|Overall Study|Moved Out of State|0|||
147293857|NCT00518115|531239954|FG009|Overall Study|Moved Out of State|1|||
147293858|NCT00843167|531239955|FG000|Treatment Period|Adverse Event|1|||
147293859|NCT00843167|531239956|FG001|Treatment Period|Adverse Event|5|||
147293860|NCT00843167|531239955|FG000|Treatment Period|Withdrawal by Subject|2|||
147293861|NCT00843167|531239956|FG001|Treatment Period|Withdrawal by Subject|3|||
147293862|NCT00127101|531239957|FG000|Base Protocol|Adverse Event|0|||
147293863|NCT00127101|531239958|FG001|Base Protocol|Adverse Event|2|||
147293864|NCT00127101|531239959|FG002|Base Protocol|Adverse Event|1|||
147293865|NCT00127101|531239960|FG003|Base Protocol|Adverse Event|0|||
147293866|NCT00127101|531239961|FG004|Base Protocol|Adverse Event|0|||
147293867|NCT00127101|531239962|FG005|Base Protocol|Adverse Event|0|||
147605753|NCT04933968|532373087|FG001|Overall Study|Sponsor terminated study|0|||
147605754|NCT04933968|532373088|FG002|Overall Study|Sponsor terminated study|0|||
147605755|NCT04933968|532373089|FG003|Overall Study|Sponsor terminated study|1|||
147605756|NCT04933968|532373090|FG004|Overall Study|Sponsor terminated study|2|||
147605757|NCT04933968|532373091|FG005|Overall Study|Sponsor terminated study|0|||
147605758|NCT04933968|532373086|FG000|Overall Study|Other|0|||
147605759|NCT04933968|532373087|FG001|Overall Study|Other|0|||
147605760|NCT04933968|532373088|FG002|Overall Study|Other|0|||
147605761|NCT04933968|532373089|FG003|Overall Study|Other|1|||
147605762|NCT04933968|532373090|FG004|Overall Study|Other|0|||
147605763|NCT04933968|532373091|FG005|Overall Study|Other|0|||
147605764|NCT04933968|532373086|FG000|Overall Study|Missing|1|||
147605765|NCT04933968|532373087|FG001|Overall Study|Missing|3|||
147605766|NCT04933968|532373088|FG002|Overall Study|Missing|2|||
147605767|NCT04933968|532373089|FG003|Overall Study|Missing|1|||
147605768|NCT04933968|532373090|FG004|Overall Study|Missing|1|||
147605769|NCT04933968|532373091|FG005|Overall Study|Missing|0|||
147605770|NCT01724489|532373092|FG000|Overall Study|Adverse Event|8|||
147605771|NCT01724489|532373093|FG001|Overall Study|Adverse Event|3|||
147605772|NCT01724489|532373092|FG000|Overall Study|Surgery, medication|1|||
147605773|NCT01724489|532373093|FG001|Overall Study|Surgery, medication|1|||
147605774|NCT01724489|532373092|FG000|Overall Study|Lost to Follow-up|1|||
147605775|NCT01724489|532373093|FG001|Overall Study|Lost to Follow-up|2|||
147605776|NCT01724489|532373092|FG000|Overall Study|Withdrawal by Subject|6|||
147605777|NCT01724489|532373093|FG001|Overall Study|Withdrawal by Subject|6|||
147605778|NCT01664130|532373096|FG000|Overall Study|competing secondary disease|2|||
147605779|NCT00554606|532373100|FG000|Overall Study|Adverse Event|3|||
147605780|NCT00554606|532373100|FG000|Overall Study|Abnormal laboratory values|1|||
147605781|NCT00554606|532373100|FG000|Overall Study|Unsatisfactory therapeutic effect|14|||
147605782|NCT00554606|532373100|FG000|Overall Study|Subject withdrew consent|2|||
147605783|NCT00554606|532373100|FG000|Overall Study|Lost to Follow-up|2|||
147605784|NCT00554606|532373100|FG000|Overall Study|Administrative problems|60|||
147605785|NCT00554606|532373100|FG000|Overall Study|Death|1|||
147605786|NCT00554606|532373100|FG000|Overall Study|Protocol deviation|2|||
147605787|NCT03323437|532373101|FG000|Overall Study|Withdrawal by Subject|0|||
147605788|NCT03323437|532373102|FG001|Overall Study|Withdrawal by Subject|4|||
147605789|NCT02119819|532373107|FG000|Overall Study|Adverse Event|3|||
147605790|NCT02119819|532373108|FG001|Overall Study|Adverse Event|1|||
147605791|NCT02119819|532373109|FG002|Overall Study|Adverse Event|2|||
147605792|NCT02119819|532373110|FG003|Overall Study|Adverse Event|3|||
147605793|NCT02119819|532373111|FG004|Overall Study|Adverse Event|0|||
147605794|NCT02119819|532373112|FG005|Overall Study|Adverse Event|1|||
147605795|NCT02119819|532373107|FG000|Overall Study|Lack of Efficacy|0|||
147605796|NCT02119819|532373108|FG001|Overall Study|Lack of Efficacy|0|||
147605797|NCT02119819|532373109|FG002|Overall Study|Lack of Efficacy|0|||
147605798|NCT02119819|532373110|FG003|Overall Study|Lack of Efficacy|0|||
147605799|NCT02119819|532373111|FG004|Overall Study|Lack of Efficacy|0|||
147605800|NCT02119819|532373112|FG005|Overall Study|Lack of Efficacy|1|||
147605801|NCT02119819|532373107|FG000|Overall Study|Lost to Follow-up|0|||
147605802|NCT02119819|532373108|FG001|Overall Study|Lost to Follow-up|0|||
147605803|NCT02119819|532373109|FG002|Overall Study|Lost to Follow-up|1|||
147605804|NCT02119819|532373110|FG003|Overall Study|Lost to Follow-up|2|||
147605805|NCT02119819|532373111|FG004|Overall Study|Lost to Follow-up|1|||
147605806|NCT02119819|532373112|FG005|Overall Study|Lost to Follow-up|2|||
147605807|NCT02119819|532373107|FG000|Overall Study|Physician Decision|1|||
147605808|NCT02119819|532373108|FG001|Overall Study|Physician Decision|1|||
147605809|NCT02119819|532373109|FG002|Overall Study|Physician Decision|0|||
147605810|NCT02119819|532373110|FG003|Overall Study|Physician Decision|0|||
147605811|NCT02119819|532373111|FG004|Overall Study|Physician Decision|0|||
147605812|NCT02119819|532373112|FG005|Overall Study|Physician Decision|1|||
147605813|NCT02119819|532373107|FG000|Overall Study|Withdrawal by Subject|5|||
147605814|NCT02119819|532373108|FG001|Overall Study|Withdrawal by Subject|3|||
147605815|NCT02119819|532373109|FG002|Overall Study|Withdrawal by Subject|0|||
147605816|NCT02119819|532373110|FG003|Overall Study|Withdrawal by Subject|0|||
147605817|NCT02119819|532373111|FG004|Overall Study|Withdrawal by Subject|6|||
147605818|NCT02119819|532373112|FG005|Overall Study|Withdrawal by Subject|10|||
147605819|NCT02119819|532373107|FG000|Overall Study|Jury Duty|0|||
147605820|NCT02119819|532373108|FG001|Overall Study|Jury Duty|0|||
147605821|NCT02119819|532373109|FG002|Overall Study|Jury Duty|1|||
147605822|NCT02119819|532373110|FG003|Overall Study|Jury Duty|0|||
147605823|NCT02119819|532373111|FG004|Overall Study|Jury Duty|0|||
147605824|NCT02119819|532373112|FG005|Overall Study|Jury Duty|0|||
147605825|NCT02119819|532373107|FG000|Overall Study|Protocol Violation|0|||
147605826|NCT02119819|532373108|FG001|Overall Study|Protocol Violation|0|||
147605827|NCT02119819|532373109|FG002|Overall Study|Protocol Violation|0|||
147605828|NCT02119819|532373110|FG003|Overall Study|Protocol Violation|1|||
147605829|NCT02119819|532373111|FG004|Overall Study|Protocol Violation|0|||
147605830|NCT02119819|532373112|FG005|Overall Study|Protocol Violation|0|||
147605831|NCT02119819|532373107|FG000|Overall Study|Left the city to get a job|0|||
147605832|NCT02119819|532373108|FG001|Overall Study|Left the city to get a job|0|||
147605833|NCT02119819|532373109|FG002|Overall Study|Left the city to get a job|0|||
147605834|NCT02119819|532373110|FG003|Overall Study|Left the city to get a job|1|||
147605835|NCT02119819|532373111|FG004|Overall Study|Left the city to get a job|0|||
147605836|NCT02119819|532373112|FG005|Overall Study|Left the city to get a job|0|||
147605837|NCT02045147|532373113|FG000|Overall Study|Withdrawal by Subject|2|||
147605838|NCT02045147|532373114|FG001|Overall Study|Withdrawal by Subject|0|||
147605839|NCT02045147|532373115|FG002|Overall Study|Withdrawal by Subject|0|||
147605840|NCT02045147|532373116|FG003|Overall Study|Withdrawal by Subject|0|||
147605841|NCT02045147|532373117|FG004|Overall Study|Withdrawal by Subject|0|||
147605842|NCT02045147|532373118|FG005|Overall Study|Withdrawal by Subject|0|||
147605843|NCT02045147|532373119|FG006|Overall Study|Withdrawal by Subject|0|||
147605844|NCT02045147|532373120|FG007|Overall Study|Withdrawal by Subject|1|||
147605845|NCT02045147|532373113|FG000|Overall Study|Did not meet inclusion criteria at hospital discharge|9|||
147605846|NCT02045147|532373114|FG001|Overall Study|Did not meet inclusion criteria at hospital discharge|12|||
147605847|NCT02045147|532373115|FG002|Overall Study|Did not meet inclusion criteria at hospital discharge|0|||
147605848|NCT02045147|532373116|FG003|Overall Study|Did not meet inclusion criteria at hospital discharge|2|||
147605849|NCT02045147|532373117|FG004|Overall Study|Did not meet inclusion criteria at hospital discharge|3|||
147605850|NCT02045147|532373118|FG005|Overall Study|Did not meet inclusion criteria at hospital discharge|10|||
147605851|NCT02045147|532373119|FG006|Overall Study|Did not meet inclusion criteria at hospital discharge|0|||
147605852|NCT02045147|532373120|FG007|Overall Study|Did not meet inclusion criteria at hospital discharge|2|||
147605853|NCT04839692|532373121|FG000|Overall Study|Withdrawal by Subject|0|||
147605854|NCT04839692|532373122|FG001|Overall Study|Withdrawal by Subject|3|||
147605855|NCT04839692|532373121|FG000|Overall Study|Physician Decision|1|||
147605856|NCT04839692|532373122|FG001|Overall Study|Physician Decision|0|||
147605857|NCT02383810|532373123|FG000|Overall Study|Physician Decision|1|||
147605858|NCT02383810|532373124|FG001|Overall Study|Physician Decision|1|||
147605859|NCT02383810|532373125|FG002|Overall Study|Physician Decision|0|||
147605860|NCT02383810|532373126|FG003|Overall Study|Physician Decision|0|||
147605861|NCT02383810|532373127|FG004|Overall Study|Physician Decision|0|||
147605862|NCT02383810|532373128|FG005|Overall Study|Physician Decision|0|||
147293868|NCT00127101|531239957|FG000|Base Protocol|Lack of Efficacy|1|||
147293869|NCT00127101|531239958|FG001|Base Protocol|Lack of Efficacy|0|||
147293870|NCT00127101|531239959|FG002|Base Protocol|Lack of Efficacy|0|||
147293871|NCT00127101|531239960|FG003|Base Protocol|Lack of Efficacy|0|||
147293872|NCT00127101|531239961|FG004|Base Protocol|Lack of Efficacy|2|||
147293873|NCT00127101|531239962|FG005|Base Protocol|Lack of Efficacy|0|||
147293874|NCT00127101|531239957|FG000|Base Protocol|Withdrawal by Subject|1|||
147338942|NCT01616459|531408333|FG003|Overall Study|Other reason|0|||
147605863|NCT02383810|532373129|FG006|Overall Study|Physician Decision|0|||
147605864|NCT02383810|532373130|FG007|Overall Study|Physician Decision|0|||
147605865|NCT02383810|532373123|FG000|Overall Study|Withdrawal by Subject|2|||
147605866|NCT02383810|532373124|FG001|Overall Study|Withdrawal by Subject|3|||
147605867|NCT02383810|532373125|FG002|Overall Study|Withdrawal by Subject|3|||
147605868|NCT02383810|532373126|FG003|Overall Study|Withdrawal by Subject|3|||
147605869|NCT02383810|532373127|FG004|Overall Study|Withdrawal by Subject|0|||
147605870|NCT02383810|532373128|FG005|Overall Study|Withdrawal by Subject|0|||
147605871|NCT02383810|532373129|FG006|Overall Study|Withdrawal by Subject|0|||
147605872|NCT02383810|532373130|FG007|Overall Study|Withdrawal by Subject|0|||
147605873|NCT02383810|532373123|FG000|Overall Study|Adverse Event|0|||
147605874|NCT02383810|532373124|FG001|Overall Study|Adverse Event|2|||
147605875|NCT02383810|532373125|FG002|Overall Study|Adverse Event|4|||
147605876|NCT02383810|532373126|FG003|Overall Study|Adverse Event|5|||
147605877|NCT02383810|532373127|FG004|Overall Study|Adverse Event|0|||
147605878|NCT02383810|532373128|FG005|Overall Study|Adverse Event|1|||
147605879|NCT02383810|532373129|FG006|Overall Study|Adverse Event|1|||
147605880|NCT02383810|532373130|FG007|Overall Study|Adverse Event|0|||
147605881|NCT02383810|532373123|FG000|Overall Study|Lost to Follow-up|0|||
147605882|NCT02383810|532373124|FG001|Overall Study|Lost to Follow-up|1|||
147605883|NCT02383810|532373125|FG002|Overall Study|Lost to Follow-up|0|||
147605884|NCT02383810|532373126|FG003|Overall Study|Lost to Follow-up|1|||
147605885|NCT02383810|532373127|FG004|Overall Study|Lost to Follow-up|0|||
147605886|NCT02383810|532373128|FG005|Overall Study|Lost to Follow-up|0|||
147605887|NCT02383810|532373129|FG006|Overall Study|Lost to Follow-up|0|||
147605888|NCT02383810|532373130|FG007|Overall Study|Lost to Follow-up|0|||
147605889|NCT02383810|532373123|FG000|Overall Study|other|0|||
147605890|NCT02383810|532373124|FG001|Overall Study|other|0|||
147605891|NCT02383810|532373125|FG002|Overall Study|other|0|||
147605892|NCT02383810|532373126|FG003|Overall Study|other|2|||
147605893|NCT02383810|532373127|FG004|Overall Study|other|0|||
147605894|NCT02383810|532373128|FG005|Overall Study|other|0|||
147293875|NCT00127101|531239958|FG001|Base Protocol|Withdrawal by Subject|2|||
147293876|NCT00127101|531239959|FG002|Base Protocol|Withdrawal by Subject|1|||
147293877|NCT00127101|531239960|FG003|Base Protocol|Withdrawal by Subject|0|||
147293878|NCT00127101|531239961|FG004|Base Protocol|Withdrawal by Subject|0|||
147293879|NCT00127101|531239962|FG005|Base Protocol|Withdrawal by Subject|1|||
147293880|NCT00127101|531239957|FG000|Continuation Phase|Adverse Event|0|||
147293881|NCT00127101|531239958|FG001|Continuation Phase|Adverse Event|0|||
147293882|NCT00127101|531239959|FG002|Continuation Phase|Adverse Event|0|||
147338943|NCT03394885|531408334|FG000|Overall Study|Adverse Event|4|||
147605895|NCT02383810|532373129|FG006|Overall Study|other|0|||
147605896|NCT02383810|532373130|FG007|Overall Study|other|0|||
147605897|NCT02383810|532373123|FG000|Overall Study|subject did not receive study treatment|0|||
147605898|NCT02383810|532373124|FG001|Overall Study|subject did not receive study treatment|1|||
147605899|NCT02383810|532373125|FG002|Overall Study|subject did not receive study treatment|0|||
147605900|NCT02383810|532373126|FG003|Overall Study|subject did not receive study treatment|0|||
147605901|NCT02383810|532373127|FG004|Overall Study|subject did not receive study treatment|0|||
147605902|NCT02383810|532373128|FG005|Overall Study|subject did not receive study treatment|0|||
147605903|NCT02383810|532373129|FG006|Overall Study|subject did not receive study treatment|0|||
147605904|NCT02383810|532373130|FG007|Overall Study|subject did not receive study treatment|0|||
147605905|NCT02861014|532373132|FG000|Primary Analysis|Adverse Event|7|||
147605906|NCT02861014|532373132|FG000|Primary Analysis|Death|1|||
147605907|NCT02861014|532373132|FG000|Primary Analysis|Lack of Efficacy|3|||
147605908|NCT02861014|532373132|FG000|Primary Analysis|Physician Decision|2|||
147605909|NCT02861014|532373132|FG000|Primary Analysis|Pregnancy|4|||
147605910|NCT02861014|532373132|FG000|Primary Analysis|Protocol Violation|2|||
147605911|NCT02861014|532373132|FG000|Primary Analysis|Study Terminated By Sponsor|3|||
147605912|NCT02861014|532373132|FG000|Primary Analysis|Withdrawal by Subject|14|||
147605913|NCT02861014|532373132|FG000|Primary Analysis|Commercial ocrelizumab|3|||
147338944|NCT03394885|531408334|FG000|Overall Study|Lack of Efficacy|1|||
147338945|NCT03394885|531408334|FG000|Overall Study|Physician Decision|1|||
147338946|NCT03394885|531408334|FG000|Overall Study|Withdrawal by Subject|8|||
147338947|NCT03394885|531408334|FG000|Overall Study|Alternative Therapy|1|||
147338948|NCT04980755|531408335|FG000|Body Reprogramming Courses|Too unwell to attend|6|||
147338949|NCT04980755|531408335|FG000|Body Reprogramming Courses|Work commitment|2|||
147338950|NCT04980755|531408335|FG000|Body Reprogramming Courses|Unsure when the course started|1|||
147338951|NCT04980755|531408335|FG000|Body Reprogramming Courses|Could not be contacted to provide a reason|6|||
147338952|NCT00801983|531408338|FG000|Period 1|Lost to Follow-up|2|||
147338953|NCT00801983|531408339|FG001|Period 1|Lost to Follow-up|0|||
147338954|NCT00801983|531408338|FG000|Period 1|Withdrawal by Subject|2|||
147605914|NCT02861014|532373132|FG000|Safety Follow-up|Adverse Event|1|||
147605915|NCT02861014|532373132|FG000|Safety Follow-up|Pregnancy|1|||
147605916|NCT02861014|532373132|FG000|Safety Follow-up|Withdrawal by Subject|9|||
147605917|NCT02861014|532373132|FG000|Safety Follow-up|Study terminated by sponsor|1|||
147605918|NCT02861014|532373132|FG000|Safety Follow-up|Physician Decision|1|||
147605919|NCT02861014|532373132|FG000|Safety Follow-up|Roll-over to a long term extension study|1|||
147605920|NCT02861014|532373132|FG000|Safety Follow-up|Commercial ocrelizumab|36|||
147605921|NCT03247816|532373135|FG000|Overall Study|Adverse Event|12|||
147605922|NCT03247816|532373135|FG000|Overall Study|Physician Decision|3|||
147605923|NCT03247816|532373135|FG000|Overall Study|Lack of Efficacy|1|||
147605924|NCT03247816|532373135|FG000|Overall Study|Lost to Follow-up|10|||
147605925|NCT03247816|532373135|FG000|Overall Study|Missing Feraccru stop date|3|||
147605926|NCT01439009|532373136|FG000|Overall Study|Physician Decision|5|||
147605927|NCT01439009|532373137|FG001|Overall Study|Physician Decision|3|||
147605928|NCT01439009|532373136|FG000|Overall Study|Protocol Violation|2|||
147605929|NCT01439009|532373137|FG001|Overall Study|Protocol Violation|0|||
147605930|NCT01439009|532373136|FG000|Overall Study|Deviation of exclusion criteria|1|||
147605931|NCT01439009|532373137|FG001|Overall Study|Deviation of exclusion criteria|0|||
147605932|NCT00926783|532373138|FG000|Overall Study|Incomplete CFAE Procedures|3|||
147605933|NCT00926783|532373139|FG001|Overall Study|Incomplete CFAE Procedures|3|||
147605934|NCT03257865|532373140|FG000|Overall Study|Adverse Event|4|||
147338955|NCT00801983|531408339|FG001|Period 1|Withdrawal by Subject|8|||
147338956|NCT00801983|531408338|FG000|Period 2|Withdrawal by Subject|2|||
147338957|NCT00801983|531408339|FG001|Period 2|Withdrawal by Subject|1|||
147605935|NCT03257865|532373141|FG001|Overall Study|Adverse Event|8|||
147605936|NCT03257865|532373140|FG000|Overall Study|Lack of Efficacy|1|||
147605937|NCT03257865|532373141|FG001|Overall Study|Lack of Efficacy|2|||
147605938|NCT03257865|532373140|FG000|Overall Study|Non-compliance with Study Drug|0|||
147605939|NCT03257865|532373141|FG001|Overall Study|Non-compliance with Study Drug|2|||
147605940|NCT03257865|532373140|FG000|Overall Study|Withdrawal by Subject|23|||
147605941|NCT03257865|532373141|FG001|Overall Study|Withdrawal by Subject|17|||
147605942|NCT03257865|532373140|FG000|Overall Study|Physician Decision|3|||
147605943|NCT03257865|532373141|FG001|Overall Study|Physician Decision|1|||
147452893|NCT00252057|531821476|FG001|Overall Study|Death|2|||
147605944|NCT03257865|532373140|FG000|Overall Study|Other|0|||
147662663|NCT02782741|532587386|FG000|Open-label Long-term: Week 50 to 289|Adverse Event|2|||
147452894|NCT00252057|531821475|FG000|Overall Study|Participant previously enrolled|0|||
147452895|NCT00252057|531821476|FG001|Overall Study|Participant previously enrolled|1|||
147452896|NCT01294800|531821478|FG000|Overall Study|Adverse Event|7|||
147605945|NCT03257865|532373141|FG001|Overall Study|Other|1|||
147605946|NCT03257865|532373140|FG000|Overall Study|Lost to Follow-up|4|||
147605947|NCT03257865|532373141|FG001|Overall Study|Lost to Follow-up|4|||
147605948|NCT01661062|532373142|FG000|Overall Study|Completed Treatment Off Study|3|||
147605949|NCT01661062|532373142|FG000|Overall Study|Withdrawal by Subject|2|||
147605950|NCT01292226|532373145|FG000|Overall Study|Adverse Event|5|||
147605951|NCT01292226|532373145|FG000|Overall Study|Death|1|||
147338958|NCT04411056|531409893|FG000|Overall Study|surgery cancelled|1|||
147338959|NCT04411056|531409894|FG001|Overall Study|surgery cancelled|0|||
147338960|NCT04411056|531409893|FG000|Overall Study|Equipment problem during intubation|0|||
147605952|NCT01292226|532373145|FG000|Overall Study|Graft loss|1|||
147605953|NCT01292226|532373145|FG000|Overall Study|Protocol Violation|3|||
147605954|NCT01292226|532373145|FG000|Overall Study|Withdrawal by Subject|1|||
147605955|NCT01292226|532373145|FG000|Overall Study|Other|2|||
147605956|NCT00423319|532373146|FG000|Overall Study|Death|2|||
147605957|NCT00423319|532373147|FG001|Overall Study|Death|0|||
147293883|NCT00127101|531239960|FG003|Continuation Phase|Adverse Event|0|||
147293884|NCT00127101|531239961|FG004|Continuation Phase|Adverse Event|1|||
147293885|NCT00127101|531239962|FG005|Continuation Phase|Adverse Event|1|||
147293886|NCT00127101|531239957|FG000|Continuation Phase|Lack of Efficacy|0|||
147293887|NCT00127101|531239958|FG001|Continuation Phase|Lack of Efficacy|0|||
147293888|NCT00127101|531239959|FG002|Continuation Phase|Lack of Efficacy|0|||
147293889|NCT00127101|531239960|FG003|Continuation Phase|Lack of Efficacy|0|||
147293890|NCT00127101|531239961|FG004|Continuation Phase|Lack of Efficacy|0|||
147293891|NCT00127101|531239962|FG005|Continuation Phase|Lack of Efficacy|1|||
147293892|NCT00127101|531239957|FG000|Continuation Phase|Withdrawal by Subject|0|||
147293893|NCT00127101|531239958|FG001|Continuation Phase|Withdrawal by Subject|0|||
147293894|NCT00127101|531239959|FG002|Continuation Phase|Withdrawal by Subject|1|||
147293895|NCT00127101|531239960|FG003|Continuation Phase|Withdrawal by Subject|0|||
147293896|NCT00127101|531239961|FG004|Continuation Phase|Withdrawal by Subject|2|||
147293897|NCT00127101|531239962|FG005|Continuation Phase|Withdrawal by Subject|1|||
147293898|NCT01662310|531239963|FG000|Run-In or Stabilization Phase|Adverse Event|11|||
147293899|NCT01662310|531239964|FG001|Run-In or Stabilization Phase|Adverse Event|0|||
147293900|NCT01662310|531239965|FG002|Run-In or Stabilization Phase|Adverse Event|0|||
147293901|NCT01662310|531239966|FG003|Run-In or Stabilization Phase|Adverse Event|0|||
147293902|NCT01662310|531239967|FG004|Run-In or Stabilization Phase|Adverse Event|0|||
147293903|NCT01662310|531239963|FG000|Run-In or Stabilization Phase|Lack of Efficacy|9|||
147293904|NCT01662310|531239964|FG001|Run-In or Stabilization Phase|Lack of Efficacy|0|||
147293905|NCT01662310|531239965|FG002|Run-In or Stabilization Phase|Lack of Efficacy|0|||
147293906|NCT01662310|531239966|FG003|Run-In or Stabilization Phase|Lack of Efficacy|0|||
147293907|NCT01662310|531239967|FG004|Run-In or Stabilization Phase|Lack of Efficacy|0|||
147293908|NCT01662310|531239963|FG000|Run-In or Stabilization Phase|Lost to Follow-up|4|||
147293909|NCT01662310|531239964|FG001|Run-In or Stabilization Phase|Lost to Follow-up|0|||
147293910|NCT01662310|531239965|FG002|Run-In or Stabilization Phase|Lost to Follow-up|0|||
147293911|NCT01662310|531239966|FG003|Run-In or Stabilization Phase|Lost to Follow-up|0|||
147293912|NCT01662310|531239967|FG004|Run-In or Stabilization Phase|Lost to Follow-up|0|||
147293913|NCT01662310|531239963|FG000|Run-In or Stabilization Phase|Protocol Violation|15|||
147293914|NCT01662310|531239964|FG001|Run-In or Stabilization Phase|Protocol Violation|0|||
147293915|NCT01662310|531239965|FG002|Run-In or Stabilization Phase|Protocol Violation|0|||
147293916|NCT01662310|531239966|FG003|Run-In or Stabilization Phase|Protocol Violation|0|||
147293917|NCT01662310|531239967|FG004|Run-In or Stabilization Phase|Protocol Violation|0|||
147293918|NCT01662310|531239963|FG000|Run-In or Stabilization Phase|Withdrawal by Subject|25|||
147293919|NCT01662310|531239964|FG001|Run-In or Stabilization Phase|Withdrawal by Subject|0|||
147293920|NCT01662310|531239965|FG002|Run-In or Stabilization Phase|Withdrawal by Subject|0|||
147293921|NCT01662310|531239966|FG003|Run-In or Stabilization Phase|Withdrawal by Subject|0|||
147338961|NCT04411056|531409894|FG001|Overall Study|Equipment problem during intubation|1|||
147338962|NCT03122886|531409900|FG000|Overall Study|Withdrawal by Subject|1|||
147338963|NCT03122886|531409901|FG001|Overall Study|Withdrawal by Subject|2|||
147338964|NCT05985044|531409902|FG000|Overall Study|Death|6|||
147338965|NCT05985044|531409902|FG000|Overall Study|Lost to Follow-up|4|||
147338966|NCT05985044|531409902|FG000|Overall Study|Incapacitation|3|||
147338967|NCT05985044|531409902|FG000|Overall Study|Withdrawal by Subject|2|||
147338968|NCT03312907|531409905|FG000|Overall Study|Adverse Event|1|||
147338969|NCT03312907|531409906|FG001|Overall Study|Adverse Event|6|||
147452897|NCT01294800|531821479|FG001|Overall Study|Adverse Event|6|||
147293922|NCT01662310|531239967|FG004|Run-In or Stabilization Phase|Withdrawal by Subject|0|||
147293923|NCT01662310|531239963|FG000|Run-In or Stabilization Phase|Other|1|||
147293924|NCT01662310|531239964|FG001|Run-In or Stabilization Phase|Other|0|||
147293925|NCT01662310|531239965|FG002|Run-In or Stabilization Phase|Other|0|||
147293926|NCT01662310|531239966|FG003|Run-In or Stabilization Phase|Other|0|||
147293927|NCT01662310|531239967|FG004|Run-In or Stabilization Phase|Other|0|||
147293928|NCT01662310|531239963|FG000|Double-Blind Phase|Adverse Event|0|||
147338970|NCT03312907|531409907|FG002|Overall Study|Adverse Event|1|||
147338971|NCT03312907|531409905|FG000|Overall Study|Protocol Violation|2|||
147605958|NCT00423319|532373146|FG000|Overall Study|Adverse Event|93|||
147605959|NCT00423319|532373147|FG001|Overall Study|Adverse Event|112|||
147293929|NCT01662310|531239964|FG001|Double-Blind Phase|Adverse Event|0|||
147293930|NCT01662310|531239965|FG002|Double-Blind Phase|Adverse Event|1|||
147293931|NCT01662310|531239966|FG003|Double-Blind Phase|Adverse Event|0|||
147293932|NCT01662310|531239967|FG004|Double-Blind Phase|Adverse Event|0|||
147338972|NCT03312907|531409906|FG001|Overall Study|Protocol Violation|3|||
147605960|NCT00423319|532373146|FG000|Overall Study|Withdrawal by Subject|86|||
147293933|NCT01662310|531239963|FG000|Double-Blind Phase|Lost to Follow-up|0|||
147338973|NCT03312907|531409907|FG002|Overall Study|Protocol Violation|4|||
147338974|NCT03312907|531409905|FG000|Overall Study|Lost to Follow-up|2|||
147293934|NCT01662310|531239964|FG001|Double-Blind Phase|Lost to Follow-up|3|||
147293935|NCT01662310|531239965|FG002|Double-Blind Phase|Lost to Follow-up|0|||
147293936|NCT01662310|531239966|FG003|Double-Blind Phase|Lost to Follow-up|0|||
147293937|NCT01662310|531239967|FG004|Double-Blind Phase|Lost to Follow-up|0|||
147293938|NCT01662310|531239963|FG000|Double-Blind Phase|Pregnancy|0|||
147293939|NCT01662310|531239964|FG001|Double-Blind Phase|Pregnancy|2|||
147293940|NCT01662310|531239965|FG002|Double-Blind Phase|Pregnancy|0|||
147293941|NCT01662310|531239966|FG003|Double-Blind Phase|Pregnancy|0|||
147293942|NCT01662310|531239967|FG004|Double-Blind Phase|Pregnancy|0|||
147293943|NCT01662310|531239963|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
147293944|NCT01662310|531239964|FG001|Double-Blind Phase|Withdrawal by Subject|9|||
147293945|NCT01662310|531239965|FG002|Double-Blind Phase|Withdrawal by Subject|3|||
147293946|NCT01662310|531239966|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
147293947|NCT01662310|531239967|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
147293948|NCT01662310|531239963|FG000|Double-Blind Phase|Other|0|||
147293949|NCT01662310|531239964|FG001|Double-Blind Phase|Other|0|||
147293950|NCT01662310|531239965|FG002|Double-Blind Phase|Other|1|||
147293951|NCT01662310|531239966|FG003|Double-Blind Phase|Other|0|||
147293952|NCT01662310|531239967|FG004|Double-Blind Phase|Other|0|||
147293953|NCT01662310|531239963|FG000|Double-Blind Phase|Randomized but not treated|0|||
147293954|NCT01662310|531239964|FG001|Double-Blind Phase|Randomized but not treated|1|||
147293955|NCT01662310|531239965|FG002|Double-Blind Phase|Randomized but not treated|0|||
147293956|NCT01662310|531239966|FG003|Double-Blind Phase|Randomized but not treated|0|||
147293957|NCT01662310|531239967|FG004|Double-Blind Phase|Randomized but not treated|0|||
147293958|NCT01662310|531239963|FG000|Open-Label Extension Phase|Adverse Event|0|||
147293959|NCT01662310|531239964|FG001|Open-Label Extension Phase|Adverse Event|0|||
147293960|NCT01662310|531239965|FG002|Open-Label Extension Phase|Adverse Event|0|||
147293961|NCT01662310|531239966|FG003|Open-Label Extension Phase|Adverse Event|3|||
147293962|NCT01662310|531239967|FG004|Open-Label Extension Phase|Adverse Event|0|||
147293963|NCT01662310|531239963|FG000|Open-Label Extension Phase|Death|0|||
147293964|NCT01662310|531239964|FG001|Open-Label Extension Phase|Death|0|||
147293965|NCT01662310|531239965|FG002|Open-Label Extension Phase|Death|0|||
147293966|NCT01662310|531239966|FG003|Open-Label Extension Phase|Death|1|||
147293967|NCT01662310|531239967|FG004|Open-Label Extension Phase|Death|0|||
147293968|NCT01662310|531239963|FG000|Open-Label Extension Phase|Lack of Efficacy|0|||
147293969|NCT01662310|531239964|FG001|Open-Label Extension Phase|Lack of Efficacy|0|||
147293970|NCT01662310|531239965|FG002|Open-Label Extension Phase|Lack of Efficacy|0|||
147293971|NCT01662310|531239966|FG003|Open-Label Extension Phase|Lack of Efficacy|2|||
147293972|NCT01662310|531239967|FG004|Open-Label Extension Phase|Lack of Efficacy|2|||
147293973|NCT01662310|531239963|FG000|Open-Label Extension Phase|Lost to Follow-up|0|||
147293974|NCT01662310|531239964|FG001|Open-Label Extension Phase|Lost to Follow-up|0|||
147293975|NCT01662310|531239965|FG002|Open-Label Extension Phase|Lost to Follow-up|0|||
147293976|NCT01662310|531239966|FG003|Open-Label Extension Phase|Lost to Follow-up|2|||
147293977|NCT01662310|531239967|FG004|Open-Label Extension Phase|Lost to Follow-up|1|||
147293978|NCT01662310|531239963|FG000|Open-Label Extension Phase|Pregnancy|0|||
147293979|NCT01662310|531239964|FG001|Open-Label Extension Phase|Pregnancy|0|||
147293980|NCT01662310|531239965|FG002|Open-Label Extension Phase|Pregnancy|0|||
147293981|NCT01662310|531239966|FG003|Open-Label Extension Phase|Pregnancy|1|||
147293982|NCT01662310|531239967|FG004|Open-Label Extension Phase|Pregnancy|0|||
147293983|NCT01662310|531239963|FG000|Open-Label Extension Phase|Withdrawal by Subject|0|||
147293984|NCT01662310|531239964|FG001|Open-Label Extension Phase|Withdrawal by Subject|0|||
147293985|NCT01662310|531239965|FG002|Open-Label Extension Phase|Withdrawal by Subject|0|||
147293986|NCT01662310|531239966|FG003|Open-Label Extension Phase|Withdrawal by Subject|2|||
147293987|NCT01662310|531239967|FG004|Open-Label Extension Phase|Withdrawal by Subject|7|||
147293988|NCT04302350|531239968|FG000|Overall Study|Physician Decision|1|||
147293989|NCT04302350|531239969|FG001|Overall Study|Physician Decision|1|||
147293990|NCT04302350|531239970|FG002|Overall Study|Physician Decision|2|||
147293991|NCT04302350|531239968|FG000|Overall Study|Lack of Efficacy|1|||
147293992|NCT04302350|531239969|FG001|Overall Study|Lack of Efficacy|1|||
147293993|NCT04302350|531239970|FG002|Overall Study|Lack of Efficacy|4|||
147293994|NCT04302350|531239968|FG000|Overall Study|Adverse Event|0|||
147293995|NCT04302350|531239969|FG001|Overall Study|Adverse Event|1|||
147293996|NCT04302350|531239970|FG002|Overall Study|Adverse Event|2|||
147293997|NCT00833638|531239971|FG000|Phase 2: Double-blind Treatment Phase|Adverse Event|1|||
147293998|NCT00833638|531239972|FG001|Phase 2: Double-blind Treatment Phase|Adverse Event|2|||
147293999|NCT00833638|531239973|FG002|Phase 2: Double-blind Treatment Phase|Adverse Event|0|||
147294000|NCT00833638|531239971|FG000|Phase 2: Double-blind Treatment Phase|Entry Criteria Not Met|3|||
147294001|NCT00833638|531239972|FG001|Phase 2: Double-blind Treatment Phase|Entry Criteria Not Met|2|||
147294002|NCT00833638|531239973|FG002|Phase 2: Double-blind Treatment Phase|Entry Criteria Not Met|1|||
147294003|NCT00833638|531239971|FG000|Phase 2: Double-blind Treatment Phase|Lost to Follow-up|1|||
147294004|NCT00833638|531239972|FG001|Phase 2: Double-blind Treatment Phase|Lost to Follow-up|2|||
147294005|NCT00833638|531239973|FG002|Phase 2: Double-blind Treatment Phase|Lost to Follow-up|1|||
147294006|NCT00833638|531239971|FG000|Phase 2: Double-blind Treatment Phase|Physician Decision|1|||
147294007|NCT00833638|531239972|FG001|Phase 2: Double-blind Treatment Phase|Physician Decision|0|||
147605961|NCT00423319|532373147|FG001|Overall Study|Withdrawal by Subject|99|||
147605962|NCT00423319|532373146|FG000|Overall Study|Lost to Follow-up|4|||
147605963|NCT00423319|532373147|FG001|Overall Study|Lost to Follow-up|3|||
147605964|NCT00423319|532373146|FG000|Overall Study|Poor compliance or noncompliance|1|||
147294008|NCT00833638|531239973|FG002|Phase 2: Double-blind Treatment Phase|Physician Decision|0|||
147294009|NCT00833638|531239971|FG000|Phase 2: Double-blind Treatment Phase|Protocol Violation|3|||
147605965|NCT00423319|532373147|FG001|Overall Study|Poor compliance or noncompliance|1|||
147294010|NCT00833638|531239972|FG001|Phase 2: Double-blind Treatment Phase|Protocol Violation|3|||
147294011|NCT00833638|531239973|FG002|Phase 2: Double-blind Treatment Phase|Protocol Violation|3|||
147294012|NCT00833638|531239971|FG000|Phase 2: Double-blind Treatment Phase|Sponsor Decision|0|||
147294013|NCT00833638|531239972|FG001|Phase 2: Double-blind Treatment Phase|Sponsor Decision|0|||
147294014|NCT00833638|531239973|FG002|Phase 2: Double-blind Treatment Phase|Sponsor Decision|2|||
147294015|NCT00833638|531239971|FG000|Phase 2: Double-blind Treatment Phase|Withdrawal by Subject|1|||
147294016|NCT00833638|531239972|FG001|Phase 2: Double-blind Treatment Phase|Withdrawal by Subject|1|||
147294017|NCT00833638|531239973|FG002|Phase 2: Double-blind Treatment Phase|Withdrawal by Subject|2|||
147294018|NCT00833638|531239971|FG000|Phase 3: Open-label Extension Phase|Lost to Follow-up|1|||
147294019|NCT00833638|531239972|FG001|Phase 3: Open-label Extension Phase|Lost to Follow-up|2|||
147294020|NCT00833638|531239973|FG002|Phase 3: Open-label Extension Phase|Lost to Follow-up|0|||
147294021|NCT00833638|531239971|FG000|Phase 3: Open-label Extension Phase|Protocol Violation|0|||
147294022|NCT00833638|531239972|FG001|Phase 3: Open-label Extension Phase|Protocol Violation|1|||
147294023|NCT00833638|531239973|FG002|Phase 3: Open-label Extension Phase|Protocol Violation|2|||
147294024|NCT01400503|531239974|FG000|Overall Study|Withdrawal by Subject|1|||
147294025|NCT01400503|531239974|FG000|Overall Study|Study Terminated by Sponsor|58|||
147294026|NCT01400503|531239974|FG000|Overall Study|Other|1|||
147294027|NCT01669122|531239975|FG000|Period I|Lost to Follow-up|1|||
147294028|NCT01669122|531239975|FG000|Washout Period II|Protocol Violation|2|||
147294029|NCT03762473|531239976|FG000|Overall Study|Death|1|||
147294030|NCT03762473|531239977|FG001|Overall Study|Death|0|||
147294031|NCT02962908|531239978|FG000|Overall Study|Lost to Follow-up|0|||
147294032|NCT02962908|531239979|FG001|Overall Study|Lost to Follow-up|3|||
147294033|NCT02962908|531239980|FG002|Overall Study|Lost to Follow-up|0|||
147294034|NCT02962908|531239981|FG003|Overall Study|Lost to Follow-up|1|||
147294035|NCT02962908|531239978|FG000|Overall Study|Withdrawal by Subject|0|||
147294036|NCT02962908|531239979|FG001|Overall Study|Withdrawal by Subject|3|||
147294037|NCT02962908|531239980|FG002|Overall Study|Withdrawal by Subject|0|||
147294038|NCT02962908|531239981|FG003|Overall Study|Withdrawal by Subject|2|||
147294039|NCT02962908|531239978|FG000|Overall Study|Protocol Violation|0|||
147294040|NCT02962908|531239979|FG001|Overall Study|Protocol Violation|1|||
147294041|NCT02962908|531239980|FG002|Overall Study|Protocol Violation|0|||
147294042|NCT02962908|531239981|FG003|Overall Study|Protocol Violation|0|||
147294043|NCT02962908|531239978|FG000|Overall Study|Physician Decision|0|||
147294044|NCT02962908|531239979|FG001|Overall Study|Physician Decision|1|||
147294045|NCT02962908|531239980|FG002|Overall Study|Physician Decision|0|||
147294046|NCT02962908|531239981|FG003|Overall Study|Physician Decision|0|||
147294047|NCT03543254|531239982|FG000|Overall Study|Lost to Follow-up|1|||
147294048|NCT02077166|531239983|FG000|Overall Study|Death|6|||
147294049|NCT02077166|531239984|FG001|Overall Study|Death|7|||
147294050|NCT02077166|531239985|FG002|Overall Study|Death|5|||
147294051|NCT02077166|531239986|FG003|Overall Study|Death|6|||
147294052|NCT02077166|531239987|FG004|Overall Study|Death|4|||
147294053|NCT02077166|531239988|FG005|Overall Study|Death|32|||
147294054|NCT02077166|531239989|FG006|Overall Study|Death|22|||
147294055|NCT02077166|531239983|FG000|Overall Study|Study Closure by Sponsor|3|||
147294056|NCT02077166|531239984|FG001|Overall Study|Study Closure by Sponsor|0|||
147294057|NCT02077166|531239985|FG002|Overall Study|Study Closure by Sponsor|2|||
147294058|NCT02077166|531239986|FG003|Overall Study|Study Closure by Sponsor|2|||
147294059|NCT02077166|531239987|FG004|Overall Study|Study Closure by Sponsor|2|||
147294060|NCT02077166|531239988|FG005|Overall Study|Study Closure by Sponsor|12|||
147294061|NCT02077166|531239989|FG006|Overall Study|Study Closure by Sponsor|4|||
147294062|NCT02077166|531239983|FG000|Overall Study|Lost to Follow-up|0|||
147294063|NCT02077166|531239984|FG001|Overall Study|Lost to Follow-up|0|||
147294064|NCT02077166|531239985|FG002|Overall Study|Lost to Follow-up|0|||
147294065|NCT02077166|531239986|FG003|Overall Study|Lost to Follow-up|0|||
147294066|NCT02077166|531239987|FG004|Overall Study|Lost to Follow-up|0|||
147294067|NCT02077166|531239988|FG005|Overall Study|Lost to Follow-up|1|||
147294068|NCT02077166|531239989|FG006|Overall Study|Lost to Follow-up|0|||
147294069|NCT02077166|531239983|FG000|Overall Study|Withdrawal by Subject|3|||
147452898|NCT01294800|531821480|FG002|Overall Study|Adverse Event|12|||
147605966|NCT00423319|532373146|FG000|Overall Study|No longer meets study criteria|15|||
147605967|NCT00423319|532373147|FG001|Overall Study|No longer meets study criteria|15|||
147605968|NCT00423319|532373146|FG000|Overall Study|Other|23|||
147294070|NCT02077166|531239984|FG001|Overall Study|Withdrawal by Subject|0|||
147294071|NCT02077166|531239985|FG002|Overall Study|Withdrawal by Subject|1|||
147294072|NCT02077166|531239986|FG003|Overall Study|Withdrawal by Subject|1|||
147294073|NCT02077166|531239987|FG004|Overall Study|Withdrawal by Subject|1|||
147605969|NCT00423319|532373147|FG001|Overall Study|Other|22|||
147294074|NCT02077166|531239988|FG005|Overall Study|Withdrawal by Subject|3|||
147294075|NCT02077166|531239989|FG006|Overall Study|Withdrawal by Subject|0|||
147294076|NCT02077166|531239983|FG000|Overall Study|Other, Not Specified|0|||
147294077|NCT02077166|531239984|FG001|Overall Study|Other, Not Specified|0|||
147605970|NCT00960115|532373158|FG000|Overall Study|Ongoing treatment at data cut-off date|19|||
147605971|NCT00960115|532373159|FG001|Overall Study|Ongoing treatment at data cut-off date|15|||
147605972|NCT04853992|532373160|FG000|Treatment Period A|Adverse Event|0|||
147605973|NCT04853992|532373161|FG001|Treatment Period A|Adverse Event|1|||
147605974|NCT04853992|532373160|FG000|Wash Out|Met exclusion criteria for next treatment phase|1|||
147605975|NCT04853992|532373161|FG001|Wash Out|Met exclusion criteria for next treatment phase|0|||
147605976|NCT02351960|532373162|FG000|Overall Study|Pretreatment Event/Adverse Event|6|||
147605977|NCT02351960|532373163|FG001|Overall Study|Pretreatment Event/Adverse Event|3|||
147605978|NCT02351960|532373162|FG000|Overall Study|Voluntary Withdrawal|5|||
147605979|NCT02351960|532373163|FG001|Overall Study|Voluntary Withdrawal|4|||
147605980|NCT02351960|532373162|FG000|Overall Study|Significant Protocol Deviation|0|||
147605981|NCT02351960|532373163|FG001|Overall Study|Significant Protocol Deviation|5|||
147605982|NCT00638027|532373164|FG000|Overall Study|Adverse Event|0|||
147605983|NCT00638027|532373165|FG001|Overall Study|Adverse Event|2|||
147605984|NCT03014180|532373166|FG000|Overall Study|Protocol Violation|2|||
147605985|NCT01284621|532373167|FG000|Washout Period 1 (7 Days)|Required unexpected medical treatment|0|||
147605986|NCT01284621|532373168|FG001|Washout Period 1 (7 Days)|Required unexpected medical treatment|0|||
147605987|NCT01284621|532373169|FG002|Washout Period 1 (7 Days)|Required unexpected medical treatment|0|||
147605988|NCT01284621|532373170|FG003|Washout Period 1 (7 Days)|Required unexpected medical treatment|0|||
147605989|NCT01284621|532373171|FG004|Washout Period 1 (7 Days)|Required unexpected medical treatment|1|||
147605990|NCT01284621|532373172|FG005|Washout Period 1 (7 Days)|Required unexpected medical treatment|0|||
147605991|NCT02099682|532373175|FG000|Overall Study|Data Not Available|51|||
147605992|NCT02099682|532373175|FG000|Overall Study|Lost to Follow-up|31|||
147605993|NCT02099682|532373175|FG000|Overall Study|Other|29|||
147605994|NCT02802631|532373176|FG000|Overall Study|Withdrawal by Subject|1|||
147605995|NCT02802631|532373177|FG001|Overall Study|Withdrawal by Subject|0|||
147605996|NCT02802631|532373178|FG002|Overall Study|Withdrawal by Subject|0|||
147605997|NCT02802631|532373179|FG003|Overall Study|Withdrawal by Subject|0|||
147605998|NCT02802631|532373180|FG004|Overall Study|Withdrawal by Subject|0|||
147605999|NCT02802631|532373181|FG005|Overall Study|Withdrawal by Subject|0|||
147606000|NCT02802631|532373182|FG006|Overall Study|Withdrawal by Subject|0|||
147606001|NCT02802631|532373183|FG007|Overall Study|Withdrawal by Subject|0|||
147606002|NCT02802631|532373176|FG000|Overall Study|Physician Decision|1|||
147606003|NCT02802631|532373177|FG001|Overall Study|Physician Decision|0|||
147606004|NCT02802631|532373178|FG002|Overall Study|Physician Decision|0|||
147606005|NCT02802631|532373179|FG003|Overall Study|Physician Decision|0|||
147606006|NCT02802631|532373180|FG004|Overall Study|Physician Decision|0|||
147606007|NCT02802631|532373181|FG005|Overall Study|Physician Decision|0|||
147606008|NCT02802631|532373182|FG006|Overall Study|Physician Decision|1|||
147606009|NCT02802631|532373183|FG007|Overall Study|Physician Decision|0|||
147606010|NCT02802631|532373176|FG000|Overall Study|Adverse Event|0|||
147606011|NCT02802631|532373177|FG001|Overall Study|Adverse Event|2|||
147606012|NCT02802631|532373178|FG002|Overall Study|Adverse Event|0|||
147606013|NCT02802631|532373179|FG003|Overall Study|Adverse Event|1|||
147606014|NCT02802631|532373180|FG004|Overall Study|Adverse Event|6|||
147606015|NCT02802631|532373181|FG005|Overall Study|Adverse Event|1|||
147606016|NCT02802631|532373182|FG006|Overall Study|Adverse Event|4|||
147606017|NCT02802631|532373183|FG007|Overall Study|Adverse Event|0|||
147606018|NCT02802631|532373176|FG000|Overall Study|Sponsor Decision|0|||
147606019|NCT02802631|532373177|FG001|Overall Study|Sponsor Decision|0|||
147606020|NCT02802631|532373178|FG002|Overall Study|Sponsor Decision|6|||
147606021|NCT02802631|532373179|FG003|Overall Study|Sponsor Decision|0|||
147606022|NCT02802631|532373180|FG004|Overall Study|Sponsor Decision|2|||
147606023|NCT02802631|532373181|FG005|Overall Study|Sponsor Decision|0|||
147606024|NCT02802631|532373182|FG006|Overall Study|Sponsor Decision|0|||
147606025|NCT02802631|532373183|FG007|Overall Study|Sponsor Decision|4|||
147606026|NCT02212379|532373184|FG000|From Baseline to Week 48|Lack of Efficacy|1|||
147606027|NCT02212379|532373184|FG000|From Baseline to Week 48|Adverse Event|7|||
147606028|NCT02212379|532373184|FG000|From Baseline to Week 48|Withdrawal by Subject|1|||
147606029|NCT02212379|532373184|FG000|From Week 48 to Week 96|Lack of Efficacy|1|||
147606030|NCT02212379|532373184|FG000|From Week 48 to Week 96|Adverse Event|1|||
147606031|NCT02212379|532373184|FG000|From Week 48 to Week 96|Withdrawal by Subject|2|||
147294078|NCT02077166|531239985|FG002|Overall Study|Other, Not Specified|1|||
147294079|NCT02077166|531239986|FG003|Overall Study|Other, Not Specified|0|||
147294080|NCT02077166|531239987|FG004|Overall Study|Other, Not Specified|1|||
147452899|NCT01294800|531821481|FG003|Overall Study|Adverse Event|5|||
147606032|NCT00704730|532373185|FG000|Overall Study|Adverse Event|35|||
147606033|NCT00704730|532373186|FG001|Overall Study|Adverse Event|9|||
147606034|NCT00704730|532373185|FG000|Overall Study|Death|11|||
147606035|NCT00704730|532373186|FG001|Overall Study|Death|5|||
147606036|NCT00704730|532373185|FG000|Overall Study|Physician Decision|2|||
147606037|NCT00704730|532373186|FG001|Overall Study|Physician Decision|0|||
147606038|NCT00704730|532373185|FG000|Overall Study|Did not receive drug|5|||
147606039|NCT00704730|532373186|FG001|Overall Study|Did not receive drug|2|||
147606040|NCT00704730|532373185|FG000|Overall Study|Disease progression per PI|58|||
147606041|NCT00704730|532373186|FG001|Overall Study|Disease progression per PI|67|||
147606042|NCT00704730|532373185|FG000|Overall Study|data unavailable|1|||
147606043|NCT00704730|532373186|FG001|Overall Study|data unavailable|0|||
147606044|NCT00704730|532373185|FG000|Overall Study|Withdrawal by Subject|9|||
147606045|NCT00704730|532373186|FG001|Overall Study|Withdrawal by Subject|13|||
147606046|NCT03395405|532375119|FG000|Overall Study|Death|0|||
147606047|NCT03395405|532375120|FG001|Overall Study|Death|2|||
147606048|NCT03395405|532375119|FG000|Overall Study|Lost to Follow-up|0|||
147606049|NCT03395405|532375120|FG001|Overall Study|Lost to Follow-up|1|||
147606050|NCT03395405|532375119|FG000|Overall Study|Protocol Violation|0|||
147606051|NCT03395405|532375120|FG001|Overall Study|Protocol Violation|1|||
147606052|NCT03395405|532375119|FG000|Overall Study|Withdrawal by Subject|3|||
147606053|NCT03395405|532375120|FG001|Overall Study|Withdrawal by Subject|1|||
147606054|NCT03395405|532375119|FG000|Overall Study|COVID-19 Pandemic|1|||
147606055|NCT03395405|532375120|FG001|Overall Study|COVID-19 Pandemic|0|||
147606056|NCT00660907|532375123|FG000|Overall Study|Incorrect Enrollment|1|||
147606057|NCT00660907|532375124|FG001|Overall Study|Incorrect Enrollment|1|||
147606058|NCT00660907|532375123|FG000|Overall Study|Adverse Event|33|||
147606059|NCT00660907|532375124|FG001|Overall Study|Adverse Event|19|||
147606060|NCT00660907|532375123|FG000|Overall Study|Subject No Longer Meets Study Criteria|6|||
147606061|NCT00660907|532375124|FG001|Overall Study|Subject No Longer Meets Study Criteria|27|||
147606062|NCT00660907|532375123|FG000|Overall Study|Withdrawal by Subject|23|||
147606063|NCT00660907|532375124|FG001|Overall Study|Withdrawal by Subject|32|||
147606064|NCT00660907|532375123|FG000|Overall Study|Lost to Follow-up|3|||
147606065|NCT00660907|532375124|FG001|Overall Study|Lost to Follow-up|3|||
147606066|NCT00660907|532375123|FG000|Overall Study|Poor/Non-Compliance|5|||
147606067|NCT00660907|532375124|FG001|Overall Study|Poor/Non-Compliance|1|||
147606068|NCT00660907|532375123|FG000|Overall Study|Safety|1|||
147606069|NCT00660907|532375124|FG001|Overall Study|Safety|0|||
147606070|NCT00660907|532375123|FG000|Overall Study|Death|1|||
147606071|NCT00660907|532375124|FG001|Overall Study|Death|3|||
147606072|NCT00660907|532375123|FG000|Overall Study|Various|11|||
147606073|NCT00660907|532375124|FG001|Overall Study|Various|8|||
147606074|NCT01908907|532375125|FG000|Overall Study|Physician Decision|1|||
147606075|NCT01908907|532375126|FG001|Overall Study|Physician Decision|0|||
147606076|NCT01908907|532375125|FG000|Overall Study|Protocol Violation|1|||
147606077|NCT01908907|532375126|FG001|Overall Study|Protocol Violation|0|||
147606078|NCT04975191|532375127|FG000|Overall Study|Protocol Violation|1|||
147606079|NCT04975191|532375128|FG001|Overall Study|Protocol Violation|2|||
147606080|NCT04975191|532375129|FG002|Overall Study|Protocol Violation|2|||
147606081|NCT04975191|532375130|FG003|Overall Study|Protocol Violation|2|||
147606082|NCT04975191|532375127|FG000|Overall Study|Lost to Follow-up|13|||
147606083|NCT04975191|532375128|FG001|Overall Study|Lost to Follow-up|3|||
147606084|NCT04975191|532375129|FG002|Overall Study|Lost to Follow-up|8|||
147606085|NCT04975191|532375130|FG003|Overall Study|Lost to Follow-up|8|||
147606086|NCT00761657|532375131|FG000|Part 1 (up to Day 57)|Adverse Event|0|||
147606087|NCT00761657|532375132|FG001|Part 1 (up to Day 57)|Adverse Event|0|||
147606088|NCT00761657|532375133|FG002|Part 1 (up to Day 57)|Adverse Event|0|||
147606089|NCT00761657|532375134|FG003|Part 1 (up to Day 57)|Adverse Event|1|||
147606090|NCT00761657|532375135|FG004|Part 1 (up to Day 57)|Adverse Event|0|||
147606091|NCT00761657|532375136|FG005|Part 1 (up to Day 57)|Adverse Event|0|||
147606092|NCT00761657|532375137|FG006|Part 1 (up to Day 57)|Adverse Event|0|||
147606093|NCT00761657|532375138|FG007|Part 1 (up to Day 57)|Adverse Event|0|||
147606094|NCT00761657|532375139|FG008|Part 1 (up to Day 57)|Adverse Event|0|||
147606095|NCT00761657|532375131|FG000|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
147606096|NCT00761657|532375132|FG001|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
147606097|NCT00761657|532375133|FG002|Part 1 (up to Day 57)|Withdrawal by Subject|1|||
147294081|NCT02077166|531239988|FG005|Overall Study|Other, Not Specified|7|||
147294082|NCT02077166|531239989|FG006|Overall Study|Other, Not Specified|8|||
147294083|NCT03519854|531239990|FG000|Overall Study|Technical Error|0|||
147294084|NCT03519854|531239991|FG001|Overall Study|Technical Error|0|||
147606098|NCT00761657|532375134|FG003|Part 1 (up to Day 57)|Withdrawal by Subject|1|||
147606099|NCT00761657|532375135|FG004|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
147606100|NCT00761657|532375136|FG005|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
147606101|NCT00761657|532375137|FG006|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
147606102|NCT00761657|532375138|FG007|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
147294085|NCT03519854|531239992|FG002|Overall Study|Technical Error|1|||
147294086|NCT03519854|531239993|FG003|Overall Study|Technical Error|0|||
147606103|NCT00761657|532375139|FG008|Part 1 (up to Day 57)|Withdrawal by Subject|0|||
147606104|NCT00761657|532375131|FG000|Part 1 (up to Day 57)|Sponsor Decision|0|||
147606105|NCT00761657|532375132|FG001|Part 1 (up to Day 57)|Sponsor Decision|0|||
147606106|NCT00761657|532375133|FG002|Part 1 (up to Day 57)|Sponsor Decision|3|||
147606107|NCT00761657|532375134|FG003|Part 1 (up to Day 57)|Sponsor Decision|4|||
147606108|NCT00761657|532375135|FG004|Part 1 (up to Day 57)|Sponsor Decision|0|||
147606109|NCT00761657|532375136|FG005|Part 1 (up to Day 57)|Sponsor Decision|0|||
147606110|NCT00761657|532375137|FG006|Part 1 (up to Day 57)|Sponsor Decision|1|||
147606111|NCT00761657|532375138|FG007|Part 1 (up to Day 57)|Sponsor Decision|1|||
147606112|NCT00761657|532375139|FG008|Part 1 (up to Day 57)|Sponsor Decision|1|||
147606113|NCT00761657|532375131|FG000|Part 2 (up to Day 114)|Adverse Event|0|||
147606114|NCT00761657|532375132|FG001|Part 2 (up to Day 114)|Adverse Event|0|||
147606115|NCT00761657|532375133|FG002|Part 2 (up to Day 114)|Adverse Event|0|||
147606116|NCT00761657|532375134|FG003|Part 2 (up to Day 114)|Adverse Event|0|||
147606117|NCT00761657|532375135|FG004|Part 2 (up to Day 114)|Adverse Event|0|||
147606118|NCT00761657|532375136|FG005|Part 2 (up to Day 114)|Adverse Event|0|||
147606119|NCT00761657|532375137|FG006|Part 2 (up to Day 114)|Adverse Event|0|||
147606120|NCT00761657|532375138|FG007|Part 2 (up to Day 114)|Adverse Event|0|||
147606121|NCT00761657|532375139|FG008|Part 2 (up to Day 114)|Adverse Event|1|||
147606122|NCT00359801|532375149|FG000|Overall Study|Lost to Follow-up|72|||
147606123|NCT00359801|532375150|FG001|Overall Study|Lost to Follow-up|58|||
147606124|NCT00359801|532375149|FG000|Overall Study|Withdrawal by Subject|143|||
147606125|NCT00359801|532375150|FG001|Overall Study|Withdrawal by Subject|96|||
147606126|NCT00359801|532375149|FG000|Overall Study|Other|66|||
147606127|NCT00359801|532375150|FG001|Overall Study|Other|46|||
147606128|NCT00359801|532375149|FG000|Overall Study|Final Status Unknown: missing data|7|||
147606129|NCT00359801|532375150|FG001|Overall Study|Final Status Unknown: missing data|4|||
147606130|NCT00359801|532375149|FG000|Overall Study|Sponsor Decision|17|||
147606131|NCT00359801|532375150|FG001|Overall Study|Sponsor Decision|16|||
147294087|NCT03519854|531239994|FG004|Overall Study|Technical Error|0|||
147294088|NCT03519854|531239995|FG005|Overall Study|Technical Error|0|||
147294089|NCT03519854|531239996|FG006|Overall Study|Technical Error|0|||
147294090|NCT03519854|531239997|FG007|Overall Study|Technical Error|0|||
147294091|NCT03519854|531239998|FG008|Overall Study|Technical Error|0|||
147294092|NCT03519854|531239999|FG009|Overall Study|Technical Error|0|||
147294093|NCT03519854|531240000|FG010|Overall Study|Technical Error|0|||
147294094|NCT03519854|531240001|FG011|Overall Study|Technical Error|0|||
147294095|NCT03519854|531240002|FG012|Overall Study|Technical Error|0|||
147294096|NCT03519854|531240003|FG013|Overall Study|Technical Error|0|||
147294097|NCT03519854|531240004|FG014|Overall Study|Technical Error|0|||
147294098|NCT03519854|531240005|FG015|Overall Study|Technical Error|0|||
147294099|NCT03519854|531240006|FG016|Overall Study|Technical Error|0|||
147294100|NCT03519854|531240007|FG017|Overall Study|Technical Error|0|||
147294101|NCT05132699|531240008|FG000|Overall Study|Withdrawal by Subject|3|||
147294102|NCT05132699|531240009|FG001|Overall Study|Withdrawal by Subject|0|||
147294103|NCT01951625|531240012|FG000|Treatment Period|Protocol Violation|2|||
147294104|NCT01951625|531240013|FG001|Treatment Period|Protocol Violation|0|||
147294105|NCT01951625|531240014|FG002|Treatment Period|Protocol Violation|1|||
147294106|NCT01951625|531240015|FG003|Treatment Period|Protocol Violation|3|||
147294107|NCT01951625|531240016|FG004|Treatment Period|Protocol Violation|2|||
147294108|NCT01951625|531240012|FG000|Treatment Period|Physician Decision|0|||
147294109|NCT01951625|531240013|FG001|Treatment Period|Physician Decision|0|||
147294110|NCT01951625|531240014|FG002|Treatment Period|Physician Decision|0|||
147294111|NCT01951625|531240015|FG003|Treatment Period|Physician Decision|0|||
147294112|NCT01951625|531240016|FG004|Treatment Period|Physician Decision|1|||
147294113|NCT01951625|531240012|FG000|Treatment Period|Protocol driven decision point|0|||
147294114|NCT01951625|531240013|FG001|Treatment Period|Protocol driven decision point|5|||
147294115|NCT01951625|531240014|FG002|Treatment Period|Protocol driven decision point|0|||
147294116|NCT01951625|531240015|FG003|Treatment Period|Protocol driven decision point|2|||
147294117|NCT01951625|531240016|FG004|Treatment Period|Protocol driven decision point|1|||
147294118|NCT01951625|531240012|FG000|Treatment Period|Non compliance with study drug|1|||
147294119|NCT01951625|531240013|FG001|Treatment Period|Non compliance with study drug|2|||
147294120|NCT01951625|531240014|FG002|Treatment Period|Non compliance with study drug|2|||
147294121|NCT01951625|531240015|FG003|Treatment Period|Non compliance with study drug|0|||
147294122|NCT01951625|531240016|FG004|Treatment Period|Non compliance with study drug|0|||
147294123|NCT01951625|531240012|FG000|Treatment Period|Death|3|||
147294124|NCT01951625|531240013|FG001|Treatment Period|Death|2|||
147294125|NCT01951625|531240014|FG002|Treatment Period|Death|2|||
147294126|NCT01951625|531240015|FG003|Treatment Period|Death|1|||
147294127|NCT01951625|531240016|FG004|Treatment Period|Death|2|||
147294128|NCT01951625|531240012|FG000|Treatment Period|Adverse Event|7|||
147294129|NCT01951625|531240013|FG001|Treatment Period|Adverse Event|10|||
147452900|NCT01294800|531821478|FG000|Overall Study|Subject Withdrew Consent|2|||
147452901|NCT01294800|531821479|FG001|Overall Study|Subject Withdrew Consent|2|||
147606132|NCT02245412|532375156|FG000|Treatment Period|Death|1|||
147606133|NCT02245412|532375157|FG001|Treatment Period|Death|1|||
147294130|NCT01951625|531240014|FG002|Treatment Period|Adverse Event|9|||
147294131|NCT01951625|531240015|FG003|Treatment Period|Adverse Event|8|||
147294132|NCT01951625|531240016|FG004|Treatment Period|Adverse Event|8|||
147294133|NCT01951625|531240012|FG000|Treatment Period|Withdrawal by Subject|5|||
147294134|NCT01951625|531240013|FG001|Treatment Period|Withdrawal by Subject|2|||
147606134|NCT02245412|532375158|FG002|Treatment Period|Death|0|||
147606135|NCT02245412|532375156|FG000|Treatment Period|Physician Decision|1|||
147606136|NCT02245412|532375157|FG001|Treatment Period|Physician Decision|1|||
147294135|NCT01951625|531240014|FG002|Treatment Period|Withdrawal by Subject|1|||
147294136|NCT01951625|531240015|FG003|Treatment Period|Withdrawal by Subject|7|||
147294137|NCT01951625|531240016|FG004|Treatment Period|Withdrawal by Subject|3|||
147294138|NCT01951625|531240012|FG000|Treatment Period|Lost to Follow-up|1|||
147294139|NCT01951625|531240013|FG001|Treatment Period|Lost to Follow-up|0|||
147294140|NCT01951625|531240014|FG002|Treatment Period|Lost to Follow-up|0|||
147294141|NCT01951625|531240015|FG003|Treatment Period|Lost to Follow-up|1|||
147294142|NCT01951625|531240016|FG004|Treatment Period|Lost to Follow-up|0|||
147294143|NCT01951625|531240012|FG000|Follow Up Period|Non-compliance with study drug|1|||
147294144|NCT01951625|531240013|FG001|Follow Up Period|Non-compliance with study drug|0|||
147294145|NCT01951625|531240014|FG002|Follow Up Period|Non-compliance with study drug|0|||
147294146|NCT01951625|531240015|FG003|Follow Up Period|Non-compliance with study drug|0|||
147294147|NCT01951625|531240016|FG004|Follow Up Period|Non-compliance with study drug|0|||
147294148|NCT01951625|531240012|FG000|Follow Up Period|Death|1|||
147294149|NCT01951625|531240013|FG001|Follow Up Period|Death|3|||
147294150|NCT01951625|531240014|FG002|Follow Up Period|Death|2|||
147294151|NCT01951625|531240015|FG003|Follow Up Period|Death|2|||
147294152|NCT01951625|531240016|FG004|Follow Up Period|Death|1|||
147294153|NCT01951625|531240012|FG000|Follow Up Period|Logistical difficulties|1|||
147294154|NCT01951625|531240013|FG001|Follow Up Period|Logistical difficulties|2|||
147294155|NCT01951625|531240014|FG002|Follow Up Period|Logistical difficulties|0|||
147294156|NCT01951625|531240015|FG003|Follow Up Period|Logistical difficulties|0|||
147294157|NCT01951625|531240016|FG004|Follow Up Period|Logistical difficulties|0|||
147294158|NCT01951625|531240012|FG000|Follow Up Period|Adverse Event|0|||
147294159|NCT01951625|531240013|FG001|Follow Up Period|Adverse Event|3|||
147294160|NCT01951625|531240014|FG002|Follow Up Period|Adverse Event|2|||
147294161|NCT01951625|531240015|FG003|Follow Up Period|Adverse Event|3|||
147294162|NCT01951625|531240016|FG004|Follow Up Period|Adverse Event|5|||
147294163|NCT01951625|531240012|FG000|Follow Up Period|Withdrawal by Subject|4|||
147294164|NCT01951625|531240013|FG001|Follow Up Period|Withdrawal by Subject|1|||
147294165|NCT01951625|531240014|FG002|Follow Up Period|Withdrawal by Subject|0|||
147294166|NCT01951625|531240015|FG003|Follow Up Period|Withdrawal by Subject|5|||
147294167|NCT01951625|531240016|FG004|Follow Up Period|Withdrawal by Subject|3|||
147294168|NCT01951625|531240012|FG000|Follow Up Period|Lost to Follow-up|1|||
147294169|NCT01951625|531240013|FG001|Follow Up Period|Lost to Follow-up|0|||
147294170|NCT01951625|531240014|FG002|Follow Up Period|Lost to Follow-up|0|||
147294171|NCT01951625|531240015|FG003|Follow Up Period|Lost to Follow-up|1|||
147294172|NCT01951625|531240016|FG004|Follow Up Period|Lost to Follow-up|1|||
147294173|NCT00655980|531240017|FG000|Overall Study|surgery canceled; or subject or anesthes|26|||
147294174|NCT00655980|531240018|FG001|Overall Study|surgery canceled; or subject or anesthes|31|||
147294175|NCT00655980|531240019|FG002|Overall Study|surgery canceled; or subject or anesthes|5|||
147294176|NCT04918784|531242512|FG000|Overall Study|Amputation - no longer eligible|1|||
147294177|NCT04918784|531242513|FG001|Overall Study|Amputation - no longer eligible|2|||
147294178|NCT04918784|531242512|FG000|Overall Study|Death|1|||
147294179|NCT04918784|531242513|FG001|Overall Study|Death|0|||
147294180|NCT04918784|531242512|FG000|Overall Study|patient non-compliance|3|||
147294181|NCT04918784|531242513|FG001|Overall Study|patient non-compliance|1|||
147294182|NCT04918784|531242512|FG000|Overall Study|Adverse Event|1|||
147294183|NCT04918784|531242513|FG001|Overall Study|Adverse Event|0|||
147294184|NCT01712009|531242514|FG000|Overall Study|Withdrawal by Subject|24|||
147294185|NCT01712009|531242515|FG001|Overall Study|Withdrawal by Subject|15|||
147294186|NCT01712009|531242516|FG002|Overall Study|Withdrawal by Subject|8|||
147294187|NCT01712009|531242514|FG000|Overall Study|Lost to Follow-up|2|||
147294188|NCT01712009|531242515|FG001|Overall Study|Lost to Follow-up|0|||
147294189|NCT01712009|531242516|FG002|Overall Study|Lost to Follow-up|1|||
147294190|NCT01712009|531242514|FG000|Overall Study|Decision by Sponsor|12|||
147294191|NCT01712009|531242515|FG001|Overall Study|Decision by Sponsor|14|||
147294192|NCT01712009|531242516|FG002|Overall Study|Decision by Sponsor|12|||
147294193|NCT02822222|531242517|FG000|Overall Study|Protocol requirement SBP<110 mmHg|1|||
147294194|NCT02822222|531242518|FG001|Overall Study|Protocol requirement SBP<110 mmHg|0|||
147294195|NCT00428090|531242519|FG000|Overall Study|Adverse Event|10|||
147294196|NCT00428090|531242520|FG001|Overall Study|Adverse Event|8|||
147294197|NCT00428090|531242521|FG002|Overall Study|Adverse Event|10|||
147294198|NCT00428090|531242522|FG003|Overall Study|Adverse Event|11|||
147294199|NCT00428090|531242519|FG000|Overall Study|Lost to Follow-up|3|||
147294200|NCT00428090|531242520|FG001|Overall Study|Lost to Follow-up|6|||
147452902|NCT01294800|531821480|FG002|Overall Study|Subject Withdrew Consent|2|||
147294201|NCT00428090|531242521|FG002|Overall Study|Lost to Follow-up|1|||
147294202|NCT00428090|531242522|FG003|Overall Study|Lost to Follow-up|4|||
147294203|NCT00428090|531242519|FG000|Overall Study|Protocol Violation|3|||
147294204|NCT00428090|531242520|FG001|Overall Study|Protocol Violation|1|||
147294205|NCT00428090|531242521|FG002|Overall Study|Protocol Violation|3|||
147294206|NCT00428090|531242522|FG003|Overall Study|Protocol Violation|3|||
147294207|NCT00428090|531242519|FG000|Overall Study|Withdrawal by Subject|10|||
147294208|NCT00428090|531242520|FG001|Overall Study|Withdrawal by Subject|12|||
147294209|NCT00428090|531242521|FG002|Overall Study|Withdrawal by Subject|15|||
147294210|NCT00428090|531242522|FG003|Overall Study|Withdrawal by Subject|5|||
147294211|NCT00428090|531242519|FG000|Overall Study|Sponsor terminated study|0|||
147294212|NCT00428090|531242520|FG001|Overall Study|Sponsor terminated study|1|||
147294213|NCT00428090|531242521|FG002|Overall Study|Sponsor terminated study|0|||
147294214|NCT00428090|531242522|FG003|Overall Study|Sponsor terminated study|0|||
147294215|NCT00428090|531242519|FG000|Overall Study|Non-compliance|4|||
147294216|NCT00428090|531242520|FG001|Overall Study|Non-compliance|0|||
147294217|NCT00428090|531242521|FG002|Overall Study|Non-compliance|1|||
147294218|NCT00428090|531242522|FG003|Overall Study|Non-compliance|3|||
147294219|NCT00428090|531242519|FG000|Overall Study|Par. did not returned to visit|1|||
147294220|NCT00428090|531242520|FG001|Overall Study|Par. did not returned to visit|0|||
147294221|NCT00428090|531242521|FG002|Overall Study|Par. did not returned to visit|0|||
147294222|NCT00428090|531242522|FG003|Overall Study|Par. did not returned to visit|1|||
147294223|NCT00428090|531242519|FG000|Overall Study|Follow-Up visit not possible|1|||
147294224|NCT00428090|531242520|FG001|Overall Study|Follow-Up visit not possible|0|||
147294225|NCT00428090|531242521|FG002|Overall Study|Follow-Up visit not possible|0|||
147294226|NCT00428090|531242522|FG003|Overall Study|Follow-Up visit not possible|0|||
147294227|NCT00428090|531242519|FG000|Overall Study|Prohibited medication used for SAE|1|||
147294228|NCT00428090|531242520|FG001|Overall Study|Prohibited medication used for SAE|0|||
147294229|NCT00428090|531242521|FG002|Overall Study|Prohibited medication used for SAE|0|||
147294230|NCT00428090|531242522|FG003|Overall Study|Prohibited medication used for SAE|0|||
147294231|NCT00428090|531242519|FG000|Overall Study|Death of par.|1|||
147294232|NCT00428090|531242520|FG001|Overall Study|Death of par.|0|||
147294233|NCT00428090|531242521|FG002|Overall Study|Death of par.|1|||
147294234|NCT00428090|531242522|FG003|Overall Study|Death of par.|0|||
147294235|NCT00428090|531242519|FG000|Overall Study|Visit 7 exceed the visit window|0|||
147294236|NCT00428090|531242520|FG001|Overall Study|Visit 7 exceed the visit window|1|||
147294237|NCT00428090|531242521|FG002|Overall Study|Visit 7 exceed the visit window|0|||
147294238|NCT00428090|531242522|FG003|Overall Study|Visit 7 exceed the visit window|0|||
147294239|NCT00428090|531242519|FG000|Overall Study|Medical monitor terminated par.|0|||
147294240|NCT00428090|531242520|FG001|Overall Study|Medical monitor terminated par.|1|||
147294241|NCT00428090|531242521|FG002|Overall Study|Medical monitor terminated par.|0|||
147294242|NCT00428090|531242522|FG003|Overall Study|Medical monitor terminated par.|0|||
147294243|NCT00428090|531242519|FG000|Overall Study|Mental status of par. was|0|||
147294244|NCT00428090|531242520|FG001|Overall Study|Mental status of par. was|1|||
147294245|NCT00428090|531242521|FG002|Overall Study|Mental status of par. was|0|||
147294246|NCT00428090|531242522|FG003|Overall Study|Mental status of par. was|0|||
147294247|NCT00428090|531242519|FG000|Overall Study|Worsening of AD|0|||
147294248|NCT00428090|531242520|FG001|Overall Study|Worsening of AD|0|||
147294249|NCT00428090|531242521|FG002|Overall Study|Worsening of AD|1|||
147294250|NCT00428090|531242522|FG003|Overall Study|Worsening of AD|0|||
147294251|NCT00428090|531242519|FG000|Overall Study|Excluded for concerning QTc value|0|||
147294252|NCT00428090|531242520|FG001|Overall Study|Excluded for concerning QTc value|0|||
147294253|NCT00428090|531242521|FG002|Overall Study|Excluded for concerning QTc value|1|||
147294254|NCT00428090|531242522|FG003|Overall Study|Excluded for concerning QTc value|0|||
147294255|NCT00428090|531242519|FG000|Overall Study|Insufficient AD documentation|0|||
147294256|NCT00428090|531242520|FG001|Overall Study|Insufficient AD documentation|0|||
147294257|NCT00428090|531242521|FG002|Overall Study|Insufficient AD documentation|1|||
147294258|NCT00428090|531242522|FG003|Overall Study|Insufficient AD documentation|0|||
147294259|NCT00428090|531242519|FG000|Overall Study|High MMSE scores|0|||
147294260|NCT00428090|531242520|FG001|Overall Study|High MMSE scores|0|||
147294261|NCT00428090|531242521|FG002|Overall Study|High MMSE scores|1|||
147294262|NCT00428090|531242522|FG003|Overall Study|High MMSE scores|0|||
147294263|NCT00428090|531242519|FG000|Overall Study|Deterioration of cognitive status|0|||
147294264|NCT00428090|531242520|FG001|Overall Study|Deterioration of cognitive status|0|||
147294265|NCT00428090|531242521|FG002|Overall Study|Deterioration of cognitive status|1|||
147294266|NCT00428090|531242522|FG003|Overall Study|Deterioration of cognitive status|0|||
147294267|NCT00428090|531242519|FG000|Overall Study|Serious adverse event|0|||
147294268|NCT00428090|531242520|FG001|Overall Study|Serious adverse event|0|||
147294269|NCT00428090|531242521|FG002|Overall Study|Serious adverse event|1|||
147294270|NCT00428090|531242522|FG003|Overall Study|Serious adverse event|0|||
147294271|NCT00428090|531242519|FG000|Overall Study|Excluded for heart insufficiency|0|||
147294272|NCT00428090|531242520|FG001|Overall Study|Excluded for heart insufficiency|0|||
147294273|NCT00428090|531242521|FG002|Overall Study|Excluded for heart insufficiency|1|||
147294274|NCT00428090|531242522|FG003|Overall Study|Excluded for heart insufficiency|0|||
147294275|NCT00428090|531242519|FG000|Overall Study|Raised Creatinine Value|0|||
147294276|NCT00428090|531242520|FG001|Overall Study|Raised Creatinine Value|0|||
147294277|NCT00428090|531242521|FG002|Overall Study|Raised Creatinine Value|0|||
147294278|NCT00428090|531242522|FG003|Overall Study|Raised Creatinine Value|1|||
147294279|NCT02690974|531242530|FG000|Overall Study|Adverse Event|16|||
147294280|NCT02690974|531242530|FG000|Overall Study|Death|9|||
147294281|NCT02690974|531242530|FG000|Overall Study|Subject/guardian decision|4|||
147294282|NCT02690974|531242530|FG000|Overall Study|Lost to Follow-up|3|||
147294283|NCT02690974|531242530|FG000|Overall Study|Withdrawal of Informed Consent|3|||
147294284|NCT02690974|531242530|FG000|Overall Study|Physician Decision|2|||
147294285|NCT02690974|531242530|FG000|Overall Study|Non-compliance with study treatment|1|||
147294286|NCT02690974|531242530|FG000|Overall Study|Protocol-defined stopping criteria|1|||
147294287|NCT02690974|531242530|FG000|Overall Study|Protocol Deviation|1|||
147294288|NCT02184611|531242533|FG000|Overall Study|Lack of Efficacy|11|||
147294289|NCT02184611|531242534|FG001|Overall Study|Lack of Efficacy|15|||
147294290|NCT02184611|531242533|FG000|Overall Study|Withdrawal by Subject|5|||
147294291|NCT02184611|531242534|FG001|Overall Study|Withdrawal by Subject|6|||
147294292|NCT02184611|531242533|FG000|Overall Study|Adverse Event|4|||
147294293|NCT02184611|531242534|FG001|Overall Study|Adverse Event|5|||
147294294|NCT02184611|531242533|FG000|Overall Study|Protocol Violation|1|||
147294295|NCT02184611|531242534|FG001|Overall Study|Protocol Violation|1|||
147294296|NCT02184611|531242533|FG000|Overall Study|Protocol defined stopping criteria|0|||
147294297|NCT02184611|531242534|FG001|Overall Study|Protocol defined stopping criteria|1|||
147294298|NCT00160680|531242535|FG000|Overall Study|Adverse Event|0|||
147294299|NCT00160680|531242536|FG001|Overall Study|Adverse Event|1|||
147294300|NCT00160680|531242535|FG000|Overall Study|Lack of Efficacy|2|||
147294301|NCT00160680|531242536|FG001|Overall Study|Lack of Efficacy|1|||
147294302|NCT00160680|531242535|FG000|Overall Study|Lost to Follow-up|3|||
147294303|NCT00160680|531242536|FG001|Overall Study|Lost to Follow-up|2|||
147294304|NCT00160680|531242535|FG000|Overall Study|Withdrawal by Subject|4|||
147294305|NCT00160680|531242536|FG001|Overall Study|Withdrawal by Subject|9|||
147294306|NCT03232983|531242539|FG000|Period 1|Physician Decision|0|||
147294307|NCT03232983|531242540|FG001|Period 1|Physician Decision|0|||
147294308|NCT03232983|531242541|FG002|Period 1|Physician Decision|1|||
147294309|NCT03232983|531242542|FG003|Period 1|Physician Decision|0|||
147294310|NCT03232983|531242539|FG000|Washout Period 2|Physician Decision|0|||
147294311|NCT03232983|531242540|FG001|Washout Period 2|Physician Decision|0|||
147294312|NCT03232983|531242541|FG002|Washout Period 2|Physician Decision|1|||
147294313|NCT03232983|531242542|FG003|Washout Period 2|Physician Decision|0|||
147294314|NCT03232983|531242539|FG000|Washout Period 2|Withdrawal by Subject|0|||
147294315|NCT03232983|531242540|FG001|Washout Period 2|Withdrawal by Subject|0|||
147294316|NCT03232983|531242541|FG002|Washout Period 2|Withdrawal by Subject|0|||
147294317|NCT03232983|531242542|FG003|Washout Period 2|Withdrawal by Subject|1|||
147294318|NCT03232983|531242539|FG000|Period 4|Withdrawal by Subject|1|||
147294319|NCT03232983|531242540|FG001|Period 4|Withdrawal by Subject|0|||
147294320|NCT03232983|531242541|FG002|Period 4|Withdrawal by Subject|0|||
147338975|NCT03312907|531409906|FG001|Overall Study|Lost to Follow-up|3|||
147338976|NCT03312907|531409907|FG002|Overall Study|Lost to Follow-up|2|||
147338977|NCT03312907|531409905|FG000|Overall Study|Physician Decision|3|||
147338978|NCT03312907|531409906|FG001|Overall Study|Physician Decision|4|||
147338979|NCT03312907|531409907|FG002|Overall Study|Physician Decision|2|||
147338980|NCT03312907|531409905|FG000|Overall Study|Withdrawal by Subject|9|||
147338981|NCT03312907|531409906|FG001|Overall Study|Withdrawal by Subject|14|||
147338982|NCT03312907|531409907|FG002|Overall Study|Withdrawal by Subject|10|||
147294321|NCT03232983|531242542|FG003|Period 4|Withdrawal by Subject|0|||
147294322|NCT01615328|531242543|FG000|Overall Study|Lost to Follow-up|3|||
147294323|NCT01615328|531242544|FG001|Overall Study|Lost to Follow-up|5|||
147294324|NCT01137474|531242551|FG000|Overall Study|Adverse Event|3|||
147338983|NCT03189524|531409908|FG000|Overall Study|Study terminated by Sponsor after final analysis and all remaining participants transferred to LTE|7|||
147338984|NCT03189524|531409909|FG001|Overall Study|Study terminated by Sponsor after final analysis and all remaining participants transferred to LTE|5|||
147338985|NCT03189524|531409910|FG002|Overall Study|Study terminated by Sponsor after final analysis and all remaining participants transferred to LTE|11|||
147338986|NCT03189524|531409908|FG000|Overall Study|Death|2|||
147338987|NCT03189524|531409909|FG001|Overall Study|Death|2|||
147338988|NCT03189524|531409910|FG002|Overall Study|Death|1|||
147338989|NCT03189524|531409908|FG000|Overall Study|Lost to Follow-up|1|||
147338990|NCT03189524|531409909|FG001|Overall Study|Lost to Follow-up|0|||
147338991|NCT03189524|531409910|FG002|Overall Study|Lost to Follow-up|8|||
147338992|NCT03189524|531409908|FG000|Overall Study|Withdrawal by Subject|1|||
147338993|NCT03189524|531409909|FG001|Overall Study|Withdrawal by Subject|1|||
147338994|NCT03189524|531409910|FG002|Overall Study|Withdrawal by Subject|3|||
147338995|NCT03189524|531409908|FG000|Overall Study|Progressive Disease|0|||
147338996|NCT03189524|531409909|FG001|Overall Study|Progressive Disease|2|||
147338997|NCT03189524|531409910|FG002|Overall Study|Progressive Disease|0|||
147452903|NCT01294800|531821481|FG003|Overall Study|Subject Withdrew Consent|11|||
147338998|NCT01780298|531409912|FG000|Overall Study|Physician Decision|1|||
147338999|NCT01780298|531409913|FG001|Overall Study|Physician Decision|5|||
147452904|NCT01294800|531821478|FG000|Overall Study|Lost to Follow-up|0|||
147294325|NCT01137474|531242552|FG001|Overall Study|Adverse Event|5|||
147294326|NCT01137474|531242553|FG002|Overall Study|Adverse Event|1|||
147294327|NCT01137474|531242554|FG003|Overall Study|Adverse Event|3|||
147294328|NCT01137474|531242551|FG000|Overall Study|Withdrawal by Subject|7|||
147294329|NCT01137474|531242552|FG001|Overall Study|Withdrawal by Subject|2|||
147339000|NCT01780298|531409914|FG002|Overall Study|Physician Decision|1|||
147339001|NCT01780298|531409915|FG003|Overall Study|Physician Decision|1|||
147339002|NCT01780298|531409912|FG000|Overall Study|Subject not matched|1|||
147339003|NCT01780298|531409913|FG001|Overall Study|Subject not matched|0|||
147339004|NCT01780298|531409914|FG002|Overall Study|Subject not matched|1|||
147294330|NCT01137474|531242553|FG002|Overall Study|Withdrawal by Subject|6|||
147294331|NCT01137474|531242554|FG003|Overall Study|Withdrawal by Subject|9|||
147294332|NCT01137474|531242551|FG000|Overall Study|No longer met study criteria|6|||
147294333|NCT01137474|531242552|FG001|Overall Study|No longer met study criteria|1|||
147294334|NCT01137474|531242553|FG002|Overall Study|No longer met study criteria|0|||
147294335|NCT01137474|531242554|FG003|Overall Study|No longer met study criteria|5|||
147294336|NCT01137474|531242551|FG000|Overall Study|Lost to Follow-up|5|||
147294337|NCT01137474|531242552|FG001|Overall Study|Lost to Follow-up|1|||
147294338|NCT01137474|531242553|FG002|Overall Study|Lost to Follow-up|0|||
147294339|NCT01137474|531242554|FG003|Overall Study|Lost to Follow-up|2|||
147294340|NCT01137474|531242551|FG000|Overall Study|Lack of Efficacy|0|||
147294341|NCT01137474|531242552|FG001|Overall Study|Lack of Efficacy|0|||
147294342|NCT01137474|531242553|FG002|Overall Study|Lack of Efficacy|0|||
147294343|NCT01137474|531242554|FG003|Overall Study|Lack of Efficacy|2|||
147294344|NCT01137474|531242551|FG000|Overall Study|Other|3|||
147294345|NCT01137474|531242552|FG001|Overall Study|Other|1|||
147294346|NCT01137474|531242553|FG002|Overall Study|Other|0|||
147294347|NCT01137474|531242554|FG003|Overall Study|Other|0|||
147606137|NCT02245412|532375158|FG002|Treatment Period|Physician Decision|0|||
147294348|NCT01137474|531242551|FG000|Overall Study|Pregnancy|0|||
147294349|NCT01137474|531242552|FG001|Overall Study|Pregnancy|1|||
147294350|NCT01137474|531242553|FG002|Overall Study|Pregnancy|0|||
147294351|NCT01137474|531242554|FG003|Overall Study|Pregnancy|0|||
147294352|NCT01137474|531242551|FG000|Overall Study|Administrative reason by sponsor|0|||
147294353|NCT01137474|531242552|FG001|Overall Study|Administrative reason by sponsor|1|||
147294354|NCT01137474|531242553|FG002|Overall Study|Administrative reason by sponsor|0|||
147294355|NCT01137474|531242554|FG003|Overall Study|Administrative reason by sponsor|0|||
147294356|NCT05072080|531242557|FG000|Overall Study|Death|0|||
147294357|NCT05072080|531242558|FG001|Overall Study|Death|0|||
147294358|NCT05072080|531242559|FG002|Overall Study|Death|1|||
147294359|NCT05072080|531242560|FG003|Overall Study|Death|0|||
147294360|NCT05072080|531242557|FG000|Overall Study|Lost to Follow-up|65|||
147294361|NCT05072080|531242558|FG001|Overall Study|Lost to Follow-up|70|||
147294362|NCT05072080|531242559|FG002|Overall Study|Lost to Follow-up|58|||
147294363|NCT05072080|531242560|FG003|Overall Study|Lost to Follow-up|23|||
147294364|NCT05072080|531242557|FG000|Overall Study|Physician Decision|2|||
147294365|NCT05072080|531242558|FG001|Overall Study|Physician Decision|1|||
147294366|NCT05072080|531242559|FG002|Overall Study|Physician Decision|1|||
147294367|NCT05072080|531242560|FG003|Overall Study|Physician Decision|0|||
147294368|NCT05072080|531242557|FG000|Overall Study|Withdrawal by Subject|45|||
147294369|NCT05072080|531242558|FG001|Overall Study|Withdrawal by Subject|30|||
147294370|NCT05072080|531242559|FG002|Overall Study|Withdrawal by Subject|27|||
147294371|NCT05072080|531242560|FG003|Overall Study|Withdrawal by Subject|7|||
147294372|NCT05072080|531242557|FG000|Overall Study|Sponsor Decision|0|||
147294373|NCT05072080|531242558|FG001|Overall Study|Sponsor Decision|1|||
147294374|NCT05072080|531242559|FG002|Overall Study|Sponsor Decision|0|||
147294375|NCT05072080|531242560|FG003|Overall Study|Sponsor Decision|0|||
147294376|NCT05072080|531242557|FG000|Overall Study|Subject moved|1|||
147294377|NCT05072080|531242558|FG001|Overall Study|Subject moved|3|||
147294378|NCT05072080|531242559|FG002|Overall Study|Subject moved|5|||
147294379|NCT05072080|531242560|FG003|Overall Study|Subject moved|2|||
147294380|NCT05072080|531242557|FG000|Overall Study|Withdrawal by parent|0|||
147294381|NCT05072080|531242558|FG001|Overall Study|Withdrawal by parent|0|||
147294382|NCT05072080|531242559|FG002|Overall Study|Withdrawal by parent|1|||
147294383|NCT05072080|531242560|FG003|Overall Study|Withdrawal by parent|0|||
147294384|NCT05072080|531242557|FG000|Overall Study|Subject was deployed|0|||
147294385|NCT05072080|531242558|FG001|Overall Study|Subject was deployed|1|||
147294386|NCT05072080|531242559|FG002|Overall Study|Subject was deployed|0|||
147294387|NCT05072080|531242560|FG003|Overall Study|Subject was deployed|0|||
147294388|NCT05072080|531242557|FG000|Overall Study|Subject left site without receiving dose|0|||
147294389|NCT05072080|531242558|FG001|Overall Study|Subject left site without receiving dose|1|||
147294390|NCT05072080|531242559|FG002|Overall Study|Subject left site without receiving dose|0|||
147294391|NCT05072080|531242560|FG003|Overall Study|Subject left site without receiving dose|0|||
147294392|NCT05072080|531242557|FG000|Overall Study|Subject incarcerated|0|||
147294393|NCT05072080|531242558|FG001|Overall Study|Subject incarcerated|1|||
147294394|NCT05072080|531242559|FG002|Overall Study|Subject incarcerated|0|||
147339005|NCT01780298|531409915|FG003|Overall Study|Subject not matched|0|||
147294395|NCT05072080|531242560|FG003|Overall Study|Subject incarcerated|1|||
147294396|NCT05072080|531242557|FG000|Overall Study|Noncompliance (protocol, study, visits, e-diary, etc.)|0|||
147294397|NCT05072080|531242558|FG001|Overall Study|Noncompliance (protocol, study, visits, e-diary, etc.)|2|||
147294398|NCT05072080|531242559|FG002|Overall Study|Noncompliance (protocol, study, visits, e-diary, etc.)|1|||
147294399|NCT05072080|531242560|FG003|Overall Study|Noncompliance (protocol, study, visits, e-diary, etc.)|1|||
147294400|NCT05072080|531242557|FG000|Overall Study|Subject missed last visit (Day 183)|3|||
147294401|NCT05072080|531242558|FG001|Overall Study|Subject missed last visit (Day 183)|1|||
147294402|NCT05072080|531242559|FG002|Overall Study|Subject missed last visit (Day 183)|1|||
147294403|NCT05072080|531242560|FG003|Overall Study|Subject missed last visit (Day 183)|0|||
147294404|NCT04867369|531242561|FG000|Overall Study|Withdrawal by Subject|1|||
147606138|NCT02245412|532375156|FG000|Treatment Period|Withdrawal by Subject|2|||
147606139|NCT02245412|532375157|FG001|Treatment Period|Withdrawal by Subject|1|||
147606140|NCT02245412|532375158|FG002|Treatment Period|Withdrawal by Subject|0|||
147606141|NCT02245412|532375156|FG000|Treatment Period|Biopsy did not confirm GI GVHD|1|||
147606142|NCT02245412|532375157|FG001|Treatment Period|Biopsy did not confirm GI GVHD|0|||
147606143|NCT02245412|532375158|FG002|Treatment Period|Biopsy did not confirm GI GVHD|0|||
147294405|NCT04867369|531242562|FG001|Overall Study|Withdrawal by Subject|0|||
147294406|NCT05554237|531242563|FG000|Part 2 (7 Days)|Adverse Event|0|||
147294407|NCT05554237|531242564|FG001|Part 2 (7 Days)|Adverse Event|0|||
147294408|NCT05554237|531242565|FG002|Part 2 (7 Days)|Adverse Event|0|||
147294409|NCT05554237|531242566|FG003|Part 2 (7 Days)|Adverse Event|0|||
147294410|NCT05554237|531242567|FG004|Part 2 (7 Days)|Adverse Event|2|||
147294411|NCT05554237|531242568|FG005|Part 2 (7 Days)|Adverse Event|0|||
147294412|NCT05554237|531242569|FG006|Part 2 (7 Days)|Adverse Event|0|||
147294413|NCT05554237|531242570|FG007|Part 2 (7 Days)|Adverse Event|0|||
147294414|NCT05554237|531242571|FG008|Part 2 (7 Days)|Adverse Event|0|||
147294415|NCT05554237|531242572|FG009|Part 2 (7 Days)|Adverse Event|1|||
147294416|NCT05554237|531242573|FG010|Part 2 (7 Days)|Adverse Event|0|||
147294417|NCT05554237|531242574|FG011|Part 2 (7 Days)|Adverse Event|0|||
147294418|NCT05554237|531242575|FG012|Part 2 (7 Days)|Adverse Event|1|||
147294419|NCT05554237|531242576|FG013|Part 2 (7 Days)|Adverse Event|0|||
147294420|NCT04575467|531242580|FG000|Overall Study|Adverse Event|0|||
147294421|NCT04575467|531242581|FG001|Overall Study|Adverse Event|1|||
147294422|NCT04575467|531242582|FG002|Overall Study|Adverse Event|0|||
147294423|NCT04575467|531242583|FG003|Overall Study|Adverse Event|0|||
147294424|NCT01152580|531242586|FG000|Overall Study|Withdrawal by Subject|0|||
147294425|NCT01152580|531242587|FG001|Overall Study|Withdrawal by Subject|1|||
147294426|NCT02677116|531242593|FG000|Overall Study|Adverse Event|0|||
147294427|NCT02677116|531242594|FG001|Overall Study|Adverse Event|1|||
147294428|NCT02677116|531242595|FG002|Overall Study|Adverse Event|0|||
147294429|NCT02677116|531242596|FG003|Overall Study|Adverse Event|0|||
147294430|NCT02677116|531242597|FG004|Overall Study|Adverse Event|0|||
147294431|NCT02677116|531242598|FG005|Overall Study|Adverse Event|1|||
147294432|NCT02677116|531242599|FG006|Overall Study|Adverse Event|1|||
147294433|NCT02677116|531242600|FG007|Overall Study|Adverse Event|0|||
147294434|NCT02677116|531242601|FG008|Overall Study|Adverse Event|0|||
147294435|NCT02677116|531242593|FG000|Overall Study|Physician Decision|0|||
147294436|NCT02677116|531242594|FG001|Overall Study|Physician Decision|2|||
147294437|NCT02677116|531242595|FG002|Overall Study|Physician Decision|3|||
147294438|NCT02677116|531242596|FG003|Overall Study|Physician Decision|2|||
147294439|NCT02677116|531242597|FG004|Overall Study|Physician Decision|1|||
147294440|NCT02677116|531242598|FG005|Overall Study|Physician Decision|3|||
147294441|NCT02677116|531242599|FG006|Overall Study|Physician Decision|1|||
147294442|NCT02677116|531242600|FG007|Overall Study|Physician Decision|1|||
147294443|NCT02677116|531242601|FG008|Overall Study|Physician Decision|2|||
147294444|NCT02677116|531242593|FG000|Overall Study|Withdrawal by parent or guardian|2|||
147294445|NCT02677116|531242594|FG001|Overall Study|Withdrawal by parent or guardian|1|||
147294446|NCT02677116|531242595|FG002|Overall Study|Withdrawal by parent or guardian|0|||
147294447|NCT02677116|531242596|FG003|Overall Study|Withdrawal by parent or guardian|1|||
147294448|NCT02677116|531242597|FG004|Overall Study|Withdrawal by parent or guardian|0|||
147294449|NCT02677116|531242598|FG005|Overall Study|Withdrawal by parent or guardian|0|||
147294450|NCT02677116|531242599|FG006|Overall Study|Withdrawal by parent or guardian|2|||
147294451|NCT02677116|531242600|FG007|Overall Study|Withdrawal by parent or guardian|1|||
147606144|NCT02245412|532375156|FG000|Follow-Up Period|Death|4|||
147606145|NCT02245412|532375157|FG001|Follow-Up Period|Death|2|||
147606146|NCT02245412|532375158|FG002|Follow-Up Period|Death|1|||
147294452|NCT02677116|531242601|FG008|Overall Study|Withdrawal by parent or guardian|0|||
147294453|NCT02677116|531242593|FG000|Overall Study|Withdrawal by Subject|1|||
147294454|NCT02677116|531242594|FG001|Overall Study|Withdrawal by Subject|0|||
147294455|NCT02677116|531242595|FG002|Overall Study|Withdrawal by Subject|0|||
147294456|NCT02677116|531242596|FG003|Overall Study|Withdrawal by Subject|0|||
147294457|NCT02677116|531242597|FG004|Overall Study|Withdrawal by Subject|0|||
147294458|NCT02677116|531242598|FG005|Overall Study|Withdrawal by Subject|0|||
147294459|NCT02677116|531242599|FG006|Overall Study|Withdrawal by Subject|0|||
147606147|NCT02245412|532375156|FG000|Follow-Up Period|Physician Decision|1|||
147606148|NCT02245412|532375157|FG001|Follow-Up Period|Physician Decision|0|||
147294460|NCT02677116|531242600|FG007|Overall Study|Withdrawal by Subject|0|||
147294461|NCT02677116|531242601|FG008|Overall Study|Withdrawal by Subject|0|||
147294462|NCT03182868|531242602|FG000|Overall Study|Protocol Violation|3|||
147294463|NCT03182868|531242603|FG001|Overall Study|Protocol Violation|0|||
147294464|NCT03182868|531242604|FG002|Overall Study|Protocol Violation|4|||
147294465|NCT03182868|531242605|FG003|Overall Study|Protocol Violation|1|||
147294466|NCT03182868|531242606|FG004|Overall Study|Protocol Violation|8|||
147294467|NCT03342638|531242607|FG000|Overall Study|Withdrawal by Subject|1|||
147294468|NCT03342638|531242608|FG001|Overall Study|Withdrawal by Subject|0|||
147294469|NCT03342638|531242607|FG000|Overall Study|Physician Decision|0|||
147294470|NCT03342638|531242608|FG001|Overall Study|Physician Decision|1|||
147294471|NCT02275065|531242614|FG000|Overall Study|Randomized but not treated|1|||
147294472|NCT02275065|531242615|FG001|Overall Study|Randomized but not treated|0|||
147294473|NCT02275065|531242616|FG002|Overall Study|Randomized but not treated|1|||
147294474|NCT02275065|531242617|FG003|Overall Study|Randomized but not treated|1|||
147294475|NCT02275065|531242618|FG004|Overall Study|Randomized but not treated|0|||
147294476|NCT03213158|531242621|FG000|Overall Study|Withdrawal by Subject|1|||
147294477|NCT03213158|531242621|FG000|Overall Study|Physician Decision|2|||
147294478|NCT01569438|531242628|FG000|Overall Study|Lack of Efficacy|1|||
147294479|NCT01569438|531242629|FG001|Overall Study|Lack of Efficacy|2|||
147294480|NCT01569438|531242628|FG000|Overall Study|Withdrawal by Subject|0|||
147294481|NCT01569438|531242629|FG001|Overall Study|Withdrawal by Subject|3|||
147294482|NCT01569438|531242628|FG000|Overall Study|Adverse Event|2|||
147294483|NCT01569438|531242629|FG001|Overall Study|Adverse Event|15|||
147294484|NCT01569438|531242628|FG000|Overall Study|Protocol Violation|2|||
147294485|NCT01569438|531242629|FG001|Overall Study|Protocol Violation|0|||
147294486|NCT01569438|531242628|FG000|Overall Study|Decrease of GFR greater than 30 ml/min|1|||
147294487|NCT01569438|531242629|FG001|Overall Study|Decrease of GFR greater than 30 ml/min|0|||
147294488|NCT01569438|531242628|FG000|Overall Study|Sponsor/Physician decision|1|||
147294489|NCT01569438|531242629|FG001|Overall Study|Sponsor/Physician decision|1|||
147294490|NCT01569438|531242628|FG000|Overall Study|Unable to adhere to study schedule|0|||
147294491|NCT01569438|531242629|FG001|Overall Study|Unable to adhere to study schedule|1|||
147294492|NCT01207102|531242630|FG000|Overall Study|Withdrawal by Subject|5|||
147294493|NCT01207102|531242630|FG000|Overall Study|Adverse Event|2|||
147294494|NCT01207102|531242630|FG000|Overall Study|progression|2|||
147294495|NCT01207102|531242630|FG000|Overall Study|Withdrawal by Treating Physician|1|||
147294496|NCT03649230|531242631|FG000|Overall Study|Adverse Event|12|||
147294497|NCT03649230|531242631|FG000|Overall Study|Death|8|||
147294498|NCT03649230|531242631|FG000|Overall Study|Withdrawal by Subject|6|||
147294499|NCT03649230|531242631|FG000|Overall Study|Physician Decision|5|||
147294500|NCT03649230|531242631|FG000|Overall Study|Disease progression|5|||
147294501|NCT03649230|531242631|FG000|Overall Study|Switched to non-HEC|5|||
147294502|NCT03649230|531242631|FG000|Overall Study|Chemotherapy discontinued|4|||
147294503|NCT03649230|531242631|FG000|Overall Study|Received only 3 HEC cycles|4|||
147294504|NCT03649230|531242631|FG000|Overall Study|Screen Failure|3|||
147294505|NCT03649230|531242631|FG000|Overall Study|Patient stopped treatment|2|||
147294506|NCT03649230|531242631|FG000|Overall Study|Protocol Violation|1|||
147294507|NCT03649230|531242631|FG000|Overall Study|Non-compliance|1|||
147294508|NCT03649230|531242631|FG000|Overall Study|Patient Received Cisplatin days 1-3 q 3 weeks|1|||
147294509|NCT01693068|531242632|FG000|Randomization Period|On-study|2|||
147294510|NCT01693068|531242633|FG001|Randomization Period|On-study|5|||
147294511|NCT01693068|531242634|FG002|Randomization Period|On-study|0|||
147294512|NCT01693068|531242632|FG000|Cross-over (Dacarbazine To Pimasertib)|On-study|0|||
147294513|NCT01693068|531242633|FG001|Cross-over (Dacarbazine To Pimasertib)|On-study|0|||
147294514|NCT01693068|531242634|FG002|Cross-over (Dacarbazine To Pimasertib)|On-study|1|||
147294515|NCT00295022|531242640|FG000|Overall Study|Adverse Event|1|||
147294516|NCT00295022|531242641|FG001|Overall Study|Adverse Event|1|||
147294517|NCT00295022|531242642|FG002|Overall Study|Adverse Event|2|||
147294518|NCT00295022|531242640|FG000|Overall Study|Lost to Follow-up|0|||
147294519|NCT00295022|531242641|FG001|Overall Study|Lost to Follow-up|0|||
147294520|NCT00295022|531242642|FG002|Overall Study|Lost to Follow-up|1|||
147294521|NCT00295022|531242640|FG000|Overall Study|Withdrawal by Subject|0|||
147294522|NCT00295022|531242641|FG001|Overall Study|Withdrawal by Subject|0|||
147294523|NCT00295022|531242642|FG002|Overall Study|Withdrawal by Subject|2|||
147294524|NCT00734630|531242644|FG000|Overall Study|Lack of Efficacy|4|||
147294525|NCT00734630|531242645|FG001|Overall Study|Lack of Efficacy|4|||
147294526|NCT00734630|531242644|FG000|Overall Study|Withdrawal by Subject|7|||
147294527|NCT00734630|531242645|FG001|Overall Study|Withdrawal by Subject|9|||
147294528|NCT00734630|531242644|FG000|Overall Study|Lost to Follow-up|13|||
147294529|NCT00734630|531242645|FG001|Overall Study|Lost to Follow-up|7|||
147294530|NCT00734630|531242644|FG000|Overall Study|Protocol Violation|0|||
147294531|NCT00734630|531242645|FG001|Overall Study|Protocol Violation|3|||
147339006|NCT01780298|531409912|FG000|Overall Study|Adverse Event|0|||
147339007|NCT01780298|531409913|FG001|Overall Study|Adverse Event|0|||
147294532|NCT00734630|531242644|FG000|Overall Study|Inclusion/Exclusion criteria not met|0|||
147294533|NCT00734630|531242645|FG001|Overall Study|Inclusion/Exclusion criteria not met|1|||
147294534|NCT00734630|531242644|FG000|Overall Study|Adverse Event|3|||
147294535|NCT00734630|531242645|FG001|Overall Study|Adverse Event|6|||
147294536|NCT00734630|531242644|FG000|Overall Study|Randomized in Error|0|||
147294537|NCT00734630|531242645|FG001|Overall Study|Randomized in Error|1|||
147339008|NCT01780298|531409914|FG002|Overall Study|Adverse Event|2|||
147339009|NCT01780298|531409915|FG003|Overall Study|Adverse Event|0|||
147294538|NCT00734630|531242644|FG000|Overall Study|Tested Positive for Illegal Drug Use|1|||
147294539|NCT00734630|531242645|FG001|Overall Study|Tested Positive for Illegal Drug Use|1|||
147294540|NCT00734630|531242644|FG000|Overall Study|Poor Compliance|1|||
147294541|NCT00734630|531242645|FG001|Overall Study|Poor Compliance|1|||
147294542|NCT01239030|531242646|FG000|Double Blind|Adverse Event|0|||
147294543|NCT01239030|531242647|FG001|Double Blind|Adverse Event|1|||
147294544|NCT01239030|531242648|FG002|Double Blind|Adverse Event|0|||
147294545|NCT01239030|531242649|FG003|Double Blind|Adverse Event|2|||
147294546|NCT01239030|531242650|FG004|Double Blind|Adverse Event|0|||
147294547|NCT01239030|531242646|FG000|Double Blind|Withdrawal by Subject|0|||
147294548|NCT01239030|531242647|FG001|Double Blind|Withdrawal by Subject|1|||
147294549|NCT01239030|531242648|FG002|Double Blind|Withdrawal by Subject|1|||
147294550|NCT01239030|531242649|FG003|Double Blind|Withdrawal by Subject|0|||
147294551|NCT01239030|531242650|FG004|Double Blind|Withdrawal by Subject|1|||
147294552|NCT01239030|531242646|FG000|Double Blind|Lost to Follow-up|1|||
147294553|NCT01239030|531242647|FG001|Double Blind|Lost to Follow-up|1|||
147294554|NCT01239030|531242648|FG002|Double Blind|Lost to Follow-up|0|||
147294555|NCT01239030|531242649|FG003|Double Blind|Lost to Follow-up|0|||
147294556|NCT01239030|531242650|FG004|Double Blind|Lost to Follow-up|0|||
147294557|NCT01239030|531242646|FG000|Double Blind|Physician Decision|0|||
147294558|NCT01239030|531242647|FG001|Double Blind|Physician Decision|1|||
147294559|NCT01239030|531242648|FG002|Double Blind|Physician Decision|0|||
147294560|NCT01239030|531242649|FG003|Double Blind|Physician Decision|0|||
147294561|NCT01239030|531242650|FG004|Double Blind|Physician Decision|0|||
147294562|NCT01239030|531242646|FG000|Dose Optimization (Open Label)|Adverse Event|2|||
147294563|NCT01239030|531242647|FG001|Dose Optimization (Open Label)|Adverse Event|0|||
147294564|NCT01239030|531242648|FG002|Dose Optimization (Open Label)|Adverse Event|2|||
147294565|NCT01239030|531242649|FG003|Dose Optimization (Open Label)|Adverse Event|0|||
147294566|NCT01239030|531242650|FG004|Dose Optimization (Open Label)|Adverse Event|5|||
147294567|NCT01239030|531242646|FG000|Dose Optimization (Open Label)|Withdrawal by Subject|4|||
147294568|NCT01239030|531242647|FG001|Dose Optimization (Open Label)|Withdrawal by Subject|1|||
147294569|NCT01239030|531242648|FG002|Dose Optimization (Open Label)|Withdrawal by Subject|0|||
147294570|NCT01239030|531242649|FG003|Dose Optimization (Open Label)|Withdrawal by Subject|2|||
147294571|NCT01239030|531242650|FG004|Dose Optimization (Open Label)|Withdrawal by Subject|1|||
147294572|NCT01239030|531242646|FG000|Dose Optimization (Open Label)|Lost to Follow-up|1|||
147294573|NCT01239030|531242647|FG001|Dose Optimization (Open Label)|Lost to Follow-up|1|||
147294574|NCT01239030|531242648|FG002|Dose Optimization (Open Label)|Lost to Follow-up|0|||
147294575|NCT01239030|531242649|FG003|Dose Optimization (Open Label)|Lost to Follow-up|0|||
147294576|NCT01239030|531242650|FG004|Dose Optimization (Open Label)|Lost to Follow-up|1|||
147294577|NCT01239030|531242646|FG000|Dose Optimization (Open Label)|Physician Decision|0|||
147294578|NCT01239030|531242647|FG001|Dose Optimization (Open Label)|Physician Decision|0|||
147294579|NCT01239030|531242648|FG002|Dose Optimization (Open Label)|Physician Decision|0|||
147294580|NCT01239030|531242649|FG003|Dose Optimization (Open Label)|Physician Decision|1|||
147294581|NCT01239030|531242650|FG004|Dose Optimization (Open Label)|Physician Decision|0|||
147294582|NCT00977665|531242651|FG000|Overall Study|Withdrawal by Subject|1|||
147294583|NCT00977665|531242652|FG001|Overall Study|Withdrawal by Subject|3|||
147294584|NCT00977665|531242651|FG000|Overall Study|Physician Decision|2|||
147294585|NCT00977665|531242652|FG001|Overall Study|Physician Decision|1|||
147294586|NCT00977665|531242651|FG000|Overall Study|Sponsor requested withdrawal|0|||
147294587|NCT00977665|531242652|FG001|Overall Study|Sponsor requested withdrawal|1|||
147294588|NCT00977665|531242651|FG000|Overall Study|Lost to Follow-up|1|||
147294589|NCT00977665|531242652|FG001|Overall Study|Lost to Follow-up|0|||
147294590|NCT00977665|531242651|FG000|Overall Study|Death|3|||
147294591|NCT00977665|531242652|FG001|Overall Study|Death|2|||
147294592|NCT00977665|531242651|FG000|Overall Study|Adverse Event|14|||
147294593|NCT00977665|531242652|FG001|Overall Study|Adverse Event|7|||
147294594|NCT00977665|531242651|FG000|Overall Study|Treatment failure|0|||
147294595|NCT00977665|531242652|FG001|Overall Study|Treatment failure|1|||
147294596|NCT01330433|531242653|FG000|Overall Study|Death|1|||
147294597|NCT01330433|531242654|FG001|Overall Study|Death|3|||
147606149|NCT02245412|532375158|FG002|Follow-Up Period|Physician Decision|0|||
147606150|NCT02245412|532375156|FG000|Follow-Up Period|Other - Terminated by Sponsor|0|||
147606151|NCT02245412|532375157|FG001|Follow-Up Period|Other - Terminated by Sponsor|0|||
147606152|NCT02245412|532375158|FG002|Follow-Up Period|Other - Terminated by Sponsor|1|||
147606153|NCT01056289|532375159|FG000|Open-label Phase|Adverse Event|29|||
147294598|NCT01330433|531242653|FG000|Overall Study|Lost to Follow-up|1|||
147294599|NCT01330433|531242654|FG001|Overall Study|Lost to Follow-up|0|||
147294600|NCT03240692|531242665|FG000|Overall Study|Physician Decision|1|||
147294601|NCT03240692|531242665|FG000|Overall Study|Withdrawal by Subject|1|||
147294602|NCT02300220|531242666|FG000|Overall Study|Lost to Follow-up|1|||
147294603|NCT02300220|531242667|FG001|Overall Study|Lost to Follow-up|2|||
147294604|NCT02300220|531242666|FG000|Overall Study|Death|1|||
147294605|NCT02300220|531242667|FG001|Overall Study|Death|1|||
147339010|NCT03873779|531409916|FG000|Overall Study|Withdrawal by Subject|1|||
147339011|NCT04252586|531409918|FG000|Overall Study|Withdrawal by parent/guardian|3|||
147294606|NCT02300220|531242666|FG000|Overall Study|Adverse Event|1|||
147294607|NCT02300220|531242667|FG001|Overall Study|Adverse Event|1|||
147294608|NCT02300220|531242666|FG000|Overall Study|Protocol Violation|1|||
147294609|NCT02300220|531242667|FG001|Overall Study|Protocol Violation|0|||
147294610|NCT02300220|531242666|FG000|Overall Study|Withdrawal by Subject|0|||
147294611|NCT02300220|531242667|FG001|Overall Study|Withdrawal by Subject|2|||
147294612|NCT02300220|531242666|FG000|Overall Study|Did not tolerate IMP|0|||
147294613|NCT02300220|531242667|FG001|Overall Study|Did not tolerate IMP|1|||
147294614|NCT02291614|531242668|FG000|Overall Study|Lost to Follow-up|0|||
147294615|NCT02291614|531242669|FG001|Overall Study|Lost to Follow-up|0|||
147294616|NCT02291614|531242670|FG002|Overall Study|Lost to Follow-up|0|||
147294617|NCT02291614|531242671|FG003|Overall Study|Lost to Follow-up|0|||
147294618|NCT02291614|531242672|FG004|Overall Study|Lost to Follow-up|0|||
147294619|NCT02291614|531242673|FG005|Overall Study|Lost to Follow-up|0|||
147294620|NCT02291614|531242674|FG006|Overall Study|Lost to Follow-up|0|||
147294621|NCT02291614|531242675|FG007|Overall Study|Lost to Follow-up|1|||
147294622|NCT02291614|531242676|FG008|Overall Study|Lost to Follow-up|0|||
147294623|NCT02291614|531242677|FG009|Overall Study|Lost to Follow-up|0|||
147294624|NCT02291614|531242678|FG010|Overall Study|Lost to Follow-up|0|||
147294625|NCT02291614|531242668|FG000|Overall Study|Withdrawal by Subject|0|||
147294626|NCT02291614|531242669|FG001|Overall Study|Withdrawal by Subject|1|||
147294627|NCT02291614|531242670|FG002|Overall Study|Withdrawal by Subject|0|||
147294628|NCT02291614|531242671|FG003|Overall Study|Withdrawal by Subject|0|||
147294629|NCT02291614|531242672|FG004|Overall Study|Withdrawal by Subject|0|||
147294630|NCT02291614|531242673|FG005|Overall Study|Withdrawal by Subject|0|||
147294631|NCT02291614|531242674|FG006|Overall Study|Withdrawal by Subject|0|||
147294632|NCT02291614|531242675|FG007|Overall Study|Withdrawal by Subject|0|||
147294633|NCT02291614|531242676|FG008|Overall Study|Withdrawal by Subject|0|||
147294634|NCT02291614|531242677|FG009|Overall Study|Withdrawal by Subject|2|||
147294635|NCT02291614|531242678|FG010|Overall Study|Withdrawal by Subject|2|||
147294636|NCT02291614|531242668|FG000|Overall Study|Decision by sponsor|0|||
147294637|NCT02291614|531242669|FG001|Overall Study|Decision by sponsor|0|||
147294638|NCT02291614|531242670|FG002|Overall Study|Decision by sponsor|0|||
147294639|NCT02291614|531242671|FG003|Overall Study|Decision by sponsor|1|||
147294640|NCT02291614|531242672|FG004|Overall Study|Decision by sponsor|0|||
147294641|NCT02291614|531242673|FG005|Overall Study|Decision by sponsor|0|||
147294642|NCT02291614|531242674|FG006|Overall Study|Decision by sponsor|0|||
147294643|NCT02291614|531242675|FG007|Overall Study|Decision by sponsor|0|||
147294644|NCT02291614|531242676|FG008|Overall Study|Decision by sponsor|0|||
147294645|NCT02291614|531242677|FG009|Overall Study|Decision by sponsor|0|||
147294646|NCT02291614|531242678|FG010|Overall Study|Decision by sponsor|0|||
147294647|NCT02291614|531242668|FG000|Overall Study|Death|0|||
147294648|NCT02291614|531242669|FG001|Overall Study|Death|0|||
147294649|NCT02291614|531242670|FG002|Overall Study|Death|1|||
147294650|NCT02291614|531242671|FG003|Overall Study|Death|0|||
147294651|NCT02291614|531242672|FG004|Overall Study|Death|1|||
147294652|NCT02291614|531242673|FG005|Overall Study|Death|1|||
147294653|NCT02291614|531242674|FG006|Overall Study|Death|1|||
147294654|NCT02291614|531242675|FG007|Overall Study|Death|0|||
147294655|NCT02291614|531242676|FG008|Overall Study|Death|0|||
147294656|NCT02291614|531242677|FG009|Overall Study|Death|0|||
147294657|NCT02291614|531242678|FG010|Overall Study|Death|0|||
147294658|NCT02432105|531242682|FG000|Overall Study|Lost to Follow-up|1|||
147294659|NCT02432105|531242683|FG001|Overall Study|Lost to Follow-up|1|||
147294660|NCT02432105|531242684|FG002|Overall Study|Lost to Follow-up|0|||
147294661|NCT02432105|531242682|FG000|Overall Study|Withdrawal by Subject|1|||
147294662|NCT02432105|531242683|FG001|Overall Study|Withdrawal by Subject|0|||
147294663|NCT02432105|531242684|FG002|Overall Study|Withdrawal by Subject|1|||
147294664|NCT02432105|531242682|FG000|Overall Study|Culture positive for yeast|0|||
147294665|NCT02432105|531242683|FG001|Overall Study|Culture positive for yeast|1|||
147294666|NCT02432105|531242684|FG002|Overall Study|Culture positive for yeast|0|||
147294667|NCT02432105|531242682|FG000|Overall Study|Randomized in error|0|||
147294668|NCT02432105|531242683|FG001|Overall Study|Randomized in error|0|||
147294669|NCT02432105|531242684|FG002|Overall Study|Randomized in error|2|||
147294670|NCT02012491|531242689|FG000|Overall Study|Lost to Follow-up|1|||
147294671|NCT02012491|531242690|FG001|Overall Study|Lost to Follow-up|0|||
147294672|NCT02012491|531242689|FG000|Overall Study|Protocol Violation|0|||
147294673|NCT02012491|531242690|FG001|Overall Study|Protocol Violation|1|||
147294674|NCT02012491|531242689|FG000|Overall Study|Withdrawal by Subject|1|||
147294675|NCT02012491|531242690|FG001|Overall Study|Withdrawal by Subject|0|||
147294676|NCT03969719|531242701|FG000|Overall Study|Other reasons not specified|1|||
147294677|NCT03969719|531242702|FG001|Overall Study|Other reasons not specified|1|||
147294678|NCT03969719|531242703|FG002|Overall Study|Other reasons not specified|3|||
147294679|NCT03969719|531242701|FG000|Overall Study|Withdrawal by Subject|2|||
147606154|NCT01056289|532375160|FG001|Open-label Phase|Adverse Event|0|||
147606155|NCT01056289|532375161|FG002|Open-label Phase|Adverse Event|0|||
147294680|NCT03969719|531242702|FG001|Overall Study|Withdrawal by Subject|3|||
147294681|NCT03969719|531242703|FG002|Overall Study|Withdrawal by Subject|2|||
147294682|NCT03969719|531242701|FG000|Overall Study|Protocol Violation|1|||
147294683|NCT03969719|531242702|FG001|Overall Study|Protocol Violation|2|||
147294684|NCT03969719|531242703|FG002|Overall Study|Protocol Violation|0|||
147294685|NCT03969719|531242701|FG000|Overall Study|Adverse Event|0|||
147294686|NCT03969719|531242702|FG001|Overall Study|Adverse Event|2|||
147294687|NCT03969719|531242703|FG002|Overall Study|Adverse Event|0|||
147294688|NCT03969719|531242701|FG000|Overall Study|Lost to Follow-up|0|||
147294689|NCT03969719|531242702|FG001|Overall Study|Lost to Follow-up|1|||
147294690|NCT03969719|531242703|FG002|Overall Study|Lost to Follow-up|0|||
147294691|NCT05608629|531242704|FG000|Overall Study|Lost to Follow-up|2|||
147294692|NCT02130193|531242705|FG000|Part B: 52-week Double-blind Period|Adverse Event|0|||
147294693|NCT02130193|531242706|FG001|Part B: 52-week Double-blind Period|Adverse Event|5|||
147294694|NCT02130193|531242707|FG002|Part B: 52-week Double-blind Period|Adverse Event|3|||
147294695|NCT02130193|531242705|FG000|Part B: 52-week Double-blind Period|Protocol Violation|0|||
147294696|NCT02130193|531242706|FG001|Part B: 52-week Double-blind Period|Protocol Violation|2|||
147294697|NCT02130193|531242707|FG002|Part B: 52-week Double-blind Period|Protocol Violation|1|||
147294698|NCT02130193|531242705|FG000|Part B: 52-week Double-blind Period|Physician Decision|0|||
147294699|NCT02130193|531242706|FG001|Part B: 52-week Double-blind Period|Physician Decision|0|||
147294700|NCT02130193|531242707|FG002|Part B: 52-week Double-blind Period|Physician Decision|1|||
147294701|NCT02130193|531242705|FG000|Part B: 52-week Double-blind Period|Withdrawal by Subject|0|||
147294702|NCT02130193|531242706|FG001|Part B: 52-week Double-blind Period|Withdrawal by Subject|3|||
147294703|NCT02130193|531242707|FG002|Part B: 52-week Double-blind Period|Withdrawal by Subject|3|||
147294704|NCT01212770|531242708|FG000|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|10|||
147294705|NCT01212770|531242709|FG001|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|12|||
147294706|NCT01212770|531242710|FG002|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|8|||
147294707|NCT01212770|531242711|FG003|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
147294708|NCT01212770|531242712|FG004|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
147294709|NCT01212770|531242713|FG005|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
147294710|NCT01212770|531242714|FG006|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
147294711|NCT01212770|531242715|FG007|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
147294712|NCT01212770|531242716|FG008|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
147294713|NCT01212770|531242708|FG000|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|6|||
147294714|NCT01212770|531242709|FG001|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|5|||
147294715|NCT01212770|531242710|FG002|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|7|||
147294716|NCT01212770|531242711|FG003|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
147294717|NCT01212770|531242712|FG004|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
147294718|NCT01212770|531242713|FG005|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
147294719|NCT01212770|531242714|FG006|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
147294720|NCT01212770|531242715|FG007|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
147294721|NCT01212770|531242716|FG008|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
147294722|NCT01212770|531242708|FG000|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|3|||
147294723|NCT01212770|531242709|FG001|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|4|||
147294724|NCT01212770|531242710|FG002|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|1|||
147294725|NCT01212770|531242711|FG003|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
147294726|NCT01212770|531242712|FG004|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
147294727|NCT01212770|531242713|FG005|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
147294728|NCT01212770|531242714|FG006|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
147294729|NCT01212770|531242715|FG007|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
147294730|NCT01212770|531242716|FG008|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
147294731|NCT01212770|531242708|FG000|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1|||
147294732|NCT01212770|531242709|FG001|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
147294733|NCT01212770|531242710|FG002|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|3|||
147294734|NCT01212770|531242711|FG003|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
147339012|NCT04252586|531409918|FG000|Overall Study|Adverse Event|1|||
147339013|NCT04252586|531409918|FG000|Overall Study|Death|2|||
147339014|NCT04252586|531409918|FG000|Overall Study|Study terminated by sponsor|4|||
147339015|NCT04252586|531409918|FG000|Overall Study|Sponsor request|10|||
147339016|NCT04252586|531409918|FG000|Overall Study|Did not complete treatment period|1|||
147339017|NCT03740009|531409920|FG000|Overall Study|Physician Decision|9|||
147339018|NCT03740009|531409920|FG000|Overall Study|Lost to Follow-up|1|||
147339019|NCT01236001|531409921|FG000|Overall Study|Adverse Event|5|||
147339020|NCT01236001|531409922|FG001|Overall Study|Adverse Event|14|||
147339021|NCT01236001|531409921|FG000|Overall Study|Lack of Efficacy|6|||
147339022|NCT01236001|531409922|FG001|Overall Study|Lack of Efficacy|6|||
147339023|NCT01236001|531409921|FG000|Overall Study|Lost to Follow-up|6|||
147452905|NCT01294800|531821479|FG001|Overall Study|Lost to Follow-up|0|||
147452906|NCT01294800|531821480|FG002|Overall Study|Lost to Follow-up|1|||
147452907|NCT01294800|531821481|FG003|Overall Study|Lost to Follow-up|0|||
147452908|NCT01294800|531821478|FG000|Overall Study|Non-compliance With Protocol|0|||
147452909|NCT01294800|531821479|FG001|Overall Study|Non-compliance With Protocol|1|||
147606156|NCT01056289|532375162|FG003|Open-label Phase|Adverse Event|0|||
147339024|NCT01236001|531409922|FG001|Overall Study|Lost to Follow-up|1|||
147339025|NCT01236001|531409921|FG000|Overall Study|Incompliance|1|||
147339026|NCT01236001|531409922|FG001|Overall Study|Incompliance|0|||
147452910|NCT01294800|531821480|FG002|Overall Study|Non-compliance With Protocol|1|||
147606157|NCT01056289|532375159|FG000|Open-label Phase|Lost to Follow-up|30|||
147606158|NCT01056289|532375160|FG001|Open-label Phase|Lost to Follow-up|0|||
147606159|NCT01056289|532375161|FG002|Open-label Phase|Lost to Follow-up|0|||
147452911|NCT01294800|531821481|FG003|Overall Study|Non-compliance With Protocol|0|||
147452912|NCT01294800|531821478|FG000|Overall Study|Did Not Meet Protocol Eligibility|2|||
147294735|NCT01212770|531242712|FG004|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
147294736|NCT01212770|531242713|FG005|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
147294737|NCT01212770|531242714|FG006|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
147294738|NCT01212770|531242715|FG007|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
147294739|NCT01212770|531242716|FG008|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
147294740|NCT01212770|531242708|FG000|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
147294741|NCT01212770|531242709|FG001|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
147294742|NCT01212770|531242710|FG002|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1|||
147294743|NCT01212770|531242711|FG003|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
147294744|NCT01212770|531242712|FG004|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
147294745|NCT01212770|531242713|FG005|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
147294746|NCT01212770|531242714|FG006|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
147294747|NCT01212770|531242715|FG007|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
147294748|NCT01212770|531242716|FG008|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
147294749|NCT01212770|531242708|FG000|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|3|||
147294750|NCT01212770|531242709|FG001|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|1|||
147294751|NCT01212770|531242710|FG002|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|2|||
147294752|NCT01212770|531242711|FG003|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
147294753|NCT01212770|531242712|FG004|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
147294754|NCT01212770|531242713|FG005|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
147294755|NCT01212770|531242714|FG006|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
147294756|NCT01212770|531242715|FG007|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
147294757|NCT01212770|531242716|FG008|Placebo-controlled Phase (Week 0 - 24)|Miscellaneous|0|||
147294758|NCT01212770|531242708|FG000|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0|||
147294759|NCT01212770|531242709|FG001|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|6|||
147294760|NCT01212770|531242710|FG002|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|2|||
147294761|NCT01212770|531242711|FG003|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|2|||
147294762|NCT01212770|531242712|FG004|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0|||
147294763|NCT01212770|531242713|FG005|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0|||
147294764|NCT01212770|531242714|FG006|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|1|||
147294765|NCT01212770|531242715|FG007|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0|||
147294766|NCT01212770|531242716|FG008|Active Treatment Phase (Weeks 25 - 52)|Adverse Event|0|||
147294767|NCT01212770|531242708|FG000|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0|||
147294768|NCT01212770|531242709|FG001|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|7|||
147294769|NCT01212770|531242710|FG002|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|5|||
147294770|NCT01212770|531242711|FG003|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|4|||
147294771|NCT01212770|531242712|FG004|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|1|||
147294772|NCT01212770|531242713|FG005|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|2|||
147294773|NCT01212770|531242714|FG006|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0|||
147294774|NCT01212770|531242715|FG007|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0|||
147294775|NCT01212770|531242716|FG008|Active Treatment Phase (Weeks 25 - 52)|Lack of Efficacy|0|||
147294776|NCT01212770|531242708|FG000|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|0|||
147294777|NCT01212770|531242709|FG001|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|6|||
147452913|NCT01294800|531821479|FG001|Overall Study|Did Not Meet Protocol Eligibility|1|||
147452914|NCT01294800|531821480|FG002|Overall Study|Did Not Meet Protocol Eligibility|1|||
147452915|NCT01294800|531821481|FG003|Overall Study|Did Not Meet Protocol Eligibility|0|||
147606160|NCT01056289|532375162|FG003|Open-label Phase|Lost to Follow-up|0|||
147606161|NCT01056289|532375159|FG000|Open-label Phase|Other|9|||
147606162|NCT01056289|532375160|FG001|Open-label Phase|Other|0|||
147606163|NCT01056289|532375161|FG002|Open-label Phase|Other|0|||
147606164|NCT01056289|532375162|FG003|Open-label Phase|Other|0|||
147606165|NCT01056289|532375159|FG000|Open-label Phase|Protocol Violation|6|||
147606166|NCT01056289|532375160|FG001|Open-label Phase|Protocol Violation|0|||
147606167|NCT01056289|532375161|FG002|Open-label Phase|Protocol Violation|0|||
147606168|NCT01056289|532375162|FG003|Open-label Phase|Protocol Violation|0|||
147606169|NCT01056289|532375159|FG000|Open-label Phase|Withdrawal by Subject|26|||
147606170|NCT01056289|532375160|FG001|Open-label Phase|Withdrawal by Subject|0|||
147606171|NCT01056289|532375161|FG002|Open-label Phase|Withdrawal by Subject|0|||
147606172|NCT01056289|532375162|FG003|Open-label Phase|Withdrawal by Subject|0|||
147606173|NCT01056289|532375159|FG000|Open-label Phase|Lack of Efficacy|18|||
147606174|NCT01056289|532375160|FG001|Open-label Phase|Lack of Efficacy|0|||
147294778|NCT01212770|531242710|FG002|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|3|||
147452916|NCT00493038|531821483|FG000|Treatment|Adverse Event|8|||
147452917|NCT00493038|531821484|FG001|Treatment|Adverse Event|4|||
147452918|NCT00493038|531821483|FG000|Treatment|Lost to Follow-up|5|||
147606175|NCT01056289|532375161|FG002|Open-label Phase|Lack of Efficacy|0|||
147606176|NCT01056289|532375162|FG003|Open-label Phase|Lack of Efficacy|0|||
147294779|NCT01212770|531242711|FG003|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|3|||
147294780|NCT01212770|531242712|FG004|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|1|||
147294781|NCT01212770|531242713|FG005|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|1|||
147294782|NCT01212770|531242714|FG006|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|1|||
147294783|NCT01212770|531242715|FG007|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|0|||
147294784|NCT01212770|531242716|FG008|Active Treatment Phase (Weeks 25 - 52)|Withdrawal by Subject|0|||
147294785|NCT01212770|531242708|FG000|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
147294786|NCT01212770|531242709|FG001|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
147294787|NCT01212770|531242710|FG002|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|1|||
147294788|NCT01212770|531242711|FG003|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
147294789|NCT01212770|531242712|FG004|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
147294790|NCT01212770|531242713|FG005|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
147294791|NCT01212770|531242714|FG006|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
147294792|NCT01212770|531242715|FG007|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
147294793|NCT01212770|531242716|FG008|Active Treatment Phase (Weeks 25 - 52)|Lost to Follow-up|0|||
147294794|NCT01212770|531242708|FG000|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
147294795|NCT01212770|531242709|FG001|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
147294796|NCT01212770|531242710|FG002|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
147294797|NCT01212770|531242711|FG003|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|1|||
147294798|NCT01212770|531242712|FG004|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
147294799|NCT01212770|531242713|FG005|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
147294800|NCT01212770|531242714|FG006|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
147294801|NCT01212770|531242715|FG007|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
147294802|NCT01212770|531242716|FG008|Active Treatment Phase (Weeks 25 - 52)|Protocol Violation|0|||
147294803|NCT01212770|531242708|FG000|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
147294804|NCT01212770|531242709|FG001|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
147294805|NCT01212770|531242710|FG002|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|1|||
147294806|NCT01212770|531242711|FG003|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|1|||
147294807|NCT01212770|531242712|FG004|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
147294808|NCT01212770|531242713|FG005|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
147294809|NCT01212770|531242714|FG006|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
147294810|NCT01212770|531242715|FG007|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
147294811|NCT01212770|531242716|FG008|Active Treatment Phase (Weeks 25 - 52)|Miscellaneous|0|||
147294812|NCT01212770|531242708|FG000|Long-term Safety Phase (Year 2)|Adverse Event|0|||
147294813|NCT01212770|531242709|FG001|Long-term Safety Phase (Year 2)|Adverse Event|3|||
147294814|NCT01212770|531242710|FG002|Long-term Safety Phase (Year 2)|Adverse Event|3|||
147294815|NCT01212770|531242711|FG003|Long-term Safety Phase (Year 2)|Adverse Event|0|||
147294816|NCT01212770|531242712|FG004|Long-term Safety Phase (Year 2)|Adverse Event|0|||
147294817|NCT01212770|531242713|FG005|Long-term Safety Phase (Year 2)|Adverse Event|0|||
147294818|NCT01212770|531242714|FG006|Long-term Safety Phase (Year 2)|Adverse Event|0|||
147294819|NCT01212770|531242715|FG007|Long-term Safety Phase (Year 2)|Adverse Event|0|||
147294820|NCT01212770|531242716|FG008|Long-term Safety Phase (Year 2)|Adverse Event|2|||
147294821|NCT01212770|531242708|FG000|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
147606177|NCT01056289|532375159|FG000|Open-label Phase|Not randomized to Double-blind phase|1|||
147606178|NCT01056289|532375160|FG001|Open-label Phase|Not randomized to Double-blind phase|0|||
147606179|NCT01056289|532375161|FG002|Open-label Phase|Not randomized to Double-blind phase|0|||
147606180|NCT01056289|532375162|FG003|Open-label Phase|Not randomized to Double-blind phase|0|||
147606181|NCT01056289|532375159|FG000|Double-blind Phase|Adverse Event|0|||
147606182|NCT01056289|532375160|FG001|Double-blind Phase|Adverse Event|1|||
147606183|NCT01056289|532375161|FG002|Double-blind Phase|Adverse Event|2|||
147606184|NCT01056289|532375162|FG003|Double-blind Phase|Adverse Event|1|||
147606185|NCT01056289|532375159|FG000|Double-blind Phase|Lost to Follow-up|0|||
147606186|NCT01056289|532375160|FG001|Double-blind Phase|Lost to Follow-up|2|||
147606187|NCT01056289|532375161|FG002|Double-blind Phase|Lost to Follow-up|2|||
147606188|NCT01056289|532375162|FG003|Double-blind Phase|Lost to Follow-up|2|||
147606189|NCT01056289|532375159|FG000|Double-blind Phase|Other|0|||
147606190|NCT01056289|532375160|FG001|Double-blind Phase|Other|0|||
147606191|NCT01056289|532375161|FG002|Double-blind Phase|Other|1|||
147606192|NCT01056289|532375162|FG003|Double-blind Phase|Other|2|||
147606193|NCT01056289|532375159|FG000|Double-blind Phase|Protocol Violation|0|||
147606194|NCT01056289|532375160|FG001|Double-blind Phase|Protocol Violation|0|||
147294822|NCT01212770|531242709|FG001|Long-term Safety Phase (Year 2)|Lack of Efficacy|6|||
147294823|NCT01212770|531242710|FG002|Long-term Safety Phase (Year 2)|Lack of Efficacy|7|||
147294824|NCT01212770|531242711|FG003|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
147294825|NCT01212770|531242712|FG004|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
147294826|NCT01212770|531242713|FG005|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
147294827|NCT01212770|531242714|FG006|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
147294828|NCT01212770|531242715|FG007|Long-term Safety Phase (Year 2)|Lack of Efficacy|4|||
147606195|NCT01056289|532375161|FG002|Double-blind Phase|Protocol Violation|1|||
147294829|NCT01212770|531242716|FG008|Long-term Safety Phase (Year 2)|Lack of Efficacy|6|||
147294830|NCT01212770|531242708|FG000|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
147294831|NCT01212770|531242709|FG001|Long-term Safety Phase (Year 2)|Non-compliance to study drug|1|||
147294832|NCT01212770|531242710|FG002|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
147294833|NCT01212770|531242711|FG003|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
147294834|NCT01212770|531242712|FG004|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
147294835|NCT01212770|531242713|FG005|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
147294836|NCT01212770|531242714|FG006|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
147294837|NCT01212770|531242715|FG007|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
147294838|NCT01212770|531242716|FG008|Long-term Safety Phase (Year 2)|Non-compliance to study drug|0|||
147294839|NCT01212770|531242708|FG000|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
147294840|NCT01212770|531242709|FG001|Long-term Safety Phase (Year 2)|Withdrawal by Subject|9|||
147294841|NCT01212770|531242710|FG002|Long-term Safety Phase (Year 2)|Withdrawal by Subject|3|||
147294842|NCT01212770|531242711|FG003|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
147294843|NCT01212770|531242712|FG004|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
147294844|NCT01212770|531242713|FG005|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
147294845|NCT01212770|531242714|FG006|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
147294846|NCT01212770|531242715|FG007|Long-term Safety Phase (Year 2)|Withdrawal by Subject|4|||
147294847|NCT01212770|531242716|FG008|Long-term Safety Phase (Year 2)|Withdrawal by Subject|4|||
147294848|NCT01212770|531242708|FG000|Long-term Safety Phase (Year 2)|Lost to Follow-up|0|||
147294849|NCT01212770|531242709|FG001|Long-term Safety Phase (Year 2)|Lost to Follow-up|2|||
147294850|NCT01212770|531242710|FG002|Long-term Safety Phase (Year 2)|Lost to Follow-up|1|||
147294851|NCT01212770|531242711|FG003|Long-term Safety Phase (Year 2)|Lost to Follow-up|0|||
147294852|NCT01212770|531242712|FG004|Long-term Safety Phase (Year 2)|Lost to Follow-up|0|||
147294853|NCT01212770|531242713|FG005|Long-term Safety Phase (Year 2)|Lost to Follow-up|0|||
147294854|NCT01212770|531242714|FG006|Long-term Safety Phase (Year 2)|Lost to Follow-up|0|||
147294855|NCT01212770|531242715|FG007|Long-term Safety Phase (Year 2)|Lost to Follow-up|1|||
147294856|NCT01212770|531242716|FG008|Long-term Safety Phase (Year 2)|Lost to Follow-up|1|||
147294857|NCT01212770|531242708|FG000|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
147294858|NCT01212770|531242709|FG001|Long-term Safety Phase (Year 2)|Miscellaneous|2|||
147294859|NCT01212770|531242710|FG002|Long-term Safety Phase (Year 2)|Miscellaneous|1|||
147294860|NCT01212770|531242711|FG003|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
147294861|NCT01212770|531242712|FG004|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
147294862|NCT01212770|531242713|FG005|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
147294863|NCT01212770|531242714|FG006|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
147294864|NCT01212770|531242715|FG007|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
147294865|NCT01212770|531242716|FG008|Long-term Safety Phase (Year 2)|Miscellaneous|1|||
147294866|NCT01212770|531242708|FG000|Long-term Safety Phase (Year 3)|Adverse Event|0|||
147294867|NCT01212770|531242709|FG001|Long-term Safety Phase (Year 3)|Adverse Event|2|||
147294868|NCT01212770|531242710|FG002|Long-term Safety Phase (Year 3)|Adverse Event|2|||
147294869|NCT01212770|531242711|FG003|Long-term Safety Phase (Year 3)|Adverse Event|0|||
147294870|NCT01212770|531242712|FG004|Long-term Safety Phase (Year 3)|Adverse Event|0|||
147294871|NCT01212770|531242713|FG005|Long-term Safety Phase (Year 3)|Adverse Event|0|||
147294872|NCT01212770|531242714|FG006|Long-term Safety Phase (Year 3)|Adverse Event|0|||
147294873|NCT01212770|531242715|FG007|Long-term Safety Phase (Year 3)|Adverse Event|2|||
147294874|NCT01212770|531242716|FG008|Long-term Safety Phase (Year 3)|Adverse Event|1|||
147294875|NCT01212770|531242708|FG000|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
147294876|NCT01212770|531242709|FG001|Long-term Safety Phase (Year 3)|Lack of Efficacy|3|||
147294877|NCT01212770|531242710|FG002|Long-term Safety Phase (Year 3)|Lack of Efficacy|4|||
147294878|NCT01212770|531242711|FG003|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
147294879|NCT01212770|531242712|FG004|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
147294880|NCT01212770|531242713|FG005|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
147294881|NCT01212770|531242714|FG006|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
147294882|NCT01212770|531242715|FG007|Long-term Safety Phase (Year 3)|Lack of Efficacy|2|||
147294883|NCT01212770|531242716|FG008|Long-term Safety Phase (Year 3)|Lack of Efficacy|2|||
147294884|NCT01212770|531242708|FG000|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
147294885|NCT01212770|531242709|FG001|Long-term Safety Phase (Year 3)|Withdrawal by Subject|3|||
147294886|NCT01212770|531242710|FG002|Long-term Safety Phase (Year 3)|Withdrawal by Subject|4|||
147294887|NCT01212770|531242711|FG003|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
147294888|NCT01212770|531242712|FG004|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
147294889|NCT01212770|531242713|FG005|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
147294890|NCT01212770|531242714|FG006|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
147339027|NCT01236001|531409921|FG000|Overall Study|Planned Visit After End of Study|0|||
147339028|NCT01236001|531409922|FG001|Overall Study|Planned Visit After End of Study|1|||
147339029|NCT02988817|531409923|FG000|Overall Study|Withdrawal by Subject|1|||
147339030|NCT02988817|531409924|FG001|Overall Study|Withdrawal by Subject|0|||
147606196|NCT01056289|532375162|FG003|Double-blind Phase|Protocol Violation|1|||
147339031|NCT02988817|531409925|FG002|Overall Study|Withdrawal by Subject|0|||
147294891|NCT01212770|531242715|FG007|Long-term Safety Phase (Year 3)|Withdrawal by Subject|1|||
147294892|NCT01212770|531242716|FG008|Long-term Safety Phase (Year 3)|Withdrawal by Subject|1|||
147294893|NCT01212770|531242708|FG000|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
147294894|NCT01212770|531242709|FG001|Long-term Safety Phase (Year 3)|Lost to Follow-up|1|||
147294895|NCT01212770|531242710|FG002|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
147294896|NCT01212770|531242711|FG003|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
147294897|NCT01212770|531242712|FG004|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
147294898|NCT01212770|531242713|FG005|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
147294899|NCT01212770|531242714|FG006|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
147294900|NCT01212770|531242715|FG007|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
147294901|NCT01212770|531242716|FG008|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
147294902|NCT01212770|531242708|FG000|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
147294903|NCT01212770|531242709|FG001|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
147294904|NCT01212770|531242710|FG002|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
147294905|NCT01212770|531242711|FG003|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
147294906|NCT01212770|531242712|FG004|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
147294907|NCT01212770|531242713|FG005|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
147294908|NCT01212770|531242714|FG006|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
147294909|NCT01212770|531242715|FG007|Long-term Safety Phase (Year 3)|Protocol Violation|1|||
147294910|NCT01212770|531242716|FG008|Long-term Safety Phase (Year 3)|Protocol Violation|0|||
147294911|NCT01212770|531242708|FG000|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
147294912|NCT01212770|531242709|FG001|Long-term Safety Phase (Year 3)|Miscellaneous|2|||
147294913|NCT01212770|531242710|FG002|Long-term Safety Phase (Year 3)|Miscellaneous|1|||
147294914|NCT01212770|531242711|FG003|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
147294915|NCT01212770|531242712|FG004|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
147294916|NCT01212770|531242713|FG005|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
147294917|NCT01212770|531242714|FG006|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
147294918|NCT01212770|531242715|FG007|Long-term Safety Phase (Year 3)|Miscellaneous|1|||
147294919|NCT01212770|531242716|FG008|Long-term Safety Phase (Year 3)|Miscellaneous|1|||
147294920|NCT01212770|531242708|FG000|Long-term Safety Phase (Year 4)|Adverse Event|0|||
147294921|NCT01212770|531242709|FG001|Long-term Safety Phase (Year 4)|Adverse Event|1|||
147294922|NCT01212770|531242710|FG002|Long-term Safety Phase (Year 4)|Adverse Event|1|||
147294923|NCT01212770|531242711|FG003|Long-term Safety Phase (Year 4)|Adverse Event|0|||
147294924|NCT01212770|531242712|FG004|Long-term Safety Phase (Year 4)|Adverse Event|0|||
147294925|NCT01212770|531242713|FG005|Long-term Safety Phase (Year 4)|Adverse Event|0|||
147294926|NCT01212770|531242714|FG006|Long-term Safety Phase (Year 4)|Adverse Event|0|||
147294927|NCT01212770|531242715|FG007|Long-term Safety Phase (Year 4)|Adverse Event|0|||
147294928|NCT01212770|531242716|FG008|Long-term Safety Phase (Year 4)|Adverse Event|1|||
147294929|NCT01212770|531242708|FG000|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
147294930|NCT01212770|531242709|FG001|Long-term Safety Phase (Year 4)|Lack of Efficacy|1|||
147294931|NCT01212770|531242710|FG002|Long-term Safety Phase (Year 4)|Lack of Efficacy|5|||
147294932|NCT01212770|531242711|FG003|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
147294933|NCT01212770|531242712|FG004|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
147294934|NCT01212770|531242713|FG005|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
147294935|NCT01212770|531242714|FG006|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
147294936|NCT01212770|531242715|FG007|Long-term Safety Phase (Year 4)|Lack of Efficacy|2|||
147294937|NCT01212770|531242716|FG008|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
147294938|NCT01212770|531242708|FG000|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
147294939|NCT01212770|531242709|FG001|Long-term Safety Phase (Year 4)|Non-compliance with study drug|1|||
147294940|NCT01212770|531242710|FG002|Long-term Safety Phase (Year 4)|Non-compliance with study drug|1|||
147294941|NCT01212770|531242711|FG003|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
147294942|NCT01212770|531242712|FG004|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
147294943|NCT01212770|531242713|FG005|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
147294944|NCT01212770|531242714|FG006|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
147339032|NCT02988817|531409926|FG003|Overall Study|Withdrawal by Subject|1|||
147339033|NCT02988817|531409927|FG004|Overall Study|Withdrawal by Subject|3|||
147606197|NCT01056289|532375159|FG000|Double-blind Phase|Withdrawal by Subject|0|||
147606198|NCT01056289|532375160|FG001|Double-blind Phase|Withdrawal by Subject|0|||
147606199|NCT01056289|532375161|FG002|Double-blind Phase|Withdrawal by Subject|4|||
147606200|NCT01056289|532375162|FG003|Double-blind Phase|Withdrawal by Subject|2|||
147606201|NCT01056289|532375159|FG000|Double-blind Phase|Discontinuation symptom|0|||
147606202|NCT01056289|532375160|FG001|Double-blind Phase|Discontinuation symptom|1|||
147606203|NCT01056289|532375161|FG002|Double-blind Phase|Discontinuation symptom|2|||
147606204|NCT01056289|532375162|FG003|Double-blind Phase|Discontinuation symptom|2|||
147606205|NCT01056289|532375159|FG000|Double-blind Phase|Physician Decision|0|||
147294945|NCT01212770|531242715|FG007|Long-term Safety Phase (Year 4)|Non-compliance with study drug|1|||
147294946|NCT01212770|531242716|FG008|Long-term Safety Phase (Year 4)|Non-compliance with study drug|0|||
147452919|NCT00493038|531821484|FG001|Treatment|Lost to Follow-up|3|||
147606206|NCT01056289|532375160|FG001|Double-blind Phase|Physician Decision|0|||
147294947|NCT01212770|531242708|FG000|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
147294948|NCT01212770|531242709|FG001|Long-term Safety Phase (Year 4)|Withdrawal by Subject|2|||
147294949|NCT01212770|531242710|FG002|Long-term Safety Phase (Year 4)|Withdrawal by Subject|3|||
147294950|NCT01212770|531242711|FG003|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
147294951|NCT01212770|531242712|FG004|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
147294952|NCT01212770|531242713|FG005|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
147294953|NCT01212770|531242714|FG006|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
147294954|NCT01212770|531242715|FG007|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
147294955|NCT01212770|531242716|FG008|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
147294956|NCT01212770|531242708|FG000|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
147294957|NCT01212770|531242709|FG001|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
147294958|NCT01212770|531242710|FG002|Long-term Safety Phase (Year 4)|Lost to Follow-up|1|||
147294959|NCT01212770|531242711|FG003|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
147294960|NCT01212770|531242712|FG004|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
147294961|NCT01212770|531242713|FG005|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
147294962|NCT01212770|531242714|FG006|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
147294963|NCT01212770|531242715|FG007|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
147294964|NCT01212770|531242716|FG008|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
147294965|NCT01212770|531242708|FG000|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
147294966|NCT01212770|531242709|FG001|Long-term Safety Phase (Year 4)|Miscellaneous|1|||
147294967|NCT01212770|531242710|FG002|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
147294968|NCT01212770|531242711|FG003|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
147294969|NCT01212770|531242712|FG004|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
147294970|NCT01212770|531242713|FG005|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
147294971|NCT01212770|531242714|FG006|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
147294972|NCT01212770|531242715|FG007|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
147294973|NCT01212770|531242716|FG008|Long-term Safety Phase (Year 4)|Miscellaneous|1|||
147294974|NCT01212770|531242708|FG000|Long-term Safety Phase (Year 5)|Missing|0|||
147294975|NCT01212770|531242709|FG001|Long-term Safety Phase (Year 5)|Missing|0|||
147294976|NCT01212770|531242710|FG002|Long-term Safety Phase (Year 5)|Missing|1|||
147294977|NCT01212770|531242711|FG003|Long-term Safety Phase (Year 5)|Missing|0|||
147294978|NCT01212770|531242712|FG004|Long-term Safety Phase (Year 5)|Missing|0|||
147294979|NCT01212770|531242713|FG005|Long-term Safety Phase (Year 5)|Missing|0|||
147294980|NCT01212770|531242714|FG006|Long-term Safety Phase (Year 5)|Missing|0|||
147294981|NCT01212770|531242715|FG007|Long-term Safety Phase (Year 5)|Missing|0|||
147294982|NCT01212770|531242716|FG008|Long-term Safety Phase (Year 5)|Missing|0|||
147294983|NCT01212770|531242708|FG000|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
147294984|NCT01212770|531242709|FG001|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
147294985|NCT01212770|531242710|FG002|Long-term Safety Phase (Year 5)|Miscellaneous|3|||
147294986|NCT01212770|531242711|FG003|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
147294987|NCT01212770|531242712|FG004|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
147294988|NCT01212770|531242713|FG005|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
147294989|NCT01212770|531242714|FG006|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
147294990|NCT01212770|531242715|FG007|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
147294991|NCT01212770|531242716|FG008|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
147294992|NCT01212770|531242708|FG000|Long-term Safety Phase (Year 5)|Adverse Event|0|||
147294993|NCT01212770|531242709|FG001|Long-term Safety Phase (Year 5)|Adverse Event|0|||
147294994|NCT01212770|531242710|FG002|Long-term Safety Phase (Year 5)|Adverse Event|2|||
147294995|NCT01212770|531242711|FG003|Long-term Safety Phase (Year 5)|Adverse Event|0|||
147339034|NCT02988817|531409928|FG005|Overall Study|Withdrawal by Subject|1|||
147339035|NCT02988817|531409929|FG006|Overall Study|Withdrawal by Subject|2|||
147339036|NCT02988817|531409930|FG007|Overall Study|Withdrawal by Subject|1|||
147339037|NCT02988817|531409931|FG008|Overall Study|Withdrawal by Subject|1|||
147339038|NCT02988817|531409932|FG009|Overall Study|Withdrawal by Subject|1|||
147339039|NCT02988817|531409933|FG010|Overall Study|Withdrawal by Subject|1|||
147339040|NCT02988817|531409934|FG011|Overall Study|Withdrawal by Subject|12|||
147294996|NCT01212770|531242712|FG004|Long-term Safety Phase (Year 5)|Adverse Event|0|||
147294997|NCT01212770|531242713|FG005|Long-term Safety Phase (Year 5)|Adverse Event|0|||
147294998|NCT01212770|531242714|FG006|Long-term Safety Phase (Year 5)|Adverse Event|0|||
147294999|NCT01212770|531242715|FG007|Long-term Safety Phase (Year 5)|Adverse Event|0|||
147295000|NCT01212770|531242716|FG008|Long-term Safety Phase (Year 5)|Adverse Event|1|||
147295001|NCT01212770|531242708|FG000|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
147295002|NCT01212770|531242709|FG001|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
147339041|NCT02988817|531409935|FG012|Overall Study|Withdrawal by Subject|6|||
147339042|NCT02988817|531409936|FG013|Overall Study|Withdrawal by Subject|6|||
147339043|NCT02988817|531409937|FG014|Overall Study|Withdrawal by Subject|4|||
147339044|NCT02988817|531409938|FG015|Overall Study|Withdrawal by Subject|5|||
147339045|NCT02988817|531409939|FG016|Overall Study|Withdrawal by Subject|4|||
147295003|NCT01212770|531242710|FG002|Long-term Safety Phase (Year 5)|Lack of Efficacy|4|||
147295004|NCT01212770|531242711|FG003|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
147339046|NCT02988817|531409940|FG017|Overall Study|Withdrawal by Subject|11|||
147295005|NCT01212770|531242712|FG004|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
147295006|NCT01212770|531242713|FG005|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
147295007|NCT01212770|531242714|FG006|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
147295008|NCT01212770|531242715|FG007|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
147295009|NCT01212770|531242716|FG008|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
147295010|NCT01212770|531242708|FG000|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
147295011|NCT01212770|531242709|FG001|Long-term Safety Phase (Year 5)|Withdrawal by Subject|2|||
147295012|NCT01212770|531242710|FG002|Long-term Safety Phase (Year 5)|Withdrawal by Subject|1|||
147295013|NCT01212770|531242711|FG003|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
147295014|NCT01212770|531242712|FG004|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
147295015|NCT01212770|531242713|FG005|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
147295016|NCT01212770|531242714|FG006|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
147295017|NCT01212770|531242715|FG007|Long-term Safety Phase (Year 5)|Withdrawal by Subject|1|||
147295018|NCT01212770|531242716|FG008|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
147295019|NCT01212770|531242708|FG000|Long-term Safety Phase (Year 5)|Death|0|||
147295020|NCT01212770|531242709|FG001|Long-term Safety Phase (Year 5)|Death|0|||
147295021|NCT01212770|531242710|FG002|Long-term Safety Phase (Year 5)|Death|0|||
147295022|NCT01212770|531242711|FG003|Long-term Safety Phase (Year 5)|Death|0|||
147295023|NCT01212770|531242712|FG004|Long-term Safety Phase (Year 5)|Death|0|||
147295024|NCT01212770|531242713|FG005|Long-term Safety Phase (Year 5)|Death|0|||
147339047|NCT02988817|531409941|FG018|Overall Study|Withdrawal by Subject|4|||
147339048|NCT02988817|531409942|FG019|Overall Study|Withdrawal by Subject|2|||
147339049|NCT02988817|531409923|FG000|Overall Study|Death|0|||
147339050|NCT02988817|531409924|FG001|Overall Study|Death|1|||
147339051|NCT02988817|531409925|FG002|Overall Study|Death|3|||
147339052|NCT02988817|531409926|FG003|Overall Study|Death|1|||
147339053|NCT02988817|531409927|FG004|Overall Study|Death|6|||
147339054|NCT02988817|531409928|FG005|Overall Study|Death|10|||
147339055|NCT02988817|531409929|FG006|Overall Study|Death|1|||
147339056|NCT02988817|531409930|FG007|Overall Study|Death|2|||
147339057|NCT02988817|531409931|FG008|Overall Study|Death|1|||
147339058|NCT02988817|531409932|FG009|Overall Study|Death|5|||
147339059|NCT02988817|531409933|FG010|Overall Study|Death|1|||
147339060|NCT02988817|531409934|FG011|Overall Study|Death|8|||
147339061|NCT02988817|531409935|FG012|Overall Study|Death|9|||
147339062|NCT02988817|531409936|FG013|Overall Study|Death|17|||
147339063|NCT02988817|531409937|FG014|Overall Study|Death|18|||
147339064|NCT02988817|531409938|FG015|Overall Study|Death|30|||
147339065|NCT02988817|531409939|FG016|Overall Study|Death|17|||
147339066|NCT02988817|531409940|FG017|Overall Study|Death|38|||
147339067|NCT02988817|531409941|FG018|Overall Study|Death|14|||
147339068|NCT02988817|531409942|FG019|Overall Study|Death|16|||
147339069|NCT02988817|531409923|FG000|Overall Study|Other|0|||
147339070|NCT02988817|531409924|FG001|Overall Study|Other|0|||
147339071|NCT02988817|531409925|FG002|Overall Study|Other|0|||
147339072|NCT02988817|531409926|FG003|Overall Study|Other|1|||
147339073|NCT02988817|531409927|FG004|Overall Study|Other|1|||
147339074|NCT02988817|531409928|FG005|Overall Study|Other|0|||
147339075|NCT02988817|531409929|FG006|Overall Study|Other|0|||
147339076|NCT02988817|531409930|FG007|Overall Study|Other|0|||
147339077|NCT02988817|531409931|FG008|Overall Study|Other|0|||
147339078|NCT02988817|531409932|FG009|Overall Study|Other|0|||
147339079|NCT02988817|531409933|FG010|Overall Study|Other|0|||
147339080|NCT02988817|531409934|FG011|Overall Study|Other|0|||
147339081|NCT02988817|531409935|FG012|Overall Study|Other|0|||
147339082|NCT02988817|531409936|FG013|Overall Study|Other|0|||
147339083|NCT02988817|531409937|FG014|Overall Study|Other|0|||
147339084|NCT02988817|531409938|FG015|Overall Study|Other|1|||
147339085|NCT02988817|531409939|FG016|Overall Study|Other|0|||
147339086|NCT02988817|531409940|FG017|Overall Study|Other|0|||
147339087|NCT02988817|531409941|FG018|Overall Study|Other|0|||
147339088|NCT02988817|531409942|FG019|Overall Study|Other|0|||
147339089|NCT02988817|531409923|FG000|Overall Study|Lost to Follow-up|0|||
147339090|NCT02988817|531409924|FG001|Overall Study|Lost to Follow-up|0|||
147339091|NCT02988817|531409925|FG002|Overall Study|Lost to Follow-up|0|||
147295025|NCT01212770|531242714|FG006|Long-term Safety Phase (Year 5)|Death|0|||
147295026|NCT01212770|531242715|FG007|Long-term Safety Phase (Year 5)|Death|1|||
147339092|NCT02988817|531409926|FG003|Overall Study|Lost to Follow-up|0|||
147339093|NCT02988817|531409927|FG004|Overall Study|Lost to Follow-up|0|||
147339094|NCT02988817|531409928|FG005|Overall Study|Lost to Follow-up|0|||
147339095|NCT02988817|531409929|FG006|Overall Study|Lost to Follow-up|0|||
147339096|NCT02988817|531409930|FG007|Overall Study|Lost to Follow-up|0|||
147339097|NCT02988817|531409931|FG008|Overall Study|Lost to Follow-up|1|||
147339098|NCT02988817|531409932|FG009|Overall Study|Lost to Follow-up|0|||
147339099|NCT02988817|531409933|FG010|Overall Study|Lost to Follow-up|1|||
147339100|NCT02988817|531409934|FG011|Overall Study|Lost to Follow-up|1|||
147339101|NCT02988817|531409935|FG012|Overall Study|Lost to Follow-up|0|||
147339102|NCT02988817|531409936|FG013|Overall Study|Lost to Follow-up|0|||
147339103|NCT02988817|531409937|FG014|Overall Study|Lost to Follow-up|1|||
147339104|NCT02988817|531409938|FG015|Overall Study|Lost to Follow-up|1|||
147339105|NCT02988817|531409939|FG016|Overall Study|Lost to Follow-up|2|||
147295027|NCT01212770|531242716|FG008|Long-term Safety Phase (Year 5)|Death|0|||
147295028|NCT00829387|531242719|FG000|Overall Study|Withdrawal by Subject|2|||
147295029|NCT00829387|531242720|FG001|Overall Study|Withdrawal by Subject|3|||
147295030|NCT00829387|531242719|FG000|Overall Study|Disqualified by PI|1|||
147295031|NCT00829387|531242720|FG001|Overall Study|Disqualified by PI|0|||
147295032|NCT00707031|531242728|FG000|Overall Study|Adverse Event|45|||
147295033|NCT00707031|531242729|FG001|Overall Study|Adverse Event|45|||
147295034|NCT00707031|531242728|FG000|Overall Study|Lack of Efficacy|19|||
147295035|NCT00707031|531242729|FG001|Overall Study|Lack of Efficacy|6|||
147295036|NCT00707031|531242728|FG000|Overall Study|Lost to Follow-up|2|||
147295037|NCT00707031|531242729|FG001|Overall Study|Lost to Follow-up|1|||
147295038|NCT00707031|531242728|FG000|Overall Study|Protocol Violation|1|||
147295039|NCT00707031|531242729|FG001|Overall Study|Protocol Violation|0|||
147295040|NCT00707031|531242728|FG000|Overall Study|Withdrawal by Subject|7|||
147295041|NCT00707031|531242729|FG001|Overall Study|Withdrawal by Subject|8|||
147295042|NCT00707031|531242728|FG000|Overall Study|Poor Compliance to Protocol|7|||
147295043|NCT00707031|531242729|FG001|Overall Study|Poor Compliance to Protocol|13|||
147295044|NCT00707031|531242728|FG000|Overall Study|Familial or Personal Reasons|12|||
147295045|NCT00707031|531242729|FG001|Overall Study|Familial or Personal Reasons|15|||
147295046|NCT00707031|531242728|FG000|Overall Study|Serious Noncompliance|2|||
147295047|NCT00707031|531242729|FG001|Overall Study|Serious Noncompliance|3|||
147295048|NCT00707031|531242728|FG000|Overall Study|Sponsor Decision|9|||
147295049|NCT00707031|531242729|FG001|Overall Study|Sponsor Decision|8|||
147295050|NCT00941330|531242730|FG000|Overall Study|Other|1|||
147295051|NCT00941330|531242731|FG001|Overall Study|Other|0|||
147295052|NCT00941330|531242730|FG000|Overall Study|Physician Decision|0|||
147295053|NCT00941330|531242731|FG001|Overall Study|Physician Decision|2|||
147295054|NCT02747238|531242732|FG000|Overall Study|Lack of Efficacy|0|||
147295055|NCT02747238|531242733|FG001|Overall Study|Lack of Efficacy|1|||
147295056|NCT02747238|531242732|FG000|Overall Study|Data lost|3|||
147295057|NCT02747238|531242733|FG001|Overall Study|Data lost|5|||
147295058|NCT00541450|531242734|FG000|Phase A|Adverse Event|3|||
147295059|NCT00541450|531242735|FG001|Phase A|Adverse Event|0|||
147295060|NCT00541450|531242734|FG000|Phase A|Creatinine/CrCl -Increase in creatinine|0|||
147295061|NCT00541450|531242735|FG001|Phase A|Creatinine/CrCl -Increase in creatinine|2|||
147295062|NCT00541450|531242734|FG000|Phase A|Hyperglycemia|0|||
147295063|NCT00541450|531242735|FG001|Phase A|Hyperglycemia|1|||
147295064|NCT00541450|531242734|FG000|Phase A|Lost to Follow-up|6|||
147295065|NCT00541450|531242735|FG001|Phase A|Lost to Follow-up|4|||
147295066|NCT00541450|531242734|FG000|Phase A|Physician Decision|2|||
147295067|NCT00541450|531242735|FG001|Phase A|Physician Decision|0|||
147295068|NCT00541450|531242734|FG000|Phase A|Protocol Violation|2|||
147295069|NCT00541450|531242735|FG001|Phase A|Protocol Violation|3|||
147295070|NCT00541450|531242734|FG000|Phase A|Withdrawal by Subject|7|||
147295071|NCT00541450|531242735|FG001|Phase A|Withdrawal by Subject|7|||
147295072|NCT00541450|531242734|FG000|Phase B|Adverse Event|6|||
147295073|NCT00541450|531242735|FG001|Phase B|Adverse Event|6|||
147295074|NCT00541450|531242734|FG000|Phase B|Hyperglycemia|10|||
147295075|NCT00541450|531242735|FG001|Phase B|Hyperglycemia|9|||
147295076|NCT00541450|531242734|FG000|Phase B|Lost to Follow-up|6|||
147295077|NCT00541450|531242735|FG001|Phase B|Lost to Follow-up|4|||
147295078|NCT00541450|531242734|FG000|Phase B|Physician Decision|4|||
147295079|NCT00541450|531242735|FG001|Phase B|Physician Decision|2|||
147295080|NCT00541450|531242734|FG000|Phase B|Pregnancy|0|||
147295081|NCT00541450|531242735|FG001|Phase B|Pregnancy|1|||
147295082|NCT00541450|531242734|FG000|Phase B|Protocol Violation|3|||
147295083|NCT00541450|531242735|FG001|Phase B|Protocol Violation|3|||
147295084|NCT00541450|531242734|FG000|Phase B|Withdrawal by Subject|8|||
147295085|NCT00541450|531242735|FG001|Phase B|Withdrawal by Subject|6|||
147295086|NCT02858895|531242736|FG000|Overall Study|Disease progression|31|||
147295087|NCT02858895|531242736|FG000|Overall Study|Death|2|||
147295088|NCT02858895|531242736|FG000|Overall Study|Adverse Event|1|||
147295089|NCT02858895|531242736|FG000|Overall Study|Withdrawal by Subject|3|||
147295090|NCT02858895|531242736|FG000|Overall Study|hospice,|1|||
147295091|NCT02858895|531242736|FG000|Overall Study|did not receive drug due to catheters misplaced|1|||
147295092|NCT05338333|531242737|FG000|Period 1, Approximately 30 Days|Adverse Event|1|||
147295093|NCT05338333|531242738|FG001|Period 1, Approximately 30 Days|Adverse Event|0|||
147295094|NCT01475136|531242739|FG000|Overall Study|Sponsor Decision|0|||
147295095|NCT01475136|531242740|FG001|Overall Study|Sponsor Decision|1|||
147295096|NCT01475136|531242741|FG002|Overall Study|Sponsor Decision|0|||
147295097|NCT01475136|531242742|FG003|Overall Study|Sponsor Decision|0|||
147295098|NCT01475136|531242739|FG000|Overall Study|Entry Criteria Not Met|0|||
147295099|NCT01475136|531242740|FG001|Overall Study|Entry Criteria Not Met|2|||
147339106|NCT02988817|531409940|FG017|Overall Study|Lost to Follow-up|3|||
147339107|NCT02988817|531409941|FG018|Overall Study|Lost to Follow-up|0|||
147339108|NCT02988817|531409942|FG019|Overall Study|Lost to Follow-up|0|||
147339109|NCT02988817|531409923|FG000|Overall Study|Sponsor decision|0|||
147339110|NCT02988817|531409924|FG001|Overall Study|Sponsor decision|0|||
147339111|NCT02988817|531409925|FG002|Overall Study|Sponsor decision|0|||
147339112|NCT02988817|531409926|FG003|Overall Study|Sponsor decision|0|||
147339113|NCT02988817|531409927|FG004|Overall Study|Sponsor decision|0|||
147295100|NCT01475136|531242741|FG002|Overall Study|Entry Criteria Not Met|3|||
147295101|NCT01475136|531242742|FG003|Overall Study|Entry Criteria Not Met|1|||
147295102|NCT01475136|531242739|FG000|Overall Study|Withdrawal by Subject|0|||
147295103|NCT01475136|531242740|FG001|Overall Study|Withdrawal by Subject|0|||
147295104|NCT01475136|531242741|FG002|Overall Study|Withdrawal by Subject|0|||
147295105|NCT01475136|531242742|FG003|Overall Study|Withdrawal by Subject|2|||
147295106|NCT01475136|531242739|FG000|Overall Study|Adverse Event|1|||
147295107|NCT01475136|531242740|FG001|Overall Study|Adverse Event|0|||
147295108|NCT01475136|531242741|FG002|Overall Study|Adverse Event|0|||
147295109|NCT01475136|531242742|FG003|Overall Study|Adverse Event|1|||
147295110|NCT01475136|531242739|FG000|Overall Study|Death|0|||
147295111|NCT01475136|531242740|FG001|Overall Study|Death|0|||
147295112|NCT01475136|531242741|FG002|Overall Study|Death|0|||
147295113|NCT01475136|531242742|FG003|Overall Study|Death|1|||
147295114|NCT01266642|531242743|FG000|Overall Study|Protocol Violation|0|||
147295115|NCT01266642|531242744|FG001|Overall Study|Protocol Violation|1|||
147295116|NCT01323530|531244597|FG000|Phase 1b (Dose Escalation Phase)|Adverse Event|2|||
147295117|NCT01323530|531244598|FG001|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
147295118|NCT01323530|531244599|FG002|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
147295119|NCT01323530|531244600|FG003|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
147295120|NCT01323530|531244601|FG004|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
147295121|NCT01323530|531244602|FG005|Phase 1b (Dose Escalation Phase)|Adverse Event|2|||
147295122|NCT01323530|531244603|FG006|Phase 1b (Dose Escalation Phase)|Adverse Event|0|||
147339114|NCT02988817|531409928|FG005|Overall Study|Sponsor decision|0|||
147339115|NCT02988817|531409929|FG006|Overall Study|Sponsor decision|0|||
147339116|NCT02988817|531409930|FG007|Overall Study|Sponsor decision|0|||
147339117|NCT02988817|531409931|FG008|Overall Study|Sponsor decision|0|||
147339118|NCT02988817|531409932|FG009|Overall Study|Sponsor decision|0|||
147339119|NCT02988817|531409933|FG010|Overall Study|Sponsor decision|0|||
147339120|NCT02988817|531409934|FG011|Overall Study|Sponsor decision|1|||
147339121|NCT02988817|531409935|FG012|Overall Study|Sponsor decision|1|||
147339122|NCT02988817|531409936|FG013|Overall Study|Sponsor decision|2|||
147339123|NCT02988817|531409937|FG014|Overall Study|Sponsor decision|2|||
147339124|NCT02988817|531409938|FG015|Overall Study|Sponsor decision|6|||
147339125|NCT02988817|531409939|FG016|Overall Study|Sponsor decision|2|||
147339126|NCT02988817|531409940|FG017|Overall Study|Sponsor decision|3|||
147339127|NCT02988817|531409941|FG018|Overall Study|Sponsor decision|2|||
147339128|NCT02988817|531409942|FG019|Overall Study|Sponsor decision|7|||
147339129|NCT02988817|531409923|FG000|Overall Study|Physician Decision|0|||
147339130|NCT02988817|531409924|FG001|Overall Study|Physician Decision|0|||
147339131|NCT02988817|531409925|FG002|Overall Study|Physician Decision|0|||
147339132|NCT02988817|531409926|FG003|Overall Study|Physician Decision|0|||
147339133|NCT02988817|531409927|FG004|Overall Study|Physician Decision|0|||
147339134|NCT02988817|531409928|FG005|Overall Study|Physician Decision|0|||
147339135|NCT02988817|531409929|FG006|Overall Study|Physician Decision|0|||
147339136|NCT02988817|531409930|FG007|Overall Study|Physician Decision|0|||
147339137|NCT02988817|531409931|FG008|Overall Study|Physician Decision|0|||
147339138|NCT02988817|531409932|FG009|Overall Study|Physician Decision|0|||
147339139|NCT02988817|531409933|FG010|Overall Study|Physician Decision|0|||
147339140|NCT02988817|531409934|FG011|Overall Study|Physician Decision|0|||
147339141|NCT02988817|531409935|FG012|Overall Study|Physician Decision|0|||
147339142|NCT02988817|531409936|FG013|Overall Study|Physician Decision|0|||
147339143|NCT02988817|531409937|FG014|Overall Study|Physician Decision|0|||
147339144|NCT02988817|531409938|FG015|Overall Study|Physician Decision|1|||
147339145|NCT02988817|531409939|FG016|Overall Study|Physician Decision|0|||
147339146|NCT02988817|531409940|FG017|Overall Study|Physician Decision|0|||
147339147|NCT02988817|531409941|FG018|Overall Study|Physician Decision|1|||
147339148|NCT02988817|531409942|FG019|Overall Study|Physician Decision|1|||
147339149|NCT05082935|531409949|FG000|Overall Study|Lost to Follow-up|549|||
147339150|NCT05082935|531409950|FG001|Overall Study|Lost to Follow-up|631|||
147339151|NCT05082935|531409949|FG000|Overall Study|Withdrawal by Subject|27|||
147339152|NCT05082935|531409950|FG001|Overall Study|Withdrawal by Subject|58|||
147295123|NCT01323530|531244597|FG000|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|1|||
147295124|NCT01323530|531244598|FG001|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|1|||
147295125|NCT01323530|531244599|FG002|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|1|||
147295126|NCT01323530|531244600|FG003|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
147295127|NCT01323530|531244601|FG004|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|2|||
147295128|NCT01323530|531244602|FG005|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
147339153|NCT04530747|531409955|FG000|Overall Study|Withdrawal by Subject|1|||
147339154|NCT04530747|531409956|FG001|Overall Study|Withdrawal by Subject|0|||
147339155|NCT03292913|531409957|FG000|Overall Study|Death|9|||
147339156|NCT03292913|531409958|FG001|Overall Study|Death|3|||
147339157|NCT03292913|531409957|FG000|Overall Study|Lost to Follow-up|49|||
147339158|NCT03292913|531409958|FG001|Overall Study|Lost to Follow-up|49|||
147339159|NCT03292913|531409957|FG000|Overall Study|Withdrawal by Subject|2|||
147339160|NCT03292913|531409958|FG001|Overall Study|Withdrawal by Subject|0|||
147339161|NCT03292913|531409957|FG000|Overall Study|Clinic closed due to COVID|22|||
147339162|NCT03292913|531409958|FG001|Overall Study|Clinic closed due to COVID|36|||
147295129|NCT01323530|531244603|FG006|Phase 1b (Dose Escalation Phase)|Withdrawal by Subject|0|||
147295130|NCT01323530|531244597|FG000|Phase 1b (Dose Escalation Phase)|Clinical Progression|0|||
147295131|NCT01323530|531244598|FG001|Phase 1b (Dose Escalation Phase)|Clinical Progression|1|||
147295132|NCT01323530|531244599|FG002|Phase 1b (Dose Escalation Phase)|Clinical Progression|0|||
147295133|NCT01323530|531244600|FG003|Phase 1b (Dose Escalation Phase)|Clinical Progression|0|||
147295134|NCT01323530|531244601|FG004|Phase 1b (Dose Escalation Phase)|Clinical Progression|1|||
147295135|NCT01323530|531244602|FG005|Phase 1b (Dose Escalation Phase)|Clinical Progression|1|||
147295136|NCT01323530|531244603|FG006|Phase 1b (Dose Escalation Phase)|Clinical Progression|0|||
147295137|NCT01323530|531244597|FG000|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
147295138|NCT01323530|531244598|FG001|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
147295139|NCT01323530|531244599|FG002|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
147295140|NCT01323530|531244600|FG003|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
147295141|NCT01323530|531244601|FG004|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
147295142|NCT01323530|531244602|FG005|Phase 2 (Dose-confirmation Phase)|Adverse Event|0|||
147295143|NCT01323530|531244603|FG006|Phase 2 (Dose-confirmation Phase)|Adverse Event|2|||
147295144|NCT01323530|531244597|FG000|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
147339163|NCT02379819|531409959|FG000|Overall Study|Withdrawal by Subject|10|||
147339164|NCT02379819|531409959|FG000|Overall Study|Death|2|||
147339165|NCT02379819|531409959|FG000|Overall Study|Lack of Efficacy|1|||
147339166|NCT02379819|531409959|FG000|Overall Study|Lost to Follow-up|1|||
147339167|NCT03950622|531409960|FG000|Overall Study|Withdrawal by Subject|1|||
147339168|NCT03950622|531409961|FG001|Overall Study|Withdrawal by Subject|0|||
147339169|NCT03950622|531409960|FG000|Overall Study|Protocol Deviation|0|||
147339170|NCT03950622|531409961|FG001|Overall Study|Protocol Deviation|1|||
147339171|NCT03950622|531409960|FG000|Overall Study|Physician Decision|1|||
147339172|NCT03950622|531409961|FG001|Overall Study|Physician Decision|0|||
147339173|NCT03950622|531409960|FG000|Overall Study|Lost to Follow-up|5|||
147339174|NCT03950622|531409961|FG001|Overall Study|Lost to Follow-up|5|||
147339175|NCT03950622|531409960|FG000|Overall Study|Death|1|||
147339176|NCT03950622|531409961|FG001|Overall Study|Death|1|||
147339177|NCT01839331|531409962|FG000|Overall Study|Early Termination|3|||
147339178|NCT01839331|531409963|FG001|Overall Study|Early Termination|0|||
147339179|NCT01839331|531409964|FG002|Overall Study|Early Termination|1|||
147339180|NCT01839331|531409965|FG003|Overall Study|Early Termination|2|||
147339181|NCT01839331|531409962|FG000|Overall Study|Protocol Violation|1|||
147339182|NCT01839331|531409963|FG001|Overall Study|Protocol Violation|6|||
147339183|NCT01839331|531409964|FG002|Overall Study|Protocol Violation|4|||
147339184|NCT01839331|531409965|FG003|Overall Study|Protocol Violation|3|||
147339185|NCT03752151|531409966|FG000|Overall Study|Withdrawal by Subject|1|||
147339186|NCT03752151|531409966|FG000|Overall Study|Protocol Violation|1|||
147339187|NCT04056624|531409967|FG000|Overall Study|Withdrawal by Subject|0|||
147339188|NCT04056624|531409968|FG001|Overall Study|Withdrawal by Subject|0|||
147339189|NCT04056624|531409969|FG002|Overall Study|Withdrawal by Subject|1|||
147339190|NCT04056624|531409967|FG000|Overall Study|Protocol Violation|1|||
147339191|NCT04056624|531409968|FG001|Overall Study|Protocol Violation|2|||
147339192|NCT04056624|531409969|FG002|Overall Study|Protocol Violation|0|||
147339193|NCT02092116|531409975|FG000|Overall Study|Withdrawal by Subject|0|||
147339194|NCT02092116|531409976|FG001|Overall Study|Withdrawal by Subject|3|||
147339195|NCT02092116|531409975|FG000|Overall Study|Adverse Event|0|||
147339196|NCT02092116|531409976|FG001|Overall Study|Adverse Event|1|||
147339197|NCT00350792|531409978|FG000|Overall Study|Adverse Event|11|||
147339198|NCT00350792|531409978|FG000|Overall Study|Death from Study Disease|1|||
147339199|NCT00350792|531409978|FG000|Overall Study|Death from Study Drug Toxicity|1|||
147339200|NCT00350792|531409978|FG000|Overall Study|Death Not Study Drug Related|2|||
147339201|NCT00350792|531409978|FG000|Overall Study|Protocol Violation|1|||
147339202|NCT00350792|531409978|FG000|Overall Study|Withdrawal by Subject|4|||
147339203|NCT00350792|531409978|FG000|Overall Study|Physician Decision|2|||
147339204|NCT00350792|531409978|FG000|Overall Study|Lack of Efficacy|11|||
147339205|NCT01792830|531409982|FG000|Overall Study|Withdrawal by Subject|22|||
147339206|NCT01792830|531409983|FG001|Overall Study|Withdrawal by Subject|0|||
147339207|NCT01792830|531409984|FG002|Overall Study|Withdrawal by Subject|0|||
147339208|NCT01792830|531409985|FG003|Overall Study|Withdrawal by Subject|2|||
147339209|NCT01792830|531409986|FG004|Overall Study|Withdrawal by Subject|1|||
147339210|NCT01792830|531409987|FG005|Overall Study|Withdrawal by Subject|1|||
147339211|NCT01792830|531409988|FG006|Overall Study|Withdrawal by Subject|1|||
147339212|NCT01792830|531409989|FG007|Overall Study|Withdrawal by Subject|1|||
147339213|NCT01792830|531409990|FG008|Overall Study|Withdrawal by Subject|7|||
147339214|NCT01792830|531409991|FG009|Overall Study|Withdrawal by Subject|0|||
147339215|NCT01792830|531409992|FG010|Overall Study|Withdrawal by Subject|2|||
147339216|NCT01792830|531409982|FG000|Overall Study|Death|3|||
147339217|NCT01792830|531409983|FG001|Overall Study|Death|0|||
147339218|NCT01792830|531409984|FG002|Overall Study|Death|0|||
147339219|NCT01792830|531409985|FG003|Overall Study|Death|1|||
147452920|NCT00493038|531821483|FG000|Treatment|Withdrawal by Subject|11|||
147339220|NCT01792830|531409986|FG004|Overall Study|Death|0|||
147339221|NCT01792830|531409987|FG005|Overall Study|Death|0|||
147339222|NCT01792830|531409988|FG006|Overall Study|Death|1|||
147295145|NCT01323530|531244598|FG001|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
147295146|NCT01323530|531244599|FG002|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
147295147|NCT01323530|531244600|FG003|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
147295148|NCT01323530|531244601|FG004|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
147295149|NCT01323530|531244602|FG005|Phase 2 (Dose-confirmation Phase)|Clinical progression|0|||
147295150|NCT01323530|531244603|FG006|Phase 2 (Dose-confirmation Phase)|Clinical progression|3|||
147295151|NCT01323530|531244597|FG000|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
147295152|NCT01323530|531244598|FG001|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
147295153|NCT01323530|531244599|FG002|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
147295154|NCT01323530|531244600|FG003|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
147295155|NCT01323530|531244601|FG004|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
147295156|NCT01323530|531244602|FG005|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|0|||
147295157|NCT01323530|531244603|FG006|Phase 2 (Dose-confirmation Phase)|Withdrawal by Subject|8|||
147295158|NCT01323530|531244597|FG000|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
147295159|NCT01323530|531244598|FG001|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
147295160|NCT01323530|531244599|FG002|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
147295161|NCT01323530|531244600|FG003|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
147295162|NCT01323530|531244601|FG004|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
147295163|NCT01323530|531244602|FG005|Phase 2 (Dose-confirmation Phase)|Investigators decision|0|||
147295164|NCT01323530|531244603|FG006|Phase 2 (Dose-confirmation Phase)|Investigators decision|3|||
147295165|NCT01323530|531244597|FG000|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
147295166|NCT01323530|531244598|FG001|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
147295167|NCT01323530|531244599|FG002|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
147295168|NCT01323530|531244600|FG003|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
147295169|NCT01323530|531244601|FG004|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
147295170|NCT01323530|531244602|FG005|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|0|||
147295171|NCT01323530|531244603|FG006|Phase 2 (Dose-confirmation Phase)|Development of bladder cancer|1|||
147295172|NCT01194570|531244604|FG000|Overall Study|Adverse Event|22|||
147295173|NCT01194570|531244605|FG001|Overall Study|Adverse Event|40|||
147295174|NCT01194570|531244604|FG000|Overall Study|Death|6|||
147295175|NCT01194570|531244605|FG001|Overall Study|Death|20|||
147295176|NCT01194570|531244604|FG000|Overall Study|Lack of Efficacy|32|||
147295177|NCT01194570|531244605|FG001|Overall Study|Lack of Efficacy|33|||
147295178|NCT01194570|531244604|FG000|Overall Study|Lost to Follow-up|4|||
147295179|NCT01194570|531244605|FG001|Overall Study|Lost to Follow-up|15|||
147295180|NCT01194570|531244604|FG000|Overall Study|Non-Compliance|2|||
147295181|NCT01194570|531244605|FG001|Overall Study|Non-Compliance|2|||
147295182|NCT01194570|531244604|FG000|Overall Study|Non-Compliance With Study Drug|2|||
147295183|NCT01194570|531244605|FG001|Overall Study|Non-Compliance With Study Drug|2|||
147295184|NCT01194570|531244604|FG000|Overall Study|Other|18|||
147295185|NCT01194570|531244605|FG001|Overall Study|Other|47|||
147295186|NCT01194570|531244604|FG000|Overall Study|Physician Decision|10|||
147295187|NCT01194570|531244605|FG001|Overall Study|Physician Decision|25|||
147295188|NCT01194570|531244604|FG000|Overall Study|Protocol Violation|1|||
147295189|NCT01194570|531244605|FG001|Overall Study|Protocol Violation|2|||
147295190|NCT01194570|531244604|FG000|Overall Study|Study Terminated By Sponsor|0|||
147295191|NCT01194570|531244605|FG001|Overall Study|Study Terminated By Sponsor|1|||
147295192|NCT01194570|531244604|FG000|Overall Study|Withdrawal by Subject|57|||
147295193|NCT01194570|531244605|FG001|Overall Study|Withdrawal by Subject|82|||
147295194|NCT01194570|531244604|FG000|Overall Study|Pregnancy|1|||
147295195|NCT01194570|531244605|FG001|Overall Study|Pregnancy|1|||
147295196|NCT00289887|531244611|FG000|Overall Study|Adverse Event|3|||
147295197|NCT00289887|531244612|FG001|Overall Study|Adverse Event|3|||
147295198|NCT00289887|531244611|FG000|Overall Study|Lack of Efficacy|3|||
147339223|NCT01792830|531409989|FG007|Overall Study|Death|0|||
147339224|NCT01792830|531409990|FG008|Overall Study|Death|1|||
147339225|NCT01792830|531409991|FG009|Overall Study|Death|0|||
147339226|NCT01792830|531409992|FG010|Overall Study|Death|1|||
147339227|NCT01792830|531409982|FG000|Overall Study|Adverse Event|0|||
147339228|NCT01792830|531409983|FG001|Overall Study|Adverse Event|0|||
147339229|NCT01792830|531409984|FG002|Overall Study|Adverse Event|0|||
147606207|NCT01056289|532375161|FG002|Double-blind Phase|Physician Decision|1|||
147606208|NCT01056289|532375162|FG003|Double-blind Phase|Physician Decision|0|||
147606209|NCT00270855|532375169|FG000|Overall Study|Withdrawal by Subject|8|||
147606210|NCT00270855|532375170|FG001|Overall Study|Withdrawal by Subject|8|||
147295199|NCT00289887|531244612|FG001|Overall Study|Lack of Efficacy|11|||
147295200|NCT00289887|531244611|FG000|Overall Study|Lost to Follow-up|3|||
147295201|NCT00289887|531244612|FG001|Overall Study|Lost to Follow-up|3|||
147295202|NCT00289887|531244611|FG000|Overall Study|Protocol Violation|3|||
147295203|NCT00289887|531244612|FG001|Overall Study|Protocol Violation|1|||
147295204|NCT00289887|531244611|FG000|Overall Study|Withdrawal by Subject|3|||
147295205|NCT00289887|531244612|FG001|Overall Study|Withdrawal by Subject|8|||
147295206|NCT00289887|531244611|FG000|Overall Study|Other|7|||
147295207|NCT00289887|531244612|FG001|Overall Study|Other|3|||
147295208|NCT01266850|531244613|FG000|Overall Study|Lost to Follow-up|19|||
147295209|NCT01266850|531244614|FG001|Overall Study|Lost to Follow-up|19|||
147295210|NCT01266850|531244615|FG002|Overall Study|Lost to Follow-up|13|||
147295211|NCT01266850|531244616|FG003|Overall Study|Lost to Follow-up|13|||
147295212|NCT01266850|531244617|FG004|Overall Study|Lost to Follow-up|12|||
147295213|NCT01266850|531244613|FG000|Overall Study|Withdrawal by Subject|8|||
147295214|NCT01266850|531244614|FG001|Overall Study|Withdrawal by Subject|9|||
147295215|NCT01266850|531244615|FG002|Overall Study|Withdrawal by Subject|6|||
147295216|NCT01266850|531244616|FG003|Overall Study|Withdrawal by Subject|9|||
147295217|NCT01266850|531244617|FG004|Overall Study|Withdrawal by Subject|12|||
147295218|NCT01266850|531244613|FG000|Overall Study|Physician Decision|3|||
147295219|NCT01266850|531244614|FG001|Overall Study|Physician Decision|6|||
147295220|NCT01266850|531244615|FG002|Overall Study|Physician Decision|4|||
147295221|NCT01266850|531244616|FG003|Overall Study|Physician Decision|4|||
147295222|NCT01266850|531244617|FG004|Overall Study|Physician Decision|3|||
147295223|NCT01266850|531244613|FG000|Overall Study|Protocol Violation|0|||
147295224|NCT01266850|531244614|FG001|Overall Study|Protocol Violation|1|||
147295225|NCT01266850|531244615|FG002|Overall Study|Protocol Violation|0|||
147295226|NCT01266850|531244616|FG003|Overall Study|Protocol Violation|1|||
147295227|NCT01266850|531244617|FG004|Overall Study|Protocol Violation|2|||
147295228|NCT01266850|531244613|FG000|Overall Study|Adverse Event|0|||
147295229|NCT01266850|531244614|FG001|Overall Study|Adverse Event|0|||
147295230|NCT01266850|531244615|FG002|Overall Study|Adverse Event|0|||
147295231|NCT01266850|531244616|FG003|Overall Study|Adverse Event|0|||
147295232|NCT01266850|531244617|FG004|Overall Study|Adverse Event|1|||
147295233|NCT01266850|531244613|FG000|Overall Study|Site Closure|0|||
147339230|NCT01792830|531409985|FG003|Overall Study|Adverse Event|0|||
147339231|NCT01792830|531409986|FG004|Overall Study|Adverse Event|0|||
147339232|NCT01792830|531409987|FG005|Overall Study|Adverse Event|0|||
147339233|NCT01792830|531409988|FG006|Overall Study|Adverse Event|0|||
147339234|NCT01792830|531409989|FG007|Overall Study|Adverse Event|0|||
147339235|NCT01792830|531409990|FG008|Overall Study|Adverse Event|1|||
147339236|NCT01792830|531409991|FG009|Overall Study|Adverse Event|0|||
147339237|NCT01792830|531409992|FG010|Overall Study|Adverse Event|0|||
147339238|NCT01943799|531409993|FG000|Overall Study|Lost to Follow-up|0|||
147339239|NCT01943799|531409994|FG001|Overall Study|Lost to Follow-up|1|||
147339240|NCT01943799|531409995|FG002|Overall Study|Lost to Follow-up|1|||
147339241|NCT01943799|531409996|FG003|Overall Study|Lost to Follow-up|0|||
147339242|NCT01943799|531409993|FG000|Overall Study|Protocol Violation|1|||
147295234|NCT01266850|531244614|FG001|Overall Study|Site Closure|1|||
147295235|NCT01266850|531244615|FG002|Overall Study|Site Closure|1|||
147295236|NCT01266850|531244616|FG003|Overall Study|Site Closure|1|||
147295237|NCT01266850|531244617|FG004|Overall Study|Site Closure|0|||
147295238|NCT04128293|531244619|FG000|Washout Period 2 (Up to 7 Days)|Study Closed/Terminated|4|||
147295239|NCT04128293|531244620|FG001|Washout Period 2 (Up to 7 Days)|Study Closed/Terminated|4|||
147295240|NCT04128293|531244621|FG002|Washout Period 2 (Up to 7 Days)|Study Closed/Terminated|4|||
147295241|NCT04128293|531244622|FG003|Washout Period 2 (Up to 7 Days)|Study Closed/Terminated|4|||
147295242|NCT02035332|531244623|FG000|Overall Study|Procedure Aborted due to Uterine Width|1|||
147295243|NCT02030015|531244628|FG000|Overall Study|Withdrawal by Subject|3|||
147295244|NCT02030015|531244628|FG000|Overall Study|Death|13|||
147295245|NCT01332227|531244630|FG000|Overall Study|Adverse Event|4|||
147295246|NCT01332227|531244631|FG001|Overall Study|Adverse Event|1|||
147295247|NCT01332227|531244630|FG000|Overall Study|Withdrawal by Subject|5|||
147339243|NCT01943799|531409994|FG001|Overall Study|Protocol Violation|0|||
147295248|NCT01332227|531244631|FG001|Overall Study|Withdrawal by Subject|1|||
147339244|NCT01943799|531409995|FG002|Overall Study|Protocol Violation|0|||
147339245|NCT01943799|531409996|FG003|Overall Study|Protocol Violation|0|||
147339246|NCT01943799|531409993|FG000|Overall Study|Withdrawal by Subject|4|||
147339247|NCT01943799|531409994|FG001|Overall Study|Withdrawal by Subject|2|||
147339248|NCT01943799|531409995|FG002|Overall Study|Withdrawal by Subject|1|||
147339249|NCT01943799|531409996|FG003|Overall Study|Withdrawal by Subject|0|||
147339250|NCT03811574|531409999|FG000|Overall Study|Withdrawal by Subject|2|||
147339251|NCT03811574|531410000|FG001|Overall Study|Withdrawal by Subject|4|||
147339252|NCT03811574|531410001|FG002|Overall Study|Withdrawal by Subject|0|||
147339253|NCT01832480|531410002|FG000|Overall Study|Lost to Follow-up|33|||
147452921|NCT00493038|531821484|FG001|Treatment|Withdrawal by Subject|12|||
147339254|NCT01832480|531410003|FG001|Overall Study|Lost to Follow-up|30|||
147339255|NCT01832480|531410002|FG000|Overall Study|Withdrawal by Subject|0|||
147339256|NCT01832480|531410003|FG001|Overall Study|Withdrawal by Subject|2|||
147295249|NCT01332227|531244630|FG000|Overall Study|Lost to Follow-up|2|||
147295250|NCT01332227|531244631|FG001|Overall Study|Lost to Follow-up|0|||
147295251|NCT01332227|531244630|FG000|Overall Study|Lack of Efficacy|3|||
147295252|NCT01332227|531244631|FG001|Overall Study|Lack of Efficacy|1|||
147295253|NCT01332227|531244630|FG000|Overall Study|Poor compliance/noncompliance|1|||
147295254|NCT01332227|531244631|FG001|Overall Study|Poor compliance/noncompliance|1|||
147295255|NCT01332227|531244630|FG000|Overall Study|Patient moved from area|1|||
147339257|NCT01832480|531410002|FG000|Overall Study|post randomization ineligible|8|||
147339258|NCT01832480|531410003|FG001|Overall Study|post randomization ineligible|10|||
147295256|NCT01332227|531244631|FG001|Overall Study|Patient moved from area|0|||
147295257|NCT01332227|531244630|FG000|Overall Study|Patient began prohibited medication|0|||
147295258|NCT01332227|531244631|FG001|Overall Study|Patient began prohibited medication|1|||
147295259|NCT00514943|531244632|FG000|Stage 1|Progressive disease|4|||
147295260|NCT00514943|531244633|FG001|Stage 1|Progressive disease|8|||
147295261|NCT00514943|531244632|FG000|Stage 1|Other Adverse Event|16|||
147295262|NCT00514943|531244633|FG001|Stage 1|Other Adverse Event|6|||
147295263|NCT00514943|531244632|FG000|Stage 1|Not treated|1|||
147295264|NCT00514943|531244633|FG001|Stage 1|Not treated|2|||
147295265|NCT00514943|531244632|FG000|Stage 1|Patient refused to continue study meds|8|||
147295266|NCT00514943|531244633|FG001|Stage 1|Patient refused to continue study meds|3|||
147295267|NCT00514943|531244632|FG000|Stage 1|Other than stated above|1|||
147295268|NCT00514943|531244633|FG001|Stage 1|Other than stated above|7|||
147295269|NCT00514943|531244632|FG000|Stage 2|Progressive disease|27|||
147295270|NCT00514943|531244633|FG001|Stage 2|Progressive disease|24|||
147295271|NCT00514943|531244632|FG000|Stage 2|Other Adverse Event|3|||
147295272|NCT00514943|531244633|FG001|Stage 2|Other Adverse Event|10|||
147295273|NCT00514943|531244632|FG000|Stage 2|Patient refused to continue study meds|2|||
147295274|NCT00514943|531244633|FG001|Stage 2|Patient refused to continue study meds|0|||
147295275|NCT00514943|531244632|FG000|Stage 2|Other than stated above|0|||
147295276|NCT00514943|531244633|FG001|Stage 2|Other than stated above|2|||
147295277|NCT03751631|531244639|FG000|Overall Study|Withdrawal by Subject|0|||
147295278|NCT03751631|531244640|FG001|Overall Study|Withdrawal by Subject|0|||
147295279|NCT03751631|531244641|FG002|Overall Study|Withdrawal by Subject|1|||
147295280|NCT03751631|531244642|FG003|Overall Study|Withdrawal by Subject|1|||
147295281|NCT03751631|531244643|FG004|Overall Study|Withdrawal by Subject|0|||
147295282|NCT03751631|531244644|FG005|Overall Study|Withdrawal by Subject|0|||
147295283|NCT00833560|531244645|FG000|Overall Study|Toxicity|13|||
147295284|NCT00833560|531244645|FG000|Overall Study|Adverse Event|11|||
147295285|NCT00833560|531244645|FG000|Overall Study|Protocol Violation|6|||
147295286|NCT00833560|531244645|FG000|Overall Study|Lack of Efficacy|4|||
147295287|NCT00833560|531244645|FG000|Overall Study|Death|2|||
147295288|NCT00833560|531244645|FG000|Overall Study|Pregression of other disease|1|||
147295289|NCT00833560|531244645|FG000|Overall Study|Other|5|||
147295290|NCT00499031|531244646|FG000|Overall Study|Improper pre-protocol treatment|1|||
147295291|NCT00499031|531244646|FG000|Overall Study|Required test not done|1|||
147295292|NCT00499031|531244646|FG000|Overall Study|Never treated|1|||
147295293|NCT03382782|531244651|FG000|Cohort 1|Withdrawal by Subject|11|||
147295294|NCT03382782|531244652|FG001|Cohort 1|Withdrawal by Subject|5|||
147295295|NCT03382782|531244653|FG002|Cohort 1|Withdrawal by Subject|0|||
147295296|NCT03382782|531244651|FG000|Cohort 2|Withdrawal by Subject|1|||
147295297|NCT03382782|531244652|FG001|Cohort 2|Withdrawal by Subject|1|||
147295298|NCT03382782|531244653|FG002|Cohort 2|Withdrawal by Subject|0|||
147295299|NCT03382782|531244651|FG000|Cohort 3|Withdrawal by Subject|1|||
147295300|NCT03382782|531244652|FG001|Cohort 3|Withdrawal by Subject|2|||
147295301|NCT03382782|531244653|FG002|Cohort 3|Withdrawal by Subject|0|||
147295302|NCT03409666|531244658|FG000|Overall Study|Physician Decision|0|||
147295303|NCT03409666|531244659|FG001|Overall Study|Physician Decision|1|||
147295304|NCT03409666|531244658|FG000|Overall Study|Protocol Violation|0|||
147295305|NCT03409666|531244659|FG001|Overall Study|Protocol Violation|3|||
147295306|NCT01791725|531244660|FG000|Overall Study|Withdrawal by Subject|0|||
147295307|NCT01791725|531244661|FG001|Overall Study|Withdrawal by Subject|1|||
147295308|NCT01791725|531244662|FG002|Overall Study|Withdrawal by Subject|0|||
147295309|NCT00512148|531244663|FG000|Primay Study Period|Withdrawal by Subject|1|||
147295310|NCT01666951|531244670|FG000|Overall Study|Not dosed|1|||
147295311|NCT01666951|531244671|FG001|Overall Study|Not dosed|1|||
147295312|NCT02366910|531244672|FG000|Overall Study|Withdrawal by Subject|2|||
147295313|NCT02366910|531244672|FG000|Overall Study|Screen Failure|3|||
147295314|NCT02623322|531244676|FG000|Overall Study|Lost to Follow-up|2|||
147295315|NCT02623322|531244677|FG001|Overall Study|Lost to Follow-up|1|||
147295316|NCT02623322|531244678|FG002|Overall Study|Lost to Follow-up|0|||
147295317|NCT03284788|531244679|FG000|Overall Study|Withdrawal by Subject|2|||
147295318|NCT03563716|531244680|FG000|Overall Study|Death|20|||
147295319|NCT03563716|531244681|FG001|Overall Study|Death|14|||
147295320|NCT03563716|531244680|FG000|Overall Study|Withdrawal by Subject|3|||
147295321|NCT03563716|531244681|FG001|Overall Study|Withdrawal by Subject|3|||
147295322|NCT03563716|531244680|FG000|Overall Study|Still on Study|45|||
147295323|NCT03563716|531244681|FG001|Overall Study|Still on Study|50|||
147295324|NCT04605978|531244685|FG000|Overall Study|Adverse Event|2|||
147295325|NCT04605978|531244686|FG001|Overall Study|Adverse Event|1|||
147295326|NCT04605978|531244685|FG000|Overall Study|Withdrawal nonmedical reason|1|||
147295327|NCT04605978|531244686|FG001|Overall Study|Withdrawal nonmedical reason|1|||
147295328|NCT03813238|531244687|FG000|Overall Study|Adverse Event|0|||
147295329|NCT03813238|531244688|FG001|Overall Study|Adverse Event|6|||
147295330|NCT03813238|531244687|FG000|Overall Study|Withdrawal by parent/guardian|0|||
147295331|NCT03813238|531244688|FG001|Overall Study|Withdrawal by parent/guardian|2|||
147295332|NCT03813238|531244687|FG000|Overall Study|Lost to Follow-up|0|||
147295333|NCT03813238|531244688|FG001|Overall Study|Lost to Follow-up|1|||
147295334|NCT03813238|531244687|FG000|Overall Study|Other than specified|1|||
147295335|NCT03813238|531244688|FG001|Overall Study|Other than specified|2|||
147295336|NCT02583425|531244689|FG000|Screening|Did not meet entry criteria|12|||
147339259|NCT05510245|531410008|FG000|Overall Study|Withdrawal by Subject|1|||
147339260|NCT05510245|531410009|FG001|Overall Study|Withdrawal by Subject|0|||
147339261|NCT05510245|531410010|FG002|Overall Study|Withdrawal by Subject|0|||
147339262|NCT01373346|531410016|FG000|Overall Study|Death|1|||
147295337|NCT02583425|531244689|FG000|Baseline|Did not meet continued criteria|5|||
147295338|NCT02583425|531244689|FG000|Treatment Period|Adverse Event|1|||
147295339|NCT03104699|531244690|FG000|Phase 1: Dose Escalation|Withdrawal by Subject|2|||
147295340|NCT03104699|531244691|FG001|Phase 1: Dose Escalation|Withdrawal by Subject|2|||
147295341|NCT03104699|531244692|FG002|Phase 1: Dose Escalation|Withdrawal by Subject|4|||
147295342|NCT03104699|531244693|FG003|Phase 1: Dose Escalation|Withdrawal by Subject|8|||
147295343|NCT03104699|531244694|FG004|Phase 1: Dose Escalation|Withdrawal by Subject|4|||
147295344|NCT03104699|531244695|FG005|Phase 1: Dose Escalation|Withdrawal by Subject|0|||
147295345|NCT03104699|531244690|FG000|Phase 1: Dose Escalation|Physician Decision|0|||
147295346|NCT03104699|531244691|FG001|Phase 1: Dose Escalation|Physician Decision|0|||
147295347|NCT03104699|531244692|FG002|Phase 1: Dose Escalation|Physician Decision|2|||
147295348|NCT03104699|531244693|FG003|Phase 1: Dose Escalation|Physician Decision|1|||
147295349|NCT03104699|531244694|FG004|Phase 1: Dose Escalation|Physician Decision|0|||
147295350|NCT03104699|531244695|FG005|Phase 1: Dose Escalation|Physician Decision|0|||
147295351|NCT03104699|531244690|FG000|Phase 1: Dose Escalation|Death|6|||
147295352|NCT03104699|531244691|FG001|Phase 1: Dose Escalation|Death|3|||
147295353|NCT03104699|531244692|FG002|Phase 1: Dose Escalation|Death|0|||
147295354|NCT03104699|531244693|FG003|Phase 1: Dose Escalation|Death|1|||
147295355|NCT03104699|531244694|FG004|Phase 1: Dose Escalation|Death|1|||
147295356|NCT03104699|531244695|FG005|Phase 1: Dose Escalation|Death|0|||
147295357|NCT03104699|531244690|FG000|Phase 1: Dose Escalation|Completed Follow Up|2|||
147295358|NCT03104699|531244691|FG001|Phase 1: Dose Escalation|Completed Follow Up|2|||
147295359|NCT03104699|531244692|FG002|Phase 1: Dose Escalation|Completed Follow Up|1|||
147295360|NCT03104699|531244693|FG003|Phase 1: Dose Escalation|Completed Follow Up|0|||
147295361|NCT03104699|531244694|FG004|Phase 1: Dose Escalation|Completed Follow Up|2|||
147295362|NCT03104699|531244695|FG005|Phase 1: Dose Escalation|Completed Follow Up|0|||
147295363|NCT03104699|531244690|FG000|Phase 1: Dose Escalation|Lost to Follow-up|0|||
147295364|NCT03104699|531244691|FG001|Phase 1: Dose Escalation|Lost to Follow-up|1|||
147295365|NCT03104699|531244692|FG002|Phase 1: Dose Escalation|Lost to Follow-up|1|||
147295366|NCT03104699|531244693|FG003|Phase 1: Dose Escalation|Lost to Follow-up|0|||
147295367|NCT03104699|531244694|FG004|Phase 1: Dose Escalation|Lost to Follow-up|0|||
147295368|NCT03104699|531244695|FG005|Phase 1: Dose Escalation|Lost to Follow-up|0|||
147295369|NCT03104699|531244690|FG000|Phase 1: Dose Escalation|Progressive Disease|0|||
147295370|NCT03104699|531244691|FG001|Phase 1: Dose Escalation|Progressive Disease|0|||
147295371|NCT03104699|531244692|FG002|Phase 1: Dose Escalation|Progressive Disease|0|||
147295372|NCT03104699|531244693|FG003|Phase 1: Dose Escalation|Progressive Disease|0|||
147295373|NCT03104699|531244694|FG004|Phase 1: Dose Escalation|Progressive Disease|1|||
147295374|NCT03104699|531244695|FG005|Phase 1: Dose Escalation|Progressive Disease|0|||
147295375|NCT03104699|531244690|FG000|Phase 1: Dose Escalation|Disease Progression|0|||
147295376|NCT03104699|531244691|FG001|Phase 1: Dose Escalation|Disease Progression|2|||
147295377|NCT03104699|531244692|FG002|Phase 1: Dose Escalation|Disease Progression|0|||
147295378|NCT03104699|531244693|FG003|Phase 1: Dose Escalation|Disease Progression|0|||
147295379|NCT03104699|531244694|FG004|Phase 1: Dose Escalation|Disease Progression|0|||
147295380|NCT03104699|531244695|FG005|Phase 1: Dose Escalation|Disease Progression|0|||
147295381|NCT03104699|531244690|FG000|Phase 1: Dose Escalation|Protocol Violation|0|||
147295382|NCT03104699|531244691|FG001|Phase 1: Dose Escalation|Protocol Violation|0|||
147295383|NCT03104699|531244692|FG002|Phase 1: Dose Escalation|Protocol Violation|0|||
147339263|NCT01198028|531410017|FG000|Overall Study|Adverse Event|5|||
147339264|NCT01198028|531410017|FG000|Overall Study|Death|3|||
147339265|NCT01198028|531410017|FG000|Overall Study|Physician Decision|2|||
147339266|NCT00970359|531410021|FG000|Overall Study|Not Treated|4|||
147295384|NCT03104699|531244693|FG003|Phase 1: Dose Escalation|Protocol Violation|0|||
147295385|NCT03104699|531244694|FG004|Phase 1: Dose Escalation|Protocol Violation|2|||
147295386|NCT03104699|531244695|FG005|Phase 1: Dose Escalation|Protocol Violation|0|||
147295387|NCT03104699|531244690|FG000|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
147295388|NCT03104699|531244691|FG001|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
147295389|NCT03104699|531244692|FG002|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
147295390|NCT03104699|531244693|FG003|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
147295391|NCT03104699|531244694|FG004|Phase 2: Dose Expansion|Withdrawal by Subject|0|||
147295392|NCT03104699|531244695|FG005|Phase 2: Dose Expansion|Withdrawal by Subject|6|||
147295393|NCT03104699|531244690|FG000|Phase 2: Dose Expansion|Death|0|||
147339267|NCT01565148|531410022|FG000|Overall Study|Withdrawal by Subject|1|||
147339268|NCT01565148|531410023|FG001|Overall Study|Withdrawal by Subject|1|||
147339269|NCT01565148|531410024|FG002|Overall Study|Withdrawal by Subject|1|||
147339270|NCT01565148|531410025|FG003|Overall Study|Withdrawal by Subject|2|||
147606211|NCT00450801|532375175|FG000|Overall Study|Death|1|||
147606212|NCT01396512|532375178|FG000|Overall Study|Withdrawal by Subject|0|||
147295394|NCT03104699|531244691|FG001|Phase 2: Dose Expansion|Death|0|||
147295395|NCT03104699|531244692|FG002|Phase 2: Dose Expansion|Death|0|||
147295396|NCT03104699|531244693|FG003|Phase 2: Dose Expansion|Death|0|||
147295397|NCT03104699|531244694|FG004|Phase 2: Dose Expansion|Death|0|||
147295398|NCT03104699|531244695|FG005|Phase 2: Dose Expansion|Death|107|||
147295399|NCT03104699|531244690|FG000|Phase 2: Dose Expansion|Participant Left to Participate in Another Trial|0|||
147295400|NCT03104699|531244691|FG001|Phase 2: Dose Expansion|Participant Left to Participate in Another Trial|0|||
147295401|NCT03104699|531244692|FG002|Phase 2: Dose Expansion|Participant Left to Participate in Another Trial|0|||
147295402|NCT03104699|531244693|FG003|Phase 2: Dose Expansion|Participant Left to Participate in Another Trial|0|||
147295403|NCT03104699|531244694|FG004|Phase 2: Dose Expansion|Participant Left to Participate in Another Trial|0|||
147295404|NCT03104699|531244695|FG005|Phase 2: Dose Expansion|Participant Left to Participate in Another Trial|1|||
147295405|NCT03104699|531244690|FG000|Phase 2: Dose Expansion|Administrative Study Closure|0|||
147295406|NCT03104699|531244691|FG001|Phase 2: Dose Expansion|Administrative Study Closure|0|||
147295407|NCT03104699|531244692|FG002|Phase 2: Dose Expansion|Administrative Study Closure|0|||
147295408|NCT03104699|531244693|FG003|Phase 2: Dose Expansion|Administrative Study Closure|0|||
147295409|NCT03104699|531244694|FG004|Phase 2: Dose Expansion|Administrative Study Closure|0|||
147295410|NCT03104699|531244695|FG005|Phase 2: Dose Expansion|Administrative Study Closure|13|||
147295411|NCT03104699|531244690|FG000|Phase 2: Dose Expansion|Lost to Follow-up|0|||
147295412|NCT03104699|531244691|FG001|Phase 2: Dose Expansion|Lost to Follow-up|0|||
147295413|NCT03104699|531244692|FG002|Phase 2: Dose Expansion|Lost to Follow-up|0|||
147295414|NCT03104699|531244693|FG003|Phase 2: Dose Expansion|Lost to Follow-up|0|||
147295415|NCT03104699|531244694|FG004|Phase 2: Dose Expansion|Lost to Follow-up|0|||
147295416|NCT03104699|531244695|FG005|Phase 2: Dose Expansion|Lost to Follow-up|5|||
147295417|NCT03104699|531244690|FG000|Phase 2: Dose Expansion|Progressive Disease|0|||
147295418|NCT03104699|531244691|FG001|Phase 2: Dose Expansion|Progressive Disease|0|||
147295419|NCT03104699|531244692|FG002|Phase 2: Dose Expansion|Progressive Disease|0|||
147295420|NCT03104699|531244693|FG003|Phase 2: Dose Expansion|Progressive Disease|0|||
147295421|NCT03104699|531244694|FG004|Phase 2: Dose Expansion|Progressive Disease|0|||
147295422|NCT03104699|531244695|FG005|Phase 2: Dose Expansion|Progressive Disease|1|||
147295423|NCT01690130|531244696|FG000|Overall Study|Subject have cancelled visit.|1|||
147295424|NCT01690130|531244697|FG001|Overall Study|Subject have cancelled visit.|0|||
147295425|NCT01644734|531244698|FG000|Overall Study|Adverse Event|4|||
147295426|NCT01644734|531244698|FG000|Overall Study|Lost to Follow-up|17|||
147295427|NCT01644734|531244698|FG000|Overall Study|Reasons other than stated above|7|||
147295428|NCT01644734|531244698|FG000|Overall Study|Missing documentation|238|||
147295429|NCT02462876|531244699|FG000|Overall Study|Death|3|||
147295430|NCT02462876|531244699|FG000|Overall Study|Lost to Follow-up|7|||
147295431|NCT02462876|531244699|FG000|Overall Study|Surgical Bypass|9|||
147295432|NCT02462876|531244699|FG000|Overall Study|Amputation Above the Metatarsals|1|||
147295433|NCT02462876|531244699|FG000|Overall Study|36 months follow-up visit missed|1|||
147295434|NCT02462876|531244699|FG000|Overall Study|Patient did not come back since 4 months follow-up|1|||
147295435|NCT02462876|531244699|FG000|Overall Study|Patient did not come back to the vascular department|1|||
147295436|NCT02462876|531244699|FG000|Overall Study|Patient contacted by phone but never came back for his follow-up visits|1|||
147295437|NCT02462876|531244699|FG000|Overall Study|Patient refused to come back|1|||
147295438|NCT02462876|531244699|FG000|Overall Study|Patient was contacted on Sep 2020. He is fine but refused to come back for his 36 months|1|||
147295439|NCT02462876|531244699|FG000|Overall Study|Patient cancelled the follow-up visit twice time|1|||
147295440|NCT01786512|531244700|FG000|Overall Study|Lost to Follow-up|0|||
147295441|NCT01786512|531244701|FG001|Overall Study|Lost to Follow-up|0|||
147295442|NCT01786512|531244702|FG002|Overall Study|Lost to Follow-up|0|||
147295443|NCT01786512|531244703|FG003|Overall Study|Lost to Follow-up|0|||
147295444|NCT01786512|531244704|FG004|Overall Study|Lost to Follow-up|0|||
147295445|NCT01786512|531244705|FG005|Overall Study|Lost to Follow-up|0|||
147295446|NCT01786512|531244706|FG006|Overall Study|Lost to Follow-up|0|||
147295447|NCT01786512|531244707|FG007|Overall Study|Lost to Follow-up|0|||
147606213|NCT01396512|532375179|FG001|Overall Study|Withdrawal by Subject|1|||
147606214|NCT02618759|532375182|FG000|Overall Study|Lost to Follow-up|0|||
147606215|NCT02618759|532375183|FG001|Overall Study|Lost to Follow-up|1|||
147606216|NCT02618759|532375182|FG000|Overall Study|Withdrawal by Subject|1|||
147606217|NCT02618759|532375183|FG001|Overall Study|Withdrawal by Subject|0|||
147606218|NCT02618759|532375182|FG000|Overall Study|Other Reasons|1|||
147606219|NCT02618759|532375183|FG001|Overall Study|Other Reasons|4|||
147606220|NCT02152605|532375184|FG000|Overall Study|Adverse Event|6|||
147606221|NCT02152605|532375185|FG001|Overall Study|Adverse Event|8|||
147606222|NCT02152605|532375184|FG000|Overall Study|Lack of Efficacy|7|||
147606223|NCT02152605|532375185|FG001|Overall Study|Lack of Efficacy|4|||
147606224|NCT02152605|532375184|FG000|Overall Study|Protocol deviation|1|||
147606225|NCT02152605|532375185|FG001|Overall Study|Protocol deviation|4|||
147606226|NCT02152605|532375184|FG000|Overall Study|Lost to Follow-up|1|||
147606227|NCT02152605|532375185|FG001|Overall Study|Lost to Follow-up|0|||
147606228|NCT02152605|532375184|FG000|Overall Study|Withdrew consent|4|||
147606229|NCT02152605|532375185|FG001|Overall Study|Withdrew consent|2|||
147662664|NCT02782741|532587387|FG001|Open-label Long-term: Week 50 to 289|Adverse Event|3|||
147295448|NCT01786512|531244708|FG008|Overall Study|Lost to Follow-up|0|||
147295449|NCT01786512|531244709|FG009|Overall Study|Lost to Follow-up|1|||
147295450|NCT01786512|531244710|FG010|Overall Study|Lost to Follow-up|0|||
147295451|NCT01786512|531244700|FG000|Overall Study|Decision by sponsor|0|||
147295452|NCT01786512|531244701|FG001|Overall Study|Decision by sponsor|0|||
147295453|NCT01786512|531244702|FG002|Overall Study|Decision by sponsor|0|||
147295454|NCT01786512|531244703|FG003|Overall Study|Decision by sponsor|0|||
147295455|NCT01786512|531244704|FG004|Overall Study|Decision by sponsor|0|||
147295456|NCT01786512|531244705|FG005|Overall Study|Decision by sponsor|0|||
147295457|NCT01786512|531244706|FG006|Overall Study|Decision by sponsor|0|||
147295458|NCT01786512|531244707|FG007|Overall Study|Decision by sponsor|0|||
147295459|NCT01786512|531244708|FG008|Overall Study|Decision by sponsor|0|||
147295460|NCT01786512|531244709|FG009|Overall Study|Decision by sponsor|0|||
147295461|NCT01786512|531244710|FG010|Overall Study|Decision by sponsor|2|||
147295462|NCT01786512|531244700|FG000|Overall Study|Withdrawal by Subject|0|||
147295463|NCT01786512|531244701|FG001|Overall Study|Withdrawal by Subject|1|||
147295464|NCT01786512|531244702|FG002|Overall Study|Withdrawal by Subject|0|||
147295465|NCT01786512|531244703|FG003|Overall Study|Withdrawal by Subject|0|||
147295466|NCT01786512|531244704|FG004|Overall Study|Withdrawal by Subject|0|||
147295467|NCT01786512|531244705|FG005|Overall Study|Withdrawal by Subject|0|||
147295468|NCT01786512|531244706|FG006|Overall Study|Withdrawal by Subject|1|||
147295469|NCT01786512|531244707|FG007|Overall Study|Withdrawal by Subject|0|||
147295470|NCT01786512|531244708|FG008|Overall Study|Withdrawal by Subject|0|||
147295471|NCT01786512|531244709|FG009|Overall Study|Withdrawal by Subject|3|||
147295472|NCT01786512|531244710|FG010|Overall Study|Withdrawal by Subject|7|||
147295473|NCT01786512|531244700|FG000|Overall Study|Death|0|||
147295474|NCT01786512|531244701|FG001|Overall Study|Death|0|||
147295475|NCT01786512|531244702|FG002|Overall Study|Death|0|||
147295476|NCT01786512|531244703|FG003|Overall Study|Death|0|||
147295477|NCT01786512|531244704|FG004|Overall Study|Death|0|||
147295478|NCT01786512|531244705|FG005|Overall Study|Death|0|||
147295479|NCT01786512|531244706|FG006|Overall Study|Death|0|||
147295480|NCT01786512|531244707|FG007|Overall Study|Death|0|||
147295481|NCT01786512|531244708|FG008|Overall Study|Death|4|||
147295482|NCT01786512|531244709|FG009|Overall Study|Death|1|||
147295483|NCT01786512|531244710|FG010|Overall Study|Death|3|||
147295484|NCT02450331|531244711|FG000|Overall Study|Death|162|||
147295485|NCT02450331|531244712|FG001|Overall Study|Death|171|||
147295486|NCT02450331|531244711|FG000|Overall Study|Lost to Follow-up|14|||
147295487|NCT02450331|531244712|FG001|Overall Study|Lost to Follow-up|12|||
147295488|NCT02450331|531244711|FG000|Overall Study|Withdrawal by Subject|55|||
147295489|NCT02450331|531244712|FG001|Overall Study|Withdrawal by Subject|44|||
147295490|NCT02450331|531244711|FG000|Overall Study|Non-specified other|1|||
147295491|NCT02450331|531244712|FG001|Overall Study|Non-specified other|1|||
147295492|NCT03581981|531244713|FG000|Overall Study|Withdrawal by Subject|12|||
147295493|NCT03581981|531244714|FG001|Overall Study|Withdrawal by Subject|13|||
147295494|NCT03581981|531244713|FG000|Overall Study|Physician Decision|1|||
147295495|NCT03581981|531244714|FG001|Overall Study|Physician Decision|2|||
147295496|NCT03581981|531244713|FG000|Overall Study|Lost to Follow-up|0|||
147295497|NCT03581981|531244714|FG001|Overall Study|Lost to Follow-up|4|||
147295498|NCT02080871|531244715|FG000|Overall Study|Death|1|||
147295499|NCT02080871|531244715|FG000|Overall Study|Lost to Follow-up|1|||
147295500|NCT02157779|531244724|FG000|Overall Study|Logistical|9|||
147295501|NCT02157779|531244725|FG001|Overall Study|Logistical|3|||
147339271|NCT01565148|531410022|FG000|Overall Study|Lost to Follow-up|4|||
147339272|NCT01565148|531410023|FG001|Overall Study|Lost to Follow-up|4|||
147339273|NCT01565148|531410024|FG002|Overall Study|Lost to Follow-up|0|||
147339274|NCT01565148|531410025|FG003|Overall Study|Lost to Follow-up|3|||
147339275|NCT01565148|531410022|FG000|Overall Study|Rescue Therapy|8|||
147295502|NCT02157779|531244724|FG000|Overall Study|Stopped attending, reason unknown|11|||
147295503|NCT02157779|531244725|FG001|Overall Study|Stopped attending, reason unknown|7|||
147295504|NCT02157779|531244724|FG000|Overall Study|No response to outreach after Baseline|1|||
147295505|NCT02157779|531244725|FG001|Overall Study|No response to outreach after Baseline|1|||
147295506|NCT02157779|531244724|FG000|Overall Study|Moved|1|||
147606230|NCT02500043|532375192|FG000|Overall Study|Randomized, but not Treated|2|||
147606231|NCT02500043|532375193|FG001|Overall Study|Randomized, but not Treated|2|||
147295507|NCT02157779|531244725|FG001|Overall Study|Moved|0|||
147339276|NCT01565148|531410023|FG001|Overall Study|Rescue Therapy|5|||
147339277|NCT01565148|531410024|FG002|Overall Study|Rescue Therapy|5|||
147339278|NCT01565148|531410025|FG003|Overall Study|Rescue Therapy|8|||
147339279|NCT01565148|531410022|FG000|Overall Study|Death|0|||
147339280|NCT01565148|531410023|FG001|Overall Study|Death|0|||
147295508|NCT02157779|531244724|FG000|Overall Study|Medical|1|||
147295509|NCT02157779|531244725|FG001|Overall Study|Medical|0|||
147295510|NCT02157779|531244724|FG000|Overall Study|Legal issue|1|||
147295511|NCT02157779|531244725|FG001|Overall Study|Legal issue|0|||
147606232|NCT02500043|532375192|FG000|Overall Study|Ongoing at Date of Cut-Off|19|||
147295512|NCT02548455|531244727|FG000|Overall Study|Withdrawal by Subject|27|||
147295513|NCT02548455|531244727|FG000|Overall Study|Death|26|||
147295514|NCT02548455|531244727|FG000|Overall Study|Lost to Follow-up|14|||
147339281|NCT01565148|531410024|FG002|Overall Study|Death|1|||
147295515|NCT02548455|531244727|FG000|Overall Study|Visit not completed|173|||
147295516|NCT01292876|531244728|FG000|Overall Study|Physician Decision|4|||
147295517|NCT04528069|531244731|FG000|Overall Study|Adverse Event|1|||
147295518|NCT04528069|531244731|FG000|Overall Study|Lost to Follow-up|1|||
147295519|NCT04528069|531244731|FG000|Overall Study|Patient Unable to Come|1|||
147295520|NCT04528069|531244731|FG000|Overall Study|Patient Unable to Attend|1|||
147295521|NCT02525874|531244732|FG000|Overall Study|Other|1|||
147295522|NCT02525874|531244732|FG000|Overall Study|Investigator Decision|1|||
147295523|NCT02525874|531244732|FG000|Overall Study|Consent withdrawn|22|||
147295524|NCT02525874|531244732|FG000|Overall Study|Non-compliance with study drug|3|||
147295525|NCT02525874|531244732|FG000|Overall Study|Adverse Event|17|||
147295526|NCT02525874|531244732|FG000|Overall Study|Lost to Follow-up|7|||
147295527|NCT02525874|531244732|FG000|Overall Study|Disease progression, defined by protocol|2|||
147295528|NCT02525874|531244732|FG000|Overall Study|Disease relapse|4|||
147295529|NCT02525874|531244732|FG000|Overall Study|Alternative Treatment for MS|2|||
147295530|NCT02525874|531244732|FG000|Overall Study|New lesions in Brain|1|||
147295531|NCT01814371|531244733|FG000|Overall Study|Lost to Follow-up|30|||
147295532|NCT01814371|531244734|FG001|Overall Study|Lost to Follow-up|27|||
147295533|NCT01692782|531244735|FG000|Overall Study|Adverse Event|12|||
147295534|NCT01692782|531244736|FG001|Overall Study|Adverse Event|32|||
147295535|NCT01692782|531244737|FG002|Overall Study|Adverse Event|2|||
147295536|NCT01692782|531244735|FG000|Overall Study|Lack of Efficacy|1|||
147295537|NCT01692782|531244736|FG001|Overall Study|Lack of Efficacy|2|||
147295538|NCT01692782|531244737|FG002|Overall Study|Lack of Efficacy|0|||
147295539|NCT01692782|531244735|FG000|Overall Study|Lost to Follow-up|2|||
147295540|NCT01692782|531244736|FG001|Overall Study|Lost to Follow-up|7|||
147295541|NCT01692782|531244737|FG002|Overall Study|Lost to Follow-up|1|||
147295542|NCT01692782|531244735|FG000|Overall Study|Pregnancy|1|||
147295543|NCT01692782|531244736|FG001|Overall Study|Pregnancy|0|||
147295544|NCT01692782|531244737|FG002|Overall Study|Pregnancy|0|||
147295545|NCT01692782|531244735|FG000|Overall Study|Protocol Violation|1|||
147295546|NCT01692782|531244736|FG001|Overall Study|Protocol Violation|0|||
147295547|NCT01692782|531244737|FG002|Overall Study|Protocol Violation|2|||
147295548|NCT01692782|531244735|FG000|Overall Study|Non-complance with study drug|0|||
147295549|NCT01692782|531244736|FG001|Overall Study|Non-complance with study drug|4|||
147295550|NCT01692782|531244737|FG002|Overall Study|Non-complance with study drug|1|||
147295551|NCT01692782|531244735|FG000|Overall Study|Non-compliant with study visits|0|||
147295552|NCT01692782|531244736|FG001|Overall Study|Non-compliant with study visits|0|||
147295553|NCT01692782|531244737|FG002|Overall Study|Non-compliant with study visits|1|||
147295554|NCT01692782|531244735|FG000|Overall Study|SAE not related to study drug|0|||
147295555|NCT01692782|531244736|FG001|Overall Study|SAE not related to study drug|1|||
147295556|NCT01692782|531244737|FG002|Overall Study|SAE not related to study drug|0|||
147295557|NCT01692782|531244735|FG000|Overall Study|Withdrawal by Subject|3|||
147295558|NCT01692782|531244736|FG001|Overall Study|Withdrawal by Subject|10|||
147295559|NCT01692782|531244737|FG002|Overall Study|Withdrawal by Subject|3|||
147295560|NCT03945188|531244741|FG000|Overall Study|Protocol Violation|1|||
147295561|NCT03945188|531244742|FG001|Overall Study|Protocol Violation|0|||
147295562|NCT03945188|531244741|FG000|Overall Study|Disease worsening|79|||
147295563|NCT03945188|531244742|FG001|Overall Study|Disease worsening|73|||
147295564|NCT03945188|531244741|FG000|Overall Study|Physician Decision|2|||
147295565|NCT03945188|531244742|FG001|Overall Study|Physician Decision|2|||
147295566|NCT03945188|531244741|FG000|Overall Study|Lack of Efficacy|7|||
147295567|NCT03945188|531244742|FG001|Overall Study|Lack of Efficacy|4|||
147295568|NCT03945188|531244741|FG000|Overall Study|Pregnancy|2|||
147295569|NCT03945188|531244742|FG001|Overall Study|Pregnancy|0|||
147295570|NCT03945188|531244741|FG000|Overall Study|Withdrawal by participant or parent/guardian|24|||
147295571|NCT03945188|531244742|FG001|Overall Study|Withdrawal by participant or parent/guardian|10|||
147295572|NCT03945188|531244741|FG000|Overall Study|Adverse Event|10|||
147295573|NCT03945188|531244742|FG001|Overall Study|Adverse Event|5|||
147295574|NCT03945188|531244741|FG000|Overall Study|Other|2|||
147295575|NCT03945188|531244742|FG001|Overall Study|Other|2|||
147295576|NCT03945188|531244741|FG000|Overall Study|Lost to Follow-up|1|||
147295577|NCT03945188|531244742|FG001|Overall Study|Lost to Follow-up|2|||
147295578|NCT00338884|531246133|FG000|Overall Study|Objective Disease Progression or Relapse|44|||
147295579|NCT00338884|531246133|FG000|Overall Study|Adverse Event|14|||
147295580|NCT00338884|531246133|FG000|Overall Study|Death|8|||
147295581|NCT00338884|531246133|FG000|Overall Study|Other|4|||
147339282|NCT01565148|531410025|FG003|Overall Study|Death|0|||
147295582|NCT00338884|531246133|FG000|Overall Study|Global Deterioration of Health Status|3|||
147295583|NCT00338884|531246133|FG000|Overall Study|Withdrawal by Subject|3|||
147295584|NCT00338884|531246133|FG000|Overall Study|Lost to Follow-up|1|||
147339283|NCT01565148|531410022|FG000|Overall Study|Physician Decision|2|||
147295585|NCT00338884|531246133|FG000|Overall Study|Randomized But Did Not Receive Treatment|1|||
147295586|NCT00781391|531246134|FG000|Overall Study|never received study drug|24|||
147295587|NCT00781391|531246135|FG001|Overall Study|never received study drug|23|||
147295588|NCT00781391|531246136|FG002|Overall Study|never received study drug|32|||
147295589|NCT00781391|531246134|FG000|Overall Study|Protocol Violation|19|||
147339284|NCT01565148|531410023|FG001|Overall Study|Physician Decision|5|||
147452922|NCT00493038|531821483|FG000|Treatment|Other|0|||
147295590|NCT00781391|531246135|FG001|Overall Study|Protocol Violation|17|||
147295591|NCT00781391|531246136|FG002|Overall Study|Protocol Violation|20|||
147452923|NCT00493038|531821484|FG001|Treatment|Other|1|||
147295592|NCT00781391|531246134|FG000|Overall Study|Death|789|||
147295593|NCT00781391|531246135|FG001|Overall Study|Death|730|||
147295594|NCT00781391|531246136|FG002|Overall Study|Death|706|||
147295595|NCT00781391|531246134|FG000|Overall Study|Withdrawal by Subject|47|||
147295596|NCT00781391|531246135|FG001|Overall Study|Withdrawal by Subject|37|||
147295597|NCT00781391|531246136|FG002|Overall Study|Withdrawal by Subject|25|||
147295598|NCT00781391|531246134|FG000|Overall Study|Lost to Follow-up|0|||
147295599|NCT00781391|531246135|FG001|Overall Study|Lost to Follow-up|0|||
147295600|NCT00781391|531246136|FG002|Overall Study|Lost to Follow-up|1|||
147295601|NCT04535947|531246137|FG000|Overall Study|Adverse Event|1|||
147295602|NCT04535947|531246138|FG001|Overall Study|Adverse Event|4|||
147295603|NCT04535947|531246137|FG000|Overall Study|Other reasons not specified|2|||
147295604|NCT04535947|531246138|FG001|Overall Study|Other reasons not specified|0|||
147295605|NCT04535947|531246137|FG000|Overall Study|Withdrawal by Subject|1|||
147295606|NCT04535947|531246138|FG001|Overall Study|Withdrawal by Subject|1|||
147295607|NCT02355002|531246151|FG000|Period 1: Phase 1, Randomized-Controlled|Protocol Violation|1|||
147295608|NCT02355002|531246152|FG001|Period 1: Phase 1, Randomized-Controlled|Protocol Violation|0|||
147295609|NCT02355002|531246151|FG000|Period 1: Phase 1, Randomized-Controlled|Adverse Event|1|||
147295610|NCT02355002|531246152|FG001|Period 1: Phase 1, Randomized-Controlled|Adverse Event|0|||
147295611|NCT02355002|531246151|FG000|Period 1: Phase 1, Randomized-Controlled|Withdrawn by principal investigator due to start of the COVID-19 lock-down|1|||
147295612|NCT02355002|531246152|FG001|Period 1: Phase 1, Randomized-Controlled|Withdrawn by principal investigator due to start of the COVID-19 lock-down|0|||
147295613|NCT02355002|531246151|FG000|Period 1: Phase 1, Randomized-Controlled|Lost to Follow-up|0|||
147295614|NCT02355002|531246152|FG001|Period 1: Phase 1, Randomized-Controlled|Lost to Follow-up|1|||
147295615|NCT02355002|531246151|FG000|Period 2: Phase 2 Open-Label|Withdrawal by Subject|2|||
147295616|NCT02355002|531246152|FG001|Period 2: Phase 2 Open-Label|Withdrawal by Subject|0|||
147295617|NCT02355002|531246151|FG000|Period 2: Phase 2 Open-Label|Participant left country|1|||
147295618|NCT02355002|531246152|FG001|Period 2: Phase 2 Open-Label|Participant left country|0|||
147295619|NCT02355002|531246151|FG000|Period 2: Phase 2 Open-Label|Withdrawn by principal investigator due to start of the COVID-19 lock-down|1|||
147295620|NCT02355002|531246152|FG001|Period 2: Phase 2 Open-Label|Withdrawn by principal investigator due to start of the COVID-19 lock-down|0|||
147295621|NCT03205371|531246160|FG000|Overall Study|Withdrawal by Subject|4|||
147295622|NCT03205371|531246161|FG001|Overall Study|Withdrawal by Subject|1|||
147295623|NCT03205371|531246162|FG002|Overall Study|Withdrawal by Subject|0|||
147295624|NCT03205371|531246163|FG003|Overall Study|Withdrawal by Subject|0|||
147295625|NCT03205371|531246164|FG004|Overall Study|Withdrawal by Subject|0|||
147295626|NCT03205371|531246165|FG005|Overall Study|Withdrawal by Subject|0|||
147295627|NCT03205371|531246166|FG006|Overall Study|Withdrawal by Subject|4|||
147295628|NCT03205371|531246167|FG007|Overall Study|Withdrawal by Subject|0|||
147295629|NCT03205371|531246168|FG008|Overall Study|Withdrawal by Subject|2|||
147295630|NCT03205371|531246169|FG009|Overall Study|Withdrawal by Subject|0|||
147295631|NCT03205371|531246170|FG010|Overall Study|Withdrawal by Subject|0|||
147295632|NCT03205371|531246171|FG011|Overall Study|Withdrawal by Subject|1|||
147295633|NCT03205371|531246160|FG000|Overall Study|Lost to Follow-up|0|||
147339285|NCT01565148|531410024|FG002|Overall Study|Physician Decision|0|||
147339286|NCT01565148|531410025|FG003|Overall Study|Physician Decision|0|||
147339287|NCT01170962|531410027|FG000|Treatment Period|Lack of Efficacy|96|||
147339288|NCT01170962|531410028|FG001|Treatment Period|Lack of Efficacy|91|||
147339289|NCT01170962|531410029|FG002|Treatment Period|Lack of Efficacy|7|||
147339290|NCT01170962|531410027|FG000|Treatment Period|Adverse Event|11|||
147339291|NCT01170962|531410028|FG001|Treatment Period|Adverse Event|12|||
147339292|NCT01170962|531410029|FG002|Treatment Period|Adverse Event|3|||
147339293|NCT01170962|531410027|FG000|Treatment Period|Withdrawal by Subject|2|||
147339294|NCT01170962|531410028|FG001|Treatment Period|Withdrawal by Subject|1|||
147339295|NCT01170962|531410029|FG002|Treatment Period|Withdrawal by Subject|0|||
147452924|NCT00493038|531821483|FG000|Follow-up|Lost to Follow-up|1|||
147452925|NCT00493038|531821484|FG001|Follow-up|Lost to Follow-up|0|||
147452926|NCT04418765|531821485|FG000|Placebo-controlled Period (24 Weeks)|Adverse Event|1|||
147295634|NCT03205371|531246161|FG001|Overall Study|Lost to Follow-up|0|||
147452927|NCT04418765|531821486|FG001|Placebo-controlled Period (24 Weeks)|Adverse Event|1|||
147452928|NCT04418765|531821487|FG002|Placebo-controlled Period (24 Weeks)|Adverse Event|6|||
147606233|NCT02500043|532375193|FG001|Overall Study|Ongoing at Date of Cut-Off|3|||
147295635|NCT03205371|531246162|FG002|Overall Study|Lost to Follow-up|0|||
147295636|NCT03205371|531246163|FG003|Overall Study|Lost to Follow-up|0|||
147295637|NCT03205371|531246164|FG004|Overall Study|Lost to Follow-up|0|||
147339296|NCT01170962|531410027|FG000|Treatment Period|Lost to Follow-up|1|||
147339297|NCT01170962|531410028|FG001|Treatment Period|Lost to Follow-up|1|||
147339298|NCT01170962|531410029|FG002|Treatment Period|Lost to Follow-up|1|||
147339299|NCT01170962|531410027|FG000|Treatment Period|Participant no longer meets criteria|0|||
147339300|NCT01170962|531410028|FG001|Treatment Period|Participant no longer meets criteria|1|||
147606234|NCT02500043|532375192|FG000|Overall Study|Adverse Event|33|||
147452929|NCT04418765|531821485|FG000|Placebo-controlled Period (24 Weeks)|Lack of Efficacy|1|||
147452930|NCT04418765|531821486|FG001|Placebo-controlled Period (24 Weeks)|Lack of Efficacy|3|||
147452931|NCT04418765|531821487|FG002|Placebo-controlled Period (24 Weeks)|Lack of Efficacy|0|||
147452932|NCT04418765|531821485|FG000|Placebo-controlled Period (24 Weeks)|Protocol Violation|0|||
147452933|NCT04418765|531821486|FG001|Placebo-controlled Period (24 Weeks)|Protocol Violation|1|||
147295638|NCT03205371|531246165|FG005|Overall Study|Lost to Follow-up|0|||
147295639|NCT03205371|531246166|FG006|Overall Study|Lost to Follow-up|5|||
147295640|NCT03205371|531246167|FG007|Overall Study|Lost to Follow-up|2|||
147295641|NCT03205371|531246168|FG008|Overall Study|Lost to Follow-up|3|||
147295642|NCT03205371|531246169|FG009|Overall Study|Lost to Follow-up|0|||
147295643|NCT03205371|531246170|FG010|Overall Study|Lost to Follow-up|0|||
147295644|NCT03205371|531246171|FG011|Overall Study|Lost to Follow-up|0|||
147295645|NCT03205371|531246160|FG000|Overall Study|Protocol Violation|0|||
147295646|NCT03205371|531246161|FG001|Overall Study|Protocol Violation|0|||
147295647|NCT03205371|531246162|FG002|Overall Study|Protocol Violation|0|||
147295648|NCT03205371|531246163|FG003|Overall Study|Protocol Violation|0|||
147295649|NCT03205371|531246164|FG004|Overall Study|Protocol Violation|0|||
147295650|NCT03205371|531246165|FG005|Overall Study|Protocol Violation|0|||
147295651|NCT03205371|531246166|FG006|Overall Study|Protocol Violation|1|||
147295652|NCT03205371|531246167|FG007|Overall Study|Protocol Violation|0|||
147295653|NCT03205371|531246168|FG008|Overall Study|Protocol Violation|0|||
147295654|NCT03205371|531246169|FG009|Overall Study|Protocol Violation|0|||
147295655|NCT03205371|531246170|FG010|Overall Study|Protocol Violation|0|||
147295656|NCT03205371|531246171|FG011|Overall Study|Protocol Violation|0|||
147295657|NCT03205371|531246160|FG000|Overall Study|Adverse Event|0|||
147295658|NCT03205371|531246161|FG001|Overall Study|Adverse Event|0|||
147295659|NCT03205371|531246162|FG002|Overall Study|Adverse Event|0|||
147295660|NCT03205371|531246163|FG003|Overall Study|Adverse Event|0|||
147295661|NCT03205371|531246164|FG004|Overall Study|Adverse Event|0|||
147295662|NCT03205371|531246165|FG005|Overall Study|Adverse Event|0|||
147295663|NCT03205371|531246166|FG006|Overall Study|Adverse Event|0|||
147295664|NCT03205371|531246167|FG007|Overall Study|Adverse Event|1|||
147295665|NCT03205371|531246168|FG008|Overall Study|Adverse Event|0|||
147295666|NCT03205371|531246169|FG009|Overall Study|Adverse Event|0|||
147295667|NCT03205371|531246170|FG010|Overall Study|Adverse Event|0|||
147295668|NCT03205371|531246171|FG011|Overall Study|Adverse Event|0|||
147295669|NCT04575051|531246176|FG000|Time Period 0|Discontinued due to death or moving to higher level of care|15|||
147295670|NCT04575051|531246177|FG001|Time Period 0|Discontinued due to death or moving to higher level of care|6|||
147295671|NCT04575051|531246178|FG002|Time Period 0|Discontinued due to death or moving to higher level of care|19|||
147295672|NCT04575051|531246179|FG003|Time Period 0|Discontinued due to death or moving to higher level of care|9|||
147295673|NCT04575051|531246180|FG004|Time Period 0|Discontinued due to death or moving to higher level of care|8|||
147295674|NCT04575051|531246176|FG000|Time Period 1|Missing follow up|1|||
147295675|NCT04575051|531246177|FG001|Time Period 1|Missing follow up|3|||
147295676|NCT04575051|531246178|FG002|Time Period 1|Missing follow up|1|||
147295677|NCT04575051|531246179|FG003|Time Period 1|Missing follow up|3|||
147295678|NCT04575051|531246180|FG004|Time Period 1|Missing follow up|2|||
147295679|NCT04575051|531246176|FG000|Time Period 1|Discontinued due to death or moving to higher level of care|13|||
147295680|NCT04575051|531246177|FG001|Time Period 1|Discontinued due to death or moving to higher level of care|14|||
147295681|NCT04575051|531246178|FG002|Time Period 1|Discontinued due to death or moving to higher level of care|9|||
147295682|NCT04575051|531246179|FG003|Time Period 1|Discontinued due to death or moving to higher level of care|15|||
147295683|NCT04575051|531246180|FG004|Time Period 1|Discontinued due to death or moving to higher level of care|14|||
147295684|NCT04575051|531246176|FG000|Time Period 2|Missing follow up|1|||
147295685|NCT04575051|531246177|FG001|Time Period 2|Missing follow up|8|||
147295686|NCT04575051|531246178|FG002|Time Period 2|Missing follow up|7|||
147295687|NCT04575051|531246179|FG003|Time Period 2|Missing follow up|0|||
147295688|NCT04575051|531246180|FG004|Time Period 2|Missing follow up|1|||
147295689|NCT04575051|531246176|FG000|Time Period 2|Discontinued due to death or moved to higher level of care|15|||
147295690|NCT04575051|531246177|FG001|Time Period 2|Discontinued due to death or moved to higher level of care|8|||
147295691|NCT04575051|531246178|FG002|Time Period 2|Discontinued due to death or moved to higher level of care|20|||
147295692|NCT04575051|531246179|FG003|Time Period 2|Discontinued due to death or moved to higher level of care|15|||
147295693|NCT04575051|531246180|FG004|Time Period 2|Discontinued due to death or moved to higher level of care|8|||
147295694|NCT04575051|531246176|FG000|Time Period 3|Missing follow up|8|||
147295695|NCT04575051|531246177|FG001|Time Period 3|Missing follow up|6|||
147295696|NCT04575051|531246178|FG002|Time Period 3|Missing follow up|4|||
147295697|NCT04575051|531246179|FG003|Time Period 3|Missing follow up|3|||
147295698|NCT04575051|531246180|FG004|Time Period 3|Missing follow up|0|||
147295699|NCT04575051|531246176|FG000|Time Period 3|Discontinued due to death or moved to higher level of care|5|||
147295700|NCT04575051|531246177|FG001|Time Period 3|Discontinued due to death or moved to higher level of care|4|||
147295701|NCT04575051|531246178|FG002|Time Period 3|Discontinued due to death or moved to higher level of care|11|||
147295702|NCT04575051|531246179|FG003|Time Period 3|Discontinued due to death or moved to higher level of care|3|||
147295703|NCT04575051|531246180|FG004|Time Period 3|Discontinued due to death or moved to higher level of care|3|||
147452934|NCT04418765|531821487|FG002|Placebo-controlled Period (24 Weeks)|Protocol Violation|1|||
147295704|NCT04575051|531246176|FG000|Time Period 4|Missing follow up|17|||
147295705|NCT04575051|531246177|FG001|Time Period 4|Missing follow up|3|||
147295706|NCT04575051|531246178|FG002|Time Period 4|Missing follow up|4|||
147295707|NCT04575051|531246179|FG003|Time Period 4|Missing follow up|2|||
147295708|NCT04575051|531246180|FG004|Time Period 4|Missing follow up|1|||
147295709|NCT04575051|531246176|FG000|Time Period 4|Discontinued due to death or moved to higher level of care|2|||
147295710|NCT04575051|531246177|FG001|Time Period 4|Discontinued due to death or moved to higher level of care|3|||
147295711|NCT04575051|531246178|FG002|Time Period 4|Discontinued due to death or moved to higher level of care|9|||
147295712|NCT04575051|531246179|FG003|Time Period 4|Discontinued due to death or moved to higher level of care|1|||
147295713|NCT04575051|531246180|FG004|Time Period 4|Discontinued due to death or moved to higher level of care|9|||
147295714|NCT04575051|531246176|FG000|Time Period 5|Missing follow up|11|||
147295715|NCT04575051|531246177|FG001|Time Period 5|Missing follow up|8|||
147295716|NCT04575051|531246178|FG002|Time Period 5|Missing follow up|12|||
147295717|NCT04575051|531246179|FG003|Time Period 5|Missing follow up|3|||
147295718|NCT04575051|531246180|FG004|Time Period 5|Missing follow up|11|||
147295719|NCT03492281|531246181|FG000|Overall Study|Withdrawal by Subject|21|||
147295720|NCT03492281|531246182|FG001|Overall Study|Withdrawal by Subject|14|||
147295721|NCT03492281|531246183|FG002|Overall Study|Withdrawal by Subject|13|||
147295722|NCT03492281|531246181|FG000|Overall Study|Lost to Follow-up|14|||
147295723|NCT03492281|531246182|FG001|Overall Study|Lost to Follow-up|15|||
147295724|NCT03492281|531246183|FG002|Overall Study|Lost to Follow-up|10|||
147295725|NCT03492281|531246181|FG000|Overall Study|Adverse Event|6|||
147295726|NCT03492281|531246182|FG001|Overall Study|Adverse Event|8|||
147295727|NCT03492281|531246183|FG002|Overall Study|Adverse Event|13|||
147295728|NCT03492281|531246181|FG000|Overall Study|Lack of Efficacy|3|||
147295729|NCT03492281|531246182|FG001|Overall Study|Lack of Efficacy|0|||
147295730|NCT03492281|531246183|FG002|Overall Study|Lack of Efficacy|1|||
147295731|NCT03492281|531246181|FG000|Overall Study|Physician Decision|1|||
147295732|NCT03492281|531246182|FG001|Overall Study|Physician Decision|0|||
147295733|NCT03492281|531246183|FG002|Overall Study|Physician Decision|3|||
147295734|NCT03492281|531246181|FG000|Overall Study|Protocol Violation|0|||
147295735|NCT03492281|531246182|FG001|Overall Study|Protocol Violation|2|||
147295736|NCT03492281|531246183|FG002|Overall Study|Protocol Violation|1|||
147295737|NCT03492281|531246181|FG000|Overall Study|Withdrawn Due to Sponsor|1|||
147295738|NCT03492281|531246182|FG001|Overall Study|Withdrawn Due to Sponsor|0|||
147295739|NCT03492281|531246183|FG002|Overall Study|Withdrawn Due to Sponsor|1|||
147295740|NCT03492281|531246181|FG000|Overall Study|Death|0|||
147295741|NCT03492281|531246182|FG001|Overall Study|Death|0|||
147295742|NCT03492281|531246183|FG002|Overall Study|Death|1|||
147295743|NCT03492281|531246181|FG000|Overall Study|Captured as Other in Database|8|||
147295744|NCT03492281|531246182|FG001|Overall Study|Captured as Other in Database|6|||
147295745|NCT03492281|531246183|FG002|Overall Study|Captured as Other in Database|3|||
147295746|NCT03624504|531246184|FG000|Overall Study|Unsuccessful Implant|1|||
147295747|NCT02363946|531246186|FG000|Overall Study|Lost to Follow-up|0|||
147295748|NCT02363946|531246187|FG001|Overall Study|Lost to Follow-up|0|||
147295749|NCT02363946|531246188|FG002|Overall Study|Lost to Follow-up|0|||
147295750|NCT02363946|531246189|FG003|Overall Study|Lost to Follow-up|0|||
147295751|NCT02363946|531246190|FG004|Overall Study|Lost to Follow-up|0|||
147295752|NCT02363946|531246191|FG005|Overall Study|Lost to Follow-up|0|||
147339301|NCT01170962|531410029|FG002|Treatment Period|Participant no longer meets criteria|0|||
147339302|NCT01170962|531410027|FG000|Treatment Period|Request to discontinue treatment|7|||
147339303|NCT01170962|531410028|FG001|Treatment Period|Request to discontinue treatment|3|||
147339304|NCT01170962|531410029|FG002|Treatment Period|Request to discontinue treatment|1|||
147339305|NCT01170962|531410027|FG000|Treatment Period|Completed 24 Week treatment period only|10|||
147339306|NCT01170962|531410028|FG001|Treatment Period|Completed 24 Week treatment period only|2|||
147339307|NCT01170962|531410029|FG002|Treatment Period|Completed 24 Week treatment period only|0|||
147339308|NCT01170962|531410027|FG000|Follow up Period|Withdrawal by Subject|14|||
147295753|NCT02363946|531246192|FG006|Overall Study|Lost to Follow-up|0|||
147295754|NCT02363946|531246193|FG007|Overall Study|Lost to Follow-up|1|||
147295755|NCT02363946|531246194|FG008|Overall Study|Lost to Follow-up|0|||
147295756|NCT02363946|531246195|FG009|Overall Study|Lost to Follow-up|0|||
147339309|NCT01170962|531410028|FG001|Follow up Period|Withdrawal by Subject|10|||
147339310|NCT01170962|531410029|FG002|Follow up Period|Withdrawal by Subject|2|||
147295757|NCT02363946|531246196|FG010|Overall Study|Lost to Follow-up|0|||
147295758|NCT02363946|531246197|FG011|Overall Study|Lost to Follow-up|0|||
147295759|NCT02363946|531246198|FG012|Overall Study|Lost to Follow-up|0|||
147295760|NCT01292239|531246199|FG000|Overall Study|Other|1|||
147295761|NCT01292239|531246200|FG001|Overall Study|Other|1|||
147295762|NCT01292239|531246199|FG000|Overall Study|Withdrawal by Subject|3|||
147295763|NCT01292239|531246200|FG001|Overall Study|Withdrawal by Subject|6|||
147295764|NCT00765388|531246201|FG000|Period 1|Lack of Efficacy|1|||
147295765|NCT00765388|531246202|FG001|Period 1|Lack of Efficacy|2|||
147295766|NCT00765388|531246201|FG000|Period 1|Lost to Follow-up|0|||
147295767|NCT00765388|531246202|FG001|Period 1|Lost to Follow-up|1|||
147295768|NCT00765388|531246201|FG000|Period 1|Herpes Zoster|0|||
147339311|NCT01170962|531410027|FG000|Follow up Period|Lost to Follow-up|13|||
147339312|NCT01170962|531410028|FG001|Follow up Period|Lost to Follow-up|8|||
147295769|NCT00765388|531246202|FG001|Period 1|Herpes Zoster|1|||
147295770|NCT00765388|531246201|FG000|Period 1|Hip operation|0|||
147295771|NCT00765388|531246202|FG001|Period 1|Hip operation|1|||
147295772|NCT03923933|531246206|FG000|Overall Study|Lost to Follow-up|1|||
147295773|NCT03923933|531246207|FG001|Overall Study|Lost to Follow-up|0|||
147295774|NCT03923933|531246206|FG000|Overall Study|Withdrawal by Subject|0|||
147295775|NCT03923933|531246207|FG001|Overall Study|Withdrawal by Subject|1|||
147339313|NCT01170962|531410029|FG002|Follow up Period|Lost to Follow-up|1|||
147339314|NCT01170962|531410027|FG000|Follow up Period|Death|2|||
147339315|NCT01170962|531410028|FG001|Follow up Period|Death|2|||
147339316|NCT01170962|531410029|FG002|Follow up Period|Death|0|||
147339317|NCT01170962|531410027|FG000|Follow up Period|Others|10|||
147339318|NCT01170962|531410028|FG001|Follow up Period|Others|7|||
147339319|NCT01170962|531410029|FG002|Follow up Period|Others|3|||
147339320|NCT03942042|531410030|FG000|Induction Dosing Period (12 Weeks)|Adverse Event|0|||
147339321|NCT03942042|531410031|FG001|Induction Dosing Period (12 Weeks)|Adverse Event|1|||
147339322|NCT03942042|531410030|FG000|Induction Dosing Period (12 Weeks)|Lack of Efficacy|1|||
147339323|NCT03942042|531410031|FG001|Induction Dosing Period (12 Weeks)|Lack of Efficacy|0|||
147295776|NCT00587964|531246208|FG000|Overall Study|Withdrawal by Subject|1|||
147295777|NCT00587964|531246208|FG000|Overall Study|Lost to Follow-up|1|||
147295778|NCT00587964|531246208|FG000|Overall Study|Patient found to be ineligible|1|||
147339324|NCT02918071|531410032|FG000|Overall Study|Withdrawal by Subject|2|||
147339325|NCT02918071|531410032|FG000|Overall Study|Lost to Follow-up|1|||
147339326|NCT04688450|531412062|FG000|Overall Study|Unable to start software due to serial communication failure|1|||
147339327|NCT04688450|531412062|FG000|Overall Study|Withdrawal by Subject|1|||
147339328|NCT02544074|531412063|FG000|Overall Study|Withdrawal by Subject|0|||
147339329|NCT02544074|531412064|FG001|Overall Study|Withdrawal by Subject|1|||
147339330|NCT02544074|531412065|FG002|Overall Study|Withdrawal by Subject|0|||
147339331|NCT02544074|531412066|FG003|Overall Study|Withdrawal by Subject|0|||
147339332|NCT02544074|531412067|FG004|Overall Study|Withdrawal by Subject|0|||
147339333|NCT02544074|531412068|FG005|Overall Study|Withdrawal by Subject|0|||
147339334|NCT02544074|531412069|FG006|Overall Study|Withdrawal by Subject|0|||
147339335|NCT02544074|531412070|FG007|Overall Study|Withdrawal by Subject|0|||
147339336|NCT02544074|531412071|FG008|Overall Study|Withdrawal by Subject|0|||
147339337|NCT02544074|531412072|FG009|Overall Study|Withdrawal by Subject|0|||
147339338|NCT02544074|531412073|FG010|Overall Study|Withdrawal by Subject|0|||
147339339|NCT02544074|531412074|FG011|Overall Study|Withdrawal by Subject|0|||
147339340|NCT02544074|531412075|FG012|Overall Study|Withdrawal by Subject|0|||
147339341|NCT02544074|531412076|FG013|Overall Study|Withdrawal by Subject|0|||
147339342|NCT02544074|531412077|FG014|Overall Study|Withdrawal by Subject|0|||
147339343|NCT02544074|531412078|FG015|Overall Study|Withdrawal by Subject|0|||
147339344|NCT02544074|531412079|FG016|Overall Study|Withdrawal by Subject|0|||
147339345|NCT02544074|531412080|FG017|Overall Study|Withdrawal by Subject|0|||
147339346|NCT02544074|531412081|FG018|Overall Study|Withdrawal by Subject|0|||
147339347|NCT02544074|531412082|FG019|Overall Study|Withdrawal by Subject|0|||
147339348|NCT02544074|531412083|FG020|Overall Study|Withdrawal by Subject|0|||
147339349|NCT02544074|531412063|FG000|Overall Study|Tablet error|0|||
147339350|NCT02544074|531412064|FG001|Overall Study|Tablet error|0|||
147339351|NCT02544074|531412065|FG002|Overall Study|Tablet error|0|||
147339352|NCT02544074|531412066|FG003|Overall Study|Tablet error|0|||
147339353|NCT02544074|531412067|FG004|Overall Study|Tablet error|0|||
147339354|NCT02544074|531412068|FG005|Overall Study|Tablet error|1|||
147295779|NCT00587964|531246208|FG000|Overall Study|Patient did not receive intervention|5|||
147339355|NCT02544074|531412069|FG006|Overall Study|Tablet error|0|||
147339356|NCT02544074|531412070|FG007|Overall Study|Tablet error|0|||
147339357|NCT02544074|531412071|FG008|Overall Study|Tablet error|0|||
147339358|NCT02544074|531412072|FG009|Overall Study|Tablet error|1|||
147339359|NCT02544074|531412073|FG010|Overall Study|Tablet error|0|||
147339360|NCT02544074|531412074|FG011|Overall Study|Tablet error|0|||
147339361|NCT02544074|531412075|FG012|Overall Study|Tablet error|0|||
147339362|NCT02544074|531412076|FG013|Overall Study|Tablet error|0|||
147339363|NCT02544074|531412077|FG014|Overall Study|Tablet error|0|||
147339364|NCT02544074|531412078|FG015|Overall Study|Tablet error|0|||
147339365|NCT02544074|531412079|FG016|Overall Study|Tablet error|0|||
147339366|NCT02544074|531412080|FG017|Overall Study|Tablet error|0|||
147339367|NCT02544074|531412081|FG018|Overall Study|Tablet error|0|||
147339368|NCT02544074|531412082|FG019|Overall Study|Tablet error|0|||
147295780|NCT00587964|531246208|FG000|Overall Study|Progression of Disease|4|||
147339369|NCT02544074|531412083|FG020|Overall Study|Tablet error|0|||
147452935|NCT04418765|531821485|FG000|Placebo-controlled Period (24 Weeks)|Withdrawal by Subject|1|||
147452936|NCT04418765|531821486|FG001|Placebo-controlled Period (24 Weeks)|Withdrawal by Subject|5|||
147339372|NCT02581215|531412088|FG000|Overall Study|Screen Failure Before Therapy Start|0|||
147295781|NCT01830127|531246211|FG000|Overall Study|Adverse Event|1|||
147339373|NCT02581215|531412089|FG001|Overall Study|Screen Failure Before Therapy Start|1|||
147339374|NCT02581215|531412088|FG000|Overall Study|Eligibility Criteria Not Met|0|||
147339375|NCT02581215|531412089|FG001|Overall Study|Eligibility Criteria Not Met|1|||
147339376|NCT02566902|531412098|FG000|Overall Study|Protocol Violation|2|||
147295782|NCT01830127|531246212|FG001|Overall Study|Adverse Event|6|||
147295783|NCT01830127|531246211|FG000|Overall Study|Lack of Efficacy|3|||
147295784|NCT01830127|531246212|FG001|Overall Study|Lack of Efficacy|0|||
147295785|NCT01830127|531246211|FG000|Overall Study|Withdrawal by Subject|1|||
147295786|NCT01830127|531246212|FG001|Overall Study|Withdrawal by Subject|1|||
147295787|NCT01830127|531246211|FG000|Overall Study|Other reason not defined above|0|||
147295788|NCT01830127|531246212|FG001|Overall Study|Other reason not defined above|2|||
147295789|NCT01302847|531246216|FG000|Overall Study|Death|0|||
147295790|NCT01302847|531246217|FG001|Overall Study|Death|1|||
147295791|NCT01302847|531246218|FG002|Overall Study|Death|0|||
147295792|NCT01302847|531246219|FG003|Overall Study|Death|0|||
147295793|NCT01302847|531246220|FG004|Overall Study|Death|0|||
147295794|NCT01302847|531246221|FG005|Overall Study|Death|1|||
147295795|NCT01302847|531246222|FG006|Overall Study|Death|1|||
147295796|NCT01302847|531246223|FG007|Overall Study|Death|0|||
147295797|NCT01302847|531246216|FG000|Overall Study|Pregnancy|2|||
147295798|NCT01302847|531246217|FG001|Overall Study|Pregnancy|0|||
147295799|NCT01302847|531246218|FG002|Overall Study|Pregnancy|0|||
147295800|NCT01302847|531246219|FG003|Overall Study|Pregnancy|0|||
147295801|NCT01302847|531246220|FG004|Overall Study|Pregnancy|0|||
147295802|NCT01302847|531246221|FG005|Overall Study|Pregnancy|0|||
147295803|NCT01302847|531246222|FG006|Overall Study|Pregnancy|0|||
147295804|NCT01302847|531246223|FG007|Overall Study|Pregnancy|0|||
147295805|NCT01302847|531246216|FG000|Overall Study|Virologic failure|0|||
147295806|NCT01302847|531246217|FG001|Overall Study|Virologic failure|2|||
147295807|NCT01302847|531246218|FG002|Overall Study|Virologic failure|0|||
147295808|NCT01302847|531246219|FG003|Overall Study|Virologic failure|2|||
147295809|NCT01302847|531246220|FG004|Overall Study|Virologic failure|1|||
147295810|NCT01302847|531246221|FG005|Overall Study|Virologic failure|3|||
147295811|NCT01302847|531246222|FG006|Overall Study|Virologic failure|1|||
147295812|NCT01302847|531246223|FG007|Overall Study|Virologic failure|2|||
147295813|NCT01302847|531246216|FG000|Overall Study|Severe debilitation, unable to continue|0|||
147295814|NCT01302847|531246217|FG001|Overall Study|Severe debilitation, unable to continue|0|||
147295815|NCT01302847|531246218|FG002|Overall Study|Severe debilitation, unable to continue|0|||
147295816|NCT01302847|531246219|FG003|Overall Study|Severe debilitation, unable to continue|0|||
147295817|NCT01302847|531246220|FG004|Overall Study|Severe debilitation, unable to continue|0|||
147295818|NCT01302847|531246221|FG005|Overall Study|Severe debilitation, unable to continue|1|||
147295819|NCT01302847|531246222|FG006|Overall Study|Severe debilitation, unable to continue|1|||
147295820|NCT01302847|531246223|FG007|Overall Study|Severe debilitation, unable to continue|0|||
147295821|NCT01302847|531246216|FG000|Overall Study|Not able to get to clinic|1|||
147295822|NCT01302847|531246217|FG001|Overall Study|Not able to get to clinic|1|||
147295823|NCT01302847|531246218|FG002|Overall Study|Not able to get to clinic|0|||
147295824|NCT01302847|531246219|FG003|Overall Study|Not able to get to clinic|0|||
147295825|NCT01302847|531246220|FG004|Overall Study|Not able to get to clinic|0|||
147295826|NCT01302847|531246221|FG005|Overall Study|Not able to get to clinic|0|||
147295827|NCT01302847|531246222|FG006|Overall Study|Not able to get to clinic|0|||
147295828|NCT01302847|531246223|FG007|Overall Study|Not able to get to clinic|0|||
147295829|NCT01302847|531246216|FG000|Overall Study|Site closing|2|||
147295830|NCT01302847|531246217|FG001|Overall Study|Site closing|2|||
147295831|NCT01302847|531246218|FG002|Overall Study|Site closing|0|||
147295832|NCT01302847|531246219|FG003|Overall Study|Site closing|0|||
147295833|NCT01302847|531246220|FG004|Overall Study|Site closing|0|||
147295834|NCT01302847|531246221|FG005|Overall Study|Site closing|0|||
147295835|NCT01302847|531246222|FG006|Overall Study|Site closing|0|||
147295836|NCT01302847|531246223|FG007|Overall Study|Site closing|0|||
147295837|NCT01302847|531246216|FG000|Overall Study|Withdrawal by Subject|1|||
147295838|NCT01302847|531246217|FG001|Overall Study|Withdrawal by Subject|0|||
147295839|NCT01302847|531246218|FG002|Overall Study|Withdrawal by Subject|0|||
147295840|NCT01302847|531246219|FG003|Overall Study|Withdrawal by Subject|0|||
147295841|NCT01302847|531246220|FG004|Overall Study|Withdrawal by Subject|1|||
147295842|NCT01302847|531246221|FG005|Overall Study|Withdrawal by Subject|0|||
147295843|NCT01302847|531246222|FG006|Overall Study|Withdrawal by Subject|0|||
147295844|NCT01302847|531246223|FG007|Overall Study|Withdrawal by Subject|1|||
147295845|NCT01302847|531246216|FG000|Overall Study|Not willing to adhere to requirements|5|||
147295846|NCT01302847|531246217|FG001|Overall Study|Not willing to adhere to requirements|0|||
147295847|NCT01302847|531246218|FG002|Overall Study|Not willing to adhere to requirements|1|||
147295848|NCT01302847|531246219|FG003|Overall Study|Not willing to adhere to requirements|0|||
147295849|NCT01302847|531246220|FG004|Overall Study|Not willing to adhere to requirements|0|||
147295850|NCT01302847|531246221|FG005|Overall Study|Not willing to adhere to requirements|0|||
147295851|NCT01302847|531246222|FG006|Overall Study|Not willing to adhere to requirements|0|||
147452937|NCT04418765|531821487|FG002|Placebo-controlled Period (24 Weeks)|Withdrawal by Subject|2|||
147295852|NCT01302847|531246223|FG007|Overall Study|Not willing to adhere to requirements|2|||
147295853|NCT01302847|531246216|FG000|Overall Study|Site unable to contact participant|2|||
147295854|NCT01302847|531246217|FG001|Overall Study|Site unable to contact participant|1|||
147295855|NCT01302847|531246218|FG002|Overall Study|Site unable to contact participant|0|||
147295856|NCT01302847|531246219|FG003|Overall Study|Site unable to contact participant|0|||
147295857|NCT01302847|531246220|FG004|Overall Study|Site unable to contact participant|0|||
147295858|NCT01302847|531246221|FG005|Overall Study|Site unable to contact participant|0|||
147295859|NCT01302847|531246222|FG006|Overall Study|Site unable to contact participant|2|||
147295860|NCT01302847|531246223|FG007|Overall Study|Site unable to contact participant|0|||
147295861|NCT01371851|531246224|FG000|Overall Study|Lost to Follow-up|5|||
147295862|NCT01371851|531246225|FG001|Overall Study|Lost to Follow-up|8|||
147295863|NCT01371851|531246224|FG000|Overall Study|was arrested and put in jail|0|||
147295864|NCT01371851|531246225|FG001|Overall Study|was arrested and put in jail|1|||
147295865|NCT01371851|531246224|FG000|Overall Study|non study related adverse event|1|||
147295866|NCT01371851|531246225|FG001|Overall Study|non study related adverse event|0|||
147295867|NCT01371851|531246224|FG000|Overall Study|Blood Pressure outside study parameters|2|||
147295868|NCT01371851|531246225|FG001|Overall Study|Blood Pressure outside study parameters|0|||
147295869|NCT00450411|531246226|FG000|Overall Study|Protocol Violation|6|||
147295870|NCT00450411|531246226|FG000|Overall Study|No protocol treatment|2|||
147295871|NCT00344461|531246229|FG000|Overall Study|Adverse Event|6|||
147295872|NCT00344461|531246229|FG000|Overall Study|Death|1|||
147295873|NCT00344461|531246229|FG000|Overall Study|Lack of Efficacy|2|||
147295874|NCT00344461|531246229|FG000|Overall Study|Lost to Follow-up|2|||
147295875|NCT00344461|531246229|FG000|Overall Study|Physician Decision|2|||
147295876|NCT00344461|531246229|FG000|Overall Study|Protocol Violation|6|||
147295877|NCT00344461|531246229|FG000|Overall Study|Withdrawal by Subject|2|||
147295878|NCT00671931|531246232|FG000|Overall Study|Physician Decision|1|||
147295879|NCT00671931|531246233|FG001|Overall Study|Physician Decision|0|||
147295880|NCT00671931|531246234|FG002|Overall Study|Physician Decision|0|||
147295881|NCT00671931|531246235|FG003|Overall Study|Physician Decision|2|||
147295882|NCT00671931|531246236|FG004|Overall Study|Physician Decision|1|||
147295883|NCT00951275|531246237|FG000|Overall Study|Administrative Reason|1|||
147295884|NCT00951275|531246237|FG000|Overall Study|Adverse Event|7|||
147295885|NCT00951275|531246237|FG000|Overall Study|Withdrawal by Subject|4|||
147295886|NCT00951275|531246237|FG000|Overall Study|Protocol Violation|1|||
147295887|NCT03645759|531246241|FG000|Overall Study|Lost to Follow-up|3|||
147295888|NCT03645759|531246242|FG001|Overall Study|Lost to Follow-up|2|||
147295889|NCT00818753|531246243|FG000|Overall Study|Protocol Violation|1|||
147295890|NCT00818753|531246244|FG001|Overall Study|Protocol Violation|0|||
147295891|NCT00818753|531246245|FG002|Overall Study|Protocol Violation|0|||
147295892|NCT00818753|531246243|FG000|Overall Study|Other reason (not specified)|0|||
147295893|NCT00818753|531246244|FG001|Overall Study|Other reason (not specified)|0|||
147295894|NCT00818753|531246245|FG002|Overall Study|Other reason (not specified)|1|||
147295895|NCT00818753|531246243|FG000|Overall Study|Randomised and not treated|2|||
147295896|NCT00818753|531246244|FG001|Overall Study|Randomised and not treated|0|||
147295897|NCT00818753|531246245|FG002|Overall Study|Randomised and not treated|0|||
147295898|NCT01389973|531246246|FG000|Overall Study|Lost to Follow-up|1|||
147295899|NCT01389973|531246246|FG000|Overall Study|Trial Stopped by Sponsor|9|||
147295900|NCT01389973|531246246|FG000|Overall Study|Other|10|||
147295901|NCT00725296|531246247|FG000|Overall Study|Adverse Event|11|||
147295902|NCT00725296|531246247|FG000|Overall Study|Lack of Efficacy|7|||
147295903|NCT00725296|531246247|FG000|Overall Study|Withdrawal by Subject|3|||
147295904|NCT00725296|531246247|FG000|Overall Study|Non-Compliance|2|||
147295905|NCT00725296|531246247|FG000|Overall Study|Lost to Follow-up|1|||
147295906|NCT00725296|531246247|FG000|Overall Study|Other|38|||
147295907|NCT02693743|531246248|FG000|Overall Study|Physician Decision|1|||
147295908|NCT02693743|531246249|FG001|Overall Study|Physician Decision|0|||
147295909|NCT03360942|531246250|FG000|Overall Study|Device explanted|2|||
147295910|NCT03360942|531246250|FG000|Overall Study|Study closure|1|||
147295911|NCT03360942|531246250|FG000|Overall Study|Withdrawal by Subject|2|||
147295912|NCT02459574|531246256|FG000|Overall Study|Withdrawal by Subject|6|||
147295913|NCT02459574|531246257|FG001|Overall Study|Withdrawal by Subject|6|||
147295914|NCT02459574|531246258|FG002|Overall Study|Withdrawal by Subject|2|||
147295915|NCT02459574|531246256|FG000|Overall Study|Lost to Follow-up|1|||
147295916|NCT02459574|531246257|FG001|Overall Study|Lost to Follow-up|1|||
147295917|NCT02459574|531246258|FG002|Overall Study|Lost to Follow-up|0|||
147295918|NCT02459574|531246256|FG000|Overall Study|Death|0|||
147295919|NCT02459574|531246257|FG001|Overall Study|Death|1|||
147295920|NCT02459574|531246258|FG002|Overall Study|Death|0|||
147295921|NCT00251745|531246260|FG000|Overall Study|Adverse Event|7|||
147295922|NCT00251745|531246261|FG001|Overall Study|Adverse Event|9|||
147295923|NCT00251745|531246262|FG002|Overall Study|Adverse Event|11|||
147295924|NCT00251745|531246260|FG000|Overall Study|Lost to Follow-up|4|||
147295925|NCT00251745|531246261|FG001|Overall Study|Lost to Follow-up|2|||
147295926|NCT00251745|531246262|FG002|Overall Study|Lost to Follow-up|5|||
147295927|NCT00251745|531246260|FG000|Overall Study|Withdrawal by Subject|13|||
147295928|NCT00251745|531246261|FG001|Overall Study|Withdrawal by Subject|7|||
147295929|NCT00251745|531246262|FG002|Overall Study|Withdrawal by Subject|3|||
147295930|NCT00251745|531246260|FG000|Overall Study|Unmet Inclusion/Exclusion Criteria|0|||
147295931|NCT00251745|531246261|FG001|Overall Study|Unmet Inclusion/Exclusion Criteria|6|||
147295932|NCT00251745|531246262|FG002|Overall Study|Unmet Inclusion/Exclusion Criteria|5|||
147295933|NCT00251745|531246260|FG000|Overall Study|Lack of Efficacy|3|||
147295934|NCT00251745|531246261|FG001|Overall Study|Lack of Efficacy|0|||
147295935|NCT00251745|531246262|FG002|Overall Study|Lack of Efficacy|0|||
147295936|NCT00251745|531246260|FG000|Overall Study|Noncompliant|0|||
147295937|NCT00251745|531246261|FG001|Overall Study|Noncompliant|2|||
147295938|NCT00251745|531246262|FG002|Overall Study|Noncompliant|2|||
147295939|NCT00251745|531246260|FG000|Overall Study|Pregnancy|0|||
147295940|NCT00251745|531246261|FG001|Overall Study|Pregnancy|1|||
147295941|NCT00251745|531246262|FG002|Overall Study|Pregnancy|0|||
147295942|NCT00251745|531246260|FG000|Overall Study|Per Subject Request|0|||
147295943|NCT00251745|531246261|FG001|Overall Study|Per Subject Request|0|||
147295944|NCT00251745|531246262|FG002|Overall Study|Per Subject Request|1|||
147295945|NCT00251745|531246260|FG000|Overall Study|Per Investigator Request|1|||
147295946|NCT00251745|531246261|FG001|Overall Study|Per Investigator Request|0|||
147295947|NCT00251745|531246262|FG002|Overall Study|Per Investigator Request|0|||
147295948|NCT04508699|531246267|FG000|Overall Study|Lack of Efficacy|2|||
147295949|NCT04508699|531246268|FG001|Overall Study|Lack of Efficacy|15|||
147295950|NCT04508699|531246267|FG000|Overall Study|Withdrawal by Subject|0|||
147295951|NCT04508699|531246268|FG001|Overall Study|Withdrawal by Subject|2|||
147295952|NCT04866017|531246269|FG000|Overall Study|Study Terminated by Sponsor|13|||
147295953|NCT04866017|531246270|FG001|Overall Study|Study Terminated by Sponsor|14|||
147295954|NCT04866017|531246271|FG002|Overall Study|Study Terminated by Sponsor|13|||
147295955|NCT04866017|531246269|FG000|Overall Study|Death|8|||
147295956|NCT04866017|531246270|FG001|Overall Study|Death|4|||
147295957|NCT04866017|531246271|FG002|Overall Study|Death|8|||
147295958|NCT04866017|531246269|FG000|Overall Study|Withdrawal by Subject|1|||
147295959|NCT04866017|531246270|FG001|Overall Study|Withdrawal by Subject|0|||
147295960|NCT04866017|531246271|FG002|Overall Study|Withdrawal by Subject|1|||
147295961|NCT04866017|531246269|FG000|Overall Study|Physician Decision|0|||
147295962|NCT04866017|531246270|FG001|Overall Study|Physician Decision|1|||
147295963|NCT04866017|531246271|FG002|Overall Study|Physician Decision|0|||
147295964|NCT03355326|531246272|FG000|Overall Study|Protocol Violation|3|||
147295965|NCT03355326|531246273|FG001|Overall Study|Protocol Violation|3|||
147295966|NCT01377480|531248033|FG000|Overall Study|Protocol Violation|0|||
147295967|NCT01377480|531248034|FG001|Overall Study|Protocol Violation|0|||
147295968|NCT01377480|531248035|FG002|Overall Study|Protocol Violation|0|||
147295969|NCT01377480|531248036|FG003|Overall Study|Protocol Violation|4|||
147295970|NCT01377480|531248033|FG000|Overall Study|Evidence of drug-induced hepatotoxicity|0|||
147295971|NCT01377480|531248034|FG001|Overall Study|Evidence of drug-induced hepatotoxicity|1|||
147295972|NCT01377480|531248035|FG002|Overall Study|Evidence of drug-induced hepatotoxicity|1|||
147295973|NCT01377480|531248036|FG003|Overall Study|Evidence of drug-induced hepatotoxicity|0|||
147295974|NCT01377480|531248033|FG000|Overall Study|Withdrawal by Subject|0|||
147295975|NCT01377480|531248034|FG001|Overall Study|Withdrawal by Subject|0|||
147295976|NCT01377480|531248035|FG002|Overall Study|Withdrawal by Subject|1|||
147295977|NCT01377480|531248036|FG003|Overall Study|Withdrawal by Subject|0|||
147295978|NCT01377480|531248033|FG000|Overall Study|Serious adverse event|0|||
147295979|NCT01377480|531248034|FG001|Overall Study|Serious adverse event|0|||
147295980|NCT01377480|531248035|FG002|Overall Study|Serious adverse event|1|||
147295981|NCT01377480|531248036|FG003|Overall Study|Serious adverse event|1|||
147295982|NCT01377480|531248033|FG000|Overall Study|Other|0|||
147295983|NCT01377480|531248034|FG001|Overall Study|Other|0|||
147295984|NCT01377480|531248035|FG002|Overall Study|Other|7|||
147295985|NCT01377480|531248036|FG003|Overall Study|Other|6|||
147295986|NCT01111123|531248040|FG000|Open- Label Phase|Failed to be clear or almost cleared|14|||
147295987|NCT01111123|531248041|FG001|Open- Label Phase|Failed to be clear or almost cleared|0|||
147295988|NCT01111123|531248040|FG000|Maintenance Phase|Lost to Follow-up|0|||
147295989|NCT01111123|531248041|FG001|Maintenance Phase|Lost to Follow-up|2|||
147295990|NCT01735201|531248042|FG000|Overall Study|Adverse Event|1|||
147295991|NCT01735201|531248043|FG001|Overall Study|Adverse Event|1|||
147295992|NCT01735201|531248044|FG002|Overall Study|Adverse Event|0|||
147295993|NCT01735201|531248045|FG003|Overall Study|Adverse Event|1|||
147295994|NCT01735201|531248046|FG004|Overall Study|Adverse Event|1|||
147295995|NCT01735201|531248047|FG005|Overall Study|Adverse Event|3|||
147295996|NCT01735201|531248048|FG006|Overall Study|Adverse Event|2|||
147295997|NCT01735201|531248049|FG007|Overall Study|Adverse Event|1|||
147295998|NCT01735201|531248042|FG000|Overall Study|Personal Reasons|1|||
147295999|NCT01735201|531248043|FG001|Overall Study|Personal Reasons|0|||
147296000|NCT01735201|531248044|FG002|Overall Study|Personal Reasons|0|||
147296001|NCT01735201|531248045|FG003|Overall Study|Personal Reasons|0|||
147296002|NCT01735201|531248046|FG004|Overall Study|Personal Reasons|0|||
147296003|NCT01735201|531248047|FG005|Overall Study|Personal Reasons|0|||
147296004|NCT01735201|531248048|FG006|Overall Study|Personal Reasons|0|||
147296005|NCT01735201|531248049|FG007|Overall Study|Personal Reasons|0|||
147296006|NCT01735201|531248042|FG000|Overall Study|Protocol Violation|1|||
147296007|NCT01735201|531248043|FG001|Overall Study|Protocol Violation|0|||
147296008|NCT01735201|531248044|FG002|Overall Study|Protocol Violation|0|||
147296009|NCT01735201|531248045|FG003|Overall Study|Protocol Violation|0|||
147296010|NCT01735201|531248046|FG004|Overall Study|Protocol Violation|0|||
147296011|NCT01735201|531248047|FG005|Overall Study|Protocol Violation|0|||
147296012|NCT01735201|531248048|FG006|Overall Study|Protocol Violation|0|||
147296013|NCT01735201|531248049|FG007|Overall Study|Protocol Violation|0|||
147296014|NCT01735201|531248042|FG000|Overall Study|Other Miscellaneous Reasons|0|||
147296015|NCT01735201|531248043|FG001|Overall Study|Other Miscellaneous Reasons|0|||
147296016|NCT01735201|531248044|FG002|Overall Study|Other Miscellaneous Reasons|0|||
147296017|NCT01735201|531248045|FG003|Overall Study|Other Miscellaneous Reasons|1|||
147296018|NCT01735201|531248046|FG004|Overall Study|Other Miscellaneous Reasons|0|||
147296019|NCT01735201|531248047|FG005|Overall Study|Other Miscellaneous Reasons|2|||
147296020|NCT01735201|531248048|FG006|Overall Study|Other Miscellaneous Reasons|1|||
147296021|NCT01735201|531248049|FG007|Overall Study|Other Miscellaneous Reasons|1|||
147296022|NCT01203930|531248054|FG000|Overall Study|Disease Progression|0|||
147296023|NCT01203930|531248055|FG001|Overall Study|Disease Progression|4|||
147296024|NCT01203930|531248054|FG000|Overall Study|Death|3|||
147296025|NCT01203930|531248055|FG001|Overall Study|Death|1|||
147296026|NCT01203930|531248054|FG000|Overall Study|Withdrew Consent|1|||
147296027|NCT01203930|531248055|FG001|Overall Study|Withdrew Consent|10|||
147296028|NCT01203930|531248054|FG000|Overall Study|Investigator Request|0|||
147296029|NCT01203930|531248055|FG001|Overall Study|Investigator Request|8|||
147296030|NCT01203930|531248054|FG000|Overall Study|Study Terminated by Sponsor|0|||
147296031|NCT01203930|531248055|FG001|Overall Study|Study Terminated by Sponsor|12|||
147296032|NCT01203930|531248054|FG000|Overall Study|Poor tolerance of study drug|0|||
147296033|NCT01203930|531248055|FG001|Overall Study|Poor tolerance of study drug|1|||
147296034|NCT01203930|531248054|FG000|Overall Study|Adverse Event|17|||
147296035|NCT01203930|531248055|FG001|Overall Study|Adverse Event|5|||
147296036|NCT03014674|531248058|FG000|Overall Study|Withdrawal by Subject|1|||
147296037|NCT03014674|531248059|FG001|Overall Study|Withdrawal by Subject|0|||
147296038|NCT03014674|531248060|FG002|Overall Study|Withdrawal by Subject|0|||
147296039|NCT00605293|531248061|FG000|Overall Study|Death|2|||
147296040|NCT00605293|531248062|FG001|Overall Study|Death|1|||
147296041|NCT00605293|531248061|FG000|Overall Study|Insufficient Therapeutic Response|2|||
147296042|NCT00605293|531248062|FG001|Overall Study|Insufficient Therapeutic Response|0|||
147296043|NCT00605293|531248061|FG000|Overall Study|Adverse Event|1|||
147296044|NCT00605293|531248062|FG001|Overall Study|Adverse Event|0|||
147296045|NCT00605293|531248061|FG000|Overall Study|Holidays Dialysis Out|1|||
147296046|NCT00605293|531248062|FG001|Overall Study|Holidays Dialysis Out|0|||
147296047|NCT00605293|531248061|FG000|Overall Study|Blood Transfusion|7|||
147296048|NCT00605293|531248062|FG001|Overall Study|Blood Transfusion|1|||
147296049|NCT00605293|531248061|FG000|Overall Study|Renal Transplantation|3|||
147296050|NCT00605293|531248062|FG001|Overall Study|Renal Transplantation|1|||
147296051|NCT00605293|531248061|FG000|Overall Study|Incorrect Epoetin Beta Administration|1|||
147296052|NCT00605293|531248062|FG001|Overall Study|Incorrect Epoetin Beta Administration|0|||
147296053|NCT00605293|531248061|FG000|Overall Study|Dialysis Out of Centre for 3 Months|0|||
147296054|NCT00605293|531248062|FG001|Overall Study|Dialysis Out of Centre for 3 Months|1|||
147296055|NCT00605293|531248061|FG000|Overall Study|Principal Investigator Decision|0|||
147296056|NCT00605293|531248062|FG001|Overall Study|Principal Investigator Decision|1|||
147296057|NCT00234052|531248063|FG000|Treatment|Withdrawal by Subject|3|||
147296058|NCT00234052|531248063|FG000|Treatment|Adverse Event|5|||
147296059|NCT00234052|531248063|FG000|Treatment|Death|2|||
147296060|NCT00234052|531248063|FG000|Treatment|Progressive Disease|11|||
147296061|NCT00234052|531248063|FG000|Follow-up for 5 Years|Death|41|||
147296062|NCT00234052|531248063|FG000|Follow-up for 5 Years|Lost to Follow-up|1|||
147296063|NCT00234052|531248063|FG000|Follow-up for 5 Years|Other|7|||
147296064|NCT01410474|531248064|FG000|Overall Study|Withdrawal by Subject|0|||
147296065|NCT01410474|531248065|FG001|Overall Study|Withdrawal by Subject|1|||
147296066|NCT02428296|531248066|FG000|Overall Study|Adverse Event|7|||
147296067|NCT02428296|531248066|FG000|Overall Study|Withdrawal by Subject|2|||
147296068|NCT00828984|531248067|FG000|Overall Study|Adverse Event|2|||
147296069|NCT00828984|531248068|FG001|Overall Study|Adverse Event|3|||
147296070|NCT00828984|531248069|FG002|Overall Study|Adverse Event|0|||
147296071|NCT00828984|531248067|FG000|Overall Study|Lost to Follow-up|5|||
147296072|NCT00828984|531248068|FG001|Overall Study|Lost to Follow-up|3|||
147296073|NCT00828984|531248069|FG002|Overall Study|Lost to Follow-up|1|||
147296074|NCT00828984|531248067|FG000|Overall Study|Withdrawal by Subject|4|||
147296075|NCT00828984|531248068|FG001|Overall Study|Withdrawal by Subject|4|||
147296076|NCT00828984|531248069|FG002|Overall Study|Withdrawal by Subject|4|||
147296077|NCT00828984|531248067|FG000|Overall Study|Ineligable|1|||
147296078|NCT00828984|531248068|FG001|Overall Study|Ineligable|2|||
147296079|NCT00828984|531248069|FG002|Overall Study|Ineligable|0|||
147296080|NCT00828984|531248067|FG000|Overall Study|Medical Contraindication|0|||
147296081|NCT00828984|531248068|FG001|Overall Study|Medical Contraindication|1|||
147296082|NCT00828984|531248069|FG002|Overall Study|Medical Contraindication|0|||
147606235|NCT02500043|532375193|FG001|Overall Study|Adverse Event|11|||
147296083|NCT00828984|531248067|FG000|Overall Study|Noncompliant|1|||
147296084|NCT00828984|531248068|FG001|Overall Study|Noncompliant|2|||
147296085|NCT00828984|531248069|FG002|Overall Study|Noncompliant|3|||
147296086|NCT00828984|531248067|FG000|Overall Study|ConMed|1|||
147296087|NCT00828984|531248068|FG001|Overall Study|ConMed|1|||
147296088|NCT00828984|531248069|FG002|Overall Study|ConMed|1|||
147296089|NCT00420199|531248070|FG000|Overall Study|Participant no longer met study criteria|1|||
147296090|NCT00420199|531248071|FG001|Overall Study|Participant no longer met study criteria|0|||
147296091|NCT00002558|531248082|FG000|Overall Study|Withdrawal by Subject|0|||
147296092|NCT00002558|531248083|FG001|Overall Study|Withdrawal by Subject|1|||
147296093|NCT01260350|531248086|FG000|Overall Study|Lack of Efficacy|0|||
147606236|NCT02500043|532375192|FG000|Overall Study|Clinical Progression|54|||
147296094|NCT01260350|531248087|FG001|Overall Study|Lack of Efficacy|0|||
147296095|NCT01260350|531248088|FG002|Overall Study|Lack of Efficacy|0|||
147296096|NCT01260350|531248089|FG003|Overall Study|Lack of Efficacy|0|||
147296097|NCT01260350|531248090|FG004|Overall Study|Lack of Efficacy|0|||
147296098|NCT01260350|531248091|FG005|Overall Study|Lack of Efficacy|0|||
147296099|NCT01260350|531248092|FG006|Overall Study|Lack of Efficacy|0|||
147296100|NCT01260350|531248093|FG007|Overall Study|Lack of Efficacy|0|||
147296101|NCT01260350|531248094|FG008|Overall Study|Lack of Efficacy|0|||
147296102|NCT01260350|531248095|FG009|Overall Study|Lack of Efficacy|0|||
147296103|NCT01260350|531248096|FG010|Overall Study|Lack of Efficacy|0|||
147296104|NCT01260350|531248097|FG011|Overall Study|Lack of Efficacy|0|||
147296105|NCT01260350|531248098|FG012|Overall Study|Lack of Efficacy|0|||
147296106|NCT01260350|531248099|FG013|Overall Study|Lack of Efficacy|0|||
147296107|NCT01260350|531248100|FG014|Overall Study|Lack of Efficacy|0|||
147296108|NCT01260350|531248101|FG015|Overall Study|Lack of Efficacy|0|||
147296109|NCT01260350|531248102|FG016|Overall Study|Lack of Efficacy|0|||
147296110|NCT01260350|531248103|FG017|Overall Study|Lack of Efficacy|1|||
147296111|NCT01260350|531248104|FG018|Overall Study|Lack of Efficacy|0|||
147296112|NCT01260350|531248105|FG019|Overall Study|Lack of Efficacy|0|||
147296113|NCT01260350|531248106|FG020|Overall Study|Lack of Efficacy|3|||
147296114|NCT01260350|531248107|FG021|Overall Study|Lack of Efficacy|0|||
147296115|NCT01260350|531248086|FG000|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
147296116|NCT01260350|531248087|FG001|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
147296117|NCT01260350|531248088|FG002|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
147296118|NCT01260350|531248089|FG003|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
147296119|NCT01260350|531248090|FG004|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
147296120|NCT01260350|531248091|FG005|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
147296121|NCT01260350|531248092|FG006|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
147296122|NCT01260350|531248093|FG007|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
147606237|NCT02500043|532375193|FG001|Overall Study|Clinical Progression|35|||
147606238|NCT02500043|532375192|FG000|Overall Study|Radiological Progression|192|||
147606239|NCT02500043|532375193|FG001|Overall Study|Radiological Progression|110|||
147296123|NCT01260350|531248094|FG008|Overall Study|Did Not Complete Follow-up 12 Visit|1|||
147296124|NCT01260350|531248095|FG009|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
147296125|NCT01260350|531248096|FG010|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
147296126|NCT01260350|531248097|FG011|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
147296127|NCT01260350|531248098|FG012|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
147296128|NCT01260350|531248099|FG013|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
147296129|NCT01260350|531248100|FG014|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
147296130|NCT01260350|531248101|FG015|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
147296131|NCT01260350|531248102|FG016|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
147296132|NCT01260350|531248103|FG017|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
147296133|NCT01260350|531248104|FG018|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
147296134|NCT01260350|531248105|FG019|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
147296135|NCT01260350|531248106|FG020|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
147296136|NCT01260350|531248107|FG021|Overall Study|Did Not Complete Follow-up 12 Visit|0|||
147296137|NCT00558428|531248108|FG000|Overall Study|Adverse Event|6|||
147296138|NCT00558428|531248109|FG001|Overall Study|Adverse Event|22|||
147296139|NCT00558428|531248110|FG002|Overall Study|Adverse Event|3|||
147296140|NCT00558428|531248111|FG003|Overall Study|Adverse Event|4|||
147296141|NCT00558428|531248108|FG000|Overall Study|Lost to Follow-up|0|||
147296142|NCT00558428|531248109|FG001|Overall Study|Lost to Follow-up|1|||
147296143|NCT00558428|531248110|FG002|Overall Study|Lost to Follow-up|0|||
147296144|NCT00558428|531248111|FG003|Overall Study|Lost to Follow-up|0|||
147296145|NCT00558428|531248108|FG000|Overall Study|Lack of Efficacy|0|||
147296146|NCT00558428|531248109|FG001|Overall Study|Lack of Efficacy|0|||
147296147|NCT00558428|531248110|FG002|Overall Study|Lack of Efficacy|1|||
147296148|NCT00558428|531248111|FG003|Overall Study|Lack of Efficacy|2|||
147296149|NCT00558428|531248108|FG000|Overall Study|Non compliant with protocol|1|||
147296150|NCT00558428|531248109|FG001|Overall Study|Non compliant with protocol|0|||
147296151|NCT00558428|531248110|FG002|Overall Study|Non compliant with protocol|0|||
147296152|NCT00558428|531248111|FG003|Overall Study|Non compliant with protocol|3|||
147296153|NCT00558428|531248108|FG000|Overall Study|Consent withdrawn|2|||
147296154|NCT00558428|531248109|FG001|Overall Study|Consent withdrawn|1|||
147296155|NCT00558428|531248110|FG002|Overall Study|Consent withdrawn|0|||
147296156|NCT00558428|531248111|FG003|Overall Study|Consent withdrawn|1|||
147296157|NCT00558428|531248108|FG000|Overall Study|Other|3|||
147296158|NCT00558428|531248109|FG001|Overall Study|Other|0|||
147296159|NCT00558428|531248110|FG002|Overall Study|Other|0|||
147296160|NCT00558428|531248111|FG003|Overall Study|Other|1|||
147296161|NCT00626028|531248112|FG000|Overall Study|Adverse Event|1|||
147296162|NCT00626028|531248113|FG001|Overall Study|Adverse Event|1|||
147606240|NCT02500043|532375192|FG000|Overall Study|Physician's Decision|11|||
147339377|NCT02566902|531412099|FG001|Overall Study|Protocol Violation|1|||
147339378|NCT04425629|531412102|FG000|Overall Study|Adverse Event|0|||
147339379|NCT04425629|531412103|FG001|Overall Study|Adverse Event|0|||
147339380|NCT04425629|531412104|FG002|Overall Study|Adverse Event|0|||
147339381|NCT04425629|531412105|FG003|Overall Study|Adverse Event|0|||
147339382|NCT04425629|531412106|FG004|Overall Study|Adverse Event|1|||
147339383|NCT04425629|531412107|FG005|Overall Study|Adverse Event|0|||
147339384|NCT04425629|531412108|FG006|Overall Study|Adverse Event|0|||
147339385|NCT04425629|531412109|FG007|Overall Study|Adverse Event|0|||
147339386|NCT04425629|531412110|FG008|Overall Study|Adverse Event|0|||
147339387|NCT04425629|531412111|FG009|Overall Study|Adverse Event|3|||
147296163|NCT00626028|531248112|FG000|Overall Study|Device Failure|0|||
147296164|NCT00626028|531248113|FG001|Overall Study|Device Failure|1|||
147296165|NCT00626028|531248112|FG000|Overall Study|Physician Decision|2|||
147296166|NCT00626028|531248113|FG001|Overall Study|Physician Decision|1|||
147296167|NCT00626028|531248112|FG000|Overall Study|Inclusion/Exclusion Criteria|3|||
147296168|NCT00626028|531248113|FG001|Overall Study|Inclusion/Exclusion Criteria|6|||
147296169|NCT05224050|531248114|FG000|Overall Study|Withdrawal by Subject|9|||
147296170|NCT05224050|531248114|FG000|Overall Study|Lost to Follow-up|3|||
147296171|NCT04385368|531248115|FG000|Overall Study|Death|5|||
147296172|NCT04385368|531248116|FG001|Overall Study|Death|5|||
147296173|NCT04385368|531248115|FG000|Overall Study|Physician Decision|3|||
147296174|NCT04385368|531248116|FG001|Overall Study|Physician Decision|0|||
147296175|NCT04385368|531248115|FG000|Overall Study|Withdrawal by Subject|4|||
147296176|NCT04385368|531248116|FG001|Overall Study|Withdrawal by Subject|3|||
147296177|NCT02123108|531248119|FG000|Overall Study|Death|2|||
147296178|NCT02123108|531248120|FG001|Overall Study|Death|3|||
147296179|NCT00716092|531248121|FG000|Overall Study|Other incl. Lack of Efficacy|2|||
147296180|NCT00716092|531248122|FG001|Overall Study|Other incl. Lack of Efficacy|1|||
147296181|NCT00716092|531248123|FG002|Overall Study|Other incl. Lack of Efficacy|0|||
147296182|NCT02219048|531248124|FG000|Overall Study|Adverse Event|2|||
147296183|NCT02219048|531248125|FG001|Overall Study|Adverse Event|5|||
147339388|NCT04425629|531412112|FG010|Overall Study|Adverse Event|2|||
147339389|NCT04425629|531412113|FG011|Overall Study|Adverse Event|1|||
147339390|NCT04425629|531412114|FG012|Overall Study|Adverse Event|1|||
147339391|NCT04425629|531412115|FG013|Overall Study|Adverse Event|0|||
147339392|NCT04425629|531412116|FG014|Overall Study|Adverse Event|0|||
147339393|NCT04425629|531412117|FG015|Overall Study|Adverse Event|0|||
147339394|NCT04425629|531412118|FG016|Overall Study|Adverse Event|0|||
147339395|NCT04425629|531412119|FG017|Overall Study|Adverse Event|0|||
147339396|NCT04425629|531412120|FG018|Overall Study|Adverse Event|0|||
147339397|NCT04425629|531412102|FG000|Overall Study|Lost to Follow-up|1|||
147339398|NCT04425629|531412103|FG001|Overall Study|Lost to Follow-up|3|||
147339399|NCT04425629|531412104|FG002|Overall Study|Lost to Follow-up|1|||
147339400|NCT04425629|531412105|FG003|Overall Study|Lost to Follow-up|7|||
147339401|NCT04425629|531412106|FG004|Overall Study|Lost to Follow-up|1|||
147339402|NCT04425629|531412107|FG005|Overall Study|Lost to Follow-up|2|||
147339403|NCT04425629|531412108|FG006|Overall Study|Lost to Follow-up|1|||
147339404|NCT04425629|531412109|FG007|Overall Study|Lost to Follow-up|0|||
147339405|NCT04425629|531412110|FG008|Overall Study|Lost to Follow-up|1|||
147339406|NCT04425629|531412111|FG009|Overall Study|Lost to Follow-up|64|||
147339407|NCT04425629|531412112|FG010|Overall Study|Lost to Follow-up|70|||
147339408|NCT04425629|531412113|FG011|Overall Study|Lost to Follow-up|98|||
147339409|NCT04425629|531412114|FG012|Overall Study|Lost to Follow-up|30|||
147339410|NCT04425629|531412115|FG013|Overall Study|Lost to Follow-up|0|||
147339411|NCT04425629|531412116|FG014|Overall Study|Lost to Follow-up|5|||
147339412|NCT04425629|531412117|FG015|Overall Study|Lost to Follow-up|4|||
147339413|NCT04425629|531412118|FG016|Overall Study|Lost to Follow-up|0|||
147339414|NCT04425629|531412119|FG017|Overall Study|Lost to Follow-up|3|||
147339415|NCT04425629|531412120|FG018|Overall Study|Lost to Follow-up|1|||
147339416|NCT04425629|531412102|FG000|Overall Study|Subject Decision|0|||
147339417|NCT04425629|531412103|FG001|Overall Study|Subject Decision|2|||
147339418|NCT04425629|531412104|FG002|Overall Study|Subject Decision|1|||
147296184|NCT02219048|531248124|FG000|Overall Study|No longer meets eligibility criteria|1|||
147296185|NCT02219048|531248125|FG001|Overall Study|No longer meets eligibility criteria|0|||
147296186|NCT02219048|531248124|FG000|Overall Study|Study terminated by sponsor|16|||
147296187|NCT02219048|531248125|FG001|Overall Study|Study terminated by sponsor|15|||
147296188|NCT02219048|531248124|FG000|Overall Study|Withdrawal by Subject|2|||
147296189|NCT02219048|531248125|FG001|Overall Study|Withdrawal by Subject|0|||
147296190|NCT02219048|531248124|FG000|Overall Study|Other|0|||
147296191|NCT02219048|531248125|FG001|Overall Study|Other|1|||
147339419|NCT04425629|531412105|FG003|Overall Study|Subject Decision|3|||
147339420|NCT04425629|531412106|FG004|Overall Study|Subject Decision|6|||
147339421|NCT04425629|531412107|FG005|Overall Study|Subject Decision|6|||
147339422|NCT04425629|531412108|FG006|Overall Study|Subject Decision|3|||
147339423|NCT04425629|531412109|FG007|Overall Study|Subject Decision|3|||
147339424|NCT04425629|531412110|FG008|Overall Study|Subject Decision|1|||
147296192|NCT02436330|531248126|FG000|Cohort 1|Lost to Follow-up|5|||
147339425|NCT04425629|531412111|FG009|Overall Study|Subject Decision|70|||
147339426|NCT04425629|531412112|FG010|Overall Study|Subject Decision|95|||
147296193|NCT02436330|531248127|FG001|Cohort 1|Lost to Follow-up|2|||
147296194|NCT02436330|531248126|FG000|Cohort 1|Withdrawal by Subject|0|||
147296195|NCT02436330|531248127|FG001|Cohort 1|Withdrawal by Subject|1|||
147296196|NCT02436330|531248126|FG000|Cohort 2|Lost to Follow-up|2|||
147296197|NCT02436330|531248127|FG001|Cohort 2|Lost to Follow-up|0|||
147296198|NCT02436330|531248126|FG000|Cohort 2|Withdrawal by Subject|2|||
147296199|NCT02436330|531248127|FG001|Cohort 2|Withdrawal by Subject|3|||
147296200|NCT02436330|531248126|FG000|Cohort 3|Lost to Follow-up|1|||
147296201|NCT02436330|531248127|FG001|Cohort 3|Lost to Follow-up|0|||
147296202|NCT02436330|531248126|FG000|Cohort 3|Withdrawal by Subject|4|||
147296203|NCT02436330|531248127|FG001|Cohort 3|Withdrawal by Subject|0|||
147296204|NCT02436330|531248126|FG000|Cohort 4|Lost to Follow-up|1|||
147296205|NCT02436330|531248127|FG001|Cohort 4|Lost to Follow-up|0|||
147296206|NCT02436330|531248126|FG000|Cohort 4|Withdrawal by Subject|1|||
147296207|NCT02436330|531248127|FG001|Cohort 4|Withdrawal by Subject|0|||
147296208|NCT02436330|531248126|FG000|Cohort 5|Lost to Follow-up|3|||
147296209|NCT02436330|531248127|FG001|Cohort 5|Lost to Follow-up|2|||
147296210|NCT02436330|531248126|FG000|Cohort 5|Withdrawal by Subject|3|||
147296211|NCT02436330|531248127|FG001|Cohort 5|Withdrawal by Subject|2|||
147296212|NCT02436330|531248126|FG000|Cohort 6|Lost to Follow-up|2|||
147296213|NCT02436330|531248127|FG001|Cohort 6|Lost to Follow-up|0|||
147296214|NCT02436330|531248126|FG000|Cohort 6|Withdrawal by Subject|1|||
147296215|NCT02436330|531248127|FG001|Cohort 6|Withdrawal by Subject|1|||
147296216|NCT02054806|531248128|FG000|Overall Study|Sponsor Decision|31|||
147296217|NCT02054806|531248128|FG000|Overall Study|Withdrawal by Subject|43|||
147296218|NCT02054806|531248128|FG000|Overall Study|Protocol Violation|2|||
147296219|NCT02054806|531248128|FG000|Overall Study|Lost to Follow-up|10|||
147296220|NCT02054806|531248128|FG000|Overall Study|Death|391|||
147296221|NCT01132326|531248129|FG000|Overall Study|Lack of Efficacy|25|||
147296222|NCT01132326|531248129|FG000|Overall Study|Adverse Event|37|||
147296223|NCT01132326|531248129|FG000|Overall Study|Protocol Violation|1|||
147296224|NCT01132326|531248129|FG000|Overall Study|Lost to Follow-up|16|||
147296225|NCT01132326|531248129|FG000|Overall Study|Withdrawal by Subject|40|||
147296226|NCT01132326|531248129|FG000|Overall Study|Physician Decision|10|||
147296227|NCT01132326|531248129|FG000|Overall Study|Study Termination|80|||
147296228|NCT01132326|531248129|FG000|Overall Study|Declining Health|1|||
147296229|NCT01132326|531248129|FG000|Overall Study|Pregnancy|1|||
147296230|NCT01132326|531248129|FG000|Overall Study|Caregiver Withdrew Consent|1|||
147296231|NCT01132326|531248129|FG000|Overall Study|Death|5|||
147296232|NCT01132326|531248129|FG000|Overall Study|Subject Unable to Come To Visits|1|||
147296233|NCT00677235|531248130|FG000|Overall Study|Withdrawal by Subject|1|||
147296234|NCT00677235|531248131|FG001|Overall Study|Withdrawal by Subject|1|||
147296235|NCT00677235|531248130|FG000|Overall Study|Lost to Follow-up|2|||
147296236|NCT00677235|531248131|FG001|Overall Study|Lost to Follow-up|1|||
147296237|NCT00677235|531248130|FG000|Overall Study|Death|37|||
147296238|NCT00677235|531248131|FG001|Overall Study|Death|36|||
147296239|NCT00677235|531248130|FG000|Overall Study|Adverse Experience|1|||
147296240|NCT00677235|531248131|FG001|Overall Study|Adverse Experience|0|||
147296241|NCT00952367|531248132|FG000|Overall Study|Withdrawal by Subject|2|||
147296242|NCT00952367|531248132|FG000|Overall Study|Noncoordination|1|||
147296243|NCT00952367|531248132|FG000|Overall Study|Protocol Violation|3|||
147296244|NCT02230956|531248133|FG000|Overall Study|Adverse Event|1|||
147296245|NCT02230956|531248134|FG001|Overall Study|Adverse Event|1|||
147296246|NCT02230956|531248135|FG002|Overall Study|Adverse Event|0|||
147296247|NCT02230956|531248133|FG000|Overall Study|Lack of Efficacy|1|||
147296248|NCT02230956|531248134|FG001|Overall Study|Lack of Efficacy|1|||
147296249|NCT02230956|531248135|FG002|Overall Study|Lack of Efficacy|1|||
147296250|NCT02230956|531248133|FG000|Overall Study|Lost to Follow-up|1|||
147296251|NCT02230956|531248134|FG001|Overall Study|Lost to Follow-up|1|||
147296252|NCT02230956|531248135|FG002|Overall Study|Lost to Follow-up|2|||
147296253|NCT02230956|531248133|FG000|Overall Study|Personal Reasons|2|||
147296254|NCT02230956|531248134|FG001|Overall Study|Personal Reasons|1|||
147296255|NCT02230956|531248135|FG002|Overall Study|Personal Reasons|1|||
147296256|NCT02230956|531248133|FG000|Overall Study|Protocol Violation|0|||
147296257|NCT02230956|531248134|FG001|Overall Study|Protocol Violation|1|||
147296258|NCT02230956|531248135|FG002|Overall Study|Protocol Violation|1|||
147296259|NCT02230956|531248133|FG000|Overall Study|Other Miscellaneous Reason|0|||
147296260|NCT02230956|531248134|FG001|Overall Study|Other Miscellaneous Reason|1|||
147296261|NCT02230956|531248135|FG002|Overall Study|Other Miscellaneous Reason|2|||
147296262|NCT03575325|531248137|FG000|Overall Study|Death|1|||
147296263|NCT05711641|531248138|FG000|Washout (2 Weeks)|Lost to Follow-up|2|||
147296264|NCT05711641|531248139|FG001|Washout (2 Weeks)|Lost to Follow-up|1|||
147296265|NCT05711641|531248138|FG000|Second Intervention (Single Dose)|Imperceptible tinnitus on the day of the assessment|1|||
147296266|NCT05711641|531248139|FG001|Second Intervention (Single Dose)|Imperceptible tinnitus on the day of the assessment|0|||
147296267|NCT03574597|531248140|FG000|Overall Study|Withdrawal by Subject|67|||
147296268|NCT03574597|531248141|FG001|Overall Study|Withdrawal by Subject|96|||
147296269|NCT03574597|531248140|FG000|Overall Study|Lost to Follow-up|192|||
147296270|NCT03574597|531248141|FG001|Overall Study|Lost to Follow-up|188|||
147296271|NCT02355743|531248142|FG000|Overall Study|Withdrawal by Subject|1|||
147296272|NCT02355743|531248142|FG000|Overall Study|Lost to Follow-up|1|||
147296273|NCT02862457|531248146|FG000|Overall Study|Death|1|||
147296274|NCT02862457|531248147|FG001|Overall Study|Death|3|||
147296275|NCT02862457|531248148|FG002|Overall Study|Death|2|||
147296276|NCT02862457|531248149|FG003|Overall Study|Death|3|||
147296277|NCT02862457|531248150|FG004|Overall Study|Death|0|||
147296278|NCT02862457|531248151|FG005|Overall Study|Death|2|||
147296279|NCT02862457|531248152|FG006|Overall Study|Death|1|||
147296280|NCT02862457|531248146|FG000|Overall Study|Lost to Follow-up|1|||
147296281|NCT02862457|531248147|FG001|Overall Study|Lost to Follow-up|0|||
147296282|NCT02862457|531248148|FG002|Overall Study|Lost to Follow-up|0|||
147296283|NCT02862457|531248149|FG003|Overall Study|Lost to Follow-up|1|||
147296284|NCT02862457|531248150|FG004|Overall Study|Lost to Follow-up|0|||
147296285|NCT02862457|531248151|FG005|Overall Study|Lost to Follow-up|0|||
147296286|NCT02862457|531248152|FG006|Overall Study|Lost to Follow-up|0|||
147296287|NCT02862457|531248146|FG000|Overall Study|Withdrawal by Subject|0|||
147296288|NCT02862457|531248147|FG001|Overall Study|Withdrawal by Subject|0|||
147296289|NCT02862457|531248148|FG002|Overall Study|Withdrawal by Subject|1|||
147296290|NCT02862457|531248149|FG003|Overall Study|Withdrawal by Subject|0|||
147296291|NCT02862457|531248150|FG004|Overall Study|Withdrawal by Subject|0|||
147296292|NCT02862457|531248151|FG005|Overall Study|Withdrawal by Subject|1|||
147296293|NCT02862457|531248152|FG006|Overall Study|Withdrawal by Subject|0|||
147296294|NCT00951483|531248155|FG000|Overall Study|Physician Decision|4|||
147296295|NCT00951483|531248156|FG001|Overall Study|Physician Decision|0|||
147296296|NCT00951483|531248155|FG000|Overall Study|Withdrawal by Subject|15|||
147296297|NCT00951483|531248156|FG001|Overall Study|Withdrawal by Subject|0|||
147296298|NCT03565887|531248157|FG000|Overall Study|Adverse Event|1|||
147296299|NCT03565887|531248158|FG001|Overall Study|Adverse Event|0|||
147296300|NCT03565887|531248157|FG000|Overall Study|Withdrawal by Subject|0|||
147296301|NCT03565887|531248158|FG001|Overall Study|Withdrawal by Subject|2|||
147296302|NCT03364751|531248159|FG000|Overall Study|Withdrawal by Subject|1|||
147296303|NCT03364751|531248160|FG001|Overall Study|Withdrawal by Subject|0|||
147296304|NCT03364751|531248161|FG002|Overall Study|Withdrawal by Subject|0|||
147296305|NCT03364751|531248162|FG003|Overall Study|Withdrawal by Subject|0|||
147296306|NCT03364751|531248159|FG000|Overall Study|Lost to Follow-up|0|||
147296307|NCT03364751|531248160|FG001|Overall Study|Lost to Follow-up|1|||
147296308|NCT03364751|531248161|FG002|Overall Study|Lost to Follow-up|0|||
147296309|NCT03364751|531248162|FG003|Overall Study|Lost to Follow-up|0|||
147296310|NCT02975973|531248163|FG000|Overall Study|Adverse Event|1|||
147296311|NCT02975973|531248164|FG001|Overall Study|Adverse Event|1|||
147296312|NCT02975973|531248165|FG002|Overall Study|Adverse Event|1|||
147296313|NCT02975973|531248166|FG003|Overall Study|Adverse Event|0|||
147296314|NCT03804710|531248168|FG000|Overall Study|Adverse Event|0|||
147296315|NCT03804710|531248169|FG001|Overall Study|Adverse Event|3|||
147296316|NCT03804710|531248168|FG000|Overall Study|Withdrawal by Subject|2|||
147296317|NCT03804710|531248169|FG001|Overall Study|Withdrawal by Subject|1|||
147296318|NCT03804710|531248168|FG000|Overall Study|Other|0|||
147296319|NCT03804710|531248169|FG001|Overall Study|Other|1|||
147296320|NCT04542018|531248170|FG000|Overall Study|Withdrawal by Subject|0|||
147296321|NCT04542018|531248171|FG001|Overall Study|Withdrawal by Subject|0|||
147296322|NCT04542018|531248172|FG002|Overall Study|Withdrawal by Subject|4|||
147296323|NCT04542018|531248170|FG000|Overall Study|Protocol Violation|0|||
147296324|NCT04542018|531248171|FG001|Overall Study|Protocol Violation|0|||
147296325|NCT04542018|531248172|FG002|Overall Study|Protocol Violation|2|||
147296326|NCT03583554|531248173|FG000|Period 2|Did not receive treatment due to loss of contact|1|||
147296327|NCT03583554|531248174|FG001|Period 2|Did not receive treatment due to loss of contact|0|||
147296328|NCT03583554|531248175|FG002|Period 2|Did not receive treatment due to loss of contact|1|||
147296329|NCT03178266|531248176|FG000|Overall Study|Death|0|||
147296330|NCT03178266|531248177|FG001|Overall Study|Death|1|||
147296331|NCT03178266|531248176|FG000|Overall Study|Disont. Early|0|||
147296332|NCT03178266|531248177|FG001|Overall Study|Disont. Early|1|||
147296333|NCT03178266|531248176|FG000|Overall Study|Withdrawal by Subject|0|||
147339427|NCT04425629|531412113|FG011|Overall Study|Subject Decision|124|||
147339428|NCT04425629|531412114|FG012|Overall Study|Subject Decision|25|||
147296334|NCT03178266|531248177|FG001|Overall Study|Withdrawal by Subject|2|||
147296335|NCT00262821|531248183|FG000|Overall Study|Ineligible - wrong stage|0|||
147296336|NCT00262821|531248184|FG001|Overall Study|Ineligible - wrong stage|3|||
147296337|NCT00262821|531248183|FG000|Overall Study|Ineligible - wrong cell type|2|||
147296338|NCT00262821|531248184|FG001|Overall Study|Ineligible - wrong cell type|2|||
147296339|NCT00262821|531248183|FG000|Overall Study|Ineligible - wrong primary|0|||
147296340|NCT00262821|531248184|FG001|Overall Study|Ineligible - wrong primary|1|||
147296341|NCT00262821|531248183|FG000|Overall Study|Ineligible - inadequate pathology|1|||
147296342|NCT00262821|531248184|FG001|Overall Study|Ineligible - inadequate pathology|3|||
147296343|NCT00262821|531248183|FG000|Overall Study|Ineligible - elevated creatinine|0|||
147296344|NCT00262821|531248184|FG001|Overall Study|Ineligible - elevated creatinine|2|||
147339429|NCT04425629|531412115|FG013|Overall Study|Subject Decision|0|||
147296345|NCT00262821|531248183|FG000|Overall Study|Ineligible - required test not done|1|||
147296346|NCT00262821|531248184|FG001|Overall Study|Ineligible - required test not done|4|||
147296347|NCT00262821|531248183|FG000|Overall Study|Inevaluable - inadequate data|0|||
147296348|NCT00262821|531248184|FG001|Overall Study|Inevaluable - inadequate data|4|||
147296349|NCT00528775|531248185|FG000|Overall Study|Other not specified|1|||
147296350|NCT01777854|531248188|FG000|Overall Study|Physician Decision|3|||
147296351|NCT01777854|531248189|FG001|Overall Study|Physician Decision|3|||
147296352|NCT01297959|531248195|FG000|Overall Study|Adverse Event|0|||
147296353|NCT01297959|531248196|FG001|Overall Study|Adverse Event|1|||
147296354|NCT01297959|531248195|FG000|Overall Study|Protocol Violation|2|||
147296355|NCT01297959|531248196|FG001|Overall Study|Protocol Violation|1|||
147296356|NCT01297959|531248195|FG000|Overall Study|Withdrawal by Subject|5|||
147296357|NCT01297959|531248196|FG001|Overall Study|Withdrawal by Subject|4|||
147296358|NCT01297959|531248195|FG000|Overall Study|Physician Decision|0|||
147296359|NCT01297959|531248196|FG001|Overall Study|Physician Decision|1|||
147296360|NCT01297959|531248195|FG000|Overall Study|Unrelated medical illness / complication|0|||
147296361|NCT01297959|531248196|FG001|Overall Study|Unrelated medical illness / complication|2|||
147296362|NCT01297959|531248195|FG000|Overall Study|Other|13|||
147296363|NCT01297959|531248196|FG001|Overall Study|Other|7|||
147296364|NCT01667432|531248197|FG000|Overall Study|Premature Study Termination|26|||
147296365|NCT01667432|531248197|FG000|Overall Study|Failure to Return|10|||
147296366|NCT01667432|531248197|FG000|Overall Study|Moved to Another Center|3|||
147296367|NCT01667432|531248197|FG000|Overall Study|Lost to Follow-up|3|||
147296368|NCT01667432|531248197|FG000|Overall Study|Refused Treatment/Withdrew Consent|1|||
147296369|NCT01667432|531248197|FG000|Overall Study|Insufficient Therapeutic Response|4|||
147296370|NCT01667432|531248197|FG000|Overall Study|Adverse Event|1|||
147296371|NCT01667432|531248197|FG000|Overall Study|Protocol Deviation|2|||
147296372|NCT01667432|531248197|FG000|Overall Study|Principal Investigator Decision|1|||
147296373|NCT01667432|531248197|FG000|Overall Study|Reason Not Specified|2|||
147296374|NCT01667432|531248197|FG000|Overall Study|Missing Information|4|||
147296375|NCT02048072|531248202|FG000|Overall Study|Adverse Event|3|||
147296376|NCT02048072|531248202|FG000|Overall Study|Lost to Follow-up|1|||
147296377|NCT01648270|531248203|FG000|Intravenous Buprenorphine|Withdrawal by Subject|12|||
147296378|NCT03456700|531248204|FG000|Overall Study|Withdrawal by Subject|1|||
147296379|NCT04154787|531248205|FG000|Overall Study|Adverse Event|0|||
147296380|NCT04154787|531248206|FG001|Overall Study|Adverse Event|1|||
147296381|NCT04154787|531248207|FG002|Overall Study|Adverse Event|0|||
147296382|NCT04154787|531248205|FG000|Overall Study|Patient Requires Other Treatment|0|||
147296383|NCT04154787|531248206|FG001|Overall Study|Patient Requires Other Treatment|1|||
147296384|NCT04154787|531248207|FG002|Overall Study|Patient Requires Other Treatment|0|||
147296385|NCT04154787|531248205|FG000|Overall Study|Study Terminated By Sponsor|0|||
147296386|NCT04154787|531248206|FG001|Overall Study|Study Terminated By Sponsor|6|||
147296387|NCT04154787|531248207|FG002|Overall Study|Study Terminated By Sponsor|1|||
147296388|NCT04154787|531248205|FG000|Overall Study|Subject Decision|0|||
147296389|NCT04154787|531248206|FG001|Overall Study|Subject Decision|1|||
147296390|NCT04154787|531248207|FG002|Overall Study|Subject Decision|0|||
147296391|NCT04154787|531248205|FG000|Overall Study|Suspected Lack Of Efficacy|0|||
147296392|NCT04154787|531248206|FG001|Overall Study|Suspected Lack Of Efficacy|1|||
147296393|NCT04154787|531248207|FG002|Overall Study|Suspected Lack Of Efficacy|0|||
147296394|NCT03053050|531248208|FG000|Randomized Phase|Study Terminated by Sponsor|259|||
147296395|NCT03053050|531248209|FG001|Randomized Phase|Study Terminated by Sponsor|260|||
147296396|NCT03053050|531248210|FG002|Randomized Phase|Study Terminated by Sponsor|128|||
147296397|NCT03053050|531248211|FG003|Randomized Phase|Study Terminated by Sponsor|0|||
147296398|NCT03053050|531248208|FG000|Randomized Phase|Withdrew Consent|16|||
147296399|NCT03053050|531248209|FG001|Randomized Phase|Withdrew Consent|8|||
147296400|NCT03053050|531248210|FG002|Randomized Phase|Withdrew Consent|9|||
147296401|NCT03053050|531248211|FG003|Randomized Phase|Withdrew Consent|0|||
147296402|NCT03053050|531248208|FG000|Randomized Phase|Investigator's Discretion|6|||
147296403|NCT03053050|531248209|FG001|Randomized Phase|Investigator's Discretion|6|||
147606241|NCT02500043|532375193|FG001|Overall Study|Physician's Decision|3|||
147606242|NCT02500043|532375192|FG000|Overall Study|Withdrawal by Subject|14|||
147606243|NCT02500043|532375193|FG001|Overall Study|Withdrawal by Subject|4|||
147606244|NCT02500043|532375192|FG000|Overall Study|Death|11|||
147606245|NCT02500043|532375193|FG001|Overall Study|Death|2|||
147296404|NCT03053050|531248210|FG002|Randomized Phase|Investigator's Discretion|3|||
147606246|NCT02500043|532375192|FG000|Overall Study|Protocol Deviation|1|||
147606247|NCT02500043|532375193|FG001|Overall Study|Protocol Deviation|0|||
147606248|NCT01371747|532375194|FG000|Overall Study|Adverse Event|4|||
147296405|NCT03053050|531248211|FG003|Randomized Phase|Investigator's Discretion|0|||
147296406|NCT03053050|531248208|FG000|Randomized Phase|Lost to Follow-up|5|||
147296407|NCT03053050|531248209|FG001|Randomized Phase|Lost to Follow-up|1|||
147296408|NCT03053050|531248210|FG002|Randomized Phase|Lost to Follow-up|1|||
147296409|NCT03053050|531248211|FG003|Randomized Phase|Lost to Follow-up|0|||
147296410|NCT03053050|531248208|FG000|Randomized Phase|Adverse Event|0|||
147296411|NCT03053050|531248209|FG001|Randomized Phase|Adverse Event|1|||
147606249|NCT01371747|532375195|FG001|Overall Study|Adverse Event|2|||
147296412|NCT03053050|531248210|FG002|Randomized Phase|Adverse Event|0|||
147606250|NCT01371747|532375196|FG002|Overall Study|Adverse Event|7|||
147296413|NCT03053050|531248211|FG003|Randomized Phase|Adverse Event|0|||
147606251|NCT01371747|532375197|FG003|Overall Study|Adverse Event|2|||
147606252|NCT01371747|532375198|FG004|Overall Study|Adverse Event|2|||
147296414|NCT03053050|531248208|FG000|Randomized Phase|Randomized but Never Treated|2|||
147296415|NCT03053050|531248209|FG001|Randomized Phase|Randomized but Never Treated|2|||
147296416|NCT03053050|531248210|FG002|Randomized Phase|Randomized but Never Treated|2|||
147296417|NCT03053050|531248211|FG003|Randomized Phase|Randomized but Never Treated|0|||
147296418|NCT03053050|531248208|FG000|Randomized Phase|Entered the Open-Label Phase|36|||
147296419|NCT03053050|531248209|FG001|Randomized Phase|Entered the Open-Label Phase|45|||
147296420|NCT03053050|531248210|FG002|Randomized Phase|Entered the Open-Label Phase|18|||
147296421|NCT03053050|531248211|FG003|Randomized Phase|Entered the Open-Label Phase|0|||
147296422|NCT03053050|531248208|FG000|Open-label Phase|Study Terminated by Sponsor|0|||
147296423|NCT03053050|531248209|FG001|Open-label Phase|Study Terminated by Sponsor|0|||
147296424|NCT03053050|531248210|FG002|Open-label Phase|Study Terminated by Sponsor|0|||
147296425|NCT03053050|531248211|FG003|Open-label Phase|Study Terminated by Sponsor|89|||
147296426|NCT03053050|531248208|FG000|Open-label Phase|Withdrew Consent|0|||
147296427|NCT03053050|531248209|FG001|Open-label Phase|Withdrew Consent|0|||
147296428|NCT03053050|531248210|FG002|Open-label Phase|Withdrew Consent|0|||
147296429|NCT03053050|531248211|FG003|Open-label Phase|Withdrew Consent|6|||
147296430|NCT03053050|531248208|FG000|Open-label Phase|Investigator's Discretion|0|||
147296431|NCT03053050|531248209|FG001|Open-label Phase|Investigator's Discretion|0|||
147296432|NCT03053050|531248210|FG002|Open-label Phase|Investigator's Discretion|0|||
147296433|NCT03053050|531248211|FG003|Open-label Phase|Investigator's Discretion|4|||
147296434|NCT03703466|531248212|FG000|Overall Study|Death|2|||
147296435|NCT03703466|531248213|FG001|Overall Study|Death|1|||
147296436|NCT03703466|531248214|FG002|Overall Study|Death|0|||
147296437|NCT03703466|531248212|FG000|Overall Study|Withdrawal by Subject|0|||
147296438|NCT03703466|531248213|FG001|Overall Study|Withdrawal by Subject|3|||
147296439|NCT03703466|531248214|FG002|Overall Study|Withdrawal by Subject|0|||
147296440|NCT03703466|531248212|FG000|Overall Study|Completed < 3 Cycles|2|||
147296441|NCT03703466|531248213|FG001|Overall Study|Completed < 3 Cycles|2|||
147296442|NCT03703466|531248214|FG002|Overall Study|Completed < 3 Cycles|2|||
147296443|NCT01553318|531250521|FG000|Overall Study|Protocol Violation|3|||
147296444|NCT01553318|531250522|FG001|Overall Study|Protocol Violation|2|||
147296445|NCT02178059|531250524|FG000|Washout|Physician Decision|1|||
147296446|NCT02178059|531250525|FG001|Washout|Physician Decision|0|||
147296447|NCT02586025|531250528|FG000|Neoadjuvant Treatment|Withdrawal by Subject|4|||
147296448|NCT02586025|531250529|FG001|Neoadjuvant Treatment|Withdrawal by Subject|3|||
147296449|NCT02586025|531250528|FG000|Neoadjuvant Treatment|Progression of Disease|2|||
147296450|NCT02586025|531250529|FG001|Neoadjuvant Treatment|Progression of Disease|3|||
147296451|NCT02586025|531250528|FG000|Neoadjuvant Treatment|Did Not Receive Study Drug|1|||
147296452|NCT02586025|531250529|FG001|Neoadjuvant Treatment|Did Not Receive Study Drug|0|||
147296453|NCT02586025|531250528|FG000|Neoadjuvant Treatment|Death|1|||
147296454|NCT02586025|531250529|FG001|Neoadjuvant Treatment|Death|0|||
147296455|NCT02586025|531250528|FG000|Neoadjuvant Treatment|Adverse Event|1|||
147296456|NCT02586025|531250529|FG001|Neoadjuvant Treatment|Adverse Event|0|||
147296457|NCT02586025|531250528|FG000|Neoadjuvant Treatment|Physician Decision|2|||
147296458|NCT02586025|531250529|FG001|Neoadjuvant Treatment|Physician Decision|1|||
147296459|NCT02586025|531250528|FG000|Adjuvant Treatment|Withdrawal by Subject|5|||
147296460|NCT02586025|531250529|FG001|Adjuvant Treatment|Withdrawal by Subject|3|||
147296461|NCT02586025|531250528|FG000|Adjuvant Treatment|Recurrent Disease|4|||
147296462|NCT02586025|531250529|FG001|Adjuvant Treatment|Recurrent Disease|5|||
147296463|NCT02586025|531250528|FG000|Adjuvant Treatment|Physician Decision|0|||
147296464|NCT02586025|531250529|FG001|Adjuvant Treatment|Physician Decision|1|||
147296465|NCT02586025|531250528|FG000|Adjuvant Treatment|Pregnancy|1|||
147296466|NCT02586025|531250529|FG001|Adjuvant Treatment|Pregnancy|0|||
147296467|NCT02586025|531250528|FG000|Treatment-Free Follow-Up|Death|11|||
147296468|NCT02586025|531250529|FG001|Treatment-Free Follow-Up|Death|11|||
147296469|NCT02586025|531250528|FG000|Treatment-Free Follow-Up|Lost to Follow-up|9|||
147296470|NCT02586025|531250529|FG001|Treatment-Free Follow-Up|Lost to Follow-up|4|||
147296471|NCT02586025|531250528|FG000|Treatment-Free Follow-Up|Withdrawal by Subject|13|||
147296472|NCT02586025|531250529|FG001|Treatment-Free Follow-Up|Withdrawal by Subject|3|||
147296473|NCT02586025|531250528|FG000|Treatment-Free Follow-Up|Non-compliance|0|||
147296474|NCT02586025|531250529|FG001|Treatment-Free Follow-Up|Non-compliance|1|||
147296475|NCT02586025|531250528|FG000|Treatment-Free Follow-Up|Reason Not Specified|0|||
147296476|NCT02586025|531250529|FG001|Treatment-Free Follow-Up|Reason Not Specified|3|||
147296477|NCT03597568|531250530|FG000|Overall Study|Withdrawal by Subject|1|||
147296478|NCT03597568|531250531|FG001|Overall Study|Withdrawal by Subject|1|||
147296479|NCT03597568|531250530|FG000|Overall Study|Unable to analyze vascular data|1|||
147296480|NCT03597568|531250531|FG001|Overall Study|Unable to analyze vascular data|1|||
147296481|NCT00999466|531250534|FG000|Main Part|Withdrawal by Subject|0|||
147296482|NCT00999466|531250535|FG001|Main Part|Withdrawal by Subject|0|||
147296483|NCT00999466|531250536|FG002|Main Part|Withdrawal by Subject|2|||
147296484|NCT00999466|531250534|FG000|Main Part|Adverse Event|0|||
147296485|NCT00999466|531250535|FG001|Main Part|Adverse Event|4|||
147452938|NCT04418765|531821485|FG000|Placebo-controlled Period (24 Weeks)|Lost to Follow-up|0|||
147296486|NCT00999466|531250536|FG002|Main Part|Adverse Event|2|||
147296487|NCT03255824|531250538|FG000|Overall Study|Under-sedation|2|||
147296488|NCT03255824|531250539|FG001|Overall Study|Under-sedation|1|||
147296489|NCT02001194|531250541|FG000|Intervention Period (13 Weeks)|No longer interested|1|||
147296490|NCT02001194|531250542|FG001|Intervention Period (13 Weeks)|No longer interested|0|||
147296491|NCT02001194|531250543|FG002|Intervention Period (13 Weeks)|No longer interested|2|||
147296492|NCT02001194|531250544|FG003|Intervention Period (13 Weeks)|No longer interested|2|||
147296493|NCT02001194|531250541|FG000|Follow-Up Period (13 Weeks)|No longer interested|3|||
147296494|NCT02001194|531250542|FG001|Follow-Up Period (13 Weeks)|No longer interested|2|||
147296495|NCT02001194|531250543|FG002|Follow-Up Period (13 Weeks)|No longer interested|1|||
147296496|NCT02001194|531250544|FG003|Follow-Up Period (13 Weeks)|No longer interested|0|||
147296497|NCT03040713|531250546|FG000|Overall Study|Positive amyloid scan|3|||
147296498|NCT02565914|531250553|FG000|Part A (Up to 96 Weeks)|Adverse Event|17|||
147296499|NCT02565914|531250553|FG000|Part A (Up to 96 Weeks)|Withdrawal of consent (not due to AE)|25|||
147296500|NCT02565914|531250553|FG000|Part A (Up to 96 Weeks)|Lost to Follow-up|12|||
147296501|NCT02565914|531250553|FG000|Part A (Up to 96 Weeks)|Death (not treatment emergent)|1|||
147296502|NCT02565914|531250553|FG000|Part A (Up to 96 Weeks)|Other noncompliance|6|||
147296503|NCT02565914|531250553|FG000|Part A (Up to 96 Weeks)|Physician Decision|6|||
147296504|NCT02565914|531250553|FG000|Part A (Up to 96 Weeks)|Parent study termination by sponsor|1|||
147296505|NCT02565914|531250553|FG000|Part A (Up to 96 Weeks)|Commercial drug available|5|||
147296506|NCT02565914|531250553|FG000|Part A (Up to 96 Weeks)|Other|18|||
147296507|NCT02565914|531250553|FG000|Part A (Up to 96 Weeks)|Enrolled, but did not receive study drug|2|||
147296508|NCT02565914|531250553|FG000|Part B (Up to 96 Weeks)|Physician Decision|1|||
147296509|NCT02565914|531250553|FG000|Part B (Up to 96 Weeks)|Other|1|||
147296510|NCT02565914|531250553|FG000|Part B (Up to 96 Weeks)|Enrolled, but did not receive study drug|1|||
147296511|NCT02565914|531250553|FG000|Part B (Up to 96 Weeks)|Adverse Event|4|||
147296512|NCT02565914|531250553|FG000|Part B (Up to 96 Weeks)|Sponsor Decision|2|||
147296513|NCT02565914|531250553|FG000|Part B (Up to 96 Weeks)|Rolled over into another study|25|||
147296514|NCT02565914|531250553|FG000|Part B (Up to 96 Weeks)|Withdrawal of consent (not due to AE)|6|||
147296515|NCT02565914|531250553|FG000|Part B (Up to 96 Weeks)|Commercial drug is available for participant|196|||
147296516|NCT02565914|531250553|FG000|Part C (Up to 192 Weeks)|Physician Decision|5|||
147296517|NCT02565914|531250553|FG000|Part C (Up to 192 Weeks)|Adverse Event|1|||
147296518|NCT02565914|531250553|FG000|Part C (Up to 192 Weeks)|Other non-compliance|2|||
147296519|NCT02565914|531250553|FG000|Part C (Up to 192 Weeks)|Rolled over into another study|11|||
147296520|NCT02565914|531250553|FG000|Part C (Up to 192 Weeks)|Withdrawal of consent (not due to AE)|4|||
147296521|NCT02565914|531250553|FG000|Part C (Up to 192 Weeks)|Commercial drug is available for participant|174|||
147296522|NCT02570126|531250558|FG000|Overall Study|Lost to Follow-up|2|||
147296523|NCT02570126|531250559|FG001|Overall Study|Lost to Follow-up|0|||
147296524|NCT02570126|531250558|FG000|Overall Study|Unable To Arrange Visit 3|1|||
147296525|NCT02570126|531250559|FG001|Overall Study|Unable To Arrange Visit 3|0|||
147296526|NCT02570126|531250558|FG000|Overall Study|Violation Of Procedures GSK|0|||
147296527|NCT02570126|531250559|FG001|Overall Study|Violation Of Procedures GSK|1|||
147296528|NCT02570126|531250558|FG000|Overall Study|Protocol Violation|0|||
147296529|NCT02570126|531250559|FG001|Overall Study|Protocol Violation|1|||
147296530|NCT02570126|531250558|FG000|Overall Study|Withdrawal by Subject|3|||
147296531|NCT02570126|531250559|FG001|Overall Study|Withdrawal by Subject|7|||
147296532|NCT00831779|531250561|FG000|Overall Study|Lost to Follow-up|1|||
147606253|NCT01371747|532375199|FG005|Overall Study|Adverse Event|2|||
147296533|NCT00831779|531250562|FG001|Overall Study|Lost to Follow-up|0|||
147296534|NCT00831779|531250561|FG000|Overall Study|No longer met criteria|0|||
147296535|NCT00831779|531250562|FG001|Overall Study|No longer met criteria|1|||
147296536|NCT04683926|531250570|FG000|Intervention 2 (1 Day)|Adverse Event|0|||
147296537|NCT04683926|531250571|FG001|Intervention 2 (1 Day)|Adverse Event|0|||
147296538|NCT04683926|531250572|FG002|Intervention 2 (1 Day)|Adverse Event|0|||
147296539|NCT04683926|531250573|FG003|Intervention 2 (1 Day)|Adverse Event|1|||
147296540|NCT01040260|531250575|FG000|Overall Study|Withdrawal by Subject|12|||
147296541|NCT01040260|531250576|FG001|Overall Study|Withdrawal by Subject|6|||
147296542|NCT01040260|531250575|FG000|Overall Study|Lost to Follow-up|3|||
147296543|NCT01040260|531250576|FG001|Overall Study|Lost to Follow-up|5|||
147296544|NCT01113502|531250580|FG000|Overall Study|Withdrawal by Subject|1|||
147296545|NCT01113502|531250581|FG001|Overall Study|Withdrawal by Subject|0|||
147296546|NCT01113502|531250582|FG002|Overall Study|Withdrawal by Subject|1|||
147339430|NCT04425629|531412116|FG014|Overall Study|Subject Decision|1|||
147339431|NCT04425629|531412117|FG015|Overall Study|Subject Decision|4|||
147339432|NCT04425629|531412118|FG016|Overall Study|Subject Decision|1|||
147339433|NCT04425629|531412119|FG017|Overall Study|Subject Decision|0|||
147339434|NCT04425629|531412120|FG018|Overall Study|Subject Decision|2|||
147339435|NCT04425629|531412102|FG000|Overall Study|Death|0|||
147339436|NCT04425629|531412103|FG001|Overall Study|Death|0|||
147339437|NCT04425629|531412104|FG002|Overall Study|Death|0|||
147606254|NCT01371747|532375194|FG000|Overall Study|Death|1|||
147296547|NCT01113502|531250583|FG003|Overall Study|Withdrawal by Subject|1|||
147296548|NCT01113502|531250584|FG004|Overall Study|Withdrawal by Subject|0|||
147339438|NCT04425629|531412105|FG003|Overall Study|Death|0|||
147296549|NCT01113502|531250580|FG000|Overall Study|Adverse Event|0|||
147296550|NCT01113502|531250581|FG001|Overall Study|Adverse Event|0|||
147296551|NCT01113502|531250582|FG002|Overall Study|Adverse Event|3|||
147296552|NCT01113502|531250583|FG003|Overall Study|Adverse Event|2|||
147296553|NCT01113502|531250584|FG004|Overall Study|Adverse Event|0|||
147296554|NCT01970982|531250587|FG000|Overall Study|Withdrawal by Subject|0|||
147296555|NCT01970982|531250588|FG001|Overall Study|Withdrawal by Subject|0|||
147296556|NCT01970982|531250589|FG002|Overall Study|Withdrawal by Subject|2|||
147296557|NCT00708916|531250592|FG000|Overall Study|Subject Noncompliance|2|||
147296558|NCT00708916|531250592|FG000|Overall Study|Adverse Event|2|||
147296559|NCT01984684|531250595|FG000|Overall Study|Lost to Follow-up|25|||
147296560|NCT01984684|531250596|FG001|Overall Study|Lost to Follow-up|24|||
147296561|NCT01984684|531250595|FG000|Overall Study|Adverse Event|8|||
147296562|NCT01984684|531250596|FG001|Overall Study|Adverse Event|12|||
147296563|NCT01984684|531250595|FG000|Overall Study|Withdrawal by Subject|9|||
147296564|NCT01984684|531250596|FG001|Overall Study|Withdrawal by Subject|9|||
147296565|NCT01984684|531250595|FG000|Overall Study|Lack of Efficacy|3|||
147296566|NCT01984684|531250596|FG001|Overall Study|Lack of Efficacy|6|||
147296567|NCT01984684|531250595|FG000|Overall Study|Physician Decision|4|||
147296568|NCT01984684|531250596|FG001|Overall Study|Physician Decision|2|||
147296569|NCT01984684|531250595|FG000|Overall Study|Protocol Violation|4|||
147296570|NCT01984684|531250596|FG001|Overall Study|Protocol Violation|2|||
147296571|NCT01984684|531250595|FG000|Overall Study|Death|0|||
147296572|NCT01984684|531250596|FG001|Overall Study|Death|1|||
147296573|NCT01984684|531250595|FG000|Overall Study|Noncompliance with study drug|2|||
147296574|NCT01984684|531250596|FG001|Overall Study|Noncompliance with study drug|1|||
147296575|NCT01984684|531250595|FG000|Overall Study|Subject incarcerated|1|||
147296576|NCT01984684|531250596|FG001|Overall Study|Subject incarcerated|0|||
147296577|NCT01984684|531250595|FG000|Overall Study|Study drug not available at site|1|||
147296578|NCT01984684|531250596|FG001|Overall Study|Study drug not available at site|1|||
147296579|NCT01984684|531250595|FG000|Overall Study|Subject had inadequate IV access|0|||
147296580|NCT01984684|531250596|FG001|Overall Study|Subject had inadequate IV access|1|||
147296581|NCT02835339|531250600|FG000|Overall Study|Did not receive allocated intervention|13|||
147296582|NCT02835339|531250601|FG001|Overall Study|Did not receive allocated intervention|16|||
147296583|NCT01077544|531250602|FG000|Overall Study|New Cancer Therapy|3|||
147296584|NCT01077544|531250603|FG001|Overall Study|New Cancer Therapy|3|||
147296585|NCT01077544|531250602|FG000|Overall Study|Adverse Event|0|||
147296586|NCT01077544|531250603|FG001|Overall Study|Adverse Event|1|||
147296587|NCT01077544|531250602|FG000|Overall Study|Disease Progression|0|||
147296588|NCT01077544|531250603|FG001|Overall Study|Disease Progression|1|||
147296589|NCT03923959|531250612|FG000|Overall Study|Death|16|||
147296590|NCT03923959|531250613|FG001|Overall Study|Death|12|||
147296591|NCT03923959|531250612|FG000|Overall Study|Lost to Follow-up|56|||
147296592|NCT03923959|531250613|FG001|Overall Study|Lost to Follow-up|56|||
147296593|NCT03923959|531250612|FG000|Overall Study|Withdrawal by Subject|1|||
147296594|NCT03923959|531250613|FG001|Overall Study|Withdrawal by Subject|1|||
147296595|NCT03923959|531250612|FG000|Overall Study|Participant enrolled twice for separate hip fractures - one enrollment removed.|0|||
147296596|NCT03923959|531250613|FG001|Overall Study|Participant enrolled twice for separate hip fractures - one enrollment removed.|1|||
147296597|NCT04918147|531250614|FG000|Overall Study|Disease flare as defined in protocol|0|||
147296598|NCT04918147|531250615|FG001|Overall Study|Disease flare as defined in protocol|2|||
147296599|NCT01362439|531250616|FG000|Overall Study|Adverse Event|1|||
147296600|NCT01362439|531250616|FG000|Overall Study|Lack of Efficacy|3|||
147296601|NCT01362439|531250616|FG000|Overall Study|Lost to Follow-up|2|||
147296602|NCT01362439|531250616|FG000|Overall Study|Study medication non-compliant|1|||
147296603|NCT01362439|531250616|FG000|Overall Study|Participant who withdrew consent|8|||
147296604|NCT04040751|531250627|FG000|Overall Study|Withdrawal by Subject|2|||
147296605|NCT04040751|531250628|FG001|Overall Study|Withdrawal by Subject|0|||
147296606|NCT04040751|531250629|FG002|Overall Study|Withdrawal by Subject|2|||
147296607|NCT04040751|531250630|FG003|Overall Study|Withdrawal by Subject|0|||
147296608|NCT04212091|531250631|FG000|Overall Study|Lost to Follow-up|0|||
147339439|NCT04425629|531412106|FG004|Overall Study|Death|0|||
147339440|NCT04425629|531412107|FG005|Overall Study|Death|0|||
147339441|NCT04425629|531412108|FG006|Overall Study|Death|0|||
147339442|NCT04425629|531412109|FG007|Overall Study|Death|0|||
147339443|NCT04425629|531412110|FG008|Overall Study|Death|0|||
147339444|NCT04425629|531412111|FG009|Overall Study|Death|11|||
147296609|NCT04212091|531250632|FG001|Overall Study|Lost to Follow-up|0|||
147296610|NCT04212091|531250633|FG002|Overall Study|Lost to Follow-up|0|||
147296611|NCT04212091|531250634|FG003|Overall Study|Lost to Follow-up|0|||
147296612|NCT04212091|531250635|FG004|Overall Study|Lost to Follow-up|1|||
147296613|NCT04212091|531250636|FG005|Overall Study|Lost to Follow-up|1|||
147296614|NCT04212091|531250631|FG000|Overall Study|Participant unable to adhere to visit|0|||
147296615|NCT04212091|531250632|FG001|Overall Study|Participant unable to adhere to visit|0|||
147296616|NCT04212091|531250633|FG002|Overall Study|Participant unable to adhere to visit|0|||
147296617|NCT04212091|531250634|FG003|Overall Study|Participant unable to adhere to visit|0|||
147339445|NCT04425629|531412112|FG010|Overall Study|Death|2|||
147296618|NCT04212091|531250635|FG004|Overall Study|Participant unable to adhere to visit|1|||
147296619|NCT04212091|531250636|FG005|Overall Study|Participant unable to adhere to visit|0|||
147296620|NCT02712905|531250637|FG000|Monotherapy|Death|2|||
147296621|NCT02712905|531250638|FG001|Monotherapy|Death|5|||
147296622|NCT02712905|531250639|FG002|Monotherapy|Death|0|||
147296623|NCT02712905|531250640|FG003|Monotherapy|Death|3|||
147296624|NCT02712905|531250641|FG004|Monotherapy|Death|15|||
147296625|NCT02712905|531250642|FG005|Monotherapy|Death|1|||
147296626|NCT02712905|531250643|FG006|Monotherapy|Death|3|||
147296627|NCT02712905|531250644|FG007|Monotherapy|Death|3|||
147296628|NCT02712905|531250645|FG008|Monotherapy|Death|0|||
147296629|NCT02712905|531250646|FG009|Monotherapy|Death|27|||
147296630|NCT02712905|531250647|FG010|Monotherapy|Death|2|||
147296631|NCT02712905|531250648|FG011|Monotherapy|Death|5|||
147296632|NCT02712905|531250649|FG012|Monotherapy|Death|0|||
147296633|NCT02712905|531250650|FG013|Monotherapy|Death|0|||
147296634|NCT02712905|531250651|FG014|Monotherapy|Death|0|||
147296635|NCT02712905|531250652|FG015|Monotherapy|Death|0|||
147296636|NCT02712905|531250653|FG016|Monotherapy|Death|0|||
147296637|NCT02712905|531250654|FG017|Monotherapy|Death|0|||
147296638|NCT02712905|531250637|FG000|Monotherapy|Lost to Follow-up|0|||
147296639|NCT02712905|531250638|FG001|Monotherapy|Lost to Follow-up|1|||
147296640|NCT02712905|531250639|FG002|Monotherapy|Lost to Follow-up|0|||
147296641|NCT02712905|531250640|FG003|Monotherapy|Lost to Follow-up|1|||
147296642|NCT02712905|531250641|FG004|Monotherapy|Lost to Follow-up|0|||
147296643|NCT02712905|531250642|FG005|Monotherapy|Lost to Follow-up|0|||
147296644|NCT02712905|531250643|FG006|Monotherapy|Lost to Follow-up|0|||
147296645|NCT02712905|531250644|FG007|Monotherapy|Lost to Follow-up|0|||
147296646|NCT02712905|531250645|FG008|Monotherapy|Lost to Follow-up|0|||
147296647|NCT02712905|531250646|FG009|Monotherapy|Lost to Follow-up|2|||
147296648|NCT02712905|531250647|FG010|Monotherapy|Lost to Follow-up|0|||
147296649|NCT02712905|531250648|FG011|Monotherapy|Lost to Follow-up|0|||
147296650|NCT02712905|531250649|FG012|Monotherapy|Lost to Follow-up|0|||
147296651|NCT02712905|531250650|FG013|Monotherapy|Lost to Follow-up|0|||
147296652|NCT02712905|531250651|FG014|Monotherapy|Lost to Follow-up|0|||
147296653|NCT02712905|531250652|FG015|Monotherapy|Lost to Follow-up|0|||
147296654|NCT02712905|531250653|FG016|Monotherapy|Lost to Follow-up|0|||
147296655|NCT02712905|531250654|FG017|Monotherapy|Lost to Follow-up|0|||
147296656|NCT02712905|531250637|FG000|Monotherapy|Physician Decision|1|||
147296657|NCT02712905|531250638|FG001|Monotherapy|Physician Decision|0|||
147296658|NCT02712905|531250639|FG002|Monotherapy|Physician Decision|0|||
147296659|NCT02712905|531250640|FG003|Monotherapy|Physician Decision|1|||
147296660|NCT02712905|531250641|FG004|Monotherapy|Physician Decision|0|||
147296661|NCT02712905|531250642|FG005|Monotherapy|Physician Decision|0|||
147296662|NCT02712905|531250643|FG006|Monotherapy|Physician Decision|0|||
147296663|NCT02712905|531250644|FG007|Monotherapy|Physician Decision|0|||
147296664|NCT02712905|531250645|FG008|Monotherapy|Physician Decision|0|||
147296665|NCT02712905|531250646|FG009|Monotherapy|Physician Decision|1|||
147296666|NCT02712905|531250647|FG010|Monotherapy|Physician Decision|0|||
147296667|NCT02712905|531250648|FG011|Monotherapy|Physician Decision|0|||
147296668|NCT02712905|531250649|FG012|Monotherapy|Physician Decision|0|||
147296669|NCT02712905|531250650|FG013|Monotherapy|Physician Decision|0|||
147296670|NCT02712905|531250651|FG014|Monotherapy|Physician Decision|0|||
147296671|NCT02712905|531250652|FG015|Monotherapy|Physician Decision|0|||
147296672|NCT02712905|531250653|FG016|Monotherapy|Physician Decision|0|||
147296673|NCT02712905|531250654|FG017|Monotherapy|Physician Decision|0|||
147296674|NCT02712905|531250637|FG000|Monotherapy|Study Terminated by Sponsor|0|||
147296675|NCT02712905|531250638|FG001|Monotherapy|Study Terminated by Sponsor|0|||
147296676|NCT02712905|531250639|FG002|Monotherapy|Study Terminated by Sponsor|0|||
147296677|NCT02712905|531250640|FG003|Monotherapy|Study Terminated by Sponsor|0|||
147296678|NCT02712905|531250641|FG004|Monotherapy|Study Terminated by Sponsor|1|||
147296679|NCT02712905|531250642|FG005|Monotherapy|Study Terminated by Sponsor|0|||
147296680|NCT02712905|531250643|FG006|Monotherapy|Study Terminated by Sponsor|0|||
147296681|NCT02712905|531250644|FG007|Monotherapy|Study Terminated by Sponsor|0|||
147296682|NCT02712905|531250645|FG008|Monotherapy|Study Terminated by Sponsor|0|||
147296683|NCT02712905|531250646|FG009|Monotherapy|Study Terminated by Sponsor|2|||
147296684|NCT02712905|531250647|FG010|Monotherapy|Study Terminated by Sponsor|0|||
147296685|NCT02712905|531250648|FG011|Monotherapy|Study Terminated by Sponsor|0|||
147296686|NCT02712905|531250649|FG012|Monotherapy|Study Terminated by Sponsor|0|||
147296687|NCT02712905|531250650|FG013|Monotherapy|Study Terminated by Sponsor|0|||
147296688|NCT02712905|531250651|FG014|Monotherapy|Study Terminated by Sponsor|0|||
147296689|NCT02712905|531250652|FG015|Monotherapy|Study Terminated by Sponsor|0|||
147296690|NCT02712905|531250653|FG016|Monotherapy|Study Terminated by Sponsor|0|||
147296691|NCT02712905|531250654|FG017|Monotherapy|Study Terminated by Sponsor|0|||
147296692|NCT02712905|531250637|FG000|Monotherapy|Withdrawal by Subject|0|||
147296693|NCT02712905|531250638|FG001|Monotherapy|Withdrawal by Subject|0|||
147296694|NCT02712905|531250639|FG002|Monotherapy|Withdrawal by Subject|1|||
147296695|NCT02712905|531250640|FG003|Monotherapy|Withdrawal by Subject|0|||
147296696|NCT02712905|531250641|FG004|Monotherapy|Withdrawal by Subject|2|||
147296697|NCT02712905|531250642|FG005|Monotherapy|Withdrawal by Subject|0|||
147296698|NCT02712905|531250643|FG006|Monotherapy|Withdrawal by Subject|0|||
147296699|NCT02712905|531250644|FG007|Monotherapy|Withdrawal by Subject|0|||
147296700|NCT02712905|531250645|FG008|Monotherapy|Withdrawal by Subject|0|||
147296701|NCT02712905|531250646|FG009|Monotherapy|Withdrawal by Subject|4|||
147296702|NCT02712905|531250647|FG010|Monotherapy|Withdrawal by Subject|1|||
147296703|NCT02712905|531250648|FG011|Monotherapy|Withdrawal by Subject|2|||
147296704|NCT02712905|531250649|FG012|Monotherapy|Withdrawal by Subject|0|||
147296705|NCT02712905|531250650|FG013|Monotherapy|Withdrawal by Subject|0|||
147296706|NCT02712905|531250651|FG014|Monotherapy|Withdrawal by Subject|0|||
147296707|NCT02712905|531250652|FG015|Monotherapy|Withdrawal by Subject|0|||
147296708|NCT02712905|531250653|FG016|Monotherapy|Withdrawal by Subject|0|||
147296709|NCT02712905|531250654|FG017|Monotherapy|Withdrawal by Subject|0|||
147296710|NCT02712905|531250637|FG000|Monotherapy|Started New Cancer Drug|0|||
147296711|NCT02712905|531250638|FG001|Monotherapy|Started New Cancer Drug|0|||
147296712|NCT02712905|531250639|FG002|Monotherapy|Started New Cancer Drug|0|||
147296713|NCT02712905|531250640|FG003|Monotherapy|Started New Cancer Drug|0|||
147296714|NCT02712905|531250641|FG004|Monotherapy|Started New Cancer Drug|0|||
147296715|NCT02712905|531250642|FG005|Monotherapy|Started New Cancer Drug|1|||
147296716|NCT02712905|531250643|FG006|Monotherapy|Started New Cancer Drug|0|||
147296717|NCT02712905|531250644|FG007|Monotherapy|Started New Cancer Drug|0|||
147296718|NCT02712905|531250645|FG008|Monotherapy|Started New Cancer Drug|0|||
147296719|NCT02712905|531250646|FG009|Monotherapy|Started New Cancer Drug|0|||
147296720|NCT02712905|531250647|FG010|Monotherapy|Started New Cancer Drug|0|||
147296721|NCT02712905|531250648|FG011|Monotherapy|Started New Cancer Drug|0|||
147296722|NCT02712905|531250649|FG012|Monotherapy|Started New Cancer Drug|0|||
147296723|NCT02712905|531250650|FG013|Monotherapy|Started New Cancer Drug|0|||
147296724|NCT02712905|531250651|FG014|Monotherapy|Started New Cancer Drug|0|||
147296725|NCT02712905|531250652|FG015|Monotherapy|Started New Cancer Drug|0|||
147296726|NCT02712905|531250653|FG016|Monotherapy|Started New Cancer Drug|0|||
147296727|NCT02712905|531250654|FG017|Monotherapy|Started New Cancer Drug|0|||
147296728|NCT02712905|531250637|FG000|Monotherapy|Adverse Event|0|||
147296729|NCT02712905|531250638|FG001|Monotherapy|Adverse Event|0|||
147296730|NCT02712905|531250639|FG002|Monotherapy|Adverse Event|0|||
147296731|NCT02712905|531250640|FG003|Monotherapy|Adverse Event|0|||
147296732|NCT02712905|531250641|FG004|Monotherapy|Adverse Event|0|||
147296733|NCT02712905|531250642|FG005|Monotherapy|Adverse Event|0|||
147296734|NCT02712905|531250643|FG006|Monotherapy|Adverse Event|0|||
147296735|NCT02712905|531250644|FG007|Monotherapy|Adverse Event|0|||
147296736|NCT02712905|531250645|FG008|Monotherapy|Adverse Event|1|||
147296737|NCT02712905|531250646|FG009|Monotherapy|Adverse Event|0|||
147296738|NCT02712905|531250647|FG010|Monotherapy|Adverse Event|0|||
147296739|NCT02712905|531250648|FG011|Monotherapy|Adverse Event|0|||
147296740|NCT02712905|531250649|FG012|Monotherapy|Adverse Event|0|||
147296741|NCT02712905|531250650|FG013|Monotherapy|Adverse Event|0|||
147296742|NCT02712905|531250651|FG014|Monotherapy|Adverse Event|0|||
147296743|NCT02712905|531250652|FG015|Monotherapy|Adverse Event|0|||
147296744|NCT02712905|531250653|FG016|Monotherapy|Adverse Event|0|||
147296745|NCT02712905|531250654|FG017|Monotherapy|Adverse Event|0|||
147296746|NCT02712905|531250637|FG000|Combination Therapy|Death|0|||
147296747|NCT02712905|531250638|FG001|Combination Therapy|Death|0|||
147296748|NCT02712905|531250639|FG002|Combination Therapy|Death|0|||
147296749|NCT02712905|531250640|FG003|Combination Therapy|Death|0|||
147296750|NCT02712905|531250641|FG004|Combination Therapy|Death|0|||
147296751|NCT02712905|531250642|FG005|Combination Therapy|Death|0|||
147296752|NCT02712905|531250643|FG006|Combination Therapy|Death|0|||
147296753|NCT02712905|531250644|FG007|Combination Therapy|Death|0|||
147296754|NCT02712905|531250645|FG008|Combination Therapy|Death|0|||
147296755|NCT02712905|531250646|FG009|Combination Therapy|Death|0|||
147296756|NCT02712905|531250647|FG010|Combination Therapy|Death|0|||
147296757|NCT02712905|531250648|FG011|Combination Therapy|Death|0|||
147296758|NCT02712905|531250649|FG012|Combination Therapy|Death|5|||
147296759|NCT02712905|531250650|FG013|Combination Therapy|Death|6|||
147296760|NCT02712905|531250651|FG014|Combination Therapy|Death|1|||
147296761|NCT02712905|531250652|FG015|Combination Therapy|Death|3|||
147296762|NCT02712905|531250653|FG016|Combination Therapy|Death|1|||
147296763|NCT02712905|531250654|FG017|Combination Therapy|Death|3|||
147296764|NCT02712905|531250637|FG000|Combination Therapy|Study Terminated by Sponsor|0|||
147296765|NCT02712905|531250638|FG001|Combination Therapy|Study Terminated by Sponsor|0|||
147296766|NCT02712905|531250639|FG002|Combination Therapy|Study Terminated by Sponsor|0|||
147296767|NCT02712905|531250640|FG003|Combination Therapy|Study Terminated by Sponsor|0|||
147606255|NCT01371747|532375195|FG001|Overall Study|Death|0|||
147296768|NCT02712905|531250641|FG004|Combination Therapy|Study Terminated by Sponsor|0|||
147296769|NCT02712905|531250642|FG005|Combination Therapy|Study Terminated by Sponsor|0|||
147296770|NCT02712905|531250643|FG006|Combination Therapy|Study Terminated by Sponsor|0|||
147296771|NCT02712905|531250644|FG007|Combination Therapy|Study Terminated by Sponsor|0|||
147296772|NCT02712905|531250645|FG008|Combination Therapy|Study Terminated by Sponsor|0|||
147296773|NCT02712905|531250646|FG009|Combination Therapy|Study Terminated by Sponsor|0|||
147296774|NCT02712905|531250647|FG010|Combination Therapy|Study Terminated by Sponsor|0|||
147296775|NCT02712905|531250648|FG011|Combination Therapy|Study Terminated by Sponsor|0|||
147296776|NCT02712905|531250649|FG012|Combination Therapy|Study Terminated by Sponsor|0|||
147296777|NCT02712905|531250650|FG013|Combination Therapy|Study Terminated by Sponsor|1|||
147296778|NCT02712905|531250651|FG014|Combination Therapy|Study Terminated by Sponsor|0|||
147296779|NCT02712905|531250652|FG015|Combination Therapy|Study Terminated by Sponsor|2|||
147296780|NCT02712905|531250653|FG016|Combination Therapy|Study Terminated by Sponsor|0|||
147296781|NCT02712905|531250654|FG017|Combination Therapy|Study Terminated by Sponsor|1|||
147296782|NCT02712905|531250637|FG000|Combination Therapy|Withdrawal by Subject|0|||
147296783|NCT02712905|531250638|FG001|Combination Therapy|Withdrawal by Subject|0|||
147296784|NCT02712905|531250639|FG002|Combination Therapy|Withdrawal by Subject|0|||
147296785|NCT02712905|531250640|FG003|Combination Therapy|Withdrawal by Subject|0|||
147296786|NCT02712905|531250641|FG004|Combination Therapy|Withdrawal by Subject|0|||
147296787|NCT02712905|531250642|FG005|Combination Therapy|Withdrawal by Subject|0|||
147296788|NCT02712905|531250643|FG006|Combination Therapy|Withdrawal by Subject|0|||
147296789|NCT02712905|531250644|FG007|Combination Therapy|Withdrawal by Subject|0|||
147296790|NCT02712905|531250645|FG008|Combination Therapy|Withdrawal by Subject|0|||
147296791|NCT02712905|531250646|FG009|Combination Therapy|Withdrawal by Subject|0|||
147296792|NCT02712905|531250647|FG010|Combination Therapy|Withdrawal by Subject|0|||
147296793|NCT02712905|531250648|FG011|Combination Therapy|Withdrawal by Subject|0|||
147296794|NCT02712905|531250649|FG012|Combination Therapy|Withdrawal by Subject|0|||
147296795|NCT02712905|531250650|FG013|Combination Therapy|Withdrawal by Subject|0|||
147296796|NCT02712905|531250651|FG014|Combination Therapy|Withdrawal by Subject|0|||
147296797|NCT02712905|531250652|FG015|Combination Therapy|Withdrawal by Subject|1|||
147296798|NCT02712905|531250653|FG016|Combination Therapy|Withdrawal by Subject|0|||
147296799|NCT02712905|531250654|FG017|Combination Therapy|Withdrawal by Subject|2|||
147296800|NCT02712905|531250637|FG000|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
147296801|NCT02712905|531250638|FG001|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
147296802|NCT02712905|531250639|FG002|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
147296803|NCT02712905|531250640|FG003|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
147296804|NCT02712905|531250641|FG004|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
147296805|NCT02712905|531250642|FG005|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
147296806|NCT02712905|531250643|FG006|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
147296807|NCT02712905|531250644|FG007|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
147296808|NCT02712905|531250645|FG008|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
147296809|NCT02712905|531250646|FG009|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
147296810|NCT02712905|531250647|FG010|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
147296811|NCT02712905|531250648|FG011|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
147296812|NCT02712905|531250649|FG012|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
147296813|NCT02712905|531250650|FG013|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
147296814|NCT02712905|531250651|FG014|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
147296815|NCT02712905|531250652|FG015|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|1|||
147296816|NCT02712905|531250653|FG016|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
147296817|NCT02712905|531250654|FG017|Combination Therapy|Unknown; Did Not Complete End of Study Case Report Form Prior to Site Closure|0|||
147296818|NCT03721965|531250655|FG000|Overall Study|Death|1|||
147296819|NCT03721965|531250655|FG000|Overall Study|Study Terminated by Sponsor|1|||
147296820|NCT04085328|531250656|FG000|Overall Study|Witihdrew Consent|16|||
147296821|NCT04085328|531250657|FG001|Overall Study|Witihdrew Consent|16|||
147296822|NCT04085328|531250656|FG000|Overall Study|Adverse Event|8|||
147296823|NCT04085328|531250657|FG001|Overall Study|Adverse Event|7|||
147296824|NCT04085328|531250656|FG000|Overall Study|Lost to Follow-up|7|||
147296825|NCT04085328|531250657|FG001|Overall Study|Lost to Follow-up|2|||
147296826|NCT04085328|531250656|FG000|Overall Study|Physician Decision|0|||
147296827|NCT04085328|531250657|FG001|Overall Study|Physician Decision|1|||
147296828|NCT04085328|531250656|FG000|Overall Study|Pregnancy|0|||
147296829|NCT04085328|531250657|FG001|Overall Study|Pregnancy|1|||
147296830|NCT04085328|531250656|FG000|Overall Study|Reasons Related to COVID-19|5|||
147296831|NCT04085328|531250657|FG001|Overall Study|Reasons Related to COVID-19|8|||
147296832|NCT04085328|531250656|FG000|Overall Study|Did not meet inclusion criteria|1|||
147296833|NCT04085328|531250657|FG001|Overall Study|Did not meet inclusion criteria|1|||
147296834|NCT04085328|531250656|FG000|Overall Study|Early termination|1|||
147296835|NCT04085328|531250657|FG001|Overall Study|Early termination|0|||
147662665|NCT02782741|532587388|FG002|Open-label Long-term: Week 50 to 289|Adverse Event|0|||
147296836|NCT00689221|531250658|FG000|Overall Study|Ongoing at cut-off date|39|||
147296837|NCT00689221|531250659|FG001|Overall Study|Ongoing at cut-off date|36|||
147296838|NCT01812655|531250663|FG000|Overall Study|Protocol Violation|1|||
147296839|NCT01812655|531250664|FG001|Overall Study|Protocol Violation|1|||
147296840|NCT01812655|531250665|FG002|Overall Study|Protocol Violation|0|||
147662666|NCT02782741|532587386|FG000|Open-label Long-term: Week 50 to 289|Poor compliance to protocol|0|||
147296841|NCT04435665|531250667|FG000|Overall Study|Lost to Follow-up|0|||
147296842|NCT04435665|531250668|FG001|Overall Study|Lost to Follow-up|0|||
147296843|NCT04435665|531250669|FG002|Overall Study|Lost to Follow-up|0|||
147296844|NCT04435665|531250670|FG003|Overall Study|Lost to Follow-up|1|||
147296845|NCT02454101|531250671|FG000|Overall Study|Adverse Event|2|||
147296846|NCT02454101|531250672|FG001|Overall Study|Adverse Event|3|||
147296847|NCT02454101|531250671|FG000|Overall Study|Lost to Follow-up|3|||
147296848|NCT02454101|531250672|FG001|Overall Study|Lost to Follow-up|4|||
147296849|NCT00419263|531250673|FG000|Overall Study|Lost to Follow-up|2|||
147296850|NCT00419263|531250674|FG001|Overall Study|Lost to Follow-up|1|||
147296851|NCT00419263|531250675|FG002|Overall Study|Lost to Follow-up|1|||
147296852|NCT00419263|531250673|FG000|Overall Study|Randomized in Error, Not Treated|1|||
147296853|NCT00419263|531250674|FG001|Overall Study|Randomized in Error, Not Treated|1|||
147296854|NCT00419263|531250675|FG002|Overall Study|Randomized in Error, Not Treated|0|||
147296855|NCT00419263|531250673|FG000|Overall Study|Adverse Event|0|||
147296856|NCT00419263|531250674|FG001|Overall Study|Adverse Event|0|||
147296857|NCT00419263|531250675|FG002|Overall Study|Adverse Event|1|||
147296858|NCT00419263|531250673|FG000|Overall Study|Withdrawal by Subject|0|||
147296859|NCT00419263|531250674|FG001|Overall Study|Withdrawal by Subject|0|||
147296860|NCT00419263|531250675|FG002|Overall Study|Withdrawal by Subject|1|||
147296861|NCT02342886|531250676|FG000|Overall Study|Treatment non-compliance|1|||
147296862|NCT02342886|531250677|FG001|Overall Study|Treatment non-compliance|0|||
147296863|NCT02342886|531250678|FG002|Overall Study|Treatment non-compliance|0|||
147296864|NCT02342886|531250679|FG003|Overall Study|Treatment non-compliance|1|||
147296865|NCT02342886|531250680|FG004|Overall Study|Treatment non-compliance|0|||
147296866|NCT02342886|531250676|FG000|Overall Study|Late exclusion: rifampicin resistance|1|||
147296867|NCT02342886|531250677|FG001|Overall Study|Late exclusion: rifampicin resistance|0|||
147296868|NCT02342886|531250678|FG002|Overall Study|Late exclusion: rifampicin resistance|0|||
147296869|NCT02342886|531250679|FG003|Overall Study|Late exclusion: rifampicin resistance|0|||
147296870|NCT02342886|531250680|FG004|Overall Study|Late exclusion: rifampicin resistance|0|||
147296871|NCT02342886|531250676|FG000|Overall Study|Adverse event/specific toxicity|4|||
147296872|NCT02342886|531250677|FG001|Overall Study|Adverse event/specific toxicity|3|||
147339446|NCT04425629|531412113|FG011|Overall Study|Death|4|||
147339447|NCT04425629|531412114|FG012|Overall Study|Death|0|||
147339448|NCT04425629|531412115|FG013|Overall Study|Death|0|||
147339449|NCT04425629|531412116|FG014|Overall Study|Death|0|||
147339450|NCT04425629|531412117|FG015|Overall Study|Death|0|||
147339451|NCT04425629|531412118|FG016|Overall Study|Death|0|||
147339452|NCT04425629|531412119|FG017|Overall Study|Death|0|||
147339453|NCT04425629|531412120|FG018|Overall Study|Death|0|||
147339454|NCT04425629|531412102|FG000|Overall Study|Sponsor Request|0|||
147339455|NCT04425629|531412103|FG001|Overall Study|Sponsor Request|0|||
147339456|NCT04425629|531412104|FG002|Overall Study|Sponsor Request|0|||
147339457|NCT04425629|531412105|FG003|Overall Study|Sponsor Request|2|||
147339458|NCT04425629|531412106|FG004|Overall Study|Sponsor Request|2|||
147339459|NCT04425629|531412107|FG005|Overall Study|Sponsor Request|2|||
147339460|NCT04425629|531412108|FG006|Overall Study|Sponsor Request|1|||
147339461|NCT04425629|531412109|FG007|Overall Study|Sponsor Request|0|||
147339462|NCT04425629|531412110|FG008|Overall Study|Sponsor Request|0|||
147339463|NCT04425629|531412111|FG009|Overall Study|Sponsor Request|9|||
147339464|NCT04425629|531412112|FG010|Overall Study|Sponsor Request|9|||
147339465|NCT04425629|531412113|FG011|Overall Study|Sponsor Request|10|||
147339466|NCT04425629|531412114|FG012|Overall Study|Sponsor Request|8|||
147339467|NCT04425629|531412115|FG013|Overall Study|Sponsor Request|0|||
147339468|NCT04425629|531412116|FG014|Overall Study|Sponsor Request|0|||
147339469|NCT04425629|531412117|FG015|Overall Study|Sponsor Request|1|||
147339470|NCT04425629|531412118|FG016|Overall Study|Sponsor Request|0|||
147296873|NCT02342886|531250678|FG002|Overall Study|Adverse event/specific toxicity|11|||
147296874|NCT02342886|531250679|FG003|Overall Study|Adverse event/specific toxicity|2|||
147296875|NCT02342886|531250680|FG004|Overall Study|Adverse event/specific toxicity|1|||
147296876|NCT02342886|531250676|FG000|Overall Study|Lost to Follow-up|1|||
147296877|NCT02342886|531250677|FG001|Overall Study|Lost to Follow-up|0|||
147296878|NCT02342886|531250678|FG002|Overall Study|Lost to Follow-up|0|||
147296879|NCT02342886|531250679|FG003|Overall Study|Lost to Follow-up|0|||
147296880|NCT02342886|531250680|FG004|Overall Study|Lost to Follow-up|0|||
147296881|NCT02342886|531250676|FG000|Overall Study|Death|1|||
147296882|NCT02342886|531250677|FG001|Overall Study|Death|2|||
147296883|NCT02342886|531250678|FG002|Overall Study|Death|1|||
147296884|NCT02342886|531250679|FG003|Overall Study|Death|0|||
147296885|NCT02342886|531250680|FG004|Overall Study|Death|1|||
147296886|NCT02342886|531250676|FG000|Overall Study|Withdrawal by Subject|0|||
147296887|NCT02342886|531250677|FG001|Overall Study|Withdrawal by Subject|1|||
147296888|NCT02342886|531250678|FG002|Overall Study|Withdrawal by Subject|0|||
147296889|NCT02342886|531250679|FG003|Overall Study|Withdrawal by Subject|1|||
147339471|NCT04425629|531412119|FG017|Overall Study|Sponsor Request|0|||
147339472|NCT04425629|531412120|FG018|Overall Study|Sponsor Request|0|||
147339473|NCT04425629|531412102|FG000|Overall Study|Physician Decision|0|||
147339474|NCT04425629|531412103|FG001|Overall Study|Physician Decision|0|||
147339475|NCT04425629|531412104|FG002|Overall Study|Physician Decision|0|||
147339476|NCT04425629|531412105|FG003|Overall Study|Physician Decision|0|||
147339477|NCT04425629|531412106|FG004|Overall Study|Physician Decision|0|||
147339478|NCT04425629|531412107|FG005|Overall Study|Physician Decision|0|||
147339479|NCT04425629|531412108|FG006|Overall Study|Physician Decision|0|||
147296890|NCT02342886|531250680|FG004|Overall Study|Withdrawal by Subject|0|||
147296891|NCT02342886|531250676|FG000|Overall Study|Investigator/sponsor decision|0|||
147296892|NCT02342886|531250677|FG001|Overall Study|Investigator/sponsor decision|2|||
147296893|NCT02342886|531250678|FG002|Overall Study|Investigator/sponsor decision|0|||
147296894|NCT02342886|531250679|FG003|Overall Study|Investigator/sponsor decision|3|||
147296895|NCT02342886|531250680|FG004|Overall Study|Investigator/sponsor decision|1|||
147296896|NCT02342886|531250676|FG000|Overall Study|Pregnancy|0|||
147296897|NCT02342886|531250677|FG001|Overall Study|Pregnancy|0|||
147296898|NCT02342886|531250678|FG002|Overall Study|Pregnancy|2|||
147296899|NCT02342886|531250679|FG003|Overall Study|Pregnancy|0|||
147296900|NCT02342886|531250680|FG004|Overall Study|Pregnancy|0|||
147296901|NCT02342886|531250676|FG000|Overall Study|Late exclusion: pyrazinamide resistance|0|||
147296902|NCT02342886|531250677|FG001|Overall Study|Late exclusion: pyrazinamide resistance|0|||
147296903|NCT02342886|531250678|FG002|Overall Study|Late exclusion: pyrazinamide resistance|1|||
147296904|NCT02342886|531250679|FG003|Overall Study|Late exclusion: pyrazinamide resistance|0|||
147296905|NCT02342886|531250680|FG004|Overall Study|Late exclusion: pyrazinamide resistance|0|||
147296906|NCT02342886|531250676|FG000|Overall Study|Protocol Violation|0|||
147296907|NCT02342886|531250677|FG001|Overall Study|Protocol Violation|0|||
147296908|NCT02342886|531250678|FG002|Overall Study|Protocol Violation|0|||
147296909|NCT02342886|531250679|FG003|Overall Study|Protocol Violation|2|||
147296910|NCT02342886|531250680|FG004|Overall Study|Protocol Violation|0|||
147296911|NCT01328080|531250681|FG000|Overall Study|Lost to Follow-up|5|||
147296912|NCT00765674|531250682|FG000|Overall Study|Adverse Event|7|||
147296913|NCT00765674|531250683|FG001|Overall Study|Adverse Event|2|||
147296914|NCT00765674|531250684|FG002|Overall Study|Adverse Event|8|||
147296915|NCT00765674|531250685|FG003|Overall Study|Adverse Event|11|||
147296916|NCT00765674|531250682|FG000|Overall Study|Abnormal Laboratory Value(s)|0|||
147296917|NCT00765674|531250683|FG001|Overall Study|Abnormal Laboratory Value(s)|0|||
147296918|NCT00765674|531250684|FG002|Overall Study|Abnormal Laboratory Value(s)|1|||
147296919|NCT00765674|531250685|FG003|Overall Study|Abnormal Laboratory Value(s)|0|||
147296920|NCT00765674|531250682|FG000|Overall Study|Abnormal Test Procedure Result(s)|1|||
147296921|NCT00765674|531250683|FG001|Overall Study|Abnormal Test Procedure Result(s)|3|||
147296922|NCT00765674|531250684|FG002|Overall Study|Abnormal Test Procedure Result(s)|1|||
147296923|NCT00765674|531250685|FG003|Overall Study|Abnormal Test Procedure Result(s)|2|||
147296924|NCT00765674|531250682|FG000|Overall Study|Lack of Efficacy|2|||
147296925|NCT00765674|531250683|FG001|Overall Study|Lack of Efficacy|3|||
147296926|NCT00765674|531250684|FG002|Overall Study|Lack of Efficacy|1|||
147296927|NCT00765674|531250685|FG003|Overall Study|Lack of Efficacy|2|||
147296928|NCT00765674|531250682|FG000|Overall Study|Protocol Violation|2|||
147296929|NCT00765674|531250683|FG001|Overall Study|Protocol Violation|0|||
147296930|NCT00765674|531250684|FG002|Overall Study|Protocol Violation|1|||
147296931|NCT00765674|531250685|FG003|Overall Study|Protocol Violation|0|||
147296932|NCT00765674|531250682|FG000|Overall Study|Withdrawal by Subject|5|||
147296933|NCT00765674|531250683|FG001|Overall Study|Withdrawal by Subject|7|||
147296934|NCT00765674|531250684|FG002|Overall Study|Withdrawal by Subject|3|||
147296935|NCT00765674|531250685|FG003|Overall Study|Withdrawal by Subject|8|||
147296936|NCT00765674|531250682|FG000|Overall Study|Lost to Follow-up|4|||
147296937|NCT00765674|531250683|FG001|Overall Study|Lost to Follow-up|6|||
147296938|NCT00765674|531250684|FG002|Overall Study|Lost to Follow-up|2|||
147296939|NCT00765674|531250685|FG003|Overall Study|Lost to Follow-up|1|||
147296940|NCT00765674|531250682|FG000|Overall Study|Randomized in Error - No Study Drug|0|||
147339480|NCT04425629|531412109|FG007|Overall Study|Physician Decision|0|||
147339481|NCT04425629|531412110|FG008|Overall Study|Physician Decision|0|||
147339482|NCT04425629|531412111|FG009|Overall Study|Physician Decision|4|||
147339483|NCT04425629|531412112|FG010|Overall Study|Physician Decision|3|||
147339484|NCT04425629|531412113|FG011|Overall Study|Physician Decision|5|||
147339485|NCT04425629|531412114|FG012|Overall Study|Physician Decision|1|||
147339486|NCT04425629|531412115|FG013|Overall Study|Physician Decision|0|||
147339487|NCT04425629|531412116|FG014|Overall Study|Physician Decision|0|||
147296941|NCT00765674|531250683|FG001|Overall Study|Randomized in Error - No Study Drug|1|||
147296942|NCT00765674|531250684|FG002|Overall Study|Randomized in Error - No Study Drug|0|||
147296943|NCT00765674|531250685|FG003|Overall Study|Randomized in Error - No Study Drug|1|||
147296944|NCT03015402|531250686|FG000|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
147296945|NCT03015402|531250687|FG001|First Intervention (10 Weeks)|Withdrawal by Subject|2|||
147296946|NCT03015402|531250686|FG000|Washout (2 Weeks)|Withdrawal by Subject|1|||
147339488|NCT04425629|531412117|FG015|Overall Study|Physician Decision|1|||
147662667|NCT02782741|532587387|FG001|Open-label Long-term: Week 50 to 289|Poor compliance to protocol|1|||
147296947|NCT03015402|531250687|FG001|Washout (2 Weeks)|Withdrawal by Subject|0|||
147296948|NCT01813474|531250693|FG000|Overall Study|Withdrawal by Subject|0|||
147296949|NCT01813474|531250694|FG001|Overall Study|Withdrawal by Subject|0|||
147339489|NCT04425629|531412118|FG016|Overall Study|Physician Decision|0|||
147339490|NCT04425629|531412119|FG017|Overall Study|Physician Decision|0|||
147339491|NCT04425629|531412120|FG018|Overall Study|Physician Decision|0|||
147339492|NCT04425629|531412102|FG000|Overall Study|Lack of Efficacy|0|||
147296950|NCT01813474|531250695|FG002|Overall Study|Withdrawal by Subject|1|||
147296951|NCT01813474|531250693|FG000|Overall Study|Adverse Event|1|||
147296952|NCT01813474|531250694|FG001|Overall Study|Adverse Event|1|||
147296953|NCT01813474|531250695|FG002|Overall Study|Adverse Event|0|||
147296954|NCT01813474|531250693|FG000|Overall Study|Lack of Efficacy|2|||
147296955|NCT01813474|531250694|FG001|Overall Study|Lack of Efficacy|6|||
147296956|NCT01813474|531250695|FG002|Overall Study|Lack of Efficacy|9|||
147296957|NCT01813474|531250693|FG000|Overall Study|Death|0|||
147296958|NCT01813474|531250694|FG001|Overall Study|Death|0|||
147296959|NCT01813474|531250695|FG002|Overall Study|Death|1|||
147296960|NCT00316082|531250696|FG000|Overall Study|Lack of Efficacy|2|||
147296961|NCT00316082|531250697|FG001|Overall Study|Lack of Efficacy|3|||
147296962|NCT00316082|531250698|FG002|Overall Study|Lack of Efficacy|3|||
147296963|NCT00316082|531250699|FG003|Overall Study|Lack of Efficacy|4|||
147296964|NCT00316082|531250700|FG004|Overall Study|Lack of Efficacy|6|||
147296965|NCT00316082|531250696|FG000|Overall Study|Withdrawal of Consent by Subject|10|||
147296966|NCT00316082|531250697|FG001|Overall Study|Withdrawal of Consent by Subject|8|||
147296967|NCT00316082|531250698|FG002|Overall Study|Withdrawal of Consent by Subject|2|||
147296968|NCT00316082|531250699|FG003|Overall Study|Withdrawal of Consent by Subject|9|||
147296969|NCT00316082|531250700|FG004|Overall Study|Withdrawal of Consent by Subject|5|||
147296970|NCT00316082|531250696|FG000|Overall Study|Lost to Follow-up|7|||
147296971|NCT00316082|531250697|FG001|Overall Study|Lost to Follow-up|6|||
147296972|NCT00316082|531250698|FG002|Overall Study|Lost to Follow-up|7|||
147296973|NCT00316082|531250699|FG003|Overall Study|Lost to Follow-up|8|||
147296974|NCT00316082|531250700|FG004|Overall Study|Lost to Follow-up|6|||
147296975|NCT00316082|531250696|FG000|Overall Study|Poor/noncompliance|6|||
147296976|NCT00316082|531250697|FG001|Overall Study|Poor/noncompliance|1|||
147296977|NCT00316082|531250698|FG002|Overall Study|Poor/noncompliance|4|||
147296978|NCT00316082|531250699|FG003|Overall Study|Poor/noncompliance|1|||
147296979|NCT00316082|531250700|FG004|Overall Study|Poor/noncompliance|4|||
147296980|NCT00316082|531250696|FG000|Overall Study|Adverse Event|4|||
147296981|NCT00316082|531250697|FG001|Overall Study|Adverse Event|2|||
147296982|NCT00316082|531250698|FG002|Overall Study|Adverse Event|5|||
147296983|NCT00316082|531250699|FG003|Overall Study|Adverse Event|1|||
147296984|NCT00316082|531250700|FG004|Overall Study|Adverse Event|3|||
147296985|NCT00316082|531250696|FG000|Overall Study|Subject no longer meets study criteria|3|||
147296986|NCT00316082|531250697|FG001|Overall Study|Subject no longer meets study criteria|1|||
147296987|NCT00316082|531250698|FG002|Overall Study|Subject no longer meets study criteria|2|||
147296988|NCT00316082|531250699|FG003|Overall Study|Subject no longer meets study criteria|2|||
147296989|NCT00316082|531250700|FG004|Overall Study|Subject no longer meets study criteria|1|||
147296990|NCT00316082|531250696|FG000|Overall Study|Physician Decision|1|||
147296991|NCT00316082|531250697|FG001|Overall Study|Physician Decision|1|||
147296992|NCT00316082|531250698|FG002|Overall Study|Physician Decision|2|||
147296993|NCT00316082|531250699|FG003|Overall Study|Physician Decision|1|||
147296994|NCT00316082|531250700|FG004|Overall Study|Physician Decision|1|||
147296995|NCT00316082|531250696|FG000|Overall Study|Death|0|||
147296996|NCT00316082|531250697|FG001|Overall Study|Death|0|||
147296997|NCT00316082|531250698|FG002|Overall Study|Death|1|||
147296998|NCT00316082|531250699|FG003|Overall Study|Death|0|||
147296999|NCT00316082|531250700|FG004|Overall Study|Death|0|||
147297000|NCT00316082|531250696|FG000|Overall Study|Administrative reason by sponsor|0|||
147297001|NCT00316082|531250697|FG001|Overall Study|Administrative reason by sponsor|0|||
147297002|NCT00316082|531250698|FG002|Overall Study|Administrative reason by sponsor|1|||
147297003|NCT00316082|531250699|FG003|Overall Study|Administrative reason by sponsor|0|||
147297004|NCT00316082|531250700|FG004|Overall Study|Administrative reason by sponsor|0|||
147297005|NCT01995461|531250703|FG000|Overall Study|Death|1|||
147297006|NCT01995461|531250703|FG000|Overall Study|Lost to Follow-up|2|||
147297007|NCT01995461|531250703|FG000|Overall Study|Withdrawal by Subject|2|||
147297008|NCT00540124|531250704|FG000|Overall Study|Adverse Event|0|||
147452939|NCT04418765|531821486|FG001|Placebo-controlled Period (24 Weeks)|Lost to Follow-up|1|||
147452940|NCT04418765|531821487|FG002|Placebo-controlled Period (24 Weeks)|Lost to Follow-up|0|||
147452941|NCT04418765|531821485|FG000|Placebo-controlled Period (24 Weeks)|Other than specified|2|||
147452942|NCT04418765|531821486|FG001|Placebo-controlled Period (24 Weeks)|Other than specified|0|||
147452943|NCT04418765|531821487|FG002|Placebo-controlled Period (24 Weeks)|Other than specified|1|||
147297009|NCT00540124|531250705|FG001|Overall Study|Adverse Event|2|||
147297010|NCT00540124|531250706|FG002|Overall Study|Adverse Event|1|||
147452944|NCT04418765|531821485|FG000|Placebo-controlled Period (24 Weeks)|Randomized but not treated|1|||
147297011|NCT00540124|531250704|FG000|Overall Study|Entry Criteria Not Met|2|||
147297012|NCT00540124|531250705|FG001|Overall Study|Entry Criteria Not Met|0|||
147297013|NCT00540124|531250706|FG002|Overall Study|Entry Criteria Not Met|0|||
147297014|NCT00540124|531250704|FG000|Overall Study|Lack of Efficacy|1|||
147297015|NCT00540124|531250705|FG001|Overall Study|Lack of Efficacy|0|||
147297016|NCT00540124|531250706|FG002|Overall Study|Lack of Efficacy|0|||
147452945|NCT04418765|531821486|FG001|Placebo-controlled Period (24 Weeks)|Randomized but not treated|0|||
147297017|NCT00540124|531250704|FG000|Overall Study|Withdrawal by Subject|1|||
147297018|NCT00540124|531250705|FG001|Overall Study|Withdrawal by Subject|1|||
147297019|NCT00540124|531250706|FG002|Overall Study|Withdrawal by Subject|0|||
147297020|NCT03311373|531250713|FG000|Overall Study|Adverse Event|1|||
147297021|NCT03311373|531250713|FG000|Overall Study|Protocol Discontinuation Criteria|3|||
147297022|NCT03311373|531250713|FG000|Overall Study|Lost to Follow-up|1|||
147297023|NCT03311373|531250713|FG000|Overall Study|Physician Decision|1|||
147297024|NCT03311373|531250713|FG000|Overall Study|Withdrawal by Subject|3|||
147297025|NCT00374322|531250721|FG000|Overall Study|Lost to Follow-up|92|||
147297026|NCT00374322|531250722|FG001|Overall Study|Lost to Follow-up|90|||
147297027|NCT00374322|531250721|FG000|Overall Study|Protocol Violation|8|||
147297028|NCT00374322|531250722|FG001|Overall Study|Protocol Violation|3|||
147297029|NCT00374322|531250721|FG000|Overall Study|Withdrawal by Subject|235|||
147297030|NCT00374322|531250722|FG001|Overall Study|Withdrawal by Subject|167|||
147297031|NCT00374322|531250721|FG000|Overall Study|Sponsor Terminated Study|866|||
147297032|NCT00374322|531250722|FG001|Overall Study|Sponsor Terminated Study|990|||
147297033|NCT00374322|531250721|FG000|Overall Study|Physician Decision|36|||
147297034|NCT00374322|531250722|FG001|Overall Study|Physician Decision|32|||
147297035|NCT00374322|531250721|FG000|Overall Study|Par. Consented to Survival FU Only|3|||
147297036|NCT00374322|531250722|FG001|Overall Study|Par. Consented to Survival FU Only|1|||
147297037|NCT00374322|531250721|FG000|Overall Study|Sponsor Decision|2|||
147297038|NCT00374322|531250722|FG001|Overall Study|Sponsor Decision|3|||
147297039|NCT00374322|531250721|FG000|Overall Study|FU by a Non-Principal Investigator (PI)|2|||
147297040|NCT00374322|531250722|FG001|Overall Study|FU by a Non-Principal Investigator (PI)|3|||
147297041|NCT00374322|531250721|FG000|Overall Study|Seen in FU by a Non-Primary Investigator|1|||
147297042|NCT00374322|531250722|FG001|Overall Study|Seen in FU by a Non-Primary Investigator|0|||
147297043|NCT00374322|531250721|FG000|Overall Study|Severe Toxicity|1|||
147297044|NCT00374322|531250722|FG001|Overall Study|Severe Toxicity|0|||
147297045|NCT00374322|531250721|FG000|Overall Study|Site Closed|2|||
147297046|NCT00374322|531250722|FG001|Overall Study|Site Closed|2|||
147297047|NCT00374322|531250721|FG000|Overall Study|Participant Changed Physician|1|||
147297048|NCT00374322|531250722|FG001|Overall Study|Participant Changed Physician|0|||
147297049|NCT00374322|531250721|FG000|Overall Study|Started Another Chemotherapy Regimen|0|||
147297050|NCT00374322|531250722|FG001|Overall Study|Started Another Chemotherapy Regimen|1|||
147297051|NCT00374322|531250721|FG000|Overall Study|Noncompliance with Study Requirements|0|||
147297052|NCT00374322|531250722|FG001|Overall Study|Noncompliance with Study Requirements|1|||
147297053|NCT00374322|531250721|FG000|Overall Study|Withdrew Consent During Follow-up|0|||
147297054|NCT00374322|531250722|FG001|Overall Study|Withdrew Consent During Follow-up|5|||
147297055|NCT00374322|531250721|FG000|Overall Study|Did Not Receive Study Medication|8|||
147297056|NCT00374322|531250722|FG001|Overall Study|Did Not Receive Study Medication|6|||
147297057|NCT01112579|531250723|FG000|Overall Study|Missed Visit|1|||
147297058|NCT01112579|531250724|FG001|Overall Study|Missed Visit|1|||
147297059|NCT01112579|531250723|FG000|Overall Study|Death|0|||
147297060|NCT01112579|531250724|FG001|Overall Study|Death|2|||
147297061|NCT00902694|531250725|FG000|Overall Study|Death|1|||
147297062|NCT00902694|531250726|FG001|Overall Study|Death|3|||
147297063|NCT00902694|531250725|FG000|Overall Study|Lost to Follow-up|1|||
147297064|NCT00902694|531250726|FG001|Overall Study|Lost to Follow-up|0|||
147297065|NCT00902694|531250725|FG000|Overall Study|Censored per protocol|3|||
147297066|NCT00902694|531250726|FG001|Overall Study|Censored per protocol|1|||
147297067|NCT00902694|531250725|FG000|Overall Study|Pregnancy|1|||
147297068|NCT00902694|531250726|FG001|Overall Study|Pregnancy|1|||
147297069|NCT00902694|531250725|FG000|Overall Study|Incarceration|1|||
147297070|NCT00902694|531250726|FG001|Overall Study|Incarceration|0|||
147297071|NCT04969263|531250727|FG000|Overall Study|Death|1|||
147297072|NCT04969263|531250727|FG000|Overall Study|Lost to Follow-up|2|||
147297073|NCT04969263|531250727|FG000|Overall Study|Withdrawal by Subject|5|||
147297074|NCT04969263|531250727|FG000|Overall Study|Physician decision due to both medical and non-medical considerations|1|||
147297075|NCT00175825|531252199|FG000|Overall Study|Adverse Event|3|||
147297076|NCT00175825|531252200|FG001|Overall Study|Adverse Event|2|||
147297077|NCT00175825|531252201|FG002|Overall Study|Adverse Event|1|||
147297078|NCT00175825|531252202|FG003|Overall Study|Adverse Event|1|||
147297079|NCT00175825|531252199|FG000|Overall Study|Lost to Follow-up|1|||
147297080|NCT00175825|531252200|FG001|Overall Study|Lost to Follow-up|2|||
147297081|NCT00175825|531252201|FG002|Overall Study|Lost to Follow-up|0|||
147297082|NCT00175825|531252202|FG003|Overall Study|Lost to Follow-up|0|||
147297083|NCT00175825|531252199|FG000|Overall Study|Withdrawal by Subject|1|||
147297084|NCT00175825|531252200|FG001|Overall Study|Withdrawal by Subject|0|||
147297085|NCT00175825|531252201|FG002|Overall Study|Withdrawal by Subject|0|||
147297086|NCT00175825|531252202|FG003|Overall Study|Withdrawal by Subject|0|||
147297087|NCT04098406|531252203|FG000|Overall Study|Adverse Event|2|||
147297088|NCT04098406|531252204|FG001|Overall Study|Adverse Event|1|||
147297089|NCT04098406|531252203|FG000|Overall Study|Withdrawal by Subject|1|||
147297090|NCT04098406|531252204|FG001|Overall Study|Withdrawal by Subject|0|||
147297091|NCT01357616|531252205|FG000|Overall Study|Adverse Event|1|||
147606256|NCT01371747|532375196|FG002|Overall Study|Death|4|||
147297092|NCT01357616|531252206|FG001|Overall Study|Adverse Event|1|||
147606257|NCT01371747|532375197|FG003|Overall Study|Death|1|||
147606258|NCT01371747|532375198|FG004|Overall Study|Death|2|||
147606259|NCT01371747|532375199|FG005|Overall Study|Death|0|||
147606260|NCT01371747|532375194|FG000|Overall Study|Abnormal Renal Function|0|||
147606261|NCT01371747|532375195|FG001|Overall Study|Abnormal Renal Function|2|||
147606262|NCT01371747|532375196|FG002|Overall Study|Abnormal Renal Function|0|||
147606263|NCT01371747|532375197|FG003|Overall Study|Abnormal Renal Function|1|||
147606264|NCT01371747|532375198|FG004|Overall Study|Abnormal Renal Function|0|||
147297093|NCT01357616|531252205|FG000|Overall Study|Lost to Follow-up|4|||
147297094|NCT01357616|531252206|FG001|Overall Study|Lost to Follow-up|3|||
147297095|NCT01357616|531252205|FG000|Overall Study|Protocol Violation|0|||
147297096|NCT01357616|531252206|FG001|Overall Study|Protocol Violation|2|||
147297097|NCT01357616|531252205|FG000|Overall Study|Inadequate Control of IOP|1|||
147297098|NCT01357616|531252206|FG001|Overall Study|Inadequate Control of IOP|2|||
147297099|NCT01357616|531252205|FG000|Overall Study|Decision Unrelated to Adverse Event|3|||
147297100|NCT01357616|531252206|FG001|Overall Study|Decision Unrelated to Adverse Event|1|||
147297101|NCT01357616|531252205|FG000|Overall Study|Withdrawal by Subject|1|||
147297102|NCT01357616|531252206|FG001|Overall Study|Withdrawal by Subject|0|||
147297103|NCT03432364|531252207|FG000|Follow Up (Weeks 52-156 Post Infusion)|Withdrawal by Subject|1|||
147297104|NCT00522301|531252208|FG000|Overall Study|Withdrawal by Subject|1|||
147297105|NCT00522301|531252208|FG000|Overall Study|Adverse Event|5|||
147297106|NCT01699022|531252213|FG000|Overall Study|Early discontinuation from the study|3|||
147297107|NCT02066402|531252214|FG000|Overall Study|Adverse Event|1|||
147297108|NCT02066402|531252215|FG001|Overall Study|Adverse Event|2|||
147297109|NCT02066402|531252214|FG000|Overall Study|Lost to Follow-up|11|||
147297110|NCT02066402|531252215|FG001|Overall Study|Lost to Follow-up|8|||
147297111|NCT02066402|531252214|FG000|Overall Study|Withdrawal by Subject|14|||
147297112|NCT02066402|531252215|FG001|Overall Study|Withdrawal by Subject|11|||
147297113|NCT02066402|531252214|FG000|Overall Study|Progressive disease-clinical progression|0|||
147297114|NCT02066402|531252215|FG001|Overall Study|Progressive disease-clinical progression|1|||
147297115|NCT02066402|531252214|FG000|Overall Study|Protocol driven decision point|0|||
147297116|NCT02066402|531252215|FG001|Overall Study|Protocol driven decision point|1|||
147297117|NCT00152464|531252216|FG000|Overall Study|Adverse Event|3|||
147297118|NCT00152464|531252217|FG001|Overall Study|Adverse Event|6|||
147297119|NCT00152464|531252216|FG000|Overall Study|Lost to Follow-up|8|||
147297120|NCT00152464|531252217|FG001|Overall Study|Lost to Follow-up|4|||
147297121|NCT00152464|531252216|FG000|Overall Study|Protocol Violation|3|||
147297122|NCT00152464|531252217|FG001|Overall Study|Protocol Violation|1|||
147297123|NCT00152464|531252216|FG000|Overall Study|Withdrawal by Subject|21|||
147297124|NCT00152464|531252217|FG001|Overall Study|Withdrawal by Subject|22|||
147297125|NCT00152464|531252216|FG000|Overall Study|Atopic dermatitis poorly controlled|0|||
147297126|NCT00152464|531252217|FG001|Overall Study|Atopic dermatitis poorly controlled|1|||
147297127|NCT00152464|531252216|FG000|Overall Study|Eczema deterioration|0|||
147297128|NCT00152464|531252217|FG001|Overall Study|Eczema deterioration|1|||
147297129|NCT00152464|531252216|FG000|Overall Study|Parent decision|1|||
147297130|NCT00152464|531252217|FG001|Overall Study|Parent decision|1|||
147297131|NCT00152464|531252216|FG000|Overall Study|Investigator decision|1|||
147297132|NCT00152464|531252217|FG001|Overall Study|Investigator decision|0|||
147297133|NCT00152464|531252216|FG000|Overall Study|Lack of Efficacy|1|||
147297134|NCT00152464|531252217|FG001|Overall Study|Lack of Efficacy|0|||
147297135|NCT00152464|531252216|FG000|Overall Study|Eczema poorly controlled|1|||
147297136|NCT00152464|531252217|FG001|Overall Study|Eczema poorly controlled|0|||
147297137|NCT00152464|531252216|FG000|Overall Study|Patient relocated|1|||
147606265|NCT01371747|532375199|FG005|Overall Study|Abnormal Renal Function|1|||
147606266|NCT01371747|532375194|FG000|Overall Study|High Serum Potassium Results|1|||
147606267|NCT01371747|532375195|FG001|Overall Study|High Serum Potassium Results|1|||
147606268|NCT01371747|532375196|FG002|Overall Study|High Serum Potassium Results|1|||
147297138|NCT00152464|531252217|FG001|Overall Study|Patient relocated|0|||
147297139|NCT04465357|531252219|FG000|Overall Study|Adverse Event|2|||
147297140|NCT04465357|531252219|FG000|Overall Study|Lack of Efficacy|1|||
147297141|NCT04465357|531252219|FG000|Overall Study|Lost to Follow-up|2|||
147297142|NCT04465357|531252219|FG000|Overall Study|Withdrawal by Subject|6|||
147297143|NCT04465357|531252219|FG000|Overall Study|Protocol specified withdrawal criterion met|2|||
147297144|NCT00917579|531252223|FG000|Washout >= 2 Weeks|Adverse Event|1|||
147297145|NCT00917579|531252224|FG001|Washout >= 2 Weeks|Adverse Event|0|||
147297146|NCT00917579|531252223|FG000|Washout >= 2 Weeks|Withdrawal by Subject|1|||
147297147|NCT00917579|531252224|FG001|Washout >= 2 Weeks|Withdrawal by Subject|0|||
147297148|NCT00754338|531252225|FG000|First Intervention for Phase1&Phase2|Withdrawal by Subject|0|||
147297149|NCT00754338|531252226|FG001|First Intervention for Phase1&Phase2|Withdrawal by Subject|3|||
147297150|NCT00754338|531252227|FG002|First Intervention for Phase1&Phase2|Withdrawal by Subject|3|||
147297151|NCT00754338|531252228|FG003|First Intervention for Phase1&Phase2|Withdrawal by Subject|0|||
147606269|NCT01371747|532375197|FG003|Overall Study|High Serum Potassium Results|2|||
147606270|NCT01371747|532375198|FG004|Overall Study|High Serum Potassium Results|0|||
147297152|NCT00754338|531252225|FG000|Second Intervention for Phase1&Phase2|Withdrawal by Subject|0|||
147297153|NCT00754338|531252226|FG001|Second Intervention for Phase1&Phase2|Withdrawal by Subject|1|||
147297154|NCT00754338|531252227|FG002|Second Intervention for Phase1&Phase2|Withdrawal by Subject|0|||
147339493|NCT04425629|531412103|FG001|Overall Study|Lack of Efficacy|0|||
147606271|NCT01371747|532375199|FG005|Overall Study|High Serum Potassium Results|2|||
147606272|NCT01371747|532375194|FG000|Overall Study|Low Serum Potassium Results|1|||
147297155|NCT00754338|531252228|FG003|Second Intervention for Phase1&Phase2|Withdrawal by Subject|1|||
147297156|NCT04020341|531252229|FG000|Overall Study|Adverse Event|8|||
147297157|NCT04020341|531252230|FG001|Overall Study|Adverse Event|6|||
147297158|NCT04020341|531252229|FG000|Overall Study|Lost to Follow-up|8|||
147297159|NCT04020341|531252230|FG001|Overall Study|Lost to Follow-up|2|||
147297160|NCT04020341|531252229|FG000|Overall Study|Withdrawal by Subject|16|||
147297161|NCT04020341|531252230|FG001|Overall Study|Withdrawal by Subject|16|||
147297162|NCT04020341|531252229|FG000|Overall Study|Participant not able to swallow the tablet|1|||
147297163|NCT04020341|531252230|FG001|Overall Study|Participant not able to swallow the tablet|0|||
147297164|NCT04020341|531252229|FG000|Overall Study|Physician Decision|0|||
147297165|NCT04020341|531252230|FG001|Overall Study|Physician Decision|2|||
147297166|NCT04020341|531252229|FG000|Overall Study|Protocol Deviation|0|||
147297167|NCT04020341|531252230|FG001|Overall Study|Protocol Deviation|2|||
147297168|NCT04555096|531252234|FG000|Overall Study|Death|4|||
147297169|NCT04555096|531252235|FG001|Overall Study|Death|4|||
147297170|NCT04555096|531252234|FG000|Overall Study|Withdrawal by Subject|1|||
147297171|NCT04555096|531252235|FG001|Overall Study|Withdrawal by Subject|0|||
147297172|NCT04555096|531252234|FG000|Overall Study|Other|0|||
147297173|NCT04555096|531252235|FG001|Overall Study|Other|1|||
147297174|NCT04495179|531252242|FG000|Overall Study|Lost to Follow-up|0|||
147297175|NCT04495179|531252243|FG001|Overall Study|Lost to Follow-up|1|||
147297176|NCT04495179|531252242|FG000|Overall Study|Withdrawal by Subject|2|||
147297177|NCT04495179|531252243|FG001|Overall Study|Withdrawal by Subject|4|||
147297178|NCT04495179|531252242|FG000|Overall Study|Study terminated by sponsor|0|||
147297179|NCT04495179|531252243|FG001|Overall Study|Study terminated by sponsor|18|||
147297180|NCT04495179|531252242|FG000|Overall Study|Death|0|||
147297181|NCT04495179|531252243|FG001|Overall Study|Death|4|||
147297182|NCT04495179|531252242|FG000|Overall Study|Adverse Event|0|||
147297183|NCT04495179|531252243|FG001|Overall Study|Adverse Event|1|||
147297184|NCT00162370|531252244|FG000|Efficacy Population|Lost to Follow-up|51|||
147297185|NCT00569582|531252245|FG000|Overall Study|Withdrawal by Subject|5|||
147297186|NCT00569582|531252245|FG000|Overall Study|Death|2|||
147297187|NCT00569582|531252245|FG000|Overall Study|Adverse Event|7|||
147297188|NCT00569582|531252245|FG000|Overall Study|Subject was too ill to travel.|1|||
147297189|NCT00569582|531252245|FG000|Overall Study|Subject was non-compliant.|1|||
147297190|NCT02612311|531252248|FG000|Overall Study|Adverse Event|16|||
147297191|NCT02612311|531252249|FG001|Overall Study|Adverse Event|12|||
147297192|NCT02612311|531252250|FG002|Overall Study|Adverse Event|7|||
147297193|NCT02612311|531252251|FG003|Overall Study|Adverse Event|13|||
147297194|NCT02612311|531252248|FG000|Overall Study|Death|29|||
147297195|NCT02612311|531252249|FG001|Overall Study|Death|10|||
147297196|NCT02612311|531252250|FG002|Overall Study|Death|11|||
147297197|NCT02612311|531252251|FG003|Overall Study|Death|11|||
147297198|NCT02612311|531252248|FG000|Overall Study|Initiation of Non-protocol Intervention|5|||
147297199|NCT02612311|531252249|FG001|Overall Study|Initiation of Non-protocol Intervention|3|||
147297200|NCT02612311|531252250|FG002|Overall Study|Initiation of Non-protocol Intervention|0|||
147297201|NCT02612311|531252251|FG003|Overall Study|Initiation of Non-protocol Intervention|0|||
147297202|NCT02612311|531252248|FG000|Overall Study|Investigator's Decision|11|||
147297203|NCT02612311|531252249|FG001|Overall Study|Investigator's Decision|15|||
147297204|NCT02612311|531252250|FG002|Overall Study|Investigator's Decision|6|||
147297205|NCT02612311|531252251|FG003|Overall Study|Investigator's Decision|6|||
147297206|NCT02612311|531252248|FG000|Overall Study|Lack of Efficacy|0|||
147606273|NCT01371747|532375195|FG001|Overall Study|Low Serum Potassium Results|1|||
147606274|NCT01371747|532375196|FG002|Overall Study|Low Serum Potassium Results|1|||
147297207|NCT02612311|531252249|FG001|Overall Study|Lack of Efficacy|0|||
147297208|NCT02612311|531252250|FG002|Overall Study|Lack of Efficacy|1|||
147297209|NCT02612311|531252251|FG003|Overall Study|Lack of Efficacy|1|||
147297210|NCT02612311|531252248|FG000|Overall Study|Lost to Follow-up|2|||
147297211|NCT02612311|531252249|FG001|Overall Study|Lost to Follow-up|2|||
147297212|NCT02612311|531252250|FG002|Overall Study|Lost to Follow-up|1|||
147297213|NCT02612311|531252251|FG003|Overall Study|Lost to Follow-up|2|||
147297214|NCT02612311|531252248|FG000|Overall Study|Progressive Disease Confirmed by Central Radiology|75|||
147297215|NCT02612311|531252249|FG001|Overall Study|Progressive Disease Confirmed by Central Radiology|113|||
147297216|NCT02612311|531252250|FG002|Overall Study|Progressive Disease Confirmed by Central Radiology|38|||
147297217|NCT02612311|531252251|FG003|Overall Study|Progressive Disease Confirmed by Central Radiology|43|||
147297218|NCT02612311|531252248|FG000|Overall Study|Site Terminated by Sponsor|29|||
147297219|NCT02612311|531252249|FG001|Overall Study|Site Terminated by Sponsor|12|||
147297220|NCT02612311|531252250|FG002|Overall Study|Site Terminated by Sponsor|13|||
147297221|NCT02612311|531252251|FG003|Overall Study|Site Terminated by Sponsor|5|||
147297222|NCT02612311|531252248|FG000|Overall Study|Withdrawal by Subject of Consent or to Discontinue Treatment|29|||
147297223|NCT02612311|531252249|FG001|Overall Study|Withdrawal by Subject of Consent or to Discontinue Treatment|24|||
147297224|NCT02612311|531252250|FG002|Overall Study|Withdrawal by Subject of Consent or to Discontinue Treatment|6|||
147297225|NCT02612311|531252251|FG003|Overall Study|Withdrawal by Subject of Consent or to Discontinue Treatment|5|||
147297226|NCT02612311|531252248|FG000|Overall Study|Reason Not Specified|3|||
147297227|NCT02612311|531252249|FG001|Overall Study|Reason Not Specified|7|||
147297228|NCT02612311|531252250|FG002|Overall Study|Reason Not Specified|4|||
147297229|NCT02612311|531252251|FG003|Overall Study|Reason Not Specified|5|||
147297230|NCT02612311|531252248|FG000|Overall Study|Unknown/Missing|10|||
147297231|NCT02612311|531252249|FG001|Overall Study|Unknown/Missing|13|||
147297232|NCT02612311|531252250|FG002|Overall Study|Unknown/Missing|4|||
147297233|NCT02612311|531252251|FG003|Overall Study|Unknown/Missing|0|||
147297234|NCT02612311|531252248|FG000|Overall Study|Non-Compliance with Study|1|||
147297235|NCT02612311|531252249|FG001|Overall Study|Non-Compliance with Study|0|||
147297236|NCT02612311|531252250|FG002|Overall Study|Non-Compliance with Study|0|||
147297237|NCT02612311|531252251|FG003|Overall Study|Non-Compliance with Study|0|||
147297238|NCT01596582|531252252|FG000|Overall Study|Deemed ineligible after study visit|3|||
147297239|NCT01596582|531252253|FG001|Overall Study|Deemed ineligible after study visit|6|||
147297240|NCT01596582|531252252|FG000|Overall Study|Missing all outcome data|1|||
147297241|NCT01596582|531252253|FG001|Overall Study|Missing all outcome data|1|||
147297242|NCT01428076|531252254|FG000|Overall Study|Adverse Event|0|||
147297243|NCT01428076|531252255|FG001|Overall Study|Adverse Event|1|||
147297244|NCT00862134|531252259|FG000|Overall Study|Death|1|||
147297245|NCT00862134|531252260|FG001|Overall Study|Death|0|||
147297246|NCT00862134|531252259|FG000|Overall Study|Physician Decision|0|||
147297247|NCT00862134|531252260|FG001|Overall Study|Physician Decision|1|||
147297248|NCT00862134|531252259|FG000|Overall Study|Withdrawal by Subject|1|||
147297249|NCT00862134|531252260|FG001|Overall Study|Withdrawal by Subject|2|||
147297250|NCT00862134|531252259|FG000|Overall Study|Sponsor terminated study|5|||
147297251|NCT00862134|531252260|FG001|Overall Study|Sponsor terminated study|7|||
147297252|NCT00862134|531252259|FG000|Overall Study|Adverse Event|2|||
147297253|NCT00862134|531252260|FG001|Overall Study|Adverse Event|2|||
147297254|NCT00862134|531252259|FG000|Overall Study|Withdrew prior to dosing|2|||
147297255|NCT00862134|531252260|FG001|Overall Study|Withdrew prior to dosing|0|||
147297256|NCT02191267|531252261|FG000|Overall Study|Withdrawal by Subject|1|||
147297257|NCT02191267|531252262|FG001|Overall Study|Withdrawal by Subject|0|||
147297258|NCT02191267|531252263|FG002|Overall Study|Withdrawal by Subject|0|||
147297259|NCT02216773|531252264|FG000|Overall Study|Disease progression|4|||
147297260|NCT02216773|531252265|FG001|Overall Study|Disease progression|2|||
147297261|NCT02216773|531252264|FG000|Overall Study|Insufficient FLRV|4|||
147297262|NCT02216773|531252265|FG001|Overall Study|Insufficient FLRV|0|||
147297263|NCT02216773|531252264|FG000|Overall Study|Abandoned|4|||
147297264|NCT02216773|531252265|FG001|Overall Study|Abandoned|3|||
147297265|NCT02124265|531252269|FG000|Overall Study|Adverse Event|1|||
147297266|NCT04510675|531252272|FG000|Overall Study|Withdrawal by Subject|5|||
147297267|NCT00810264|531252273|FG000|Overall Study|Lost to Follow-up|191|||
147297268|NCT00810264|531252273|FG000|Overall Study|Withdrawal by subject or physician|721|||
147297269|NCT00810264|531252273|FG000|Overall Study|Death|641|||
147297270|NCT01563536|531252274|FG000|Overall Study|Withdrawal by Subject|0|||
147297271|NCT01563536|531252275|FG001|Overall Study|Withdrawal by Subject|2|||
147297272|NCT01563536|531252274|FG000|Overall Study|Lost to Follow-up|1|||
147297273|NCT01563536|531252275|FG001|Overall Study|Lost to Follow-up|0|||
147297274|NCT00538590|531252283|FG000|Overall Study|Death|1|||
147297275|NCT00538590|531252284|FG001|Overall Study|Death|0|||
147297276|NCT00567190|531252285|FG000|Overall Study|Death|235|||
147297277|NCT00567190|531252286|FG001|Overall Study|Death|280|||
147297278|NCT00567190|531252285|FG000|Overall Study|Withdrew Consent or Lost to Follow-up|48|||
147297279|NCT00567190|531252286|FG001|Overall Study|Withdrew Consent or Lost to Follow-up|53|||
147297280|NCT00058123|531252295|FG000|Overall Study|Wrong histology|9|||
147297281|NCT00058123|531252295|FG000|Overall Study|Received >3 prior treatments|1|||
147339494|NCT04425629|531412104|FG002|Overall Study|Lack of Efficacy|0|||
147339495|NCT04425629|531412105|FG003|Overall Study|Lack of Efficacy|0|||
147339496|NCT04425629|531412106|FG004|Overall Study|Lack of Efficacy|0|||
147339497|NCT04425629|531412107|FG005|Overall Study|Lack of Efficacy|0|||
147339498|NCT04425629|531412108|FG006|Overall Study|Lack of Efficacy|0|||
147339499|NCT04425629|531412109|FG007|Overall Study|Lack of Efficacy|0|||
147339500|NCT04425629|531412110|FG008|Overall Study|Lack of Efficacy|0|||
147339501|NCT04425629|531412111|FG009|Overall Study|Lack of Efficacy|0|||
147339502|NCT04425629|531412112|FG010|Overall Study|Lack of Efficacy|1|||
147339503|NCT04425629|531412113|FG011|Overall Study|Lack of Efficacy|0|||
147297282|NCT00636610|531252296|FG000|Overall Study|Adverse Event|4|||
147297283|NCT00636610|531252297|FG001|Overall Study|Adverse Event|4|||
147297284|NCT00636610|531252296|FG000|Overall Study|Death|6|||
147297285|NCT00636610|531252297|FG001|Overall Study|Death|3|||
147297286|NCT00636610|531252296|FG000|Overall Study|Physician decision to withdraw patient|15|||
147297287|NCT00636610|531252297|FG001|Overall Study|Physician decision to withdraw patient|9|||
147297288|NCT00636610|531252296|FG000|Overall Study|Subject decision to withdraw|15|||
147297289|NCT00636610|531252297|FG001|Overall Study|Subject decision to withdraw|11|||
147297290|NCT00636610|531252296|FG000|Overall Study|Disease progression - radiographic|41|||
147297291|NCT00636610|531252297|FG001|Overall Study|Disease progression - radiographic|51|||
147297292|NCT00636610|531252296|FG000|Overall Study|Disease progression - clinical|8|||
147297293|NCT00636610|531252297|FG001|Overall Study|Disease progression - clinical|3|||
147297294|NCT00636610|531252296|FG000|Overall Study|Reason for discontinuation not available|3|||
147297295|NCT00636610|531252297|FG001|Overall Study|Reason for discontinuation not available|2|||
147297296|NCT00313820|531252298|FG000|Assigned to Treatment|Other|1|||
147297297|NCT00313820|531252299|FG001|Assigned to Treatment|Other|0|||
147297298|NCT00313820|531252298|FG000|Pregabalin or Placebo Treatment Period|Adverse Event|9|||
147297299|NCT00313820|531252299|FG001|Pregabalin or Placebo Treatment Period|Adverse Event|4|||
147297300|NCT00313820|531252298|FG000|Pregabalin or Placebo Treatment Period|Lack of Efficacy|0|||
147297301|NCT00313820|531252299|FG001|Pregabalin or Placebo Treatment Period|Lack of Efficacy|1|||
147297302|NCT00313820|531252298|FG000|Pregabalin or Placebo Treatment Period|Lost to Follow-up|0|||
147297303|NCT00313820|531252299|FG001|Pregabalin or Placebo Treatment Period|Lost to Follow-up|7|||
147297304|NCT00313820|531252298|FG000|Pregabalin or Placebo Treatment Period|Withdrawal by Subject|6|||
147297305|NCT00313820|531252299|FG001|Pregabalin or Placebo Treatment Period|Withdrawal by Subject|4|||
147297306|NCT00313820|531252298|FG000|Pregabalin or Placebo Treatment Period|Other|2|||
147297307|NCT00313820|531252299|FG001|Pregabalin or Placebo Treatment Period|Other|3|||
147297308|NCT00553696|531252304|FG000|Overall Study|Adverse Event|2|||
147297309|NCT00553696|531252305|FG001|Overall Study|Adverse Event|4|||
147297310|NCT00553696|531252306|FG002|Overall Study|Adverse Event|0|||
147297311|NCT00553696|531252307|FG003|Overall Study|Adverse Event|1|||
147297312|NCT00553696|531252304|FG000|Overall Study|Global deterioration of health status|0|||
147297313|NCT00553696|531252305|FG001|Overall Study|Global deterioration of health status|2|||
147297314|NCT00553696|531252306|FG002|Overall Study|Global deterioration of health status|0|||
147297315|NCT00553696|531252307|FG003|Overall Study|Global deterioration of health status|0|||
147297316|NCT00553696|531252304|FG000|Overall Study|Objective progression or relapse|2|||
147297317|NCT00553696|531252305|FG001|Overall Study|Objective progression or relapse|9|||
147297318|NCT00553696|531252306|FG002|Overall Study|Objective progression or relapse|6|||
147297319|NCT00553696|531252307|FG003|Overall Study|Objective progression or relapse|0|||
147297320|NCT00553696|531252304|FG000|Overall Study|Withdrawal by Subject|0|||
147297321|NCT00553696|531252305|FG001|Overall Study|Withdrawal by Subject|1|||
147297322|NCT00553696|531252306|FG002|Overall Study|Withdrawal by Subject|0|||
147297323|NCT00553696|531252307|FG003|Overall Study|Withdrawal by Subject|0|||
147297324|NCT00686881|531252308|FG000|Overall Study|Withdrawal by Subject|11|||
147297325|NCT00686881|531252309|FG001|Overall Study|Withdrawal by Subject|18|||
147297326|NCT00686881|531252308|FG000|Overall Study|Lost to Follow-up|0|||
147297327|NCT00686881|531252309|FG001|Overall Study|Lost to Follow-up|1|||
147297328|NCT00686881|531252308|FG000|Overall Study|Treatment-related adverse event|10|||
147297329|NCT00686881|531252309|FG001|Overall Study|Treatment-related adverse event|9|||
147297330|NCT00686881|531252308|FG000|Overall Study|Met discontinuation criteria|5|||
147297331|NCT00686881|531252309|FG001|Overall Study|Met discontinuation criteria|0|||
147297332|NCT00686881|531252308|FG000|Overall Study|Onset of malignant tumor|11|||
147297333|NCT00686881|531252309|FG001|Overall Study|Onset of malignant tumor|11|||
147297334|NCT00686881|531252308|FG000|Overall Study|Lack of Efficacy|4|||
147297335|NCT00686881|531252309|FG001|Overall Study|Lack of Efficacy|3|||
147297336|NCT00686881|531252308|FG000|Overall Study|Physician Decision|1|||
147297337|NCT00686881|531252309|FG001|Overall Study|Physician Decision|0|||
147297338|NCT00686881|531252308|FG000|Overall Study|Circumstances of site|1|||
147297339|NCT00686881|531252309|FG001|Overall Study|Circumstances of site|1|||
147297340|NCT00686881|531252308|FG000|Overall Study|Did not meet protocol eligibility|1|||
147297341|NCT00686881|531252309|FG001|Overall Study|Did not meet protocol eligibility|0|||
147297342|NCT00686881|531252308|FG000|Overall Study|Irregular visits|1|||
147297343|NCT00686881|531252309|FG001|Overall Study|Irregular visits|0|||
147297344|NCT00686881|531252308|FG000|Overall Study|Study discontinuation|35|||
147297345|NCT00686881|531252309|FG001|Overall Study|Study discontinuation|32|||
147297346|NCT00686881|531252308|FG000|Overall Study|Never received study drug|2|||
147297347|NCT00686881|531252309|FG001|Overall Study|Never received study drug|6|||
147297348|NCT02085252|531252310|FG000|Overall Study|Withdrawal of Consent|1|||
147297349|NCT02085252|531252311|FG001|Overall Study|Withdrawal of Consent|0|||
147297350|NCT02085252|531252310|FG000|Overall Study|Adverse Event|0|||
147297351|NCT02085252|531252311|FG001|Overall Study|Adverse Event|1|||
147297352|NCT02085252|531252310|FG000|Overall Study|Discontinuation Due to Patient Decision|0|||
147297353|NCT02085252|531252311|FG001|Overall Study|Discontinuation Due to Patient Decision|1|||
147297354|NCT02085252|531252310|FG000|Overall Study|Reason Not Specified|0|||
147297355|NCT02085252|531252311|FG001|Overall Study|Reason Not Specified|1|||
147297356|NCT02085252|531252310|FG000|Overall Study|Reason Unknown|0|||
147297357|NCT02085252|531252311|FG001|Overall Study|Reason Unknown|1|||
147297358|NCT02925676|531252313|FG000|Overall Study|Withdrawal by Subject|1|||
147452946|NCT04418765|531821487|FG002|Placebo-controlled Period (24 Weeks)|Randomized but not treated|0|||
147297359|NCT03260868|531252317|FG000|Overall Study|Poor Compliance to Protocol|0|||
147297360|NCT03260868|531252318|FG001|Overall Study|Poor Compliance to Protocol|2|||
147297361|NCT03260868|531252317|FG000|Overall Study|Study Terminated By Sponsor|2|||
147297362|NCT03260868|531252318|FG001|Overall Study|Study Terminated By Sponsor|1|||
147297363|NCT03260868|531252317|FG000|Overall Study|Other than specified above|1|||
147452947|NCT04418765|531821485|FG000|Extension Period (48 Weeks)|Adverse Event|0|||
147297364|NCT03260868|531252318|FG001|Overall Study|Other than specified above|0|||
147297365|NCT01298999|531252319|FG000|Overall Study|Physician Decision|0|||
147297366|NCT01298999|531252320|FG001|Overall Study|Physician Decision|1|||
147297367|NCT01298999|531252319|FG000|Overall Study|Baseline Endoscopy showed low grade dysplasia or indefinite for dysplasia|3|||
147297368|NCT01298999|531252320|FG001|Overall Study|Baseline Endoscopy showed low grade dysplasia or indefinite for dysplasia|0|||
147297369|NCT02151266|531252321|FG000|Overall Study|Lost to Follow-up|1|||
147297370|NCT02151266|531252322|FG001|Overall Study|Lost to Follow-up|4|||
147297371|NCT02151266|531252323|FG002|Overall Study|Lost to Follow-up|1|||
147297372|NCT02151266|531252321|FG000|Overall Study|Did NOT receive intervention|3|||
147297373|NCT02151266|531252322|FG001|Overall Study|Did NOT receive intervention|6|||
147297374|NCT02151266|531252323|FG002|Overall Study|Did NOT receive intervention|2|||
147297375|NCT02151266|531252321|FG000|Overall Study|Not able to exercise|4|||
147297376|NCT02151266|531252322|FG001|Overall Study|Not able to exercise|5|||
147297377|NCT02151266|531252323|FG002|Overall Study|Not able to exercise|4|||
147297378|NCT04839965|531252325|FG000|Overall Study|Death|6|||
147297379|NCT04839965|531252326|FG001|Overall Study|Death|6|||
147297380|NCT04839965|531252325|FG000|Overall Study|Lost to Follow-up|1|||
147297381|NCT04839965|531252326|FG001|Overall Study|Lost to Follow-up|0|||
147297382|NCT00981084|531252327|FG000|Post Intervention (Data Analysis)|poor effort|1|||
147297383|NCT00981084|531252328|FG001|Post Intervention (Data Analysis)|poor effort|1|||
147297384|NCT00981084|531252327|FG000|Post Intervention (Data Analysis)|imbalance in disease subtype|1|||
147297385|NCT00981084|531252328|FG001|Post Intervention (Data Analysis)|imbalance in disease subtype|0|||
147297386|NCT02291679|531252329|FG000|Overall Study|Adverse Event|2|||
147297387|NCT02291679|531252330|FG001|Overall Study|Adverse Event|12|||
147297388|NCT02291679|531252331|FG002|Overall Study|Adverse Event|19|||
147297389|NCT02291679|531252329|FG000|Overall Study|Protocol Violation|5|||
147297390|NCT02291679|531252330|FG001|Overall Study|Protocol Violation|1|||
147297391|NCT02291679|531252331|FG002|Overall Study|Protocol Violation|7|||
147297392|NCT02291679|531252329|FG000|Overall Study|Withdrew Consent|18|||
147297393|NCT02291679|531252330|FG001|Overall Study|Withdrew Consent|10|||
147297394|NCT02291679|531252331|FG002|Overall Study|Withdrew Consent|15|||
147297395|NCT02291679|531252329|FG000|Overall Study|Lost to Follow-up|12|||
147297396|NCT02291679|531252330|FG001|Overall Study|Lost to Follow-up|10|||
147297397|NCT02291679|531252331|FG002|Overall Study|Lost to Follow-up|9|||
147297398|NCT02291679|531252329|FG000|Overall Study|Insufficient Therapeutic Response|5|||
147297399|NCT02291679|531252330|FG001|Overall Study|Insufficient Therapeutic Response|5|||
147297400|NCT02291679|531252331|FG002|Overall Study|Insufficient Therapeutic Response|7|||
147297401|NCT02291679|531252329|FG000|Overall Study|Other|2|||
147297402|NCT02291679|531252330|FG001|Overall Study|Other|4|||
147297403|NCT02291679|531252331|FG002|Overall Study|Other|2|||
147297404|NCT02276222|531252332|FG000|Overall Study|Adverse Event|62|||
147297405|NCT02276222|531252333|FG001|Overall Study|Adverse Event|11|||
147297406|NCT02276222|531252332|FG000|Overall Study|Death|3|||
147297407|NCT02276222|531252333|FG001|Overall Study|Death|4|||
147297408|NCT02276222|531252332|FG000|Overall Study|Lack of Efficacy|13|||
147297409|NCT02276222|531252333|FG001|Overall Study|Lack of Efficacy|3|||
147297410|NCT02276222|531252332|FG000|Overall Study|Protocol Violation|3|||
147297411|NCT02276222|531252333|FG001|Overall Study|Protocol Violation|2|||
147297412|NCT02276222|531252332|FG000|Overall Study|Withdrawal by Subject|79|||
147297413|NCT02276222|531252333|FG001|Overall Study|Withdrawal by Subject|33|||
147297414|NCT02276222|531252332|FG000|Overall Study|non compliance with study medication|6|||
147297415|NCT02276222|531252333|FG001|Overall Study|non compliance with study medication|2|||
147297416|NCT02276222|531252332|FG000|Overall Study|sponsor decision|0|||
147297417|NCT02276222|531252333|FG001|Overall Study|sponsor decision|3|||
147297418|NCT02276222|531252332|FG000|Overall Study|Lost to Follow-up|15|||
147297419|NCT02276222|531252333|FG001|Overall Study|Lost to Follow-up|5|||
147297420|NCT02276222|531252332|FG000|Overall Study|Physician Decision|2|||
147297421|NCT02276222|531252333|FG001|Overall Study|Physician Decision|1|||
147297422|NCT02276222|531252332|FG000|Overall Study|sheduling conflict|1|||
147297423|NCT02276222|531252333|FG001|Overall Study|sheduling conflict|0|||
147297424|NCT02276222|531252332|FG000|Overall Study|subject withdrew after randomization|1|||
147297425|NCT02276222|531252333|FG001|Overall Study|subject withdrew after randomization|0|||
147297426|NCT02170025|531252334|FG000|Overall Study|Adverse Event|2|||
147297427|NCT02170025|531252335|FG001|Overall Study|Adverse Event|0|||
147297428|NCT02543658|531253893|FG000|Overall Study|Lack of Efficacy|0|||
147297429|NCT02543658|531253894|FG001|Overall Study|Lack of Efficacy|4|||
147297430|NCT00437645|531253901|FG000|Overall Study|Adverse Event|15|||
147297431|NCT00437645|531253902|FG001|Overall Study|Adverse Event|84|||
147297432|NCT00437645|531253901|FG000|Overall Study|Withdrawal by Subject|10|||
147452948|NCT04418765|531821486|FG001|Extension Period (48 Weeks)|Adverse Event|2|||
147297433|NCT00437645|531253902|FG001|Overall Study|Withdrawal by Subject|22|||
147297434|NCT00437645|531253901|FG000|Overall Study|Protocol Violation|3|||
147297435|NCT00437645|531253902|FG001|Overall Study|Protocol Violation|3|||
147297436|NCT00437645|531253901|FG000|Overall Study|Lost to Follow-up|2|||
147297437|NCT00437645|531253902|FG001|Overall Study|Lost to Follow-up|3|||
147297438|NCT00437645|531253901|FG000|Overall Study|Administrative problems|2|||
147297439|NCT00437645|531253902|FG001|Overall Study|Administrative problems|1|||
147297440|NCT00437645|531253901|FG000|Overall Study|Lack of Efficacy|2|||
147297441|NCT00437645|531253902|FG001|Overall Study|Lack of Efficacy|1|||
147297442|NCT00437645|531253901|FG000|Overall Study|Condition no longer requires study drug|1|||
147297443|NCT00437645|531253902|FG001|Overall Study|Condition no longer requires study drug|1|||
147297444|NCT03966053|531253903|FG000|Overall Study|Withdrawal by subject prior to starting study drug.|1|||
147297445|NCT04586569|531253904|FG000|Overall Study|Withdrawal by Subject|0|||
147297446|NCT04586569|531253905|FG001|Overall Study|Withdrawal by Subject|2|||
147297447|NCT04586569|531253904|FG000|Overall Study|No longer eligible|2|||
147297448|NCT04586569|531253905|FG001|Overall Study|No longer eligible|3|||
147297449|NCT04586569|531253904|FG000|Overall Study|Physician Decision|1|||
147297450|NCT04586569|531253905|FG001|Overall Study|Physician Decision|0|||
147297451|NCT02127372|531253907|FG000|Overall Study|Withdrawal by Subject|1|||
147297452|NCT02127372|531253908|FG001|Overall Study|Withdrawal by Subject|0|||
147297453|NCT03548207|531253909|FG000|Overall Study|Death|10|||
147297454|NCT03548207|531253910|FG001|Overall Study|Death|23|||
147297455|NCT03548207|531253911|FG002|Overall Study|Death|3|||
147297456|NCT03548207|531253909|FG000|Overall Study|Lost to Follow-up|0|||
147297457|NCT03548207|531253910|FG001|Overall Study|Lost to Follow-up|2|||
147297458|NCT03548207|531253911|FG002|Overall Study|Lost to Follow-up|0|||
147297459|NCT03548207|531253909|FG000|Overall Study|Withdrawal by Subject|0|||
147297460|NCT03548207|531253910|FG001|Overall Study|Withdrawal by Subject|3|||
147297461|NCT03548207|531253911|FG002|Overall Study|Withdrawal by Subject|0|||
147297462|NCT03548207|531253909|FG000|Overall Study|Sponsor decision|19|||
147297463|NCT03548207|531253910|FG001|Overall Study|Sponsor decision|40|||
147297464|NCT03548207|531253911|FG002|Overall Study|Sponsor decision|6|||
147297465|NCT03548207|531253909|FG000|Overall Study|Randomized but not treated|6|||
147297466|NCT03548207|531253910|FG001|Overall Study|Randomized but not treated|10|||
147297467|NCT03548207|531253911|FG002|Overall Study|Randomized but not treated|4|||
147297468|NCT01756352|531253912|FG000|Overall Study|moved away and lost to followup|1|||
147297469|NCT00415610|531253913|FG000|Overall Study|Death|3|||
147297470|NCT00415610|531253914|FG001|Overall Study|Death|2|||
147297471|NCT00415610|531253915|FG002|Overall Study|Death|5|||
147297472|NCT00337272|531253916|FG000|Screening Period (Pre-randomization)|Withdrawal by Subject|2|||
147297473|NCT00337272|531253917|FG001|Screening Period (Pre-randomization)|Withdrawal by Subject|0|||
147297474|NCT00337272|531253916|FG000|Screening Period (Pre-randomization)|Non-compliance|1|||
147297475|NCT00337272|531253917|FG001|Screening Period (Pre-randomization)|Non-compliance|0|||
147297476|NCT00337272|531253916|FG000|Screening Period (Pre-randomization)|Screen failure|3|||
147297477|NCT00337272|531253917|FG001|Screening Period (Pre-randomization)|Screen failure|0|||
147297478|NCT00337272|531253916|FG000|Treatment Period|Non-compliance|1|||
147297479|NCT00337272|531253917|FG001|Treatment Period|Non-compliance|1|||
147297480|NCT00337272|531253916|FG000|Treatment Period|Withdrawal by Subject|0|||
147297481|NCT00337272|531253917|FG001|Treatment Period|Withdrawal by Subject|1|||
147297482|NCT00337272|531253916|FG000|Withdrawal Period|Non-compliance|0|||
147297483|NCT00337272|531253917|FG001|Withdrawal Period|Non-compliance|1|||
147297484|NCT04539821|531253921|FG000|Overall Study|Withdrawal by Subject|2|||
147297485|NCT04539821|531253921|FG000|Overall Study|continued care with their physician|20|||
147297486|NCT04539821|531253921|FG000|Overall Study|treatment needs outside scope of VCPM|3|||
147297487|NCT04493931|531253924|FG000|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|1|||
147297488|NCT04493931|531253925|FG001|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
147297489|NCT04493931|531253926|FG002|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
147297490|NCT04493931|531253927|FG003|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
147297491|NCT04493931|531253928|FG004|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
147297492|NCT04493931|531253929|FG005|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
147297493|NCT04493931|531253930|FG006|Cohort1:Treatment Period 1(Up to 3 Days)|Adverse Event|0|||
147297494|NCT04493931|531253924|FG000|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
147297495|NCT04493931|531253925|FG001|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|2|||
147297496|NCT04493931|531253926|FG002|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
147297497|NCT04493931|531253927|FG003|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
147297498|NCT04493931|531253928|FG004|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
147297499|NCT04493931|531253929|FG005|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
147297500|NCT04493931|531253930|FG006|Cohort2:Treatment Period2(Up to 10 Days)|Physician Decision|0|||
147297501|NCT04493931|531253924|FG000|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
147297502|NCT04493931|531253925|FG001|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|1|||
147297503|NCT04493931|531253926|FG002|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
147297504|NCT04493931|531253927|FG003|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
147297505|NCT04493931|531253928|FG004|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
147297506|NCT04493931|531253929|FG005|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
147297507|NCT04493931|531253930|FG006|Cohort2:Treatment Period2(Up to 10 Days)|Withdrawal by Subject|0|||
147297508|NCT04493931|531253924|FG000|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
147297509|NCT04493931|531253925|FG001|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
147297510|NCT04493931|531253926|FG002|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|1|||
147339504|NCT04425629|531412114|FG012|Overall Study|Lack of Efficacy|0|||
147339505|NCT04425629|531412115|FG013|Overall Study|Lack of Efficacy|0|||
147339506|NCT04425629|531412116|FG014|Overall Study|Lack of Efficacy|0|||
147339507|NCT04425629|531412117|FG015|Overall Study|Lack of Efficacy|0|||
147339508|NCT04425629|531412118|FG016|Overall Study|Lack of Efficacy|0|||
147339509|NCT04425629|531412119|FG017|Overall Study|Lack of Efficacy|0|||
147297511|NCT04493931|531253927|FG003|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
147297512|NCT04493931|531253928|FG004|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
147297513|NCT04493931|531253929|FG005|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
147297514|NCT04493931|531253930|FG006|Cohort3:Treatment Period 1(Up to 5 Days)|Protocol Violation|0|||
147297515|NCT03338894|531253931|FG000|Overall Study|Withdrew, or not able to attend 9 or more classes, or did not complete final survey.|22|||
147297516|NCT00266825|531253938|FG000|Completed Follow-Up|Lost to Follow-up|14|||
147297517|NCT00266825|531253939|FG001|Completed Follow-Up|Lost to Follow-up|19|||
147297518|NCT00266825|531253938|FG000|Completed Follow-Up|Withdrawal by Subject|11|||
147297519|NCT00266825|531253939|FG001|Completed Follow-Up|Withdrawal by Subject|5|||
147297520|NCT00430248|531253940|FG000|Overall Study|Adverse Event|49|||
147297521|NCT00430248|531253941|FG001|Overall Study|Adverse Event|61|||
147297522|NCT00430248|531253942|FG002|Overall Study|Adverse Event|64|||
147297523|NCT00430248|531253940|FG000|Overall Study|Protocol Violation|10|||
147297524|NCT00430248|531253941|FG001|Overall Study|Protocol Violation|2|||
147297525|NCT00430248|531253942|FG002|Overall Study|Protocol Violation|4|||
147297526|NCT00430248|531253940|FG000|Overall Study|Personal Reasons|12|||
147297527|NCT00430248|531253941|FG001|Overall Study|Personal Reasons|24|||
147297528|NCT00430248|531253942|FG002|Overall Study|Personal Reasons|9|||
147297529|NCT00430248|531253940|FG000|Overall Study|Lost to Follow-up|28|||
147297530|NCT00430248|531253941|FG001|Overall Study|Lost to Follow-up|33|||
147297531|NCT00430248|531253942|FG002|Overall Study|Lost to Follow-up|28|||
147297532|NCT00430248|531253940|FG000|Overall Study|Therapeutic Failure|1|||
147297533|NCT00430248|531253941|FG001|Overall Study|Therapeutic Failure|1|||
147297534|NCT00430248|531253942|FG002|Overall Study|Therapeutic Failure|1|||
147297535|NCT00430248|531253940|FG000|Overall Study|Withdrawal by Subject|14|||
147297536|NCT00430248|531253941|FG001|Overall Study|Withdrawal by Subject|20|||
147297537|NCT00430248|531253942|FG002|Overall Study|Withdrawal by Subject|16|||
147297538|NCT00430248|531253940|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
147297539|NCT00430248|531253941|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|2|||
147297540|NCT00430248|531253942|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
147297541|NCT00430248|531253940|FG000|Overall Study|Gout Flare|3|||
147297542|NCT00430248|531253941|FG001|Overall Study|Gout Flare|7|||
147297543|NCT00430248|531253942|FG002|Overall Study|Gout Flare|2|||
147297544|NCT00430248|531253940|FG000|Overall Study|Reason Not Specified|8|||
147297545|NCT00430248|531253941|FG001|Overall Study|Reason Not Specified|8|||
147297546|NCT00430248|531253942|FG002|Overall Study|Reason Not Specified|11|||
147339510|NCT04425629|531412120|FG018|Overall Study|Lack of Efficacy|0|||
147339511|NCT00232180|531412121|FG000|Double-blind (DB) Phase|Death|186|||
147339512|NCT00232180|531412122|FG001|Double-blind (DB) Phase|Death|222|||
147339513|NCT00232180|531412123|FG002|Double-blind (DB) Phase|Death|0|||
147339514|NCT00232180|531412121|FG000|Double-blind (DB) Phase|Lost to Follow-up|34|||
147339515|NCT00232180|531412122|FG001|Double-blind (DB) Phase|Lost to Follow-up|28|||
147339516|NCT00232180|531412123|FG002|Double-blind (DB) Phase|Lost to Follow-up|0|||
147339517|NCT00232180|531412121|FG000|Double-blind (DB) Phase|Withdrawal by Subject|131|||
147339518|NCT00232180|531412122|FG001|Double-blind (DB) Phase|Withdrawal by Subject|148|||
147339519|NCT00232180|531412123|FG002|Double-blind (DB) Phase|Withdrawal by Subject|0|||
147339520|NCT00232180|531412121|FG000|Double-blind (DB) Phase|Protocol Violation|28|||
147339521|NCT00232180|531412122|FG001|Double-blind (DB) Phase|Protocol Violation|21|||
147339522|NCT00232180|531412123|FG002|Double-blind (DB) Phase|Protocol Violation|0|||
147339523|NCT00232180|531412121|FG000|Double-blind (DB) Phase|Adverse Event|83|||
147339524|NCT00232180|531412122|FG001|Double-blind (DB) Phase|Adverse Event|100|||
147339525|NCT00232180|531412123|FG002|Double-blind (DB) Phase|Adverse Event|0|||
147339526|NCT00232180|531412121|FG000|Double-blind (DB) Phase|Other|70|||
147452949|NCT04418765|531821487|FG002|Extension Period (48 Weeks)|Adverse Event|9|||
147452950|NCT04418765|531821485|FG000|Extension Period (48 Weeks)|Lack of Efficacy|0|||
147606275|NCT01371747|532375197|FG003|Overall Study|Low Serum Potassium Results|1|||
147606276|NCT01371747|532375198|FG004|Overall Study|Low Serum Potassium Results|0|||
147297547|NCT01127646|531253943|FG000|Overall Study|Entry Criteria Not Met|1|||
147297548|NCT01127646|531253944|FG001|Overall Study|Entry Criteria Not Met|0|||
147297549|NCT01127646|531253943|FG000|Overall Study|Protocol Violation|0|||
147297550|NCT01127646|531253944|FG001|Overall Study|Protocol Violation|1|||
147297551|NCT03466086|531253945|FG000|Period 1|Sponsor decision due to study timeline|1|||
147297552|NCT03466086|531253946|FG001|Period 1|Sponsor decision due to study timeline|0|||
147297553|NCT03466086|531253945|FG000|Period 1|Withdrawal by Subject|1|||
147339527|NCT00232180|531412122|FG001|Double-blind (DB) Phase|Other|75|||
147339528|NCT00232180|531412123|FG002|Double-blind (DB) Phase|Other|0|||
147339529|NCT00232180|531412121|FG000|Double-blind (DB) Phase|Randomized but not treated|3|||
147339530|NCT00232180|531412122|FG001|Double-blind (DB) Phase|Randomized but not treated|4|||
147339531|NCT00232180|531412123|FG002|Double-blind (DB) Phase|Randomized but not treated|0|||
147339532|NCT00232180|531412121|FG000|Double-blind (DB) Phase|Laboratory abnormality|6|||
147606277|NCT01371747|532375199|FG005|Overall Study|Low Serum Potassium Results|3|||
147606278|NCT01371747|532375194|FG000|Overall Study|Protocol Violation|0|||
147606279|NCT01371747|532375195|FG001|Overall Study|Protocol Violation|0|||
147606280|NCT01371747|532375196|FG002|Overall Study|Protocol Violation|1|||
147297554|NCT03466086|531253946|FG001|Period 1|Withdrawal by Subject|0|||
147297555|NCT01754467|531253947|FG000|Overall Study|Lost to Follow-up|1|||
147297556|NCT01970462|531253948|FG000|Overall Study|Lost to Follow-up|0|||
147297557|NCT01970462|531253949|FG001|Overall Study|Lost to Follow-up|2|||
147297558|NCT05763628|531253952|FG000|Period 1: First Intervention, 2 Weeks|Protocol Violation|0|||
147297559|NCT05763628|531253953|FG001|Period 1: First Intervention, 2 Weeks|Protocol Violation|1|||
147297560|NCT05763628|531253952|FG000|Period 1: First Intervention, 2 Weeks|Withdrawal by Subject|0|||
147297561|NCT05763628|531253953|FG001|Period 1: First Intervention, 2 Weeks|Withdrawal by Subject|1|||
147297562|NCT05763628|531253952|FG000|Period 2: Second Intervention, 2 Weeks|Protocol Violation|1|||
147297563|NCT05763628|531253953|FG001|Period 2: Second Intervention, 2 Weeks|Protocol Violation|0|||
147297564|NCT04721925|531253955|FG000|2-Month Assessment|Lost to Follow-up|5|||
147297565|NCT04721925|531253956|FG001|2-Month Assessment|Lost to Follow-up|3|||
147297566|NCT04721925|531253955|FG000|4-Month Assessment|Lost to Follow-up|3|||
147297567|NCT04721925|531253956|FG001|4-Month Assessment|Lost to Follow-up|6|||
147297568|NCT03002610|531253957|FG000|Overall Study|Withdrawal by Subject|6|||
147297569|NCT03002610|531253958|FG001|Overall Study|Withdrawal by Subject|25|||
147297570|NCT03002610|531253959|FG002|Overall Study|Withdrawal by Subject|13|||
147297571|NCT03802123|531253960|FG000|Overall Study|Withdrawal by Subject|3|||
147297572|NCT03802123|531253960|FG000|Overall Study|Physician Decision|1|||
147297573|NCT03802123|531253960|FG000|Overall Study|Subject moved to hospice care|1|||
147297574|NCT03802123|531253960|FG000|Overall Study|technician error|1|||
147297575|NCT03802123|531253960|FG000|Overall Study|Death|3|||
147297576|NCT00658567|531253961|FG000|Overall Study|Adverse Event|5|||
147297577|NCT00658567|531253962|FG001|Overall Study|Adverse Event|2|||
147297578|NCT00658567|531253963|FG002|Overall Study|Adverse Event|3|||
147297579|NCT00658567|531253961|FG000|Overall Study|Voluntary Withdrawal of Consent|2|||
147297580|NCT00658567|531253962|FG001|Overall Study|Voluntary Withdrawal of Consent|0|||
147297581|NCT00658567|531253963|FG002|Overall Study|Voluntary Withdrawal of Consent|2|||
147297582|NCT00658567|531253961|FG000|Overall Study|Physician Decision|0|||
147297583|NCT00658567|531253962|FG001|Overall Study|Physician Decision|1|||
147297584|NCT00658567|531253963|FG002|Overall Study|Physician Decision|0|||
147297585|NCT00658567|531253961|FG000|Overall Study|At Discretion of Sponsor|1|||
147297586|NCT00658567|531253962|FG001|Overall Study|At Discretion of Sponsor|1|||
147297587|NCT00658567|531253963|FG002|Overall Study|At Discretion of Sponsor|1|||
147297588|NCT04860518|531253964|FG000|Overall Study|Screen Failure, patient was not dosed|1|||
147606281|NCT01371747|532375197|FG003|Overall Study|Protocol Violation|0|||
147297589|NCT04860518|531253965|FG001|Overall Study|Screen Failure, patient was not dosed|1|||
147297590|NCT06134180|531253968|FG000|Overall Study|Lost to Follow-up|4|||
147297591|NCT01936857|531253969|FG000|Overall Study|Sent to prison or 06 center|11|||
147297592|NCT01936857|531253970|FG001|Overall Study|Sent to prison or 06 center|12|||
147297593|NCT01936857|531253969|FG000|Overall Study|Lost to Follow-up|10|||
147297594|NCT01936857|531253970|FG001|Overall Study|Lost to Follow-up|7|||
147297595|NCT01936857|531253969|FG000|Overall Study|Death|7|||
147297596|NCT01936857|531253970|FG001|Overall Study|Death|3|||
147297597|NCT01936857|531253969|FG000|Overall Study|Moved|2|||
147297598|NCT01936857|531253970|FG001|Overall Study|Moved|1|||
147297599|NCT01936857|531253969|FG000|Overall Study|Withdrawal by Subject|1|||
147297600|NCT01936857|531253970|FG001|Overall Study|Withdrawal by Subject|0|||
147297601|NCT01936857|531253969|FG000|Overall Study|Side effect of medication|1|||
147297602|NCT01936857|531253970|FG001|Overall Study|Side effect of medication|0|||
147297603|NCT01936857|531253969|FG000|Overall Study|Other|2|||
147297604|NCT01936857|531253970|FG001|Overall Study|Other|2|||
147297605|NCT02279043|531253971|FG000|Overall Study|Post-rand. exclusion - not eligible|1|||
147297606|NCT02279043|531253972|FG001|Overall Study|Post-rand. exclusion - not eligible|1|||
147297607|NCT02279043|531253973|FG002|Overall Study|Post-rand. exclusion - not eligible|0|||
147297608|NCT02279043|531253971|FG000|Overall Study|Lost to Follow-up|46|||
147297609|NCT02279043|531253972|FG001|Overall Study|Lost to Follow-up|88|||
147297610|NCT02279043|531253973|FG002|Overall Study|Lost to Follow-up|0|||
147297611|NCT01939548|531253974|FG000|Overall Study|Non compliance|0|||
147297612|NCT01939548|531253975|FG001|Overall Study|Non compliance|2|||
147297613|NCT01939548|531253976|FG002|Overall Study|Non compliance|0|||
147297614|NCT01939548|531253974|FG000|Overall Study|Study Terminated by Sponsor|17|||
147297615|NCT01939548|531253975|FG001|Overall Study|Study Terminated by Sponsor|19|||
147297616|NCT01939548|531253976|FG002|Overall Study|Study Terminated by Sponsor|12|||
147297617|NCT01939548|531253974|FG000|Overall Study|Insufficient Clinical Response|1|||
147297618|NCT01939548|531253975|FG001|Overall Study|Insufficient Clinical Response|0|||
147297619|NCT01939548|531253976|FG002|Overall Study|Insufficient Clinical Response|0|||
147297620|NCT01939548|531253974|FG000|Overall Study|Did Not Meet Entrance Criteria|1|||
147297621|NCT01939548|531253975|FG001|Overall Study|Did Not Meet Entrance Criteria|0|||
147297622|NCT01939548|531253976|FG002|Overall Study|Did Not Meet Entrance Criteria|0|||
147606282|NCT01371747|532375198|FG004|Overall Study|Protocol Violation|0|||
147606283|NCT01371747|532375199|FG005|Overall Study|Protocol Violation|0|||
147297623|NCT01939548|531253974|FG000|Overall Study|Withdrawal by Subject|4|||
147297624|NCT01939548|531253975|FG001|Overall Study|Withdrawal by Subject|4|||
147297625|NCT01939548|531253976|FG002|Overall Study|Withdrawal by Subject|1|||
147297626|NCT01939548|531253974|FG000|Overall Study|Protocol Violation|7|||
147339533|NCT00232180|531412122|FG001|Double-blind (DB) Phase|Laboratory abnormality|7|||
147339534|NCT00232180|531412123|FG002|Double-blind (DB) Phase|Laboratory abnormality|0|||
147339535|NCT00232180|531412121|FG000|Open Label Phase|Death|0|||
147339536|NCT00232180|531412122|FG001|Open Label Phase|Death|0|||
147339537|NCT00232180|531412123|FG002|Open Label Phase|Death|48|||
147339538|NCT00232180|531412121|FG000|Open Label Phase|Lost to Follow-up|0|||
147339539|NCT00232180|531412122|FG001|Open Label Phase|Lost to Follow-up|0|||
147339540|NCT00232180|531412123|FG002|Open Label Phase|Lost to Follow-up|5|||
147452951|NCT04418765|531821486|FG001|Extension Period (48 Weeks)|Lack of Efficacy|13|||
147452952|NCT04418765|531821487|FG002|Extension Period (48 Weeks)|Lack of Efficacy|13|||
147452953|NCT04418765|531821485|FG000|Extension Period (48 Weeks)|Withdrawal by Subject|0|||
147452954|NCT04418765|531821486|FG001|Extension Period (48 Weeks)|Withdrawal by Subject|21|||
147452955|NCT04418765|531821487|FG002|Extension Period (48 Weeks)|Withdrawal by Subject|14|||
147452956|NCT04418765|531821485|FG000|Extension Period (48 Weeks)|Non-compliance with study drug|0|||
147452957|NCT04418765|531821486|FG001|Extension Period (48 Weeks)|Non-compliance with study drug|0|||
147452958|NCT04418765|531821487|FG002|Extension Period (48 Weeks)|Non-compliance with study drug|2|||
147452959|NCT04418765|531821485|FG000|Extension Period (48 Weeks)|Protocol Violation|0|||
147452960|NCT04418765|531821486|FG001|Extension Period (48 Weeks)|Protocol Violation|0|||
147452961|NCT04418765|531821487|FG002|Extension Period (48 Weeks)|Protocol Violation|2|||
147452962|NCT04418765|531821485|FG000|Extension Period (48 Weeks)|Other than specified|0|||
147452963|NCT04418765|531821486|FG001|Extension Period (48 Weeks)|Other than specified|5|||
147452964|NCT04418765|531821487|FG002|Extension Period (48 Weeks)|Other than specified|2|||
147452965|NCT03345472|531821488|FG000|Implant to 3 Months|Withdrawal by Subject|2|||
147452966|NCT03345472|531821488|FG000|Implant to 3 Months|Physician Decision|1|||
147452967|NCT03345472|531821488|FG000|Implant to 3 Months|Adverse Event|1|||
147452968|NCT03345472|531821488|FG000|3 Months to 12 Months|Physician Decision|3|||
147452969|NCT03345472|531821488|FG000|3 Months to 12 Months|Lost to Follow-up|2|||
147452970|NCT03345472|531821488|FG000|3 Months to 12 Months|Withdrawal by Subject|1|||
147452971|NCT03345472|531821488|FG000|3 Months to 12 Months|Adverse Event|1|||
147452972|NCT03345472|531821488|FG000|3 Months to 12 Months|Death|1|||
147452973|NCT01926782|531821489|FG000|Overall Study|Participant moved|2|||
147452974|NCT01926782|531821490|FG001|Overall Study|Participant moved|0|||
147452975|NCT01926782|531821491|FG002|Overall Study|Participant moved|1|||
147452976|NCT01926782|531821492|FG003|Overall Study|Participant moved|1|||
147452977|NCT01926782|531821493|FG004|Overall Study|Participant moved|0|||
147452978|NCT01926782|531821494|FG005|Overall Study|Participant moved|3|||
147297627|NCT01939548|531253975|FG001|Overall Study|Protocol Violation|6|||
147297628|NCT01939548|531253976|FG002|Overall Study|Protocol Violation|5|||
147297629|NCT01939548|531253974|FG000|Overall Study|Lost to Follow-up|5|||
147297630|NCT01939548|531253975|FG001|Overall Study|Lost to Follow-up|5|||
147297631|NCT01939548|531253976|FG002|Overall Study|Lost to Follow-up|3|||
147297632|NCT01939548|531253974|FG000|Overall Study|Adverse Event|2|||
147297633|NCT01939548|531253975|FG001|Overall Study|Adverse Event|9|||
147297634|NCT01939548|531253976|FG002|Overall Study|Adverse Event|7|||
147297635|NCT01939548|531253974|FG000|Overall Study|Death|0|||
147297636|NCT01939548|531253975|FG001|Overall Study|Death|0|||
147297637|NCT01939548|531253976|FG002|Overall Study|Death|1|||
147297638|NCT01939548|531253974|FG000|Overall Study|Participant dropped|0|||
147297639|NCT01939548|531253975|FG001|Overall Study|Participant dropped|0|||
147297640|NCT01939548|531253976|FG002|Overall Study|Participant dropped|1|||
147297641|NCT01939548|531253974|FG000|Overall Study|Participant unwilling to continue|0|||
147297642|NCT01939548|531253975|FG001|Overall Study|Participant unwilling to continue|1|||
147297643|NCT01939548|531253976|FG002|Overall Study|Participant unwilling to continue|0|||
147339541|NCT00232180|531412121|FG000|Open Label Phase|Protocol Violation|0|||
147452979|NCT01926782|531821489|FG000|Overall Study|Physician Decision|0|||
147452980|NCT01926782|531821490|FG001|Overall Study|Physician Decision|2|||
147452981|NCT01926782|531821491|FG002|Overall Study|Physician Decision|1|||
147339542|NCT00232180|531412122|FG001|Open Label Phase|Protocol Violation|0|||
147452982|NCT01926782|531821492|FG003|Overall Study|Physician Decision|1|||
147452983|NCT01926782|531821493|FG004|Overall Study|Physician Decision|0|||
147452984|NCT01926782|531821494|FG005|Overall Study|Physician Decision|0|||
147297644|NCT01939548|531253974|FG000|Overall Study|Participant withdrew consent|0|||
147297645|NCT01939548|531253975|FG001|Overall Study|Participant withdrew consent|2|||
147297646|NCT01939548|531253976|FG002|Overall Study|Participant withdrew consent|0|||
147297647|NCT01939548|531253974|FG000|Overall Study|Did not complete follow-up|0|||
147297648|NCT01939548|531253975|FG001|Overall Study|Did not complete follow-up|1|||
147297649|NCT01939548|531253976|FG002|Overall Study|Did not complete follow-up|0|||
147452985|NCT01926782|531821489|FG000|Overall Study|Other than specified|2|||
147452986|NCT01926782|531821490|FG001|Overall Study|Other than specified|3|||
147297650|NCT00490282|531253977|FG000|Overall Study|Withdrawal by Subject|3|||
147339543|NCT00232180|531412123|FG002|Open Label Phase|Protocol Violation|3|||
147339544|NCT00232180|531412121|FG000|Open Label Phase|Study terminated by sponsor|0|||
147606284|NCT01371747|532375194|FG000|Overall Study|Non-Compliance|3|||
147606285|NCT01371747|532375195|FG001|Overall Study|Non-Compliance|4|||
147606286|NCT01371747|532375196|FG002|Overall Study|Non-Compliance|3|||
147606287|NCT01371747|532375197|FG003|Overall Study|Non-Compliance|0|||
147606288|NCT01371747|532375198|FG004|Overall Study|Non-Compliance|0|||
147297651|NCT01494584|531253982|FG000|Overall Study|Study Closed/Terminated|1|||
147297652|NCT01499082|531253983|FG000|Overall Study|Randomized but not Treated|0|||
147297653|NCT01499082|531253984|FG001|Overall Study|Randomized but not Treated|1|||
147297654|NCT01499082|531253983|FG000|Overall Study|Adverse Event|12|||
147297655|NCT01499082|531253984|FG001|Overall Study|Adverse Event|16|||
147297656|NCT01499082|531253983|FG000|Overall Study|Lack of Efficacy|1|||
147297657|NCT01499082|531253984|FG001|Overall Study|Lack of Efficacy|1|||
147297658|NCT01499082|531253983|FG000|Overall Study|Protocol Violation|6|||
147297659|NCT01499082|531253984|FG001|Overall Study|Protocol Violation|8|||
147297660|NCT01499082|531253983|FG000|Overall Study|Diverse Reasons|18|||
147297661|NCT01499082|531253984|FG001|Overall Study|Diverse Reasons|14|||
147297662|NCT01499082|531253983|FG000|Overall Study|Site Closure for Noncompliance|5|||
147297663|NCT01499082|531253984|FG001|Overall Study|Site Closure for Noncompliance|2|||
147297664|NCT01499082|531253983|FG000|Overall Study|Hypoglycemia|2|||
147297665|NCT01499082|531253984|FG001|Overall Study|Hypoglycemia|3|||
147297666|NCT01499082|531253983|FG000|Overall Study|Lost to Follow-up|1|||
147297667|NCT01499082|531253984|FG001|Overall Study|Lost to Follow-up|3|||
147297668|NCT05380947|531253990|FG000|Washout Period 1|Not attend visit|1|||
147297669|NCT05380947|531253991|FG001|Washout Period 1|Not attend visit|0|||
147297670|NCT05380947|531253992|FG002|Washout Period 1|Not attend visit|0|||
147297671|NCT05380947|531253993|FG003|Washout Period 1|Not attend visit|0|||
147297672|NCT05380947|531253990|FG000|Washout Period 2|Adverse Event|1|||
147297673|NCT05380947|531253991|FG001|Washout Period 2|Adverse Event|0|||
147297674|NCT05380947|531253992|FG002|Washout Period 2|Adverse Event|0|||
147297675|NCT05380947|531253993|FG003|Washout Period 2|Adverse Event|0|||
147297676|NCT05380947|531253990|FG000|Washout Period 3|Adverse Event|0|||
147297677|NCT05380947|531253991|FG001|Washout Period 3|Adverse Event|1|||
147297678|NCT05380947|531253992|FG002|Washout Period 3|Adverse Event|0|||
147297679|NCT05380947|531253993|FG003|Washout Period 3|Adverse Event|0|||
147297680|NCT05380947|531253990|FG000|Washout Period 3|Not attend visit|0|||
147297681|NCT05380947|531253991|FG001|Washout Period 3|Not attend visit|1|||
147297682|NCT05380947|531253992|FG002|Washout Period 3|Not attend visit|0|||
147297683|NCT05380947|531253993|FG003|Washout Period 3|Not attend visit|1|||
147297684|NCT01256567|531253995|FG000|Overall Study|Withdrawal by Subject|1|||
147297685|NCT02453685|531254008|FG000|Overall Study|Adverse Event|0|||
147297686|NCT02453685|531254009|FG001|Overall Study|Adverse Event|1|||
147297687|NCT02453685|531254008|FG000|Overall Study|Protocol Violation|7|||
147297688|NCT02453685|531254009|FG001|Overall Study|Protocol Violation|4|||
147297689|NCT02453685|531254008|FG000|Overall Study|Lost to Follow-up|0|||
147297690|NCT02453685|531254009|FG001|Overall Study|Lost to Follow-up|1|||
147297691|NCT02453685|531254008|FG000|Overall Study|Withdrawal by Subject|8|||
147297692|NCT02453685|531254009|FG001|Overall Study|Withdrawal by Subject|4|||
147297693|NCT02453685|531254008|FG000|Overall Study|Unclassified|4|||
147297694|NCT02453685|531254009|FG001|Overall Study|Unclassified|2|||
147297695|NCT00522626|531254014|FG000|Overall Study|Lost to Follow-up|7|||
147297696|NCT01169675|531254017|FG000|Overall Study|Progressive disease|13|||
147297697|NCT01169675|531254018|FG001|Overall Study|Progressive disease|2|||
147297698|NCT01169675|531254019|FG002|Overall Study|Progressive disease|5|||
147297699|NCT01169675|531254020|FG003|Overall Study|Progressive disease|15|||
147297700|NCT01169675|531254021|FG004|Overall Study|Progressive disease|1|||
147297701|NCT01169675|531254017|FG000|Overall Study|Dose Limiting Toxicity (DLT)|1|||
147297702|NCT01169675|531254018|FG001|Overall Study|Dose Limiting Toxicity (DLT)|0|||
147297703|NCT01169675|531254019|FG002|Overall Study|Dose Limiting Toxicity (DLT)|0|||
147297704|NCT01169675|531254020|FG003|Overall Study|Dose Limiting Toxicity (DLT)|0|||
147297705|NCT01169675|531254021|FG004|Overall Study|Dose Limiting Toxicity (DLT)|2|||
147297706|NCT01169675|531254017|FG000|Overall Study|Adverse Event|5|||
147297707|NCT01169675|531254018|FG001|Overall Study|Adverse Event|1|||
147452987|NCT01926782|531821491|FG002|Overall Study|Other than specified|5|||
147452988|NCT01926782|531821492|FG003|Overall Study|Other than specified|12|||
147606289|NCT01371747|532375199|FG005|Overall Study|Non-Compliance|1|||
147297708|NCT01169675|531254019|FG002|Overall Study|Adverse Event|2|||
147297709|NCT01169675|531254020|FG003|Overall Study|Adverse Event|0|||
147297710|NCT01169675|531254021|FG004|Overall Study|Adverse Event|0|||
147297711|NCT01169675|531254017|FG000|Overall Study|Withdrawal by Subject|1|||
147297712|NCT01169675|531254018|FG001|Overall Study|Withdrawal by Subject|0|||
147297713|NCT01169675|531254019|FG002|Overall Study|Withdrawal by Subject|0|||
147297714|NCT01169675|531254020|FG003|Overall Study|Withdrawal by Subject|1|||
147297715|NCT01169675|531254021|FG004|Overall Study|Withdrawal by Subject|2|||
147297716|NCT01169675|531254017|FG000|Overall Study|Other Reason Not Defined Above|0|||
147297717|NCT01169675|531254018|FG001|Overall Study|Other Reason Not Defined Above|0|||
147297718|NCT01169675|531254019|FG002|Overall Study|Other Reason Not Defined Above|0|||
147297719|NCT01169675|531254020|FG003|Overall Study|Other Reason Not Defined Above|1|||
147297720|NCT01169675|531254021|FG004|Overall Study|Other Reason Not Defined Above|1|||
147297721|NCT02816138|531254024|FG000|Overall Study|Adverse Event|1|||
147297722|NCT02355028|531254025|FG000|Overall Study|Adverse Event|2|||
147297723|NCT02355028|531254026|FG001|Overall Study|Adverse Event|0|||
147297724|NCT02355028|531254025|FG000|Overall Study|Withdrawal by Subject|1|||
147297725|NCT02355028|531254026|FG001|Overall Study|Withdrawal by Subject|1|||
147297726|NCT02355028|531254025|FG000|Overall Study|Deemed ineligible after randomization|8|||
147297727|NCT02355028|531254026|FG001|Overall Study|Deemed ineligible after randomization|4|||
147297728|NCT04102579|531254027|FG000|Overall Study|Withdrawal by Subject|3|||
147297729|NCT04102579|531254028|FG001|Overall Study|Withdrawal by Subject|4|||
147297730|NCT04102579|531254027|FG000|Overall Study|Lost to Follow-up|0|||
147297731|NCT04102579|531254028|FG001|Overall Study|Lost to Follow-up|1|||
147297732|NCT04102579|531254027|FG000|Overall Study|Discontinued Due to COVID-19-related Study Pause|3|||
147297733|NCT04102579|531254028|FG001|Overall Study|Discontinued Due to COVID-19-related Study Pause|4|||
147297734|NCT04102579|531254027|FG000|Overall Study|Other than Specified|1|||
147297735|NCT04102579|531254028|FG001|Overall Study|Other than Specified|0|||
147297736|NCT04102579|531254027|FG000|Overall Study|Not Dosed with Study Drug|0|||
147297737|NCT04102579|531254028|FG001|Overall Study|Not Dosed with Study Drug|1|||
147297738|NCT05899686|531254029|FG000|Overall Study|Protocol Violation|1|||
147297739|NCT00572195|531254030|FG000|Overall Study|Withdrawal by Subject|50|||
147297740|NCT00572195|531254030|FG000|Overall Study|Death|9|||
147297741|NCT00572195|531254030|FG000|Overall Study|Adverse Event|4|||
147297742|NCT00572195|531254030|FG000|Overall Study|Lost to Follow-up|5|||
147297743|NCT01525602|531254031|FG000|Overall Study|Adverse Event|1|||
147297744|NCT01525602|531254032|FG001|Overall Study|Adverse Event|0|||
147297745|NCT01525602|531254033|FG002|Overall Study|Adverse Event|1|||
147297746|NCT01525602|531254034|FG003|Overall Study|Adverse Event|1|||
147297747|NCT01525602|531254035|FG004|Overall Study|Adverse Event|3|||
147297748|NCT01525602|531254036|FG005|Overall Study|Adverse Event|3|||
147297749|NCT01525602|531254037|FG006|Overall Study|Adverse Event|0|||
147297750|NCT01525602|531254038|FG007|Overall Study|Adverse Event|1|||
147297751|NCT01525602|531254031|FG000|Overall Study|Disease progression|6|||
147297752|NCT01525602|531254032|FG001|Overall Study|Disease progression|3|||
147297753|NCT01525602|531254033|FG002|Overall Study|Disease progression|2|||
147297754|NCT01525602|531254034|FG003|Overall Study|Disease progression|5|||
147297755|NCT01525602|531254035|FG004|Overall Study|Disease progression|22|||
147297756|NCT01525602|531254036|FG005|Overall Study|Disease progression|2|||
147297757|NCT01525602|531254037|FG006|Overall Study|Disease progression|3|||
147297758|NCT01525602|531254038|FG007|Overall Study|Disease progression|3|||
147297759|NCT01525602|531254031|FG000|Overall Study|Clinical progression|2|||
147297760|NCT01525602|531254032|FG001|Overall Study|Clinical progression|0|||
147297761|NCT01525602|531254033|FG002|Overall Study|Clinical progression|0|||
147297762|NCT01525602|531254034|FG003|Overall Study|Clinical progression|0|||
147297763|NCT01525602|531254035|FG004|Overall Study|Clinical progression|0|||
147297764|NCT01525602|531254036|FG005|Overall Study|Clinical progression|0|||
147297765|NCT01525602|531254037|FG006|Overall Study|Clinical progression|1|||
147297766|NCT01525602|531254038|FG007|Overall Study|Clinical progression|1|||
147297767|NCT01525602|531254031|FG000|Overall Study|Non-compliance|0|||
147297768|NCT01525602|531254032|FG001|Overall Study|Non-compliance|0|||
147297769|NCT01525602|531254033|FG002|Overall Study|Non-compliance|0|||
147297770|NCT01525602|531254034|FG003|Overall Study|Non-compliance|0|||
147297771|NCT01525602|531254035|FG004|Overall Study|Non-compliance|1|||
147297772|NCT01525602|531254036|FG005|Overall Study|Non-compliance|0|||
147297773|NCT01525602|531254037|FG006|Overall Study|Non-compliance|0|||
147297774|NCT01525602|531254038|FG007|Overall Study|Non-compliance|0|||
147297775|NCT01525602|531254031|FG000|Overall Study|Withdrawal by Subject|0|||
147297776|NCT01525602|531254032|FG001|Overall Study|Withdrawal by Subject|0|||
147297777|NCT01525602|531254033|FG002|Overall Study|Withdrawal by Subject|0|||
147297778|NCT01525602|531254034|FG003|Overall Study|Withdrawal by Subject|0|||
147297779|NCT01525602|531254035|FG004|Overall Study|Withdrawal by Subject|3|||
147297780|NCT01525602|531254036|FG005|Overall Study|Withdrawal by Subject|1|||
147297781|NCT01525602|531254037|FG006|Overall Study|Withdrawal by Subject|0|||
147297782|NCT01525602|531254038|FG007|Overall Study|Withdrawal by Subject|1|||
147297783|NCT01525602|531254031|FG000|Overall Study|Physician Decision|0|||
147606290|NCT01371747|532375194|FG000|Overall Study|Physician Decision|0|||
147297784|NCT01525602|531254032|FG001|Overall Study|Physician Decision|0|||
147297785|NCT01525602|531254033|FG002|Overall Study|Physician Decision|0|||
147297786|NCT01525602|531254034|FG003|Overall Study|Physician Decision|0|||
147297787|NCT01525602|531254035|FG004|Overall Study|Physician Decision|3|||
147297788|NCT01525602|531254036|FG005|Overall Study|Physician Decision|0|||
147297789|NCT01525602|531254037|FG006|Overall Study|Physician Decision|1|||
147297790|NCT01525602|531254038|FG007|Overall Study|Physician Decision|0|||
147297791|NCT01525602|531254031|FG000|Overall Study|Death|0|||
147297792|NCT01525602|531254032|FG001|Overall Study|Death|0|||
147297793|NCT01525602|531254033|FG002|Overall Study|Death|0|||
147297794|NCT01525602|531254034|FG003|Overall Study|Death|0|||
147297795|NCT01525602|531254035|FG004|Overall Study|Death|1|||
147297796|NCT01525602|531254036|FG005|Overall Study|Death|1|||
147297797|NCT01525602|531254037|FG006|Overall Study|Death|0|||
147297798|NCT01525602|531254038|FG007|Overall Study|Death|0|||
147339545|NCT00232180|531412122|FG001|Open Label Phase|Study terminated by sponsor|0|||
147339546|NCT00232180|531412123|FG002|Open Label Phase|Study terminated by sponsor|3|||
147339547|NCT00232180|531412121|FG000|Open Label Phase|Withdrawal by Subject|0|||
147339548|NCT00232180|531412122|FG001|Open Label Phase|Withdrawal by Subject|0|||
147339549|NCT00232180|531412123|FG002|Open Label Phase|Withdrawal by Subject|37|||
147339550|NCT00232180|531412121|FG000|Open Label Phase|Other|0|||
147339551|NCT00232180|531412122|FG001|Open Label Phase|Other|0|||
147339552|NCT00232180|531412123|FG002|Open Label Phase|Other|16|||
147297799|NCT01525602|531254031|FG000|Overall Study|Unqualified based on biopsy; not dosed|0|||
147339553|NCT00232180|531412121|FG000|Open Label Phase|Adverse Event|0|||
147297800|NCT01525602|531254032|FG001|Overall Study|Unqualified based on biopsy; not dosed|0|||
147297801|NCT01525602|531254033|FG002|Overall Study|Unqualified based on biopsy; not dosed|0|||
147297802|NCT01525602|531254034|FG003|Overall Study|Unqualified based on biopsy; not dosed|0|||
147297803|NCT01525602|531254035|FG004|Overall Study|Unqualified based on biopsy; not dosed|0|||
147297804|NCT01525602|531254036|FG005|Overall Study|Unqualified based on biopsy; not dosed|0|||
147297805|NCT01525602|531254037|FG006|Overall Study|Unqualified based on biopsy; not dosed|1|||
147297806|NCT01525602|531254038|FG007|Overall Study|Unqualified based on biopsy; not dosed|1|||
147297807|NCT02532179|531255900|FG000|Overall Study|Lost to Follow-up|1|||
147297808|NCT02532179|531255900|FG000|Overall Study|Pregnancy|1|||
147297809|NCT02532179|531255900|FG000|Overall Study|Subject received depot steroid injection|1|||
147297810|NCT01337674|531255906|FG000|Treatment Period 1|Adverse Event|0|||
147297811|NCT01337674|531255907|FG001|Treatment Period 1|Adverse Event|1|||
147297812|NCT01337674|531255908|FG002|Treatment Period 1|Adverse Event|0|||
147297813|NCT01337674|531255909|FG003|Treatment Period 1|Adverse Event|0|||
147297814|NCT01337674|531255906|FG000|Treatment Period 1|Discontinued due to blood draws|0|||
147297815|NCT01337674|531255907|FG001|Treatment Period 1|Discontinued due to blood draws|0|||
147297816|NCT01337674|531255908|FG002|Treatment Period 1|Discontinued due to blood draws|0|||
147297817|NCT01337674|531255909|FG003|Treatment Period 1|Discontinued due to blood draws|1|||
147297818|NCT01337674|531255906|FG000|Treatment Period 2|Withdrawal by Subject|0|||
147297819|NCT01337674|531255907|FG001|Treatment Period 2|Withdrawal by Subject|0|||
147297820|NCT01337674|531255908|FG002|Treatment Period 2|Withdrawal by Subject|1|||
147297821|NCT01337674|531255909|FG003|Treatment Period 2|Withdrawal by Subject|0|||
147297822|NCT03076970|531255910|FG000|Washout Period 2|Adverse Event|0|||
147297823|NCT03076970|531255911|FG001|Washout Period 2|Adverse Event|0|||
147297824|NCT03076970|531255912|FG002|Washout Period 2|Adverse Event|0|||
147297825|NCT03076970|531255913|FG003|Washout Period 2|Adverse Event|0|||
147297826|NCT03076970|531255914|FG004|Washout Period 2|Adverse Event|1|||
147297827|NCT03076970|531255915|FG005|Washout Period 2|Adverse Event|0|||
147297828|NCT03076970|531255910|FG000|Period 3|Withdrawal by Subject|0|||
147297829|NCT03076970|531255911|FG001|Period 3|Withdrawal by Subject|0|||
147297830|NCT03076970|531255912|FG002|Period 3|Withdrawal by Subject|0|||
147297831|NCT03076970|531255913|FG003|Period 3|Withdrawal by Subject|0|||
147297832|NCT03076970|531255914|FG004|Period 3|Withdrawal by Subject|0|||
147297833|NCT03076970|531255915|FG005|Period 3|Withdrawal by Subject|1|||
147297834|NCT03076970|531255910|FG000|Period 3|Failure to meet I/E criteria|0|||
147297835|NCT03076970|531255911|FG001|Period 3|Failure to meet I/E criteria|0|||
147297836|NCT03076970|531255912|FG002|Period 3|Failure to meet I/E criteria|0|||
147297837|NCT03076970|531255913|FG003|Period 3|Failure to meet I/E criteria|0|||
147297838|NCT03076970|531255914|FG004|Period 3|Failure to meet I/E criteria|1|||
147297839|NCT03076970|531255915|FG005|Period 3|Failure to meet I/E criteria|0|||
147339554|NCT00232180|531412122|FG001|Open Label Phase|Adverse Event|0|||
147339555|NCT00232180|531412123|FG002|Open Label Phase|Adverse Event|25|||
147339556|NCT00232180|531412121|FG000|Open Label Phase|Laboratory abnormality|0|||
147339557|NCT00232180|531412122|FG001|Open Label Phase|Laboratory abnormality|0|||
147339558|NCT00232180|531412123|FG002|Open Label Phase|Laboratory abnormality|10|||
147339559|NCT00232180|531412121|FG000|Open Label Phase|Randomized but not treated|0|||
147339560|NCT00232180|531412122|FG001|Open Label Phase|Randomized but not treated|0|||
147452989|NCT01926782|531821493|FG004|Overall Study|Other than specified|4|||
147452990|NCT01926782|531821494|FG005|Overall Study|Other than specified|11|||
147606291|NCT01371747|532375195|FG001|Overall Study|Physician Decision|0|||
147339561|NCT00232180|531412123|FG002|Open Label Phase|Randomized but not treated|1|||
147339562|NCT02748317|531412124|FG000|Overall Study|Withdrawal by Subject|14|||
147339563|NCT02748317|531412124|FG000|Overall Study|Lost to Follow-up|8|||
147339564|NCT02748317|531412124|FG000|Overall Study|Death|1|||
147339565|NCT00414544|531412125|FG000|Overall Study|Lost to Follow-up|14|||
147339566|NCT04259450|531412126|FG000|Overall Study|Adverse event/ Toxicity|0|||
147297840|NCT00789815|531255916|FG000|Overall Study|Protocol Violation|6|||
147297841|NCT00789815|531255917|FG001|Overall Study|Protocol Violation|1|||
147297842|NCT00789815|531255916|FG000|Overall Study|Intubation due to massive bleeding|1|||
147297843|NCT00789815|531255917|FG001|Overall Study|Intubation due to massive bleeding|0|||
147297844|NCT00119405|531255918|FG000|Overall Study|Withdrawal by Subject|1|||
147339567|NCT04259450|531412127|FG001|Overall Study|Adverse event/ Toxicity|3|||
147339568|NCT04259450|531412128|FG002|Overall Study|Adverse event/ Toxicity|0|||
147339569|NCT04259450|531412129|FG003|Overall Study|Adverse event/ Toxicity|1|||
147606292|NCT01371747|532375196|FG002|Overall Study|Physician Decision|0|||
147297845|NCT04958785|531255922|FG000|Overall Study|Study Terminated by Sponsor|4|||
147297846|NCT04958785|531255923|FG001|Overall Study|Study Terminated by Sponsor|10|||
147297847|NCT04958785|531255924|FG002|Overall Study|Study Terminated by Sponsor|7|||
147297848|NCT04958785|531255925|FG003|Overall Study|Study Terminated by Sponsor|6|||
147297849|NCT04958785|531255926|FG004|Overall Study|Study Terminated by Sponsor|34|||
147297850|NCT04958785|531255922|FG000|Overall Study|Death|2|||
147297851|NCT04958785|531255923|FG001|Overall Study|Death|3|||
147297852|NCT04958785|531255924|FG002|Overall Study|Death|4|||
147297853|NCT04958785|531255925|FG003|Overall Study|Death|5|||
147297854|NCT04958785|531255926|FG004|Overall Study|Death|5|||
147297855|NCT04958785|531255922|FG000|Overall Study|Withdrew consent|2|||
147297856|NCT04958785|531255923|FG001|Overall Study|Withdrew consent|0|||
147297857|NCT04958785|531255924|FG002|Overall Study|Withdrew consent|3|||
147297858|NCT04958785|531255925|FG003|Overall Study|Withdrew consent|1|||
147297859|NCT04958785|531255926|FG004|Overall Study|Withdrew consent|0|||
147297860|NCT04958785|531255922|FG000|Overall Study|Investigator's discretion|0|||
147606293|NCT01371747|532375197|FG003|Overall Study|Physician Decision|0|||
147606294|NCT01371747|532375198|FG004|Overall Study|Physician Decision|1|||
147606295|NCT01371747|532375199|FG005|Overall Study|Physician Decision|0|||
147297861|NCT04958785|531255923|FG001|Overall Study|Investigator's discretion|1|||
147297862|NCT04958785|531255924|FG002|Overall Study|Investigator's discretion|0|||
147297863|NCT04958785|531255925|FG003|Overall Study|Investigator's discretion|1|||
147297864|NCT04958785|531255926|FG004|Overall Study|Investigator's discretion|2|||
147297865|NCT04958785|531255922|FG000|Overall Study|Adverse Event|0|||
147297866|NCT04958785|531255923|FG001|Overall Study|Adverse Event|0|||
147297867|NCT04958785|531255924|FG002|Overall Study|Adverse Event|0|||
147297868|NCT04958785|531255925|FG003|Overall Study|Adverse Event|0|||
147297869|NCT04958785|531255926|FG004|Overall Study|Adverse Event|1|||
147297870|NCT04958785|531255922|FG000|Overall Study|Lost to Follow-up|0|||
147297871|NCT04958785|531255923|FG001|Overall Study|Lost to Follow-up|0|||
147297872|NCT04958785|531255924|FG002|Overall Study|Lost to Follow-up|0|||
147297873|NCT04958785|531255925|FG003|Overall Study|Lost to Follow-up|0|||
147297874|NCT04958785|531255926|FG004|Overall Study|Lost to Follow-up|1|||
147297875|NCT01224925|531255927|FG000|Overall Study|Lost to Follow-up|3|||
147297876|NCT01224925|531255928|FG001|Overall Study|Lost to Follow-up|2|||
147297877|NCT00949884|531255931|FG000|Overall Study|Adverse Event|14|||
147297878|NCT00949884|531255932|FG001|Overall Study|Adverse Event|3|||
147297879|NCT00949884|531255933|FG002|Overall Study|Adverse Event|12|||
147297880|NCT00949884|531255931|FG000|Overall Study|Did not meet inclusion/exclusion|2|||
147297881|NCT00949884|531255932|FG001|Overall Study|Did not meet inclusion/exclusion|1|||
147297882|NCT00949884|531255933|FG002|Overall Study|Did not meet inclusion/exclusion|3|||
147297883|NCT00949884|531255931|FG000|Overall Study|Lost to Follow-up|7|||
147297884|NCT00949884|531255932|FG001|Overall Study|Lost to Follow-up|5|||
147297885|NCT00949884|531255933|FG002|Overall Study|Lost to Follow-up|5|||
147297886|NCT00949884|531255931|FG000|Overall Study|Physician Decision|5|||
147297887|NCT00949884|531255932|FG001|Overall Study|Physician Decision|0|||
147297888|NCT00949884|531255933|FG002|Overall Study|Physician Decision|6|||
147297889|NCT00949884|531255931|FG000|Overall Study|Treatment non-compliance|5|||
147297890|NCT00949884|531255932|FG001|Overall Study|Treatment non-compliance|0|||
147339570|NCT04259450|531412130|FG004|Overall Study|Adverse event/ Toxicity|0|||
147339571|NCT04259450|531412131|FG005|Overall Study|Adverse event/ Toxicity|0|||
147339572|NCT04259450|531412132|FG006|Overall Study|Adverse event/ Toxicity|0|||
147339573|NCT04259450|531412133|FG007|Overall Study|Adverse event/ Toxicity|1|||
147339574|NCT04259450|531412134|FG008|Overall Study|Adverse event/ Toxicity|0|||
147339575|NCT04259450|531412135|FG009|Overall Study|Adverse event/ Toxicity|3|||
147339576|NCT04259450|531412126|FG000|Overall Study|Disease progression|2|||
147606296|NCT01371747|532375194|FG000|Overall Study|Withdrawal by Subject|6|||
147606297|NCT01371747|532375195|FG001|Overall Study|Withdrawal by Subject|12|||
147297891|NCT00949884|531255933|FG002|Overall Study|Treatment non-compliance|8|||
147297892|NCT00949884|531255931|FG000|Overall Study|Withdrawal by Subject|13|||
147297893|NCT00949884|531255932|FG001|Overall Study|Withdrawal by Subject|4|||
147297894|NCT00949884|531255933|FG002|Overall Study|Withdrawal by Subject|16|||
147297895|NCT00949884|531255931|FG000|Overall Study|Lack of Efficacy|4|||
147297896|NCT00949884|531255932|FG001|Overall Study|Lack of Efficacy|2|||
147297897|NCT00949884|531255933|FG002|Overall Study|Lack of Efficacy|7|||
147339577|NCT04259450|531412127|FG001|Overall Study|Disease progression|3|||
147339578|NCT04259450|531412128|FG002|Overall Study|Disease progression|4|||
147297898|NCT00949884|531255931|FG000|Overall Study|Study terminated by sponsor|0|||
147297899|NCT00949884|531255932|FG001|Overall Study|Study terminated by sponsor|0|||
147297900|NCT00949884|531255933|FG002|Overall Study|Study terminated by sponsor|1|||
147297901|NCT00245102|531255934|FG000|Overall Study|Not Treated|1|||
147297902|NCT00245102|531255935|FG001|Overall Study|Not Treated|0|||
147297903|NCT00245102|531255936|FG002|Overall Study|Not Treated|1|||
147339579|NCT04259450|531412129|FG003|Overall Study|Disease progression|4|||
147606298|NCT01371747|532375196|FG002|Overall Study|Withdrawal by Subject|5|||
147297904|NCT00245102|531255937|FG003|Overall Study|Not Treated|0|||
147297905|NCT00245102|531255938|FG004|Overall Study|Not Treated|0|||
147297906|NCT00245102|531255939|FG005|Overall Study|Not Treated|0|||
147339580|NCT04259450|531412130|FG004|Overall Study|Disease progression|6|||
147297907|NCT00245102|531255934|FG000|Overall Study|Protocol Violation|1|||
147297908|NCT00245102|531255935|FG001|Overall Study|Protocol Violation|0|||
147297909|NCT00245102|531255936|FG002|Overall Study|Protocol Violation|0|||
147297910|NCT00245102|531255937|FG003|Overall Study|Protocol Violation|0|||
147297911|NCT00245102|531255938|FG004|Overall Study|Protocol Violation|0|||
147297912|NCT00245102|531255939|FG005|Overall Study|Protocol Violation|0|||
147297913|NCT00245102|531255934|FG000|Overall Study|Death|0|||
147297914|NCT00245102|531255935|FG001|Overall Study|Death|0|||
147297915|NCT00245102|531255936|FG002|Overall Study|Death|0|||
147297916|NCT00245102|531255937|FG003|Overall Study|Death|1|||
147297917|NCT00245102|531255938|FG004|Overall Study|Death|0|||
147297918|NCT00245102|531255939|FG005|Overall Study|Death|0|||
147297919|NCT00245102|531255934|FG000|Overall Study|Adverse Event|4|||
147297920|NCT00245102|531255935|FG001|Overall Study|Adverse Event|2|||
147297921|NCT00245102|531255936|FG002|Overall Study|Adverse Event|5|||
147297922|NCT00245102|531255937|FG003|Overall Study|Adverse Event|1|||
147297923|NCT00245102|531255938|FG004|Overall Study|Adverse Event|0|||
147297924|NCT00245102|531255939|FG005|Overall Study|Adverse Event|2|||
147297925|NCT00245102|531255934|FG000|Overall Study|Decline in performance|0|||
147297926|NCT00245102|531255935|FG001|Overall Study|Decline in performance|2|||
147297927|NCT00245102|531255936|FG002|Overall Study|Decline in performance|0|||
147297928|NCT00245102|531255937|FG003|Overall Study|Decline in performance|1|||
147297929|NCT00245102|531255938|FG004|Overall Study|Decline in performance|0|||
147297930|NCT00245102|531255939|FG005|Overall Study|Decline in performance|2|||
147297931|NCT00245102|531255934|FG000|Overall Study|Participant needed surgery|0|||
147297932|NCT00245102|531255935|FG001|Overall Study|Participant needed surgery|0|||
147297933|NCT00245102|531255936|FG002|Overall Study|Participant needed surgery|1|||
147297934|NCT00245102|531255937|FG003|Overall Study|Participant needed surgery|0|||
147297935|NCT00245102|531255938|FG004|Overall Study|Participant needed surgery|0|||
147297936|NCT00245102|531255939|FG005|Overall Study|Participant needed surgery|0|||
147297937|NCT00245102|531255934|FG000|Overall Study|Clinical progression|1|||
147297938|NCT00245102|531255935|FG001|Overall Study|Clinical progression|0|||
147297939|NCT00245102|531255936|FG002|Overall Study|Clinical progression|0|||
147297940|NCT00245102|531255937|FG003|Overall Study|Clinical progression|0|||
147297941|NCT00245102|531255938|FG004|Overall Study|Clinical progression|0|||
147297942|NCT00245102|531255939|FG005|Overall Study|Clinical progression|0|||
147297943|NCT02293395|531255946|FG000|Overall Study|Lost to Follow-up|1|||
147297944|NCT02293395|531255947|FG001|Overall Study|Lost to Follow-up|0|||
147297945|NCT02293395|531255946|FG000|Overall Study|Withdrawal by Subject|8|||
147297946|NCT02293395|531255947|FG001|Overall Study|Withdrawal by Subject|7|||
147297947|NCT00224770|531255953|FG000|Overall Study|Lost to Follow-up|4|||
147297948|NCT00224770|531255954|FG001|Overall Study|Lost to Follow-up|2|||
147297949|NCT00224770|531255955|FG002|Overall Study|Lost to Follow-up|0|||
147297950|NCT01106430|531255956|FG000|Overall Study|Adverse Event|8|||
147297951|NCT01106430|531255957|FG001|Overall Study|Adverse Event|10|||
147297952|NCT01106430|531255956|FG000|Overall Study|Lack of Efficacy|2|||
147297953|NCT01106430|531255957|FG001|Overall Study|Lack of Efficacy|13|||
147297954|NCT01106430|531255956|FG000|Overall Study|Lost to Follow-up|5|||
147297955|NCT01106430|531255957|FG001|Overall Study|Lost to Follow-up|1|||
147297956|NCT01106430|531255956|FG000|Overall Study|Early Termination Requested By Sponsor|1|||
147297957|NCT01106430|531255957|FG001|Overall Study|Early Termination Requested By Sponsor|0|||
147297958|NCT01106430|531255956|FG000|Overall Study|Moved Out Of State|0|||
147297959|NCT01106430|531255957|FG001|Overall Study|Moved Out Of State|1|||
147297960|NCT01106430|531255956|FG000|Overall Study|Refused To Take Medication|0|||
147297961|NCT01106430|531255957|FG001|Overall Study|Refused To Take Medication|1|||
147297962|NCT01106430|531255956|FG000|Overall Study|Noncompliance|0|||
147297963|NCT01106430|531255957|FG001|Overall Study|Noncompliance|1|||
147297964|NCT01106430|531255956|FG000|Overall Study|Hard Time Swallowing The Pills|1|||
147297965|NCT01106430|531255957|FG001|Overall Study|Hard Time Swallowing The Pills|0|||
147297966|NCT01106430|531255956|FG000|Overall Study|Previous Use Of Marijuana|1|||
147297967|NCT01106430|531255957|FG001|Overall Study|Previous Use Of Marijuana|0|||
147297968|NCT01106430|531255956|FG000|Overall Study|Protocol Violation|7|||
147297969|NCT01106430|531255957|FG001|Overall Study|Protocol Violation|2|||
147297970|NCT01106430|531255956|FG000|Overall Study|Withdrawal by Subject|8|||
147297971|NCT01106430|531255957|FG001|Overall Study|Withdrawal by Subject|4|||
147297972|NCT00662857|531255960|FG000|Washout 1 (3 - 14 Days)|Physician Decision|0|||
147297973|NCT00662857|531255961|FG001|Washout 1 (3 - 14 Days)|Physician Decision|1|||
147297974|NCT00662857|531255960|FG000|Washout 1 (3 - 14 Days)|Withdrawal by Subject|0|||
147297975|NCT00662857|531255961|FG001|Washout 1 (3 - 14 Days)|Withdrawal by Subject|1|||
147297976|NCT00662857|531255960|FG000|Washout 2 (3 - 14 Days)|Cannot Use Clamp Data|1|||
147606299|NCT01371747|532375197|FG003|Overall Study|Withdrawal by Subject|2|||
147297977|NCT00662857|531255961|FG001|Washout 2 (3 - 14 Days)|Cannot Use Clamp Data|0|||
147297978|NCT00989092|531255962|FG000|Overall Study|Physician Decision|9|||
147297979|NCT00989092|531255963|FG001|Overall Study|Physician Decision|6|||
147606300|NCT01371747|532375198|FG004|Overall Study|Withdrawal by Subject|2|||
147606301|NCT01371747|532375199|FG005|Overall Study|Withdrawal by Subject|4|||
147297980|NCT00989092|531255962|FG000|Overall Study|Adverse Event|20|||
147297981|NCT00989092|531255963|FG001|Overall Study|Adverse Event|1|||
147606302|NCT01371747|532375194|FG000|Overall Study|Other Reasons|2|||
147606303|NCT01371747|532375195|FG001|Overall Study|Other Reasons|1|||
147606304|NCT01371747|532375196|FG002|Overall Study|Other Reasons|2|||
147606305|NCT01371747|532375197|FG003|Overall Study|Other Reasons|0|||
147297982|NCT00989092|531255962|FG000|Overall Study|Chemotherapy initiated|12|||
147297983|NCT00989092|531255963|FG001|Overall Study|Chemotherapy initiated|4|||
147297984|NCT00989092|531255962|FG000|Overall Study|Withdrawal by Subject|17|||
147297985|NCT00989092|531255963|FG001|Overall Study|Withdrawal by Subject|9|||
147297986|NCT00989092|531255962|FG000|Overall Study|Death|14|||
147297987|NCT00989092|531255963|FG001|Overall Study|Death|2|||
147297988|NCT00989092|531255962|FG000|Overall Study|Ineligibility determined|3|||
147297989|NCT00989092|531255963|FG001|Overall Study|Ineligibility determined|3|||
147297990|NCT00989092|531255962|FG000|Overall Study|Lost to Follow-up|6|||
147297991|NCT00989092|531255963|FG001|Overall Study|Lost to Follow-up|2|||
147297992|NCT00989092|531255962|FG000|Overall Study|Other|3|||
147297993|NCT00989092|531255963|FG001|Overall Study|Other|1|||
147297994|NCT00989092|531255962|FG000|Overall Study|Protocol deviation|2|||
147297995|NCT00989092|531255963|FG001|Overall Study|Protocol deviation|0|||
147297996|NCT00989092|531255962|FG000|Overall Study|Erythropoietin therapy initiated|2|||
147297997|NCT00989092|531255963|FG001|Overall Study|Erythropoietin therapy initiated|0|||
147297998|NCT00989092|531255962|FG000|Overall Study|Did not receive study drug|2|||
147297999|NCT00989092|531255963|FG001|Overall Study|Did not receive study drug|0|||
147298000|NCT02832622|531255965|FG000|Overall Study|MPP not programmed|1259|||
147298001|NCT02832622|531255965|FG000|Overall Study|Withdrawal by Subject|123|||
147298002|NCT02832622|531255965|FG000|Overall Study|Death|119|||
147298003|NCT02832622|531255965|FG000|Overall Study|Unsuccessful CRT implant|93|||
147298004|NCT02832622|531255965|FG000|Overall Study|Lost to Follow-up|45|||
147298005|NCT02832622|531255965|FG000|Overall Study|Patient non-compliance|42|||
147298006|NCT02832622|531255965|FG000|Overall Study|Withdrawal by other reasons|25|||
147298007|NCT02832622|531255965|FG000|Overall Study|System explant|24|||
147298008|NCT02832622|531255965|FG000|Overall Study|Physician Decision|6|||
147298009|NCT02173548|531255966|FG000|Overall Study|Lost to Follow-up|0|||
147298010|NCT02173548|531255967|FG001|Overall Study|Lost to Follow-up|2|||
147298011|NCT02173548|531255966|FG000|Overall Study|Withdrawal by Subject|1|||
147298012|NCT02173548|531255967|FG001|Overall Study|Withdrawal by Subject|0|||
147298013|NCT03822117|531255970|FG000|Overall Study|Death|18|||
147298014|NCT03822117|531255971|FG001|Overall Study|Death|17|||
147298015|NCT03822117|531255972|FG002|Overall Study|Death|12|||
147298016|NCT03822117|531255973|FG003|Overall Study|Death|4|||
147298017|NCT03822117|531255970|FG000|Overall Study|Lost to Follow-up|1|||
147298018|NCT03822117|531255971|FG001|Overall Study|Lost to Follow-up|2|||
147298019|NCT03822117|531255972|FG002|Overall Study|Lost to Follow-up|3|||
147298020|NCT03822117|531255973|FG003|Overall Study|Lost to Follow-up|0|||
147298021|NCT03822117|531255970|FG000|Overall Study|Study Terminated by Sponsor|25|||
147298022|NCT03822117|531255971|FG001|Overall Study|Study Terminated by Sponsor|11|||
147298023|NCT03822117|531255972|FG002|Overall Study|Study Terminated by Sponsor|6|||
147298024|NCT03822117|531255973|FG003|Overall Study|Study Terminated by Sponsor|0|||
147298025|NCT03822117|531255970|FG000|Overall Study|Withdrawal by Subject|4|||
147298026|NCT03822117|531255971|FG001|Overall Study|Withdrawal by Subject|0|||
147298027|NCT03822117|531255972|FG002|Overall Study|Withdrawal by Subject|3|||
147298028|NCT03822117|531255973|FG003|Overall Study|Withdrawal by Subject|0|||
147606306|NCT01371747|532375198|FG004|Overall Study|Other Reasons|0|||
147298029|NCT03822117|531255970|FG000|Overall Study|Disease Progression|1|||
147298030|NCT03822117|531255971|FG001|Overall Study|Disease Progression|2|||
147298031|NCT03822117|531255972|FG002|Overall Study|Disease Progression|1|||
147298032|NCT03822117|531255973|FG003|Overall Study|Disease Progression|0|||
147298033|NCT03822117|531255970|FG000|Overall Study|Never Returned to Hospital|0|||
147298034|NCT03822117|531255971|FG001|Overall Study|Never Returned to Hospital|0|||
147298035|NCT03822117|531255972|FG002|Overall Study|Never Returned to Hospital|1|||
147298036|NCT03822117|531255973|FG003|Overall Study|Never Returned to Hospital|0|||
147298037|NCT05131165|531255975|FG000|Overall Study|Death|1|||
147298038|NCT05131165|531255976|FG001|Overall Study|Death|1|||
147298039|NCT05131165|531255977|FG002|Overall Study|Death|0|||
147298040|NCT05131165|531255975|FG000|Overall Study|Lost to Follow-up|2|||
147298041|NCT05131165|531255976|FG001|Overall Study|Lost to Follow-up|2|||
147298042|NCT05131165|531255977|FG002|Overall Study|Lost to Follow-up|5|||
147298043|NCT05131165|531255975|FG000|Overall Study|Transferred out of clinic|1|||
147298044|NCT05131165|531255976|FG001|Overall Study|Transferred out of clinic|0|||
147298045|NCT05131165|531255977|FG002|Overall Study|Transferred out of clinic|3|||
147298046|NCT05131165|531255975|FG000|Overall Study|Dropped out|1|||
147298047|NCT05131165|531255976|FG001|Overall Study|Dropped out|2|||
147298048|NCT05131165|531255977|FG002|Overall Study|Dropped out|0|||
147298049|NCT03320018|531255986|FG000|Treatment Period|Withdrawal by Subject|1|||
147606307|NCT01371747|532375199|FG005|Overall Study|Other Reasons|1|||
147606308|NCT02856555|532375200|FG000|Overall Study|Adverse Event|1|||
147298050|NCT03320018|531255987|FG001|Treatment Period|Withdrawal by Subject|0|||
147298051|NCT03320018|531255986|FG000|Day 90 Follow up|Death|0|||
147298052|NCT03320018|531255987|FG001|Day 90 Follow up|Death|1|||
147298053|NCT02691182|531255988|FG000|Overall Study|Withdrawal by Subject|4|||
147606309|NCT02856555|532375201|FG001|Overall Study|Adverse Event|0|||
147298054|NCT02691182|531255989|FG001|Overall Study|Withdrawal by Subject|7|||
147298055|NCT02691182|531255990|FG002|Overall Study|Withdrawal by Subject|6|||
147298056|NCT02691182|531255991|FG003|Overall Study|Withdrawal by Subject|8|||
147298057|NCT02691182|531255988|FG000|Overall Study|Withdrawal by Parent/Guardian|9|||
147298058|NCT02691182|531255989|FG001|Overall Study|Withdrawal by Parent/Guardian|47|||
147298059|NCT02691182|531255990|FG002|Overall Study|Withdrawal by Parent/Guardian|33|||
147298060|NCT02691182|531255991|FG003|Overall Study|Withdrawal by Parent/Guardian|38|||
147298061|NCT02691182|531255988|FG000|Overall Study|Lost to Follow-up|8|||
147298062|NCT02691182|531255989|FG001|Overall Study|Lost to Follow-up|33|||
147298063|NCT02691182|531255990|FG002|Overall Study|Lost to Follow-up|19|||
147298064|NCT02691182|531255991|FG003|Overall Study|Lost to Follow-up|22|||
147298065|NCT02691182|531255988|FG000|Overall Study|Adverse Event|3|||
147298066|NCT02691182|531255989|FG001|Overall Study|Adverse Event|10|||
147298067|NCT02691182|531255990|FG002|Overall Study|Adverse Event|10|||
147298068|NCT02691182|531255991|FG003|Overall Study|Adverse Event|11|||
147298069|NCT02691182|531255988|FG000|Overall Study|Physician Decision|3|||
147298070|NCT02691182|531255989|FG001|Overall Study|Physician Decision|7|||
147298071|NCT02691182|531255990|FG002|Overall Study|Physician Decision|14|||
147298072|NCT02691182|531255991|FG003|Overall Study|Physician Decision|8|||
147298073|NCT02691182|531255988|FG000|Overall Study|Lack of Efficacy|0|||
147298074|NCT02691182|531255989|FG001|Overall Study|Lack of Efficacy|0|||
147298075|NCT02691182|531255990|FG002|Overall Study|Lack of Efficacy|0|||
147298076|NCT02691182|531255991|FG003|Overall Study|Lack of Efficacy|4|||
147298077|NCT02691182|531255988|FG000|Overall Study|Protocol Violation|2|||
147298078|NCT02691182|531255989|FG001|Overall Study|Protocol Violation|6|||
147298079|NCT02691182|531255990|FG002|Overall Study|Protocol Violation|6|||
147298080|NCT02691182|531255991|FG003|Overall Study|Protocol Violation|8|||
147298081|NCT02691182|531255988|FG000|Overall Study|Sponsor terminated study, SM non-compliance, Site closure, Subjects relocated or hospitalized.|9|||
147298082|NCT02691182|531255989|FG001|Overall Study|Sponsor terminated study, SM non-compliance, Site closure, Subjects relocated or hospitalized.|43|||
147298083|NCT02691182|531255990|FG002|Overall Study|Sponsor terminated study, SM non-compliance, Site closure, Subjects relocated or hospitalized.|40|||
147298084|NCT02691182|531255991|FG003|Overall Study|Sponsor terminated study, SM non-compliance, Site closure, Subjects relocated or hospitalized.|58|||
147298085|NCT02691182|531255988|FG000|Overall Study|Missing|0|||
147298086|NCT02691182|531255989|FG001|Overall Study|Missing|5|||
147298087|NCT02691182|531255990|FG002|Overall Study|Missing|1|||
147298088|NCT02691182|531255991|FG003|Overall Study|Missing|5|||
147298089|NCT02563002|531255994|FG000|Overall Study|Death|72|||
147298090|NCT02563002|531255995|FG001|Overall Study|Death|87|||
147298091|NCT02563002|531255994|FG000|Overall Study|Lost to Follow-up|5|||
147298092|NCT02563002|531255995|FG001|Overall Study|Lost to Follow-up|0|||
147298093|NCT02563002|531255994|FG000|Overall Study|Physician Decision|0|||
147298094|NCT02563002|531255995|FG001|Overall Study|Physician Decision|2|||
147298095|NCT02563002|531255994|FG000|Overall Study|Withdrawal by Subject|2|||
147298096|NCT02563002|531255995|FG001|Overall Study|Withdrawal by Subject|10|||
147298097|NCT02563002|531255994|FG000|Overall Study|Sponsor decision|74|||
147298098|NCT02563002|531255995|FG001|Overall Study|Sponsor decision|55|||
147298099|NCT05453110|531256006|FG000|Overall Study|Received intervention but did not complete primary outcome measure|5|||
147298100|NCT05453110|531256007|FG001|Overall Study|Received intervention but did not complete primary outcome measure|5|||
147298101|NCT05453110|531256008|FG002|Overall Study|Received intervention but did not complete primary outcome measure|6|||
147298102|NCT05906368|531256009|FG000|Overall Study|Withdrawal by Subject|1|||
147298103|NCT05906368|531256010|FG001|Overall Study|Withdrawal by Subject|1|||
147298104|NCT05906368|531256009|FG000|Overall Study|Ineligibility criteria identified|2|||
147298105|NCT05906368|531256010|FG001|Overall Study|Ineligibility criteria identified|0|||
147298106|NCT04570436|531256020|FG000|Overall Study|Adverse Event|0|||
147298107|NCT04570436|531256021|FG001|Overall Study|Adverse Event|0|||
147298108|NCT04570436|531256022|FG002|Overall Study|Adverse Event|1|||
147298109|NCT04570436|531256023|FG003|Overall Study|Adverse Event|0|||
147298110|NCT04570436|531256024|FG004|Overall Study|Adverse Event|0|||
147339581|NCT04259450|531412131|FG005|Overall Study|Disease progression|6|||
147339582|NCT04259450|531412132|FG006|Overall Study|Disease progression|6|||
147339583|NCT04259450|531412133|FG007|Overall Study|Disease progression|15|||
147339584|NCT04259450|531412134|FG008|Overall Study|Disease progression|6|||
147339585|NCT04259450|531412135|FG009|Overall Study|Disease progression|18|||
147298111|NCT04570436|531256025|FG005|Overall Study|Adverse Event|0|||
147298112|NCT04570436|531256026|FG006|Overall Study|Adverse Event|0|||
147298113|NCT04570436|531256027|FG007|Overall Study|Adverse Event|0|||
147298114|NCT04570436|531256028|FG008|Overall Study|Adverse Event|0|||
147298115|NCT04570436|531256029|FG009|Overall Study|Adverse Event|0|||
147339586|NCT04259450|531412126|FG000|Overall Study|Death|0|||
147339587|NCT04259450|531412127|FG001|Overall Study|Death|0|||
147298116|NCT04570436|531256020|FG000|Overall Study|Physician Decision|1|||
147298117|NCT04570436|531256021|FG001|Overall Study|Physician Decision|0|||
147298118|NCT04570436|531256022|FG002|Overall Study|Physician Decision|0|||
147298119|NCT04570436|531256023|FG003|Overall Study|Physician Decision|0|||
147298120|NCT04570436|531256024|FG004|Overall Study|Physician Decision|0|||
147298121|NCT04570436|531256025|FG005|Overall Study|Physician Decision|0|||
147339588|NCT04259450|531412128|FG002|Overall Study|Death|0|||
147606310|NCT02856555|532375202|FG002|Overall Study|Adverse Event|0|||
147606311|NCT02856555|532375200|FG000|Overall Study|Lost to Follow-up|1|||
147606312|NCT02856555|532375201|FG001|Overall Study|Lost to Follow-up|3|||
147606313|NCT02856555|532375202|FG002|Overall Study|Lost to Follow-up|0|||
147606314|NCT02856555|532375200|FG000|Overall Study|Withdrawal by Subject|3|||
147606315|NCT02856555|532375201|FG001|Overall Study|Withdrawal by Subject|0|||
147298122|NCT04570436|531256026|FG006|Overall Study|Physician Decision|0|||
147298123|NCT04570436|531256027|FG007|Overall Study|Physician Decision|0|||
147298124|NCT04570436|531256028|FG008|Overall Study|Physician Decision|0|||
147298125|NCT04570436|531256029|FG009|Overall Study|Physician Decision|0|||
147298126|NCT01274182|531256030|FG000|Overall Study|Unsatisfactory therapeutic effect|6|||
147298127|NCT01274182|531256031|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
147298128|NCT01274182|531256032|FG002|Overall Study|Unsatisfactory therapeutic effect|4|||
147298129|NCT01274182|531256030|FG000|Overall Study|Adverse Event|4|||
147298130|NCT01274182|531256031|FG001|Overall Study|Adverse Event|5|||
147298131|NCT01274182|531256032|FG002|Overall Study|Adverse Event|3|||
147298132|NCT01274182|531256030|FG000|Overall Study|Withdrawal by Subject|5|||
147298133|NCT01274182|531256031|FG001|Overall Study|Withdrawal by Subject|5|||
147298134|NCT01274182|531256032|FG002|Overall Study|Withdrawal by Subject|3|||
147298135|NCT01274182|531256030|FG000|Overall Study|Lost to Follow-up|2|||
147298136|NCT01274182|531256031|FG001|Overall Study|Lost to Follow-up|3|||
147298137|NCT01274182|531256032|FG002|Overall Study|Lost to Follow-up|1|||
147298138|NCT01274182|531256030|FG000|Overall Study|Protocol Violation|3|||
147298139|NCT01274182|531256031|FG001|Overall Study|Protocol Violation|2|||
147298140|NCT01274182|531256032|FG002|Overall Study|Protocol Violation|0|||
147298141|NCT01274182|531256030|FG000|Overall Study|Death|1|||
147339589|NCT04259450|531412129|FG003|Overall Study|Death|0|||
147298142|NCT01274182|531256031|FG001|Overall Study|Death|0|||
147298143|NCT01274182|531256032|FG002|Overall Study|Death|1|||
147298144|NCT01822587|531256033|FG000|Overall Study|Lost to Follow-up|7|||
147298145|NCT01822587|531256034|FG001|Overall Study|Lost to Follow-up|9|||
147298146|NCT01822587|531256035|FG002|Overall Study|Lost to Follow-up|12|||
147298147|NCT01822587|531256033|FG000|Overall Study|Physician Decision|9|||
147298148|NCT01822587|531256034|FG001|Overall Study|Physician Decision|6|||
147298149|NCT01822587|531256035|FG002|Overall Study|Physician Decision|6|||
147298150|NCT00691938|531256036|FG000|Overall Study|QTc prolongation|1|||
147298151|NCT00691938|531256037|FG001|Overall Study|QTc prolongation|0|||
147298152|NCT00691938|531256038|FG002|Overall Study|QTc prolongation|0|||
147298153|NCT00691938|531256039|FG003|Overall Study|QTc prolongation|0|||
147298154|NCT00691938|531256040|FG004|Overall Study|QTc prolongation|0|||
147298155|NCT00691938|531256041|FG005|Overall Study|QTc prolongation|0|||
147298156|NCT00691938|531256042|FG006|Overall Study|QTc prolongation|0|||
147298157|NCT00594854|531256045|FG000|Overall Study|Study terminated|7|||
147298158|NCT00594854|531256046|FG001|Overall Study|Study terminated|10|||
147298159|NCT03172702|531256049|FG000|Overall Study|Adverse Event|9|||
147298160|NCT03172702|531256049|FG000|Overall Study|Death|2|||
147298161|NCT03172702|531256049|FG000|Overall Study|Study-specific Withdrawal Criteria|10|||
147298162|NCT03172702|531256049|FG000|Overall Study|Withdrawal by Subject|5|||
147298163|NCT03172702|531256049|FG000|Overall Study|Other|2|||
147298164|NCT03292146|531256050|FG000|Baseline to 12 months|Relocation|1|||
147298165|NCT03292146|531256051|FG001|Baseline to 12 months|Relocation|0|||
147298166|NCT03292146|531256050|FG000|Baseline to 12 months|Seeking higher level of care for eating disorder|1|||
147298167|NCT03292146|531256051|FG001|Baseline to 12 months|Seeking higher level of care for eating disorder|0|||
147298168|NCT03292146|531256050|FG000|Baseline to 12 months|Seeking treatment for chronic fatigue syndrome|0|||
147298169|NCT03292146|531256051|FG001|Baseline to 12 months|Seeking treatment for chronic fatigue syndrome|1|||
147298170|NCT03292146|531256050|FG000|12 months to 24 months|Planning pregnancy|2|||
147298171|NCT03292146|531256051|FG001|12 months to 24 months|Planning pregnancy|2|||
147298172|NCT03292146|531256050|FG000|12 months to 24 months|Personal reasons|1|||
147339590|NCT04259450|531412130|FG004|Overall Study|Death|0|||
147606316|NCT02856555|532375202|FG002|Overall Study|Withdrawal by Subject|0|||
147606317|NCT02856555|532375200|FG000|Overall Study|Randomized but Never Treated|0|||
147606318|NCT02856555|532375201|FG001|Overall Study|Randomized but Never Treated|1|||
147606319|NCT02856555|532375202|FG002|Overall Study|Randomized but Never Treated|0|||
147298173|NCT03292146|531256051|FG001|12 months to 24 months|Personal reasons|0|||
147298174|NCT03292146|531256050|FG000|12 months to 24 months|Lost to Follow-up|0|||
147298175|NCT03292146|531256051|FG001|12 months to 24 months|Lost to Follow-up|1|||
147339591|NCT04259450|531412131|FG005|Overall Study|Death|0|||
147606320|NCT02094417|532375206|FG000|Overall Study|Adverse Event|0|||
147606321|NCT02094417|532375207|FG001|Overall Study|Adverse Event|0|||
147298176|NCT02954354|531256052|FG000|Overall Study|Adverse Event|2|||
147298177|NCT02954354|531256053|FG001|Overall Study|Adverse Event|2|||
147298178|NCT02954354|531256054|FG002|Overall Study|Adverse Event|4|||
147298179|NCT02954354|531256052|FG000|Overall Study|Failure to Meet Eligibility Criteria|1|||
147298180|NCT02954354|531256053|FG001|Overall Study|Failure to Meet Eligibility Criteria|0|||
147298181|NCT02954354|531256054|FG002|Overall Study|Failure to Meet Eligibility Criteria|0|||
147298182|NCT02954354|531256052|FG000|Overall Study|Lack of Efficacy|0|||
147339592|NCT04259450|531412132|FG006|Overall Study|Death|0|||
147339593|NCT04259450|531412133|FG007|Overall Study|Death|1|||
147339594|NCT04259450|531412134|FG008|Overall Study|Death|1|||
147339595|NCT04259450|531412135|FG009|Overall Study|Death|0|||
147339596|NCT04259450|531412126|FG000|Overall Study|Withdrawal by Subject|0|||
147339597|NCT04259450|531412127|FG001|Overall Study|Withdrawal by Subject|0|||
147339598|NCT04259450|531412128|FG002|Overall Study|Withdrawal by Subject|0|||
147339599|NCT04259450|531412129|FG003|Overall Study|Withdrawal by Subject|0|||
147339600|NCT04259450|531412130|FG004|Overall Study|Withdrawal by Subject|0|||
147339601|NCT04259450|531412131|FG005|Overall Study|Withdrawal by Subject|0|||
147339602|NCT04259450|531412132|FG006|Overall Study|Withdrawal by Subject|0|||
147339603|NCT04259450|531412133|FG007|Overall Study|Withdrawal by Subject|1|||
147339604|NCT04259450|531412134|FG008|Overall Study|Withdrawal by Subject|0|||
147339605|NCT04259450|531412135|FG009|Overall Study|Withdrawal by Subject|0|||
147339606|NCT04259450|531412126|FG000|Overall Study|Other than listed|0|||
147339607|NCT04259450|531412127|FG001|Overall Study|Other than listed|0|||
147339608|NCT04259450|531412128|FG002|Overall Study|Other than listed|0|||
147339609|NCT04259450|531412129|FG003|Overall Study|Other than listed|0|||
147339610|NCT04259450|531412130|FG004|Overall Study|Other than listed|0|||
147339611|NCT04259450|531412131|FG005|Overall Study|Other than listed|0|||
147298183|NCT02954354|531256053|FG001|Overall Study|Lack of Efficacy|2|||
147298184|NCT02954354|531256054|FG002|Overall Study|Lack of Efficacy|0|||
147298185|NCT02954354|531256052|FG000|Overall Study|Withdrawal by Subject|17|||
147298186|NCT02954354|531256053|FG001|Overall Study|Withdrawal by Subject|9|||
147298187|NCT02954354|531256054|FG002|Overall Study|Withdrawal by Subject|11|||
147298188|NCT02954354|531256052|FG000|Overall Study|Lost to Follow-up|12|||
147298189|NCT02954354|531256053|FG001|Overall Study|Lost to Follow-up|5|||
147298190|NCT02954354|531256054|FG002|Overall Study|Lost to Follow-up|0|||
147298191|NCT02954354|531256052|FG000|Overall Study|Miscellaneous|2|||
147298192|NCT02954354|531256053|FG001|Overall Study|Miscellaneous|2|||
147298193|NCT02954354|531256054|FG002|Overall Study|Miscellaneous|1|||
147298194|NCT03039023|531256055|FG000|Overall Study|Withdrawal by Subject|1|||
147298195|NCT03039023|531256056|FG001|Overall Study|Withdrawal by Subject|0|||
147298196|NCT03039023|531256057|FG002|Overall Study|Withdrawal by Subject|1|||
147298197|NCT03039023|531256058|FG003|Overall Study|Withdrawal by Subject|1|||
147298198|NCT03039023|531256059|FG004|Overall Study|Withdrawal by Subject|0|||
147298199|NCT03039023|531256055|FG000|Overall Study|Physician Decision|0|||
147298200|NCT03039023|531256056|FG001|Overall Study|Physician Decision|0|||
147298201|NCT03039023|531256057|FG002|Overall Study|Physician Decision|0|||
147298202|NCT03039023|531256058|FG003|Overall Study|Physician Decision|1|||
147298203|NCT03039023|531256059|FG004|Overall Study|Physician Decision|0|||
147298204|NCT04672941|531256062|FG000|Overall Study|Investigator decision|1|||
147298205|NCT04672941|531256062|FG000|Overall Study|Treatment with Spiolto® Respimat® discontinuation|2|||
147298206|NCT04672941|531256062|FG000|Overall Study|COVID-19 related but no adverse event|1|||
147298207|NCT04672941|531256062|FG000|Overall Study|Adverse Event|2|||
147298208|NCT04672941|531256062|FG000|Overall Study|Lost to Follow-up|2|||
147298209|NCT00045305|531256063|FG000|Overall Study|Lack of Efficacy|6|||
147298210|NCT00045305|531256063|FG000|Overall Study|Adverse Event|3|||
147298211|NCT00045305|531256063|FG000|Overall Study|Death|3|||
147298212|NCT00045305|531256063|FG000|Overall Study|site error|2|||
147298213|NCT06213701|531256065|FG000|Overall Study|Withdrawal by Subject|2|||
147298214|NCT06213701|531256066|FG001|Overall Study|Withdrawal by Subject|1|||
147298215|NCT06213701|531256067|FG002|Overall Study|Withdrawal by Subject|0|||
147298216|NCT00453986|531256068|FG000|Overall Study|Lost to Follow-up|6|||
147298217|NCT00453986|531256069|FG001|Overall Study|Lost to Follow-up|5|||
147298218|NCT00453986|531256070|FG002|Overall Study|Lost to Follow-up|6|||
147298219|NCT00453986|531256071|FG003|Overall Study|Lost to Follow-up|2|||
147298220|NCT00453986|531256072|FG004|Overall Study|Lost to Follow-up|0|||
147298221|NCT01024608|531256075|FG000|Overall Study|Adverse Event|1|||
147339612|NCT04259450|531412132|FG006|Overall Study|Other than listed|0|||
147339613|NCT04259450|531412133|FG007|Overall Study|Other than listed|1|||
147339614|NCT04259450|531412134|FG008|Overall Study|Other than listed|1|||
147339615|NCT04259450|531412135|FG009|Overall Study|Other than listed|2|||
147339616|NCT03452189|531412136|FG000|First Intervention (3 Months)|Adverse Event|1|||
147339617|NCT03452189|531412137|FG001|First Intervention (3 Months)|Adverse Event|0|||
147339618|NCT03452189|531412136|FG000|First Intervention (3 Months)|insufficient samples of plasma and stool|4|||
147339619|NCT03452189|531412137|FG001|First Intervention (3 Months)|insufficient samples of plasma and stool|0|||
147298222|NCT01024608|531256076|FG001|Overall Study|Adverse Event|0|||
147298223|NCT01024608|531256075|FG000|Overall Study|Withdrawal by Subject|1|||
147339620|NCT02724592|531412144|FG000|Overall Study|Lost to Follow-up|4|||
147339621|NCT02724592|531412145|FG001|Overall Study|Lost to Follow-up|1|||
147298224|NCT01024608|531256076|FG001|Overall Study|Withdrawal by Subject|0|||
147298225|NCT01024608|531256075|FG000|Overall Study|Lost to Follow-up|0|||
147298226|NCT01024608|531256076|FG001|Overall Study|Lost to Follow-up|1|||
147298227|NCT01024608|531256075|FG000|Overall Study|Protocol Violation|0|||
147298228|NCT01024608|531256076|FG001|Overall Study|Protocol Violation|3|||
147339622|NCT04723394|531412148|FG000|Overall Study|Adverse Event|0|||
147339623|NCT04723394|531412149|FG001|Overall Study|Adverse Event|3|||
147339624|NCT04723394|531412148|FG000|Overall Study|Death|8|||
147452991|NCT01926782|531821489|FG000|Overall Study|Adverse Event|13|||
147452992|NCT01926782|531821490|FG001|Overall Study|Adverse Event|4|||
147452993|NCT01926782|531821491|FG002|Overall Study|Adverse Event|17|||
147452994|NCT01926782|531821492|FG003|Overall Study|Adverse Event|4|||
147298229|NCT01024608|531256075|FG000|Overall Study|Never received study treatment|2|||
147298230|NCT01024608|531256076|FG001|Overall Study|Never received study treatment|0|||
147298231|NCT02412137|531256086|FG000|Overall Study|Withdrawal by Subject|2|||
147298232|NCT02412137|531256087|FG001|Overall Study|Withdrawal by Subject|0|||
147298233|NCT02412137|531256086|FG000|Overall Study|Lost to Follow-up|21|||
147298234|NCT02412137|531256087|FG001|Overall Study|Lost to Follow-up|14|||
147298235|NCT02412137|531256086|FG000|Overall Study|Physician Decision|28|||
147298236|NCT02412137|531256087|FG001|Overall Study|Physician Decision|9|||
147298237|NCT00608582|531256099|FG000|Overall Study|Lost to Follow-up|2|||
147298238|NCT00608582|531256100|FG001|Overall Study|Lost to Follow-up|0|||
147298239|NCT00608582|531256099|FG000|Overall Study|No Best Response in Phase 1 located|1|||
147298240|NCT00608582|531256100|FG001|Overall Study|No Best Response in Phase 1 located|1|||
147298241|NCT00608582|531256099|FG000|Overall Study|Illicit Drug Use|1|||
147298242|NCT00608582|531256100|FG001|Overall Study|Illicit Drug Use|0|||
147298243|NCT00608582|531256099|FG000|Overall Study|Early stage Design Change|0|||
147298244|NCT00608582|531256100|FG001|Overall Study|Early stage Design Change|3|||
147298245|NCT02240108|531257771|FG000|Overall Study|Other than specified|8|||
147298246|NCT02240108|531257772|FG001|Overall Study|Other than specified|6|||
147298247|NCT02240108|531257771|FG000|Overall Study|Adverse Event|1|||
147298248|NCT02240108|531257772|FG001|Overall Study|Adverse Event|9|||
147298249|NCT02240108|531257771|FG000|Overall Study|Pregnancy|1|||
147298250|NCT02240108|531257772|FG001|Overall Study|Pregnancy|0|||
147298251|NCT02240108|531257771|FG000|Overall Study|Withdrawal by Subject|4|||
147298252|NCT02240108|531257772|FG001|Overall Study|Withdrawal by Subject|9|||
147298253|NCT02240108|531257771|FG000|Overall Study|StudyTerminated by Sponsor|0|||
147298254|NCT02240108|531257772|FG001|Overall Study|StudyTerminated by Sponsor|1|||
147298255|NCT02472652|531257777|FG000|Overall Study|Lost to Follow-up|1|||
147298256|NCT00998400|531257782|FG000|Overall Study|Lack of interest/motivation|1|||
147298257|NCT00998400|531257783|FG001|Overall Study|Lack of interest/motivation|2|||
147298258|NCT00998400|531257782|FG000|Overall Study|Logistical problems|1|||
147298259|NCT00998400|531257783|FG001|Overall Study|Logistical problems|0|||
147298260|NCT03704584|531257784|FG000|Overall Study|Withdrawal by Subject|1|||
147298261|NCT03704584|531257785|FG001|Overall Study|Withdrawal by Subject|0|||
147298262|NCT03185832|531257786|FG000|Overall Study|Death|9|||
147298263|NCT03185832|531257787|FG001|Overall Study|Death|14|||
147298264|NCT03185832|531257788|FG002|Overall Study|Death|9|||
147452995|NCT01926782|531821493|FG004|Overall Study|Adverse Event|3|||
147298265|NCT03185832|531257789|FG003|Overall Study|Death|7|||
147298266|NCT03185832|531257786|FG000|Overall Study|Withdrawn - vital status available|0|||
147298267|NCT03185832|531257787|FG001|Overall Study|Withdrawn - vital status available|1|||
147298268|NCT03185832|531257788|FG002|Overall Study|Withdrawn - vital status available|1|||
147298269|NCT03185832|531257789|FG003|Overall Study|Withdrawn - vital status available|4|||
147298270|NCT01083641|531257790|FG000|Overall Study|Withdrawal by Subject|2|||
147298271|NCT03439189|531257791|FG000|Overall Study|Protocol Violation|19|||
147298272|NCT03439189|531257791|FG000|Overall Study|Lack of Efficacy|63|||
147298273|NCT03412812|531257792|FG000|Level 1|Death|3|||
147298274|NCT03412812|531257793|FG001|Level 1|Death|0|||
147298275|NCT03412812|531257792|FG000|Level 1|Adverse Event|0|||
147298276|NCT03412812|531257793|FG001|Level 1|Adverse Event|1|||
147298277|NCT01777321|531257794|FG000|Overall Study|Withdrawal by Subject|0|||
147298278|NCT01777321|531257795|FG001|Overall Study|Withdrawal by Subject|1|||
147298279|NCT03837509|531257796|FG000|Phase 1|Death|5|||
147298280|NCT03837509|531257797|FG001|Phase 1|Death|2|||
147298281|NCT03837509|531257798|FG002|Phase 1|Death|0|||
147298282|NCT03837509|531257799|FG003|Phase 1|Death|0|||
147298283|NCT03837509|531257800|FG004|Phase 1|Death|0|||
147298284|NCT03837509|531257796|FG000|Phase 2|Death|0|||
147452996|NCT01926782|531821494|FG005|Overall Study|Adverse Event|14|||
147452997|NCT01926782|531821489|FG000|Overall Study|Poor compliance to protocol|5|||
147452998|NCT01926782|531821490|FG001|Overall Study|Poor compliance to protocol|3|||
147298285|NCT03837509|531257797|FG001|Phase 2|Death|0|||
147452999|NCT01926782|531821491|FG002|Overall Study|Poor compliance to protocol|8|||
147298286|NCT03837509|531257798|FG002|Phase 2|Death|0|||
147298287|NCT03837509|531257799|FG003|Phase 2|Death|1|||
147298288|NCT03837509|531257800|FG004|Phase 2|Death|1|||
147298289|NCT03315143|531257806|FG000|Overall Study|Death|240|||
147298290|NCT03315143|531257807|FG001|Overall Study|Death|246|||
147453000|NCT01926782|531821492|FG003|Overall Study|Poor compliance to protocol|0|||
147298291|NCT03315143|531257806|FG000|Overall Study|Withdrawal by Subject|57|||
147298292|NCT03315143|531257807|FG001|Overall Study|Withdrawal by Subject|68|||
147298293|NCT03315143|531257806|FG000|Overall Study|Site Terminated by Sponsor|256|||
147298294|NCT03315143|531257807|FG001|Overall Study|Site Terminated by Sponsor|282|||
147453001|NCT01926782|531821493|FG004|Overall Study|Poor compliance to protocol|1|||
147453002|NCT01926782|531821494|FG005|Overall Study|Poor compliance to protocol|6|||
147298295|NCT03315143|531257806|FG000|Overall Study|Study Terminated by Sponsor|4723|||
147298296|NCT03315143|531257807|FG001|Overall Study|Study Terminated by Sponsor|4664|||
147298297|NCT03315143|531257806|FG000|Overall Study|Reason not Specified|16|||
147298298|NCT03315143|531257807|FG001|Overall Study|Reason not Specified|32|||
147298299|NCT02799784|531257808|FG000|Treatment Period 1 (TP1- 8 Weeks)|Lost to Follow-up|1|||
147298300|NCT02799784|531257809|FG001|Treatment Period 1 (TP1- 8 Weeks)|Lost to Follow-up|1|||
147298301|NCT02799784|531257808|FG000|Treatment Period 1 (TP1- 8 Weeks)|Withdrawal by Subject|5|||
147298302|NCT02799784|531257809|FG001|Treatment Period 1 (TP1- 8 Weeks)|Withdrawal by Subject|0|||
147298303|NCT02799784|531257808|FG000|Treatment Period 2 (TP2 - 8 Weeks)|Adverse Event|0|||
147298304|NCT02799784|531257809|FG001|Treatment Period 2 (TP2 - 8 Weeks)|Adverse Event|1|||
147298305|NCT02799784|531257808|FG000|Treatment Period 2 (TP2 - 8 Weeks)|Par. reached protocol stopping criteria|1|||
147298306|NCT02799784|531257809|FG001|Treatment Period 2 (TP2 - 8 Weeks)|Par. reached protocol stopping criteria|0|||
147298307|NCT02799784|531257808|FG000|Treatment Period 2 (TP2 - 8 Weeks)|Lost to Follow-up|0|||
147298308|NCT02799784|531257809|FG001|Treatment Period 2 (TP2 - 8 Weeks)|Lost to Follow-up|1|||
147298309|NCT02799784|531257808|FG000|Treatment Period 2 (TP2 - 8 Weeks)|Withdrawal by Subject|0|||
147298310|NCT02799784|531257809|FG001|Treatment Period 2 (TP2 - 8 Weeks)|Withdrawal by Subject|1|||
147298311|NCT01804816|531257810|FG000|No acupuncture (initial 5 weeks)|Withdrawal by Subject|3|||
147298312|NCT01804816|531257810|FG000|Acupuncture (second 5 weeks)|Physician Decision|1|||
147298313|NCT01050816|531257811|FG000|Overall Study|Lost to Follow-up|2|||
147298314|NCT01050816|531257811|FG000|Overall Study|patient's refusal|2|||
147298315|NCT03086330|531257812|FG000|Overall Study|Withdrawal by Subject|3|||
147298316|NCT03086330|531257813|FG001|Overall Study|Withdrawal by Subject|2|||
147298317|NCT03086330|531257812|FG000|Overall Study|Lost to Follow-up|1|||
147298318|NCT03086330|531257813|FG001|Overall Study|Lost to Follow-up|2|||
147298319|NCT01256411|531257816|FG000|Extension by Maximum Treatment|Protocol deviation|0|||
147298320|NCT01256411|531257817|FG001|Extension by Maximum Treatment|Protocol deviation|0|||
147298321|NCT01256411|531257818|FG002|Extension by Maximum Treatment|Protocol deviation|1|||
147298322|NCT01256411|531257819|FG003|Extension by Maximum Treatment|Protocol deviation|0|||
147298323|NCT01256411|531257820|FG004|Extension by Maximum Treatment|Protocol deviation|0|||
147298324|NCT01256411|531257821|FG005|Extension by Maximum Treatment|Protocol deviation|0|||
147298325|NCT01256411|531257816|FG000|Extension by Maximum Treatment|Lost to Follow-up|1|||
147298326|NCT01256411|531257817|FG001|Extension by Maximum Treatment|Lost to Follow-up|2|||
147298327|NCT01256411|531257818|FG002|Extension by Maximum Treatment|Lost to Follow-up|0|||
147298328|NCT01256411|531257819|FG003|Extension by Maximum Treatment|Lost to Follow-up|0|||
147298329|NCT01256411|531257820|FG004|Extension by Maximum Treatment|Lost to Follow-up|0|||
147298330|NCT01256411|531257821|FG005|Extension by Maximum Treatment|Lost to Follow-up|0|||
147298331|NCT01256411|531257816|FG000|Extension by Maximum Treatment|Withdrawal by Subject|1|||
147298332|NCT01256411|531257817|FG001|Extension by Maximum Treatment|Withdrawal by Subject|6|||
147298333|NCT01256411|531257818|FG002|Extension by Maximum Treatment|Withdrawal by Subject|1|||
147298334|NCT01256411|531257819|FG003|Extension by Maximum Treatment|Withdrawal by Subject|0|||
147298335|NCT01256411|531257820|FG004|Extension by Maximum Treatment|Withdrawal by Subject|0|||
147298336|NCT01256411|531257821|FG005|Extension by Maximum Treatment|Withdrawal by Subject|0|||
147298337|NCT01256411|531257816|FG000|Extension by Maximum Treatment|Lack of Efficacy|1|||
147298338|NCT01256411|531257817|FG001|Extension by Maximum Treatment|Lack of Efficacy|0|||
147298339|NCT01256411|531257818|FG002|Extension by Maximum Treatment|Lack of Efficacy|1|||
147298340|NCT01256411|531257819|FG003|Extension by Maximum Treatment|Lack of Efficacy|0|||
147298341|NCT01256411|531257820|FG004|Extension by Maximum Treatment|Lack of Efficacy|0|||
147298342|NCT01256411|531257821|FG005|Extension by Maximum Treatment|Lack of Efficacy|0|||
147298343|NCT01256411|531257816|FG000|Extension by Maximum Treatment|Adverse Event|4|||
147298344|NCT01256411|531257817|FG001|Extension by Maximum Treatment|Adverse Event|2|||
147298345|NCT01256411|531257818|FG002|Extension by Maximum Treatment|Adverse Event|1|||
147298346|NCT01256411|531257819|FG003|Extension by Maximum Treatment|Adverse Event|0|||
147298347|NCT01256411|531257820|FG004|Extension by Maximum Treatment|Adverse Event|0|||
147298348|NCT01256411|531257821|FG005|Extension by Maximum Treatment|Adverse Event|0|||
147298349|NCT01256411|531257816|FG000|Extension by Mono or Combination Therapy|Adverse Event|0|||
147298350|NCT01256411|531257817|FG001|Extension by Mono or Combination Therapy|Adverse Event|0|||
147298351|NCT01256411|531257818|FG002|Extension by Mono or Combination Therapy|Adverse Event|0|||
147298352|NCT01256411|531257819|FG003|Extension by Mono or Combination Therapy|Adverse Event|0|||
147339625|NCT04723394|531412149|FG001|Overall Study|Death|8|||
147339626|NCT04723394|531412148|FG000|Overall Study|Lost to Follow-up|20|||
147339627|NCT04723394|531412149|FG001|Overall Study|Lost to Follow-up|17|||
147339628|NCT04723394|531412148|FG000|Overall Study|Physician Decision|1|||
147339629|NCT04723394|531412149|FG001|Overall Study|Physician Decision|0|||
147339630|NCT04723394|531412148|FG000|Overall Study|Withdrawal by Subject|20|||
147339631|NCT04723394|531412149|FG001|Overall Study|Withdrawal by Subject|34|||
147339632|NCT04723394|531412148|FG000|Overall Study|Participants withdrawn due to eligibility, eligibility, moving, and being randomized in error.|0|||
147339633|NCT04723394|531412149|FG001|Overall Study|Participants withdrawn due to eligibility, eligibility, moving, and being randomized in error.|2|||
147339634|NCT00371787|531412150|FG000|Overall Study|Withdrawal by Subject|3|||
147339635|NCT00371787|531412151|FG001|Overall Study|Withdrawal by Subject|1|||
147339636|NCT01972724|531412152|FG000|Double-Blind|Rescue Criteria Met|1|||
147298353|NCT01256411|531257820|FG004|Extension by Mono or Combination Therapy|Adverse Event|6|||
147298354|NCT01256411|531257821|FG005|Extension by Mono or Combination Therapy|Adverse Event|1|||
147298355|NCT01256411|531257816|FG000|Extension by Mono or Combination Therapy|Protocol deviation|0|||
147298356|NCT01256411|531257817|FG001|Extension by Mono or Combination Therapy|Protocol deviation|0|||
147298357|NCT01256411|531257818|FG002|Extension by Mono or Combination Therapy|Protocol deviation|0|||
147298358|NCT01256411|531257819|FG003|Extension by Mono or Combination Therapy|Protocol deviation|0|||
147298359|NCT01256411|531257820|FG004|Extension by Mono or Combination Therapy|Protocol deviation|0|||
147298360|NCT01256411|531257821|FG005|Extension by Mono or Combination Therapy|Protocol deviation|1|||
147298361|NCT01256411|531257816|FG000|Extension by Mono or Combination Therapy|Lost to Follow-up|0|||
147298362|NCT01256411|531257817|FG001|Extension by Mono or Combination Therapy|Lost to Follow-up|0|||
147298363|NCT01256411|531257818|FG002|Extension by Mono or Combination Therapy|Lost to Follow-up|0|||
147298364|NCT01256411|531257819|FG003|Extension by Mono or Combination Therapy|Lost to Follow-up|0|||
147298365|NCT01256411|531257820|FG004|Extension by Mono or Combination Therapy|Lost to Follow-up|3|||
147298366|NCT01256411|531257821|FG005|Extension by Mono or Combination Therapy|Lost to Follow-up|0|||
147298367|NCT01256411|531257816|FG000|Extension by Mono or Combination Therapy|Withdrawal by Subject|0|||
147298368|NCT01256411|531257817|FG001|Extension by Mono or Combination Therapy|Withdrawal by Subject|0|||
147298369|NCT01256411|531257818|FG002|Extension by Mono or Combination Therapy|Withdrawal by Subject|0|||
147298370|NCT01256411|531257819|FG003|Extension by Mono or Combination Therapy|Withdrawal by Subject|0|||
147298371|NCT01256411|531257820|FG004|Extension by Mono or Combination Therapy|Withdrawal by Subject|7|||
147298372|NCT01256411|531257821|FG005|Extension by Mono or Combination Therapy|Withdrawal by Subject|1|||
147298373|NCT01256411|531257816|FG000|Extension by Mono or Combination Therapy|Lack of Efficacy|0|||
147298374|NCT01256411|531257817|FG001|Extension by Mono or Combination Therapy|Lack of Efficacy|0|||
147298375|NCT01256411|531257818|FG002|Extension by Mono or Combination Therapy|Lack of Efficacy|0|||
147298376|NCT01256411|531257819|FG003|Extension by Mono or Combination Therapy|Lack of Efficacy|0|||
147298377|NCT01256411|531257820|FG004|Extension by Mono or Combination Therapy|Lack of Efficacy|1|||
147298378|NCT01256411|531257821|FG005|Extension by Mono or Combination Therapy|Lack of Efficacy|1|||
147298379|NCT01445652|531257822|FG000|Overall Study|Not comfortable in lenses|5|||
147298380|NCT01445652|531257823|FG001|Overall Study|Not comfortable in lenses|0|||
147298381|NCT01445652|531257822|FG000|Overall Study|Failed to attend scheduled visit|2|||
147298382|NCT01445652|531257823|FG001|Overall Study|Failed to attend scheduled visit|3|||
147298383|NCT01445652|531257822|FG000|Overall Study|Failed teach session|2|||
147298384|NCT01445652|531257823|FG001|Overall Study|Failed teach session|0|||
147298385|NCT01445652|531257822|FG000|Overall Study|Adverse Event|1|||
147298386|NCT01445652|531257823|FG001|Overall Study|Adverse Event|0|||
147298387|NCT00929162|531257824|FG000|Overall Study|Adverse Event|8|||
147298388|NCT00929162|531257825|FG001|Overall Study|Adverse Event|5|||
147298389|NCT00929162|531257824|FG000|Overall Study|Withdrawal by Subject|3|||
147298390|NCT00929162|531257825|FG001|Overall Study|Withdrawal by Subject|1|||
147298391|NCT00929162|531257824|FG000|Overall Study|Protocol Violation|32|||
147298392|NCT00929162|531257825|FG001|Overall Study|Protocol Violation|30|||
147298393|NCT00929162|531257824|FG000|Overall Study|Other termination reason|5|||
147298394|NCT00929162|531257825|FG001|Overall Study|Other termination reason|6|||
147298395|NCT00117676|531257828|FG000|Double-blind Period Through Week 48|Randomized but Not Treated|4|||
147298396|NCT00117676|531257829|FG001|Double-blind Period Through Week 48|Randomized but Not Treated|3|||
147298397|NCT00117676|531257828|FG000|Double-blind Period Through Week 48|Lost to Follow-up|1|||
147298398|NCT00117676|531257829|FG001|Double-blind Period Through Week 48|Lost to Follow-up|0|||
147298399|NCT00117676|531257828|FG000|Double-blind Period Through Week 48|Protocol Violation|0|||
147298400|NCT00117676|531257829|FG001|Double-blind Period Through Week 48|Protocol Violation|1|||
147298401|NCT00117676|531257828|FG000|Double-blind Period Through Week 48|Safety, Tolerability, or Efficacy Reason|5|||
147298402|NCT00117676|531257829|FG001|Double-blind Period Through Week 48|Safety, Tolerability, or Efficacy Reason|2|||
147298403|NCT00117676|531257828|FG000|Double-blind Period Through Week 48|Withdrew Consent|0|||
147298404|NCT00117676|531257829|FG001|Double-blind Period Through Week 48|Withdrew Consent|1|||
147298405|NCT00117676|531257828|FG000|Open-label Period: Weeks 49 - 96|Lost to Follow-up|2|||
147298406|NCT00117676|531257829|FG001|Open-label Period: Weeks 49 - 96|Lost to Follow-up|0|||
147298407|NCT00117676|531257828|FG000|Open-label Period: Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|3|||
147298408|NCT00117676|531257829|FG001|Open-label Period: Weeks 49 - 96|Safety, Tolerability, or Efficacy Reason|1|||
147298409|NCT00117676|531257828|FG000|Open-label Period: Weeks 49 - 96|Withdrew Consent|5|||
147298410|NCT00117676|531257829|FG001|Open-label Period: Weeks 49 - 96|Withdrew Consent|1|||
147298411|NCT00117676|531257828|FG000|Open-label Period: Weeks 97 - 144|Lost to Follow-up|4|||
147298412|NCT00117676|531257829|FG001|Open-label Period: Weeks 97 - 144|Lost to Follow-up|1|||
147298413|NCT00117676|531257828|FG000|Open-label Period: Weeks 97 - 144|Safety, Tolerability, or Efficacy Reason|1|||
147298414|NCT00117676|531257829|FG001|Open-label Period: Weeks 97 - 144|Safety, Tolerability, or Efficacy Reason|0|||
147298415|NCT00117676|531257828|FG000|Open-label Period: Weeks 97 - 144|Withdrew Consent|1|||
147298416|NCT00117676|531257829|FG001|Open-label Period: Weeks 97 - 144|Withdrew Consent|0|||
147339637|NCT01972724|531412153|FG001|Double-Blind|Rescue Criteria Met|0|||
147339638|NCT01972724|531412154|FG002|Double-Blind|Rescue Criteria Met|0|||
147298417|NCT00117676|531257828|FG000|Open-label Period: Weeks 145 - 192|Investigator's Discretion|2|||
147298418|NCT00117676|531257829|FG001|Open-label Period: Weeks 145 - 192|Investigator's Discretion|0|||
147298419|NCT00117676|531257828|FG000|Open-label Period: Weeks 145 - 192|Lost to Follow-up|3|||
147298420|NCT00117676|531257829|FG001|Open-label Period: Weeks 145 - 192|Lost to Follow-up|1|||
147298421|NCT00117676|531257828|FG000|Open-label Period: Weeks 145 - 192|Withdrew Consent|5|||
147298422|NCT00117676|531257829|FG001|Open-label Period: Weeks 145 - 192|Withdrew Consent|2|||
147298423|NCT00117676|531257828|FG000|Open-label Period: Weeks 193 - 240|Investigator's Discretion|1|||
147298424|NCT00117676|531257829|FG001|Open-label Period: Weeks 193 - 240|Investigator's Discretion|1|||
147298425|NCT00117676|531257828|FG000|Open-label Period: Weeks 193 - 240|Lost to Follow-up|0|||
147298426|NCT00117676|531257829|FG001|Open-label Period: Weeks 193 - 240|Lost to Follow-up|1|||
147298427|NCT00117676|531257828|FG000|Open-label Period: Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|2|||
147298428|NCT00117676|531257829|FG001|Open-label Period: Weeks 193 - 240|Safety, Tolerability, or Efficacy Reason|0|||
147298429|NCT00117676|531257828|FG000|Open-label Period: Weeks 193 - 240|Withdrew Consent|4|||
147298430|NCT00117676|531257829|FG001|Open-label Period: Weeks 193 - 240|Withdrew Consent|1|||
147298431|NCT00117676|531257828|FG000|Open-label Period: Weeks 241 - 288|Investigator's Discretion|0|||
147298432|NCT00117676|531257829|FG001|Open-label Period: Weeks 241 - 288|Investigator's Discretion|1|||
147298433|NCT00117676|531257828|FG000|Open-label Period: Weeks 241 - 288|Lost to Follow-up|2|||
147298434|NCT00117676|531257829|FG001|Open-label Period: Weeks 241 - 288|Lost to Follow-up|1|||
147298435|NCT00117676|531257828|FG000|Open-label Period: Weeks 241 - 288|Protocol Violation|2|||
147298436|NCT00117676|531257829|FG001|Open-label Period: Weeks 241 - 288|Protocol Violation|0|||
147298437|NCT00117676|531257828|FG000|Open-label Period: Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|1|||
147298438|NCT00117676|531257829|FG001|Open-label Period: Weeks 241 - 288|Safety, Tolerability, or Efficacy Reason|0|||
147298439|NCT00117676|531257828|FG000|Open-label Period: Weeks 241 - 288|Withdrew Consent|5|||
147298440|NCT00117676|531257829|FG001|Open-label Period: Weeks 241 - 288|Withdrew Consent|1|||
147298441|NCT00117676|531257828|FG000|Open-label Period: Weeks 289 - 336|Investigator's Discretion|7|||
147298442|NCT00117676|531257829|FG001|Open-label Period: Weeks 289 - 336|Investigator's Discretion|4|||
147298443|NCT00117676|531257828|FG000|Open-label Period: Weeks 289 - 336|Lost to Follow-up|2|||
147298444|NCT00117676|531257829|FG001|Open-label Period: Weeks 289 - 336|Lost to Follow-up|2|||
147298445|NCT00117676|531257828|FG000|Open-label Period: Weeks 289 - 336|Withdrew Consent|0|||
147298446|NCT00117676|531257829|FG001|Open-label Period: Weeks 289 - 336|Withdrew Consent|1|||
147298447|NCT00117676|531257828|FG000|Open-label Period: Weeks 337 - 384|Investigator's Discretion|1|||
147298448|NCT00117676|531257829|FG001|Open-label Period: Weeks 337 - 384|Investigator's Discretion|1|||
147298449|NCT00117676|531257828|FG000|Open-label Period: Weeks 337 - 384|Lost to Follow-up|3|||
147298450|NCT00117676|531257829|FG001|Open-label Period: Weeks 337 - 384|Lost to Follow-up|1|||
147298451|NCT00117676|531257828|FG000|Open-label Period: Weeks 337 - 384|Study Site Discontinued|1|||
147298452|NCT00117676|531257829|FG001|Open-label Period: Weeks 337 - 384|Study Site Discontinued|0|||
147298453|NCT00117676|531257828|FG000|Open-label Period: Weeks 337 - 384|Withdrew Consent|2|||
147298454|NCT00117676|531257829|FG001|Open-label Period: Weeks 337 - 384|Withdrew Consent|1|||
147298455|NCT00117676|531257828|FG000|Open-label Period: Weeks 385 - 432|Investigator's Discretion|0|||
147298456|NCT00117676|531257829|FG001|Open-label Period: Weeks 385 - 432|Investigator's Discretion|1|||
147298457|NCT00117676|531257828|FG000|Open-label Period: Weeks 385 - 432|Safety, Tolerability, or Efficacy Reason|0|||
147298458|NCT00117676|531257829|FG001|Open-label Period: Weeks 385 - 432|Safety, Tolerability, or Efficacy Reason|1|||
147298459|NCT00117676|531257828|FG000|Open-label Period: Weeks 433 - 480|Lost to Follow-up|1|||
147298460|NCT00117676|531257829|FG001|Open-label Period: Weeks 433 - 480|Lost to Follow-up|0|||
147298461|NCT00117676|531257828|FG000|Open-label Period: Weeks 433 - 480|Safety, Tolerability, or Efficacy Reason|1|||
147298462|NCT00117676|531257829|FG001|Open-label Period: Weeks 433 - 480|Safety, Tolerability, or Efficacy Reason|1|||
147298463|NCT00117676|531257828|FG000|Open-label Period: Weeks 433 - 480|Withdrew Consent|0|||
147298464|NCT00117676|531257829|FG001|Open-label Period: Weeks 433 - 480|Withdrew Consent|1|||
147298465|NCT00952822|531257830|FG000|1st Pharmacokinetic Evaluation|Lost to Follow-up|0|||
147298466|NCT00952822|531257831|FG001|1st Pharmacokinetic Evaluation|Lost to Follow-up|1|||
147298467|NCT00952822|531257832|FG002|1st Pharmacokinetic Evaluation|Lost to Follow-up|0|||
147298468|NCT00952822|531257833|FG003|1st Pharmacokinetic Evaluation|Lost to Follow-up|0|||
147298469|NCT00952822|531257830|FG000|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|0|||
147298470|NCT00952822|531257831|FG001|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|0|||
147298471|NCT00952822|531257832|FG002|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|1|||
147298472|NCT00952822|531257833|FG003|2nd Pharmacokinetic Evaluation|Withdrawal by Subject|0|||
147298473|NCT01281644|531257836|FG000|Overall Study|Lost to Follow-up|3|||
147298474|NCT01281644|531257836|FG000|Overall Study|Withdrawal by Subject|2|||
147298475|NCT01755702|531257837|FG000|Wash Out Period I|Other Reason|3|||
147298476|NCT01755702|531257837|FG000|Washout Period II|Other Reason|5|||
147298477|NCT03701399|531257842|FG000|Overall Study|Adverse Event|3|||
147298478|NCT03701399|531257843|FG001|Overall Study|Adverse Event|5|||
147298479|NCT03701399|531257842|FG000|Overall Study|Withdrawal by Subject|6|||
147298480|NCT03701399|531257843|FG001|Overall Study|Withdrawal by Subject|3|||
147339639|NCT01972724|531412152|FG000|Double-Blind|Adverse Event|1|||
147339640|NCT01972724|531412153|FG001|Double-Blind|Adverse Event|0|||
147339641|NCT01972724|531412154|FG002|Double-Blind|Adverse Event|0|||
147339642|NCT01972724|531412152|FG000|Double-Blind|Withdrawal of Consent|2|||
147339643|NCT01972724|531412153|FG001|Double-Blind|Withdrawal of Consent|1|||
147339644|NCT01972724|531412154|FG002|Double-Blind|Withdrawal of Consent|0|||
147339645|NCT01972724|531412152|FG000|Double-Blind|Significant Protocol Deviation|5|||
147339646|NCT01972724|531412153|FG001|Double-Blind|Significant Protocol Deviation|8|||
147339647|NCT01972724|531412154|FG002|Double-Blind|Significant Protocol Deviation|0|||
147339648|NCT01972724|531412152|FG000|Open-Label|Withdrew Consent|0|||
147339649|NCT01972724|531412153|FG001|Open-Label|Withdrew Consent|0|||
147339650|NCT01972724|531412154|FG002|Open-Label|Withdrew Consent|3|||
147339651|NCT01972724|531412152|FG000|Open-Label|Significant Protocol Deviation|0|||
147339652|NCT01972724|531412153|FG001|Open-Label|Significant Protocol Deviation|0|||
147339653|NCT01972724|531412154|FG002|Open-Label|Significant Protocol Deviation|2|||
147339654|NCT01546753|531412162|FG000|Overall Study|anxiety|1|||
147339655|NCT01546753|531412163|FG001|Overall Study|anxiety|1|||
147339656|NCT01546753|531412162|FG000|Overall Study|diagnosis of ulcerative colitis|1|||
147339657|NCT01546753|531412163|FG001|Overall Study|diagnosis of ulcerative colitis|0|||
147339658|NCT03036813|531412164|FG000|Overall Study|Adverse Event|6|||
147339659|NCT03036813|531412165|FG001|Overall Study|Adverse Event|11|||
147339660|NCT03036813|531412166|FG002|Overall Study|Adverse Event|6|||
147339661|NCT03036813|531412164|FG000|Overall Study|Withdrawal by Subject|12|||
147339662|NCT03036813|531412165|FG001|Overall Study|Withdrawal by Subject|6|||
147339663|NCT03036813|531412166|FG002|Overall Study|Withdrawal by Subject|10|||
147339664|NCT03036813|531412164|FG000|Overall Study|Lost to Follow-up|1|||
147339665|NCT03036813|531412165|FG001|Overall Study|Lost to Follow-up|1|||
147339666|NCT03036813|531412166|FG002|Overall Study|Lost to Follow-up|0|||
147298481|NCT03701399|531257842|FG000|Overall Study|Investigators decision|1|||
147298482|NCT03701399|531257843|FG001|Overall Study|Investigators decision|2|||
147298483|NCT03701399|531257842|FG000|Overall Study|Lost to Follow-up|1|||
147298484|NCT03701399|531257843|FG001|Overall Study|Lost to Follow-up|2|||
147298485|NCT03701399|531257842|FG000|Overall Study|Death|1|||
147298486|NCT03701399|531257843|FG001|Overall Study|Death|1|||
147298487|NCT03701399|531257842|FG000|Overall Study|Randomized but not treated|1|||
147298488|NCT03701399|531257843|FG001|Overall Study|Randomized but not treated|0|||
147298489|NCT03440372|531257844|FG000|Treatment|Adverse Event|16|||
147298490|NCT03440372|531257845|FG001|Treatment|Adverse Event|8|||
147298491|NCT03440372|531257844|FG000|Treatment|Lack of Efficacy|4|||
147298492|NCT03440372|531257845|FG001|Treatment|Lack of Efficacy|2|||
147298493|NCT03440372|531257844|FG000|Treatment|Withdrawal by Subject|12|||
147298494|NCT03440372|531257845|FG001|Treatment|Withdrawal by Subject|8|||
147298495|NCT03440372|531257844|FG000|Treatment|Lost to Follow-up|1|||
147298496|NCT03440372|531257845|FG001|Treatment|Lost to Follow-up|0|||
147298497|NCT03440372|531257844|FG000|Treatment|Pregnancy|1|||
147298498|NCT03440372|531257845|FG001|Treatment|Pregnancy|0|||
147298499|NCT03440372|531257844|FG000|Treatment|Study Terminated by Sponsor|2|||
147298500|NCT03440372|531257845|FG001|Treatment|Study Terminated by Sponsor|1|||
147298501|NCT03440372|531257844|FG000|Treatment|Other Reason|2|||
147298502|NCT03440372|531257845|FG001|Treatment|Other Reason|3|||
147298503|NCT00448448|531257846|FG000|Overall Study|Withdrawal by Subject|13|||
147298504|NCT00448448|531257847|FG001|Overall Study|Withdrawal by Subject|2|||
147298505|NCT00448448|531257846|FG000|Overall Study|On protocol when study ended|83|||
147298506|NCT00448448|531257847|FG001|Overall Study|On protocol when study ended|36|||
147298507|NCT00448448|531257846|FG000|Overall Study|Lost to Follow-up|2|||
147298508|NCT00448448|531257847|FG001|Overall Study|Lost to Follow-up|1|||
147298509|NCT00448448|531257846|FG000|Overall Study|Wrong diagnosis (n=3) or other|2|||
147298510|NCT00448448|531257847|FG001|Overall Study|Wrong diagnosis (n=3) or other|1|||
147298511|NCT00448448|531257846|FG000|Overall Study|Signed consent lost|0|||
147298512|NCT00448448|531257847|FG001|Overall Study|Signed consent lost|1|||
147298513|NCT03945292|531257848|FG000|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|1|||
147298514|NCT03945292|531257849|FG001|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|0|||
147339667|NCT03036813|531412164|FG000|Overall Study|Physician Decision|2|||
147339668|NCT03036813|531412165|FG001|Overall Study|Physician Decision|1|||
147339669|NCT03036813|531412166|FG002|Overall Study|Physician Decision|1|||
147339670|NCT03036813|531412164|FG000|Overall Study|Non-Compliance|1|||
147339671|NCT03036813|531412165|FG001|Overall Study|Non-Compliance|5|||
147339672|NCT03036813|531412166|FG002|Overall Study|Non-Compliance|3|||
147339673|NCT03036813|531412164|FG000|Overall Study|Pregnancy|0|||
147339674|NCT03036813|531412165|FG001|Overall Study|Pregnancy|0|||
147339675|NCT03036813|531412166|FG002|Overall Study|Pregnancy|1|||
147339676|NCT03036813|531412164|FG000|Overall Study|Other|0|||
147339677|NCT03036813|531412165|FG001|Overall Study|Other|3|||
147339678|NCT03036813|531412166|FG002|Overall Study|Other|5|||
147298515|NCT03945292|531257850|FG002|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|1|||
147298516|NCT03945292|531257851|FG003|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|0|||
147339679|NCT01102231|531412167|FG000|Overall Study|Protocol Violation|3|||
147298517|NCT03945292|531257852|FG004|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|0|||
147453003|NCT01926782|531821489|FG000|Overall Study|Randomized and not treated|0|||
147453004|NCT01926782|531821490|FG001|Overall Study|Randomized and not treated|0|||
147453005|NCT01926782|531821491|FG002|Overall Study|Randomized and not treated|0|||
147453006|NCT01926782|531821492|FG003|Overall Study|Randomized and not treated|1|||
147453007|NCT01926782|531821493|FG004|Overall Study|Randomized and not treated|0|||
147453008|NCT01926782|531821494|FG005|Overall Study|Randomized and not treated|0|||
147606322|NCT02094417|532375208|FG002|Overall Study|Adverse Event|0|||
147606323|NCT02094417|532375209|FG003|Overall Study|Adverse Event|1|||
147606324|NCT02094417|532375206|FG000|Overall Study|Eligibility criteria|0|||
147606325|NCT02094417|532375207|FG001|Overall Study|Eligibility criteria|1|||
147606326|NCT02094417|532375208|FG002|Overall Study|Eligibility criteria|0|||
147298518|NCT03945292|531257853|FG005|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|0|||
147298519|NCT03945292|531257854|FG006|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|0|||
147298520|NCT03945292|531257855|FG007|Double-Blind (DB) Period: Weeks 0 to 48|Withdrawal by Subject|0|||
147298521|NCT03945292|531257848|FG000|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|0|||
147298522|NCT03945292|531257849|FG001|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|0|||
147298523|NCT03945292|531257850|FG002|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|1|||
147298524|NCT03945292|531257851|FG003|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|0|||
147298525|NCT03945292|531257852|FG004|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|0|||
147298526|NCT03945292|531257853|FG005|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|0|||
147298527|NCT03945292|531257854|FG006|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|0|||
147298528|NCT03945292|531257855|FG007|Double-Blind (DB) Period: Weeks 0 to 48|Adverse Event|0|||
147298529|NCT03945292|531257848|FG000|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|0|||
147298530|NCT03945292|531257849|FG001|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|0|||
147298531|NCT03945292|531257850|FG002|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|0|||
147298532|NCT03945292|531257851|FG003|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|0|||
147298533|NCT03945292|531257852|FG004|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|0|||
147298534|NCT03945292|531257853|FG005|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|0|||
147298535|NCT03945292|531257854|FG006|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|0|||
147298536|NCT03945292|531257855|FG007|Open-Label (OL) Period: Weeks 48 to 196|Adverse Event|1|||
147298537|NCT02684006|531257856|FG000|Overall Study|Other|18|||
147298538|NCT02684006|531257857|FG001|Overall Study|Other|6|||
147298539|NCT02684006|531257856|FG000|Overall Study|Protocol Violation|2|||
147298540|NCT02684006|531257857|FG001|Overall Study|Protocol Violation|1|||
147298541|NCT02684006|531257856|FG000|Overall Study|Non-compliance with study drug|1|||
147298542|NCT02684006|531257857|FG001|Overall Study|Non-compliance with study drug|1|||
147298543|NCT02684006|531257856|FG000|Overall Study|No longer met eligibility criteria|6|||
147298544|NCT02684006|531257857|FG001|Overall Study|No longer met eligibility criteria|2|||
147298545|NCT02684006|531257856|FG000|Overall Study|Lost to Follow-up|0|||
147298546|NCT02684006|531257857|FG001|Overall Study|Lost to Follow-up|1|||
147298547|NCT02684006|531257856|FG000|Overall Study|Death|25|||
147298548|NCT02684006|531257857|FG001|Overall Study|Death|22|||
147298549|NCT02684006|531257856|FG000|Overall Study|Global deterioration of health status|18|||
147298550|NCT02684006|531257857|FG001|Overall Study|Global deterioration of health status|20|||
147298551|NCT02684006|531257856|FG000|Overall Study|Physician Decision|15|||
147298552|NCT02684006|531257857|FG001|Overall Study|Physician Decision|8|||
147298553|NCT02684006|531257856|FG000|Overall Study|Adverse Event|86|||
147298554|NCT02684006|531257857|FG001|Overall Study|Adverse Event|65|||
147298555|NCT02684006|531257856|FG000|Overall Study|Withdrawal by Subject|29|||
147298556|NCT02684006|531257857|FG001|Overall Study|Withdrawal by Subject|43|||
147298557|NCT02684006|531257856|FG000|Overall Study|Progressive disease|236|||
147298558|NCT02684006|531257857|FG001|Overall Study|Progressive disease|266|||
147298559|NCT02684006|531257856|FG000|Overall Study|Participation terminated by sponsor|6|||
147298560|NCT02684006|531257857|FG001|Overall Study|Participation terminated by sponsor|9|||
147298561|NCT04642898|531257858|FG000|Overall Study|Withdrawal by Subject|2|||
147298562|NCT04642898|531257859|FG001|Overall Study|Withdrawal by Subject|4|||
147298563|NCT04642898|531257860|FG002|Overall Study|Withdrawal by Subject|4|||
147298564|NCT04642898|531257861|FG003|Overall Study|Withdrawal by Subject|6|||
147298565|NCT04642898|531257862|FG004|Overall Study|Withdrawal by Subject|2|||
147298566|NCT04642898|531257863|FG005|Overall Study|Withdrawal by Subject|6|||
147298567|NCT04642898|531257858|FG000|Overall Study|Lost to Follow-up|0|||
147298568|NCT04642898|531257859|FG001|Overall Study|Lost to Follow-up|0|||
147298569|NCT04642898|531257860|FG002|Overall Study|Lost to Follow-up|0|||
147453009|NCT01926782|531821489|FG000|Overall Study|Withdrawal by Subject|6|||
147606327|NCT02094417|532375209|FG003|Overall Study|Eligibility criteria|0|||
147298570|NCT04642898|531257861|FG003|Overall Study|Lost to Follow-up|2|||
147298571|NCT04642898|531257862|FG004|Overall Study|Lost to Follow-up|0|||
147298572|NCT04642898|531257863|FG005|Overall Study|Lost to Follow-up|1|||
147298573|NCT04642898|531257858|FG000|Overall Study|Therapist left trial before patient completed treatment|1|||
147298574|NCT04642898|531257859|FG001|Overall Study|Therapist left trial before patient completed treatment|0|||
147298575|NCT04642898|531257860|FG002|Overall Study|Therapist left trial before patient completed treatment|0|||
147453010|NCT01926782|531821490|FG001|Overall Study|Withdrawal by Subject|1|||
147339680|NCT01102231|531412167|FG000|Overall Study|Lack of Efficacy|2|||
147339681|NCT01102231|531412167|FG000|Overall Study|Death|2|||
147339682|NCT01102231|531412167|FG000|Overall Study|Adverse Event|3|||
147339683|NCT01102231|531412167|FG000|Overall Study|Withdrawal by Subject|1|||
147339684|NCT01102231|531412167|FG000|Overall Study|Did not received the treatment|4|||
147339685|NCT00311363|531412170|FG000|24-Week Single-Blind Treatment Period|Adverse Event|42|||
147339686|NCT00311363|531412171|FG001|24-Week Single-Blind Treatment Period|Adverse Event|0|||
147339687|NCT00311363|531412172|FG002|24-Week Single-Blind Treatment Period|Adverse Event|0|||
147339688|NCT00311363|531412170|FG000|24-Week Single-Blind Treatment Period|Lack of Efficacy|13|||
147339689|NCT00311363|531412171|FG001|24-Week Single-Blind Treatment Period|Lack of Efficacy|0|||
147339690|NCT00311363|531412172|FG002|24-Week Single-Blind Treatment Period|Lack of Efficacy|0|||
147606328|NCT02094417|532375206|FG000|Overall Study|No responder|4|||
147606329|NCT02094417|532375207|FG001|Overall Study|No responder|4|||
147606330|NCT02094417|532375208|FG002|Overall Study|No responder|4|||
147298576|NCT04642898|531257861|FG003|Overall Study|Therapist left trial before patient completed treatment|0|||
147298577|NCT04642898|531257862|FG004|Overall Study|Therapist left trial before patient completed treatment|0|||
147298578|NCT04642898|531257863|FG005|Overall Study|Therapist left trial before patient completed treatment|1|||
147298579|NCT04642898|531257858|FG000|Overall Study|Ineligible due to conflict of interest with therapist|0|||
147298580|NCT04642898|531257859|FG001|Overall Study|Ineligible due to conflict of interest with therapist|0|||
147298581|NCT04642898|531257860|FG002|Overall Study|Ineligible due to conflict of interest with therapist|0|||
147298582|NCT04642898|531257861|FG003|Overall Study|Ineligible due to conflict of interest with therapist|0|||
147298583|NCT04642898|531257862|FG004|Overall Study|Ineligible due to conflict of interest with therapist|1|||
147298584|NCT04642898|531257863|FG005|Overall Study|Ineligible due to conflict of interest with therapist|0|||
147298585|NCT04280562|531257864|FG000|Study|Adverse Event|2|||
147298586|NCT04280562|531257865|FG001|Study|Adverse Event|0|||
147298587|NCT04280562|531257864|FG000|Study|Lost to Follow-up|3|||
147298588|NCT04280562|531257865|FG001|Study|Lost to Follow-up|3|||
147298589|NCT01368965|531257869|FG000|Overall Study|Lost to Follow-up|12|||
147298590|NCT02618967|531257870|FG000|Overall Study|Lost to Follow-up|0|||
147298591|NCT02618967|531257871|FG001|Overall Study|Lost to Follow-up|0|||
147298592|NCT02618967|531257872|FG002|Overall Study|Lost to Follow-up|1|||
147298593|NCT02618967|531257873|FG003|Overall Study|Lost to Follow-up|0|||
147298594|NCT02618967|531257874|FG004|Overall Study|Lost to Follow-up|2|||
147298595|NCT02618967|531257875|FG005|Overall Study|Lost to Follow-up|0|||
147298596|NCT02618967|531257876|FG006|Overall Study|Lost to Follow-up|0|||
147298597|NCT02618967|531257877|FG007|Overall Study|Lost to Follow-up|0|||
147298598|NCT02618967|531257870|FG000|Overall Study|Withdrawal by Subject|1|||
147298599|NCT02618967|531257871|FG001|Overall Study|Withdrawal by Subject|0|||
147298600|NCT02618967|531257872|FG002|Overall Study|Withdrawal by Subject|0|||
147298601|NCT02618967|531257873|FG003|Overall Study|Withdrawal by Subject|0|||
147298602|NCT02618967|531257874|FG004|Overall Study|Withdrawal by Subject|0|||
147298603|NCT02618967|531257875|FG005|Overall Study|Withdrawal by Subject|0|||
147298604|NCT02618967|531257876|FG006|Overall Study|Withdrawal by Subject|0|||
147298605|NCT02618967|531257877|FG007|Overall Study|Withdrawal by Subject|0|||
147298606|NCT04559568|531257881|FG000|Overall Study|Physician Decision|0|||
147298607|NCT04559568|531257882|FG001|Overall Study|Physician Decision|0|||
147298608|NCT04559568|531257883|FG002|Overall Study|Physician Decision|0|||
147298609|NCT04559568|531257884|FG003|Overall Study|Physician Decision|0|||
147298610|NCT04559568|531257885|FG004|Overall Study|Physician Decision|0|||
147298611|NCT04559568|531257886|FG005|Overall Study|Physician Decision|0|||
147298612|NCT04559568|531257887|FG006|Overall Study|Physician Decision|0|||
147298613|NCT04559568|531257888|FG007|Overall Study|Physician Decision|0|||
147298614|NCT04559568|531257889|FG008|Overall Study|Physician Decision|0|||
147298615|NCT04559568|531257890|FG009|Overall Study|Physician Decision|1|||
147298616|NCT04559568|531257891|FG010|Overall Study|Physician Decision|0|||
147298617|NCT04559568|531257881|FG000|Overall Study|Withdrawal by Subject|0|||
147339691|NCT00311363|531412170|FG000|24-Week Single-Blind Treatment Period|Withdrawal by Subject|27|||
147339692|NCT00311363|531412171|FG001|24-Week Single-Blind Treatment Period|Withdrawal by Subject|0|||
147339693|NCT00311363|531412172|FG002|24-Week Single-Blind Treatment Period|Withdrawal by Subject|0|||
147339694|NCT00311363|531412170|FG000|24-Week Single-Blind Treatment Period|Lost to Follow-up|12|||
147339695|NCT00311363|531412171|FG001|24-Week Single-Blind Treatment Period|Lost to Follow-up|0|||
147339696|NCT00311363|531412172|FG002|24-Week Single-Blind Treatment Period|Lost to Follow-up|0|||
147339697|NCT00311363|531412170|FG000|24-Week Single-Blind Treatment Period|Protocol Violation|8|||
147339698|NCT00311363|531412171|FG001|24-Week Single-Blind Treatment Period|Protocol Violation|0|||
147339699|NCT00311363|531412172|FG002|24-Week Single-Blind Treatment Period|Protocol Violation|0|||
147339700|NCT00311363|531412170|FG000|24-Week Single-Blind Treatment Period|Elective Surgery|1|||
147339701|NCT00311363|531412171|FG001|24-Week Single-Blind Treatment Period|Elective Surgery|0|||
147339702|NCT00311363|531412172|FG002|24-Week Single-Blind Treatment Period|Elective Surgery|0|||
147339703|NCT00311363|531412170|FG000|24-Week Single-Blind Treatment Period|Work Shift Changed to Evenings|1|||
147339704|NCT00311363|531412171|FG001|24-Week Single-Blind Treatment Period|Work Shift Changed to Evenings|0|||
147339705|NCT00311363|531412172|FG002|24-Week Single-Blind Treatment Period|Work Shift Changed to Evenings|0|||
147298618|NCT04559568|531257882|FG001|Overall Study|Withdrawal by Subject|0|||
147298619|NCT04559568|531257883|FG002|Overall Study|Withdrawal by Subject|0|||
147298620|NCT04559568|531257884|FG003|Overall Study|Withdrawal by Subject|0|||
147298621|NCT04559568|531257885|FG004|Overall Study|Withdrawal by Subject|0|||
147298622|NCT04559568|531257886|FG005|Overall Study|Withdrawal by Subject|0|||
147298623|NCT04559568|531257887|FG006|Overall Study|Withdrawal by Subject|0|||
147298624|NCT04559568|531257888|FG007|Overall Study|Withdrawal by Subject|0|||
147298625|NCT04559568|531257889|FG008|Overall Study|Withdrawal by Subject|0|||
147298626|NCT04559568|531257890|FG009|Overall Study|Withdrawal by Subject|0|||
147298627|NCT04559568|531257891|FG010|Overall Study|Withdrawal by Subject|1|||
147298628|NCT05103384|531257894|FG000|Overall Study|Too severely affected Off Meds/Off DBS to complete entire protocol|4|||
147298629|NCT05608499|531257895|FG000|Overall Study|Lack of Efficacy|1|||
147298630|NCT05608499|531257896|FG001|Overall Study|Lack of Efficacy|0|||
147298631|NCT05608499|531257895|FG000|Overall Study|Lost to Follow-up|0|||
147298632|NCT05608499|531257896|FG001|Overall Study|Lost to Follow-up|1|||
147298633|NCT00514735|531257897|FG000|Overall Study|Withdrawal by Subject|13|||
147298634|NCT00514735|531257898|FG001|Overall Study|Withdrawal by Subject|5|||
147298635|NCT00514735|531257897|FG000|Overall Study|Death|1|||
147298636|NCT00514735|531257898|FG001|Overall Study|Death|0|||
147298637|NCT00514735|531257897|FG000|Overall Study|Lost to Follow-up|0|||
147298638|NCT00514735|531257898|FG001|Overall Study|Lost to Follow-up|1|||
147298639|NCT02660827|531257901|FG000|From Study to End of Continued Access|Withdrawal by Subject|21|||
147298640|NCT02660827|531257901|FG000|From Study to End of Continued Access|Withdrawal by Sponsor|2|||
147298641|NCT02660827|531257901|FG000|From Study to End of Continued Access|Adverse Event|3|||
147298642|NCT02660827|531257901|FG000|From Study to End of Continued Access|didn't participate continued access period|5|||
147298643|NCT02660827|531257901|FG000|Period 1: Study Period|Withdrawal by Subject|1|||
147298644|NCT02660827|531257901|FG000|Period 2: Continued Access Period|Withdrawal by Subject|20|||
147298645|NCT02660827|531257901|FG000|Period 2: Continued Access Period|Withdrawal by Sponsor|2|||
147298646|NCT02660827|531257901|FG000|Period 2: Continued Access Period|Adverse Event|3|||
147298647|NCT01422408|531257902|FG000|Overall Study|Adverse Event|1|||
147298648|NCT01422408|531257902|FG000|Overall Study|Withdrawal by Subject|3|||
147298649|NCT02953938|531257903|FG000|Overall Study|Adverse Event|0|||
147298650|NCT02953938|531257904|FG001|Overall Study|Adverse Event|1|||
147298651|NCT02953938|531257903|FG000|Overall Study|Withdrawal by Subject|1|||
147298652|NCT02953938|531257904|FG001|Overall Study|Withdrawal by Subject|1|||
147298653|NCT04274894|531257909|FG000|Overall Study|Adverse Event|7|||
147298654|NCT04274894|531257909|FG000|Overall Study|Withdrew consent|5|||
147298655|NCT04274894|531257909|FG000|Overall Study|Lost to Follow-up|9|||
147298656|NCT04274894|531257909|FG000|Overall Study|COVID-19 infection|1|||
147298657|NCT04274894|531257909|FG000|Overall Study|Other, not specified|20|||
147298658|NCT03848403|531257910|FG000|Period 2 (Day 8)|Adverse Event|1|||
147298659|NCT03848403|531257911|FG001|Period 2 (Day 8)|Adverse Event|2|||
147298660|NCT03848403|531257912|FG002|Period 2 (Day 8)|Adverse Event|2|||
147298661|NCT03848403|531257910|FG000|Period 2 (Day 8)|Physician Decision|0|||
147298662|NCT03848403|531257911|FG001|Period 2 (Day 8)|Physician Decision|1|||
147298663|NCT03848403|531257912|FG002|Period 2 (Day 8)|Physician Decision|0|||
147298664|NCT03848403|531257910|FG000|Period 2 (Day 8)|Sponsor Decision|8|||
147298665|NCT03848403|531257911|FG001|Period 2 (Day 8)|Sponsor Decision|6|||
147298666|NCT03848403|531257912|FG002|Period 2 (Day 8)|Sponsor Decision|5|||
147298667|NCT00168038|531257913|FG000|Overall Study|Adverse Event|1|||
147298668|NCT00168038|531257913|FG000|Overall Study|Therapy failure|1|||
147298669|NCT04198805|531257916|FG000|Overall Study|Death|0|||
147298670|NCT04198805|531257917|FG001|Overall Study|Death|0|||
147298671|NCT04198805|531257918|FG002|Overall Study|Death|0|||
147298672|NCT04198805|531257919|FG003|Overall Study|Death|1|||
147298673|NCT04198805|531257916|FG000|Overall Study|Early Termination|8|||
147298674|NCT04198805|531257917|FG001|Overall Study|Early Termination|4|||
147298675|NCT04198805|531257918|FG002|Overall Study|Early Termination|6|||
147298676|NCT04198805|531257919|FG003|Overall Study|Early Termination|9|||
147298677|NCT03599349|531257922|FG000|Overall Study|Lost to Follow-up|1|||
147298678|NCT05007392|531257923|FG000|Overall Study|Randomized but not treated|1|||
147298679|NCT05007392|531257924|FG001|Overall Study|Randomized but not treated|2|||
147298680|NCT05007392|531257923|FG000|Overall Study|Other|5|||
147298681|NCT05007392|531257924|FG001|Overall Study|Other|4|||
147298682|NCT05007392|531257923|FG000|Overall Study|Lost to Follow-up|1|||
147298683|NCT05007392|531257924|FG001|Overall Study|Lost to Follow-up|2|||
147298684|NCT05007392|531257923|FG000|Overall Study|Serum uric acid (SUA) level of <=2.0 milligram per deciliter (mg/dL) for 2 consecutive visits|0|||
147298685|NCT05007392|531257924|FG001|Overall Study|Serum uric acid (SUA) level of <=2.0 milligram per deciliter (mg/dL) for 2 consecutive visits|1|||
147298686|NCT05007392|531257923|FG000|Overall Study|Use of prohibited concomitant drug|1|||
147298687|NCT05007392|531257924|FG001|Overall Study|Use of prohibited concomitant drug|1|||
147298688|NCT05007392|531257923|FG000|Overall Study|Inadequate therapeutic effect or progression of disease|1|||
147298689|NCT05007392|531257924|FG001|Overall Study|Inadequate therapeutic effect or progression of disease|0|||
147298690|NCT05007392|531257923|FG000|Overall Study|Adverse Event|10|||
147298691|NCT05007392|531257924|FG001|Overall Study|Adverse Event|6|||
147298692|NCT05007392|531257923|FG000|Overall Study|Participant choice|5|||
147339706|NCT00311363|531412170|FG000|24-Week Single-Blind Treatment Period|Pregnancy|1|||
147339707|NCT00311363|531412171|FG001|24-Week Single-Blind Treatment Period|Pregnancy|0|||
147339708|NCT00311363|531412172|FG002|24-Week Single-Blind Treatment Period|Pregnancy|0|||
147339709|NCT00311363|531412170|FG000|24-Week Single-Blind Treatment Period|Death|1|||
147339710|NCT00311363|531412171|FG001|24-Week Single-Blind Treatment Period|Death|0|||
147339711|NCT00311363|531412172|FG002|24-Week Single-Blind Treatment Period|Death|0|||
147339712|NCT00311363|531412170|FG000|12-Week Double-Blind Treatment Period|Adverse Event|0|||
147339713|NCT00311363|531412171|FG001|12-Week Double-Blind Treatment Period|Adverse Event|3|||
147339714|NCT00311363|531412172|FG002|12-Week Double-Blind Treatment Period|Adverse Event|0|||
147339715|NCT00311363|531412170|FG000|12-Week Double-Blind Treatment Period|Lost to Follow-up|0|||
147339716|NCT00311363|531412171|FG001|12-Week Double-Blind Treatment Period|Lost to Follow-up|1|||
147339717|NCT00311363|531412172|FG002|12-Week Double-Blind Treatment Period|Lost to Follow-up|2|||
147339718|NCT00311363|531412170|FG000|12-Week Double-Blind Treatment Period|Lack of Efficacy|0|||
147339719|NCT00311363|531412171|FG001|12-Week Double-Blind Treatment Period|Lack of Efficacy|6|||
147339720|NCT00311363|531412172|FG002|12-Week Double-Blind Treatment Period|Lack of Efficacy|4|||
147339721|NCT00311363|531412170|FG000|12-Week Double-Blind Treatment Period|Withdrawal by Subject|0|||
147339722|NCT00311363|531412171|FG001|12-Week Double-Blind Treatment Period|Withdrawal by Subject|2|||
147298693|NCT05007392|531257924|FG001|Overall Study|Participant choice|10|||
147298694|NCT05007392|531257923|FG000|Overall Study|Withdrawal of consent|5|||
147298695|NCT05007392|531257924|FG001|Overall Study|Withdrawal of consent|4|||
147298696|NCT00803452|531257925|FG000|Overall Study|Adverse Event|0|||
147298697|NCT00803452|531257926|FG001|Overall Study|Adverse Event|2|||
147298698|NCT00803452|531257925|FG000|Overall Study|Lost to Follow-up|0|||
147298699|NCT00803452|531257926|FG001|Overall Study|Lost to Follow-up|3|||
147298700|NCT01659151|531257931|FG000|Overall Study|Inadequate TIL growth|1|||
147298701|NCT00939484|531259413|FG000|Overall Study|Progression/Relapse|8|||
147298702|NCT00939484|531259414|FG001|Overall Study|Progression/Relapse|20|||
147298703|NCT00939484|531259415|FG002|Overall Study|Progression/Relapse|3|||
147298704|NCT04233372|531259416|FG000|Overall Study|Lost to Follow-up|104|||
147298705|NCT04233372|531259416|FG000|Overall Study|Adverse Event|8|||
147298706|NCT04233372|531259416|FG000|Overall Study|Withdrawal by Subject|2|||
147298707|NCT03938454|531259417|FG000|Overall Study|Protocol Violation|1|||
147298708|NCT03938454|531259417|FG000|Overall Study|Withdrawal by Subject|2|||
147298709|NCT03938454|531259417|FG000|Overall Study|Lost to Follow-up|3|||
147298710|NCT01090310|531259418|FG000|Core Study|Adverse Event|2|||
147298711|NCT01090310|531259419|FG001|Core Study|Adverse Event|2|||
147298712|NCT01090310|531259420|FG002|Core Study|Adverse Event|1|||
147298713|NCT01090310|531259421|FG003|Core Study|Adverse Event|1|||
147298714|NCT01090310|531259418|FG000|Core Study|Subject withdrew consent|0|||
147298715|NCT01090310|531259419|FG001|Core Study|Subject withdrew consent|3|||
147298716|NCT01090310|531259420|FG002|Core Study|Subject withdrew consent|1|||
147298717|NCT01090310|531259421|FG003|Core Study|Subject withdrew consent|1|||
147298718|NCT01090310|531259418|FG000|Core Study|Abnormal test procedure result|0|||
147298719|NCT01090310|531259419|FG001|Core Study|Abnormal test procedure result|0|||
147298720|NCT01090310|531259420|FG002|Core Study|Abnormal test procedure result|1|||
147298721|NCT01090310|531259421|FG003|Core Study|Abnormal test procedure result|0|||
147298722|NCT01090310|531259418|FG000|Core Study|Administrative reasons|5|||
147298723|NCT01090310|531259419|FG001|Core Study|Administrative reasons|6|||
147298724|NCT01090310|531259420|FG002|Core Study|Administrative reasons|4|||
147298725|NCT01090310|531259421|FG003|Core Study|Administrative reasons|4|||
147298726|NCT01090310|531259418|FG000|Core Study|Protocol deviation|1|||
147298727|NCT01090310|531259419|FG001|Core Study|Protocol deviation|0|||
147298728|NCT01090310|531259420|FG002|Core Study|Protocol deviation|0|||
147298729|NCT01090310|531259421|FG003|Core Study|Protocol deviation|1|||
147298730|NCT01090310|531259418|FG000|Extension Study|Aministrative problems|13|||
147298731|NCT01090310|531259419|FG001|Extension Study|Aministrative problems|15|||
147298732|NCT01090310|531259420|FG002|Extension Study|Aministrative problems|14|||
147298733|NCT01090310|531259421|FG003|Extension Study|Aministrative problems|18|||
147298734|NCT01090310|531259418|FG000|Extension Study|Adverse Event|0|||
147339723|NCT00311363|531412172|FG002|12-Week Double-Blind Treatment Period|Withdrawal by Subject|4|||
147339724|NCT00311363|531412170|FG000|12-Week Double-Blind Treatment Period|Protocol Violation|0|||
147339725|NCT00311363|531412171|FG001|12-Week Double-Blind Treatment Period|Protocol Violation|1|||
147298735|NCT01090310|531259419|FG001|Extension Study|Adverse Event|0|||
147298736|NCT01090310|531259420|FG002|Extension Study|Adverse Event|0|||
147298737|NCT01090310|531259421|FG003|Extension Study|Adverse Event|1|||
147298738|NCT01090310|531259418|FG000|Extension Study|Unsatisfactory therapeutic effect|1|||
147298739|NCT01090310|531259419|FG001|Extension Study|Unsatisfactory therapeutic effect|0|||
147298740|NCT01090310|531259420|FG002|Extension Study|Unsatisfactory therapeutic effect|1|||
147298741|NCT01090310|531259421|FG003|Extension Study|Unsatisfactory therapeutic effect|1|||
147298742|NCT01090310|531259418|FG000|Extension Study|Subject withdrew consent|0|||
147298743|NCT01090310|531259419|FG001|Extension Study|Subject withdrew consent|1|||
147339726|NCT00311363|531412172|FG002|12-Week Double-Blind Treatment Period|Protocol Violation|2|||
147298744|NCT01090310|531259420|FG002|Extension Study|Subject withdrew consent|0|||
147298745|NCT01090310|531259421|FG003|Extension Study|Subject withdrew consent|0|||
147339727|NCT00311363|531412170|FG000|12-Week Double-Blind Treatment Period|Per Sponsor, Unknown|0|||
147339728|NCT00311363|531412171|FG001|12-Week Double-Blind Treatment Period|Per Sponsor, Unknown|1|||
147339729|NCT00311363|531412172|FG002|12-Week Double-Blind Treatment Period|Per Sponsor, Unknown|0|||
147339730|NCT01697969|531412173|FG000|Overall Study|Did not meet inc/exc criteria|3|||
147339731|NCT05609032|531412175|FG000|Overall Study|Lost to Follow-up|3|||
147339732|NCT05609032|531412176|FG001|Overall Study|Lost to Follow-up|1|||
147339733|NCT05609032|531412175|FG000|Overall Study|Withdrawal by Subject|1|||
147339734|NCT05609032|531412176|FG001|Overall Study|Withdrawal by Subject|0|||
147339735|NCT03764475|531412177|FG000|Overall Study|Adverse Event|11|||
147339736|NCT03764475|531412178|FG001|Overall Study|Adverse Event|2|||
147339737|NCT03764475|531412177|FG000|Overall Study|Lost to Follow-up|24|||
147339738|NCT03764475|531412178|FG001|Overall Study|Lost to Follow-up|10|||
147339739|NCT03764475|531412177|FG000|Overall Study|Withdrawal by Subject|26|||
147339740|NCT03764475|531412178|FG001|Overall Study|Withdrawal by Subject|10|||
147339741|NCT03764475|531412177|FG000|Overall Study|Lack of Efficacy|3|||
147339742|NCT03764475|531412178|FG001|Overall Study|Lack of Efficacy|0|||
147339743|NCT03764475|531412177|FG000|Overall Study|COVID-19 Disruption|2|||
147339744|NCT03764475|531412178|FG001|Overall Study|COVID-19 Disruption|0|||
147339745|NCT01759771|531412182|FG000|Overall Study|Withdrawal by Subject|1|||
147339746|NCT01759771|531412183|FG001|Overall Study|Withdrawal by Subject|1|||
147339747|NCT02528188|531412184|FG000|Overall Study|Adverse Event|23|||
147339748|NCT02528188|531412185|FG001|Overall Study|Adverse Event|22|||
147339749|NCT02528188|531412186|FG002|Overall Study|Adverse Event|8|||
147339750|NCT02528188|531412184|FG000|Overall Study|Protocol Violation|4|||
147339751|NCT02528188|531412185|FG001|Overall Study|Protocol Violation|6|||
147339752|NCT02528188|531412186|FG002|Overall Study|Protocol Violation|4|||
147339753|NCT02528188|531412184|FG000|Overall Study|Lack of Efficacy|19|||
147339754|NCT02528188|531412185|FG001|Overall Study|Lack of Efficacy|21|||
147339755|NCT02528188|531412186|FG002|Overall Study|Lack of Efficacy|22|||
147339756|NCT02528188|531412184|FG000|Overall Study|Withdrawal by Subject|97|||
147339757|NCT02528188|531412185|FG001|Overall Study|Withdrawal by Subject|104|||
147339758|NCT02528188|531412186|FG002|Overall Study|Withdrawal by Subject|100|||
147339759|NCT02528188|531412184|FG000|Overall Study|Lost to Follow-up|25|||
147339760|NCT02528188|531412185|FG001|Overall Study|Lost to Follow-up|21|||
147339761|NCT02528188|531412186|FG002|Overall Study|Lost to Follow-up|31|||
147339762|NCT02528188|531412184|FG000|Overall Study|Death|4|||
147339763|NCT02528188|531412185|FG001|Overall Study|Death|4|||
147339764|NCT02528188|531412186|FG002|Overall Study|Death|0|||
147339765|NCT02528188|531412184|FG000|Overall Study|Other|89|||
147339766|NCT02528188|531412185|FG001|Overall Study|Other|91|||
147339767|NCT02528188|531412186|FG002|Overall Study|Other|74|||
147339768|NCT02528188|531412184|FG000|Overall Study|Randomized but not treated|6|||
147339769|NCT02528188|531412185|FG001|Overall Study|Randomized but not treated|7|||
147339770|NCT02528188|531412186|FG002|Overall Study|Randomized but not treated|12|||
147339771|NCT05368831|531412187|FG000|200 mg NST-1024 (QD)|Adverse Event|3|||
147339772|NCT00529659|531412188|FG000|Overall Study|Adverse Event|8|||
147339773|NCT00529659|531412189|FG001|Overall Study|Adverse Event|7|||
147339774|NCT00529659|531412188|FG000|Overall Study|Lost to Follow-up|0|||
147339775|NCT00529659|531412189|FG001|Overall Study|Lost to Follow-up|2|||
147339776|NCT00529659|531412188|FG000|Overall Study|Physician Decision|0|||
147339777|NCT00529659|531412189|FG001|Overall Study|Physician Decision|2|||
147298746|NCT00695786|531259422|FG000|Overall Study|Adverse Event|0|||
147298747|NCT00695786|531259423|FG001|Overall Study|Adverse Event|3|||
147298748|NCT00695786|531259424|FG002|Overall Study|Adverse Event|4|||
147298749|NCT00695786|531259425|FG003|Overall Study|Adverse Event|2|||
147298750|NCT00695786|531259422|FG000|Overall Study|Lost to Follow-up|0|||
147298751|NCT00695786|531259423|FG001|Overall Study|Lost to Follow-up|5|||
147298752|NCT00695786|531259424|FG002|Overall Study|Lost to Follow-up|1|||
147298753|NCT00695786|531259425|FG003|Overall Study|Lost to Follow-up|1|||
147298754|NCT00695786|531259422|FG000|Overall Study|Withdrawal by Subject|0|||
147298755|NCT00695786|531259423|FG001|Overall Study|Withdrawal by Subject|4|||
147298756|NCT00695786|531259424|FG002|Overall Study|Withdrawal by Subject|3|||
147298757|NCT00695786|531259425|FG003|Overall Study|Withdrawal by Subject|1|||
147298758|NCT00695786|531259422|FG000|Overall Study|Deemed Ineligible|1|||
147298759|NCT00695786|531259423|FG001|Overall Study|Deemed Ineligible|0|||
147298760|NCT00695786|531259424|FG002|Overall Study|Deemed Ineligible|0|||
147298761|NCT00695786|531259425|FG003|Overall Study|Deemed Ineligible|0|||
147298762|NCT00695786|531259422|FG000|Overall Study|Lack of Efficacy|0|||
147298763|NCT00695786|531259423|FG001|Overall Study|Lack of Efficacy|0|||
147298764|NCT00695786|531259424|FG002|Overall Study|Lack of Efficacy|0|||
147298765|NCT00695786|531259425|FG003|Overall Study|Lack of Efficacy|4|||
147298766|NCT01364922|531259431|FG000|Open-label (OL) Period|Adverse Event|7|||
147298767|NCT01364922|531259432|FG001|Open-label (OL) Period|Adverse Event|0|||
147298768|NCT01364922|531259433|FG002|Open-label (OL) Period|Adverse Event|0|||
147298769|NCT01364922|531259431|FG000|Open-label (OL) Period|Did Not Meet Randomization Criteria|6|||
147298770|NCT01364922|531259432|FG001|Open-label (OL) Period|Did Not Meet Randomization Criteria|0|||
147298771|NCT01364922|531259433|FG002|Open-label (OL) Period|Did Not Meet Randomization Criteria|0|||
147298772|NCT01364922|531259431|FG000|Open-label (OL) Period|Withdrawal by Subject|4|||
147298773|NCT01364922|531259432|FG001|Open-label (OL) Period|Withdrawal by Subject|0|||
147298774|NCT01364922|531259433|FG002|Open-label (OL) Period|Withdrawal by Subject|0|||
147298775|NCT01364922|531259431|FG000|Open-label (OL) Period|Lack of Efficacy|3|||
147298776|NCT01364922|531259432|FG001|Open-label (OL) Period|Lack of Efficacy|0|||
147298777|NCT01364922|531259433|FG002|Open-label (OL) Period|Lack of Efficacy|0|||
147298778|NCT01364922|531259431|FG000|Open-label (OL) Period|Lost to Follow-up|1|||
147298779|NCT01364922|531259432|FG001|Open-label (OL) Period|Lost to Follow-up|0|||
147298780|NCT01364922|531259433|FG002|Open-label (OL) Period|Lost to Follow-up|0|||
147298781|NCT01364922|531259431|FG000|Open-label (OL) Period|Other, Unspecified|1|||
147298782|NCT01364922|531259432|FG001|Open-label (OL) Period|Other, Unspecified|0|||
147298783|NCT01364922|531259433|FG002|Open-label (OL) Period|Other, Unspecified|0|||
147298784|NCT01364922|531259431|FG000|Double-Blind (DB) Period|Lack of Efficacy|0|||
147298785|NCT01364922|531259432|FG001|Double-Blind (DB) Period|Lack of Efficacy|3|||
147298786|NCT01364922|531259433|FG002|Double-Blind (DB) Period|Lack of Efficacy|4|||
147298787|NCT01364922|531259431|FG000|Double-Blind (DB) Period|Subject Noncompliant|0|||
147298788|NCT01364922|531259432|FG001|Double-Blind (DB) Period|Subject Noncompliant|1|||
147298789|NCT01364922|531259433|FG002|Double-Blind (DB) Period|Subject Noncompliant|0|||
147298790|NCT01364922|531259431|FG000|Double-Blind (DB) Period|Adverse Event|0|||
147298791|NCT01364922|531259432|FG001|Double-Blind (DB) Period|Adverse Event|0|||
147298792|NCT01364922|531259433|FG002|Double-Blind (DB) Period|Adverse Event|1|||
147298793|NCT01364922|531259431|FG000|Double-Blind (DB) Period|Other, Unspecified|0|||
147298794|NCT01364922|531259432|FG001|Double-Blind (DB) Period|Other, Unspecified|1|||
147298795|NCT01364922|531259433|FG002|Double-Blind (DB) Period|Other, Unspecified|0|||
147298796|NCT04244396|531259436|FG000|Overall Study|Subject did not meet screening inclusion/exclusion criteria|1|||
147298797|NCT04244396|531259436|FG000|Overall Study|Withdrawal by Subject|2|||
147298798|NCT04244396|531259436|FG000|Overall Study|Study termination|37|||
147298799|NCT01787097|531259437|FG000|Overall Study|Withdrawal by Subject|1|||
147298800|NCT01787097|531259438|FG001|Overall Study|Withdrawal by Subject|0|||
147298801|NCT01787097|531259439|FG002|Overall Study|Withdrawal by Subject|0|||
147298802|NCT01787097|531259440|FG003|Overall Study|Withdrawal by Subject|0|||
147298803|NCT05178121|531259441|FG000|Overall Study|Other|4|||
147298804|NCT05178121|531259441|FG000|Overall Study|Data collection ended before participant reached 6 months|1|||
147298805|NCT01953003|531259442|FG000|Overall Study|Not treated|0|||
147298806|NCT01953003|531259443|FG001|Overall Study|Not treated|1|||
147298807|NCT01953003|531259442|FG000|Overall Study|Progressive disease|35|||
147298808|NCT01953003|531259443|FG001|Overall Study|Progressive disease|45|||
147298809|NCT01953003|531259442|FG000|Overall Study|Related Adverse events|7|||
147298810|NCT01953003|531259443|FG001|Overall Study|Related Adverse events|2|||
147298811|NCT01953003|531259442|FG000|Overall Study|Non-related adverse events|0|||
147298812|NCT01953003|531259443|FG001|Overall Study|Non-related adverse events|2|||
147298813|NCT01953003|531259442|FG000|Overall Study|Protocol Violation|0|||
147298814|NCT01953003|531259443|FG001|Overall Study|Protocol Violation|1|||
147298815|NCT01953003|531259442|FG000|Overall Study|Withdrawal by Subject|14|||
147298816|NCT01953003|531259443|FG001|Overall Study|Withdrawal by Subject|4|||
147298817|NCT00553501|531259446|FG000|Overall Study|Adverse Event|2|||
147298818|NCT00553501|531259446|FG000|Overall Study|Death|1|||
147298819|NCT00553501|531259446|FG000|Overall Study|Progression|1|||
147298820|NCT01464021|531259450|FG000|Overall Study|Withdrawal by Subject|13|||
147298821|NCT01464021|531259450|FG000|Overall Study|Lost to Follow-up|1|||
147298822|NCT01464021|531259450|FG000|Overall Study|Lack of Efficacy|1|||
147298823|NCT01464021|531259450|FG000|Overall Study|various|11|||
147298824|NCT03391765|531259452|FG000|Overall Study|Adverse Event|2|||
147298825|NCT03391765|531259453|FG001|Overall Study|Adverse Event|0|||
147298826|NCT03391765|531259454|FG002|Overall Study|Adverse Event|0|||
147298827|NCT03391765|531259455|FG003|Overall Study|Adverse Event|2|||
147298828|NCT03391765|531259452|FG000|Overall Study|Withdrew consent|5|||
147298829|NCT03391765|531259453|FG001|Overall Study|Withdrew consent|7|||
147298830|NCT03391765|531259454|FG002|Overall Study|Withdrew consent|2|||
147298831|NCT03391765|531259455|FG003|Overall Study|Withdrew consent|5|||
147298832|NCT03391765|531259452|FG000|Overall Study|Other, not specified|44|||
147298833|NCT03391765|531259453|FG001|Overall Study|Other, not specified|38|||
147298834|NCT03391765|531259454|FG002|Overall Study|Other, not specified|21|||
147298835|NCT03391765|531259455|FG003|Overall Study|Other, not specified|16|||
147298836|NCT00944658|531259456|FG000|Treatment 12 Weeks|Adverse Event|0|||
147298837|NCT00944658|531259457|FG001|Treatment 12 Weeks|Adverse Event|2|||
147298838|NCT01255592|531259458|FG000|Overall Study|Adverse Event|5|||
147298839|NCT01255592|531259459|FG001|Overall Study|Adverse Event|0|||
147298840|NCT01255592|531259458|FG000|Overall Study|Withdrawal by Subject|1|||
147298841|NCT01255592|531259459|FG001|Overall Study|Withdrawal by Subject|0|||
147298842|NCT01255592|531259458|FG000|Overall Study|Other|0|||
147298843|NCT01255592|531259459|FG001|Overall Study|Other|1|||
147298844|NCT00838682|531259465|FG000|Overall Study|Lost to Follow-up|21|||
147298845|NCT00838682|531259466|FG001|Overall Study|Lost to Follow-up|14|||
147298846|NCT00838682|531259465|FG000|Overall Study|detection of exclusion criteria|4|||
147298847|NCT00838682|531259466|FG001|Overall Study|detection of exclusion criteria|3|||
147298848|NCT00838682|531259465|FG000|Overall Study|Protocol Violation|0|||
147339778|NCT00529659|531412188|FG000|Overall Study|Protocol Violation|2|||
147339779|NCT00529659|531412189|FG001|Overall Study|Protocol Violation|6|||
147339780|NCT00529659|531412188|FG000|Overall Study|Withdrawal by Subject|1|||
147339781|NCT00529659|531412189|FG001|Overall Study|Withdrawal by Subject|6|||
147339782|NCT03887650|531412190|FG000|Preoperative-48 Hours Postoperative|Withdrawal by Subject|0|||
147339783|NCT03887650|531412191|FG001|Preoperative-48 Hours Postoperative|Withdrawal by Subject|1|||
147339784|NCT03887650|531412190|FG000|48-96 Hours Postoperative|Withdrawal by Subject|0|||
147339785|NCT03887650|531412191|FG001|48-96 Hours Postoperative|Withdrawal by Subject|2|||
147339786|NCT03887650|531412190|FG000|60 Postoperative Days|Withdrawal by Subject|1|||
147339787|NCT03887650|531412191|FG001|60 Postoperative Days|Withdrawal by Subject|0|||
147339788|NCT04200365|531412195|FG000|Overall Study|Adverse Event|2|||
147339789|NCT04200365|531412195|FG000|Overall Study|Progressive Disease|4|||
147339790|NCT04200365|531412195|FG000|Overall Study|Lack of Efficacy|1|||
147339791|NCT04200365|531412195|FG000|Overall Study|Study Closure|4|||
147339792|NCT01499199|531412198|FG000|Overall Study|Adverse Event|1|||
147339793|NCT01499199|531412198|FG000|Overall Study|Lack of Efficacy|1|||
147339794|NCT01692730|531412199|FG000|Overall Study|Lost to Follow-up|225|||
147339795|NCT01692730|531412200|FG001|Overall Study|Lost to Follow-up|227|||
147339796|NCT01199575|531412201|FG000|Overall Study|Withdrawal by Subject|5|||
147339797|NCT01849055|531412202|FG000|Overall Study|Withdrawal by Subject|0|||
147339798|NCT01849055|531412203|FG001|Overall Study|Withdrawal by Subject|0|||
147339799|NCT01849055|531412204|FG002|Overall Study|Withdrawal by Subject|1|||
147339800|NCT01849055|531412205|FG003|Overall Study|Withdrawal by Subject|0|||
147339801|NCT01849055|531412206|FG004|Overall Study|Withdrawal by Subject|0|||
147339802|NCT01849055|531412207|FG005|Overall Study|Withdrawal by Subject|0|||
147339803|NCT00223795|531412208|FG000|First Intervention - Eight Weeks|Lost to Follow-up|7|||
147339804|NCT00223795|531412209|FG001|First Intervention - Eight Weeks|Lost to Follow-up|9|||
147339805|NCT00223795|531412208|FG000|Second Intervention - All Use Canes 4 mo|Lost to Follow-up|1|||
147339806|NCT00223795|531412209|FG001|Second Intervention - All Use Canes 4 mo|Lost to Follow-up|1|||
147339807|NCT02139943|531412216|FG000|Overall Study|Adverse Event|0|||
147339808|NCT02139943|531412217|FG001|Overall Study|Adverse Event|1|||
147339809|NCT02139943|531412218|FG002|Overall Study|Adverse Event|2|||
147339810|NCT02139943|531412216|FG000|Overall Study|Lost to Follow-up|3|||
147339811|NCT02139943|531412217|FG001|Overall Study|Lost to Follow-up|2|||
147339812|NCT02139943|531412218|FG002|Overall Study|Lost to Follow-up|2|||
147339813|NCT02139943|531412216|FG000|Overall Study|Withdrawal by Subject|4|||
147339814|NCT02139943|531412217|FG001|Overall Study|Withdrawal by Subject|3|||
147339815|NCT02139943|531412218|FG002|Overall Study|Withdrawal by Subject|0|||
147339816|NCT02139943|531412216|FG000|Overall Study|Other|0|||
147339817|NCT02139943|531412217|FG001|Overall Study|Other|0|||
147339818|NCT02139943|531412218|FG002|Overall Study|Other|1|||
147339819|NCT02139943|531412216|FG000|Overall Study|Participant wishes to discontinue|2|||
147339820|NCT02139943|531412217|FG001|Overall Study|Participant wishes to discontinue|0|||
147339821|NCT02139943|531412218|FG002|Overall Study|Participant wishes to discontinue|0|||
147339822|NCT02139943|531412216|FG000|Overall Study|Participant in Poor Compliance|1|||
147339823|NCT02139943|531412217|FG001|Overall Study|Participant in Poor Compliance|0|||
147339824|NCT02139943|531412218|FG002|Overall Study|Participant in Poor Compliance|1|||
147339825|NCT02139943|531412216|FG000|Overall Study|eGFR Withdrawal Criteria|0|||
147339826|NCT02139943|531412217|FG001|Overall Study|eGFR Withdrawal Criteria|0|||
147339827|NCT02139943|531412218|FG002|Overall Study|eGFR Withdrawal Criteria|1|||
147339828|NCT02299375|531412219|FG000|Overall Study|Adverse Event, serious fatal|1|||
147339829|NCT02299375|531412220|FG001|Overall Study|Adverse Event, serious fatal|3|||
147339830|NCT02299375|531412219|FG000|Overall Study|Adverse Event, non-fatal|8|||
147339831|NCT02299375|531412220|FG001|Overall Study|Adverse Event, non-fatal|9|||
147339832|NCT02299375|531412219|FG000|Overall Study|Lack of Efficacy|1|||
147339833|NCT02299375|531412220|FG001|Overall Study|Lack of Efficacy|3|||
147339834|NCT02299375|531412219|FG000|Overall Study|Protocol Violation|1|||
147339835|NCT02299375|531412220|FG001|Overall Study|Protocol Violation|3|||
147339836|NCT02299375|531412219|FG000|Overall Study|Other: Met stopping criteria|1|||
147339837|NCT02299375|531412220|FG001|Overall Study|Other: Met stopping criteria|0|||
147662668|NCT02782741|532587388|FG002|Open-label Long-term: Week 50 to 289|Poor compliance to protocol|0|||
147662669|NCT02782741|532587386|FG000|Open-label Long-term: Week 50 to 289|Other|5|||
147662670|NCT02782741|532587387|FG001|Open-label Long-term: Week 50 to 289|Other|4|||
147662671|NCT02782741|532587388|FG002|Open-label Long-term: Week 50 to 289|Other|0|||
147662672|NCT04157088|532587389|FG000|Overall Study|Study terminated by sponsor|23|||
147339838|NCT02299375|531412219|FG000|Overall Study|Other: Study closed/terminated|66|||
147339839|NCT02299375|531412220|FG001|Overall Study|Other: Study closed/terminated|55|||
147339840|NCT02299375|531412219|FG000|Overall Study|Lost to Follow-up|0|||
147339841|NCT02299375|531412220|FG001|Overall Study|Lost to Follow-up|2|||
147339842|NCT02299375|531412219|FG000|Overall Study|Physician Decision|1|||
147339843|NCT02299375|531412220|FG001|Overall Study|Physician Decision|1|||
147339844|NCT02299375|531412219|FG000|Overall Study|Withdrawal by Subject|1|||
147339845|NCT02299375|531412220|FG001|Overall Study|Withdrawal by Subject|4|||
147339846|NCT00704184|531412225|FG000|Double-Blind Treatment|Withdrawal by Subject|1|||
147339847|NCT00704184|531412226|FG001|Double-Blind Treatment|Withdrawal by Subject|0|||
147339848|NCT00704184|531412227|FG002|Double-Blind Treatment|Withdrawal by Subject|0|||
147339849|NCT00704184|531412228|FG003|Double-Blind Treatment|Withdrawal by Subject|0|||
147339850|NCT00704184|531412229|FG004|Double-Blind Treatment|Withdrawal by Subject|0|||
147339851|NCT00704184|531412225|FG000|Open-Label Treatment|Adverse Event|0|||
147339852|NCT00704184|531412226|FG001|Open-Label Treatment|Adverse Event|0|||
147339853|NCT00704184|531412227|FG002|Open-Label Treatment|Adverse Event|2|||
147339854|NCT00704184|531412228|FG003|Open-Label Treatment|Adverse Event|0|||
147339855|NCT00704184|531412229|FG004|Open-Label Treatment|Adverse Event|1|||
147339856|NCT00704184|531412225|FG000|Open-Label Treatment|Lack of Efficacy|0|||
147339857|NCT00704184|531412226|FG001|Open-Label Treatment|Lack of Efficacy|2|||
147339858|NCT00704184|531412227|FG002|Open-Label Treatment|Lack of Efficacy|2|||
147339859|NCT00704184|531412228|FG003|Open-Label Treatment|Lack of Efficacy|2|||
147339860|NCT00704184|531412229|FG004|Open-Label Treatment|Lack of Efficacy|1|||
147339861|NCT00704184|531412225|FG000|Open-Label Treatment|Physician Decision|0|||
147339862|NCT00704184|531412226|FG001|Open-Label Treatment|Physician Decision|0|||
147339863|NCT00704184|531412227|FG002|Open-Label Treatment|Physician Decision|0|||
147339864|NCT00704184|531412228|FG003|Open-Label Treatment|Physician Decision|0|||
147339865|NCT00704184|531412229|FG004|Open-Label Treatment|Physician Decision|1|||
147339866|NCT00704184|531412225|FG000|Open-Label Treatment|Withdrawal by Subject|1|||
147339867|NCT00704184|531412226|FG001|Open-Label Treatment|Withdrawal by Subject|0|||
147339868|NCT00704184|531412227|FG002|Open-Label Treatment|Withdrawal by Subject|0|||
147339869|NCT00704184|531412228|FG003|Open-Label Treatment|Withdrawal by Subject|3|||
147339870|NCT00704184|531412229|FG004|Open-Label Treatment|Withdrawal by Subject|0|||
147339871|NCT00716859|531412230|FG000|Overall Study|Adverse Event|4|||
147339872|NCT00716859|531412231|FG001|Overall Study|Adverse Event|1|||
147339873|NCT00716859|531412230|FG000|Overall Study|Lack of Efficacy|3|||
147339874|NCT00716859|531412231|FG001|Overall Study|Lack of Efficacy|0|||
147339875|NCT00716859|531412230|FG000|Overall Study|Withdrawal by Subject|1|||
147339876|NCT00716859|531412231|FG001|Overall Study|Withdrawal by Subject|3|||
147339877|NCT00716859|531412230|FG000|Overall Study|Not treated|1|||
147339878|NCT00716859|531412231|FG001|Overall Study|Not treated|1|||
147339879|NCT00411216|531412242|FG000|Overall Study|Ten participants were entered into the c|0|||
147339880|NCT00411216|531412243|FG001|Overall Study|Ten participants were entered into the c|2|||
147339881|NCT01251354|531412248|FG000|Overall Study|Adverse Event|1|||
147339882|NCT01251354|531412248|FG000|Overall Study|Investigator's Decision|1|||
147339883|NCT01251354|531412248|FG000|Overall Study|Disease Progression|4|||
147339884|NCT03422276|531414008|FG000|Overall Study|Withdrawal by Subject|21|||
147339885|NCT03422276|531414009|FG001|Overall Study|Withdrawal by Subject|25|||
147339886|NCT03422276|531414010|FG002|Overall Study|Withdrawal by Subject|14|||
147339887|NCT03422276|531414011|FG003|Overall Study|Withdrawal by Subject|16|||
147339888|NCT03422276|531414008|FG000|Overall Study|Death|14|||
147339889|NCT03422276|531414009|FG001|Overall Study|Death|21|||
147339890|NCT03422276|531414010|FG002|Overall Study|Death|3|||
147339891|NCT03422276|531414011|FG003|Overall Study|Death|1|||
147339892|NCT03422276|531414008|FG000|Overall Study|Discontinued, ineligible|4|||
147339893|NCT03422276|531414009|FG001|Overall Study|Discontinued, ineligible|3|||
147339894|NCT03422276|531414010|FG002|Overall Study|Discontinued, ineligible|0|||
147339895|NCT03422276|531414011|FG003|Overall Study|Discontinued, ineligible|0|||
147606331|NCT02094417|532375209|FG003|Overall Study|No responder|3|||
147606332|NCT02094417|532375206|FG000|Overall Study|Unable to conduct observations or assess|0|||
147606333|NCT02094417|532375207|FG001|Overall Study|Unable to conduct observations or assess|1|||
147339896|NCT03422276|531414008|FG000|Overall Study|Lost to Follow-up|15|||
147339897|NCT03422276|531414009|FG001|Overall Study|Lost to Follow-up|8|||
147339898|NCT03422276|531414010|FG002|Overall Study|Lost to Follow-up|13|||
147339899|NCT03422276|531414011|FG003|Overall Study|Lost to Follow-up|4|||
147339900|NCT03422276|531414008|FG000|Overall Study|Discontinued, researcher decided not in participant's best interest|1|||
147339901|NCT03422276|531414009|FG001|Overall Study|Discontinued, researcher decided not in participant's best interest|0|||
147339902|NCT03422276|531414010|FG002|Overall Study|Discontinued, researcher decided not in participant's best interest|1|||
147339903|NCT03422276|531414011|FG003|Overall Study|Discontinued, researcher decided not in participant's best interest|0|||
147339904|NCT03422276|531414008|FG000|Overall Study|Incarcerated prior to first follow-up|0|||
147339905|NCT03422276|531414009|FG001|Overall Study|Incarcerated prior to first follow-up|1|||
147339906|NCT03422276|531414010|FG002|Overall Study|Incarcerated prior to first follow-up|0|||
147339907|NCT03422276|531414011|FG003|Overall Study|Incarcerated prior to first follow-up|0|||
147339908|NCT03422276|531414008|FG000|Overall Study|Discontinued, no longer caregiver for patient participant|0|||
147339909|NCT03422276|531414009|FG001|Overall Study|Discontinued, no longer caregiver for patient participant|0|||
147606334|NCT02094417|532375208|FG002|Overall Study|Unable to conduct observations or assess|0|||
147606335|NCT02094417|532375209|FG003|Overall Study|Unable to conduct observations or assess|0|||
147606336|NCT02094417|532375206|FG000|Overall Study|Withdrawal by Subject|1|||
147606337|NCT02094417|532375207|FG001|Overall Study|Withdrawal by Subject|2|||
147606338|NCT02094417|532375208|FG002|Overall Study|Withdrawal by Subject|1|||
147339910|NCT03422276|531414010|FG002|Overall Study|Discontinued, no longer caregiver for patient participant|10|||
147339911|NCT03422276|531414011|FG003|Overall Study|Discontinued, no longer caregiver for patient participant|3|||
147453011|NCT01926782|531821491|FG002|Overall Study|Withdrawal by Subject|8|||
147453012|NCT01926782|531821492|FG003|Overall Study|Withdrawal by Subject|1|||
147339912|NCT03422276|531414008|FG000|Overall Study|Discontinued, for caregiver, death of patient participant|0|||
147339913|NCT03422276|531414009|FG001|Overall Study|Discontinued, for caregiver, death of patient participant|0|||
147339914|NCT03422276|531414010|FG002|Overall Study|Discontinued, for caregiver, death of patient participant|8|||
147339915|NCT03422276|531414011|FG003|Overall Study|Discontinued, for caregiver, death of patient participant|17|||
147339916|NCT03422276|531414008|FG000|Overall Study|Discontinued, for caregiver, patient participant was determined to be ineligible|0|||
147339917|NCT03422276|531414009|FG001|Overall Study|Discontinued, for caregiver, patient participant was determined to be ineligible|0|||
147339918|NCT03422276|531414010|FG002|Overall Study|Discontinued, for caregiver, patient participant was determined to be ineligible|1|||
147339919|NCT03422276|531414011|FG003|Overall Study|Discontinued, for caregiver, patient participant was determined to be ineligible|0|||
147339920|NCT02279095|531414017|FG000|Overall Study|Non-Compliance|1|||
147339921|NCT02279095|531414017|FG000|Overall Study|Withdrawal by Subject|8|||
147339922|NCT02279095|531414017|FG000|Overall Study|Adverse Event|2|||
147339923|NCT02279095|531414017|FG000|Overall Study|Other|7|||
147339924|NCT02279095|531414017|FG000|Overall Study|Lost to Follow-up|1|||
147453013|NCT01926782|531821493|FG004|Overall Study|Withdrawal by Subject|0|||
147606339|NCT02094417|532375209|FG003|Overall Study|Withdrawal by Subject|3|||
147298849|NCT00838682|531259466|FG001|Overall Study|Protocol Violation|1|||
147298850|NCT00838682|531259465|FG000|Overall Study|Withdrawal by Subject|0|||
147298851|NCT00838682|531259466|FG001|Overall Study|Withdrawal by Subject|1|||
147298852|NCT03928028|531259469|FG000|Overall Study|Physician Decision|9|||
147298853|NCT03928028|531259470|FG001|Overall Study|Physician Decision|6|||
147298854|NCT03928028|531259471|FG002|Overall Study|Physician Decision|3|||
147298855|NCT03928028|531259469|FG000|Overall Study|Withdrawal by Subject|12|||
147298856|NCT03928028|531259470|FG001|Overall Study|Withdrawal by Subject|3|||
147298857|NCT03928028|531259471|FG002|Overall Study|Withdrawal by Subject|3|||
147298858|NCT04525547|531259477|FG000|Overall Study|Not treated with Ofev|2|||
147298859|NCT04525547|531259477|FG000|Overall Study|Off-label use|2|||
147298860|NCT04525547|531259477|FG000|Overall Study|Lost to Follow-up|1|||
147298861|NCT00800202|531259478|FG000|Overall Study|Adverse Event|7|||
147298862|NCT00800202|531259479|FG001|Overall Study|Adverse Event|6|||
147298863|NCT00800202|531259478|FG000|Overall Study|Death|1|||
147298864|NCT00800202|531259479|FG001|Overall Study|Death|0|||
147298865|NCT00800202|531259478|FG000|Overall Study|Other|5|||
147298866|NCT00800202|531259479|FG001|Overall Study|Other|0|||
147298867|NCT00800202|531259478|FG000|Overall Study|Disease Progression|54|||
147298868|NCT00800202|531259479|FG001|Overall Study|Disease Progression|18|||
147298869|NCT02641392|531259485|FG000|Overall Study|Lost to Follow-up|0|||
147298870|NCT02641392|531259486|FG001|Overall Study|Lost to Follow-up|0|||
147298871|NCT02641392|531259487|FG002|Overall Study|Lost to Follow-up|2|||
147298872|NCT02641392|531259485|FG000|Overall Study|Withdrawal by Subject|0|||
147298873|NCT02641392|531259486|FG001|Overall Study|Withdrawal by Subject|0|||
147298874|NCT02641392|531259487|FG002|Overall Study|Withdrawal by Subject|17|||
147298875|NCT02641392|531259485|FG000|Overall Study|Adverse Event|0|||
147298876|NCT02641392|531259486|FG001|Overall Study|Adverse Event|1|||
147298877|NCT02641392|531259487|FG002|Overall Study|Adverse Event|25|||
147298878|NCT02641392|531259485|FG000|Overall Study|Study Terminated by Sponsor|4|||
147298879|NCT02641392|531259486|FG001|Overall Study|Study Terminated by Sponsor|12|||
147298880|NCT02641392|531259487|FG002|Overall Study|Study Terminated by Sponsor|144|||
147298881|NCT02641392|531259485|FG000|Overall Study|Lack of Efficacy|0|||
147298882|NCT02641392|531259486|FG001|Overall Study|Lack of Efficacy|0|||
147298883|NCT02641392|531259487|FG002|Overall Study|Lack of Efficacy|101|||
147298884|NCT02641392|531259485|FG000|Overall Study|Miscellaneous|0|||
147298885|NCT02641392|531259486|FG001|Overall Study|Miscellaneous|0|||
147298886|NCT02641392|531259487|FG002|Overall Study|Miscellaneous|3|||
147298887|NCT02641392|531259485|FG000|Overall Study|Death|0|||
147298888|NCT02641392|531259486|FG001|Overall Study|Death|0|||
147298889|NCT02641392|531259487|FG002|Overall Study|Death|1|||
147298890|NCT02052310|531259488|FG000|Overall Study|Death|64|||
147298891|NCT02052310|531259489|FG001|Overall Study|Death|54|||
147298892|NCT02052310|531259488|FG000|Overall Study|Withdrawal by Subject|37|||
147298893|NCT02052310|531259489|FG001|Overall Study|Withdrawal by Subject|49|||
147298894|NCT02052310|531259488|FG000|Overall Study|Other than specified|32|||
147298895|NCT02052310|531259489|FG001|Overall Study|Other than specified|29|||
147298896|NCT02052310|531259488|FG000|Overall Study|Adverse Event|29|||
147298897|NCT02052310|531259489|FG001|Overall Study|Adverse Event|22|||
147298898|NCT02052310|531259488|FG000|Overall Study|Kidney Transplant|23|||
147298899|NCT02052310|531259489|FG001|Overall Study|Kidney Transplant|29|||
147298900|NCT02052310|531259488|FG000|Overall Study|Physician Decision|14|||
147298901|NCT02052310|531259489|FG001|Overall Study|Physician Decision|7|||
147298902|NCT02052310|531259488|FG000|Overall Study|Lack of Efficacy|6|||
147298903|NCT02052310|531259489|FG001|Overall Study|Lack of Efficacy|1|||
147298904|NCT02052310|531259488|FG000|Overall Study|Site Terminated by Sponsor|5|||
147298905|NCT02052310|531259489|FG001|Overall Study|Site Terminated by Sponsor|13|||
147298906|NCT02052310|531259488|FG000|Overall Study|Lost to Follow-up|4|||
147298907|NCT02052310|531259489|FG001|Overall Study|Lost to Follow-up|2|||
147606340|NCT01473524|532375210|FG000|DB Phase|Adverse Event|4|||
147606341|NCT01473524|532375211|FG001|DB Phase|Adverse Event|8|||
147606342|NCT01473524|532375212|FG002|DB Phase|Adverse Event|2|||
147606343|NCT01473524|532375213|FG003|DB Phase|Adverse Event|0|||
147606344|NCT01473524|532375214|FG004|DB Phase|Adverse Event|0|||
147606345|NCT01473524|532375215|FG005|DB Phase|Adverse Event|0|||
147606346|NCT01473524|532375210|FG000|DB Phase|Death|1|||
147606347|NCT01473524|532375211|FG001|DB Phase|Death|0|||
147606348|NCT01473524|532375212|FG002|DB Phase|Death|0|||
147606349|NCT01473524|532375213|FG003|DB Phase|Death|0|||
147606350|NCT01473524|532375214|FG004|DB Phase|Death|0|||
147606351|NCT01473524|532375215|FG005|DB Phase|Death|0|||
147606352|NCT01473524|532375210|FG000|DB Phase|Withdrawal by Subject|2|||
147662673|NCT04157088|532587389|FG000|Overall Study|Withdrawal by Subject|4|||
147662674|NCT04157088|532587389|FG000|Overall Study|Lost to Follow-up|2|||
147662675|NCT04157088|532587389|FG000|Overall Study|Death|1|||
147662676|NCT02421419|532587390|FG000|Overall Study|Physician Decision|0|||
147662677|NCT02421419|532587391|FG001|Overall Study|Physician Decision|0|||
147662678|NCT02421419|532587392|FG002|Overall Study|Physician Decision|1|||
147662679|NCT01676701|532587394|FG000|Overall Study|Protocol Violation|1|||
147662680|NCT01676701|532587395|FG001|Overall Study|Protocol Violation|0|||
147662681|NCT01676701|532587394|FG000|Overall Study|Sponsor Decision|3|||
147662682|NCT01676701|532587395|FG001|Overall Study|Sponsor Decision|4|||
147662683|NCT02115607|532587396|FG000|Overall Study|Withdrawal by Subject|1|||
147662684|NCT00196105|532587400|FG000|Overall Study|Lost to Follow-up|4|||
147662685|NCT00196105|532587401|FG001|Overall Study|Lost to Follow-up|5|||
147662686|NCT00196105|532587402|FG002|Overall Study|Lost to Follow-up|7|||
147662687|NCT04863872|532587403|FG000|Overall Study|Withdrawal by Subject|4|||
147662688|NCT04863872|532587404|FG001|Overall Study|Withdrawal by Subject|15|||
147662689|NCT04863872|532587403|FG000|Overall Study|Death|5|||
147662690|NCT04863872|532587404|FG001|Overall Study|Death|2|||
147662691|NCT04863872|532587403|FG000|Overall Study|Lost to Follow-up|2|||
147662692|NCT04863872|532587404|FG001|Overall Study|Lost to Follow-up|1|||
147662693|NCT04058028|532587408|FG000|Overall Study|Withdrawal of Consent from Study|12|||
147662694|NCT04058028|532587409|FG001|Overall Study|Withdrawal of Consent from Study|8|||
147662695|NCT04058028|532587410|FG002|Overall Study|Withdrawal of Consent from Study|6|||
147662696|NCT04058028|532587411|FG003|Overall Study|Withdrawal of Consent from Study|7|||
147662697|NCT04058028|532587408|FG000|Overall Study|Decision by Sponsor|13|||
147298908|NCT02052310|531259488|FG000|Overall Study|Protocol Violation|1|||
147298909|NCT02052310|531259489|FG001|Overall Study|Protocol Violation|6|||
147298910|NCT03518125|531259490|FG000|Overall Study|Lost to Follow-up|0|||
147298911|NCT03518125|531259491|FG001|Overall Study|Lost to Follow-up|2|||
147298912|NCT03518125|531259492|FG002|Overall Study|Lost to Follow-up|0|||
147298913|NCT03518125|531259493|FG003|Overall Study|Lost to Follow-up|0|||
147298914|NCT03518125|531259494|FG004|Overall Study|Lost to Follow-up|3|||
147298915|NCT03518125|531259495|FG005|Overall Study|Lost to Follow-up|5|||
147298916|NCT03518125|531259490|FG000|Overall Study|Physician Decision|0|||
147298917|NCT03518125|531259491|FG001|Overall Study|Physician Decision|1|||
147298918|NCT03518125|531259492|FG002|Overall Study|Physician Decision|0|||
147298919|NCT03518125|531259493|FG003|Overall Study|Physician Decision|0|||
147298920|NCT03518125|531259494|FG004|Overall Study|Physician Decision|0|||
147298921|NCT03518125|531259495|FG005|Overall Study|Physician Decision|0|||
147298922|NCT03518125|531259490|FG000|Overall Study|Withdrawal by Subject|1|||
147298923|NCT03518125|531259491|FG001|Overall Study|Withdrawal by Subject|1|||
147298924|NCT03518125|531259492|FG002|Overall Study|Withdrawal by Subject|0|||
147298925|NCT03518125|531259493|FG003|Overall Study|Withdrawal by Subject|1|||
147298926|NCT03518125|531259494|FG004|Overall Study|Withdrawal by Subject|1|||
147298927|NCT03518125|531259495|FG005|Overall Study|Withdrawal by Subject|3|||
147298928|NCT03518125|531259490|FG000|Overall Study|Missed Day 394 Visit|1|||
147298929|NCT03518125|531259491|FG001|Overall Study|Missed Day 394 Visit|0|||
147298930|NCT03518125|531259492|FG002|Overall Study|Missed Day 394 Visit|0|||
147298931|NCT03518125|531259493|FG003|Overall Study|Missed Day 394 Visit|0|||
147298932|NCT03518125|531259494|FG004|Overall Study|Missed Day 394 Visit|0|||
147298933|NCT03518125|531259495|FG005|Overall Study|Missed Day 394 Visit|0|||
147298934|NCT04452877|531259496|FG000|Overall Study|Adverse Event|5|||
147298935|NCT04452877|531259496|FG000|Overall Study|Lost to Follow-up|1|||
147298936|NCT04452877|531259496|FG000|Overall Study|Physician Decision|4|||
147298937|NCT04452877|531259496|FG000|Overall Study|Progressive Disease|18|||
147298938|NCT04452877|531259496|FG000|Overall Study|Withdrawal by Subject|3|||
147298939|NCT01505387|531259497|FG000|Overall Study|Protocol Violation|1|||
147298940|NCT01505387|531259498|FG001|Overall Study|Protocol Violation|0|||
147298941|NCT01505387|531259497|FG000|Overall Study|Withdrawal by Subject|1|||
147298942|NCT01505387|531259498|FG001|Overall Study|Withdrawal by Subject|1|||
147298943|NCT01301391|531259499|FG000|Overall Study|Death|13|||
147298944|NCT01301391|531259499|FG000|Overall Study|Lost to Follow-up|3|||
147298945|NCT01301391|531259499|FG000|Overall Study|Physician Decision|2|||
147298946|NCT01301391|531259499|FG000|Overall Study|Sponsor's decision|8|||
147298947|NCT00595504|531259500|FG000|Overall Study|Withdrawal by Subject|1|||
147298948|NCT00595504|531259501|FG001|Overall Study|Withdrawal by Subject|3|||
147298949|NCT00595504|531259500|FG000|Overall Study|Physician Decision|1|||
147298950|NCT00595504|531259501|FG001|Overall Study|Physician Decision|0|||
147298951|NCT01949870|531259502|FG000|Overall Study|Lack of Efficacy|2|||
147298952|NCT01949870|531259502|FG000|Overall Study|Adverse Event|1|||
147298953|NCT01949870|531259502|FG000|Overall Study|Study termination|1|||
147298954|NCT01949870|531259502|FG000|Overall Study|Eligibility requirements not fulfilled|2|||
147298955|NCT00293267|531259503|FG000|Primary Study - Double-Blind Week 0-48|Never Treated|2|||
147298956|NCT00293267|531259504|FG001|Primary Study - Double-Blind Week 0-48|Never Treated|0|||
147298957|NCT00293267|531259503|FG000|Primary Study - Double-Blind Week 0-48|Adverse Event|1|||
147298958|NCT00293267|531259504|FG001|Primary Study - Double-Blind Week 0-48|Adverse Event|1|||
147298959|NCT00293267|531259503|FG000|Primary Study - Double-Blind Week 0-48|Death|3|||
147298960|NCT00293267|531259504|FG001|Primary Study - Double-Blind Week 0-48|Death|3|||
147298961|NCT00293267|531259503|FG000|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|0|||
147298962|NCT00293267|531259504|FG001|Primary Study - Double-Blind Week 0-48|Lack of Efficacy|2|||
147298963|NCT00293267|531259503|FG000|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|1|||
147298964|NCT00293267|531259504|FG001|Primary Study - Double-Blind Week 0-48|Lost to Follow-up|1|||
147298965|NCT00293267|531259503|FG000|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|1|||
147298966|NCT00293267|531259504|FG001|Primary Study - Double-Blind Week 0-48|Withdrawal by Subject|1|||
147298967|NCT00293267|531259503|FG000|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|33|||
147298968|NCT00293267|531259504|FG001|Primary Study - Double-Blind Week 0-48|Entered OLPVF Phase|60|||
147298969|NCT00293267|531259503|FG000|Extension - Double-Blind Week 49-156|Adverse Event|1|||
147298970|NCT00293267|531259504|FG001|Extension - Double-Blind Week 49-156|Adverse Event|4|||
147298971|NCT00293267|531259503|FG000|Extension - Double-Blind Week 49-156|Lack of Efficacy|7|||
147298972|NCT00293267|531259504|FG001|Extension - Double-Blind Week 49-156|Lack of Efficacy|1|||
147298973|NCT00293267|531259503|FG000|Extension - Double-Blind Week 49-156|Lost to Follow-up|4|||
147298974|NCT00293267|531259504|FG001|Extension - Double-Blind Week 49-156|Lost to Follow-up|0|||
147298975|NCT00293267|531259503|FG000|Extension - Double-Blind Week 49-156|Withdrawal by Subject|13|||
147298976|NCT00293267|531259504|FG001|Extension - Double-Blind Week 49-156|Withdrawal by Subject|4|||
147298977|NCT00293267|531259503|FG000|Extension - Double-Blind Week 49-156|Death|3|||
147298978|NCT00293267|531259504|FG001|Extension - Double-Blind Week 49-156|Death|0|||
147298979|NCT00293267|531259503|FG000|Extension - Double-Blind Week 49-156|Participant relocated or site terminated|2|||
147298980|NCT00293267|531259504|FG001|Extension - Double-Blind Week 49-156|Participant relocated or site terminated|0|||
147298981|NCT00293267|531259503|FG000|Extension - Double-Blind Week 49-156|Other Reason|7|||
147298982|NCT00293267|531259504|FG001|Extension - Double-Blind Week 49-156|Other Reason|0|||
147298983|NCT00293267|531259503|FG000|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|15|||
147298984|NCT00293267|531259504|FG001|Extension - Double-Blind Week 49-156|Entered OLPVF Phase|6|||
147298985|NCT00293267|531259503|FG000|Extension - Open-Label Week 157-240|Adverse Event|5|||
147298986|NCT00293267|531259504|FG001|Extension - Open-Label Week 157-240|Adverse Event|0|||
147298987|NCT00293267|531259503|FG000|Extension - Open-Label Week 157-240|Lack of Efficacy|7|||
147298988|NCT00293267|531259504|FG001|Extension - Open-Label Week 157-240|Lack of Efficacy|0|||
147298989|NCT00293267|531259503|FG000|Extension - Open-Label Week 157-240|Lost to Follow-up|1|||
147298990|NCT00293267|531259504|FG001|Extension - Open-Label Week 157-240|Lost to Follow-up|0|||
147298991|NCT00293267|531259503|FG000|Extension - Open-Label Week 157-240|Withdrawal by Subject|2|||
147298992|NCT00293267|531259504|FG001|Extension - Open-Label Week 157-240|Withdrawal by Subject|1|||
147298993|NCT00293267|531259503|FG000|Extension - Open-Label Week 157-240|Participant relocated or site terminated|2|||
147298994|NCT00293267|531259504|FG001|Extension - Open-Label Week 157-240|Participant relocated or site terminated|0|||
147298995|NCT00293267|531259503|FG000|Extension - Open-Label Week 157-240|Other Reason|3|||
147298996|NCT00293267|531259504|FG001|Extension - Open-Label Week 157-240|Other Reason|1|||
147298997|NCT00293267|531259503|FG000|Open-Label Post Virologic Failure Phase|Adverse Event|2|||
147298998|NCT00293267|531259504|FG001|Open-Label Post Virologic Failure Phase|Adverse Event|3|||
147298999|NCT00293267|531259503|FG000|Open-Label Post Virologic Failure Phase|Lack of Efficacy|23|||
147299000|NCT00293267|531259504|FG001|Open-Label Post Virologic Failure Phase|Lack of Efficacy|19|||
147299001|NCT00293267|531259503|FG000|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|2|||
147299002|NCT00293267|531259504|FG001|Open-Label Post Virologic Failure Phase|Withdrawal by Subject|4|||
147299003|NCT00293267|531259503|FG000|Open-Label Post Virologic Failure Phase|Lost to Follow-up|2|||
147299004|NCT00293267|531259504|FG001|Open-Label Post Virologic Failure Phase|Lost to Follow-up|2|||
147299005|NCT00293267|531259503|FG000|Open-Label Post Virologic Failure Phase|Laboratory Adverse Event|0|||
147299006|NCT00293267|531259504|FG001|Open-Label Post Virologic Failure Phase|Laboratory Adverse Event|2|||
147299007|NCT00293267|531259503|FG000|Open-Label Post Virologic Failure Phase|Participant Moved or Site Terminated|0|||
147299008|NCT00293267|531259504|FG001|Open-Label Post Virologic Failure Phase|Participant Moved or Site Terminated|2|||
147299009|NCT00293267|531259503|FG000|Open-Label Post Virologic Failure Phase|Other Reason|4|||
147299010|NCT00293267|531259504|FG001|Open-Label Post Virologic Failure Phase|Other Reason|5|||
147299011|NCT02182973|531259505|FG000|Overall Study|Withdrawal by Subject|3|||
147299012|NCT02182973|531259506|FG001|Overall Study|Withdrawal by Subject|0|||
147299013|NCT01235546|531259507|FG000|Overall Study|Staff error, medication not administered|1|||
147339925|NCT05938413|531414018|FG000|Overall Study|Lost to Follow-up|1|||
147339926|NCT05938413|531414019|FG001|Overall Study|Lost to Follow-up|7|||
147339927|NCT05938413|531414018|FG000|Overall Study|Withdrawal by Subject|1|||
147339928|NCT05938413|531414019|FG001|Overall Study|Withdrawal by Subject|1|||
147339929|NCT04922021|531414020|FG000|Overall Study|Withdrawal by Subject|4|||
147339930|NCT04922021|531414021|FG001|Overall Study|Withdrawal by Subject|10|||
147339931|NCT04922021|531414020|FG000|Overall Study|Adverse Event|2|||
147339932|NCT04922021|531414021|FG001|Overall Study|Adverse Event|2|||
147339933|NCT04922021|531414020|FG000|Overall Study|Lack of Efficacy|0|||
147339934|NCT04922021|531414021|FG001|Overall Study|Lack of Efficacy|1|||
147339935|NCT04922021|531414020|FG000|Overall Study|Multiple reasons|1|||
147339936|NCT04922021|531414021|FG001|Overall Study|Multiple reasons|0|||
147339937|NCT03237481|531414030|FG000|Overall Study|Lost to Follow-up|1|||
147339938|NCT03237481|531414031|FG001|Overall Study|Lost to Follow-up|0|||
147339939|NCT03237481|531414032|FG002|Overall Study|Lost to Follow-up|0|||
147339940|NCT03237481|531414030|FG000|Overall Study|Protocol Violation|1|||
147339941|NCT03237481|531414031|FG001|Overall Study|Protocol Violation|0|||
147339942|NCT03237481|531414032|FG002|Overall Study|Protocol Violation|0|||
147339943|NCT03237481|531414030|FG000|Overall Study|Withdrawal by Subject|3|||
147339944|NCT03237481|531414031|FG001|Overall Study|Withdrawal by Subject|2|||
147339945|NCT03237481|531414032|FG002|Overall Study|Withdrawal by Subject|1|||
147339946|NCT03481777|531414033|FG000|Overall Study|Withdrawal by Subject|36|||
147339947|NCT03481777|531414034|FG001|Overall Study|Withdrawal by Subject|31|||
147339948|NCT03481777|531414033|FG000|Overall Study|Non stroke = non target population|277|||
147339949|NCT03481777|531414034|FG001|Overall Study|Non stroke = non target population|254|||
147339950|NCT04139668|531414039|FG000|Overall Study|Withdrawal by Subject|1|||
147339951|NCT04300647|531414044|FG000|Pre-Crossover|Death|19|||
147339952|NCT04300647|531414045|FG001|Pre-Crossover|Death|58|||
147339953|NCT04300647|531414046|FG002|Pre-Crossover|Death|0|||
147339954|NCT04300647|531414044|FG000|Pre-Crossover|Lost to Follow-up|0|||
147339955|NCT04300647|531414045|FG001|Pre-Crossover|Lost to Follow-up|3|||
147339956|NCT04300647|531414046|FG002|Pre-Crossover|Lost to Follow-up|0|||
147339957|NCT04300647|531414044|FG000|Pre-Crossover|Withdrawal by Subject|2|||
147339958|NCT04300647|531414045|FG001|Pre-Crossover|Withdrawal by Subject|4|||
147339959|NCT04300647|531414046|FG002|Pre-Crossover|Withdrawal by Subject|0|||
147339960|NCT04300647|531414044|FG000|Pre-Crossover|On-going in Study|24|||
147339961|NCT04300647|531414045|FG001|Pre-Crossover|On-going in Study|61|||
147339962|NCT04300647|531414046|FG002|Pre-Crossover|On-going in Study|0|||
147339963|NCT04300647|531414044|FG000|Post-Crossover|Death|0|||
147339964|NCT04300647|531414045|FG001|Post-Crossover|Death|0|||
147339965|NCT04300647|531414046|FG002|Post-Crossover|Death|3|||
147339966|NCT04300647|531414044|FG000|Post-Crossover|Lost to Follow-up|0|||
147339967|NCT04300647|531414045|FG001|Post-Crossover|Lost to Follow-up|0|||
147339968|NCT04300647|531414046|FG002|Post-Crossover|Lost to Follow-up|1|||
147339969|NCT04300647|531414044|FG000|Post-Crossover|Withdrawal by Subject|0|||
147339970|NCT04300647|531414045|FG001|Post-Crossover|Withdrawal by Subject|0|||
147339971|NCT04300647|531414046|FG002|Post-Crossover|Withdrawal by Subject|1|||
147339972|NCT04300647|531414044|FG000|Post-Crossover|On-going in Study|0|||
147339973|NCT04300647|531414045|FG001|Post-Crossover|On-going in Study|0|||
147339974|NCT04300647|531414046|FG002|Post-Crossover|On-going in Study|8|||
147339975|NCT05386238|531414052|FG000|Overall Study|Lost to Follow-up|3|||
147339976|NCT05386238|531414053|FG001|Overall Study|Lost to Follow-up|2|||
147339977|NCT05386238|531414052|FG000|Overall Study|Withdrawal by Subject|0|||
147339978|NCT05386238|531414053|FG001|Overall Study|Withdrawal by Subject|1|||
147339979|NCT04907474|531414054|FG000|Overall Study|Not eligible for study per Inc/Exc and was not treated. Not included in analysis.|1|||
147339980|NCT04907474|531414055|FG001|Overall Study|Not eligible for study per Inc/Exc and was not treated. Not included in analysis.|0|||
147339981|NCT04714320|531414061|FG000|Overall Study|Voluntary Withdrawal|4|||
147339982|NCT04714320|531414062|FG001|Overall Study|Voluntary Withdrawal|1|||
147339983|NCT04714320|531414063|FG002|Overall Study|Voluntary Withdrawal|2|||
147339984|NCT04714320|531414061|FG000|Overall Study|Adverse Event or Serious Adverse Event (SAE)|0|||
147339985|NCT04714320|531414062|FG001|Overall Study|Adverse Event or Serious Adverse Event (SAE)|0|||
147339986|NCT04714320|531414063|FG002|Overall Study|Adverse Event or Serious Adverse Event (SAE)|1|||
147339987|NCT04714320|531414061|FG000|Overall Study|Reason Not Specified|1|||
147339988|NCT04714320|531414062|FG001|Overall Study|Reason Not Specified|3|||
147339989|NCT04714320|531414063|FG002|Overall Study|Reason Not Specified|3|||
147339990|NCT01353313|531414064|FG000|Overall Study|Lost to Follow-up|22|||
147339991|NCT01353313|531414065|FG001|Overall Study|Lost to Follow-up|23|||
147339992|NCT01353313|531414064|FG000|Overall Study|Incomplete Follow-up or No Study Data|12|||
147339993|NCT01353313|531414065|FG001|Overall Study|Incomplete Follow-up or No Study Data|15|||
147339994|NCT04755660|531414066|FG000|Overall Study|Lost to Follow-up|1|||
147339995|NCT04755660|531414067|FG001|Overall Study|Lost to Follow-up|1|||
147339996|NCT04755660|531414068|FG002|Overall Study|Lost to Follow-up|0|||
147339997|NCT04755660|531414066|FG000|Overall Study|Withdrawal by Subject|0|||
147339998|NCT04755660|531414067|FG001|Overall Study|Withdrawal by Subject|1|||
147339999|NCT04755660|531414068|FG002|Overall Study|Withdrawal by Subject|1|||
147340000|NCT04755660|531414066|FG000|Overall Study|Physician Decision|0|||
147340001|NCT04755660|531414067|FG001|Overall Study|Physician Decision|0|||
147299014|NCT01235546|531259508|FG001|Overall Study|Staff error, medication not administered|0|||
147299015|NCT01235546|531259507|FG000|Overall Study|Protocol Violation|1|||
147299016|NCT01235546|531259508|FG001|Overall Study|Protocol Violation|1|||
147299017|NCT01123382|531259509|FG000|Overall Study|Withdrawal by Subject|1|||
147299018|NCT01123382|531259510|FG001|Overall Study|Withdrawal by Subject|4|||
147299019|NCT01123382|531259509|FG000|Overall Study|Lost to Follow-up|1|||
147299020|NCT01123382|531259510|FG001|Overall Study|Lost to Follow-up|2|||
147299021|NCT02740049|531259511|FG000|Overall Study|Isolated cells did not grow sufficiently|1|||
147299022|NCT02274857|531259512|FG000|Overall Study|Adverse Event|1|||
147299023|NCT02274857|531259513|FG001|Overall Study|Adverse Event|0|||
147299024|NCT02274857|531259512|FG000|Overall Study|Death|1|||
147299025|NCT02274857|531259513|FG001|Overall Study|Death|2|||
147299026|NCT02274857|531259512|FG000|Overall Study|Lost to Follow-up|3|||
147299027|NCT02274857|531259513|FG001|Overall Study|Lost to Follow-up|0|||
147299028|NCT02274857|531259512|FG000|Overall Study|Physician Decision|2|||
147299029|NCT02274857|531259513|FG001|Overall Study|Physician Decision|0|||
147299030|NCT02274857|531259512|FG000|Overall Study|Trial screen failure|0|||
147299031|NCT02274857|531259513|FG001|Overall Study|Trial screen failure|2|||
147299032|NCT02274857|531259512|FG000|Overall Study|Withdrawal by Subject|11|||
147299033|NCT02274857|531259513|FG001|Overall Study|Withdrawal by Subject|2|||
147299034|NCT02274857|531259512|FG000|Overall Study|Other|2|||
147299035|NCT02274857|531259513|FG001|Overall Study|Other|0|||
147299036|NCT02403180|531259516|FG000|Pre-Treatment Period|Withdrawal by subject prior to treatment|0|||
147299037|NCT02403180|531259517|FG001|Pre-Treatment Period|Withdrawal by subject prior to treatment|1|||
147299038|NCT02403180|531259516|FG000|Period 2 (5 Days)|Withdrawal by Subject|0|||
147299039|NCT02403180|531259517|FG001|Period 2 (5 Days)|Withdrawal by Subject|1|||
147299040|NCT03338829|531259520|FG000|Overall Study|Lost to Follow-up|4|||
147299041|NCT03338829|531259521|FG001|Overall Study|Lost to Follow-up|2|||
147299042|NCT03338829|531259522|FG002|Overall Study|Lost to Follow-up|4|||
147299043|NCT03338829|531259520|FG000|Overall Study|Pregnancy loss|1|||
147299044|NCT03338829|531259521|FG001|Overall Study|Pregnancy loss|1|||
147299045|NCT03338829|531259522|FG002|Overall Study|Pregnancy loss|0|||
147299046|NCT03338829|531259520|FG000|Overall Study|Protocol Violation|0|||
147299047|NCT03338829|531259521|FG001|Overall Study|Protocol Violation|1|||
147299048|NCT03338829|531259522|FG002|Overall Study|Protocol Violation|0|||
147299049|NCT02340026|531259523|FG000|Treatment Phase|Withdrawal by Subject|2|||
147299050|NCT02340026|531259524|FG001|Treatment Phase|Withdrawal by Subject|2|||
147299051|NCT02340026|531259523|FG000|Follow-up Phase|Lost to Follow-up|1|||
147299052|NCT02340026|531259524|FG001|Follow-up Phase|Lost to Follow-up|0|||
147299053|NCT04393441|531259534|FG000|Overall Study|Adverse Event|0|||
147299054|NCT04393441|531259535|FG001|Overall Study|Adverse Event|3|||
147299055|NCT04393441|531259534|FG000|Overall Study|Withdrawal by Subject|5|||
147299056|NCT04393441|531259535|FG001|Overall Study|Withdrawal by Subject|7|||
147299057|NCT04393441|531259534|FG000|Overall Study|Lost to Follow-up|0|||
147299058|NCT04393441|531259535|FG001|Overall Study|Lost to Follow-up|2|||
147299059|NCT04393441|531259534|FG000|Overall Study|Protocol Deviation|2|||
147299060|NCT04393441|531259535|FG001|Overall Study|Protocol Deviation|1|||
147299061|NCT04393441|531259534|FG000|Overall Study|Reason not Specified|1|||
147299062|NCT04393441|531259535|FG001|Overall Study|Reason not Specified|1|||
147299063|NCT02782169|531259536|FG000|Overall Study|Lost to Follow-up|1|||
147299064|NCT02782169|531259537|FG001|Overall Study|Lost to Follow-up|2|||
147299065|NCT04003610|531259538|FG000|Overall Study|Lost to Follow-up|0|||
147299066|NCT04003610|531259539|FG001|Overall Study|Lost to Follow-up|1|||
147299067|NCT04003610|531259540|FG002|Overall Study|Lost to Follow-up|0|||
147299068|NCT04003610|531259538|FG000|Overall Study|Death|0|||
147299069|NCT04003610|531259539|FG001|Overall Study|Death|0|||
147299070|NCT04003610|531259540|FG002|Overall Study|Death|3|||
147299071|NCT04003610|531259538|FG000|Overall Study|Study Terminated by Sponsor|0|||
147299072|NCT04003610|531259539|FG001|Overall Study|Study Terminated by Sponsor|0|||
147299073|NCT04003610|531259540|FG002|Overall Study|Study Terminated by Sponsor|3|||
147299074|NCT00771810|531259541|FG000|Overall Study|Adverse Event|3|||
147299075|NCT00771810|531259542|FG001|Overall Study|Adverse Event|0|||
147299076|NCT00771810|531259543|FG002|Overall Study|Adverse Event|2|||
147299077|NCT00771810|531259541|FG000|Overall Study|Lost to Follow-up|0|||
147299078|NCT00771810|531259542|FG001|Overall Study|Lost to Follow-up|0|||
147299079|NCT00771810|531259543|FG002|Overall Study|Lost to Follow-up|1|||
147299080|NCT00771810|531259541|FG000|Overall Study|Physician Decision|1|||
147299081|NCT00771810|531259542|FG001|Overall Study|Physician Decision|2|||
147299082|NCT00771810|531259543|FG002|Overall Study|Physician Decision|2|||
147299083|NCT00771810|531259541|FG000|Overall Study|Protocol Violation|0|||
147299084|NCT00771810|531259542|FG001|Overall Study|Protocol Violation|1|||
147299085|NCT00771810|531259543|FG002|Overall Study|Protocol Violation|1|||
147299086|NCT00771810|531259541|FG000|Overall Study|Withdrawal by Subject|1|||
147299087|NCT00771810|531259542|FG001|Overall Study|Withdrawal by Subject|2|||
147299088|NCT00771810|531259543|FG002|Overall Study|Withdrawal by Subject|0|||
147299089|NCT00771810|531259541|FG000|Overall Study|Other|0|||
147299090|NCT00771810|531259542|FG001|Overall Study|Other|0|||
147606353|NCT01473524|532375211|FG001|DB Phase|Withdrawal by Subject|1|||
147299091|NCT00771810|531259543|FG002|Overall Study|Other|1|||
147340002|NCT04755660|531414068|FG002|Overall Study|Physician Decision|1|||
147340003|NCT02824029|531414070|FG000|Overall Study|Didn't receive treatment|2|||
147340004|NCT02824029|531414070|FG000|Overall Study|Patient decision to discontinue treatment|3|||
147340005|NCT02824029|531414070|FG000|Overall Study|Non-compliant|5|||
147340006|NCT02824029|531414070|FG000|Overall Study|Progression of disease|15|||
147340007|NCT02824029|531414070|FG000|Overall Study|Inadequate response to therapy|2|||
147340008|NCT02824029|531414070|FG000|Overall Study|Possible progression per treating physician|1|||
147340009|NCT00610649|531414074|FG000|Overall Study|Adverse Event|1|||
147340010|NCT00610649|531414075|FG001|Overall Study|Adverse Event|0|||
147340011|NCT00610649|531414076|FG002|Overall Study|Adverse Event|0|||
147340012|NCT00610649|531414077|FG003|Overall Study|Adverse Event|0|||
147340013|NCT00610649|531414078|FG004|Overall Study|Adverse Event|0|||
147340014|NCT00610649|531414079|FG005|Overall Study|Adverse Event|0|||
147340015|NCT00610649|531414080|FG006|Overall Study|Adverse Event|0|||
147340016|NCT00610649|531414081|FG007|Overall Study|Adverse Event|0|||
147340017|NCT00610649|531414082|FG008|Overall Study|Adverse Event|0|||
147340018|NCT00610649|531414083|FG009|Overall Study|Adverse Event|0|||
147340019|NCT00610649|531414084|FG010|Overall Study|Adverse Event|1|||
147340020|NCT00610649|531414074|FG000|Overall Study|Family Emergency|0|||
147340021|NCT00610649|531414075|FG001|Overall Study|Family Emergency|1|||
147340022|NCT00610649|531414076|FG002|Overall Study|Family Emergency|0|||
147340023|NCT00610649|531414077|FG003|Overall Study|Family Emergency|0|||
147340024|NCT00610649|531414078|FG004|Overall Study|Family Emergency|0|||
147340025|NCT00610649|531414079|FG005|Overall Study|Family Emergency|0|||
147340026|NCT00610649|531414080|FG006|Overall Study|Family Emergency|0|||
147340027|NCT00610649|531414081|FG007|Overall Study|Family Emergency|0|||
147340028|NCT00610649|531414082|FG008|Overall Study|Family Emergency|0|||
147340029|NCT00610649|531414083|FG009|Overall Study|Family Emergency|0|||
147340030|NCT00610649|531414084|FG010|Overall Study|Family Emergency|0|||
147340031|NCT00610649|531414074|FG000|Overall Study|Withdrawal by Subject|0|||
147340032|NCT00610649|531414075|FG001|Overall Study|Withdrawal by Subject|0|||
147340033|NCT00610649|531414076|FG002|Overall Study|Withdrawal by Subject|0|||
147340034|NCT00610649|531414077|FG003|Overall Study|Withdrawal by Subject|0|||
147340035|NCT00610649|531414078|FG004|Overall Study|Withdrawal by Subject|0|||
147340036|NCT00610649|531414079|FG005|Overall Study|Withdrawal by Subject|0|||
147340037|NCT00610649|531414080|FG006|Overall Study|Withdrawal by Subject|0|||
147340038|NCT00610649|531414081|FG007|Overall Study|Withdrawal by Subject|0|||
147340039|NCT00610649|531414082|FG008|Overall Study|Withdrawal by Subject|0|||
147340040|NCT00610649|531414083|FG009|Overall Study|Withdrawal by Subject|1|||
147340041|NCT00610649|531414084|FG010|Overall Study|Withdrawal by Subject|0|||
147340042|NCT00332241|531414085|FG000|Overall Study|Lack of Efficacy|6|||
147340043|NCT00332241|531414086|FG001|Overall Study|Lack of Efficacy|1|||
147340044|NCT00332241|531414085|FG000|Overall Study|Adverse Event|3|||
147340045|NCT00332241|531414086|FG001|Overall Study|Adverse Event|5|||
147340046|NCT00332241|531414085|FG000|Overall Study|Withdrawal by Subject|2|||
147340047|NCT00332241|531414086|FG001|Overall Study|Withdrawal by Subject|1|||
147340048|NCT00332241|531414085|FG000|Overall Study|Lost to Follow-up|4|||
147340049|NCT00332241|531414086|FG001|Overall Study|Lost to Follow-up|1|||
147340050|NCT00802464|531414087|FG000|Month 0 - Month 8|Adverse Event|0|||
147340051|NCT00802464|531414088|FG001|Month 0 - Month 8|Adverse Event|1|||
147340052|NCT00802464|531414089|FG002|Month 0 - Month 8|Adverse Event|1|||
147340053|NCT00802464|531414090|FG003|Month 0 - Month 8|Adverse Event|2|||
147340054|NCT00802464|531414087|FG000|Month 0 - Month 8|Protocol Violation|0|||
147340055|NCT00802464|531414088|FG001|Month 0 - Month 8|Protocol Violation|0|||
147340056|NCT00802464|531414089|FG002|Month 0 - Month 8|Protocol Violation|1|||
147340057|NCT00802464|531414090|FG003|Month 0 - Month 8|Protocol Violation|0|||
147340058|NCT00802464|531414087|FG000|Month 0 - Month 8|Withdrawal by Subject|0|||
147340059|NCT00802464|531414088|FG001|Month 0 - Month 8|Withdrawal by Subject|1|||
147340060|NCT00802464|531414089|FG002|Month 0 - Month 8|Withdrawal by Subject|2|||
147340061|NCT00802464|531414090|FG003|Month 0 - Month 8|Withdrawal by Subject|5|||
147340062|NCT00802464|531414087|FG000|Month 0 - Month 8|Lost to Follow-up|0|||
147340063|NCT00802464|531414088|FG001|Month 0 - Month 8|Lost to Follow-up|1|||
147340064|NCT00802464|531414089|FG002|Month 0 - Month 8|Lost to Follow-up|2|||
147340065|NCT00802464|531414090|FG003|Month 0 - Month 8|Lost to Follow-up|2|||
147340066|NCT00802464|531414087|FG000|Month 0 - Month 8|Other|0|||
147340067|NCT00802464|531414088|FG001|Month 0 - Month 8|Other|0|||
147340068|NCT00802464|531414089|FG002|Month 0 - Month 8|Other|1|||
147340069|NCT00802464|531414090|FG003|Month 0 - Month 8|Other|0|||
147340070|NCT00802464|531414087|FG000|Month 8 - Month 14|Adverse Event|0|||
147340071|NCT00802464|531414088|FG001|Month 8 - Month 14|Adverse Event|1|||
147340072|NCT00802464|531414089|FG002|Month 8 - Month 14|Adverse Event|0|||
147340073|NCT00802464|531414090|FG003|Month 8 - Month 14|Adverse Event|0|||
147340074|NCT00802464|531414087|FG000|Month 8 - Month 14|Withdrawal by Subject|1|||
147340075|NCT00802464|531414088|FG001|Month 8 - Month 14|Withdrawal by Subject|1|||
147340076|NCT00802464|531414089|FG002|Month 8 - Month 14|Withdrawal by Subject|0|||
147340077|NCT00802464|531414090|FG003|Month 8 - Month 14|Withdrawal by Subject|0|||
147340078|NCT00802464|531414087|FG000|Month 8 - Month 14|Lost to Follow-up|0|||
147340079|NCT00802464|531414088|FG001|Month 8 - Month 14|Lost to Follow-up|0|||
147340080|NCT00802464|531414089|FG002|Month 8 - Month 14|Lost to Follow-up|1|||
147340081|NCT00802464|531414090|FG003|Month 8 - Month 14|Lost to Follow-up|0|||
147606354|NCT01473524|532375212|FG002|DB Phase|Withdrawal by Subject|1|||
147606355|NCT01473524|532375213|FG003|DB Phase|Withdrawal by Subject|0|||
147606356|NCT01473524|532375214|FG004|DB Phase|Withdrawal by Subject|0|||
147606357|NCT01473524|532375215|FG005|DB Phase|Withdrawal by Subject|0|||
147606358|NCT01473524|532375210|FG000|LTSE Phase|Withdrawal by Subject|0|||
147606359|NCT01473524|532375211|FG001|LTSE Phase|Withdrawal by Subject|0|||
147340082|NCT04512482|531414093|FG000|Second Intervention (1 Day)|Protocol Violation|2|||
147340083|NCT04512482|531414094|FG001|Second Intervention (1 Day)|Protocol Violation|1|||
147340084|NCT01939899|531414095|FG000|Lead-in Dose Finding Phase|Death|0|||
147340085|NCT01939899|531414096|FG001|Lead-in Dose Finding Phase|Death|3|||
147340086|NCT01939899|531414097|FG002|Lead-in Dose Finding Phase|Death|1|||
147340087|NCT01939899|531414098|FG003|Lead-in Dose Finding Phase|Death|0|||
147340088|NCT01939899|531414099|FG004|Lead-in Dose Finding Phase|Death|0|||
147340089|NCT01939899|531414095|FG000|Lead-in Dose Finding Phase|Disease Progression|2|||
147340090|NCT01939899|531414096|FG001|Lead-in Dose Finding Phase|Disease Progression|4|||
147340091|NCT01939899|531414097|FG002|Lead-in Dose Finding Phase|Disease Progression|3|||
147340092|NCT01939899|531414098|FG003|Lead-in Dose Finding Phase|Disease Progression|0|||
147340093|NCT01939899|531414099|FG004|Lead-in Dose Finding Phase|Disease Progression|0|||
147340094|NCT01939899|531414095|FG000|Lead-in Dose Finding Phase|Other|0|||
147340095|NCT01939899|531414096|FG001|Lead-in Dose Finding Phase|Other|0|||
147340096|NCT01939899|531414097|FG002|Lead-in Dose Finding Phase|Other|1|||
147340097|NCT01939899|531414098|FG003|Lead-in Dose Finding Phase|Other|0|||
147340098|NCT01939899|531414099|FG004|Lead-in Dose Finding Phase|Other|0|||
147340099|NCT01939899|531414095|FG000|Phase 2|Withdrawal by Subject|0|||
147340100|NCT01939899|531414096|FG001|Phase 2|Withdrawal by Subject|0|||
147340101|NCT01939899|531414097|FG002|Phase 2|Withdrawal by Subject|0|||
147340102|NCT01939899|531414098|FG003|Phase 2|Withdrawal by Subject|2|||
147340103|NCT01939899|531414099|FG004|Phase 2|Withdrawal by Subject|0|||
147340104|NCT01939899|531414095|FG000|Phase 2|Disease Progression|0|||
147340105|NCT01939899|531414096|FG001|Phase 2|Disease Progression|0|||
147340106|NCT01939899|531414097|FG002|Phase 2|Disease Progression|0|||
147340107|NCT01939899|531414098|FG003|Phase 2|Disease Progression|9|||
147340108|NCT01939899|531414099|FG004|Phase 2|Disease Progression|1|||
147340109|NCT02706717|531414102|FG000|Overall Study|Withdrawal by Subject|1|||
147340110|NCT02706717|531414103|FG001|Overall Study|Withdrawal by Subject|8|||
147340111|NCT02706717|531414102|FG000|Overall Study|Lost to Follow-up|0|||
147340112|NCT02706717|531414103|FG001|Overall Study|Lost to Follow-up|1|||
147340113|NCT02706717|531414102|FG000|Overall Study|Physician Decision|0|||
147340114|NCT02706717|531414103|FG001|Overall Study|Physician Decision|1|||
147340115|NCT02706717|531414102|FG000|Overall Study|Death|0|||
147340116|NCT02706717|531414103|FG001|Overall Study|Death|1|||
147340117|NCT00106080|531414107|FG000|Overall Study|Withdrew/Loss to follow-up|43|||
147340118|NCT00106080|531414108|FG001|Overall Study|Withdrew/Loss to follow-up|27|||
147340119|NCT01414738|531414109|FG000|Overall Study|Death|26|||
147340120|NCT01414738|531414109|FG000|Overall Study|Refused testing|5|||
147340121|NCT01414738|531414109|FG000|Overall Study|Lost to Follow-up|2|||
147340122|NCT01414738|531414109|FG000|Overall Study|Refused, disease progression|8|||
147340123|NCT01414738|531414109|FG000|Overall Study|(Unknown) NOS (Not Otherwise Specified)|3|||
147340124|NCT01266122|531414111|FG000|Overall Study|Lost to Follow-up|6|||
147340125|NCT01266122|531414112|FG001|Overall Study|Lost to Follow-up|6|||
147340126|NCT00421889|531414113|FG000|Overall Study|Adverse Event|1|||
147340127|NCT00421889|531414114|FG001|Overall Study|Adverse Event|0|||
147340128|NCT00421889|531414115|FG002|Overall Study|Adverse Event|1|||
147340129|NCT00421889|531414116|FG003|Overall Study|Adverse Event|1|||
147340130|NCT00421889|531414117|FG004|Overall Study|Adverse Event|1|||
147606360|NCT01473524|532375212|FG002|LTSE Phase|Withdrawal by Subject|0|||
147606361|NCT01473524|532375213|FG003|LTSE Phase|Withdrawal by Subject|3|||
147606362|NCT01473524|532375214|FG004|LTSE Phase|Withdrawal by Subject|3|||
147606363|NCT01473524|532375215|FG005|LTSE Phase|Withdrawal by Subject|6|||
147606364|NCT01473524|532375210|FG000|LTSE Phase|Death|0|||
147606365|NCT01473524|532375211|FG001|LTSE Phase|Death|0|||
147606366|NCT01473524|532375212|FG002|LTSE Phase|Death|0|||
147606367|NCT01473524|532375213|FG003|LTSE Phase|Death|0|||
147340131|NCT00421889|531414118|FG005|Overall Study|Adverse Event|4|||
147340132|NCT00421889|531414119|FG006|Overall Study|Adverse Event|1|||
147340133|NCT00421889|531414120|FG007|Overall Study|Adverse Event|0|||
147340134|NCT00421889|531414121|FG008|Overall Study|Adverse Event|2|||
147340135|NCT00421889|531414113|FG000|Overall Study|Withdrawal by Subject|1|||
147340136|NCT00421889|531414114|FG001|Overall Study|Withdrawal by Subject|3|||
147340137|NCT00421889|531414115|FG002|Overall Study|Withdrawal by Subject|0|||
147340138|NCT00421889|531414116|FG003|Overall Study|Withdrawal by Subject|0|||
147340139|NCT00421889|531414117|FG004|Overall Study|Withdrawal by Subject|2|||
147340140|NCT00421889|531414118|FG005|Overall Study|Withdrawal by Subject|0|||
147340141|NCT00421889|531414119|FG006|Overall Study|Withdrawal by Subject|0|||
147340142|NCT00421889|531414120|FG007|Overall Study|Withdrawal by Subject|0|||
147606368|NCT01473524|532375214|FG004|LTSE Phase|Death|1|||
147606369|NCT01473524|532375215|FG005|LTSE Phase|Death|0|||
147606370|NCT01473524|532375210|FG000|LTSE Phase|Adverse Event of Pruritus|0|||
147340143|NCT00421889|531414121|FG008|Overall Study|Withdrawal by Subject|0|||
147340144|NCT00421889|531414113|FG000|Overall Study|Death|0|||
147340145|NCT00421889|531414114|FG001|Overall Study|Death|0|||
147606371|NCT01473524|532375211|FG001|LTSE Phase|Adverse Event of Pruritus|0|||
147606372|NCT01473524|532375212|FG002|LTSE Phase|Adverse Event of Pruritus|0|||
147606373|NCT01473524|532375213|FG003|LTSE Phase|Adverse Event of Pruritus|1|||
147606374|NCT01473524|532375214|FG004|LTSE Phase|Adverse Event of Pruritus|5|||
147340146|NCT00421889|531414115|FG002|Overall Study|Death|0|||
147340147|NCT00421889|531414116|FG003|Overall Study|Death|0|||
147340148|NCT00421889|531414117|FG004|Overall Study|Death|1|||
147340149|NCT00421889|531414118|FG005|Overall Study|Death|1|||
147340150|NCT00421889|531414119|FG006|Overall Study|Death|0|||
147340151|NCT00421889|531414120|FG007|Overall Study|Death|0|||
147340152|NCT00421889|531414121|FG008|Overall Study|Death|0|||
147340153|NCT00421889|531414113|FG000|Overall Study|Progressive disease|3|||
147340154|NCT00421889|531414114|FG001|Overall Study|Progressive disease|2|||
147340155|NCT00421889|531414115|FG002|Overall Study|Progressive disease|2|||
147340156|NCT00421889|531414116|FG003|Overall Study|Progressive disease|3|||
147340157|NCT00421889|531414117|FG004|Overall Study|Progressive disease|2|||
147340158|NCT00421889|531414118|FG005|Overall Study|Progressive disease|21|||
147340159|NCT00421889|531414119|FG006|Overall Study|Progressive disease|3|||
147340160|NCT00421889|531414120|FG007|Overall Study|Progressive disease|1|||
147340161|NCT00421889|531414121|FG008|Overall Study|Progressive disease|5|||
147340162|NCT00421889|531414113|FG000|Overall Study|Patient/Investigator request|0|||
147340163|NCT00421889|531414114|FG001|Overall Study|Patient/Investigator request|0|||
147340164|NCT00421889|531414115|FG002|Overall Study|Patient/Investigator request|0|||
147340165|NCT00421889|531414116|FG003|Overall Study|Patient/Investigator request|0|||
147340166|NCT00421889|531414117|FG004|Overall Study|Patient/Investigator request|0|||
147340167|NCT00421889|531414118|FG005|Overall Study|Patient/Investigator request|9|||
147340168|NCT00421889|531414119|FG006|Overall Study|Patient/Investigator request|0|||
147340169|NCT00421889|531414120|FG007|Overall Study|Patient/Investigator request|1|||
147340170|NCT00421889|531414121|FG008|Overall Study|Patient/Investigator request|3|||
147340171|NCT00421889|531414113|FG000|Overall Study|Lost to Follow-up|0|||
147340172|NCT00421889|531414114|FG001|Overall Study|Lost to Follow-up|0|||
147340173|NCT00421889|531414115|FG002|Overall Study|Lost to Follow-up|0|||
147340174|NCT00421889|531414116|FG003|Overall Study|Lost to Follow-up|0|||
147340175|NCT00421889|531414117|FG004|Overall Study|Lost to Follow-up|0|||
147340176|NCT00421889|531414118|FG005|Overall Study|Lost to Follow-up|0|||
147340177|NCT00421889|531414119|FG006|Overall Study|Lost to Follow-up|0|||
147340178|NCT00421889|531414120|FG007|Overall Study|Lost to Follow-up|0|||
147340179|NCT00421889|531414121|FG008|Overall Study|Lost to Follow-up|1|||
147340180|NCT00978042|531414122|FG000|Initial Treatment Period|Treated in Error|0|||
147340181|NCT00978042|531414123|FG001|Initial Treatment Period|Treated in Error|3|||
147340182|NCT00978042|531414122|FG000|Initial Treatment Period|Ineligibility|1|||
147340183|NCT00978042|531414123|FG001|Initial Treatment Period|Ineligibility|0|||
147340184|NCT00978042|531414122|FG000|Initial Treatment Period|Lost to Follow-up|21|||
147340185|NCT00978042|531414123|FG001|Initial Treatment Period|Lost to Follow-up|3|||
147340186|NCT00978042|531414122|FG000|Initial Treatment Period|Adverse Event|2|||
147340187|NCT00978042|531414123|FG001|Initial Treatment Period|Adverse Event|0|||
147340188|NCT00978042|531414122|FG000|Initial Treatment Period|Discontinuation by Investigator/Sponsor|2|||
147340189|NCT00978042|531414123|FG001|Initial Treatment Period|Discontinuation by Investigator/Sponsor|0|||
147340190|NCT00978042|531414122|FG000|Initial Treatment Period|Consent withdrawn|22|||
147340191|NCT00978042|531414123|FG001|Initial Treatment Period|Consent withdrawn|9|||
147340192|NCT00978042|531414122|FG000|Initial Treatment Period|Other Miscellaneous Reasons|13|||
147340193|NCT00978042|531414123|FG001|Initial Treatment Period|Other Miscellaneous Reasons|0|||
147340194|NCT00529516|531414124|FG000|Overall Study|Adverse Event|2|||
147606375|NCT01473524|532375215|FG005|LTSE Phase|Adverse Event of Pruritus|2|||
147340195|NCT00529516|531414125|FG001|Overall Study|Adverse Event|1|||
147340196|NCT00529516|531414126|FG002|Overall Study|Adverse Event|0|||
147340197|NCT00529516|531414124|FG000|Overall Study|Withdrawal by Subject|1|||
147340198|NCT00529516|531414125|FG001|Overall Study|Withdrawal by Subject|1|||
147340199|NCT00529516|531414126|FG002|Overall Study|Withdrawal by Subject|0|||
147606376|NCT01473524|532375210|FG000|LTSE Phase|Other Clinical/ Laboratory Adverse Event|0|||
147340200|NCT00529516|531414124|FG000|Overall Study|Lost to Follow-up|0|||
147340201|NCT00529516|531414125|FG001|Overall Study|Lost to Follow-up|0|||
147340202|NCT00529516|531414126|FG002|Overall Study|Lost to Follow-up|1|||
147340203|NCT00703820|531414129|FG000|Overall Study|Adverse Event|12|||
147340204|NCT00703820|531414130|FG001|Overall Study|Adverse Event|17|||
147340205|NCT00703820|531414129|FG000|Overall Study|Death|5|||
147340206|NCT00703820|531414130|FG001|Overall Study|Death|0|||
147340207|NCT00703820|531414129|FG000|Overall Study|Lack of Efficacy|11|||
147340208|NCT00703820|531414130|FG001|Overall Study|Lack of Efficacy|11|||
147340209|NCT00703820|531414129|FG000|Overall Study|Received non-protocol therapy|1|||
147340210|NCT00703820|531414130|FG001|Overall Study|Received non-protocol therapy|0|||
147340211|NCT00703820|531414129|FG000|Overall Study|Physician Decision|4|||
147340212|NCT00703820|531414130|FG001|Overall Study|Physician Decision|5|||
147606377|NCT01473524|532375211|FG001|LTSE Phase|Other Clinical/ Laboratory Adverse Event|0|||
147453014|NCT01926782|531821494|FG005|Overall Study|Withdrawal by Subject|5|||
147453015|NCT01926782|531821489|FG000|Overall Study|Related to study drug administration|0|||
147606378|NCT01473524|532375212|FG002|LTSE Phase|Other Clinical/ Laboratory Adverse Event|0|||
147606379|NCT01473524|532375213|FG003|LTSE Phase|Other Clinical/ Laboratory Adverse Event|2|||
147606380|NCT01473524|532375214|FG004|LTSE Phase|Other Clinical/ Laboratory Adverse Event|4|||
147606381|NCT01473524|532375215|FG005|LTSE Phase|Other Clinical/ Laboratory Adverse Event|6|||
147606382|NCT01473524|532375210|FG000|LTSE Phase|Lost to Follow-up|0|||
147606383|NCT01473524|532375211|FG001|LTSE Phase|Lost to Follow-up|0|||
147606384|NCT01473524|532375212|FG002|LTSE Phase|Lost to Follow-up|0|||
147606385|NCT01473524|532375213|FG003|LTSE Phase|Lost to Follow-up|1|||
147606386|NCT01473524|532375214|FG004|LTSE Phase|Lost to Follow-up|3|||
147606387|NCT01473524|532375215|FG005|LTSE Phase|Lost to Follow-up|2|||
147606388|NCT01473524|532375210|FG000|LTSE Phase|Principal Investigator Decision|0|||
147606389|NCT01473524|532375211|FG001|LTSE Phase|Principal Investigator Decision|0|||
147299092|NCT06223373|531259549|FG000|Overall Study|Lost to Follow-up|1|||
147299093|NCT06223373|531259550|FG001|Overall Study|Lost to Follow-up|2|||
147299094|NCT03421808|531259552|FG000|Overall Study|COVID related problems|2|||
147299095|NCT03421808|531259553|FG001|Overall Study|COVID related problems|0|||
147299096|NCT03421808|531259552|FG000|Overall Study|Withdrawal by Subject|1|||
147299097|NCT03421808|531259553|FG001|Overall Study|Withdrawal by Subject|0|||
147299098|NCT03421808|531259552|FG000|Overall Study|Protocol Violation|0|||
147299099|NCT03421808|531259553|FG001|Overall Study|Protocol Violation|1|||
147299100|NCT03764774|531259554|FG000|Overall Study|Withdrawal by Subject|0|||
147299101|NCT03764774|531259555|FG001|Overall Study|Withdrawal by Subject|0|||
147299102|NCT03764774|531259556|FG002|Overall Study|Withdrawal by Subject|0|||
147299103|NCT03764774|531259557|FG003|Overall Study|Withdrawal by Subject|0|||
147299104|NCT03764774|531259558|FG004|Overall Study|Withdrawal by Subject|0|||
147299105|NCT03764774|531259559|FG005|Overall Study|Withdrawal by Subject|0|||
147299106|NCT03764774|531259560|FG006|Overall Study|Withdrawal by Subject|0|||
147299107|NCT03764774|531259561|FG007|Overall Study|Withdrawal by Subject|0|||
147299108|NCT03764774|531259562|FG008|Overall Study|Withdrawal by Subject|0|||
147299109|NCT03764774|531259563|FG009|Overall Study|Withdrawal by Subject|0|||
147299110|NCT03764774|531259564|FG010|Overall Study|Withdrawal by Subject|1|||
147299111|NCT03764774|531259565|FG011|Overall Study|Withdrawal by Subject|0|||
147299112|NCT03764774|531259566|FG012|Overall Study|Withdrawal by Subject|0|||
147299113|NCT03764774|531259567|FG013|Overall Study|Withdrawal by Subject|0|||
147299114|NCT03764774|531259554|FG000|Overall Study|Adverse Event|0|||
147299115|NCT03764774|531259555|FG001|Overall Study|Adverse Event|0|||
147299116|NCT03764774|531259556|FG002|Overall Study|Adverse Event|0|||
147299117|NCT03764774|531259557|FG003|Overall Study|Adverse Event|0|||
147299118|NCT03764774|531259558|FG004|Overall Study|Adverse Event|0|||
147299119|NCT03764774|531259559|FG005|Overall Study|Adverse Event|0|||
147299120|NCT03764774|531259560|FG006|Overall Study|Adverse Event|0|||
147299121|NCT03764774|531259561|FG007|Overall Study|Adverse Event|0|||
147299122|NCT03764774|531259562|FG008|Overall Study|Adverse Event|0|||
147299123|NCT03764774|531259563|FG009|Overall Study|Adverse Event|0|||
147299124|NCT03764774|531259564|FG010|Overall Study|Adverse Event|0|||
147299125|NCT03764774|531259565|FG011|Overall Study|Adverse Event|0|||
147299126|NCT03764774|531259566|FG012|Overall Study|Adverse Event|2|||
147299127|NCT03764774|531259567|FG013|Overall Study|Adverse Event|0|||
147299128|NCT03764774|531259554|FG000|Overall Study|Lost to Follow-up|0|||
147299129|NCT03764774|531259555|FG001|Overall Study|Lost to Follow-up|0|||
147299130|NCT03764774|531259556|FG002|Overall Study|Lost to Follow-up|0|||
147299131|NCT03764774|531259557|FG003|Overall Study|Lost to Follow-up|0|||
147299132|NCT03764774|531259558|FG004|Overall Study|Lost to Follow-up|0|||
147299133|NCT03764774|531259559|FG005|Overall Study|Lost to Follow-up|0|||
147299134|NCT03764774|531259560|FG006|Overall Study|Lost to Follow-up|0|||
147299135|NCT03764774|531259561|FG007|Overall Study|Lost to Follow-up|0|||
147299136|NCT03764774|531259562|FG008|Overall Study|Lost to Follow-up|0|||
147299137|NCT03764774|531259563|FG009|Overall Study|Lost to Follow-up|0|||
147299138|NCT03764774|531259564|FG010|Overall Study|Lost to Follow-up|0|||
147299139|NCT03764774|531259565|FG011|Overall Study|Lost to Follow-up|0|||
147299140|NCT03764774|531259566|FG012|Overall Study|Lost to Follow-up|0|||
147299141|NCT03764774|531259567|FG013|Overall Study|Lost to Follow-up|1|||
147299142|NCT03764774|531259554|FG000|Overall Study|Physician Decision|0|||
147299143|NCT03764774|531259555|FG001|Overall Study|Physician Decision|0|||
147299144|NCT03764774|531259556|FG002|Overall Study|Physician Decision|0|||
147299145|NCT03764774|531259557|FG003|Overall Study|Physician Decision|0|||
147299146|NCT03764774|531259558|FG004|Overall Study|Physician Decision|0|||
147299147|NCT03764774|531259559|FG005|Overall Study|Physician Decision|0|||
147299148|NCT03764774|531259560|FG006|Overall Study|Physician Decision|0|||
147299149|NCT03764774|531259561|FG007|Overall Study|Physician Decision|0|||
147606390|NCT01473524|532375212|FG002|LTSE Phase|Principal Investigator Decision|0|||
147299150|NCT03764774|531259562|FG008|Overall Study|Physician Decision|0|||
147299151|NCT03764774|531259563|FG009|Overall Study|Physician Decision|4|||
147299152|NCT03764774|531259564|FG010|Overall Study|Physician Decision|1|||
147299153|NCT03764774|531259565|FG011|Overall Study|Physician Decision|4|||
147299154|NCT03764774|531259566|FG012|Overall Study|Physician Decision|9|||
147340213|NCT00703820|531414129|FG000|Overall Study|Withdrawal by Subject|2|||
147340214|NCT00703820|531414130|FG001|Overall Study|Withdrawal by Subject|1|||
147340215|NCT00761605|531414133|FG000|Overall Study|Adverse Event|26|||
147340216|NCT00761605|531414133|FG000|Overall Study|Death|2|||
147340217|NCT00761605|531414133|FG000|Overall Study|Lack of Efficacy|26|||
147340218|NCT00761605|531414133|FG000|Overall Study|Lost to Follow-up|29|||
147340219|NCT00761605|531414133|FG000|Overall Study|Withdrawal by Subject|37|||
147340220|NCT00761605|531414133|FG000|Overall Study|Other|21|||
147340221|NCT01985334|531414138|FG000|Overall Study|Administrative problems|1|||
147340222|NCT01985334|531414139|FG001|Overall Study|Administrative problems|1|||
147340223|NCT01985334|531414140|FG002|Overall Study|Administrative problems|0|||
147340224|NCT01985334|531414141|FG003|Overall Study|Administrative problems|2|||
147340225|NCT01985334|531414142|FG004|Overall Study|Administrative problems|0|||
147340226|NCT01985334|531414143|FG005|Overall Study|Administrative problems|1|||
147340227|NCT01985334|531414144|FG006|Overall Study|Administrative problems|1|||
147340228|NCT01985334|531414145|FG007|Overall Study|Administrative problems|3|||
147340229|NCT01985334|531414138|FG000|Overall Study|Death|1|||
147340230|NCT01985334|531414139|FG001|Overall Study|Death|0|||
147340231|NCT01985334|531414140|FG002|Overall Study|Death|0|||
147340232|NCT01985334|531414141|FG003|Overall Study|Death|3|||
147340233|NCT01985334|531414142|FG004|Overall Study|Death|0|||
147340234|NCT01985334|531414143|FG005|Overall Study|Death|0|||
147340235|NCT01985334|531414144|FG006|Overall Study|Death|1|||
147340236|NCT01985334|531414145|FG007|Overall Study|Death|2|||
147340237|NCT01985334|531414138|FG000|Overall Study|Worsening of disease|0|||
147340238|NCT01985334|531414139|FG001|Overall Study|Worsening of disease|0|||
147340239|NCT01985334|531414140|FG002|Overall Study|Worsening of disease|0|||
147340240|NCT01985334|531414141|FG003|Overall Study|Worsening of disease|1|||
147340241|NCT01985334|531414142|FG004|Overall Study|Worsening of disease|0|||
147340242|NCT01985334|531414143|FG005|Overall Study|Worsening of disease|3|||
147340243|NCT01985334|531414144|FG006|Overall Study|Worsening of disease|0|||
147340244|NCT01985334|531414145|FG007|Overall Study|Worsening of disease|1|||
147340245|NCT01985334|531414138|FG000|Overall Study|Other|2|||
147340246|NCT01985334|531414139|FG001|Overall Study|Other|9|||
147340247|NCT01985334|531414140|FG002|Overall Study|Other|7|||
147340248|NCT01985334|531414141|FG003|Overall Study|Other|17|||
147340249|NCT01985334|531414142|FG004|Overall Study|Other|4|||
147340250|NCT01985334|531414143|FG005|Overall Study|Other|8|||
147340251|NCT01985334|531414144|FG006|Overall Study|Other|4|||
147340252|NCT01985334|531414145|FG007|Overall Study|Other|7|||
147340253|NCT01985334|531414138|FG000|Overall Study|Protocol deviation|6|||
147340254|NCT01985334|531414139|FG001|Overall Study|Protocol deviation|31|||
147340255|NCT01985334|531414140|FG002|Overall Study|Protocol deviation|25|||
147340256|NCT01985334|531414141|FG003|Overall Study|Protocol deviation|84|||
147340257|NCT01985334|531414142|FG004|Overall Study|Protocol deviation|17|||
147340258|NCT01985334|531414143|FG005|Overall Study|Protocol deviation|47|||
147340259|NCT01985334|531414144|FG006|Overall Study|Protocol deviation|15|||
147340260|NCT01985334|531414145|FG007|Overall Study|Protocol deviation|42|||
147340261|NCT01985334|531414138|FG000|Overall Study|Moderate / severe COPD exacerbation|5|||
147340262|NCT01985334|531414139|FG001|Overall Study|Moderate / severe COPD exacerbation|14|||
147340263|NCT01985334|531414140|FG002|Overall Study|Moderate / severe COPD exacerbation|12|||
147340264|NCT01985334|531414141|FG003|Overall Study|Moderate / severe COPD exacerbation|40|||
147340265|NCT01985334|531414142|FG004|Overall Study|Moderate / severe COPD exacerbation|6|||
147340266|NCT01985334|531414143|FG005|Overall Study|Moderate / severe COPD exacerbation|40|||
147340267|NCT01985334|531414144|FG006|Overall Study|Moderate / severe COPD exacerbation|8|||
147340268|NCT01985334|531414145|FG007|Overall Study|Moderate / severe COPD exacerbation|19|||
147340269|NCT01985334|531414138|FG000|Overall Study|Subject withdrawal of consent|3|||
147340270|NCT01985334|531414139|FG001|Overall Study|Subject withdrawal of consent|6|||
147340271|NCT01985334|531414140|FG002|Overall Study|Subject withdrawal of consent|2|||
147340272|NCT01985334|531414141|FG003|Overall Study|Subject withdrawal of consent|28|||
147453016|NCT01926782|531821490|FG001|Overall Study|Related to study drug administration|0|||
147453017|NCT01926782|531821491|FG002|Overall Study|Related to study drug administration|0|||
147453018|NCT01926782|531821492|FG003|Overall Study|Related to study drug administration|0|||
147340273|NCT01985334|531414142|FG004|Overall Study|Subject withdrawal of consent|4|||
147340274|NCT01985334|531414143|FG005|Overall Study|Subject withdrawal of consent|19|||
147340275|NCT01985334|531414144|FG006|Overall Study|Subject withdrawal of consent|0|||
147340276|NCT01985334|531414145|FG007|Overall Study|Subject withdrawal of consent|20|||
147340277|NCT01985334|531414138|FG000|Overall Study|Adverse Event|0|||
147340278|NCT01985334|531414139|FG001|Overall Study|Adverse Event|8|||
147340279|NCT01985334|531414140|FG002|Overall Study|Adverse Event|2|||
147340280|NCT01985334|531414141|FG003|Overall Study|Adverse Event|26|||
147340281|NCT01985334|531414142|FG004|Overall Study|Adverse Event|3|||
147340282|NCT01985334|531414143|FG005|Overall Study|Adverse Event|18|||
147340283|NCT01985334|531414144|FG006|Overall Study|Adverse Event|3|||
147340284|NCT01985334|531414145|FG007|Overall Study|Adverse Event|15|||
147340285|NCT01985334|531414138|FG000|Overall Study|Other|4|||
147340286|NCT01985334|531414139|FG001|Overall Study|Other|2|||
147340287|NCT01985334|531414140|FG002|Overall Study|Other|3|||
147340288|NCT01985334|531414141|FG003|Overall Study|Other|10|||
147340289|NCT01985334|531414142|FG004|Overall Study|Other|1|||
147340290|NCT01985334|531414143|FG005|Overall Study|Other|6|||
147340291|NCT01985334|531414144|FG006|Overall Study|Other|2|||
147340292|NCT01985334|531414145|FG007|Overall Study|Other|2|||
147340293|NCT01985334|531414138|FG000|Overall Study|Medication non-compliance|0|||
147340294|NCT01985334|531414139|FG001|Overall Study|Medication non-compliance|4|||
147340295|NCT01985334|531414140|FG002|Overall Study|Medication non-compliance|1|||
147340296|NCT01985334|531414141|FG003|Overall Study|Medication non-compliance|6|||
147340297|NCT01985334|531414142|FG004|Overall Study|Medication non-compliance|2|||
147340298|NCT01985334|531414143|FG005|Overall Study|Medication non-compliance|3|||
147340299|NCT01985334|531414144|FG006|Overall Study|Medication non-compliance|1|||
147340300|NCT01985334|531414145|FG007|Overall Study|Medication non-compliance|3|||
147340301|NCT01985334|531414138|FG000|Overall Study|Use of prohibited treatment|1|||
147340302|NCT01985334|531414139|FG001|Overall Study|Use of prohibited treatment|4|||
147340303|NCT01985334|531414140|FG002|Overall Study|Use of prohibited treatment|1|||
147340304|NCT01985334|531414141|FG003|Overall Study|Use of prohibited treatment|2|||
147340305|NCT01985334|531414142|FG004|Overall Study|Use of prohibited treatment|1|||
147340306|NCT01985334|531414143|FG005|Overall Study|Use of prohibited treatment|6|||
147340307|NCT01985334|531414144|FG006|Overall Study|Use of prohibited treatment|2|||
147340308|NCT01985334|531414145|FG007|Overall Study|Use of prohibited treatment|0|||
147340309|NCT01985334|531414138|FG000|Overall Study|Investigator decision|0|||
147340310|NCT01985334|531414139|FG001|Overall Study|Investigator decision|3|||
147340311|NCT01985334|531414140|FG002|Overall Study|Investigator decision|0|||
147340312|NCT01985334|531414141|FG003|Overall Study|Investigator decision|7|||
147340313|NCT01985334|531414142|FG004|Overall Study|Investigator decision|1|||
147340314|NCT01985334|531414143|FG005|Overall Study|Investigator decision|1|||
147340315|NCT01985334|531414144|FG006|Overall Study|Investigator decision|0|||
147340316|NCT01985334|531414145|FG007|Overall Study|Investigator decision|4|||
147340317|NCT01985334|531414138|FG000|Overall Study|Lost to Follow-up|0|||
147340318|NCT01985334|531414139|FG001|Overall Study|Lost to Follow-up|2|||
147340319|NCT01985334|531414140|FG002|Overall Study|Lost to Follow-up|0|||
147340320|NCT01985334|531414141|FG003|Overall Study|Lost to Follow-up|3|||
147340321|NCT01985334|531414142|FG004|Overall Study|Lost to Follow-up|1|||
147340322|NCT01985334|531414143|FG005|Overall Study|Lost to Follow-up|4|||
147340323|NCT01985334|531414144|FG006|Overall Study|Lost to Follow-up|0|||
147340324|NCT01985334|531414145|FG007|Overall Study|Lost to Follow-up|3|||
147340325|NCT00546754|531414146|FG000|Overall Study|Serious Adverse Event|1|||
147340326|NCT00546754|531414147|FG001|Overall Study|Serious Adverse Event|1|||
147340327|NCT00546754|531414146|FG000|Overall Study|Adverse Event|11|||
147340328|NCT00546754|531414147|FG001|Overall Study|Adverse Event|16|||
147340329|NCT00546754|531414146|FG000|Overall Study|Lack of Efficacy|1|||
147340330|NCT00546754|531414147|FG001|Overall Study|Lack of Efficacy|1|||
147340331|NCT00546754|531414146|FG000|Overall Study|Lost to Follow-up|9|||
147662698|NCT04058028|532587409|FG001|Overall Study|Decision by Sponsor|4|||
147340332|NCT00546754|531414147|FG001|Overall Study|Lost to Follow-up|15|||
147340333|NCT00546754|531414146|FG000|Overall Study|Protocol Violation|3|||
147340334|NCT00546754|531414147|FG001|Overall Study|Protocol Violation|0|||
147340335|NCT00546754|531414146|FG000|Overall Study|Withdrawal by Subject|6|||
147340336|NCT00546754|531414147|FG001|Overall Study|Withdrawal by Subject|7|||
147340337|NCT00546754|531414146|FG000|Overall Study|Dyspnea|1|||
147340338|NCT00546754|531414147|FG001|Overall Study|Dyspnea|0|||
147340339|NCT00546754|531414146|FG000|Overall Study|Per Data Query, Less Than 4 Wks Coversyl|1|||
147340340|NCT00546754|531414147|FG001|Overall Study|Per Data Query, Less Than 4 Wks Coversyl|0|||
147340341|NCT00546754|531414146|FG000|Overall Study|Hip Replacement|1|||
147340342|NCT00546754|531414147|FG001|Overall Study|Hip Replacement|0|||
147340343|NCT00546754|531414146|FG000|Overall Study|Suicide|1|||
147340344|NCT00546754|531414147|FG001|Overall Study|Suicide|0|||
147340345|NCT00546754|531414146|FG000|Overall Study|Missing Cooperation|1|||
147340346|NCT00546754|531414147|FG001|Overall Study|Missing Cooperation|0|||
147340347|NCT00546754|531414146|FG000|Overall Study|Elevated Creatinine and Potassium levels|0|||
147662699|NCT04058028|532587410|FG002|Overall Study|Decision by Sponsor|1|||
147662700|NCT04058028|532587411|FG003|Overall Study|Decision by Sponsor|35|||
147340348|NCT00546754|531414147|FG001|Overall Study|Elevated Creatinine and Potassium levels|1|||
147340349|NCT00546754|531414146|FG000|Overall Study|Patient's Decision|0|||
147340350|NCT00546754|531414147|FG001|Overall Study|Patient's Decision|1|||
147340351|NCT00546754|531414146|FG000|Overall Study|Missing|14|||
147340352|NCT00546754|531414147|FG001|Overall Study|Missing|7|||
147340353|NCT00396084|531414148|FG000|Overall Study|Adverse Event|0|||
147340354|NCT00396084|531414149|FG001|Overall Study|Adverse Event|0|||
147340355|NCT00396084|531414150|FG002|Overall Study|Adverse Event|0|||
147340356|NCT00396084|531414151|FG003|Overall Study|Adverse Event|0|||
147340357|NCT00396084|531414152|FG004|Overall Study|Adverse Event|1|||
147340358|NCT00396084|531414153|FG005|Overall Study|Adverse Event|2|||
147340359|NCT00396084|531414148|FG000|Overall Study|Withdrawal by Subject|0|||
147340360|NCT00396084|531414149|FG001|Overall Study|Withdrawal by Subject|0|||
147340361|NCT00396084|531414150|FG002|Overall Study|Withdrawal by Subject|0|||
147340362|NCT00396084|531414151|FG003|Overall Study|Withdrawal by Subject|1|||
147662701|NCT04058028|532587408|FG000|Overall Study|Lost to Follow-up|1|||
147340363|NCT00396084|531414152|FG004|Overall Study|Withdrawal by Subject|0|||
147340364|NCT00396084|531414153|FG005|Overall Study|Withdrawal by Subject|0|||
147340365|NCT04556981|531414154|FG000|Overall Study|Death|0|||
147340366|NCT04556981|531414155|FG001|Overall Study|Death|1|||
147340367|NCT04556981|531414154|FG000|Overall Study|Lost to Follow-up|2|||
147340368|NCT04556981|531414155|FG001|Overall Study|Lost to Follow-up|11|||
147340369|NCT04556981|531414154|FG000|Overall Study|Moved from the study area|1|||
147340370|NCT04556981|531414155|FG001|Overall Study|Moved from the study area|4|||
147340371|NCT04556981|531414154|FG000|Overall Study|Withdrawal by Subject|2|||
147340372|NCT04556981|531414155|FG001|Overall Study|Withdrawal by Subject|2|||
147340373|NCT04556981|531414154|FG000|Overall Study|Other|2|||
147340374|NCT04556981|531414155|FG001|Overall Study|Other|1|||
147340375|NCT02574455|531414159|FG000|Overall Study|Death|197|||
147340376|NCT02574455|531414160|FG001|Overall Study|Death|210|||
147340377|NCT02574455|531414159|FG000|Overall Study|Withdrawal of Consent|11|||
147340378|NCT02574455|531414160|FG001|Overall Study|Withdrawal of Consent|28|||
147340379|NCT02574455|531414159|FG000|Overall Study|Lost to Follow-up|4|||
147340380|NCT02574455|531414160|FG001|Overall Study|Lost to Follow-up|4|||
147340381|NCT02574455|531414159|FG000|Overall Study|Sponsor's Decision|55|||
147340382|NCT02574455|531414160|FG001|Overall Study|Sponsor's Decision|20|||
147340383|NCT03565315|531414165|FG000|Overall Study|IND Sponsor/PI Voluntary Study Pause|0|||
147340384|NCT03565315|531414166|FG001|Overall Study|IND Sponsor/PI Voluntary Study Pause|0|||
147340385|NCT03565315|531414167|FG002|Overall Study|IND Sponsor/PI Voluntary Study Pause|0|||
147340386|NCT03565315|531414168|FG003|Overall Study|IND Sponsor/PI Voluntary Study Pause|1|||
147340387|NCT01083316|531414169|FG000|Overall Study|Adverse Event|2|||
147340388|NCT01083316|531414169|FG000|Overall Study|Withdrawal by Subject|1|||
147340389|NCT01239316|531414172|FG000|Overall Study|Progression/Relapse|11|||
147340390|NCT01239316|531414172|FG000|Overall Study|Adverse Event|1|||
147340391|NCT05057897|531415611|FG000|Overall Study|Site closure|2|||
147340392|NCT05057897|531415612|FG001|Overall Study|Site closure|2|||
147340393|NCT05057897|531415611|FG000|Overall Study|Death|1|||
147340394|NCT05057897|531415612|FG001|Overall Study|Death|0|||
147340395|NCT04524390|531415613|FG000|Double Blind|Consent Withdrawal by subject|2|||
147340396|NCT04524390|531415614|FG001|Double Blind|Consent Withdrawal by subject|1|||
147340397|NCT04524390|531415615|FG002|Double Blind|Consent Withdrawal by subject|0|||
147340398|NCT04524390|531415613|FG000|Double Blind|Adverse Event|5|||
147340399|NCT04524390|531415614|FG001|Double Blind|Adverse Event|3|||
147340400|NCT04524390|531415615|FG002|Double Blind|Adverse Event|0|||
147340401|NCT04524390|531415613|FG000|Double Blind|Liver Transplant|5|||
147340402|NCT04524390|531415614|FG001|Double Blind|Liver Transplant|6|||
147340403|NCT04524390|531415615|FG002|Double Blind|Liver Transplant|0|||
147340404|NCT04524390|531415613|FG000|Double Blind|Disease Progression|0|||
147340405|NCT04524390|531415614|FG001|Double Blind|Disease Progression|1|||
147340406|NCT04524390|531415615|FG002|Double Blind|Disease Progression|0|||
147340407|NCT04524390|531415613|FG000|Open-Label|Drug interruption criteria|0|||
147340408|NCT04524390|531415614|FG001|Open-Label|Drug interruption criteria|0|||
147340409|NCT04524390|531415615|FG002|Open-Label|Drug interruption criteria|1|||
147340410|NCT04524390|531415613|FG000|Open-Label|Liver Transplant|0|||
147340411|NCT04524390|531415614|FG001|Open-Label|Liver Transplant|0|||
147340412|NCT04524390|531415615|FG002|Open-Label|Liver Transplant|1|||
147340413|NCT04524390|531415613|FG000|Open-Label|Disease Progression|0|||
147340414|NCT04524390|531415614|FG001|Open-Label|Disease Progression|0|||
147340415|NCT04524390|531415615|FG002|Open-Label|Disease Progression|1|||
147340416|NCT04524390|531415613|FG000|Open-Label|Adverse Event|0|||
147340417|NCT04524390|531415614|FG001|Open-Label|Adverse Event|0|||
147340418|NCT04524390|531415615|FG002|Open-Label|Adverse Event|3|||
147340419|NCT04524390|531415613|FG000|Open-Label|Study Termination by sponsor|0|||
147340420|NCT04524390|531415614|FG001|Open-Label|Study Termination by sponsor|0|||
147340421|NCT04524390|531415615|FG002|Open-Label|Study Termination by sponsor|45|||
147340422|NCT03088813|531415618|FG000|Part 1: Dose Evaluation (Up to Week 172)|Withdrawal by Subject|0|||
147340423|NCT03088813|531415619|FG001|Part 1: Dose Evaluation (Up to Week 172)|Withdrawal by Subject|1|||
147340424|NCT03088813|531415620|FG002|Part 1: Dose Evaluation (Up to Week 172)|Withdrawal by Subject|0|||
147606391|NCT01473524|532375213|FG003|LTSE Phase|Principal Investigator Decision|1|||
147606392|NCT01473524|532375214|FG004|LTSE Phase|Principal Investigator Decision|1|||
147606393|NCT01473524|532375215|FG005|LTSE Phase|Principal Investigator Decision|3|||
147340425|NCT03088813|531415621|FG003|Part 1: Dose Evaluation (Up to Week 172)|Withdrawal by Subject|0|||
147340426|NCT03088813|531415618|FG000|Part 2: Randomized Study (Upto Week 197)|Protocol Violation|0|||
147340427|NCT03088813|531415619|FG001|Part 2: Randomized Study (Upto Week 197)|Protocol Violation|0|||
147340428|NCT03088813|531415620|FG002|Part 2: Randomized Study (Upto Week 197)|Protocol Violation|1|||
147340429|NCT03088813|531415621|FG003|Part 2: Randomized Study (Upto Week 197)|Protocol Violation|0|||
147340430|NCT03088813|531415618|FG000|Part 2: Randomized Study (Upto Week 197)|Investigator decision|0|||
147340431|NCT03088813|531415619|FG001|Part 2: Randomized Study (Upto Week 197)|Investigator decision|0|||
147340432|NCT03088813|531415620|FG002|Part 2: Randomized Study (Upto Week 197)|Investigator decision|2|||
147340433|NCT03088813|531415621|FG003|Part 2: Randomized Study (Upto Week 197)|Investigator decision|2|||
147340434|NCT03088813|531415618|FG000|Part 2: Randomized Study (Upto Week 197)|Lost to Follow-up|0|||
147606394|NCT01473524|532375210|FG000|LTSE Phase|Liver Transplantation|0|||
147606395|NCT01473524|532375211|FG001|LTSE Phase|Liver Transplantation|0|||
147606396|NCT01473524|532375212|FG002|LTSE Phase|Liver Transplantation|0|||
147606397|NCT01473524|532375213|FG003|LTSE Phase|Liver Transplantation|0|||
147606398|NCT01473524|532375214|FG004|LTSE Phase|Liver Transplantation|0|||
147606399|NCT01473524|532375215|FG005|LTSE Phase|Liver Transplantation|1|||
147606400|NCT01473524|532375210|FG000|LTSE Phase|Pregnancy|0|||
147340435|NCT03088813|531415619|FG001|Part 2: Randomized Study (Upto Week 197)|Lost to Follow-up|0|||
147340436|NCT03088813|531415620|FG002|Part 2: Randomized Study (Upto Week 197)|Lost to Follow-up|3|||
147340437|NCT03088813|531415621|FG003|Part 2: Randomized Study (Upto Week 197)|Lost to Follow-up|4|||
147340438|NCT03088813|531415618|FG000|Part 2: Randomized Study (Upto Week 197)|Withdrawal by Subject|0|||
147340439|NCT03088813|531415619|FG001|Part 2: Randomized Study (Upto Week 197)|Withdrawal by Subject|0|||
147340440|NCT03088813|531415620|FG002|Part 2: Randomized Study (Upto Week 197)|Withdrawal by Subject|18|||
147340441|NCT03088813|531415621|FG003|Part 2: Randomized Study (Upto Week 197)|Withdrawal by Subject|14|||
147340442|NCT03088813|531415618|FG000|Part 2: Randomized Study (Upto Week 197)|Screen failure|0|||
147340443|NCT03088813|531415619|FG001|Part 2: Randomized Study (Upto Week 197)|Screen failure|0|||
147340444|NCT03088813|531415620|FG002|Part 2: Randomized Study (Upto Week 197)|Screen failure|0|||
147340445|NCT03088813|531415621|FG003|Part 2: Randomized Study (Upto Week 197)|Screen failure|1|||
147340446|NCT03088813|531415618|FG000|Part 2: Randomized Study (Upto Week 197)|Other|0|||
147340447|NCT03088813|531415619|FG001|Part 2: Randomized Study (Upto Week 197)|Other|0|||
147340448|NCT03088813|531415620|FG002|Part 2: Randomized Study (Upto Week 197)|Other|3|||
147340449|NCT03088813|531415621|FG003|Part 2: Randomized Study (Upto Week 197)|Other|0|||
147340450|NCT03613740|531415625|FG000|Overall Study|Lost to Follow-up|1|||
147340451|NCT03613740|531415626|FG001|Overall Study|Lost to Follow-up|1|||
147340452|NCT04279574|531415627|FG000|Overall Study|Death|1|||
147340453|NCT04279574|531415628|FG001|Overall Study|Death|0|||
147340454|NCT04279574|531415627|FG000|Overall Study|lost restoration, tooth fracture|1|||
147340455|NCT04279574|531415628|FG001|Overall Study|lost restoration, tooth fracture|0|||
147340456|NCT04279574|531415627|FG000|Overall Study|Lost to Follow-up|0|||
147340457|NCT04279574|531415628|FG001|Overall Study|Lost to Follow-up|1|||
147340458|NCT03575052|531415629|FG000|Overall Study|Adverse Event|6|||
147340459|NCT03575052|531415630|FG001|Overall Study|Adverse Event|10|||
147340460|NCT03575052|531415629|FG000|Overall Study|Not further specified|5|||
147340461|NCT03575052|531415630|FG001|Overall Study|Not further specified|7|||
147340462|NCT03575052|531415629|FG000|Overall Study|Withdrawal by Subject|5|||
147340463|NCT03575052|531415630|FG001|Overall Study|Withdrawal by Subject|6|||
147340464|NCT03575052|531415629|FG000|Overall Study|Lost to Follow-up|3|||
147340465|NCT03575052|531415630|FG001|Overall Study|Lost to Follow-up|0|||
147340466|NCT03575052|531415629|FG000|Overall Study|Death|2|||
147340467|NCT03575052|531415630|FG001|Overall Study|Death|1|||
147340468|NCT03575052|531415629|FG000|Overall Study|Lack of Efficacy|2|||
147340469|NCT03575052|531415630|FG001|Overall Study|Lack of Efficacy|1|||
147340470|NCT03575052|531415629|FG000|Overall Study|Study drug noncompliance|1|||
147340471|NCT03575052|531415630|FG001|Overall Study|Study drug noncompliance|2|||
147340472|NCT03575052|531415629|FG000|Overall Study|Protocol Violation|0|||
147340473|NCT03575052|531415630|FG001|Overall Study|Protocol Violation|2|||
147340474|NCT03575052|531415629|FG000|Overall Study|Physician Decision|1|||
147340475|NCT03575052|531415630|FG001|Overall Study|Physician Decision|0|||
147340476|NCT04188379|531415631|FG000|Overall Study|Withdrawal by Subject|10|||
147340477|NCT04188379|531415632|FG001|Overall Study|Withdrawal by Subject|3|||
147340478|NCT04188379|531415631|FG000|Overall Study|Physician Decision|0|||
147340479|NCT04188379|531415632|FG001|Overall Study|Physician Decision|1|||
147340480|NCT04188379|531415631|FG000|Overall Study|Adverse Event|3|||
147340481|NCT04188379|531415632|FG001|Overall Study|Adverse Event|1|||
147340482|NCT04188379|531415631|FG000|Overall Study|Pregnancy|1|||
147340483|NCT04188379|531415632|FG001|Overall Study|Pregnancy|0|||
147340484|NCT04188379|531415631|FG000|Overall Study|Lack of Efficacy|8|||
147453019|NCT01926782|531821493|FG004|Overall Study|Related to study drug administration|0|||
147453020|NCT01926782|531821494|FG005|Overall Study|Related to study drug administration|2|||
147453021|NCT02728830|531821524|FG000|Overall Study|Exclusionary Surgery|9|||
147453022|NCT02728830|531821524|FG000|Overall Study|Exclusionary Pathology|6|||
147606401|NCT01473524|532375211|FG001|LTSE Phase|Pregnancy|0|||
147606402|NCT01473524|532375212|FG002|LTSE Phase|Pregnancy|0|||
147606403|NCT01473524|532375213|FG003|LTSE Phase|Pregnancy|1|||
147606404|NCT01473524|532375214|FG004|LTSE Phase|Pregnancy|0|||
147340485|NCT04188379|531415632|FG001|Overall Study|Lack of Efficacy|5|||
147340486|NCT04188379|531415631|FG000|Overall Study|Other|0|||
147340487|NCT04188379|531415632|FG001|Overall Study|Other|3|||
147340488|NCT01693120|531415634|FG000|Enrollment|Lost to Follow-up|1|||
147340489|NCT01693120|531415634|FG000|Enrollment|Withdrawal by Subject|10|||
147340490|NCT01693120|531415634|FG000|Enrollment|Protocol Violation|46|||
147340491|NCT01693120|531415634|FG000|Enrollment|Physician Decision|3|||
147340492|NCT01693120|531415634|FG000|Enrollment|Adverse Event|1|||
147606405|NCT01473524|532375215|FG005|LTSE Phase|Pregnancy|0|||
147606406|NCT01473524|532375210|FG000|LTSE Phase|Protocol Violation|0|||
147340493|NCT01693120|531415634|FG000|Enrollment|Study closed|8|||
147606407|NCT01473524|532375211|FG001|LTSE Phase|Protocol Violation|0|||
147606408|NCT01473524|532375212|FG002|LTSE Phase|Protocol Violation|0|||
147606409|NCT01473524|532375213|FG003|LTSE Phase|Protocol Violation|0|||
147606410|NCT01473524|532375214|FG004|LTSE Phase|Protocol Violation|0|||
147606411|NCT01473524|532375215|FG005|LTSE Phase|Protocol Violation|1|||
147606412|NCT01544179|532375217|FG000|Overall Study|Death|50|||
147606413|NCT01544179|532375218|FG001|Overall Study|Death|37|||
147606414|NCT01544179|532375217|FG000|Overall Study|Lost to Follow-up|0|||
147299155|NCT03764774|531259567|FG013|Overall Study|Physician Decision|0|||
147299156|NCT03764774|531259554|FG000|Overall Study|Study Termination|0|||
147299157|NCT03764774|531259555|FG001|Overall Study|Study Termination|0|||
147299158|NCT03764774|531259556|FG002|Overall Study|Study Termination|0|||
147299159|NCT03764774|531259557|FG003|Overall Study|Study Termination|0|||
147299160|NCT03764774|531259558|FG004|Overall Study|Study Termination|0|||
147299161|NCT03764774|531259559|FG005|Overall Study|Study Termination|0|||
147299162|NCT03764774|531259560|FG006|Overall Study|Study Termination|0|||
147299163|NCT03764774|531259561|FG007|Overall Study|Study Termination|0|||
147299164|NCT03764774|531259562|FG008|Overall Study|Study Termination|0|||
147299165|NCT03764774|531259563|FG009|Overall Study|Study Termination|1|||
147299166|NCT03764774|531259564|FG010|Overall Study|Study Termination|0|||
147299167|NCT03764774|531259565|FG011|Overall Study|Study Termination|0|||
147299168|NCT03764774|531259566|FG012|Overall Study|Study Termination|0|||
147299169|NCT03764774|531259567|FG013|Overall Study|Study Termination|2|||
147299170|NCT05809596|531259570|FG000|Overall Study|Death|16|||
147299171|NCT05809596|531259570|FG000|Overall Study|Withdrawal by Subject|4|||
147299172|NCT05809596|531259570|FG000|Overall Study|Physician Decision|1|||
147299173|NCT05809596|531259570|FG000|Overall Study|Missed Visit|2|||
147299174|NCT05809596|531259570|FG000|Overall Study|Other|3|||
147299175|NCT03770494|531259572|FG000|Overall Study|Lost to Follow-up|0|||
147299176|NCT03770494|531259573|FG001|Overall Study|Lost to Follow-up|0|||
147299177|NCT03770494|531259574|FG002|Overall Study|Lost to Follow-up|1|||
147299178|NCT03770494|531259575|FG003|Overall Study|Lost to Follow-up|1|||
147299179|NCT03770494|531259576|FG004|Overall Study|Lost to Follow-up|1|||
147299180|NCT03770494|531259577|FG005|Overall Study|Lost to Follow-up|0|||
147299181|NCT03770494|531259578|FG006|Overall Study|Lost to Follow-up|0|||
147299182|NCT03770494|531259579|FG007|Overall Study|Lost to Follow-up|0|||
147299183|NCT03770494|531259580|FG008|Overall Study|Lost to Follow-up|0|||
147299184|NCT03770494|531259581|FG009|Overall Study|Lost to Follow-up|0|||
147299185|NCT03770494|531259582|FG010|Overall Study|Lost to Follow-up|0|||
147299186|NCT03770494|531259583|FG011|Overall Study|Lost to Follow-up|0|||
147299187|NCT03770494|531259584|FG012|Overall Study|Lost to Follow-up|0|||
147299188|NCT03770494|531259585|FG013|Overall Study|Lost to Follow-up|0|||
147299189|NCT03770494|531259572|FG000|Overall Study|Study terminated by sponsor|1|||
147299190|NCT03770494|531259573|FG001|Overall Study|Study terminated by sponsor|2|||
147299191|NCT03770494|531259574|FG002|Overall Study|Study terminated by sponsor|1|||
147299192|NCT03770494|531259575|FG003|Overall Study|Study terminated by sponsor|1|||
147299193|NCT03770494|531259576|FG004|Overall Study|Study terminated by sponsor|1|||
147299194|NCT03770494|531259577|FG005|Overall Study|Study terminated by sponsor|2|||
147299195|NCT03770494|531259578|FG006|Overall Study|Study terminated by sponsor|1|||
147299196|NCT03770494|531259579|FG007|Overall Study|Study terminated by sponsor|2|||
147299197|NCT03770494|531259580|FG008|Overall Study|Study terminated by sponsor|1|||
147299198|NCT03770494|531259581|FG009|Overall Study|Study terminated by sponsor|2|||
147299199|NCT03770494|531259582|FG010|Overall Study|Study terminated by sponsor|1|||
147299200|NCT03770494|531259583|FG011|Overall Study|Study terminated by sponsor|2|||
147299201|NCT03770494|531259584|FG012|Overall Study|Study terminated by sponsor|0|||
147299202|NCT03770494|531259585|FG013|Overall Study|Study terminated by sponsor|0|||
147299203|NCT03770494|531259572|FG000|Overall Study|Withdrawal by Subject|1|||
147299204|NCT03770494|531259573|FG001|Overall Study|Withdrawal by Subject|1|||
147299205|NCT03770494|531259574|FG002|Overall Study|Withdrawal by Subject|0|||
147299206|NCT03770494|531259575|FG003|Overall Study|Withdrawal by Subject|0|||
147299207|NCT03770494|531259576|FG004|Overall Study|Withdrawal by Subject|2|||
147299208|NCT03770494|531259577|FG005|Overall Study|Withdrawal by Subject|2|||
147299209|NCT03770494|531259578|FG006|Overall Study|Withdrawal by Subject|2|||
147299210|NCT03770494|531259579|FG007|Overall Study|Withdrawal by Subject|0|||
147299211|NCT03770494|531259580|FG008|Overall Study|Withdrawal by Subject|2|||
147299212|NCT03770494|531259581|FG009|Overall Study|Withdrawal by Subject|3|||
147299213|NCT03770494|531259582|FG010|Overall Study|Withdrawal by Subject|1|||
147299214|NCT03770494|531259583|FG011|Overall Study|Withdrawal by Subject|0|||
147299215|NCT03770494|531259584|FG012|Overall Study|Withdrawal by Subject|0|||
147299216|NCT03770494|531259585|FG013|Overall Study|Withdrawal by Subject|0|||
147299217|NCT04922554|531259586|FG000|Overall Study|Adverse Event|4|||
147299218|NCT04922554|531259587|FG001|Overall Study|Adverse Event|0|||
147299219|NCT04922554|531259586|FG000|Overall Study|Withdrawal by Subject|1|||
147299220|NCT04922554|531259587|FG001|Overall Study|Withdrawal by Subject|0|||
147299221|NCT01345630|531261064|FG000|Overall Study|Adverse Event|22|||
147299222|NCT01345630|531261065|FG001|Overall Study|Adverse Event|23|||
147299223|NCT01345630|531261064|FG000|Overall Study|Lost to Follow-up|17|||
147299224|NCT01345630|531261065|FG001|Overall Study|Lost to Follow-up|16|||
147299225|NCT01345630|531261064|FG000|Overall Study|Protocol Violation|4|||
147606415|NCT01544179|532375218|FG001|Overall Study|Lost to Follow-up|1|||
147453023|NCT02728830|531821524|FG000|Overall Study|Physician Decision|3|||
147453024|NCT02728830|531821524|FG000|Overall Study|Withdrawal by Subject|2|||
147453025|NCT02728830|531821524|FG000|Overall Study|Lost to Follow-up|1|||
147453026|NCT02728830|531821524|FG000|Overall Study|Exclusionary Lab Values|1|||
147340494|NCT01693120|531415634|FG000|Enrollment|Other|1|||
147340495|NCT01693120|531415634|FG000|Phased RF Study Procedure and Follow-up|Lost to Follow-up|1|||
147340496|NCT01693120|531415634|FG000|Phased RF Study Procedure and Follow-up|Withdrawal by Subject|5|||
147340497|NCT01693120|531415634|FG000|Phased RF Study Procedure and Follow-up|Physician Decision|3|||
147340498|NCT01693120|531415634|FG000|Phased RF Study Procedure and Follow-up|Protocol Violation|1|||
147340499|NCT01693120|531415634|FG000|Phased RF Study Procedure and Follow-up|Other reasons|7|||
147340500|NCT02411084|531415644|FG000|Overall Study|Lack of Efficacy|6|||
147340501|NCT02411084|531415645|FG001|Overall Study|Lack of Efficacy|3|||
147340502|NCT02411084|531415644|FG000|Overall Study|Death|5|||
147340503|NCT02411084|531415645|FG001|Overall Study|Death|4|||
147340504|NCT02411084|531415644|FG000|Overall Study|Adverse Event|2|||
147340505|NCT02411084|531415645|FG001|Overall Study|Adverse Event|1|||
147340506|NCT02411084|531415644|FG000|Overall Study|Other reasons|0|||
147340507|NCT02411084|531415645|FG001|Overall Study|Other reasons|5|||
147340508|NCT03624972|531415646|FG000|Overall Study|Lost to Follow-up|2|||
147340509|NCT03624972|531415647|FG001|Overall Study|Lost to Follow-up|0|||
147340510|NCT03624972|531415648|FG002|Overall Study|Lost to Follow-up|0|||
147340511|NCT03624972|531415646|FG000|Overall Study|Withdrawal by Subject|0|||
147340512|NCT03624972|531415647|FG001|Overall Study|Withdrawal by Subject|2|||
147340513|NCT03624972|531415648|FG002|Overall Study|Withdrawal by Subject|0|||
147340514|NCT03112174|531415649|FG000|Overall Study|Withdrawal by Subject|3|||
147340515|NCT03112174|531415650|FG001|Overall Study|Withdrawal by Subject|0|||
147340516|NCT03112174|531415651|FG002|Overall Study|Withdrawal by Subject|11|||
147340517|NCT03112174|531415652|FG003|Overall Study|Withdrawal by Subject|9|||
147340518|NCT03112174|531415653|FG004|Overall Study|Withdrawal by Subject|7|||
147340519|NCT03112174|531415649|FG000|Overall Study|Lost to Follow-up|1|||
147340520|NCT03112174|531415650|FG001|Overall Study|Lost to Follow-up|1|||
147340521|NCT03112174|531415651|FG002|Overall Study|Lost to Follow-up|2|||
147340522|NCT03112174|531415652|FG003|Overall Study|Lost to Follow-up|3|||
147340523|NCT03112174|531415653|FG004|Overall Study|Lost to Follow-up|2|||
147340524|NCT03112174|531415649|FG000|Overall Study|Death|8|||
147340525|NCT03112174|531415650|FG001|Overall Study|Death|3|||
147340526|NCT03112174|531415651|FG002|Overall Study|Death|67|||
147340527|NCT03112174|531415652|FG003|Overall Study|Death|73|||
147340528|NCT03112174|531415653|FG004|Overall Study|Death|18|||
147340529|NCT03112174|531415649|FG000|Overall Study|Other, Not Specified|1|||
147340530|NCT03112174|531415650|FG001|Overall Study|Other, Not Specified|0|||
147340531|NCT03112174|531415651|FG002|Overall Study|Other, Not Specified|1|||
147340532|NCT03112174|531415652|FG003|Overall Study|Other, Not Specified|2|||
147340533|NCT03112174|531415653|FG004|Overall Study|Other, Not Specified|0|||
147340534|NCT01534494|531415657|FG000|Overall Study|Withdrawal by Subject|1|||
147340535|NCT05137236|531415658|FG000|Part A|Other than Specified|1|||
147340536|NCT05137236|531415659|FG001|Part A|Other than Specified|0|||
147340537|NCT05137236|531415660|FG002|Part A|Other than Specified|0|||
147340538|NCT05137236|531415661|FG003|Part A|Other than Specified|0|||
147340539|NCT05137236|531415662|FG004|Part A|Other than Specified|0|||
147340540|NCT05137236|531415663|FG005|Part A|Other than Specified|0|||
147340541|NCT05137236|531415664|FG006|Part A|Other than Specified|0|||
147340542|NCT05137236|531415665|FG007|Part A|Other than Specified|0|||
147453027|NCT02728830|531821524|FG000|Overall Study|Contraindicated Illness|1|||
147453028|NCT02728830|531821524|FG000|Overall Study|Language Barrier|1|||
147340543|NCT05137236|531415658|FG000|Part A|Withdrawal by Subject|0|||
147340544|NCT05137236|531415659|FG001|Part A|Withdrawal by Subject|4|||
147340545|NCT05137236|531415660|FG002|Part A|Withdrawal by Subject|1|||
147340546|NCT05137236|531415661|FG003|Part A|Withdrawal by Subject|1|||
147340547|NCT05137236|531415662|FG004|Part A|Withdrawal by Subject|3|||
147606416|NCT01544179|532375217|FG000|Overall Study|Adverse Event|0|||
147606417|NCT01544179|532375218|FG001|Overall Study|Adverse Event|1|||
147606418|NCT01544179|532375217|FG000|Overall Study|Withdrawal by Subject|12|||
147340548|NCT05137236|531415663|FG005|Part A|Withdrawal by Subject|2|||
147340549|NCT05137236|531415664|FG006|Part A|Withdrawal by Subject|0|||
147340550|NCT05137236|531415665|FG007|Part A|Withdrawal by Subject|0|||
147340551|NCT05137236|531415658|FG000|Part A|Lost to Follow-up|5|||
147340552|NCT05137236|531415659|FG001|Part A|Lost to Follow-up|7|||
147340553|NCT05137236|531415660|FG002|Part A|Lost to Follow-up|1|||
147340554|NCT05137236|531415661|FG003|Part A|Lost to Follow-up|3|||
147340555|NCT05137236|531415662|FG004|Part A|Lost to Follow-up|3|||
147340556|NCT05137236|531415663|FG005|Part A|Lost to Follow-up|8|||
147340557|NCT05137236|531415664|FG006|Part A|Lost to Follow-up|0|||
147340558|NCT05137236|531415665|FG007|Part A|Lost to Follow-up|0|||
147340559|NCT05137236|531415658|FG000|Part B|Withdrawal by Subject|0|||
147340560|NCT05137236|531415659|FG001|Part B|Withdrawal by Subject|0|||
147340561|NCT05137236|531415660|FG002|Part B|Withdrawal by Subject|0|||
147340562|NCT05137236|531415661|FG003|Part B|Withdrawal by Subject|0|||
147340563|NCT05137236|531415662|FG004|Part B|Withdrawal by Subject|0|||
147606419|NCT01544179|532375218|FG001|Overall Study|Withdrawal by Subject|7|||
147340564|NCT05137236|531415663|FG005|Part B|Withdrawal by Subject|0|||
147340565|NCT05137236|531415664|FG006|Part B|Withdrawal by Subject|0|||
147340566|NCT05137236|531415665|FG007|Part B|Withdrawal by Subject|2|||
147340567|NCT05137236|531415658|FG000|Part B|Lost to Follow-up|0|||
147340568|NCT05137236|531415659|FG001|Part B|Lost to Follow-up|0|||
147340569|NCT05137236|531415660|FG002|Part B|Lost to Follow-up|0|||
147340570|NCT05137236|531415661|FG003|Part B|Lost to Follow-up|0|||
147340571|NCT05137236|531415662|FG004|Part B|Lost to Follow-up|0|||
147340572|NCT05137236|531415663|FG005|Part B|Lost to Follow-up|0|||
147340573|NCT05137236|531415664|FG006|Part B|Lost to Follow-up|5|||
147340574|NCT05137236|531415665|FG007|Part B|Lost to Follow-up|5|||
147340575|NCT05137236|531415658|FG000|Part B|Death|0|||
147340576|NCT05137236|531415659|FG001|Part B|Death|0|||
147340577|NCT05137236|531415660|FG002|Part B|Death|0|||
147340578|NCT05137236|531415661|FG003|Part B|Death|0|||
147340579|NCT05137236|531415662|FG004|Part B|Death|0|||
147340580|NCT05137236|531415663|FG005|Part B|Death|0|||
147340581|NCT05137236|531415664|FG006|Part B|Death|0|||
147340582|NCT05137236|531415665|FG007|Part B|Death|2|||
147340583|NCT00431834|531415674|FG000|Overall Study|Withdrawal by Subject|7|||
147340584|NCT00431834|531415674|FG000|Overall Study|Death|3|||
147340585|NCT00431834|531415674|FG000|Overall Study|Missed Endpoint Visit|2|||
147340586|NCT00431834|531415674|FG000|Overall Study|Lost to Follow-up|1|||
147340587|NCT02622568|531415675|FG000|Overall Study|Lost to Follow-up|5|||
147340588|NCT02622568|531415676|FG001|Overall Study|Lost to Follow-up|5|||
147340589|NCT02647905|531415683|FG000|Overall Study|Lost to Follow-up|1|||
147340590|NCT02647905|531415683|FG000|Overall Study|Withdrawal by Subject|2|||
147340591|NCT05119855|531415686|FG000|Overall Study|Randomized by Mistake Without Study Treatment|0|||
147340592|NCT05119855|531415687|FG001|Overall Study|Randomized by Mistake Without Study Treatment|1|||
147340593|NCT05119855|531415686|FG000|Overall Study|Withdrawal By Parent/Guardian|10|||
147340594|NCT05119855|531415687|FG001|Overall Study|Withdrawal By Parent/Guardian|10|||
147340595|NCT05119855|531415686|FG000|Overall Study|Lost to Follow-up|6|||
147340596|NCT05119855|531415687|FG001|Overall Study|Lost to Follow-up|8|||
147340597|NCT02597920|531415691|FG000|Overall Study|Worsening of other pre-existing disease|0|||
147340598|NCT02597920|531415692|FG001|Overall Study|Worsening of other pre-existing disease|1|||
147453029|NCT00070941|531821526|FG000|Overall Study|Adverse Event|10|||
147453030|NCT00070941|531821527|FG001|Overall Study|Adverse Event|8|||
147453031|NCT00070941|531821528|FG002|Overall Study|Adverse Event|4|||
147340599|NCT02597920|531415693|FG002|Overall Study|Worsening of other pre-existing disease|0|||
147340600|NCT02597920|531415691|FG000|Overall Study|Other adverse event|20|||
147340601|NCT02597920|531415692|FG001|Overall Study|Other adverse event|30|||
147340602|NCT02597920|531415693|FG002|Overall Study|Other adverse event|0|||
147340603|NCT02597920|531415691|FG000|Overall Study|Lost to Follow-up|7|||
147340604|NCT02597920|531415692|FG001|Overall Study|Lost to Follow-up|9|||
147340605|NCT02597920|531415693|FG002|Overall Study|Lost to Follow-up|0|||
147340606|NCT02597920|531415691|FG000|Overall Study|Refuse to continue in the study|3|||
147340607|NCT02597920|531415692|FG001|Overall Study|Refuse to continue in the study|13|||
147340608|NCT02597920|531415693|FG002|Overall Study|Refuse to continue in the study|1|||
147340609|NCT02597920|531415691|FG000|Overall Study|Other than specified|10|||
147340610|NCT02597920|531415692|FG001|Overall Study|Other than specified|31|||
147340611|NCT02597920|531415693|FG002|Overall Study|Other than specified|5|||
147340612|NCT02597920|531415691|FG000|Overall Study|Other|1|||
147340613|NCT02597920|531415692|FG001|Overall Study|Other|0|||
147340614|NCT02597920|531415693|FG002|Overall Study|Other|0|||
147340615|NCT00642850|531415694|FG000|Overall Study|Death|7|||
147340616|NCT00642850|531415694|FG000|Overall Study|Adverse Event|2|||
147340617|NCT00642850|531415694|FG000|Overall Study|Lack of Efficacy|1|||
147340618|NCT00642850|531415694|FG000|Overall Study|Protocol Violation|2|||
147340619|NCT00642850|531415694|FG000|Overall Study|Kidney transplantation|8|||
147340620|NCT00642850|531415694|FG000|Overall Study|Blood transfusion|6|||
147453032|NCT00623428|531821531|FG000|Treatment Period|Adverse event/intercurrent illness|0|||
147453033|NCT00623428|531821532|FG001|Treatment Period|Adverse event/intercurrent illness|9|||
147453034|NCT00623428|531821531|FG000|Treatment Period|Death|0|||
147340621|NCT00642850|531415694|FG000|Overall Study|Other reasons|7|||
147340622|NCT05489484|531415701|FG000|Overall Study|withdrawn|1|||
147340623|NCT03756571|531415703|FG000|Overall Study|Lost to Follow-up|1|||
147340624|NCT03756571|531415704|FG001|Overall Study|Lost to Follow-up|1|||
147340625|NCT01290341|531415707|FG000|Overall Study|Protocol Violation|7|||
147340626|NCT01290341|531415708|FG001|Overall Study|Protocol Violation|3|||
147340627|NCT01290341|531415707|FG000|Overall Study|Adverse Event|1|||
147340628|NCT01290341|531415708|FG001|Overall Study|Adverse Event|0|||
147340629|NCT01290341|531415707|FG000|Overall Study|Lost to Follow-up|21|||
147340630|NCT01290341|531415708|FG001|Overall Study|Lost to Follow-up|10|||
147453035|NCT00623428|531821532|FG001|Treatment Period|Death|1|||
147340631|NCT01290341|531415707|FG000|Overall Study|Withdrawal by Subject|19|||
147340632|NCT01290341|531415708|FG001|Overall Study|Withdrawal by Subject|5|||
147340633|NCT01290341|531415707|FG000|Overall Study|Negative baseline culture and others|44|||
147340634|NCT01290341|531415708|FG001|Overall Study|Negative baseline culture and others|11|||
147340635|NCT00785512|531415715|FG000|Overall Study|Inclusion/Exclusion not meet|0|||
147340636|NCT00785512|531415716|FG001|Overall Study|Inclusion/Exclusion not meet|0|||
147340637|NCT00785512|531415715|FG000|Overall Study|Adverse Event|0|||
147340638|NCT00785512|531415716|FG001|Overall Study|Adverse Event|0|||
147340639|NCT00785512|531415715|FG000|Overall Study|Lack of Efficacy|0|||
147340640|NCT00785512|531415716|FG001|Overall Study|Lack of Efficacy|2|||
147340641|NCT00785512|531415715|FG000|Overall Study|Withdrawal by Subject|0|||
147340642|NCT00785512|531415716|FG001|Overall Study|Withdrawal by Subject|1|||
147340643|NCT00785512|531415715|FG000|Overall Study|Lost to Follow-up|3|||
147340644|NCT00785512|531415716|FG001|Overall Study|Lost to Follow-up|0|||
147340645|NCT00785512|531415715|FG000|Overall Study|Precedure Refused|0|||
147340646|NCT00785512|531415716|FG001|Overall Study|Precedure Refused|0|||
147340647|NCT00785512|531415715|FG000|Overall Study|IVRS Programing Error|0|||
147340648|NCT00785512|531415716|FG001|Overall Study|IVRS Programing Error|0|||
147340649|NCT00785512|531415715|FG000|Overall Study|Physician Decision|0|||
147340650|NCT00785512|531415716|FG001|Overall Study|Physician Decision|0|||
147340651|NCT00785512|531415715|FG000|Overall Study|Lack of compliance|0|||
147340652|NCT00785512|531415716|FG001|Overall Study|Lack of compliance|1|||
147340653|NCT00440011|531415724|FG000|Overall Study|Adverse Event|2|||
147340654|NCT00440011|531415725|FG001|Overall Study|Adverse Event|0|||
147340655|NCT00440011|531415724|FG000|Overall Study|Lost to Follow-up|0|||
147340656|NCT00440011|531415725|FG001|Overall Study|Lost to Follow-up|2|||
147340657|NCT00440011|531415724|FG000|Overall Study|Protocol Violation|1|||
147340658|NCT00440011|531415725|FG001|Overall Study|Protocol Violation|1|||
147340659|NCT00440011|531415724|FG000|Overall Study|Withdrawal by Subject|1|||
147340660|NCT00440011|531415725|FG001|Overall Study|Withdrawal by Subject|0|||
147340661|NCT03960463|531416914|FG000|Overall Study|Withdrawal by Subject|2|||
147340662|NCT03960463|531416915|FG001|Overall Study|Withdrawal by Subject|0|||
147340663|NCT05568615|531416916|FG000|Overall Study|Death|1|||
147340664|NCT05568615|531416916|FG000|Overall Study|Physician Decision|1|||
147340665|NCT05194917|531416917|FG000|Overall Study|Lost to Follow-up|7|||
147340666|NCT05194917|531416918|FG001|Overall Study|Lost to Follow-up|5|||
147340667|NCT05194917|531416919|FG002|Overall Study|Lost to Follow-up|6|||
147340668|NCT05194917|531416920|FG003|Overall Study|Lost to Follow-up|5|||
147340669|NCT05505045|531416924|FG000|Overall Study|Withdrawal by Subject|2|||
147340670|NCT05505045|531416925|FG001|Overall Study|Withdrawal by Subject|1|||
147340671|NCT03346538|531416929|FG000|Overall Study|Physician Decision|0|||
147340672|NCT03346538|531416930|FG001|Overall Study|Physician Decision|1|||
147340673|NCT03346538|531416931|FG002|Overall Study|Physician Decision|0|||
147340674|NCT03346538|531416929|FG000|Overall Study|Withdrawal by Subject|3|||
147340675|NCT03346538|531416930|FG001|Overall Study|Withdrawal by Subject|2|||
147340676|NCT03346538|531416931|FG002|Overall Study|Withdrawal by Subject|0|||
147340677|NCT03346538|531416929|FG000|Overall Study|One subject of control group who discontinued prior to initiation of study drug administration.|0|||
147340678|NCT03346538|531416930|FG001|Overall Study|One subject of control group who discontinued prior to initiation of study drug administration.|0|||
147340679|NCT03346538|531416931|FG002|Overall Study|One subject of control group who discontinued prior to initiation of study drug administration.|1|||
147340680|NCT05672667|531416932|FG000|Overall Study|Vasovagal reaction with IV cannulation. Oxytocin was not infused and subject was withdrawn.|1|||
147340681|NCT01903811|531416940|FG000|Overall Study|No measurable disease|1|||
147340682|NCT01903811|531416941|FG001|Overall Study|No measurable disease|1|||
147340683|NCT01903811|531416940|FG000|Overall Study|Incomplete/discontinued prior therapy|1|||
147340684|NCT01903811|531416941|FG001|Overall Study|Incomplete/discontinued prior therapy|1|||
147340685|NCT01903811|531416940|FG000|Overall Study|Baseline lab missing/incomplete/untimely|6|||
147340686|NCT01903811|531416941|FG001|Overall Study|Baseline lab missing/incomplete/untimely|11|||
147340687|NCT01903811|531416940|FG000|Overall Study|Withdrawal by Subject|0|||
147340688|NCT01903811|531416941|FG001|Overall Study|Withdrawal by Subject|1|||
147340689|NCT04540913|531416942|FG000|Overall Study|Withdrawal by Subject|14|||
147340690|NCT04540913|531416943|FG001|Overall Study|Withdrawal by Subject|3|||
147340691|NCT00444600|531416944|FG000|Overall Study|Death|7|||
147340692|NCT00444600|531416945|FG001|Overall Study|Death|5|||
147340693|NCT00444600|531416946|FG002|Overall Study|Death|3|||
147340694|NCT00444600|531416947|FG003|Overall Study|Death|2|||
147340695|NCT00444600|531416944|FG000|Overall Study|Dropped|11|||
147340696|NCT00444600|531416945|FG001|Overall Study|Dropped|11|||
147340697|NCT00444600|531416946|FG002|Overall Study|Dropped|7|||
147340698|NCT00444600|531416947|FG003|Overall Study|Dropped|7|||
147340699|NCT00444600|531416944|FG000|Overall Study|Missed visit|1|||
147340700|NCT00444600|531416945|FG001|Overall Study|Missed visit|0|||
147340701|NCT00444600|531416946|FG002|Overall Study|Missed visit|0|||
147340702|NCT00444600|531416947|FG003|Overall Study|Missed visit|1|||
147340703|NCT05132478|531416948|FG000|Overall Study|did not complete survey after consent|1|||
147340704|NCT05132478|531416949|FG001|Overall Study|did not complete survey after consent|1|||
147662702|NCT04058028|532587409|FG001|Overall Study|Lost to Follow-up|1|||
147662703|NCT04058028|532587410|FG002|Overall Study|Lost to Follow-up|1|||
147340705|NCT05132478|531416948|FG000|Overall Study|excluded from analysis because survey was completed >30 days past biopsy|3|||
147340706|NCT05132478|531416949|FG001|Overall Study|excluded from analysis because survey was completed >30 days past biopsy|3|||
147340707|NCT02549170|531416952|FG000|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and Entered Epoch 2 (E2)|17|||
147340708|NCT02549170|531416953|FG001|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and Entered Epoch 2 (E2)|4|||
147340709|NCT02549170|531416954|FG002|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and Entered Epoch 2 (E2)|0|||
147340710|NCT02549170|531416955|FG003|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and Entered Epoch 2 (E2)|0|||
147340711|NCT02549170|531416956|FG004|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and Entered Epoch 2 (E2)|0|||
147340712|NCT02549170|531416952|FG000|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and did not Enter E2|5|||
147340713|NCT02549170|531416953|FG001|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and did not Enter E2|2|||
147340714|NCT02549170|531416954|FG002|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and did not Enter E2|0|||
147340715|NCT02549170|531416955|FG003|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and did not Enter E2|0|||
147340716|NCT02549170|531416956|FG004|Epoch 1: Day 1 to Approximately 32 Weeks|Relapsed and did not Enter E2|0|||
147340717|NCT02549170|531416952|FG000|Epoch 1: Day 1 to Approximately 32 Weeks|Did not Relapse;Ended Treatment (ET) From Epoch1|2|||
147340718|NCT02549170|531416953|FG001|Epoch 1: Day 1 to Approximately 32 Weeks|Did not Relapse;Ended Treatment (ET) From Epoch1|8|||
147340719|NCT02549170|531416954|FG002|Epoch 1: Day 1 to Approximately 32 Weeks|Did not Relapse;Ended Treatment (ET) From Epoch1|0|||
147340720|NCT02549170|531416955|FG003|Epoch 1: Day 1 to Approximately 32 Weeks|Did not Relapse;Ended Treatment (ET) From Epoch1|0|||
147340721|NCT02549170|531416956|FG004|Epoch 1: Day 1 to Approximately 32 Weeks|Did not Relapse;Ended Treatment (ET) From Epoch1|0|||
147340722|NCT03051165|531416957|FG000|Overall Study|Withdrawal by Subject|1|||
147340723|NCT03051165|531416957|FG000|Overall Study|Early termination of study|12|||
147340724|NCT00520546|531416960|FG000|Overall Study|Withdrawal by Subject|1|||
147340725|NCT00520546|531416960|FG000|Overall Study|failed radiopharmaceut. synthesis of FEC|5|||
147340726|NCT03076515|531416961|FG000|Overall Study|DMC decision based on interim analysis|25|||
147340727|NCT03076515|531416962|FG001|Overall Study|DMC decision based on interim analysis|29|||
147340728|NCT03988023|531416966|FG000|Overall Study|Non-compliance|3|||
147340729|NCT03988023|531416967|FG001|Overall Study|Non-compliance|0|||
147340730|NCT03988023|531416966|FG000|Overall Study|Withdrawal by Subject|39|||
147340731|NCT03988023|531416967|FG001|Overall Study|Withdrawal by Subject|37|||
147340732|NCT03988023|531416966|FG000|Overall Study|Adverse Event|0|||
147340733|NCT03988023|531416967|FG001|Overall Study|Adverse Event|2|||
147340734|NCT03988023|531416966|FG000|Overall Study|Physician Decision|0|||
147340735|NCT03988023|531416967|FG001|Overall Study|Physician Decision|1|||
147340736|NCT03988023|531416966|FG000|Overall Study|Lost to Follow-up|5|||
147340737|NCT03988023|531416967|FG001|Overall Study|Lost to Follow-up|8|||
147340738|NCT03988023|531416966|FG000|Overall Study|Sponsor decision to terminate follow up|10|||
147340739|NCT03988023|531416967|FG001|Overall Study|Sponsor decision to terminate follow up|12|||
147340740|NCT03988023|531416966|FG000|Overall Study|Lack of Efficacy|3|||
147340741|NCT03988023|531416967|FG001|Overall Study|Lack of Efficacy|1|||
147340742|NCT03988023|531416966|FG000|Overall Study|COVID-19 pandemic|225|||
147340743|NCT03988023|531416967|FG001|Overall Study|COVID-19 pandemic|227|||
147340744|NCT02101281|531416968|FG000|Overall Study|Adverse Event|0|||
147340745|NCT02101281|531416969|FG001|Overall Study|Adverse Event|1|||
147340746|NCT00174382|531416970|FG000|Overall Study|Death|2|||
147340747|NCT00174382|531416970|FG000|Overall Study|Adverse Event|19|||
147340748|NCT00174382|531416970|FG000|Overall Study|Withdrawal by Subject|6|||
147340749|NCT00174382|531416970|FG000|Overall Study|Protocol Violation|3|||
147340750|NCT00174382|531416970|FG000|Overall Study|Arrived early for last visit in error|1|||
147340751|NCT00174382|531416970|FG000|Overall Study|Subject felt pill not effective enough|1|||
147340752|NCT00174382|531416970|FG000|Overall Study|Lost to Follow-up|1|||
147340753|NCT00529100|531416972|FG000|Overall Study|Adverse Event|0|||
147340754|NCT00529100|531416973|FG001|Overall Study|Adverse Event|5|||
147340755|NCT00529100|531416972|FG000|Overall Study|Protocol Violation|0|||
147340756|NCT00529100|531416973|FG001|Overall Study|Protocol Violation|1|||
147340757|NCT00529100|531416972|FG000|Overall Study|Progressive Disease|0|||
147340758|NCT00529100|531416973|FG001|Overall Study|Progressive Disease|1|||
147340759|NCT00529100|531416972|FG000|Overall Study|Withdrawal by Subject|0|||
147340760|NCT00529100|531416973|FG001|Overall Study|Withdrawal by Subject|1|||
147340761|NCT00529100|531416972|FG000|Overall Study|Participant Ineligibility|0|||
147340762|NCT00529100|531416973|FG001|Overall Study|Participant Ineligibility|1|||
147340763|NCT03733119|531416974|FG000|Overall Study|Physician Decision|2|||
147340764|NCT03733119|531416975|FG001|Overall Study|Physician Decision|1|||
147340765|NCT03733119|531416974|FG000|Overall Study|ineligible to treat per protocol|0|||
147340766|NCT03733119|531416975|FG001|Overall Study|ineligible to treat per protocol|1|||
147340767|NCT03684044|531416981|FG000|Overall Study|Adverse Event|3|||
147340768|NCT03684044|531416982|FG001|Overall Study|Adverse Event|0|||
147340769|NCT03684044|531416981|FG000|Overall Study|Death|4|||
147340770|NCT03684044|531416982|FG001|Overall Study|Death|7|||
147340771|NCT03684044|531416981|FG000|Overall Study|Lost to Follow-up|3|||
147453036|NCT00623428|531821531|FG000|Treatment Period|Did not cooperate / refused treatment|0|||
147606420|NCT01544179|532375217|FG000|Overall Study|Eligibility criteria not fulfilled|1|||
147606421|NCT01544179|532375218|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
147606422|NCT03146962|532375221|FG000|Overall Study|Lost to Follow-up|1|||
147340772|NCT03684044|531416982|FG001|Overall Study|Lost to Follow-up|2|||
147340773|NCT03684044|531416981|FG000|Overall Study|Patient Not Available|0|||
147340774|NCT03684044|531416982|FG001|Overall Study|Patient Not Available|2|||
147340775|NCT03684044|531416981|FG000|Overall Study|Physician Decision|1|||
147340776|NCT03684044|531416982|FG001|Overall Study|Physician Decision|0|||
147340777|NCT03684044|531416981|FG000|Overall Study|Withdrawal by Subject|11|||
147340778|NCT03684044|531416982|FG001|Overall Study|Withdrawal by Subject|9|||
147340779|NCT03703336|531416983|FG000|Overall Study|Parent withdrew consent|29|||
147340780|NCT03703336|531416984|FG001|Overall Study|Parent withdrew consent|8|||
147340781|NCT03703336|531416983|FG000|Overall Study|Migration|3|||
147340782|NCT03703336|531416984|FG001|Overall Study|Migration|3|||
147340783|NCT03703336|531416983|FG000|Overall Study|Protocol Violation|3|||
147340784|NCT03703336|531416984|FG001|Overall Study|Protocol Violation|1|||
147340785|NCT03703336|531416983|FG000|Overall Study|Physician Decision|2|||
147340786|NCT03703336|531416984|FG001|Overall Study|Physician Decision|0|||
147340787|NCT03703336|531416983|FG000|Overall Study|Adverse Event|0|||
147340788|NCT03703336|531416984|FG001|Overall Study|Adverse Event|2|||
147340789|NCT03703336|531416983|FG000|Overall Study|Lost to Follow-up|1|||
147340790|NCT03703336|531416984|FG001|Overall Study|Lost to Follow-up|0|||
147340791|NCT00595413|531416985|FG000|Overall Study|Adverse Event|0|||
147340792|NCT00595413|531416986|FG001|Overall Study|Adverse Event|2|||
147340793|NCT00595413|531416987|FG002|Overall Study|Adverse Event|1|||
147340794|NCT00595413|531416988|FG003|Overall Study|Adverse Event|1|||
147340795|NCT00595413|531416985|FG000|Overall Study|Lost to Follow-up|2|||
147340796|NCT00595413|531416986|FG001|Overall Study|Lost to Follow-up|2|||
147340797|NCT00595413|531416987|FG002|Overall Study|Lost to Follow-up|1|||
147340798|NCT00595413|531416988|FG003|Overall Study|Lost to Follow-up|3|||
147340799|NCT00595413|531416985|FG000|Overall Study|Death|0|||
147340800|NCT00595413|531416986|FG001|Overall Study|Death|0|||
147340801|NCT00595413|531416987|FG002|Overall Study|Death|1|||
147340802|NCT00595413|531416988|FG003|Overall Study|Death|0|||
147340803|NCT00595413|531416985|FG000|Overall Study|Other|5|||
147340804|NCT00595413|531416986|FG001|Overall Study|Other|1|||
147340805|NCT00595413|531416987|FG002|Overall Study|Other|5|||
147340806|NCT00595413|531416988|FG003|Overall Study|Other|0|||
147340807|NCT00807937|531416989|FG000|Overall Study|Adverse Event|12|||
147340808|NCT00807937|531416990|FG001|Overall Study|Adverse Event|12|||
147340809|NCT00807937|531416991|FG002|Overall Study|Adverse Event|5|||
147340810|NCT00807937|531416992|FG003|Overall Study|Adverse Event|4|||
147340811|NCT00807937|531416989|FG000|Overall Study|Protocol Violation|4|||
147340812|NCT00807937|531416990|FG001|Overall Study|Protocol Violation|5|||
147340813|NCT00807937|531416991|FG002|Overall Study|Protocol Violation|3|||
147340814|NCT00807937|531416992|FG003|Overall Study|Protocol Violation|3|||
147340815|NCT00807937|531416989|FG000|Overall Study|Withdrawal by Subject|5|||
147340816|NCT00807937|531416990|FG001|Overall Study|Withdrawal by Subject|4|||
147340817|NCT00807937|531416991|FG002|Overall Study|Withdrawal by Subject|1|||
147340818|NCT00807937|531416992|FG003|Overall Study|Withdrawal by Subject|4|||
147340819|NCT00807937|531416989|FG000|Overall Study|Lost to Follow-up|4|||
147340820|NCT00807937|531416990|FG001|Overall Study|Lost to Follow-up|0|||
147340821|NCT00807937|531416991|FG002|Overall Study|Lost to Follow-up|2|||
147340822|NCT00807937|531416992|FG003|Overall Study|Lost to Follow-up|1|||
147340823|NCT00807937|531416989|FG000|Overall Study|Lack of Efficacy|0|||
147340824|NCT00807937|531416990|FG001|Overall Study|Lack of Efficacy|0|||
147340825|NCT00807937|531416991|FG002|Overall Study|Lack of Efficacy|1|||
147340826|NCT00807937|531416992|FG003|Overall Study|Lack of Efficacy|2|||
147340827|NCT00807937|531416989|FG000|Overall Study|Intake of prohibited medicine|0|||
147340828|NCT00807937|531416990|FG001|Overall Study|Intake of prohibited medicine|0|||
147340829|NCT00807937|531416991|FG002|Overall Study|Intake of prohibited medicine|2|||
147340830|NCT00807937|531416992|FG003|Overall Study|Intake of prohibited medicine|0|||
147340831|NCT00807937|531416989|FG000|Overall Study|All other reasons (not provided)|2|||
147340832|NCT00807937|531416990|FG001|Overall Study|All other reasons (not provided)|4|||
147340833|NCT00807937|531416991|FG002|Overall Study|All other reasons (not provided)|0|||
147340834|NCT00807937|531416992|FG003|Overall Study|All other reasons (not provided)|1|||
147340835|NCT04629950|531416995|FG000|Double-Blind Placebo Controlled Trial|Lost to Follow-up|1|||
147340836|NCT04629950|531416996|FG001|Double-Blind Placebo Controlled Trial|Lost to Follow-up|1|||
147340837|NCT04629950|531416997|FG002|Double-Blind Placebo Controlled Trial|Lost to Follow-up|0|||
147340838|NCT04629950|531416998|FG003|Double-Blind Placebo Controlled Trial|Lost to Follow-up|0|||
147340839|NCT04629950|531416995|FG000|Double-Blind Placebo Controlled Trial|Withdrawal by Subject|0|||
147340840|NCT04629950|531416996|FG001|Double-Blind Placebo Controlled Trial|Withdrawal by Subject|2|||
147340841|NCT04629950|531416997|FG002|Double-Blind Placebo Controlled Trial|Withdrawal by Subject|0|||
147340842|NCT04629950|531416998|FG003|Double-Blind Placebo Controlled Trial|Withdrawal by Subject|0|||
147340843|NCT04629950|531416995|FG000|Double-Blind Placebo Controlled Trial|Adverse Event|0|||
147340844|NCT04629950|531416996|FG001|Double-Blind Placebo Controlled Trial|Adverse Event|2|||
147340845|NCT04629950|531416997|FG002|Double-Blind Placebo Controlled Trial|Adverse Event|0|||
147340846|NCT04629950|531416998|FG003|Double-Blind Placebo Controlled Trial|Adverse Event|0|||
147340847|NCT04629950|531416995|FG000|Extension Study|Withdrawal by Subject|0|||
147340848|NCT04629950|531416996|FG001|Extension Study|Withdrawal by Subject|0|||
147606423|NCT03146962|532375222|FG001|Overall Study|Lost to Follow-up|1|||
147340849|NCT04629950|531416997|FG002|Extension Study|Withdrawal by Subject|1|||
147340850|NCT04629950|531416998|FG003|Extension Study|Withdrawal by Subject|0|||
147340851|NCT04629950|531416995|FG000|Extension Study|Adverse Event|0|||
147340852|NCT04629950|531416996|FG001|Extension Study|Adverse Event|0|||
147453037|NCT00623428|531821532|FG001|Treatment Period|Did not cooperate / refused treatment|13|||
147453038|NCT00623428|531821531|FG000|Treatment Period|Insufficient therapeutic response|0|||
147453039|NCT00623428|531821532|FG001|Treatment Period|Insufficient therapeutic response|2|||
147453040|NCT00623428|531821531|FG000|Treatment Period|Other|0|||
147606424|NCT03146962|532375223|FG002|Overall Study|Lost to Follow-up|0|||
147299226|NCT01345630|531261065|FG001|Overall Study|Protocol Violation|1|||
147299227|NCT01345630|531261064|FG000|Overall Study|Medication error without associated AE|0|||
147299228|NCT01345630|531261065|FG001|Overall Study|Medication error without associated AE|1|||
147299229|NCT01345630|531261064|FG000|Overall Study|Study terminated by sponsor|254|||
147299230|NCT01345630|531261065|FG001|Overall Study|Study terminated by sponsor|285|||
147299231|NCT01345630|531261064|FG000|Overall Study|Other reasons|6|||
147299232|NCT01345630|531261065|FG001|Overall Study|Other reasons|8|||
147299233|NCT01345630|531261064|FG000|Overall Study|Withdrawn due to pregnancy|1|||
147299234|NCT01345630|531261065|FG001|Overall Study|Withdrawn due to pregnancy|2|||
147299235|NCT01345630|531261064|FG000|Overall Study|No longer willing to participate|9|||
147299236|NCT01345630|531261065|FG001|Overall Study|No longer willing to participate|12|||
147299237|NCT01345630|531261064|FG000|Overall Study|Insufficient clinical response|48|||
147299238|NCT01345630|531261065|FG001|Overall Study|Insufficient clinical response|11|||
147299239|NCT01289418|531261066|FG000|Day 8 Survey|email address invalid|283|||
147299240|NCT01289418|531261066|FG000|Day 8 Survey|participants did not complete the survey|1935|||
147299241|NCT01289418|531261066|FG000|Day 29 Survey|email address invalid|283|||
147299242|NCT01289418|531261066|FG000|Day 29 Survey|participants did not complete the survey|2185|||
147299243|NCT01352585|531261068|FG000|Overall Study|Adverse Event|2|||
147299244|NCT01352585|531261069|FG001|Overall Study|Adverse Event|1|||
147299245|NCT01352585|531261068|FG000|Overall Study|Lost to Follow-up|1|||
147299246|NCT01352585|531261069|FG001|Overall Study|Lost to Follow-up|0|||
147299247|NCT01352585|531261068|FG000|Overall Study|Other|5|||
147299248|NCT01352585|531261069|FG001|Overall Study|Other|2|||
147299249|NCT02459262|531261089|FG000|Overall Study|Withdrawal by Subject|0|||
147299250|NCT02459262|531261090|FG001|Overall Study|Withdrawal by Subject|0|||
147299251|NCT02459262|531261091|FG002|Overall Study|Withdrawal by Subject|0|||
147299252|NCT02459262|531261092|FG003|Overall Study|Withdrawal by Subject|0|||
147299253|NCT02459262|531261093|FG004|Overall Study|Withdrawal by Subject|0|||
147299254|NCT02459262|531261094|FG005|Overall Study|Withdrawal by Subject|0|||
147299255|NCT02459262|531261095|FG006|Overall Study|Withdrawal by Subject|0|||
147299256|NCT02459262|531261096|FG007|Overall Study|Withdrawal by Subject|0|||
147299257|NCT02459262|531261097|FG008|Overall Study|Withdrawal by Subject|0|||
147299258|NCT02459262|531261098|FG009|Overall Study|Withdrawal by Subject|1|||
147299259|NCT02459262|531261099|FG010|Overall Study|Withdrawal by Subject|0|||
147299260|NCT00549757|531261106|FG000|Active Treatment Phase: Max. 50 Months|Adverse Event|590|||
147299261|NCT00549757|531261107|FG001|Active Treatment Phase: Max. 50 Months|Adverse Event|462|||
147299262|NCT00549757|531261106|FG000|Active Treatment Phase: Max. 50 Months|Abnormal laboratory value(s)|98|||
147299263|NCT00549757|531261107|FG001|Active Treatment Phase: Max. 50 Months|Abnormal laboratory value(s)|58|||
147299264|NCT00549757|531261106|FG000|Active Treatment Phase: Max. 50 Months|Abnormal test procedure result(s)|7|||
147299265|NCT00549757|531261107|FG001|Active Treatment Phase: Max. 50 Months|Abnormal test procedure result(s)|7|||
147299266|NCT00549757|531261106|FG000|Active Treatment Phase: Max. 50 Months|Unsatisfactory therapeutic effect|47|||
147299267|NCT00549757|531261107|FG001|Active Treatment Phase: Max. 50 Months|Unsatisfactory therapeutic effect|53|||
147299268|NCT00549757|531261106|FG000|Active Treatment Phase: Max. 50 Months|Subject withdrew consent|38|||
147299269|NCT00549757|531261107|FG001|Active Treatment Phase: Max. 50 Months|Subject withdrew consent|38|||
147299270|NCT00549757|531261106|FG000|Active Treatment Phase: Max. 50 Months|Lost to Follow-up|41|||
147299271|NCT00549757|531261107|FG001|Active Treatment Phase: Max. 50 Months|Lost to Follow-up|29|||
147299272|NCT00549757|531261106|FG000|Active Treatment Phase: Max. 50 Months|Administrative problems|2857|||
147299273|NCT00549757|531261107|FG001|Active Treatment Phase: Max. 50 Months|Administrative problems|3019|||
147299274|NCT00549757|531261106|FG000|Active Treatment Phase: Max. 50 Months|Death|188|||
147299275|NCT00549757|531261107|FG001|Active Treatment Phase: Max. 50 Months|Death|200|||
147299276|NCT00549757|531261106|FG000|Active Treatment Phase: Max. 50 Months|Patient's request|353|||
147299277|NCT00549757|531261107|FG001|Active Treatment Phase: Max. 50 Months|Patient's request|380|||
147299278|NCT00549757|531261106|FG000|Active Treatment Phase: Max. 50 Months|Incorrect Entry|69|||
147299279|NCT00549757|531261107|FG001|Active Treatment Phase: Max. 50 Months|Incorrect Entry|55|||
147299280|NCT00549757|531261106|FG000|Active Treatment Phase: Max. 50 Months|Missing data|8|||
147299281|NCT00549757|531261107|FG001|Active Treatment Phase: Max. 50 Months|Missing data|9|||
147299282|NCT00549757|531261106|FG000|Extension Period (in Average 9 Months)|Death|143|||
147299283|NCT00549757|531261107|FG001|Extension Period (in Average 9 Months)|Death|136|||
147299284|NCT00549757|531261106|FG000|Extension Period (in Average 9 Months)|Lost to Follow-up|52|||
147299285|NCT00549757|531261107|FG001|Extension Period (in Average 9 Months)|Lost to Follow-up|47|||
147299286|NCT00549757|531261106|FG000|Extension Period (in Average 9 Months)|Withdrawal by Subject|9|||
147299287|NCT00549757|531261107|FG001|Extension Period (in Average 9 Months)|Withdrawal by Subject|16|||
147299288|NCT00549757|531261106|FG000|Extension Period (in Average 9 Months)|Patient's request|421|||
147453041|NCT00623428|531821532|FG001|Treatment Period|Other|1|||
147453042|NCT00623428|531821531|FG000|Treatment Period|Withdrawal by Subject|0|||
147340853|NCT04629950|531416997|FG002|Extension Study|Adverse Event|0|||
147340854|NCT04629950|531416998|FG003|Extension Study|Adverse Event|1|||
147340855|NCT03233633|531416999|FG000|Overall Study|Adverse Event|2|||
147340856|NCT03233633|531416999|FG000|Overall Study|Less Than 3 Days of Data|6|||
147340857|NCT02088853|531417000|FG000|Overall Study|Pregnancy|1|||
147340858|NCT02088853|531417001|FG001|Overall Study|Pregnancy|0|||
147340859|NCT00603954|531417004|FG000|Overall Study|Protocol Violation|1|||
147340860|NCT00603954|531417005|FG001|Overall Study|Protocol Violation|2|||
147340861|NCT02708108|531417006|FG000|Overall Study|Death|1|||
147340862|NCT02708108|531417007|FG001|Overall Study|Death|2|||
147340863|NCT02708108|531417006|FG000|Overall Study|Regimen change|1|||
147340864|NCT02708108|531417007|FG001|Overall Study|Regimen change|0|||
147340865|NCT02708108|531417006|FG000|Overall Study|No MRD and no imaging available|0|||
147340866|NCT02708108|531417007|FG001|Overall Study|No MRD and no imaging available|1|||
147340867|NCT02568683|531417008|FG000|Overall Study|Death|0|||
147340868|NCT02568683|531417009|FG001|Overall Study|Death|2|||
147340869|NCT02568683|531417008|FG000|Overall Study|Withdrew Consent|1|||
147340870|NCT02568683|531417009|FG001|Overall Study|Withdrew Consent|0|||
147340871|NCT02568683|531417008|FG000|Overall Study|Study Terminated By Sponsor|5|||
147340872|NCT02568683|531417009|FG001|Overall Study|Study Terminated By Sponsor|2|||
147340873|NCT00580866|531417021|FG000|Overall Study|Lost to Follow-up|2|||
147340874|NCT00580866|531417022|FG001|Overall Study|Lost to Follow-up|2|||
147340875|NCT00609336|531417023|FG000|Overall Study|Protocol Violation|3|||
147340876|NCT00609336|531417023|FG000|Overall Study|Death|1|||
147340877|NCT00609336|531417023|FG000|Overall Study|LA or Met at Surgery|9|||
147340878|NCT02477605|531417024|FG000|Overall Study|Discontinued prior to treatment|1|||
147340879|NCT02477605|531417025|FG001|Overall Study|Discontinued prior to treatment|0|||
147340880|NCT02477605|531417024|FG000|Overall Study|Lost to Follow-up|0|||
147340881|NCT02477605|531417025|FG001|Overall Study|Lost to Follow-up|2|||
147340882|NCT02477605|531417024|FG000|Overall Study|Withdrawal by Subject|0|||
147340883|NCT02477605|531417025|FG001|Overall Study|Withdrawal by Subject|1|||
147340884|NCT02477605|531417024|FG000|Overall Study|Administered gas during surgery|0|||
147340885|NCT02477605|531417025|FG001|Overall Study|Administered gas during surgery|1|||
147340886|NCT01388361|531417026|FG000|Overall Study|Adverse Event|0|||
147340887|NCT01388361|531417027|FG001|Overall Study|Adverse Event|5|||
147340888|NCT01388361|531417028|FG002|Overall Study|Adverse Event|1|||
147340889|NCT01388361|531417026|FG000|Overall Study|Protocol Violation|0|||
147340890|NCT01388361|531417027|FG001|Overall Study|Protocol Violation|0|||
147340891|NCT01388361|531417028|FG002|Overall Study|Protocol Violation|2|||
147340892|NCT01388361|531417026|FG000|Overall Study|Withdrawal criteria|12|||
147340893|NCT01388361|531417027|FG001|Overall Study|Withdrawal criteria|7|||
147340894|NCT01388361|531417028|FG002|Overall Study|Withdrawal criteria|10|||
147340895|NCT01388361|531417026|FG000|Overall Study|Unclassified|0|||
147340896|NCT01388361|531417027|FG001|Overall Study|Unclassified|0|||
147340897|NCT01388361|531417028|FG002|Overall Study|Unclassified|1|||
147340898|NCT01061671|531417030|FG000|Overall Study|Withdrawal by Subject|16|||
147340899|NCT01061671|531417031|FG001|Overall Study|Withdrawal by Subject|20|||
147340900|NCT01061671|531417030|FG000|Overall Study|Lost to Follow-up|3|||
147340901|NCT01061671|531417031|FG001|Overall Study|Lost to Follow-up|5|||
147340902|NCT01061671|531417030|FG000|Overall Study|Death|28|||
147340903|NCT01061671|531417031|FG001|Overall Study|Death|30|||
147340904|NCT00419341|531417035|FG000|Wash in/Wash Out Period|Withdrawal by Subject|8|||
147340905|NCT00419341|531417035|FG000|Wash in/Wash Out Period|Adverse Event|2|||
147340906|NCT00419341|531417035|FG000|Wash in/Wash Out Period|Disqualifying laboratory results|1|||
147340907|NCT00419341|531417035|FG000|Efficacy Period|Withdrawal by Subject|6|||
147340908|NCT00419341|531417035|FG000|Efficacy Period|Protocol Violation|1|||
147340909|NCT00419341|531417035|FG000|Efficacy Period|Lost to Follow-up|1|||
147340910|NCT00419341|531417035|FG000|Efficacy Period|Non-compliance|1|||
147340911|NCT00419341|531417035|FG000|Efficacy Period|Termination of study site|1|||
147340912|NCT01925339|531417039|FG000|Overall Study|Adverse Event|2|||
147340913|NCT01925339|531417040|FG001|Overall Study|Adverse Event|0|||
147340914|NCT04043455|531418243|FG000|Main Study Double-Blind Treatment Period|Adverse Event|2|||
147340915|NCT04043455|531418244|FG001|Main Study Double-Blind Treatment Period|Adverse Event|3|||
147340916|NCT04043455|531418245|FG002|Main Study Double-Blind Treatment Period|Adverse Event|2|||
147340917|NCT04043455|531418246|FG003|Main Study Double-Blind Treatment Period|Adverse Event|3|||
147340918|NCT04043455|531418247|FG004|Main Study Double-Blind Treatment Period|Adverse Event|0|||
147340919|NCT04043455|531418248|FG005|Main Study Double-Blind Treatment Period|Adverse Event|0|||
147340920|NCT04043455|531418243|FG000|Main Study Double-Blind Treatment Period|Withdrawal by Subject|4|||
147340921|NCT04043455|531418244|FG001|Main Study Double-Blind Treatment Period|Withdrawal by Subject|5|||
147340922|NCT04043455|531418245|FG002|Main Study Double-Blind Treatment Period|Withdrawal by Subject|4|||
147340923|NCT04043455|531418246|FG003|Main Study Double-Blind Treatment Period|Withdrawal by Subject|9|||
147340924|NCT04043455|531418247|FG004|Main Study Double-Blind Treatment Period|Withdrawal by Subject|0|||
147340925|NCT04043455|531418248|FG005|Main Study Double-Blind Treatment Period|Withdrawal by Subject|0|||
147340926|NCT04043455|531418243|FG000|Main Study Double-Blind Treatment Period|Physician Decision|0|||
147340927|NCT04043455|531418244|FG001|Main Study Double-Blind Treatment Period|Physician Decision|2|||
147606425|NCT03146962|532375224|FG003|Overall Study|Lost to Follow-up|0|||
147340928|NCT04043455|531418245|FG002|Main Study Double-Blind Treatment Period|Physician Decision|1|||
147340929|NCT04043455|531418246|FG003|Main Study Double-Blind Treatment Period|Physician Decision|0|||
147340930|NCT04043455|531418247|FG004|Main Study Double-Blind Treatment Period|Physician Decision|0|||
147340931|NCT04043455|531418248|FG005|Main Study Double-Blind Treatment Period|Physician Decision|0|||
147340932|NCT04043455|531418243|FG000|Main Study Double-Blind Treatment Period|Lost to Follow-up|1|||
147340933|NCT04043455|531418244|FG001|Main Study Double-Blind Treatment Period|Lost to Follow-up|2|||
147340934|NCT04043455|531418245|FG002|Main Study Double-Blind Treatment Period|Lost to Follow-up|1|||
147340935|NCT04043455|531418246|FG003|Main Study Double-Blind Treatment Period|Lost to Follow-up|0|||
147340936|NCT04043455|531418247|FG004|Main Study Double-Blind Treatment Period|Lost to Follow-up|0|||
147340937|NCT04043455|531418248|FG005|Main Study Double-Blind Treatment Period|Lost to Follow-up|0|||
147340938|NCT04043455|531418243|FG000|Main Study Double-Blind Treatment Period|Protocol Violation|0|||
147340939|NCT04043455|531418244|FG001|Main Study Double-Blind Treatment Period|Protocol Violation|1|||
147340940|NCT04043455|531418245|FG002|Main Study Double-Blind Treatment Period|Protocol Violation|0|||
147340941|NCT04043455|531418246|FG003|Main Study Double-Blind Treatment Period|Protocol Violation|0|||
147340942|NCT04043455|531418247|FG004|Main Study Double-Blind Treatment Period|Protocol Violation|0|||
147340943|NCT04043455|531418248|FG005|Main Study Double-Blind Treatment Period|Protocol Violation|0|||
147340944|NCT04043455|531418243|FG000|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|1|||
147340945|NCT04043455|531418244|FG001|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|0|||
147340946|NCT04043455|531418245|FG002|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|0|||
147340947|NCT04043455|531418246|FG003|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|0|||
147340948|NCT04043455|531418247|FG004|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|0|||
147340949|NCT04043455|531418248|FG005|Main Study Double-Blind Treatment Period|Regional site closure order due to Covid 19|0|||
147340950|NCT04043455|531418243|FG000|Main Study Double-Blind Treatment Period|Did not receive treatment|0|||
147340951|NCT04043455|531418244|FG001|Main Study Double-Blind Treatment Period|Did not receive treatment|1|||
147340952|NCT04043455|531418245|FG002|Main Study Double-Blind Treatment Period|Did not receive treatment|0|||
147340953|NCT04043455|531418246|FG003|Main Study Double-Blind Treatment Period|Did not receive treatment|0|||
147340954|NCT04043455|531418247|FG004|Main Study Double-Blind Treatment Period|Did not receive treatment|0|||
147340955|NCT04043455|531418248|FG005|Main Study Double-Blind Treatment Period|Did not receive treatment|0|||
147340956|NCT04043455|531418243|FG000|Double-Blind LTE Treatment Period|Adverse Event|0|||
147340957|NCT04043455|531418244|FG001|Double-Blind LTE Treatment Period|Adverse Event|0|||
147340958|NCT04043455|531418245|FG002|Double-Blind LTE Treatment Period|Adverse Event|0|||
147340959|NCT04043455|531418246|FG003|Double-Blind LTE Treatment Period|Adverse Event|0|||
147340960|NCT04043455|531418247|FG004|Double-Blind LTE Treatment Period|Adverse Event|0|||
147340961|NCT04043455|531418248|FG005|Double-Blind LTE Treatment Period|Adverse Event|2|||
147340962|NCT04043455|531418243|FG000|Double-Blind LTE Treatment Period|Withdrawal by Subject|0|||
147340963|NCT04043455|531418244|FG001|Double-Blind LTE Treatment Period|Withdrawal by Subject|0|||
147340964|NCT04043455|531418245|FG002|Double-Blind LTE Treatment Period|Withdrawal by Subject|0|||
147340965|NCT04043455|531418246|FG003|Double-Blind LTE Treatment Period|Withdrawal by Subject|0|||
147340966|NCT04043455|531418247|FG004|Double-Blind LTE Treatment Period|Withdrawal by Subject|5|||
147340967|NCT04043455|531418248|FG005|Double-Blind LTE Treatment Period|Withdrawal by Subject|6|||
147340968|NCT04043455|531418243|FG000|Double-Blind LTE Treatment Period|Lost to Follow-up|0|||
147340969|NCT04043455|531418244|FG001|Double-Blind LTE Treatment Period|Lost to Follow-up|0|||
147340970|NCT04043455|531418245|FG002|Double-Blind LTE Treatment Period|Lost to Follow-up|0|||
147340971|NCT04043455|531418246|FG003|Double-Blind LTE Treatment Period|Lost to Follow-up|0|||
147340972|NCT04043455|531418247|FG004|Double-Blind LTE Treatment Period|Lost to Follow-up|1|||
147340973|NCT04043455|531418248|FG005|Double-Blind LTE Treatment Period|Lost to Follow-up|0|||
147340974|NCT04043455|531418243|FG000|Double-Blind LTE Treatment Period|Study termination by Sponsor|0|||
147340975|NCT04043455|531418244|FG001|Double-Blind LTE Treatment Period|Study termination by Sponsor|0|||
147340976|NCT04043455|531418245|FG002|Double-Blind LTE Treatment Period|Study termination by Sponsor|0|||
147340977|NCT04043455|531418246|FG003|Double-Blind LTE Treatment Period|Study termination by Sponsor|0|||
147340978|NCT04043455|531418247|FG004|Double-Blind LTE Treatment Period|Study termination by Sponsor|47|||
147340979|NCT04043455|531418248|FG005|Double-Blind LTE Treatment Period|Study termination by Sponsor|44|||
147340980|NCT01998984|531418249|FG000|Overall Study|Adverse Event|0|||
147340981|NCT01998984|531418250|FG001|Overall Study|Adverse Event|0|||
147340982|NCT01998984|531418251|FG002|Overall Study|Adverse Event|0|||
147340983|NCT01998984|531418252|FG003|Overall Study|Adverse Event|1|||
147340984|NCT01998984|531418249|FG000|Overall Study|Lost to Follow-up|0|||
147340985|NCT01998984|531418250|FG001|Overall Study|Lost to Follow-up|1|||
147340986|NCT01998984|531418251|FG002|Overall Study|Lost to Follow-up|0|||
147340987|NCT01998984|531418252|FG003|Overall Study|Lost to Follow-up|1|||
147340988|NCT01998984|531418249|FG000|Overall Study|Withdrawal by Subject|0|||
147340989|NCT01998984|531418250|FG001|Overall Study|Withdrawal by Subject|0|||
147340990|NCT01998984|531418251|FG002|Overall Study|Withdrawal by Subject|1|||
147453043|NCT00623428|531821532|FG001|Treatment Period|Withdrawal by Subject|1|||
147606426|NCT03146962|532375225|FG004|Overall Study|Lost to Follow-up|0|||
147606427|NCT03146962|532375226|FG005|Overall Study|Lost to Follow-up|0|||
147606428|NCT03146962|532375227|FG006|Overall Study|Lost to Follow-up|0|||
147606429|NCT03146962|532375228|FG007|Overall Study|Lost to Follow-up|0|||
147606430|NCT03146962|532375229|FG008|Overall Study|Lost to Follow-up|0|||
147606431|NCT03146962|532375230|FG009|Overall Study|Lost to Follow-up|0|||
147606432|NCT03146962|532375221|FG000|Overall Study|Adverse Event|0|||
147606433|NCT03146962|532375222|FG001|Overall Study|Adverse Event|3|||
147606434|NCT03146962|532375223|FG002|Overall Study|Adverse Event|0|||
147606435|NCT03146962|532375224|FG003|Overall Study|Adverse Event|0|||
147606436|NCT03146962|532375225|FG004|Overall Study|Adverse Event|0|||
147606437|NCT03146962|532375226|FG005|Overall Study|Adverse Event|0|||
147606438|NCT03146962|532375227|FG006|Overall Study|Adverse Event|0|||
147606439|NCT03146962|532375228|FG007|Overall Study|Adverse Event|1|||
147606440|NCT03146962|532375229|FG008|Overall Study|Adverse Event|0|||
147606441|NCT03146962|532375230|FG009|Overall Study|Adverse Event|0|||
147606442|NCT03146962|532375221|FG000|Overall Study|Withdrawal by Subject|0|||
147606443|NCT03146962|532375222|FG001|Overall Study|Withdrawal by Subject|0|||
147606444|NCT03146962|532375223|FG002|Overall Study|Withdrawal by Subject|0|||
147299289|NCT00549757|531261107|FG001|Extension Period (in Average 9 Months)|Patient's request|436|||
147299290|NCT01814748|531261110|FG000|Overall Study|Lost to Follow-up|1|||
147299291|NCT01814748|531261111|FG001|Overall Study|Lost to Follow-up|2|||
147299292|NCT01814748|531261110|FG000|Overall Study|Study site terminated by sponsor|1|||
147299293|NCT01814748|531261111|FG001|Overall Study|Study site terminated by sponsor|1|||
147299294|NCT01814748|531261110|FG000|Overall Study|Withdrawal by Subject|6|||
147299295|NCT01814748|531261111|FG001|Overall Study|Withdrawal by Subject|4|||
147299296|NCT00330174|531261113|FG000|Overall Study|Withdrawal by Subject|7|||
147299297|NCT00330174|531261114|FG001|Overall Study|Withdrawal by Subject|7|||
147299298|NCT00330174|531261113|FG000|Overall Study|Lost to Follow-up|4|||
147299299|NCT00330174|531261114|FG001|Overall Study|Lost to Follow-up|1|||
147299300|NCT00330174|531261113|FG000|Overall Study|Clinical deterioration|1|||
147299301|NCT00330174|531261114|FG001|Overall Study|Clinical deterioration|2|||
147299302|NCT00330174|531261113|FG000|Overall Study|Excessive missed visits|3|||
147299303|NCT00330174|531261114|FG001|Overall Study|Excessive missed visits|8|||
147299304|NCT00330174|531261113|FG000|Overall Study|Miscellaneous reasons|7|||
147299305|NCT00330174|531261114|FG001|Overall Study|Miscellaneous reasons|1|||
147299306|NCT02316769|531261117|FG000|Overall Study|Physician Decision|1|||
147299307|NCT02316769|531261118|FG001|Overall Study|Physician Decision|0|||
147299308|NCT02316769|531261117|FG000|Overall Study|Withdrawal by Subject|1|||
147299309|NCT02316769|531261118|FG001|Overall Study|Withdrawal by Subject|0|||
147299310|NCT00645164|531261122|FG000|Overall Study|Lost to Follow-up|2|||
147299311|NCT00645164|531261122|FG000|Overall Study|Withdrawal by Subject|4|||
147299312|NCT00645164|531261122|FG000|Overall Study|Protocol Violation|1|||
147299313|NCT04751942|531261129|FG000|Overall Study|Lost to Follow-up|9|||
147299314|NCT04751942|531261130|FG001|Overall Study|Lost to Follow-up|6|||
147299315|NCT00724152|531261140|FG000|Two-arm Study Period|Withdrawal by Subject|3|||
147299316|NCT00724152|531261141|FG001|Two-arm Study Period|Withdrawal by Subject|2|||
147299317|NCT00724152|531261142|FG002|Two-arm Study Period|Withdrawal by Subject|0|||
147299318|NCT00724152|531261140|FG000|Three-arm Study Period (+Standard Care)|Withdrawal by Subject|1|||
147299319|NCT00724152|531261141|FG001|Three-arm Study Period (+Standard Care)|Withdrawal by Subject|2|||
147299320|NCT00724152|531261142|FG002|Three-arm Study Period (+Standard Care)|Withdrawal by Subject|1|||
147299321|NCT00386022|531261143|FG000|Plus Estrogen|Lost to Follow-up|2|||
147299322|NCT00386022|531261144|FG001|Plus Estrogen|Lost to Follow-up|0|||
147299323|NCT00386022|531261143|FG000|Plus Estrogen|Adverse Event|0|||
147299324|NCT00386022|531261144|FG001|Plus Estrogen|Adverse Event|1|||
147299325|NCT03266770|531261147|FG000|Overall Study|Physician Decision|3|||
147299326|NCT03266770|531261147|FG000|Overall Study|Insufficient study supplies|1|||
147299327|NCT03266770|531261147|FG000|Overall Study|Adverse Event|1|||
147299328|NCT02657031|531261151|FG000|Overall Study|Adverse Event|1|||
147299329|NCT02657031|531261152|FG001|Overall Study|Adverse Event|2|||
147299330|NCT03078816|531261153|FG000|Overall Study|Withdrawal by Subject|1|||
147299331|NCT02114151|531261154|FG000|Overall Study|Death|1|||
147299332|NCT02114151|531261154|FG000|Overall Study|Lost to Follow-up|1|||
147299333|NCT02114151|531261154|FG000|Overall Study|Withdrawal by Subject|5|||
147340991|NCT01998984|531418252|FG003|Overall Study|Withdrawal by Subject|0|||
147340992|NCT01998984|531418249|FG000|Overall Study|Other|0|||
147340993|NCT01998984|531418250|FG001|Overall Study|Other|0|||
147606445|NCT03146962|532375224|FG003|Overall Study|Withdrawal by Subject|0|||
147606446|NCT03146962|532375225|FG004|Overall Study|Withdrawal by Subject|1|||
147299334|NCT02638948|531261157|FG000|Overall Study|Withdrawal by Subject|4|||
147299335|NCT02638948|531261158|FG001|Overall Study|Withdrawal by Subject|5|||
147299336|NCT02638948|531261159|FG002|Overall Study|Withdrawal by Subject|3|||
147299337|NCT02638948|531261160|FG003|Overall Study|Withdrawal by Subject|1|||
147299338|NCT02638948|531261157|FG000|Overall Study|Administrative Reason by Sponsor|0|||
147299339|NCT02638948|531261158|FG001|Overall Study|Administrative Reason by Sponsor|1|||
147299340|NCT02638948|531261159|FG002|Overall Study|Administrative Reason by Sponsor|0|||
147340994|NCT01998984|531418251|FG002|Overall Study|Other|0|||
147340995|NCT01998984|531418252|FG003|Overall Study|Other|1|||
147340996|NCT03025789|531418253|FG000|Overall Study|Lack of Efficacy|6|||
147340997|NCT03025789|531418254|FG001|Overall Study|Lack of Efficacy|1|||
147340998|NCT03025789|531418253|FG000|Overall Study|Death|1|||
147340999|NCT03025789|531418254|FG001|Overall Study|Death|0|||
147341000|NCT03025789|531418253|FG000|Overall Study|Withdrawal by Subject|0|||
147341001|NCT03025789|531418254|FG001|Overall Study|Withdrawal by Subject|2|||
147341002|NCT04440176|531418256|FG000|Overall Study|Withdrawal by Subject|5|||
147341003|NCT04440176|531418257|FG001|Overall Study|Withdrawal by Subject|3|||
147341004|NCT04440176|531418256|FG000|Overall Study|Withdrawal by parent/guardian|4|||
147341005|NCT04440176|531418257|FG001|Overall Study|Withdrawal by parent/guardian|5|||
147341006|NCT04440176|531418256|FG000|Overall Study|Adverse Event|2|||
147341007|NCT04440176|531418257|FG001|Overall Study|Adverse Event|6|||
147341008|NCT04440176|531418256|FG000|Overall Study|Lost to Follow-up|22|||
147341009|NCT04440176|531418257|FG001|Overall Study|Lost to Follow-up|23|||
147341010|NCT04440176|531418256|FG000|Overall Study|Medication error without associated adverse event|0|||
147341011|NCT04440176|531418257|FG001|Overall Study|Medication error without associated adverse event|1|||
147341012|NCT04440176|531418256|FG000|Overall Study|No longer met eligibility criteria|7|||
147341013|NCT04440176|531418257|FG001|Overall Study|No longer met eligibility criteria|1|||
147341014|NCT04440176|531418256|FG000|Overall Study|Other|1|||
147341015|NCT04440176|531418257|FG001|Overall Study|Other|2|||
147341016|NCT04440176|531418256|FG000|Overall Study|Protocol deviation|6|||
147341017|NCT04440176|531418257|FG001|Overall Study|Protocol deviation|8|||
147299341|NCT02638948|531261160|FG003|Overall Study|Administrative Reason by Sponsor|4|||
147299342|NCT02638948|531261157|FG000|Overall Study|Adverse Event|0|||
147299343|NCT02638948|531261158|FG001|Overall Study|Adverse Event|0|||
147299344|NCT02638948|531261159|FG002|Overall Study|Adverse Event|1|||
147299345|NCT02638948|531261160|FG003|Overall Study|Adverse Event|1|||
147299346|NCT02638948|531261157|FG000|Overall Study|Lack of Efficacy|1|||
147299347|NCT02638948|531261158|FG001|Overall Study|Lack of Efficacy|1|||
147299348|NCT02638948|531261159|FG002|Overall Study|Lack of Efficacy|0|||
147299349|NCT02638948|531261160|FG003|Overall Study|Lack of Efficacy|0|||
147299350|NCT02638948|531261157|FG000|Overall Study|Lost to Follow-up|0|||
147299351|NCT02638948|531261158|FG001|Overall Study|Lost to Follow-up|0|||
147299352|NCT02638948|531261159|FG002|Overall Study|Lost to Follow-up|1|||
147299353|NCT02638948|531261160|FG003|Overall Study|Lost to Follow-up|1|||
147299354|NCT02638948|531261157|FG000|Overall Study|Poor/Non-Compliance|0|||
147299355|NCT02638948|531261158|FG001|Overall Study|Poor/Non-Compliance|2|||
147299356|NCT02638948|531261159|FG002|Overall Study|Poor/Non-Compliance|1|||
147299357|NCT02638948|531261160|FG003|Overall Study|Poor/Non-Compliance|0|||
147299358|NCT02638948|531261157|FG000|Overall Study|Participant no longer met study criteria|0|||
147299359|NCT02638948|531261158|FG001|Overall Study|Participant no longer met study criteria|1|||
147299360|NCT02638948|531261159|FG002|Overall Study|Participant no longer met study criteria|0|||
147299361|NCT02638948|531261160|FG003|Overall Study|Participant no longer met study criteria|0|||
147299362|NCT02638948|531261157|FG000|Overall Study|Other than specified above|4|||
147299363|NCT02638948|531261158|FG001|Overall Study|Other than specified above|1|||
147299364|NCT02638948|531261159|FG002|Overall Study|Other than specified above|1|||
147299365|NCT02638948|531261160|FG003|Overall Study|Other than specified above|1|||
147299366|NCT01218126|531261165|FG000|Overall Study|Adverse Event|8|||
147299367|NCT01218126|531261166|FG001|Overall Study|Adverse Event|10|||
147299368|NCT01218126|531261167|FG002|Overall Study|Adverse Event|12|||
147299369|NCT01218126|531261168|FG003|Overall Study|Adverse Event|16|||
147299370|NCT01218126|531261165|FG000|Overall Study|Lack of Efficacy|7|||
147299371|NCT01218126|531261166|FG001|Overall Study|Lack of Efficacy|2|||
147299372|NCT01218126|531261167|FG002|Overall Study|Lack of Efficacy|2|||
147299373|NCT01218126|531261168|FG003|Overall Study|Lack of Efficacy|6|||
147299374|NCT01218126|531261165|FG000|Overall Study|Protocol Violation|5|||
147299375|NCT01218126|531261166|FG001|Overall Study|Protocol Violation|2|||
147299376|NCT01218126|531261167|FG002|Overall Study|Protocol Violation|2|||
147299377|NCT01218126|531261168|FG003|Overall Study|Protocol Violation|3|||
147299378|NCT01218126|531261165|FG000|Overall Study|Protocol-defined stopping criteria|1|||
147299379|NCT01218126|531261166|FG001|Overall Study|Protocol-defined stopping criteria|1|||
147299380|NCT01218126|531261167|FG002|Overall Study|Protocol-defined stopping criteria|0|||
147299381|NCT01218126|531261168|FG003|Overall Study|Protocol-defined stopping criteria|0|||
147299382|NCT01218126|531261165|FG000|Overall Study|Lost to Follow-up|0|||
147341018|NCT04440176|531418256|FG000|Overall Study|Randomized but not vaccinated|6|||
147341019|NCT04440176|531418257|FG001|Overall Study|Randomized but not vaccinated|3|||
147341020|NCT01631214|531418258|FG000|Overall Study|Withdrawal by Subject|276|||
147341021|NCT01631214|531418259|FG001|Overall Study|Withdrawal by Subject|290|||
147606447|NCT03146962|532375226|FG005|Overall Study|Withdrawal by Subject|0|||
147299383|NCT01218126|531261166|FG001|Overall Study|Lost to Follow-up|0|||
147299384|NCT01218126|531261167|FG002|Overall Study|Lost to Follow-up|0|||
147299385|NCT01218126|531261168|FG003|Overall Study|Lost to Follow-up|2|||
147299386|NCT01218126|531261165|FG000|Overall Study|Physician Decision|1|||
147299387|NCT01218126|531261166|FG001|Overall Study|Physician Decision|2|||
147299388|NCT01218126|531261167|FG002|Overall Study|Physician Decision|4|||
147299389|NCT01218126|531261168|FG003|Overall Study|Physician Decision|2|||
147341022|NCT01631214|531418258|FG000|Overall Study|Death|113|||
147341023|NCT01631214|531418259|FG001|Overall Study|Death|106|||
147341024|NCT01631214|531418258|FG000|Overall Study|Lost to Follow-up|54|||
147341025|NCT01631214|531418259|FG001|Overall Study|Lost to Follow-up|40|||
147341026|NCT01631214|531418258|FG000|Overall Study|Adverse Event|45|||
147341027|NCT01631214|531418259|FG001|Overall Study|Adverse Event|45|||
147341028|NCT01631214|531418258|FG000|Overall Study|Other|22|||
147341029|NCT01631214|531418259|FG001|Overall Study|Other|19|||
147341030|NCT01631214|531418258|FG000|Overall Study|Noncompliance|16|||
147341031|NCT01631214|531418259|FG001|Overall Study|Noncompliance|15|||
147341032|NCT01631214|531418258|FG000|Overall Study|Requirement for Alternative Therapy|8|||
147341033|NCT01631214|531418259|FG001|Overall Study|Requirement for Alternative Therapy|3|||
147341034|NCT01631214|531418258|FG000|Overall Study|Protocol Deviation|4|||
147341035|NCT01631214|531418259|FG001|Overall Study|Protocol Deviation|3|||
147341036|NCT01631214|531418258|FG000|Overall Study|Ineligibility determined|5|||
147341037|NCT01631214|531418259|FG001|Overall Study|Ineligibility determined|2|||
147341038|NCT01631214|531418258|FG000|Overall Study|Administrative Decision|1|||
147341039|NCT01631214|531418259|FG001|Overall Study|Administrative Decision|0|||
147341040|NCT05288283|531418260|FG000|Overall Study|Study Terminated Early|1|||
147341041|NCT05288283|531418261|FG001|Overall Study|Study Terminated Early|1|||
147341042|NCT04153565|531418262|FG000|Overall Study|Death|13|||
147341043|NCT02991807|531418263|FG000|Overall Study|Withdrawal by Subject|2|||
147341044|NCT02991807|531418264|FG001|Overall Study|Withdrawal by Subject|1|||
147341045|NCT02991807|531418263|FG000|Overall Study|Physician Decision|0|||
147341046|NCT02991807|531418264|FG001|Overall Study|Physician Decision|1|||
147341047|NCT02991807|531418263|FG000|Overall Study|Investigator decision at baseline given safety concerns related to drug administration compliance|1|||
147341048|NCT02991807|531418264|FG001|Overall Study|Investigator decision at baseline given safety concerns related to drug administration compliance|0|||
147341049|NCT02300298|531418265|FG000|Disposition for Nintedanib|Progressive disease|10|||
147341050|NCT02300298|531418266|FG001|Disposition for Nintedanib|Progressive disease|0|||
147341051|NCT02300298|531418265|FG000|Disposition for Docetaxel|Progressive disease|0|||
147341052|NCT02300298|531418266|FG001|Disposition for Docetaxel|Progressive disease|6|||
147341053|NCT02300298|531418265|FG000|Disposition for Docetaxel|other adverse event|0|||
147341054|NCT02300298|531418266|FG001|Disposition for Docetaxel|other adverse event|4|||
147341055|NCT03285763|531418267|FG000|Overall Study|Death|470|||
147341056|NCT03285763|531418267|FG000|Overall Study|Lost to Follow-up|18|||
147341057|NCT03285763|531418267|FG000|Overall Study|Physician Decision|2|||
147341058|NCT03285763|531418267|FG000|Overall Study|Study Terminated By Sponsor|79|||
147341059|NCT03285763|531418267|FG000|Overall Study|Withdrawal by Subject|33|||
147341060|NCT00402246|531418268|FG000|Overall Study|Death|62|||
147341061|NCT00402246|531418269|FG001|Overall Study|Death|58|||
147341062|NCT00402246|531418268|FG000|Overall Study|Lost to Follow-up|20|||
147341063|NCT00402246|531418269|FG001|Overall Study|Lost to Follow-up|28|||
147341064|NCT00402246|531418268|FG000|Overall Study|Withdrawal by Subject|72|||
147341065|NCT00402246|531418269|FG001|Overall Study|Withdrawal by Subject|87|||
147341066|NCT00402246|531418268|FG000|Overall Study|Physician Decision|24|||
147341067|NCT00402246|531418269|FG001|Overall Study|Physician Decision|26|||
147341068|NCT00402246|531418268|FG000|Overall Study|Protocol Violation|25|||
147341069|NCT00402246|531418269|FG001|Overall Study|Protocol Violation|24|||
147341070|NCT00402246|531418268|FG000|Overall Study|Missed Final Visit|1|||
147341071|NCT00402246|531418269|FG001|Overall Study|Missed Final Visit|2|||
147341072|NCT00402246|531418268|FG000|Overall Study|Insurance Issues|2|||
147341073|NCT00402246|531418269|FG001|Overall Study|Insurance Issues|1|||
147341074|NCT00402246|531418268|FG000|Overall Study|Heart Transplant|0|||
147341075|NCT00402246|531418269|FG001|Overall Study|Heart Transplant|1|||
147341076|NCT00402246|531418268|FG000|Overall Study|Patient's device explanted|6|||
147341077|NCT00402246|531418269|FG001|Overall Study|Patient's device explanted|2|||
147341078|NCT00402246|531418268|FG000|Overall Study|Center Closure|5|||
147341079|NCT00402246|531418269|FG001|Overall Study|Center Closure|3|||
147341080|NCT00402246|531418268|FG000|Overall Study|Deterioriating Condition|3|||
147341081|NCT00402246|531418269|FG001|Overall Study|Deterioriating Condition|2|||
147662704|NCT04058028|532587411|FG003|Overall Study|Lost to Follow-up|0|||
147662705|NCT04058028|532587408|FG000|Overall Study|Death|0|||
147662706|NCT04058028|532587409|FG001|Overall Study|Death|1|||
147662707|NCT04058028|532587410|FG002|Overall Study|Death|0|||
147341082|NCT01808339|531418275|FG000|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
147341083|NCT01808339|531418276|FG001|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
147341084|NCT01808339|531418277|FG002|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
147662708|NCT04058028|532587411|FG003|Overall Study|Death|0|||
147341085|NCT01808339|531418278|FG003|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|1|||
147341086|NCT01808339|531418279|FG004|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|2|||
147341087|NCT01808339|531418280|FG005|Treatment Period 1 (14 Days)|Met Protocol-defined Stopping Criteria|1|||
147341088|NCT01808339|531418275|FG000|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
147341089|NCT01808339|531418276|FG001|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
147341090|NCT01808339|531418277|FG002|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
147662709|NCT02227784|532587412|FG000|Double-Blind Phase|Adverse Event|3|||
147606448|NCT03146962|532375227|FG006|Overall Study|Withdrawal by Subject|0|||
147606449|NCT03146962|532375228|FG007|Overall Study|Withdrawal by Subject|0|||
147606450|NCT03146962|532375229|FG008|Overall Study|Withdrawal by Subject|0|||
147606451|NCT03146962|532375230|FG009|Overall Study|Withdrawal by Subject|0|||
147606452|NCT03146962|532375221|FG000|Overall Study|Death|0|||
147606453|NCT03146962|532375222|FG001|Overall Study|Death|1|||
147606454|NCT03146962|532375223|FG002|Overall Study|Death|0|||
147606455|NCT03146962|532375224|FG003|Overall Study|Death|0|||
147606456|NCT03146962|532375225|FG004|Overall Study|Death|0|||
147606457|NCT03146962|532375226|FG005|Overall Study|Death|0|||
147606458|NCT03146962|532375227|FG006|Overall Study|Death|0|||
147606459|NCT03146962|532375228|FG007|Overall Study|Death|0|||
147606460|NCT03146962|532375229|FG008|Overall Study|Death|0|||
147606461|NCT03146962|532375230|FG009|Overall Study|Death|0|||
147606462|NCT03146962|532375221|FG000|Overall Study|COVID Precautions|1|||
147606463|NCT03146962|532375222|FG001|Overall Study|COVID Precautions|0|||
147606464|NCT03146962|532375223|FG002|Overall Study|COVID Precautions|0|||
147606465|NCT03146962|532375224|FG003|Overall Study|COVID Precautions|0|||
147606466|NCT03146962|532375225|FG004|Overall Study|COVID Precautions|0|||
147606467|NCT03146962|532375226|FG005|Overall Study|COVID Precautions|0|||
147299390|NCT01218126|531261165|FG000|Overall Study|Withdrawal by Subject|2|||
147299391|NCT01218126|531261166|FG001|Overall Study|Withdrawal by Subject|5|||
147299392|NCT01218126|531261167|FG002|Overall Study|Withdrawal by Subject|4|||
147299393|NCT01218126|531261168|FG003|Overall Study|Withdrawal by Subject|6|||
147299394|NCT01860703|531261171|FG000|Overall Study|Adverse Event|1|||
147299395|NCT01860703|531261172|FG001|Overall Study|Adverse Event|4|||
147299396|NCT01860703|531261173|FG002|Overall Study|Adverse Event|0|||
147299397|NCT01860703|531261174|FG003|Overall Study|Adverse Event|2|||
147299398|NCT01860703|531261171|FG000|Overall Study|Withdrawal by Subject|0|||
147299399|NCT01860703|531261172|FG001|Overall Study|Withdrawal by Subject|1|||
147299400|NCT01860703|531261173|FG002|Overall Study|Withdrawal by Subject|0|||
147299401|NCT01860703|531261174|FG003|Overall Study|Withdrawal by Subject|0|||
147299402|NCT01860703|531261171|FG000|Overall Study|Personal reason|1|||
147299403|NCT01860703|531261172|FG001|Overall Study|Personal reason|0|||
147299404|NCT01860703|531261173|FG002|Overall Study|Personal reason|1|||
147299405|NCT01860703|531261174|FG003|Overall Study|Personal reason|0|||
147299406|NCT00696410|531261178|FG000|Overall Study|Lost to Follow-up|2|||
147299407|NCT00696410|531261179|FG001|Overall Study|Lost to Follow-up|0|||
147299408|NCT00696410|531261178|FG000|Overall Study|Withdrawal by Subject|8|||
147299409|NCT00696410|531261179|FG001|Overall Study|Withdrawal by Subject|0|||
147299410|NCT00696410|531261178|FG000|Overall Study|Physician Decision|3|||
147299411|NCT00696410|531261179|FG001|Overall Study|Physician Decision|0|||
147299412|NCT03184792|531261183|FG000|Overall Study|Pandemic|2|||
147299413|NCT03184792|531261184|FG001|Overall Study|Pandemic|2|||
147299414|NCT02495025|531261185|FG000|Overall Study|Lost to Follow-up|21|||
147299415|NCT02495025|531261186|FG001|Overall Study|Lost to Follow-up|14|||
147299416|NCT02495025|531261185|FG000|Overall Study|Withdrawal by Subject|5|||
147299417|NCT02495025|531261186|FG001|Overall Study|Withdrawal by Subject|0|||
147299418|NCT02134587|531261188|FG000|Overall Study|Did not completed all meetings|30|||
147299419|NCT00265889|531261189|FG000|Overall Study|Physician Decision|1|||
147299420|NCT00265889|531261189|FG000|Overall Study|Protocol Violation|1|||
147299421|NCT00265889|531261189|FG000|Overall Study|Insurance denied the request|3|||
147299422|NCT02778100|531261195|FG000|Period 1 (Common Cold)|Withdrawal by Subject|1|||
147299423|NCT02778100|531261196|FG001|Period 1 (Common Cold)|Withdrawal by Subject|0|||
147299424|NCT01515748|531261202|FG000|Overall Study|Withdrawal by Subject|32|||
147299425|NCT01515748|531261203|FG001|Overall Study|Withdrawal by Subject|41|||
147299426|NCT01515748|531261202|FG000|Overall Study|Lost to Follow-up|2|||
147299427|NCT01515748|531261203|FG001|Overall Study|Lost to Follow-up|4|||
147299428|NCT01515748|531261202|FG000|Overall Study|Other than specified above|5|||
147299429|NCT01515748|531261203|FG001|Overall Study|Other than specified above|10|||
147299430|NCT03221387|531261204|FG000|Overall Study|Lost to Follow-up|1|||
147299431|NCT03221387|531261204|FG000|Overall Study|Lung transplant|1|||
147299432|NCT02365519|531261205|FG000|Randomized and Treated|Adverse Event|0|||
147299433|NCT02365519|531261206|FG001|Randomized and Treated|Adverse Event|1|||
147299434|NCT02365519|531261207|FG002|Randomized and Treated|Adverse Event|0|||
147299435|NCT02365519|531261205|FG000|Randomized and Treated|Withdrawal by Subject|0|||
147299436|NCT02365519|531261206|FG001|Randomized and Treated|Withdrawal by Subject|1|||
147606468|NCT03146962|532375227|FG006|Overall Study|COVID Precautions|0|||
147662710|NCT02227784|532587413|FG001|Double-Blind Phase|Adverse Event|2|||
147299437|NCT02365519|531261207|FG002|Randomized and Treated|Withdrawal by Subject|1|||
147299438|NCT01971723|531261208|FG000|Overall Study|Withdrawal by Subject|1|||
147299439|NCT01971723|531261209|FG001|Overall Study|Withdrawal by Subject|1|||
147299440|NCT01971723|531261208|FG000|Overall Study|Protocol Violation|1|||
147299441|NCT01971723|531261209|FG001|Overall Study|Protocol Violation|2|||
147299442|NCT00657618|531261210|FG000|Overall Study|Adverse Event|32|||
147299443|NCT00657618|531261210|FG000|Overall Study|Withdrawal by Subject|8|||
147606469|NCT03146962|532375228|FG007|Overall Study|COVID Precautions|0|||
147606470|NCT03146962|532375229|FG008|Overall Study|COVID Precautions|0|||
147662711|NCT02227784|532587414|FG002|Double-Blind Phase|Adverse Event|1|||
147341091|NCT01808339|531418278|FG003|Treatment Period 1 (14 Days)|Withdrawal by Subject|1|||
147341092|NCT01808339|531418279|FG004|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
147341093|NCT01808339|531418280|FG005|Treatment Period 1 (14 Days)|Withdrawal by Subject|0|||
147341094|NCT01808339|531418275|FG000|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
147341095|NCT01808339|531418276|FG001|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
147453044|NCT00623428|531821531|FG000|Follow-up Period|Relapse post-treatment|11|||
147453045|NCT00623428|531821532|FG001|Follow-up Period|Relapse post-treatment|3|||
147453046|NCT00623428|531821531|FG000|Follow-up Period|Failure to return|10|||
147453047|NCT00623428|531821532|FG001|Follow-up Period|Failure to return|2|||
147453048|NCT00623428|531821531|FG000|Follow-up Period|Patient withdrew consent|5|||
147453049|NCT00623428|531821532|FG001|Follow-up Period|Patient withdrew consent|4|||
147453050|NCT00623428|531821531|FG000|Follow-up Period|HCV-RNA detectable at end of treatment|2|||
147453051|NCT00623428|531821532|FG001|Follow-up Period|HCV-RNA detectable at end of treatment|1|||
147453052|NCT00623428|531821531|FG000|Follow-up Period|Did not cooperate|0|||
147453053|NCT00623428|531821532|FG001|Follow-up Period|Did not cooperate|3|||
147453054|NCT00623428|531821531|FG000|Follow-up Period|Reason not specified|1|||
147453055|NCT00623428|531821532|FG001|Follow-up Period|Reason not specified|1|||
147453056|NCT00623428|531821531|FG000|Follow-up Period|Death|0|||
147453057|NCT00623428|531821532|FG001|Follow-up Period|Death|1|||
147453058|NCT01692301|531821535|FG000|Overall Study|Adverse Event|15|||
147453059|NCT01692301|531821536|FG001|Overall Study|Adverse Event|12|||
147453060|NCT01692301|531821535|FG000|Overall Study|Death|1|||
147453061|NCT01692301|531821536|FG001|Overall Study|Death|2|||
147453062|NCT01692301|531821535|FG000|Overall Study|Lack of Efficacy|0|||
147453063|NCT01692301|531821536|FG001|Overall Study|Lack of Efficacy|5|||
147453064|NCT01692301|531821535|FG000|Overall Study|Non-compliance with study treatment|1|||
147453065|NCT01692301|531821536|FG001|Overall Study|Non-compliance with study treatment|2|||
147453066|NCT01692301|531821535|FG000|Overall Study|Protocol deviation|9|||
147453067|NCT01692301|531821536|FG001|Overall Study|Protocol deviation|2|||
147453068|NCT01692301|531821535|FG000|Overall Study|Patient/guardian decision|16|||
147453069|NCT01692301|531821536|FG001|Overall Study|Patient/guardian decision|15|||
147453070|NCT01692301|531821535|FG000|Overall Study|Technical problems|0|||
147453071|NCT01692301|531821536|FG001|Overall Study|Technical problems|1|||
147453072|NCT01692301|531821535|FG000|Overall Study|Physician Decision|2|||
147606471|NCT03146962|532375230|FG009|Overall Study|COVID Precautions|0|||
147606472|NCT03146962|532375221|FG000|Overall Study|Physician Decision|0|||
147606473|NCT03146962|532375222|FG001|Overall Study|Physician Decision|0|||
147606474|NCT03146962|532375223|FG002|Overall Study|Physician Decision|0|||
147606475|NCT03146962|532375224|FG003|Overall Study|Physician Decision|0|||
147606476|NCT03146962|532375225|FG004|Overall Study|Physician Decision|0|||
147341096|NCT01808339|531418277|FG002|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|1|||
147341097|NCT01808339|531418278|FG003|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
147341098|NCT01808339|531418279|FG004|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
147341099|NCT01808339|531418280|FG005|Treatment Period 3 (14 Days)|Met Protocol-defined Stopping Criteria|0|||
147341100|NCT02932579|531418282|FG000|Overall Study|Withdrawal by Subject|4|||
147341101|NCT02932579|531418283|FG001|Overall Study|Withdrawal by Subject|1|||
147341102|NCT00111813|531418284|FG000|Overall Study|Adverse Event|1|||
147341103|NCT00111813|531418285|FG001|Overall Study|Adverse Event|2|||
147341104|NCT00111813|531418286|FG002|Overall Study|Adverse Event|4|||
147341105|NCT00111813|531418287|FG003|Overall Study|Adverse Event|2|||
147341106|NCT00111813|531418288|FG004|Overall Study|Adverse Event|2|||
147341107|NCT00111813|531418289|FG005|Overall Study|Adverse Event|2|||
147341108|NCT00111813|531418284|FG000|Overall Study|Progressive disease|2|||
147341109|NCT00111813|531418285|FG001|Overall Study|Progressive disease|1|||
147606477|NCT03146962|532375226|FG005|Overall Study|Physician Decision|0|||
147606478|NCT03146962|532375227|FG006|Overall Study|Physician Decision|0|||
147341110|NCT00111813|531418286|FG002|Overall Study|Progressive disease|5|||
147341111|NCT00111813|531418287|FG003|Overall Study|Progressive disease|3|||
147341112|NCT00111813|531418288|FG004|Overall Study|Progressive disease|4|||
147341113|NCT00111813|531418289|FG005|Overall Study|Progressive disease|3|||
147341114|NCT00111813|531418284|FG000|Overall Study|Lack of Efficacy|0|||
147341115|NCT00111813|531418285|FG001|Overall Study|Lack of Efficacy|0|||
147341116|NCT00111813|531418286|FG002|Overall Study|Lack of Efficacy|0|||
147341117|NCT00111813|531418287|FG003|Overall Study|Lack of Efficacy|0|||
147341118|NCT00111813|531418288|FG004|Overall Study|Lack of Efficacy|0|||
147453073|NCT01692301|531821536|FG001|Overall Study|Physician Decision|2|||
147606479|NCT03146962|532375228|FG007|Overall Study|Physician Decision|0|||
147341119|NCT00111813|531418289|FG005|Overall Study|Lack of Efficacy|1|||
147341120|NCT00111813|531418284|FG000|Overall Study|Other|0|||
147341121|NCT00111813|531418285|FG001|Overall Study|Other|0|||
147453074|NCT01692301|531821535|FG000|Overall Study|Lost to Follow-up|1|||
147453075|NCT01692301|531821536|FG001|Overall Study|Lost to Follow-up|1|||
147453076|NCT01142726|531821537|FG000|Treatment Phase: Day 1 Through Month 12|Adverse Event|5|||
147453077|NCT01142726|531821538|FG001|Treatment Phase: Day 1 Through Month 12|Adverse Event|8|||
147453078|NCT01142726|531821539|FG002|Treatment Phase: Day 1 Through Month 12|Adverse Event|5|||
147606480|NCT03146962|532375229|FG008|Overall Study|Physician Decision|0|||
147341122|NCT00111813|531418286|FG002|Overall Study|Other|1|||
147341123|NCT00111813|531418287|FG003|Overall Study|Other|0|||
147341124|NCT00111813|531418288|FG004|Overall Study|Other|0|||
147341125|NCT00111813|531418289|FG005|Overall Study|Other|0|||
147341126|NCT00818246|531418291|FG000|Overall Study|Impossible to match pictures|5|||
147341127|NCT02121002|531418295|FG000|Overall Study|Physician Decision|2|||
147341128|NCT02121002|531418296|FG001|Overall Study|Physician Decision|0|||
147341129|NCT02121002|531418297|FG002|Overall Study|Physician Decision|0|||
147341130|NCT02121002|531418295|FG000|Overall Study|Withdrawal by Subject|3|||
147341131|NCT02121002|531418296|FG001|Overall Study|Withdrawal by Subject|1|||
147341132|NCT02121002|531418297|FG002|Overall Study|Withdrawal by Subject|4|||
147341133|NCT02121002|531418295|FG000|Overall Study|Protocol Violation|1|||
147341134|NCT02121002|531418296|FG001|Overall Study|Protocol Violation|2|||
147341135|NCT02121002|531418297|FG002|Overall Study|Protocol Violation|4|||
147341136|NCT02121002|531418295|FG000|Overall Study|Concomitant therapy|0|||
147341137|NCT02121002|531418296|FG001|Overall Study|Concomitant therapy|1|||
147341138|NCT02121002|531418297|FG002|Overall Study|Concomitant therapy|1|||
147341139|NCT02121002|531418295|FG000|Overall Study|Others|1|||
147341140|NCT02121002|531418296|FG001|Overall Study|Others|0|||
147341141|NCT02121002|531418297|FG002|Overall Study|Others|1|||
147341142|NCT01007396|531418298|FG000|Overall Study|Lost to Follow-up|47|||
147341143|NCT00409838|531418299|FG000|Short-term Period|Adverse Event|0|||
147341144|NCT00409838|531418300|FG001|Short-term Period|Adverse Event|1|||
147341145|NCT00409838|531418299|FG000|Short-term Period|Lost to Follow-up|0|||
147341146|NCT00409838|531418300|FG001|Short-term Period|Lost to Follow-up|1|||
147341147|NCT00409838|531418299|FG000|Short-term Period|Withdrawal by Subject|2|||
147341148|NCT00409838|531418300|FG001|Short-term Period|Withdrawal by Subject|3|||
147341149|NCT00409838|531418299|FG000|Short-term Period|Never Treated|1|||
147341150|NCT00409838|531418300|FG001|Short-term Period|Never Treated|0|||
147341151|NCT00409838|531418299|FG000|Long-term Extension Period|Adverse Event|10|||
147341152|NCT00409838|531418300|FG001|Long-term Extension Period|Adverse Event|0|||
147341153|NCT00409838|531418299|FG000|Long-term Extension Period|Death|1|||
147341154|NCT00409838|531418300|FG001|Long-term Extension Period|Death|0|||
147341155|NCT00409838|531418299|FG000|Long-term Extension Period|Lack of Efficacy|2|||
147341156|NCT00409838|531418300|FG001|Long-term Extension Period|Lack of Efficacy|0|||
147341157|NCT00409838|531418299|FG000|Long-term Extension Period|Withdrawal by Subject|3|||
147341158|NCT00409838|531418300|FG001|Long-term Extension Period|Withdrawal by Subject|0|||
147341159|NCT00409838|531418299|FG000|Long-term Extension Period|Poor compliance/noncompliance|1|||
147341160|NCT00409838|531418300|FG001|Long-term Extension Period|Poor compliance/noncompliance|0|||
147341161|NCT00409838|531418299|FG000|Long-term Extension Period|Pregnancy|1|||
147341162|NCT00409838|531418300|FG001|Long-term Extension Period|Pregnancy|0|||
147341163|NCT04788641|531418301|FG000|Treatment Period 2 (4 Days)|Protocol Violation|0|||
147341164|NCT04788641|531418302|FG001|Treatment Period 2 (4 Days)|Protocol Violation|0|||
147341165|NCT04788641|531418303|FG002|Treatment Period 2 (4 Days)|Protocol Violation|1|||
147341166|NCT04788641|531418304|FG003|Treatment Period 2 (4 Days)|Protocol Violation|0|||
147341167|NCT04788641|531418301|FG000|Treatment Period 2 (4 Days)|Participant decided to discontinue further participation|1|||
147341168|NCT04788641|531418302|FG001|Treatment Period 2 (4 Days)|Participant decided to discontinue further participation|0|||
147341169|NCT04788641|531418303|FG002|Treatment Period 2 (4 Days)|Participant decided to discontinue further participation|0|||
147341170|NCT04788641|531418304|FG003|Treatment Period 2 (4 Days)|Participant decided to discontinue further participation|0|||
147341171|NCT04788641|531418301|FG000|Treatment Period 2 (4 Days)|Adverse Event|0|||
147341172|NCT04788641|531418302|FG001|Treatment Period 2 (4 Days)|Adverse Event|0|||
147341173|NCT04788641|531418303|FG002|Treatment Period 2 (4 Days)|Adverse Event|1|||
147341174|NCT04788641|531418304|FG003|Treatment Period 2 (4 Days)|Adverse Event|0|||
147341175|NCT01250769|531418305|FG000|Overall Study|Withdrawal by Subject|0|||
147341176|NCT01250769|531418306|FG001|Overall Study|Withdrawal by Subject|1|||
147453079|NCT01142726|531821537|FG000|Treatment Phase: Day 1 Through Month 12|Withdrawal by Subject|4|||
147453080|NCT01142726|531821538|FG001|Treatment Phase: Day 1 Through Month 12|Withdrawal by Subject|9|||
147453081|NCT01142726|531821539|FG002|Treatment Phase: Day 1 Through Month 12|Withdrawal by Subject|3|||
147453082|NCT01142726|531821537|FG000|Treatment Phase: Day 1 Through Month 12|Lost to Follow-up|1|||
147453083|NCT01142726|531821538|FG001|Treatment Phase: Day 1 Through Month 12|Lost to Follow-up|2|||
147341177|NCT01250769|531418307|FG002|Overall Study|Withdrawal by Subject|1|||
147341178|NCT01250769|531418308|FG003|Overall Study|Withdrawal by Subject|0|||
147453084|NCT01142726|531821539|FG002|Treatment Phase: Day 1 Through Month 12|Lost to Follow-up|1|||
147341179|NCT01250769|531418305|FG000|Overall Study|Adverse Event|0|||
147341180|NCT01250769|531418306|FG001|Overall Study|Adverse Event|0|||
147453085|NCT01142726|531821537|FG000|Treatment Phase: Day 1 Through Month 12|Poor compliance/noncompliance|1|||
147453086|NCT01142726|531821538|FG001|Treatment Phase: Day 1 Through Month 12|Poor compliance/noncompliance|0|||
147606481|NCT03146962|532375230|FG009|Overall Study|Physician Decision|1|||
147662712|NCT02227784|532587415|FG003|Double-Blind Phase|Adverse Event|3|||
147341181|NCT01250769|531418307|FG002|Overall Study|Adverse Event|1|||
147341182|NCT01250769|531418308|FG003|Overall Study|Adverse Event|0|||
147341183|NCT03283371|531418309|FG000|Placebo-controlled|Adverse Event|1|||
147341184|NCT03283371|531418310|FG001|Placebo-controlled|Adverse Event|1|||
147341185|NCT03283371|531418311|FG002|Placebo-controlled|Adverse Event|0|||
147341186|NCT03283371|531418312|FG003|Placebo-controlled|Adverse Event|0|||
147341187|NCT03283371|531418309|FG000|Placebo-controlled|Lack of Efficacy|1|||
147341188|NCT03283371|531418310|FG001|Placebo-controlled|Lack of Efficacy|0|||
147341189|NCT03283371|531418311|FG002|Placebo-controlled|Lack of Efficacy|0|||
147341190|NCT03283371|531418312|FG003|Placebo-controlled|Lack of Efficacy|0|||
147341191|NCT03283371|531418309|FG000|Placebo-controlled|Withdrawal by Subject|1|||
147341192|NCT03283371|531418310|FG001|Placebo-controlled|Withdrawal by Subject|1|||
147341193|NCT03283371|531418311|FG002|Placebo-controlled|Withdrawal by Subject|0|||
147341194|NCT03283371|531418312|FG003|Placebo-controlled|Withdrawal by Subject|0|||
147341195|NCT03283371|531418309|FG000|Placebo-controlled|Participants Did Not Receive Study Drug|0|||
147341196|NCT03283371|531418310|FG001|Placebo-controlled|Participants Did Not Receive Study Drug|1|||
147341197|NCT03283371|531418311|FG002|Placebo-controlled|Participants Did Not Receive Study Drug|0|||
147341198|NCT03283371|531418312|FG003|Placebo-controlled|Participants Did Not Receive Study Drug|0|||
147341199|NCT03283371|531418309|FG000|Open-label Phase|Adverse Event|0|||
147341200|NCT03283371|531418310|FG001|Open-label Phase|Adverse Event|0|||
147341201|NCT03283371|531418311|FG002|Open-label Phase|Adverse Event|2|||
147341202|NCT03283371|531418312|FG003|Open-label Phase|Adverse Event|0|||
147341203|NCT03283371|531418309|FG000|Open-label Phase|Withdrawal by Subject|0|||
147341204|NCT03283371|531418310|FG001|Open-label Phase|Withdrawal by Subject|0|||
147341205|NCT03283371|531418311|FG002|Open-label Phase|Withdrawal by Subject|1|||
147341206|NCT03283371|531418312|FG003|Open-label Phase|Withdrawal by Subject|0|||
147341207|NCT03283371|531418309|FG000|Open-label Phase|Other|0|||
147341208|NCT03283371|531418310|FG001|Open-label Phase|Other|0|||
147341209|NCT03283371|531418311|FG002|Open-label Phase|Other|1|||
147341210|NCT03283371|531418312|FG003|Open-label Phase|Other|1|||
147341211|NCT00243503|531418313|FG000|Overall Study|Adverse Event|11|||
147341212|NCT00243503|531418313|FG000|Overall Study|Withdrawal by Subject|1|||
147341213|NCT00243503|531418313|FG000|Overall Study|Lack of Efficacy|44|||
147341214|NCT00243503|531418313|FG000|Overall Study|Death|1|||
147341215|NCT00243503|531418313|FG000|Overall Study|Other|1|||
147341216|NCT00914589|531418314|FG000|Overall Study|Adverse Event|1|||
147341217|NCT00914589|531418315|FG001|Overall Study|Adverse Event|0|||
147341218|NCT00914589|531418316|FG002|Overall Study|Adverse Event|1|||
147341219|NCT00914589|531418314|FG000|Overall Study|Protocol Violation|8|||
147341220|NCT00914589|531418315|FG001|Overall Study|Protocol Violation|6|||
147341221|NCT00914589|531418316|FG002|Overall Study|Protocol Violation|3|||
147341222|NCT00914589|531418314|FG000|Overall Study|unclassified|16|||
147341223|NCT00914589|531418315|FG001|Overall Study|unclassified|9|||
147341224|NCT00914589|531418316|FG002|Overall Study|unclassified|7|||
147341225|NCT00914589|531418314|FG000|Overall Study|Death|0|||
147341226|NCT00914589|531418315|FG001|Overall Study|Death|1|||
147341227|NCT00914589|531418316|FG002|Overall Study|Death|1|||
147341228|NCT00093015|531418321|FG000|Overall Study|Withdrawal by Subject|194|||
147341229|NCT00093015|531418322|FG001|Overall Study|Withdrawal by Subject|171|||
147341230|NCT00093015|531418321|FG000|Overall Study|Lost to Follow-up|96|||
147341231|NCT00093015|531418322|FG001|Overall Study|Lost to Follow-up|108|||
147341232|NCT00093015|531418321|FG000|Overall Study|Death|375|||
147341233|NCT00093015|531418322|FG001|Overall Study|Death|385|||
147341234|NCT00296036|531418323|FG000|Overall Study|Withdrawal by Subject|1|||
147341235|NCT00296036|531418324|FG001|Overall Study|Withdrawal by Subject|0|||
147341236|NCT00296036|531418325|FG002|Overall Study|Withdrawal by Subject|2|||
147341237|NCT00296036|531418326|FG003|Overall Study|Withdrawal by Subject|1|||
147341238|NCT00296036|531418327|FG004|Overall Study|Withdrawal by Subject|2|||
147341239|NCT00296036|531418328|FG005|Overall Study|Withdrawal by Subject|1|||
147341240|NCT00296036|531418323|FG000|Overall Study|Protocol Violation|0|||
147341241|NCT00296036|531418324|FG001|Overall Study|Protocol Violation|0|||
147341242|NCT00296036|531418325|FG002|Overall Study|Protocol Violation|0|||
147341243|NCT00296036|531418326|FG003|Overall Study|Protocol Violation|0|||
147341244|NCT00296036|531418327|FG004|Overall Study|Protocol Violation|0|||
147341245|NCT00296036|531418328|FG005|Overall Study|Protocol Violation|3|||
147341246|NCT03403413|531418329|FG000|Overall Study|Lack of Efficacy|2|||
147341247|NCT03951805|531418332|FG000|Overall Study|Adverse Event|1|||
147341248|NCT03951805|531418333|FG001|Overall Study|Adverse Event|0|||
147341249|NCT03951805|531418334|FG002|Overall Study|Adverse Event|0|||
147341250|NCT03951805|531418335|FG003|Overall Study|Adverse Event|0|||
147341251|NCT01198145|531418336|FG000|Overall Study|Withdrawal by Subject|1|||
147453087|NCT01142726|531821539|FG002|Treatment Phase: Day 1 Through Month 12|Poor compliance/noncompliance|0|||
147453088|NCT01142726|531821537|FG000|Treatment Phase: Day 1 Through Month 12|Lack of Efficacy|5|||
147341252|NCT01198145|531418337|FG001|Overall Study|Withdrawal by Subject|1|||
147341253|NCT03830866|531418338|FG000|Overall Study|Death|90|||
147341254|NCT03830866|531418339|FG001|Overall Study|Death|111|||
147341255|NCT03830866|531418338|FG000|Overall Study|Lost to Follow-up|7|||
147341256|NCT03830866|531418339|FG001|Overall Study|Lost to Follow-up|7|||
147341257|NCT03830866|531418338|FG000|Overall Study|Withdrawal by Subject|19|||
147341258|NCT03830866|531418339|FG001|Overall Study|Withdrawal by Subject|16|||
147341259|NCT03830866|531418338|FG000|Overall Study|No longer eligible due to additional cancer diagnosis|0|||
147341260|NCT03830866|531418339|FG001|Overall Study|No longer eligible due to additional cancer diagnosis|1|||
147341261|NCT03830866|531418338|FG000|Overall Study|Other|1|||
147341262|NCT03830866|531418339|FG001|Overall Study|Other|1|||
147341263|NCT00510887|531418341|FG000|Overall Study|Lost to Follow-up|1|||
147341264|NCT00068601|531418346|FG000|Overall Study|Ineligible|11|||
147341265|NCT00068601|531418347|FG001|Overall Study|Ineligible|13|||
147341266|NCT00068601|531418346|FG000|Overall Study|Not evaluable: withdrew consent|5|||
147341267|NCT00068601|531418347|FG001|Overall Study|Not evaluable: withdrew consent|4|||
147341268|NCT00068601|531418346|FG000|Overall Study|Not evaluable: hysterectomy/oophorectomy|2|||
147341269|NCT00068601|531418347|FG001|Overall Study|Not evaluable: hysterectomy/oophorectomy|4|||
147341270|NCT00068601|531418346|FG000|Overall Study|Death|11|||
147341271|NCT00068601|531418347|FG001|Overall Study|Death|3|||
147341272|NCT00068601|531418346|FG000|Overall Study|Lost to Follow-up|3|||
147341273|NCT00068601|531418347|FG001|Overall Study|Lost to Follow-up|2|||
147341274|NCT00068601|531418346|FG000|Overall Study|Missing primary outcome data|30|||
147341275|NCT00068601|531418347|FG001|Overall Study|Missing primary outcome data|34|||
147341276|NCT02692417|531418358|FG000|Overall Study|Withdrawal by Subject|5|||
147341277|NCT02692417|531418359|FG001|Overall Study|Withdrawal by Subject|1|||
147341278|NCT02692417|531418358|FG000|Overall Study|Adverse Event|1|||
147341279|NCT02692417|531418359|FG001|Overall Study|Adverse Event|0|||
147341280|NCT02409667|531418360|FG000|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|6|||
147341281|NCT02409667|531418361|FG001|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|0|||
147341282|NCT02409667|531418362|FG002|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|0|||
147341283|NCT02409667|531418363|FG003|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|0|||
147341284|NCT02409667|531418364|FG004|Treatment Period 1, Baseline to Week 24|Withdrawal of informed consent|0|||
147341285|NCT02409667|531418360|FG000|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|6|||
147341286|NCT02409667|531418361|FG001|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|0|||
147341287|NCT02409667|531418362|FG002|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|0|||
147341288|NCT02409667|531418363|FG003|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|0|||
147341289|NCT02409667|531418364|FG004|Treatment Period 1, Baseline to Week 24|Withdrawal by Subject|0|||
147341290|NCT02409667|531418360|FG000|Treatment Period 1, Baseline to Week 24|Protocol deviation|20|||
147341291|NCT02409667|531418361|FG001|Treatment Period 1, Baseline to Week 24|Protocol deviation|0|||
147341292|NCT02409667|531418362|FG002|Treatment Period 1, Baseline to Week 24|Protocol deviation|0|||
147341293|NCT02409667|531418363|FG003|Treatment Period 1, Baseline to Week 24|Protocol deviation|0|||
147341294|NCT02409667|531418364|FG004|Treatment Period 1, Baseline to Week 24|Protocol deviation|0|||
147341295|NCT02409667|531418360|FG000|Treatment Period 1, Baseline to Week 24|Pregnancy|1|||
147341296|NCT02409667|531418361|FG001|Treatment Period 1, Baseline to Week 24|Pregnancy|0|||
147341297|NCT02409667|531418362|FG002|Treatment Period 1, Baseline to Week 24|Pregnancy|0|||
147341298|NCT02409667|531418363|FG003|Treatment Period 1, Baseline to Week 24|Pregnancy|0|||
147341299|NCT02409667|531418364|FG004|Treatment Period 1, Baseline to Week 24|Pregnancy|0|||
147341300|NCT02409667|531418360|FG000|Treatment Period 1, Baseline to Week 24|Physician Decision|4|||
147341301|NCT02409667|531418361|FG001|Treatment Period 1, Baseline to Week 24|Physician Decision|0|||
147341302|NCT02409667|531418362|FG002|Treatment Period 1, Baseline to Week 24|Physician Decision|0|||
147341303|NCT02409667|531418363|FG003|Treatment Period 1, Baseline to Week 24|Physician Decision|0|||
147341304|NCT02409667|531418364|FG004|Treatment Period 1, Baseline to Week 24|Physician Decision|0|||
147341305|NCT02409667|531418360|FG000|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|5|||
147341306|NCT02409667|531418361|FG001|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|0|||
147341307|NCT02409667|531418362|FG002|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|0|||
147341308|NCT02409667|531418363|FG003|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|0|||
147341309|NCT02409667|531418364|FG004|Treatment Period 1, Baseline to Week 24|Non-compliance with study treatment|0|||
147341310|NCT02409667|531418360|FG000|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|6|||
147341311|NCT02409667|531418361|FG001|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|0|||
147341312|NCT02409667|531418362|FG002|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|0|||
147341313|NCT02409667|531418363|FG003|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|0|||
147341314|NCT02409667|531418364|FG004|Treatment Period 1, Baseline to Week 24|Lost to Follow-up|0|||
147341315|NCT02409667|531418360|FG000|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|48|||
147341316|NCT02409667|531418361|FG001|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|0|||
147341317|NCT02409667|531418362|FG002|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|0|||
147341318|NCT02409667|531418363|FG003|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|0|||
147341319|NCT02409667|531418364|FG004|Treatment Period 1, Baseline to Week 24|Lack of Efficacy|0|||
147341320|NCT02409667|531418360|FG000|Treatment Period 1, Baseline to Week 24|Adverse Event|25|||
147341321|NCT02409667|531418361|FG001|Treatment Period 1, Baseline to Week 24|Adverse Event|0|||
147341322|NCT02409667|531418362|FG002|Treatment Period 1, Baseline to Week 24|Adverse Event|0|||
147341323|NCT02409667|531418363|FG003|Treatment Period 1, Baseline to Week 24|Adverse Event|0|||
147341324|NCT02409667|531418364|FG004|Treatment Period 1, Baseline to Week 24|Adverse Event|0|||
147341325|NCT02409667|531418360|FG000|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|0|||
147341326|NCT02409667|531418361|FG001|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|7|||
147341327|NCT02409667|531418362|FG002|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|4|||
147299444|NCT00657618|531261210|FG000|Overall Study|negative for leishmaniasis|2|||
147299445|NCT00657618|531261210|FG000|Overall Study|didn't start due to schedule conflicts|1|||
147299446|NCT05774197|531261211|FG000|Overall Study|Did not complete all the surveys required for study.|15|||
147299447|NCT05073133|531261213|FG000|Overall Study|Death|2|||
147299448|NCT05002218|531261214|FG000|Overall Study|Lost to Follow-up|5|||
147299449|NCT05002218|531261215|FG001|Overall Study|Lost to Follow-up|6|||
147299450|NCT04120233|531261216|FG000|Overall Study|Adverse Event|0|||
147299451|NCT04120233|531261217|FG001|Overall Study|Adverse Event|0|||
147299452|NCT04120233|531261218|FG002|Overall Study|Adverse Event|0|||
147299453|NCT04120233|531261219|FG003|Overall Study|Adverse Event|0|||
147299454|NCT04120233|531261220|FG004|Overall Study|Adverse Event|1|||
147299455|NCT04120233|531261221|FG005|Overall Study|Adverse Event|0|||
147299456|NCT04981678|531261222|FG000|Overall Study|Lost to Follow-up|0|||
147299457|NCT04981678|531261223|FG001|Overall Study|Lost to Follow-up|1|||
147299458|NCT01984697|531262720|FG000|Overall Study|Adverse Event|0|||
147299459|NCT01984697|531262721|FG001|Overall Study|Adverse Event|0|||
147299460|NCT01984697|531262722|FG002|Overall Study|Adverse Event|2|||
147299461|NCT01984697|531262723|FG003|Overall Study|Adverse Event|0|||
147299462|NCT01984697|531262724|FG004|Overall Study|Adverse Event|0|||
147299463|NCT01984697|531262720|FG000|Overall Study|Lost to Follow-up|14|||
147299464|NCT01984697|531262721|FG001|Overall Study|Lost to Follow-up|5|||
147299465|NCT01984697|531262722|FG002|Overall Study|Lost to Follow-up|10|||
147299466|NCT01984697|531262723|FG003|Overall Study|Lost to Follow-up|6|||
147299467|NCT01984697|531262724|FG004|Overall Study|Lost to Follow-up|21|||
147299468|NCT01984697|531262720|FG000|Overall Study|Physician Decision|3|||
147299469|NCT01984697|531262721|FG001|Overall Study|Physician Decision|0|||
147299470|NCT01984697|531262722|FG002|Overall Study|Physician Decision|0|||
147299471|NCT01984697|531262723|FG003|Overall Study|Physician Decision|1|||
147299472|NCT01984697|531262724|FG004|Overall Study|Physician Decision|0|||
147299473|NCT01984697|531262720|FG000|Overall Study|Protocol Violation|8|||
147299474|NCT01984697|531262721|FG001|Overall Study|Protocol Violation|5|||
147299475|NCT01984697|531262722|FG002|Overall Study|Protocol Violation|3|||
147299476|NCT01984697|531262723|FG003|Overall Study|Protocol Violation|2|||
147299477|NCT01984697|531262724|FG004|Overall Study|Protocol Violation|0|||
147299478|NCT01984697|531262720|FG000|Overall Study|Withdrawal by Subject|15|||
147299479|NCT01984697|531262721|FG001|Overall Study|Withdrawal by Subject|21|||
147299480|NCT01984697|531262722|FG002|Overall Study|Withdrawal by Subject|13|||
147299481|NCT01984697|531262723|FG003|Overall Study|Withdrawal by Subject|11|||
147299482|NCT01984697|531262724|FG004|Overall Study|Withdrawal by Subject|13|||
147299483|NCT01984697|531262720|FG000|Overall Study|Missed last follow-up visit|1|||
147299484|NCT01984697|531262721|FG001|Overall Study|Missed last follow-up visit|0|||
147299485|NCT01984697|531262722|FG002|Overall Study|Missed last follow-up visit|0|||
147299486|NCT01984697|531262723|FG003|Overall Study|Missed last follow-up visit|0|||
147299487|NCT01984697|531262724|FG004|Overall Study|Missed last follow-up visit|0|||
147299488|NCT01984697|531262720|FG000|Overall Study|Death|0|||
147299489|NCT01984697|531262721|FG001|Overall Study|Death|0|||
147299490|NCT01984697|531262722|FG002|Overall Study|Death|0|||
147299491|NCT01984697|531262723|FG003|Overall Study|Death|1|||
147299492|NCT01984697|531262724|FG004|Overall Study|Death|0|||
147299493|NCT01984697|531262720|FG000|Overall Study|Pregnancy|2|||
147299494|NCT01984697|531262721|FG001|Overall Study|Pregnancy|0|||
147299495|NCT01984697|531262722|FG002|Overall Study|Pregnancy|1|||
147299496|NCT01984697|531262723|FG003|Overall Study|Pregnancy|0|||
147299497|NCT01984697|531262724|FG004|Overall Study|Pregnancy|1|||
147299498|NCT03092375|531262731|FG000|Overall Study|Lack of Efficacy|0|||
147299499|NCT03092375|531262732|FG001|Overall Study|Lack of Efficacy|1|||
147299500|NCT03092375|531262733|FG002|Overall Study|Lack of Efficacy|1|||
147299501|NCT03092375|531262734|FG003|Overall Study|Lack of Efficacy|0|||
147299502|NCT00949715|531262735|FG000|Overall Study|Physician Decision|1|||
147299503|NCT00949715|531262736|FG001|Overall Study|Physician Decision|0|||
147299504|NCT00949715|531262735|FG000|Overall Study|Lost to Follow-up|1|||
147299505|NCT00949715|531262736|FG001|Overall Study|Lost to Follow-up|0|||
147299506|NCT00949715|531262735|FG000|Overall Study|Missing 24 month LVEF measurement|2|||
147299507|NCT00949715|531262736|FG001|Overall Study|Missing 24 month LVEF measurement|0|||
147299508|NCT00861614|531262737|FG000|Overall Study|Disease Progression|182|||
147299509|NCT00861614|531262738|FG001|Overall Study|Disease Progression|263|||
147299510|NCT00861614|531262737|FG000|Overall Study|Study Drug Toxicity|79|||
147299511|NCT00861614|531262738|FG001|Overall Study|Study Drug Toxicity|6|||
147299512|NCT00861614|531262737|FG000|Overall Study|Death|32|||
147299513|NCT00861614|531262738|FG001|Overall Study|Death|19|||
147299514|NCT00861614|531262737|FG000|Overall Study|Adverse Event|27|||
147299515|NCT00861614|531262738|FG001|Overall Study|Adverse Event|23|||
147299516|NCT00861614|531262737|FG000|Overall Study|Withdrawal by Subject|34|||
147299517|NCT00861614|531262738|FG001|Overall Study|Withdrawal by Subject|35|||
147299518|NCT00861614|531262737|FG000|Overall Study|Other|17|||
147299519|NCT00861614|531262738|FG001|Overall Study|Other|22|||
147299520|NCT02243280|531262739|FG000|Treated|Adverse Event|1|||
147299521|NCT02243280|531262740|FG001|Treated|Adverse Event|0|||
147299522|NCT02243280|531262741|FG002|Treated|Adverse Event|0|||
147299523|NCT02243280|531262742|FG003|Treated|Adverse Event|0|||
147299524|NCT02243280|531262743|FG004|Treated|Adverse Event|0|||
147606482|NCT03146962|532375221|FG000|Overall Study|Started New Treatment|0|||
147606483|NCT03146962|532375222|FG001|Overall Study|Started New Treatment|1|||
147606484|NCT03146962|532375223|FG002|Overall Study|Started New Treatment|0|||
147606485|NCT03146962|532375224|FG003|Overall Study|Started New Treatment|0|||
147606486|NCT03146962|532375225|FG004|Overall Study|Started New Treatment|0|||
147606487|NCT03146962|532375226|FG005|Overall Study|Started New Treatment|0|||
147606488|NCT03146962|532375227|FG006|Overall Study|Started New Treatment|0|||
147606489|NCT03146962|532375228|FG007|Overall Study|Started New Treatment|0|||
147299525|NCT02243280|531262744|FG005|Treated|Adverse Event|0|||
147299526|NCT02243280|531262745|FG006|Treated|Adverse Event|0|||
147299527|NCT02243280|531262746|FG007|Treated|Adverse Event|0|||
147299528|NCT02243280|531262747|FG008|Treated|Adverse Event|0|||
147299529|NCT02243280|531262748|FG009|Treated|Adverse Event|0|||
147299530|NCT02243280|531262749|FG010|Treated|Adverse Event|1|||
147299531|NCT02243280|531262739|FG000|Treated|Lost to Follow-up|0|||
147299532|NCT02243280|531262740|FG001|Treated|Lost to Follow-up|0|||
147299533|NCT02243280|531262741|FG002|Treated|Lost to Follow-up|0|||
147299534|NCT02243280|531262742|FG003|Treated|Lost to Follow-up|0|||
147299535|NCT02243280|531262743|FG004|Treated|Lost to Follow-up|0|||
147299536|NCT02243280|531262744|FG005|Treated|Lost to Follow-up|0|||
147299537|NCT02243280|531262745|FG006|Treated|Lost to Follow-up|0|||
147299538|NCT02243280|531262746|FG007|Treated|Lost to Follow-up|0|||
147299539|NCT02243280|531262747|FG008|Treated|Lost to Follow-up|1|||
147299540|NCT02243280|531262748|FG009|Treated|Lost to Follow-up|0|||
147299541|NCT02243280|531262749|FG010|Treated|Lost to Follow-up|2|||
147299542|NCT01807156|531262750|FG000|Overall Study|Physician Decision|1|||
147299543|NCT01493687|531262754|FG000|Part A Vehicle Control (12 Weeks)|Pregnancy|2|||
147299544|NCT01493687|531262755|FG001|Part A Vehicle Control (12 Weeks)|Pregnancy|0|||
147299545|NCT01493687|531262754|FG000|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|0|||
147299546|NCT01493687|531262755|FG001|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|1|||
147299547|NCT01493687|531262754|FG000|Part A Vehicle Control (12 Weeks)|Adverse Event|7|||
147299548|NCT01493687|531262755|FG001|Part A Vehicle Control (12 Weeks)|Adverse Event|4|||
147299549|NCT01493687|531262754|FG000|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|18|||
147299550|NCT01493687|531262755|FG001|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|7|||
147299551|NCT01493687|531262754|FG000|Part A Vehicle Control (12 Weeks)|Protocol Violation|2|||
147299552|NCT01493687|531262755|FG001|Part A Vehicle Control (12 Weeks)|Protocol Violation|1|||
147299553|NCT01493687|531262754|FG000|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|7|||
147299554|NCT01493687|531262755|FG001|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|8|||
147299555|NCT01493687|531262754|FG000|Part A Vehicle Control (12 Weeks)|Other (noted on CRF)|1|||
147299556|NCT01493687|531262755|FG001|Part A Vehicle Control (12 Weeks)|Other (noted on CRF)|1|||
147299557|NCT01493687|531262754|FG000|Part B Long Term Active Control 40 Weeks|Pregnancy|5|||
147299558|NCT01493687|531262755|FG001|Part B Long Term Active Control 40 Weeks|Pregnancy|1|||
147299559|NCT01493687|531262754|FG000|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|2|||
147299560|NCT01493687|531262755|FG001|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|3|||
147299561|NCT01493687|531262754|FG000|Part B Long Term Active Control 40 Weeks|Adverse Event|5|||
147299562|NCT01493687|531262755|FG001|Part B Long Term Active Control 40 Weeks|Adverse Event|4|||
147299563|NCT01493687|531262754|FG000|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|27|||
147299564|NCT01493687|531262755|FG001|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|16|||
147299565|NCT01493687|531262754|FG000|Part B Long Term Active Control 40 Weeks|Protocol Violation|1|||
147299566|NCT01493687|531262755|FG001|Part B Long Term Active Control 40 Weeks|Protocol Violation|0|||
147299567|NCT01493687|531262754|FG000|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|16|||
147299568|NCT01493687|531262755|FG001|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|10|||
147299569|NCT01493687|531262754|FG000|Part B Long Term Active Control 40 Weeks|Other (noted on eCRF)|5|||
147299570|NCT01493687|531262755|FG001|Part B Long Term Active Control 40 Weeks|Other (noted on eCRF)|1|||
147299571|NCT01493687|531262754|FG000|Part C Safety Follow up (4 Weeks)|Adverse Event|0|||
147299572|NCT01493687|531262755|FG001|Part C Safety Follow up (4 Weeks)|Adverse Event|1|||
147299573|NCT02323646|531262759|FG000|Treatment Course 1|Adverse Event|1|||
147299574|NCT02323646|531262760|FG001|Treatment Course 1|Adverse Event|0|||
147299575|NCT02323646|531262761|FG002|Treatment Course 1|Adverse Event|1|||
147299576|NCT02323646|531262759|FG000|Treatment Course 1|Heavy Bleeding|1|||
147299577|NCT02323646|531262760|FG001|Treatment Course 1|Heavy Bleeding|1|||
147299578|NCT02323646|531262761|FG002|Treatment Course 1|Heavy Bleeding|0|||
147299579|NCT02323646|531262759|FG000|Treatment Course 1|Lost to Follow-up|1|||
147299580|NCT02323646|531262760|FG001|Treatment Course 1|Lost to Follow-up|0|||
147299581|NCT02323646|531262761|FG002|Treatment Course 1|Lost to Follow-up|2|||
147299582|NCT02323646|531262759|FG000|Treatment Course 1|Withdrawal by Subject|0|||
147299583|NCT02323646|531262760|FG001|Treatment Course 1|Withdrawal by Subject|2|||
147299584|NCT02323646|531262761|FG002|Treatment Course 1|Withdrawal by Subject|0|||
147299585|NCT02323646|531262759|FG000|Treatment Course 2|Adverse Event|1|||
147299586|NCT02323646|531262760|FG001|Treatment Course 2|Adverse Event|0|||
147299587|NCT02323646|531262761|FG002|Treatment Course 2|Adverse Event|1|||
147299588|NCT02323646|531262759|FG000|Treatment Course 2|Lost to Follow-up|0|||
147606490|NCT03146962|532375229|FG008|Overall Study|Started New Treatment|0|||
147299589|NCT02323646|531262760|FG001|Treatment Course 2|Lost to Follow-up|0|||
147299590|NCT02323646|531262761|FG002|Treatment Course 2|Lost to Follow-up|1|||
147299591|NCT02323646|531262759|FG000|Treatment Course 2|Non-compliance|0|||
147341328|NCT02409667|531418363|FG003|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|3|||
147299592|NCT02323646|531262760|FG001|Treatment Course 2|Non-compliance|1|||
147299593|NCT02323646|531262761|FG002|Treatment Course 2|Non-compliance|1|||
147299594|NCT00521144|531262762|FG000|Overall Study|Not Treated|0|||
147299595|NCT00521144|531262763|FG001|Overall Study|Not Treated|0|||
147299596|NCT00521144|531262764|FG002|Overall Study|Not Treated|0|||
147299597|NCT00521144|531262765|FG003|Overall Study|Not Treated|1|||
147299598|NCT00521144|531262766|FG004|Overall Study|Not Treated|0|||
147299599|NCT00521144|531262762|FG000|Overall Study|Adverse Event|0|||
147299600|NCT00521144|531262763|FG001|Overall Study|Adverse Event|1|||
147299601|NCT00521144|531262764|FG002|Overall Study|Adverse Event|0|||
147299602|NCT00521144|531262765|FG003|Overall Study|Adverse Event|0|||
147299603|NCT00521144|531262766|FG004|Overall Study|Adverse Event|1|||
147299604|NCT00521144|531262762|FG000|Overall Study|Progressive Disease|4|||
147299605|NCT00521144|531262763|FG001|Overall Study|Progressive Disease|2|||
147299606|NCT00521144|531262764|FG002|Overall Study|Progressive Disease|2|||
147299607|NCT00521144|531262765|FG003|Overall Study|Progressive Disease|0|||
147299608|NCT00521144|531262766|FG004|Overall Study|Progressive Disease|6|||
147299609|NCT01370525|531262767|FG000|Overall Study|Voluntary Discontinuation by Subject|2|||
147299610|NCT01370525|531262768|FG001|Overall Study|Voluntary Discontinuation by Subject|3|||
147299611|NCT01370525|531262767|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
147299612|NCT01370525|531262768|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
147299613|NCT01370525|531262767|FG000|Overall Study|Adverse Event|0|||
147299614|NCT01370525|531262768|FG001|Overall Study|Adverse Event|1|||
147299615|NCT01370525|531262767|FG000|Overall Study|Protocol Violation|2|||
147299616|NCT01370525|531262768|FG001|Overall Study|Protocol Violation|1|||
147299617|NCT01370525|531262767|FG000|Overall Study|Lost to follow up|2|||
147299618|NCT01370525|531262768|FG001|Overall Study|Lost to follow up|6|||
147299619|NCT04791761|531262771|FG000|Overall Study|Lost to Follow-up|8|||
147299620|NCT04791761|531262772|FG001|Overall Study|Lost to Follow-up|6|||
147299621|NCT04791761|531262773|FG002|Overall Study|Lost to Follow-up|10|||
147299622|NCT04791761|531262771|FG000|Overall Study|Withdrawal by Subject|0|||
147299623|NCT04791761|531262772|FG001|Overall Study|Withdrawal by Subject|1|||
147299624|NCT04791761|531262773|FG002|Overall Study|Withdrawal by Subject|1|||
147299625|NCT04791761|531262771|FG000|Overall Study|Protocol Violation|0|||
147299626|NCT04791761|531262772|FG001|Overall Study|Protocol Violation|1|||
147299627|NCT04791761|531262773|FG002|Overall Study|Protocol Violation|1|||
147299628|NCT00180479|531262777|FG000|Overall Study|Death|4|||
147299629|NCT00180479|531262778|FG001|Overall Study|Death|2|||
147299630|NCT00180479|531262777|FG000|Overall Study|Lost to Follow-up|9|||
147299631|NCT00180479|531262778|FG001|Overall Study|Lost to Follow-up|7|||
147299632|NCT00180479|531262777|FG000|Overall Study|Withdrawal by Subject|3|||
147299633|NCT00180479|531262778|FG001|Overall Study|Withdrawal by Subject|3|||
147299634|NCT00180479|531262777|FG000|Overall Study|Informed consent not signed|0|||
147299635|NCT00180479|531262778|FG001|Overall Study|Informed consent not signed|1|||
147299636|NCT00526630|531262779|FG000|First Intervention Period - 12 Weeks|Withdrawn|0|||
147299637|NCT00526630|531262780|FG001|First Intervention Period - 12 Weeks|Withdrawn|3|||
147299638|NCT00526630|531262779|FG000|Second Intervention Period - 12 Weeks|Withdrawn|2|||
147299639|NCT00526630|531262780|FG001|Second Intervention Period - 12 Weeks|Withdrawn|1|||
147299640|NCT05168579|531262781|FG000|Overall Study|Lack of Consent|1|||
147299641|NCT05168579|531262782|FG001|Overall Study|Lack of Consent|0|||
147299642|NCT05168579|531262781|FG000|Overall Study|Conflicts with time|2|||
147299643|NCT05168579|531262782|FG001|Overall Study|Conflicts with time|0|||
147299644|NCT05168579|531262781|FG000|Overall Study|Time slots were full|3|||
147299645|NCT05168579|531262782|FG001|Overall Study|Time slots were full|0|||
147299646|NCT05168579|531262781|FG000|Overall Study|Lost to Follow-up|0|||
147299647|NCT05168579|531262782|FG001|Overall Study|Lost to Follow-up|15|||
147299648|NCT00840801|531262783|FG000|Part A: Screening- Day 28 Postdose 2|Screen failure|1|||
147299649|NCT00840801|531262784|FG001|Part A: Screening- Day 28 Postdose 2|Screen failure|0|||
147299650|NCT00840801|531262785|FG002|Part A: Screening- Day 28 Postdose 2|Screen failure|0|||
147299651|NCT00840801|531262783|FG000|Part B:Day 28 Postdose2-Day 28 Postdose3|Lost to Follow-up|0|||
147299652|NCT00840801|531262784|FG001|Part B:Day 28 Postdose2-Day 28 Postdose3|Lost to Follow-up|0|||
147299653|NCT00840801|531262785|FG002|Part B:Day 28 Postdose2-Day 28 Postdose3|Lost to Follow-up|1|||
147299654|NCT00840801|531262783|FG000|Part B:Day 28 Postdose2-Day 28 Postdose3|Other|0|||
147299655|NCT00840801|531262784|FG001|Part B:Day 28 Postdose2-Day 28 Postdose3|Other|0|||
147299656|NCT00840801|531262785|FG002|Part B:Day 28 Postdose2-Day 28 Postdose3|Other|1|||
147299657|NCT00840801|531262783|FG000|Part B:Day 28 Postdose2-Day 28 Postdose3|Refused blood draw|0|||
147299658|NCT00840801|531262784|FG001|Part B:Day 28 Postdose2-Day 28 Postdose3|Refused blood draw|0|||
147341329|NCT02409667|531418364|FG004|Treatment Period 2, Week 24 to Week 52)|Lost to Follow-up|0|||
147299659|NCT00840801|531262785|FG002|Part B:Day 28 Postdose2-Day 28 Postdose3|Refused blood draw|2|||
147299660|NCT01242748|531262786|FG000|Overall Study|Adverse Event|10|||
147299661|NCT01242748|531262787|FG001|Overall Study|Adverse Event|5|||
147299662|NCT01242748|531262786|FG000|Overall Study|Lost to Follow-up|6|||
147299663|NCT01242748|531262787|FG001|Overall Study|Lost to Follow-up|2|||
147341330|NCT02409667|531418360|FG000|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|0|||
147341331|NCT02409667|531418361|FG001|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|0|||
147341332|NCT02409667|531418362|FG002|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|0|||
147341333|NCT02409667|531418363|FG003|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|2|||
147341334|NCT02409667|531418364|FG004|Treatment Period 2, Week 24 to Week 52)|Lack of Efficacy|0|||
147341335|NCT02409667|531418360|FG000|Treatment Period 2, Week 24 to Week 52)|Adverse Event|0|||
147341336|NCT02409667|531418361|FG001|Treatment Period 2, Week 24 to Week 52)|Adverse Event|7|||
147341337|NCT02409667|531418362|FG002|Treatment Period 2, Week 24 to Week 52)|Adverse Event|4|||
147341338|NCT02409667|531418363|FG003|Treatment Period 2, Week 24 to Week 52)|Adverse Event|1|||
147341339|NCT02409667|531418364|FG004|Treatment Period 2, Week 24 to Week 52)|Adverse Event|2|||
147341340|NCT02409667|531418360|FG000|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|0|||
147341341|NCT02409667|531418361|FG001|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|5|||
147341342|NCT02409667|531418362|FG002|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|4|||
147341343|NCT02409667|531418363|FG003|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|0|||
147341344|NCT02409667|531418364|FG004|Treatment Period 2, Week 24 to Week 52)|Withdrawal of informed consent|0|||
147341345|NCT02409667|531418360|FG000|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|0|||
147341346|NCT02409667|531418361|FG001|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|4|||
147341347|NCT02409667|531418362|FG002|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|5|||
147341348|NCT02409667|531418363|FG003|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|2|||
147341349|NCT02409667|531418364|FG004|Treatment Period 2, Week 24 to Week 52)|Withdrawal by Subject|0|||
147341350|NCT02409667|531418360|FG000|Treatment Period 2, Week 24 to Week 52)|Pregnancy|0|||
147341351|NCT02409667|531418361|FG001|Treatment Period 2, Week 24 to Week 52)|Pregnancy|0|||
147341352|NCT02409667|531418362|FG002|Treatment Period 2, Week 24 to Week 52)|Pregnancy|1|||
147341353|NCT02409667|531418363|FG003|Treatment Period 2, Week 24 to Week 52)|Pregnancy|0|||
147341354|NCT02409667|531418364|FG004|Treatment Period 2, Week 24 to Week 52)|Pregnancy|1|||
147341355|NCT02409667|531418360|FG000|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|0|||
147341356|NCT02409667|531418361|FG001|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|0|||
147341357|NCT02409667|531418362|FG002|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|3|||
147341358|NCT02409667|531418363|FG003|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|0|||
147341359|NCT02409667|531418364|FG004|Treatment Period 2, Week 24 to Week 52)|Protocol deviation|0|||
147341360|NCT01205048|531418365|FG000|Overall Study|Withdrawal by Subject|14|||
147341361|NCT01205048|531418365|FG000|Overall Study|Clinical Investigation Plan Violation|1|||
147341362|NCT01205048|531418365|FG000|Overall Study|Lost to Follow-up|4|||
147341363|NCT01205048|531418365|FG000|Overall Study|Other|2|||
147341364|NCT01255670|531418366|FG000|Overall Study|Adverse Event|10|||
147341365|NCT01255670|531418367|FG001|Overall Study|Adverse Event|10|||
147341366|NCT01255670|531418366|FG000|Overall Study|Lost to Follow-up|16|||
147341367|NCT01255670|531418367|FG001|Overall Study|Lost to Follow-up|10|||
147341368|NCT03892564|531418368|FG000|Overall Study|Withdrawal by Subject|2|||
147341369|NCT03664960|531418369|FG000|Overall Study|Adverse Event|0|||
147341370|NCT03664960|531418370|FG001|Overall Study|Adverse Event|3|||
147341371|NCT03664960|531418369|FG000|Overall Study|Lost to Follow-up|3|||
147341372|NCT03664960|531418370|FG001|Overall Study|Lost to Follow-up|2|||
147341373|NCT03664960|531418369|FG000|Overall Study|Physician Decision|1|||
147341374|NCT03664960|531418370|FG001|Overall Study|Physician Decision|0|||
147341375|NCT03664960|531418369|FG000|Overall Study|Withdrawal by Subject|3|||
147341376|NCT03664960|531418370|FG001|Overall Study|Withdrawal by Subject|14|||
147341377|NCT03664960|531418369|FG000|Overall Study|Sponsor Decision|1|||
147341378|NCT03664960|531418370|FG001|Overall Study|Sponsor Decision|1|||
147341379|NCT03664960|531418369|FG000|Overall Study|Other|1|||
147341380|NCT03664960|531418370|FG001|Overall Study|Other|2|||
147341381|NCT03997916|531418379|FG000|Overall Study|Protocol Violation|35|||
147341382|NCT01207492|531418380|FG000|Overall Study|Still on study|1|||
147341383|NCT01207492|531418380|FG000|Overall Study|Withdrawal by Subject|9|||
147341384|NCT01207492|531418380|FG000|Overall Study|Physician Decision|1|||
147341385|NCT01207492|531418380|FG000|Overall Study|Progressive disease|3|||
147341386|NCT01207492|531418380|FG000|Overall Study|Toxicity|1|||
147341387|NCT02769858|531418381|FG000|Overall Study|Withdrawal by Subject|2|||
147341388|NCT03783026|531419942|FG000|Treatment Phase|Adverse Event|15|||
147341389|NCT03783026|531419942|FG000|Treatment Phase|Lack of Efficacy|11|||
147341390|NCT03783026|531419942|FG000|Treatment Phase|Withdrawal by Subject|6|||
147341391|NCT03783026|531419942|FG000|Treatment Phase|Lost to Follow-up|2|||
147341392|NCT03783026|531419942|FG000|Treatment Phase|Protocol Deviation|8|||
147341393|NCT03783026|531419942|FG000|Treatment Phase|Did Not Receive Treatment|1|||
147341394|NCT03783026|531419942|FG000|Observational Follow-up Phase|Lost to Follow-up|3|||
147341395|NCT04814186|531419943|FG000|Treatment Phase|Adverse Event|1|||
147662713|NCT02227784|532587416|FG004|Double-Blind Phase|Adverse Event|0|||
147341396|NCT04814186|531419943|FG000|Treatment Phase|Death|6|||
147341397|NCT04814186|531419943|FG000|Treatment Phase|Withdrawal by Subject|2|||
147662714|NCT02227784|532587412|FG000|Double-Blind Phase|Physician Decision|1|||
147341398|NCT04814186|531419943|FG000|Treatment Phase|Other|1|||
147341399|NCT04814186|531419943|FG000|Follow-Up Phase|Adverse Event|1|||
147341400|NCT04814186|531419943|FG000|Follow-Up Phase|Death|6|||
147341401|NCT04814186|531419943|FG000|Follow-Up Phase|Withdrawal by Subject|1|||
147341402|NCT04814186|531419943|FG000|Follow-Up Phase|Other|1|||
147341403|NCT01853748|531419947|FG000|Allocation|Withdrawal by Subject|1|||
147341404|NCT01853748|531419948|FG001|Allocation|Withdrawal by Subject|13|||
147341405|NCT01853748|531419947|FG000|Allocation|not sufficient to receive intervention|0|||
147341406|NCT01853748|531419948|FG001|Allocation|not sufficient to receive intervention|1|||
147341407|NCT01853748|531419947|FG000|Follow-Up|Withdrawal by Subject|7|||
147341408|NCT01853748|531419948|FG001|Follow-Up|Withdrawal by Subject|6|||
147341409|NCT01853748|531419947|FG000|Follow-Up|Adverse Event|67|||
147341410|NCT01853748|531419948|FG001|Follow-Up|Adverse Event|7|||
147341411|NCT01853748|531419947|FG000|Follow-Up|not available for data collection|16|||
147341412|NCT01853748|531419948|FG001|Follow-Up|not available for data collection|4|||
147341413|NCT01643070|531419953|FG000|Overall Study|Withdrawal by Subject|3|||
147341414|NCT01643070|531419954|FG001|Overall Study|Withdrawal by Subject|1|||
147341415|NCT01643070|531419953|FG000|Overall Study|Death|1|||
147341416|NCT01643070|531419954|FG001|Overall Study|Death|0|||
147341417|NCT01643070|531419953|FG000|Overall Study|Pregressive disease|0|||
147341418|NCT01643070|531419954|FG001|Overall Study|Pregressive disease|2|||
147341419|NCT04941287|531419955|FG000|Overall Study|Rapid decline before starting treatment|3|||
147341420|NCT04941287|531419956|FG001|Overall Study|Rapid decline before starting treatment|1|||
147341421|NCT02980276|531419957|FG000|Overall Study|Withdrawal by Subject|4|||
147341422|NCT02980276|531419958|FG001|Overall Study|Withdrawal by Subject|4|||
147341423|NCT02980276|531419957|FG000|Overall Study|Physician Decision|0|||
147341424|NCT02980276|531419958|FG001|Overall Study|Physician Decision|1|||
147341425|NCT02980276|531419957|FG000|Overall Study|Lost to Follow-up|18|||
147341426|NCT02980276|531419958|FG001|Overall Study|Lost to Follow-up|18|||
147341427|NCT02980276|531419957|FG000|Overall Study|Death|1|||
147341428|NCT02980276|531419958|FG001|Overall Study|Death|0|||
147341429|NCT02980276|531419957|FG000|Overall Study|Miscellaneous other|10|||
147341430|NCT02980276|531419958|FG001|Overall Study|Miscellaneous other|4|||
147341431|NCT03990649|531419963|FG000|Part A: DB Treatment Period (15 Weeks)|Adverse Event|0|||
147341432|NCT03990649|531419964|FG001|Part A: DB Treatment Period (15 Weeks)|Adverse Event|1|||
147341433|NCT03990649|531419965|FG002|Part A: DB Treatment Period (15 Weeks)|Adverse Event|0|||
147341434|NCT03990649|531419963|FG000|Part A: DB Treatment Period (15 Weeks)|Lost to Follow-up|0|||
147341435|NCT03990649|531419964|FG001|Part A: DB Treatment Period (15 Weeks)|Lost to Follow-up|1|||
147341436|NCT03990649|531419965|FG002|Part A: DB Treatment Period (15 Weeks)|Lost to Follow-up|0|||
147341437|NCT03990649|531419963|FG000|Part A: DB Treatment Period (15 Weeks)|Withdrawal by Subject|2|||
147341438|NCT03990649|531419964|FG001|Part A: DB Treatment Period (15 Weeks)|Withdrawal by Subject|0|||
147341439|NCT03990649|531419965|FG002|Part A: DB Treatment Period (15 Weeks)|Withdrawal by Subject|0|||
147341440|NCT03990649|531419963|FG000|Part A: DB Treatment Period (15 Weeks)|Reason not Specified|1|||
147341441|NCT03990649|531419964|FG001|Part A: DB Treatment Period (15 Weeks)|Reason not Specified|1|||
147341442|NCT03990649|531419965|FG002|Part A: DB Treatment Period (15 Weeks)|Reason not Specified|0|||
147341443|NCT03990649|531419963|FG000|Part B: OL Extension Period (14 Weeks)|Adverse Event|0|||
147341444|NCT03990649|531419964|FG001|Part B: OL Extension Period (14 Weeks)|Adverse Event|0|||
147341445|NCT03990649|531419965|FG002|Part B: OL Extension Period (14 Weeks)|Adverse Event|1|||
147341446|NCT03990649|531419963|FG000|Part B: OL Extension Period (14 Weeks)|Withdrawal by Subject|0|||
147341447|NCT03990649|531419964|FG001|Part B: OL Extension Period (14 Weeks)|Withdrawal by Subject|0|||
147341448|NCT03990649|531419965|FG002|Part B: OL Extension Period (14 Weeks)|Withdrawal by Subject|2|||
147341449|NCT03990649|531419963|FG000|Part B: OL Extension Period (14 Weeks)|Reason not Specified|0|||
147341450|NCT03990649|531419964|FG001|Part B: OL Extension Period (14 Weeks)|Reason not Specified|0|||
147341451|NCT03990649|531419965|FG002|Part B: OL Extension Period (14 Weeks)|Reason not Specified|1|||
147341452|NCT05773313|531419966|FG000|Overall Study|Lost to Follow-up|3|||
147341453|NCT03050814|531419967|FG000|Overall Study|Screen failures|0|||
147341454|NCT03050814|531419968|FG001|Overall Study|Screen failures|0|||
147341455|NCT03050814|531419969|FG002|Overall Study|Screen failures|4|||
147341456|NCT01443845|531419970|FG000|Overall Study|Protocol Violation|43|||
147341457|NCT01443845|531419971|FG001|Overall Study|Protocol Violation|45|||
147341458|NCT01443845|531419970|FG000|Overall Study|Other reasons, such as COPD exacerbation|44|||
147341459|NCT01443845|531419971|FG001|Overall Study|Other reasons, such as COPD exacerbation|44|||
147341460|NCT01443845|531419970|FG000|Overall Study|Deterioration in pulmonary function|1|||
147341461|NCT01443845|531419971|FG001|Overall Study|Deterioration in pulmonary function|4|||
147341462|NCT01443845|531419970|FG000|Overall Study|Lack of Efficacy|10|||
147341463|NCT01443845|531419971|FG001|Overall Study|Lack of Efficacy|5|||
147341464|NCT01443845|531419970|FG000|Overall Study|Adverse Event|64|||
147341465|NCT01443845|531419971|FG001|Overall Study|Adverse Event|138|||
147341466|NCT01443845|531419970|FG000|Overall Study|Withdrawal by Subject|63|||
147341467|NCT01443845|531419971|FG001|Overall Study|Withdrawal by Subject|67|||
147341468|NCT01443845|531419970|FG000|Overall Study|Military Conflict - Site Terminated|20|||
147341469|NCT01443845|531419971|FG001|Overall Study|Military Conflict - Site Terminated|21|||
147341470|NCT01443845|531419970|FG000|Overall Study|Lost to Follow-up|9|||
147341471|NCT01443845|531419971|FG001|Overall Study|Lost to Follow-up|13|||
147341472|NCT01471691|531419975|FG000|Overall Study|Lack of Efficacy|0|||
147341473|NCT01471691|531419976|FG001|Overall Study|Lack of Efficacy|1|||
147341474|NCT01854385|531419977|FG000|Pre-Treatment|Withdrawal by Subject|4|||
147341475|NCT01854385|531419977|FG000|Pre-Treatment|Did not meet criteria based on headache number|15|||
147341476|NCT01854385|531419977|FG000|Pre-Treatment|Disqualified based on blood pressure requirement|3|||
147341477|NCT01854385|531419977|FG000|Pre-Treatment|Unable to come for study visits|1|||
147341478|NCT01854385|531419977|FG000|Treatment|Lost to Follow-up|1|||
147341479|NCT01610297|531419978|FG000|Overall Study|Lost to Follow-up|1|||
147341480|NCT01121991|531419980|FG000|Overall Study|Lack of Ovarian Response|2|||
147341481|NCT01121991|531419980|FG000|Overall Study|No Oocytes Retrieved|3|||
147341482|NCT01121991|531419980|FG000|Overall Study|No Fertilization|1|||
147341483|NCT02590432|531419981|FG000|Open-label Treatment Period|Adverse Event|97|||
147341484|NCT02590432|531419982|FG001|Open-label Treatment Period|Adverse Event|79|||
147341485|NCT02590432|531419983|FG002|Open-label Treatment Period|Adverse Event|0|||
147341486|NCT02590432|531419984|FG003|Open-label Treatment Period|Adverse Event|0|||
147341487|NCT02590432|531419985|FG004|Open-label Treatment Period|Adverse Event|0|||
147341488|NCT02590432|531419986|FG005|Open-label Treatment Period|Adverse Event|0|||
147341489|NCT02590432|531419987|FG006|Open-label Treatment Period|Adverse Event|0|||
147341490|NCT02590432|531419988|FG007|Open-label Treatment Period|Adverse Event|0|||
147341491|NCT02590432|531419989|FG008|Open-label Treatment Period|Adverse Event|0|||
147341492|NCT02590432|531419981|FG000|Open-label Treatment Period|Lack of Efficacy|14|||
147341493|NCT02590432|531419982|FG001|Open-label Treatment Period|Lack of Efficacy|5|||
147341494|NCT02590432|531419983|FG002|Open-label Treatment Period|Lack of Efficacy|0|||
147341495|NCT02590432|531419984|FG003|Open-label Treatment Period|Lack of Efficacy|0|||
147341496|NCT02590432|531419985|FG004|Open-label Treatment Period|Lack of Efficacy|0|||
147341497|NCT02590432|531419986|FG005|Open-label Treatment Period|Lack of Efficacy|0|||
147341498|NCT02590432|531419987|FG006|Open-label Treatment Period|Lack of Efficacy|0|||
147341499|NCT02590432|531419988|FG007|Open-label Treatment Period|Lack of Efficacy|0|||
147341500|NCT02590432|531419989|FG008|Open-label Treatment Period|Lack of Efficacy|0|||
147341501|NCT02590432|531419981|FG000|Open-label Treatment Period|Withdrawal of Consent|43|||
147341502|NCT02590432|531419982|FG001|Open-label Treatment Period|Withdrawal of Consent|28|||
147341503|NCT02590432|531419983|FG002|Open-label Treatment Period|Withdrawal of Consent|0|||
147341504|NCT02590432|531419984|FG003|Open-label Treatment Period|Withdrawal of Consent|0|||
147341505|NCT02590432|531419985|FG004|Open-label Treatment Period|Withdrawal of Consent|0|||
147341506|NCT02590432|531419986|FG005|Open-label Treatment Period|Withdrawal of Consent|0|||
147341507|NCT02590432|531419987|FG006|Open-label Treatment Period|Withdrawal of Consent|0|||
147341508|NCT02590432|531419988|FG007|Open-label Treatment Period|Withdrawal of Consent|0|||
147341509|NCT02590432|531419989|FG008|Open-label Treatment Period|Withdrawal of Consent|0|||
147341510|NCT02590432|531419981|FG000|Open-label Treatment Period|Lost to Follow-up|51|||
147341511|NCT02590432|531419982|FG001|Open-label Treatment Period|Lost to Follow-up|29|||
147341512|NCT02590432|531419983|FG002|Open-label Treatment Period|Lost to Follow-up|0|||
147341513|NCT02590432|531419984|FG003|Open-label Treatment Period|Lost to Follow-up|0|||
147341514|NCT02590432|531419985|FG004|Open-label Treatment Period|Lost to Follow-up|0|||
147341515|NCT02590432|531419986|FG005|Open-label Treatment Period|Lost to Follow-up|0|||
147341516|NCT02590432|531419987|FG006|Open-label Treatment Period|Lost to Follow-up|0|||
147341517|NCT02590432|531419988|FG007|Open-label Treatment Period|Lost to Follow-up|0|||
147341518|NCT02590432|531419989|FG008|Open-label Treatment Period|Lost to Follow-up|0|||
147341519|NCT02590432|531419981|FG000|Open-label Treatment Period|Protocol Violation|10|||
147341520|NCT02590432|531419982|FG001|Open-label Treatment Period|Protocol Violation|4|||
147341521|NCT02590432|531419983|FG002|Open-label Treatment Period|Protocol Violation|0|||
147341522|NCT02590432|531419984|FG003|Open-label Treatment Period|Protocol Violation|0|||
147341523|NCT02590432|531419985|FG004|Open-label Treatment Period|Protocol Violation|0|||
147341524|NCT02590432|531419986|FG005|Open-label Treatment Period|Protocol Violation|0|||
147341525|NCT02590432|531419987|FG006|Open-label Treatment Period|Protocol Violation|0|||
147341526|NCT02590432|531419988|FG007|Open-label Treatment Period|Protocol Violation|0|||
147341527|NCT02590432|531419989|FG008|Open-label Treatment Period|Protocol Violation|0|||
147341528|NCT02590432|531419981|FG000|Open-label Treatment Period|Non-compliance with Study Drug|7|||
147341529|NCT02590432|531419982|FG001|Open-label Treatment Period|Non-compliance with Study Drug|1|||
147341530|NCT02590432|531419983|FG002|Open-label Treatment Period|Non-compliance with Study Drug|0|||
147341531|NCT02590432|531419984|FG003|Open-label Treatment Period|Non-compliance with Study Drug|0|||
147341532|NCT02590432|531419985|FG004|Open-label Treatment Period|Non-compliance with Study Drug|0|||
147341533|NCT02590432|531419986|FG005|Open-label Treatment Period|Non-compliance with Study Drug|0|||
147341534|NCT02590432|531419987|FG006|Open-label Treatment Period|Non-compliance with Study Drug|0|||
147341535|NCT02590432|531419988|FG007|Open-label Treatment Period|Non-compliance with Study Drug|0|||
147341536|NCT02590432|531419989|FG008|Open-label Treatment Period|Non-compliance with Study Drug|0|||
147341537|NCT02590432|531419981|FG000|Open-label Treatment Period|Other Miscellaneous Reasons|10|||
147341538|NCT02590432|531419982|FG001|Open-label Treatment Period|Other Miscellaneous Reasons|6|||
147341539|NCT02590432|531419983|FG002|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
147341540|NCT02590432|531419984|FG003|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
147606491|NCT03146962|532375230|FG009|Overall Study|Started New Treatment|0|||
147606492|NCT00049530|532375231|FG000|Overall Study|Lack of Efficacy|25|||
147341541|NCT02590432|531419985|FG004|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
147341542|NCT02590432|531419986|FG005|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
147341543|NCT02590432|531419987|FG006|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
147341544|NCT02590432|531419988|FG007|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
147341545|NCT02590432|531419989|FG008|Open-label Treatment Period|Other Miscellaneous Reasons|0|||
147341546|NCT02590432|531419981|FG000|Double-blind Treatment Period|Adverse Event|0|||
147341547|NCT02590432|531419982|FG001|Double-blind Treatment Period|Adverse Event|0|||
147341548|NCT02590432|531419983|FG002|Double-blind Treatment Period|Adverse Event|14|||
147341549|NCT02590432|531419984|FG003|Double-blind Treatment Period|Adverse Event|12|||
147341550|NCT02590432|531419985|FG004|Double-blind Treatment Period|Adverse Event|6|||
147341551|NCT02590432|531419986|FG005|Double-blind Treatment Period|Adverse Event|22|||
147341552|NCT02590432|531419987|FG006|Double-blind Treatment Period|Adverse Event|20|||
147341553|NCT02590432|531419988|FG007|Double-blind Treatment Period|Adverse Event|0|||
147341554|NCT02590432|531419989|FG008|Double-blind Treatment Period|Adverse Event|0|||
147341555|NCT02590432|531419981|FG000|Double-blind Treatment Period|Lack of Efficacy|0|||
147341556|NCT02590432|531419982|FG001|Double-blind Treatment Period|Lack of Efficacy|0|||
147341557|NCT02590432|531419983|FG002|Double-blind Treatment Period|Lack of Efficacy|1|||
147341558|NCT02590432|531419984|FG003|Double-blind Treatment Period|Lack of Efficacy|0|||
147341559|NCT02590432|531419985|FG004|Double-blind Treatment Period|Lack of Efficacy|0|||
147341560|NCT02590432|531419986|FG005|Double-blind Treatment Period|Lack of Efficacy|0|||
147341561|NCT02590432|531419987|FG006|Double-blind Treatment Period|Lack of Efficacy|0|||
147341562|NCT02590432|531419988|FG007|Double-blind Treatment Period|Lack of Efficacy|0|||
147341563|NCT02590432|531419989|FG008|Double-blind Treatment Period|Lack of Efficacy|0|||
147341564|NCT02590432|531419981|FG000|Double-blind Treatment Period|Withdrawal of Consent|0|||
147341565|NCT02590432|531419982|FG001|Double-blind Treatment Period|Withdrawal of Consent|0|||
147341566|NCT02590432|531419983|FG002|Double-blind Treatment Period|Withdrawal of Consent|1|||
147341567|NCT02590432|531419984|FG003|Double-blind Treatment Period|Withdrawal of Consent|3|||
147341568|NCT02590432|531419985|FG004|Double-blind Treatment Period|Withdrawal of Consent|3|||
147341569|NCT02590432|531419986|FG005|Double-blind Treatment Period|Withdrawal of Consent|1|||
147341570|NCT02590432|531419987|FG006|Double-blind Treatment Period|Withdrawal of Consent|1|||
147341571|NCT02590432|531419988|FG007|Double-blind Treatment Period|Withdrawal of Consent|0|||
147341572|NCT02590432|531419989|FG008|Double-blind Treatment Period|Withdrawal of Consent|0|||
147341573|NCT02590432|531419981|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
147341574|NCT02590432|531419982|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
147341575|NCT02590432|531419983|FG002|Double-blind Treatment Period|Lost to Follow-up|1|||
147341576|NCT02590432|531419984|FG003|Double-blind Treatment Period|Lost to Follow-up|0|||
147341577|NCT02590432|531419985|FG004|Double-blind Treatment Period|Lost to Follow-up|0|||
147341578|NCT02590432|531419986|FG005|Double-blind Treatment Period|Lost to Follow-up|2|||
147341579|NCT02590432|531419987|FG006|Double-blind Treatment Period|Lost to Follow-up|0|||
147341580|NCT02590432|531419988|FG007|Double-blind Treatment Period|Lost to Follow-up|0|||
147341581|NCT02590432|531419989|FG008|Double-blind Treatment Period|Lost to Follow-up|0|||
147341582|NCT02590432|531419981|FG000|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
147341583|NCT02590432|531419982|FG001|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
147341584|NCT02590432|531419983|FG002|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
147341585|NCT02590432|531419984|FG003|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
147341586|NCT02590432|531419985|FG004|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
147341587|NCT02590432|531419986|FG005|Double-blind Treatment Period|Non-compliance with Study Drug|1|||
147341588|NCT02590432|531419987|FG006|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
147341589|NCT02590432|531419988|FG007|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
147341590|NCT02590432|531419989|FG008|Double-blind Treatment Period|Non-compliance with Study Drug|0|||
147341591|NCT02590432|531419981|FG000|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
147341592|NCT02590432|531419982|FG001|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
147341593|NCT02590432|531419983|FG002|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
147341594|NCT02590432|531419984|FG003|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
147341595|NCT02590432|531419985|FG004|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
147341596|NCT02590432|531419986|FG005|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
147341597|NCT02590432|531419987|FG006|Dose-reduced Open Label Treatment Period|Adverse Event|0|||
147341598|NCT02590432|531419988|FG007|Dose-reduced Open Label Treatment Period|Adverse Event|12|||
147341599|NCT02590432|531419989|FG008|Dose-reduced Open Label Treatment Period|Adverse Event|15|||
147341600|NCT02590432|531419981|FG000|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
147341601|NCT02590432|531419982|FG001|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
147341602|NCT02590432|531419983|FG002|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
147341603|NCT02590432|531419984|FG003|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
147341604|NCT02590432|531419985|FG004|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
147341605|NCT02590432|531419986|FG005|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
147453089|NCT01142726|531821538|FG001|Treatment Phase: Day 1 Through Month 12|Lack of Efficacy|6|||
147453090|NCT01142726|531821539|FG002|Treatment Phase: Day 1 Through Month 12|Lack of Efficacy|11|||
147341606|NCT02590432|531419987|FG006|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
147341607|NCT02590432|531419988|FG007|Dose-reduced Open Label Treatment Period|Lack of Efficacy|1|||
147341608|NCT02590432|531419989|FG008|Dose-reduced Open Label Treatment Period|Lack of Efficacy|0|||
147341609|NCT02590432|531419981|FG000|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
147341610|NCT02590432|531419982|FG001|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
147341611|NCT02590432|531419983|FG002|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
147341612|NCT02590432|531419984|FG003|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
147341613|NCT02590432|531419985|FG004|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
147341614|NCT02590432|531419986|FG005|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
147341615|NCT02590432|531419987|FG006|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|0|||
147341616|NCT02590432|531419988|FG007|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|3|||
147341617|NCT02590432|531419989|FG008|Dose-reduced Open Label Treatment Period|Withdrawal of Consent|1|||
147341618|NCT02590432|531419981|FG000|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
147341619|NCT02590432|531419982|FG001|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
147341620|NCT02590432|531419983|FG002|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
147341621|NCT02590432|531419984|FG003|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
147341622|NCT02590432|531419985|FG004|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
147341623|NCT02590432|531419986|FG005|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
147341624|NCT02590432|531419987|FG006|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
147341625|NCT02590432|531419988|FG007|Dose-reduced Open Label Treatment Period|Lost to Follow-up|0|||
147341626|NCT02590432|531419989|FG008|Dose-reduced Open Label Treatment Period|Lost to Follow-up|1|||
147341627|NCT02590432|531419981|FG000|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
147341628|NCT02590432|531419982|FG001|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
147341629|NCT02590432|531419983|FG002|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
147341630|NCT02590432|531419984|FG003|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
147341631|NCT02590432|531419985|FG004|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
147341632|NCT02590432|531419986|FG005|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
147341633|NCT02590432|531419987|FG006|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
147341634|NCT02590432|531419988|FG007|Dose-reduced Open Label Treatment Period|Protocol Violation|0|||
147341635|NCT02590432|531419989|FG008|Dose-reduced Open Label Treatment Period|Protocol Violation|1|||
147341636|NCT02590432|531419981|FG000|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
147341637|NCT02590432|531419982|FG001|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
147341638|NCT02590432|531419983|FG002|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
147341639|NCT02590432|531419984|FG003|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
147341640|NCT02590432|531419985|FG004|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
147341641|NCT02590432|531419986|FG005|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
147341642|NCT02590432|531419987|FG006|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
147341643|NCT02590432|531419988|FG007|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|1|||
147341644|NCT02590432|531419989|FG008|Dose-reduced Open Label Treatment Period|Non-compliance with Study Drug|0|||
147341645|NCT02590432|531419981|FG000|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
147341646|NCT02590432|531419982|FG001|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
147341647|NCT02590432|531419983|FG002|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
147341648|NCT02590432|531419984|FG003|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
147341649|NCT02590432|531419985|FG004|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
147341650|NCT02590432|531419986|FG005|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
147341651|NCT02590432|531419987|FG006|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
147341652|NCT02590432|531419988|FG007|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|1|||
147341653|NCT02590432|531419989|FG008|Dose-reduced Open Label Treatment Period|Other Miscellaneous Reasons|0|||
147341654|NCT05052996|531419994|FG000|Overall Study|Still on study|0|||
147341655|NCT05052996|531419995|FG001|Overall Study|Still on study|0|||
147341656|NCT05052996|531419996|FG002|Overall Study|Still on study|47|||
147341657|NCT05052996|531419997|FG003|Overall Study|Still on study|44|||
147341658|NCT05052996|531419994|FG000|Overall Study|Cohort terminated by sponsor|21|||
147341659|NCT05052996|531419995|FG001|Overall Study|Cohort terminated by sponsor|12|||
147341660|NCT05052996|531419996|FG002|Overall Study|Cohort terminated by sponsor|0|||
147341661|NCT05052996|531419997|FG003|Overall Study|Cohort terminated by sponsor|0|||
147341662|NCT05052996|531419994|FG000|Overall Study|Withdrew consent|1|||
147341663|NCT05052996|531419995|FG001|Overall Study|Withdrew consent|0|||
147341664|NCT05052996|531419996|FG002|Overall Study|Withdrew consent|1|||
147341665|NCT05052996|531419997|FG003|Overall Study|Withdrew consent|2|||
147341666|NCT05052996|531419994|FG000|Overall Study|Lost to Follow-up|1|||
147341667|NCT05052996|531419995|FG001|Overall Study|Lost to Follow-up|0|||
147341668|NCT05052996|531419996|FG002|Overall Study|Lost to Follow-up|0|||
147341669|NCT05052996|531419997|FG003|Overall Study|Lost to Follow-up|2|||
147341670|NCT05052996|531419994|FG000|Overall Study|Adverse Event|0|||
147341671|NCT05052996|531419995|FG001|Overall Study|Adverse Event|0|||
147341672|NCT05052996|531419996|FG002|Overall Study|Adverse Event|2|||
147341673|NCT05052996|531419997|FG003|Overall Study|Adverse Event|0|||
147341674|NCT05052996|531419994|FG000|Overall Study|Randomized but never treated|0|||
147341675|NCT05052996|531419995|FG001|Overall Study|Randomized but never treated|0|||
147341676|NCT05052996|531419996|FG002|Overall Study|Randomized but never treated|1|||
147341677|NCT05052996|531419997|FG003|Overall Study|Randomized but never treated|1|||
147341678|NCT05052996|531419994|FG000|Overall Study|Protocol Violation|1|||
147341679|NCT05052996|531419995|FG001|Overall Study|Protocol Violation|0|||
147341680|NCT05052996|531419996|FG002|Overall Study|Protocol Violation|0|||
147341681|NCT05052996|531419997|FG003|Overall Study|Protocol Violation|0|||
147341682|NCT05782231|531419999|FG000|Overall Study|Withdrawal by Subject|1|||
147341683|NCT01561989|531420000|FG000|Overall Study|accural target not met.|5|||
147341684|NCT01561989|531420001|FG001|Overall Study|accural target not met.|6|||
147341685|NCT01736215|531420002|FG000|Overall Study|Early termination of erythropoietin use|1|||
147341686|NCT01736215|531420002|FG000|Overall Study|Adverse Event|4|||
147341687|NCT01736215|531420002|FG000|Overall Study|Progressive disease stop chemotherapy|1|||
147341688|NCT01736215|531420002|FG000|Overall Study|Insufficient data to perform analysis|8|||
147341689|NCT03447249|531420003|FG000|Overall Study|Adverse Event|1|||
147341690|NCT03447249|531420004|FG001|Overall Study|Adverse Event|0|||
147341691|NCT03447249|531420003|FG000|Overall Study|Withdrawal of consent (not due to AE)|1|||
147341692|NCT03447249|531420004|FG001|Overall Study|Withdrawal of consent (not due to AE)|0|||
147341693|NCT03447249|531420003|FG000|Overall Study|Other|3|||
147341694|NCT03447249|531420004|FG001|Overall Study|Other|0|||
147341695|NCT01248936|531420005|FG000|Overall Study|Sponsor Decision|259|||
147341696|NCT01248936|531420005|FG000|Overall Study|Progression of Disease|50|||
147341697|NCT01248936|531420005|FG000|Overall Study|Death|26|||
147341698|NCT01248936|531420005|FG000|Overall Study|Withdrawal of Consent|20|||
147341699|NCT01248936|531420005|FG000|Overall Study|Adverse Event|8|||
147341700|NCT01248936|531420005|FG000|Overall Study|Lost to Follow-up|7|||
147341701|NCT01248936|531420005|FG000|Overall Study|Refused Treatment|1|||
147341702|NCT01248936|531420005|FG000|Overall Study|Other reason|3|||
147341703|NCT03485950|531420006|FG000|Overall Study|Adverse Event|1|||
147341704|NCT03485950|531420007|FG001|Overall Study|Adverse Event|0|||
147341705|NCT03485950|531420006|FG000|Overall Study|Death|3|||
147341706|NCT03485950|531420007|FG001|Overall Study|Death|2|||
147341707|NCT03485950|531420006|FG000|Overall Study|Withdrawal by Subject|3|||
147341708|NCT03485950|531420007|FG001|Overall Study|Withdrawal by Subject|0|||
147341709|NCT00988858|531420008|FG000|Overall Study|Adverse Event|7|||
147341710|NCT00988858|531420008|FG000|Overall Study|Death|1|||
147341711|NCT00988858|531420008|FG000|Overall Study|Physician Decision|1|||
147341712|NCT00988858|531420008|FG000|Overall Study|Sponsor Decision|1|||
147341713|NCT00567489|531420009|FG000|Overall Study|Adverse Event|6|||
147341714|NCT00567489|531420010|FG001|Overall Study|Adverse Event|14|||
147341715|NCT00567489|531420009|FG000|Overall Study|Physician Decision|0|||
147341716|NCT00567489|531420010|FG001|Overall Study|Physician Decision|4|||
147341717|NCT00567489|531420009|FG000|Overall Study|Withdrawal by Subject|0|||
147341718|NCT00567489|531420010|FG001|Overall Study|Withdrawal by Subject|2|||
147341719|NCT00567489|531420009|FG000|Overall Study|Renal Transplantation|0|||
147341720|NCT00567489|531420010|FG001|Overall Study|Renal Transplantation|3|||
147341721|NCT00567489|531420009|FG000|Overall Study|Other|1|||
147341722|NCT00567489|531420010|FG001|Overall Study|Other|0|||
147341723|NCT04732338|531420018|FG000|Overall Study|Lost to Follow-up|3|||
147341724|NCT04732338|531420019|FG001|Overall Study|Lost to Follow-up|3|||
147341725|NCT02372253|531420023|FG000|Overall Study|Non Compliance|2|||
147341726|NCT02372253|531420024|FG001|Overall Study|Non Compliance|0|||
147341727|NCT01803555|531420025|FG000|Overall Study|Adverse Event|3|||
147341728|NCT01803555|531420026|FG001|Overall Study|Adverse Event|2|||
147606493|NCT00049530|532375231|FG000|Overall Study|Adverse Event|2|||
147606494|NCT00049530|532375231|FG000|Overall Study|Death|1|||
147606495|NCT00049530|532375231|FG000|Overall Study|symptomatic deterioration|1|||
147606496|NCT00049530|532375231|FG000|Overall Study|ineligible|3|||
147341729|NCT01803555|531420025|FG000|Overall Study|Withdrawal by Subject|3|||
147606497|NCT01696058|532375236|FG000|Overall Study|Adverse Event|21|||
147606498|NCT01696058|532375237|FG001|Overall Study|Adverse Event|11|||
147341730|NCT01803555|531420026|FG001|Overall Study|Withdrawal by Subject|3|||
147341731|NCT01803555|531420025|FG000|Overall Study|Non-compliance|1|||
147341732|NCT01803555|531420026|FG001|Overall Study|Non-compliance|1|||
147341733|NCT01803555|531420025|FG000|Overall Study|Protocol Violation|3|||
147341734|NCT01803555|531420026|FG001|Overall Study|Protocol Violation|5|||
147341735|NCT01803555|531420025|FG000|Overall Study|Lost to Follow-up|0|||
147341736|NCT01803555|531420026|FG001|Overall Study|Lost to Follow-up|2|||
147341737|NCT01803555|531420025|FG000|Overall Study|Other than specified|3|||
147341738|NCT01803555|531420026|FG001|Overall Study|Other than specified|5|||
147606499|NCT01696058|532375236|FG000|Overall Study|Lack of Efficacy|2|||
147341739|NCT01551355|531420035|FG000|Overall Study|Lost to Follow-up|51|||
147341740|NCT01551355|531420036|FG001|Overall Study|Lost to Follow-up|49|||
147606500|NCT01696058|532375237|FG001|Overall Study|Lack of Efficacy|3|||
147341741|NCT01551355|531420037|FG002|Overall Study|Lost to Follow-up|34|||
147341742|NCT01551355|531420038|FG003|Overall Study|Lost to Follow-up|24|||
147606501|NCT01696058|532375236|FG000|Overall Study|Protocol Violation|9|||
147606502|NCT01696058|532375237|FG001|Overall Study|Protocol Violation|3|||
147341743|NCT01551355|531420039|FG004|Overall Study|Lost to Follow-up|9|||
147341744|NCT01551355|531420040|FG005|Overall Study|Lost to Follow-up|6|||
147341745|NCT01094184|531420041|FG000|Overall Study|Death|35|||
147341746|NCT01094184|531420042|FG001|Overall Study|Death|11|||
147341747|NCT04766034|531420043|FG000|Aim 2 - Pre-Randomization Survey|Never been enrolled in SNAP and/or live in a household with at least 4 people|0|||
147341748|NCT04766034|531420044|FG001|Aim 2 - Pre-Randomization Survey|Never been enrolled in SNAP and/or live in a household with at least 4 people|0|||
147341749|NCT04766034|531420045|FG002|Aim 2 - Pre-Randomization Survey|Never been enrolled in SNAP and/or live in a household with at least 4 people|0|||
147341750|NCT04766034|531420046|FG003|Aim 2 - Pre-Randomization Survey|Never been enrolled in SNAP and/or live in a household with at least 4 people|0|||
147341751|NCT04766034|531420047|FG004|Aim 2 - Pre-Randomization Survey|Never been enrolled in SNAP and/or live in a household with at least 4 people|3752|||
147341752|NCT04766034|531420043|FG000|Aim 2 - Pre-Randomization Survey|Did not finish survey|0|||
147341753|NCT04766034|531420044|FG001|Aim 2 - Pre-Randomization Survey|Did not finish survey|0|||
147341754|NCT04766034|531420045|FG002|Aim 2 - Pre-Randomization Survey|Did not finish survey|0|||
147341755|NCT04766034|531420046|FG003|Aim 2 - Pre-Randomization Survey|Did not finish survey|0|||
147341756|NCT04766034|531420047|FG004|Aim 2 - Pre-Randomization Survey|Did not finish survey|120|||
147341757|NCT04766034|531420043|FG000|Aim 3 - Randomization/Online Shopping|Reused same IP address, and/or finished the survey in under one-third of median completion time|67|||
147341758|NCT04766034|531420044|FG001|Aim 3 - Randomization/Online Shopping|Reused same IP address, and/or finished the survey in under one-third of median completion time|86|||
147341759|NCT04766034|531420045|FG002|Aim 3 - Randomization/Online Shopping|Reused same IP address, and/or finished the survey in under one-third of median completion time|75|||
147341760|NCT04766034|531420046|FG003|Aim 3 - Randomization/Online Shopping|Reused same IP address, and/or finished the survey in under one-third of median completion time|84|||
147341761|NCT04766034|531420047|FG004|Aim 3 - Randomization/Online Shopping|Reused same IP address, and/or finished the survey in under one-third of median completion time|0|||
147341762|NCT04766034|531420043|FG000|Aim 3 - Randomization/Online Shopping|Did not finish the shopping task|206|||
147341763|NCT04766034|531420044|FG001|Aim 3 - Randomization/Online Shopping|Did not finish the shopping task|223|||
147341764|NCT04766034|531420045|FG002|Aim 3 - Randomization/Online Shopping|Did not finish the shopping task|155|||
147341765|NCT04766034|531420046|FG003|Aim 3 - Randomization/Online Shopping|Did not finish the shopping task|198|||
147341766|NCT04766034|531420047|FG004|Aim 3 - Randomization/Online Shopping|Did not finish the shopping task|0|||
147341767|NCT00823472|531420048|FG000|Overall Study|Physician Decision|24|||
147341768|NCT00823472|531420049|FG001|Overall Study|Physician Decision|28|||
147341769|NCT04019444|531420050|FG000|Overall Study|Withdrawal by Subject|0|||
147341770|NCT04019444|531420051|FG001|Overall Study|Withdrawal by Subject|1|||
147341771|NCT04019444|531420052|FG002|Overall Study|Withdrawal by Subject|0|||
147341772|NCT04019444|531420053|FG003|Overall Study|Withdrawal by Subject|1|||
147341773|NCT04019444|531420050|FG000|Overall Study|Solicited Event|0|||
147341774|NCT04019444|531420051|FG001|Overall Study|Solicited Event|0|||
147341775|NCT04019444|531420052|FG002|Overall Study|Solicited Event|2|||
147341776|NCT04019444|531420053|FG003|Overall Study|Solicited Event|0|||
147341777|NCT04992390|531420059|FG000|Run-In/Screening Week|Recorded fewer than three intrusive memories|0|||
147341778|NCT04992390|531420060|FG001|Run-In/Screening Week|Recorded fewer than three intrusive memories|0|||
147341779|NCT04992390|531420061|FG002|Run-In/Screening Week|Recorded fewer than three intrusive memories|7|||
147341780|NCT04992390|531420059|FG000|Run-In/Screening Week|Lost to Follow-up|0|||
147341781|NCT04992390|531420060|FG001|Run-In/Screening Week|Lost to Follow-up|0|||
147341782|NCT04992390|531420061|FG002|Run-In/Screening Week|Lost to Follow-up|6|||
147341783|NCT04992390|531420059|FG000|Run-In/Screening Week|Withdrawal by Subject|0|||
147341784|NCT04992390|531420060|FG001|Run-In/Screening Week|Withdrawal by Subject|0|||
147341785|NCT04992390|531420061|FG002|Run-In/Screening Week|Withdrawal by Subject|1|||
147341786|NCT04992390|531420059|FG000|Baseline Questionnaires|Lost to Follow-up|0|||
147341787|NCT04992390|531420060|FG001|Baseline Questionnaires|Lost to Follow-up|0|||
147341788|NCT04992390|531420061|FG002|Baseline Questionnaires|Lost to Follow-up|1|||
147341789|NCT04992390|531420059|FG000|Baseline Questionnaires|Withdrawal by Subject|0|||
147341790|NCT04992390|531420060|FG001|Baseline Questionnaires|Withdrawal by Subject|0|||
147341791|NCT04992390|531420061|FG002|Baseline Questionnaires|Withdrawal by Subject|1|||
147341792|NCT04992390|531420059|FG000|Week 4 Primary Outcome|Lost to Follow-up|3|||
147341793|NCT04992390|531420060|FG001|Week 4 Primary Outcome|Lost to Follow-up|2|||
147341794|NCT04992390|531420061|FG002|Week 4 Primary Outcome|Lost to Follow-up|0|||
147341795|NCT04992390|531420059|FG000|Week 4 Primary Outcome|Withdrawal by Subject|0|||
147341796|NCT04992390|531420060|FG001|Week 4 Primary Outcome|Withdrawal by Subject|2|||
147606503|NCT01696058|532375236|FG000|Overall Study|Lost to Follow-up|2|||
147606504|NCT01696058|532375237|FG001|Overall Study|Lost to Follow-up|5|||
147606505|NCT01696058|532375236|FG000|Overall Study|Withdrawal by Subject|4|||
147606506|NCT01696058|532375237|FG001|Overall Study|Withdrawal by Subject|6|||
147606507|NCT01696058|532375236|FG000|Overall Study|Other reason prematurely discontinued|5|||
147606508|NCT01696058|532375237|FG001|Overall Study|Other reason prematurely discontinued|3|||
147606509|NCT01934335|532375238|FG000|Overall Study|Withdrawal by Subject|1|||
147341797|NCT04992390|531420061|FG002|Week 4 Primary Outcome|Withdrawal by Subject|0|||
147341798|NCT04992390|531420059|FG000|Week 4 Primary Outcome|Did not complete week 4 diary but not lost to follow-up|1|||
147341799|NCT04992390|531420060|FG001|Week 4 Primary Outcome|Did not complete week 4 diary but not lost to follow-up|0|||
147341800|NCT04992390|531420061|FG002|Week 4 Primary Outcome|Did not complete week 4 diary but not lost to follow-up|0|||
147341801|NCT04992390|531420059|FG000|Week 4 Secondary Outcomes|Lost to Follow-up|3|||
147341802|NCT04992390|531420060|FG001|Week 4 Secondary Outcomes|Lost to Follow-up|0|||
147341803|NCT04992390|531420061|FG002|Week 4 Secondary Outcomes|Lost to Follow-up|0|||
147341804|NCT04992390|531420059|FG000|Week 4 Secondary Outcomes|Withdrawal by Subject|1|||
147341805|NCT04992390|531420060|FG001|Week 4 Secondary Outcomes|Withdrawal by Subject|0|||
147341806|NCT04992390|531420061|FG002|Week 4 Secondary Outcomes|Withdrawal by Subject|0|||
147341807|NCT04992390|531420059|FG000|Week 4 Secondary Outcomes|Secondary questionnaires missing/partially complete|5|||
147341808|NCT04992390|531420060|FG001|Week 4 Secondary Outcomes|Secondary questionnaires missing/partially complete|1|||
147341809|NCT04992390|531420061|FG002|Week 4 Secondary Outcomes|Secondary questionnaires missing/partially complete|0|||
147341810|NCT04992390|531420059|FG000|Delayed Arm Receive Intervention|Withdrawal by Subject|0|||
147341811|NCT04992390|531420060|FG001|Delayed Arm Receive Intervention|Withdrawal by Subject|1|||
147341812|NCT04992390|531420061|FG002|Delayed Arm Receive Intervention|Withdrawal by Subject|0|||
147341813|NCT04992390|531420059|FG000|Week 8 Replication After Crossover|Lost to Follow-up|0|||
147341814|NCT04992390|531420060|FG001|Week 8 Replication After Crossover|Lost to Follow-up|4|||
147341815|NCT04992390|531420061|FG002|Week 8 Replication After Crossover|Lost to Follow-up|0|||
147341816|NCT04992390|531420059|FG000|Week 8 Replication After Crossover|Withdrawal by Subject|0|||
147341817|NCT04992390|531420060|FG001|Week 8 Replication After Crossover|Withdrawal by Subject|2|||
147341818|NCT04992390|531420061|FG002|Week 8 Replication After Crossover|Withdrawal by Subject|0|||
147341819|NCT04992390|531420059|FG000|Week 8 - Other Secondary Outcomes|Lost to Follow-up|2|||
147341820|NCT04992390|531420060|FG001|Week 8 - Other Secondary Outcomes|Lost to Follow-up|0|||
147341821|NCT04992390|531420061|FG002|Week 8 - Other Secondary Outcomes|Lost to Follow-up|0|||
147341822|NCT04992390|531420059|FG000|Week 8 - Other Secondary Outcomes|Secondary questionnaires partially complete|0|||
147341823|NCT04992390|531420060|FG001|Week 8 - Other Secondary Outcomes|Secondary questionnaires partially complete|3|||
147341824|NCT04992390|531420061|FG002|Week 8 - Other Secondary Outcomes|Secondary questionnaires partially complete|0|||
147341825|NCT03807778|531420064|FG000|Overall Study|Adverse Event|0|||
147341826|NCT03807778|531420065|FG001|Overall Study|Adverse Event|0|||
147341827|NCT03807778|531420066|FG002|Overall Study|Adverse Event|3|||
147341828|NCT03807778|531420067|FG003|Overall Study|Adverse Event|5|||
147341829|NCT03807778|531420064|FG000|Overall Study|Progressive Disease|4|||
147341830|NCT03807778|531420065|FG001|Overall Study|Progressive Disease|2|||
147341831|NCT03807778|531420066|FG002|Overall Study|Progressive Disease|8|||
147341832|NCT03807778|531420067|FG003|Overall Study|Progressive Disease|15|||
147341833|NCT03807778|531420064|FG000|Overall Study|Symptomatic Deterioration|0|||
147341834|NCT03807778|531420065|FG001|Overall Study|Symptomatic Deterioration|1|||
147341835|NCT03807778|531420066|FG002|Overall Study|Symptomatic Deterioration|0|||
147341836|NCT03807778|531420067|FG003|Overall Study|Symptomatic Deterioration|1|||
147341837|NCT03807778|531420064|FG000|Overall Study|Withdrawal by Subject|0|||
147341838|NCT03807778|531420065|FG001|Overall Study|Withdrawal by Subject|1|||
147341839|NCT03807778|531420066|FG002|Overall Study|Withdrawal by Subject|0|||
147341840|NCT03807778|531420067|FG003|Overall Study|Withdrawal by Subject|1|||
147341841|NCT03807778|531420064|FG000|Overall Study|Ongoing at data cut- off date (08 November 2021)|0|||
147341842|NCT03807778|531420065|FG001|Overall Study|Ongoing at data cut- off date (08 November 2021)|0|||
147341843|NCT03807778|531420066|FG002|Overall Study|Ongoing at data cut- off date (08 November 2021)|1|||
147341844|NCT03807778|531420067|FG003|Overall Study|Ongoing at data cut- off date (08 November 2021)|11|||
147341845|NCT05094141|531420068|FG000|Overall Study|Death|0|||
147341846|NCT05094141|531420069|FG001|Overall Study|Death|0|||
147341847|NCT05094141|531420070|FG002|Overall Study|Death|1|||
147341848|NCT05094141|531420068|FG000|Overall Study|Withdrawal by Subject|0|||
147341849|NCT05094141|531420069|FG001|Overall Study|Withdrawal by Subject|0|||
147341850|NCT05094141|531420070|FG002|Overall Study|Withdrawal by Subject|1|||
147341851|NCT05094141|531420068|FG000|Overall Study|Subject did not want to wear the VR Helmet|0|||
147341852|NCT05094141|531420069|FG001|Overall Study|Subject did not want to wear the VR Helmet|0|||
147341853|NCT05094141|531420070|FG002|Overall Study|Subject did not want to wear the VR Helmet|2|||
147341854|NCT05094141|531420068|FG000|Overall Study|Did not participate in randomization|0|||
147341855|NCT05094141|531420069|FG001|Overall Study|Did not participate in randomization|0|||
147341856|NCT05094141|531420070|FG002|Overall Study|Did not participate in randomization|33|||
147341857|NCT01216176|531422391|FG000|Overall Study|Adverse Event|0|||
147341858|NCT01216176|531422392|FG001|Overall Study|Adverse Event|8|||
147341859|NCT01216176|531422393|FG002|Overall Study|Adverse Event|0|||
147341860|NCT01216176|531422391|FG000|Overall Study|Physician Decision|0|||
147341861|NCT01216176|531422392|FG001|Overall Study|Physician Decision|0|||
147341862|NCT01216176|531422393|FG002|Overall Study|Physician Decision|1|||
147341863|NCT01600014|531422396|FG000|1. Cycle & Observation Period D1 to W52|Withdrawal by Subject|24|||
147341864|NCT01600014|531422397|FG001|1. Cycle & Observation Period D1 to W52|Withdrawal by Subject|0|||
147341865|NCT01600014|531422396|FG000|1. Cycle & Observation Period D1 to W52|Included in 2nd cycle|203|||
147341866|NCT01600014|531422397|FG001|1. Cycle & Observation Period D1 to W52|Included in 2nd cycle|0|||
147341867|NCT01600014|531422396|FG000|1. Cycle & Observation Period D1 to W52|Adverse Event|6|||
147341868|NCT01600014|531422397|FG001|1. Cycle & Observation Period D1 to W52|Adverse Event|0|||
147341869|NCT01600014|531422396|FG000|1. Cycle & Observation Period D1 to W52|Other|27|||
147341870|NCT01600014|531422397|FG001|1. Cycle & Observation Period D1 to W52|Other|0|||
147341871|NCT01600014|531422396|FG000|1. Cycle & Observation Period D1 to W52|Exclusion Criteria Emerging during Study|14|||
147341872|NCT01600014|531422397|FG001|1. Cycle & Observation Period D1 to W52|Exclusion Criteria Emerging during Study|0|||
147341873|NCT01600014|531422396|FG000|1. Cycle & Observation Period D1 to W52|Protocol Violation|6|||
147341874|NCT01600014|531422397|FG001|1. Cycle & Observation Period D1 to W52|Protocol Violation|0|||
147341875|NCT01600014|531422396|FG000|1. Cycle & Observation Period D1 to W52|Lost to Follow-up|8|||
147341876|NCT01600014|531422397|FG001|1. Cycle & Observation Period D1 to W52|Lost to Follow-up|0|||
147341877|NCT01600014|531422396|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Death|1|||
147341878|NCT01600014|531422397|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Death|2|||
147341879|NCT01600014|531422396|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Other|1|||
147341880|NCT01600014|531422397|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Other|3|||
147341881|NCT01600014|531422396|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Withdrawal by Subject|2|||
147341882|NCT01600014|531422397|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Withdrawal by Subject|1|||
147341883|NCT01600014|531422396|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Lack of Efficacy|1|||
147341884|NCT01600014|531422397|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Lack of Efficacy|0|||
147341885|NCT01600014|531422396|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Protocol Violation|5|||
147341886|NCT01600014|531422397|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Protocol Violation|0|||
147341887|NCT01600014|531422396|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Exclusion Criteria Emerging during Study|1|||
147341888|NCT01600014|531422397|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Exclusion Criteria Emerging during Study|1|||
147341889|NCT01600014|531422396|FG000|2. Cycle Recalcitrant Subgroup W8 to W52|Lost to Follow-up|1|||
147341890|NCT01600014|531422397|FG001|2. Cycle Recalcitrant Subgroup W8 to W52|Lost to Follow-up|3|||
147341891|NCT01600014|531422396|FG000|2. Cycl Recurrent Subgroup W26/44 to W52|Adverse Event|1|||
147341892|NCT01600014|531422397|FG001|2. Cycl Recurrent Subgroup W26/44 to W52|Adverse Event|0|||
147341893|NCT01600014|531422396|FG000|2. Cycl Recurrent Subgroup W26/44 to W52|Withdrawal by Subject|1|||
147341894|NCT01600014|531422397|FG001|2. Cycl Recurrent Subgroup W26/44 to W52|Withdrawal by Subject|0|||
147341895|NCT01600014|531422396|FG000|2. Cycl Recurrent Subgroup W26/44 to W52|Lost to Follow-up|1|||
147341896|NCT01600014|531422397|FG001|2. Cycl Recurrent Subgroup W26/44 to W52|Lost to Follow-up|0|||
147341897|NCT04278586|531422400|FG000|Overall Study|Withdrawal by Subject|13|||
147341898|NCT04278586|531422401|FG001|Overall Study|Withdrawal by Subject|6|||
147341899|NCT04278586|531422400|FG000|Overall Study|Lost to Follow-up|37|||
147341900|NCT04278586|531422401|FG001|Overall Study|Lost to Follow-up|24|||
147341901|NCT02791230|531422402|FG000|Overall Study|Adverse Event|10|||
147341902|NCT02791230|531422403|FG001|Overall Study|Adverse Event|9|||
147341903|NCT02791230|531422404|FG002|Overall Study|Adverse Event|66|||
147341904|NCT02791230|531422402|FG000|Overall Study|Death|38|||
147341905|NCT02791230|531422403|FG001|Overall Study|Death|25|||
147341906|NCT02791230|531422404|FG002|Overall Study|Death|184|||
147341907|NCT02791230|531422402|FG000|Overall Study|Lack of Efficacy|1|||
147341908|NCT02791230|531422403|FG001|Overall Study|Lack of Efficacy|0|||
147341909|NCT02791230|531422404|FG002|Overall Study|Lack of Efficacy|3|||
147341910|NCT02791230|531422402|FG000|Overall Study|Lost to Follow-up|0|||
147341911|NCT02791230|531422403|FG001|Overall Study|Lost to Follow-up|0|||
147341912|NCT02791230|531422404|FG002|Overall Study|Lost to Follow-up|10|||
147341913|NCT02791230|531422402|FG000|Overall Study|Failure to Meet Randomization Criteria|3|||
147341914|NCT02791230|531422403|FG001|Overall Study|Failure to Meet Randomization Criteria|2|||
147341915|NCT02791230|531422404|FG002|Overall Study|Failure to Meet Randomization Criteria|15|||
147341916|NCT02791230|531422402|FG000|Overall Study|Medication Error Without Associated Adverse Event|0|||
147341917|NCT02791230|531422403|FG001|Overall Study|Medication Error Without Associated Adverse Event|1|||
147341918|NCT02791230|531422404|FG002|Overall Study|Medication Error Without Associated Adverse Event|1|||
147341919|NCT02791230|531422402|FG000|Overall Study|Study sites terminated by sponsor|1|||
147341920|NCT02791230|531422403|FG001|Overall Study|Study sites terminated by sponsor|0|||
147341921|NCT02791230|531422404|FG002|Overall Study|Study sites terminated by sponsor|5|||
147341922|NCT02791230|531422402|FG000|Overall Study|Other|9|||
147341923|NCT02791230|531422403|FG001|Overall Study|Other|1|||
147341924|NCT02791230|531422404|FG002|Overall Study|Other|28|||
147341925|NCT02791230|531422402|FG000|Overall Study|Protocol Violation|0|||
147453091|NCT01142726|531821537|FG000|Withdrawal Phase: Months 12 up to 24|Adverse Event|0|||
147606510|NCT01934335|532375239|FG001|Overall Study|Withdrawal by Subject|1|||
147341926|NCT02791230|531422403|FG001|Overall Study|Protocol Violation|0|||
147341927|NCT02791230|531422404|FG002|Overall Study|Protocol Violation|4|||
147341928|NCT02791230|531422402|FG000|Overall Study|Withdrawal by Subject|24|||
147341929|NCT02791230|531422403|FG001|Overall Study|Withdrawal by Subject|13|||
147341930|NCT02791230|531422404|FG002|Overall Study|Withdrawal by Subject|172|||
147341931|NCT02791230|531422402|FG000|Overall Study|Enrolled but not treated|0|||
147341932|NCT02791230|531422403|FG001|Overall Study|Enrolled but not treated|0|||
147341933|NCT02791230|531422404|FG002|Overall Study|Enrolled but not treated|5|||
147341934|NCT04201834|531422412|FG000|Overall Study|Screen fail|1|||
147341935|NCT04104321|531422415|FG000|Overall Study|didn't take the study drug|3|||
147341936|NCT04038957|531422416|FG000|Overall Study|Withdrawal by Subject|1|||
147341937|NCT04038957|531422416|FG000|Overall Study|SUBJECT WAS WITHDRAWN DUE TO SAFETY REASON|1|||
147341938|NCT04065048|531422417|FG000|Overall Study|Withdrawal by Subject|1|||
147341939|NCT04065048|531422418|FG001|Overall Study|Withdrawal by Subject|2|||
147341940|NCT04065048|531422419|FG002|Overall Study|Withdrawal by Subject|1|||
147341941|NCT04065048|531422420|FG003|Overall Study|Withdrawal by Subject|1|||
147341942|NCT04065048|531422417|FG000|Overall Study|Adverse Event|1|||
147341943|NCT04065048|531422418|FG001|Overall Study|Adverse Event|0|||
147341944|NCT04065048|531422419|FG002|Overall Study|Adverse Event|1|||
147341945|NCT04065048|531422420|FG003|Overall Study|Adverse Event|0|||
147341946|NCT03554265|531422422|FG000|Overall Study|Withdrawal by Subject|2|||
147341947|NCT03554265|531422423|FG001|Overall Study|Withdrawal by Subject|2|||
147341948|NCT03554265|531422424|FG002|Overall Study|Withdrawal by Subject|3|||
147341949|NCT03554265|531422422|FG000|Overall Study|Physician Decision|0|||
147341950|NCT03554265|531422423|FG001|Overall Study|Physician Decision|0|||
147341951|NCT03554265|531422424|FG002|Overall Study|Physician Decision|1|||
147341952|NCT02652260|531422425|FG000|Base Study|Pregnancy|0|||
147341953|NCT02652260|531422426|FG001|Base Study|Pregnancy|1|||
147341954|NCT02652260|531422425|FG000|Base Study|Withdrawal by Subject|0|||
147341955|NCT02652260|531422426|FG001|Base Study|Withdrawal by Subject|1|||
147341956|NCT02652260|531422425|FG000|Study Extension 1 (Open-Label)|Withdrawal by Subject|1|||
147341957|NCT02652260|531422426|FG001|Study Extension 1 (Open-Label)|Withdrawal by Subject|2|||
147341958|NCT02652260|531422425|FG000|Study Extension 1 (Open-Label)|Pregnancy|1|||
147341959|NCT02652260|531422426|FG001|Study Extension 1 (Open-Label)|Pregnancy|1|||
147341960|NCT02652260|531422425|FG000|Study Extension 1 (Open-Label)|Lack of Efficacy|1|||
147341961|NCT02652260|531422426|FG001|Study Extension 1 (Open-Label)|Lack of Efficacy|1|||
147341962|NCT02652260|531422425|FG000|Study Extension 1 (Open-Label)|Availability of study drug locally|1|||
147341963|NCT02652260|531422426|FG001|Study Extension 1 (Open-Label)|Availability of study drug locally|1|||
147453092|NCT01142726|531821538|FG001|Withdrawal Phase: Months 12 up to 24|Adverse Event|0|||
147341964|NCT02652260|531422425|FG000|Study Extension 1 (Open-Label)|Adverse Event|0|||
147341965|NCT02652260|531422426|FG001|Study Extension 1 (Open-Label)|Adverse Event|2|||
147341966|NCT02652260|531422425|FG000|Study Extension 2 (Open-Label)|Adverse Event|1|||
147341967|NCT02652260|531422426|FG001|Study Extension 2 (Open-Label)|Adverse Event|0|||
147341968|NCT02652260|531422425|FG000|Study Extension 2 (Open-Label)|Availability of study drug locally|18|||
147341969|NCT02652260|531422426|FG001|Study Extension 2 (Open-Label)|Availability of study drug locally|13|||
147341970|NCT02652260|531422425|FG000|Study Extension 2 (Open-Label)|Lost to Follow-up|1|||
147341971|NCT02652260|531422426|FG001|Study Extension 2 (Open-Label)|Lost to Follow-up|0|||
147341972|NCT02652260|531422425|FG000|Study Extension 2 (Open-Label)|Non-Compliance with study drug|1|||
147341973|NCT02652260|531422426|FG001|Study Extension 2 (Open-Label)|Non-Compliance with study drug|0|||
147341974|NCT02652260|531422425|FG000|Study Extension 2 (Open-Label)|Pregnancy|1|||
147341975|NCT02652260|531422426|FG001|Study Extension 2 (Open-Label)|Pregnancy|1|||
147341976|NCT02652260|531422425|FG000|Study Extension 3 (Open-Label)|Physician Decision|7|||
147341977|NCT02652260|531422426|FG001|Study Extension 3 (Open-Label)|Physician Decision|10|||
147341978|NCT02652260|531422425|FG000|Study Extension 3 (Open-Label)|Pregnancy|0|||
147341979|NCT02652260|531422426|FG001|Study Extension 3 (Open-Label)|Pregnancy|1|||
147341980|NCT02723955|531422427|FG000|Escalation Phase|Death|1|||
147341981|NCT02723955|531422428|FG001|Escalation Phase|Death|1|||
147341982|NCT02723955|531422429|FG002|Escalation Phase|Death|2|||
147341983|NCT02723955|531422430|FG003|Escalation Phase|Death|7|||
147341984|NCT02723955|531422431|FG004|Escalation Phase|Death|18|||
147341985|NCT02723955|531422432|FG005|Escalation Phase|Death|17|||
147341986|NCT02723955|531422433|FG006|Escalation Phase|Death|11|||
147341987|NCT02723955|531422434|FG007|Escalation Phase|Death|21|||
147341988|NCT02723955|531422435|FG008|Escalation Phase|Death|3|||
147341989|NCT02723955|531422436|FG009|Escalation Phase|Death|0|||
147341990|NCT02723955|531422437|FG010|Escalation Phase|Death|0|||
147341991|NCT02723955|531422438|FG011|Escalation Phase|Death|0|||
147341992|NCT02723955|531422439|FG012|Escalation Phase|Death|2|||
147341993|NCT02723955|531422440|FG013|Escalation Phase|Death|4|||
147341994|NCT02723955|531422441|FG014|Escalation Phase|Death|5|||
147341995|NCT02723955|531422442|FG015|Escalation Phase|Death|6|||
147341996|NCT02723955|531422443|FG016|Escalation Phase|Death|6|||
147341997|NCT02723955|531422444|FG017|Escalation Phase|Death|7|||
147341998|NCT02723955|531422445|FG018|Escalation Phase|Death|1|||
147341999|NCT02723955|531422446|FG019|Escalation Phase|Death|3|||
147342000|NCT02723955|531422447|FG020|Escalation Phase|Death|13|||
147342001|NCT02723955|531422448|FG021|Escalation Phase|Death|3|||
147342002|NCT02723955|531422449|FG022|Escalation Phase|Death|2|||
147342003|NCT02723955|531422450|FG023|Escalation Phase|Death|4|||
147342004|NCT02723955|531422451|FG024|Escalation Phase|Death|31|||
147342005|NCT02723955|531422452|FG025|Escalation Phase|Death|7|||
147342006|NCT02723955|531422453|FG026|Escalation Phase|Death|13|||
147342007|NCT02723955|531422454|FG027|Escalation Phase|Death|0|||
147342008|NCT02723955|531422455|FG028|Escalation Phase|Death|1|||
147606511|NCT01421511|532375240|FG000|Overall Study|Lost to Follow-up|11|||
147606512|NCT01421511|532375241|FG001|Overall Study|Lost to Follow-up|14|||
147606513|NCT01421511|532375240|FG000|Overall Study|Randomized but didn't receive study drug|1|||
147606514|NCT01421511|532375241|FG001|Overall Study|Randomized but didn't receive study drug|7|||
147606515|NCT01421511|532375240|FG000|Overall Study|Physician Decision|0|||
147606516|NCT01421511|532375241|FG001|Overall Study|Physician Decision|1|||
147606517|NCT01421511|532375240|FG000|Overall Study|Withdrawal by Subject|6|||
147606518|NCT01421511|532375241|FG001|Overall Study|Withdrawal by Subject|5|||
147342009|NCT02723955|531422456|FG029|Escalation Phase|Death|0|||
147342010|NCT02723955|531422457|FG030|Escalation Phase|Death|0|||
147342011|NCT02723955|531422458|FG031|Escalation Phase|Death|0|||
147342012|NCT02723955|531422459|FG032|Escalation Phase|Death|0|||
147342013|NCT02723955|531422460|FG033|Escalation Phase|Death|0|||
147342014|NCT02723955|531422461|FG034|Escalation Phase|Death|0|||
147342015|NCT02723955|531422462|FG035|Escalation Phase|Death|0|||
147342016|NCT02723955|531422463|FG036|Escalation Phase|Death|0|||
147342017|NCT02723955|531422464|FG037|Escalation Phase|Death|0|||
147342018|NCT02723955|531422465|FG038|Escalation Phase|Death|0|||
147342019|NCT02723955|531422466|FG039|Escalation Phase|Death|0|||
147342020|NCT02723955|531422467|FG040|Escalation Phase|Death|0|||
147342021|NCT02723955|531422468|FG041|Escalation Phase|Death|0|||
147342022|NCT02723955|531422469|FG042|Escalation Phase|Death|0|||
147342023|NCT02723955|531422427|FG000|Escalation Phase|Lost to Follow-up|0|||
147342024|NCT02723955|531422428|FG001|Escalation Phase|Lost to Follow-up|0|||
147342025|NCT02723955|531422429|FG002|Escalation Phase|Lost to Follow-up|0|||
147342026|NCT02723955|531422430|FG003|Escalation Phase|Lost to Follow-up|0|||
147342027|NCT02723955|531422431|FG004|Escalation Phase|Lost to Follow-up|0|||
147342028|NCT02723955|531422432|FG005|Escalation Phase|Lost to Follow-up|2|||
147342029|NCT02723955|531422433|FG006|Escalation Phase|Lost to Follow-up|1|||
147342030|NCT02723955|531422434|FG007|Escalation Phase|Lost to Follow-up|1|||
147342031|NCT02723955|531422435|FG008|Escalation Phase|Lost to Follow-up|1|||
147342032|NCT02723955|531422436|FG009|Escalation Phase|Lost to Follow-up|0|||
147342033|NCT02723955|531422437|FG010|Escalation Phase|Lost to Follow-up|0|||
147342034|NCT02723955|531422438|FG011|Escalation Phase|Lost to Follow-up|0|||
147342035|NCT02723955|531422439|FG012|Escalation Phase|Lost to Follow-up|1|||
147342036|NCT02723955|531422440|FG013|Escalation Phase|Lost to Follow-up|0|||
147342037|NCT02723955|531422441|FG014|Escalation Phase|Lost to Follow-up|0|||
147342038|NCT02723955|531422442|FG015|Escalation Phase|Lost to Follow-up|0|||
147342039|NCT02723955|531422443|FG016|Escalation Phase|Lost to Follow-up|1|||
147342040|NCT02723955|531422444|FG017|Escalation Phase|Lost to Follow-up|2|||
147342041|NCT02723955|531422445|FG018|Escalation Phase|Lost to Follow-up|0|||
147342042|NCT02723955|531422446|FG019|Escalation Phase|Lost to Follow-up|1|||
147342043|NCT02723955|531422447|FG020|Escalation Phase|Lost to Follow-up|2|||
147342044|NCT02723955|531422448|FG021|Escalation Phase|Lost to Follow-up|1|||
147342045|NCT02723955|531422449|FG022|Escalation Phase|Lost to Follow-up|0|||
147342046|NCT02723955|531422450|FG023|Escalation Phase|Lost to Follow-up|0|||
147342047|NCT02723955|531422451|FG024|Escalation Phase|Lost to Follow-up|1|||
147342048|NCT02723955|531422452|FG025|Escalation Phase|Lost to Follow-up|1|||
147342049|NCT02723955|531422453|FG026|Escalation Phase|Lost to Follow-up|3|||
147342050|NCT02723955|531422454|FG027|Escalation Phase|Lost to Follow-up|0|||
147342051|NCT02723955|531422455|FG028|Escalation Phase|Lost to Follow-up|1|||
147342052|NCT02723955|531422456|FG029|Escalation Phase|Lost to Follow-up|0|||
147342053|NCT02723955|531422457|FG030|Escalation Phase|Lost to Follow-up|0|||
147342054|NCT02723955|531422458|FG031|Escalation Phase|Lost to Follow-up|0|||
147342055|NCT02723955|531422459|FG032|Escalation Phase|Lost to Follow-up|0|||
147342056|NCT02723955|531422460|FG033|Escalation Phase|Lost to Follow-up|0|||
147342057|NCT02723955|531422461|FG034|Escalation Phase|Lost to Follow-up|0|||
147342058|NCT02723955|531422462|FG035|Escalation Phase|Lost to Follow-up|0|||
147342059|NCT02723955|531422463|FG036|Escalation Phase|Lost to Follow-up|0|||
147342060|NCT02723955|531422464|FG037|Escalation Phase|Lost to Follow-up|0|||
147342061|NCT02723955|531422465|FG038|Escalation Phase|Lost to Follow-up|0|||
147342062|NCT02723955|531422466|FG039|Escalation Phase|Lost to Follow-up|0|||
147342063|NCT02723955|531422467|FG040|Escalation Phase|Lost to Follow-up|0|||
147342064|NCT02723955|531422468|FG041|Escalation Phase|Lost to Follow-up|0|||
147342065|NCT02723955|531422469|FG042|Escalation Phase|Lost to Follow-up|0|||
147342066|NCT02723955|531422427|FG000|Escalation Phase|Physician Decision|0|||
147342067|NCT02723955|531422428|FG001|Escalation Phase|Physician Decision|0|||
147342068|NCT02723955|531422429|FG002|Escalation Phase|Physician Decision|0|||
147342069|NCT02723955|531422430|FG003|Escalation Phase|Physician Decision|0|||
147606519|NCT01421511|532375240|FG000|Overall Study|Death|1|||
147606520|NCT01421511|532375241|FG001|Overall Study|Death|1|||
147606521|NCT05384171|532375242|FG000|Overall Study|Lost to Follow-up|9|||
147342070|NCT02723955|531422431|FG004|Escalation Phase|Physician Decision|0|||
147342071|NCT02723955|531422432|FG005|Escalation Phase|Physician Decision|2|||
147342072|NCT02723955|531422433|FG006|Escalation Phase|Physician Decision|0|||
147342073|NCT02723955|531422434|FG007|Escalation Phase|Physician Decision|0|||
147342074|NCT02723955|531422435|FG008|Escalation Phase|Physician Decision|0|||
147342075|NCT02723955|531422436|FG009|Escalation Phase|Physician Decision|0|||
147342076|NCT02723955|531422437|FG010|Escalation Phase|Physician Decision|0|||
147342077|NCT02723955|531422438|FG011|Escalation Phase|Physician Decision|0|||
147342078|NCT02723955|531422439|FG012|Escalation Phase|Physician Decision|0|||
147342079|NCT02723955|531422440|FG013|Escalation Phase|Physician Decision|0|||
147342080|NCT02723955|531422441|FG014|Escalation Phase|Physician Decision|0|||
147342081|NCT02723955|531422442|FG015|Escalation Phase|Physician Decision|0|||
147342082|NCT02723955|531422443|FG016|Escalation Phase|Physician Decision|0|||
147342083|NCT02723955|531422444|FG017|Escalation Phase|Physician Decision|0|||
147342084|NCT02723955|531422445|FG018|Escalation Phase|Physician Decision|0|||
147342085|NCT02723955|531422446|FG019|Escalation Phase|Physician Decision|0|||
147342086|NCT02723955|531422447|FG020|Escalation Phase|Physician Decision|0|||
147342087|NCT02723955|531422448|FG021|Escalation Phase|Physician Decision|0|||
147342088|NCT02723955|531422449|FG022|Escalation Phase|Physician Decision|0|||
147342089|NCT02723955|531422450|FG023|Escalation Phase|Physician Decision|0|||
147342090|NCT02723955|531422451|FG024|Escalation Phase|Physician Decision|0|||
147342091|NCT02723955|531422452|FG025|Escalation Phase|Physician Decision|0|||
147342092|NCT02723955|531422453|FG026|Escalation Phase|Physician Decision|2|||
147342093|NCT02723955|531422454|FG027|Escalation Phase|Physician Decision|0|||
147342094|NCT02723955|531422455|FG028|Escalation Phase|Physician Decision|0|||
147342095|NCT02723955|531422456|FG029|Escalation Phase|Physician Decision|0|||
147342096|NCT02723955|531422457|FG030|Escalation Phase|Physician Decision|0|||
147342097|NCT02723955|531422458|FG031|Escalation Phase|Physician Decision|0|||
147342098|NCT02723955|531422459|FG032|Escalation Phase|Physician Decision|0|||
147342099|NCT02723955|531422460|FG033|Escalation Phase|Physician Decision|0|||
147606522|NCT05384171|532375243|FG001|Overall Study|Lost to Follow-up|9|||
147606523|NCT05384171|532375242|FG000|Overall Study|Withdrawal by Subject|3|||
147606524|NCT05384171|532375243|FG001|Overall Study|Withdrawal by Subject|0|||
147342100|NCT02723955|531422461|FG034|Escalation Phase|Physician Decision|0|||
147342101|NCT02723955|531422462|FG035|Escalation Phase|Physician Decision|0|||
147342102|NCT02723955|531422463|FG036|Escalation Phase|Physician Decision|0|||
147342103|NCT02723955|531422464|FG037|Escalation Phase|Physician Decision|0|||
147342104|NCT02723955|531422465|FG038|Escalation Phase|Physician Decision|0|||
147342105|NCT02723955|531422466|FG039|Escalation Phase|Physician Decision|0|||
147342106|NCT02723955|531422467|FG040|Escalation Phase|Physician Decision|0|||
147342107|NCT02723955|531422468|FG041|Escalation Phase|Physician Decision|0|||
147342108|NCT02723955|531422469|FG042|Escalation Phase|Physician Decision|0|||
147342109|NCT02723955|531422427|FG000|Escalation Phase|Withdrawal by Subject|0|||
147342110|NCT02723955|531422428|FG001|Escalation Phase|Withdrawal by Subject|0|||
147342111|NCT02723955|531422429|FG002|Escalation Phase|Withdrawal by Subject|0|||
147342112|NCT02723955|531422430|FG003|Escalation Phase|Withdrawal by Subject|0|||
147342113|NCT02723955|531422431|FG004|Escalation Phase|Withdrawal by Subject|1|||
147342114|NCT02723955|531422432|FG005|Escalation Phase|Withdrawal by Subject|1|||
147342115|NCT02723955|531422433|FG006|Escalation Phase|Withdrawal by Subject|1|||
147342116|NCT02723955|531422434|FG007|Escalation Phase|Withdrawal by Subject|1|||
147342117|NCT02723955|531422435|FG008|Escalation Phase|Withdrawal by Subject|0|||
147342118|NCT02723955|531422436|FG009|Escalation Phase|Withdrawal by Subject|0|||
147342119|NCT02723955|531422437|FG010|Escalation Phase|Withdrawal by Subject|0|||
147342120|NCT02723955|531422438|FG011|Escalation Phase|Withdrawal by Subject|0|||
147342121|NCT02723955|531422439|FG012|Escalation Phase|Withdrawal by Subject|1|||
147342122|NCT02723955|531422440|FG013|Escalation Phase|Withdrawal by Subject|0|||
147342123|NCT02723955|531422441|FG014|Escalation Phase|Withdrawal by Subject|0|||
147342124|NCT02723955|531422442|FG015|Escalation Phase|Withdrawal by Subject|0|||
147342125|NCT02723955|531422443|FG016|Escalation Phase|Withdrawal by Subject|1|||
147342126|NCT02723955|531422444|FG017|Escalation Phase|Withdrawal by Subject|0|||
147342127|NCT02723955|531422445|FG018|Escalation Phase|Withdrawal by Subject|0|||
147342128|NCT02723955|531422446|FG019|Escalation Phase|Withdrawal by Subject|0|||
147342129|NCT02723955|531422447|FG020|Escalation Phase|Withdrawal by Subject|0|||
147342130|NCT02723955|531422448|FG021|Escalation Phase|Withdrawal by Subject|0|||
147606525|NCT00749892|532375244|FG000|Overall Study|Withdrawal by Subject|3|||
147342131|NCT02723955|531422449|FG022|Escalation Phase|Withdrawal by Subject|0|||
147342132|NCT02723955|531422450|FG023|Escalation Phase|Withdrawal by Subject|2|||
147342133|NCT02723955|531422451|FG024|Escalation Phase|Withdrawal by Subject|0|||
147342134|NCT02723955|531422452|FG025|Escalation Phase|Withdrawal by Subject|1|||
147342135|NCT02723955|531422453|FG026|Escalation Phase|Withdrawal by Subject|0|||
147342136|NCT02723955|531422454|FG027|Escalation Phase|Withdrawal by Subject|0|||
147342137|NCT02723955|531422455|FG028|Escalation Phase|Withdrawal by Subject|1|||
147342138|NCT02723955|531422456|FG029|Escalation Phase|Withdrawal by Subject|0|||
147342139|NCT02723955|531422457|FG030|Escalation Phase|Withdrawal by Subject|0|||
147342140|NCT02723955|531422458|FG031|Escalation Phase|Withdrawal by Subject|0|||
147342141|NCT02723955|531422459|FG032|Escalation Phase|Withdrawal by Subject|0|||
147342142|NCT02723955|531422460|FG033|Escalation Phase|Withdrawal by Subject|0|||
147342143|NCT02723955|531422461|FG034|Escalation Phase|Withdrawal by Subject|0|||
147342144|NCT02723955|531422462|FG035|Escalation Phase|Withdrawal by Subject|0|||
147606526|NCT04581369|532375245|FG000|Overall Study|Death|7|||
147342145|NCT02723955|531422463|FG036|Escalation Phase|Withdrawal by Subject|0|||
147606527|NCT04581369|532375246|FG001|Overall Study|Death|6|||
147342146|NCT02723955|531422464|FG037|Escalation Phase|Withdrawal by Subject|0|||
147342147|NCT02723955|531422465|FG038|Escalation Phase|Withdrawal by Subject|0|||
147342148|NCT02723955|531422466|FG039|Escalation Phase|Withdrawal by Subject|0|||
147342149|NCT02723955|531422467|FG040|Escalation Phase|Withdrawal by Subject|0|||
147342150|NCT02723955|531422468|FG041|Escalation Phase|Withdrawal by Subject|0|||
147342151|NCT02723955|531422469|FG042|Escalation Phase|Withdrawal by Subject|0|||
147342152|NCT02723955|531422427|FG000|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
147342153|NCT02723955|531422428|FG001|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
147342154|NCT02723955|531422429|FG002|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
147342155|NCT02723955|531422430|FG003|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
147342156|NCT02723955|531422431|FG004|Escalation Phase|Participants were crossed over OR were re-treated following progression|5|||
147342157|NCT02723955|531422432|FG005|Escalation Phase|Participants were crossed over OR were re-treated following progression|2|||
147342158|NCT02723955|531422433|FG006|Escalation Phase|Participants were crossed over OR were re-treated following progression|2|||
147342159|NCT02723955|531422434|FG007|Escalation Phase|Participants were crossed over OR were re-treated following progression|4|||
147342160|NCT02723955|531422435|FG008|Escalation Phase|Participants were crossed over OR were re-treated following progression|3|||
147342161|NCT02723955|531422436|FG009|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
147342162|NCT02723955|531422437|FG010|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
147342163|NCT02723955|531422438|FG011|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
147342164|NCT02723955|531422439|FG012|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
147342165|NCT02723955|531422440|FG013|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
147342166|NCT02723955|531422441|FG014|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
147342167|NCT02723955|531422442|FG015|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
147342168|NCT02723955|531422443|FG016|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
147342169|NCT02723955|531422444|FG017|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
147342170|NCT02723955|531422445|FG018|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
147342171|NCT02723955|531422446|FG019|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
147342172|NCT02723955|531422447|FG020|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
147342173|NCT02723955|531422448|FG021|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
147342174|NCT02723955|531422449|FG022|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
147342175|NCT02723955|531422450|FG023|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
147342176|NCT02723955|531422451|FG024|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
147342177|NCT02723955|531422452|FG025|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
147342178|NCT02723955|531422453|FG026|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
147342179|NCT02723955|531422454|FG027|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
147342180|NCT02723955|531422455|FG028|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
147342181|NCT02723955|531422456|FG029|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
147342182|NCT02723955|531422457|FG030|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
147342183|NCT02723955|531422458|FG031|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
147342184|NCT02723955|531422459|FG032|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
147606528|NCT04581369|532375247|FG002|Overall Study|Death|0|||
147606529|NCT04581369|532375245|FG000|Overall Study|Lost to Follow-up|7|||
147606530|NCT04581369|532375246|FG001|Overall Study|Lost to Follow-up|3|||
147606531|NCT04581369|532375247|FG002|Overall Study|Lost to Follow-up|0|||
147606532|NCT04581369|532375245|FG000|Overall Study|liver transplant|2|||
147606533|NCT04581369|532375246|FG001|Overall Study|liver transplant|2|||
147606534|NCT04581369|532375247|FG002|Overall Study|liver transplant|0|||
147606535|NCT04581369|532375245|FG000|Overall Study|transitioned to hospice care|0|||
147662715|NCT02227784|532587413|FG001|Double-Blind Phase|Physician Decision|0|||
147342185|NCT02723955|531422460|FG033|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
147342186|NCT02723955|531422461|FG034|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
147342187|NCT02723955|531422462|FG035|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
147342188|NCT02723955|531422463|FG036|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
147342189|NCT02723955|531422464|FG037|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
147342190|NCT02723955|531422465|FG038|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
147342191|NCT02723955|531422466|FG039|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
147606536|NCT04581369|532375246|FG001|Overall Study|transitioned to hospice care|5|||
147606537|NCT04581369|532375247|FG002|Overall Study|transitioned to hospice care|0|||
147606538|NCT00780910|532375248|FG000|Overall Study|Adverse Event|2|||
147342192|NCT02723955|531422467|FG040|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
147342193|NCT02723955|531422468|FG041|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
147342194|NCT02723955|531422469|FG042|Escalation Phase|Participants were crossed over OR were re-treated following progression|0|||
147342195|NCT02723955|531422427|FG000|Escalation Phase|Site Closed|0|||
147342196|NCT02723955|531422428|FG001|Escalation Phase|Site Closed|0|||
147342197|NCT02723955|531422429|FG002|Escalation Phase|Site Closed|0|||
147342198|NCT02723955|531422430|FG003|Escalation Phase|Site Closed|0|||
147342199|NCT02723955|531422431|FG004|Escalation Phase|Site Closed|0|||
147342200|NCT02723955|531422432|FG005|Escalation Phase|Site Closed|0|||
147342201|NCT02723955|531422433|FG006|Escalation Phase|Site Closed|0|||
147342202|NCT02723955|531422434|FG007|Escalation Phase|Site Closed|0|||
147342203|NCT02723955|531422435|FG008|Escalation Phase|Site Closed|0|||
147342204|NCT02723955|531422436|FG009|Escalation Phase|Site Closed|0|||
147342205|NCT02723955|531422437|FG010|Escalation Phase|Site Closed|0|||
147342206|NCT02723955|531422438|FG011|Escalation Phase|Site Closed|0|||
147342207|NCT02723955|531422439|FG012|Escalation Phase|Site Closed|0|||
147342208|NCT02723955|531422440|FG013|Escalation Phase|Site Closed|0|||
147342209|NCT02723955|531422441|FG014|Escalation Phase|Site Closed|0|||
147342210|NCT02723955|531422442|FG015|Escalation Phase|Site Closed|1|||
147342211|NCT02723955|531422443|FG016|Escalation Phase|Site Closed|0|||
147342212|NCT02723955|531422444|FG017|Escalation Phase|Site Closed|2|||
147342213|NCT02723955|531422445|FG018|Escalation Phase|Site Closed|0|||
147342214|NCT02723955|531422446|FG019|Escalation Phase|Site Closed|0|||
147342215|NCT02723955|531422447|FG020|Escalation Phase|Site Closed|1|||
147342216|NCT02723955|531422448|FG021|Escalation Phase|Site Closed|0|||
147342217|NCT02723955|531422449|FG022|Escalation Phase|Site Closed|0|||
147342218|NCT02723955|531422450|FG023|Escalation Phase|Site Closed|0|||
147342219|NCT02723955|531422451|FG024|Escalation Phase|Site Closed|3|||
147342220|NCT02723955|531422452|FG025|Escalation Phase|Site Closed|1|||
147342221|NCT02723955|531422453|FG026|Escalation Phase|Site Closed|3|||
147342222|NCT02723955|531422454|FG027|Escalation Phase|Site Closed|1|||
147342223|NCT02723955|531422455|FG028|Escalation Phase|Site Closed|1|||
147342224|NCT02723955|531422456|FG029|Escalation Phase|Site Closed|0|||
147342225|NCT02723955|531422457|FG030|Escalation Phase|Site Closed|0|||
147342226|NCT02723955|531422458|FG031|Escalation Phase|Site Closed|0|||
147342227|NCT02723955|531422459|FG032|Escalation Phase|Site Closed|0|||
147342228|NCT02723955|531422460|FG033|Escalation Phase|Site Closed|0|||
147342229|NCT02723955|531422461|FG034|Escalation Phase|Site Closed|0|||
147342230|NCT02723955|531422462|FG035|Escalation Phase|Site Closed|0|||
147342231|NCT02723955|531422463|FG036|Escalation Phase|Site Closed|0|||
147342232|NCT02723955|531422464|FG037|Escalation Phase|Site Closed|0|||
147342233|NCT02723955|531422465|FG038|Escalation Phase|Site Closed|0|||
147342234|NCT02723955|531422466|FG039|Escalation Phase|Site Closed|0|||
147342235|NCT02723955|531422467|FG040|Escalation Phase|Site Closed|0|||
147342236|NCT02723955|531422468|FG041|Escalation Phase|Site Closed|0|||
147342237|NCT02723955|531422469|FG042|Escalation Phase|Site Closed|0|||
147342238|NCT02723955|531422427|FG000|Expansion Phase|Death|0|||
147342239|NCT02723955|531422428|FG001|Expansion Phase|Death|0|||
147342240|NCT02723955|531422429|FG002|Expansion Phase|Death|0|||
147342241|NCT02723955|531422430|FG003|Expansion Phase|Death|0|||
147342242|NCT02723955|531422431|FG004|Expansion Phase|Death|0|||
147342243|NCT02723955|531422432|FG005|Expansion Phase|Death|0|||
147342244|NCT02723955|531422433|FG006|Expansion Phase|Death|0|||
147342245|NCT02723955|531422434|FG007|Expansion Phase|Death|0|||
147342246|NCT02723955|531422435|FG008|Expansion Phase|Death|0|||
147342247|NCT02723955|531422436|FG009|Expansion Phase|Death|25|||
147342248|NCT02723955|531422437|FG010|Expansion Phase|Death|69|||
147342249|NCT02723955|531422438|FG011|Expansion Phase|Death|48|||
147342250|NCT02723955|531422439|FG012|Expansion Phase|Death|0|||
147342251|NCT02723955|531422440|FG013|Expansion Phase|Death|0|||
147342252|NCT02723955|531422441|FG014|Expansion Phase|Death|0|||
147342253|NCT02723955|531422442|FG015|Expansion Phase|Death|0|||
147342254|NCT02723955|531422443|FG016|Expansion Phase|Death|0|||
147342255|NCT02723955|531422444|FG017|Expansion Phase|Death|0|||
147342256|NCT02723955|531422445|FG018|Expansion Phase|Death|0|||
147342257|NCT02723955|531422446|FG019|Expansion Phase|Death|0|||
147342258|NCT02723955|531422447|FG020|Expansion Phase|Death|0|||
147342259|NCT02723955|531422448|FG021|Expansion Phase|Death|0|||
147342260|NCT02723955|531422449|FG022|Expansion Phase|Death|0|||
147342261|NCT02723955|531422450|FG023|Expansion Phase|Death|0|||
147342262|NCT02723955|531422451|FG024|Expansion Phase|Death|0|||
147342263|NCT02723955|531422452|FG025|Expansion Phase|Death|0|||
147342264|NCT02723955|531422453|FG026|Expansion Phase|Death|0|||
147342265|NCT02723955|531422454|FG027|Expansion Phase|Death|0|||
147342266|NCT02723955|531422455|FG028|Expansion Phase|Death|0|||
147342267|NCT02723955|531422456|FG029|Expansion Phase|Death|12|||
147342268|NCT02723955|531422457|FG030|Expansion Phase|Death|202|||
147342269|NCT02723955|531422458|FG031|Expansion Phase|Death|31|||
147342270|NCT02723955|531422459|FG032|Expansion Phase|Death|17|||
147342271|NCT02723955|531422460|FG033|Expansion Phase|Death|2|||
147342272|NCT02723955|531422461|FG034|Expansion Phase|Death|3|||
147342273|NCT02723955|531422462|FG035|Expansion Phase|Death|3|||
147342274|NCT02723955|531422463|FG036|Expansion Phase|Death|1|||
147342275|NCT02723955|531422464|FG037|Expansion Phase|Death|0|||
147342276|NCT02723955|531422465|FG038|Expansion Phase|Death|0|||
147342277|NCT02723955|531422466|FG039|Expansion Phase|Death|0|||
147342278|NCT02723955|531422467|FG040|Expansion Phase|Death|0|||
147342279|NCT02723955|531422468|FG041|Expansion Phase|Death|0|||
147342280|NCT02723955|531422469|FG042|Expansion Phase|Death|0|||
147342281|NCT02723955|531422427|FG000|Expansion Phase|Lost to Follow-up|0|||
147342282|NCT02723955|531422428|FG001|Expansion Phase|Lost to Follow-up|0|||
147342283|NCT02723955|531422429|FG002|Expansion Phase|Lost to Follow-up|0|||
147342284|NCT02723955|531422430|FG003|Expansion Phase|Lost to Follow-up|0|||
147342285|NCT02723955|531422431|FG004|Expansion Phase|Lost to Follow-up|0|||
147342286|NCT02723955|531422432|FG005|Expansion Phase|Lost to Follow-up|0|||
147342287|NCT02723955|531422433|FG006|Expansion Phase|Lost to Follow-up|0|||
147342288|NCT02723955|531422434|FG007|Expansion Phase|Lost to Follow-up|0|||
147342289|NCT02723955|531422435|FG008|Expansion Phase|Lost to Follow-up|0|||
147342290|NCT02723955|531422436|FG009|Expansion Phase|Lost to Follow-up|0|||
147342291|NCT02723955|531422437|FG010|Expansion Phase|Lost to Follow-up|4|||
147342292|NCT02723955|531422438|FG011|Expansion Phase|Lost to Follow-up|1|||
147342293|NCT02723955|531422439|FG012|Expansion Phase|Lost to Follow-up|0|||
147342294|NCT02723955|531422440|FG013|Expansion Phase|Lost to Follow-up|0|||
147342295|NCT02723955|531422441|FG014|Expansion Phase|Lost to Follow-up|0|||
147342296|NCT02723955|531422442|FG015|Expansion Phase|Lost to Follow-up|0|||
147342297|NCT02723955|531422443|FG016|Expansion Phase|Lost to Follow-up|0|||
147342298|NCT02723955|531422444|FG017|Expansion Phase|Lost to Follow-up|0|||
147342299|NCT02723955|531422445|FG018|Expansion Phase|Lost to Follow-up|0|||
147342300|NCT02723955|531422446|FG019|Expansion Phase|Lost to Follow-up|0|||
147342301|NCT02723955|531422447|FG020|Expansion Phase|Lost to Follow-up|0|||
147342302|NCT02723955|531422448|FG021|Expansion Phase|Lost to Follow-up|0|||
147342303|NCT02723955|531422449|FG022|Expansion Phase|Lost to Follow-up|0|||
147342304|NCT02723955|531422450|FG023|Expansion Phase|Lost to Follow-up|0|||
147342305|NCT02723955|531422451|FG024|Expansion Phase|Lost to Follow-up|0|||
147342306|NCT02723955|531422452|FG025|Expansion Phase|Lost to Follow-up|0|||
147342307|NCT02723955|531422453|FG026|Expansion Phase|Lost to Follow-up|0|||
147342308|NCT02723955|531422454|FG027|Expansion Phase|Lost to Follow-up|0|||
147342309|NCT02723955|531422455|FG028|Expansion Phase|Lost to Follow-up|0|||
147342310|NCT02723955|531422456|FG029|Expansion Phase|Lost to Follow-up|1|||
147342311|NCT02723955|531422457|FG030|Expansion Phase|Lost to Follow-up|19|||
147342312|NCT02723955|531422458|FG031|Expansion Phase|Lost to Follow-up|2|||
147342313|NCT02723955|531422459|FG032|Expansion Phase|Lost to Follow-up|1|||
147342314|NCT02723955|531422460|FG033|Expansion Phase|Lost to Follow-up|0|||
147342315|NCT02723955|531422461|FG034|Expansion Phase|Lost to Follow-up|0|||
147342316|NCT02723955|531422462|FG035|Expansion Phase|Lost to Follow-up|0|||
147342317|NCT02723955|531422463|FG036|Expansion Phase|Lost to Follow-up|0|||
147342318|NCT02723955|531422464|FG037|Expansion Phase|Lost to Follow-up|0|||
147342319|NCT02723955|531422465|FG038|Expansion Phase|Lost to Follow-up|0|||
147342320|NCT02723955|531422466|FG039|Expansion Phase|Lost to Follow-up|0|||
147342321|NCT02723955|531422467|FG040|Expansion Phase|Lost to Follow-up|0|||
147342322|NCT02723955|531422468|FG041|Expansion Phase|Lost to Follow-up|0|||
147342323|NCT02723955|531422469|FG042|Expansion Phase|Lost to Follow-up|0|||
147342324|NCT02723955|531422427|FG000|Expansion Phase|Physician Decision|0|||
147342325|NCT02723955|531422428|FG001|Expansion Phase|Physician Decision|0|||
147342326|NCT02723955|531422429|FG002|Expansion Phase|Physician Decision|0|||
147342327|NCT02723955|531422430|FG003|Expansion Phase|Physician Decision|0|||
147342328|NCT02723955|531422431|FG004|Expansion Phase|Physician Decision|0|||
147342329|NCT02723955|531422432|FG005|Expansion Phase|Physician Decision|0|||
147342330|NCT02723955|531422433|FG006|Expansion Phase|Physician Decision|0|||
147342331|NCT02723955|531422434|FG007|Expansion Phase|Physician Decision|0|||
147342332|NCT02723955|531422435|FG008|Expansion Phase|Physician Decision|0|||
147342333|NCT02723955|531422436|FG009|Expansion Phase|Physician Decision|0|||
147342334|NCT02723955|531422437|FG010|Expansion Phase|Physician Decision|0|||
147342335|NCT02723955|531422438|FG011|Expansion Phase|Physician Decision|0|||
147342336|NCT02723955|531422439|FG012|Expansion Phase|Physician Decision|0|||
147342337|NCT02723955|531422440|FG013|Expansion Phase|Physician Decision|0|||
147342338|NCT02723955|531422441|FG014|Expansion Phase|Physician Decision|0|||
147342339|NCT02723955|531422442|FG015|Expansion Phase|Physician Decision|0|||
147342340|NCT02723955|531422443|FG016|Expansion Phase|Physician Decision|0|||
147342341|NCT02723955|531422444|FG017|Expansion Phase|Physician Decision|0|||
147342342|NCT02723955|531422445|FG018|Expansion Phase|Physician Decision|0|||
147342343|NCT02723955|531422446|FG019|Expansion Phase|Physician Decision|0|||
147342344|NCT02723955|531422447|FG020|Expansion Phase|Physician Decision|0|||
147342345|NCT02723955|531422448|FG021|Expansion Phase|Physician Decision|0|||
147342346|NCT02723955|531422449|FG022|Expansion Phase|Physician Decision|0|||
147342347|NCT02723955|531422450|FG023|Expansion Phase|Physician Decision|0|||
147342348|NCT02723955|531422451|FG024|Expansion Phase|Physician Decision|0|||
147342349|NCT02723955|531422452|FG025|Expansion Phase|Physician Decision|0|||
147342350|NCT02723955|531422453|FG026|Expansion Phase|Physician Decision|0|||
147342351|NCT02723955|531422454|FG027|Expansion Phase|Physician Decision|0|||
147342352|NCT02723955|531422455|FG028|Expansion Phase|Physician Decision|0|||
147342353|NCT02723955|531422456|FG029|Expansion Phase|Physician Decision|0|||
147342354|NCT02723955|531422457|FG030|Expansion Phase|Physician Decision|1|||
147342355|NCT02723955|531422458|FG031|Expansion Phase|Physician Decision|1|||
147342356|NCT02723955|531422459|FG032|Expansion Phase|Physician Decision|0|||
147342357|NCT02723955|531422460|FG033|Expansion Phase|Physician Decision|0|||
147342358|NCT02723955|531422461|FG034|Expansion Phase|Physician Decision|0|||
147342359|NCT02723955|531422462|FG035|Expansion Phase|Physician Decision|0|||
147342360|NCT02723955|531422463|FG036|Expansion Phase|Physician Decision|0|||
147342361|NCT02723955|531422464|FG037|Expansion Phase|Physician Decision|0|||
147342362|NCT02723955|531422465|FG038|Expansion Phase|Physician Decision|0|||
147342363|NCT02723955|531422466|FG039|Expansion Phase|Physician Decision|0|||
147342364|NCT02723955|531422467|FG040|Expansion Phase|Physician Decision|0|||
147342365|NCT02723955|531422468|FG041|Expansion Phase|Physician Decision|0|||
147342366|NCT02723955|531422469|FG042|Expansion Phase|Physician Decision|0|||
147342367|NCT02723955|531422427|FG000|Expansion Phase|Withdrawal by Subject|0|||
147342368|NCT02723955|531422428|FG001|Expansion Phase|Withdrawal by Subject|0|||
147342369|NCT02723955|531422429|FG002|Expansion Phase|Withdrawal by Subject|0|||
147342370|NCT02723955|531422430|FG003|Expansion Phase|Withdrawal by Subject|0|||
147342371|NCT02723955|531422431|FG004|Expansion Phase|Withdrawal by Subject|0|||
147342372|NCT02723955|531422432|FG005|Expansion Phase|Withdrawal by Subject|0|||
147342373|NCT02723955|531422433|FG006|Expansion Phase|Withdrawal by Subject|0|||
147342374|NCT02723955|531422434|FG007|Expansion Phase|Withdrawal by Subject|0|||
147342375|NCT02723955|531422435|FG008|Expansion Phase|Withdrawal by Subject|0|||
147342376|NCT02723955|531422436|FG009|Expansion Phase|Withdrawal by Subject|2|||
147342377|NCT02723955|531422437|FG010|Expansion Phase|Withdrawal by Subject|1|||
147342378|NCT02723955|531422438|FG011|Expansion Phase|Withdrawal by Subject|0|||
147342379|NCT02723955|531422439|FG012|Expansion Phase|Withdrawal by Subject|0|||
147342380|NCT02723955|531422440|FG013|Expansion Phase|Withdrawal by Subject|0|||
147342381|NCT02723955|531422441|FG014|Expansion Phase|Withdrawal by Subject|0|||
147342382|NCT02723955|531422442|FG015|Expansion Phase|Withdrawal by Subject|0|||
147342383|NCT02723955|531422443|FG016|Expansion Phase|Withdrawal by Subject|0|||
147342384|NCT02723955|531422444|FG017|Expansion Phase|Withdrawal by Subject|0|||
147342385|NCT02723955|531422445|FG018|Expansion Phase|Withdrawal by Subject|0|||
147342386|NCT02723955|531422446|FG019|Expansion Phase|Withdrawal by Subject|0|||
147342387|NCT02723955|531422447|FG020|Expansion Phase|Withdrawal by Subject|0|||
147342388|NCT02723955|531422448|FG021|Expansion Phase|Withdrawal by Subject|0|||
147342389|NCT02723955|531422449|FG022|Expansion Phase|Withdrawal by Subject|0|||
147342390|NCT02723955|531422450|FG023|Expansion Phase|Withdrawal by Subject|0|||
147342391|NCT02723955|531422451|FG024|Expansion Phase|Withdrawal by Subject|0|||
147342392|NCT02723955|531422452|FG025|Expansion Phase|Withdrawal by Subject|0|||
147342393|NCT02723955|531422453|FG026|Expansion Phase|Withdrawal by Subject|0|||
147342394|NCT02723955|531422454|FG027|Expansion Phase|Withdrawal by Subject|0|||
147342395|NCT02723955|531422455|FG028|Expansion Phase|Withdrawal by Subject|0|||
147342396|NCT02723955|531422456|FG029|Expansion Phase|Withdrawal by Subject|0|||
147342397|NCT02723955|531422457|FG030|Expansion Phase|Withdrawal by Subject|8|||
147342398|NCT02723955|531422458|FG031|Expansion Phase|Withdrawal by Subject|4|||
147342399|NCT02723955|531422459|FG032|Expansion Phase|Withdrawal by Subject|0|||
147342400|NCT02723955|531422460|FG033|Expansion Phase|Withdrawal by Subject|0|||
147342401|NCT02723955|531422461|FG034|Expansion Phase|Withdrawal by Subject|0|||
147342402|NCT02723955|531422462|FG035|Expansion Phase|Withdrawal by Subject|1|||
147342403|NCT02723955|531422463|FG036|Expansion Phase|Withdrawal by Subject|0|||
147342404|NCT02723955|531422464|FG037|Expansion Phase|Withdrawal by Subject|0|||
147342405|NCT02723955|531422465|FG038|Expansion Phase|Withdrawal by Subject|0|||
147342406|NCT02723955|531422466|FG039|Expansion Phase|Withdrawal by Subject|0|||
147342407|NCT02723955|531422467|FG040|Expansion Phase|Withdrawal by Subject|0|||
147342408|NCT02723955|531422468|FG041|Expansion Phase|Withdrawal by Subject|0|||
147342409|NCT02723955|531422469|FG042|Expansion Phase|Withdrawal by Subject|0|||
147342410|NCT02723955|531422427|FG000|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
147342411|NCT02723955|531422428|FG001|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
147342412|NCT02723955|531422429|FG002|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
147342413|NCT02723955|531422430|FG003|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
147342414|NCT02723955|531422431|FG004|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
147342415|NCT02723955|531422432|FG005|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
147342416|NCT02723955|531422433|FG006|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
147342417|NCT02723955|531422434|FG007|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
147342418|NCT02723955|531422435|FG008|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
147342419|NCT02723955|531422436|FG009|Expansion Phase|Participants were crossed over OR were re-treated following progression|10|||
147342420|NCT02723955|531422437|FG010|Expansion Phase|Participants were crossed over OR were re-treated following progression|36|||
147342421|NCT02723955|531422438|FG011|Expansion Phase|Participants were crossed over OR were re-treated following progression|1|||
147453093|NCT01142726|531821539|FG002|Withdrawal Phase: Months 12 up to 24|Adverse Event|1|||
147606539|NCT01111825|532375249|FG000|Overall Study|Withdrawal by Subject|0|||
147342422|NCT02723955|531422439|FG012|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
147342423|NCT02723955|531422440|FG013|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
147342424|NCT02723955|531422441|FG014|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
147342425|NCT02723955|531422442|FG015|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
147342426|NCT02723955|531422443|FG016|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
147342427|NCT02723955|531422444|FG017|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
147342428|NCT02723955|531422445|FG018|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
147342429|NCT02723955|531422446|FG019|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
147342430|NCT02723955|531422447|FG020|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
147342431|NCT02723955|531422448|FG021|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
147342432|NCT02723955|531422449|FG022|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
147342433|NCT02723955|531422450|FG023|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
147342434|NCT02723955|531422451|FG024|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
147342435|NCT02723955|531422452|FG025|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
147342436|NCT02723955|531422453|FG026|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
147342437|NCT02723955|531422454|FG027|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
147342438|NCT02723955|531422455|FG028|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
147342439|NCT02723955|531422456|FG029|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
147342440|NCT02723955|531422457|FG030|Expansion Phase|Participants were crossed over OR were re-treated following progression|3|||
147342441|NCT02723955|531422458|FG031|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
147342442|NCT02723955|531422459|FG032|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
147342443|NCT02723955|531422460|FG033|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
147342444|NCT02723955|531422461|FG034|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
147342445|NCT02723955|531422462|FG035|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
147342446|NCT02723955|531422463|FG036|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
147342447|NCT02723955|531422464|FG037|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
147342448|NCT02723955|531422465|FG038|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
147342449|NCT02723955|531422466|FG039|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
147342450|NCT02723955|531422467|FG040|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
147342451|NCT02723955|531422468|FG041|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
147342452|NCT02723955|531422469|FG042|Expansion Phase|Participants were crossed over OR were re-treated following progression|0|||
147342453|NCT02723955|531422427|FG000|Expansion Phase|Site Closed|0|||
147342454|NCT02723955|531422428|FG001|Expansion Phase|Site Closed|0|||
147342455|NCT02723955|531422429|FG002|Expansion Phase|Site Closed|0|||
147342456|NCT02723955|531422430|FG003|Expansion Phase|Site Closed|0|||
147342457|NCT02723955|531422431|FG004|Expansion Phase|Site Closed|0|||
147342458|NCT02723955|531422432|FG005|Expansion Phase|Site Closed|0|||
147342459|NCT02723955|531422433|FG006|Expansion Phase|Site Closed|0|||
147342460|NCT02723955|531422434|FG007|Expansion Phase|Site Closed|0|||
147342461|NCT02723955|531422435|FG008|Expansion Phase|Site Closed|0|||
147342462|NCT02723955|531422436|FG009|Expansion Phase|Site Closed|1|||
147342463|NCT02723955|531422437|FG010|Expansion Phase|Site Closed|2|||
147342464|NCT02723955|531422438|FG011|Expansion Phase|Site Closed|6|||
147342465|NCT02723955|531422439|FG012|Expansion Phase|Site Closed|0|||
147342466|NCT02723955|531422440|FG013|Expansion Phase|Site Closed|0|||
147342467|NCT02723955|531422441|FG014|Expansion Phase|Site Closed|0|||
147342468|NCT02723955|531422442|FG015|Expansion Phase|Site Closed|0|||
147342469|NCT02723955|531422443|FG016|Expansion Phase|Site Closed|0|||
147342470|NCT02723955|531422444|FG017|Expansion Phase|Site Closed|0|||
147342471|NCT02723955|531422445|FG018|Expansion Phase|Site Closed|0|||
147342472|NCT02723955|531422446|FG019|Expansion Phase|Site Closed|0|||
147342473|NCT02723955|531422447|FG020|Expansion Phase|Site Closed|0|||
147342474|NCT02723955|531422448|FG021|Expansion Phase|Site Closed|0|||
147342475|NCT02723955|531422449|FG022|Expansion Phase|Site Closed|0|||
147342476|NCT02723955|531422450|FG023|Expansion Phase|Site Closed|0|||
147342477|NCT02723955|531422451|FG024|Expansion Phase|Site Closed|0|||
147342478|NCT02723955|531422452|FG025|Expansion Phase|Site Closed|0|||
147342479|NCT02723955|531422453|FG026|Expansion Phase|Site Closed|0|||
147342480|NCT02723955|531422454|FG027|Expansion Phase|Site Closed|0|||
147342481|NCT02723955|531422455|FG028|Expansion Phase|Site Closed|0|||
147606540|NCT01111825|532375250|FG001|Overall Study|Withdrawal by Subject|0|||
147606541|NCT01111825|532375251|FG002|Overall Study|Withdrawal by Subject|1|||
147606542|NCT01111825|532375252|FG003|Overall Study|Withdrawal by Subject|0|||
147606543|NCT01111825|532375249|FG000|Overall Study|Lost to Follow-up|0|||
147606544|NCT01111825|532375250|FG001|Overall Study|Lost to Follow-up|0|||
147342482|NCT02723955|531422456|FG029|Expansion Phase|Site Closed|0|||
147342483|NCT02723955|531422457|FG030|Expansion Phase|Site Closed|8|||
147342484|NCT02723955|531422458|FG031|Expansion Phase|Site Closed|4|||
147342485|NCT02723955|531422459|FG032|Expansion Phase|Site Closed|2|||
147342486|NCT02723955|531422460|FG033|Expansion Phase|Site Closed|2|||
147342487|NCT02723955|531422461|FG034|Expansion Phase|Site Closed|0|||
147342488|NCT02723955|531422462|FG035|Expansion Phase|Site Closed|0|||
147342489|NCT02723955|531422463|FG036|Expansion Phase|Site Closed|0|||
147342490|NCT02723955|531422464|FG037|Expansion Phase|Site Closed|0|||
147342491|NCT02723955|531422465|FG038|Expansion Phase|Site Closed|0|||
147342492|NCT02723955|531422466|FG039|Expansion Phase|Site Closed|0|||
147342493|NCT02723955|531422467|FG040|Expansion Phase|Site Closed|0|||
147342494|NCT02723955|531422468|FG041|Expansion Phase|Site Closed|0|||
147342495|NCT02723955|531422469|FG042|Expansion Phase|Site Closed|0|||
147342496|NCT02723955|531422427|FG000|Crossover/ Re-treatment Phase|Death|0|||
147342497|NCT02723955|531422428|FG001|Crossover/ Re-treatment Phase|Death|0|||
147342498|NCT02723955|531422429|FG002|Crossover/ Re-treatment Phase|Death|0|||
147342499|NCT02723955|531422430|FG003|Crossover/ Re-treatment Phase|Death|0|||
147342500|NCT02723955|531422431|FG004|Crossover/ Re-treatment Phase|Death|0|||
147342501|NCT02723955|531422432|FG005|Crossover/ Re-treatment Phase|Death|0|||
147342502|NCT02723955|531422433|FG006|Crossover/ Re-treatment Phase|Death|0|||
147342503|NCT02723955|531422434|FG007|Crossover/ Re-treatment Phase|Death|0|||
147342504|NCT02723955|531422435|FG008|Crossover/ Re-treatment Phase|Death|0|||
147342505|NCT02723955|531422436|FG009|Crossover/ Re-treatment Phase|Death|0|||
147342506|NCT02723955|531422437|FG010|Crossover/ Re-treatment Phase|Death|0|||
147342507|NCT02723955|531422438|FG011|Crossover/ Re-treatment Phase|Death|0|||
147342508|NCT02723955|531422439|FG012|Crossover/ Re-treatment Phase|Death|0|||
147342509|NCT02723955|531422440|FG013|Crossover/ Re-treatment Phase|Death|0|||
147342510|NCT02723955|531422441|FG014|Crossover/ Re-treatment Phase|Death|0|||
147342511|NCT02723955|531422442|FG015|Crossover/ Re-treatment Phase|Death|0|||
147342512|NCT02723955|531422443|FG016|Crossover/ Re-treatment Phase|Death|0|||
147342513|NCT02723955|531422444|FG017|Crossover/ Re-treatment Phase|Death|0|||
147342514|NCT02723955|531422445|FG018|Crossover/ Re-treatment Phase|Death|0|||
147342515|NCT02723955|531422446|FG019|Crossover/ Re-treatment Phase|Death|0|||
147342516|NCT02723955|531422447|FG020|Crossover/ Re-treatment Phase|Death|0|||
147342517|NCT02723955|531422448|FG021|Crossover/ Re-treatment Phase|Death|0|||
147342518|NCT02723955|531422449|FG022|Crossover/ Re-treatment Phase|Death|0|||
147342519|NCT02723955|531422450|FG023|Crossover/ Re-treatment Phase|Death|0|||
147342520|NCT02723955|531422451|FG024|Crossover/ Re-treatment Phase|Death|0|||
147342521|NCT02723955|531422452|FG025|Crossover/ Re-treatment Phase|Death|0|||
147342522|NCT02723955|531422453|FG026|Crossover/ Re-treatment Phase|Death|0|||
147342523|NCT02723955|531422454|FG027|Crossover/ Re-treatment Phase|Death|0|||
147342524|NCT02723955|531422455|FG028|Crossover/ Re-treatment Phase|Death|0|||
147342525|NCT02723955|531422456|FG029|Crossover/ Re-treatment Phase|Death|0|||
147342526|NCT02723955|531422457|FG030|Crossover/ Re-treatment Phase|Death|0|||
147342527|NCT02723955|531422458|FG031|Crossover/ Re-treatment Phase|Death|0|||
147342528|NCT02723955|531422459|FG032|Crossover/ Re-treatment Phase|Death|0|||
147342529|NCT02723955|531422460|FG033|Crossover/ Re-treatment Phase|Death|0|||
147342530|NCT02723955|531422461|FG034|Crossover/ Re-treatment Phase|Death|0|||
147342531|NCT02723955|531422462|FG035|Crossover/ Re-treatment Phase|Death|0|||
147342532|NCT02723955|531422463|FG036|Crossover/ Re-treatment Phase|Death|0|||
147342533|NCT02723955|531422464|FG037|Crossover/ Re-treatment Phase|Death|1|||
147342534|NCT02723955|531422465|FG038|Crossover/ Re-treatment Phase|Death|14|||
147342535|NCT02723955|531422466|FG039|Crossover/ Re-treatment Phase|Death|32|||
147342536|NCT02723955|531422467|FG040|Crossover/ Re-treatment Phase|Death|2|||
147342537|NCT02723955|531422468|FG041|Crossover/ Re-treatment Phase|Death|1|||
147342538|NCT02723955|531422469|FG042|Crossover/ Re-treatment Phase|Death|0|||
147342539|NCT02723955|531422427|FG000|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
147342540|NCT02723955|531422428|FG001|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
147342541|NCT02723955|531422429|FG002|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
147342542|NCT02723955|531422430|FG003|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
147342543|NCT02723955|531422431|FG004|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
147342544|NCT02723955|531422432|FG005|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
147342545|NCT02723955|531422433|FG006|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
147342546|NCT02723955|531422434|FG007|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
147342547|NCT02723955|531422435|FG008|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
147342548|NCT02723955|531422436|FG009|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
147342549|NCT02723955|531422437|FG010|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
147342550|NCT02723955|531422438|FG011|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
147342551|NCT02723955|531422439|FG012|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
147342552|NCT02723955|531422440|FG013|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
147342553|NCT02723955|531422441|FG014|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
147342554|NCT02723955|531422442|FG015|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
147606545|NCT01111825|532375251|FG002|Overall Study|Lost to Follow-up|3|||
147606546|NCT01111825|532375252|FG003|Overall Study|Lost to Follow-up|1|||
147299664|NCT01242748|531262786|FG000|Overall Study|Physician Decision|3|||
147299665|NCT01242748|531262787|FG001|Overall Study|Physician Decision|2|||
147299666|NCT01242748|531262786|FG000|Overall Study|Protocol Violation|1|||
147299667|NCT01242748|531262787|FG001|Overall Study|Protocol Violation|0|||
147299668|NCT01242748|531262786|FG000|Overall Study|Withdrawal by Subject|10|||
147299669|NCT01242748|531262787|FG001|Overall Study|Withdrawal by Subject|2|||
147299670|NCT01242748|531262786|FG000|Overall Study|Miscellaneous reasons|8|||
147299671|NCT01242748|531262787|FG001|Overall Study|Miscellaneous reasons|3|||
147299672|NCT00335452|531262788|FG000|Overall Study|Death|156|||
147299673|NCT00335452|531262789|FG001|Overall Study|Death|144|||
147299674|NCT00335452|531262790|FG002|Overall Study|Death|158|||
147299675|NCT00335452|531262791|FG003|Overall Study|Death|129|||
147299676|NCT00335452|531262788|FG000|Overall Study|Lost to Follow-up|2|||
147299677|NCT00335452|531262789|FG001|Overall Study|Lost to Follow-up|3|||
147299678|NCT00335452|531262790|FG002|Overall Study|Lost to Follow-up|1|||
147299679|NCT00335452|531262791|FG003|Overall Study|Lost to Follow-up|2|||
147299680|NCT02736825|531262792|FG000|Overall Study|Lost to Follow-up|10|||
147299681|NCT02736825|531262793|FG001|Overall Study|Lost to Follow-up|11|||
147299682|NCT02736825|531262792|FG000|Overall Study|Early Termination|0|||
147299683|NCT02736825|531262793|FG001|Overall Study|Early Termination|1|||
147299684|NCT00790452|531262795|FG000|Overall Study|Drug supply issue|1|||
147299685|NCT00790452|531262796|FG001|Overall Study|Drug supply issue|0|||
147299686|NCT02940574|531262797|FG000|From Study Start to 1-month Follow-up|Withdrawal by Subject|1|||
147299687|NCT02940574|531262798|FG001|From Study Start to 1-month Follow-up|Withdrawal by Subject|0|||
147299688|NCT02940574|531262797|FG000|1-year Follow-up|Lost to Follow-up|3|||
147299689|NCT02940574|531262798|FG001|1-year Follow-up|Lost to Follow-up|4|||
147299690|NCT01750879|531262801|FG000|Overall Study|Adverse Event|8|||
147299691|NCT01750879|531262802|FG001|Overall Study|Adverse Event|0|||
147299692|NCT01750879|531262801|FG000|Overall Study|Lack of Efficacy|1|||
147299693|NCT01750879|531262802|FG001|Overall Study|Lack of Efficacy|0|||
147299694|NCT01750879|531262801|FG000|Overall Study|Withdrawal by Subject|1|||
147299695|NCT01750879|531262802|FG001|Overall Study|Withdrawal by Subject|0|||
147299696|NCT01750879|531262801|FG000|Overall Study|Did not complete per protocol|0|||
147299697|NCT01750879|531262802|FG001|Overall Study|Did not complete per protocol|3|||
147299698|NCT04810221|531262803|FG000|Overall Study|Physician Decision|3|||
147299699|NCT03642938|531262804|FG000|Overall Study|Withdrawal by Subject|0|||
147299700|NCT03642938|531262805|FG001|Overall Study|Withdrawal by Subject|0|||
147299701|NCT03642938|531262806|FG002|Overall Study|Withdrawal by Subject|0|||
147299702|NCT03642938|531262807|FG003|Overall Study|Withdrawal by Subject|1|||
147299703|NCT00105235|531262808|FG000|Overall Study|Death|4|||
147299704|NCT00105235|531262808|FG000|Overall Study|Physician Decision|1|||
147299705|NCT00105235|531262808|FG000|Overall Study|Withdrawal by Subject|2|||
147299706|NCT01964326|531262809|FG000|Overall Study|Adverse Event|48|||
147299707|NCT01964326|531262809|FG000|Overall Study|Death|2|||
147299708|NCT01964326|531262809|FG000|Overall Study|Protocol Violation|4|||
147299709|NCT01964326|531262809|FG000|Overall Study|Lost to Follow-up|88|||
147299710|NCT01964326|531262809|FG000|Overall Study|Withdrawal by Subject|87|||
147299711|NCT01964326|531262809|FG000|Overall Study|Pregnancy|1|||
147299712|NCT01964326|531262809|FG000|Overall Study|No Longer Meets Eligibility Criteria|1|||
147299713|NCT01964326|531262809|FG000|Overall Study|Physician Decision|55|||
147299714|NCT01964326|531262809|FG000|Overall Study|Investigator Discretion|1|||
147299715|NCT01964326|531262809|FG000|Overall Study|Other|9|||
147299716|NCT01964326|531262809|FG000|Overall Study|Did not meet eligibility criteria|1|||
147299717|NCT02347657|531262810|FG000|Overall Study|Physician Decision|0|||
147299718|NCT02347657|531262811|FG001|Overall Study|Physician Decision|1|||
147299719|NCT02347657|531262810|FG000|Overall Study|Adverse Event|8|||
147299720|NCT02347657|531262811|FG001|Overall Study|Adverse Event|4|||
147299721|NCT02347657|531262810|FG000|Overall Study|Withdrawal by Subject|6|||
147299722|NCT02347657|531262811|FG001|Overall Study|Withdrawal by Subject|7|||
147299723|NCT02347657|531262810|FG000|Overall Study|Randomized but not treated|1|||
147299724|NCT02347657|531262811|FG001|Overall Study|Randomized but not treated|0|||
147299725|NCT02347657|531262810|FG000|Overall Study|Other|3|||
147299726|NCT02347657|531262811|FG001|Overall Study|Other|3|||
147299727|NCT01621880|531262818|FG000|Overall Study|Adverse Event|5|||
147299728|NCT01621880|531262819|FG001|Overall Study|Adverse Event|1|||
147299729|NCT01621880|531262818|FG000|Overall Study|Withdrawal by Subject|5|||
147299730|NCT01621880|531262819|FG001|Overall Study|Withdrawal by Subject|4|||
147299731|NCT01662063|531262820|FG000|Overall Study|Adverse Event or Intercurrent Illness|1|||
147299732|NCT01662063|531262821|FG001|Overall Study|Adverse Event or Intercurrent Illness|12|||
147606547|NCT01111825|532375249|FG000|Overall Study|Adverse Event|2|||
147299733|NCT01662063|531262822|FG002|Overall Study|Adverse Event or Intercurrent Illness|0|||
147299734|NCT01662063|531262820|FG000|Overall Study|Lack of Efficacy|1|||
147299735|NCT01662063|531262821|FG001|Overall Study|Lack of Efficacy|6|||
147299736|NCT01662063|531262822|FG002|Overall Study|Lack of Efficacy|0|||
147299737|NCT01662063|531262820|FG000|Overall Study|Lost to Follow-up|0|||
147299738|NCT01662063|531262821|FG001|Overall Study|Lost to Follow-up|4|||
147342555|NCT02723955|531422443|FG016|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
147342556|NCT02723955|531422444|FG017|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
147342557|NCT02723955|531422445|FG018|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
147342558|NCT02723955|531422446|FG019|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
147342559|NCT02723955|531422447|FG020|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
147342560|NCT02723955|531422448|FG021|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
147342561|NCT02723955|531422449|FG022|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
147342562|NCT02723955|531422450|FG023|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
147342563|NCT02723955|531422451|FG024|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
147342564|NCT02723955|531422452|FG025|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
147342565|NCT02723955|531422453|FG026|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
147342566|NCT02723955|531422454|FG027|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
147342567|NCT02723955|531422455|FG028|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
147342568|NCT02723955|531422456|FG029|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
147342569|NCT02723955|531422457|FG030|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
147342570|NCT02723955|531422458|FG031|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
147342571|NCT02723955|531422459|FG032|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
147342572|NCT02723955|531422460|FG033|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
147342573|NCT02723955|531422461|FG034|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
147342574|NCT02723955|531422462|FG035|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
147342575|NCT02723955|531422463|FG036|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
147342576|NCT02723955|531422464|FG037|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
147342577|NCT02723955|531422465|FG038|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
147342578|NCT02723955|531422466|FG039|Crossover/ Re-treatment Phase|Lost to Follow-up|4|||
147342579|NCT02723955|531422467|FG040|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
147342580|NCT02723955|531422468|FG041|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
147342581|NCT02723955|531422469|FG042|Crossover/ Re-treatment Phase|Lost to Follow-up|0|||
147342582|NCT02723955|531422427|FG000|Crossover/ Re-treatment Phase|Physician Decision|0|||
147342583|NCT02723955|531422428|FG001|Crossover/ Re-treatment Phase|Physician Decision|0|||
147342584|NCT02723955|531422429|FG002|Crossover/ Re-treatment Phase|Physician Decision|0|||
147342585|NCT02723955|531422430|FG003|Crossover/ Re-treatment Phase|Physician Decision|0|||
147342586|NCT02723955|531422431|FG004|Crossover/ Re-treatment Phase|Physician Decision|0|||
147342587|NCT02723955|531422432|FG005|Crossover/ Re-treatment Phase|Physician Decision|0|||
147342588|NCT02723955|531422433|FG006|Crossover/ Re-treatment Phase|Physician Decision|0|||
147342589|NCT02723955|531422434|FG007|Crossover/ Re-treatment Phase|Physician Decision|0|||
147342590|NCT02723955|531422435|FG008|Crossover/ Re-treatment Phase|Physician Decision|0|||
147342591|NCT02723955|531422436|FG009|Crossover/ Re-treatment Phase|Physician Decision|0|||
147342592|NCT02723955|531422437|FG010|Crossover/ Re-treatment Phase|Physician Decision|0|||
147342593|NCT02723955|531422438|FG011|Crossover/ Re-treatment Phase|Physician Decision|0|||
147342594|NCT02723955|531422439|FG012|Crossover/ Re-treatment Phase|Physician Decision|0|||
147342595|NCT02723955|531422440|FG013|Crossover/ Re-treatment Phase|Physician Decision|0|||
147342596|NCT02723955|531422441|FG014|Crossover/ Re-treatment Phase|Physician Decision|0|||
147342597|NCT02723955|531422442|FG015|Crossover/ Re-treatment Phase|Physician Decision|0|||
147342598|NCT02723955|531422443|FG016|Crossover/ Re-treatment Phase|Physician Decision|0|||
147342599|NCT02723955|531422444|FG017|Crossover/ Re-treatment Phase|Physician Decision|0|||
147342600|NCT02723955|531422445|FG018|Crossover/ Re-treatment Phase|Physician Decision|0|||
147342601|NCT02723955|531422446|FG019|Crossover/ Re-treatment Phase|Physician Decision|0|||
147342602|NCT02723955|531422447|FG020|Crossover/ Re-treatment Phase|Physician Decision|0|||
147342603|NCT02723955|531422448|FG021|Crossover/ Re-treatment Phase|Physician Decision|0|||
147342604|NCT02723955|531422449|FG022|Crossover/ Re-treatment Phase|Physician Decision|0|||
147342605|NCT02723955|531422450|FG023|Crossover/ Re-treatment Phase|Physician Decision|0|||
147342606|NCT02723955|531422451|FG024|Crossover/ Re-treatment Phase|Physician Decision|0|||
147342607|NCT02723955|531422452|FG025|Crossover/ Re-treatment Phase|Physician Decision|0|||
147342608|NCT02723955|531422453|FG026|Crossover/ Re-treatment Phase|Physician Decision|0|||
147342609|NCT02723955|531422454|FG027|Crossover/ Re-treatment Phase|Physician Decision|0|||
147342610|NCT02723955|531422455|FG028|Crossover/ Re-treatment Phase|Physician Decision|0|||
147342611|NCT02723955|531422456|FG029|Crossover/ Re-treatment Phase|Physician Decision|0|||
147342612|NCT02723955|531422457|FG030|Crossover/ Re-treatment Phase|Physician Decision|0|||
147342613|NCT02723955|531422458|FG031|Crossover/ Re-treatment Phase|Physician Decision|0|||
147342614|NCT02723955|531422459|FG032|Crossover/ Re-treatment Phase|Physician Decision|0|||
147342615|NCT02723955|531422460|FG033|Crossover/ Re-treatment Phase|Physician Decision|0|||
147342616|NCT02723955|531422461|FG034|Crossover/ Re-treatment Phase|Physician Decision|0|||
147342617|NCT02723955|531422462|FG035|Crossover/ Re-treatment Phase|Physician Decision|0|||
147606548|NCT01111825|532375250|FG001|Overall Study|Adverse Event|1|||
147606549|NCT01111825|532375251|FG002|Overall Study|Adverse Event|4|||
147342618|NCT02723955|531422463|FG036|Crossover/ Re-treatment Phase|Physician Decision|0|||
147342619|NCT02723955|531422464|FG037|Crossover/ Re-treatment Phase|Physician Decision|0|||
147342620|NCT02723955|531422465|FG038|Crossover/ Re-treatment Phase|Physician Decision|1|||
147342621|NCT02723955|531422466|FG039|Crossover/ Re-treatment Phase|Physician Decision|1|||
147606550|NCT01111825|532375252|FG003|Overall Study|Adverse Event|0|||
147342622|NCT02723955|531422467|FG040|Crossover/ Re-treatment Phase|Physician Decision|0|||
147342623|NCT02723955|531422468|FG041|Crossover/ Re-treatment Phase|Physician Decision|0|||
147342624|NCT02723955|531422469|FG042|Crossover/ Re-treatment Phase|Physician Decision|1|||
147342625|NCT02723955|531422427|FG000|Crossover/ Re-treatment Phase|Site Closed|0|||
147342626|NCT02723955|531422428|FG001|Crossover/ Re-treatment Phase|Site Closed|0|||
147342627|NCT02723955|531422429|FG002|Crossover/ Re-treatment Phase|Site Closed|0|||
147342628|NCT02723955|531422430|FG003|Crossover/ Re-treatment Phase|Site Closed|0|||
147342629|NCT02723955|531422431|FG004|Crossover/ Re-treatment Phase|Site Closed|0|||
147342630|NCT02723955|531422432|FG005|Crossover/ Re-treatment Phase|Site Closed|0|||
147342631|NCT02723955|531422433|FG006|Crossover/ Re-treatment Phase|Site Closed|0|||
147342632|NCT02723955|531422434|FG007|Crossover/ Re-treatment Phase|Site Closed|0|||
147342633|NCT02723955|531422435|FG008|Crossover/ Re-treatment Phase|Site Closed|0|||
147342634|NCT02723955|531422436|FG009|Crossover/ Re-treatment Phase|Site Closed|0|||
147342635|NCT02723955|531422437|FG010|Crossover/ Re-treatment Phase|Site Closed|0|||
147342636|NCT02723955|531422438|FG011|Crossover/ Re-treatment Phase|Site Closed|0|||
147342637|NCT02723955|531422439|FG012|Crossover/ Re-treatment Phase|Site Closed|0|||
147342638|NCT02723955|531422440|FG013|Crossover/ Re-treatment Phase|Site Closed|0|||
147342639|NCT02723955|531422441|FG014|Crossover/ Re-treatment Phase|Site Closed|0|||
147342640|NCT02723955|531422442|FG015|Crossover/ Re-treatment Phase|Site Closed|0|||
147342641|NCT02723955|531422443|FG016|Crossover/ Re-treatment Phase|Site Closed|0|||
147342642|NCT02723955|531422444|FG017|Crossover/ Re-treatment Phase|Site Closed|0|||
147342643|NCT02723955|531422445|FG018|Crossover/ Re-treatment Phase|Site Closed|0|||
147342644|NCT02723955|531422446|FG019|Crossover/ Re-treatment Phase|Site Closed|0|||
147342645|NCT02723955|531422447|FG020|Crossover/ Re-treatment Phase|Site Closed|0|||
147342646|NCT02723955|531422448|FG021|Crossover/ Re-treatment Phase|Site Closed|0|||
147342647|NCT02723955|531422449|FG022|Crossover/ Re-treatment Phase|Site Closed|0|||
147342648|NCT02723955|531422450|FG023|Crossover/ Re-treatment Phase|Site Closed|0|||
147342649|NCT02723955|531422451|FG024|Crossover/ Re-treatment Phase|Site Closed|0|||
147342650|NCT02723955|531422452|FG025|Crossover/ Re-treatment Phase|Site Closed|0|||
147342651|NCT02723955|531422453|FG026|Crossover/ Re-treatment Phase|Site Closed|0|||
147342652|NCT02723955|531422454|FG027|Crossover/ Re-treatment Phase|Site Closed|0|||
147342653|NCT02723955|531422455|FG028|Crossover/ Re-treatment Phase|Site Closed|0|||
147342654|NCT02723955|531422456|FG029|Crossover/ Re-treatment Phase|Site Closed|0|||
147342655|NCT02723955|531422457|FG030|Crossover/ Re-treatment Phase|Site Closed|0|||
147342656|NCT02723955|531422458|FG031|Crossover/ Re-treatment Phase|Site Closed|0|||
147342657|NCT02723955|531422459|FG032|Crossover/ Re-treatment Phase|Site Closed|0|||
147342658|NCT02723955|531422460|FG033|Crossover/ Re-treatment Phase|Site Closed|0|||
147342659|NCT02723955|531422461|FG034|Crossover/ Re-treatment Phase|Site Closed|0|||
147342660|NCT02723955|531422462|FG035|Crossover/ Re-treatment Phase|Site Closed|0|||
147342661|NCT02723955|531422463|FG036|Crossover/ Re-treatment Phase|Site Closed|0|||
147342662|NCT02723955|531422464|FG037|Crossover/ Re-treatment Phase|Site Closed|0|||
147342663|NCT02723955|531422465|FG038|Crossover/ Re-treatment Phase|Site Closed|4|||
147342664|NCT02723955|531422466|FG039|Crossover/ Re-treatment Phase|Site Closed|2|||
147342665|NCT02723955|531422467|FG040|Crossover/ Re-treatment Phase|Site Closed|0|||
147342666|NCT02723955|531422468|FG041|Crossover/ Re-treatment Phase|Site Closed|0|||
147342667|NCT02723955|531422469|FG042|Crossover/ Re-treatment Phase|Site Closed|0|||
147342668|NCT04999085|531422470|FG000|Overall Study|Death|1|||
147342669|NCT05056246|531422473|FG000|Overall Study|Adverse Event|0|||
147342670|NCT05056246|531422474|FG001|Overall Study|Adverse Event|0|||
147342671|NCT05056246|531422475|FG002|Overall Study|Adverse Event|0|||
147342672|NCT05056246|531422476|FG003|Overall Study|Adverse Event|0|||
147342673|NCT05056246|531422477|FG004|Overall Study|Adverse Event|1|||
147342674|NCT05056246|531422473|FG000|Overall Study|Lost to Follow-up|0|||
147342675|NCT05056246|531422474|FG001|Overall Study|Lost to Follow-up|0|||
147342676|NCT05056246|531422475|FG002|Overall Study|Lost to Follow-up|0|||
147342677|NCT05056246|531422476|FG003|Overall Study|Lost to Follow-up|2|||
147342678|NCT05056246|531422477|FG004|Overall Study|Lost to Follow-up|0|||
147342679|NCT05056246|531422473|FG000|Overall Study|Withdrawal by Subject|0|||
147342680|NCT05056246|531422474|FG001|Overall Study|Withdrawal by Subject|1|||
147342681|NCT05056246|531422475|FG002|Overall Study|Withdrawal by Subject|0|||
147342682|NCT05056246|531422476|FG003|Overall Study|Withdrawal by Subject|0|||
147342683|NCT05056246|531422477|FG004|Overall Study|Withdrawal by Subject|0|||
147342684|NCT05096819|531422482|FG000|Overall Study|Withdrawal by Subject|3|||
147342685|NCT05096819|531422483|FG001|Overall Study|Withdrawal by Subject|0|||
147342686|NCT03324984|531422484|FG000|Overall Study|Inability to place a spinal anesthesia due to the patients' anatomy|1|||
147342687|NCT03324984|531422485|FG001|Overall Study|Inability to place a spinal anesthesia due to the patients' anatomy|4|||
147342688|NCT02152137|531422487|FG000|Overall Study|Withdrawal by Subject|1|||
147342689|NCT02152137|531422487|FG000|Overall Study|Originally assigned to Arm B|3|||
147342690|NCT04878354|531422488|FG000|Overall Study|Adverse Event|4|||
147342691|NCT04878354|531422489|FG001|Overall Study|Adverse Event|13|||
147342692|NCT04878354|531422488|FG000|Overall Study|Withdrawal by Subject|14|||
147342693|NCT04878354|531422489|FG001|Overall Study|Withdrawal by Subject|12|||
147342694|NCT04878354|531422488|FG000|Overall Study|Lost to Follow-up|4|||
147606551|NCT01111825|532375249|FG000|Overall Study|Disease Progression|1|||
147606552|NCT01111825|532375250|FG001|Overall Study|Disease Progression|0|||
147342695|NCT04878354|531422489|FG001|Overall Study|Lost to Follow-up|1|||
147342696|NCT04878354|531422488|FG000|Overall Study|Lack of Efficacy|1|||
147342697|NCT04878354|531422489|FG001|Overall Study|Lack of Efficacy|0|||
147342698|NCT04878354|531422488|FG000|Overall Study|Protocol Violation|0|||
147342699|NCT04878354|531422489|FG001|Overall Study|Protocol Violation|1|||
147342700|NCT04878354|531422488|FG000|Overall Study|"Reason stated as other in CRF"|2|||
147342701|NCT04878354|531422489|FG001|Overall Study|"Reason stated as other in CRF"|3|||
147342702|NCT03358875|531422490|FG000|Overall Study|Death|409|||
147342703|NCT03358875|531422491|FG001|Overall Study|Death|223|||
147342704|NCT03358875|531422490|FG000|Overall Study|Study Closed by Sponsor|66|||
147342705|NCT03358875|531422491|FG001|Overall Study|Study Closed by Sponsor|29|||
147342706|NCT03358875|531422490|FG000|Overall Study|Withdrawal by Subject|13|||
147342707|NCT03358875|531422491|FG001|Overall Study|Withdrawal by Subject|16|||
147342708|NCT03358875|531422490|FG000|Overall Study|Lost to Follow-up|13|||
147342709|NCT03358875|531422491|FG001|Overall Study|Lost to Follow-up|2|||
147342710|NCT03358875|531422490|FG000|Overall Study|Miscellaneous|33|||
147342711|NCT03358875|531422491|FG001|Overall Study|Miscellaneous|0|||
147342712|NCT03358875|531422490|FG000|Overall Study|Remained on Study|1|||
147342713|NCT03358875|531422491|FG001|Overall Study|Remained on Study|0|||
147342714|NCT06194214|531422504|FG000|Overall Study|Adverse Event|1|||
147342715|NCT05687903|531422505|FG000|Overall Study|Protocol Deviation|1|||
147342716|NCT05687903|531422506|FG001|Overall Study|Protocol Deviation|1|||
147342717|NCT05687903|531422507|FG002|Overall Study|Protocol Deviation|0|||
147342718|NCT05687903|531422508|FG003|Overall Study|Protocol Deviation|1|||
147342719|NCT05687903|531422509|FG004|Overall Study|Protocol Deviation|0|||
147342720|NCT04847999|531422510|FG000|Overall Study|Lost to Follow-up|0|||
147342721|NCT04847999|531422511|FG001|Overall Study|Lost to Follow-up|1|||
147342722|NCT02879448|531422512|FG000|Overall Study|Death|251|||
147342723|NCT02879448|531422513|FG001|Overall Study|Death|263|||
147342724|NCT02879448|531422512|FG000|Overall Study|Lost to Follow-up|23|||
147342725|NCT02879448|531422513|FG001|Overall Study|Lost to Follow-up|28|||
147342726|NCT02879448|531422512|FG000|Overall Study|Withdrawal by Subject|42|||
147342727|NCT02879448|531422513|FG001|Overall Study|Withdrawal by Subject|79|||
147342728|NCT02879448|531422512|FG000|Overall Study|Other Reasons|8|||
147342729|NCT02879448|531422513|FG001|Overall Study|Other Reasons|12|||
147342730|NCT04300231|531422523|FG000|Overall Study|Protocol Violation|4|||
147342731|NCT04300231|531422524|FG001|Overall Study|Protocol Violation|3|||
147342732|NCT04300231|531422525|FG002|Overall Study|Protocol Violation|0|||
147342733|NCT04300231|531422526|FG003|Overall Study|Protocol Violation|2|||
147342734|NCT02386553|531422528|FG000|Overall Study|Reason Not Specified|1|||
147342735|NCT02386553|531422529|FG001|Overall Study|Reason Not Specified|1|||
147342736|NCT02386553|531422528|FG000|Overall Study|Withdrawal by parent/Guardian|1|||
147342737|NCT02386553|531422529|FG001|Overall Study|Withdrawal by parent/Guardian|0|||
147342738|NCT02006758|531422533|FG000|Overall Study|Protocol Violation|1|||
147342739|NCT02006758|531422533|FG000|Overall Study|Death|1|||
147342740|NCT02006758|531422533|FG000|Overall Study|Lost to Follow-up|4|||
147342741|NCT02006758|531422533|FG000|Overall Study|Withdrawal by Subject|4|||
147342742|NCT02006758|531422533|FG000|Overall Study|Procedurally excluded|1|||
147342743|NCT02006758|531422533|FG000|Overall Study|Other|2|||
147342744|NCT02740231|531422534|FG000|Overall Study|Withdrawal by Subject|1|||
147342745|NCT02740231|531422535|FG001|Overall Study|Withdrawal by Subject|1|||
147342746|NCT02740231|531422536|FG002|Overall Study|Withdrawal by Subject|1|||
147342747|NCT02740231|531422537|FG003|Overall Study|Withdrawal by Subject|0|||
147342748|NCT02740231|531422534|FG000|Overall Study|Lack of Efficacy|0|||
147342749|NCT02740231|531422535|FG001|Overall Study|Lack of Efficacy|1|||
147342750|NCT02740231|531422536|FG002|Overall Study|Lack of Efficacy|0|||
147342751|NCT02740231|531422537|FG003|Overall Study|Lack of Efficacy|4|||
147342752|NCT02740231|531422534|FG000|Overall Study|Lost to Follow-up|1|||
147342753|NCT02740231|531422535|FG001|Overall Study|Lost to Follow-up|3|||
147342754|NCT02740231|531422536|FG002|Overall Study|Lost to Follow-up|0|||
147342755|NCT02740231|531422537|FG003|Overall Study|Lost to Follow-up|3|||
147342756|NCT02740231|531422534|FG000|Overall Study|Adverse Event|0|||
147342757|NCT02740231|531422535|FG001|Overall Study|Adverse Event|1|||
147342758|NCT02740231|531422536|FG002|Overall Study|Adverse Event|0|||
147342759|NCT02740231|531422537|FG003|Overall Study|Adverse Event|1|||
147342760|NCT03655262|531422538|FG000|Overall Study|Withdrawal by Subject|0|||
147342761|NCT03655262|531422539|FG001|Overall Study|Withdrawal by Subject|0|||
147342762|NCT03655262|531422540|FG002|Overall Study|Withdrawal by Subject|1|||
147342763|NCT04328727|531422541|FG000|Overall Study|Guardian Decision|1|||
147342764|NCT04328727|531422541|FG000|Overall Study|Participant decision|4|||
147342765|NCT04328727|531422541|FG000|Overall Study|Death|3|||
147342766|NCT04583423|531422542|FG000|Overall Study|Lost to Follow-up|0|||
147342767|NCT04583423|531422543|FG001|Overall Study|Lost to Follow-up|1|||
147342768|NCT04583423|531422544|FG002|Overall Study|Lost to Follow-up|0|||
147342769|NCT04583423|531422545|FG003|Overall Study|Lost to Follow-up|2|||
147342770|NCT04583423|531422542|FG000|Overall Study|Study Terminated by Sponsor|32|||
147342771|NCT04583423|531422543|FG001|Overall Study|Study Terminated by Sponsor|35|||
147342772|NCT04583423|531422544|FG002|Overall Study|Study Terminated by Sponsor|36|||
147342773|NCT04583423|531422545|FG003|Overall Study|Study Terminated by Sponsor|33|||
147606553|NCT01111825|532375251|FG002|Overall Study|Disease Progression|0|||
147606554|NCT01111825|532375252|FG003|Overall Study|Disease Progression|0|||
147606555|NCT01111825|532375249|FG000|Overall Study|Discontinuation by Sponsor|0|||
147606556|NCT01111825|532375250|FG001|Overall Study|Discontinuation by Sponsor|0|||
147342774|NCT04583423|531422542|FG000|Overall Study|Withdrawal by Subject|3|||
147342775|NCT04583423|531422543|FG001|Overall Study|Withdrawal by Subject|1|||
147342776|NCT04583423|531422544|FG002|Overall Study|Withdrawal by Subject|2|||
147342777|NCT04583423|531422545|FG003|Overall Study|Withdrawal by Subject|1|||
147342778|NCT02238483|531422546|FG000|Overall Study|Withdrawal by Subject|2|||
147342779|NCT02238483|531422547|FG001|Overall Study|Withdrawal by Subject|7|||
147342780|NCT02238483|531422546|FG000|Overall Study|Lost to Follow-up|1|||
147342781|NCT02238483|531422547|FG001|Overall Study|Lost to Follow-up|1|||
147342782|NCT02238483|531422546|FG000|Overall Study|Protocol Violation|1|||
147342783|NCT02238483|531422547|FG001|Overall Study|Protocol Violation|2|||
147342784|NCT02238483|531422546|FG000|Overall Study|Death|1|||
147342785|NCT02238483|531422547|FG001|Overall Study|Death|0|||
147342786|NCT02238483|531422546|FG000|Overall Study|Adverse Event|7|||
147342787|NCT02238483|531422547|FG001|Overall Study|Adverse Event|3|||
147342788|NCT02238483|531422546|FG000|Overall Study|Withdrawn due to physician decision|1|||
147342789|NCT02238483|531422547|FG001|Overall Study|Withdrawn due to physician decision|0|||
147342790|NCT02238483|531422546|FG000|Overall Study|Completion status not recorded|1|||
147342791|NCT02238483|531422547|FG001|Overall Study|Completion status not recorded|1|||
147342792|NCT02238483|531422546|FG000|Overall Study|Illness in family member|1|||
147342793|NCT02238483|531422547|FG001|Overall Study|Illness in family member|0|||
147342794|NCT00390299|531422548|FG000|Overall Study|Cancellation|1|||
147342795|NCT00390299|531422549|FG001|Overall Study|Cancellation|0|||
147342796|NCT00390299|531422550|FG002|Overall Study|Cancellation|0|||
147342797|NCT00390299|531422551|FG003|Overall Study|Cancellation|0|||
147342798|NCT00390299|531422552|FG004|Overall Study|Cancellation|0|||
147342799|NCT00331136|531422555|FG000|Overall Study|Adverse Event|3|||
147342800|NCT00331136|531422556|FG001|Overall Study|Adverse Event|5|||
147342801|NCT00331136|531422557|FG002|Overall Study|Adverse Event|0|||
147342802|NCT00331136|531422558|FG003|Overall Study|Adverse Event|1|||
147342803|NCT00331136|531422555|FG000|Overall Study|Withdrawal by Subject|0|||
147342804|NCT00331136|531422556|FG001|Overall Study|Withdrawal by Subject|1|||
147342805|NCT00331136|531422557|FG002|Overall Study|Withdrawal by Subject|0|||
147342806|NCT00331136|531422558|FG003|Overall Study|Withdrawal by Subject|0|||
147342807|NCT00331136|531422555|FG000|Overall Study|Lost to Follow-up|0|||
147342808|NCT00331136|531422556|FG001|Overall Study|Lost to Follow-up|1|||
147342809|NCT00331136|531422557|FG002|Overall Study|Lost to Follow-up|0|||
147342810|NCT00331136|531422558|FG003|Overall Study|Lost to Follow-up|0|||
147342811|NCT00331136|531422555|FG000|Overall Study|Protocol Violation|1|||
147342812|NCT00331136|531422556|FG001|Overall Study|Protocol Violation|0|||
147342813|NCT00331136|531422557|FG002|Overall Study|Protocol Violation|0|||
147342814|NCT00331136|531422558|FG003|Overall Study|Protocol Violation|0|||
147342815|NCT00331136|531422555|FG000|Overall Study|Not treated|1|||
147342816|NCT00331136|531422556|FG001|Overall Study|Not treated|0|||
147342817|NCT00331136|531422557|FG002|Overall Study|Not treated|0|||
147342818|NCT00331136|531422558|FG003|Overall Study|Not treated|0|||
147342819|NCT03750968|531422562|FG000|Overall Study|Adverse Event|2|||
147342820|NCT03750968|531422563|FG001|Overall Study|Adverse Event|0|||
147342821|NCT03750968|531422562|FG000|Overall Study|Lost to Follow-up|1|||
147342822|NCT03750968|531422563|FG001|Overall Study|Lost to Follow-up|3|||
147342823|NCT02178098|531422564|FG000|Overall Study|Withdrawal by Subject|0|||
147342824|NCT02178098|531422565|FG001|Overall Study|Withdrawal by Subject|6|||
147342825|NCT02178098|531422564|FG000|Overall Study|Adverse Event|1|||
147342826|NCT02178098|531422565|FG001|Overall Study|Adverse Event|2|||
147342827|NCT02178098|531422564|FG000|Overall Study|Protocol Violation|1|||
147342828|NCT02178098|531422565|FG001|Overall Study|Protocol Violation|1|||
147342829|NCT02178098|531422564|FG000|Overall Study|Lost to Follow-up|0|||
147342830|NCT02178098|531422565|FG001|Overall Study|Lost to Follow-up|1|||
147342831|NCT02178098|531422564|FG000|Overall Study|Sponsor Request|1|||
147342832|NCT02178098|531422565|FG001|Overall Study|Sponsor Request|0|||
147342833|NCT02178098|531422564|FG000|Overall Study|Other|2|||
147342834|NCT02178098|531422565|FG001|Overall Study|Other|2|||
147342835|NCT03101371|531422568|FG000|Overall Study|Physician Decision|0|||
147342836|NCT03101371|531422569|FG001|Overall Study|Physician Decision|1|||
147342837|NCT03101371|531422568|FG000|Overall Study|Lost to Follow-up|1|||
147342838|NCT03101371|531422569|FG001|Overall Study|Lost to Follow-up|4|||
147342839|NCT03101371|531422568|FG000|Overall Study|Did not meet eligibility criteria|2|||
147342840|NCT03101371|531422569|FG001|Overall Study|Did not meet eligibility criteria|1|||
147342841|NCT05028582|531422570|FG000|Overall Study|Lost to Follow-up|11|||
147342842|NCT05028582|531422571|FG001|Overall Study|Lost to Follow-up|9|||
147342843|NCT05028582|531422570|FG000|Overall Study|Withdrawal by Subject|9|||
147342844|NCT05028582|531422571|FG001|Overall Study|Withdrawal by Subject|10|||
147342845|NCT05028582|531422570|FG000|Overall Study|Adverse Event|5|||
147342846|NCT05028582|531422571|FG001|Overall Study|Adverse Event|2|||
147342847|NCT05028582|531422570|FG000|Overall Study|Miscellaneous|3|||
147606557|NCT01111825|532375251|FG002|Overall Study|Discontinuation by Sponsor|0|||
147342848|NCT05028582|531422571|FG001|Overall Study|Miscellaneous|2|||
147342849|NCT05028582|531422570|FG000|Overall Study|Lack of Efficacy|3|||
147342850|NCT05028582|531422571|FG001|Overall Study|Lack of Efficacy|1|||
147342851|NCT05028582|531422570|FG000|Overall Study|Physician Decision|0|||
147342852|NCT05028582|531422571|FG001|Overall Study|Physician Decision|1|||
147342853|NCT04939246|531422572|FG000|After Treatment|Death|4|||
147342854|NCT04939246|531422572|FG000|After Treatment|Lost to Follow-up|1|||
147342855|NCT04939246|531422572|FG000|After Treatment|Discharged to hospice|2|||
147342856|NCT02576509|531423943|FG000|Pre-Treatment Period|Participant request to stop therapy|0|||
147342857|NCT02576509|531423944|FG001|Pre-Treatment Period|Participant request to stop therapy|2|||
147342858|NCT02576509|531423943|FG000|Pre-Treatment Period|Participant withdrew consent|1|||
147342859|NCT02576509|531423944|FG001|Pre-Treatment Period|Participant withdrew consent|5|||
147342860|NCT02576509|531423943|FG000|Pre-Treatment Period|Participant no longer meets criteria|3|||
147342861|NCT02576509|531423944|FG001|Pre-Treatment Period|Participant no longer meets criteria|2|||
147342862|NCT02576509|531423943|FG000|Treatment Period|Disease progression|263|||
147342863|NCT02576509|531423944|FG001|Treatment Period|Disease progression|244|||
147342864|NCT02576509|531423943|FG000|Treatment Period|Study drug toxicity|37|||
147342865|NCT02576509|531423944|FG001|Treatment Period|Study drug toxicity|41|||
147342866|NCT02576509|531423943|FG000|Treatment Period|Death|1|||
147342867|NCT02576509|531423944|FG001|Treatment Period|Death|1|||
147342868|NCT02576509|531423943|FG000|Treatment Period|Adverse event unrelated to study drug|39|||
147342869|NCT02576509|531423944|FG001|Treatment Period|Adverse event unrelated to study drug|41|||
147342870|NCT02576509|531423943|FG000|Treatment Period|Participant request to stop treatment|8|||
147342871|NCT02576509|531423944|FG001|Treatment Period|Participant request to stop treatment|18|||
147342872|NCT02576509|531423943|FG000|Treatment Period|Participant withdrew consent|3|||
147342873|NCT02576509|531423944|FG001|Treatment Period|Participant withdrew consent|7|||
147342874|NCT02576509|531423943|FG000|Treatment Period|Lost to Follow-up|0|||
147342875|NCT02576509|531423944|FG001|Treatment Period|Lost to Follow-up|1|||
147342876|NCT02576509|531423943|FG000|Treatment Period|Maximum clinical benefit|1|||
147342877|NCT02576509|531423944|FG001|Treatment Period|Maximum clinical benefit|0|||
147342878|NCT02576509|531423943|FG000|Treatment Period|Poor/non-compliance|1|||
147342879|NCT02576509|531423944|FG001|Treatment Period|Poor/non-compliance|1|||
147342880|NCT02576509|531423943|FG000|Treatment Period|Participant no longer meets criteria|1|||
147342881|NCT02576509|531423944|FG001|Treatment Period|Participant no longer meets criteria|0|||
147342882|NCT02576509|531423943|FG000|Treatment Period|Other reason|12|||
147342883|NCT02576509|531423944|FG001|Treatment Period|Other reason|8|||
147342884|NCT02576509|531423943|FG000|Treatment Period|NOT REPORTED|1|||
147342885|NCT02576509|531423944|FG001|Treatment Period|NOT REPORTED|0|||
147342886|NCT02576509|531423943|FG000|Treatment Period|Administrative reason by sponsor|0|||
147342887|NCT02576509|531423944|FG001|Treatment Period|Administrative reason by sponsor|1|||
147342888|NCT03398148|531423945|FG000|Substudy 1 Period 1|Adverse Event|5|||
147342889|NCT03398148|531423946|FG001|Substudy 1 Period 1|Adverse Event|2|||
147342890|NCT03398148|531423947|FG002|Substudy 1 Period 1|Adverse Event|2|||
147342891|NCT03398148|531423948|FG003|Substudy 1 Period 1|Adverse Event|0|||
147342892|NCT03398148|531423949|FG004|Substudy 1 Period 1|Adverse Event|8|||
147342893|NCT03398148|531423950|FG005|Substudy 1 Period 1|Adverse Event|0|||
147342894|NCT03398148|531423951|FG006|Substudy 1 Period 1|Adverse Event|0|||
147342895|NCT03398148|531423952|FG007|Substudy 1 Period 1|Adverse Event|0|||
147342896|NCT03398148|531423953|FG008|Substudy 1 Period 1|Adverse Event|0|||
147342897|NCT03398148|531423954|FG009|Substudy 1 Period 1|Adverse Event|0|||
147342898|NCT03398148|531423955|FG010|Substudy 1 Period 1|Adverse Event|0|||
147342899|NCT03398148|531423956|FG011|Substudy 1 Period 1|Adverse Event|0|||
147342900|NCT03398148|531423957|FG012|Substudy 1 Period 1|Adverse Event|0|||
147342901|NCT03398148|531423958|FG013|Substudy 1 Period 1|Adverse Event|0|||
147342902|NCT03398148|531423959|FG014|Substudy 1 Period 1|Adverse Event|0|||
147342903|NCT03398148|531423945|FG000|Substudy 1 Period 1|WITHDREW CONSENT|1|||
147342904|NCT03398148|531423946|FG001|Substudy 1 Period 1|WITHDREW CONSENT|2|||
147342905|NCT03398148|531423947|FG002|Substudy 1 Period 1|WITHDREW CONSENT|0|||
147342906|NCT03398148|531423948|FG003|Substudy 1 Period 1|WITHDREW CONSENT|1|||
147342907|NCT03398148|531423949|FG004|Substudy 1 Period 1|WITHDREW CONSENT|3|||
147606558|NCT01111825|532375252|FG003|Overall Study|Discontinuation by Sponsor|20|||
147606559|NCT01377987|532375255|FG000|Washout (7 Days)|Withdrawal by Subject|1|||
147342908|NCT03398148|531423950|FG005|Substudy 1 Period 1|WITHDREW CONSENT|0|||
147342909|NCT03398148|531423951|FG006|Substudy 1 Period 1|WITHDREW CONSENT|0|||
147342910|NCT03398148|531423952|FG007|Substudy 1 Period 1|WITHDREW CONSENT|0|||
147342911|NCT03398148|531423953|FG008|Substudy 1 Period 1|WITHDREW CONSENT|0|||
147342912|NCT03398148|531423954|FG009|Substudy 1 Period 1|WITHDREW CONSENT|0|||
147342913|NCT03398148|531423955|FG010|Substudy 1 Period 1|WITHDREW CONSENT|0|||
147342914|NCT03398148|531423956|FG011|Substudy 1 Period 1|WITHDREW CONSENT|0|||
147342915|NCT03398148|531423957|FG012|Substudy 1 Period 1|WITHDREW CONSENT|0|||
147342916|NCT03398148|531423958|FG013|Substudy 1 Period 1|WITHDREW CONSENT|0|||
147342917|NCT03398148|531423959|FG014|Substudy 1 Period 1|WITHDREW CONSENT|0|||
147342918|NCT03398148|531423945|FG000|Substudy 1 Period 1|Lack of Efficacy|1|||
147342919|NCT03398148|531423946|FG001|Substudy 1 Period 1|Lack of Efficacy|1|||
147342920|NCT03398148|531423947|FG002|Substudy 1 Period 1|Lack of Efficacy|1|||
147342921|NCT03398148|531423948|FG003|Substudy 1 Period 1|Lack of Efficacy|0|||
147342922|NCT03398148|531423949|FG004|Substudy 1 Period 1|Lack of Efficacy|20|||
147342923|NCT03398148|531423950|FG005|Substudy 1 Period 1|Lack of Efficacy|0|||
147342924|NCT03398148|531423951|FG006|Substudy 1 Period 1|Lack of Efficacy|0|||
147342925|NCT03398148|531423952|FG007|Substudy 1 Period 1|Lack of Efficacy|0|||
147342926|NCT03398148|531423953|FG008|Substudy 1 Period 1|Lack of Efficacy|0|||
147342927|NCT03398148|531423954|FG009|Substudy 1 Period 1|Lack of Efficacy|0|||
147342928|NCT03398148|531423955|FG010|Substudy 1 Period 1|Lack of Efficacy|0|||
147342929|NCT03398148|531423956|FG011|Substudy 1 Period 1|Lack of Efficacy|0|||
147342930|NCT03398148|531423957|FG012|Substudy 1 Period 1|Lack of Efficacy|0|||
147342931|NCT03398148|531423958|FG013|Substudy 1 Period 1|Lack of Efficacy|0|||
147342932|NCT03398148|531423959|FG014|Substudy 1 Period 1|Lack of Efficacy|0|||
147342933|NCT03398148|531423945|FG000|Substudy 1 Period 1|Other|0|||
147342934|NCT03398148|531423946|FG001|Substudy 1 Period 1|Other|1|||
147342935|NCT03398148|531423947|FG002|Substudy 1 Period 1|Other|0|||
147342936|NCT03398148|531423948|FG003|Substudy 1 Period 1|Other|0|||
147342937|NCT03398148|531423949|FG004|Substudy 1 Period 1|Other|3|||
147342938|NCT03398148|531423950|FG005|Substudy 1 Period 1|Other|0|||
147342939|NCT03398148|531423951|FG006|Substudy 1 Period 1|Other|0|||
147342940|NCT03398148|531423952|FG007|Substudy 1 Period 1|Other|0|||
147342941|NCT03398148|531423953|FG008|Substudy 1 Period 1|Other|0|||
147342942|NCT03398148|531423954|FG009|Substudy 1 Period 1|Other|0|||
147342943|NCT03398148|531423955|FG010|Substudy 1 Period 1|Other|0|||
147342944|NCT03398148|531423956|FG011|Substudy 1 Period 1|Other|0|||
147342945|NCT03398148|531423957|FG012|Substudy 1 Period 1|Other|0|||
147342946|NCT03398148|531423958|FG013|Substudy 1 Period 1|Other|0|||
147342947|NCT03398148|531423959|FG014|Substudy 1 Period 1|Other|0|||
147342948|NCT03398148|531423945|FG000|Substudy 1 Period 1|Enrolled but not Treated|0|||
147342949|NCT03398148|531423946|FG001|Substudy 1 Period 1|Enrolled but not Treated|0|||
147342950|NCT03398148|531423947|FG002|Substudy 1 Period 1|Enrolled but not Treated|0|||
147342951|NCT03398148|531423948|FG003|Substudy 1 Period 1|Enrolled but not Treated|0|||
147342952|NCT03398148|531423949|FG004|Substudy 1 Period 1|Enrolled but not Treated|1|||
147342953|NCT03398148|531423950|FG005|Substudy 1 Period 1|Enrolled but not Treated|0|||
147342954|NCT03398148|531423951|FG006|Substudy 1 Period 1|Enrolled but not Treated|0|||
147342955|NCT03398148|531423952|FG007|Substudy 1 Period 1|Enrolled but not Treated|0|||
147342956|NCT03398148|531423953|FG008|Substudy 1 Period 1|Enrolled but not Treated|0|||
147342957|NCT03398148|531423954|FG009|Substudy 1 Period 1|Enrolled but not Treated|0|||
147342958|NCT03398148|531423955|FG010|Substudy 1 Period 1|Enrolled but not Treated|0|||
147342959|NCT03398148|531423956|FG011|Substudy 1 Period 1|Enrolled but not Treated|0|||
147342960|NCT03398148|531423957|FG012|Substudy 1 Period 1|Enrolled but not Treated|0|||
147342961|NCT03398148|531423958|FG013|Substudy 1 Period 1|Enrolled but not Treated|0|||
147342962|NCT03398148|531423959|FG014|Substudy 1 Period 1|Enrolled but not Treated|0|||
147342963|NCT03398148|531423945|FG000|Substudy 1 Period 2|Adverse Event|0|||
147342964|NCT03398148|531423946|FG001|Substudy 1 Period 2|Adverse Event|0|||
147342965|NCT03398148|531423947|FG002|Substudy 1 Period 2|Adverse Event|0|||
147342966|NCT03398148|531423948|FG003|Substudy 1 Period 2|Adverse Event|0|||
147342967|NCT03398148|531423949|FG004|Substudy 1 Period 2|Adverse Event|0|||
147342968|NCT03398148|531423950|FG005|Substudy 1 Period 2|Adverse Event|2|||
147342969|NCT03398148|531423951|FG006|Substudy 1 Period 2|Adverse Event|4|||
147342970|NCT03398148|531423952|FG007|Substudy 1 Period 2|Adverse Event|0|||
147342971|NCT03398148|531423953|FG008|Substudy 1 Period 2|Adverse Event|0|||
147342972|NCT03398148|531423954|FG009|Substudy 1 Period 2|Adverse Event|0|||
147342973|NCT03398148|531423955|FG010|Substudy 1 Period 2|Adverse Event|0|||
147342974|NCT03398148|531423956|FG011|Substudy 1 Period 2|Adverse Event|0|||
147342975|NCT03398148|531423957|FG012|Substudy 1 Period 2|Adverse Event|0|||
147342976|NCT03398148|531423958|FG013|Substudy 1 Period 2|Adverse Event|0|||
147342977|NCT03398148|531423959|FG014|Substudy 1 Period 2|Adverse Event|0|||
147342978|NCT03398148|531423945|FG000|Substudy 1 Period 2|WITHDREW CONSENT|0|||
147342979|NCT03398148|531423946|FG001|Substudy 1 Period 2|WITHDREW CONSENT|0|||
147342980|NCT03398148|531423947|FG002|Substudy 1 Period 2|WITHDREW CONSENT|0|||
147342981|NCT03398148|531423948|FG003|Substudy 1 Period 2|WITHDREW CONSENT|0|||
147342982|NCT03398148|531423949|FG004|Substudy 1 Period 2|WITHDREW CONSENT|0|||
147342983|NCT03398148|531423950|FG005|Substudy 1 Period 2|WITHDREW CONSENT|0|||
147342984|NCT03398148|531423951|FG006|Substudy 1 Period 2|WITHDREW CONSENT|1|||
147342985|NCT03398148|531423952|FG007|Substudy 1 Period 2|WITHDREW CONSENT|2|||
147342986|NCT03398148|531423953|FG008|Substudy 1 Period 2|WITHDREW CONSENT|0|||
147342987|NCT03398148|531423954|FG009|Substudy 1 Period 2|WITHDREW CONSENT|0|||
147342988|NCT03398148|531423955|FG010|Substudy 1 Period 2|WITHDREW CONSENT|0|||
147342989|NCT03398148|531423956|FG011|Substudy 1 Period 2|WITHDREW CONSENT|0|||
147342990|NCT03398148|531423957|FG012|Substudy 1 Period 2|WITHDREW CONSENT|0|||
147342991|NCT03398148|531423958|FG013|Substudy 1 Period 2|WITHDREW CONSENT|0|||
147342992|NCT03398148|531423959|FG014|Substudy 1 Period 2|WITHDREW CONSENT|0|||
147342993|NCT03398148|531423945|FG000|Substudy 1 Period 2|Lack of Efficacy|0|||
147342994|NCT03398148|531423946|FG001|Substudy 1 Period 2|Lack of Efficacy|0|||
147342995|NCT03398148|531423947|FG002|Substudy 1 Period 2|Lack of Efficacy|0|||
147342996|NCT03398148|531423948|FG003|Substudy 1 Period 2|Lack of Efficacy|0|||
147342997|NCT03398148|531423949|FG004|Substudy 1 Period 2|Lack of Efficacy|0|||
147342998|NCT03398148|531423950|FG005|Substudy 1 Period 2|Lack of Efficacy|5|||
147342999|NCT03398148|531423951|FG006|Substudy 1 Period 2|Lack of Efficacy|5|||
147343000|NCT03398148|531423952|FG007|Substudy 1 Period 2|Lack of Efficacy|0|||
147343001|NCT03398148|531423953|FG008|Substudy 1 Period 2|Lack of Efficacy|2|||
147343002|NCT03398148|531423954|FG009|Substudy 1 Period 2|Lack of Efficacy|0|||
147343003|NCT03398148|531423955|FG010|Substudy 1 Period 2|Lack of Efficacy|0|||
147343004|NCT03398148|531423956|FG011|Substudy 1 Period 2|Lack of Efficacy|0|||
147343005|NCT03398148|531423957|FG012|Substudy 1 Period 2|Lack of Efficacy|0|||
147343006|NCT03398148|531423958|FG013|Substudy 1 Period 2|Lack of Efficacy|0|||
147343007|NCT03398148|531423959|FG014|Substudy 1 Period 2|Lack of Efficacy|0|||
147343008|NCT03398148|531423945|FG000|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
147343009|NCT03398148|531423946|FG001|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
147343010|NCT03398148|531423947|FG002|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
147343011|NCT03398148|531423948|FG003|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
147343012|NCT03398148|531423949|FG004|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
147343013|NCT03398148|531423950|FG005|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
147343014|NCT03398148|531423951|FG006|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|1|||
147343015|NCT03398148|531423952|FG007|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
147343016|NCT03398148|531423953|FG008|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
147343017|NCT03398148|531423954|FG009|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
147343018|NCT03398148|531423955|FG010|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
147343019|NCT03398148|531423956|FG011|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
147343020|NCT03398148|531423957|FG012|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
147343021|NCT03398148|531423958|FG013|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
147343022|NCT03398148|531423959|FG014|Substudy 1 Period 2|COVID-19 LOGISTICAL RESTRICTIONS|0|||
147343023|NCT03398148|531423945|FG000|Substudy 1 Period 2|Other|0|||
147343024|NCT03398148|531423946|FG001|Substudy 1 Period 2|Other|0|||
147343025|NCT03398148|531423947|FG002|Substudy 1 Period 2|Other|0|||
147343026|NCT03398148|531423948|FG003|Substudy 1 Period 2|Other|0|||
147343027|NCT03398148|531423949|FG004|Substudy 1 Period 2|Other|0|||
147343028|NCT03398148|531423950|FG005|Substudy 1 Period 2|Other|0|||
147343029|NCT03398148|531423951|FG006|Substudy 1 Period 2|Other|1|||
147343030|NCT03398148|531423952|FG007|Substudy 1 Period 2|Other|0|||
147343031|NCT03398148|531423953|FG008|Substudy 1 Period 2|Other|0|||
147343032|NCT03398148|531423954|FG009|Substudy 1 Period 2|Other|0|||
147343033|NCT03398148|531423955|FG010|Substudy 1 Period 2|Other|0|||
147343034|NCT03398148|531423956|FG011|Substudy 1 Period 2|Other|0|||
147343035|NCT03398148|531423957|FG012|Substudy 1 Period 2|Other|0|||
147343036|NCT03398148|531423958|FG013|Substudy 1 Period 2|Other|0|||
147343037|NCT03398148|531423959|FG014|Substudy 1 Period 2|Other|0|||
147343038|NCT03398148|531423945|FG000|Substudy 1 Period 2|Enrolled but not Treated|0|||
147343039|NCT03398148|531423946|FG001|Substudy 1 Period 2|Enrolled but not Treated|0|||
147343040|NCT03398148|531423947|FG002|Substudy 1 Period 2|Enrolled but not Treated|0|||
147343041|NCT03398148|531423948|FG003|Substudy 1 Period 2|Enrolled but not Treated|0|||
147343042|NCT03398148|531423949|FG004|Substudy 1 Period 2|Enrolled but not Treated|0|||
147343043|NCT03398148|531423950|FG005|Substudy 1 Period 2|Enrolled but not Treated|0|||
147343044|NCT03398148|531423951|FG006|Substudy 1 Period 2|Enrolled but not Treated|1|||
147343045|NCT03398148|531423952|FG007|Substudy 1 Period 2|Enrolled but not Treated|0|||
147343046|NCT03398148|531423953|FG008|Substudy 1 Period 2|Enrolled but not Treated|0|||
147343047|NCT03398148|531423954|FG009|Substudy 1 Period 2|Enrolled but not Treated|0|||
147343048|NCT03398148|531423955|FG010|Substudy 1 Period 2|Enrolled but not Treated|0|||
147343049|NCT03398148|531423956|FG011|Substudy 1 Period 2|Enrolled but not Treated|0|||
147343050|NCT03398148|531423957|FG012|Substudy 1 Period 2|Enrolled but not Treated|0|||
147343051|NCT03398148|531423958|FG013|Substudy 1 Period 2|Enrolled but not Treated|0|||
147343052|NCT03398148|531423959|FG014|Substudy 1 Period 2|Enrolled but not Treated|0|||
147343053|NCT03398148|531423945|FG000|Substudy 2 Period 1|Adverse Event|0|||
147343054|NCT03398148|531423946|FG001|Substudy 2 Period 1|Adverse Event|0|||
147343055|NCT03398148|531423947|FG002|Substudy 2 Period 1|Adverse Event|0|||
147343056|NCT03398148|531423948|FG003|Substudy 2 Period 1|Adverse Event|0|||
147343057|NCT03398148|531423949|FG004|Substudy 2 Period 1|Adverse Event|0|||
147343058|NCT03398148|531423950|FG005|Substudy 2 Period 1|Adverse Event|0|||
147343059|NCT03398148|531423951|FG006|Substudy 2 Period 1|Adverse Event|0|||
147343060|NCT03398148|531423952|FG007|Substudy 2 Period 1|Adverse Event|0|||
147343061|NCT03398148|531423953|FG008|Substudy 2 Period 1|Adverse Event|0|||
147343062|NCT03398148|531423954|FG009|Substudy 2 Period 1|Adverse Event|12|||
147343063|NCT03398148|531423955|FG010|Substudy 2 Period 1|Adverse Event|2|||
147343064|NCT03398148|531423956|FG011|Substudy 2 Period 1|Adverse Event|0|||
147343065|NCT03398148|531423957|FG012|Substudy 2 Period 1|Adverse Event|0|||
147343066|NCT03398148|531423958|FG013|Substudy 2 Period 1|Adverse Event|0|||
147343067|NCT03398148|531423959|FG014|Substudy 2 Period 1|Adverse Event|0|||
147343068|NCT03398148|531423945|FG000|Substudy 2 Period 1|WITHDREW CONSENT|0|||
147343069|NCT03398148|531423946|FG001|Substudy 2 Period 1|WITHDREW CONSENT|0|||
147343070|NCT03398148|531423947|FG002|Substudy 2 Period 1|WITHDREW CONSENT|0|||
147343071|NCT03398148|531423948|FG003|Substudy 2 Period 1|WITHDREW CONSENT|0|||
147343072|NCT03398148|531423949|FG004|Substudy 2 Period 1|WITHDREW CONSENT|0|||
147343073|NCT03398148|531423950|FG005|Substudy 2 Period 1|WITHDREW CONSENT|0|||
147343074|NCT03398148|531423951|FG006|Substudy 2 Period 1|WITHDREW CONSENT|0|||
147343075|NCT03398148|531423952|FG007|Substudy 2 Period 1|WITHDREW CONSENT|0|||
147343076|NCT03398148|531423953|FG008|Substudy 2 Period 1|WITHDREW CONSENT|0|||
147343077|NCT03398148|531423954|FG009|Substudy 2 Period 1|WITHDREW CONSENT|6|||
147343078|NCT03398148|531423955|FG010|Substudy 2 Period 1|WITHDREW CONSENT|4|||
147343079|NCT03398148|531423956|FG011|Substudy 2 Period 1|WITHDREW CONSENT|0|||
147343080|NCT03398148|531423957|FG012|Substudy 2 Period 1|WITHDREW CONSENT|0|||
147343081|NCT03398148|531423958|FG013|Substudy 2 Period 1|WITHDREW CONSENT|0|||
147343082|NCT03398148|531423959|FG014|Substudy 2 Period 1|WITHDREW CONSENT|0|||
147343083|NCT03398148|531423945|FG000|Substudy 2 Period 1|Lack of Efficacy|0|||
147343084|NCT03398148|531423946|FG001|Substudy 2 Period 1|Lack of Efficacy|0|||
147343085|NCT03398148|531423947|FG002|Substudy 2 Period 1|Lack of Efficacy|0|||
147343086|NCT03398148|531423948|FG003|Substudy 2 Period 1|Lack of Efficacy|0|||
147343087|NCT03398148|531423949|FG004|Substudy 2 Period 1|Lack of Efficacy|0|||
147343088|NCT03398148|531423950|FG005|Substudy 2 Period 1|Lack of Efficacy|0|||
147343089|NCT03398148|531423951|FG006|Substudy 2 Period 1|Lack of Efficacy|0|||
147343090|NCT03398148|531423952|FG007|Substudy 2 Period 1|Lack of Efficacy|0|||
147343091|NCT03398148|531423953|FG008|Substudy 2 Period 1|Lack of Efficacy|0|||
147343092|NCT03398148|531423954|FG009|Substudy 2 Period 1|Lack of Efficacy|6|||
147343093|NCT03398148|531423955|FG010|Substudy 2 Period 1|Lack of Efficacy|1|||
147343094|NCT03398148|531423956|FG011|Substudy 2 Period 1|Lack of Efficacy|0|||
147343095|NCT03398148|531423957|FG012|Substudy 2 Period 1|Lack of Efficacy|0|||
147343096|NCT03398148|531423958|FG013|Substudy 2 Period 1|Lack of Efficacy|0|||
147343097|NCT03398148|531423959|FG014|Substudy 2 Period 1|Lack of Efficacy|0|||
147343098|NCT03398148|531423945|FG000|Substudy 2 Period 1|COVID-19 INFECTION|0|||
147343099|NCT03398148|531423946|FG001|Substudy 2 Period 1|COVID-19 INFECTION|0|||
147343100|NCT03398148|531423947|FG002|Substudy 2 Period 1|COVID-19 INFECTION|0|||
147343101|NCT03398148|531423948|FG003|Substudy 2 Period 1|COVID-19 INFECTION|0|||
147343102|NCT03398148|531423949|FG004|Substudy 2 Period 1|COVID-19 INFECTION|0|||
147343103|NCT03398148|531423950|FG005|Substudy 2 Period 1|COVID-19 INFECTION|0|||
147343104|NCT03398148|531423951|FG006|Substudy 2 Period 1|COVID-19 INFECTION|0|||
147343105|NCT03398148|531423952|FG007|Substudy 2 Period 1|COVID-19 INFECTION|0|||
147343106|NCT03398148|531423953|FG008|Substudy 2 Period 1|COVID-19 INFECTION|0|||
147343107|NCT03398148|531423954|FG009|Substudy 2 Period 1|COVID-19 INFECTION|0|||
147343108|NCT03398148|531423955|FG010|Substudy 2 Period 1|COVID-19 INFECTION|1|||
147343109|NCT03398148|531423956|FG011|Substudy 2 Period 1|COVID-19 INFECTION|0|||
147343110|NCT03398148|531423957|FG012|Substudy 2 Period 1|COVID-19 INFECTION|0|||
147343111|NCT03398148|531423958|FG013|Substudy 2 Period 1|COVID-19 INFECTION|0|||
147343112|NCT03398148|531423959|FG014|Substudy 2 Period 1|COVID-19 INFECTION|0|||
147343113|NCT03398148|531423945|FG000|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
147343114|NCT03398148|531423946|FG001|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
147343115|NCT03398148|531423947|FG002|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
147343116|NCT03398148|531423948|FG003|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
147343117|NCT03398148|531423949|FG004|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
147343118|NCT03398148|531423950|FG005|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
147343119|NCT03398148|531423951|FG006|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
147343120|NCT03398148|531423952|FG007|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
147343121|NCT03398148|531423953|FG008|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
147343122|NCT03398148|531423954|FG009|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
147343123|NCT03398148|531423955|FG010|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|1|||
147343124|NCT03398148|531423956|FG011|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
147343125|NCT03398148|531423957|FG012|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
147343126|NCT03398148|531423958|FG013|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
147343127|NCT03398148|531423959|FG014|Substudy 2 Period 1|COVID-19 LOGISTICAL RESTRICTIONS|0|||
147343128|NCT03398148|531423945|FG000|Substudy 2 Period 1|Other|0|||
147343129|NCT03398148|531423946|FG001|Substudy 2 Period 1|Other|0|||
147343130|NCT03398148|531423947|FG002|Substudy 2 Period 1|Other|0|||
147343131|NCT03398148|531423948|FG003|Substudy 2 Period 1|Other|0|||
147343132|NCT03398148|531423949|FG004|Substudy 2 Period 1|Other|0|||
147343133|NCT03398148|531423950|FG005|Substudy 2 Period 1|Other|0|||
147343134|NCT03398148|531423951|FG006|Substudy 2 Period 1|Other|0|||
147343135|NCT03398148|531423952|FG007|Substudy 2 Period 1|Other|0|||
147343136|NCT03398148|531423953|FG008|Substudy 2 Period 1|Other|0|||
147343137|NCT03398148|531423954|FG009|Substudy 2 Period 1|Other|4|||
147343138|NCT03398148|531423955|FG010|Substudy 2 Period 1|Other|4|||
147343139|NCT03398148|531423956|FG011|Substudy 2 Period 1|Other|0|||
147343140|NCT03398148|531423957|FG012|Substudy 2 Period 1|Other|0|||
147343141|NCT03398148|531423958|FG013|Substudy 2 Period 1|Other|0|||
147343142|NCT03398148|531423959|FG014|Substudy 2 Period 1|Other|0|||
147343143|NCT03398148|531423945|FG000|Substudy 2 Period 1|Enrolled but not Treated|0|||
147343144|NCT03398148|531423946|FG001|Substudy 2 Period 1|Enrolled but not Treated|0|||
147343145|NCT03398148|531423947|FG002|Substudy 2 Period 1|Enrolled but not Treated|0|||
147453094|NCT01142726|531821537|FG000|Withdrawal Phase: Months 12 up to 24|Withdrawal by Subject|1|||
147343146|NCT03398148|531423948|FG003|Substudy 2 Period 1|Enrolled but not Treated|0|||
147343147|NCT03398148|531423949|FG004|Substudy 2 Period 1|Enrolled but not Treated|0|||
147343148|NCT03398148|531423950|FG005|Substudy 2 Period 1|Enrolled but not Treated|0|||
147343149|NCT03398148|531423951|FG006|Substudy 2 Period 1|Enrolled but not Treated|0|||
147343150|NCT03398148|531423952|FG007|Substudy 2 Period 1|Enrolled but not Treated|0|||
147343151|NCT03398148|531423953|FG008|Substudy 2 Period 1|Enrolled but not Treated|0|||
147343152|NCT03398148|531423954|FG009|Substudy 2 Period 1|Enrolled but not Treated|0|||
147343153|NCT03398148|531423955|FG010|Substudy 2 Period 1|Enrolled but not Treated|2|||
147343154|NCT03398148|531423956|FG011|Substudy 2 Period 1|Enrolled but not Treated|0|||
147343155|NCT03398148|531423957|FG012|Substudy 2 Period 1|Enrolled but not Treated|0|||
147343156|NCT03398148|531423958|FG013|Substudy 2 Period 1|Enrolled but not Treated|0|||
147343157|NCT03398148|531423959|FG014|Substudy 2 Period 1|Enrolled but not Treated|0|||
147343158|NCT03398148|531423945|FG000|Substudy 2 Period 2|Adverse Event|0|||
147343159|NCT03398148|531423946|FG001|Substudy 2 Period 2|Adverse Event|0|||
147343160|NCT03398148|531423947|FG002|Substudy 2 Period 2|Adverse Event|0|||
147343161|NCT03398148|531423948|FG003|Substudy 2 Period 2|Adverse Event|0|||
147343162|NCT03398148|531423949|FG004|Substudy 2 Period 2|Adverse Event|0|||
147343163|NCT03398148|531423950|FG005|Substudy 2 Period 2|Adverse Event|0|||
147343164|NCT03398148|531423951|FG006|Substudy 2 Period 2|Adverse Event|0|||
147343165|NCT03398148|531423952|FG007|Substudy 2 Period 2|Adverse Event|0|||
147343166|NCT03398148|531423953|FG008|Substudy 2 Period 2|Adverse Event|0|||
147343167|NCT03398148|531423954|FG009|Substudy 2 Period 2|Adverse Event|0|||
147343168|NCT03398148|531423955|FG010|Substudy 2 Period 2|Adverse Event|0|||
147343169|NCT03398148|531423956|FG011|Substudy 2 Period 2|Adverse Event|0|||
147343170|NCT03398148|531423957|FG012|Substudy 2 Period 2|Adverse Event|0|||
147343171|NCT03398148|531423958|FG013|Substudy 2 Period 2|Adverse Event|1|||
147343172|NCT03398148|531423959|FG014|Substudy 2 Period 2|Adverse Event|3|||
147343173|NCT03398148|531423945|FG000|Substudy 2 Period 2|Lost to Follow-up|0|||
147343174|NCT03398148|531423946|FG001|Substudy 2 Period 2|Lost to Follow-up|0|||
147343175|NCT03398148|531423947|FG002|Substudy 2 Period 2|Lost to Follow-up|0|||
147343176|NCT03398148|531423948|FG003|Substudy 2 Period 2|Lost to Follow-up|0|||
147343177|NCT03398148|531423949|FG004|Substudy 2 Period 2|Lost to Follow-up|0|||
147343178|NCT03398148|531423950|FG005|Substudy 2 Period 2|Lost to Follow-up|0|||
147343179|NCT03398148|531423951|FG006|Substudy 2 Period 2|Lost to Follow-up|0|||
147343180|NCT03398148|531423952|FG007|Substudy 2 Period 2|Lost to Follow-up|0|||
147343181|NCT03398148|531423953|FG008|Substudy 2 Period 2|Lost to Follow-up|0|||
147343182|NCT03398148|531423954|FG009|Substudy 2 Period 2|Lost to Follow-up|0|||
147343183|NCT03398148|531423955|FG010|Substudy 2 Period 2|Lost to Follow-up|0|||
147343184|NCT03398148|531423956|FG011|Substudy 2 Period 2|Lost to Follow-up|1|||
147343185|NCT03398148|531423957|FG012|Substudy 2 Period 2|Lost to Follow-up|1|||
147343186|NCT03398148|531423958|FG013|Substudy 2 Period 2|Lost to Follow-up|0|||
147343187|NCT03398148|531423959|FG014|Substudy 2 Period 2|Lost to Follow-up|0|||
147343188|NCT03398148|531423945|FG000|Substudy 2 Period 2|WITHDREW CONSENT|0|||
147343189|NCT03398148|531423946|FG001|Substudy 2 Period 2|WITHDREW CONSENT|0|||
147343190|NCT03398148|531423947|FG002|Substudy 2 Period 2|WITHDREW CONSENT|0|||
147343191|NCT03398148|531423948|FG003|Substudy 2 Period 2|WITHDREW CONSENT|0|||
147343192|NCT03398148|531423949|FG004|Substudy 2 Period 2|WITHDREW CONSENT|0|||
147343193|NCT03398148|531423950|FG005|Substudy 2 Period 2|WITHDREW CONSENT|0|||
147343194|NCT03398148|531423951|FG006|Substudy 2 Period 2|WITHDREW CONSENT|0|||
147343195|NCT03398148|531423952|FG007|Substudy 2 Period 2|WITHDREW CONSENT|0|||
147343196|NCT03398148|531423953|FG008|Substudy 2 Period 2|WITHDREW CONSENT|0|||
147343197|NCT03398148|531423954|FG009|Substudy 2 Period 2|WITHDREW CONSENT|0|||
147343198|NCT03398148|531423955|FG010|Substudy 2 Period 2|WITHDREW CONSENT|0|||
147343199|NCT03398148|531423956|FG011|Substudy 2 Period 2|WITHDREW CONSENT|4|||
147343200|NCT03398148|531423957|FG012|Substudy 2 Period 2|WITHDREW CONSENT|0|||
147343201|NCT03398148|531423958|FG013|Substudy 2 Period 2|WITHDREW CONSENT|2|||
147343202|NCT03398148|531423959|FG014|Substudy 2 Period 2|WITHDREW CONSENT|1|||
147343203|NCT03398148|531423945|FG000|Substudy 2 Period 2|Lack of Efficacy|0|||
147343204|NCT03398148|531423946|FG001|Substudy 2 Period 2|Lack of Efficacy|0|||
147343205|NCT03398148|531423947|FG002|Substudy 2 Period 2|Lack of Efficacy|0|||
147343206|NCT03398148|531423948|FG003|Substudy 2 Period 2|Lack of Efficacy|0|||
147343207|NCT03398148|531423949|FG004|Substudy 2 Period 2|Lack of Efficacy|0|||
147343208|NCT03398148|531423950|FG005|Substudy 2 Period 2|Lack of Efficacy|0|||
147343209|NCT03398148|531423951|FG006|Substudy 2 Period 2|Lack of Efficacy|0|||
147343210|NCT03398148|531423952|FG007|Substudy 2 Period 2|Lack of Efficacy|0|||
147343211|NCT03398148|531423953|FG008|Substudy 2 Period 2|Lack of Efficacy|0|||
147343212|NCT03398148|531423954|FG009|Substudy 2 Period 2|Lack of Efficacy|0|||
147343213|NCT03398148|531423955|FG010|Substudy 2 Period 2|Lack of Efficacy|0|||
147343214|NCT03398148|531423956|FG011|Substudy 2 Period 2|Lack of Efficacy|1|||
147343215|NCT03398148|531423957|FG012|Substudy 2 Period 2|Lack of Efficacy|4|||
147343216|NCT03398148|531423958|FG013|Substudy 2 Period 2|Lack of Efficacy|3|||
147343217|NCT03398148|531423959|FG014|Substudy 2 Period 2|Lack of Efficacy|4|||
147343218|NCT03398148|531423945|FG000|Substudy 2 Period 2|Other|0|||
147343219|NCT03398148|531423946|FG001|Substudy 2 Period 2|Other|0|||
147343220|NCT03398148|531423947|FG002|Substudy 2 Period 2|Other|0|||
147343221|NCT03398148|531423948|FG003|Substudy 2 Period 2|Other|0|||
147343222|NCT03398148|531423949|FG004|Substudy 2 Period 2|Other|0|||
147343223|NCT03398148|531423950|FG005|Substudy 2 Period 2|Other|0|||
147343224|NCT03398148|531423951|FG006|Substudy 2 Period 2|Other|0|||
147343225|NCT03398148|531423952|FG007|Substudy 2 Period 2|Other|0|||
147343226|NCT03398148|531423953|FG008|Substudy 2 Period 2|Other|0|||
147343227|NCT03398148|531423954|FG009|Substudy 2 Period 2|Other|0|||
147343228|NCT03398148|531423955|FG010|Substudy 2 Period 2|Other|0|||
147343229|NCT03398148|531423956|FG011|Substudy 2 Period 2|Other|0|||
147343230|NCT03398148|531423957|FG012|Substudy 2 Period 2|Other|0|||
147343231|NCT03398148|531423958|FG013|Substudy 2 Period 2|Other|1|||
147343232|NCT03398148|531423959|FG014|Substudy 2 Period 2|Other|1|||
147343233|NCT03398148|531423945|FG000|Substudy 2 Period 2|Enrolled but not Treated|0|||
147343234|NCT03398148|531423946|FG001|Substudy 2 Period 2|Enrolled but not Treated|0|||
147343235|NCT03398148|531423947|FG002|Substudy 2 Period 2|Enrolled but not Treated|0|||
147343236|NCT03398148|531423948|FG003|Substudy 2 Period 2|Enrolled but not Treated|0|||
147343237|NCT03398148|531423949|FG004|Substudy 2 Period 2|Enrolled but not Treated|0|||
147343238|NCT03398148|531423950|FG005|Substudy 2 Period 2|Enrolled but not Treated|0|||
147343239|NCT03398148|531423951|FG006|Substudy 2 Period 2|Enrolled but not Treated|0|||
147343240|NCT03398148|531423952|FG007|Substudy 2 Period 2|Enrolled but not Treated|0|||
147343241|NCT03398148|531423953|FG008|Substudy 2 Period 2|Enrolled but not Treated|0|||
147343242|NCT03398148|531423954|FG009|Substudy 2 Period 2|Enrolled but not Treated|0|||
147343243|NCT03398148|531423955|FG010|Substudy 2 Period 2|Enrolled but not Treated|0|||
147343244|NCT03398148|531423956|FG011|Substudy 2 Period 2|Enrolled but not Treated|0|||
147343245|NCT03398148|531423957|FG012|Substudy 2 Period 2|Enrolled but not Treated|1|||
147343246|NCT03398148|531423958|FG013|Substudy 2 Period 2|Enrolled but not Treated|0|||
147343247|NCT03398148|531423959|FG014|Substudy 2 Period 2|Enrolled but not Treated|1|||
147343248|NCT00212355|531423960|FG000|Overall Study|Adverse Event|1|||
147343249|NCT00212355|531423960|FG000|Overall Study|Withdrawal by Subject|1|||
147343250|NCT00212355|531423960|FG000|Overall Study|A change of address|1|||
147343251|NCT03012841|531423966|FG000|Overall Study|Protocol Violation|0|||
147343252|NCT03012841|531423967|FG001|Overall Study|Protocol Violation|10|||
147343253|NCT03012841|531423966|FG000|Overall Study|Lost to Follow-up|6|||
147343254|NCT03012841|531423967|FG001|Overall Study|Lost to Follow-up|1|||
147343255|NCT03012841|531423966|FG000|Overall Study|Withdrawal by Subject|6|||
147343256|NCT03012841|531423967|FG001|Overall Study|Withdrawal by Subject|0|||
147343257|NCT03012841|531423966|FG000|Overall Study|Unable to complete 12 month visit|6|||
147343258|NCT03012841|531423967|FG001|Overall Study|Unable to complete 12 month visit|0|||
147343259|NCT03012841|531423966|FG000|Overall Study|Subject relocation|1|||
147343260|NCT03012841|531423967|FG001|Overall Study|Subject relocation|0|||
147343261|NCT03012841|531423966|FG000|Overall Study|Seasonal winter travel|1|||
147343262|NCT03012841|531423967|FG001|Overall Study|Seasonal winter travel|0|||
147343263|NCT03012841|531423966|FG000|Overall Study|Physician Decision|0|||
147343264|NCT03012841|531423967|FG001|Overall Study|Physician Decision|2|||
147343265|NCT03012841|531423966|FG000|Overall Study|No ablation performed|0|||
147343266|NCT03012841|531423967|FG001|Overall Study|No ablation performed|2|||
147343267|NCT03012841|531423966|FG000|Overall Study|Study reached n=165 treated subject cap|0|||
147343268|NCT03012841|531423967|FG001|Overall Study|Study reached n=165 treated subject cap|5|||
147343269|NCT03012841|531423966|FG000|Overall Study|Insurance change|0|||
147343270|NCT03012841|531423967|FG001|Overall Study|Insurance change|1|||
147343271|NCT03954184|531423968|FG000|Overall Study|Lost to Follow-up|500|||
147343272|NCT03954184|531423969|FG001|Overall Study|Lost to Follow-up|0|||
147343273|NCT03397108|531423970|FG000|Overall Study|Lost to Follow-up|15|||
147343274|NCT03397108|531423971|FG001|Overall Study|Lost to Follow-up|0|||
147343275|NCT03397108|531423970|FG000|Overall Study|Insufficient milk production|3|||
147343276|NCT03397108|531423971|FG001|Overall Study|Insufficient milk production|2|||
147343277|NCT03397108|531423970|FG000|Overall Study|Withdrawal by Subject|2|||
147343278|NCT03397108|531423971|FG001|Overall Study|Withdrawal by Subject|0|||
147343279|NCT05104697|531423972|FG000|Overall Study|Withdrawal by Subject|0|||
147343280|NCT05104697|531423973|FG001|Overall Study|Withdrawal by Subject|1|||
147343281|NCT04468776|531423976|FG000|Overall Study|Lost to Follow-up|4|||
147343282|NCT04468776|531423977|FG001|Overall Study|Lost to Follow-up|3|||
147343283|NCT04468776|531423978|FG002|Overall Study|Lost to Follow-up|4|||
147343284|NCT04468776|531423976|FG000|Overall Study|Withdrawal by Subject|1|||
147343285|NCT04468776|531423977|FG001|Overall Study|Withdrawal by Subject|10|||
147343286|NCT04468776|531423978|FG002|Overall Study|Withdrawal by Subject|4|||
147343287|NCT04468776|531423976|FG000|Overall Study|Physician Decision|0|||
147343288|NCT04468776|531423977|FG001|Overall Study|Physician Decision|1|||
147343289|NCT04468776|531423978|FG002|Overall Study|Physician Decision|1|||
147343290|NCT05613205|531423979|FG000|Overall Study|Lost to Follow-up|0|||
147343291|NCT05613205|531423980|FG001|Overall Study|Lost to Follow-up|0|||
147343292|NCT05613205|531423981|FG002|Overall Study|Lost to Follow-up|1|||
147343293|NCT05613205|531423982|FG003|Overall Study|Lost to Follow-up|1|||
147343294|NCT05613205|531423983|FG004|Overall Study|Lost to Follow-up|0|||
147343295|NCT05613205|531423979|FG000|Overall Study|Withdrawal by Subject|0|||
147343296|NCT05613205|531423980|FG001|Overall Study|Withdrawal by Subject|0|||
147343297|NCT05613205|531423981|FG002|Overall Study|Withdrawal by Subject|1|||
147453095|NCT01142726|531821538|FG001|Withdrawal Phase: Months 12 up to 24|Withdrawal by Subject|1|||
147606560|NCT01377987|532375256|FG001|Washout (7 Days)|Withdrawal by Subject|1|||
147606561|NCT00195338|532375259|FG000|Overall Study|Lost to Follow-up|2|||
147606562|NCT00195338|532375259|FG000|Overall Study|Adverse Event|5|||
147343298|NCT05613205|531423982|FG003|Overall Study|Withdrawal by Subject|1|||
147343299|NCT05613205|531423983|FG004|Overall Study|Withdrawal by Subject|0|||
147343300|NCT03103321|531423986|FG000|Overall Study|Protocol Violation|1|||
147343301|NCT03103321|531423987|FG001|Overall Study|Protocol Violation|1|||
147343302|NCT03103321|531423988|FG002|Overall Study|Protocol Violation|1|||
147343303|NCT03103321|531423989|FG003|Overall Study|Protocol Violation|0|||
147343304|NCT06629454|531423993|FG000|Overall Study|Withdraw by Clinician Decision|1|||
147343305|NCT01704079|531423994|FG000|Overall Study|Withdrawal by Subject|5|||
147343306|NCT01704079|531423995|FG001|Overall Study|Withdrawal by Subject|7|||
147343307|NCT01704079|531423994|FG000|Overall Study|Lost to Follow-up|2|||
147343308|NCT01704079|531423995|FG001|Overall Study|Lost to Follow-up|5|||
147343309|NCT01704079|531423994|FG000|Overall Study|Adverse Event|4|||
147343310|NCT01704079|531423995|FG001|Overall Study|Adverse Event|7|||
147343311|NCT01704079|531423994|FG000|Overall Study|Protocol Violation|1|||
147343312|NCT01704079|531423995|FG001|Overall Study|Protocol Violation|0|||
147343313|NCT01704079|531423994|FG000|Overall Study|Subject noncompliance|2|||
147343314|NCT01704079|531423995|FG001|Overall Study|Subject noncompliance|3|||
147343315|NCT01704079|531423994|FG000|Overall Study|Serum Calcium >/= 11.0 mg/dL, repeat con|0|||
147343316|NCT01704079|531423995|FG001|Overall Study|Serum Calcium >/= 11.0 mg/dL, repeat con|1|||
147343317|NCT05846646|531424001|FG000|Overall Study|Physician Decision|1|||
147343318|NCT05846646|531424002|FG001|Overall Study|Physician Decision|0|||
147343319|NCT05846646|531424003|FG002|Overall Study|Physician Decision|0|||
147343320|NCT05846646|531424001|FG000|Overall Study|Lack of Efficacy|1|||
147343321|NCT05846646|531424002|FG001|Overall Study|Lack of Efficacy|1|||
147343322|NCT05846646|531424003|FG002|Overall Study|Lack of Efficacy|0|||
147343323|NCT05846646|531424001|FG000|Overall Study|Early Study Termination|1|||
147343324|NCT05846646|531424002|FG001|Overall Study|Early Study Termination|2|||
147343325|NCT05846646|531424003|FG002|Overall Study|Early Study Termination|0|||
147343326|NCT00505934|531424004|FG000|Overall Study|Adverse Event|1|||
147343327|NCT00505934|531424004|FG000|Overall Study|Other: Unable to obtain IV & PK samples|1|||
147343328|NCT00505934|531424004|FG000|Overall Study|Other: IV dose needed to be changed|1|||
147343329|NCT02461628|531424009|FG000|Overall Study|Refused to complete survey|4|||
147343330|NCT02461628|531424010|FG001|Overall Study|Refused to complete survey|7|||
147343331|NCT02015520|531424011|FG000|Overall Study|Lack of Efficacy|1|||
147343332|NCT02015520|531424012|FG001|Overall Study|Lack of Efficacy|0|||
147343333|NCT02015520|531424013|FG002|Overall Study|Lack of Efficacy|3|||
147343334|NCT02015520|531424014|FG003|Overall Study|Lack of Efficacy|2|||
147343335|NCT02015520|531424011|FG000|Overall Study|Adverse Event|0|||
147343336|NCT02015520|531424012|FG001|Overall Study|Adverse Event|0|||
147343337|NCT02015520|531424013|FG002|Overall Study|Adverse Event|0|||
147343338|NCT02015520|531424014|FG003|Overall Study|Adverse Event|1|||
147343339|NCT02015520|531424011|FG000|Overall Study|Withdrawal by Subject|2|||
147343340|NCT02015520|531424012|FG001|Overall Study|Withdrawal by Subject|2|||
147343341|NCT02015520|531424013|FG002|Overall Study|Withdrawal by Subject|1|||
147343342|NCT02015520|531424014|FG003|Overall Study|Withdrawal by Subject|0|||
147343343|NCT02015520|531424011|FG000|Overall Study|Death|1|||
147343344|NCT02015520|531424012|FG001|Overall Study|Death|0|||
147343345|NCT02015520|531424013|FG002|Overall Study|Death|0|||
147343346|NCT02015520|531424014|FG003|Overall Study|Death|0|||
147343347|NCT02015520|531424011|FG000|Overall Study|Lost to Follow-up|0|||
147343348|NCT02015520|531424012|FG001|Overall Study|Lost to Follow-up|0|||
147343349|NCT02015520|531424013|FG002|Overall Study|Lost to Follow-up|1|||
147343350|NCT02015520|531424014|FG003|Overall Study|Lost to Follow-up|0|||
147343351|NCT02015520|531424011|FG000|Overall Study|Subject Request to Discontinue Study Treatment|1|||
147343352|NCT02015520|531424012|FG001|Overall Study|Subject Request to Discontinue Study Treatment|1|||
147343353|NCT02015520|531424013|FG002|Overall Study|Subject Request to Discontinue Study Treatment|2|||
147343354|NCT02015520|531424014|FG003|Overall Study|Subject Request to Discontinue Study Treatment|1|||
147343355|NCT02015520|531424011|FG000|Overall Study|Subject no Longer Meets Study Criteria|0|||
147343356|NCT02015520|531424012|FG001|Overall Study|Subject no Longer Meets Study Criteria|1|||
147343357|NCT02015520|531424013|FG002|Overall Study|Subject no Longer Meets Study Criteria|0|||
147343358|NCT02015520|531424014|FG003|Overall Study|Subject no Longer Meets Study Criteria|0|||
147343359|NCT00998881|531424018|FG000|Overall Study|Adverse Event|2|||
147343360|NCT00998881|531424019|FG001|Overall Study|Adverse Event|2|||
147343361|NCT00998881|531424018|FG000|Overall Study|Lack of Efficacy|1|||
147343362|NCT00998881|531424019|FG001|Overall Study|Lack of Efficacy|0|||
147343363|NCT00998881|531424018|FG000|Overall Study|Physician Decision|3|||
147343364|NCT00998881|531424019|FG001|Overall Study|Physician Decision|0|||
147343365|NCT00998881|531424018|FG000|Overall Study|Withdrawal by Subject|1|||
147343366|NCT00998881|531424019|FG001|Overall Study|Withdrawal by Subject|0|||
147343367|NCT00998881|531424018|FG000|Overall Study|Personal matter|1|||
147343368|NCT00998881|531424019|FG001|Overall Study|Personal matter|0|||
147343369|NCT04149002|531424021|FG000|Overall Study|Lost to Follow-up|1|||
147343370|NCT04149002|531424022|FG001|Overall Study|Lost to Follow-up|0|||
147606563|NCT00195338|532375259|FG000|Overall Study|Lack of Efficacy|1|||
147606564|NCT00195338|532375259|FG000|Overall Study|Early closure of the site|4|||
147606565|NCT00811928|532375260|FG000|Overall Study|AEs and SAEs Including Death|7|||
147606566|NCT00811928|532375261|FG001|Overall Study|AEs and SAEs Including Death|11|||
147606567|NCT00811928|532375260|FG000|Overall Study|Withdrawal by Subject|18|||
147606568|NCT00811928|532375261|FG001|Overall Study|Withdrawal by Subject|12|||
147606569|NCT00811928|532375260|FG000|Overall Study|Did Not Take Study Drug|3|||
147606570|NCT00811928|532375261|FG001|Overall Study|Did Not Take Study Drug|0|||
147606571|NCT00811928|532375260|FG000|Overall Study|Without Primary Efficacy Endpoint Data|7|||
147299739|NCT01662063|531262822|FG002|Overall Study|Lost to Follow-up|0|||
147299740|NCT01662063|531262820|FG000|Overall Study|Protocol Violation|1|||
147299741|NCT01662063|531262821|FG001|Overall Study|Protocol Violation|0|||
147299742|NCT01662063|531262822|FG002|Overall Study|Protocol Violation|0|||
147299743|NCT01662063|531262820|FG000|Overall Study|Withdrawal by Subject|2|||
147299744|NCT01662063|531262821|FG001|Overall Study|Withdrawal by Subject|4|||
147299745|NCT01662063|531262822|FG002|Overall Study|Withdrawal by Subject|1|||
147299746|NCT01662063|531262820|FG000|Overall Study|Physician Decision|0|||
147299747|NCT01662063|531262821|FG001|Overall Study|Physician Decision|2|||
147299748|NCT01662063|531262822|FG002|Overall Study|Physician Decision|0|||
147299749|NCT01662063|531262820|FG000|Overall Study|Other|0|||
147299750|NCT01662063|531262821|FG001|Overall Study|Other|1|||
147299751|NCT01662063|531262822|FG002|Overall Study|Other|0|||
147299752|NCT01477853|531262829|FG000|Phase A|Adverse Event|1|||
147299753|NCT01477853|531262830|FG001|Phase A|Adverse Event|2|||
147299754|NCT01477853|531262831|FG002|Phase A|Adverse Event|2|||
147299755|NCT01477853|531262829|FG000|Phase A|Lost to Follow-up|4|||
147299756|NCT01477853|531262830|FG001|Phase A|Lost to Follow-up|3|||
147299757|NCT01477853|531262831|FG002|Phase A|Lost to Follow-up|2|||
147299758|NCT01477853|531262829|FG000|Phase A|Physician Decision|1|||
147299759|NCT01477853|531262830|FG001|Phase A|Physician Decision|0|||
147299760|NCT01477853|531262831|FG002|Phase A|Physician Decision|1|||
147299761|NCT01477853|531262829|FG000|Phase A|Study terminated by sponsor|37|||
147299762|NCT01477853|531262830|FG001|Phase A|Study terminated by sponsor|40|||
147299763|NCT01477853|531262831|FG002|Phase A|Study terminated by sponsor|39|||
147299764|NCT01477853|531262829|FG000|Phase B|Lost to Follow-up|0|||
147299765|NCT01477853|531262830|FG001|Phase B|Lost to Follow-up|1|||
147299766|NCT01477853|531262831|FG002|Phase B|Lost to Follow-up|0|||
147299767|NCT01477853|531262829|FG000|Phase B|Study terminated by sponsor|12|||
147299768|NCT01477853|531262830|FG001|Phase B|Study terminated by sponsor|10|||
147299769|NCT01477853|531262831|FG002|Phase B|Study terminated by sponsor|11|||
147299770|NCT00677352|531262834|FG000|Treatment Phase|Adverse Event|14|||
147299771|NCT00677352|531262835|FG001|Treatment Phase|Adverse Event|22|||
147299772|NCT00677352|531262834|FG000|Treatment Phase|Lack of Efficacy|2|||
147299773|NCT00677352|531262835|FG001|Treatment Phase|Lack of Efficacy|3|||
147299774|NCT00677352|531262834|FG000|Treatment Phase|Lost to Follow-up|0|||
147299775|NCT00677352|531262835|FG001|Treatment Phase|Lost to Follow-up|1|||
147299776|NCT00677352|531262834|FG000|Treatment Phase|Withdrawal by Subject|7|||
147299777|NCT00677352|531262835|FG001|Treatment Phase|Withdrawal by Subject|7|||
147299778|NCT00677352|531262834|FG000|Treatment Phase|Physician Decision|1|||
147299779|NCT00677352|531262835|FG001|Treatment Phase|Physician Decision|0|||
147299780|NCT00677352|531262834|FG000|Treatment Phase|Pregnancy|0|||
147299781|NCT00677352|531262835|FG001|Treatment Phase|Pregnancy|1|||
147299782|NCT00677352|531262834|FG000|Treatment Phase|Protocol Violation|1|||
147299783|NCT00677352|531262835|FG001|Treatment Phase|Protocol Violation|1|||
147299784|NCT00677352|531262834|FG000|Treatment Phase|Transference or work related matter|0|||
147299785|NCT00677352|531262835|FG001|Treatment Phase|Transference or work related matter|5|||
147299786|NCT00677352|531262834|FG000|Treatment Phase|Not treated|0|||
147299787|NCT00677352|531262835|FG001|Treatment Phase|Not treated|2|||
147299788|NCT00677352|531262834|FG000|Tapering Phase|Adverse Event|1|||
147299789|NCT00677352|531262835|FG001|Tapering Phase|Adverse Event|5|||
147299790|NCT00677352|531262834|FG000|Tapering Phase|Withdrawal by Subject|5|||
147299791|NCT00677352|531262835|FG001|Tapering Phase|Withdrawal by Subject|3|||
147299792|NCT00677352|531262834|FG000|Tapering Phase|Pregnancy|0|||
147299793|NCT00677352|531262835|FG001|Tapering Phase|Pregnancy|1|||
147299794|NCT00677352|531262834|FG000|Tapering Phase|Job transfer|0|||
147299795|NCT00677352|531262835|FG001|Tapering Phase|Job transfer|1|||
147299796|NCT04044456|531262841|FG000|Overall Study|Lost to Follow-up|4|||
147299797|NCT04044456|531262842|FG001|Overall Study|Lost to Follow-up|1|||
147299798|NCT04044456|531262841|FG000|Overall Study|Withdrawal by Subject|1|||
147299799|NCT04044456|531262842|FG001|Overall Study|Withdrawal by Subject|0|||
147299800|NCT01972529|531262843|FG000|Overall Study|Adverse Event|0|||
147299801|NCT01972529|531262844|FG001|Overall Study|Adverse Event|1|||
147299802|NCT01972529|531262845|FG002|Overall Study|Adverse Event|0|||
147299803|NCT01972529|531262846|FG003|Overall Study|Adverse Event|0|||
147299804|NCT01972529|531262843|FG000|Overall Study|Lost to Follow-up|1|||
147299805|NCT01972529|531262844|FG001|Overall Study|Lost to Follow-up|0|||
147299806|NCT01972529|531262845|FG002|Overall Study|Lost to Follow-up|0|||
147299807|NCT01972529|531262846|FG003|Overall Study|Lost to Follow-up|0|||
147453096|NCT01142726|531821539|FG002|Withdrawal Phase: Months 12 up to 24|Withdrawal by Subject|2|||
147299808|NCT01972529|531262843|FG000|Overall Study|Participant Choice|0|||
147299809|NCT01972529|531262844|FG001|Overall Study|Participant Choice|1|||
147299810|NCT01972529|531262845|FG002|Overall Study|Participant Choice|0|||
147299811|NCT01972529|531262846|FG003|Overall Study|Participant Choice|0|||
147299812|NCT01972529|531262843|FG000|Overall Study|Withdrawl of Consent|1|||
147299813|NCT01972529|531262844|FG001|Overall Study|Withdrawl of Consent|2|||
147299814|NCT01972529|531262845|FG002|Overall Study|Withdrawl of Consent|0|||
147299815|NCT01972529|531262846|FG003|Overall Study|Withdrawl of Consent|1|||
147299816|NCT01972529|531262843|FG000|Overall Study|Other|0|||
147299817|NCT01972529|531262844|FG001|Overall Study|Other|0|||
147299818|NCT01972529|531262845|FG002|Overall Study|Other|0|||
147299819|NCT01972529|531262846|FG003|Overall Study|Other|2|||
147299820|NCT01972529|531262843|FG000|Overall Study|Not treated|0|||
147299821|NCT01972529|531262844|FG001|Overall Study|Not treated|1|||
147299822|NCT01972529|531262845|FG002|Overall Study|Not treated|2|||
147299823|NCT01972529|531262846|FG003|Overall Study|Not treated|1|||
147299824|NCT01201811|531262847|FG000|Overall Study|Adverse Event|6|||
147299825|NCT01201811|531262847|FG000|Overall Study|Disease progression|3|||
147299826|NCT01201811|531262847|FG000|Overall Study|Withdrawal by Subject|3|||
147299827|NCT01201811|531262847|FG000|Overall Study|Death|4|||
147299828|NCT01201811|531262847|FG000|Overall Study|Treatment Failure|2|||
147299829|NCT01201811|531262847|FG000|Overall Study|Physician Decision|1|||
147299830|NCT00715429|531262848|FG000|Overall Study|Did not complete the study diary|0|||
147299831|NCT00715429|531262849|FG001|Overall Study|Did not complete the study diary|1|||
147299832|NCT04899245|531262850|FG000|Overall Study|Withdrawal by Subject|3|||
147299833|NCT04899245|531262851|FG001|Overall Study|Withdrawal by Subject|5|||
147299834|NCT04899245|531262852|FG002|Overall Study|Withdrawal by Subject|2|||
147299835|NCT04899245|531262850|FG000|Overall Study|No longer eligible - Left staff position|0|||
147299836|NCT04899245|531262851|FG001|Overall Study|No longer eligible - Left staff position|0|||
147299837|NCT04899245|531262852|FG002|Overall Study|No longer eligible - Left staff position|1|||
147299838|NCT04899245|531262850|FG000|Overall Study|No longer eligible - Child graduated from school program|19|||
147299839|NCT04899245|531262851|FG001|Overall Study|No longer eligible - Child graduated from school program|21|||
147299840|NCT04899245|531262852|FG002|Overall Study|No longer eligible - Child graduated from school program|0|||
147299841|NCT04899245|531262850|FG000|Overall Study|No longer eligible - Moved away from area|2|||
147299842|NCT04899245|531262851|FG001|Overall Study|No longer eligible - Moved away from area|2|||
147299843|NCT04899245|531262852|FG002|Overall Study|No longer eligible - Moved away from area|0|||
147299844|NCT03188055|531262856|FG000|Overall Study|Unavailable for training|0|||
147299845|NCT03188055|531262857|FG001|Overall Study|Unavailable for training|0|||
147299846|NCT03188055|531262858|FG002|Overall Study|Unavailable for training|19|||
147299847|NCT03188055|531262859|FG003|Overall Study|Unavailable for training|0|||
147299848|NCT03188055|531262860|FG004|Overall Study|Unavailable for training|0|||
147299849|NCT03188055|531262861|FG005|Overall Study|Unavailable for training|0|||
147299850|NCT03188055|531262856|FG000|Overall Study|Lost to Follow-up|0|||
147299851|NCT03188055|531262857|FG001|Overall Study|Lost to Follow-up|18|||
147299852|NCT03188055|531262858|FG002|Overall Study|Lost to Follow-up|0|||
147299853|NCT03188055|531262859|FG003|Overall Study|Lost to Follow-up|11|||
147299854|NCT03188055|531262860|FG004|Overall Study|Lost to Follow-up|0|||
147299855|NCT03188055|531262861|FG005|Overall Study|Lost to Follow-up|0|||
147299856|NCT03188055|531262856|FG000|Overall Study|Withdrawal by Subject|0|||
147299857|NCT03188055|531262857|FG001|Overall Study|Withdrawal by Subject|1|||
147299858|NCT03188055|531262858|FG002|Overall Study|Withdrawal by Subject|0|||
147299859|NCT03188055|531262859|FG003|Overall Study|Withdrawal by Subject|1|||
147299860|NCT03188055|531262860|FG004|Overall Study|Withdrawal by Subject|0|||
147299861|NCT03188055|531262861|FG005|Overall Study|Withdrawal by Subject|0|||
147299862|NCT03017079|531262862|FG000|Overall Study|Physician Decision|1|||
147299863|NCT03017079|531262863|FG001|Overall Study|Physician Decision|1|||
147299864|NCT03017079|531262862|FG000|Overall Study|Death|3|||
147299865|NCT03017079|531262863|FG001|Overall Study|Death|2|||
147299866|NCT03017079|531262862|FG000|Overall Study|Lack of Efficacy|2|||
147299867|NCT03017079|531262863|FG001|Overall Study|Lack of Efficacy|2|||
147299868|NCT03017079|531262862|FG000|Overall Study|Protocol Violation|0|||
147299869|NCT03017079|531262863|FG001|Overall Study|Protocol Violation|1|||
147299870|NCT03657277|531262864|FG000|Overall Study|Physician Decision|2|||
147299871|NCT03657277|531262864|FG000|Overall Study|Lost to Follow-up|1|||
147299872|NCT03657277|531262864|FG000|Overall Study|Covid-19 Research Halt at University of Iowa-Withdrawal of subjects|8|||
147299873|NCT04349280|531262865|FG000|Main Study (Up to Approx. 95 Weeks)|Ongoing|1|||
147299874|NCT04349280|531262866|FG001|Main Study (Up to Approx. 95 Weeks)|Ongoing|0|||
147299875|NCT04349280|531262865|FG000|Main Study (Up to Approx. 95 Weeks)|Death|12|||
147299876|NCT04349280|531262866|FG001|Main Study (Up to Approx. 95 Weeks)|Death|0|||
147299877|NCT04349280|531262865|FG000|PACT Phase (Up to Approx. 56 Weeks)|Adverse Event|0|||
147299878|NCT04349280|531262866|FG001|PACT Phase (Up to Approx. 56 Weeks)|Adverse Event|1|||
147299879|NCT02286089|531262869|FG000|Overall Study|Ongoing in Study|1|||
147343371|NCT04149002|531424021|FG000|Overall Study|Withdrawal by Subject|1|||
147343372|NCT04149002|531424022|FG001|Overall Study|Withdrawal by Subject|0|||
147343373|NCT04704284|531424023|FG000|Overall Study|Withdrawal by Subject|1|||
147343374|NCT03930420|531424028|FG000|Overall Study|Withdrawal by Subject|7|||
147343375|NCT03930420|531424029|FG001|Overall Study|Withdrawal by Subject|9|||
147343376|NCT02538341|531424034|FG000|Overall Study|Lost to Follow-up|51|||
147343377|NCT02538341|531424035|FG001|Overall Study|Lost to Follow-up|46|||
147343378|NCT02538341|531424034|FG000|Overall Study|Withdrawal by Subject|3|||
147343379|NCT02538341|531424035|FG001|Overall Study|Withdrawal by Subject|1|||
147343380|NCT02538341|531424034|FG000|Overall Study|Death|2|||
147343381|NCT02538341|531424035|FG001|Overall Study|Death|0|||
147343382|NCT02321514|531424036|FG000|Overall Study|Death|15|||
147343383|NCT02321514|531424036|FG000|Overall Study|Missed Visit|7|||
147343384|NCT02321514|531424036|FG000|Overall Study|Study Exit|3|||
147343385|NCT00393484|531424039|FG000|Double-blind Period (Day 1 to Week 96)|Adverse Event|0|||
147343386|NCT00393484|531424040|FG001|Double-blind Period (Day 1 to Week 96)|Adverse Event|1|||
147343387|NCT00393484|531424039|FG000|Double-blind Period (Day 1 to Week 96)|Withdrawal by Subject|2|||
147343388|NCT00393484|531424040|FG001|Double-blind Period (Day 1 to Week 96)|Withdrawal by Subject|0|||
147343389|NCT00393484|531424039|FG000|Double-blind Period (Day 1 to Week 96)|No longer met inclusion criteria|0|||
147343390|NCT00393484|531424040|FG001|Double-blind Period (Day 1 to Week 96)|No longer met inclusion criteria|3|||
147343391|NCT00393484|531424039|FG000|Double-blind Period (Day 1 to Week 96)|Lack of Efficacy|0|||
147343392|NCT00393484|531424040|FG001|Double-blind Period (Day 1 to Week 96)|Lack of Efficacy|6|||
147343393|NCT00393484|531424039|FG000|Double-blind Period (Day 1 to Week 96)|Lost to Follow-up|0|||
147343394|NCT00393484|531424040|FG001|Double-blind Period (Day 1 to Week 96)|Lost to Follow-up|2|||
147343395|NCT00393484|531424039|FG000|Open-label Period (Weeks 96 to 240)|Withdrawal by Subject|4|||
147343396|NCT00393484|531424040|FG001|Open-label Period (Weeks 96 to 240)|Withdrawal by Subject|1|||
147343397|NCT00393484|531424039|FG000|Open-label Period (Weeks 96 to 240)|Death|1|||
147343398|NCT00393484|531424040|FG001|Open-label Period (Weeks 96 to 240)|Death|0|||
147343399|NCT00393484|531424039|FG000|Open-label Period (Weeks 96 to 240)|Lost to Follow-up|1|||
147343400|NCT00393484|531424040|FG001|Open-label Period (Weeks 96 to 240)|Lost to Follow-up|2|||
147343401|NCT00393484|531424039|FG000|Open-label Period (Weeks 96 to 240)|Noncompliance|2|||
147343402|NCT00393484|531424040|FG001|Open-label Period (Weeks 96 to 240)|Noncompliance|2|||
147343403|NCT00393484|531424039|FG000|Open-label Period (Weeks 96 to 240)|Lack of Efficacy|0|||
147343404|NCT00393484|531424040|FG001|Open-label Period (Weeks 96 to 240)|Lack of Efficacy|18|||
147343405|NCT00088413|531424051|FG000|Overall Study|Limited supply of trmt drug (PANVAC-f)|0|||
147343406|NCT00088413|531424052|FG001|Overall Study|Limited supply of trmt drug (PANVAC-f)|0|||
147343407|NCT00088413|531424053|FG002|Overall Study|Limited supply of trmt drug (PANVAC-f)|1|||
147343408|NCT00088413|531424054|FG003|Overall Study|Limited supply of trmt drug (PANVAC-f)|0|||
147343409|NCT00088413|531424051|FG000|Overall Study|Adverse Events/Side Effects|0|||
147343410|NCT00088413|531424052|FG001|Overall Study|Adverse Events/Side Effects|1|||
147343411|NCT00088413|531424053|FG002|Overall Study|Adverse Events/Side Effects|1|||
147343412|NCT00088413|531424054|FG003|Overall Study|Adverse Events/Side Effects|0|||
147343413|NCT00088413|531424051|FG000|Overall Study|Refused trmt Off-study per pt wishes|0|||
147343414|NCT00088413|531424052|FG001|Overall Study|Refused trmt Off-study per pt wishes|1|||
147343415|NCT00088413|531424053|FG002|Overall Study|Refused trmt Off-study per pt wishes|1|||
147343416|NCT00088413|531424054|FG003|Overall Study|Refused trmt Off-study per pt wishes|0|||
147343417|NCT00088413|531424051|FG000|Overall Study|Off study due to missing a vaccine dose|1|||
147343418|NCT00088413|531424052|FG001|Overall Study|Off study due to missing a vaccine dose|0|||
147343419|NCT00088413|531424053|FG002|Overall Study|Off study due to missing a vaccine dose|0|||
147343420|NCT00088413|531424054|FG003|Overall Study|Off study due to missing a vaccine dose|0|||
147343421|NCT00088413|531424051|FG000|Overall Study|Death|0|||
147343422|NCT00088413|531424052|FG001|Overall Study|Death|1|||
147343423|NCT00088413|531424053|FG002|Overall Study|Death|0|||
147343424|NCT00088413|531424054|FG003|Overall Study|Death|0|||
147343425|NCT00088413|531424051|FG000|Overall Study|Progressive disease|9|||
147343426|NCT00088413|531424052|FG001|Overall Study|Progressive disease|11|||
147343427|NCT00088413|531424053|FG002|Overall Study|Progressive disease|8|||
147343428|NCT00088413|531424054|FG003|Overall Study|Progressive disease|14|||
147343429|NCT00088413|531424051|FG000|Overall Study|Other|0|||
147453097|NCT01142726|531821537|FG000|Withdrawal Phase: Months 12 up to 24|Pregnancy|1|||
147343430|NCT00088413|531424052|FG001|Overall Study|Other|1|||
147343431|NCT00088413|531424053|FG002|Overall Study|Other|0|||
147453098|NCT01142726|531821538|FG001|Withdrawal Phase: Months 12 up to 24|Pregnancy|0|||
147343432|NCT00088413|531424054|FG003|Overall Study|Other|0|||
147343433|NCT00088413|531424051|FG000|Overall Study|Patient unevaluable due to adverse event|0|||
147343434|NCT00088413|531424052|FG001|Overall Study|Patient unevaluable due to adverse event|0|||
147343435|NCT00088413|531424053|FG002|Overall Study|Patient unevaluable due to adverse event|1|||
147343436|NCT00088413|531424054|FG003|Overall Study|Patient unevaluable due to adverse event|0|||
147343437|NCT01044303|531424058|FG000|Overall Study|Lost to Follow-up|2|||
147343438|NCT02539225|531424059|FG000|Part A|Adverse Event|13|||
147343439|NCT02539225|531424060|FG001|Part A|Adverse Event|4|||
147343440|NCT02539225|531424059|FG000|Part A|Withdrawal by Subject|2|||
147343441|NCT02539225|531424060|FG001|Part A|Withdrawal by Subject|4|||
147343442|NCT02539225|531424059|FG000|Part A|Physician Decision|4|||
147343443|NCT02539225|531424060|FG001|Part A|Physician Decision|7|||
147343444|NCT02539225|531424059|FG000|Part A|Did Not Receive study Drug|1|||
147343445|NCT02539225|531424060|FG001|Part A|Did Not Receive study Drug|1|||
147343446|NCT02539225|531424059|FG000|Pre Treatment for Part B|Progressive disease|1|||
147343447|NCT02539225|531424060|FG001|Pre Treatment for Part B|Progressive disease|1|||
147343448|NCT02539225|531424059|FG000|Pre Treatment for Part B|Adverse Event|1|||
147343449|NCT02539225|531424060|FG001|Pre Treatment for Part B|Adverse Event|1|||
147343450|NCT02539225|531424059|FG000|Pre Treatment for Part B|Withdrawal by Subject|1|||
147343451|NCT02539225|531424060|FG001|Pre Treatment for Part B|Withdrawal by Subject|0|||
147343452|NCT02539225|531424059|FG000|Pre Treatment for Part B|Physician Decision|2|||
147343453|NCT02539225|531424060|FG001|Pre Treatment for Part B|Physician Decision|0|||
147343454|NCT02539225|531424059|FG000|Part B|Adverse Event|4|||
147343455|NCT02539225|531424060|FG001|Part B|Adverse Event|4|||
147343456|NCT02539225|531424059|FG000|Part B|Withdrawal by Subject|0|||
147343457|NCT02539225|531424060|FG001|Part B|Withdrawal by Subject|3|||
147343458|NCT02539225|531424059|FG000|Part B|Physician Decision|0|||
147343459|NCT02539225|531424060|FG001|Part B|Physician Decision|9|||
147343460|NCT01109524|531424065|FG000|Overall Study|Disease Progression|29|||
147343461|NCT01109524|531424065|FG000|Overall Study|Study Drug toxicity|6|||
147343462|NCT01109524|531424065|FG000|Overall Study|Adverse Event|4|||
147343463|NCT01109524|531424065|FG000|Overall Study|Withdrawal by Subject|2|||
147343464|NCT01109524|531424065|FG000|Overall Study|Maximum clinical benefit|3|||
147343465|NCT01109524|531424065|FG000|Overall Study|Death|2|||
147343466|NCT01109524|531424065|FG000|Overall Study|No longer meets criteria|2|||
147343467|NCT01109524|531424065|FG000|Overall Study|Participant requested to end treatment|4|||
147343468|NCT01109524|531424065|FG000|Overall Study|Other|5|||
147343469|NCT02318134|531424071|FG000|Overall Study|Withdrawal by Subject|2|||
147343470|NCT02318134|531424072|FG001|Overall Study|Withdrawal by Subject|1|||
147343471|NCT00031694|531424077|FG000|Overall Study|Adverse Event|12|||
147343472|NCT00031694|531424077|FG000|Overall Study|Death|2|||
147343473|NCT00031694|531424077|FG000|Overall Study|Withdrawal by Subject|5|||
147343474|NCT01976312|531424078|FG000|Overall Study|Pregnancy|0|||
147343475|NCT01976312|531424079|FG001|Overall Study|Pregnancy|1|||
147343476|NCT01976312|531424078|FG000|Overall Study|Lost to Follow-up|2|||
147343477|NCT01976312|531424079|FG001|Overall Study|Lost to Follow-up|0|||
147343478|NCT01976312|531424078|FG000|Overall Study|Withdrawal by Subject|7|||
147343479|NCT01976312|531424079|FG001|Overall Study|Withdrawal by Subject|2|||
147343480|NCT01976312|531424078|FG000|Overall Study|Adverse Event|6|||
147343481|NCT01976312|531424079|FG001|Overall Study|Adverse Event|6|||
147343482|NCT01976312|531424078|FG000|Overall Study|Protocol Violation|2|||
147343483|NCT01976312|531424079|FG001|Overall Study|Protocol Violation|0|||
147343484|NCT01538719|531424084|FG000|Overall Study|Lost to Follow-up|2|||
147343485|NCT01538719|531424085|FG001|Overall Study|Lost to Follow-up|0|||
147343486|NCT02556138|531424086|FG000|Overall Study|Withdrawal by Subject|1|||
147343487|NCT02807779|531424089|FG000|Overall Study|Lost to Follow-up|1|||
147343488|NCT02807779|531424090|FG001|Overall Study|Lost to Follow-up|0|||
147343489|NCT02807779|531424091|FG002|Overall Study|Lost to Follow-up|0|||
147343490|NCT02807779|531424089|FG000|Overall Study|Physician Decision|2|||
147343491|NCT02807779|531424090|FG001|Overall Study|Physician Decision|0|||
147343492|NCT02807779|531424091|FG002|Overall Study|Physician Decision|1|||
147343493|NCT02807779|531424089|FG000|Overall Study|Death|1|||
147343494|NCT02807779|531424090|FG001|Overall Study|Death|1|||
147343495|NCT02807779|531424091|FG002|Overall Study|Death|0|||
147343496|NCT06024174|531424092|FG000|Overall Study|Other Reasons|1|||
147343497|NCT06024174|531424092|FG000|Overall Study|Study terminated by Sponsor|4|||
147343498|NCT03725722|531426299|FG000|Overall Study|Lack of Efficacy|2|||
147343499|NCT03725722|531426300|FG001|Overall Study|Lack of Efficacy|1|||
147343500|NCT03725722|531426301|FG002|Overall Study|Lack of Efficacy|2|||
147343501|NCT03725722|531426302|FG003|Overall Study|Lack of Efficacy|0|||
147343502|NCT03725722|531426303|FG004|Overall Study|Lack of Efficacy|2|||
147343503|NCT03725722|531426299|FG000|Overall Study|Adverse Event|2|||
147343504|NCT03725722|531426300|FG001|Overall Study|Adverse Event|2|||
147343505|NCT03725722|531426301|FG002|Overall Study|Adverse Event|1|||
147343506|NCT03725722|531426302|FG003|Overall Study|Adverse Event|0|||
147343507|NCT03725722|531426303|FG004|Overall Study|Adverse Event|6|||
147343508|NCT03725722|531426299|FG000|Overall Study|Withdrawal by Subject|4|||
147343509|NCT03725722|531426300|FG001|Overall Study|Withdrawal by Subject|1|||
147343510|NCT03725722|531426301|FG002|Overall Study|Withdrawal by Subject|0|||
147343511|NCT03725722|531426302|FG003|Overall Study|Withdrawal by Subject|4|||
147343512|NCT03725722|531426303|FG004|Overall Study|Withdrawal by Subject|4|||
147343513|NCT03725722|531426299|FG000|Overall Study|Lost to Follow-up|3|||
147343514|NCT03725722|531426300|FG001|Overall Study|Lost to Follow-up|1|||
147343515|NCT03725722|531426301|FG002|Overall Study|Lost to Follow-up|2|||
147343516|NCT03725722|531426302|FG003|Overall Study|Lost to Follow-up|2|||
147343517|NCT03725722|531426303|FG004|Overall Study|Lost to Follow-up|1|||
147343518|NCT03725722|531426299|FG000|Overall Study|Personal reasons|0|||
147343519|NCT03725722|531426300|FG001|Overall Study|Personal reasons|0|||
147343520|NCT03725722|531426301|FG002|Overall Study|Personal reasons|1|||
147343521|NCT03725722|531426302|FG003|Overall Study|Personal reasons|0|||
147343522|NCT03725722|531426303|FG004|Overall Study|Personal reasons|1|||
147343523|NCT03725722|531426299|FG000|Overall Study|COVID-19 situation|0|||
147343524|NCT03725722|531426300|FG001|Overall Study|COVID-19 situation|1|||
147343525|NCT03725722|531426301|FG002|Overall Study|COVID-19 situation|0|||
147343526|NCT03725722|531426302|FG003|Overall Study|COVID-19 situation|0|||
147343527|NCT03725722|531426303|FG004|Overall Study|COVID-19 situation|0|||
147343528|NCT04310735|531426304|FG000|Overall Study|Withdrawal by Subject|1|||
147343529|NCT04310735|531426305|FG001|Overall Study|Withdrawal by Subject|3|||
147343530|NCT04310735|531426306|FG002|Overall Study|Withdrawal by Subject|8|||
147343531|NCT04310735|531426304|FG000|Overall Study|Equipment malfunction|0|||
147343532|NCT04310735|531426305|FG001|Overall Study|Equipment malfunction|1|||
147343533|NCT04310735|531426306|FG002|Overall Study|Equipment malfunction|0|||
147343534|NCT03398200|531426307|FG000|Overall Study|Withdrawal by Subject|0|||
147343535|NCT03398200|531426308|FG001|Overall Study|Withdrawal by Subject|1|||
147343536|NCT01649271|531426309|FG000|Overall Study|Progressive disease|4|||
147343537|NCT01649271|531426310|FG001|Overall Study|Progressive disease|5|||
147343538|NCT01649271|531426309|FG000|Overall Study|Other Adverse Event|0|||
147343539|NCT01649271|531426310|FG001|Overall Study|Other Adverse Event|2|||
147343540|NCT01649271|531426309|FG000|Overall Study|Withdrawal by Subject|1|||
147343541|NCT01649271|531426310|FG001|Overall Study|Withdrawal by Subject|0|||
147343542|NCT01649271|531426309|FG000|Overall Study|Other than stated above|1|||
147343543|NCT01649271|531426310|FG001|Overall Study|Other than stated above|0|||
147343544|NCT05644002|531426313|FG000|Overall Study|Lost to Follow-up|1|||
147343545|NCT05644002|531426314|FG001|Overall Study|Lost to Follow-up|2|||
147343546|NCT05644002|531426313|FG000|Overall Study|Withdrawal by Subject|0|||
147343547|NCT05644002|531426314|FG001|Overall Study|Withdrawal by Subject|1|||
147343548|NCT04842500|531426315|FG000|Overall Study|Withdrawal by Subject|4|||
147343549|NCT04842500|531426316|FG001|Overall Study|Withdrawal by Subject|1|||
147343550|NCT04842500|531426317|FG002|Overall Study|Withdrawal by Subject|2|||
147343551|NCT04842500|531426318|FG003|Overall Study|Withdrawal by Subject|3|||
147343552|NCT04842500|531426315|FG000|Overall Study|Protocol Violation|1|||
147343553|NCT04842500|531426316|FG001|Overall Study|Protocol Violation|0|||
147343554|NCT04842500|531426317|FG002|Overall Study|Protocol Violation|0|||
147343555|NCT04842500|531426318|FG003|Overall Study|Protocol Violation|1|||
147343556|NCT05756075|531426321|FG000|Overall Study|Withdrawal by Subject|16|||
147343557|NCT05756075|531426322|FG001|Overall Study|Withdrawal by Subject|9|||
147343558|NCT02605837|531426326|FG000|Overall Study|Adverse Event|3|||
147343559|NCT02605837|531426327|FG001|Overall Study|Adverse Event|1|||
147343560|NCT02605837|531426326|FG000|Overall Study|Non-Compliance with Study Drug|0|||
147343561|NCT02605837|531426327|FG001|Overall Study|Non-Compliance with Study Drug|1|||
147343562|NCT02605837|531426326|FG000|Overall Study|Withdrawal by Subject|8|||
147343563|NCT02605837|531426327|FG001|Overall Study|Withdrawal by Subject|8|||
147343564|NCT02605837|531426326|FG000|Overall Study|Physician Decision|0|||
147343565|NCT02605837|531426327|FG001|Overall Study|Physician Decision|1|||
147343566|NCT05075408|531426328|FG000|Overall Study|Withdrawal by Subject|5|||
147343567|NCT05075408|531426329|FG001|Overall Study|Withdrawal by Subject|3|||
147343568|NCT05075408|531426330|FG002|Overall Study|Withdrawal by Subject|4|||
147343569|NCT05075408|531426328|FG000|Overall Study|Adverse Event|5|||
147343570|NCT05075408|531426329|FG001|Overall Study|Adverse Event|7|||
147343571|NCT05075408|531426330|FG002|Overall Study|Adverse Event|8|||
147343572|NCT05075408|531426328|FG000|Overall Study|Protocol Violation|0|||
147343573|NCT05075408|531426329|FG001|Overall Study|Protocol Violation|1|||
147343574|NCT05075408|531426330|FG002|Overall Study|Protocol Violation|0|||
147343575|NCT05075408|531426328|FG000|Overall Study|Lost to Follow-up|2|||
147343576|NCT05075408|531426329|FG001|Overall Study|Lost to Follow-up|1|||
147343577|NCT05075408|531426330|FG002|Overall Study|Lost to Follow-up|1|||
147343578|NCT05075408|531426328|FG000|Overall Study|Physician Decision|1|||
147343579|NCT05075408|531426329|FG001|Overall Study|Physician Decision|0|||
147343580|NCT05075408|531426330|FG002|Overall Study|Physician Decision|0|||
147343581|NCT05075408|531426328|FG000|Overall Study|Other-unspecified|3|||
147343582|NCT05075408|531426329|FG001|Overall Study|Other-unspecified|2|||
147343583|NCT05075408|531426330|FG002|Overall Study|Other-unspecified|0|||
147343584|NCT05419505|531426332|FG000|Overall Study|Adverse Event|0|||
147343585|NCT05419505|531426333|FG001|Overall Study|Adverse Event|0|||
147343586|NCT05419505|531426334|FG002|Overall Study|Adverse Event|0|||
147343587|NCT05419505|531426335|FG003|Overall Study|Adverse Event|1|||
147343588|NCT05419505|531426336|FG004|Overall Study|Adverse Event|0|||
147343589|NCT05419505|531426337|FG005|Overall Study|Adverse Event|0|||
147343590|NCT05419505|531426338|FG006|Overall Study|Adverse Event|0|||
147343591|NCT05419505|531426339|FG007|Overall Study|Adverse Event|0|||
147343592|NCT05419505|531426332|FG000|Overall Study|Withdrawal by Subject|1|||
147343593|NCT05419505|531426333|FG001|Overall Study|Withdrawal by Subject|2|||
147606572|NCT00811928|532375261|FG001|Overall Study|Without Primary Efficacy Endpoint Data|4|||
147343594|NCT05419505|531426334|FG002|Overall Study|Withdrawal by Subject|0|||
147343595|NCT05419505|531426335|FG003|Overall Study|Withdrawal by Subject|0|||
147343596|NCT05419505|531426336|FG004|Overall Study|Withdrawal by Subject|0|||
147343597|NCT05419505|531426337|FG005|Overall Study|Withdrawal by Subject|0|||
147343598|NCT05419505|531426338|FG006|Overall Study|Withdrawal by Subject|1|||
147343599|NCT05419505|531426339|FG007|Overall Study|Withdrawal by Subject|0|||
147343600|NCT05419505|531426332|FG000|Overall Study|Lost to Follow-up|2|||
147606573|NCT00811928|532375260|FG000|Overall Study|Investigator Decision|2|||
147606574|NCT00811928|532375261|FG001|Overall Study|Investigator Decision|1|||
147343601|NCT05419505|531426333|FG001|Overall Study|Lost to Follow-up|1|||
147343602|NCT05419505|531426334|FG002|Overall Study|Lost to Follow-up|0|||
147343603|NCT05419505|531426335|FG003|Overall Study|Lost to Follow-up|0|||
147343604|NCT05419505|531426336|FG004|Overall Study|Lost to Follow-up|1|||
147343605|NCT05419505|531426337|FG005|Overall Study|Lost to Follow-up|2|||
147343606|NCT05419505|531426338|FG006|Overall Study|Lost to Follow-up|0|||
147343607|NCT05419505|531426339|FG007|Overall Study|Lost to Follow-up|1|||
147343608|NCT02780388|531426342|FG000|Overall Study|Lost to Follow-up|0|||
147343609|NCT02780388|531426343|FG001|Overall Study|Lost to Follow-up|1|||
147343610|NCT02780388|531426344|FG002|Overall Study|Lost to Follow-up|0|||
147343611|NCT02780388|531426345|FG003|Overall Study|Lost to Follow-up|0|||
147343612|NCT02780388|531426346|FG004|Overall Study|Lost to Follow-up|0|||
147343613|NCT02780388|531426342|FG000|Overall Study|Withdrawal by Subject|1|||
147343614|NCT02780388|531426343|FG001|Overall Study|Withdrawal by Subject|1|||
147343615|NCT02780388|531426344|FG002|Overall Study|Withdrawal by Subject|0|||
147343616|NCT02780388|531426345|FG003|Overall Study|Withdrawal by Subject|0|||
147343617|NCT02780388|531426346|FG004|Overall Study|Withdrawal by Subject|0|||
147343618|NCT04527146|531426347|FG000|Overall Study|Withdrawal by Subject|12|||
147343619|NCT04527146|531426348|FG001|Overall Study|Withdrawal by Subject|15|||
147343620|NCT04527146|531426349|FG002|Overall Study|Withdrawal by Subject|7|||
147343621|NCT04527146|531426350|FG003|Overall Study|Withdrawal by Subject|16|||
147343622|NCT04527146|531426347|FG000|Overall Study|Lost to Follow-up|13|||
147343623|NCT04527146|531426348|FG001|Overall Study|Lost to Follow-up|9|||
147343624|NCT04527146|531426349|FG002|Overall Study|Lost to Follow-up|16|||
147343625|NCT04527146|531426350|FG003|Overall Study|Lost to Follow-up|13|||
147343626|NCT04527146|531426347|FG000|Overall Study|Death|0|||
147343627|NCT04527146|531426348|FG001|Overall Study|Death|1|||
147343628|NCT04527146|531426349|FG002|Overall Study|Death|1|||
147343629|NCT04527146|531426350|FG003|Overall Study|Death|0|||
147343630|NCT04527146|531426347|FG000|Overall Study|Adverse Event|0|||
147343631|NCT04527146|531426348|FG001|Overall Study|Adverse Event|0|||
147343632|NCT04527146|531426349|FG002|Overall Study|Adverse Event|1|||
147343633|NCT04527146|531426350|FG003|Overall Study|Adverse Event|0|||
147343634|NCT04527146|531426347|FG000|Overall Study|Ineligible after randomization|2|||
147343635|NCT04527146|531426348|FG001|Overall Study|Ineligible after randomization|0|||
147343636|NCT04527146|531426349|FG002|Overall Study|Ineligible after randomization|2|||
147343637|NCT04527146|531426350|FG003|Overall Study|Ineligible after randomization|2|||
147343638|NCT04527146|531426347|FG000|Overall Study|Moved to a different group|6|||
147343639|NCT04527146|531426348|FG001|Overall Study|Moved to a different group|3|||
147343640|NCT04527146|531426349|FG002|Overall Study|Moved to a different group|0|||
147343641|NCT04527146|531426350|FG003|Overall Study|Moved to a different group|2|||
147343642|NCT05107401|531426351|FG000|Overall Study|Lost to Follow-up|13|||
147343643|NCT05107401|531426352|FG001|Overall Study|Lost to Follow-up|12|||
147343644|NCT04337372|531426354|FG000|Day 1: Eye-tracking Measures|Protocol Violation|1|||
147343645|NCT04337372|531426355|FG001|Day 1: Eye-tracking Measures|Protocol Violation|3|||
147343646|NCT04337372|531426356|FG002|Day 1: Eye-tracking Measures|Protocol Violation|7|||
147343647|NCT04337372|531426357|FG003|Day 1: Eye-tracking Measures|Protocol Violation|11|||
147343648|NCT04337372|531426354|FG000|Day 1: Eye-tracking Measures|Equipment Failure|0|||
147343649|NCT04337372|531426355|FG001|Day 1: Eye-tracking Measures|Equipment Failure|0|||
147343650|NCT04337372|531426356|FG002|Day 1: Eye-tracking Measures|Equipment Failure|2|||
147343651|NCT04337372|531426357|FG003|Day 1: Eye-tracking Measures|Equipment Failure|2|||
147606575|NCT00811928|532375260|FG000|Overall Study|Poor Compliance|2|||
147606576|NCT00811928|532375261|FG001|Overall Study|Poor Compliance|5|||
147606577|NCT04106661|532375264|FG000|Overall Study|Protocol Violation|3|||
147606578|NCT04106661|532375265|FG001|Overall Study|Protocol Violation|0|||
147606579|NCT04106661|532375264|FG000|Overall Study|Scheduling difficulties|1|||
147343652|NCT04337372|531426354|FG000|Day 2: EEG Measures|Lost to Follow-up|0|||
147343653|NCT04337372|531426355|FG001|Day 2: EEG Measures|Lost to Follow-up|3|||
147343654|NCT04337372|531426356|FG002|Day 2: EEG Measures|Lost to Follow-up|2|||
147343655|NCT04337372|531426357|FG003|Day 2: EEG Measures|Lost to Follow-up|5|||
147343656|NCT04337372|531426354|FG000|Day 2: EEG Measures|Protocol Violation|6|||
147606580|NCT04106661|532375265|FG001|Overall Study|Scheduling difficulties|1|||
147343657|NCT04337372|531426355|FG001|Day 2: EEG Measures|Protocol Violation|6|||
147343658|NCT04337372|531426356|FG002|Day 2: EEG Measures|Protocol Violation|5|||
147343659|NCT04337372|531426357|FG003|Day 2: EEG Measures|Protocol Violation|17|||
147343660|NCT05307783|531426358|FG000|Overall Study|Death|7|||
147343661|NCT05307783|531426358|FG000|Overall Study|Lost to Follow-up|4|||
147606581|NCT00233402|532375266|FG000|Overall Study|No pathology data|12|||
147343662|NCT04883645|531426359|FG000|Overall Study|Death|1|||
147343663|NCT03460236|531426363|FG000|Overall Study|failed radiographic screening|16|||
147343664|NCT03460236|531426363|FG000|Overall Study|Withdrawal by Subject|11|||
147606582|NCT00233402|532375267|FG001|Overall Study|No pathology data|9|||
147343665|NCT04869982|531426373|FG000|Overall Study|Consent withdrawal, not due to a (S)AE|7|||
147343666|NCT04869982|531426374|FG001|Overall Study|Consent withdrawal, not due to a (S)AE|2|||
147343667|NCT04869982|531426373|FG000|Overall Study|Migrated / moved from the study area|1|||
147343668|NCT04869982|531426374|FG001|Overall Study|Migrated / moved from the study area|1|||
147343669|NCT04869982|531426373|FG000|Overall Study|Adverse event requiring expedited reporting|13|||
147343670|NCT04869982|531426374|FG001|Overall Study|Adverse event requiring expedited reporting|11|||
147343671|NCT04869982|531426373|FG000|Overall Study|Unsolicited non-serious adverse event|1|||
147343672|NCT04869982|531426374|FG001|Overall Study|Unsolicited non-serious adverse event|1|||
147343673|NCT04869982|531426373|FG000|Overall Study|Solicited adverse event|2|||
147343674|NCT04869982|531426374|FG001|Overall Study|Solicited adverse event|1|||
147343675|NCT04608045|531426375|FG000|Overall Study|Physician Decision|1|||
147343676|NCT02473250|531426377|FG000|Overall Study|Lost to Follow-up|10|||
147343677|NCT02473250|531426377|FG000|Overall Study|Physician Decision|5|||
147343678|NCT02473250|531426377|FG000|Overall Study|Did not tolerate medication washout|3|||
147343679|NCT02473250|531426377|FG000|Overall Study|Antidepressant effect of divalproex|2|||
147343680|NCT06023082|531426378|FG000|Overall Study|Withdrawal by Subject|2|||
147343681|NCT06023082|531426378|FG000|Overall Study|Lost to Follow-up|15|||
147343682|NCT06023082|531426378|FG000|Overall Study|Side effects|5|||
147343683|NCT03584516|531426379|FG000|Part 1|Death|2|||
147343684|NCT03584516|531426380|FG001|Part 1|Death|3|||
147343685|NCT03584516|531426381|FG002|Part 1|Death|0|||
147343686|NCT03584516|531426382|FG003|Part 1|Death|0|||
147343687|NCT03584516|531426383|FG004|Part 1|Death|0|||
147343688|NCT03584516|531426384|FG005|Part 1|Death|0|||
147343689|NCT03584516|531426379|FG000|Part 1|Withdrawal by Subject|2|||
147343690|NCT03584516|531426380|FG001|Part 1|Withdrawal by Subject|0|||
147343691|NCT03584516|531426381|FG002|Part 1|Withdrawal by Subject|0|||
147343692|NCT03584516|531426382|FG003|Part 1|Withdrawal by Subject|0|||
147343693|NCT03584516|531426383|FG004|Part 1|Withdrawal by Subject|0|||
147343694|NCT03584516|531426384|FG005|Part 1|Withdrawal by Subject|0|||
147606583|NCT00233402|532375266|FG000|Overall Study|No Ta/T1|89|||
147606584|NCT00233402|532375267|FG001|Overall Study|No Ta/T1|94|||
147606585|NCT00233402|532375266|FG000|Overall Study|Lost to follow up etc|3|||
147343695|NCT03584516|531426379|FG000|Part 1|Lost to Follow-up|1|||
147343696|NCT03584516|531426380|FG001|Part 1|Lost to Follow-up|0|||
147343697|NCT03584516|531426381|FG002|Part 1|Lost to Follow-up|0|||
147343698|NCT03584516|531426382|FG003|Part 1|Lost to Follow-up|0|||
147343699|NCT03584516|531426383|FG004|Part 1|Lost to Follow-up|0|||
147343700|NCT03584516|531426384|FG005|Part 1|Lost to Follow-up|0|||
147343701|NCT03584516|531426379|FG000|Part 1|Study Terminated by Sponsor|0|||
147343702|NCT03584516|531426380|FG001|Part 1|Study Terminated by Sponsor|2|||
147343703|NCT03584516|531426381|FG002|Part 1|Study Terminated by Sponsor|0|||
147343704|NCT03584516|531426382|FG003|Part 1|Study Terminated by Sponsor|0|||
147343705|NCT03584516|531426383|FG004|Part 1|Study Terminated by Sponsor|0|||
147343706|NCT03584516|531426384|FG005|Part 1|Study Terminated by Sponsor|0|||
147343707|NCT03584516|531426379|FG000|Part 1 Expansion|Death|0|||
147343708|NCT03584516|531426380|FG001|Part 1 Expansion|Death|0|||
147343709|NCT03584516|531426381|FG002|Part 1 Expansion|Death|9|||
147606586|NCT00233402|532375267|FG001|Overall Study|Lost to follow up etc|21|||
147606587|NCT03503864|532375270|FG000|Overall Study|Protocol Violation|6|||
147343710|NCT03584516|531426382|FG003|Part 1 Expansion|Death|8|||
147343711|NCT03584516|531426383|FG004|Part 1 Expansion|Death|4|||
147343712|NCT03584516|531426384|FG005|Part 1 Expansion|Death|5|||
147606588|NCT03503864|532375270|FG000|Overall Study|Withdrawal by Subject|7|||
147606589|NCT02639052|532375271|FG000|Overall Study|Lost to Follow-up|1|||
147606590|NCT04572893|532375272|FG000|Part A|Adverse Event|1|||
147606591|NCT04572893|532375273|FG001|Part A|Adverse Event|0|||
147606592|NCT04572893|532375274|FG002|Part A|Adverse Event|0|||
147606593|NCT04572893|532375275|FG003|Part A|Adverse Event|0|||
147606594|NCT04572893|532375276|FG004|Part A|Adverse Event|0|||
147606595|NCT04572893|532375277|FG005|Part A|Adverse Event|0|||
147606596|NCT04572893|532375278|FG006|Part A|Adverse Event|0|||
147343713|NCT03584516|531426379|FG000|Part 1 Expansion|Lost to Follow-up|0|||
147343714|NCT03584516|531426380|FG001|Part 1 Expansion|Lost to Follow-up|0|||
147343715|NCT03584516|531426381|FG002|Part 1 Expansion|Lost to Follow-up|0|||
147343716|NCT03584516|531426382|FG003|Part 1 Expansion|Lost to Follow-up|1|||
147343717|NCT03584516|531426383|FG004|Part 1 Expansion|Lost to Follow-up|0|||
147343718|NCT03584516|531426384|FG005|Part 1 Expansion|Lost to Follow-up|0|||
147606597|NCT04572893|532375272|FG000|Part B|Withdrawal by Subject|0|||
147606598|NCT04572893|532375273|FG001|Part B|Withdrawal by Subject|0|||
147606599|NCT04572893|532375274|FG002|Part B|Withdrawal by Subject|0|||
147343719|NCT03584516|531426379|FG000|Part 1 Expansion|Physician Decision|0|||
147343720|NCT03584516|531426380|FG001|Part 1 Expansion|Physician Decision|0|||
147343721|NCT03584516|531426381|FG002|Part 1 Expansion|Physician Decision|4|||
147343722|NCT03584516|531426382|FG003|Part 1 Expansion|Physician Decision|3|||
147606600|NCT04572893|532375275|FG003|Part B|Withdrawal by Subject|0|||
147606601|NCT04572893|532375276|FG004|Part B|Withdrawal by Subject|0|||
147606602|NCT04572893|532375277|FG005|Part B|Withdrawal by Subject|1|||
147343723|NCT03584516|531426383|FG004|Part 1 Expansion|Physician Decision|2|||
147606603|NCT04572893|532375278|FG006|Part B|Withdrawal by Subject|0|||
147606604|NCT04572893|532375272|FG000|Part B|Study terminated by sponsor|0|||
147606605|NCT04572893|532375273|FG001|Part B|Study terminated by sponsor|0|||
147606606|NCT04572893|532375274|FG002|Part B|Study terminated by sponsor|0|||
147606607|NCT04572893|532375275|FG003|Part B|Study terminated by sponsor|0|||
147606608|NCT04572893|532375276|FG004|Part B|Study terminated by sponsor|7|||
147606609|NCT04572893|532375277|FG005|Part B|Study terminated by sponsor|5|||
147606610|NCT04572893|532375278|FG006|Part B|Study terminated by sponsor|3|||
147606611|NCT04572893|532375272|FG000|Part B|Lost to Follow-up|0|||
147606612|NCT04572893|532375273|FG001|Part B|Lost to Follow-up|0|||
147299880|NCT02286089|531262870|FG001|Overall Study|Ongoing in Study|1|||
147299881|NCT02286089|531262871|FG002|Overall Study|Ongoing in Study|4|||
147299882|NCT02286089|531262872|FG003|Overall Study|Ongoing in Study|10|||
147299883|NCT02286089|531262869|FG000|Overall Study|Withdrawal by Subject|0|||
147299884|NCT02286089|531262870|FG001|Overall Study|Withdrawal by Subject|0|||
147299885|NCT02286089|531262871|FG002|Overall Study|Withdrawal by Subject|2|||
147299886|NCT02286089|531262872|FG003|Overall Study|Withdrawal by Subject|2|||
147299887|NCT02093663|531264556|FG000|Double Blind Acute Phase (8 Weeks)|Adverse Event|1|||
147299888|NCT02093663|531264557|FG001|Double Blind Acute Phase (8 Weeks)|Adverse Event|0|||
147299889|NCT02093663|531264558|FG002|Double Blind Acute Phase (8 Weeks)|Adverse Event|0|||
147299890|NCT02093663|531264559|FG003|Double Blind Acute Phase (8 Weeks)|Adverse Event|0|||
147299891|NCT02093663|531264560|FG004|Double Blind Acute Phase (8 Weeks)|Adverse Event|0|||
147299892|NCT02093663|531264556|FG000|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|5|||
147299893|NCT02093663|531264557|FG001|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|0|||
147299894|NCT02093663|531264558|FG002|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|0|||
147299895|NCT02093663|531264559|FG003|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|0|||
147299896|NCT02093663|531264560|FG004|Double Blind Acute Phase (8 Weeks)|Lack of Efficacy|0|||
147299897|NCT02093663|531264556|FG000|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|2|||
147299898|NCT02093663|531264557|FG001|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|4|||
147299899|NCT02093663|531264558|FG002|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|0|||
147299900|NCT02093663|531264559|FG003|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|0|||
147299901|NCT02093663|531264560|FG004|Double Blind Acute Phase (8 Weeks)|Subjects who Continued in the Study|0|||
147299902|NCT02093663|531264556|FG000|Open Label Acute Phase (8 Weeks)|Adverse Event|0|||
147299903|NCT02093663|531264557|FG001|Open Label Acute Phase (8 Weeks)|Adverse Event|0|||
147299904|NCT02093663|531264558|FG002|Open Label Acute Phase (8 Weeks)|Adverse Event|1|||
147299905|NCT02093663|531264559|FG003|Open Label Acute Phase (8 Weeks)|Adverse Event|0|||
147299906|NCT02093663|531264560|FG004|Open Label Acute Phase (8 Weeks)|Adverse Event|0|||
147299907|NCT02093663|531264556|FG000|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|0|||
147299908|NCT02093663|531264557|FG001|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|0|||
147299909|NCT02093663|531264558|FG002|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|5|||
147299910|NCT02093663|531264559|FG003|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|0|||
147299911|NCT02093663|531264560|FG004|Open Label Acute Phase (8 Weeks)|Lack of Efficacy|0|||
147299912|NCT02093663|531264556|FG000|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|0|||
147299913|NCT02093663|531264557|FG001|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|0|||
147299914|NCT02093663|531264558|FG002|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|0|||
147299915|NCT02093663|531264559|FG003|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|3|||
147299916|NCT02093663|531264560|FG004|Double Blind Maintenance Phase(26 Weeks)|Adverse Event|2|||
147299917|NCT02093663|531264556|FG000|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|0|||
147299918|NCT02093663|531264557|FG001|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|0|||
147299919|NCT02093663|531264558|FG002|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|0|||
147299920|NCT02093663|531264559|FG003|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|6|||
147299921|NCT02093663|531264560|FG004|Double Blind Maintenance Phase(26 Weeks)|Lack of Efficacy|7|||
147299922|NCT02093663|531264556|FG000|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|0|||
147299923|NCT02093663|531264557|FG001|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|0|||
147299924|NCT02093663|531264558|FG002|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|0|||
147299925|NCT02093663|531264559|FG003|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|1|||
147299926|NCT02093663|531264560|FG004|Double Blind Maintenance Phase(26 Weeks)|Other (unspecified)|1|||
147299927|NCT02093663|531264556|FG000|Double Blind Maintenance Phase(26 Weeks)|Missing|0|||
147299928|NCT02093663|531264557|FG001|Double Blind Maintenance Phase(26 Weeks)|Missing|0|||
147299929|NCT02093663|531264558|FG002|Double Blind Maintenance Phase(26 Weeks)|Missing|0|||
147299930|NCT02093663|531264559|FG003|Double Blind Maintenance Phase(26 Weeks)|Missing|0|||
147299931|NCT02093663|531264560|FG004|Double Blind Maintenance Phase(26 Weeks)|Missing|1|||
147299932|NCT00508404|531264561|FG000|Overall Study|Ongoing at Data Cut-off|12|||
147299933|NCT00508404|531264561|FG000|Overall Study|Adverse Event|2|||
147299934|NCT00508404|531264561|FG000|Overall Study|Death|16|||
147299935|NCT00508404|531264561|FG000|Overall Study|Physician Decision|2|||
147299936|NCT00508404|531264561|FG000|Overall Study|Withdrawal by Subject|3|||
147299937|NCT00508404|531264561|FG000|Overall Study|Protocol-specified Criteria|2|||
147343724|NCT03584516|531426384|FG005|Part 1 Expansion|Physician Decision|3|||
147343725|NCT03584516|531426379|FG000|Part 1 Expansion|Study Terminated by Sponsor|0|||
147343726|NCT03584516|531426380|FG001|Part 1 Expansion|Study Terminated by Sponsor|0|||
147343727|NCT03584516|531426381|FG002|Part 1 Expansion|Study Terminated by Sponsor|17|||
147343728|NCT03584516|531426382|FG003|Part 1 Expansion|Study Terminated by Sponsor|20|||
147343729|NCT03584516|531426383|FG004|Part 1 Expansion|Study Terminated by Sponsor|20|||
147343730|NCT03584516|531426384|FG005|Part 1 Expansion|Study Terminated by Sponsor|23|||
147343731|NCT03584516|531426379|FG000|Part 1 Expansion|Withdrawal by Subject|0|||
147343732|NCT03584516|531426380|FG001|Part 1 Expansion|Withdrawal by Subject|0|||
147343733|NCT03584516|531426381|FG002|Part 1 Expansion|Withdrawal by Subject|2|||
147343734|NCT03584516|531426382|FG003|Part 1 Expansion|Withdrawal by Subject|4|||
147343735|NCT03584516|531426383|FG004|Part 1 Expansion|Withdrawal by Subject|2|||
147343736|NCT03584516|531426384|FG005|Part 1 Expansion|Withdrawal by Subject|3|||
147343737|NCT03584516|531426379|FG000|Part 1 Expansion|Discontinued Treatment and Terminated CS Tapering|0|||
147343738|NCT03584516|531426380|FG001|Part 1 Expansion|Discontinued Treatment and Terminated CS Tapering|0|||
147343739|NCT03584516|531426381|FG002|Part 1 Expansion|Discontinued Treatment and Terminated CS Tapering|0|||
147343740|NCT03584516|531426382|FG003|Part 1 Expansion|Discontinued Treatment and Terminated CS Tapering|1|||
147343741|NCT03584516|531426383|FG004|Part 1 Expansion|Discontinued Treatment and Terminated CS Tapering|0|||
147343742|NCT03584516|531426384|FG005|Part 1 Expansion|Discontinued Treatment and Terminated CS Tapering|0|||
147343743|NCT03584516|531426379|FG000|Part 1 Expansion|Disease Progression; cGVHD Flare|0|||
147343744|NCT03584516|531426380|FG001|Part 1 Expansion|Disease Progression; cGVHD Flare|0|||
147343745|NCT03584516|531426381|FG002|Part 1 Expansion|Disease Progression; cGVHD Flare|0|||
147343746|NCT03584516|531426382|FG003|Part 1 Expansion|Disease Progression; cGVHD Flare|0|||
147343747|NCT03584516|531426383|FG004|Part 1 Expansion|Disease Progression; cGVHD Flare|0|||
147343748|NCT03584516|531426384|FG005|Part 1 Expansion|Disease Progression; cGVHD Flare|1|||
147343749|NCT05986565|531426385|FG000|Overall Study|Lost to Follow-up|8|||
147343750|NCT05986565|531426386|FG001|Overall Study|Lost to Follow-up|3|||
147343751|NCT05986565|531426385|FG000|Overall Study|Withdrawal by Subject|0|||
147343752|NCT05986565|531426386|FG001|Overall Study|Withdrawal by Subject|1|||
147343753|NCT00670046|531426389|FG000|Overall Study|Lost to Follow-up|1|||
147343754|NCT00670046|531426390|FG001|Overall Study|Lost to Follow-up|1|||
147343755|NCT00670046|531426389|FG000|Overall Study|Withdrawal by Subject|0|||
147343756|NCT00670046|531426390|FG001|Overall Study|Withdrawal by Subject|1|||
147453099|NCT01142726|531821539|FG002|Withdrawal Phase: Months 12 up to 24|Pregnancy|1|||
147453100|NCT01142726|531821537|FG000|Withdrawal Phase: Months 12 up to 24|Lost to Follow-up|2|||
147453101|NCT01142726|531821538|FG001|Withdrawal Phase: Months 12 up to 24|Lost to Follow-up|0|||
147453102|NCT01142726|531821539|FG002|Withdrawal Phase: Months 12 up to 24|Lost to Follow-up|0|||
147453103|NCT01142726|531821537|FG000|Withdrawal Phase: Months 12 up to 24|No longer met study criteria|1|||
147453104|NCT01142726|531821538|FG001|Withdrawal Phase: Months 12 up to 24|No longer met study criteria|0|||
147453105|NCT01142726|531821539|FG002|Withdrawal Phase: Months 12 up to 24|No longer met study criteria|0|||
147453106|NCT01142726|531821537|FG000|Withdrawal Phase: Months 12 up to 24|Lack of Efficacy|65|||
147453107|NCT01142726|531821538|FG001|Withdrawal Phase: Months 12 up to 24|Lack of Efficacy|54|||
147453108|NCT01142726|531821539|FG002|Withdrawal Phase: Months 12 up to 24|Lack of Efficacy|53|||
147453109|NCT01142726|531821537|FG000|Withdrawal Phase: Months 12 up to 24|non-specified|0|||
147453110|NCT01142726|531821538|FG001|Withdrawal Phase: Months 12 up to 24|non-specified|1|||
147453111|NCT01142726|531821539|FG002|Withdrawal Phase: Months 12 up to 24|non-specified|1|||
147453112|NCT01142726|531821537|FG000|Re-Exposure Phase: Months 24 up to 30|Adverse Event|0|||
147453113|NCT01142726|531821538|FG001|Re-Exposure Phase: Months 24 up to 30|Adverse Event|0|||
147453114|NCT01142726|531821539|FG002|Re-Exposure Phase: Months 24 up to 30|Adverse Event|1|||
147453115|NCT01142726|531821537|FG000|Re-Exposure Phase: Months 24 up to 30|Withdrawal by Subject|1|||
147453116|NCT01142726|531821538|FG001|Re-Exposure Phase: Months 24 up to 30|Withdrawal by Subject|1|||
147453117|NCT01142726|531821539|FG002|Re-Exposure Phase: Months 24 up to 30|Withdrawal by Subject|1|||
147453118|NCT01142726|531821537|FG000|Re-Exposure Phase: Months 24 up to 30|Pregnancy|0|||
147453119|NCT01142726|531821538|FG001|Re-Exposure Phase: Months 24 up to 30|Pregnancy|0|||
147453120|NCT01142726|531821539|FG002|Re-Exposure Phase: Months 24 up to 30|Pregnancy|1|||
147453121|NCT01142726|531821537|FG000|Re-Exposure Phase: Months 24 up to 30|Lack of Efficacy|0|||
147453122|NCT01142726|531821538|FG001|Re-Exposure Phase: Months 24 up to 30|Lack of Efficacy|1|||
147453123|NCT01142726|531821539|FG002|Re-Exposure Phase: Months 24 up to 30|Lack of Efficacy|0|||
147453124|NCT01568593|531821540|FG000|Overall Study|Lack of Efficacy|4|||
147453125|NCT01568593|531821541|FG001|Overall Study|Lack of Efficacy|1|||
147453126|NCT01568593|531821540|FG000|Overall Study|Adverse Event|3|||
147453127|NCT01568593|531821541|FG001|Overall Study|Adverse Event|2|||
147453128|NCT02780648|531821543|FG000|Overall Study|Disease Progression|1|||
147453129|NCT02780648|531821544|FG001|Overall Study|Disease Progression|0|||
147453130|NCT00293579|531821551|FG000|Overall Study|Withdrawal by Subject|1|||
147453131|NCT00419380|531821552|FG000|Overall Study|Lack of Efficacy|1|||
147453132|NCT00419380|531821553|FG001|Overall Study|Lack of Efficacy|7|||
147453133|NCT00419380|531821552|FG000|Overall Study|Physician Decision|0|||
147453134|NCT00419380|531821553|FG001|Overall Study|Physician Decision|1|||
147453135|NCT00419380|531821552|FG000|Overall Study|Lost to Follow-up|0|||
147453136|NCT00419380|531821553|FG001|Overall Study|Lost to Follow-up|1|||
147453137|NCT00419380|531821552|FG000|Overall Study|Withdrawal by Subject|0|||
147453138|NCT00419380|531821553|FG001|Overall Study|Withdrawal by Subject|1|||
147453139|NCT03099707|531821554|FG000|Overall Study|Withdrawal by Subject|0|||
147453140|NCT03099707|531821555|FG001|Overall Study|Withdrawal by Subject|3|||
147453141|NCT03099707|531821554|FG000|Overall Study|Lost to Follow-up|0|||
147343805|NCT04759833|531426407|FG000|PartA:Placebo-controlled Period(12Weeks)|Adverse Event|1|||
147343806|NCT04759833|531426408|FG001|PartA:Placebo-controlled Period(12Weeks)|Adverse Event|4|||
147343807|NCT04759833|531426409|FG002|PartA:Placebo-controlled Period(12Weeks)|Adverse Event|2|||
147343808|NCT04759833|531426410|FG003|PartA:Placebo-controlled Period(12Weeks)|Adverse Event|0|||
147343809|NCT04759833|531426411|FG004|PartA:Placebo-controlled Period(12Weeks)|Adverse Event|0|||
147343810|NCT04759833|531426407|FG000|PartA:Placebo-controlled Period(12Weeks)|Lack of Efficacy|0|||
147343811|NCT04759833|531426408|FG001|PartA:Placebo-controlled Period(12Weeks)|Lack of Efficacy|0|||
147343812|NCT04759833|531426409|FG002|PartA:Placebo-controlled Period(12Weeks)|Lack of Efficacy|1|||
147343813|NCT04759833|531426410|FG003|PartA:Placebo-controlled Period(12Weeks)|Lack of Efficacy|0|||
147343814|NCT04759833|531426411|FG004|PartA:Placebo-controlled Period(12Weeks)|Lack of Efficacy|0|||
147343815|NCT04759833|531426407|FG000|PartA:Placebo-controlled Period(12Weeks)|Lost to Follow-up|4|||
147343816|NCT04759833|531426408|FG001|PartA:Placebo-controlled Period(12Weeks)|Lost to Follow-up|1|||
147343817|NCT04759833|531426409|FG002|PartA:Placebo-controlled Period(12Weeks)|Lost to Follow-up|4|||
147343818|NCT04759833|531426410|FG003|PartA:Placebo-controlled Period(12Weeks)|Lost to Follow-up|0|||
147343819|NCT04759833|531426411|FG004|PartA:Placebo-controlled Period(12Weeks)|Lost to Follow-up|0|||
147343820|NCT04759833|531426407|FG000|PartA:Placebo-controlled Period(12Weeks)|Study Terminated by Sponsor|0|||
147343821|NCT04759833|531426408|FG001|PartA:Placebo-controlled Period(12Weeks)|Study Terminated by Sponsor|2|||
147343822|NCT04759833|531426409|FG002|PartA:Placebo-controlled Period(12Weeks)|Study Terminated by Sponsor|3|||
147343823|NCT04759833|531426410|FG003|PartA:Placebo-controlled Period(12Weeks)|Study Terminated by Sponsor|0|||
147343824|NCT04759833|531426411|FG004|PartA:Placebo-controlled Period(12Weeks)|Study Terminated by Sponsor|0|||
147343825|NCT04759833|531426407|FG000|PartA:Placebo-controlled Period(12Weeks)|Withdrawal of Consent by Participant|5|||
147343826|NCT04759833|531426408|FG001|PartA:Placebo-controlled Period(12Weeks)|Withdrawal of Consent by Participant|3|||
147343827|NCT04759833|531426409|FG002|PartA:Placebo-controlled Period(12Weeks)|Withdrawal of Consent by Participant|9|||
147343828|NCT04759833|531426410|FG003|PartA:Placebo-controlled Period(12Weeks)|Withdrawal of Consent by Participant|0|||
147343829|NCT04759833|531426411|FG004|PartA:Placebo-controlled Period(12Weeks)|Withdrawal of Consent by Participant|0|||
147343830|NCT04759833|531426407|FG000|PartA:Placebo-controlled Period(12Weeks)|Noncompliance with Study Drug|0|||
147343831|NCT04759833|531426408|FG001|PartA:Placebo-controlled Period(12Weeks)|Noncompliance with Study Drug|0|||
147343832|NCT04759833|531426409|FG002|PartA:Placebo-controlled Period(12Weeks)|Noncompliance with Study Drug|1|||
147343833|NCT04759833|531426410|FG003|PartA:Placebo-controlled Period(12Weeks)|Noncompliance with Study Drug|0|||
147343834|NCT04759833|531426411|FG004|PartA:Placebo-controlled Period(12Weeks)|Noncompliance with Study Drug|0|||
147343835|NCT04759833|531426407|FG000|PartA:Placebo-controlled Period(12Weeks)|Physician Decision|0|||
147343836|NCT04759833|531426408|FG001|PartA:Placebo-controlled Period(12Weeks)|Physician Decision|1|||
147343837|NCT04759833|531426409|FG002|PartA:Placebo-controlled Period(12Weeks)|Physician Decision|0|||
147343838|NCT04759833|531426410|FG003|PartA:Placebo-controlled Period(12Weeks)|Physician Decision|0|||
147343839|NCT04759833|531426411|FG004|PartA:Placebo-controlled Period(12Weeks)|Physician Decision|0|||
147343840|NCT04759833|531426407|FG000|Part B:Safety Extension Period(40 Weeks)|Adverse Event|0|||
147343841|NCT04759833|531426408|FG001|Part B:Safety Extension Period(40 Weeks)|Adverse Event|0|||
147343842|NCT04759833|531426409|FG002|Part B:Safety Extension Period(40 Weeks)|Adverse Event|0|||
147343843|NCT04759833|531426410|FG003|Part B:Safety Extension Period(40 Weeks)|Adverse Event|1|||
147343844|NCT04759833|531426411|FG004|Part B:Safety Extension Period(40 Weeks)|Adverse Event|1|||
147343845|NCT04759833|531426407|FG000|Part B:Safety Extension Period(40 Weeks)|Lack of Efficacy|0|||
147343846|NCT04759833|531426408|FG001|Part B:Safety Extension Period(40 Weeks)|Lack of Efficacy|0|||
147343847|NCT04759833|531426409|FG002|Part B:Safety Extension Period(40 Weeks)|Lack of Efficacy|0|||
147343848|NCT04759833|531426410|FG003|Part B:Safety Extension Period(40 Weeks)|Lack of Efficacy|0|||
147343849|NCT04759833|531426411|FG004|Part B:Safety Extension Period(40 Weeks)|Lack of Efficacy|1|||
147343850|NCT04759833|531426407|FG000|Part B:Safety Extension Period(40 Weeks)|Lost to Follow-up|0|||
147343851|NCT04759833|531426408|FG001|Part B:Safety Extension Period(40 Weeks)|Lost to Follow-up|0|||
147343852|NCT04759833|531426409|FG002|Part B:Safety Extension Period(40 Weeks)|Lost to Follow-up|0|||
147343853|NCT04759833|531426410|FG003|Part B:Safety Extension Period(40 Weeks)|Lost to Follow-up|1|||
147343854|NCT04759833|531426411|FG004|Part B:Safety Extension Period(40 Weeks)|Lost to Follow-up|3|||
147343855|NCT04759833|531426407|FG000|Part B:Safety Extension Period(40 Weeks)|Study Terminated by Sponsor|0|||
147343856|NCT04759833|531426408|FG001|Part B:Safety Extension Period(40 Weeks)|Study Terminated by Sponsor|0|||
147343857|NCT04759833|531426409|FG002|Part B:Safety Extension Period(40 Weeks)|Study Terminated by Sponsor|0|||
147343858|NCT04759833|531426410|FG003|Part B:Safety Extension Period(40 Weeks)|Study Terminated by Sponsor|21|||
147343859|NCT04759833|531426411|FG004|Part B:Safety Extension Period(40 Weeks)|Study Terminated by Sponsor|16|||
147343860|NCT04759833|531426407|FG000|Part B:Safety Extension Period(40 Weeks)|Withdrawal of Consent by Participant|0|||
147606613|NCT04572893|532375274|FG002|Part B|Lost to Follow-up|0|||
147606614|NCT04572893|532375275|FG003|Part B|Lost to Follow-up|0|||
147606615|NCT04572893|532375276|FG004|Part B|Lost to Follow-up|0|||
147606616|NCT04572893|532375277|FG005|Part B|Lost to Follow-up|0|||
147606617|NCT04572893|532375278|FG006|Part B|Lost to Follow-up|1|||
147606618|NCT04572893|532375272|FG000|Part B|Adverse Event|0|||
147606619|NCT04572893|532375273|FG001|Part B|Adverse Event|0|||
147343861|NCT04759833|531426408|FG001|Part B:Safety Extension Period(40 Weeks)|Withdrawal of Consent by Participant|0|||
147343862|NCT04759833|531426409|FG002|Part B:Safety Extension Period(40 Weeks)|Withdrawal of Consent by Participant|0|||
147343863|NCT04759833|531426410|FG003|Part B:Safety Extension Period(40 Weeks)|Withdrawal of Consent by Participant|4|||
147343864|NCT04759833|531426411|FG004|Part B:Safety Extension Period(40 Weeks)|Withdrawal of Consent by Participant|8|||
147343865|NCT04759833|531426407|FG000|Part B:Safety Extension Period(40 Weeks)|Reason not Specified|0|||
147343866|NCT04759833|531426408|FG001|Part B:Safety Extension Period(40 Weeks)|Reason not Specified|0|||
147343867|NCT04759833|531426409|FG002|Part B:Safety Extension Period(40 Weeks)|Reason not Specified|0|||
147343868|NCT04759833|531426410|FG003|Part B:Safety Extension Period(40 Weeks)|Reason not Specified|8|||
147343869|NCT04759833|531426411|FG004|Part B:Safety Extension Period(40 Weeks)|Reason not Specified|5|||
147343870|NCT03446157|531426412|FG000|Overall Study|Death|11|||
147343871|NCT03446157|531426413|FG001|Overall Study|Death|9|||
147343872|NCT03446157|531426412|FG000|Overall Study|Lost to Follow-up|0|||
147343873|NCT03446157|531426413|FG001|Overall Study|Lost to Follow-up|1|||
147343874|NCT03446157|531426412|FG000|Overall Study|Withdrawal by Subject|2|||
147343875|NCT03446157|531426413|FG001|Overall Study|Withdrawal by Subject|1|||
147343876|NCT01619410|531426414|FG000|Overall Study|Lost to Follow-up|7|||
147343877|NCT01619410|531426415|FG001|Overall Study|Lost to Follow-up|4|||
147343878|NCT02462759|531426420|FG000|Part 1: Double Blind|Death|1|||
147343879|NCT02462759|531426421|FG001|Part 1: Double Blind|Death|0|||
147343880|NCT02462759|531426422|FG002|Part 1: Double Blind|Death|0|||
147343881|NCT04110054|531426423|FG000|Overall Study|COVID-19 reason other than AE|0|||
147343882|NCT04110054|531426424|FG001|Overall Study|COVID-19 reason other than AE|0|||
147343883|NCT04110054|531426425|FG002|Overall Study|COVID-19 reason other than AE|2|||
147343884|NCT04110054|531426426|FG003|Overall Study|COVID-19 reason other than AE|0|||
147343885|NCT04110054|531426423|FG000|Overall Study|Withdrawal by Subject|0|||
147343886|NCT04110054|531426424|FG001|Overall Study|Withdrawal by Subject|3|||
147343887|NCT04110054|531426425|FG002|Overall Study|Withdrawal by Subject|2|||
147343888|NCT04110054|531426426|FG003|Overall Study|Withdrawal by Subject|0|||
147343889|NCT04110054|531426423|FG000|Overall Study|Adverse Event|1|||
147343890|NCT04110054|531426424|FG001|Overall Study|Adverse Event|1|||
147343891|NCT04110054|531426425|FG002|Overall Study|Adverse Event|4|||
147343892|NCT04110054|531426426|FG003|Overall Study|Adverse Event|3|||
147343893|NCT01000480|531426428|FG000|Induction Phase|Adverse Event|2|||
147343894|NCT01000480|531426428|FG000|Induction Phase|Lost to Follow-up|1|||
147343895|NCT01000480|531426428|FG000|Induction Phase|Physician Decision|1|||
147343896|NCT01000480|531426428|FG000|Induction Phase|Entry Criteria Not Met|3|||
147343897|NCT01000480|531426428|FG000|Concurrent Therapy Phase|Adverse Event|4|||
147343898|NCT01000480|531426428|FG000|Concurrent Therapy Phase|Protocol Violation|2|||
147343899|NCT01000480|531426428|FG000|Concurrent Therapy Phase|Withdrawal by Subject|3|||
147343900|NCT01000480|531426428|FG000|Concurrent Therapy Phase|Physician Decision|1|||
147343901|NCT02374307|531426432|FG000|3-months Follow-up|Lost to Follow-up|1|||
147343902|NCT02374307|531426433|FG001|3-months Follow-up|Lost to Follow-up|2|||
147343903|NCT02374307|531426432|FG000|3-months Follow-up|Withdrawal by Subject|1|||
147343904|NCT02374307|531426433|FG001|3-months Follow-up|Withdrawal by Subject|4|||
147343905|NCT02374307|531426432|FG000|3-months Follow-up|Death|1|||
147343906|NCT02374307|531426433|FG001|3-months Follow-up|Death|2|||
147343907|NCT02374307|531426432|FG000|3-months Follow-up|Missed first follow-up|5|||
147343908|NCT02374307|531426433|FG001|3-months Follow-up|Missed first follow-up|1|||
147343909|NCT02374307|531426432|FG000|6-months Follow-up|Lost to Follow-up|1|||
147343910|NCT02374307|531426433|FG001|6-months Follow-up|Lost to Follow-up|2|||
147343911|NCT02374307|531426432|FG000|6-months Follow-up|Death|2|||
147343912|NCT02374307|531426433|FG001|6-months Follow-up|Death|1|||
147343913|NCT02374307|531426432|FG000|6-months Follow-up|Withdrawal by Subject|0|||
147343914|NCT02374307|531426433|FG001|6-months Follow-up|Withdrawal by Subject|3|||
147343915|NCT00632203|531426434|FG000|Overall Study|Did not start study treatment|1|||
147343916|NCT00632203|531426435|FG001|Overall Study|Did not start study treatment|0|||
147343917|NCT04452318|531426438|FG000|Overall Study|Physician Decision|1|||
147343918|NCT04452318|531426439|FG001|Overall Study|Physician Decision|2|||
147343919|NCT04452318|531426440|FG002|Overall Study|Physician Decision|0|||
147343920|NCT04452318|531426441|FG003|Overall Study|Physician Decision|2|||
147343921|NCT04452318|531426442|FG004|Overall Study|Physician Decision|0|||
147343922|NCT04452318|531426443|FG005|Overall Study|Physician Decision|2|||
147343923|NCT04452318|531426444|FG006|Overall Study|Physician Decision|5|||
147343924|NCT04452318|531426438|FG000|Overall Study|Death|2|||
147343925|NCT04452318|531426439|FG001|Overall Study|Death|3|||
147606620|NCT04572893|532375274|FG002|Part B|Adverse Event|0|||
147606621|NCT04572893|532375275|FG003|Part B|Adverse Event|0|||
147606622|NCT04572893|532375276|FG004|Part B|Adverse Event|1|||
147606623|NCT04572893|532375277|FG005|Part B|Adverse Event|1|||
147606624|NCT04572893|532375278|FG006|Part B|Adverse Event|0|||
147606625|NCT05038800|532375279|FG000|Overall Study|Death|1|||
147606626|NCT05038800|532375280|FG001|Overall Study|Death|1|||
147606627|NCT05038800|532375281|FG002|Overall Study|Death|5|||
147606628|NCT05038800|532375282|FG003|Overall Study|Death|3|||
147606629|NCT05038800|532375283|FG004|Overall Study|Death|1|||
147606630|NCT05038800|532375279|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
147606631|NCT05038800|532375280|FG001|Overall Study|Randomized By Mistake Without Study Treatment|0|||
147606632|NCT05038800|532375281|FG002|Overall Study|Randomized By Mistake Without Study Treatment|0|||
147606633|NCT05038800|532375282|FG003|Overall Study|Randomized By Mistake Without Study Treatment|0|||
147606634|NCT05038800|532375283|FG004|Overall Study|Randomized By Mistake Without Study Treatment|1|||
147606635|NCT05038800|532375279|FG000|Overall Study|Lack of Efficacy|0|||
147343926|NCT04452318|531426440|FG002|Overall Study|Death|0|||
147343927|NCT04452318|531426441|FG003|Overall Study|Death|0|||
147343928|NCT04452318|531426442|FG004|Overall Study|Death|0|||
147343929|NCT04452318|531426443|FG005|Overall Study|Death|0|||
147343930|NCT04452318|531426444|FG006|Overall Study|Death|0|||
147343931|NCT04452318|531426438|FG000|Overall Study|Lost to Follow-up|38|||
147343932|NCT04452318|531426439|FG001|Overall Study|Lost to Follow-up|28|||
147343933|NCT04452318|531426440|FG002|Overall Study|Lost to Follow-up|0|||
147343934|NCT04452318|531426441|FG003|Overall Study|Lost to Follow-up|3|||
147343935|NCT04452318|531426442|FG004|Overall Study|Lost to Follow-up|3|||
147343936|NCT04452318|531426443|FG005|Overall Study|Lost to Follow-up|2|||
147343937|NCT04452318|531426444|FG006|Overall Study|Lost to Follow-up|1|||
147343938|NCT04452318|531426438|FG000|Overall Study|Withdrawal by Subject|46|||
147343939|NCT04452318|531426439|FG001|Overall Study|Withdrawal by Subject|40|||
147343940|NCT04452318|531426440|FG002|Overall Study|Withdrawal by Subject|0|||
147343941|NCT04452318|531426441|FG003|Overall Study|Withdrawal by Subject|18|||
147343942|NCT04452318|531426442|FG004|Overall Study|Withdrawal by Subject|6|||
147343943|NCT04452318|531426443|FG005|Overall Study|Withdrawal by Subject|8|||
147343944|NCT04452318|531426444|FG006|Overall Study|Withdrawal by Subject|6|||
147343945|NCT02554786|531426445|FG000|Overall Study|Subject/guardian decision|29|||
147343946|NCT02554786|531426446|FG001|Overall Study|Subject/guardian decision|17|||
147343947|NCT02554786|531426447|FG002|Overall Study|Subject/guardian decision|18|||
147343948|NCT02554786|531426448|FG003|Overall Study|Subject/guardian decision|30|||
147343949|NCT02554786|531426449|FG004|Overall Study|Subject/guardian decision|20|||
147343950|NCT02554786|531426445|FG000|Overall Study|Lost to Follow-up|4|||
147343951|NCT02554786|531426446|FG001|Overall Study|Lost to Follow-up|3|||
147343952|NCT02554786|531426447|FG002|Overall Study|Lost to Follow-up|4|||
147343953|NCT02554786|531426448|FG003|Overall Study|Lost to Follow-up|2|||
147343954|NCT02554786|531426449|FG004|Overall Study|Lost to Follow-up|2|||
147343955|NCT02554786|531426445|FG000|Overall Study|Protocol deviation|1|||
147343956|NCT02554786|531426446|FG001|Overall Study|Protocol deviation|3|||
147343957|NCT02554786|531426447|FG002|Overall Study|Protocol deviation|3|||
147343958|NCT02554786|531426448|FG003|Overall Study|Protocol deviation|4|||
147343959|NCT02554786|531426449|FG004|Overall Study|Protocol deviation|2|||
147343960|NCT02554786|531426445|FG000|Overall Study|Technical problems|1|||
147343961|NCT02554786|531426446|FG001|Overall Study|Technical problems|1|||
147606636|NCT05038800|532375280|FG001|Overall Study|Lack of Efficacy|0|||
147343962|NCT02554786|531426447|FG002|Overall Study|Technical problems|0|||
147343963|NCT02554786|531426448|FG003|Overall Study|Technical problems|2|||
147343964|NCT02554786|531426449|FG004|Overall Study|Technical problems|1|||
147343965|NCT02554786|531426445|FG000|Overall Study|Adverse Event|0|||
147343966|NCT02554786|531426446|FG001|Overall Study|Adverse Event|0|||
147343967|NCT02554786|531426447|FG002|Overall Study|Adverse Event|0|||
147343968|NCT02554786|531426448|FG003|Overall Study|Adverse Event|0|||
147343969|NCT02554786|531426449|FG004|Overall Study|Adverse Event|2|||
147343970|NCT02554786|531426445|FG000|Overall Study|Death|0|||
147343971|NCT02554786|531426446|FG001|Overall Study|Death|0|||
147343972|NCT02554786|531426447|FG002|Overall Study|Death|0|||
147343973|NCT02554786|531426448|FG003|Overall Study|Death|1|||
147343974|NCT02554786|531426449|FG004|Overall Study|Death|0|||
147343975|NCT02554786|531426445|FG000|Overall Study|Non-compliance with study treatment|0|||
147343976|NCT02554786|531426446|FG001|Overall Study|Non-compliance with study treatment|1|||
147343977|NCT02554786|531426447|FG002|Overall Study|Non-compliance with study treatment|1|||
147343978|NCT02554786|531426448|FG003|Overall Study|Non-compliance with study treatment|0|||
147343979|NCT02554786|531426449|FG004|Overall Study|Non-compliance with study treatment|1|||
147343980|NCT02554786|531426445|FG000|Overall Study|Physician Decision|0|||
147343981|NCT02554786|531426446|FG001|Overall Study|Physician Decision|1|||
147343982|NCT02554786|531426447|FG002|Overall Study|Physician Decision|4|||
147343983|NCT02554786|531426448|FG003|Overall Study|Physician Decision|1|||
147343984|NCT02554786|531426449|FG004|Overall Study|Physician Decision|1|||
147343985|NCT02554786|531426445|FG000|Overall Study|Pregnancy|0|||
147343986|NCT02554786|531426446|FG001|Overall Study|Pregnancy|0|||
147343987|NCT02554786|531426447|FG002|Overall Study|Pregnancy|0|||
147343988|NCT02554786|531426448|FG003|Overall Study|Pregnancy|1|||
147343989|NCT02554786|531426449|FG004|Overall Study|Pregnancy|1|||
147343990|NCT00604669|531426450|FG000|Overall Study|lack of information in chart|7|||
147343991|NCT01695954|531426451|FG000|Overall Study|Withdrawal by Subject|4|||
147343992|NCT01695954|531426452|FG001|Overall Study|Withdrawal by Subject|0|||
147343993|NCT01695954|531426451|FG000|Overall Study|Adverse Event|0|||
147343994|NCT01695954|531426452|FG001|Overall Study|Adverse Event|2|||
147343995|NCT03330795|531426471|FG000|Overall Study|Death|3|||
147343996|NCT03330795|531426471|FG000|Overall Study|No longer eligible to receive transplants or study interventions due to medical contraindication|1|||
147343997|NCT00539734|531426473|FG000|Overall Study|Protocol Violation|1|||
147343998|NCT01771731|531426474|FG000|Overall Study|Physician Decision|1|||
147343999|NCT01771731|531426475|FG001|Overall Study|Physician Decision|0|||
147344000|NCT01771731|531426474|FG000|Overall Study|Protocol Violation|0|||
147344001|NCT01771731|531426475|FG001|Overall Study|Protocol Violation|1|||
147344002|NCT01771731|531426474|FG000|Overall Study|Adverse event: Pain Crisis|1|||
147344003|NCT01771731|531426475|FG001|Overall Study|Adverse event: Pain Crisis|1|||
147344004|NCT00065260|531426476|FG000|Overall Study|Death|0|||
147344005|NCT00065260|531426477|FG001|Overall Study|Death|1|||
147344006|NCT01037985|531426481|FG000|Part A: Skin Testing (50 Days)|Withdrawal by Subject|3|||
147344007|NCT01037985|531426482|FG001|Part A: Skin Testing (50 Days)|Withdrawal by Subject|0|||
147344008|NCT01037985|531426481|FG000|Part A: Skin Testing (50 Days)|Physician Decision|1|||
147344009|NCT01037985|531426482|FG001|Part A: Skin Testing (50 Days)|Physician Decision|0|||
147344010|NCT01037985|531426481|FG000|Part B:Abdominoplasty Surgery (24 Weeks)|Lost to Follow-up|0|||
147344011|NCT01037985|531426482|FG001|Part B:Abdominoplasty Surgery (24 Weeks)|Lost to Follow-up|1|||
147344012|NCT01037985|531426481|FG000|Part B:Abdominoplasty Surgery (24 Weeks)|Positive Skin Sensitization|0|||
147344013|NCT01037985|531426482|FG001|Part B:Abdominoplasty Surgery (24 Weeks)|Positive Skin Sensitization|4|||
147344014|NCT01609218|531426484|FG000|Period 1|Adverse Event|3|||
147344015|NCT01609218|531426485|FG001|Period 1|Adverse Event|5|||
147344016|NCT01609218|531426484|FG000|Period 1|Sponsor Decision|0|||
147344017|NCT01609218|531426485|FG001|Period 1|Sponsor Decision|1|||
147344018|NCT01609218|531426484|FG000|Period 2|Adverse Event|1|||
147344019|NCT01609218|531426485|FG001|Period 2|Adverse Event|0|||
147344020|NCT00774852|531426486|FG000|Overall Study|Adverse Event|9|||
147344021|NCT00774852|531426487|FG001|Overall Study|Adverse Event|6|||
147344022|NCT00774852|531426486|FG000|Overall Study|Death|2|||
147344023|NCT00774852|531426487|FG001|Overall Study|Death|1|||
147344024|NCT00774852|531426486|FG000|Overall Study|Lack of Efficacy|3|||
147344025|NCT00774852|531426487|FG001|Overall Study|Lack of Efficacy|7|||
147344026|NCT00774852|531426486|FG000|Overall Study|Lost to Follow-up|9|||
147344027|NCT00774852|531426487|FG001|Overall Study|Lost to Follow-up|5|||
147344028|NCT00774852|531426486|FG000|Overall Study|Physician Decision|2|||
147344029|NCT00774852|531426487|FG001|Overall Study|Physician Decision|6|||
147344030|NCT00774852|531426486|FG000|Overall Study|Pregnancy|1|||
147344031|NCT00774852|531426487|FG001|Overall Study|Pregnancy|2|||
147344032|NCT00774852|531426486|FG000|Overall Study|Withdrawal by Subject|2|||
147344033|NCT00774852|531426487|FG001|Overall Study|Withdrawal by Subject|2|||
147344034|NCT00774852|531426486|FG000|Overall Study|Non-responder|15|||
147344035|NCT00774852|531426487|FG001|Overall Study|Non-responder|11|||
147344036|NCT00774852|531426486|FG000|Overall Study|Subject non-compliance|0|||
147344037|NCT00774852|531426487|FG001|Overall Study|Subject non-compliance|1|||
147344038|NCT00774852|531426486|FG000|Overall Study|Protocol Violation|1|||
147344039|NCT00774852|531426487|FG001|Overall Study|Protocol Violation|0|||
147344040|NCT00774852|531426486|FG000|Overall Study|Subject received prohibited medication|1|||
147344041|NCT00774852|531426487|FG001|Overall Study|Subject received prohibited medication|0|||
147344042|NCT04428112|531426488|FG000|Overall Study|Administratively removed prior to group delivery: unable to verify identify, duplicate, PLWD death|4|||
147344043|NCT04428112|531426489|FG001|Overall Study|Administratively removed prior to group delivery: unable to verify identify, duplicate, PLWD death|5|||
147344044|NCT04428112|531426488|FG000|Overall Study|Planned study completion at 6-months. 2 final cohorts initiated with known follow up of 6 months.|68|||
147344045|NCT04428112|531426489|FG001|Overall Study|Planned study completion at 6-months. 2 final cohorts initiated with known follow up of 6 months.|29|||
147344046|NCT04428112|531426488|FG000|Overall Study|Withdrawal by Subject|9|||
147344047|NCT04428112|531426489|FG001|Overall Study|Withdrawal by Subject|4|||
147344048|NCT04428112|531426488|FG000|Overall Study|Lost to Follow-up|27|||
147344049|NCT04428112|531426489|FG001|Overall Study|Lost to Follow-up|7|||
147344050|NCT05134337|531428288|FG000|Overall Study|Subject Discontinued Out of Precaution Due to Covid-19|3|||
147344051|NCT05134337|531428289|FG001|Overall Study|Subject Discontinued Out of Precaution Due to Covid-19|0|||
147344052|NCT03481660|531428293|FG000|Overall Study|Adverse Event|5|||
147344053|NCT03481660|531428294|FG001|Overall Study|Adverse Event|4|||
147344054|NCT03481660|531428293|FG000|Overall Study|Death|13|||
147344055|NCT03481660|531428294|FG001|Overall Study|Death|9|||
147344056|NCT03481660|531428293|FG000|Overall Study|Lost to Follow-up|2|||
147344057|NCT03481660|531428294|FG001|Overall Study|Lost to Follow-up|2|||
147344058|NCT03481660|531428293|FG000|Overall Study|Physician Decision|2|||
147344059|NCT03481660|531428294|FG001|Overall Study|Physician Decision|3|||
147344060|NCT03481660|531428293|FG000|Overall Study|Withdrawal by Subject|14|||
147344061|NCT03481660|531428294|FG001|Overall Study|Withdrawal by Subject|7|||
147344062|NCT01259401|531428295|FG000|4-month Follow-up|Death|0|||
147344063|NCT01259401|531428296|FG001|4-month Follow-up|Death|1|||
147344064|NCT01259401|531428295|FG000|4-month Follow-up|Lost to Follow-up|0|||
147344065|NCT01259401|531428296|FG001|4-month Follow-up|Lost to Follow-up|1|||
147606637|NCT05038800|532375281|FG002|Overall Study|Lack of Efficacy|0|||
147344066|NCT00186992|531428297|FG000|Overall Study|Withdrawal by Subject|5|||
147606638|NCT05038800|532375282|FG003|Overall Study|Lack of Efficacy|0|||
147606639|NCT05038800|532375283|FG004|Overall Study|Lack of Efficacy|1|||
147606640|NCT00121134|532375284|FG000|Overall Study|Progression of Disease|5|||
147344067|NCT00186992|531428297|FG000|Overall Study|Physician's discretion|13|||
147344068|NCT00186992|531428297|FG000|Overall Study|PI Discretion|4|||
147344069|NCT00186992|531428297|FG000|Overall Study|Ineligible|2|||
147344070|NCT00186992|531428297|FG000|Overall Study|Lost to Follow-up|2|||
147344071|NCT00186992|531428297|FG000|Overall Study|Still on Study|9|||
147344072|NCT03683069|531428298|FG000|Overall Study|see limitations|12|||
147344073|NCT03683069|531428299|FG001|Overall Study|see limitations|13|||
147344074|NCT05696080|531428300|FG000|Overall Study|Lost to Follow-up|2|||
147344075|NCT05696080|531428301|FG001|Overall Study|Lost to Follow-up|1|||
147344076|NCT05696080|531428300|FG000|Overall Study|Physician Decision|1|||
147344077|NCT05696080|531428301|FG001|Overall Study|Physician Decision|0|||
147344078|NCT05696080|531428300|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
147344079|NCT05696080|531428301|FG001|Overall Study|Randomized By Mistake Without Study Treatment|1|||
147344080|NCT05696080|531428300|FG000|Overall Study|Withdrawal by Subject|12|||
147344081|NCT05696080|531428301|FG001|Overall Study|Withdrawal by Subject|0|||
147344082|NCT05478525|531428304|FG000|Overall Study|Withdrawal by Subject|0|||
147344083|NCT05478525|531428305|FG001|Overall Study|Withdrawal by Subject|1|||
147344084|NCT05478525|531428306|FG002|Overall Study|Withdrawal by Subject|2|||
147344085|NCT05478525|531428307|FG003|Overall Study|Withdrawal by Subject|0|||
147344086|NCT05478525|531428304|FG000|Overall Study|COVID-19 Infection|2|||
147344087|NCT05478525|531428305|FG001|Overall Study|COVID-19 Infection|0|||
147344088|NCT05478525|531428306|FG002|Overall Study|COVID-19 Infection|1|||
147344089|NCT05478525|531428307|FG003|Overall Study|COVID-19 Infection|1|||
147344090|NCT01991977|531428308|FG000|Overall Study|Withdrew prior to receiving treatment|7|||
147344091|NCT01991977|531428308|FG000|Overall Study|Withdrew after start of treatment|5|||
147344092|NCT03845465|531428310|FG000|Baseline Through Intervention|Withdrawal by Subject|4|||
147344093|NCT03845465|531428311|FG001|Baseline Through Intervention|Withdrawal by Subject|0|||
147344094|NCT03845465|531428310|FG000|6-month Data Collection|Withdrawal by Subject|0|||
147344095|NCT03845465|531428311|FG001|6-month Data Collection|Withdrawal by Subject|2|||
147344096|NCT03845465|531428310|FG000|12-month Data Collection|Withdrawal by Subject|0|||
147344097|NCT03845465|531428311|FG001|12-month Data Collection|Withdrawal by Subject|2|||
147344098|NCT05656911|531428312|FG000|Treatment Phase|Physician Decision|2|||
147344099|NCT05656911|531428313|FG001|Treatment Phase|Physician Decision|0|||
147344100|NCT05656911|531428312|FG000|Treatment Phase|Lack of Efficacy|6|||
147344101|NCT05656911|531428313|FG001|Treatment Phase|Lack of Efficacy|3|||
147344102|NCT05656911|531428312|FG000|Treatment Phase|Subject Decision|4|||
147344103|NCT05656911|531428313|FG001|Treatment Phase|Subject Decision|2|||
147344104|NCT05656911|531428312|FG000|Treatment Phase|Other Reasons|1|||
147344105|NCT05656911|531428313|FG001|Treatment Phase|Other Reasons|0|||
147344106|NCT05656911|531428312|FG000|Treatment Phase|Adverse Event|3|||
147344107|NCT05656911|531428313|FG001|Treatment Phase|Adverse Event|1|||
147344108|NCT05656911|531428312|FG000|Follow-up Phase|Subject Decision|0|||
147344109|NCT05656911|531428313|FG001|Follow-up Phase|Subject Decision|1|||
147344110|NCT05656911|531428312|FG000|Follow-up Phase|Missing|1|||
147344111|NCT05656911|531428313|FG001|Follow-up Phase|Missing|0|||
147344112|NCT03547908|531428314|FG000|Blinded Phase|Lost to Follow-up|3|||
147344113|NCT03547908|531428315|FG001|Blinded Phase|Lost to Follow-up|3|||
147344114|NCT03547908|531428316|FG002|Blinded Phase|Lost to Follow-up|0|||
147344115|NCT03547908|531428317|FG003|Blinded Phase|Lost to Follow-up|0|||
147344116|NCT03547908|531428314|FG000|Blinded Phase|Withdrew Consent|2|||
147344117|NCT03547908|531428315|FG001|Blinded Phase|Withdrew Consent|3|||
147344118|NCT03547908|531428316|FG002|Blinded Phase|Withdrew Consent|0|||
147344119|NCT03547908|531428317|FG003|Blinded Phase|Withdrew Consent|0|||
147344120|NCT03547908|531428314|FG000|Blinded Phase|Investigator's Discretion|2|||
147344121|NCT03547908|531428315|FG001|Blinded Phase|Investigator's Discretion|1|||
147344122|NCT03547908|531428316|FG002|Blinded Phase|Investigator's Discretion|0|||
147344123|NCT03547908|531428317|FG003|Blinded Phase|Investigator's Discretion|0|||
147344124|NCT03547908|531428314|FG000|Blinded Phase|Death|2|||
147344125|NCT03547908|531428315|FG001|Blinded Phase|Death|0|||
147344126|NCT03547908|531428316|FG002|Blinded Phase|Death|0|||
147344127|NCT03547908|531428317|FG003|Blinded Phase|Death|0|||
147606641|NCT00121134|532375285|FG001|Overall Study|Progression of Disease|3|||
147344128|NCT03547908|531428314|FG000|Blinded Phase|Non-compliance With Study Drug|0|||
147344129|NCT03547908|531428315|FG001|Blinded Phase|Non-compliance With Study Drug|2|||
147344130|NCT03547908|531428316|FG002|Blinded Phase|Non-compliance With Study Drug|0|||
147344131|NCT03547908|531428317|FG003|Blinded Phase|Non-compliance With Study Drug|0|||
147344132|NCT03547908|531428314|FG000|Blinded Phase|Adverse Event|1|||
147344133|NCT03547908|531428315|FG001|Blinded Phase|Adverse Event|0|||
147344134|NCT03547908|531428316|FG002|Blinded Phase|Adverse Event|0|||
147344135|NCT03547908|531428317|FG003|Blinded Phase|Adverse Event|0|||
147344136|NCT03547908|531428314|FG000|Blinded Phase|Randomized But Never Treated|1|||
147344137|NCT03547908|531428315|FG001|Blinded Phase|Randomized But Never Treated|0|||
147344138|NCT03547908|531428316|FG002|Blinded Phase|Randomized But Never Treated|0|||
147344139|NCT03547908|531428317|FG003|Blinded Phase|Randomized But Never Treated|0|||
147344140|NCT03547908|531428314|FG000|Open-label Extension Phase|Lost to Follow-up|0|||
147344141|NCT03547908|531428315|FG001|Open-label Extension Phase|Lost to Follow-up|0|||
147344142|NCT03547908|531428316|FG002|Open-label Extension Phase|Lost to Follow-up|3|||
147344143|NCT03547908|531428317|FG003|Open-label Extension Phase|Lost to Follow-up|1|||
147344144|NCT03547908|531428314|FG000|Open-label Extension Phase|Death|0|||
147344145|NCT03547908|531428315|FG001|Open-label Extension Phase|Death|0|||
147344146|NCT03547908|531428316|FG002|Open-label Extension Phase|Death|1|||
147344147|NCT03547908|531428317|FG003|Open-label Extension Phase|Death|0|||
147344148|NCT04607044|531428324|FG000|Overall Study|Study Early Termination by Sponsor.|40|||
147344149|NCT04607044|531428324|FG000|Overall Study|Adverse Event|1|||
147344150|NCT04607044|531428324|FG000|Overall Study|Did not receive study device|3|||
147344151|NCT04607044|531428324|FG000|Overall Study|Death|1|||
147344152|NCT05403801|531428325|FG000|Overall Study|Withdrawal by Subject|2|||
147344153|NCT03416023|531428326|FG000|Overall Study|Exclusion criteria failure|1|||
147344154|NCT03416023|531428326|FG000|Overall Study|Withdrawal by Subject|6|||
147344155|NCT03416023|531428326|FG000|Overall Study|Explanted|7|||
147344156|NCT03416023|531428326|FG000|Overall Study|Physician Decision|1|||
147344157|NCT03416023|531428326|FG000|Overall Study|Lost to Follow-up|1|||
147344158|NCT03416023|531428326|FG000|Overall Study|Death|1|||
147344159|NCT03651895|531428327|FG000|First Drug Assignment|Adverse Event|4|||
147344160|NCT03651895|531428328|FG001|First Drug Assignment|Adverse Event|5|||
147344161|NCT03651895|531428327|FG000|Second Drug Assignment - Crossover|Adverse Event|1|||
147344162|NCT03651895|531428328|FG001|Second Drug Assignment - Crossover|Adverse Event|1|||
147344163|NCT02837510|531428329|FG000|1st Pretreatment fMRI Session|Lost to Follow-up|1|||
147344164|NCT02837510|531428330|FG001|1st Pretreatment fMRI Session|Lost to Follow-up|1|||
147344165|NCT02837510|531428329|FG000|Washout (2 Weeks)|Adverse Event|0|||
147344166|NCT02837510|531428330|FG001|Washout (2 Weeks)|Adverse Event|1|||
147344167|NCT02837510|531428329|FG000|Washout (2 Weeks)|Lost to Follow-up|1|||
147344168|NCT02837510|531428330|FG001|Washout (2 Weeks)|Lost to Follow-up|0|||
147344169|NCT02837510|531428329|FG000|2nd Pretreatment fMRI Session|Adverse Event|1|||
147344170|NCT02837510|531428330|FG001|2nd Pretreatment fMRI Session|Adverse Event|0|||
147344171|NCT02837510|531428329|FG000|2nd Pretreatment fMRI Session|Lost to Follow-up|0|||
147344172|NCT02837510|531428330|FG001|2nd Pretreatment fMRI Session|Lost to Follow-up|1|||
147344173|NCT02837510|531428329|FG000|Quit Attempt (6 Months)|Adverse Event|2|||
147344174|NCT02837510|531428330|FG001|Quit Attempt (6 Months)|Adverse Event|2|||
147344175|NCT03857620|531428331|FG000|Overall Study|Death|4|||
147344176|NCT03857620|531428332|FG001|Overall Study|Death|5|||
147344177|NCT03857620|531428333|FG002|Overall Study|Death|7|||
147344178|NCT03857620|531428331|FG000|Overall Study|Lost to Follow-up|2|||
147344179|NCT03857620|531428332|FG001|Overall Study|Lost to Follow-up|5|||
147344180|NCT03857620|531428333|FG002|Overall Study|Lost to Follow-up|3|||
147344181|NCT03857620|531428331|FG000|Overall Study|Disease progression or relapse after study registration|1|||
147344182|NCT03857620|531428332|FG001|Overall Study|Disease progression or relapse after study registration|5|||
147344183|NCT03857620|531428333|FG002|Overall Study|Disease progression or relapse after study registration|1|||
147344184|NCT03857620|531428331|FG000|Overall Study|Ineligible|5|||
147344185|NCT03857620|531428332|FG001|Overall Study|Ineligible|0|||
147344186|NCT03857620|531428333|FG002|Overall Study|Ineligible|2|||
147344187|NCT03857620|531428331|FG000|Overall Study|No malignancy|1|||
147344188|NCT03857620|531428332|FG001|Overall Study|No malignancy|0|||
147344189|NCT03857620|531428333|FG002|Overall Study|No malignancy|1|||
147344190|NCT03857620|531428331|FG000|Overall Study|Patient withdrawal/refusal prior to surgery|2|||
147344191|NCT03857620|531428332|FG001|Overall Study|Patient withdrawal/refusal prior to surgery|0|||
147344192|NCT03857620|531428333|FG002|Overall Study|Patient withdrawal/refusal prior to surgery|0|||
147344193|NCT03857620|531428331|FG000|Overall Study|Patient withdrawal/refusal after surgery performed|4|||
147344194|NCT03857620|531428332|FG001|Overall Study|Patient withdrawal/refusal after surgery performed|7|||
147344195|NCT03857620|531428333|FG002|Overall Study|Patient withdrawal/refusal after surgery performed|2|||
147344196|NCT03857620|531428331|FG000|Overall Study|Surgery not performed due to worsening performance status/medical ineligibility|4|||
147344197|NCT03857620|531428332|FG001|Overall Study|Surgery not performed due to worsening performance status/medical ineligibility|4|||
147344198|NCT03857620|531428333|FG002|Overall Study|Surgery not performed due to worsening performance status/medical ineligibility|3|||
147344199|NCT03857620|531428331|FG000|Overall Study|Surgery not performed, patient decision|0|||
147344200|NCT03857620|531428332|FG001|Overall Study|Surgery not performed, patient decision|3|||
147344201|NCT03857620|531428333|FG002|Overall Study|Surgery not performed, patient decision|1|||
147344202|NCT03857620|531428331|FG000|Overall Study|Surgery not performed, other reason|3|||
147344203|NCT03857620|531428332|FG001|Overall Study|Surgery not performed, other reason|1|||
147344204|NCT03857620|531428333|FG002|Overall Study|Surgery not performed, other reason|4|||
147344205|NCT03857620|531428331|FG000|Overall Study|Worsening performance status after surgery performed|0|||
147344206|NCT03857620|531428332|FG001|Overall Study|Worsening performance status after surgery performed|1|||
147344207|NCT03857620|531428333|FG002|Overall Study|Worsening performance status after surgery performed|1|||
147344208|NCT03271151|531428334|FG000|Overall Study|Lost to Follow-up|1|||
147606642|NCT00121134|532375286|FG002|Overall Study|Progression of Disease|4|||
147344209|NCT03271151|531428335|FG001|Overall Study|Lost to Follow-up|3|||
147344210|NCT03271151|531428334|FG000|Overall Study|Withdrawal by Subject|1|||
147344211|NCT03271151|531428335|FG001|Overall Study|Withdrawal by Subject|0|||
147344212|NCT04118452|531428336|FG000|Overall Study|Lost to Follow-up|5|||
147344213|NCT04118452|531428337|FG001|Overall Study|Lost to Follow-up|5|||
147344214|NCT04118452|531428336|FG000|Overall Study|Withdrawal by Subject|17|||
147344215|NCT04118452|531428337|FG001|Overall Study|Withdrawal by Subject|17|||
147344216|NCT03215030|531428338|FG000|Part 1: Dose Escalation|Lost to Follow-up|1|||
147344217|NCT03215030|531428339|FG001|Part 1: Dose Escalation|Lost to Follow-up|1|||
147344218|NCT03215030|531428340|FG002|Part 1: Dose Escalation|Lost to Follow-up|0|||
147344219|NCT03215030|531428341|FG003|Part 1: Dose Escalation|Lost to Follow-up|1|||
147344220|NCT03215030|531428342|FG004|Part 1: Dose Escalation|Lost to Follow-up|0|||
147344221|NCT03215030|531428343|FG005|Part 1: Dose Escalation|Lost to Follow-up|0|||
147344222|NCT03215030|531428344|FG006|Part 1: Dose Escalation|Lost to Follow-up|0|||
147344223|NCT03215030|531428345|FG007|Part 1: Dose Escalation|Lost to Follow-up|0|||
147344224|NCT03215030|531428346|FG008|Part 1: Dose Escalation|Lost to Follow-up|0|||
147344225|NCT03215030|531428347|FG009|Part 1: Dose Escalation|Lost to Follow-up|0|||
147344226|NCT03215030|531428348|FG010|Part 1: Dose Escalation|Lost to Follow-up|0|||
147344227|NCT03215030|531428349|FG011|Part 1: Dose Escalation|Lost to Follow-up|0|||
147344228|NCT03215030|531428338|FG000|Part 1: Dose Escalation|Withdrawal by Subject|2|||
147344229|NCT03215030|531428339|FG001|Part 1: Dose Escalation|Withdrawal by Subject|0|||
147344230|NCT03215030|531428340|FG002|Part 1: Dose Escalation|Withdrawal by Subject|0|||
147344231|NCT03215030|531428341|FG003|Part 1: Dose Escalation|Withdrawal by Subject|2|||
147344232|NCT03215030|531428342|FG004|Part 1: Dose Escalation|Withdrawal by Subject|0|||
147344233|NCT03215030|531428343|FG005|Part 1: Dose Escalation|Withdrawal by Subject|0|||
147344234|NCT03215030|531428344|FG006|Part 1: Dose Escalation|Withdrawal by Subject|0|||
147344235|NCT03215030|531428345|FG007|Part 1: Dose Escalation|Withdrawal by Subject|0|||
147344236|NCT03215030|531428346|FG008|Part 1: Dose Escalation|Withdrawal by Subject|0|||
147344237|NCT03215030|531428347|FG009|Part 1: Dose Escalation|Withdrawal by Subject|0|||
147344238|NCT03215030|531428348|FG010|Part 1: Dose Escalation|Withdrawal by Subject|0|||
147344239|NCT03215030|531428349|FG011|Part 1: Dose Escalation|Withdrawal by Subject|0|||
147344240|NCT03215030|531428338|FG000|Part 1: Dose Escalation|Death|15|||
147344241|NCT03215030|531428339|FG001|Part 1: Dose Escalation|Death|6|||
147344242|NCT03215030|531428340|FG002|Part 1: Dose Escalation|Death|6|||
147344243|NCT03215030|531428341|FG003|Part 1: Dose Escalation|Death|8|||
147344244|NCT03215030|531428342|FG004|Part 1: Dose Escalation|Death|0|||
147344245|NCT03215030|531428343|FG005|Part 1: Dose Escalation|Death|0|||
147344246|NCT03215030|531428344|FG006|Part 1: Dose Escalation|Death|0|||
147344247|NCT03215030|531428345|FG007|Part 1: Dose Escalation|Death|0|||
147344248|NCT03215030|531428346|FG008|Part 1: Dose Escalation|Death|0|||
147344249|NCT03215030|531428347|FG009|Part 1: Dose Escalation|Death|0|||
147344250|NCT03215030|531428348|FG010|Part 1: Dose Escalation|Death|0|||
147344251|NCT03215030|531428349|FG011|Part 1: Dose Escalation|Death|0|||
147344252|NCT03215030|531428338|FG000|Part 1: Dose Escalation|Reason Not Specified|0|||
147344253|NCT03215030|531428339|FG001|Part 1: Dose Escalation|Reason Not Specified|0|||
147344254|NCT03215030|531428340|FG002|Part 1: Dose Escalation|Reason Not Specified|0|||
147344255|NCT03215030|531428341|FG003|Part 1: Dose Escalation|Reason Not Specified|3|||
147344256|NCT03215030|531428342|FG004|Part 1: Dose Escalation|Reason Not Specified|0|||
147344257|NCT03215030|531428343|FG005|Part 1: Dose Escalation|Reason Not Specified|0|||
147344258|NCT03215030|531428344|FG006|Part 1: Dose Escalation|Reason Not Specified|0|||
147344259|NCT03215030|531428345|FG007|Part 1: Dose Escalation|Reason Not Specified|0|||
147344260|NCT03215030|531428346|FG008|Part 1: Dose Escalation|Reason Not Specified|0|||
147344261|NCT03215030|531428347|FG009|Part 1: Dose Escalation|Reason Not Specified|0|||
147344262|NCT03215030|531428348|FG010|Part 1: Dose Escalation|Reason Not Specified|0|||
147344263|NCT03215030|531428349|FG011|Part 1: Dose Escalation|Reason Not Specified|0|||
147344264|NCT03215030|531428338|FG000|Part 2: Dose Expansion|Study Terminated by Sponsor|0|||
147344265|NCT03215030|531428339|FG001|Part 2: Dose Expansion|Study Terminated by Sponsor|0|||
147344266|NCT03215030|531428340|FG002|Part 2: Dose Expansion|Study Terminated by Sponsor|0|||
147344267|NCT03215030|531428341|FG003|Part 2: Dose Expansion|Study Terminated by Sponsor|0|||
147344268|NCT03215030|531428342|FG004|Part 2: Dose Expansion|Study Terminated by Sponsor|0|||
147344269|NCT03215030|531428343|FG005|Part 2: Dose Expansion|Study Terminated by Sponsor|0|||
147344270|NCT03215030|531428344|FG006|Part 2: Dose Expansion|Study Terminated by Sponsor|0|||
147344271|NCT03215030|531428345|FG007|Part 2: Dose Expansion|Study Terminated by Sponsor|1|||
147344272|NCT03215030|531428346|FG008|Part 2: Dose Expansion|Study Terminated by Sponsor|0|||
147344273|NCT03215030|531428347|FG009|Part 2: Dose Expansion|Study Terminated by Sponsor|0|||
147344274|NCT03215030|531428348|FG010|Part 2: Dose Expansion|Study Terminated by Sponsor|0|||
147344275|NCT03215030|531428349|FG011|Part 2: Dose Expansion|Study Terminated by Sponsor|0|||
147344276|NCT03215030|531428338|FG000|Part 2: Dose Expansion|Withdrawal by Subject|0|||
147344277|NCT03215030|531428339|FG001|Part 2: Dose Expansion|Withdrawal by Subject|0|||
147344278|NCT03215030|531428340|FG002|Part 2: Dose Expansion|Withdrawal by Subject|0|||
147344279|NCT03215030|531428341|FG003|Part 2: Dose Expansion|Withdrawal by Subject|0|||
147606643|NCT00121134|532375287|FG003|Overall Study|Progression of Disease|2|||
147606644|NCT00121134|532375284|FG000|Overall Study|Toxicity|4|||
147606645|NCT00121134|532375285|FG001|Overall Study|Toxicity|7|||
147606646|NCT00121134|532375286|FG002|Overall Study|Toxicity|13|||
147606647|NCT00121134|532375287|FG003|Overall Study|Toxicity|5|||
147606648|NCT00121134|532375284|FG000|Overall Study|Physician Decision|6|||
147606649|NCT00121134|532375285|FG001|Overall Study|Physician Decision|4|||
147606650|NCT00121134|532375286|FG002|Overall Study|Physician Decision|4|||
147344280|NCT03215030|531428342|FG004|Part 2: Dose Expansion|Withdrawal by Subject|1|||
147344281|NCT03215030|531428343|FG005|Part 2: Dose Expansion|Withdrawal by Subject|1|||
147344282|NCT03215030|531428344|FG006|Part 2: Dose Expansion|Withdrawal by Subject|5|||
147344283|NCT03215030|531428345|FG007|Part 2: Dose Expansion|Withdrawal by Subject|2|||
147344284|NCT03215030|531428346|FG008|Part 2: Dose Expansion|Withdrawal by Subject|0|||
147344285|NCT03215030|531428347|FG009|Part 2: Dose Expansion|Withdrawal by Subject|0|||
147344286|NCT03215030|531428348|FG010|Part 2: Dose Expansion|Withdrawal by Subject|0|||
147344287|NCT03215030|531428349|FG011|Part 2: Dose Expansion|Withdrawal by Subject|0|||
147344288|NCT03215030|531428338|FG000|Part 2: Dose Expansion|Death|0|||
147344289|NCT03215030|531428339|FG001|Part 2: Dose Expansion|Death|0|||
147344290|NCT03215030|531428340|FG002|Part 2: Dose Expansion|Death|0|||
147344291|NCT03215030|531428341|FG003|Part 2: Dose Expansion|Death|0|||
147344292|NCT03215030|531428342|FG004|Part 2: Dose Expansion|Death|3|||
147344293|NCT03215030|531428343|FG005|Part 2: Dose Expansion|Death|1|||
147344294|NCT03215030|531428344|FG006|Part 2: Dose Expansion|Death|5|||
147344295|NCT03215030|531428345|FG007|Part 2: Dose Expansion|Death|4|||
147344296|NCT03215030|531428346|FG008|Part 2: Dose Expansion|Death|0|||
147344297|NCT03215030|531428347|FG009|Part 2: Dose Expansion|Death|0|||
147344298|NCT03215030|531428348|FG010|Part 2: Dose Expansion|Death|0|||
147344299|NCT03215030|531428349|FG011|Part 2: Dose Expansion|Death|0|||
147344300|NCT03215030|531428338|FG000|Part 2: Dose Expansion|Reason Not Specified|0|||
147344301|NCT03215030|531428339|FG001|Part 2: Dose Expansion|Reason Not Specified|0|||
147344302|NCT03215030|531428340|FG002|Part 2: Dose Expansion|Reason Not Specified|0|||
147344303|NCT03215030|531428341|FG003|Part 2: Dose Expansion|Reason Not Specified|0|||
147344304|NCT03215030|531428342|FG004|Part 2: Dose Expansion|Reason Not Specified|0|||
147344305|NCT03215030|531428343|FG005|Part 2: Dose Expansion|Reason Not Specified|0|||
147344306|NCT03215030|531428344|FG006|Part 2: Dose Expansion|Reason Not Specified|4|||
147344307|NCT03215030|531428345|FG007|Part 2: Dose Expansion|Reason Not Specified|2|||
147344308|NCT03215030|531428346|FG008|Part 2: Dose Expansion|Reason Not Specified|0|||
147344309|NCT03215030|531428347|FG009|Part 2: Dose Expansion|Reason Not Specified|0|||
147344310|NCT03215030|531428348|FG010|Part 2: Dose Expansion|Reason Not Specified|0|||
147344311|NCT03215030|531428349|FG011|Part 2: Dose Expansion|Reason Not Specified|0|||
147344312|NCT03215030|531428338|FG000|Part 3: Dose Extension|Lost to Follow-up|0|||
147344313|NCT03215030|531428339|FG001|Part 3: Dose Extension|Lost to Follow-up|0|||
147344314|NCT03215030|531428340|FG002|Part 3: Dose Extension|Lost to Follow-up|0|||
147344315|NCT03215030|531428341|FG003|Part 3: Dose Extension|Lost to Follow-up|0|||
147344316|NCT03215030|531428342|FG004|Part 3: Dose Extension|Lost to Follow-up|0|||
147344317|NCT03215030|531428343|FG005|Part 3: Dose Extension|Lost to Follow-up|0|||
147344318|NCT03215030|531428344|FG006|Part 3: Dose Extension|Lost to Follow-up|0|||
147344319|NCT03215030|531428345|FG007|Part 3: Dose Extension|Lost to Follow-up|0|||
147344320|NCT03215030|531428346|FG008|Part 3: Dose Extension|Lost to Follow-up|0|||
147344321|NCT03215030|531428347|FG009|Part 3: Dose Extension|Lost to Follow-up|2|||
147344322|NCT03215030|531428348|FG010|Part 3: Dose Extension|Lost to Follow-up|0|||
147344323|NCT03215030|531428349|FG011|Part 3: Dose Extension|Lost to Follow-up|0|||
147344324|NCT03215030|531428338|FG000|Part 3: Dose Extension|Study Terminated by Sponsor|0|||
147344325|NCT03215030|531428339|FG001|Part 3: Dose Extension|Study Terminated by Sponsor|0|||
147344326|NCT03215030|531428340|FG002|Part 3: Dose Extension|Study Terminated by Sponsor|0|||
147344327|NCT03215030|531428341|FG003|Part 3: Dose Extension|Study Terminated by Sponsor|0|||
147344328|NCT03215030|531428342|FG004|Part 3: Dose Extension|Study Terminated by Sponsor|0|||
147344329|NCT03215030|531428343|FG005|Part 3: Dose Extension|Study Terminated by Sponsor|0|||
147606651|NCT00121134|532375287|FG003|Overall Study|Physician Decision|1|||
147606652|NCT00121134|532375284|FG000|Overall Study|Treatment Delay|1|||
147606653|NCT00121134|532375285|FG001|Overall Study|Treatment Delay|0|||
147606654|NCT00121134|532375286|FG002|Overall Study|Treatment Delay|0|||
147344330|NCT03215030|531428344|FG006|Part 3: Dose Extension|Study Terminated by Sponsor|0|||
147344331|NCT03215030|531428345|FG007|Part 3: Dose Extension|Study Terminated by Sponsor|0|||
147344332|NCT03215030|531428346|FG008|Part 3: Dose Extension|Study Terminated by Sponsor|38|||
147344333|NCT03215030|531428347|FG009|Part 3: Dose Extension|Study Terminated by Sponsor|39|||
147344334|NCT03215030|531428348|FG010|Part 3: Dose Extension|Study Terminated by Sponsor|0|||
147606655|NCT00121134|532375287|FG003|Overall Study|Treatment Delay|0|||
147606656|NCT00121134|532375284|FG000|Overall Study|Intercurrent Illness|0|||
147344335|NCT03215030|531428349|FG011|Part 3: Dose Extension|Study Terminated by Sponsor|0|||
147344336|NCT03215030|531428338|FG000|Part 3: Dose Extension|Withdrawal by Subject|0|||
147344337|NCT03215030|531428339|FG001|Part 3: Dose Extension|Withdrawal by Subject|0|||
147606657|NCT00121134|532375285|FG001|Overall Study|Intercurrent Illness|0|||
147606658|NCT00121134|532375286|FG002|Overall Study|Intercurrent Illness|0|||
147344338|NCT03215030|531428340|FG002|Part 3: Dose Extension|Withdrawal by Subject|0|||
147344339|NCT03215030|531428341|FG003|Part 3: Dose Extension|Withdrawal by Subject|0|||
147344340|NCT03215030|531428342|FG004|Part 3: Dose Extension|Withdrawal by Subject|0|||
147344341|NCT03215030|531428343|FG005|Part 3: Dose Extension|Withdrawal by Subject|0|||
147344342|NCT03215030|531428344|FG006|Part 3: Dose Extension|Withdrawal by Subject|0|||
147344343|NCT03215030|531428345|FG007|Part 3: Dose Extension|Withdrawal by Subject|0|||
147344344|NCT03215030|531428346|FG008|Part 3: Dose Extension|Withdrawal by Subject|6|||
147344345|NCT03215030|531428347|FG009|Part 3: Dose Extension|Withdrawal by Subject|7|||
147344346|NCT03215030|531428348|FG010|Part 3: Dose Extension|Withdrawal by Subject|0|||
147344347|NCT03215030|531428349|FG011|Part 3: Dose Extension|Withdrawal by Subject|0|||
147344348|NCT03215030|531428338|FG000|Part 3: Dose Extension|Death|0|||
147344349|NCT03215030|531428339|FG001|Part 3: Dose Extension|Death|0|||
147344350|NCT03215030|531428340|FG002|Part 3: Dose Extension|Death|0|||
147344351|NCT03215030|531428341|FG003|Part 3: Dose Extension|Death|0|||
147344352|NCT03215030|531428342|FG004|Part 3: Dose Extension|Death|0|||
147344353|NCT03215030|531428343|FG005|Part 3: Dose Extension|Death|0|||
147344354|NCT03215030|531428344|FG006|Part 3: Dose Extension|Death|0|||
147344355|NCT03215030|531428345|FG007|Part 3: Dose Extension|Death|0|||
147344356|NCT03215030|531428346|FG008|Part 3: Dose Extension|Death|19|||
147344357|NCT03215030|531428347|FG009|Part 3: Dose Extension|Death|20|||
147344358|NCT03215030|531428348|FG010|Part 3: Dose Extension|Death|0|||
147344359|NCT03215030|531428349|FG011|Part 3: Dose Extension|Death|0|||
147344360|NCT03215030|531428338|FG000|Part 3: Dose Extension|Reason Not Specified|0|||
147344361|NCT03215030|531428339|FG001|Part 3: Dose Extension|Reason Not Specified|0|||
147344362|NCT03215030|531428340|FG002|Part 3: Dose Extension|Reason Not Specified|0|||
147344363|NCT03215030|531428341|FG003|Part 3: Dose Extension|Reason Not Specified|0|||
147344364|NCT03215030|531428342|FG004|Part 3: Dose Extension|Reason Not Specified|0|||
147344365|NCT03215030|531428343|FG005|Part 3: Dose Extension|Reason Not Specified|0|||
147344366|NCT03215030|531428344|FG006|Part 3: Dose Extension|Reason Not Specified|0|||
147344367|NCT03215030|531428345|FG007|Part 3: Dose Extension|Reason Not Specified|0|||
147344368|NCT03215030|531428346|FG008|Part 3: Dose Extension|Reason Not Specified|3|||
147344369|NCT03215030|531428347|FG009|Part 3: Dose Extension|Reason Not Specified|0|||
147344370|NCT03215030|531428348|FG010|Part 3: Dose Extension|Reason Not Specified|0|||
147344371|NCT03215030|531428349|FG011|Part 3: Dose Extension|Reason Not Specified|0|||
147344372|NCT03215030|531428338|FG000|Japan Safety Lead-In|Study Terminated by Sponsor|0|||
147344373|NCT03215030|531428339|FG001|Japan Safety Lead-In|Study Terminated by Sponsor|0|||
147344374|NCT03215030|531428340|FG002|Japan Safety Lead-In|Study Terminated by Sponsor|0|||
147344375|NCT03215030|531428341|FG003|Japan Safety Lead-In|Study Terminated by Sponsor|0|||
147344376|NCT03215030|531428342|FG004|Japan Safety Lead-In|Study Terminated by Sponsor|0|||
147344377|NCT03215030|531428343|FG005|Japan Safety Lead-In|Study Terminated by Sponsor|0|||
147344378|NCT03215030|531428344|FG006|Japan Safety Lead-In|Study Terminated by Sponsor|0|||
147344379|NCT03215030|531428345|FG007|Japan Safety Lead-In|Study Terminated by Sponsor|0|||
147344380|NCT03215030|531428346|FG008|Japan Safety Lead-In|Study Terminated by Sponsor|0|||
147344381|NCT03215030|531428347|FG009|Japan Safety Lead-In|Study Terminated by Sponsor|0|||
147344382|NCT03215030|531428348|FG010|Japan Safety Lead-In|Study Terminated by Sponsor|3|||
147344383|NCT03215030|531428349|FG011|Japan Safety Lead-In|Study Terminated by Sponsor|2|||
147344384|NCT03438188|531428350|FG000|Scan 1(Smoking, Abstinent or Non-smoker)|Withdrawal by Subject|1|||
147344385|NCT03438188|531428351|FG001|Scan 1(Smoking, Abstinent or Non-smoker)|Withdrawal by Subject|1|||
147344386|NCT03438188|531428352|FG002|Scan 1(Smoking, Abstinent or Non-smoker)|Withdrawal by Subject|1|||
147344387|NCT03438188|531428350|FG000|Scan 1(Smoking, Abstinent or Non-smoker)|Lost to Follow-up|4|||
147344388|NCT03438188|531428351|FG001|Scan 1(Smoking, Abstinent or Non-smoker)|Lost to Follow-up|3|||
147344389|NCT03438188|531428352|FG002|Scan 1(Smoking, Abstinent or Non-smoker)|Lost to Follow-up|2|||
147344390|NCT03438188|531428350|FG000|Scan 1(Smoking, Abstinent or Non-smoker)|change in eligibility|3|||
147344391|NCT03438188|531428351|FG001|Scan 1(Smoking, Abstinent or Non-smoker)|change in eligibility|4|||
147344392|NCT03438188|531428352|FG002|Scan 1(Smoking, Abstinent or Non-smoker)|change in eligibility|1|||
147344393|NCT03438188|531428350|FG000|Washout Period (Smoking or Abstinent)|Lost to Follow-up|0|||
147344394|NCT03438188|531428351|FG001|Washout Period (Smoking or Abstinent)|Lost to Follow-up|2|||
147344395|NCT03438188|531428352|FG002|Washout Period (Smoking or Abstinent)|Lost to Follow-up|0|||
147344396|NCT03438188|531428350|FG000|Washout Period (Smoking or Abstinent)|change in eligibility|3|||
147344397|NCT03438188|531428351|FG001|Washout Period (Smoking or Abstinent)|change in eligibility|2|||
147606659|NCT00121134|532375287|FG003|Overall Study|Intercurrent Illness|1|||
147606660|NCT00121134|532375284|FG000|Overall Study|Patient Personal Reasons|0|||
147606661|NCT00121134|532375285|FG001|Overall Study|Patient Personal Reasons|1|||
147606662|NCT00121134|532375286|FG002|Overall Study|Patient Personal Reasons|0|||
147344398|NCT03438188|531428352|FG002|Washout Period (Smoking or Abstinent)|change in eligibility|0|||
147344399|NCT03433339|531428353|FG000|Overall Study|Lost to Follow-up|2|||
147344400|NCT03433339|531428354|FG001|Overall Study|Lost to Follow-up|0|||
147344401|NCT03433339|531428353|FG000|Overall Study|Coronavirus disease (COVID-19) Pandemic Related Restrictions|0|||
147344402|NCT03433339|531428354|FG001|Overall Study|Coronavirus disease (COVID-19) Pandemic Related Restrictions|2|||
147344403|NCT03433339|531428353|FG000|Overall Study|Withdrawal by Subject|0|||
147344404|NCT03433339|531428354|FG001|Overall Study|Withdrawal by Subject|2|||
147344405|NCT05952076|531428355|FG000|Overall Study|Death|1|||
147344406|NCT05952076|531428356|FG001|Overall Study|Death|1|||
147344407|NCT05952076|531428355|FG000|Overall Study|Lost to Follow-up|0|||
147344408|NCT05952076|531428356|FG001|Overall Study|Lost to Follow-up|1|||
147344409|NCT04143061|531428358|FG000|Overall Study|Protocol Deviation|0|||
147344410|NCT04143061|531428359|FG001|Overall Study|Protocol Deviation|0|||
147344411|NCT04143061|531428360|FG002|Overall Study|Protocol Deviation|0|||
147344412|NCT04143061|531428361|FG003|Overall Study|Protocol Deviation|0|||
147344413|NCT04143061|531428362|FG004|Overall Study|Protocol Deviation|0|||
147344414|NCT04143061|531428363|FG005|Overall Study|Protocol Deviation|0|||
147344415|NCT04143061|531428364|FG006|Overall Study|Protocol Deviation|5|||
147344416|NCT04143061|531428365|FG007|Overall Study|Protocol Deviation|5|||
147344417|NCT04143061|531428358|FG000|Overall Study|Withdrawal by Subject|2|||
147344418|NCT04143061|531428359|FG001|Overall Study|Withdrawal by Subject|0|||
147344419|NCT04143061|531428360|FG002|Overall Study|Withdrawal by Subject|0|||
147344420|NCT04143061|531428361|FG003|Overall Study|Withdrawal by Subject|0|||
147344421|NCT04143061|531428362|FG004|Overall Study|Withdrawal by Subject|0|||
147344422|NCT04143061|531428363|FG005|Overall Study|Withdrawal by Subject|1|||
147344423|NCT04143061|531428364|FG006|Overall Study|Withdrawal by Subject|0|||
147344424|NCT04143061|531428365|FG007|Overall Study|Withdrawal by Subject|0|||
147344425|NCT04143061|531428358|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
147344426|NCT04143061|531428359|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
147344427|NCT04143061|531428360|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
147344428|NCT04143061|531428361|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
147344429|NCT04143061|531428362|FG004|Overall Study|Withdrawal by Parent/Guardian|8|||
147344430|NCT04143061|531428363|FG005|Overall Study|Withdrawal by Parent/Guardian|3|||
147344431|NCT04143061|531428364|FG006|Overall Study|Withdrawal by Parent/Guardian|2|||
147344432|NCT04143061|531428365|FG007|Overall Study|Withdrawal by Parent/Guardian|7|||
147344433|NCT03602014|531428372|FG000|Overall Study|Lost to Follow-up|2|||
147344434|NCT03602014|531428373|FG001|Overall Study|Lost to Follow-up|0|||
147344435|NCT03602014|531428374|FG002|Overall Study|Lost to Follow-up|0|||
147344436|NCT01898494|531428378|FG000|Step 1 (Arm S - Transoral Surgery)|Physician Decision|0|||
147344437|NCT01898494|531428379|FG001|Step 1 (Arm S - Transoral Surgery)|Physician Decision|0|||
147344438|NCT01898494|531428380|FG002|Step 1 (Arm S - Transoral Surgery)|Physician Decision|0|||
147344439|NCT01898494|531428381|FG003|Step 1 (Arm S - Transoral Surgery)|Physician Decision|0|||
147344440|NCT01898494|531428382|FG004|Step 1 (Arm S - Transoral Surgery)|Physician Decision|2|||
147344441|NCT01898494|531428378|FG000|Step 1 (Arm S - Transoral Surgery)|Adverse Event|0|||
147344442|NCT01898494|531428379|FG001|Step 1 (Arm S - Transoral Surgery)|Adverse Event|0|||
147344443|NCT01898494|531428380|FG002|Step 1 (Arm S - Transoral Surgery)|Adverse Event|0|||
147344444|NCT01898494|531428381|FG003|Step 1 (Arm S - Transoral Surgery)|Adverse Event|0|||
147344445|NCT01898494|531428382|FG004|Step 1 (Arm S - Transoral Surgery)|Adverse Event|1|||
147344446|NCT01898494|531428378|FG000|Step 1 (Arm S - Transoral Surgery)|Patient ineligible|0|||
147344447|NCT01898494|531428379|FG001|Step 1 (Arm S - Transoral Surgery)|Patient ineligible|0|||
147344448|NCT01898494|531428380|FG002|Step 1 (Arm S - Transoral Surgery)|Patient ineligible|0|||
147344449|NCT01898494|531428381|FG003|Step 1 (Arm S - Transoral Surgery)|Patient ineligible|0|||
147344450|NCT01898494|531428382|FG004|Step 1 (Arm S - Transoral Surgery)|Patient ineligible|7|||
147344451|NCT01898494|531428378|FG000|Step 1 (Arm S - Transoral Surgery)|Withdrawal by Subject|0|||
147606663|NCT00121134|532375287|FG003|Overall Study|Patient Personal Reasons|0|||
147606664|NCT02478320|532375288|FG000|Overall Study|Adverse Event|2|||
147606665|NCT02478320|532375289|FG001|Overall Study|Adverse Event|0|||
147606666|NCT02478320|532375288|FG000|Overall Study|Death|1|||
147606667|NCT02478320|532375289|FG001|Overall Study|Death|0|||
147606668|NCT02478320|532375288|FG000|Overall Study|Lack of Efficacy|4|||
147606669|NCT02478320|532375289|FG001|Overall Study|Lack of Efficacy|0|||
147606670|NCT02478320|532375288|FG000|Overall Study|Withdrawal by Subject|2|||
147606671|NCT02478320|532375289|FG001|Overall Study|Withdrawal by Subject|0|||
147606672|NCT02478320|532375288|FG000|Overall Study|Screen Failure|3|||
147606673|NCT02478320|532375289|FG001|Overall Study|Screen Failure|0|||
147606674|NCT02533375|532375291|FG000|Overall Study|Lack of Efficacy|3|||
147606675|NCT02533375|532375291|FG000|Overall Study|Adverse Event|2|||
147606676|NCT00673387|532375292|FG000|Overall Study|Withdrawal by Subject|15|||
147606677|NCT00673387|532375293|FG001|Overall Study|Withdrawal by Subject|16|||
147606678|NCT00673387|532375294|FG002|Overall Study|Withdrawal by Subject|20|||
147606679|NCT00673387|532375295|FG003|Overall Study|Withdrawal by Subject|16|||
147606680|NCT00673387|532375296|FG004|Overall Study|Withdrawal by Subject|18|||
147606681|NCT00673387|532375297|FG005|Overall Study|Withdrawal by Subject|21|||
147606682|NCT00673387|532375298|FG006|Overall Study|Withdrawal by Subject|15|||
147606683|NCT00673387|532375299|FG007|Overall Study|Withdrawal by Subject|21|||
147344452|NCT01898494|531428379|FG001|Step 1 (Arm S - Transoral Surgery)|Withdrawal by Subject|0|||
147344453|NCT01898494|531428380|FG002|Step 1 (Arm S - Transoral Surgery)|Withdrawal by Subject|0|||
147344454|NCT01898494|531428381|FG003|Step 1 (Arm S - Transoral Surgery)|Withdrawal by Subject|0|||
147453142|NCT03099707|531821555|FG001|Overall Study|Lost to Follow-up|1|||
147606684|NCT00673387|532375292|FG000|Overall Study|Adverse Event|3|||
147344455|NCT01898494|531428382|FG004|Step 1 (Arm S - Transoral Surgery)|Withdrawal by Subject|9|||
147344456|NCT01898494|531428378|FG000|Step 1 (Arm S - Transoral Surgery)|Disease progression|0|||
147344457|NCT01898494|531428379|FG001|Step 1 (Arm S - Transoral Surgery)|Disease progression|0|||
147344458|NCT01898494|531428380|FG002|Step 1 (Arm S - Transoral Surgery)|Disease progression|0|||
147344459|NCT01898494|531428381|FG003|Step 1 (Arm S - Transoral Surgery)|Disease progression|0|||
147344460|NCT01898494|531428382|FG004|Step 1 (Arm S - Transoral Surgery)|Disease progression|2|||
147344461|NCT01898494|531428378|FG000|Step 1 (Arm S - Transoral Surgery)|Death|0|||
147344462|NCT01898494|531428379|FG001|Step 1 (Arm S - Transoral Surgery)|Death|0|||
147344463|NCT01898494|531428380|FG002|Step 1 (Arm S - Transoral Surgery)|Death|0|||
147344464|NCT01898494|531428381|FG003|Step 1 (Arm S - Transoral Surgery)|Death|0|||
147344465|NCT01898494|531428382|FG004|Step 1 (Arm S - Transoral Surgery)|Death|1|||
147344466|NCT01898494|531428378|FG000|Step 1 (Arm S - Transoral Surgery)|Alternative therapy|0|||
147344467|NCT01898494|531428379|FG001|Step 1 (Arm S - Transoral Surgery)|Alternative therapy|0|||
147344468|NCT01898494|531428380|FG002|Step 1 (Arm S - Transoral Surgery)|Alternative therapy|0|||
147344469|NCT01898494|531428381|FG003|Step 1 (Arm S - Transoral Surgery)|Alternative therapy|0|||
147344470|NCT01898494|531428382|FG004|Step 1 (Arm S - Transoral Surgery)|Alternative therapy|1|||
147344471|NCT01898494|531428378|FG000|Step 1 (Arm S - Transoral Surgery)|Surgery planned but not performed|0|||
147344472|NCT01898494|531428379|FG001|Step 1 (Arm S - Transoral Surgery)|Surgery planned but not performed|0|||
147344473|NCT01898494|531428380|FG002|Step 1 (Arm S - Transoral Surgery)|Surgery planned but not performed|0|||
147344474|NCT01898494|531428381|FG003|Step 1 (Arm S - Transoral Surgery)|Surgery planned but not performed|0|||
147344475|NCT01898494|531428382|FG004|Step 1 (Arm S - Transoral Surgery)|Surgery planned but not performed|1|||
147344476|NCT01898494|531428378|FG000|Step 2 (Adjuvant Treatment)|Adverse Event|0|||
147344477|NCT01898494|531428379|FG001|Step 2 (Adjuvant Treatment)|Adverse Event|0|||
147344478|NCT01898494|531428380|FG002|Step 2 (Adjuvant Treatment)|Adverse Event|2|||
147344479|NCT01898494|531428381|FG003|Step 2 (Adjuvant Treatment)|Adverse Event|3|||
147344480|NCT01898494|531428382|FG004|Step 2 (Adjuvant Treatment)|Adverse Event|0|||
147344481|NCT01898494|531428378|FG000|Step 2 (Adjuvant Treatment)|Withdrawal by Subject|0|||
147344482|NCT01898494|531428379|FG001|Step 2 (Adjuvant Treatment)|Withdrawal by Subject|0|||
147344483|NCT01898494|531428380|FG002|Step 2 (Adjuvant Treatment)|Withdrawal by Subject|6|||
147344484|NCT01898494|531428381|FG003|Step 2 (Adjuvant Treatment)|Withdrawal by Subject|3|||
147344485|NCT01898494|531428382|FG004|Step 2 (Adjuvant Treatment)|Withdrawal by Subject|0|||
147344486|NCT01898494|531428378|FG000|Step 2 (Adjuvant Treatment)|Death|0|||
147344487|NCT01898494|531428379|FG001|Step 2 (Adjuvant Treatment)|Death|0|||
147344488|NCT01898494|531428380|FG002|Step 2 (Adjuvant Treatment)|Death|0|||
147344489|NCT01898494|531428381|FG003|Step 2 (Adjuvant Treatment)|Death|1|||
147344490|NCT01898494|531428382|FG004|Step 2 (Adjuvant Treatment)|Death|0|||
147344491|NCT01898494|531428378|FG000|Step 2 (Adjuvant Treatment)|Physician Decision|0|||
147344492|NCT01898494|531428379|FG001|Step 2 (Adjuvant Treatment)|Physician Decision|1|||
147344493|NCT01898494|531428380|FG002|Step 2 (Adjuvant Treatment)|Physician Decision|0|||
147344494|NCT01898494|531428381|FG003|Step 2 (Adjuvant Treatment)|Physician Decision|0|||
147344495|NCT01898494|531428382|FG004|Step 2 (Adjuvant Treatment)|Physician Decision|0|||
147344496|NCT01898494|531428378|FG000|Step 2 (Adjuvant Treatment)|Alternative therapy|0|||
147344497|NCT01898494|531428379|FG001|Step 2 (Adjuvant Treatment)|Alternative therapy|0|||
147344498|NCT01898494|531428380|FG002|Step 2 (Adjuvant Treatment)|Alternative therapy|1|||
147344499|NCT01898494|531428381|FG003|Step 2 (Adjuvant Treatment)|Alternative therapy|0|||
147344500|NCT01898494|531428382|FG004|Step 2 (Adjuvant Treatment)|Alternative therapy|0|||
147344501|NCT01898494|531428378|FG000|Step 2 (Adjuvant Treatment)|Never started treatment|0|||
147344502|NCT01898494|531428379|FG001|Step 2 (Adjuvant Treatment)|Never started treatment|6|||
147344503|NCT01898494|531428380|FG002|Step 2 (Adjuvant Treatment)|Never started treatment|5|||
147344504|NCT01898494|531428381|FG003|Step 2 (Adjuvant Treatment)|Never started treatment|4|||
147344505|NCT01898494|531428382|FG004|Step 2 (Adjuvant Treatment)|Never started treatment|0|||
147344506|NCT03289039|531428385|FG000|Overall Study|Withdrawal by Subject|0|||
147344507|NCT03289039|531428386|FG001|Overall Study|Withdrawal by Subject|1|||
147344508|NCT03289039|531428385|FG000|Overall Study|Became ineligible prior to treatment start|0|||
147344509|NCT03289039|531428386|FG001|Overall Study|Became ineligible prior to treatment start|1|||
147344510|NCT03289039|531428385|FG000|Overall Study|progressed before treatment start|1|||
147344511|NCT03289039|531428386|FG001|Overall Study|progressed before treatment start|0|||
147344512|NCT02819843|531428387|FG000|Overall Study|Disease progression before RT|0|||
147344513|NCT02819843|531428388|FG001|Overall Study|Disease progression before RT|1|||
147344514|NCT04732494|531428389|FG000|Overall Study|Death|39|||
147344515|NCT04732494|531428390|FG001|Overall Study|Death|36|||
147344516|NCT04732494|531428389|FG000|Overall Study|Study Closed by Sponsor|20|||
147344517|NCT04732494|531428390|FG001|Overall Study|Study Closed by Sponsor|15|||
147344518|NCT04732494|531428389|FG000|Overall Study|Withdrawal by Subject|2|||
147344519|NCT04732494|531428390|FG001|Overall Study|Withdrawal by Subject|7|||
147606685|NCT00673387|532375293|FG001|Overall Study|Adverse Event|1|||
147344520|NCT04732494|531428389|FG000|Overall Study|Lost to Follow-up|1|||
147344521|NCT04732494|531428390|FG001|Overall Study|Lost to Follow-up|5|||
147344522|NCT03055858|531428391|FG000|Overall Study|Death|9|||
147344523|NCT03055858|531428391|FG000|Overall Study|Withdrawal by Subject|11|||
147344524|NCT03055858|531428391|FG000|Overall Study|Lost to Follow-up|6|||
147344525|NCT03055858|531428391|FG000|Overall Study|Missed Follow-Up Visits|18|||
147344526|NCT01718743|531428396|FG000|Overall Study|Physician Decision|7|||
147344527|NCT01718743|531428396|FG000|Overall Study|Withdrawal by Subject|14|||
147344528|NCT01718743|531428396|FG000|Overall Study|Progressive Disease|22|||
147344529|NCT01718743|531428396|FG000|Overall Study|Toxicity|1|||
147344530|NCT01718743|531428396|FG000|Overall Study|Malignancy|1|||
147344531|NCT02728557|531428397|FG000|Overall Study|Dissatisfaction with assigned treatment|1|||
147344532|NCT02728557|531428398|FG001|Overall Study|Dissatisfaction with assigned treatment|3|||
147344533|NCT02728557|531428397|FG000|Overall Study|Dissatisfaction with research tasks|0|||
147344534|NCT02728557|531428398|FG001|Overall Study|Dissatisfaction with research tasks|1|||
147344535|NCT02728557|531428397|FG000|Overall Study|Scheduling or change in availability|1|||
147344536|NCT02728557|531428398|FG001|Overall Study|Scheduling or change in availability|1|||
147344537|NCT03416010|531428399|FG000|Timepoint 0 (<19 Weeks Gestation)|medically excluded or aged out prior to initiating intervention|11|||
147344538|NCT03416010|531428400|FG001|Timepoint 0 (<19 Weeks Gestation)|medically excluded or aged out prior to initiating intervention|32|||
147344539|NCT03416010|531428399|FG000|Timepoint 1 (31 Gestational Weeks)|Withdrawal by Subject|27|||
147344540|NCT03416010|531428400|FG001|Timepoint 1 (31 Gestational Weeks)|Withdrawal by Subject|38|||
147344541|NCT03416010|531428399|FG000|Timepoint 1 (31 Gestational Weeks)|Lost to Follow-up|11|||
147344542|NCT03416010|531428400|FG001|Timepoint 1 (31 Gestational Weeks)|Lost to Follow-up|12|||
147344543|NCT03416010|531428399|FG000|Timepoint 2 (6 Weeks Postpartum)|Withdrawal by Subject|1|||
147344544|NCT03416010|531428400|FG001|Timepoint 2 (6 Weeks Postpartum)|Withdrawal by Subject|0|||
147344545|NCT03416010|531428399|FG000|Timepoint 2 (6 Weeks Postpartum)|Lost to Follow-up|1|||
147344546|NCT03416010|531428400|FG001|Timepoint 2 (6 Weeks Postpartum)|Lost to Follow-up|3|||
147344547|NCT03416010|531428399|FG000|Timepoint 3 (6 Months Postpartum)|Lost to Follow-up|1|||
147344548|NCT03416010|531428400|FG001|Timepoint 3 (6 Months Postpartum)|Lost to Follow-up|3|||
147344549|NCT03416010|531428399|FG000|Timepoint 3 (6 Months Postpartum)|Missing Data|2|||
147344550|NCT03416010|531428400|FG001|Timepoint 3 (6 Months Postpartum)|Missing Data|3|||
147344551|NCT03948763|531428404|FG000|Overall Study|Sponsor's decision|0|||
147344552|NCT03948763|531428405|FG001|Overall Study|Sponsor's decision|2|||
147344553|NCT03948763|531428406|FG002|Overall Study|Sponsor's decision|6|||
147344554|NCT03948763|531428407|FG003|Overall Study|Sponsor's decision|4|||
147344555|NCT03948763|531428408|FG004|Overall Study|Sponsor's decision|0|||
147344556|NCT03948763|531428404|FG000|Overall Study|Physician Decision|0|||
147344557|NCT03948763|531428405|FG001|Overall Study|Physician Decision|0|||
147344558|NCT03948763|531428406|FG002|Overall Study|Physician Decision|1|||
147344559|NCT03948763|531428407|FG003|Overall Study|Physician Decision|0|||
147344560|NCT03948763|531428408|FG004|Overall Study|Physician Decision|0|||
147344561|NCT03948763|531428404|FG000|Overall Study|Lost to Follow-up|0|||
147344562|NCT03948763|531428405|FG001|Overall Study|Lost to Follow-up|0|||
147344563|NCT03948763|531428406|FG002|Overall Study|Lost to Follow-up|0|||
147344564|NCT03948763|531428407|FG003|Overall Study|Lost to Follow-up|0|||
147344565|NCT03948763|531428408|FG004|Overall Study|Lost to Follow-up|1|||
147344566|NCT03948763|531428404|FG000|Overall Study|Death|2|||
147344567|NCT03948763|531428405|FG001|Overall Study|Death|12|||
147344568|NCT03948763|531428406|FG002|Overall Study|Death|13|||
147344569|NCT03948763|531428407|FG003|Overall Study|Death|10|||
147344570|NCT03948763|531428408|FG004|Overall Study|Death|11|||
147344571|NCT03948763|531428404|FG000|Overall Study|Withdrawal by Subject|1|||
147344572|NCT03948763|531428405|FG001|Overall Study|Withdrawal by Subject|1|||
147344573|NCT03948763|531428406|FG002|Overall Study|Withdrawal by Subject|0|||
147344574|NCT03948763|531428407|FG003|Overall Study|Withdrawal by Subject|2|||
147344575|NCT03948763|531428408|FG004|Overall Study|Withdrawal by Subject|4|||
147344576|NCT01426412|531428409|FG000|Overall Study|Withdrawal by Subject|1|||
147344577|NCT01426412|531428410|FG001|Overall Study|Withdrawal by Subject|0|||
147344578|NCT01426412|531428411|FG002|Overall Study|Withdrawal by Subject|0|||
147344579|NCT01426412|531428412|FG003|Overall Study|Withdrawal by Subject|0|||
147344580|NCT01426412|531428413|FG004|Overall Study|Withdrawal by Subject|1|||
147344581|NCT01426412|531428414|FG005|Overall Study|Withdrawal by Subject|0|||
147344582|NCT01426412|531428415|FG006|Overall Study|Withdrawal by Subject|0|||
147344583|NCT01426412|531428416|FG007|Overall Study|Withdrawal by Subject|3|||
147344584|NCT01426412|531428417|FG008|Overall Study|Withdrawal by Subject|1|||
147344585|NCT02376790|531428419|FG000|Overall Study|Withdrawal by Subject|43|||
147344586|NCT02376790|531428420|FG001|Overall Study|Withdrawal by Subject|36|||
147344587|NCT02376790|531428421|FG002|Overall Study|Withdrawal by Subject|37|||
147344588|NCT02376790|531428419|FG000|Overall Study|Decision by Sponsor|2|||
147344589|NCT02376790|531428420|FG001|Overall Study|Decision by Sponsor|1|||
147344590|NCT02376790|531428421|FG002|Overall Study|Decision by Sponsor|4|||
147344591|NCT02376790|531428419|FG000|Overall Study|Lost to Follow-up|15|||
147344592|NCT02376790|531428420|FG001|Overall Study|Lost to Follow-up|10|||
147344593|NCT02376790|531428421|FG002|Overall Study|Lost to Follow-up|12|||
147344594|NCT03014453|531428422|FG000|Overall Study|Lost to Follow-up|12|||
147344595|NCT03014453|531428422|FG000|Overall Study|Discontinued GER|3|||
147344596|NCT03014453|531428422|FG000|Overall Study|Excluded|19|||
147344597|NCT03014453|531428422|FG000|Overall Study|Refused to take part in|37|||
147344598|NCT05450458|531428423|FG000|Overall Study|Lost to Follow-up|4|||
147344599|NCT02141074|531428428|FG000|Pre-prophylaxis|Adverse Event|3|||
147344600|NCT02141074|531428429|FG001|Pre-prophylaxis|Adverse Event|0|||
147344601|NCT02141074|531428428|FG000|Prophylaxis|Withdrawal by parent/guardian|0|||
147344602|NCT02141074|531428429|FG001|Prophylaxis|Withdrawal by parent/guardian|2|||
147344603|NCT02141074|531428428|FG000|Prophylaxis|Adverse Event|0|||
147344604|NCT02141074|531428429|FG001|Prophylaxis|Adverse Event|4|||
147344605|NCT02141074|531428428|FG000|Prophylaxis|Withdrawn due to closure of trial|0|||
147344606|NCT02141074|531428429|FG001|Prophylaxis|Withdrawn due to closure of trial|3|||
147344607|NCT02141074|531428428|FG000|Prophylaxis|Withdrawal by Subject|0|||
147344608|NCT02141074|531428429|FG001|Prophylaxis|Withdrawal by Subject|1|||
147344609|NCT01070069|531428430|FG000|Overall Study|Death|1|||
147344610|NCT01070069|531428431|FG001|Overall Study|Death|0|||
147344611|NCT01070069|531428432|FG002|Overall Study|Death|2|||
147344612|NCT01070069|531428433|FG003|Overall Study|Death|0|||
147344613|NCT01070069|531428434|FG004|Overall Study|Death|1|||
147344614|NCT01070069|531428430|FG000|Overall Study|Withdrawal by Subject|1|||
147344615|NCT01070069|531428431|FG001|Overall Study|Withdrawal by Subject|1|||
147344616|NCT01070069|531428432|FG002|Overall Study|Withdrawal by Subject|4|||
147344617|NCT01070069|531428433|FG003|Overall Study|Withdrawal by Subject|0|||
147344618|NCT01070069|531428434|FG004|Overall Study|Withdrawal by Subject|0|||
147344619|NCT01070069|531428430|FG000|Overall Study|Lost to Follow-up|4|||
147344620|NCT01070069|531428431|FG001|Overall Study|Lost to Follow-up|1|||
147344621|NCT01070069|531428432|FG002|Overall Study|Lost to Follow-up|0|||
147344622|NCT01070069|531428433|FG003|Overall Study|Lost to Follow-up|0|||
147344623|NCT01070069|531428434|FG004|Overall Study|Lost to Follow-up|3|||
147344624|NCT00262301|531428437|FG000|Double-blind Phase|Lost to Follow-up|1|||
147344625|NCT00262301|531428438|FG001|Double-blind Phase|Lost to Follow-up|0|||
147344626|NCT00262301|531428439|FG002|Double-blind Phase|Lost to Follow-up|0|||
147344627|NCT00262301|531428437|FG000|Double-blind Phase|"worsening of HAE symptoms"|0|||
147344628|NCT00262301|531428438|FG001|Double-blind Phase|"worsening of HAE symptoms"|1|||
147344629|NCT00262301|531428439|FG002|Double-blind Phase|"worsening of HAE symptoms"|0|||
147344630|NCT03101930|531428440|FG000|Overall Study|Withdrawal by Subject|2|||
147344631|NCT03101930|531428441|FG001|Overall Study|Withdrawal by Subject|1|||
147344632|NCT03101930|531428442|FG002|Overall Study|Withdrawal by Subject|2|||
147344633|NCT03201562|531428443|FG000|Overall Study|Physician Decision|0|||
147344634|NCT03201562|531428444|FG001|Overall Study|Physician Decision|0|||
147344635|NCT03201562|531428445|FG002|Overall Study|Physician Decision|1|||
147344636|NCT03201562|531428443|FG000|Overall Study|Adverse Event|0|||
147344637|NCT03201562|531428444|FG001|Overall Study|Adverse Event|0|||
147344638|NCT03201562|531428445|FG002|Overall Study|Adverse Event|1|||
147344639|NCT03201562|531428443|FG000|Overall Study|Lost to Follow-up|0|||
147344640|NCT03201562|531428444|FG001|Overall Study|Lost to Follow-up|1|||
147344641|NCT03201562|531428445|FG002|Overall Study|Lost to Follow-up|2|||
147344642|NCT00001277|531428446|FG000|Overall Study|Adverse Event|0|||
147344643|NCT00001277|531428447|FG001|Overall Study|Adverse Event|0|||
147344644|NCT00001277|531428448|FG002|Overall Study|Adverse Event|1|||
147344645|NCT00001277|531428446|FG000|Overall Study|The tracer F-DOPA did not meet Quality Control Standards|0|||
147344646|NCT00001277|531428447|FG001|Overall Study|The tracer F-DOPA did not meet Quality Control Standards|0|||
147344647|NCT00001277|531428448|FG002|Overall Study|The tracer F-DOPA did not meet Quality Control Standards|2|||
147344648|NCT04484935|531428449|FG000|Overall Study|Other|0|||
147344649|NCT04484935|531428450|FG001|Overall Study|Other|1|||
147344650|NCT04484935|531428449|FG000|Overall Study|Withdrawal by parent/guardian|0|||
147344651|NCT04484935|531428450|FG001|Overall Study|Withdrawal by parent/guardian|1|||
147344652|NCT04484935|531428449|FG000|Overall Study|Lost to Follow-up|1|||
147344653|NCT04484935|531428450|FG001|Overall Study|Lost to Follow-up|0|||
147344654|NCT04484935|531428449|FG000|Overall Study|Death|2|||
147344655|NCT04484935|531428450|FG001|Overall Study|Death|1|||
147344656|NCT04048382|531428454|FG000|3-Month Follow Up|Enrolled but did not complete survey|2|||
147344657|NCT04048382|531428455|FG001|3-Month Follow Up|Enrolled but did not complete survey|0|||
147344658|NCT04048382|531428454|FG000|3-Month Follow Up|Withdrawal by Subject|0|||
147344659|NCT04048382|531428455|FG001|3-Month Follow Up|Withdrawal by Subject|1|||
147344660|NCT04048382|531428454|FG000|6-Month Follow up|Enrolled but did not complete survey|2|||
147344661|NCT04048382|531428455|FG001|6-Month Follow up|Enrolled but did not complete survey|0|||
147344662|NCT05368558|531428458|FG000|Double Blind Period (DBP)|Withdrawal by Subject|1|||
147344663|NCT05368558|531428459|FG001|Double Blind Period (DBP)|Withdrawal by Subject|1|||
147344664|NCT05368558|531428460|FG002|Double Blind Period (DBP)|Withdrawal by Subject|2|||
147344665|NCT05368558|531428461|FG003|Double Blind Period (DBP)|Withdrawal by Subject|0|||
147344666|NCT05368558|531428462|FG004|Double Blind Period (DBP)|Withdrawal by Subject|0|||
147344667|NCT05368558|531428463|FG005|Double Blind Period (DBP)|Withdrawal by Subject|0|||
147344668|NCT05368558|531428464|FG006|Double Blind Period (DBP)|Withdrawal by Subject|0|||
147344669|NCT05368558|531428465|FG007|Double Blind Period (DBP)|Withdrawal by Subject|0|||
147344670|NCT05368558|531428466|FG008|Double Blind Period (DBP)|Withdrawal by Subject|0|||
147344671|NCT05368558|531428467|FG009|Double Blind Period (DBP)|Withdrawal by Subject|0|||
147344672|NCT05368558|531428468|FG010|Double Blind Period (DBP)|Withdrawal by Subject|0|||
147344673|NCT05368558|531428469|FG011|Double Blind Period (DBP)|Withdrawal by Subject|0|||
147344674|NCT05368558|531428458|FG000|Blinded Extension Period (BEP)|Withdrawal by Subject|0|||
147344675|NCT05368558|531428459|FG001|Blinded Extension Period (BEP)|Withdrawal by Subject|0|||
147344676|NCT05368558|531428460|FG002|Blinded Extension Period (BEP)|Withdrawal by Subject|0|||
147344677|NCT05368558|531428461|FG003|Blinded Extension Period (BEP)|Withdrawal by Subject|1|||
147344678|NCT05368558|531428462|FG004|Blinded Extension Period (BEP)|Withdrawal by Subject|0|||
147344679|NCT05368558|531428463|FG005|Blinded Extension Period (BEP)|Withdrawal by Subject|2|||
147344680|NCT05368558|531428464|FG006|Blinded Extension Period (BEP)|Withdrawal by Subject|0|||
147344681|NCT05368558|531428465|FG007|Blinded Extension Period (BEP)|Withdrawal by Subject|0|||
147344682|NCT05368558|531428466|FG008|Blinded Extension Period (BEP)|Withdrawal by Subject|0|||
147344683|NCT05368558|531428467|FG009|Blinded Extension Period (BEP)|Withdrawal by Subject|0|||
147344684|NCT05368558|531428468|FG010|Blinded Extension Period (BEP)|Withdrawal by Subject|0|||
147344685|NCT05368558|531428469|FG011|Blinded Extension Period (BEP)|Withdrawal by Subject|0|||
147344686|NCT05368558|531428458|FG000|Blinded Extension Period (BEP)|Study terminated by sponsor|0|||
147344687|NCT05368558|531428459|FG001|Blinded Extension Period (BEP)|Study terminated by sponsor|0|||
147344688|NCT05368558|531428460|FG002|Blinded Extension Period (BEP)|Study terminated by sponsor|0|||
147344689|NCT05368558|531428461|FG003|Blinded Extension Period (BEP)|Study terminated by sponsor|1|||
147344690|NCT05368558|531428462|FG004|Blinded Extension Period (BEP)|Study terminated by sponsor|0|||
147344691|NCT05368558|531428463|FG005|Blinded Extension Period (BEP)|Study terminated by sponsor|0|||
147344692|NCT05368558|531428464|FG006|Blinded Extension Period (BEP)|Study terminated by sponsor|0|||
147344693|NCT05368558|531428465|FG007|Blinded Extension Period (BEP)|Study terminated by sponsor|0|||
147344694|NCT05368558|531428466|FG008|Blinded Extension Period (BEP)|Study terminated by sponsor|0|||
147344695|NCT05368558|531428467|FG009|Blinded Extension Period (BEP)|Study terminated by sponsor|0|||
147344696|NCT05368558|531428468|FG010|Blinded Extension Period (BEP)|Study terminated by sponsor|0|||
147344697|NCT05368558|531428469|FG011|Blinded Extension Period (BEP)|Study terminated by sponsor|0|||
147344698|NCT05368558|531428458|FG000|Blinded Extension Period (BEP)|other|0|||
147344699|NCT05368558|531428459|FG001|Blinded Extension Period (BEP)|other|0|||
147344700|NCT05368558|531428460|FG002|Blinded Extension Period (BEP)|other|0|||
147344701|NCT05368558|531428461|FG003|Blinded Extension Period (BEP)|other|0|||
147344702|NCT05368558|531428462|FG004|Blinded Extension Period (BEP)|other|0|||
147344703|NCT05368558|531428463|FG005|Blinded Extension Period (BEP)|other|1|||
147344704|NCT05368558|531428464|FG006|Blinded Extension Period (BEP)|other|0|||
147344705|NCT05368558|531428465|FG007|Blinded Extension Period (BEP)|other|0|||
147344706|NCT05368558|531428466|FG008|Blinded Extension Period (BEP)|other|0|||
147344707|NCT05368558|531428467|FG009|Blinded Extension Period (BEP)|other|0|||
147344708|NCT05368558|531428468|FG010|Blinded Extension Period (BEP)|other|0|||
147344709|NCT05368558|531428469|FG011|Blinded Extension Period (BEP)|other|0|||
147344710|NCT03744312|531430368|FG000|Overall Study|Withdrawal by Subject|0|||
147344711|NCT03744312|531430369|FG001|Overall Study|Withdrawal by Subject|1|||
147344712|NCT03744312|531430368|FG000|Overall Study|Screen fail|0|||
147344713|NCT03744312|531430369|FG001|Overall Study|Screen fail|1|||
147344714|NCT04579380|531430370|FG000|Overall Study|Death|9|||
147344715|NCT04579380|531430371|FG001|Overall Study|Death|22|||
147344716|NCT04579380|531430372|FG002|Overall Study|Death|22|||
147344717|NCT04579380|531430373|FG003|Overall Study|Death|17|||
147344718|NCT04579380|531430374|FG004|Overall Study|Death|6|||
147344719|NCT04579380|531430375|FG005|Overall Study|Death|21|||
147344720|NCT04579380|531430376|FG006|Overall Study|Death|10|||
147344721|NCT04579380|531430377|FG007|Overall Study|Death|11|||
147344722|NCT04579380|531430378|FG008|Overall Study|Death|25|||
147344723|NCT04579380|531430370|FG000|Overall Study|Withdrawal by Subject|0|||
147344724|NCT04579380|531430371|FG001|Overall Study|Withdrawal by Subject|3|||
147344725|NCT04579380|531430372|FG002|Overall Study|Withdrawal by Subject|4|||
147344726|NCT04579380|531430373|FG003|Overall Study|Withdrawal by Subject|0|||
147344727|NCT04579380|531430374|FG004|Overall Study|Withdrawal by Subject|1|||
147344728|NCT04579380|531430375|FG005|Overall Study|Withdrawal by Subject|2|||
147344729|NCT04579380|531430376|FG006|Overall Study|Withdrawal by Subject|0|||
147344730|NCT04579380|531430377|FG007|Overall Study|Withdrawal by Subject|1|||
147606686|NCT00673387|532375294|FG002|Overall Study|Adverse Event|5|||
147606687|NCT00673387|532375295|FG003|Overall Study|Adverse Event|2|||
147606688|NCT00673387|532375296|FG004|Overall Study|Adverse Event|6|||
147606689|NCT00673387|532375297|FG005|Overall Study|Adverse Event|2|||
147606690|NCT00673387|532375298|FG006|Overall Study|Adverse Event|5|||
147344731|NCT04579380|531430378|FG008|Overall Study|Withdrawal by Subject|2|||
147344732|NCT04579380|531430370|FG000|Overall Study|Ongoing|2|||
147344733|NCT04579380|531430371|FG001|Overall Study|Ongoing|6|||
147344734|NCT04579380|531430372|FG002|Overall Study|Ongoing|4|||
147606691|NCT00673387|532375299|FG007|Overall Study|Adverse Event|5|||
147344735|NCT04579380|531430373|FG003|Overall Study|Ongoing|8|||
147344736|NCT04579380|531430374|FG004|Overall Study|Ongoing|5|||
147606692|NCT00673387|532375292|FG000|Overall Study|Physician Decision|0|||
147344737|NCT04579380|531430375|FG005|Overall Study|Ongoing|8|||
147344738|NCT04579380|531430376|FG006|Overall Study|Ongoing|3|||
147344739|NCT04579380|531430377|FG007|Overall Study|Ongoing|19|||
147344740|NCT04579380|531430378|FG008|Overall Study|Ongoing|6|||
147606693|NCT00673387|532375293|FG001|Overall Study|Physician Decision|0|||
147344741|NCT03821844|531430379|FG000|Overall Study|Death|37|||
147344742|NCT03821844|531430380|FG001|Overall Study|Death|31|||
147344743|NCT03821844|531430379|FG000|Overall Study|Discharged|10|||
147344744|NCT03821844|531430380|FG001|Overall Study|Discharged|14|||
147344745|NCT03821844|531430379|FG000|Overall Study|Not present in facility at followup|2|||
147344746|NCT03821844|531430380|FG001|Overall Study|Not present in facility at followup|3|||
147344747|NCT03913195|531430381|FG000|Overall Study|Adverse Event|0|||
147344748|NCT03913195|531430382|FG001|Overall Study|Adverse Event|0|||
147344749|NCT03913195|531430383|FG002|Overall Study|Adverse Event|1|||
147344750|NCT03913195|531430384|FG003|Overall Study|Adverse Event|1|||
147344751|NCT03913195|531430385|FG004|Overall Study|Adverse Event|0|||
147344752|NCT03913195|531430381|FG000|Overall Study|Withdrawal by Subject|0|||
147344753|NCT03913195|531430382|FG001|Overall Study|Withdrawal by Subject|0|||
147344754|NCT03913195|531430383|FG002|Overall Study|Withdrawal by Subject|1|||
147344755|NCT03913195|531430384|FG003|Overall Study|Withdrawal by Subject|0|||
147344756|NCT03913195|531430385|FG004|Overall Study|Withdrawal by Subject|1|||
147344757|NCT03913195|531430381|FG000|Overall Study|non adherence to study|0|||
147344758|NCT03913195|531430382|FG001|Overall Study|non adherence to study|0|||
147344759|NCT03913195|531430383|FG002|Overall Study|non adherence to study|1|||
147344760|NCT03913195|531430384|FG003|Overall Study|non adherence to study|0|||
147344761|NCT03913195|531430385|FG004|Overall Study|non adherence to study|0|||
147344762|NCT05307978|531430386|FG000|Overall Study|Lost to Follow-up|0|||
147344763|NCT05307978|531430387|FG001|Overall Study|Lost to Follow-up|1|||
147344764|NCT05307978|531430388|FG002|Overall Study|Lost to Follow-up|0|||
147344765|NCT05307978|531430389|FG003|Overall Study|Lost to Follow-up|4|||
147344766|NCT05307978|531430390|FG004|Overall Study|Lost to Follow-up|0|||
147344767|NCT05307978|531430391|FG005|Overall Study|Lost to Follow-up|0|||
147344768|NCT05307978|531430392|FG006|Overall Study|Lost to Follow-up|1|||
147344769|NCT04855760|531430395|FG000|Overall Study|Adverse Event|21|||
147344770|NCT04855760|531430395|FG000|Overall Study|Withdrawal by Subject|116|||
147344771|NCT04855760|531430395|FG000|Overall Study|Lack of Efficacy|21|||
147344772|NCT04855760|531430395|FG000|Overall Study|Lost to Follow-up|49|||
147344773|NCT04855760|531430395|FG000|Overall Study|Protocol Violation|2|||
147344774|NCT04855760|531430395|FG000|Overall Study|Physician Decision|5|||
147344775|NCT04855760|531430395|FG000|Overall Study|Pregnancy|1|||
147344776|NCT04855760|531430395|FG000|Overall Study|Non-Compliance with Study Drug|11|||
147344777|NCT04855760|531430395|FG000|Overall Study|Non-Compliance with Study Schedule|4|||
147344778|NCT04855760|531430395|FG000|Overall Study|Study Completed by Sponsor|202|||
147344779|NCT04855760|531430395|FG000|Overall Study|Other|13|||
147344780|NCT04840199|531430396|FG000|Overall Study|Study Terminated by Sponsor|8|||
147344781|NCT04840199|531430397|FG001|Overall Study|Study Terminated by Sponsor|9|||
147344782|NCT04840199|531430396|FG000|Overall Study|Lost to Follow-up|0|||
147344783|NCT04840199|531430397|FG001|Overall Study|Lost to Follow-up|2|||
147344784|NCT04840199|531430396|FG000|Overall Study|Withdrawal by Subject|2|||
147344785|NCT04840199|531430397|FG001|Overall Study|Withdrawal by Subject|0|||
147344786|NCT04840199|531430396|FG000|Overall Study|Found to Not Meet Eligibility Criteria After Randomization (Never Started Treatment)|1|||
147344787|NCT04840199|531430397|FG001|Overall Study|Found to Not Meet Eligibility Criteria After Randomization (Never Started Treatment)|1|||
147344788|NCT03517553|531430398|FG000|Overall Study|Withdrawal by Subject|2|||
147344789|NCT02201108|531430399|FG000|Double-blind Period (up to Week 96)|Adverse Event|0|||
147344790|NCT02201108|531430400|FG001|Double-blind Period (up to Week 96)|Adverse Event|6|||
147344791|NCT02201108|531430401|FG002|Double-blind Period (up to Week 96)|Adverse Event|0|||
147344792|NCT02201108|531430399|FG000|Double-blind Period (up to Week 96)|Lack of Efficacy|2|||
147344793|NCT02201108|531430400|FG001|Double-blind Period (up to Week 96)|Lack of Efficacy|1|||
147344794|NCT02201108|531430401|FG002|Double-blind Period (up to Week 96)|Lack of Efficacy|0|||
147344795|NCT02201108|531430399|FG000|Double-blind Period (up to Week 96)|Withdrawal by Subject|2|||
147344796|NCT02201108|531430400|FG001|Double-blind Period (up to Week 96)|Withdrawal by Subject|0|||
147344797|NCT02201108|531430401|FG002|Double-blind Period (up to Week 96)|Withdrawal by Subject|0|||
147344798|NCT02201108|531430399|FG000|Open Label Period (up to Week 192)|Lack of Efficacy|10|||
147344799|NCT02201108|531430400|FG001|Open Label Period (up to Week 192)|Lack of Efficacy|14|||
147344800|NCT02201108|531430401|FG002|Open Label Period (up to Week 192)|Lack of Efficacy|0|||
147344801|NCT02201108|531430399|FG000|Open Label Period (up to Week 192)|Poor compliance to protocol|0|||
147344802|NCT02201108|531430400|FG001|Open Label Period (up to Week 192)|Poor compliance to protocol|1|||
147606694|NCT00673387|532375294|FG002|Overall Study|Physician Decision|0|||
147344803|NCT02201108|531430401|FG002|Open Label Period (up to Week 192)|Poor compliance to protocol|0|||
147344804|NCT02201108|531430399|FG000|Open Label Period (up to Week 192)|Other reason|4|||
147344805|NCT02201108|531430400|FG001|Open Label Period (up to Week 192)|Other reason|7|||
147344806|NCT02201108|531430401|FG002|Open Label Period (up to Week 192)|Other reason|0|||
147344807|NCT02201108|531430399|FG000|Open Label Period (up to Week 192)|Adverse Event|7|||
147344808|NCT02201108|531430400|FG001|Open Label Period (up to Week 192)|Adverse Event|5|||
147344809|NCT02201108|531430401|FG002|Open Label Period (up to Week 192)|Adverse Event|0|||
147344810|NCT02201108|531430399|FG000|Extension Period (Up to Week 492)|Adverse Event|0|||
147344811|NCT02201108|531430400|FG001|Extension Period (Up to Week 492)|Adverse Event|0|||
147344812|NCT02201108|531430401|FG002|Extension Period (Up to Week 492)|Adverse Event|2|||
147344813|NCT02201108|531430399|FG000|Extension Period (Up to Week 492)|Poor compliance to protocol|0|||
147344814|NCT02201108|531430400|FG001|Extension Period (Up to Week 492)|Poor compliance to protocol|0|||
147344815|NCT02201108|531430401|FG002|Extension Period (Up to Week 492)|Poor compliance to protocol|1|||
147344816|NCT05215847|531430402|FG000|Overall Study|Lost to Follow-up|1|||
147344817|NCT04586920|531430404|FG000|Overall Study|Lost to Follow-up|0|||
147344818|NCT04586920|531430405|FG001|Overall Study|Lost to Follow-up|0|||
147344819|NCT04586920|531430406|FG002|Overall Study|Lost to Follow-up|0|||
147344820|NCT04586920|531430407|FG003|Overall Study|Lost to Follow-up|0|||
147344821|NCT04586920|531430408|FG004|Overall Study|Lost to Follow-up|0|||
147344822|NCT04586920|531430409|FG005|Overall Study|Lost to Follow-up|0|||
147344823|NCT04586920|531430410|FG006|Overall Study|Lost to Follow-up|1|||
147344824|NCT04586920|531430411|FG007|Overall Study|Lost to Follow-up|1|||
147344825|NCT04586920|531430412|FG008|Overall Study|Lost to Follow-up|0|||
147344826|NCT04586920|531430413|FG009|Overall Study|Lost to Follow-up|1|||
147344827|NCT04586920|531430414|FG010|Overall Study|Lost to Follow-up|0|||
147344828|NCT04586920|531430415|FG011|Overall Study|Lost to Follow-up|0|||
147344829|NCT04586920|531430416|FG012|Overall Study|Lost to Follow-up|0|||
147344830|NCT04586920|531430417|FG013|Overall Study|Lost to Follow-up|1|||
147344831|NCT04586920|531430418|FG014|Overall Study|Lost to Follow-up|0|||
147344832|NCT04586920|531430419|FG015|Overall Study|Lost to Follow-up|0|||
147344833|NCT04586920|531430420|FG016|Overall Study|Lost to Follow-up|0|||
147344834|NCT04586920|531430421|FG017|Overall Study|Lost to Follow-up|0|||
147344835|NCT04586920|531430404|FG000|Overall Study|Withdrawal by Subject|0|||
147344836|NCT04586920|531430405|FG001|Overall Study|Withdrawal by Subject|0|||
147344837|NCT04586920|531430406|FG002|Overall Study|Withdrawal by Subject|0|||
147344838|NCT04586920|531430407|FG003|Overall Study|Withdrawal by Subject|0|||
147344839|NCT04586920|531430408|FG004|Overall Study|Withdrawal by Subject|0|||
147344840|NCT04586920|531430409|FG005|Overall Study|Withdrawal by Subject|0|||
147344841|NCT04586920|531430410|FG006|Overall Study|Withdrawal by Subject|0|||
147344842|NCT04586920|531430411|FG007|Overall Study|Withdrawal by Subject|1|||
147344843|NCT04586920|531430412|FG008|Overall Study|Withdrawal by Subject|0|||
147344844|NCT04586920|531430413|FG009|Overall Study|Withdrawal by Subject|1|||
147344845|NCT04586920|531430414|FG010|Overall Study|Withdrawal by Subject|0|||
147344846|NCT04586920|531430415|FG011|Overall Study|Withdrawal by Subject|1|||
147344847|NCT04586920|531430416|FG012|Overall Study|Withdrawal by Subject|0|||
147344848|NCT04586920|531430417|FG013|Overall Study|Withdrawal by Subject|0|||
147344849|NCT04586920|531430418|FG014|Overall Study|Withdrawal by Subject|0|||
147344850|NCT04586920|531430419|FG015|Overall Study|Withdrawal by Subject|0|||
147344851|NCT04586920|531430420|FG016|Overall Study|Withdrawal by Subject|0|||
147344852|NCT04586920|531430421|FG017|Overall Study|Withdrawal by Subject|0|||
147344853|NCT05136404|531430423|FG000|Period 1|Adverse Event|0|||
147344854|NCT05136404|531430424|FG001|Period 1|Adverse Event|1|||
147344855|NCT05136404|531430425|FG002|Period 1|Adverse Event|1|||
147344856|NCT05136404|531430423|FG000|Period 2|Inappropriate Behavior|0|||
147344857|NCT05136404|531430424|FG001|Period 2|Inappropriate Behavior|0|||
147344858|NCT05136404|531430425|FG002|Period 2|Inappropriate Behavior|1|||
147344859|NCT05136404|531430423|FG000|Period 3|Adverse Event|0|||
147344860|NCT05136404|531430424|FG001|Period 3|Adverse Event|0|||
147344861|NCT05136404|531430425|FG002|Period 3|Adverse Event|1|||
147344862|NCT02553642|531430426|FG000|Overall Study|Withdrawal by Subject|0|||
147344863|NCT02553642|531430427|FG001|Overall Study|Withdrawal by Subject|3|||
147344864|NCT02553642|531430426|FG000|Overall Study|Physician Decision|0|||
147344865|NCT02553642|531430427|FG001|Overall Study|Physician Decision|1|||
147344866|NCT02553642|531430426|FG000|Overall Study|Additional cancer dx|0|||
147344867|NCT02553642|531430427|FG001|Overall Study|Additional cancer dx|1|||
147344868|NCT02553642|531430426|FG000|Overall Study|Never started treatment|0|||
147344869|NCT02553642|531430427|FG001|Overall Study|Never started treatment|1|||
147344870|NCT04600752|531430428|FG000|Overall Study|Physician Decision|0|||
147344871|NCT04600752|531430429|FG001|Overall Study|Physician Decision|0|||
147344872|NCT04600752|531430430|FG002|Overall Study|Physician Decision|1|||
147344873|NCT04600752|531430428|FG000|Overall Study|Adverse Event|0|||
147344874|NCT04600752|531430429|FG001|Overall Study|Adverse Event|1|||
147344875|NCT04600752|531430430|FG002|Overall Study|Adverse Event|0|||
147344876|NCT04600752|531430428|FG000|Overall Study|Withdrawal by Subject|2|||
147344877|NCT04600752|531430429|FG001|Overall Study|Withdrawal by Subject|1|||
147344878|NCT04600752|531430430|FG002|Overall Study|Withdrawal by Subject|0|||
147606695|NCT00673387|532375295|FG003|Overall Study|Physician Decision|0|||
147606696|NCT00673387|532375296|FG004|Overall Study|Physician Decision|0|||
147606697|NCT00673387|532375297|FG005|Overall Study|Physician Decision|5|||
147606698|NCT00673387|532375298|FG006|Overall Study|Physician Decision|1|||
147344879|NCT04600752|531430428|FG000|Overall Study|Lack of Efficacy|1|||
147344880|NCT04600752|531430429|FG001|Overall Study|Lack of Efficacy|0|||
147344881|NCT04600752|531430430|FG002|Overall Study|Lack of Efficacy|0|||
147344882|NCT03732820|531430431|FG000|Overall Study|Death|168|||
147344883|NCT03732820|531430432|FG001|Overall Study|Death|203|||
147344884|NCT03732820|531430431|FG000|Overall Study|Other|2|||
147344885|NCT03732820|531430432|FG001|Overall Study|Other|2|||
147344886|NCT03732820|531430431|FG000|Overall Study|Failure to meet randomisation criteria|1|||
147606699|NCT00673387|532375299|FG007|Overall Study|Physician Decision|1|||
147344887|NCT03732820|531430432|FG001|Overall Study|Failure to meet randomisation criteria|1|||
147344888|NCT03732820|531430431|FG000|Overall Study|Patient decision|14|||
147344889|NCT03732820|531430432|FG001|Overall Study|Patient decision|10|||
147344890|NCT03732820|531430431|FG000|Overall Study|Screen failure|0|||
147344891|NCT03732820|531430432|FG001|Overall Study|Screen failure|1|||
147344892|NCT03732820|531430431|FG000|Overall Study|Patients ongoing study at data cut off|210|||
147344893|NCT03732820|531430432|FG001|Overall Study|Patients ongoing study at data cut off|178|||
147344894|NCT03732820|531430431|FG000|Overall Study|Lost to Follow-up|4|||
147344895|NCT03732820|531430432|FG001|Overall Study|Lost to Follow-up|2|||
147344896|NCT04287985|531430440|FG000|Overall Study|Adverse Event|1|||
147344897|NCT04287985|531430441|FG001|Overall Study|Adverse Event|0|||
147344898|NCT04287985|531430442|FG002|Overall Study|Adverse Event|0|||
147344899|NCT04287985|531430443|FG003|Overall Study|Adverse Event|0|||
147344900|NCT04287985|531430440|FG000|Overall Study|Protocol Violation|0|||
147344901|NCT04287985|531430441|FG001|Overall Study|Protocol Violation|1|||
147344902|NCT04287985|531430442|FG002|Overall Study|Protocol Violation|0|||
147344903|NCT04287985|531430443|FG003|Overall Study|Protocol Violation|0|||
147344904|NCT04287985|531430440|FG000|Overall Study|Physician Decision|0|||
147344905|NCT04287985|531430441|FG001|Overall Study|Physician Decision|0|||
147344906|NCT04287985|531430442|FG002|Overall Study|Physician Decision|0|||
147344907|NCT04287985|531430443|FG003|Overall Study|Physician Decision|1|||
147344908|NCT04287985|531430440|FG000|Overall Study|Withdrawal by Subject|2|||
147344909|NCT04287985|531430441|FG001|Overall Study|Withdrawal by Subject|1|||
147344910|NCT04287985|531430442|FG002|Overall Study|Withdrawal by Subject|1|||
147344911|NCT04287985|531430443|FG003|Overall Study|Withdrawal by Subject|2|||
147344912|NCT01340066|531430444|FG000|Placebo Run in Period|Screen Failures|27|||
147344913|NCT01340066|531430445|FG001|Placebo Run in Period|Screen Failures|0|||
147344914|NCT01340066|531430446|FG002|Placebo Run in Period|Screen Failures|0|||
147344915|NCT01340066|531430444|FG000|5 Week Double Blind Randomization Period|Adverse Event|0|||
147344916|NCT01340066|531430445|FG001|5 Week Double Blind Randomization Period|Adverse Event|2|||
147344917|NCT01340066|531430446|FG002|5 Week Double Blind Randomization Period|Adverse Event|2|||
147344918|NCT01340066|531430444|FG000|5 Week Double Blind Randomization Period|Physician Decision|0|||
147344919|NCT01340066|531430445|FG001|5 Week Double Blind Randomization Period|Physician Decision|1|||
147344920|NCT01340066|531430446|FG002|5 Week Double Blind Randomization Period|Physician Decision|0|||
147344921|NCT01340066|531430444|FG000|5 Week Double Blind Randomization Period|Withdrawal by Subject|0|||
147344922|NCT01340066|531430445|FG001|5 Week Double Blind Randomization Period|Withdrawal by Subject|2|||
147344923|NCT01340066|531430446|FG002|5 Week Double Blind Randomization Period|Withdrawal by Subject|1|||
147344924|NCT02789020|531430447|FG000|Overall Study|Withdrawal by Subject|6|||
147344925|NCT02789020|531430448|FG001|Overall Study|Withdrawal by Subject|5|||
147344926|NCT03771352|531430454|FG000|Overall Study|Screen failure|2|||
147344927|NCT03771352|531430454|FG000|Overall Study|Withdrawal by Subject|2|||
147344928|NCT03338816|531430460|FG000|6-Month DB + Open-Label Extension Period|Adverse Event|0|||
147344929|NCT03338816|531430461|FG001|6-Month DB + Open-Label Extension Period|Adverse Event|0|||
147344930|NCT03338816|531430462|FG002|6-Month DB + Open-Label Extension Period|Adverse Event|2|||
147344931|NCT03338816|531430463|FG003|6-Month DB + Open-Label Extension Period|Adverse Event|0|||
147344932|NCT03338816|531430460|FG000|6-Month DB + Open-Label Extension Period|Death|0|||
147344933|NCT03338816|531430461|FG001|6-Month DB + Open-Label Extension Period|Death|0|||
147344934|NCT03338816|531430462|FG002|6-Month DB + Open-Label Extension Period|Death|0|||
147344935|NCT03338816|531430463|FG003|6-Month DB + Open-Label Extension Period|Death|1|||
147344936|NCT03338816|531430460|FG000|6-Month DB + Open-Label Extension Period|Lost to Follow-up|0|||
147344937|NCT03338816|531430461|FG001|6-Month DB + Open-Label Extension Period|Lost to Follow-up|0|||
147344938|NCT03338816|531430462|FG002|6-Month DB + Open-Label Extension Period|Lost to Follow-up|1|||
147344939|NCT03338816|531430463|FG003|6-Month DB + Open-Label Extension Period|Lost to Follow-up|0|||
147344940|NCT03338816|531430460|FG000|6-Month DB + Open-Label Extension Period|Physician Decision|0|||
147344941|NCT03338816|531430461|FG001|6-Month DB + Open-Label Extension Period|Physician Decision|0|||
147344942|NCT03338816|531430462|FG002|6-Month DB + Open-Label Extension Period|Physician Decision|1|||
147344943|NCT03338816|531430463|FG003|6-Month DB + Open-Label Extension Period|Physician Decision|0|||
147344944|NCT03338816|531430460|FG000|6-Month DB + Open-Label Extension Period|Pregnancy|0|||
147344945|NCT03338816|531430461|FG001|6-Month DB + Open-Label Extension Period|Pregnancy|0|||
147344946|NCT03338816|531430462|FG002|6-Month DB + Open-Label Extension Period|Pregnancy|1|||
147344947|NCT03338816|531430463|FG003|6-Month DB + Open-Label Extension Period|Pregnancy|1|||
147453143|NCT03167073|531821556|FG000|Overall Study|Stillbirth|1|||
147606700|NCT00673387|532375292|FG000|Overall Study|Protocol Violation|3|||
147606701|NCT00673387|532375293|FG001|Overall Study|Protocol Violation|0|||
147606702|NCT00673387|532375294|FG002|Overall Study|Protocol Violation|1|||
147344948|NCT03338816|531430460|FG000|6-Month DB + Open-Label Extension Period|Withdrawal by Subject|0|||
147344949|NCT03338816|531430461|FG001|6-Month DB + Open-Label Extension Period|Withdrawal by Subject|0|||
147344950|NCT03338816|531430462|FG002|6-Month DB + Open-Label Extension Period|Withdrawal by Subject|3|||
147344951|NCT03338816|531430463|FG003|6-Month DB + Open-Label Extension Period|Withdrawal by Subject|3|||
147344952|NCT03338816|531430460|FG000|6-Month DB + Open-Label Extension Period|Patient Desired Lower Dose|0|||
147344953|NCT03338816|531430461|FG001|6-Month DB + Open-Label Extension Period|Patient Desired Lower Dose|0|||
147344954|NCT03338816|531430462|FG002|6-Month DB + Open-Label Extension Period|Patient Desired Lower Dose|0|||
147344955|NCT03338816|531430463|FG003|6-Month DB + Open-Label Extension Period|Patient Desired Lower Dose|1|||
147344956|NCT01948661|531430474|FG000|Overall Study|Withdrawal by Subject|2|||
147344957|NCT01948661|531430475|FG001|Overall Study|Withdrawal by Subject|4|||
147344958|NCT03271489|531430476|FG000|Double-Blind (DB) Period|Adverse Event|4|||
147344959|NCT03271489|531430477|FG001|Double-Blind (DB) Period|Adverse Event|1|||
147344960|NCT03271489|531430476|FG000|Double-Blind (DB) Period|Withdrawal by Subject|13|||
147344961|NCT03271489|531430477|FG001|Double-Blind (DB) Period|Withdrawal by Subject|10|||
147344962|NCT03271489|531430476|FG000|Double-Blind (DB) Period|Lost to Follow-up|9|||
147344963|NCT03271489|531430477|FG001|Double-Blind (DB) Period|Lost to Follow-up|9|||
147662716|NCT02227784|532587414|FG002|Double-Blind Phase|Physician Decision|0|||
147662717|NCT02227784|532587415|FG003|Double-Blind Phase|Physician Decision|1|||
147662718|NCT02227784|532587416|FG004|Double-Blind Phase|Physician Decision|0|||
147662719|NCT02227784|532587412|FG000|Double-Blind Phase|Protocol Violation|0|||
147662720|NCT02227784|532587413|FG001|Double-Blind Phase|Protocol Violation|0|||
147344964|NCT03271489|531430476|FG000|Double-Blind (DB) Period|Requires surgery or invasive intervention for treatment of uterine fibroids|3|||
147344965|NCT03271489|531430477|FG001|Double-Blind (DB) Period|Requires surgery or invasive intervention for treatment of uterine fibroids|2|||
147344966|NCT03271489|531430476|FG000|Double-Blind (DB) Period|Non-compliance with study procedures|0|||
147344967|NCT03271489|531430477|FG001|Double-Blind (DB) Period|Non-compliance with study procedures|1|||
147344968|NCT03271489|531430476|FG000|Double-Blind (DB) Period|Other|6|||
147299938|NCT00508404|531264561|FG000|Overall Study|Lost to Follow-up|2|||
147299939|NCT00508404|531264561|FG000|Overall Study|Other - Not Specified|3|||
147299940|NCT01424930|531264563|FG000|Overall Study|Adverse Event|0|||
147299941|NCT01424930|531264564|FG001|Overall Study|Adverse Event|1|||
147299942|NCT01424930|531264563|FG000|Overall Study|Death|1|||
147299943|NCT01424930|531264564|FG001|Overall Study|Death|0|||
147299944|NCT01424930|531264563|FG000|Overall Study|Progressive Disease|3|||
147299945|NCT01424930|531264564|FG001|Overall Study|Progressive Disease|6|||
147299946|NCT01424930|531264563|FG000|Overall Study|Screen Failure|0|||
147299947|NCT01424930|531264564|FG001|Overall Study|Screen Failure|1|||
147299948|NCT01424930|531264563|FG000|Overall Study|Reason not specified|0|||
147299949|NCT01424930|531264564|FG001|Overall Study|Reason not specified|6|||
147299950|NCT01197508|531264569|FG000|Overall Study|Withdrawal by Subject|8|||
147299951|NCT01197508|531264570|FG001|Overall Study|Withdrawal by Subject|7|||
147299952|NCT01197508|531264571|FG002|Overall Study|Withdrawal by Subject|15|||
147299953|NCT01197508|531264572|FG003|Overall Study|Withdrawal by Subject|4|||
147299954|NCT01197508|531264569|FG000|Overall Study|Eligiblity criteria not fulfilled|0|||
147299955|NCT01197508|531264570|FG001|Overall Study|Eligiblity criteria not fulfilled|0|||
147299956|NCT01197508|531264571|FG002|Overall Study|Eligiblity criteria not fulfilled|2|||
147299957|NCT01197508|531264572|FG003|Overall Study|Eligiblity criteria not fulfilled|0|||
147299958|NCT01197508|531264569|FG000|Overall Study|Adverse Event|10|||
147299959|NCT01197508|531264570|FG001|Overall Study|Adverse Event|13|||
147299960|NCT01197508|531264571|FG002|Overall Study|Adverse Event|23|||
147299961|NCT01197508|531264572|FG003|Overall Study|Adverse Event|3|||
147299962|NCT01197508|531264569|FG000|Overall Study|Severe non-compliance to protocol|0|||
147299963|NCT01197508|531264570|FG001|Overall Study|Severe non-compliance to protocol|3|||
147299964|NCT01197508|531264571|FG002|Overall Study|Severe non-compliance to protocol|1|||
147299965|NCT01197508|531264572|FG003|Overall Study|Severe non-compliance to protocol|3|||
147299966|NCT01197508|531264569|FG000|Overall Study|Condition under investigation worsened|1|||
147299967|NCT01197508|531264570|FG001|Overall Study|Condition under investigation worsened|1|||
147299968|NCT01197508|531264571|FG002|Overall Study|Condition under investigation worsened|1|||
147299969|NCT01197508|531264572|FG003|Overall Study|Condition under investigation worsened|1|||
147299970|NCT01197508|531264569|FG000|Overall Study|Lack of Efficacy|1|||
147299971|NCT01197508|531264570|FG001|Overall Study|Lack of Efficacy|2|||
147299972|NCT01197508|531264571|FG002|Overall Study|Lack of Efficacy|2|||
147299973|NCT01197508|531264572|FG003|Overall Study|Lack of Efficacy|1|||
147299974|NCT01197508|531264569|FG000|Overall Study|Study-specific withdrawal criteria|0|||
147299975|NCT01197508|531264570|FG001|Overall Study|Study-specific withdrawal criteria|0|||
147299976|NCT01197508|531264571|FG002|Overall Study|Study-specific withdrawal criteria|1|||
147299977|NCT01197508|531264572|FG003|Overall Study|Study-specific withdrawal criteria|2|||
147299978|NCT01197508|531264569|FG000|Overall Study|Lost to Follow-up|1|||
147299979|NCT01197508|531264570|FG001|Overall Study|Lost to Follow-up|1|||
147299980|NCT01197508|531264571|FG002|Overall Study|Lost to Follow-up|2|||
147299981|NCT01197508|531264572|FG003|Overall Study|Lost to Follow-up|0|||
147299982|NCT01197508|531264569|FG000|Overall Study|Other|2|||
147299983|NCT01197508|531264570|FG001|Overall Study|Other|3|||
147299984|NCT01197508|531264571|FG002|Overall Study|Other|2|||
147299985|NCT01197508|531264572|FG003|Overall Study|Other|2|||
147299986|NCT01078155|531264573|FG000|Overall Study|Adverse Event|7|||
147299987|NCT01078155|531264573|FG000|Overall Study|Lack of Efficacy|16|||
147344969|NCT03271489|531430477|FG001|Double-Blind (DB) Period|Other|1|||
147344970|NCT03271489|531430476|FG000|Double-Blind (DB) Period|Missing|1|||
147344971|NCT03271489|531430477|FG001|Double-Blind (DB) Period|Missing|0|||
147344972|NCT03271489|531430476|FG000|Open-Label (OL) Period|Adverse Event|2|||
147344973|NCT03271489|531430477|FG001|Open-Label (OL) Period|Adverse Event|0|||
147344974|NCT03271489|531430476|FG000|Open-Label (OL) Period|Withdrawal by Subject|14|||
147344975|NCT03271489|531430477|FG001|Open-Label (OL) Period|Withdrawal by Subject|8|||
147344976|NCT03271489|531430476|FG000|Open-Label (OL) Period|Lost to Follow-up|10|||
147344977|NCT03271489|531430477|FG001|Open-Label (OL) Period|Lost to Follow-up|5|||
147344978|NCT03271489|531430476|FG000|Open-Label (OL) Period|Non-compliance with study procedures|4|||
147344979|NCT03271489|531430477|FG001|Open-Label (OL) Period|Non-compliance with study procedures|1|||
147344980|NCT03271489|531430476|FG000|Open-Label (OL) Period|No Specified|2|||
147344981|NCT03271489|531430477|FG001|Open-Label (OL) Period|No Specified|2|||
147344982|NCT03271489|531430476|FG000|Open-Label (OL) Period|Missing|2|||
147344983|NCT03271489|531430477|FG001|Open-Label (OL) Period|Missing|0|||
147344984|NCT03271489|531430476|FG000|Post-Treatment Follow-Up (PTFU) Period|Adverse Event|16|||
147344985|NCT03271489|531430477|FG001|Post-Treatment Follow-Up (PTFU) Period|Adverse Event|6|||
147344986|NCT03271489|531430476|FG000|Post-Treatment Follow-Up (PTFU) Period|Withdrawal by Subject|40|||
147344987|NCT03271489|531430477|FG001|Post-Treatment Follow-Up (PTFU) Period|Withdrawal by Subject|26|||
147344988|NCT03271489|531430476|FG000|Post-Treatment Follow-Up (PTFU) Period|Lost to Follow-up|35|||
147344989|NCT03271489|531430477|FG001|Post-Treatment Follow-Up (PTFU) Period|Lost to Follow-up|24|||
147344990|NCT03271489|531430476|FG000|Post-Treatment Follow-Up (PTFU) Period|Requires surgery or invasive intervention for treatment of uterine fibroids|5|||
147344991|NCT03271489|531430477|FG001|Post-Treatment Follow-Up (PTFU) Period|Requires surgery or invasive intervention for treatment of uterine fibroids|3|||
147344992|NCT03271489|531430476|FG000|Post-Treatment Follow-Up (PTFU) Period|Non-compliance with study procedures|9|||
147344993|NCT03271489|531430477|FG001|Post-Treatment Follow-Up (PTFU) Period|Non-compliance with study procedures|2|||
147344994|NCT03271489|531430476|FG000|Post-Treatment Follow-Up (PTFU) Period|COVID-19 logistical restrictions|1|||
147344995|NCT03271489|531430477|FG001|Post-Treatment Follow-Up (PTFU) Period|COVID-19 logistical restrictions|0|||
147344996|NCT03271489|531430476|FG000|Post-Treatment Follow-Up (PTFU) Period|Other|21|||
147344997|NCT03271489|531430477|FG001|Post-Treatment Follow-Up (PTFU) Period|Other|10|||
147344998|NCT03271489|531430476|FG000|Post-Treatment Follow-Up (PTFU) Period|Missing|3|||
147344999|NCT03271489|531430477|FG001|Post-Treatment Follow-Up (PTFU) Period|Missing|2|||
147345000|NCT06061081|531430478|FG000|Overall Study|Withdrawal by Subject|1|||
147345001|NCT06061081|531430479|FG001|Overall Study|Withdrawal by Subject|0|||
147345002|NCT06061081|531430480|FG002|Overall Study|Withdrawal by Subject|0|||
147345003|NCT06061081|531430481|FG003|Overall Study|Withdrawal by Subject|0|||
147345004|NCT06061081|531430482|FG004|Overall Study|Withdrawal by Subject|0|||
147345005|NCT02252172|531430483|FG000|Overall Study|Lost to Follow-up|9|||
147345006|NCT02252172|531430484|FG001|Overall Study|Lost to Follow-up|6|||
147345007|NCT02252172|531430483|FG000|Overall Study|Death|218|||
147345008|NCT02252172|531430484|FG001|Overall Study|Death|175|||
147345009|NCT02252172|531430483|FG000|Overall Study|Withdrawal by Subject|20|||
147345010|NCT02252172|531430484|FG001|Overall Study|Withdrawal by Subject|15|||
147345011|NCT02252172|531430483|FG000|Overall Study|Physician Decision|0|||
147345012|NCT02252172|531430484|FG001|Overall Study|Physician Decision|1|||
147345013|NCT02252172|531430483|FG000|Overall Study|End of data collection|122|||
147345014|NCT02252172|531430484|FG001|Overall Study|End of data collection|170|||
147345015|NCT02252172|531430483|FG000|Overall Study|Site closure|0|||
147345016|NCT02252172|531430484|FG001|Overall Study|Site closure|1|||
147345017|NCT05575076|531430485|FG000|Overall Study|Adverse Event|24|||
147345018|NCT05575076|531430485|FG000|Overall Study|Death|7|||
147345019|NCT05575076|531430485|FG000|Overall Study|Lost to Follow-up|16|||
147345020|NCT05575076|531430485|FG000|Overall Study|Non-Compliance|3|||
147345021|NCT05575076|531430485|FG000|Overall Study|Physician Decision|6|||
147345022|NCT05575076|531430485|FG000|Overall Study|Sponsor Requests to be Withdrawn|7|||
147345023|NCT05575076|531430485|FG000|Overall Study|Withdrawal by Subject|71|||
147345024|NCT05575076|531430485|FG000|Overall Study|Study Terminated by Sponsor|630|||
147345025|NCT05575076|531430485|FG000|Overall Study|Other|17|||
147345026|NCT03380390|531430486|FG000|Overall Study|Adverse Event|3|||
147345027|NCT02886286|531430487|FG000|Overall Study|pump motor stall|0|||
147345028|NCT02886286|531430488|FG001|Overall Study|pump motor stall|1|||
147345029|NCT01127373|531430489|FG000|Overall Study|Not Treated|3|||
147345030|NCT01127373|531430489|FG000|Overall Study|Lost to Follow-up|7|||
147345031|NCT01127373|531430489|FG000|Overall Study|Withdrawal by Subject|1|||
147345032|NCT01127373|531430489|FG000|Overall Study|Disease progression|1|||
147345033|NCT00522951|531430494|FG000|Period 1|body motion|0|||
147345034|NCT00522951|531430495|FG001|Period 1|body motion|1|||
147345035|NCT00522951|531430494|FG000|Washout Period|Adverse Event|0|||
147345036|NCT00522951|531430495|FG001|Washout Period|Adverse Event|1|||
147345037|NCT00522951|531430494|FG000|Washout Period|Death|0|||
147345038|NCT00522951|531430495|FG001|Washout Period|Death|1|||
147345039|NCT00522951|531430494|FG000|Period 2|Withdrawal by Subject|1|||
147345040|NCT00522951|531430495|FG001|Period 2|Withdrawal by Subject|0|||
147345041|NCT00522951|531430494|FG000|Period 2|residual contrast medium|1|||
147345042|NCT00522951|531430495|FG001|Period 2|residual contrast medium|1|||
147345043|NCT01017146|531430500|FG000|Overall Study|Adverse Event|11|||
147345044|NCT01017146|531430501|FG001|Overall Study|Adverse Event|1|||
147345045|NCT01017146|531430500|FG000|Overall Study|Lost to Follow-up|14|||
147345046|NCT01017146|531430501|FG001|Overall Study|Lost to Follow-up|14|||
147345047|NCT01017146|531430500|FG000|Overall Study|Noncompliance with Study Product|1|||
147345048|NCT01017146|531430501|FG001|Overall Study|Noncompliance with Study Product|1|||
147345049|NCT01017146|531430500|FG000|Overall Study|Withdrawal by Subject|32|||
147345050|NCT01017146|531430501|FG001|Overall Study|Withdrawal by Subject|16|||
147345051|NCT01017146|531430500|FG000|Overall Study|Relocation|0|||
147345052|NCT01017146|531430501|FG001|Overall Study|Relocation|4|||
147345053|NCT01017146|531430500|FG000|Overall Study|Pregnancy|2|||
147345054|NCT01017146|531430501|FG001|Overall Study|Pregnancy|1|||
147345055|NCT01017146|531430500|FG000|Overall Study|Protocol Violation|2|||
147345056|NCT01017146|531430501|FG001|Overall Study|Protocol Violation|0|||
147345057|NCT01017146|531430500|FG000|Overall Study|Took Excluded Medication|2|||
147345058|NCT01017146|531430501|FG001|Overall Study|Took Excluded Medication|0|||
147345059|NCT01017146|531430500|FG000|Overall Study|Did Not Meet Eligibility Criteria|1|||
147345060|NCT01017146|531430501|FG001|Overall Study|Did Not Meet Eligibility Criteria|2|||
147345061|NCT01017146|531430500|FG000|Overall Study|Change in Work Situation|1|||
147345062|NCT01017146|531430501|FG001|Overall Study|Change in Work Situation|0|||
147345063|NCT01747486|531430502|FG000|Stage 1|Physician Decision|3|||
147345064|NCT01747486|531430503|FG001|Stage 1|Physician Decision|0|||
147345065|NCT01747486|531430502|FG000|Stage 1|Withdrawal by Subject|4|||
147345066|NCT01747486|531430503|FG001|Stage 1|Withdrawal by Subject|3|||
147345067|NCT01747486|531430502|FG000|Stage 1|Disease progression|4|||
147345068|NCT01747486|531430503|FG001|Stage 1|Disease progression|9|||
147345069|NCT01747486|531430502|FG000|Stage 1|Death|1|||
147345070|NCT01747486|531430503|FG001|Stage 1|Death|1|||
147345071|NCT01747486|531430502|FG000|Stage 2|Physician Decision|2|||
147345072|NCT01747486|531430503|FG001|Stage 2|Physician Decision|0|||
147345073|NCT01747486|531430502|FG000|Stage 2|Withdrawal by Subject|1|||
147345074|NCT01747486|531430503|FG001|Stage 2|Withdrawal by Subject|0|||
147345075|NCT01747486|531430502|FG000|Stage 2|New Cancer Therapy|3|||
147345076|NCT01747486|531430503|FG001|Stage 2|New Cancer Therapy|0|||
147345077|NCT01747486|531430502|FG000|Stage 2|Disease Progression|3|||
147345078|NCT01747486|531430503|FG001|Stage 2|Disease Progression|0|||
147345079|NCT01084707|531430507|FG000|Overall Study|Withdrawal by Subject|6|||
147345080|NCT00087139|531430508|FG000|Overall Study|Adverse Event|18|||
147345081|NCT00087139|531430509|FG001|Overall Study|Adverse Event|17|||
147345082|NCT00087139|531430510|FG002|Overall Study|Adverse Event|13|||
147345083|NCT00087139|531430508|FG000|Overall Study|Death|2|||
147345084|NCT00087139|531430509|FG001|Overall Study|Death|1|||
147345085|NCT00087139|531430510|FG002|Overall Study|Death|0|||
147345086|NCT00087139|531430508|FG000|Overall Study|Withdrawal by Subject|3|||
147345087|NCT00087139|531430509|FG001|Overall Study|Withdrawal by Subject|2|||
147345088|NCT00087139|531430510|FG002|Overall Study|Withdrawal by Subject|2|||
147345089|NCT00087139|531430508|FG000|Overall Study|Physician Decision|1|||
147345090|NCT00087139|531430509|FG001|Overall Study|Physician Decision|1|||
147345091|NCT00087139|531430510|FG002|Overall Study|Physician Decision|1|||
147345092|NCT00087139|531430508|FG000|Overall Study|Disease progression|9|||
147345093|NCT00087139|531430509|FG001|Overall Study|Disease progression|19|||
147606703|NCT00673387|532375295|FG003|Overall Study|Protocol Violation|2|||
147606704|NCT00673387|532375296|FG004|Overall Study|Protocol Violation|0|||
147606705|NCT00673387|532375297|FG005|Overall Study|Protocol Violation|1|||
147606706|NCT00673387|532375298|FG006|Overall Study|Protocol Violation|1|||
147606707|NCT00673387|532375299|FG007|Overall Study|Protocol Violation|3|||
147606708|NCT00673387|532375292|FG000|Overall Study|Lost to Follow-up|8|||
147606709|NCT00673387|532375293|FG001|Overall Study|Lost to Follow-up|6|||
147606710|NCT00673387|532375294|FG002|Overall Study|Lost to Follow-up|5|||
147606711|NCT00673387|532375295|FG003|Overall Study|Lost to Follow-up|6|||
147606712|NCT00673387|532375296|FG004|Overall Study|Lost to Follow-up|6|||
147345094|NCT00087139|531430510|FG002|Overall Study|Disease progression|12|||
147345095|NCT00087139|531430508|FG000|Overall Study|Ineligible|4|||
147345096|NCT00087139|531430509|FG001|Overall Study|Ineligible|7|||
147345097|NCT00087139|531430510|FG002|Overall Study|Ineligible|4|||
147345098|NCT00087139|531430508|FG000|Overall Study|Symptomatic deterioration|1|||
147345099|NCT00087139|531430509|FG001|Overall Study|Symptomatic deterioration|1|||
147345100|NCT00087139|531430510|FG002|Overall Study|Symptomatic deterioration|3|||
147345101|NCT00087139|531430508|FG000|Overall Study|Use of coumadin|1|||
147345102|NCT00087139|531430509|FG001|Overall Study|Use of coumadin|0|||
147345103|NCT00087139|531430510|FG002|Overall Study|Use of coumadin|0|||
147345104|NCT00087139|531430508|FG000|Overall Study|Response achieved|0|||
147345105|NCT00087139|531430509|FG001|Overall Study|Response achieved|1|||
147345106|NCT00087139|531430510|FG002|Overall Study|Response achieved|0|||
147345107|NCT00087139|531430508|FG000|Overall Study|Extradural disease|0|||
147345108|NCT00087139|531430509|FG001|Overall Study|Extradural disease|0|||
147345109|NCT00087139|531430510|FG002|Overall Study|Extradural disease|1|||
147345110|NCT00976495|531430511|FG000|Overall Study|Withdrawal by Subject|0|||
147345111|NCT00976495|531430512|FG001|Overall Study|Withdrawal by Subject|1|||
147345112|NCT00976495|531430513|FG002|Overall Study|Withdrawal by Subject|0|||
147345113|NCT02272816|531430514|FG000|Overall Study|Adverse Event|1|||
147345114|NCT05171777|531430515|FG000|Treatment Crossover Period|Adverse Event|9|||
147345115|NCT05171777|531430516|FG001|Treatment Crossover Period|Adverse Event|6|||
147345116|NCT05171777|531430517|FG002|Treatment Crossover Period|Adverse Event|0|||
147345117|NCT05171777|531430518|FG003|Treatment Crossover Period|Adverse Event|0|||
147345118|NCT05171777|531430515|FG000|Treatment Crossover Period|Death|5|||
147345119|NCT05171777|531430516|FG001|Treatment Crossover Period|Death|5|||
147345120|NCT05171777|531430517|FG002|Treatment Crossover Period|Death|0|||
147345121|NCT05171777|531430518|FG003|Treatment Crossover Period|Death|0|||
147345122|NCT05171777|531430515|FG000|Treatment Crossover Period|Disease Relapse|0|||
147345123|NCT05171777|531430516|FG001|Treatment Crossover Period|Disease Relapse|1|||
147345124|NCT05171777|531430517|FG002|Treatment Crossover Period|Disease Relapse|0|||
147345125|NCT05171777|531430518|FG003|Treatment Crossover Period|Disease Relapse|0|||
147345126|NCT05171777|531430515|FG000|Treatment Crossover Period|Reason not Specified|2|||
147345127|NCT05171777|531430516|FG001|Treatment Crossover Period|Reason not Specified|1|||
147345128|NCT05171777|531430517|FG002|Treatment Crossover Period|Reason not Specified|0|||
147345129|NCT05171777|531430518|FG003|Treatment Crossover Period|Reason not Specified|0|||
147345130|NCT05171777|531430515|FG000|Treatment Crossover Period|Physician Decision|0|||
147345131|NCT05171777|531430516|FG001|Treatment Crossover Period|Physician Decision|1|||
147345132|NCT05171777|531430517|FG002|Treatment Crossover Period|Physician Decision|0|||
147345133|NCT05171777|531430518|FG003|Treatment Crossover Period|Physician Decision|0|||
147345134|NCT05171777|531430515|FG000|Treatment Crossover Period|Progressive Disease|13|||
147345135|NCT05171777|531430516|FG001|Treatment Crossover Period|Progressive Disease|9|||
147345136|NCT05171777|531430517|FG002|Treatment Crossover Period|Progressive Disease|0|||
147345137|NCT05171777|531430518|FG003|Treatment Crossover Period|Progressive Disease|0|||
147345138|NCT05171777|531430515|FG000|Treatment Crossover Period|Protocol Violation|0|||
147345139|NCT05171777|531430516|FG001|Treatment Crossover Period|Protocol Violation|2|||
147345140|NCT05171777|531430517|FG002|Treatment Crossover Period|Protocol Violation|0|||
147345141|NCT05171777|531430518|FG003|Treatment Crossover Period|Protocol Violation|0|||
147345142|NCT05171777|531430515|FG000|Treatment Crossover Period|Symptomatic Deterioration|0|||
147345143|NCT05171777|531430516|FG001|Treatment Crossover Period|Symptomatic Deterioration|1|||
147345144|NCT05171777|531430517|FG002|Treatment Crossover Period|Symptomatic Deterioration|0|||
147345145|NCT05171777|531430518|FG003|Treatment Crossover Period|Symptomatic Deterioration|0|||
147345146|NCT05171777|531430515|FG000|Treatment Crossover Period|Withdrawal by Subject|4|||
147345147|NCT05171777|531430516|FG001|Treatment Crossover Period|Withdrawal by Subject|4|||
147345148|NCT05171777|531430517|FG002|Treatment Crossover Period|Withdrawal by Subject|0|||
147345149|NCT05171777|531430518|FG003|Treatment Crossover Period|Withdrawal by Subject|0|||
147345150|NCT05171777|531430515|FG000|Treatment Crossover Period|Ongoing in the Crossover Period|3|||
147345151|NCT05171777|531430516|FG001|Treatment Crossover Period|Ongoing in the Crossover Period|6|||
147345152|NCT05171777|531430517|FG002|Treatment Crossover Period|Ongoing in the Crossover Period|0|||
147345153|NCT05171777|531430518|FG003|Treatment Crossover Period|Ongoing in the Crossover Period|0|||
147345154|NCT05171777|531430515|FG000|Treatment Continuation Period|Death|0|||
147345155|NCT05171777|531430516|FG001|Treatment Continuation Period|Death|0|||
147345156|NCT05171777|531430517|FG002|Treatment Continuation Period|Death|1|||
147345157|NCT05171777|531430518|FG003|Treatment Continuation Period|Death|6|||
147345158|NCT05171777|531430515|FG000|Treatment Continuation Period|Ongoing in Continuation Period|0|||
147345159|NCT05171777|531430516|FG001|Treatment Continuation Period|Ongoing in Continuation Period|0|||
147345160|NCT05171777|531430517|FG002|Treatment Continuation Period|Ongoing in Continuation Period|21|||
147345161|NCT05171777|531430518|FG003|Treatment Continuation Period|Ongoing in Continuation Period|79|||
147345162|NCT04154384|531430519|FG000|Overall Study|Lost to Follow-up|24|||
147345163|NCT04154384|531430520|FG001|Overall Study|Lost to Follow-up|33|||
147345164|NCT04154384|531430521|FG002|Overall Study|Lost to Follow-up|0|||
147345165|NCT04154384|531430519|FG000|Overall Study|Withdrawal by Subject|7|||
147345166|NCT04154384|531430520|FG001|Overall Study|Withdrawal by Subject|18|||
147345167|NCT04154384|531430521|FG002|Overall Study|Withdrawal by Subject|0|||
147345168|NCT04154384|531430519|FG000|Overall Study|Missing outcome data|1|||
147345169|NCT04154384|531430520|FG001|Overall Study|Missing outcome data|0|||
147345170|NCT04154384|531430521|FG002|Overall Study|Missing outcome data|0|||
147345171|NCT01136876|531430522|FG000|Overall Study|Lost to Follow-up|0|||
147345172|NCT01136876|531430523|FG001|Overall Study|Lost to Follow-up|1|||
147345173|NCT01136876|531430522|FG000|Overall Study|Physician Decision|3|||
147345174|NCT01136876|531430523|FG001|Overall Study|Physician Decision|5|||
147345175|NCT01136876|531430522|FG000|Overall Study|Missing NGAL measurement|2|||
147345176|NCT01136876|531430523|FG001|Overall Study|Missing NGAL measurement|5|||
147345177|NCT05321069|531430524|FG000|Overall Study|Adverse Event|52|||
147345178|NCT05321069|531430525|FG001|Overall Study|Adverse Event|52|||
147345179|NCT05321069|531430526|FG002|Overall Study|Adverse Event|64|||
147345180|NCT05321069|531430524|FG000|Overall Study|Protocol Violation|1|||
147345181|NCT05321069|531430525|FG001|Overall Study|Protocol Violation|1|||
147345182|NCT05321069|531430526|FG002|Overall Study|Protocol Violation|0|||
147345183|NCT05321069|531430524|FG000|Overall Study|Withdrawal by Subject|23|||
147345184|NCT05321069|531430525|FG001|Overall Study|Withdrawal by Subject|18|||
147345185|NCT05321069|531430526|FG002|Overall Study|Withdrawal by Subject|12|||
147345186|NCT05321069|531430524|FG000|Overall Study|Lost to Follow-up|1|||
147345187|NCT05321069|531430525|FG001|Overall Study|Lost to Follow-up|0|||
147345188|NCT05321069|531430526|FG002|Overall Study|Lost to Follow-up|1|||
147345189|NCT05321069|531430524|FG000|Overall Study|No reason stated by the participants|23|||
147345190|NCT05321069|531430525|FG001|Overall Study|No reason stated by the participants|22|||
147345191|NCT05321069|531430526|FG002|Overall Study|No reason stated by the participants|16|||
147345192|NCT05321069|531430524|FG000|Overall Study|Lack of Efficacy|1|||
147345193|NCT05321069|531430525|FG001|Overall Study|Lack of Efficacy|1|||
147345194|NCT05321069|531430526|FG002|Overall Study|Lack of Efficacy|0|||
147345195|NCT02412748|531430529|FG000|Overall Study|Lost to Follow-up|38|||
147345196|NCT02412748|531430530|FG001|Overall Study|Lost to Follow-up|39|||
147345197|NCT04128319|531430531|FG000|Overall Study|Death|3|||
147345198|NCT01227265|531430536|FG000|Overall Study|Did Not Receive Treatment|1|||
147345199|NCT01227265|531430537|FG001|Overall Study|Did Not Receive Treatment|2|||
147345200|NCT01227265|531430538|FG002|Overall Study|Did Not Receive Treatment|0|||
147345201|NCT01227265|531430536|FG000|Overall Study|Administrative|1|||
147345202|NCT01227265|531430537|FG001|Overall Study|Administrative|0|||
147345203|NCT01227265|531430538|FG002|Overall Study|Administrative|2|||
147345204|NCT01227265|531430536|FG000|Overall Study|Did Not Meet Protocol Eligibility|0|||
147345205|NCT01227265|531430537|FG001|Overall Study|Did Not Meet Protocol Eligibility|0|||
147345206|NCT01227265|531430538|FG002|Overall Study|Did Not Meet Protocol Eligibility|1|||
147345207|NCT01227265|531430536|FG000|Overall Study|Protocol Violation|2|||
147345208|NCT01227265|531430537|FG001|Overall Study|Protocol Violation|1|||
147345209|NCT01227265|531430538|FG002|Overall Study|Protocol Violation|0|||
147345210|NCT01227265|531430536|FG000|Overall Study|Withdrawal by Subject|7|||
147345211|NCT01227265|531430537|FG001|Overall Study|Withdrawal by Subject|7|||
147345212|NCT01227265|531430538|FG002|Overall Study|Withdrawal by Subject|3|||
147345213|NCT01227265|531430536|FG000|Overall Study|Lost to Follow-up|2|||
147345214|NCT01227265|531430537|FG001|Overall Study|Lost to Follow-up|0|||
147345215|NCT01227265|531430538|FG002|Overall Study|Lost to Follow-up|3|||
147345216|NCT01227265|531430536|FG000|Overall Study|Adverse Event|6|||
147345217|NCT01227265|531430537|FG001|Overall Study|Adverse Event|10|||
147345218|NCT01227265|531430538|FG002|Overall Study|Adverse Event|5|||
147345219|NCT03481816|531430540|FG000|Starting Dose|Refused further vaccines after 1 dose|1|||
147345220|NCT03481816|531430541|FG001|Starting Dose|Refused further vaccines after 1 dose|0|||
147345221|NCT03481816|531430540|FG000|Dose Expansion|Off treatment due to progressive disease|0|||
147345222|NCT03481816|531430541|FG001|Dose Expansion|Off treatment due to progressive disease|5|||
147345223|NCT03481816|531430540|FG000|Dose Expansion|Withdrawal by Subject|0|||
147345224|NCT03481816|531430541|FG001|Dose Expansion|Withdrawal by Subject|2|||
147345225|NCT03481816|531430540|FG000|Dose Expansion|Physician Decision|0|||
147345226|NCT03481816|531430541|FG001|Dose Expansion|Physician Decision|5|||
147345227|NCT02269475|531430542|FG000|Overall Study|Meet Exclusion Criteria No. 17|3|||
147345228|NCT02269475|531430543|FG001|Overall Study|Meet Exclusion Criteria No. 17|0|||
147345229|NCT02269475|531430542|FG000|Overall Study|Withdrawal by Subject|0|||
147345230|NCT02269475|531430543|FG001|Overall Study|Withdrawal by Subject|1|||
147345231|NCT03582722|531430546|FG000|Overall Study|Lost to Follow-up|1|||
147345232|NCT03582722|531430547|FG001|Overall Study|Lost to Follow-up|4|||
147345233|NCT03582722|531430546|FG000|Overall Study|Withdrawal by Subject|3|||
147345234|NCT03582722|531430547|FG001|Overall Study|Withdrawal by Subject|3|||
147345235|NCT04994509|531430548|FG000|Overall Study|Still on Study (Participants Continuing in Randomized Blinded Phase)|1909|||
147345236|NCT04994509|531430549|FG001|Overall Study|Still on Study (Participants Continuing in Randomized Blinded Phase)|1910|||
147345237|NCT04994509|531430550|FG002|Overall Study|Still on Study (Participants Continuing in Randomized Blinded Phase)|937|||
147345238|NCT04994509|531430548|FG000|Overall Study|Withdrew Consent|73|||
147345239|NCT04994509|531430549|FG001|Overall Study|Withdrew Consent|72|||
147345240|NCT04994509|531430550|FG002|Overall Study|Withdrew Consent|46|||
147345241|NCT04994509|531430548|FG000|Overall Study|Lost to Follow-up|39|||
147345242|NCT04994509|531430549|FG001|Overall Study|Lost to Follow-up|36|||
147345243|NCT04994509|531430550|FG002|Overall Study|Lost to Follow-up|26|||
147345244|NCT04994509|531430548|FG000|Overall Study|HIV-1 Infection|4|||
147345245|NCT04994509|531430549|FG001|Overall Study|HIV-1 Infection|20|||
147345246|NCT04994509|531430550|FG002|Overall Study|HIV-1 Infection|12|||
147345247|NCT04994509|531430548|FG000|Overall Study|Investigator's Discretion|9|||
147345248|NCT04994509|531430549|FG001|Overall Study|Investigator's Discretion|8|||
147345249|NCT04994509|531430550|FG002|Overall Study|Investigator's Discretion|11|||
147345250|NCT04994509|531430548|FG000|Overall Study|Randomized but Never Treated|10|||
147345251|NCT04994509|531430549|FG001|Overall Study|Randomized but Never Treated|10|||
147345252|NCT04994509|531430550|FG002|Overall Study|Randomized but Never Treated|3|||
147345253|NCT04994509|531430548|FG000|Overall Study|Pregnancy|5|||
147345254|NCT04994509|531430549|FG001|Overall Study|Pregnancy|5|||
147345255|NCT04994509|531430550|FG002|Overall Study|Pregnancy|0|||
147345256|NCT04994509|531430548|FG000|Overall Study|Death|0|||
147345257|NCT04994509|531430549|FG001|Overall Study|Death|5|||
147345258|NCT04994509|531430550|FG002|Overall Study|Death|0|||
147345259|NCT04994509|531430548|FG000|Overall Study|Adverse Event|2|||
147345260|NCT04994509|531430549|FG001|Overall Study|Adverse Event|1|||
147345261|NCT04994509|531430550|FG002|Overall Study|Adverse Event|0|||
147345262|NCT04994509|531430548|FG000|Overall Study|Non-compliance With Study Drug|1|||
147345263|NCT04994509|531430549|FG001|Overall Study|Non-compliance With Study Drug|1|||
147345264|NCT04994509|531430550|FG002|Overall Study|Non-compliance With Study Drug|1|||
147345265|NCT04994509|531430548|FG000|Overall Study|Withdrew Assent|3|||
147345266|NCT04994509|531430549|FG001|Overall Study|Withdrew Assent|0|||
147345267|NCT04994509|531430550|FG002|Overall Study|Withdrew Assent|0|||
147345268|NCT04994509|531430548|FG000|Overall Study|Protocol Violation|1|||
147345269|NCT04994509|531430549|FG001|Overall Study|Protocol Violation|0|||
147345270|NCT04994509|531430550|FG002|Overall Study|Protocol Violation|0|||
147345271|NCT04402294|531430552|FG000|Washout (at Least 7 Days)|Withdrawal by Subject|1|||
147345272|NCT04402294|531430553|FG001|Washout (at Least 7 Days)|Withdrawal by Subject|0|||
147345273|NCT04402294|531430552|FG000|Washout (at Least 7 Days)|Insufficient study funds to continue with their participation.|0|||
147345274|NCT04402294|531430553|FG001|Washout (at Least 7 Days)|Insufficient study funds to continue with their participation.|1|||
147345275|NCT04459416|531432818|FG000|Overall Study|Lost to Follow-up|2|||
147345276|NCT04459416|531432819|FG001|Overall Study|Lost to Follow-up|0|||
147345277|NCT04459416|531432818|FG000|Overall Study|Withdrawal by Subject|8|||
147345278|NCT04459416|531432819|FG001|Overall Study|Withdrawal by Subject|10|||
147345279|NCT04459416|531432818|FG000|Overall Study|Disease progression|0|||
147345280|NCT04459416|531432819|FG001|Overall Study|Disease progression|3|||
147345281|NCT02525692|531432820|FG000|Overall Study|Withdrawal by Subject|1|||
147345282|NCT02525692|531432821|FG001|Overall Study|Withdrawal by Subject|1|||
147345283|NCT02525692|531432822|FG002|Overall Study|Withdrawal by Subject|0|||
147345284|NCT02525692|531432823|FG003|Overall Study|Withdrawal by Subject|5|||
147345285|NCT02525692|531432824|FG004|Overall Study|Withdrawal by Subject|0|||
147345286|NCT02525692|531432825|FG005|Overall Study|Withdrawal by Subject|1|||
147345287|NCT02525692|531432820|FG000|Overall Study|Death|16|||
147345288|NCT02525692|531432821|FG001|Overall Study|Death|18|||
147345289|NCT02525692|531432822|FG002|Overall Study|Death|7|||
147345290|NCT02525692|531432823|FG003|Overall Study|Death|20|||
147345291|NCT02525692|531432824|FG004|Overall Study|Death|3|||
147345292|NCT02525692|531432825|FG005|Overall Study|Death|6|||
147345293|NCT02525692|531432820|FG000|Overall Study|Lost to Follow-up|0|||
147345294|NCT02525692|531432821|FG001|Overall Study|Lost to Follow-up|0|||
147345295|NCT02525692|531432822|FG002|Overall Study|Lost to Follow-up|1|||
147345296|NCT02525692|531432823|FG003|Overall Study|Lost to Follow-up|5|||
147345297|NCT02525692|531432824|FG004|Overall Study|Lost to Follow-up|0|||
147345298|NCT02525692|531432825|FG005|Overall Study|Lost to Follow-up|0|||
147345299|NCT05510232|531432826|FG000|Overall Study|Withdrawal by Subject|2|||
147345300|NCT05510232|531432827|FG001|Overall Study|Withdrawal by Subject|7|||
147345301|NCT05510232|531432828|FG002|Overall Study|Withdrawal by Subject|6|||
147345302|NCT00979576|531432838|FG000|Combination Treatment Phase|Progressive disease|3|||
147345303|NCT00979576|531432839|FG001|Combination Treatment Phase|Progressive disease|1|||
147345304|NCT00979576|531432840|FG002|Combination Treatment Phase|Progressive disease|5|||
147345305|NCT00979576|531432838|FG000|Combination Treatment Phase|Dose limiting toxicity|0|||
147345306|NCT00979576|531432839|FG001|Combination Treatment Phase|Dose limiting toxicity|3|||
147345307|NCT00979576|531432840|FG002|Combination Treatment Phase|Dose limiting toxicity|2|||
147345308|NCT00979576|531432838|FG000|Combination Treatment Phase|Adverse Event|0|||
147345309|NCT00979576|531432839|FG001|Combination Treatment Phase|Adverse Event|2|||
147345310|NCT00979576|531432840|FG002|Combination Treatment Phase|Adverse Event|2|||
147345311|NCT00979576|531432838|FG000|Combination Followed by Monotherapy|Progressive Disease|0|||
147345312|NCT00979576|531432839|FG001|Combination Followed by Monotherapy|Progressive Disease|2|||
147345313|NCT00979576|531432840|FG002|Combination Followed by Monotherapy|Progressive Disease|1|||
147345314|NCT03424811|531432847|FG000|Overall Study|Lost to Follow-up|9|||
147345315|NCT03424811|531432848|FG001|Overall Study|Lost to Follow-up|0|||
147345316|NCT00567398|531432850|FG000|Overall Study|Adverse Event|6|||
147345317|NCT00567398|531432851|FG001|Overall Study|Adverse Event|14|||
147345318|NCT00567398|531432850|FG000|Overall Study|Physician Decision|0|||
147345319|NCT00567398|531432851|FG001|Overall Study|Physician Decision|4|||
147345320|NCT00567398|531432850|FG000|Overall Study|Withdrawal by Subject|0|||
147345321|NCT00567398|531432851|FG001|Overall Study|Withdrawal by Subject|2|||
147345322|NCT00567398|531432850|FG000|Overall Study|Renal Transplantation|0|||
147345323|NCT00567398|531432851|FG001|Overall Study|Renal Transplantation|3|||
147345324|NCT00567398|531432850|FG000|Overall Study|Other|1|||
147345325|NCT00567398|531432851|FG001|Overall Study|Other|0|||
147345326|NCT04247542|531432856|FG000|2B: Double-Blind Active-Controlled|Did not receive study drug|0|||
147345327|NCT04247542|531432857|FG001|2B: Double-Blind Active-Controlled|Did not receive study drug|1|||
147345328|NCT04247542|531432858|FG002|2B: Double-Blind Active-Controlled|Did not receive study drug|0|||
147345329|NCT04247542|531432856|FG000|2B: Double-Blind Active-Controlled|Treatment completed but incorrectly recorded as discountinued.|0|||
147345330|NCT04247542|531432857|FG001|2B: Double-Blind Active-Controlled|Treatment completed but incorrectly recorded as discountinued.|1|||
147345331|NCT04247542|531432858|FG002|2B: Double-Blind Active-Controlled|Treatment completed but incorrectly recorded as discountinued.|1|||
147345332|NCT04905407|531432860|FG000|Part 1 and Part 2|Withdrawal by Subject|2|||
147345333|NCT04905407|531432861|FG001|Part 1 and Part 2|Withdrawal by Subject|1|||
147453144|NCT03167073|531821557|FG001|Overall Study|Stillbirth|0|||
147345334|NCT04905407|531432862|FG002|Part 1 and Part 2|Withdrawal by Subject|1|||
147345335|NCT04905407|531432863|FG003|Part 1 and Part 2|Withdrawal by Subject|0|||
147345336|NCT04905407|531432860|FG000|Part 1 and Part 2|Death|7|||
147345337|NCT04905407|531432861|FG001|Part 1 and Part 2|Death|7|||
147345338|NCT04905407|531432862|FG002|Part 1 and Part 2|Death|7|||
147345339|NCT04905407|531432863|FG003|Part 1 and Part 2|Death|0|||
147345340|NCT04905407|531432860|FG000|Part 1 and Part 2|Other than specified|0|||
147345341|NCT04905407|531432861|FG001|Part 1 and Part 2|Other than specified|0|||
147345342|NCT04905407|531432862|FG002|Part 1 and Part 2|Other than specified|1|||
147345343|NCT04905407|531432863|FG003|Part 1 and Part 2|Other than specified|0|||
147345344|NCT04905407|531432860|FG000|Part 3|Death|0|||
147345345|NCT04905407|531432861|FG001|Part 3|Death|0|||
147345346|NCT04905407|531432862|FG002|Part 3|Death|0|||
147345347|NCT04905407|531432863|FG003|Part 3|Death|2|||
147345348|NCT05444192|531432871|FG000|Overall Study|Lost to Follow-up|1|||
147345349|NCT05444192|531432872|FG001|Overall Study|Lost to Follow-up|0|||
147345350|NCT01532388|531432874|FG000|3-month Follow-up|Lost to Follow-up|68|||
147345351|NCT01532388|531432875|FG001|3-month Follow-up|Lost to Follow-up|68|||
147345352|NCT01532388|531432874|FG000|6-month Follow-up|Lost to Follow-up|74|||
147345353|NCT01532388|531432875|FG001|6-month Follow-up|Lost to Follow-up|66|||
147345354|NCT01532388|531432874|FG000|12-month Follow-up|Lost to Follow-up|69|||
147345355|NCT01532388|531432875|FG001|12-month Follow-up|Lost to Follow-up|67|||
147345356|NCT00792636|531432876|FG000|Overall Study|Protocol Violation|17|||
147345357|NCT00792636|531432877|FG001|Overall Study|Protocol Violation|23|||
147345358|NCT00792636|531432878|FG002|Overall Study|Protocol Violation|20|||
147345359|NCT00792636|531432876|FG000|Overall Study|Met Protocol-defined Stopping Criteria|19|||
147345360|NCT00792636|531432877|FG001|Overall Study|Met Protocol-defined Stopping Criteria|20|||
147345361|NCT00792636|531432878|FG002|Overall Study|Met Protocol-defined Stopping Criteria|20|||
147345362|NCT00792636|531432876|FG000|Overall Study|Lost to Follow-up|13|||
147345363|NCT00792636|531432877|FG001|Overall Study|Lost to Follow-up|19|||
147345364|NCT00792636|531432878|FG002|Overall Study|Lost to Follow-up|14|||
147345365|NCT00792636|531432876|FG000|Overall Study|Withdrew Consent|10|||
147345366|NCT00792636|531432877|FG001|Overall Study|Withdrew Consent|13|||
147345367|NCT00792636|531432878|FG002|Overall Study|Withdrew Consent|9|||
147345368|NCT00792636|531432876|FG000|Overall Study|Lack of Efficacy|3|||
147345369|NCT00792636|531432877|FG001|Overall Study|Lack of Efficacy|4|||
147345370|NCT00792636|531432878|FG002|Overall Study|Lack of Efficacy|13|||
147345371|NCT00792636|531432876|FG000|Overall Study|Adverse Event|4|||
147345372|NCT00792636|531432877|FG001|Overall Study|Adverse Event|2|||
147345373|NCT00792636|531432878|FG002|Overall Study|Adverse Event|3|||
147345374|NCT00792636|531432876|FG000|Overall Study|Investigator Discretion|2|||
147345375|NCT00792636|531432877|FG001|Overall Study|Investigator Discretion|0|||
147345376|NCT00792636|531432878|FG002|Overall Study|Investigator Discretion|2|||
147345377|NCT01046136|531432879|FG000|Overall Study|Withdrawal by Subject|0|||
147345378|NCT01046136|531432880|FG001|Overall Study|Withdrawal by Subject|4|||
147345379|NCT01046136|531432879|FG000|Overall Study|Physician Decision|1|||
147345380|NCT01046136|531432880|FG001|Overall Study|Physician Decision|1|||
147345381|NCT01046136|531432879|FG000|Overall Study|Lost to Follow-up|3|||
147345382|NCT01046136|531432880|FG001|Overall Study|Lost to Follow-up|3|||
147345383|NCT04579250|531432881|FG000|Overall Study|Withdrawal by Subject|1|||
147345384|NCT04579250|531432882|FG001|Overall Study|Withdrawal by Subject|1|||
147345385|NCT04579250|531432883|FG002|Overall Study|Withdrawal by Subject|0|||
147345386|NCT04579250|531432881|FG000|Overall Study|Lost to Follow-up|1|||
147345387|NCT04579250|531432882|FG001|Overall Study|Lost to Follow-up|1|||
147345388|NCT04579250|531432883|FG002|Overall Study|Lost to Follow-up|0|||
147345389|NCT04579250|531432881|FG000|Overall Study|Moved from area|0|||
147345390|NCT04579250|531432882|FG001|Overall Study|Moved from area|1|||
147345391|NCT04579250|531432883|FG002|Overall Study|Moved from area|2|||
147345392|NCT01376700|531432887|FG000|Overall Study|Sponsor terminated study early|8|||
147453145|NCT01276236|531821558|FG000|Overall Study|Lack of Efficacy|2|||
147453146|NCT01276236|531821558|FG000|Overall Study|Withdrawal by Subject|4|||
147606713|NCT00673387|532375297|FG005|Overall Study|Lost to Follow-up|5|||
147606714|NCT00673387|532375298|FG006|Overall Study|Lost to Follow-up|8|||
147345393|NCT01376700|531432887|FG000|Overall Study|Low or high titer inhibitor|8|||
147345394|NCT00727909|531432888|FG000|Overall Study|Withdrawal by Subject|5|||
147345395|NCT00727909|531432889|FG001|Overall Study|Withdrawal by Subject|11|||
147345396|NCT00727909|531432890|FG002|Overall Study|Withdrawal by Subject|8|||
147345397|NCT00727909|531432891|FG003|Overall Study|Withdrawal by Subject|5|||
147345398|NCT00727909|531432888|FG000|Overall Study|Death|0|||
147345399|NCT00727909|531432889|FG001|Overall Study|Death|0|||
147345400|NCT00727909|531432890|FG002|Overall Study|Death|1|||
147345401|NCT00727909|531432891|FG003|Overall Study|Death|0|||
147345402|NCT01696773|531432892|FG000|Days 15-27, Washout|Adverse Event|1|||
147345403|NCT01696773|531432893|FG001|Days 15-27, Washout|Adverse Event|0|||
147345404|NCT05623345|531432902|FG000|Overall Study|Withdrawal by Subject|14|||
147345405|NCT05623345|531432903|FG001|Overall Study|Withdrawal by Subject|0|||
147345406|NCT05623345|531432904|FG002|Overall Study|Withdrawal by Subject|9|||
147345407|NCT05623345|531432905|FG003|Overall Study|Withdrawal by Subject|20|||
147606715|NCT00673387|532375299|FG007|Overall Study|Lost to Follow-up|5|||
147345408|NCT05623345|531432902|FG000|Overall Study|Lost to Follow-up|3|||
147345409|NCT05623345|531432903|FG001|Overall Study|Lost to Follow-up|0|||
147345410|NCT05623345|531432904|FG002|Overall Study|Lost to Follow-up|7|||
147345411|NCT05623345|531432905|FG003|Overall Study|Lost to Follow-up|2|||
147345412|NCT05623345|531432902|FG000|Overall Study|Termination of Study By Sponsor|37|||
147345413|NCT05623345|531432903|FG001|Overall Study|Termination of Study By Sponsor|4|||
147345414|NCT05623345|531432904|FG002|Overall Study|Termination of Study By Sponsor|40|||
147345415|NCT05623345|531432905|FG003|Overall Study|Termination of Study By Sponsor|38|||
147345416|NCT05384730|531432906|FG000|Overall Study|Adverse Event|1|||
147345417|NCT05384730|531432907|FG001|Overall Study|Adverse Event|0|||
147345418|NCT05384730|531432906|FG000|Overall Study|Lack of social support|2|||
147345419|NCT05384730|531432907|FG001|Overall Study|Lack of social support|0|||
147345420|NCT05384730|531432906|FG000|Overall Study|Hospital readmission|2|||
147345421|NCT05384730|531432907|FG001|Overall Study|Hospital readmission|0|||
147345422|NCT05384730|531432906|FG000|Overall Study|Disease progression|5|||
147345423|NCT05384730|531432907|FG001|Overall Study|Disease progression|0|||
147345424|NCT05384730|531432906|FG000|Overall Study|Overwhelmed with College commitments|0|||
147345425|NCT05384730|531432907|FG001|Overall Study|Overwhelmed with College commitments|2|||
147345426|NCT00411151|531432908|FG000|Overall Study|Death|38|||
147345427|NCT00411151|531432908|FG000|Overall Study|Withdrawal by Subject|2|||
147345428|NCT00411151|531432908|FG000|Overall Study|Lost to Follow-up|2|||
147345429|NCT00411151|531432908|FG000|Overall Study|Protocol Violation|1|||
147345430|NCT00411151|531432908|FG000|Overall Study|Trial prematurely closed|4|||
147345431|NCT02638337|531432917|FG000|Overall Study|Adverse Event|6|||
147345432|NCT02638337|531432918|FG001|Overall Study|Adverse Event|10|||
147345433|NCT02638337|531432917|FG000|Overall Study|Protocol Violation|3|||
147345434|NCT02638337|531432918|FG001|Overall Study|Protocol Violation|0|||
147345435|NCT02638337|531432917|FG000|Overall Study|Withdrawal by Subject|13|||
147345436|NCT02638337|531432918|FG001|Overall Study|Withdrawal by Subject|16|||
147345437|NCT02638337|531432917|FG000|Overall Study|Lost to Follow-up|7|||
147345438|NCT02638337|531432918|FG001|Overall Study|Lost to Follow-up|7|||
147345439|NCT02638337|531432917|FG000|Overall Study|Other - Miscellaneous|4|||
147345440|NCT02638337|531432918|FG001|Overall Study|Other - Miscellaneous|3|||
147345441|NCT00274469|531432919|FG000|Overall Study|Death|63|||
147345442|NCT00274469|531432920|FG001|Overall Study|Death|74|||
147345443|NCT00274469|531432919|FG000|Overall Study|Did not consent to OS follow-up|16|||
147345444|NCT00274469|531432920|FG001|Overall Study|Did not consent to OS follow-up|19|||
147345445|NCT04238247|531432921|FG000|Phase 1: Baseline Intervention|Withdrawal by Subject|3|||
147345446|NCT04238247|531432922|FG001|Phase 1: Baseline Intervention|Withdrawal by Subject|19|||
147345447|NCT04238247|531432923|FG002|Phase 1: Baseline Intervention|Withdrawal by Subject|0|||
147345448|NCT04238247|531432924|FG003|Phase 1: Baseline Intervention|Withdrawal by Subject|0|||
147345449|NCT04238247|531432921|FG000|Phase 1: Baseline Intervention|Lost to Follow-up|11|||
147345450|NCT04238247|531432922|FG001|Phase 1: Baseline Intervention|Lost to Follow-up|49|||
147345451|NCT04238247|531432923|FG002|Phase 1: Baseline Intervention|Lost to Follow-up|0|||
147345452|NCT04238247|531432924|FG003|Phase 1: Baseline Intervention|Lost to Follow-up|0|||
147345453|NCT04238247|531432921|FG000|Phase 2: Rerandomized at 6 Months|Withdrawal by Subject|0|||
147345454|NCT04238247|531432922|FG001|Phase 2: Rerandomized at 6 Months|Withdrawal by Subject|1|||
147345455|NCT04238247|531432923|FG002|Phase 2: Rerandomized at 6 Months|Withdrawal by Subject|0|||
147345456|NCT04238247|531432924|FG003|Phase 2: Rerandomized at 6 Months|Withdrawal by Subject|2|||
147345457|NCT04238247|531432921|FG000|Phase 2: Rerandomized at 6 Months|Lost to Follow-up|7|||
147345458|NCT04238247|531432922|FG001|Phase 2: Rerandomized at 6 Months|Lost to Follow-up|11|||
147345459|NCT04238247|531432923|FG002|Phase 2: Rerandomized at 6 Months|Lost to Follow-up|8|||
147345460|NCT04238247|531432924|FG003|Phase 2: Rerandomized at 6 Months|Lost to Follow-up|4|||
147345461|NCT04950127|531432925|FG000|Part A (Day 1 to Week 24)|Adverse Event|4|||
147345462|NCT04950127|531432926|FG001|Part A (Day 1 to Week 24)|Adverse Event|2|||
147345463|NCT04950127|531432927|FG002|Part A (Day 1 to Week 24)|Adverse Event|0|||
147345464|NCT04950127|531432928|FG003|Part A (Day 1 to Week 24)|Adverse Event|0|||
147345465|NCT04950127|531432929|FG004|Part A (Day 1 to Week 24)|Adverse Event|0|||
147345466|NCT04950127|531432930|FG005|Part A (Day 1 to Week 24)|Adverse Event|0|||
147345467|NCT04950127|531432925|FG000|Part A (Day 1 to Week 24)|Physician Decision|3|||
147345468|NCT04950127|531432926|FG001|Part A (Day 1 to Week 24)|Physician Decision|2|||
147345469|NCT04950127|531432927|FG002|Part A (Day 1 to Week 24)|Physician Decision|0|||
147345470|NCT04950127|531432928|FG003|Part A (Day 1 to Week 24)|Physician Decision|0|||
147345471|NCT04950127|531432929|FG004|Part A (Day 1 to Week 24)|Physician Decision|0|||
147345472|NCT04950127|531432930|FG005|Part A (Day 1 to Week 24)|Physician Decision|0|||
147345473|NCT04950127|531432925|FG000|Part A (Day 1 to Week 24)|Withdrawal by Subject|9|||
147345474|NCT04950127|531432926|FG001|Part A (Day 1 to Week 24)|Withdrawal by Subject|7|||
147345475|NCT04950127|531432927|FG002|Part A (Day 1 to Week 24)|Withdrawal by Subject|0|||
147345476|NCT04950127|531432928|FG003|Part A (Day 1 to Week 24)|Withdrawal by Subject|0|||
147345477|NCT04950127|531432929|FG004|Part A (Day 1 to Week 24)|Withdrawal by Subject|0|||
147345478|NCT04950127|531432930|FG005|Part A (Day 1 to Week 24)|Withdrawal by Subject|0|||
147345479|NCT04950127|531432925|FG000|Part B (Week 24 to Week 32)|Withdrawal by Subject|0|||
147345480|NCT04950127|531432926|FG001|Part B (Week 24 to Week 32)|Withdrawal by Subject|0|||
147345481|NCT04950127|531432927|FG002|Part B (Week 24 to Week 32)|Withdrawal by Subject|0|||
147345482|NCT04950127|531432928|FG003|Part B (Week 24 to Week 32)|Withdrawal by Subject|0|||
147345483|NCT04950127|531432929|FG004|Part B (Week 24 to Week 32)|Withdrawal by Subject|0|||
147345484|NCT04950127|531432930|FG005|Part B (Week 24 to Week 32)|Withdrawal by Subject|4|||
147345485|NCT04950127|531432925|FG000|Part B (Week 24 to Week 32)|Physician Decision|0|||
147345486|NCT04950127|531432926|FG001|Part B (Week 24 to Week 32)|Physician Decision|0|||
147345487|NCT04950127|531432927|FG002|Part B (Week 24 to Week 32)|Physician Decision|0|||
147345488|NCT04950127|531432928|FG003|Part B (Week 24 to Week 32)|Physician Decision|0|||
147345489|NCT04950127|531432929|FG004|Part B (Week 24 to Week 32)|Physician Decision|0|||
147345490|NCT04950127|531432930|FG005|Part B (Week 24 to Week 32)|Physician Decision|1|||
147345491|NCT01711632|531432931|FG000|Overall Study|Adverse Event|4|||
147345492|NCT01711632|531432931|FG000|Overall Study|Death|3|||
147345493|NCT01711632|531432931|FG000|Overall Study|Lost to Follow-up|3|||
147345494|NCT01711632|531432931|FG000|Overall Study|Withdrawal by Subject|4|||
147345495|NCT01711632|531432931|FG000|Overall Study|Progressive disease|2|||
147345496|NCT01711632|531432931|FG000|Overall Study|No follow up required in re-treatment|3|||
147345497|NCT01711632|531432931|FG000|Overall Study|No follow up required in re-treatment|3|||
147345498|NCT04315181|531432932|FG000|Overall Study|Non-responsive to drug conditions.|1|||
147345499|NCT03833167|531432933|FG000|Overall Study|Withdrawal by Subject|4|||
147345500|NCT03833167|531432934|FG001|Overall Study|Withdrawal by Subject|6|||
147345501|NCT03833167|531432933|FG000|Overall Study|Ongoing|186|||
147345502|NCT03833167|531432934|FG001|Overall Study|Ongoing|194|||
147345503|NCT03833167|531432933|FG000|Overall Study|Lost to Follow-up|1|||
147345504|NCT03833167|531432934|FG001|Overall Study|Lost to Follow-up|1|||
147345505|NCT03833167|531432933|FG000|Overall Study|Physician Decision|0|||
147345506|NCT03833167|531432934|FG001|Overall Study|Physician Decision|2|||
147345507|NCT03833167|531432933|FG000|Overall Study|Death|34|||
147345508|NCT03833167|531432934|FG001|Overall Study|Death|22|||
147345509|NCT02860130|531432935|FG000|Overall Study|Adverse Event|2|||
147345510|NCT02860130|531432936|FG001|Overall Study|Adverse Event|3|||
147345511|NCT02860130|531432935|FG000|Overall Study|Protocol Violation|1|||
147345512|NCT02860130|531432936|FG001|Overall Study|Protocol Violation|1|||
147345513|NCT02860130|531432935|FG000|Overall Study|Withdrawal by Subject|0|||
147345514|NCT02860130|531432936|FG001|Overall Study|Withdrawal by Subject|2|||
147345515|NCT02860130|531432935|FG000|Overall Study|Physician Decision|2|||
147345516|NCT02860130|531432936|FG001|Overall Study|Physician Decision|2|||
147345517|NCT02860130|531432935|FG000|Overall Study|Other|2|||
147345518|NCT02860130|531432936|FG001|Overall Study|Other|1|||
147345519|NCT01467427|531432937|FG000|Overall Study|Withdrawal by Subject|1|||
147345520|NCT01467427|531432938|FG001|Overall Study|Withdrawal by Subject|0|||
147345521|NCT01467427|531432937|FG000|Overall Study|Not continuing in extension phase|0|||
147345522|NCT01467427|531432938|FG001|Overall Study|Not continuing in extension phase|2|||
147345523|NCT01467427|531432937|FG000|Overall Study|Withdrawal during extension phase,- Non-compliance|0|||
147345524|NCT01467427|531432938|FG001|Overall Study|Withdrawal during extension phase,- Non-compliance|1|||
147345525|NCT01467427|531432937|FG000|Overall Study|Withdrawal during extension phase, Withdrawal criteria|0|||
147345526|NCT01467427|531432938|FG001|Overall Study|Withdrawal during extension phase, Withdrawal criteria|2|||
147345527|NCT01467427|531432937|FG000|Overall Study|Withdrawal during extension phase, Withdrawal of consent|2|||
147606716|NCT00418821|532375300|FG000|Overall Study|Fulfils one of the exclusion criteria|1|||
147606717|NCT04400682|532375305|FG000|Period 1|Withdrawal by Subject|1|||
147606718|NCT04400682|532375306|FG001|Period 1|Withdrawal by Subject|4|||
147606719|NCT02105974|532375307|FG000|2 Week Run-in Period|Withdrew during pre-screen period|158|||
147606720|NCT02105974|532375308|FG001|2 Week Run-in Period|Withdrew during pre-screen period|0|||
147606721|NCT02105974|532375309|FG002|2 Week Run-in Period|Withdrew during pre-screen period|0|||
147606722|NCT02105974|532375307|FG000|2 Week Run-in Period|Did not meet inclusion/exclusion criteri|603|||
147606723|NCT02105974|532375308|FG001|2 Week Run-in Period|Did not meet inclusion/exclusion criteri|0|||
147606724|NCT02105974|532375309|FG002|2 Week Run-in Period|Did not meet inclusion/exclusion criteri|0|||
147606725|NCT02105974|532375307|FG000|2 Week Run-in Period|Adverse Event|6|||
147606726|NCT02105974|532375308|FG001|2 Week Run-in Period|Adverse Event|0|||
147606727|NCT02105974|532375309|FG002|2 Week Run-in Period|Adverse Event|0|||
147606728|NCT02105974|532375307|FG000|2 Week Run-in Period|Study closed/terminated|1|||
147606729|NCT02105974|532375308|FG001|2 Week Run-in Period|Study closed/terminated|0|||
147606730|NCT02105974|532375309|FG002|2 Week Run-in Period|Study closed/terminated|0|||
147345528|NCT01467427|531432938|FG001|Overall Study|Withdrawal during extension phase, Withdrawal of consent|1|||
147345529|NCT01467427|531432937|FG000|Overall Study|Withdrawal during extension phase, Other|3|||
147606731|NCT02105974|532375307|FG000|2 Week Run-in Period|Lost to Follow-up|2|||
147606732|NCT02105974|532375308|FG001|2 Week Run-in Period|Lost to Follow-up|0|||
147606733|NCT02105974|532375309|FG002|2 Week Run-in Period|Lost to Follow-up|0|||
147606734|NCT02105974|532375307|FG000|2 Week Run-in Period|Withdrew consent|23|||
147345530|NCT01467427|531432938|FG001|Overall Study|Withdrawal during extension phase, Other|3|||
147345531|NCT05494788|531432942|FG000|Initial Treatment Period|Adverse Event|2|||
147345532|NCT05494788|531432942|FG000|Initial Treatment Period|Withdrawal by Subject|1|||
147345533|NCT05494788|531432942|FG000|Extension Period|Adverse Event|1|||
147345534|NCT05494788|531432942|FG000|Extension Period|Withdrawal by Subject|1|||
147345535|NCT05480943|531432943|FG000|Evaluation for Thiamine Deficiency|Lost to Follow-up|31|||
147345536|NCT05480943|531432943|FG000|Evaluation for Thiamine Deficiency|Protocol Violation|12|||
147345537|NCT05480943|531432943|FG000|Evaluation for Thiamine Deficiency|Withdrawal by Subject|1|||
147345538|NCT05480943|531432943|FG000|Suspected Thiamine Deficiency|Lost to Follow-up|64|||
147345539|NCT00976937|531432945|FG000|Overall Study|Adverse Event|4|||
147345540|NCT00976937|531432946|FG001|Overall Study|Adverse Event|5|||
147345541|NCT00976937|531432945|FG000|Overall Study|Lost to Follow-up|2|||
147345542|NCT00976937|531432946|FG001|Overall Study|Lost to Follow-up|1|||
147345543|NCT00976937|531432945|FG000|Overall Study|Withdrawal by Subject|5|||
147345544|NCT00976937|531432946|FG001|Overall Study|Withdrawal by Subject|3|||
147345545|NCT00976937|531432945|FG000|Overall Study|Poor compliance to protocol|3|||
147345546|NCT00976937|531432946|FG001|Overall Study|Poor compliance to protocol|0|||
147345547|NCT00976937|531432945|FG000|Overall Study|Personal and Familial Reason|2|||
147345548|NCT00976937|531432946|FG001|Overall Study|Personal and Familial Reason|2|||
147345549|NCT03069313|531432947|FG000|Overall Study|Adverse Event|5|||
147345550|NCT04218266|531432948|FG000|Overall Study|Death|1|||
147345551|NCT04218266|531432949|FG001|Overall Study|Death|2|||
147345552|NCT04218266|531432950|FG002|Overall Study|Death|3|||
147345553|NCT04218266|531432948|FG000|Overall Study|Adverse Event|13|||
147345554|NCT04218266|531432949|FG001|Overall Study|Adverse Event|14|||
147345555|NCT04218266|531432950|FG002|Overall Study|Adverse Event|11|||
147345556|NCT04218266|531432948|FG000|Overall Study|Other|7|||
147345557|NCT04218266|531432949|FG001|Overall Study|Other|5|||
147345558|NCT04218266|531432950|FG002|Overall Study|Other|14|||
147345559|NCT04218266|531432948|FG000|Overall Study|Physician Decision|1|||
147345560|NCT04218266|531432949|FG001|Overall Study|Physician Decision|3|||
147345561|NCT04218266|531432950|FG002|Overall Study|Physician Decision|2|||
147345562|NCT04218266|531432948|FG000|Overall Study|Non-compliance with study drug|0|||
147345563|NCT04218266|531432949|FG001|Overall Study|Non-compliance with study drug|0|||
147345564|NCT04218266|531432950|FG002|Overall Study|Non-compliance with study drug|1|||
147345565|NCT04218266|531432948|FG000|Overall Study|Withdrawal by Subject|1|||
147345566|NCT04218266|531432949|FG001|Overall Study|Withdrawal by Subject|3|||
147345567|NCT04218266|531432950|FG002|Overall Study|Withdrawal by Subject|1|||
147345568|NCT04218266|531432948|FG000|Overall Study|Study drug never administered|2|||
147345569|NCT04218266|531432949|FG001|Overall Study|Study drug never administered|0|||
147345570|NCT04218266|531432950|FG002|Overall Study|Study drug never administered|0|||
147345571|NCT03432858|531432953|FG000|Overall Study|Protocol Violation|2|||
147345572|NCT03432858|531432954|FG001|Overall Study|Protocol Violation|1|||
147345573|NCT03432858|531432955|FG002|Overall Study|Protocol Violation|9|||
147345574|NCT03432858|531432953|FG000|Overall Study|Withdrawal by Subject|0|||
147345575|NCT03432858|531432954|FG001|Overall Study|Withdrawal by Subject|1|||
147345576|NCT03432858|531432955|FG002|Overall Study|Withdrawal by Subject|1|||
147345577|NCT03432858|531432953|FG000|Overall Study|Procedure canceled/rescheduled|0|||
147345578|NCT03432858|531432954|FG001|Overall Study|Procedure canceled/rescheduled|9|||
147345579|NCT03432858|531432955|FG002|Overall Study|Procedure canceled/rescheduled|6|||
147345580|NCT03432858|531432953|FG000|Overall Study|Required postop mobilization with splinting|0|||
147345581|NCT03432858|531432954|FG001|Overall Study|Required postop mobilization with splinting|0|||
147662721|NCT02227784|532587414|FG002|Double-Blind Phase|Protocol Violation|1|||
147662722|NCT02227784|532587415|FG003|Double-Blind Phase|Protocol Violation|1|||
147662723|NCT02227784|532587416|FG004|Double-Blind Phase|Protocol Violation|0|||
147345582|NCT03432858|531432955|FG002|Overall Study|Required postop mobilization with splinting|1|||
147345583|NCT01011946|531432956|FG000|Overall Study|Transferred to another hospital|2|||
147345584|NCT01011946|531432956|FG000|Overall Study|No pathological lab value|1|||
147345585|NCT04820686|531432957|FG000|Overall Study|Withdrawal by Subject|5|||
147345586|NCT04820686|531432958|FG001|Overall Study|Withdrawal by Subject|2|||
147345587|NCT04820686|531432959|FG002|Overall Study|Withdrawal by Subject|3|||
147345588|NCT04820686|531432957|FG000|Overall Study|Study Termination|25|||
147345589|NCT04820686|531432958|FG001|Overall Study|Study Termination|13|||
147345590|NCT04820686|531432959|FG002|Overall Study|Study Termination|14|||
147345591|NCT04820686|531432957|FG000|Overall Study|Adverse Event|0|||
147345592|NCT04820686|531432958|FG001|Overall Study|Adverse Event|1|||
147345593|NCT04820686|531432959|FG002|Overall Study|Adverse Event|0|||
147345594|NCT01424670|531432960|FG000|6-Month Intensive Period (182 Days)|Adverse Event|2|||
147345595|NCT01424670|531432961|FG001|6-Month Intensive Period (182 Days)|Adverse Event|2|||
147345596|NCT01424670|531432960|FG000|6-Month Intensive Period (182 Days)|Lost to Follow-up|0|||
147345597|NCT01424670|531432961|FG001|6-Month Intensive Period (182 Days)|Lost to Follow-up|1|||
147345598|NCT01424670|531432960|FG000|6-Month Intensive Period (182 Days)|Met Protocol Withdrawal Criteria|2|||
147345599|NCT01424670|531432961|FG001|6-Month Intensive Period (182 Days)|Met Protocol Withdrawal Criteria|1|||
147345600|NCT01424670|531432960|FG000|6-Month Intensive Period (182 Days)|Physician Decision|2|||
147345601|NCT01424670|531432961|FG001|6-Month Intensive Period (182 Days)|Physician Decision|3|||
147345602|NCT01424670|531432960|FG000|6-Month Intensive Period (182 Days)|Withdrawal by Subject|13|||
147345603|NCT01424670|531432961|FG001|6-Month Intensive Period (182 Days)|Withdrawal by Subject|7|||
147345604|NCT01424670|531432960|FG000|Continuation Period|Adverse Event|13|||
147345605|NCT01424670|531432961|FG001|Continuation Period|Adverse Event|5|||
147345606|NCT01424670|531432960|FG000|Continuation Period|Lost to Follow-up|2|||
147345607|NCT01424670|531432961|FG001|Continuation Period|Lost to Follow-up|0|||
147345608|NCT01424670|531432960|FG000|Continuation Period|Met Protocol Withdrawal Criteria|1|||
147345609|NCT01424670|531432961|FG001|Continuation Period|Met Protocol Withdrawal Criteria|1|||
147345610|NCT01424670|531432960|FG000|Continuation Period|Physician Decision|5|||
147345611|NCT01424670|531432961|FG001|Continuation Period|Physician Decision|4|||
147345612|NCT01424670|531432960|FG000|Continuation Period|Withdrawal by Subject|13|||
147345613|NCT01424670|531432961|FG001|Continuation Period|Withdrawal by Subject|4|||
147345614|NCT00761189|531432962|FG000|Overall Study|Adverse Event|42|||
147345615|NCT00761189|531432962|FG000|Overall Study|Lack of Efficacy|45|||
147345616|NCT00761189|531432962|FG000|Overall Study|Lost to Follow-up|36|||
147345617|NCT00761189|531432962|FG000|Overall Study|Withdrawal by Subject|49|||
147345618|NCT00761189|531432962|FG000|Overall Study|Other|13|||
147345619|NCT04377308|531432963|FG000|Overall Study|Withdrawal by Subject|0|||
147345620|NCT04377308|531432964|FG001|Overall Study|Withdrawal by Subject|1|||
147345621|NCT01494922|531432965|FG000|Overall Study|Adverse Event|1|||
147345622|NCT02759016|531432966|FG000|Overall Study|Not treated with BI 836826|1|||
147345623|NCT02759016|531432967|FG001|Overall Study|Not treated with BI 836826|0|||
147345624|NCT02759016|531432966|FG000|Overall Study|Progressive disease|1|||
147345625|NCT02759016|531432967|FG001|Overall Study|Progressive disease|0|||
147345626|NCT02759016|531432966|FG000|Overall Study|SD, PR-MRDpos or PR-L|0|||
147345627|NCT02759016|531432967|FG001|Overall Study|SD, PR-MRDpos or PR-L|2|||
147345628|NCT02759016|531432966|FG000|Overall Study|Other not defined above|2|||
147345629|NCT02759016|531432967|FG001|Overall Study|Other not defined above|1|||
147345630|NCT03988842|531432968|FG000|Overall Study|Death|1|||
147345631|NCT02891915|531432969|FG000|Overall Study|Enrolled but Treatment Not Administered|6|||
147345632|NCT02891915|531432970|FG001|Overall Study|Enrolled but Treatment Not Administered|4|||
147345633|NCT02891915|531432969|FG000|Overall Study|Withdrawal by Subject|3|||
147345634|NCT02891915|531432970|FG001|Overall Study|Withdrawal by Subject|3|||
147345635|NCT02891915|531432969|FG000|Overall Study|Became Ineligible After Enrollment|2|||
147345636|NCT02891915|531432970|FG001|Overall Study|Became Ineligible After Enrollment|1|||
147345637|NCT02891915|531432969|FG000|Overall Study|Lost to Follow-up|1|||
147345638|NCT02891915|531432970|FG001|Overall Study|Lost to Follow-up|4|||
147345639|NCT02891915|531432969|FG000|Overall Study|Physician Decision|1|||
147345640|NCT02891915|531432970|FG001|Overall Study|Physician Decision|0|||
147345641|NCT00709098|531432973|FG000|Double-blind Period|Withdrawal of consent|3|||
147345642|NCT00709098|531432974|FG001|Double-blind Period|Withdrawal of consent|3|||
147345643|NCT00709098|531432975|FG002|Double-blind Period|Withdrawal of consent|0|||
147345644|NCT00709098|531432973|FG000|Double-blind Period|Administrative reason|1|||
147345645|NCT00709098|531432974|FG001|Double-blind Period|Administrative reason|3|||
147345646|NCT00709098|531432975|FG002|Double-blind Period|Administrative reason|0|||
147345647|NCT00709098|531432973|FG000|Double-blind Period|Death|1|||
147345648|NCT00709098|531432974|FG001|Double-blind Period|Death|1|||
147345649|NCT00709098|531432975|FG002|Double-blind Period|Death|0|||
147345650|NCT00709098|531432973|FG000|Double-blind Period|Lost to Follow-up|1|||
147345651|NCT00709098|531432974|FG001|Double-blind Period|Lost to Follow-up|1|||
147345652|NCT00709098|531432975|FG002|Double-blind Period|Lost to Follow-up|0|||
147345653|NCT00709098|531432973|FG000|Open-label Period|Withdrawal of consent|0|||
147345654|NCT00709098|531432974|FG001|Open-label Period|Withdrawal of consent|0|||
147345655|NCT00709098|531432975|FG002|Open-label Period|Withdrawal of consent|7|||
147345656|NCT00709098|531432973|FG000|Open-label Period|Administrative reason|0|||
147345657|NCT00709098|531432974|FG001|Open-label Period|Administrative reason|0|||
147345658|NCT00709098|531432975|FG002|Open-label Period|Administrative reason|5|||
147345659|NCT00709098|531432973|FG000|Open-label Period|Death|0|||
147345660|NCT00709098|531432974|FG001|Open-label Period|Death|0|||
147345661|NCT00709098|531432975|FG002|Open-label Period|Death|1|||
147345662|NCT00709098|531432973|FG000|Open-label Period|Lost to Follow-up|0|||
147345663|NCT00709098|531432974|FG001|Open-label Period|Lost to Follow-up|0|||
147345664|NCT00709098|531432975|FG002|Open-label Period|Lost to Follow-up|1|||
147345665|NCT03939312|531432977|FG000|OL Treatment Period (40 Weeks)|Withdrawal Criteria at Visit 1|43|||
147345666|NCT03939312|531432977|FG000|OL Treatment Period (40 Weeks)|Adverse Event|25|||
147345667|NCT03939312|531432977|FG000|OL Treatment Period (40 Weeks)|Lack of Efficacy|4|||
147606735|NCT02105974|532375308|FG001|2 Week Run-in Period|Withdrew consent|0|||
147345668|NCT03939312|531432977|FG000|OL Treatment Period (40 Weeks)|Withdrawal by Subject|35|||
147345669|NCT03939312|531432977|FG000|OL Treatment Period (40 Weeks)|Lost to Follow-up|19|||
147606736|NCT02105974|532375309|FG002|2 Week Run-in Period|Withdrew consent|0|||
147606737|NCT02105974|532375307|FG000|2 Week Run-in Period|Investigator discretion|8|||
147606738|NCT02105974|532375308|FG001|2 Week Run-in Period|Investigator discretion|0|||
147606739|NCT02105974|532375309|FG002|2 Week Run-in Period|Investigator discretion|0|||
147606740|NCT02105974|532375307|FG000|12 Week (Wk) Treatment Period (TP)|Adverse Event|0|||
147345670|NCT03939312|531432977|FG000|OL Treatment Period (40 Weeks)|Pregnancy|3|||
147345671|NCT03939312|531432977|FG000|OL Treatment Period (40 Weeks)|Protocol Deviation|16|||
147345672|NCT03939312|531432977|FG000|OL Treatment Period (40 Weeks)|Non-compliance With Study Drug|4|||
147345673|NCT03939312|531432977|FG000|OL Treatment Period (40 Weeks)|Site Terminated by Sponsor|3|||
147345674|NCT03939312|531432977|FG000|OL Treatment Period (40 Weeks)|Reason Not Specified|22|||
147345675|NCT03939312|531432977|FG000|Safety Follow-up 4 Weeks (Up to Week 44)|Withdrawal by Subject|12|||
147345676|NCT03939312|531432977|FG000|Safety Follow-up 4 Weeks (Up to Week 44)|Lost to Follow-up|4|||
147345677|NCT02119650|531432979|FG000|Overall Study|Adverse Event|3|||
147345678|NCT02119650|531432980|FG001|Overall Study|Adverse Event|4|||
147345679|NCT02119650|531432979|FG000|Overall Study|Subject decision|2|||
147345680|NCT02119650|531432980|FG001|Overall Study|Subject decision|3|||
147345681|NCT02119650|531432979|FG000|Overall Study|Disease progression|11|||
147345682|NCT02119650|531432980|FG001|Overall Study|Disease progression|14|||
147345683|NCT02119650|531432979|FG000|Overall Study|Death|5|||
147345684|NCT02119650|531432980|FG001|Overall Study|Death|1|||
147345685|NCT02119650|531432979|FG000|Overall Study|Noncompliance with study treatment|1|||
147345686|NCT02119650|531432980|FG001|Overall Study|Noncompliance with study treatment|1|||
147345687|NCT02119650|531432979|FG000|Overall Study|Study terminated by the sponsor|1|||
147345688|NCT02119650|531432980|FG001|Overall Study|Study terminated by the sponsor|0|||
147345689|NCT02119650|531432979|FG000|Overall Study|Physician Decision|0|||
147345690|NCT02119650|531432980|FG001|Overall Study|Physician Decision|2|||
147345691|NCT02119650|531432979|FG000|Overall Study|Multiple reasons for termination|2|||
147345692|NCT02119650|531432980|FG001|Overall Study|Multiple reasons for termination|1|||
147345693|NCT02730871|531432981|FG000|Overall Study|Adverse Event|6|||
147453147|NCT03127384|531821560|FG000|Overall Study|Lost to Follow-up|4|||
147453148|NCT03127384|531821560|FG000|Overall Study|Subject request|2|||
147453149|NCT00343889|531821568|FG000|Overall Study|Lost to Follow-up|2|||
147453150|NCT00343889|531821569|FG001|Overall Study|Lost to Follow-up|0|||
147345694|NCT02730871|531432982|FG001|Overall Study|Adverse Event|0|||
147345695|NCT04623775|531432983|FG000|Randomization|No Longer Meets Study Criteria|2|||
147345696|NCT04623775|531432984|FG001|Randomization|No Longer Meets Study Criteria|1|||
147345697|NCT04623775|531432985|FG002|Randomization|No Longer Meets Study Criteria|0|||
147345698|NCT04623775|531432986|FG003|Randomization|No Longer Meets Study Criteria|0|||
147345699|NCT04623775|531432983|FG000|Randomization|Withdrew Consent|0|||
147345700|NCT04623775|531432984|FG001|Randomization|Withdrew Consent|0|||
147345701|NCT04623775|531432985|FG002|Randomization|Withdrew Consent|0|||
147345702|NCT04623775|531432986|FG003|Randomization|Withdrew Consent|1|||
147345703|NCT04623775|531432983|FG000|Randomization|Other Reasons|0|||
147345704|NCT04623775|531432984|FG001|Randomization|Other Reasons|0|||
147345705|NCT04623775|531432985|FG002|Randomization|Other Reasons|0|||
147345706|NCT04623775|531432986|FG003|Randomization|Other Reasons|1|||
147345707|NCT04623775|531432983|FG000|Treatment Period|participant withdrew consent|4|||
147345708|NCT04623775|531432984|FG001|Treatment Period|participant withdrew consent|0|||
147345709|NCT04623775|531432985|FG002|Treatment Period|participant withdrew consent|1|||
147345710|NCT04623775|531432986|FG003|Treatment Period|participant withdrew consent|2|||
147345711|NCT04623775|531432983|FG000|Treatment Period|Death|3|||
147345712|NCT04623775|531432984|FG001|Treatment Period|Death|1|||
147345713|NCT04623775|531432985|FG002|Treatment Period|Death|4|||
147345714|NCT04623775|531432986|FG003|Treatment Period|Death|2|||
147345715|NCT04623775|531432983|FG000|Treatment Period|Lost to Follow-up|0|||
147345716|NCT04623775|531432984|FG001|Treatment Period|Lost to Follow-up|2|||
147345717|NCT04623775|531432985|FG002|Treatment Period|Lost to Follow-up|0|||
147345718|NCT04623775|531432986|FG003|Treatment Period|Lost to Follow-up|0|||
147345719|NCT04623775|531432983|FG000|Treatment Period|poor/non compliance|0|||
147345720|NCT04623775|531432984|FG001|Treatment Period|poor/non compliance|0|||
147345721|NCT04623775|531432985|FG002|Treatment Period|poor/non compliance|1|||
147345722|NCT04623775|531432986|FG003|Treatment Period|poor/non compliance|0|||
147345723|NCT04623775|531432983|FG000|Treatment Period|participant no longer meets study criteria|0|||
147345724|NCT04623775|531432984|FG001|Treatment Period|participant no longer meets study criteria|1|||
147345725|NCT04623775|531432985|FG002|Treatment Period|participant no longer meets study criteria|0|||
147345726|NCT04623775|531432986|FG003|Treatment Period|participant no longer meets study criteria|0|||
147453151|NCT00343889|531821568|FG000|Overall Study|Withdrawal by Subject|0|||
147453152|NCT00343889|531821569|FG001|Overall Study|Withdrawal by Subject|1|||
147453153|NCT00343889|531821568|FG000|Overall Study|Protocol Violation|1|||
147453154|NCT00343889|531821569|FG001|Overall Study|Protocol Violation|0|||
147453155|NCT01294579|531821572|FG000|Overall Study|Disease progression|12|||
147453156|NCT01294579|531821572|FG000|Overall Study|Adverse Event|11|||
147453157|NCT01294579|531821572|FG000|Overall Study|Study closed/terminated|3|||
147345727|NCT04623775|531432983|FG000|Treatment Period|administrative reasons by sponsor|3|||
147453158|NCT01294579|531821572|FG000|Overall Study|Lost to Follow-up|1|||
147453159|NCT01294579|531821572|FG000|Overall Study|Physician Decision|3|||
147453160|NCT01294579|531821572|FG000|Overall Study|Withdrawal by Subject|5|||
147453161|NCT04472429|531821573|FG000|Randomized Period|Ongoing|90|||
147345728|NCT04623775|531432984|FG001|Treatment Period|administrative reasons by sponsor|2|||
147345729|NCT04623775|531432985|FG002|Treatment Period|administrative reasons by sponsor|0|||
147345730|NCT04623775|531432986|FG003|Treatment Period|administrative reasons by sponsor|0|||
147345731|NCT04623775|531432983|FG000|Treatment Period|other reasons|2|||
147345732|NCT04623775|531432984|FG001|Treatment Period|other reasons|0|||
147345733|NCT04623775|531432985|FG002|Treatment Period|other reasons|1|||
147453162|NCT04472429|531821574|FG001|Randomized Period|Ongoing|40|||
147453163|NCT04472429|531821575|FG002|Randomized Period|Ongoing|0|||
147345734|NCT04623775|531432986|FG003|Treatment Period|other reasons|1|||
147345735|NCT04623775|531432983|FG000|Treatment Period|disease progression|40|||
147345736|NCT04623775|531432984|FG001|Treatment Period|disease progression|35|||
147345737|NCT04623775|531432985|FG002|Treatment Period|disease progression|63|||
147345738|NCT04623775|531432986|FG003|Treatment Period|disease progression|63|||
147345739|NCT04623775|531432983|FG000|Treatment Period|study drug toxicity|12|||
147345740|NCT04623775|531432984|FG001|Treatment Period|study drug toxicity|15|||
147345741|NCT04623775|531432985|FG002|Treatment Period|study drug toxicity|13|||
147345742|NCT04623775|531432986|FG003|Treatment Period|study drug toxicity|12|||
147345743|NCT04623775|531432983|FG000|Treatment Period|AE unrelated to study drug|4|||
147345744|NCT04623775|531432984|FG001|Treatment Period|AE unrelated to study drug|9|||
147345745|NCT04623775|531432985|FG002|Treatment Period|AE unrelated to study drug|12|||
147345746|NCT04623775|531432986|FG003|Treatment Period|AE unrelated to study drug|9|||
147345747|NCT04623775|531432983|FG000|Treatment Period|participant request to discontinue treatment|0|||
147345748|NCT04623775|531432984|FG001|Treatment Period|participant request to discontinue treatment|2|||
147345749|NCT04623775|531432985|FG002|Treatment Period|participant request to discontinue treatment|2|||
147345750|NCT04623775|531432986|FG003|Treatment Period|participant request to discontinue treatment|0|||
147345751|NCT03978637|531432989|FG000|Overall Study|Death|0|||
147345752|NCT03978637|531432990|FG001|Overall Study|Death|2|||
147345753|NCT03978637|531432991|FG002|Overall Study|Death|2|||
147345754|NCT03978637|531432992|FG003|Overall Study|Death|0|||
147345755|NCT03978637|531432989|FG000|Overall Study|Withdrawal by Subject|0|||
147345756|NCT03978637|531432990|FG001|Overall Study|Withdrawal by Subject|0|||
147345757|NCT03978637|531432991|FG002|Overall Study|Withdrawal by Subject|1|||
147345758|NCT03978637|531432992|FG003|Overall Study|Withdrawal by Subject|0|||
147345759|NCT03978637|531432989|FG000|Overall Study|Transitioned to Itacitinib Rollover Trial|1|||
147345760|NCT03978637|531432990|FG001|Overall Study|Transitioned to Itacitinib Rollover Trial|3|||
147345761|NCT03978637|531432991|FG002|Overall Study|Transitioned to Itacitinib Rollover Trial|2|||
147345762|NCT03978637|531432992|FG003|Overall Study|Transitioned to Itacitinib Rollover Trial|0|||
147345763|NCT01959698|531432993|FG000|Overall Study|Adverse Event|0|||
147345764|NCT01959698|531432994|FG001|Overall Study|Adverse Event|0|||
147345765|NCT01959698|531432995|FG002|Overall Study|Adverse Event|0|||
147345766|NCT01959698|531432996|FG003|Overall Study|Adverse Event|0|||
147345767|NCT01959698|531432997|FG004|Overall Study|Adverse Event|0|||
147345768|NCT01959698|531432998|FG005|Overall Study|Adverse Event|0|||
147345769|NCT01959698|531432999|FG006|Overall Study|Adverse Event|1|||
147345770|NCT01959698|531432993|FG000|Overall Study|Physician Decision|1|||
147345771|NCT01959698|531432994|FG001|Overall Study|Physician Decision|0|||
147345772|NCT01959698|531432995|FG002|Overall Study|Physician Decision|1|||
147345773|NCT01959698|531432996|FG003|Overall Study|Physician Decision|2|||
147345774|NCT01959698|531432997|FG004|Overall Study|Physician Decision|0|||
147345775|NCT01959698|531432998|FG005|Overall Study|Physician Decision|3|||
147345776|NCT01959698|531432999|FG006|Overall Study|Physician Decision|3|||
147345777|NCT04924062|531434927|FG000|Overall Study|Death|49|||
147345778|NCT04924062|531434928|FG001|Overall Study|Death|63|||
147345779|NCT04924062|531434927|FG000|Overall Study|Participant On-going|26|||
147345780|NCT04924062|531434928|FG001|Overall Study|Participant On-going|20|||
147345781|NCT03899961|531434929|FG000|Overall Study|-delivery prior to|2|||
147345782|NCT03899961|531434930|FG001|Overall Study|-delivery prior to|7|||
147345783|NCT03899961|531434929|FG000|Overall Study|req general anesth|1|||
147345784|NCT03899961|531434930|FG001|Overall Study|req general anesth|2|||
147345785|NCT03899961|531434929|FG000|Overall Study|capacity|5|||
147345786|NCT03899961|531434930|FG001|Overall Study|capacity|6|||
147345787|NCT03899961|531434929|FG000|Overall Study|Withdrawal by Subject|1|||
147345788|NCT03899961|531434930|FG001|Overall Study|Withdrawal by Subject|1|||
147345789|NCT04112316|531434935|FG000|First Period (8 Weeks)|Protocol Violation|1|||
147345790|NCT04112316|531434936|FG001|First Period (8 Weeks)|Protocol Violation|0|||
147345791|NCT04112316|531434935|FG000|First Period (8 Weeks)|Lost to Follow-up|1|||
147345792|NCT04112316|531434936|FG001|First Period (8 Weeks)|Lost to Follow-up|0|||
147345793|NCT04093362|531434937|FG000|Overall Study|Study Termination|1|||
147345794|NCT04093362|531434938|FG001|Overall Study|Study Termination|1|||
147345795|NCT04093362|531434937|FG000|Overall Study|Withdrawal of Consent|1|||
147345796|NCT04093362|531434938|FG001|Overall Study|Withdrawal of Consent|0|||
147345797|NCT04093362|531434937|FG000|Overall Study|Death|1|||
147345798|NCT04093362|531434938|FG001|Overall Study|Death|3|||
147345799|NCT04093362|531434937|FG000|Overall Study|Reason not Specified|1|||
147345800|NCT04093362|531434938|FG001|Overall Study|Reason not Specified|2|||
147345801|NCT03055377|531434948|FG000|Treatment Phase|Lost to Follow-up|28|||
147345802|NCT03055377|531434949|FG001|Treatment Phase|Lost to Follow-up|24|||
147345803|NCT03055377|531434948|FG000|Post-Treatment Follow-Up|Lost to Follow-up|26|||
147345804|NCT03055377|531434949|FG001|Post-Treatment Follow-Up|Lost to Follow-up|21|||
147345805|NCT01938547|531434958|FG000|Overall Study|Physician Decision|1|||
147345806|NCT04823611|531434961|FG000|Overall Study|Adverse Event|2|||
147345807|NCT04823611|531434962|FG001|Overall Study|Adverse Event|0|||
147345808|NCT04823611|531434963|FG002|Overall Study|Adverse Event|1|||
147345809|NCT04823611|531434964|FG003|Overall Study|Adverse Event|0|||
147345810|NCT04823611|531434965|FG004|Overall Study|Adverse Event|0|||
147345811|NCT04823611|531434966|FG005|Overall Study|Adverse Event|0|||
147345812|NCT04823611|531434967|FG006|Overall Study|Adverse Event|0|||
147345813|NCT04716634|531434970|FG000|Overall Study|Death|24|||
147345814|NCT04716634|531434971|FG001|Overall Study|Death|24|||
147345815|NCT04716634|531434972|FG002|Overall Study|Death|8|||
147345816|NCT04716634|531434970|FG000|Overall Study|Closed by Sponsor|4|||
147345817|NCT04716634|531434971|FG001|Overall Study|Closed by Sponsor|4|||
147345818|NCT04716634|531434972|FG002|Overall Study|Closed by Sponsor|5|||
147345819|NCT04716634|531434970|FG000|Overall Study|Lost to Follow-up|1|||
147345820|NCT04716634|531434971|FG001|Overall Study|Lost to Follow-up|0|||
147345821|NCT04716634|531434972|FG002|Overall Study|Lost to Follow-up|1|||
147345822|NCT04716634|531434970|FG000|Overall Study|Withdrawal by Subject|0|||
147345823|NCT04716634|531434971|FG001|Overall Study|Withdrawal by Subject|0|||
147345824|NCT04716634|531434972|FG002|Overall Study|Withdrawal by Subject|1|||
147345825|NCT01673984|531434976|FG000|Overall Study|Adverse Event|1|||
147345826|NCT01673984|531434977|FG001|Overall Study|Adverse Event|0|||
147345827|NCT01673984|531434976|FG000|Overall Study|Study termination|9|||
147345828|NCT01673984|531434977|FG001|Overall Study|Study termination|6|||
147345829|NCT00150813|531434978|FG000|Overall Study|Adverse Event|1|||
147345830|NCT00150813|531434978|FG000|Overall Study|Lack of Efficacy|1|||
147345831|NCT00150813|531434978|FG000|Overall Study|Lost to Follow-up|5|||
147345832|NCT00150813|531434978|FG000|Overall Study|Withdrawal by Subject|5|||
147345833|NCT00150813|531434978|FG000|Overall Study|Remission|3|||
147345834|NCT00150813|531434978|FG000|Overall Study|Planned pregancy|1|||
147345835|NCT00150813|531434978|FG000|Overall Study|Switch to commercially available LEV|2|||
147345836|NCT01820260|531434979|FG000|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
147345837|NCT01820260|531434980|FG001|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
147345838|NCT01820260|531434981|FG002|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
147345839|NCT01820260|531434982|FG003|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
147345840|NCT01820260|531434983|FG004|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
147345841|NCT01820260|531434984|FG005|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
147345842|NCT01820260|531434985|FG006|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|1|||
147345843|NCT01820260|531434986|FG007|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
147345844|NCT01820260|531434987|FG008|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
147345845|NCT01820260|531434988|FG009|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
147345846|NCT01820260|531434989|FG010|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
147345847|NCT01820260|531434990|FG011|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
147345848|NCT01820260|531434991|FG012|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
147345849|NCT01820260|531434992|FG013|Phase 1 (Part 1)|Subject withdrew after randomization before treatment assignment|0|||
147345850|NCT01820260|531434979|FG000|Phase 2 (Part 2)|Withdrawal by Subject|0|||
147345851|NCT01820260|531434980|FG001|Phase 2 (Part 2)|Withdrawal by Subject|0|||
147345852|NCT01820260|531434981|FG002|Phase 2 (Part 2)|Withdrawal by Subject|0|||
147345853|NCT01820260|531434982|FG003|Phase 2 (Part 2)|Withdrawal by Subject|0|||
147345854|NCT01820260|531434983|FG004|Phase 2 (Part 2)|Withdrawal by Subject|0|||
147345855|NCT01820260|531434984|FG005|Phase 2 (Part 2)|Withdrawal by Subject|0|||
147345856|NCT01820260|531434985|FG006|Phase 2 (Part 2)|Withdrawal by Subject|0|||
147345857|NCT01820260|531434986|FG007|Phase 2 (Part 2)|Withdrawal by Subject|0|||
147345858|NCT01820260|531434987|FG008|Phase 2 (Part 2)|Withdrawal by Subject|0|||
147345859|NCT01820260|531434988|FG009|Phase 2 (Part 2)|Withdrawal by Subject|1|||
147345860|NCT01820260|531434989|FG010|Phase 2 (Part 2)|Withdrawal by Subject|0|||
147345861|NCT01820260|531434990|FG011|Phase 2 (Part 2)|Withdrawal by Subject|0|||
147345862|NCT01820260|531434991|FG012|Phase 2 (Part 2)|Withdrawal by Subject|0|||
147345863|NCT01820260|531434992|FG013|Phase 2 (Part 2)|Withdrawal by Subject|0|||
147345864|NCT04424927|531434993|FG000|Single-blind Period (4 Weeks)|Not treated|1|||
147345865|NCT04424927|531434994|FG001|Single-blind Period (4 Weeks)|Not treated|0|||
147345866|NCT04424927|531434995|FG002|Single-blind Period (4 Weeks)|Not treated|0|||
147345867|NCT04424927|531434996|FG003|Single-blind Period (4 Weeks)|Not treated|0|||
147345868|NCT04424927|531434997|FG004|Single-blind Period (4 Weeks)|Not treated|0|||
147345869|NCT04424927|531434993|FG000|Single-blind Period (4 Weeks)|Run-in failure|27|||
147345870|NCT04424927|531434994|FG001|Single-blind Period (4 Weeks)|Run-in failure|0|||
147345871|NCT04424927|531434995|FG002|Single-blind Period (4 Weeks)|Run-in failure|0|||
147345872|NCT04424927|531434996|FG003|Single-blind Period (4 Weeks)|Run-in failure|0|||
147345873|NCT04424927|531434997|FG004|Single-blind Period (4 Weeks)|Run-in failure|0|||
147345874|NCT04424927|531434993|FG000|Single-blind Period (4 Weeks)|Withdrawal by Subject|7|||
147345875|NCT04424927|531434994|FG001|Single-blind Period (4 Weeks)|Withdrawal by Subject|0|||
147345876|NCT04424927|531434995|FG002|Single-blind Period (4 Weeks)|Withdrawal by Subject|0|||
147345877|NCT04424927|531434996|FG003|Single-blind Period (4 Weeks)|Withdrawal by Subject|0|||
147345878|NCT04424927|531434997|FG004|Single-blind Period (4 Weeks)|Withdrawal by Subject|0|||
147345879|NCT04424927|531434993|FG000|Single-blind Period (4 Weeks)|Investigator or sponsor judgement|1|||
147345880|NCT04424927|531434994|FG001|Single-blind Period (4 Weeks)|Investigator or sponsor judgement|0|||
147345881|NCT04424927|531434995|FG002|Single-blind Period (4 Weeks)|Investigator or sponsor judgement|0|||
147345882|NCT04424927|531434996|FG003|Single-blind Period (4 Weeks)|Investigator or sponsor judgement|0|||
147345883|NCT04424927|531434997|FG004|Single-blind Period (4 Weeks)|Investigator or sponsor judgement|0|||
147345884|NCT04424927|531434993|FG000|Double-blind Period (24 Weeks)|Lost to Follow-up|0|||
147345885|NCT04424927|531434994|FG001|Double-blind Period (24 Weeks)|Lost to Follow-up|1|||
147345886|NCT04424927|531434995|FG002|Double-blind Period (24 Weeks)|Lost to Follow-up|1|||
147345887|NCT04424927|531434996|FG003|Double-blind Period (24 Weeks)|Lost to Follow-up|0|||
147345888|NCT04424927|531434997|FG004|Double-blind Period (24 Weeks)|Lost to Follow-up|0|||
147345889|NCT04424927|531434993|FG000|Double-blind Period (24 Weeks)|Withdrawal by Subject|0|||
147345890|NCT04424927|531434994|FG001|Double-blind Period (24 Weeks)|Withdrawal by Subject|3|||
147345891|NCT04424927|531434995|FG002|Double-blind Period (24 Weeks)|Withdrawal by Subject|5|||
147345892|NCT04424927|531434996|FG003|Double-blind Period (24 Weeks)|Withdrawal by Subject|5|||
147345893|NCT04424927|531434997|FG004|Double-blind Period (24 Weeks)|Withdrawal by Subject|6|||
147345894|NCT04424927|531434993|FG000|Double-blind Period (24 Weeks)|Investigator or Sponsor judgement|0|||
147345895|NCT04424927|531434994|FG001|Double-blind Period (24 Weeks)|Investigator or Sponsor judgement|1|||
147345896|NCT04424927|531434995|FG002|Double-blind Period (24 Weeks)|Investigator or Sponsor judgement|0|||
147345897|NCT04424927|531434996|FG003|Double-blind Period (24 Weeks)|Investigator or Sponsor judgement|0|||
147345898|NCT04424927|531434997|FG004|Double-blind Period (24 Weeks)|Investigator or Sponsor judgement|1|||
147345899|NCT04424927|531434993|FG000|Double-blind Period (24 Weeks)|Other|0|||
147345900|NCT04424927|531434994|FG001|Double-blind Period (24 Weeks)|Other|1|||
147345901|NCT04424927|531434995|FG002|Double-blind Period (24 Weeks)|Other|3|||
147345902|NCT04424927|531434996|FG003|Double-blind Period (24 Weeks)|Other|1|||
147345903|NCT04424927|531434997|FG004|Double-blind Period (24 Weeks)|Other|0|||
147345904|NCT02365766|531434999|FG000|Overall Study|Withdrawal by Subject|0|||
147345905|NCT02365766|531435000|FG001|Overall Study|Withdrawal by Subject|0|||
147345906|NCT02365766|531435001|FG002|Overall Study|Withdrawal by Subject|1|||
147345907|NCT02365766|531434999|FG000|Overall Study|Eligibility Criteria Not Met|0|||
147345908|NCT02365766|531435000|FG001|Overall Study|Eligibility Criteria Not Met|0|||
147345909|NCT02365766|531435001|FG002|Overall Study|Eligibility Criteria Not Met|1|||
147345910|NCT04791709|531435010|FG000|Overall Study|Withdrawal by Subject|3|||
147345911|NCT02724956|531435011|FG000|Overall Study|Physician Decision|1|||
147345912|NCT02724956|531435012|FG001|Overall Study|Physician Decision|0|||
147345913|NCT02724956|531435011|FG000|Overall Study|Lack of Efficacy|0|||
147345914|NCT02724956|531435012|FG001|Overall Study|Lack of Efficacy|1|||
147345915|NCT02724956|531435011|FG000|Overall Study|Withdrawal by Subject|0|||
147345916|NCT02724956|531435012|FG001|Overall Study|Withdrawal by Subject|1|||
147345917|NCT00650104|531435013|FG000|Overall Study|Adverse Event|17|||
147345918|NCT00650104|531435013|FG000|Overall Study|Death|2|||
147345919|NCT00650104|531435013|FG000|Overall Study|Withdrawal by Subject|11|||
147345920|NCT00650104|531435013|FG000|Overall Study|Physician Decision|7|||
147345921|NCT00650104|531435013|FG000|Overall Study|Lost to Follow-up|1|||
147345922|NCT00650104|531435013|FG000|Overall Study|Non-compliance|2|||
147345923|NCT00650104|531435013|FG000|Overall Study|Sponsor Terminated Dosing|1|||
147345924|NCT00894543|531435014|FG000|Baseline to Week 4|No diary or lost or withdrew|3|||
147345925|NCT00894543|531435015|FG001|Baseline to Week 4|No diary or lost or withdrew|2|||
147345926|NCT00894543|531435014|FG000|Week 4 to Week 8|No diary or lost or withdrew|4|||
147345927|NCT00894543|531435015|FG001|Week 4 to Week 8|No diary or lost or withdrew|2|||
147345928|NCT04048681|531435016|FG000|Overall Study|family emergency|0|||
147345929|NCT04048681|531435017|FG001|Overall Study|family emergency|0|||
147345930|NCT04048681|531435018|FG002|Overall Study|family emergency|0|||
147345931|NCT04048681|531435019|FG003|Overall Study|family emergency|1|||
147345932|NCT04048681|531435020|FG004|Overall Study|family emergency|0|||
147345933|NCT03385629|531435026|FG000|Follow-up Well Child Visit 2|Lost to Follow-up|214|||
147345934|NCT03385629|531435027|FG001|Follow-up Well Child Visit 2|Lost to Follow-up|160|||
147345935|NCT03385629|531435026|FG000|Follow-up Well Child Visit 2|Withdrawal by Subject|6|||
147345936|NCT03385629|531435027|FG001|Follow-up Well Child Visit 2|Withdrawal by Subject|3|||
147345937|NCT03385629|531435026|FG000|Follow-up Well Child Visit 3|Lost to Follow-up|266|||
147345938|NCT03385629|531435027|FG001|Follow-up Well Child Visit 3|Lost to Follow-up|186|||
147345939|NCT02919449|531435028|FG000|Overall Study|Withdrawal by Subject|1|||
147345940|NCT02919449|531435028|FG000|Overall Study|Investigator decision|1|||
147345941|NCT02058108|531435029|FG000|Overall Study|Abnormal Laboratory Values|0|||
147345942|NCT02058108|531435030|FG001|Overall Study|Abnormal Laboratory Values|1|||
147345943|NCT02058108|531435029|FG000|Overall Study|Unsatisfactory therapeutic effect|37|||
147345944|NCT02058108|531435030|FG001|Overall Study|Unsatisfactory therapeutic effect|4|||
147345945|NCT02058108|531435029|FG000|Overall Study|No longer requires study drug|0|||
147345946|NCT02058108|531435030|FG001|Overall Study|No longer requires study drug|1|||
147345947|NCT02058108|531435029|FG000|Overall Study|Withdrawal by Subject|1|||
147345948|NCT02058108|531435030|FG001|Overall Study|Withdrawal by Subject|0|||
147345949|NCT02058108|531435029|FG000|Overall Study|Administrative problems|3|||
147345950|NCT02058108|531435030|FG001|Overall Study|Administrative problems|3|||
147345951|NCT02058108|531435029|FG000|Overall Study|Protocol Violation|0|||
147453164|NCT04472429|531821573|FG000|Randomized Period|Death|52|||
147606741|NCT02105974|532375308|FG001|12 Week (Wk) Treatment Period (TP)|Adverse Event|14|||
147345952|NCT02058108|531435030|FG001|Overall Study|Protocol Violation|1|||
147345953|NCT01989455|531435033|FG000|Overall Study|Adverse Event|0|||
147345954|NCT01989455|531435034|FG001|Overall Study|Adverse Event|1|||
147345955|NCT01989455|531435035|FG002|Overall Study|Adverse Event|0|||
147345956|NCT01989455|531435036|FG003|Overall Study|Adverse Event|0|||
147345957|NCT01989455|531435037|FG004|Overall Study|Adverse Event|0|||
147345958|NCT01989455|531435033|FG000|Overall Study|Withdrawal by Subject|0|||
147345959|NCT01989455|531435034|FG001|Overall Study|Withdrawal by Subject|1|||
147345960|NCT01989455|531435035|FG002|Overall Study|Withdrawal by Subject|0|||
147345961|NCT01989455|531435036|FG003|Overall Study|Withdrawal by Subject|0|||
147345962|NCT01989455|531435037|FG004|Overall Study|Withdrawal by Subject|0|||
147345963|NCT01989455|531435033|FG000|Overall Study|Technical problems with infusion|0|||
147345964|NCT01989455|531435034|FG001|Overall Study|Technical problems with infusion|0|||
147345965|NCT01989455|531435035|FG002|Overall Study|Technical problems with infusion|1|||
147345966|NCT01989455|531435036|FG003|Overall Study|Technical problems with infusion|0|||
147345967|NCT01989455|531435037|FG004|Overall Study|Technical problems with infusion|1|||
147345968|NCT00999167|531435038|FG000|Part A: Open Label Safety run-in|Met protocol defined stopping rule|4|||
147345969|NCT00999167|531435039|FG001|Part A: Open Label Safety run-in|Met protocol defined stopping rule|0|||
147345970|NCT00999167|531435040|FG002|Part A: Open Label Safety run-in|Met protocol defined stopping rule|0|||
147345971|NCT00999167|531435038|FG000|Part A: Open Label Safety run-in|Adverse Event|3|||
147345972|NCT00999167|531435039|FG001|Part A: Open Label Safety run-in|Adverse Event|0|||
147345973|NCT00999167|531435040|FG002|Part A: Open Label Safety run-in|Adverse Event|0|||
147345974|NCT00999167|531435038|FG000|Part B: Randomized, Placebo Controlled|Met protocol defined stopping rule|0|||
147345975|NCT00999167|531435039|FG001|Part B: Randomized, Placebo Controlled|Met protocol defined stopping rule|19|||
147345976|NCT00999167|531435040|FG002|Part B: Randomized, Placebo Controlled|Met protocol defined stopping rule|16|||
147345977|NCT00999167|531435038|FG000|Part B: Randomized, Placebo Controlled|Withdrawal by Subject|0|||
147606742|NCT02105974|532375309|FG002|12 Week (Wk) Treatment Period (TP)|Adverse Event|18|||
147606743|NCT02105974|532375307|FG000|12 Week (Wk) Treatment Period (TP)|Lack of Efficacy|0|||
147606744|NCT02105974|532375308|FG001|12 Week (Wk) Treatment Period (TP)|Lack of Efficacy|6|||
147606745|NCT02105974|532375309|FG002|12 Week (Wk) Treatment Period (TP)|Lack of Efficacy|9|||
147606746|NCT02105974|532375307|FG000|12 Week (Wk) Treatment Period (TP)|Protocol deviation|0|||
147606747|NCT02105974|532375308|FG001|12 Week (Wk) Treatment Period (TP)|Protocol deviation|2|||
147606748|NCT02105974|532375309|FG002|12 Week (Wk) Treatment Period (TP)|Protocol deviation|6|||
147606749|NCT02105974|532375307|FG000|12 Week (Wk) Treatment Period (TP)|Participant reached stopping criteria|0|||
147606750|NCT02105974|532375308|FG001|12 Week (Wk) Treatment Period (TP)|Participant reached stopping criteria|1|||
147345978|NCT00999167|531435039|FG001|Part B: Randomized, Placebo Controlled|Withdrawal by Subject|7|||
147345979|NCT00999167|531435040|FG002|Part B: Randomized, Placebo Controlled|Withdrawal by Subject|4|||
147345980|NCT00999167|531435038|FG000|Part B: Randomized, Placebo Controlled|Adverse Event|0|||
147345981|NCT00999167|531435039|FG001|Part B: Randomized, Placebo Controlled|Adverse Event|6|||
147606751|NCT02105974|532375309|FG002|12 Week (Wk) Treatment Period (TP)|Participant reached stopping criteria|2|||
147606752|NCT02105974|532375307|FG000|12 Week (Wk) Treatment Period (TP)|Lost to Follow-up|0|||
147606753|NCT02105974|532375308|FG001|12 Week (Wk) Treatment Period (TP)|Lost to Follow-up|0|||
147606754|NCT02105974|532375309|FG002|12 Week (Wk) Treatment Period (TP)|Lost to Follow-up|1|||
147606755|NCT02105974|532375307|FG000|12 Week (Wk) Treatment Period (TP)|Physician Decision|0|||
147606756|NCT02105974|532375308|FG001|12 Week (Wk) Treatment Period (TP)|Physician Decision|7|||
147606757|NCT02105974|532375309|FG002|12 Week (Wk) Treatment Period (TP)|Physician Decision|4|||
147345982|NCT00999167|531435040|FG002|Part B: Randomized, Placebo Controlled|Adverse Event|1|||
147345983|NCT00999167|531435038|FG000|Part B: Randomized, Placebo Controlled|Noncompliance|0|||
147345984|NCT00999167|531435039|FG001|Part B: Randomized, Placebo Controlled|Noncompliance|1|||
147345985|NCT00999167|531435040|FG002|Part B: Randomized, Placebo Controlled|Noncompliance|0|||
147345986|NCT00999167|531435038|FG000|Part B: Randomized, Placebo Controlled|Physician Decision|0|||
147345987|NCT00999167|531435039|FG001|Part B: Randomized, Placebo Controlled|Physician Decision|1|||
147345988|NCT00999167|531435040|FG002|Part B: Randomized, Placebo Controlled|Physician Decision|0|||
147345989|NCT00999167|531435038|FG000|Part B: Randomized, Placebo Controlled|Physician stopped drug|0|||
147345990|NCT00999167|531435039|FG001|Part B: Randomized, Placebo Controlled|Physician stopped drug|1|||
147345991|NCT00999167|531435040|FG002|Part B: Randomized, Placebo Controlled|Physician stopped drug|0|||
147345992|NCT00448669|531435041|FG000|Overall Study|Lost to Follow-up|52|||
147345993|NCT00448669|531435042|FG001|Overall Study|Lost to Follow-up|63|||
147606758|NCT02105974|532375307|FG000|12 Week (Wk) Treatment Period (TP)|Withdrawal by Subject|0|||
147606759|NCT02105974|532375308|FG001|12 Week (Wk) Treatment Period (TP)|Withdrawal by Subject|12|||
147345994|NCT00448669|531435041|FG000|Overall Study|Withdrawal by Subject|90|||
147345995|NCT00448669|531435042|FG001|Overall Study|Withdrawal by Subject|74|||
147345996|NCT00448669|531435041|FG000|Overall Study|Relocated|49|||
147345997|NCT00448669|531435042|FG001|Overall Study|Relocated|36|||
147345998|NCT00448669|531435041|FG000|Overall Study|Were withdrawn by investigator|10|||
147345999|NCT00448669|531435042|FG001|Overall Study|Were withdrawn by investigator|6|||
147606760|NCT02105974|532375309|FG002|12 Week (Wk) Treatment Period (TP)|Withdrawal by Subject|18|||
147453165|NCT04472429|531821574|FG001|Randomized Period|Death|37|||
147453166|NCT04472429|531821575|FG002|Randomized Period|Death|0|||
147453167|NCT04472429|531821573|FG000|Randomized Period|Lost to Follow-up|4|||
147453168|NCT04472429|531821574|FG001|Randomized Period|Lost to Follow-up|0|||
147453169|NCT04472429|531821575|FG002|Randomized Period|Lost to Follow-up|0|||
147453170|NCT04472429|531821573|FG000|Randomized Period|Physician Decision|1|||
147453171|NCT04472429|531821574|FG001|Randomized Period|Physician Decision|2|||
147453172|NCT04472429|531821575|FG002|Randomized Period|Physician Decision|0|||
147453173|NCT04472429|531821573|FG000|Randomized Period|Withdrawal by Subject|6|||
147453174|NCT04472429|531821574|FG001|Randomized Period|Withdrawal by Subject|5|||
147453175|NCT04472429|531821575|FG002|Randomized Period|Withdrawal by Subject|0|||
147453176|NCT04472429|531821573|FG000|Randomized Period|Inclusion Criterion Not Met on Day of Planned Dose|0|||
147453177|NCT04472429|531821574|FG001|Randomized Period|Inclusion Criterion Not Met on Day of Planned Dose|1|||
147453178|NCT04472429|531821575|FG002|Randomized Period|Inclusion Criterion Not Met on Day of Planned Dose|0|||
147453179|NCT04472429|531821573|FG000|Randomized Period|New Diagnosis of Lymphoma|1|||
147453180|NCT04472429|531821574|FG001|Randomized Period|New Diagnosis of Lymphoma|0|||
147453181|NCT04472429|531821575|FG002|Randomized Period|New Diagnosis of Lymphoma|0|||
147453182|NCT04472429|531821573|FG000|Open-label Monotherapy Period|Ongoing|0|||
147453183|NCT04472429|531821574|FG001|Open-label Monotherapy Period|Ongoing|0|||
147453184|NCT04472429|531821575|FG002|Open-label Monotherapy Period|Ongoing|32|||
147453185|NCT04472429|531821573|FG000|Open-label Monotherapy Period|Death|0|||
147453186|NCT04472429|531821574|FG001|Open-label Monotherapy Period|Death|0|||
147453187|NCT04472429|531821575|FG002|Open-label Monotherapy Period|Death|35|||
147453188|NCT04472429|531821573|FG000|Open-label Monotherapy Period|Lost to Follow-up|0|||
147453189|NCT04472429|531821574|FG001|Open-label Monotherapy Period|Lost to Follow-up|0|||
147453190|NCT04472429|531821575|FG002|Open-label Monotherapy Period|Lost to Follow-up|2|||
147453191|NCT01180660|531821576|FG000|Overall Study|Changed to open surgery|1|||
147453192|NCT01180660|531821577|FG001|Overall Study|Changed to open surgery|0|||
147453193|NCT00262873|531821578|FG000|Overall Study|Adverse Event|3|||
147453194|NCT00262873|531821578|FG000|Overall Study|Withdrawal by Subject|5|||
147453195|NCT00088374|531821579|FG000|Overall Study|patient did not receive any 17AAG|1|||
147453196|NCT00088374|531821579|FG000|Overall Study|patient received <1 cycle only of 17AAG|1|||
147453197|NCT05073458|531821584|FG000|24-week Double-blind Period|Adverse Event|1|||
147453198|NCT05073458|531821585|FG001|24-week Double-blind Period|Adverse Event|0|||
147453199|NCT05073458|531821584|FG000|24-week Double-blind Period|Physician Decision|1|||
147453200|NCT05073458|531821585|FG001|24-week Double-blind Period|Physician Decision|0|||
147453201|NCT05073458|531821584|FG000|24-week Double-blind Period|Study Terminated by Sponsor|1|||
147453202|NCT05073458|531821585|FG001|24-week Double-blind Period|Study Terminated by Sponsor|1|||
147453203|NCT05073458|531821584|FG000|24-week Double-blind Period|Withdrawal by Subject|0|||
147453204|NCT05073458|531821585|FG001|24-week Double-blind Period|Withdrawal by Subject|1|||
147453205|NCT05073458|531821584|FG000|24-week Open-label Period|Withdrawal by Subject|1|||
147453206|NCT05073458|531821585|FG001|24-week Open-label Period|Withdrawal by Subject|0|||
147453207|NCT05073458|531821584|FG000|24-week Open-label Period|Adverse Event|1|||
147346000|NCT00448669|531435041|FG000|Overall Study|Death|2|||
147346001|NCT00448669|531435042|FG001|Overall Study|Death|4|||
147346002|NCT00448669|531435041|FG000|Overall Study|Had other reasons|5|||
147346003|NCT00448669|531435042|FG001|Overall Study|Had other reasons|6|||
147346004|NCT00448669|531435041|FG000|Overall Study|HIV-infected at enrollment|1|||
147346005|NCT00448669|531435042|FG001|Overall Study|HIV-infected at enrollment|2|||
147346006|NCT00448669|531435041|FG000|Overall Study|Never started drug|9|||
147346007|NCT00448669|531435042|FG001|Overall Study|Never started drug|7|||
147346008|NCT05512962|531435043|FG000|Overall Study|Withdrawal by Subject|1|||
147346009|NCT05512962|531435044|FG001|Overall Study|Withdrawal by Subject|0|||
147346010|NCT04838613|531435045|FG000|Overall Study|Withdrawal by Subject|3|||
147346011|NCT04838613|531435046|FG001|Overall Study|Withdrawal by Subject|6|||
147346012|NCT04838613|531435045|FG000|Overall Study|Protocol Deviation|3|||
147346013|NCT04838613|531435046|FG001|Overall Study|Protocol Deviation|2|||
147346014|NCT04838613|531435045|FG000|Overall Study|Technical Problems|0|||
147346015|NCT04838613|531435046|FG001|Overall Study|Technical Problems|5|||
147346016|NCT04838613|531435045|FG000|Overall Study|Physician Decision|2|||
147346017|NCT04838613|531435046|FG001|Overall Study|Physician Decision|0|||
147346018|NCT04970654|531435047|FG000|Overall Study|Withdrawal by parents/guardian|1|||
147453208|NCT05073458|531821585|FG001|24-week Open-label Period|Adverse Event|2|||
147453209|NCT01632566|531821586|FG000|Overall Study|Withdrawal by Subject|0|||
147453210|NCT01632566|531821587|FG001|Overall Study|Withdrawal by Subject|1|||
147453211|NCT01632566|531821588|FG002|Overall Study|Withdrawal by Subject|0|||
147453212|NCT01632566|531821589|FG003|Overall Study|Withdrawal by Subject|0|||
147453213|NCT01632566|531821590|FG004|Overall Study|Withdrawal by Subject|0|||
147453214|NCT01632566|531821586|FG000|Overall Study|Sponsor Decision|0|||
147453215|NCT01632566|531821587|FG001|Overall Study|Sponsor Decision|2|||
147346019|NCT04970654|531435048|FG001|Overall Study|Withdrawal by parents/guardian|2|||
147346020|NCT04970654|531435047|FG000|Overall Study|Unclassified|2|||
147346021|NCT04970654|531435048|FG001|Overall Study|Unclassified|1|||
147346022|NCT04970654|531435047|FG000|Overall Study|Lost to Follow-up|1|||
147346023|NCT04970654|531435048|FG001|Overall Study|Lost to Follow-up|0|||
147346024|NCT02137850|531435049|FG000|Main Phase: Pre-Prophylaxis|Withdrawal by parent/guardian|1|||
147346025|NCT02137850|531435050|FG001|Main Phase: Pre-Prophylaxis|Withdrawal by parent/guardian|0|||
147346026|NCT02137850|531435051|FG002|Main Phase: Pre-Prophylaxis|Withdrawal by parent/guardian|0|||
147346027|NCT02137850|531435049|FG000|Main Phase: Pre-Prophylaxis|Protocol Violation|1|||
147346028|NCT02137850|531435050|FG001|Main Phase: Pre-Prophylaxis|Protocol Violation|0|||
147346029|NCT02137850|531435051|FG002|Main Phase: Pre-Prophylaxis|Protocol Violation|0|||
147346030|NCT02137850|531435049|FG000|Main Phase: Pre-Prophylaxis|Adverse Event|3|||
147346031|NCT02137850|531435050|FG001|Main Phase: Pre-Prophylaxis|Adverse Event|0|||
147346032|NCT02137850|531435051|FG002|Main Phase: Pre-Prophylaxis|Adverse Event|0|||
147346033|NCT02137850|531435049|FG000|Main Phase: Pre-Prophylaxis|Withdrawal by Subject|2|||
147346034|NCT02137850|531435050|FG001|Main Phase: Pre-Prophylaxis|Withdrawal by Subject|0|||
147346035|NCT02137850|531435051|FG002|Main Phase: Pre-Prophylaxis|Withdrawal by Subject|0|||
147453216|NCT01632566|531821588|FG002|Overall Study|Sponsor Decision|9|||
147453217|NCT01632566|531821589|FG003|Overall Study|Sponsor Decision|2|||
147453218|NCT01632566|531821590|FG004|Overall Study|Sponsor Decision|2|||
147453219|NCT04428424|531821591|FG000|Overall Study|Does not meet entrance criteria|132|||
147453220|NCT04428424|531821591|FG000|Overall Study|Lost to Follow-up|115|||
147346036|NCT02137850|531435049|FG000|Main Phase: Pre-Prophylaxis|Lack of Efficacy|1|||
147346037|NCT02137850|531435050|FG001|Main Phase: Pre-Prophylaxis|Lack of Efficacy|0|||
147346038|NCT02137850|531435051|FG002|Main Phase: Pre-Prophylaxis|Lack of Efficacy|0|||
147346039|NCT02137850|531435049|FG000|Main Phase: Pre-Prophylaxis|Other|3|||
147453221|NCT01262365|531823966|FG000|Overall Study|Lack of Efficacy|35|||
147453222|NCT01262365|531823967|FG001|Overall Study|Lack of Efficacy|30|||
147453223|NCT01262365|531823968|FG002|Overall Study|Lack of Efficacy|47|||
147453224|NCT01262365|531823966|FG000|Overall Study|Protocol Violation|3|||
147453225|NCT01262365|531823967|FG001|Overall Study|Protocol Violation|1|||
147453226|NCT01262365|531823968|FG002|Overall Study|Protocol Violation|1|||
147453227|NCT01262365|531823966|FG000|Overall Study|Lost to Follow-up|3|||
147453228|NCT01262365|531823967|FG001|Overall Study|Lost to Follow-up|7|||
147453229|NCT01262365|531823968|FG002|Overall Study|Lost to Follow-up|6|||
147453230|NCT01262365|531823966|FG000|Overall Study|Withdrawal by Subject|17|||
147453231|NCT01262365|531823967|FG001|Overall Study|Withdrawal by Subject|22|||
147453232|NCT01262365|531823968|FG002|Overall Study|Withdrawal by Subject|22|||
147453233|NCT01262365|531823966|FG000|Overall Study|Death|1|||
147453234|NCT01262365|531823967|FG001|Overall Study|Death|2|||
147453235|NCT01262365|531823968|FG002|Overall Study|Death|1|||
147453236|NCT01262365|531823966|FG000|Overall Study|Adverse Event|26|||
147453237|NCT01262365|531823967|FG001|Overall Study|Adverse Event|16|||
147453238|NCT01262365|531823968|FG002|Overall Study|Adverse Event|11|||
147453239|NCT01262365|531823966|FG000|Overall Study|sponsor decision|1|||
147453240|NCT01262365|531823967|FG001|Overall Study|sponsor decision|1|||
147453241|NCT01262365|531823968|FG002|Overall Study|sponsor decision|0|||
147453242|NCT01262365|531823966|FG000|Overall Study|Randomization error|1|||
147453243|NCT01262365|531823967|FG001|Overall Study|Randomization error|0|||
147453244|NCT01262365|531823968|FG002|Overall Study|Randomization error|2|||
147453245|NCT01262365|531823966|FG000|Overall Study|Non-compliance|1|||
147453246|NCT01262365|531823967|FG001|Overall Study|Non-compliance|0|||
147453247|NCT01262365|531823968|FG002|Overall Study|Non-compliance|2|||
147346040|NCT02137850|531435050|FG001|Main Phase: Pre-Prophylaxis|Other|0|||
147346041|NCT02137850|531435051|FG002|Main Phase: Pre-Prophylaxis|Other|0|||
147346042|NCT02137850|531435049|FG000|Main Phase: Prophylaxis|Withdrawal by parent/guardian|0|||
147346043|NCT02137850|531435050|FG001|Main Phase: Prophylaxis|Withdrawal by parent/guardian|2|||
147346044|NCT02137850|531435051|FG002|Main Phase: Prophylaxis|Withdrawal by parent/guardian|0|||
147346045|NCT02137850|531435049|FG000|Main Phase: Prophylaxis|Protocol Violation|0|||
147346046|NCT02137850|531435050|FG001|Main Phase: Prophylaxis|Protocol Violation|1|||
147346047|NCT02137850|531435051|FG002|Main Phase: Prophylaxis|Protocol Violation|0|||
147346048|NCT02137850|531435049|FG000|Main Phase: Prophylaxis|Adverse Event|0|||
147346049|NCT02137850|531435050|FG001|Main Phase: Prophylaxis|Adverse Event|4|||
147346050|NCT02137850|531435051|FG002|Main Phase: Prophylaxis|Adverse Event|0|||
147453248|NCT01262365|531823966|FG000|Overall Study|Suspected pregnancy|1|||
147453249|NCT01262365|531823967|FG001|Overall Study|Suspected pregnancy|0|||
147453250|NCT01262365|531823968|FG002|Overall Study|Suspected pregnancy|0|||
147453251|NCT01262365|531823966|FG000|Overall Study|Patient pregnant|1|||
147453252|NCT01262365|531823967|FG001|Overall Study|Patient pregnant|0|||
147453253|NCT01262365|531823968|FG002|Overall Study|Patient pregnant|1|||
147453254|NCT01262365|531823966|FG000|Overall Study|Toxicity related to study drug|0|||
147453255|NCT01262365|531823967|FG001|Overall Study|Toxicity related to study drug|1|||
147453256|NCT01262365|531823968|FG002|Overall Study|Toxicity related to study drug|0|||
147453257|NCT01262365|531823966|FG000|Overall Study|Cannot tolerate the protocol|0|||
147453258|NCT01262365|531823967|FG001|Overall Study|Cannot tolerate the protocol|1|||
147453259|NCT01262365|531823968|FG002|Overall Study|Cannot tolerate the protocol|0|||
147453260|NCT01262365|531823966|FG000|Overall Study|Patient unavailable|0|||
147453261|NCT01262365|531823967|FG001|Overall Study|Patient unavailable|0|||
147453262|NCT01262365|531823968|FG002|Overall Study|Patient unavailable|1|||
147346051|NCT02137850|531435049|FG000|Main Phase: Prophylaxis|Lack of Efficacy|0|||
147346052|NCT02137850|531435050|FG001|Main Phase: Prophylaxis|Lack of Efficacy|1|||
147346053|NCT02137850|531435051|FG002|Main Phase: Prophylaxis|Lack of Efficacy|0|||
147346054|NCT02137850|531435049|FG000|Main Phase: Prophylaxis|Other|0|||
147346055|NCT02137850|531435050|FG001|Main Phase: Prophylaxis|Other|1|||
147346056|NCT02137850|531435051|FG002|Main Phase: Prophylaxis|Other|0|||
147346057|NCT02137850|531435049|FG000|Main Phase: Prophylaxis|Switched to ITI without completing main phase|0|||
147346058|NCT02137850|531435050|FG001|Main Phase: Prophylaxis|Switched to ITI without completing main phase|2|||
147346059|NCT02137850|531435051|FG002|Main Phase: Prophylaxis|Switched to ITI without completing main phase|0|||
147346060|NCT02137850|531435049|FG000|Main Phase: Prophylaxis|Early site closure|0|||
147346061|NCT02137850|531435050|FG001|Main Phase: Prophylaxis|Early site closure|2|||
147346062|NCT02137850|531435051|FG002|Main Phase: Prophylaxis|Early site closure|0|||
147346063|NCT02137850|531435049|FG000|Main Phase: Prophylaxis|Lost to Follow-up|0|||
147346064|NCT02137850|531435050|FG001|Main Phase: Prophylaxis|Lost to Follow-up|1|||
147346065|NCT02137850|531435051|FG002|Main Phase: Prophylaxis|Lost to Follow-up|0|||
147346066|NCT02137850|531435049|FG000|Immune Tolerance Induction|Withdrawal by parent/guardian|0|||
147346067|NCT02137850|531435050|FG001|Immune Tolerance Induction|Withdrawal by parent/guardian|0|||
147346068|NCT02137850|531435051|FG002|Immune Tolerance Induction|Withdrawal by parent/guardian|1|||
147346069|NCT02137850|531435049|FG000|Immune Tolerance Induction|Lack of Efficacy|0|||
147346070|NCT02137850|531435050|FG001|Immune Tolerance Induction|Lack of Efficacy|0|||
147346071|NCT02137850|531435051|FG002|Immune Tolerance Induction|Lack of Efficacy|1|||
147346072|NCT02137850|531435049|FG000|Immune Tolerance Induction|Undergone minor surgery|0|||
147346073|NCT02137850|531435050|FG001|Immune Tolerance Induction|Undergone minor surgery|0|||
147346074|NCT02137850|531435051|FG002|Immune Tolerance Induction|Undergone minor surgery|2|||
147346075|NCT02137850|531435049|FG000|Extension Phase: Prophylaxis|Adverse Event|0|||
147346076|NCT02137850|531435050|FG001|Extension Phase: Prophylaxis|Adverse Event|1|||
147346077|NCT02137850|531435051|FG002|Extension Phase: Prophylaxis|Adverse Event|0|||
147346078|NCT02137850|531435049|FG000|Extension Phase: Prophylaxis|Protocol Violation|0|||
147346079|NCT02137850|531435050|FG001|Extension Phase: Prophylaxis|Protocol Violation|1|||
147346080|NCT02137850|531435051|FG002|Extension Phase: Prophylaxis|Protocol Violation|0|||
147346081|NCT02137850|531435049|FG000|Extension Phase: Prophylaxis|Withdrawal by parent/guardian|0|||
147346082|NCT02137850|531435050|FG001|Extension Phase: Prophylaxis|Withdrawal by parent/guardian|1|||
147346083|NCT02137850|531435051|FG002|Extension Phase: Prophylaxis|Withdrawal by parent/guardian|0|||
147346084|NCT02137850|531435049|FG000|Extension Phase: Prophylaxis|Other|0|||
147346085|NCT02137850|531435050|FG001|Extension Phase: Prophylaxis|Other|1|||
147346086|NCT02137850|531435051|FG002|Extension Phase: Prophylaxis|Other|0|||
147346087|NCT02137850|531435049|FG000|Extension Phase: Prophylaxis|Early site closure|0|||
147346088|NCT02137850|531435050|FG001|Extension Phase: Prophylaxis|Early site closure|2|||
147346089|NCT02137850|531435051|FG002|Extension Phase: Prophylaxis|Early site closure|0|||
147346090|NCT00136435|531435052|FG000|Overall Study|Ineligible|8|||
147346091|NCT00136435|531435052|FG000|Overall Study|Induction Death|1|||
147346092|NCT00136435|531435052|FG000|Overall Study|Induction Failure|10|||
147346093|NCT00136435|531435052|FG000|Overall Study|Withdrew prior to initiating imatinib/Ph+|3|||
147346094|NCT00136435|531435052|FG000|Overall Study|Withdrawal by Subject|3|||
147346095|NCT00136435|531435052|FG000|Overall Study|Adverse Event|19|||
147346096|NCT00136435|531435052|FG000|Overall Study|Relapse|4|||
147346097|NCT00136435|531435052|FG000|Overall Study|Transplant in first Complete Remission (CR)|16|||
147346098|NCT02794480|531435053|FG000|Period 1: Treatment Period 1 (28 Days)|Adverse Event|0|||
147346099|NCT02794480|531435054|FG001|Period 1: Treatment Period 1 (28 Days)|Adverse Event|0|||
147346100|NCT02794480|531435055|FG002|Period 1: Treatment Period 1 (28 Days)|Adverse Event|1|||
147346101|NCT02794480|531435056|FG003|Period 1: Treatment Period 1 (28 Days)|Adverse Event|0|||
147346102|NCT02794480|531435053|FG000|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|0|||
147346103|NCT02794480|531435054|FG001|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|0|||
147346104|NCT02794480|531435055|FG002|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|1|||
147346105|NCT02794480|531435056|FG003|Period 1: Treatment Period 1 (28 Days)|Protocol Violation|0|||
147346106|NCT02794480|531435053|FG000|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
147346107|NCT02794480|531435054|FG001|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
147346108|NCT02794480|531435055|FG002|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
147346109|NCT02794480|531435056|FG003|Period 1: Treatment Period 1 (28 Days)|Lost to Follow-up|2|||
147346110|NCT02794480|531435053|FG000|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
147346111|NCT02794480|531435054|FG001|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|2|||
147346112|NCT02794480|531435055|FG002|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
147346113|NCT02794480|531435056|FG003|Period 1: Treatment Period 1 (28 Days)|Withdrawal by Subject|1|||
147346114|NCT02794480|531435053|FG000|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|1|||
147346115|NCT02794480|531435054|FG001|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
147346116|NCT02794480|531435055|FG002|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
147346117|NCT02794480|531435056|FG003|Period 2: Treatment Period 2 (28 Days)|Withdrawal by Subject|1|||
147346118|NCT00632749|531435057|FG000|Overall Study|Progressive disease|3|||
147662724|NCT02227784|532587412|FG000|Double-Blind Phase|Sponsor Decision|34|||
147662725|NCT02227784|532587413|FG001|Double-Blind Phase|Sponsor Decision|15|||
147346119|NCT00632749|531435058|FG001|Overall Study|Progressive disease|2|||
147346120|NCT00632749|531435059|FG002|Overall Study|Progressive disease|2|||
147346121|NCT00632749|531435060|FG003|Overall Study|Progressive disease|2|||
147346122|NCT00632749|531435061|FG004|Overall Study|Progressive disease|4|||
147346123|NCT00632749|531435062|FG005|Overall Study|Progressive disease|4|||
147346124|NCT00632749|531435063|FG006|Overall Study|Progressive disease|3|||
147346125|NCT00632749|531435064|FG007|Overall Study|Progressive disease|2|||
147346126|NCT00632749|531435065|FG008|Overall Study|Progressive disease|3|||
147346127|NCT00632749|531435066|FG009|Overall Study|Progressive disease|2|||
147346128|NCT00632749|531435067|FG010|Overall Study|Progressive disease|4|||
147346129|NCT00632749|531435068|FG011|Overall Study|Progressive disease|3|||
147346130|NCT00632749|531435069|FG012|Overall Study|Progressive disease|2|||
147346131|NCT00632749|531435070|FG013|Overall Study|Progressive disease|4|||
147346132|NCT00632749|531435057|FG000|Overall Study|Other Adverse event|1|||
147346133|NCT00632749|531435058|FG001|Overall Study|Other Adverse event|1|||
147346134|NCT00632749|531435059|FG002|Overall Study|Other Adverse event|1|||
147346135|NCT00632749|531435060|FG003|Overall Study|Other Adverse event|1|||
147346136|NCT00632749|531435061|FG004|Overall Study|Other Adverse event|2|||
147346137|NCT00632749|531435062|FG005|Overall Study|Other Adverse event|4|||
147346138|NCT00632749|531435063|FG006|Overall Study|Other Adverse event|1|||
147346139|NCT00632749|531435064|FG007|Overall Study|Other Adverse event|2|||
147346140|NCT00632749|531435065|FG008|Overall Study|Other Adverse event|2|||
147346141|NCT00632749|531435066|FG009|Overall Study|Other Adverse event|0|||
147346142|NCT00632749|531435067|FG010|Overall Study|Other Adverse event|1|||
147346143|NCT00632749|531435068|FG011|Overall Study|Other Adverse event|0|||
147346144|NCT00632749|531435069|FG012|Overall Study|Other Adverse event|1|||
147346145|NCT00632749|531435070|FG013|Overall Study|Other Adverse event|0|||
147346146|NCT00632749|531435057|FG000|Overall Study|Refuse to continue medication|0|||
147346147|NCT00632749|531435058|FG001|Overall Study|Refuse to continue medication|0|||
147346148|NCT00632749|531435059|FG002|Overall Study|Refuse to continue medication|0|||
147346149|NCT00632749|531435060|FG003|Overall Study|Refuse to continue medication|1|||
147346150|NCT00632749|531435061|FG004|Overall Study|Refuse to continue medication|0|||
147346151|NCT00632749|531435062|FG005|Overall Study|Refuse to continue medication|0|||
147346152|NCT00632749|531435063|FG006|Overall Study|Refuse to continue medication|0|||
147346153|NCT00632749|531435064|FG007|Overall Study|Refuse to continue medication|0|||
147346154|NCT00632749|531435065|FG008|Overall Study|Refuse to continue medication|0|||
147346155|NCT00632749|531435066|FG009|Overall Study|Refuse to continue medication|1|||
147346156|NCT00632749|531435067|FG010|Overall Study|Refuse to continue medication|0|||
147346157|NCT00632749|531435068|FG011|Overall Study|Refuse to continue medication|0|||
147346158|NCT00632749|531435069|FG012|Overall Study|Refuse to continue medication|0|||
147346159|NCT00632749|531435070|FG013|Overall Study|Refuse to continue medication|0|||
147346160|NCT00632749|531435057|FG000|Overall Study|Reason other than those specified above|0|||
147346161|NCT00632749|531435058|FG001|Overall Study|Reason other than those specified above|2|||
147346162|NCT00632749|531435059|FG002|Overall Study|Reason other than those specified above|0|||
147346163|NCT00632749|531435060|FG003|Overall Study|Reason other than those specified above|0|||
147346164|NCT00632749|531435061|FG004|Overall Study|Reason other than those specified above|1|||
147346165|NCT00632749|531435062|FG005|Overall Study|Reason other than those specified above|0|||
147346166|NCT00632749|531435063|FG006|Overall Study|Reason other than those specified above|1|||
147346167|NCT00632749|531435064|FG007|Overall Study|Reason other than those specified above|0|||
147346168|NCT00632749|531435065|FG008|Overall Study|Reason other than those specified above|0|||
147346169|NCT00632749|531435066|FG009|Overall Study|Reason other than those specified above|0|||
147346170|NCT00632749|531435067|FG010|Overall Study|Reason other than those specified above|2|||
147346171|NCT00632749|531435068|FG011|Overall Study|Reason other than those specified above|1|||
147346172|NCT00632749|531435069|FG012|Overall Study|Reason other than those specified above|0|||
147606761|NCT00477633|532375310|FG000|Overall Study|Did not receive treatment|23|||
147606762|NCT00477633|532375310|FG000|Overall Study|Adverse Event|143|||
147606763|NCT00477633|532375310|FG000|Overall Study|Pregnancy|23|||
147346173|NCT00632749|531435070|FG013|Overall Study|Reason other than those specified above|2|||
147346174|NCT04999592|531435071|FG000|Overall Study|Withdrawal by Subject|1|||
147346175|NCT04999592|531435072|FG001|Overall Study|Withdrawal by Subject|0|||
147346176|NCT02671435|531435079|FG000|Overall Study|Death|1|||
147346177|NCT02671435|531435080|FG001|Overall Study|Death|3|||
147346178|NCT02671435|531435081|FG002|Overall Study|Death|0|||
147606764|NCT00477633|532375310|FG000|Overall Study|Lost to Follow-up|271|||
147346179|NCT02671435|531435082|FG003|Overall Study|Death|16|||
147346180|NCT02671435|531435083|FG004|Overall Study|Death|14|||
147346181|NCT02671435|531435084|FG005|Overall Study|Death|29|||
147346182|NCT02671435|531435085|FG006|Overall Study|Death|34|||
147346183|NCT02671435|531435086|FG007|Overall Study|Death|28|||
147346184|NCT02671435|531435087|FG008|Overall Study|Death|19|||
147346185|NCT02671435|531435088|FG009|Overall Study|Death|10|||
147346186|NCT02671435|531435089|FG010|Overall Study|Death|8|||
147346187|NCT02671435|531435090|FG011|Overall Study|Death|29|||
147346188|NCT02671435|531435091|FG012|Overall Study|Death|29|||
147346189|NCT02671435|531435092|FG013|Overall Study|Death|29|||
147346190|NCT02671435|531435093|FG014|Overall Study|Death|27|||
147606765|NCT00477633|532375310|FG000|Overall Study|Withdrawal by Subject|149|||
147346191|NCT02671435|531435079|FG000|Overall Study|Lost to Follow-up|0|||
147346192|NCT02671435|531435080|FG001|Overall Study|Lost to Follow-up|0|||
147346193|NCT02671435|531435081|FG002|Overall Study|Lost to Follow-up|1|||
147346194|NCT02671435|531435082|FG003|Overall Study|Lost to Follow-up|0|||
147346195|NCT02671435|531435083|FG004|Overall Study|Lost to Follow-up|1|||
147346196|NCT02671435|531435084|FG005|Overall Study|Lost to Follow-up|1|||
147346197|NCT02671435|531435085|FG006|Overall Study|Lost to Follow-up|2|||
147346198|NCT02671435|531435086|FG007|Overall Study|Lost to Follow-up|2|||
147346199|NCT02671435|531435087|FG008|Overall Study|Lost to Follow-up|0|||
147346200|NCT02671435|531435088|FG009|Overall Study|Lost to Follow-up|2|||
147346201|NCT02671435|531435089|FG010|Overall Study|Lost to Follow-up|0|||
147346202|NCT02671435|531435090|FG011|Overall Study|Lost to Follow-up|3|||
147346203|NCT02671435|531435091|FG012|Overall Study|Lost to Follow-up|3|||
147346204|NCT02671435|531435092|FG013|Overall Study|Lost to Follow-up|2|||
147606766|NCT00477633|532375310|FG000|Overall Study|Protocol Violation|25|||
147606767|NCT00477633|532375310|FG000|Overall Study|Various (Moving, Enrollment closed)|75|||
147606768|NCT02968849|532375311|FG000|Overall Study|Death|8|||
147606769|NCT02968849|532375312|FG001|Overall Study|Death|10|||
147606770|NCT02968849|532375311|FG000|Overall Study|Lost to Follow-up|31|||
147606771|NCT02968849|532375312|FG001|Overall Study|Lost to Follow-up|29|||
147606772|NCT02968849|532375311|FG000|Overall Study|Withdrawal by Subject|73|||
147606773|NCT02968849|532375312|FG001|Overall Study|Withdrawal by Subject|64|||
147606774|NCT02968849|532375311|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|13|||
147606775|NCT02968849|532375312|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|21|||
147606776|NCT02968849|532375311|FG000|Overall Study|Physician Decision|6|||
147606777|NCT02968849|532375312|FG001|Overall Study|Physician Decision|9|||
147606778|NCT02968849|532375311|FG000|Overall Study|Other|16|||
147606779|NCT02968849|532375312|FG001|Overall Study|Other|10|||
147606780|NCT00478244|532377117|FG000|Overall Study|Did not receive transplant|1|||
147606781|NCT00580788|532377118|FG000|Overall Study|Adverse Event|0|||
147346205|NCT02671435|531435093|FG014|Overall Study|Lost to Follow-up|0|||
147346206|NCT02671435|531435079|FG000|Overall Study|Withdrawal by Subject|2|||
147346207|NCT02671435|531435080|FG001|Overall Study|Withdrawal by Subject|0|||
147346208|NCT02671435|531435081|FG002|Overall Study|Withdrawal by Subject|2|||
147346209|NCT02671435|531435082|FG003|Overall Study|Withdrawal by Subject|2|||
147346210|NCT02671435|531435083|FG004|Overall Study|Withdrawal by Subject|2|||
147346211|NCT02671435|531435084|FG005|Overall Study|Withdrawal by Subject|7|||
147346212|NCT02671435|531435085|FG006|Overall Study|Withdrawal by Subject|2|||
147346213|NCT02671435|531435086|FG007|Overall Study|Withdrawal by Subject|7|||
147346214|NCT02671435|531435087|FG008|Overall Study|Withdrawal by Subject|1|||
147346215|NCT02671435|531435088|FG009|Overall Study|Withdrawal by Subject|1|||
147346216|NCT02671435|531435089|FG010|Overall Study|Withdrawal by Subject|2|||
147346217|NCT02671435|531435090|FG011|Overall Study|Withdrawal by Subject|4|||
147346218|NCT02671435|531435091|FG012|Overall Study|Withdrawal by Subject|4|||
147346219|NCT02671435|531435092|FG013|Overall Study|Withdrawal by Subject|4|||
147346220|NCT02671435|531435093|FG014|Overall Study|Withdrawal by Subject|2|||
147346221|NCT02671435|531435079|FG000|Overall Study|Un-specified|0|||
147346222|NCT02671435|531435080|FG001|Overall Study|Un-specified|0|||
147346223|NCT02671435|531435081|FG002|Overall Study|Un-specified|0|||
147346224|NCT02671435|531435082|FG003|Overall Study|Un-specified|0|||
147346225|NCT02671435|531435083|FG004|Overall Study|Un-specified|1|||
147346226|NCT02671435|531435084|FG005|Overall Study|Un-specified|3|||
147346227|NCT02671435|531435085|FG006|Overall Study|Un-specified|2|||
147346228|NCT02671435|531435086|FG007|Overall Study|Un-specified|3|||
147453263|NCT02792842|531823975|FG000|Overall Study|Adverse Event|4|||
147606782|NCT00580788|532377119|FG001|Overall Study|Adverse Event|0|||
147606783|NCT00580788|532377120|FG002|Overall Study|Adverse Event|0|||
147606784|NCT00580788|532377121|FG003|Overall Study|Adverse Event|1|||
147606785|NCT03301649|532377124|FG000|Overall Study|Need alternate therapy due to live lice|17|||
147606786|NCT03301649|532377125|FG001|Overall Study|Need alternate therapy due to live lice|25|||
147606787|NCT03301649|532377126|FG002|Overall Study|Need alternate therapy due to live lice|81|||
147606788|NCT03301649|532377124|FG000|Overall Study|Lost to Follow-up|11|||
147606789|NCT03301649|532377125|FG001|Overall Study|Lost to Follow-up|11|||
147606790|NCT03301649|532377126|FG002|Overall Study|Lost to Follow-up|3|||
147662726|NCT02227784|532587414|FG002|Double-Blind Phase|Sponsor Decision|14|||
147346229|NCT02671435|531435087|FG008|Overall Study|Un-specified|0|||
147346230|NCT02671435|531435088|FG009|Overall Study|Un-specified|5|||
147346231|NCT02671435|531435089|FG010|Overall Study|Un-specified|8|||
147606791|NCT03301649|532377124|FG000|Overall Study|Protocol Violation|0|||
147606792|NCT03301649|532377125|FG001|Overall Study|Protocol Violation|1|||
147346232|NCT02671435|531435090|FG011|Overall Study|Un-specified|4|||
147346233|NCT02671435|531435091|FG012|Overall Study|Un-specified|5|||
147346234|NCT02671435|531435092|FG013|Overall Study|Un-specified|9|||
147346235|NCT02671435|531435093|FG014|Overall Study|Un-specified|8|||
147346236|NCT04095104|531435094|FG000|Overall Study|Withdrawal by Subject|0|||
147346237|NCT04095104|531435095|FG001|Overall Study|Withdrawal by Subject|1|||
147346238|NCT01721291|531435098|FG000|Overall Study|Withdrawal by Subject|1|||
147346239|NCT01721291|531435099|FG001|Overall Study|Withdrawal by Subject|0|||
147346240|NCT01721291|531435098|FG000|Overall Study|did not like the treatment|1|||
147346241|NCT01721291|531435099|FG001|Overall Study|did not like the treatment|0|||
147346242|NCT01091168|531435100|FG000|Overall Study|Progressive disease|250|||
147346243|NCT01091168|531435101|FG001|Overall Study|Progressive disease|234|||
147346244|NCT01091168|531435100|FG000|Overall Study|Adverse Event|21|||
147346245|NCT01091168|531435101|FG001|Overall Study|Adverse Event|24|||
147346246|NCT01091168|531435100|FG000|Overall Study|Lost to Follow-up|0|||
147346247|NCT01091168|531435101|FG001|Overall Study|Lost to Follow-up|1|||
147346248|NCT01091168|531435100|FG000|Overall Study|Physician, patient's decision, other|27|||
147346249|NCT01091168|531435101|FG001|Overall Study|Physician, patient's decision, other|37|||
147346250|NCT03767517|531435102|FG000|Overall Study|Lost to Follow-up|16|||
147346251|NCT03767517|531435103|FG001|Overall Study|Lost to Follow-up|10|||
147346252|NCT03767517|531435102|FG000|Overall Study|Death|2|||
147346253|NCT03767517|531435103|FG001|Overall Study|Death|3|||
147346254|NCT01303445|531435106|FG000|First Intervention (7 Days)|Withdrawal by Subject|1|||
147346255|NCT01303445|531435107|FG001|First Intervention (7 Days)|Withdrawal by Subject|0|||
147346256|NCT01303445|531435106|FG000|Second Intervention (7 Days)|Adverse Event|0|||
147346257|NCT01303445|531435107|FG001|Second Intervention (7 Days)|Adverse Event|2|||
147346258|NCT01303445|531435106|FG000|Second Intervention (7 Days)|Withdrawal by Subject|1|||
147346259|NCT01303445|531435107|FG001|Second Intervention (7 Days)|Withdrawal by Subject|0|||
147346260|NCT01303445|531435106|FG000|Washout (14 Days)|Protocol Violation|1|||
147346261|NCT01303445|531435107|FG001|Washout (14 Days)|Protocol Violation|0|||
147346262|NCT01303445|531435106|FG000|Washout (14 Days)|Lost to Follow-up|0|||
147346263|NCT01303445|531435107|FG001|Washout (14 Days)|Lost to Follow-up|2|||
147346264|NCT01303445|531435106|FG000|Fourth Intervention (7 Days)|Withdrawal by Subject|1|||
147346265|NCT01303445|531435107|FG001|Fourth Intervention (7 Days)|Withdrawal by Subject|0|||
147346266|NCT01303445|531435106|FG000|Follow-up Period (14 Days)|Withdrawal by Subject|0|||
147346267|NCT01303445|531435107|FG001|Follow-up Period (14 Days)|Withdrawal by Subject|1|||
147346268|NCT04059354|531436345|FG000|Overall Study|COVID-19 pandemic|3|||
147346269|NCT02396199|531436347|FG000|Overall Study|Lost to Follow-up|1|||
147346270|NCT02396199|531436347|FG000|Overall Study|Death|4|||
147346271|NCT04868110|531436352|FG000|Overall Study|Withdrawal by Subject|3|||
147346272|NCT04868110|531436353|FG001|Overall Study|Withdrawal by Subject|4|||
147346273|NCT03263026|531436354|FG000|Overall Study|Withdrawal by Subject|1|||
147346274|NCT03263026|531436355|FG001|Overall Study|Withdrawal by Subject|0|||
147346275|NCT03263026|531436354|FG000|Overall Study|Death|1|||
147346276|NCT03263026|531436355|FG001|Overall Study|Death|0|||
147346277|NCT03263026|531436354|FG000|Overall Study|Other/ Various|41|||
147346278|NCT03263026|531436355|FG001|Overall Study|Other/ Various|29|||
147346279|NCT05320432|531436359|FG000|Overall Study|Withdrawal by Subject|0|||
147346280|NCT05320432|531436360|FG001|Overall Study|Withdrawal by Subject|2|||
147346281|NCT05415410|531436367|FG000|Overall Study|Death|3|||
147346282|NCT05415410|531436368|FG001|Overall Study|Death|6|||
147346283|NCT05415410|531436369|FG002|Overall Study|Death|1|||
147346284|NCT05415410|531436367|FG000|Overall Study|Trial Terminated by Sponsor|1|||
147346285|NCT05415410|531436368|FG001|Overall Study|Trial Terminated by Sponsor|5|||
147346286|NCT05415410|531436369|FG002|Overall Study|Trial Terminated by Sponsor|0|||
147346287|NCT05415410|531436367|FG000|Overall Study|Adverse Event|2|||
147346288|NCT05415410|531436368|FG001|Overall Study|Adverse Event|1|||
147346289|NCT05415410|531436369|FG002|Overall Study|Adverse Event|0|||
147346290|NCT05415410|531436367|FG000|Overall Study|Physician Decision due to Non-Compliance|1|||
147346291|NCT05415410|531436368|FG001|Overall Study|Physician Decision due to Non-Compliance|0|||
147346292|NCT05415410|531436369|FG002|Overall Study|Physician Decision due to Non-Compliance|0|||
147346293|NCT05415410|531436367|FG000|Overall Study|Withdrawal by Subject|1|||
147346294|NCT05415410|531436368|FG001|Overall Study|Withdrawal by Subject|0|||
147346295|NCT05415410|531436369|FG002|Overall Study|Withdrawal by Subject|0|||
147346296|NCT05415410|531436367|FG000|Overall Study|Pregnancy|5|||
147346297|NCT05415410|531436368|FG001|Overall Study|Pregnancy|2|||
147346298|NCT05415410|531436369|FG002|Overall Study|Pregnancy|0|||
147346299|NCT04711135|531436376|FG000|Overall Study|Physician Decision|0|||
147346300|NCT04711135|531436377|FG001|Overall Study|Physician Decision|1|||
147346301|NCT04711135|531436376|FG000|Overall Study|Ongoing treatment|0|||
147346302|NCT04711135|531436377|FG001|Overall Study|Ongoing treatment|1|||
147346303|NCT03578536|531436381|FG000|Overall Study|Lost to Follow-up|1|||
147346304|NCT02538900|531436383|FG000|Overall Study|Death|2|||
147346305|NCT02538900|531436384|FG001|Overall Study|Death|2|||
147346306|NCT02538900|531436385|FG002|Overall Study|Death|2|||
147346307|NCT02538900|531436383|FG000|Overall Study|Withdrawal by Subject|18|||
147346308|NCT02538900|531436384|FG001|Overall Study|Withdrawal by Subject|16|||
147346309|NCT02538900|531436385|FG002|Overall Study|Withdrawal by Subject|15|||
147346310|NCT02874534|531436386|FG000|Overall Study|Withdrawal by Subject|5|||
147346311|NCT02874534|531436387|FG001|Overall Study|Withdrawal by Subject|8|||
147346312|NCT02874534|531436386|FG000|Overall Study|Lost to Follow-up|2|||
147346313|NCT02874534|531436387|FG001|Overall Study|Lost to Follow-up|2|||
147346314|NCT02874534|531436386|FG000|Overall Study|Ongoing in study|1|||
147346315|NCT02874534|531436387|FG001|Overall Study|Ongoing in study|1|||
147346316|NCT04431726|531436388|FG000|Overall Study|Ongoing in the Study|55|||
147346317|NCT04281485|531436389|FG000|Overall Study|No Longer Met Eligibility Criteria|0|||
147346318|NCT04281485|531436390|FG001|Overall Study|No Longer Met Eligibility Criteria|2|||
147346319|NCT04281485|531436389|FG000|Overall Study|Ongoing (Safety data collection)|10|||
147346320|NCT04281485|531436390|FG001|Overall Study|Ongoing (Safety data collection)|5|||
147346321|NCT01095796|531436391|FG000|Overall Study|Randomized but Not Treated|5|||
147606793|NCT03301649|532377126|FG002|Overall Study|Protocol Violation|1|||
147606794|NCT03301649|532377124|FG000|Overall Study|Withdrawal by Subject|10|||
147606795|NCT03301649|532377125|FG001|Overall Study|Withdrawal by Subject|4|||
147606796|NCT03301649|532377126|FG002|Overall Study|Withdrawal by Subject|0|||
147606797|NCT03301649|532377124|FG000|Overall Study|Other than specified|5|||
147606798|NCT03301649|532377125|FG001|Overall Study|Other than specified|3|||
147606799|NCT03301649|532377126|FG002|Overall Study|Other than specified|0|||
147346322|NCT01095796|531436392|FG001|Overall Study|Randomized but Not Treated|2|||
147346323|NCT01095796|531436391|FG000|Overall Study|Adverse Event|9|||
147346324|NCT01095796|531436392|FG001|Overall Study|Adverse Event|19|||
147606800|NCT01403051|532377127|FG000|Overall Study|Protocol Violation|2|||
147346325|NCT01095796|531436391|FG000|Overall Study|Death|3|||
147346326|NCT01095796|531436392|FG001|Overall Study|Death|2|||
147346327|NCT01095796|531436391|FG000|Overall Study|Pregnancy|2|||
147346328|NCT01095796|531436392|FG001|Overall Study|Pregnancy|0|||
147346329|NCT01095796|531436391|FG000|Overall Study|Lack of Efficacy|5|||
147346330|NCT01095796|531436392|FG001|Overall Study|Lack of Efficacy|3|||
147346331|NCT01095796|531436391|FG000|Overall Study|Investigator's Discretion|7|||
147346332|NCT01095796|531436392|FG001|Overall Study|Investigator's Discretion|2|||
147346333|NCT01095796|531436391|FG000|Overall Study|Withdrew Consent|16|||
147346334|NCT01095796|531436392|FG001|Overall Study|Withdrew Consent|22|||
147346335|NCT01095796|531436391|FG000|Overall Study|Lost to Follow-up|27|||
147346336|NCT01095796|531436392|FG001|Overall Study|Lost to Follow-up|29|||
147346337|NCT01095796|531436391|FG000|Overall Study|Participant Noncompliance|5|||
147346338|NCT01095796|531436392|FG001|Overall Study|Participant Noncompliance|10|||
147346339|NCT01095796|531436391|FG000|Overall Study|Protocol Violation|1|||
147346340|NCT01095796|531436392|FG001|Overall Study|Protocol Violation|0|||
147346341|NCT01095796|531436391|FG000|Overall Study|Participant Transferred to Another Study|215|||
147346342|NCT01095796|531436392|FG001|Overall Study|Participant Transferred to Another Study|200|||
147346343|NCT03517969|531436398|FG000|Overall Study|Never started protocol treatment|3|||
147346344|NCT03517969|531436399|FG001|Overall Study|Never started protocol treatment|5|||
147346345|NCT03517969|531436398|FG000|Overall Study|Disease progression|11|||
147346346|NCT03517969|531436399|FG001|Overall Study|Disease progression|16|||
147346347|NCT03517969|531436398|FG000|Overall Study|PSA progression|8|||
147346348|NCT03517969|531436399|FG001|Overall Study|PSA progression|1|||
147662727|NCT02227784|532587415|FG003|Double-Blind Phase|Sponsor Decision|32|||
147662728|NCT02227784|532587416|FG004|Double-Blind Phase|Sponsor Decision|0|||
147662729|NCT02227784|532587412|FG000|Double-Blind Phase|Withdrawal by Subject|2|||
147662730|NCT02227784|532587413|FG001|Double-Blind Phase|Withdrawal by Subject|1|||
147662731|NCT02227784|532587414|FG002|Double-Blind Phase|Withdrawal by Subject|5|||
147662732|NCT02227784|532587415|FG003|Double-Blind Phase|Withdrawal by Subject|2|||
147346349|NCT03517969|531436398|FG000|Overall Study|Clinical progression|4|||
147346350|NCT03517969|531436399|FG001|Overall Study|Clinical progression|2|||
147346351|NCT03517969|531436398|FG000|Overall Study|Adverse Event|5|||
147346352|NCT03517969|531436399|FG001|Overall Study|Adverse Event|4|||
147346353|NCT03517969|531436398|FG000|Overall Study|Intercurrent illness|1|||
147346354|NCT03517969|531436399|FG001|Overall Study|Intercurrent illness|2|||
147346355|NCT03517969|531436398|FG000|Overall Study|Death|1|||
147346356|NCT03517969|531436399|FG001|Overall Study|Death|1|||
147346357|NCT03517969|531436398|FG000|Overall Study|Withdrawal by Subject|1|||
147346358|NCT03517969|531436399|FG001|Overall Study|Withdrawal by Subject|2|||
147346359|NCT03517969|531436398|FG000|Overall Study|Physician Decision|1|||
147606801|NCT01403051|532377128|FG001|Overall Study|Protocol Violation|0|||
147606802|NCT01403051|532377127|FG000|Overall Study|Death|1|||
147606803|NCT01403051|532377128|FG001|Overall Study|Death|0|||
147606804|NCT01403051|532377127|FG000|Overall Study|Withdrawal by Subject|2|||
147346360|NCT03517969|531436399|FG001|Overall Study|Physician Decision|1|||
147346361|NCT03517969|531436398|FG000|Overall Study|No clinical benefit|1|||
147346362|NCT03517969|531436399|FG001|Overall Study|No clinical benefit|0|||
147346363|NCT03517969|531436398|FG000|Overall Study|Delayed treatment for dental treatment|1|||
147346364|NCT03517969|531436399|FG001|Overall Study|Delayed treatment for dental treatment|0|||
147346365|NCT03517969|531436398|FG000|Overall Study|Difficult to maintain appointment|0|||
147346366|NCT03517969|531436399|FG001|Overall Study|Difficult to maintain appointment|1|||
147346367|NCT03517969|531436398|FG000|Overall Study|Protocol Violation|0|||
147346368|NCT03517969|531436399|FG001|Overall Study|Protocol Violation|1|||
147346369|NCT02140645|531436400|FG000|Overall Study|Not linked|5489|||
147606805|NCT01403051|532377128|FG001|Overall Study|Withdrawal by Subject|1|||
147606806|NCT01403051|532377127|FG000|Overall Study|Lost to Follow-up|5|||
147606807|NCT01403051|532377128|FG001|Overall Study|Lost to Follow-up|5|||
147606808|NCT00887289|532377133|FG000|Overall Study|Lack of Efficacy|14|||
147662733|NCT02227784|532587416|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
147346370|NCT02140645|531436401|FG001|Overall Study|Not linked|61654|||
147346371|NCT02140645|531436402|FG002|Overall Study|Not linked|4236|||
147346372|NCT02140645|531436403|FG003|Overall Study|Not linked|13833|||
147346373|NCT02140645|531436404|FG004|Overall Study|Not linked|3286|||
147346374|NCT02140645|531436405|FG005|Overall Study|Not linked|70896|||
147346375|NCT04854096|531436406|FG000|Overall Study|Adverse Event|1|||
147346376|NCT04854096|531436407|FG001|Overall Study|Adverse Event|0|||
147346377|NCT04854096|531436406|FG000|Overall Study|Study terminated by Sponsor due to business reasons.|2|||
147346378|NCT04854096|531436407|FG001|Overall Study|Study terminated by Sponsor due to business reasons.|2|||
147346379|NCT04854096|531436406|FG000|Overall Study|Withdrawal by Subject|1|||
147346380|NCT04854096|531436407|FG001|Overall Study|Withdrawal by Subject|0|||
147346381|NCT04854096|531436406|FG000|Overall Study|Other reasons|1|||
147346382|NCT04854096|531436407|FG001|Overall Study|Other reasons|0|||
147346383|NCT02965846|531436410|FG000|Overall Study|Lost to Follow-up|1|||
147346384|NCT02965846|531436411|FG001|Overall Study|Lost to Follow-up|0|||
147346385|NCT02965846|531436412|FG002|Overall Study|Lost to Follow-up|0|||
147346386|NCT02965846|531436410|FG000|Overall Study|Withdrawal by Subject|0|||
147346387|NCT02965846|531436411|FG001|Overall Study|Withdrawal by Subject|1|||
147346388|NCT02965846|531436412|FG002|Overall Study|Withdrawal by Subject|0|||
147346389|NCT02965846|531436410|FG000|Overall Study|Study Terminated By Sponsor|4|||
147346390|NCT02965846|531436411|FG001|Overall Study|Study Terminated By Sponsor|4|||
147346391|NCT02965846|531436412|FG002|Overall Study|Study Terminated By Sponsor|0|||
147346392|NCT02965846|531436410|FG000|Overall Study|Participants not randomized|0|||
147346393|NCT02965846|531436411|FG001|Overall Study|Participants not randomized|0|||
147346394|NCT02965846|531436412|FG002|Overall Study|Participants not randomized|33|||
147346395|NCT02814838|531436413|FG000|Overall Study|3 agreed dates for the final visit missed|1|||
147346396|NCT02814838|531436414|FG001|Overall Study|3 agreed dates for the final visit missed|0|||
147346397|NCT02814838|531436413|FG000|Overall Study|Consent withdrawal|1|||
147346398|NCT02814838|531436414|FG001|Overall Study|Consent withdrawal|1|||
147346399|NCT00593489|531436415|FG000|Allocation|did not attend workshop; allocation not|2|||
147346400|NCT00593489|531436416|FG001|Allocation|did not attend workshop; allocation not|1|||
147346401|NCT00901901|531436417|FG000|Treatment Period|Adverse Event|120|||
147346402|NCT00901901|531436418|FG001|Treatment Period|Adverse Event|128|||
147346403|NCT00901901|531436417|FG000|Treatment Period|Withdrawal by Subject|26|||
147346404|NCT00901901|531436418|FG001|Treatment Period|Withdrawal by Subject|24|||
147346405|NCT00901901|531436417|FG000|Treatment Period|Physician Decision|2|||
147346406|NCT00901901|531436418|FG001|Treatment Period|Physician Decision|2|||
147346407|NCT00901901|531436417|FG000|Treatment Period|Lost to Follow-up|3|||
147346408|NCT00901901|531436418|FG001|Treatment Period|Lost to Follow-up|5|||
147346409|NCT00901901|531436417|FG000|Treatment Period|Noncompliance with study medication|4|||
147346410|NCT00901901|531436418|FG001|Treatment Period|Noncompliance with study medication|1|||
147346411|NCT00901901|531436417|FG000|Treatment Period|Missing|1|||
147346412|NCT00901901|531436418|FG001|Treatment Period|Missing|0|||
147346413|NCT00901901|531436417|FG000|Treatment Period|Never treated|0|||
147346414|NCT00901901|531436418|FG001|Treatment Period|Never treated|3|||
147346415|NCT00901901|531436417|FG000|Treatment Period|Protocol driven decision point|0|||
147346416|NCT00901901|531436418|FG001|Treatment Period|Protocol driven decision point|2|||
147346417|NCT00901901|531436417|FG000|Treatment Period|Study terminated by sponsor|2|||
147346418|NCT00901901|531436418|FG001|Treatment Period|Study terminated by sponsor|0|||
147346419|NCT00901901|531436417|FG000|Treatment Period|Protocol Violation|5|||
147346420|NCT00901901|531436418|FG001|Treatment Period|Protocol Violation|9|||
147346421|NCT00901901|531436417|FG000|Treatment Period|Switch to commercial drug|1|||
147346422|NCT00901901|531436418|FG001|Treatment Period|Switch to commercial drug|1|||
147346423|NCT00901901|531436417|FG000|Treatment Period|Transfer to treatment continuation study|5|||
147346424|NCT00901901|531436418|FG001|Treatment Period|Transfer to treatment continuation study|2|||
147346425|NCT00901901|531436417|FG000|Follow-up Period|Death|181|||
147346426|NCT00901901|531436418|FG001|Follow-up Period|Death|208|||
147346427|NCT00901901|531436417|FG000|Follow-up Period|Protocol driven decision point|47|||
147346428|NCT00901901|531436418|FG001|Follow-up Period|Protocol driven decision point|36|||
147346429|NCT00901901|531436417|FG000|Follow-up Period|Withdrawal by Subject|6|||
147346430|NCT00901901|531436418|FG001|Follow-up Period|Withdrawal by Subject|9|||
147346431|NCT00901901|531436417|FG000|Follow-up Period|Lost to Follow-up|12|||
147453264|NCT02792842|531823976|FG001|Overall Study|Adverse Event|2|||
147606809|NCT00887289|532377133|FG000|Overall Study|Adverse Event|27|||
147606810|NCT00887289|532377133|FG000|Overall Study|Withdrawal by Subject|26|||
147606811|NCT00887289|532377133|FG000|Overall Study|Lost to Follow-up|8|||
147346432|NCT00901901|531436418|FG001|Follow-up Period|Lost to Follow-up|8|||
147346433|NCT00901901|531436417|FG000|Follow-up Period|Missing|94|||
147346434|NCT00901901|531436418|FG001|Follow-up Period|Missing|80|||
147606812|NCT00887289|532377133|FG000|Overall Study|Other|20|||
147346435|NCT00073749|531436419|FG000|Overall Study|Disease Progression|2|||
147346436|NCT00073749|531436420|FG001|Overall Study|Disease Progression|0|||
147346437|NCT00073749|531436421|FG002|Overall Study|Disease Progression|3|||
147346438|NCT00073749|531436422|FG003|Overall Study|Disease Progression|2|||
147346439|NCT00073749|531436423|FG004|Overall Study|Disease Progression|3|||
147606813|NCT03022084|532377134|FG000|Overall Study|Lost to Follow-up|2|||
147606814|NCT03022084|532377135|FG001|Overall Study|Lost to Follow-up|3|||
147606815|NCT02932306|532377139|FG000|Overall Study|Withdrawal by Subject|16|||
147606816|NCT02932306|532377140|FG001|Overall Study|Withdrawal by Subject|25|||
147606817|NCT02932306|532377139|FG000|Overall Study|Adverse Event|3|||
147346440|NCT00073749|531436424|FG005|Overall Study|Disease Progression|1|||
147346441|NCT00073749|531436425|FG006|Overall Study|Disease Progression|3|||
147346442|NCT00073749|531436419|FG000|Overall Study|Death|0|||
147346443|NCT00073749|531436420|FG001|Overall Study|Death|1|||
147346444|NCT00073749|531436421|FG002|Overall Study|Death|1|||
147346445|NCT00073749|531436422|FG003|Overall Study|Death|0|||
147346446|NCT00073749|531436423|FG004|Overall Study|Death|0|||
147346447|NCT00073749|531436424|FG005|Overall Study|Death|0|||
147346448|NCT00073749|531436425|FG006|Overall Study|Death|29|||
147346449|NCT00073749|531436419|FG000|Overall Study|Adverse Event|0|||
147346450|NCT00073749|531436420|FG001|Overall Study|Adverse Event|3|||
147346451|NCT00073749|531436421|FG002|Overall Study|Adverse Event|6|||
147346452|NCT00073749|531436422|FG003|Overall Study|Adverse Event|4|||
147346453|NCT00073749|531436423|FG004|Overall Study|Adverse Event|2|||
147346454|NCT00073749|531436424|FG005|Overall Study|Adverse Event|1|||
147346455|NCT00073749|531436425|FG006|Overall Study|Adverse Event|0|||
147346456|NCT00073749|531436419|FG000|Overall Study|Physician Decision|0|||
147346457|NCT00073749|531436420|FG001|Overall Study|Physician Decision|0|||
147346458|NCT00073749|531436421|FG002|Overall Study|Physician Decision|1|||
147346459|NCT00073749|531436422|FG003|Overall Study|Physician Decision|0|||
147346460|NCT00073749|531436423|FG004|Overall Study|Physician Decision|0|||
147346461|NCT00073749|531436424|FG005|Overall Study|Physician Decision|2|||
147346462|NCT00073749|531436425|FG006|Overall Study|Physician Decision|0|||
147346463|NCT00073749|531436419|FG000|Overall Study|Withdrawal by Subject|0|||
147346464|NCT00073749|531436420|FG001|Overall Study|Withdrawal by Subject|1|||
147346465|NCT00073749|531436421|FG002|Overall Study|Withdrawal by Subject|0|||
147346466|NCT00073749|531436422|FG003|Overall Study|Withdrawal by Subject|0|||
147346467|NCT00073749|531436423|FG004|Overall Study|Withdrawal by Subject|1|||
147346468|NCT00073749|531436424|FG005|Overall Study|Withdrawal by Subject|0|||
147346469|NCT00073749|531436425|FG006|Overall Study|Withdrawal by Subject|2|||
147346470|NCT00073749|531436419|FG000|Overall Study|Discontinuation of Study by Sponsor|0|||
147346471|NCT00073749|531436420|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
147346472|NCT00073749|531436421|FG002|Overall Study|Discontinuation of Study by Sponsor|0|||
147346473|NCT00073749|531436422|FG003|Overall Study|Discontinuation of Study by Sponsor|0|||
147346474|NCT00073749|531436423|FG004|Overall Study|Discontinuation of Study by Sponsor|0|||
147346475|NCT00073749|531436424|FG005|Overall Study|Discontinuation of Study by Sponsor|0|||
147346476|NCT00073749|531436425|FG006|Overall Study|Discontinuation of Study by Sponsor|4|||
147346477|NCT00073749|531436419|FG000|Overall Study|Lost to Follow-up|0|||
147346478|NCT00073749|531436420|FG001|Overall Study|Lost to Follow-up|0|||
147346479|NCT00073749|531436421|FG002|Overall Study|Lost to Follow-up|0|||
147346480|NCT00073749|531436422|FG003|Overall Study|Lost to Follow-up|0|||
147346481|NCT00073749|531436423|FG004|Overall Study|Lost to Follow-up|0|||
147346482|NCT00073749|531436424|FG005|Overall Study|Lost to Follow-up|0|||
147346483|NCT00073749|531436425|FG006|Overall Study|Lost to Follow-up|2|||
147346484|NCT00073749|531436419|FG000|Overall Study|Other|0|||
147346485|NCT00073749|531436420|FG001|Overall Study|Other|0|||
147346486|NCT00073749|531436421|FG002|Overall Study|Other|0|||
147346487|NCT00073749|531436422|FG003|Overall Study|Other|0|||
147346488|NCT00073749|531436423|FG004|Overall Study|Other|0|||
147346489|NCT00073749|531436424|FG005|Overall Study|Other|2|||
147346490|NCT00073749|531436425|FG006|Overall Study|Other|0|||
147346491|NCT00611559|531436428|FG000|Overall Study|Lost to Follow-up|0|||
147346492|NCT00611559|531436429|FG001|Overall Study|Lost to Follow-up|1|||
147346493|NCT00611559|531436430|FG002|Overall Study|Lost to Follow-up|0|||
147346494|NCT00611559|531436428|FG000|Overall Study|Protocol Violation|1|||
147346495|NCT00611559|531436429|FG001|Overall Study|Protocol Violation|0|||
147346496|NCT00611559|531436430|FG002|Overall Study|Protocol Violation|1|||
147346497|NCT00879333|531436431|FG000|Overall Study|Adverse Event|94|||
147606818|NCT02932306|532377140|FG001|Overall Study|Adverse Event|0|||
147606819|NCT02932306|532377139|FG000|Overall Study|Pregnancy|2|||
147346498|NCT00879333|531436432|FG001|Overall Study|Adverse Event|34|||
147346499|NCT00879333|531436431|FG000|Overall Study|Abnormal Laboratory Value|1|||
147346500|NCT00879333|531436432|FG001|Overall Study|Abnormal Laboratory Value|0|||
147346501|NCT00879333|531436431|FG000|Overall Study|Withdrawal by Subject|20|||
147606820|NCT02932306|532377140|FG001|Overall Study|Pregnancy|0|||
147346502|NCT00879333|531436432|FG001|Overall Study|Withdrawal by Subject|7|||
147346503|NCT00879333|531436431|FG000|Overall Study|Lost to Follow-up|2|||
147346504|NCT00879333|531436432|FG001|Overall Study|Lost to Follow-up|1|||
147346505|NCT00879333|531436431|FG000|Overall Study|Administrative Problems|2|||
147606821|NCT02932306|532377139|FG000|Overall Study|Protocol Violation|1|||
147606822|NCT02932306|532377140|FG001|Overall Study|Protocol Violation|1|||
147606823|NCT02932306|532377139|FG000|Overall Study|Noncompliance with Study Drug|1|||
147346506|NCT00879333|531436432|FG001|Overall Study|Administrative Problems|0|||
147346507|NCT00879333|531436431|FG000|Overall Study|Death|16|||
147346508|NCT00879333|531436432|FG001|Overall Study|Death|5|||
147346509|NCT00879333|531436431|FG000|Overall Study|Disease Progression|292|||
147346510|NCT00879333|531436432|FG001|Overall Study|Disease Progression|169|||
147346511|NCT00879333|531436431|FG000|Overall Study|Protocol Violation|1|||
147346512|NCT00879333|531436432|FG001|Overall Study|Protocol Violation|1|||
147346513|NCT05048186|531436436|FG000|Overall Study|inconsistent answers for main decision for adhd treatment|9|||
147346514|NCT05048186|531436437|FG001|Overall Study|inconsistent answers for main decision for adhd treatment|0|||
147346515|NCT05048186|531436436|FG000|Overall Study|did not have sufficient information to calculate the SDM Process score (primary outcome)|1|||
147346516|NCT05048186|531436437|FG001|Overall Study|did not have sufficient information to calculate the SDM Process score (primary outcome)|4|||
147346517|NCT00951379|531436438|FG000|Overall Study|Adverse Event|4|||
147346518|NCT00951379|531436439|FG001|Overall Study|Adverse Event|1|||
147346519|NCT00951379|531436438|FG000|Overall Study|Withdrawal by Subject|1|||
147346520|NCT00951379|531436439|FG001|Overall Study|Withdrawal by Subject|0|||
147346521|NCT00951379|531436438|FG000|Overall Study|Noncompliance|1|||
147346522|NCT00951379|531436439|FG001|Overall Study|Noncompliance|0|||
147346523|NCT00951379|531436438|FG000|Overall Study|Disease Progression|0|||
147346524|NCT00951379|531436439|FG001|Overall Study|Disease Progression|1|||
147346525|NCT02742519|531436443|FG000|Part 1 Treatment Period 2 (8 Weeks)|Availability of commercial drug|1|||
147346526|NCT02742519|531436444|FG001|Part 1 Treatment Period 2 (8 Weeks)|Availability of commercial drug|1|||
147346527|NCT02742519|531436445|FG002|Part 1 Treatment Period 2 (8 Weeks)|Availability of commercial drug|0|||
147346528|NCT02742519|531436443|FG000|Part 2 Open Label Period (32 Weeks)|Availability of commercial drug|0|||
147346529|NCT02742519|531436444|FG001|Part 2 Open Label Period (32 Weeks)|Availability of commercial drug|0|||
147346530|NCT02742519|531436445|FG002|Part 2 Open Label Period (32 Weeks)|Availability of commercial drug|9|||
147346531|NCT02742519|531436443|FG000|Part 2 Open Label Period (32 Weeks)|Other|0|||
147346532|NCT02742519|531436444|FG001|Part 2 Open Label Period (32 Weeks)|Other|0|||
147346533|NCT02742519|531436445|FG002|Part 2 Open Label Period (32 Weeks)|Other|1|||
147346534|NCT01872078|531436446|FG000|Overall Study|Adverse Event|0|||
147346535|NCT01872078|531436447|FG001|Overall Study|Adverse Event|0|||
147346536|NCT01872078|531436448|FG002|Overall Study|Adverse Event|1|||
147346537|NCT01872078|531436449|FG003|Overall Study|Adverse Event|0|||
147346538|NCT01872078|531436446|FG000|Overall Study|Dose administration non-compliance|0|||
147346539|NCT01872078|531436447|FG001|Overall Study|Dose administration non-compliance|0|||
147346540|NCT01872078|531436448|FG002|Overall Study|Dose administration non-compliance|0|||
147346541|NCT01872078|531436449|FG003|Overall Study|Dose administration non-compliance|1|||
147346542|NCT01872078|531436446|FG000|Overall Study|Protocol Violation|0|||
147346543|NCT01872078|531436447|FG001|Overall Study|Protocol Violation|0|||
147606824|NCT02932306|532377140|FG001|Overall Study|Noncompliance with Study Drug|1|||
147346544|NCT01872078|531436448|FG002|Overall Study|Protocol Violation|1|||
147346545|NCT01872078|531436449|FG003|Overall Study|Protocol Violation|0|||
147346546|NCT01872078|531436446|FG000|Overall Study|Withdrawal by Subject|0|||
147346547|NCT01872078|531436447|FG001|Overall Study|Withdrawal by Subject|0|||
147346548|NCT01872078|531436448|FG002|Overall Study|Withdrawal by Subject|1|||
147346549|NCT01872078|531436449|FG003|Overall Study|Withdrawal by Subject|0|||
147346550|NCT01872078|531436446|FG000|Overall Study|Patient met exclusion criterion 16.|0|||
147346551|NCT01872078|531436447|FG001|Overall Study|Patient met exclusion criterion 16.|0|||
147346552|NCT01872078|531436448|FG002|Overall Study|Patient met exclusion criterion 16.|0|||
147346553|NCT01872078|531436449|FG003|Overall Study|Patient met exclusion criterion 16.|1|||
147346554|NCT03912831|531436450|FG000|Overall Study|Death|1|||
147346555|NCT03912831|531436451|FG001|Overall Study|Death|1|||
147346556|NCT03912831|531436452|FG002|Overall Study|Death|1|||
147346557|NCT03912831|531436453|FG003|Overall Study|Death|1|||
147346558|NCT03912831|531436454|FG004|Overall Study|Death|1|||
147346559|NCT03912831|531436455|FG005|Overall Study|Death|1|||
147346560|NCT03912831|531436450|FG000|Overall Study|Reason not Specified|0|||
147346561|NCT03912831|531436451|FG001|Overall Study|Reason not Specified|0|||
147346562|NCT03912831|531436452|FG002|Overall Study|Reason not Specified|0|||
147346563|NCT03912831|531436453|FG003|Overall Study|Reason not Specified|0|||
147346564|NCT03912831|531436454|FG004|Overall Study|Reason not Specified|1|||
147346565|NCT03912831|531436455|FG005|Overall Study|Reason not Specified|0|||
147346566|NCT03912831|531436450|FG000|Overall Study|Withdrawal by Participant|0|||
147346567|NCT03912831|531436451|FG001|Overall Study|Withdrawal by Participant|0|||
147346568|NCT03912831|531436452|FG002|Overall Study|Withdrawal by Participant|0|||
147346569|NCT03912831|531436453|FG003|Overall Study|Withdrawal by Participant|0|||
147346570|NCT03912831|531436454|FG004|Overall Study|Withdrawal by Participant|1|||
147346571|NCT03912831|531436455|FG005|Overall Study|Withdrawal by Participant|0|||
147346572|NCT05239039|531436461|FG000|Overall Study|Withdrawal by Subject|0|||
147346573|NCT05239039|531436462|FG001|Overall Study|Withdrawal by Subject|1|||
147346574|NCT03690206|531436463|FG000|Overall Study|Withdrawal by Subject|2|||
147346575|NCT03690206|531436464|FG001|Overall Study|Withdrawal by Subject|0|||
147346576|NCT03690206|531436465|FG002|Overall Study|Withdrawal by Subject|0|||
147346577|NCT03690206|531436463|FG000|Overall Study|ICF withdrawal|2|||
147346578|NCT03690206|531436464|FG001|Overall Study|ICF withdrawal|0|||
147346579|NCT03690206|531436465|FG002|Overall Study|ICF withdrawal|0|||
147346580|NCT03152786|531437539|FG000|Overall Study|Withdrawal by Subject|2|||
147346581|NCT03152786|531437540|FG001|Overall Study|Withdrawal by Subject|1|||
147606825|NCT02932306|532377139|FG000|Overall Study|Lost to Follow-up|36|||
147346582|NCT02349412|531437545|FG000|Overall Study|Withdrawal by Subject|7|||
147346583|NCT02349412|531437546|FG001|Overall Study|Withdrawal by Subject|7|||
147346584|NCT04533022|531437547|FG000|Overall Study|Withdrawal by Subject|15|||
147346585|NCT04533022|531437547|FG000|Overall Study|Adverse Event|6|||
147346586|NCT04533022|531437547|FG000|Overall Study|Death|1|||
147346587|NCT04533022|531437547|FG000|Overall Study|FVC decline and FVCpp<60%|2|||
147346588|NCT04533022|531437547|FG000|Overall Study|FVC decline, FVCpp<60% and worsening of respiratory symptoms|1|||
147346589|NCT02163447|531437548|FG000|Overall Study|Withdrawal by Subject|2|||
147346590|NCT02163447|531437549|FG001|Overall Study|Withdrawal by Subject|0|||
147346591|NCT02163447|531437550|FG002|Overall Study|Withdrawal by Subject|1|||
147346592|NCT02163447|531437548|FG000|Overall Study|Lost to Follow-up|1|||
147346593|NCT02163447|531437549|FG001|Overall Study|Lost to Follow-up|3|||
147346594|NCT02163447|531437550|FG002|Overall Study|Lost to Follow-up|0|||
147346595|NCT02163447|531437548|FG000|Overall Study|Moved out of study area|2|||
147346596|NCT02163447|531437549|FG001|Overall Study|Moved out of study area|3|||
147346597|NCT02163447|531437550|FG002|Overall Study|Moved out of study area|2|||
147346598|NCT02163447|531437548|FG000|Overall Study|Became HIV infected at time of delivery|1|||
147346599|NCT02163447|531437549|FG001|Overall Study|Became HIV infected at time of delivery|0|||
147346600|NCT02163447|531437550|FG002|Overall Study|Became HIV infected at time of delivery|0|||
147346601|NCT03897686|531437552|FG000|Overall Study|Protocol Violation|1|||
147346602|NCT03897686|531437553|FG001|Overall Study|Protocol Violation|1|||
147346603|NCT03897686|531437552|FG000|Overall Study|Withdrawal by Subject|1|||
147346604|NCT03897686|531437553|FG001|Overall Study|Withdrawal by Subject|1|||
147346605|NCT05415436|531437554|FG000|Overall Study|Surgeon cancelled procedure|1|||
147346606|NCT05415436|531437555|FG001|Overall Study|Surgeon cancelled procedure|0|||
147346607|NCT05415436|531437554|FG000|Overall Study|Death|1|||
147346608|NCT05415436|531437555|FG001|Overall Study|Death|0|||
147346609|NCT02597946|531437559|FG000|Overall Study|Withdrawal by Subject|1|||
147346610|NCT02597946|531437559|FG000|Overall Study|Progressive disease|16|||
147346611|NCT02597946|531437559|FG000|Overall Study|Other than above|1|||
147346612|NCT05038566|531437569|FG000|Overall Study|Technical Difficulties with the Device|0|||
147346613|NCT05038566|531437570|FG001|Overall Study|Technical Difficulties with the Device|1|||
147346614|NCT00739648|531437577|FG000|Overall Study|Adverse Event|3|||
147346615|NCT00739648|531437578|FG001|Overall Study|Adverse Event|15|||
147346616|NCT00739648|531437577|FG000|Overall Study|Withdrawal by Subject|13|||
147346617|NCT00739648|531437578|FG001|Overall Study|Withdrawal by Subject|25|||
147346618|NCT00739648|531437577|FG000|Overall Study|Lost to Follow-up|4|||
147346619|NCT00739648|531437578|FG001|Overall Study|Lost to Follow-up|7|||
147346620|NCT00739648|531437577|FG000|Overall Study|Death|2|||
147346621|NCT00739648|531437578|FG001|Overall Study|Death|0|||
147346622|NCT00739648|531437577|FG000|Overall Study|Do not know|4|||
147346623|NCT00739648|531437578|FG001|Overall Study|Do not know|6|||
147346624|NCT02840474|531437581|FG000|Overall Study|Lost to Follow-up|1|||
147346625|NCT02840474|531437582|FG001|Overall Study|Lost to Follow-up|0|||
147346626|NCT03192891|531437583|FG000|Overall Study|Lost to Follow-up|55|||
147346627|NCT04850807|531437584|FG000|Overall Study|Death|50|||
147346628|NCT04850807|531437585|FG001|Overall Study|Death|55|||
147346629|NCT04850807|531437584|FG000|Overall Study|Discharged|17|||
147346630|NCT04850807|531437585|FG001|Overall Study|Discharged|13|||
147346631|NCT04850807|531437584|FG000|Overall Study|Incomplete baseline data|3|||
147346632|NCT04850807|531437585|FG001|Overall Study|Incomplete baseline data|2|||
147346633|NCT03739996|531437586|FG000|Step 1 (Oral CAB + 2 NRTIs)|Determined to be ineligible|1|||
147346634|NCT03739996|531437586|FG000|Step 2 (CAB LA + VRC07-523LS)|Death|1|||
147346635|NCT03739996|531437586|FG000|Step 2 (CAB LA + VRC07-523LS)|Adverse Event|1|||
147346636|NCT03739996|531437586|FG000|Step 2 (CAB LA + VRC07-523LS)|Withdrawal by Subject|1|||
147346637|NCT03739996|531437586|FG000|Step 2 (CAB LA + VRC07-523LS)|Virologic failure, as defined by the protocol|5|||
147346638|NCT03739996|531437586|FG000|Step 2 (CAB LA + VRC07-523LS)|Participant refusal to remain on long-acting treatment|3|||
147346639|NCT03739996|531437586|FG000|Step 3 (SOC ART)|Death|1|||
147346640|NCT03739996|531437586|FG000|Step 3 (SOC ART)|Participant moved|1|||
147453265|NCT02792842|531823977|FG002|Overall Study|Adverse Event|3|||
147453266|NCT02792842|531823975|FG000|Overall Study|Withdrawal by Subject|0|||
147346643|NCT05387447|531437588|FG000|Overall Study|Participants changed their minds about study participation.|3|||
147346644|NCT05387447|531437589|FG001|Overall Study|Participants changed their minds about study participation.|5|||
147346645|NCT04178733|531437590|FG000|Overall Study|Investigator Decision|0|||
147346646|NCT04178733|531437591|FG001|Overall Study|Investigator Decision|0|||
147346647|NCT04178733|531437592|FG002|Overall Study|Investigator Decision|0|||
147346648|NCT04178733|531437593|FG003|Overall Study|Investigator Decision|1|||
147346649|NCT04178733|531437594|FG004|Overall Study|Investigator Decision|2|||
147346650|NCT03655132|531437597|FG000|Overall Study|Lost to Follow-up|2|||
147346651|NCT03655132|531437598|FG001|Overall Study|Lost to Follow-up|1|||
147346652|NCT03655132|531437597|FG000|Overall Study|Withdrawal by Subject|0|||
147346653|NCT03655132|531437598|FG001|Overall Study|Withdrawal by Subject|1|||
147346654|NCT03655132|531437597|FG000|Overall Study|Withdrawn prior to intervention due to physical impairment interfering with study participation|0|||
147346655|NCT03655132|531437598|FG001|Overall Study|Withdrawn prior to intervention due to physical impairment interfering with study participation|1|||
147346656|NCT02651324|531437600|FG000|Overall Study|drug not administered, due dispensing issue|1|||
147346657|NCT02651324|531437601|FG001|Overall Study|drug not administered, due dispensing issue|0|||
147346658|NCT05919082|531437604|FG000|Overall Study|Adverse Event|3|||
147346659|NCT05919082|531437605|FG001|Overall Study|Adverse Event|0|||
147346660|NCT05919082|531437604|FG000|Overall Study|Lost to Follow-up|0|||
147346661|NCT05919082|531437605|FG001|Overall Study|Lost to Follow-up|1|||
147346662|NCT05919082|531437604|FG000|Overall Study|Withdrawal by Subject|8|||
147346663|NCT05919082|531437605|FG001|Overall Study|Withdrawal by Subject|9|||
147346664|NCT05919082|531437604|FG000|Overall Study|Lack of Efficacy|0|||
147346665|NCT05919082|531437605|FG001|Overall Study|Lack of Efficacy|1|||
147346666|NCT05919082|531437604|FG000|Overall Study|Investigator Decision|1|||
147346667|NCT05919082|531437605|FG001|Overall Study|Investigator Decision|0|||
147346668|NCT02697136|531437607|FG000|Overall Study|Adverse Event|3|||
147346669|NCT02697136|531437608|FG001|Overall Study|Adverse Event|0|||
147346670|NCT02500758|531437609|FG000|First Intervention (2 Minutes)|Withdrawal by Subject|0|||
147346671|NCT02500758|531437610|FG001|First Intervention (2 Minutes)|Withdrawal by Subject|1|||
147346672|NCT02500758|531437609|FG000|Washout (1 Week)|Lost to Follow-up|2|||
147346673|NCT02500758|531437610|FG001|Washout (1 Week)|Lost to Follow-up|2|||
147346674|NCT02500758|531437609|FG000|Second Intervention (2 Minutes)|Withdrawal by Subject|2|||
147346675|NCT02500758|531437610|FG001|Second Intervention (2 Minutes)|Withdrawal by Subject|0|||
147346676|NCT02500758|531437609|FG000|Second Intervention (2 Minutes)|Lost to Follow-up|0|||
147346677|NCT02500758|531437610|FG001|Second Intervention (2 Minutes)|Lost to Follow-up|1|||
147346678|NCT02500758|531437609|FG000|Second Intervention (2 Minutes)|Protocol Violation|1|||
147346679|NCT02500758|531437610|FG001|Second Intervention (2 Minutes)|Protocol Violation|1|||
147346680|NCT02923180|531437611|FG000|Overall Study|Off Study Due to Detectable PSA|13|||
147346681|NCT02923180|531437611|FG000|Overall Study|Remaining in Long Term Follow Up for PSA|13|||
147346682|NCT05198310|531437612|FG000|Overall Study|Lost to Follow-up|0|||
147346683|NCT05198310|531437613|FG001|Overall Study|Lost to Follow-up|1|||
147346684|NCT05198310|531437614|FG002|Overall Study|Lost to Follow-up|0|||
147346685|NCT05198310|531437615|FG003|Overall Study|Lost to Follow-up|0|||
147346686|NCT05198310|531437616|FG004|Overall Study|Lost to Follow-up|0|||
147346687|NCT05198310|531437617|FG005|Overall Study|Lost to Follow-up|0|||
147346688|NCT05198310|531437618|FG006|Overall Study|Lost to Follow-up|0|||
147346689|NCT05198310|531437619|FG007|Overall Study|Lost to Follow-up|0|||
147346690|NCT05198310|531437612|FG000|Overall Study|Withdrawal by Subject|0|||
147346691|NCT05198310|531437613|FG001|Overall Study|Withdrawal by Subject|0|||
147346692|NCT05198310|531437614|FG002|Overall Study|Withdrawal by Subject|0|||
147346693|NCT05198310|531437615|FG003|Overall Study|Withdrawal by Subject|2|||
147346694|NCT05198310|531437616|FG004|Overall Study|Withdrawal by Subject|0|||
147346695|NCT05198310|531437617|FG005|Overall Study|Withdrawal by Subject|2|||
147346696|NCT05198310|531437618|FG006|Overall Study|Withdrawal by Subject|1|||
147346697|NCT05198310|531437619|FG007|Overall Study|Withdrawal by Subject|3|||
147346698|NCT04436107|531437620|FG000|Overall Study|Sponsor Ended Study|2|||
147346699|NCT04436107|531437621|FG001|Overall Study|Sponsor Ended Study|4|||
147346700|NCT04436107|531437622|FG002|Overall Study|Sponsor Ended Study|8|||
147346701|NCT04436107|531437623|FG003|Overall Study|Sponsor Ended Study|20|||
147346702|NCT04436107|531437620|FG000|Overall Study|Death|3|||
147346703|NCT04436107|531437621|FG001|Overall Study|Death|5|||
147346704|NCT04436107|531437622|FG002|Overall Study|Death|3|||
147346705|NCT04436107|531437623|FG003|Overall Study|Death|18|||
147346706|NCT04436107|531437620|FG000|Overall Study|Withdrawal by Subject|1|||
147346707|NCT04436107|531437621|FG001|Overall Study|Withdrawal by Subject|1|||
147346708|NCT04436107|531437622|FG002|Overall Study|Withdrawal by Subject|0|||
147346709|NCT04436107|531437623|FG003|Overall Study|Withdrawal by Subject|1|||
147346710|NCT04116736|531437624|FG000|Overall Study|Withdrew consent during study|3|||
147346711|NCT04116736|531437625|FG001|Overall Study|Withdrew consent during study|1|||
147346712|NCT04116736|531437624|FG000|Overall Study|Subject no longer meets eligibility criteria|1|||
147346713|NCT04116736|531437625|FG001|Overall Study|Subject no longer meets eligibility criteria|4|||
147346714|NCT04116736|531437624|FG000|Overall Study|Subject withdrawn due to non-compliance to protocol|11|||
147346715|NCT04116736|531437625|FG001|Overall Study|Subject withdrawn due to non-compliance to protocol|7|||
147606826|NCT02932306|532377140|FG001|Overall Study|Lost to Follow-up|40|||
147346716|NCT04116736|531437624|FG000|Overall Study|Switched to a different type of contact lens due to discomfort and dryness|1|||
147346717|NCT04116736|531437625|FG001|Overall Study|Switched to a different type of contact lens due to discomfort and dryness|0|||
147346718|NCT04116736|531437624|FG000|Overall Study|Subject was enrolled in error|2|||
147346719|NCT04116736|531437625|FG001|Overall Study|Subject was enrolled in error|0|||
147346720|NCT04116736|531437624|FG000|Overall Study|PI confirmed subject was not over 18 when enrolled in study. Subject discontinued|1|||
147346721|NCT04116736|531437625|FG001|Overall Study|PI confirmed subject was not over 18 when enrolled in study. Subject discontinued|0|||
147346722|NCT04116736|531437624|FG000|Overall Study|Subject did not like the lenses graduation change|1|||
147346723|NCT04116736|531437625|FG001|Overall Study|Subject did not like the lenses graduation change|0|||
147346724|NCT04116736|531437624|FG000|Overall Study|Subject stopped wearing study lenses after 2 weeks due to dryness|1|||
147346725|NCT04116736|531437625|FG001|Overall Study|Subject stopped wearing study lenses after 2 weeks due to dryness|0|||
147346726|NCT01101451|531437628|FG000|Overall Study|Eligible and never treated|0|||
147346727|NCT01101451|531437629|FG001|Overall Study|Eligible and never treated|5|||
147346728|NCT01101451|531437628|FG000|Overall Study|Ineligible and treated|12|||
147346729|NCT01101451|531437629|FG001|Overall Study|Ineligible and treated|8|||
147346730|NCT01101451|531437628|FG000|Overall Study|Ineligible and never treated|2|||
147346731|NCT01101451|531437629|FG001|Overall Study|Ineligible and never treated|2|||
147346732|NCT03580369|531437632|FG000|Overall Study|No treatment due to mis-randomization|1|||
147346733|NCT03580369|531437633|FG001|Overall Study|No treatment due to mis-randomization|0|||
147346734|NCT03580369|531437634|FG002|Overall Study|No treatment due to mis-randomization|0|||
147346735|NCT03580369|531437635|FG003|Overall Study|No treatment due to mis-randomization|0|||
147346736|NCT03580369|531437636|FG004|Overall Study|No treatment due to mis-randomization|3|||
147346737|NCT03580369|531437637|FG005|Overall Study|No treatment due to mis-randomization|0|||
147346738|NCT03580369|531437638|FG006|Overall Study|No treatment due to mis-randomization|0|||
147346739|NCT03580369|531437639|FG007|Overall Study|No treatment due to mis-randomization|0|||
147346740|NCT03580369|531437632|FG000|Overall Study|Reason unknown|0|||
147346741|NCT03580369|531437633|FG001|Overall Study|Reason unknown|0|||
147346742|NCT03580369|531437634|FG002|Overall Study|Reason unknown|1|||
147346743|NCT03580369|531437635|FG003|Overall Study|Reason unknown|0|||
147346744|NCT03580369|531437636|FG004|Overall Study|Reason unknown|0|||
147346745|NCT03580369|531437637|FG005|Overall Study|Reason unknown|0|||
147346746|NCT03580369|531437638|FG006|Overall Study|Reason unknown|0|||
147346747|NCT03580369|531437639|FG007|Overall Study|Reason unknown|0|||
147346748|NCT03580369|531437632|FG000|Overall Study|Technical problems|0|||
147346749|NCT03580369|531437633|FG001|Overall Study|Technical problems|0|||
147346750|NCT03580369|531437634|FG002|Overall Study|Technical problems|0|||
147346751|NCT03580369|531437635|FG003|Overall Study|Technical problems|0|||
147346752|NCT03580369|531437636|FG004|Overall Study|Technical problems|1|||
147346753|NCT03580369|531437637|FG005|Overall Study|Technical problems|0|||
147346754|NCT03580369|531437638|FG006|Overall Study|Technical problems|2|||
147346755|NCT03580369|531437639|FG007|Overall Study|Technical problems|0|||
147346756|NCT03580369|531437632|FG000|Overall Study|Pregnancy|2|||
147346757|NCT03580369|531437633|FG001|Overall Study|Pregnancy|0|||
147346758|NCT03580369|531437634|FG002|Overall Study|Pregnancy|3|||
147346759|NCT03580369|531437635|FG003|Overall Study|Pregnancy|0|||
147346760|NCT03580369|531437636|FG004|Overall Study|Pregnancy|2|||
147346761|NCT03580369|531437637|FG005|Overall Study|Pregnancy|0|||
147346762|NCT03580369|531437638|FG006|Overall Study|Pregnancy|0|||
147346763|NCT03580369|531437639|FG007|Overall Study|Pregnancy|0|||
147346764|NCT03580369|531437632|FG000|Overall Study|Lost to Follow-up|2|||
147346765|NCT03580369|531437633|FG001|Overall Study|Lost to Follow-up|0|||
147346766|NCT03580369|531437634|FG002|Overall Study|Lost to Follow-up|2|||
147346767|NCT03580369|531437635|FG003|Overall Study|Lost to Follow-up|0|||
147346768|NCT03580369|531437636|FG004|Overall Study|Lost to Follow-up|3|||
147346769|NCT03580369|531437637|FG005|Overall Study|Lost to Follow-up|0|||
147346770|NCT03580369|531437638|FG006|Overall Study|Lost to Follow-up|1|||
147346771|NCT03580369|531437639|FG007|Overall Study|Lost to Follow-up|0|||
147346772|NCT03580369|531437632|FG000|Overall Study|Physician Decision|4|||
147346773|NCT03580369|531437633|FG001|Overall Study|Physician Decision|0|||
147346774|NCT03580369|531437634|FG002|Overall Study|Physician Decision|4|||
147346775|NCT03580369|531437635|FG003|Overall Study|Physician Decision|1|||
147346776|NCT03580369|531437636|FG004|Overall Study|Physician Decision|1|||
147346777|NCT03580369|531437637|FG005|Overall Study|Physician Decision|0|||
147346778|NCT03580369|531437638|FG006|Overall Study|Physician Decision|0|||
147346779|NCT03580369|531437639|FG007|Overall Study|Physician Decision|0|||
147346780|NCT03580369|531437632|FG000|Overall Study|Lack of Efficacy|3|||
147346781|NCT03580369|531437633|FG001|Overall Study|Lack of Efficacy|0|||
147346782|NCT03580369|531437634|FG002|Overall Study|Lack of Efficacy|7|||
147346783|NCT03580369|531437635|FG003|Overall Study|Lack of Efficacy|0|||
147346784|NCT03580369|531437636|FG004|Overall Study|Lack of Efficacy|2|||
147346785|NCT03580369|531437637|FG005|Overall Study|Lack of Efficacy|0|||
147346786|NCT03580369|531437638|FG006|Overall Study|Lack of Efficacy|3|||
147346787|NCT03580369|531437639|FG007|Overall Study|Lack of Efficacy|0|||
147346788|NCT03580369|531437632|FG000|Overall Study|Protocol Violation|6|||
147346789|NCT03580369|531437633|FG001|Overall Study|Protocol Violation|0|||
147346790|NCT03580369|531437634|FG002|Overall Study|Protocol Violation|6|||
147346791|NCT03580369|531437635|FG003|Overall Study|Protocol Violation|1|||
147346792|NCT03580369|531437636|FG004|Overall Study|Protocol Violation|8|||
147346793|NCT03580369|531437637|FG005|Overall Study|Protocol Violation|2|||
147346794|NCT03580369|531437638|FG006|Overall Study|Protocol Violation|1|||
147346795|NCT03580369|531437639|FG007|Overall Study|Protocol Violation|0|||
147346796|NCT03580369|531437632|FG000|Overall Study|Adverse Event|7|||
147346797|NCT03580369|531437633|FG001|Overall Study|Adverse Event|0|||
147346798|NCT03580369|531437634|FG002|Overall Study|Adverse Event|14|||
147346799|NCT03580369|531437635|FG003|Overall Study|Adverse Event|1|||
147346800|NCT03580369|531437636|FG004|Overall Study|Adverse Event|6|||
147346801|NCT03580369|531437637|FG005|Overall Study|Adverse Event|0|||
147346802|NCT03580369|531437638|FG006|Overall Study|Adverse Event|1|||
147346803|NCT03580369|531437639|FG007|Overall Study|Adverse Event|0|||
147453267|NCT02792842|531823976|FG001|Overall Study|Withdrawal by Subject|1|||
147346804|NCT03580369|531437632|FG000|Overall Study|Withdrawal by Subject|19|||
147346805|NCT03580369|531437633|FG001|Overall Study|Withdrawal by Subject|0|||
147346806|NCT03580369|531437634|FG002|Overall Study|Withdrawal by Subject|17|||
147346807|NCT03580369|531437635|FG003|Overall Study|Withdrawal by Subject|0|||
147346808|NCT03580369|531437636|FG004|Overall Study|Withdrawal by Subject|16|||
147346809|NCT03580369|531437637|FG005|Overall Study|Withdrawal by Subject|1|||
147346810|NCT03580369|531437638|FG006|Overall Study|Withdrawal by Subject|7|||
147346811|NCT03580369|531437639|FG007|Overall Study|Withdrawal by Subject|0|||
147346812|NCT04923347|531438868|FG000|Overall Study|Withdrawal by Subject|14|||
147346813|NCT06066541|531438869|FG000|Enrollment Wave 1 (August 18, 2023)|Excluded due to membership changes|107|||
147346814|NCT06066541|531438870|FG001|Enrollment Wave 1 (August 18, 2023)|Excluded due to membership changes|122|||
147346815|NCT06066541|531438871|FG002|Enrollment Wave 1 (August 18, 2023)|Excluded due to membership changes|128|||
147346816|NCT06066541|531438872|FG003|Enrollment Wave 1 (August 18, 2023)|Excluded due to membership changes|110|||
147346817|NCT06066541|531438873|FG004|Enrollment Wave 1 (August 18, 2023)|Excluded due to membership changes|125|||
147346818|NCT06066541|531438874|FG005|Enrollment Wave 1 (August 18, 2023)|Excluded due to membership changes|123|||
147346819|NCT06066541|531438875|FG006|Enrollment Wave 1 (August 18, 2023)|Excluded due to membership changes|123|||
147346820|NCT06066541|531438869|FG000|Enrollment Wave 2 (August 24, 2023)|Excluded due to membership changes|6|||
147346821|NCT06066541|531438870|FG001|Enrollment Wave 2 (August 24, 2023)|Excluded due to membership changes|9|||
147346822|NCT06066541|531438871|FG002|Enrollment Wave 2 (August 24, 2023)|Excluded due to membership changes|3|||
147346823|NCT06066541|531438872|FG003|Enrollment Wave 2 (August 24, 2023)|Excluded due to membership changes|8|||
147346824|NCT06066541|531438873|FG004|Enrollment Wave 2 (August 24, 2023)|Excluded due to membership changes|7|||
147346825|NCT06066541|531438874|FG005|Enrollment Wave 2 (August 24, 2023)|Excluded due to membership changes|11|||
147346826|NCT06066541|531438875|FG006|Enrollment Wave 2 (August 24, 2023)|Excluded due to membership changes|5|||
147346827|NCT04052516|531438876|FG000|Overall Study|Withdrawal by Subject|4|||
147346828|NCT04052516|531438877|FG001|Overall Study|Withdrawal by Subject|5|||
147346829|NCT04052516|531438878|FG002|Overall Study|Withdrawal by Subject|6|||
147346830|NCT04052516|531438876|FG000|Overall Study|Adverse Event|3|||
147346831|NCT04052516|531438877|FG001|Overall Study|Adverse Event|2|||
147346832|NCT04052516|531438878|FG002|Overall Study|Adverse Event|8|||
147346833|NCT04052516|531438876|FG000|Overall Study|Lost to Follow-up|2|||
147346834|NCT04052516|531438877|FG001|Overall Study|Lost to Follow-up|5|||
147346835|NCT04052516|531438878|FG002|Overall Study|Lost to Follow-up|3|||
147346836|NCT04052516|531438876|FG000|Overall Study|Protocol Violation|1|||
147346837|NCT04052516|531438877|FG001|Overall Study|Protocol Violation|1|||
147346838|NCT04052516|531438878|FG002|Overall Study|Protocol Violation|0|||
147346839|NCT04052516|531438876|FG000|Overall Study|Death|1|||
147346840|NCT04052516|531438877|FG001|Overall Study|Death|0|||
147346841|NCT04052516|531438878|FG002|Overall Study|Death|0|||
147346842|NCT04052516|531438876|FG000|Overall Study|Physician Decision|0|||
147346843|NCT04052516|531438877|FG001|Overall Study|Physician Decision|1|||
147346844|NCT04052516|531438878|FG002|Overall Study|Physician Decision|0|||
147346845|NCT04052516|531438876|FG000|Overall Study|Pregnancy|1|||
147346846|NCT04052516|531438877|FG001|Overall Study|Pregnancy|0|||
147346847|NCT04052516|531438878|FG002|Overall Study|Pregnancy|0|||
147346848|NCT04052516|531438876|FG000|Overall Study|Requirement of prohibited concomitant medication|1|||
147346849|NCT04052516|531438877|FG001|Overall Study|Requirement of prohibited concomitant medication|0|||
147346850|NCT04052516|531438878|FG002|Overall Study|Requirement of prohibited concomitant medication|0|||
147346851|NCT04052516|531438876|FG000|Overall Study|Reason not recorded|0|||
147346852|NCT04052516|531438877|FG001|Overall Study|Reason not recorded|1|||
147346853|NCT04052516|531438878|FG002|Overall Study|Reason not recorded|0|||
147346854|NCT03819686|531438879|FG000|Overall Study|Lost to Follow-up|2|||
147346855|NCT03819686|531438880|FG001|Overall Study|Lost to Follow-up|3|||
147346856|NCT03157167|531438883|FG000|Overall Study|Withdrawal by Subject|1|||
147346857|NCT03157167|531438884|FG001|Overall Study|Withdrawal by Subject|0|||
147346858|NCT03157167|531438885|FG002|Overall Study|Withdrawal by Subject|0|||
147346859|NCT04842643|531438888|FG000|Overall Study|Physician Decision|1|||
147346860|NCT04842643|531438888|FG000|Overall Study|Other|1|||
147346861|NCT03484702|531438889|FG000|Treatment Period|Death|3|||
147346862|NCT03484702|531438890|FG001|Treatment Period|Death|1|||
147346863|NCT03484702|531438891|FG002|Treatment Period|Death|0|||
147346864|NCT03484702|531438892|FG003|Treatment Period|Death|0|||
147346865|NCT03484702|531438893|FG004|Treatment Period|Death|0|||
147346866|NCT03484702|531438894|FG005|Treatment Period|Death|0|||
147346867|NCT03484702|531438889|FG000|Treatment Period|Adverse Event|1|||
147346868|NCT03484702|531438890|FG001|Treatment Period|Adverse Event|0|||
147346869|NCT03484702|531438891|FG002|Treatment Period|Adverse Event|0|||
147346870|NCT03484702|531438892|FG003|Treatment Period|Adverse Event|0|||
147346871|NCT03484702|531438893|FG004|Treatment Period|Adverse Event|0|||
147346872|NCT03484702|531438894|FG005|Treatment Period|Adverse Event|0|||
147346873|NCT03484702|531438889|FG000|Treatment Period|Participant Withdrew from Study|0|||
147346874|NCT03484702|531438890|FG001|Treatment Period|Participant Withdrew from Study|1|||
147346875|NCT03484702|531438891|FG002|Treatment Period|Participant Withdrew from Study|0|||
147346876|NCT03484702|531438892|FG003|Treatment Period|Participant Withdrew from Study|0|||
147346877|NCT03484702|531438893|FG004|Treatment Period|Participant Withdrew from Study|0|||
147346878|NCT03484702|531438894|FG005|Treatment Period|Participant Withdrew from Study|0|||
147346879|NCT03484702|531438889|FG000|Treatment Period|Physician Decision|0|||
147346880|NCT03484702|531438890|FG001|Treatment Period|Physician Decision|1|||
147346881|NCT03484702|531438891|FG002|Treatment Period|Physician Decision|0|||
147346882|NCT03484702|531438892|FG003|Treatment Period|Physician Decision|0|||
147346883|NCT03484702|531438893|FG004|Treatment Period|Physician Decision|0|||
147346884|NCT03484702|531438894|FG005|Treatment Period|Physician Decision|1|||
147346885|NCT01894061|531438898|FG000|Overall Study|Screen failure|1|||
147346886|NCT01894061|531438898|FG000|Overall Study|Withdrawal by Subject|1|||
147346887|NCT05141903|531438900|FG000|Overall Study|Withdrawal by Subject|0|||
147346888|NCT05141903|531438901|FG001|Overall Study|Withdrawal by Subject|1|||
147346889|NCT05141903|531438902|FG002|Overall Study|Withdrawal by Subject|1|||
147346890|NCT05141903|531438903|FG003|Overall Study|Withdrawal by Subject|0|||
147346891|NCT05141903|531438904|FG004|Overall Study|Withdrawal by Subject|0|||
147346892|NCT05141903|531438900|FG000|Overall Study|Other|1|||
147346893|NCT05141903|531438901|FG001|Overall Study|Other|1|||
147346894|NCT05141903|531438902|FG002|Overall Study|Other|0|||
147346895|NCT05141903|531438903|FG003|Overall Study|Other|0|||
147346896|NCT05141903|531438904|FG004|Overall Study|Other|0|||
147346897|NCT02630823|531438908|FG000|Overall Study|Withdrawal by Subject|1|||
147346898|NCT02630823|531438908|FG000|Overall Study|Did not undergo cytoreductive surgery due to pre-operative disease progression|1|||
147346899|NCT02287311|531438913|FG000|Cohort 1: Dose Level 1|Death|2|||
147346900|NCT02287311|531438914|FG001|Cohort 1: Dose Level 1|Death|0|||
147346901|NCT02287311|531438915|FG002|Cohort 1: Dose Level 1|Death|0|||
147346902|NCT02287311|531438916|FG003|Cohort 1: Dose Level 1|Death|3|||
147346903|NCT02287311|531438917|FG004|Cohort 1: Dose Level 1|Death|0|||
147346904|NCT02287311|531438918|FG005|Cohort 1: Dose Level 1|Death|0|||
147346905|NCT02287311|531438919|FG006|Cohort 1: Dose Level 1|Death|1|||
147346906|NCT02287311|531438920|FG007|Cohort 1: Dose Level 1|Death|0|||
147346907|NCT02287311|531438921|FG008|Cohort 1: Dose Level 1|Death|0|||
147346908|NCT02287311|531438913|FG000|Cohort 1: Dose Level 1|Lost to Follow-up|0|||
147346909|NCT02287311|531438914|FG001|Cohort 1: Dose Level 1|Lost to Follow-up|0|||
147346910|NCT02287311|531438915|FG002|Cohort 1: Dose Level 1|Lost to Follow-up|0|||
147346911|NCT02287311|531438916|FG003|Cohort 1: Dose Level 1|Lost to Follow-up|2|||
147346912|NCT02287311|531438917|FG004|Cohort 1: Dose Level 1|Lost to Follow-up|0|||
147346913|NCT02287311|531438918|FG005|Cohort 1: Dose Level 1|Lost to Follow-up|0|||
147346914|NCT02287311|531438919|FG006|Cohort 1: Dose Level 1|Lost to Follow-up|1|||
147346915|NCT02287311|531438920|FG007|Cohort 1: Dose Level 1|Lost to Follow-up|0|||
147346916|NCT02287311|531438921|FG008|Cohort 1: Dose Level 1|Lost to Follow-up|0|||
147346917|NCT02287311|531438913|FG000|Cohort 1: Dose Level 1|Physician Decision|1|||
147346918|NCT02287311|531438914|FG001|Cohort 1: Dose Level 1|Physician Decision|0|||
147346919|NCT02287311|531438915|FG002|Cohort 1: Dose Level 1|Physician Decision|0|||
147346920|NCT02287311|531438916|FG003|Cohort 1: Dose Level 1|Physician Decision|0|||
147346921|NCT02287311|531438917|FG004|Cohort 1: Dose Level 1|Physician Decision|0|||
147346922|NCT02287311|531438918|FG005|Cohort 1: Dose Level 1|Physician Decision|0|||
147346923|NCT02287311|531438919|FG006|Cohort 1: Dose Level 1|Physician Decision|0|||
147346924|NCT02287311|531438920|FG007|Cohort 1: Dose Level 1|Physician Decision|0|||
147346925|NCT02287311|531438921|FG008|Cohort 1: Dose Level 1|Physician Decision|0|||
147346926|NCT02287311|531438913|FG000|Cohort 2: Dose Level 2|Death|0|||
147346927|NCT02287311|531438914|FG001|Cohort 2: Dose Level 2|Death|2|||
147346928|NCT02287311|531438915|FG002|Cohort 2: Dose Level 2|Death|0|||
147346929|NCT02287311|531438916|FG003|Cohort 2: Dose Level 2|Death|0|||
147346930|NCT02287311|531438917|FG004|Cohort 2: Dose Level 2|Death|2|||
147346931|NCT02287311|531438918|FG005|Cohort 2: Dose Level 2|Death|0|||
147346932|NCT02287311|531438919|FG006|Cohort 2: Dose Level 2|Death|0|||
147346933|NCT02287311|531438920|FG007|Cohort 2: Dose Level 2|Death|2|||
147346934|NCT02287311|531438921|FG008|Cohort 2: Dose Level 2|Death|0|||
147346935|NCT02287311|531438913|FG000|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
147346936|NCT02287311|531438914|FG001|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
147346937|NCT02287311|531438915|FG002|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
147346938|NCT02287311|531438916|FG003|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
147346939|NCT02287311|531438917|FG004|Cohort 2: Dose Level 2|Lost to Follow-up|1|||
147346940|NCT02287311|531438918|FG005|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
147346941|NCT02287311|531438919|FG006|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
147346942|NCT02287311|531438920|FG007|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
147346943|NCT02287311|531438921|FG008|Cohort 2: Dose Level 2|Lost to Follow-up|0|||
147453268|NCT02792842|531823977|FG002|Overall Study|Withdrawal by Subject|2|||
147453269|NCT02792842|531823975|FG000|Overall Study|Lost to Follow-up|0|||
147346944|NCT02287311|531438913|FG000|Cohort 2: Dose Level 2|Refused follow-up|0|||
147346945|NCT02287311|531438914|FG001|Cohort 2: Dose Level 2|Refused follow-up|1|||
147346946|NCT02287311|531438915|FG002|Cohort 2: Dose Level 2|Refused follow-up|0|||
147346947|NCT02287311|531438916|FG003|Cohort 2: Dose Level 2|Refused follow-up|0|||
147346948|NCT02287311|531438917|FG004|Cohort 2: Dose Level 2|Refused follow-up|0|||
147346949|NCT02287311|531438918|FG005|Cohort 2: Dose Level 2|Refused follow-up|0|||
147346950|NCT02287311|531438919|FG006|Cohort 2: Dose Level 2|Refused follow-up|0|||
147346951|NCT02287311|531438920|FG007|Cohort 2: Dose Level 2|Refused follow-up|0|||
147346952|NCT02287311|531438921|FG008|Cohort 2: Dose Level 2|Refused follow-up|0|||
147346953|NCT02287311|531438913|FG000|Cohort 3: Dose Level 3|Death|0|||
147346954|NCT02287311|531438914|FG001|Cohort 3: Dose Level 3|Death|0|||
147346955|NCT02287311|531438915|FG002|Cohort 3: Dose Level 3|Death|4|||
147346956|NCT02287311|531438916|FG003|Cohort 3: Dose Level 3|Death|0|||
147346957|NCT02287311|531438917|FG004|Cohort 3: Dose Level 3|Death|0|||
147346958|NCT02287311|531438918|FG005|Cohort 3: Dose Level 3|Death|4|||
147346959|NCT02287311|531438919|FG006|Cohort 3: Dose Level 3|Death|0|||
147346960|NCT02287311|531438920|FG007|Cohort 3: Dose Level 3|Death|0|||
147346961|NCT02287311|531438921|FG008|Cohort 3: Dose Level 3|Death|2|||
147346962|NCT02287311|531438913|FG000|Cohort 3: Dose Level 3|Lost to Follow-up|0|||
147346963|NCT02287311|531438914|FG001|Cohort 3: Dose Level 3|Lost to Follow-up|0|||
147346964|NCT02287311|531438915|FG002|Cohort 3: Dose Level 3|Lost to Follow-up|2|||
147346965|NCT02287311|531438916|FG003|Cohort 3: Dose Level 3|Lost to Follow-up|0|||
147346966|NCT02287311|531438917|FG004|Cohort 3: Dose Level 3|Lost to Follow-up|0|||
147346967|NCT02287311|531438918|FG005|Cohort 3: Dose Level 3|Lost to Follow-up|2|||
147346968|NCT02287311|531438919|FG006|Cohort 3: Dose Level 3|Lost to Follow-up|0|||
147346969|NCT02287311|531438920|FG007|Cohort 3: Dose Level 3|Lost to Follow-up|0|||
147346970|NCT02287311|531438921|FG008|Cohort 3: Dose Level 3|Lost to Follow-up|0|||
147346971|NCT02287311|531438913|FG000|Cohort 3: Dose Level 3|On long-term follow-up|0|||
147346972|NCT02287311|531438914|FG001|Cohort 3: Dose Level 3|On long-term follow-up|0|||
147346973|NCT02287311|531438915|FG002|Cohort 3: Dose Level 3|On long-term follow-up|0|||
147346974|NCT02287311|531438916|FG003|Cohort 3: Dose Level 3|On long-term follow-up|0|||
147346975|NCT02287311|531438917|FG004|Cohort 3: Dose Level 3|On long-term follow-up|0|||
147346976|NCT02287311|531438918|FG005|Cohort 3: Dose Level 3|On long-term follow-up|1|||
147346977|NCT02287311|531438919|FG006|Cohort 3: Dose Level 3|On long-term follow-up|0|||
147346978|NCT02287311|531438920|FG007|Cohort 3: Dose Level 3|On long-term follow-up|0|||
147346979|NCT02287311|531438921|FG008|Cohort 3: Dose Level 3|On long-term follow-up|1|||
147346980|NCT05461131|531438922|FG000|Overall Study|Lost to Follow-up|0|||
147346981|NCT05461131|531438923|FG001|Overall Study|Lost to Follow-up|2|||
147346982|NCT04538417|531438924|FG000|Overall Study|Withdrawal by Subject|2|||
147346983|NCT04549168|531438926|FG000|Randomization Phase|Adverse Event|0|||
147346984|NCT04549168|531438927|FG001|Randomization Phase|Adverse Event|0|||
147346985|NCT04549168|531438928|FG002|Randomization Phase|Adverse Event|1|||
147346986|NCT04549168|531438926|FG000|Randomization Phase|Other|0|||
147346987|NCT04549168|531438927|FG001|Randomization Phase|Other|2|||
147346988|NCT04549168|531438928|FG002|Randomization Phase|Other|0|||
147346989|NCT04549168|531438926|FG000|Randomization Phase|Withdrawal by Subject|0|||
147346990|NCT04549168|531438927|FG001|Randomization Phase|Withdrawal by Subject|2|||
147346991|NCT04549168|531438928|FG002|Randomization Phase|Withdrawal by Subject|1|||
147346992|NCT00676715|531438931|FG000|Treatment Period (TP)|Adverse Event|0|||
147346993|NCT00676715|531438932|FG001|Treatment Period (TP)|Adverse Event|3|||
147346994|NCT00676715|531438933|FG002|Treatment Period (TP)|Adverse Event|2|||
147346995|NCT00676715|531438934|FG003|Treatment Period (TP)|Adverse Event|2|||
147346996|NCT00676715|531438931|FG000|Treatment Period (TP)|Death|0|||
147346997|NCT00676715|531438932|FG001|Treatment Period (TP)|Death|0|||
147346998|NCT00676715|531438933|FG002|Treatment Period (TP)|Death|1|||
147346999|NCT00676715|531438934|FG003|Treatment Period (TP)|Death|0|||
147347000|NCT00676715|531438931|FG000|Treatment Period (TP)|Failure to return|1|||
147347001|NCT00676715|531438932|FG001|Treatment Period (TP)|Failure to return|0|||
147347002|NCT00676715|531438933|FG002|Treatment Period (TP)|Failure to return|0|||
147347003|NCT00676715|531438934|FG003|Treatment Period (TP)|Failure to return|0|||
147347004|NCT00676715|531438931|FG000|Treatment Period (TP)|Violation of selection criteria at entry|0|||
147347005|NCT00676715|531438932|FG001|Treatment Period (TP)|Violation of selection criteria at entry|0|||
147347006|NCT00676715|531438933|FG002|Treatment Period (TP)|Violation of selection criteria at entry|1|||
147347007|NCT00676715|531438934|FG003|Treatment Period (TP)|Violation of selection criteria at entry|0|||
147347008|NCT00676715|531438931|FG000|Treatment Period (TP)|Refused treatment/did not cooperate|1|||
147347009|NCT00676715|531438932|FG001|Treatment Period (TP)|Refused treatment/did not cooperate|2|||
147347010|NCT00676715|531438933|FG002|Treatment Period (TP)|Refused treatment/did not cooperate|3|||
147347011|NCT00676715|531438934|FG003|Treatment Period (TP)|Refused treatment/did not cooperate|1|||
147347012|NCT00676715|531438931|FG000|Treatment Period (TP)|Withdrew consent|3|||
147347013|NCT00676715|531438932|FG001|Treatment Period (TP)|Withdrew consent|3|||
147453270|NCT02792842|531823976|FG001|Overall Study|Lost to Follow-up|0|||
147606827|NCT02932306|532377139|FG000|Overall Study|Withdrawal by Parent or Guardian|6|||
147606828|NCT02932306|532377140|FG001|Overall Study|Withdrawal by Parent or Guardian|8|||
147606829|NCT02932306|532377139|FG000|Overall Study|Lack of Efficacy|0|||
147606830|NCT02932306|532377140|FG001|Overall Study|Lack of Efficacy|2|||
147347014|NCT00676715|531438933|FG002|Treatment Period (TP)|Withdrew consent|3|||
147347015|NCT00676715|531438934|FG003|Treatment Period (TP)|Withdrew consent|3|||
147347016|NCT00676715|531438931|FG000|Treatment Period (TP)|Insufficient therapeutic response|1|||
147347017|NCT00676715|531438932|FG001|Treatment Period (TP)|Insufficient therapeutic response|1|||
147347018|NCT00676715|531438933|FG002|Treatment Period (TP)|Insufficient therapeutic response|2|||
147347019|NCT00676715|531438934|FG003|Treatment Period (TP)|Insufficient therapeutic response|1|||
147347020|NCT00676715|531438931|FG000|Treatment Period (TP)|Administrative|0|||
147347021|NCT00676715|531438932|FG001|Treatment Period (TP)|Administrative|0|||
147347022|NCT00676715|531438933|FG002|Treatment Period (TP)|Administrative|0|||
147347023|NCT00676715|531438934|FG003|Treatment Period (TP)|Administrative|1|||
147347024|NCT00676715|531438931|FG000|Treatment-free Period (TFP)|Withdrawal by Subject|3|||
147347025|NCT00676715|531438932|FG001|Treatment-free Period (TFP)|Withdrawal by Subject|3|||
147347026|NCT00676715|531438933|FG002|Treatment-free Period (TFP)|Withdrawal by Subject|4|||
147347027|NCT00676715|531438934|FG003|Treatment-free Period (TFP)|Withdrawal by Subject|5|||
147347028|NCT00676715|531438931|FG000|Treatment-free Period (TFP)|Reason not provided|8|||
147347029|NCT00676715|531438932|FG001|Treatment-free Period (TFP)|Reason not provided|10|||
147347030|NCT00676715|531438933|FG002|Treatment-free Period (TFP)|Reason not provided|8|||
147347031|NCT00676715|531438934|FG003|Treatment-free Period (TFP)|Reason not provided|7|||
147347032|NCT00676715|531438931|FG000|Treatment-free Period (TFP)|Lost to Follow-up|2|||
147347033|NCT00676715|531438932|FG001|Treatment-free Period (TFP)|Lost to Follow-up|2|||
147347034|NCT00676715|531438933|FG002|Treatment-free Period (TFP)|Lost to Follow-up|6|||
147347035|NCT00676715|531438934|FG003|Treatment-free Period (TFP)|Lost to Follow-up|2|||
147347036|NCT00676715|531438931|FG000|Treatment-free Period (TFP)|Adverse Event|0|||
147347037|NCT00676715|531438932|FG001|Treatment-free Period (TFP)|Adverse Event|0|||
147347038|NCT00676715|531438933|FG002|Treatment-free Period (TFP)|Adverse Event|1|||
147347039|NCT00676715|531438934|FG003|Treatment-free Period (TFP)|Adverse Event|0|||
147347040|NCT00676715|531438931|FG000|Treatment-free Period (TFP)|Death|1|||
147347041|NCT00676715|531438932|FG001|Treatment-free Period (TFP)|Death|1|||
147347042|NCT00676715|531438933|FG002|Treatment-free Period (TFP)|Death|1|||
147347043|NCT00676715|531438934|FG003|Treatment-free Period (TFP)|Death|0|||
147347044|NCT00676715|531438931|FG000|Open Label Extension (OLE)|Reason not provided|3|||
147347045|NCT00676715|531438932|FG001|Open Label Extension (OLE)|Reason not provided|4|||
147347046|NCT00676715|531438933|FG002|Open Label Extension (OLE)|Reason not provided|1|||
147347047|NCT00676715|531438934|FG003|Open Label Extension (OLE)|Reason not provided|4|||
147347048|NCT00676715|531438931|FG000|Open Label Extension (OLE)|Lost to Follow-up|0|||
147347049|NCT00676715|531438932|FG001|Open Label Extension (OLE)|Lost to Follow-up|0|||
147347050|NCT00676715|531438933|FG002|Open Label Extension (OLE)|Lost to Follow-up|1|||
147347051|NCT00676715|531438934|FG003|Open Label Extension (OLE)|Lost to Follow-up|1|||
147347052|NCT00676715|531438931|FG000|Open Label Extension (OLE)|Withdrawal by Subject|2|||
147347053|NCT00676715|531438932|FG001|Open Label Extension (OLE)|Withdrawal by Subject|4|||
147347054|NCT00676715|531438933|FG002|Open Label Extension (OLE)|Withdrawal by Subject|3|||
147347055|NCT00676715|531438934|FG003|Open Label Extension (OLE)|Withdrawal by Subject|3|||
147347056|NCT00676715|531438931|FG000|Open Label Extension (OLE)|Adverse Event|0|||
147347057|NCT00676715|531438932|FG001|Open Label Extension (OLE)|Adverse Event|3|||
147347058|NCT00676715|531438933|FG002|Open Label Extension (OLE)|Adverse Event|1|||
147347059|NCT00676715|531438934|FG003|Open Label Extension (OLE)|Adverse Event|0|||
147347060|NCT00676715|531438931|FG000|Open Label Extension (OLE)|Death|2|||
147347061|NCT00676715|531438932|FG001|Open Label Extension (OLE)|Death|0|||
147347062|NCT00676715|531438933|FG002|Open Label Extension (OLE)|Death|2|||
147347063|NCT00676715|531438934|FG003|Open Label Extension (OLE)|Death|2|||
147347064|NCT02249949|531438935|FG000|Overall Study|Cancelled prior to treatment|2|||
147347065|NCT02728076|531438940|FG000|Overall Study|Physician Decision|4|||
147347066|NCT05054374|531438957|FG000|Overall Study|Withdrawal by Subject|1|||
147347067|NCT05054374|531438958|FG001|Overall Study|Withdrawal by Subject|0|||
147347068|NCT05054374|531438959|FG002|Overall Study|Withdrawal by Subject|0|||
147347069|NCT05054374|531438960|FG003|Overall Study|Withdrawal by Subject|0|||
147347070|NCT05054374|531438957|FG000|Overall Study|Progressive Disease|5|||
147347071|NCT05054374|531438958|FG001|Overall Study|Progressive Disease|0|||
147347072|NCT05054374|531438959|FG002|Overall Study|Progressive Disease|0|||
147347073|NCT05054374|531438960|FG003|Overall Study|Progressive Disease|0|||
147347074|NCT01707030|531438961|FG000|Overall Study|Death|1|||
147347075|NCT01707030|531438962|FG001|Overall Study|Death|1|||
147347076|NCT01707030|531438961|FG000|Overall Study|Withdrawal by Subject|2|||
147347077|NCT01707030|531438962|FG001|Overall Study|Withdrawal by Subject|3|||
147347078|NCT01707030|531438961|FG000|Overall Study|Lost to Follow-up|8|||
147347079|NCT01707030|531438962|FG001|Overall Study|Lost to Follow-up|13|||
147347080|NCT04437433|531438963|FG000|Overall Study|Met Withdrawal Criteria at Visit 1- Laboratory Values|7|||
147347081|NCT04437433|531438964|FG001|Overall Study|Met Withdrawal Criteria at Visit 1- Laboratory Values|0|||
147347082|NCT04437433|531438963|FG000|Overall Study|Met Withdrawal Criteria at Visit 1- ECG|1|||
147347083|NCT04437433|531438964|FG001|Overall Study|Met Withdrawal Criteria at Visit 1- ECG|0|||
147347084|NCT04437433|531438963|FG000|Overall Study|Adverse Event|9|||
147347085|NCT04437433|531438964|FG001|Overall Study|Adverse Event|0|||
147347086|NCT04437433|531438963|FG000|Overall Study|Lack of Efficacy|4|||
147347087|NCT04437433|531438964|FG001|Overall Study|Lack of Efficacy|0|||
147347088|NCT04437433|531438963|FG000|Overall Study|Withdrawal by Subject|4|||
147347089|NCT04437433|531438964|FG001|Overall Study|Withdrawal by Subject|1|||
147347090|NCT04437433|531438963|FG000|Overall Study|Protocol Deviation|0|||
147347091|NCT04437433|531438964|FG001|Overall Study|Protocol Deviation|1|||
147347092|NCT04437433|531438963|FG000|Overall Study|Other, not specified|0|||
147347093|NCT04437433|531438964|FG001|Overall Study|Other, not specified|1|||
147347094|NCT04245501|531438965|FG000|Overall Study|Adverse Event|2|||
147347095|NCT04245501|531438966|FG001|Overall Study|Adverse Event|0|||
147347096|NCT04245501|531438965|FG000|Overall Study|ineligible participant unknowingly enrolled|0|||
147347097|NCT04245501|531438966|FG001|Overall Study|ineligible participant unknowingly enrolled|1|||
147347098|NCT03526861|531438967|FG000|Initial Treatment Period|Not dosed|1|||
147347099|NCT03526861|531438968|FG001|Initial Treatment Period|Not dosed|1|||
147347100|NCT03526861|531438969|FG002|Initial Treatment Period|Not dosed|1|||
147347101|NCT03526861|531438970|FG003|Initial Treatment Period|Not dosed|0|||
147347102|NCT03526861|531438971|FG004|Initial Treatment Period|Not dosed|0|||
147347103|NCT03526861|531438972|FG005|Initial Treatment Period|Not dosed|0|||
147347104|NCT03526861|531438973|FG006|Initial Treatment Period|Not dosed|0|||
147347105|NCT03526861|531438974|FG007|Initial Treatment Period|Not dosed|0|||
147347106|NCT03526861|531438975|FG008|Initial Treatment Period|Not dosed|0|||
147347107|NCT03526861|531438967|FG000|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|3|||
147347108|NCT03526861|531438968|FG001|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|1|||
147347109|NCT03526861|531438969|FG002|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|5|||
147347110|NCT03526861|531438970|FG003|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
147347111|NCT03526861|531438971|FG004|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
147347112|NCT03526861|531438972|FG005|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
147347113|NCT03526861|531438973|FG006|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
147347114|NCT03526861|531438974|FG007|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
147347115|NCT03526861|531438975|FG008|Initial Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
147347116|NCT03526861|531438967|FG000|Initial Treatment Period|Subject discontinued IMP before Week 16|3|||
147347117|NCT03526861|531438968|FG001|Initial Treatment Period|Subject discontinued IMP before Week 16|5|||
147347118|NCT03526861|531438969|FG002|Initial Treatment Period|Subject discontinued IMP before Week 16|8|||
147347119|NCT03526861|531438970|FG003|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
147347120|NCT03526861|531438971|FG004|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
147347121|NCT03526861|531438972|FG005|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
147347122|NCT03526861|531438973|FG006|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
147347123|NCT03526861|531438974|FG007|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
147347124|NCT03526861|531438975|FG008|Initial Treatment Period|Subject discontinued IMP before Week 16|0|||
147347125|NCT03526861|531438967|FG000|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
147347126|NCT03526861|531438968|FG001|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
147347127|NCT03526861|531438969|FG002|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
147347128|NCT03526861|531438970|FG003|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|1|||
147347129|NCT03526861|531438971|FG004|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|1|||
147347130|NCT03526861|531438972|FG005|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
147347131|NCT03526861|531438973|FG006|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|1|||
147347132|NCT03526861|531438974|FG007|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
147347133|NCT03526861|531438975|FG008|Maintenance Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
147347134|NCT03526861|531438967|FG000|Maintenance Treatment Period|Subject transferred to open-label treatment|0|||
147347135|NCT03526861|531438968|FG001|Maintenance Treatment Period|Subject transferred to open-label treatment|0|||
147347136|NCT03526861|531438969|FG002|Maintenance Treatment Period|Subject transferred to open-label treatment|0|||
147347137|NCT03526861|531438970|FG003|Maintenance Treatment Period|Subject transferred to open-label treatment|6|||
147347138|NCT03526861|531438971|FG004|Maintenance Treatment Period|Subject transferred to open-label treatment|5|||
147347139|NCT03526861|531438972|FG005|Maintenance Treatment Period|Subject transferred to open-label treatment|4|||
147347140|NCT03526861|531438973|FG006|Maintenance Treatment Period|Subject transferred to open-label treatment|5|||
147347141|NCT03526861|531438974|FG007|Maintenance Treatment Period|Subject transferred to open-label treatment|2|||
147347142|NCT03526861|531438975|FG008|Maintenance Treatment Period|Subject transferred to open-label treatment|0|||
147347143|NCT03526861|531438967|FG000|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
147347144|NCT03526861|531438968|FG001|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
147347145|NCT03526861|531438969|FG002|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
147347146|NCT03526861|531438970|FG003|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|1|||
147453271|NCT02792842|531823977|FG002|Overall Study|Lost to Follow-up|1|||
147453272|NCT02792842|531823975|FG000|Overall Study|Schedule delay|0|||
147453273|NCT02792842|531823976|FG001|Overall Study|Schedule delay|1|||
147453274|NCT02792842|531823977|FG002|Overall Study|Schedule delay|1|||
147606831|NCT02932306|532377139|FG000|Overall Study|Worsening condition|2|||
147606832|NCT02932306|532377140|FG001|Overall Study|Worsening condition|0|||
147606833|NCT02932306|532377139|FG000|Overall Study|Withdrew due to burning,itching,stinging|1|||
147347147|NCT03526861|531438971|FG004|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
147347148|NCT03526861|531438972|FG005|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
147347149|NCT03526861|531438973|FG006|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
147347150|NCT03526861|531438974|FG007|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
147347151|NCT03526861|531438975|FG008|Maintenance Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
147347152|NCT03526861|531438967|FG000|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
147347153|NCT03526861|531438968|FG001|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
147347154|NCT03526861|531438969|FG002|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
147347155|NCT03526861|531438970|FG003|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
147347156|NCT03526861|531438971|FG004|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
147347157|NCT03526861|531438972|FG005|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
147347158|NCT03526861|531438973|FG006|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
147347159|NCT03526861|531438974|FG007|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|0|||
147347160|NCT03526861|531438975|FG008|Open-label Treatment Period|Subject discontinued IMP between Week 16 and Week 52|19|||
147347161|NCT03526861|531438967|FG000|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
147347162|NCT03526861|531438968|FG001|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
147347163|NCT03526861|531438969|FG002|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
147347164|NCT03526861|531438970|FG003|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
147347165|NCT03526861|531438971|FG004|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
147347166|NCT03526861|531438972|FG005|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
147347167|NCT03526861|531438973|FG006|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
147347168|NCT03526861|531438974|FG007|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|0|||
147347169|NCT03526861|531438975|FG008|Open-label Treatment Period|Completed treatment (received the last planned dose of IMP) and withdrew from the trial at Week 50|1|||
147347170|NCT03526861|531438967|FG000|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
147347171|NCT03526861|531438968|FG001|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
147347172|NCT03526861|531438969|FG002|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
147347173|NCT03526861|531438970|FG003|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
147347174|NCT03526861|531438971|FG004|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
147347175|NCT03526861|531438972|FG005|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
147347176|NCT03526861|531438973|FG006|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
147347177|NCT03526861|531438974|FG007|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|0|||
147347178|NCT03526861|531438975|FG008|Open-label Treatment Period|Randomised at site with quality/GCP issues identified, subject withdrawn from the trial|8|||
147347179|NCT00601900|531438979|FG000|Overall Study|Withdrawal by Subject|0|||
147347180|NCT00601900|531438980|FG001|Overall Study|Withdrawal by Subject|3|||
147347181|NCT02323321|531438985|FG000|Overall Study|Re-Transplant|1|||
147347182|NCT02323321|531438985|FG000|Overall Study|Death|12|||
147347183|NCT00446225|531438986|FG000|Overall Study|Protocol Violation|1|||
147347184|NCT00446225|531438987|FG001|Overall Study|Protocol Violation|0|||
147347185|NCT01057433|531438990|FG000|Overall Study|Adverse Event|1|||
147347186|NCT05268302|531438991|FG000|Overall Study|Death|0|||
147347187|NCT05268302|531438992|FG001|Overall Study|Death|1|||
147347188|NCT04093752|531438996|FG000|Overall Study|Adverse Event|7|||
147347189|NCT04093752|531438997|FG001|Overall Study|Adverse Event|19|||
147347190|NCT04093752|531438998|FG002|Overall Study|Adverse Event|18|||
147347191|NCT04093752|531438999|FG003|Overall Study|Adverse Event|4|||
147347192|NCT04093752|531438996|FG000|Overall Study|Withdrawal by Subject|6|||
147347193|NCT04093752|531438997|FG001|Overall Study|Withdrawal by Subject|6|||
147347194|NCT04093752|531438998|FG002|Overall Study|Withdrawal by Subject|8|||
147347195|NCT04093752|531438999|FG003|Overall Study|Withdrawal by Subject|20|||
147347196|NCT04093752|531438996|FG000|Overall Study|Lost to Follow-up|2|||
147347197|NCT04093752|531438997|FG001|Overall Study|Lost to Follow-up|1|||
147347198|NCT04093752|531438998|FG002|Overall Study|Lost to Follow-up|1|||
147347199|NCT04093752|531438999|FG003|Overall Study|Lost to Follow-up|1|||
147347200|NCT04093752|531438996|FG000|Overall Study|Death|0|||
147347201|NCT04093752|531438997|FG001|Overall Study|Death|0|||
147347202|NCT04093752|531438998|FG002|Overall Study|Death|1|||
147347203|NCT04093752|531438999|FG003|Overall Study|Death|2|||
147347204|NCT04093752|531438996|FG000|Overall Study|Participant Could Not Continue Due to Work Related Reasons|0|||
147347205|NCT04093752|531438997|FG001|Overall Study|Participant Could Not Continue Due to Work Related Reasons|1|||
147347206|NCT04093752|531438998|FG002|Overall Study|Participant Could Not Continue Due to Work Related Reasons|0|||
147347207|NCT04093752|531438999|FG003|Overall Study|Participant Could Not Continue Due to Work Related Reasons|1|||
147347208|NCT04093752|531438996|FG000|Overall Study|Covid 19|0|||
147347209|NCT04093752|531438997|FG001|Overall Study|Covid 19|0|||
147347210|NCT04093752|531438998|FG002|Overall Study|Covid 19|0|||
147347211|NCT04093752|531438999|FG003|Overall Study|Covid 19|1|||
147347212|NCT04093752|531438996|FG000|Overall Study|Participant Thought there were Too Many Adverse Events|0|||
147347213|NCT04093752|531438997|FG001|Overall Study|Participant Thought there were Too Many Adverse Events|0|||
147347214|NCT04093752|531438998|FG002|Overall Study|Participant Thought there were Too Many Adverse Events|1|||
147347215|NCT04093752|531438999|FG003|Overall Study|Participant Thought there were Too Many Adverse Events|0|||
147347216|NCT04093752|531438996|FG000|Overall Study|Participant was Reluctant to Follow-up|1|||
147347217|NCT04093752|531438997|FG001|Overall Study|Participant was Reluctant to Follow-up|0|||
147347218|NCT04093752|531438998|FG002|Overall Study|Participant was Reluctant to Follow-up|0|||
147347219|NCT04093752|531438999|FG003|Overall Study|Participant was Reluctant to Follow-up|0|||
147347220|NCT04093752|531438996|FG000|Overall Study|Participant Did Not Come for the Visit|1|||
147347221|NCT04093752|531438997|FG001|Overall Study|Participant Did Not Come for the Visit|0|||
147347222|NCT04093752|531438998|FG002|Overall Study|Participant Did Not Come for the Visit|0|||
147347223|NCT04093752|531438999|FG003|Overall Study|Participant Did Not Come for the Visit|0|||
147347224|NCT03527160|531439005|FG000|Overall Study|No urine collected|13|||
147347225|NCT03527160|531439005|FG000|Overall Study|No clinical serum creatinine collected|6|||
147347226|NCT03527160|531439005|FG000|Overall Study|Did not meet inclusion|2|||
147347227|NCT02910713|531439006|FG000|Overall Study|Protocol Violation|2|||
147347228|NCT02910713|531439006|FG000|Overall Study|Subject Choice|4|||
147347229|NCT02910713|531439006|FG000|Overall Study|Received One Application|10|||
147347230|NCT02910713|531439006|FG000|Overall Study|Received Neither Application|18|||
147347231|NCT02910713|531439006|FG000|Overall Study|Enrollment cap|7|||
147347232|NCT02910713|531439006|FG000|Overall Study|Investigator Discretion|1|||
147347233|NCT04442126|531439015|FG000|Overall Study|Withdrawal by Subject|0|||
147347234|NCT04442126|531439016|FG001|Overall Study|Withdrawal by Subject|0|||
147347235|NCT04442126|531439017|FG002|Overall Study|Withdrawal by Subject|0|||
147347236|NCT04442126|531439018|FG003|Overall Study|Withdrawal by Subject|2|||
147347237|NCT04442126|531439019|FG004|Overall Study|Withdrawal by Subject|1|||
147347238|NCT04442126|531439020|FG005|Overall Study|Withdrawal by Subject|0|||
147347239|NCT04442126|531439021|FG006|Overall Study|Withdrawal by Subject|1|||
147347240|NCT04442126|531439022|FG007|Overall Study|Withdrawal by Subject|1|||
147347241|NCT04442126|531439023|FG008|Overall Study|Withdrawal by Subject|3|||
147347242|NCT04442126|531439015|FG000|Overall Study|Death|1|||
147347243|NCT04442126|531439016|FG001|Overall Study|Death|0|||
147347244|NCT04442126|531439017|FG002|Overall Study|Death|0|||
147606834|NCT02932306|532377140|FG001|Overall Study|Withdrew due to burning,itching,stinging|0|||
147347245|NCT04442126|531439018|FG003|Overall Study|Death|1|||
147347246|NCT04442126|531439019|FG004|Overall Study|Death|2|||
147347247|NCT04442126|531439020|FG005|Overall Study|Death|2|||
147347248|NCT04442126|531439021|FG006|Overall Study|Death|4|||
147347249|NCT04442126|531439022|FG007|Overall Study|Death|1|||
147347250|NCT04442126|531439023|FG008|Overall Study|Death|5|||
147347251|NCT04442126|531439015|FG000|Overall Study|Study Terminated by Sponsor|0|||
147347252|NCT04442126|531439016|FG001|Overall Study|Study Terminated by Sponsor|0|||
147347253|NCT04442126|531439017|FG002|Overall Study|Study Terminated by Sponsor|0|||
147347254|NCT04442126|531439018|FG003|Overall Study|Study Terminated by Sponsor|0|||
147347255|NCT04442126|531439019|FG004|Overall Study|Study Terminated by Sponsor|0|||
147347256|NCT04442126|531439020|FG005|Overall Study|Study Terminated by Sponsor|1|||
147347257|NCT04442126|531439021|FG006|Overall Study|Study Terminated by Sponsor|4|||
147347258|NCT04442126|531439022|FG007|Overall Study|Study Terminated by Sponsor|2|||
147347259|NCT04442126|531439023|FG008|Overall Study|Study Terminated by Sponsor|10|||
147347260|NCT04442126|531439015|FG000|Overall Study|Lost to Follow-up|0|||
147347261|NCT04442126|531439016|FG001|Overall Study|Lost to Follow-up|0|||
147347262|NCT04442126|531439017|FG002|Overall Study|Lost to Follow-up|0|||
147606835|NCT03559400|532377145|FG000|Overall Study|Lost to Follow-up|9|||
147606836|NCT03559400|532377146|FG001|Overall Study|Lost to Follow-up|7|||
147606837|NCT03559400|532377145|FG000|Overall Study|Death|0|||
147347263|NCT04442126|531439018|FG003|Overall Study|Lost to Follow-up|0|||
147347264|NCT04442126|531439019|FG004|Overall Study|Lost to Follow-up|0|||
147606838|NCT03559400|532377146|FG001|Overall Study|Death|2|||
147347265|NCT04442126|531439020|FG005|Overall Study|Lost to Follow-up|0|||
147347266|NCT04442126|531439021|FG006|Overall Study|Lost to Follow-up|0|||
147347267|NCT04442126|531439022|FG007|Overall Study|Lost to Follow-up|1|||
147347268|NCT04442126|531439023|FG008|Overall Study|Lost to Follow-up|2|||
147347269|NCT04442126|531439015|FG000|Overall Study|Progressive Disease|0|||
147347270|NCT04442126|531439016|FG001|Overall Study|Progressive Disease|1|||
147347271|NCT04442126|531439017|FG002|Overall Study|Progressive Disease|3|||
147606839|NCT00509366|532377147|FG000|Overall Study|Not Treated (Screen Failure)|1|||
147347272|NCT04442126|531439018|FG003|Overall Study|Progressive Disease|0|||
147347273|NCT04442126|531439019|FG004|Overall Study|Progressive Disease|3|||
147347274|NCT04442126|531439020|FG005|Overall Study|Progressive Disease|0|||
147347275|NCT04442126|531439021|FG006|Overall Study|Progressive Disease|0|||
147347276|NCT04442126|531439022|FG007|Overall Study|Progressive Disease|0|||
147347277|NCT04442126|531439023|FG008|Overall Study|Progressive Disease|0|||
147347278|NCT04442126|531439015|FG000|Overall Study|Other|0|||
147347279|NCT04442126|531439016|FG001|Overall Study|Other|0|||
147347280|NCT04442126|531439017|FG002|Overall Study|Other|0|||
147347281|NCT04442126|531439018|FG003|Overall Study|Other|0|||
147347282|NCT04442126|531439019|FG004|Overall Study|Other|0|||
147347283|NCT04442126|531439020|FG005|Overall Study|Other|0|||
147347284|NCT04442126|531439021|FG006|Overall Study|Other|0|||
147347285|NCT04442126|531439022|FG007|Overall Study|Other|0|||
147347286|NCT04442126|531439023|FG008|Overall Study|Other|1|||
147347287|NCT06450405|531439024|FG000|Overall Study|Study funding terminated.|0|||
147347288|NCT06450405|531439025|FG001|Overall Study|Study funding terminated.|2|||
147347289|NCT05338086|531440740|FG000|Main Treatment Period (Day1 to Month 12)|Adverse Event|4|||
147347290|NCT05338086|531440741|FG001|Main Treatment Period (Day1 to Month 12)|Adverse Event|0|||
147347291|NCT05338086|531440742|FG002|Main Treatment Period (Day1 to Month 12)|Adverse Event|0|||
147347292|NCT05338086|531440743|FG003|Main Treatment Period (Day1 to Month 12)|Adverse Event|0|||
147347293|NCT05338086|531440744|FG004|Main Treatment Period (Day1 to Month 12)|Adverse Event|0|||
147347294|NCT05338086|531440740|FG000|Main Treatment Period (Day1 to Month 12)|Lost to Follow-up|1|||
147347295|NCT05338086|531440741|FG001|Main Treatment Period (Day1 to Month 12)|Lost to Follow-up|2|||
147347296|NCT05338086|531440742|FG002|Main Treatment Period (Day1 to Month 12)|Lost to Follow-up|0|||
147347297|NCT05338086|531440743|FG003|Main Treatment Period (Day1 to Month 12)|Lost to Follow-up|0|||
147347298|NCT05338086|531440744|FG004|Main Treatment Period (Day1 to Month 12)|Lost to Follow-up|0|||
147347299|NCT05338086|531440740|FG000|Main Treatment Period (Day1 to Month 12)|Protocol Violation|1|||
147347300|NCT05338086|531440741|FG001|Main Treatment Period (Day1 to Month 12)|Protocol Violation|1|||
147347301|NCT05338086|531440742|FG002|Main Treatment Period (Day1 to Month 12)|Protocol Violation|0|||
147347302|NCT05338086|531440743|FG003|Main Treatment Period (Day1 to Month 12)|Protocol Violation|0|||
147347303|NCT05338086|531440744|FG004|Main Treatment Period (Day1 to Month 12)|Protocol Violation|0|||
147347304|NCT05338086|531440740|FG000|Main Treatment Period (Day1 to Month 12)|unrelated medical conditions|1|||
147347305|NCT05338086|531440741|FG001|Main Treatment Period (Day1 to Month 12)|unrelated medical conditions|0|||
147347306|NCT05338086|531440742|FG002|Main Treatment Period (Day1 to Month 12)|unrelated medical conditions|0|||
147347307|NCT05338086|531440743|FG003|Main Treatment Period (Day1 to Month 12)|unrelated medical conditions|0|||
147347308|NCT05338086|531440744|FG004|Main Treatment Period (Day1 to Month 12)|unrelated medical conditions|0|||
147347309|NCT05338086|531440740|FG000|Main Treatment Period (Day1 to Month 12)|subject dosed in error and did not meet eligibility criteria|6|||
147347310|NCT05338086|531440741|FG001|Main Treatment Period (Day1 to Month 12)|subject dosed in error and did not meet eligibility criteria|6|||
147347311|NCT05338086|531440742|FG002|Main Treatment Period (Day1 to Month 12)|subject dosed in error and did not meet eligibility criteria|0|||
147347312|NCT05338086|531440743|FG003|Main Treatment Period (Day1 to Month 12)|subject dosed in error and did not meet eligibility criteria|0|||
147347313|NCT05338086|531440744|FG004|Main Treatment Period (Day1 to Month 12)|subject dosed in error and did not meet eligibility criteria|0|||
147347314|NCT05338086|531440740|FG000|Main Treatment Period (Day1 to Month 12)|other|23|||
147347315|NCT05338086|531440741|FG001|Main Treatment Period (Day1 to Month 12)|other|16|||
147347316|NCT05338086|531440742|FG002|Main Treatment Period (Day1 to Month 12)|other|0|||
147347317|NCT05338086|531440743|FG003|Main Treatment Period (Day1 to Month 12)|other|0|||
147347318|NCT05338086|531440744|FG004|Main Treatment Period (Day1 to Month 12)|other|0|||
147347319|NCT05338086|531440740|FG000|Transition Period (M12 to M18)|Death|0|||
147347320|NCT05338086|531440741|FG001|Transition Period (M12 to M18)|Death|0|||
147347321|NCT05338086|531440742|FG002|Transition Period (M12 to M18)|Death|1|||
147347322|NCT05338086|531440743|FG003|Transition Period (M12 to M18)|Death|0|||
147347323|NCT05338086|531440744|FG004|Transition Period (M12 to M18)|Death|0|||
147347324|NCT05338086|531440740|FG000|Transition Period (M12 to M18)|Withdrawal by Subject|0|||
147347325|NCT05338086|531440741|FG001|Transition Period (M12 to M18)|Withdrawal by Subject|0|||
147347326|NCT05338086|531440742|FG002|Transition Period (M12 to M18)|Withdrawal by Subject|4|||
147347327|NCT05338086|531440743|FG003|Transition Period (M12 to M18)|Withdrawal by Subject|3|||
147347328|NCT05338086|531440744|FG004|Transition Period (M12 to M18)|Withdrawal by Subject|2|||
147347329|NCT05338086|531440740|FG000|Transition Period (M12 to M18)|Burden of study procedures|0|||
147347330|NCT05338086|531440741|FG001|Transition Period (M12 to M18)|Burden of study procedures|0|||
147347331|NCT05338086|531440742|FG002|Transition Period (M12 to M18)|Burden of study procedures|1|||
147347332|NCT05338086|531440743|FG003|Transition Period (M12 to M18)|Burden of study procedures|0|||
147347333|NCT05338086|531440744|FG004|Transition Period (M12 to M18)|Burden of study procedures|0|||
147347334|NCT05338086|531440740|FG000|Transition Period (M12 to M18)|Subject left the country|0|||
147347335|NCT05338086|531440741|FG001|Transition Period (M12 to M18)|Subject left the country|0|||
147347336|NCT05338086|531440742|FG002|Transition Period (M12 to M18)|Subject left the country|0|||
147347337|NCT05338086|531440743|FG003|Transition Period (M12 to M18)|Subject left the country|0|||
147347338|NCT05338086|531440744|FG004|Transition Period (M12 to M18)|Subject left the country|1|||
147606840|NCT00509366|532377148|FG001|Overall Study|Not Treated (Screen Failure)|1|||
147606841|NCT00509366|532377149|FG002|Overall Study|Not Treated (Screen Failure)|1|||
147606842|NCT00509366|532377150|FG003|Overall Study|Not Treated (Screen Failure)|0|||
147606843|NCT00509366|532377151|FG004|Overall Study|Not Treated (Screen Failure)|0|||
147606844|NCT00282919|532377152|FG000|Overall Study|Lack of Efficacy|4|||
147347339|NCT03940703|531440745|FG000|Overall Study|Still under treatment|31|||
147347340|NCT03940703|531440746|FG001|Overall Study|Still under treatment|0|||
147347341|NCT05113966|531440756|FG000|Overall Study|Death|21|||
147347342|NCT05113966|531440756|FG000|Overall Study|Study Terminated by Sponsor|9|||
147347343|NCT05386355|531440757|FG000|Overall Study|Each group had an ineligible child (i.e., one over 18 years old and one less than 6-months old).|1|||
147347344|NCT05386355|531440758|FG001|Overall Study|Each group had an ineligible child (i.e., one over 18 years old and one less than 6-months old).|1|||
147347345|NCT05386355|531440759|FG002|Overall Study|Each group had an ineligible child (i.e., one over 18 years old and one less than 6-months old).|1|||
147347346|NCT05386355|531440760|FG003|Overall Study|Each group had an ineligible child (i.e., one over 18 years old and one less than 6-months old).|1|||
147347347|NCT03625882|531440762|FG000|Overall Study|Protocol Violation|3|||
147347348|NCT05110495|531440765|FG000|Overall Study|Lost to Follow-up|1|||
147347349|NCT05110495|531440765|FG000|Overall Study|Completed treatment with IMP but disease progressed prior to surgery.|1|||
147347350|NCT03896516|531440770|FG000|Stage I (GLWL-01 or Placebo)|Withdrawal by Subject|1|||
147347351|NCT03896516|531440771|FG001|Stage I (GLWL-01 or Placebo)|Withdrawal by Subject|0|||
147347352|NCT03896516|531440770|FG000|Stage I (GLWL-01 or Placebo)|Physician Decision|1|||
147347353|NCT03896516|531440771|FG001|Stage I (GLWL-01 or Placebo)|Physician Decision|1|||
147347354|NCT03896516|531440770|FG000|Washout Period|Physician Decision|3|||
147347355|NCT03896516|531440771|FG001|Washout Period|Physician Decision|1|||
147347356|NCT03896516|531440770|FG000|Stage II (GLWL-01 or Placebo)|Physician Decision|0|||
147347357|NCT03896516|531440771|FG001|Stage II (GLWL-01 or Placebo)|Physician Decision|1|||
147347358|NCT02682316|531440776|FG000|Overall Study|Benign Final Pathology|27|||
147347359|NCT02682316|531440777|FG001|Overall Study|Benign Final Pathology|26|||
147347360|NCT02682316|531440776|FG000|Overall Study|Reoperation before 30 days|7|||
147347361|NCT02682316|531440777|FG001|Overall Study|Reoperation before 30 days|6|||
147347362|NCT02682316|531440776|FG000|Overall Study|Ineligible|1|||
147347363|NCT02682316|531440777|FG001|Overall Study|Ineligible|0|||
147347364|NCT02682316|531440776|FG000|Overall Study|Death|1|||
147347365|NCT02682316|531440777|FG001|Overall Study|Death|0|||
147347366|NCT02682316|531440776|FG000|Overall Study|Lost to Follow-up|7|||
147347367|NCT02682316|531440777|FG001|Overall Study|Lost to Follow-up|3|||
147347368|NCT02662062|531440783|FG000|Overall Study|Withdrawal by Subject|1|||
147347369|NCT05374837|531440784|FG000|Overall Study|Lost to Follow-up|17|||
147347370|NCT05374837|531440785|FG001|Overall Study|Lost to Follow-up|18|||
147347371|NCT05406921|531440786|FG000|Overall Study|Withdrawal by Subject|25|||
147347372|NCT05406921|531440787|FG001|Overall Study|Withdrawal by Subject|0|||
147347373|NCT05406921|531440788|FG002|Overall Study|Withdrawal by Subject|25|||
147347374|NCT05406921|531440786|FG000|Overall Study|Protocol Violation|0|||
147347375|NCT05406921|531440787|FG001|Overall Study|Protocol Violation|12|||
147347376|NCT05406921|531440788|FG002|Overall Study|Protocol Violation|0|||
147347377|NCT04831281|531440791|FG000|Overall Study|Adverse Event|1|||
147347378|NCT04831281|531440792|FG001|Overall Study|Adverse Event|0|||
147347379|NCT04831281|531440793|FG002|Overall Study|Adverse Event|3|||
147347380|NCT04831281|531440791|FG000|Overall Study|Withdrawal by Subject|0|||
147347381|NCT04831281|531440792|FG001|Overall Study|Withdrawal by Subject|1|||
147347382|NCT04831281|531440793|FG002|Overall Study|Withdrawal by Subject|2|||
147347383|NCT04831281|531440791|FG000|Overall Study|Undetermined|1|||
147347384|NCT04831281|531440792|FG001|Overall Study|Undetermined|1|||
147347385|NCT04831281|531440793|FG002|Overall Study|Undetermined|0|||
147347386|NCT05249439|531440794|FG000|Overall Study|Withdrawal by Subject|2|||
147347387|NCT05249439|531440795|FG001|Overall Study|Withdrawal by Subject|5|||
147606845|NCT00282919|532377152|FG000|Overall Study|Withdrawal by Subject|1|||
147606846|NCT00282919|532377152|FG000|Overall Study|Asymptomatic Parasitemia|2|||
147606847|NCT01438996|532377155|FG000|Overall Study|Not meeting Inclusion Criteria|4|||
147606848|NCT01438996|532377156|FG001|Overall Study|Not meeting Inclusion Criteria|1|||
147606849|NCT01438996|532377157|FG002|Overall Study|Not meeting Inclusion Criteria|0|||
147606850|NCT01433549|532377158|FG000|Phase 2: Second Study Product|Adverse Event|0|||
147606851|NCT01433549|532377159|FG001|Phase 2: Second Study Product|Adverse Event|1|||
147606852|NCT04497948|532377162|FG000|Overall Study|Death|2|||
147606853|NCT00696787|532377163|FG000|Overall Study|Adverse Event|1|||
147606854|NCT00696787|532377164|FG001|Overall Study|Adverse Event|0|||
147347388|NCT05249439|531440794|FG000|Overall Study|Physician Decision|3|||
147347389|NCT05249439|531440795|FG001|Overall Study|Physician Decision|1|||
147347390|NCT02097420|531440796|FG000|Overall Study|Death|6|||
147347391|NCT02097420|531440796|FG000|Overall Study|Valve explanted|13|||
147347392|NCT02097420|531440796|FG000|Overall Study|Other Reason|1|||
147347393|NCT05059262|531440797|FG000|Part 1: Double Blind (Weeks 1 - 24)|Subsequent TGCT therapy and/or surgery|3|||
147606855|NCT00696787|532377165|FG002|Overall Study|Adverse Event|6|||
147347394|NCT05059262|531440798|FG001|Part 1: Double Blind (Weeks 1 - 24)|Subsequent TGCT therapy and/or surgery|0|||
147347395|NCT05059262|531440797|FG000|Part 1: Double Blind (Weeks 1 - 24)|Withdrawal by Subject|3|||
147347396|NCT05059262|531440798|FG001|Part 1: Double Blind (Weeks 1 - 24)|Withdrawal by Subject|3|||
147347397|NCT05059262|531440797|FG000|Part 1: Double Blind (Weeks 1 - 24)|Physician Decision|1|||
147347398|NCT05059262|531440798|FG001|Part 1: Double Blind (Weeks 1 - 24)|Physician Decision|1|||
147347399|NCT05059262|531440797|FG000|Part 1: Double Blind (Weeks 1 - 24)|Other reasons|0|||
147347400|NCT05059262|531440798|FG001|Part 1: Double Blind (Weeks 1 - 24)|Other reasons|1|||
147347401|NCT05059262|531440797|FG000|Part 1: Double Blind (Weeks 1 - 24)|Ongoing in study|1|||
147347402|NCT05059262|531440798|FG001|Part 1: Double Blind (Weeks 1 - 24)|Ongoing in study|0|||
147347403|NCT05059262|531440797|FG000|Part 2: Open Label (Weeks 25 - EoS)|Death|1|||
147347404|NCT05059262|531440798|FG001|Part 2: Open Label (Weeks 25 - EoS)|Death|0|||
147347405|NCT05059262|531440797|FG000|Part 2: Open Label (Weeks 25 - EoS)|Withdrawal by Subject|0|||
147347406|NCT05059262|531440798|FG001|Part 2: Open Label (Weeks 25 - EoS)|Withdrawal by Subject|1|||
147347407|NCT05059262|531440797|FG000|Part 2: Open Label (Weeks 25 - EoS)|Lost to Follow-up|0|||
147347408|NCT05059262|531440798|FG001|Part 2: Open Label (Weeks 25 - EoS)|Lost to Follow-up|2|||
147347409|NCT05059262|531440797|FG000|Part 2: Open Label (Weeks 25 - EoS)|Ongoing in study|73|||
147347410|NCT05059262|531440798|FG001|Part 2: Open Label (Weeks 25 - EoS)|Ongoing in study|32|||
147347411|NCT05021640|531440802|FG000|Overall Study|Lost to Follow-up|0|||
147347412|NCT05021640|531440803|FG001|Overall Study|Lost to Follow-up|0|||
147347413|NCT05021640|531440804|FG002|Overall Study|Lost to Follow-up|0|||
147347414|NCT05021640|531440805|FG003|Overall Study|Lost to Follow-up|0|||
147347415|NCT05021640|531440806|FG004|Overall Study|Lost to Follow-up|1|||
147347416|NCT04737772|531440807|FG000|Phase 2 Study|Lost to Follow-up|15|||
147347417|NCT04737772|531440808|FG001|Phase 2 Study|Lost to Follow-up|15|||
147347418|NCT04737772|531440807|FG000|Phase 2 Study|Withdrawal by Subject|0|||
147347419|NCT04737772|531440808|FG001|Phase 2 Study|Withdrawal by Subject|1|||
147347420|NCT04737772|531440807|FG000|Phase 2 Study|Did not take any coaching calls|4|||
147347421|NCT04737772|531440808|FG001|Phase 2 Study|Did not take any coaching calls|0|||
147347422|NCT04737772|531440807|FG000|Pilot Phase 1 of Study|Withdrawal by Subject|0|||
147347423|NCT04737772|531440808|FG001|Pilot Phase 1 of Study|Withdrawal by Subject|1|||
147347424|NCT04737772|531440807|FG000|Pilot Phase 1 of Study|Randomized but ineligible|0|||
147347425|NCT04737772|531440808|FG001|Pilot Phase 1 of Study|Randomized but ineligible|1|||
147347426|NCT02549339|531440809|FG000|3-day Treatment and 8-week Follow-up|Protocol Violation|2|||
147347427|NCT02549339|531440810|FG001|3-day Treatment and 8-week Follow-up|Protocol Violation|0|||
147347428|NCT02549339|531440809|FG000|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|1|||
147347429|NCT02549339|531440810|FG001|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|3|||
147347430|NCT02549339|531440809|FG000|3-day Treatment and 8-week Follow-up|Other|1|||
147347431|NCT02549339|531440810|FG001|3-day Treatment and 8-week Follow-up|Other|0|||
147347432|NCT02549339|531440809|FG000|3-day Treatment and 8-week Follow-up|Lost to Follow-up|0|||
147347433|NCT02549339|531440810|FG001|3-day Treatment and 8-week Follow-up|Lost to Follow-up|2|||
147347434|NCT02549339|531440809|FG000|12-month Follow-up|Lack of Efficacy|0|||
147347435|NCT02549339|531440810|FG001|12-month Follow-up|Lack of Efficacy|2|||
147347436|NCT02549339|531440809|FG000|12-month Follow-up|Withdrawal by Subject|8|||
147347437|NCT02549339|531440810|FG001|12-month Follow-up|Withdrawal by Subject|3|||
147347438|NCT02549339|531440809|FG000|12-month Follow-up|Lost to Follow-up|1|||
147347439|NCT02549339|531440810|FG001|12-month Follow-up|Lost to Follow-up|3|||
147347440|NCT02549339|531440809|FG000|12-month Follow-up|Other|0|||
147347441|NCT02549339|531440810|FG001|12-month Follow-up|Other|3|||
147347442|NCT05691309|531440811|FG000|Overall Study|vancomycin discontinued by clinical team|2|||
147347443|NCT05691309|531440811|FG000|Overall Study|vancomycin levels not evaluable|2|||
147347444|NCT04820855|531440813|FG000|Overall Study|Lost to Follow-up|6|||
147347445|NCT04820855|531440814|FG001|Overall Study|Lost to Follow-up|9|||
147347446|NCT04838262|531440815|FG000|Overall Study|Withdrawal by Subject|9|||
147347447|NCT04838262|531440816|FG001|Overall Study|Withdrawal by Subject|4|||
147347448|NCT04382898|531440823|FG000|Part 1: Dose Titration|Withdrawal by Subject|1|||
147347449|NCT04382898|531440824|FG001|Part 1: Dose Titration|Withdrawal by Subject|0|||
147347450|NCT04382898|531440825|FG002|Part 1: Dose Titration|Withdrawal by Subject|0|||
147347451|NCT04382898|531440826|FG003|Part 1: Dose Titration|Withdrawal by Subject|0|||
147347452|NCT04382898|531440827|FG004|Part 1: Dose Titration|Withdrawal by Subject|0|||
147347453|NCT04382898|531440823|FG000|Part 1: Dose Titration|Death|6|||
147347454|NCT04382898|531440824|FG001|Part 1: Dose Titration|Death|0|||
147347455|NCT04382898|531440825|FG002|Part 1: Dose Titration|Death|0|||
147347456|NCT04382898|531440826|FG003|Part 1: Dose Titration|Death|0|||
147347457|NCT04382898|531440827|FG004|Part 1: Dose Titration|Death|0|||
147347458|NCT04382898|531440823|FG000|Part 2: Dose Expansion|Withdrawal by Subject|0|||
147347459|NCT04382898|531440824|FG001|Part 2: Dose Expansion|Withdrawal by Subject|0|||
147347460|NCT04382898|531440825|FG002|Part 2: Dose Expansion|Withdrawal by Subject|1|||
147347461|NCT04382898|531440826|FG003|Part 2: Dose Expansion|Withdrawal by Subject|0|||
147347462|NCT04382898|531440827|FG004|Part 2: Dose Expansion|Withdrawal by Subject|0|||
147347463|NCT04382898|531440823|FG000|Part 2: Dose Expansion|Lost to Follow-up|0|||
147347464|NCT04382898|531440824|FG001|Part 2: Dose Expansion|Lost to Follow-up|0|||
147347465|NCT04382898|531440825|FG002|Part 2: Dose Expansion|Lost to Follow-up|1|||
147347466|NCT04382898|531440826|FG003|Part 2: Dose Expansion|Lost to Follow-up|0|||
147347467|NCT04382898|531440827|FG004|Part 2: Dose Expansion|Lost to Follow-up|0|||
147347468|NCT04382898|531440823|FG000|Part 2: Dose Expansion|Death|0|||
147347469|NCT04382898|531440824|FG001|Part 2: Dose Expansion|Death|17|||
147347470|NCT04382898|531440825|FG002|Part 2: Dose Expansion|Death|13|||
147347471|NCT04382898|531440826|FG003|Part 2: Dose Expansion|Death|1|||
147347472|NCT04382898|531440827|FG004|Part 2: Dose Expansion|Death|0|||
147347473|NCT04382898|531440823|FG000|Part 2: Dose Expansion|Progressive Disease|0|||
147347474|NCT04382898|531440824|FG001|Part 2: Dose Expansion|Progressive Disease|0|||
147347475|NCT04382898|531440825|FG002|Part 2: Dose Expansion|Progressive Disease|1|||
147347476|NCT04382898|531440826|FG003|Part 2: Dose Expansion|Progressive Disease|0|||
147347477|NCT04382898|531440827|FG004|Part 2: Dose Expansion|Progressive Disease|0|||
147347478|NCT04382898|531440823|FG000|Part 2: Dose Expansion|Study Terminated By Sponsor|0|||
147347479|NCT04382898|531440824|FG001|Part 2: Dose Expansion|Study Terminated By Sponsor|1|||
147347480|NCT04382898|531440825|FG002|Part 2: Dose Expansion|Study Terminated By Sponsor|1|||
147347481|NCT04382898|531440826|FG003|Part 2: Dose Expansion|Study Terminated By Sponsor|0|||
147347482|NCT04382898|531440827|FG004|Part 2: Dose Expansion|Study Terminated By Sponsor|1|||
147347483|NCT04382898|531440823|FG000|Part 2: Dose Expansion|Other|0|||
147347484|NCT04382898|531440824|FG001|Part 2: Dose Expansion|Other|0|||
147347485|NCT04382898|531440825|FG002|Part 2: Dose Expansion|Other|1|||
147347486|NCT04382898|531440826|FG003|Part 2: Dose Expansion|Other|0|||
147347487|NCT04382898|531440827|FG004|Part 2: Dose Expansion|Other|0|||
147347488|NCT05229120|531440828|FG000|Overall Study|Withdrawal by Subject|8|||
147347489|NCT05956002|531440832|FG000|Treatment Period 3|Adverse Event|0|||
147347490|NCT05956002|531440833|FG001|Treatment Period 3|Adverse Event|0|||
147347491|NCT05956002|531440834|FG002|Treatment Period 3|Adverse Event|1|||
147347492|NCT05956002|531440835|FG003|Treatment Period 3|Adverse Event|0|||
147347493|NCT02307565|531440836|FG000|Overall Study|Adverse Event|3|||
147347494|NCT02307565|531440837|FG001|Overall Study|Adverse Event|2|||
147347495|NCT02307565|531440836|FG000|Overall Study|Withdrawal by Subject|2|||
147347496|NCT02307565|531440837|FG001|Overall Study|Withdrawal by Subject|2|||
147347497|NCT04936035|531440838|FG000|Overall Study|Adverse Event|0|||
147347498|NCT04936035|531440839|FG001|Overall Study|Adverse Event|1|||
147347499|NCT04936035|531440840|FG002|Overall Study|Adverse Event|0|||
147347500|NCT04936035|531440841|FG003|Overall Study|Adverse Event|0|||
147347501|NCT04936035|531440842|FG004|Overall Study|Adverse Event|0|||
147347502|NCT04936035|531440838|FG000|Overall Study|Death|0|||
147347503|NCT04936035|531440839|FG001|Overall Study|Death|0|||
147347504|NCT04936035|531440840|FG002|Overall Study|Death|0|||
147347505|NCT04936035|531440841|FG003|Overall Study|Death|1|||
147347506|NCT04936035|531440842|FG004|Overall Study|Death|0|||
147347507|NCT04936035|531440838|FG000|Overall Study|Lost to Follow-up|0|||
147347508|NCT04936035|531440839|FG001|Overall Study|Lost to Follow-up|1|||
147347509|NCT04936035|531440840|FG002|Overall Study|Lost to Follow-up|1|||
147347510|NCT04936035|531440841|FG003|Overall Study|Lost to Follow-up|2|||
147347511|NCT04936035|531440842|FG004|Overall Study|Lost to Follow-up|1|||
147347512|NCT04936035|531440838|FG000|Overall Study|Physician Decision|0|||
147347513|NCT04936035|531440839|FG001|Overall Study|Physician Decision|1|||
147347514|NCT04936035|531440840|FG002|Overall Study|Physician Decision|0|||
147347515|NCT04936035|531440841|FG003|Overall Study|Physician Decision|0|||
147347516|NCT04936035|531440842|FG004|Overall Study|Physician Decision|0|||
147347517|NCT04936035|531440838|FG000|Overall Study|Protocol Deviation|0|||
147347518|NCT04936035|531440839|FG001|Overall Study|Protocol Deviation|0|||
147347519|NCT04936035|531440840|FG002|Overall Study|Protocol Deviation|1|||
147347520|NCT04936035|531440841|FG003|Overall Study|Protocol Deviation|0|||
147347521|NCT04936035|531440842|FG004|Overall Study|Protocol Deviation|0|||
147347522|NCT04936035|531440838|FG000|Overall Study|Subject Stopped Participation in the Study|5|||
147347523|NCT04936035|531440839|FG001|Overall Study|Subject Stopped Participation in the Study|5|||
147347524|NCT04936035|531440840|FG002|Overall Study|Subject Stopped Participation in the Study|1|||
147347525|NCT04936035|531440841|FG003|Overall Study|Subject Stopped Participation in the Study|2|||
147347526|NCT04936035|531440842|FG004|Overall Study|Subject Stopped Participation in the Study|3|||
147347527|NCT04936035|531440838|FG000|Overall Study|Reason Unknown|0|||
147347528|NCT04936035|531440839|FG001|Overall Study|Reason Unknown|0|||
147347529|NCT04936035|531440840|FG002|Overall Study|Reason Unknown|0|||
147347530|NCT04936035|531440841|FG003|Overall Study|Reason Unknown|0|||
147347531|NCT04936035|531440842|FG004|Overall Study|Reason Unknown|1|||
147347532|NCT04936035|531440838|FG000|Overall Study|Withdrawal by Subject|1|||
147347533|NCT04936035|531440839|FG001|Overall Study|Withdrawal by Subject|0|||
147347534|NCT04936035|531440840|FG002|Overall Study|Withdrawal by Subject|0|||
147347535|NCT04936035|531440841|FG003|Overall Study|Withdrawal by Subject|0|||
147347536|NCT04936035|531440842|FG004|Overall Study|Withdrawal by Subject|0|||
147347537|NCT04936035|531440838|FG000|Overall Study|Discontinued Treatment due to Participant's Decision but Ongoing in Safety Follow-up|0|||
147347538|NCT04936035|531440839|FG001|Overall Study|Discontinued Treatment due to Participant's Decision but Ongoing in Safety Follow-up|0|||
147347539|NCT04936035|531440840|FG002|Overall Study|Discontinued Treatment due to Participant's Decision but Ongoing in Safety Follow-up|0|||
147347540|NCT04936035|531440841|FG003|Overall Study|Discontinued Treatment due to Participant's Decision but Ongoing in Safety Follow-up|2|||
147347541|NCT04936035|531440842|FG004|Overall Study|Discontinued Treatment due to Participant's Decision but Ongoing in Safety Follow-up|0|||
147347542|NCT04936035|531440838|FG000|Overall Study|Discontinued Treatment due to Physician Decision but Ongoing in Safety Follow-up|0|||
147347543|NCT04936035|531440839|FG001|Overall Study|Discontinued Treatment due to Physician Decision but Ongoing in Safety Follow-up|0|||
147347544|NCT04936035|531440840|FG002|Overall Study|Discontinued Treatment due to Physician Decision but Ongoing in Safety Follow-up|0|||
147347545|NCT04936035|531440841|FG003|Overall Study|Discontinued Treatment due to Physician Decision but Ongoing in Safety Follow-up|0|||
147347546|NCT04936035|531440842|FG004|Overall Study|Discontinued Treatment due to Physician Decision but Ongoing in Safety Follow-up|1|||
147347547|NCT04936035|531440838|FG000|Overall Study|Discontinued Treatment due to Adverse Event but Ongoing in Safety Follow-up|0|||
147347548|NCT04936035|531440839|FG001|Overall Study|Discontinued Treatment due to Adverse Event but Ongoing in Safety Follow-up|0|||
147347549|NCT04936035|531440840|FG002|Overall Study|Discontinued Treatment due to Adverse Event but Ongoing in Safety Follow-up|0|||
147347550|NCT04936035|531440841|FG003|Overall Study|Discontinued Treatment due to Adverse Event but Ongoing in Safety Follow-up|0|||
147347551|NCT04936035|531440842|FG004|Overall Study|Discontinued Treatment due to Adverse Event but Ongoing in Safety Follow-up|1|||
147347552|NCT04401800|531440843|FG000|Overall Study|Death|17|||
147347553|NCT04401800|531440843|FG000|Overall Study|Lost to Follow-up|5|||
147347554|NCT04401800|531440843|FG000|Overall Study|Withdrawal by Subject|4|||
147347555|NCT04391894|531440856|FG000|Overall Study|Adverse Event|1|||
147347556|NCT04391894|531440857|FG001|Overall Study|Adverse Event|1|||
147347557|NCT04391894|531440858|FG002|Overall Study|Adverse Event|1|||
147347558|NCT04391894|531440859|FG003|Overall Study|Adverse Event|1|||
147347559|NCT04391894|531440860|FG004|Overall Study|Adverse Event|1|||
147347560|NCT04391894|531440856|FG000|Overall Study|Lost to Follow-up|1|||
147347561|NCT04391894|531440857|FG001|Overall Study|Lost to Follow-up|0|||
147347562|NCT04391894|531440858|FG002|Overall Study|Lost to Follow-up|0|||
147347563|NCT04391894|531440859|FG003|Overall Study|Lost to Follow-up|0|||
147347564|NCT04391894|531440860|FG004|Overall Study|Lost to Follow-up|0|||
147347565|NCT04391894|531440856|FG000|Overall Study|Protocol Violation|0|||
147347566|NCT04391894|531440857|FG001|Overall Study|Protocol Violation|0|||
147347567|NCT04391894|531440858|FG002|Overall Study|Protocol Violation|0|||
147347568|NCT04391894|531440859|FG003|Overall Study|Protocol Violation|1|||
147347569|NCT04391894|531440860|FG004|Overall Study|Protocol Violation|0|||
147347570|NCT04391894|531440856|FG000|Overall Study|Withdrawal by Subject|2|||
147347571|NCT04391894|531440857|FG001|Overall Study|Withdrawal by Subject|0|||
147347572|NCT04391894|531440858|FG002|Overall Study|Withdrawal by Subject|3|||
147347573|NCT04391894|531440859|FG003|Overall Study|Withdrawal by Subject|0|||
147347574|NCT04391894|531440860|FG004|Overall Study|Withdrawal by Subject|1|||
147347575|NCT04391894|531440856|FG000|Overall Study|Unsatisfactory Therapeutic effect|0|||
147347576|NCT04391894|531440857|FG001|Overall Study|Unsatisfactory Therapeutic effect|0|||
147347577|NCT04391894|531440858|FG002|Overall Study|Unsatisfactory Therapeutic effect|0|||
147347578|NCT04391894|531440859|FG003|Overall Study|Unsatisfactory Therapeutic effect|0|||
147347579|NCT04391894|531440860|FG004|Overall Study|Unsatisfactory Therapeutic effect|1|||
147347580|NCT04450342|531440864|FG000|Overall Study|Adverse Event|1|||
147347581|NCT04450342|531440865|FG001|Overall Study|Adverse Event|1|||
147347582|NCT04450342|531440866|FG002|Overall Study|Adverse Event|0|||
147347583|NCT04450342|531440864|FG000|Overall Study|Device not used|1|||
147347584|NCT04450342|531440865|FG001|Overall Study|Device not used|0|||
147347585|NCT04450342|531440866|FG002|Overall Study|Device not used|0|||
147347586|NCT04450342|531440864|FG000|Overall Study|Withdrawal by Subject & Study Terminated by Sponsor|1|||
147347587|NCT04450342|531440865|FG001|Overall Study|Withdrawal by Subject & Study Terminated by Sponsor|0|||
147347588|NCT04450342|531440866|FG002|Overall Study|Withdrawal by Subject & Study Terminated by Sponsor|0|||
147347589|NCT04450342|531440864|FG000|Overall Study|Physician Decision|1|||
147347590|NCT04450342|531440865|FG001|Overall Study|Physician Decision|0|||
147347591|NCT04450342|531440866|FG002|Overall Study|Physician Decision|1|||
147347592|NCT04450342|531440864|FG000|Overall Study|Protocol Deviation|0|||
147347593|NCT04450342|531440865|FG001|Overall Study|Protocol Deviation|1|||
147347594|NCT04450342|531440866|FG002|Overall Study|Protocol Deviation|0|||
147347595|NCT04450342|531440864|FG000|Overall Study|Reoperation|1|||
147347596|NCT04450342|531440865|FG001|Overall Study|Reoperation|1|||
147347597|NCT04450342|531440866|FG002|Overall Study|Reoperation|0|||
147347598|NCT04450342|531440864|FG000|Overall Study|Screen Failures|0|||
147347599|NCT04450342|531440865|FG001|Overall Study|Screen Failures|0|||
147347600|NCT04450342|531440866|FG002|Overall Study|Screen Failures|2|||
147347601|NCT04450342|531440864|FG000|Overall Study|Site Terminated by Sponsor|1|||
147347602|NCT04450342|531440865|FG001|Overall Study|Site Terminated by Sponsor|1|||
147347603|NCT04450342|531440866|FG002|Overall Study|Site Terminated by Sponsor|1|||
147347604|NCT04450342|531440864|FG000|Overall Study|Study Terminated by Sponsor|31|||
147347605|NCT04450342|531440865|FG001|Overall Study|Study Terminated by Sponsor|29|||
147347606|NCT04450342|531440866|FG002|Overall Study|Study Terminated by Sponsor|6|||
147347607|NCT04450342|531440864|FG000|Overall Study|Withdrawal by Subject|0|||
147347608|NCT04450342|531440865|FG001|Overall Study|Withdrawal by Subject|1|||
147347609|NCT04450342|531440866|FG002|Overall Study|Withdrawal by Subject|2|||
147347610|NCT05633407|531440867|FG000|Overall Study|Physician Decision|2|||
147347611|NCT05633407|531440868|FG001|Overall Study|Physician Decision|0|||
147347612|NCT05633407|531440867|FG000|Overall Study|Adverse Event|1|||
147347613|NCT05633407|531440868|FG001|Overall Study|Adverse Event|0|||
147347614|NCT05633407|531440867|FG000|Overall Study|Withdrawal by Subject|1|||
147347615|NCT05633407|531440868|FG001|Overall Study|Withdrawal by Subject|0|||
147347616|NCT05633407|531440867|FG000|Overall Study|Other|1|||
147347617|NCT05633407|531440868|FG001|Overall Study|Other|1|||
147347618|NCT00220740|531440871|FG000|Efficacy Period|Entered rescue treatment with placebo|23|||
147347619|NCT00220740|531440872|FG001|Efficacy Period|Entered rescue treatment with placebo|0|||
147347620|NCT00220740|531440871|FG000|Efficacy Period|Adverse Event|1|||
147347621|NCT00220740|531440872|FG001|Efficacy Period|Adverse Event|1|||
147347622|NCT00220740|531440871|FG000|Efficacy Period|Withdrawal by Subject|1|||
147347623|NCT00220740|531440872|FG001|Efficacy Period|Withdrawal by Subject|0|||
147347624|NCT00220740|531440871|FG000|Efficacy Period|Protocol Violation|1|||
147347625|NCT00220740|531440872|FG001|Efficacy Period|Protocol Violation|0|||
147347626|NCT00220740|531440871|FG000|Efficacy Period|Entered Rescue Treatment with IGIV-C|0|||
147347627|NCT00220740|531440872|FG001|Efficacy Period|Entered Rescue Treatment with IGIV-C|45|||
147347628|NCT04757610|531440874|FG000|Overall Study|Adverse Event|13|||
147347629|NCT04757610|531440875|FG001|Overall Study|Adverse Event|10|||
147347630|NCT04757610|531440876|FG002|Overall Study|Adverse Event|5|||
147347631|NCT04757610|531440874|FG000|Overall Study|Death|5|||
147347632|NCT04757610|531440875|FG001|Overall Study|Death|13|||
147347633|NCT04757610|531440876|FG002|Overall Study|Death|8|||
147347634|NCT04757610|531440874|FG000|Overall Study|Lack of Efficacy|1|||
147347635|NCT04757610|531440875|FG001|Overall Study|Lack of Efficacy|2|||
147347636|NCT04757610|531440876|FG002|Overall Study|Lack of Efficacy|3|||
147347637|NCT04757610|531440874|FG000|Overall Study|Lost to Follow-up|7|||
147347638|NCT04757610|531440875|FG001|Overall Study|Lost to Follow-up|2|||
147347639|NCT04757610|531440876|FG002|Overall Study|Lost to Follow-up|7|||
147347640|NCT04757610|531440874|FG000|Overall Study|Physician Decision|4|||
147347641|NCT04757610|531440875|FG001|Overall Study|Physician Decision|1|||
147347642|NCT04757610|531440876|FG002|Overall Study|Physician Decision|2|||
147347643|NCT04757610|531440874|FG000|Overall Study|Withdrawal by Subject|26|||
147347644|NCT04757610|531440875|FG001|Overall Study|Withdrawal by Subject|25|||
147347645|NCT04757610|531440876|FG002|Overall Study|Withdrawal by Subject|25|||
147347646|NCT04757610|531440874|FG000|Overall Study|Study Terminated by Sponsor|105|||
147347647|NCT04757610|531440875|FG001|Overall Study|Study Terminated by Sponsor|105|||
147347648|NCT04757610|531440876|FG002|Overall Study|Study Terminated by Sponsor|110|||
147347649|NCT04757610|531440874|FG000|Overall Study|Randomized in Error|1|||
147347650|NCT04757610|531440875|FG001|Overall Study|Randomized in Error|0|||
147347651|NCT04757610|531440876|FG002|Overall Study|Randomized in Error|0|||
147347652|NCT04774237|531440881|FG000|Visit 2 First Intervention|Withdrawal by Subject|0|||
147347653|NCT04774237|531440882|FG001|Visit 2 First Intervention|Withdrawal by Subject|0|||
147347654|NCT04774237|531440883|FG002|Visit 2 First Intervention|Withdrawal by Subject|0|||
147347655|NCT04774237|531440884|FG003|Visit 2 First Intervention|Withdrawal by Subject|0|||
147347656|NCT04774237|531440885|FG004|Visit 2 First Intervention|Withdrawal by Subject|1|||
147347657|NCT04774237|531440886|FG005|Visit 2 First Intervention|Withdrawal by Subject|0|||
147347658|NCT00753090|531442257|FG000|Overall Study|Withdrawal by Subject|10|||
147347659|NCT00753090|531442258|FG001|Overall Study|Withdrawal by Subject|10|||
147347660|NCT00753090|531442257|FG000|Overall Study|Death|17|||
147347661|NCT00753090|531442258|FG001|Overall Study|Death|6|||
147347662|NCT00753090|531442257|FG000|Overall Study|Study Prosthesis Removed|12|||
147347663|NCT00753090|531442258|FG001|Overall Study|Study Prosthesis Removed|3|||
147347664|NCT00753090|531442257|FG000|Overall Study|Lost to Follow-up|2|||
147347665|NCT00753090|531442258|FG001|Overall Study|Lost to Follow-up|2|||
147347666|NCT00753090|531442257|FG000|Overall Study|Other|127|||
147347667|NCT00753090|531442258|FG001|Overall Study|Other|75|||
147347668|NCT06143670|531442261|FG000|Overall Study|Lost to Follow-up|0|||
147347669|NCT06143670|531442262|FG001|Overall Study|Lost to Follow-up|1|||
147347670|NCT06143670|531442261|FG000|Overall Study|Withdrawal by Subject|3|||
147347671|NCT06143670|531442262|FG001|Overall Study|Withdrawal by Subject|0|||
147347672|NCT03747484|531442263|FG000|Overall Study|Lack of Efficacy|0|||
147347673|NCT03747484|531442264|FG001|Overall Study|Lack of Efficacy|1|||
147347674|NCT03747484|531442265|FG002|Overall Study|Lack of Efficacy|1|||
147347675|NCT03747484|531442266|FG003|Overall Study|Lack of Efficacy|2|||
147347676|NCT03747484|531442267|FG004|Overall Study|Lack of Efficacy|2|||
147347677|NCT04521478|531442272|FG000|Overall Study|Protocol Violation|2|||
147347678|NCT04521478|531442273|FG001|Overall Study|Protocol Violation|0|||
147347679|NCT04521478|531442274|FG002|Overall Study|Protocol Violation|1|||
147347680|NCT04521478|531442275|FG003|Overall Study|Protocol Violation|0|||
147347681|NCT04521478|531442276|FG004|Overall Study|Protocol Violation|0|||
147347682|NCT04521478|531442277|FG005|Overall Study|Protocol Violation|0|||
147347683|NCT04521478|531442272|FG000|Overall Study|Technical Problems|0|||
147347684|NCT04521478|531442273|FG001|Overall Study|Technical Problems|0|||
147347685|NCT04521478|531442274|FG002|Overall Study|Technical Problems|0|||
147347686|NCT04521478|531442275|FG003|Overall Study|Technical Problems|1|||
147347687|NCT04521478|531442276|FG004|Overall Study|Technical Problems|0|||
147347688|NCT04521478|531442277|FG005|Overall Study|Technical Problems|0|||
147347689|NCT04521478|531442272|FG000|Overall Study|Burden of Study Procedures|1|||
147347690|NCT04521478|531442273|FG001|Overall Study|Burden of Study Procedures|0|||
147347691|NCT04521478|531442274|FG002|Overall Study|Burden of Study Procedures|0|||
147347692|NCT04521478|531442275|FG003|Overall Study|Burden of Study Procedures|1|||
147347693|NCT04521478|531442276|FG004|Overall Study|Burden of Study Procedures|0|||
147347694|NCT04521478|531442277|FG005|Overall Study|Burden of Study Procedures|1|||
147347695|NCT04521478|531442272|FG000|Overall Study|Lack of Efficacy|0|||
147347696|NCT04521478|531442273|FG001|Overall Study|Lack of Efficacy|0|||
147347697|NCT04521478|531442274|FG002|Overall Study|Lack of Efficacy|0|||
147347698|NCT04521478|531442275|FG003|Overall Study|Lack of Efficacy|0|||
147347699|NCT04521478|531442276|FG004|Overall Study|Lack of Efficacy|1|||
147347700|NCT04521478|531442277|FG005|Overall Study|Lack of Efficacy|1|||
147347701|NCT04521478|531442272|FG000|Overall Study|Adverse Event|7|||
147347702|NCT04521478|531442273|FG001|Overall Study|Adverse Event|0|||
147347703|NCT04521478|531442274|FG002|Overall Study|Adverse Event|2|||
147347704|NCT04521478|531442275|FG003|Overall Study|Adverse Event|1|||
147347705|NCT04521478|531442276|FG004|Overall Study|Adverse Event|2|||
147347706|NCT04521478|531442277|FG005|Overall Study|Adverse Event|7|||
147347707|NCT04521478|531442272|FG000|Overall Study|No Reason Available|0|||
147347708|NCT04521478|531442273|FG001|Overall Study|No Reason Available|2|||
147347709|NCT04521478|531442274|FG002|Overall Study|No Reason Available|0|||
147347710|NCT04521478|531442275|FG003|Overall Study|No Reason Available|0|||
147347711|NCT04521478|531442276|FG004|Overall Study|No Reason Available|1|||
147347712|NCT04521478|531442277|FG005|Overall Study|No Reason Available|0|||
147347713|NCT04521478|531442272|FG000|Overall Study|Other than listed|3|||
147347714|NCT04521478|531442273|FG001|Overall Study|Other than listed|3|||
147347715|NCT04521478|531442274|FG002|Overall Study|Other than listed|3|||
147347716|NCT04521478|531442275|FG003|Overall Study|Other than listed|2|||
147347717|NCT04521478|531442276|FG004|Overall Study|Other than listed|3|||
147347718|NCT04521478|531442277|FG005|Overall Study|Other than listed|3|||
147347719|NCT04521478|531442272|FG000|Overall Study|Not treated|0|||
147347720|NCT04521478|531442273|FG001|Overall Study|Not treated|0|||
147347721|NCT04521478|531442274|FG002|Overall Study|Not treated|0|||
147347722|NCT04521478|531442275|FG003|Overall Study|Not treated|0|||
147347723|NCT04521478|531442276|FG004|Overall Study|Not treated|0|||
147347724|NCT04521478|531442277|FG005|Overall Study|Not treated|1|||
147347725|NCT05058391|531442280|FG000|Overall Study|Adverse Event|1|||
147347726|NCT03833245|531442283|FG000|Overall Study|Death|0|||
147347727|NCT03833245|531442284|FG001|Overall Study|Death|1|||
147347728|NCT03775109|531442286|FG000|Overall Study|Adverse Event|1|||
147347729|NCT03775109|531442287|FG001|Overall Study|Adverse Event|0|||
147347730|NCT03775109|531442286|FG000|Overall Study|COVID-19 outbreak|2|||
147347731|NCT03775109|531442287|FG001|Overall Study|COVID-19 outbreak|0|||
147347732|NCT03775109|531442286|FG000|Overall Study|Lost to Follow-up|0|||
147347733|NCT03775109|531442287|FG001|Overall Study|Lost to Follow-up|2|||
147347734|NCT03775109|531442286|FG000|Overall Study|Withdrawal by Subject|1|||
147347735|NCT03775109|531442287|FG001|Overall Study|Withdrawal by Subject|1|||
147347736|NCT03775109|531442286|FG000|Overall Study|Death|0|||
147347737|NCT03775109|531442287|FG001|Overall Study|Death|1|||
147347738|NCT03775109|531442286|FG000|Overall Study|Lack of Efficacy|1|||
147347739|NCT03775109|531442287|FG001|Overall Study|Lack of Efficacy|0|||
147347740|NCT03347383|531442288|FG000|Overall Study|Death|39|||
147347741|NCT03347383|531442288|FG000|Overall Study|Withdrawal by Subject|3|||
147453275|NCT02064387|531823978|FG000|Part 1 Max 23.5 Months Followup Duration|Death|0|||
147347742|NCT03347383|531442288|FG000|Overall Study|Lost to Follow-up|9|||
147347743|NCT04173663|531442293|FG000|Overall Study|Withdrawal by Subject|1|||
147347744|NCT04173663|531442294|FG001|Overall Study|Withdrawal by Subject|6|||
147347745|NCT04173663|531442293|FG000|Overall Study|Lost to Follow-up|17|||
147453276|NCT02064387|531823979|FG001|Part 1 Max 23.5 Months Followup Duration|Death|0|||
147347746|NCT04173663|531442294|FG001|Overall Study|Lost to Follow-up|24|||
147347747|NCT04402489|531442296|FG000|26 Weeks Double-Blind Treatment (DBT)|Adverse Event|0|||
147347748|NCT04402489|531442297|FG001|26 Weeks Double-Blind Treatment (DBT)|Adverse Event|1|||
147347749|NCT04402489|531442298|FG002|26 Weeks Double-Blind Treatment (DBT)|Adverse Event|0|||
147347750|NCT04402489|531442299|FG003|26 Weeks Double-Blind Treatment (DBT)|Adverse Event|0|||
147347751|NCT04402489|531442300|FG004|26 Weeks Double-Blind Treatment (DBT)|Adverse Event|0|||
147347752|NCT04402489|531442296|FG000|26 Weeks Double-Blind Treatment (DBT)|Physician Decision|1|||
147347753|NCT04402489|531442297|FG001|26 Weeks Double-Blind Treatment (DBT)|Physician Decision|0|||
147347754|NCT04402489|531442298|FG002|26 Weeks Double-Blind Treatment (DBT)|Physician Decision|0|||
147347755|NCT04402489|531442299|FG003|26 Weeks Double-Blind Treatment (DBT)|Physician Decision|0|||
147347756|NCT04402489|531442300|FG004|26 Weeks Double-Blind Treatment (DBT)|Physician Decision|0|||
147347757|NCT04402489|531442296|FG000|26 Weeks Double-Blind Treatment (DBT)|Withdrawal by Subject|3|||
147347758|NCT04402489|531442297|FG001|26 Weeks Double-Blind Treatment (DBT)|Withdrawal by Subject|2|||
147347759|NCT04402489|531442298|FG002|26 Weeks Double-Blind Treatment (DBT)|Withdrawal by Subject|2|||
147347760|NCT04402489|531442299|FG003|26 Weeks Double-Blind Treatment (DBT)|Withdrawal by Subject|0|||
147347761|NCT04402489|531442300|FG004|26 Weeks Double-Blind Treatment (DBT)|Withdrawal by Subject|0|||
147347762|NCT04402489|531442296|FG000|26 Weeks Double-Blind Extension (DBE)|Adverse Event|0|||
147347763|NCT04402489|531442297|FG001|26 Weeks Double-Blind Extension (DBE)|Adverse Event|0|||
147347764|NCT04402489|531442298|FG002|26 Weeks Double-Blind Extension (DBE)|Adverse Event|1|||
147347765|NCT04402489|531442299|FG003|26 Weeks Double-Blind Extension (DBE)|Adverse Event|0|||
147347766|NCT04402489|531442300|FG004|26 Weeks Double-Blind Extension (DBE)|Adverse Event|0|||
147347767|NCT04402489|531442296|FG000|26 Weeks Double-Blind Extension (DBE)|Lost to Follow-up|0|||
147347768|NCT04402489|531442297|FG001|26 Weeks Double-Blind Extension (DBE)|Lost to Follow-up|0|||
147347769|NCT04402489|531442298|FG002|26 Weeks Double-Blind Extension (DBE)|Lost to Follow-up|0|||
147347770|NCT04402489|531442299|FG003|26 Weeks Double-Blind Extension (DBE)|Lost to Follow-up|1|||
147347771|NCT04402489|531442300|FG004|26 Weeks Double-Blind Extension (DBE)|Lost to Follow-up|0|||
147347772|NCT04402489|531442296|FG000|26 Weeks Double-Blind Extension (DBE)|Withdrawal by Subject|0|||
147347773|NCT04402489|531442297|FG001|26 Weeks Double-Blind Extension (DBE)|Withdrawal by Subject|1|||
147347774|NCT04402489|531442298|FG002|26 Weeks Double-Blind Extension (DBE)|Withdrawal by Subject|2|||
147347775|NCT04402489|531442299|FG003|26 Weeks Double-Blind Extension (DBE)|Withdrawal by Subject|0|||
147347776|NCT04402489|531442300|FG004|26 Weeks Double-Blind Extension (DBE)|Withdrawal by Subject|0|||
147347777|NCT03089398|531442311|FG000|Overall Study|Death|4|||
147347778|NCT03089398|531442312|FG001|Overall Study|Death|9|||
147347779|NCT03089398|531442311|FG000|Overall Study|Lost to Follow-up|21|||
147347780|NCT03089398|531442312|FG001|Overall Study|Lost to Follow-up|30|||
147347781|NCT03089398|531442311|FG000|Overall Study|Withdrawal by Subject|2|||
147347782|NCT03089398|531442312|FG001|Overall Study|Withdrawal by Subject|2|||
147347783|NCT05439603|531442313|FG000|Overall Study|met withdrawal criteria|2|||
147347784|NCT04630262|531442316|FG000|Overall Study|Intraoperative Screen Failure|5|||
147347785|NCT04630262|531442316|FG000|Overall Study|Study terminated prematurely|71|||
147347786|NCT04630262|531442316|FG000|Overall Study|Withdrawal by Subject|2|||
147347787|NCT04630262|531442316|FG000|Overall Study|Physician Decision|2|||
147347788|NCT01195831|531442317|FG000|Overall Study|Lost to Follow-up|2|||
147347789|NCT01195831|531442318|FG001|Overall Study|Lost to Follow-up|4|||
147347790|NCT01195831|531442317|FG000|Overall Study|Withdrawal by Subject|2|||
147347791|NCT01195831|531442318|FG001|Overall Study|Withdrawal by Subject|2|||
147347792|NCT01195831|531442317|FG000|Overall Study|Adverse Event|4|||
147347793|NCT01195831|531442318|FG001|Overall Study|Adverse Event|2|||
147347794|NCT01195831|531442317|FG000|Overall Study|Protocol Violation|0|||
147347795|NCT01195831|531442318|FG001|Overall Study|Protocol Violation|2|||
147347796|NCT04703322|531442319|FG000|Overall Study|Ongoing|8|||
147347797|NCT04703322|531442319|FG000|Overall Study|Withdrawal by Subject|1|||
147347798|NCT01180634|531442322|FG000|Overall Study|Adverse Event|4|||
147347799|NCT01180634|531442323|FG001|Overall Study|Adverse Event|1|||
147347800|NCT01180634|531442322|FG000|Overall Study|Miscellaneous|2|||
147347801|NCT01180634|531442323|FG001|Overall Study|Miscellaneous|0|||
147347802|NCT01180634|531442322|FG000|Overall Study|Withdrawal by Subject|4|||
147347803|NCT01180634|531442323|FG001|Overall Study|Withdrawal by Subject|0|||
147347804|NCT04419168|531442324|FG000|Overall Study|Protocol Violation|1|||
147347805|NCT04419168|531442325|FG001|Overall Study|Protocol Violation|1|||
147347806|NCT04419168|531442324|FG000|Overall Study|Lost to Follow-up|7|||
147347807|NCT04419168|531442325|FG001|Overall Study|Lost to Follow-up|7|||
147347808|NCT04419168|531442324|FG000|Overall Study|Missed 6-month Visit|48|||
147347809|NCT04419168|531442325|FG001|Overall Study|Missed 6-month Visit|45|||
147347810|NCT03713086|531442327|FG000|Overall Study|Withdrawal by Subject|0|||
147347811|NCT03713086|531442328|FG001|Overall Study|Withdrawal by Subject|2|||
147347812|NCT03713086|531442329|FG002|Overall Study|Withdrawal by Subject|1|||
147347813|NCT03713086|531442330|FG003|Overall Study|Withdrawal by Subject|0|||
147347814|NCT03713086|531442327|FG000|Overall Study|Lost to Follow-up|0|||
147347815|NCT03713086|531442328|FG001|Overall Study|Lost to Follow-up|1|||
147347816|NCT03713086|531442329|FG002|Overall Study|Lost to Follow-up|0|||
147347817|NCT03713086|531442330|FG003|Overall Study|Lost to Follow-up|1|||
147347818|NCT05009251|531442331|FG000|Overall Study|Protocol Violation|100|||
147347819|NCT05009251|531442332|FG001|Overall Study|Protocol Violation|105|||
147347820|NCT05009251|531442333|FG002|Overall Study|Protocol Violation|119|||
147347821|NCT05009251|531442334|FG003|Overall Study|Protocol Violation|120|||
147347822|NCT05009251|531442335|FG004|Overall Study|Protocol Violation|119|||
147347823|NCT05009251|531442331|FG000|Overall Study|Death|25|||
147347824|NCT05009251|531442332|FG001|Overall Study|Death|22|||
147347825|NCT05009251|531442333|FG002|Overall Study|Death|24|||
147347826|NCT05009251|531442334|FG003|Overall Study|Death|19|||
147347827|NCT05009251|531442335|FG004|Overall Study|Death|15|||
147347828|NCT06311084|531442340|FG000|Overall Study|Lost to Follow-up|14|||
147347829|NCT03988634|531442341|FG000|Double-Blind|Adverse Event|4|||
147347830|NCT03988634|531442342|FG001|Double-Blind|Adverse Event|0|||
147347831|NCT03988634|531442343|FG002|Double-Blind|Adverse Event|0|||
147347832|NCT03988634|531442341|FG000|Double-Blind|Death|18|||
147347833|NCT03988634|531442342|FG001|Double-Blind|Death|26|||
147347834|NCT03988634|531442343|FG002|Double-Blind|Death|0|||
147347835|NCT03988634|531442341|FG000|Double-Blind|Lost to Follow-up|6|||
147347836|NCT03988634|531442342|FG001|Double-Blind|Lost to Follow-up|7|||
147347837|NCT03988634|531442343|FG002|Double-Blind|Lost to Follow-up|0|||
147347838|NCT03988634|531442341|FG000|Double-Blind|Physician Decision|9|||
147347839|NCT03988634|531442342|FG001|Double-Blind|Physician Decision|5|||
147347840|NCT03988634|531442343|FG002|Double-Blind|Physician Decision|0|||
147347841|NCT03988634|531442341|FG000|Double-Blind|Subject decision|24|||
147347842|NCT03988634|531442342|FG001|Double-Blind|Subject decision|13|||
147347843|NCT03988634|531442343|FG002|Double-Blind|Subject decision|0|||
147347844|NCT03988634|531442341|FG000|Open-Label|Adverse Event|0|||
147347845|NCT03988634|531442342|FG001|Open-Label|Adverse Event|0|||
147347846|NCT03988634|531442343|FG002|Open-Label|Adverse Event|7|||
147347847|NCT03988634|531442341|FG000|Open-Label|Physician Decision|0|||
147347848|NCT03988634|531442342|FG001|Open-Label|Physician Decision|0|||
147347849|NCT03988634|531442343|FG002|Open-Label|Physician Decision|1|||
147347850|NCT03988634|531442341|FG000|Open-Label|Technical problems|0|||
147347851|NCT03988634|531442342|FG001|Open-Label|Technical problems|0|||
147347852|NCT03988634|531442343|FG002|Open-Label|Technical problems|1|||
147347853|NCT03161379|531442358|FG000|Overall Study|Withdrawal by Subject|4|||
147347854|NCT03161379|531442358|FG000|Overall Study|disease progression during chemotherapy|5|||
147347855|NCT03161379|531442358|FG000|Overall Study|no longer surgical candidate after chemotherapy|2|||
147347856|NCT03161379|531442358|FG000|Overall Study|not eligible to start study drug after chemotherapy|2|||
147347857|NCT03393975|531442360|FG000|Urgent Treatment Period|Physician Decision|0|||
147347858|NCT03393975|531442361|FG001|Urgent Treatment Period|Physician Decision|0|||
147347859|NCT03393975|531442362|FG002|Urgent Treatment Period|Physician Decision|0|||
147347860|NCT03393975|531442363|FG003|Urgent Treatment Period|Physician Decision|1|||
147347861|NCT03393975|531442360|FG000|Prophylaxis Period 1|Reason not Specified|0|||
147347862|NCT03393975|531442361|FG001|Prophylaxis Period 1|Reason not Specified|1|||
147347863|NCT03393975|531442362|FG002|Prophylaxis Period 1|Reason not Specified|0|||
147347864|NCT03393975|531442363|FG003|Prophylaxis Period 1|Reason not Specified|0|||
147347865|NCT03393975|531442360|FG000|Prophylaxis Period 2|Reason not Specified|0|||
147347866|NCT03393975|531442361|FG001|Prophylaxis Period 2|Reason not Specified|1|||
147347867|NCT03393975|531442362|FG002|Prophylaxis Period 2|Reason not Specified|0|||
147347868|NCT03393975|531442363|FG003|Prophylaxis Period 2|Reason not Specified|0|||
147347869|NCT03315754|531442364|FG000|Overall Study|COVID-19 complications leading to death|1|||
147347870|NCT03315754|531442364|FG000|Overall Study|insurance coverage issue|1|||
147347871|NCT04089371|531442365|FG000|Overall Study|Withdrawal by Subject|0|||
147347872|NCT04089371|531442366|FG001|Overall Study|Withdrawal by Subject|1|||
147347873|NCT04089371|531442365|FG000|Overall Study|Study terminated early|0|||
147347874|NCT04089371|531442366|FG001|Overall Study|Study terminated early|9|||
147347875|NCT03932682|531442367|FG000|Overall Study|Death|1|||
147347876|NCT03932682|531442368|FG001|Overall Study|Death|2|||
147347877|NCT03932682|531442367|FG000|Overall Study|Withdrawal by Subject|37|||
147347878|NCT03932682|531442368|FG001|Overall Study|Withdrawal by Subject|45|||
147347879|NCT03932682|531442367|FG000|Overall Study|Lost to Follow-up|19|||
147347880|NCT03932682|531442368|FG001|Overall Study|Lost to Follow-up|25|||
147347881|NCT03932682|531442367|FG000|Overall Study|Protocol Violation|0|||
147347882|NCT03932682|531442368|FG001|Overall Study|Protocol Violation|2|||
147347883|NCT03932682|531442367|FG000|Overall Study|Other|9|||
147347884|NCT03932682|531442368|FG001|Overall Study|Other|23|||
147347885|NCT01772472|531442369|FG000|Overall Study|Death|126|||
147347886|NCT01772472|531442370|FG001|Overall Study|Death|94|||
147347887|NCT01772472|531442369|FG000|Overall Study|Lost to Follow-up|51|||
147347888|NCT01772472|531442370|FG001|Overall Study|Lost to Follow-up|50|||
147347889|NCT01772472|531442369|FG000|Overall Study|Other|9|||
147347890|NCT01772472|531442370|FG001|Overall Study|Other|7|||
147347891|NCT01772472|531442369|FG000|Overall Study|Physician Decision|1|||
147347892|NCT01772472|531442370|FG001|Overall Study|Physician Decision|7|||
147347893|NCT01772472|531442369|FG000|Overall Study|Withdrawal by Subject|115|||
147347894|NCT01772472|531442370|FG001|Overall Study|Withdrawal by Subject|90|||
147347895|NCT01772472|531442369|FG000|Overall Study|Follow-up Terminated by Sponsor|441|||
147347896|NCT01772472|531442370|FG001|Overall Study|Follow-up Terminated by Sponsor|495|||
147347897|NCT03361748|531442371|FG000|Overall Study|Death|77|||
147347898|NCT03361748|531442371|FG000|Overall Study|Lost to Follow-up|4|||
147347899|NCT03361748|531442371|FG000|Overall Study|Withdrawal by Subject|20|||
147347900|NCT05691452|531443711|FG000|Overall Study|Withdrawal by Subject|1|||
147347901|NCT05691452|531443712|FG001|Overall Study|Withdrawal by Subject|1|||
147347902|NCT05691452|531443713|FG002|Overall Study|Withdrawal by Subject|0|||
147347903|NCT05691452|531443711|FG000|Overall Study|Physician Decision|1|||
147347904|NCT05691452|531443712|FG001|Overall Study|Physician Decision|0|||
147347905|NCT05691452|531443713|FG002|Overall Study|Physician Decision|0|||
147347906|NCT05691452|531443711|FG000|Overall Study|Lost to Follow-up|0|||
147347907|NCT05691452|531443712|FG001|Overall Study|Lost to Follow-up|0|||
147347908|NCT05691452|531443713|FG002|Overall Study|Lost to Follow-up|1|||
147347909|NCT05691452|531443711|FG000|Overall Study|Adverse Event|0|||
147347910|NCT05691452|531443712|FG001|Overall Study|Adverse Event|0|||
147347911|NCT05691452|531443713|FG002|Overall Study|Adverse Event|1|||
147347912|NCT05816551|531443722|FG000|Overall Study|Withdrawal by Subject|0|||
147347913|NCT05816551|531443723|FG001|Overall Study|Withdrawal by Subject|1|||
147347914|NCT05816551|531443722|FG000|Overall Study|Withdrawn by Primary Investigator|3|||
147347915|NCT05816551|531443723|FG001|Overall Study|Withdrawn by Primary Investigator|0|||
147347916|NCT05062265|531443734|FG000|Overall Study|Withdrawal by Subject|1|||
147347917|NCT05062265|531443735|FG001|Overall Study|Withdrawal by Subject|0|||
147347918|NCT05418296|531443740|FG000|Overall Study|Withdrawal by Subject|4|||
147347919|NCT05418296|531443741|FG001|Overall Study|Withdrawal by Subject|1|||
147347920|NCT05382936|531443742|FG000|Overall Study|Progressive Disease|3|||
147606856|NCT00696787|532377163|FG000|Overall Study|Discontinuation by Sponsor|9|||
147606857|NCT00696787|532377164|FG001|Overall Study|Discontinuation by Sponsor|13|||
147606858|NCT00696787|532377165|FG002|Overall Study|Discontinuation by Sponsor|14|||
147606859|NCT00696787|532377163|FG000|Overall Study|Lack of Efficacy|0|||
147606860|NCT00696787|532377164|FG001|Overall Study|Lack of Efficacy|1|||
147606861|NCT00696787|532377165|FG002|Overall Study|Lack of Efficacy|0|||
147606862|NCT00696787|532377163|FG000|Overall Study|Lost to Follow-up|4|||
147606863|NCT00696787|532377164|FG001|Overall Study|Lost to Follow-up|0|||
147606864|NCT00696787|532377165|FG002|Overall Study|Lost to Follow-up|3|||
147606865|NCT00696787|532377163|FG000|Overall Study|Withdrawal by Subject|0|||
147606866|NCT00696787|532377164|FG001|Overall Study|Withdrawal by Subject|3|||
147606867|NCT00696787|532377165|FG002|Overall Study|Withdrawal by Subject|2|||
147347921|NCT05382936|531443743|FG001|Overall Study|Progressive Disease|5|||
147347922|NCT05382936|531443744|FG002|Overall Study|Progressive Disease|2|||
147347923|NCT05382936|531443745|FG003|Overall Study|Progressive Disease|5|||
147347924|NCT05382936|531443742|FG000|Overall Study|Adverse Event|0|||
147347925|NCT05382936|531443743|FG001|Overall Study|Adverse Event|1|||
147347926|NCT05382936|531443744|FG002|Overall Study|Adverse Event|1|||
147347927|NCT05382936|531443745|FG003|Overall Study|Adverse Event|0|||
147347928|NCT05382936|531443742|FG000|Overall Study|Deteriorated Performance Status. Unlikely Benefit|0|||
147347929|NCT05382936|531443743|FG001|Overall Study|Deteriorated Performance Status. Unlikely Benefit|1|||
147347930|NCT05382936|531443744|FG002|Overall Study|Deteriorated Performance Status. Unlikely Benefit|0|||
147347931|NCT05382936|531443745|FG003|Overall Study|Deteriorated Performance Status. Unlikely Benefit|0|||
147347932|NCT05382936|531443742|FG000|Overall Study|Withdrawal by Subject|0|||
147347933|NCT05382936|531443743|FG001|Overall Study|Withdrawal by Subject|0|||
147347934|NCT05382936|531443744|FG002|Overall Study|Withdrawal by Subject|1|||
147347935|NCT05382936|531443745|FG003|Overall Study|Withdrawal by Subject|1|||
147347936|NCT03101904|531443746|FG000|Wash Out (10 Days)|Adverse Event|1|||
147347937|NCT03101904|531443747|FG001|Wash Out (10 Days)|Adverse Event|0|||
147347938|NCT03101904|531443746|FG000|Wash Out (10 Days)|Lost to Follow-up|2|||
147347939|NCT03101904|531443747|FG001|Wash Out (10 Days)|Lost to Follow-up|0|||
147347940|NCT03692611|531443749|FG000|Overall Study|Found to be ineligible postrandomization|3|||
147347941|NCT03692611|531443750|FG001|Overall Study|Found to be ineligible postrandomization|0|||
147347942|NCT00616967|531443751|FG000|Overall Study|Withdrawal by Subject|0|||
147347943|NCT00616967|531443752|FG001|Overall Study|Withdrawal by Subject|0|||
147347944|NCT00616967|531443753|FG002|Overall Study|Withdrawal by Subject|1|||
147347945|NCT02910583|531443754|FG000|Overall Study|Death|7|||
147347946|NCT02910583|531443755|FG001|Overall Study|Death|3|||
147347947|NCT02910583|531443754|FG000|Overall Study|Lost to Follow-up|1|||
147347948|NCT02910583|531443755|FG001|Overall Study|Lost to Follow-up|0|||
147347949|NCT02910583|531443754|FG000|Overall Study|Withdrawal by Subject|12|||
147347950|NCT02910583|531443755|FG001|Overall Study|Withdrawal by Subject|8|||
147347951|NCT02910583|531443754|FG000|Overall Study|Other, Not Specified|6|||
147347952|NCT02910583|531443755|FG001|Overall Study|Other, Not Specified|3|||
147347953|NCT04263311|531443756|FG000|Overall Study|Lost to Follow-up|1|||
147347954|NCT04263311|531443757|FG001|Overall Study|Lost to Follow-up|2|||
147347955|NCT04263311|531443758|FG002|Overall Study|Lost to Follow-up|0|||
147347956|NCT04263311|531443756|FG000|Overall Study|Health Issues|1|||
147347957|NCT04263311|531443757|FG001|Overall Study|Health Issues|0|||
147347958|NCT04263311|531443758|FG002|Overall Study|Health Issues|0|||
147347959|NCT04263311|531443756|FG000|Overall Study|Left the country|1|||
147347960|NCT04263311|531443757|FG001|Overall Study|Left the country|0|||
147347961|NCT04263311|531443758|FG002|Overall Study|Left the country|0|||
147347962|NCT04263311|531443756|FG000|Overall Study|Unable to maintain time commitment|1|||
147347963|NCT04263311|531443757|FG001|Overall Study|Unable to maintain time commitment|0|||
147347964|NCT04263311|531443758|FG002|Overall Study|Unable to maintain time commitment|0|||
147347965|NCT04263311|531443756|FG000|Overall Study|No longer interested|1|||
147347966|NCT04263311|531443757|FG001|Overall Study|No longer interested|0|||
147347967|NCT04263311|531443758|FG002|Overall Study|No longer interested|0|||
147347968|NCT04263311|531443756|FG000|Overall Study|Ineligible post consent|0|||
147347969|NCT04263311|531443757|FG001|Overall Study|Ineligible post consent|0|||
147347970|NCT04263311|531443758|FG002|Overall Study|Ineligible post consent|5|||
147347971|NCT03958955|531443759|FG000|Overall Study|Adverse Event|1|||
147347972|NCT04673929|531443760|FG000|Overall Study|Death|73|||
147347973|NCT04673929|531443760|FG000|Overall Study|Did not reach the 2 year follow up point (observational study)|43|||
147347974|NCT05082909|531443762|FG000|Overall Study|Protocol Violation|0|||
147347975|NCT05082909|531443763|FG001|Overall Study|Protocol Violation|0|||
147347976|NCT05082909|531443764|FG002|Overall Study|Protocol Violation|1|||
147347977|NCT05082909|531443765|FG003|Overall Study|Protocol Violation|0|||
147347978|NCT05082909|531443766|FG004|Overall Study|Protocol Violation|0|||
147347979|NCT05082909|531443767|FG005|Overall Study|Protocol Violation|0|||
147347980|NCT04088630|531443768|FG000|Overall Study|Lost to Follow-up|3|||
147606868|NCT00696787|532377163|FG000|Overall Study|Failed to return|1|||
147347981|NCT04088630|531443769|FG001|Overall Study|Lost to Follow-up|2|||
147347982|NCT04088630|531443770|FG002|Overall Study|Lost to Follow-up|6|||
147347983|NCT04088630|531443768|FG000|Overall Study|Death|3|||
147347984|NCT04088630|531443769|FG001|Overall Study|Death|1|||
147347985|NCT04088630|531443770|FG002|Overall Study|Death|1|||
147347986|NCT04088630|531443768|FG000|Overall Study|Physician Decision|0|||
147347987|NCT04088630|531443769|FG001|Overall Study|Physician Decision|1|||
147347988|NCT04088630|531443770|FG002|Overall Study|Physician Decision|1|||
147347989|NCT02954341|531443771|FG000|Overall Study|Attempted Implant unsuccessful|5|||
147347990|NCT02954341|531443771|FG000|Overall Study|Death|90|||
147347991|NCT02954341|531443771|FG000|Overall Study|Withdrawal by Subject|4|||
147347992|NCT02954341|531443771|FG000|Overall Study|Physician Decision|13|||
147347993|NCT02954341|531443771|FG000|Overall Study|Not Implanted due to COVID restrictions|1|||
147347994|NCT02954341|531443771|FG000|Overall Study|Not implanted due to physician's decision|1|||
147347995|NCT02954341|531443771|FG000|Overall Study|Withdrawn Prior Implant Attempt|17|||
147347996|NCT04024813|531443774|FG000|Overall Study|Study terminated by Sponsor|1|||
147347997|NCT02900924|531443776|FG000|Overall Study|Death|52|||
147347998|NCT02900924|531443776|FG000|Overall Study|Lost to Follow-up|4|||
147347999|NCT02900924|531443776|FG000|Overall Study|Withdrawal by Subject|20|||
147348000|NCT02900924|531443776|FG000|Overall Study|Missed Visit|33|||
147348001|NCT05536440|531443777|FG000|Overall Study|Adverse Event|0|||
147348002|NCT05536440|531443778|FG001|Overall Study|Adverse Event|0|||
147348003|NCT05536440|531443779|FG002|Overall Study|Adverse Event|0|||
147348004|NCT05536440|531443780|FG003|Overall Study|Adverse Event|0|||
147348005|NCT05536440|531443781|FG004|Overall Study|Adverse Event|0|||
147348006|NCT05536440|531443782|FG005|Overall Study|Adverse Event|0|||
147348007|NCT05536440|531443783|FG006|Overall Study|Adverse Event|0|||
147348008|NCT05536440|531443784|FG007|Overall Study|Adverse Event|0|||
147348009|NCT05536440|531443785|FG008|Overall Study|Adverse Event|1|||
147348010|NCT00931710|531443788|FG000|Overall Study|Adverse Event|16|||
147348011|NCT00931710|531443789|FG001|Overall Study|Adverse Event|10|||
147348012|NCT00931710|531443788|FG000|Overall Study|Abnormal test procedure results|2|||
147348013|NCT00931710|531443789|FG001|Overall Study|Abnormal test procedure results|0|||
147348014|NCT00931710|531443788|FG000|Overall Study|Unsatisfactory therapeutic effects|5|||
147348015|NCT00931710|531443789|FG001|Overall Study|Unsatisfactory therapeutic effects|12|||
147348016|NCT00931710|531443788|FG000|Overall Study|Patient withdrew consent|4|||
147348017|NCT00931710|531443789|FG001|Overall Study|Patient withdrew consent|9|||
147348018|NCT00931710|531443788|FG000|Overall Study|Lost to Follow-up|6|||
147348019|NCT00931710|531443789|FG001|Overall Study|Lost to Follow-up|5|||
147348020|NCT00931710|531443788|FG000|Overall Study|Protocol deviation|1|||
147348021|NCT00931710|531443789|FG001|Overall Study|Protocol deviation|2|||
147348022|NCT03338790|531443793|FG000|Overall Study|Disease Progression|65|||
147348023|NCT03338790|531443794|FG001|Overall Study|Disease Progression|43|||
147348024|NCT03338790|531443795|FG002|Overall Study|Disease Progression|50|||
147348025|NCT03338790|531443796|FG003|Overall Study|Disease Progression|37|||
147348026|NCT03338790|531443793|FG000|Overall Study|Study Drug Toxicity|9|||
147348027|NCT03338790|531443794|FG001|Overall Study|Study Drug Toxicity|8|||
147348028|NCT03338790|531443795|FG002|Overall Study|Study Drug Toxicity|15|||
147348029|NCT03338790|531443796|FG003|Overall Study|Study Drug Toxicity|0|||
147348030|NCT03338790|531443793|FG000|Overall Study|Death|1|||
147348031|NCT03338790|531443794|FG001|Overall Study|Death|1|||
147348032|NCT03338790|531443795|FG002|Overall Study|Death|1|||
147348033|NCT03338790|531443796|FG003|Overall Study|Death|0|||
147348034|NCT03338790|531443793|FG000|Overall Study|Adverse Event unrelated to Study Drug|4|||
147348035|NCT03338790|531443794|FG001|Overall Study|Adverse Event unrelated to Study Drug|4|||
147348036|NCT03338790|531443795|FG002|Overall Study|Adverse Event unrelated to Study Drug|6|||
147348037|NCT03338790|531443796|FG003|Overall Study|Adverse Event unrelated to Study Drug|4|||
147348038|NCT03338790|531443793|FG000|Overall Study|Participant request to discontinue study treatment|3|||
147348039|NCT03338790|531443794|FG001|Overall Study|Participant request to discontinue study treatment|3|||
147348040|NCT03338790|531443795|FG002|Overall Study|Participant request to discontinue study treatment|2|||
147348041|NCT03338790|531443796|FG003|Overall Study|Participant request to discontinue study treatment|1|||
147348042|NCT03338790|531443793|FG000|Overall Study|Poor/non-compliance|0|||
147348043|NCT03338790|531443794|FG001|Overall Study|Poor/non-compliance|1|||
147348044|NCT03338790|531443795|FG002|Overall Study|Poor/non-compliance|0|||
147348045|NCT03338790|531443796|FG003|Overall Study|Poor/non-compliance|0|||
147348046|NCT03338790|531443793|FG000|Overall Study|Participant withdrew consent|1|||
147348047|NCT03338790|531443794|FG001|Overall Study|Participant withdrew consent|0|||
147348048|NCT03338790|531443795|FG002|Overall Study|Participant withdrew consent|1|||
147348049|NCT03338790|531443796|FG003|Overall Study|Participant withdrew consent|1|||
147348050|NCT03338790|531443793|FG000|Overall Study|Other reasons|0|||
147348051|NCT03338790|531443794|FG001|Overall Study|Other reasons|5|||
147348052|NCT03338790|531443795|FG002|Overall Study|Other reasons|0|||
147348053|NCT03338790|531443796|FG003|Overall Study|Other reasons|2|||
147348054|NCT03338790|531443793|FG000|Overall Study|Not reported|0|||
147348055|NCT03338790|531443794|FG001|Overall Study|Not reported|0|||
147348056|NCT03338790|531443795|FG002|Overall Study|Not reported|1|||
147348057|NCT03338790|531443796|FG003|Overall Study|Not reported|0|||
147348058|NCT03338790|531443793|FG000|Overall Study|Completed treatment period|1|||
147348059|NCT03338790|531443794|FG001|Overall Study|Completed treatment period|2|||
147348060|NCT03338790|531443795|FG002|Overall Study|Completed treatment period|0|||
147348061|NCT03338790|531443796|FG003|Overall Study|Completed treatment period|0|||
147348062|NCT04410042|531443799|FG000|Overall Study|Not Eligible|1|||
147348063|NCT04410042|531443800|FG001|Overall Study|Not Eligible|1|||
147348064|NCT01494662|531443801|FG000|Overall Study|Withdrawal by Subject|0|||
147348065|NCT01494662|531443802|FG001|Overall Study|Withdrawal by Subject|0|||
147348066|NCT01494662|531443803|FG002|Overall Study|Withdrawal by Subject|1|||
147348067|NCT01494662|531443804|FG003|Overall Study|Withdrawal by Subject|0|||
147348068|NCT01494662|531443805|FG004|Overall Study|Withdrawal by Subject|0|||
147348069|NCT01494662|531443806|FG005|Overall Study|Withdrawal by Subject|0|||
147348070|NCT01494662|531443807|FG006|Overall Study|Withdrawal by Subject|0|||
147348071|NCT01494662|531443801|FG000|Overall Study|Physician Decision|0|||
147348072|NCT01494662|531443802|FG001|Overall Study|Physician Decision|0|||
147348073|NCT01494662|531443803|FG002|Overall Study|Physician Decision|1|||
147348074|NCT01494662|531443804|FG003|Overall Study|Physician Decision|0|||
147348075|NCT01494662|531443805|FG004|Overall Study|Physician Decision|0|||
147348076|NCT01494662|531443806|FG005|Overall Study|Physician Decision|0|||
147348077|NCT01494662|531443807|FG006|Overall Study|Physician Decision|0|||
147348078|NCT04072822|531443808|FG000|Treatment|Adverse Event|9|||
147348079|NCT04072822|531443809|FG001|Treatment|Adverse Event|5|||
147348080|NCT04072822|531443808|FG000|Treatment|Met Stopping Criteria|13|||
147348081|NCT04072822|531443809|FG001|Treatment|Met Stopping Criteria|24|||
147348082|NCT04072822|531443808|FG000|Treatment|Averse Event and Met Stopping Criteria|2|||
147348083|NCT04072822|531443809|FG001|Treatment|Averse Event and Met Stopping Criteria|9|||
147348084|NCT04072822|531443808|FG000|Treatment|Withdrawal by Subject|0|||
147348085|NCT04072822|531443809|FG001|Treatment|Withdrawal by Subject|2|||
147348086|NCT04072822|531443808|FG000|Treatment|Death|0|||
147348087|NCT04072822|531443809|FG001|Treatment|Death|2|||
147348088|NCT04072822|531443808|FG000|Treatment|Lost to Follow-up|11|||
147348089|NCT04072822|531443809|FG001|Treatment|Lost to Follow-up|3|||
147348090|NCT04072822|531443808|FG000|Treatment|Physician Decision|1|||
147348091|NCT04072822|531443809|FG001|Treatment|Physician Decision|0|||
147348092|NCT04072822|531443808|FG000|Treatment|Other|7|||
147348093|NCT04072822|531443809|FG001|Treatment|Other|9|||
147348094|NCT04072822|531443808|FG000|Follow-up|Withdrawal by Subject|1|||
147348095|NCT04072822|531443809|FG001|Follow-up|Withdrawal by Subject|0|||
147348096|NCT04072822|531443808|FG000|Follow-up|Lost to Follow-up|5|||
147348097|NCT04072822|531443809|FG001|Follow-up|Lost to Follow-up|4|||
147348098|NCT05481320|531443810|FG000|Overall Study|Withdrawal by Subject|1|||
147348099|NCT05481320|531443811|FG001|Overall Study|Withdrawal by Subject|1|||
147348100|NCT05481320|531443810|FG000|Overall Study|Care recipent passed away|0|||
147348101|NCT05481320|531443811|FG001|Overall Study|Care recipent passed away|1|||
147348102|NCT05481320|531443810|FG000|Overall Study|Out-of-window assessment|0|||
147348103|NCT05481320|531443811|FG001|Overall Study|Out-of-window assessment|1|||
147348104|NCT05481320|531443810|FG000|Overall Study|No longer a primary caregiver|3|||
147348105|NCT05481320|531443811|FG001|Overall Study|No longer a primary caregiver|0|||
147348106|NCT05481320|531443810|FG000|Overall Study|Unable to contact|1|||
147348107|NCT05481320|531443811|FG001|Overall Study|Unable to contact|0|||
147348108|NCT02811679|531443812|FG000|Overall Study|Adverse Event|1|||
147348109|NCT02811679|531443812|FG000|Overall Study|Lack of Efficacy|6|||
147348110|NCT02811679|531443812|FG000|Overall Study|Early study closure due to slow accrual|3|||
147348111|NCT05319860|531443816|FG000|Overall Study|Death|1|||
147348112|NCT05319860|531443817|FG001|Overall Study|Death|1|||
147348113|NCT05319860|531443816|FG000|Overall Study|Lost to Follow-up|3|||
147348114|NCT05319860|531443817|FG001|Overall Study|Lost to Follow-up|1|||
147348115|NCT05319860|531443816|FG000|Overall Study|Withdrawal by Subject|1|||
147348116|NCT05319860|531443817|FG001|Overall Study|Withdrawal by Subject|7|||
147348117|NCT04314895|531443818|FG000|Overall Study|Lost to Follow-up|1|||
147348118|NCT04314895|531443818|FG000|Overall Study|Death|10|||
147348119|NCT04314895|531443818|FG000|Overall Study|Physician Decision|2|||
147348120|NCT03941860|531443819|FG000|Overall Study|Withdrawal by Subject|0|||
147348121|NCT03941860|531443820|FG001|Overall Study|Withdrawal by Subject|1|||
147348122|NCT03930342|531443825|FG000|Overall Study|Lost to Follow-up|70|||
147348123|NCT03930342|531443826|FG001|Overall Study|Lost to Follow-up|77|||
147348124|NCT02596126|531443827|FG000|Overall Study|Lost to Follow-up|12|||
147348125|NCT02596126|531443828|FG001|Overall Study|Lost to Follow-up|21|||
147348126|NCT02596126|531443827|FG000|Overall Study|Protocol Violation|7|||
147348127|NCT02596126|531443828|FG001|Overall Study|Protocol Violation|9|||
147348128|NCT05792423|531443836|FG000|Overall Study|Withdrawal by Subject|2|||
147348129|NCT02471638|531443837|FG000|Overall Study|Early Term Withdrawal|10|||
147348130|NCT04593472|531445596|FG000|Overall Study|Death|31|||
147348131|NCT04593472|531445597|FG001|Overall Study|Death|27|||
147348132|NCT04593472|531445596|FG000|Overall Study|Withdrawal by Subject|12|||
147348133|NCT04593472|531445597|FG001|Overall Study|Withdrawal by Subject|12|||
147348134|NCT04593472|531445596|FG000|Overall Study|Dropped due to provider change between either 6, 12 or 24 months|33|||
147348135|NCT04593472|531445597|FG001|Overall Study|Dropped due to provider change between either 6, 12 or 24 months|22|||
147348136|NCT04593472|531445596|FG000|Overall Study|Dropped due to caregiver change between either 6, 12 or 24 months|5|||
147348137|NCT04593472|531445597|FG001|Overall Study|Dropped due to caregiver change between either 6, 12 or 24 months|4|||
147348138|NCT04593472|531445596|FG000|Overall Study|Dropped due to participants missing assessment at both 6 and 12-month|0|||
147348139|NCT04593472|531445597|FG001|Overall Study|Dropped due to participants missing assessment at both 6 and 12-month|2|||
147348140|NCT04593472|531445596|FG000|Overall Study|Lost to Follow-up|0|||
147348141|NCT04593472|531445597|FG001|Overall Study|Lost to Follow-up|2|||
147348142|NCT04593472|531445596|FG000|Overall Study|Still collecting 24-month assessment|17|||
147348143|NCT04593472|531445597|FG001|Overall Study|Still collecting 24-month assessment|10|||
147348144|NCT03648840|531445598|FG000|First IV Infusion Session|Adverse Event|0|||
147348145|NCT03648840|531445599|FG001|First IV Infusion Session|Adverse Event|2|||
147348146|NCT03648840|531445598|FG000|Session 1 to Session 2 Interval|Pandemic|0|||
147348147|NCT03648840|531445599|FG001|Session 1 to Session 2 Interval|Pandemic|1|||
147348148|NCT03648840|531445598|FG000|Session 2 to Imaging Interval|Participant declined fMRI at enrollment|8|||
147348149|NCT03648840|531445599|FG001|Session 2 to Imaging Interval|Participant declined fMRI at enrollment|11|||
147348150|NCT03648840|531445598|FG000|Session 2 to Imaging Interval|MRI exclusion (left handed)|3|||
147348151|NCT03648840|531445599|FG001|Session 2 to Imaging Interval|MRI exclusion (left handed)|5|||
147348152|NCT05063994|531445604|FG000|Cortef Run-In|Withdrawal of Consent|1|||
147348153|NCT05063994|531445605|FG001|Cortef Run-In|Withdrawal of Consent|0|||
147348154|NCT05063994|531445606|FG002|Cortef Run-In|Withdrawal of Consent|0|||
147348155|NCT05063994|531445604|FG000|Cortef Run-In|Did not meet the inclusion/exclusion criteria at end of Run-In|1|||
147348156|NCT05063994|531445605|FG001|Cortef Run-In|Did not meet the inclusion/exclusion criteria at end of Run-In|0|||
147348157|NCT05063994|531445606|FG002|Cortef Run-In|Did not meet the inclusion/exclusion criteria at end of Run-In|0|||
147348158|NCT05063994|531445604|FG000|Treatment|Physician Decision|0|||
147348159|NCT05063994|531445605|FG001|Treatment|Physician Decision|0|||
147348160|NCT05063994|531445606|FG002|Treatment|Physician Decision|1|||
147348161|NCT05063994|531445604|FG000|Treatment|Withdrawal by Subject|0|||
147348162|NCT05063994|531445605|FG001|Treatment|Withdrawal by Subject|0|||
147348163|NCT05063994|531445606|FG002|Treatment|Withdrawal by Subject|1|||
147348164|NCT05063994|531445604|FG000|Treatment|Withdrawal of Consent|0|||
147348165|NCT05063994|531445605|FG001|Treatment|Withdrawal of Consent|0|||
147348166|NCT05063994|531445606|FG002|Treatment|Withdrawal of Consent|1|||
147348167|NCT04638998|531445609|FG000|Overall Study|Withdrawal by Subject|1|||
147348168|NCT04638998|531445610|FG001|Overall Study|Withdrawal by Subject|3|||
147348169|NCT03692676|531445611|FG000|Overall Study|exclude patients with prior use|4424|||
147348170|NCT03692676|531445612|FG001|Overall Study|exclude patients with prior use|24726|||
147348171|NCT03692676|531445613|FG002|Overall Study|exclude patients with prior use|0|||
147348172|NCT03692676|531445614|FG003|Overall Study|exclude patients with prior use|0|||
147348173|NCT03692676|531445611|FG000|Overall Study|exclude patients without concurrent ICS/LABA FDC use|2480|||
147348174|NCT03692676|531445612|FG001|Overall Study|exclude patients without concurrent ICS/LABA FDC use|19037|||
147348175|NCT03692676|531445613|FG002|Overall Study|exclude patients without concurrent ICS/LABA FDC use|0|||
147348176|NCT03692676|531445614|FG003|Overall Study|exclude patients without concurrent ICS/LABA FDC use|0|||
147348177|NCT03692676|531445611|FG000|Overall Study|exclude patients without prior recorded asthma diagnosis|881|||
147348178|NCT03692676|531445612|FG001|Overall Study|exclude patients without prior recorded asthma diagnosis|563|||
147348179|NCT03692676|531445613|FG002|Overall Study|exclude patients without prior recorded asthma diagnosis|6281|||
147348180|NCT03692676|531445614|FG003|Overall Study|exclude patients without prior recorded asthma diagnosis|558|||
147348181|NCT03692676|531445611|FG000|Overall Study|exclude patients less than 18 years of age on index date|8|||
147348182|NCT03692676|531445612|FG001|Overall Study|exclude patients less than 18 years of age on index date|613|||
147348183|NCT03692676|531445613|FG002|Overall Study|exclude patients less than 18 years of age on index date|836|||
147348184|NCT03692676|531445614|FG003|Overall Study|exclude patients less than 18 years of age on index date|193|||
147348185|NCT03692676|531445611|FG000|Overall Study|exclude patients with less than 1 year prior continous UTS enrollment|149|||
147348186|NCT03692676|531445612|FG001|Overall Study|exclude patients with less than 1 year prior continous UTS enrollment|717|||
147348187|NCT03692676|531445613|FG002|Overall Study|exclude patients with less than 1 year prior continous UTS enrollment|1723|||
147348188|NCT03692676|531445614|FG003|Overall Study|exclude patients with less than 1 year prior continous UTS enrollment|273|||
147348189|NCT03692676|531445611|FG000|Overall Study|exclude patients with prior LAMA use (any time prior to index date)|1208|||
147348190|NCT03692676|531445612|FG001|Overall Study|exclude patients with prior LAMA use (any time prior to index date)|759|||
147348191|NCT03692676|531445613|FG002|Overall Study|exclude patients with prior LAMA use (any time prior to index date)|7419|||
147348192|NCT03692676|531445614|FG003|Overall Study|exclude patients with prior LAMA use (any time prior to index date)|684|||
147348193|NCT03692676|531445611|FG000|Overall Study|exclude patients with prior recorded COPD diagnosis|275|||
147348194|NCT03692676|531445612|FG001|Overall Study|exclude patients with prior recorded COPD diagnosis|218|||
147348195|NCT03692676|531445613|FG002|Overall Study|exclude patients with prior recorded COPD diagnosis|1515|||
147348196|NCT03692676|531445614|FG003|Overall Study|exclude patients with prior recorded COPD diagnosis|173|||
147348197|NCT03692676|531445611|FG000|Overall Study|exclude patients with multiple FDC prescriptions on index date|0|||
147348198|NCT03692676|531445612|FG001|Overall Study|exclude patients with multiple FDC prescriptions on index date|0|||
147348199|NCT03692676|531445613|FG002|Overall Study|exclude patients with multiple FDC prescriptions on index date|1147|||
147348200|NCT03692676|531445614|FG003|Overall Study|exclude patients with multiple FDC prescriptions on index date|4|||
147348201|NCT03692676|531445611|FG000|Overall Study|exclude patients with prior use of same substances and device|0|||
147348202|NCT03692676|531445612|FG001|Overall Study|exclude patients with prior use of same substances and device|0|||
147348203|NCT03692676|531445613|FG002|Overall Study|exclude patients with prior use of same substances and device|3700|||
147348204|NCT03692676|531445614|FG003|Overall Study|exclude patients with prior use of same substances and device|0|||
147348205|NCT03692676|531445611|FG000|Overall Study|exclude patients without ICS/LABA FDC prescription within 3 months prior to index date|0|||
147453277|NCT02064387|531823980|FG002|Part 1 Max 23.5 Months Followup Duration|Death|0|||
147453278|NCT02064387|531823981|FG003|Part 1 Max 23.5 Months Followup Duration|Death|0|||
147453279|NCT02064387|531823982|FG004|Part 1 Max 23.5 Months Followup Duration|Death|0|||
147453280|NCT02064387|531823983|FG005|Part 1 Max 23.5 Months Followup Duration|Death|0|||
147453281|NCT02064387|531823984|FG006|Part 1 Max 23.5 Months Followup Duration|Death|0|||
147348206|NCT03692676|531445612|FG001|Overall Study|exclude patients without ICS/LABA FDC prescription within 3 months prior to index date|0|||
147348207|NCT03692676|531445613|FG002|Overall Study|exclude patients without ICS/LABA FDC prescription within 3 months prior to index date|14965|||
147348208|NCT03692676|531445614|FG003|Overall Study|exclude patients without ICS/LABA FDC prescription within 3 months prior to index date|1198|||
147348209|NCT03692676|531445611|FG000|Overall Study|exclude patients with different substance(s)/device at preceding prescription|0|||
147348210|NCT03692676|531445612|FG001|Overall Study|exclude patients with different substance(s)/device at preceding prescription|0|||
147348211|NCT03692676|531445613|FG002|Overall Study|exclude patients with different substance(s)/device at preceding prescription|0|||
147348212|NCT03692676|531445614|FG003|Overall Study|exclude patients with different substance(s)/device at preceding prescription|223|||
147348213|NCT03692676|531445611|FG000|Overall Study|Other|0|||
147348214|NCT03692676|531445612|FG001|Overall Study|Other|805|||
147348215|NCT03692676|531445613|FG002|Overall Study|Other|758|||
147348216|NCT03692676|531445614|FG003|Overall Study|Other|277|||
147348217|NCT03692676|531445611|FG000|Overall Study|exclude patients with multiple substance(s)/device at preceding prescription|0|||
147348218|NCT03692676|531445612|FG001|Overall Study|exclude patients with multiple substance(s)/device at preceding prescription|0|||
147348219|NCT03692676|531445613|FG002|Overall Study|exclude patients with multiple substance(s)/device at preceding prescription|0|||
147348220|NCT03692676|531445614|FG003|Overall Study|exclude patients with multiple substance(s)/device at preceding prescription|3|||
147348221|NCT04490915|531445616|FG000|DB Treatment Period (24 Weeks)|Withdrawal by Subject|2|||
147348222|NCT04490915|531445617|FG001|DB Treatment Period (24 Weeks)|Withdrawal by Subject|3|||
147348223|NCT04490915|531445616|FG000|DB Treatment Period (24 Weeks)|Lost to Follow-up|1|||
147348224|NCT04490915|531445617|FG001|DB Treatment Period (24 Weeks)|Lost to Follow-up|1|||
147348225|NCT04490915|531445616|FG000|DB Treatment Period (24 Weeks)|Adverse Event|0|||
147348226|NCT04490915|531445617|FG001|DB Treatment Period (24 Weeks)|Adverse Event|1|||
147348227|NCT04490915|531445616|FG000|OL Treatment Period (6 Months)|Withdrawal by Subject|1|||
147348228|NCT04490915|531445617|FG001|OL Treatment Period (6 Months)|Withdrawal by Subject|0|||
147348229|NCT04490915|531445616|FG000|OL Treatment Period (6 Months)|Lost to Follow-up|0|||
147348230|NCT04490915|531445617|FG001|OL Treatment Period (6 Months)|Lost to Follow-up|1|||
147348231|NCT04490915|531445616|FG000|OL Treatment Period (6 Months)|Adverse Event|0|||
147348232|NCT04490915|531445617|FG001|OL Treatment Period (6 Months)|Adverse Event|1|||
147348233|NCT04490915|531445616|FG000|OL Treatment Period (6 Months)|Ongoing in the Study|34|||
147348234|NCT04490915|531445617|FG001|OL Treatment Period (6 Months)|Ongoing in the Study|58|||
147348235|NCT04725240|531445618|FG000|Overall Study|Adverse Event|2|||
147348236|NCT02312960|531445620|FG000|Overall Study|Death|24|||
147348237|NCT02312960|531445621|FG001|Overall Study|Death|32|||
147348238|NCT02312960|531445622|FG002|Overall Study|Death|25|||
147348239|NCT02312960|531445623|FG003|Overall Study|Death|11|||
147348240|NCT02312960|531445624|FG004|Overall Study|Death|5|||
147348241|NCT02312960|531445625|FG005|Overall Study|Death|5|||
147348242|NCT02312960|531445626|FG006|Overall Study|Death|8|||
147348243|NCT02312960|531445627|FG007|Overall Study|Death|5|||
147348244|NCT02312960|531445628|FG008|Overall Study|Death|7|||
147348245|NCT02312960|531445629|FG009|Overall Study|Death|3|||
147348246|NCT02312960|531445630|FG010|Overall Study|Death|3|||
147348247|NCT02312960|531445631|FG011|Overall Study|Death|1|||
147348248|NCT02312960|531445632|FG012|Overall Study|Death|25|||
147348249|NCT02312960|531445633|FG013|Overall Study|Death|19|||
147348250|NCT02312960|531445620|FG000|Overall Study|Missing|0|||
147348251|NCT02312960|531445621|FG001|Overall Study|Missing|0|||
147348252|NCT02312960|531445622|FG002|Overall Study|Missing|2|||
147348253|NCT02312960|531445623|FG003|Overall Study|Missing|0|||
147348254|NCT02312960|531445624|FG004|Overall Study|Missing|0|||
147348255|NCT02312960|531445625|FG005|Overall Study|Missing|0|||
147348256|NCT02312960|531445626|FG006|Overall Study|Missing|0|||
147348257|NCT02312960|531445627|FG007|Overall Study|Missing|0|||
147348258|NCT02312960|531445628|FG008|Overall Study|Missing|0|||
147348259|NCT02312960|531445629|FG009|Overall Study|Missing|0|||
147348260|NCT02312960|531445630|FG010|Overall Study|Missing|0|||
147606869|NCT00696787|532377164|FG001|Overall Study|Failed to return|3|||
147348261|NCT02312960|531445631|FG011|Overall Study|Missing|0|||
147348262|NCT02312960|531445632|FG012|Overall Study|Missing|0|||
147348263|NCT02312960|531445633|FG013|Overall Study|Missing|0|||
147348264|NCT02312960|531445620|FG000|Overall Study|Lost to Follow-up|0|||
147348265|NCT02312960|531445621|FG001|Overall Study|Lost to Follow-up|0|||
147348266|NCT02312960|531445622|FG002|Overall Study|Lost to Follow-up|1|||
147348267|NCT02312960|531445623|FG003|Overall Study|Lost to Follow-up|0|||
147606870|NCT00696787|532377165|FG002|Overall Study|Failed to return|1|||
147606871|NCT02549027|532377167|FG000|Washout After Period 4|Withdrawal by Subject|0|||
147606872|NCT02549027|532377168|FG001|Washout After Period 4|Withdrawal by Subject|1|||
147606873|NCT02549027|532377169|FG002|Washout After Period 4|Withdrawal by Subject|1|||
147348268|NCT02312960|531445624|FG004|Overall Study|Lost to Follow-up|0|||
147348269|NCT02312960|531445625|FG005|Overall Study|Lost to Follow-up|0|||
147348270|NCT02312960|531445626|FG006|Overall Study|Lost to Follow-up|1|||
147348271|NCT02312960|531445627|FG007|Overall Study|Lost to Follow-up|1|||
147348272|NCT02312960|531445628|FG008|Overall Study|Lost to Follow-up|0|||
147348273|NCT02312960|531445629|FG009|Overall Study|Lost to Follow-up|1|||
147348274|NCT02312960|531445630|FG010|Overall Study|Lost to Follow-up|0|||
147348275|NCT02312960|531445631|FG011|Overall Study|Lost to Follow-up|0|||
147348276|NCT02312960|531445632|FG012|Overall Study|Lost to Follow-up|1|||
147348277|NCT02312960|531445633|FG013|Overall Study|Lost to Follow-up|0|||
147348278|NCT02312960|531445620|FG000|Overall Study|Withdrawal by Subject|1|||
147348279|NCT02312960|531445621|FG001|Overall Study|Withdrawal by Subject|2|||
147348280|NCT02312960|531445622|FG002|Overall Study|Withdrawal by Subject|0|||
147348281|NCT02312960|531445623|FG003|Overall Study|Withdrawal by Subject|0|||
147348282|NCT02312960|531445624|FG004|Overall Study|Withdrawal by Subject|1|||
147348283|NCT02312960|531445625|FG005|Overall Study|Withdrawal by Subject|0|||
147348284|NCT02312960|531445626|FG006|Overall Study|Withdrawal by Subject|1|||
147348285|NCT02312960|531445627|FG007|Overall Study|Withdrawal by Subject|2|||
147348286|NCT02312960|531445628|FG008|Overall Study|Withdrawal by Subject|2|||
147348287|NCT02312960|531445629|FG009|Overall Study|Withdrawal by Subject|3|||
147348288|NCT02312960|531445630|FG010|Overall Study|Withdrawal by Subject|0|||
147348289|NCT02312960|531445631|FG011|Overall Study|Withdrawal by Subject|0|||
147348290|NCT02312960|531445632|FG012|Overall Study|Withdrawal by Subject|2|||
147348291|NCT02312960|531445633|FG013|Overall Study|Withdrawal by Subject|0|||
147348292|NCT04060355|531445635|FG000|Overall Study|Lost to Follow-up|41|||
147348293|NCT01140880|531445636|FG000|Overall Study|Death|0|||
147348294|NCT01140880|531445637|FG001|Overall Study|Death|1|||
147348295|NCT01140880|531445636|FG000|Overall Study|Withdrawal by Subject|6|||
147348296|NCT01140880|531445637|FG001|Overall Study|Withdrawal by Subject|3|||
147348297|NCT01140880|531445636|FG000|Overall Study|Lost to Follow-up|8|||
147348298|NCT01140880|531445637|FG001|Overall Study|Lost to Follow-up|10|||
147348299|NCT01140880|531445636|FG000|Overall Study|Protocol Violation|0|||
147348300|NCT01140880|531445637|FG001|Overall Study|Protocol Violation|30|||
147348301|NCT04421378|531445641|FG000|Overall Study|Adverse Event|2|||
147348302|NCT04421378|531445642|FG001|Overall Study|Adverse Event|7|||
147348303|NCT04421378|531445643|FG002|Overall Study|Adverse Event|0|||
147348304|NCT04421378|531445644|FG003|Overall Study|Adverse Event|1|||
147348305|NCT04421378|531445645|FG004|Overall Study|Adverse Event|0|||
147348306|NCT04421378|531445641|FG000|Overall Study|Physician Decision|1|||
147348307|NCT04421378|531445642|FG001|Overall Study|Physician Decision|2|||
147348308|NCT04421378|531445643|FG002|Overall Study|Physician Decision|0|||
147348309|NCT04421378|531445644|FG003|Overall Study|Physician Decision|0|||
147348310|NCT04421378|531445645|FG004|Overall Study|Physician Decision|0|||
147348311|NCT04421378|531445641|FG000|Overall Study|Progressive Disease|16|||
147348312|NCT04421378|531445642|FG001|Overall Study|Progressive Disease|4|||
147348313|NCT04421378|531445643|FG002|Overall Study|Progressive Disease|18|||
147348314|NCT04421378|531445644|FG003|Overall Study|Progressive Disease|11|||
147348315|NCT04421378|531445645|FG004|Overall Study|Progressive Disease|3|||
147348316|NCT04421378|531445641|FG000|Overall Study|Study Terminated by Sponsor|0|||
147348317|NCT04421378|531445642|FG001|Overall Study|Study Terminated by Sponsor|1|||
147348318|NCT04421378|531445643|FG002|Overall Study|Study Terminated by Sponsor|1|||
147348319|NCT04421378|531445644|FG003|Overall Study|Study Terminated by Sponsor|0|||
147348320|NCT04421378|531445645|FG004|Overall Study|Study Terminated by Sponsor|0|||
147348321|NCT04421378|531445641|FG000|Overall Study|Withdrawal by Subject|3|||
147348322|NCT04421378|531445642|FG001|Overall Study|Withdrawal by Subject|1|||
147606874|NCT02549027|532377170|FG003|Washout After Period 4|Withdrawal by Subject|1|||
147348323|NCT04421378|531445643|FG002|Overall Study|Withdrawal by Subject|0|||
147348324|NCT04421378|531445644|FG003|Overall Study|Withdrawal by Subject|2|||
147348325|NCT04421378|531445645|FG004|Overall Study|Withdrawal by Subject|0|||
147348326|NCT04421378|531445641|FG000|Overall Study|Other|1|||
147348327|NCT04421378|531445642|FG001|Overall Study|Other|0|||
147348328|NCT04421378|531445643|FG002|Overall Study|Other|0|||
147348329|NCT04421378|531445644|FG003|Overall Study|Other|0|||
147348330|NCT04421378|531445645|FG004|Overall Study|Other|0|||
147348331|NCT02927769|531445646|FG000|Induction Phase|Study drug toxicity|1|||
147348332|NCT02927769|531445647|FG001|Induction Phase|Study drug toxicity|1|||
147348333|NCT02927769|531445646|FG000|Induction Phase|Disease progression|0|||
147348334|NCT02927769|531445647|FG001|Induction Phase|Disease progression|1|||
147348335|NCT02927769|531445646|FG000|Intensification Phase|Study drug toxicity|1|||
147348336|NCT02927769|531445647|FG001|Intensification Phase|Study drug toxicity|0|||
147348337|NCT02807636|531445648|FG000|Overall Study|Lost to Follow-up|10|||
147348338|NCT02807636|531445649|FG001|Overall Study|Lost to Follow-up|13|||
147348339|NCT02807636|531445650|FG002|Overall Study|Lost to Follow-up|6|||
147348340|NCT02807636|531445648|FG000|Overall Study|Protocol Deviation|1|||
147348341|NCT02807636|531445649|FG001|Overall Study|Protocol Deviation|0|||
147348342|NCT02807636|531445650|FG002|Overall Study|Protocol Deviation|0|||
147348343|NCT02807636|531445648|FG000|Overall Study|Symptomatic Deterioration|0|||
147348344|NCT02807636|531445649|FG001|Overall Study|Symptomatic Deterioration|1|||
147348345|NCT02807636|531445650|FG002|Overall Study|Symptomatic Deterioration|0|||
147348346|NCT02807636|531445648|FG000|Overall Study|Withdrawal by Subject|39|||
147348347|NCT02807636|531445649|FG001|Overall Study|Withdrawal by Subject|28|||
147348348|NCT02807636|531445650|FG002|Overall Study|Withdrawal by Subject|24|||
147348349|NCT02807636|531445648|FG000|Overall Study|Death|303|||
147348350|NCT02807636|531445649|FG001|Overall Study|Death|332|||
147348351|NCT02807636|531445650|FG002|Overall Study|Death|272|||
147348352|NCT02807636|531445648|FG000|Overall Study|Study Terminated By Sponsor|47|||
147348353|NCT02807636|531445649|FG001|Overall Study|Study Terminated By Sponsor|76|||
147348354|NCT02807636|531445650|FG002|Overall Study|Study Terminated By Sponsor|60|||
147348355|NCT02807636|531445648|FG000|Overall Study|Physician Decision|0|||
147348356|NCT02807636|531445649|FG001|Overall Study|Physician Decision|1|||
147348357|NCT02807636|531445650|FG002|Overall Study|Physician Decision|0|||
147348358|NCT03175029|531445651|FG000|Overall Study|Withdrawal by Subject|2|||
147348359|NCT03175029|531445652|FG001|Overall Study|Withdrawal by Subject|1|||
147348360|NCT03175029|531445651|FG000|Overall Study|Study treatment becomes impossible due to changing hospital or other reasons|1|||
147348361|NCT03175029|531445652|FG001|Overall Study|Study treatment becomes impossible due to changing hospital or other reasons|0|||
147348362|NCT05227209|531445655|FG000|Overall Study|Adverse Event|11|||
147348363|NCT05227209|531445655|FG000|Overall Study|Lost to Follow-up|1|||
147348364|NCT05227209|531445655|FG000|Overall Study|Withdrawal by Subject|7|||
147348365|NCT05227209|531445655|FG000|Overall Study|Other Early Termination Reason (Not Listed on CRF)|36|||
147348366|NCT05633953|531445656|FG000|Overall Study|Adverse Event|7|||
147348367|NCT05633953|531445656|FG000|Overall Study|Death|30|||
147348368|NCT05633953|531445656|FG000|Overall Study|Lost to Follow-up|1|||
147348369|NCT05633953|531445656|FG000|Overall Study|Osilodrostat discontinued|4|||
147348370|NCT05633953|531445656|FG000|Overall Study|Physician Decision|1|||
147348371|NCT05633953|531445656|FG000|Overall Study|Planned surgery related to Cushing Syndrome (CS)|15|||
147348372|NCT05633953|531445656|FG000|Overall Study|Progressive disease|2|||
147348373|NCT00512070|531445664|FG000|Phase I - Olanzapine Only|Lost to Follow-up|4|||
147348374|NCT00512070|531445665|FG001|Phase I - Olanzapine Only|Lost to Follow-up|0|||
147348375|NCT00512070|531445666|FG002|Phase I - Olanzapine Only|Lost to Follow-up|0|||
147348376|NCT00512070|531445664|FG000|Phase II - Randomization to Melatonin|Data unable to be collected|0|||
147348377|NCT00512070|531445665|FG001|Phase II - Randomization to Melatonin|Data unable to be collected|2|||
147348378|NCT00512070|531445666|FG002|Phase II - Randomization to Melatonin|Data unable to be collected|1|||
147348379|NCT00961571|531445667|FG000|Overall Study|Physician Decision|39|||
147348380|NCT05524233|531445668|FG000|Overall Study|Lost to Follow-up|2|||
147348381|NCT05524233|531445668|FG000|Overall Study|Adverse Event|2|||
147348382|NCT05524233|531445668|FG000|Overall Study|Withdrawal by Subject|1|||
147348383|NCT05337748|531445672|FG000|Overall Study|Withdrawal by Subject|1|||
147348384|NCT05337748|531445673|FG001|Overall Study|Withdrawal by Subject|0|||
147348385|NCT05337748|531445672|FG000|Overall Study|Death|1|||
147348386|NCT05337748|531445673|FG001|Overall Study|Death|0|||
147348387|NCT02506959|531445674|FG000|Overall Study|Physician Decision|2|||
147348388|NCT02506959|531445675|FG001|Overall Study|Physician Decision|1|||
147348389|NCT03453619|531445679|FG000|Core Study (Part A)|Physician Decision|0|||
147348390|NCT03453619|531445680|FG001|Core Study (Part A)|Physician Decision|0|||
147348391|NCT03453619|531445681|FG002|Core Study (Part A)|Physician Decision|2|||
147348392|NCT03453619|531445682|FG003|Core Study (Part A)|Physician Decision|0|||
147348393|NCT03453619|531445679|FG000|Core Study (Part A)|Withdrawal by Subject|2|||
147348394|NCT03453619|531445680|FG001|Core Study (Part A)|Withdrawal by Subject|0|||
147348395|NCT03453619|531445681|FG002|Core Study (Part A)|Withdrawal by Subject|2|||
147348396|NCT03453619|531445682|FG003|Core Study (Part A)|Withdrawal by Subject|1|||
147348397|NCT03453619|531445679|FG000|Core Study (Part A)|Other|0|||
147453282|NCT02064387|531823985|FG007|Part 1 Max 23.5 Months Followup Duration|Death|1|||
147453283|NCT02064387|531823986|FG008|Part 1 Max 23.5 Months Followup Duration|Death|0|||
147453284|NCT02064387|531823987|FG009|Part 1 Max 23.5 Months Followup Duration|Death|1|||
147453285|NCT02064387|531823988|FG010|Part 1 Max 23.5 Months Followup Duration|Death|0|||
147453286|NCT02064387|531823989|FG011|Part 1 Max 23.5 Months Followup Duration|Death|0|||
147348398|NCT03453619|531445680|FG001|Core Study (Part A)|Other|1|||
147348399|NCT03453619|531445681|FG002|Core Study (Part A)|Other|0|||
147348400|NCT03453619|531445682|FG003|Core Study (Part A)|Other|0|||
147348401|NCT03453619|531445679|FG000|Long-Term Extension (Part B)|Adverse Event|1|||
147348402|NCT03453619|531445680|FG001|Long-Term Extension (Part B)|Adverse Event|0|||
147348403|NCT03453619|531445681|FG002|Long-Term Extension (Part B)|Adverse Event|0|||
147348404|NCT03453619|531445682|FG003|Long-Term Extension (Part B)|Adverse Event|0|||
147348405|NCT03453619|531445679|FG000|Long-Term Extension (Part B)|Lost to Follow-up|1|||
147348406|NCT03453619|531445680|FG001|Long-Term Extension (Part B)|Lost to Follow-up|0|||
147348407|NCT03453619|531445681|FG002|Long-Term Extension (Part B)|Lost to Follow-up|0|||
147348408|NCT03453619|531445682|FG003|Long-Term Extension (Part B)|Lost to Follow-up|1|||
147348409|NCT03453619|531445679|FG000|Long-Term Extension (Part B)|Non-compliance with study drug|0|||
147348410|NCT03453619|531445680|FG001|Long-Term Extension (Part B)|Non-compliance with study drug|0|||
147348411|NCT03453619|531445681|FG002|Long-Term Extension (Part B)|Non-compliance with study drug|0|||
147348412|NCT03453619|531445682|FG003|Long-Term Extension (Part B)|Non-compliance with study drug|1|||
147348413|NCT03453619|531445679|FG000|Long-Term Extension (Part B)|Physician Decision|0|||
147348414|NCT03453619|531445680|FG001|Long-Term Extension (Part B)|Physician Decision|1|||
147348415|NCT03453619|531445681|FG002|Long-Term Extension (Part B)|Physician Decision|0|||
147348416|NCT03453619|531445682|FG003|Long-Term Extension (Part B)|Physician Decision|0|||
147348417|NCT05862870|531445685|FG000|Overall Study|Lost to Follow-up|3|||
147348418|NCT04321031|531445686|FG000|Overall Study|Adverse Event|0|||
147348419|NCT04321031|531445687|FG001|Overall Study|Adverse Event|2|||
147348420|NCT04321031|531445688|FG002|Overall Study|Adverse Event|2|||
147348421|NCT04321031|531445689|FG003|Overall Study|Adverse Event|2|||
147348422|NCT04321031|531445690|FG004|Overall Study|Adverse Event|2|||
147348423|NCT04321031|531445691|FG005|Overall Study|Adverse Event|2|||
147348424|NCT04321031|531445692|FG006|Overall Study|Adverse Event|0|||
147348425|NCT04321031|531445686|FG000|Overall Study|Lost to Follow-up|0|||
147348426|NCT04321031|531445687|FG001|Overall Study|Lost to Follow-up|0|||
147348427|NCT04321031|531445688|FG002|Overall Study|Lost to Follow-up|0|||
147348428|NCT04321031|531445689|FG003|Overall Study|Lost to Follow-up|1|||
147348429|NCT04321031|531445690|FG004|Overall Study|Lost to Follow-up|0|||
147348430|NCT04321031|531445691|FG005|Overall Study|Lost to Follow-up|2|||
147348431|NCT04321031|531445692|FG006|Overall Study|Lost to Follow-up|1|||
147348432|NCT04321031|531445686|FG000|Overall Study|Withdrawal by Subject|2|||
147348433|NCT04321031|531445687|FG001|Overall Study|Withdrawal by Subject|2|||
147348434|NCT04321031|531445688|FG002|Overall Study|Withdrawal by Subject|1|||
147348435|NCT04321031|531445689|FG003|Overall Study|Withdrawal by Subject|3|||
147348436|NCT04321031|531445690|FG004|Overall Study|Withdrawal by Subject|1|||
147348437|NCT04321031|531445691|FG005|Overall Study|Withdrawal by Subject|0|||
147348438|NCT04321031|531445692|FG006|Overall Study|Withdrawal by Subject|1|||
147348439|NCT04321031|531445686|FG000|Overall Study|Non-compliance with study drug|0|||
147348440|NCT04321031|531445687|FG001|Overall Study|Non-compliance with study drug|0|||
147348441|NCT04321031|531445688|FG002|Overall Study|Non-compliance with study drug|0|||
147348442|NCT04321031|531445689|FG003|Overall Study|Non-compliance with study drug|0|||
147348443|NCT04321031|531445690|FG004|Overall Study|Non-compliance with study drug|0|||
147348444|NCT04321031|531445691|FG005|Overall Study|Non-compliance with study drug|1|||
147348445|NCT04321031|531445692|FG006|Overall Study|Non-compliance with study drug|0|||
147348446|NCT04321031|531445686|FG000|Overall Study|Other|0|||
147348447|NCT04321031|531445687|FG001|Overall Study|Other|0|||
147348448|NCT04321031|531445688|FG002|Overall Study|Other|0|||
147348449|NCT04321031|531445689|FG003|Overall Study|Other|1|||
147348450|NCT04321031|531445690|FG004|Overall Study|Other|0|||
147348451|NCT04321031|531445691|FG005|Overall Study|Other|0|||
147348452|NCT04321031|531445692|FG006|Overall Study|Other|0|||
147348453|NCT03143153|531445695|FG000|Pre-Treatment|Participant request to discontinue study treatment|0|||
147348454|NCT03143153|531445696|FG001|Pre-Treatment|Participant request to discontinue study treatment|0|||
147348455|NCT03143153|531445697|FG002|Pre-Treatment|Participant request to discontinue study treatment|2|||
147348456|NCT03143153|531445695|FG000|Pre-Treatment|Participant withdrew consent|0|||
147348457|NCT03143153|531445696|FG001|Pre-Treatment|Participant withdrew consent|1|||
147348458|NCT03143153|531445697|FG002|Pre-Treatment|Participant withdrew consent|12|||
147348459|NCT03143153|531445695|FG000|Pre-Treatment|Participant no longer meets study criteria|0|||
147348460|NCT03143153|531445696|FG001|Pre-Treatment|Participant no longer meets study criteria|4|||
147348461|NCT03143153|531445697|FG002|Pre-Treatment|Participant no longer meets study criteria|2|||
147348462|NCT03143153|531445695|FG000|Pre-Treatment|Other Reasons|1|||
147348463|NCT03143153|531445696|FG001|Pre-Treatment|Other Reasons|2|||
147348464|NCT03143153|531445697|FG002|Pre-Treatment|Other Reasons|1|||
147348465|NCT03143153|531445695|FG000|Pre-Treatment|Disease Progression|1|||
147348466|NCT03143153|531445696|FG001|Pre-Treatment|Disease Progression|1|||
147348467|NCT03143153|531445697|FG002|Pre-Treatment|Disease Progression|2|||
147348468|NCT03143153|531445695|FG000|Pre-Treatment|Adverse event unrelated to study drug|1|||
147348469|NCT03143153|531445696|FG001|Pre-Treatment|Adverse event unrelated to study drug|3|||
147348470|NCT03143153|531445697|FG002|Pre-Treatment|Adverse event unrelated to study drug|1|||
147348471|NCT03143153|531445695|FG000|Treatment|Disease progression|174|||
147348472|NCT03143153|531445696|FG001|Treatment|Disease progression|184|||
147348473|NCT03143153|531445697|FG002|Treatment|Disease progression|193|||
147348474|NCT03143153|531445695|FG000|Treatment|Study drug toxicity|59|||
147348475|NCT03143153|531445696|FG001|Treatment|Study drug toxicity|33|||
147348476|NCT03143153|531445697|FG002|Treatment|Study drug toxicity|40|||
147348477|NCT03143153|531445695|FG000|Treatment|Death|5|||
147348478|NCT03143153|531445696|FG001|Treatment|Death|3|||
147348479|NCT03143153|531445697|FG002|Treatment|Death|4|||
147348480|NCT03143153|531445695|FG000|Treatment|Adverse event unrelated to study drug|19|||
147348481|NCT03143153|531445696|FG001|Treatment|Adverse event unrelated to study drug|28|||
147348482|NCT03143153|531445697|FG002|Treatment|Adverse event unrelated to study drug|12|||
147348483|NCT03143153|531445695|FG000|Treatment|Participant request to discontinue study treatment|13|||
147348484|NCT03143153|531445696|FG001|Treatment|Participant request to discontinue study treatment|15|||
147348485|NCT03143153|531445697|FG002|Treatment|Participant request to discontinue study treatment|20|||
147348486|NCT03143153|531445695|FG000|Treatment|Participant withdrew consent|3|||
147348487|NCT03143153|531445696|FG001|Treatment|Participant withdrew consent|4|||
147348488|NCT03143153|531445697|FG002|Treatment|Participant withdrew consent|12|||
147348489|NCT03143153|531445695|FG000|Treatment|Pregnancy|1|||
147348490|NCT03143153|531445696|FG001|Treatment|Pregnancy|0|||
147348491|NCT03143153|531445697|FG002|Treatment|Pregnancy|0|||
147348492|NCT03143153|531445695|FG000|Treatment|Maximum clinical benefit|1|||
147348493|NCT03143153|531445696|FG001|Treatment|Maximum clinical benefit|3|||
147348494|NCT03143153|531445697|FG002|Treatment|Maximum clinical benefit|4|||
147348495|NCT03143153|531445695|FG000|Treatment|Completed treatment as per Protocol|13|||
147348496|NCT03143153|531445696|FG001|Treatment|Completed treatment as per Protocol|8|||
147348497|NCT03143153|531445697|FG002|Treatment|Completed treatment as per Protocol|0|||
147348498|NCT03143153|531445695|FG000|Treatment|Other reasons|12|||
147348499|NCT03143153|531445696|FG001|Treatment|Other reasons|7|||
147348500|NCT03143153|531445697|FG002|Treatment|Other reasons|15|||
147348501|NCT03143153|531445695|FG000|Treatment|Not reported|1|||
147348502|NCT03143153|531445696|FG001|Treatment|Not reported|0|||
147348503|NCT03143153|531445697|FG002|Treatment|Not reported|0|||
147348504|NCT05470400|531445706|FG000|Overall Study|Lost to Follow-up|0|||
147348505|NCT05470400|531445707|FG001|Overall Study|Lost to Follow-up|0|||
147348506|NCT05470400|531445708|FG002|Overall Study|Lost to Follow-up|0|||
147348507|NCT05470400|531445709|FG003|Overall Study|Lost to Follow-up|0|||
147348508|NCT05470400|531445710|FG004|Overall Study|Lost to Follow-up|0|||
147348509|NCT05470400|531445711|FG005|Overall Study|Lost to Follow-up|0|||
147348510|NCT05470400|531445712|FG006|Overall Study|Lost to Follow-up|0|||
147348511|NCT05470400|531445713|FG007|Overall Study|Lost to Follow-up|1|||
147348512|NCT05470400|531445706|FG000|Overall Study|Withdrawal by Subject|1|||
147348513|NCT05470400|531445707|FG001|Overall Study|Withdrawal by Subject|0|||
147348514|NCT05470400|531445708|FG002|Overall Study|Withdrawal by Subject|0|||
147348515|NCT05470400|531445709|FG003|Overall Study|Withdrawal by Subject|0|||
147348516|NCT05470400|531445710|FG004|Overall Study|Withdrawal by Subject|0|||
147348517|NCT05470400|531445711|FG005|Overall Study|Withdrawal by Subject|1|||
147348518|NCT05470400|531445712|FG006|Overall Study|Withdrawal by Subject|0|||
147348519|NCT05470400|531445713|FG007|Overall Study|Withdrawal by Subject|2|||
147348520|NCT04812535|531445722|FG000|Overall Study|Withdrawal by Subject|0|||
147348521|NCT04812535|531445723|FG001|Overall Study|Withdrawal by Subject|0|||
147348522|NCT04812535|531445724|FG002|Overall Study|Withdrawal by Subject|0|||
147348523|NCT04812535|531445725|FG003|Overall Study|Withdrawal by Subject|1|||
147348524|NCT04812535|531445722|FG000|Overall Study|Death|7|||
147348525|NCT04812535|531445723|FG001|Overall Study|Death|2|||
147348526|NCT04812535|531445724|FG002|Overall Study|Death|4|||
147348527|NCT04812535|531445725|FG003|Overall Study|Death|1|||
147348528|NCT04812535|531445722|FG000|Overall Study|Due to premature study termination by sponsor|2|||
147348529|NCT04812535|531445723|FG001|Overall Study|Due to premature study termination by sponsor|0|||
147348530|NCT04812535|531445724|FG002|Overall Study|Due to premature study termination by sponsor|1|||
147348531|NCT04812535|531445725|FG003|Overall Study|Due to premature study termination by sponsor|3|||
147348532|NCT03436745|531445726|FG000|Overall Study|Ineligible|0|||
147348533|NCT03436745|531445727|FG001|Overall Study|Ineligible|0|||
147348534|NCT03436745|531445728|FG002|Overall Study|Ineligible|1|||
147348535|NCT03846505|531445731|FG000|Treatment Phase|Withdrawal by Subject|9|||
147348536|NCT03846505|531445732|FG001|Treatment Phase|Withdrawal by Subject|11|||
147348537|NCT03846505|531445731|FG000|Treatment Phase|Lost to Follow-up|6|||
147348538|NCT03846505|531445732|FG001|Treatment Phase|Lost to Follow-up|2|||
147348539|NCT03846505|531445731|FG000|Treatment Phase|Opted out of intervention but completed assessments|5|||
147348540|NCT03846505|531445732|FG001|Treatment Phase|Opted out of intervention but completed assessments|3|||
147348541|NCT03846505|531445731|FG000|Completed Follow Up Phase (6-month)|Lost to Follow-up|6|||
147348542|NCT03846505|531445732|FG001|Completed Follow Up Phase (6-month)|Lost to Follow-up|1|||
147348543|NCT05592418|531445733|FG000|Overall Study|Adverse Event|1|||
147348544|NCT05592418|531445734|FG001|Overall Study|Adverse Event|0|||
147348545|NCT05592418|531445733|FG000|Overall Study|Lost to Follow-up|1|||
147348546|NCT05592418|531445734|FG001|Overall Study|Lost to Follow-up|3|||
147453287|NCT02064387|531823978|FG000|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
147348547|NCT05592418|531445733|FG000|Overall Study|Withdrawal by Subject|2|||
147348548|NCT05592418|531445734|FG001|Overall Study|Withdrawal by Subject|7|||
147348549|NCT05569252|531445735|FG000|Overall Study|Adverse event (central vision loss)|1|||
147348550|NCT05569252|531445736|FG001|Overall Study|Adverse event (central vision loss)|0|||
147348551|NCT05569252|531445737|FG002|Overall Study|Adverse event (central vision loss)|0|||
147348552|NCT05569252|531445738|FG003|Overall Study|Adverse event (central vision loss)|0|||
147348553|NCT03665597|531445739|FG000|Period 1|Adverse Event|1|||
147348554|NCT03665597|531445740|FG001|Period 1|Adverse Event|0|||
147453288|NCT02064387|531823979|FG001|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
147348555|NCT03665597|531445741|FG002|Period 1|Adverse Event|0|||
147348556|NCT03665597|531445742|FG003|Period 1|Adverse Event|1|||
147348557|NCT03665597|531445743|FG004|Period 1|Adverse Event|0|||
147348558|NCT03665597|531445744|FG005|Period 1|Adverse Event|0|||
147348559|NCT03665597|531445745|FG006|Period 1|Adverse Event|0|||
147348560|NCT03665597|531445739|FG000|Period 1|Screen Failure|0|||
147348561|NCT03665597|531445740|FG001|Period 1|Screen Failure|0|||
147348562|NCT03665597|531445741|FG002|Period 1|Screen Failure|0|||
147348563|NCT03665597|531445742|FG003|Period 1|Screen Failure|1|||
147348564|NCT03665597|531445743|FG004|Period 1|Screen Failure|0|||
147348565|NCT03665597|531445744|FG005|Period 1|Screen Failure|0|||
147348566|NCT03665597|531445745|FG006|Period 1|Screen Failure|0|||
147348567|NCT03665597|531445739|FG000|Period 1|Death|0|||
147348568|NCT03665597|531445740|FG001|Period 1|Death|0|||
147348569|NCT03665597|531445741|FG002|Period 1|Death|0|||
147348570|NCT03665597|531445742|FG003|Period 1|Death|0|||
147348571|NCT03665597|531445743|FG004|Period 1|Death|0|||
147348572|NCT03665597|531445744|FG005|Period 1|Death|0|||
147348573|NCT03665597|531445745|FG006|Period 1|Death|45|||
147348574|NCT03665597|531445739|FG000|Period 1|Withdrawal by Subject|0|||
147348575|NCT03665597|531445740|FG001|Period 1|Withdrawal by Subject|0|||
147348576|NCT03665597|531445741|FG002|Period 1|Withdrawal by Subject|0|||
147348577|NCT03665597|531445742|FG003|Period 1|Withdrawal by Subject|0|||
147348578|NCT03665597|531445743|FG004|Period 1|Withdrawal by Subject|0|||
147348579|NCT03665597|531445744|FG005|Period 1|Withdrawal by Subject|0|||
147348580|NCT03665597|531445745|FG006|Period 1|Withdrawal by Subject|5|||
147348581|NCT03665597|531445739|FG000|Period 2|Adverse Event|0|||
147348582|NCT03665597|531445740|FG001|Period 2|Adverse Event|0|||
147348583|NCT03665597|531445741|FG002|Period 2|Adverse Event|0|||
147348584|NCT03665597|531445742|FG003|Period 2|Adverse Event|0|||
147348585|NCT03665597|531445743|FG004|Period 2|Adverse Event|0|||
147348586|NCT03665597|531445744|FG005|Period 2|Adverse Event|1|||
147348587|NCT03665597|531445745|FG006|Period 2|Adverse Event|0|||
147348588|NCT03665597|531445739|FG000|Period 3|Adverse Event|0|||
147348589|NCT03665597|531445740|FG001|Period 3|Adverse Event|1|||
147348590|NCT03665597|531445741|FG002|Period 3|Adverse Event|0|||
147348591|NCT03665597|531445742|FG003|Period 3|Adverse Event|0|||
147348592|NCT03665597|531445743|FG004|Period 3|Adverse Event|0|||
147348593|NCT03665597|531445744|FG005|Period 3|Adverse Event|0|||
147348594|NCT03665597|531445745|FG006|Period 3|Adverse Event|0|||
147348595|NCT03665597|531445739|FG000|Period 3|Death|0|||
147348596|NCT03665597|531445740|FG001|Period 3|Death|0|||
147348597|NCT03665597|531445741|FG002|Period 3|Death|0|||
147348598|NCT03665597|531445742|FG003|Period 3|Death|0|||
147348599|NCT03665597|531445743|FG004|Period 3|Death|1|||
147348600|NCT03665597|531445744|FG005|Period 3|Death|0|||
147348601|NCT03665597|531445745|FG006|Period 3|Death|0|||
147348602|NCT03665597|531445739|FG000|Period 4|Adverse Event|2|||
147348603|NCT03665597|531445740|FG001|Period 4|Adverse Event|2|||
147348604|NCT03665597|531445741|FG002|Period 4|Adverse Event|2|||
147348605|NCT03665597|531445742|FG003|Period 4|Adverse Event|2|||
147348606|NCT03665597|531445743|FG004|Period 4|Adverse Event|1|||
147348607|NCT03665597|531445744|FG005|Period 4|Adverse Event|0|||
147348608|NCT03665597|531445745|FG006|Period 4|Adverse Event|0|||
147348609|NCT03665597|531445739|FG000|Period 4|Death|0|||
147348610|NCT03665597|531445740|FG001|Period 4|Death|0|||
147348611|NCT03665597|531445741|FG002|Period 4|Death|2|||
147348612|NCT03665597|531445742|FG003|Period 4|Death|0|||
147348613|NCT03665597|531445743|FG004|Period 4|Death|0|||
147348614|NCT03665597|531445744|FG005|Period 4|Death|0|||
147348615|NCT03665597|531445745|FG006|Period 4|Death|0|||
147348616|NCT03665597|531445739|FG000|Period 4|Physician Decision|1|||
147348617|NCT03665597|531445740|FG001|Period 4|Physician Decision|2|||
147348618|NCT03665597|531445741|FG002|Period 4|Physician Decision|0|||
147348619|NCT03665597|531445742|FG003|Period 4|Physician Decision|0|||
147348620|NCT03665597|531445743|FG004|Period 4|Physician Decision|0|||
147348621|NCT03665597|531445744|FG005|Period 4|Physician Decision|0|||
147348622|NCT03665597|531445745|FG006|Period 4|Physician Decision|0|||
147606875|NCT02549027|532377171|FG004|Washout After Period 4|Withdrawal by Subject|0|||
147606876|NCT02549027|532377172|FG005|Washout After Period 4|Withdrawal by Subject|0|||
147348623|NCT04831216|531445746|FG000|Overall Study|Lost to Follow-up|32|||
147348624|NCT05371652|531445749|FG000|Overall Study|Non-Compliance with Study Schedule|9|||
147348625|NCT05371652|531445749|FG000|Overall Study|Withdrawal by Subject|12|||
147348626|NCT05371652|531445749|FG000|Overall Study|Adverse Event|1|||
147348627|NCT05371652|531445749|FG000|Overall Study|Other|11|||
147348628|NCT03978871|531445750|FG000|Overall Study|Lost to Follow-up|11|||
147348629|NCT03978871|531445751|FG001|Overall Study|Lost to Follow-up|12|||
147348630|NCT01361711|531445753|FG000|Trial Entry (Registration)|Patient did not meet Protocol criteria for trial entry|1|||
147348631|NCT01361711|531445753|FG000|Week 9 Bone Marrow Response Assessment|Complete Remission in Week 8|1|||
147348632|NCT01361711|531445753|FG000|Continued Treatment After 9 Weeks|Complete Remission in Week 9|7|||
147348633|NCT01361711|531445753|FG000|Continued Treatment After 12 Weeks|Complete Remission in Week 12|2|||
147348634|NCT01361711|531445753|FG000|Continued Treatment After 12 Weeks|Progressive Disease at Week 11|1|||
147348635|NCT01361711|531445753|FG000|Completed Week 18 of Treatment|Complete Remission|2|||
147348636|NCT01361711|531445753|FG000|Completed Week 18 of Treatment|Other|9|||
147348637|NCT01361711|531445753|FG000|10 Year Follow-up|Still in follow-up|22|||
147348638|NCT01361711|531445753|FG000|10 Year Follow-up|Death|7|||
147348639|NCT01361711|531445753|FG000|10 Year Follow-up|Developed new cancer|1|||
147348640|NCT01361711|531445753|FG000|10 Year Follow-up|Lost to Follow-up|2|||
147348641|NCT01361711|531445753|FG000|10 Year Follow-up|New treatment started|6|||
147606877|NCT02549027|532377167|FG000|Period 5 - MK-6096 or Placebo|Protocol Violation|0|||
147606878|NCT02549027|532377168|FG001|Period 5 - MK-6096 or Placebo|Protocol Violation|0|||
147606879|NCT02549027|532377169|FG002|Period 5 - MK-6096 or Placebo|Protocol Violation|0|||
147606880|NCT02549027|532377170|FG003|Period 5 - MK-6096 or Placebo|Protocol Violation|0|||
147606881|NCT02549027|532377171|FG004|Period 5 - MK-6096 or Placebo|Protocol Violation|2|||
147606882|NCT02549027|532377172|FG005|Period 5 - MK-6096 or Placebo|Protocol Violation|0|||
147606883|NCT02186834|532377173|FG000|Dose Escalation|Death|0|||
147606884|NCT02186834|532377174|FG001|Dose Escalation|Death|0|||
147606885|NCT02186834|532377175|FG002|Dose Escalation|Death|0|||
147606886|NCT02186834|532377176|FG003|Dose Escalation|Death|1|||
147606887|NCT02186834|532377177|FG004|Dose Escalation|Death|0|||
147606888|NCT02186834|532377178|FG005|Dose Escalation|Death|0|||
147606889|NCT02186834|532377173|FG000|Treatment at RP2D|Died prior to treatment|0|||
147606890|NCT02186834|532377174|FG001|Treatment at RP2D|Died prior to treatment|0|||
147606891|NCT02186834|532377175|FG002|Treatment at RP2D|Died prior to treatment|0|||
147606892|NCT02186834|532377176|FG003|Treatment at RP2D|Died prior to treatment|0|||
147348642|NCT01361711|531445753|FG000|10 Year Follow-up|Progressive Disease and New treatment started|11|||
147348643|NCT01361711|531445753|FG000|10 Year Follow-up|Progressive Disease|1|||
147348644|NCT02187003|531447355|FG000|Overall Study|Adverse Event|2|||
147348645|NCT02187003|531447356|FG001|Overall Study|Adverse Event|0|||
147348646|NCT02187003|531447355|FG000|Overall Study|Lost to Follow-up|14|||
147348647|NCT02187003|531447356|FG001|Overall Study|Lost to Follow-up|10|||
147348648|NCT02187003|531447355|FG000|Overall Study|Withdrawal by Subject|3|||
147348649|NCT02187003|531447356|FG001|Overall Study|Withdrawal by Subject|7|||
147348650|NCT02187003|531447355|FG000|Overall Study|Protocol Violation|2|||
147348651|NCT02187003|531447356|FG001|Overall Study|Protocol Violation|4|||
147348652|NCT02187003|531447355|FG000|Overall Study|Other|5|||
147348653|NCT02187003|531447356|FG001|Overall Study|Other|5|||
147348654|NCT02187003|531447355|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
147348655|NCT02187003|531447356|FG001|Overall Study|Withdrawal by Parent/Guardian|5|||
147348656|NCT04833777|531447360|FG000|Overall Study|Lost to Follow-up|1|||
147348657|NCT04833777|531447361|FG001|Overall Study|Lost to Follow-up|0|||
147348658|NCT04083235|531447389|FG000|Overall Study|Death|252|||
147348659|NCT04083235|531447390|FG001|Overall Study|Death|277|||
147348660|NCT04083235|531447389|FG000|Overall Study|Withdrawal by Subject|13|||
147348661|NCT04083235|531447390|FG001|Overall Study|Withdrawal by Subject|17|||
147348662|NCT04083235|531447389|FG000|Overall Study|Lost to Follow-up|1|||
147348663|NCT04083235|531447390|FG001|Overall Study|Lost to Follow-up|1|||
147348664|NCT04083235|531447389|FG000|Overall Study|Does not meet entry criteria|1|||
147348665|NCT04083235|531447390|FG001|Overall Study|Does not meet entry criteria|0|||
147348666|NCT04083235|531447389|FG000|Overall Study|Did not receive treatment|13|||
147348667|NCT04083235|531447390|FG001|Overall Study|Did not receive treatment|8|||
147348668|NCT04083235|531447389|FG000|Overall Study|Ongoing at the time of DCO|44|||
147348669|NCT04083235|531447390|FG001|Overall Study|Ongoing at the time of DCO|7|||
147348670|NCT02724878|531447393|FG000|Overall Study|Still on Active Therapy|15|||
147348671|NCT02724878|531447393|FG000|Overall Study|Disease Progression|31|||
147348672|NCT02724878|531447393|FG000|Overall Study|Toxicity|5|||
147348673|NCT02724878|531447393|FG000|Overall Study|Death|1|||
147348674|NCT02724878|531447393|FG000|Overall Study|Withdrawal by Subject|4|||
147348675|NCT02724878|531447393|FG000|Overall Study|Lost to Follow-up|2|||
147348676|NCT02724878|531447393|FG000|Overall Study|Protocol Violation|1|||
147348677|NCT02724878|531447393|FG000|Overall Study|Ineligible for Study Drug|5|||
147348678|NCT02724878|531447393|FG000|Overall Study|not started|1|||
147348679|NCT03779204|531447394|FG000|Overall Study|Lost to Follow-up|2|||
147348680|NCT03779204|531447395|FG001|Overall Study|Lost to Follow-up|0|||
147348681|NCT04258709|531447396|FG000|Overall Study|Lost to Follow-up|10|||
147348682|NCT04258709|531447397|FG001|Overall Study|Lost to Follow-up|4|||
147348683|NCT04258709|531447396|FG000|Overall Study|Withdrawal by Subject|1|||
147348684|NCT04258709|531447397|FG001|Overall Study|Withdrawal by Subject|0|||
147348685|NCT04258709|531447396|FG000|Overall Study|Fetal demise|0|||
147348686|NCT04258709|531447397|FG001|Overall Study|Fetal demise|1|||
147348687|NCT04258709|531447396|FG000|Overall Study|Protocol Violation|1|||
147348688|NCT04258709|531447397|FG001|Overall Study|Protocol Violation|1|||
147348689|NCT02592330|531447398|FG000|Overall Study|Withdrawal by Subject|1|||
147348690|NCT02592330|531447399|FG001|Overall Study|Withdrawal by Subject|0|||
147606893|NCT02186834|532377177|FG004|Treatment at RP2D|Died prior to treatment|0|||
147606894|NCT02186834|532377178|FG005|Treatment at RP2D|Died prior to treatment|1|||
147348691|NCT02592330|531447398|FG000|Overall Study|Failed Biopsy|1|||
147348692|NCT02592330|531447399|FG001|Overall Study|Failed Biopsy|0|||
147348693|NCT03090152|531447400|FG000|Overall Study|Withdrawal by Subject|0|||
147348694|NCT03090152|531447401|FG001|Overall Study|Withdrawal by Subject|2|||
147348695|NCT03090152|531447402|FG002|Overall Study|Withdrawal by Subject|1|||
147348696|NCT03090152|531447400|FG000|Overall Study|Surgery Canceled|1|||
147348697|NCT03090152|531447401|FG001|Overall Study|Surgery Canceled|0|||
147348698|NCT03090152|531447402|FG002|Overall Study|Surgery Canceled|0|||
147348699|NCT03090152|531447400|FG000|Overall Study|Epidural catheter could not be placed|0|||
147606895|NCT00106964|532377187|FG000|Overall Study|Lost to Follow-up|8|||
147606896|NCT00106964|532377188|FG001|Overall Study|Lost to Follow-up|6|||
147348700|NCT03090152|531447401|FG001|Overall Study|Epidural catheter could not be placed|2|||
147348701|NCT03090152|531447402|FG002|Overall Study|Epidural catheter could not be placed|0|||
147348702|NCT02729311|531447406|FG000|Overall Study|Withdrawal by Subject|8|||
147348703|NCT02729311|531447407|FG001|Overall Study|Withdrawal by Subject|2|||
147348704|NCT05324124|531447408|FG000|Period 1|Withdrawal by Subject|1|||
147348705|NCT05324124|531447409|FG001|Period 1|Withdrawal by Subject|0|||
147348706|NCT05324124|531447408|FG000|Period 1|Physician Decision|0|||
147348707|NCT05324124|531447409|FG001|Period 1|Physician Decision|1|||
147348708|NCT04034251|531447410|FG000|Overall Study|Screen failure due to development of solid organ mets in lung; no longer met eligibility criteria.|1|||
147348709|NCT04034251|531447411|FG001|Overall Study|Screen failure due to development of solid organ mets in lung; no longer met eligibility criteria.|0|||
147348710|NCT04034251|531447412|FG002|Overall Study|Screen failure due to development of solid organ mets in lung; no longer met eligibility criteria.|0|||
147348711|NCT05034952|531447413|FG000|Overall Study|Adverse Event|1|||
147348712|NCT05034952|531447414|FG001|Overall Study|Adverse Event|0|||
147348713|NCT05034952|531447415|FG002|Overall Study|Adverse Event|0|||
147348714|NCT05034952|531447416|FG003|Overall Study|Adverse Event|0|||
147348715|NCT05034952|531447413|FG000|Overall Study|Withdrawal of consent (not due to AE)|0|||
147348716|NCT05034952|531447414|FG001|Overall Study|Withdrawal of consent (not due to AE)|2|||
147348717|NCT05034952|531447415|FG002|Overall Study|Withdrawal of consent (not due to AE)|1|||
147348718|NCT05034952|531447416|FG003|Overall Study|Withdrawal of consent (not due to AE)|0|||
147348719|NCT05034952|531447413|FG000|Overall Study|Lost to Follow-up|1|||
147348720|NCT05034952|531447414|FG001|Overall Study|Lost to Follow-up|4|||
147348721|NCT05034952|531447415|FG002|Overall Study|Lost to Follow-up|3|||
147348722|NCT05034952|531447416|FG003|Overall Study|Lost to Follow-up|3|||
147348723|NCT05034952|531447413|FG000|Overall Study|Other|0|||
147348724|NCT05034952|531447414|FG001|Overall Study|Other|0|||
147348725|NCT05034952|531447415|FG002|Overall Study|Other|0|||
147348726|NCT05034952|531447416|FG003|Overall Study|Other|1|||
147348727|NCT02287610|531447417|FG000|Overall Study|Lost to Follow-up|3|||
147348728|NCT02287610|531447417|FG000|Overall Study|Withdrawal by Subject|8|||
147348729|NCT02287610|531447417|FG000|Overall Study|Excluded-investigator non-responsiveness|5|||
147348730|NCT04950660|531447418|FG000|Overall Study|Protocol Violation|4|||
147348731|NCT04950660|531447419|FG001|Overall Study|Protocol Violation|2|||
147348732|NCT04950660|531447418|FG000|Overall Study|Poor pain control, switch to Oxycodone|1|||
147348733|NCT04950660|531447419|FG001|Overall Study|Poor pain control, switch to Oxycodone|1|||
147348734|NCT04950660|531447418|FG000|Overall Study|Withdrawal by Subject|0|||
147348735|NCT04950660|531447419|FG001|Overall Study|Withdrawal by Subject|1|||
147348736|NCT04950660|531447418|FG000|Overall Study|Hypotension|1|||
147348737|NCT04950660|531447419|FG001|Overall Study|Hypotension|0|||
147348738|NCT04783935|531447438|FG000|Overall Study|Withdrawal by Subject|6|||
147348739|NCT04783935|531447438|FG000|Overall Study|PROGRESSIVE DISEASE|2|||
147348740|NCT04783935|531447438|FG000|Overall Study|PATIENT HAS MOVED AND GOES TO ANOTHER HOSPITAL|1|||
147348741|NCT04783935|531447438|FG000|Overall Study|Lost to Follow-up|3|||
147348742|NCT04783935|531447438|FG000|Overall Study|PROTOCOL NON-COMPLIANCE|1|||
147348743|NCT02437318|531447440|FG000|Overall Study|Progressive disease|207|||
147348744|NCT02437318|531447441|FG001|Overall Study|Progressive disease|240|||
147348745|NCT02437318|531447440|FG000|Overall Study|Subject/guardian decision|24|||
147348746|NCT02437318|531447441|FG001|Overall Study|Subject/guardian decision|11|||
147348747|NCT02437318|531447440|FG000|Overall Study|Physician Decision|29|||
147348748|NCT02437318|531447441|FG001|Overall Study|Physician Decision|22|||
147348749|NCT02437318|531447440|FG000|Overall Study|Adverse Event|14|||
147348750|NCT02437318|531447441|FG001|Overall Study|Adverse Event|4|||
147348751|NCT02437318|531447440|FG000|Overall Study|Death|4|||
147348752|NCT02437318|531447441|FG001|Overall Study|Death|4|||
147348753|NCT02437318|531447440|FG000|Overall Study|Protocol deviation|5|||
147348754|NCT02437318|531447441|FG001|Overall Study|Protocol deviation|7|||
147348755|NCT02437318|531447440|FG000|Overall Study|Sponsor decision|1|||
147348756|NCT02437318|531447441|FG001|Overall Study|Sponsor decision|0|||
147348757|NCT00920621|531447447|FG000|Overall Study|Lost to Follow-up|16|||
147348758|NCT00920621|531447448|FG001|Overall Study|Lost to Follow-up|17|||
147348759|NCT00920621|531447449|FG002|Overall Study|Lost to Follow-up|19|||
147348760|NCT00920621|531447450|FG003|Overall Study|Lost to Follow-up|21|||
147348761|NCT00920621|531447447|FG000|Overall Study|Fetal/neonatal deaths|16|||
147348762|NCT00920621|531447448|FG001|Overall Study|Fetal/neonatal deaths|14|||
147348763|NCT00920621|531447449|FG002|Overall Study|Fetal/neonatal deaths|16|||
147348764|NCT00920621|531447450|FG003|Overall Study|Fetal/neonatal deaths|14|||
147348765|NCT00920621|531447447|FG000|Overall Study|Blood sample not collected|22|||
147348766|NCT00920621|531447448|FG001|Overall Study|Blood sample not collected|14|||
147348767|NCT00920621|531447449|FG002|Overall Study|Blood sample not collected|0|||
147348768|NCT00920621|531447450|FG003|Overall Study|Blood sample not collected|0|||
147348769|NCT06074523|531447451|FG000|Overall Study|missing data in one condition, participant failed to fill out all data forms|9|||
147348770|NCT06074523|531447451|FG000|Overall Study|Withdrawal by Subject|1|||
147348771|NCT01426425|531447452|FG000|Overall Study|Exited prior to EP study|22|||
147348772|NCT01426425|531447452|FG000|Overall Study|Inclusion/exclusion criteria not met|151|||
147348773|NCT01426425|531447452|FG000|Overall Study|Met inclusion/exclusion, not treated|2|||
147348774|NCT03281291|531447453|FG000|Overall Study|Serious Adverse Event And/Or pIMD|2|||
147348775|NCT03281291|531447454|FG001|Overall Study|Serious Adverse Event And/Or pIMD|1|||
147348776|NCT03281291|531447455|FG002|Overall Study|Serious Adverse Event And/Or pIMD|0|||
147348777|NCT03281291|531447456|FG003|Overall Study|Serious Adverse Event And/Or pIMD|4|||
147348778|NCT03281291|531447457|FG004|Overall Study|Serious Adverse Event And/Or pIMD|1|||
147348779|NCT03281291|531447453|FG000|Overall Study|Protocol Deviation|2|||
147348780|NCT03281291|531447454|FG001|Overall Study|Protocol Deviation|0|||
147348781|NCT03281291|531447455|FG002|Overall Study|Protocol Deviation|1|||
147348782|NCT03281291|531447456|FG003|Overall Study|Protocol Deviation|2|||
147348783|NCT03281291|531447457|FG004|Overall Study|Protocol Deviation|1|||
147348784|NCT03281291|531447453|FG000|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|29|||
147348785|NCT03281291|531447454|FG001|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|21|||
147348786|NCT03281291|531447455|FG002|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|13|||
147348787|NCT03281291|531447456|FG003|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|21|||
147348788|NCT03281291|531447457|FG004|Overall Study|Consent Withdrawal, Not Due To An Adverse Event/A Serious Adverse Event|16|||
147348789|NCT03281291|531447453|FG000|Overall Study|Migrated / Moved From The Study Area|26|||
147348790|NCT03281291|531447454|FG001|Overall Study|Migrated / Moved From The Study Area|28|||
147348791|NCT03281291|531447455|FG002|Overall Study|Migrated / Moved From The Study Area|44|||
147348792|NCT03281291|531447456|FG003|Overall Study|Migrated / Moved From The Study Area|29|||
147348793|NCT03281291|531447457|FG004|Overall Study|Migrated / Moved From The Study Area|27|||
147348794|NCT03281291|531447453|FG000|Overall Study|Lost to Follow-up|10|||
147348795|NCT03281291|531447454|FG001|Overall Study|Lost to Follow-up|10|||
147348796|NCT03281291|531447455|FG002|Overall Study|Lost to Follow-up|4|||
147348797|NCT03281291|531447456|FG003|Overall Study|Lost to Follow-up|6|||
147348798|NCT03281291|531447457|FG004|Overall Study|Lost to Follow-up|10|||
147348799|NCT03281291|531447453|FG000|Overall Study|Other|0|||
147348800|NCT03281291|531447454|FG001|Overall Study|Other|2|||
147348801|NCT03281291|531447455|FG002|Overall Study|Other|0|||
147348802|NCT03281291|531447456|FG003|Overall Study|Other|2|||
147348803|NCT03281291|531447457|FG004|Overall Study|Other|1|||
147348804|NCT04956861|531447458|FG000|Overall Study|Withdrawal by Subject|4|||
147348805|NCT04956861|531447459|FG001|Overall Study|Withdrawal by Subject|4|||
147348806|NCT04956861|531447460|FG002|Overall Study|Withdrawal by Subject|2|||
147348807|NCT04956861|531447458|FG000|Overall Study|Physician Decision|4|||
147348808|NCT04956861|531447459|FG001|Overall Study|Physician Decision|5|||
147348809|NCT04956861|531447460|FG002|Overall Study|Physician Decision|1|||
147348810|NCT04237298|531447464|FG000|Overall Study|Lost to Follow-up|4|||
147348811|NCT04237298|531447465|FG001|Overall Study|Lost to Follow-up|5|||
147348812|NCT02530671|531447466|FG000|Overall Study|Lost to Follow-up|2|||
147348813|NCT02530671|531447467|FG001|Overall Study|Lost to Follow-up|0|||
147348814|NCT02530671|531447466|FG000|Overall Study|Withdrawal by Subject|1|||
147348815|NCT02530671|531447467|FG001|Overall Study|Withdrawal by Subject|0|||
147348816|NCT03126019|531447469|FG000|Overall Study|Death|5|||
147348817|NCT03126019|531447470|FG001|Overall Study|Death|27|||
147348818|NCT03126019|531447469|FG000|Overall Study|Lost to Follow-up|2|||
147348819|NCT03126019|531447470|FG001|Overall Study|Lost to Follow-up|4|||
147348820|NCT03126019|531447469|FG000|Overall Study|Withdrawal by Subject|1|||
147348821|NCT03126019|531447470|FG001|Overall Study|Withdrawal by Subject|9|||
147348822|NCT03126019|531447469|FG000|Overall Study|Physician Decision|1|||
147348823|NCT03126019|531447470|FG001|Overall Study|Physician Decision|0|||
147348824|NCT03126019|531447469|FG000|Overall Study|Transitioned to Rollover Study|0|||
147348825|NCT03126019|531447470|FG001|Overall Study|Transitioned to Rollover Study|11|||
147348826|NCT03126019|531447469|FG000|Overall Study|Did Not Return to Site for Care|0|||
147348827|NCT03126019|531447470|FG001|Overall Study|Did Not Return to Site for Care|1|||
147348828|NCT03126019|531447469|FG000|Overall Study|Site Closed|0|||
147348829|NCT03126019|531447470|FG001|Overall Study|Site Closed|1|||
147348830|NCT00170573|531447472|FG000|Overall Study|Violation of inclusion criteria|13|||
147348831|NCT04556656|531447473|FG000|Overall Study|Withdrawal by Subject|14|||
147348832|NCT04556656|531447474|FG001|Overall Study|Withdrawal by Subject|12|||
147348833|NCT04556656|531447473|FG000|Overall Study|Physician Decision|1|||
147348834|NCT04556656|531447474|FG001|Overall Study|Physician Decision|0|||
147348835|NCT04556656|531447473|FG000|Overall Study|Adverse Event|4|||
147348836|NCT04556656|531447474|FG001|Overall Study|Adverse Event|7|||
147348837|NCT04556656|531447473|FG000|Overall Study|Death|4|||
147348838|NCT04556656|531447474|FG001|Overall Study|Death|0|||
147348839|NCT04556656|531447473|FG000|Overall Study|Lost to Follow-up|3|||
147348840|NCT04556656|531447474|FG001|Overall Study|Lost to Follow-up|2|||
147348841|NCT04556656|531447473|FG000|Overall Study|Not further specified|2|||
147348842|NCT04556656|531447474|FG001|Overall Study|Not further specified|1|||
147348843|NCT04541706|531447475|FG000|Overall Study|Withdrawal by Subject|3|||
147348844|NCT04541706|531447475|FG000|Overall Study|Progressive disease|33|||
147348845|NCT04541706|531447475|FG000|Overall Study|Physician Decision|1|||
147348846|NCT04541706|531447475|FG000|Overall Study|Lost to Follow-up|2|||
147348847|NCT04541706|531447475|FG000|Overall Study|Death|5|||
147348848|NCT04541706|531447475|FG000|Overall Study|Adverse Event|1|||
147348849|NCT05563246|531447486|FG000|Overall Study|Withdrawal by Subject|1|||
147348850|NCT05563246|531447487|FG001|Overall Study|Withdrawal by Subject|2|||
147348851|NCT05563246|531447488|FG002|Overall Study|Withdrawal by Subject|0|||
147348852|NCT05563246|531447489|FG003|Overall Study|Withdrawal by Subject|0|||
147348853|NCT05563246|531447486|FG000|Overall Study|Protocol Deviation|0|||
147348854|NCT05563246|531447487|FG001|Overall Study|Protocol Deviation|1|||
147348855|NCT05563246|531447488|FG002|Overall Study|Protocol Deviation|0|||
147348856|NCT05563246|531447489|FG003|Overall Study|Protocol Deviation|0|||
147348857|NCT05563246|531447486|FG000|Overall Study|Physician Decision|0|||
147348858|NCT05563246|531447487|FG001|Overall Study|Physician Decision|1|||
147348859|NCT05563246|531447488|FG002|Overall Study|Physician Decision|0|||
147348860|NCT05563246|531447489|FG003|Overall Study|Physician Decision|0|||
147348861|NCT05563246|531447486|FG000|Overall Study|Adverse Event|0|||
147348862|NCT05563246|531447487|FG001|Overall Study|Adverse Event|0|||
147348863|NCT05563246|531447488|FG002|Overall Study|Adverse Event|2|||
147348864|NCT05563246|531447489|FG003|Overall Study|Adverse Event|0|||
147348865|NCT05563246|531447486|FG000|Overall Study|Lost to Follow-up|0|||
147348866|NCT05563246|531447487|FG001|Overall Study|Lost to Follow-up|0|||
147348867|NCT05563246|531447488|FG002|Overall Study|Lost to Follow-up|1|||
147348868|NCT05563246|531447489|FG003|Overall Study|Lost to Follow-up|0|||
147348869|NCT01566695|531447490|FG000|Overall Study|Lack of Efficacy|1|||
147348870|NCT01566695|531447491|FG001|Overall Study|Lack of Efficacy|0|||
147348871|NCT01566695|531447490|FG000|Overall Study|Adverse Event|3|||
147348872|NCT01566695|531447491|FG001|Overall Study|Adverse Event|0|||
147348873|NCT01566695|531447490|FG000|Overall Study|Death|79|||
147348874|NCT01566695|531447491|FG001|Overall Study|Death|86|||
147348875|NCT01566695|531447490|FG000|Overall Study|Withdrawal by Subject|13|||
147348876|NCT01566695|531447491|FG001|Overall Study|Withdrawal by Subject|12|||
147348877|NCT01566695|531447490|FG000|Overall Study|Lost to Follow-up|0|||
147348878|NCT01566695|531447491|FG001|Overall Study|Lost to Follow-up|3|||
147348879|NCT01566695|531447490|FG000|Overall Study|Other reasons|11|||
147348880|NCT01566695|531447491|FG001|Overall Study|Other reasons|8|||
147348881|NCT03763708|531447492|FG000|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|4|||
147348882|NCT03763708|531447493|FG001|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
147348883|NCT03763708|531447494|FG002|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
147348884|NCT03763708|531447495|FG003|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
147348885|NCT03763708|531447496|FG004|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
147348886|NCT03763708|531447497|FG005|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
147348887|NCT03763708|531447498|FG006|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
147348888|NCT03763708|531447499|FG007|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
147348889|NCT03763708|531447500|FG008|Cohort 1: Low Energy -Continuous|Withdrawal by Subject|0|||
147348890|NCT03763708|531447492|FG000|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
147348891|NCT03763708|531447493|FG001|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
147348892|NCT03763708|531447494|FG002|Cohort 3: Cycling Evolve|Withdrawal by Subject|1|||
147348893|NCT03763708|531447495|FG003|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
147348894|NCT03763708|531447496|FG004|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
147348895|NCT03763708|531447497|FG005|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
147348896|NCT03763708|531447498|FG006|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
147348897|NCT03763708|531447499|FG007|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
147348898|NCT03763708|531447500|FG008|Cohort 3: Cycling Evolve|Withdrawal by Subject|0|||
147348899|NCT03763708|531447492|FG000|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
147348900|NCT03763708|531447493|FG001|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
147348901|NCT03763708|531447494|FG002|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
147348902|NCT03763708|531447495|FG003|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|2|||
147348903|NCT03763708|531447496|FG004|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
147348904|NCT03763708|531447497|FG005|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
147348905|NCT03763708|531447498|FG006|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
147348906|NCT03763708|531447499|FG007|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
147348907|NCT03763708|531447500|FG008|Cohort 4: Low Energy Cycling 1|Withdrawal by Subject|0|||
147348908|NCT03763708|531447492|FG000|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
147348909|NCT03763708|531447493|FG001|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
147348910|NCT03763708|531447494|FG002|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
147348911|NCT03763708|531447495|FG003|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
147348912|NCT03763708|531447496|FG004|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|2|||
147348913|NCT03763708|531447497|FG005|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
147348914|NCT03763708|531447498|FG006|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
147348915|NCT03763708|531447499|FG007|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
147348916|NCT03763708|531447500|FG008|Cohort 5: Low Energy Cycling 2|Withdrawal by Subject|0|||
147348917|NCT03763708|531447492|FG000|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
147348918|NCT03763708|531447493|FG001|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
147348919|NCT03763708|531447494|FG002|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
147348920|NCT03763708|531447495|FG003|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
147348921|NCT03763708|531447496|FG004|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
147348922|NCT03763708|531447497|FG005|Cohort 6: DTM-LE SCS|Withdrawal by Subject|2|||
147348923|NCT03763708|531447498|FG006|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
147348924|NCT03763708|531447499|FG007|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
147348925|NCT03763708|531447500|FG008|Cohort 6: DTM-LE SCS|Withdrawal by Subject|0|||
147348926|NCT03763708|531447492|FG000|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
147348927|NCT03763708|531447493|FG001|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
147348928|NCT03763708|531447494|FG002|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
147348929|NCT03763708|531447495|FG003|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
147348930|NCT03763708|531447496|FG004|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
147348931|NCT03763708|531447497|FG005|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
147348932|NCT03763708|531447498|FG006|Cohort 7: Super Cycle|Withdrawal by Subject|9|||
147348933|NCT03763708|531447499|FG007|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
147348934|NCT03763708|531447500|FG008|Cohort 7: Super Cycle|Withdrawal by Subject|0|||
147348935|NCT03763708|531447492|FG000|Cohort 7: Super Cycle|Adverse Event|0|||
147348936|NCT03763708|531447493|FG001|Cohort 7: Super Cycle|Adverse Event|0|||
147348937|NCT03763708|531447494|FG002|Cohort 7: Super Cycle|Adverse Event|0|||
147348938|NCT03763708|531447495|FG003|Cohort 7: Super Cycle|Adverse Event|0|||
147348939|NCT03763708|531447496|FG004|Cohort 7: Super Cycle|Adverse Event|0|||
147348940|NCT03763708|531447497|FG005|Cohort 7: Super Cycle|Adverse Event|0|||
147348941|NCT03763708|531447498|FG006|Cohort 7: Super Cycle|Adverse Event|1|||
147348942|NCT03763708|531447499|FG007|Cohort 7: Super Cycle|Adverse Event|0|||
147348943|NCT03763708|531447500|FG008|Cohort 7: Super Cycle|Adverse Event|0|||
147348944|NCT03763708|531447492|FG000|Cohort 7: Super Cycle|Screen Failure|0|||
147348945|NCT03763708|531447493|FG001|Cohort 7: Super Cycle|Screen Failure|0|||
147348946|NCT03763708|531447494|FG002|Cohort 7: Super Cycle|Screen Failure|0|||
147348947|NCT03763708|531447495|FG003|Cohort 7: Super Cycle|Screen Failure|0|||
147348948|NCT03763708|531447496|FG004|Cohort 7: Super Cycle|Screen Failure|0|||
147348949|NCT03763708|531447497|FG005|Cohort 7: Super Cycle|Screen Failure|0|||
147348950|NCT03763708|531447498|FG006|Cohort 7: Super Cycle|Screen Failure|1|||
147348951|NCT03763708|531447499|FG007|Cohort 7: Super Cycle|Screen Failure|0|||
147348952|NCT03763708|531447500|FG008|Cohort 7: Super Cycle|Screen Failure|0|||
147348953|NCT03763708|531447492|FG000|Cohort 9: DPN Flow|Screen Failure|0|||
147348954|NCT03763708|531447493|FG001|Cohort 9: DPN Flow|Screen Failure|0|||
147348955|NCT03763708|531447494|FG002|Cohort 9: DPN Flow|Screen Failure|0|||
147348956|NCT03763708|531447495|FG003|Cohort 9: DPN Flow|Screen Failure|0|||
147348957|NCT03763708|531447496|FG004|Cohort 9: DPN Flow|Screen Failure|0|||
147348958|NCT03763708|531447497|FG005|Cohort 9: DPN Flow|Screen Failure|0|||
147348959|NCT03763708|531447498|FG006|Cohort 9: DPN Flow|Screen Failure|0|||
147348960|NCT03763708|531447499|FG007|Cohort 9: DPN Flow|Screen Failure|0|||
147348961|NCT03763708|531447500|FG008|Cohort 9: DPN Flow|Screen Failure|1|||
147348962|NCT04294225|531447505|FG000|Anastrozole 1 mg/Day|Discontinued due to COVID|1|||
147348963|NCT04294225|531447505|FG000|Anastrozole 1 mg/Day|Discontinued due to adverse events|3|||
147348964|NCT04294225|531447505|FG000|Anastrozole 1 mg/Day|Withdrawal by Subject|5|||
147348965|NCT04294225|531447505|FG000|Anastrozole 1 mg/Day|Ineligible|2|||
147348966|NCT04294225|531447505|FG000|Anastrozole 10 mg/Day|Withdrawal by Subject|1|||
147348967|NCT01331005|531449221|FG000|Overall Study|Lost to Follow-up|2|||
147348968|NCT01331005|531449222|FG001|Overall Study|Lost to Follow-up|1|||
147348969|NCT01331005|531449221|FG000|Overall Study|Withdrawal by Subject|2|||
147348970|NCT01331005|531449222|FG001|Overall Study|Withdrawal by Subject|3|||
147348971|NCT03016169|531449223|FG000|Overall Study|Lost to Follow-up|4|||
147348972|NCT03016169|531449223|FG000|Overall Study|Death|54|||
147348973|NCT03016169|531449223|FG000|Overall Study|Device Explant|11|||
147348974|NCT03016169|531449223|FG000|Overall Study|Withdrawal by Subject|19|||
147348975|NCT03016169|531449223|FG000|Overall Study|Other Reasons|1|||
147348976|NCT03131648|531449225|FG000|Initial Treatment Period|Not dosed|2|||
147348977|NCT03131648|531449226|FG001|Initial Treatment Period|Not dosed|2|||
147348978|NCT03131648|531449227|FG002|Initial Treatment Period|Not dosed|0|||
147348979|NCT03131648|531449228|FG003|Initial Treatment Period|Not dosed|0|||
147348980|NCT03131648|531449229|FG004|Initial Treatment Period|Not dosed|0|||
147348981|NCT03131648|531449230|FG005|Initial Treatment Period|Not dosed|0|||
147348982|NCT03131648|531449231|FG006|Initial Treatment Period|Not dosed|0|||
147662734|NCT02227784|532587412|FG000|Open-Label Extension Phase (OLE)|Adverse Event|0|||
147662735|NCT02227784|532587413|FG001|Open-Label Extension Phase (OLE)|Adverse Event|0|||
147662736|NCT02227784|532587414|FG002|Open-Label Extension Phase (OLE)|Adverse Event|0|||
147662737|NCT02227784|532587415|FG003|Open-Label Extension Phase (OLE)|Adverse Event|0|||
147348983|NCT03131648|531449232|FG007|Initial Treatment Period|Not dosed|0|||
147348984|NCT03131648|531449225|FG000|Initial Treatment Period|Discontinued IMP before Week 16|51|||
147348985|NCT03131648|531449226|FG001|Initial Treatment Period|Discontinued IMP before Week 16|18|||
147348986|NCT03131648|531449227|FG002|Initial Treatment Period|Discontinued IMP before Week 16|0|||
147348987|NCT03131648|531449228|FG003|Initial Treatment Period|Discontinued IMP before Week 16|0|||
147348988|NCT03131648|531449229|FG004|Initial Treatment Period|Discontinued IMP before Week 16|0|||
147348989|NCT03131648|531449230|FG005|Initial Treatment Period|Discontinued IMP before Week 16|0|||
147348990|NCT03131648|531449231|FG006|Initial Treatment Period|Discontinued IMP before Week 16|0|||
147662738|NCT02227784|532587416|FG004|Open-Label Extension Phase (OLE)|Adverse Event|1|||
147348991|NCT03131648|531449232|FG007|Initial Treatment Period|Discontinued IMP before Week 16|0|||
147348992|NCT03131648|531449225|FG000|Open-label Treatment|Discontinued IMP|0|||
147348993|NCT03131648|531449226|FG001|Open-label Treatment|Discontinued IMP|0|||
147348994|NCT03131648|531449227|FG002|Open-label Treatment|Discontinued IMP|0|||
147348995|NCT03131648|531449228|FG003|Open-label Treatment|Discontinued IMP|0|||
147348996|NCT03131648|531449229|FG004|Open-label Treatment|Discontinued IMP|0|||
147348997|NCT03131648|531449230|FG005|Open-label Treatment|Discontinued IMP|0|||
147348998|NCT03131648|531449231|FG006|Open-label Treatment|Discontinued IMP|112|||
147348999|NCT03131648|531449232|FG007|Open-label Treatment|Discontinued IMP|0|||
147349000|NCT03131648|531449225|FG000|Open-label Treatment|Completed Week 50|0|||
147349001|NCT03131648|531449226|FG001|Open-label Treatment|Completed Week 50|0|||
147349002|NCT03131648|531449227|FG002|Open-label Treatment|Completed Week 50|0|||
147349003|NCT03131648|531449228|FG003|Open-label Treatment|Completed Week 50|0|||
147349004|NCT03131648|531449229|FG004|Open-label Treatment|Completed Week 50|0|||
147349005|NCT03131648|531449230|FG005|Open-label Treatment|Completed Week 50|0|||
147349006|NCT03131648|531449231|FG006|Open-label Treatment|Completed Week 50|6|||
147349007|NCT03131648|531449232|FG007|Open-label Treatment|Completed Week 50|0|||
147349008|NCT03131648|531449225|FG000|Maintenance Treatment Period|Not dosed|0|||
147349009|NCT03131648|531449226|FG001|Maintenance Treatment Period|Not dosed|0|||
147349010|NCT03131648|531449227|FG002|Maintenance Treatment Period|Not dosed|3|||
147349011|NCT03131648|531449228|FG003|Maintenance Treatment Period|Not dosed|2|||
147349012|NCT03131648|531449229|FG004|Maintenance Treatment Period|Not dosed|1|||
147349013|NCT03131648|531449230|FG005|Maintenance Treatment Period|Not dosed|0|||
147349014|NCT03131648|531449231|FG006|Maintenance Treatment Period|Not dosed|0|||
147349015|NCT03131648|531449232|FG007|Maintenance Treatment Period|Not dosed|0|||
147349016|NCT03131648|531449225|FG000|Maintenance Treatment Period|Discontinued IMP|0|||
147349017|NCT03131648|531449226|FG001|Maintenance Treatment Period|Discontinued IMP|0|||
147349018|NCT03131648|531449227|FG002|Maintenance Treatment Period|Discontinued IMP|3|||
147349019|NCT03131648|531449228|FG003|Maintenance Treatment Period|Discontinued IMP|5|||
147349020|NCT03131648|531449229|FG004|Maintenance Treatment Period|Discontinued IMP|4|||
147349021|NCT03131648|531449230|FG005|Maintenance Treatment Period|Discontinued IMP|4|||
147349022|NCT03131648|531449231|FG006|Maintenance Treatment Period|Discontinued IMP|0|||
147349023|NCT03131648|531449232|FG007|Maintenance Treatment Period|Discontinued IMP|0|||
147349024|NCT03131648|531449225|FG000|Maintenance Treatment Period|Transfer to open-label treatment|0|||
147349025|NCT03131648|531449226|FG001|Maintenance Treatment Period|Transfer to open-label treatment|0|||
147349026|NCT03131648|531449227|FG002|Maintenance Treatment Period|Transfer to open-label treatment|21|||
147349027|NCT03131648|531449228|FG003|Maintenance Treatment Period|Transfer to open-label treatment|18|||
147349028|NCT03131648|531449229|FG004|Maintenance Treatment Period|Transfer to open-label treatment|9|||
147349029|NCT03131648|531449230|FG005|Maintenance Treatment Period|Transfer to open-label treatment|10|||
147349030|NCT03131648|531449231|FG006|Maintenance Treatment Period|Transfer to open-label treatment|0|||
147349031|NCT03131648|531449232|FG007|Maintenance Treatment Period|Transfer to open-label treatment|0|||
147349032|NCT03131648|531449225|FG000|Maintenance Treatment Period|Completed Week 50|0|||
147349033|NCT03131648|531449226|FG001|Maintenance Treatment Period|Completed Week 50|0|||
147349034|NCT03131648|531449227|FG002|Maintenance Treatment Period|Completed Week 50|0|||
147349035|NCT03131648|531449228|FG003|Maintenance Treatment Period|Completed Week 50|0|||
147349036|NCT03131648|531449229|FG004|Maintenance Treatment Period|Completed Week 50|1|||
147349037|NCT03131648|531449230|FG005|Maintenance Treatment Period|Completed Week 50|0|||
147349038|NCT03131648|531449231|FG006|Maintenance Treatment Period|Completed Week 50|0|||
147349039|NCT03131648|531449232|FG007|Maintenance Treatment Period|Completed Week 50|0|||
147349040|NCT03131648|531449225|FG000|Open-label (Short Term Extension)|Discontinued IMP|0|||
147349041|NCT03131648|531449226|FG001|Open-label (Short Term Extension)|Discontinued IMP|0|||
147349042|NCT03131648|531449227|FG002|Open-label (Short Term Extension)|Discontinued IMP|0|||
147349043|NCT03131648|531449228|FG003|Open-label (Short Term Extension)|Discontinued IMP|0|||
147606897|NCT00106964|532377189|FG002|Overall Study|Lost to Follow-up|2|||
147606898|NCT00106964|532377187|FG000|Overall Study|Pregnancy|2|||
147606899|NCT00106964|532377188|FG001|Overall Study|Pregnancy|3|||
147606900|NCT00106964|532377189|FG002|Overall Study|Pregnancy|2|||
147606901|NCT00106964|532377187|FG000|Overall Study|Death|1|||
147606902|NCT00106964|532377188|FG001|Overall Study|Death|1|||
147606903|NCT00106964|532377189|FG002|Overall Study|Death|0|||
147606904|NCT00106964|532377187|FG000|Overall Study|Incarceration|0|||
147606905|NCT00106964|532377188|FG001|Overall Study|Incarceration|1|||
147606906|NCT00106964|532377189|FG002|Overall Study|Incarceration|0|||
147606907|NCT00106964|532377187|FG000|Overall Study|Site Funding Terminated|0|||
147349044|NCT03131648|531449229|FG004|Open-label (Short Term Extension)|Discontinued IMP|0|||
147349045|NCT03131648|531449230|FG005|Open-label (Short Term Extension)|Discontinued IMP|0|||
147349046|NCT03131648|531449231|FG006|Open-label (Short Term Extension)|Discontinued IMP|0|||
147349047|NCT03131648|531449232|FG007|Open-label (Short Term Extension)|Discontinued IMP|3|||
147606908|NCT00106964|532377188|FG001|Overall Study|Site Funding Terminated|1|||
147606909|NCT00106964|532377189|FG002|Overall Study|Site Funding Terminated|1|||
147606910|NCT00106964|532377187|FG000|Overall Study|Failure to adhere|2|||
147606911|NCT00106964|532377188|FG001|Overall Study|Failure to adhere|0|||
147349048|NCT04150718|531449240|FG000|Overall Study|Withdrawal by Subject|2|||
147349049|NCT04150718|531449241|FG001|Overall Study|Withdrawal by Subject|7|||
147349050|NCT04150718|531449242|FG002|Overall Study|Withdrawal by Subject|1|||
147349051|NCT04150718|531449240|FG000|Overall Study|Lost to Follow-up|1|||
147349052|NCT04150718|531449241|FG001|Overall Study|Lost to Follow-up|2|||
147349053|NCT04150718|531449242|FG002|Overall Study|Lost to Follow-up|0|||
147349054|NCT04150718|531449240|FG000|Overall Study|Ineligible|1|||
147349055|NCT04150718|531449241|FG001|Overall Study|Ineligible|0|||
147349056|NCT04150718|531449242|FG002|Overall Study|Ineligible|10|||
147349057|NCT01416831|531449260|FG000|Cycles 1 & 2 (Weeks 1-14)|Death|1|||
147349058|NCT01416831|531449261|FG001|Cycles 1 & 2 (Weeks 1-14)|Death|2|||
147349059|NCT04784559|531449264|FG000|Overall Study|Withdrawal by Subject|3|||
147349060|NCT04784559|531449265|FG001|Overall Study|Withdrawal by Subject|2|||
147349061|NCT04784559|531449266|FG002|Overall Study|Withdrawal by Subject|1|||
147349062|NCT04784559|531449264|FG000|Overall Study|Death|2|||
147349063|NCT04784559|531449265|FG001|Overall Study|Death|1|||
147349064|NCT04784559|531449266|FG002|Overall Study|Death|2|||
147349065|NCT04784559|531449264|FG000|Overall Study|Lost to Follow-up|0|||
147349066|NCT04784559|531449265|FG001|Overall Study|Lost to Follow-up|0|||
147349067|NCT04784559|531449266|FG002|Overall Study|Lost to Follow-up|2|||
147349068|NCT04784559|531449264|FG000|Overall Study|Participant worsened, PI decision|1|||
147349069|NCT04784559|531449265|FG001|Overall Study|Participant worsened, PI decision|0|||
147349070|NCT04784559|531449266|FG002|Overall Study|Participant worsened, PI decision|0|||
147349071|NCT04784559|531449264|FG000|Overall Study|Participant deterioration becoming a candidate for treatment with TZB|1|||
147349072|NCT04784559|531449265|FG001|Overall Study|Participant deterioration becoming a candidate for treatment with TZB|0|||
147349073|NCT04784559|531449266|FG002|Overall Study|Participant deterioration becoming a candidate for treatment with TZB|0|||
147349074|NCT04784559|531449264|FG000|Overall Study|Participant admitted in other hospital due to a serious adverse event|1|||
147349075|NCT04784559|531449265|FG001|Overall Study|Participant admitted in other hospital due to a serious adverse event|0|||
147349076|NCT04784559|531449266|FG002|Overall Study|Participant admitted in other hospital due to a serious adverse event|0|||
147349077|NCT04784559|531449264|FG000|Overall Study|Did not meet all inclusion criteria|0|||
147349078|NCT04784559|531449265|FG001|Overall Study|Did not meet all inclusion criteria|1|||
147349079|NCT04784559|531449266|FG002|Overall Study|Did not meet all inclusion criteria|0|||
147349080|NCT04784559|531449264|FG000|Overall Study|The participant was transferred to IRCU|0|||
147349081|NCT04784559|531449265|FG001|Overall Study|The participant was transferred to IRCU|1|||
147349082|NCT04784559|531449266|FG002|Overall Study|The participant was transferred to IRCU|0|||
147349083|NCT04784559|531449264|FG000|Overall Study|SAE|0|||
147349084|NCT04784559|531449265|FG001|Overall Study|SAE|1|||
147349085|NCT04784559|531449266|FG002|Overall Study|SAE|0|||
147349086|NCT04784559|531449264|FG000|Overall Study|Discontinued as was found to be ineligible|0|||
147349087|NCT04784559|531449265|FG001|Overall Study|Discontinued as was found to be ineligible|0|||
147349088|NCT04784559|531449266|FG002|Overall Study|Discontinued as was found to be ineligible|1|||
147349089|NCT03138512|531449268|FG000|Randomization|Participants withdrew consent|0|||
147349090|NCT03138512|531449269|FG001|Randomization|Participants withdrew consent|1|||
147349091|NCT03138512|531449270|FG002|Randomization|Participants withdrew consent|1|||
147349092|NCT03138512|531449271|FG003|Randomization|Participants withdrew consent|0|||
147349093|NCT03138512|531449272|FG004|Randomization|Participants withdrew consent|0|||
147349094|NCT03138512|531449268|FG000|Randomization|Participant no longer meets study criteria|0|||
147349095|NCT03138512|531449269|FG001|Randomization|Participant no longer meets study criteria|3|||
147349096|NCT03138512|531449270|FG002|Randomization|Participant no longer meets study criteria|1|||
147349097|NCT03138512|531449271|FG003|Randomization|Participant no longer meets study criteria|1|||
147349098|NCT03138512|531449272|FG004|Randomization|Participant no longer meets study criteria|3|||
147349099|NCT03138512|531449268|FG000|Randomization|Other reasons|1|||
147349100|NCT03138512|531449269|FG001|Randomization|Other reasons|0|||
147349101|NCT03138512|531449270|FG002|Randomization|Other reasons|0|||
147349102|NCT03138512|531449271|FG003|Randomization|Other reasons|0|||
147349103|NCT03138512|531449272|FG004|Randomization|Other reasons|0|||
147349104|NCT03138512|531449268|FG000|Treatment Part A|Disease recurrence|10|||
147349105|NCT03138512|531449269|FG001|Treatment Part A|Disease recurrence|20|||
147349106|NCT03138512|531449270|FG002|Treatment Part A|Disease recurrence|0|||
147349107|NCT03138512|531449271|FG003|Treatment Part A|Disease recurrence|0|||
147349108|NCT03138512|531449272|FG004|Treatment Part A|Disease recurrence|0|||
147349109|NCT03138512|531449268|FG000|Treatment Part A|Study Drug Toxicity|132|||
147349110|NCT03138512|531449269|FG001|Treatment Part A|Study Drug Toxicity|5|||
147349111|NCT03138512|531449270|FG002|Treatment Part A|Study Drug Toxicity|0|||
147349112|NCT03138512|531449271|FG003|Treatment Part A|Study Drug Toxicity|0|||
147349113|NCT03138512|531449272|FG004|Treatment Part A|Study Drug Toxicity|0|||
147349114|NCT03138512|531449268|FG000|Treatment Part A|Death|1|||
147349115|NCT03138512|531449269|FG001|Treatment Part A|Death|0|||
147349116|NCT03138512|531449270|FG002|Treatment Part A|Death|0|||
147349117|NCT03138512|531449271|FG003|Treatment Part A|Death|0|||
147349118|NCT03138512|531449272|FG004|Treatment Part A|Death|0|||
147349119|NCT03138512|531449268|FG000|Treatment Part A|Adverse event unrelated to study drug|9|||
147349120|NCT03138512|531449269|FG001|Treatment Part A|Adverse event unrelated to study drug|4|||
147349121|NCT03138512|531449270|FG002|Treatment Part A|Adverse event unrelated to study drug|0|||
147349122|NCT03138512|531449271|FG003|Treatment Part A|Adverse event unrelated to study drug|0|||
147349123|NCT03138512|531449272|FG004|Treatment Part A|Adverse event unrelated to study drug|0|||
147349124|NCT03138512|531449268|FG000|Treatment Part A|Participant request to discontinue treatment|9|||
147349125|NCT03138512|531449269|FG001|Treatment Part A|Participant request to discontinue treatment|4|||
147349126|NCT03138512|531449270|FG002|Treatment Part A|Participant request to discontinue treatment|0|||
147349127|NCT03138512|531449271|FG003|Treatment Part A|Participant request to discontinue treatment|0|||
147349128|NCT03138512|531449272|FG004|Treatment Part A|Participant request to discontinue treatment|0|||
147349129|NCT03138512|531449268|FG000|Treatment Part A|Participant withdrew consent|2|||
147349130|NCT03138512|531449269|FG001|Treatment Part A|Participant withdrew consent|4|||
147349131|NCT03138512|531449270|FG002|Treatment Part A|Participant withdrew consent|0|||
147349132|NCT03138512|531449271|FG003|Treatment Part A|Participant withdrew consent|0|||
147349133|NCT03138512|531449272|FG004|Treatment Part A|Participant withdrew consent|0|||
147349134|NCT03138512|531449268|FG000|Treatment Part A|Lost to Follow-up|0|||
147349135|NCT03138512|531449269|FG001|Treatment Part A|Lost to Follow-up|1|||
147349136|NCT03138512|531449270|FG002|Treatment Part A|Lost to Follow-up|0|||
147349137|NCT03138512|531449271|FG003|Treatment Part A|Lost to Follow-up|0|||
147349138|NCT03138512|531449272|FG004|Treatment Part A|Lost to Follow-up|0|||
147349139|NCT03138512|531449268|FG000|Treatment Part A|Poor/non-compliance|1|||
147349140|NCT03138512|531449269|FG001|Treatment Part A|Poor/non-compliance|0|||
147349141|NCT03138512|531449270|FG002|Treatment Part A|Poor/non-compliance|0|||
147349142|NCT03138512|531449271|FG003|Treatment Part A|Poor/non-compliance|0|||
147349143|NCT03138512|531449272|FG004|Treatment Part A|Poor/non-compliance|0|||
147349144|NCT03138512|531449268|FG000|Treatment Part A|Pregnancy|0|||
147349145|NCT03138512|531449269|FG001|Treatment Part A|Pregnancy|1|||
147349146|NCT03138512|531449270|FG002|Treatment Part A|Pregnancy|0|||
147349147|NCT03138512|531449271|FG003|Treatment Part A|Pregnancy|0|||
147349148|NCT03138512|531449272|FG004|Treatment Part A|Pregnancy|0|||
147349149|NCT03138512|531449268|FG000|Treatment Part A|Other reasons|11|||
147349150|NCT03138512|531449269|FG001|Treatment Part A|Other reasons|8|||
147349151|NCT03138512|531449270|FG002|Treatment Part A|Other reasons|0|||
147349152|NCT03138512|531449271|FG003|Treatment Part A|Other reasons|0|||
147349153|NCT03138512|531449272|FG004|Treatment Part A|Other reasons|0|||
147349154|NCT03138512|531449268|FG000|Treatment Part B|Disease recurrence|0|||
147349155|NCT03138512|531449269|FG001|Treatment Part B|Disease recurrence|0|||
147349156|NCT03138512|531449270|FG002|Treatment Part B|Disease recurrence|6|||
147349157|NCT03138512|531449271|FG003|Treatment Part B|Disease recurrence|12|||
147349158|NCT03138512|531449272|FG004|Treatment Part B|Disease recurrence|10|||
147349159|NCT03138512|531449268|FG000|Treatment Part B|Study drug toxicity|0|||
147349160|NCT03138512|531449269|FG001|Treatment Part B|Study drug toxicity|0|||
147349161|NCT03138512|531449270|FG002|Treatment Part B|Study drug toxicity|63|||
147349162|NCT03138512|531449271|FG003|Treatment Part B|Study drug toxicity|3|||
147349163|NCT03138512|531449272|FG004|Treatment Part B|Study drug toxicity|45|||
147349164|NCT03138512|531449268|FG000|Treatment Part B|Death|0|||
147349165|NCT03138512|531449269|FG001|Treatment Part B|Death|0|||
147349166|NCT03138512|531449270|FG002|Treatment Part B|Death|1|||
147349167|NCT03138512|531449271|FG003|Treatment Part B|Death|0|||
147349168|NCT03138512|531449272|FG004|Treatment Part B|Death|0|||
147349169|NCT03138512|531449268|FG000|Treatment Part B|Adverse event unrelated to study drug|0|||
147349170|NCT03138512|531449269|FG001|Treatment Part B|Adverse event unrelated to study drug|0|||
147349171|NCT03138512|531449270|FG002|Treatment Part B|Adverse event unrelated to study drug|5|||
147349172|NCT03138512|531449271|FG003|Treatment Part B|Adverse event unrelated to study drug|2|||
147349173|NCT03138512|531449272|FG004|Treatment Part B|Adverse event unrelated to study drug|12|||
147349174|NCT03138512|531449268|FG000|Treatment Part B|Participants request to discontinue study treatment|0|||
147349175|NCT03138512|531449269|FG001|Treatment Part B|Participants request to discontinue study treatment|0|||
147349176|NCT03138512|531449270|FG002|Treatment Part B|Participants request to discontinue study treatment|6|||
147349177|NCT03138512|531449271|FG003|Treatment Part B|Participants request to discontinue study treatment|4|||
147349178|NCT03138512|531449272|FG004|Treatment Part B|Participants request to discontinue study treatment|6|||
147349179|NCT03138512|531449268|FG000|Treatment Part B|Participant withdrew consent|0|||
147349180|NCT03138512|531449269|FG001|Treatment Part B|Participant withdrew consent|0|||
147349181|NCT03138512|531449270|FG002|Treatment Part B|Participant withdrew consent|1|||
147349182|NCT03138512|531449271|FG003|Treatment Part B|Participant withdrew consent|1|||
147349183|NCT03138512|531449272|FG004|Treatment Part B|Participant withdrew consent|2|||
147349184|NCT03138512|531449268|FG000|Treatment Part B|Lost to Follow-up|0|||
147349185|NCT03138512|531449269|FG001|Treatment Part B|Lost to Follow-up|0|||
147349186|NCT03138512|531449270|FG002|Treatment Part B|Lost to Follow-up|0|||
147349187|NCT03138512|531449271|FG003|Treatment Part B|Lost to Follow-up|1|||
147349188|NCT03138512|531449272|FG004|Treatment Part B|Lost to Follow-up|0|||
147349189|NCT03138512|531449268|FG000|Treatment Part B|Poor/non-compliance|0|||
147349190|NCT03138512|531449269|FG001|Treatment Part B|Poor/non-compliance|0|||
147349191|NCT03138512|531449270|FG002|Treatment Part B|Poor/non-compliance|1|||
147349192|NCT03138512|531449271|FG003|Treatment Part B|Poor/non-compliance|1|||
147349193|NCT03138512|531449272|FG004|Treatment Part B|Poor/non-compliance|1|||
147349194|NCT03138512|531449268|FG000|Treatment Part B|Other reasons|0|||
147349195|NCT03138512|531449269|FG001|Treatment Part B|Other reasons|0|||
147349196|NCT03138512|531449270|FG002|Treatment Part B|Other reasons|3|||
147349197|NCT03138512|531449271|FG003|Treatment Part B|Other reasons|1|||
147349198|NCT03138512|531449272|FG004|Treatment Part B|Other reasons|5|||
147349199|NCT05323084|531449274|FG000|Period 2 - Washout|Lost to Follow-up|0|||
147349200|NCT05323084|531449275|FG001|Period 2 - Washout|Lost to Follow-up|1|||
147349201|NCT04382404|531449276|FG000|Overall Study|Adverse Event|1|||
147349202|NCT04382404|531449276|FG000|Overall Study|Lost to Follow-up|2|||
147349203|NCT01809691|531449281|FG000|Overall Study|Currently on Treatment|192|||
147349204|NCT01809691|531449282|FG001|Overall Study|Currently on Treatment|100|||
147349205|NCT01809691|531449281|FG000|Overall Study|No Protocol Treatment|10|||
147349206|NCT01809691|531449282|FG001|Overall Study|No Protocol Treatment|11|||
147349207|NCT01809691|531449281|FG000|Overall Study|Adverse Event|80|||
147349208|NCT01809691|531449282|FG001|Overall Study|Adverse Event|21|||
147349209|NCT01809691|531449281|FG000|Overall Study|Disease Progression|226|||
147349210|NCT01809691|531449282|FG001|Overall Study|Disease Progression|372|||
147349211|NCT01809691|531449281|FG000|Overall Study|Death|26|||
147349212|NCT01809691|531449282|FG001|Overall Study|Death|13|||
147349213|NCT01809691|531449281|FG000|Overall Study|Participant Refusal|70|||
147349214|NCT01809691|531449282|FG001|Overall Study|Participant Refusal|72|||
147349215|NCT01809691|531449281|FG000|Overall Study|Other, Not Specified|34|||
147349216|NCT01809691|531449282|FG001|Overall Study|Other, Not Specified|52|||
147349217|NCT01580488|531449283|FG000|Overall Study|Withdrawal by Subject|1|||
147349218|NCT04588298|531449295|FG000|Overall Study|Adverse Event|0|||
147349219|NCT04588298|531449296|FG001|Overall Study|Adverse Event|0|||
147349220|NCT04588298|531449297|FG002|Overall Study|Adverse Event|1|||
147349221|NCT04588298|531449298|FG003|Overall Study|Adverse Event|0|||
147349222|NCT04588298|531449299|FG004|Overall Study|Adverse Event|2|||
147349223|NCT04588298|531449295|FG000|Overall Study|Withdrawal by Subject|1|||
147349224|NCT04588298|531449296|FG001|Overall Study|Withdrawal by Subject|0|||
147349225|NCT04588298|531449297|FG002|Overall Study|Withdrawal by Subject|0|||
147349226|NCT04588298|531449298|FG003|Overall Study|Withdrawal by Subject|1|||
147349227|NCT04588298|531449299|FG004|Overall Study|Withdrawal by Subject|0|||
147349228|NCT02281955|531449304|FG000|Overall Study|Death|1|||
147349229|NCT02783300|531449312|FG000|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
147349230|NCT02783300|531449313|FG001|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
147349231|NCT02783300|531449314|FG002|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
147349232|NCT02783300|531449315|FG003|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
147349233|NCT02783300|531449316|FG004|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
147349234|NCT02783300|531449317|FG005|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
147349235|NCT02783300|531449318|FG006|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|1|||
147349236|NCT02783300|531449319|FG007|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
147349237|NCT02783300|531449320|FG008|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
147349238|NCT02783300|531449321|FG009|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
147349239|NCT02783300|531449322|FG010|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
147349240|NCT02783300|531449323|FG011|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
147349241|NCT02783300|531449324|FG012|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
147349242|NCT02783300|531449325|FG013|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
147349243|NCT02783300|531449326|FG014|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
147349244|NCT02783300|531449327|FG015|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
147349245|NCT02783300|531449328|FG016|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
147349246|NCT02783300|531449329|FG017|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
147349247|NCT02783300|531449330|FG018|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
147349248|NCT02783300|531449331|FG019|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
147349249|NCT02783300|531449332|FG020|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
147349250|NCT02783300|531449333|FG021|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
147349251|NCT02783300|531449334|FG022|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
147349252|NCT02783300|531449335|FG023|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
147349253|NCT02783300|531449336|FG024|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
147349254|NCT02783300|531449337|FG025|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
147349255|NCT02783300|531449338|FG026|Part 1- Dose Escalation Phase|Site Terminated by Sponsor|0|||
147349256|NCT02783300|531449312|FG000|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
147349257|NCT02783300|531449313|FG001|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
147349258|NCT02783300|531449314|FG002|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
147349259|NCT02783300|531449315|FG003|Part 1- Dose Escalation Phase|Lost to Follow-up|1|||
147349260|NCT02783300|531449316|FG004|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
147349261|NCT02783300|531449317|FG005|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
147349262|NCT02783300|531449318|FG006|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
147606912|NCT00106964|532377189|FG002|Overall Study|Failure to adhere|0|||
147349263|NCT02783300|531449319|FG007|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
147349264|NCT02783300|531449320|FG008|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
147349265|NCT02783300|531449321|FG009|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
147349266|NCT02783300|531449322|FG010|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
147349267|NCT02783300|531449323|FG011|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
147349268|NCT02783300|531449324|FG012|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
147349269|NCT02783300|531449325|FG013|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
147349270|NCT02783300|531449326|FG014|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
147349271|NCT02783300|531449327|FG015|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
147349272|NCT02783300|531449328|FG016|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
147349273|NCT02783300|531449329|FG017|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
147349274|NCT02783300|531449330|FG018|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
147349275|NCT02783300|531449331|FG019|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
147349276|NCT02783300|531449332|FG020|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
147349277|NCT02783300|531449333|FG021|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
147349278|NCT02783300|531449334|FG022|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
147349279|NCT02783300|531449335|FG023|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
147349280|NCT02783300|531449336|FG024|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
147349281|NCT02783300|531449337|FG025|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
147349282|NCT02783300|531449338|FG026|Part 1- Dose Escalation Phase|Lost to Follow-up|0|||
147349283|NCT02783300|531449312|FG000|Part 1- Dose Escalation Phase|Other reasons|0|||
147349284|NCT02783300|531449313|FG001|Part 1- Dose Escalation Phase|Other reasons|0|||
147349285|NCT02783300|531449314|FG002|Part 1- Dose Escalation Phase|Other reasons|0|||
147349286|NCT02783300|531449315|FG003|Part 1- Dose Escalation Phase|Other reasons|0|||
147349287|NCT02783300|531449316|FG004|Part 1- Dose Escalation Phase|Other reasons|0|||
147349288|NCT02783300|531449317|FG005|Part 1- Dose Escalation Phase|Other reasons|0|||
147349289|NCT02783300|531449318|FG006|Part 1- Dose Escalation Phase|Other reasons|0|||
147349290|NCT02783300|531449319|FG007|Part 1- Dose Escalation Phase|Other reasons|0|||
147349291|NCT02783300|531449320|FG008|Part 1- Dose Escalation Phase|Other reasons|0|||
147349292|NCT02783300|531449321|FG009|Part 1- Dose Escalation Phase|Other reasons|0|||
147349293|NCT02783300|531449322|FG010|Part 1- Dose Escalation Phase|Other reasons|0|||
147349294|NCT02783300|531449323|FG011|Part 1- Dose Escalation Phase|Other reasons|0|||
147349295|NCT02783300|531449324|FG012|Part 1- Dose Escalation Phase|Other reasons|2|||
147349296|NCT02783300|531449325|FG013|Part 1- Dose Escalation Phase|Other reasons|0|||
147606913|NCT00106964|532377187|FG000|Overall Study|Did not meet eligibility criteria|0|||
147606914|NCT00106964|532377188|FG001|Overall Study|Did not meet eligibility criteria|2|||
147606915|NCT00106964|532377189|FG002|Overall Study|Did not meet eligibility criteria|2|||
147606916|NCT00106964|532377187|FG000|Overall Study|Required disallowed medication|0|||
147606917|NCT00106964|532377188|FG001|Overall Study|Required disallowed medication|1|||
147349297|NCT02783300|531449326|FG014|Part 1- Dose Escalation Phase|Other reasons|0|||
147349298|NCT02783300|531449327|FG015|Part 1- Dose Escalation Phase|Other reasons|0|||
147349299|NCT02783300|531449328|FG016|Part 1- Dose Escalation Phase|Other reasons|0|||
147349300|NCT02783300|531449329|FG017|Part 1- Dose Escalation Phase|Other reasons|0|||
147349301|NCT02783300|531449330|FG018|Part 1- Dose Escalation Phase|Other reasons|0|||
147349302|NCT02783300|531449331|FG019|Part 1- Dose Escalation Phase|Other reasons|0|||
147349303|NCT02783300|531449332|FG020|Part 1- Dose Escalation Phase|Other reasons|0|||
147349304|NCT02783300|531449333|FG021|Part 1- Dose Escalation Phase|Other reasons|0|||
147349305|NCT02783300|531449334|FG022|Part 1- Dose Escalation Phase|Other reasons|0|||
147349306|NCT02783300|531449335|FG023|Part 1- Dose Escalation Phase|Other reasons|0|||
147349307|NCT02783300|531449336|FG024|Part 1- Dose Escalation Phase|Other reasons|0|||
147349308|NCT02783300|531449337|FG025|Part 1- Dose Escalation Phase|Other reasons|0|||
147349309|NCT02783300|531449338|FG026|Part 1- Dose Escalation Phase|Other reasons|0|||
147349310|NCT02783300|531449312|FG000|Part 1- Dose Escalation Phase|Investigator discretion|0|||
147349311|NCT02783300|531449313|FG001|Part 1- Dose Escalation Phase|Investigator discretion|0|||
147349312|NCT02783300|531449314|FG002|Part 1- Dose Escalation Phase|Investigator discretion|0|||
147349313|NCT02783300|531449315|FG003|Part 1- Dose Escalation Phase|Investigator discretion|0|||
147349314|NCT02783300|531449316|FG004|Part 1- Dose Escalation Phase|Investigator discretion|0|||
147349315|NCT02783300|531449317|FG005|Part 1- Dose Escalation Phase|Investigator discretion|0|||
147349316|NCT02783300|531449318|FG006|Part 1- Dose Escalation Phase|Investigator discretion|4|||
147349317|NCT02783300|531449319|FG007|Part 1- Dose Escalation Phase|Investigator discretion|0|||
147349318|NCT02783300|531449320|FG008|Part 1- Dose Escalation Phase|Investigator discretion|0|||
147349319|NCT02783300|531449321|FG009|Part 1- Dose Escalation Phase|Investigator discretion|0|||
147349320|NCT02783300|531449322|FG010|Part 1- Dose Escalation Phase|Investigator discretion|0|||
147349321|NCT02783300|531449323|FG011|Part 1- Dose Escalation Phase|Investigator discretion|0|||
147349322|NCT02783300|531449324|FG012|Part 1- Dose Escalation Phase|Investigator discretion|3|||
147606918|NCT00106964|532377189|FG002|Overall Study|Required disallowed medication|0|||
147606919|NCT04746794|532377190|FG000|Overall Study|Did not complete any study assessment|50303|||
147606920|NCT04746794|532377191|FG001|Overall Study|Did not complete any study assessment|44997|||
147606921|NCT03207243|532377192|FG000|Overall Study|Adverse Event|2|||
147606922|NCT03207243|532377193|FG001|Overall Study|Adverse Event|2|||
147349323|NCT02783300|531449325|FG013|Part 1- Dose Escalation Phase|Investigator discretion|0|||
147349324|NCT02783300|531449326|FG014|Part 1- Dose Escalation Phase|Investigator discretion|0|||
147349325|NCT02783300|531449327|FG015|Part 1- Dose Escalation Phase|Investigator discretion|0|||
147349326|NCT02783300|531449328|FG016|Part 1- Dose Escalation Phase|Investigator discretion|0|||
147349327|NCT02783300|531449329|FG017|Part 1- Dose Escalation Phase|Investigator discretion|0|||
147349328|NCT02783300|531449330|FG018|Part 1- Dose Escalation Phase|Investigator discretion|0|||
147349329|NCT02783300|531449331|FG019|Part 1- Dose Escalation Phase|Investigator discretion|0|||
147349330|NCT02783300|531449332|FG020|Part 1- Dose Escalation Phase|Investigator discretion|0|||
147349331|NCT02783300|531449333|FG021|Part 1- Dose Escalation Phase|Investigator discretion|0|||
147349332|NCT02783300|531449334|FG022|Part 1- Dose Escalation Phase|Investigator discretion|0|||
147349333|NCT02783300|531449335|FG023|Part 1- Dose Escalation Phase|Investigator discretion|0|||
147349334|NCT02783300|531449336|FG024|Part 1- Dose Escalation Phase|Investigator discretion|0|||
147349335|NCT02783300|531449337|FG025|Part 1- Dose Escalation Phase|Investigator discretion|0|||
147349336|NCT02783300|531449338|FG026|Part 1- Dose Escalation Phase|Investigator discretion|0|||
147349337|NCT02783300|531449312|FG000|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
147349338|NCT02783300|531449313|FG001|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
147349339|NCT02783300|531449314|FG002|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
147349340|NCT02783300|531449315|FG003|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
147349341|NCT02783300|531449316|FG004|Part 1- Dose Escalation Phase|Withdrawal by Subject|1|||
147349342|NCT02783300|531449317|FG005|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
147349343|NCT02783300|531449318|FG006|Part 1- Dose Escalation Phase|Withdrawal by Subject|1|||
147349344|NCT02783300|531449319|FG007|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
147349345|NCT02783300|531449320|FG008|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
147349346|NCT02783300|531449321|FG009|Part 1- Dose Escalation Phase|Withdrawal by Subject|1|||
147349347|NCT02783300|531449322|FG010|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
147349348|NCT02783300|531449323|FG011|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
147349349|NCT02783300|531449324|FG012|Part 1- Dose Escalation Phase|Withdrawal by Subject|2|||
147349350|NCT02783300|531449325|FG013|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
147349351|NCT02783300|531449326|FG014|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
147349352|NCT02783300|531449327|FG015|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
147349353|NCT02783300|531449328|FG016|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
147349354|NCT02783300|531449329|FG017|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
147349355|NCT02783300|531449330|FG018|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
147349356|NCT02783300|531449331|FG019|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
147349357|NCT02783300|531449332|FG020|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
147349358|NCT02783300|531449333|FG021|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
147349359|NCT02783300|531449334|FG022|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
147349360|NCT02783300|531449335|FG023|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
147349361|NCT02783300|531449336|FG024|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
147349362|NCT02783300|531449337|FG025|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
147349363|NCT02783300|531449338|FG026|Part 1- Dose Escalation Phase|Withdrawal by Subject|0|||
147349364|NCT02783300|531449312|FG000|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
147349365|NCT02783300|531449313|FG001|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
147349366|NCT02783300|531449314|FG002|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
147349367|NCT02783300|531449315|FG003|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
147349368|NCT02783300|531449316|FG004|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
147349369|NCT02783300|531449317|FG005|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
147349370|NCT02783300|531449318|FG006|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
147349371|NCT02783300|531449319|FG007|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
147349372|NCT02783300|531449320|FG008|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
147349373|NCT02783300|531449321|FG009|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
147349374|NCT02783300|531449322|FG010|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
147349375|NCT02783300|531449323|FG011|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
147349376|NCT02783300|531449324|FG012|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
147349377|NCT02783300|531449325|FG013|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
147349378|NCT02783300|531449326|FG014|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
147349379|NCT02783300|531449327|FG015|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|1|||
147349380|NCT02783300|531449328|FG016|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
147349381|NCT02783300|531449329|FG017|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|2|||
147349382|NCT02783300|531449330|FG018|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|2|||
147349383|NCT02783300|531449331|FG019|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|1|||
147349384|NCT02783300|531449332|FG020|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
147349385|NCT02783300|531449333|FG021|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
147349386|NCT02783300|531449334|FG022|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
147349387|NCT02783300|531449335|FG023|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
147349388|NCT02783300|531449336|FG024|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|1|||
147349389|NCT02783300|531449337|FG025|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
147349390|NCT02783300|531449338|FG026|Part 2- Disease-specific Expansion Phase|Lost to Follow-up|0|||
147349391|NCT02783300|531449312|FG000|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
147349392|NCT02783300|531449313|FG001|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
147349393|NCT02783300|531449314|FG002|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
147349394|NCT02783300|531449315|FG003|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
147349395|NCT02783300|531449316|FG004|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
147349396|NCT02783300|531449317|FG005|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
147349397|NCT02783300|531449318|FG006|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
147349398|NCT02783300|531449319|FG007|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
147349399|NCT02783300|531449320|FG008|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
147349400|NCT02783300|531449321|FG009|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
147349401|NCT02783300|531449322|FG010|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
147349402|NCT02783300|531449323|FG011|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
147349403|NCT02783300|531449324|FG012|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
147349404|NCT02783300|531449325|FG013|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
147349405|NCT02783300|531449326|FG014|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
147349406|NCT02783300|531449327|FG015|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
147349407|NCT02783300|531449328|FG016|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|1|||
147349408|NCT02783300|531449329|FG017|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
147349409|NCT02783300|531449330|FG018|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|1|||
147349410|NCT02783300|531449331|FG019|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|2|||
147349411|NCT02783300|531449332|FG020|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
147349412|NCT02783300|531449333|FG021|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
147349413|NCT02783300|531449334|FG022|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
147349414|NCT02783300|531449335|FG023|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
147349415|NCT02783300|531449336|FG024|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
147349416|NCT02783300|531449337|FG025|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
147349417|NCT02783300|531449338|FG026|Part 2- Disease-specific Expansion Phase|Site Terminated by Sponsor|0|||
147349418|NCT02783300|531449312|FG000|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
147349419|NCT02783300|531449313|FG001|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
147349420|NCT02783300|531449314|FG002|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
147349421|NCT02783300|531449315|FG003|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
147349422|NCT02783300|531449316|FG004|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
147349423|NCT02783300|531449317|FG005|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
147349424|NCT02783300|531449318|FG006|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
147349425|NCT02783300|531449319|FG007|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
147349426|NCT02783300|531449320|FG008|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
147349427|NCT02783300|531449321|FG009|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
147349428|NCT02783300|531449322|FG010|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
147349429|NCT02783300|531449323|FG011|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
147349430|NCT02783300|531449324|FG012|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
147349431|NCT02783300|531449325|FG013|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
147349432|NCT02783300|531449326|FG014|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
147349433|NCT02783300|531449327|FG015|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
147349434|NCT02783300|531449328|FG016|Part 2- Disease-specific Expansion Phase|Other reasons|1|||
147349435|NCT02783300|531449329|FG017|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
147349436|NCT02783300|531449330|FG018|Part 2- Disease-specific Expansion Phase|Other reasons|1|||
147349437|NCT02783300|531449331|FG019|Part 2- Disease-specific Expansion Phase|Other reasons|3|||
147349438|NCT02783300|531449332|FG020|Part 2- Disease-specific Expansion Phase|Other reasons|1|||
147349439|NCT02783300|531449333|FG021|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
147349440|NCT02783300|531449334|FG022|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
147349441|NCT02783300|531449335|FG023|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
147349442|NCT02783300|531449336|FG024|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
147349443|NCT02783300|531449337|FG025|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
147349444|NCT02783300|531449338|FG026|Part 2- Disease-specific Expansion Phase|Other reasons|0|||
147349445|NCT02783300|531449312|FG000|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
147349446|NCT02783300|531449313|FG001|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
147349447|NCT02783300|531449314|FG002|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
147349448|NCT02783300|531449315|FG003|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
147349449|NCT02783300|531449316|FG004|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
147349450|NCT02783300|531449317|FG005|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
147349451|NCT02783300|531449318|FG006|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
147349452|NCT02783300|531449319|FG007|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
147349453|NCT02783300|531449320|FG008|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
147349454|NCT02783300|531449321|FG009|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
147349455|NCT02783300|531449322|FG010|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
147349456|NCT02783300|531449323|FG011|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
147349457|NCT02783300|531449324|FG012|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
147349458|NCT02783300|531449325|FG013|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
147349459|NCT02783300|531449326|FG014|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
147349460|NCT02783300|531449327|FG015|Part 2- Disease-specific Expansion Phase|Investigator site closed|1|||
147349461|NCT02783300|531449328|FG016|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
147349462|NCT02783300|531449329|FG017|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
147349463|NCT02783300|531449330|FG018|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
147349464|NCT02783300|531449331|FG019|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
147349465|NCT02783300|531449332|FG020|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
147349466|NCT02783300|531449333|FG021|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
147349467|NCT02783300|531449334|FG022|Part 2- Disease-specific Expansion Phase|Investigator site closed|1|||
147349468|NCT02783300|531449335|FG023|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
147349469|NCT02783300|531449336|FG024|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
147349470|NCT02783300|531449337|FG025|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
147349471|NCT02783300|531449338|FG026|Part 2- Disease-specific Expansion Phase|Investigator site closed|0|||
147349472|NCT02783300|531449312|FG000|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
147349473|NCT02783300|531449313|FG001|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
147349474|NCT02783300|531449314|FG002|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
147349475|NCT02783300|531449315|FG003|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
147349476|NCT02783300|531449316|FG004|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
147349477|NCT02783300|531449317|FG005|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
147349478|NCT02783300|531449318|FG006|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
147349479|NCT02783300|531449319|FG007|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
147349480|NCT02783300|531449320|FG008|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
147349481|NCT02783300|531449321|FG009|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
147349482|NCT02783300|531449322|FG010|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
147349483|NCT02783300|531449323|FG011|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
147349484|NCT02783300|531449324|FG012|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
147349485|NCT02783300|531449325|FG013|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|1|||
147349486|NCT02783300|531449326|FG014|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|3|||
147349487|NCT02783300|531449327|FG015|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|2|||
147349488|NCT02783300|531449328|FG016|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|1|||
147349489|NCT02783300|531449329|FG017|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
147349490|NCT02783300|531449330|FG018|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|7|||
147349491|NCT02783300|531449331|FG019|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|2|||
147349492|NCT02783300|531449332|FG020|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
147349493|NCT02783300|531449333|FG021|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
147349494|NCT02783300|531449334|FG022|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
147349495|NCT02783300|531449335|FG023|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
147349496|NCT02783300|531449336|FG024|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
147349497|NCT02783300|531449337|FG025|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
147349498|NCT02783300|531449338|FG026|Part 2- Disease-specific Expansion Phase|Withdrawal by Subject|0|||
147349499|NCT02783300|531449312|FG000|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
147349500|NCT02783300|531449313|FG001|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
147349501|NCT02783300|531449314|FG002|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
147349502|NCT02783300|531449315|FG003|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
147349503|NCT02783300|531449316|FG004|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
147349504|NCT02783300|531449317|FG005|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
147349505|NCT02783300|531449318|FG006|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
147349506|NCT02783300|531449319|FG007|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
147349507|NCT02783300|531449320|FG008|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
147662739|NCT02227784|532587412|FG000|Open-Label Extension Phase (OLE)|Death|0|||
147662740|NCT02227784|532587413|FG001|Open-Label Extension Phase (OLE)|Death|0|||
147349508|NCT02783300|531449321|FG009|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
147349509|NCT02783300|531449322|FG010|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
147349510|NCT02783300|531449323|FG011|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
147349511|NCT02783300|531449324|FG012|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
147349512|NCT02783300|531449325|FG013|Part 2- Disease-specific Expansion Phase|Investigator discretion|5|||
147349513|NCT02783300|531449326|FG014|Part 2- Disease-specific Expansion Phase|Investigator discretion|3|||
147349514|NCT02783300|531449327|FG015|Part 2- Disease-specific Expansion Phase|Investigator discretion|3|||
147349515|NCT02783300|531449328|FG016|Part 2- Disease-specific Expansion Phase|Investigator discretion|3|||
147349516|NCT02783300|531449329|FG017|Part 2- Disease-specific Expansion Phase|Investigator discretion|1|||
147349517|NCT02783300|531449330|FG018|Part 2- Disease-specific Expansion Phase|Investigator discretion|3|||
147349518|NCT02783300|531449331|FG019|Part 2- Disease-specific Expansion Phase|Investigator discretion|5|||
147349519|NCT02783300|531449332|FG020|Part 2- Disease-specific Expansion Phase|Investigator discretion|1|||
147349520|NCT02783300|531449333|FG021|Part 2- Disease-specific Expansion Phase|Investigator discretion|1|||
147349521|NCT02783300|531449334|FG022|Part 2- Disease-specific Expansion Phase|Investigator discretion|2|||
147349522|NCT02783300|531449335|FG023|Part 2- Disease-specific Expansion Phase|Investigator discretion|1|||
147349523|NCT02783300|531449336|FG024|Part 2- Disease-specific Expansion Phase|Investigator discretion|3|||
147349524|NCT02783300|531449337|FG025|Part 2- Disease-specific Expansion Phase|Investigator discretion|4|||
147349525|NCT02783300|531449338|FG026|Part 2- Disease-specific Expansion Phase|Investigator discretion|0|||
147349526|NCT02783300|531449312|FG000|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
147349527|NCT02783300|531449313|FG001|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
147349528|NCT02783300|531449314|FG002|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
147349529|NCT02783300|531449315|FG003|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
147349530|NCT02783300|531449316|FG004|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
147349531|NCT02783300|531449317|FG005|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
147349532|NCT02783300|531449318|FG006|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
147349533|NCT02783300|531449319|FG007|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
147349534|NCT02783300|531449320|FG008|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
147349535|NCT02783300|531449321|FG009|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
147349536|NCT02783300|531449322|FG010|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
147349537|NCT02783300|531449323|FG011|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
147349538|NCT02783300|531449324|FG012|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
147349539|NCT02783300|531449325|FG013|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
147349540|NCT02783300|531449326|FG014|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
147349541|NCT02783300|531449327|FG015|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
147349542|NCT02783300|531449328|FG016|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
147349543|NCT02783300|531449329|FG017|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
147349544|NCT02783300|531449330|FG018|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
147349545|NCT02783300|531449331|FG019|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
147349546|NCT02783300|531449332|FG020|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
147349547|NCT02783300|531449333|FG021|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
147349548|NCT02783300|531449334|FG022|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
147349549|NCT02783300|531449335|FG023|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
147349550|NCT02783300|531449336|FG024|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
147349551|NCT02783300|531449337|FG025|Part 3- Dose Determination Phase|Withdrawal by Subject|0|||
147349552|NCT02783300|531449338|FG026|Part 3- Dose Determination Phase|Withdrawal by Subject|1|||
147349553|NCT02783300|531449312|FG000|Part 3- Dose Determination Phase|Investigator discretion|0|||
147349554|NCT02783300|531449313|FG001|Part 3- Dose Determination Phase|Investigator discretion|0|||
147349555|NCT02783300|531449314|FG002|Part 3- Dose Determination Phase|Investigator discretion|0|||
147349556|NCT02783300|531449315|FG003|Part 3- Dose Determination Phase|Investigator discretion|0|||
147349557|NCT02783300|531449316|FG004|Part 3- Dose Determination Phase|Investigator discretion|0|||
147349558|NCT02783300|531449317|FG005|Part 3- Dose Determination Phase|Investigator discretion|0|||
147349559|NCT02783300|531449318|FG006|Part 3- Dose Determination Phase|Investigator discretion|0|||
147349560|NCT02783300|531449319|FG007|Part 3- Dose Determination Phase|Investigator discretion|0|||
147349561|NCT02783300|531449320|FG008|Part 3- Dose Determination Phase|Investigator discretion|0|||
147349562|NCT02783300|531449321|FG009|Part 3- Dose Determination Phase|Investigator discretion|0|||
147349563|NCT02783300|531449322|FG010|Part 3- Dose Determination Phase|Investigator discretion|0|||
147349564|NCT02783300|531449323|FG011|Part 3- Dose Determination Phase|Investigator discretion|0|||
147606923|NCT03207243|532377192|FG000|Overall Study|Loss of Asthma Control|47|||
147606924|NCT03207243|532377193|FG001|Overall Study|Loss of Asthma Control|31|||
147606925|NCT03207243|532377192|FG000|Overall Study|Withdrawal by Subject|2|||
147606926|NCT03207243|532377193|FG001|Overall Study|Withdrawal by Subject|4|||
147606927|NCT03207243|532377192|FG000|Overall Study|Physician Decision|1|||
147606928|NCT03207243|532377193|FG001|Overall Study|Physician Decision|1|||
147606929|NCT03207243|532377192|FG000|Overall Study|Lost to Follow-up|0|||
147606930|NCT03207243|532377193|FG001|Overall Study|Lost to Follow-up|1|||
147606931|NCT03207243|532377192|FG000|Overall Study|Protocol Specified Withdrawal Criteria|7|||
147349565|NCT02783300|531449324|FG012|Part 3- Dose Determination Phase|Investigator discretion|0|||
147349566|NCT02783300|531449325|FG013|Part 3- Dose Determination Phase|Investigator discretion|0|||
147349567|NCT02783300|531449326|FG014|Part 3- Dose Determination Phase|Investigator discretion|0|||
147349568|NCT02783300|531449327|FG015|Part 3- Dose Determination Phase|Investigator discretion|0|||
147349569|NCT02783300|531449328|FG016|Part 3- Dose Determination Phase|Investigator discretion|0|||
147349570|NCT02783300|531449329|FG017|Part 3- Dose Determination Phase|Investigator discretion|0|||
147349571|NCT02783300|531449330|FG018|Part 3- Dose Determination Phase|Investigator discretion|0|||
147349572|NCT02783300|531449331|FG019|Part 3- Dose Determination Phase|Investigator discretion|0|||
147349573|NCT02783300|531449332|FG020|Part 3- Dose Determination Phase|Investigator discretion|0|||
147349574|NCT02783300|531449333|FG021|Part 3- Dose Determination Phase|Investigator discretion|0|||
147349575|NCT02783300|531449334|FG022|Part 3- Dose Determination Phase|Investigator discretion|0|||
147349576|NCT02783300|531449335|FG023|Part 3- Dose Determination Phase|Investigator discretion|0|||
147349577|NCT02783300|531449336|FG024|Part 3- Dose Determination Phase|Investigator discretion|0|||
147349578|NCT02783300|531449337|FG025|Part 3- Dose Determination Phase|Investigator discretion|0|||
147349579|NCT02783300|531449338|FG026|Part 3- Dose Determination Phase|Investigator discretion|3|||
147349580|NCT03535272|531449339|FG000|Overall Study|Lost to Follow-up|71|||
147349581|NCT03535272|531449340|FG001|Overall Study|Lost to Follow-up|73|||
147349582|NCT03892616|531449343|FG000|Washout Period 2|Met discontinuation criterion|0|||
147349583|NCT03892616|531449344|FG001|Washout Period 2|Met discontinuation criterion|0|||
147349584|NCT03892616|531449345|FG002|Washout Period 2|Met discontinuation criterion|0|||
147349585|NCT03892616|531449346|FG003|Washout Period 2|Met discontinuation criterion|0|||
147349586|NCT03892616|531449347|FG004|Washout Period 2|Met discontinuation criterion|0|||
147349587|NCT03892616|531449348|FG005|Washout Period 2|Met discontinuation criterion|0|||
147349588|NCT03892616|531449349|FG006|Washout Period 2|Met discontinuation criterion|0|||
147349589|NCT03892616|531449350|FG007|Washout Period 2|Met discontinuation criterion|0|||
147349590|NCT03892616|531449351|FG008|Washout Period 2|Met discontinuation criterion|1|||
147349591|NCT03892616|531449352|FG009|Washout Period 2|Met discontinuation criterion|0|||
147349592|NCT03892616|531449353|FG010|Washout Period 2|Met discontinuation criterion|0|||
147349593|NCT03892616|531449354|FG011|Washout Period 2|Met discontinuation criterion|0|||
147349594|NCT02243709|531449355|FG000|Phase 1|Lost to Follow-up|0|||
147349595|NCT02243709|531449356|FG001|Phase 1|Lost to Follow-up|1|||
147349596|NCT02243709|531449355|FG000|Phase 1|Withdrawal by Subject|1|||
147349597|NCT02243709|531449356|FG001|Phase 1|Withdrawal by Subject|0|||
147349598|NCT02243709|531449355|FG000|Phase 1|Protocol Violation|0|||
147349599|NCT02243709|531449356|FG001|Phase 1|Protocol Violation|1|||
147349600|NCT02243709|531449355|FG000|Phase 1|Adverse Event|0|||
147349601|NCT02243709|531449356|FG001|Phase 1|Adverse Event|1|||
147349602|NCT04347161|531449361|FG000|Overall Study|Death|0|||
147349603|NCT04347161|531449362|FG001|Overall Study|Death|2|||
147349604|NCT04347161|531449361|FG000|Overall Study|Withdrawal by Subject|1|||
147349605|NCT04347161|531449362|FG001|Overall Study|Withdrawal by Subject|0|||
147349606|NCT04347161|531449361|FG000|Overall Study|Lost to Follow-up|0|||
147349607|NCT04347161|531449362|FG001|Overall Study|Lost to Follow-up|1|||
147349608|NCT04347161|531449361|FG000|Overall Study|No longer on study medication|1|||
147349609|NCT04347161|531449362|FG001|Overall Study|No longer on study medication|1|||
147349610|NCT04533347|531449363|FG000|Overall Study|Adverse Event|1|||
147349611|NCT04533347|531449364|FG001|Overall Study|Adverse Event|2|||
147349612|NCT04533347|531449363|FG000|Overall Study|Lost to Follow-up|2|||
147349613|NCT04533347|531449364|FG001|Overall Study|Lost to Follow-up|0|||
147349614|NCT04533347|531449363|FG000|Overall Study|Withdrawal by Subject|1|||
147349615|NCT04533347|531449364|FG001|Overall Study|Withdrawal by Subject|0|||
147349616|NCT05520190|531449365|FG000|Overall Study|Lost to Follow-up|7|||
147349617|NCT05520190|531449365|FG000|Overall Study|Withdrawal by Subject|2|||
147349618|NCT01748448|531449366|FG000|Treatment Period|Consent withdrawn by subject|1|||
147349619|NCT01748448|531449367|FG001|Treatment Period|Consent withdrawn by subject|0|||
147349620|NCT01748448|531449366|FG000|Treatment Period|Adverse Event|1|||
147349621|NCT01748448|531449367|FG001|Treatment Period|Adverse Event|0|||
147349622|NCT01748448|531449366|FG000|Treatment Period|Personal|0|||
147349623|NCT01748448|531449367|FG001|Treatment Period|Personal|1|||
147349624|NCT03699709|531449375|FG000|Overall Study|Death|1|||
147349625|NCT03699709|531449376|FG001|Overall Study|Death|2|||
147349626|NCT03699709|531449375|FG000|Overall Study|Lost to Follow-up|10|||
147349627|NCT03699709|531449376|FG001|Overall Study|Lost to Follow-up|3|||
147349628|NCT03699709|531449375|FG000|Overall Study|Withdrawal by Subject|5|||
147349629|NCT03699709|531449376|FG001|Overall Study|Withdrawal by Subject|0|||
147349630|NCT03699709|531449375|FG000|Overall Study|incarcerated|1|||
147349631|NCT03699709|531449376|FG001|Overall Study|incarcerated|0|||
147349632|NCT03699709|531449375|FG000|Overall Study|scheduled, but no show|0|||
147349633|NCT03699709|531449376|FG001|Overall Study|scheduled, but no show|1|||
147606932|NCT03207243|532377193|FG001|Overall Study|Protocol Specified Withdrawal Criteria|2|||
147349634|NCT02907099|531449377|FG000|Overall Study|Adverse Event|1|||
147349635|NCT02907099|531449377|FG000|Overall Study|Withdrawal by Subject|2|||
147349636|NCT02907099|531449377|FG000|Overall Study|Screen Fail|2|||
147349637|NCT02913872|531449382|FG000|Overall Study|Withdrawal by Subject|1|||
147349638|NCT04739956|531449383|FG000|Overall Study|Withdrawal by Subject|1|||
147606933|NCT03207243|532377192|FG000|Overall Study|Protocol Violation|0|||
147606934|NCT03207243|532377193|FG001|Overall Study|Protocol Violation|3|||
147606935|NCT01422187|532377198|FG000|Overall Study|Personal reason|1|||
147606936|NCT01422187|532377199|FG001|Overall Study|Personal reason|0|||
147606937|NCT01422187|532377200|FG002|Overall Study|Personal reason|0|||
147606938|NCT01422187|532377198|FG000|Overall Study|Lost to Follow-up|0|||
147606939|NCT01422187|532377199|FG001|Overall Study|Lost to Follow-up|1|||
147606940|NCT01422187|532377200|FG002|Overall Study|Lost to Follow-up|0|||
147349639|NCT04739956|531449384|FG001|Overall Study|Withdrawal by Subject|1|||
147349640|NCT03519581|531449385|FG000|Overall Study|Lost to Follow-up|3|||
147349641|NCT03519581|531449386|FG001|Overall Study|Lost to Follow-up|2|||
147349642|NCT03519581|531449385|FG000|Overall Study|Adverse Event|5|||
147349643|NCT03519581|531449386|FG001|Overall Study|Adverse Event|2|||
147349644|NCT03519581|531449385|FG000|Overall Study|Withdrawal by Subject|2|||
147349645|NCT03519581|531449386|FG001|Overall Study|Withdrawal by Subject|0|||
147349646|NCT03519581|531449385|FG000|Overall Study|Change to insurance|2|||
147349647|NCT03519581|531449386|FG001|Overall Study|Change to insurance|1|||
147349648|NCT03519581|531449385|FG000|Overall Study|Other|2|||
147349649|NCT03519581|531449386|FG001|Overall Study|Other|4|||
147349650|NCT03110315|531449387|FG000|Overall Study|Withdrawal by Subject|1|||
147349651|NCT03110315|531449388|FG001|Overall Study|Withdrawal by Subject|0|||
147349652|NCT02736409|531451136|FG000|Overall Study|Withdrawal by Subject|4|||
147349653|NCT02736409|531451137|FG001|Overall Study|Withdrawal by Subject|2|||
147349654|NCT02736409|531451138|FG002|Overall Study|Withdrawal by Subject|17|||
147349655|NCT02736409|531451139|FG003|Overall Study|Withdrawal by Subject|3|||
147349656|NCT02736409|531451136|FG000|Overall Study|Non-Compliance with Study Drug|0|||
147349657|NCT02736409|531451137|FG001|Overall Study|Non-Compliance with Study Drug|0|||
147349658|NCT02736409|531451138|FG002|Overall Study|Non-Compliance with Study Drug|0|||
147349659|NCT02736409|531451139|FG003|Overall Study|Non-Compliance with Study Drug|1|||
147349660|NCT02736409|531451136|FG000|Overall Study|Adverse Event|0|||
147349661|NCT02736409|531451137|FG001|Overall Study|Adverse Event|1|||
147349662|NCT02736409|531451138|FG002|Overall Study|Adverse Event|5|||
147349663|NCT02736409|531451139|FG003|Overall Study|Adverse Event|4|||
147349664|NCT02736409|531451136|FG000|Overall Study|Other|0|||
147349665|NCT02736409|531451137|FG001|Overall Study|Other|0|||
147349666|NCT02736409|531451138|FG002|Overall Study|Other|1|||
147349667|NCT02736409|531451139|FG003|Overall Study|Other|1|||
147349668|NCT02736409|531451136|FG000|Overall Study|Pregnancy|0|||
147349669|NCT02736409|531451137|FG001|Overall Study|Pregnancy|0|||
147349670|NCT02736409|531451138|FG002|Overall Study|Pregnancy|1|||
147349671|NCT02736409|531451139|FG003|Overall Study|Pregnancy|0|||
147349672|NCT02736409|531451136|FG000|Overall Study|Lost to Follow-up|0|||
147349673|NCT02736409|531451137|FG001|Overall Study|Lost to Follow-up|0|||
147349674|NCT02736409|531451138|FG002|Overall Study|Lost to Follow-up|2|||
147349675|NCT02736409|531451139|FG003|Overall Study|Lost to Follow-up|1|||
147349676|NCT02736409|531451136|FG000|Overall Study|Physician Decision|0|||
147349677|NCT02736409|531451137|FG001|Overall Study|Physician Decision|0|||
147349678|NCT02736409|531451138|FG002|Overall Study|Physician Decision|0|||
147349679|NCT02736409|531451139|FG003|Overall Study|Physician Decision|2|||
147349680|NCT04390048|531451140|FG000|Overall Study|Withdrawal by Subject|1|||
147349681|NCT04390048|531451141|FG001|Overall Study|Withdrawal by Subject|3|||
147349682|NCT01415154|531451142|FG000|Overall Study|Lack of Efficacy|4|||
147349683|NCT01415154|531451143|FG001|Overall Study|Lack of Efficacy|5|||
147606941|NCT00168818|532377201|FG000|Overall Study|Adverse Event|23|||
147349684|NCT01415154|531451142|FG000|Overall Study|Withdrawal by Subject|7|||
147349685|NCT01415154|531451143|FG001|Overall Study|Withdrawal by Subject|8|||
147349686|NCT01415154|531451142|FG000|Overall Study|Lost to Follow-up|1|||
147349687|NCT01415154|531451143|FG001|Overall Study|Lost to Follow-up|4|||
147349688|NCT01415154|531451142|FG000|Overall Study|Protocol Violation|0|||
147349689|NCT01415154|531451143|FG001|Overall Study|Protocol Violation|1|||
147349690|NCT01415154|531451142|FG000|Overall Study|Satisfactory Response|0|||
147349691|NCT01415154|531451143|FG001|Overall Study|Satisfactory Response|1|||
147349692|NCT01415154|531451142|FG000|Overall Study|Adverse Event|1|||
147349693|NCT01415154|531451143|FG001|Overall Study|Adverse Event|1|||
147349694|NCT06283173|531451162|FG000|Overall Study|Did not show for first visit|10|||
147349695|NCT06283173|531451162|FG000|Overall Study|Lost to Follow-up|12|||
147349696|NCT06283173|531451162|FG000|Overall Study|Physician Decision|7|||
147349697|NCT05687916|531451163|FG000|Overall Study|Adverse Event|1|||
147349698|NCT05687916|531451164|FG001|Overall Study|Adverse Event|2|||
147349699|NCT05687916|531451165|FG002|Overall Study|Adverse Event|0|||
147349700|NCT05687916|531451163|FG000|Overall Study|Withdrawal by Subject|1|||
147349701|NCT05687916|531451164|FG001|Overall Study|Withdrawal by Subject|0|||
147606942|NCT00168818|532377202|FG001|Overall Study|Adverse Event|29|||
147606943|NCT00168818|532377203|FG002|Overall Study|Adverse Event|31|||
147349702|NCT05687916|531451165|FG002|Overall Study|Withdrawal by Subject|1|||
147349703|NCT05687916|531451163|FG000|Overall Study|Protocol Violation|0|||
147349704|NCT05687916|531451164|FG001|Overall Study|Protocol Violation|2|||
147349705|NCT05687916|531451165|FG002|Overall Study|Protocol Violation|1|||
147606944|NCT00168818|532377201|FG000|Overall Study|Protocol Violation|16|||
147606945|NCT00168818|532377202|FG001|Overall Study|Protocol Violation|11|||
147349706|NCT05687916|531451163|FG000|Overall Study|Reason not Specified|1|||
147349707|NCT05687916|531451164|FG001|Overall Study|Reason not Specified|0|||
147349708|NCT05687916|531451165|FG002|Overall Study|Reason not Specified|0|||
147349709|NCT03332017|531451166|FG000|Overall Study|Lost to Follow-up|1|||
147349710|NCT03332017|531451167|FG001|Overall Study|Lost to Follow-up|2|||
147349711|NCT03332017|531451166|FG000|Overall Study|Death|17|||
147349712|NCT03332017|531451167|FG001|Overall Study|Death|16|||
147349713|NCT03332017|531451166|FG000|Overall Study|Withdrawal by Subject|6|||
147349714|NCT03332017|531451167|FG001|Overall Study|Withdrawal by Subject|14|||
147606946|NCT00168818|532377203|FG002|Overall Study|Protocol Violation|11|||
147349715|NCT03332017|531451166|FG000|Overall Study|Other|1|||
147349716|NCT03332017|531451167|FG001|Overall Study|Other|3|||
147349717|NCT03332017|531451166|FG000|Overall Study|Remained in Study (Ongoing)|47|||
147349718|NCT03332017|531451167|FG001|Overall Study|Remained in Study (Ongoing)|110|||
147349719|NCT01261312|531451168|FG000|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|27|||
147349720|NCT01261312|531451169|FG001|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|26|||
147349721|NCT01261312|531451170|FG002|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|9|||
147349722|NCT01261312|531451171|FG003|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
147349723|NCT01261312|531451172|FG004|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
147349724|NCT01261312|531451173|FG005|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
147349725|NCT01261312|531451174|FG006|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
147349726|NCT01261312|531451175|FG007|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
147349727|NCT01261312|531451176|FG008|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
147349728|NCT01261312|531451177|FG009|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
147349729|NCT01261312|531451178|FG010|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
147349730|NCT01261312|531451179|FG011|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
147349731|NCT01261312|531451180|FG012|Dose Escalation Phase (Day 0- Week 170)|Progressive Disease|0|||
147349732|NCT01261312|531451168|FG000|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|1|||
147349733|NCT01261312|531451169|FG001|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|1|||
147349734|NCT01261312|531451170|FG002|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
147349735|NCT01261312|531451171|FG003|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
147349736|NCT01261312|531451172|FG004|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
147349737|NCT01261312|531451173|FG005|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
147349738|NCT01261312|531451174|FG006|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
147349739|NCT01261312|531451175|FG007|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
147349740|NCT01261312|531451176|FG008|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
147349741|NCT01261312|531451177|FG009|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
147349742|NCT01261312|531451178|FG010|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
147349743|NCT01261312|531451179|FG011|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
147349744|NCT01261312|531451180|FG012|Dose Escalation Phase (Day 0- Week 170)|Adverse Event|0|||
147349745|NCT01261312|531451168|FG000|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|3|||
147349746|NCT01261312|531451169|FG001|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|2|||
147349747|NCT01261312|531451170|FG002|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
147349748|NCT01261312|531451171|FG003|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
147349749|NCT01261312|531451172|FG004|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
147349750|NCT01261312|531451173|FG005|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
147349751|NCT01261312|531451174|FG006|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
147349752|NCT01261312|531451175|FG007|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
147349753|NCT01261312|531451176|FG008|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
147349754|NCT01261312|531451177|FG009|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
147349755|NCT01261312|531451178|FG010|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
147349756|NCT01261312|531451179|FG011|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
147349757|NCT01261312|531451180|FG012|Dose Escalation Phase (Day 0- Week 170)|Subject Withdrew Consent|0|||
147349758|NCT01261312|531451168|FG000|Dose Escalation Phase (Day 0- Week 170)|Death|5|||
147349759|NCT01261312|531451169|FG001|Dose Escalation Phase (Day 0- Week 170)|Death|4|||
147349760|NCT01261312|531451170|FG002|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
147349761|NCT01261312|531451171|FG003|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
147349762|NCT01261312|531451172|FG004|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
147349763|NCT01261312|531451173|FG005|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
147606947|NCT00168818|532377201|FG000|Overall Study|Lost to Follow-up|13|||
147606948|NCT00168818|532377202|FG001|Overall Study|Lost to Follow-up|4|||
147606949|NCT00168818|532377203|FG002|Overall Study|Lost to Follow-up|15|||
147606950|NCT00168818|532377201|FG000|Overall Study|Withdrawal by Subject|43|||
147606951|NCT00168818|532377202|FG001|Overall Study|Withdrawal by Subject|41|||
147606952|NCT00168818|532377203|FG002|Overall Study|Withdrawal by Subject|37|||
147606953|NCT00168818|532377201|FG000|Overall Study|Other|22|||
147606954|NCT00168818|532377202|FG001|Overall Study|Other|24|||
147606955|NCT00168818|532377203|FG002|Overall Study|Other|30|||
147606956|NCT00168818|532377201|FG000|Treatment|Adverse Event|77|||
147349764|NCT01261312|531451174|FG006|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
147349765|NCT01261312|531451175|FG007|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
147606957|NCT00168818|532377202|FG001|Treatment|Adverse Event|89|||
147606958|NCT00168818|532377203|FG002|Treatment|Adverse Event|68|||
147606959|NCT00168818|532377201|FG000|Treatment|Protocol Violation|8|||
147606960|NCT00168818|532377202|FG001|Treatment|Protocol Violation|11|||
147606961|NCT00168818|532377203|FG002|Treatment|Protocol Violation|11|||
147606962|NCT00168818|532377201|FG000|Treatment|Lost to Follow-up|0|||
147606963|NCT00168818|532377202|FG001|Treatment|Lost to Follow-up|2|||
147606964|NCT00168818|532377203|FG002|Treatment|Lost to Follow-up|1|||
147606965|NCT00168818|532377201|FG000|Treatment|Withdrawal by Subject|25|||
147349766|NCT01261312|531451176|FG008|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
147349767|NCT01261312|531451177|FG009|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
147349768|NCT01261312|531451178|FG010|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
147349769|NCT01261312|531451179|FG011|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
147349770|NCT01261312|531451180|FG012|Dose Escalation Phase (Day 0- Week 170)|Death|0|||
147349771|NCT01261312|531451168|FG000|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|4|||
147349772|NCT01261312|531451169|FG001|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|1|||
147349773|NCT01261312|531451170|FG002|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|3|||
147349774|NCT01261312|531451171|FG003|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
147349775|NCT01261312|531451172|FG004|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
147349776|NCT01261312|531451173|FG005|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
147349777|NCT01261312|531451174|FG006|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
147349778|NCT01261312|531451175|FG007|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
147349779|NCT01261312|531451176|FG008|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
147349780|NCT01261312|531451177|FG009|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
147349781|NCT01261312|531451178|FG010|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
147349782|NCT01261312|531451179|FG011|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
147349783|NCT01261312|531451180|FG012|Dose Escalation Phase (Day 0- Week 170)|Investigator Decision|0|||
147349784|NCT01261312|531451168|FG000|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|1|||
147349785|NCT01261312|531451169|FG001|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|1|||
147349786|NCT01261312|531451170|FG002|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|1|||
147349787|NCT01261312|531451171|FG003|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
147349788|NCT01261312|531451172|FG004|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
147349789|NCT01261312|531451173|FG005|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
147349790|NCT01261312|531451174|FG006|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
147349791|NCT01261312|531451175|FG007|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
147349792|NCT01261312|531451176|FG008|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
147349793|NCT01261312|531451177|FG009|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
147349794|NCT01261312|531451178|FG010|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
147349795|NCT01261312|531451179|FG011|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
147349796|NCT01261312|531451180|FG012|Dose Escalation Phase (Day 0- Week 170)|Hematopoietic Cell Transplant (HCT)|0|||
147349797|NCT01261312|531451168|FG000|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|3|||
147349798|NCT01261312|531451169|FG001|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
147349799|NCT01261312|531451170|FG002|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|2|||
147349800|NCT01261312|531451171|FG003|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
147349801|NCT01261312|531451172|FG004|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
147349802|NCT01261312|531451173|FG005|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
147349803|NCT01261312|531451174|FG006|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
147349804|NCT01261312|531451175|FG007|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
147349805|NCT01261312|531451176|FG008|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
147349806|NCT01261312|531451177|FG009|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
147349807|NCT01261312|531451178|FG010|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
147349808|NCT01261312|531451179|FG011|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
147349809|NCT01261312|531451180|FG012|Dose Escalation Phase (Day 0- Week 170)|Reason not Specified|0|||
147349810|NCT01261312|531451168|FG000|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
147349811|NCT01261312|531451169|FG001|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
147349812|NCT01261312|531451170|FG002|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
147349813|NCT01261312|531451171|FG003|DE Phase: r/r AML (Week 75-242)|Progressive Disease|14|||
147349814|NCT01261312|531451172|FG004|DE Phase: r/r AML (Week 75-242)|Progressive Disease|16|||
147349815|NCT01261312|531451173|FG005|DE Phase: r/r AML (Week 75-242)|Progressive Disease|24|||
147349816|NCT01261312|531451174|FG006|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
147606966|NCT00168818|532377202|FG001|Treatment|Withdrawal by Subject|20|||
147606967|NCT00168818|532377203|FG002|Treatment|Withdrawal by Subject|22|||
147349817|NCT01261312|531451175|FG007|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
147349818|NCT01261312|531451176|FG008|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
147349819|NCT01261312|531451177|FG009|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
147349820|NCT01261312|531451178|FG010|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
147349821|NCT01261312|531451179|FG011|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
147349822|NCT01261312|531451180|FG012|DE Phase: r/r AML (Week 75-242)|Progressive Disease|0|||
147349823|NCT01261312|531451168|FG000|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
147349824|NCT01261312|531451169|FG001|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
147349825|NCT01261312|531451170|FG002|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
147349826|NCT01261312|531451171|FG003|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
147349827|NCT01261312|531451172|FG004|DE Phase: r/r AML (Week 75-242)|Adverse Event|2|||
147349828|NCT01261312|531451173|FG005|DE Phase: r/r AML (Week 75-242)|Adverse Event|2|||
147349829|NCT01261312|531451174|FG006|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
147349830|NCT01261312|531451175|FG007|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
147349831|NCT01261312|531451176|FG008|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
147349832|NCT01261312|531451177|FG009|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
147349833|NCT01261312|531451178|FG010|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
147349834|NCT01261312|531451179|FG011|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
147349835|NCT01261312|531451180|FG012|DE Phase: r/r AML (Week 75-242)|Adverse Event|0|||
147349836|NCT01261312|531451168|FG000|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
147349837|NCT01261312|531451169|FG001|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
147349838|NCT01261312|531451170|FG002|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
147349839|NCT01261312|531451171|FG003|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
147349840|NCT01261312|531451172|FG004|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|1|||
147349841|NCT01261312|531451173|FG005|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|2|||
147349842|NCT01261312|531451174|FG006|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
147349843|NCT01261312|531451175|FG007|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
147349844|NCT01261312|531451176|FG008|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
147349845|NCT01261312|531451177|FG009|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
147349846|NCT01261312|531451178|FG010|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
147349847|NCT01261312|531451179|FG011|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
147349848|NCT01261312|531451180|FG012|DE Phase: r/r AML (Week 75-242)|Withdrew Consent|0|||
147349849|NCT01261312|531451168|FG000|DE Phase: r/r AML (Week 75-242)|Death|0|||
147349850|NCT01261312|531451169|FG001|DE Phase: r/r AML (Week 75-242)|Death|0|||
147349851|NCT01261312|531451170|FG002|DE Phase: r/r AML (Week 75-242)|Death|0|||
147349852|NCT01261312|531451171|FG003|DE Phase: r/r AML (Week 75-242)|Death|4|||
147349853|NCT01261312|531451172|FG004|DE Phase: r/r AML (Week 75-242)|Death|3|||
147349854|NCT01261312|531451173|FG005|DE Phase: r/r AML (Week 75-242)|Death|10|||
147349855|NCT01261312|531451174|FG006|DE Phase: r/r AML (Week 75-242)|Death|0|||
147349856|NCT01261312|531451175|FG007|DE Phase: r/r AML (Week 75-242)|Death|0|||
147349857|NCT01261312|531451176|FG008|DE Phase: r/r AML (Week 75-242)|Death|0|||
147349858|NCT01261312|531451177|FG009|DE Phase: r/r AML (Week 75-242)|Death|0|||
147349859|NCT01261312|531451178|FG010|DE Phase: r/r AML (Week 75-242)|Death|0|||
147349860|NCT01261312|531451179|FG011|DE Phase: r/r AML (Week 75-242)|Death|0|||
147349861|NCT01261312|531451180|FG012|DE Phase: r/r AML (Week 75-242)|Death|0|||
147349862|NCT01261312|531451168|FG000|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
147349863|NCT01261312|531451169|FG001|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
147349864|NCT01261312|531451170|FG002|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
147349865|NCT01261312|531451171|FG003|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
147349866|NCT01261312|531451172|FG004|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
147349867|NCT01261312|531451173|FG005|DE Phase: r/r AML (Week 75-242)|Investigator Decision|6|||
147349868|NCT01261312|531451174|FG006|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
147349869|NCT01261312|531451175|FG007|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
147349870|NCT01261312|531451176|FG008|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
147349871|NCT01261312|531451177|FG009|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
147453289|NCT02064387|531823980|FG002|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
147606968|NCT00168818|532377201|FG000|Treatment|Other|23|||
147606969|NCT00168818|532377202|FG001|Treatment|Other|29|||
147349872|NCT01261312|531451178|FG010|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
147349873|NCT01261312|531451179|FG011|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
147349874|NCT01261312|531451180|FG012|DE Phase: r/r AML (Week 75-242)|Investigator Decision|0|||
147349875|NCT01261312|531451168|FG000|DE Phase: r/r AML (Week 75-242)|HCT|0|||
147349876|NCT01261312|531451169|FG001|DE Phase: r/r AML (Week 75-242)|HCT|0|||
147349877|NCT01261312|531451170|FG002|DE Phase: r/r AML (Week 75-242)|HCT|0|||
147349878|NCT01261312|531451171|FG003|DE Phase: r/r AML (Week 75-242)|HCT|5|||
147349879|NCT01261312|531451172|FG004|DE Phase: r/r AML (Week 75-242)|HCT|3|||
147349880|NCT01261312|531451173|FG005|DE Phase: r/r AML (Week 75-242)|HCT|9|||
147349881|NCT01261312|531451174|FG006|DE Phase: r/r AML (Week 75-242)|HCT|0|||
147349882|NCT01261312|531451175|FG007|DE Phase: r/r AML (Week 75-242)|HCT|0|||
147606970|NCT00168818|532377203|FG002|Treatment|Other|31|||
147606971|NCT00603837|532377206|FG000|Overall Study|Physician Decision|3|||
147349883|NCT01261312|531451176|FG008|DE Phase: r/r AML (Week 75-242)|HCT|0|||
147349884|NCT01261312|531451177|FG009|DE Phase: r/r AML (Week 75-242)|HCT|0|||
147349885|NCT01261312|531451178|FG010|DE Phase: r/r AML (Week 75-242)|HCT|0|||
147349886|NCT01261312|531451179|FG011|DE Phase: r/r AML (Week 75-242)|HCT|0|||
147349887|NCT01261312|531451180|FG012|DE Phase: r/r AML (Week 75-242)|HCT|0|||
147349888|NCT01261312|531451168|FG000|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
147349889|NCT01261312|531451169|FG001|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
147349890|NCT01261312|531451170|FG002|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
147349891|NCT01261312|531451171|FG003|DE Phase: r/r AML (Week 75-242)|Reason not Specified|1|||
147349892|NCT01261312|531451172|FG004|DE Phase: r/r AML (Week 75-242)|Reason not Specified|2|||
147349893|NCT01261312|531451173|FG005|DE Phase: r/r AML (Week 75-242)|Reason not Specified|2|||
147349894|NCT01261312|531451174|FG006|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
147349895|NCT01261312|531451175|FG007|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
147349896|NCT01261312|531451176|FG008|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
147349897|NCT01261312|531451177|FG009|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
147349898|NCT01261312|531451178|FG010|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
147349899|NCT01261312|531451179|FG011|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
147349900|NCT01261312|531451180|FG012|DE Phase: r/r AML (Week 75-242)|Reason not Specified|0|||
147349901|NCT01261312|531451168|FG000|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
147349902|NCT01261312|531451169|FG001|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
147349903|NCT01261312|531451170|FG002|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
147349904|NCT01261312|531451171|FG003|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
147349905|NCT01261312|531451172|FG004|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
147349906|NCT01261312|531451173|FG005|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
147349907|NCT01261312|531451174|FG006|DE Phase: TN AML (Week 85-283)|Progressive Disease|9|||
147349908|NCT01261312|531451175|FG007|DE Phase: TN AML (Week 85-283)|Progressive Disease|11|||
147349909|NCT01261312|531451176|FG008|DE Phase: TN AML (Week 85-283)|Progressive Disease|17|||
147349910|NCT01261312|531451177|FG009|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
147349911|NCT01261312|531451178|FG010|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
147349912|NCT01261312|531451179|FG011|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
147349913|NCT01261312|531451180|FG012|DE Phase: TN AML (Week 85-283)|Progressive Disease|0|||
147349914|NCT01261312|531451168|FG000|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
147349915|NCT01261312|531451169|FG001|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
147349916|NCT01261312|531451170|FG002|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
147349917|NCT01261312|531451171|FG003|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
147349918|NCT01261312|531451172|FG004|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
147349919|NCT01261312|531451173|FG005|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
147349920|NCT01261312|531451174|FG006|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
147349921|NCT01261312|531451175|FG007|DE Phase: TN AML (Week 85-283)|Adverse Event|1|||
147349922|NCT01261312|531451176|FG008|DE Phase: TN AML (Week 85-283)|Adverse Event|2|||
147349923|NCT01261312|531451177|FG009|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
147349924|NCT01261312|531451178|FG010|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
147349925|NCT01261312|531451179|FG011|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
147349926|NCT01261312|531451180|FG012|DE Phase: TN AML (Week 85-283)|Adverse Event|0|||
147349927|NCT01261312|531451168|FG000|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
147349928|NCT01261312|531451169|FG001|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
147349929|NCT01261312|531451170|FG002|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
147349930|NCT01261312|531451171|FG003|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
147349931|NCT01261312|531451172|FG004|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
147349932|NCT01261312|531451173|FG005|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
147349933|NCT01261312|531451174|FG006|DE Phase: TN AML (Week 85-283)|Withdrew Consent|3|||
147349934|NCT01261312|531451175|FG007|DE Phase: TN AML (Week 85-283)|Withdrew Consent|3|||
147349935|NCT01261312|531451176|FG008|DE Phase: TN AML (Week 85-283)|Withdrew Consent|3|||
147349936|NCT01261312|531451177|FG009|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
147349937|NCT01261312|531451178|FG010|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
147349938|NCT01261312|531451179|FG011|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
147349939|NCT01261312|531451180|FG012|DE Phase: TN AML (Week 85-283)|Withdrew Consent|0|||
147349940|NCT01261312|531451168|FG000|DE Phase: TN AML (Week 85-283)|Death|0|||
147349941|NCT01261312|531451169|FG001|DE Phase: TN AML (Week 85-283)|Death|0|||
147349942|NCT01261312|531451170|FG002|DE Phase: TN AML (Week 85-283)|Death|0|||
147349943|NCT01261312|531451171|FG003|DE Phase: TN AML (Week 85-283)|Death|0|||
147349944|NCT01261312|531451172|FG004|DE Phase: TN AML (Week 85-283)|Death|0|||
147349945|NCT01261312|531451173|FG005|DE Phase: TN AML (Week 85-283)|Death|0|||
147349946|NCT01261312|531451174|FG006|DE Phase: TN AML (Week 85-283)|Death|4|||
147349947|NCT01261312|531451175|FG007|DE Phase: TN AML (Week 85-283)|Death|7|||
147349948|NCT01261312|531451176|FG008|DE Phase: TN AML (Week 85-283)|Death|11|||
147349949|NCT01261312|531451177|FG009|DE Phase: TN AML (Week 85-283)|Death|0|||
147349950|NCT01261312|531451178|FG010|DE Phase: TN AML (Week 85-283)|Death|0|||
147349951|NCT01261312|531451179|FG011|DE Phase: TN AML (Week 85-283)|Death|0|||
147349952|NCT01261312|531451180|FG012|DE Phase: TN AML (Week 85-283)|Death|0|||
147349953|NCT01261312|531451168|FG000|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
147349954|NCT01261312|531451169|FG001|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
147349955|NCT01261312|531451170|FG002|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
147349956|NCT01261312|531451171|FG003|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
147349957|NCT01261312|531451172|FG004|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
147349958|NCT01261312|531451173|FG005|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
147349959|NCT01261312|531451174|FG006|DE Phase: TN AML (Week 85-283)|Investigator Decision|2|||
147349960|NCT01261312|531451175|FG007|DE Phase: TN AML (Week 85-283)|Investigator Decision|2|||
147349961|NCT01261312|531451176|FG008|DE Phase: TN AML (Week 85-283)|Investigator Decision|9|||
147349962|NCT01261312|531451177|FG009|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
147349963|NCT01261312|531451178|FG010|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
147349964|NCT01261312|531451179|FG011|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
147349965|NCT01261312|531451180|FG012|DE Phase: TN AML (Week 85-283)|Investigator Decision|0|||
147349966|NCT01261312|531451168|FG000|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
147349967|NCT01261312|531451169|FG001|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
147349968|NCT01261312|531451170|FG002|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
147349969|NCT01261312|531451171|FG003|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
147349970|NCT01261312|531451172|FG004|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
147349971|NCT01261312|531451173|FG005|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
147349972|NCT01261312|531451174|FG006|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|2|||
147349973|NCT01261312|531451175|FG007|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|1|||
147349974|NCT01261312|531451176|FG008|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|2|||
147349975|NCT01261312|531451177|FG009|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
147349976|NCT01261312|531451178|FG010|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
147349977|NCT01261312|531451179|FG011|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
147349978|NCT01261312|531451180|FG012|DE Phase: TN AML (Week 85-283)|Bone marrow (BM)/Stem cell transplant|0|||
147349979|NCT01261312|531451168|FG000|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
147349980|NCT01261312|531451169|FG001|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
147349981|NCT01261312|531451170|FG002|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
147349982|NCT01261312|531451171|FG003|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
147349983|NCT01261312|531451172|FG004|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
147349984|NCT01261312|531451173|FG005|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
147349985|NCT01261312|531451174|FG006|DE Phase: TN AML (Week 85-283)|Reason not Specified|5|||
147349986|NCT01261312|531451175|FG007|DE Phase: TN AML (Week 85-283)|Reason not Specified|1|||
147349987|NCT01261312|531451176|FG008|DE Phase: TN AML (Week 85-283)|Reason not Specified|6|||
147349988|NCT01261312|531451177|FG009|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
147349989|NCT01261312|531451178|FG010|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
147349990|NCT01261312|531451179|FG011|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
147349991|NCT01261312|531451180|FG012|DE Phase: TN AML (Week 85-283)|Reason not Specified|0|||
147349992|NCT01261312|531451168|FG000|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
147349993|NCT01261312|531451169|FG001|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
147349994|NCT01261312|531451170|FG002|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
147349995|NCT01261312|531451171|FG003|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
147349996|NCT01261312|531451172|FG004|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
147349997|NCT01261312|531451173|FG005|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
147349998|NCT01261312|531451174|FG006|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
147349999|NCT01261312|531451175|FG007|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
147350000|NCT01261312|531451176|FG008|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|0|||
147350001|NCT01261312|531451177|FG009|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|7|||
147350002|NCT01261312|531451178|FG010|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|7|||
147350003|NCT01261312|531451179|FG011|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|9|||
147350004|NCT01261312|531451180|FG012|DE Phase: r/r MDS &TN MDS (Week 78-298)|Progressive Disease|2|||
147350005|NCT01261312|531451168|FG000|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
147350006|NCT01261312|531451169|FG001|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
147350007|NCT01261312|531451170|FG002|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
147350008|NCT01261312|531451171|FG003|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
147350009|NCT01261312|531451172|FG004|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
147350010|NCT01261312|531451173|FG005|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
147350011|NCT01261312|531451174|FG006|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
147350012|NCT01261312|531451175|FG007|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
147350013|NCT01261312|531451176|FG008|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
147350014|NCT01261312|531451177|FG009|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|2|||
147350015|NCT01261312|531451178|FG010|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|0|||
147350016|NCT01261312|531451179|FG011|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|3|||
147350017|NCT01261312|531451180|FG012|DE Phase: r/r MDS &TN MDS (Week 78-298)|Adverse Event|3|||
147350018|NCT01261312|531451168|FG000|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
147350019|NCT01261312|531451169|FG001|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
147350020|NCT01261312|531451170|FG002|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
147350021|NCT01261312|531451171|FG003|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
147350022|NCT01261312|531451172|FG004|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
147350023|NCT01261312|531451173|FG005|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
147350024|NCT01261312|531451174|FG006|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
147350025|NCT01261312|531451175|FG007|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
147350026|NCT01261312|531451176|FG008|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|0|||
147350027|NCT01261312|531451177|FG009|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|4|||
147350028|NCT01261312|531451178|FG010|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|5|||
147350029|NCT01261312|531451179|FG011|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|3|||
147350030|NCT01261312|531451180|FG012|DE Phase: r/r MDS &TN MDS (Week 78-298)|Withdrew Consent|3|||
147350031|NCT01261312|531451168|FG000|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
147350032|NCT01261312|531451169|FG001|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
147350033|NCT01261312|531451170|FG002|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
147350034|NCT01261312|531451171|FG003|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
147350035|NCT01261312|531451172|FG004|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
147350036|NCT01261312|531451173|FG005|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
147350037|NCT01261312|531451174|FG006|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
147350038|NCT01261312|531451175|FG007|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
147350039|NCT01261312|531451176|FG008|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|0|||
147350040|NCT01261312|531451177|FG009|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|2|||
147350041|NCT01261312|531451178|FG010|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|4|||
147350042|NCT01261312|531451179|FG011|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|1|||
147350043|NCT01261312|531451180|FG012|DE Phase: r/r MDS &TN MDS (Week 78-298)|Death|2|||
147350044|NCT01261312|531451168|FG000|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
147350045|NCT01261312|531451169|FG001|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
147350046|NCT01261312|531451170|FG002|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
147350047|NCT01261312|531451171|FG003|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
147350048|NCT01261312|531451172|FG004|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
147350049|NCT01261312|531451173|FG005|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
147350050|NCT01261312|531451174|FG006|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
147350051|NCT01261312|531451175|FG007|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
147350052|NCT01261312|531451176|FG008|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|0|||
147350053|NCT01261312|531451177|FG009|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|5|||
147350054|NCT01261312|531451178|FG010|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|6|||
147350055|NCT01261312|531451179|FG011|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|3|||
147350056|NCT01261312|531451180|FG012|DE Phase: r/r MDS &TN MDS (Week 78-298)|Investigator Decision|5|||
147350057|NCT01261312|531451168|FG000|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
147350058|NCT01261312|531451169|FG001|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
147350059|NCT01261312|531451170|FG002|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
147350060|NCT01261312|531451171|FG003|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
147350061|NCT01261312|531451172|FG004|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
147350062|NCT01261312|531451173|FG005|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
147350063|NCT01261312|531451174|FG006|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
147350064|NCT01261312|531451175|FG007|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
147350065|NCT01261312|531451176|FG008|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|0|||
147350066|NCT01261312|531451177|FG009|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|3|||
147350067|NCT01261312|531451178|FG010|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|1|||
147350068|NCT01261312|531451179|FG011|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|6|||
147350069|NCT01261312|531451180|FG012|DE Phase: r/r MDS &TN MDS (Week 78-298)|BM/Stem Cell Transplant|4|||
147350070|NCT01261312|531451168|FG000|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
147350071|NCT01261312|531451169|FG001|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
147350072|NCT01261312|531451170|FG002|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
147350073|NCT01261312|531451171|FG003|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
147350074|NCT01261312|531451172|FG004|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
147453290|NCT02064387|531823981|FG003|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
147453291|NCT02064387|531823982|FG004|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
147606972|NCT00603837|532377207|FG001|Overall Study|Physician Decision|0|||
147606973|NCT04611529|532377208|FG000|2-day Follow up|Lost to Follow-up|5|||
147606974|NCT04611529|532377209|FG001|2-day Follow up|Lost to Follow-up|6|||
147606975|NCT04611529|532377210|FG002|2-day Follow up|Lost to Follow-up|3|||
147606976|NCT02538965|532377216|FG000|Treatment Period|Other = Death due to disease progression|1|||
147606977|NCT02538965|532377216|FG000|Treatment Period|Adverse Event|2|||
147606978|NCT02538965|532377216|FG000|Treatment Period|Withdrawal by Parent/Guardian|2|||
147606979|NCT02538965|532377216|FG000|Treatment Period|Treatment Failure|9|||
147606980|NCT02538965|532377216|FG000|Treatment Period|Disease Progression|1|||
147350075|NCT01261312|531451173|FG005|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
147350076|NCT01261312|531451174|FG006|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
147606981|NCT02538965|532377216|FG000|Treatment Period|Physician Decision|2|||
147606982|NCT02538965|532377216|FG000|Follow-Up Period|Other = Death due to disease progression|13|||
147606983|NCT02538965|532377216|FG000|Follow-Up Period|Withdrawal by Parent|4|||
147350077|NCT01261312|531451175|FG007|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
147350078|NCT01261312|531451176|FG008|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|0|||
147350079|NCT01261312|531451177|FG009|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|2|||
147350080|NCT01261312|531451178|FG010|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|2|||
147350081|NCT01261312|531451179|FG011|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|2|||
147350082|NCT01261312|531451180|FG012|DE Phase: r/r MDS &TN MDS (Week 78-298)|Reason not Specified|1|||
147350083|NCT03336333|531451188|FG000|Overall Study|Remained on study at time of data cut-off|202|||
147350084|NCT03336333|531451189|FG001|Overall Study|Remained on study at time of data cut-off|219|||
147350085|NCT03336333|531451190|FG002|Overall Study|Remained on study at time of data cut-off|102|||
147350086|NCT03336333|531451188|FG000|Overall Study|Death|14|||
147350087|NCT03336333|531451189|FG001|Overall Study|Death|16|||
147350088|NCT03336333|531451190|FG002|Overall Study|Death|8|||
147350089|NCT03336333|531451188|FG000|Overall Study|Withdrawal by Subject|16|||
147350090|NCT03336333|531451189|FG001|Overall Study|Withdrawal by Subject|5|||
147350091|NCT03336333|531451190|FG002|Overall Study|Withdrawal by Subject|1|||
147350092|NCT03336333|531451188|FG000|Overall Study|Physician Decision|5|||
147350093|NCT03336333|531451189|FG001|Overall Study|Physician Decision|1|||
147350094|NCT03336333|531451190|FG002|Overall Study|Physician Decision|0|||
147350095|NCT03336333|531451188|FG000|Overall Study|Lost to Follow-up|1|||
147350096|NCT03336333|531451189|FG001|Overall Study|Lost to Follow-up|0|||
147350097|NCT03336333|531451190|FG002|Overall Study|Lost to Follow-up|0|||
147350098|NCT04927065|531451191|FG000|First Booster|Adverse Event|1|||
147350099|NCT04927065|531451192|FG001|First Booster|Adverse Event|0|||
147350100|NCT04927065|531451193|FG002|First Booster|Adverse Event|0|||
147350101|NCT04927065|531451194|FG003|First Booster|Adverse Event|0|||
147350102|NCT04927065|531451195|FG004|First Booster|Adverse Event|0|||
147350103|NCT04927065|531451196|FG005|First Booster|Adverse Event|0|||
147350104|NCT04927065|531451197|FG006|First Booster|Adverse Event|0|||
147350105|NCT04927065|531451198|FG007|First Booster|Adverse Event|1|||
147350106|NCT04927065|531451199|FG008|First Booster|Adverse Event|0|||
147350107|NCT04927065|531451200|FG009|First Booster|Adverse Event|0|||
147350108|NCT04927065|531451201|FG010|First Booster|Adverse Event|0|||
147350109|NCT04927065|531451202|FG011|First Booster|Adverse Event|0|||
147350110|NCT04927065|531451203|FG012|First Booster|Adverse Event|0|||
147350111|NCT04927065|531451204|FG013|First Booster|Adverse Event|0|||
147350112|NCT04927065|531451205|FG014|First Booster|Adverse Event|0|||
147350113|NCT04927065|531451206|FG015|First Booster|Adverse Event|0|||
147350114|NCT04927065|531451191|FG000|First Booster|Death|1|||
147350115|NCT04927065|531451192|FG001|First Booster|Death|0|||
147350116|NCT04927065|531451193|FG002|First Booster|Death|0|||
147350117|NCT04927065|531451194|FG003|First Booster|Death|1|||
147350118|NCT04927065|531451195|FG004|First Booster|Death|0|||
147350119|NCT04927065|531451196|FG005|First Booster|Death|1|||
147350120|NCT04927065|531451197|FG006|First Booster|Death|0|||
147350121|NCT04927065|531451198|FG007|First Booster|Death|0|||
147350122|NCT04927065|531451199|FG008|First Booster|Death|0|||
147350123|NCT04927065|531451200|FG009|First Booster|Death|0|||
147350124|NCT04927065|531451201|FG010|First Booster|Death|0|||
147350125|NCT04927065|531451202|FG011|First Booster|Death|0|||
147350126|NCT04927065|531451203|FG012|First Booster|Death|0|||
147350127|NCT04927065|531451204|FG013|First Booster|Death|0|||
147350128|NCT04927065|531451205|FG014|First Booster|Death|0|||
147350129|NCT04927065|531451206|FG015|First Booster|Death|0|||
147350130|NCT04927065|531451191|FG000|First Booster|Lost to Follow-up|8|||
147350131|NCT04927065|531451192|FG001|First Booster|Lost to Follow-up|20|||
147350132|NCT04927065|531451193|FG002|First Booster|Lost to Follow-up|0|||
147350133|NCT04927065|531451194|FG003|First Booster|Lost to Follow-up|11|||
147350134|NCT04927065|531451195|FG004|First Booster|Lost to Follow-up|43|||
147350135|NCT04927065|531451196|FG005|First Booster|Lost to Follow-up|30|||
147350136|NCT04927065|531451197|FG006|First Booster|Lost to Follow-up|28|||
147350137|NCT04927065|531451198|FG007|First Booster|Lost to Follow-up|23|||
147350138|NCT04927065|531451199|FG008|First Booster|Lost to Follow-up|4|||
147350139|NCT04927065|531451200|FG009|First Booster|Lost to Follow-up|15|||
147350140|NCT04927065|531451201|FG010|First Booster|Lost to Follow-up|0|||
147350141|NCT04927065|531451202|FG011|First Booster|Lost to Follow-up|0|||
147350142|NCT04927065|531451203|FG012|First Booster|Lost to Follow-up|0|||
147606984|NCT00875797|532377217|FG000|Overall Study|Protocol Violation|6|||
147606985|NCT00875797|532377218|FG001|Overall Study|Protocol Violation|3|||
147606986|NCT00425373|532377222|FG000|Overall Study|Adverse Event|2|||
147606987|NCT00425373|532377223|FG001|Overall Study|Adverse Event|2|||
147606988|NCT00425373|532377224|FG002|Overall Study|Adverse Event|0|||
147606989|NCT00425373|532377225|FG003|Overall Study|Adverse Event|1|||
147606990|NCT00425373|532377226|FG004|Overall Study|Adverse Event|4|||
147606991|NCT00425373|532377227|FG005|Overall Study|Adverse Event|6|||
147606992|NCT00425373|532377228|FG006|Overall Study|Adverse Event|2|||
147606993|NCT00425373|532377229|FG007|Overall Study|Adverse Event|3|||
147606994|NCT00425373|532377230|FG008|Overall Study|Adverse Event|8|||
147606995|NCT00425373|532377222|FG000|Overall Study|Lost to Follow-up|0|||
147606996|NCT00425373|532377223|FG001|Overall Study|Lost to Follow-up|1|||
147606997|NCT00425373|532377224|FG002|Overall Study|Lost to Follow-up|0|||
147606998|NCT00425373|532377225|FG003|Overall Study|Lost to Follow-up|0|||
147606999|NCT00425373|532377226|FG004|Overall Study|Lost to Follow-up|1|||
147607000|NCT00425373|532377227|FG005|Overall Study|Lost to Follow-up|0|||
147607001|NCT00425373|532377228|FG006|Overall Study|Lost to Follow-up|0|||
147350143|NCT04927065|531451204|FG013|First Booster|Lost to Follow-up|0|||
147350144|NCT04927065|531451205|FG014|First Booster|Lost to Follow-up|0|||
147350145|NCT04927065|531451206|FG015|First Booster|Lost to Follow-up|0|||
147350146|NCT04927065|531451191|FG000|First Booster|Physician Decision|1|||
147350147|NCT04927065|531451192|FG001|First Booster|Physician Decision|0|||
147350148|NCT04927065|531451193|FG002|First Booster|Physician Decision|0|||
147350149|NCT04927065|531451194|FG003|First Booster|Physician Decision|3|||
147350150|NCT04927065|531451195|FG004|First Booster|Physician Decision|1|||
147350151|NCT04927065|531451196|FG005|First Booster|Physician Decision|1|||
147350152|NCT04927065|531451197|FG006|First Booster|Physician Decision|0|||
147350153|NCT04927065|531451198|FG007|First Booster|Physician Decision|3|||
147350154|NCT04927065|531451199|FG008|First Booster|Physician Decision|0|||
147350155|NCT04927065|531451200|FG009|First Booster|Physician Decision|0|||
147350156|NCT04927065|531451201|FG010|First Booster|Physician Decision|0|||
147350157|NCT04927065|531451202|FG011|First Booster|Physician Decision|0|||
147350158|NCT04927065|531451203|FG012|First Booster|Physician Decision|0|||
147350159|NCT04927065|531451204|FG013|First Booster|Physician Decision|0|||
147350160|NCT04927065|531451205|FG014|First Booster|Physician Decision|0|||
147350161|NCT04927065|531451206|FG015|First Booster|Physician Decision|0|||
147350162|NCT04927065|531451191|FG000|First Booster|Protocol Violation|4|||
147350163|NCT04927065|531451192|FG001|First Booster|Protocol Violation|4|||
147350164|NCT04927065|531451193|FG002|First Booster|Protocol Violation|0|||
147350165|NCT04927065|531451194|FG003|First Booster|Protocol Violation|3|||
147350166|NCT04927065|531451195|FG004|First Booster|Protocol Violation|0|||
147350167|NCT04927065|531451196|FG005|First Booster|Protocol Violation|0|||
147350168|NCT04927065|531451197|FG006|First Booster|Protocol Violation|0|||
147350169|NCT04927065|531451198|FG007|First Booster|Protocol Violation|2|||
147350170|NCT04927065|531451199|FG008|First Booster|Protocol Violation|0|||
147350171|NCT04927065|531451200|FG009|First Booster|Protocol Violation|0|||
147350172|NCT04927065|531451201|FG010|First Booster|Protocol Violation|0|||
147350173|NCT04927065|531451202|FG011|First Booster|Protocol Violation|0|||
147350174|NCT04927065|531451203|FG012|First Booster|Protocol Violation|0|||
147350175|NCT04927065|531451204|FG013|First Booster|Protocol Violation|0|||
147350176|NCT04927065|531451205|FG014|First Booster|Protocol Violation|0|||
147350177|NCT04927065|531451206|FG015|First Booster|Protocol Violation|0|||
147350178|NCT04927065|531451191|FG000|First Booster|Withdrawal by Subject|8|||
147350179|NCT04927065|531451192|FG001|First Booster|Withdrawal by Subject|23|||
147350180|NCT04927065|531451193|FG002|First Booster|Withdrawal by Subject|0|||
147350181|NCT04927065|531451194|FG003|First Booster|Withdrawal by Subject|19|||
147350182|NCT04927065|531451195|FG004|First Booster|Withdrawal by Subject|20|||
147350183|NCT04927065|531451196|FG005|First Booster|Withdrawal by Subject|15|||
147350184|NCT04927065|531451197|FG006|First Booster|Withdrawal by Subject|6|||
147350185|NCT04927065|531451198|FG007|First Booster|Withdrawal by Subject|24|||
147350186|NCT04927065|531451199|FG008|First Booster|Withdrawal by Subject|0|||
147350187|NCT04927065|531451200|FG009|First Booster|Withdrawal by Subject|4|||
147350188|NCT04927065|531451201|FG010|First Booster|Withdrawal by Subject|0|||
147350189|NCT04927065|531451202|FG011|First Booster|Withdrawal by Subject|0|||
147350190|NCT04927065|531451203|FG012|First Booster|Withdrawal by Subject|0|||
147350191|NCT04927065|531451204|FG013|First Booster|Withdrawal by Subject|0|||
147350192|NCT04927065|531451205|FG014|First Booster|Withdrawal by Subject|0|||
147607002|NCT00425373|532377229|FG007|Overall Study|Lost to Follow-up|0|||
147607003|NCT00425373|532377230|FG008|Overall Study|Lost to Follow-up|0|||
147607004|NCT00425373|532377222|FG000|Overall Study|Protocol Violation|1|||
147607005|NCT00425373|532377223|FG001|Overall Study|Protocol Violation|0|||
147350193|NCT04927065|531451206|FG015|First Booster|Withdrawal by Subject|0|||
147350194|NCT04927065|531451191|FG000|First Booster|Other Than Specified|1|||
147350195|NCT04927065|531451192|FG001|First Booster|Other Than Specified|1|||
147350196|NCT04927065|531451193|FG002|First Booster|Other Than Specified|0|||
147350197|NCT04927065|531451194|FG003|First Booster|Other Than Specified|1|||
147350198|NCT04927065|531451195|FG004|First Booster|Other Than Specified|2|||
147350199|NCT04927065|531451196|FG005|First Booster|Other Than Specified|3|||
147607006|NCT00425373|532377224|FG002|Overall Study|Protocol Violation|1|||
147350200|NCT04927065|531451197|FG006|First Booster|Other Than Specified|2|||
147350201|NCT04927065|531451198|FG007|First Booster|Other Than Specified|6|||
147350202|NCT04927065|531451199|FG008|First Booster|Other Than Specified|0|||
147350203|NCT04927065|531451200|FG009|First Booster|Other Than Specified|4|||
147350204|NCT04927065|531451201|FG010|First Booster|Other Than Specified|0|||
147350205|NCT04927065|531451202|FG011|First Booster|Other Than Specified|0|||
147350206|NCT04927065|531451203|FG012|First Booster|Other Than Specified|0|||
147607007|NCT00425373|532377225|FG003|Overall Study|Protocol Violation|0|||
147607008|NCT00425373|532377226|FG004|Overall Study|Protocol Violation|0|||
147607009|NCT00425373|532377227|FG005|Overall Study|Protocol Violation|0|||
147607010|NCT00425373|532377228|FG006|Overall Study|Protocol Violation|0|||
147350207|NCT04927065|531451204|FG013|First Booster|Other Than Specified|0|||
147350208|NCT04927065|531451205|FG014|First Booster|Other Than Specified|0|||
147350209|NCT04927065|531451206|FG015|First Booster|Other Than Specified|0|||
147350210|NCT04927065|531451191|FG000|Second Booster|Death|0|||
147350211|NCT04927065|531451192|FG001|Second Booster|Death|0|||
147350212|NCT04927065|531451193|FG002|Second Booster|Death|0|||
147350213|NCT04927065|531451194|FG003|Second Booster|Death|0|||
147350214|NCT04927065|531451195|FG004|Second Booster|Death|0|||
147350215|NCT04927065|531451196|FG005|Second Booster|Death|0|||
147350216|NCT04927065|531451197|FG006|Second Booster|Death|0|||
147350217|NCT04927065|531451198|FG007|Second Booster|Death|0|||
147350218|NCT04927065|531451199|FG008|Second Booster|Death|0|||
147350219|NCT04927065|531451200|FG009|Second Booster|Death|0|||
147350220|NCT04927065|531451201|FG010|Second Booster|Death|2|||
147350221|NCT04927065|531451202|FG011|Second Booster|Death|0|||
147350222|NCT04927065|531451203|FG012|Second Booster|Death|2|||
147350223|NCT04927065|531451204|FG013|Second Booster|Death|2|||
147350224|NCT04927065|531451205|FG014|Second Booster|Death|0|||
147350225|NCT04927065|531451206|FG015|Second Booster|Death|0|||
147350226|NCT04927065|531451191|FG000|Second Booster|Lost to Follow-up|0|||
147350227|NCT04927065|531451192|FG001|Second Booster|Lost to Follow-up|0|||
147350228|NCT04927065|531451193|FG002|Second Booster|Lost to Follow-up|3|||
147350229|NCT04927065|531451194|FG003|Second Booster|Lost to Follow-up|0|||
147350230|NCT04927065|531451195|FG004|Second Booster|Lost to Follow-up|0|||
147350231|NCT04927065|531451196|FG005|Second Booster|Lost to Follow-up|0|||
147350232|NCT04927065|531451197|FG006|Second Booster|Lost to Follow-up|0|||
147350233|NCT04927065|531451198|FG007|Second Booster|Lost to Follow-up|0|||
147350234|NCT04927065|531451199|FG008|Second Booster|Lost to Follow-up|0|||
147350235|NCT04927065|531451200|FG009|Second Booster|Lost to Follow-up|0|||
147350236|NCT04927065|531451201|FG010|Second Booster|Lost to Follow-up|14|||
147350237|NCT04927065|531451202|FG011|Second Booster|Lost to Follow-up|10|||
147350238|NCT04927065|531451203|FG012|Second Booster|Lost to Follow-up|13|||
147350239|NCT04927065|531451204|FG013|Second Booster|Lost to Follow-up|16|||
147350240|NCT04927065|531451205|FG014|Second Booster|Lost to Follow-up|0|||
147350241|NCT04927065|531451206|FG015|Second Booster|Lost to Follow-up|0|||
147350242|NCT04927065|531451191|FG000|Second Booster|Physician Decision|0|||
147350243|NCT04927065|531451192|FG001|Second Booster|Physician Decision|0|||
147350244|NCT04927065|531451193|FG002|Second Booster|Physician Decision|0|||
147350245|NCT04927065|531451194|FG003|Second Booster|Physician Decision|0|||
147350246|NCT04927065|531451195|FG004|Second Booster|Physician Decision|0|||
147350247|NCT04927065|531451196|FG005|Second Booster|Physician Decision|0|||
147350248|NCT04927065|531451197|FG006|Second Booster|Physician Decision|0|||
147350249|NCT04927065|531451198|FG007|Second Booster|Physician Decision|0|||
147350250|NCT04927065|531451199|FG008|Second Booster|Physician Decision|0|||
147350251|NCT04927065|531451200|FG009|Second Booster|Physician Decision|0|||
147350252|NCT04927065|531451201|FG010|Second Booster|Physician Decision|0|||
147350253|NCT04927065|531451202|FG011|Second Booster|Physician Decision|3|||
147350254|NCT04927065|531451203|FG012|Second Booster|Physician Decision|0|||
147350255|NCT04927065|531451204|FG013|Second Booster|Physician Decision|1|||
147350256|NCT04927065|531451205|FG014|Second Booster|Physician Decision|0|||
147350257|NCT04927065|531451206|FG015|Second Booster|Physician Decision|0|||
147350258|NCT04927065|531451191|FG000|Second Booster|Withdrawal by Subject|0|||
147350259|NCT04927065|531451192|FG001|Second Booster|Withdrawal by Subject|0|||
147350260|NCT04927065|531451193|FG002|Second Booster|Withdrawal by Subject|4|||
147350261|NCT04927065|531451194|FG003|Second Booster|Withdrawal by Subject|0|||
147350262|NCT04927065|531451195|FG004|Second Booster|Withdrawal by Subject|0|||
147453292|NCT02064387|531823983|FG005|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
147607011|NCT00425373|532377229|FG007|Overall Study|Protocol Violation|5|||
147607012|NCT00425373|532377230|FG008|Overall Study|Protocol Violation|3|||
147350263|NCT04927065|531451196|FG005|Second Booster|Withdrawal by Subject|0|||
147350264|NCT04927065|531451197|FG006|Second Booster|Withdrawal by Subject|0|||
147350265|NCT04927065|531451198|FG007|Second Booster|Withdrawal by Subject|0|||
147350266|NCT04927065|531451199|FG008|Second Booster|Withdrawal by Subject|0|||
147350267|NCT04927065|531451200|FG009|Second Booster|Withdrawal by Subject|0|||
147350268|NCT04927065|531451201|FG010|Second Booster|Withdrawal by Subject|3|||
147350269|NCT04927065|531451202|FG011|Second Booster|Withdrawal by Subject|16|||
147607013|NCT00425373|532377222|FG000|Overall Study|Withdrawal by Subject|2|||
147350270|NCT04927065|531451203|FG012|Second Booster|Withdrawal by Subject|13|||
147350271|NCT04927065|531451204|FG013|Second Booster|Withdrawal by Subject|9|||
147350272|NCT04927065|531451205|FG014|Second Booster|Withdrawal by Subject|0|||
147350273|NCT04927065|531451206|FG015|Second Booster|Withdrawal by Subject|0|||
147350274|NCT04927065|531451191|FG000|Second Booster|Other Than Specified|0|||
147350275|NCT04927065|531451192|FG001|Second Booster|Other Than Specified|0|||
147350276|NCT04927065|531451193|FG002|Second Booster|Other Than Specified|0|||
147350277|NCT04927065|531451194|FG003|Second Booster|Other Than Specified|0|||
147350278|NCT04927065|531451195|FG004|Second Booster|Other Than Specified|0|||
147350279|NCT04927065|531451196|FG005|Second Booster|Other Than Specified|0|||
147350280|NCT04927065|531451197|FG006|Second Booster|Other Than Specified|0|||
147350281|NCT04927065|531451198|FG007|Second Booster|Other Than Specified|0|||
147350282|NCT04927065|531451199|FG008|Second Booster|Other Than Specified|0|||
147350283|NCT04927065|531451200|FG009|Second Booster|Other Than Specified|0|||
147350284|NCT04927065|531451201|FG010|Second Booster|Other Than Specified|1|||
147350285|NCT04927065|531451202|FG011|Second Booster|Other Than Specified|1|||
147350286|NCT04927065|531451203|FG012|Second Booster|Other Than Specified|4|||
147350287|NCT04927065|531451204|FG013|Second Booster|Other Than Specified|0|||
147350288|NCT04927065|531451205|FG014|Second Booster|Other Than Specified|0|||
147350289|NCT04927065|531451206|FG015|Second Booster|Other Than Specified|0|||
147350290|NCT04927065|531451191|FG000|Third Booster|Lost to Follow-up|0|||
147350291|NCT04927065|531451192|FG001|Third Booster|Lost to Follow-up|0|||
147350292|NCT04927065|531451193|FG002|Third Booster|Lost to Follow-up|0|||
147350293|NCT04927065|531451194|FG003|Third Booster|Lost to Follow-up|0|||
147350294|NCT04927065|531451195|FG004|Third Booster|Lost to Follow-up|0|||
147350295|NCT04927065|531451196|FG005|Third Booster|Lost to Follow-up|0|||
147350296|NCT04927065|531451197|FG006|Third Booster|Lost to Follow-up|0|||
147350297|NCT04927065|531451198|FG007|Third Booster|Lost to Follow-up|0|||
147350298|NCT04927065|531451199|FG008|Third Booster|Lost to Follow-up|0|||
147350299|NCT04927065|531451200|FG009|Third Booster|Lost to Follow-up|0|||
147350300|NCT04927065|531451201|FG010|Third Booster|Lost to Follow-up|0|||
147350301|NCT04927065|531451202|FG011|Third Booster|Lost to Follow-up|0|||
147350302|NCT04927065|531451203|FG012|Third Booster|Lost to Follow-up|0|||
147350303|NCT04927065|531451204|FG013|Third Booster|Lost to Follow-up|0|||
147350304|NCT04927065|531451205|FG014|Third Booster|Lost to Follow-up|0|||
147350305|NCT04927065|531451206|FG015|Third Booster|Lost to Follow-up|1|||
147350306|NCT04927065|531451191|FG000|Third Booster|Withdrawal by Subject|0|||
147350307|NCT04927065|531451192|FG001|Third Booster|Withdrawal by Subject|0|||
147350308|NCT04927065|531451193|FG002|Third Booster|Withdrawal by Subject|0|||
147350309|NCT04927065|531451194|FG003|Third Booster|Withdrawal by Subject|0|||
147350310|NCT04927065|531451195|FG004|Third Booster|Withdrawal by Subject|0|||
147350311|NCT04927065|531451196|FG005|Third Booster|Withdrawal by Subject|0|||
147350312|NCT04927065|531451197|FG006|Third Booster|Withdrawal by Subject|0|||
147350313|NCT04927065|531451198|FG007|Third Booster|Withdrawal by Subject|0|||
147350314|NCT04927065|531451199|FG008|Third Booster|Withdrawal by Subject|0|||
147350315|NCT04927065|531451200|FG009|Third Booster|Withdrawal by Subject|0|||
147350316|NCT04927065|531451201|FG010|Third Booster|Withdrawal by Subject|0|||
147350317|NCT04927065|531451202|FG011|Third Booster|Withdrawal by Subject|0|||
147350318|NCT04927065|531451203|FG012|Third Booster|Withdrawal by Subject|0|||
147350319|NCT04927065|531451204|FG013|Third Booster|Withdrawal by Subject|0|||
147350320|NCT04927065|531451205|FG014|Third Booster|Withdrawal by Subject|0|||
147350321|NCT04927065|531451206|FG015|Third Booster|Withdrawal by Subject|1|||
147350322|NCT03406871|531451207|FG000|Dose Escalation Cohort|DLT assesment cancellation**|1|||
147350323|NCT03406871|531451208|FG001|Dose Escalation Cohort|DLT assesment cancellation**|1|||
147350324|NCT03406871|531451209|FG002|Dose Escalation Cohort|DLT assesment cancellation**|0|||
147350325|NCT03406871|531451207|FG000|Expansion Cohort(Final Analysis)|Completion of 54 doses of Nivolumab|4|||
147607014|NCT00425373|532377223|FG001|Overall Study|Withdrawal by Subject|0|||
147607015|NCT00425373|532377224|FG002|Overall Study|Withdrawal by Subject|2|||
147350326|NCT03406871|531451208|FG001|Expansion Cohort(Final Analysis)|Completion of 54 doses of Nivolumab|2|||
147350327|NCT03406871|531451209|FG002|Expansion Cohort(Final Analysis)|Completion of 54 doses of Nivolumab|1|||
147350328|NCT03406871|531451207|FG000|Expansion Cohort(Final Analysis)|Progression of primary disease|17|||
147350329|NCT03406871|531451208|FG001|Expansion Cohort(Final Analysis)|Progression of primary disease|22|||
147350330|NCT03406871|531451209|FG002|Expansion Cohort(Final Analysis)|Progression of primary disease|1|||
147350331|NCT03406871|531451207|FG000|Expansion Cohort(Final Analysis)|Physician Decision|1|||
147350332|NCT03406871|531451208|FG001|Expansion Cohort(Final Analysis)|Physician Decision|0|||
147350333|NCT03406871|531451209|FG002|Expansion Cohort(Final Analysis)|Physician Decision|0|||
147350334|NCT03406871|531451207|FG000|Expansion Cohort(Final Analysis)|Death|0|||
147350335|NCT03406871|531451208|FG001|Expansion Cohort(Final Analysis)|Death|1|||
147607016|NCT00425373|532377225|FG003|Overall Study|Withdrawal by Subject|1|||
147350336|NCT03406871|531451209|FG002|Expansion Cohort(Final Analysis)|Death|0|||
147350337|NCT03406871|531451207|FG000|Expansion Cohort(Final Analysis)|Adverse Event|0|||
147350338|NCT03406871|531451208|FG001|Expansion Cohort(Final Analysis)|Adverse Event|0|||
147350339|NCT03406871|531451209|FG002|Expansion Cohort(Final Analysis)|Adverse Event|1|||
147350340|NCT04021602|531451212|FG000|Overall Study|Lost to Follow-up|3|||
147350341|NCT04021602|531451213|FG001|Overall Study|Lost to Follow-up|3|||
147350342|NCT04021602|531451214|FG002|Overall Study|Lost to Follow-up|1|||
147607017|NCT00425373|532377226|FG004|Overall Study|Withdrawal by Subject|4|||
147607018|NCT00425373|532377227|FG005|Overall Study|Withdrawal by Subject|0|||
147607019|NCT00425373|532377228|FG006|Overall Study|Withdrawal by Subject|2|||
147607020|NCT00425373|532377229|FG007|Overall Study|Withdrawal by Subject|2|||
147607021|NCT00425373|532377230|FG008|Overall Study|Withdrawal by Subject|2|||
147607022|NCT00425373|532377222|FG000|Overall Study|Lack of Efficacy|0|||
147607023|NCT00425373|532377223|FG001|Overall Study|Lack of Efficacy|0|||
147607024|NCT00425373|532377224|FG002|Overall Study|Lack of Efficacy|0|||
147607025|NCT00425373|532377225|FG003|Overall Study|Lack of Efficacy|0|||
147607026|NCT00425373|532377226|FG004|Overall Study|Lack of Efficacy|1|||
147607027|NCT00425373|532377227|FG005|Overall Study|Lack of Efficacy|3|||
147607028|NCT00425373|532377228|FG006|Overall Study|Lack of Efficacy|3|||
147607029|NCT00425373|532377229|FG007|Overall Study|Lack of Efficacy|0|||
147607030|NCT00425373|532377230|FG008|Overall Study|Lack of Efficacy|5|||
147607031|NCT02960490|532377232|FG000|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|3|||
147607032|NCT02960490|532377233|FG001|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|2|||
147607033|NCT02960490|532377234|FG002|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
147607034|NCT02960490|532377235|FG003|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
147607035|NCT02960490|532377236|FG004|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
147607036|NCT02960490|532377237|FG005|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
147607037|NCT02960490|532377238|FG006|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
147607038|NCT02960490|532377239|FG007|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
147607039|NCT02960490|532377240|FG008|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
147607040|NCT02960490|532377241|FG009|Treatment Phase(Double-blind): 12 Weeks|Lack of Efficacy|0|||
147607041|NCT02960490|532377232|FG000|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
147607042|NCT02960490|532377233|FG001|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|1|||
147607043|NCT02960490|532377234|FG002|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
147607044|NCT02960490|532377235|FG003|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
147607045|NCT02960490|532377236|FG004|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
147607046|NCT02960490|532377237|FG005|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
147607047|NCT02960490|532377238|FG006|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
147607048|NCT02960490|532377239|FG007|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
147607049|NCT02960490|532377240|FG008|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
147607050|NCT02960490|532377241|FG009|Treatment Phase(Double-blind): 12 Weeks|Adverse Event|0|||
147607051|NCT02960490|532377232|FG000|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|1|||
147607052|NCT02960490|532377233|FG001|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|2|||
147607053|NCT02960490|532377234|FG002|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
147350343|NCT04021602|531451212|FG000|Overall Study|Adverse Event|1|||
147350344|NCT04021602|531451213|FG001|Overall Study|Adverse Event|0|||
147350345|NCT04021602|531451214|FG002|Overall Study|Adverse Event|1|||
147350346|NCT04169373|531451221|FG000|Week 1 to Week 14|Adverse Event|1|||
147350347|NCT04169373|531451222|FG001|Week 1 to Week 14|Adverse Event|0|||
147350348|NCT04169373|531451223|FG002|Week 1 to Week 14|Adverse Event|1|||
147350349|NCT04169373|531451224|FG003|Week 1 to Week 14|Adverse Event|2|||
147350350|NCT04169373|531451221|FG000|Week 1 to Week 14|Withdrawal by Subject|2|||
147350351|NCT04169373|531451222|FG001|Week 1 to Week 14|Withdrawal by Subject|0|||
147350352|NCT04169373|531451223|FG002|Week 1 to Week 14|Withdrawal by Subject|5|||
147350353|NCT04169373|531451224|FG003|Week 1 to Week 14|Withdrawal by Subject|6|||
147350354|NCT04169373|531451221|FG000|Week 1 to Week 14|Lost to Follow-up|1|||
147350355|NCT04169373|531451222|FG001|Week 1 to Week 14|Lost to Follow-up|1|||
147350356|NCT04169373|531451223|FG002|Week 1 to Week 14|Lost to Follow-up|0|||
147350357|NCT04169373|531451224|FG003|Week 1 to Week 14|Lost to Follow-up|1|||
147350358|NCT04169373|531451221|FG000|Week 1 to Week 14|Coronavirus Disease of 2019 (COVID-19) Logistical Restrictions|0|||
147350359|NCT04169373|531451222|FG001|Week 1 to Week 14|Coronavirus Disease of 2019 (COVID-19) Logistical Restrictions|1|||
147350360|NCT04169373|531451223|FG002|Week 1 to Week 14|Coronavirus Disease of 2019 (COVID-19) Logistical Restrictions|0|||
147350361|NCT04169373|531451224|FG003|Week 1 to Week 14|Coronavirus Disease of 2019 (COVID-19) Logistical Restrictions|0|||
147350362|NCT04169373|531451221|FG000|Week 1 to Week 14|Other|1|||
147350363|NCT04169373|531451222|FG001|Week 1 to Week 14|Other|3|||
147350364|NCT04169373|531451223|FG002|Week 1 to Week 14|Other|3|||
147350365|NCT04169373|531451224|FG003|Week 1 to Week 14|Other|5|||
147350366|NCT04169373|531451221|FG000|Week 14 to Week 52|Adverse Event|1|||
147350367|NCT04169373|531451222|FG001|Week 14 to Week 52|Adverse Event|0|||
147350368|NCT04169373|531451223|FG002|Week 14 to Week 52|Adverse Event|0|||
147350369|NCT04169373|531451224|FG003|Week 14 to Week 52|Adverse Event|1|||
147350370|NCT04169373|531451221|FG000|Week 14 to Week 52|Withdrawal by Subject|4|||
147350371|NCT04169373|531451222|FG001|Week 14 to Week 52|Withdrawal by Subject|5|||
147350372|NCT04169373|531451223|FG002|Week 14 to Week 52|Withdrawal by Subject|7|||
147350373|NCT04169373|531451224|FG003|Week 14 to Week 52|Withdrawal by Subject|2|||
147350374|NCT04169373|531451221|FG000|Week 14 to Week 52|Lost to Follow-up|2|||
147350375|NCT04169373|531451222|FG001|Week 14 to Week 52|Lost to Follow-up|1|||
147350376|NCT04169373|531451223|FG002|Week 14 to Week 52|Lost to Follow-up|0|||
147350377|NCT04169373|531451224|FG003|Week 14 to Week 52|Lost to Follow-up|1|||
147350378|NCT04169373|531451221|FG000|Week 14 to Week 52|COVID-19 Logistical Restrictions|1|||
147607054|NCT02960490|532377235|FG003|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
147607055|NCT02960490|532377236|FG004|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
147607056|NCT02960490|532377237|FG005|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
147607057|NCT02960490|532377238|FG006|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
147607058|NCT02960490|532377239|FG007|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
147350379|NCT04169373|531451222|FG001|Week 14 to Week 52|COVID-19 Logistical Restrictions|0|||
147350380|NCT04169373|531451223|FG002|Week 14 to Week 52|COVID-19 Logistical Restrictions|0|||
147350381|NCT04169373|531451224|FG003|Week 14 to Week 52|COVID-19 Logistical Restrictions|0|||
147350382|NCT04169373|531451221|FG000|Week 14 to Week 52|Other|4|||
147350383|NCT04169373|531451222|FG001|Week 14 to Week 52|Other|5|||
147350384|NCT04169373|531451223|FG002|Week 14 to Week 52|Other|4|||
147350385|NCT04169373|531451224|FG003|Week 14 to Week 52|Other|5|||
147350386|NCT04169373|531451221|FG000|Week 14 to Week 52|Ongoing|0|||
147350387|NCT04169373|531451222|FG001|Week 14 to Week 52|Ongoing|1|||
147350388|NCT04169373|531451223|FG002|Week 14 to Week 52|Ongoing|0|||
147350389|NCT04169373|531451224|FG003|Week 14 to Week 52|Ongoing|0|||
147350390|NCT04610892|531451225|FG000|Overall Study|Adverse Event|1|||
147350391|NCT04610892|531451226|FG001|Overall Study|Adverse Event|0|||
147350392|NCT04610892|531451227|FG002|Overall Study|Adverse Event|0|||
147350393|NCT04610892|531451228|FG003|Overall Study|Adverse Event|1|||
147350394|NCT04610892|531451229|FG004|Overall Study|Adverse Event|3|||
147350395|NCT04610892|531451225|FG000|Overall Study|Death|0|||
147350396|NCT04610892|531451226|FG001|Overall Study|Death|1|||
147350397|NCT04610892|531451227|FG002|Overall Study|Death|0|||
147350398|NCT04610892|531451228|FG003|Overall Study|Death|1|||
147350399|NCT04610892|531451229|FG004|Overall Study|Death|0|||
147350400|NCT04610892|531451225|FG000|Overall Study|Withdrawal by Subject|3|||
147350401|NCT04610892|531451226|FG001|Overall Study|Withdrawal by Subject|2|||
147350402|NCT04610892|531451227|FG002|Overall Study|Withdrawal by Subject|0|||
147350403|NCT04610892|531451228|FG003|Overall Study|Withdrawal by Subject|6|||
147350404|NCT04610892|531451229|FG004|Overall Study|Withdrawal by Subject|6|||
147350405|NCT04610892|531451225|FG000|Overall Study|Subjects who did not receive treatment|1|||
147350406|NCT04610892|531451226|FG001|Overall Study|Subjects who did not receive treatment|0|||
147350407|NCT04610892|531451227|FG002|Overall Study|Subjects who did not receive treatment|0|||
147350408|NCT04610892|531451228|FG003|Overall Study|Subjects who did not receive treatment|0|||
147350409|NCT04610892|531451229|FG004|Overall Study|Subjects who did not receive treatment|2|||
147350410|NCT03924986|531451236|FG000|Overall Study|Death|57|||
147350411|NCT03924986|531451237|FG001|Overall Study|Death|66|||
147350412|NCT03924986|531451236|FG000|Overall Study|Study Concluded by Sponsor|51|||
147350413|NCT03924986|531451237|FG001|Overall Study|Study Concluded by Sponsor|41|||
147350414|NCT03924986|531451236|FG000|Overall Study|Withdrawal by Subject|15|||
147350415|NCT03924986|531451237|FG001|Overall Study|Withdrawal by Subject|20|||
147350416|NCT03924986|531451236|FG000|Overall Study|Lost to Follow-up|7|||
147350417|NCT03924986|531451237|FG001|Overall Study|Lost to Follow-up|5|||
147350418|NCT03924986|531451236|FG000|Overall Study|Miscellaneous|1|||
147350419|NCT03924986|531451237|FG001|Overall Study|Miscellaneous|0|||
147350420|NCT02689284|531451238|FG000|Overall Study|Adverse Event|1|||
147350421|NCT02689284|531451239|FG001|Overall Study|Adverse Event|8|||
147350422|NCT02689284|531451238|FG000|Overall Study|Death|0|||
147607059|NCT02960490|532377240|FG008|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
147607060|NCT02960490|532377241|FG009|Treatment Phase(Double-blind): 12 Weeks|Disease Progression|0|||
147607061|NCT02960490|532377232|FG000|Treatment Phase(Double-blind): 12 Weeks|Not treated|1|||
147607062|NCT02960490|532377233|FG001|Treatment Phase(Double-blind): 12 Weeks|Not treated|1|||
147350423|NCT02689284|531451239|FG001|Overall Study|Death|1|||
147350424|NCT02689284|531451238|FG000|Overall Study|Physician Decision|1|||
147350425|NCT02689284|531451239|FG001|Overall Study|Physician Decision|2|||
147350426|NCT02689284|531451238|FG000|Overall Study|Withdrawal by Subject|0|||
147350427|NCT02689284|531451239|FG001|Overall Study|Withdrawal by Subject|1|||
147350428|NCT02689284|531451238|FG000|Overall Study|progression of cancer|1|||
147350429|NCT02689284|531451239|FG001|Overall Study|progression of cancer|72|||
147350430|NCT02689284|531451238|FG000|Overall Study|decreased heart function|0|||
147350431|NCT02689284|531451239|FG001|Overall Study|decreased heart function|1|||
147350432|NCT02689284|531451238|FG000|Overall Study|concern for anemia|0|||
147350433|NCT02689284|531451239|FG001|Overall Study|concern for anemia|1|||
147350434|NCT02689284|531451238|FG000|Overall Study|no measurable cancer for evaluation|0|||
147350435|NCT02689284|531451239|FG001|Overall Study|no measurable cancer for evaluation|1|||
147453293|NCT02064387|531823984|FG006|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
147453294|NCT02064387|531823985|FG007|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|1|||
147350436|NCT05516147|531451242|FG000|Overall Study|Scheduling Conflicts Made it Impossible for them to participate|2|||
147350437|NCT03396926|531451244|FG000|Expansion Cohort|Participants did not complete follow-up scan required for disease response outcomes|0|||
147350438|NCT03396926|531451245|FG001|Expansion Cohort|Participants did not complete follow-up scan required for disease response outcomes|4|||
147350439|NCT02035787|531451246|FG000|Overall Study- 12 Months|Adverse Event|3|||
147350440|NCT02035787|531451247|FG001|Overall Study- 12 Months|Adverse Event|0|||
147350441|NCT02035787|531451246|FG000|Overall Study- 12 Months|Complete response|4|||
147350442|NCT02035787|531451247|FG001|Overall Study- 12 Months|Complete response|1|||
147350443|NCT02035787|531451246|FG000|Overall Study- 12 Months|Protocol Violation|1|||
147350444|NCT02035787|531451247|FG001|Overall Study- 12 Months|Protocol Violation|1|||
147350445|NCT06414213|531451248|FG000|Overall Study|Lost to Follow-up|1|||
147350446|NCT06414213|531451249|FG001|Overall Study|Lost to Follow-up|1|||
147350447|NCT06414213|531451250|FG002|Overall Study|Lost to Follow-up|3|||
147350448|NCT00450658|531451253|FG000|Overall Study|Adverse Event|24|||
147350449|NCT00450658|531451254|FG001|Overall Study|Adverse Event|15|||
147350450|NCT00450658|531451253|FG000|Overall Study|Withdrawal by Subject|43|||
147350451|NCT00450658|531451254|FG001|Overall Study|Withdrawal by Subject|26|||
147350452|NCT00450658|531451253|FG000|Overall Study|Lost to Follow-up|22|||
147350453|NCT00450658|531451254|FG001|Overall Study|Lost to Follow-up|5|||
147350454|NCT00450658|531451253|FG000|Overall Study|UGI ulcer|33|||
147350455|NCT00450658|531451254|FG001|Overall Study|UGI ulcer|34|||
147350456|NCT00450658|531451253|FG000|Overall Study|misc|21|||
147350457|NCT00450658|531451254|FG001|Overall Study|misc|10|||
147350458|NCT05311384|531451259|FG000|Overall Study|Uncontrolled health conditions|2|||
147350459|NCT05311384|531451259|FG000|Overall Study|Withdrawal by Subject|1|||
147350460|NCT04322643|531451260|FG000|Overall Study|Study halted prematurely therefore treatment halted.|4|||
147350461|NCT03302494|531451263|FG000|Overall Study|Other|7|||
147350462|NCT03302494|531451264|FG001|Overall Study|Other|4|||
147350463|NCT03302494|531451265|FG002|Overall Study|Other|6|||
147350464|NCT03302494|531451263|FG000|Overall Study|Withdrawal by Subject|10|||
147350465|NCT03302494|531451264|FG001|Overall Study|Withdrawal by Subject|2|||
147350466|NCT03302494|531451265|FG002|Overall Study|Withdrawal by Subject|9|||
147350467|NCT03302494|531451263|FG000|Overall Study|Study Terminated by Sponsor|32|||
147350468|NCT03302494|531451264|FG001|Overall Study|Study Terminated by Sponsor|29|||
147350469|NCT03302494|531451265|FG002|Overall Study|Study Terminated by Sponsor|30|||
147350470|NCT03302494|531451263|FG000|Overall Study|Physician Decision|1|||
147350471|NCT03302494|531451264|FG001|Overall Study|Physician Decision|0|||
147350472|NCT03302494|531451265|FG002|Overall Study|Physician Decision|1|||
147350473|NCT03302494|531451263|FG000|Overall Study|Lost to Follow-up|1|||
147350474|NCT03302494|531451264|FG001|Overall Study|Lost to Follow-up|3|||
147350475|NCT03302494|531451265|FG002|Overall Study|Lost to Follow-up|3|||
147350476|NCT03302494|531451263|FG000|Overall Study|Death|13|||
147350477|NCT03302494|531451264|FG001|Overall Study|Death|11|||
147350478|NCT03302494|531451265|FG002|Overall Study|Death|4|||
147350479|NCT03302494|531451263|FG000|Overall Study|Adverse Event|1|||
147350480|NCT03302494|531451264|FG001|Overall Study|Adverse Event|2|||
147350481|NCT03302494|531451265|FG002|Overall Study|Adverse Event|0|||
147350482|NCT03302494|531451263|FG000|Overall Study|Randomized but not treated and discontinued during study hold|0|||
147350483|NCT03302494|531451264|FG001|Overall Study|Randomized but not treated and discontinued during study hold|2|||
147350484|NCT03302494|531451265|FG002|Overall Study|Randomized but not treated and discontinued during study hold|2|||
147350485|NCT05134233|531451266|FG000|Overall Study|Pregnancy|1|||
147350486|NCT05134233|531451266|FG000|Overall Study|MEP value too low|2|||
147350487|NCT05134233|531451266|FG000|Overall Study|Lost to Follow-up|1|||
147350488|NCT01573442|531451267|FG000|Overall Study|Cancels|9|||
147350489|NCT01573442|531451268|FG001|Overall Study|Cancels|10|||
147350490|NCT05710107|531451271|FG000|Overall Study|Withdrawal by Subject|1|||
147350491|NCT05710107|531451272|FG001|Overall Study|Withdrawal by Subject|1|||
147350492|NCT05710107|531451271|FG000|Overall Study|Lost to Follow-up|8|||
147350493|NCT05710107|531451272|FG001|Overall Study|Lost to Follow-up|9|||
147350494|NCT05710107|531451271|FG000|Overall Study|Unable to place assigned block|2|||
147350495|NCT05710107|531451272|FG001|Overall Study|Unable to place assigned block|0|||
147350496|NCT05710107|531451271|FG000|Overall Study|Withdrawn by study team|0|||
147350497|NCT05710107|531451272|FG001|Overall Study|Withdrawn by study team|1|||
147350498|NCT04952909|531451277|FG000|Overall Study|Death|3|||
147350499|NCT02515773|531451281|FG000|Overall Study|Withdrawal by Subject|12|||
147350500|NCT02515773|531451282|FG001|Overall Study|Withdrawal by Subject|2|||
147350501|NCT02515773|531451281|FG000|Overall Study|Lost to Follow-up|119|||
147350502|NCT02515773|531451282|FG001|Overall Study|Lost to Follow-up|126|||
147350503|NCT02515773|531451281|FG000|Overall Study|Discharged from Clinic Services|53|||
147350504|NCT02515773|531451282|FG001|Overall Study|Discharged from Clinic Services|84|||
147350505|NCT02515773|531451281|FG000|Overall Study|Censored (study ended before participant could complete)|18|||
147350506|NCT02515773|531451282|FG001|Overall Study|Censored (study ended before participant could complete)|24|||
147350507|NCT02515773|531451281|FG000|Overall Study|Follow-up at non-study site|8|||
147350508|NCT02515773|531451282|FG001|Overall Study|Follow-up at non-study site|16|||
147350509|NCT02515773|531451281|FG000|Overall Study|Moved from area|9|||
147350510|NCT02515773|531451282|FG001|Overall Study|Moved from area|14|||
147350511|NCT05434078|531451283|FG000|Overall Study|Lost to Follow-up|2|||
147350512|NCT05434078|531451284|FG001|Overall Study|Lost to Follow-up|1|||
147350513|NCT05434078|531451283|FG000|Overall Study|Withdrawal by Subject|1|||
147350514|NCT05434078|531451284|FG001|Overall Study|Withdrawal by Subject|0|||
147350515|NCT04072380|531451286|FG000|Overall Study|Adverse Event|4|||
147607063|NCT02960490|532377234|FG002|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
147607064|NCT02960490|532377235|FG003|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
147607065|NCT02960490|532377236|FG004|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
147350516|NCT04072380|531451287|FG001|Overall Study|Adverse Event|6|||
147350517|NCT04072380|531451288|FG002|Overall Study|Adverse Event|0|||
147350518|NCT04072380|531451286|FG000|Overall Study|Withdrawal by Subject|3|||
147350519|NCT04072380|531451287|FG001|Overall Study|Withdrawal by Subject|1|||
147350520|NCT04072380|531451288|FG002|Overall Study|Withdrawal by Subject|1|||
147350521|NCT04072380|531451286|FG000|Overall Study|Physician Decision|2|||
147350522|NCT04072380|531451287|FG001|Overall Study|Physician Decision|0|||
147350523|NCT04072380|531451288|FG002|Overall Study|Physician Decision|0|||
147350524|NCT04072380|531451286|FG000|Overall Study|Protocol Violation|0|||
147350525|NCT04072380|531451287|FG001|Overall Study|Protocol Violation|2|||
147350526|NCT04072380|531451288|FG002|Overall Study|Protocol Violation|3|||
147350527|NCT04072380|531451286|FG000|Overall Study|Intercurrent Illness and Others|3|||
147350528|NCT04072380|531451287|FG001|Overall Study|Intercurrent Illness and Others|5|||
147350529|NCT04072380|531451288|FG002|Overall Study|Intercurrent Illness and Others|6|||
147350530|NCT03652688|531451289|FG000|Baseline|Withdrawal by Subject|0|||
147350531|NCT03652688|531451290|FG001|Baseline|Withdrawal by Subject|3|||
147350532|NCT03652688|531451289|FG000|Follow-up|Lost to Follow-up|56|||
147350533|NCT03652688|531451290|FG001|Follow-up|Lost to Follow-up|54|||
147350534|NCT03468218|531451294|FG000|Overall Study|Adverse Event|5|||
147350535|NCT03468218|531451294|FG000|Overall Study|Progressive Disease|16|||
147350536|NCT03468218|531451294|FG000|Overall Study|Death|1|||
147350537|NCT03468218|531451294|FG000|Overall Study|Alternate therapy|1|||
147350538|NCT03468218|531451294|FG000|Overall Study|Withdrawal by Subject|2|||
147350539|NCT03033576|531451295|FG000|Overall Study|Ineligible|1|||
147350540|NCT03033576|531451296|FG001|Overall Study|Ineligible|1|||
147350541|NCT03033576|531451295|FG000|Overall Study|Adverse Event|4|||
147350542|NCT03033576|531451296|FG001|Overall Study|Adverse Event|20|||
147350543|NCT03033576|531451295|FG000|Overall Study|Progression/relapse|9|||
147350544|NCT03033576|531451296|FG001|Overall Study|Progression/relapse|36|||
147350545|NCT03033576|531451295|FG000|Overall Study|Death|1|||
147350546|NCT03033576|531451296|FG001|Overall Study|Death|1|||
147350547|NCT03033576|531451295|FG000|Overall Study|Patient refusal|1|||
147350548|NCT03033576|531451296|FG001|Overall Study|Patient refusal|6|||
147350549|NCT03033576|531451295|FG000|Overall Study|Other, unspecified reasons|0|||
147350550|NCT03033576|531451296|FG001|Overall Study|Other, unspecified reasons|4|||
147350551|NCT03033576|531451295|FG000|Overall Study|Currently on protocol therapy|0|||
147350552|NCT03033576|531451296|FG001|Overall Study|Currently on protocol therapy|2|||
147350553|NCT03557697|531451297|FG000|Overall Study|Withdrawal by Subject|2|||
147350554|NCT03557697|531451298|FG001|Overall Study|Withdrawal by Subject|4|||
147350555|NCT01214616|531451302|FG000|Overall Study|Progressive disease|2|||
147350556|NCT01214616|531451303|FG001|Overall Study|Progressive disease|2|||
147350557|NCT01214616|531451304|FG002|Overall Study|Progressive disease|2|||
147350558|NCT01214616|531451305|FG003|Overall Study|Progressive disease|4|||
147350559|NCT01214616|531451302|FG000|Overall Study|Dose limiting toxicity|0|||
147350560|NCT01214616|531451303|FG001|Overall Study|Dose limiting toxicity|2|||
147350561|NCT01214616|531451304|FG002|Overall Study|Dose limiting toxicity|0|||
147350562|NCT01214616|531451305|FG003|Overall Study|Dose limiting toxicity|0|||
147350563|NCT01214616|531451302|FG000|Overall Study|Other adverse events|0|||
147350564|NCT01214616|531451303|FG001|Overall Study|Other adverse events|1|||
147350565|NCT01214616|531451304|FG002|Overall Study|Other adverse events|1|||
147350566|NCT01214616|531451305|FG003|Overall Study|Other adverse events|1|||
147350567|NCT01214616|531451302|FG000|Overall Study|Withdrawal by Subject|1|||
147350568|NCT01214616|531451303|FG001|Overall Study|Withdrawal by Subject|0|||
147350569|NCT01214616|531451304|FG002|Overall Study|Withdrawal by Subject|0|||
147350570|NCT01214616|531451305|FG003|Overall Study|Withdrawal by Subject|1|||
147350571|NCT03047928|531453226|FG000|Overall Study|Adverse Event|0|||
147350572|NCT03047928|531453227|FG001|Overall Study|Adverse Event|2|||
147350573|NCT03047928|531453228|FG002|Overall Study|Adverse Event|0|||
147350574|NCT03047928|531453226|FG000|Overall Study|Protocol Violation|0|||
147350575|NCT03047928|531453227|FG001|Overall Study|Protocol Violation|1|||
147607066|NCT02960490|532377237|FG005|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
147350576|NCT03047928|531453228|FG002|Overall Study|Protocol Violation|0|||
147350577|NCT03047928|531453226|FG000|Overall Study|included in another protocol|0|||
147350578|NCT03047928|531453227|FG001|Overall Study|included in another protocol|1|||
147350579|NCT03047928|531453228|FG002|Overall Study|included in another protocol|0|||
147350580|NCT04005716|531453232|FG000|Overall Study|Death|175|||
147350581|NCT04005716|531453233|FG001|Overall Study|Death|196|||
147350582|NCT04005716|531453232|FG000|Overall Study|Withdrawal by Subject|1|||
147350583|NCT04005716|531453233|FG001|Overall Study|Withdrawal by Subject|6|||
147350584|NCT04005716|531453232|FG000|Overall Study|Lost to Follow-up|2|||
147350585|NCT04005716|531453233|FG001|Overall Study|Lost to Follow-up|2|||
147350586|NCT05178316|531453235|FG000|Overall Study|Adverse Event|5|||
147350587|NCT05178316|531453236|FG001|Overall Study|Adverse Event|4|||
147350588|NCT05178316|531453237|FG002|Overall Study|Adverse Event|9|||
147350589|NCT05178316|531453235|FG000|Overall Study|Enrolled in Error|1|||
147350590|NCT05178316|531453236|FG001|Overall Study|Enrolled in Error|2|||
147350591|NCT05178316|531453237|FG002|Overall Study|Enrolled in Error|1|||
147350592|NCT05178316|531453235|FG000|Overall Study|Lost to Follow-up|3|||
147350593|NCT05178316|531453236|FG001|Overall Study|Lost to Follow-up|15|||
147350594|NCT05178316|531453237|FG002|Overall Study|Lost to Follow-up|11|||
147350595|NCT05178316|531453235|FG000|Overall Study|Noncompliance|1|||
147350596|NCT05178316|531453236|FG001|Overall Study|Noncompliance|3|||
147350597|NCT05178316|531453237|FG002|Overall Study|Noncompliance|1|||
147350598|NCT05178316|531453235|FG000|Overall Study|Other|0|||
147350599|NCT05178316|531453236|FG001|Overall Study|Other|1|||
147350600|NCT05178316|531453237|FG002|Overall Study|Other|0|||
147350601|NCT05178316|531453235|FG000|Overall Study|Physician Decision|0|||
147350602|NCT05178316|531453236|FG001|Overall Study|Physician Decision|3|||
147350603|NCT05178316|531453237|FG002|Overall Study|Physician Decision|2|||
147350604|NCT05178316|531453235|FG000|Overall Study|Protocol deviation|1|||
147350605|NCT05178316|531453236|FG001|Overall Study|Protocol deviation|0|||
147350606|NCT05178316|531453237|FG002|Overall Study|Protocol deviation|1|||
147350607|NCT05178316|531453235|FG000|Overall Study|Sponsor decision|1|||
147350608|NCT05178316|531453236|FG001|Overall Study|Sponsor decision|0|||
147350609|NCT05178316|531453237|FG002|Overall Study|Sponsor decision|1|||
147350610|NCT05178316|531453235|FG000|Overall Study|Withdrawal by Subject|5|||
147350611|NCT05178316|531453236|FG001|Overall Study|Withdrawal by Subject|11|||
147350612|NCT05178316|531453237|FG002|Overall Study|Withdrawal by Subject|5|||
147350613|NCT03683719|531453238|FG000|Overall Study|Lack of Efficacy|1|||
147350614|NCT03683719|531453239|FG001|Overall Study|Lack of Efficacy|3|||
147350615|NCT03683719|531453240|FG002|Overall Study|Lack of Efficacy|4|||
147350616|NCT03683719|531453241|FG003|Overall Study|Lack of Efficacy|0|||
147350617|NCT03683719|531453242|FG004|Overall Study|Lack of Efficacy|4|||
147350618|NCT03683719|531453238|FG000|Overall Study|Adverse Event|6|||
147350619|NCT03683719|531453239|FG001|Overall Study|Adverse Event|6|||
147350620|NCT03683719|531453240|FG002|Overall Study|Adverse Event|0|||
147350621|NCT03683719|531453241|FG003|Overall Study|Adverse Event|1|||
147350622|NCT03683719|531453242|FG004|Overall Study|Adverse Event|3|||
147350623|NCT03683719|531453238|FG000|Overall Study|Withdrawal by Subject|4|||
147350624|NCT03683719|531453239|FG001|Overall Study|Withdrawal by Subject|4|||
147350625|NCT03683719|531453240|FG002|Overall Study|Withdrawal by Subject|3|||
147350626|NCT03683719|531453241|FG003|Overall Study|Withdrawal by Subject|5|||
147350627|NCT03683719|531453242|FG004|Overall Study|Withdrawal by Subject|5|||
147350628|NCT03683719|531453238|FG000|Overall Study|Lost to Follow-up|1|||
147350629|NCT03683719|531453239|FG001|Overall Study|Lost to Follow-up|0|||
147350630|NCT03683719|531453240|FG002|Overall Study|Lost to Follow-up|0|||
147350631|NCT03683719|531453241|FG003|Overall Study|Lost to Follow-up|1|||
147350632|NCT03683719|531453242|FG004|Overall Study|Lost to Follow-up|1|||
147350633|NCT03683719|531453238|FG000|Overall Study|Other personal reasons|0|||
147350634|NCT03683719|531453239|FG001|Overall Study|Other personal reasons|0|||
147350635|NCT03683719|531453240|FG002|Overall Study|Other personal reasons|1|||
147350636|NCT03683719|531453241|FG003|Overall Study|Other personal reasons|0|||
147350637|NCT03683719|531453242|FG004|Overall Study|Other personal reasons|1|||
147453295|NCT02064387|531823986|FG008|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
147453296|NCT02064387|531823987|FG009|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
147453297|NCT02064387|531823988|FG010|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
147607067|NCT02960490|532377238|FG006|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
147607068|NCT02960490|532377239|FG007|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
147607069|NCT02960490|532377240|FG008|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
147607070|NCT02960490|532377241|FG009|Treatment Phase(Double-blind): 12 Weeks|Not treated|0|||
147607071|NCT02960490|532377232|FG000|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
147607072|NCT02960490|532377233|FG001|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
147607073|NCT02960490|532377234|FG002|Re-randomized Participants: 12 Weeks|Lack of Efficacy|1|||
147607074|NCT02960490|532377235|FG003|Re-randomized Participants: 12 Weeks|Lack of Efficacy|1|||
147607075|NCT02960490|532377236|FG004|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
147607076|NCT02960490|532377237|FG005|Re-randomized Participants: 12 Weeks|Lack of Efficacy|2|||
147350638|NCT03907397|531453243|FG000|Overall Study|Lost to Follow-up|0|||
147350639|NCT03907397|531453244|FG001|Overall Study|Lost to Follow-up|1|||
147350640|NCT03907397|531453243|FG000|Overall Study|Physician Decision|2|||
147350641|NCT03907397|531453244|FG001|Overall Study|Physician Decision|1|||
147350642|NCT03907397|531453243|FG000|Overall Study|Withdrawal by Subject|5|||
147350643|NCT03907397|531453244|FG001|Overall Study|Withdrawal by Subject|4|||
147350644|NCT03907397|531453243|FG000|Overall Study|withdrew after Day 1 of the primary endpoint desensitization visit.|1|||
147350645|NCT03907397|531453244|FG001|Overall Study|withdrew after Day 1 of the primary endpoint desensitization visit.|0|||
147350646|NCT05369403|531453245|FG000|Treatment Period 1: Week 0 to Week 16|Adverse Event|5|||
147350647|NCT05369403|531453246|FG001|Treatment Period 1: Week 0 to Week 16|Adverse Event|0|||
147350648|NCT05369403|531453247|FG002|Treatment Period 1: Week 0 to Week 16|Adverse Event|0|||
147350649|NCT05369403|531453245|FG000|Treatment Period 1: Week 0 to Week 16|Protocol Deviation|1|||
147350650|NCT05369403|531453246|FG001|Treatment Period 1: Week 0 to Week 16|Protocol Deviation|0|||
147350651|NCT05369403|531453247|FG002|Treatment Period 1: Week 0 to Week 16|Protocol Deviation|0|||
147350652|NCT05369403|531453245|FG000|Treatment Period 1: Week 0 to Week 16|Lack of Efficacy|1|||
147350653|NCT05369403|531453246|FG001|Treatment Period 1: Week 0 to Week 16|Lack of Efficacy|0|||
147350654|NCT05369403|531453247|FG002|Treatment Period 1: Week 0 to Week 16|Lack of Efficacy|0|||
147350655|NCT05369403|531453245|FG000|Treatment Period 1: Week 0 to Week 16|Withdrawal by Subject|12|||
147350656|NCT05369403|531453246|FG001|Treatment Period 1: Week 0 to Week 16|Withdrawal by Subject|0|||
147350657|NCT05369403|531453247|FG002|Treatment Period 1: Week 0 to Week 16|Withdrawal by Subject|0|||
147350658|NCT05369403|531453245|FG000|Treatment Period 1: Week 0 to Week 16|Physician Decision|2|||
147350659|NCT05369403|531453246|FG001|Treatment Period 1: Week 0 to Week 16|Physician Decision|0|||
147350660|NCT05369403|531453247|FG002|Treatment Period 1: Week 0 to Week 16|Physician Decision|0|||
147350661|NCT05369403|531453245|FG000|Treatment Period 1: Week 0 to Week 16|Lost to Follow-up|4|||
147350662|NCT05369403|531453246|FG001|Treatment Period 1: Week 0 to Week 16|Lost to Follow-up|0|||
147350663|NCT05369403|531453247|FG002|Treatment Period 1: Week 0 to Week 16|Lost to Follow-up|0|||
147350664|NCT05369403|531453245|FG000|Treatment Period 1: Week 0 to Week 16|Participant enrolled but didn't meet inclusion criteria 11|1|||
147350665|NCT05369403|531453246|FG001|Treatment Period 1: Week 0 to Week 16|Participant enrolled but didn't meet inclusion criteria 11|0|||
147350666|NCT05369403|531453247|FG002|Treatment Period 1: Week 0 to Week 16|Participant enrolled but didn't meet inclusion criteria 11|0|||
147350667|NCT05369403|531453245|FG000|Treatment Period 1: Week 0 to Week 16|Participant enrolled but did not meet inclusion criteria 3|1|||
147350668|NCT05369403|531453246|FG001|Treatment Period 1: Week 0 to Week 16|Participant enrolled but did not meet inclusion criteria 3|0|||
147350669|NCT05369403|531453247|FG002|Treatment Period 1: Week 0 to Week 16|Participant enrolled but did not meet inclusion criteria 3|0|||
147350670|NCT05369403|531453245|FG000|Treatment Period 2: Weeks 16 to Week 24|Protocol Deviation|0|||
147350671|NCT05369403|531453246|FG001|Treatment Period 2: Weeks 16 to Week 24|Protocol Deviation|1|||
147453298|NCT02064387|531823989|FG011|Part 1 Max 23.5 Months Followup Duration|Lost to Follow-up|0|||
147453299|NCT02064387|531823978|FG000|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
147453300|NCT02064387|531823979|FG001|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
147453301|NCT02064387|531823980|FG002|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
147453302|NCT02064387|531823981|FG003|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
147453303|NCT02064387|531823982|FG004|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
147453304|NCT02064387|531823983|FG005|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
147453305|NCT02064387|531823984|FG006|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
147453306|NCT02064387|531823985|FG007|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
147453307|NCT02064387|531823986|FG008|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|1|||
147453308|NCT02064387|531823987|FG009|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
147453309|NCT02064387|531823988|FG010|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
147453310|NCT02064387|531823989|FG011|Part 1 Max 23.5 Months Followup Duration|Withdrawal by Subject|0|||
147453311|NCT02064387|531823978|FG000|Part 2 Max 35 Months Followup Duration|Death|0|||
147453312|NCT02064387|531823979|FG001|Part 2 Max 35 Months Followup Duration|Death|0|||
147453313|NCT02064387|531823980|FG002|Part 2 Max 35 Months Followup Duration|Death|0|||
147453314|NCT02064387|531823981|FG003|Part 2 Max 35 Months Followup Duration|Death|0|||
147453315|NCT02064387|531823982|FG004|Part 2 Max 35 Months Followup Duration|Death|0|||
147453316|NCT02064387|531823983|FG005|Part 2 Max 35 Months Followup Duration|Death|0|||
147453317|NCT02064387|531823984|FG006|Part 2 Max 35 Months Followup Duration|Death|0|||
147453318|NCT02064387|531823985|FG007|Part 2 Max 35 Months Followup Duration|Death|0|||
147453319|NCT02064387|531823986|FG008|Part 2 Max 35 Months Followup Duration|Death|0|||
147453320|NCT02064387|531823987|FG009|Part 2 Max 35 Months Followup Duration|Death|0|||
147453321|NCT02064387|531823988|FG010|Part 2 Max 35 Months Followup Duration|Death|5|||
147453322|NCT02064387|531823989|FG011|Part 2 Max 35 Months Followup Duration|Death|3|||
147453323|NCT02064387|531823978|FG000|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
147453324|NCT02064387|531823979|FG001|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
147453325|NCT02064387|531823980|FG002|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
147453326|NCT02064387|531823981|FG003|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
147453327|NCT02064387|531823982|FG004|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
147453328|NCT02064387|531823983|FG005|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
147453329|NCT02064387|531823984|FG006|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
147453330|NCT02064387|531823985|FG007|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
147453331|NCT02064387|531823986|FG008|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
147453332|NCT02064387|531823987|FG009|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
147453333|NCT02064387|531823988|FG010|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|1|||
147453334|NCT02064387|531823989|FG011|Part 2 Max 35 Months Followup Duration|Withdrawal by Subject|0|||
147453335|NCT03728309|531823993|FG000|Overall Study|Randomized but not Treated|0|||
147453336|NCT03728309|531823994|FG001|Overall Study|Randomized but not Treated|1|||
147453337|NCT03728309|531823993|FG000|Overall Study|Adverse Event|0|||
147453338|NCT03728309|531823994|FG001|Overall Study|Adverse Event|1|||
147453339|NCT03728309|531823993|FG000|Overall Study|Withdrawal by Subject|2|||
147350672|NCT05369403|531453247|FG002|Treatment Period 2: Weeks 16 to Week 24|Protocol Deviation|4|||
147350673|NCT05369403|531453245|FG000|Treatment Period 2: Weeks 16 to Week 24|Withdrawal by Subject|0|||
147350674|NCT05369403|531453246|FG001|Treatment Period 2: Weeks 16 to Week 24|Withdrawal by Subject|1|||
147350675|NCT05369403|531453247|FG002|Treatment Period 2: Weeks 16 to Week 24|Withdrawal by Subject|0|||
147350676|NCT05369403|531453245|FG000|Treatment Period 2: Weeks 16 to Week 24|Lost to Follow-up|0|||
147350677|NCT05369403|531453246|FG001|Treatment Period 2: Weeks 16 to Week 24|Lost to Follow-up|1|||
147350678|NCT05369403|531453247|FG002|Treatment Period 2: Weeks 16 to Week 24|Lost to Follow-up|0|||
147350679|NCT03056040|531453251|FG000|Primary Evaluation Period|Withdrawal by Subject|1|||
147350680|NCT03056040|531453252|FG001|Primary Evaluation Period|Withdrawal by Subject|1|||
147350681|NCT03056040|531453251|FG000|Primary Evaluation Period|Lack of Efficacy|0|||
147350682|NCT03056040|531453252|FG001|Primary Evaluation Period|Lack of Efficacy|1|||
147350683|NCT03056040|531453251|FG000|Primary Evaluation Period|Pregnancy|0|||
147350684|NCT03056040|531453252|FG001|Primary Evaluation Period|Pregnancy|1|||
147350685|NCT03056040|531453251|FG000|Primary Evaluation Period|Randomized, not treated|1|||
147350686|NCT03056040|531453252|FG001|Primary Evaluation Period|Randomized, not treated|1|||
147350687|NCT03056040|531453251|FG000|Extension Period|Physician Decision|3|||
147350688|NCT03056040|531453252|FG001|Extension Period|Physician Decision|3|||
147350689|NCT03056040|531453251|FG000|Extension Period|Lost to Follow-up|0|||
147350690|NCT03056040|531453252|FG001|Extension Period|Lost to Follow-up|1|||
147350691|NCT03056040|531453251|FG000|Extension Period|Death|0|||
147350692|NCT03056040|531453252|FG001|Extension Period|Death|3|||
147350693|NCT03056040|531453251|FG000|Extension Period|Withdrawal by Subject|1|||
147350694|NCT03056040|531453252|FG001|Extension Period|Withdrawal by Subject|0|||
147350695|NCT03445988|531453255|FG000|Overall Study|Lost to Follow-up|14|||
147350696|NCT03445988|531453256|FG001|Overall Study|Lost to Follow-up|26|||
147350697|NCT03445988|531453257|FG002|Overall Study|Lost to Follow-up|27|||
147350698|NCT03445988|531453258|FG003|Overall Study|Lost to Follow-up|66|||
147350699|NCT03445988|531453255|FG000|Overall Study|Withdrawal by Subject|7|||
147350700|NCT03445988|531453256|FG001|Overall Study|Withdrawal by Subject|4|||
147350701|NCT03445988|531453257|FG002|Overall Study|Withdrawal by Subject|3|||
147350702|NCT03445988|531453258|FG003|Overall Study|Withdrawal by Subject|5|||
147350703|NCT03445988|531453255|FG000|Overall Study|Death (unrelated to study)|5|||
147350704|NCT03445988|531453256|FG001|Overall Study|Death (unrelated to study)|1|||
147350705|NCT03445988|531453257|FG002|Overall Study|Death (unrelated to study)|2|||
147350706|NCT03445988|531453258|FG003|Overall Study|Death (unrelated to study)|4|||
147350707|NCT03232138|531453259|FG000|Overall Study|Physician Decision|1|||
147350708|NCT03232138|531453260|FG001|Overall Study|Physician Decision|0|||
147350709|NCT03232138|531453259|FG000|Overall Study|Adverse Event|2|||
147350710|NCT03232138|531453260|FG001|Overall Study|Adverse Event|0|||
147350711|NCT03232138|531453259|FG000|Overall Study|Withdrawal by Subject|1|||
147350712|NCT03232138|531453260|FG001|Overall Study|Withdrawal by Subject|2|||
147350713|NCT03920111|531453264|FG000|Overall Study|suspected covid - unable to attend study visit|0|||
147350714|NCT03920111|531453265|FG001|Overall Study|suspected covid - unable to attend study visit|0|||
147350715|NCT03920111|531453266|FG002|Overall Study|suspected covid - unable to attend study visit|1|||
147350716|NCT05268393|531453267|FG000|Overall Study|Withdrawal by Subject|2|||
147350717|NCT05268393|531453268|FG001|Overall Study|Withdrawal by Subject|1|||
147350718|NCT04727554|531453269|FG000|Overall Study|Lost to Follow-up|0|||
147350719|NCT04727554|531453270|FG001|Overall Study|Lost to Follow-up|1|||
147350720|NCT04727554|531453269|FG000|Overall Study|Death|2|||
147350721|NCT04727554|531453270|FG001|Overall Study|Death|6|||
147350722|NCT04727554|531453269|FG000|Overall Study|Withdrawal by Subject|1|||
147350723|NCT04727554|531453270|FG001|Overall Study|Withdrawal by Subject|0|||
147350724|NCT05763823|531453271|FG000|Overall Study|Death|6|||
147350725|NCT05763823|531453271|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
147350726|NCT05763823|531453271|FG000|Overall Study|Withdrawal by Subject|6|||
147350727|NCT01997840|531453274|FG000|Overall Study|Lost to Follow-up|0|||
147350728|NCT01997840|531453275|FG001|Overall Study|Lost to Follow-up|0|||
147350729|NCT01997840|531453276|FG002|Overall Study|Lost to Follow-up|1|||
147350730|NCT01997840|531453277|FG003|Overall Study|Lost to Follow-up|0|||
147350731|NCT01997840|531453274|FG000|Overall Study|Withdrawal by participant|0|||
147350732|NCT01997840|531453275|FG001|Overall Study|Withdrawal by participant|0|||
147662741|NCT02227784|532587414|FG002|Open-Label Extension Phase (OLE)|Death|0|||
147350733|NCT01997840|531453276|FG002|Overall Study|Withdrawal by participant|8|||
147350734|NCT01997840|531453277|FG003|Overall Study|Withdrawal by participant|1|||
147350735|NCT01997840|531453274|FG000|Overall Study|Physician Decision|0|||
147662742|NCT02227784|532587415|FG003|Open-Label Extension Phase (OLE)|Death|0|||
147350736|NCT01997840|531453275|FG001|Overall Study|Physician Decision|0|||
147350737|NCT01997840|531453276|FG002|Overall Study|Physician Decision|3|||
147350738|NCT01997840|531453277|FG003|Overall Study|Physician Decision|0|||
147350739|NCT01997840|531453274|FG000|Overall Study|Progressive disease|3|||
147350740|NCT01997840|531453275|FG001|Overall Study|Progressive disease|4|||
147350741|NCT01997840|531453276|FG002|Overall Study|Progressive disease|57|||
147350742|NCT01997840|531453277|FG003|Overall Study|Progressive disease|8|||
147350743|NCT01997840|531453274|FG000|Overall Study|Other reasons|0|||
147350744|NCT01997840|531453275|FG001|Overall Study|Other reasons|0|||
147350745|NCT01997840|531453276|FG002|Overall Study|Other reasons|1|||
147350746|NCT01997840|531453277|FG003|Overall Study|Other reasons|0|||
147607077|NCT02960490|532377238|FG006|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
147607078|NCT02960490|532377239|FG007|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
147607079|NCT02960490|532377240|FG008|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
147607080|NCT02960490|532377241|FG009|Re-randomized Participants: 12 Weeks|Lack of Efficacy|0|||
147607081|NCT02960490|532377232|FG000|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
147607082|NCT02960490|532377233|FG001|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
147350747|NCT01997840|531453274|FG000|Overall Study|Adverse Event|0|||
147350748|NCT01997840|531453275|FG001|Overall Study|Adverse Event|0|||
147350749|NCT01997840|531453276|FG002|Overall Study|Adverse Event|15|||
147350750|NCT01997840|531453277|FG003|Overall Study|Adverse Event|2|||
147350751|NCT05256706|531453279|FG000|Overall Study|Lost to Follow-up|9|||
147350752|NCT05256706|531453280|FG001|Overall Study|Lost to Follow-up|3|||
147350753|NCT05256706|531453279|FG000|Overall Study|Withdrawal by Subject|7|||
147350754|NCT05256706|531453280|FG001|Overall Study|Withdrawal by Subject|11|||
147350755|NCT05256706|531453279|FG000|Overall Study|Screen Failures|3|||
147350756|NCT05256706|531453280|FG001|Overall Study|Screen Failures|0|||
147350757|NCT03850678|531453283|FG000|Overall Study|Withdrawal by Subject|3|||
147350758|NCT03850678|531453284|FG001|Overall Study|Withdrawal by Subject|0|||
147350759|NCT03850678|531453283|FG000|Overall Study|Experimenter Error|1|||
147350760|NCT03850678|531453284|FG001|Overall Study|Experimenter Error|1|||
147350761|NCT03850678|531453283|FG000|Overall Study|Did Not Condition To Experiment|7|||
147350762|NCT03850678|531453284|FG001|Overall Study|Did Not Condition To Experiment|2|||
147350763|NCT03720795|531453285|FG000|Phase 1|Lost to Follow-up|4|||
147350764|NCT03720795|531453285|FG000|Phase 1|Withdrawal by Subject|6|||
147350765|NCT03720795|531453285|FG000|Phase 1|Protocol Violation|1|||
147350766|NCT03720795|531453285|FG000|Phase 1|Other|1|||
147350767|NCT03720795|531453285|FG000|Phase 2|Lost to Follow-up|5|||
147350768|NCT03720795|531453285|FG000|Phase 2|Withdrawal by Subject|10|||
147350769|NCT03720795|531453285|FG000|Phase 2|Protocol Violation|2|||
147350770|NCT03720795|531453285|FG000|3 Month Follow Up|Lost to Follow-up|2|||
147350771|NCT04166773|531453288|FG000|Overall Study|Adverse Event|2|||
147350772|NCT04166773|531453289|FG001|Overall Study|Adverse Event|0|||
147453340|NCT03728309|531823994|FG001|Overall Study|Withdrawal by Subject|8|||
147453341|NCT03728309|531823993|FG000|Overall Study|Lost to Follow-up|9|||
147453342|NCT03728309|531823994|FG001|Overall Study|Lost to Follow-up|10|||
147453343|NCT03728309|531823993|FG000|Overall Study|Protocol Deviation|0|||
147453344|NCT03728309|531823994|FG001|Overall Study|Protocol Deviation|1|||
147453345|NCT03728309|531823993|FG000|Overall Study|Due to COVID|1|||
147453346|NCT03728309|531823994|FG001|Overall Study|Due to COVID|3|||
147453347|NCT02436876|531823995|FG000|Overall Study|Lost to Follow-up|0|||
147453348|NCT02436876|531823996|FG001|Overall Study|Lost to Follow-up|1|||
147453349|NCT02436876|531823997|FG002|Overall Study|Lost to Follow-up|1|||
147453350|NCT02436876|531823998|FG003|Overall Study|Lost to Follow-up|1|||
147453351|NCT02436876|531823995|FG000|Overall Study|Withdrawal by Subject|1|||
147453352|NCT02436876|531823996|FG001|Overall Study|Withdrawal by Subject|0|||
147453353|NCT02436876|531823997|FG002|Overall Study|Withdrawal by Subject|0|||
147453354|NCT02436876|531823998|FG003|Overall Study|Withdrawal by Subject|1|||
147453355|NCT02436876|531823995|FG000|Overall Study|Physician Decision|0|||
147453356|NCT02436876|531823996|FG001|Overall Study|Physician Decision|2|||
147453357|NCT02436876|531823997|FG002|Overall Study|Physician Decision|1|||
147453358|NCT02436876|531823998|FG003|Overall Study|Physician Decision|0|||
147453359|NCT02436876|531823995|FG000|Overall Study|Inadequate amount of study drug available for randomization|0|||
147453360|NCT02436876|531823996|FG001|Overall Study|Inadequate amount of study drug available for randomization|1|||
147453361|NCT02436876|531823997|FG002|Overall Study|Inadequate amount of study drug available for randomization|0|||
147453362|NCT02436876|531823998|FG003|Overall Study|Inadequate amount of study drug available for randomization|0|||
147453363|NCT00999908|531824001|FG000|Treatment Period 1|Subject withdrew consent|2|||
147453364|NCT00999908|531824002|FG001|Treatment Period 1|Subject withdrew consent|0|||
147453365|NCT00999908|531824003|FG002|Treatment Period 1|Subject withdrew consent|0|||
147453366|NCT00999908|531824001|FG000|Treatment Period 2|Protocol Violation|1|||
147453367|NCT00999908|531824002|FG001|Treatment Period 2|Protocol Violation|0|||
147453368|NCT00999908|531824003|FG002|Treatment Period 2|Protocol Violation|0|||
147453369|NCT01290692|531824004|FG000|Overall Study|Lack of sufficient efficacy as patients were immunocompromised|7|||
147607083|NCT02960490|532377234|FG002|Re-randomized Participants: 12 Weeks|Adverse Event|1|||
147453370|NCT03403205|531824008|FG000|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|4|||
147607084|NCT02960490|532377235|FG003|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
147350773|NCT04166773|531453290|FG002|Overall Study|Adverse Event|2|||
147350774|NCT04166773|531453291|FG003|Overall Study|Adverse Event|1|||
147350775|NCT04166773|531453288|FG000|Overall Study|Lost to Follow-up|4|||
147350776|NCT04166773|531453289|FG001|Overall Study|Lost to Follow-up|2|||
147350777|NCT04166773|531453290|FG002|Overall Study|Lost to Follow-up|1|||
147350778|NCT04166773|531453291|FG003|Overall Study|Lost to Follow-up|3|||
147453371|NCT03403205|531824009|FG001|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|2|||
147350779|NCT04166773|531453288|FG000|Overall Study|Physician Decision|0|||
147350780|NCT04166773|531453289|FG001|Overall Study|Physician Decision|0|||
147350781|NCT04166773|531453290|FG002|Overall Study|Physician Decision|0|||
147350782|NCT04166773|531453291|FG003|Overall Study|Physician Decision|1|||
147350783|NCT04166773|531453288|FG000|Overall Study|Withdrawal by Subject|1|||
147350784|NCT04166773|531453289|FG001|Overall Study|Withdrawal by Subject|1|||
147350785|NCT04166773|531453290|FG002|Overall Study|Withdrawal by Subject|2|||
147350786|NCT04166773|531453291|FG003|Overall Study|Withdrawal by Subject|5|||
147350787|NCT04763265|531453292|FG000|Overall Study|Adverse Event|1|||
147350788|NCT04763265|531453293|FG001|Overall Study|Adverse Event|0|||
147350789|NCT04763265|531453292|FG000|Overall Study|Lost to Follow-up|2|||
147350790|NCT04763265|531453293|FG001|Overall Study|Lost to Follow-up|4|||
147350791|NCT04763265|531453292|FG000|Overall Study|Withdrawal by Subject|0|||
147350792|NCT04763265|531453293|FG001|Overall Study|Withdrawal by Subject|1|||
147350793|NCT03269136|531453298|FG000|Part 1: Dose Escalation|Other|0|||
147350794|NCT03269136|531453299|FG001|Part 1: Dose Escalation|Other|0|||
147350795|NCT03269136|531453300|FG002|Part 1: Dose Escalation|Other|0|||
147350796|NCT03269136|531453301|FG003|Part 1: Dose Escalation|Other|0|||
147350797|NCT03269136|531453302|FG004|Part 1: Dose Escalation|Other|0|||
147350798|NCT03269136|531453303|FG005|Part 1: Dose Escalation|Other|0|||
147350799|NCT03269136|531453304|FG006|Part 1: Dose Escalation|Other|0|||
147350800|NCT03269136|531453305|FG007|Part 1: Dose Escalation|Other|0|||
147350801|NCT03269136|531453306|FG008|Part 1: Dose Escalation|Other|0|||
147350802|NCT03269136|531453307|FG009|Part 1: Dose Escalation|Other|0|||
147350803|NCT03269136|531453308|FG010|Part 1: Dose Escalation|Other|1|||
147350804|NCT03269136|531453309|FG011|Part 1: Dose Escalation|Other|1|||
147350805|NCT03269136|531453310|FG012|Part 1: Dose Escalation|Other|1|||
147350806|NCT03269136|531453311|FG013|Part 1: Dose Escalation|Other|0|||
147350807|NCT03269136|531453312|FG014|Part 1: Dose Escalation|Other|3|||
147350808|NCT03269136|531453313|FG015|Part 1: Dose Escalation|Other|1|||
147350809|NCT03269136|531453314|FG016|Part 1: Dose Escalation|Other|1|||
147350810|NCT03269136|531453315|FG017|Part 1: Dose Escalation|Other|0|||
147350811|NCT03269136|531453298|FG000|Part 1: Dose Escalation|Refused Further Treatment|0|||
147350812|NCT03269136|531453299|FG001|Part 1: Dose Escalation|Refused Further Treatment|0|||
147350813|NCT03269136|531453300|FG002|Part 1: Dose Escalation|Refused Further Treatment|0|||
147350814|NCT03269136|531453301|FG003|Part 1: Dose Escalation|Refused Further Treatment|0|||
147350815|NCT03269136|531453302|FG004|Part 1: Dose Escalation|Refused Further Treatment|0|||
147350816|NCT03269136|531453303|FG005|Part 1: Dose Escalation|Refused Further Treatment|0|||
147350817|NCT03269136|531453304|FG006|Part 1: Dose Escalation|Refused Further Treatment|1|||
147350818|NCT03269136|531453305|FG007|Part 1: Dose Escalation|Refused Further Treatment|0|||
147350819|NCT03269136|531453306|FG008|Part 1: Dose Escalation|Refused Further Treatment|1|||
147350820|NCT03269136|531453307|FG009|Part 1: Dose Escalation|Refused Further Treatment|0|||
147350821|NCT03269136|531453308|FG010|Part 1: Dose Escalation|Refused Further Treatment|0|||
147350822|NCT03269136|531453309|FG011|Part 1: Dose Escalation|Refused Further Treatment|0|||
147350823|NCT03269136|531453310|FG012|Part 1: Dose Escalation|Refused Further Treatment|1|||
147350824|NCT03269136|531453311|FG013|Part 1: Dose Escalation|Refused Further Treatment|0|||
147350825|NCT03269136|531453312|FG014|Part 1: Dose Escalation|Refused Further Treatment|0|||
147350826|NCT03269136|531453313|FG015|Part 1: Dose Escalation|Refused Further Treatment|0|||
147350827|NCT03269136|531453314|FG016|Part 1: Dose Escalation|Refused Further Treatment|0|||
147350828|NCT03269136|531453315|FG017|Part 1: Dose Escalation|Refused Further Treatment|0|||
147350829|NCT03269136|531453298|FG000|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
147350830|NCT03269136|531453299|FG001|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
147350831|NCT03269136|531453300|FG002|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
147350832|NCT03269136|531453301|FG003|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
147350833|NCT03269136|531453302|FG004|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
147350834|NCT03269136|531453303|FG005|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
147350835|NCT03269136|531453304|FG006|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
147350836|NCT03269136|531453305|FG007|Part 1: Dose Escalation|Global Deterioration of Health Status|1|||
147350837|NCT03269136|531453306|FG008|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
147350838|NCT03269136|531453307|FG009|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
147350839|NCT03269136|531453308|FG010|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
147350840|NCT03269136|531453309|FG011|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
147350841|NCT03269136|531453310|FG012|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
147350842|NCT03269136|531453311|FG013|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
147350843|NCT03269136|531453312|FG014|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
147350844|NCT03269136|531453313|FG015|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
147350845|NCT03269136|531453314|FG016|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
147350846|NCT03269136|531453315|FG017|Part 1: Dose Escalation|Global Deterioration of Health Status|0|||
147350847|NCT03269136|531453298|FG000|Part 1: Dose Escalation|Lost to Follow-up|0|||
147350848|NCT03269136|531453299|FG001|Part 1: Dose Escalation|Lost to Follow-up|0|||
147350849|NCT03269136|531453300|FG002|Part 1: Dose Escalation|Lost to Follow-up|0|||
147350850|NCT03269136|531453301|FG003|Part 1: Dose Escalation|Lost to Follow-up|0|||
147350851|NCT03269136|531453302|FG004|Part 1: Dose Escalation|Lost to Follow-up|0|||
147350852|NCT03269136|531453303|FG005|Part 1: Dose Escalation|Lost to Follow-up|0|||
147350853|NCT03269136|531453304|FG006|Part 1: Dose Escalation|Lost to Follow-up|0|||
147350854|NCT03269136|531453305|FG007|Part 1: Dose Escalation|Lost to Follow-up|0|||
147350855|NCT03269136|531453306|FG008|Part 1: Dose Escalation|Lost to Follow-up|0|||
147350856|NCT03269136|531453307|FG009|Part 1: Dose Escalation|Lost to Follow-up|1|||
147350857|NCT03269136|531453308|FG010|Part 1: Dose Escalation|Lost to Follow-up|0|||
147350858|NCT03269136|531453309|FG011|Part 1: Dose Escalation|Lost to Follow-up|0|||
147350859|NCT03269136|531453310|FG012|Part 1: Dose Escalation|Lost to Follow-up|0|||
147350860|NCT03269136|531453311|FG013|Part 1: Dose Escalation|Lost to Follow-up|0|||
147350861|NCT03269136|531453312|FG014|Part 1: Dose Escalation|Lost to Follow-up|0|||
147350862|NCT03269136|531453313|FG015|Part 1: Dose Escalation|Lost to Follow-up|0|||
147350863|NCT03269136|531453314|FG016|Part 1: Dose Escalation|Lost to Follow-up|0|||
147350864|NCT03269136|531453315|FG017|Part 1: Dose Escalation|Lost to Follow-up|0|||
147350865|NCT03269136|531453298|FG000|Part 1: Dose Escalation|Death|0|||
147350866|NCT03269136|531453299|FG001|Part 1: Dose Escalation|Death|0|||
147350867|NCT03269136|531453300|FG002|Part 1: Dose Escalation|Death|0|||
147350868|NCT03269136|531453301|FG003|Part 1: Dose Escalation|Death|0|||
147350869|NCT03269136|531453302|FG004|Part 1: Dose Escalation|Death|0|||
147350870|NCT03269136|531453303|FG005|Part 1: Dose Escalation|Death|0|||
147350871|NCT03269136|531453304|FG006|Part 1: Dose Escalation|Death|0|||
147350872|NCT03269136|531453305|FG007|Part 1: Dose Escalation|Death|0|||
147350873|NCT03269136|531453306|FG008|Part 1: Dose Escalation|Death|0|||
147350874|NCT03269136|531453307|FG009|Part 1: Dose Escalation|Death|1|||
147350875|NCT03269136|531453308|FG010|Part 1: Dose Escalation|Death|0|||
147350876|NCT03269136|531453309|FG011|Part 1: Dose Escalation|Death|1|||
147350877|NCT03269136|531453310|FG012|Part 1: Dose Escalation|Death|0|||
147350878|NCT03269136|531453311|FG013|Part 1: Dose Escalation|Death|1|||
147350879|NCT03269136|531453312|FG014|Part 1: Dose Escalation|Death|0|||
147350880|NCT03269136|531453313|FG015|Part 1: Dose Escalation|Death|0|||
147350881|NCT03269136|531453314|FG016|Part 1: Dose Escalation|Death|2|||
147350882|NCT03269136|531453315|FG017|Part 1: Dose Escalation|Death|0|||
147350883|NCT03269136|531453298|FG000|Part 1: Dose Escalation|Disease Relapse|0|||
147350884|NCT03269136|531453299|FG001|Part 1: Dose Escalation|Disease Relapse|0|||
147350885|NCT03269136|531453300|FG002|Part 1: Dose Escalation|Disease Relapse|0|||
147607085|NCT02960490|532377236|FG004|Re-randomized Participants: 12 Weeks|Adverse Event|1|||
147350886|NCT03269136|531453301|FG003|Part 1: Dose Escalation|Disease Relapse|0|||
147350887|NCT03269136|531453302|FG004|Part 1: Dose Escalation|Disease Relapse|0|||
147350888|NCT03269136|531453303|FG005|Part 1: Dose Escalation|Disease Relapse|0|||
147350889|NCT03269136|531453304|FG006|Part 1: Dose Escalation|Disease Relapse|0|||
147350890|NCT03269136|531453305|FG007|Part 1: Dose Escalation|Disease Relapse|0|||
147350891|NCT03269136|531453306|FG008|Part 1: Dose Escalation|Disease Relapse|0|||
147350892|NCT03269136|531453307|FG009|Part 1: Dose Escalation|Disease Relapse|1|||
147350893|NCT03269136|531453308|FG010|Part 1: Dose Escalation|Disease Relapse|0|||
147350894|NCT03269136|531453309|FG011|Part 1: Dose Escalation|Disease Relapse|0|||
147350895|NCT03269136|531453310|FG012|Part 1: Dose Escalation|Disease Relapse|0|||
147350896|NCT03269136|531453311|FG013|Part 1: Dose Escalation|Disease Relapse|0|||
147350897|NCT03269136|531453312|FG014|Part 1: Dose Escalation|Disease Relapse|0|||
147350898|NCT03269136|531453313|FG015|Part 1: Dose Escalation|Disease Relapse|0|||
147350899|NCT03269136|531453314|FG016|Part 1: Dose Escalation|Disease Relapse|0|||
147350900|NCT03269136|531453315|FG017|Part 1: Dose Escalation|Disease Relapse|0|||
147350901|NCT03269136|531453298|FG000|Part 1: Dose Escalation|Adverse Event|0|||
147350902|NCT03269136|531453299|FG001|Part 1: Dose Escalation|Adverse Event|0|||
147350903|NCT03269136|531453300|FG002|Part 1: Dose Escalation|Adverse Event|0|||
147350904|NCT03269136|531453301|FG003|Part 1: Dose Escalation|Adverse Event|0|||
147350905|NCT03269136|531453302|FG004|Part 1: Dose Escalation|Adverse Event|0|||
147350906|NCT03269136|531453303|FG005|Part 1: Dose Escalation|Adverse Event|0|||
147350907|NCT03269136|531453304|FG006|Part 1: Dose Escalation|Adverse Event|2|||
147350908|NCT03269136|531453305|FG007|Part 1: Dose Escalation|Adverse Event|0|||
147350909|NCT03269136|531453306|FG008|Part 1: Dose Escalation|Adverse Event|0|||
147350910|NCT03269136|531453307|FG009|Part 1: Dose Escalation|Adverse Event|0|||
147350911|NCT03269136|531453308|FG010|Part 1: Dose Escalation|Adverse Event|1|||
147350912|NCT03269136|531453309|FG011|Part 1: Dose Escalation|Adverse Event|2|||
147350913|NCT03269136|531453310|FG012|Part 1: Dose Escalation|Adverse Event|0|||
147350914|NCT03269136|531453311|FG013|Part 1: Dose Escalation|Adverse Event|1|||
147350915|NCT03269136|531453312|FG014|Part 1: Dose Escalation|Adverse Event|0|||
147350916|NCT03269136|531453313|FG015|Part 1: Dose Escalation|Adverse Event|0|||
147350917|NCT03269136|531453314|FG016|Part 1: Dose Escalation|Adverse Event|1|||
147350918|NCT03269136|531453315|FG017|Part 1: Dose Escalation|Adverse Event|0|||
147350919|NCT03269136|531453298|FG000|Part 1: Dose Escalation|Progressive Disease|2|||
147350920|NCT03269136|531453299|FG001|Part 1: Dose Escalation|Progressive Disease|3|||
147350921|NCT03269136|531453300|FG002|Part 1: Dose Escalation|Progressive Disease|2|||
147350922|NCT03269136|531453301|FG003|Part 1: Dose Escalation|Progressive Disease|3|||
147350923|NCT03269136|531453302|FG004|Part 1: Dose Escalation|Progressive Disease|2|||
147350924|NCT03269136|531453303|FG005|Part 1: Dose Escalation|Progressive Disease|5|||
147350925|NCT03269136|531453304|FG006|Part 1: Dose Escalation|Progressive Disease|3|||
147350926|NCT03269136|531453305|FG007|Part 1: Dose Escalation|Progressive Disease|5|||
147350927|NCT03269136|531453306|FG008|Part 1: Dose Escalation|Progressive Disease|3|||
147350928|NCT03269136|531453307|FG009|Part 1: Dose Escalation|Progressive Disease|1|||
147350929|NCT03269136|531453308|FG010|Part 1: Dose Escalation|Progressive Disease|2|||
147350930|NCT03269136|531453309|FG011|Part 1: Dose Escalation|Progressive Disease|2|||
147350931|NCT03269136|531453310|FG012|Part 1: Dose Escalation|Progressive Disease|3|||
147350932|NCT03269136|531453311|FG013|Part 1: Dose Escalation|Progressive Disease|3|||
147607086|NCT02960490|532377237|FG005|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
147607087|NCT02960490|532377238|FG006|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
147607088|NCT02960490|532377239|FG007|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
147607089|NCT02960490|532377240|FG008|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
147607090|NCT02960490|532377241|FG009|Re-randomized Participants: 12 Weeks|Adverse Event|0|||
147607091|NCT02960490|532377232|FG000|Re-randomized Participants: 12 Weeks|Other|0|||
147350933|NCT03269136|531453312|FG014|Part 1: Dose Escalation|Progressive Disease|8|||
147350934|NCT03269136|531453313|FG015|Part 1: Dose Escalation|Progressive Disease|3|||
147350935|NCT03269136|531453314|FG016|Part 1: Dose Escalation|Progressive Disease|4|||
147350936|NCT03269136|531453315|FG017|Part 1: Dose Escalation|Progressive Disease|0|||
147350937|NCT03269136|531453298|FG000|Part 1: Dose Escalation|Withdrawal by Subject|0|||
147350938|NCT03269136|531453299|FG001|Part 1: Dose Escalation|Withdrawal by Subject|0|||
147350939|NCT03269136|531453300|FG002|Part 1: Dose Escalation|Withdrawal by Subject|0|||
147350940|NCT03269136|531453301|FG003|Part 1: Dose Escalation|Withdrawal by Subject|0|||
147350941|NCT03269136|531453302|FG004|Part 1: Dose Escalation|Withdrawal by Subject|0|||
147350942|NCT03269136|531453303|FG005|Part 1: Dose Escalation|Withdrawal by Subject|0|||
147350943|NCT03269136|531453304|FG006|Part 1: Dose Escalation|Withdrawal by Subject|0|||
147350944|NCT03269136|531453305|FG007|Part 1: Dose Escalation|Withdrawal by Subject|0|||
147350945|NCT03269136|531453306|FG008|Part 1: Dose Escalation|Withdrawal by Subject|0|||
147350946|NCT03269136|531453307|FG009|Part 1: Dose Escalation|Withdrawal by Subject|0|||
147350947|NCT03269136|531453308|FG010|Part 1: Dose Escalation|Withdrawal by Subject|0|||
147350948|NCT03269136|531453309|FG011|Part 1: Dose Escalation|Withdrawal by Subject|0|||
147350949|NCT03269136|531453310|FG012|Part 1: Dose Escalation|Withdrawal by Subject|1|||
147350950|NCT03269136|531453311|FG013|Part 1: Dose Escalation|Withdrawal by Subject|2|||
147350951|NCT03269136|531453312|FG014|Part 1: Dose Escalation|Withdrawal by Subject|2|||
147350952|NCT03269136|531453313|FG015|Part 1: Dose Escalation|Withdrawal by Subject|0|||
147350953|NCT03269136|531453314|FG016|Part 1: Dose Escalation|Withdrawal by Subject|1|||
147350954|NCT03269136|531453315|FG017|Part 1: Dose Escalation|Withdrawal by Subject|0|||
147350955|NCT03269136|531453298|FG000|Part 2A: Dose Expansion|Other|0|||
147350956|NCT03269136|531453299|FG001|Part 2A: Dose Expansion|Other|0|||
147350957|NCT03269136|531453300|FG002|Part 2A: Dose Expansion|Other|0|||
147350958|NCT03269136|531453301|FG003|Part 2A: Dose Expansion|Other|0|||
147350959|NCT03269136|531453302|FG004|Part 2A: Dose Expansion|Other|0|||
147350960|NCT03269136|531453303|FG005|Part 2A: Dose Expansion|Other|0|||
147350961|NCT03269136|531453304|FG006|Part 2A: Dose Expansion|Other|0|||
147350962|NCT03269136|531453305|FG007|Part 2A: Dose Expansion|Other|0|||
147350963|NCT03269136|531453306|FG008|Part 2A: Dose Expansion|Other|0|||
147350964|NCT03269136|531453307|FG009|Part 2A: Dose Expansion|Other|0|||
147350965|NCT03269136|531453308|FG010|Part 2A: Dose Expansion|Other|0|||
147350966|NCT03269136|531453309|FG011|Part 2A: Dose Expansion|Other|0|||
147350967|NCT03269136|531453310|FG012|Part 2A: Dose Expansion|Other|0|||
147453372|NCT03403205|531824010|FG002|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|2|||
147453373|NCT03403205|531824011|FG003|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|1|||
147453374|NCT03403205|531824012|FG004|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
147453375|NCT03403205|531824013|FG005|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
147453376|NCT03403205|531824008|FG000|Primary Evaluation Period (48 Weeks)|Adverse Event|4|||
147453377|NCT03403205|531824009|FG001|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
147453378|NCT03403205|531824010|FG002|Primary Evaluation Period (48 Weeks)|Adverse Event|1|||
147453379|NCT03403205|531824011|FG003|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
147453380|NCT03403205|531824012|FG004|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
147453381|NCT03403205|531824013|FG005|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
147453382|NCT03403205|531824008|FG000|Primary Evaluation Period (48 Weeks)|Death|1|||
147453383|NCT03403205|531824009|FG001|Primary Evaluation Period (48 Weeks)|Death|0|||
147453384|NCT03403205|531824010|FG002|Primary Evaluation Period (48 Weeks)|Death|1|||
147453385|NCT03403205|531824011|FG003|Primary Evaluation Period (48 Weeks)|Death|0|||
147453386|NCT03403205|531824012|FG004|Primary Evaluation Period (48 Weeks)|Death|0|||
147607092|NCT02960490|532377233|FG001|Re-randomized Participants: 12 Weeks|Other|0|||
147607093|NCT02960490|532377234|FG002|Re-randomized Participants: 12 Weeks|Other|0|||
147607094|NCT02960490|532377235|FG003|Re-randomized Participants: 12 Weeks|Other|1|||
147607095|NCT02960490|532377236|FG004|Re-randomized Participants: 12 Weeks|Other|0|||
147350968|NCT03269136|531453311|FG013|Part 2A: Dose Expansion|Other|0|||
147350969|NCT03269136|531453312|FG014|Part 2A: Dose Expansion|Other|0|||
147453387|NCT03403205|531824013|FG005|Primary Evaluation Period (48 Weeks)|Death|0|||
147453388|NCT03403205|531824008|FG000|Primary Evaluation Period (48 Weeks)|Lost to Follow-up|1|||
147607096|NCT02960490|532377237|FG005|Re-randomized Participants: 12 Weeks|Other|0|||
147350970|NCT03269136|531453313|FG015|Part 2A: Dose Expansion|Other|0|||
147350971|NCT03269136|531453314|FG016|Part 2A: Dose Expansion|Other|0|||
147350972|NCT03269136|531453315|FG017|Part 2A: Dose Expansion|Other|1|||
147350973|NCT03269136|531453298|FG000|Part 2A: Dose Expansion|Refused Further Treatment|0|||
147350974|NCT03269136|531453299|FG001|Part 2A: Dose Expansion|Refused Further Treatment|0|||
147350975|NCT03269136|531453300|FG002|Part 2A: Dose Expansion|Refused Further Treatment|0|||
147350976|NCT03269136|531453301|FG003|Part 2A: Dose Expansion|Refused Further Treatment|0|||
147350977|NCT03269136|531453302|FG004|Part 2A: Dose Expansion|Refused Further Treatment|0|||
147350978|NCT03269136|531453303|FG005|Part 2A: Dose Expansion|Refused Further Treatment|0|||
147350979|NCT03269136|531453304|FG006|Part 2A: Dose Expansion|Refused Further Treatment|0|||
147350980|NCT03269136|531453305|FG007|Part 2A: Dose Expansion|Refused Further Treatment|0|||
147350981|NCT03269136|531453306|FG008|Part 2A: Dose Expansion|Refused Further Treatment|0|||
147350982|NCT03269136|531453307|FG009|Part 2A: Dose Expansion|Refused Further Treatment|0|||
147350983|NCT03269136|531453308|FG010|Part 2A: Dose Expansion|Refused Further Treatment|0|||
147350984|NCT03269136|531453309|FG011|Part 2A: Dose Expansion|Refused Further Treatment|0|||
147350985|NCT03269136|531453310|FG012|Part 2A: Dose Expansion|Refused Further Treatment|0|||
147350986|NCT03269136|531453311|FG013|Part 2A: Dose Expansion|Refused Further Treatment|0|||
147350987|NCT03269136|531453312|FG014|Part 2A: Dose Expansion|Refused Further Treatment|0|||
147350988|NCT03269136|531453313|FG015|Part 2A: Dose Expansion|Refused Further Treatment|0|||
147350989|NCT03269136|531453314|FG016|Part 2A: Dose Expansion|Refused Further Treatment|0|||
147350990|NCT03269136|531453315|FG017|Part 2A: Dose Expansion|Refused Further Treatment|2|||
147350991|NCT03269136|531453298|FG000|Part 2A: Dose Expansion|Disease Relapse|0|||
147350992|NCT03269136|531453299|FG001|Part 2A: Dose Expansion|Disease Relapse|0|||
147350993|NCT03269136|531453300|FG002|Part 2A: Dose Expansion|Disease Relapse|0|||
147350994|NCT03269136|531453301|FG003|Part 2A: Dose Expansion|Disease Relapse|0|||
147350995|NCT03269136|531453302|FG004|Part 2A: Dose Expansion|Disease Relapse|0|||
147350996|NCT03269136|531453303|FG005|Part 2A: Dose Expansion|Disease Relapse|0|||
147350997|NCT03269136|531453304|FG006|Part 2A: Dose Expansion|Disease Relapse|0|||
147350998|NCT03269136|531453305|FG007|Part 2A: Dose Expansion|Disease Relapse|0|||
147350999|NCT03269136|531453306|FG008|Part 2A: Dose Expansion|Disease Relapse|0|||
147351000|NCT03269136|531453307|FG009|Part 2A: Dose Expansion|Disease Relapse|0|||
147351001|NCT03269136|531453308|FG010|Part 2A: Dose Expansion|Disease Relapse|0|||
147351002|NCT03269136|531453309|FG011|Part 2A: Dose Expansion|Disease Relapse|0|||
147351003|NCT03269136|531453310|FG012|Part 2A: Dose Expansion|Disease Relapse|0|||
147351004|NCT03269136|531453311|FG013|Part 2A: Dose Expansion|Disease Relapse|0|||
147351005|NCT03269136|531453312|FG014|Part 2A: Dose Expansion|Disease Relapse|0|||
147351006|NCT03269136|531453313|FG015|Part 2A: Dose Expansion|Disease Relapse|0|||
147351007|NCT03269136|531453314|FG016|Part 2A: Dose Expansion|Disease Relapse|0|||
147351008|NCT03269136|531453315|FG017|Part 2A: Dose Expansion|Disease Relapse|1|||
147351009|NCT03269136|531453298|FG000|Part 2A: Dose Expansion|Progressive Disease|0|||
147351010|NCT03269136|531453299|FG001|Part 2A: Dose Expansion|Progressive Disease|0|||
147351011|NCT03269136|531453300|FG002|Part 2A: Dose Expansion|Progressive Disease|0|||
147351012|NCT03269136|531453301|FG003|Part 2A: Dose Expansion|Progressive Disease|0|||
147351013|NCT03269136|531453302|FG004|Part 2A: Dose Expansion|Progressive Disease|0|||
147351014|NCT03269136|531453303|FG005|Part 2A: Dose Expansion|Progressive Disease|0|||
147351015|NCT03269136|531453304|FG006|Part 2A: Dose Expansion|Progressive Disease|0|||
147351016|NCT03269136|531453305|FG007|Part 2A: Dose Expansion|Progressive Disease|0|||
147351017|NCT03269136|531453306|FG008|Part 2A: Dose Expansion|Progressive Disease|0|||
147351018|NCT03269136|531453307|FG009|Part 2A: Dose Expansion|Progressive Disease|0|||
147351019|NCT03269136|531453308|FG010|Part 2A: Dose Expansion|Progressive Disease|0|||
147351020|NCT03269136|531453309|FG011|Part 2A: Dose Expansion|Progressive Disease|0|||
147351021|NCT03269136|531453310|FG012|Part 2A: Dose Expansion|Progressive Disease|0|||
147351022|NCT03269136|531453311|FG013|Part 2A: Dose Expansion|Progressive Disease|0|||
147351023|NCT03269136|531453312|FG014|Part 2A: Dose Expansion|Progressive Disease|0|||
147351024|NCT03269136|531453313|FG015|Part 2A: Dose Expansion|Progressive Disease|0|||
147351025|NCT03269136|531453314|FG016|Part 2A: Dose Expansion|Progressive Disease|0|||
147351026|NCT03269136|531453315|FG017|Part 2A: Dose Expansion|Progressive Disease|9|||
147351027|NCT03269136|531453298|FG000|Part 2A: Dose Expansion|Adverse Event|0|||
147351028|NCT03269136|531453299|FG001|Part 2A: Dose Expansion|Adverse Event|0|||
147351029|NCT03269136|531453300|FG002|Part 2A: Dose Expansion|Adverse Event|0|||
147351030|NCT03269136|531453301|FG003|Part 2A: Dose Expansion|Adverse Event|0|||
147351031|NCT03269136|531453302|FG004|Part 2A: Dose Expansion|Adverse Event|0|||
147351032|NCT03269136|531453303|FG005|Part 2A: Dose Expansion|Adverse Event|0|||
147351033|NCT03269136|531453304|FG006|Part 2A: Dose Expansion|Adverse Event|0|||
147351034|NCT03269136|531453305|FG007|Part 2A: Dose Expansion|Adverse Event|0|||
147351035|NCT03269136|531453306|FG008|Part 2A: Dose Expansion|Adverse Event|0|||
147351036|NCT03269136|531453307|FG009|Part 2A: Dose Expansion|Adverse Event|0|||
147351037|NCT03269136|531453308|FG010|Part 2A: Dose Expansion|Adverse Event|0|||
147351038|NCT03269136|531453309|FG011|Part 2A: Dose Expansion|Adverse Event|0|||
147351039|NCT03269136|531453310|FG012|Part 2A: Dose Expansion|Adverse Event|0|||
147351040|NCT03269136|531453311|FG013|Part 2A: Dose Expansion|Adverse Event|0|||
147351041|NCT03269136|531453312|FG014|Part 2A: Dose Expansion|Adverse Event|0|||
147351042|NCT03269136|531453313|FG015|Part 2A: Dose Expansion|Adverse Event|0|||
147351043|NCT03269136|531453314|FG016|Part 2A: Dose Expansion|Adverse Event|0|||
147351044|NCT03269136|531453315|FG017|Part 2A: Dose Expansion|Adverse Event|2|||
147351045|NCT05071807|531453316|FG000|Overall Study|Withdrawal by Subject|4|||
147351046|NCT05071807|531453317|FG001|Overall Study|Withdrawal by Subject|0|||
147351047|NCT05071807|531453316|FG000|Overall Study|Unrelated medical issues|3|||
147351048|NCT05071807|531453317|FG001|Overall Study|Unrelated medical issues|0|||
147351049|NCT05071807|531453316|FG000|Overall Study|Relocated|0|||
147351050|NCT05071807|531453317|FG001|Overall Study|Relocated|1|||
147351051|NCT05308004|531453319|FG000|Overall Study|Not seen by Palliative Care NP|0|||
147351052|NCT05308004|531453320|FG001|Overall Study|Not seen by Palliative Care NP|1|||
147351053|NCT04552223|531453327|FG000|Overall Study|Withdrawal by Subject|1|||
147351054|NCT04856163|531453328|FG000|Overall Study|Lost to Follow-up|97|||
147351055|NCT04856163|531453329|FG001|Overall Study|Lost to Follow-up|100|||
147351056|NCT04359108|531453336|FG000|Overall Study|Withdrawal by Subject|1|||
147351057|NCT04359108|531453337|FG001|Overall Study|Withdrawal by Subject|0|||
147351058|NCT04359108|531453336|FG000|Overall Study|Unable or too feeble to walk independently|0|||
147351059|NCT04359108|531453337|FG001|Overall Study|Unable or too feeble to walk independently|2|||
147351060|NCT04359108|531453336|FG000|Overall Study|Argus II system stopped functioning|0|||
147351061|NCT04359108|531453337|FG001|Overall Study|Argus II system stopped functioning|1|||
147351062|NCT04359108|531453336|FG000|Overall Study|Died of natural causes unrelated to the study before study ended|0|||
147351063|NCT04359108|531453337|FG001|Overall Study|Died of natural causes unrelated to the study before study ended|2|||
147351064|NCT06393088|531453338|FG000|Overall Study|Withdrawal by Subject|0|||
147351065|NCT06393088|531453339|FG001|Overall Study|Withdrawal by Subject|2|||
147351066|NCT04176965|531453340|FG000|Overall Study|Death|1|||
147351067|NCT04176965|531453341|FG001|Overall Study|Death|2|||
147351068|NCT04176965|531453340|FG000|Overall Study|Lost to Follow-up|10|||
147351069|NCT04176965|531453341|FG001|Overall Study|Lost to Follow-up|2|||
147351070|NCT04176965|531453340|FG000|Overall Study|Withdrawal by Subject|6|||
147351071|NCT04176965|531453341|FG001|Overall Study|Withdrawal by Subject|1|||
147351072|NCT04924660|531453344|FG000|United States|Death|29|||
147351073|NCT04924660|531453345|FG001|United States|Death|32|||
147453389|NCT03403205|531824009|FG001|Primary Evaluation Period (48 Weeks)|Lost to Follow-up|1|||
147453390|NCT03403205|531824010|FG002|Primary Evaluation Period (48 Weeks)|Lost to Follow-up|0|||
147453391|NCT03403205|531824011|FG003|Primary Evaluation Period (48 Weeks)|Lost to Follow-up|0|||
147453392|NCT03403205|531824012|FG004|Primary Evaluation Period (48 Weeks)|Lost to Follow-up|0|||
147453393|NCT03403205|531824013|FG005|Primary Evaluation Period (48 Weeks)|Lost to Follow-up|0|||
147453394|NCT03403205|531824008|FG000|Primary Evaluation Period (48 Weeks)|Pregnancy|1|||
147453395|NCT03403205|531824009|FG001|Primary Evaluation Period (48 Weeks)|Pregnancy|0|||
147453396|NCT03403205|531824010|FG002|Primary Evaluation Period (48 Weeks)|Pregnancy|0|||
147662743|NCT02227784|532587416|FG004|Open-Label Extension Phase (OLE)|Death|1|||
147453397|NCT03403205|531824011|FG003|Primary Evaluation Period (48 Weeks)|Pregnancy|0|||
147453398|NCT03403205|531824012|FG004|Primary Evaluation Period (48 Weeks)|Pregnancy|0|||
147453399|NCT03403205|531824013|FG005|Primary Evaluation Period (48 Weeks)|Pregnancy|0|||
147453400|NCT03403205|531824008|FG000|Primary Evaluation Period (48 Weeks)|Protocol Deviation|0|||
147453401|NCT03403205|531824009|FG001|Primary Evaluation Period (48 Weeks)|Protocol Deviation|1|||
147453402|NCT03403205|531824010|FG002|Primary Evaluation Period (48 Weeks)|Protocol Deviation|0|||
147453403|NCT03403205|531824011|FG003|Primary Evaluation Period (48 Weeks)|Protocol Deviation|0|||
147453404|NCT03403205|531824012|FG004|Primary Evaluation Period (48 Weeks)|Protocol Deviation|0|||
147453405|NCT03403205|531824013|FG005|Primary Evaluation Period (48 Weeks)|Protocol Deviation|0|||
147453406|NCT03403205|531824008|FG000|Primary Evaluation Period (48 Weeks)|Randomized but not treated|1|||
147453407|NCT03403205|531824009|FG001|Primary Evaluation Period (48 Weeks)|Randomized but not treated|0|||
147453408|NCT03403205|531824010|FG002|Primary Evaluation Period (48 Weeks)|Randomized but not treated|4|||
147453409|NCT03403205|531824011|FG003|Primary Evaluation Period (48 Weeks)|Randomized but not treated|2|||
147453410|NCT03403205|531824012|FG004|Primary Evaluation Period (48 Weeks)|Randomized but not treated|0|||
147453411|NCT03403205|531824013|FG005|Primary Evaluation Period (48 Weeks)|Randomized but not treated|0|||
147453412|NCT03403205|531824008|FG000|Extension Period (Up to 60 Months)|Withdrawal by Subject|6|||
147453413|NCT03403205|531824009|FG001|Extension Period (Up to 60 Months)|Withdrawal by Subject|7|||
147453414|NCT03403205|531824010|FG002|Extension Period (Up to 60 Months)|Withdrawal by Subject|2|||
147453415|NCT03403205|531824011|FG003|Extension Period (Up to 60 Months)|Withdrawal by Subject|1|||
147453416|NCT03403205|531824012|FG004|Extension Period (Up to 60 Months)|Withdrawal by Subject|0|||
147453417|NCT03403205|531824013|FG005|Extension Period (Up to 60 Months)|Withdrawal by Subject|2|||
147453418|NCT03403205|531824008|FG000|Extension Period (Up to 60 Months)|Adverse Event|6|||
147453419|NCT03403205|531824009|FG001|Extension Period (Up to 60 Months)|Adverse Event|3|||
147453420|NCT03403205|531824010|FG002|Extension Period (Up to 60 Months)|Adverse Event|1|||
147351074|NCT04924660|531453346|FG002|United States|Death|34|||
147351075|NCT04924660|531453347|FG003|United States|Death|25|||
147351076|NCT04924660|531453348|FG004|United States|Death|26|||
147351077|NCT04924660|531453349|FG005|United States|Death|23|||
147351078|NCT04924660|531453344|FG000|United States|Lost to Follow-up|15|||
147351079|NCT04924660|531453345|FG001|United States|Lost to Follow-up|10|||
147453421|NCT03403205|531824011|FG003|Extension Period (Up to 60 Months)|Adverse Event|1|||
147351080|NCT04924660|531453346|FG002|United States|Lost to Follow-up|13|||
147351081|NCT04924660|531453347|FG003|United States|Lost to Follow-up|5|||
147351082|NCT04924660|531453348|FG004|United States|Lost to Follow-up|19|||
147351083|NCT04924660|531453349|FG005|United States|Lost to Follow-up|20|||
147351084|NCT04924660|531453344|FG000|United States|Withdrawal by Subject|8|||
147351085|NCT04924660|531453345|FG001|United States|Withdrawal by Subject|3|||
147351086|NCT04924660|531453346|FG002|United States|Withdrawal by Subject|3|||
147351087|NCT04924660|531453347|FG003|United States|Withdrawal by Subject|3|||
147351088|NCT04924660|531453348|FG004|United States|Withdrawal by Subject|8|||
147351089|NCT04924660|531453349|FG005|United States|Withdrawal by Subject|4|||
147351090|NCT04924660|531453344|FG000|Spain|Death|0|||
147351091|NCT04924660|531453345|FG001|Spain|Death|0|||
147351092|NCT04924660|531453346|FG002|Spain|Death|0|||
147351093|NCT04924660|531453347|FG003|Spain|Death|0|||
147351094|NCT04924660|531453348|FG004|Spain|Death|0|||
147351095|NCT04924660|531453349|FG005|Spain|Death|2|||
147351096|NCT04924660|531453344|FG000|Spain|Lost to Follow-up|0|||
147351097|NCT04924660|531453345|FG001|Spain|Lost to Follow-up|0|||
147351098|NCT04924660|531453346|FG002|Spain|Lost to Follow-up|0|||
147351099|NCT04924660|531453347|FG003|Spain|Lost to Follow-up|0|||
147351100|NCT04924660|531453348|FG004|Spain|Lost to Follow-up|1|||
147351101|NCT04924660|531453349|FG005|Spain|Lost to Follow-up|0|||
147351102|NCT04924660|531453344|FG000|Brazil|Death|0|||
147351103|NCT04924660|531453345|FG001|Brazil|Death|0|||
147351104|NCT04924660|531453346|FG002|Brazil|Death|0|||
147351105|NCT04924660|531453347|FG003|Brazil|Death|0|||
147351106|NCT04924660|531453348|FG004|Brazil|Death|1|||
147351107|NCT04924660|531453349|FG005|Brazil|Death|0|||
147351108|NCT04924660|531453344|FG000|Italy|Lost to Follow-up|0|||
147351109|NCT04924660|531453345|FG001|Italy|Lost to Follow-up|0|||
147351110|NCT04924660|531453346|FG002|Italy|Lost to Follow-up|0|||
147351111|NCT04924660|531453347|FG003|Italy|Lost to Follow-up|0|||
147351112|NCT04924660|531453348|FG004|Italy|Lost to Follow-up|0|||
147351113|NCT04924660|531453349|FG005|Italy|Lost to Follow-up|1|||
147351114|NCT04924660|531453344|FG000|South Africa|Death|0|||
147351115|NCT04924660|531453345|FG001|South Africa|Death|0|||
147351116|NCT04924660|531453346|FG002|South Africa|Death|0|||
147351117|NCT04924660|531453347|FG003|South Africa|Death|0|||
147351118|NCT04924660|531453348|FG004|South Africa|Death|0|||
147351119|NCT04924660|531453349|FG005|South Africa|Death|1|||
147351120|NCT04924660|531453344|FG000|South Africa|Lost to Follow-up|0|||
147351121|NCT04924660|531453345|FG001|South Africa|Lost to Follow-up|0|||
147351122|NCT04924660|531453346|FG002|South Africa|Lost to Follow-up|0|||
147351123|NCT04924660|531453347|FG003|South Africa|Lost to Follow-up|0|||
147351124|NCT04924660|531453348|FG004|South Africa|Lost to Follow-up|0|||
147351125|NCT04924660|531453349|FG005|South Africa|Lost to Follow-up|1|||
147351126|NCT05894577|531453350|FG000|Overall Study|No receipt of study drug|14|||
147351127|NCT05894577|531453351|FG001|Overall Study|No receipt of study drug|13|||
147351128|NCT05894577|531453350|FG000|Overall Study|Randomized not enrolled (Drug not received)|11|||
147351129|NCT05894577|531453351|FG001|Overall Study|Randomized not enrolled (Drug not received)|14|||
147351130|NCT05894577|531453350|FG000|Overall Study|Screen Fail|2|||
147351131|NCT05894577|531453351|FG001|Overall Study|Screen Fail|0|||
147351132|NCT05894577|531453350|FG000|Overall Study|Study drug recall|86|||
147351133|NCT05894577|531453351|FG001|Overall Study|Study drug recall|63|||
147351134|NCT02949362|531453356|FG000|Retrospective Period|Inform consent not signed by participant|4|||
147351135|NCT02949362|531453357|FG001|Retrospective Period|Inform consent not signed by participant|1|||
147351136|NCT02949362|531453358|FG002|Retrospective Period|Inform consent not signed by participant|0|||
147351137|NCT02949362|531453359|FG003|Retrospective Period|Inform consent not signed by participant|0|||
147351138|NCT02949362|531453356|FG000|Prospective Period|Discontinued the study early but didn't complete an ET Visit.|0|||
147351139|NCT02949362|531453357|FG001|Prospective Period|Discontinued the study early but didn't complete an ET Visit.|0|||
147351140|NCT02949362|531453358|FG002|Prospective Period|Discontinued the study early but didn't complete an ET Visit.|1|||
147351141|NCT02949362|531453359|FG003|Prospective Period|Discontinued the study early but didn't complete an ET Visit.|0|||
147351142|NCT02949362|531453356|FG000|Prospective Period|Other|0|||
147351143|NCT02949362|531453357|FG001|Prospective Period|Other|0|||
147351144|NCT02949362|531453358|FG002|Prospective Period|Other|0|||
147351145|NCT02949362|531453359|FG003|Prospective Period|Other|4|||
147351146|NCT03476460|531453360|FG000|Overall Study|Withdrawal by Subject|3|||
147351147|NCT03476460|531453361|FG001|Overall Study|Withdrawal by Subject|2|||
147351148|NCT03476460|531453360|FG000|Overall Study|Non-compliance with treatment|3|||
147351149|NCT03476460|531453361|FG001|Overall Study|Non-compliance with treatment|0|||
147351150|NCT03476460|531453360|FG000|Overall Study|Missing laboratory tests|5|||
147351151|NCT03476460|531453361|FG001|Overall Study|Missing laboratory tests|5|||
147351152|NCT03476460|531453360|FG000|Overall Study|Adverse Event|0|||
147351153|NCT03476460|531453361|FG001|Overall Study|Adverse Event|1|||
147351154|NCT04015167|531453365|FG000|Overall Study|Lost to Follow-up|40|||
147351155|NCT04015167|531453365|FG000|Overall Study|Adverse Event|5|||
147351156|NCT04015167|531453365|FG000|Overall Study|Withdrawal by Subject|2|||
147351157|NCT04015167|531453365|FG000|Overall Study|Subject went to jail|1|||
147351158|NCT03640312|531453366|FG000|Overall Study|Lost to Follow-up|3|||
147351159|NCT03640312|531453367|FG001|Overall Study|Lost to Follow-up|6|||
147607097|NCT02960490|532377238|FG006|Re-randomized Participants: 12 Weeks|Other|0|||
147607098|NCT02960490|532377239|FG007|Re-randomized Participants: 12 Weeks|Other|0|||
147607099|NCT02960490|532377240|FG008|Re-randomized Participants: 12 Weeks|Other|0|||
147607100|NCT02960490|532377241|FG009|Re-randomized Participants: 12 Weeks|Other|0|||
147607101|NCT02960490|532377232|FG000|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
147351160|NCT02761057|531453373|FG000|Overall Study|Ineligible - No Measurable Disease|1|||
147351161|NCT02761057|531453374|FG001|Overall Study|Ineligible - No Measurable Disease|1|||
147351162|NCT02761057|531453375|FG002|Overall Study|Ineligible - No Measurable Disease|0|||
147351163|NCT02761057|531453376|FG003|Overall Study|Ineligible - No Measurable Disease|1|||
147351164|NCT02761057|531453373|FG000|Overall Study|Ineligible - Inadequate Baseline Disease Assessment|1|||
147351165|NCT02761057|531453374|FG001|Overall Study|Ineligible - Inadequate Baseline Disease Assessment|1|||
147351166|NCT02761057|531453375|FG002|Overall Study|Ineligible - Inadequate Baseline Disease Assessment|0|||
147351167|NCT02761057|531453376|FG003|Overall Study|Ineligible - Inadequate Baseline Disease Assessment|0|||
147351168|NCT02761057|531453373|FG000|Overall Study|Currently On Study Treatment|0|||
147351169|NCT02761057|531453374|FG001|Overall Study|Currently On Study Treatment|3|||
147351170|NCT02761057|531453375|FG002|Overall Study|Currently On Study Treatment|0|||
147351171|NCT02761057|531453376|FG003|Overall Study|Currently On Study Treatment|0|||
147351172|NCT02761057|531453373|FG000|Overall Study|Adverse Event|11|||
147351173|NCT02761057|531453374|FG001|Overall Study|Adverse Event|9|||
147351174|NCT02761057|531453375|FG002|Overall Study|Adverse Event|5|||
147351175|NCT02761057|531453376|FG003|Overall Study|Adverse Event|3|||
147351176|NCT02761057|531453373|FG000|Overall Study|Refusal Unrelated to Adverse Event|2|||
147351177|NCT02761057|531453374|FG001|Overall Study|Refusal Unrelated to Adverse Event|2|||
147351178|NCT02761057|531453375|FG002|Overall Study|Refusal Unrelated to Adverse Event|0|||
147351179|NCT02761057|531453376|FG003|Overall Study|Refusal Unrelated to Adverse Event|2|||
147351180|NCT02761057|531453373|FG000|Overall Study|Progression/Relapse|29|||
147351181|NCT02761057|531453374|FG001|Overall Study|Progression/Relapse|27|||
147351182|NCT02761057|531453375|FG002|Overall Study|Progression/Relapse|20|||
147351183|NCT02761057|531453376|FG003|Overall Study|Progression/Relapse|23|||
147351184|NCT02761057|531453373|FG000|Overall Study|Death|2|||
147351185|NCT02761057|531453374|FG001|Overall Study|Death|2|||
147351186|NCT02761057|531453375|FG002|Overall Study|Death|1|||
147351187|NCT02761057|531453376|FG003|Overall Study|Death|1|||
147351188|NCT02761057|531453373|FG000|Overall Study|Other - Not Protocol Specified|2|||
147351189|NCT02761057|531453374|FG001|Overall Study|Other - Not Protocol Specified|1|||
147351190|NCT02761057|531453375|FG002|Overall Study|Other - Not Protocol Specified|2|||
147351191|NCT02761057|531453376|FG003|Overall Study|Other - Not Protocol Specified|0|||
147351192|NCT06037369|531453377|FG000|Overall Study|Lost to Follow-up|0|||
147351193|NCT06037369|531453378|FG001|Overall Study|Lost to Follow-up|1|||
147351194|NCT05008835|531453380|FG000|Overall Study|Adverse Event|5|||
147351195|NCT05008835|531453381|FG001|Overall Study|Adverse Event|2|||
147351196|NCT05008835|531453382|FG002|Overall Study|Adverse Event|1|||
147351197|NCT05008835|531453380|FG000|Overall Study|Lack of Efficacy|0|||
147351198|NCT05008835|531453381|FG001|Overall Study|Lack of Efficacy|0|||
147351199|NCT05008835|531453382|FG002|Overall Study|Lack of Efficacy|1|||
147351200|NCT05008835|531453380|FG000|Overall Study|Study terminated by sponsor|0|||
147351201|NCT05008835|531453381|FG001|Overall Study|Study terminated by sponsor|0|||
147351202|NCT05008835|531453382|FG002|Overall Study|Study terminated by sponsor|1|||
147351203|NCT05008835|531453380|FG000|Overall Study|Not further specified|3|||
147351204|NCT05008835|531453381|FG001|Overall Study|Not further specified|2|||
147351205|NCT05008835|531453382|FG002|Overall Study|Not further specified|1|||
147351206|NCT04876118|531453387|FG000|Overall Study|Pregnancy|1|||
147351207|NCT04876118|531453387|FG000|Overall Study|Withdrawal by Subject|14|||
147351208|NCT05089734|531453388|FG000|Overall Study|Still on study|122|||
147351209|NCT05089734|531453389|FG001|Overall Study|Still on study|101|||
147351210|NCT05089734|531453388|FG000|Overall Study|Death|161|||
147351211|NCT05089734|531453389|FG001|Overall Study|Death|179|||
147351212|NCT05089734|531453388|FG000|Overall Study|Withdrew consent|11|||
147351213|NCT05089734|531453389|FG001|Overall Study|Withdrew consent|24|||
147351214|NCT05089734|531453388|FG000|Overall Study|Lost to Follow-up|5|||
147351215|NCT05089734|531453389|FG001|Overall Study|Lost to Follow-up|0|||
147351216|NCT05179395|531453390|FG000|Overall Study|Lack of Efficacy|1|||
147351217|NCT00812461|531453391|FG000|All Randomised Patients|Did not receive placebo/nalmefene|23|||
147351218|NCT00812461|531453392|FG001|All Randomised Patients|Did not receive placebo/nalmefene|17|||
147351219|NCT00812461|531453391|FG000|All Treated Patients|Adverse Event|8|||
147351220|NCT00812461|531453392|FG001|All Treated Patients|Adverse Event|15|||
147351221|NCT00812461|531453391|FG000|All Treated Patients|Lack of Efficacy|13|||
147351222|NCT00812461|531453392|FG001|All Treated Patients|Lack of Efficacy|7|||
147351223|NCT00812461|531453391|FG000|All Treated Patients|Non-compliance|6|||
147351224|NCT00812461|531453392|FG001|All Treated Patients|Non-compliance|9|||
147351225|NCT00812461|531453391|FG000|All Treated Patients|Protocol Violation|36|||
147351226|NCT00812461|531453392|FG001|All Treated Patients|Protocol Violation|27|||
147351227|NCT00812461|531453391|FG000|All Treated Patients|Withdrawal by Subject|45|||
147351228|NCT00812461|531453392|FG001|All Treated Patients|Withdrawal by Subject|54|||
147351229|NCT00812461|531453391|FG000|All Treated Patients|Lost to Follow-up|11|||
147351230|NCT00812461|531453392|FG001|All Treated Patients|Lost to Follow-up|14|||
147351231|NCT00812461|531453391|FG000|All Treated Patients|Other Reason|13|||
147351232|NCT00812461|531453392|FG001|All Treated Patients|Other Reason|21|||
147351233|NCT03366649|531455135|FG000|Overall Study|Failed preoperative screening|4|||
147351234|NCT03366649|531455136|FG001|Overall Study|Failed preoperative screening|0|||
147351235|NCT03366649|531455137|FG002|Overall Study|Failed preoperative screening|0|||
147351236|NCT03366649|531455135|FG000|Overall Study|Had concomitant valves replacements, therefore not included in data analysis|4|||
147351237|NCT03366649|531455136|FG001|Overall Study|Had concomitant valves replacements, therefore not included in data analysis|0|||
147351238|NCT03366649|531455137|FG002|Overall Study|Had concomitant valves replacements, therefore not included in data analysis|0|||
147351239|NCT03673111|531455138|FG000|Overall Study|Protocol Violation|0|||
147351240|NCT03673111|531455139|FG001|Overall Study|Protocol Violation|0|||
147351241|NCT03673111|531455140|FG002|Overall Study|Protocol Violation|0|||
147351242|NCT03673111|531455141|FG003|Overall Study|Protocol Violation|0|||
147351243|NCT03673111|531455142|FG004|Overall Study|Protocol Violation|0|||
147351244|NCT03673111|531455143|FG005|Overall Study|Protocol Violation|0|||
147351245|NCT03673111|531455144|FG006|Overall Study|Protocol Violation|0|||
147351246|NCT03673111|531455145|FG007|Overall Study|Protocol Violation|0|||
147351247|NCT03673111|531455146|FG008|Overall Study|Protocol Violation|0|||
147351248|NCT03673111|531455147|FG009|Overall Study|Protocol Violation|0|||
147351249|NCT03673111|531455148|FG010|Overall Study|Protocol Violation|1|||
147351250|NCT03673111|531455149|FG011|Overall Study|Protocol Violation|0|||
147351251|NCT03673111|531455150|FG012|Overall Study|Protocol Violation|0|||
147351252|NCT03673111|531455151|FG013|Overall Study|Protocol Violation|0|||
147351253|NCT03673111|531455138|FG000|Overall Study|Adverse Event|1|||
147351254|NCT03673111|531455139|FG001|Overall Study|Adverse Event|0|||
147351255|NCT03673111|531455140|FG002|Overall Study|Adverse Event|0|||
147351256|NCT03673111|531455141|FG003|Overall Study|Adverse Event|0|||
147351257|NCT03673111|531455142|FG004|Overall Study|Adverse Event|0|||
147351258|NCT03673111|531455143|FG005|Overall Study|Adverse Event|0|||
147351259|NCT03673111|531455144|FG006|Overall Study|Adverse Event|0|||
147351260|NCT03673111|531455145|FG007|Overall Study|Adverse Event|0|||
147351261|NCT03673111|531455146|FG008|Overall Study|Adverse Event|0|||
147351262|NCT03673111|531455147|FG009|Overall Study|Adverse Event|0|||
147351263|NCT03673111|531455148|FG010|Overall Study|Adverse Event|0|||
147351264|NCT03673111|531455149|FG011|Overall Study|Adverse Event|0|||
147351265|NCT03673111|531455150|FG012|Overall Study|Adverse Event|0|||
147351266|NCT03673111|531455151|FG013|Overall Study|Adverse Event|0|||
147351267|NCT03792555|531455152|FG000|Titration Period: up to 9 Weeks|COVID-19|0|||
147351268|NCT03792555|531455153|FG001|Titration Period: up to 9 Weeks|COVID-19|0|||
147351269|NCT03792555|531455154|FG002|Titration Period: up to 9 Weeks|COVID-19|1|||
147351270|NCT03792555|531455152|FG000|Randomized Withdrawal: up to 4 Weeks|Participants who did not meet randomization criteria did not enter the Randomized Withdrawal Period.|0|||
147351271|NCT03792555|531455153|FG001|Randomized Withdrawal: up to 4 Weeks|Participants who did not meet randomization criteria did not enter the Randomized Withdrawal Period.|0|||
147351272|NCT03792555|531455154|FG002|Randomized Withdrawal: up to 4 Weeks|Participants who did not meet randomization criteria did not enter the Randomized Withdrawal Period.|5|||
147351273|NCT03792555|531455152|FG000|Follow-up Period: up to 4 Weeks|COVID-19|0|||
147351274|NCT03792555|531455153|FG001|Follow-up Period: up to 4 Weeks|COVID-19|1|||
147351275|NCT03792555|531455154|FG002|Follow-up Period: up to 4 Weeks|COVID-19|0|||
147351276|NCT04485039|531455158|FG000|TPOXX Only|Adverse Event|2|||
147351277|NCT04485039|531455158|FG000|TPOXX Only|Physician Decision|1|||
147351278|NCT04485039|531455158|FG000|TPOXX With Sevelamer Carbonate|Adverse Event|1|||
147351279|NCT04485039|531455158|FG000|TPOXX With Sevelamer Carbonate|Withdrawal by Subject|1|||
147351280|NCT00378105|531455160|FG000|Overall Study|Adverse Event|3|||
147351281|NCT00378105|531455161|FG001|Overall Study|Adverse Event|1|||
147351282|NCT00378105|531455160|FG000|Overall Study|Withdrawal by Subject|3|||
147351283|NCT00378105|531455161|FG001|Overall Study|Withdrawal by Subject|3|||
147351284|NCT00378105|531455160|FG000|Overall Study|Death|1|||
147351285|NCT00378105|531455161|FG001|Overall Study|Death|0|||
147351286|NCT00378105|531455160|FG000|Overall Study|Going to transplant|7|||
147351287|NCT00378105|531455161|FG001|Overall Study|Going to transplant|8|||
147351288|NCT00378105|531455160|FG000|Overall Study|Progressive disease|3|||
147351289|NCT00378105|531455161|FG001|Overall Study|Progressive disease|3|||
147351290|NCT00378105|531455160|FG000|Overall Study|remain on study|3|||
147351291|NCT00378105|531455161|FG001|Overall Study|remain on study|11|||
147351292|NCT00378105|531455160|FG000|Overall Study|Physician Decision|0|||
147351293|NCT00378105|531455161|FG001|Overall Study|Physician Decision|2|||
147351294|NCT00378105|531455160|FG000|Overall Study|Going non-protocol therapy|0|||
147351295|NCT00378105|531455161|FG001|Overall Study|Going non-protocol therapy|1|||
147351296|NCT00378105|531455160|FG000|Overall Study|necessity to increase lenalidomide dose|0|||
147351297|NCT00378105|531455161|FG001|Overall Study|necessity to increase lenalidomide dose|1|||
147351298|NCT02120456|531455162|FG000|Part 2 Double-blind Phase|Lost to Follow-up|0|||
147351299|NCT02120456|531455163|FG001|Part 2 Double-blind Phase|Lost to Follow-up|0|||
147351300|NCT02120456|531455164|FG002|Part 2 Double-blind Phase|Lost to Follow-up|0|||
147351301|NCT02120456|531455165|FG003|Part 2 Double-blind Phase|Lost to Follow-up|0|||
147351302|NCT02120456|531455166|FG004|Part 2 Double-blind Phase|Lost to Follow-up|0|||
147351303|NCT02120456|531455167|FG005|Part 2 Double-blind Phase|Lost to Follow-up|0|||
147351304|NCT02120456|531455168|FG006|Part 2 Double-blind Phase|Lost to Follow-up|1|||
147351305|NCT02120456|531455169|FG007|Part 2 Double-blind Phase|Lost to Follow-up|0|||
147351306|NCT02120456|531455170|FG008|Part 2 Double-blind Phase|Lost to Follow-up|0|||
147351307|NCT02120456|531455162|FG000|Part 2 Double-blind Phase|Withdrawal of consent|0|||
147351308|NCT02120456|531455163|FG001|Part 2 Double-blind Phase|Withdrawal of consent|0|||
147351309|NCT02120456|531455164|FG002|Part 2 Double-blind Phase|Withdrawal of consent|0|||
147351310|NCT02120456|531455165|FG003|Part 2 Double-blind Phase|Withdrawal of consent|0|||
147351311|NCT02120456|531455166|FG004|Part 2 Double-blind Phase|Withdrawal of consent|0|||
147351312|NCT02120456|531455167|FG005|Part 2 Double-blind Phase|Withdrawal of consent|0|||
147351313|NCT02120456|531455168|FG006|Part 2 Double-blind Phase|Withdrawal of consent|1|||
147351314|NCT02120456|531455169|FG007|Part 2 Double-blind Phase|Withdrawal of consent|0|||
147351315|NCT02120456|531455170|FG008|Part 2 Double-blind Phase|Withdrawal of consent|0|||
147351316|NCT02120456|531455162|FG000|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
147351317|NCT02120456|531455163|FG001|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
147351318|NCT02120456|531455164|FG002|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
147351319|NCT02120456|531455165|FG003|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
147351320|NCT02120456|531455166|FG004|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
147351321|NCT02120456|531455167|FG005|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
147351322|NCT02120456|531455168|FG006|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
147351323|NCT02120456|531455169|FG007|Part 2 Double-blind Phase|Unable to attend visit due to work|0|||
147351324|NCT02120456|531455170|FG008|Part 2 Double-blind Phase|Unable to attend visit due to work|1|||
147351325|NCT05192200|531455171|FG000|Treatment Period|Other|1|||
147351326|NCT05192200|531455171|FG000|Treatment Period|Lack of Efficacy|1|||
147351327|NCT05192200|531455171|FG000|Treatment Period|Withdrawal by Subject|1|||
147351328|NCT05192200|531455171|FG000|Follow-up|Withdrawal by Subject|1|||
147351329|NCT03623321|531455172|FG000|Overall Study|Adverse Event|32|||
147351330|NCT03623321|531455172|FG000|Overall Study|Death|9|||
147351331|NCT03623321|531455172|FG000|Overall Study|Lack of Efficacy|9|||
147351332|NCT03623321|531455172|FG000|Overall Study|Lost to Follow-up|6|||
147351333|NCT03623321|531455172|FG000|Overall Study|Noncompliance with study drug|6|||
147351334|NCT03623321|531455172|FG000|Overall Study|Use of prohibited medication|3|||
147351335|NCT03623321|531455172|FG000|Overall Study|Physician Decision|5|||
147351336|NCT03623321|531455172|FG000|Overall Study|Protocol Violation|1|||
147351337|NCT03623321|531455172|FG000|Overall Study|Consent withdrawn by patient or legally accepted representative|29|||
147351338|NCT03623321|531455172|FG000|Overall Study|Not further specified|43|||
147351339|NCT04241068|531455175|FG000|Core Treatment Period|Adverse Event|91|||
147351340|NCT04241068|531455175|FG000|Core Treatment Period|Change of Treatment|4|||
147351341|NCT04241068|531455175|FG000|Core Treatment Period|Consent Withdrawn|143|||
147351342|NCT04241068|531455175|FG000|Core Treatment Period|Death|26|||
147351343|NCT04241068|531455175|FG000|Core Treatment Period|Disease Progression|67|||
147351344|NCT04241068|531455175|FG000|Core Treatment Period|Investigator Decision|40|||
147351345|NCT04241068|531455175|FG000|Core Treatment Period|Loss of Capacity|9|||
147351346|NCT04241068|531455175|FG000|Core Treatment Period|Lost to Follow-up|11|||
147351347|NCT04241068|531455175|FG000|Core Treatment Period|Relocation|4|||
147351348|NCT04241068|531455175|FG000|Core Treatment Period|Study Terminated by Sponsor|1|||
147351349|NCT04241068|531455175|FG000|Core Treatment Period|Study Visit Burden|40|||
147351350|NCT04241068|531455175|FG000|Core Treatment Period|Withdrawal by Guardian/caretaker|99|||
147351351|NCT04241068|531455175|FG000|Core Treatment Period|Missing|2|||
147351352|NCT04241068|531455175|FG000|Core Treatment Period|Reason Not Specified|41|||
147351353|NCT04241068|531455175|FG000|LTE Period|Adverse Event|19|||
147351354|NCT04241068|531455175|FG000|LTE Period|Change of Treatment|1|||
147351355|NCT04241068|531455175|FG000|LTE Period|Consent Withdrawn|71|||
147351356|NCT04241068|531455175|FG000|LTE Period|Death|8|||
147351357|NCT04241068|531455175|FG000|LTE Period|Disease Progression|11|||
147351358|NCT04241068|531455175|FG000|LTE Period|Investigator Decision|12|||
147351359|NCT04241068|531455175|FG000|LTE Period|Loss of Capacity|2|||
147351360|NCT04241068|531455175|FG000|LTE Period|Lost to Follow-up|7|||
147351361|NCT04241068|531455175|FG000|LTE Period|Relocation|6|||
147351362|NCT04241068|531455175|FG000|LTE Period|Site Terminated by Sponsor|26|||
147351363|NCT04241068|531455175|FG000|LTE Period|Study Terminated by Sponsor|276|||
147607102|NCT02960490|532377233|FG001|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
147607103|NCT02960490|532377234|FG002|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
147351364|NCT04241068|531455175|FG000|LTE Period|Study Visit Burden|10|||
147351365|NCT04241068|531455175|FG000|LTE Period|Withdrawal by Guardian/caretaker|19|||
147351366|NCT04241068|531455175|FG000|LTE Period|Reason Not Specified|65|||
147351367|NCT03443323|531455177|FG000|Overall Study|Lost to Follow-up|2|||
147607104|NCT02960490|532377235|FG003|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
147607105|NCT02960490|532377236|FG004|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
147607106|NCT02960490|532377237|FG005|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
147351368|NCT03443323|531455178|FG001|Overall Study|Lost to Follow-up|2|||
147351369|NCT03443323|531455177|FG000|Overall Study|PI withdrawal|1|||
147351370|NCT03443323|531455178|FG001|Overall Study|PI withdrawal|0|||
147351371|NCT04492007|531455179|FG000|Overall Study|Lost to Follow-up|1|||
147351372|NCT04492007|531455180|FG001|Overall Study|Lost to Follow-up|1|||
147351373|NCT04492007|531455181|FG002|Overall Study|Lost to Follow-up|2|||
147351374|NCT04492007|531455182|FG003|Overall Study|Lost to Follow-up|2|||
147351375|NCT04492007|531455179|FG000|Overall Study|Protocol Violation|1|||
147351376|NCT04492007|531455180|FG001|Overall Study|Protocol Violation|1|||
147351377|NCT04492007|531455181|FG002|Overall Study|Protocol Violation|1|||
147351378|NCT04492007|531455182|FG003|Overall Study|Protocol Violation|1|||
147351379|NCT04492007|531455179|FG000|Overall Study|Withdrawal by Subject|0|||
147351380|NCT04492007|531455180|FG001|Overall Study|Withdrawal by Subject|0|||
147351381|NCT04492007|531455181|FG002|Overall Study|Withdrawal by Subject|1|||
147351382|NCT04492007|531455182|FG003|Overall Study|Withdrawal by Subject|1|||
147351383|NCT04177823|531455185|FG000|Overall Study|Physician Decision|1|||
147351384|NCT04177823|531455185|FG000|Overall Study|Withdrawal by Subject|1|||
147351385|NCT04229992|531455186|FG000|Overall Study|Withdrawal by Subject|0|||
147351386|NCT04229992|531455187|FG001|Overall Study|Withdrawal by Subject|2|||
147351387|NCT04229992|531455188|FG002|Overall Study|Withdrawal by Subject|1|||
147351388|NCT04229992|531455189|FG003|Overall Study|Withdrawal by Subject|1|||
147351389|NCT04229992|531455186|FG000|Overall Study|Adverse Event|1|||
147351390|NCT04229992|531455187|FG001|Overall Study|Adverse Event|1|||
147351391|NCT04229992|531455188|FG002|Overall Study|Adverse Event|3|||
147351392|NCT04229992|531455189|FG003|Overall Study|Adverse Event|1|||
147351393|NCT04229992|531455186|FG000|Overall Study|Lost to Follow-up|0|||
147351394|NCT04229992|531455187|FG001|Overall Study|Lost to Follow-up|0|||
147351395|NCT04229992|531455188|FG002|Overall Study|Lost to Follow-up|0|||
147351396|NCT04229992|531455189|FG003|Overall Study|Lost to Follow-up|1|||
147351397|NCT03770273|531455190|FG000|Overall Study|Adverse Event|2|||
147351398|NCT03770273|531455191|FG001|Overall Study|Adverse Event|0|||
147351399|NCT03770273|531455190|FG000|Overall Study|Lost to Follow-up|1|||
147351400|NCT03770273|531455191|FG001|Overall Study|Lost to Follow-up|1|||
147351401|NCT00418886|531455192|FG000|Randomized Period|discontinue treatment survival follow-up|90|||
147351402|NCT00418886|531455193|FG001|Randomized Period|discontinue treatment survival follow-up|91|||
147351403|NCT00418886|531455192|FG000|Randomized Period|Death|122|||
147453422|NCT03403205|531824012|FG004|Extension Period (Up to 60 Months)|Adverse Event|0|||
147453423|NCT03403205|531824013|FG005|Extension Period (Up to 60 Months)|Adverse Event|0|||
147453424|NCT03403205|531824008|FG000|Extension Period (Up to 60 Months)|Death|1|||
147453425|NCT03403205|531824009|FG001|Extension Period (Up to 60 Months)|Death|0|||
147607107|NCT02960490|532377238|FG006|Extension Phase(Open-label): 80 Weeks|Adverse Event|3|||
147607108|NCT02960490|532377239|FG007|Extension Phase(Open-label): 80 Weeks|Adverse Event|1|||
147607109|NCT02960490|532377240|FG008|Extension Phase(Open-label): 80 Weeks|Adverse Event|1|||
147607110|NCT02960490|532377241|FG009|Extension Phase(Open-label): 80 Weeks|Adverse Event|0|||
147607111|NCT02960490|532377232|FG000|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
147607112|NCT02960490|532377233|FG001|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
147607113|NCT02960490|532377234|FG002|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
147607114|NCT02960490|532377235|FG003|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
147607115|NCT02960490|532377236|FG004|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
147607116|NCT02960490|532377237|FG005|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
147607117|NCT02960490|532377238|FG006|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
147607118|NCT02960490|532377239|FG007|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|1|||
147607119|NCT02960490|532377240|FG008|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
147607120|NCT02960490|532377241|FG009|Extension Phase(Open-label): 80 Weeks|Withdrawal by Subject|0|||
147607121|NCT02960490|532377232|FG000|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
147607122|NCT02960490|532377233|FG001|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
147607123|NCT02960490|532377234|FG002|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
147607124|NCT02960490|532377235|FG003|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
147607125|NCT02960490|532377236|FG004|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
147607126|NCT02960490|532377237|FG005|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|0|||
147607127|NCT02960490|532377238|FG006|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|4|||
147607128|NCT02960490|532377239|FG007|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|3|||
147607129|NCT02960490|532377240|FG008|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|3|||
147607130|NCT02960490|532377241|FG009|Extension Phase(Open-label): 80 Weeks|Lack of Efficacy|7|||
147607131|NCT02960490|532377232|FG000|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
147607132|NCT02960490|532377233|FG001|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
147607133|NCT02960490|532377234|FG002|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
147607134|NCT02960490|532377235|FG003|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
147351404|NCT00418886|531455193|FG001|Randomized Period|Death|147|||
147351405|NCT00418886|531455192|FG000|Randomized Period|Withdrawal by Subject|9|||
147351406|NCT00418886|531455193|FG001|Randomized Period|Withdrawal by Subject|10|||
147351407|NCT00418886|531455192|FG000|Randomized Period|Lost to Follow-up|4|||
147351408|NCT00418886|531455193|FG001|Randomized Period|Lost to Follow-up|6|||
147607135|NCT02960490|532377236|FG004|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
147351409|NCT00418886|531455192|FG000|Randomized Period|withdrawn due to other reason|1|||
147351410|NCT00418886|531455193|FG001|Randomized Period|withdrawn due to other reason|0|||
147351411|NCT00418886|531455192|FG000|Randomized Period|randomised but no treatment received|0|||
147351412|NCT00418886|531455193|FG001|Randomized Period|randomised but no treatment received|1|||
147351413|NCT04060654|531455194|FG000|Overall Study|Withdrawal by Subject|1|||
147351414|NCT04060654|531455194|FG000|Overall Study|Lost to Follow-up|5|||
147351415|NCT03707951|531455195|FG000|Overall Study|Lost to Follow-up|8|||
147351416|NCT03707951|531455196|FG001|Overall Study|Lost to Follow-up|17|||
147351417|NCT03707951|531455195|FG000|Overall Study|Withdrawal by Subject|6|||
147351418|NCT03707951|531455196|FG001|Overall Study|Withdrawal by Subject|6|||
147351419|NCT04887129|531455197|FG000|Overall Study|Lost to Follow-up|0|||
147351420|NCT04887129|531455198|FG001|Overall Study|Lost to Follow-up|24|||
147351421|NCT04887129|531455197|FG000|Overall Study|Withdrawal by Subject|9|||
147351422|NCT04887129|531455198|FG001|Overall Study|Withdrawal by Subject|57|||
147351423|NCT04887129|531455197|FG000|Overall Study|Other|2|||
147351424|NCT04887129|531455198|FG001|Overall Study|Other|9|||
147351425|NCT01999075|531455200|FG000|Overall Study|Lost to Follow-up|0|||
147351426|NCT01999075|531455201|FG001|Overall Study|Lost to Follow-up|2|||
147351427|NCT01999075|531455200|FG000|Overall Study|Withdrawal by Subject|2|||
147351428|NCT01999075|531455201|FG001|Overall Study|Withdrawal by Subject|7|||
147351429|NCT01999075|531455200|FG000|Overall Study|Enrolled in drug trial|3|||
147351430|NCT01999075|531455201|FG001|Overall Study|Enrolled in drug trial|1|||
147351431|NCT01999075|531455200|FG000|Overall Study|Became ineligible|0|||
147351432|NCT01999075|531455201|FG001|Overall Study|Became ineligible|2|||
147607136|NCT02960490|532377237|FG005|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
147607137|NCT02960490|532377238|FG006|Extension Phase(Open-label): 80 Weeks|Disease Progression|2|||
147607138|NCT02960490|532377239|FG007|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
147607139|NCT02960490|532377240|FG008|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
147607140|NCT02960490|532377241|FG009|Extension Phase(Open-label): 80 Weeks|Disease Progression|0|||
147607141|NCT02960490|532377232|FG000|Extension Phase(Open-label): 80 Weeks|Other|0|||
147351433|NCT03792256|531455203|FG000|Overall Study|Death|0|||
147351434|NCT03792256|531455204|FG001|Overall Study|Death|1|||
147351435|NCT03792256|531455203|FG000|Overall Study|Lack of Efficacy|0|||
147351436|NCT03792256|531455204|FG001|Overall Study|Lack of Efficacy|1|||
147351437|NCT03792256|531455203|FG000|Overall Study|Withdrawal by Subject|0|||
147351438|NCT03792256|531455204|FG001|Overall Study|Withdrawal by Subject|1|||
147351439|NCT04760678|531455205|FG000|Overall Study|Death|13|||
147351440|NCT04760678|531455205|FG000|Overall Study|Lost to Follow-up|48|||
147351441|NCT04760678|531455205|FG000|Overall Study|Withdrawal by Subject|1|||
147351442|NCT04562649|531455206|FG000|Overall Study|Withdrawal by Subject|11|||
147351443|NCT04562649|531455207|FG001|Overall Study|Withdrawal by Subject|8|||
147351444|NCT04562649|531455206|FG000|Overall Study|Lost to Follow-up|26|||
147351445|NCT04562649|531455207|FG001|Overall Study|Lost to Follow-up|20|||
147351446|NCT05368103|531455208|FG000|Overall Study|Withdrawal by Subject|4|||
147351447|NCT05368103|531455208|FG000|Overall Study|Lost to Follow-up|1|||
147351448|NCT05368103|531455208|FG000|Overall Study|Lack of Efficacy|3|||
147351449|NCT03675282|531455211|FG000|Overall Study|Lost to Follow-up|4|||
147351450|NCT03675282|531455212|FG001|Overall Study|Lost to Follow-up|8|||
147351451|NCT03675282|531455213|FG002|Overall Study|Lost to Follow-up|1|||
147351452|NCT03675282|531455214|FG003|Overall Study|Lost to Follow-up|0|||
147351453|NCT03675282|531455215|FG004|Overall Study|Lost to Follow-up|2|||
147351454|NCT03675282|531455216|FG005|Overall Study|Lost to Follow-up|7|||
147351455|NCT03675282|531455211|FG000|Overall Study|received clinical care that was exclusionary to the study|0|||
147351456|NCT03675282|531455212|FG001|Overall Study|received clinical care that was exclusionary to the study|2|||
147351457|NCT03675282|531455213|FG002|Overall Study|received clinical care that was exclusionary to the study|0|||
147351458|NCT03675282|531455214|FG003|Overall Study|received clinical care that was exclusionary to the study|0|||
147351459|NCT03675282|531455215|FG004|Overall Study|received clinical care that was exclusionary to the study|0|||
147351460|NCT03675282|531455216|FG005|Overall Study|received clinical care that was exclusionary to the study|0|||
147351461|NCT03675282|531455211|FG000|Overall Study|Physician Decision|1|||
147351462|NCT03675282|531455212|FG001|Overall Study|Physician Decision|0|||
147351463|NCT03675282|531455213|FG002|Overall Study|Physician Decision|0|||
147351464|NCT03675282|531455214|FG003|Overall Study|Physician Decision|0|||
147351465|NCT03675282|531455215|FG004|Overall Study|Physician Decision|0|||
147351466|NCT03675282|531455216|FG005|Overall Study|Physician Decision|0|||
147351467|NCT05784662|531455220|FG000|Overall Study|Lost to Follow-up|21|||
147453426|NCT03403205|531824010|FG002|Extension Period (Up to 60 Months)|Death|0|||
147607142|NCT02960490|532377233|FG001|Extension Phase(Open-label): 80 Weeks|Other|0|||
147351468|NCT05784662|531455221|FG001|Overall Study|Lost to Follow-up|17|||
147351469|NCT04274764|531455222|FG000|Overall Study|Date of scheduled followup visit was after trial stop date|62|||
147351470|NCT04274764|531455223|FG001|Overall Study|Date of scheduled followup visit was after trial stop date|70|||
147351471|NCT03611621|531455239|FG000|Overall Study|Graft loss|3|||
147351472|NCT03611621|531455239|FG000|Overall Study|Death|3|||
147351473|NCT03611621|531455239|FG000|Overall Study|Lost to Follow-up|1|||
147453427|NCT03403205|531824011|FG003|Extension Period (Up to 60 Months)|Death|0|||
147607143|NCT02960490|532377234|FG002|Extension Phase(Open-label): 80 Weeks|Other|0|||
147351474|NCT05177848|531455244|FG000|Overall Study|Lost to Follow-up|1|||
147351475|NCT05177848|531455245|FG001|Overall Study|Lost to Follow-up|4|||
147351476|NCT05177848|531455244|FG000|Overall Study|Discontinued|2|||
147351477|NCT05177848|531455245|FG001|Overall Study|Discontinued|1|||
147351478|NCT03853746|531455246|FG000|Overall Study|Withdrawal by Subject|1|||
147351479|NCT01084876|531455247|FG000|Main Study Treatment Period|Adverse Event|12|||
147351480|NCT01084876|531455248|FG001|Main Study Treatment Period|Adverse Event|7|||
147351481|NCT01084876|531455247|FG000|Main Study Treatment Period|Disease Progression|41|||
147351482|NCT01084876|531455248|FG001|Main Study Treatment Period|Disease Progression|24|||
147351483|NCT01084876|531455247|FG000|Main Study Treatment Period|Physician Decision|2|||
147607144|NCT02960490|532377235|FG003|Extension Phase(Open-label): 80 Weeks|Other|0|||
147351484|NCT01084876|531455248|FG001|Main Study Treatment Period|Physician Decision|0|||
147351485|NCT01084876|531455247|FG000|Main Study Treatment Period|Withdrawal by Subject|4|||
147351486|NCT01084876|531455248|FG001|Main Study Treatment Period|Withdrawal by Subject|6|||
147351487|NCT01084876|531455247|FG000|Main Study Treatment Period|Other Reason|0|||
147351488|NCT01084876|531455248|FG001|Main Study Treatment Period|Other Reason|1|||
147351489|NCT01084876|531455247|FG000|Main Study Treatment Period|Other|0|||
147351490|NCT01084876|531455248|FG001|Main Study Treatment Period|Other|1|||
147351491|NCT01084876|531455247|FG000|Treatment Period Beyond Cycle 8|Adverse Event|8|||
147351492|NCT01084876|531455248|FG001|Treatment Period Beyond Cycle 8|Adverse Event|2|||
147351493|NCT01084876|531455247|FG000|Treatment Period Beyond Cycle 8|Disease Progression|129|||
147351494|NCT01084876|531455248|FG001|Treatment Period Beyond Cycle 8|Disease Progression|119|||
147351495|NCT01084876|531455247|FG000|Treatment Period Beyond Cycle 8|Physician Decision|6|||
147351496|NCT01084876|531455248|FG001|Treatment Period Beyond Cycle 8|Physician Decision|5|||
147351497|NCT01084876|531455247|FG000|Treatment Period Beyond Cycle 8|Withdrawal by Subject|12|||
147351498|NCT01084876|531455248|FG001|Treatment Period Beyond Cycle 8|Withdrawal by Subject|20|||
147351499|NCT01084876|531455247|FG000|Treatment Period Beyond Cycle 8|Other Reason|7|||
147351500|NCT01084876|531455248|FG001|Treatment Period Beyond Cycle 8|Other Reason|13|||
147351501|NCT01084876|531455247|FG000|Treatment Period Beyond Cycle 8|Other|6|||
147351502|NCT01084876|531455248|FG001|Treatment Period Beyond Cycle 8|Other|9|||
147351503|NCT05486078|531455260|FG000|Overall Study|4 drop out and one withdrawn|5|||
147351504|NCT02724631|531455261|FG000|Overall Study|unable to clear indwelling feeding tube device|1|||
147351505|NCT05076708|531455262|FG000|Overall Study|Withdrawal by Subject|4|||
147351506|NCT05076708|531455262|FG000|Overall Study|Lost to study during switch phase|8|||
147351507|NCT02908477|531455263|FG000|Overall Study|Withdrawal by Subject|8|||
147351508|NCT02908477|531455264|FG001|Overall Study|Withdrawal by Subject|28|||
147351509|NCT04971395|531455267|FG000|Overall Study|Withdrawal by Subject|0|||
147351510|NCT04971395|531455268|FG001|Overall Study|Withdrawal by Subject|1|||
147351511|NCT04971395|531455269|FG002|Overall Study|Withdrawal by Subject|0|||
147351512|NCT02924272|531455271|FG000|Overall Study|Site Terminated by Sponsor|4|||
147351513|NCT02924272|531455272|FG001|Overall Study|Site Terminated by Sponsor|1|||
147351514|NCT02924272|531455271|FG000|Overall Study|Withdrawal by Subject|2|||
147351515|NCT02924272|531455272|FG001|Overall Study|Withdrawal by Subject|0|||
147351516|NCT02924272|531455271|FG000|Overall Study|Adverse Event|3|||
147351517|NCT02924272|531455272|FG001|Overall Study|Adverse Event|0|||
147351518|NCT02924272|531455271|FG000|Overall Study|Progressive Disease|11|||
147351519|NCT02924272|531455272|FG001|Overall Study|Progressive Disease|8|||
147351520|NCT02924272|531455271|FG000|Overall Study|Clinical Deterioration|1|||
147351521|NCT02924272|531455272|FG001|Overall Study|Clinical Deterioration|0|||
147351522|NCT02924272|531455271|FG000|Overall Study|Death|1|||
147351523|NCT02924272|531455272|FG001|Overall Study|Death|0|||
147351524|NCT02924272|531455271|FG000|Overall Study|Reason Not Specified|1|||
147607145|NCT02960490|532377236|FG004|Extension Phase(Open-label): 80 Weeks|Other|0|||
147607146|NCT02960490|532377237|FG005|Extension Phase(Open-label): 80 Weeks|Other|0|||
147607147|NCT02960490|532377238|FG006|Extension Phase(Open-label): 80 Weeks|Other|0|||
147607148|NCT02960490|532377239|FG007|Extension Phase(Open-label): 80 Weeks|Other|1|||
147607149|NCT02960490|532377240|FG008|Extension Phase(Open-label): 80 Weeks|Other|0|||
147607150|NCT02960490|532377241|FG009|Extension Phase(Open-label): 80 Weeks|Other|0|||
147607151|NCT01590797|532377244|FG000|Overall Study|Adverse Event|4|||
147607152|NCT01590797|532377245|FG001|Overall Study|Adverse Event|3|||
147351525|NCT02924272|531455272|FG001|Overall Study|Reason Not Specified|0|||
147351526|NCT03150810|531455277|FG000|Overall Study|Death|4|||
147351527|NCT03150810|531455278|FG001|Overall Study|Death|8|||
147351528|NCT03150810|531455279|FG002|Overall Study|Death|7|||
147351529|NCT03150810|531455280|FG003|Overall Study|Death|2|||
147351530|NCT03150810|531455281|FG004|Overall Study|Death|2|||
147351531|NCT03150810|531455282|FG005|Overall Study|Death|10|||
147351532|NCT03150810|531455283|FG006|Overall Study|Death|8|||
147351533|NCT03150810|531455284|FG007|Overall Study|Death|6|||
147351534|NCT03150810|531455285|FG008|Overall Study|Death|18|||
147351535|NCT03150810|531455286|FG009|Overall Study|Death|3|||
147351536|NCT03150810|531455287|FG010|Overall Study|Death|19|||
147351537|NCT03150810|531455288|FG011|Overall Study|Death|1|||
147607153|NCT01590797|532377244|FG000|Overall Study|Lack of Efficacy|0|||
147607154|NCT01590797|532377245|FG001|Overall Study|Lack of Efficacy|2|||
147607155|NCT01590797|532377244|FG000|Overall Study|Lost to Follow-up|0|||
147607156|NCT01590797|532377245|FG001|Overall Study|Lost to Follow-up|1|||
147607157|NCT01590797|532377244|FG000|Overall Study|Protocol Violation|4|||
147607158|NCT01590797|532377245|FG001|Overall Study|Protocol Violation|1|||
147607159|NCT01590797|532377244|FG000|Overall Study|Withdrawal by Subject|7|||
147607160|NCT01590797|532377245|FG001|Overall Study|Withdrawal by Subject|5|||
147607161|NCT01590797|532377244|FG000|Overall Study|Other Protocol Specified Criteria|2|||
147607162|NCT01590797|532377245|FG001|Overall Study|Other Protocol Specified Criteria|4|||
147607163|NCT04893018|532377246|FG000|Overall Study|Lost to Follow-up|1|||
147607164|NCT04893018|532377247|FG001|Overall Study|Lost to Follow-up|0|||
147607165|NCT04893018|532377246|FG000|Overall Study|Withdrawal by Subject|2|||
147607166|NCT04893018|532377247|FG001|Overall Study|Withdrawal by Subject|0|||
147607167|NCT04893018|532377246|FG000|Overall Study|Study Terminated|1|||
147607168|NCT04893018|532377247|FG001|Overall Study|Study Terminated|2|||
147607169|NCT00314951|532377254|FG000|Treatment|Didn't meet criteria for mITT population|16|||
147607170|NCT00314951|532377255|FG001|Treatment|Didn't meet criteria for mITT population|11|||
147607171|NCT00314951|532377254|FG000|Follow-up|mITT failure|44|||
147607172|NCT00314951|532377255|FG001|Follow-up|mITT failure|34|||
147351538|NCT03150810|531455289|FG012|Overall Study|Death|19|||
147351539|NCT03150810|531455277|FG000|Overall Study|Withdrawal by Subject|0|||
147351540|NCT03150810|531455278|FG001|Overall Study|Withdrawal by Subject|1|||
147351541|NCT03150810|531455279|FG002|Overall Study|Withdrawal by Subject|1|||
147351542|NCT03150810|531455280|FG003|Overall Study|Withdrawal by Subject|1|||
147351543|NCT03150810|531455281|FG004|Overall Study|Withdrawal by Subject|0|||
147351544|NCT03150810|531455282|FG005|Overall Study|Withdrawal by Subject|0|||
147351545|NCT03150810|531455283|FG006|Overall Study|Withdrawal by Subject|2|||
147351546|NCT03150810|531455284|FG007|Overall Study|Withdrawal by Subject|0|||
147351547|NCT03150810|531455285|FG008|Overall Study|Withdrawal by Subject|2|||
147351548|NCT03150810|531455286|FG009|Overall Study|Withdrawal by Subject|0|||
147351549|NCT03150810|531455287|FG010|Overall Study|Withdrawal by Subject|1|||
147351550|NCT03150810|531455288|FG011|Overall Study|Withdrawal by Subject|0|||
147351551|NCT03150810|531455289|FG012|Overall Study|Withdrawal by Subject|1|||
147351552|NCT03150810|531455277|FG000|Overall Study|Sponsor Decision|0|||
147351553|NCT03150810|531455278|FG001|Overall Study|Sponsor Decision|2|||
147351554|NCT03150810|531455279|FG002|Overall Study|Sponsor Decision|0|||
147351555|NCT03150810|531455280|FG003|Overall Study|Sponsor Decision|0|||
147351556|NCT03150810|531455281|FG004|Overall Study|Sponsor Decision|1|||
147351557|NCT03150810|531455282|FG005|Overall Study|Sponsor Decision|1|||
147351558|NCT03150810|531455283|FG006|Overall Study|Sponsor Decision|0|||
147351559|NCT03150810|531455284|FG007|Overall Study|Sponsor Decision|0|||
147351560|NCT03150810|531455285|FG008|Overall Study|Sponsor Decision|1|||
147351561|NCT03150810|531455286|FG009|Overall Study|Sponsor Decision|0|||
147351562|NCT03150810|531455287|FG010|Overall Study|Sponsor Decision|0|||
147351563|NCT03150810|531455288|FG011|Overall Study|Sponsor Decision|0|||
147351564|NCT03150810|531455289|FG012|Overall Study|Sponsor Decision|5|||
147351565|NCT03150810|531455277|FG000|Overall Study|Lost to Follow-up|0|||
147351566|NCT03150810|531455278|FG001|Overall Study|Lost to Follow-up|1|||
147351567|NCT03150810|531455279|FG002|Overall Study|Lost to Follow-up|1|||
147607173|NCT00468650|532377256|FG000|Overall Study|Lost to Follow-up|4|||
147607174|NCT00468650|532377256|FG000|Overall Study|Withdrawal by Subject|2|||
147607175|NCT00468650|532377256|FG000|Overall Study|Protocol Violation|1|||
147607176|NCT02087189|532377257|FG000|Overall Study|enrolled but did not receive a TD01 as implant|2|||
147607177|NCT00642278|532377260|FG000|Overall Study|Adverse Event|2|||
147607178|NCT00642278|532377261|FG001|Overall Study|Adverse Event|1|||
147607179|NCT00642278|532377262|FG002|Overall Study|Adverse Event|3|||
147607180|NCT00642278|532377263|FG003|Overall Study|Adverse Event|1|||
147607181|NCT00642278|532377264|FG004|Overall Study|Adverse Event|2|||
147607182|NCT00642278|532377265|FG005|Overall Study|Adverse Event|2|||
147607183|NCT00642278|532377266|FG006|Overall Study|Adverse Event|0|||
147607184|NCT00642278|532377260|FG000|Overall Study|Lack of Efficacy|0|||
147351568|NCT03150810|531455280|FG003|Overall Study|Lost to Follow-up|0|||
147351569|NCT03150810|531455281|FG004|Overall Study|Lost to Follow-up|0|||
147351570|NCT03150810|531455282|FG005|Overall Study|Lost to Follow-up|0|||
147351571|NCT03150810|531455283|FG006|Overall Study|Lost to Follow-up|1|||
147351572|NCT03150810|531455284|FG007|Overall Study|Lost to Follow-up|0|||
147351573|NCT03150810|531455285|FG008|Overall Study|Lost to Follow-up|0|||
147351574|NCT03150810|531455286|FG009|Overall Study|Lost to Follow-up|0|||
147351575|NCT03150810|531455287|FG010|Overall Study|Lost to Follow-up|1|||
147607185|NCT00642278|532377261|FG001|Overall Study|Lack of Efficacy|1|||
147607186|NCT00642278|532377262|FG002|Overall Study|Lack of Efficacy|0|||
147607187|NCT00642278|532377263|FG003|Overall Study|Lack of Efficacy|0|||
147607188|NCT00642278|532377264|FG004|Overall Study|Lack of Efficacy|0|||
147607189|NCT00642278|532377265|FG005|Overall Study|Lack of Efficacy|0|||
147351576|NCT03150810|531455288|FG011|Overall Study|Lost to Follow-up|0|||
147351577|NCT03150810|531455289|FG012|Overall Study|Lost to Follow-up|0|||
147351578|NCT03150810|531455277|FG000|Overall Study|Physician Decision|0|||
147351579|NCT03150810|531455278|FG001|Overall Study|Physician Decision|0|||
147351580|NCT03150810|531455279|FG002|Overall Study|Physician Decision|0|||
147607190|NCT00642278|532377266|FG006|Overall Study|Lack of Efficacy|0|||
147607191|NCT00642278|532377260|FG000|Overall Study|Lost to Follow-up|5|||
147607192|NCT00642278|532377261|FG001|Overall Study|Lost to Follow-up|1|||
147607193|NCT00642278|532377262|FG002|Overall Study|Lost to Follow-up|0|||
147607194|NCT00642278|532377263|FG003|Overall Study|Lost to Follow-up|1|||
147607195|NCT00642278|532377264|FG004|Overall Study|Lost to Follow-up|0|||
147607196|NCT00642278|532377265|FG005|Overall Study|Lost to Follow-up|1|||
147607197|NCT00642278|532377266|FG006|Overall Study|Lost to Follow-up|1|||
147607198|NCT00642278|532377260|FG000|Overall Study|Physician Decision|0|||
147607199|NCT00642278|532377261|FG001|Overall Study|Physician Decision|0|||
147607200|NCT00642278|532377262|FG002|Overall Study|Physician Decision|0|||
147607201|NCT00642278|532377263|FG003|Overall Study|Physician Decision|1|||
147607202|NCT00642278|532377264|FG004|Overall Study|Physician Decision|0|||
147607203|NCT00642278|532377265|FG005|Overall Study|Physician Decision|0|||
147607204|NCT00642278|532377266|FG006|Overall Study|Physician Decision|0|||
147607205|NCT00642278|532377260|FG000|Overall Study|Protocol Violation|0|||
147351581|NCT03150810|531455280|FG003|Overall Study|Physician Decision|0|||
147351582|NCT03150810|531455281|FG004|Overall Study|Physician Decision|0|||
147351583|NCT03150810|531455282|FG005|Overall Study|Physician Decision|1|||
147351584|NCT03150810|531455283|FG006|Overall Study|Physician Decision|1|||
147351585|NCT03150810|531455284|FG007|Overall Study|Physician Decision|0|||
147351586|NCT03150810|531455285|FG008|Overall Study|Physician Decision|0|||
147351587|NCT03150810|531455286|FG009|Overall Study|Physician Decision|0|||
147351588|NCT03150810|531455287|FG010|Overall Study|Physician Decision|0|||
147351589|NCT03150810|531455288|FG011|Overall Study|Physician Decision|0|||
147351590|NCT03150810|531455289|FG012|Overall Study|Physician Decision|0|||
147351591|NCT03150810|531455277|FG000|Overall Study|Site withdrawal from study|0|||
147351592|NCT03150810|531455278|FG001|Overall Study|Site withdrawal from study|1|||
147351593|NCT03150810|531455279|FG002|Overall Study|Site withdrawal from study|0|||
147351594|NCT03150810|531455280|FG003|Overall Study|Site withdrawal from study|0|||
147351595|NCT03150810|531455281|FG004|Overall Study|Site withdrawal from study|0|||
147351596|NCT03150810|531455282|FG005|Overall Study|Site withdrawal from study|0|||
147351597|NCT03150810|531455283|FG006|Overall Study|Site withdrawal from study|0|||
147351598|NCT03150810|531455284|FG007|Overall Study|Site withdrawal from study|0|||
147351599|NCT03150810|531455285|FG008|Overall Study|Site withdrawal from study|0|||
147351600|NCT03150810|531455286|FG009|Overall Study|Site withdrawal from study|1|||
147351601|NCT03150810|531455287|FG010|Overall Study|Site withdrawal from study|1|||
147351602|NCT03150810|531455288|FG011|Overall Study|Site withdrawal from study|0|||
147351603|NCT03150810|531455289|FG012|Overall Study|Site withdrawal from study|0|||
147351604|NCT03150810|531455277|FG000|Overall Study|Hospice|0|||
147351605|NCT03150810|531455278|FG001|Overall Study|Hospice|0|||
147351606|NCT03150810|531455279|FG002|Overall Study|Hospice|0|||
147351607|NCT03150810|531455280|FG003|Overall Study|Hospice|0|||
147351608|NCT03150810|531455281|FG004|Overall Study|Hospice|0|||
147351609|NCT03150810|531455282|FG005|Overall Study|Hospice|1|||
147351610|NCT03150810|531455283|FG006|Overall Study|Hospice|0|||
147351611|NCT03150810|531455284|FG007|Overall Study|Hospice|0|||
147351612|NCT03150810|531455285|FG008|Overall Study|Hospice|0|||
147351613|NCT03150810|531455286|FG009|Overall Study|Hospice|0|||
147351614|NCT03150810|531455287|FG010|Overall Study|Hospice|0|||
147351615|NCT03150810|531455288|FG011|Overall Study|Hospice|0|||
147351616|NCT03150810|531455289|FG012|Overall Study|Hospice|0|||
147351617|NCT03150810|531455277|FG000|Overall Study|Participant relocated abroad.|0|||
147351618|NCT03150810|531455278|FG001|Overall Study|Participant relocated abroad.|0|||
147351619|NCT03150810|531455279|FG002|Overall Study|Participant relocated abroad.|0|||
147351620|NCT03150810|531455280|FG003|Overall Study|Participant relocated abroad.|0|||
147351621|NCT03150810|531455281|FG004|Overall Study|Participant relocated abroad.|0|||
147351622|NCT03150810|531455282|FG005|Overall Study|Participant relocated abroad.|1|||
147351623|NCT03150810|531455283|FG006|Overall Study|Participant relocated abroad.|0|||
147351624|NCT03150810|531455284|FG007|Overall Study|Participant relocated abroad.|0|||
147351625|NCT03150810|531455285|FG008|Overall Study|Participant relocated abroad.|0|||
147351626|NCT03150810|531455286|FG009|Overall Study|Participant relocated abroad.|0|||
147351627|NCT03150810|531455287|FG010|Overall Study|Participant relocated abroad.|0|||
147351628|NCT03150810|531455288|FG011|Overall Study|Participant relocated abroad.|0|||
147607206|NCT00642278|532377261|FG001|Overall Study|Protocol Violation|0|||
147607207|NCT00642278|532377262|FG002|Overall Study|Protocol Violation|1|||
147662744|NCT02227784|532587412|FG000|Open-Label Extension Phase (OLE)|Sponsor Decision|0|||
147351629|NCT03150810|531455289|FG012|Overall Study|Participant relocated abroad.|0|||
147351630|NCT03150810|531455277|FG000|Overall Study|Transferred care to oncologist|0|||
147351631|NCT03150810|531455278|FG001|Overall Study|Transferred care to oncologist|0|||
147351632|NCT03150810|531455279|FG002|Overall Study|Transferred care to oncologist|0|||
147351633|NCT03150810|531455280|FG003|Overall Study|Transferred care to oncologist|0|||
147351634|NCT03150810|531455281|FG004|Overall Study|Transferred care to oncologist|0|||
147351635|NCT03150810|531455282|FG005|Overall Study|Transferred care to oncologist|0|||
147351636|NCT03150810|531455283|FG006|Overall Study|Transferred care to oncologist|2|||
147351637|NCT03150810|531455284|FG007|Overall Study|Transferred care to oncologist|0|||
147351638|NCT03150810|531455285|FG008|Overall Study|Transferred care to oncologist|0|||
147607208|NCT00642278|532377263|FG003|Overall Study|Protocol Violation|1|||
147351639|NCT03150810|531455286|FG009|Overall Study|Transferred care to oncologist|0|||
147351640|NCT03150810|531455287|FG010|Overall Study|Transferred care to oncologist|0|||
147351641|NCT03150810|531455288|FG011|Overall Study|Transferred care to oncologist|0|||
147351642|NCT03150810|531455289|FG012|Overall Study|Transferred care to oncologist|0|||
147351643|NCT03903146|531455290|FG000|Overall Study|Lost to Follow-up|6|||
147351644|NCT03903146|531455291|FG001|Overall Study|Lost to Follow-up|4|||
147351645|NCT03903146|531455290|FG000|Overall Study|Withdrawal by Subject|0|||
147351646|NCT03903146|531455291|FG001|Overall Study|Withdrawal by Subject|1|||
147351647|NCT02919683|531455292|FG000|Post-Surgery Follow-Up|Death|2|||
147351648|NCT02919683|531455293|FG001|Post-Surgery Follow-Up|Death|2|||
147351649|NCT02919683|531455292|FG000|Post-Surgery Follow-Up|Patient is still completing follow-ups|1|||
147351650|NCT02919683|531455293|FG001|Post-Surgery Follow-Up|Patient is still completing follow-ups|0|||
147351651|NCT05551637|531455296|FG000|Overall Study|Lack of Efficacy|0|||
147351652|NCT05551637|531455297|FG001|Overall Study|Lack of Efficacy|6|||
147351653|NCT05551637|531455296|FG000|Overall Study|Lost to Follow-up|1|||
147351654|NCT05551637|531455297|FG001|Overall Study|Lost to Follow-up|1|||
147351655|NCT06491433|531455298|FG000|Overall Study|Protocol Violation|51|||
147351656|NCT06491433|531455298|FG000|Overall Study|consent withdrawal|2|||
147351657|NCT06491433|531455298|FG000|Overall Study|screen failure|1|||
147351658|NCT03197662|531455302|FG000|Overall Study|Withdrawn by family|0|||
147351659|NCT03197662|531455303|FG001|Overall Study|Withdrawn by family|2|||
147351660|NCT03721952|531455304|FG000|Overall Study|Lost to Follow-up|0|||
147351661|NCT03721952|531455305|FG001|Overall Study|Lost to Follow-up|0|||
147351662|NCT03721952|531455306|FG002|Overall Study|Lost to Follow-up|2|||
147351663|NCT03721952|531455307|FG003|Overall Study|Lost to Follow-up|0|||
147351664|NCT03721952|531455308|FG004|Overall Study|Lost to Follow-up|0|||
147351665|NCT03721952|531455304|FG000|Overall Study|Protocol Violation|0|||
147351666|NCT03721952|531455305|FG001|Overall Study|Protocol Violation|1|||
147351667|NCT03721952|531455306|FG002|Overall Study|Protocol Violation|0|||
147351668|NCT03721952|531455307|FG003|Overall Study|Protocol Violation|0|||
147351669|NCT03721952|531455308|FG004|Overall Study|Protocol Violation|0|||
147351670|NCT03721952|531455304|FG000|Overall Study|Withdrawal by Subject|1|||
147351671|NCT03721952|531455305|FG001|Overall Study|Withdrawal by Subject|0|||
147351672|NCT03721952|531455306|FG002|Overall Study|Withdrawal by Subject|40|||
147351673|NCT03721952|531455307|FG003|Overall Study|Withdrawal by Subject|28|||
147351674|NCT03721952|531455308|FG004|Overall Study|Withdrawal by Subject|0|||
147351675|NCT04495894|531455312|FG000|Overall Study|Withdrawal by Subject|2|||
147351676|NCT04495894|531455313|FG001|Overall Study|Withdrawal by Subject|0|||
147351677|NCT04495894|531455314|FG002|Overall Study|Withdrawal by Subject|2|||
147351678|NCT04495894|531455315|FG003|Overall Study|Withdrawal by Subject|3|||
147351679|NCT04495894|531455312|FG000|Overall Study|Early termination|0|||
147351680|NCT04495894|531455313|FG001|Overall Study|Early termination|0|||
147351681|NCT04495894|531455314|FG002|Overall Study|Early termination|3|||
147351682|NCT04495894|531455315|FG003|Overall Study|Early termination|0|||
147351683|NCT01000961|531455316|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|0|||
147351684|NCT01000961|531455317|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
147351685|NCT01000961|531455316|FG000|First Intervention (3 Weeks)|Infection after pre-planned surgery|0|||
147351686|NCT01000961|531455317|FG001|First Intervention (3 Weeks)|Infection after pre-planned surgery|1|||
147351687|NCT05609760|531455330|FG000|Overall Study|Lost to Follow-up|0|||
147351688|NCT05609760|531455331|FG001|Overall Study|Lost to Follow-up|1|||
147351689|NCT05609760|531455330|FG000|Overall Study|Withdrawal by Subject|1|||
147351690|NCT05609760|531455331|FG001|Overall Study|Withdrawal by Subject|0|||
147351691|NCT03396588|531455332|FG000|Overall Study|Physician Decision|2|||
147351692|NCT03396588|531455333|FG001|Overall Study|Physician Decision|3|||
147351693|NCT05351554|531455334|FG000|Overall Study|Study terminated by sponsor|1|||
147351694|NCT04353661|531457211|FG000|Overall Study|Protocol Violation|0|||
147453428|NCT03403205|531824012|FG004|Extension Period (Up to 60 Months)|Death|0|||
147453429|NCT03403205|531824013|FG005|Extension Period (Up to 60 Months)|Death|0|||
147607209|NCT00642278|532377264|FG004|Overall Study|Protocol Violation|0|||
147351695|NCT04353661|531457212|FG001|Overall Study|Protocol Violation|0|||
147351696|NCT04353661|531457213|FG002|Overall Study|Protocol Violation|1|||
147453430|NCT03403205|531824008|FG000|Extension Period (Up to 60 Months)|Lost to Follow-up|1|||
147453431|NCT03403205|531824009|FG001|Extension Period (Up to 60 Months)|Lost to Follow-up|0|||
147607210|NCT00642278|532377265|FG005|Overall Study|Protocol Violation|1|||
147351697|NCT04353661|531457211|FG000|Overall Study|Study termination by the Sponsor|1|||
147351698|NCT04353661|531457212|FG001|Overall Study|Study termination by the Sponsor|1|||
147453432|NCT03403205|531824010|FG002|Extension Period (Up to 60 Months)|Lost to Follow-up|0|||
147351699|NCT04353661|531457213|FG002|Overall Study|Study termination by the Sponsor|1|||
147351700|NCT00667251|531457214|FG000|Overall Study|Disease progression|232|||
147351701|NCT00667251|531457215|FG001|Overall Study|Disease progression|203|||
147351702|NCT00667251|531457214|FG000|Overall Study|Toxicity|44|||
147351703|NCT00667251|531457215|FG001|Overall Study|Toxicity|23|||
147351704|NCT00667251|531457214|FG000|Overall Study|Subject Reached Protocol-Defined Stopping Criteria|18|||
147351705|NCT00667251|531457215|FG001|Overall Study|Subject Reached Protocol-Defined Stopping Criteria|70|||
147351706|NCT00667251|531457214|FG000|Overall Study|Refused further treatment (not due to toxicity)|8|||
147607211|NCT00642278|532377266|FG006|Overall Study|Protocol Violation|2|||
147607212|NCT00642278|532377260|FG000|Overall Study|Withdrawal by Subject|1|||
147607213|NCT00642278|532377261|FG001|Overall Study|Withdrawal by Subject|1|||
147607214|NCT00642278|532377262|FG002|Overall Study|Withdrawal by Subject|1|||
147607215|NCT00642278|532377263|FG003|Overall Study|Withdrawal by Subject|3|||
147607216|NCT00642278|532377264|FG004|Overall Study|Withdrawal by Subject|6|||
147607217|NCT00642278|532377265|FG005|Overall Study|Withdrawal by Subject|2|||
147607218|NCT00642278|532377266|FG006|Overall Study|Withdrawal by Subject|2|||
147607219|NCT00642278|532377260|FG000|Overall Study|Noncompliance with study drug regimen|0|||
147607220|NCT00642278|532377261|FG001|Overall Study|Noncompliance with study drug regimen|0|||
147607221|NCT00642278|532377262|FG002|Overall Study|Noncompliance with study drug regimen|0|||
147607222|NCT00642278|532377263|FG003|Overall Study|Noncompliance with study drug regimen|1|||
147607223|NCT00642278|532377264|FG004|Overall Study|Noncompliance with study drug regimen|0|||
147607224|NCT00642278|532377265|FG005|Overall Study|Noncompliance with study drug regimen|0|||
147607225|NCT00642278|532377266|FG006|Overall Study|Noncompliance with study drug regimen|0|||
147607226|NCT00642278|532377260|FG000|Overall Study|Other|2|||
147607227|NCT00642278|532377261|FG001|Overall Study|Other|1|||
147607228|NCT00642278|532377262|FG002|Overall Study|Other|0|||
147607229|NCT00642278|532377263|FG003|Overall Study|Other|1|||
147453433|NCT03403205|531824011|FG003|Extension Period (Up to 60 Months)|Lost to Follow-up|0|||
147453434|NCT03403205|531824012|FG004|Extension Period (Up to 60 Months)|Lost to Follow-up|0|||
147607230|NCT00642278|532377264|FG004|Overall Study|Other|0|||
147607231|NCT00642278|532377265|FG005|Overall Study|Other|1|||
147607232|NCT00642278|532377266|FG006|Overall Study|Other|0|||
147351707|NCT00667251|531457215|FG001|Overall Study|Refused further treatment (not due to toxicity)|7|||
147351708|NCT00667251|531457214|FG000|Overall Study|Symptomatic progression|8|||
147351709|NCT00667251|531457215|FG001|Overall Study|Symptomatic progression|4|||
147351710|NCT00667251|531457214|FG000|Overall Study|Death|6|||
147351711|NCT00667251|531457215|FG001|Overall Study|Death|11|||
147351712|NCT00667251|531457214|FG000|Overall Study|Intercurrent illness|5|||
147351713|NCT00667251|531457215|FG001|Overall Study|Intercurrent illness|6|||
147351714|NCT00667251|531457214|FG000|Overall Study|Primary reason for withdrawal = missing|1|||
147351715|NCT00667251|531457215|FG001|Overall Study|Primary reason for withdrawal = missing|1|||
147351716|NCT00667251|531457214|FG000|Overall Study|Randomized not Treated|4|||
147351717|NCT00667251|531457215|FG001|Overall Study|Randomized not Treated|1|||
147351718|NCT02727699|531457217|FG000|Overall Study|Adverse Event|2|||
147351719|NCT02727699|531457218|FG001|Overall Study|Adverse Event|0|||
147351720|NCT02727699|531457217|FG000|Overall Study|Withdrawal by Subject|5|||
147351721|NCT02727699|531457218|FG001|Overall Study|Withdrawal by Subject|3|||
147351722|NCT02727699|531457217|FG000|Overall Study|Protocol Violation|0|||
147351723|NCT02727699|531457218|FG001|Overall Study|Protocol Violation|1|||
147351724|NCT02727699|531457217|FG000|Overall Study|Physician Decision|0|||
147351725|NCT02727699|531457218|FG001|Overall Study|Physician Decision|1|||
147351726|NCT02727699|531457217|FG000|Overall Study|Lost to Follow-up|1|||
147351727|NCT02727699|531457218|FG001|Overall Study|Lost to Follow-up|0|||
147351728|NCT02727699|531457217|FG000|Overall Study|Sponsor Decision|1|||
147351729|NCT02727699|531457218|FG001|Overall Study|Sponsor Decision|0|||
147351730|NCT02671903|531457230|FG000|Period 0 (Run-In)|Death|0|||
147351731|NCT02671903|531457231|FG001|Period 0 (Run-In)|Death|0|||
147351732|NCT02671903|531457232|FG002|Period 0 (Run-In)|Death|3|||
147351733|NCT02671903|531457230|FG000|Period 0 (Run-In)|Physician Decision|0|||
147351734|NCT02671903|531457231|FG001|Period 0 (Run-In)|Physician Decision|0|||
147351735|NCT02671903|531457232|FG002|Period 0 (Run-In)|Physician Decision|4|||
147351736|NCT02671903|531457230|FG000|Period 0 (Run-In)|Withdrawal by Subject|0|||
147351737|NCT02671903|531457231|FG001|Period 0 (Run-In)|Withdrawal by Subject|0|||
147351738|NCT02671903|531457232|FG002|Period 0 (Run-In)|Withdrawal by Subject|4|||
147351739|NCT02671903|531457230|FG000|Period 0 (Run-In)|Protocol Violation|0|||
147351740|NCT02671903|531457231|FG001|Period 0 (Run-In)|Protocol Violation|0|||
147351741|NCT02671903|531457232|FG002|Period 0 (Run-In)|Protocol Violation|1|||
147351742|NCT02671903|531457230|FG000|Period 0 (Run-In)|Adverse Event|0|||
147351743|NCT02671903|531457231|FG001|Period 0 (Run-In)|Adverse Event|0|||
147351744|NCT02671903|531457232|FG002|Period 0 (Run-In)|Adverse Event|1|||
147351745|NCT02671903|531457230|FG000|Period 0 (Run-In)|Implantation Failure|0|||
147351746|NCT02671903|531457231|FG001|Period 0 (Run-In)|Implantation Failure|0|||
147351747|NCT02671903|531457232|FG002|Period 0 (Run-In)|Implantation Failure|2|||
147351748|NCT02671903|531457230|FG000|Period 0 (Run-In)|Lost to Follow-up|0|||
147607233|NCT00090363|532377267|FG000|Overall Study|Lost to Follow-up|1|||
147607234|NCT00090363|532377268|FG001|Overall Study|Lost to Follow-up|2|||
147607235|NCT00090363|532377269|FG002|Overall Study|Lost to Follow-up|1|||
147607236|NCT00090363|532377267|FG000|Overall Study|Withdrawal by Subject|7|||
147607237|NCT00090363|532377268|FG001|Overall Study|Withdrawal by Subject|7|||
147351749|NCT02671903|531457231|FG001|Period 0 (Run-In)|Lost to Follow-up|0|||
147351750|NCT02671903|531457232|FG002|Period 0 (Run-In)|Lost to Follow-up|1|||
147351751|NCT03376321|531457233|FG000|Overall Study|Other|5|||
147351752|NCT03376321|531457234|FG001|Overall Study|Other|1|||
147351753|NCT03376321|531457233|FG000|Overall Study|Withdrawal by Subject|8|||
147351754|NCT03376321|531457234|FG001|Overall Study|Withdrawal by Subject|14|||
147351755|NCT03376321|531457233|FG000|Overall Study|Lost to Follow-up|1|||
147607238|NCT00090363|532377269|FG002|Overall Study|Withdrawal by Subject|6|||
147607239|NCT00090363|532377267|FG000|Overall Study|Study-specific discontinuation criteria|75|||
147607240|NCT00090363|532377268|FG001|Overall Study|Study-specific discontinuation criteria|74|||
147607241|NCT00090363|532377269|FG002|Overall Study|Study-specific discontinuation criteria|62|||
147607242|NCT00090363|532377267|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
147607243|NCT00090363|532377268|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
147607244|NCT00090363|532377269|FG002|Overall Study|Eligibility criteria not fulfilled|1|||
147607245|NCT00090363|532377267|FG000|Overall Study|Consent expired|7|||
147607246|NCT00090363|532377268|FG001|Overall Study|Consent expired|10|||
147607247|NCT00090363|532377269|FG002|Overall Study|Consent expired|9|||
147607248|NCT00090363|532377267|FG000|Overall Study|Reasons not specified|2|||
147607249|NCT00090363|532377268|FG001|Overall Study|Reasons not specified|1|||
147607250|NCT00090363|532377269|FG002|Overall Study|Reasons not specified|1|||
147607251|NCT00090363|532377267|FG000|Overall Study|Continuing on study off treatment|14|||
147607252|NCT00090363|532377268|FG001|Overall Study|Continuing on study off treatment|13|||
147607253|NCT00090363|532377269|FG002|Overall Study|Continuing on study off treatment|16|||
147607254|NCT03713619|532377270|FG000|Treatment Period 1 (Until Week 16)|Adverse Event|4|||
147607255|NCT03713619|532377271|FG001|Treatment Period 1 (Until Week 16)|Adverse Event|0|||
147607256|NCT03713619|532377272|FG002|Treatment Period 1 (Until Week 16)|Adverse Event|1|||
147607257|NCT03713619|532377273|FG003|Treatment Period 1 (Until Week 16)|Adverse Event|0|||
147607258|NCT03713619|532377274|FG004|Treatment Period 1 (Until Week 16)|Adverse Event|0|||
147607259|NCT03713619|532377270|FG000|Treatment Period 1 (Until Week 16)|Lost to Follow-up|3|||
147607260|NCT03713619|532377271|FG001|Treatment Period 1 (Until Week 16)|Lost to Follow-up|1|||
147607261|NCT03713619|532377272|FG002|Treatment Period 1 (Until Week 16)|Lost to Follow-up|1|||
147607262|NCT03713619|532377273|FG003|Treatment Period 1 (Until Week 16)|Lost to Follow-up|0|||
147607263|NCT03713619|532377274|FG004|Treatment Period 1 (Until Week 16)|Lost to Follow-up|0|||
147607264|NCT03713619|532377270|FG000|Treatment Period 1 (Until Week 16)|Physician Decision|1|||
147607265|NCT03713619|532377271|FG001|Treatment Period 1 (Until Week 16)|Physician Decision|1|||
147607266|NCT03713619|532377272|FG002|Treatment Period 1 (Until Week 16)|Physician Decision|1|||
147351756|NCT03376321|531457234|FG001|Overall Study|Lost to Follow-up|7|||
147351757|NCT03376321|531457233|FG000|Overall Study|Death|4|||
147351758|NCT03376321|531457234|FG001|Overall Study|Death|0|||
147351759|NCT03376321|531457233|FG000|Overall Study|Randomized, not treated|5|||
147351760|NCT03376321|531457234|FG001|Overall Study|Randomized, not treated|3|||
147351761|NCT02992925|531457235|FG000|Cohort 2|Physician Decision|0|||
147351762|NCT02992925|531457236|FG001|Cohort 2|Physician Decision|0|||
147351763|NCT02992925|531457237|FG002|Cohort 2|Physician Decision|1|||
147351764|NCT02992925|531457238|FG003|Cohort 2|Physician Decision|0|||
147351765|NCT02992925|531457235|FG000|Cohort 2|Withdrawal by parent/guardian|0|||
147351766|NCT02992925|531457236|FG001|Cohort 2|Withdrawal by parent/guardian|0|||
147351767|NCT02992925|531457237|FG002|Cohort 2|Withdrawal by parent/guardian|0|||
147351768|NCT02992925|531457238|FG003|Cohort 2|Withdrawal by parent/guardian|2|||
147351769|NCT02995434|531457239|FG000|Overall Study|Adverse Event|1|||
147351770|NCT02995434|531457240|FG001|Overall Study|Adverse Event|0|||
147351771|NCT02995434|531457239|FG000|Overall Study|Withdrawal by Subject|6|||
147351772|NCT02995434|531457240|FG001|Overall Study|Withdrawal by Subject|3|||
147351773|NCT05273749|531457241|FG000|Overall Study|Adverse Event|14|||
147351774|NCT05273749|531457242|FG001|Overall Study|Adverse Event|8|||
147351775|NCT05273749|531457241|FG000|Overall Study|Lack of Efficacy|2|||
147351776|NCT05273749|531457242|FG001|Overall Study|Lack of Efficacy|8|||
147351777|NCT05273749|531457241|FG000|Overall Study|Physician Decision|0|||
147351778|NCT05273749|531457242|FG001|Overall Study|Physician Decision|2|||
147351779|NCT05273749|531457241|FG000|Overall Study|Withdrawal by Subject|14|||
147351780|NCT05273749|531457242|FG001|Overall Study|Withdrawal by Subject|16|||
147351781|NCT05273749|531457241|FG000|Overall Study|Lost to Follow-up|10|||
147351782|NCT05273749|531457242|FG001|Overall Study|Lost to Follow-up|10|||
147351783|NCT05273749|531457241|FG000|Overall Study|Pregnancy|1|||
147351784|NCT05273749|531457242|FG001|Overall Study|Pregnancy|0|||
147351785|NCT05273749|531457241|FG000|Overall Study|Non-Compliance|3|||
147351786|NCT05273749|531457242|FG001|Overall Study|Non-Compliance|2|||
147351787|NCT05273749|531457241|FG000|Overall Study|Patient should not have been randomized due to ongoing unstable medical condition|0|||
147351788|NCT05273749|531457242|FG001|Overall Study|Patient should not have been randomized due to ongoing unstable medical condition|1|||
147351789|NCT02543281|531457245|FG000|Overall Study|Lost to Follow-up|0|||
147351790|NCT02543281|531457246|FG001|Overall Study|Lost to Follow-up|0|||
147351791|NCT02543281|531457247|FG002|Overall Study|Lost to Follow-up|1|||
147351792|NCT05247489|531457248|FG000|Overall Study|Lost to Follow-up|5|||
147607267|NCT03713619|532377273|FG003|Treatment Period 1 (Until Week 16)|Physician Decision|0|||
147607268|NCT03713619|532377274|FG004|Treatment Period 1 (Until Week 16)|Physician Decision|0|||
147351793|NCT05247489|531457249|FG001|Overall Study|Lost to Follow-up|1|||
147351794|NCT05247489|531457248|FG000|Overall Study|Withdrawal by Subject|6|||
147351795|NCT05247489|531457249|FG001|Overall Study|Withdrawal by Subject|7|||
147351796|NCT05247489|531457248|FG000|Overall Study|Withdrawn by Sponsor: Noncompliance|0|||
147351797|NCT05247489|531457249|FG001|Overall Study|Withdrawn by Sponsor: Noncompliance|1|||
147351798|NCT05247489|531457248|FG000|Overall Study|Left Country|1|||
147607269|NCT03713619|532377270|FG000|Treatment Period 1 (Until Week 16)|Technical problems|1|||
147607270|NCT03713619|532377271|FG001|Treatment Period 1 (Until Week 16)|Technical problems|0|||
147607271|NCT03713619|532377272|FG002|Treatment Period 1 (Until Week 16)|Technical problems|0|||
147607272|NCT03713619|532377273|FG003|Treatment Period 1 (Until Week 16)|Technical problems|0|||
147607273|NCT03713619|532377274|FG004|Treatment Period 1 (Until Week 16)|Technical problems|0|||
147607274|NCT03713619|532377270|FG000|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|4|||
147351799|NCT05247489|531457249|FG001|Overall Study|Left Country|0|||
147351800|NCT05247489|531457248|FG000|Overall Study|Noncompliance with Investigational Product|1|||
147351801|NCT05247489|531457249|FG001|Overall Study|Noncompliance with Investigational Product|0|||
147351802|NCT05247489|531457248|FG000|Overall Study|Withdrawn by Sponsor: Surgery to Remove Excess Skin|1|||
147351803|NCT05247489|531457249|FG001|Overall Study|Withdrawn by Sponsor: Surgery to Remove Excess Skin|0|||
147351804|NCT04179500|531457250|FG000|Treatment|Withdrawal by Subject|1|||
147351805|NCT04179500|531457250|FG000|Treatment|Adverse Event|2|||
147351806|NCT04179500|531457250|FG000|Treatment|pyrazinamide resistance|1|||
147351807|NCT04896476|531457256|FG000|Overall Study|Withdrawal by Subject|1|||
147351808|NCT04896476|531457256|FG000|Overall Study|Lost to Follow-up|2|||
147351809|NCT05948670|531457257|FG000|Overall Study|Protocol Violation|6|||
147351810|NCT05948670|531457258|FG001|Overall Study|Protocol Violation|8|||
147351811|NCT05948670|531457257|FG000|Overall Study|Withdrawal by Subject|0|||
147351812|NCT05948670|531457258|FG001|Overall Study|Withdrawal by Subject|1|||
147351813|NCT02677298|531457272|FG000|Double Blind Phase|Adverse Event|2|||
147351814|NCT02677298|531457273|FG001|Double Blind Phase|Adverse Event|1|||
147351815|NCT02677298|531457274|FG002|Double Blind Phase|Adverse Event|0|||
147351816|NCT02677298|531457272|FG000|Double Blind Phase|Physician Decision|5|||
147351817|NCT02677298|531457273|FG001|Double Blind Phase|Physician Decision|0|||
147351818|NCT02677298|531457274|FG002|Double Blind Phase|Physician Decision|0|||
147351819|NCT02677298|531457272|FG000|Double Blind Phase|Lost to Follow-up|11|||
147351820|NCT02677298|531457273|FG001|Double Blind Phase|Lost to Follow-up|7|||
147351821|NCT02677298|531457274|FG002|Double Blind Phase|Lost to Follow-up|0|||
147351822|NCT02677298|531457272|FG000|Double Blind Phase|Withdrawal by Subject|11|||
147351823|NCT02677298|531457273|FG001|Double Blind Phase|Withdrawal by Subject|8|||
147351824|NCT02677298|531457274|FG002|Double Blind Phase|Withdrawal by Subject|0|||
147351825|NCT02677298|531457272|FG000|Double Blind Phase|No study drug available at site|0|||
147351826|NCT02677298|531457273|FG001|Double Blind Phase|No study drug available at site|1|||
147351827|NCT02677298|531457274|FG002|Double Blind Phase|No study drug available at site|0|||
147351828|NCT02677298|531457272|FG000|Open Label Phase|Adverse Event|0|||
147662745|NCT02227784|532587413|FG001|Open-Label Extension Phase (OLE)|Sponsor Decision|0|||
147662746|NCT02227784|532587414|FG002|Open-Label Extension Phase (OLE)|Sponsor Decision|0|||
147662747|NCT02227784|532587415|FG003|Open-Label Extension Phase (OLE)|Sponsor Decision|0|||
147662748|NCT02227784|532587416|FG004|Open-Label Extension Phase (OLE)|Sponsor Decision|243|||
147662749|NCT02227784|532587412|FG000|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0|||
147662750|NCT02227784|532587413|FG001|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0|||
147662751|NCT02227784|532587414|FG002|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0|||
147662752|NCT02227784|532587415|FG003|Open-Label Extension Phase (OLE)|Withdrawal by Subject|0|||
147662753|NCT02227784|532587416|FG004|Open-Label Extension Phase (OLE)|Withdrawal by Subject|3|||
147351829|NCT02677298|531457273|FG001|Open Label Phase|Adverse Event|0|||
147351830|NCT02677298|531457274|FG002|Open Label Phase|Adverse Event|4|||
147351831|NCT02677298|531457272|FG000|Open Label Phase|Physician Decision|0|||
147351832|NCT02677298|531457273|FG001|Open Label Phase|Physician Decision|0|||
147351833|NCT02677298|531457274|FG002|Open Label Phase|Physician Decision|1|||
147351834|NCT02677298|531457272|FG000|Open Label Phase|Lost to Follow-up|0|||
147351835|NCT02677298|531457273|FG001|Open Label Phase|Lost to Follow-up|0|||
147351836|NCT02677298|531457274|FG002|Open Label Phase|Lost to Follow-up|17|||
147351837|NCT02677298|531457272|FG000|Open Label Phase|Withdrawal by Subject|0|||
147351838|NCT02677298|531457273|FG001|Open Label Phase|Withdrawal by Subject|0|||
147351839|NCT02677298|531457274|FG002|Open Label Phase|Withdrawal by Subject|38|||
147351840|NCT04526704|531457282|FG000|Overall Study|Adverse Event|1|||
147351841|NCT04526704|531457283|FG001|Overall Study|Adverse Event|0|||
147351842|NCT04526704|531457282|FG000|Overall Study|Physician Decision|1|||
147351843|NCT04526704|531457283|FG001|Overall Study|Physician Decision|0|||
147351844|NCT04526704|531457282|FG000|Overall Study|Withdrawal by Subject|2|||
147351845|NCT04526704|531457283|FG001|Overall Study|Withdrawal by Subject|0|||
147351846|NCT00881621|531457284|FG000|Overall Study|Physician Decision|34|||
147351847|NCT05116787|531457285|FG000|Part 1:DB Phase (up to 12 Weeks)|Withdrawal by Subject|0|||
147351848|NCT05116787|531457286|FG001|Part 1:DB Phase (up to 12 Weeks)|Withdrawal by Subject|1|||
147351849|NCT05116787|531457285|FG000|Part 1:DB Phase (up to 12 Weeks)|Pregnancy|1|||
147351850|NCT05116787|531457286|FG001|Part 1:DB Phase (up to 12 Weeks)|Pregnancy|0|||
147351851|NCT05116787|531457285|FG000|Part 1:DB Phase (up to 12 Weeks)|Adverse Event|1|||
147662754|NCT04010461|532587417|FG000|Overall Study|COVID based withdrawal|5|||
147351852|NCT05116787|531457286|FG001|Part 1:DB Phase (up to 12 Weeks)|Adverse Event|0|||
147351853|NCT05116787|531457285|FG000|Part 2:Open-label Phase (up to 52 Weeks)|Miscellaneous|4|||
147351854|NCT05116787|531457286|FG001|Part 2:Open-label Phase (up to 52 Weeks)|Miscellaneous|0|||
147351855|NCT02737436|531457287|FG000|Washout Period|Lost to Follow-up|5|||
147351856|NCT02737436|531457288|FG001|Washout Period|Lost to Follow-up|11|||
147351857|NCT02737436|531457287|FG000|Data Analysis|Scanning data problems|5|||
147351858|NCT02737436|531457288|FG001|Data Analysis|Scanning data problems|8|||
147351859|NCT05179837|531457290|FG000|Overall Study|Lesion turned out to be scar tissue and not a polyp|1|||
147351860|NCT05179837|531457290|FG000|Overall Study|Device malfunctioned|1|||
147351861|NCT05179837|531457290|FG000|Overall Study|Image quality too low|2|||
147351862|NCT03158129|531457291|FG000|Overall Study|Adverse Event|0|||
147351863|NCT03158129|531457292|FG001|Overall Study|Adverse Event|1|||
147351864|NCT03158129|531457293|FG002|Overall Study|Adverse Event|0|||
147351865|NCT03158129|531457294|FG003|Overall Study|Adverse Event|0|||
147351866|NCT03158129|531457291|FG000|Overall Study|Death|0|||
147351867|NCT03158129|531457292|FG001|Overall Study|Death|0|||
147351868|NCT03158129|531457293|FG002|Overall Study|Death|0|||
147351869|NCT03158129|531457294|FG003|Overall Study|Death|1|||
147351870|NCT03158129|531457291|FG000|Overall Study|High surgical risk|1|||
147351871|NCT03158129|531457292|FG001|Overall Study|High surgical risk|1|||
147351872|NCT03158129|531457293|FG002|Overall Study|High surgical risk|0|||
147351873|NCT03158129|531457294|FG003|Overall Study|High surgical risk|0|||
147351874|NCT03158129|531457291|FG000|Overall Study|Progression|1|||
147351875|NCT03158129|531457292|FG001|Overall Study|Progression|1|||
147351876|NCT03158129|531457293|FG002|Overall Study|Progression|0|||
147607275|NCT03713619|532377271|FG001|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|9|||
147351877|NCT03158129|531457294|FG003|Overall Study|Progression|0|||
147351878|NCT03158129|531457291|FG000|Overall Study|Lack of resectability|0|||
147351879|NCT03158129|531457292|FG001|Overall Study|Lack of resectability|1|||
147351880|NCT03158129|531457293|FG002|Overall Study|Lack of resectability|0|||
147351881|NCT03158129|531457294|FG003|Overall Study|Lack of resectability|0|||
147351882|NCT03158129|531457291|FG000|Overall Study|Declined surgery|0|||
147351883|NCT03158129|531457292|FG001|Overall Study|Declined surgery|1|||
147351884|NCT03158129|531457293|FG002|Overall Study|Declined surgery|0|||
147351885|NCT03158129|531457294|FG003|Overall Study|Declined surgery|0|||
147351886|NCT03158129|531457291|FG000|Overall Study|No longer surgical candidate|0|||
147351887|NCT03158129|531457292|FG001|Overall Study|No longer surgical candidate|0|||
147351888|NCT03158129|531457293|FG002|Overall Study|No longer surgical candidate|0|||
147351889|NCT03158129|531457294|FG003|Overall Study|No longer surgical candidate|1|||
147351890|NCT03719443|531457295|FG000|Overall Study|Lost to Follow-up|0|||
147351891|NCT03719443|531457296|FG001|Overall Study|Lost to Follow-up|0|||
147351892|NCT03719443|531457297|FG002|Overall Study|Lost to Follow-up|1|||
147351893|NCT03719443|531457298|FG003|Overall Study|Lost to Follow-up|0|||
147351894|NCT03719443|531457299|FG004|Overall Study|Lost to Follow-up|1|||
147351895|NCT03719443|531457300|FG005|Overall Study|Lost to Follow-up|0|||
147351896|NCT03719443|531457301|FG006|Overall Study|Lost to Follow-up|1|||
147351897|NCT03719443|531457295|FG000|Overall Study|Withdrawal by Subject|0|||
147351898|NCT03719443|531457296|FG001|Overall Study|Withdrawal by Subject|0|||
147351899|NCT03719443|531457297|FG002|Overall Study|Withdrawal by Subject|1|||
147351900|NCT03719443|531457298|FG003|Overall Study|Withdrawal by Subject|0|||
147351901|NCT03719443|531457299|FG004|Overall Study|Withdrawal by Subject|0|||
147351902|NCT03719443|531457300|FG005|Overall Study|Withdrawal by Subject|0|||
147351903|NCT03719443|531457301|FG006|Overall Study|Withdrawal by Subject|0|||
147351904|NCT05051124|531457302|FG000|Overall Study|Lost to Follow-up|2|||
147351905|NCT05051124|531457302|FG000|Overall Study|Withdrawal by Subject|1|||
147351906|NCT05051124|531457302|FG000|Overall Study|Residential relocation|2|||
147351907|NCT05051124|531457302|FG000|Overall Study|Death|1|||
147351908|NCT04782973|531457303|FG000|Overall Study|Withdrawal by Subject|5|||
147351909|NCT04782973|531457303|FG000|Overall Study|Protocol Violation|6|||
147351910|NCT04782973|531457303|FG000|Overall Study|No Longer Eligible Post-Consent|8|||
147351911|NCT00554788|531457304|FG000|Overall Study|Adverse Event|0|||
147351912|NCT00554788|531457305|FG001|Overall Study|Adverse Event|1|||
147351913|NCT00554788|531457306|FG002|Overall Study|Adverse Event|2|||
147351914|NCT00554788|531457304|FG000|Overall Study|Lost to Follow-up|4|||
147351915|NCT00554788|531457305|FG001|Overall Study|Lost to Follow-up|3|||
147351916|NCT00554788|531457306|FG002|Overall Study|Lost to Follow-up|3|||
147351917|NCT00554788|531457304|FG000|Overall Study|Physician Decision|1|||
147351918|NCT00554788|531457305|FG001|Overall Study|Physician Decision|1|||
147351919|NCT00554788|531457306|FG002|Overall Study|Physician Decision|3|||
147351920|NCT00554788|531457304|FG000|Overall Study|Withdrawal by Subject|0|||
147351921|NCT00554788|531457305|FG001|Overall Study|Withdrawal by Subject|0|||
147351922|NCT00554788|531457306|FG002|Overall Study|Withdrawal by Subject|1|||
147351923|NCT00554788|531457304|FG000|Overall Study|Refusal of further protocol therapy|0|||
147351924|NCT00554788|531457305|FG001|Overall Study|Refusal of further protocol therapy|1|||
147351925|NCT00554788|531457306|FG002|Overall Study|Refusal of further protocol therapy|1|||
147351926|NCT00554788|531457304|FG000|Overall Study|Progressive disease|0|||
147351927|NCT00554788|531457305|FG001|Overall Study|Progressive disease|0|||
147351928|NCT00554788|531457306|FG002|Overall Study|Progressive disease|3|||
147351929|NCT00554788|531457304|FG000|Overall Study|Ineligible|2|||
147351930|NCT00554788|531457305|FG001|Overall Study|Ineligible|0|||
147351931|NCT00554788|531457306|FG002|Overall Study|Ineligible|1|||
147453435|NCT03403205|531824013|FG005|Extension Period (Up to 60 Months)|Lost to Follow-up|0|||
147351932|NCT02577835|531457308|FG000|Overall Study|Ambulatory blood pressure recordings were not valid for the analysis|142|||
147351933|NCT04749615|531457309|FG000|Overall Study|Lost to Follow-up|6|||
147351934|NCT04749615|531457310|FG001|Overall Study|Lost to Follow-up|10|||
147351935|NCT05292365|531457324|FG000|Overall Study|Met Exclusion Criteria: Participant disenrolled from their complex care program|1|||
147351936|NCT05292365|531457325|FG001|Overall Study|Met Exclusion Criteria: Participant disenrolled from their complex care program|1|||
147351937|NCT05292365|531457326|FG002|Overall Study|Met Exclusion Criteria: Participant disenrolled from their complex care program|0|||
147351938|NCT05292365|531457327|FG003|Overall Study|Met Exclusion Criteria: Participant disenrolled from their complex care program|0|||
147351939|NCT03364647|531457328|FG000|Overall Study|Withdrawal by Subject|3|||
147351940|NCT03364647|531457329|FG001|Overall Study|Withdrawal by Subject|1|||
147351941|NCT05746455|531457338|FG000|Overall Study|Discharged from Clinical Service|1|||
147351942|NCT05746455|531457338|FG000|Overall Study|Lost to Follow-up|1|||
147351943|NCT03896789|531457343|FG000|Baseline|Lost to Follow-up|1|||
147351944|NCT03896789|531457344|FG001|Baseline|Lost to Follow-up|2|||
147351945|NCT03896789|531457343|FG000|Baseline|Death|3|||
147351946|NCT03896789|531457344|FG001|Baseline|Death|6|||
147351947|NCT03896789|531457343|FG000|Post-Randomization|Lost to Follow-up|12|||
147351948|NCT03896789|531457344|FG001|Post-Randomization|Lost to Follow-up|11|||
147351949|NCT03896789|531457343|FG000|Post-Randomization|Death|12|||
147351950|NCT03896789|531457344|FG001|Post-Randomization|Death|13|||
147351951|NCT03447470|531457349|FG000|Overall Study|Death|0|||
147351952|NCT03447470|531457350|FG001|Overall Study|Death|1|||
147351953|NCT03447470|531457351|FG002|Overall Study|Death|3|||
147351954|NCT03447470|531457352|FG003|Overall Study|Death|0|||
147351955|NCT03447470|531457353|FG004|Overall Study|Death|1|||
147351956|NCT03447470|531457354|FG005|Overall Study|Death|0|||
147351957|NCT03447470|531457355|FG006|Overall Study|Death|3|||
147351958|NCT03447470|531457356|FG007|Overall Study|Death|3|||
147351959|NCT03447470|531457357|FG008|Overall Study|Death|1|||
147607276|NCT03713619|532377272|FG002|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|5|||
147607277|NCT03713619|532377273|FG003|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|0|||
147607278|NCT03713619|532377274|FG004|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|0|||
147351960|NCT03447470|531457349|FG000|Overall Study|Withdrawal by Subject|1|||
147351961|NCT03447470|531457350|FG001|Overall Study|Withdrawal by Subject|0|||
147351962|NCT03447470|531457351|FG002|Overall Study|Withdrawal by Subject|0|||
147351963|NCT03447470|531457352|FG003|Overall Study|Withdrawal by Subject|0|||
147351964|NCT03447470|531457353|FG004|Overall Study|Withdrawal by Subject|1|||
147351965|NCT03447470|531457354|FG005|Overall Study|Withdrawal by Subject|0|||
147351966|NCT03447470|531457355|FG006|Overall Study|Withdrawal by Subject|1|||
147351967|NCT03447470|531457356|FG007|Overall Study|Withdrawal by Subject|1|||
147351968|NCT03447470|531457357|FG008|Overall Study|Withdrawal by Subject|3|||
147351969|NCT03447470|531457349|FG000|Overall Study|Treatment discontinued|3|||
147351970|NCT03447470|531457350|FG001|Overall Study|Treatment discontinued|2|||
147351971|NCT03447470|531457351|FG002|Overall Study|Treatment discontinued|4|||
147351972|NCT03447470|531457352|FG003|Overall Study|Treatment discontinued|6|||
147351973|NCT03447470|531457353|FG004|Overall Study|Treatment discontinued|2|||
147351974|NCT03447470|531457354|FG005|Overall Study|Treatment discontinued|1|||
147351975|NCT03447470|531457355|FG006|Overall Study|Treatment discontinued|2|||
147351976|NCT03447470|531457356|FG007|Overall Study|Treatment discontinued|4|||
147351977|NCT03447470|531457357|FG008|Overall Study|Treatment discontinued|3|||
147351978|NCT05184192|531457359|FG000|Overall Study|Lost to Follow-up|4|||
147351979|NCT05184192|531457360|FG001|Overall Study|Lost to Follow-up|7|||
147351980|NCT05184192|531457359|FG000|Overall Study|Adverse Event|1|||
147351981|NCT05184192|531457360|FG001|Overall Study|Adverse Event|4|||
147351982|NCT05184192|531457359|FG000|Overall Study|PI withdrawal|1|||
147351983|NCT05184192|531457360|FG001|Overall Study|PI withdrawal|2|||
147351984|NCT05184192|531457359|FG000|Overall Study|Withdrew due to adverse effect|1|||
147351985|NCT05184192|531457360|FG001|Overall Study|Withdrew due to adverse effect|0|||
147351986|NCT05184192|531457359|FG000|Overall Study|Medication schedule|1|||
147351987|NCT05184192|531457360|FG001|Overall Study|Medication schedule|0|||
147351988|NCT05184192|531457359|FG000|Overall Study|Concern for adverse effects|0|||
147351989|NCT05184192|531457360|FG001|Overall Study|Concern for adverse effects|4|||
147351990|NCT04295798|531457366|FG000|Overall Study|Lost to Follow-up|1|||
147351991|NCT04624633|531457367|FG000|Overall Study|Subject Needed Surgery, Radiation or Other Therapy|0|||
147607279|NCT03713619|532377270|FG000|Treatment Period 1 (Until Week 16)|Misrandomized|0|||
147607280|NCT03713619|532377271|FG001|Treatment Period 1 (Until Week 16)|Misrandomized|0|||
147351992|NCT04624633|531457368|FG001|Overall Study|Subject Needed Surgery, Radiation or Other Therapy|1|||
147351993|NCT04624633|531457367|FG000|Overall Study|Death|1|||
147351994|NCT04624633|531457368|FG001|Overall Study|Death|0|||
147351995|NCT01902173|531457369|FG000|Phase 1 Doublet Regimen Cohort 1|Adverse Event|1|||
147351996|NCT01902173|531457370|FG001|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0|||
147351997|NCT01902173|531457371|FG002|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0|||
147351998|NCT01902173|531457372|FG003|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0|||
147351999|NCT01902173|531457373|FG004|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0|||
147607281|NCT03713619|532377272|FG002|Treatment Period 1 (Until Week 16)|Misrandomized|1|||
147352000|NCT01902173|531457374|FG005|Phase 1 Doublet Regimen Cohort 1|Adverse Event|0|||
147352001|NCT01902173|531457369|FG000|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|2|||
147352002|NCT01902173|531457370|FG001|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0|||
147352003|NCT01902173|531457371|FG002|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0|||
147352004|NCT01902173|531457372|FG003|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0|||
147352005|NCT01902173|531457373|FG004|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0|||
147352006|NCT01902173|531457374|FG005|Phase 1 Doublet Regimen Cohort 1|Progression/relapse|0|||
147352007|NCT01902173|531457369|FG000|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0|||
147352008|NCT01902173|531457370|FG001|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|5|||
147352009|NCT01902173|531457371|FG002|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0|||
147352010|NCT01902173|531457372|FG003|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0|||
147352011|NCT01902173|531457373|FG004|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0|||
147352012|NCT01902173|531457374|FG005|Phase 1 Doublet Regimen Cohort 2|Progression/relapse|0|||
147352013|NCT01902173|531457369|FG000|Phase 1 Doublet Regimen Cohort 2|Ineligible|0|||
147352014|NCT01902173|531457370|FG001|Phase 1 Doublet Regimen Cohort 2|Ineligible|1|||
147352015|NCT01902173|531457371|FG002|Phase 1 Doublet Regimen Cohort 2|Ineligible|0|||
147352016|NCT01902173|531457372|FG003|Phase 1 Doublet Regimen Cohort 2|Ineligible|0|||
147352017|NCT01902173|531457373|FG004|Phase 1 Doublet Regimen Cohort 2|Ineligible|0|||
147352018|NCT01902173|531457374|FG005|Phase 1 Doublet Regimen Cohort 2|Ineligible|0|||
147352019|NCT01902173|531457369|FG000|Phase 1 Doublet Regimen Cohort 2|No treated|0|||
147352020|NCT01902173|531457370|FG001|Phase 1 Doublet Regimen Cohort 2|No treated|3|||
147352021|NCT01902173|531457371|FG002|Phase 1 Doublet Regimen Cohort 2|No treated|0|||
147352022|NCT01902173|531457372|FG003|Phase 1 Doublet Regimen Cohort 2|No treated|0|||
147352023|NCT01902173|531457373|FG004|Phase 1 Doublet Regimen Cohort 2|No treated|0|||
147352024|NCT01902173|531457374|FG005|Phase 1 Doublet Regimen Cohort 2|No treated|0|||
147352025|NCT01902173|531457369|FG000|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0|||
147352026|NCT01902173|531457370|FG001|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0|||
147352027|NCT01902173|531457371|FG002|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|3|||
147352028|NCT01902173|531457372|FG003|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0|||
147352029|NCT01902173|531457373|FG004|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0|||
147352030|NCT01902173|531457374|FG005|Phase 1 Triplet Regimen Cohort 1|Progression/relapse|0|||
147352031|NCT01902173|531457369|FG000|Phase 1 Triplet Regimen Cohort 1|Ineligible|0|||
147352032|NCT01902173|531457370|FG001|Phase 1 Triplet Regimen Cohort 1|Ineligible|0|||
147352033|NCT01902173|531457371|FG002|Phase 1 Triplet Regimen Cohort 1|Ineligible|1|||
147352034|NCT01902173|531457372|FG003|Phase 1 Triplet Regimen Cohort 1|Ineligible|0|||
147352035|NCT01902173|531457373|FG004|Phase 1 Triplet Regimen Cohort 1|Ineligible|0|||
147352036|NCT01902173|531457374|FG005|Phase 1 Triplet Regimen Cohort 1|Ineligible|0|||
147352037|NCT01902173|531457369|FG000|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0|||
147352038|NCT01902173|531457370|FG001|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0|||
147352039|NCT01902173|531457371|FG002|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0|||
147352040|NCT01902173|531457372|FG003|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|1|||
147352041|NCT01902173|531457373|FG004|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0|||
147352042|NCT01902173|531457374|FG005|Phase 1 Triplet Regimen Cohort 2|Ongoing treatment|0|||
147352043|NCT01902173|531457369|FG000|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0|||
147352044|NCT01902173|531457370|FG001|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0|||
147352045|NCT01902173|531457371|FG002|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0|||
147352046|NCT01902173|531457372|FG003|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|2|||
147352047|NCT01902173|531457373|FG004|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0|||
147352048|NCT01902173|531457374|FG005|Phase 1 Triplet Regimen Cohort 2|Progression/relapse|0|||
147352049|NCT01902173|531457369|FG000|Phase 1 Triplet Regimen Cohort 3|Ongoing|0|||
147352050|NCT01902173|531457370|FG001|Phase 1 Triplet Regimen Cohort 3|Ongoing|0|||
147352051|NCT01902173|531457371|FG002|Phase 1 Triplet Regimen Cohort 3|Ongoing|0|||
147352052|NCT01902173|531457372|FG003|Phase 1 Triplet Regimen Cohort 3|Ongoing|0|||
147352053|NCT01902173|531457373|FG004|Phase 1 Triplet Regimen Cohort 3|Ongoing|1|||
147352054|NCT01902173|531457374|FG005|Phase 1 Triplet Regimen Cohort 3|Ongoing|0|||
147352055|NCT01902173|531457369|FG000|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0|||
147352056|NCT01902173|531457370|FG001|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0|||
147352057|NCT01902173|531457371|FG002|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0|||
147352058|NCT01902173|531457372|FG003|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0|||
147352059|NCT01902173|531457373|FG004|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|2|||
147352060|NCT01902173|531457374|FG005|Phase 1 Triplet Regimen Cohort 3|Progression/relapse|0|||
147352061|NCT01902173|531457369|FG000|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0|||
147352062|NCT01902173|531457370|FG001|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0|||
147352063|NCT01902173|531457371|FG002|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0|||
147352064|NCT01902173|531457372|FG003|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0|||
147352065|NCT01902173|531457373|FG004|Phase 1 Triplet Regimen Cohort 4|Adverse Event|0|||
147352066|NCT01902173|531457374|FG005|Phase 1 Triplet Regimen Cohort 4|Adverse Event|1|||
147352067|NCT01902173|531457369|FG000|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0|||
147607282|NCT03713619|532377273|FG003|Treatment Period 1 (Until Week 16)|Misrandomized|0|||
147607283|NCT03713619|532377274|FG004|Treatment Period 1 (Until Week 16)|Misrandomized|0|||
147607284|NCT03713619|532377270|FG000|Treatment Period 1 (Until Week 16)|Severe GCP Violation|1|||
147607285|NCT03713619|532377271|FG001|Treatment Period 1 (Until Week 16)|Severe GCP Violation|1|||
147607286|NCT03713619|532377272|FG002|Treatment Period 1 (Until Week 16)|Severe GCP Violation|0|||
147607287|NCT03713619|532377273|FG003|Treatment Period 1 (Until Week 16)|Severe GCP Violation|0|||
147607288|NCT03713619|532377274|FG004|Treatment Period 1 (Until Week 16)|Severe GCP Violation|0|||
147607289|NCT03713619|532377270|FG000|Treatment Period 2 (After Week 16)|Adverse Event|6|||
147607290|NCT03713619|532377271|FG001|Treatment Period 2 (After Week 16)|Adverse Event|5|||
147607291|NCT03713619|532377272|FG002|Treatment Period 2 (After Week 16)|Adverse Event|0|||
147607292|NCT03713619|532377273|FG003|Treatment Period 2 (After Week 16)|Adverse Event|1|||
147352068|NCT01902173|531457370|FG001|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0|||
147352069|NCT01902173|531457371|FG002|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0|||
147352070|NCT01902173|531457372|FG003|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0|||
147352071|NCT01902173|531457373|FG004|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|0|||
147352072|NCT01902173|531457374|FG005|Phase 1 Triplet Regimen Cohort 4|Progression/relapse|3|||
147352073|NCT01902173|531457369|FG000|Phase 1 Triplet Regimen Cohort 4|Death|0|||
147352074|NCT01902173|531457370|FG001|Phase 1 Triplet Regimen Cohort 4|Death|0|||
147352075|NCT01902173|531457371|FG002|Phase 1 Triplet Regimen Cohort 4|Death|0|||
147352076|NCT01902173|531457372|FG003|Phase 1 Triplet Regimen Cohort 4|Death|0|||
147352077|NCT01902173|531457373|FG004|Phase 1 Triplet Regimen Cohort 4|Death|0|||
147352078|NCT01902173|531457374|FG005|Phase 1 Triplet Regimen Cohort 4|Death|1|||
147352079|NCT04625283|531457376|FG000|Overall Study|post randomization exclusion|28|||
147607293|NCT03713619|532377274|FG004|Treatment Period 2 (After Week 16)|Adverse Event|2|||
147607294|NCT03713619|532377270|FG000|Treatment Period 2 (After Week 16)|Pregnancy|1|||
147352080|NCT04625283|531457377|FG001|Overall Study|post randomization exclusion|20|||
147352081|NCT03382652|531457378|FG000|Overall Study|Lost to Follow-up|6|||
147352082|NCT03382652|531457378|FG000|Overall Study|Death|4|||
147352083|NCT03382652|531457378|FG000|Overall Study|Revision|5|||
147352084|NCT03382652|531457378|FG000|Overall Study|Patient withdrew|3|||
147352085|NCT03382652|531457378|FG000|Overall Study|Other reasons|21|||
147352086|NCT05603143|531457379|FG000|Overall Study|Withdrew consent|6|||
147352087|NCT05603143|531457380|FG001|Overall Study|Withdrew consent|2|||
147352088|NCT05603143|531457379|FG000|Overall Study|Randomized but never treated|0|||
147352089|NCT05603143|531457380|FG001|Overall Study|Randomized but never treated|3|||
147352090|NCT05603143|531457379|FG000|Overall Study|Adverse Event|2|||
147352091|NCT05603143|531457380|FG001|Overall Study|Adverse Event|0|||
147352092|NCT05603143|531457379|FG000|Overall Study|Death|0|||
147352093|NCT05603143|531457380|FG001|Overall Study|Death|1|||
147352094|NCT05603143|531457379|FG000|Overall Study|Investigator's discretion|1|||
147352095|NCT05603143|531457380|FG001|Overall Study|Investigator's discretion|0|||
147352096|NCT05603143|531457379|FG000|Overall Study|Lost to Follow-up|0|||
147352097|NCT05603143|531457380|FG001|Overall Study|Lost to Follow-up|1|||
147352098|NCT05603143|531457379|FG000|Overall Study|Protocol Violation|0|||
147352099|NCT05603143|531457380|FG001|Overall Study|Protocol Violation|1|||
147352100|NCT05783102|531457381|FG000|Overall Study|Lost to Follow-up|1|||
147352101|NCT05783102|531457381|FG000|Overall Study|Withdrawal by Subject|2|||
147352102|NCT04505904|531457382|FG000|Overall Study|Withdrawal by Subject|1|||
147352103|NCT04505904|531457383|FG001|Overall Study|Withdrawal by Subject|2|||
147352104|NCT04505904|531457384|FG002|Overall Study|Withdrawal by Subject|0|||
147352105|NCT04505904|531457385|FG003|Overall Study|Withdrawal by Subject|0|||
147352106|NCT04505904|531457382|FG000|Overall Study|Physician Decision|1|||
147352107|NCT04505904|531457383|FG001|Overall Study|Physician Decision|0|||
147352108|NCT04505904|531457384|FG002|Overall Study|Physician Decision|0|||
147352109|NCT04505904|531457385|FG003|Overall Study|Physician Decision|0|||
147352110|NCT04505904|531457382|FG000|Overall Study|Adverse Event|0|||
147352111|NCT04505904|531457383|FG001|Overall Study|Adverse Event|1|||
147607295|NCT03713619|532377271|FG001|Treatment Period 2 (After Week 16)|Pregnancy|0|||
147352112|NCT04505904|531457384|FG002|Overall Study|Adverse Event|0|||
147352113|NCT04505904|531457385|FG003|Overall Study|Adverse Event|0|||
147352114|NCT04277442|531457388|FG000|Overall Study|Death|1|||
147352115|NCT05084508|531457389|FG000|Overall Study|Lost to Follow-up|6|||
147352116|NCT05084508|531457390|FG001|Overall Study|Lost to Follow-up|3|||
147352117|NCT05084508|531457391|FG002|Overall Study|Lost to Follow-up|7|||
147352118|NCT05084508|531457392|FG003|Overall Study|Lost to Follow-up|3|||
147352119|NCT05084508|531457389|FG000|Overall Study|Withdrawal by Subject|0|||
147352120|NCT05084508|531457390|FG001|Overall Study|Withdrawal by Subject|2|||
147352121|NCT05084508|531457391|FG002|Overall Study|Withdrawal by Subject|3|||
147352122|NCT05084508|531457392|FG003|Overall Study|Withdrawal by Subject|1|||
147352123|NCT05084508|531457389|FG000|Overall Study|Other|0|||
147352124|NCT05084508|531457390|FG001|Overall Study|Other|0|||
147352125|NCT05084508|531457391|FG002|Overall Study|Other|0|||
147352126|NCT05084508|531457392|FG003|Overall Study|Other|1|||
147352127|NCT05093829|531457394|FG000|Step 2 Randomization|Lost to follow-up, ineligibility, or Group 2 target met|0|||
147453436|NCT03403205|531824008|FG000|Extension Period (Up to 60 Months)|Pregnancy|1|||
147352128|NCT05093829|531457395|FG001|Step 2 Randomization|Lost to follow-up, ineligibility, or Group 2 target met|0|||
147352129|NCT05093829|531457396|FG002|Step 2 Randomization|Lost to follow-up, ineligibility, or Group 2 target met|123|||
147352130|NCT05093829|531457397|FG003|Step 2 Randomization|Lost to follow-up, ineligibility, or Group 2 target met|0|||
147352131|NCT05093829|531457398|FG004|Step 2 Randomization|Lost to follow-up, ineligibility, or Group 2 target met|0|||
147352132|NCT05302596|531457401|FG000|Overall Study|Withdrawal by Subject|1|||
147352133|NCT05302596|531457402|FG001|Overall Study|Withdrawal by Subject|1|||
147352134|NCT04806594|531459507|FG000|Overall Study|Withdrawal by Subject|2|||
147453437|NCT03403205|531824009|FG001|Extension Period (Up to 60 Months)|Pregnancy|1|||
147352135|NCT04806594|531459507|FG000|Overall Study|Did never apply the study product and did not attend following visits.|1|||
147352136|NCT04318548|531459508|FG000|Overall Study|Adverse Event|0|||
147352137|NCT04318548|531459509|FG001|Overall Study|Adverse Event|0|||
147352138|NCT04318548|531459510|FG002|Overall Study|Adverse Event|1|||
147352139|NCT04318548|531459508|FG000|Overall Study|Lost to Follow-up|6|||
147352140|NCT04318548|531459509|FG001|Overall Study|Lost to Follow-up|13|||
147352141|NCT04318548|531459510|FG002|Overall Study|Lost to Follow-up|9|||
147352142|NCT04318548|531459508|FG000|Overall Study|Protocol Violation|1|||
147352143|NCT04318548|531459509|FG001|Overall Study|Protocol Violation|0|||
147352144|NCT04318548|531459510|FG002|Overall Study|Protocol Violation|2|||
147352145|NCT04318548|531459508|FG000|Overall Study|Consent withdrawal, not due to a (S)AE|5|||
147352146|NCT04318548|531459509|FG001|Overall Study|Consent withdrawal, not due to a (S)AE|9|||
147352147|NCT04318548|531459510|FG002|Overall Study|Consent withdrawal, not due to a (S)AE|6|||
147352148|NCT04318548|531459508|FG000|Overall Study|Migrated / moved from the study area|0|||
147352149|NCT04318548|531459509|FG001|Overall Study|Migrated / moved from the study area|0|||
147352150|NCT04318548|531459510|FG002|Overall Study|Migrated / moved from the study area|1|||
147352151|NCT04318548|531459508|FG000|Overall Study|Other|1|||
147352152|NCT04318548|531459509|FG001|Overall Study|Other|2|||
147352153|NCT04318548|531459510|FG002|Overall Study|Other|3|||
147352154|NCT05215314|531459517|FG000|Overall Study|Lost to Follow-up|2|||
147352155|NCT05215314|531459518|FG001|Overall Study|Lost to Follow-up|2|||
147352156|NCT05215314|531459517|FG000|Overall Study|Withdrawal by Subject|2|||
147352157|NCT05215314|531459518|FG001|Overall Study|Withdrawal by Subject|0|||
147352158|NCT05215314|531459517|FG000|Overall Study|Physician Decision|1|||
147352159|NCT05215314|531459518|FG001|Overall Study|Physician Decision|0|||
147352160|NCT01744782|531459519|FG000|Overall Study|Death|1|||
147352161|NCT01785719|531459520|FG000|4-week Baseline Evaluation|Physician Decision|1|||
147352162|NCT01785719|531459521|FG001|4-week Baseline Evaluation|Physician Decision|0|||
147352163|NCT01785719|531459520|FG000|4-week Baseline Evaluation|Withdrawal by Subject|1|||
147352164|NCT01785719|531459521|FG001|4-week Baseline Evaluation|Withdrawal by Subject|2|||
147352165|NCT01785719|531459520|FG000|4-week Baseline Evaluation|Lost to Follow-up|0|||
147352166|NCT01785719|531459521|FG001|4-week Baseline Evaluation|Lost to Follow-up|1|||
147352167|NCT01785719|531459520|FG000|4-week Baseline Evaluation|Pregnancy|0|||
147352168|NCT01785719|531459521|FG001|4-week Baseline Evaluation|Pregnancy|2|||
147352169|NCT01785719|531459520|FG000|4-week Baseline Evaluation|Poor vein access and/or ultrasound image quality|4|||
147352170|NCT01785719|531459521|FG001|4-week Baseline Evaluation|Poor vein access and/or ultrasound image quality|8|||
147352171|NCT01785719|531459520|FG000|4-week Baseline Evaluation|Exclusionary medication|2|||
147352172|NCT01785719|531459521|FG001|4-week Baseline Evaluation|Exclusionary medication|0|||
147352173|NCT01785719|531459520|FG000|Hypocaloric Dietary Intervention|Adverse Event|1|||
147352174|NCT01785719|531459521|FG001|Hypocaloric Dietary Intervention|Adverse Event|0|||
147352175|NCT01785719|531459520|FG000|Hypocaloric Dietary Intervention|Physician Decision|1|||
147352176|NCT01785719|531459521|FG001|Hypocaloric Dietary Intervention|Physician Decision|0|||
147352177|NCT01785719|531459520|FG000|Hypocaloric Dietary Intervention|Withdrawal by Investigator - Poor Compliance|1|||
147352178|NCT01785719|531459521|FG001|Hypocaloric Dietary Intervention|Withdrawal by Investigator - Poor Compliance|2|||
147352179|NCT01785719|531459520|FG000|Hypocaloric Dietary Intervention|Research Restrictions (COVID)|1|||
147352180|NCT01785719|531459521|FG001|Hypocaloric Dietary Intervention|Research Restrictions (COVID)|2|||
147352181|NCT01785719|531459520|FG000|Hypocaloric Dietary Intervention|Poor vein access and/or ultrasound image quality|0|||
147352182|NCT01785719|531459521|FG001|Hypocaloric Dietary Intervention|Poor vein access and/or ultrasound image quality|1|||
147352183|NCT01785719|531459520|FG000|Hypocaloric Dietary Intervention|Participant initiated an exclusionary medication.|0|||
147352184|NCT01785719|531459521|FG001|Hypocaloric Dietary Intervention|Participant initiated an exclusionary medication.|1|||
147352185|NCT01785719|531459520|FG000|6-month Post-intervention Follow-up|Lost to Follow-up|12|||
147352186|NCT01785719|531459521|FG001|6-month Post-intervention Follow-up|Lost to Follow-up|2|||
147352187|NCT01785719|531459520|FG000|6-month Post-intervention Follow-up|Pregnancy|0|||
147352188|NCT01785719|531459521|FG001|6-month Post-intervention Follow-up|Pregnancy|1|||
147352189|NCT01785719|531459520|FG000|6-month Post-intervention Follow-up|Exclusionary medication|0|||
147352190|NCT01785719|531459521|FG001|6-month Post-intervention Follow-up|Exclusionary medication|1|||
147352191|NCT03457142|531459522|FG000|Overall Study|Death|1|||
147352192|NCT01413100|531459523|FG000|Overall Study|Withdrawal by Subject|1|||
147453438|NCT03403205|531824010|FG002|Extension Period (Up to 60 Months)|Pregnancy|0|||
147453439|NCT03403205|531824011|FG003|Extension Period (Up to 60 Months)|Pregnancy|0|||
147352193|NCT03476187|531459530|FG000|Overall Study|Protocol Violation|7|||
147352194|NCT03476187|531459530|FG000|Overall Study|Physician Decision|5|||
147352195|NCT05875142|531459535|FG000|Overall Study|Lost to Follow-up|0|||
147352196|NCT05875142|531459536|FG001|Overall Study|Lost to Follow-up|1|||
147352197|NCT05875142|531459537|FG002|Overall Study|Lost to Follow-up|1|||
147352198|NCT03436290|531459538|FG000|Overall Study|Post-randomization Exclusion|1|||
147352199|NCT03436290|531459539|FG001|Overall Study|Post-randomization Exclusion|0|||
147352200|NCT03436290|531459538|FG000|Overall Study|Death|6|||
147352201|NCT03436290|531459539|FG001|Overall Study|Death|0|||
147352202|NCT03436290|531459538|FG000|Overall Study|Withdrawal by Subject|4|||
147352203|NCT03436290|531459539|FG001|Overall Study|Withdrawal by Subject|0|||
147352204|NCT03436290|531459538|FG000|Overall Study|Protocol Violation|30|||
147352205|NCT03436290|531459539|FG001|Overall Study|Protocol Violation|0|||
147352206|NCT03988608|531459540|FG000|Overall Study|Adverse Event|1|||
147352207|NCT03988608|531459540|FG000|Overall Study|Lost to Follow-up|1|||
147352208|NCT03988608|531459540|FG000|Overall Study|Withdrawal by Subject|3|||
147352209|NCT03988608|531459540|FG000|Overall Study|Death|1|||
147352210|NCT04142788|531459541|FG000|Overall Study|Trial terminated prematurely|2|||
147352211|NCT04142788|531459542|FG001|Overall Study|Trial terminated prematurely|2|||
147352212|NCT04256941|531459553|FG000|Overall Study|Withdrawal by Subject|0|||
147352213|NCT04256941|531459554|FG001|Overall Study|Withdrawal by Subject|1|||
147352214|NCT04256941|531459553|FG000|Overall Study|Death|1|||
147352215|NCT04256941|531459554|FG001|Overall Study|Death|0|||
147352216|NCT04256941|531459553|FG000|Overall Study|Disease Progession|0|||
147352217|NCT04256941|531459554|FG001|Overall Study|Disease Progession|2|||
147352218|NCT03766009|531459571|FG000|Usual Care|Death|0|||
147352219|NCT03766009|531459572|FG001|Usual Care|Death|0|||
147352220|NCT03766009|531459573|FG002|Usual Care|Death|0|||
147352221|NCT03766009|531459574|FG003|Usual Care|Death|1|||
147352222|NCT03766009|531459575|FG004|Usual Care|Death|0|||
147352223|NCT03766009|531459576|FG005|Usual Care|Death|0|||
147352224|NCT03766009|531459571|FG000|Usual Care|Lost to Follow-up|0|||
147352225|NCT03766009|531459572|FG001|Usual Care|Lost to Follow-up|0|||
147352226|NCT03766009|531459573|FG002|Usual Care|Lost to Follow-up|0|||
147352227|NCT03766009|531459574|FG003|Usual Care|Lost to Follow-up|1|||
147352228|NCT03766009|531459575|FG004|Usual Care|Lost to Follow-up|0|||
147352229|NCT03766009|531459576|FG005|Usual Care|Lost to Follow-up|0|||
147352230|NCT03766009|531459571|FG000|Usual Care|Treatment goals changed due to metastatic disease|0|||
147352231|NCT03766009|531459572|FG001|Usual Care|Treatment goals changed due to metastatic disease|0|||
147352232|NCT03766009|531459573|FG002|Usual Care|Treatment goals changed due to metastatic disease|2|||
147352233|NCT03766009|531459574|FG003|Usual Care|Treatment goals changed due to metastatic disease|0|||
147352234|NCT03766009|531459575|FG004|Usual Care|Treatment goals changed due to metastatic disease|1|||
147352235|NCT03766009|531459576|FG005|Usual Care|Treatment goals changed due to metastatic disease|0|||
147352236|NCT03766009|531459571|FG000|Usual Care|Transferred care/moved out of state, limited information on chart review|0|||
147352237|NCT03766009|531459572|FG001|Usual Care|Transferred care/moved out of state, limited information on chart review|1|||
147352238|NCT03766009|531459573|FG002|Usual Care|Transferred care/moved out of state, limited information on chart review|0|||
147352239|NCT03766009|531459574|FG003|Usual Care|Transferred care/moved out of state, limited information on chart review|1|||
147352240|NCT03766009|531459575|FG004|Usual Care|Transferred care/moved out of state, limited information on chart review|0|||
147352241|NCT03766009|531459576|FG005|Usual Care|Transferred care/moved out of state, limited information on chart review|0|||
147352242|NCT03766009|531459571|FG000|Usual Care|No treatment or declined surgery|0|||
147352243|NCT03766009|531459572|FG001|Usual Care|No treatment or declined surgery|0|||
147352244|NCT03766009|531459573|FG002|Usual Care|No treatment or declined surgery|0|||
147352245|NCT03766009|531459574|FG003|Usual Care|No treatment or declined surgery|2|||
147352246|NCT03766009|531459575|FG004|Usual Care|No treatment or declined surgery|0|||
147352247|NCT03766009|531459576|FG005|Usual Care|No treatment or declined surgery|0|||
147352248|NCT03766009|531459571|FG000|Usual Care|No surgery but had lymph node dissection instead|0|||
147352249|NCT03766009|531459572|FG001|Usual Care|No surgery but had lymph node dissection instead|0|||
147352250|NCT03766009|531459573|FG002|Usual Care|No surgery but had lymph node dissection instead|0|||
147352251|NCT03766009|531459574|FG003|Usual Care|No surgery but had lymph node dissection instead|1|||
147352252|NCT03766009|531459575|FG004|Usual Care|No surgery but had lymph node dissection instead|0|||
147352253|NCT03766009|531459576|FG005|Usual Care|No surgery but had lymph node dissection instead|0|||
147352254|NCT03766009|531459571|FG000|Usual Care|No surgery since patient had a good response to endocrine therapy|0|||
147352255|NCT03766009|531459572|FG001|Usual Care|No surgery since patient had a good response to endocrine therapy|1|||
147352256|NCT03766009|531459573|FG002|Usual Care|No surgery since patient had a good response to endocrine therapy|0|||
147352257|NCT03766009|531459574|FG003|Usual Care|No surgery since patient had a good response to endocrine therapy|0|||
147352258|NCT03766009|531459575|FG004|Usual Care|No surgery since patient had a good response to endocrine therapy|0|||
147352259|NCT03766009|531459576|FG005|Usual Care|No surgery since patient had a good response to endocrine therapy|0|||
147352260|NCT03766009|531459571|FG000|Usual Care|Ineligible|0|||
147352261|NCT03766009|531459572|FG001|Usual Care|Ineligible|1|||
147352262|NCT03766009|531459573|FG002|Usual Care|Ineligible|0|||
147352263|NCT03766009|531459574|FG003|Usual Care|Ineligible|0|||
147352264|NCT03766009|531459575|FG004|Usual Care|Ineligible|0|||
147352265|NCT03766009|531459576|FG005|Usual Care|Ineligible|0|||
147352266|NCT03766009|531459571|FG000|Usual Care|Other: Staff turnover|0|||
147352267|NCT03766009|531459572|FG001|Usual Care|Other: Staff turnover|0|||
147352268|NCT03766009|531459573|FG002|Usual Care|Other: Staff turnover|0|||
147352269|NCT03766009|531459574|FG003|Usual Care|Other: Staff turnover|0|||
147607296|NCT03713619|532377272|FG002|Treatment Period 2 (After Week 16)|Pregnancy|0|||
147607297|NCT03713619|532377273|FG003|Treatment Period 2 (After Week 16)|Pregnancy|1|||
147607298|NCT03713619|532377274|FG004|Treatment Period 2 (After Week 16)|Pregnancy|0|||
147352270|NCT03766009|531459575|FG004|Usual Care|Other: Staff turnover|0|||
147352271|NCT03766009|531459576|FG005|Usual Care|Other: Staff turnover|2|||
147352272|NCT03936322|531459578|FG000|Overall Study|Lost to Follow-up|1|||
147352273|NCT03936322|531459578|FG000|Overall Study|Infant Death after delivery; therefore, no further follow up occurred|1|||
147352274|NCT02734290|531459579|FG000|Overall Study|Adverse Event|1|||
147352275|NCT02734290|531459580|FG001|Overall Study|Adverse Event|0|||
147352276|NCT02734290|531459579|FG000|Overall Study|Death|1|||
147352277|NCT02734290|531459580|FG001|Overall Study|Death|0|||
147352278|NCT03829410|531459582|FG000|Overall Study|Adverse Event|1|||
147352279|NCT03829410|531459583|FG001|Overall Study|Adverse Event|0|||
147352280|NCT03829410|531459584|FG002|Overall Study|Adverse Event|1|||
147352281|NCT03829410|531459585|FG003|Overall Study|Adverse Event|4|||
147352282|NCT03829410|531459582|FG000|Overall Study|Physician Decision|0|||
147352283|NCT03829410|531459583|FG001|Overall Study|Physician Decision|0|||
147352284|NCT03829410|531459584|FG002|Overall Study|Physician Decision|0|||
147352285|NCT03829410|531459585|FG003|Overall Study|Physician Decision|2|||
147352286|NCT03829410|531459582|FG000|Overall Study|Disease Progressing|3|||
147352287|NCT03829410|531459583|FG001|Overall Study|Disease Progressing|4|||
147352288|NCT03829410|531459584|FG002|Overall Study|Disease Progressing|2|||
147352289|NCT03829410|531459585|FG003|Overall Study|Disease Progressing|31|||
147352290|NCT03829410|531459582|FG000|Overall Study|Miscellaneous|2|||
147352291|NCT03829410|531459583|FG001|Overall Study|Miscellaneous|4|||
147352292|NCT03829410|531459584|FG002|Overall Study|Miscellaneous|3|||
147352293|NCT03829410|531459585|FG003|Overall Study|Miscellaneous|10|||
147352294|NCT06205407|531459586|FG000|Period 2|Withdrawal by Subject|0|||
147352295|NCT06205407|531459587|FG001|Period 2|Withdrawal by Subject|1|||
147352296|NCT06205407|531459586|FG000|Period 2|Adverse Event|2|||
147352297|NCT06205407|531459587|FG001|Period 2|Adverse Event|1|||
147352298|NCT02962895|531459589|FG000|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|1|||
147352299|NCT02962895|531459590|FG001|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|1|||
147352300|NCT02962895|531459591|FG002|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|2|||
147352301|NCT02962895|531459592|FG003|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|0|||
147352302|NCT02962895|531459593|FG004|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|0|||
147352303|NCT02962895|531459594|FG005|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|0|||
147352304|NCT02962895|531459595|FG006|Period 2 (Randomized Set: Up to Week 24)|Withdrawal by Subject|0|||
147352305|NCT02962895|531459589|FG000|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|0|||
147352306|NCT02962895|531459590|FG001|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|1|||
147352307|NCT02962895|531459591|FG002|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|0|||
147352308|NCT02962895|531459592|FG003|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|0|||
147352309|NCT02962895|531459593|FG004|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|0|||
147352310|NCT02962895|531459594|FG005|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|0|||
147352311|NCT02962895|531459595|FG006|Period 2 (Randomized Set: Up to Week 24)|Withdrawal of Informed Consent|0|||
147352312|NCT02962895|531459589|FG000|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|0|||
147352313|NCT02962895|531459590|FG001|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|2|||
147352314|NCT02962895|531459591|FG002|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|2|||
147352315|NCT02962895|531459592|FG003|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|0|||
147352316|NCT02962895|531459593|FG004|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|0|||
147352317|NCT02962895|531459594|FG005|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|0|||
147352318|NCT02962895|531459595|FG006|Period 2 (Randomized Set: Up to Week 24)|Adverse Event|0|||
147352319|NCT02962895|531459589|FG000|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|1|||
147352320|NCT02962895|531459590|FG001|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|0|||
147352321|NCT02962895|531459591|FG002|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|0|||
147352322|NCT02962895|531459592|FG003|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|0|||
147352323|NCT02962895|531459593|FG004|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|0|||
147352324|NCT02962895|531459594|FG005|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|0|||
147352325|NCT02962895|531459595|FG006|Period 2 (Randomized Set: Up to Week 24)|New therapy for indication|0|||
147352326|NCT02962895|531459589|FG000|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|0|||
147352327|NCT02962895|531459590|FG001|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|1|||
147352328|NCT02962895|531459591|FG002|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|0|||
147607299|NCT03713619|532377270|FG000|Treatment Period 2 (After Week 16)|Withdrawal by Subject|26|||
147352329|NCT02962895|531459592|FG003|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|0|||
147352330|NCT02962895|531459593|FG004|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|0|||
147352331|NCT02962895|531459594|FG005|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|0|||
147352332|NCT02962895|531459595|FG006|Period 2 (Randomized Set: Up to Week 24)|Non-compliance with treatment|0|||
147352333|NCT02962895|531459589|FG000|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|0|||
147352334|NCT02962895|531459590|FG001|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|0|||
147352335|NCT02962895|531459591|FG002|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|0|||
147352336|NCT02962895|531459592|FG003|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|1|||
147352337|NCT02962895|531459593|FG004|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|0|||
147352338|NCT02962895|531459594|FG005|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|0|||
147352339|NCT02962895|531459595|FG006|Period 2 (Randomized Set: Up to Week 24)|Pregnancy|0|||
147352340|NCT02962895|531459589|FG000|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|0|||
147352341|NCT02962895|531459590|FG001|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|0|||
147352342|NCT02962895|531459591|FG002|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|0|||
147352343|NCT02962895|531459592|FG003|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|0|||
147352344|NCT02962895|531459593|FG004|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|0|||
147352345|NCT02962895|531459594|FG005|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|0|||
147352346|NCT02962895|531459595|FG006|Period 3 (Randomized Set / Weeks: 24-52)|Patient/guardian decision|1|||
147352347|NCT02962895|531459589|FG000|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|0|||
147352348|NCT02962895|531459590|FG001|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|0|||
147352349|NCT02962895|531459591|FG002|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|0|||
147352350|NCT02962895|531459592|FG003|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|0|||
147352351|NCT02962895|531459593|FG004|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|5|||
147352352|NCT02962895|531459594|FG005|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|0|||
147352353|NCT02962895|531459595|FG006|Period 3 (Randomized Set / Weeks: 24-52)|Adverse Event|2|||
147352354|NCT02962895|531459589|FG000|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|0|||
147352355|NCT02962895|531459590|FG001|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|0|||
147352356|NCT02962895|531459591|FG002|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|0|||
147352357|NCT02962895|531459592|FG003|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|0|||
147352358|NCT02962895|531459593|FG004|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|0|||
147352359|NCT02962895|531459594|FG005|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|0|||
147352360|NCT02962895|531459595|FG006|Period 3 (Randomized Set / Weeks: 24-52)|Pregnancy|1|||
147352361|NCT02962895|531459589|FG000|Period 4 (Safety Follow-Up)|Lack of Efficacy|0|||
147352362|NCT02962895|531459590|FG001|Period 4 (Safety Follow-Up)|Lack of Efficacy|1|||
147352363|NCT02962895|531459591|FG002|Period 4 (Safety Follow-Up)|Lack of Efficacy|0|||
147352364|NCT02962895|531459592|FG003|Period 4 (Safety Follow-Up)|Lack of Efficacy|0|||
147352365|NCT02962895|531459593|FG004|Period 4 (Safety Follow-Up)|Lack of Efficacy|0|||
147352366|NCT02962895|531459594|FG005|Period 4 (Safety Follow-Up)|Lack of Efficacy|0|||
147352367|NCT02962895|531459595|FG006|Period 4 (Safety Follow-Up)|Lack of Efficacy|0|||
147352368|NCT02962895|531459589|FG000|Period 4 (Safety Follow-Up)|Lost to Follow-up|0|||
147352369|NCT02962895|531459590|FG001|Period 4 (Safety Follow-Up)|Lost to Follow-up|0|||
147352370|NCT02962895|531459591|FG002|Period 4 (Safety Follow-Up)|Lost to Follow-up|0|||
147352371|NCT02962895|531459592|FG003|Period 4 (Safety Follow-Up)|Lost to Follow-up|0|||
147352372|NCT02962895|531459593|FG004|Period 4 (Safety Follow-Up)|Lost to Follow-up|1|||
147352373|NCT02962895|531459594|FG005|Period 4 (Safety Follow-Up)|Lost to Follow-up|0|||
147352374|NCT02962895|531459595|FG006|Period 4 (Safety Follow-Up)|Lost to Follow-up|0|||
147352375|NCT02962895|531459589|FG000|Period 4 (Safety Follow-Up)|New therapy for indication|0|||
147352376|NCT02962895|531459590|FG001|Period 4 (Safety Follow-Up)|New therapy for indication|0|||
147352377|NCT02962895|531459591|FG002|Period 4 (Safety Follow-Up)|New therapy for indication|0|||
147352378|NCT02962895|531459592|FG003|Period 4 (Safety Follow-Up)|New therapy for indication|0|||
147352379|NCT02962895|531459593|FG004|Period 4 (Safety Follow-Up)|New therapy for indication|1|||
147352380|NCT02962895|531459594|FG005|Period 4 (Safety Follow-Up)|New therapy for indication|0|||
147352381|NCT02962895|531459595|FG006|Period 4 (Safety Follow-Up)|New therapy for indication|0|||
147352382|NCT02962895|531459589|FG000|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|0|||
147352383|NCT02962895|531459590|FG001|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|3|||
147352384|NCT02962895|531459591|FG002|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|1|||
147352385|NCT02962895|531459592|FG003|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|2|||
147352386|NCT02962895|531459593|FG004|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|0|||
147352387|NCT02962895|531459594|FG005|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|0|||
147352388|NCT02962895|531459595|FG006|Period 4 (Safety Follow-Up)|Withdrawal of informed consent|0|||
147352389|NCT02962895|531459589|FG000|Period 4 (Safety Follow-Up)|Withdrawal by Subject|0|||
147352390|NCT02962895|531459590|FG001|Period 4 (Safety Follow-Up)|Withdrawal by Subject|2|||
147352391|NCT02962895|531459591|FG002|Period 4 (Safety Follow-Up)|Withdrawal by Subject|3|||
147352392|NCT02962895|531459592|FG003|Period 4 (Safety Follow-Up)|Withdrawal by Subject|1|||
147352393|NCT02962895|531459593|FG004|Period 4 (Safety Follow-Up)|Withdrawal by Subject|2|||
147352394|NCT02962895|531459594|FG005|Period 4 (Safety Follow-Up)|Withdrawal by Subject|2|||
147352395|NCT02962895|531459595|FG006|Period 4 (Safety Follow-Up)|Withdrawal by Subject|0|||
147352396|NCT02936752|531459596|FG000|Overall Study|Death|2|||
147352397|NCT02936752|531459597|FG001|Overall Study|Death|1|||
147352398|NCT02936752|531459596|FG000|Overall Study|Physician Decision|4|||
147352399|NCT02936752|531459597|FG001|Overall Study|Physician Decision|0|||
147352400|NCT02936752|531459596|FG000|Overall Study|Withdrawal by Subject|0|||
147352401|NCT02936752|531459597|FG001|Overall Study|Withdrawal by Subject|2|||
147352402|NCT05282173|531459610|FG000|Overall Study|Missed|3|||
147352403|NCT05282173|531459611|FG001|Overall Study|Missed|2|||
147352404|NCT05282173|531459612|FG002|Overall Study|Missed|4|||
147352405|NCT04719390|531459621|FG000|Overall Study|Withdrawal by Subject|1|||
147352406|NCT03307343|531459622|FG000|Overall Study|Withdrawal by Subject|1|||
147352407|NCT03307343|531459623|FG001|Overall Study|Withdrawal by Subject|2|||
147352408|NCT03307343|531459622|FG000|Overall Study|Pregnancy|0|||
147352409|NCT03307343|531459623|FG001|Overall Study|Pregnancy|2|||
147352410|NCT03307343|531459622|FG000|Overall Study|Physician Decision|1|||
147352411|NCT03307343|531459623|FG001|Overall Study|Physician Decision|0|||
147352412|NCT03307343|531459622|FG000|Overall Study|Lost to Follow-up|0|||
147352413|NCT03307343|531459623|FG001|Overall Study|Lost to Follow-up|2|||
147352414|NCT01798498|531459632|FG000|Overall Study|Lost to Follow-up|1|||
147352415|NCT01606215|531459634|FG000|Treatment to 1st Group - Placebo to 2nd|Failure to expand autologous mesenchymal stem cell product according to protocol specifications|4|||
147352416|NCT01606215|531459635|FG001|Treatment to 1st Group - Placebo to 2nd|Failure to expand autologous mesenchymal stem cell product according to protocol specifications|4|||
147352417|NCT04592549|531459636|FG000|Overall Study|Withdrawal by Subject|0|||
147352418|NCT04592549|531459637|FG001|Overall Study|Withdrawal by Subject|1|||
147352419|NCT04592549|531459638|FG002|Overall Study|Withdrawal by Subject|0|||
147352420|NCT04592549|531459639|FG003|Overall Study|Withdrawal by Subject|1|||
147352421|NCT04592549|531459640|FG004|Overall Study|Withdrawal by Subject|1|||
147352422|NCT04592549|531459641|FG005|Overall Study|Withdrawal by Subject|0|||
147352423|NCT04592549|531459636|FG000|Overall Study|Lost to Follow-up|2|||
147352424|NCT04592549|531459637|FG001|Overall Study|Lost to Follow-up|0|||
147352425|NCT04592549|531459638|FG002|Overall Study|Lost to Follow-up|0|||
147352426|NCT04592549|531459639|FG003|Overall Study|Lost to Follow-up|1|||
147352427|NCT04592549|531459640|FG004|Overall Study|Lost to Follow-up|1|||
147352428|NCT04592549|531459641|FG005|Overall Study|Lost to Follow-up|1|||
147352429|NCT01959425|531459642|FG000|Overall Study|Withdrawal by Subject|5|||
147352430|NCT01959425|531459643|FG001|Overall Study|Withdrawal by Subject|4|||
147352431|NCT01959425|531459642|FG000|Overall Study|Lost to Follow-up|1|||
147352432|NCT01959425|531459643|FG001|Overall Study|Lost to Follow-up|0|||
147352433|NCT01959425|531459642|FG000|Overall Study|Discontinued Subjects|6|||
147352434|NCT01959425|531459643|FG001|Overall Study|Discontinued Subjects|4|||
147352435|NCT01824394|531459646|FG000|Overall Study|Early Termination|1|||
147352436|NCT01824394|531459647|FG001|Overall Study|Early Termination|1|||
147352437|NCT01824394|531459648|FG002|Overall Study|Early Termination|3|||
147352438|NCT01824394|531459646|FG000|Overall Study|Withdrawn due to Study Termination|91|||
147352439|NCT01824394|531459647|FG001|Overall Study|Withdrawn due to Study Termination|83|||
147352440|NCT01824394|531459648|FG002|Overall Study|Withdrawn due to Study Termination|41|||
147352441|NCT01824394|531459646|FG000|Overall Study|Lost to Follow-up|0|||
147352442|NCT01824394|531459647|FG001|Overall Study|Lost to Follow-up|9|||
147352443|NCT01824394|531459648|FG002|Overall Study|Lost to Follow-up|3|||
147352444|NCT01824394|531459646|FG000|Overall Study|Death|3|||
147352445|NCT01824394|531459647|FG001|Overall Study|Death|2|||
147352446|NCT01824394|531459648|FG002|Overall Study|Death|4|||
147352447|NCT01824394|531459646|FG000|Overall Study|Discontinued Subjects|1|||
147352448|NCT01824394|531459647|FG001|Overall Study|Discontinued Subjects|1|||
147352449|NCT01824394|531459648|FG002|Overall Study|Discontinued Subjects|2|||
147352450|NCT01824394|531459646|FG000|Overall Study|Excluded Subjects(No catheter inserted)|23|||
147352451|NCT01824394|531459647|FG001|Overall Study|Excluded Subjects(No catheter inserted)|20|||
147453440|NCT03403205|531824012|FG004|Extension Period (Up to 60 Months)|Pregnancy|0|||
147453441|NCT03403205|531824013|FG005|Extension Period (Up to 60 Months)|Pregnancy|0|||
147453442|NCT03403205|531824008|FG000|Extension Period (Up to 60 Months)|Protocol Deviation|1|||
147453443|NCT03403205|531824009|FG001|Extension Period (Up to 60 Months)|Protocol Deviation|0|||
147453444|NCT03403205|531824010|FG002|Extension Period (Up to 60 Months)|Protocol Deviation|0|||
147453445|NCT03403205|531824011|FG003|Extension Period (Up to 60 Months)|Protocol Deviation|0|||
147453446|NCT03403205|531824012|FG004|Extension Period (Up to 60 Months)|Protocol Deviation|0|||
147453447|NCT03403205|531824013|FG005|Extension Period (Up to 60 Months)|Protocol Deviation|0|||
147453448|NCT03403205|531824008|FG000|Extension Period (Up to 60 Months)|Study Terminated by Sponsor|66|||
147352452|NCT01824394|531459648|FG002|Overall Study|Excluded Subjects(No catheter inserted)|21|||
147352453|NCT02619838|531459649|FG000|Overall Study|Lost to Follow-up|9|||
147352454|NCT02619838|531459649|FG000|Overall Study|Withdrawal by Subject|15|||
147352455|NCT05020249|531459650|FG000|Overall Study|Protocol Violation|1|||
147352456|NCT05020249|531459651|FG001|Overall Study|Protocol Violation|0|||
147352457|NCT05364671|531459652|FG000|Overall Study|Negative PCR result for SARS-CoV-2|20|||
147352458|NCT05364671|531459653|FG001|Overall Study|Negative PCR result for SARS-CoV-2|26|||
147607300|NCT03713619|532377271|FG001|Treatment Period 2 (After Week 16)|Withdrawal by Subject|20|||
147607301|NCT03713619|532377272|FG002|Treatment Period 2 (After Week 16)|Withdrawal by Subject|0|||
147607302|NCT03713619|532377273|FG003|Treatment Period 2 (After Week 16)|Withdrawal by Subject|10|||
147607303|NCT03713619|532377274|FG004|Treatment Period 2 (After Week 16)|Withdrawal by Subject|6|||
147607304|NCT03713619|532377270|FG000|Treatment Period 2 (After Week 16)|Poor efficacy|1|||
147607305|NCT03713619|532377271|FG001|Treatment Period 2 (After Week 16)|Poor efficacy|2|||
147607306|NCT03713619|532377272|FG002|Treatment Period 2 (After Week 16)|Poor efficacy|0|||
147607307|NCT03713619|532377273|FG003|Treatment Period 2 (After Week 16)|Poor efficacy|2|||
147607308|NCT03713619|532377274|FG004|Treatment Period 2 (After Week 16)|Poor efficacy|1|||
147607309|NCT03713619|532377270|FG000|Treatment Period 2 (After Week 16)|Lost to Follow-up|3|||
147607310|NCT03713619|532377271|FG001|Treatment Period 2 (After Week 16)|Lost to Follow-up|3|||
147607311|NCT03713619|532377272|FG002|Treatment Period 2 (After Week 16)|Lost to Follow-up|0|||
147607312|NCT03713619|532377273|FG003|Treatment Period 2 (After Week 16)|Lost to Follow-up|2|||
147607313|NCT03713619|532377274|FG004|Treatment Period 2 (After Week 16)|Lost to Follow-up|2|||
147607314|NCT03713619|532377270|FG000|Treatment Period 2 (After Week 16)|Physician Decision|0|||
147607315|NCT03713619|532377271|FG001|Treatment Period 2 (After Week 16)|Physician Decision|2|||
147607316|NCT03713619|532377272|FG002|Treatment Period 2 (After Week 16)|Physician Decision|0|||
147607317|NCT03713619|532377273|FG003|Treatment Period 2 (After Week 16)|Physician Decision|1|||
147607318|NCT03713619|532377274|FG004|Treatment Period 2 (After Week 16)|Physician Decision|1|||
147607319|NCT04642365|532377278|FG000|Overall Study|Death|3|||
147607320|NCT04642365|532377279|FG001|Overall Study|Death|2|||
147607321|NCT04642365|532377280|FG002|Overall Study|Death|4|||
147607322|NCT04642365|532377281|FG003|Overall Study|Death|5|||
147607323|NCT04642365|532377282|FG004|Overall Study|Death|5|||
147607324|NCT04642365|532377283|FG005|Overall Study|Death|3|||
147607325|NCT04642365|532377284|FG006|Overall Study|Death|2|||
147607326|NCT04642365|532377285|FG007|Overall Study|Death|1|||
147607327|NCT04642365|532377278|FG000|Overall Study|Physician Decision|1|||
147607328|NCT04642365|532377279|FG001|Overall Study|Physician Decision|0|||
147607329|NCT04642365|532377280|FG002|Overall Study|Physician Decision|0|||
147607330|NCT04642365|532377281|FG003|Overall Study|Physician Decision|0|||
147607331|NCT04642365|532377282|FG004|Overall Study|Physician Decision|0|||
147607332|NCT04642365|532377283|FG005|Overall Study|Physician Decision|0|||
147607333|NCT04642365|532377284|FG006|Overall Study|Physician Decision|0|||
147607334|NCT04642365|532377285|FG007|Overall Study|Physician Decision|0|||
147607335|NCT04642365|532377278|FG000|Overall Study|Progressive Disease|1|||
147352459|NCT05364671|531459652|FG000|Overall Study|Patient's inability or refusal to comply with protocol requirements|3|||
147352460|NCT05364671|531459653|FG001|Overall Study|Patient's inability or refusal to comply with protocol requirements|1|||
147352461|NCT05364671|531459652|FG000|Overall Study|Need to prescribe prohibited drugs in this study|1|||
147352462|NCT05364671|531459653|FG001|Overall Study|Need to prescribe prohibited drugs in this study|3|||
147352463|NCT05364671|531459652|FG000|Overall Study|Patient's desire to complete the study early due to treatment failure or any other reason|2|||
147352464|NCT05364671|531459653|FG001|Overall Study|Patient's desire to complete the study early due to treatment failure or any other reason|0|||
147352465|NCT05364671|531459652|FG000|Overall Study|Deviation from the schedule of face-to-face visits on more than 1 day|0|||
147352466|NCT05364671|531459653|FG001|Overall Study|Deviation from the schedule of face-to-face visits on more than 1 day|1|||
147352467|NCT03536754|531459656|FG000|Double Blind Period 1|Withdrawal by Subject|0|||
147352468|NCT03536754|531459657|FG001|Double Blind Period 1|Withdrawal by Subject|0|||
147352469|NCT03536754|531459658|FG002|Double Blind Period 1|Withdrawal by Subject|1|||
147352470|NCT03536754|531459659|FG003|Double Blind Period 1|Withdrawal by Subject|0|||
147352471|NCT03536754|531459660|FG004|Double Blind Period 1|Withdrawal by Subject|0|||
147352472|NCT03536754|531459656|FG000|Open Label Extension|Other|0|||
147352473|NCT03536754|531459657|FG001|Open Label Extension|Other|0|||
147352474|NCT03536754|531459658|FG002|Open Label Extension|Other|0|||
147352475|NCT03536754|531459659|FG003|Open Label Extension|Other|0|||
147352476|NCT03536754|531459660|FG004|Open Label Extension|Other|1|||
147352477|NCT04810650|531459664|FG000|Overall Study|Disenrolled in error|0|||
147352478|NCT04810650|531459665|FG001|Overall Study|Disenrolled in error|0|||
147352479|NCT04810650|531459666|FG002|Overall Study|Disenrolled in error|0|||
147352480|NCT04810650|531459667|FG003|Overall Study|Disenrolled in error|0|||
147352481|NCT04810650|531459668|FG004|Overall Study|Disenrolled in error|0|||
147352482|NCT04810650|531459669|FG005|Overall Study|Disenrolled in error|0|||
147352483|NCT04810650|531459670|FG006|Overall Study|Disenrolled in error|0|||
147352484|NCT04810650|531459671|FG007|Overall Study|Disenrolled in error|0|||
147352485|NCT04810650|531459672|FG008|Overall Study|Disenrolled in error|1|||
147352486|NCT04810650|531459673|FG009|Overall Study|Disenrolled in error|0|||
147607336|NCT04642365|532377279|FG001|Overall Study|Progressive Disease|1|||
147607337|NCT04642365|532377280|FG002|Overall Study|Progressive Disease|1|||
147607338|NCT04642365|532377281|FG003|Overall Study|Progressive Disease|0|||
147607339|NCT04642365|532377282|FG004|Overall Study|Progressive Disease|0|||
147607340|NCT04642365|532377283|FG005|Overall Study|Progressive Disease|0|||
147607341|NCT04642365|532377284|FG006|Overall Study|Progressive Disease|1|||
147352487|NCT04810650|531459674|FG010|Overall Study|Disenrolled in error|0|||
147352488|NCT04810650|531459675|FG011|Overall Study|Disenrolled in error|0|||
147352489|NCT04810650|531459676|FG012|Overall Study|Disenrolled in error|0|||
147352490|NCT04810650|531459677|FG013|Overall Study|Disenrolled in error|0|||
147352491|NCT04810650|531459664|FG000|Overall Study|Death|0|||
147352492|NCT04810650|531459665|FG001|Overall Study|Death|0|||
147352493|NCT04810650|531459666|FG002|Overall Study|Death|0|||
147352494|NCT04810650|531459667|FG003|Overall Study|Death|0|||
147352495|NCT04810650|531459668|FG004|Overall Study|Death|0|||
147352496|NCT04810650|531459669|FG005|Overall Study|Death|0|||
147352497|NCT04810650|531459670|FG006|Overall Study|Death|2|||
147352498|NCT04810650|531459671|FG007|Overall Study|Death|2|||
147352499|NCT04810650|531459672|FG008|Overall Study|Death|0|||
147352500|NCT04810650|531459673|FG009|Overall Study|Death|1|||
147352501|NCT04810650|531459674|FG010|Overall Study|Death|0|||
147352502|NCT04810650|531459675|FG011|Overall Study|Death|0|||
147352503|NCT04810650|531459676|FG012|Overall Study|Death|2|||
147352504|NCT04810650|531459677|FG013|Overall Study|Death|1|||
147352505|NCT04810650|531459664|FG000|Overall Study|Moved/transferred care|0|||
147352506|NCT04810650|531459665|FG001|Overall Study|Moved/transferred care|0|||
147352507|NCT04810650|531459666|FG002|Overall Study|Moved/transferred care|0|||
147352508|NCT04810650|531459667|FG003|Overall Study|Moved/transferred care|0|||
147352509|NCT04810650|531459668|FG004|Overall Study|Moved/transferred care|0|||
147352510|NCT04810650|531459669|FG005|Overall Study|Moved/transferred care|0|||
147352511|NCT04810650|531459670|FG006|Overall Study|Moved/transferred care|0|||
147352512|NCT04810650|531459671|FG007|Overall Study|Moved/transferred care|1|||
147352513|NCT04810650|531459672|FG008|Overall Study|Moved/transferred care|12|||
147352514|NCT04810650|531459673|FG009|Overall Study|Moved/transferred care|10|||
147352515|NCT04810650|531459674|FG010|Overall Study|Moved/transferred care|0|||
147352516|NCT04810650|531459675|FG011|Overall Study|Moved/transferred care|0|||
147352517|NCT04810650|531459676|FG012|Overall Study|Moved/transferred care|0|||
147352518|NCT04810650|531459677|FG013|Overall Study|Moved/transferred care|0|||
147352519|NCT04810650|531459664|FG000|Overall Study|Lost to Follow-up|15|||
147352520|NCT04810650|531459665|FG001|Overall Study|Lost to Follow-up|12|||
147352521|NCT04810650|531459666|FG002|Overall Study|Lost to Follow-up|7|||
147352522|NCT04810650|531459667|FG003|Overall Study|Lost to Follow-up|9|||
147352523|NCT04810650|531459668|FG004|Overall Study|Lost to Follow-up|10|||
147352524|NCT04810650|531459669|FG005|Overall Study|Lost to Follow-up|6|||
147352525|NCT04810650|531459670|FG006|Overall Study|Lost to Follow-up|0|||
147352526|NCT04810650|531459671|FG007|Overall Study|Lost to Follow-up|0|||
147352527|NCT04810650|531459672|FG008|Overall Study|Lost to Follow-up|0|||
147352528|NCT04810650|531459673|FG009|Overall Study|Lost to Follow-up|0|||
147352529|NCT04810650|531459674|FG010|Overall Study|Lost to Follow-up|1|||
147352530|NCT04810650|531459675|FG011|Overall Study|Lost to Follow-up|0|||
147352531|NCT04810650|531459676|FG012|Overall Study|Lost to Follow-up|3|||
147352532|NCT04810650|531459677|FG013|Overall Study|Lost to Follow-up|9|||
147352533|NCT04810650|531459664|FG000|Overall Study|Participant declined|0|||
147352534|NCT04810650|531459665|FG001|Overall Study|Participant declined|0|||
147352535|NCT04810650|531459666|FG002|Overall Study|Participant declined|0|||
147352536|NCT04810650|531459667|FG003|Overall Study|Participant declined|0|||
147352537|NCT04810650|531459668|FG004|Overall Study|Participant declined|0|||
147352538|NCT04810650|531459669|FG005|Overall Study|Participant declined|0|||
147352539|NCT04810650|531459670|FG006|Overall Study|Participant declined|0|||
147352540|NCT04810650|531459671|FG007|Overall Study|Participant declined|0|||
147352541|NCT04810650|531459672|FG008|Overall Study|Participant declined|0|||
147352542|NCT04810650|531459673|FG009|Overall Study|Participant declined|0|||
147352543|NCT04810650|531459674|FG010|Overall Study|Participant declined|2|||
147352544|NCT04810650|531459675|FG011|Overall Study|Participant declined|0|||
147352545|NCT04810650|531459676|FG012|Overall Study|Participant declined|0|||
147352546|NCT04810650|531459677|FG013|Overall Study|Participant declined|0|||
147352547|NCT05794243|531459678|FG000|Overall Study|Withdrawal by Subject|1|||
147352548|NCT05794243|531459679|FG001|Overall Study|Withdrawal by Subject|0|||
147352549|NCT05794243|531459680|FG002|Overall Study|Withdrawal by Subject|1|||
147352550|NCT05794243|531459678|FG000|Overall Study|Physician Decision|0|||
147352551|NCT05794243|531459679|FG001|Overall Study|Physician Decision|3|||
147352552|NCT05794243|531459680|FG002|Overall Study|Physician Decision|1|||
147352553|NCT00686335|531459681|FG000|Run-in Period|Adverse Event|1|||
147352554|NCT00686335|531459681|FG000|Run-in Period|asthma exacerbation|1|||
147352555|NCT00686335|531459681|FG000|Run-in Period|violation of inclusion/exclusion criteri|3|||
147352556|NCT04652700|531459684|FG000|Part 1: Blinded Study Medication|Adverse Event|1|||
147352557|NCT04652700|531459685|FG001|Part 1: Blinded Study Medication|Adverse Event|0|||
147352558|NCT04652700|531459684|FG000|Part 1: Blinded Study Medication|Lost to Follow-up|7|||
147352559|NCT04652700|531459685|FG001|Part 1: Blinded Study Medication|Lost to Follow-up|2|||
147352560|NCT04652700|531459684|FG000|Part 1: Blinded Study Medication|Multiple reasons (primarily discontinuation of blinded treatment)|308|||
147352561|NCT04652700|531459685|FG001|Part 1: Blinded Study Medication|Multiple reasons (primarily discontinuation of blinded treatment)|160|||
147352562|NCT04652700|531459684|FG000|Part 1: Blinded Study Medication|Withdrawal by Subject|12|||
147352563|NCT04652700|531459685|FG001|Part 1: Blinded Study Medication|Withdrawal by Subject|4|||
147352564|NCT04652700|531459684|FG000|Parts 2 and 3: Open-Label FTC TDF or TAF|Lost to Follow-up|34|||
147352565|NCT04652700|531459685|FG001|Parts 2 and 3: Open-Label FTC TDF or TAF|Lost to Follow-up|9|||
147352566|NCT04652700|531459684|FG000|Parts 2 and 3: Open-Label FTC TDF or TAF|Not reported|6|||
147352567|NCT04652700|531459685|FG001|Parts 2 and 3: Open-Label FTC TDF or TAF|Not reported|1|||
147352568|NCT04652700|531459684|FG000|Parts 2 and 3: Open-Label FTC TDF or TAF|Physician Decision|0|||
147352569|NCT04652700|531459685|FG001|Parts 2 and 3: Open-Label FTC TDF or TAF|Physician Decision|2|||
147352570|NCT04652700|531459684|FG000|Parts 2 and 3: Open-Label FTC TDF or TAF|Study terminated by Sponsor|227|||
147352571|NCT04652700|531459685|FG001|Parts 2 and 3: Open-Label FTC TDF or TAF|Study terminated by Sponsor|119|||
147352572|NCT04652700|531459684|FG000|Parts 2 and 3: Open-Label FTC TDF or TAF|Withdrawal by Subject|39|||
147352573|NCT04652700|531459685|FG001|Parts 2 and 3: Open-Label FTC TDF or TAF|Withdrawal by Subject|23|||
147352574|NCT04187833|531459686|FG000|Overall Study|Withdrawal by Subject|1|||
147352575|NCT04209465|531459689|FG000|Overall Study|Adverse Event|0|||
147352576|NCT04209465|531459690|FG001|Overall Study|Adverse Event|0|||
147352577|NCT04209465|531459691|FG002|Overall Study|Adverse Event|0|||
147352578|NCT04209465|531459692|FG003|Overall Study|Adverse Event|0|||
147352579|NCT04209465|531459693|FG004|Overall Study|Adverse Event|0|||
147352580|NCT04209465|531459694|FG005|Overall Study|Adverse Event|1|||
147352581|NCT04209465|531459695|FG006|Overall Study|Adverse Event|0|||
147352582|NCT04209465|531459696|FG007|Overall Study|Adverse Event|0|||
147352583|NCT04209465|531459697|FG008|Overall Study|Adverse Event|1|||
147352584|NCT04209465|531459698|FG009|Overall Study|Adverse Event|0|||
147352585|NCT04209465|531459699|FG010|Overall Study|Adverse Event|2|||
147352586|NCT04209465|531459700|FG011|Overall Study|Adverse Event|1|||
147352587|NCT04209465|531459701|FG012|Overall Study|Adverse Event|1|||
147352588|NCT04209465|531459689|FG000|Overall Study|Death|1|||
147352589|NCT04209465|531459690|FG001|Overall Study|Death|0|||
147352590|NCT04209465|531459691|FG002|Overall Study|Death|0|||
147352591|NCT04209465|531459692|FG003|Overall Study|Death|0|||
147352592|NCT04209465|531459693|FG004|Overall Study|Death|2|||
147352593|NCT04209465|531459694|FG005|Overall Study|Death|7|||
147352594|NCT04209465|531459695|FG006|Overall Study|Death|2|||
147352595|NCT04209465|531459696|FG007|Overall Study|Death|2|||
147352596|NCT04209465|531459697|FG008|Overall Study|Death|1|||
147352597|NCT04209465|531459698|FG009|Overall Study|Death|1|||
147352598|NCT04209465|531459699|FG010|Overall Study|Death|1|||
147352599|NCT04209465|531459700|FG011|Overall Study|Death|0|||
147352600|NCT04209465|531459701|FG012|Overall Study|Death|10|||
147352601|NCT04209465|531459689|FG000|Overall Study|Physician Decision|0|||
147352602|NCT04209465|531459690|FG001|Overall Study|Physician Decision|1|||
147352603|NCT04209465|531459691|FG002|Overall Study|Physician Decision|0|||
147352604|NCT04209465|531459692|FG003|Overall Study|Physician Decision|0|||
147352605|NCT04209465|531459693|FG004|Overall Study|Physician Decision|0|||
147352606|NCT04209465|531459694|FG005|Overall Study|Physician Decision|0|||
147352607|NCT04209465|531459695|FG006|Overall Study|Physician Decision|0|||
147352608|NCT04209465|531459696|FG007|Overall Study|Physician Decision|0|||
147352609|NCT04209465|531459697|FG008|Overall Study|Physician Decision|0|||
147352610|NCT04209465|531459698|FG009|Overall Study|Physician Decision|0|||
147352611|NCT04209465|531459699|FG010|Overall Study|Physician Decision|0|||
147352612|NCT04209465|531459700|FG011|Overall Study|Physician Decision|0|||
147352613|NCT04209465|531459701|FG012|Overall Study|Physician Decision|0|||
147352614|NCT04209465|531459689|FG000|Overall Study|Progressive Disease|0|||
147352615|NCT04209465|531459690|FG001|Overall Study|Progressive Disease|0|||
147352616|NCT04209465|531459691|FG002|Overall Study|Progressive Disease|1|||
147352617|NCT04209465|531459692|FG003|Overall Study|Progressive Disease|2|||
147352618|NCT04209465|531459693|FG004|Overall Study|Progressive Disease|8|||
147352619|NCT04209465|531459694|FG005|Overall Study|Progressive Disease|5|||
147352620|NCT04209465|531459695|FG006|Overall Study|Progressive Disease|3|||
147352621|NCT04209465|531459696|FG007|Overall Study|Progressive Disease|4|||
147352622|NCT04209465|531459697|FG008|Overall Study|Progressive Disease|1|||
147352623|NCT04209465|531459698|FG009|Overall Study|Progressive Disease|3|||
147352624|NCT04209465|531459699|FG010|Overall Study|Progressive Disease|2|||
147352625|NCT04209465|531459700|FG011|Overall Study|Progressive Disease|1|||
147352626|NCT04209465|531459701|FG012|Overall Study|Progressive Disease|0|||
147352627|NCT04209465|531459689|FG000|Overall Study|Withdrawal by Subject|0|||
147352628|NCT04209465|531459690|FG001|Overall Study|Withdrawal by Subject|0|||
147352629|NCT04209465|531459691|FG002|Overall Study|Withdrawal by Subject|0|||
147352630|NCT04209465|531459692|FG003|Overall Study|Withdrawal by Subject|0|||
147352631|NCT04209465|531459693|FG004|Overall Study|Withdrawal by Subject|0|||
147352632|NCT04209465|531459694|FG005|Overall Study|Withdrawal by Subject|1|||
147352633|NCT04209465|531459695|FG006|Overall Study|Withdrawal by Subject|2|||
147352634|NCT04209465|531459696|FG007|Overall Study|Withdrawal by Subject|0|||
147352635|NCT04209465|531459697|FG008|Overall Study|Withdrawal by Subject|1|||
147352636|NCT04209465|531459698|FG009|Overall Study|Withdrawal by Subject|0|||
147352637|NCT04209465|531459699|FG010|Overall Study|Withdrawal by Subject|0|||
147352638|NCT04209465|531459700|FG011|Overall Study|Withdrawal by Subject|2|||
147352639|NCT04209465|531459701|FG012|Overall Study|Withdrawal by Subject|2|||
147352640|NCT04209465|531459689|FG000|Overall Study|Lost to Follow-up|0|||
147352641|NCT04209465|531459690|FG001|Overall Study|Lost to Follow-up|0|||
147352642|NCT04209465|531459691|FG002|Overall Study|Lost to Follow-up|0|||
147607342|NCT04642365|532377285|FG007|Overall Study|Progressive Disease|0|||
147607343|NCT04642365|532377278|FG000|Overall Study|Study Terminated By Sponsor|0|||
147607344|NCT04642365|532377279|FG001|Overall Study|Study Terminated By Sponsor|2|||
147607345|NCT04642365|532377280|FG002|Overall Study|Study Terminated By Sponsor|1|||
147607346|NCT04642365|532377281|FG003|Overall Study|Study Terminated By Sponsor|1|||
147607347|NCT04642365|532377282|FG004|Overall Study|Study Terminated By Sponsor|1|||
147607348|NCT04642365|532377283|FG005|Overall Study|Study Terminated By Sponsor|2|||
147607349|NCT04642365|532377284|FG006|Overall Study|Study Terminated By Sponsor|2|||
147607350|NCT04642365|532377285|FG007|Overall Study|Study Terminated By Sponsor|1|||
147607351|NCT04642365|532377278|FG000|Overall Study|Symptomatic Deterioration|1|||
147607352|NCT04642365|532377279|FG001|Overall Study|Symptomatic Deterioration|1|||
147607353|NCT04642365|532377280|FG002|Overall Study|Symptomatic Deterioration|0|||
147607354|NCT04642365|532377281|FG003|Overall Study|Symptomatic Deterioration|0|||
147607355|NCT04642365|532377282|FG004|Overall Study|Symptomatic Deterioration|0|||
147352643|NCT04209465|531459692|FG003|Overall Study|Lost to Follow-up|0|||
147352644|NCT04209465|531459693|FG004|Overall Study|Lost to Follow-up|0|||
147352645|NCT04209465|531459694|FG005|Overall Study|Lost to Follow-up|1|||
147352646|NCT04209465|531459695|FG006|Overall Study|Lost to Follow-up|0|||
147352647|NCT04209465|531459696|FG007|Overall Study|Lost to Follow-up|0|||
147352648|NCT04209465|531459697|FG008|Overall Study|Lost to Follow-up|1|||
147352649|NCT04209465|531459698|FG009|Overall Study|Lost to Follow-up|0|||
147352650|NCT04209465|531459699|FG010|Overall Study|Lost to Follow-up|0|||
147352651|NCT04209465|531459700|FG011|Overall Study|Lost to Follow-up|1|||
147352652|NCT04209465|531459701|FG012|Overall Study|Lost to Follow-up|0|||
147352653|NCT04209465|531459689|FG000|Overall Study|Started new therapy|0|||
147352654|NCT04209465|531459690|FG001|Overall Study|Started new therapy|0|||
147352655|NCT04209465|531459691|FG002|Overall Study|Started new therapy|0|||
147352656|NCT04209465|531459692|FG003|Overall Study|Started new therapy|0|||
147352657|NCT04209465|531459693|FG004|Overall Study|Started new therapy|0|||
147352658|NCT04209465|531459694|FG005|Overall Study|Started new therapy|1|||
147352659|NCT04209465|531459695|FG006|Overall Study|Started new therapy|0|||
147352660|NCT04209465|531459696|FG007|Overall Study|Started new therapy|0|||
147352661|NCT04209465|531459697|FG008|Overall Study|Started new therapy|0|||
147352662|NCT04209465|531459698|FG009|Overall Study|Started new therapy|0|||
147352663|NCT04209465|531459699|FG010|Overall Study|Started new therapy|0|||
147352664|NCT04209465|531459700|FG011|Overall Study|Started new therapy|0|||
147352665|NCT04209465|531459701|FG012|Overall Study|Started new therapy|0|||
147352666|NCT04209465|531459689|FG000|Overall Study|Study terminated early by sponsor|0|||
147352667|NCT04209465|531459690|FG001|Overall Study|Study terminated early by sponsor|0|||
147352668|NCT04209465|531459691|FG002|Overall Study|Study terminated early by sponsor|0|||
147352669|NCT04209465|531459692|FG003|Overall Study|Study terminated early by sponsor|0|||
147352670|NCT04209465|531459693|FG004|Overall Study|Study terminated early by sponsor|0|||
147352671|NCT04209465|531459694|FG005|Overall Study|Study terminated early by sponsor|0|||
147352672|NCT04209465|531459695|FG006|Overall Study|Study terminated early by sponsor|3|||
147352673|NCT04209465|531459696|FG007|Overall Study|Study terminated early by sponsor|0|||
147352674|NCT04209465|531459697|FG008|Overall Study|Study terminated early by sponsor|0|||
147352675|NCT04209465|531459698|FG009|Overall Study|Study terminated early by sponsor|0|||
147352676|NCT04209465|531459699|FG010|Overall Study|Study terminated early by sponsor|0|||
147352677|NCT04209465|531459700|FG011|Overall Study|Study terminated early by sponsor|0|||
147352678|NCT04209465|531459701|FG012|Overall Study|Study terminated early by sponsor|3|||
147352679|NCT04209465|531459689|FG000|Overall Study|Other|0|||
147352680|NCT04209465|531459690|FG001|Overall Study|Other|0|||
147352681|NCT04209465|531459691|FG002|Overall Study|Other|0|||
147352682|NCT04209465|531459692|FG003|Overall Study|Other|0|||
147352683|NCT04209465|531459693|FG004|Overall Study|Other|0|||
147352684|NCT04209465|531459694|FG005|Overall Study|Other|0|||
147352685|NCT04209465|531459695|FG006|Overall Study|Other|0|||
147352686|NCT04209465|531459696|FG007|Overall Study|Other|0|||
147352687|NCT04209465|531459697|FG008|Overall Study|Other|1|||
147352688|NCT04209465|531459698|FG009|Overall Study|Other|0|||
147352689|NCT04209465|531459699|FG010|Overall Study|Other|0|||
147352690|NCT04209465|531459700|FG011|Overall Study|Other|0|||
147607356|NCT04642365|532377283|FG005|Overall Study|Symptomatic Deterioration|1|||
147662755|NCT04010461|532587417|FG000|Overall Study|Withdrawal by Subject|5|||
147662756|NCT04010461|532587417|FG000|Overall Study|Adverse Event|1|||
147352691|NCT04209465|531459701|FG012|Overall Study|Other|0|||
147352692|NCT03097549|531459702|FG000|Overall Study|Withdrawal by Subject|1|||
147352693|NCT03097549|531459703|FG001|Overall Study|Withdrawal by Subject|0|||
147352694|NCT03097549|531459702|FG000|Overall Study|Lost to Follow-up|1|||
147352695|NCT03097549|531459703|FG001|Overall Study|Lost to Follow-up|0|||
147352696|NCT02921230|531461630|FG000|Overall Study|Withdrawal by Subject|20|||
147352697|NCT02921230|531461631|FG001|Overall Study|Withdrawal by Subject|8|||
147352698|NCT02921230|531461630|FG000|Overall Study|Death|12|||
147352699|NCT02921230|531461631|FG001|Overall Study|Death|3|||
147607357|NCT04642365|532377284|FG006|Overall Study|Symptomatic Deterioration|0|||
147352700|NCT02921230|531461630|FG000|Overall Study|Protocol Violation|17|||
147352701|NCT02921230|531461631|FG001|Overall Study|Protocol Violation|6|||
147352702|NCT02921230|531461630|FG000|Overall Study|Early completion|5|||
147607358|NCT04642365|532377285|FG007|Overall Study|Symptomatic Deterioration|0|||
147607359|NCT04642365|532377278|FG000|Overall Study|Withdrawal by Subject|0|||
147607360|NCT04642365|532377279|FG001|Overall Study|Withdrawal by Subject|0|||
147607361|NCT04642365|532377280|FG002|Overall Study|Withdrawal by Subject|1|||
147352703|NCT02921230|531461631|FG001|Overall Study|Early completion|1|||
147352704|NCT02921230|531461630|FG000|Overall Study|Pending data entry|1|||
147352705|NCT02921230|531461631|FG001|Overall Study|Pending data entry|0|||
147352706|NCT04977947|531461632|FG000|Overall Study|Lost to Follow-up|1|||
147352707|NCT04977947|531461633|FG001|Overall Study|Lost to Follow-up|1|||
147352708|NCT03338933|531461634|FG000|Screening Visit|Lost to Follow-up|1|||
147352709|NCT03338933|531461635|FG001|Screening Visit|Lost to Follow-up|3|||
147352710|NCT03338933|531461636|FG002|Screening Visit|Lost to Follow-up|1|||
147352711|NCT03338933|531461637|FG003|Screening Visit|Lost to Follow-up|4|||
147352712|NCT03338933|531461634|FG000|Screening Visit|Screen fail after consent|2|||
147352713|NCT03338933|531461635|FG001|Screening Visit|Screen fail after consent|7|||
147352714|NCT03338933|531461636|FG002|Screening Visit|Screen fail after consent|1|||
147352715|NCT03338933|531461637|FG003|Screening Visit|Screen fail after consent|4|||
147352716|NCT03338933|531461634|FG000|Check-In Visit (Alcohol Groups Only)|Lost to Follow-up|0|||
147352717|NCT03338933|531461635|FG001|Check-In Visit (Alcohol Groups Only)|Lost to Follow-up|0|||
147352718|NCT03338933|531461636|FG002|Check-In Visit (Alcohol Groups Only)|Lost to Follow-up|2|||
147352719|NCT03338933|531461637|FG003|Check-In Visit (Alcohol Groups Only)|Lost to Follow-up|9|||
147352720|NCT03338933|531461634|FG000|Check-In Visit (Alcohol Groups Only)|Deemed no longer eligible due to changes in health|0|||
147352721|NCT03338933|531461635|FG001|Check-In Visit (Alcohol Groups Only)|Deemed no longer eligible due to changes in health|0|||
147352722|NCT03338933|531461636|FG002|Check-In Visit (Alcohol Groups Only)|Deemed no longer eligible due to changes in health|1|||
147352723|NCT03338933|531461637|FG003|Check-In Visit (Alcohol Groups Only)|Deemed no longer eligible due to changes in health|1|||
147352724|NCT03338933|531461634|FG000|Follow-up Visit (Alcohol Groups Only)|Could not complete in-person items due to COVID-19 shutdown|0|||
147352725|NCT03338933|531461635|FG001|Follow-up Visit (Alcohol Groups Only)|Could not complete in-person items due to COVID-19 shutdown|0|||
147352726|NCT03338933|531461636|FG002|Follow-up Visit (Alcohol Groups Only)|Could not complete in-person items due to COVID-19 shutdown|1|||
147352727|NCT03338933|531461637|FG003|Follow-up Visit (Alcohol Groups Only)|Could not complete in-person items due to COVID-19 shutdown|2|||
147352728|NCT01396278|531461638|FG000|Overall Study|Adverse Event|0|||
147352729|NCT01396278|531461639|FG001|Overall Study|Adverse Event|0|||
147352730|NCT01396278|531461640|FG002|Overall Study|Adverse Event|0|||
147352731|NCT01396278|531461641|FG003|Overall Study|Adverse Event|2|||
147352732|NCT01396278|531461642|FG004|Overall Study|Adverse Event|0|||
147352733|NCT01396278|531461638|FG000|Overall Study|Withdraw due to trial termination|2|||
147352734|NCT01396278|531461639|FG001|Overall Study|Withdraw due to trial termination|1|||
147352735|NCT01396278|531461640|FG002|Overall Study|Withdraw due to trial termination|1|||
147352736|NCT01396278|531461641|FG003|Overall Study|Withdraw due to trial termination|0|||
147352737|NCT01396278|531461642|FG004|Overall Study|Withdraw due to trial termination|2|||
147352738|NCT04515576|531461643|FG000|Overall Study|Withdrawal by Subject|0|||
147352739|NCT04515576|531461644|FG001|Overall Study|Withdrawal by Subject|0|||
147352740|NCT04515576|531461645|FG002|Overall Study|Withdrawal by Subject|0|||
147352741|NCT04515576|531461646|FG003|Overall Study|Withdrawal by Subject|0|||
147352742|NCT04515576|531461647|FG004|Overall Study|Withdrawal by Subject|0|||
147352743|NCT04515576|531461648|FG005|Overall Study|Withdrawal by Subject|1|||
147352744|NCT00999804|531461649|FG000|Overall Study|Lack of Efficacy|9|||
147352745|NCT00999804|531461650|FG001|Overall Study|Lack of Efficacy|2|||
147352746|NCT00999804|531461649|FG000|Overall Study|Adverse Event|4|||
147352747|NCT00999804|531461650|FG001|Overall Study|Adverse Event|3|||
147352748|NCT00999804|531461649|FG000|Overall Study|Withdrawal by Subject|4|||
147352749|NCT00999804|531461650|FG001|Overall Study|Withdrawal by Subject|0|||
147352750|NCT00999804|531461649|FG000|Overall Study|Death|1|||
147352751|NCT00999804|531461650|FG001|Overall Study|Death|0|||
147352752|NCT00999804|531461649|FG000|Overall Study|Ineligible|3|||
147352753|NCT00999804|531461650|FG001|Overall Study|Ineligible|0|||
147352754|NCT05653427|531461651|FG000|Overall Study|Study Terminated by Sponsor|13|||
147352755|NCT03891667|531461655|FG000|Overall Study|Physician Decision|1|||
147352756|NCT03891667|531461656|FG001|Overall Study|Physician Decision|1|||
147352757|NCT03891667|531461655|FG000|Overall Study|COVID related pause|1|||
147352758|NCT03891667|531461656|FG001|Overall Study|COVID related pause|0|||
147453449|NCT03403205|531824009|FG001|Extension Period (Up to 60 Months)|Study Terminated by Sponsor|32|||
147607362|NCT04642365|532377281|FG003|Overall Study|Withdrawal by Subject|1|||
147607363|NCT04642365|532377282|FG004|Overall Study|Withdrawal by Subject|0|||
147607364|NCT04642365|532377283|FG005|Overall Study|Withdrawal by Subject|0|||
147607365|NCT04642365|532377284|FG006|Overall Study|Withdrawal by Subject|2|||
147607366|NCT04642365|532377285|FG007|Overall Study|Withdrawal by Subject|0|||
147352759|NCT03891667|531461655|FG000|Overall Study|Withdrawal by Subject|0|||
147352760|NCT03891667|531461656|FG001|Overall Study|Withdrawal by Subject|1|||
147352761|NCT03891667|531461655|FG000|Overall Study|Adverse Event|0|||
147352762|NCT03891667|531461656|FG001|Overall Study|Adverse Event|1|||
147607367|NCT04642365|532377278|FG000|Overall Study|Adverse Event|0|||
147607368|NCT04642365|532377279|FG001|Overall Study|Adverse Event|0|||
147607369|NCT04642365|532377280|FG002|Overall Study|Adverse Event|0|||
147453450|NCT03403205|531824010|FG002|Extension Period (Up to 60 Months)|Study Terminated by Sponsor|21|||
147352763|NCT05590403|531461660|FG000|Overall Study|Lost to Follow-up|13|||
147352764|NCT05590403|531461661|FG001|Overall Study|Lost to Follow-up|1|||
147352765|NCT05590403|531461662|FG002|Overall Study|Lost to Follow-up|7|||
147352766|NCT05590403|531461663|FG003|Overall Study|Lost to Follow-up|3|||
147352767|NCT05590403|531461664|FG004|Overall Study|Lost to Follow-up|4|||
147352768|NCT05590403|531461660|FG000|Overall Study|Consent withdrawal, not due to a (S)AE|4|||
147352769|NCT05590403|531461661|FG001|Overall Study|Consent withdrawal, not due to a (S)AE|6|||
147352770|NCT05590403|531461662|FG002|Overall Study|Consent withdrawal, not due to a (S)AE|4|||
147352771|NCT05590403|531461663|FG003|Overall Study|Consent withdrawal, not due to a (S)AE|2|||
147352772|NCT05590403|531461664|FG004|Overall Study|Consent withdrawal, not due to a (S)AE|7|||
147352773|NCT05590403|531461660|FG000|Overall Study|Other|2|||
147352774|NCT05590403|531461661|FG001|Overall Study|Other|0|||
147352775|NCT05590403|531461662|FG002|Overall Study|Other|2|||
147352776|NCT05590403|531461663|FG003|Overall Study|Other|2|||
147352777|NCT05590403|531461664|FG004|Overall Study|Other|0|||
147352778|NCT05590403|531461660|FG000|Overall Study|Migrated / moved from the study area|1|||
147352779|NCT05590403|531461661|FG001|Overall Study|Migrated / moved from the study area|1|||
147352780|NCT05590403|531461662|FG002|Overall Study|Migrated / moved from the study area|0|||
147352781|NCT05590403|531461663|FG003|Overall Study|Migrated / moved from the study area|3|||
147352782|NCT05590403|531461664|FG004|Overall Study|Migrated / moved from the study area|1|||
147352783|NCT05590403|531461660|FG000|Overall Study|Adverse event requiring expedited reporting|0|||
147352784|NCT05590403|531461661|FG001|Overall Study|Adverse event requiring expedited reporting|0|||
147352785|NCT05590403|531461662|FG002|Overall Study|Adverse event requiring expedited reporting|4|||
147352786|NCT05590403|531461663|FG003|Overall Study|Adverse event requiring expedited reporting|1|||
147352787|NCT05590403|531461664|FG004|Overall Study|Adverse event requiring expedited reporting|0|||
147352788|NCT05659537|531461665|FG000|Overall Study|Adverse Event|5|||
147352789|NCT05659537|531461665|FG000|Overall Study|Lost to Follow-up|4|||
147352790|NCT05659537|531461665|FG000|Overall Study|Withdrawal by Subject|13|||
147352791|NCT05659537|531461665|FG000|Overall Study|Migration from the Study Site Such That Follow Up Visits are not Possible|3|||
147352792|NCT05659537|531461665|FG000|Overall Study|Participant had low absolute neutrophil count value|1|||
147352793|NCT05659537|531461665|FG000|Overall Study|Participant was suffering from anaemia|1|||
147352794|NCT04717492|531461669|FG000|Overall Study|Withdrawal by Subject|2|||
147352795|NCT04717492|531461670|FG001|Overall Study|Withdrawal by Subject|13|||
147352796|NCT04717492|531461669|FG000|Overall Study|Lost to Follow-up|2|||
147352797|NCT04717492|531461670|FG001|Overall Study|Lost to Follow-up|9|||
147352798|NCT04456517|531461671|FG000|First Intervention:Baseline to 12 Weeks|Adverse Event|0|||
147352799|NCT04456517|531461672|FG001|First Intervention:Baseline to 12 Weeks|Adverse Event|1|||
147352800|NCT03575897|531461673|FG000|Overall Study|Lost to Follow-up|12|||
147352801|NCT03575897|531461674|FG001|Overall Study|Lost to Follow-up|13|||
147352802|NCT01160211|531461676|FG000|Overall Study|Subject Reached Protocol-Defined Stopping Criteria|49|||
147352803|NCT01160211|531461677|FG001|Overall Study|Subject Reached Protocol-Defined Stopping Criteria|49|||
147352804|NCT01160211|531461678|FG002|Overall Study|Subject Reached Protocol-Defined Stopping Criteria|59|||
147352805|NCT01160211|531461676|FG000|Overall Study|Lost to Follow-up|4|||
147352806|NCT01160211|531461677|FG001|Overall Study|Lost to Follow-up|8|||
147352807|NCT01160211|531461678|FG002|Overall Study|Lost to Follow-up|4|||
147352808|NCT01160211|531461676|FG000|Overall Study|Physician Decision|1|||
147352809|NCT01160211|531461677|FG001|Overall Study|Physician Decision|0|||
147352810|NCT01160211|531461678|FG002|Overall Study|Physician Decision|0|||
147352811|NCT01160211|531461676|FG000|Overall Study|Withdrawal by Subject|4|||
147352812|NCT01160211|531461677|FG001|Overall Study|Withdrawal by Subject|2|||
147352813|NCT01160211|531461678|FG002|Overall Study|Withdrawal by Subject|2|||
147352814|NCT01160211|531461676|FG000|Overall Study|Data unavailable due to regulatory issues|2|||
147352815|NCT01160211|531461677|FG001|Overall Study|Data unavailable due to regulatory issues|0|||
147352816|NCT01160211|531461678|FG002|Overall Study|Data unavailable due to regulatory issues|2|||
147352817|NCT03611491|531461683|FG000|Overall Study|Lost to Follow-up|1|||
147352818|NCT04676022|531461684|FG000|Overall Study|Screen Failure/|1|||
147352819|NCT04676022|531461685|FG001|Overall Study|Screen Failure/|1|||
147352820|NCT04676022|531461686|FG002|Overall Study|Screen Failure/|85|||
147352821|NCT04676022|531461684|FG000|Overall Study|Lost to Follow-up|1|||
147352822|NCT04676022|531461685|FG001|Overall Study|Lost to Follow-up|1|||
147352823|NCT04676022|531461686|FG002|Overall Study|Lost to Follow-up|0|||
147352824|NCT04676022|531461684|FG000|Overall Study|Adverse Event|2|||
147453451|NCT03403205|531824011|FG003|Extension Period (Up to 60 Months)|Study Terminated by Sponsor|10|||
147352825|NCT04676022|531461685|FG001|Overall Study|Adverse Event|0|||
147352826|NCT04676022|531461686|FG002|Overall Study|Adverse Event|1|||
147352827|NCT04676022|531461684|FG000|Overall Study|Physician Decision|2|||
147352828|NCT04676022|531461685|FG001|Overall Study|Physician Decision|0|||
147352829|NCT04676022|531461686|FG002|Overall Study|Physician Decision|1|||
147352830|NCT04676022|531461684|FG000|Overall Study|Withdrawal by Subject|3|||
147352831|NCT04676022|531461685|FG001|Overall Study|Withdrawal by Subject|1|||
147352832|NCT04676022|531461686|FG002|Overall Study|Withdrawal by Subject|6|||
147453452|NCT03403205|531824012|FG004|Extension Period (Up to 60 Months)|Study Terminated by Sponsor|7|||
147352833|NCT04676022|531461684|FG000|Overall Study|Will not move forward with permanent implant|6|||
147352834|NCT04676022|531461685|FG001|Overall Study|Will not move forward with permanent implant|0|||
147352835|NCT04676022|531461686|FG002|Overall Study|Will not move forward with permanent implant|0|||
147352836|NCT04676022|531461684|FG000|Overall Study|Various reasons (moved, no longer meets criteria, visit not done etc.)|7|||
147352837|NCT04676022|531461685|FG001|Overall Study|Various reasons (moved, no longer meets criteria, visit not done etc.)|1|||
147352838|NCT04676022|531461686|FG002|Overall Study|Various reasons (moved, no longer meets criteria, visit not done etc.)|1|||
147352839|NCT05409183|531461689|FG000|Complete Study|Adverse Event|1|||
147352840|NCT05409183|531461690|FG001|Complete Study|Adverse Event|2|||
147352841|NCT05409183|531461689|FG000|Complete Study|Withdrawal by Subject|3|||
147352842|NCT05409183|531461690|FG001|Complete Study|Withdrawal by Subject|0|||
147352843|NCT02274662|531461691|FG000|Overall Study|Death|1|||
147352844|NCT02274662|531461691|FG000|Overall Study|Lost to Follow-up|3|||
147352845|NCT03194217|531461692|FG000|Overall Study|Adverse Event|0|||
147352846|NCT03194217|531461693|FG001|Overall Study|Adverse Event|2|||
147352847|NCT03194217|531461694|FG002|Overall Study|Adverse Event|3|||
147352848|NCT03194217|531461695|FG003|Overall Study|Adverse Event|3|||
147352849|NCT03194217|531461692|FG000|Overall Study|Failure to meet randomisation criteria|0|||
147352850|NCT03194217|531461693|FG001|Overall Study|Failure to meet randomisation criteria|0|||
147352851|NCT03194217|531461694|FG002|Overall Study|Failure to meet randomisation criteria|0|||
147352852|NCT03194217|531461695|FG003|Overall Study|Failure to meet randomisation criteria|1|||
147352853|NCT03194217|531461692|FG000|Overall Study|Other|0|||
147352854|NCT03194217|531461693|FG001|Overall Study|Other|1|||
147352855|NCT03194217|531461694|FG002|Overall Study|Other|1|||
147352856|NCT03194217|531461695|FG003|Overall Study|Other|0|||
147352857|NCT04806451|531461696|FG000|DB Treatment Period (28 Weeks)|Withdrawal by Subject|3|||
147352858|NCT04806451|531461697|FG001|DB Treatment Period (28 Weeks)|Withdrawal by Subject|1|||
147352859|NCT04806451|531461696|FG000|DB Treatment Period (28 Weeks)|Adverse Event|0|||
147352860|NCT04806451|531461697|FG001|DB Treatment Period (28 Weeks)|Adverse Event|2|||
147352861|NCT04806451|531461696|FG000|OL Treatment Period (24 Weeks)|Ongoing in the Study|16|||
147352862|NCT04806451|531461697|FG001|OL Treatment Period (24 Weeks)|Ongoing in the Study|37|||
147352863|NCT05835336|531461698|FG000|Overall Study|Withdrawal by Subject|5|||
147352864|NCT05835336|531461698|FG000|Overall Study|Did not complete the personalization process|3|||
147352865|NCT03134196|531461710|FG000|Overall Study|Death|2|||
147352866|NCT03134196|531461711|FG001|Overall Study|Death|1|||
147352867|NCT03134196|531461710|FG000|Overall Study|Lost to Follow-up|13|||
147352868|NCT03134196|531461711|FG001|Overall Study|Lost to Follow-up|15|||
147352869|NCT03134196|531461710|FG000|Overall Study|Physician Decision|0|||
147352870|NCT03134196|531461711|FG001|Overall Study|Physician Decision|1|||
147352871|NCT03134196|531461710|FG000|Overall Study|Withdrawal by Subject|19|||
147352872|NCT03134196|531461711|FG001|Overall Study|Withdrawal by Subject|12|||
147352873|NCT03134196|531461710|FG000|Overall Study|Site Unable to Contact Participant|2|||
147352874|NCT03134196|531461711|FG001|Overall Study|Site Unable to Contact Participant|0|||
147352875|NCT03134196|531461710|FG000|Overall Study|Site Closed Scheduling Conflict|1|||
147352876|NCT03134196|531461711|FG001|Overall Study|Site Closed Scheduling Conflict|0|||
147352877|NCT03134196|531461710|FG000|Overall Study|Scheduling Conflict|1|||
147352878|NCT03134196|531461711|FG001|Overall Study|Scheduling Conflict|0|||
147352879|NCT03016754|531461713|FG000|Overall Study|Death|5|||
147352880|NCT03016754|531461714|FG001|Overall Study|Death|4|||
147352881|NCT03016754|531461715|FG002|Overall Study|Death|5|||
147352882|NCT03016754|531461716|FG003|Overall Study|Death|1|||
147352883|NCT03016754|531461713|FG000|Overall Study|Lost to Follow-up|23|||
147352884|NCT03016754|531461714|FG001|Overall Study|Lost to Follow-up|17|||
147352885|NCT03016754|531461715|FG002|Overall Study|Lost to Follow-up|4|||
147352886|NCT03016754|531461716|FG003|Overall Study|Lost to Follow-up|2|||
147352887|NCT03016754|531461713|FG000|Overall Study|Withdrawal by Subject|6|||
147352888|NCT03016754|531461714|FG001|Overall Study|Withdrawal by Subject|6|||
147352889|NCT03016754|531461715|FG002|Overall Study|Withdrawal by Subject|2|||
147352890|NCT03016754|531461716|FG003|Overall Study|Withdrawal by Subject|2|||
147352891|NCT03016754|531461713|FG000|Overall Study|Other/Unknown|2|||
147352892|NCT03016754|531461714|FG001|Overall Study|Other/Unknown|4|||
147352893|NCT03016754|531461715|FG002|Overall Study|Other/Unknown|2|||
147352894|NCT03016754|531461716|FG003|Overall Study|Other/Unknown|1|||
147352895|NCT03016754|531461713|FG000|Overall Study|Protocol Violation|0|||
147352896|NCT03016754|531461714|FG001|Overall Study|Protocol Violation|0|||
147352897|NCT03016754|531461715|FG002|Overall Study|Protocol Violation|0|||
147352898|NCT03016754|531461716|FG003|Overall Study|Protocol Violation|4|||
147352899|NCT04683744|531461718|FG000|Overall Study|withdrawn (determined not eligible after enrollment)|0|||
147352900|NCT04683744|531461719|FG001|Overall Study|withdrawn (determined not eligible after enrollment)|0|||
147352901|NCT04683744|531461720|FG002|Overall Study|withdrawn (determined not eligible after enrollment)|1|||
147352902|NCT04185298|531461722|FG000|Overall Study|Lost to Follow-up|1|||
147352903|NCT04185298|531461723|FG001|Overall Study|Lost to Follow-up|3|||
147352904|NCT04185298|531461722|FG000|Overall Study|Withdrawal by Subject|0|||
147352905|NCT04185298|531461723|FG001|Overall Study|Withdrawal by Subject|3|||
147352906|NCT04927364|531461726|FG000|Overall Study|Withdrawal by Subject|3|||
147352907|NCT04927364|531461726|FG000|Overall Study|Unable to complete preassessment MRI|1|||
147352908|NCT04316871|531461733|FG000|Overall Study|Protocol Violation|2|||
147352909|NCT04316871|531461734|FG001|Overall Study|Protocol Violation|2|||
147352910|NCT04316871|531461735|FG002|Overall Study|Protocol Violation|2|||
147352911|NCT04316871|531461736|FG003|Overall Study|Protocol Violation|2|||
147352912|NCT04650269|531461737|FG000|Overall Study|Death|3|||
147352913|NCT04650269|531461737|FG000|Overall Study|Lost to Follow-up|6|||
147352914|NCT05087992|531461738|FG000|Overall Study|Adverse Event|0|||
147352915|NCT05087992|531461739|FG001|Overall Study|Adverse Event|1|||
147352916|NCT05087992|531461740|FG002|Overall Study|Adverse Event|0|||
147352917|NCT05087992|531461738|FG000|Overall Study|Withdrawal by Subject|2|||
147352918|NCT05087992|531461739|FG001|Overall Study|Withdrawal by Subject|0|||
147352919|NCT05087992|531461740|FG002|Overall Study|Withdrawal by Subject|0|||
147352920|NCT05087992|531461738|FG000|Overall Study|clinical disease progression|3|||
147352921|NCT05087992|531461739|FG001|Overall Study|clinical disease progression|1|||
147352922|NCT05087992|531461740|FG002|Overall Study|clinical disease progression|0|||
147352923|NCT05087992|531461738|FG000|Overall Study|objective disease progression|4|||
147352924|NCT05087992|531461739|FG001|Overall Study|objective disease progression|1|||
147352925|NCT05087992|531461740|FG002|Overall Study|objective disease progression|0|||
147352926|NCT04091750|531461741|FG000|Overall Study|Adverse Event|4|||
147352927|NCT04091750|531461741|FG000|Overall Study|Withdrawal by Subject|1|||
147352928|NCT02919306|531461742|FG000|Overall Study|Withdrawal by Subject|1|||
147352929|NCT02919306|531461743|FG001|Overall Study|Withdrawal by Subject|0|||
147352930|NCT02919306|531461742|FG000|Overall Study|Protocol Violation|1|||
147352931|NCT02919306|531461743|FG001|Overall Study|Protocol Violation|0|||
147352932|NCT04473222|531461744|FG000|Overall Study|Lost to Follow-up|13|||
147352933|NCT04473222|531461745|FG001|Overall Study|Lost to Follow-up|13|||
147352934|NCT04473222|531461744|FG000|Overall Study|Withdrawal by Subject|0|||
147352935|NCT04473222|531461745|FG001|Overall Study|Withdrawal by Subject|1|||
147352936|NCT04473222|531461744|FG000|Overall Study|Participant partially completed baseline surveys, then lost contact, then re-consented|0|||
147352937|NCT04473222|531461745|FG001|Overall Study|Participant partially completed baseline surveys, then lost contact, then re-consented|1|||
147352938|NCT04293055|531461746|FG000|Overall Study|Lost to Follow-up|1|||
147352939|NCT04293055|531461747|FG001|Overall Study|Lost to Follow-up|1|||
147352940|NCT04293055|531461746|FG000|Overall Study|Did not trigger randomization|6|||
147352941|NCT04293055|531461747|FG001|Overall Study|Did not trigger randomization|5|||
147352942|NCT03560609|531461748|FG000|Overall Study|Study terminated due to departure of Principal Investigator from Sponsoring institution|3|||
147352943|NCT03560609|531461749|FG001|Overall Study|Study terminated due to departure of Principal Investigator from Sponsoring institution|0|||
147352944|NCT01369355|531461762|FG000|Week 0 - Week 44 (Maintenance)|Adverse Event|9|||
147352945|NCT01369355|531461763|FG001|Week 0 - Week 44 (Maintenance)|Adverse Event|12|||
147352946|NCT01369355|531461764|FG002|Week 0 - Week 44 (Maintenance)|Adverse Event|6|||
147352947|NCT01369355|531461765|FG003|Week 0 - Week 44 (Maintenance)|Adverse Event|7|||
147352948|NCT01369355|531461766|FG004|Week 0 - Week 44 (Maintenance)|Adverse Event|14|||
147352949|NCT01369355|531461767|FG005|Week 0 - Week 44 (Maintenance)|Adverse Event|25|||
147352950|NCT01369355|531461768|FG006|Week 0 - Week 44 (Maintenance)|Adverse Event|0|||
147352951|NCT01369355|531461769|FG007|Week 0 - Week 44 (Maintenance)|Adverse Event|0|||
147352952|NCT01369355|531461770|FG008|Week 0 - Week 44 (Maintenance)|Adverse Event|0|||
147352953|NCT01369355|531461762|FG000|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|15|||
147352954|NCT01369355|531461763|FG001|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|14|||
147352955|NCT01369355|531461764|FG002|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|15|||
147352956|NCT01369355|531461765|FG003|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|15|||
147352957|NCT01369355|531461766|FG004|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|126|||
147352958|NCT01369355|531461767|FG005|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|217|||
147352959|NCT01369355|531461768|FG006|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|0|||
147352960|NCT01369355|531461769|FG007|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|0|||
147352961|NCT01369355|531461770|FG008|Week 0 - Week 44 (Maintenance)|Lack of Efficacy|0|||
147352962|NCT01369355|531461762|FG000|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
147352963|NCT01369355|531461763|FG001|Week 0 - Week 44 (Maintenance)|Protocol Violation|1|||
147352964|NCT01369355|531461764|FG002|Week 0 - Week 44 (Maintenance)|Protocol Violation|1|||
147453453|NCT03403205|531824013|FG005|Extension Period (Up to 60 Months)|Study Terminated by Sponsor|8|||
147453454|NCT03403205|531824008|FG000|Extension Period (Up to 60 Months)|Other than specified|5|||
147453455|NCT03403205|531824009|FG001|Extension Period (Up to 60 Months)|Other than specified|5|||
147453456|NCT03403205|531824010|FG002|Extension Period (Up to 60 Months)|Other than specified|3|||
147453457|NCT03403205|531824011|FG003|Extension Period (Up to 60 Months)|Other than specified|0|||
147453458|NCT03403205|531824012|FG004|Extension Period (Up to 60 Months)|Other than specified|1|||
147453459|NCT03403205|531824013|FG005|Extension Period (Up to 60 Months)|Other than specified|0|||
147453460|NCT03403205|531824008|FG000|Extension Period (Up to 60 Months)|Physician Decision|2|||
147453461|NCT03403205|531824009|FG001|Extension Period (Up to 60 Months)|Physician Decision|1|||
147453462|NCT03403205|531824010|FG002|Extension Period (Up to 60 Months)|Physician Decision|1|||
147453463|NCT03403205|531824011|FG003|Extension Period (Up to 60 Months)|Physician Decision|0|||
147453464|NCT03403205|531824012|FG004|Extension Period (Up to 60 Months)|Physician Decision|0|||
147352965|NCT01369355|531461765|FG003|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
147352966|NCT01369355|531461766|FG004|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
147352967|NCT01369355|531461767|FG005|Week 0 - Week 44 (Maintenance)|Protocol Violation|2|||
147352968|NCT01369355|531461768|FG006|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
147352969|NCT01369355|531461769|FG007|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
147352970|NCT01369355|531461770|FG008|Week 0 - Week 44 (Maintenance)|Protocol Violation|0|||
147352971|NCT01369355|531461762|FG000|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|1|||
147352972|NCT01369355|531461763|FG001|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|0|||
147352973|NCT01369355|531461764|FG002|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|1|||
147352974|NCT01369355|531461765|FG003|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|2|||
147352975|NCT01369355|531461766|FG004|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|5|||
147352976|NCT01369355|531461767|FG005|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|6|||
147352977|NCT01369355|531461768|FG006|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|0|||
147352978|NCT01369355|531461769|FG007|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|0|||
147352979|NCT01369355|531461770|FG008|Week 0 - Week 44 (Maintenance)|Lost to Follow-up|0|||
147352980|NCT01369355|531461762|FG000|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|6|||
147352981|NCT01369355|531461763|FG001|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|2|||
147352982|NCT01369355|531461764|FG002|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|7|||
147352983|NCT01369355|531461765|FG003|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|6|||
147352984|NCT01369355|531461766|FG004|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|8|||
147352985|NCT01369355|531461767|FG005|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|22|||
147352986|NCT01369355|531461768|FG006|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|0|||
147352987|NCT01369355|531461769|FG007|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|0|||
147352988|NCT01369355|531461770|FG008|Week 0 - Week 44 (Maintenance)|Withdrawal by Subject|0|||
147352989|NCT01369355|531461762|FG000|Week 0 - Week 44 (Maintenance)|Other|0|||
147352990|NCT01369355|531461763|FG001|Week 0 - Week 44 (Maintenance)|Other|0|||
147352991|NCT01369355|531461764|FG002|Week 0 - Week 44 (Maintenance)|Other|1|||
147352992|NCT01369355|531461765|FG003|Week 0 - Week 44 (Maintenance)|Other|0|||
147352993|NCT01369355|531461766|FG004|Week 0 - Week 44 (Maintenance)|Other|1|||
147352994|NCT01369355|531461767|FG005|Week 0 - Week 44 (Maintenance)|Other|0|||
147352995|NCT01369355|531461768|FG006|Week 0 - Week 44 (Maintenance)|Other|0|||
147352996|NCT01369355|531461769|FG007|Week 0 - Week 44 (Maintenance)|Other|0|||
147352997|NCT01369355|531461770|FG008|Week 0 - Week 44 (Maintenance)|Other|0|||
147352998|NCT01369355|531461762|FG000|Long-term Extension (Week 44-272)|Adverse Event|0|||
147352999|NCT01369355|531461763|FG001|Long-term Extension (Week 44-272)|Adverse Event|0|||
147353000|NCT01369355|531461764|FG002|Long-term Extension (Week 44-272)|Adverse Event|0|||
147353001|NCT01369355|531461765|FG003|Long-term Extension (Week 44-272)|Adverse Event|0|||
147353002|NCT01369355|531461766|FG004|Long-term Extension (Week 44-272)|Adverse Event|0|||
147353003|NCT01369355|531461767|FG005|Long-term Extension (Week 44-272)|Adverse Event|0|||
147353004|NCT01369355|531461768|FG006|Long-term Extension (Week 44-272)|Adverse Event|15|||
147353005|NCT01369355|531461769|FG007|Long-term Extension (Week 44-272)|Adverse Event|29|||
147353006|NCT01369355|531461770|FG008|Long-term Extension (Week 44-272)|Adverse Event|53|||
147353007|NCT01369355|531461762|FG000|Long-term Extension (Week 44-272)|Death|0|||
147353008|NCT01369355|531461763|FG001|Long-term Extension (Week 44-272)|Death|0|||
147353009|NCT01369355|531461764|FG002|Long-term Extension (Week 44-272)|Death|0|||
147353010|NCT01369355|531461765|FG003|Long-term Extension (Week 44-272)|Death|0|||
147353011|NCT01369355|531461766|FG004|Long-term Extension (Week 44-272)|Death|0|||
147353012|NCT01369355|531461767|FG005|Long-term Extension (Week 44-272)|Death|0|||
147353013|NCT01369355|531461768|FG006|Long-term Extension (Week 44-272)|Death|0|||
147353014|NCT01369355|531461769|FG007|Long-term Extension (Week 44-272)|Death|1|||
147353015|NCT01369355|531461770|FG008|Long-term Extension (Week 44-272)|Death|3|||
147353016|NCT01369355|531461762|FG000|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
147353017|NCT01369355|531461763|FG001|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
147353018|NCT01369355|531461764|FG002|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
147353019|NCT01369355|531461765|FG003|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
147353020|NCT01369355|531461766|FG004|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
147353021|NCT01369355|531461767|FG005|Long-term Extension (Week 44-272)|Lack of Efficacy|0|||
147607370|NCT04642365|532377281|FG003|Overall Study|Adverse Event|0|||
147607371|NCT04642365|532377282|FG004|Overall Study|Adverse Event|0|||
147607372|NCT04642365|532377283|FG005|Overall Study|Adverse Event|0|||
147607373|NCT04642365|532377284|FG006|Overall Study|Adverse Event|0|||
147607374|NCT04642365|532377285|FG007|Overall Study|Adverse Event|1|||
147607375|NCT02552212|532377286|FG000|Double-Blind Period (Week 0 - 52)|Adverse Event|6|||
147607376|NCT02552212|532377287|FG001|Double-Blind Period (Week 0 - 52)|Adverse Event|3|||
147353022|NCT01369355|531461768|FG006|Long-term Extension (Week 44-272)|Lack of Efficacy|12|||
147353023|NCT01369355|531461769|FG007|Long-term Extension (Week 44-272)|Lack of Efficacy|26|||
147353024|NCT01369355|531461770|FG008|Long-term Extension (Week 44-272)|Lack of Efficacy|29|||
147353025|NCT01369355|531461762|FG000|Long-term Extension (Week 44-272)|Protocol Violation|0|||
147607377|NCT02552212|532377288|FG002|Double-Blind Period (Week 0 - 52)|Adverse Event|0|||
147607378|NCT02552212|532377286|FG000|Double-Blind Period (Week 0 - 52)|Lack of Efficacy|2|||
147353026|NCT01369355|531461763|FG001|Long-term Extension (Week 44-272)|Protocol Violation|0|||
147353027|NCT01369355|531461764|FG002|Long-term Extension (Week 44-272)|Protocol Violation|0|||
147353028|NCT01369355|531461765|FG003|Long-term Extension (Week 44-272)|Protocol Violation|0|||
147353029|NCT01369355|531461766|FG004|Long-term Extension (Week 44-272)|Protocol Violation|0|||
147353030|NCT01369355|531461767|FG005|Long-term Extension (Week 44-272)|Protocol Violation|0|||
147353031|NCT01369355|531461768|FG006|Long-term Extension (Week 44-272)|Protocol Violation|0|||
147353032|NCT01369355|531461769|FG007|Long-term Extension (Week 44-272)|Protocol Violation|1|||
147353033|NCT01369355|531461770|FG008|Long-term Extension (Week 44-272)|Protocol Violation|2|||
147353034|NCT01369355|531461762|FG000|Long-term Extension (Week 44-272)|Physician Decision|0|||
147353035|NCT01369355|531461763|FG001|Long-term Extension (Week 44-272)|Physician Decision|0|||
147353036|NCT01369355|531461764|FG002|Long-term Extension (Week 44-272)|Physician Decision|0|||
147353037|NCT01369355|531461765|FG003|Long-term Extension (Week 44-272)|Physician Decision|0|||
147353038|NCT01369355|531461766|FG004|Long-term Extension (Week 44-272)|Physician Decision|0|||
147353039|NCT01369355|531461767|FG005|Long-term Extension (Week 44-272)|Physician Decision|0|||
147353040|NCT01369355|531461768|FG006|Long-term Extension (Week 44-272)|Physician Decision|1|||
147353041|NCT01369355|531461769|FG007|Long-term Extension (Week 44-272)|Physician Decision|5|||
147353042|NCT01369355|531461770|FG008|Long-term Extension (Week 44-272)|Physician Decision|11|||
147353043|NCT01369355|531461762|FG000|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
147353044|NCT01369355|531461763|FG001|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
147353045|NCT01369355|531461764|FG002|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
147353046|NCT01369355|531461765|FG003|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
147353047|NCT01369355|531461766|FG004|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
147353048|NCT01369355|531461767|FG005|Long-term Extension (Week 44-272)|Lost to Follow-up|0|||
147353049|NCT01369355|531461768|FG006|Long-term Extension (Week 44-272)|Lost to Follow-up|1|||
147353050|NCT01369355|531461769|FG007|Long-term Extension (Week 44-272)|Lost to Follow-up|5|||
147353051|NCT01369355|531461770|FG008|Long-term Extension (Week 44-272)|Lost to Follow-up|9|||
147353052|NCT01369355|531461762|FG000|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
147353053|NCT01369355|531461763|FG001|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
147353054|NCT01369355|531461764|FG002|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
147353055|NCT01369355|531461765|FG003|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
147353056|NCT01369355|531461766|FG004|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
147353057|NCT01369355|531461767|FG005|Long-term Extension (Week 44-272)|Withdrawal by Subject|0|||
147353058|NCT01369355|531461768|FG006|Long-term Extension (Week 44-272)|Withdrawal by Subject|12|||
147353059|NCT01369355|531461769|FG007|Long-term Extension (Week 44-272)|Withdrawal by Subject|30|||
147353060|NCT01369355|531461770|FG008|Long-term Extension (Week 44-272)|Withdrawal by Subject|47|||
147353061|NCT01369355|531461762|FG000|Long-term Extension (Week 44-272)|Other|0|||
147353062|NCT01369355|531461763|FG001|Long-term Extension (Week 44-272)|Other|0|||
147353063|NCT01369355|531461764|FG002|Long-term Extension (Week 44-272)|Other|0|||
147353064|NCT01369355|531461765|FG003|Long-term Extension (Week 44-272)|Other|0|||
147353065|NCT01369355|531461766|FG004|Long-term Extension (Week 44-272)|Other|0|||
147353066|NCT01369355|531461767|FG005|Long-term Extension (Week 44-272)|Other|0|||
147353067|NCT01369355|531461768|FG006|Long-term Extension (Week 44-272)|Other|110|||
147353068|NCT01369355|531461769|FG007|Long-term Extension (Week 44-272)|Other|9|||
147353069|NCT01369355|531461770|FG008|Long-term Extension (Week 44-272)|Other|17|||
147353070|NCT02319759|531461773|FG000|Week 0 - 16|Lack of Efficacy|1|||
147353071|NCT02319759|531461774|FG001|Week 0 - 16|Lack of Efficacy|0|||
147353072|NCT02319759|531461775|FG002|Week 0 - 16|Lack of Efficacy|0|||
147353073|NCT02319759|531461776|FG003|Week 0 - 16|Lack of Efficacy|0|||
147353074|NCT02319759|531461777|FG004|Week 0 - 16|Lack of Efficacy|0|||
147353075|NCT02319759|531461773|FG000|Week 0 - 16|Not met all Inclusion Criteria|0|||
147353076|NCT02319759|531461774|FG001|Week 0 - 16|Not met all Inclusion Criteria|0|||
147353077|NCT02319759|531461775|FG002|Week 0 - 16|Not met all Inclusion Criteria|1|||
147353078|NCT02319759|531461776|FG003|Week 0 - 16|Not met all Inclusion Criteria|0|||
147353079|NCT02319759|531461777|FG004|Week 0 - 16|Not met all Inclusion Criteria|0|||
147353080|NCT02319759|531461773|FG000|Week 16 - 24|Lack of Efficacy|1|||
147353081|NCT02319759|531461774|FG001|Week 16 - 24|Lack of Efficacy|0|||
147353082|NCT02319759|531461775|FG002|Week 16 - 24|Lack of Efficacy|1|||
147353083|NCT02319759|531461776|FG003|Week 16 - 24|Lack of Efficacy|0|||
147353084|NCT02319759|531461777|FG004|Week 16 - 24|Lack of Efficacy|0|||
147353085|NCT02319759|531461773|FG000|Week 16 - 24|Lost to Follow-up|1|||
147353086|NCT02319759|531461774|FG001|Week 16 - 24|Lost to Follow-up|0|||
147353087|NCT02319759|531461775|FG002|Week 16 - 24|Lost to Follow-up|0|||
147353088|NCT02319759|531461776|FG003|Week 16 - 24|Lost to Follow-up|0|||
147353089|NCT02319759|531461777|FG004|Week 16 - 24|Lost to Follow-up|0|||
147353090|NCT02319759|531461773|FG000|Week 16 - 24|Withdrawal by Subject|0|||
147353091|NCT02319759|531461774|FG001|Week 16 - 24|Withdrawal by Subject|0|||
147353092|NCT02319759|531461775|FG002|Week 16 - 24|Withdrawal by Subject|2|||
147353093|NCT02319759|531461776|FG003|Week 16 - 24|Withdrawal by Subject|0|||
147353094|NCT02319759|531461777|FG004|Week 16 - 24|Withdrawal by Subject|0|||
147453465|NCT03403205|531824013|FG005|Extension Period (Up to 60 Months)|Physician Decision|0|||
147353095|NCT02319759|531461773|FG000|Week 24 - 56|Adverse Event|0|||
147353096|NCT02319759|531461774|FG001|Week 24 - 56|Adverse Event|0|||
147353097|NCT02319759|531461775|FG002|Week 24 - 56|Adverse Event|2|||
147353098|NCT02319759|531461776|FG003|Week 24 - 56|Adverse Event|0|||
147353099|NCT02319759|531461777|FG004|Week 24 - 56|Adverse Event|0|||
147353100|NCT02319759|531461773|FG000|Week 24 - 56|Lack of Efficacy|0|||
147353101|NCT02319759|531461774|FG001|Week 24 - 56|Lack of Efficacy|0|||
147353102|NCT02319759|531461775|FG002|Week 24 - 56|Lack of Efficacy|0|||
147353103|NCT02319759|531461776|FG003|Week 24 - 56|Lack of Efficacy|2|||
147353104|NCT02319759|531461777|FG004|Week 24 - 56|Lack of Efficacy|1|||
147353105|NCT02319759|531461773|FG000|Week 24 - 56|Withdrawal by Subject|0|||
147453466|NCT00706030|531824014|FG000|Overall Study|Disease Progression|4|||
147453467|NCT00706030|531824015|FG001|Overall Study|Disease Progression|6|||
147453468|NCT00706030|531824016|FG002|Overall Study|Disease Progression|46|||
147453469|NCT00706030|531824017|FG003|Overall Study|Disease Progression|12|||
147453470|NCT00706030|531824014|FG000|Overall Study|Adverse Event|1|||
147453471|NCT00706030|531824015|FG001|Overall Study|Adverse Event|0|||
147453472|NCT00706030|531824016|FG002|Overall Study|Adverse Event|4|||
147453473|NCT00706030|531824017|FG003|Overall Study|Adverse Event|2|||
147453474|NCT00706030|531824014|FG000|Overall Study|Withdrawal by Subject|1|||
147453475|NCT00706030|531824015|FG001|Overall Study|Withdrawal by Subject|0|||
147453476|NCT00706030|531824016|FG002|Overall Study|Withdrawal by Subject|2|||
147453477|NCT00706030|531824017|FG003|Overall Study|Withdrawal by Subject|0|||
147453478|NCT00706030|531824014|FG000|Overall Study|Physician Decision|0|||
147453479|NCT00706030|531824015|FG001|Overall Study|Physician Decision|0|||
147453480|NCT00706030|531824016|FG002|Overall Study|Physician Decision|2|||
147453481|NCT00706030|531824017|FG003|Overall Study|Physician Decision|0|||
147453482|NCT00706030|531824014|FG000|Overall Study|Not recorded|0|||
147453483|NCT00706030|531824015|FG001|Overall Study|Not recorded|0|||
147453484|NCT00706030|531824016|FG002|Overall Study|Not recorded|2|||
147453485|NCT00706030|531824017|FG003|Overall Study|Not recorded|0|||
147453486|NCT00706030|531824014|FG000|Overall Study|Protocol Violation|0|||
147453487|NCT00706030|531824015|FG001|Overall Study|Protocol Violation|0|||
147453488|NCT00706030|531824016|FG002|Overall Study|Protocol Violation|1|||
147453489|NCT00706030|531824017|FG003|Overall Study|Protocol Violation|1|||
147453490|NCT00706030|531824014|FG000|Overall Study|Failed to return|0|||
147453491|NCT00706030|531824015|FG001|Overall Study|Failed to return|0|||
147453492|NCT00706030|531824016|FG002|Overall Study|Failed to return|1|||
147453493|NCT00706030|531824017|FG003|Overall Study|Failed to return|0|||
147453494|NCT00706030|531824014|FG000|Overall Study|Symptomatic Deterioration|0|||
147453495|NCT00706030|531824015|FG001|Overall Study|Symptomatic Deterioration|0|||
147453496|NCT00706030|531824016|FG002|Overall Study|Symptomatic Deterioration|1|||
147453497|NCT00706030|531824017|FG003|Overall Study|Symptomatic Deterioration|0|||
147453498|NCT00706030|531824014|FG000|Overall Study|No treatment received|0|||
147453499|NCT00706030|531824015|FG001|Overall Study|No treatment received|0|||
147453500|NCT00706030|531824016|FG002|Overall Study|No treatment received|0|||
147453501|NCT00706030|531824017|FG003|Overall Study|No treatment received|1|||
147453502|NCT00706030|531824014|FG000|Overall Study|Death|0|||
147453503|NCT00706030|531824015|FG001|Overall Study|Death|0|||
147453504|NCT00706030|531824016|FG002|Overall Study|Death|1|||
147453505|NCT00706030|531824017|FG003|Overall Study|Death|0|||
147453506|NCT02682901|531824018|FG000|Overall Study|Adverse Event|10|||
147453507|NCT02682901|531824019|FG001|Overall Study|Adverse Event|3|||
147453508|NCT02682901|531824018|FG000|Overall Study|Lack of Efficacy|0|||
147453509|NCT02682901|531824019|FG001|Overall Study|Lack of Efficacy|1|||
147453510|NCT00844753|531824020|FG000|Overall Study|Lack of Efficacy|1|||
147453511|NCT00844753|531824021|FG001|Overall Study|Lack of Efficacy|0|||
147453512|NCT00844753|531824022|FG002|Overall Study|Lack of Efficacy|2|||
147453513|NCT00844753|531824023|FG003|Overall Study|Lack of Efficacy|2|||
147453514|NCT00844753|531824020|FG000|Overall Study|Adverse Event|3|||
147453515|NCT00844753|531824021|FG001|Overall Study|Adverse Event|2|||
147453516|NCT00844753|531824022|FG002|Overall Study|Adverse Event|5|||
147453517|NCT00844753|531824023|FG003|Overall Study|Adverse Event|5|||
147453518|NCT00844753|531824020|FG000|Overall Study|Lost to Follow-up|1|||
147353106|NCT02319759|531461774|FG001|Week 24 - 56|Withdrawal by Subject|1|||
147353107|NCT02319759|531461775|FG002|Week 24 - 56|Withdrawal by Subject|0|||
147353108|NCT02319759|531461776|FG003|Week 24 - 56|Withdrawal by Subject|0|||
147353109|NCT02319759|531461777|FG004|Week 24 - 56|Withdrawal by Subject|0|||
147453519|NCT00844753|531824021|FG001|Overall Study|Lost to Follow-up|1|||
147453520|NCT00844753|531824022|FG002|Overall Study|Lost to Follow-up|0|||
147453521|NCT00844753|531824023|FG003|Overall Study|Lost to Follow-up|1|||
147453522|NCT00844753|531824020|FG000|Overall Study|could not swallow medication|2|||
147453523|NCT00844753|531824021|FG001|Overall Study|could not swallow medication|0|||
147453524|NCT00844753|531824022|FG002|Overall Study|could not swallow medication|0|||
147453525|NCT00844753|531824023|FG003|Overall Study|could not swallow medication|0|||
147353110|NCT02319759|531461773|FG000|Week 24 - 56|Lost to Follow-up|0|||
147353111|NCT02319759|531461774|FG001|Week 24 - 56|Lost to Follow-up|0|||
147453526|NCT00844753|531824020|FG000|Overall Study|Withdrawal by Subject|1|||
147453527|NCT00844753|531824021|FG001|Overall Study|Withdrawal by Subject|0|||
147353112|NCT02319759|531461775|FG002|Week 24 - 56|Lost to Follow-up|0|||
147353113|NCT02319759|531461776|FG003|Week 24 - 56|Lost to Follow-up|0|||
147353114|NCT02319759|531461777|FG004|Week 24 - 56|Lost to Follow-up|1|||
147353115|NCT06424236|531461778|FG000|Overall Study|Adverse Event|0|||
147353116|NCT06424236|531461779|FG001|Overall Study|Adverse Event|1|||
147353117|NCT06424236|531461780|FG002|Overall Study|Adverse Event|0|||
147353118|NCT06424236|531461778|FG000|Overall Study|Withdrawal by Subject|3|||
147353119|NCT06424236|531461779|FG001|Overall Study|Withdrawal by Subject|1|||
147353120|NCT06424236|531461780|FG002|Overall Study|Withdrawal by Subject|2|||
147353121|NCT06424236|531461778|FG000|Overall Study|Physician Decision|0|||
147353122|NCT06424236|531461779|FG001|Overall Study|Physician Decision|1|||
147353123|NCT06424236|531461780|FG002|Overall Study|Physician Decision|0|||
147353124|NCT06424236|531461778|FG000|Overall Study|Study Terminated by Sponsor|11|||
147353125|NCT06424236|531461779|FG001|Overall Study|Study Terminated by Sponsor|20|||
147353126|NCT06424236|531461780|FG002|Overall Study|Study Terminated by Sponsor|16|||
147353127|NCT06424236|531461778|FG000|Overall Study|Lost to Follow-up|0|||
147353128|NCT06424236|531461779|FG001|Overall Study|Lost to Follow-up|1|||
147353129|NCT06424236|531461780|FG002|Overall Study|Lost to Follow-up|0|||
147353130|NCT06424236|531461778|FG000|Overall Study|Disease Progression|0|||
147353131|NCT06424236|531461779|FG001|Overall Study|Disease Progression|1|||
147353132|NCT06424236|531461780|FG002|Overall Study|Disease Progression|2|||
147353133|NCT06424236|531461778|FG000|Overall Study|Other|0|||
147353134|NCT06424236|531461779|FG001|Overall Study|Other|0|||
147353135|NCT06424236|531461780|FG002|Overall Study|Other|1|||
147353136|NCT02262728|531461782|FG000|Follow-up Phase (3 Years)|Death|0|||
147353137|NCT02262728|531461783|FG001|Follow-up Phase (3 Years)|Death|1|||
147353138|NCT02262728|531461782|FG000|Follow-up Phase (3 Years)|Lost to Follow-up|4|||
147353139|NCT02262728|531461783|FG001|Follow-up Phase (3 Years)|Lost to Follow-up|1|||
147353140|NCT02262728|531461782|FG000|Follow-up Phase (3 Years)|Withdrawal by Subject|0|||
147353141|NCT02262728|531461783|FG001|Follow-up Phase (3 Years)|Withdrawal by Subject|1|||
147353142|NCT00227344|531461784|FG000|Overall Study|study terminated early|12|||
147353143|NCT00227344|531461785|FG001|Overall Study|study terminated early|5|||
147353144|NCT01987895|531461786|FG000|Overall Study|Withdrawal by Subject|12|||
147353145|NCT01987895|531461787|FG001|Overall Study|Withdrawal by Subject|7|||
147353146|NCT01987895|531461786|FG000|Overall Study|Physician Decision|8|||
147353147|NCT01987895|531461787|FG001|Overall Study|Physician Decision|10|||
147353148|NCT01987895|531461786|FG000|Overall Study|Death|7|||
147353149|NCT01987895|531461787|FG001|Overall Study|Death|7|||
147353150|NCT01987895|531461786|FG000|Overall Study|Lost to Follow-up|3|||
147353151|NCT01987895|531461787|FG001|Overall Study|Lost to Follow-up|5|||
147353152|NCT01987895|531461786|FG000|Overall Study|randomized before giving IC|0|||
147353153|NCT01987895|531461787|FG001|Overall Study|randomized before giving IC|1|||
147353154|NCT05006872|531461791|FG000|Overall Study|Lost to Follow-up|37|||
147353155|NCT05006872|531461792|FG001|Overall Study|Lost to Follow-up|31|||
147353156|NCT04971681|531461795|FG000|Followup|Lost to Follow-up|1|||
147353157|NCT04971681|531461796|FG001|Followup|Lost to Follow-up|0|||
147453528|NCT00844753|531824022|FG002|Overall Study|Withdrawal by Subject|0|||
147453529|NCT00844753|531824023|FG003|Overall Study|Withdrawal by Subject|3|||
147453530|NCT05130463|531824024|FG000|Overall Study|Unspecified reasons|2|||
147453531|NCT05130463|531824024|FG000|Overall Study|off-label indication dose|435|||
147453532|NCT03440814|531824027|FG000|Overall Study|Adverse Event|2|||
147453533|NCT03440814|531824028|FG001|Overall Study|Adverse Event|1|||
147353164|NCT05647304|531461799|FG000|Overall Study|Withdrawal by Subject|1|||
147353165|NCT05647304|531461800|FG001|Overall Study|Withdrawal by Subject|0|||
147353166|NCT04171999|531461801|FG000|Overall Study|deemed ineligible after randomization|2|||
147353167|NCT04171999|531461802|FG001|Overall Study|deemed ineligible after randomization|1|||
147353168|NCT06181760|531461805|FG000|First Intervention (Fasted)|Withdrawal by Subject|0|||
147353169|NCT06181760|531461806|FG001|First Intervention (Fasted)|Withdrawal by Subject|0|||
147353170|NCT06181760|531461807|FG002|First Intervention (Fasted)|Withdrawal by Subject|0|||
147353171|NCT06181760|531461808|FG003|First Intervention (Fasted)|Withdrawal by Subject|1|||
147353172|NCT03524612|531461809|FG000|Overall Study|Lack of Efficacy|10|||
147353173|NCT03524612|531461809|FG000|Overall Study|Physician Decision (Patient non-compliant)|1|||
147353174|NCT03524612|531461809|FG000|Overall Study|Adverse Event|10|||
147353175|NCT03524612|531461809|FG000|Overall Study|Withdrawal by Subject|7|||
147353176|NCT03524612|531461809|FG000|Overall Study|Patient Decision (Patient Changed Her Address)|1|||
147353177|NCT03524612|531461809|FG000|Overall Study|Patient Decision (Personal Reasons)|1|||
147353178|NCT03524612|531461809|FG000|Overall Study|New therapy for study indication|6|||
147353179|NCT03524612|531461809|FG000|Overall Study|Death|3|||
147353180|NCT03524612|531461809|FG000|Overall Study|Lost to Follow-up|2|||
147353181|NCT03524612|531461809|FG000|Overall Study|Protocol Violation|1|||
147353182|NCT04623671|531461810|FG000|Overall Study|Adverse Event|0|||
147353183|NCT04623671|531461811|FG001|Overall Study|Adverse Event|1|||
147353184|NCT04623671|531461810|FG000|Overall Study|Lost to Follow-up|2|||
147353185|NCT04623671|531461811|FG001|Overall Study|Lost to Follow-up|1|||
147353186|NCT04623671|531461810|FG000|Overall Study|Death|5|||
147353187|NCT04623671|531461811|FG001|Overall Study|Death|5|||
147353188|NCT00613106|531461812|FG000|Overall Study|Adverse Event|3|||
147353189|NCT00613106|531461813|FG001|Overall Study|Adverse Event|1|||
147607379|NCT02552212|532377287|FG001|Double-Blind Period (Week 0 - 52)|Lack of Efficacy|2|||
147607380|NCT02552212|532377288|FG002|Double-Blind Period (Week 0 - 52)|Lack of Efficacy|0|||
147353190|NCT00613106|531461812|FG000|Overall Study|Withdrawal by Subject|6|||
147353191|NCT00613106|531461813|FG001|Overall Study|Withdrawal by Subject|3|||
147353192|NCT00613106|531461812|FG000|Overall Study|Lost to Follow-up|7|||
147353193|NCT00613106|531461813|FG001|Overall Study|Lost to Follow-up|2|||
147353194|NCT00613106|531461812|FG000|Overall Study|misc|4|||
147353195|NCT00613106|531461813|FG001|Overall Study|misc|3|||
147353196|NCT05296525|531461820|FG000|Dose Level 4 (Week 62 - Week 114)|Early termination by Sponsor|0|||
147353197|NCT05296525|531461821|FG001|Dose Level 4 (Week 62 - Week 114)|Early termination by Sponsor|0|||
147353198|NCT05296525|531461822|FG002|Dose Level 4 (Week 62 - Week 114)|Early termination by Sponsor|0|||
147353199|NCT05296525|531461823|FG003|Dose Level 4 (Week 62 - Week 114)|Early termination by Sponsor|3|||
147353200|NCT01420237|531461824|FG000|Overall Study|Death|13|||
147353201|NCT01420237|531461824|FG000|Overall Study|Withdrawal by Subject|41|||
147353202|NCT01420237|531461824|FG000|Overall Study|Lost to Follow-up|32|||
147353203|NCT01420237|531461824|FG000|Overall Study|Adverse Event|10|||
147353204|NCT01420237|531461824|FG000|Overall Study|Investigative Site Termination|43|||
147353205|NCT01420237|531461824|FG000|Overall Study|Censored because study device not implanted|21|||
147353206|NCT01420237|531461824|FG000|Overall Study|Censored because surgery not performed|2|||
147353207|NCT01420237|531461824|FG000|Overall Study|Censored because of Inclusion Exclusion Violation|11|||
147353208|NCT01420237|531461824|FG000|Overall Study|Sponsor terminated study early|127|||
147353209|NCT04492722|531461825|FG000|Overall Study|Adverse Event|7|||
147353210|NCT04492722|531461826|FG001|Overall Study|Adverse Event|2|||
147353211|NCT04492722|531461827|FG002|Overall Study|Adverse Event|3|||
147353212|NCT04492722|531461828|FG003|Overall Study|Adverse Event|0|||
147353213|NCT04492722|531461825|FG000|Overall Study|Death|0|||
147353214|NCT04492722|531461826|FG001|Overall Study|Death|0|||
147353215|NCT04492722|531461827|FG002|Overall Study|Death|0|||
147353216|NCT04492722|531461828|FG003|Overall Study|Death|1|||
147353217|NCT04492722|531461825|FG000|Overall Study|Lost to Follow-up|0|||
147353218|NCT04492722|531461826|FG001|Overall Study|Lost to Follow-up|1|||
147353219|NCT04492722|531461827|FG002|Overall Study|Lost to Follow-up|0|||
147353220|NCT04492722|531461828|FG003|Overall Study|Lost to Follow-up|1|||
147353221|NCT04492722|531461825|FG000|Overall Study|Physician Decision|0|||
147353222|NCT04492722|531461826|FG001|Overall Study|Physician Decision|3|||
147353223|NCT04492722|531461827|FG002|Overall Study|Physician Decision|1|||
147353224|NCT04492722|531461828|FG003|Overall Study|Physician Decision|1|||
147353225|NCT04492722|531461825|FG000|Overall Study|Withdrawal by Subject|6|||
147353226|NCT04492722|531461826|FG001|Overall Study|Withdrawal by Subject|6|||
147353227|NCT04492722|531461827|FG002|Overall Study|Withdrawal by Subject|0|||
147353228|NCT04492722|531461828|FG003|Overall Study|Withdrawal by Subject|3|||
147353229|NCT04492722|531461825|FG000|Overall Study|Development of Study Specific Withdrawal Criteria|3|||
147353230|NCT04492722|531461826|FG001|Overall Study|Development of Study Specific Withdrawal Criteria|1|||
147353231|NCT04492722|531461827|FG002|Overall Study|Development of Study Specific Withdrawal Criteria|2|||
147353232|NCT04492722|531461828|FG003|Overall Study|Development of Study Specific Withdrawal Criteria|2|||
147353233|NCT04492722|531461825|FG000|Overall Study|Due to Covid-19 pandemic|7|||
147353234|NCT04492722|531461826|FG001|Overall Study|Due to Covid-19 pandemic|3|||
147353235|NCT04492722|531461827|FG002|Overall Study|Due to Covid-19 pandemic|7|||
147353236|NCT04492722|531461828|FG003|Overall Study|Due to Covid-19 pandemic|6|||
147353237|NCT04492722|531461825|FG000|Overall Study|Failure to meet randomisation criteria|2|||
147353238|NCT04492722|531461826|FG001|Overall Study|Failure to meet randomisation criteria|3|||
147353239|NCT04492722|531461827|FG002|Overall Study|Failure to meet randomisation criteria|4|||
147353240|NCT04492722|531461828|FG003|Overall Study|Failure to meet randomisation criteria|2|||
147353241|NCT04492722|531461825|FG000|Overall Study|Early termination from the study|54|||
147353242|NCT04492722|531461826|FG001|Overall Study|Early termination from the study|51|||
147353243|NCT04492722|531461827|FG002|Overall Study|Early termination from the study|50|||
147353244|NCT04492722|531461828|FG003|Overall Study|Early termination from the study|50|||
147353245|NCT04492722|531461825|FG000|Overall Study|Missing|3|||
147353246|NCT04492722|531461826|FG001|Overall Study|Missing|0|||
147353247|NCT04492722|531461827|FG002|Overall Study|Missing|0|||
147353248|NCT04492722|531461828|FG003|Overall Study|Missing|5|||
147353249|NCT04492722|531461825|FG000|Overall Study|Participants who did not receive treatment|0|||
147353250|NCT04492722|531461826|FG001|Overall Study|Participants who did not receive treatment|1|||
147353251|NCT04492722|531461827|FG002|Overall Study|Participants who did not receive treatment|4|||
147353252|NCT04492722|531461828|FG003|Overall Study|Participants who did not receive treatment|0|||
147353253|NCT04029688|531464200|FG000|Overall Study|Death|8|||
147353254|NCT04029688|531464201|FG001|Overall Study|Death|3|||
147453534|NCT03440814|531824027|FG000|Overall Study|Lost to Follow-up|2|||
147353255|NCT04029688|531464202|FG002|Overall Study|Death|6|||
147353256|NCT04029688|531464203|FG003|Overall Study|Death|2|||
147353257|NCT04029688|531464204|FG004|Overall Study|Death|5|||
147353258|NCT04029688|531464205|FG005|Overall Study|Death|0|||
147353259|NCT04029688|531464206|FG006|Overall Study|Death|2|||
147353260|NCT04029688|531464207|FG007|Overall Study|Death|3|||
147353261|NCT04029688|531464200|FG000|Overall Study|Study Terminated by Sponsor|0|||
147453535|NCT03440814|531824028|FG001|Overall Study|Lost to Follow-up|0|||
147453536|NCT03440814|531824027|FG000|Overall Study|Consent withdrawn by parent/legal guardian|1|||
147453537|NCT03440814|531824028|FG001|Overall Study|Consent withdrawn by parent/legal guardian|0|||
147453538|NCT02751502|531824029|FG000|Overall Study|Lack of funding|4|||
147607381|NCT02552212|532377286|FG000|Double-Blind Period (Week 0 - 52)|Protocol Violation|1|||
147353262|NCT04029688|531464201|FG001|Overall Study|Study Terminated by Sponsor|0|||
147353263|NCT04029688|531464202|FG002|Overall Study|Study Terminated by Sponsor|0|||
147353264|NCT04029688|531464203|FG003|Overall Study|Study Terminated by Sponsor|0|||
147353265|NCT04029688|531464204|FG004|Overall Study|Study Terminated by Sponsor|1|||
147353266|NCT04029688|531464205|FG005|Overall Study|Study Terminated by Sponsor|3|||
147353267|NCT04029688|531464206|FG006|Overall Study|Study Terminated by Sponsor|1|||
147353268|NCT04029688|531464207|FG007|Overall Study|Study Terminated by Sponsor|3|||
147353269|NCT04029688|531464200|FG000|Overall Study|Withdrawal by Subject|0|||
147353270|NCT04029688|531464201|FG001|Overall Study|Withdrawal by Subject|0|||
147353271|NCT04029688|531464202|FG002|Overall Study|Withdrawal by Subject|0|||
147353272|NCT04029688|531464203|FG003|Overall Study|Withdrawal by Subject|1|||
147353273|NCT04029688|531464204|FG004|Overall Study|Withdrawal by Subject|0|||
147353274|NCT04029688|531464205|FG005|Overall Study|Withdrawal by Subject|0|||
147353275|NCT04029688|531464206|FG006|Overall Study|Withdrawal by Subject|0|||
147353276|NCT04029688|531464207|FG007|Overall Study|Withdrawal by Subject|0|||
147353277|NCT04130438|531464208|FG000|Overall Study|Lost to Follow-up|0|||
147353278|NCT04130438|531464209|FG001|Overall Study|Lost to Follow-up|0|||
147353279|NCT04130438|531464210|FG002|Overall Study|Lost to Follow-up|1|||
147353280|NCT04764448|531464214|FG000|Overall Study|Study terminated by sponsor|2|||
147353281|NCT04764448|531464215|FG001|Overall Study|Study terminated by sponsor|2|||
147353282|NCT04764448|531464216|FG002|Overall Study|Study terminated by sponsor|5|||
147353283|NCT04764448|531464214|FG000|Overall Study|Withdrawal by Subject|3|||
147353284|NCT04764448|531464215|FG001|Overall Study|Withdrawal by Subject|3|||
147353285|NCT04764448|531464216|FG002|Overall Study|Withdrawal by Subject|1|||
147353286|NCT03812679|531464217|FG000|Overall Study|Adverse Event|2|||
147353287|NCT03812679|531464217|FG000|Overall Study|Missed >4 consecutive therapy days|1|||
147353288|NCT03812679|531464217|FG000|Overall Study|Renal transplant|1|||
147353289|NCT03812679|531464217|FG000|Overall Study|Withdrawal by Subject|1|||
147353290|NCT03812679|531464217|FG000|Overall Study|Termination of study|2|||
147353291|NCT03812679|531464217|FG000|Overall Study|Water device replacement|1|||
147353292|NCT03953508|531464218|FG000|Baseline|Lost to Follow-up|3|||
147353293|NCT03953508|531464219|FG001|Baseline|Lost to Follow-up|2|||
147353294|NCT03953508|531464218|FG000|6-month Follow-up|Lost to Follow-up|62|||
147353295|NCT03953508|531464219|FG001|6-month Follow-up|Lost to Follow-up|70|||
147353296|NCT05119023|531464222|FG000|Characterization of Learning-visits 1&2|Withdrawal by Subject|1|||
147353297|NCT05119023|531464222|FG000|Characterization of Learning-visits 1&2|Change in health status unrelated to study rendered unable to participate|2|||
147353298|NCT05119023|531464222|FG000|Characterization of Learning-visits 1&2|Lost to Follow-up|1|||
147353299|NCT04489771|531464226|FG000|Overall Study|Death|27|||
147353300|NCT04489771|531464227|FG001|Overall Study|Death|25|||
147353301|NCT04489771|531464226|FG000|Overall Study|Withdrawal by Subject|1|||
147353302|NCT04489771|531464227|FG001|Overall Study|Withdrawal by Subject|0|||
147353303|NCT04489771|531464226|FG000|Overall Study|Participants Ongoing in Study|50|||
147353304|NCT04489771|531464227|FG001|Overall Study|Participants Ongoing in Study|51|||
147353305|NCT04509674|531464230|FG000|Overall Study|Not treated|33|||
147353306|NCT04509674|531464231|FG001|Overall Study|Not treated|26|||
147353307|NCT04509674|531464230|FG000|Overall Study|Protocol Violation|9|||
147353308|NCT04509674|531464231|FG001|Overall Study|Protocol Violation|10|||
147353309|NCT04509674|531464230|FG000|Overall Study|Lost to Follow-up|31|||
147353310|NCT04509674|531464231|FG001|Overall Study|Lost to Follow-up|39|||
147353311|NCT04509674|531464230|FG000|Overall Study|Patient refusal to continue, not due to adverse event|452|||
147353312|NCT04509674|531464231|FG001|Overall Study|Patient refusal to continue, not due to adverse event|418|||
147353313|NCT04509674|531464230|FG000|Overall Study|Adverse event, serious fatal event|11|||
147353314|NCT04509674|531464231|FG001|Overall Study|Adverse event, serious fatal event|4|||
147353315|NCT04509674|531464230|FG000|Overall Study|Adverse event, non-fatal event|107|||
147353316|NCT04509674|531464231|FG001|Overall Study|Adverse event, non-fatal event|118|||
147353317|NCT04509674|531464230|FG000|Overall Study|Other reason than listed|106|||
147353318|NCT04509674|531464231|FG001|Overall Study|Other reason than listed|95|||
147353319|NCT04064164|531464240|FG000|Overall Study|Withdrawal by Subject|8|||
147353320|NCT04064164|531464241|FG001|Overall Study|Withdrawal by Subject|8|||
147353321|NCT04059484|531464243|FG000|Overall Study|Adverse Event|2|||
147353322|NCT04059484|531464244|FG001|Overall Study|Adverse Event|5|||
147353323|NCT04059484|531464243|FG000|Overall Study|Withdrawal by Subject|5|||
147353324|NCT04059484|531464244|FG001|Overall Study|Withdrawal by Subject|3|||
147453539|NCT00852995|531824030|FG000|Overall Study|Adverse Event|1|||
147453540|NCT00852995|531824031|FG001|Overall Study|Adverse Event|0|||
147607382|NCT02552212|532377287|FG001|Double-Blind Period (Week 0 - 52)|Protocol Violation|1|||
147353325|NCT04059484|531464243|FG000|Overall Study|Progressive disease|112|||
147353326|NCT04059484|531464244|FG001|Overall Study|Progressive disease|112|||
147353327|NCT04059484|531464243|FG000|Overall Study|Other|8|||
147353328|NCT04059484|531464244|FG001|Overall Study|Other|3|||
147353329|NCT04059484|531464243|FG000|Overall Study|Ongoing|20|||
147353330|NCT04059484|531464244|FG001|Overall Study|Ongoing|20|||
147353331|NCT04292223|531464245|FG000|Overall Study|Adverse Event|1|||
147353332|NCT04292223|531464245|FG000|Overall Study|Lost to Follow-up|1|||
147353333|NCT04292223|531464245|FG000|Overall Study|Noncompliance with study drug|2|||
147353334|NCT04292223|531464245|FG000|Overall Study|Patient moved out of the state|1|||
147353335|NCT06190691|531464246|FG000|Overall Study|Adverse Event|2|||
147353336|NCT06190691|531464247|FG001|Overall Study|Adverse Event|0|||
147353337|NCT06190691|531464248|FG002|Overall Study|Adverse Event|0|||
147353338|NCT06190691|531464249|FG003|Overall Study|Adverse Event|0|||
147353339|NCT02023866|531464251|FG000|Overall Study|Non-compliance|2|||
147353340|NCT02023866|531464251|FG000|Overall Study|Adverse Event|3|||
147353341|NCT02023866|531464251|FG000|Overall Study|Withdrawal by Subject|1|||
147353342|NCT03839940|531464252|FG000|Overall Study|Withdrawal by Subject|3|||
147353343|NCT03839940|531464253|FG001|Overall Study|Withdrawal by Subject|0|||
147353344|NCT03839940|531464252|FG000|Overall Study|Protocol Violation|0|||
147353345|NCT03839940|531464253|FG001|Overall Study|Protocol Violation|1|||
147353346|NCT03839940|531464252|FG000|Overall Study|No Post-Baseline Pain Score Data|1|||
147353347|NCT03839940|531464253|FG001|Overall Study|No Post-Baseline Pain Score Data|1|||
147353348|NCT03524118|531464255|FG000|Overall Study|Lost to Follow-up|0|||
147353349|NCT03524118|531464256|FG001|Overall Study|Lost to Follow-up|0|||
147353350|NCT03524118|531464257|FG002|Overall Study|Lost to Follow-up|0|||
147353351|NCT03524118|531464258|FG003|Overall Study|Lost to Follow-up|0|||
147353352|NCT03524118|531464259|FG004|Overall Study|Lost to Follow-up|1|||
147353353|NCT03524118|531464260|FG005|Overall Study|Lost to Follow-up|0|||
147353354|NCT03524118|531464255|FG000|Overall Study|Other|0|||
147353355|NCT03524118|531464256|FG001|Overall Study|Other|1|||
147353356|NCT03524118|531464257|FG002|Overall Study|Other|0|||
147353357|NCT03524118|531464258|FG003|Overall Study|Other|0|||
147353358|NCT03524118|531464259|FG004|Overall Study|Other|1|||
147353359|NCT03524118|531464260|FG005|Overall Study|Other|1|||
147353360|NCT03524118|531464255|FG000|Overall Study|Physician Decision|0|||
147353361|NCT03524118|531464256|FG001|Overall Study|Physician Decision|0|||
147353362|NCT03524118|531464257|FG002|Overall Study|Physician Decision|0|||
147353363|NCT03524118|531464258|FG003|Overall Study|Physician Decision|0|||
147353364|NCT03524118|531464259|FG004|Overall Study|Physician Decision|1|||
147353365|NCT03524118|531464260|FG005|Overall Study|Physician Decision|0|||
147353366|NCT03524118|531464255|FG000|Overall Study|Protocol Violation|0|||
147353367|NCT03524118|531464256|FG001|Overall Study|Protocol Violation|0|||
147353368|NCT03524118|531464257|FG002|Overall Study|Protocol Violation|1|||
147353369|NCT03524118|531464258|FG003|Overall Study|Protocol Violation|0|||
147353370|NCT03524118|531464259|FG004|Overall Study|Protocol Violation|1|||
147353371|NCT03524118|531464260|FG005|Overall Study|Protocol Violation|0|||
147353372|NCT03524118|531464255|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
147353373|NCT03524118|531464256|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
147353374|NCT03524118|531464257|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
147353375|NCT03524118|531464258|FG003|Overall Study|Withdrawal by Parent/Guardian|1|||
147353376|NCT03524118|531464259|FG004|Overall Study|Withdrawal by Parent/Guardian|3|||
147353377|NCT03524118|531464260|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
147353378|NCT01437709|531464261|FG000|Overall Study|Adverse Event|0|||
147353379|NCT01437709|531464262|FG001|Overall Study|Adverse Event|1|||
147353380|NCT01437709|531464263|FG002|Overall Study|Adverse Event|0|||
147353381|NCT01437709|531464261|FG000|Overall Study|Pt trasnferred care|0|||
147353382|NCT01437709|531464262|FG001|Overall Study|Pt trasnferred care|1|||
147353383|NCT01437709|531464263|FG002|Overall Study|Pt trasnferred care|0|||
147353384|NCT01842542|531464264|FG000|Overall Study|Withdrawal by Subject|2|||
147353385|NCT01842542|531464264|FG000|Overall Study|Lack of Efficacy|1|||
147353386|NCT01842542|531464264|FG000|Overall Study|Protocol Non-compliance|2|||
147353387|NCT01842542|531464264|FG000|Overall Study|Lost to Follow-up|1|||
147353388|NCT01715285|531464265|FG000|Double Blind Period (Up to 23 Months)|Adverse Event|53|||
147353389|NCT01715285|531464266|FG001|Double Blind Period (Up to 23 Months)|Adverse Event|31|||
147353390|NCT01715285|531464267|FG002|Double Blind Period (Up to 23 Months)|Adverse Event|0|||
147353391|NCT01715285|531464265|FG000|Double Blind Period (Up to 23 Months)|Death|43|||
147353392|NCT01715285|531464266|FG001|Double Blind Period (Up to 23 Months)|Death|25|||
147353393|NCT01715285|531464267|FG002|Double Blind Period (Up to 23 Months)|Death|0|||
147353394|NCT01715285|531464265|FG000|Double Blind Period (Up to 23 Months)|Lost to Follow-up|3|||
147353395|NCT01715285|531464266|FG001|Double Blind Period (Up to 23 Months)|Lost to Follow-up|2|||
147353396|NCT01715285|531464267|FG002|Double Blind Period (Up to 23 Months)|Lost to Follow-up|0|||
147607383|NCT02552212|532377288|FG002|Double-Blind Period (Week 0 - 52)|Protocol Violation|0|||
147353397|NCT01715285|531464265|FG000|Double Blind Period (Up to 23 Months)|Physician Decision|21|||
147353398|NCT01715285|531464266|FG001|Double Blind Period (Up to 23 Months)|Physician Decision|23|||
147353399|NCT01715285|531464267|FG002|Double Blind Period (Up to 23 Months)|Physician Decision|0|||
147353400|NCT01715285|531464265|FG000|Double Blind Period (Up to 23 Months)|Withdrawal by Subject|52|||
147353401|NCT01715285|531464266|FG001|Double Blind Period (Up to 23 Months)|Withdrawal by Subject|47|||
147353402|NCT01715285|531464267|FG002|Double Blind Period (Up to 23 Months)|Withdrawal by Subject|0|||
147353403|NCT01715285|531464265|FG000|Double Blind Period (Up to 23 Months)|Progressive Disease|254|||
147353404|NCT01715285|531464266|FG001|Double Blind Period (Up to 23 Months)|Progressive Disease|388|||
147353405|NCT01715285|531464267|FG002|Double Blind Period (Up to 23 Months)|Progressive Disease|0|||
147353406|NCT01715285|531464265|FG000|Double Blind Period (Up to 23 Months)|Noncompliance With Study Drug|4|||
147353407|NCT01715285|531464266|FG001|Double Blind Period (Up to 23 Months)|Noncompliance With Study Drug|2|||
147353408|NCT01715285|531464267|FG002|Double Blind Period (Up to 23 Months)|Noncompliance With Study Drug|0|||
147353409|NCT01715285|531464265|FG000|Double Blind Period (Up to 23 Months)|Placebo Cross-Over|0|||
147353410|NCT01715285|531464266|FG001|Double Blind Period (Up to 23 Months)|Placebo Cross-Over|72|||
147353411|NCT01715285|531464267|FG002|Double Blind Period (Up to 23 Months)|Placebo Cross-Over|0|||
147353412|NCT01715285|531464265|FG000|Double Blind Period (Up to 23 Months)|Other|167|||
147353413|NCT01715285|531464266|FG001|Double Blind Period (Up to 23 Months)|Other|12|||
147353414|NCT01715285|531464267|FG002|Double Blind Period (Up to 23 Months)|Other|0|||
147353415|NCT01715285|531464265|FG000|OLE Phase (Up to 15.6 Months)|Death|0|||
147353416|NCT01715285|531464266|FG001|OLE Phase (Up to 15.6 Months)|Death|0|||
147353417|NCT01715285|531464267|FG002|OLE Phase (Up to 15.6 Months)|Death|4|||
147353418|NCT01715285|531464265|FG000|OLE Phase (Up to 15.6 Months)|Other|0|||
147353419|NCT01715285|531464266|FG001|OLE Phase (Up to 15.6 Months)|Other|0|||
147353420|NCT01715285|531464267|FG002|OLE Phase (Up to 15.6 Months)|Other|60|||
147353421|NCT01715285|531464265|FG000|OLE Phase (Up to 15.6 Months)|Progressive Disease|0|||
147353422|NCT01715285|531464266|FG001|OLE Phase (Up to 15.6 Months)|Progressive Disease|0|||
147353423|NCT01715285|531464267|FG002|OLE Phase (Up to 15.6 Months)|Progressive Disease|1|||
147353424|NCT01715285|531464265|FG000|OLE Phase (Up to 15.6 Months)|Withdrawal by Subject|0|||
147353425|NCT01715285|531464266|FG001|OLE Phase (Up to 15.6 Months)|Withdrawal by Subject|0|||
147353426|NCT01715285|531464267|FG002|OLE Phase (Up to 15.6 Months)|Withdrawal by Subject|6|||
147353427|NCT01715285|531464265|FG000|OLE Phase (Up to 15.6 Months)|Adverse Event|0|||
147353428|NCT01715285|531464266|FG001|OLE Phase (Up to 15.6 Months)|Adverse Event|0|||
147353429|NCT01715285|531464267|FG002|OLE Phase (Up to 15.6 Months)|Adverse Event|1|||
147353430|NCT05780437|531464268|FG000|Overall Study|Withdrawal by Subject|22|||
147353431|NCT05780437|531464269|FG001|Overall Study|Withdrawal by Subject|16|||
147353432|NCT03452579|531464276|FG000|Overall Study|Death|0|||
147353433|NCT03452579|531464277|FG001|Overall Study|Death|1|||
147353434|NCT03452579|531464276|FG000|Overall Study|Withdrawal by Subject|2|||
147353435|NCT03452579|531464277|FG001|Overall Study|Withdrawal by Subject|0|||
147353436|NCT03452579|531464276|FG000|Overall Study|Disease progression, relapse during active treatment|38|||
147353437|NCT03452579|531464277|FG001|Overall Study|Disease progression, relapse during active treatment|37|||
147353438|NCT03452579|531464276|FG000|Overall Study|Physician Decision|1|||
147353439|NCT03452579|531464277|FG001|Overall Study|Physician Decision|1|||
147353440|NCT03452579|531464276|FG000|Overall Study|Adverse Event|1|||
147353441|NCT03452579|531464277|FG001|Overall Study|Adverse Event|4|||
147353442|NCT02573493|531464283|FG000|Overall Study|Determined to not be eligible after enrollment|0|||
147353443|NCT02573493|531464284|FG001|Overall Study|Determined to not be eligible after enrollment|0|||
147353444|NCT02573493|531464285|FG002|Overall Study|Determined to not be eligible after enrollment|0|||
147353445|NCT02573493|531464286|FG003|Overall Study|Determined to not be eligible after enrollment|1|||
147353446|NCT02677805|531464290|FG000|Double Blind Phase|Lost to Follow-up|8|||
147353447|NCT02677805|531464291|FG001|Double Blind Phase|Lost to Follow-up|3|||
147353448|NCT02677805|531464292|FG002|Double Blind Phase|Lost to Follow-up|0|||
147353449|NCT02677805|531464290|FG000|Double Blind Phase|Withdrawal by Subject|5|||
147353450|NCT02677805|531464291|FG001|Double Blind Phase|Withdrawal by Subject|2|||
147353451|NCT02677805|531464292|FG002|Double Blind Phase|Withdrawal by Subject|0|||
147353452|NCT02677805|531464290|FG000|Open Label Phase|Lost to Follow-up|0|||
147353453|NCT02677805|531464291|FG001|Open Label Phase|Lost to Follow-up|0|||
147353454|NCT02677805|531464292|FG002|Open Label Phase|Lost to Follow-up|10|||
147353455|NCT02677805|531464290|FG000|Open Label Phase|Withdrawal by Subject|0|||
147353456|NCT02677805|531464291|FG001|Open Label Phase|Withdrawal by Subject|0|||
147353457|NCT02677805|531464292|FG002|Open Label Phase|Withdrawal by Subject|6|||
147353458|NCT04350463|531464297|FG000|Overall Study|Other reason|0|||
147353459|NCT04350463|531464298|FG001|Overall Study|Other reason|0|||
147353460|NCT04350463|531464299|FG002|Overall Study|Other reason|0|||
147353461|NCT04350463|531464300|FG003|Overall Study|Other reason|1|||
147353462|NCT04350463|531464297|FG000|Overall Study|Lost to Follow-up|0|||
147353463|NCT04350463|531464298|FG001|Overall Study|Lost to Follow-up|0|||
147353464|NCT04350463|531464299|FG002|Overall Study|Lost to Follow-up|0|||
147353465|NCT04350463|531464300|FG003|Overall Study|Lost to Follow-up|2|||
147353466|NCT04350463|531464297|FG000|Overall Study|Withdrawal by Subject|4|||
147353467|NCT04350463|531464298|FG001|Overall Study|Withdrawal by Subject|0|||
147353468|NCT04350463|531464299|FG002|Overall Study|Withdrawal by Subject|1|||
147353469|NCT04350463|531464300|FG003|Overall Study|Withdrawal by Subject|4|||
147353470|NCT04350463|531464297|FG000|Overall Study|Adverse Event|0|||
147353471|NCT04350463|531464298|FG001|Overall Study|Adverse Event|0|||
147353472|NCT04350463|531464299|FG002|Overall Study|Adverse Event|0|||
147353473|NCT04350463|531464300|FG003|Overall Study|Adverse Event|2|||
147353474|NCT04350463|531464297|FG000|Overall Study|Death|27|||
147353475|NCT04350463|531464298|FG001|Overall Study|Death|2|||
147353476|NCT04350463|531464299|FG002|Overall Study|Death|13|||
147353477|NCT04350463|531464300|FG003|Overall Study|Death|26|||
147353478|NCT04111536|531464301|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|0|||
147353479|NCT04111536|531464302|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|1|||
147353480|NCT04111536|531464301|FG000|First Intervention (8 Weeks)|Adverse Event|0|||
147607384|NCT02552212|532377286|FG000|Double-Blind Period (Week 0 - 52)|Lost to Follow-up|1|||
147607385|NCT02552212|532377287|FG001|Double-Blind Period (Week 0 - 52)|Lost to Follow-up|0|||
147607386|NCT02552212|532377288|FG002|Double-Blind Period (Week 0 - 52)|Lost to Follow-up|0|||
147607387|NCT02552212|532377286|FG000|Double-Blind Period (Week 0 - 52)|Withdrawal by Subject|3|||
147607388|NCT02552212|532377287|FG001|Double-Blind Period (Week 0 - 52)|Withdrawal by Subject|7|||
147607389|NCT02552212|532377288|FG002|Double-Blind Period (Week 0 - 52)|Withdrawal by Subject|0|||
147607390|NCT02552212|532377286|FG000|Double-Blind Period (Week 0 - 52)|Study non-compliance|1|||
147607391|NCT02552212|532377287|FG001|Double-Blind Period (Week 0 - 52)|Study non-compliance|1|||
147607392|NCT02552212|532377288|FG002|Double-Blind Period (Week 0 - 52)|Study non-compliance|0|||
147607393|NCT02552212|532377286|FG000|Double-Blind Period (Week 0 - 52)|Patient's decision|0|||
147607394|NCT02552212|532377287|FG001|Double-Blind Period (Week 0 - 52)|Patient's decision|1|||
147607395|NCT02552212|532377288|FG002|Double-Blind Period (Week 0 - 52)|Patient's decision|0|||
147607396|NCT02552212|532377286|FG000|Double-Blind Period (Week 0 - 52)|As per suggestion|0|||
147607397|NCT02552212|532377287|FG001|Double-Blind Period (Week 0 - 52)|As per suggestion|1|||
147607398|NCT02552212|532377288|FG002|Double-Blind Period (Week 0 - 52)|As per suggestion|0|||
147607399|NCT02552212|532377286|FG000|Double-Blind Period (Week 0 - 52)|Not eligible|0|||
147607400|NCT02552212|532377287|FG001|Double-Blind Period (Week 0 - 52)|Not eligible|1|||
147607401|NCT02552212|532377288|FG002|Double-Blind Period (Week 0 - 52)|Not eligible|0|||
147607402|NCT02552212|532377286|FG000|Double-Blind Period (Week 0 - 52)|Missing/Unspecified|1|||
147607403|NCT02552212|532377287|FG001|Double-Blind Period (Week 0 - 52)|Missing/Unspecified|0|||
147607404|NCT02552212|532377288|FG002|Double-Blind Period (Week 0 - 52)|Missing/Unspecified|0|||
147607405|NCT02552212|532377286|FG000|SFE Period (Week 52 - 156)|Adverse Event|0|||
147607406|NCT02552212|532377287|FG001|SFE Period (Week 52 - 156)|Adverse Event|0|||
147607407|NCT02552212|532377288|FG002|SFE Period (Week 52 - 156)|Adverse Event|5|||
147607408|NCT02552212|532377286|FG000|SFE Period (Week 52 - 156)|Lack of Efficacy|0|||
147607409|NCT02552212|532377287|FG001|SFE Period (Week 52 - 156)|Lack of Efficacy|0|||
147607410|NCT02552212|532377288|FG002|SFE Period (Week 52 - 156)|Lack of Efficacy|4|||
147353481|NCT04111536|531464302|FG001|First Intervention (8 Weeks)|Adverse Event|1|||
147353482|NCT04111536|531464301|FG000|Second Intervention (8 Weeks)|Lost to Follow-up|1|||
147353483|NCT04111536|531464302|FG001|Second Intervention (8 Weeks)|Lost to Follow-up|0|||
147353484|NCT04111536|531464301|FG000|Second Intervention (8 Weeks)|Adverse Event|0|||
147353485|NCT04111536|531464302|FG001|Second Intervention (8 Weeks)|Adverse Event|1|||
147353486|NCT03544281|531464303|FG000|Main Study Phase|Death|3|||
147353487|NCT03544281|531464304|FG001|Main Study Phase|Death|2|||
147353488|NCT03544281|531464305|FG002|Main Study Phase|Death|6|||
147353489|NCT03544281|531464306|FG003|Main Study Phase|Death|8|||
147353490|NCT03544281|531464307|FG004|Main Study Phase|Death|4|||
147353491|NCT03544281|531464308|FG005|Main Study Phase|Death|2|||
147353492|NCT03544281|531464309|FG006|Main Study Phase|Death|4|||
147353493|NCT03544281|531464310|FG007|Main Study Phase|Death|5|||
147353494|NCT03544281|531464311|FG008|Main Study Phase|Death|5|||
147353495|NCT03544281|531464312|FG009|Main Study Phase|Death|8|||
147353496|NCT03544281|531464313|FG010|Main Study Phase|Death|6|||
147353497|NCT03544281|531464314|FG011|Main Study Phase|Death|4|||
147353498|NCT03544281|531464315|FG012|Main Study Phase|Death|0|||
147353499|NCT03544281|531464316|FG013|Main Study Phase|Death|0|||
147353500|NCT03544281|531464317|FG014|Main Study Phase|Death|0|||
147353501|NCT03544281|531464318|FG015|Main Study Phase|Death|0|||
147353502|NCT03544281|531464319|FG016|Main Study Phase|Death|0|||
147353503|NCT03544281|531464320|FG017|Main Study Phase|Death|0|||
147353504|NCT03544281|531464321|FG018|Main Study Phase|Death|0|||
147353505|NCT03544281|531464322|FG019|Main Study Phase|Death|0|||
147353506|NCT03544281|531464323|FG020|Main Study Phase|Death|0|||
147353507|NCT03544281|531464324|FG021|Main Study Phase|Death|0|||
147353508|NCT03544281|531464303|FG000|Main Study Phase|Lost to Follow-up|0|||
147607411|NCT02552212|532377286|FG000|SFE Period (Week 52 - 156)|Lost to Follow-up|0|||
147607412|NCT02552212|532377287|FG001|SFE Period (Week 52 - 156)|Lost to Follow-up|0|||
147607413|NCT02552212|532377288|FG002|SFE Period (Week 52 - 156)|Lost to Follow-up|2|||
147607414|NCT02552212|532377286|FG000|SFE Period (Week 52 - 156)|Withdrawal by Subject|0|||
147607415|NCT02552212|532377287|FG001|SFE Period (Week 52 - 156)|Withdrawal by Subject|0|||
147607416|NCT02552212|532377288|FG002|SFE Period (Week 52 - 156)|Withdrawal by Subject|18|||
147607417|NCT02552212|532377286|FG000|SFE Period (Week 52 - 156)|Return to standard-of-care /OL CZP|0|||
147353509|NCT03544281|531464304|FG001|Main Study Phase|Lost to Follow-up|0|||
147353510|NCT03544281|531464305|FG002|Main Study Phase|Lost to Follow-up|0|||
147353511|NCT03544281|531464306|FG003|Main Study Phase|Lost to Follow-up|0|||
147353512|NCT03544281|531464307|FG004|Main Study Phase|Lost to Follow-up|0|||
147353513|NCT03544281|531464308|FG005|Main Study Phase|Lost to Follow-up|0|||
147353514|NCT03544281|531464309|FG006|Main Study Phase|Lost to Follow-up|0|||
147353515|NCT03544281|531464310|FG007|Main Study Phase|Lost to Follow-up|0|||
147353516|NCT03544281|531464311|FG008|Main Study Phase|Lost to Follow-up|0|||
147353517|NCT03544281|531464312|FG009|Main Study Phase|Lost to Follow-up|0|||
147353518|NCT03544281|531464313|FG010|Main Study Phase|Lost to Follow-up|1|||
147353519|NCT03544281|531464314|FG011|Main Study Phase|Lost to Follow-up|0|||
147353520|NCT03544281|531464315|FG012|Main Study Phase|Lost to Follow-up|0|||
147353521|NCT03544281|531464316|FG013|Main Study Phase|Lost to Follow-up|0|||
147353522|NCT03544281|531464317|FG014|Main Study Phase|Lost to Follow-up|0|||
147353523|NCT03544281|531464318|FG015|Main Study Phase|Lost to Follow-up|0|||
147353524|NCT03544281|531464319|FG016|Main Study Phase|Lost to Follow-up|0|||
147353525|NCT03544281|531464320|FG017|Main Study Phase|Lost to Follow-up|0|||
147353526|NCT03544281|531464321|FG018|Main Study Phase|Lost to Follow-up|0|||
147353527|NCT03544281|531464322|FG019|Main Study Phase|Lost to Follow-up|0|||
147353528|NCT03544281|531464323|FG020|Main Study Phase|Lost to Follow-up|0|||
147353529|NCT03544281|531464324|FG021|Main Study Phase|Lost to Follow-up|0|||
147353530|NCT03544281|531464303|FG000|Main Study Phase|Physician Decision|0|||
147353531|NCT03544281|531464304|FG001|Main Study Phase|Physician Decision|0|||
147353532|NCT03544281|531464305|FG002|Main Study Phase|Physician Decision|0|||
147353533|NCT03544281|531464306|FG003|Main Study Phase|Physician Decision|0|||
147353534|NCT03544281|531464307|FG004|Main Study Phase|Physician Decision|0|||
147353535|NCT03544281|531464308|FG005|Main Study Phase|Physician Decision|0|||
147353536|NCT03544281|531464309|FG006|Main Study Phase|Physician Decision|0|||
147353537|NCT03544281|531464310|FG007|Main Study Phase|Physician Decision|1|||
147353538|NCT03544281|531464311|FG008|Main Study Phase|Physician Decision|0|||
147353539|NCT03544281|531464312|FG009|Main Study Phase|Physician Decision|0|||
147353540|NCT03544281|531464313|FG010|Main Study Phase|Physician Decision|0|||
147353541|NCT03544281|531464314|FG011|Main Study Phase|Physician Decision|0|||
147353542|NCT03544281|531464315|FG012|Main Study Phase|Physician Decision|0|||
147353543|NCT03544281|531464316|FG013|Main Study Phase|Physician Decision|0|||
147353544|NCT03544281|531464317|FG014|Main Study Phase|Physician Decision|0|||
147353545|NCT03544281|531464318|FG015|Main Study Phase|Physician Decision|0|||
147353546|NCT03544281|531464319|FG016|Main Study Phase|Physician Decision|0|||
147353547|NCT03544281|531464320|FG017|Main Study Phase|Physician Decision|0|||
147353548|NCT03544281|531464321|FG018|Main Study Phase|Physician Decision|0|||
147353549|NCT03544281|531464322|FG019|Main Study Phase|Physician Decision|0|||
147353550|NCT03544281|531464323|FG020|Main Study Phase|Physician Decision|0|||
147353551|NCT03544281|531464324|FG021|Main Study Phase|Physician Decision|0|||
147353552|NCT03544281|531464303|FG000|Main Study Phase|Withdrawal by Subject|2|||
147353553|NCT03544281|531464304|FG001|Main Study Phase|Withdrawal by Subject|0|||
147353554|NCT03544281|531464305|FG002|Main Study Phase|Withdrawal by Subject|1|||
147353555|NCT03544281|531464306|FG003|Main Study Phase|Withdrawal by Subject|2|||
147353556|NCT03544281|531464307|FG004|Main Study Phase|Withdrawal by Subject|0|||
147353557|NCT03544281|531464308|FG005|Main Study Phase|Withdrawal by Subject|0|||
147353558|NCT03544281|531464309|FG006|Main Study Phase|Withdrawal by Subject|0|||
147353559|NCT03544281|531464310|FG007|Main Study Phase|Withdrawal by Subject|0|||
147353560|NCT03544281|531464311|FG008|Main Study Phase|Withdrawal by Subject|2|||
147353561|NCT03544281|531464312|FG009|Main Study Phase|Withdrawal by Subject|3|||
147353562|NCT03544281|531464313|FG010|Main Study Phase|Withdrawal by Subject|0|||
147353563|NCT03544281|531464314|FG011|Main Study Phase|Withdrawal by Subject|4|||
147353564|NCT03544281|531464315|FG012|Main Study Phase|Withdrawal by Subject|0|||
147353565|NCT03544281|531464316|FG013|Main Study Phase|Withdrawal by Subject|0|||
147353566|NCT03544281|531464317|FG014|Main Study Phase|Withdrawal by Subject|0|||
147353567|NCT03544281|531464318|FG015|Main Study Phase|Withdrawal by Subject|0|||
147353568|NCT03544281|531464319|FG016|Main Study Phase|Withdrawal by Subject|0|||
147353569|NCT03544281|531464320|FG017|Main Study Phase|Withdrawal by Subject|0|||
147353570|NCT03544281|531464321|FG018|Main Study Phase|Withdrawal by Subject|0|||
147353571|NCT03544281|531464322|FG019|Main Study Phase|Withdrawal by Subject|0|||
147353572|NCT03544281|531464323|FG020|Main Study Phase|Withdrawal by Subject|0|||
147353573|NCT03544281|531464324|FG021|Main Study Phase|Withdrawal by Subject|0|||
147353574|NCT03544281|531464303|FG000|Main Study Phase|Ongoing|3|||
147353575|NCT03544281|531464304|FG001|Main Study Phase|Ongoing|1|||
147353576|NCT03544281|531464305|FG002|Main Study Phase|Ongoing|2|||
147353577|NCT03544281|531464306|FG003|Main Study Phase|Ongoing|4|||
147353578|NCT03544281|531464307|FG004|Main Study Phase|Ongoing|2|||
147453541|NCT00852995|531824032|FG002|Overall Study|Adverse Event|4|||
147353579|NCT03544281|531464308|FG005|Main Study Phase|Ongoing|4|||
147353580|NCT03544281|531464309|FG006|Main Study Phase|Ongoing|4|||
147353581|NCT03544281|531464310|FG007|Main Study Phase|Ongoing|0|||
147353582|NCT03544281|531464311|FG008|Main Study Phase|Ongoing|2|||
147353583|NCT03544281|531464312|FG009|Main Study Phase|Ongoing|2|||
147453542|NCT00852995|531824033|FG003|Overall Study|Adverse Event|0|||
147453543|NCT00852995|531824034|FG004|Overall Study|Adverse Event|0|||
147353584|NCT03544281|531464313|FG010|Main Study Phase|Ongoing|1|||
147353585|NCT03544281|531464314|FG011|Main Study Phase|Ongoing|0|||
147353586|NCT03544281|531464315|FG012|Main Study Phase|Ongoing|0|||
147353587|NCT03544281|531464316|FG013|Main Study Phase|Ongoing|0|||
147353588|NCT03544281|531464317|FG014|Main Study Phase|Ongoing|0|||
147353589|NCT03544281|531464318|FG015|Main Study Phase|Ongoing|0|||
147353590|NCT03544281|531464319|FG016|Main Study Phase|Ongoing|0|||
147353591|NCT03544281|531464320|FG017|Main Study Phase|Ongoing|0|||
147353592|NCT03544281|531464321|FG018|Main Study Phase|Ongoing|0|||
147353593|NCT03544281|531464322|FG019|Main Study Phase|Ongoing|0|||
147353594|NCT03544281|531464323|FG020|Main Study Phase|Ongoing|0|||
147353595|NCT03544281|531464324|FG021|Main Study Phase|Ongoing|0|||
147353596|NCT03544281|531464303|FG000|Main Study Phase|Investigator Site Closed|0|||
147353597|NCT03544281|531464304|FG001|Main Study Phase|Investigator Site Closed|0|||
147353598|NCT03544281|531464305|FG002|Main Study Phase|Investigator Site Closed|0|||
147353599|NCT03544281|531464306|FG003|Main Study Phase|Investigator Site Closed|0|||
147353600|NCT03544281|531464307|FG004|Main Study Phase|Investigator Site Closed|0|||
147353601|NCT03544281|531464308|FG005|Main Study Phase|Investigator Site Closed|0|||
147353602|NCT03544281|531464309|FG006|Main Study Phase|Investigator Site Closed|0|||
147353603|NCT03544281|531464310|FG007|Main Study Phase|Investigator Site Closed|0|||
147353604|NCT03544281|531464311|FG008|Main Study Phase|Investigator Site Closed|0|||
147353605|NCT03544281|531464312|FG009|Main Study Phase|Investigator Site Closed|1|||
147353606|NCT03544281|531464313|FG010|Main Study Phase|Investigator Site Closed|0|||
147353607|NCT03544281|531464314|FG011|Main Study Phase|Investigator Site Closed|0|||
147353608|NCT03544281|531464315|FG012|Main Study Phase|Investigator Site Closed|0|||
147353609|NCT03544281|531464316|FG013|Main Study Phase|Investigator Site Closed|0|||
147353610|NCT03544281|531464317|FG014|Main Study Phase|Investigator Site Closed|0|||
147353611|NCT03544281|531464318|FG015|Main Study Phase|Investigator Site Closed|0|||
147353612|NCT03544281|531464319|FG016|Main Study Phase|Investigator Site Closed|0|||
147353613|NCT03544281|531464320|FG017|Main Study Phase|Investigator Site Closed|0|||
147353614|NCT03544281|531464321|FG018|Main Study Phase|Investigator Site Closed|0|||
147353615|NCT03544281|531464322|FG019|Main Study Phase|Investigator Site Closed|0|||
147353616|NCT03544281|531464323|FG020|Main Study Phase|Investigator Site Closed|0|||
147353617|NCT03544281|531464324|FG021|Main Study Phase|Investigator Site Closed|0|||
147353618|NCT03544281|531464303|FG000|Main Study Phase|Did not receive study treatment|0|||
147353619|NCT03544281|531464304|FG001|Main Study Phase|Did not receive study treatment|0|||
147353620|NCT03544281|531464305|FG002|Main Study Phase|Did not receive study treatment|0|||
147353621|NCT03544281|531464306|FG003|Main Study Phase|Did not receive study treatment|0|||
147353622|NCT03544281|531464307|FG004|Main Study Phase|Did not receive study treatment|0|||
147353623|NCT03544281|531464308|FG005|Main Study Phase|Did not receive study treatment|0|||
147353624|NCT03544281|531464309|FG006|Main Study Phase|Did not receive study treatment|1|||
147353625|NCT03544281|531464310|FG007|Main Study Phase|Did not receive study treatment|0|||
147353626|NCT03544281|531464311|FG008|Main Study Phase|Did not receive study treatment|0|||
147353627|NCT03544281|531464312|FG009|Main Study Phase|Did not receive study treatment|0|||
147353628|NCT03544281|531464313|FG010|Main Study Phase|Did not receive study treatment|0|||
147353629|NCT03544281|531464314|FG011|Main Study Phase|Did not receive study treatment|0|||
147353630|NCT03544281|531464315|FG012|Main Study Phase|Did not receive study treatment|0|||
147353631|NCT03544281|531464316|FG013|Main Study Phase|Did not receive study treatment|0|||
147353632|NCT03544281|531464317|FG014|Main Study Phase|Did not receive study treatment|0|||
147353633|NCT03544281|531464318|FG015|Main Study Phase|Did not receive study treatment|0|||
147353634|NCT03544281|531464319|FG016|Main Study Phase|Did not receive study treatment|0|||
147353635|NCT03544281|531464320|FG017|Main Study Phase|Did not receive study treatment|0|||
147353636|NCT03544281|531464321|FG018|Main Study Phase|Did not receive study treatment|0|||
147353637|NCT03544281|531464322|FG019|Main Study Phase|Did not receive study treatment|0|||
147353638|NCT03544281|531464323|FG020|Main Study Phase|Did not receive study treatment|0|||
147353639|NCT03544281|531464324|FG021|Main Study Phase|Did not receive study treatment|0|||
147353640|NCT03544281|531464303|FG000|PACT Phase|Adverse Event|0|||
147353641|NCT03544281|531464304|FG001|PACT Phase|Adverse Event|0|||
147353642|NCT03544281|531464305|FG002|PACT Phase|Adverse Event|0|||
147353643|NCT03544281|531464306|FG003|PACT Phase|Adverse Event|0|||
147353644|NCT03544281|531464307|FG004|PACT Phase|Adverse Event|0|||
147353645|NCT03544281|531464308|FG005|PACT Phase|Adverse Event|0|||
147353646|NCT03544281|531464309|FG006|PACT Phase|Adverse Event|0|||
147353647|NCT03544281|531464310|FG007|PACT Phase|Adverse Event|0|||
147353648|NCT03544281|531464311|FG008|PACT Phase|Adverse Event|0|||
147353649|NCT03544281|531464312|FG009|PACT Phase|Adverse Event|0|||
147353650|NCT03544281|531464313|FG010|PACT Phase|Adverse Event|0|||
147353651|NCT03544281|531464314|FG011|PACT Phase|Adverse Event|0|||
147353652|NCT03544281|531464315|FG012|PACT Phase|Adverse Event|1|||
147353653|NCT03544281|531464316|FG013|PACT Phase|Adverse Event|0|||
147353654|NCT03544281|531464317|FG014|PACT Phase|Adverse Event|0|||
147353655|NCT03544281|531464318|FG015|PACT Phase|Adverse Event|0|||
147353656|NCT03544281|531464319|FG016|PACT Phase|Adverse Event|0|||
147353657|NCT03544281|531464320|FG017|PACT Phase|Adverse Event|1|||
147453544|NCT00852995|531824030|FG000|Overall Study|Lost to Follow-up|0|||
147353658|NCT03544281|531464321|FG018|PACT Phase|Adverse Event|1|||
147353659|NCT03544281|531464322|FG019|PACT Phase|Adverse Event|0|||
147353660|NCT03544281|531464323|FG020|PACT Phase|Adverse Event|0|||
147353661|NCT03544281|531464324|FG021|PACT Phase|Adverse Event|0|||
147453545|NCT00852995|531824031|FG001|Overall Study|Lost to Follow-up|1|||
147353662|NCT02547987|531464325|FG000|Overall Study|Withdrawal by Subject|1|||
147353663|NCT02547987|531464325|FG000|Overall Study|Adverse Event|2|||
147353664|NCT04282148|531464326|FG000|Overall Study|Death|7|||
147353665|NCT04282148|531464326|FG000|Overall Study|Withdrawal by Subject|1|||
147353666|NCT04282148|531464326|FG000|Overall Study|Physician Decision|1|||
147353667|NCT04938492|531464328|FG000|Overall Study|Lost to Follow-up|17|||
147353668|NCT04938492|531464329|FG001|Overall Study|Lost to Follow-up|18|||
147353669|NCT01648023|531464330|FG000|Overall Study|Screen Fail Post Randomization|1|||
147353670|NCT01648023|531464331|FG001|Overall Study|Screen Fail Post Randomization|2|||
147353671|NCT04137289|531464334|FG000|Overall Study|Death|0|||
147353672|NCT04137289|531464335|FG001|Overall Study|Death|0|||
147353673|NCT04137289|531464336|FG002|Overall Study|Death|0|||
147353674|NCT04137289|531464337|FG003|Overall Study|Death|0|||
147353675|NCT04137289|531464338|FG004|Overall Study|Death|0|||
147353676|NCT04137289|531464339|FG005|Overall Study|Death|0|||
147353677|NCT04137289|531464340|FG006|Overall Study|Death|1|||
147353678|NCT04137289|531464341|FG007|Overall Study|Death|0|||
147353679|NCT04137289|531464342|FG008|Overall Study|Death|0|||
147353680|NCT04137289|531464334|FG000|Overall Study|Clinical disease progression|0|||
147353681|NCT04137289|531464335|FG001|Overall Study|Clinical disease progression|0|||
147353682|NCT04137289|531464336|FG002|Overall Study|Clinical disease progression|0|||
147353683|NCT04137289|531464337|FG003|Overall Study|Clinical disease progression|4|||
147353684|NCT04137289|531464338|FG004|Overall Study|Clinical disease progression|4|||
147353685|NCT04137289|531464339|FG005|Overall Study|Clinical disease progression|2|||
147353686|NCT04137289|531464340|FG006|Overall Study|Clinical disease progression|5|||
147353687|NCT04137289|531464341|FG007|Overall Study|Clinical disease progression|1|||
147353688|NCT04137289|531464342|FG008|Overall Study|Clinical disease progression|0|||
147353689|NCT04137289|531464334|FG000|Overall Study|Lost to Follow-up|0|||
147353690|NCT04137289|531464335|FG001|Overall Study|Lost to Follow-up|0|||
147353691|NCT04137289|531464336|FG002|Overall Study|Lost to Follow-up|0|||
147353692|NCT04137289|531464337|FG003|Overall Study|Lost to Follow-up|1|||
147353693|NCT04137289|531464338|FG004|Overall Study|Lost to Follow-up|0|||
147353694|NCT04137289|531464339|FG005|Overall Study|Lost to Follow-up|0|||
147353695|NCT04137289|531464340|FG006|Overall Study|Lost to Follow-up|0|||
147353696|NCT04137289|531464341|FG007|Overall Study|Lost to Follow-up|0|||
147353697|NCT04137289|531464342|FG008|Overall Study|Lost to Follow-up|0|||
147353698|NCT04137289|531464334|FG000|Overall Study|Adverse Event|0|||
147353699|NCT04137289|531464335|FG001|Overall Study|Adverse Event|0|||
147353700|NCT04137289|531464336|FG002|Overall Study|Adverse Event|1|||
147353701|NCT04137289|531464337|FG003|Overall Study|Adverse Event|0|||
147353702|NCT04137289|531464338|FG004|Overall Study|Adverse Event|0|||
147353703|NCT04137289|531464339|FG005|Overall Study|Adverse Event|1|||
147353704|NCT04137289|531464340|FG006|Overall Study|Adverse Event|0|||
147353705|NCT04137289|531464341|FG007|Overall Study|Adverse Event|0|||
147353706|NCT04137289|531464342|FG008|Overall Study|Adverse Event|0|||
147353707|NCT04137289|531464334|FG000|Overall Study|Lack of clinical benefit|0|||
147353708|NCT04137289|531464335|FG001|Overall Study|Lack of clinical benefit|0|||
147353709|NCT04137289|531464336|FG002|Overall Study|Lack of clinical benefit|0|||
147353710|NCT04137289|531464337|FG003|Overall Study|Lack of clinical benefit|0|||
147353711|NCT04137289|531464338|FG004|Overall Study|Lack of clinical benefit|0|||
147353712|NCT04137289|531464339|FG005|Overall Study|Lack of clinical benefit|0|||
147353713|NCT04137289|531464340|FG006|Overall Study|Lack of clinical benefit|0|||
147353714|NCT04137289|531464341|FG007|Overall Study|Lack of clinical benefit|0|||
147353715|NCT04137289|531464342|FG008|Overall Study|Lack of clinical benefit|1|||
147353716|NCT04137289|531464334|FG000|Overall Study|Objective disease progression|1|||
147353717|NCT04137289|531464335|FG001|Overall Study|Objective disease progression|1|||
147353718|NCT04137289|531464336|FG002|Overall Study|Objective disease progression|6|||
147353719|NCT04137289|531464337|FG003|Overall Study|Objective disease progression|18|||
147353720|NCT04137289|531464338|FG004|Overall Study|Objective disease progression|12|||
147353721|NCT04137289|531464339|FG005|Overall Study|Objective disease progression|20|||
147353722|NCT04137289|531464340|FG006|Overall Study|Objective disease progression|18|||
147353723|NCT04137289|531464341|FG007|Overall Study|Objective disease progression|7|||
147353724|NCT04137289|531464342|FG008|Overall Study|Objective disease progression|6|||
147353725|NCT04307355|531464343|FG000|Overall Study|Non-Compliance|3|||
147353726|NCT04307355|531464344|FG001|Overall Study|Non-Compliance|3|||
147353727|NCT04307355|531464345|FG002|Overall Study|Non-Compliance|0|||
147353728|NCT02547363|531464350|FG000|3-day Treatment and 8-week Follow-up|Adverse Event|0|||
147353729|NCT02547363|531464351|FG001|3-day Treatment and 8-week Follow-up|Adverse Event|1|||
147353730|NCT02547363|531464350|FG000|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|2|||
147353731|NCT02547363|531464351|FG001|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|8|||
147353732|NCT02547363|531464350|FG000|3-day Treatment and 8-week Follow-up|Lost to Follow-up|1|||
147353733|NCT02547363|531464351|FG001|3-day Treatment and 8-week Follow-up|Lost to Follow-up|1|||
147353734|NCT02547363|531464350|FG000|3-day Treatment and 8-week Follow-up|Other|1|||
147353735|NCT02547363|531464351|FG001|3-day Treatment and 8-week Follow-up|Other|1|||
147353736|NCT02547363|531464350|FG000|12-month Follow-up|Withdrawal by Subject|4|||
147353737|NCT02547363|531464351|FG001|12-month Follow-up|Withdrawal by Subject|3|||
147353738|NCT02547363|531464350|FG000|12-month Follow-up|Lost to Follow-up|4|||
147353739|NCT02547363|531464351|FG001|12-month Follow-up|Lost to Follow-up|1|||
147353740|NCT02547363|531464350|FG000|12-month Follow-up|Lack of Efficacy|1|||
147353741|NCT02547363|531464351|FG001|12-month Follow-up|Lack of Efficacy|1|||
147353742|NCT02547363|531464350|FG000|12-month Follow-up|Other|1|||
147353743|NCT02547363|531464351|FG001|12-month Follow-up|Other|0|||
147353744|NCT05028634|531466475|FG000|Overall Study|Withdrawal by Subject|0|||
147353745|NCT05028634|531466476|FG001|Overall Study|Withdrawal by Subject|1|||
147353746|NCT02140554|531466477|FG000|Overall Study|Withdrawal of consent|1|||
147353747|NCT02140554|531466478|FG001|Overall Study|Withdrawal of consent|0|||
147353748|NCT02140554|531466479|FG002|Overall Study|Withdrawal of consent|4|||
147353749|NCT02140554|531466477|FG000|Overall Study|Physician Decision|1|||
147353750|NCT02140554|531466478|FG001|Overall Study|Physician Decision|0|||
147353751|NCT02140554|531466479|FG002|Overall Study|Physician Decision|2|||
147353752|NCT02140554|531466477|FG000|Overall Study|Death|0|||
147353753|NCT02140554|531466478|FG001|Overall Study|Death|0|||
147353754|NCT02140554|531466479|FG002|Overall Study|Death|1|||
147353755|NCT02140554|531466477|FG000|Overall Study|Discontinued due to failure to mobilize|0|||
147353756|NCT02140554|531466478|FG001|Overall Study|Discontinued due to failure to mobilize|0|||
147353757|NCT02140554|531466479|FG002|Overall Study|Discontinued due to failure to mobilize|1|||
147353758|NCT03771417|531466480|FG000|Overall Study|Withdrawal by Subject|1|||
147353759|NCT03771417|531466481|FG001|Overall Study|Withdrawal by Subject|0|||
147353760|NCT03771417|531466482|FG002|Overall Study|Withdrawal by Subject|0|||
147353761|NCT03771417|531466480|FG000|Overall Study|Covid-19 Shutdown|0|||
147353762|NCT03771417|531466481|FG001|Overall Study|Covid-19 Shutdown|1|||
147353763|NCT03771417|531466482|FG002|Overall Study|Covid-19 Shutdown|0|||
147353764|NCT02100813|531466483|FG000|Overall Study|Adverse Event|0|||
147607418|NCT02552212|532377287|FG001|SFE Period (Week 52 - 156)|Return to standard-of-care /OL CZP|0|||
147607419|NCT02552212|532377288|FG002|SFE Period (Week 52 - 156)|Return to standard-of-care /OL CZP|1|||
147607420|NCT02552212|532377286|FG000|SFE Period (Week 52 - 156)|Patient's personal reason|0|||
147607421|NCT02552212|532377287|FG001|SFE Period (Week 52 - 156)|Patient's personal reason|0|||
147607422|NCT02552212|532377288|FG002|SFE Period (Week 52 - 156)|Patient's personal reason|1|||
147607423|NCT02552212|532377286|FG000|SFE Period (Week 52 - 156)|Investigator decision|0|||
147607424|NCT02552212|532377287|FG001|SFE Period (Week 52 - 156)|Investigator decision|0|||
147607425|NCT02552212|532377288|FG002|SFE Period (Week 52 - 156)|Investigator decision|1|||
147607426|NCT02552212|532377286|FG000|SFE Period (Week 52 - 156)|Subject withdrew consent due to traveling to site|0|||
147607427|NCT02552212|532377287|FG001|SFE Period (Week 52 - 156)|Subject withdrew consent due to traveling to site|0|||
147607428|NCT02552212|532377288|FG002|SFE Period (Week 52 - 156)|Subject withdrew consent due to traveling to site|1|||
147607429|NCT02552212|532377286|FG000|SFE Period (Week 52 - 156)|Compassionate access|0|||
147607430|NCT02552212|532377287|FG001|SFE Period (Week 52 - 156)|Compassionate access|0|||
147607431|NCT02552212|532377288|FG002|SFE Period (Week 52 - 156)|Compassionate access|2|||
147607432|NCT02552212|532377286|FG000|SFE Period (Week 52 - 156)|Patient travelling for study unable to continue|0|||
147607433|NCT02552212|532377287|FG001|SFE Period (Week 52 - 156)|Patient travelling for study unable to continue|0|||
147607434|NCT02552212|532377288|FG002|SFE Period (Week 52 - 156)|Patient travelling for study unable to continue|1|||
147607435|NCT02552212|532377286|FG000|SFE Period (Week 52 - 156)|Decision of Patient|0|||
147607436|NCT02552212|532377287|FG001|SFE Period (Week 52 - 156)|Decision of Patient|0|||
147607437|NCT02552212|532377288|FG002|SFE Period (Week 52 - 156)|Decision of Patient|1|||
147607438|NCT02728843|532377289|FG000|Overall Study|Adverse Event|0|||
147607439|NCT02728843|532377290|FG001|Overall Study|Adverse Event|2|||
147607440|NCT02728843|532377291|FG002|Overall Study|Adverse Event|3|||
147607441|NCT02728843|532377292|FG003|Overall Study|Adverse Event|1|||
147607442|NCT02728843|532377293|FG004|Overall Study|Adverse Event|2|||
147607443|NCT02728843|532377289|FG000|Overall Study|Lack of Efficacy|0|||
147607444|NCT02728843|532377290|FG001|Overall Study|Lack of Efficacy|1|||
147607445|NCT02728843|532377291|FG002|Overall Study|Lack of Efficacy|1|||
147607446|NCT02728843|532377292|FG003|Overall Study|Lack of Efficacy|0|||
147607447|NCT02728843|532377293|FG004|Overall Study|Lack of Efficacy|0|||
147607448|NCT02728843|532377289|FG000|Overall Study|Protocol Violation|2|||
147607449|NCT02728843|532377290|FG001|Overall Study|Protocol Violation|0|||
147607450|NCT02728843|532377291|FG002|Overall Study|Protocol Violation|4|||
147607451|NCT02728843|532377292|FG003|Overall Study|Protocol Violation|2|||
147607452|NCT02728843|532377293|FG004|Overall Study|Protocol Violation|2|||
147607453|NCT02728843|532377289|FG000|Overall Study|Withdrawal by Subject|1|||
147607454|NCT02728843|532377290|FG001|Overall Study|Withdrawal by Subject|0|||
147607455|NCT02728843|532377291|FG002|Overall Study|Withdrawal by Subject|0|||
147607456|NCT02728843|532377292|FG003|Overall Study|Withdrawal by Subject|1|||
147607457|NCT02728843|532377293|FG004|Overall Study|Withdrawal by Subject|0|||
147607458|NCT02728843|532377289|FG000|Overall Study|Use of rescue medication|0|||
147607459|NCT02728843|532377290|FG001|Overall Study|Use of rescue medication|2|||
147607460|NCT02728843|532377291|FG002|Overall Study|Use of rescue medication|0|||
147607461|NCT02728843|532377292|FG003|Overall Study|Use of rescue medication|2|||
147607462|NCT02728843|532377293|FG004|Overall Study|Use of rescue medication|1|||
147607463|NCT01671332|532377294|FG000|Overall Study|Withdrawal by Subject|1|||
147607464|NCT01671332|532377295|FG001|Overall Study|Withdrawal by Subject|1|||
147607465|NCT00459043|532378714|FG000|Overall Study|Withdrawal by Subject|1|||
147607466|NCT00459043|532378715|FG001|Overall Study|Withdrawal by Subject|0|||
147607467|NCT01392963|532378716|FG000|Week 0 (First Intervention)|Lost to Follow-up|0|||
147607468|NCT01392963|532378717|FG001|Week 0 (First Intervention)|Lost to Follow-up|1|||
147607469|NCT01392963|532378716|FG000|Week 0 (First Intervention)|Withdrawal by Subject|0|||
147353765|NCT02100813|531466484|FG001|Overall Study|Adverse Event|0|||
147353766|NCT02100813|531466485|FG002|Overall Study|Adverse Event|0|||
147353767|NCT02100813|531466486|FG003|Overall Study|Adverse Event|0|||
147353768|NCT02100813|531466487|FG004|Overall Study|Adverse Event|0|||
147353769|NCT02100813|531466488|FG005|Overall Study|Adverse Event|0|||
147353770|NCT02100813|531466489|FG006|Overall Study|Adverse Event|0|||
147353771|NCT02100813|531466490|FG007|Overall Study|Adverse Event|1|||
147353772|NCT00506519|531466497|FG000|Overall Study|Death|4|||
147353773|NCT00506519|531466498|FG001|Overall Study|Death|6|||
147353774|NCT00506519|531466499|FG002|Overall Study|Death|0|||
147353775|NCT00506519|531466497|FG000|Overall Study|Adverse Event|1|||
147353776|NCT00506519|531466498|FG001|Overall Study|Adverse Event|0|||
147353777|NCT00506519|531466499|FG002|Overall Study|Adverse Event|0|||
147353778|NCT02975882|531466500|FG000|Overall Study|Adverse Event|1|||
147353779|NCT02975882|531466501|FG001|Overall Study|Adverse Event|2|||
147353780|NCT02975882|531466502|FG002|Overall Study|Adverse Event|1|||
147353781|NCT02975882|531466503|FG003|Overall Study|Adverse Event|1|||
147353782|NCT02975882|531466500|FG000|Overall Study|Death|0|||
147353783|NCT02975882|531466501|FG001|Overall Study|Death|1|||
147353784|NCT02975882|531466502|FG002|Overall Study|Death|0|||
147353785|NCT02975882|531466503|FG003|Overall Study|Death|0|||
147353786|NCT02975882|531466500|FG000|Overall Study|Lack of Efficacy|3|||
147353787|NCT02975882|531466501|FG001|Overall Study|Lack of Efficacy|7|||
147353788|NCT02975882|531466502|FG002|Overall Study|Lack of Efficacy|4|||
147353789|NCT02975882|531466503|FG003|Overall Study|Lack of Efficacy|3|||
147353790|NCT02975882|531466500|FG000|Overall Study|Physician Decision|0|||
147353791|NCT02975882|531466501|FG001|Overall Study|Physician Decision|2|||
147353792|NCT02975882|531466502|FG002|Overall Study|Physician Decision|4|||
147353793|NCT02975882|531466503|FG003|Overall Study|Physician Decision|2|||
147353794|NCT02975882|531466500|FG000|Overall Study|Ineligible|0|||
147353795|NCT02975882|531466501|FG001|Overall Study|Ineligible|1|||
147353796|NCT02975882|531466502|FG002|Overall Study|Ineligible|0|||
147353797|NCT02975882|531466503|FG003|Overall Study|Ineligible|0|||
147353798|NCT02105766|531466504|FG000|Overall Study|Physician Decision|1|||
147353799|NCT02105766|531466505|FG001|Overall Study|Physician Decision|1|||
147353800|NCT02105766|531466506|FG002|Overall Study|Physician Decision|0|||
147353801|NCT02105766|531466504|FG000|Overall Study|Lost to Follow-up|2|||
147353802|NCT02105766|531466505|FG001|Overall Study|Lost to Follow-up|0|||
147353803|NCT02105766|531466506|FG002|Overall Study|Lost to Follow-up|0|||
147353804|NCT02105766|531466504|FG000|Overall Study|Death|1|||
147353805|NCT02105766|531466505|FG001|Overall Study|Death|1|||
147353806|NCT02105766|531466506|FG002|Overall Study|Death|0|||
147353807|NCT02985957|531466507|FG000|Pre-Treatment Period|Participant no longer meets study criteria|0|||
147353808|NCT02985957|531466508|FG001|Pre-Treatment Period|Participant no longer meets study criteria|0|||
147353809|NCT02985957|531466509|FG002|Pre-Treatment Period|Participant no longer meets study criteria|0|||
147353810|NCT02985957|531466510|FG003|Pre-Treatment Period|Participant no longer meets study criteria|0|||
147353811|NCT02985957|531466511|FG004|Pre-Treatment Period|Participant no longer meets study criteria|1|||
147353812|NCT02985957|531466512|FG005|Pre-Treatment Period|Participant no longer meets study criteria|0|||
147353813|NCT02985957|531466513|FG006|Pre-Treatment Period|Participant no longer meets study criteria|0|||
147353814|NCT02985957|531466507|FG000|Pre-Treatment Period|Participant withdrew consent|0|||
147353815|NCT02985957|531466508|FG001|Pre-Treatment Period|Participant withdrew consent|0|||
147353816|NCT02985957|531466509|FG002|Pre-Treatment Period|Participant withdrew consent|0|||
147353817|NCT02985957|531466510|FG003|Pre-Treatment Period|Participant withdrew consent|0|||
147353818|NCT02985957|531466511|FG004|Pre-Treatment Period|Participant withdrew consent|0|||
147353819|NCT02985957|531466512|FG005|Pre-Treatment Period|Participant withdrew consent|0|||
147353820|NCT02985957|531466513|FG006|Pre-Treatment Period|Participant withdrew consent|1|||
147353821|NCT02985957|531466507|FG000|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
147353822|NCT02985957|531466508|FG001|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
147353823|NCT02985957|531466509|FG002|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
147353824|NCT02985957|531466510|FG003|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
147353825|NCT02985957|531466511|FG004|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
147353826|NCT02985957|531466512|FG005|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
147353827|NCT02985957|531466513|FG006|Pre-Treatment Period|Adverse event unrelated to study drug|1|||
147353828|NCT02985957|531466507|FG000|Treatment Period|Death|0|||
147353829|NCT02985957|531466508|FG001|Treatment Period|Death|0|||
147353830|NCT02985957|531466509|FG002|Treatment Period|Death|0|||
147353831|NCT02985957|531466510|FG003|Treatment Period|Death|0|||
147353832|NCT02985957|531466511|FG004|Treatment Period|Death|1|||
147353833|NCT02985957|531466512|FG005|Treatment Period|Death|0|||
147353834|NCT02985957|531466513|FG006|Treatment Period|Death|0|||
147353835|NCT02985957|531466507|FG000|Treatment Period|Participant withdrew consent|0|||
147353836|NCT02985957|531466508|FG001|Treatment Period|Participant withdrew consent|0|||
147353837|NCT02985957|531466509|FG002|Treatment Period|Participant withdrew consent|0|||
147353838|NCT02985957|531466510|FG003|Treatment Period|Participant withdrew consent|1|||
147353839|NCT02985957|531466511|FG004|Treatment Period|Participant withdrew consent|3|||
147353840|NCT02985957|531466512|FG005|Treatment Period|Participant withdrew consent|0|||
147353841|NCT02985957|531466513|FG006|Treatment Period|Participant withdrew consent|1|||
147353842|NCT02985957|531466507|FG000|Treatment Period|Lost to Follow-up|0|||
147353843|NCT02985957|531466508|FG001|Treatment Period|Lost to Follow-up|0|||
147353844|NCT02985957|531466509|FG002|Treatment Period|Lost to Follow-up|0|||
147353845|NCT02985957|531466510|FG003|Treatment Period|Lost to Follow-up|0|||
147353846|NCT02985957|531466511|FG004|Treatment Period|Lost to Follow-up|1|||
147353847|NCT02985957|531466512|FG005|Treatment Period|Lost to Follow-up|0|||
147353848|NCT02985957|531466513|FG006|Treatment Period|Lost to Follow-up|0|||
147353849|NCT02985957|531466507|FG000|Treatment Period|Other reasons|0|||
147353850|NCT02985957|531466508|FG001|Treatment Period|Other reasons|0|||
147353851|NCT02985957|531466509|FG002|Treatment Period|Other reasons|1|||
147353852|NCT02985957|531466510|FG003|Treatment Period|Other reasons|3|||
147353853|NCT02985957|531466511|FG004|Treatment Period|Other reasons|6|||
147353854|NCT02985957|531466512|FG005|Treatment Period|Other reasons|0|||
147353855|NCT02985957|531466513|FG006|Treatment Period|Other reasons|1|||
147353856|NCT02985957|531466507|FG000|Treatment Period|Not reported|0|||
147353857|NCT02985957|531466508|FG001|Treatment Period|Not reported|1|||
147353858|NCT02985957|531466509|FG002|Treatment Period|Not reported|2|||
147353859|NCT02985957|531466510|FG003|Treatment Period|Not reported|5|||
147353860|NCT02985957|531466511|FG004|Treatment Period|Not reported|0|||
147353861|NCT02985957|531466512|FG005|Treatment Period|Not reported|0|||
147353862|NCT02985957|531466513|FG006|Treatment Period|Not reported|0|||
147353863|NCT02985957|531466507|FG000|Treatment Period|Maximum clinical benefit|0|||
147353864|NCT02985957|531466508|FG001|Treatment Period|Maximum clinical benefit|0|||
147353865|NCT02985957|531466509|FG002|Treatment Period|Maximum clinical benefit|1|||
147353866|NCT02985957|531466510|FG003|Treatment Period|Maximum clinical benefit|1|||
147353867|NCT02985957|531466511|FG004|Treatment Period|Maximum clinical benefit|0|||
147353868|NCT02985957|531466512|FG005|Treatment Period|Maximum clinical benefit|0|||
147353869|NCT02985957|531466513|FG006|Treatment Period|Maximum clinical benefit|2|||
147353870|NCT02985957|531466507|FG000|Treatment Period|Adverse event unrelated to study drug|1|||
147353871|NCT02985957|531466508|FG001|Treatment Period|Adverse event unrelated to study drug|4|||
147353872|NCT02985957|531466509|FG002|Treatment Period|Adverse event unrelated to study drug|1|||
147353873|NCT02985957|531466510|FG003|Treatment Period|Adverse event unrelated to study drug|3|||
147353874|NCT02985957|531466511|FG004|Treatment Period|Adverse event unrelated to study drug|7|||
147353875|NCT02985957|531466512|FG005|Treatment Period|Adverse event unrelated to study drug|2|||
147353876|NCT02985957|531466513|FG006|Treatment Period|Adverse event unrelated to study drug|7|||
147353877|NCT02985957|531466507|FG000|Treatment Period|Study drug toxicity|1|||
147353878|NCT02985957|531466508|FG001|Treatment Period|Study drug toxicity|23|||
147353879|NCT02985957|531466509|FG002|Treatment Period|Study drug toxicity|20|||
147353880|NCT02985957|531466510|FG003|Treatment Period|Study drug toxicity|11|||
147353881|NCT02985957|531466511|FG004|Treatment Period|Study drug toxicity|19|||
147353882|NCT02985957|531466512|FG005|Treatment Period|Study drug toxicity|3|||
147353883|NCT02985957|531466513|FG006|Treatment Period|Study drug toxicity|5|||
147353884|NCT02985957|531466507|FG000|Treatment Period|Disease progression|0|||
147353885|NCT02985957|531466508|FG001|Treatment Period|Disease progression|16|||
147353886|NCT02985957|531466509|FG002|Treatment Period|Disease progression|20|||
147353887|NCT02985957|531466510|FG003|Treatment Period|Disease progression|39|||
147353888|NCT02985957|531466511|FG004|Treatment Period|Disease progression|29|||
147353889|NCT02985957|531466512|FG005|Treatment Period|Disease progression|11|||
147353890|NCT02985957|531466513|FG006|Treatment Period|Disease progression|28|||
147353891|NCT02985957|531466507|FG000|Treatment Period|Participant request to discontinue study treatment|0|||
147353892|NCT02985957|531466508|FG001|Treatment Period|Participant request to discontinue study treatment|0|||
147353893|NCT02985957|531466509|FG002|Treatment Period|Participant request to discontinue study treatment|0|||
147353894|NCT02985957|531466510|FG003|Treatment Period|Participant request to discontinue study treatment|4|||
147353895|NCT02985957|531466511|FG004|Treatment Period|Participant request to discontinue study treatment|2|||
147353896|NCT02985957|531466512|FG005|Treatment Period|Participant request to discontinue study treatment|2|||
147353897|NCT02985957|531466513|FG006|Treatment Period|Participant request to discontinue study treatment|3|||
147353898|NCT02985957|531466507|FG000|Treatment Period|Poor/Non-Compliance|0|||
147353899|NCT02985957|531466508|FG001|Treatment Period|Poor/Non-Compliance|0|||
147353900|NCT02985957|531466509|FG002|Treatment Period|Poor/Non-Compliance|0|||
147353901|NCT02985957|531466510|FG003|Treatment Period|Poor/Non-Compliance|0|||
147353902|NCT02985957|531466511|FG004|Treatment Period|Poor/Non-Compliance|1|||
147353903|NCT02985957|531466512|FG005|Treatment Period|Poor/Non-Compliance|1|||
147662757|NCT04010461|532587417|FG000|Overall Study|No Motor Threshold obtainable|1|||
147662758|NCT04010461|532587417|FG000|Overall Study|Physician Decision|1|||
147353904|NCT02985957|531466513|FG006|Treatment Period|Poor/Non-Compliance|0|||
147353905|NCT02985957|531466507|FG000|Treatment Period|Continuing in Treatment Period|0|||
147353906|NCT02985957|531466508|FG001|Treatment Period|Continuing in Treatment Period|1|||
147353907|NCT02985957|531466509|FG002|Treatment Period|Continuing in Treatment Period|0|||
147353908|NCT02985957|531466510|FG003|Treatment Period|Continuing in Treatment Period|4|||
147353909|NCT02985957|531466511|FG004|Treatment Period|Continuing in Treatment Period|4|||
147453546|NCT00852995|531824032|FG002|Overall Study|Lost to Follow-up|1|||
147662759|NCT00102596|532587418|FG000|Part A|Screen failures|6|||
147353910|NCT02985957|531466512|FG005|Treatment Period|Continuing in Treatment Period|0|||
147353911|NCT02985957|531466513|FG006|Treatment Period|Continuing in Treatment Period|0|||
147353912|NCT04342494|531466514|FG000|Overall Study|Questionnaire partially completed|1|||
147353913|NCT04342494|531466515|FG001|Overall Study|Questionnaire partially completed|0|||
147353914|NCT04342494|531466516|FG002|Overall Study|Questionnaire partially completed|2|||
147353915|NCT04342494|531466517|FG003|Overall Study|Questionnaire partially completed|0|||
147353916|NCT04342494|531466518|FG004|Overall Study|Questionnaire partially completed|1|||
147353917|NCT04342494|531466514|FG000|Overall Study|Lost to Follow-up|49|||
147353918|NCT04342494|531466515|FG001|Overall Study|Lost to Follow-up|38|||
147353919|NCT04342494|531466516|FG002|Overall Study|Lost to Follow-up|34|||
147353920|NCT04342494|531466517|FG003|Overall Study|Lost to Follow-up|34|||
147353921|NCT04342494|531466518|FG004|Overall Study|Lost to Follow-up|35|||
147353922|NCT00753545|531466522|FG000|Overall Study|Death|98|||
147353923|NCT00753545|531466523|FG001|Overall Study|Death|112|||
147353924|NCT00753545|531466522|FG000|Overall Study|Lost to Follow-up|2|||
147353925|NCT00753545|531466523|FG001|Overall Study|Lost to Follow-up|3|||
147353926|NCT00753545|531466522|FG000|Overall Study|Protocol Violation|1|||
147353927|NCT00753545|531466523|FG001|Overall Study|Protocol Violation|0|||
147353928|NCT00753545|531466522|FG000|Overall Study|Voluntary Discontinuation of Patient|7|||
147353929|NCT00753545|531466523|FG001|Overall Study|Voluntary Discontinuation of Patient|3|||
147353930|NCT02485938|531466524|FG000|Overall Study|Withdrawal of consent|2|||
147353931|NCT02485938|531466525|FG001|Overall Study|Withdrawal of consent|0|||
147353932|NCT04633122|531466526|FG000|Overall Study|Remained on treatment|19|||
147353933|NCT04633122|531466527|FG001|Overall Study|Remained on treatment|14|||
147353934|NCT04633122|531466526|FG000|Overall Study|Survival follow-up stopped|22|||
147353935|NCT04633122|531466527|FG001|Overall Study|Survival follow-up stopped|25|||
147353936|NCT03241745|531466528|FG000|Overall Study|Adverse Event|7|||
147353937|NCT03241745|531466528|FG000|Overall Study|Death|1|||
147353938|NCT03241745|531466528|FG000|Overall Study|Withdrawal by Subject|5|||
147353939|NCT03241745|531466528|FG000|Overall Study|Treatment delay >28 days|2|||
147353940|NCT03241745|531466528|FG000|Overall Study|Lack of Efficacy|14|||
147353941|NCT04799899|531466529|FG000|Overall Study|Lost to Follow-up|2|||
147353942|NCT04799899|531466530|FG001|Overall Study|Lost to Follow-up|4|||
147353943|NCT04019873|531466531|FG000|Overall Study|Discontinued from the treatment|1|||
147353944|NCT04019873|531466532|FG001|Overall Study|Discontinued from the treatment|39|||
147353945|NCT04019873|531466533|FG002|Overall Study|Discontinued from the treatment|2|||
147353946|NCT04908722|531466536|FG000|Overall Study|Protocol deviation|1|||
147353947|NCT04908722|531466537|FG001|Overall Study|Protocol deviation|0|||
147353948|NCT04908722|531466538|FG002|Overall Study|Protocol deviation|0|||
147353949|NCT04908722|531466539|FG003|Overall Study|Protocol deviation|0|||
147353950|NCT04908722|531466540|FG004|Overall Study|Protocol deviation|0|||
147353951|NCT04908722|531466541|FG005|Overall Study|Protocol deviation|1|||
147353952|NCT04908722|531466536|FG000|Overall Study|Lost to Follow-up|33|||
147353953|NCT04908722|531466537|FG001|Overall Study|Lost to Follow-up|33|||
147353954|NCT04908722|531466538|FG002|Overall Study|Lost to Follow-up|36|||
147353955|NCT04908722|531466539|FG003|Overall Study|Lost to Follow-up|30|||
147353956|NCT04908722|531466540|FG004|Overall Study|Lost to Follow-up|32|||
147353957|NCT04908722|531466541|FG005|Overall Study|Lost to Follow-up|34|||
147353958|NCT04908722|531466536|FG000|Overall Study|Physician Decision|1|||
147353959|NCT04908722|531466537|FG001|Overall Study|Physician Decision|1|||
147353960|NCT04908722|531466538|FG002|Overall Study|Physician Decision|1|||
147353961|NCT04908722|531466539|FG003|Overall Study|Physician Decision|2|||
147353962|NCT04908722|531466540|FG004|Overall Study|Physician Decision|0|||
147353963|NCT04908722|531466541|FG005|Overall Study|Physician Decision|0|||
147353964|NCT04908722|531466536|FG000|Overall Study|Death|1|||
147353965|NCT04908722|531466537|FG001|Overall Study|Death|0|||
147353966|NCT04908722|531466538|FG002|Overall Study|Death|0|||
147353967|NCT04908722|531466539|FG003|Overall Study|Death|0|||
147353968|NCT04908722|531466540|FG004|Overall Study|Death|0|||
147353969|NCT04908722|531466541|FG005|Overall Study|Death|1|||
147353970|NCT04908722|531466536|FG000|Overall Study|Withdrawal by Subject|12|||
147353971|NCT04908722|531466537|FG001|Overall Study|Withdrawal by Subject|8|||
147353972|NCT04908722|531466538|FG002|Overall Study|Withdrawal by Subject|7|||
147353973|NCT04908722|531466539|FG003|Overall Study|Withdrawal by Subject|6|||
147353974|NCT04908722|531466540|FG004|Overall Study|Withdrawal by Subject|12|||
147353975|NCT04908722|531466541|FG005|Overall Study|Withdrawal by Subject|14|||
147353976|NCT04908722|531466536|FG000|Overall Study|Other|3|||
147353977|NCT04908722|531466537|FG001|Overall Study|Other|1|||
147353978|NCT04908722|531466538|FG002|Overall Study|Other|3|||
147353979|NCT04908722|531466539|FG003|Overall Study|Other|2|||
147353980|NCT04908722|531466540|FG004|Overall Study|Other|4|||
147353981|NCT04908722|531466541|FG005|Overall Study|Other|1|||
147353982|NCT04908722|531466536|FG000|Overall Study|Initiated prohibited medication|0|||
147353983|NCT04908722|531466537|FG001|Overall Study|Initiated prohibited medication|0|||
147353984|NCT04908722|531466538|FG002|Overall Study|Initiated prohibited medication|0|||
147353985|NCT04908722|531466539|FG003|Overall Study|Initiated prohibited medication|1|||
147353986|NCT04908722|531466540|FG004|Overall Study|Initiated prohibited medication|0|||
147353987|NCT04908722|531466541|FG005|Overall Study|Initiated prohibited medication|1|||
147353988|NCT04908722|531466536|FG000|Overall Study|Randomized but not vaccinated|3|||
147353989|NCT04908722|531466537|FG001|Overall Study|Randomized but not vaccinated|1|||
147353990|NCT04908722|531466538|FG002|Overall Study|Randomized but not vaccinated|2|||
147353991|NCT04908722|531466539|FG003|Overall Study|Randomized but not vaccinated|2|||
147353992|NCT04908722|531466540|FG004|Overall Study|Randomized but not vaccinated|3|||
147353993|NCT04908722|531466541|FG005|Overall Study|Randomized but not vaccinated|4|||
147353994|NCT03339713|531466542|FG000|Overall Study|Lost to Follow-up|2|||
147353995|NCT03339713|531466543|FG001|Overall Study|Lost to Follow-up|1|||
147353996|NCT03339713|531466542|FG000|Overall Study|Protocol Violation|1|||
147353997|NCT03339713|531466543|FG001|Overall Study|Protocol Violation|0|||
147353998|NCT03339713|531466542|FG000|Overall Study|Withdrawal by Subject|1|||
147353999|NCT03339713|531466543|FG001|Overall Study|Withdrawal by Subject|1|||
147354000|NCT04858321|531466544|FG000|Overall Study|Withdrawal by Subject|3|||
147354001|NCT03092518|531466546|FG000|Overall Study|Ineligible|2|||
147354002|NCT05170009|531466550|FG000|Overall Study|Physician Decision|0|||
147354003|NCT05170009|531466551|FG001|Overall Study|Physician Decision|1|||
147354004|NCT04925986|531466552|FG000|Overall Study|Death|0|||
147354005|NCT04925986|531466553|FG001|Overall Study|Death|0|||
147354006|NCT04925986|531466554|FG002|Overall Study|Death|2|||
147354007|NCT04925986|531466555|FG003|Overall Study|Death|0|||
147354008|NCT04925986|531466552|FG000|Overall Study|Lack of Efficacy|1|||
147354009|NCT04925986|531466553|FG001|Overall Study|Lack of Efficacy|2|||
147354010|NCT04925986|531466554|FG002|Overall Study|Lack of Efficacy|0|||
147354011|NCT04925986|531466555|FG003|Overall Study|Lack of Efficacy|1|||
147354012|NCT04925986|531466552|FG000|Overall Study|Withdrawal by Subject|0|||
147354013|NCT04925986|531466553|FG001|Overall Study|Withdrawal by Subject|0|||
147354014|NCT04925986|531466554|FG002|Overall Study|Withdrawal by Subject|1|||
147354015|NCT04925986|531466555|FG003|Overall Study|Withdrawal by Subject|2|||
147354016|NCT04629716|531466557|FG000|Overall Study|Lost to Follow-up|7|||
147354017|NCT04629716|531466558|FG001|Overall Study|Lost to Follow-up|3|||
147354018|NCT04770532|531466559|FG000|Overall Study|Withdrawal by Subject|0|||
147354019|NCT04770532|531466560|FG001|Overall Study|Withdrawal by Subject|3|||
147354020|NCT04770532|531466559|FG000|Overall Study|Physician Decision|1|||
147354021|NCT04770532|531466560|FG001|Overall Study|Physician Decision|0|||
147354022|NCT04770532|531466559|FG000|Overall Study|Death|2|||
147354023|NCT04770532|531466560|FG001|Overall Study|Death|2|||
147354024|NCT05457647|531466561|FG000|Overall Study|Lost to Follow-up|3|||
147354025|NCT03448107|531466563|FG000|Overall Study|Lost to Follow-up|229|||
147354026|NCT03448107|531466564|FG001|Overall Study|Lost to Follow-up|258|||
147354027|NCT04025554|531466565|FG000|Overall Study|Adverse Event|3|||
147354028|NCT03115476|531466566|FG000|LP0084-1369|Death|1|||
147354029|NCT03115476|531466567|FG001|LP0084-1369|Death|0|||
147354030|NCT03115476|531466568|FG002|LP0084-1369|Death|2|||
147354031|NCT03115476|531466566|FG000|LP0084-1369|Trial terminated by Sponsor|190|||
147354032|NCT03115476|531466567|FG001|LP0084-1369|Trial terminated by Sponsor|210|||
147354033|NCT03115476|531466568|FG002|LP0084-1369|Trial terminated by Sponsor|160|||
147354034|NCT05257486|531466572|FG000|Overall Study|Protocol Violation|3|||
147354035|NCT02310646|531466573|FG000|First Intervention (Day 1 - Day 7)|Withdrawal by Subject|1|||
147354036|NCT02310646|531466574|FG001|First Intervention (Day 1 - Day 7)|Withdrawal by Subject|0|||
147354037|NCT02310646|531466573|FG000|First Intervention (Day 1 - Day 7)|Lost to Follow-up|1|||
147354038|NCT02310646|531466574|FG001|First Intervention (Day 1 - Day 7)|Lost to Follow-up|0|||
147354039|NCT03021096|531466575|FG000|Overall Study|Lost to Follow-up|4|||
147354040|NCT03021096|531466575|FG000|Overall Study|Protocol Violation|2|||
147354041|NCT04700163|531466576|FG000|Overall Study|Lost to Follow-up|0|||
147354042|NCT04700163|531466577|FG001|Overall Study|Lost to Follow-up|0|||
147354043|NCT04700163|531466578|FG002|Overall Study|Lost to Follow-up|0|||
147354044|NCT04700163|531466579|FG003|Overall Study|Lost to Follow-up|0|||
147354045|NCT04700163|531466580|FG004|Overall Study|Lost to Follow-up|0|||
147354046|NCT04700163|531466581|FG005|Overall Study|Lost to Follow-up|1|||
147354047|NCT03865498|531466588|FG000|Overall Study|Lack of Efficacy|12|||
147354048|NCT03865498|531466589|FG001|Overall Study|Lack of Efficacy|11|||
147453547|NCT00852995|531824033|FG003|Overall Study|Lost to Follow-up|0|||
147354049|NCT03865498|531466588|FG000|Overall Study|Lost to Follow-up|125|||
147354050|NCT03865498|531466589|FG001|Overall Study|Lost to Follow-up|133|||
147354051|NCT03865498|531466588|FG000|Overall Study|Withdrawal by Subject|2|||
147453548|NCT00852995|531824034|FG004|Overall Study|Lost to Follow-up|0|||
147354052|NCT03865498|531466589|FG001|Overall Study|Withdrawal by Subject|4|||
147354053|NCT04137367|531466592|FG000|Overall Study|Lost to Follow-up|8|||
147354054|NCT04137367|531466593|FG001|Overall Study|Lost to Follow-up|6|||
147354055|NCT04137367|531466594|FG002|Overall Study|Lost to Follow-up|4|||
147354056|NCT04065841|531466599|FG000|Overall Study|Adverse Event|4|||
147354057|NCT04065841|531466600|FG001|Overall Study|Adverse Event|2|||
147354058|NCT04065841|531466601|FG002|Overall Study|Adverse Event|10|||
147607470|NCT01392963|532378717|FG001|Week 0 (First Intervention)|Withdrawal by Subject|1|||
147354059|NCT04065841|531466602|FG003|Overall Study|Adverse Event|1|||
147354060|NCT04065841|531466599|FG000|Overall Study|Lost to Follow-up|1|||
147354061|NCT04065841|531466600|FG001|Overall Study|Lost to Follow-up|2|||
147354062|NCT04065841|531466601|FG002|Overall Study|Lost to Follow-up|2|||
147354063|NCT04065841|531466602|FG003|Overall Study|Lost to Follow-up|2|||
147354064|NCT04065841|531466599|FG000|Overall Study|Physician Decision|1|||
147354065|NCT04065841|531466600|FG001|Overall Study|Physician Decision|0|||
147354066|NCT04065841|531466601|FG002|Overall Study|Physician Decision|0|||
147354067|NCT04065841|531466602|FG003|Overall Study|Physician Decision|0|||
147354068|NCT04065841|531466599|FG000|Overall Study|Protocol Violation|0|||
147354069|NCT04065841|531466600|FG001|Overall Study|Protocol Violation|1|||
147354070|NCT04065841|531466601|FG002|Overall Study|Protocol Violation|0|||
147354071|NCT04065841|531466602|FG003|Overall Study|Protocol Violation|0|||
147354072|NCT04065841|531466599|FG000|Overall Study|Study terminated by Sponsor|22|||
147354073|NCT04065841|531466600|FG001|Overall Study|Study terminated by Sponsor|16|||
147354074|NCT04065841|531466601|FG002|Overall Study|Study terminated by Sponsor|28|||
147354075|NCT04065841|531466602|FG003|Overall Study|Study terminated by Sponsor|17|||
147354076|NCT04065841|531466599|FG000|Overall Study|Withdrawal by Subject|1|||
147354077|NCT04065841|531466600|FG001|Overall Study|Withdrawal by Subject|1|||
147354078|NCT04065841|531466601|FG002|Overall Study|Withdrawal by Subject|2|||
147354079|NCT04065841|531466602|FG003|Overall Study|Withdrawal by Subject|0|||
147354080|NCT04338061|531466604|FG000|Double-blind Treatment Period: 156 Weeks|Withdrawal by Subject|59|||
147354081|NCT04338061|531466605|FG001|Double-blind Treatment Period: 156 Weeks|Withdrawal by Subject|52|||
147354082|NCT04338061|531466604|FG000|Double-blind Treatment Period: 156 Weeks|Lack of Efficacy|11|||
147354083|NCT04338061|531466605|FG001|Double-blind Treatment Period: 156 Weeks|Lack of Efficacy|16|||
147354084|NCT04338061|531466604|FG000|Double-blind Treatment Period: 156 Weeks|Other Reasons|17|||
147354085|NCT04338061|531466605|FG001|Double-blind Treatment Period: 156 Weeks|Other Reasons|22|||
147354086|NCT04338061|531466604|FG000|Double-blind Treatment Period: 156 Weeks|Adverse Event|67|||
147354087|NCT04338061|531466605|FG001|Double-blind Treatment Period: 156 Weeks|Adverse Event|70|||
147354088|NCT04338061|531466604|FG000|Double-blind Treatment Period: 156 Weeks|Protocol Non-Compliance|9|||
147354089|NCT04338061|531466605|FG001|Double-blind Treatment Period: 156 Weeks|Protocol Non-Compliance|8|||
147354090|NCT04338061|531466604|FG000|Double-blind Treatment Period: 156 Weeks|Lost to Follow-up|11|||
147354091|NCT04338061|531466605|FG001|Double-blind Treatment Period: 156 Weeks|Lost to Follow-up|3|||
147354092|NCT04338061|531466604|FG000|Double-blind Treatment Period: 156 Weeks|Randomized, but not treated|0|||
147354093|NCT04338061|531466605|FG001|Double-blind Treatment Period: 156 Weeks|Randomized, but not treated|2|||
147354094|NCT04338061|531466604|FG000|Double-blind Extension Period: 96 Weeks|Withdrawal by Subject|2|||
147354095|NCT04338061|531466605|FG001|Double-blind Extension Period: 96 Weeks|Withdrawal by Subject|1|||
147354096|NCT04338061|531466604|FG000|Double-blind Extension Period: 96 Weeks|Lost to Follow-up|1|||
147354097|NCT04338061|531466605|FG001|Double-blind Extension Period: 96 Weeks|Lost to Follow-up|2|||
147354098|NCT04338061|531466604|FG000|Double-blind Extension Period: 96 Weeks|Adverse Event|1|||
147354099|NCT04338061|531466605|FG001|Double-blind Extension Period: 96 Weeks|Adverse Event|1|||
147354100|NCT04338061|531466604|FG000|Double-blind Extension Period: 96 Weeks|Protocol Non-Compliance|1|||
147354101|NCT04338061|531466605|FG001|Double-blind Extension Period: 96 Weeks|Protocol Non-Compliance|0|||
147354102|NCT04338061|531466604|FG000|Double-blind Extension Period: 96 Weeks|Other Reasons|4|||
147354103|NCT04338061|531466605|FG001|Double-blind Extension Period: 96 Weeks|Other Reasons|8|||
147354104|NCT04074759|531466606|FG000|Overall Study|Withdrawal by Subject|0|||
147354105|NCT04074759|531466607|FG001|Overall Study|Withdrawal by Subject|0|||
147354106|NCT04074759|531466608|FG002|Overall Study|Withdrawal by Subject|0|||
147354107|NCT04074759|531466609|FG003|Overall Study|Withdrawal by Subject|0|||
147354108|NCT04074759|531466610|FG004|Overall Study|Withdrawal by Subject|0|||
147354109|NCT04074759|531466611|FG005|Overall Study|Withdrawal by Subject|2|||
147354110|NCT04074759|531466612|FG006|Overall Study|Withdrawal by Subject|0|||
147354111|NCT04074759|531466613|FG007|Overall Study|Withdrawal by Subject|2|||
147354112|NCT04074759|531466614|FG008|Overall Study|Withdrawal by Subject|1|||
147354113|NCT04074759|531466615|FG009|Overall Study|Withdrawal by Subject|2|||
147354114|NCT04074759|531466616|FG010|Overall Study|Withdrawal by Subject|9|||
147354115|NCT04074759|531466617|FG011|Overall Study|Withdrawal by Subject|2|||
147354116|NCT04074759|531466618|FG012|Overall Study|Withdrawal by Subject|1|||
147354117|NCT04074759|531466619|FG013|Overall Study|Withdrawal by Subject|3|||
147354118|NCT04074759|531466620|FG014|Overall Study|Withdrawal by Subject|2|||
147354119|NCT04074759|531466621|FG015|Overall Study|Withdrawal by Subject|0|||
147354120|NCT04074759|531466622|FG016|Overall Study|Withdrawal by Subject|0|||
147354121|NCT04074759|531466623|FG017|Overall Study|Withdrawal by Subject|3|||
147354122|NCT04074759|531466624|FG018|Overall Study|Withdrawal by Subject|1|||
147354123|NCT04074759|531466606|FG000|Overall Study|Death|1|||
147354124|NCT04074759|531466607|FG001|Overall Study|Death|0|||
147354125|NCT04074759|531466608|FG002|Overall Study|Death|1|||
147354126|NCT04074759|531466609|FG003|Overall Study|Death|1|||
147354127|NCT04074759|531466610|FG004|Overall Study|Death|2|||
147354128|NCT04074759|531466611|FG005|Overall Study|Death|0|||
147354129|NCT04074759|531466612|FG006|Overall Study|Death|1|||
147354130|NCT04074759|531466613|FG007|Overall Study|Death|0|||
147354131|NCT04074759|531466614|FG008|Overall Study|Death|3|||
147354132|NCT04074759|531466615|FG009|Overall Study|Death|2|||
147354133|NCT04074759|531466616|FG010|Overall Study|Death|4|||
147354134|NCT04074759|531466617|FG011|Overall Study|Death|1|||
147354135|NCT04074759|531466618|FG012|Overall Study|Death|0|||
147354136|NCT04074759|531466619|FG013|Overall Study|Death|2|||
147662760|NCT00102596|532587419|FG001|Part A|Screen failures|0|||
147662761|NCT00102596|532587418|FG000|Part A|Adverse Event|1|||
147662762|NCT00102596|532587419|FG001|Part A|Adverse Event|0|||
147662763|NCT01275144|532587420|FG000|Second Intervention (6 Days)|Withdrawal by Subject|1|||
147662764|NCT01275144|532587421|FG001|Second Intervention (6 Days)|Withdrawal by Subject|0|||
147662765|NCT05607576|532587423|FG000|Overall Study|immediate sensor error|2|||
147662766|NCT05607576|532587423|FG000|Overall Study|Physician Decision|2|||
147662767|NCT01827592|532587424|FG000|Overall Study|Adverse Event|11|||
147662768|NCT01827592|532587425|FG001|Overall Study|Adverse Event|9|||
147662769|NCT01827592|532587426|FG002|Overall Study|Adverse Event|2|||
147662770|NCT01827592|532587424|FG000|Overall Study|Physician Decision|0|||
147662771|NCT01827592|532587425|FG001|Overall Study|Physician Decision|2|||
147662772|NCT01827592|532587426|FG002|Overall Study|Physician Decision|1|||
147662773|NCT01827592|532587424|FG000|Overall Study|Protocol Violation|2|||
147662774|NCT01827592|532587425|FG001|Overall Study|Protocol Violation|1|||
147662775|NCT01827592|532587426|FG002|Overall Study|Protocol Violation|0|||
147662776|NCT01827592|532587424|FG000|Overall Study|Lost to Follow-up|1|||
147662777|NCT01827592|532587425|FG001|Overall Study|Lost to Follow-up|2|||
147662778|NCT01827592|532587426|FG002|Overall Study|Lost to Follow-up|2|||
147662779|NCT01827592|532587424|FG000|Overall Study|Withdrawal by Subject|12|||
147662780|NCT01827592|532587425|FG001|Overall Study|Withdrawal by Subject|11|||
147662781|NCT01827592|532587426|FG002|Overall Study|Withdrawal by Subject|11|||
147662782|NCT01827592|532587424|FG000|Overall Study|Patient's substantial non-compliance|1|||
147662783|NCT01827592|532587425|FG001|Overall Study|Patient's substantial non-compliance|1|||
147662784|NCT01827592|532587426|FG002|Overall Study|Patient's substantial non-compliance|6|||
147662785|NCT01827592|532587424|FG000|Overall Study|Trial terminated by Sponsor|47|||
147662786|NCT01827592|532587425|FG001|Overall Study|Trial terminated by Sponsor|53|||
147662787|NCT01827592|532587426|FG002|Overall Study|Trial terminated by Sponsor|51|||
147662788|NCT01827592|532587424|FG000|Overall Study|Others|0|||
147662789|NCT01827592|532587425|FG001|Overall Study|Others|1|||
147662790|NCT01827592|532587426|FG002|Overall Study|Others|3|||
147662791|NCT02532283|532587431|FG000|Overall Study|Adverse Event|0|||
147662792|NCT02532283|532587432|FG001|Overall Study|Adverse Event|1|||
147662793|NCT02532283|532587431|FG000|Overall Study|Death|1|||
147662794|NCT02532283|532587432|FG001|Overall Study|Death|0|||
147662795|NCT02532283|532587431|FG000|Overall Study|Lost to Follow-up|0|||
147662796|NCT02532283|532587432|FG001|Overall Study|Lost to Follow-up|1|||
147662797|NCT02532283|532587431|FG000|Overall Study|Withdrawal by Subject|8|||
147662798|NCT02532283|532587432|FG001|Overall Study|Withdrawal by Subject|3|||
147662799|NCT01945944|532587433|FG000|Overall Study|Adverse Event|0|||
147662800|NCT01945944|532587434|FG001|Overall Study|Adverse Event|2|||
147662801|NCT01945944|532587433|FG000|Overall Study|Physician Decision|1|||
147354137|NCT04074759|531466620|FG014|Overall Study|Death|1|||
147354138|NCT04074759|531466621|FG015|Overall Study|Death|0|||
147354139|NCT04074759|531466622|FG016|Overall Study|Death|1|||
147354140|NCT04074759|531466623|FG017|Overall Study|Death|0|||
147354141|NCT04074759|531466624|FG018|Overall Study|Death|1|||
147354142|NCT04074759|531466606|FG000|Overall Study|Lost to Follow-up|0|||
147354143|NCT04074759|531466607|FG001|Overall Study|Lost to Follow-up|0|||
147354144|NCT04074759|531466608|FG002|Overall Study|Lost to Follow-up|0|||
147354145|NCT04074759|531466609|FG003|Overall Study|Lost to Follow-up|0|||
147354146|NCT04074759|531466610|FG004|Overall Study|Lost to Follow-up|0|||
147354147|NCT04074759|531466611|FG005|Overall Study|Lost to Follow-up|0|||
147354148|NCT04074759|531466612|FG006|Overall Study|Lost to Follow-up|0|||
147354149|NCT04074759|531466613|FG007|Overall Study|Lost to Follow-up|0|||
147354150|NCT04074759|531466614|FG008|Overall Study|Lost to Follow-up|0|||
147354151|NCT04074759|531466615|FG009|Overall Study|Lost to Follow-up|0|||
147354152|NCT04074759|531466616|FG010|Overall Study|Lost to Follow-up|1|||
147354153|NCT04074759|531466617|FG011|Overall Study|Lost to Follow-up|0|||
147354154|NCT04074759|531466618|FG012|Overall Study|Lost to Follow-up|0|||
147354155|NCT04074759|531466619|FG013|Overall Study|Lost to Follow-up|0|||
147354156|NCT04074759|531466620|FG014|Overall Study|Lost to Follow-up|0|||
147354157|NCT04074759|531466621|FG015|Overall Study|Lost to Follow-up|0|||
147354158|NCT04074759|531466622|FG016|Overall Study|Lost to Follow-up|1|||
147354159|NCT04074759|531466623|FG017|Overall Study|Lost to Follow-up|0|||
147354160|NCT04074759|531466624|FG018|Overall Study|Lost to Follow-up|1|||
147354161|NCT04074759|531466606|FG000|Overall Study|Other|0|||
147354162|NCT04074759|531466607|FG001|Overall Study|Other|1|||
147354163|NCT04074759|531466608|FG002|Overall Study|Other|1|||
147354164|NCT04074759|531466609|FG003|Overall Study|Other|0|||
147354165|NCT04074759|531466610|FG004|Overall Study|Other|2|||
147354166|NCT04074759|531466611|FG005|Overall Study|Other|1|||
147354167|NCT04074759|531466612|FG006|Overall Study|Other|2|||
147354168|NCT04074759|531466613|FG007|Overall Study|Other|1|||
147354169|NCT04074759|531466614|FG008|Overall Study|Other|1|||
147662802|NCT01945944|532587434|FG001|Overall Study|Physician Decision|0|||
147662803|NCT01945944|532587433|FG000|Overall Study|Withdrawal by Subject|0|||
147354170|NCT04074759|531466615|FG009|Overall Study|Other|4|||
147354171|NCT04074759|531466616|FG010|Overall Study|Other|4|||
147354172|NCT04074759|531466617|FG011|Overall Study|Other|2|||
147662804|NCT01945944|532587434|FG001|Overall Study|Withdrawal by Subject|1|||
147354173|NCT04074759|531466618|FG012|Overall Study|Other|0|||
147354174|NCT04074759|531466619|FG013|Overall Study|Other|0|||
147354175|NCT04074759|531466620|FG014|Overall Study|Other|0|||
147354176|NCT04074759|531466621|FG015|Overall Study|Other|1|||
147354177|NCT04074759|531466622|FG016|Overall Study|Other|0|||
147354178|NCT04074759|531466623|FG017|Overall Study|Other|0|||
147354179|NCT04074759|531466624|FG018|Overall Study|Other|0|||
147354180|NCT04074759|531466606|FG000|Overall Study|Missing end of study status|0|||
147354181|NCT04074759|531466607|FG001|Overall Study|Missing end of study status|0|||
147354182|NCT04074759|531466608|FG002|Overall Study|Missing end of study status|0|||
147354183|NCT04074759|531466609|FG003|Overall Study|Missing end of study status|0|||
147354184|NCT04074759|531466610|FG004|Overall Study|Missing end of study status|0|||
147354185|NCT04074759|531466611|FG005|Overall Study|Missing end of study status|0|||
147354186|NCT04074759|531466612|FG006|Overall Study|Missing end of study status|0|||
147354187|NCT04074759|531466613|FG007|Overall Study|Missing end of study status|0|||
147354188|NCT04074759|531466614|FG008|Overall Study|Missing end of study status|0|||
147354189|NCT04074759|531466615|FG009|Overall Study|Missing end of study status|0|||
147354190|NCT04074759|531466616|FG010|Overall Study|Missing end of study status|2|||
147354191|NCT04074759|531466617|FG011|Overall Study|Missing end of study status|0|||
147354192|NCT04074759|531466618|FG012|Overall Study|Missing end of study status|0|||
147354193|NCT04074759|531466619|FG013|Overall Study|Missing end of study status|0|||
147354194|NCT04074759|531466620|FG014|Overall Study|Missing end of study status|0|||
147453549|NCT00852995|531824030|FG000|Overall Study|Withdrawal by Subject|4|||
147453550|NCT00852995|531824031|FG001|Overall Study|Withdrawal by Subject|0|||
147453551|NCT00852995|531824032|FG002|Overall Study|Withdrawal by Subject|0|||
147354195|NCT04074759|531466621|FG015|Overall Study|Missing end of study status|0|||
147354196|NCT04074759|531466622|FG016|Overall Study|Missing end of study status|1|||
147354197|NCT04074759|531466623|FG017|Overall Study|Missing end of study status|0|||
147354198|NCT04074759|531466624|FG018|Overall Study|Missing end of study status|0|||
147354199|NCT03631784|531466625|FG000|Overall Study|Participants Ongoing|1|||
147354200|NCT03631784|531466626|FG001|Overall Study|Participants Ongoing|0|||
147354201|NCT03631784|531466625|FG000|Overall Study|Withdrawal by Subject|3|||
147354202|NCT03631784|531466626|FG001|Overall Study|Withdrawal by Subject|3|||
147453552|NCT00852995|531824033|FG003|Overall Study|Withdrawal by Subject|1|||
147453553|NCT00852995|531824034|FG004|Overall Study|Withdrawal by Subject|2|||
147453554|NCT00852995|531824030|FG000|Overall Study|Non-Compliance|0|||
147453555|NCT00852995|531824031|FG001|Overall Study|Non-Compliance|0|||
147453556|NCT00852995|531824032|FG002|Overall Study|Non-Compliance|0|||
147453557|NCT00852995|531824033|FG003|Overall Study|Non-Compliance|2|||
147453558|NCT00852995|531824034|FG004|Overall Study|Non-Compliance|0|||
147453559|NCT00852995|531824030|FG000|Overall Study|Progressive Disease|1|||
147453560|NCT00852995|531824031|FG001|Overall Study|Progressive Disease|0|||
147453561|NCT00852995|531824032|FG002|Overall Study|Progressive Disease|0|||
147453562|NCT00852995|531824033|FG003|Overall Study|Progressive Disease|2|||
147453563|NCT00852995|531824034|FG004|Overall Study|Progressive Disease|1|||
147453564|NCT00852995|531824030|FG000|Overall Study|Physician Decision|1|||
147453565|NCT00852995|531824031|FG001|Overall Study|Physician Decision|0|||
147453566|NCT00852995|531824032|FG002|Overall Study|Physician Decision|0|||
147453567|NCT00852995|531824033|FG003|Overall Study|Physician Decision|0|||
147453568|NCT00852995|531824034|FG004|Overall Study|Physician Decision|0|||
147453569|NCT00852995|531824030|FG000|Overall Study|Protocol Violation|0|||
147453570|NCT00852995|531824031|FG001|Overall Study|Protocol Violation|0|||
147453571|NCT00852995|531824032|FG002|Overall Study|Protocol Violation|0|||
147453572|NCT00852995|531824033|FG003|Overall Study|Protocol Violation|0|||
147453573|NCT00852995|531824034|FG004|Overall Study|Protocol Violation|1|||
147453574|NCT00852995|531824030|FG000|Overall Study|Moved Out of Area|1|||
147453575|NCT00852995|531824031|FG001|Overall Study|Moved Out of Area|0|||
147453576|NCT00852995|531824032|FG002|Overall Study|Moved Out of Area|0|||
147453577|NCT00852995|531824033|FG003|Overall Study|Moved Out of Area|0|||
147453578|NCT00852995|531824034|FG004|Overall Study|Moved Out of Area|0|||
147453579|NCT03595553|531824035|FG000|Overall Study|Withdrawal by Subject|20|||
147453580|NCT03595553|531824036|FG001|Overall Study|Withdrawal by Subject|8|||
147453581|NCT03595553|531824035|FG000|Overall Study|Physician Decision|3|||
147453582|NCT03595553|531824036|FG001|Overall Study|Physician Decision|2|||
147453583|NCT03595553|531824035|FG000|Overall Study|Adverse Event|2|||
147453584|NCT03595553|531824036|FG001|Overall Study|Adverse Event|5|||
147453585|NCT03595553|531824035|FG000|Overall Study|Death|24|||
147453586|NCT03595553|531824036|FG001|Overall Study|Death|22|||
147453587|NCT03595553|531824035|FG000|Overall Study|Lost to Follow-up|6|||
147453588|NCT03595553|531824036|FG001|Overall Study|Lost to Follow-up|7|||
147453589|NCT03595553|531824035|FG000|Overall Study|Other as indicated in CSR|3|||
147453590|NCT03595553|531824036|FG001|Overall Study|Other as indicated in CSR|3|||
147453591|NCT03595553|531824035|FG000|Overall Study|Sponsor Decision|0|||
147453592|NCT03595553|531824036|FG001|Overall Study|Sponsor Decision|1|||
147453593|NCT02573155|531824037|FG000|Washout Between Treatment Period 1 and 2|Physician Decision|0|||
147354203|NCT03631784|531466625|FG000|Overall Study|Sponsor's Decision|36|||
147354204|NCT03631784|531466626|FG001|Overall Study|Sponsor's Decision|52|||
147453594|NCT02573155|531824038|FG001|Washout Between Treatment Period 1 and 2|Physician Decision|1|||
147607471|NCT01392963|532378716|FG000|Week 24 Follow-up|Lost to Follow-up|2|||
147607472|NCT01392963|532378717|FG001|Week 24 Follow-up|Lost to Follow-up|0|||
147607473|NCT03156504|532378721|FG000|Overall Study|Withdrawal by Subject|1|||
147607474|NCT03333941|532378722|FG000|Overall Study|Lost to Follow-up|10|||
147607475|NCT03333941|532378722|FG000|Overall Study|Death|2|||
147607476|NCT03333941|532378722|FG000|Overall Study|Adverse Event|1|||
147607477|NCT00741286|532378730|FG000|Overall Study|Lost to Follow-up|15|||
147607478|NCT00741286|532378731|FG001|Overall Study|Lost to Follow-up|10|||
147607479|NCT00741286|532378730|FG000|Overall Study|Adverse Event|1|||
147607480|NCT00741286|532378731|FG001|Overall Study|Adverse Event|6|||
147607481|NCT00741286|532378730|FG000|Overall Study|Protocol Violation|3|||
147607482|NCT00741286|532378731|FG001|Overall Study|Protocol Violation|2|||
147607483|NCT00741286|532378730|FG000|Overall Study|Primary Outcome|1|||
147607484|NCT00741286|532378731|FG001|Overall Study|Primary Outcome|1|||
147607485|NCT02842073|532378734|FG000|Overall Study|Withdrawal by Subject|1|||
147607486|NCT01333397|532378735|FG000|Overall Study|Lost to Follow-up|1|||
147607487|NCT01333397|532378736|FG001|Overall Study|Lost to Follow-up|0|||
147607488|NCT01333397|532378737|FG002|Overall Study|Lost to Follow-up|0|||
147607489|NCT01333397|532378738|FG003|Overall Study|Lost to Follow-up|1|||
147607490|NCT01333397|532378739|FG004|Overall Study|Lost to Follow-up|0|||
147607491|NCT01085357|532378740|FG000|Overall Study|Adverse Event|1|||
147453595|NCT02573155|531824037|FG000|Washout Between Treatment Period 1 and 2|Withdrawal by Subject|0|||
147453596|NCT02573155|531824038|FG001|Washout Between Treatment Period 1 and 2|Withdrawal by Subject|1|||
147453597|NCT02573155|531824037|FG000|Washout Between Treatment Period 1 and 2|Adverse Event|0|||
147453598|NCT02573155|531824038|FG001|Washout Between Treatment Period 1 and 2|Adverse Event|3|||
147453599|NCT02573155|531824037|FG000|Washout Between Treatment Period 2 and 3|Sponsor's decision|1|||
147453600|NCT02573155|531824038|FG001|Washout Between Treatment Period 2 and 3|Sponsor's decision|0|||
147453601|NCT02573155|531824037|FG000|Washout Between Treatment Period 2 and 3|Adverse Event|0|||
147453602|NCT02573155|531824038|FG001|Washout Between Treatment Period 2 and 3|Adverse Event|2|||
147453603|NCT02573155|531824037|FG000|Washout Between Treatment Period 3 and 4|Stability/variability criteria not met|0|||
147453604|NCT02573155|531824038|FG001|Washout Between Treatment Period 3 and 4|Stability/variability criteria not met|1|||
147453605|NCT02573155|531824037|FG000|Washout Between Treatment Period 3 and 4|Adverse Event|0|||
147453606|NCT02573155|531824038|FG001|Washout Between Treatment Period 3 and 4|Adverse Event|1|||
147453607|NCT02573155|531824037|FG000|Washout Between Treatment Period 4 and 5|Adverse Event|0|||
147453608|NCT02573155|531824038|FG001|Washout Between Treatment Period 4 and 5|Adverse Event|1|||
147453609|NCT00371865|531824041|FG000|Overall Study|Lack of Efficacy|0|||
147453610|NCT00371865|531824042|FG001|Overall Study|Lack of Efficacy|2|||
147453611|NCT00371865|531824041|FG000|Overall Study|Protocol Violation|3|||
147453612|NCT00371865|531824042|FG001|Overall Study|Protocol Violation|2|||
147453613|NCT00371865|531824041|FG000|Overall Study|Withdrawal by Subject|12|||
147453614|NCT00371865|531824042|FG001|Overall Study|Withdrawal by Subject|10|||
147453615|NCT02158091|531824053|FG000|Overall Study|DLT|2|||
147453616|NCT02158091|531824054|FG001|Overall Study|DLT|1|||
147453617|NCT02158091|531824055|FG002|Overall Study|DLT|0|||
147453618|NCT05913232|531824056|FG000|Overall Study|Adverse Event|0|||
147453619|NCT05913232|531824057|FG001|Overall Study|Adverse Event|2|||
147453620|NCT05913232|531824058|FG002|Overall Study|Adverse Event|1|||
147453621|NCT05913232|531824059|FG003|Overall Study|Adverse Event|1|||
147453622|NCT01318109|531824060|FG000|Overall Study|Adverse Event|0|||
147453623|NCT01318109|531824061|FG001|Overall Study|Adverse Event|2|||
147453624|NCT01318109|531824062|FG002|Overall Study|Adverse Event|0|||
147453625|NCT01318109|531824060|FG000|Overall Study|Withdrawal by Subject|1|||
147453626|NCT01318109|531824061|FG001|Overall Study|Withdrawal by Subject|0|||
147453627|NCT01318109|531824062|FG002|Overall Study|Withdrawal by Subject|0|||
147453628|NCT01318109|531824060|FG000|Overall Study|Schedule Conflict|0|||
147453629|NCT01318109|531824061|FG001|Overall Study|Schedule Conflict|1|||
147453630|NCT01318109|531824062|FG002|Overall Study|Schedule Conflict|0|||
147453631|NCT01328951|531824063|FG000|Overall Study|Disease Progression|17|||
147453632|NCT01328951|531824064|FG001|Overall Study|Disease Progression|14|||
147453633|NCT01328951|531824063|FG000|Overall Study|Adverse Event|2|||
147453634|NCT01328951|531824064|FG001|Overall Study|Adverse Event|0|||
147453635|NCT01328951|531824063|FG000|Overall Study|Death|243|||
147453636|NCT01328951|531824064|FG001|Overall Study|Death|258|||
147453637|NCT01328951|531824063|FG000|Overall Study|Lost to Follow-up|6|||
147453638|NCT01328951|531824064|FG001|Overall Study|Lost to Follow-up|7|||
147453639|NCT01328951|531824063|FG000|Overall Study|Withdrawal by Subject|6|||
147453640|NCT01328951|531824064|FG001|Overall Study|Withdrawal by Subject|6|||
147453641|NCT01328951|531824063|FG000|Overall Study|Study Closed by the Sponsor|36|||
147453642|NCT01328951|531824064|FG001|Overall Study|Study Closed by the Sponsor|31|||
147453643|NCT01328951|531824063|FG000|Overall Study|Other|11|||
147453644|NCT01328951|531824064|FG001|Overall Study|Other|6|||
147453645|NCT01627899|531824072|FG000|Overall Study|Study terminated early by sponsor.|5|||
147453646|NCT05103332|531824073|FG000|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
147607492|NCT01085357|532378741|FG001|Overall Study|Adverse Event|1|||
147607493|NCT01085357|532378740|FG000|Overall Study|Subject Decision|4|||
147607494|NCT01085357|532378741|FG001|Overall Study|Subject Decision|3|||
147354205|NCT03631784|531466625|FG000|Overall Study|Lost to Follow-up|1|||
147354206|NCT03631784|531466626|FG001|Overall Study|Lost to Follow-up|0|||
147354207|NCT03631784|531466625|FG000|Overall Study|Death|71|||
147354208|NCT03631784|531466626|FG001|Overall Study|Death|49|||
147354209|NCT05329220|531466627|FG000|Active Trial Period|Adverse Event|0|||
147354210|NCT05329220|531466628|FG001|Active Trial Period|Adverse Event|0|||
147354211|NCT05329220|531466629|FG002|Active Trial Period|Adverse Event|0|||
147354212|NCT05329220|531466630|FG003|Active Trial Period|Adverse Event|0|||
147354213|NCT05329220|531466631|FG004|Active Trial Period|Adverse Event|1|||
147354214|NCT05329220|531466632|FG005|Active Trial Period|Adverse Event|0|||
147354215|NCT05329220|531466627|FG000|Active Trial Period|Lost to Follow-up|0|||
147354216|NCT05329220|531466628|FG001|Active Trial Period|Lost to Follow-up|0|||
147354217|NCT05329220|531466629|FG002|Active Trial Period|Lost to Follow-up|0|||
147354218|NCT05329220|531466630|FG003|Active Trial Period|Lost to Follow-up|0|||
147354219|NCT05329220|531466631|FG004|Active Trial Period|Lost to Follow-up|32|||
147354220|NCT05329220|531466632|FG005|Active Trial Period|Lost to Follow-up|28|||
147354221|NCT05329220|531466627|FG000|Active Trial Period|Physician Decision|0|||
147354222|NCT05329220|531466628|FG001|Active Trial Period|Physician Decision|0|||
147354223|NCT05329220|531466629|FG002|Active Trial Period|Physician Decision|0|||
147354224|NCT05329220|531466630|FG003|Active Trial Period|Physician Decision|0|||
147354225|NCT05329220|531466631|FG004|Active Trial Period|Physician Decision|2|||
147354226|NCT05329220|531466632|FG005|Active Trial Period|Physician Decision|0|||
147354227|NCT05329220|531466627|FG000|Active Trial Period|Protocol Violation|0|||
147354228|NCT05329220|531466628|FG001|Active Trial Period|Protocol Violation|0|||
147354229|NCT05329220|531466629|FG002|Active Trial Period|Protocol Violation|0|||
147354230|NCT05329220|531466630|FG003|Active Trial Period|Protocol Violation|0|||
147354231|NCT05329220|531466631|FG004|Active Trial Period|Protocol Violation|1|||
147354232|NCT05329220|531466632|FG005|Active Trial Period|Protocol Violation|3|||
147354233|NCT05329220|531466627|FG000|Active Trial Period|Withdrawal by Subject|0|||
147354234|NCT05329220|531466628|FG001|Active Trial Period|Withdrawal by Subject|0|||
147354235|NCT05329220|531466629|FG002|Active Trial Period|Withdrawal by Subject|0|||
147354236|NCT05329220|531466630|FG003|Active Trial Period|Withdrawal by Subject|1|||
147354237|NCT05329220|531466631|FG004|Active Trial Period|Withdrawal by Subject|12|||
147354238|NCT05329220|531466632|FG005|Active Trial Period|Withdrawal by Subject|13|||
147354239|NCT05329220|531466627|FG000|Active Trial Period|SPONSOR GUIDANCE DUE TO SUBJECT'S CHANGE IN SCHEDULE WITH TRAVELING OUT OF THE COUNTRY|0|||
147354240|NCT05329220|531466628|FG001|Active Trial Period|SPONSOR GUIDANCE DUE TO SUBJECT'S CHANGE IN SCHEDULE WITH TRAVELING OUT OF THE COUNTRY|0|||
147354241|NCT05329220|531466629|FG002|Active Trial Period|SPONSOR GUIDANCE DUE TO SUBJECT'S CHANGE IN SCHEDULE WITH TRAVELING OUT OF THE COUNTRY|0|||
147354242|NCT05329220|531466630|FG003|Active Trial Period|SPONSOR GUIDANCE DUE TO SUBJECT'S CHANGE IN SCHEDULE WITH TRAVELING OUT OF THE COUNTRY|0|||
147354243|NCT05329220|531466631|FG004|Active Trial Period|SPONSOR GUIDANCE DUE TO SUBJECT'S CHANGE IN SCHEDULE WITH TRAVELING OUT OF THE COUNTRY|0|||
147354244|NCT05329220|531466632|FG005|Active Trial Period|SPONSOR GUIDANCE DUE TO SUBJECT'S CHANGE IN SCHEDULE WITH TRAVELING OUT OF THE COUNTRY|1|||
147354245|NCT05329220|531466627|FG000|Active Trial Period|THE PARTICIPANT HAD TO BE DROPPED FROM THE STUDY AS THEY WERE UNABLE TO CONTINUE.|0|||
147354246|NCT05329220|531466628|FG001|Active Trial Period|THE PARTICIPANT HAD TO BE DROPPED FROM THE STUDY AS THEY WERE UNABLE TO CONTINUE.|0|||
147354247|NCT05329220|531466629|FG002|Active Trial Period|THE PARTICIPANT HAD TO BE DROPPED FROM THE STUDY AS THEY WERE UNABLE TO CONTINUE.|0|||
147354248|NCT05329220|531466630|FG003|Active Trial Period|THE PARTICIPANT HAD TO BE DROPPED FROM THE STUDY AS THEY WERE UNABLE TO CONTINUE.|0|||
147354249|NCT05329220|531466631|FG004|Active Trial Period|THE PARTICIPANT HAD TO BE DROPPED FROM THE STUDY AS THEY WERE UNABLE TO CONTINUE.|0|||
147354250|NCT05329220|531466632|FG005|Active Trial Period|THE PARTICIPANT HAD TO BE DROPPED FROM THE STUDY AS THEY WERE UNABLE TO CONTINUE.|1|||
147354251|NCT05329220|531466627|FG000|Active Trial Period|SUBJECT WAS OOW|0|||
147354252|NCT05329220|531466628|FG001|Active Trial Period|SUBJECT WAS OOW|0|||
147354253|NCT05329220|531466629|FG002|Active Trial Period|SUBJECT WAS OOW|0|||
147354254|NCT05329220|531466630|FG003|Active Trial Period|SUBJECT WAS OOW|0|||
147354255|NCT05329220|531466631|FG004|Active Trial Period|SUBJECT WAS OOW|0|||
147354256|NCT05329220|531466632|FG005|Active Trial Period|SUBJECT WAS OOW|1|||
147354257|NCT05329220|531466627|FG000|Follow-up Period|Adverse Event|0|||
147354258|NCT05329220|531466628|FG001|Follow-up Period|Adverse Event|0|||
147354259|NCT05329220|531466629|FG002|Follow-up Period|Adverse Event|0|||
147354260|NCT05329220|531466630|FG003|Follow-up Period|Adverse Event|0|||
147354261|NCT05329220|531466631|FG004|Follow-up Period|Adverse Event|2|||
147354262|NCT05329220|531466632|FG005|Follow-up Period|Adverse Event|1|||
147354263|NCT05329220|531466627|FG000|Follow-up Period|Death|0|||
147354264|NCT05329220|531466628|FG001|Follow-up Period|Death|0|||
147354265|NCT05329220|531466629|FG002|Follow-up Period|Death|1|||
147354266|NCT05329220|531466630|FG003|Follow-up Period|Death|1|||
147354267|NCT05329220|531466631|FG004|Follow-up Period|Death|0|||
147354268|NCT05329220|531466632|FG005|Follow-up Period|Death|1|||
147354269|NCT05329220|531466627|FG000|Follow-up Period|Lost to Follow-up|0|||
147354270|NCT05329220|531466628|FG001|Follow-up Period|Lost to Follow-up|1|||
147354271|NCT05329220|531466629|FG002|Follow-up Period|Lost to Follow-up|2|||
147354272|NCT05329220|531466630|FG003|Follow-up Period|Lost to Follow-up|2|||
147354273|NCT05329220|531466631|FG004|Follow-up Period|Lost to Follow-up|113|||
147354274|NCT05329220|531466632|FG005|Follow-up Period|Lost to Follow-up|89|||
147354275|NCT05329220|531466627|FG000|Follow-up Period|Physician Decision|0|||
147354276|NCT05329220|531466628|FG001|Follow-up Period|Physician Decision|0|||
147354277|NCT05329220|531466629|FG002|Follow-up Period|Physician Decision|0|||
147354278|NCT05329220|531466630|FG003|Follow-up Period|Physician Decision|0|||
147354279|NCT05329220|531466631|FG004|Follow-up Period|Physician Decision|2|||
147354280|NCT05329220|531466632|FG005|Follow-up Period|Physician Decision|2|||
147354281|NCT05329220|531466627|FG000|Follow-up Period|Protocol Violation|0|||
147354282|NCT05329220|531466628|FG001|Follow-up Period|Protocol Violation|0|||
147354283|NCT05329220|531466629|FG002|Follow-up Period|Protocol Violation|0|||
147354284|NCT05329220|531466630|FG003|Follow-up Period|Protocol Violation|0|||
147354285|NCT05329220|531466631|FG004|Follow-up Period|Protocol Violation|0|||
147354286|NCT05329220|531466632|FG005|Follow-up Period|Protocol Violation|1|||
147354287|NCT05329220|531466627|FG000|Follow-up Period|Withdrawal by Subject|0|||
147354288|NCT05329220|531466628|FG001|Follow-up Period|Withdrawal by Subject|0|||
147354289|NCT05329220|531466629|FG002|Follow-up Period|Withdrawal by Subject|1|||
147354290|NCT05329220|531466630|FG003|Follow-up Period|Withdrawal by Subject|1|||
147354291|NCT05329220|531466631|FG004|Follow-up Period|Withdrawal by Subject|34|||
147354292|NCT05329220|531466632|FG005|Follow-up Period|Withdrawal by Subject|35|||
147354293|NCT05329220|531466627|FG000|Follow-up Period|PATIENT WORKS IN AUSTRALIA SINCE JUNE2023|0|||
147354294|NCT05329220|531466628|FG001|Follow-up Period|PATIENT WORKS IN AUSTRALIA SINCE JUNE2023|0|||
147354295|NCT05329220|531466629|FG002|Follow-up Period|PATIENT WORKS IN AUSTRALIA SINCE JUNE2023|1|||
147354296|NCT05329220|531466630|FG003|Follow-up Period|PATIENT WORKS IN AUSTRALIA SINCE JUNE2023|0|||
147354297|NCT05329220|531466631|FG004|Follow-up Period|PATIENT WORKS IN AUSTRALIA SINCE JUNE2023|0|||
147354298|NCT05329220|531466632|FG005|Follow-up Period|PATIENT WORKS IN AUSTRALIA SINCE JUNE2023|0|||
147354299|NCT05329220|531466627|FG000|Follow-up Period|SUBJECT WAS GOING OUT OF TOWN FOR AN EXTENDED PERIOD OF TIME|0|||
147354300|NCT05329220|531466628|FG001|Follow-up Period|SUBJECT WAS GOING OUT OF TOWN FOR AN EXTENDED PERIOD OF TIME|0|||
147354301|NCT05329220|531466629|FG002|Follow-up Period|SUBJECT WAS GOING OUT OF TOWN FOR AN EXTENDED PERIOD OF TIME|0|||
147354302|NCT05329220|531466630|FG003|Follow-up Period|SUBJECT WAS GOING OUT OF TOWN FOR AN EXTENDED PERIOD OF TIME|0|||
147354303|NCT05329220|531466631|FG004|Follow-up Period|SUBJECT WAS GOING OUT OF TOWN FOR AN EXTENDED PERIOD OF TIME|1|||
147354304|NCT05329220|531466632|FG005|Follow-up Period|SUBJECT WAS GOING OUT OF TOWN FOR AN EXTENDED PERIOD OF TIME|0|||
147354305|NCT05329220|531466627|FG000|Follow-up Period|SUBJECT NON-COMPLIANCE|0|||
147354306|NCT05329220|531466628|FG001|Follow-up Period|SUBJECT NON-COMPLIANCE|0|||
147354307|NCT05329220|531466629|FG002|Follow-up Period|SUBJECT NON-COMPLIANCE|0|||
147354308|NCT05329220|531466630|FG003|Follow-up Period|SUBJECT NON-COMPLIANCE|0|||
147354309|NCT05329220|531466631|FG004|Follow-up Period|SUBJECT NON-COMPLIANCE|1|||
147354310|NCT05329220|531466632|FG005|Follow-up Period|SUBJECT NON-COMPLIANCE|0|||
147354311|NCT05329220|531466627|FG000|Follow-up Period|SUBJECT MOVED OUT OF TOWN|0|||
147354312|NCT05329220|531466628|FG001|Follow-up Period|SUBJECT MOVED OUT OF TOWN|0|||
147354313|NCT05329220|531466629|FG002|Follow-up Period|SUBJECT MOVED OUT OF TOWN|0|||
147354314|NCT05329220|531466630|FG003|Follow-up Period|SUBJECT MOVED OUT OF TOWN|0|||
147354315|NCT05329220|531466631|FG004|Follow-up Period|SUBJECT MOVED OUT OF TOWN|0|||
147354316|NCT05329220|531466632|FG005|Follow-up Period|SUBJECT MOVED OUT OF TOWN|1|||
147354317|NCT05329220|531466627|FG000|Follow-up Period|EARLY TERMINATION|0|||
147354318|NCT05329220|531466628|FG001|Follow-up Period|EARLY TERMINATION|0|||
147354319|NCT05329220|531466629|FG002|Follow-up Period|EARLY TERMINATION|0|||
147354320|NCT05329220|531466630|FG003|Follow-up Period|EARLY TERMINATION|0|||
147354321|NCT05329220|531466631|FG004|Follow-up Period|EARLY TERMINATION|0|||
147354322|NCT05329220|531466632|FG005|Follow-up Period|EARLY TERMINATION|1|||
147354323|NCT05329220|531466627|FG000|Follow-up Period|SUBJECT HAD BUT DID NOT COMPLETE THEIR FINAL VISIT WITHIN 14 DAYS BEFORE THE V1 + 182 DAYS|0|||
147354324|NCT05329220|531466628|FG001|Follow-up Period|SUBJECT HAD BUT DID NOT COMPLETE THEIR FINAL VISIT WITHIN 14 DAYS BEFORE THE V1 + 182 DAYS|0|||
147354325|NCT05329220|531466629|FG002|Follow-up Period|SUBJECT HAD BUT DID NOT COMPLETE THEIR FINAL VISIT WITHIN 14 DAYS BEFORE THE V1 + 182 DAYS|0|||
147354326|NCT05329220|531466630|FG003|Follow-up Period|SUBJECT HAD BUT DID NOT COMPLETE THEIR FINAL VISIT WITHIN 14 DAYS BEFORE THE V1 + 182 DAYS|0|||
147354327|NCT05329220|531466631|FG004|Follow-up Period|SUBJECT HAD BUT DID NOT COMPLETE THEIR FINAL VISIT WITHIN 14 DAYS BEFORE THE V1 + 182 DAYS|0|||
147354328|NCT05329220|531466632|FG005|Follow-up Period|SUBJECT HAD BUT DID NOT COMPLETE THEIR FINAL VISIT WITHIN 14 DAYS BEFORE THE V1 + 182 DAYS|2|||
147354329|NCT05329220|531466627|FG000|Follow-up Period|DROPPED|0|||
147354330|NCT05329220|531466628|FG001|Follow-up Period|DROPPED|0|||
147354331|NCT05329220|531466629|FG002|Follow-up Period|DROPPED|0|||
147354332|NCT05329220|531466630|FG003|Follow-up Period|DROPPED|0|||
147354333|NCT05329220|531466631|FG004|Follow-up Period|DROPPED|0|||
147354334|NCT05329220|531466632|FG005|Follow-up Period|DROPPED|1|||
147354335|NCT05329220|531466627|FG000|Follow-up Period|DROPPED DUE TO BEING UNABLE TO CONTINUE IN THE TRIAL.|0|||
147354336|NCT05329220|531466628|FG001|Follow-up Period|DROPPED DUE TO BEING UNABLE TO CONTINUE IN THE TRIAL.|0|||
147354337|NCT05329220|531466629|FG002|Follow-up Period|DROPPED DUE TO BEING UNABLE TO CONTINUE IN THE TRIAL.|0|||
147354338|NCT05329220|531466630|FG003|Follow-up Period|DROPPED DUE TO BEING UNABLE TO CONTINUE IN THE TRIAL.|0|||
147354339|NCT05329220|531466631|FG004|Follow-up Period|DROPPED DUE TO BEING UNABLE TO CONTINUE IN THE TRIAL.|0|||
147453647|NCT05103332|531824074|FG001|DB Period (6 Months=168 Days)|Lost to Follow-up|2|||
147354340|NCT05329220|531466632|FG005|Follow-up Period|DROPPED DUE TO BEING UNABLE TO CONTINUE IN THE TRIAL.|1|||
147354341|NCT02465268|531466634|FG000|Overall Study|Withdrawal by Subject|4|||
147354342|NCT02465268|531466635|FG001|Overall Study|Withdrawal by Subject|3|||
147354343|NCT02465268|531466636|FG002|Overall Study|Withdrawal by Subject|1|||
147354344|NCT02465268|531466634|FG000|Overall Study|Not evaluable per protocol criteria|3|||
147354345|NCT02465268|531466635|FG001|Overall Study|Not evaluable per protocol criteria|2|||
147354346|NCT02465268|531466636|FG002|Overall Study|Not evaluable per protocol criteria|1|||
147354347|NCT02465268|531466634|FG000|Overall Study|did not meet eligibility prior to Cycle #1|8|||
147354348|NCT02465268|531466635|FG001|Overall Study|did not meet eligibility prior to Cycle #1|9|||
147354349|NCT02465268|531466636|FG002|Overall Study|did not meet eligibility prior to Cycle #1|9|||
147354350|NCT02465268|531466634|FG000|Overall Study|Study drug did not pass QA/QC|1|||
147354351|NCT02465268|531466635|FG001|Overall Study|Study drug did not pass QA/QC|0|||
147354352|NCT02465268|531466636|FG002|Overall Study|Study drug did not pass QA/QC|0|||
147354353|NCT02465268|531466634|FG000|Overall Study|Adverse Event|0|||
147354354|NCT02465268|531466635|FG001|Overall Study|Adverse Event|1|||
147354355|NCT02465268|531466636|FG002|Overall Study|Adverse Event|0|||
147354356|NCT02465268|531466634|FG000|Overall Study|Physician Decision|0|||
147354357|NCT02465268|531466635|FG001|Overall Study|Physician Decision|1|||
147354358|NCT02465268|531466636|FG002|Overall Study|Physician Decision|0|||
147354359|NCT00324805|531466637|FG000|Overall Study|Adverse Event|62|||
147354360|NCT00324805|531466638|FG001|Overall Study|Adverse Event|203|||
147354361|NCT00324805|531466637|FG000|Overall Study|Progression|7|||
147354362|NCT00324805|531466638|FG001|Overall Study|Progression|35|||
147354363|NCT00324805|531466637|FG000|Overall Study|Withdrawal by Subject|51|||
147354364|NCT00324805|531466638|FG001|Overall Study|Withdrawal by Subject|174|||
147354365|NCT00324805|531466637|FG000|Overall Study|Death|6|||
147354366|NCT00324805|531466638|FG001|Overall Study|Death|9|||
147354367|NCT00324805|531466637|FG000|Overall Study|Alternative therapy|4|||
147354368|NCT00324805|531466638|FG001|Overall Study|Alternative therapy|8|||
147354369|NCT00324805|531466637|FG000|Overall Study|Other complicating disease|1|||
147354370|NCT00324805|531466638|FG001|Overall Study|Other complicating disease|9|||
147354371|NCT00324805|531466637|FG000|Overall Study|Other reasons|7|||
147354372|NCT00324805|531466638|FG001|Overall Study|Other reasons|26|||
147354373|NCT00324805|531466637|FG000|Overall Study|Other|0|||
147354374|NCT00324805|531466638|FG001|Overall Study|Other|2|||
147354375|NCT00324805|531466637|FG000|Overall Study|Did not start therapy|12|||
147354376|NCT00324805|531466638|FG001|Overall Study|Did not start therapy|17|||
147354377|NCT03931174|531466640|FG000|Providers|Staff left organization|26|||
147354378|NCT03931174|531466641|FG001|Providers|Staff left organization|25|||
147354379|NCT03931174|531466640|FG000|Providers|Staff on leave/no longer engaged in implementation initiative|11|||
147354380|NCT03931174|531466641|FG001|Providers|Staff on leave/no longer engaged in implementation initiative|4|||
147354381|NCT03931174|531466640|FG000|Providers|Lost to Follow-up|4|||
147354382|NCT03931174|531466641|FG001|Providers|Lost to Follow-up|4|||
147354383|NCT03931174|531466640|FG000|Patients|Post-consent screening failure|1|||
147354384|NCT03931174|531466641|FG001|Patients|Post-consent screening failure|1|||
147354385|NCT03931174|531466640|FG000|Patients|Death|1|||
147354386|NCT03931174|531466641|FG001|Patients|Death|1|||
147354387|NCT03931174|531466640|FG000|Patients|Lost to Follow-up|60|||
147354388|NCT03931174|531466641|FG001|Patients|Lost to Follow-up|89|||
147354389|NCT03322267|531466642|FG000|Overall Study|Lack of Efficacy|11|||
147354390|NCT03322267|531466642|FG000|Overall Study|Adverse Event|1|||
147354391|NCT03322267|531466642|FG000|Overall Study|Withdrawal by Subject|2|||
147354392|NCT05792085|531466643|FG000|Overall Study|Death|0|||
147354393|NCT05792085|531466644|FG001|Overall Study|Death|0|||
147354394|NCT05792085|531466645|FG002|Overall Study|Death|0|||
147354395|NCT05792085|531466646|FG003|Overall Study|Death|0|||
147354396|NCT05792085|531466647|FG004|Overall Study|Death|1|||
147354397|NCT05386030|531466650|FG000|Overall Study|Death|1|||
147354398|NCT05386030|531466651|FG001|Overall Study|Death|0|||
147354399|NCT05386030|531466650|FG000|Overall Study|Physician Decision|2|||
147354400|NCT05386030|531466651|FG001|Overall Study|Physician Decision|1|||
147354401|NCT05386030|531466650|FG000|Overall Study|Lost to Follow-up|19|||
147354402|NCT05386030|531466651|FG001|Overall Study|Lost to Follow-up|7|||
147354403|NCT05386030|531466650|FG000|Overall Study|Withdrawal by Subject|20|||
147354404|NCT05386030|531466651|FG001|Overall Study|Withdrawal by Subject|10|||
147607495|NCT01085357|532378740|FG000|Overall Study|Investigator Decision|1|||
147607496|NCT01085357|532378741|FG001|Overall Study|Investigator Decision|1|||
147354405|NCT05386030|531466650|FG000|Overall Study|Eligibility criteria violation|1|||
147354406|NCT05386030|531466651|FG001|Overall Study|Eligibility criteria violation|1|||
147607497|NCT01085357|532378740|FG000|Overall Study|Death|11|||
147354407|NCT05386030|531466650|FG000|Overall Study|Personal Reasons|1|||
147354408|NCT05386030|531466651|FG001|Overall Study|Personal Reasons|0|||
147354409|NCT05228457|531466652|FG000|Overall Study|Withdrawal by Subject|1|||
147354410|NCT05228457|531466653|FG001|Overall Study|Withdrawal by Subject|1|||
147354411|NCT03213691|531466658|FG000|Overall Study|Adverse Event|2|||
147354412|NCT03213691|531466658|FG000|Overall Study|Death|3|||
147354413|NCT03213691|531466658|FG000|Overall Study|Physician Decision|1|||
147354414|NCT03213691|531466658|FG000|Overall Study|Progressive Disease|14|||
147354415|NCT03213691|531466658|FG000|Overall Study|Ineligible|1|||
147354416|NCT03161028|531466661|FG000|Overall Study|Withdrawal by Subject|6|||
147354417|NCT03161028|531466662|FG001|Overall Study|Withdrawal by Subject|4|||
147354418|NCT03161028|531466661|FG000|Overall Study|Adverse Event|5|||
147354419|NCT03161028|531466662|FG001|Overall Study|Adverse Event|1|||
147354420|NCT03161028|531466661|FG000|Overall Study|Study drug side effects|2|||
147354421|NCT03161028|531466662|FG001|Overall Study|Study drug side effects|2|||
147354422|NCT03161028|531466661|FG000|Overall Study|Administrative PD/UP|4|||
147354423|NCT03161028|531466662|FG001|Overall Study|Administrative PD/UP|2|||
147354424|NCT03161028|531466661|FG000|Overall Study|Lost to Follow-up|2|||
147354425|NCT03161028|531466662|FG001|Overall Study|Lost to Follow-up|0|||
147354426|NCT03161028|531466661|FG000|Overall Study|Unable to comply with procedures|1|||
147354427|NCT03161028|531466662|FG001|Overall Study|Unable to comply with procedures|1|||
147354428|NCT03492216|531466663|FG000|Overall Study|Death|1|||
147354429|NCT03492216|531466664|FG001|Overall Study|Death|0|||
147354430|NCT03492216|531466665|FG002|Overall Study|Death|4|||
147354431|NCT03492216|531466666|FG003|Overall Study|Death|0|||
147354432|NCT03492216|531466663|FG000|Overall Study|Withdrawal by Subject|5|||
147354433|NCT03492216|531466664|FG001|Overall Study|Withdrawal by Subject|3|||
147354434|NCT03492216|531466665|FG002|Overall Study|Withdrawal by Subject|1|||
147354435|NCT03492216|531466666|FG003|Overall Study|Withdrawal by Subject|1|||
147354436|NCT03492216|531466663|FG000|Overall Study|Lost to Follow-up|9|||
147354437|NCT03492216|531466664|FG001|Overall Study|Lost to Follow-up|2|||
147354438|NCT03492216|531466665|FG002|Overall Study|Lost to Follow-up|7|||
147354439|NCT03492216|531466666|FG003|Overall Study|Lost to Follow-up|8|||
147354440|NCT03492216|531466663|FG000|Overall Study|Moved|5|||
147354441|NCT03492216|531466664|FG001|Overall Study|Moved|3|||
147354442|NCT03492216|531466665|FG002|Overall Study|Moved|3|||
147354443|NCT03492216|531466666|FG003|Overall Study|Moved|5|||
147354444|NCT03492216|531466663|FG000|Overall Study|Too ill|0|||
147354445|NCT03492216|531466664|FG001|Overall Study|Too ill|1|||
147354446|NCT03492216|531466665|FG002|Overall Study|Too ill|0|||
147354447|NCT03492216|531466666|FG003|Overall Study|Too ill|0|||
147354448|NCT03492216|531466663|FG000|Overall Study|Incarcerated|0|||
147354449|NCT03492216|531466664|FG001|Overall Study|Incarcerated|0|||
147354450|NCT03492216|531466665|FG002|Overall Study|Incarcerated|2|||
147354451|NCT03492216|531466666|FG003|Overall Study|Incarcerated|0|||
147354452|NCT00736723|531466667|FG000|Overall Study|Withdrawal by Subject|4|||
147354453|NCT00736723|531466668|FG001|Overall Study|Withdrawal by Subject|3|||
147354454|NCT04797897|531466671|FG000|Overall Study|Study Termination by Sponsor|1|||
147354455|NCT04797897|531466672|FG001|Overall Study|Study Termination by Sponsor|1|||
147354456|NCT01799265|531466674|FG000|Overall Study|Lost to Follow-up|1|||
147354457|NCT01799265|531466675|FG001|Overall Study|Lost to Follow-up|0|||
147354458|NCT01799265|531466674|FG000|Overall Study|Protocol Violation|2|||
147354459|NCT01799265|531466675|FG001|Overall Study|Protocol Violation|1|||
147354460|NCT01799265|531466674|FG000|Overall Study|inadequate sleep study|0|||
147354461|NCT01799265|531466675|FG001|Overall Study|inadequate sleep study|2|||
147354462|NCT04049643|531466679|FG000|Overall Study|Lack of Efficacy|1|||
147354463|NCT04049643|531466680|FG001|Overall Study|Lack of Efficacy|1|||
147354464|NCT04049643|531466681|FG002|Overall Study|Lack of Efficacy|0|||
147354465|NCT04049643|531466679|FG000|Overall Study|Health concern (unrelated to the intervention of the study)|0|||
147354466|NCT04049643|531466680|FG001|Overall Study|Health concern (unrelated to the intervention of the study)|0|||
147354467|NCT04049643|531466681|FG002|Overall Study|Health concern (unrelated to the intervention of the study)|1|||
147354468|NCT03774082|531466682|FG000|Overall Study|Death|6|||
147354469|NCT03774082|531466683|FG001|Overall Study|Death|3|||
147354470|NCT03774082|531466684|FG002|Overall Study|Death|2|||
147354471|NCT03774082|531466682|FG000|Overall Study|Subject decision|0|||
147354472|NCT03774082|531466683|FG001|Overall Study|Subject decision|3|||
147607498|NCT01085357|532378741|FG001|Overall Study|Death|1|||
147607499|NCT01085357|532378740|FG000|Overall Study|Lost to Follow-up|2|||
147354473|NCT03774082|531466684|FG002|Overall Study|Subject decision|0|||
147354474|NCT03774082|531466682|FG000|Overall Study|Lost to Follow-up|2|||
147354475|NCT03774082|531466683|FG001|Overall Study|Lost to Follow-up|0|||
147354476|NCT03774082|531466684|FG002|Overall Study|Lost to Follow-up|0|||
147354477|NCT03774082|531466682|FG000|Overall Study|Guardian decision|0|||
147354478|NCT03774082|531466683|FG001|Overall Study|Guardian decision|0|||
147354479|NCT03774082|531466684|FG002|Overall Study|Guardian decision|1|||
147354480|NCT03774082|531466682|FG000|Overall Study|Enrolled but received treatment beyond protocol requirement|0|||
147354481|NCT03774082|531466683|FG001|Overall Study|Enrolled but received treatment beyond protocol requirement|1|||
147354482|NCT03774082|531466684|FG002|Overall Study|Enrolled but received treatment beyond protocol requirement|0|||
147354483|NCT05030233|531466685|FG000|Overall Study|withdrawn for transfer|1|||
147354484|NCT05030233|531466686|FG001|Overall Study|withdrawn for transfer|0|||
147354485|NCT04728347|531468594|FG000|Overall Study|Sponsor decision|0|||
147354486|NCT04728347|531468595|FG001|Overall Study|Sponsor decision|0|||
147354487|NCT04728347|531468596|FG002|Overall Study|Sponsor decision|1|||
147354488|NCT04728347|531468597|FG003|Overall Study|Sponsor decision|0|||
147354489|NCT01186367|531468599|FG000|Overall Study|Lost to Follow-up|7|||
147354490|NCT01186367|531468600|FG001|Overall Study|Lost to Follow-up|4|||
147354491|NCT01186367|531468601|FG002|Overall Study|Lost to Follow-up|7|||
147354492|NCT01186367|531468599|FG000|Overall Study|Did not receive study treatment|0|||
147354493|NCT01186367|531468600|FG001|Overall Study|Did not receive study treatment|1|||
147607500|NCT01085357|532378741|FG001|Overall Study|Lost to Follow-up|0|||
147607501|NCT05320887|532378746|FG000|Overall Study|Lost to Follow-up|0|||
147607502|NCT05320887|532378747|FG001|Overall Study|Lost to Follow-up|3|||
147607503|NCT05320887|532378748|FG002|Overall Study|Lost to Follow-up|0|||
147607504|NCT05320887|532378749|FG003|Overall Study|Lost to Follow-up|0|||
147607505|NCT02910011|532378752|FG000|Overall Study|Physician Decision|2|||
147607506|NCT00920790|532378753|FG000|Overall Study|aggravation of general condition|14|||
147607507|NCT02460679|532378754|FG000|Overall Study|Investigator Decision|1|||
147607508|NCT02460679|532378754|FG000|Overall Study|Withdrawal by Subject|4|||
147607509|NCT04411914|532378755|FG000|CLAV 500mg/Day for Days 1-3|Adverse Event|1|||
147607510|NCT04411914|532378756|FG001|CLAV 500mg/Day for Days 1-3|Adverse Event|0|||
147607511|NCT02015065|532378763|FG000|Overall Study|Death on study|1|||
147607512|NCT02015065|532378764|FG001|Overall Study|Death on study|2|||
147607513|NCT02015065|532378765|FG002|Overall Study|Death on study|1|||
147607514|NCT00478426|532378770|FG000|Overall Study|Withdrawal by Subject|1|||
147607515|NCT00789737|532378771|FG000|Overall Study|Withdrawal by Subject|13|||
147607516|NCT00789737|532378772|FG001|Overall Study|Withdrawal by Subject|22|||
147607517|NCT00789737|532378771|FG000|Overall Study|Lost to Follow-up|10|||
147607518|NCT00789737|532378772|FG001|Overall Study|Lost to Follow-up|14|||
147607519|NCT00789737|532378771|FG000|Overall Study|Adverse Event|8|||
147607520|NCT00789737|532378772|FG001|Overall Study|Adverse Event|8|||
147607521|NCT00789737|532378771|FG000|Overall Study|Protocol Violation|3|||
147607522|NCT00789737|532378772|FG001|Overall Study|Protocol Violation|0|||
147607523|NCT00789737|532378771|FG000|Overall Study|Lack of Efficacy|3|||
147607524|NCT00789737|532378772|FG001|Overall Study|Lack of Efficacy|0|||
147607525|NCT00789737|532378771|FG000|Overall Study|hyperglycemia that met protocol-specifie|0|||
147607526|NCT00789737|532378772|FG001|Overall Study|hyperglycemia that met protocol-specifie|4|||
147607527|NCT00789737|532378771|FG000|Overall Study|Other|11|||
147607528|NCT00789737|532378772|FG001|Overall Study|Other|7|||
147607529|NCT01189487|532378773|FG000|Overall Study|Lack of Efficacy|2|||
147607530|NCT01189487|532378773|FG000|Overall Study|Adverse Event|1|||
147607531|NCT04630158|532378774|FG000|Overall Study|Adverse Event|1|||
147607532|NCT04630158|532378775|FG001|Overall Study|Adverse Event|1|||
147607533|NCT04630158|532378776|FG002|Overall Study|Adverse Event|1|||
147607534|NCT04630158|532378774|FG000|Overall Study|Physician Decision|0|||
147607535|NCT04630158|532378775|FG001|Overall Study|Physician Decision|2|||
147607536|NCT04630158|532378776|FG002|Overall Study|Physician Decision|0|||
147607537|NCT04630158|532378774|FG000|Overall Study|Protocol Violation|1|||
147607538|NCT04630158|532378775|FG001|Overall Study|Protocol Violation|0|||
147607539|NCT04630158|532378776|FG002|Overall Study|Protocol Violation|1|||
147607540|NCT04630158|532378774|FG000|Overall Study|Withdrawal by Subject|2|||
147607541|NCT04630158|532378775|FG001|Overall Study|Withdrawal by Subject|1|||
147607542|NCT04630158|532378776|FG002|Overall Study|Withdrawal by Subject|2|||
147607543|NCT03136965|532378779|FG000|Overall Study|Lost to Follow-up|0|||
147607544|NCT03136965|532378780|FG001|Overall Study|Lost to Follow-up|1|||
147607545|NCT03136965|532378781|FG002|Overall Study|Lost to Follow-up|0|||
147607546|NCT01210612|532378784|FG000|Overall Study|Withdrawal by Subject|0|||
147607547|NCT01210612|532378785|FG001|Overall Study|Withdrawal by Subject|2|||
147607548|NCT02290223|532378786|FG000|6 Months|Lost to Follow-up|9|||
147607549|NCT02290223|532378787|FG001|6 Months|Lost to Follow-up|6|||
147607550|NCT02290223|532378786|FG000|6 Months|Withdrawal by Subject|5|||
147607551|NCT02290223|532378787|FG001|6 Months|Withdrawal by Subject|0|||
147607552|NCT02290223|532378786|FG000|6 Months|deceased (not related to study)|2|||
147607553|NCT02290223|532378787|FG001|6 Months|deceased (not related to study)|0|||
147607554|NCT02290223|532378786|FG000|12 Months|Lost to Follow-up|16|||
147607555|NCT02290223|532378787|FG001|12 Months|Lost to Follow-up|10|||
147607556|NCT02290223|532378786|FG000|12 Months|Refusal|0|||
147607557|NCT02290223|532378787|FG001|12 Months|Refusal|1|||
147607558|NCT05293639|532378788|FG000|Overall Study|Withdrawal by Subject|1|||
147607559|NCT05293639|532378789|FG001|Overall Study|Withdrawal by Subject|1|||
147607560|NCT05293639|532378790|FG002|Overall Study|Withdrawal by Subject|2|||
147607561|NCT05293639|532378788|FG000|Overall Study|Death|0|||
147607562|NCT05293639|532378789|FG001|Overall Study|Death|1|||
147607563|NCT05293639|532378790|FG002|Overall Study|Death|0|||
147607564|NCT05293639|532378788|FG000|Overall Study|Lost to Follow-up|0|||
147607565|NCT05293639|532378789|FG001|Overall Study|Lost to Follow-up|0|||
147607566|NCT05293639|532378790|FG002|Overall Study|Lost to Follow-up|5|||
147607567|NCT05293639|532378788|FG000|Overall Study|Other|0|||
147607568|NCT05293639|532378789|FG001|Overall Study|Other|0|||
147607569|NCT05293639|532378790|FG002|Overall Study|Other|1|||
147607570|NCT00813800|532378796|FG000|Overall Study|Screen Failure after Consent|2|||
147607571|NCT00813800|532378796|FG000|Overall Study|Adverse Event|1|||
147607572|NCT00813800|532378796|FG000|Overall Study|Worsening of depression|2|||
147607573|NCT00813800|532378796|FG000|Overall Study|Physician Decision|1|||
147354494|NCT01186367|531468601|FG002|Overall Study|Did not receive study treatment|0|||
147354495|NCT03867500|531468602|FG000|Saline Infustion Intervention|Withdrawal by Subject|1|||
147354496|NCT01098812|531468603|FG000|Overall Study|Death|2|||
147354497|NCT01098812|531468604|FG001|Overall Study|Death|0|||
147354498|NCT01098812|531468605|FG002|Overall Study|Death|1|||
147354499|NCT01098812|531468603|FG000|Overall Study|Lost to Follow-up|0|||
147354500|NCT01098812|531468604|FG001|Overall Study|Lost to Follow-up|1|||
147354501|NCT01098812|531468605|FG002|Overall Study|Lost to Follow-up|0|||
147354502|NCT03474679|531468621|FG000|Overall Study|Death|7|||
147354503|NCT03474679|531468621|FG000|Overall Study|Withdrawal by Subject|1|||
147354504|NCT01539083|531468628|FG000|Before Randomization (VCD Induction)|Withdrawal by Subject|4|||
147354505|NCT01539083|531468629|FG001|Before Randomization (VCD Induction)|Withdrawal by Subject|0|||
147354506|NCT01539083|531468630|FG002|Before Randomization (VCD Induction)|Withdrawal by Subject|0|||
147354507|NCT01539083|531468628|FG000|Before Randomization (VCD Induction)|Adverse Event|14|||
147354508|NCT01539083|531468629|FG001|Before Randomization (VCD Induction)|Adverse Event|0|||
147354509|NCT01539083|531468630|FG002|Before Randomization (VCD Induction)|Adverse Event|0|||
147354510|NCT01539083|531468628|FG000|Before Randomization (VCD Induction)|Death|6|||
147354511|NCT01539083|531468629|FG001|Before Randomization (VCD Induction)|Death|0|||
147354512|NCT01539083|531468630|FG002|Before Randomization (VCD Induction)|Death|0|||
147354513|NCT01539083|531468628|FG000|Before Randomization (VCD Induction)|Protocol Violation|2|||
147354514|NCT01539083|531468629|FG001|Before Randomization (VCD Induction)|Protocol Violation|0|||
147354515|NCT01539083|531468630|FG002|Before Randomization (VCD Induction)|Protocol Violation|0|||
147354516|NCT01539083|531468628|FG000|Before Randomization (VCD Induction)|Physician Decision|14|||
147354517|NCT01539083|531468629|FG001|Before Randomization (VCD Induction)|Physician Decision|0|||
147354518|NCT01539083|531468630|FG002|Before Randomization (VCD Induction)|Physician Decision|0|||
147354519|NCT01539083|531468628|FG000|Before Randomization (VCD Induction)|Progressive Disease|8|||
147354520|NCT01539083|531468629|FG001|Before Randomization (VCD Induction)|Progressive Disease|0|||
147354521|NCT01539083|531468630|FG002|Before Randomization (VCD Induction)|Progressive Disease|0|||
147354522|NCT01539083|531468628|FG000|Before Randomization (VCD Induction)|Other|5|||
147354523|NCT01539083|531468629|FG001|Before Randomization (VCD Induction)|Other|0|||
147354524|NCT01539083|531468630|FG002|Before Randomization (VCD Induction)|Other|0|||
147354525|NCT01539083|531468628|FG000|After Randomization (TP and VTP)|Physician Decision|0|||
147354526|NCT01539083|531468629|FG001|After Randomization (TP and VTP)|Physician Decision|0|||
147354527|NCT01539083|531468630|FG002|After Randomization (TP and VTP)|Physician Decision|1|||
147354528|NCT01539083|531468628|FG000|After Randomization (TP and VTP)|Other|0|||
147354529|NCT01539083|531468629|FG001|After Randomization (TP and VTP)|Other|1|||
147354530|NCT01539083|531468630|FG002|After Randomization (TP and VTP)|Other|1|||
147354531|NCT01539083|531468628|FG000|After Randomization (TP and VTP)|Adverse Event|0|||
147354532|NCT01539083|531468629|FG001|After Randomization (TP and VTP)|Adverse Event|1|||
147354533|NCT01539083|531468630|FG002|After Randomization (TP and VTP)|Adverse Event|1|||
147354534|NCT01539083|531468628|FG000|After Randomization (TP and VTP)|Lost to Follow-up|0|||
147354535|NCT01539083|531468629|FG001|After Randomization (TP and VTP)|Lost to Follow-up|2|||
147354536|NCT01539083|531468630|FG002|After Randomization (TP and VTP)|Lost to Follow-up|2|||
147354537|NCT01539083|531468628|FG000|After Randomization (TP and VTP)|Withdrawal by Subject|0|||
147354538|NCT01539083|531468629|FG001|After Randomization (TP and VTP)|Withdrawal by Subject|5|||
147354539|NCT01539083|531468630|FG002|After Randomization (TP and VTP)|Withdrawal by Subject|4|||
147354540|NCT01539083|531468628|FG000|After Randomization (TP and VTP)|Progressive Disease|0|||
147354541|NCT01539083|531468629|FG001|After Randomization (TP and VTP)|Progressive Disease|6|||
147354542|NCT01539083|531468630|FG002|After Randomization (TP and VTP)|Progressive Disease|3|||
147354543|NCT01539083|531468628|FG000|After Randomization (TP and VTP)|Death|0|||
147354544|NCT01539083|531468629|FG001|After Randomization (TP and VTP)|Death|6|||
147354545|NCT01539083|531468630|FG002|After Randomization (TP and VTP)|Death|11|||
147354546|NCT05499377|531468639|FG000|Overall Study|Withdrawal by Subject|2|||
147354547|NCT05499377|531468640|FG001|Overall Study|Withdrawal by Subject|0|||
147354548|NCT05499377|531468639|FG000|Overall Study|Physician Decision|1|||
147354549|NCT05499377|531468640|FG001|Overall Study|Physician Decision|0|||
147354550|NCT04149704|531468641|FG000|Three Month Follow-up|Death|2|||
147354551|NCT04149704|531468642|FG001|Three Month Follow-up|Death|0|||
147354552|NCT04149704|531468643|FG002|Three Month Follow-up|Death|0|||
147354553|NCT04149704|531468644|FG003|Three Month Follow-up|Death|0|||
147354554|NCT04149704|531468641|FG000|Three Month Follow-up|Lost to Follow-up|1|||
147354555|NCT04149704|531468642|FG001|Three Month Follow-up|Lost to Follow-up|4|||
147354556|NCT04149704|531468643|FG002|Three Month Follow-up|Lost to Follow-up|5|||
147354557|NCT04149704|531468644|FG003|Three Month Follow-up|Lost to Follow-up|5|||
147354558|NCT04149704|531468641|FG000|Three Month Follow-up|Withdrawal by Subject|1|||
147354559|NCT04149704|531468642|FG001|Three Month Follow-up|Withdrawal by Subject|0|||
147354560|NCT04149704|531468643|FG002|Three Month Follow-up|Withdrawal by Subject|0|||
147354561|NCT04149704|531468644|FG003|Three Month Follow-up|Withdrawal by Subject|0|||
147354562|NCT04149704|531468641|FG000|Three Month Follow-up|Not completed as dyad (one member of dayd did not complete initial timepoint so withdrawn from study|1|||
147453648|NCT05103332|531824075|FG002|DB Period (6 Months=168 Days)|Lost to Follow-up|1|||
147354563|NCT04149704|531468642|FG001|Three Month Follow-up|Not completed as dyad (one member of dayd did not complete initial timepoint so withdrawn from study|0|||
147354564|NCT04149704|531468643|FG002|Three Month Follow-up|Not completed as dyad (one member of dayd did not complete initial timepoint so withdrawn from study|0|||
147354565|NCT04149704|531468644|FG003|Three Month Follow-up|Not completed as dyad (one member of dayd did not complete initial timepoint so withdrawn from study|1|||
147354566|NCT04632992|531468651|FG000|Overall Study|Adverse Event|0|||
147354567|NCT04632992|531468652|FG001|Overall Study|Adverse Event|0|||
147354568|NCT04632992|531468653|FG002|Overall Study|Adverse Event|0|||
147354569|NCT04632992|531468654|FG003|Overall Study|Adverse Event|0|||
147354570|NCT04632992|531468655|FG004|Overall Study|Adverse Event|0|||
147354571|NCT04632992|531468656|FG005|Overall Study|Adverse Event|0|||
147354572|NCT04632992|531468657|FG006|Overall Study|Adverse Event|0|||
147354573|NCT04632992|531468658|FG007|Overall Study|Adverse Event|0|||
147354574|NCT04632992|531468659|FG008|Overall Study|Adverse Event|0|||
147354575|NCT04632992|531468660|FG009|Overall Study|Adverse Event|0|||
147354576|NCT04632992|531468661|FG010|Overall Study|Adverse Event|0|||
147354577|NCT04632992|531468662|FG011|Overall Study|Adverse Event|0|||
147354578|NCT04632992|531468663|FG012|Overall Study|Adverse Event|1|||
147354579|NCT04632992|531468664|FG013|Overall Study|Adverse Event|0|||
147354580|NCT04632992|531468651|FG000|Overall Study|Death|17|||
147354581|NCT04632992|531468652|FG001|Overall Study|Death|1|||
147354582|NCT04632992|531468653|FG002|Overall Study|Death|14|||
147354583|NCT04632992|531468654|FG003|Overall Study|Death|14|||
147354584|NCT04632992|531468655|FG004|Overall Study|Death|13|||
147354585|NCT04632992|531468656|FG005|Overall Study|Death|6|||
147354586|NCT04632992|531468657|FG006|Overall Study|Death|7|||
147354587|NCT04632992|531468658|FG007|Overall Study|Death|12|||
147354588|NCT04632992|531468659|FG008|Overall Study|Death|15|||
147354589|NCT04632992|531468660|FG009|Overall Study|Death|20|||
147354590|NCT04632992|531468661|FG010|Overall Study|Death|8|||
147354591|NCT04632992|531468662|FG011|Overall Study|Death|2|||
147354592|NCT04632992|531468663|FG012|Overall Study|Death|10|||
147354593|NCT04632992|531468664|FG013|Overall Study|Death|1|||
147354594|NCT04632992|531468651|FG000|Overall Study|Lost to Follow-up|1|||
147354595|NCT04632992|531468652|FG001|Overall Study|Lost to Follow-up|0|||
147354596|NCT04632992|531468653|FG002|Overall Study|Lost to Follow-up|1|||
147354597|NCT04632992|531468654|FG003|Overall Study|Lost to Follow-up|0|||
147354598|NCT04632992|531468655|FG004|Overall Study|Lost to Follow-up|2|||
147354599|NCT04632992|531468656|FG005|Overall Study|Lost to Follow-up|0|||
147354600|NCT04632992|531468657|FG006|Overall Study|Lost to Follow-up|1|||
147354601|NCT04632992|531468658|FG007|Overall Study|Lost to Follow-up|1|||
147354602|NCT04632992|531468659|FG008|Overall Study|Lost to Follow-up|1|||
147354603|NCT04632992|531468660|FG009|Overall Study|Lost to Follow-up|1|||
147354604|NCT04632992|531468661|FG010|Overall Study|Lost to Follow-up|2|||
147354605|NCT04632992|531468662|FG011|Overall Study|Lost to Follow-up|0|||
147354606|NCT04632992|531468663|FG012|Overall Study|Lost to Follow-up|0|||
147354607|NCT04632992|531468664|FG013|Overall Study|Lost to Follow-up|0|||
147354608|NCT04632992|531468651|FG000|Overall Study|Reason not Specified|2|||
147354609|NCT04632992|531468652|FG001|Overall Study|Reason not Specified|0|||
147354610|NCT04632992|531468653|FG002|Overall Study|Reason not Specified|1|||
147354611|NCT04632992|531468654|FG003|Overall Study|Reason not Specified|1|||
147354612|NCT04632992|531468655|FG004|Overall Study|Reason not Specified|0|||
147354613|NCT04632992|531468656|FG005|Overall Study|Reason not Specified|0|||
147354614|NCT04632992|531468657|FG006|Overall Study|Reason not Specified|0|||
147354615|NCT04632992|531468658|FG007|Overall Study|Reason not Specified|0|||
147354616|NCT04632992|531468659|FG008|Overall Study|Reason not Specified|0|||
147354617|NCT04632992|531468660|FG009|Overall Study|Reason not Specified|0|||
147354618|NCT04632992|531468661|FG010|Overall Study|Reason not Specified|1|||
147607574|NCT01860677|532378797|FG000|Second Intervention (1 Day)|Lost to Follow-up|7|||
147607575|NCT01860677|532378798|FG001|Second Intervention (1 Day)|Lost to Follow-up|0|||
147607576|NCT02785952|532378799|FG000|Overall Study|Adverse Event|31|||
147354619|NCT04632992|531468662|FG011|Overall Study|Reason not Specified|0|||
147354620|NCT04632992|531468663|FG012|Overall Study|Reason not Specified|0|||
147354621|NCT04632992|531468664|FG013|Overall Study|Reason not Specified|0|||
147354622|NCT04632992|531468651|FG000|Overall Study|Physician Decision|0|||
147607577|NCT02785952|532378800|FG001|Overall Study|Adverse Event|19|||
147607578|NCT02785952|532378799|FG000|Overall Study|Refusal unrelated to adverse events|10|||
147354623|NCT04632992|531468652|FG001|Overall Study|Physician Decision|0|||
147354624|NCT04632992|531468653|FG002|Overall Study|Physician Decision|0|||
147354625|NCT04632992|531468654|FG003|Overall Study|Physician Decision|2|||
147354626|NCT04632992|531468655|FG004|Overall Study|Physician Decision|1|||
147354627|NCT04632992|531468656|FG005|Overall Study|Physician Decision|0|||
147453649|NCT05103332|531824076|FG003|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
147354628|NCT04632992|531468657|FG006|Overall Study|Physician Decision|0|||
147354629|NCT04632992|531468658|FG007|Overall Study|Physician Decision|0|||
147354630|NCT04632992|531468659|FG008|Overall Study|Physician Decision|0|||
147354631|NCT04632992|531468660|FG009|Overall Study|Physician Decision|0|||
147354632|NCT04632992|531468661|FG010|Overall Study|Physician Decision|0|||
147354633|NCT04632992|531468662|FG011|Overall Study|Physician Decision|0|||
147607579|NCT02785952|532378800|FG001|Overall Study|Refusal unrelated to adverse events|5|||
147354634|NCT04632992|531468663|FG012|Overall Study|Physician Decision|3|||
147354635|NCT04632992|531468664|FG013|Overall Study|Physician Decision|0|||
147354636|NCT04632992|531468651|FG000|Overall Study|Progressive Disease|0|||
147354637|NCT04632992|531468652|FG001|Overall Study|Progressive Disease|0|||
147354638|NCT04632992|531468653|FG002|Overall Study|Progressive Disease|0|||
147354639|NCT04632992|531468654|FG003|Overall Study|Progressive Disease|0|||
147354640|NCT04632992|531468655|FG004|Overall Study|Progressive Disease|1|||
147354641|NCT04632992|531468656|FG005|Overall Study|Progressive Disease|0|||
147354642|NCT04632992|531468657|FG006|Overall Study|Progressive Disease|0|||
147354643|NCT04632992|531468658|FG007|Overall Study|Progressive Disease|0|||
147354644|NCT04632992|531468659|FG008|Overall Study|Progressive Disease|0|||
147354645|NCT04632992|531468660|FG009|Overall Study|Progressive Disease|1|||
147354646|NCT04632992|531468661|FG010|Overall Study|Progressive Disease|1|||
147354647|NCT04632992|531468662|FG011|Overall Study|Progressive Disease|0|||
147354648|NCT04632992|531468663|FG012|Overall Study|Progressive Disease|2|||
147354649|NCT04632992|531468664|FG013|Overall Study|Progressive Disease|0|||
147354650|NCT04632992|531468651|FG000|Overall Study|Withdrawal by Subject|4|||
147354651|NCT04632992|531468652|FG001|Overall Study|Withdrawal by Subject|1|||
147354652|NCT04632992|531468653|FG002|Overall Study|Withdrawal by Subject|5|||
147354653|NCT04632992|531468654|FG003|Overall Study|Withdrawal by Subject|4|||
147354654|NCT04632992|531468655|FG004|Overall Study|Withdrawal by Subject|3|||
147354655|NCT04632992|531468656|FG005|Overall Study|Withdrawal by Subject|3|||
147354656|NCT04632992|531468657|FG006|Overall Study|Withdrawal by Subject|0|||
147354657|NCT04632992|531468658|FG007|Overall Study|Withdrawal by Subject|5|||
147354658|NCT04632992|531468659|FG008|Overall Study|Withdrawal by Subject|0|||
147354659|NCT04632992|531468660|FG009|Overall Study|Withdrawal by Subject|2|||
147354660|NCT04632992|531468661|FG010|Overall Study|Withdrawal by Subject|8|||
147354661|NCT04632992|531468662|FG011|Overall Study|Withdrawal by Subject|0|||
147354662|NCT04632992|531468663|FG012|Overall Study|Withdrawal by Subject|1|||
147354663|NCT04632992|531468664|FG013|Overall Study|Withdrawal by Subject|1|||
147354664|NCT05714761|531468665|FG000|Overall Study|Lost to Follow-up|3|||
147354665|NCT05714761|531468665|FG000|Overall Study|Withdrawal by Subject|3|||
147354666|NCT05714761|531468665|FG000|Overall Study|unblinding of sensor data|1|||
147354667|NCT05714761|531468665|FG000|Overall Study|did not complete routine postpartum OGTT|9|||
147354668|NCT05714761|531468665|FG000|Overall Study|did not return second CGM sensor|4|||
147354669|NCT02146378|531468667|FG000|Overall Study|No information of administration|2|||
147354670|NCT03603600|531468676|FG000|Overall Study|Withdrawal by Subject|5|||
147354671|NCT03603600|531468677|FG001|Overall Study|Withdrawal by Subject|7|||
147354672|NCT03603600|531468676|FG000|Overall Study|Lost to Follow-up|2|||
147354673|NCT03603600|531468677|FG001|Overall Study|Lost to Follow-up|3|||
147354674|NCT03603600|531468676|FG000|Overall Study|Death|3|||
147354675|NCT03603600|531468677|FG001|Overall Study|Death|1|||
147354676|NCT03603600|531468676|FG000|Overall Study|Physician Decision|2|||
147354677|NCT03603600|531468677|FG001|Overall Study|Physician Decision|1|||
147354678|NCT03603600|531468676|FG000|Overall Study|Other reason|1|||
147354679|NCT03603600|531468677|FG001|Overall Study|Other reason|0|||
147354680|NCT04973254|531468678|FG000|Overall Study|Not adherent|0|||
147354681|NCT04973254|531468679|FG001|Overall Study|Not adherent|1|||
147354682|NCT04973254|531468680|FG002|Overall Study|Not adherent|0|||
147354683|NCT05089019|531468681|FG000|Period 1|Withdrawal by Subject|0|||
147354684|NCT05089019|531468682|FG001|Period 1|Withdrawal by Subject|1|||
147354685|NCT05089019|531468681|FG000|Washout Period|Adverse Event|3|||
147354686|NCT05089019|531468682|FG001|Washout Period|Adverse Event|4|||
147354687|NCT05089019|531468681|FG000|Washout Period|Lost to Follow-up|1|||
147354688|NCT05089019|531468682|FG001|Washout Period|Lost to Follow-up|0|||
147354689|NCT05089019|531468681|FG000|Washout Period|Physician Decision|2|||
147354690|NCT05089019|531468682|FG001|Washout Period|Physician Decision|0|||
147354691|NCT05089019|531468681|FG000|Washout Period|Withdrawal by Subject|6|||
147354692|NCT05089019|531468682|FG001|Washout Period|Withdrawal by Subject|3|||
147354693|NCT05089019|531468681|FG000|Period 2|Adverse Event|4|||
147354694|NCT05089019|531468682|FG001|Period 2|Adverse Event|2|||
147354695|NCT05089019|531468681|FG000|Period 2|Lost to Follow-up|1|||
147354696|NCT05089019|531468682|FG001|Period 2|Lost to Follow-up|0|||
147354697|NCT05089019|531468681|FG000|Period 2|Withdrawal by Subject|0|||
147354698|NCT05089019|531468682|FG001|Period 2|Withdrawal by Subject|1|||
147662805|NCT04376515|532587435|FG000|Overall Study|Found to have been vaccinated before study start|6|||
147354699|NCT02683447|531468684|FG000|Overall Study|Lost to Follow-up|2|||
147354700|NCT01943409|531468686|FG000|Overall Study|resumed oral/entral|24|||
147354701|NCT01943409|531468687|FG001|Overall Study|resumed oral/entral|20|||
147354702|NCT01943409|531468686|FG000|Overall Study|Protocol Violation|14|||
147354703|NCT01943409|531468687|FG001|Overall Study|Protocol Violation|24|||
147354704|NCT01943409|531468686|FG000|Overall Study|Death|3|||
147354705|NCT01943409|531468687|FG001|Overall Study|Death|1|||
147354706|NCT01943409|531468686|FG000|Overall Study|Withdrawal by Subject|4|||
147354707|NCT01943409|531468687|FG001|Overall Study|Withdrawal by Subject|3|||
147354708|NCT04542317|531468688|FG000|Overall Study|Care recipients passed away|18|||
147354709|NCT04542317|531468689|FG001|Overall Study|Care recipients passed away|13|||
147354710|NCT04542317|531468688|FG000|Overall Study|No longer a primary caregiver|5|||
147354711|NCT04542317|531468689|FG001|Overall Study|No longer a primary caregiver|1|||
147354712|NCT04542317|531468688|FG000|Overall Study|Withdrawal by Subject|4|||
147354713|NCT04542317|531468689|FG001|Overall Study|Withdrawal by Subject|2|||
147354714|NCT04542317|531468688|FG000|Overall Study|Caregivers passed away|0|||
147354715|NCT04542317|531468689|FG001|Overall Study|Caregivers passed away|2|||
147354716|NCT05543629|531468694|FG000|Overall Study|Death|1|||
147354717|NCT05543629|531468695|FG001|Overall Study|Death|0|||
147354718|NCT05543629|531468696|FG002|Overall Study|Death|1|||
147354719|NCT05543629|531468697|FG003|Overall Study|Death|0|||
147354720|NCT05543629|531468698|FG004|Overall Study|Death|0|||
147354721|NCT05543629|531468699|FG005|Overall Study|Death|1|||
147354722|NCT05543629|531468700|FG006|Overall Study|Death|2|||
147354723|NCT05543629|531468701|FG007|Overall Study|Death|2|||
147354724|NCT05543629|531468694|FG000|Overall Study|Other Reasons|0|||
147354725|NCT05543629|531468695|FG001|Overall Study|Other Reasons|0|||
147354726|NCT05543629|531468696|FG002|Overall Study|Other Reasons|0|||
147354727|NCT05543629|531468697|FG003|Overall Study|Other Reasons|0|||
147354728|NCT05543629|531468698|FG004|Overall Study|Other Reasons|1|||
147354729|NCT05543629|531468699|FG005|Overall Study|Other Reasons|0|||
147354730|NCT05543629|531468700|FG006|Overall Study|Other Reasons|0|||
147354731|NCT05543629|531468701|FG007|Overall Study|Other Reasons|0|||
147354732|NCT05543629|531468694|FG000|Overall Study|Physician Decision|0|||
147354733|NCT05543629|531468695|FG001|Overall Study|Physician Decision|0|||
147354734|NCT05543629|531468696|FG002|Overall Study|Physician Decision|3|||
147354735|NCT05543629|531468697|FG003|Overall Study|Physician Decision|0|||
147354736|NCT05543629|531468698|FG004|Overall Study|Physician Decision|0|||
147354737|NCT05543629|531468699|FG005|Overall Study|Physician Decision|0|||
147354738|NCT05543629|531468700|FG006|Overall Study|Physician Decision|1|||
147354739|NCT05543629|531468701|FG007|Overall Study|Physician Decision|0|||
147354740|NCT05543629|531468694|FG000|Overall Study|Study terminated by Sponsor|1|||
147354741|NCT05543629|531468695|FG001|Overall Study|Study terminated by Sponsor|0|||
147354742|NCT05543629|531468696|FG002|Overall Study|Study terminated by Sponsor|0|||
147354743|NCT05543629|531468697|FG003|Overall Study|Study terminated by Sponsor|1|||
147354744|NCT05543629|531468698|FG004|Overall Study|Study terminated by Sponsor|0|||
147354745|NCT05543629|531468699|FG005|Overall Study|Study terminated by Sponsor|4|||
147354746|NCT05543629|531468700|FG006|Overall Study|Study terminated by Sponsor|1|||
147607580|NCT02785952|532378799|FG000|Overall Study|Disease progression/relapse|61|||
147607581|NCT02785952|532378800|FG001|Overall Study|Disease progression/relapse|89|||
147607582|NCT02785952|532378799|FG000|Overall Study|Death|11|||
147607583|NCT02785952|532378800|FG001|Overall Study|Death|7|||
147607584|NCT02785952|532378799|FG000|Overall Study|Other- not protocol specified|6|||
147607585|NCT02785952|532378800|FG001|Overall Study|Other- not protocol specified|4|||
147607586|NCT02785952|532378799|FG000|Overall Study|On protocol treatment|6|||
147607587|NCT02785952|532378800|FG001|Overall Study|On protocol treatment|3|||
147607588|NCT01144715|532378801|FG000|Overall Study|Lost to Follow-up|2|||
147607589|NCT01144715|532378802|FG001|Overall Study|Lost to Follow-up|1|||
147607590|NCT01144715|532378801|FG000|Overall Study|Withdrawal by Subject|2|||
147607591|NCT01144715|532378802|FG001|Overall Study|Withdrawal by Subject|1|||
147607592|NCT01144715|532378801|FG000|Overall Study|Adverse Event|0|||
147607593|NCT01144715|532378802|FG001|Overall Study|Adverse Event|1|||
147607594|NCT03553576|532378803|FG000|Overall Study|MD withdrew (pump settings changed d/t interscapular pain)|1|||
147607595|NCT03553576|532378804|FG001|Overall Study|MD withdrew (pump settings changed d/t interscapular pain)|1|||
147607596|NCT03553576|532378803|FG000|Overall Study|Unintentional dural puncture during epidural procedure|0|||
147607597|NCT03553576|532378804|FG001|Overall Study|Unintentional dural puncture during epidural procedure|1|||
147607598|NCT03553576|532378803|FG000|Overall Study|No cerebral spinal fluid obtained during epidural procedure a straight catheter was used|0|||
147607599|NCT03553576|532378804|FG001|Overall Study|No cerebral spinal fluid obtained during epidural procedure a straight catheter was used|1|||
147607600|NCT03553576|532378803|FG000|Overall Study|Fentanyl and or clonidine administered via epidural catheter|1|||
147607601|NCT03553576|532378804|FG001|Overall Study|Fentanyl and or clonidine administered via epidural catheter|2|||
147607602|NCT03553576|532378803|FG000|Overall Study|First redose of anesthetic by anesthesiologist administered under 90 minutes after catheter placed|1|||
147607603|NCT03553576|532378804|FG001|Overall Study|First redose of anesthetic by anesthesiologist administered under 90 minutes after catheter placed|1|||
147607604|NCT03553576|532378803|FG000|Overall Study|Greater than 3 redoses of anesthetic by the anesthesiologist using the epidural catheter|1|||
147607605|NCT03553576|532378804|FG001|Overall Study|Greater than 3 redoses of anesthetic by the anesthesiologist using the epidural catheter|0|||
147607606|NCT03553576|532378803|FG000|Overall Study|Physician Decision|2|||
147607607|NCT03553576|532378804|FG001|Overall Study|Physician Decision|5|||
147607608|NCT00351533|532378808|FG000|Overall Study|Extubated before first BAL|1|||
147607609|NCT00351533|532378809|FG001|Overall Study|Extubated before first BAL|0|||
147607610|NCT00351533|532378808|FG000|Overall Study|Lost to Follow-up|1|||
147607611|NCT00351533|532378809|FG001|Overall Study|Lost to Follow-up|3|||
147607612|NCT00351533|532378808|FG000|Overall Study|Physician Decision|0|||
147607613|NCT00351533|532378809|FG001|Overall Study|Physician Decision|1|||
147607614|NCT00351533|532378808|FG000|Overall Study|Withdrawal by Subject|0|||
147607615|NCT00351533|532378809|FG001|Overall Study|Withdrawal by Subject|1|||
147607616|NCT03185013|532378810|FG000|Overall Study|Withdrawal by Subject|5|||
147607617|NCT03185013|532378811|FG001|Overall Study|Withdrawal by Subject|3|||
147354747|NCT05543629|531468701|FG007|Overall Study|Study terminated by Sponsor|0|||
147354748|NCT05543629|531468694|FG000|Overall Study|Withdrawal by Subject|1|||
147354749|NCT05543629|531468695|FG001|Overall Study|Withdrawal by Subject|1|||
147354750|NCT05543629|531468696|FG002|Overall Study|Withdrawal by Subject|0|||
147354751|NCT05543629|531468697|FG003|Overall Study|Withdrawal by Subject|2|||
147354752|NCT05543629|531468698|FG004|Overall Study|Withdrawal by Subject|1|||
147354753|NCT05543629|531468699|FG005|Overall Study|Withdrawal by Subject|1|||
147354754|NCT05543629|531468700|FG006|Overall Study|Withdrawal by Subject|1|||
147354755|NCT05543629|531468701|FG007|Overall Study|Withdrawal by Subject|1|||
147354756|NCT05543629|531468694|FG000|Overall Study|Not Reported|2|||
147354757|NCT05543629|531468695|FG001|Overall Study|Not Reported|2|||
147354758|NCT05543629|531468696|FG002|Overall Study|Not Reported|0|||
147354759|NCT05543629|531468697|FG003|Overall Study|Not Reported|0|||
147354760|NCT05543629|531468698|FG004|Overall Study|Not Reported|1|||
147354761|NCT05543629|531468699|FG005|Overall Study|Not Reported|1|||
147354762|NCT05543629|531468700|FG006|Overall Study|Not Reported|3|||
147354763|NCT05543629|531468701|FG007|Overall Study|Not Reported|0|||
147354764|NCT03313076|531468702|FG000|Overall Study|Withdrawal by Subject|2|||
147354765|NCT03313076|531468703|FG001|Overall Study|Withdrawal by Subject|0|||
147354766|NCT03313076|531468704|FG002|Overall Study|Withdrawal by Subject|0|||
147354767|NCT03313076|531468705|FG003|Overall Study|Withdrawal by Subject|0|||
147354768|NCT03313076|531468702|FG000|Overall Study|Lost to Follow-up|0|||
147354769|NCT03313076|531468703|FG001|Overall Study|Lost to Follow-up|2|||
147354770|NCT03313076|531468704|FG002|Overall Study|Lost to Follow-up|2|||
147354771|NCT03313076|531468705|FG003|Overall Study|Lost to Follow-up|2|||
147354772|NCT05869383|531468706|FG000|Overall Study|Withdrawal by Subject|2|||
147354773|NCT05869383|531468707|FG001|Overall Study|Withdrawal by Subject|0|||
147354774|NCT03270501|531468712|FG000|Overall Study|Screen failure|6|||
147354775|NCT03270501|531468712|FG000|Overall Study|Lost to Follow-up|2|||
147354776|NCT03270501|531468712|FG000|Overall Study|Adverse Event|1|||
147354777|NCT04599062|531468723|FG000|Overall Study|Physician Decision|1|||
147354778|NCT04599062|531468724|FG001|Overall Study|Physician Decision|0|||
147354779|NCT01175356|531468727|FG000|Overall Study|Death|1|||
147354780|NCT01175356|531468727|FG000|Overall Study|Lack of Efficacy|12|||
147354781|NCT01175356|531468727|FG000|Overall Study|Lost to Follow-up|1|||
147354782|NCT01175356|531468727|FG000|Overall Study|Physician Decision|23|||
147354783|NCT01175356|531468727|FG000|Overall Study|Ineligible|1|||
147354784|NCT01175356|531468727|FG000|Overall Study|Treatment Slot Not Available|18|||
147354785|NCT01175356|531468727|FG000|Overall Study|Refusal by patient/parent/guardian|6|||
147354786|NCT01175356|531468727|FG000|Overall Study|Pts MIBG non-avid after enrollment|2|||
147354787|NCT01175356|531468727|FG000|Overall Study|On other COG study w/tumor tx intent|7|||
147354788|NCT01175356|531468727|FG000|Overall Study|Inadequate stem cell for transplant|1|||
147354789|NCT01175356|531468727|FG000|Overall Study|Initiation other tx prior to completion|9|||
147354790|NCT04436276|531468728|FG000|Overall Study|Adverse Event|0|||
147354791|NCT04436276|531468729|FG001|Overall Study|Adverse Event|0|||
147354792|NCT04436276|531468730|FG002|Overall Study|Adverse Event|0|||
147354793|NCT04436276|531468731|FG003|Overall Study|Adverse Event|0|||
147354794|NCT04436276|531468732|FG004|Overall Study|Adverse Event|0|||
147354795|NCT04436276|531468733|FG005|Overall Study|Adverse Event|0|||
147354796|NCT04436276|531468734|FG006|Overall Study|Adverse Event|0|||
147354797|NCT04436276|531468735|FG007|Overall Study|Adverse Event|0|||
147354798|NCT04436276|531468736|FG008|Overall Study|Adverse Event|0|||
147354799|NCT04436276|531468737|FG009|Overall Study|Adverse Event|0|||
147354800|NCT04436276|531468738|FG010|Overall Study|Adverse Event|0|||
147354801|NCT04436276|531468739|FG011|Overall Study|Adverse Event|0|||
147354802|NCT04436276|531468740|FG012|Overall Study|Adverse Event|0|||
147354803|NCT04436276|531468741|FG013|Overall Study|Adverse Event|0|||
147354804|NCT04436276|531468742|FG014|Overall Study|Adverse Event|0|||
147354805|NCT04436276|531468743|FG015|Overall Study|Adverse Event|0|||
147354806|NCT04436276|531468744|FG016|Overall Study|Adverse Event|1|||
147354807|NCT04436276|531468745|FG017|Overall Study|Adverse Event|0|||
147607618|NCT03185013|532378810|FG000|Overall Study|Adverse Event|1|||
147607619|NCT03185013|532378811|FG001|Overall Study|Adverse Event|0|||
147607620|NCT03185013|532378810|FG000|Overall Study|Progressive Disease|1|||
147354808|NCT04436276|531468746|FG018|Overall Study|Adverse Event|0|||
147354809|NCT04436276|531468747|FG019|Overall Study|Adverse Event|0|||
147354810|NCT04436276|531468748|FG020|Overall Study|Adverse Event|0|||
147354811|NCT04436276|531468749|FG021|Overall Study|Adverse Event|0|||
147354812|NCT04436276|531468750|FG022|Overall Study|Adverse Event|0|||
147354813|NCT04436276|531468728|FG000|Overall Study|Death|0|||
147354814|NCT04436276|531468729|FG001|Overall Study|Death|0|||
147354815|NCT04436276|531468730|FG002|Overall Study|Death|0|||
147354816|NCT04436276|531468731|FG003|Overall Study|Death|0|||
147354817|NCT04436276|531468732|FG004|Overall Study|Death|0|||
147354818|NCT04436276|531468733|FG005|Overall Study|Death|0|||
147354819|NCT04436276|531468734|FG006|Overall Study|Death|0|||
147354820|NCT04436276|531468735|FG007|Overall Study|Death|0|||
147354821|NCT04436276|531468736|FG008|Overall Study|Death|0|||
147354822|NCT04436276|531468737|FG009|Overall Study|Death|0|||
147607621|NCT03185013|532378811|FG001|Overall Study|Progressive Disease|0|||
147354823|NCT04436276|531468738|FG010|Overall Study|Death|0|||
147354824|NCT04436276|531468739|FG011|Overall Study|Death|0|||
147354825|NCT04436276|531468740|FG012|Overall Study|Death|1|||
147354826|NCT04436276|531468741|FG013|Overall Study|Death|0|||
147354827|NCT04436276|531468742|FG014|Overall Study|Death|1|||
147354828|NCT04436276|531468743|FG015|Overall Study|Death|0|||
147354829|NCT04436276|531468744|FG016|Overall Study|Death|0|||
147354830|NCT04436276|531468745|FG017|Overall Study|Death|0|||
147354831|NCT04436276|531468746|FG018|Overall Study|Death|0|||
147354832|NCT04436276|531468747|FG019|Overall Study|Death|2|||
147354833|NCT04436276|531468748|FG020|Overall Study|Death|0|||
147354834|NCT04436276|531468749|FG021|Overall Study|Death|1|||
147354835|NCT04436276|531468750|FG022|Overall Study|Death|0|||
147354836|NCT04436276|531468728|FG000|Overall Study|Lost to Follow-up|0|||
147354837|NCT04436276|531468729|FG001|Overall Study|Lost to Follow-up|2|||
147354838|NCT04436276|531468730|FG002|Overall Study|Lost to Follow-up|2|||
147354839|NCT04436276|531468731|FG003|Overall Study|Lost to Follow-up|1|||
147354840|NCT04436276|531468732|FG004|Overall Study|Lost to Follow-up|4|||
147354841|NCT04436276|531468733|FG005|Overall Study|Lost to Follow-up|1|||
147354842|NCT04436276|531468734|FG006|Overall Study|Lost to Follow-up|0|||
147354843|NCT04436276|531468735|FG007|Overall Study|Lost to Follow-up|0|||
147354844|NCT04436276|531468736|FG008|Overall Study|Lost to Follow-up|1|||
147354845|NCT04436276|531468737|FG009|Overall Study|Lost to Follow-up|0|||
147354846|NCT04436276|531468738|FG010|Overall Study|Lost to Follow-up|5|||
147354847|NCT04436276|531468739|FG011|Overall Study|Lost to Follow-up|5|||
147354848|NCT04436276|531468740|FG012|Overall Study|Lost to Follow-up|4|||
147354849|NCT04436276|531468741|FG013|Overall Study|Lost to Follow-up|1|||
147354850|NCT04436276|531468742|FG014|Overall Study|Lost to Follow-up|7|||
147354851|NCT04436276|531468743|FG015|Overall Study|Lost to Follow-up|7|||
147354852|NCT04436276|531468744|FG016|Overall Study|Lost to Follow-up|1|||
147354853|NCT04436276|531468745|FG017|Overall Study|Lost to Follow-up|0|||
147354854|NCT04436276|531468746|FG018|Overall Study|Lost to Follow-up|1|||
147354855|NCT04436276|531468747|FG019|Overall Study|Lost to Follow-up|1|||
147354856|NCT04436276|531468748|FG020|Overall Study|Lost to Follow-up|2|||
147354857|NCT04436276|531468749|FG021|Overall Study|Lost to Follow-up|1|||
147354858|NCT04436276|531468750|FG022|Overall Study|Lost to Follow-up|1|||
147354859|NCT04436276|531468728|FG000|Overall Study|Physician Decision|1|||
147354860|NCT04436276|531468729|FG001|Overall Study|Physician Decision|0|||
147354861|NCT04436276|531468730|FG002|Overall Study|Physician Decision|2|||
147354862|NCT04436276|531468731|FG003|Overall Study|Physician Decision|1|||
147354863|NCT04436276|531468732|FG004|Overall Study|Physician Decision|0|||
147354864|NCT04436276|531468733|FG005|Overall Study|Physician Decision|0|||
147354865|NCT04436276|531468734|FG006|Overall Study|Physician Decision|0|||
147354866|NCT04436276|531468735|FG007|Overall Study|Physician Decision|0|||
147354867|NCT04436276|531468736|FG008|Overall Study|Physician Decision|0|||
147354868|NCT04436276|531468737|FG009|Overall Study|Physician Decision|0|||
147354869|NCT04436276|531468738|FG010|Overall Study|Physician Decision|0|||
147354870|NCT04436276|531468739|FG011|Overall Study|Physician Decision|1|||
147354871|NCT04436276|531468740|FG012|Overall Study|Physician Decision|2|||
147354872|NCT04436276|531468741|FG013|Overall Study|Physician Decision|0|||
147354873|NCT04436276|531468742|FG014|Overall Study|Physician Decision|0|||
147354874|NCT04436276|531468743|FG015|Overall Study|Physician Decision|0|||
147354875|NCT04436276|531468744|FG016|Overall Study|Physician Decision|0|||
147354876|NCT04436276|531468745|FG017|Overall Study|Physician Decision|0|||
147607622|NCT03185013|532378810|FG000|Overall Study|Lost to Follow-up|8|||
147607623|NCT03185013|532378811|FG001|Overall Study|Lost to Follow-up|2|||
147607624|NCT03185013|532378810|FG000|Overall Study|Physician Decision|1|||
147607625|NCT03185013|532378811|FG001|Overall Study|Physician Decision|0|||
147607626|NCT03185013|532378810|FG000|Overall Study|Protocol Deviation|2|||
147607627|NCT03185013|532378811|FG001|Overall Study|Protocol Deviation|0|||
147607628|NCT03185013|532378810|FG000|Overall Study|Reason not Specified|3|||
147607629|NCT03185013|532378811|FG001|Overall Study|Reason not Specified|2|||
147607630|NCT03185013|532378810|FG000|Overall Study|Death|1|||
147607631|NCT03185013|532378811|FG001|Overall Study|Death|0|||
147607632|NCT00197496|532378815|FG000|Baseline to Discharge|not interested|1|||
147607633|NCT00197496|532378816|FG001|Baseline to Discharge|not interested|0|||
147607634|NCT00197496|532378815|FG000|Baseline to Discharge|MRSA|1|||
147607635|NCT00197496|532378816|FG001|Baseline to Discharge|MRSA|0|||
147354877|NCT04436276|531468746|FG018|Overall Study|Physician Decision|0|||
147354878|NCT04436276|531468747|FG019|Overall Study|Physician Decision|0|||
147354879|NCT04436276|531468748|FG020|Overall Study|Physician Decision|1|||
147354880|NCT04436276|531468749|FG021|Overall Study|Physician Decision|2|||
147354881|NCT04436276|531468750|FG022|Overall Study|Physician Decision|0|||
147354882|NCT04436276|531468728|FG000|Overall Study|Protocol Violation|0|||
147354883|NCT04436276|531468729|FG001|Overall Study|Protocol Violation|0|||
147354884|NCT04436276|531468730|FG002|Overall Study|Protocol Violation|0|||
147354885|NCT04436276|531468731|FG003|Overall Study|Protocol Violation|0|||
147354886|NCT04436276|531468732|FG004|Overall Study|Protocol Violation|0|||
147354887|NCT04436276|531468733|FG005|Overall Study|Protocol Violation|0|||
147354888|NCT04436276|531468734|FG006|Overall Study|Protocol Violation|0|||
147354889|NCT04436276|531468735|FG007|Overall Study|Protocol Violation|0|||
147354890|NCT04436276|531468736|FG008|Overall Study|Protocol Violation|0|||
147354891|NCT04436276|531468737|FG009|Overall Study|Protocol Violation|0|||
147354892|NCT04436276|531468738|FG010|Overall Study|Protocol Violation|0|||
147354893|NCT04436276|531468739|FG011|Overall Study|Protocol Violation|0|||
147354894|NCT04436276|531468740|FG012|Overall Study|Protocol Violation|0|||
147354895|NCT04436276|531468741|FG013|Overall Study|Protocol Violation|1|||
147354896|NCT04436276|531468742|FG014|Overall Study|Protocol Violation|0|||
147354897|NCT04436276|531468743|FG015|Overall Study|Protocol Violation|1|||
147354898|NCT04436276|531468744|FG016|Overall Study|Protocol Violation|0|||
147354899|NCT04436276|531468745|FG017|Overall Study|Protocol Violation|0|||
147354900|NCT04436276|531468746|FG018|Overall Study|Protocol Violation|0|||
147354901|NCT04436276|531468747|FG019|Overall Study|Protocol Violation|0|||
147354902|NCT04436276|531468748|FG020|Overall Study|Protocol Violation|0|||
147354903|NCT04436276|531468749|FG021|Overall Study|Protocol Violation|0|||
147354904|NCT04436276|531468750|FG022|Overall Study|Protocol Violation|0|||
147354905|NCT04436276|531468728|FG000|Overall Study|Withdrawal by Subject|25|||
147354906|NCT04436276|531468729|FG001|Overall Study|Withdrawal by Subject|22|||
147354907|NCT04436276|531468730|FG002|Overall Study|Withdrawal by Subject|24|||
147354908|NCT04436276|531468731|FG003|Overall Study|Withdrawal by Subject|23|||
147354909|NCT04436276|531468732|FG004|Overall Study|Withdrawal by Subject|14|||
147354910|NCT04436276|531468733|FG005|Overall Study|Withdrawal by Subject|0|||
147299988|NCT01078155|531264573|FG000|Overall Study|Participant's Decision|6|||
147299989|NCT01078155|531264573|FG000|Overall Study|Lost to Follow-up|15|||
147299990|NCT03286751|531264574|FG000|Washout Period 1|Withdrawal by Subject|0|||
147299991|NCT03286751|531264575|FG001|Washout Period 1|Withdrawal by Subject|0|||
147299992|NCT03286751|531264576|FG002|Washout Period 1|Withdrawal by Subject|0|||
147299993|NCT03286751|531264577|FG003|Washout Period 1|Withdrawal by Subject|0|||
147299994|NCT03286751|531264578|FG004|Washout Period 1|Withdrawal by Subject|1|||
147299995|NCT03286751|531264579|FG005|Washout Period 1|Withdrawal by Subject|0|||
147354911|NCT04436276|531468734|FG006|Overall Study|Withdrawal by Subject|0|||
147354912|NCT04436276|531468735|FG007|Overall Study|Withdrawal by Subject|1|||
147354913|NCT04436276|531468736|FG008|Overall Study|Withdrawal by Subject|0|||
147354914|NCT04436276|531468737|FG009|Overall Study|Withdrawal by Subject|1|||
147354915|NCT04436276|531468738|FG010|Overall Study|Withdrawal by Subject|17|||
147354916|NCT04436276|531468739|FG011|Overall Study|Withdrawal by Subject|7|||
147354917|NCT04436276|531468740|FG012|Overall Study|Withdrawal by Subject|10|||
147354918|NCT04436276|531468741|FG013|Overall Study|Withdrawal by Subject|6|||
147354919|NCT04436276|531468742|FG014|Overall Study|Withdrawal by Subject|20|||
147354920|NCT04436276|531468743|FG015|Overall Study|Withdrawal by Subject|6|||
147354921|NCT04436276|531468744|FG016|Overall Study|Withdrawal by Subject|11|||
147354922|NCT04436276|531468745|FG017|Overall Study|Withdrawal by Subject|4|||
147354923|NCT04436276|531468746|FG018|Overall Study|Withdrawal by Subject|14|||
147354924|NCT04436276|531468747|FG019|Overall Study|Withdrawal by Subject|24|||
147354925|NCT04436276|531468748|FG020|Overall Study|Withdrawal by Subject|24|||
147354926|NCT04436276|531468749|FG021|Overall Study|Withdrawal by Subject|16|||
147354927|NCT04436276|531468750|FG022|Overall Study|Withdrawal by Subject|14|||
147354928|NCT04436276|531468728|FG000|Overall Study|Other|3|||
147354929|NCT04436276|531468729|FG001|Overall Study|Other|2|||
147354930|NCT04436276|531468730|FG002|Overall Study|Other|5|||
147354931|NCT04436276|531468731|FG003|Overall Study|Other|9|||
147354932|NCT04436276|531468732|FG004|Overall Study|Other|23|||
147354933|NCT04436276|531468733|FG005|Overall Study|Other|1|||
147354934|NCT04436276|531468734|FG006|Overall Study|Other|0|||
147354935|NCT04436276|531468735|FG007|Overall Study|Other|0|||
147354936|NCT04436276|531468736|FG008|Overall Study|Other|0|||
147354937|NCT04436276|531468737|FG009|Overall Study|Other|0|||
147354938|NCT04436276|531468738|FG010|Overall Study|Other|3|||
147354939|NCT04436276|531468739|FG011|Overall Study|Other|1|||
147354940|NCT04436276|531468740|FG012|Overall Study|Other|1|||
147354941|NCT04436276|531468741|FG013|Overall Study|Other|2|||
147354942|NCT04436276|531468742|FG014|Overall Study|Other|3|||
147354943|NCT04436276|531468743|FG015|Overall Study|Other|0|||
147354944|NCT04436276|531468744|FG016|Overall Study|Other|0|||
147354945|NCT04436276|531468745|FG017|Overall Study|Other|6|||
147354946|NCT04436276|531468746|FG018|Overall Study|Other|1|||
147354947|NCT04436276|531468747|FG019|Overall Study|Other|0|||
147354948|NCT04436276|531468748|FG020|Overall Study|Other|2|||
147354949|NCT04436276|531468749|FG021|Overall Study|Other|2|||
147354950|NCT04436276|531468750|FG022|Overall Study|Other|60|||
147354951|NCT03852472|531468751|FG000|Period 1 - 12 Weeks|Withdrawal by Subject|8|||
147354952|NCT03852472|531468752|FG001|Period 1 - 12 Weeks|Withdrawal by Subject|10|||
147354953|NCT03852472|531468753|FG002|Period 1 - 12 Weeks|Withdrawal by Subject|7|||
147354954|NCT03852472|531468754|FG003|Period 1 - 12 Weeks|Withdrawal by Subject|0|||
147354955|NCT03852472|531468755|FG004|Period 1 - 12 Weeks|Withdrawal by Subject|0|||
147354956|NCT03852472|531468751|FG000|Period 1 - 12 Weeks|Subject noncompliance with dosing or diary completion|0|||
147354957|NCT03852472|531468752|FG001|Period 1 - 12 Weeks|Subject noncompliance with dosing or diary completion|1|||
147354958|NCT03852472|531468753|FG002|Period 1 - 12 Weeks|Subject noncompliance with dosing or diary completion|3|||
147354959|NCT03852472|531468754|FG003|Period 1 - 12 Weeks|Subject noncompliance with dosing or diary completion|0|||
147354960|NCT03852472|531468755|FG004|Period 1 - 12 Weeks|Subject noncompliance with dosing or diary completion|0|||
147354961|NCT03852472|531468751|FG000|Period 1 - 12 Weeks|Lost to Follow-up|5|||
147354962|NCT03852472|531468752|FG001|Period 1 - 12 Weeks|Lost to Follow-up|5|||
147354963|NCT03852472|531468753|FG002|Period 1 - 12 Weeks|Lost to Follow-up|7|||
147354964|NCT03852472|531468754|FG003|Period 1 - 12 Weeks|Lost to Follow-up|0|||
147354965|NCT03852472|531468755|FG004|Period 1 - 12 Weeks|Lost to Follow-up|0|||
147354966|NCT03852472|531468751|FG000|Period 1 - 12 Weeks|Noncompliance with the protocol|2|||
147354967|NCT03852472|531468752|FG001|Period 1 - 12 Weeks|Noncompliance with the protocol|0|||
147354968|NCT03852472|531468753|FG002|Period 1 - 12 Weeks|Noncompliance with the protocol|4|||
147354969|NCT03852472|531468754|FG003|Period 1 - 12 Weeks|Noncompliance with the protocol|0|||
147607636|NCT00197496|532378815|FG000|Baseline to Discharge|Physician Decision|0|||
147607637|NCT00197496|532378816|FG001|Baseline to Discharge|Physician Decision|1|||
147607638|NCT00197496|532378815|FG000|Baseline to Discharge|Protocol Violation|0|||
147607639|NCT00197496|532378816|FG001|Baseline to Discharge|Protocol Violation|1|||
147607640|NCT00197496|532378815|FG000|Follow-up|Lost to Follow-up|2|||
147607641|NCT00197496|532378816|FG001|Follow-up|Lost to Follow-up|1|||
147607642|NCT00857584|532378819|FG000|Overall Study|Lack of Efficacy|1|||
147607643|NCT00857584|532378820|FG001|Overall Study|Lack of Efficacy|2|||
147607644|NCT00857584|532378819|FG000|Overall Study|Adverse Event|2|||
147607645|NCT00857584|532378820|FG001|Overall Study|Adverse Event|2|||
147354970|NCT03852472|531468755|FG004|Period 1 - 12 Weeks|Noncompliance with the protocol|0|||
147354971|NCT03852472|531468751|FG000|Period 1 - 12 Weeks|At the discretion of the investigator or sponsor for any reason|0|||
147354972|NCT03852472|531468752|FG001|Period 1 - 12 Weeks|At the discretion of the investigator or sponsor for any reason|3|||
147354973|NCT03852472|531468753|FG002|Period 1 - 12 Weeks|At the discretion of the investigator or sponsor for any reason|0|||
147354974|NCT03852472|531468754|FG003|Period 1 - 12 Weeks|At the discretion of the investigator or sponsor for any reason|0|||
147354975|NCT03852472|531468755|FG004|Period 1 - 12 Weeks|At the discretion of the investigator or sponsor for any reason|0|||
147354976|NCT03852472|531468751|FG000|Period 1 - 12 Weeks|Adverse Event|4|||
147354977|NCT03852472|531468752|FG001|Period 1 - 12 Weeks|Adverse Event|6|||
147354978|NCT03852472|531468753|FG002|Period 1 - 12 Weeks|Adverse Event|4|||
147354979|NCT03852472|531468754|FG003|Period 1 - 12 Weeks|Adverse Event|0|||
147354980|NCT03852472|531468755|FG004|Period 1 - 12 Weeks|Adverse Event|0|||
147354981|NCT03852472|531468751|FG000|Period 1 - 12 Weeks|Reason not stated|2|||
147354982|NCT03852472|531468752|FG001|Period 1 - 12 Weeks|Reason not stated|1|||
147354983|NCT03852472|531468753|FG002|Period 1 - 12 Weeks|Reason not stated|0|||
147354984|NCT03852472|531468754|FG003|Period 1 - 12 Weeks|Reason not stated|0|||
147354985|NCT03852472|531468755|FG004|Period 1 - 12 Weeks|Reason not stated|0|||
147354986|NCT03852472|531468751|FG000|Period 2 - Week 44|Withdrawal by Subject|0|||
147354987|NCT03852472|531468752|FG001|Period 2 - Week 44|Withdrawal by Subject|22|||
147354988|NCT03852472|531468753|FG002|Period 2 - Week 44|Withdrawal by Subject|15|||
147354989|NCT03852472|531468754|FG003|Period 2 - Week 44|Withdrawal by Subject|10|||
147354990|NCT03852472|531468755|FG004|Period 2 - Week 44|Withdrawal by Subject|10|||
147354991|NCT03852472|531468751|FG000|Period 2 - Week 44|Subject noncompliance with dosing or diary completion|0|||
147354992|NCT03852472|531468752|FG001|Period 2 - Week 44|Subject noncompliance with dosing or diary completion|2|||
147354993|NCT03852472|531468753|FG002|Period 2 - Week 44|Subject noncompliance with dosing or diary completion|1|||
147354994|NCT03852472|531468754|FG003|Period 2 - Week 44|Subject noncompliance with dosing or diary completion|1|||
147354995|NCT03852472|531468755|FG004|Period 2 - Week 44|Subject noncompliance with dosing or diary completion|0|||
147354996|NCT03852472|531468751|FG000|Period 2 - Week 44|Lost to Follow-up|0|||
147354997|NCT03852472|531468752|FG001|Period 2 - Week 44|Lost to Follow-up|8|||
147354998|NCT03852472|531468753|FG002|Period 2 - Week 44|Lost to Follow-up|12|||
147354999|NCT03852472|531468754|FG003|Period 2 - Week 44|Lost to Follow-up|1|||
147355000|NCT03852472|531468755|FG004|Period 2 - Week 44|Lost to Follow-up|2|||
147355001|NCT03852472|531468751|FG000|Period 2 - Week 44|Noncompliance with the protocol|0|||
147355002|NCT03852472|531468752|FG001|Period 2 - Week 44|Noncompliance with the protocol|2|||
147355003|NCT03852472|531468753|FG002|Period 2 - Week 44|Noncompliance with the protocol|1|||
147355004|NCT03852472|531468754|FG003|Period 2 - Week 44|Noncompliance with the protocol|0|||
147355005|NCT03852472|531468755|FG004|Period 2 - Week 44|Noncompliance with the protocol|0|||
147355006|NCT03852472|531468751|FG000|Period 2 - Week 44|At the discretion of the investigator or sponsor for any reason|0|||
147355007|NCT03852472|531468752|FG001|Period 2 - Week 44|At the discretion of the investigator or sponsor for any reason|1|||
147355008|NCT03852472|531468753|FG002|Period 2 - Week 44|At the discretion of the investigator or sponsor for any reason|3|||
147355009|NCT03852472|531468754|FG003|Period 2 - Week 44|At the discretion of the investigator or sponsor for any reason|2|||
147355010|NCT03852472|531468755|FG004|Period 2 - Week 44|At the discretion of the investigator or sponsor for any reason|3|||
147355011|NCT03852472|531468751|FG000|Period 2 - Week 44|Adverse Event|0|||
147453650|NCT05103332|531824077|FG004|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
147453651|NCT05103332|531824078|FG005|DB Period (6 Months=168 Days)|Lost to Follow-up|2|||
147607646|NCT00857584|532378819|FG000|Overall Study|Physician Decision|1|||
147607647|NCT00857584|532378820|FG001|Overall Study|Physician Decision|1|||
147607648|NCT01102374|532378821|FG000|Overall Study|Death|9|||
147607649|NCT01102374|532378822|FG001|Overall Study|Death|13|||
147607650|NCT01102374|532378821|FG000|Overall Study|Lost to Follow-up|7|||
147607651|NCT01102374|532378822|FG001|Overall Study|Lost to Follow-up|6|||
147355012|NCT03852472|531468752|FG001|Period 2 - Week 44|Adverse Event|3|||
147355013|NCT03852472|531468753|FG002|Period 2 - Week 44|Adverse Event|1|||
147355014|NCT03852472|531468754|FG003|Period 2 - Week 44|Adverse Event|2|||
147355015|NCT03852472|531468755|FG004|Period 2 - Week 44|Adverse Event|2|||
147355016|NCT03852472|531468751|FG000|Period 2 - Week 44|COVID-19 Related|0|||
147355017|NCT03852472|531468752|FG001|Period 2 - Week 44|COVID-19 Related|0|||
147355018|NCT03852472|531468753|FG002|Period 2 - Week 44|COVID-19 Related|0|||
147355019|NCT03852472|531468754|FG003|Period 2 - Week 44|COVID-19 Related|1|||
147355020|NCT03852472|531468755|FG004|Period 2 - Week 44|COVID-19 Related|0|||
147355021|NCT03852472|531468751|FG000|Period 2 - Week 44|Reason not stated|0|||
147355022|NCT03852472|531468752|FG001|Period 2 - Week 44|Reason not stated|0|||
147355023|NCT03852472|531468753|FG002|Period 2 - Week 44|Reason not stated|0|||
147355024|NCT03852472|531468754|FG003|Period 2 - Week 44|Reason not stated|0|||
147355025|NCT03852472|531468755|FG004|Period 2 - Week 44|Reason not stated|1|||
147355026|NCT05977530|531468756|FG000|Overall Study|Withdrawal by Subject|1|||
147355027|NCT05977530|531468756|FG000|Overall Study|injury unrelated to research participation. Unable to enter swimming pool to participate in protocol|1|||
147355028|NCT04719832|531468759|FG000|Overall Study|Adverse Event|2|||
147355029|NCT04719832|531468760|FG001|Overall Study|Adverse Event|0|||
147355030|NCT04719832|531468759|FG000|Overall Study|Lack of Efficacy|2|||
147355031|NCT04719832|531468760|FG001|Overall Study|Lack of Efficacy|4|||
147355032|NCT04719832|531468759|FG000|Overall Study|Lost to Follow-up|0|||
147355033|NCT04719832|531468760|FG001|Overall Study|Lost to Follow-up|2|||
147355034|NCT04719832|531468759|FG000|Overall Study|Physician Decision|0|||
147355035|NCT04719832|531468760|FG001|Overall Study|Physician Decision|1|||
147355036|NCT04719832|531468759|FG000|Overall Study|Pregnancy|1|||
147355037|NCT04719832|531468760|FG001|Overall Study|Pregnancy|1|||
147355038|NCT04719832|531468759|FG000|Overall Study|Withdrawal by Subject|5|||
147355039|NCT04719832|531468760|FG001|Overall Study|Withdrawal by Subject|5|||
147355040|NCT04719832|531468759|FG000|Overall Study|Randomized, not treated|0|||
147355041|NCT04719832|531468760|FG001|Overall Study|Randomized, not treated|2|||
147355042|NCT04719832|531468759|FG000|Overall Study|GCP violations|4|||
147355043|NCT04719832|531468760|FG001|Overall Study|GCP violations|7|||
147355044|NCT03058289|531468761|FG000|Overall Study|Radiographic Deterioration|0|||
147355045|NCT03058289|531468762|FG001|Overall Study|Radiographic Deterioration|3|||
147355046|NCT03058289|531468763|FG002|Overall Study|Radiographic Deterioration|1|||
147355047|NCT03058289|531468764|FG003|Overall Study|Radiographic Deterioration|2|||
147355048|NCT03058289|531468765|FG004|Overall Study|Radiographic Deterioration|6|||
147355049|NCT03058289|531468766|FG005|Overall Study|Radiographic Deterioration|3|||
147355050|NCT03058289|531468767|FG006|Overall Study|Radiographic Deterioration|0|||
147355051|NCT03058289|531468768|FG007|Overall Study|Radiographic Deterioration|4|||
147355052|NCT03058289|531468769|FG008|Overall Study|Radiographic Deterioration|2|||
147355053|NCT03058289|531468761|FG000|Overall Study|Adverse Event|2|||
147355054|NCT03058289|531468762|FG001|Overall Study|Adverse Event|0|||
147355055|NCT03058289|531468763|FG002|Overall Study|Adverse Event|1|||
147355056|NCT03058289|531468764|FG003|Overall Study|Adverse Event|3|||
147355057|NCT03058289|531468765|FG004|Overall Study|Adverse Event|1|||
147355058|NCT03058289|531468766|FG005|Overall Study|Adverse Event|0|||
147355059|NCT03058289|531468767|FG006|Overall Study|Adverse Event|1|||
147453652|NCT05103332|531824079|FG006|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
147453653|NCT05103332|531824080|FG007|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
147453654|NCT05103332|531824081|FG008|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
147453655|NCT05103332|531824082|FG009|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
147453656|NCT05103332|531824083|FG010|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
147453657|NCT05103332|531824084|FG011|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
147453658|NCT05103332|531824085|FG012|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
147607652|NCT01104792|532378823|FG000|Overall Study|Adverse Event|77|||
147355060|NCT03058289|531468768|FG007|Overall Study|Adverse Event|3|||
147355061|NCT03058289|531468769|FG008|Overall Study|Adverse Event|0|||
147355062|NCT03058289|531468761|FG000|Overall Study|Withdrawal by Subject|0|||
147355063|NCT03058289|531468762|FG001|Overall Study|Withdrawal by Subject|0|||
147355064|NCT03058289|531468763|FG002|Overall Study|Withdrawal by Subject|0|||
147355065|NCT03058289|531468764|FG003|Overall Study|Withdrawal by Subject|2|||
147355066|NCT03058289|531468765|FG004|Overall Study|Withdrawal by Subject|0|||
147355067|NCT03058289|531468766|FG005|Overall Study|Withdrawal by Subject|2|||
147355068|NCT03058289|531468767|FG006|Overall Study|Withdrawal by Subject|0|||
147355069|NCT03058289|531468768|FG007|Overall Study|Withdrawal by Subject|4|||
147355070|NCT03058289|531468769|FG008|Overall Study|Withdrawal by Subject|1|||
147355071|NCT03058289|531468761|FG000|Overall Study|Physician Decision|1|||
147355072|NCT03058289|531468762|FG001|Overall Study|Physician Decision|0|||
147355073|NCT03058289|531468763|FG002|Overall Study|Physician Decision|0|||
147355074|NCT03058289|531468764|FG003|Overall Study|Physician Decision|2|||
147355075|NCT03058289|531468765|FG004|Overall Study|Physician Decision|1|||
147355076|NCT03058289|531468766|FG005|Overall Study|Physician Decision|0|||
147355077|NCT03058289|531468767|FG006|Overall Study|Physician Decision|2|||
147355078|NCT03058289|531468768|FG007|Overall Study|Physician Decision|3|||
147355079|NCT03058289|531468769|FG008|Overall Study|Physician Decision|0|||
147607653|NCT01104792|532378823|FG000|Overall Study|Insufficient Therapeutic Response|22|||
147355080|NCT03058289|531468761|FG000|Overall Study|Clinical Deterioration|2|||
147355081|NCT03058289|531468762|FG001|Overall Study|Clinical Deterioration|0|||
147355082|NCT03058289|531468763|FG002|Overall Study|Clinical Deterioration|0|||
147355083|NCT03058289|531468764|FG003|Overall Study|Clinical Deterioration|2|||
147355084|NCT03058289|531468765|FG004|Overall Study|Clinical Deterioration|1|||
147355085|NCT03058289|531468766|FG005|Overall Study|Clinical Deterioration|1|||
147355086|NCT03058289|531468767|FG006|Overall Study|Clinical Deterioration|0|||
147355087|NCT03058289|531468768|FG007|Overall Study|Clinical Deterioration|3|||
147355088|NCT03058289|531468769|FG008|Overall Study|Clinical Deterioration|2|||
147355089|NCT03058289|531468761|FG000|Overall Study|Lost to Follow-up|0|||
147355090|NCT03058289|531468762|FG001|Overall Study|Lost to Follow-up|0|||
147355091|NCT03058289|531468763|FG002|Overall Study|Lost to Follow-up|0|||
147355092|NCT03058289|531468764|FG003|Overall Study|Lost to Follow-up|0|||
147355093|NCT03058289|531468765|FG004|Overall Study|Lost to Follow-up|1|||
147355094|NCT03058289|531468766|FG005|Overall Study|Lost to Follow-up|0|||
147355095|NCT03058289|531468767|FG006|Overall Study|Lost to Follow-up|0|||
147355096|NCT03058289|531468768|FG007|Overall Study|Lost to Follow-up|0|||
147355097|NCT03058289|531468769|FG008|Overall Study|Lost to Follow-up|0|||
147355098|NCT03058289|531468761|FG000|Overall Study|Refused Further Treatment|0|||
147355099|NCT03058289|531468762|FG001|Overall Study|Refused Further Treatment|0|||
147355100|NCT03058289|531468763|FG002|Overall Study|Refused Further Treatment|1|||
147355101|NCT03058289|531468764|FG003|Overall Study|Refused Further Treatment|0|||
147355102|NCT03058289|531468765|FG004|Overall Study|Refused Further Treatment|1|||
147355103|NCT03058289|531468766|FG005|Overall Study|Refused Further Treatment|0|||
147355104|NCT03058289|531468767|FG006|Overall Study|Refused Further Treatment|0|||
147355105|NCT03058289|531468768|FG007|Overall Study|Refused Further Treatment|0|||
147355106|NCT03058289|531468769|FG008|Overall Study|Refused Further Treatment|0|||
147355107|NCT03058289|531468761|FG000|Overall Study|Rapid Progression of Disease|0|||
147355108|NCT03058289|531468762|FG001|Overall Study|Rapid Progression of Disease|0|||
147355109|NCT03058289|531468763|FG002|Overall Study|Rapid Progression of Disease|0|||
147355110|NCT03058289|531468764|FG003|Overall Study|Rapid Progression of Disease|1|||
147355111|NCT03058289|531468765|FG004|Overall Study|Rapid Progression of Disease|0|||
147355112|NCT03058289|531468766|FG005|Overall Study|Rapid Progression of Disease|0|||
147355113|NCT03058289|531468767|FG006|Overall Study|Rapid Progression of Disease|0|||
147355114|NCT03058289|531468768|FG007|Overall Study|Rapid Progression of Disease|0|||
147355115|NCT03058289|531468769|FG008|Overall Study|Rapid Progression of Disease|0|||
147355116|NCT03084536|531468770|FG000|Overall Study|Determined to be ineligible|0|||
147355117|NCT03084536|531468771|FG001|Overall Study|Determined to be ineligible|0|||
147355118|NCT03084536|531468772|FG002|Overall Study|Determined to be ineligible|16|||
147355119|NCT03084536|531468770|FG000|Overall Study|Withdrawal by Subject|0|||
147355120|NCT03084536|531468771|FG001|Overall Study|Withdrawal by Subject|0|||
147355121|NCT03084536|531468772|FG002|Overall Study|Withdrawal by Subject|4|||
147355122|NCT03084536|531468770|FG000|Overall Study|Physician Decision|0|||
147355123|NCT03084536|531468771|FG001|Overall Study|Physician Decision|0|||
147355124|NCT03084536|531468772|FG002|Overall Study|Physician Decision|3|||
147355125|NCT03084536|531468770|FG000|Overall Study|Death|0|||
147355126|NCT03084536|531468771|FG001|Overall Study|Death|0|||
147355127|NCT03084536|531468772|FG002|Overall Study|Death|1|||
147355128|NCT03084536|531468770|FG000|Overall Study|Lost to Follow-up|0|||
147355129|NCT03084536|531468771|FG001|Overall Study|Lost to Follow-up|0|||
147355130|NCT03084536|531468772|FG002|Overall Study|Lost to Follow-up|1|||
147355131|NCT03084536|531468770|FG000|Overall Study|Protocol Violation|0|||
147355132|NCT03084536|531468771|FG001|Overall Study|Protocol Violation|0|||
147355133|NCT03084536|531468772|FG002|Overall Study|Protocol Violation|1|||
147355134|NCT03084536|531468770|FG000|Overall Study|Withdrawn due to time of surgery being moved up.|0|||
147355135|NCT03084536|531468771|FG001|Overall Study|Withdrawn due to time of surgery being moved up.|0|||
147355136|NCT03084536|531468772|FG002|Overall Study|Withdrawn due to time of surgery being moved up.|1|||
147355137|NCT05192109|531468777|FG000|First Behavioral Task (3 Minutes)|Withdrawal by Subject|9|||
147355138|NCT05192109|531468778|FG001|First Behavioral Task (3 Minutes)|Withdrawal by Subject|11|||
147355139|NCT05192109|531468779|FG002|First Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
147355140|NCT05192109|531468780|FG003|First Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
147355141|NCT05192109|531468777|FG000|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|9|||
147355142|NCT05192109|531468778|FG001|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|11|||
147355143|NCT05192109|531468779|FG002|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
147355144|NCT05192109|531468780|FG003|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
147355145|NCT04515849|531468781|FG000|Overall Study|Adverse Event|0|||
147355146|NCT04515849|531468782|FG001|Overall Study|Adverse Event|0|||
147355147|NCT04515849|531468783|FG002|Overall Study|Adverse Event|0|||
147355148|NCT04515849|531468784|FG003|Overall Study|Adverse Event|1|||
147355149|NCT04515849|531468785|FG004|Overall Study|Adverse Event|2|||
147355150|NCT04515849|531468781|FG000|Overall Study|Death|2|||
147355151|NCT04515849|531468782|FG001|Overall Study|Death|0|||
147355152|NCT04515849|531468783|FG002|Overall Study|Death|0|||
147355153|NCT04515849|531468784|FG003|Overall Study|Death|0|||
147355154|NCT04515849|531468785|FG004|Overall Study|Death|0|||
147355155|NCT04515849|531468781|FG000|Overall Study|Other:family emergency|0|||
147355156|NCT04515849|531468782|FG001|Overall Study|Other:family emergency|0|||
147355157|NCT04515849|531468783|FG002|Overall Study|Other:family emergency|0|||
147355158|NCT04515849|531468784|FG003|Overall Study|Other:family emergency|1|||
147355159|NCT04515849|531468785|FG004|Overall Study|Other:family emergency|0|||
147355160|NCT04515849|531468781|FG000|Overall Study|Other:randomised by error|0|||
147355161|NCT04515849|531468782|FG001|Overall Study|Other:randomised by error|1|||
147355162|NCT04515849|531468783|FG002|Overall Study|Other:randomised by error|0|||
147355163|NCT04515849|531468784|FG003|Overall Study|Other:randomised by error|0|||
147355164|NCT04515849|531468785|FG004|Overall Study|Other:randomised by error|0|||
147355165|NCT04515849|531468781|FG000|Overall Study|Other:subject hasa to fly to greece for a family emergency and will not be back till 4-5 months|0|||
147355166|NCT04515849|531468782|FG001|Overall Study|Other:subject hasa to fly to greece for a family emergency and will not be back till 4-5 months|0|||
147355167|NCT04515849|531468783|FG002|Overall Study|Other:subject hasa to fly to greece for a family emergency and will not be back till 4-5 months|0|||
147355168|NCT04515849|531468784|FG003|Overall Study|Other:subject hasa to fly to greece for a family emergency and will not be back till 4-5 months|1|||
147355169|NCT04515849|531468785|FG004|Overall Study|Other:subject hasa to fly to greece for a family emergency and will not be back till 4-5 months|0|||
147355170|NCT04515849|531468781|FG000|Overall Study|Physician Decision|0|||
147355171|NCT04515849|531468782|FG001|Overall Study|Physician Decision|1|||
147607654|NCT01104792|532378823|FG000|Overall Study|Protocol Violation|45|||
147607655|NCT01104792|532378823|FG000|Overall Study|Withdrawal of Consent|179|||
147607656|NCT01104792|532378823|FG000|Overall Study|Lost to Follow-up|43|||
147607657|NCT01104792|532378823|FG000|Overall Study|Reasons Not Specified|27|||
147607658|NCT01104792|532378823|FG000|Overall Study|Did Not Meet Eligibility Criteria|133|||
147607659|NCT02056392|532378826|FG000|Overall Study|Lost to Follow-up|0|||
147607660|NCT02056392|532378827|FG001|Overall Study|Lost to Follow-up|1|||
147607661|NCT02056392|532378828|FG002|Overall Study|Lost to Follow-up|2|||
147607662|NCT02056392|532378829|FG003|Overall Study|Lost to Follow-up|0|||
147607663|NCT02056392|532378830|FG004|Overall Study|Lost to Follow-up|0|||
147607664|NCT02056392|532378831|FG005|Overall Study|Lost to Follow-up|0|||
147607665|NCT02056392|532378826|FG000|Overall Study|Protocol Violation|1|||
147607666|NCT02056392|532378827|FG001|Overall Study|Protocol Violation|0|||
147607667|NCT02056392|532378828|FG002|Overall Study|Protocol Violation|1|||
147607668|NCT02056392|532378829|FG003|Overall Study|Protocol Violation|0|||
147607669|NCT02056392|532378830|FG004|Overall Study|Protocol Violation|0|||
147607670|NCT02056392|532378831|FG005|Overall Study|Protocol Violation|0|||
147607671|NCT02056392|532378826|FG000|Overall Study|Withdrawal by Subject|1|||
147607672|NCT02056392|532378827|FG001|Overall Study|Withdrawal by Subject|0|||
147607673|NCT02056392|532378828|FG002|Overall Study|Withdrawal by Subject|0|||
147607674|NCT02056392|532378829|FG003|Overall Study|Withdrawal by Subject|0|||
147607675|NCT02056392|532378830|FG004|Overall Study|Withdrawal by Subject|1|||
147607676|NCT02056392|532378831|FG005|Overall Study|Withdrawal by Subject|0|||
147355172|NCT04515849|531468783|FG002|Overall Study|Physician Decision|0|||
147355173|NCT04515849|531468784|FG003|Overall Study|Physician Decision|0|||
147355174|NCT04515849|531468785|FG004|Overall Study|Physician Decision|0|||
147355175|NCT04515849|531468781|FG000|Overall Study|Withdrawal by Subject|1|||
147355176|NCT04515849|531468782|FG001|Overall Study|Withdrawal by Subject|2|||
147355177|NCT04515849|531468783|FG002|Overall Study|Withdrawal by Subject|1|||
147355178|NCT04515849|531468784|FG003|Overall Study|Withdrawal by Subject|0|||
147355179|NCT04515849|531468785|FG004|Overall Study|Withdrawal by Subject|0|||
147355180|NCT04437615|531468793|FG000|Overall Study|Screen Fails/Withdrawal|1089|||
147355181|NCT02696707|531470401|FG000|Per Protocol Population|Physician Decision|2|||
147355182|NCT02696707|531470402|FG001|Per Protocol Population|Physician Decision|1|||
147355183|NCT02696707|531470401|FG000|Per Protocol Population|Participant Decision|0|||
147355184|NCT02696707|531470402|FG001|Per Protocol Population|Participant Decision|2|||
147355185|NCT02696707|531470401|FG000|Completed Study as Planned|Reason = LVEF|2|||
147355186|NCT02696707|531470402|FG001|Completed Study as Planned|Reason = LVEF|2|||
147355187|NCT02696707|531470401|FG000|Completed Study as Planned|Protocol Violation|2|||
147355188|NCT02696707|531470402|FG001|Completed Study as Planned|Protocol Violation|6|||
147355189|NCT02696707|531470401|FG000|Completed Study as Planned|Metastatic disease|3|||
147355190|NCT02696707|531470402|FG001|Completed Study as Planned|Metastatic disease|0|||
147355191|NCT02696707|531470401|FG000|Completed Study as Planned|Location|1|||
147607677|NCT01806506|532378832|FG000|Overall Study|Lost to Follow-up|2|||
147607678|NCT01806506|532378833|FG001|Overall Study|Lost to Follow-up|1|||
147607679|NCT02092467|532378836|FG000|Overall Study|Death|49|||
147355192|NCT02696707|531470402|FG001|Completed Study as Planned|Location|1|||
147355193|NCT03869866|531470409|FG000|Overall Study|Protocol Violation|1|||
147607680|NCT02092467|532378837|FG001|Overall Study|Death|66|||
147607681|NCT02092467|532378838|FG002|Overall Study|Death|38|||
147355194|NCT03869866|531470409|FG000|Overall Study|Withdrawal by Subject|3|||
147607682|NCT02092467|532378836|FG000|Overall Study|Lost to Follow-up|38|||
147607683|NCT02092467|532378837|FG001|Overall Study|Lost to Follow-up|35|||
147355195|NCT06516705|531470410|FG000|T1( Before Hypoglycemia Education)|Withdrawal by Subject|1|||
147607684|NCT02092467|532378838|FG002|Overall Study|Lost to Follow-up|40|||
147607685|NCT02092467|532378836|FG000|Overall Study|Global Deterioration of Health Status|1|||
147607686|NCT02092467|532378837|FG001|Overall Study|Global Deterioration of Health Status|0|||
147355196|NCT06516705|531470411|FG001|T1( Before Hypoglycemia Education)|Withdrawal by Subject|0|||
147355197|NCT06516705|531470410|FG000|T3 ( 3 Month After Education)|No follow-up clinic visits|3|||
147355198|NCT06516705|531470411|FG001|T3 ( 3 Month After Education)|No follow-up clinic visits|3|||
147355199|NCT06516705|531470410|FG000|T3 ( 3 Month After Education)|covid-19|1|||
147355200|NCT06516705|531470411|FG001|T3 ( 3 Month After Education)|covid-19|2|||
147355201|NCT06516705|531470410|FG000|T3 ( 3 Month After Education)|Refused to respond|0|||
147355202|NCT06516705|531470411|FG001|T3 ( 3 Month After Education)|Refused to respond|1|||
147355203|NCT06516705|531470410|FG000|T4 ( 6 Month After Education)|No follow-up clinic visits|3|||
147355204|NCT06516705|531470411|FG001|T4 ( 6 Month After Education)|No follow-up clinic visits|3|||
147355205|NCT06516705|531470410|FG000|T4 ( 6 Month After Education)|covid-19|3|||
147355206|NCT06516705|531470411|FG001|T4 ( 6 Month After Education)|covid-19|2|||
147355207|NCT06516705|531470410|FG000|T4 ( 6 Month After Education)|Refused to respond|0|||
147355208|NCT06516705|531470411|FG001|T4 ( 6 Month After Education)|Refused to respond|1|||
147355209|NCT05579899|531470412|FG000|Overall Study|Lost to Follow-up|3|||
147355210|NCT05579899|531470413|FG001|Overall Study|Lost to Follow-up|1|||
147355211|NCT05579899|531470412|FG000|Overall Study|Adverse Event|0|||
147355212|NCT05579899|531470413|FG001|Overall Study|Adverse Event|3|||
147355213|NCT05579899|531470412|FG000|Overall Study|Pregnancy|0|||
147355214|NCT05579899|531470413|FG001|Overall Study|Pregnancy|1|||
147355215|NCT05579899|531470412|FG000|Overall Study|Withdrawal by Subject|0|||
147355216|NCT05579899|531470413|FG001|Overall Study|Withdrawal by Subject|3|||
147355217|NCT05453773|531470414|FG000|Overall Study|Withdrawal by Subject|3|||
147355218|NCT05453773|531470414|FG000|Overall Study|Lost to Follow-up|3|||
147355219|NCT05453773|531470414|FG000|Overall Study|Difficult Blood Draw|3|||
147355220|NCT03023410|531470417|FG000|Overall Study|study termination|0|||
147355221|NCT03023410|531470418|FG001|Overall Study|study termination|1|||
147355222|NCT04963270|531470424|FG000|Double-Blind Period (24 Weeks)|Adverse Event|1|||
147355223|NCT04963270|531470425|FG001|Double-Blind Period (24 Weeks)|Adverse Event|2|||
147355224|NCT04963270|531470426|FG002|Double-Blind Period (24 Weeks)|Adverse Event|0|||
147355225|NCT04963270|531470427|FG003|Double-Blind Period (24 Weeks)|Adverse Event|0|||
147355226|NCT04963270|531470424|FG000|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
147355227|NCT04963270|531470425|FG001|Double-Blind Period (24 Weeks)|Withdrawal by Subject|1|||
147355228|NCT04963270|531470426|FG002|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
147355229|NCT04963270|531470427|FG003|Double-Blind Period (24 Weeks)|Withdrawal by Subject|0|||
147355230|NCT04963270|531470424|FG000|Double-Blind Period (24 Weeks)|Protocol Violation|1|||
147355231|NCT04963270|531470425|FG001|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
147355232|NCT04963270|531470426|FG002|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
147355233|NCT04963270|531470427|FG003|Double-Blind Period (24 Weeks)|Protocol Violation|0|||
147355234|NCT04963270|531470424|FG000|Double-Blind Period (24 Weeks)|Study Terminated by Sponsor|2|||
147355235|NCT04963270|531470425|FG001|Double-Blind Period (24 Weeks)|Study Terminated by Sponsor|0|||
147355236|NCT04963270|531470426|FG002|Double-Blind Period (24 Weeks)|Study Terminated by Sponsor|0|||
147355237|NCT04963270|531470427|FG003|Double-Blind Period (24 Weeks)|Study Terminated by Sponsor|0|||
147355238|NCT04963270|531470424|FG000|Double-Blind Period (24 Weeks)|Reason Not Specified|0|||
147355239|NCT04963270|531470425|FG001|Double-Blind Period (24 Weeks)|Reason Not Specified|1|||
147355240|NCT04963270|531470426|FG002|Double-Blind Period (24 Weeks)|Reason Not Specified|0|||
147355241|NCT04963270|531470427|FG003|Double-Blind Period (24 Weeks)|Reason Not Specified|0|||
147355242|NCT04963270|531470424|FG000|Open Label Extension Period (92 Weeks)|Lack of Efficacy|0|||
147355243|NCT04963270|531470425|FG001|Open Label Extension Period (92 Weeks)|Lack of Efficacy|0|||
147355244|NCT04963270|531470426|FG002|Open Label Extension Period (92 Weeks)|Lack of Efficacy|0|||
147355245|NCT04963270|531470427|FG003|Open Label Extension Period (92 Weeks)|Lack of Efficacy|1|||
147355246|NCT04963270|531470424|FG000|Open Label Extension Period (92 Weeks)|Lost to Follow-up|0|||
147355247|NCT04963270|531470425|FG001|Open Label Extension Period (92 Weeks)|Lost to Follow-up|0|||
147355248|NCT04963270|531470426|FG002|Open Label Extension Period (92 Weeks)|Lost to Follow-up|2|||
147355249|NCT04963270|531470427|FG003|Open Label Extension Period (92 Weeks)|Lost to Follow-up|0|||
147355250|NCT04963270|531470424|FG000|Open Label Extension Period (92 Weeks)|Withdrawal by Subject|0|||
147355251|NCT04963270|531470425|FG001|Open Label Extension Period (92 Weeks)|Withdrawal by Subject|0|||
147355252|NCT04963270|531470426|FG002|Open Label Extension Period (92 Weeks)|Withdrawal by Subject|2|||
147355253|NCT04963270|531470427|FG003|Open Label Extension Period (92 Weeks)|Withdrawal by Subject|6|||
147355254|NCT04963270|531470424|FG000|Open Label Extension Period (92 Weeks)|Physician Decision|0|||
147355255|NCT04963270|531470425|FG001|Open Label Extension Period (92 Weeks)|Physician Decision|0|||
147355256|NCT04963270|531470426|FG002|Open Label Extension Period (92 Weeks)|Physician Decision|1|||
147355257|NCT04963270|531470427|FG003|Open Label Extension Period (92 Weeks)|Physician Decision|1|||
147607687|NCT02092467|532378838|FG002|Overall Study|Global Deterioration of Health Status|0|||
147355258|NCT04963270|531470424|FG000|Open Label Extension Period (92 Weeks)|Pregnancy|0|||
147355259|NCT04963270|531470425|FG001|Open Label Extension Period (92 Weeks)|Pregnancy|0|||
147355260|NCT04963270|531470426|FG002|Open Label Extension Period (92 Weeks)|Pregnancy|1|||
147355261|NCT04963270|531470427|FG003|Open Label Extension Period (92 Weeks)|Pregnancy|0|||
147355262|NCT04963270|531470424|FG000|Open Label Extension Period (92 Weeks)|Study Terminated by Sponsor|0|||
147607688|NCT02092467|532378836|FG000|Overall Study|Other|32|||
147607689|NCT02092467|532378837|FG001|Overall Study|Other|30|||
147607690|NCT02092467|532378838|FG002|Overall Study|Other|24|||
147607691|NCT02092467|532378836|FG000|Overall Study|Withdrawal by Subject|282|||
147607692|NCT02092467|532378837|FG001|Overall Study|Withdrawal by Subject|327|||
147607693|NCT02092467|532378838|FG002|Overall Study|Withdrawal by Subject|289|||
147607694|NCT02092467|532378836|FG000|Overall Study|Randomized but not treated|2|||
147607695|NCT02092467|532378837|FG001|Overall Study|Randomized but not treated|1|||
147607696|NCT02092467|532378838|FG002|Overall Study|Randomized but not treated|7|||
147607697|NCT02952898|532378841|FG000|Overall Study|Withdrawal by Subject|10|||
147607698|NCT02952898|532378842|FG001|Overall Study|Withdrawal by Subject|8|||
147607699|NCT02952898|532378843|FG002|Overall Study|Withdrawal by Subject|8|||
147607700|NCT02952898|532378841|FG000|Overall Study|Adverse Event|8|||
147607701|NCT02952898|532378842|FG001|Overall Study|Adverse Event|8|||
147607702|NCT02952898|532378843|FG002|Overall Study|Adverse Event|3|||
147607703|NCT02952898|532378841|FG000|Overall Study|Lost to Follow-up|3|||
147607704|NCT02952898|532378842|FG001|Overall Study|Lost to Follow-up|2|||
147607705|NCT02952898|532378843|FG002|Overall Study|Lost to Follow-up|2|||
147607706|NCT02952898|532378841|FG000|Overall Study|Non-compliance with study drug|1|||
147607707|NCT02952898|532378842|FG001|Overall Study|Non-compliance with study drug|1|||
147607708|NCT02952898|532378843|FG002|Overall Study|Non-compliance with study drug|2|||
147607709|NCT04844762|532378846|FG000|Phase 1 First Smoking Session (2 Hrs)|Lost to Follow-up|0|||
147607710|NCT04844762|532378847|FG001|Phase 1 First Smoking Session (2 Hrs)|Lost to Follow-up|0|||
147607711|NCT04844762|532378848|FG002|Phase 1 First Smoking Session (2 Hrs)|Lost to Follow-up|2|||
147607712|NCT04844762|532378849|FG003|Phase 1 First Smoking Session (2 Hrs)|Lost to Follow-up|0|||
147355263|NCT04963270|531470425|FG001|Open Label Extension Period (92 Weeks)|Study Terminated by Sponsor|0|||
147355264|NCT04963270|531470426|FG002|Open Label Extension Period (92 Weeks)|Study Terminated by Sponsor|82|||
147355265|NCT04963270|531470427|FG003|Open Label Extension Period (92 Weeks)|Study Terminated by Sponsor|81|||
147355266|NCT04963270|531470424|FG000|Open Label Extension Period (92 Weeks)|Reason Not Specified|0|||
147355267|NCT04963270|531470425|FG001|Open Label Extension Period (92 Weeks)|Reason Not Specified|0|||
147355268|NCT04963270|531470426|FG002|Open Label Extension Period (92 Weeks)|Reason Not Specified|0|||
147355269|NCT04963270|531470427|FG003|Open Label Extension Period (92 Weeks)|Reason Not Specified|1|||
147355270|NCT04963270|531470424|FG000|Open Label Extension Period (92 Weeks)|Reason Unknown|0|||
147355271|NCT04963270|531470425|FG001|Open Label Extension Period (92 Weeks)|Reason Unknown|0|||
147355272|NCT04963270|531470426|FG002|Open Label Extension Period (92 Weeks)|Reason Unknown|0|||
147355273|NCT04963270|531470427|FG003|Open Label Extension Period (92 Weeks)|Reason Unknown|1|||
147355274|NCT04963270|531470424|FG000|Open Label Extension Period (92 Weeks)|Adverse Event|0|||
147355275|NCT04963270|531470425|FG001|Open Label Extension Period (92 Weeks)|Adverse Event|0|||
147355276|NCT04963270|531470426|FG002|Open Label Extension Period (92 Weeks)|Adverse Event|0|||
147355277|NCT04963270|531470427|FG003|Open Label Extension Period (92 Weeks)|Adverse Event|1|||
147355278|NCT04802967|531470428|FG000|Part B|Withdrawal by Subject|0|||
147355279|NCT04802967|531470429|FG001|Part B|Withdrawal by Subject|0|||
147355280|NCT04802967|531470430|FG002|Part B|Withdrawal by Subject|0|||
147355281|NCT04802967|531470431|FG003|Part B|Withdrawal by Subject|0|||
147355282|NCT04802967|531470432|FG004|Part B|Withdrawal by Subject|0|||
147355283|NCT04802967|531470433|FG005|Part B|Withdrawal by Subject|1|||
147355284|NCT04802967|531470434|FG006|Part B|Withdrawal by Subject|0|||
147607713|NCT04844762|532378850|FG004|Phase 1 First Smoking Session (2 Hrs)|Lost to Follow-up|0|||
147607714|NCT04844762|532378851|FG005|Phase 1 First Smoking Session (2 Hrs)|Lost to Follow-up|0|||
147607715|NCT04844762|532378846|FG000|Phase 1 First Smoking Session (2 Hrs)|Ineligible|0|||
147607716|NCT04844762|532378847|FG001|Phase 1 First Smoking Session (2 Hrs)|Ineligible|1|||
147607717|NCT04844762|532378848|FG002|Phase 1 First Smoking Session (2 Hrs)|Ineligible|0|||
147355285|NCT04802967|531470435|FG007|Part B|Withdrawal by Subject|0|||
147355286|NCT04802967|531470436|FG008|Part B|Withdrawal by Subject|0|||
147355287|NCT04802967|531470437|FG009|Part B|Withdrawal by Subject|0|||
147355288|NCT04332926|531470447|FG000|Overall Study|Withdrawal by Subject|6|||
147355289|NCT04332926|531470447|FG000|Overall Study|Physician Decision|6|||
147355290|NCT04376502|531470450|FG000|Overall Study|Deemed ineligible after being enrolled|1|||
147355291|NCT02268253|531470451|FG000|Stage 1|Withdrawal by Subject|1|||
147355292|NCT02268253|531470452|FG001|Stage 1|Withdrawal by Subject|0|||
147355293|NCT02268253|531470453|FG002|Stage 1|Withdrawal by Subject|0|||
147355294|NCT02268253|531470454|FG003|Stage 1|Withdrawal by Subject|0|||
147355295|NCT02268253|531470455|FG004|Stage 1|Withdrawal by Subject|0|||
147355296|NCT02268253|531470456|FG005|Stage 1|Withdrawal by Subject|0|||
147355297|NCT02268253|531470457|FG006|Stage 1|Withdrawal by Subject|0|||
147607718|NCT04844762|532378849|FG003|Phase 1 First Smoking Session (2 Hrs)|Ineligible|1|||
147607719|NCT04844762|532378850|FG004|Phase 1 First Smoking Session (2 Hrs)|Ineligible|0|||
147607720|NCT04844762|532378851|FG005|Phase 1 First Smoking Session (2 Hrs)|Ineligible|1|||
147607721|NCT04844762|532378846|FG000|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
147607722|NCT04844762|532378847|FG001|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
147607723|NCT04844762|532378848|FG002|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Subject|1|||
147607724|NCT04844762|532378849|FG003|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Subject|3|||
147355298|NCT02268253|531470451|FG000|Stage 1|Death|0|||
147607725|NCT04844762|532378850|FG004|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
147607726|NCT04844762|532378851|FG005|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Subject|1|||
147355299|NCT02268253|531470452|FG001|Stage 1|Death|2|||
147355300|NCT02268253|531470453|FG002|Stage 1|Death|2|||
147355301|NCT02268253|531470454|FG003|Stage 1|Death|2|||
147355302|NCT02268253|531470455|FG004|Stage 1|Death|1|||
147355303|NCT02268253|531470456|FG005|Stage 1|Death|1|||
147355304|NCT02268253|531470457|FG006|Stage 1|Death|0|||
147355305|NCT02268253|531470451|FG000|Stage 2|Disease Recurrence/ Progression|0|||
147355306|NCT02268253|531470452|FG001|Stage 2|Disease Recurrence/ Progression|0|||
147355307|NCT02268253|531470453|FG002|Stage 2|Disease Recurrence/ Progression|1|||
147355308|NCT02268253|531470454|FG003|Stage 2|Disease Recurrence/ Progression|0|||
147355309|NCT02268253|531470455|FG004|Stage 2|Disease Recurrence/ Progression|0|||
147355310|NCT02268253|531470456|FG005|Stage 2|Disease Recurrence/ Progression|0|||
147355311|NCT02268253|531470457|FG006|Stage 2|Disease Recurrence/ Progression|0|||
147355312|NCT02268253|531470451|FG000|Stage 2|Withdrawal by Subject|0|||
147355313|NCT02268253|531470452|FG001|Stage 2|Withdrawal by Subject|0|||
147355314|NCT02268253|531470453|FG002|Stage 2|Withdrawal by Subject|2|||
147355315|NCT02268253|531470454|FG003|Stage 2|Withdrawal by Subject|0|||
147355316|NCT02268253|531470455|FG004|Stage 2|Withdrawal by Subject|0|||
147355317|NCT02268253|531470456|FG005|Stage 2|Withdrawal by Subject|2|||
147355318|NCT02268253|531470457|FG006|Stage 2|Withdrawal by Subject|0|||
147355319|NCT02268253|531470451|FG000|Stage 2|Completion of 7 or More Cycles of Treatment|0|||
147355320|NCT02268253|531470452|FG001|Stage 2|Completion of 7 or More Cycles of Treatment|0|||
147355321|NCT02268253|531470453|FG002|Stage 2|Completion of 7 or More Cycles of Treatment|2|||
147355322|NCT02268253|531470454|FG003|Stage 2|Completion of 7 or More Cycles of Treatment|0|||
147355323|NCT02268253|531470455|FG004|Stage 2|Completion of 7 or More Cycles of Treatment|0|||
147355324|NCT02268253|531470456|FG005|Stage 2|Completion of 7 or More Cycles of Treatment|7|||
147355325|NCT02268253|531470457|FG006|Stage 2|Completion of 7 or More Cycles of Treatment|0|||
147355326|NCT02268253|531470451|FG000|Stage 2|Death|0|||
147355327|NCT02268253|531470452|FG001|Stage 2|Death|0|||
147355328|NCT02268253|531470453|FG002|Stage 2|Death|19|||
147355329|NCT02268253|531470454|FG003|Stage 2|Death|0|||
147355330|NCT02268253|531470455|FG004|Stage 2|Death|0|||
147355331|NCT02268253|531470456|FG005|Stage 2|Death|20|||
147355332|NCT02268253|531470457|FG006|Stage 2|Death|1|||
147355333|NCT02268253|531470451|FG000|Stage 2|Lost to Follow-up|0|||
147355334|NCT02268253|531470452|FG001|Stage 2|Lost to Follow-up|0|||
147355335|NCT02268253|531470453|FG002|Stage 2|Lost to Follow-up|0|||
147355336|NCT02268253|531470454|FG003|Stage 2|Lost to Follow-up|0|||
147355337|NCT02268253|531470455|FG004|Stage 2|Lost to Follow-up|0|||
147355338|NCT02268253|531470456|FG005|Stage 2|Lost to Follow-up|4|||
147355339|NCT02268253|531470457|FG006|Stage 2|Lost to Follow-up|0|||
147355340|NCT02268253|531470451|FG000|Stage 2|Transferred to Hospice|0|||
147355341|NCT02268253|531470452|FG001|Stage 2|Transferred to Hospice|0|||
147355342|NCT02268253|531470453|FG002|Stage 2|Transferred to Hospice|0|||
147355343|NCT02268253|531470454|FG003|Stage 2|Transferred to Hospice|0|||
147355344|NCT02268253|531470455|FG004|Stage 2|Transferred to Hospice|0|||
147355345|NCT02268253|531470456|FG005|Stage 2|Transferred to Hospice|2|||
147355346|NCT02268253|531470457|FG006|Stage 2|Transferred to Hospice|0|||
147355347|NCT02268253|531470451|FG000|Stage 3A|Disease Recurrence/ Progression|0|||
147355348|NCT02268253|531470452|FG001|Stage 3A|Disease Recurrence/ Progression|0|||
147355349|NCT02268253|531470453|FG002|Stage 3A|Disease Recurrence/ Progression|1|||
147355350|NCT02268253|531470454|FG003|Stage 3A|Disease Recurrence/ Progression|0|||
147355351|NCT02268253|531470455|FG004|Stage 3A|Disease Recurrence/ Progression|0|||
147355352|NCT02268253|531470456|FG005|Stage 3A|Disease Recurrence/ Progression|0|||
147355353|NCT02268253|531470457|FG006|Stage 3A|Disease Recurrence/ Progression|0|||
147355354|NCT02268253|531470451|FG000|Stage 3A|Withdrawal by Subject|0|||
147355355|NCT02268253|531470452|FG001|Stage 3A|Withdrawal by Subject|0|||
147355356|NCT02268253|531470453|FG002|Stage 3A|Withdrawal by Subject|2|||
147355357|NCT02268253|531470454|FG003|Stage 3A|Withdrawal by Subject|0|||
147355358|NCT02268253|531470455|FG004|Stage 3A|Withdrawal by Subject|0|||
147355359|NCT02268253|531470456|FG005|Stage 3A|Withdrawal by Subject|0|||
147355360|NCT02268253|531470457|FG006|Stage 3A|Withdrawal by Subject|0|||
147355361|NCT02268253|531470451|FG000|Stage 3A|Physician Decision|0|||
147355362|NCT02268253|531470452|FG001|Stage 3A|Physician Decision|0|||
147355363|NCT02268253|531470453|FG002|Stage 3A|Physician Decision|2|||
147355364|NCT02268253|531470454|FG003|Stage 3A|Physician Decision|0|||
147355365|NCT02268253|531470455|FG004|Stage 3A|Physician Decision|0|||
147355366|NCT02268253|531470456|FG005|Stage 3A|Physician Decision|0|||
147355367|NCT02268253|531470457|FG006|Stage 3A|Physician Decision|0|||
147355368|NCT02268253|531470451|FG000|Stage 3A|Study Terminated by Sponsor|0|||
147355369|NCT02268253|531470452|FG001|Stage 3A|Study Terminated by Sponsor|0|||
147355370|NCT02268253|531470453|FG002|Stage 3A|Study Terminated by Sponsor|2|||
147355371|NCT02268253|531470454|FG003|Stage 3A|Study Terminated by Sponsor|0|||
147355372|NCT02268253|531470455|FG004|Stage 3A|Study Terminated by Sponsor|0|||
147355373|NCT02268253|531470456|FG005|Stage 3A|Study Terminated by Sponsor|0|||
147355374|NCT02268253|531470457|FG006|Stage 3A|Study Terminated by Sponsor|0|||
147355375|NCT02268253|531470451|FG000|Stage 3A|Lost to Follow-up|0|||
147355376|NCT02268253|531470452|FG001|Stage 3A|Lost to Follow-up|0|||
147355377|NCT02268253|531470453|FG002|Stage 3A|Lost to Follow-up|1|||
147355378|NCT02268253|531470454|FG003|Stage 3A|Lost to Follow-up|0|||
147355379|NCT02268253|531470455|FG004|Stage 3A|Lost to Follow-up|0|||
147355380|NCT02268253|531470456|FG005|Stage 3A|Lost to Follow-up|0|||
147355381|NCT02268253|531470457|FG006|Stage 3A|Lost to Follow-up|0|||
147355382|NCT02268253|531470451|FG000|Stage 3A|Death|0|||
147355383|NCT02268253|531470452|FG001|Stage 3A|Death|0|||
147355384|NCT02268253|531470453|FG002|Stage 3A|Death|5|||
147355385|NCT02268253|531470454|FG003|Stage 3A|Death|0|||
147355386|NCT02268253|531470455|FG004|Stage 3A|Death|0|||
147355387|NCT02268253|531470456|FG005|Stage 3A|Death|0|||
147355388|NCT02268253|531470457|FG006|Stage 3A|Death|0|||
147355389|NCT02547233|531470458|FG000|3-day Treatment and 8-week Follow-up|Adverse Event|1|||
147355390|NCT02547233|531470459|FG001|3-day Treatment and 8-week Follow-up|Adverse Event|0|||
147355391|NCT02547233|531470458|FG000|3-day Treatment and 8-week Follow-up|Unacceptable Local Skin Response|1|||
147355392|NCT02547233|531470459|FG001|3-day Treatment and 8-week Follow-up|Unacceptable Local Skin Response|0|||
147355393|NCT02547233|531470458|FG000|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|0|||
147355394|NCT02547233|531470459|FG001|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|9|||
147355395|NCT02547233|531470458|FG000|3-day Treatment and 8-week Follow-up|Lost to Follow-up|0|||
147355396|NCT02547233|531470459|FG001|3-day Treatment and 8-week Follow-up|Lost to Follow-up|1|||
147355397|NCT02547233|531470458|FG000|12-month Follow-up|Withdrawal by Subject|10|||
147355398|NCT02547233|531470459|FG001|12-month Follow-up|Withdrawal by Subject|10|||
147355399|NCT02547233|531470458|FG000|12-month Follow-up|Lost to Follow-up|3|||
147355400|NCT02547233|531470459|FG001|12-month Follow-up|Lost to Follow-up|3|||
147355401|NCT02547233|531470458|FG000|12-month Follow-up|Lack of Efficacy|1|||
147355402|NCT02547233|531470459|FG001|12-month Follow-up|Lack of Efficacy|2|||
147355403|NCT02547233|531470458|FG000|12-month Follow-up|Protocol Violation|0|||
147355404|NCT02547233|531470459|FG001|12-month Follow-up|Protocol Violation|1|||
147355405|NCT02547233|531470458|FG000|12-month Follow-up|Other|0|||
147355406|NCT02547233|531470459|FG001|12-month Follow-up|Other|1|||
147355407|NCT06019559|531470460|FG000|Overall Study|Withdrawal by Subject|7|||
147355408|NCT06019559|531470461|FG001|Overall Study|Withdrawal by Subject|6|||
147355409|NCT06019559|531470462|FG002|Overall Study|Withdrawal by Subject|5|||
147355410|NCT06019559|531470460|FG000|Overall Study|Lost to Follow-up|2|||
147355411|NCT06019559|531470461|FG001|Overall Study|Lost to Follow-up|0|||
147355412|NCT06019559|531470462|FG002|Overall Study|Lost to Follow-up|3|||
147355413|NCT05949788|531470463|FG000|Overall Study|severe birth deformity|2|||
147355414|NCT05949788|531470464|FG001|Overall Study|severe birth deformity|7|||
147355415|NCT05949788|531470463|FG000|Overall Study|twin-twin transfusion syndrome|2|||
147355416|NCT05949788|531470464|FG001|Overall Study|twin-twin transfusion syndrome|7|||
147355417|NCT05949788|531470463|FG000|Overall Study|neonatal hemolytic disease|3|||
147355418|NCT05949788|531470464|FG001|Overall Study|neonatal hemolytic disease|8|||
147355419|NCT05949788|531470463|FG000|Overall Study|death within 14 days after birth|2|||
147355420|NCT05949788|531470464|FG001|Overall Study|death within 14 days after birth|6|||
147355421|NCT05949788|531470463|FG000|Overall Study|transfer to another hospital|2|||
147355422|NCT05949788|531470464|FG001|Overall Study|transfer to another hospital|6|||
147355423|NCT05213390|531470465|FG000|Overall Study|Withdrawal by Subject|2|||
147355424|NCT05213390|531470465|FG000|Overall Study|Lost to Follow-up|12|||
147355425|NCT05213390|531470465|FG000|Overall Study|Protocol Violation|9|||
147355426|NCT01824537|531470466|FG000|Overall Study|Lost to Follow-up|78|||
147355427|NCT01824537|531470467|FG001|Overall Study|Lost to Follow-up|87|||
147355428|NCT05362487|531470468|FG000|Overall Study|Study was prematurely terminated as per Sponsor's decision|4|||
147355429|NCT06215521|531470470|FG000|Treatment Period 1 (Day 1)|Adverse Event|0|||
147355430|NCT06215521|531470471|FG001|Treatment Period 1 (Day 1)|Adverse Event|1|||
147355431|NCT06215521|531470472|FG002|Treatment Period 1 (Day 1)|Adverse Event|0|||
147355432|NCT06215521|531470473|FG003|Treatment Period 1 (Day 1)|Adverse Event|0|||
147355433|NCT06215521|531470474|FG004|Treatment Period 1 (Day 1)|Adverse Event|0|||
147355434|NCT06215521|531470475|FG005|Treatment Period 1 (Day 1)|Adverse Event|0|||
147355435|NCT04096040|531470476|FG000|Overall Study|Protocol Violation|12|||
147355436|NCT04096040|531470476|FG000|Overall Study|Non-compliant site|4|||
147355437|NCT04044768|531470479|FG000|Overall Study|Ongoing in Interventional phase at data cut-off|8|||
147355438|NCT04044768|531470480|FG001|Overall Study|Ongoing in Interventional phase at data cut-off|0|||
147355439|NCT03808818|531470485|FG000|Overall Study|Death|6|||
147355440|NCT03808818|531470486|FG001|Overall Study|Death|6|||
147355441|NCT03808818|531470485|FG000|Overall Study|Withdrawal by Subject|7|||
147355442|NCT03808818|531470486|FG001|Overall Study|Withdrawal by Subject|18|||
147355443|NCT03808818|531470485|FG000|Overall Study|Lost to Follow-up|31|||
147355444|NCT03808818|531470486|FG001|Overall Study|Lost to Follow-up|33|||
147355445|NCT05415722|531470487|FG000|Overall Study|Lost to Follow-up|0|||
147355446|NCT05415722|531470488|FG001|Overall Study|Lost to Follow-up|2|||
147355447|NCT05415722|531470489|FG002|Overall Study|Lost to Follow-up|0|||
147355448|NCT05415722|531470490|FG003|Overall Study|Lost to Follow-up|1|||
147355449|NCT05415722|531470491|FG004|Overall Study|Lost to Follow-up|0|||
147355450|NCT05415722|531470492|FG005|Overall Study|Lost to Follow-up|0|||
147355451|NCT05415722|531470493|FG006|Overall Study|Lost to Follow-up|1|||
147355452|NCT05415722|531470487|FG000|Overall Study|Physician Decision|0|||
147453659|NCT05103332|531824086|FG013|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
147453660|NCT05103332|531824087|FG014|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
147607727|NCT04844762|532378846|FG000|Phase 1 Second Smoking Session (2 Hrs)|Lost to Follow-up|0|||
147607728|NCT04844762|532378847|FG001|Phase 1 Second Smoking Session (2 Hrs)|Lost to Follow-up|0|||
147607729|NCT04844762|532378848|FG002|Phase 1 Second Smoking Session (2 Hrs)|Lost to Follow-up|1|||
147607730|NCT04844762|532378849|FG003|Phase 1 Second Smoking Session (2 Hrs)|Lost to Follow-up|1|||
147607731|NCT04844762|532378850|FG004|Phase 1 Second Smoking Session (2 Hrs)|Lost to Follow-up|2|||
147355453|NCT05415722|531470488|FG001|Overall Study|Physician Decision|0|||
147355454|NCT05415722|531470489|FG002|Overall Study|Physician Decision|0|||
147355455|NCT05415722|531470490|FG003|Overall Study|Physician Decision|1|||
147355456|NCT05415722|531470491|FG004|Overall Study|Physician Decision|0|||
147355457|NCT05415722|531470492|FG005|Overall Study|Physician Decision|0|||
147355458|NCT05415722|531470493|FG006|Overall Study|Physician Decision|1|||
147355459|NCT05415722|531470487|FG000|Overall Study|Protocol Violation|0|||
147355460|NCT05415722|531470488|FG001|Overall Study|Protocol Violation|0|||
147355461|NCT05415722|531470489|FG002|Overall Study|Protocol Violation|0|||
147355462|NCT05415722|531470490|FG003|Overall Study|Protocol Violation|1|||
147355463|NCT05415722|531470491|FG004|Overall Study|Protocol Violation|0|||
147355464|NCT05415722|531470492|FG005|Overall Study|Protocol Violation|0|||
147355465|NCT05415722|531470493|FG006|Overall Study|Protocol Violation|0|||
147355466|NCT05415722|531470487|FG000|Overall Study|Sponsor Discretion|0|||
147355467|NCT05415722|531470488|FG001|Overall Study|Sponsor Discretion|0|||
147355468|NCT05415722|531470489|FG002|Overall Study|Sponsor Discretion|0|||
147355469|NCT05415722|531470490|FG003|Overall Study|Sponsor Discretion|0|||
147355470|NCT05415722|531470491|FG004|Overall Study|Sponsor Discretion|1|||
147355471|NCT05415722|531470492|FG005|Overall Study|Sponsor Discretion|1|||
147355472|NCT05415722|531470493|FG006|Overall Study|Sponsor Discretion|0|||
147355473|NCT05415722|531470487|FG000|Overall Study|Withdrawal by Subject|0|||
147355474|NCT05415722|531470488|FG001|Overall Study|Withdrawal by Subject|1|||
147355475|NCT05415722|531470489|FG002|Overall Study|Withdrawal by Subject|0|||
147355476|NCT05415722|531470490|FG003|Overall Study|Withdrawal by Subject|1|||
147355477|NCT05415722|531470491|FG004|Overall Study|Withdrawal by Subject|1|||
147355478|NCT05415722|531470492|FG005|Overall Study|Withdrawal by Subject|0|||
147355479|NCT05415722|531470493|FG006|Overall Study|Withdrawal by Subject|1|||
147355480|NCT04537715|531470499|FG000|Overall Study|Death|3|||
147355481|NCT04537715|531470500|FG001|Overall Study|Death|1|||
147355482|NCT04537715|531470499|FG000|Overall Study|Withdrawal by Subject|3|||
147355483|NCT04537715|531470500|FG001|Overall Study|Withdrawal by Subject|1|||
147355484|NCT04537715|531470499|FG000|Overall Study|Other|4|||
147355485|NCT04537715|531470500|FG001|Overall Study|Other|3|||
147355486|NCT04537715|531470499|FG000|Overall Study|Progressive disease|1|||
147355487|NCT04537715|531470500|FG001|Overall Study|Progressive disease|0|||
147355488|NCT02191618|531470501|FG000|Overall Study|Withdrawal by Subject|3|||
147355489|NCT02191618|531470501|FG000|Overall Study|Missed Visit|4|||
147355490|NCT03031470|531470502|FG000|Overall Study|Adverse Event|3|||
147355491|NCT03031470|531470503|FG001|Overall Study|Adverse Event|0|||
147355492|NCT03031470|531470502|FG000|Overall Study|Death|3|||
147355493|NCT03031470|531470503|FG001|Overall Study|Death|1|||
147355494|NCT03031470|531470502|FG000|Overall Study|Lost to Follow-up|1|||
147355495|NCT03031470|531470503|FG001|Overall Study|Lost to Follow-up|1|||
147355496|NCT03031470|531470502|FG000|Overall Study|Withdrawal by Subject|1|||
147355497|NCT03031470|531470503|FG001|Overall Study|Withdrawal by Subject|0|||
147355498|NCT03031470|531470502|FG000|Overall Study|Protocol entry criteria not met|0|||
147355499|NCT03031470|531470503|FG001|Overall Study|Protocol entry criteria not met|1|||
147355500|NCT03031470|531470502|FG000|Overall Study|Cancel the operation|0|||
147355501|NCT03031470|531470503|FG001|Overall Study|Cancel the operation|1|||
147355502|NCT02489903|531470509|FG000|Screening|Screen Failure|24|||
147355503|NCT02489903|531470510|FG001|Screening|Screen Failure|0|||
147355504|NCT02489903|531470511|FG002|Screening|Screen Failure|0|||
147607732|NCT04844762|532378851|FG005|Phase 1 Second Smoking Session (2 Hrs)|Lost to Follow-up|0|||
147662806|NCT04376515|532587436|FG001|Overall Study|Found to have been vaccinated before study start|6|||
147355505|NCT02489903|531470512|FG003|Screening|Screen Failure|8|||
147355506|NCT02489903|531470509|FG000|Randomized and Received Treatment|Protocol Violation|0|||
147355507|NCT02489903|531470510|FG001|Randomized and Received Treatment|Protocol Violation|1|||
147355508|NCT02489903|531470511|FG002|Randomized and Received Treatment|Protocol Violation|0|||
147355509|NCT02489903|531470512|FG003|Randomized and Received Treatment|Protocol Violation|0|||
147355510|NCT02489903|531470509|FG000|Randomized and Received Treatment|Baseline Drop Out|3|||
147355511|NCT02489903|531470510|FG001|Randomized and Received Treatment|Baseline Drop Out|0|||
147355512|NCT02489903|531470511|FG002|Randomized and Received Treatment|Baseline Drop Out|0|||
147355513|NCT02489903|531470512|FG003|Randomized and Received Treatment|Baseline Drop Out|0|||
147355514|NCT02489903|531470509|FG000|Randomized and Received Treatment|Withdrawal by Subject|6|||
147355515|NCT02489903|531470510|FG001|Randomized and Received Treatment|Withdrawal by Subject|2|||
147355516|NCT02489903|531470511|FG002|Randomized and Received Treatment|Withdrawal by Subject|0|||
147355517|NCT02489903|531470512|FG003|Randomized and Received Treatment|Withdrawal by Subject|0|||
147355518|NCT02489903|531470509|FG000|Randomized and Received Treatment|Death|10|||
147355519|NCT02489903|531470510|FG001|Randomized and Received Treatment|Death|1|||
147355520|NCT02489903|531470511|FG002|Randomized and Received Treatment|Death|0|||
147355521|NCT02489903|531470512|FG003|Randomized and Received Treatment|Death|0|||
147355522|NCT03848065|531470513|FG000|Overall Study|Death|0|||
147355523|NCT03848065|531470514|FG001|Overall Study|Death|1|||
147355524|NCT03848065|531470515|FG002|Overall Study|Death|0|||
147355525|NCT03848065|531470513|FG000|Overall Study|Lost to Follow-up|0|||
147355526|NCT03848065|531470514|FG001|Overall Study|Lost to Follow-up|0|||
147355527|NCT03848065|531470515|FG002|Overall Study|Lost to Follow-up|1|||
147355528|NCT03848065|531470513|FG000|Overall Study|Physician Decision|0|||
147355529|NCT03848065|531470514|FG001|Overall Study|Physician Decision|0|||
147355530|NCT03848065|531470515|FG002|Overall Study|Physician Decision|1|||
147355531|NCT03496168|531470516|FG000|Overall Study|Other Reasons|1|||
147355532|NCT03496168|531470516|FG000|Overall Study|Adverse Event|1|||
147355533|NCT04568603|531470521|FG000|Overall Study|Physician Decision|1|||
147355534|NCT04564742|531470522|FG000|Overall Study|Lost to Follow-up|1|||
147355535|NCT04564742|531470523|FG001|Overall Study|Lost to Follow-up|0|||
147355536|NCT04564742|531470522|FG000|Overall Study|Consent Withdrawal|4|||
147355537|NCT04564742|531470523|FG001|Overall Study|Consent Withdrawal|4|||
147355538|NCT05126433|531470527|FG000|Overall Study|Withdrawal by Subject|3|||
147355539|NCT05126433|531470528|FG001|Overall Study|Withdrawal by Subject|0|||
147355540|NCT05126433|531470529|FG002|Overall Study|Withdrawal by Subject|4|||
147355541|NCT05126433|531470527|FG000|Overall Study|Death|9|||
147355542|NCT05126433|531470528|FG001|Overall Study|Death|3|||
147355543|NCT05126433|531470529|FG002|Overall Study|Death|5|||
147355544|NCT05126433|531470527|FG000|Overall Study|Study Terminated by sponsor|0|||
147355545|NCT05126433|531470528|FG001|Overall Study|Study Terminated by sponsor|1|||
147355546|NCT05126433|531470529|FG002|Overall Study|Study Terminated by sponsor|2|||
147355547|NCT05126433|531470527|FG000|Overall Study|Progressive Disease|1|||
147355548|NCT05126433|531470528|FG001|Overall Study|Progressive Disease|4|||
147355549|NCT05126433|531470529|FG002|Overall Study|Progressive Disease|3|||
147355550|NCT05126433|531470527|FG000|Overall Study|Sponsor decision- no further OS follow up required|2|||
147355551|NCT05126433|531470528|FG001|Overall Study|Sponsor decision- no further OS follow up required|4|||
147355552|NCT05126433|531470529|FG002|Overall Study|Sponsor decision- no further OS follow up required|6|||
147355553|NCT05144009|531470530|FG000|Overall Study|Lost to Follow-up|0|||
147355554|NCT05144009|531470531|FG001|Overall Study|Lost to Follow-up|1|||
147355555|NCT05144009|531470530|FG000|Overall Study|Study Termination by the Sponsor|11|||
147355556|NCT05144009|531470531|FG001|Overall Study|Study Termination by the Sponsor|11|||
147355557|NCT05144009|531470530|FG000|Overall Study|Disease Progression|1|||
147355558|NCT05144009|531470531|FG001|Overall Study|Disease Progression|0|||
147355559|NCT05144009|531470530|FG000|Overall Study|Participant Decision|0|||
147355560|NCT05144009|531470531|FG001|Overall Study|Participant Decision|2|||
147355561|NCT05144009|531470530|FG000|Overall Study|Death|5|||
147355562|NCT05144009|531470531|FG001|Overall Study|Death|10|||
147355563|NCT00764751|531470532|FG000|Overall Study|Adverse Event|1|||
147355564|NCT00764751|531470533|FG001|Overall Study|Adverse Event|1|||
147355565|NCT00764751|531470532|FG000|Overall Study|Psoriasis flare up on the scalp|1|||
147355566|NCT00764751|531470533|FG001|Overall Study|Psoriasis flare up on the scalp|0|||
147355567|NCT04948697|531470545|FG000|Overall Study|Progressive disease|27|||
147355568|NCT04948697|531470546|FG001|Overall Study|Progressive disease|18|||
147355569|NCT04948697|531470545|FG000|Overall Study|Adverse Event|14|||
147355570|NCT04948697|531470546|FG001|Overall Study|Adverse Event|4|||
147355571|NCT04948697|531470545|FG000|Overall Study|Participant moved to long term extension study|7|||
147355572|NCT04948697|531470546|FG001|Overall Study|Participant moved to long term extension study|4|||
147355573|NCT04948697|531470545|FG000|Overall Study|Withdrawal by Subject|10|||
147355574|NCT04948697|531470546|FG001|Overall Study|Withdrawal by Subject|0|||
147355575|NCT04948697|531470545|FG000|Overall Study|Closed by Sponsor|3|||
147355576|NCT04948697|531470546|FG001|Overall Study|Closed by Sponsor|2|||
147355577|NCT04948697|531470545|FG000|Overall Study|Physician Decision|0|||
147355578|NCT04948697|531470546|FG001|Overall Study|Physician Decision|2|||
147355579|NCT04948697|531470545|FG000|Overall Study|Lost to Follow-up|0|||
147355580|NCT04948697|531470546|FG001|Overall Study|Lost to Follow-up|1|||
147355581|NCT04948697|531470545|FG000|Overall Study|Other-Miscellaneous|1|||
147355582|NCT04948697|531470546|FG001|Overall Study|Other-Miscellaneous|0|||
147607733|NCT04844762|532378846|FG000|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Study Team|1|||
147453661|NCT05103332|531824088|FG015|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
147607734|NCT04844762|532378847|FG001|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Study Team|2|||
147662807|NCT03811821|532587437|FG000|Overall Study|Adverse Event|1|||
147355583|NCT04948697|531470545|FG000|Overall Study|Randomized but not treated|0|||
147355584|NCT04948697|531470546|FG001|Overall Study|Randomized but not treated|1|||
147355585|NCT05201079|531470547|FG000|Overall Study|Adverse Event|7|||
147355586|NCT05201079|531470548|FG001|Overall Study|Adverse Event|11|||
147355587|NCT05201079|531470547|FG000|Overall Study|Death|1|||
147355588|NCT05201079|531470548|FG001|Overall Study|Death|1|||
147355589|NCT05201079|531470547|FG000|Overall Study|Lack of Efficacy|0|||
147355590|NCT05201079|531470548|FG001|Overall Study|Lack of Efficacy|2|||
147355591|NCT05201079|531470547|FG000|Overall Study|Lost to Follow-up|0|||
147355592|NCT05201079|531470548|FG001|Overall Study|Lost to Follow-up|1|||
147607735|NCT04844762|532378848|FG002|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
147607736|NCT04844762|532378849|FG003|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
147355593|NCT05201079|531470547|FG000|Overall Study|Physician Decision|1|||
147355594|NCT05201079|531470548|FG001|Overall Study|Physician Decision|1|||
147355595|NCT05201079|531470547|FG000|Overall Study|Protocol Violation|1|||
147355596|NCT05201079|531470548|FG001|Overall Study|Protocol Violation|0|||
147355597|NCT05201079|531470547|FG000|Overall Study|Withdrawal by Subject|1|||
147355598|NCT05201079|531470548|FG001|Overall Study|Withdrawal by Subject|0|||
147355599|NCT05201079|531470547|FG000|Overall Study|Forbidden medication|9|||
147355600|NCT05201079|531470548|FG001|Overall Study|Forbidden medication|5|||
147355601|NCT05201079|531470547|FG000|Overall Study|Transfer to another hospital|0|||
147355602|NCT05201079|531470548|FG001|Overall Study|Transfer to another hospital|1|||
147355603|NCT05201079|531470547|FG000|Overall Study|Clinical condition|1|||
147355604|NCT05201079|531470548|FG001|Overall Study|Clinical condition|0|||
147355605|NCT05201079|531470547|FG000|Overall Study|SAE and sepsis|1|||
147355606|NCT05201079|531470548|FG001|Overall Study|SAE and sepsis|0|||
147355607|NCT04145440|531470549|FG000|Overall Study|Physician Decision|3|||
147355608|NCT04145440|531470550|FG001|Overall Study|Physician Decision|0|||
147355609|NCT04145440|531470549|FG000|Overall Study|Use of prohibited therapy|2|||
147355610|NCT04145440|531470550|FG001|Overall Study|Use of prohibited therapy|3|||
147355611|NCT05281562|531470553|FG000|Overall Study|Ineligible patient|1|||
147355612|NCT05281562|531470554|FG001|Overall Study|Ineligible patient|0|||
147355613|NCT04898673|531470556|FG000|Overall Study|Screenfail|1|||
147355614|NCT04898673|531470557|FG001|Overall Study|Screenfail|0|||
147355615|NCT03365882|531470560|FG000|Randomization|Still Receiving Protocol Treatment|2|||
147355616|NCT03365882|531470561|FG001|Randomization|Still Receiving Protocol Treatment|0|||
147355617|NCT03365882|531470560|FG000|Randomization|Adverse Event|1|||
147355618|NCT03365882|531470561|FG001|Randomization|Adverse Event|2|||
147355619|NCT03365882|531470560|FG000|Randomization|Refusal Unrelated to Adverse Event|0|||
147355620|NCT03365882|531470561|FG001|Randomization|Refusal Unrelated to Adverse Event|1|||
147355621|NCT03365882|531470560|FG000|Randomization|Progression/Relapse|21|||
147355622|NCT03365882|531470561|FG001|Randomization|Progression/Relapse|3|||
147355623|NCT03365882|531470560|FG000|Randomization|Death|1|||
147355624|NCT03365882|531470561|FG001|Randomization|Death|0|||
147355625|NCT03365882|531470560|FG000|Randomization|Other - Not Protocol Specified|1|||
147355626|NCT03365882|531470561|FG001|Randomization|Other - Not Protocol Specified|1|||
147355627|NCT03365882|531470560|FG000|Randomization|Major Protocol Deviation|0|||
147355628|NCT03365882|531470561|FG001|Randomization|Major Protocol Deviation|1|||
147355629|NCT03365882|531470560|FG000|Crossover: Trastuzumab + Pertuzumab|Still Receiving Protocol Treatment|0|||
147355630|NCT03365882|531470561|FG001|Crossover: Trastuzumab + Pertuzumab|Still Receiving Protocol Treatment|1|||
147355631|NCT03365882|531470560|FG000|Crossover: Trastuzumab + Pertuzumab|Progression/Relapse|0|||
147355632|NCT03365882|531470561|FG001|Crossover: Trastuzumab + Pertuzumab|Progression/Relapse|13|||
147355633|NCT03365882|531470560|FG000|Crossover: Trastuzumab + Pertuzumab|Other - Not Protocol Specified|0|||
147355634|NCT03365882|531470561|FG001|Crossover: Trastuzumab + Pertuzumab|Other - Not Protocol Specified|4|||
147355635|NCT03365882|531470560|FG000|Crossover: Trastuzumab + Pertuzumab|Adverse Event|0|||
147355636|NCT03365882|531470561|FG001|Crossover: Trastuzumab + Pertuzumab|Adverse Event|2|||
147355637|NCT06181227|531472202|FG000|Overall Study|Study terminated by sponsor|7|||
147355638|NCT06181227|531472203|FG001|Overall Study|Study terminated by sponsor|9|||
147355639|NCT00470704|531472206|FG000|Overall Study|Withdrawal by Subject|4|||
147355640|NCT00470704|531472207|FG001|Overall Study|Withdrawal by Subject|3|||
147355641|NCT00470704|531472206|FG000|Overall Study|Relapse/Progression|37|||
147355642|NCT00470704|531472207|FG001|Overall Study|Relapse/Progression|42|||
147355643|NCT00470704|531472206|FG000|Overall Study|toxicity|0|||
147355644|NCT00470704|531472207|FG001|Overall Study|toxicity|1|||
147355645|NCT02561247|531472208|FG000|Overall Study|Protocol Violation|1|||
147355646|NCT02561247|531472208|FG000|Overall Study|Withdrawal by Subject|1|||
147355647|NCT02561247|531472208|FG000|Overall Study|Two filter changes required within the first 24 hours.|4|||
147355648|NCT05540665|531472209|FG000|Overall Study|Study terminated by sponsor|6|||
147355649|NCT05540665|531472210|FG001|Overall Study|Study terminated by sponsor|6|||
147355650|NCT05540665|531472211|FG002|Overall Study|Study terminated by sponsor|7|||
147355651|NCT03462030|531472214|FG000|Overall Study|Withdrawal by Subject|1|||
147355652|NCT03462030|531472215|FG001|Overall Study|Withdrawal by Subject|1|||
147355653|NCT02675751|531472216|FG000|Overall Study|Lost to Follow-up|16|||
147355654|NCT03371381|531472217|FG000|Overall Study|Death|5|||
147607737|NCT04844762|532378850|FG004|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
147355655|NCT03371381|531472217|FG000|Overall Study|Study terminated by sponsor|3|||
147355656|NCT03371381|531472217|FG000|Overall Study|Other|4|||
147355657|NCT02979327|531472218|FG000|First Intervention|Protocol Violation|1|||
147355658|NCT02979327|531472219|FG001|First Intervention|Protocol Violation|0|||
147355659|NCT01073566|531472220|FG000|Period 2 (6 Weeks)|Adverse Event|1|||
147355660|NCT01073566|531472221|FG001|Period 2 (6 Weeks)|Adverse Event|0|||
147355661|NCT05672069|531472225|FG000|Overall Study|Implant removal|1|||
147355662|NCT05672069|531472225|FG000|Overall Study|Lost to Follow-up|2|||
147355663|NCT03858634|531472228|FG000|Overall Study|Withdrawal by Subject|1|||
147355664|NCT03858634|531472229|FG001|Overall Study|Withdrawal by Subject|0|||
147607738|NCT04844762|532378851|FG005|Phase 1 Second Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
147607739|NCT04844762|532378846|FG000|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Subject|1|||
147607740|NCT04844762|532378847|FG001|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
147607741|NCT04844762|532378848|FG002|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
147607742|NCT04844762|532378849|FG003|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
147355665|NCT03858634|531472228|FG000|Overall Study|Adverse Event|1|||
147355666|NCT03858634|531472229|FG001|Overall Study|Adverse Event|0|||
147355667|NCT03858634|531472228|FG000|Overall Study|Lost to Follow-up|0|||
147355668|NCT03858634|531472229|FG001|Overall Study|Lost to Follow-up|1|||
147355669|NCT03858634|531472228|FG000|Overall Study|Other, Not Specified|1|||
147355670|NCT03858634|531472229|FG001|Overall Study|Other, Not Specified|1|||
147355671|NCT03150173|531472230|FG000|Overall Study|Lost to Follow-up|13|||
147355672|NCT03150173|531472231|FG001|Overall Study|Lost to Follow-up|5|||
147355673|NCT03461276|531472233|FG000|Part A (18-24 Months Duration)|Adverse event, serious fatal|1|||
147355674|NCT03461276|531472234|FG001|Part A (18-24 Months Duration)|Adverse event, serious fatal|1|||
147355675|NCT03461276|531472233|FG000|Part A (18-24 Months Duration)|Physician Decision|1|||
147355676|NCT03461276|531472234|FG001|Part A (18-24 Months Duration)|Physician Decision|0|||
147355677|NCT03461276|531472233|FG000|Part A (18-24 Months Duration)|Withdrawal by Subject|1|||
147355678|NCT03461276|531472234|FG001|Part A (18-24 Months Duration)|Withdrawal by Subject|1|||
147355679|NCT03461276|531472233|FG000|Part A (18-24 Months Duration)|Adverse event, non-fatal|3|||
147355680|NCT03461276|531472234|FG001|Part A (18-24 Months Duration)|Adverse event, non-fatal|1|||
147355681|NCT03461276|531472233|FG000|Part A (18-24 Months Duration)|Patient heath status|0|||
147355682|NCT03461276|531472234|FG001|Part A (18-24 Months Duration)|Patient heath status|1|||
147355683|NCT03461276|531472233|FG000|Part A (18-24 Months Duration)|Patient/caregiver's decision|3|||
147355684|NCT03461276|531472234|FG001|Part A (18-24 Months Duration)|Patient/caregiver's decision|3|||
147355685|NCT03461276|531472233|FG000|Part B (18 Months Duration)|Lost to Follow-up|1|||
147355686|NCT03461276|531472234|FG001|Part B (18 Months Duration)|Lost to Follow-up|0|||
147355687|NCT03461276|531472233|FG000|Part B (18 Months Duration)|Withdrawal by Subject|0|||
147355688|NCT03461276|531472234|FG001|Part B (18 Months Duration)|Withdrawal by Subject|1|||
147355689|NCT03461276|531472233|FG000|Part B (18 Months Duration)|Adverse event, non-fatal|0|||
147355690|NCT03461276|531472234|FG001|Part B (18 Months Duration)|Adverse event, non-fatal|1|||
147355691|NCT03461276|531472233|FG000|Part B (18 Months Duration)|Patient/caregiver's decision|3|||
147355692|NCT03461276|531472234|FG001|Part B (18 Months Duration)|Patient/caregiver's decision|0|||
147355693|NCT01802788|531472236|FG000|Overall Study|Withdrawal by Subject|102|||
147355694|NCT01802788|531472237|FG001|Overall Study|Withdrawal by Subject|5|||
147355695|NCT01802788|531472236|FG000|Overall Study|Death|382|||
147355696|NCT01802788|531472237|FG001|Overall Study|Death|18|||
147355697|NCT01802788|531472236|FG000|Overall Study|Lost to Follow-up|31|||
147355698|NCT01802788|531472237|FG001|Overall Study|Lost to Follow-up|2|||
147355699|NCT01802788|531472236|FG000|Overall Study|Physician Decision|3|||
147355700|NCT01802788|531472237|FG001|Overall Study|Physician Decision|0|||
147355701|NCT01802788|531472236|FG000|Overall Study|Patient Non-Compliance|1|||
147355702|NCT01802788|531472237|FG001|Overall Study|Patient Non-Compliance|0|||
147355703|NCT01802788|531472236|FG000|Overall Study|Study Stopped/Terminated at Site|5|||
147355704|NCT01802788|531472237|FG001|Overall Study|Study Stopped/Terminated at Site|0|||
147355705|NCT01802788|531472236|FG000|Overall Study|Other Reasons|19|||
147355706|NCT01802788|531472237|FG001|Overall Study|Other Reasons|0|||
147355707|NCT02043678|531472238|FG000|Overall Study|Never treated|11|||
147355708|NCT02043678|531472239|FG001|Overall Study|Never treated|9|||
147355709|NCT02043678|531472238|FG000|Overall Study|AE with clinical progressive disease(PD)|20|||
147355710|NCT02043678|531472239|FG001|Overall Study|AE with clinical progressive disease(PD)|19|||
147355711|NCT02043678|531472238|FG000|Overall Study|AE without clinical PD|54|||
147355712|NCT02043678|531472239|FG001|Overall Study|AE without clinical PD|36|||
147355713|NCT02043678|531472238|FG000|Overall Study|Lost to Follow-up|1|||
147355714|NCT02043678|531472239|FG001|Overall Study|Lost to Follow-up|1|||
147355715|NCT02043678|531472238|FG000|Overall Study|Other|10|||
147355716|NCT02043678|531472239|FG001|Overall Study|Other|14|||
147355717|NCT02043678|531472238|FG000|Overall Study|Clinical PD|114|||
147355718|NCT02043678|531472239|FG001|Overall Study|Clinical PD|148|||
147355719|NCT02043678|531472238|FG000|Overall Study|Radiological PD|100|||
147355720|NCT02043678|531472239|FG001|Overall Study|Radiological PD|90|||
147607743|NCT04844762|532378850|FG004|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
147355721|NCT02043678|531472238|FG000|Overall Study|Protocol-driven decision point|59|||
147355722|NCT02043678|531472239|FG001|Overall Study|Protocol-driven decision point|58|||
147607744|NCT04844762|532378851|FG005|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
147355723|NCT02043678|531472238|FG000|Overall Study|Withdrawal by Subject|16|||
147355724|NCT02043678|531472239|FG001|Overall Study|Withdrawal by Subject|20|||
147355725|NCT02043678|531472238|FG000|Overall Study|Protocol Violation|1|||
147355726|NCT02043678|531472239|FG001|Overall Study|Protocol Violation|0|||
147355727|NCT02043678|531472238|FG000|Overall Study|Deterioration of general conditions|1|||
147355728|NCT02043678|531472239|FG001|Overall Study|Deterioration of general conditions|1|||
147355729|NCT02043678|531472238|FG000|Overall Study|Logistical difficulties|2|||
147355730|NCT02043678|531472239|FG001|Overall Study|Logistical difficulties|0|||
147355731|NCT02043678|531472238|FG000|Overall Study|Non-compliance with study drug|3|||
147355732|NCT02043678|531472239|FG001|Overall Study|Non-compliance with study drug|1|||
147355733|NCT02043678|531472238|FG000|Overall Study|Physician Decision|4|||
147355734|NCT02043678|531472239|FG001|Overall Study|Physician Decision|3|||
147355735|NCT02043678|531472238|FG000|Overall Study|Subject decision|0|||
147355736|NCT02043678|531472239|FG001|Overall Study|Subject decision|1|||
147355737|NCT02043678|531472238|FG000|Overall Study|Switching to other therapy|3|||
147355738|NCT02043678|531472239|FG001|Overall Study|Switching to other therapy|2|||
147355739|NCT02043678|531472238|FG000|Overall Study|Ongoing with commercial abiraterone/prednisone outside study|1|||
147355740|NCT02043678|531472239|FG001|Overall Study|Ongoing with commercial abiraterone/prednisone outside study|1|||
147355741|NCT02043678|531472238|FG000|Overall Study|Missing|1|||
147355742|NCT02043678|531472239|FG001|Overall Study|Missing|0|||
147355743|NCT02043678|531472238|FG000|Overall Study|Adverse Event|0|||
147355744|NCT02043678|531472239|FG001|Overall Study|Adverse Event|1|||
147355745|NCT03216057|531472240|FG000|Overall Study|Lost to Follow-up|2|||
147355746|NCT03216057|531472241|FG001|Overall Study|Lost to Follow-up|2|||
147355747|NCT03904147|531472246|FG000|Overall Study|Death|15|||
147355748|NCT03904147|531472247|FG001|Overall Study|Death|13|||
147607745|NCT04844762|532378846|FG000|Phase 1 Third Smoking Session (2 Hrs)|Lost to Follow-up|0|||
147607746|NCT04844762|532378847|FG001|Phase 1 Third Smoking Session (2 Hrs)|Lost to Follow-up|0|||
147607747|NCT04844762|532378848|FG002|Phase 1 Third Smoking Session (2 Hrs)|Lost to Follow-up|0|||
147607748|NCT04844762|532378849|FG003|Phase 1 Third Smoking Session (2 Hrs)|Lost to Follow-up|0|||
147607749|NCT04844762|532378850|FG004|Phase 1 Third Smoking Session (2 Hrs)|Lost to Follow-up|1|||
147607750|NCT04844762|532378851|FG005|Phase 1 Third Smoking Session (2 Hrs)|Lost to Follow-up|0|||
147607751|NCT04844762|532378846|FG000|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Study Team|1|||
147607752|NCT04844762|532378847|FG001|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
147607753|NCT04844762|532378848|FG002|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
147607754|NCT04844762|532378849|FG003|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
147607755|NCT04844762|532378850|FG004|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
147355749|NCT03904147|531472248|FG002|Overall Study|Death|15|||
147355750|NCT03904147|531472246|FG000|Overall Study|Withdrawal by Subject|7|||
147355751|NCT03904147|531472247|FG001|Overall Study|Withdrawal by Subject|12|||
147355752|NCT03904147|531472248|FG002|Overall Study|Withdrawal by Subject|1|||
147355753|NCT03904147|531472246|FG000|Overall Study|1Y visit completed after 365 days|1|||
147355754|NCT03904147|531472247|FG001|Overall Study|1Y visit completed after 365 days|1|||
147355755|NCT03904147|531472248|FG002|Overall Study|1Y visit completed after 365 days|0|||
147355756|NCT05269667|531472249|FG000|Overall Study|Study Terminated by Sponsor|4|||
147355757|NCT05270408|531472253|FG000|Started Treatment|Withdrawal by Subject|0|||
147355758|NCT05270408|531472254|FG001|Started Treatment|Withdrawal by Subject|0|||
147355759|NCT05270408|531472255|FG002|Started Treatment|Withdrawal by Subject|3|||
147355760|NCT05270408|531472253|FG000|Started Treatment|Adverse Event|0|||
147355761|NCT05270408|531472254|FG001|Started Treatment|Adverse Event|0|||
147355762|NCT05270408|531472255|FG002|Started Treatment|Adverse Event|1|||
147355763|NCT05270408|531472253|FG000|Follow-Up at 2 Months|Lost to Follow-up|1|||
147355764|NCT05270408|531472254|FG001|Follow-Up at 2 Months|Lost to Follow-up|0|||
147355765|NCT05270408|531472255|FG002|Follow-Up at 2 Months|Lost to Follow-up|0|||
147355766|NCT03768505|531472256|FG000|Overall Study|sponsor decision|76|||
147355767|NCT03768505|531472256|FG000|Overall Study|Death|35|||
147355768|NCT03768505|531472256|FG000|Overall Study|Other -Various|30|||
147355769|NCT03768505|531472256|FG000|Overall Study|Withdrawal by Subject|22|||
147355770|NCT03768505|531472256|FG000|Overall Study|Lost to Follow-up|6|||
147355771|NCT04032704|531472260|FG000|Part A|Withdrawal by Subject|0|||
147355772|NCT04032704|531472261|FG001|Part A|Withdrawal by Subject|0|||
147355773|NCT04032704|531472262|FG002|Part A|Withdrawal by Subject|3|||
147355774|NCT04032704|531472263|FG003|Part A|Withdrawal by Subject|0|||
147355775|NCT04032704|531472264|FG004|Part A|Withdrawal by Subject|1|||
147355776|NCT04032704|531472265|FG005|Part A|Withdrawal by Subject|7|||
147355777|NCT04032704|531472266|FG006|Part A|Withdrawal by Subject|0|||
147355778|NCT04032704|531472267|FG007|Part A|Withdrawal by Subject|0|||
147355779|NCT04032704|531472268|FG008|Part A|Withdrawal by Subject|0|||
147355780|NCT04032704|531472269|FG009|Part A|Withdrawal by Subject|0|||
147355781|NCT04032704|531472270|FG010|Part A|Withdrawal by Subject|0|||
147355782|NCT04032704|531472271|FG011|Part A|Withdrawal by Subject|0|||
147355783|NCT04032704|531472272|FG012|Part A|Withdrawal by Subject|0|||
147355784|NCT04032704|531472273|FG013|Part A|Withdrawal by Subject|0|||
147355785|NCT04032704|531472274|FG014|Part A|Withdrawal by Subject|0|||
147355786|NCT04032704|531472275|FG015|Part A|Withdrawal by Subject|0|||
147355787|NCT04032704|531472276|FG016|Part A|Withdrawal by Subject|0|||
147355788|NCT04032704|531472277|FG017|Part A|Withdrawal by Subject|0|||
147355789|NCT04032704|531472260|FG000|Part A|Lost to Follow-up|1|||
147355790|NCT04032704|531472261|FG001|Part A|Lost to Follow-up|0|||
147355791|NCT04032704|531472262|FG002|Part A|Lost to Follow-up|0|||
147355792|NCT04032704|531472263|FG003|Part A|Lost to Follow-up|0|||
147355793|NCT04032704|531472264|FG004|Part A|Lost to Follow-up|0|||
147355794|NCT04032704|531472265|FG005|Part A|Lost to Follow-up|0|||
147355795|NCT04032704|531472266|FG006|Part A|Lost to Follow-up|0|||
147355796|NCT04032704|531472267|FG007|Part A|Lost to Follow-up|0|||
147355797|NCT04032704|531472268|FG008|Part A|Lost to Follow-up|0|||
147355798|NCT04032704|531472269|FG009|Part A|Lost to Follow-up|0|||
147355799|NCT04032704|531472270|FG010|Part A|Lost to Follow-up|0|||
147355800|NCT04032704|531472271|FG011|Part A|Lost to Follow-up|0|||
147355801|NCT04032704|531472272|FG012|Part A|Lost to Follow-up|0|||
147355802|NCT04032704|531472273|FG013|Part A|Lost to Follow-up|0|||
147355803|NCT04032704|531472274|FG014|Part A|Lost to Follow-up|0|||
147355804|NCT04032704|531472275|FG015|Part A|Lost to Follow-up|0|||
147355805|NCT04032704|531472276|FG016|Part A|Lost to Follow-up|0|||
147355806|NCT04032704|531472277|FG017|Part A|Lost to Follow-up|0|||
147355807|NCT04032704|531472260|FG000|Part A|Death|9|||
147355808|NCT04032704|531472261|FG001|Part A|Death|2|||
147355809|NCT04032704|531472262|FG002|Part A|Death|10|||
147355810|NCT04032704|531472263|FG003|Part A|Death|7|||
147355811|NCT04032704|531472264|FG004|Part A|Death|4|||
147355812|NCT04032704|531472265|FG005|Part A|Death|5|||
147355813|NCT04032704|531472266|FG006|Part A|Death|0|||
147355814|NCT04032704|531472267|FG007|Part A|Death|0|||
147355815|NCT04032704|531472268|FG008|Part A|Death|0|||
147355816|NCT04032704|531472269|FG009|Part A|Death|0|||
147355817|NCT04032704|531472270|FG010|Part A|Death|0|||
147355818|NCT04032704|531472271|FG011|Part A|Death|0|||
147355819|NCT04032704|531472272|FG012|Part A|Death|0|||
147355820|NCT04032704|531472273|FG013|Part A|Death|0|||
147355821|NCT04032704|531472274|FG014|Part A|Death|0|||
147355822|NCT04032704|531472275|FG015|Part A|Death|0|||
147355823|NCT04032704|531472276|FG016|Part A|Death|0|||
147355824|NCT04032704|531472277|FG017|Part A|Death|0|||
147355825|NCT04032704|531472260|FG000|Part B|Other|0|||
147355826|NCT04032704|531472261|FG001|Part B|Other|0|||
147355827|NCT04032704|531472262|FG002|Part B|Other|0|||
147355828|NCT04032704|531472263|FG003|Part B|Other|0|||
147355829|NCT04032704|531472264|FG004|Part B|Other|0|||
147355830|NCT04032704|531472265|FG005|Part B|Other|0|||
147355831|NCT04032704|531472266|FG006|Part B|Other|0|||
147355832|NCT04032704|531472267|FG007|Part B|Other|1|||
147355833|NCT04032704|531472268|FG008|Part B|Other|2|||
147355834|NCT04032704|531472269|FG009|Part B|Other|1|||
147355835|NCT04032704|531472270|FG010|Part B|Other|1|||
147355836|NCT04032704|531472271|FG011|Part B|Other|1|||
147355837|NCT04032704|531472272|FG012|Part B|Other|5|||
147355838|NCT04032704|531472273|FG013|Part B|Other|13|||
147355839|NCT04032704|531472274|FG014|Part B|Other|0|||
147355840|NCT04032704|531472275|FG015|Part B|Other|0|||
147355841|NCT04032704|531472276|FG016|Part B|Other|0|||
147355842|NCT04032704|531472277|FG017|Part B|Other|0|||
147355843|NCT04032704|531472260|FG000|Part B|Study termination by Sponsor|0|||
147355844|NCT04032704|531472261|FG001|Part B|Study termination by Sponsor|0|||
147355845|NCT04032704|531472262|FG002|Part B|Study termination by Sponsor|0|||
147355846|NCT04032704|531472263|FG003|Part B|Study termination by Sponsor|0|||
147355847|NCT04032704|531472264|FG004|Part B|Study termination by Sponsor|0|||
147355848|NCT04032704|531472265|FG005|Part B|Study termination by Sponsor|0|||
147355849|NCT04032704|531472266|FG006|Part B|Study termination by Sponsor|0|||
147355850|NCT04032704|531472267|FG007|Part B|Study termination by Sponsor|0|||
147355851|NCT04032704|531472268|FG008|Part B|Study termination by Sponsor|1|||
147355852|NCT04032704|531472269|FG009|Part B|Study termination by Sponsor|0|||
147355853|NCT04032704|531472270|FG010|Part B|Study termination by Sponsor|0|||
147355854|NCT04032704|531472271|FG011|Part B|Study termination by Sponsor|0|||
147355855|NCT04032704|531472272|FG012|Part B|Study termination by Sponsor|0|||
147355856|NCT04032704|531472273|FG013|Part B|Study termination by Sponsor|0|||
147355857|NCT04032704|531472274|FG014|Part B|Study termination by Sponsor|0|||
147355858|NCT04032704|531472275|FG015|Part B|Study termination by Sponsor|0|||
147355859|NCT04032704|531472276|FG016|Part B|Study termination by Sponsor|0|||
147355860|NCT04032704|531472277|FG017|Part B|Study termination by Sponsor|0|||
147355861|NCT04032704|531472260|FG000|Part B|Withdrawal by Subject|0|||
147355862|NCT04032704|531472261|FG001|Part B|Withdrawal by Subject|0|||
147355863|NCT04032704|531472262|FG002|Part B|Withdrawal by Subject|0|||
147355864|NCT04032704|531472263|FG003|Part B|Withdrawal by Subject|0|||
147355865|NCT04032704|531472264|FG004|Part B|Withdrawal by Subject|0|||
147355866|NCT04032704|531472265|FG005|Part B|Withdrawal by Subject|0|||
147355867|NCT04032704|531472266|FG006|Part B|Withdrawal by Subject|3|||
147355868|NCT04032704|531472267|FG007|Part B|Withdrawal by Subject|2|||
147355869|NCT04032704|531472268|FG008|Part B|Withdrawal by Subject|2|||
147355870|NCT04032704|531472269|FG009|Part B|Withdrawal by Subject|1|||
147662808|NCT03811821|532587438|FG001|Overall Study|Adverse Event|1|||
147355871|NCT04032704|531472270|FG010|Part B|Withdrawal by Subject|4|||
147355872|NCT04032704|531472271|FG011|Part B|Withdrawal by Subject|6|||
147355873|NCT04032704|531472272|FG012|Part B|Withdrawal by Subject|2|||
147355874|NCT04032704|531472273|FG013|Part B|Withdrawal by Subject|1|||
147355875|NCT04032704|531472274|FG014|Part B|Withdrawal by Subject|0|||
147355876|NCT04032704|531472275|FG015|Part B|Withdrawal by Subject|1|||
147355877|NCT04032704|531472276|FG016|Part B|Withdrawal by Subject|0|||
147355878|NCT04032704|531472277|FG017|Part B|Withdrawal by Subject|0|||
147355879|NCT04032704|531472260|FG000|Part B|Lost to Follow-up|0|||
147355880|NCT04032704|531472261|FG001|Part B|Lost to Follow-up|0|||
147607756|NCT04844762|532378851|FG005|Phase 1 Third Smoking Session (2 Hrs)|Withdrawal by Study Team|0|||
147607757|NCT04844762|532378846|FG000|Phase 1 Fourth Smoking Session (2 Hrs)|Withdrawal by Subject|1|||
147607758|NCT04844762|532378847|FG001|Phase 1 Fourth Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
147607759|NCT04844762|532378848|FG002|Phase 1 Fourth Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
147607760|NCT04844762|532378849|FG003|Phase 1 Fourth Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
147607761|NCT04844762|532378850|FG004|Phase 1 Fourth Smoking Session (2 Hrs)|Withdrawal by Subject|0|||
147607762|NCT04844762|532378851|FG005|Phase 1 Fourth Smoking Session (2 Hrs)|Withdrawal by Subject|1|||
147607763|NCT04844762|532378846|FG000|Phase 1 Fourth Smoking Session (2 Hrs)|Ineligible|0|||
147607764|NCT04844762|532378847|FG001|Phase 1 Fourth Smoking Session (2 Hrs)|Ineligible|1|||
147607765|NCT04844762|532378848|FG002|Phase 1 Fourth Smoking Session (2 Hrs)|Ineligible|0|||
147607766|NCT04844762|532378849|FG003|Phase 1 Fourth Smoking Session (2 Hrs)|Ineligible|0|||
147607767|NCT04844762|532378850|FG004|Phase 1 Fourth Smoking Session (2 Hrs)|Ineligible|0|||
147607768|NCT04844762|532378851|FG005|Phase 1 Fourth Smoking Session (2 Hrs)|Ineligible|0|||
147607769|NCT04844762|532378846|FG000|Phase 3 Chosen Product Visit (~3 Hrs)|Lost to Follow-up|0|||
147607770|NCT04844762|532378847|FG001|Phase 3 Chosen Product Visit (~3 Hrs)|Lost to Follow-up|0|||
147607771|NCT04844762|532378848|FG002|Phase 3 Chosen Product Visit (~3 Hrs)|Lost to Follow-up|0|||
147355881|NCT04032704|531472262|FG002|Part B|Lost to Follow-up|0|||
147355882|NCT04032704|531472263|FG003|Part B|Lost to Follow-up|0|||
147355883|NCT04032704|531472264|FG004|Part B|Lost to Follow-up|0|||
147355884|NCT04032704|531472265|FG005|Part B|Lost to Follow-up|0|||
147355885|NCT04032704|531472266|FG006|Part B|Lost to Follow-up|0|||
147355886|NCT04032704|531472267|FG007|Part B|Lost to Follow-up|0|||
147355887|NCT04032704|531472268|FG008|Part B|Lost to Follow-up|0|||
147355888|NCT04032704|531472269|FG009|Part B|Lost to Follow-up|0|||
147355889|NCT04032704|531472270|FG010|Part B|Lost to Follow-up|0|||
147355890|NCT04032704|531472271|FG011|Part B|Lost to Follow-up|1|||
147355891|NCT04032704|531472272|FG012|Part B|Lost to Follow-up|0|||
147355892|NCT04032704|531472273|FG013|Part B|Lost to Follow-up|0|||
147355893|NCT04032704|531472274|FG014|Part B|Lost to Follow-up|0|||
147355894|NCT04032704|531472275|FG015|Part B|Lost to Follow-up|0|||
147355895|NCT04032704|531472276|FG016|Part B|Lost to Follow-up|0|||
147355896|NCT04032704|531472277|FG017|Part B|Lost to Follow-up|0|||
147355897|NCT04032704|531472260|FG000|Part B|Death|0|||
147355898|NCT04032704|531472261|FG001|Part B|Death|0|||
147355899|NCT04032704|531472262|FG002|Part B|Death|0|||
147355900|NCT04032704|531472263|FG003|Part B|Death|0|||
147355901|NCT04032704|531472264|FG004|Part B|Death|0|||
147355902|NCT04032704|531472265|FG005|Part B|Death|0|||
147355903|NCT04032704|531472266|FG006|Part B|Death|13|||
147355904|NCT04032704|531472267|FG007|Part B|Death|13|||
147355905|NCT04032704|531472268|FG008|Part B|Death|14|||
147355906|NCT04032704|531472269|FG009|Part B|Death|12|||
147355907|NCT04032704|531472270|FG010|Part B|Death|12|||
147355908|NCT04032704|531472271|FG011|Part B|Death|13|||
147355909|NCT04032704|531472272|FG012|Part B|Death|7|||
147355910|NCT04032704|531472273|FG013|Part B|Death|17|||
147355911|NCT04032704|531472274|FG014|Part B|Death|2|||
147355912|NCT04032704|531472275|FG015|Part B|Death|1|||
147355913|NCT04032704|531472276|FG016|Part B|Death|2|||
147355914|NCT04032704|531472277|FG017|Part B|Death|2|||
147355915|NCT04992520|531472281|FG000|Part A: First Challenge|Withdrawal by Subject|1|||
147355916|NCT04992520|531472282|FG001|Part A: First Challenge|Withdrawal by Subject|0|||
147355917|NCT04992520|531472283|FG002|Part A: First Challenge|Withdrawal by Subject|0|||
147355918|NCT04992520|531472284|FG003|Part A: First Challenge|Withdrawal by Subject|1|||
147355919|NCT04992520|531472285|FG004|Part A: First Challenge|Withdrawal by Subject|0|||
147355920|NCT04992520|531472286|FG005|Part A: First Challenge|Withdrawal by Subject|0|||
147355921|NCT04992520|531472281|FG000|Part A: First Challenge|Non-compliance|0|||
147355922|NCT04992520|531472282|FG001|Part A: First Challenge|Non-compliance|0|||
147355923|NCT04992520|531472283|FG002|Part A: First Challenge|Non-compliance|0|||
147355924|NCT04992520|531472284|FG003|Part A: First Challenge|Non-compliance|1|||
147355925|NCT04992520|531472285|FG004|Part A: First Challenge|Non-compliance|0|||
147355926|NCT04992520|531472286|FG005|Part A: First Challenge|Non-compliance|0|||
147355927|NCT04992520|531472281|FG000|Part B: 3 Months Later/Second Challenge|Withdrawal by Subject|0|||
147355928|NCT04992520|531472282|FG001|Part B: 3 Months Later/Second Challenge|Withdrawal by Subject|0|||
147355929|NCT04992520|531472283|FG002|Part B: 3 Months Later/Second Challenge|Withdrawal by Subject|1|||
147355930|NCT04992520|531472284|FG003|Part B: 3 Months Later/Second Challenge|Withdrawal by Subject|0|||
147355931|NCT04992520|531472285|FG004|Part B: 3 Months Later/Second Challenge|Withdrawal by Subject|0|||
147355932|NCT04992520|531472286|FG005|Part B: 3 Months Later/Second Challenge|Withdrawal by Subject|1|||
147355933|NCT04992520|531472281|FG000|Part B: 3 Months Later/Second Challenge|Lost to Follow-up|0|||
147355934|NCT04992520|531472282|FG001|Part B: 3 Months Later/Second Challenge|Lost to Follow-up|0|||
147355935|NCT04992520|531472283|FG002|Part B: 3 Months Later/Second Challenge|Lost to Follow-up|1|||
147355936|NCT04992520|531472284|FG003|Part B: 3 Months Later/Second Challenge|Lost to Follow-up|0|||
147355937|NCT04992520|531472285|FG004|Part B: 3 Months Later/Second Challenge|Lost to Follow-up|0|||
147355938|NCT04992520|531472286|FG005|Part B: 3 Months Later/Second Challenge|Lost to Follow-up|0|||
147355939|NCT04103580|531472289|FG000|Phase 1 Active Caregiving|Lost to Follow-up|18|||
147355940|NCT04103580|531472290|FG001|Phase 1 Active Caregiving|Lost to Follow-up|45|||
147355941|NCT04103580|531472289|FG000|Phase 1 Active Caregiving|Withdrawal by Subject|5|||
147355942|NCT04103580|531472290|FG001|Phase 1 Active Caregiving|Withdrawal by Subject|14|||
147355943|NCT04103580|531472289|FG000|Phase 1 Active Caregiving|Decertified from Hospice|3|||
147355944|NCT04103580|531472290|FG001|Phase 1 Active Caregiving|Decertified from Hospice|1|||
147355945|NCT04103580|531472289|FG000|Phase 1 Active Caregiving|Care Recipient Died before First Follow-up|41|||
147355946|NCT04103580|531472290|FG001|Phase 1 Active Caregiving|Care Recipient Died before First Follow-up|35|||
147355947|NCT04103580|531472289|FG000|Phase 1 Active Caregiving|Not truly randomized (cohort-randomized with other family caregivers)|13|||
147355948|NCT04103580|531472290|FG001|Phase 1 Active Caregiving|Not truly randomized (cohort-randomized with other family caregivers)|19|||
147355949|NCT04103580|531472289|FG000|Phase 1 Active Caregiving|Other|3|||
147355950|NCT04103580|531472290|FG001|Phase 1 Active Caregiving|Other|3|||
147355951|NCT04103580|531472289|FG000|Phase 2 Bereavement|Lost to Follow-up|2|||
147355952|NCT04103580|531472290|FG001|Phase 2 Bereavement|Lost to Follow-up|6|||
147355953|NCT04103580|531472289|FG000|Phase 2 Bereavement|Withdrawal by Subject|1|||
147355954|NCT04103580|531472290|FG001|Phase 2 Bereavement|Withdrawal by Subject|4|||
147355955|NCT04103580|531472289|FG000|Phase 2 Bereavement|Not truly randomized (cohort-randomized with other family caregivers)|6|||
147355956|NCT04103580|531472290|FG001|Phase 2 Bereavement|Not truly randomized (cohort-randomized with other family caregivers)|7|||
147355957|NCT04103580|531472289|FG000|Phase 2 Bereavement|Other|8|||
147355958|NCT04103580|531472290|FG001|Phase 2 Bereavement|Other|6|||
147355959|NCT01919554|531472300|FG000|Overall Study|Withdrawal by Subject|0|||
147355960|NCT01919554|531472301|FG001|Overall Study|Withdrawal by Subject|0|||
147355961|NCT01919554|531472302|FG002|Overall Study|Withdrawal by Subject|1|||
147355962|NCT01919554|531472303|FG003|Overall Study|Withdrawal by Subject|1|||
147355963|NCT06457802|531472304|FG000|Overall Study|Early termination of study prior to participant completion|2|||
147355964|NCT06457802|531472305|FG001|Overall Study|Early termination of study prior to participant completion|2|||
147355965|NCT04880863|531472307|FG000|Overall Study|Adverse Event|1|||
147355966|NCT04880863|531472307|FG000|Overall Study|Patient decision|2|||
147355967|NCT04880863|531472307|FG000|Overall Study|Confirmed Disease Progression|15|||
147355968|NCT04880863|531472307|FG000|Overall Study|Death|3|||
147355969|NCT04880863|531472307|FG000|Overall Study|Physician Decision|4|||
147355970|NCT04880863|531472307|FG000|Overall Study|Unconfirmed Disease Progression|4|||
147355971|NCT04880863|531472307|FG000|Overall Study|Withdrawal by Subject|2|||
147355972|NCT04880863|531472307|FG000|Overall Study|Study discontinuation by the sponsor|4|||
147355973|NCT04880863|531472307|FG000|Overall Study|Progression disease identified by lumbar puncture|1|||
147355974|NCT04880863|531472307|FG000|Overall Study|Not received study drug NAP|2|||
147355975|NCT01152450|531472308|FG000|Period 1 (4 Weeks)|Adverse Event|0|||
147355976|NCT01152450|531472309|FG001|Period 1 (4 Weeks)|Adverse Event|0|||
147355977|NCT01152450|531472310|FG002|Period 1 (4 Weeks)|Adverse Event|0|||
147355978|NCT01152450|531472311|FG003|Period 1 (4 Weeks)|Adverse Event|0|||
147355979|NCT01152450|531472312|FG004|Period 1 (4 Weeks)|Adverse Event|1|||
147355980|NCT01152450|531472313|FG005|Period 1 (4 Weeks)|Adverse Event|1|||
147355981|NCT01152450|531472308|FG000|Period 1 (4 Weeks)|Protocol Violation|0|||
147355982|NCT01152450|531472309|FG001|Period 1 (4 Weeks)|Protocol Violation|0|||
147355983|NCT01152450|531472310|FG002|Period 1 (4 Weeks)|Protocol Violation|0|||
147355984|NCT01152450|531472311|FG003|Period 1 (4 Weeks)|Protocol Violation|0|||
147355985|NCT01152450|531472312|FG004|Period 1 (4 Weeks)|Protocol Violation|1|||
147355986|NCT01152450|531472313|FG005|Period 1 (4 Weeks)|Protocol Violation|0|||
147355987|NCT01152450|531472308|FG000|Period 1 (4 Weeks)|Lost to Follow-up|0|||
147355988|NCT01152450|531472309|FG001|Period 1 (4 Weeks)|Lost to Follow-up|1|||
147355989|NCT01152450|531472310|FG002|Period 1 (4 Weeks)|Lost to Follow-up|1|||
147355990|NCT01152450|531472311|FG003|Period 1 (4 Weeks)|Lost to Follow-up|0|||
147355991|NCT01152450|531472312|FG004|Period 1 (4 Weeks)|Lost to Follow-up|0|||
147355992|NCT01152450|531472313|FG005|Period 1 (4 Weeks)|Lost to Follow-up|0|||
147355993|NCT05239455|531472314|FG000|Overall Study|Adverse Event|1|||
147355994|NCT05239455|531472314|FG000|Overall Study|Sponsor Decision|5|||
147355995|NCT05239455|531472314|FG000|Overall Study|Incomplete Blood Collection|1|||
147355996|NCT03459729|531472315|FG000|Overall Study|Physician Decision|2|||
147355997|NCT05704543|531472317|FG000|Overall Study|Withdrawal by Subject|1|||
147355998|NCT05704543|531472318|FG001|Overall Study|Withdrawal by Subject|1|||
147355999|NCT05704543|531472319|FG002|Overall Study|Withdrawal by Subject|0|||
147356000|NCT05704543|531472320|FG003|Overall Study|Withdrawal by Subject|2|||
147356001|NCT05704543|531472317|FG000|Overall Study|Lost to Follow-up|1|||
147356002|NCT05704543|531472318|FG001|Overall Study|Lost to Follow-up|2|||
147356003|NCT05704543|531472319|FG002|Overall Study|Lost to Follow-up|0|||
147356004|NCT05704543|531472320|FG003|Overall Study|Lost to Follow-up|0|||
147607772|NCT04844762|532378849|FG003|Phase 3 Chosen Product Visit (~3 Hrs)|Lost to Follow-up|1|||
147607773|NCT04844762|532378850|FG004|Phase 3 Chosen Product Visit (~3 Hrs)|Lost to Follow-up|0|||
147356005|NCT05576155|531472326|FG000|Overall Study|Withdrawal by Subject|1|||
147356006|NCT05576155|531472327|FG001|Overall Study|Withdrawal by Subject|1|||
147356007|NCT04081103|531472328|FG000|Overall Study|Adverse Event|1|||
147356008|NCT04081103|531472329|FG001|Overall Study|Adverse Event|1|||
147356009|NCT04081103|531472330|FG002|Overall Study|Adverse Event|1|||
147356010|NCT04081103|531472328|FG000|Overall Study|Physician Decision|0|||
147607774|NCT04844762|532378851|FG005|Phase 3 Chosen Product Visit (~3 Hrs)|Lost to Follow-up|0|||
147356011|NCT04081103|531472329|FG001|Overall Study|Physician Decision|0|||
147356012|NCT04081103|531472330|FG002|Overall Study|Physician Decision|1|||
147356013|NCT04828005|531472333|FG000|Part 1 Setup: Washout (4 Days)|Withdrawal by Subject|2|||
147356014|NCT04828005|531472334|FG001|Part 1 Setup: Washout (4 Days)|Withdrawal by Subject|0|||
147356015|NCT04828005|531472335|FG002|Part 1 Setup: Washout (4 Days)|Withdrawal by Subject|0|||
147356016|NCT04828005|531472336|FG003|Part 1 Setup: Washout (4 Days)|Withdrawal by Subject|0|||
147356017|NCT04828005|531472333|FG000|Part 2: 1st Treatment (1 Day)|Withdrawal by Subject|0|||
147356018|NCT04828005|531472334|FG001|Part 2: 1st Treatment (1 Day)|Withdrawal by Subject|0|||
147356019|NCT04828005|531472335|FG002|Part 2: 1st Treatment (1 Day)|Withdrawal by Subject|2|||
147356020|NCT04828005|531472336|FG003|Part 2: 1st Treatment (1 Day)|Withdrawal by Subject|1|||
147356021|NCT04828005|531472333|FG000|Part 2: 1st Treatment (1 Day)|Adverse Event|0|||
147356022|NCT04828005|531472334|FG001|Part 2: 1st Treatment (1 Day)|Adverse Event|0|||
147356023|NCT04828005|531472335|FG002|Part 2: 1st Treatment (1 Day)|Adverse Event|3|||
147356024|NCT04828005|531472336|FG003|Part 2: 1st Treatment (1 Day)|Adverse Event|0|||
147356025|NCT04828005|531472333|FG000|Part 2: 1st Treatment (1 Day)|Protocol Violation|0|||
147356026|NCT04828005|531472334|FG001|Part 2: 1st Treatment (1 Day)|Protocol Violation|0|||
147356027|NCT04828005|531472335|FG002|Part 2: 1st Treatment (1 Day)|Protocol Violation|2|||
147356028|NCT04828005|531472336|FG003|Part 2: 1st Treatment (1 Day)|Protocol Violation|1|||
147356029|NCT04828005|531472333|FG000|Part 2: 1st Treatment (1 Day)|Equipment failure|0|||
147356030|NCT04828005|531472334|FG001|Part 2: 1st Treatment (1 Day)|Equipment failure|0|||
147356031|NCT04828005|531472335|FG002|Part 2: 1st Treatment (1 Day)|Equipment failure|0|||
147356032|NCT04828005|531472336|FG003|Part 2: 1st Treatment (1 Day)|Equipment failure|1|||
147356033|NCT04828005|531472333|FG000|Part 2: Washout (4 Days)|Withdrawal by Subject|0|||
147356034|NCT04828005|531472334|FG001|Part 2: Washout (4 Days)|Withdrawal by Subject|0|||
147356035|NCT04828005|531472335|FG002|Part 2: Washout (4 Days)|Withdrawal by Subject|2|||
147356036|NCT04828005|531472336|FG003|Part 2: Washout (4 Days)|Withdrawal by Subject|0|||
147356037|NCT04828005|531472333|FG000|Part 2: Washout (4 Days)|Physician Decision|0|||
147356038|NCT04828005|531472334|FG001|Part 2: Washout (4 Days)|Physician Decision|0|||
147356039|NCT04828005|531472335|FG002|Part 2: Washout (4 Days)|Physician Decision|0|||
147356040|NCT04828005|531472336|FG003|Part 2: Washout (4 Days)|Physician Decision|2|||
147356041|NCT04828005|531472333|FG000|Part 2: 2nd Treatment (1 Day)|Protocol Violation|0|||
147356042|NCT04828005|531472334|FG001|Part 2: 2nd Treatment (1 Day)|Protocol Violation|0|||
147356043|NCT04828005|531472335|FG002|Part 2: 2nd Treatment (1 Day)|Protocol Violation|0|||
147356044|NCT04828005|531472336|FG003|Part 2: 2nd Treatment (1 Day)|Protocol Violation|2|||
147356045|NCT04828005|531472333|FG000|Part 2: 2nd Treatment (1 Day)|Adverse Event|0|||
147356046|NCT04828005|531472334|FG001|Part 2: 2nd Treatment (1 Day)|Adverse Event|0|||
147356047|NCT04828005|531472335|FG002|Part 2: 2nd Treatment (1 Day)|Adverse Event|0|||
147356048|NCT04828005|531472336|FG003|Part 2: 2nd Treatment (1 Day)|Adverse Event|1|||
147356049|NCT03287817|531473929|FG000|Overall Study|Progressive disease|4|||
147356050|NCT03287817|531473930|FG001|Overall Study|Progressive disease|2|||
147356051|NCT03287817|531473931|FG002|Overall Study|Progressive disease|3|||
147356052|NCT03287817|531473932|FG003|Overall Study|Progressive disease|10|||
147356053|NCT03287817|531473933|FG004|Overall Study|Progressive disease|8|||
147356054|NCT03287817|531473929|FG000|Overall Study|Death|0|||
147356055|NCT03287817|531473930|FG001|Overall Study|Death|0|||
147356056|NCT03287817|531473931|FG002|Overall Study|Death|2|||
147356057|NCT03287817|531473932|FG003|Overall Study|Death|3|||
147356058|NCT03287817|531473933|FG004|Overall Study|Death|4|||
147356059|NCT03287817|531473929|FG000|Overall Study|Physician Decision|0|||
147356060|NCT03287817|531473930|FG001|Overall Study|Physician Decision|0|||
147356061|NCT03287817|531473931|FG002|Overall Study|Physician Decision|0|||
147356062|NCT03287817|531473932|FG003|Overall Study|Physician Decision|1|||
147356063|NCT03287817|531473933|FG004|Overall Study|Physician Decision|0|||
147356064|NCT03287817|531473929|FG000|Overall Study|Withdrawal by Subject|0|||
147356065|NCT03287817|531473930|FG001|Overall Study|Withdrawal by Subject|0|||
147453662|NCT05103332|531824089|FG016|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
147453663|NCT05103332|531824090|FG017|DB Period (6 Months=168 Days)|Lost to Follow-up|0|||
147453664|NCT05103332|531824073|FG000|DB Period (6 Months=168 Days)|Physician Decision|0|||
147453665|NCT05103332|531824074|FG001|DB Period (6 Months=168 Days)|Physician Decision|1|||
147453666|NCT05103332|531824075|FG002|DB Period (6 Months=168 Days)|Physician Decision|0|||
147453667|NCT05103332|531824076|FG003|DB Period (6 Months=168 Days)|Physician Decision|1|||
147453668|NCT05103332|531824077|FG004|DB Period (6 Months=168 Days)|Physician Decision|0|||
147453669|NCT05103332|531824078|FG005|DB Period (6 Months=168 Days)|Physician Decision|0|||
147453670|NCT05103332|531824079|FG006|DB Period (6 Months=168 Days)|Physician Decision|0|||
147453671|NCT05103332|531824080|FG007|DB Period (6 Months=168 Days)|Physician Decision|0|||
147607775|NCT01200069|532380592|FG000|Overall Study|Withdrawal by Subject|0|||
147356066|NCT03287817|531473931|FG002|Overall Study|Withdrawal by Subject|0|||
147356067|NCT03287817|531473932|FG003|Overall Study|Withdrawal by Subject|0|||
147356068|NCT03287817|531473933|FG004|Overall Study|Withdrawal by Subject|4|||
147356069|NCT05543915|531473934|FG000|Overall Study|Lost to Follow-up|0|||
147356070|NCT05543915|531473935|FG001|Overall Study|Lost to Follow-up|1|||
147356071|NCT01824875|531473937|FG000|Overall Study|Disease progression|22|||
147453672|NCT05103332|531824081|FG008|DB Period (6 Months=168 Days)|Physician Decision|0|||
147356072|NCT01824875|531473938|FG001|Overall Study|Disease progression|15|||
147356073|NCT01824875|531473937|FG000|Overall Study|Withdrawal by Subject|5|||
147356074|NCT01824875|531473938|FG001|Overall Study|Withdrawal by Subject|4|||
147356075|NCT01824875|531473937|FG000|Overall Study|Adverse Event|4|||
147356076|NCT01824875|531473938|FG001|Overall Study|Adverse Event|10|||
147356077|NCT01824875|531473937|FG000|Overall Study|Alternative therapy|3|||
147356078|NCT01824875|531473938|FG001|Overall Study|Alternative therapy|0|||
147356079|NCT01824875|531473937|FG000|Overall Study|Complicating disease|1|||
147356080|NCT01824875|531473938|FG001|Overall Study|Complicating disease|0|||
147356081|NCT01824875|531473937|FG000|Overall Study|Physician Decision|0|||
147356082|NCT01824875|531473938|FG001|Overall Study|Physician Decision|1|||
147356083|NCT01824875|531473937|FG000|Overall Study|Non-compliance|1|||
147356084|NCT01824875|531473938|FG001|Overall Study|Non-compliance|1|||
147356085|NCT01824875|531473937|FG000|Overall Study|Treatment ended early due to mis-interpretation of protocol|1|||
147356086|NCT01824875|531473938|FG001|Overall Study|Treatment ended early due to mis-interpretation of protocol|0|||
147356087|NCT01824875|531473937|FG000|Overall Study|Administrative issues|0|||
147356088|NCT01824875|531473938|FG001|Overall Study|Administrative issues|2|||
147356089|NCT01824875|531473937|FG000|Overall Study|Ineligible or never started treatment|9|||
147356090|NCT01824875|531473938|FG001|Overall Study|Ineligible or never started treatment|5|||
147356091|NCT01824875|531473937|FG000|Overall Study|Other|0|||
147356092|NCT01824875|531473938|FG001|Overall Study|Other|2|||
147356093|NCT04195698|531473941|FG000|Overall Study|Adverse Event|4|||
147356094|NCT04195698|531473942|FG001|Overall Study|Adverse Event|11|||
147356095|NCT04195698|531473941|FG000|Overall Study|Withdrawal by Subject|9|||
147356096|NCT04195698|531473942|FG001|Overall Study|Withdrawal by Subject|10|||
147356097|NCT04195698|531473941|FG000|Overall Study|Lost to Follow-up|5|||
147356098|NCT04195698|531473942|FG001|Overall Study|Lost to Follow-up|4|||
147356099|NCT04195698|531473941|FG000|Overall Study|Lack of Efficacy|2|||
147356100|NCT04195698|531473942|FG001|Overall Study|Lack of Efficacy|10|||
147356101|NCT04195698|531473941|FG000|Overall Study|Other|5|||
147356102|NCT04195698|531473942|FG001|Overall Study|Other|4|||
147356103|NCT05459688|531473943|FG000|Overall Study|Lost to Follow-up|6|||
147356104|NCT05459688|531473943|FG000|Overall Study|Physician Decision|1|||
147356105|NCT05459688|531473943|FG000|Overall Study|Withdrawal by Subject|19|||
147356106|NCT05459688|531473943|FG000|Overall Study|Noncompliance, Subject unable to complete last visit.|3|||
147356107|NCT01129102|531473944|FG000|Overall Study|No study drug treatment|2|||
147356108|NCT01129102|531473945|FG001|Overall Study|No study drug treatment|3|||
147356109|NCT01129102|531473946|FG002|Overall Study|No study drug treatment|1|||
147356110|NCT01129102|531473944|FG000|Overall Study|Withdrawal by Subject|2|||
147356111|NCT01129102|531473945|FG001|Overall Study|Withdrawal by Subject|0|||
147356112|NCT01129102|531473946|FG002|Overall Study|Withdrawal by Subject|3|||
147356113|NCT01129102|531473944|FG000|Overall Study|Protocol Violation|0|||
147356114|NCT01129102|531473945|FG001|Overall Study|Protocol Violation|1|||
147356115|NCT01129102|531473946|FG002|Overall Study|Protocol Violation|1|||
147356116|NCT01129102|531473944|FG000|Overall Study|Pregnancy|0|||
147356117|NCT01129102|531473945|FG001|Overall Study|Pregnancy|0|||
147356118|NCT01129102|531473946|FG002|Overall Study|Pregnancy|1|||
147356119|NCT01129102|531473944|FG000|Overall Study|Adverse Event|2|||
147356120|NCT01129102|531473945|FG001|Overall Study|Adverse Event|2|||
147356121|NCT01129102|531473946|FG002|Overall Study|Adverse Event|1|||
147356122|NCT01129102|531473944|FG000|Overall Study|Lost to Follow-up|2|||
147356123|NCT01129102|531473945|FG001|Overall Study|Lost to Follow-up|0|||
147356124|NCT01129102|531473946|FG002|Overall Study|Lost to Follow-up|0|||
147356125|NCT03379675|531473949|FG000|Overall Study|Lost to Follow-up|0|||
147356126|NCT03379675|531473950|FG001|Overall Study|Lost to Follow-up|1|||
147356127|NCT03379675|531473951|FG002|Overall Study|Lost to Follow-up|0|||
147356128|NCT03379675|531473949|FG000|Overall Study|Adverse Event|2|||
147356129|NCT03379675|531473950|FG001|Overall Study|Adverse Event|0|||
147356130|NCT03379675|531473951|FG002|Overall Study|Adverse Event|0|||
147356131|NCT03379675|531473949|FG000|Overall Study|Withdrawal by Subject|2|||
147356132|NCT03379675|531473950|FG001|Overall Study|Withdrawal by Subject|1|||
147356133|NCT03379675|531473951|FG002|Overall Study|Withdrawal by Subject|2|||
147356134|NCT02817776|531473952|FG000|Overall Study|Excluded|33|||
147356135|NCT02817776|531473952|FG000|Overall Study|Lost to Follow-up|20|||
147356136|NCT02817776|531473952|FG000|Overall Study|Withdrawal by Subject|33|||
147356137|NCT02817776|531473952|FG000|Overall Study|Death|2|||
147356138|NCT03381196|531473955|FG000|Overall Study|Withdrawal by Subject|7|||
147356139|NCT03381196|531473956|FG001|Overall Study|Withdrawal by Subject|7|||
147356140|NCT03381196|531473955|FG000|Overall Study|Other|0|||
147356141|NCT03381196|531473956|FG001|Overall Study|Other|1|||
147356142|NCT03381196|531473955|FG000|Overall Study|Lost to Follow-up|5|||
147356143|NCT03381196|531473956|FG001|Overall Study|Lost to Follow-up|4|||
147356144|NCT03381196|531473955|FG000|Overall Study|Death|0|||
147356145|NCT03381196|531473956|FG001|Overall Study|Death|1|||
147356146|NCT03381196|531473955|FG000|Overall Study|Adverse Event|1|||
147356147|NCT03381196|531473956|FG001|Overall Study|Adverse Event|0|||
147356148|NCT03381196|531473955|FG000|Overall Study|Randomized, not treated|3|||
147356149|NCT03381196|531473956|FG001|Overall Study|Randomized, not treated|6|||
147356150|NCT02359890|531473957|FG000|Overall Study|Not meeting eligibility|4|||
147356151|NCT02359890|531473957|FG000|Overall Study|Never treated with study catheter|6|||
147356152|NCT03628924|531473958|FG000|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|2|||
147356153|NCT03628924|531473959|FG001|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
147356154|NCT03628924|531473960|FG002|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
147356155|NCT03628924|531473961|FG003|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
147356156|NCT03628924|531473962|FG004|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
147356157|NCT03628924|531473963|FG005|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
147356158|NCT03628924|531473964|FG006|Placebo Controlled Period (Week 0 - 16)|Lost to Follow-up|0|||
147356159|NCT03628924|531473958|FG000|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
147356160|NCT03628924|531473959|FG001|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
147356161|NCT03628924|531473960|FG002|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|1|||
147356162|NCT03628924|531473961|FG003|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
147356163|NCT03628924|531473962|FG004|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
147356164|NCT03628924|531473963|FG005|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
147356165|NCT03628924|531473964|FG006|Placebo Controlled Period (Week 0 - 16)|Withdrawal by Subject|0|||
147356166|NCT03628924|531473958|FG000|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|1|||
147356167|NCT03628924|531473959|FG001|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|2|||
147356168|NCT03628924|531473960|FG002|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|1|||
147356169|NCT03628924|531473961|FG003|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|0|||
147356170|NCT03628924|531473962|FG004|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|0|||
147356171|NCT03628924|531473963|FG005|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|0|||
147356172|NCT03628924|531473964|FG006|Placebo Controlled Period (Week 0 - 16)|Protocol Violation|0|||
147356173|NCT03628924|531473958|FG000|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
147356174|NCT03628924|531473959|FG001|Placebo Controlled Period (Week 0 - 16)|Adverse Event|1|||
147356175|NCT03628924|531473960|FG002|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
147356176|NCT03628924|531473961|FG003|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
147356177|NCT03628924|531473962|FG004|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
147356178|NCT03628924|531473963|FG005|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
147356179|NCT03628924|531473964|FG006|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
147356180|NCT03628924|531473958|FG000|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|3|||
147356181|NCT03628924|531473959|FG001|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0|||
147356182|NCT03628924|531473960|FG002|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|1|||
147356183|NCT03628924|531473961|FG003|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0|||
147356184|NCT03628924|531473962|FG004|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0|||
147356185|NCT03628924|531473963|FG005|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0|||
147356186|NCT03628924|531473964|FG006|Placebo Controlled Period (Week 0 - 16)|Lack of Efficacy|0|||
147356187|NCT03628924|531473958|FG000|Active Treatment Period (Week 16-48)|Lost to Follow-up|0|||
147356188|NCT03628924|531473959|FG001|Active Treatment Period (Week 16-48)|Lost to Follow-up|0|||
147356189|NCT03628924|531473960|FG002|Active Treatment Period (Week 16-48)|Lost to Follow-up|0|||
147356190|NCT03628924|531473961|FG003|Active Treatment Period (Week 16-48)|Lost to Follow-up|1|||
147356191|NCT03628924|531473962|FG004|Active Treatment Period (Week 16-48)|Lost to Follow-up|1|||
147356192|NCT03628924|531473963|FG005|Active Treatment Period (Week 16-48)|Lost to Follow-up|2|||
147356193|NCT03628924|531473964|FG006|Active Treatment Period (Week 16-48)|Lost to Follow-up|1|||
147356194|NCT03628924|531473958|FG000|Active Treatment Period (Week 16-48)|Adverse Event|0|||
147356195|NCT03628924|531473959|FG001|Active Treatment Period (Week 16-48)|Adverse Event|0|||
147356196|NCT03628924|531473960|FG002|Active Treatment Period (Week 16-48)|Adverse Event|0|||
147356197|NCT03628924|531473961|FG003|Active Treatment Period (Week 16-48)|Adverse Event|1|||
147356198|NCT03628924|531473962|FG004|Active Treatment Period (Week 16-48)|Adverse Event|0|||
147356199|NCT03628924|531473963|FG005|Active Treatment Period (Week 16-48)|Adverse Event|2|||
147356200|NCT03628924|531473964|FG006|Active Treatment Period (Week 16-48)|Adverse Event|4|||
147356201|NCT03628924|531473958|FG000|Active Treatment Period (Week 16-48)|Protocol Violation|0|||
147356202|NCT03628924|531473959|FG001|Active Treatment Period (Week 16-48)|Protocol Violation|0|||
147356203|NCT03628924|531473960|FG002|Active Treatment Period (Week 16-48)|Protocol Violation|0|||
147356204|NCT03628924|531473961|FG003|Active Treatment Period (Week 16-48)|Protocol Violation|1|||
147356205|NCT03628924|531473962|FG004|Active Treatment Period (Week 16-48)|Protocol Violation|1|||
147356206|NCT03628924|531473963|FG005|Active Treatment Period (Week 16-48)|Protocol Violation|0|||
147356207|NCT03628924|531473964|FG006|Active Treatment Period (Week 16-48)|Protocol Violation|1|||
147356208|NCT03628924|531473958|FG000|Active Treatment Period (Week 16-48)|Lack of Efficacy|0|||
147356209|NCT03628924|531473959|FG001|Active Treatment Period (Week 16-48)|Lack of Efficacy|0|||
147356210|NCT03628924|531473960|FG002|Active Treatment Period (Week 16-48)|Lack of Efficacy|0|||
147356211|NCT03628924|531473961|FG003|Active Treatment Period (Week 16-48)|Lack of Efficacy|5|||
147356212|NCT03628924|531473962|FG004|Active Treatment Period (Week 16-48)|Lack of Efficacy|1|||
147607776|NCT01200069|532380593|FG001|Overall Study|Withdrawal by Subject|1|||
147607777|NCT03408639|532380594|FG000|Overall Study|Death|5|||
147607778|NCT03408639|532380595|FG001|Overall Study|Death|5|||
147356213|NCT03628924|531473963|FG005|Active Treatment Period (Week 16-48)|Lack of Efficacy|4|||
147356214|NCT03628924|531473964|FG006|Active Treatment Period (Week 16-48)|Lack of Efficacy|2|||
147356215|NCT03628924|531473958|FG000|Active Treatment Period (Week 16-48)|Withdrawal by Subject|0|||
147356216|NCT03628924|531473959|FG001|Active Treatment Period (Week 16-48)|Withdrawal by Subject|0|||
147356217|NCT03628924|531473960|FG002|Active Treatment Period (Week 16-48)|Withdrawal by Subject|0|||
147356218|NCT03628924|531473961|FG003|Active Treatment Period (Week 16-48)|Withdrawal by Subject|0|||
147356219|NCT03628924|531473962|FG004|Active Treatment Period (Week 16-48)|Withdrawal by Subject|1|||
147356220|NCT03628924|531473963|FG005|Active Treatment Period (Week 16-48)|Withdrawal by Subject|5|||
147356221|NCT03628924|531473964|FG006|Active Treatment Period (Week 16-48)|Withdrawal by Subject|3|||
147356222|NCT04499924|531473968|FG000|Overall Study|Study termination by sponsor|4|||
147356223|NCT04499924|531473969|FG001|Overall Study|Study termination by sponsor|6|||
147356224|NCT04499924|531473968|FG000|Overall Study|Withdrawal by Subject|1|||
147356225|NCT04499924|531473969|FG001|Overall Study|Withdrawal by Subject|3|||
147356226|NCT03011333|531473972|FG000|Overall Study|Lost to Follow-up|0|||
147356227|NCT03011333|531473973|FG001|Overall Study|Lost to Follow-up|1|||
147356228|NCT03011333|531473974|FG002|Overall Study|Lost to Follow-up|0|||
147356229|NCT03011333|531473975|FG003|Overall Study|Lost to Follow-up|1|||
147356230|NCT03011333|531473976|FG004|Overall Study|Lost to Follow-up|4|||
147356231|NCT03011333|531473977|FG005|Overall Study|Lost to Follow-up|4|||
147356232|NCT03011333|531473978|FG006|Overall Study|Lost to Follow-up|5|||
147356233|NCT04413708|531473979|FG000|Overall Study|Lost to Follow-up|1|||
147356234|NCT04413708|531473980|FG001|Overall Study|Lost to Follow-up|2|||
147356235|NCT02861300|531473983|FG000|Overall Study|Death|0|||
147356236|NCT02861300|531473984|FG001|Overall Study|Death|0|||
147356237|NCT02861300|531473985|FG002|Overall Study|Death|0|||
147356238|NCT02861300|531473986|FG003|Overall Study|Death|0|||
147356239|NCT02861300|531473987|FG004|Overall Study|Death|0|||
147607779|NCT03408639|532380594|FG000|Overall Study|Lost to Follow-up|1|||
147607780|NCT03408639|532380595|FG001|Overall Study|Lost to Follow-up|4|||
147607781|NCT03408639|532380594|FG000|Overall Study|Withdrawal by Subject|2|||
147607782|NCT03408639|532380595|FG001|Overall Study|Withdrawal by Subject|7|||
147607783|NCT03408639|532380594|FG000|Overall Study|Physician Decision|3|||
147607784|NCT03408639|532380595|FG001|Overall Study|Physician Decision|6|||
147607785|NCT04998851|532380596|FG000|Treatment and Sampling Period (60 Days)|Withdrawal by Subject|1|||
147607786|NCT04998851|532380597|FG001|Treatment and Sampling Period (60 Days)|Withdrawal by Subject|1|||
147607787|NCT04998851|532380596|FG000|Vaccination Period (11 Months)|Withdrawal by Subject|1|||
147607788|NCT04998851|532380597|FG001|Vaccination Period (11 Months)|Withdrawal by Subject|1|||
147607789|NCT00070499|532380598|FG000|Overall Study|Adverse Event|6|||
147607790|NCT00070499|532380599|FG001|Overall Study|Adverse Event|6|||
147607791|NCT00070499|532380600|FG002|Overall Study|Adverse Event|19|||
147607792|NCT00070499|532380601|FG003|Overall Study|Adverse Event|15|||
147607793|NCT00070499|532380598|FG000|Overall Study|Refusal unrelated to adverse effects|7|||
147607794|NCT00070499|532380599|FG001|Overall Study|Refusal unrelated to adverse effects|5|||
147607795|NCT00070499|532380600|FG002|Overall Study|Refusal unrelated to adverse effects|5|||
147607796|NCT00070499|532380601|FG003|Overall Study|Refusal unrelated to adverse effects|8|||
147607797|NCT00070499|532380598|FG000|Overall Study|Progression/relapse|4|||
147607798|NCT00070499|532380599|FG001|Overall Study|Progression/relapse|2|||
147607799|NCT00070499|532380600|FG002|Overall Study|Progression/relapse|1|||
147607800|NCT00070499|532380601|FG003|Overall Study|Progression/relapse|4|||
147356240|NCT02861300|531473988|FG005|Overall Study|Death|0|||
147356241|NCT02861300|531473989|FG006|Overall Study|Death|24|||
147356242|NCT02861300|531473983|FG000|Overall Study|Delay in treatment|0|||
147356243|NCT02861300|531473984|FG001|Overall Study|Delay in treatment|0|||
147356244|NCT02861300|531473985|FG002|Overall Study|Delay in treatment|0|||
147356245|NCT02861300|531473986|FG003|Overall Study|Delay in treatment|0|||
147356246|NCT02861300|531473987|FG004|Overall Study|Delay in treatment|0|||
147356247|NCT02861300|531473988|FG005|Overall Study|Delay in treatment|1|||
147356248|NCT02861300|531473989|FG006|Overall Study|Delay in treatment|0|||
147356249|NCT02861300|531473983|FG000|Overall Study|Disease Progression|0|||
147356250|NCT02861300|531473984|FG001|Overall Study|Disease Progression|1|||
147453673|NCT05103332|531824082|FG009|DB Period (6 Months=168 Days)|Physician Decision|0|||
147453674|NCT05103332|531824083|FG010|DB Period (6 Months=168 Days)|Physician Decision|0|||
147607801|NCT00070499|532380598|FG000|Overall Study|Death|1|||
147607802|NCT00070499|532380599|FG001|Overall Study|Death|1|||
147607803|NCT00070499|532380600|FG002|Overall Study|Death|1|||
147607804|NCT00070499|532380601|FG003|Overall Study|Death|2|||
147356251|NCT02861300|531473985|FG002|Overall Study|Disease Progression|0|||
147356252|NCT02861300|531473986|FG003|Overall Study|Disease Progression|0|||
147356253|NCT02861300|531473987|FG004|Overall Study|Disease Progression|0|||
147356254|NCT02861300|531473988|FG005|Overall Study|Disease Progression|0|||
147607805|NCT00070499|532380598|FG000|Overall Study|Other - not protocol specified|7|||
147607806|NCT00070499|532380599|FG001|Overall Study|Other - not protocol specified|3|||
147356255|NCT02861300|531473989|FG006|Overall Study|Disease Progression|2|||
147356256|NCT02861300|531473983|FG000|Overall Study|Patient decision/withdrawal/refusal|0|||
147453675|NCT05103332|531824084|FG011|DB Period (6 Months=168 Days)|Physician Decision|0|||
147356257|NCT02861300|531473984|FG001|Overall Study|Patient decision/withdrawal/refusal|0|||
147356258|NCT02861300|531473985|FG002|Overall Study|Patient decision/withdrawal/refusal|0|||
147356259|NCT02861300|531473986|FG003|Overall Study|Patient decision/withdrawal/refusal|0|||
147356260|NCT02861300|531473987|FG004|Overall Study|Patient decision/withdrawal/refusal|0|||
147356261|NCT02861300|531473988|FG005|Overall Study|Patient decision/withdrawal/refusal|0|||
147356262|NCT02861300|531473989|FG006|Overall Study|Patient decision/withdrawal/refusal|2|||
147356263|NCT02861300|531473983|FG000|Overall Study|Clinical Complications|0|||
147356264|NCT02861300|531473984|FG001|Overall Study|Clinical Complications|0|||
147356265|NCT02861300|531473985|FG002|Overall Study|Clinical Complications|0|||
147356266|NCT02861300|531473986|FG003|Overall Study|Clinical Complications|0|||
147356267|NCT02861300|531473987|FG004|Overall Study|Clinical Complications|0|||
147356268|NCT02861300|531473988|FG005|Overall Study|Clinical Complications|0|||
147356269|NCT02861300|531473989|FG006|Overall Study|Clinical Complications|1|||
147356270|NCT03133546|531473995|FG000|Overall Study|Death|46|||
147356271|NCT03133546|531473996|FG001|Overall Study|Death|43|||
147356272|NCT03133546|531473995|FG000|Overall Study|Withdrawal/Lost to follow-up|5|||
147356273|NCT03133546|531473996|FG001|Overall Study|Withdrawal/Lost to follow-up|7|||
147356274|NCT01501955|531474000|FG000|Overall Study|Withdrawal by Subject|1|||
147356275|NCT01501955|531474001|FG001|Overall Study|Withdrawal by Subject|0|||
147356276|NCT01501955|531474000|FG000|Overall Study|Adverse Event|1|||
147356277|NCT01501955|531474001|FG001|Overall Study|Adverse Event|3|||
147356278|NCT05034328|531474002|FG000|Overall Study|Protocol Violation|1|||
147356279|NCT05034328|531474003|FG001|Overall Study|Protocol Violation|0|||
147356280|NCT05034328|531474002|FG000|Overall Study|Lost to Follow-up|0|||
147356281|NCT05034328|531474003|FG001|Overall Study|Lost to Follow-up|10|||
147356282|NCT02993159|531474004|FG000|Overall Study|Withdrawal by Subject|1|||
147356283|NCT02993159|531474005|FG001|Overall Study|Withdrawal by Subject|3|||
147356284|NCT02993159|531474004|FG000|Overall Study|Protocol Violation|1|||
147356285|NCT02993159|531474005|FG001|Overall Study|Protocol Violation|0|||
147356286|NCT02993159|531474004|FG000|Overall Study|Opted out of surgery|2|||
147356287|NCT02993159|531474005|FG001|Overall Study|Opted out of surgery|0|||
147356288|NCT02993159|531474004|FG000|Overall Study|Surgery postponed due to COVID-19 and started AI|1|||
147356289|NCT02993159|531474005|FG001|Overall Study|Surgery postponed due to COVID-19 and started AI|1|||
147356290|NCT02993159|531474004|FG000|Overall Study|Physician Decision|0|||
147356291|NCT02993159|531474005|FG001|Overall Study|Physician Decision|1|||
147356292|NCT05399459|531474007|FG000|Overall Study|Randomized but not treated|29|||
147356293|NCT05399459|531474008|FG001|Overall Study|Randomized but not treated|30|||
147356294|NCT05399459|531474009|FG002|Overall Study|Randomized but not treated|38|||
147356295|NCT05399459|531474007|FG000|Overall Study|Lost to Follow-up|1|||
147356296|NCT05399459|531474008|FG001|Overall Study|Lost to Follow-up|0|||
147356297|NCT05399459|531474009|FG002|Overall Study|Lost to Follow-up|0|||
147356298|NCT03625167|531474011|FG000|Overall Study|Protocol Violation|5|||
147356299|NCT02231164|531474012|FG000|Overall Study|Adverse Event|1|||
147356300|NCT02231164|531474013|FG001|Overall Study|Adverse Event|1|||
147356301|NCT02231164|531474012|FG000|Overall Study|Lack of Efficacy|4|||
147356302|NCT02231164|531474013|FG001|Overall Study|Lack of Efficacy|3|||
147356303|NCT02231164|531474012|FG000|Overall Study|Withdrawal by Subject|1|||
147356304|NCT02231164|531474013|FG001|Overall Study|Withdrawal by Subject|2|||
147356305|NCT06103188|531474015|FG000|Overall Study|Lost to Follow-up|1|||
147356306|NCT06103188|531474016|FG001|Overall Study|Lost to Follow-up|6|||
147356307|NCT06103188|531474017|FG002|Overall Study|Lost to Follow-up|4|||
147356308|NCT02969707|531474022|FG000|Overall Study|Withdrawal by Subject|6|||
147356309|NCT02969707|531474023|FG001|Overall Study|Withdrawal by Subject|5|||
147356310|NCT02969707|531474022|FG000|Overall Study|Severe anxiety|0|||
147356311|NCT02969707|531474023|FG001|Overall Study|Severe anxiety|1|||
147356312|NCT02969707|531474022|FG000|Overall Study|Positive toxicology screen|0|||
147356313|NCT02969707|531474023|FG001|Overall Study|Positive toxicology screen|2|||
147356314|NCT02969707|531474022|FG000|Overall Study|Claustrophobia|2|||
147356315|NCT02969707|531474023|FG001|Overall Study|Claustrophobia|2|||
147356316|NCT02969707|531474022|FG000|Overall Study|Non-compliance|1|||
147356317|NCT02969707|531474023|FG001|Overall Study|Non-compliance|2|||
147356318|NCT05583578|531474026|FG000|Overall Study|Withdrawal by Subject|2|||
147356319|NCT05583578|531474027|FG001|Overall Study|Withdrawal by Subject|0|||
147356320|NCT04314713|531474029|FG000|Overall Study|Lost to Follow-up|0|||
147356321|NCT04314713|531474030|FG001|Overall Study|Lost to Follow-up|0|||
147356322|NCT04314713|531474031|FG002|Overall Study|Lost to Follow-up|0|||
147356323|NCT04314713|531474032|FG003|Overall Study|Lost to Follow-up|1|||
147356324|NCT04314713|531474033|FG004|Overall Study|Lost to Follow-up|0|||
147356325|NCT04314713|531474034|FG005|Overall Study|Lost to Follow-up|0|||
147453676|NCT05103332|531824085|FG012|DB Period (6 Months=168 Days)|Physician Decision|0|||
147453677|NCT05103332|531824086|FG013|DB Period (6 Months=168 Days)|Physician Decision|0|||
147356326|NCT00248287|531474035|FG000|Overall Study|Adverse Event|11|||
147356327|NCT00248287|531474036|FG001|Overall Study|Adverse Event|10|||
147356328|NCT00248287|531474035|FG000|Overall Study|Death|1|||
147356329|NCT00248287|531474036|FG001|Overall Study|Death|0|||
147356330|NCT00248287|531474035|FG000|Overall Study|Lost to Follow-up|0|||
147356331|NCT00248287|531474036|FG001|Overall Study|Lost to Follow-up|1|||
147356332|NCT00248287|531474035|FG000|Overall Study|Investigator Request|4|||
147356333|NCT00248287|531474036|FG001|Overall Study|Investigator Request|3|||
147356334|NCT00248287|531474035|FG000|Overall Study|Patient Request|5|||
147356335|NCT00248287|531474036|FG001|Overall Study|Patient Request|3|||
147356336|NCT00248287|531474035|FG000|Overall Study|Other|3|||
147356337|NCT00248287|531474036|FG001|Overall Study|Other|2|||
147356338|NCT04248725|531474039|FG000|Post-Treatment|Lost to Follow-up|6|||
147356339|NCT04248725|531474040|FG001|Post-Treatment|Lost to Follow-up|5|||
147356340|NCT04248725|531474039|FG000|6-Month Follow Up|Lost to Follow-up|9|||
147356341|NCT04248725|531474040|FG001|6-Month Follow Up|Lost to Follow-up|8|||
147356342|NCT04524442|531474049|FG000|Overall Study|Subject Decision|1|||
147356343|NCT01544114|531474062|FG000|Overall Study|Withdrawal by Subject|0|||
147356344|NCT01544114|531474063|FG001|Overall Study|Withdrawal by Subject|0|||
147356345|NCT01544114|531474064|FG002|Overall Study|Withdrawal by Subject|3|||
147356346|NCT01544114|531474062|FG000|Overall Study|Lost to Follow-up|0|||
147356347|NCT01544114|531474063|FG001|Overall Study|Lost to Follow-up|2|||
147356348|NCT01544114|531474064|FG002|Overall Study|Lost to Follow-up|0|||
147356349|NCT01544114|531474062|FG000|Overall Study|Adverse Event|1|||
147356350|NCT01544114|531474063|FG001|Overall Study|Adverse Event|1|||
147356351|NCT01544114|531474064|FG002|Overall Study|Adverse Event|2|||
147356352|NCT01544114|531474062|FG000|Overall Study|Protocol Violation|0|||
147356353|NCT01544114|531474063|FG001|Overall Study|Protocol Violation|1|||
147356354|NCT01544114|531474064|FG002|Overall Study|Protocol Violation|0|||
147356355|NCT02601313|531474069|FG000|Overall Study|Death|2|||
147356356|NCT02601313|531474070|FG001|Overall Study|Death|41|||
147356357|NCT02601313|531474071|FG002|Overall Study|Death|6|||
147356358|NCT02601313|531474069|FG000|Overall Study|Enrolled but never treated|0|||
147356359|NCT02601313|531474070|FG001|Overall Study|Enrolled but never treated|6|||
147356360|NCT02601313|531474071|FG002|Overall Study|Enrolled but never treated|3|||
147356361|NCT02601313|531474069|FG000|Overall Study|Enrolled, did not initiate AC|4|||
147356362|NCT02601313|531474070|FG001|Overall Study|Enrolled, did not initiate AC|0|||
147356363|NCT02601313|531474071|FG002|Overall Study|Enrolled, did not initiate AC|0|||
147356364|NCT02601313|531474069|FG000|Overall Study|Full consent withdrawal|0|||
147356365|NCT02601313|531474070|FG001|Overall Study|Full consent withdrawal|3|||
147356366|NCT02601313|531474071|FG002|Overall Study|Full consent withdrawal|2|||
147356367|NCT02601313|531474069|FG000|Overall Study|Lost to Follow-up|0|||
147356368|NCT02601313|531474070|FG001|Overall Study|Lost to Follow-up|1|||
147356369|NCT02601313|531474071|FG002|Overall Study|Lost to Follow-up|1|||
147356370|NCT03800654|531474072|FG000|Overall Study|Time constraints|3|||
147356371|NCT03800654|531474073|FG001|Overall Study|Time constraints|3|||
147356372|NCT03800654|531474074|FG002|Overall Study|Time constraints|3|||
147356373|NCT03800654|531474072|FG000|Overall Study|Did Not Meet Inclusion Criteria|1|||
147356374|NCT03800654|531474073|FG001|Overall Study|Did Not Meet Inclusion Criteria|0|||
147356375|NCT03800654|531474074|FG002|Overall Study|Did Not Meet Inclusion Criteria|0|||
147356376|NCT03800654|531474072|FG000|Overall Study|Lost to Follow-up|2|||
147356377|NCT03800654|531474073|FG001|Overall Study|Lost to Follow-up|1|||
147356378|NCT03800654|531474074|FG002|Overall Study|Lost to Follow-up|6|||
147356379|NCT03800654|531474072|FG000|Overall Study|Medical Health Issue|0|||
147356380|NCT03800654|531474073|FG001|Overall Study|Medical Health Issue|0|||
147356381|NCT03800654|531474074|FG002|Overall Study|Medical Health Issue|1|||
147356382|NCT03800654|531474072|FG000|Overall Study|Personal Issues|0|||
147356383|NCT03800654|531474073|FG001|Overall Study|Personal Issues|2|||
147356384|NCT03800654|531474074|FG002|Overall Study|Personal Issues|0|||
147356385|NCT03800654|531474072|FG000|Overall Study|Protocol Violation|0|||
147356386|NCT03800654|531474073|FG001|Overall Study|Protocol Violation|1|||
147356387|NCT03800654|531474074|FG002|Overall Study|Protocol Violation|0|||
147356388|NCT06182033|531474075|FG000|Overall Study|No baseline survey provided. Needed for target child selection.|1|||
147356389|NCT06182033|531474076|FG001|Overall Study|No baseline survey provided. Needed for target child selection.|1|||
147356390|NCT06182033|531474075|FG000|Overall Study|Target child relocation|1|||
147356391|NCT06182033|531474076|FG001|Overall Study|Target child relocation|1|||
147356392|NCT06182033|531474075|FG000|Overall Study|Withdrawal by Subject|1|||
147356393|NCT06182033|531474076|FG001|Overall Study|Withdrawal by Subject|0|||
147607807|NCT00070499|532380600|FG002|Overall Study|Other - not protocol specified|12|||
147356394|NCT04830800|531474087|FG000|Overall Study|4 subject was missing value at visit 7 (Day 197) due to migrated/moved from the study area.|2|||
147356395|NCT04830800|531474088|FG001|Overall Study|4 subject was missing value at visit 7 (Day 197) due to migrated/moved from the study area.|1|||
147356396|NCT04830800|531474089|FG002|Overall Study|4 subject was missing value at visit 7 (Day 197) due to migrated/moved from the study area.|0|||
147356397|NCT04830800|531474090|FG003|Overall Study|4 subject was missing value at visit 7 (Day 197) due to migrated/moved from the study area.|1|||
147356398|NCT04830800|531474091|FG004|Overall Study|4 subject was missing value at visit 7 (Day 197) due to migrated/moved from the study area.|0|||
147356399|NCT02151981|531474092|FG000|Overall Study|Death|184|||
147356400|NCT02151981|531474093|FG001|Overall Study|Death|88|||
147356401|NCT02151981|531474092|FG000|Overall Study|Lost to Follow-up|7|||
147356402|NCT02151981|531474093|FG001|Overall Study|Lost to Follow-up|1|||
147356403|NCT02151981|531474092|FG000|Overall Study|Withdrawal by Subject|27|||
147356404|NCT02151981|531474093|FG001|Overall Study|Withdrawal by Subject|21|||
147356405|NCT02151981|531474092|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
147356406|NCT02151981|531474093|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
147356407|NCT02151981|531474092|FG000|Overall Study|Other reasons|1|||
147356408|NCT02151981|531474093|FG001|Overall Study|Other reasons|2|||
147356409|NCT05251909|531476068|FG000|Open Label Extension|Subjects who discontinued treatment with study drug in OLE but completed study follow-up|1|||
147356410|NCT05251909|531476069|FG001|Open Label Extension|Subjects who discontinued treatment with study drug in OLE but completed study follow-up|1|||
147356411|NCT04987320|531476070|FG000|Overall Study|Withdrawal by Subject|0|||
147356412|NCT04987320|531476071|FG001|Overall Study|Withdrawal by Subject|1|||
147356413|NCT00085735|531476072|FG000|Overall Study|Adverse Event|1|||
147356414|NCT00085735|531476073|FG001|Overall Study|Adverse Event|0|||
147356415|NCT00085735|531476074|FG002|Overall Study|Adverse Event|0|||
147356416|NCT00085735|531476075|FG003|Overall Study|Adverse Event|0|||
147356417|NCT00085735|531476076|FG004|Overall Study|Adverse Event|0|||
147356418|NCT00085735|531476077|FG005|Overall Study|Adverse Event|0|||
147356419|NCT00085735|531476072|FG000|Overall Study|Lack of Efficacy|2|||
147356420|NCT00085735|531476073|FG001|Overall Study|Lack of Efficacy|4|||
147356421|NCT00085735|531476074|FG002|Overall Study|Lack of Efficacy|6|||
147356422|NCT00085735|531476075|FG003|Overall Study|Lack of Efficacy|3|||
147356423|NCT00085735|531476076|FG004|Overall Study|Lack of Efficacy|4|||
147356424|NCT00085735|531476077|FG005|Overall Study|Lack of Efficacy|3|||
147356425|NCT00085735|531476072|FG000|Overall Study|Lost to Follow-up|0|||
147356426|NCT00085735|531476073|FG001|Overall Study|Lost to Follow-up|1|||
147356427|NCT00085735|531476074|FG002|Overall Study|Lost to Follow-up|0|||
147356428|NCT00085735|531476075|FG003|Overall Study|Lost to Follow-up|0|||
147356429|NCT00085735|531476076|FG004|Overall Study|Lost to Follow-up|1|||
147356430|NCT00085735|531476077|FG005|Overall Study|Lost to Follow-up|0|||
147356431|NCT00085735|531476072|FG000|Overall Study|Physician Decision|2|||
147356432|NCT00085735|531476073|FG001|Overall Study|Physician Decision|3|||
147356433|NCT00085735|531476074|FG002|Overall Study|Physician Decision|2|||
147356434|NCT00085735|531476075|FG003|Overall Study|Physician Decision|3|||
147356435|NCT00085735|531476076|FG004|Overall Study|Physician Decision|11|||
147356436|NCT00085735|531476077|FG005|Overall Study|Physician Decision|8|||
147356437|NCT00085735|531476072|FG000|Overall Study|Protocol Violation|1|||
147356438|NCT00085735|531476073|FG001|Overall Study|Protocol Violation|0|||
147356439|NCT00085735|531476074|FG002|Overall Study|Protocol Violation|0|||
147356440|NCT00085735|531476075|FG003|Overall Study|Protocol Violation|0|||
147356441|NCT00085735|531476076|FG004|Overall Study|Protocol Violation|0|||
147356442|NCT00085735|531476077|FG005|Overall Study|Protocol Violation|0|||
147356443|NCT00085735|531476072|FG000|Overall Study|Withdrawal by Subject|1|||
147356444|NCT00085735|531476073|FG001|Overall Study|Withdrawal by Subject|0|||
147356445|NCT00085735|531476074|FG002|Overall Study|Withdrawal by Subject|4|||
147356446|NCT00085735|531476075|FG003|Overall Study|Withdrawal by Subject|5|||
147356447|NCT00085735|531476076|FG004|Overall Study|Withdrawal by Subject|7|||
147356448|NCT00085735|531476077|FG005|Overall Study|Withdrawal by Subject|8|||
147356449|NCT00085735|531476072|FG000|Overall Study|Patient ineligible|1|||
147356450|NCT00085735|531476073|FG001|Overall Study|Patient ineligible|0|||
147356451|NCT00085735|531476074|FG002|Overall Study|Patient ineligible|3|||
147356452|NCT00085735|531476075|FG003|Overall Study|Patient ineligible|7|||
147356453|NCT00085735|531476076|FG004|Overall Study|Patient ineligible|17|||
147356454|NCT00085735|531476077|FG005|Overall Study|Patient ineligible|8|||
147356455|NCT00085735|531476072|FG000|Overall Study|Excess residual disease|2|||
147356456|NCT00085735|531476073|FG001|Overall Study|Excess residual disease|2|||
147356457|NCT00085735|531476074|FG002|Overall Study|Excess residual disease|1|||
147356458|NCT00085735|531476075|FG003|Overall Study|Excess residual disease|1|||
147356459|NCT00085735|531476076|FG004|Overall Study|Excess residual disease|1|||
147356460|NCT00085735|531476077|FG005|Overall Study|Excess residual disease|4|||
147356461|NCT00085735|531476072|FG000|Overall Study|Reason not documented|1|||
147356462|NCT00085735|531476073|FG001|Overall Study|Reason not documented|0|||
147356463|NCT00085735|531476074|FG002|Overall Study|Reason not documented|1|||
147356464|NCT00085735|531476075|FG003|Overall Study|Reason not documented|0|||
147356465|NCT00085735|531476076|FG004|Overall Study|Reason not documented|1|||
147356466|NCT00085735|531476077|FG005|Overall Study|Reason not documented|0|||
147356467|NCT00085735|531476072|FG000|Overall Study|Pt transferred to inst w/out study open|1|||
147356468|NCT00085735|531476073|FG001|Overall Study|Pt transferred to inst w/out study open|0|||
147356469|NCT00085735|531476074|FG002|Overall Study|Pt transferred to inst w/out study open|0|||
147356470|NCT00085735|531476075|FG003|Overall Study|Pt transferred to inst w/out study open|0|||
147356471|NCT00085735|531476076|FG004|Overall Study|Pt transferred to inst w/out study open|0|||
147356472|NCT00085735|531476077|FG005|Overall Study|Pt transferred to inst w/out study open|0|||
147356473|NCT00433329|531476078|FG000|Overall Study|Adverse Event|9|||
147356474|NCT00433329|531476078|FG000|Overall Study|Death|4|||
147356475|NCT00433329|531476078|FG000|Overall Study|Withdrew consent|3|||
147356476|NCT00433329|531476078|FG000|Overall Study|Discontinued sildenafil|2|||
147356477|NCT00433329|531476078|FG000|Overall Study|Moved out of state|1|||
147356478|NCT00433329|531476078|FG000|Overall Study|Lost to Follow-up|1|||
147356479|NCT00433329|531476078|FG000|Overall Study|Physician Decision|1|||
147356480|NCT02598388|531476079|FG000|Overall Study|Lost to Follow-up|1|||
147356481|NCT02598388|531476080|FG001|Overall Study|Lost to Follow-up|0|||
147356482|NCT02598388|531476081|FG002|Overall Study|Lost to Follow-up|1|||
147356483|NCT02598388|531476082|FG003|Overall Study|Lost to Follow-up|0|||
147356484|NCT02598388|531476083|FG004|Overall Study|Lost to Follow-up|5|||
147356485|NCT02598388|531476084|FG005|Overall Study|Lost to Follow-up|1|||
147356486|NCT02598388|531476085|FG006|Overall Study|Lost to Follow-up|2|||
147356487|NCT02598388|531476086|FG007|Overall Study|Lost to Follow-up|1|||
147356488|NCT02598388|531476087|FG008|Overall Study|Lost to Follow-up|0|||
147356489|NCT02598388|531476088|FG009|Overall Study|Lost to Follow-up|0|||
147356490|NCT02598388|531476089|FG010|Overall Study|Lost to Follow-up|1|||
147356491|NCT02598388|531476090|FG011|Overall Study|Lost to Follow-up|0|||
147356492|NCT02598388|531476079|FG000|Overall Study|Withdrawal by Subject|0|||
147356493|NCT02598388|531476080|FG001|Overall Study|Withdrawal by Subject|0|||
147356494|NCT02598388|531476081|FG002|Overall Study|Withdrawal by Subject|0|||
147356495|NCT02598388|531476082|FG003|Overall Study|Withdrawal by Subject|0|||
147356496|NCT02598388|531476083|FG004|Overall Study|Withdrawal by Subject|2|||
147356497|NCT02598388|531476084|FG005|Overall Study|Withdrawal by Subject|0|||
147356498|NCT02598388|531476085|FG006|Overall Study|Withdrawal by Subject|2|||
147356499|NCT02598388|531476086|FG007|Overall Study|Withdrawal by Subject|0|||
147356500|NCT02598388|531476087|FG008|Overall Study|Withdrawal by Subject|0|||
147356501|NCT02598388|531476088|FG009|Overall Study|Withdrawal by Subject|1|||
147356502|NCT02598388|531476089|FG010|Overall Study|Withdrawal by Subject|0|||
147356503|NCT02598388|531476090|FG011|Overall Study|Withdrawal by Subject|0|||
147356504|NCT02598388|531476079|FG000|Overall Study|Other|0|||
147356505|NCT02598388|531476080|FG001|Overall Study|Other|0|||
147356506|NCT02598388|531476081|FG002|Overall Study|Other|1|||
147356507|NCT02598388|531476082|FG003|Overall Study|Other|0|||
147356508|NCT02598388|531476083|FG004|Overall Study|Other|3|||
147356509|NCT02598388|531476084|FG005|Overall Study|Other|0|||
147356510|NCT02598388|531476085|FG006|Overall Study|Other|1|||
147356511|NCT02598388|531476086|FG007|Overall Study|Other|0|||
147356512|NCT02598388|531476087|FG008|Overall Study|Other|0|||
147356513|NCT02598388|531476088|FG009|Overall Study|Other|0|||
147356514|NCT02598388|531476089|FG010|Overall Study|Other|0|||
147356515|NCT02598388|531476090|FG011|Overall Study|Other|0|||
147356516|NCT05256017|531476092|FG000|Treatment Period|Withdrawal by Subject|1|||
147356517|NCT05256017|531476093|FG001|Treatment Period|Withdrawal by Subject|1|||
147356518|NCT05256017|531476092|FG000|Follow-up|Lost to Follow-up|7|||
147356519|NCT05256017|531476093|FG001|Follow-up|Lost to Follow-up|1|||
147356520|NCT05256017|531476092|FG000|Follow-up|Withdrawal by Subject|1|||
147356521|NCT05256017|531476093|FG001|Follow-up|Withdrawal by Subject|0|||
147356522|NCT05256017|531476092|FG000|Follow-up|Death|0|||
147356523|NCT05256017|531476093|FG001|Follow-up|Death|1|||
147356524|NCT06132282|531476094|FG000|Overall Study|Lost to Follow-up|31|||
147356525|NCT04663737|531476101|FG000|Overall Study|Withdrawal by Subject|2|||
147356526|NCT04663737|531476102|FG001|Overall Study|Withdrawal by Subject|0|||
147356527|NCT03907878|531476103|FG000|Treatment Period|Withdrawal by Subject|5|||
147356528|NCT03907878|531476103|FG000|Treatment Period|Adverse Event|4|||
147356529|NCT03907878|531476103|FG000|Treatment Period|Lack of Efficacy|1|||
147356530|NCT03907878|531476103|FG000|Treatment Period|Protocol Violation|1|||
147356531|NCT03907878|531476103|FG000|Follow-up Period|Adverse Event|3|||
147356532|NCT03907878|531476103|FG000|Follow-up Period|Withdrawal by Subject|3|||
147356533|NCT02841579|531476111|FG000|Overall Study|Death|1|||
147356534|NCT02841579|531476111|FG000|Overall Study|Adverse Event|1|||
147356535|NCT02841579|531476111|FG000|Overall Study|Lack of Efficacy|9|||
147356536|NCT02998268|531476112|FG000|Overall Study|Adverse Event|0|||
147356537|NCT02998268|531476113|FG001|Overall Study|Adverse Event|2|||
147356538|NCT02998268|531476112|FG000|Overall Study|Withdrawal by Subject|0|||
147356539|NCT02998268|531476113|FG001|Overall Study|Withdrawal by Subject|1|||
147356540|NCT02815566|531476114|FG000|Overall Study|Adverse Event|1|||
147356541|NCT02815566|531476115|FG001|Overall Study|Adverse Event|1|||
147356542|NCT02815566|531476114|FG000|Overall Study|Withdrawal by Subject|1|||
147356543|NCT02815566|531476115|FG001|Overall Study|Withdrawal by Subject|0|||
147356544|NCT02815566|531476114|FG000|Overall Study|Lost to Follow-up|0|||
147356545|NCT02815566|531476115|FG001|Overall Study|Lost to Follow-up|1|||
147356546|NCT03020199|531476116|FG000|Treatment Period|Adverse Event|0|||
147356547|NCT03020199|531476117|FG001|Treatment Period|Adverse Event|2|||
147356548|NCT03020199|531476116|FG000|Treatment Period|Lack of Efficacy|1|||
147356549|NCT03020199|531476117|FG001|Treatment Period|Lack of Efficacy|6|||
147356550|NCT03020199|531476116|FG000|Treatment Period|Lost to Follow-up|1|||
147356551|NCT03020199|531476117|FG001|Treatment Period|Lost to Follow-up|6|||
147356552|NCT03020199|531476116|FG000|Treatment Period|Physician Decision|0|||
147356553|NCT03020199|531476117|FG001|Treatment Period|Physician Decision|1|||
147356554|NCT03020199|531476116|FG000|Treatment Period|Subject/guardian decision|8|||
147356555|NCT03020199|531476117|FG001|Treatment Period|Subject/guardian decision|15|||
147356556|NCT03020199|531476116|FG000|Treatment Period|Subjects not treated|3|||
147356557|NCT03020199|531476117|FG001|Treatment Period|Subjects not treated|4|||
147356558|NCT03020199|531476116|FG000|Follow-up Period|Disease relapse|32|||
147356559|NCT03020199|531476117|FG001|Follow-up Period|Disease relapse|7|||
147356560|NCT03020199|531476116|FG000|Follow-up Period|Lack of Efficacy|1|||
147356561|NCT03020199|531476117|FG001|Follow-up Period|Lack of Efficacy|2|||
147356562|NCT03020199|531476116|FG000|Follow-up Period|Lost to Follow-up|4|||
147356563|NCT03020199|531476117|FG001|Follow-up Period|Lost to Follow-up|6|||
147356564|NCT03020199|531476116|FG000|Follow-up Period|Physician Decision|2|||
147356565|NCT03020199|531476117|FG001|Follow-up Period|Physician Decision|2|||
147356566|NCT03020199|531476116|FG000|Follow-up Period|Protocol Violation|1|||
147356567|NCT03020199|531476117|FG001|Follow-up Period|Protocol Violation|2|||
147356568|NCT03020199|531476116|FG000|Follow-up Period|Study terminated by Sponsor|6|||
147356569|NCT03020199|531476117|FG001|Follow-up Period|Study terminated by Sponsor|3|||
147356570|NCT03020199|531476116|FG000|Follow-up Period|Subject/guardian decision|14|||
147356571|NCT03020199|531476117|FG001|Follow-up Period|Subject/guardian decision|9|||
147356572|NCT04313972|531476118|FG000|Overall Study|Withdrawal by Subject|0|||
147356573|NCT04313972|531476119|FG001|Overall Study|Withdrawal by Subject|1|||
147356574|NCT05877976|531476120|FG000|Overall Study|Lost to Follow-up|31|||
147356575|NCT04568486|531476124|FG000|Overall Study|Withdrawal by Subject|26|||
147356576|NCT04568486|531476124|FG000|Overall Study|Lost to Follow-up|7|||
147356577|NCT01210807|531476125|FG000|Overall Study|Lost to Follow-up|1|||
147356578|NCT01210807|531476126|FG001|Overall Study|Lost to Follow-up|2|||
147356579|NCT01210807|531476125|FG000|Overall Study|Not implanted bilaterally|2|||
147356580|NCT01210807|531476126|FG001|Overall Study|Not implanted bilaterally|1|||
147356581|NCT05477186|531476130|FG000|Overall Study|Vaccine not administered|0|||
147356582|NCT05477186|531476131|FG001|Overall Study|Vaccine not administered|2|||
147356583|NCT05477186|531476132|FG002|Overall Study|Vaccine not administered|1|||
147356584|NCT05477186|531476133|FG003|Overall Study|Vaccine not administered|0|||
147356585|NCT05477186|531476134|FG004|Overall Study|Vaccine not administered|1|||
147356586|NCT05477186|531476135|FG005|Overall Study|Vaccine not administered|0|||
147356587|NCT05477186|531476136|FG006|Overall Study|Vaccine not administered|0|||
147356588|NCT05477186|531476130|FG000|Overall Study|Withdrawal by Subject|1|||
147356589|NCT05477186|531476131|FG001|Overall Study|Withdrawal by Subject|0|||
147356590|NCT05477186|531476132|FG002|Overall Study|Withdrawal by Subject|0|||
147356591|NCT05477186|531476133|FG003|Overall Study|Withdrawal by Subject|0|||
147356592|NCT05477186|531476134|FG004|Overall Study|Withdrawal by Subject|0|||
147356593|NCT05477186|531476135|FG005|Overall Study|Withdrawal by Subject|1|||
147356594|NCT05477186|531476136|FG006|Overall Study|Withdrawal by Subject|0|||
147356595|NCT05477186|531476130|FG000|Overall Study|Lost to Follow-up|1|||
147356596|NCT05477186|531476131|FG001|Overall Study|Lost to Follow-up|0|||
147356597|NCT05477186|531476132|FG002|Overall Study|Lost to Follow-up|2|||
147356598|NCT05477186|531476133|FG003|Overall Study|Lost to Follow-up|1|||
147356599|NCT05477186|531476134|FG004|Overall Study|Lost to Follow-up|1|||
147356600|NCT05477186|531476135|FG005|Overall Study|Lost to Follow-up|0|||
147356601|NCT05477186|531476136|FG006|Overall Study|Lost to Follow-up|2|||
147356602|NCT05496231|531476140|FG000|Overall Study|Adverse Event|1|||
147356603|NCT05496231|531476141|FG001|Overall Study|Adverse Event|1|||
147356604|NCT05496231|531476142|FG002|Overall Study|Adverse Event|0|||
147356605|NCT05496231|531476143|FG003|Overall Study|Adverse Event|4|||
147356606|NCT05496231|531476140|FG000|Overall Study|Withdrawal by Subject|5|||
147356607|NCT05496231|531476141|FG001|Overall Study|Withdrawal by Subject|5|||
147356608|NCT05496231|531476142|FG002|Overall Study|Withdrawal by Subject|4|||
147356609|NCT05496231|531476143|FG003|Overall Study|Withdrawal by Subject|11|||
147356610|NCT05496231|531476140|FG000|Overall Study|Migrated/moved from the study area|3|||
147356611|NCT05496231|531476141|FG001|Overall Study|Migrated/moved from the study area|5|||
147356612|NCT05496231|531476142|FG002|Overall Study|Migrated/moved from the study area|3|||
147356613|NCT05496231|531476143|FG003|Overall Study|Migrated/moved from the study area|3|||
147356614|NCT05496231|531476140|FG000|Overall Study|Lost to Follow-up|13|||
147356615|NCT05496231|531476141|FG001|Overall Study|Lost to Follow-up|6|||
147356616|NCT05496231|531476142|FG002|Overall Study|Lost to Follow-up|11|||
147356617|NCT05496231|531476143|FG003|Overall Study|Lost to Follow-up|6|||
147356618|NCT05496231|531476140|FG000|Overall Study|Other|9|||
147356619|NCT05496231|531476141|FG001|Overall Study|Other|7|||
147356620|NCT05496231|531476142|FG002|Overall Study|Other|7|||
147356621|NCT05496231|531476143|FG003|Overall Study|Other|8|||
147356622|NCT05526430|531476146|FG000|Overall Study|Withdrawal by Subject|0|||
147356623|NCT05526430|531476147|FG001|Overall Study|Withdrawal by Subject|2|||
147356624|NCT05526430|531476148|FG002|Overall Study|Withdrawal by Subject|0|||
147356625|NCT05526430|531476149|FG003|Overall Study|Withdrawal by Subject|0|||
147356626|NCT02305888|531476158|FG000|Overall Study|Lost to Follow-up|0|||
147356627|NCT02305888|531476159|FG001|Overall Study|Lost to Follow-up|0|||
147356628|NCT02305888|531476160|FG002|Overall Study|Lost to Follow-up|1|||
147356629|NCT02305888|531476158|FG000|Overall Study|Adverse Event|0|||
147356630|NCT02305888|531476159|FG001|Overall Study|Adverse Event|1|||
147356631|NCT02305888|531476160|FG002|Overall Study|Adverse Event|0|||
147356632|NCT05940194|531476165|FG000|Overall Study|Adverse Event|0|||
147356633|NCT05940194|531476166|FG001|Overall Study|Adverse Event|1|||
147356634|NCT05940194|531476167|FG002|Overall Study|Adverse Event|0|||
147356635|NCT05940194|531476165|FG000|Overall Study|Migrated/Moved from the study area|2|||
147356636|NCT05940194|531476166|FG001|Overall Study|Migrated/Moved from the study area|2|||
147356637|NCT05940194|531476167|FG002|Overall Study|Migrated/Moved from the study area|4|||
147356638|NCT04914676|531476168|FG000|Overall Study|Study termination|3|||
147356639|NCT04914676|531476169|FG001|Overall Study|Study termination|0|||
147356640|NCT03085810|531476170|FG000|Main Study|Withdrawal by Subject|77|||
147356641|NCT03085810|531476171|FG001|Main Study|Withdrawal by Subject|0|||
147356642|NCT03085810|531476172|FG002|Main Study|Withdrawal by Subject|0|||
147356643|NCT03085810|531476170|FG000|Main Study|Terminated By Sponsor|14|||
147356644|NCT03085810|531476171|FG001|Main Study|Terminated By Sponsor|0|||
147356645|NCT03085810|531476172|FG002|Main Study|Terminated By Sponsor|0|||
147356646|NCT03085810|531476170|FG000|Main Study|Protocol Violation|15|||
147356647|NCT03085810|531476171|FG001|Main Study|Protocol Violation|0|||
147356648|NCT03085810|531476172|FG002|Main Study|Protocol Violation|0|||
147356649|NCT03085810|531476170|FG000|Main Study|Physician Decision|13|||
147356650|NCT03085810|531476171|FG001|Main Study|Physician Decision|0|||
147356651|NCT03085810|531476172|FG002|Main Study|Physician Decision|0|||
147356652|NCT03085810|531476170|FG000|Main Study|Lost to Follow-up|17|||
147356653|NCT03085810|531476171|FG001|Main Study|Lost to Follow-up|0|||
147356654|NCT03085810|531476172|FG002|Main Study|Lost to Follow-up|0|||
147356655|NCT03085810|531476170|FG000|Main Study|Adverse Event|25|||
147356656|NCT03085810|531476171|FG001|Main Study|Adverse Event|0|||
147356657|NCT03085810|531476172|FG002|Main Study|Adverse Event|0|||
147356658|NCT03085810|531476170|FG000|Main Study|Pregnancy|7|||
147356659|NCT03085810|531476171|FG001|Main Study|Pregnancy|0|||
147356660|NCT03085810|531476172|FG002|Main Study|Pregnancy|0|||
147356661|NCT03085810|531476170|FG000|Main Study|Changed to Commercial Ocrelizumab|4|||
147356662|NCT03085810|531476171|FG001|Main Study|Changed to Commercial Ocrelizumab|0|||
147356663|NCT03085810|531476172|FG002|Main Study|Changed to Commercial Ocrelizumab|0|||
147356664|NCT03085810|531476170|FG000|Main Study|Lack of Efficacy|10|||
147356665|NCT03085810|531476171|FG001|Main Study|Lack of Efficacy|0|||
147356666|NCT03085810|531476172|FG002|Main Study|Lack of Efficacy|0|||
147356667|NCT03085810|531476170|FG000|Main Study|Death|12|||
147356668|NCT03085810|531476171|FG001|Main Study|Death|0|||
147356669|NCT03085810|531476172|FG002|Main Study|Death|0|||
147356670|NCT03085810|531476170|FG000|Main Study|Disease progression|1|||
147356671|NCT03085810|531476171|FG001|Main Study|Disease progression|0|||
147356672|NCT03085810|531476172|FG002|Main Study|Disease progression|0|||
147356673|NCT03085810|531476170|FG000|Main Study|Site Closure|3|||
147356674|NCT03085810|531476171|FG001|Main Study|Site Closure|0|||
147356675|NCT03085810|531476172|FG002|Main Study|Site Closure|0|||
147356676|NCT03085810|531476170|FG000|Main Study|Planned pregnancy|17|||
147356677|NCT03085810|531476171|FG001|Main Study|Planned pregnancy|0|||
147356678|NCT03085810|531476172|FG002|Main Study|Planned pregnancy|0|||
147356679|NCT03085810|531476170|FG000|Substudy (Week 24 to Week 144)|Withdrawal due to Infusion Related Reaction (IRR)|0|||
147356680|NCT03085810|531476171|FG001|Substudy (Week 24 to Week 144)|Withdrawal due to Infusion Related Reaction (IRR)|0|||
147356681|NCT03085810|531476172|FG002|Substudy (Week 24 to Week 144)|Withdrawal due to Infusion Related Reaction (IRR)|3|||
147356682|NCT03085810|531476170|FG000|Substudy (Week 24 to Week 144)|Withdrawal by Subject|0|||
147356683|NCT03085810|531476171|FG001|Substudy (Week 24 to Week 144)|Withdrawal by Subject|5|||
147356684|NCT03085810|531476172|FG002|Substudy (Week 24 to Week 144)|Withdrawal by Subject|7|||
147356685|NCT03085810|531476170|FG000|Substudy (Week 24 to Week 144)|Substudy Stopped by Sponsor|0|||
147356686|NCT03085810|531476171|FG001|Substudy (Week 24 to Week 144)|Substudy Stopped by Sponsor|355|||
147356687|NCT03085810|531476172|FG002|Substudy (Week 24 to Week 144)|Substudy Stopped by Sponsor|352|||
147356688|NCT03085810|531476170|FG000|Substudy (Week 24 to Week 144)|Reason Not Specified|0|||
147356689|NCT03085810|531476171|FG001|Substudy (Week 24 to Week 144)|Reason Not Specified|13|||
147356690|NCT03085810|531476172|FG002|Substudy (Week 24 to Week 144)|Reason Not Specified|8|||
147356691|NCT03024437|531476173|FG000|Overall Study|Adverse Event|0|||
147356692|NCT03024437|531476174|FG001|Overall Study|Adverse Event|1|||
147356693|NCT03024437|531476175|FG002|Overall Study|Adverse Event|3|||
147356694|NCT03024437|531476176|FG003|Overall Study|Adverse Event|5|||
147356695|NCT03024437|531476177|FG004|Overall Study|Adverse Event|0|||
147356696|NCT03024437|531476173|FG000|Overall Study|Physician Decision|1|||
147356697|NCT03024437|531476174|FG001|Overall Study|Physician Decision|0|||
147356698|NCT03024437|531476175|FG002|Overall Study|Physician Decision|0|||
147356699|NCT03024437|531476176|FG003|Overall Study|Physician Decision|1|||
147356700|NCT03024437|531476177|FG004|Overall Study|Physician Decision|0|||
147356701|NCT03024437|531476173|FG000|Overall Study|Disease progression, relapse|1|||
147356702|NCT03024437|531476174|FG001|Overall Study|Disease progression, relapse|0|||
147356703|NCT03024437|531476175|FG002|Overall Study|Disease progression, relapse|0|||
147356704|NCT03024437|531476176|FG003|Overall Study|Disease progression, relapse|3|||
147356705|NCT03024437|531476177|FG004|Overall Study|Disease progression, relapse|0|||
147356706|NCT03024437|531476173|FG000|Overall Study|Disease progression, refractory disease|4|||
147356707|NCT03024437|531476174|FG001|Overall Study|Disease progression, refractory disease|4|||
147356708|NCT03024437|531476175|FG002|Overall Study|Disease progression, refractory disease|2|||
147356709|NCT03024437|531476176|FG003|Overall Study|Disease progression, refractory disease|2|||
147356710|NCT03024437|531476177|FG004|Overall Study|Disease progression, refractory disease|1|||
147356711|NCT03024437|531476173|FG000|Overall Study|Newly diagnosed cancer|0|||
147607808|NCT00070499|532380601|FG003|Overall Study|Other - not protocol specified|20|||
147356712|NCT03024437|531476174|FG001|Overall Study|Newly diagnosed cancer|0|||
147356713|NCT03024437|531476175|FG002|Overall Study|Newly diagnosed cancer|0|||
147356714|NCT03024437|531476176|FG003|Overall Study|Newly diagnosed cancer|1|||
147356715|NCT03024437|531476177|FG004|Overall Study|Newly diagnosed cancer|0|||
147356716|NCT03024437|531476173|FG000|Overall Study|Moved out of state|0|||
147356717|NCT03024437|531476174|FG001|Overall Study|Moved out of state|1|||
147356718|NCT03024437|531476175|FG002|Overall Study|Moved out of state|0|||
147356719|NCT03024437|531476176|FG003|Overall Study|Moved out of state|0|||
147356720|NCT03024437|531476177|FG004|Overall Study|Moved out of state|0|||
147356721|NCT03024437|531476173|FG000|Overall Study|Needed an alternative therapy prohibited by protocol|0|||
147356722|NCT03024437|531476174|FG001|Overall Study|Needed an alternative therapy prohibited by protocol|0|||
147356723|NCT03024437|531476175|FG002|Overall Study|Needed an alternative therapy prohibited by protocol|1|||
147356724|NCT03024437|531476176|FG003|Overall Study|Needed an alternative therapy prohibited by protocol|0|||
147356725|NCT03024437|531476177|FG004|Overall Study|Needed an alternative therapy prohibited by protocol|0|||
147356726|NCT04625465|531476180|FG000|Overall Study|Lost to Follow-up|2|||
147356727|NCT04625465|531476181|FG001|Overall Study|Lost to Follow-up|2|||
147356728|NCT04625465|531476182|FG002|Overall Study|Lost to Follow-up|1|||
147356729|NCT04625465|531476183|FG003|Overall Study|Lost to Follow-up|0|||
147356730|NCT04625465|531476184|FG004|Overall Study|Lost to Follow-up|0|||
147356731|NCT04625465|531476185|FG005|Overall Study|Lost to Follow-up|2|||
147356732|NCT04625465|531476186|FG006|Overall Study|Lost to Follow-up|0|||
147356733|NCT04625465|531476187|FG007|Overall Study|Lost to Follow-up|0|||
147356734|NCT04625465|531476180|FG000|Overall Study|Death|1|||
147356735|NCT04625465|531476181|FG001|Overall Study|Death|0|||
147356736|NCT04625465|531476182|FG002|Overall Study|Death|0|||
147356737|NCT04625465|531476183|FG003|Overall Study|Death|0|||
147356738|NCT04625465|531476184|FG004|Overall Study|Death|0|||
147356739|NCT04625465|531476185|FG005|Overall Study|Death|0|||
147356740|NCT04625465|531476186|FG006|Overall Study|Death|0|||
147356741|NCT04625465|531476187|FG007|Overall Study|Death|0|||
147356742|NCT04625465|531476180|FG000|Overall Study|Withdrawal by Subject|1|||
147356743|NCT04625465|531476181|FG001|Overall Study|Withdrawal by Subject|0|||
147356744|NCT04625465|531476182|FG002|Overall Study|Withdrawal by Subject|4|||
147356745|NCT04625465|531476183|FG003|Overall Study|Withdrawal by Subject|4|||
147356746|NCT04625465|531476184|FG004|Overall Study|Withdrawal by Subject|4|||
147356747|NCT04625465|531476185|FG005|Overall Study|Withdrawal by Subject|0|||
147356748|NCT04625465|531476186|FG006|Overall Study|Withdrawal by Subject|0|||
147356749|NCT04625465|531476187|FG007|Overall Study|Withdrawal by Subject|0|||
147356750|NCT05566639|531476195|FG000|Overall Study|Adverse Event|1|||
147356751|NCT05566639|531476196|FG001|Overall Study|Adverse Event|1|||
147356752|NCT05566639|531476195|FG000|Overall Study|Serious Adverse Event|1|||
147356753|NCT05566639|531476196|FG001|Overall Study|Serious Adverse Event|3|||
147356754|NCT05566639|531476195|FG000|Overall Study|Death|44|||
147356755|NCT05566639|531476196|FG001|Overall Study|Death|45|||
147356756|NCT05566639|531476195|FG000|Overall Study|Lost to Follow-up|467|||
147356757|NCT05566639|531476196|FG001|Overall Study|Lost to Follow-up|461|||
147356758|NCT05566639|531476195|FG000|Overall Study|Physician Decision|45|||
147356759|NCT05566639|531476196|FG001|Overall Study|Physician Decision|44|||
147356760|NCT05566639|531476195|FG000|Overall Study|Protocol Deviation|4|||
147356761|NCT05566639|531476196|FG001|Overall Study|Protocol Deviation|4|||
147356762|NCT05566639|531476195|FG000|Overall Study|Withdrawal by Subject|277|||
147356763|NCT05566639|531476196|FG001|Overall Study|Withdrawal by Subject|271|||
147356764|NCT05566639|531476195|FG000|Overall Study|Other Than Specified|52|||
147356765|NCT05566639|531476196|FG001|Overall Study|Other Than Specified|64|||
147356766|NCT04054193|531476204|FG000|Cycle 1|Physician Decision|1|||
147356767|NCT04054193|531476204|FG000|Cycle 1|Consent withdrawn by parent/guardian|1|||
147356768|NCT04054193|531476204|FG000|Cycle 1|Allocated but not treated|3|||
147356769|NCT04054193|531476204|FG000|Cycles 2-3|Physician Decision|2|||
147356770|NCT04054193|531476204|FG000|Cycles 2-3|Consent withdrawn by parent/guardian|2|||
147356771|NCT04054193|531476204|FG000|Cycles 2-3|Various reasons|17|||
147356772|NCT05436262|531476207|FG000|Pre-Randomization|Withdrawal by Subject|1|||
147356773|NCT05436262|531476208|FG001|Pre-Randomization|Withdrawal by Subject|0|||
147356774|NCT05436262|531476209|FG002|Pre-Randomization|Withdrawal by Subject|0|||
147356775|NCT05436262|531476207|FG000|Randomization|Withdrawal by Subject|0|||
147356776|NCT05436262|531476208|FG001|Randomization|Withdrawal by Subject|1|||
147356777|NCT05436262|531476209|FG002|Randomization|Withdrawal by Subject|0|||
147356778|NCT03710603|531476210|FG000|Overall Study|Adverse Event|1|||
147356779|NCT03710603|531476211|FG001|Overall Study|Adverse Event|0|||
147356780|NCT03710603|531476210|FG000|Overall Study|Death|44|||
147356781|NCT03710603|531476211|FG001|Overall Study|Death|34|||
147356782|NCT03710603|531476210|FG000|Overall Study|Lost to Follow-up|3|||
147356783|NCT03710603|531476211|FG001|Overall Study|Lost to Follow-up|5|||
147356784|NCT03710603|531476210|FG000|Overall Study|Withdrawal by Subject|11|||
147356785|NCT03710603|531476211|FG001|Overall Study|Withdrawal by Subject|10|||
147356786|NCT02626533|531476212|FG000|Overall Study|Protocol Violation|14|||
147356787|NCT02626533|531476212|FG000|Overall Study|Patients were found have meet criteria under the exclusion criterion|2|||
147356788|NCT02626533|531476212|FG000|Overall Study|Withdrawal by Subject|1|||
147356789|NCT04753697|531476213|FG000|Induction Phase|Withdrawal by Subject|12|||
147356790|NCT04753697|531476214|FG001|Induction Phase|Withdrawal by Subject|5|||
147356791|NCT04753697|531476215|FG002|Induction Phase|Withdrawal by Subject|6|||
147356792|NCT04753697|531476213|FG000|Induction Phase|Physician Decision|1|||
147356793|NCT04753697|531476214|FG001|Induction Phase|Physician Decision|0|||
147356794|NCT04753697|531476215|FG002|Induction Phase|Physician Decision|0|||
147356795|NCT04753697|531476213|FG000|Induction Phase|Lost to Follow-up|2|||
147356796|NCT04753697|531476214|FG001|Induction Phase|Lost to Follow-up|2|||
147356797|NCT04753697|531476215|FG002|Induction Phase|Lost to Follow-up|1|||
147356798|NCT04753697|531476213|FG000|Induction Phase|Lack of Efficacy|1|||
147356799|NCT04753697|531476214|FG001|Induction Phase|Lack of Efficacy|0|||
147356800|NCT04753697|531476215|FG002|Induction Phase|Lack of Efficacy|0|||
147356801|NCT04753697|531476213|FG000|Maintenance Phase|Physician Decision|0|||
147356802|NCT04753697|531476214|FG001|Maintenance Phase|Physician Decision|0|||
147356803|NCT04753697|531476215|FG002|Maintenance Phase|Physician Decision|1|||
147356804|NCT04753697|531476213|FG000|Maintenance Phase|Withdrawal by Subject|3|||
147356805|NCT04753697|531476214|FG001|Maintenance Phase|Withdrawal by Subject|4|||
147356806|NCT04753697|531476215|FG002|Maintenance Phase|Withdrawal by Subject|6|||
147356807|NCT04753697|531476213|FG000|Maintenance Phase|Lost to Follow-up|2|||
147356808|NCT04753697|531476214|FG001|Maintenance Phase|Lost to Follow-up|2|||
147356809|NCT04753697|531476215|FG002|Maintenance Phase|Lost to Follow-up|0|||
147356810|NCT04753697|531476213|FG000|Maintenance Phase|NON-COMPLIANCE WITH STUDY DRUG|1|||
147356811|NCT04753697|531476214|FG001|Maintenance Phase|NON-COMPLIANCE WITH STUDY DRUG|0|||
147356812|NCT04753697|531476215|FG002|Maintenance Phase|NON-COMPLIANCE WITH STUDY DRUG|0|||
147356813|NCT04753697|531476213|FG000|Maintenance Phase|Adverse Event|0|||
147356814|NCT04753697|531476214|FG001|Maintenance Phase|Adverse Event|1|||
147356815|NCT04753697|531476215|FG002|Maintenance Phase|Adverse Event|1|||
147356816|NCT04753697|531476213|FG000|Maintenance Phase|WITHDRAWAL BY PARENT/GUARDIAN|1|||
147356817|NCT04753697|531476214|FG001|Maintenance Phase|WITHDRAWAL BY PARENT/GUARDIAN|0|||
147356818|NCT04753697|531476215|FG002|Maintenance Phase|WITHDRAWAL BY PARENT/GUARDIAN|0|||
147356819|NCT03701763|531476218|FG000|Placebo-controlled Phase|Adverse Event|1|||
147356820|NCT03701763|531476219|FG001|Placebo-controlled Phase|Adverse Event|5|||
147356821|NCT03701763|531476220|FG002|Placebo-controlled Phase|Adverse Event|0|||
147356822|NCT03701763|531476221|FG003|Placebo-controlled Phase|Adverse Event|0|||
147356823|NCT03701763|531476218|FG000|Placebo-controlled Phase|Lack of Efficacy|2|||
147356824|NCT03701763|531476219|FG001|Placebo-controlled Phase|Lack of Efficacy|0|||
147356825|NCT03701763|531476220|FG002|Placebo-controlled Phase|Lack of Efficacy|0|||
147356826|NCT03701763|531476221|FG003|Placebo-controlled Phase|Lack of Efficacy|0|||
147356827|NCT03701763|531476218|FG000|Placebo-controlled Phase|Miscellaneous|2|||
147356828|NCT03701763|531476219|FG001|Placebo-controlled Phase|Miscellaneous|0|||
147356829|NCT03701763|531476220|FG002|Placebo-controlled Phase|Miscellaneous|0|||
147356830|NCT03701763|531476221|FG003|Placebo-controlled Phase|Miscellaneous|0|||
147356831|NCT03701763|531476218|FG000|Placebo-controlled Phase|Withdrawal by Parent/Guardian|3|||
147356832|NCT03701763|531476219|FG001|Placebo-controlled Phase|Withdrawal by Parent/Guardian|5|||
147356833|NCT03701763|531476220|FG002|Placebo-controlled Phase|Withdrawal by Parent/Guardian|0|||
147356834|NCT03701763|531476221|FG003|Placebo-controlled Phase|Withdrawal by Parent/Guardian|0|||
147356835|NCT03701763|531476218|FG000|Placebo-controlled Phase|Lost to Follow-up|0|||
147356836|NCT03701763|531476219|FG001|Placebo-controlled Phase|Lost to Follow-up|1|||
147356837|NCT03701763|531476220|FG002|Placebo-controlled Phase|Lost to Follow-up|0|||
147356838|NCT03701763|531476221|FG003|Placebo-controlled Phase|Lost to Follow-up|0|||
147356839|NCT03701763|531476218|FG000|Placebo-controlled Phase|Withdrawal by Subject|2|||
147356840|NCT03701763|531476219|FG001|Placebo-controlled Phase|Withdrawal by Subject|3|||
147356841|NCT03701763|531476220|FG002|Placebo-controlled Phase|Withdrawal by Subject|0|||
147356842|NCT03701763|531476221|FG003|Placebo-controlled Phase|Withdrawal by Subject|0|||
147356843|NCT03701763|531476218|FG000|Apremilast Extension Phase|Withdrawal by Subject|0|||
147356844|NCT03701763|531476219|FG001|Apremilast Extension Phase|Withdrawal by Subject|0|||
147356845|NCT03701763|531476220|FG002|Apremilast Extension Phase|Withdrawal by Subject|1|||
147356846|NCT03701763|531476221|FG003|Apremilast Extension Phase|Withdrawal by Subject|3|||
147356847|NCT03701763|531476218|FG000|Apremilast Extension Phase|Lack of Efficacy|0|||
147356848|NCT03701763|531476219|FG001|Apremilast Extension Phase|Lack of Efficacy|0|||
147356849|NCT03701763|531476220|FG002|Apremilast Extension Phase|Lack of Efficacy|3|||
147356850|NCT03701763|531476221|FG003|Apremilast Extension Phase|Lack of Efficacy|8|||
147356851|NCT03701763|531476218|FG000|Apremilast Extension Phase|Adverse Event|0|||
147356852|NCT03701763|531476219|FG001|Apremilast Extension Phase|Adverse Event|0|||
147356853|NCT03701763|531476220|FG002|Apremilast Extension Phase|Adverse Event|3|||
147356854|NCT03701763|531476221|FG003|Apremilast Extension Phase|Adverse Event|1|||
147356855|NCT03701763|531476218|FG000|Apremilast Extension Phase|Miscellaneous|0|||
147356856|NCT03701763|531476219|FG001|Apremilast Extension Phase|Miscellaneous|0|||
147356857|NCT03701763|531476220|FG002|Apremilast Extension Phase|Miscellaneous|2|||
147607809|NCT00070499|532380598|FG000|Overall Study|Still on protocol treatment|10|||
147607810|NCT00070499|532380599|FG001|Overall Study|Still on protocol treatment|4|||
147607811|NCT00070499|532380600|FG002|Overall Study|Still on protocol treatment|79|||
147607812|NCT00070499|532380601|FG003|Overall Study|Still on protocol treatment|57|||
147607813|NCT00070499|532380598|FG000|Overall Study|Did not start treatment|1|||
147607814|NCT00070499|532380599|FG001|Overall Study|Did not start treatment|0|||
147356858|NCT03701763|531476221|FG003|Apremilast Extension Phase|Miscellaneous|1|||
147356859|NCT03701763|531476218|FG000|Apremilast Extension Phase|Withdrawal by Parent/Guardian|0|||
147356860|NCT03701763|531476219|FG001|Apremilast Extension Phase|Withdrawal by Parent/Guardian|0|||
147356861|NCT03701763|531476220|FG002|Apremilast Extension Phase|Withdrawal by Parent/Guardian|1|||
147356862|NCT03701763|531476221|FG003|Apremilast Extension Phase|Withdrawal by Parent/Guardian|8|||
147356863|NCT03701763|531476218|FG000|Apremilast Extension Phase|Lost to Follow-up|0|||
147356864|NCT03701763|531476219|FG001|Apremilast Extension Phase|Lost to Follow-up|0|||
147356865|NCT03701763|531476220|FG002|Apremilast Extension Phase|Lost to Follow-up|0|||
147356866|NCT03701763|531476221|FG003|Apremilast Extension Phase|Lost to Follow-up|2|||
147356867|NCT03701763|531476218|FG000|Apremilast Extension Phase|Non-compliance with Study Drug|0|||
147356868|NCT03701763|531476219|FG001|Apremilast Extension Phase|Non-compliance with Study Drug|0|||
147356869|NCT03701763|531476220|FG002|Apremilast Extension Phase|Non-compliance with Study Drug|1|||
147356870|NCT03701763|531476221|FG003|Apremilast Extension Phase|Non-compliance with Study Drug|1|||
147356871|NCT03701763|531476218|FG000|14-Week Observational Follow-up Phase|Miscellaneous|0|||
147356872|NCT03701763|531476219|FG001|14-Week Observational Follow-up Phase|Miscellaneous|0|||
147356873|NCT03701763|531476220|FG002|14-Week Observational Follow-up Phase|Miscellaneous|1|||
147356874|NCT03701763|531476221|FG003|14-Week Observational Follow-up Phase|Miscellaneous|0|||
147356875|NCT03701763|531476218|FG000|14-Week Observational Follow-up Phase|Withdrawal by Parent/Guardian|0|||
147356876|NCT03701763|531476219|FG001|14-Week Observational Follow-up Phase|Withdrawal by Parent/Guardian|1|||
147356877|NCT03701763|531476220|FG002|14-Week Observational Follow-up Phase|Withdrawal by Parent/Guardian|1|||
147356878|NCT03701763|531476221|FG003|14-Week Observational Follow-up Phase|Withdrawal by Parent/Guardian|0|||
147356879|NCT03701763|531476218|FG000|14-Week Observational Follow-up Phase|Other|0|||
147356880|NCT03701763|531476219|FG001|14-Week Observational Follow-up Phase|Other|0|||
147356881|NCT03701763|531476220|FG002|14-Week Observational Follow-up Phase|Other|1|||
147356882|NCT03701763|531476221|FG003|14-Week Observational Follow-up Phase|Other|0|||
147356883|NCT03701763|531476218|FG000|14-Week Observational Follow-up Phase|Lost to Follow-up|0|||
147356884|NCT03701763|531476219|FG001|14-Week Observational Follow-up Phase|Lost to Follow-up|0|||
147356885|NCT03701763|531476220|FG002|14-Week Observational Follow-up Phase|Lost to Follow-up|0|||
147356886|NCT03701763|531476221|FG003|14-Week Observational Follow-up Phase|Lost to Follow-up|1|||
147356887|NCT03701763|531476218|FG000|14-Week Observational Follow-up Phase|Withdrawal by Subject|0|||
147356888|NCT03701763|531476219|FG001|14-Week Observational Follow-up Phase|Withdrawal by Subject|0|||
147356889|NCT03701763|531476220|FG002|14-Week Observational Follow-up Phase|Withdrawal by Subject|0|||
147356890|NCT03701763|531476221|FG003|14-Week Observational Follow-up Phase|Withdrawal by Subject|2|||
147356891|NCT04200456|531476222|FG000|Overall Study|Physician Decision|0|||
147356892|NCT04200456|531476223|FG001|Overall Study|Physician Decision|1|||
147356893|NCT04200456|531476222|FG000|Overall Study|Withdrawal by Subject|2|||
147356894|NCT04200456|531476223|FG001|Overall Study|Withdrawal by Subject|2|||
147356895|NCT04200456|531476222|FG000|Overall Study|Lack of Efficacy|1|||
147356896|NCT04200456|531476223|FG001|Overall Study|Lack of Efficacy|1|||
147356897|NCT04200456|531476222|FG000|Overall Study|Adverse event, non-fatal|0|||
147356898|NCT04200456|531476223|FG001|Overall Study|Adverse event, non-fatal|1|||
147356899|NCT04200456|531476222|FG000|Overall Study|Administration of Rescue and concern about IMP|0|||
147356900|NCT04200456|531476223|FG001|Overall Study|Administration of Rescue and concern about IMP|1|||
147356901|NCT03785964|531476226|FG000|Overall Study|Adverse Event|14|||
147356902|NCT03785964|531476227|FG001|Overall Study|Adverse Event|1|||
147356903|NCT03785964|531476226|FG000|Overall Study|Unqualified Clinical Progression|1|||
147356904|NCT03785964|531476227|FG001|Overall Study|Unqualified Clinical Progression|1|||
147356905|NCT03785964|531476226|FG000|Overall Study|Participant non-compliance|1|||
147356906|NCT03785964|531476227|FG001|Overall Study|Participant non-compliance|1|||
147356907|NCT03785964|531476226|FG000|Overall Study|Not treated|1|||
147356908|NCT03785964|531476227|FG001|Overall Study|Not treated|0|||
147356909|NCT03785964|531476226|FG000|Overall Study|Other reason|5|||
147356910|NCT03785964|531476227|FG001|Overall Study|Other reason|11|||
147356911|NCT03785964|531476226|FG000|Overall Study|Ongoing (still on treatment) pertains to treatment status at the time of the primary analysis|36|||
147356912|NCT03785964|531476227|FG001|Overall Study|Ongoing (still on treatment) pertains to treatment status at the time of the primary analysis|23|||
147356913|NCT05070728|531476228|FG000|Overall Study|Sponsor decided to stop study enrollment and terminate the study|0|||
147356914|NCT05070728|531476229|FG001|Overall Study|Sponsor decided to stop study enrollment and terminate the study|6|||
147356915|NCT05446168|531476230|FG000|Overall Study|Physician Decision|0|||
147356916|NCT05446168|531476231|FG001|Overall Study|Physician Decision|1|||
147356917|NCT02733159|531476233|FG000|Overall Study|Adverse Event|1|||
147356918|NCT02733159|531476233|FG000|Overall Study|Lack of disease progression|1|||
147356919|NCT03257410|531478343|FG000|Overall Study|Adverse Event|2|||
147356920|NCT03257410|531478344|FG001|Overall Study|Adverse Event|3|||
147356921|NCT03257410|531478343|FG000|Overall Study|Protocol Violation|1|||
147356922|NCT03257410|531478344|FG001|Overall Study|Protocol Violation|2|||
147356923|NCT03257410|531478343|FG000|Overall Study|Lost to Follow-up|1|||
147356924|NCT03257410|531478344|FG001|Overall Study|Lost to Follow-up|0|||
147356925|NCT03257410|531478343|FG000|Overall Study|Withdrawal by Subject|1|||
147356926|NCT03257410|531478344|FG001|Overall Study|Withdrawal by Subject|2|||
147356927|NCT03257410|531478343|FG000|Overall Study|Physician Decision|1|||
147356928|NCT03257410|531478344|FG001|Overall Study|Physician Decision|1|||
147356929|NCT03257410|531478343|FG000|Overall Study|Renal transplantation|2|||
147356930|NCT03257410|531478344|FG001|Overall Study|Renal transplantation|0|||
147356931|NCT03257410|531478343|FG000|Overall Study|Switch to peritoneal dialysis|1|||
147356932|NCT03257410|531478344|FG001|Overall Study|Switch to peritoneal dialysis|0|||
147356933|NCT03257410|531478343|FG000|Overall Study|Death|3|||
147356934|NCT03257410|531478344|FG001|Overall Study|Death|2|||
147356935|NCT03257410|531478343|FG000|Overall Study|Change to another dialysis center|2|||
147356936|NCT03257410|531478344|FG001|Overall Study|Change to another dialysis center|2|||
147356937|NCT03257410|531478343|FG000|Overall Study|Missing 3 consecutive study treatments|5|||
147356938|NCT03257410|531478344|FG001|Overall Study|Missing 3 consecutive study treatments|6|||
147356939|NCT03257410|531478343|FG000|Overall Study|Miscellaneous|2|||
147356940|NCT03257410|531478344|FG001|Overall Study|Miscellaneous|2|||
147356941|NCT03257410|531478343|FG000|Overall Study|Other|0|||
147356942|NCT03257410|531478344|FG001|Overall Study|Other|1|||
147356943|NCT03854227|531478349|FG000|Overall Study|Adverse Event|0|||
147356944|NCT03854227|531478350|FG001|Overall Study|Adverse Event|0|||
147356945|NCT03854227|531478351|FG002|Overall Study|Adverse Event|0|||
147356946|NCT03854227|531478352|FG003|Overall Study|Adverse Event|1|||
147356947|NCT03854227|531478353|FG004|Overall Study|Adverse Event|0|||
147356948|NCT03854227|531478354|FG005|Overall Study|Adverse Event|0|||
147356949|NCT03854227|531478355|FG006|Overall Study|Adverse Event|1|||
147356950|NCT03854227|531478356|FG007|Overall Study|Adverse Event|0|||
147356951|NCT03854227|531478357|FG008|Overall Study|Adverse Event|0|||
147356952|NCT03854227|531478358|FG009|Overall Study|Adverse Event|3|||
147356953|NCT03854227|531478359|FG010|Overall Study|Adverse Event|0|||
147356954|NCT03854227|531478360|FG011|Overall Study|Adverse Event|1|||
147356955|NCT03854227|531478349|FG000|Overall Study|Death|0|||
147453678|NCT05103332|531824087|FG014|DB Period (6 Months=168 Days)|Physician Decision|0|||
147453679|NCT05103332|531824088|FG015|DB Period (6 Months=168 Days)|Physician Decision|0|||
147453680|NCT05103332|531824089|FG016|DB Period (6 Months=168 Days)|Physician Decision|0|||
147453681|NCT05103332|531824090|FG017|DB Period (6 Months=168 Days)|Physician Decision|0|||
147453682|NCT05103332|531824073|FG000|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|2|||
147453683|NCT05103332|531824074|FG001|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|3|||
147453684|NCT05103332|531824075|FG002|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|5|||
147453685|NCT05103332|531824076|FG003|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|3|||
147453686|NCT05103332|531824077|FG004|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|3|||
147453687|NCT05103332|531824078|FG005|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|6|||
147453688|NCT05103332|531824079|FG006|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
147453689|NCT05103332|531824080|FG007|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
147453690|NCT05103332|531824081|FG008|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
147453691|NCT05103332|531824082|FG009|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
147453692|NCT05103332|531824083|FG010|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
147453693|NCT05103332|531824084|FG011|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
147453694|NCT05103332|531824085|FG012|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
147453695|NCT05103332|531824086|FG013|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
147356956|NCT03854227|531478350|FG001|Overall Study|Death|0|||
147356957|NCT03854227|531478351|FG002|Overall Study|Death|0|||
147356958|NCT03854227|531478352|FG003|Overall Study|Death|0|||
147356959|NCT03854227|531478353|FG004|Overall Study|Death|0|||
147356960|NCT03854227|531478354|FG005|Overall Study|Death|1|||
147356961|NCT03854227|531478355|FG006|Overall Study|Death|0|||
147356962|NCT03854227|531478356|FG007|Overall Study|Death|0|||
147356963|NCT03854227|531478357|FG008|Overall Study|Death|0|||
147356964|NCT03854227|531478358|FG009|Overall Study|Death|1|||
147356965|NCT03854227|531478359|FG010|Overall Study|Death|0|||
147356966|NCT03854227|531478360|FG011|Overall Study|Death|1|||
147356967|NCT03854227|531478349|FG000|Overall Study|Physician Decision|0|||
147356968|NCT03854227|531478350|FG001|Overall Study|Physician Decision|0|||
147356969|NCT03854227|531478351|FG002|Overall Study|Physician Decision|0|||
147356970|NCT03854227|531478352|FG003|Overall Study|Physician Decision|0|||
147356971|NCT03854227|531478353|FG004|Overall Study|Physician Decision|0|||
147356972|NCT03854227|531478354|FG005|Overall Study|Physician Decision|1|||
147356973|NCT03854227|531478355|FG006|Overall Study|Physician Decision|0|||
147356974|NCT03854227|531478356|FG007|Overall Study|Physician Decision|0|||
147356975|NCT03854227|531478357|FG008|Overall Study|Physician Decision|1|||
147356976|NCT03854227|531478358|FG009|Overall Study|Physician Decision|1|||
147356977|NCT03854227|531478359|FG010|Overall Study|Physician Decision|0|||
147356978|NCT03854227|531478360|FG011|Overall Study|Physician Decision|1|||
147356979|NCT03854227|531478349|FG000|Overall Study|Progressive disease|1|||
147356980|NCT03854227|531478350|FG001|Overall Study|Progressive disease|1|||
147356981|NCT03854227|531478351|FG002|Overall Study|Progressive disease|1|||
147356982|NCT03854227|531478352|FG003|Overall Study|Progressive disease|2|||
147356983|NCT03854227|531478353|FG004|Overall Study|Progressive disease|3|||
147356984|NCT03854227|531478354|FG005|Overall Study|Progressive disease|1|||
147356985|NCT03854227|531478355|FG006|Overall Study|Progressive disease|2|||
147356986|NCT03854227|531478356|FG007|Overall Study|Progressive disease|5|||
147356987|NCT03854227|531478357|FG008|Overall Study|Progressive disease|2|||
147356988|NCT03854227|531478358|FG009|Overall Study|Progressive disease|5|||
147356989|NCT03854227|531478359|FG010|Overall Study|Progressive disease|1|||
147356990|NCT03854227|531478360|FG011|Overall Study|Progressive disease|6|||
147356991|NCT03854227|531478349|FG000|Overall Study|Study terminated by sponsor|0|||
147356992|NCT03854227|531478350|FG001|Overall Study|Study terminated by sponsor|0|||
147356993|NCT03854227|531478351|FG002|Overall Study|Study terminated by sponsor|0|||
147356994|NCT03854227|531478352|FG003|Overall Study|Study terminated by sponsor|0|||
147356995|NCT03854227|531478353|FG004|Overall Study|Study terminated by sponsor|0|||
147356996|NCT03854227|531478354|FG005|Overall Study|Study terminated by sponsor|0|||
147356997|NCT03854227|531478355|FG006|Overall Study|Study terminated by sponsor|0|||
147356998|NCT03854227|531478356|FG007|Overall Study|Study terminated by sponsor|0|||
147356999|NCT03854227|531478357|FG008|Overall Study|Study terminated by sponsor|0|||
147357000|NCT03854227|531478358|FG009|Overall Study|Study terminated by sponsor|1|||
147357001|NCT03854227|531478359|FG010|Overall Study|Study terminated by sponsor|0|||
147357002|NCT03854227|531478360|FG011|Overall Study|Study terminated by sponsor|0|||
147357003|NCT03854227|531478349|FG000|Overall Study|Withdrawal by Subject|0|||
147357004|NCT03854227|531478350|FG001|Overall Study|Withdrawal by Subject|0|||
147357005|NCT03854227|531478351|FG002|Overall Study|Withdrawal by Subject|1|||
147357006|NCT03854227|531478352|FG003|Overall Study|Withdrawal by Subject|0|||
147357007|NCT03854227|531478353|FG004|Overall Study|Withdrawal by Subject|0|||
147357008|NCT03854227|531478354|FG005|Overall Study|Withdrawal by Subject|0|||
147357009|NCT03854227|531478355|FG006|Overall Study|Withdrawal by Subject|0|||
147357010|NCT03854227|531478356|FG007|Overall Study|Withdrawal by Subject|0|||
147357011|NCT03854227|531478357|FG008|Overall Study|Withdrawal by Subject|0|||
147357012|NCT03854227|531478358|FG009|Overall Study|Withdrawal by Subject|1|||
147357013|NCT03854227|531478359|FG010|Overall Study|Withdrawal by Subject|1|||
147357014|NCT03854227|531478360|FG011|Overall Study|Withdrawal by Subject|0|||
147357015|NCT03854227|531478349|FG000|Overall Study|Disease relapse|0|||
147357016|NCT03854227|531478350|FG001|Overall Study|Disease relapse|0|||
147357017|NCT03854227|531478351|FG002|Overall Study|Disease relapse|0|||
147357018|NCT03854227|531478352|FG003|Overall Study|Disease relapse|0|||
147357019|NCT03854227|531478353|FG004|Overall Study|Disease relapse|0|||
147357020|NCT03854227|531478354|FG005|Overall Study|Disease relapse|0|||
147357021|NCT03854227|531478355|FG006|Overall Study|Disease relapse|0|||
147357022|NCT03854227|531478356|FG007|Overall Study|Disease relapse|0|||
147357023|NCT03854227|531478357|FG008|Overall Study|Disease relapse|1|||
147357024|NCT03854227|531478358|FG009|Overall Study|Disease relapse|0|||
147357025|NCT03854227|531478359|FG010|Overall Study|Disease relapse|0|||
147357026|NCT03854227|531478360|FG011|Overall Study|Disease relapse|0|||
147357027|NCT03854227|531478349|FG000|Overall Study|Global deterioration of health status|0|||
147453696|NCT05103332|531824087|FG014|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
147453697|NCT05103332|531824088|FG015|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
147453698|NCT05103332|531824089|FG016|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
147453699|NCT05103332|531824090|FG017|DB Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
147453700|NCT05103332|531824073|FG000|DB Period (6 Months=168 Days)|Other|0|||
147453701|NCT05103332|531824074|FG001|DB Period (6 Months=168 Days)|Other|0|||
147453702|NCT05103332|531824075|FG002|DB Period (6 Months=168 Days)|Other|0|||
147453703|NCT05103332|531824076|FG003|DB Period (6 Months=168 Days)|Other|1|||
147453704|NCT05103332|531824077|FG004|DB Period (6 Months=168 Days)|Other|0|||
147453705|NCT05103332|531824078|FG005|DB Period (6 Months=168 Days)|Other|0|||
147453706|NCT05103332|531824079|FG006|DB Period (6 Months=168 Days)|Other|0|||
147453707|NCT05103332|531824080|FG007|DB Period (6 Months=168 Days)|Other|0|||
147453708|NCT05103332|531824081|FG008|DB Period (6 Months=168 Days)|Other|0|||
147453709|NCT05103332|531824082|FG009|DB Period (6 Months=168 Days)|Other|0|||
147453710|NCT05103332|531824083|FG010|DB Period (6 Months=168 Days)|Other|0|||
147453711|NCT05103332|531824084|FG011|DB Period (6 Months=168 Days)|Other|0|||
147453712|NCT05103332|531824085|FG012|DB Period (6 Months=168 Days)|Other|0|||
147453713|NCT05103332|531824086|FG013|DB Period (6 Months=168 Days)|Other|0|||
147357028|NCT03854227|531478350|FG001|Overall Study|Global deterioration of health status|0|||
147357029|NCT03854227|531478351|FG002|Overall Study|Global deterioration of health status|0|||
147357030|NCT03854227|531478352|FG003|Overall Study|Global deterioration of health status|0|||
147357031|NCT03854227|531478353|FG004|Overall Study|Global deterioration of health status|0|||
147357032|NCT03854227|531478354|FG005|Overall Study|Global deterioration of health status|1|||
147357033|NCT03854227|531478355|FG006|Overall Study|Global deterioration of health status|0|||
147357034|NCT03854227|531478356|FG007|Overall Study|Global deterioration of health status|1|||
147357035|NCT03854227|531478357|FG008|Overall Study|Global deterioration of health status|0|||
147357036|NCT03854227|531478358|FG009|Overall Study|Global deterioration of health status|0|||
147357037|NCT03854227|531478359|FG010|Overall Study|Global deterioration of health status|0|||
147357038|NCT03854227|531478360|FG011|Overall Study|Global deterioration of health status|0|||
147357039|NCT03854227|531478349|FG000|Overall Study|Refused further treatment|0|||
147357040|NCT03854227|531478350|FG001|Overall Study|Refused further treatment|0|||
147357041|NCT03854227|531478351|FG002|Overall Study|Refused further treatment|0|||
147357042|NCT03854227|531478352|FG003|Overall Study|Refused further treatment|0|||
147357043|NCT03854227|531478353|FG004|Overall Study|Refused further treatment|0|||
147357044|NCT03854227|531478354|FG005|Overall Study|Refused further treatment|0|||
147357045|NCT03854227|531478355|FG006|Overall Study|Refused further treatment|0|||
147357046|NCT03854227|531478356|FG007|Overall Study|Refused further treatment|0|||
147357047|NCT03854227|531478357|FG008|Overall Study|Refused further treatment|0|||
147357048|NCT03854227|531478358|FG009|Overall Study|Refused further treatment|1|||
147357049|NCT03854227|531478359|FG010|Overall Study|Refused further treatment|0|||
147357050|NCT03854227|531478360|FG011|Overall Study|Refused further treatment|1|||
147357051|NCT03854227|531478349|FG000|Overall Study|Other|0|||
147357052|NCT03854227|531478350|FG001|Overall Study|Other|0|||
147357053|NCT03854227|531478351|FG002|Overall Study|Other|0|||
147357054|NCT03854227|531478352|FG003|Overall Study|Other|0|||
147357055|NCT03854227|531478353|FG004|Overall Study|Other|0|||
147357056|NCT03854227|531478354|FG005|Overall Study|Other|0|||
147357057|NCT03854227|531478355|FG006|Overall Study|Other|0|||
147357058|NCT03854227|531478356|FG007|Overall Study|Other|0|||
147357059|NCT03854227|531478357|FG008|Overall Study|Other|1|||
147357060|NCT03854227|531478358|FG009|Overall Study|Other|1|||
147357061|NCT03854227|531478359|FG010|Overall Study|Other|0|||
147357062|NCT03854227|531478360|FG011|Overall Study|Other|0|||
147357063|NCT03668236|531478361|FG000|90-day Follow-up|Withdrawal by Subject|3|||
147357064|NCT03668236|531478362|FG001|90-day Follow-up|Withdrawal by Subject|2|||
147357065|NCT03668236|531478361|FG000|90-day Follow-up|Lost to Follow-up|3|||
147357066|NCT03668236|531478362|FG001|90-day Follow-up|Lost to Follow-up|1|||
147357067|NCT03668236|531478361|FG000|Baseline Characteristics|Lost to Follow-up|9|||
147357068|NCT03668236|531478362|FG001|Baseline Characteristics|Lost to Follow-up|5|||
147357069|NCT03668236|531478361|FG000|1-year Follow-up|Withdrawal by Subject|17|||
147357070|NCT03668236|531478362|FG001|1-year Follow-up|Withdrawal by Subject|15|||
147357071|NCT03748953|531478363|FG000|Treatment Prior to Amendment 08|Discontinued to Switch to Ixazomib|0|||
147357072|NCT03748953|531478364|FG001|Treatment Prior to Amendment 08|Discontinued to Switch to Ixazomib|2|||
147357073|NCT03748953|531478363|FG000|Treatment Prior to Amendment 08|Reason not Specified|0|||
147357074|NCT03748953|531478364|FG001|Treatment Prior to Amendment 08|Reason not Specified|2|||
147357075|NCT03748953|531478363|FG000|Treatment Post Amendment 08|Withdrawal by Subject|18|||
147357076|NCT03748953|531478364|FG001|Treatment Post Amendment 08|Withdrawal by Subject|0|||
147357077|NCT03748953|531478363|FG000|Treatment Post Amendment 08|Reason not Specified|16|||
147357078|NCT03748953|531478364|FG001|Treatment Post Amendment 08|Reason not Specified|0|||
147357079|NCT03748953|531478363|FG000|Treatment Post Amendment 08|Lost to Follow-up|1|||
147357080|NCT03748953|531478364|FG001|Treatment Post Amendment 08|Lost to Follow-up|0|||
147357081|NCT02276885|531478365|FG000|Overall Study|Withdrawal by Subject|2|||
147357082|NCT02276885|531478366|FG001|Overall Study|Withdrawal by Subject|0|||
147357083|NCT02276885|531478365|FG000|Overall Study|Lost to Follow-up|5|||
147357084|NCT02276885|531478366|FG001|Overall Study|Lost to Follow-up|2|||
147357085|NCT01574274|531478367|FG000|Overall Study|Ineligible|0|||
147357086|NCT01574274|531478368|FG001|Overall Study|Ineligible|1|||
147357087|NCT01574274|531478367|FG000|Overall Study|Withdrawal of Consent During Induction|1|||
147357088|NCT01574274|531478368|FG001|Overall Study|Withdrawal of Consent During Induction|1|||
147357089|NCT01574274|531478367|FG000|Overall Study|Ph+ B-ALL|3|||
147357090|NCT01574274|531478368|FG001|Overall Study|Ph+ B-ALL|4|||
147357091|NCT01574274|531478367|FG000|Overall Study|Induction Death|2|||
147357092|NCT01574274|531478368|FG001|Overall Study|Induction Death|0|||
147357093|NCT01574274|531478367|FG000|Overall Study|Induction Failure|4|||
147357094|NCT01574274|531478368|FG001|Overall Study|Induction Failure|1|||
147357095|NCT01574274|531478367|FG000|Overall Study|Adverse Event|16|||
147357096|NCT01574274|531478368|FG001|Overall Study|Adverse Event|13|||
147357097|NCT01574274|531478367|FG000|Overall Study|Remission Death|1|||
147357098|NCT01574274|531478368|FG001|Overall Study|Remission Death|0|||
147357099|NCT01574274|531478367|FG000|Overall Study|Withdrawal from Treatment but Agrees to be Followed|2|||
147357100|NCT01574274|531478368|FG001|Overall Study|Withdrawal from Treatment but Agrees to be Followed|0|||
147357101|NCT01574274|531478367|FG000|Overall Study|Other, unknown|3|||
147357102|NCT01574274|531478368|FG001|Overall Study|Other, unknown|2|||
147357103|NCT04676763|531478369|FG000|Part 1 (Up to Day 1)|Protocol Violation|0|||
147357104|NCT04676763|531478370|FG001|Part 1 (Up to Day 1)|Protocol Violation|1|||
147357105|NCT04676763|531478371|FG002|Part 1 (Up to Day 1)|Protocol Violation|0|||
147357106|NCT04676763|531478369|FG000|Part 1 (Up to Day 1)|Physician Decision|0|||
147357107|NCT04676763|531478370|FG001|Part 1 (Up to Day 1)|Physician Decision|1|||
147357108|NCT04676763|531478371|FG002|Part 1 (Up to Day 1)|Physician Decision|0|||
147357109|NCT04676763|531478369|FG000|Part 1 (Up to Day 1)|Withdrawal by Subject|0|||
147357110|NCT04676763|531478370|FG001|Part 1 (Up to Day 1)|Withdrawal by Subject|1|||
147357111|NCT04676763|531478371|FG002|Part 1 (Up to Day 1)|Withdrawal by Subject|0|||
147357112|NCT01593917|531478376|FG000|Overall Study|Death|67|||
147453714|NCT05103332|531824087|FG014|DB Period (6 Months=168 Days)|Other|0|||
147357113|NCT01593917|531478376|FG000|Overall Study|Valve-in-valve Transcatheter Aortic Valve Implantation (TAVI) or Surgical Explant|60|||
147357114|NCT01593917|531478376|FG000|Overall Study|Withdrawal by Subject|23|||
147357115|NCT01593917|531478376|FG000|Overall Study|Lost to Follow-up|12|||
147357116|NCT01593917|531478376|FG000|Overall Study|Protocol Violation|5|||
147357117|NCT01593917|531478376|FG000|Overall Study|Physician Decision|3|||
147357118|NCT04016662|531478377|FG000|Run-In Phase|Death|1|||
147357119|NCT04016662|531478377|FG000|Run-In Phase|Withdrawal by Subject|11|||
147357120|NCT04016662|531478377|FG000|Run-In Phase|Not meeting screening eligibility|9|||
147357121|NCT04016662|531478377|FG000|Run-In Phase|Physician Decision|3|||
147357122|NCT04016662|531478377|FG000|HCL (12 Weeks)|Withdrawal by Subject|1|||
147357123|NCT04016662|531478377|FG000|PLGS (12 Weeks)|Death|1|||
147357124|NCT04016662|531478377|FG000|SAP (12 Weeks)|Death|1|||
147357125|NCT04225273|531478378|FG000|Overall Study|Lost to Follow-up|3|||
147357126|NCT03652389|531478379|FG000|Overall Study|Lost to Follow-up|1|||
147357127|NCT03652389|531478380|FG001|Overall Study|Lost to Follow-up|5|||
147357128|NCT03652389|531478379|FG000|Overall Study|Withdrawal by Subject|5|||
147357129|NCT03652389|531478380|FG001|Overall Study|Withdrawal by Subject|1|||
147357130|NCT03652389|531478379|FG000|Overall Study|New diagnosis|2|||
147357131|NCT03652389|531478380|FG001|Overall Study|New diagnosis|0|||
147357132|NCT02714257|531478399|FG000|Overall Study|Withdrawal by Subject|6|||
147357133|NCT02714257|531478400|FG001|Overall Study|Withdrawal by Subject|11|||
147357134|NCT02714257|531478399|FG000|Overall Study|Death|3|||
147357135|NCT02714257|531478400|FG001|Overall Study|Death|4|||
147357136|NCT02714257|531478399|FG000|Overall Study|Lost to Follow-up|1|||
147357137|NCT02714257|531478400|FG001|Overall Study|Lost to Follow-up|6|||
147357138|NCT03656510|531478404|FG000|Overall Study|Lost to Follow-up|1|||
147357139|NCT03656510|531478405|FG001|Overall Study|Lost to Follow-up|0|||
147357140|NCT03656510|531478406|FG002|Overall Study|Lost to Follow-up|0|||
147357141|NCT03656510|531478407|FG003|Overall Study|Lost to Follow-up|0|||
147357142|NCT03656510|531478408|FG004|Overall Study|Lost to Follow-up|0|||
147357143|NCT03656510|531478409|FG005|Overall Study|Lost to Follow-up|0|||
147357144|NCT03656510|531478404|FG000|Overall Study|Withdrawal by Subject|1|||
147357145|NCT03656510|531478405|FG001|Overall Study|Withdrawal by Subject|1|||
147357146|NCT03656510|531478406|FG002|Overall Study|Withdrawal by Subject|0|||
147357147|NCT03656510|531478407|FG003|Overall Study|Withdrawal by Subject|1|||
147357148|NCT03656510|531478408|FG004|Overall Study|Withdrawal by Subject|0|||
147357149|NCT03656510|531478409|FG005|Overall Study|Withdrawal by Subject|0|||
147357150|NCT03974178|531478412|FG000|Overall Study|Death|0|||
147357151|NCT03974178|531478413|FG001|Overall Study|Death|1|||
147357152|NCT03899259|531478417|FG000|Overall Study|Adverse Event|5|||
147357153|NCT03899259|531478418|FG001|Overall Study|Adverse Event|4|||
147357154|NCT03899259|531478419|FG002|Overall Study|Adverse Event|6|||
147357155|NCT03899259|531478417|FG000|Overall Study|Lack of Efficacy|5|||
147357156|NCT03899259|531478418|FG001|Overall Study|Lack of Efficacy|0|||
147357157|NCT03899259|531478419|FG002|Overall Study|Lack of Efficacy|2|||
147357158|NCT03899259|531478417|FG000|Overall Study|Pregnancy|3|||
147357159|NCT03899259|531478418|FG001|Overall Study|Pregnancy|0|||
147357160|NCT03899259|531478419|FG002|Overall Study|Pregnancy|1|||
147357161|NCT03899259|531478417|FG000|Overall Study|Physician Decision|0|||
147357162|NCT03899259|531478418|FG001|Overall Study|Physician Decision|1|||
147357163|NCT03899259|531478419|FG002|Overall Study|Physician Decision|0|||
147357164|NCT03899259|531478417|FG000|Overall Study|Protocol Deviation|1|||
147357165|NCT03899259|531478418|FG001|Overall Study|Protocol Deviation|1|||
147357166|NCT03899259|531478419|FG002|Overall Study|Protocol Deviation|1|||
147357167|NCT03899259|531478417|FG000|Overall Study|Withdrawal by Subject|8|||
147357168|NCT03899259|531478418|FG001|Overall Study|Withdrawal by Subject|10|||
147453715|NCT05103332|531824088|FG015|DB Period (6 Months=168 Days)|Other|0|||
147453716|NCT05103332|531824089|FG016|DB Period (6 Months=168 Days)|Other|0|||
147453717|NCT05103332|531824090|FG017|DB Period (6 Months=168 Days)|Other|0|||
147453718|NCT05103332|531824073|FG000|OLE Period (24 Months=672 Days)|Adverse Event|0|||
147453719|NCT05103332|531824074|FG001|OLE Period (24 Months=672 Days)|Adverse Event|0|||
147357169|NCT03899259|531478419|FG002|Overall Study|Withdrawal by Subject|12|||
147357170|NCT03899259|531478417|FG000|Overall Study|Lost to Follow-up|5|||
147453720|NCT05103332|531824075|FG002|OLE Period (24 Months=672 Days)|Adverse Event|0|||
147357171|NCT03899259|531478418|FG001|Overall Study|Lost to Follow-up|6|||
147357172|NCT03899259|531478419|FG002|Overall Study|Lost to Follow-up|2|||
147357173|NCT03899259|531478417|FG000|Overall Study|Lack of Adherence|1|||
147357174|NCT03899259|531478418|FG001|Overall Study|Lack of Adherence|0|||
147357175|NCT03899259|531478419|FG002|Overall Study|Lack of Adherence|0|||
147357176|NCT03899259|531478417|FG000|Overall Study|Screen Failure|1|||
147357177|NCT03899259|531478418|FG001|Overall Study|Screen Failure|0|||
147357178|NCT03899259|531478419|FG002|Overall Study|Screen Failure|0|||
147357179|NCT03899259|531478417|FG000|Overall Study|Ongoing Study Participation|127|||
147357180|NCT03899259|531478418|FG001|Overall Study|Ongoing Study Participation|134|||
147357181|NCT03899259|531478419|FG002|Overall Study|Ongoing Study Participation|210|||
147357182|NCT05670587|531478420|FG000|Overall Study|Withdrawal by Subject|3|||
147357183|NCT01733316|531478424|FG000|RP103 Phase|Non-compliance|1|||
147357184|NCT01733316|531478424|FG000|Long Term Extension Phase|Adverse Event|1|||
147357185|NCT01733316|531478424|FG000|Long Term Extension Phase|Consent Withdrawn by Subject|2|||
147357186|NCT01733316|531478424|FG000|Long Term Extension Phase|Sponsor Decision|2|||
147357187|NCT04508309|531478425|FG000|Overall Study|Death|0|||
147357188|NCT04508309|531478426|FG001|Overall Study|Death|0|||
147357189|NCT04508309|531478427|FG002|Overall Study|Death|0|||
147357190|NCT04508309|531478428|FG003|Overall Study|Death|0|||
147357191|NCT04508309|531478429|FG004|Overall Study|Death|1|||
147357192|NCT04508309|531478425|FG000|Overall Study|Lost to Follow-up|0|||
147357193|NCT04508309|531478426|FG001|Overall Study|Lost to Follow-up|0|||
147357194|NCT04508309|531478427|FG002|Overall Study|Lost to Follow-up|1|||
147357195|NCT04508309|531478428|FG003|Overall Study|Lost to Follow-up|1|||
147357196|NCT04508309|531478429|FG004|Overall Study|Lost to Follow-up|0|||
147357197|NCT04508309|531478425|FG000|Overall Study|Withdrawal by Subject|0|||
147357198|NCT04508309|531478426|FG001|Overall Study|Withdrawal by Subject|0|||
147357199|NCT04508309|531478427|FG002|Overall Study|Withdrawal by Subject|0|||
147357200|NCT04508309|531478428|FG003|Overall Study|Withdrawal by Subject|0|||
147357201|NCT04508309|531478429|FG004|Overall Study|Withdrawal by Subject|1|||
147357202|NCT05139810|531478430|FG000|Overall Study|Voluntary Withdrawal|2|||
147357203|NCT05139810|531478431|FG001|Overall Study|Voluntary Withdrawal|1|||
147357204|NCT05139810|531478432|FG002|Overall Study|Voluntary Withdrawal|0|||
147357205|NCT05139810|531478430|FG000|Overall Study|Pregnancy|1|||
147357206|NCT05139810|531478431|FG001|Overall Study|Pregnancy|0|||
147357207|NCT05139810|531478432|FG002|Overall Study|Pregnancy|0|||
147357208|NCT05139810|531478430|FG000|Overall Study|Roll Over to CS7|19|||
147357209|NCT05139810|531478431|FG001|Overall Study|Roll Over to CS7|44|||
147357210|NCT05139810|531478432|FG002|Overall Study|Roll Over to CS7|20|||
147357211|NCT03240016|531478433|FG000|Overall Study|Adverse Event|9|||
147357212|NCT03240016|531478433|FG000|Overall Study|Withdrawal by Subject|7|||
147357213|NCT03240016|531478433|FG000|Overall Study|Death|1|||
147357214|NCT03240016|531478433|FG000|Overall Study|Physician Decision|2|||
147357215|NCT05200403|531478434|FG000|Overall Study|Withdrawal by Subject|4|||
147357216|NCT05200403|531478435|FG001|Overall Study|Withdrawal by Subject|2|||
147357217|NCT05200403|531478436|FG002|Overall Study|Withdrawal by Subject|6|||
147357218|NCT05299723|531478437|FG000|Overall Study|Withdrawal by Subject|0|||
147357219|NCT05299723|531478438|FG001|Overall Study|Withdrawal by Subject|2|||
147357220|NCT05299723|531478439|FG002|Overall Study|Withdrawal by Subject|0|||
147357221|NCT05546411|531478440|FG000|Overall Study|Progressive Disease|1|||
147357222|NCT05546411|531478441|FG001|Overall Study|Progressive Disease|0|||
147357223|NCT05546411|531478440|FG000|Overall Study|Adverse Event|0|||
147357224|NCT05546411|531478441|FG001|Overall Study|Adverse Event|1|||
147357225|NCT05546411|531478440|FG000|Overall Study|Metastatic disease|1|||
147357226|NCT05546411|531478441|FG001|Overall Study|Metastatic disease|0|||
147357227|NCT02606422|531478442|FG000|Phase 1: Immediate Follow up|Withdrawal by Subject|2|||
147357228|NCT02606422|531478443|FG001|Phase 1: Immediate Follow up|Withdrawal by Subject|0|||
147357229|NCT02606422|531478442|FG000|Phase 1, 2-Week Follow-up (Washout)|Withdrawal by Subject|2|||
147357230|NCT02606422|531478443|FG001|Phase 1, 2-Week Follow-up (Washout)|Withdrawal by Subject|0|||
147357231|NCT02606422|531478442|FG000|Phase 1 2-Month Follow-up (Washout)|Withdrawal by Subject|1|||
147357232|NCT02606422|531478443|FG001|Phase 1 2-Month Follow-up (Washout)|Withdrawal by Subject|1|||
147357233|NCT02606422|531478442|FG000|Phase 2, 2-Week Follow-up (Washout)|Withdrawal by Subject|0|||
147357234|NCT02606422|531478443|FG001|Phase 2, 2-Week Follow-up (Washout)|Withdrawal by Subject|1|||
147357235|NCT02966873|531478444|FG000|Overall Study|Lost to Follow-up|16|||
147357236|NCT02966873|531478445|FG001|Overall Study|Lost to Follow-up|15|||
147357237|NCT03235544|531478446|FG000|Overall Study|Death|11|||
147357238|NCT03235544|531478447|FG001|Overall Study|Death|31|||
147357239|NCT03235544|531478448|FG002|Overall Study|Death|19|||
147357240|NCT03235544|531478449|FG003|Overall Study|Death|34|||
147357241|NCT03235544|531478446|FG000|Overall Study|Lost to Follow-up|0|||
147357242|NCT03235544|531478447|FG001|Overall Study|Lost to Follow-up|1|||
147357243|NCT03235544|531478448|FG002|Overall Study|Lost to Follow-up|1|||
147357244|NCT03235544|531478449|FG003|Overall Study|Lost to Follow-up|1|||
147357245|NCT03235544|531478446|FG000|Overall Study|Withdrawal by Subject|0|||
147357246|NCT03235544|531478447|FG001|Overall Study|Withdrawal by Subject|3|||
147357247|NCT03235544|531478448|FG002|Overall Study|Withdrawal by Subject|1|||
147607815|NCT00070499|532380600|FG002|Overall Study|Did not start treatment|0|||
147607816|NCT00070499|532380601|FG003|Overall Study|Did not start treatment|2|||
147357248|NCT03235544|531478449|FG003|Overall Study|Withdrawal by Subject|5|||
147357249|NCT03235544|531478446|FG000|Overall Study|Disease Progression|0|||
147357250|NCT03235544|531478447|FG001|Overall Study|Disease Progression|1|||
147453721|NCT05103332|531824076|FG003|OLE Period (24 Months=672 Days)|Adverse Event|0|||
147357251|NCT03235544|531478448|FG002|Overall Study|Disease Progression|0|||
147357252|NCT03235544|531478449|FG003|Overall Study|Disease Progression|2|||
147357253|NCT03235544|531478446|FG000|Overall Study|Participant Transitioned to Rollover Protocol|0|||
147357254|NCT03235544|531478447|FG001|Overall Study|Participant Transitioned to Rollover Protocol|0|||
147357255|NCT03235544|531478448|FG002|Overall Study|Participant Transitioned to Rollover Protocol|2|||
147357256|NCT03235544|531478449|FG003|Overall Study|Participant Transitioned to Rollover Protocol|5|||
147357257|NCT03235544|531478446|FG000|Overall Study|Discomfort, Pain, and Radiographic Advancement|0|||
147357258|NCT03235544|531478447|FG001|Overall Study|Discomfort, Pain, and Radiographic Advancement|0|||
147357259|NCT03235544|531478448|FG002|Overall Study|Discomfort, Pain, and Radiographic Advancement|0|||
147357260|NCT03235544|531478449|FG003|Overall Study|Discomfort, Pain, and Radiographic Advancement|1|||
147357261|NCT00950742|531478450|FG000|Overall Study|Other Adverse Event|1|||
147357262|NCT00950742|531478451|FG001|Overall Study|Other Adverse Event|0|||
147357263|NCT00950742|531478450|FG000|Overall Study|Withdrawal by Subject|3|||
147357264|NCT00950742|531478451|FG001|Overall Study|Withdrawal by Subject|0|||
147357265|NCT00950742|531478450|FG000|Overall Study|Progressive Disease|6|||
147357266|NCT00950742|531478451|FG001|Overall Study|Progressive Disease|2|||
147357267|NCT00950742|531478450|FG000|Overall Study|Dose limiting toxicity|6|||
147357268|NCT00950742|531478451|FG001|Overall Study|Dose limiting toxicity|0|||
147357269|NCT01456949|531478453|FG000|Enrollment|PI death- incomplete data|6|||
147357270|NCT01456949|531478453|FG000|Enrollment|Death|1|||
147357271|NCT01456949|531478453|FG000|Enrollment|I/E criteria not met prior to procedure|13|||
147357272|NCT01456949|531478453|FG000|Enrollment|Physician Decision|10|||
147357273|NCT01456949|531478453|FG000|Enrollment|Withdrawal by Subject|7|||
147357274|NCT01456949|531478453|FG000|Study Cryoablation Procedure & Follow-up|Death|5|||
147357275|NCT01456949|531478453|FG000|Study Cryoablation Procedure & Follow-up|Withdrawal by Subject|23|||
147357276|NCT01456949|531478453|FG000|Study Cryoablation Procedure & Follow-up|Lost to Follow-up|11|||
147357277|NCT01456949|531478453|FG000|Study Cryoablation Procedure & Follow-up|Physician Decision|1|||
147357278|NCT01456949|531478453|FG000|Study Cryoablation Procedure & Follow-up|Subject Relocation|10|||
147357279|NCT01456949|531478453|FG000|Study Cryoablation Procedure & Follow-up|Failure to maintain study compliance|2|||
147357280|NCT01456949|531478453|FG000|Study Cryoablation Procedure & Follow-up|Rollover not included in completer total|6|||
147357281|NCT01456949|531478453|FG000|Study Cryoablation Procedure & Follow-up|Treated did not meet I/E criteria|4|||
147357282|NCT05002088|531478454|FG000|Overall Study|Withdrawal by Subject|9|||
147357283|NCT05002088|531478455|FG001|Overall Study|Withdrawal by Subject|0|||
147357284|NCT05002088|531478454|FG000|Overall Study|Lost to Follow-up|0|||
147357285|NCT05002088|531478455|FG001|Overall Study|Lost to Follow-up|1|||
147357286|NCT05002088|531478454|FG000|Overall Study|Death|16|||
147357287|NCT05002088|531478455|FG001|Overall Study|Death|2|||
147357288|NCT05002088|531478454|FG000|Overall Study|Protocol Violation|25|||
147357289|NCT05002088|531478455|FG001|Overall Study|Protocol Violation|7|||
147357290|NCT04068181|531478457|FG000|Overall Study|Death|17|||
147357291|NCT04068181|531478458|FG001|Overall Study|Death|12|||
147357292|NCT04068181|531478459|FG002|Overall Study|Death|4|||
147357293|NCT04068181|531478460|FG003|Overall Study|Death|7|||
147357294|NCT04068181|531478457|FG000|Overall Study|Lost to Follow-up|1|||
147357295|NCT04068181|531478458|FG001|Overall Study|Lost to Follow-up|0|||
147357296|NCT04068181|531478459|FG002|Overall Study|Lost to Follow-up|0|||
147357297|NCT04068181|531478460|FG003|Overall Study|Lost to Follow-up|0|||
147357298|NCT04068181|531478457|FG000|Overall Study|Withdrawal of consent from study|3|||
147357299|NCT04068181|531478458|FG001|Overall Study|Withdrawal of consent from study|0|||
147357300|NCT04068181|531478459|FG002|Overall Study|Withdrawal of consent from study|0|||
147357301|NCT04068181|531478460|FG003|Overall Study|Withdrawal of consent from study|0|||
147357302|NCT02723591|531478461|FG000|Overall Study|Adverse Event|48|||
147357303|NCT02723591|531478462|FG001|Overall Study|Adverse Event|40|||
147357304|NCT02723591|531478461|FG000|Overall Study|Death|2|||
147357305|NCT02723591|531478462|FG001|Overall Study|Death|2|||
147357306|NCT02723591|531478461|FG000|Overall Study|Lack of Efficacy|4|||
147357307|NCT02723591|531478462|FG001|Overall Study|Lack of Efficacy|3|||
147357308|NCT02723591|531478461|FG000|Overall Study|Lost to Follow-up|1|||
147357309|NCT02723591|531478462|FG001|Overall Study|Lost to Follow-up|7|||
147357310|NCT02723591|531478461|FG000|Overall Study|Protocol Violation|20|||
147357311|NCT02723591|531478462|FG001|Overall Study|Protocol Violation|23|||
147357312|NCT02723591|531478461|FG000|Overall Study|Withdrawal by Subject|4|||
147357313|NCT02723591|531478462|FG001|Overall Study|Withdrawal by Subject|8|||
147357314|NCT02723591|531478461|FG000|Overall Study|Randomized but Never Received StudyDrug|12|||
147357315|NCT02723591|531478462|FG001|Overall Study|Randomized but Never Received StudyDrug|12|||
147357316|NCT02723591|531478461|FG000|Overall Study|Miscellaneous|5|||
147357317|NCT02723591|531478462|FG001|Overall Study|Miscellaneous|6|||
147357318|NCT03599661|531478463|FG000|Overall Study|Lost to Follow-up|9|||
147357319|NCT03691935|531478464|FG000|Overall Study|Physician Decision|2|||
147357320|NCT03691935|531478465|FG001|Overall Study|Physician Decision|1|||
147357321|NCT03691935|531478464|FG000|Overall Study|Adverse Event|3|||
147357322|NCT03691935|531478465|FG001|Overall Study|Adverse Event|0|||
147357323|NCT03905798|531478475|FG000|Overall Study|No informed consent for notification/publication of study results|94|||
147357324|NCT06473662|531478476|FG000|Overall Study|Withdrawal by Subject|1|||
147357325|NCT06473662|531478477|FG001|Overall Study|Withdrawal by Subject|6|||
147357326|NCT06473662|531478478|FG002|Overall Study|Withdrawal by Subject|5|||
147453722|NCT05103332|531824077|FG004|OLE Period (24 Months=672 Days)|Adverse Event|0|||
147357327|NCT06473662|531478476|FG000|Overall Study|Uncontrolled hyperglycaemia|1|||
147357328|NCT06473662|531478477|FG001|Overall Study|Uncontrolled hyperglycaemia|2|||
147357329|NCT06473662|531478478|FG002|Overall Study|Uncontrolled hyperglycaemia|2|||
147357330|NCT06473662|531478476|FG000|Overall Study|Starting HbA1c below 7%|0|||
147357331|NCT06473662|531478477|FG001|Overall Study|Starting HbA1c below 7%|1|||
147607817|NCT00070499|532380598|FG000|Overall Study|Not eligible|2|||
147607818|NCT00070499|532380599|FG001|Overall Study|Not eligible|5|||
147607819|NCT00070499|532380600|FG002|Overall Study|Not eligible|3|||
147607820|NCT00070499|532380601|FG003|Overall Study|Not eligible|2|||
147607821|NCT00805467|532380602|FG000|Overall Study|Lack of Efficacy|0|||
147607822|NCT00805467|532380603|FG001|Overall Study|Lack of Efficacy|8|||
147357332|NCT06473662|531478478|FG002|Overall Study|Starting HbA1c below 7%|1|||
147607823|NCT00805467|532380604|FG002|Overall Study|Lack of Efficacy|13|||
147607824|NCT00805467|532380605|FG003|Overall Study|Lack of Efficacy|86|||
147607825|NCT00805467|532380602|FG000|Overall Study|Lost to Follow-up|0|||
147607826|NCT00805467|532380603|FG001|Overall Study|Lost to Follow-up|1|||
147607827|NCT00805467|532380604|FG002|Overall Study|Lost to Follow-up|7|||
147607828|NCT00805467|532380605|FG003|Overall Study|Lost to Follow-up|21|||
147607829|NCT00805467|532380602|FG000|Overall Study|Withdrawal by Subject|0|||
147607830|NCT00805467|532380603|FG001|Overall Study|Withdrawal by Subject|6|||
147607831|NCT00805467|532380604|FG002|Overall Study|Withdrawal by Subject|45|||
147607832|NCT00805467|532380605|FG003|Overall Study|Withdrawal by Subject|50|||
147607833|NCT00805467|532380602|FG000|Overall Study|Protocol Violation|0|||
147607834|NCT00805467|532380603|FG001|Overall Study|Protocol Violation|3|||
147607835|NCT00805467|532380604|FG002|Overall Study|Protocol Violation|0|||
147607836|NCT00805467|532380605|FG003|Overall Study|Protocol Violation|5|||
147607837|NCT00805467|532380602|FG000|Overall Study|Adverse Event|0|||
147607838|NCT00805467|532380603|FG001|Overall Study|Adverse Event|13|||
147607839|NCT00805467|532380604|FG002|Overall Study|Adverse Event|26|||
147607840|NCT00805467|532380605|FG003|Overall Study|Adverse Event|57|||
147607841|NCT00805467|532380602|FG000|Overall Study|Death|0|||
147607842|NCT00805467|532380603|FG001|Overall Study|Death|2|||
147607843|NCT00805467|532380604|FG002|Overall Study|Death|7|||
147357333|NCT06473662|531478476|FG000|Overall Study|No data from Central lab (protocol violation)|14|||
147357334|NCT06473662|531478477|FG001|Overall Study|No data from Central lab (protocol violation)|9|||
147357335|NCT06473662|531478478|FG002|Overall Study|No data from Central lab (protocol violation)|4|||
147357336|NCT06473662|531478476|FG000|Overall Study|Did not take medication|2|||
147357337|NCT06473662|531478477|FG001|Overall Study|Did not take medication|3|||
147357338|NCT06473662|531478478|FG002|Overall Study|Did not take medication|2|||
147357339|NCT03463044|531478481|FG000|Overall Study|Lost to Follow-up|0|||
147357340|NCT03463044|531478482|FG001|Overall Study|Lost to Follow-up|0|||
147357341|NCT03463044|531478483|FG002|Overall Study|Lost to Follow-up|0|||
147357342|NCT03463044|531478484|FG003|Overall Study|Lost to Follow-up|0|||
147357343|NCT03463044|531478485|FG004|Overall Study|Lost to Follow-up|0|||
147357344|NCT03463044|531478486|FG005|Overall Study|Lost to Follow-up|0|||
147357345|NCT03463044|531478487|FG006|Overall Study|Lost to Follow-up|0|||
147357346|NCT03463044|531478488|FG007|Overall Study|Lost to Follow-up|1|||
147357347|NCT03463044|531478489|FG008|Overall Study|Lost to Follow-up|0|||
147357348|NCT04079218|531478490|FG000|Overall Study|Death|1|||
147357349|NCT04079218|531478491|FG001|Overall Study|Death|0|||
147357350|NCT04079218|531478490|FG000|Overall Study|Withdrawal by Subject|3|||
147357351|NCT04079218|531478491|FG001|Overall Study|Withdrawal by Subject|0|||
147357352|NCT04079218|531478490|FG000|Overall Study|Physician Decision|4|||
147357353|NCT04079218|531478491|FG001|Overall Study|Physician Decision|0|||
147357354|NCT04079218|531478490|FG000|Overall Study|Lost to Follow-up|0|||
147357355|NCT04079218|531478491|FG001|Overall Study|Lost to Follow-up|1|||
147357356|NCT05907174|531478496|FG000|3-Month Assessment|Withdrawal by Subject|0|||
147357357|NCT05907174|531478497|FG001|3-Month Assessment|Withdrawal by Subject|0|||
147357358|NCT05907174|531478498|FG002|3-Month Assessment|Withdrawal by Subject|0|||
147357359|NCT05907174|531478499|FG003|3-Month Assessment|Withdrawal by Subject|1|||
147357360|NCT05907174|531478496|FG000|3-Month Assessment|Lost to Follow-up|1|||
147357361|NCT05907174|531478497|FG001|3-Month Assessment|Lost to Follow-up|1|||
147357362|NCT05907174|531478498|FG002|3-Month Assessment|Lost to Follow-up|1|||
147357363|NCT05907174|531478499|FG003|3-Month Assessment|Lost to Follow-up|1|||
147357364|NCT05907174|531478496|FG000|6-Month Assessment|Death|0|||
147357365|NCT05907174|531478497|FG001|6-Month Assessment|Death|0|||
147357366|NCT05907174|531478498|FG002|6-Month Assessment|Death|3|||
147357367|NCT05907174|531478499|FG003|6-Month Assessment|Death|0|||
147357368|NCT05907174|531478496|FG000|6-Month Assessment|Withdrawal by Subject|0|||
147453723|NCT05103332|531824078|FG005|OLE Period (24 Months=672 Days)|Adverse Event|0|||
147607844|NCT00805467|532380605|FG003|Overall Study|Death|5|||
147607845|NCT00805467|532380602|FG000|Overall Study|Physician Decision|0|||
147607846|NCT00805467|532380603|FG001|Overall Study|Physician Decision|1|||
147607847|NCT00805467|532380604|FG002|Overall Study|Physician Decision|2|||
147607848|NCT00805467|532380605|FG003|Overall Study|Physician Decision|6|||
147357369|NCT05907174|531478497|FG001|6-Month Assessment|Withdrawal by Subject|0|||
147357370|NCT05907174|531478498|FG002|6-Month Assessment|Withdrawal by Subject|1|||
147357371|NCT05907174|531478499|FG003|6-Month Assessment|Withdrawal by Subject|1|||
147607849|NCT00805467|532380602|FG000|Overall Study|Not reported|0|||
147357372|NCT05907174|531478496|FG000|6-Month Assessment|Lost to Follow-up|0|||
147357373|NCT05907174|531478497|FG001|6-Month Assessment|Lost to Follow-up|1|||
147607850|NCT00805467|532380603|FG001|Overall Study|Not reported|0|||
147607851|NCT00805467|532380604|FG002|Overall Study|Not reported|3|||
147607852|NCT00805467|532380605|FG003|Overall Study|Not reported|7|||
147357374|NCT05907174|531478498|FG002|6-Month Assessment|Lost to Follow-up|1|||
147357375|NCT05907174|531478499|FG003|6-Month Assessment|Lost to Follow-up|1|||
147357376|NCT04498390|531478500|FG000|Overall Study|Adverse Event|0|||
147357377|NCT04498390|531478501|FG001|Overall Study|Adverse Event|0|||
147357378|NCT04498390|531478502|FG002|Overall Study|Adverse Event|1|||
147357379|NCT04498390|531478503|FG003|Overall Study|Adverse Event|0|||
147357380|NCT04498390|531478504|FG004|Overall Study|Adverse Event|0|||
147357381|NCT04498390|531478500|FG000|Overall Study|Withdrawal by Subject|0|||
147357382|NCT04498390|531478501|FG001|Overall Study|Withdrawal by Subject|0|||
147357383|NCT04498390|531478502|FG002|Overall Study|Withdrawal by Subject|0|||
147357384|NCT04498390|531478503|FG003|Overall Study|Withdrawal by Subject|1|||
147357385|NCT04498390|531478504|FG004|Overall Study|Withdrawal by Subject|0|||
147357386|NCT04858451|531480358|FG000|Part 0 (Protocol Version 3.0)|Discontinued|4|||
147357387|NCT04858451|531480359|FG001|Part 0 (Protocol Version 3.0)|Discontinued|0|||
147357388|NCT04858451|531480360|FG002|Part 0 (Protocol Version 3.0)|Discontinued|0|||
147357389|NCT04858451|531480361|FG003|Part 0 (Protocol Version 3.0)|Discontinued|0|||
147357390|NCT04858451|531480362|FG004|Part 0 (Protocol Version 3.0)|Discontinued|0|||
147357391|NCT04858451|531480363|FG005|Part 0 (Protocol Version 3.0)|Discontinued|0|||
147357392|NCT04858451|531480364|FG006|Part 0 (Protocol Version 3.0)|Discontinued|0|||
147357393|NCT04858451|531480365|FG007|Part 0 (Protocol Version 3.0)|Discontinued|0|||
147357394|NCT04858451|531480366|FG008|Part 0 (Protocol Version 3.0)|Discontinued|0|||
147357395|NCT04858451|531480358|FG000|Part 2|Discontinued|0|||
147357396|NCT04858451|531480359|FG001|Part 2|Discontinued|0|||
147357397|NCT04858451|531480360|FG002|Part 2|Discontinued|0|||
147357398|NCT04858451|531480361|FG003|Part 2|Discontinued|0|||
147357399|NCT04858451|531480362|FG004|Part 2|Discontinued|0|||
147357400|NCT04858451|531480363|FG005|Part 2|Discontinued|0|||
147357401|NCT04858451|531480364|FG006|Part 2|Discontinued|0|||
147357402|NCT04858451|531480365|FG007|Part 2|Discontinued|0|||
147357403|NCT04858451|531480366|FG008|Part 2|Discontinued|63|||
147357404|NCT03314454|531480367|FG000|Overall Study|Protocol Violation|1|||
147357405|NCT04119843|531480368|FG000|Overall Study|Adverse Event|3|||
147357406|NCT04119843|531480368|FG000|Overall Study|Death|1|||
147357407|NCT04233216|531480370|FG000|Overall Study|Lost to Follow-up|1|||
147357408|NCT04233216|531480371|FG001|Overall Study|Lost to Follow-up|0|||
147357409|NCT04233216|531480372|FG002|Overall Study|Lost to Follow-up|2|||
147357410|NCT04233216|531480373|FG003|Overall Study|Lost to Follow-up|0|||
147357411|NCT04233216|531480370|FG000|Overall Study|Physician Decision|0|||
147357412|NCT04233216|531480371|FG001|Overall Study|Physician Decision|3|||
147357413|NCT04233216|531480372|FG002|Overall Study|Physician Decision|0|||
147357414|NCT04233216|531480373|FG003|Overall Study|Physician Decision|2|||
147357415|NCT04233216|531480370|FG000|Overall Study|Withdrawal by Subject|0|||
147357416|NCT04233216|531480371|FG001|Overall Study|Withdrawal by Subject|2|||
147357417|NCT04233216|531480372|FG002|Overall Study|Withdrawal by Subject|1|||
147357418|NCT04233216|531480373|FG003|Overall Study|Withdrawal by Subject|0|||
147357419|NCT04231149|531480374|FG000|Washout (Minimum 5 Days)|Withdrawal by Subject|0|||
147357420|NCT04231149|531480375|FG001|Washout (Minimum 5 Days)|Withdrawal by Subject|1|||
147357421|NCT04231149|531480376|FG002|Washout (Minimum 5 Days)|Withdrawal by Subject|0|||
147357422|NCT04231149|531480377|FG003|Washout (Minimum 5 Days)|Withdrawal by Subject|0|||
147357423|NCT04231149|531480378|FG004|Washout (Minimum 5 Days)|Withdrawal by Subject|0|||
147357424|NCT03252847|531480379|FG000|Overall Study|Withdrawal by Subject|0|||
147357425|NCT03252847|531480380|FG001|Overall Study|Withdrawal by Subject|0|||
147357426|NCT03252847|531480381|FG002|Overall Study|Withdrawal by Subject|1|||
147357427|NCT03252847|531480382|FG003|Overall Study|Withdrawal by Subject|0|||
147357428|NCT03252847|531480383|FG004|Overall Study|Withdrawal by Subject|0|||
147357429|NCT03252847|531480384|FG005|Overall Study|Withdrawal by Subject|0|||
147357430|NCT03252847|531480385|FG006|Overall Study|Withdrawal by Subject|0|||
147357431|NCT03252847|531480379|FG000|Overall Study|Other: Patient decision|0|||
147357432|NCT03252847|531480380|FG001|Overall Study|Other: Patient decision|0|||
147357433|NCT03252847|531480381|FG002|Overall Study|Other: Patient decision|0|||
147357434|NCT03252847|531480382|FG003|Overall Study|Other: Patient decision|0|||
147357435|NCT03252847|531480383|FG004|Overall Study|Other: Patient decision|1|||
147357436|NCT03252847|531480384|FG005|Overall Study|Other: Patient decision|0|||
147357437|NCT03252847|531480385|FG006|Overall Study|Other: Patient decision|0|||
147357438|NCT05808257|531480388|FG000|Overall Study|Lost to Follow-up|8|||
147357439|NCT05808257|531480389|FG001|Overall Study|Lost to Follow-up|8|||
147357440|NCT03819153|531480410|FG000|Overall Study|Withdrawal by Subject|20|||
147357441|NCT03819153|531480411|FG001|Overall Study|Withdrawal by Subject|28|||
147357442|NCT03819153|531480410|FG000|Overall Study|Lost to Follow-up|23|||
147357443|NCT03819153|531480411|FG001|Overall Study|Lost to Follow-up|30|||
147357444|NCT05374798|531480421|FG000|Overall Study|Lost to Follow-up|2|||
147357445|NCT05374798|531480421|FG000|Overall Study|Withdrawal by Subject|2|||
147357446|NCT05374798|531480421|FG000|Overall Study|Withdrawn by Principal Investigator.|2|||
147357447|NCT04471246|531480422|FG000|Overall Study|Lost to Follow-up|2|||
147357448|NCT04471246|531480423|FG001|Overall Study|Lost to Follow-up|2|||
147357449|NCT05764525|531480424|FG000|Overall Study|Inclusion/exclusion criteria not met Inclusion/exclusion criteria not met|1|||
147607853|NCT01924754|532380606|FG000|Overall Study|Lost to Follow-up|1|||
147607854|NCT01924754|532380607|FG001|Overall Study|Lost to Follow-up|2|||
147607855|NCT01924754|532380608|FG002|Overall Study|Lost to Follow-up|1|||
147607856|NCT01924754|532380606|FG000|Overall Study|Pregnancy|0|||
147607857|NCT01924754|532380607|FG001|Overall Study|Pregnancy|1|||
147607858|NCT01924754|532380608|FG002|Overall Study|Pregnancy|2|||
147357450|NCT05764525|531480425|FG001|Overall Study|Inclusion/exclusion criteria not met Inclusion/exclusion criteria not met|0|||
147357451|NCT05764525|531480424|FG000|Overall Study|Withdrawal by Subject|4|||
147357452|NCT05764525|531480425|FG001|Overall Study|Withdrawal by Subject|8|||
147357453|NCT05764525|531480424|FG000|Overall Study|Physician Decision|1|||
147357454|NCT05764525|531480425|FG001|Overall Study|Physician Decision|0|||
147357455|NCT03334630|531480426|FG000|Overall Study|Withdrawal by Subject|7|||
147357456|NCT03334630|531480427|FG001|Overall Study|Withdrawal by Subject|7|||
147357457|NCT03334630|531480426|FG000|Overall Study|Lost to Follow-up|3|||
147357458|NCT03334630|531480427|FG001|Overall Study|Lost to Follow-up|1|||
147357459|NCT03334630|531480426|FG000|Overall Study|Adverse Event|0|||
147357460|NCT03334630|531480427|FG001|Overall Study|Adverse Event|1|||
147357461|NCT03334630|531480426|FG000|Overall Study|Physician Decision|1|||
147357462|NCT03334630|531480427|FG001|Overall Study|Physician Decision|1|||
147357463|NCT03334630|531480426|FG000|Overall Study|Enrollment closed|2|||
147357464|NCT03334630|531480427|FG001|Overall Study|Enrollment closed|1|||
147357465|NCT03334630|531480426|FG000|Overall Study|Subject not treated with study ablation due to technical difficulties|0|||
147357466|NCT03334630|531480427|FG001|Overall Study|Subject not treated with study ablation due to technical difficulties|1|||
147357467|NCT03334630|531480426|FG000|Overall Study|Subject unable to complete 12-month follow-up visit|1|||
147357468|NCT03334630|531480427|FG001|Overall Study|Subject unable to complete 12-month follow-up visit|1|||
147357469|NCT05093842|531480434|FG000|Overall Study|Pregnancy loss|1|||
147357470|NCT05093842|531480435|FG001|Overall Study|Pregnancy loss|1|||
147357471|NCT05093842|531480434|FG000|Overall Study|Lost to Follow-up|6|||
147357472|NCT05093842|531480435|FG001|Overall Study|Lost to Follow-up|0|||
147357473|NCT05093842|531480434|FG000|Overall Study|Physician Decision|0|||
147357474|NCT05093842|531480435|FG001|Overall Study|Physician Decision|1|||
147357475|NCT03910478|531480441|FG000|Overall Study|Death|13|||
147357476|NCT03910478|531480442|FG001|Overall Study|Death|6|||
147357477|NCT03910478|531480441|FG000|Overall Study|Withdrawal by Subject|23|||
147357478|NCT03910478|531480442|FG001|Overall Study|Withdrawal by Subject|2|||
147357479|NCT03910478|531480441|FG000|Overall Study|Physician Decision|5|||
147357480|NCT03910478|531480442|FG001|Overall Study|Physician Decision|0|||
147357481|NCT03910478|531480441|FG000|Overall Study|Protocol Violation|1|||
147357482|NCT03910478|531480442|FG001|Overall Study|Protocol Violation|0|||
147357483|NCT03910478|531480441|FG000|Overall Study|Failure to meet continuation criteria|2|||
147357484|NCT03910478|531480442|FG001|Overall Study|Failure to meet continuation criteria|0|||
147357485|NCT03910478|531480441|FG000|Overall Study|Wouldn't proceed DBS portion, data collection only|1|||
147357486|NCT03910478|531480442|FG001|Overall Study|Wouldn't proceed DBS portion, data collection only|0|||
147357487|NCT01275677|531480449|FG000|Overall Study|Not at risk for recurrence.|1|||
147357488|NCT01275677|531480450|FG001|Overall Study|Not at risk for recurrence.|1|||
147357489|NCT01275677|531480449|FG000|Overall Study|No follow-up|26|||
147357490|NCT01275677|531480450|FG001|Overall Study|No follow-up|37|||
147357491|NCT01275677|531480449|FG000|Overall Study|No clinical follow up.|1|||
147357492|NCT01275677|531480450|FG001|Overall Study|No clinical follow up.|4|||
147357493|NCT03987022|531480451|FG000|Overall Study|Lost to Follow-up|2|||
147357494|NCT03987022|531480452|FG001|Overall Study|Lost to Follow-up|2|||
147357495|NCT03987022|531480451|FG000|Overall Study|Withdrawal by Subject|1|||
147357496|NCT03987022|531480452|FG001|Overall Study|Withdrawal by Subject|0|||
147357497|NCT03478956|531480456|FG000|Randomized Treatment Period|Adverse Event|1|||
147357498|NCT03478956|531480457|FG001|Randomized Treatment Period|Adverse Event|0|||
147357499|NCT03478956|531480458|FG002|Randomized Treatment Period|Adverse Event|0|||
147357500|NCT03478956|531480459|FG003|Randomized Treatment Period|Adverse Event|0|||
147357501|NCT03478956|531480456|FG000|Randomized Treatment Period|Withdrawal by Subject|0|||
147357502|NCT03478956|531480457|FG001|Randomized Treatment Period|Withdrawal by Subject|1|||
147357503|NCT03478956|531480458|FG002|Randomized Treatment Period|Withdrawal by Subject|0|||
147357504|NCT03478956|531480459|FG003|Randomized Treatment Period|Withdrawal by Subject|0|||
147357505|NCT03478956|531480456|FG000|Open Label Extension Period|Adverse Event|0|||
147357506|NCT03478956|531480457|FG001|Open Label Extension Period|Adverse Event|0|||
147607859|NCT02899195|532380611|FG000|Concurrent Durvalumab|Adverse Event|4|||
147357507|NCT03478956|531480458|FG002|Open Label Extension Period|Adverse Event|4|||
147357508|NCT03478956|531480459|FG003|Open Label Extension Period|Adverse Event|0|||
147357509|NCT03478956|531480456|FG000|Open Label Extension Period|Lack of Efficacy|0|||
147357510|NCT03478956|531480457|FG001|Open Label Extension Period|Lack of Efficacy|0|||
147357511|NCT03478956|531480458|FG002|Open Label Extension Period|Lack of Efficacy|8|||
147357512|NCT03478956|531480459|FG003|Open Label Extension Period|Lack of Efficacy|0|||
147357513|NCT03478956|531480456|FG000|Open Label Extension Period|Reason Not Provided|0|||
147357514|NCT03478956|531480457|FG001|Open Label Extension Period|Reason Not Provided|0|||
147357515|NCT03478956|531480458|FG002|Open Label Extension Period|Reason Not Provided|1|||
147357516|NCT03478956|531480459|FG003|Open Label Extension Period|Reason Not Provided|0|||
147357517|NCT03478956|531480456|FG000|Open Label Extension Period|Study Terminated by Sponsor|0|||
147357518|NCT03478956|531480457|FG001|Open Label Extension Period|Study Terminated by Sponsor|0|||
147357519|NCT03478956|531480458|FG002|Open Label Extension Period|Study Terminated by Sponsor|6|||
147357520|NCT03478956|531480459|FG003|Open Label Extension Period|Study Terminated by Sponsor|0|||
147357521|NCT03478956|531480456|FG000|Open Label Extension Period|Withdrawal by Subject|0|||
147357522|NCT03478956|531480457|FG001|Open Label Extension Period|Withdrawal by Subject|0|||
147357523|NCT03478956|531480458|FG002|Open Label Extension Period|Withdrawal by Subject|2|||
147357524|NCT03478956|531480459|FG003|Open Label Extension Period|Withdrawal by Subject|0|||
147357525|NCT03478956|531480456|FG000|PML Safety Monitoring Period|Study Terminated by Sponsor|0|||
147357526|NCT03478956|531480457|FG001|PML Safety Monitoring Period|Study Terminated by Sponsor|0|||
147357527|NCT03478956|531480458|FG002|PML Safety Monitoring Period|Study Terminated by Sponsor|0|||
147357528|NCT03478956|531480459|FG003|PML Safety Monitoring Period|Study Terminated by Sponsor|9|||
147357529|NCT04800211|531480460|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Adverse Event|4|||
147357530|NCT04800211|531480461|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Adverse Event|1|||
147357531|NCT04800211|531480462|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Adverse Event|0|||
147357532|NCT04800211|531480460|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Failure To Meet Ie Post Enrollment|1|||
147357533|NCT04800211|531480461|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Failure To Meet Ie Post Enrollment|0|||
147357534|NCT04800211|531480462|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Failure To Meet Ie Post Enrollment|0|||
147357535|NCT04800211|531480460|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Lost to Follow-up|8|||
147357536|NCT04800211|531480461|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Lost to Follow-up|8|||
147357537|NCT04800211|531480462|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Lost to Follow-up|2|||
147357538|NCT04800211|531480460|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Non-Compliance With Study Procedures|8|||
147357539|NCT04800211|531480461|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Non-Compliance With Study Procedures|7|||
147357540|NCT04800211|531480462|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Non-Compliance With Study Procedures|2|||
147357541|NCT04800211|531480460|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Other|1|||
147357542|NCT04800211|531480461|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Other|2|||
147357543|NCT04800211|531480462|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Other|2|||
147357544|NCT04800211|531480460|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Physician Decision|0|||
147357545|NCT04800211|531480461|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Physician Decision|0|||
147357546|NCT04800211|531480462|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Physician Decision|1|||
147357547|NCT04800211|531480460|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Pregnancy|0|||
147357548|NCT04800211|531480461|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Pregnancy|0|||
147357549|NCT04800211|531480462|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Pregnancy|1|||
147357550|NCT04800211|531480460|FG000|ALCS-RA-16-06-EV (Weeks 1-12)|Withdrawal by Subject|8|||
147357551|NCT04800211|531480461|FG001|ALCS-RA-16-06-EV (Weeks 1-12)|Withdrawal by Subject|7|||
147357552|NCT04800211|531480462|FG002|ALCS-RA-16-06-EV (Weeks 1-12)|Withdrawal by Subject|5|||
147357553|NCT04800211|531480460|FG000|ALCS-RA-17-11-EV (Weeks 12-24)|Non-Compliance With Study Procedures|0|||
147357554|NCT04800211|531480461|FG001|ALCS-RA-17-11-EV (Weeks 12-24)|Non-Compliance With Study Procedures|0|||
147357555|NCT04800211|531480462|FG002|ALCS-RA-17-11-EV (Weeks 12-24)|Non-Compliance With Study Procedures|1|||
147357556|NCT04800211|531480460|FG000|ALCS-RA-17-11-EV (Weeks 12-24)|Other|0|||
147357557|NCT04800211|531480461|FG001|ALCS-RA-17-11-EV (Weeks 12-24)|Other|0|||
147357558|NCT04800211|531480462|FG002|ALCS-RA-17-11-EV (Weeks 12-24)|Other|2|||
147357559|NCT04800211|531480460|FG000|ALCS-RA-17-11-EV (Weeks 12-24)|Withdrawal by Subject|1|||
147357560|NCT04800211|531480461|FG001|ALCS-RA-17-11-EV (Weeks 12-24)|Withdrawal by Subject|0|||
147357561|NCT04800211|531480462|FG002|ALCS-RA-17-11-EV (Weeks 12-24)|Withdrawal by Subject|0|||
147357562|NCT03734679|531480474|FG000|Overall Study|Missed Visit|1|||
147357563|NCT03088878|531480488|FG000|Overall Study|Adverse Event|0|||
147357564|NCT03088878|531480489|FG001|Overall Study|Adverse Event|0|||
147357565|NCT03088878|531480490|FG002|Overall Study|Adverse Event|0|||
147357566|NCT03088878|531480491|FG003|Overall Study|Adverse Event|0|||
147357567|NCT03088878|531480492|FG004|Overall Study|Adverse Event|4|||
147357568|NCT03088878|531480493|FG005|Overall Study|Adverse Event|2|||
147357569|NCT03088878|531480494|FG006|Overall Study|Adverse Event|1|||
147357570|NCT03088878|531480495|FG007|Overall Study|Adverse Event|0|||
147357571|NCT03088878|531480496|FG008|Overall Study|Adverse Event|0|||
147357572|NCT03088878|531480497|FG009|Overall Study|Adverse Event|0|||
147357573|NCT03088878|531480498|FG010|Overall Study|Adverse Event|0|||
147357574|NCT03088878|531480499|FG011|Overall Study|Adverse Event|0|||
147453724|NCT05103332|531824079|FG006|OLE Period (24 Months=672 Days)|Adverse Event|0|||
147453725|NCT05103332|531824080|FG007|OLE Period (24 Months=672 Days)|Adverse Event|0|||
147357575|NCT03088878|531480500|FG012|Overall Study|Adverse Event|5|||
147357576|NCT03088878|531480501|FG013|Overall Study|Adverse Event|3|||
147357577|NCT03088878|531480488|FG000|Overall Study|Clinical Progression|0|||
147357578|NCT03088878|531480489|FG001|Overall Study|Clinical Progression|0|||
147357579|NCT03088878|531480490|FG002|Overall Study|Clinical Progression|0|||
147357580|NCT03088878|531480491|FG003|Overall Study|Clinical Progression|0|||
147357581|NCT03088878|531480492|FG004|Overall Study|Clinical Progression|2|||
147357582|NCT03088878|531480493|FG005|Overall Study|Clinical Progression|0|||
147357583|NCT03088878|531480494|FG006|Overall Study|Clinical Progression|0|||
147357584|NCT03088878|531480495|FG007|Overall Study|Clinical Progression|0|||
147453726|NCT05103332|531824081|FG008|OLE Period (24 Months=672 Days)|Adverse Event|0|||
147453727|NCT05103332|531824082|FG009|OLE Period (24 Months=672 Days)|Adverse Event|0|||
147357585|NCT03088878|531480496|FG008|Overall Study|Clinical Progression|0|||
147357586|NCT03088878|531480497|FG009|Overall Study|Clinical Progression|0|||
147357587|NCT03088878|531480498|FG010|Overall Study|Clinical Progression|0|||
147357588|NCT03088878|531480499|FG011|Overall Study|Clinical Progression|0|||
147357589|NCT03088878|531480500|FG012|Overall Study|Clinical Progression|0|||
147357590|NCT03088878|531480501|FG013|Overall Study|Clinical Progression|0|||
147357591|NCT03088878|531480488|FG000|Overall Study|Death|0|||
147357592|NCT03088878|531480489|FG001|Overall Study|Death|0|||
147357593|NCT03088878|531480490|FG002|Overall Study|Death|0|||
147357594|NCT03088878|531480491|FG003|Overall Study|Death|0|||
147357595|NCT03088878|531480492|FG004|Overall Study|Death|2|||
147357596|NCT03088878|531480493|FG005|Overall Study|Death|0|||
147357597|NCT03088878|531480494|FG006|Overall Study|Death|0|||
147357598|NCT03088878|531480495|FG007|Overall Study|Death|0|||
147357599|NCT03088878|531480496|FG008|Overall Study|Death|0|||
147357600|NCT03088878|531480497|FG009|Overall Study|Death|0|||
147357601|NCT03088878|531480498|FG010|Overall Study|Death|0|||
147357602|NCT03088878|531480499|FG011|Overall Study|Death|1|||
147357603|NCT03088878|531480500|FG012|Overall Study|Death|0|||
147357604|NCT03088878|531480501|FG013|Overall Study|Death|0|||
147357605|NCT03088878|531480488|FG000|Overall Study|Disease Progression|1|||
147357606|NCT03088878|531480489|FG001|Overall Study|Disease Progression|2|||
147357607|NCT03088878|531480490|FG002|Overall Study|Disease Progression|3|||
147357608|NCT03088878|531480491|FG003|Overall Study|Disease Progression|0|||
147357609|NCT03088878|531480492|FG004|Overall Study|Disease Progression|3|||
147357610|NCT03088878|531480493|FG005|Overall Study|Disease Progression|0|||
147357611|NCT03088878|531480494|FG006|Overall Study|Disease Progression|0|||
147357612|NCT03088878|531480495|FG007|Overall Study|Disease Progression|0|||
147357613|NCT03088878|531480496|FG008|Overall Study|Disease Progression|0|||
147357614|NCT03088878|531480497|FG009|Overall Study|Disease Progression|0|||
147357615|NCT03088878|531480498|FG010|Overall Study|Disease Progression|0|||
147357616|NCT03088878|531480499|FG011|Overall Study|Disease Progression|0|||
147357617|NCT03088878|531480500|FG012|Overall Study|Disease Progression|1|||
147357618|NCT03088878|531480501|FG013|Overall Study|Disease Progression|1|||
147357619|NCT03088878|531480488|FG000|Overall Study|Initiation of Alternative Treatment|0|||
147357620|NCT03088878|531480489|FG001|Overall Study|Initiation of Alternative Treatment|0|||
147357621|NCT03088878|531480490|FG002|Overall Study|Initiation of Alternative Treatment|0|||
147357622|NCT03088878|531480491|FG003|Overall Study|Initiation of Alternative Treatment|1|||
147357623|NCT03088878|531480492|FG004|Overall Study|Initiation of Alternative Treatment|0|||
147357624|NCT03088878|531480493|FG005|Overall Study|Initiation of Alternative Treatment|0|||
147357625|NCT03088878|531480494|FG006|Overall Study|Initiation of Alternative Treatment|0|||
147357626|NCT03088878|531480495|FG007|Overall Study|Initiation of Alternative Treatment|1|||
147357627|NCT03088878|531480496|FG008|Overall Study|Initiation of Alternative Treatment|1|||
147357628|NCT03088878|531480497|FG009|Overall Study|Initiation of Alternative Treatment|0|||
147357629|NCT03088878|531480498|FG010|Overall Study|Initiation of Alternative Treatment|0|||
147357630|NCT03088878|531480499|FG011|Overall Study|Initiation of Alternative Treatment|0|||
147357631|NCT03088878|531480500|FG012|Overall Study|Initiation of Alternative Treatment|0|||
147357632|NCT03088878|531480501|FG013|Overall Study|Initiation of Alternative Treatment|0|||
147357633|NCT03088878|531480488|FG000|Overall Study|Withdrawal by Subject|0|||
147357634|NCT03088878|531480489|FG001|Overall Study|Withdrawal by Subject|0|||
147357635|NCT03088878|531480490|FG002|Overall Study|Withdrawal by Subject|0|||
147357636|NCT03088878|531480491|FG003|Overall Study|Withdrawal by Subject|1|||
147357637|NCT03088878|531480492|FG004|Overall Study|Withdrawal by Subject|4|||
147357638|NCT03088878|531480493|FG005|Overall Study|Withdrawal by Subject|1|||
147357639|NCT03088878|531480494|FG006|Overall Study|Withdrawal by Subject|1|||
147357640|NCT03088878|531480495|FG007|Overall Study|Withdrawal by Subject|0|||
147357641|NCT03088878|531480496|FG008|Overall Study|Withdrawal by Subject|1|||
147357642|NCT03088878|531480497|FG009|Overall Study|Withdrawal by Subject|2|||
147357643|NCT03088878|531480498|FG010|Overall Study|Withdrawal by Subject|0|||
147357644|NCT03088878|531480499|FG011|Overall Study|Withdrawal by Subject|2|||
147357645|NCT03088878|531480500|FG012|Overall Study|Withdrawal by Subject|1|||
147357646|NCT03088878|531480501|FG013|Overall Study|Withdrawal by Subject|0|||
147357647|NCT03088878|531480488|FG000|Overall Study|Terminated by Sponsor|2|||
147357648|NCT03088878|531480489|FG001|Overall Study|Terminated by Sponsor|1|||
147453728|NCT05103332|531824083|FG010|OLE Period (24 Months=672 Days)|Adverse Event|1|||
147453729|NCT05103332|531824084|FG011|OLE Period (24 Months=672 Days)|Adverse Event|0|||
147453730|NCT05103332|531824085|FG012|OLE Period (24 Months=672 Days)|Adverse Event|0|||
147357649|NCT03088878|531480490|FG002|Overall Study|Terminated by Sponsor|0|||
147357650|NCT03088878|531480491|FG003|Overall Study|Terminated by Sponsor|1|||
147357651|NCT03088878|531480492|FG004|Overall Study|Terminated by Sponsor|6|||
147357652|NCT03088878|531480493|FG005|Overall Study|Terminated by Sponsor|0|||
147357653|NCT03088878|531480494|FG006|Overall Study|Terminated by Sponsor|0|||
147357654|NCT03088878|531480495|FG007|Overall Study|Terminated by Sponsor|0|||
147357655|NCT03088878|531480496|FG008|Overall Study|Terminated by Sponsor|0|||
147357656|NCT03088878|531480497|FG009|Overall Study|Terminated by Sponsor|0|||
147357657|NCT03088878|531480498|FG010|Overall Study|Terminated by Sponsor|3|||
147357658|NCT03088878|531480499|FG011|Overall Study|Terminated by Sponsor|13|||
147607860|NCT02899195|532380611|FG000|Concurrent Durvalumab|Physician Decision|1|||
147607861|NCT02899195|532380611|FG000|Concurrent Durvalumab|Withdrawal by Subject|1|||
147607862|NCT02899195|532380611|FG000|Concurrent Durvalumab|Progressive Disease|5|||
147357659|NCT03088878|531480500|FG012|Overall Study|Terminated by Sponsor|2|||
147357660|NCT03088878|531480501|FG013|Overall Study|Terminated by Sponsor|1|||
147357661|NCT03088878|531480488|FG000|Overall Study|Completed 2 years of Treatment|0|||
147357662|NCT03088878|531480489|FG001|Overall Study|Completed 2 years of Treatment|0|||
147357663|NCT03088878|531480490|FG002|Overall Study|Completed 2 years of Treatment|0|||
147357664|NCT03088878|531480491|FG003|Overall Study|Completed 2 years of Treatment|0|||
147357665|NCT03088878|531480492|FG004|Overall Study|Completed 2 years of Treatment|0|||
147357666|NCT03088878|531480493|FG005|Overall Study|Completed 2 years of Treatment|0|||
147357667|NCT03088878|531480494|FG006|Overall Study|Completed 2 years of Treatment|1|||
147357668|NCT03088878|531480495|FG007|Overall Study|Completed 2 years of Treatment|0|||
147357669|NCT03088878|531480496|FG008|Overall Study|Completed 2 years of Treatment|0|||
147357670|NCT03088878|531480497|FG009|Overall Study|Completed 2 years of Treatment|1|||
147357671|NCT03088878|531480498|FG010|Overall Study|Completed 2 years of Treatment|0|||
147357672|NCT03088878|531480499|FG011|Overall Study|Completed 2 years of Treatment|0|||
147357673|NCT03088878|531480500|FG012|Overall Study|Completed 2 years of Treatment|8|||
147357674|NCT03088878|531480501|FG013|Overall Study|Completed 2 years of Treatment|3|||
147357675|NCT03088878|531480488|FG000|Overall Study|Physician Decision|0|||
147357676|NCT03088878|531480489|FG001|Overall Study|Physician Decision|0|||
147357677|NCT03088878|531480490|FG002|Overall Study|Physician Decision|0|||
147357678|NCT03088878|531480491|FG003|Overall Study|Physician Decision|0|||
147357679|NCT03088878|531480492|FG004|Overall Study|Physician Decision|0|||
147357680|NCT03088878|531480493|FG005|Overall Study|Physician Decision|0|||
147357681|NCT03088878|531480494|FG006|Overall Study|Physician Decision|0|||
147357682|NCT03088878|531480495|FG007|Overall Study|Physician Decision|2|||
147357683|NCT03088878|531480496|FG008|Overall Study|Physician Decision|1|||
147357684|NCT03088878|531480497|FG009|Overall Study|Physician Decision|0|||
147357685|NCT03088878|531480498|FG010|Overall Study|Physician Decision|0|||
147357686|NCT03088878|531480499|FG011|Overall Study|Physician Decision|0|||
147357687|NCT03088878|531480500|FG012|Overall Study|Physician Decision|0|||
147357688|NCT03088878|531480501|FG013|Overall Study|Physician Decision|1|||
147357689|NCT03088878|531480488|FG000|Overall Study|COVID Related noncompliance|0|||
147357690|NCT03088878|531480489|FG001|Overall Study|COVID Related noncompliance|0|||
147357691|NCT03088878|531480490|FG002|Overall Study|COVID Related noncompliance|0|||
147357692|NCT03088878|531480491|FG003|Overall Study|COVID Related noncompliance|0|||
147357693|NCT03088878|531480492|FG004|Overall Study|COVID Related noncompliance|0|||
147357694|NCT03088878|531480493|FG005|Overall Study|COVID Related noncompliance|0|||
147357695|NCT03088878|531480494|FG006|Overall Study|COVID Related noncompliance|0|||
147357696|NCT03088878|531480495|FG007|Overall Study|COVID Related noncompliance|0|||
147357697|NCT03088878|531480496|FG008|Overall Study|COVID Related noncompliance|0|||
147357698|NCT03088878|531480497|FG009|Overall Study|COVID Related noncompliance|0|||
147357699|NCT03088878|531480498|FG010|Overall Study|COVID Related noncompliance|0|||
147357700|NCT03088878|531480499|FG011|Overall Study|COVID Related noncompliance|0|||
147357701|NCT03088878|531480500|FG012|Overall Study|COVID Related noncompliance|0|||
147357702|NCT03088878|531480501|FG013|Overall Study|COVID Related noncompliance|1|||
147357703|NCT03088878|531480488|FG000|Overall Study|Drug or Study Noncompliance|0|||
147357704|NCT03088878|531480489|FG001|Overall Study|Drug or Study Noncompliance|0|||
147357705|NCT03088878|531480490|FG002|Overall Study|Drug or Study Noncompliance|0|||
147357706|NCT03088878|531480491|FG003|Overall Study|Drug or Study Noncompliance|0|||
147357707|NCT03088878|531480492|FG004|Overall Study|Drug or Study Noncompliance|0|||
147357708|NCT03088878|531480493|FG005|Overall Study|Drug or Study Noncompliance|0|||
147357709|NCT03088878|531480494|FG006|Overall Study|Drug or Study Noncompliance|0|||
147357710|NCT03088878|531480495|FG007|Overall Study|Drug or Study Noncompliance|0|||
147357711|NCT03088878|531480496|FG008|Overall Study|Drug or Study Noncompliance|0|||
147357712|NCT03088878|531480497|FG009|Overall Study|Drug or Study Noncompliance|0|||
147357713|NCT03088878|531480498|FG010|Overall Study|Drug or Study Noncompliance|0|||
147357714|NCT03088878|531480499|FG011|Overall Study|Drug or Study Noncompliance|0|||
147607863|NCT02899195|532380611|FG000|Maintenance Durvalumab|Adverse Event|1|||
147607864|NCT02899195|532380611|FG000|Maintenance Durvalumab|Physician Decision|1|||
147607865|NCT02899195|532380611|FG000|Maintenance Durvalumab|Withdrawal by Subject|1|||
147357715|NCT03088878|531480500|FG012|Overall Study|Drug or Study Noncompliance|1|||
147357716|NCT03088878|531480501|FG013|Overall Study|Drug or Study Noncompliance|0|||
147357717|NCT02724969|531480502|FG000|Overall Study|Lost to Follow-up|12|||
147357718|NCT02724969|531480503|FG001|Overall Study|Lost to Follow-up|6|||
147357719|NCT02724969|531480502|FG000|Overall Study|Withdrawal by Subject|3|||
147357720|NCT02724969|531480503|FG001|Overall Study|Withdrawal by Subject|3|||
147357721|NCT02724969|531480502|FG000|Overall Study|Infant demise|0|||
147357722|NCT02724969|531480503|FG001|Overall Study|Infant demise|2|||
147357723|NCT01346540|531480504|FG000|Overall Study|Progressive disease-RECIST 1.1 criteria|3|||
147357724|NCT01346540|531480505|FG001|Overall Study|Progressive disease-RECIST 1.1 criteria|8|||
147357725|NCT01346540|531480504|FG000|Overall Study|Adverse Event|0|||
147357726|NCT01346540|531480505|FG001|Overall Study|Adverse Event|4|||
147453731|NCT05103332|531824086|FG013|OLE Period (24 Months=672 Days)|Adverse Event|0|||
147453732|NCT05103332|531824087|FG014|OLE Period (24 Months=672 Days)|Adverse Event|0|||
147453733|NCT05103332|531824088|FG015|OLE Period (24 Months=672 Days)|Adverse Event|0|||
147453734|NCT05103332|531824089|FG016|OLE Period (24 Months=672 Days)|Adverse Event|0|||
147453735|NCT05103332|531824090|FG017|OLE Period (24 Months=672 Days)|Adverse Event|0|||
147453736|NCT05103332|531824073|FG000|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
147453737|NCT05103332|531824074|FG001|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
147453738|NCT05103332|531824075|FG002|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
147453739|NCT05103332|531824076|FG003|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
147453740|NCT05103332|531824077|FG004|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
147453741|NCT05103332|531824078|FG005|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
147453742|NCT05103332|531824079|FG006|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
147453743|NCT05103332|531824080|FG007|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
147607866|NCT02899195|532380611|FG000|Maintenance Durvalumab|Progressive Disease|31|||
147607867|NCT02755649|532380612|FG000|Overall Study|Transitioned into OLE study|99|||
147607868|NCT02755649|532380613|FG001|Overall Study|Transitioned into OLE study|98|||
147607869|NCT02755649|532380614|FG002|Overall Study|Transitioned into OLE study|100|||
147607870|NCT02755649|532380612|FG000|Overall Study|Did Not Complete Follow-up Visits|1|||
147607871|NCT02755649|532380613|FG001|Overall Study|Did Not Complete Follow-up Visits|0|||
147607872|NCT02755649|532380614|FG002|Overall Study|Did Not Complete Follow-up Visits|0|||
147357727|NCT03362476|531480506|FG000|Overall Study|Withdrawal by Subject|0|||
147357728|NCT03362476|531480507|FG001|Overall Study|Withdrawal by Subject|1|||
147357729|NCT04690582|531480508|FG000|Overall Study|Withdrawal by Subject|6|||
147357730|NCT04690582|531480509|FG001|Overall Study|Withdrawal by Subject|4|||
147357731|NCT01236781|531480513|FG000|Overall Study|Ineligible|2|||
147357732|NCT01236781|531480514|FG001|Overall Study|Ineligible|1|||
147357733|NCT01236781|531480513|FG000|Overall Study|Did not complete study imaging|5|||
147357734|NCT01236781|531480514|FG001|Overall Study|Did not complete study imaging|0|||
147357735|NCT04577963|531480515|FG000|Part 2|Death|0|||
147357736|NCT04577963|531480516|FG001|Part 2|Death|1|||
147357737|NCT04577963|531480517|FG002|Part 2|Death|8|||
147357738|NCT04577963|531480518|FG003|Part 2|Death|0|||
147357739|NCT04577963|531480519|FG004|Part 2|Death|20|||
147357740|NCT04577963|531480515|FG000|Part 2|Lost to Follow-up|0|||
147357741|NCT04577963|531480516|FG001|Part 2|Lost to Follow-up|0|||
147357742|NCT04577963|531480517|FG002|Part 2|Lost to Follow-up|0|||
147357743|NCT04577963|531480518|FG003|Part 2|Lost to Follow-up|0|||
147357744|NCT04577963|531480519|FG004|Part 2|Lost to Follow-up|2|||
147357745|NCT04577963|531480515|FG000|Part 2|Withdrawal by Subject|0|||
147357746|NCT04577963|531480516|FG001|Part 2|Withdrawal by Subject|0|||
147357747|NCT04577963|531480517|FG002|Part 2|Withdrawal by Subject|0|||
147357748|NCT04577963|531480518|FG003|Part 2|Withdrawal by Subject|0|||
147357749|NCT04577963|531480519|FG004|Part 2|Withdrawal by Subject|10|||
147357750|NCT04577963|531480515|FG000|Part 2|Progressive disease|0|||
147357751|NCT04577963|531480516|FG001|Part 2|Progressive disease|0|||
147357752|NCT04577963|531480517|FG002|Part 2|Progressive disease|0|||
147357753|NCT04577963|531480518|FG003|Part 2|Progressive disease|0|||
147357754|NCT04577963|531480519|FG004|Part 2|Progressive disease|2|||
147357755|NCT04577963|531480515|FG000|Part 2|Investigator decision|0|||
147357756|NCT04577963|531480516|FG001|Part 2|Investigator decision|0|||
147357757|NCT04577963|531480517|FG002|Part 2|Investigator decision|0|||
147357758|NCT04577963|531480518|FG003|Part 2|Investigator decision|0|||
147357759|NCT04577963|531480519|FG004|Part 2|Investigator decision|1|||
147357760|NCT04577963|531480515|FG000|Part 2|Sponsor terminated study|0|||
147357761|NCT04577963|531480516|FG001|Part 2|Sponsor terminated study|0|||
147357762|NCT04577963|531480517|FG002|Part 2|Sponsor terminated study|3|||
147357763|NCT04577963|531480518|FG003|Part 2|Sponsor terminated study|1|||
147357764|NCT04577963|531480519|FG004|Part 2|Sponsor terminated study|4|||
147357765|NCT02709161|531480520|FG000|Overall Study|Withdrawal by Subject|1|||
147357766|NCT02709161|531480521|FG001|Overall Study|Withdrawal by Subject|0|||
147357767|NCT05167864|531480524|FG000|Overall Study|Lost to Follow-up|7|||
147357768|NCT05167864|531480525|FG001|Overall Study|Lost to Follow-up|6|||
147357769|NCT05167864|531480526|FG002|Overall Study|Lost to Follow-up|7|||
147357770|NCT05167864|531480527|FG003|Overall Study|Lost to Follow-up|9|||
147357771|NCT04059185|531480530|FG000|Longitudinal Assessment-Adults Only|Lost to Follow-up|187|||
147453744|NCT05103332|531824081|FG008|OLE Period (24 Months=672 Days)|Lost to Follow-up|1|||
147357772|NCT04059185|531480531|FG001|Longitudinal Assessment-Adults Only|Lost to Follow-up|195|||
147357773|NCT04059185|531480532|FG002|Longitudinal Assessment-Adults Only|Lost to Follow-up|177|||
147357774|NCT04059185|531480530|FG000|Longitudinal Assessment-Adults Only|Protocol Violation|11|||
147607873|NCT02755649|532380612|FG000|Overall Study|Physician Decision|0|||
147357775|NCT04059185|531480531|FG001|Longitudinal Assessment-Adults Only|Protocol Violation|13|||
147357776|NCT04059185|531480532|FG002|Longitudinal Assessment-Adults Only|Protocol Violation|13|||
147357777|NCT04059185|531480530|FG000|Longitudinal Assessment-Adults Only|Withdrawal by Subject|2|||
147357778|NCT04059185|531480531|FG001|Longitudinal Assessment-Adults Only|Withdrawal by Subject|2|||
147357779|NCT04059185|531480532|FG002|Longitudinal Assessment-Adults Only|Withdrawal by Subject|1|||
147357780|NCT04059185|531480530|FG000|Longitudinal Assessment-Adults Only|Baseline survey incomplete|4|||
147357781|NCT04059185|531480531|FG001|Longitudinal Assessment-Adults Only|Baseline survey incomplete|8|||
147357782|NCT04059185|531480532|FG002|Longitudinal Assessment-Adults Only|Baseline survey incomplete|3|||
147357783|NCT04059185|531480530|FG000|Longitudinal Assessment-Adults Only|Death|4|||
147357784|NCT04059185|531480531|FG001|Longitudinal Assessment-Adults Only|Death|4|||
147357785|NCT04059185|531480532|FG002|Longitudinal Assessment-Adults Only|Death|3|||
147357786|NCT04587453|531480540|FG000|Treatment Period (Week 0 to Week 16)|Premature (before Week 16) discontinuation of IMP|0|||
147357787|NCT04587453|531480541|FG001|Treatment Period (Week 0 to Week 16)|Premature (before Week 16) discontinuation of IMP|1|||
147357788|NCT04171141|531482078|FG000|Overall Study|Adverse Event|0|||
147357789|NCT04171141|531482079|FG001|Overall Study|Adverse Event|0|||
147357790|NCT04171141|531482080|FG002|Overall Study|Adverse Event|2|||
147357791|NCT04171141|531482081|FG003|Overall Study|Adverse Event|0|||
147357792|NCT04171141|531482082|FG004|Overall Study|Adverse Event|0|||
147357793|NCT04171141|531482083|FG005|Overall Study|Adverse Event|0|||
147357794|NCT04171141|531482084|FG006|Overall Study|Adverse Event|0|||
147607874|NCT02755649|532380613|FG001|Overall Study|Physician Decision|0|||
147607875|NCT02755649|532380614|FG002|Overall Study|Physician Decision|2|||
147607876|NCT02755649|532380612|FG000|Overall Study|Withdrawal by Subject|0|||
147607877|NCT02755649|532380613|FG001|Overall Study|Withdrawal by Subject|1|||
147607878|NCT02755649|532380614|FG002|Overall Study|Withdrawal by Subject|0|||
147607879|NCT02755649|532380612|FG000|Overall Study|Undecided|1|||
147357795|NCT04171141|531482085|FG007|Overall Study|Adverse Event|0|||
147357796|NCT04171141|531482086|FG008|Overall Study|Adverse Event|0|||
147357797|NCT04171141|531482087|FG009|Overall Study|Adverse Event|0|||
147357798|NCT04171141|531482088|FG010|Overall Study|Adverse Event|0|||
147357799|NCT04171141|531482089|FG011|Overall Study|Adverse Event|0|||
147357800|NCT04171141|531482090|FG012|Overall Study|Adverse Event|0|||
147357801|NCT04171141|531482091|FG013|Overall Study|Adverse Event|2|||
147357802|NCT04171141|531482092|FG014|Overall Study|Adverse Event|0|||
147357803|NCT04171141|531482093|FG015|Overall Study|Adverse Event|0|||
147357804|NCT04171141|531482078|FG000|Overall Study|Physician Decision|0|||
147357805|NCT04171141|531482079|FG001|Overall Study|Physician Decision|0|||
147357806|NCT04171141|531482080|FG002|Overall Study|Physician Decision|0|||
147357807|NCT04171141|531482081|FG003|Overall Study|Physician Decision|0|||
147357808|NCT04171141|531482082|FG004|Overall Study|Physician Decision|1|||
147357809|NCT04171141|531482083|FG005|Overall Study|Physician Decision|0|||
147357810|NCT04171141|531482084|FG006|Overall Study|Physician Decision|0|||
147357811|NCT04171141|531482085|FG007|Overall Study|Physician Decision|0|||
147357812|NCT04171141|531482086|FG008|Overall Study|Physician Decision|0|||
147357813|NCT04171141|531482087|FG009|Overall Study|Physician Decision|0|||
147357814|NCT04171141|531482088|FG010|Overall Study|Physician Decision|0|||
147357815|NCT04171141|531482089|FG011|Overall Study|Physician Decision|0|||
147357816|NCT04171141|531482090|FG012|Overall Study|Physician Decision|0|||
147357817|NCT04171141|531482091|FG013|Overall Study|Physician Decision|0|||
147357818|NCT04171141|531482092|FG014|Overall Study|Physician Decision|0|||
147357819|NCT04171141|531482093|FG015|Overall Study|Physician Decision|1|||
147357820|NCT04171141|531482078|FG000|Overall Study|Progressive disease|2|||
147357821|NCT04171141|531482079|FG001|Overall Study|Progressive disease|3|||
147357822|NCT04171141|531482080|FG002|Overall Study|Progressive disease|4|||
147357823|NCT04171141|531482081|FG003|Overall Study|Progressive disease|7|||
147357824|NCT04171141|531482082|FG004|Overall Study|Progressive disease|1|||
147357825|NCT04171141|531482083|FG005|Overall Study|Progressive disease|8|||
147357826|NCT04171141|531482084|FG006|Overall Study|Progressive disease|4|||
147357827|NCT04171141|531482085|FG007|Overall Study|Progressive disease|6|||
147357828|NCT04171141|531482086|FG008|Overall Study|Progressive disease|7|||
147357829|NCT04171141|531482087|FG009|Overall Study|Progressive disease|3|||
147357830|NCT04171141|531482088|FG010|Overall Study|Progressive disease|4|||
147357831|NCT04171141|531482089|FG011|Overall Study|Progressive disease|3|||
147357832|NCT04171141|531482090|FG012|Overall Study|Progressive disease|4|||
147357833|NCT04171141|531482091|FG013|Overall Study|Progressive disease|2|||
147357834|NCT04171141|531482092|FG014|Overall Study|Progressive disease|4|||
147357835|NCT04171141|531482093|FG015|Overall Study|Progressive disease|1|||
147357836|NCT04171141|531482078|FG000|Overall Study|Withdrawal by Subject|0|||
147357837|NCT04171141|531482079|FG001|Overall Study|Withdrawal by Subject|0|||
147357838|NCT04171141|531482080|FG002|Overall Study|Withdrawal by Subject|0|||
147357839|NCT04171141|531482081|FG003|Overall Study|Withdrawal by Subject|1|||
147357840|NCT04171141|531482082|FG004|Overall Study|Withdrawal by Subject|0|||
147357841|NCT04171141|531482083|FG005|Overall Study|Withdrawal by Subject|0|||
147357842|NCT04171141|531482084|FG006|Overall Study|Withdrawal by Subject|1|||
147357843|NCT04171141|531482085|FG007|Overall Study|Withdrawal by Subject|0|||
147357844|NCT04171141|531482086|FG008|Overall Study|Withdrawal by Subject|0|||
147357845|NCT04171141|531482087|FG009|Overall Study|Withdrawal by Subject|1|||
147357846|NCT04171141|531482088|FG010|Overall Study|Withdrawal by Subject|0|||
147357847|NCT04171141|531482089|FG011|Overall Study|Withdrawal by Subject|0|||
147357848|NCT04171141|531482090|FG012|Overall Study|Withdrawal by Subject|0|||
147357849|NCT04171141|531482091|FG013|Overall Study|Withdrawal by Subject|0|||
147357850|NCT04171141|531482092|FG014|Overall Study|Withdrawal by Subject|0|||
147357851|NCT04171141|531482093|FG015|Overall Study|Withdrawal by Subject|0|||
147357852|NCT04171141|531482078|FG000|Overall Study|Global deterioration of health status|0|||
147357853|NCT04171141|531482079|FG001|Overall Study|Global deterioration of health status|0|||
147357854|NCT04171141|531482080|FG002|Overall Study|Global deterioration of health status|0|||
147357855|NCT04171141|531482081|FG003|Overall Study|Global deterioration of health status|1|||
147357856|NCT04171141|531482082|FG004|Overall Study|Global deterioration of health status|0|||
147357857|NCT04171141|531482083|FG005|Overall Study|Global deterioration of health status|2|||
147357858|NCT04171141|531482084|FG006|Overall Study|Global deterioration of health status|1|||
147357859|NCT04171141|531482085|FG007|Overall Study|Global deterioration of health status|0|||
147357860|NCT04171141|531482086|FG008|Overall Study|Global deterioration of health status|1|||
147357861|NCT04171141|531482087|FG009|Overall Study|Global deterioration of health status|0|||
147357862|NCT04171141|531482088|FG010|Overall Study|Global deterioration of health status|0|||
147357863|NCT04171141|531482089|FG011|Overall Study|Global deterioration of health status|0|||
147357864|NCT04171141|531482090|FG012|Overall Study|Global deterioration of health status|0|||
147357865|NCT04171141|531482091|FG013|Overall Study|Global deterioration of health status|0|||
147357866|NCT04171141|531482092|FG014|Overall Study|Global deterioration of health status|1|||
147357867|NCT04171141|531482093|FG015|Overall Study|Global deterioration of health status|1|||
147357868|NCT04298983|531482098|FG000|Overall Study|Adverse Event|4|||
147357869|NCT04298983|531482098|FG000|Overall Study|Lack of Efficacy|3|||
147357870|NCT04042233|531482099|FG000|Overall Study|1st sample used for calibration of vancomycin tissue/bone concentration|1|||
147357871|NCT04042233|531482100|FG001|Overall Study|1st sample used for calibration of vancomycin tissue/bone concentration|0|||
147357872|NCT04042233|531482099|FG000|Overall Study|Protocol Violation|0|||
147357873|NCT04042233|531482100|FG001|Overall Study|Protocol Violation|2|||
147357874|NCT04907851|531482101|FG000|Overall Study|Consent withdrawn|1|||
147357875|NCT04907851|531482102|FG001|Overall Study|Consent withdrawn|2|||
147357876|NCT04907851|531482103|FG002|Overall Study|Consent withdrawn|0|||
147357877|NCT04907851|531482101|FG000|Overall Study|Death|5|||
147357878|NCT04907851|531482102|FG001|Overall Study|Death|15|||
147357879|NCT04907851|531482103|FG002|Overall Study|Death|10|||
147357880|NCT03766685|531482104|FG000|Overall Study|Lost to Follow-up|1|||
147357881|NCT03766685|531482105|FG001|Overall Study|Lost to Follow-up|1|||
147357882|NCT03766685|531482106|FG002|Overall Study|Lost to Follow-up|0|||
147357883|NCT03766685|531482107|FG003|Overall Study|Lost to Follow-up|0|||
147357884|NCT03766685|531482104|FG000|Overall Study|Adverse Event, not fatal|0|||
147357885|NCT03766685|531482105|FG001|Overall Study|Adverse Event, not fatal|1|||
147357886|NCT03766685|531482106|FG002|Overall Study|Adverse Event, not fatal|0|||
147357887|NCT03766685|531482107|FG003|Overall Study|Adverse Event, not fatal|1|||
147357888|NCT03766685|531482104|FG000|Overall Study|Withdrawal by Subject|0|||
147357889|NCT03766685|531482105|FG001|Overall Study|Withdrawal by Subject|2|||
147357890|NCT03766685|531482106|FG002|Overall Study|Withdrawal by Subject|0|||
147357891|NCT03766685|531482107|FG003|Overall Study|Withdrawal by Subject|0|||
147357892|NCT03766685|531482104|FG000|Overall Study|Protocol Violation|0|||
147357893|NCT03766685|531482105|FG001|Overall Study|Protocol Violation|1|||
147357894|NCT03766685|531482106|FG002|Overall Study|Protocol Violation|0|||
147357895|NCT03766685|531482107|FG003|Overall Study|Protocol Violation|0|||
147357896|NCT03766685|531482104|FG000|Overall Study|Non-compliance|0|||
147357897|NCT03766685|531482105|FG001|Overall Study|Non-compliance|2|||
147357898|NCT03766685|531482106|FG002|Overall Study|Non-compliance|0|||
147357899|NCT03766685|531482107|FG003|Overall Study|Non-compliance|0|||
147357900|NCT02116530|531482108|FG000|Overall Study|Withdrawal by Subject|1|||
147357901|NCT02116530|531482109|FG001|Overall Study|Withdrawal by Subject|2|||
147357902|NCT02116530|531482108|FG000|Overall Study|Adverse Event|4|||
147357903|NCT02116530|531482109|FG001|Overall Study|Adverse Event|0|||
147357904|NCT02116530|531482108|FG000|Overall Study|Physician Decision|1|||
147357905|NCT02116530|531482109|FG001|Overall Study|Physician Decision|0|||
147357906|NCT02116530|531482108|FG000|Overall Study|Lost to Follow-up|1|||
147357907|NCT02116530|531482109|FG001|Overall Study|Lost to Follow-up|0|||
147357908|NCT02116530|531482108|FG000|Overall Study|Other Medical Problems|2|||
147357909|NCT02116530|531482109|FG001|Overall Study|Other Medical Problems|2|||
147357910|NCT02927236|531482112|FG000|Characterization Phase|Physician Decision|0|||
147357911|NCT02927236|531482113|FG001|Characterization Phase|Physician Decision|3|||
147357912|NCT02927236|531482114|FG002|Characterization Phase|Physician Decision|0|||
147357913|NCT02927236|531482115|FG003|Characterization Phase|Physician Decision|2|||
147357914|NCT02927236|531482112|FG000|Characterization Phase|Lost to Follow-up|0|||
147357915|NCT02927236|531482113|FG001|Characterization Phase|Lost to Follow-up|0|||
147357916|NCT02927236|531482114|FG002|Characterization Phase|Lost to Follow-up|0|||
147453745|NCT05103332|531824082|FG009|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
147357917|NCT02927236|531482115|FG003|Characterization Phase|Lost to Follow-up|3|||
147357918|NCT02927236|531482112|FG000|Characterization Phase|Withdrawal by Subject|1|||
147357919|NCT02927236|531482113|FG001|Characterization Phase|Withdrawal by Subject|0|||
147357920|NCT02927236|531482114|FG002|Characterization Phase|Withdrawal by Subject|0|||
147357921|NCT02927236|531482115|FG003|Characterization Phase|Withdrawal by Subject|1|||
147357922|NCT02927236|531482112|FG000|Treatment Phase|Adverse Event|1|||
147357923|NCT02927236|531482113|FG001|Treatment Phase|Adverse Event|0|||
147357924|NCT02927236|531482114|FG002|Treatment Phase|Adverse Event|1|||
147357925|NCT02927236|531482115|FG003|Treatment Phase|Adverse Event|1|||
147357926|NCT02927236|531482112|FG000|Treatment Phase|Protocol Violation|3|||
147357927|NCT02927236|531482113|FG001|Treatment Phase|Protocol Violation|0|||
147357928|NCT02927236|531482114|FG002|Treatment Phase|Protocol Violation|0|||
147357929|NCT02927236|531482115|FG003|Treatment Phase|Protocol Violation|1|||
147357930|NCT02927236|531482112|FG000|Treatment Phase|Lost to Follow-up|1|||
147357931|NCT02927236|531482113|FG001|Treatment Phase|Lost to Follow-up|0|||
147357932|NCT02927236|531482114|FG002|Treatment Phase|Lost to Follow-up|0|||
147357933|NCT02927236|531482115|FG003|Treatment Phase|Lost to Follow-up|0|||
147357934|NCT02927236|531482112|FG000|Follow-up Phase|Lost to Follow-up|1|||
147357935|NCT02927236|531482113|FG001|Follow-up Phase|Lost to Follow-up|0|||
147357936|NCT02927236|531482114|FG002|Follow-up Phase|Lost to Follow-up|1|||
147357937|NCT02927236|531482115|FG003|Follow-up Phase|Lost to Follow-up|0|||
147357938|NCT04117347|531482119|FG000|Overall Study|Adverse Event|0|||
147357939|NCT04117347|531482120|FG001|Overall Study|Adverse Event|0|||
147357940|NCT04117347|531482121|FG002|Overall Study|Adverse Event|1|||
147357941|NCT04117347|531482119|FG000|Overall Study|No time for study|0|||
147357942|NCT04117347|531482120|FG001|Overall Study|No time for study|2|||
147357943|NCT04117347|531482121|FG002|Overall Study|No time for study|0|||
147357944|NCT04117347|531482119|FG000|Overall Study|Family emergency|1|||
147357945|NCT04117347|531482120|FG001|Overall Study|Family emergency|0|||
147357946|NCT04117347|531482121|FG002|Overall Study|Family emergency|0|||
147357947|NCT03511664|531482123|FG000|Overall Study|Death|457|||
147357948|NCT03511664|531482124|FG001|Overall Study|Death|201|||
147357949|NCT03511664|531482125|FG002|Overall Study|Death|21|||
147357950|NCT03511664|531482123|FG000|Overall Study|Withdrew consent|40|||
147357951|NCT03511664|531482124|FG001|Overall Study|Withdrew consent|63|||
147357952|NCT03511664|531482125|FG002|Overall Study|Withdrew consent|3|||
147357953|NCT03511664|531482123|FG000|Overall Study|Other protocol pre-specified reasons for discontinuation|15|||
147357954|NCT03511664|531482124|FG001|Overall Study|Other protocol pre-specified reasons for discontinuation|4|||
147357955|NCT03511664|531482125|FG002|Overall Study|Other protocol pre-specified reasons for discontinuation|2|||
147357956|NCT03511664|531482123|FG000|Overall Study|Lost to Follow-up|8|||
147357957|NCT03511664|531482124|FG001|Overall Study|Lost to Follow-up|5|||
147357958|NCT03511664|531482125|FG002|Overall Study|Lost to Follow-up|0|||
147357959|NCT03511664|531482123|FG000|Overall Study|Physician Decision|2|||
147357960|NCT03511664|531482124|FG001|Overall Study|Physician Decision|1|||
147357961|NCT03511664|531482125|FG002|Overall Study|Physician Decision|0|||
147357962|NCT03511664|531482123|FG000|Overall Study|Patient non-compliance|1|||
147357963|NCT03511664|531482124|FG001|Overall Study|Patient non-compliance|0|||
147357964|NCT03511664|531482125|FG002|Overall Study|Patient non-compliance|0|||
147357965|NCT01946789|531482126|FG000|Overall Study|Death|0|||
147357966|NCT01946789|531482127|FG001|Overall Study|Death|2|||
147357967|NCT01946789|531482128|FG002|Overall Study|Death|1|||
147357968|NCT01946789|531482129|FG003|Overall Study|Death|1|||
147357969|NCT01946789|531482130|FG004|Overall Study|Death|1|||
147357970|NCT01946789|531482131|FG005|Overall Study|Death|1|||
147357971|NCT01946789|531482132|FG006|Overall Study|Death|3|||
147357972|NCT01946789|531482133|FG007|Overall Study|Death|1|||
147357973|NCT01946789|531482134|FG008|Overall Study|Death|2|||
147357974|NCT01946789|531482126|FG000|Overall Study|Progressive Disease|0|||
147357975|NCT01946789|531482127|FG001|Overall Study|Progressive Disease|0|||
147357976|NCT01946789|531482128|FG002|Overall Study|Progressive Disease|1|||
147357977|NCT01946789|531482129|FG003|Overall Study|Progressive Disease|0|||
147357978|NCT01946789|531482130|FG004|Overall Study|Progressive Disease|0|||
147357979|NCT01946789|531482131|FG005|Overall Study|Progressive Disease|2|||
147357980|NCT01946789|531482132|FG006|Overall Study|Progressive Disease|0|||
147357981|NCT01946789|531482133|FG007|Overall Study|Progressive Disease|0|||
147357982|NCT01946789|531482134|FG008|Overall Study|Progressive Disease|0|||
147357983|NCT01946789|531482126|FG000|Overall Study|Withdrawal by Subject|0|||
147453746|NCT05103332|531824083|FG010|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
147607880|NCT02755649|532380613|FG001|Overall Study|Undecided|0|||
147607881|NCT02755649|532380614|FG002|Overall Study|Undecided|0|||
147607882|NCT00923273|532380620|FG000|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0|||
147607883|NCT00923273|532380621|FG001|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0|||
147607884|NCT00923273|532380622|FG002|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0|||
147357984|NCT01946789|531482127|FG001|Overall Study|Withdrawal by Subject|0|||
147357985|NCT01946789|531482128|FG002|Overall Study|Withdrawal by Subject|0|||
147357986|NCT01946789|531482129|FG003|Overall Study|Withdrawal by Subject|2|||
147357987|NCT01946789|531482130|FG004|Overall Study|Withdrawal by Subject|1|||
147357988|NCT01946789|531482131|FG005|Overall Study|Withdrawal by Subject|0|||
147357989|NCT01946789|531482132|FG006|Overall Study|Withdrawal by Subject|1|||
147357990|NCT01946789|531482133|FG007|Overall Study|Withdrawal by Subject|0|||
147357991|NCT01946789|531482134|FG008|Overall Study|Withdrawal by Subject|0|||
147357992|NCT04707625|531482153|FG000|Overall Study|IRB Required Early Termination Due to Safety Concerns|17|||
147357993|NCT05485779|531482156|FG000|Treatment Period 1 (Fasted)|Adverse Event|0|||
147357994|NCT05485779|531482157|FG001|Treatment Period 1 (Fasted)|Adverse Event|0|||
147357995|NCT05485779|531482158|FG002|Treatment Period 1 (Fasted)|Adverse Event|0|||
147357996|NCT05485779|531482159|FG003|Treatment Period 1 (Fasted)|Adverse Event|0|||
147357997|NCT05485779|531482160|FG004|Treatment Period 1 (Fasted)|Adverse Event|0|||
147357998|NCT05485779|531482161|FG005|Treatment Period 1 (Fasted)|Adverse Event|0|||
147357999|NCT05485779|531482162|FG006|Treatment Period 1 (Fasted)|Adverse Event|0|||
147358000|NCT05485779|531482163|FG007|Treatment Period 1 (Fasted)|Adverse Event|1|||
147358001|NCT05485779|531482164|FG008|Treatment Period 1 (Fasted)|Adverse Event|1|||
147358002|NCT05485779|531482165|FG009|Treatment Period 1 (Fasted)|Adverse Event|0|||
147358003|NCT05485779|531482166|FG010|Treatment Period 1 (Fasted)|Adverse Event|0|||
147358004|NCT05485779|531482156|FG000|Treatment Period 1 (Fasted)|Physician Decision|0|||
147358005|NCT05485779|531482157|FG001|Treatment Period 1 (Fasted)|Physician Decision|0|||
147358006|NCT05485779|531482158|FG002|Treatment Period 1 (Fasted)|Physician Decision|0|||
147358007|NCT05485779|531482159|FG003|Treatment Period 1 (Fasted)|Physician Decision|0|||
147358008|NCT05485779|531482160|FG004|Treatment Period 1 (Fasted)|Physician Decision|0|||
147358009|NCT05485779|531482161|FG005|Treatment Period 1 (Fasted)|Physician Decision|0|||
147358010|NCT05485779|531482162|FG006|Treatment Period 1 (Fasted)|Physician Decision|0|||
147358011|NCT05485779|531482163|FG007|Treatment Period 1 (Fasted)|Physician Decision|0|||
147358012|NCT05485779|531482164|FG008|Treatment Period 1 (Fasted)|Physician Decision|0|||
147358013|NCT05485779|531482165|FG009|Treatment Period 1 (Fasted)|Physician Decision|0|||
147358014|NCT05485779|531482166|FG010|Treatment Period 1 (Fasted)|Physician Decision|1|||
147358015|NCT05485779|531482156|FG000|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
147358016|NCT05485779|531482157|FG001|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
147358017|NCT05485779|531482158|FG002|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
147358018|NCT05485779|531482159|FG003|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|1|||
147358019|NCT05485779|531482160|FG004|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
147358020|NCT05485779|531482161|FG005|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
147358021|NCT05485779|531482162|FG006|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
147358022|NCT05485779|531482163|FG007|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
147358023|NCT05485779|531482164|FG008|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
147358024|NCT05485779|531482165|FG009|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
147358025|NCT05485779|531482166|FG010|Treatment Period 2 (Fed Groups Only)|Discontinued prior to dosing in fed period due to a failed drug screen at check-in|0|||
147358026|NCT03030261|531482168|FG000|Overall Study|Still receiving continuation therapy|5|||
147358027|NCT05293171|531482171|FG000|Washout 5 to 7 Days|Adverse Event|1|||
147358028|NCT05293171|531482172|FG001|Washout 5 to 7 Days|Adverse Event|1|||
147358029|NCT05293171|531482173|FG002|Washout 5 to 7 Days|Adverse Event|0|||
147358030|NCT05293171|531482174|FG003|Washout 5 to 7 Days|Adverse Event|0|||
147358031|NCT05293171|531482175|FG004|Washout 5 to 7 Days|Adverse Event|0|||
147358032|NCT05293171|531482176|FG005|Washout 5 to 7 Days|Adverse Event|0|||
147453747|NCT05103332|531824084|FG011|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
147453748|NCT05103332|531824085|FG012|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
147453749|NCT05103332|531824086|FG013|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
147453750|NCT05103332|531824087|FG014|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
147453751|NCT05103332|531824088|FG015|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
147453752|NCT05103332|531824089|FG016|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
147453753|NCT05103332|531824090|FG017|OLE Period (24 Months=672 Days)|Lost to Follow-up|0|||
147453754|NCT05103332|531824073|FG000|OLE Period (24 Months=672 Days)|Physician Decision|0|||
147453755|NCT05103332|531824074|FG001|OLE Period (24 Months=672 Days)|Physician Decision|0|||
147453756|NCT05103332|531824075|FG002|OLE Period (24 Months=672 Days)|Physician Decision|0|||
147453757|NCT05103332|531824076|FG003|OLE Period (24 Months=672 Days)|Physician Decision|0|||
147453758|NCT05103332|531824077|FG004|OLE Period (24 Months=672 Days)|Physician Decision|0|||
147453759|NCT05103332|531824078|FG005|OLE Period (24 Months=672 Days)|Physician Decision|0|||
147453760|NCT05103332|531824079|FG006|OLE Period (24 Months=672 Days)|Physician Decision|0|||
147453761|NCT05103332|531824080|FG007|OLE Period (24 Months=672 Days)|Physician Decision|0|||
147453762|NCT05103332|531824081|FG008|OLE Period (24 Months=672 Days)|Physician Decision|0|||
147453763|NCT05103332|531824082|FG009|OLE Period (24 Months=672 Days)|Physician Decision|0|||
147453764|NCT05103332|531824083|FG010|OLE Period (24 Months=672 Days)|Physician Decision|0|||
147453765|NCT05103332|531824084|FG011|OLE Period (24 Months=672 Days)|Physician Decision|1|||
147453766|NCT05103332|531824085|FG012|OLE Period (24 Months=672 Days)|Physician Decision|0|||
147453767|NCT05103332|531824086|FG013|OLE Period (24 Months=672 Days)|Physician Decision|0|||
147453768|NCT05103332|531824087|FG014|OLE Period (24 Months=672 Days)|Physician Decision|0|||
147453769|NCT05103332|531824088|FG015|OLE Period (24 Months=672 Days)|Physician Decision|0|||
147453770|NCT05103332|531824089|FG016|OLE Period (24 Months=672 Days)|Physician Decision|0|||
147453771|NCT05103332|531824090|FG017|OLE Period (24 Months=672 Days)|Physician Decision|0|||
147453772|NCT05103332|531824073|FG000|OLE Period (24 Months=672 Days)|Reason Not Specified|0|||
147453773|NCT05103332|531824074|FG001|OLE Period (24 Months=672 Days)|Reason Not Specified|0|||
147358033|NCT05293171|531482177|FG006|Washout 5 to 7 Days|Adverse Event|0|||
147358034|NCT05293171|531482178|FG007|Washout 5 to 7 Days|Adverse Event|0|||
147358035|NCT05293171|531482179|FG008|Washout 5 to 7 Days|Adverse Event|0|||
147358036|NCT05293171|531482180|FG009|Washout 5 to 7 Days|Adverse Event|0|||
147358037|NCT05293171|531482181|FG010|Washout 5 to 7 Days|Adverse Event|0|||
147358038|NCT05293171|531482182|FG011|Washout 5 to 7 Days|Adverse Event|0|||
147358039|NCT05293171|531482171|FG000|Washout 5 to 7 Days|Adverse Event|0|||
147358040|NCT05293171|531482172|FG001|Washout 5 to 7 Days|Adverse Event|0|||
147358041|NCT05293171|531482173|FG002|Washout 5 to 7 Days|Adverse Event|0|||
147358042|NCT05293171|531482174|FG003|Washout 5 to 7 Days|Adverse Event|0|||
147358043|NCT05293171|531482175|FG004|Washout 5 to 7 Days|Adverse Event|0|||
147358044|NCT05293171|531482176|FG005|Washout 5 to 7 Days|Adverse Event|1|||
147358045|NCT05293171|531482177|FG006|Washout 5 to 7 Days|Adverse Event|0|||
147358046|NCT05293171|531482178|FG007|Washout 5 to 7 Days|Adverse Event|0|||
147358047|NCT05293171|531482179|FG008|Washout 5 to 7 Days|Adverse Event|0|||
147358048|NCT05293171|531482180|FG009|Washout 5 to 7 Days|Adverse Event|0|||
147358049|NCT05293171|531482181|FG010|Washout 5 to 7 Days|Adverse Event|0|||
147358050|NCT05293171|531482182|FG011|Washout 5 to 7 Days|Adverse Event|0|||
147358051|NCT02052882|531482183|FG000|Overall Study|Not treated|11|||
147358052|NCT02052882|531482183|FG000|Overall Study|Protocol Violation|1|||
147358053|NCT02052882|531482183|FG000|Overall Study|Inadequate testing|1|||
147358054|NCT05170841|531482186|FG000|Single Dose Phase|Adverse Event|1|||
147358055|NCT05170841|531482187|FG001|Single Dose Phase|Adverse Event|2|||
147358056|NCT05170841|531482188|FG002|Single Dose Phase|Adverse Event|0|||
147358057|NCT05170841|531482189|FG003|Single Dose Phase|Adverse Event|2|||
147358058|NCT05170841|531482186|FG000|Multiple Dose Phase|Adverse Event|1|||
147358059|NCT05170841|531482187|FG001|Multiple Dose Phase|Adverse Event|2|||
147358060|NCT05170841|531482188|FG002|Multiple Dose Phase|Adverse Event|1|||
147358061|NCT05170841|531482189|FG003|Multiple Dose Phase|Adverse Event|4|||
147607885|NCT00923273|532380623|FG003|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|1|||
147607886|NCT00923273|532380624|FG004|Phase II Treatment Period|NE-brain mets/met disease prior enrollmt|0|||
147607887|NCT00923273|532380620|FG000|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0|||
147607888|NCT00923273|532380621|FG001|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0|||
147607889|NCT00923273|532380622|FG002|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0|||
147607890|NCT00923273|532380623|FG003|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|6|||
147607891|NCT00923273|532380624|FG004|Phase II Treatment Period|NE-not complete 2Cy trmt/no imaging done|0|||
147607892|NCT00605540|532380625|FG000|Overall Study|Death|15|||
147607893|NCT00605540|532380625|FG000|Overall Study|Lost to Follow-up|23|||
147607894|NCT00129389|532380626|FG000|Overall Study|Adverse Event|19|||
147607895|NCT00129389|532380627|FG001|Overall Study|Adverse Event|87|||
147607896|NCT00129389|532380626|FG000|Overall Study|Death|0|||
147607897|NCT00129389|532380627|FG001|Overall Study|Death|1|||
147607898|NCT00129389|532380626|FG000|Overall Study|Lost to Follow-up|2|||
147607899|NCT00129389|532380627|FG001|Overall Study|Lost to Follow-up|1|||
147607900|NCT00129389|532380626|FG000|Overall Study|Physician Decision|0|||
147607901|NCT00129389|532380627|FG001|Overall Study|Physician Decision|4|||
147607902|NCT00129389|532380626|FG000|Overall Study|Protocol Violation|0|||
147607903|NCT00129389|532380627|FG001|Overall Study|Protocol Violation|6|||
147607904|NCT00129389|532380626|FG000|Overall Study|Withdrawal by Subject|9|||
147607905|NCT00129389|532380627|FG001|Overall Study|Withdrawal by Subject|23|||
147607906|NCT00129389|532380626|FG000|Overall Study|Relapse|1|||
147358062|NCT05170841|531482186|FG000|Multiple Dose Phase|Withdrawal by Subject|0|||
147607907|NCT00129389|532380627|FG001|Overall Study|Relapse|0|||
147358063|NCT05170841|531482187|FG001|Multiple Dose Phase|Withdrawal by Subject|1|||
147358064|NCT05170841|531482188|FG002|Multiple Dose Phase|Withdrawal by Subject|0|||
147358065|NCT05170841|531482189|FG003|Multiple Dose Phase|Withdrawal by Subject|0|||
147358066|NCT02240238|531482192|FG000|Phase 1|Adverse Event|0|||
147358067|NCT02240238|531482193|FG001|Phase 1|Adverse Event|0|||
147358068|NCT02240238|531482194|FG002|Phase 1|Adverse Event|0|||
147607908|NCT00129389|532380626|FG000|Overall Study|Not eligible|1|||
147358069|NCT02240238|531482195|FG003|Phase 1|Adverse Event|0|||
147358070|NCT02240238|531482196|FG004|Phase 1|Adverse Event|0|||
147607909|NCT00129389|532380627|FG001|Overall Study|Not eligible|2|||
147358071|NCT02240238|531482197|FG005|Phase 1|Adverse Event|0|||
147358072|NCT02240238|531482198|FG006|Phase 1|Adverse Event|3|||
147358073|NCT02240238|531482199|FG007|Phase 1|Adverse Event|1|||
147607910|NCT00129389|532380626|FG000|Overall Study|Crossed to the other arm|1|||
147607911|NCT00129389|532380627|FG001|Overall Study|Crossed to the other arm|16|||
147358074|NCT02240238|531482200|FG008|Phase 1|Adverse Event|0|||
147358075|NCT02240238|531482201|FG009|Phase 1|Adverse Event|0|||
147358076|NCT02240238|531482202|FG010|Phase 1|Adverse Event|0|||
147607912|NCT01831258|532380694|FG000|Overall Study|Withdrawal by Subject|2|||
147607913|NCT01831258|532380695|FG001|Overall Study|Withdrawal by Subject|1|||
147607914|NCT01831258|532380694|FG000|Overall Study|Lost to Follow-up|3|||
147358077|NCT02240238|531482203|FG011|Phase 1|Adverse Event|0|||
147358078|NCT02240238|531482192|FG000|Phase 1|Death|0|||
147358079|NCT02240238|531482193|FG001|Phase 1|Death|0|||
147358080|NCT02240238|531482194|FG002|Phase 1|Death|0|||
147358081|NCT02240238|531482195|FG003|Phase 1|Death|0|||
147358082|NCT02240238|531482196|FG004|Phase 1|Death|0|||
147607915|NCT01831258|532380695|FG001|Overall Study|Lost to Follow-up|2|||
147607916|NCT02564887|532380704|FG000|Overall Study|Lost to Follow-up|6|||
147607917|NCT02564887|532380705|FG001|Overall Study|Lost to Follow-up|0|||
147607918|NCT01199016|532380706|FG000|Overall Study|No longer meets eligibility criteria|4|||
147607919|NCT01199016|532380706|FG000|Overall Study|Entrance criteria|5|||
147607920|NCT01199016|532380706|FG000|Overall Study|Protocol Violation|9|||
147607921|NCT01199016|532380706|FG000|Overall Study|Other|13|||
147607922|NCT01199016|532380706|FG000|Overall Study|Withdrawal by Subject|21|||
147607923|NCT01199016|532380706|FG000|Overall Study|Lost to Follow-up|25|||
147607924|NCT00339144|532380758|FG000|Overall Study|Disease progression|5|||
147607925|NCT00339144|532380759|FG001|Overall Study|Disease progression|2|||
147607926|NCT00339144|532380760|FG002|Overall Study|Disease progression|2|||
147607927|NCT00339144|532380758|FG000|Overall Study|Study drug toxicity|3|||
147607928|NCT00339144|532380759|FG001|Overall Study|Study drug toxicity|1|||
147607929|NCT00339144|532380760|FG002|Overall Study|Study drug toxicity|1|||
147607930|NCT00339144|532380758|FG000|Overall Study|Participant's request to discontinuation|1|||
147607931|NCT00339144|532380759|FG001|Overall Study|Participant's request to discontinuation|0|||
147358083|NCT02240238|531482197|FG005|Phase 1|Death|1|||
147358084|NCT02240238|531482198|FG006|Phase 1|Death|0|||
147358085|NCT02240238|531482199|FG007|Phase 1|Death|0|||
147358086|NCT02240238|531482200|FG008|Phase 1|Death|0|||
147358087|NCT02240238|531482201|FG009|Phase 1|Death|0|||
147358088|NCT02240238|531482202|FG010|Phase 1|Death|0|||
147358089|NCT02240238|531482203|FG011|Phase 1|Death|0|||
147607932|NCT00339144|532380760|FG002|Overall Study|Participant's request to discontinuation|1|||
147607933|NCT03280381|532380761|FG000|Overall Study|Physician Decision|0|||
147607934|NCT03280381|532380762|FG001|Overall Study|Physician Decision|2|||
147607935|NCT02655666|532380766|FG000|Overall Study|Sponsor stopped this clinical research.|12|||
147607936|NCT00895414|532380769|FG000|First Intervention (14 Days)|Withdrawal by Subject|1|||
147607937|NCT00895414|532380770|FG001|First Intervention (14 Days)|Withdrawal by Subject|0|||
147607938|NCT00895414|532380769|FG000|First Intervention (14 Days)|Physician Decision|0|||
147607939|NCT00895414|532380770|FG001|First Intervention (14 Days)|Physician Decision|1|||
147607940|NCT05199090|532380773|FG000|Overall Study|Adverse Event|1|||
147607941|NCT05199090|532380774|FG001|Overall Study|Adverse Event|4|||
147607942|NCT05199090|532380775|FG002|Overall Study|Adverse Event|0|||
147358090|NCT02240238|531482192|FG000|Phase 1|Sponsor termination|0|||
147358091|NCT02240238|531482193|FG001|Phase 1|Sponsor termination|0|||
147358092|NCT02240238|531482194|FG002|Phase 1|Sponsor termination|0|||
147358093|NCT02240238|531482195|FG003|Phase 1|Sponsor termination|0|||
147607943|NCT05199090|532380776|FG003|Overall Study|Adverse Event|0|||
147607944|NCT05199090|532380777|FG004|Overall Study|Adverse Event|0|||
147607945|NCT05199090|532380778|FG005|Overall Study|Adverse Event|0|||
147607946|NCT05199090|532380773|FG000|Overall Study|Lost to Follow-up|1|||
147607947|NCT05199090|532380774|FG001|Overall Study|Lost to Follow-up|0|||
147607948|NCT05199090|532380775|FG002|Overall Study|Lost to Follow-up|1|||
147607949|NCT05199090|532380776|FG003|Overall Study|Lost to Follow-up|4|||
147607950|NCT05199090|532380777|FG004|Overall Study|Lost to Follow-up|0|||
147607951|NCT05199090|532380778|FG005|Overall Study|Lost to Follow-up|5|||
147607952|NCT05199090|532380773|FG000|Overall Study|Physician Decision|0|||
147607953|NCT05199090|532380774|FG001|Overall Study|Physician Decision|0|||
147358094|NCT02240238|531482196|FG004|Phase 1|Sponsor termination|0|||
147358095|NCT02240238|531482197|FG005|Phase 1|Sponsor termination|1|||
147358096|NCT02240238|531482198|FG006|Phase 1|Sponsor termination|0|||
147607954|NCT05199090|532380775|FG002|Overall Study|Physician Decision|0|||
147607955|NCT05199090|532380776|FG003|Overall Study|Physician Decision|0|||
147607956|NCT05199090|532380777|FG004|Overall Study|Physician Decision|0|||
147607957|NCT05199090|532380778|FG005|Overall Study|Physician Decision|1|||
147607958|NCT05199090|532380773|FG000|Overall Study|Study terminated by sponsor|0|||
147607959|NCT05199090|532380774|FG001|Overall Study|Study terminated by sponsor|6|||
147607960|NCT05199090|532380775|FG002|Overall Study|Study terminated by sponsor|0|||
147607961|NCT05199090|532380776|FG003|Overall Study|Study terminated by sponsor|0|||
147607962|NCT05199090|532380777|FG004|Overall Study|Study terminated by sponsor|0|||
147607963|NCT05199090|532380778|FG005|Overall Study|Study terminated by sponsor|5|||
147607964|NCT05199090|532380773|FG000|Overall Study|Subject decision|0|||
147607965|NCT05199090|532380774|FG001|Overall Study|Subject decision|4|||
147358097|NCT02240238|531482199|FG007|Phase 1|Sponsor termination|0|||
147607966|NCT05199090|532380775|FG002|Overall Study|Subject decision|0|||
147607967|NCT05199090|532380776|FG003|Overall Study|Subject decision|2|||
147607968|NCT05199090|532380777|FG004|Overall Study|Subject decision|5|||
147607969|NCT05199090|532380778|FG005|Overall Study|Subject decision|2|||
147607970|NCT03485365|532380779|FG000|Overall Study|Protocol Violation|0|||
147607971|NCT03485365|532380780|FG001|Overall Study|Protocol Violation|0|||
147607972|NCT03485365|532380781|FG002|Overall Study|Protocol Violation|0|||
147607973|NCT03485365|532380782|FG003|Overall Study|Protocol Violation|1|||
147607974|NCT03485365|532380783|FG004|Overall Study|Protocol Violation|0|||
147358098|NCT02240238|531482200|FG008|Phase 1|Sponsor termination|0|||
147358099|NCT02240238|531482201|FG009|Phase 1|Sponsor termination|0|||
147358100|NCT02240238|531482202|FG010|Phase 1|Sponsor termination|0|||
147358101|NCT02240238|531482203|FG011|Phase 1|Sponsor termination|0|||
147358102|NCT02240238|531482192|FG000|Phase 1|Withdrawal by Subject|0|||
147607975|NCT03485365|532380784|FG005|Overall Study|Protocol Violation|0|||
147358103|NCT02240238|531482193|FG001|Phase 1|Withdrawal by Subject|0|||
147358104|NCT02240238|531482194|FG002|Phase 1|Withdrawal by Subject|0|||
147358105|NCT02240238|531482195|FG003|Phase 1|Withdrawal by Subject|0|||
147358106|NCT02240238|531482196|FG004|Phase 1|Withdrawal by Subject|0|||
147358107|NCT02240238|531482197|FG005|Phase 1|Withdrawal by Subject|2|||
147358108|NCT02240238|531482198|FG006|Phase 1|Withdrawal by Subject|0|||
147358109|NCT02240238|531482199|FG007|Phase 1|Withdrawal by Subject|0|||
147358110|NCT02240238|531482200|FG008|Phase 1|Withdrawal by Subject|0|||
147358111|NCT02240238|531482201|FG009|Phase 1|Withdrawal by Subject|0|||
147358112|NCT02240238|531482202|FG010|Phase 1|Withdrawal by Subject|0|||
147358113|NCT02240238|531482203|FG011|Phase 1|Withdrawal by Subject|0|||
147358114|NCT02240238|531482192|FG000|Phase 1|Physician Decision|0|||
147358115|NCT02240238|531482193|FG001|Phase 1|Physician Decision|0|||
147358116|NCT02240238|531482194|FG002|Phase 1|Physician Decision|0|||
147358117|NCT02240238|531482195|FG003|Phase 1|Physician Decision|0|||
147358118|NCT02240238|531482196|FG004|Phase 1|Physician Decision|0|||
147358119|NCT02240238|531482197|FG005|Phase 1|Physician Decision|2|||
147358120|NCT02240238|531482198|FG006|Phase 1|Physician Decision|0|||
147358121|NCT02240238|531482199|FG007|Phase 1|Physician Decision|0|||
147358122|NCT02240238|531482200|FG008|Phase 1|Physician Decision|0|||
147358123|NCT02240238|531482201|FG009|Phase 1|Physician Decision|0|||
147358124|NCT02240238|531482202|FG010|Phase 1|Physician Decision|0|||
147358125|NCT02240238|531482203|FG011|Phase 1|Physician Decision|0|||
147358126|NCT02240238|531482192|FG000|Phase 2|Adverse Event|0|||
147358127|NCT02240238|531482193|FG001|Phase 2|Adverse Event|0|||
147358128|NCT02240238|531482194|FG002|Phase 2|Adverse Event|0|||
147358129|NCT02240238|531482195|FG003|Phase 2|Adverse Event|0|||
147358130|NCT02240238|531482196|FG004|Phase 2|Adverse Event|0|||
147358131|NCT02240238|531482197|FG005|Phase 2|Adverse Event|0|||
147358132|NCT02240238|531482198|FG006|Phase 2|Adverse Event|0|||
147358133|NCT02240238|531482199|FG007|Phase 2|Adverse Event|0|||
147358134|NCT02240238|531482200|FG008|Phase 2|Adverse Event|0|||
147358135|NCT02240238|531482201|FG009|Phase 2|Adverse Event|7|||
147358136|NCT02240238|531482202|FG010|Phase 2|Adverse Event|14|||
147358137|NCT02240238|531482203|FG011|Phase 2|Adverse Event|2|||
147358138|NCT02240238|531482192|FG000|Phase 2|Death|0|||
147358139|NCT02240238|531482193|FG001|Phase 2|Death|0|||
147358140|NCT02240238|531482194|FG002|Phase 2|Death|0|||
147358141|NCT02240238|531482195|FG003|Phase 2|Death|0|||
147358142|NCT02240238|531482196|FG004|Phase 2|Death|0|||
147358143|NCT02240238|531482197|FG005|Phase 2|Death|0|||
147358144|NCT02240238|531482198|FG006|Phase 2|Death|0|||
147358145|NCT02240238|531482199|FG007|Phase 2|Death|0|||
147358146|NCT02240238|531482200|FG008|Phase 2|Death|0|||
147358147|NCT02240238|531482201|FG009|Phase 2|Death|3|||
147358148|NCT02240238|531482202|FG010|Phase 2|Death|2|||
147358149|NCT02240238|531482203|FG011|Phase 2|Death|1|||
147358150|NCT02240238|531482192|FG000|Phase 2|Disease progression|0|||
147358151|NCT02240238|531482193|FG001|Phase 2|Disease progression|0|||
147358152|NCT02240238|531482194|FG002|Phase 2|Disease progression|0|||
147358153|NCT02240238|531482195|FG003|Phase 2|Disease progression|0|||
147358154|NCT02240238|531482196|FG004|Phase 2|Disease progression|0|||
147358155|NCT02240238|531482197|FG005|Phase 2|Disease progression|0|||
147358156|NCT02240238|531482198|FG006|Phase 2|Disease progression|0|||
147358157|NCT02240238|531482199|FG007|Phase 2|Disease progression|0|||
147358158|NCT02240238|531482200|FG008|Phase 2|Disease progression|0|||
147358159|NCT02240238|531482201|FG009|Phase 2|Disease progression|5|||
147358160|NCT02240238|531482202|FG010|Phase 2|Disease progression|11|||
147607976|NCT03485365|532380785|FG006|Overall Study|Protocol Violation|1|||
147607977|NCT03485365|532380786|FG007|Overall Study|Protocol Violation|0|||
147607978|NCT03485365|532380787|FG008|Overall Study|Protocol Violation|0|||
147607979|NCT02181790|532380788|FG000|Overall Study|study terminated|2|||
147607980|NCT02181790|532380789|FG001|Overall Study|study terminated|0|||
147607981|NCT04988087|532380795|FG000|Overall Study|Adverse Event|4|||
147607982|NCT04988087|532380796|FG001|Overall Study|Adverse Event|0|||
147607983|NCT04988087|532380797|FG002|Overall Study|Adverse Event|0|||
147358161|NCT02240238|531482203|FG011|Phase 2|Disease progression|1|||
147358162|NCT02240238|531482192|FG000|Phase 2|Withdrawal by Subject|0|||
147358163|NCT02240238|531482193|FG001|Phase 2|Withdrawal by Subject|0|||
147358164|NCT02240238|531482194|FG002|Phase 2|Withdrawal by Subject|0|||
147358165|NCT02240238|531482195|FG003|Phase 2|Withdrawal by Subject|0|||
147358166|NCT02240238|531482196|FG004|Phase 2|Withdrawal by Subject|0|||
147358167|NCT02240238|531482197|FG005|Phase 2|Withdrawal by Subject|0|||
147358168|NCT02240238|531482198|FG006|Phase 2|Withdrawal by Subject|0|||
147358169|NCT02240238|531482199|FG007|Phase 2|Withdrawal by Subject|0|||
147358170|NCT02240238|531482200|FG008|Phase 2|Withdrawal by Subject|0|||
147358171|NCT02240238|531482201|FG009|Phase 2|Withdrawal by Subject|1|||
147358172|NCT02240238|531482202|FG010|Phase 2|Withdrawal by Subject|1|||
147358173|NCT02240238|531482203|FG011|Phase 2|Withdrawal by Subject|0|||
147358174|NCT02240238|531482192|FG000|Phase 2|Physician Decision|0|||
147358175|NCT02240238|531482193|FG001|Phase 2|Physician Decision|0|||
147358176|NCT02240238|531482194|FG002|Phase 2|Physician Decision|0|||
147607984|NCT04988087|532380798|FG003|Overall Study|Adverse Event|0|||
147358177|NCT02240238|531482195|FG003|Phase 2|Physician Decision|0|||
147358178|NCT02240238|531482196|FG004|Phase 2|Physician Decision|0|||
147358179|NCT02240238|531482197|FG005|Phase 2|Physician Decision|0|||
147358180|NCT02240238|531482198|FG006|Phase 2|Physician Decision|0|||
147358181|NCT02240238|531482199|FG007|Phase 2|Physician Decision|0|||
147358182|NCT02240238|531482200|FG008|Phase 2|Physician Decision|0|||
147358183|NCT02240238|531482201|FG009|Phase 2|Physician Decision|1|||
147358184|NCT02240238|531482202|FG010|Phase 2|Physician Decision|3|||
147358185|NCT02240238|531482203|FG011|Phase 2|Physician Decision|0|||
147358186|NCT02240238|531482192|FG000|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
147358187|NCT02240238|531482193|FG001|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
147358188|NCT02240238|531482194|FG002|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
147358189|NCT02240238|531482195|FG003|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
147358190|NCT02240238|531482196|FG004|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
147358191|NCT02240238|531482197|FG005|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
147358192|NCT02240238|531482198|FG006|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
147358193|NCT02240238|531482199|FG007|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
147358194|NCT02240238|531482200|FG008|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
147358195|NCT02240238|531482201|FG009|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|1|||
147358196|NCT02240238|531482202|FG010|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
147358197|NCT02240238|531482203|FG011|Phase 2|PARTICIPANT WAS DISCONTINUED DUE TO THEIR DETERIORATING CONDITION/CLINICAL PROGRESSION|0|||
147358198|NCT02240238|531482192|FG000|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
147358199|NCT02240238|531482193|FG001|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
147358200|NCT02240238|531482194|FG002|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
147358201|NCT02240238|531482195|FG003|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
147358202|NCT02240238|531482196|FG004|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
147358203|NCT02240238|531482197|FG005|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
147358204|NCT02240238|531482198|FG006|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
147358205|NCT02240238|531482199|FG007|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
147358206|NCT02240238|531482200|FG008|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
147358207|NCT02240238|531482201|FG009|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|1|||
147358208|NCT02240238|531482202|FG010|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
147358209|NCT02240238|531482203|FG011|Phase 2|TREATMENT NOT COMPLETED, PARTICIPANT MISSED C6D8 DUE TO PERSONAL REASON|0|||
147358210|NCT02240238|531482192|FG000|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
147358211|NCT02240238|531482193|FG001|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
147358212|NCT02240238|531482194|FG002|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
147358213|NCT02240238|531482195|FG003|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
147358214|NCT02240238|531482196|FG004|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
147358215|NCT02240238|531482197|FG005|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
147358216|NCT02240238|531482198|FG006|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
147358217|NCT02240238|531482199|FG007|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
147358218|NCT02240238|531482200|FG008|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
147358219|NCT02240238|531482201|FG009|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
147358220|NCT02240238|531482202|FG010|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|1|||
147358221|NCT02240238|531482203|FG011|Phase 2|PARTICIPANT DECIDED TO TAKE STANDARD OF CARE TREATMENT|0|||
147358222|NCT02240238|531482192|FG000|Phase 2|TREATMENT DELAY >14 DAYS|0|||
147358223|NCT02240238|531482193|FG001|Phase 2|TREATMENT DELAY >14 DAYS|0|||
147358224|NCT02240238|531482194|FG002|Phase 2|TREATMENT DELAY >14 DAYS|0|||
147358225|NCT02240238|531482195|FG003|Phase 2|TREATMENT DELAY >14 DAYS|0|||
147358226|NCT02240238|531482196|FG004|Phase 2|TREATMENT DELAY >14 DAYS|0|||
147358227|NCT02240238|531482197|FG005|Phase 2|TREATMENT DELAY >14 DAYS|0|||
147358228|NCT02240238|531482198|FG006|Phase 2|TREATMENT DELAY >14 DAYS|0|||
147358229|NCT02240238|531482199|FG007|Phase 2|TREATMENT DELAY >14 DAYS|0|||
147358230|NCT02240238|531482200|FG008|Phase 2|TREATMENT DELAY >14 DAYS|0|||
147358231|NCT02240238|531482201|FG009|Phase 2|TREATMENT DELAY >14 DAYS|0|||
147358232|NCT02240238|531482202|FG010|Phase 2|TREATMENT DELAY >14 DAYS|1|||
147358233|NCT02240238|531482203|FG011|Phase 2|TREATMENT DELAY >14 DAYS|0|||
147358234|NCT02240238|531482192|FG000|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
147358235|NCT02240238|531482193|FG001|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
147358236|NCT02240238|531482194|FG002|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
147358237|NCT02240238|531482195|FG003|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
147358238|NCT02240238|531482196|FG004|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
147453774|NCT05103332|531824075|FG002|OLE Period (24 Months=672 Days)|Reason Not Specified|0|||
147358239|NCT02240238|531482197|FG005|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
147358240|NCT02240238|531482198|FG006|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
147358241|NCT02240238|531482199|FG007|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
147358242|NCT02240238|531482200|FG008|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
147358243|NCT02240238|531482201|FG009|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
147358244|NCT02240238|531482202|FG010|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|1|||
147358245|NCT02240238|531482203|FG011|Phase 2|PARTICIPANT WAS DECLINING CLINICALLY|0|||
147358246|NCT02240238|531482192|FG000|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
147358247|NCT02240238|531482193|FG001|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
147358248|NCT02240238|531482194|FG002|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
147358249|NCT02240238|531482195|FG003|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
147358250|NCT02240238|531482196|FG004|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
147358251|NCT02240238|531482197|FG005|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
147358252|NCT02240238|531482198|FG006|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
147358253|NCT02240238|531482199|FG007|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
147358254|NCT02240238|531482200|FG008|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
147358255|NCT02240238|531482201|FG009|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
147358256|NCT02240238|531482202|FG010|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|1|||
147358257|NCT02240238|531482203|FG011|Phase 2|PARTICIPANT DECIDED TO COME OFF THE STUDY AS STUDY WAS ON HOLD. AND DECIDED TO MOVE TO SOC|0|||
147358258|NCT02240238|531482192|FG000|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
147358259|NCT02240238|531482193|FG001|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
147358260|NCT02240238|531482194|FG002|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
147358261|NCT02240238|531482195|FG003|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
147358262|NCT02240238|531482196|FG004|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
147358263|NCT02240238|531482197|FG005|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
147358264|NCT02240238|531482198|FG006|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
147358265|NCT02240238|531482199|FG007|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
147358266|NCT02240238|531482200|FG008|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
147358267|NCT02240238|531482201|FG009|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
147358268|NCT02240238|531482202|FG010|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|1|||
147358269|NCT02240238|531482203|FG011|Phase 2|CONTINUE WITH ONLY GEMCITABINE, AS PER PARTICIPANT DECISION|0|||
147358270|NCT02240238|531482192|FG000|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
147358271|NCT02240238|531482193|FG001|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
147358272|NCT02240238|531482194|FG002|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
147358273|NCT02240238|531482195|FG003|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
147358274|NCT02240238|531482196|FG004|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
147358275|NCT02240238|531482197|FG005|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
147358276|NCT02240238|531482198|FG006|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
147358277|NCT02240238|531482199|FG007|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
147358278|NCT02240238|531482200|FG008|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
147358279|NCT02240238|531482201|FG009|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
147358280|NCT02240238|531482202|FG010|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|0|||
147358281|NCT02240238|531482203|FG011|Phase 2|TREATMENT DELAY GREATER THAN 14 DAYS|1|||
147358282|NCT05216406|531482218|FG000|Overall Study|Lost to Follow-up|8|||
147358283|NCT05216406|531482219|FG001|Overall Study|Lost to Follow-up|9|||
147358284|NCT04270942|531482223|FG000|Overall Study|Death|1|||
147358285|NCT03672916|531482231|FG000|Overall Study|Death|6|||
147358286|NCT03672916|531482231|FG000|Overall Study|Lost to Follow-up|29|||
147358287|NCT03672916|531482231|FG000|Overall Study|Adverse Event|6|||
147358288|NCT03672916|531482231|FG000|Overall Study|Withdrawal by Subject|11|||
147358289|NCT04797195|531482232|FG000|Overall Study|Death|8|||
147358290|NCT04797195|531482233|FG001|Overall Study|Death|15|||
147358291|NCT04797195|531482232|FG000|Overall Study|Change from PD|15|||
147358292|NCT04797195|531482233|FG001|Overall Study|Change from PD|15|||
147358293|NCT04797195|531482232|FG000|Overall Study|Withdrawal by Subject|3|||
147358294|NCT04797195|531482233|FG001|Overall Study|Withdrawal by Subject|2|||
147358295|NCT05623228|531482235|FG000|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|1|||
147358296|NCT05623228|531482236|FG001|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|0|||
147358297|NCT05623228|531482237|FG002|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|0|||
147358298|NCT05623228|531482238|FG003|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|0|||
147358299|NCT05623228|531482239|FG004|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|0|||
147358300|NCT05623228|531482240|FG005|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|0|||
147358301|NCT05623228|531482241|FG006|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|0|||
147358302|NCT05623228|531482242|FG007|T1-T2 (11-2022-6 2023, 1 2023- 8 2023)|Anxiety|0|||
147358303|NCT05623228|531482235|FG000|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|1|||
147358304|NCT05623228|531482236|FG001|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|0|||
147358305|NCT05623228|531482237|FG002|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|1|||
147358306|NCT05623228|531482238|FG003|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|1|||
147358307|NCT05623228|531482239|FG004|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|0|||
147358308|NCT05623228|531482240|FG005|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|0|||
147358309|NCT05623228|531482241|FG006|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|0|||
147358310|NCT05623228|531482242|FG007|T1-T3 (11-2022-1-2024; 1 2023-3 2024)|Anxiety|0|||
147358311|NCT04737330|531482244|FG000|Treatment Period (Baseline to Week 16)|Lost to Follow-up|1|||
147358312|NCT04737330|531482245|FG001|Treatment Period (Baseline to Week 16)|Lost to Follow-up|0|||
147607985|NCT04988087|532380795|FG000|Overall Study|Withdrawal by Subject|1|||
147607986|NCT04988087|532380796|FG001|Overall Study|Withdrawal by Subject|1|||
147607987|NCT04988087|532380797|FG002|Overall Study|Withdrawal by Subject|0|||
147607988|NCT04988087|532380798|FG003|Overall Study|Withdrawal by Subject|0|||
147607989|NCT04988087|532380795|FG000|Overall Study|Technical problems|7|||
147607990|NCT04988087|532380796|FG001|Overall Study|Technical problems|9|||
147607991|NCT04988087|532380797|FG002|Overall Study|Technical problems|1|||
147607992|NCT04988087|532380798|FG003|Overall Study|Technical problems|2|||
147607993|NCT02752087|532380799|FG000|Washout|Physician Decision|1|||
147607994|NCT02752087|532380800|FG001|Washout|Physician Decision|0|||
147607995|NCT02458287|532380801|FG000|Overall Study|Adverse Event|0|||
147607996|NCT02458287|532380802|FG001|Overall Study|Adverse Event|0|||
147607997|NCT02458287|532380803|FG002|Overall Study|Adverse Event|0|||
147607998|NCT02458287|532380804|FG003|Overall Study|Adverse Event|1|||
147607999|NCT02458287|532380801|FG000|Overall Study|Lost to Follow-up|0|||
147608000|NCT02458287|532380802|FG001|Overall Study|Lost to Follow-up|1|||
147608001|NCT02458287|532380803|FG002|Overall Study|Lost to Follow-up|1|||
147608002|NCT02458287|532380804|FG003|Overall Study|Lost to Follow-up|0|||
147608003|NCT02458287|532380801|FG000|Overall Study|Protocol Violation|0|||
147608004|NCT02458287|532380802|FG001|Overall Study|Protocol Violation|1|||
147608005|NCT02458287|532380803|FG002|Overall Study|Protocol Violation|0|||
147608006|NCT02458287|532380804|FG003|Overall Study|Protocol Violation|0|||
147608007|NCT02458287|532380801|FG000|Overall Study|Withdrawal by Subject|0|||
147608008|NCT02458287|532380802|FG001|Overall Study|Withdrawal by Subject|2|||
147608009|NCT02458287|532380803|FG002|Overall Study|Withdrawal by Subject|2|||
147608010|NCT02458287|532380804|FG003|Overall Study|Withdrawal by Subject|1|||
147608011|NCT02458287|532380801|FG000|Overall Study|Relocated Out of State|0|||
147608012|NCT02458287|532380802|FG001|Overall Study|Relocated Out of State|0|||
147608013|NCT02458287|532380803|FG002|Overall Study|Relocated Out of State|0|||
147358313|NCT04737330|531482244|FG000|Treatment Period (Baseline to Week 16)|Study terminated by sponsor|1|||
147358314|NCT04737330|531482245|FG001|Treatment Period (Baseline to Week 16)|Study terminated by sponsor|2|||
147358315|NCT04737330|531482244|FG000|Follow-up Period (Week 16 to Week 108)|Not satisfied|1|||
147358316|NCT04737330|531482245|FG001|Follow-up Period (Week 16 to Week 108)|Not satisfied|0|||
147358317|NCT04737330|531482244|FG000|Follow-up Period (Week 16 to Week 108)|Study terminated by sponsor|3|||
147358318|NCT04737330|531482245|FG001|Follow-up Period (Week 16 to Week 108)|Study terminated by sponsor|1|||
147358319|NCT04737330|531482244|FG000|Follow-up Period (Week 16 to Week 108)|No benefit IMP|0|||
147358320|NCT04737330|531482245|FG001|Follow-up Period (Week 16 to Week 108)|No benefit IMP|1|||
147358321|NCT04737330|531482244|FG000|Follow-up Period (Week 16 to Week 108)|Therapy national guidelines|0|||
147358322|NCT04737330|531482245|FG001|Follow-up Period (Week 16 to Week 108)|Therapy national guidelines|1|||
147358323|NCT02823145|531482246|FG000|Enrollment|Other|1|||
147358324|NCT02823145|531482247|FG001|Enrollment|Other|0|||
147358325|NCT02823145|531482246|FG000|Treatment|Adverse Event|0|||
147358326|NCT02823145|531482247|FG001|Treatment|Adverse Event|11|||
147358327|NCT02823145|531482246|FG000|Treatment|Death|0|||
147358328|NCT02823145|531482247|FG001|Treatment|Death|3|||
147358329|NCT02823145|531482246|FG000|Treatment|Family Decision|0|||
147358330|NCT02823145|531482247|FG001|Treatment|Family Decision|1|||
147358331|NCT02823145|531482246|FG000|Treatment|IP approved and subject moved to commercial drug|0|||
147358332|NCT02823145|531482247|FG001|Treatment|IP approved and subject moved to commercial drug|1|||
147358333|NCT02823145|531482246|FG000|Treatment|Lack of Efficacy|0|||
147358334|NCT02823145|531482247|FG001|Treatment|Lack of Efficacy|48|||
147358335|NCT02823145|531482246|FG000|Treatment|Non-Compliance With E-Diary|0|||
147358336|NCT02823145|531482247|FG001|Treatment|Non-Compliance With E-Diary|1|||
147358337|NCT02823145|531482246|FG000|Treatment|Physician Decision|0|||
147608014|NCT02458287|532380804|FG003|Overall Study|Relocated Out of State|1|||
147608015|NCT00843635|532380805|FG000|Overall Study|Adverse Event|2|||
147608016|NCT00843635|532380806|FG001|Overall Study|Adverse Event|2|||
147608017|NCT00843635|532380807|FG002|Overall Study|Adverse Event|0|||
147608018|NCT00205803|532380809|FG000|Infant Series|Lost to Follow-up|10|||
147358338|NCT02823145|531482247|FG001|Treatment|Physician Decision|2|||
147358339|NCT02823145|531482246|FG000|Treatment|Subject has transitioned to study 1900 OLE study|0|||
147358340|NCT02823145|531482247|FG001|Treatment|Subject has transitioned to study 1900 OLE study|225|||
147358341|NCT02823145|531482246|FG000|Treatment|Subject needed to take prohibited medication|0|||
147358342|NCT02823145|531482247|FG001|Treatment|Subject needed to take prohibited medication|1|||
147608019|NCT00205803|532380810|FG001|Infant Series|Lost to Follow-up|4|||
147608020|NCT00205803|532380809|FG000|Infant Series|Withdrawal by Subject|2|||
147608021|NCT00205803|532380810|FG001|Infant Series|Withdrawal by Subject|5|||
147358343|NCT02823145|531482246|FG000|Treatment|Subject transferred to direct access programme|0|||
147358344|NCT02823145|531482247|FG001|Treatment|Subject transferred to direct access programme|1|||
147358345|NCT02823145|531482246|FG000|Treatment|Switching to commercially available drug|0|||
147358346|NCT02823145|531482247|FG001|Treatment|Switching to commercially available drug|11|||
147358347|NCT02823145|531482246|FG000|Treatment|Transitioned to commercial supply of medication|0|||
147358348|NCT02823145|531482247|FG001|Treatment|Transitioned to commercial supply of medication|1|||
147358349|NCT02823145|531482246|FG000|Treatment|Withdrawal By Caregiver|0|||
147358350|NCT02823145|531482247|FG001|Treatment|Withdrawal By Caregiver|1|||
147358351|NCT02823145|531482246|FG000|Treatment|Withdrawal by sponsor due to lack of compliance|0|||
147358352|NCT02823145|531482247|FG001|Treatment|Withdrawal by sponsor due to lack of compliance|1|||
147358353|NCT02823145|531482246|FG000|Treatment|Withdrawal by Subject|0|||
147358354|NCT02823145|531482247|FG001|Treatment|Withdrawal by Subject|16|||
147358355|NCT02823145|531482246|FG000|Treatment|Reason unknown|0|||
147358356|NCT02823145|531482247|FG001|Treatment|Reason unknown|1|||
147358357|NCT04741776|531482248|FG000|Overall Study|Withdrawal by Subject|7|||
147358358|NCT04741776|531482249|FG001|Overall Study|Withdrawal by Subject|10|||
147358359|NCT04741776|531482250|FG002|Overall Study|Withdrawal by Subject|10|||
147358360|NCT04741776|531482251|FG003|Overall Study|Withdrawal by Subject|17|||
147358361|NCT04741776|531482248|FG000|Overall Study|Death|0|||
147358362|NCT04741776|531482249|FG001|Overall Study|Death|0|||
147358363|NCT04741776|531482250|FG002|Overall Study|Death|1|||
147358364|NCT04741776|531482251|FG003|Overall Study|Death|0|||
147358365|NCT02852655|531482252|FG000|Registered and Ready to Initiate Tx|Patient deemed ineligible due to high decadron dose|0|||
147358366|NCT02852655|531482253|FG001|Registered and Ready to Initiate Tx|Patient deemed ineligible due to high decadron dose|0|||
147358367|NCT02852655|531482254|FG002|Registered and Ready to Initiate Tx|Patient deemed ineligible due to high decadron dose|1|||
147358368|NCT02852655|531482252|FG000|Registered and Ready to Initiate Tx|Withdrawal by Subject|0|||
147358369|NCT02852655|531482253|FG001|Registered and Ready to Initiate Tx|Withdrawal by Subject|0|||
147358370|NCT02852655|531482254|FG002|Registered and Ready to Initiate Tx|Withdrawal by Subject|2|||
147358371|NCT02852655|531482252|FG000|Eligible to Initiate Adjuvant MK3475|Disease Progression|1|||
147358372|NCT02852655|531482253|FG001|Eligible to Initiate Adjuvant MK3475|Disease Progression|2|||
147358373|NCT02852655|531482254|FG002|Eligible to Initiate Adjuvant MK3475|Disease Progression|2|||
147358374|NCT02852655|531482252|FG000|Eligible to Initiate Adjuvant MK3475|Surgery showed no evidence of recurrence (only treatment related changes)|0|||
147358375|NCT02852655|531482253|FG001|Eligible to Initiate Adjuvant MK3475|Surgery showed no evidence of recurrence (only treatment related changes)|1|||
147358376|NCT02852655|531482254|FG002|Eligible to Initiate Adjuvant MK3475|Surgery showed no evidence of recurrence (only treatment related changes)|0|||
147358377|NCT02852655|531482252|FG000|Adjuvant MK3475 Therapy|Disease Progression|13|||
147358378|NCT02852655|531482253|FG001|Adjuvant MK3475 Therapy|Disease Progression|21|||
147358379|NCT02852655|531482254|FG002|Adjuvant MK3475 Therapy|Disease Progression|12|||
147358380|NCT02852655|531482252|FG000|Adjuvant MK3475 Therapy|Adverse Event|1|||
147358381|NCT02852655|531482253|FG001|Adjuvant MK3475 Therapy|Adverse Event|0|||
147358382|NCT02852655|531482254|FG002|Adjuvant MK3475 Therapy|Adverse Event|0|||
147358383|NCT02852655|531482252|FG000|Adjuvant MK3475 Therapy|Withdrawal by Subject|0|||
147358384|NCT02852655|531482253|FG001|Adjuvant MK3475 Therapy|Withdrawal by Subject|1|||
147358385|NCT02852655|531482254|FG002|Adjuvant MK3475 Therapy|Withdrawal by Subject|1|||
147358386|NCT02852655|531482252|FG000|Adjuvant MK3475 Therapy|Still on Active Study Therapy|1|||
147358387|NCT02852655|531482253|FG001|Adjuvant MK3475 Therapy|Still on Active Study Therapy|0|||
147358388|NCT02852655|531482254|FG002|Adjuvant MK3475 Therapy|Still on Active Study Therapy|0|||
147358389|NCT02852655|531482252|FG000|Adjuvant MK3475 Therapy|Physician Decision|0|||
147358390|NCT02852655|531482253|FG001|Adjuvant MK3475 Therapy|Physician Decision|0|||
147358391|NCT02852655|531482254|FG002|Adjuvant MK3475 Therapy|Physician Decision|1|||
147358392|NCT05309291|531482259|FG000|Overall Study|Adverse Event|0|||
147358393|NCT05309291|531482260|FG001|Overall Study|Adverse Event|1|||
147358394|NCT05209152|531482261|FG000|Overall Study|Sponsor decision|1|||
147358395|NCT05209152|531482262|FG001|Overall Study|Sponsor decision|2|||
147358396|NCT05209152|531482261|FG000|Overall Study|Death|3|||
147608022|NCT00205803|532380809|FG000|Infant Series|Physician Decision|3|||
147608023|NCT00205803|532380810|FG001|Infant Series|Physician Decision|1|||
147608024|NCT00205803|532380809|FG000|Infant Series|Protocol Violation|1|||
147608025|NCT00205803|532380810|FG001|Infant Series|Protocol Violation|0|||
147608026|NCT00205803|532380809|FG000|Infant Series|Lost Kaiser coverage|0|||
147608027|NCT00205803|532380810|FG001|Infant Series|Lost Kaiser coverage|1|||
147608028|NCT00205803|532380809|FG000|Infant Series|Non-compliant|1|||
147358397|NCT05209152|531482262|FG001|Overall Study|Death|1|||
147358398|NCT04857723|531482264|FG000|Overall Study|Withdrawal by Subject|2|||
147358399|NCT03221426|531482265|FG000|Overall Study|Ongoing in study|212|||
147358400|NCT03221426|531482266|FG001|Overall Study|Ongoing in study|193|||
147358401|NCT03221426|531482267|FG002|Overall Study|Ongoing in study|61|||
147358402|NCT03221426|531482268|FG003|Overall Study|Ongoing in study|55|||
147358403|NCT03221426|531482265|FG000|Overall Study|Withdrawal by Subject|12|||
147358404|NCT03221426|531482266|FG001|Overall Study|Withdrawal by Subject|4|||
147358405|NCT03221426|531482267|FG002|Overall Study|Withdrawal by Subject|2|||
147358406|NCT03221426|531482268|FG003|Overall Study|Withdrawal by Subject|3|||
147358407|NCT03221426|531482265|FG000|Overall Study|Lost to Follow-up|4|||
147358408|NCT03221426|531482266|FG001|Overall Study|Lost to Follow-up|1|||
147358409|NCT03221426|531482267|FG002|Overall Study|Lost to Follow-up|1|||
147358410|NCT03221426|531482268|FG003|Overall Study|Lost to Follow-up|0|||
147358411|NCT03221426|531482265|FG000|Overall Study|Death|174|||
147358412|NCT03221426|531482266|FG001|Overall Study|Death|204|||
147358413|NCT03221426|531482267|FG002|Overall Study|Death|36|||
147358414|NCT03221426|531482268|FG003|Overall Study|Death|45|||
147358415|NCT03663569|531484682|FG000|Overall Study|Discontinuation of study|11|||
147358416|NCT03663569|531484682|FG000|Overall Study|Never taken Spiolto® Respimat®|1|||
147358417|NCT03663569|531484682|FG000|Overall Study|Deceased patient|6|||
147358418|NCT03663569|531484682|FG000|Overall Study|Lost to Follow-up|18|||
147358419|NCT03663569|531484682|FG000|Overall Study|Withdrawal of consent|5|||
147358420|NCT03663569|531484682|FG000|Overall Study|Patient's request|11|||
147358421|NCT03663569|531484682|FG000|Overall Study|Adverse Event|4|||
147358422|NCT03663569|531484682|FG000|Overall Study|Not come to second visit|3|||
147358423|NCT03663569|531484682|FG000|Overall Study|Not meet inclusion / exclusion criterion|3|||
147358424|NCT03663569|531484682|FG000|Overall Study|Serious adverse event|1|||
147358425|NCT04979442|531484683|FG000|Overall Study|Death|43|||
147358426|NCT04979442|531484684|FG001|Overall Study|Death|30|||
147358427|NCT04979442|531484683|FG000|Overall Study|Withdrawal by Subject|8|||
147358428|NCT04979442|531484684|FG001|Overall Study|Withdrawal by Subject|13|||
147358429|NCT04979442|531484683|FG000|Overall Study|Physician Decision|1|||
147358430|NCT04979442|531484684|FG001|Overall Study|Physician Decision|1|||
147358431|NCT04979442|531484683|FG000|Overall Study|Lost to Follow-up|0|||
147358432|NCT04979442|531484684|FG001|Overall Study|Lost to Follow-up|2|||
147358433|NCT04979442|531484683|FG000|Overall Study|do not want to continue|0|||
147358434|NCT04979442|531484684|FG001|Overall Study|do not want to continue|1|||
147358435|NCT04005794|531484686|FG000|Overall Study|Lost to Follow-up|0|||
147358436|NCT04005794|531484687|FG001|Overall Study|Lost to Follow-up|4|||
147358437|NCT04005794|531484688|FG002|Overall Study|Lost to Follow-up|0|||
147358438|NCT00104676|531484692|FG000|Overall Study|Death|3|||
147358439|NCT00104676|531484693|FG001|Overall Study|Death|2|||
147358440|NCT00104676|531484692|FG000|Overall Study|Withdrawal by Subject|0|||
147358441|NCT00104676|531484693|FG001|Overall Study|Withdrawal by Subject|2|||
147358442|NCT00104676|531484692|FG000|Overall Study|treatment interruption|4|||
147358443|NCT00104676|531484693|FG001|Overall Study|treatment interruption|10|||
147358444|NCT05622812|531484694|FG000|Overall Study|Withdrawal by Subject|1|||
147358445|NCT05622812|531484695|FG001|Overall Study|Withdrawal by Subject|4|||
147358446|NCT05622812|531484694|FG000|Overall Study|Lost to Follow-up|2|||
147358447|NCT05622812|531484695|FG001|Overall Study|Lost to Follow-up|1|||
147358448|NCT05297565|531484696|FG000|Overall Study|Other Reasons|0|||
147358449|NCT05297565|531484697|FG001|Overall Study|Other Reasons|1|||
147358450|NCT05297565|531484696|FG000|Overall Study|Physician Decision|0|||
147358451|NCT05297565|531484697|FG001|Overall Study|Physician Decision|1|||
147358452|NCT05297565|531484696|FG000|Overall Study|Disease recurrence|1|||
147358453|NCT05297565|531484697|FG001|Overall Study|Disease recurrence|0|||
147358454|NCT05029622|531484700|FG000|Overall Study|Lost to Follow-up|1|||
147358455|NCT01959607|531484702|FG000|First Intervention (Day 1)|Withdrawal by Subject|1|||
147358456|NCT01959607|531484703|FG001|First Intervention (Day 1)|Withdrawal by Subject|1|||
147358457|NCT01959607|531484704|FG002|First Intervention (Day 1)|Withdrawal by Subject|0|||
147358458|NCT01959607|531484705|FG003|First Intervention (Day 1)|Withdrawal by Subject|0|||
147358459|NCT03913442|531484706|FG000|Overall Study|Adverse Event|0|||
147358460|NCT03913442|531484707|FG001|Overall Study|Adverse Event|3|||
147358461|NCT03913442|531484706|FG000|Overall Study|Withdrawal by Subject|5|||
147358462|NCT03913442|531484707|FG001|Overall Study|Withdrawal by Subject|5|||
147358463|NCT03913442|531484706|FG000|Overall Study|Terminations|2|||
147358464|NCT03913442|531484707|FG001|Overall Study|Terminations|1|||
147358465|NCT03913442|531484706|FG000|Overall Study|Lost to Follow-up|2|||
147358466|NCT03913442|531484707|FG001|Overall Study|Lost to Follow-up|2|||
147608029|NCT00205803|532380810|FG001|Infant Series|Non-compliant|0|||
147608030|NCT00205803|532380809|FG000|Infant Series|Sponsor request|1|||
147608031|NCT00205803|532380810|FG001|Infant Series|Sponsor request|0|||
147608032|NCT00205803|532380809|FG000|After Infant Series|Adverse Event|1|||
147358467|NCT02433379|531484708|FG000|Overall Study|Screen Failures|55|||
147358468|NCT02433379|531484708|FG000|Overall Study|Death|57|||
147358469|NCT02433379|531484708|FG000|Overall Study|Total Withdrawals|209|||
147358470|NCT03952338|531484709|FG000|Overall Study|Lost to Follow-up|11|||
147358471|NCT03952338|531484710|FG001|Overall Study|Lost to Follow-up|17|||
147358472|NCT03952338|531484709|FG000|Overall Study|Withdrawal by Subject|1|||
147358473|NCT03952338|531484710|FG001|Overall Study|Withdrawal by Subject|1|||
147358474|NCT03952338|531484709|FG000|Overall Study|Protocol Violation|1|||
147358475|NCT03952338|531484710|FG001|Overall Study|Protocol Violation|0|||
147608033|NCT00205803|532380810|FG001|After Infant Series|Adverse Event|1|||
147608034|NCT00205803|532380809|FG000|After Infant Series|Protocol Violation|1|||
147453775|NCT05103332|531824076|FG003|OLE Period (24 Months=672 Days)|Reason Not Specified|0|||
147358476|NCT04850898|531484711|FG000|Overall Study|Inoculated with challenge virus but were not treated with IMP|1|||
147358477|NCT04850898|531484712|FG001|Overall Study|Inoculated with challenge virus but were not treated with IMP|1|||
147358478|NCT00592852|531484713|FG000|Overall Study|Non-compliance|1|||
147358479|NCT00592852|531484713|FG000|Overall Study|Adverse Event|3|||
147358480|NCT00592852|531484713|FG000|Overall Study|Found ineligible|1|||
147358481|NCT00592852|531484713|FG000|Overall Study|Withdrawal by Subject|1|||
147358482|NCT04770402|531484728|FG000|Overall Study|Lost to Follow-up|1|||
147358483|NCT04770402|531484729|FG001|Overall Study|Lost to Follow-up|2|||
147358484|NCT04770402|531484728|FG000|Overall Study|Non-compliance|1|||
147358485|NCT04770402|531484729|FG001|Overall Study|Non-compliance|0|||
147358486|NCT04770402|531484728|FG000|Overall Study|Withdrawal by Subject|0|||
147358487|NCT04770402|531484729|FG001|Overall Study|Withdrawal by Subject|1|||
147358488|NCT05274074|531484732|FG000|Overall Study|Lost to Follow-up|2|||
147358489|NCT05274074|531484733|FG001|Overall Study|Lost to Follow-up|3|||
147358490|NCT05274074|531484732|FG000|Overall Study|Withdrawal by Subject|1|||
147358491|NCT05274074|531484733|FG001|Overall Study|Withdrawal by Subject|2|||
147358492|NCT03687086|531484734|FG000|Overall Study|Withdrawal by Subject|3|||
147358493|NCT03687086|531484735|FG001|Overall Study|Withdrawal by Subject|4|||
147358494|NCT03687086|531484734|FG000|Overall Study|Lost to Follow-up|1|||
147358495|NCT03687086|531484735|FG001|Overall Study|Lost to Follow-up|1|||
147358496|NCT03687086|531484734|FG000|Overall Study|Death|1|||
147358497|NCT03687086|531484735|FG001|Overall Study|Death|0|||
147358498|NCT03687086|531484734|FG000|Overall Study|Incomplete assessment|0|||
147358499|NCT03687086|531484735|FG001|Overall Study|Incomplete assessment|2|||
147358500|NCT05194956|531484736|FG000|Washout Period|Withdrawal by Subject|0|||
147358501|NCT05194956|531484737|FG001|Washout Period|Withdrawal by Subject|2|||
147358502|NCT02505984|531484738|FG000|Overall Study|Enrolled in study under IRB Other Event (depression screening score below inclusion criteria)|1|||
147358503|NCT02505984|531484739|FG001|Overall Study|Enrolled in study under IRB Other Event (depression screening score below inclusion criteria)|0|||
147358504|NCT02505984|531484738|FG000|Overall Study|Unreliable self-report data|1|||
147358505|NCT02505984|531484739|FG001|Overall Study|Unreliable self-report data|0|||
147358506|NCT02505984|531484738|FG000|Overall Study|Study blind opened during assessment|0|||
147358507|NCT02505984|531484739|FG001|Overall Study|Study blind opened during assessment|1|||
147358508|NCT02505984|531484738|FG000|Overall Study|Noncompliance with study protocol|0|||
147358509|NCT02505984|531484739|FG001|Overall Study|Noncompliance with study protocol|1|||
147358510|NCT02593773|531484750|FG000|Overall Study|Voluntary Withdrawal|3|||
147358511|NCT02593773|531484750|FG000|Overall Study|Study Terminated by Sponsor|31|||
147358512|NCT02593773|531484750|FG000|Overall Study|Death|1|||
147358513|NCT01828099|531484753|FG000|Treatment Period|Adverse Event|24|||
147358514|NCT01828099|531484754|FG001|Treatment Period|Adverse Event|23|||
147358515|NCT01828099|531484753|FG000|Treatment Period|Death|10|||
147358516|NCT01828099|531484754|FG001|Treatment Period|Death|12|||
147358517|NCT01828099|531484753|FG000|Treatment Period|Lost to Follow-up|2|||
147358518|NCT01828099|531484754|FG001|Treatment Period|Lost to Follow-up|1|||
147358519|NCT01828099|531484753|FG000|Treatment Period|Non-compliance with study treatment|1|||
147358520|NCT01828099|531484754|FG001|Treatment Period|Non-compliance with study treatment|0|||
147358521|NCT01828099|531484753|FG000|Treatment Period|Physician Decision|17|||
147358522|NCT01828099|531484754|FG001|Treatment Period|Physician Decision|16|||
147358523|NCT01828099|531484753|FG000|Treatment Period|Progressive disease|99|||
147358524|NCT01828099|531484754|FG001|Treatment Period|Progressive disease|107|||
147358525|NCT01828099|531484753|FG000|Treatment Period|Subject/guardian decision|22|||
147358526|NCT01828099|531484754|FG001|Treatment Period|Subject/guardian decision|26|||
147358527|NCT01828099|531484753|FG000|Treatment Period|Study terminated by Sponsor|13|||
147358528|NCT01828099|531484754|FG001|Treatment Period|Study terminated by Sponsor|1|||
147358529|NCT01828099|531484753|FG000|Treatment Period|Protocol deviation|1|||
147358530|NCT01828099|531484754|FG001|Treatment Period|Protocol deviation|0|||
147358531|NCT01828099|531484753|FG000|Treatment Period|No longer requires treatment|0|||
147358532|NCT01828099|531484754|FG001|Treatment Period|No longer requires treatment|1|||
147358533|NCT01828099|531484753|FG000|Extension-treatment Phase|Adverse Event|0|||
147358534|NCT01828099|531484754|FG001|Extension-treatment Phase|Adverse Event|17|||
147358535|NCT01828099|531484753|FG000|Extension-treatment Phase|Death|0|||
147358536|NCT01828099|531484754|FG001|Extension-treatment Phase|Death|11|||
147358537|NCT01828099|531484753|FG000|Extension-treatment Phase|Physician Decision|0|||
147358538|NCT01828099|531484754|FG001|Extension-treatment Phase|Physician Decision|5|||
147608035|NCT00205803|532380810|FG001|After Infant Series|Protocol Violation|1|||
147608036|NCT00205803|532380809|FG000|After Infant Series|Lost to Follow-up|2|||
147608037|NCT00205803|532380810|FG001|After Infant Series|Lost to Follow-up|1|||
147608038|NCT00205803|532380809|FG000|After Infant Series|Physician Decision|3|||
147608039|NCT00205803|532380810|FG001|After Infant Series|Physician Decision|2|||
147608040|NCT00205803|532380809|FG000|After Infant Series|Withdrawal by Subject|1|||
147608041|NCT00205803|532380810|FG001|After Infant Series|Withdrawal by Subject|4|||
147608042|NCT00205803|532380809|FG000|After Infant Series|Other|10|||
147608043|NCT00205803|532380810|FG001|After Infant Series|Other|4|||
147608044|NCT00205803|532380809|FG000|Toddler Dose|Lost to Follow-up|2|||
147608045|NCT00205803|532380810|FG001|Toddler Dose|Lost to Follow-up|3|||
147608046|NCT03255655|532380814|FG000|Overall Study|Lost to Follow-up|7|||
147608047|NCT03255655|532380815|FG001|Overall Study|Lost to Follow-up|4|||
147608048|NCT00658021|532380816|FG000|28-Week Treatment Period|Adverse Event|3|||
147608049|NCT00658021|532380817|FG001|28-Week Treatment Period|Adverse Event|1|||
147608050|NCT00658021|532380818|FG002|28-Week Treatment Period|Adverse Event|0|||
147358539|NCT01828099|531484753|FG000|Extension-treatment Phase|Progressive disease|0|||
147358540|NCT01828099|531484754|FG001|Extension-treatment Phase|Progressive disease|54|||
147358541|NCT01828099|531484753|FG000|Extension-treatment Phase|Study terminated by sponsor|0|||
147358542|NCT01828099|531484754|FG001|Extension-treatment Phase|Study terminated by sponsor|5|||
147358543|NCT01828099|531484753|FG000|Extension-treatment Phase|Subject/guardian decision|0|||
147358544|NCT01828099|531484754|FG001|Extension-treatment Phase|Subject/guardian decision|10|||
147358545|NCT05934942|531484759|FG000|Run-in Period|Not treated|1|||
147358546|NCT05934942|531484759|FG000|Run-in Period|Withdrawal by Subject|1|||
147358547|NCT05645757|531484760|FG000|Overall Study|Enrolled but treatment not administered|0|||
147358548|NCT05645757|531484761|FG001|Overall Study|Enrolled but treatment not administered|0|||
147358549|NCT05645757|531484762|FG002|Overall Study|Enrolled but treatment not administered|0|||
147358550|NCT05645757|531484763|FG003|Overall Study|Enrolled but treatment not administered|0|||
147358551|NCT05645757|531484764|FG004|Overall Study|Enrolled but treatment not administered|1|||
147358552|NCT05645757|531484765|FG005|Overall Study|Enrolled but treatment not administered|1|||
147358553|NCT05645757|531484766|FG006|Overall Study|Enrolled but treatment not administered|0|||
147358554|NCT05645757|531484767|FG007|Overall Study|Enrolled but treatment not administered|0|||
147358555|NCT03924635|531484768|FG000|Overall Study|Withdrawal by Subject|2|||
147358556|NCT03924635|531484769|FG001|Overall Study|Withdrawal by Subject|4|||
147358557|NCT00539591|531484772|FG000|Overall Study|Toxicity|3|||
147358558|NCT00539591|531484773|FG001|Overall Study|Toxicity|0|||
147358559|NCT00539591|531484774|FG002|Overall Study|Toxicity|0|||
147358560|NCT00539591|531484772|FG000|Overall Study|Disease progression|2|||
147358561|NCT00539591|531484773|FG001|Overall Study|Disease progression|2|||
147358562|NCT00539591|531484774|FG002|Overall Study|Disease progression|3|||
147358563|NCT04362254|531484775|FG000|Overall Study|Adverse Event|1|||
147358564|NCT04362254|531484775|FG000|Overall Study|Protocol Violation|1|||
147358565|NCT04362254|531484775|FG000|Overall Study|Due to early termination of the trial|10|||
147358566|NCT04568434|531484776|FG000|Overall Study|Voluntary Withdrawal|0|||
147358567|NCT04568434|531484777|FG001|Overall Study|Voluntary Withdrawal|1|||
147358568|NCT04568434|531484778|FG002|Overall Study|Voluntary Withdrawal|1|||
147358569|NCT04568434|531484776|FG000|Overall Study|Adverse Events (AE) or Serious Adverse Events (SAE)|0|||
147358570|NCT04568434|531484777|FG001|Overall Study|Adverse Events (AE) or Serious Adverse Events (SAE)|1|||
147358571|NCT04568434|531484778|FG002|Overall Study|Adverse Events (AE) or Serious Adverse Events (SAE)|2|||
147358572|NCT04568434|531484776|FG000|Overall Study|Investigator Judgement|1|||
147358573|NCT04568434|531484777|FG001|Overall Study|Investigator Judgement|0|||
147358574|NCT04568434|531484778|FG002|Overall Study|Investigator Judgement|0|||
147358575|NCT05469464|531484779|FG000|Overall Study|Withdrawal by Subject|8|||
147358576|NCT05469464|531484780|FG001|Overall Study|Withdrawal by Subject|7|||
147358577|NCT05469464|531484781|FG002|Overall Study|Withdrawal by Subject|4|||
147358578|NCT05469464|531484782|FG003|Overall Study|Withdrawal by Subject|5|||
147358579|NCT05469464|531484779|FG000|Overall Study|Adverse Event|8|||
147358580|NCT05469464|531484780|FG001|Overall Study|Adverse Event|14|||
147453776|NCT05103332|531824077|FG004|OLE Period (24 Months=672 Days)|Reason Not Specified|0|||
147453777|NCT05103332|531824078|FG005|OLE Period (24 Months=672 Days)|Reason Not Specified|0|||
147453778|NCT05103332|531824079|FG006|OLE Period (24 Months=672 Days)|Reason Not Specified|3|||
147453779|NCT05103332|531824080|FG007|OLE Period (24 Months=672 Days)|Reason Not Specified|1|||
147453780|NCT05103332|531824081|FG008|OLE Period (24 Months=672 Days)|Reason Not Specified|0|||
147453781|NCT05103332|531824082|FG009|OLE Period (24 Months=672 Days)|Reason Not Specified|2|||
147453782|NCT05103332|531824083|FG010|OLE Period (24 Months=672 Days)|Reason Not Specified|2|||
147453783|NCT05103332|531824084|FG011|OLE Period (24 Months=672 Days)|Reason Not Specified|3|||
147453784|NCT05103332|531824085|FG012|OLE Period (24 Months=672 Days)|Reason Not Specified|0|||
147453785|NCT05103332|531824086|FG013|OLE Period (24 Months=672 Days)|Reason Not Specified|0|||
147453786|NCT05103332|531824087|FG014|OLE Period (24 Months=672 Days)|Reason Not Specified|0|||
147453787|NCT05103332|531824088|FG015|OLE Period (24 Months=672 Days)|Reason Not Specified|0|||
147453788|NCT05103332|531824089|FG016|OLE Period (24 Months=672 Days)|Reason Not Specified|0|||
147453789|NCT05103332|531824090|FG017|OLE Period (24 Months=672 Days)|Reason Not Specified|0|||
147453790|NCT05103332|531824073|FG000|SFU Period (6 Months=168 Days)|Lost to Follow-up|0|||
147608051|NCT00658021|532380816|FG000|28-Week Treatment Period|Developed study withdrawal criteria|0|||
147608052|NCT00658021|532380817|FG001|28-Week Treatment Period|Developed study withdrawal criteria|2|||
147358581|NCT05469464|531484781|FG002|Overall Study|Adverse Event|13|||
147358582|NCT05469464|531484782|FG003|Overall Study|Adverse Event|2|||
147358583|NCT05469464|531484779|FG000|Overall Study|Lost to Follow-up|2|||
147358584|NCT05469464|531484780|FG001|Overall Study|Lost to Follow-up|5|||
147358585|NCT05469464|531484781|FG002|Overall Study|Lost to Follow-up|3|||
147453791|NCT05103332|531824074|FG001|SFU Period (6 Months=168 Days)|Lost to Follow-up|0|||
147608053|NCT00658021|532380818|FG002|28-Week Treatment Period|Developed study withdrawal criteria|0|||
147358586|NCT05469464|531484782|FG003|Overall Study|Lost to Follow-up|3|||
147358587|NCT05469464|531484779|FG000|Overall Study|Lack of Efficacy|4|||
147358588|NCT05469464|531484780|FG001|Overall Study|Lack of Efficacy|1|||
147358589|NCT05469464|531484781|FG002|Overall Study|Lack of Efficacy|2|||
147358590|NCT05469464|531484782|FG003|Overall Study|Lack of Efficacy|2|||
147358591|NCT05469464|531484779|FG000|Overall Study|Physician Decision|0|||
147358592|NCT05469464|531484780|FG001|Overall Study|Physician Decision|0|||
147358593|NCT05469464|531484781|FG002|Overall Study|Physician Decision|0|||
147358594|NCT05469464|531484782|FG003|Overall Study|Physician Decision|1|||
147358595|NCT01928394|531484783|FG000|Treatment Period|Disease progression|17|||
147608054|NCT00658021|532380816|FG000|28-Week Treatment Period|Protocol Violation|0|||
147358596|NCT01928394|531484784|FG001|Treatment Period|Disease progression|2|||
147358597|NCT01928394|531484785|FG002|Treatment Period|Disease progression|12|||
147358598|NCT01928394|531484786|FG003|Treatment Period|Disease progression|48|||
147358599|NCT01928394|531484787|FG004|Treatment Period|Disease progression|3|||
147358600|NCT01928394|531484788|FG005|Treatment Period|Disease progression|25|||
147358601|NCT01928394|531484789|FG006|Treatment Period|Disease progression|38|||
147358602|NCT01928394|531484790|FG007|Treatment Period|Disease progression|16|||
147358603|NCT01928394|531484791|FG008|Treatment Period|Disease progression|3|||
147358604|NCT01928394|531484792|FG009|Treatment Period|Disease progression|11|||
147358605|NCT01928394|531484793|FG010|Treatment Period|Disease progression|22|||
147358606|NCT01928394|531484794|FG011|Treatment Period|Disease progression|73|||
147358607|NCT01928394|531484795|FG012|Treatment Period|Disease progression|38|||
147358608|NCT01928394|531484796|FG013|Treatment Period|Disease progression|118|||
147358609|NCT01928394|531484797|FG014|Treatment Period|Disease progression|59|||
147358610|NCT01928394|531484798|FG015|Treatment Period|Disease progression|1|||
147358611|NCT01928394|531484799|FG016|Treatment Period|Disease progression|43|||
147358612|NCT01928394|531484800|FG017|Treatment Period|Disease progression|56|||
147358613|NCT01928394|531484801|FG018|Treatment Period|Disease progression|50|||
147358614|NCT01928394|531484802|FG019|Treatment Period|Disease progression|71|||
147358615|NCT01928394|531484803|FG020|Treatment Period|Disease progression|30|||
147358616|NCT01928394|531484804|FG021|Treatment Period|Disease progression|31|||
147358617|NCT01928394|531484805|FG022|Treatment Period|Disease progression|31|||
147358618|NCT01928394|531484783|FG000|Treatment Period|Study drug toxicity|1|||
147358619|NCT01928394|531484784|FG001|Treatment Period|Study drug toxicity|1|||
147358620|NCT01928394|531484785|FG002|Treatment Period|Study drug toxicity|3|||
147358621|NCT01928394|531484786|FG003|Treatment Period|Study drug toxicity|3|||
147358622|NCT01928394|531484787|FG004|Treatment Period|Study drug toxicity|0|||
147358623|NCT01928394|531484788|FG005|Treatment Period|Study drug toxicity|9|||
147358624|NCT01928394|531484789|FG006|Treatment Period|Study drug toxicity|7|||
147358625|NCT01928394|531484790|FG007|Treatment Period|Study drug toxicity|1|||
147358626|NCT01928394|531484791|FG008|Treatment Period|Study drug toxicity|0|||
147358627|NCT01928394|531484792|FG009|Treatment Period|Study drug toxicity|5|||
147358628|NCT01928394|531484793|FG010|Treatment Period|Study drug toxicity|2|||
147358629|NCT01928394|531484794|FG011|Treatment Period|Study drug toxicity|3|||
147358630|NCT01928394|531484795|FG012|Treatment Period|Study drug toxicity|7|||
147358631|NCT01928394|531484796|FG013|Treatment Period|Study drug toxicity|5|||
147358632|NCT01928394|531484797|FG014|Treatment Period|Study drug toxicity|12|||
147358633|NCT01928394|531484798|FG015|Treatment Period|Study drug toxicity|0|||
147358634|NCT01928394|531484799|FG016|Treatment Period|Study drug toxicity|3|||
147358635|NCT01928394|531484800|FG017|Treatment Period|Study drug toxicity|3|||
147358636|NCT01928394|531484801|FG018|Treatment Period|Study drug toxicity|12|||
147358637|NCT01928394|531484802|FG019|Treatment Period|Study drug toxicity|15|||
147608055|NCT00658021|532380817|FG001|28-Week Treatment Period|Protocol Violation|2|||
147608056|NCT00658021|532380818|FG002|28-Week Treatment Period|Protocol Violation|1|||
147358638|NCT01928394|531484803|FG020|Treatment Period|Study drug toxicity|4|||
147358639|NCT01928394|531484804|FG021|Treatment Period|Study drug toxicity|7|||
147358640|NCT01928394|531484805|FG022|Treatment Period|Study drug toxicity|4|||
147358641|NCT01928394|531484783|FG000|Treatment Period|AE unrelated to study drug|0|||
147358642|NCT01928394|531484784|FG001|Treatment Period|AE unrelated to study drug|0|||
147608057|NCT00658021|532380816|FG000|28-Week Treatment Period|Withdrawal by Subject|1|||
147608058|NCT00658021|532380817|FG001|28-Week Treatment Period|Withdrawal by Subject|1|||
147608059|NCT00658021|532380818|FG002|28-Week Treatment Period|Withdrawal by Subject|3|||
147358643|NCT01928394|531484785|FG002|Treatment Period|AE unrelated to study drug|2|||
147358644|NCT01928394|531484786|FG003|Treatment Period|AE unrelated to study drug|3|||
147358645|NCT01928394|531484787|FG004|Treatment Period|AE unrelated to study drug|0|||
147358646|NCT01928394|531484788|FG005|Treatment Period|AE unrelated to study drug|5|||
147608060|NCT00658021|532380816|FG000|28-Week Treatment Period|Physician Decision|1|||
147608061|NCT00658021|532380817|FG001|28-Week Treatment Period|Physician Decision|2|||
147358647|NCT01928394|531484789|FG006|Treatment Period|AE unrelated to study drug|1|||
147358648|NCT01928394|531484790|FG007|Treatment Period|AE unrelated to study drug|0|||
147358649|NCT01928394|531484791|FG008|Treatment Period|AE unrelated to study drug|0|||
147358650|NCT01928394|531484792|FG009|Treatment Period|AE unrelated to study drug|2|||
147608062|NCT00658021|532380818|FG002|28-Week Treatment Period|Physician Decision|1|||
147608063|NCT00658021|532380816|FG000|28-Week Treatment Period|Withdrawal by parent/guardian|1|||
147608064|NCT00658021|532380817|FG001|28-Week Treatment Period|Withdrawal by parent/guardian|1|||
147608065|NCT00658021|532380818|FG002|28-Week Treatment Period|Withdrawal by parent/guardian|1|||
147608066|NCT00658021|532380816|FG000|28-Week Treatment Period|Loss of glucose control|1|||
147608067|NCT00658021|532380817|FG001|28-Week Treatment Period|Loss of glucose control|1|||
147608068|NCT00658021|532380818|FG002|28-Week Treatment Period|Loss of glucose control|10|||
147608069|NCT00658021|532380816|FG000|28-Week Treatment Period|Other|2|||
147608070|NCT00658021|532380817|FG001|28-Week Treatment Period|Other|3|||
147608071|NCT00658021|532380818|FG002|28-Week Treatment Period|Other|1|||
147608072|NCT00658021|532380816|FG000|28-Week Treatment Period|Did not receive treatment|2|||
147608073|NCT00658021|532380817|FG001|28-Week Treatment Period|Did not receive treatment|0|||
147608074|NCT00658021|532380818|FG002|28-Week Treatment Period|Did not receive treatment|0|||
147608075|NCT00658021|532380816|FG000|Long-term Safety Follow-up Period|Withdrawal by Subject|0|||
147608076|NCT00658021|532380817|FG001|Long-term Safety Follow-up Period|Withdrawal by Subject|1|||
147608077|NCT00658021|532380818|FG002|Long-term Safety Follow-up Period|Withdrawal by Subject|0|||
147608078|NCT00658021|532380816|FG000|Long-term Safety Follow-up Period|Physician Decision|0|||
147608079|NCT00658021|532380817|FG001|Long-term Safety Follow-up Period|Physician Decision|2|||
147608080|NCT00658021|532380818|FG002|Long-term Safety Follow-up Period|Physician Decision|0|||
147608081|NCT02203331|532380827|FG000|Overall Study|Pregnancy|1|||
147608082|NCT02203331|532380828|FG001|Overall Study|Pregnancy|0|||
147608083|NCT02203331|532380829|FG002|Overall Study|Pregnancy|0|||
147608084|NCT02203331|532380830|FG003|Overall Study|Pregnancy|0|||
147608085|NCT02203331|532380831|FG004|Overall Study|Pregnancy|2|||
147608086|NCT02203331|532380832|FG005|Overall Study|Pregnancy|0|||
147608087|NCT02203331|532380827|FG000|Overall Study|Withdrawal by Subject|1|||
147608088|NCT02203331|532380828|FG001|Overall Study|Withdrawal by Subject|0|||
147358651|NCT01928394|531484793|FG010|Treatment Period|AE unrelated to study drug|0|||
147358652|NCT01928394|531484794|FG011|Treatment Period|AE unrelated to study drug|12|||
147358653|NCT01928394|531484795|FG012|Treatment Period|AE unrelated to study drug|6|||
147358654|NCT01928394|531484796|FG013|Treatment Period|AE unrelated to study drug|13|||
147358655|NCT01928394|531484797|FG014|Treatment Period|AE unrelated to study drug|6|||
147358656|NCT01928394|531484798|FG015|Treatment Period|AE unrelated to study drug|1|||
147358657|NCT01928394|531484799|FG016|Treatment Period|AE unrelated to study drug|1|||
147358658|NCT01928394|531484800|FG017|Treatment Period|AE unrelated to study drug|6|||
147358659|NCT01928394|531484801|FG018|Treatment Period|AE unrelated to study drug|3|||
147358660|NCT01928394|531484802|FG019|Treatment Period|AE unrelated to study drug|5|||
147358661|NCT01928394|531484803|FG020|Treatment Period|AE unrelated to study drug|1|||
147358662|NCT01928394|531484804|FG021|Treatment Period|AE unrelated to study drug|1|||
147358663|NCT01928394|531484805|FG022|Treatment Period|AE unrelated to study drug|0|||
147358664|NCT01928394|531484783|FG000|Treatment Period|Participant request to stop therapy|0|||
147358665|NCT01928394|531484784|FG001|Treatment Period|Participant request to stop therapy|0|||
147358666|NCT01928394|531484785|FG002|Treatment Period|Participant request to stop therapy|0|||
147358667|NCT01928394|531484786|FG003|Treatment Period|Participant request to stop therapy|0|||
147358668|NCT01928394|531484787|FG004|Treatment Period|Participant request to stop therapy|0|||
147358669|NCT01928394|531484788|FG005|Treatment Period|Participant request to stop therapy|3|||
147358670|NCT01928394|531484789|FG006|Treatment Period|Participant request to stop therapy|3|||
147358671|NCT01928394|531484790|FG007|Treatment Period|Participant request to stop therapy|0|||
147358672|NCT01928394|531484791|FG008|Treatment Period|Participant request to stop therapy|0|||
147358673|NCT01928394|531484792|FG009|Treatment Period|Participant request to stop therapy|0|||
147358674|NCT01928394|531484793|FG010|Treatment Period|Participant request to stop therapy|3|||
147358675|NCT01928394|531484794|FG011|Treatment Period|Participant request to stop therapy|2|||
147358676|NCT01928394|531484795|FG012|Treatment Period|Participant request to stop therapy|1|||
147358677|NCT01928394|531484796|FG013|Treatment Period|Participant request to stop therapy|2|||
147358678|NCT01928394|531484797|FG014|Treatment Period|Participant request to stop therapy|4|||
147358679|NCT01928394|531484798|FG015|Treatment Period|Participant request to stop therapy|0|||
147358680|NCT01928394|531484799|FG016|Treatment Period|Participant request to stop therapy|1|||
147358681|NCT01928394|531484800|FG017|Treatment Period|Participant request to stop therapy|3|||
147453792|NCT05103332|531824075|FG002|SFU Period (6 Months=168 Days)|Lost to Follow-up|0|||
147608089|NCT02203331|532380829|FG002|Overall Study|Withdrawal by Subject|1|||
147358682|NCT01928394|531484801|FG018|Treatment Period|Participant request to stop therapy|1|||
147358683|NCT01928394|531484802|FG019|Treatment Period|Participant request to stop therapy|1|||
147358684|NCT01928394|531484803|FG020|Treatment Period|Participant request to stop therapy|3|||
147358685|NCT01928394|531484804|FG021|Treatment Period|Participant request to stop therapy|1|||
147608090|NCT02203331|532380830|FG003|Overall Study|Withdrawal by Subject|0|||
147608091|NCT02203331|532380831|FG004|Overall Study|Withdrawal by Subject|0|||
147358686|NCT01928394|531484805|FG022|Treatment Period|Participant request to stop therapy|3|||
147608092|NCT02203331|532380832|FG005|Overall Study|Withdrawal by Subject|3|||
147608093|NCT02203331|532380827|FG000|Overall Study|Adverse Event|4|||
147608094|NCT02203331|532380828|FG001|Overall Study|Adverse Event|8|||
147608095|NCT02203331|532380829|FG002|Overall Study|Adverse Event|3|||
147358687|NCT01928394|531484783|FG000|Treatment Period|Participant withdrew consent|0|||
147358688|NCT01928394|531484784|FG001|Treatment Period|Participant withdrew consent|0|||
147358689|NCT01928394|531484785|FG002|Treatment Period|Participant withdrew consent|1|||
147358690|NCT01928394|531484786|FG003|Treatment Period|Participant withdrew consent|1|||
147358691|NCT01928394|531484787|FG004|Treatment Period|Participant withdrew consent|0|||
147358692|NCT01928394|531484788|FG005|Treatment Period|Participant withdrew consent|1|||
147358693|NCT01928394|531484789|FG006|Treatment Period|Participant withdrew consent|0|||
147358694|NCT01928394|531484790|FG007|Treatment Period|Participant withdrew consent|1|||
147358695|NCT01928394|531484791|FG008|Treatment Period|Participant withdrew consent|0|||
147358696|NCT01928394|531484792|FG009|Treatment Period|Participant withdrew consent|0|||
147358697|NCT01928394|531484793|FG010|Treatment Period|Participant withdrew consent|1|||
147358698|NCT01928394|531484794|FG011|Treatment Period|Participant withdrew consent|1|||
147358699|NCT01928394|531484795|FG012|Treatment Period|Participant withdrew consent|1|||
147358700|NCT01928394|531484796|FG013|Treatment Period|Participant withdrew consent|0|||
147358701|NCT01928394|531484797|FG014|Treatment Period|Participant withdrew consent|2|||
147358702|NCT01928394|531484798|FG015|Treatment Period|Participant withdrew consent|0|||
147358703|NCT01928394|531484799|FG016|Treatment Period|Participant withdrew consent|2|||
147358704|NCT01928394|531484800|FG017|Treatment Period|Participant withdrew consent|1|||
147358705|NCT01928394|531484801|FG018|Treatment Period|Participant withdrew consent|1|||
147358706|NCT01928394|531484802|FG019|Treatment Period|Participant withdrew consent|1|||
147358707|NCT01928394|531484803|FG020|Treatment Period|Participant withdrew consent|0|||
147358708|NCT01928394|531484804|FG021|Treatment Period|Participant withdrew consent|2|||
147358709|NCT01928394|531484805|FG022|Treatment Period|Participant withdrew consent|0|||
147358710|NCT01928394|531484783|FG000|Treatment Period|Poor/non-compliance|0|||
147358711|NCT01928394|531484784|FG001|Treatment Period|Poor/non-compliance|0|||
147358712|NCT01928394|531484785|FG002|Treatment Period|Poor/non-compliance|0|||
147358713|NCT01928394|531484786|FG003|Treatment Period|Poor/non-compliance|1|||
147358714|NCT01928394|531484787|FG004|Treatment Period|Poor/non-compliance|0|||
147358715|NCT01928394|531484788|FG005|Treatment Period|Poor/non-compliance|0|||
147358716|NCT01928394|531484789|FG006|Treatment Period|Poor/non-compliance|0|||
147358717|NCT01928394|531484790|FG007|Treatment Period|Poor/non-compliance|0|||
147358718|NCT01928394|531484791|FG008|Treatment Period|Poor/non-compliance|0|||
147358719|NCT01928394|531484792|FG009|Treatment Period|Poor/non-compliance|0|||
147358720|NCT01928394|531484793|FG010|Treatment Period|Poor/non-compliance|0|||
147358721|NCT01928394|531484794|FG011|Treatment Period|Poor/non-compliance|0|||
147358722|NCT01928394|531484795|FG012|Treatment Period|Poor/non-compliance|1|||
147358723|NCT01928394|531484796|FG013|Treatment Period|Poor/non-compliance|0|||
147358724|NCT01928394|531484797|FG014|Treatment Period|Poor/non-compliance|1|||
147358725|NCT01928394|531484798|FG015|Treatment Period|Poor/non-compliance|0|||
147358726|NCT01928394|531484799|FG016|Treatment Period|Poor/non-compliance|0|||
147358727|NCT01928394|531484800|FG017|Treatment Period|Poor/non-compliance|1|||
147358728|NCT01928394|531484801|FG018|Treatment Period|Poor/non-compliance|0|||
147358729|NCT01928394|531484802|FG019|Treatment Period|Poor/non-compliance|1|||
147358730|NCT01928394|531484803|FG020|Treatment Period|Poor/non-compliance|0|||
147358731|NCT01928394|531484804|FG021|Treatment Period|Poor/non-compliance|0|||
147358732|NCT01928394|531484805|FG022|Treatment Period|Poor/non-compliance|0|||
147358733|NCT01928394|531484783|FG000|Treatment Period|other reason|0|||
147358734|NCT01928394|531484784|FG001|Treatment Period|other reason|0|||
147358735|NCT01928394|531484785|FG002|Treatment Period|other reason|0|||
147358736|NCT01928394|531484786|FG003|Treatment Period|other reason|0|||
147358737|NCT01928394|531484787|FG004|Treatment Period|other reason|0|||
147358738|NCT01928394|531484788|FG005|Treatment Period|other reason|0|||
147358739|NCT01928394|531484789|FG006|Treatment Period|other reason|0|||
147358740|NCT01928394|531484790|FG007|Treatment Period|other reason|0|||
147358741|NCT01928394|531484791|FG008|Treatment Period|other reason|0|||
147358742|NCT01928394|531484792|FG009|Treatment Period|other reason|0|||
147358743|NCT01928394|531484793|FG010|Treatment Period|other reason|1|||
147358744|NCT01928394|531484794|FG011|Treatment Period|other reason|1|||
147358745|NCT01928394|531484795|FG012|Treatment Period|other reason|1|||
147358746|NCT01928394|531484796|FG013|Treatment Period|other reason|0|||
147358747|NCT01928394|531484797|FG014|Treatment Period|other reason|1|||
147358748|NCT01928394|531484798|FG015|Treatment Period|other reason|0|||
147358749|NCT01928394|531484799|FG016|Treatment Period|other reason|0|||
147608096|NCT02203331|532380830|FG003|Overall Study|Adverse Event|4|||
147608097|NCT02203331|532380831|FG004|Overall Study|Adverse Event|3|||
147358750|NCT01928394|531484800|FG017|Treatment Period|other reason|0|||
147608098|NCT02203331|532380832|FG005|Overall Study|Adverse Event|3|||
147358751|NCT01928394|531484801|FG018|Treatment Period|other reason|2|||
147358752|NCT01928394|531484802|FG019|Treatment Period|other reason|2|||
147358753|NCT01928394|531484803|FG020|Treatment Period|other reason|0|||
147358754|NCT01928394|531484804|FG021|Treatment Period|other reason|0|||
147608099|NCT02203331|532380827|FG000|Overall Study|Other Reasons|1|||
147358755|NCT01928394|531484805|FG022|Treatment Period|other reason|0|||
147608100|NCT02203331|532380828|FG001|Overall Study|Other Reasons|2|||
147608101|NCT02203331|532380829|FG002|Overall Study|Other Reasons|0|||
147608102|NCT02203331|532380830|FG003|Overall Study|Other Reasons|2|||
147358756|NCT01928394|531484783|FG000|Treatment Period|Maximum clinical benefit|0|||
147358757|NCT01928394|531484784|FG001|Treatment Period|Maximum clinical benefit|0|||
147358758|NCT01928394|531484785|FG002|Treatment Period|Maximum clinical benefit|0|||
147358759|NCT01928394|531484786|FG003|Treatment Period|Maximum clinical benefit|0|||
147358760|NCT01928394|531484787|FG004|Treatment Period|Maximum clinical benefit|0|||
147358761|NCT01928394|531484788|FG005|Treatment Period|Maximum clinical benefit|0|||
147358762|NCT01928394|531484789|FG006|Treatment Period|Maximum clinical benefit|0|||
147358763|NCT01928394|531484790|FG007|Treatment Period|Maximum clinical benefit|0|||
147358764|NCT01928394|531484791|FG008|Treatment Period|Maximum clinical benefit|0|||
147358765|NCT01928394|531484792|FG009|Treatment Period|Maximum clinical benefit|0|||
147358766|NCT01928394|531484793|FG010|Treatment Period|Maximum clinical benefit|1|||
147358767|NCT01928394|531484794|FG011|Treatment Period|Maximum clinical benefit|1|||
147358768|NCT01928394|531484795|FG012|Treatment Period|Maximum clinical benefit|0|||
147358769|NCT01928394|531484796|FG013|Treatment Period|Maximum clinical benefit|0|||
147358770|NCT01928394|531484797|FG014|Treatment Period|Maximum clinical benefit|1|||
147358771|NCT01928394|531484798|FG015|Treatment Period|Maximum clinical benefit|0|||
147358772|NCT01928394|531484799|FG016|Treatment Period|Maximum clinical benefit|0|||
147358773|NCT01928394|531484800|FG017|Treatment Period|Maximum clinical benefit|1|||
147358774|NCT01928394|531484801|FG018|Treatment Period|Maximum clinical benefit|1|||
147358775|NCT01928394|531484802|FG019|Treatment Period|Maximum clinical benefit|0|||
147358776|NCT01928394|531484803|FG020|Treatment Period|Maximum clinical benefit|2|||
147358777|NCT01928394|531484804|FG021|Treatment Period|Maximum clinical benefit|0|||
147358778|NCT01928394|531484805|FG022|Treatment Period|Maximum clinical benefit|0|||
147358779|NCT01928394|531484783|FG000|Treatment Period|Lost to Follow-up|0|||
147358780|NCT01928394|531484784|FG001|Treatment Period|Lost to Follow-up|0|||
147358781|NCT01928394|531484785|FG002|Treatment Period|Lost to Follow-up|0|||
147358782|NCT01928394|531484786|FG003|Treatment Period|Lost to Follow-up|0|||
147358783|NCT01928394|531484787|FG004|Treatment Period|Lost to Follow-up|0|||
147358784|NCT01928394|531484788|FG005|Treatment Period|Lost to Follow-up|0|||
147358785|NCT01928394|531484789|FG006|Treatment Period|Lost to Follow-up|0|||
147358786|NCT01928394|531484790|FG007|Treatment Period|Lost to Follow-up|0|||
147358787|NCT01928394|531484791|FG008|Treatment Period|Lost to Follow-up|0|||
147358788|NCT01928394|531484792|FG009|Treatment Period|Lost to Follow-up|0|||
147358789|NCT01928394|531484793|FG010|Treatment Period|Lost to Follow-up|0|||
147358790|NCT01928394|531484794|FG011|Treatment Period|Lost to Follow-up|0|||
147358791|NCT01928394|531484795|FG012|Treatment Period|Lost to Follow-up|0|||
147358792|NCT01928394|531484796|FG013|Treatment Period|Lost to Follow-up|0|||
147358793|NCT01928394|531484797|FG014|Treatment Period|Lost to Follow-up|0|||
147358794|NCT01928394|531484798|FG015|Treatment Period|Lost to Follow-up|0|||
147358795|NCT01928394|531484799|FG016|Treatment Period|Lost to Follow-up|0|||
147358796|NCT01928394|531484800|FG017|Treatment Period|Lost to Follow-up|0|||
147358797|NCT01928394|531484801|FG018|Treatment Period|Lost to Follow-up|0|||
147358798|NCT01928394|531484802|FG019|Treatment Period|Lost to Follow-up|0|||
147358799|NCT01928394|531484803|FG020|Treatment Period|Lost to Follow-up|0|||
147358800|NCT01928394|531484804|FG021|Treatment Period|Lost to Follow-up|0|||
147358801|NCT01928394|531484805|FG022|Treatment Period|Lost to Follow-up|1|||
147358802|NCT01928394|531484783|FG000|Treatment Period|Death|0|||
147358803|NCT01928394|531484784|FG001|Treatment Period|Death|0|||
147358804|NCT01928394|531484785|FG002|Treatment Period|Death|0|||
147358805|NCT01928394|531484786|FG003|Treatment Period|Death|0|||
147358806|NCT01928394|531484787|FG004|Treatment Period|Death|0|||
147358807|NCT01928394|531484788|FG005|Treatment Period|Death|0|||
147358808|NCT01928394|531484789|FG006|Treatment Period|Death|0|||
147358809|NCT01928394|531484790|FG007|Treatment Period|Death|0|||
147358810|NCT01928394|531484791|FG008|Treatment Period|Death|0|||
147358811|NCT01928394|531484792|FG009|Treatment Period|Death|0|||
147358812|NCT01928394|531484793|FG010|Treatment Period|Death|0|||
147358813|NCT01928394|531484794|FG011|Treatment Period|Death|0|||
147358814|NCT01928394|531484795|FG012|Treatment Period|Death|0|||
147358815|NCT01928394|531484796|FG013|Treatment Period|Death|1|||
147358816|NCT01928394|531484797|FG014|Treatment Period|Death|2|||
147358817|NCT01928394|531484798|FG015|Treatment Period|Death|0|||
147358818|NCT01928394|531484799|FG016|Treatment Period|Death|0|||
147358819|NCT01928394|531484800|FG017|Treatment Period|Death|0|||
147358820|NCT01928394|531484801|FG018|Treatment Period|Death|0|||
147358821|NCT01928394|531484802|FG019|Treatment Period|Death|0|||
147358822|NCT01928394|531484803|FG020|Treatment Period|Death|0|||
147358823|NCT01928394|531484804|FG021|Treatment Period|Death|0|||
147358824|NCT01928394|531484805|FG022|Treatment Period|Death|0|||
147358825|NCT01928394|531484783|FG000|Follow-up Period|Participant withdrew consent|3|||
147358826|NCT01928394|531484784|FG001|Follow-up Period|Participant withdrew consent|0|||
147358827|NCT01928394|531484785|FG002|Follow-up Period|Participant withdrew consent|1|||
147358828|NCT01928394|531484786|FG003|Follow-up Period|Participant withdrew consent|4|||
147358829|NCT01928394|531484787|FG004|Follow-up Period|Participant withdrew consent|0|||
147358830|NCT01928394|531484788|FG005|Follow-up Period|Participant withdrew consent|2|||
147358831|NCT01928394|531484789|FG006|Follow-up Period|Participant withdrew consent|5|||
147358832|NCT01928394|531484790|FG007|Follow-up Period|Participant withdrew consent|1|||
147358833|NCT01928394|531484791|FG008|Follow-up Period|Participant withdrew consent|0|||
147358834|NCT01928394|531484792|FG009|Follow-up Period|Participant withdrew consent|0|||
147358835|NCT01928394|531484793|FG010|Follow-up Period|Participant withdrew consent|5|||
147358836|NCT01928394|531484794|FG011|Follow-up Period|Participant withdrew consent|8|||
147358837|NCT01928394|531484795|FG012|Follow-up Period|Participant withdrew consent|2|||
147358838|NCT01928394|531484796|FG013|Follow-up Period|Participant withdrew consent|12|||
147358839|NCT01928394|531484797|FG014|Follow-up Period|Participant withdrew consent|7|||
147358840|NCT01928394|531484798|FG015|Follow-up Period|Participant withdrew consent|0|||
147358841|NCT01928394|531484799|FG016|Follow-up Period|Participant withdrew consent|5|||
147358842|NCT01928394|531484800|FG017|Follow-up Period|Participant withdrew consent|3|||
147358843|NCT01928394|531484801|FG018|Follow-up Period|Participant withdrew consent|2|||
147358844|NCT01928394|531484802|FG019|Follow-up Period|Participant withdrew consent|7|||
147358845|NCT01928394|531484803|FG020|Follow-up Period|Participant withdrew consent|4|||
147358846|NCT01928394|531484804|FG021|Follow-up Period|Participant withdrew consent|6|||
147358847|NCT01928394|531484805|FG022|Follow-up Period|Participant withdrew consent|2|||
147358848|NCT01928394|531484783|FG000|Follow-up Period|Death|0|||
147358849|NCT01928394|531484784|FG001|Follow-up Period|Death|0|||
147358850|NCT01928394|531484785|FG002|Follow-up Period|Death|2|||
147358851|NCT01928394|531484786|FG003|Follow-up Period|Death|6|||
147358852|NCT01928394|531484787|FG004|Follow-up Period|Death|0|||
147358853|NCT01928394|531484788|FG005|Follow-up Period|Death|6|||
147358854|NCT01928394|531484789|FG006|Follow-up Period|Death|6|||
147358855|NCT01928394|531484790|FG007|Follow-up Period|Death|2|||
147358856|NCT01928394|531484791|FG008|Follow-up Period|Death|1|||
147358857|NCT01928394|531484792|FG009|Follow-up Period|Death|2|||
147358858|NCT01928394|531484793|FG010|Follow-up Period|Death|4|||
147358859|NCT01928394|531484794|FG011|Follow-up Period|Death|12|||
147358860|NCT01928394|531484795|FG012|Follow-up Period|Death|11|||
147358861|NCT01928394|531484796|FG013|Follow-up Period|Death|25|||
147358862|NCT01928394|531484797|FG014|Follow-up Period|Death|18|||
147358863|NCT01928394|531484798|FG015|Follow-up Period|Death|0|||
147358864|NCT01928394|531484799|FG016|Follow-up Period|Death|6|||
147358865|NCT01928394|531484800|FG017|Follow-up Period|Death|5|||
147358866|NCT01928394|531484801|FG018|Follow-up Period|Death|13|||
147358867|NCT01928394|531484802|FG019|Follow-up Period|Death|13|||
147358868|NCT01928394|531484803|FG020|Follow-up Period|Death|5|||
147358869|NCT01928394|531484804|FG021|Follow-up Period|Death|3|||
147358870|NCT01928394|531484805|FG022|Follow-up Period|Death|2|||
147358871|NCT01928394|531484783|FG000|Follow-up Period|other reason|0|||
147358872|NCT01928394|531484784|FG001|Follow-up Period|other reason|0|||
147358873|NCT01928394|531484785|FG002|Follow-up Period|other reason|0|||
147358874|NCT01928394|531484786|FG003|Follow-up Period|other reason|0|||
147358875|NCT01928394|531484787|FG004|Follow-up Period|other reason|0|||
147358876|NCT01928394|531484788|FG005|Follow-up Period|other reason|0|||
147358877|NCT01928394|531484789|FG006|Follow-up Period|other reason|1|||
147358878|NCT01928394|531484790|FG007|Follow-up Period|other reason|3|||
147358879|NCT01928394|531484791|FG008|Follow-up Period|other reason|0|||
147358880|NCT01928394|531484792|FG009|Follow-up Period|other reason|0|||
147358881|NCT01928394|531484793|FG010|Follow-up Period|other reason|2|||
147358882|NCT01928394|531484794|FG011|Follow-up Period|other reason|1|||
147358883|NCT01928394|531484795|FG012|Follow-up Period|other reason|0|||
147358884|NCT01928394|531484796|FG013|Follow-up Period|other reason|1|||
147358885|NCT01928394|531484797|FG014|Follow-up Period|other reason|4|||
147358886|NCT01928394|531484798|FG015|Follow-up Period|other reason|0|||
147358887|NCT01928394|531484799|FG016|Follow-up Period|other reason|2|||
147358888|NCT01928394|531484800|FG017|Follow-up Period|other reason|0|||
147358889|NCT01928394|531484801|FG018|Follow-up Period|other reason|1|||
147358890|NCT01928394|531484802|FG019|Follow-up Period|other reason|1|||
147358891|NCT01928394|531484803|FG020|Follow-up Period|other reason|0|||
147358892|NCT01928394|531484804|FG021|Follow-up Period|other reason|0|||
147608103|NCT02203331|532380831|FG004|Overall Study|Other Reasons|0|||
147608104|NCT02203331|532380832|FG005|Overall Study|Other Reasons|0|||
147608105|NCT02203331|532380827|FG000|Overall Study|Lack of Efficacy|0|||
147358893|NCT01928394|531484805|FG022|Follow-up Period|other reason|1|||
147358894|NCT01928394|531484783|FG000|Follow-up Period|Lost to Follow-up|0|||
147608106|NCT02203331|532380828|FG001|Overall Study|Lack of Efficacy|2|||
147608107|NCT02203331|532380829|FG002|Overall Study|Lack of Efficacy|1|||
147608108|NCT02203331|532380830|FG003|Overall Study|Lack of Efficacy|0|||
147358895|NCT01928394|531484784|FG001|Follow-up Period|Lost to Follow-up|0|||
147358896|NCT01928394|531484785|FG002|Follow-up Period|Lost to Follow-up|0|||
147608109|NCT02203331|532380831|FG004|Overall Study|Lack of Efficacy|0|||
147608110|NCT02203331|532380832|FG005|Overall Study|Lack of Efficacy|1|||
147358897|NCT01928394|531484786|FG003|Follow-up Period|Lost to Follow-up|0|||
147358898|NCT01928394|531484787|FG004|Follow-up Period|Lost to Follow-up|0|||
147358899|NCT01928394|531484788|FG005|Follow-up Period|Lost to Follow-up|0|||
147358900|NCT01928394|531484789|FG006|Follow-up Period|Lost to Follow-up|0|||
147358901|NCT01928394|531484790|FG007|Follow-up Period|Lost to Follow-up|0|||
147358902|NCT01928394|531484791|FG008|Follow-up Period|Lost to Follow-up|0|||
147358903|NCT01928394|531484792|FG009|Follow-up Period|Lost to Follow-up|0|||
147358904|NCT01928394|531484793|FG010|Follow-up Period|Lost to Follow-up|0|||
147358905|NCT01928394|531484794|FG011|Follow-up Period|Lost to Follow-up|1|||
147358906|NCT01928394|531484795|FG012|Follow-up Period|Lost to Follow-up|1|||
147358907|NCT01928394|531484796|FG013|Follow-up Period|Lost to Follow-up|0|||
147358908|NCT01928394|531484797|FG014|Follow-up Period|Lost to Follow-up|1|||
147358909|NCT01928394|531484798|FG015|Follow-up Period|Lost to Follow-up|0|||
147358910|NCT01928394|531484799|FG016|Follow-up Period|Lost to Follow-up|1|||
147358911|NCT01928394|531484800|FG017|Follow-up Period|Lost to Follow-up|0|||
147358912|NCT01928394|531484801|FG018|Follow-up Period|Lost to Follow-up|0|||
147358913|NCT01928394|531484802|FG019|Follow-up Period|Lost to Follow-up|0|||
147358914|NCT01928394|531484803|FG020|Follow-up Period|Lost to Follow-up|0|||
147358915|NCT01928394|531484804|FG021|Follow-up Period|Lost to Follow-up|0|||
147358916|NCT01928394|531484805|FG022|Follow-up Period|Lost to Follow-up|1|||
147358917|NCT02038777|531484806|FG000|Overall Study|Death|0|||
147358918|NCT02038777|531484807|FG001|Overall Study|Death|2|||
147358919|NCT02038777|531484808|FG002|Overall Study|Death|0|||
147358920|NCT02038777|531484809|FG003|Overall Study|Death|1|||
147358921|NCT02038777|531484810|FG004|Overall Study|Death|2|||
147358922|NCT02038777|531484811|FG005|Overall Study|Death|4|||
147358923|NCT02038777|531484812|FG006|Overall Study|Death|0|||
147358924|NCT02038777|531484813|FG007|Overall Study|Death|11|||
147358925|NCT02038777|531484806|FG000|Overall Study|Lost to Follow-up|0|||
147358926|NCT02038777|531484807|FG001|Overall Study|Lost to Follow-up|0|||
147358927|NCT02038777|531484808|FG002|Overall Study|Lost to Follow-up|0|||
147358928|NCT02038777|531484809|FG003|Overall Study|Lost to Follow-up|1|||
147358929|NCT02038777|531484810|FG004|Overall Study|Lost to Follow-up|0|||
147358930|NCT02038777|531484811|FG005|Overall Study|Lost to Follow-up|0|||
147358931|NCT02038777|531484812|FG006|Overall Study|Lost to Follow-up|0|||
147358932|NCT02038777|531484813|FG007|Overall Study|Lost to Follow-up|0|||
147358933|NCT02038777|531484806|FG000|Overall Study|Other|0|||
147358934|NCT02038777|531484807|FG001|Overall Study|Other|1|||
147358935|NCT02038777|531484808|FG002|Overall Study|Other|0|||
147358936|NCT02038777|531484809|FG003|Overall Study|Other|2|||
147358937|NCT02038777|531484810|FG004|Overall Study|Other|1|||
147358938|NCT02038777|531484811|FG005|Overall Study|Other|0|||
147358939|NCT02038777|531484812|FG006|Overall Study|Other|0|||
147358940|NCT02038777|531484813|FG007|Overall Study|Other|0|||
147358941|NCT02038777|531484806|FG000|Overall Study|Randomized but not treated|0|||
147358942|NCT02038777|531484807|FG001|Overall Study|Randomized but not treated|1|||
147358943|NCT02038777|531484808|FG002|Overall Study|Randomized but not treated|0|||
147358944|NCT02038777|531484809|FG003|Overall Study|Randomized but not treated|0|||
147358945|NCT02038777|531484810|FG004|Overall Study|Randomized but not treated|0|||
147358946|NCT02038777|531484811|FG005|Overall Study|Randomized but not treated|0|||
147358947|NCT02038777|531484812|FG006|Overall Study|Randomized but not treated|0|||
147358948|NCT02038777|531484813|FG007|Overall Study|Randomized but not treated|0|||
147358949|NCT02038777|531484806|FG000|Overall Study|Started Chemotherapy|1|||
147358950|NCT02038777|531484807|FG001|Overall Study|Started Chemotherapy|0|||
147358951|NCT02038777|531484808|FG002|Overall Study|Started Chemotherapy|3|||
147358952|NCT02038777|531484809|FG003|Overall Study|Started Chemotherapy|0|||
147358953|NCT02038777|531484810|FG004|Overall Study|Started Chemotherapy|0|||
147358954|NCT02038777|531484811|FG005|Overall Study|Started Chemotherapy|0|||
147358955|NCT02038777|531484812|FG006|Overall Study|Started Chemotherapy|0|||
147358956|NCT02038777|531484813|FG007|Overall Study|Started Chemotherapy|0|||
147358957|NCT02038777|531484806|FG000|Overall Study|participation terminated by sponsor|0|||
147358958|NCT02038777|531484807|FG001|Overall Study|participation terminated by sponsor|0|||
147358959|NCT02038777|531484808|FG002|Overall Study|participation terminated by sponsor|0|||
147358960|NCT02038777|531484809|FG003|Overall Study|participation terminated by sponsor|0|||
147358961|NCT02038777|531484810|FG004|Overall Study|participation terminated by sponsor|0|||
147358962|NCT02038777|531484811|FG005|Overall Study|participation terminated by sponsor|0|||
147358963|NCT02038777|531484812|FG006|Overall Study|participation terminated by sponsor|1|||
147358964|NCT02038777|531484813|FG007|Overall Study|participation terminated by sponsor|1|||
147358965|NCT04299464|531484814|FG000|Overall Study|Adverse Event|1|||
147358966|NCT04299464|531484815|FG001|Overall Study|Adverse Event|0|||
147358967|NCT04299464|531484816|FG002|Overall Study|Adverse Event|2|||
147358968|NCT04299464|531484814|FG000|Overall Study|Non-compliance with Study Drug|1|||
147358969|NCT04299464|531484815|FG001|Overall Study|Non-compliance with Study Drug|0|||
147358970|NCT04299464|531484816|FG002|Overall Study|Non-compliance with Study Drug|0|||
147358971|NCT04299464|531484814|FG000|Overall Study|Reason not Specified|0|||
147358972|NCT04299464|531484815|FG001|Overall Study|Reason not Specified|1|||
147358973|NCT04299464|531484816|FG002|Overall Study|Reason not Specified|3|||
147358974|NCT04299464|531484814|FG000|Overall Study|Physician Decision|0|||
147358975|NCT04299464|531484815|FG001|Overall Study|Physician Decision|1|||
147358976|NCT04299464|531484816|FG002|Overall Study|Physician Decision|1|||
147358977|NCT04299464|531484814|FG000|Overall Study|Withdrawal by Subject|0|||
147358978|NCT04299464|531484815|FG001|Overall Study|Withdrawal by Subject|2|||
147358979|NCT04299464|531484816|FG002|Overall Study|Withdrawal by Subject|1|||
147358980|NCT04826471|531484817|FG000|Overall Study|Lost to Follow-up|2|||
147358981|NCT04826471|531484817|FG000|Overall Study|Protocol Violation|3|||
147358982|NCT04826471|531484817|FG000|Overall Study|Withdrawal by Subject|1|||
147358983|NCT04971109|531484825|FG000|Overall Study|Adverse Event|4|||
147358984|NCT04971109|531484826|FG001|Overall Study|Adverse Event|3|||
147358985|NCT04971109|531484825|FG000|Overall Study|Failure to Meet Cont. Criteria|7|||
147358986|NCT04971109|531484826|FG001|Overall Study|Failure to Meet Cont. Criteria|0|||
147358987|NCT04971109|531484825|FG000|Overall Study|Lost to Follow-up|8|||
147358988|NCT04971109|531484826|FG001|Overall Study|Lost to Follow-up|2|||
147358989|NCT04971109|531484825|FG000|Overall Study|Physician Decision|5|||
147358990|NCT04971109|531484826|FG001|Overall Study|Physician Decision|0|||
147358991|NCT04971109|531484825|FG000|Overall Study|Protocol Violation|0|||
147358992|NCT04971109|531484826|FG001|Overall Study|Protocol Violation|1|||
147358993|NCT04971109|531484825|FG000|Overall Study|Withdrawal by Subject|18|||
147358994|NCT04971109|531484826|FG001|Overall Study|Withdrawal by Subject|3|||
147358995|NCT04971109|531484825|FG000|Overall Study|Subject was randomized in error|1|||
147358996|NCT04971109|531484826|FG001|Overall Study|Subject was randomized in error|0|||
147358997|NCT03209973|531484827|FG000|Overall Study|Withdrawal by Subject|7|||
147358998|NCT03209973|531484827|FG000|Overall Study|Lost to Follow-up|2|||
147358999|NCT03209973|531484827|FG000|Overall Study|Death|8|||
147359000|NCT03209973|531484827|FG000|Overall Study|Transferred to Long Term Extension (LTE) study|32|||
147359001|NCT03209973|531484827|FG000|Overall Study|Sponsor Decision|18|||
147359002|NCT03209973|531484827|FG000|Overall Study|Participant Withdrew Due to Higher Risk than Benefit of Treatment|1|||
147359003|NCT03209973|531484827|FG000|Overall Study|Participant Refused to Return to Treatment|2|||
147359004|NCT05123586|531484829|FG000|Overall Study|Physician Decision|1|||
147359005|NCT05123586|531484830|FG001|Overall Study|Physician Decision|1|||
147359006|NCT05123586|531484829|FG000|Overall Study|Withdrawal by Subject|0|||
147359007|NCT05123586|531484830|FG001|Overall Study|Withdrawal by Subject|3|||
147359008|NCT01651403|531484840|FG000|Double-Blind Period (Through Week 48/72)|Participant Noncompliance|1|||
147359009|NCT01651403|531484841|FG001|Double-Blind Period (Through Week 48/72)|Participant Noncompliance|1|||
147359010|NCT01651403|531484840|FG000|Double-Blind Period (Through Week 48/72)|Withdrew Consent/Assent|3|||
147359011|NCT01651403|531484841|FG001|Double-Blind Period (Through Week 48/72)|Withdrew Consent/Assent|3|||
147359012|NCT01651403|531484840|FG000|Double-Blind Period (Through Week 48/72)|Randomized but not Treated|0|||
147359013|NCT01651403|531484841|FG001|Double-Blind Period (Through Week 48/72)|Randomized but not Treated|1|||
147359014|NCT01651403|531484840|FG000|Open-Label Phase (Weeks 49/73-192)|Continuing Study|13|||
147359015|NCT01651403|531484841|FG001|Open-Label Phase (Weeks 49/73-192)|Continuing Study|9|||
147359016|NCT01651403|531484840|FG000|Open-Label Phase (Weeks 49/73-192)|Investigator decision|2|||
147359017|NCT01651403|531484841|FG001|Open-Label Phase (Weeks 49/73-192)|Investigator decision|1|||
147359018|NCT01651403|531484840|FG000|Open-Label Phase (Weeks 49/73-192)|Withdrew consent/assent|6|||
147359019|NCT01651403|531484841|FG001|Open-Label Phase (Weeks 49/73-192)|Withdrew consent/assent|4|||
147359020|NCT05090683|531484844|FG000|Overall Study|Lost to Follow-up|10|||
147359021|NCT05090683|531484845|FG001|Overall Study|Lost to Follow-up|2|||
147359022|NCT05090683|531484844|FG000|Overall Study|Withdrawal by Subject|15|||
147359023|NCT05090683|531484845|FG001|Overall Study|Withdrawal by Subject|0|||
147359024|NCT04032847|531484846|FG000|Overall Study|Study termination by sponsor|8|||
147359025|NCT04032847|531484847|FG001|Overall Study|Study termination by sponsor|0|||
147359026|NCT04032847|531484848|FG002|Overall Study|Study termination by sponsor|4|||
147359027|NCT04032847|531484846|FG000|Overall Study|Death|12|||
147359028|NCT04032847|531484847|FG001|Overall Study|Death|0|||
147359029|NCT04032847|531484848|FG002|Overall Study|Death|0|||
147359030|NCT04032847|531484846|FG000|Overall Study|Progressive disease|2|||
147359031|NCT04032847|531484847|FG001|Overall Study|Progressive disease|0|||
147359032|NCT04032847|531484848|FG002|Overall Study|Progressive disease|1|||
147359033|NCT03325985|531484849|FG000|Overall Study|Lost to Follow-up|122|||
147359034|NCT03325985|531484850|FG001|Overall Study|Lost to Follow-up|26|||
147359035|NCT03325985|531484851|FG002|Overall Study|Lost to Follow-up|141|||
147359036|NCT03325985|531484852|FG003|Overall Study|Lost to Follow-up|28|||
147359037|NCT03325985|531484849|FG000|Overall Study|Death|99|||
147359038|NCT03325985|531484850|FG001|Overall Study|Death|36|||
147359039|NCT03325985|531484851|FG002|Overall Study|Death|94|||
147359040|NCT03325985|531484852|FG003|Overall Study|Death|32|||
147359041|NCT03213665|531484853|FG000|Overall Study|Adverse Event|1|||
147359042|NCT03213665|531484853|FG000|Overall Study|Physician Decision|2|||
147359043|NCT03213665|531484853|FG000|Overall Study|Withdrawal by Subject|3|||
147453793|NCT05103332|531824076|FG003|SFU Period (6 Months=168 Days)|Lost to Follow-up|0|||
147608111|NCT02203331|532380827|FG000|Overall Study|Protocol Violation|0|||
147608112|NCT02203331|532380828|FG001|Overall Study|Protocol Violation|2|||
147608113|NCT02203331|532380829|FG002|Overall Study|Protocol Violation|0|||
147608114|NCT02203331|532380830|FG003|Overall Study|Protocol Violation|1|||
147359044|NCT03213665|531484853|FG000|Overall Study|Progressive Disease|13|||
147359045|NCT03056573|531484854|FG000|Overall Study|Death|2|||
147359046|NCT03056573|531484855|FG001|Overall Study|Death|4|||
147359047|NCT03056573|531484854|FG000|Overall Study|Withdrawal by Subject|2|||
147359048|NCT03056573|531484855|FG001|Overall Study|Withdrawal by Subject|0|||
147359049|NCT03056573|531484854|FG000|Overall Study|Lost to Follow-up|1|||
147359050|NCT03056573|531484855|FG001|Overall Study|Lost to Follow-up|1|||
147359051|NCT00323856|531484856|FG000|Overall Study|Withdrawal by Subject|1|||
147359052|NCT00323856|531484856|FG000|Overall Study|Was uncooperative and noncompliant|1|||
147359053|NCT00323856|531484856|FG000|Overall Study|Reason not specified|1|||
147359054|NCT00323856|531484856|FG000|Overall Study|Missing|2|||
147359055|NCT04086121|531484857|FG000|Overall Study|Other than listed|8|||
147359056|NCT04086121|531484857|FG000|Overall Study|Withdrawal by Subject|3|||
147359057|NCT04086121|531484857|FG000|Overall Study|Lost to Follow-up|2|||
147359058|NCT04086121|531484857|FG000|Overall Study|Adverse Event|1|||
147359059|NCT05292391|531484860|FG000|Overall Study|Lost to Follow-up|0|||
147359060|NCT05292391|531484861|FG001|Overall Study|Lost to Follow-up|0|||
147359061|NCT05292391|531484862|FG002|Overall Study|Lost to Follow-up|0|||
147359062|NCT05292391|531484863|FG003|Overall Study|Lost to Follow-up|1|||
147359063|NCT05292391|531484864|FG004|Overall Study|Lost to Follow-up|0|||
147359064|NCT05809453|531486434|FG000|Overall Study|Withdrawal by Subject|1|||
147359065|NCT05809453|531486435|FG001|Overall Study|Withdrawal by Subject|0|||
147359066|NCT05809453|531486436|FG002|Overall Study|Withdrawal by Subject|0|||
147359067|NCT05809453|531486437|FG003|Overall Study|Withdrawal by Subject|0|||
147359068|NCT03916185|531486441|FG000|Overall Study|Lost to Follow-up|0|||
147359069|NCT03916185|531486442|FG001|Overall Study|Lost to Follow-up|1|||
147359070|NCT03916185|531486443|FG002|Overall Study|Lost to Follow-up|0|||
147359071|NCT03916185|531486444|FG003|Overall Study|Lost to Follow-up|0|||
147359072|NCT03916185|531486441|FG000|Overall Study|Moved|1|||
147359073|NCT03916185|531486442|FG001|Overall Study|Moved|0|||
147359074|NCT03916185|531486443|FG002|Overall Study|Moved|0|||
147359075|NCT03916185|531486444|FG003|Overall Study|Moved|1|||
147359076|NCT03916185|531486441|FG000|Overall Study|Not Able to Get to Clinic|1|||
147359077|NCT03916185|531486442|FG001|Overall Study|Not Able to Get to Clinic|0|||
147359078|NCT03916185|531486443|FG002|Overall Study|Not Able to Get to Clinic|0|||
147359079|NCT03916185|531486444|FG003|Overall Study|Not Able to Get to Clinic|0|||
147359080|NCT02844465|531486448|FG000|Overall Study|Screen Failure|36|||
147359081|NCT02844465|531486448|FG000|Overall Study|Withdrawal Prior to Procedure|17|||
147359082|NCT02844465|531486448|FG000|Overall Study|Withdrawal by Subject|5|||
147359083|NCT02844465|531486448|FG000|Overall Study|Lost to Follow-up|1|||
147359084|NCT02844465|531486448|FG000|Overall Study|Retreatment|1|||
147359085|NCT05671653|531486449|FG000|Cohort 1 Period 6 - Treatment|Other|0|||
147359086|NCT05671653|531486450|FG001|Cohort 1 Period 6 - Treatment|Other|0|||
147359087|NCT05671653|531486451|FG002|Cohort 1 Period 6 - Treatment|Other|0|||
147359088|NCT05671653|531486452|FG003|Cohort 1 Period 6 - Treatment|Other|0|||
147359089|NCT05671653|531486453|FG004|Cohort 1 Period 6 - Treatment|Other|0|||
147359090|NCT05671653|531486454|FG005|Cohort 1 Period 6 - Treatment|Other|1|||
147359091|NCT05671653|531486455|FG006|Cohort 1 Period 6 - Treatment|Other|0|||
147359092|NCT05671653|531486456|FG007|Cohort 1 Period 6 - Treatment|Other|0|||
147359093|NCT05671653|531486457|FG008|Cohort 1 Period 6 - Treatment|Other|0|||
147359094|NCT05671653|531486458|FG009|Cohort 1 Period 6 - Treatment|Other|0|||
147359095|NCT05671653|531486459|FG010|Cohort 1 Period 6 - Treatment|Other|0|||
147359096|NCT05671653|531486460|FG011|Cohort 1 Period 6 - Treatment|Other|0|||
147359097|NCT05671653|531486461|FG012|Cohort 1 Period 6 - Treatment|Other|0|||
147359098|NCT05671653|531486449|FG000|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
147359099|NCT05671653|531486450|FG001|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
147359100|NCT05671653|531486451|FG002|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
147359101|NCT05671653|531486452|FG003|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
147359102|NCT05671653|531486453|FG004|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
147359103|NCT05671653|531486454|FG005|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|5|||
147359104|NCT05671653|531486455|FG006|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
147359105|NCT05671653|531486456|FG007|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
147359106|NCT05671653|531486457|FG008|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
147359107|NCT05671653|531486458|FG009|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
147359108|NCT05671653|531486459|FG010|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
147359109|NCT05671653|531486460|FG011|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
147359110|NCT05671653|531486461|FG012|Cohort 1 Period 6 - Treatment|Study Terminated by Sponsor|0|||
147359111|NCT05671653|531486449|FG000|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
147359112|NCT05671653|531486450|FG001|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
147359113|NCT05671653|531486451|FG002|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
147359114|NCT05671653|531486452|FG003|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
147359115|NCT05671653|531486453|FG004|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
147359116|NCT05671653|531486454|FG005|Cohort 1 Period 6 - Treatment|Adverse Event|2|||
147359117|NCT05671653|531486455|FG006|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
147359118|NCT05671653|531486456|FG007|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
147359119|NCT05671653|531486457|FG008|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
147359120|NCT05671653|531486458|FG009|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
147359121|NCT05671653|531486459|FG010|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
147359122|NCT05671653|531486460|FG011|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
147359123|NCT05671653|531486461|FG012|Cohort 1 Period 6 - Treatment|Adverse Event|0|||
147359124|NCT05671653|531486449|FG000|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
147359125|NCT05671653|531486450|FG001|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
147359126|NCT05671653|531486451|FG002|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
147359127|NCT05671653|531486452|FG003|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
147608115|NCT02203331|532380831|FG004|Overall Study|Protocol Violation|1|||
147608116|NCT02203331|532380832|FG005|Overall Study|Protocol Violation|0|||
147608117|NCT02203331|532380827|FG000|Overall Study|Lost to Follow-up|0|||
147608118|NCT02203331|532380828|FG001|Overall Study|Lost to Follow-up|0|||
147359128|NCT05671653|531486453|FG004|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
147359129|NCT05671653|531486454|FG005|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
147359130|NCT05671653|531486455|FG006|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
147359131|NCT05671653|531486456|FG007|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
147359132|NCT05671653|531486457|FG008|Cohort 1 Period 9 - Treatment|Adverse Event|1|||
147359133|NCT05671653|531486458|FG009|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
147359134|NCT05671653|531486459|FG010|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
147359135|NCT05671653|531486460|FG011|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
147359136|NCT05671653|531486461|FG012|Cohort 1 Period 9 - Treatment|Adverse Event|0|||
147359137|NCT05671653|531486449|FG000|Cohort 2 Period 2|Adverse Event|0|||
147359138|NCT05671653|531486450|FG001|Cohort 2 Period 2|Adverse Event|0|||
147359139|NCT05671653|531486451|FG002|Cohort 2 Period 2|Adverse Event|0|||
147359140|NCT05671653|531486452|FG003|Cohort 2 Period 2|Adverse Event|0|||
147359141|NCT05671653|531486453|FG004|Cohort 2 Period 2|Adverse Event|0|||
147359142|NCT05671653|531486454|FG005|Cohort 2 Period 2|Adverse Event|0|||
147359143|NCT05671653|531486455|FG006|Cohort 2 Period 2|Adverse Event|0|||
147359144|NCT05671653|531486456|FG007|Cohort 2 Period 2|Adverse Event|0|||
147359145|NCT05671653|531486457|FG008|Cohort 2 Period 2|Adverse Event|0|||
147359146|NCT05671653|531486458|FG009|Cohort 2 Period 2|Adverse Event|0|||
147608119|NCT02203331|532380829|FG002|Overall Study|Lost to Follow-up|0|||
147608120|NCT02203331|532380830|FG003|Overall Study|Lost to Follow-up|0|||
147608121|NCT02203331|532380831|FG004|Overall Study|Lost to Follow-up|1|||
147608122|NCT02203331|532380832|FG005|Overall Study|Lost to Follow-up|0|||
147608123|NCT02542605|532380837|FG000|Part B: Challenge Phase|Sponsor decision|1|||
147608124|NCT02542605|532380838|FG001|Part B: Challenge Phase|Sponsor decision|0|||
147608125|NCT02542605|532380839|FG002|Part B: Challenge Phase|Sponsor decision|0|||
147608126|NCT02542605|532380837|FG000|Part B: Randomization Phase|Withdrawal by Subject|0|||
147608127|NCT02542605|532380838|FG001|Part B: Randomization Phase|Withdrawal by Subject|0|||
147608128|NCT02542605|532380839|FG002|Part B: Randomization Phase|Withdrawal by Subject|1|||
147608129|NCT02682927|532380840|FG000|Overall Study|Adverse Event|0|||
147608130|NCT02682927|532380841|FG001|Overall Study|Adverse Event|0|||
147608131|NCT02682927|532380842|FG002|Overall Study|Adverse Event|5|||
147608132|NCT02682927|532380843|FG003|Overall Study|Adverse Event|1|||
147608133|NCT02682927|532380844|FG004|Overall Study|Adverse Event|0|||
147608134|NCT02682927|532380845|FG005|Overall Study|Adverse Event|2|||
147608135|NCT02682927|532380840|FG000|Overall Study|Death|0|||
147608136|NCT02682927|532380841|FG001|Overall Study|Death|0|||
147608137|NCT02682927|532380842|FG002|Overall Study|Death|0|||
147608138|NCT02682927|532380843|FG003|Overall Study|Death|1|||
147608139|NCT02682927|532380844|FG004|Overall Study|Death|0|||
147608140|NCT02682927|532380845|FG005|Overall Study|Death|0|||
147608141|NCT02682927|532380840|FG000|Overall Study|Lack of Efficacy|1|||
147608142|NCT02682927|532380841|FG001|Overall Study|Lack of Efficacy|0|||
147608143|NCT02682927|532380842|FG002|Overall Study|Lack of Efficacy|0|||
147608144|NCT02682927|532380843|FG003|Overall Study|Lack of Efficacy|1|||
147608145|NCT02682927|532380844|FG004|Overall Study|Lack of Efficacy|0|||
147608146|NCT02682927|532380845|FG005|Overall Study|Lack of Efficacy|0|||
147608147|NCT02682927|532380840|FG000|Overall Study|Other|0|||
147608148|NCT02682927|532380841|FG001|Overall Study|Other|0|||
147608149|NCT02682927|532380842|FG002|Overall Study|Other|0|||
147608150|NCT02682927|532380843|FG003|Overall Study|Other|2|||
147608151|NCT02682927|532380844|FG004|Overall Study|Other|0|||
147608152|NCT02682927|532380845|FG005|Overall Study|Other|0|||
147608153|NCT02682927|532380840|FG000|Overall Study|Withdrawal by Subject|2|||
147608154|NCT02682927|532380841|FG001|Overall Study|Withdrawal by Subject|0|||
147608155|NCT02682927|532380842|FG002|Overall Study|Withdrawal by Subject|1|||
147608156|NCT02682927|532380843|FG003|Overall Study|Withdrawal by Subject|0|||
147608157|NCT02682927|532380844|FG004|Overall Study|Withdrawal by Subject|1|||
147608158|NCT02682927|532380845|FG005|Overall Study|Withdrawal by Subject|1|||
147608159|NCT03462459|532380849|FG000|Overall Study|Death|1|||
147608160|NCT03462459|532380850|FG001|Overall Study|Death|0|||
147608161|NCT03462459|532380849|FG000|Overall Study|Lack of Efficacy|2|||
147608162|NCT03462459|532380850|FG001|Overall Study|Lack of Efficacy|4|||
147608163|NCT03462459|532380849|FG000|Overall Study|Lost to Follow-up|1|||
147608164|NCT03462459|532380850|FG001|Overall Study|Lost to Follow-up|3|||
147608165|NCT03462459|532380849|FG000|Overall Study|Unable to complete doses of study drug/placebo|0|||
147608166|NCT03462459|532380850|FG001|Overall Study|Unable to complete doses of study drug/placebo|3|||
147608167|NCT03462459|532380849|FG000|Overall Study|Withdrawal by Subject|3|||
147359147|NCT05671653|531486459|FG010|Cohort 2 Period 2|Adverse Event|1|||
147359148|NCT05671653|531486460|FG011|Cohort 2 Period 2|Adverse Event|0|||
147359149|NCT05671653|531486461|FG012|Cohort 2 Period 2|Adverse Event|0|||
147359150|NCT05671653|531486449|FG000|Cohort 2 Period 2|Lost to Follow-up|0|||
147359151|NCT05671653|531486450|FG001|Cohort 2 Period 2|Lost to Follow-up|0|||
147608168|NCT03462459|532380850|FG001|Overall Study|Withdrawal by Subject|2|||
147608169|NCT03462459|532380849|FG000|Overall Study|Unable to obtain stool samples at visit|0|||
147608170|NCT03462459|532380850|FG001|Overall Study|Unable to obtain stool samples at visit|1|||
147608171|NCT02551666|532380852|FG000|Overall Study|Withdrawal by Subject|1|||
147359152|NCT05671653|531486451|FG002|Cohort 2 Period 2|Lost to Follow-up|0|||
147359153|NCT05671653|531486452|FG003|Cohort 2 Period 2|Lost to Follow-up|0|||
147359154|NCT05671653|531486453|FG004|Cohort 2 Period 2|Lost to Follow-up|0|||
147359155|NCT05671653|531486454|FG005|Cohort 2 Period 2|Lost to Follow-up|0|||
147359156|NCT05671653|531486455|FG006|Cohort 2 Period 2|Lost to Follow-up|0|||
147359157|NCT05671653|531486456|FG007|Cohort 2 Period 2|Lost to Follow-up|0|||
147359158|NCT05671653|531486457|FG008|Cohort 2 Period 2|Lost to Follow-up|0|||
147359159|NCT05671653|531486458|FG009|Cohort 2 Period 2|Lost to Follow-up|0|||
147359160|NCT05671653|531486459|FG010|Cohort 2 Period 2|Lost to Follow-up|1|||
147359161|NCT05671653|531486460|FG011|Cohort 2 Period 2|Lost to Follow-up|0|||
147359162|NCT05671653|531486461|FG012|Cohort 2 Period 2|Lost to Follow-up|0|||
147359163|NCT05671653|531486449|FG000|Cohort 2 Period 2|Pregnancy|0|||
147359164|NCT05671653|531486450|FG001|Cohort 2 Period 2|Pregnancy|0|||
147359165|NCT05671653|531486451|FG002|Cohort 2 Period 2|Pregnancy|0|||
147359166|NCT05671653|531486452|FG003|Cohort 2 Period 2|Pregnancy|0|||
147359167|NCT05671653|531486453|FG004|Cohort 2 Period 2|Pregnancy|0|||
147359168|NCT05671653|531486454|FG005|Cohort 2 Period 2|Pregnancy|0|||
147359169|NCT05671653|531486455|FG006|Cohort 2 Period 2|Pregnancy|0|||
147359170|NCT05671653|531486456|FG007|Cohort 2 Period 2|Pregnancy|0|||
147359171|NCT05671653|531486457|FG008|Cohort 2 Period 2|Pregnancy|0|||
147359172|NCT05671653|531486458|FG009|Cohort 2 Period 2|Pregnancy|0|||
147359173|NCT05671653|531486459|FG010|Cohort 2 Period 2|Pregnancy|1|||
147359174|NCT05671653|531486460|FG011|Cohort 2 Period 2|Pregnancy|0|||
147359175|NCT05671653|531486461|FG012|Cohort 2 Period 2|Pregnancy|0|||
147359176|NCT05671653|531486449|FG000|Cohort 2 Period 2|Withdrawal by Subject|0|||
147359177|NCT05671653|531486450|FG001|Cohort 2 Period 2|Withdrawal by Subject|0|||
147359178|NCT05671653|531486451|FG002|Cohort 2 Period 2|Withdrawal by Subject|0|||
147359179|NCT05671653|531486452|FG003|Cohort 2 Period 2|Withdrawal by Subject|0|||
147359180|NCT05671653|531486453|FG004|Cohort 2 Period 2|Withdrawal by Subject|0|||
147359181|NCT05671653|531486454|FG005|Cohort 2 Period 2|Withdrawal by Subject|0|||
147359182|NCT05671653|531486455|FG006|Cohort 2 Period 2|Withdrawal by Subject|0|||
147359183|NCT05671653|531486456|FG007|Cohort 2 Period 2|Withdrawal by Subject|0|||
147359184|NCT05671653|531486457|FG008|Cohort 2 Period 2|Withdrawal by Subject|0|||
147359185|NCT05671653|531486458|FG009|Cohort 2 Period 2|Withdrawal by Subject|0|||
147359186|NCT05671653|531486459|FG010|Cohort 2 Period 2|Withdrawal by Subject|1|||
147359187|NCT05671653|531486460|FG011|Cohort 2 Period 2|Withdrawal by Subject|0|||
147359188|NCT05671653|531486461|FG012|Cohort 2 Period 2|Withdrawal by Subject|0|||
147359189|NCT05671653|531486449|FG000|Cohort 2 Period 2|Other|0|||
147359190|NCT05671653|531486450|FG001|Cohort 2 Period 2|Other|0|||
147359191|NCT05671653|531486451|FG002|Cohort 2 Period 2|Other|0|||
147359192|NCT05671653|531486452|FG003|Cohort 2 Period 2|Other|0|||
147359193|NCT05671653|531486453|FG004|Cohort 2 Period 2|Other|0|||
147359194|NCT05671653|531486454|FG005|Cohort 2 Period 2|Other|0|||
147359195|NCT05671653|531486455|FG006|Cohort 2 Period 2|Other|0|||
147359196|NCT05671653|531486456|FG007|Cohort 2 Period 2|Other|0|||
147359197|NCT05671653|531486457|FG008|Cohort 2 Period 2|Other|0|||
147359198|NCT05671653|531486458|FG009|Cohort 2 Period 2|Other|0|||
147359199|NCT05671653|531486459|FG010|Cohort 2 Period 2|Other|1|||
147359200|NCT05671653|531486460|FG011|Cohort 2 Period 2|Other|0|||
147359201|NCT05671653|531486461|FG012|Cohort 2 Period 2|Other|0|||
147608172|NCT02551666|532380853|FG001|Overall Study|Withdrawal by Subject|3|||
147608173|NCT01177059|532380854|FG000|Overall Study|Received placebo in OTH/OZ1-INT-1 study|30|||
147359202|NCT05671653|531486449|FG000|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
147359203|NCT05671653|531486450|FG001|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
147359204|NCT05671653|531486451|FG002|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
147359205|NCT05671653|531486452|FG003|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
147453794|NCT05103332|531824077|FG004|SFU Period (6 Months=168 Days)|Lost to Follow-up|0|||
147608174|NCT01177059|532380854|FG000|Overall Study|Withdrew consent|2|||
147608175|NCT01177059|532380854|FG000|Overall Study|Lost to Follow-up|18|||
147608176|NCT04051619|532380855|FG000|2nd Allocation (Cross Over)|Lost to Follow-up|1|||
147608177|NCT04051619|532380856|FG001|2nd Allocation (Cross Over)|Lost to Follow-up|2|||
147359206|NCT05671653|531486453|FG004|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
147359207|NCT05671653|531486454|FG005|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
147359208|NCT05671653|531486455|FG006|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
147359209|NCT05671653|531486456|FG007|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
147359210|NCT05671653|531486457|FG008|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
147359211|NCT05671653|531486458|FG009|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
147359212|NCT05671653|531486459|FG010|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
147359213|NCT05671653|531486460|FG011|Cohort 2 Period 3 - Treatment|Adverse Event|1|||
147359214|NCT05671653|531486461|FG012|Cohort 2 Period 3 - Treatment|Adverse Event|0|||
147359215|NCT01197378|531486465|FG000|Overall Study|Adverse Event|3|||
147359216|NCT01197378|531486465|FG000|Overall Study|Withdrawal by Subject|1|||
147359217|NCT01197378|531486465|FG000|Overall Study|Physician Decision|1|||
147359218|NCT01197378|531486465|FG000|Overall Study|Other|2|||
147359219|NCT06232590|531486472|FG000|Period 2: Second Intervention|Unable to attend study visit|1|||
147359220|NCT06232590|531486473|FG001|Period 2: Second Intervention|Unable to attend study visit|0|||
147359221|NCT02589795|531486474|FG000|Overall Study|Lost to Follow-up|1|||
147359222|NCT02589795|531486475|FG001|Overall Study|Lost to Follow-up|0|||
147359223|NCT02589795|531486476|FG002|Overall Study|Lost to Follow-up|0|||
147359224|NCT02589795|531486474|FG000|Overall Study|Withdrawal by Subject|0|||
147359225|NCT02589795|531486475|FG001|Overall Study|Withdrawal by Subject|0|||
147359226|NCT02589795|531486476|FG002|Overall Study|Withdrawal by Subject|2|||
147359227|NCT02589795|531486474|FG000|Overall Study|Protocol Violation|0|||
147359228|NCT02589795|531486475|FG001|Overall Study|Protocol Violation|0|||
147359229|NCT02589795|531486476|FG002|Overall Study|Protocol Violation|1|||
147359230|NCT04909801|531486477|FG000|Overall Study|Lack of Efficacy|2|||
147359231|NCT04909801|531486478|FG001|Overall Study|Lack of Efficacy|1|||
147359232|NCT04909801|531486477|FG000|Overall Study|Adverse Event|1|||
147359233|NCT04909801|531486478|FG001|Overall Study|Adverse Event|2|||
147359234|NCT04909801|531486477|FG000|Overall Study|Participant request to discontinue study treatment|1|||
147359235|NCT04909801|531486478|FG001|Overall Study|Participant request to discontinue study treatment|2|||
147359236|NCT04909801|531486477|FG000|Overall Study|Withdrawal by Subject|2|||
147359237|NCT04909801|531486478|FG001|Overall Study|Withdrawal by Subject|1|||
147359238|NCT04909801|531486477|FG000|Overall Study|other reasons|1|||
147359239|NCT04909801|531486478|FG001|Overall Study|other reasons|1|||
147359240|NCT04811040|531486479|FG000|Overall Study|Lost to Follow-up|2|||
147359241|NCT04811040|531486480|FG001|Overall Study|Lost to Follow-up|0|||
147359242|NCT04811040|531486481|FG002|Overall Study|Lost to Follow-up|0|||
147359243|NCT04811040|531486482|FG003|Overall Study|Lost to Follow-up|0|||
147359244|NCT04811040|531486479|FG000|Overall Study|Withdrew consent|1|||
147453795|NCT05103332|531824078|FG005|SFU Period (6 Months=168 Days)|Lost to Follow-up|0|||
147453796|NCT05103332|531824079|FG006|SFU Period (6 Months=168 Days)|Lost to Follow-up|0|||
147453797|NCT05103332|531824080|FG007|SFU Period (6 Months=168 Days)|Lost to Follow-up|0|||
147453798|NCT05103332|531824081|FG008|SFU Period (6 Months=168 Days)|Lost to Follow-up|0|||
147453799|NCT05103332|531824082|FG009|SFU Period (6 Months=168 Days)|Lost to Follow-up|0|||
147453800|NCT05103332|531824083|FG010|SFU Period (6 Months=168 Days)|Lost to Follow-up|0|||
147453801|NCT05103332|531824084|FG011|SFU Period (6 Months=168 Days)|Lost to Follow-up|0|||
147453802|NCT05103332|531824085|FG012|SFU Period (6 Months=168 Days)|Lost to Follow-up|2|||
147453803|NCT05103332|531824086|FG013|SFU Period (6 Months=168 Days)|Lost to Follow-up|1|||
147453804|NCT05103332|531824087|FG014|SFU Period (6 Months=168 Days)|Lost to Follow-up|5|||
147453805|NCT05103332|531824088|FG015|SFU Period (6 Months=168 Days)|Lost to Follow-up|3|||
147453806|NCT05103332|531824089|FG016|SFU Period (6 Months=168 Days)|Lost to Follow-up|4|||
147453807|NCT05103332|531824090|FG017|SFU Period (6 Months=168 Days)|Lost to Follow-up|4|||
147453808|NCT05103332|531824073|FG000|SFU Period (6 Months=168 Days)|Physician Decision|0|||
147453809|NCT05103332|531824074|FG001|SFU Period (6 Months=168 Days)|Physician Decision|0|||
147453810|NCT05103332|531824075|FG002|SFU Period (6 Months=168 Days)|Physician Decision|0|||
147453811|NCT05103332|531824076|FG003|SFU Period (6 Months=168 Days)|Physician Decision|0|||
147453812|NCT05103332|531824077|FG004|SFU Period (6 Months=168 Days)|Physician Decision|0|||
147453813|NCT05103332|531824078|FG005|SFU Period (6 Months=168 Days)|Physician Decision|0|||
147453814|NCT05103332|531824079|FG006|SFU Period (6 Months=168 Days)|Physician Decision|0|||
147453815|NCT05103332|531824080|FG007|SFU Period (6 Months=168 Days)|Physician Decision|0|||
147453816|NCT05103332|531824081|FG008|SFU Period (6 Months=168 Days)|Physician Decision|0|||
147453817|NCT05103332|531824082|FG009|SFU Period (6 Months=168 Days)|Physician Decision|0|||
147453818|NCT05103332|531824083|FG010|SFU Period (6 Months=168 Days)|Physician Decision|0|||
147453819|NCT05103332|531824084|FG011|SFU Period (6 Months=168 Days)|Physician Decision|0|||
147453820|NCT05103332|531824085|FG012|SFU Period (6 Months=168 Days)|Physician Decision|0|||
147453821|NCT05103332|531824086|FG013|SFU Period (6 Months=168 Days)|Physician Decision|0|||
147453822|NCT05103332|531824087|FG014|SFU Period (6 Months=168 Days)|Physician Decision|0|||
147453823|NCT05103332|531824088|FG015|SFU Period (6 Months=168 Days)|Physician Decision|0|||
147453824|NCT05103332|531824089|FG016|SFU Period (6 Months=168 Days)|Physician Decision|0|||
147453825|NCT05103332|531824090|FG017|SFU Period (6 Months=168 Days)|Physician Decision|1|||
147608178|NCT04051619|532380855|FG000|2nd Allocation (Cross Over)|Completed the study prior to initiation cross-over design|2|||
147608179|NCT04051619|532380856|FG001|2nd Allocation (Cross Over)|Completed the study prior to initiation cross-over design|2|||
147608180|NCT03132155|532382552|FG000|Overall Study|Lack of Efficacy|6|||
147608181|NCT03132155|532382552|FG000|Overall Study|Lost to Follow-up|1|||
147608182|NCT03132155|532382552|FG000|Overall Study|Withdrawal by Subject|1|||
147359245|NCT04811040|531486480|FG001|Overall Study|Withdrew consent|1|||
147359246|NCT04811040|531486481|FG002|Overall Study|Withdrew consent|0|||
147359247|NCT04811040|531486482|FG003|Overall Study|Withdrew consent|0|||
147359248|NCT00321048|531486484|FG000|Overall Study|Withdrawal by Subject|6|||
147359249|NCT00321048|531486485|FG001|Overall Study|Withdrawal by Subject|8|||
147359250|NCT05370040|531486488|FG000|Overall Study|Lost to Follow-up|0|||
147453826|NCT05103332|531824073|FG000|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
147453827|NCT05103332|531824074|FG001|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
147453828|NCT05103332|531824075|FG002|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
147608183|NCT02925403|532382556|FG000|Overall Study|Lost to Follow-up|0|||
147608184|NCT02925403|532382557|FG001|Overall Study|Lost to Follow-up|1|||
147608185|NCT04778904|532382558|FG000|Overall Study|Protocol Violation|1|||
147608186|NCT04778904|532382559|FG001|Overall Study|Protocol Violation|0|||
147608187|NCT04778904|532382560|FG002|Overall Study|Protocol Violation|0|||
147608188|NCT04778904|532382561|FG003|Overall Study|Protocol Violation|0|||
147608189|NCT04778904|532382558|FG000|Overall Study|Withdrawal by Subject|0|||
147359251|NCT05370040|531486489|FG001|Overall Study|Lost to Follow-up|0|||
147608190|NCT04778904|532382559|FG001|Overall Study|Withdrawal by Subject|0|||
147608191|NCT04778904|532382560|FG002|Overall Study|Withdrawal by Subject|1|||
147608192|NCT04778904|532382561|FG003|Overall Study|Withdrawal by Subject|0|||
147608193|NCT03452137|532382562|FG000|Overall Study|Death|67|||
147608194|NCT03452137|532382563|FG001|Overall Study|Death|70|||
147608195|NCT03452137|532382562|FG000|Overall Study|Lost to Follow-up|4|||
147608196|NCT03452137|532382563|FG001|Overall Study|Lost to Follow-up|2|||
147608197|NCT03452137|532382562|FG000|Overall Study|Physician Decision|0|||
147359252|NCT05370040|531486490|FG002|Overall Study|Lost to Follow-up|1|||
147359253|NCT05370040|531486491|FG003|Overall Study|Lost to Follow-up|0|||
147359254|NCT05370040|531486492|FG004|Overall Study|Lost to Follow-up|1|||
147359255|NCT05370040|531486493|FG005|Overall Study|Lost to Follow-up|0|||
147359256|NCT04024020|531486498|FG000|Overall Study|Withdrawal by Subject|2|||
147359257|NCT04024020|531486499|FG001|Overall Study|Withdrawal by Subject|2|||
147359258|NCT00746096|531486508|FG000|Overall Study|Adverse Event|1|||
147359259|NCT00746096|531486509|FG001|Overall Study|Adverse Event|0|||
147359260|NCT00746096|531486508|FG000|Overall Study|Withdrawal by Subject|5|||
147359261|NCT00746096|531486509|FG001|Overall Study|Withdrawal by Subject|1|||
147359262|NCT00746096|531486508|FG000|Overall Study|Lost to Follow-up|2|||
147359263|NCT00746096|531486509|FG001|Overall Study|Lost to Follow-up|1|||
147359264|NCT00746096|531486508|FG000|Overall Study|Protocol Violation|1|||
147359265|NCT00746096|531486509|FG001|Overall Study|Protocol Violation|0|||
147359266|NCT00746096|531486508|FG000|Overall Study|No study drug treatment|1|||
147359267|NCT00746096|531486509|FG001|Overall Study|No study drug treatment|1|||
147359268|NCT02296684|531486510|FG000|Overall Study|Withdrawal by Subject|0|||
147359269|NCT02296684|531486511|FG001|Overall Study|Withdrawal by Subject|1|||
147359270|NCT02296684|531486512|FG002|Overall Study|Withdrawal by Subject|1|||
147359271|NCT02296684|531486510|FG000|Overall Study|Death|2|||
147359272|NCT02296684|531486511|FG001|Overall Study|Death|0|||
147359273|NCT02296684|531486512|FG002|Overall Study|Death|0|||
147359274|NCT03571581|531486513|FG000|Overall Study|Death|2|||
147359275|NCT03571581|531486513|FG000|Overall Study|Withdrawal by Subject|2|||
147359276|NCT03295721|531486518|FG000|Overall Study|Adverse Event|1|||
147359277|NCT03295721|531486519|FG001|Overall Study|Adverse Event|0|||
147359278|NCT03295721|531486520|FG002|Overall Study|Adverse Event|0|||
147359279|NCT03295721|531486518|FG000|Overall Study|Lost to Follow-up|1|||
147359280|NCT03295721|531486519|FG001|Overall Study|Lost to Follow-up|1|||
147359281|NCT03295721|531486520|FG002|Overall Study|Lost to Follow-up|1|||
147359282|NCT03295721|531486518|FG000|Overall Study|Withdrawal by Subject|1|||
147359283|NCT03295721|531486519|FG001|Overall Study|Withdrawal by Subject|0|||
147359284|NCT03295721|531486520|FG002|Overall Study|Withdrawal by Subject|1|||
147359285|NCT03295721|531486518|FG000|Overall Study|Death|0|||
147359286|NCT03295721|531486519|FG001|Overall Study|Death|0|||
147359287|NCT03295721|531486520|FG002|Overall Study|Death|1|||
147359288|NCT00429364|531486523|FG000|Overall Study|Withdrawal by Subject|11|||
147359289|NCT00429364|531486524|FG001|Overall Study|Withdrawal by Subject|5|||
147359290|NCT00429364|531486523|FG000|Overall Study|Physician Decision|4|||
147359291|NCT00429364|531486524|FG001|Overall Study|Physician Decision|2|||
147359292|NCT00429364|531486523|FG000|Overall Study|Lost to Follow-up|7|||
147359293|NCT00429364|531486524|FG001|Overall Study|Lost to Follow-up|6|||
147359294|NCT00429364|531486523|FG000|Overall Study|Death|0|||
147359295|NCT00429364|531486524|FG001|Overall Study|Death|1|||
147359296|NCT00429364|531486523|FG000|Overall Study|Underwent aortic root surgery|10|||
147608198|NCT03452137|532382563|FG001|Overall Study|Physician Decision|1|||
147608199|NCT03452137|532382562|FG000|Overall Study|Study Terminated by Sponsor|120|||
147608200|NCT03452137|532382563|FG001|Overall Study|Study Terminated by Sponsor|121|||
147608201|NCT03452137|532382562|FG000|Overall Study|Withdrawal by Subject|12|||
147608202|NCT03452137|532382563|FG001|Overall Study|Withdrawal by Subject|9|||
147359297|NCT00429364|531486524|FG001|Overall Study|Underwent aortic root surgery|18|||
147359298|NCT00429364|531486523|FG000|Overall Study|Pregnancy|0|||
147359299|NCT00429364|531486524|FG001|Overall Study|Pregnancy|1|||
147359300|NCT04871529|531486525|FG000|Overall Study|Withdrawal by Subject|0|||
147359301|NCT04871529|531486526|FG001|Overall Study|Withdrawal by Subject|1|||
147359302|NCT04871529|531486525|FG000|Overall Study|Death|0|||
147359303|NCT04871529|531486526|FG001|Overall Study|Death|1|||
147359304|NCT04871529|531486525|FG000|Overall Study|Not protocol specified|0|||
147359305|NCT04871529|531486526|FG001|Overall Study|Not protocol specified|1|||
147359306|NCT05184452|531486527|FG000|Overall Study|Lost to Follow-up|0|||
147359307|NCT05184452|531486528|FG001|Overall Study|Lost to Follow-up|0|||
147359308|NCT05184452|531486529|FG002|Overall Study|Lost to Follow-up|0|||
147359309|NCT05184452|531486530|FG003|Overall Study|Lost to Follow-up|0|||
147608203|NCT04138043|532382564|FG000|Overall Study|Withdrawal by Subject|0|||
147608204|NCT04138043|532382565|FG001|Overall Study|Withdrawal by Subject|1|||
147608205|NCT03772717|532382566|FG000|Overall Study|Withdrawal by Subject|2|||
147608206|NCT02856802|532382567|FG000|Double-Blind Treatment Period 1|Withdrawal by Subject|0|||
147608207|NCT02856802|532382568|FG001|Double-Blind Treatment Period 1|Withdrawal by Subject|2|||
147608208|NCT02856802|532382567|FG000|Double-Blind Treatment Period 1|Lost to Follow-up|1|||
147608209|NCT02856802|532382568|FG001|Double-Blind Treatment Period 1|Lost to Follow-up|0|||
147608210|NCT02856802|532382567|FG000|Double-Blind Treatment Period 1|Protocol Violation|0|||
147359310|NCT05184452|531486531|FG004|Overall Study|Lost to Follow-up|0|||
147359311|NCT05184452|531486532|FG005|Overall Study|Lost to Follow-up|2|||
147359312|NCT05184452|531486533|FG006|Overall Study|Lost to Follow-up|0|||
147359313|NCT05184452|531486534|FG007|Overall Study|Lost to Follow-up|0|||
147608211|NCT02856802|532382568|FG001|Double-Blind Treatment Period 1|Protocol Violation|1|||
147359314|NCT05184452|531486535|FG008|Overall Study|Lost to Follow-up|0|||
147359315|NCT05184452|531486536|FG009|Overall Study|Lost to Follow-up|1|||
147359316|NCT05184452|531486527|FG000|Overall Study|Withdrawal by Subject|0|||
147359317|NCT05184452|531486528|FG001|Overall Study|Withdrawal by Subject|0|||
147359318|NCT05184452|531486529|FG002|Overall Study|Withdrawal by Subject|0|||
147359319|NCT05184452|531486530|FG003|Overall Study|Withdrawal by Subject|0|||
147359320|NCT05184452|531486531|FG004|Overall Study|Withdrawal by Subject|0|||
147359321|NCT05184452|531486532|FG005|Overall Study|Withdrawal by Subject|1|||
147359322|NCT05184452|531486533|FG006|Overall Study|Withdrawal by Subject|0|||
147359323|NCT05184452|531486534|FG007|Overall Study|Withdrawal by Subject|0|||
147359324|NCT05184452|531486535|FG008|Overall Study|Withdrawal by Subject|0|||
147359325|NCT05184452|531486536|FG009|Overall Study|Withdrawal by Subject|1|||
147359326|NCT05586490|531486537|FG000|Completed Aim 3 - Research Device Arm|Withdrawal by Subject|0|||
147359327|NCT05586490|531486538|FG001|Completed Aim 3 - Research Device Arm|Withdrawal by Subject|0|||
147359328|NCT05586490|531486539|FG002|Completed Aim 3 - Research Device Arm|Withdrawal by Subject|1|||
147359329|NCT05586490|531486540|FG003|Completed Aim 3 - Research Device Arm|Withdrawal by Subject|0|||
147359330|NCT05586490|531486541|FG004|Completed Aim 3 - Research Device Arm|Withdrawal by Subject|0|||
147359331|NCT05586490|531486537|FG000|Completed Aim 3 - Alternate Device Arm|Withdrawal by Subject|1|||
147359332|NCT05586490|531486538|FG001|Completed Aim 3 - Alternate Device Arm|Withdrawal by Subject|0|||
147359333|NCT05586490|531486539|FG002|Completed Aim 3 - Alternate Device Arm|Withdrawal by Subject|0|||
147359334|NCT05586490|531486540|FG003|Completed Aim 3 - Alternate Device Arm|Withdrawal by Subject|0|||
147359335|NCT05586490|531486541|FG004|Completed Aim 3 - Alternate Device Arm|Withdrawal by Subject|0|||
147359336|NCT05586490|531486537|FG000|Completed Aim 3 - No Device Arm|Withdrawal by Subject|1|||
147359337|NCT05586490|531486538|FG001|Completed Aim 3 - No Device Arm|Withdrawal by Subject|0|||
147359338|NCT05586490|531486539|FG002|Completed Aim 3 - No Device Arm|Withdrawal by Subject|0|||
147359339|NCT05586490|531486540|FG003|Completed Aim 3 - No Device Arm|Withdrawal by Subject|0|||
147359340|NCT05586490|531486541|FG004|Completed Aim 3 - No Device Arm|Withdrawal by Subject|0|||
147359341|NCT03034356|531486542|FG000|Baseline|Lost to Follow-up|2|||
147359342|NCT03034356|531486543|FG001|Baseline|Lost to Follow-up|4|||
147359343|NCT03034356|531486542|FG000|Baseline|Withdrawal by Subject|2|||
147359344|NCT03034356|531486543|FG001|Baseline|Withdrawal by Subject|0|||
147359345|NCT03034356|531486542|FG000|Baseline|Physician Decision|0|||
147359346|NCT03034356|531486543|FG001|Baseline|Physician Decision|1|||
147359347|NCT03034356|531486542|FG000|Post-Intervention 1 (4 Weeks)|Lost to Follow-up|1|||
147359348|NCT03034356|531486543|FG001|Post-Intervention 1 (4 Weeks)|Lost to Follow-up|0|||
147359349|NCT03034356|531486542|FG000|Post-Intervention 1 (4 Weeks)|Withdrawal by Subject|1|||
147359350|NCT03034356|531486543|FG001|Post-Intervention 1 (4 Weeks)|Withdrawal by Subject|2|||
147359351|NCT03034356|531486542|FG000|Post-Intervention 1 (4 Weeks)|Physician Decision|1|||
147359352|NCT03034356|531486543|FG001|Post-Intervention 1 (4 Weeks)|Physician Decision|0|||
147359353|NCT03034356|531486542|FG000|Post-Washout (4 Weeks)|Withdrawal by Subject|2|||
147359354|NCT03034356|531486543|FG001|Post-Washout (4 Weeks)|Withdrawal by Subject|0|||
147359355|NCT02684227|531486544|FG000|Overall Study|Adverse Event|1|||
147359356|NCT02684227|531486545|FG001|Overall Study|Adverse Event|7|||
147359357|NCT02684227|531486544|FG000|Overall Study|Death|0|||
147359358|NCT02684227|531486545|FG001|Overall Study|Death|2|||
147359359|NCT02684227|531486544|FG000|Overall Study|Withdrawal by Subject|0|||
147359360|NCT02684227|531486545|FG001|Overall Study|Withdrawal by Subject|1|||
147359361|NCT02684227|531486544|FG000|Overall Study|Progressive Disease|0|||
147453829|NCT05103332|531824076|FG003|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
147608212|NCT02856802|532382567|FG000|Double-Blind Treatment Period 1|Sponsor terminated|1|||
147608213|NCT02856802|532382568|FG001|Double-Blind Treatment Period 1|Sponsor terminated|0|||
147608214|NCT02856802|532382567|FG000|Double-Blind Treatment Period 1|Lack of diary compliance|0|||
147608215|NCT02856802|532382568|FG001|Double-Blind Treatment Period 1|Lack of diary compliance|2|||
147608216|NCT02856802|532382567|FG000|Double-Blind Treatment Period 2|Lost to Follow-up|1|||
147359362|NCT02684227|531486545|FG001|Overall Study|Progressive Disease|2|||
147359363|NCT04689256|531486547|FG000|Overall Study|Participants declined to participate in the interventions per protocol|2|||
147359364|NCT04689256|531486548|FG001|Overall Study|Participants declined to participate in the interventions per protocol|0|||
147359365|NCT05267470|531486551|FG000|Overall Study|Decision by sponsor|0|||
147359366|NCT05267470|531486552|FG001|Overall Study|Decision by sponsor|3|||
147359367|NCT05267470|531486553|FG002|Overall Study|Decision by sponsor|19|||
147359368|NCT05267470|531486554|FG003|Overall Study|Decision by sponsor|7|||
147359369|NCT05267470|531486555|FG004|Overall Study|Decision by sponsor|3|||
147359370|NCT05267470|531486551|FG000|Overall Study|Withdrawal by Subject|1|||
147359371|NCT05267470|531486552|FG001|Overall Study|Withdrawal by Subject|1|||
147359372|NCT05267470|531486553|FG002|Overall Study|Withdrawal by Subject|2|||
147359373|NCT05267470|531486554|FG003|Overall Study|Withdrawal by Subject|2|||
147359374|NCT05267470|531486555|FG004|Overall Study|Withdrawal by Subject|0|||
147359375|NCT05267470|531486551|FG000|Overall Study|Death|3|||
147359376|NCT05267470|531486552|FG001|Overall Study|Death|5|||
147359377|NCT05267470|531486553|FG002|Overall Study|Death|8|||
147359378|NCT05267470|531486554|FG003|Overall Study|Death|18|||
147359379|NCT05267470|531486555|FG004|Overall Study|Death|1|||
147359380|NCT05267470|531486551|FG000|Overall Study|Lost to Follow-up|0|||
147359381|NCT05267470|531486552|FG001|Overall Study|Lost to Follow-up|0|||
147359382|NCT05267470|531486553|FG002|Overall Study|Lost to Follow-up|0|||
147359383|NCT05267470|531486554|FG003|Overall Study|Lost to Follow-up|1|||
147359384|NCT05267470|531486555|FG004|Overall Study|Lost to Follow-up|0|||
147359385|NCT05828017|531486556|FG000|Review of Intake and Hearing Test Result|Removed by Investigator due to hearing loss change and no longer meeting study criteria.|1|||
147359386|NCT04428203|531486557|FG000|Overall Study|Adverse Event|1|||
147359387|NCT04428203|531486558|FG001|Overall Study|Adverse Event|0|||
147359388|NCT04428203|531486559|FG002|Overall Study|Adverse Event|0|||
147359389|NCT04428203|531486557|FG000|Overall Study|Withdrawal by Subject|1|||
147359390|NCT04428203|531486558|FG001|Overall Study|Withdrawal by Subject|0|||
147359391|NCT04428203|531486559|FG002|Overall Study|Withdrawal by Subject|1|||
147453830|NCT05103332|531824077|FG004|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
147453831|NCT05103332|531824078|FG005|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
147453832|NCT05103332|531824079|FG006|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
147453833|NCT05103332|531824080|FG007|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
147453834|NCT05103332|531824081|FG008|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
147453835|NCT05103332|531824082|FG009|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
147453836|NCT05103332|531824083|FG010|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
147453837|NCT05103332|531824084|FG011|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|0|||
147453838|NCT05103332|531824085|FG012|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|4|||
147453839|NCT05103332|531824086|FG013|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|3|||
147453840|NCT05103332|531824087|FG014|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|1|||
147453841|NCT05103332|531824088|FG015|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|7|||
147453842|NCT05103332|531824089|FG016|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|6|||
147453843|NCT05103332|531824090|FG017|SFU Period (6 Months=168 Days)|Participant Stopped Participation in the Study|5|||
147453844|NCT05103332|531824073|FG000|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
147453845|NCT05103332|531824074|FG001|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
147453846|NCT05103332|531824075|FG002|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
147453847|NCT05103332|531824076|FG003|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
147453848|NCT05103332|531824077|FG004|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
147453849|NCT05103332|531824078|FG005|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
147453850|NCT05103332|531824079|FG006|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
147453851|NCT05103332|531824080|FG007|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
147453852|NCT05103332|531824081|FG008|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
147453853|NCT05103332|531824082|FG009|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
147453854|NCT05103332|531824083|FG010|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
147453855|NCT05103332|531824084|FG011|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
147453856|NCT05103332|531824085|FG012|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
147453857|NCT05103332|531824086|FG013|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
147453858|NCT05103332|531824087|FG014|SFU Period (6 Months=168 Days)|Reason Not Specified|1|||
147453859|NCT05103332|531824088|FG015|SFU Period (6 Months=168 Days)|Reason Not Specified|1|||
147453860|NCT05103332|531824089|FG016|SFU Period (6 Months=168 Days)|Reason Not Specified|0|||
147453861|NCT05103332|531824090|FG017|SFU Period (6 Months=168 Days)|Reason Not Specified|2|||
147453862|NCT05103332|531824073|FG000|SFU Period (6 Months=168 Days)|Death|0|||
147453863|NCT05103332|531824074|FG001|SFU Period (6 Months=168 Days)|Death|0|||
147608217|NCT02856802|532382568|FG001|Double-Blind Treatment Period 2|Lost to Follow-up|0|||
147359392|NCT04571619|531486560|FG000|Phase 1|Death|22|||
147453864|NCT05103332|531824075|FG002|SFU Period (6 Months=168 Days)|Death|0|||
147453865|NCT05103332|531824076|FG003|SFU Period (6 Months=168 Days)|Death|0|||
147453866|NCT05103332|531824077|FG004|SFU Period (6 Months=168 Days)|Death|0|||
147359393|NCT04571619|531486561|FG001|Phase 1|Death|18|||
147359394|NCT04571619|531486560|FG000|Phase 1|Withdrawal by Subject|7|||
147359395|NCT04571619|531486561|FG001|Phase 1|Withdrawal by Subject|2|||
147359396|NCT04571619|531486560|FG000|Phase 2|Death|13|||
147359397|NCT04571619|531486561|FG001|Phase 2|Death|16|||
147359398|NCT04571619|531486560|FG000|Phase 2|Withdrawal by Subject|6|||
147359399|NCT04571619|531486561|FG001|Phase 2|Withdrawal by Subject|4|||
147359400|NCT02361216|531486562|FG000|3 Day Treatment and 8 Week Follow/up|Lack of Efficacy|0|||
147359401|NCT02361216|531486563|FG001|3 Day Treatment and 8 Week Follow/up|Lack of Efficacy|1|||
147359402|NCT02361216|531486562|FG000|3 Day Treatment and 8 Week Follow/up|Adverse Event|1|||
147359403|NCT02361216|531486563|FG001|3 Day Treatment and 8 Week Follow/up|Adverse Event|2|||
147359404|NCT02361216|531486562|FG000|3 Day Treatment and 8 Week Follow/up|Unacceptable Local Skin Reaction (LSR)|1|||
147359405|NCT02361216|531486563|FG001|3 Day Treatment and 8 Week Follow/up|Unacceptable Local Skin Reaction (LSR)|0|||
147359406|NCT02361216|531486562|FG000|3 Day Treatment and 8 Week Follow/up|Withdrawal by Subject|6|||
147359407|NCT02361216|531486563|FG001|3 Day Treatment and 8 Week Follow/up|Withdrawal by Subject|11|||
147359408|NCT02361216|531486562|FG000|3 Day Treatment and 8 Week Follow/up|Trial site closed|3|||
147359409|NCT02361216|531486563|FG001|3 Day Treatment and 8 Week Follow/up|Trial site closed|3|||
147359410|NCT02361216|531486562|FG000|3 Day Treatment and 8 Week Follow/up|Lost to Follow-up|0|||
147359411|NCT02361216|531486563|FG001|3 Day Treatment and 8 Week Follow/up|Lost to Follow-up|2|||
147359412|NCT02460458|531487991|FG000|Confirmatory Phase|Patients excluded basing on phenotype central analysis|31|||
147359413|NCT02460458|531487991|FG000|Confirmatory Phase|Lack of sample to analyse|19|||
147359414|NCT02460458|531487991|FG000|Confirmatory Phase|Patients excluded due to lack of central characterized VWD mutations|5|||
147359415|NCT02460458|531487991|FG000|First Prospective Phase|Lost to Follow-up|84|||
147359416|NCT02460458|531487991|FG000|Confirmation of Clinical Phase Data|Lost to Follow-up|34|||
147359417|NCT04550221|531487995|FG000|Overall Study|Lost to Follow-up|0|||
147359418|NCT04550221|531487996|FG001|Overall Study|Lost to Follow-up|4|||
147359419|NCT04550221|531487995|FG000|Overall Study|Withdrawn|3|||
147359420|NCT04550221|531487996|FG001|Overall Study|Withdrawn|0|||
147359421|NCT04550221|531487995|FG000|Overall Study|Moved from the study area after receiving the intervention|2|||
147359422|NCT04550221|531487996|FG001|Overall Study|Moved from the study area after receiving the intervention|0|||
147359423|NCT04447040|531487997|FG000|Overall Study|Lost to Follow-up|2|||
147359424|NCT04447040|531487998|FG001|Overall Study|Lost to Follow-up|1|||
147359425|NCT04447040|531487999|FG002|Overall Study|Lost to Follow-up|3|||
147359426|NCT04447040|531488000|FG003|Overall Study|Lost to Follow-up|3|||
147359427|NCT04447040|531488001|FG004|Overall Study|Lost to Follow-up|1|||
147359428|NCT04447040|531488002|FG005|Overall Study|Lost to Follow-up|3|||
147359429|NCT04447040|531487997|FG000|Overall Study|Withdrawal by Subject|0|||
147359430|NCT04447040|531487998|FG001|Overall Study|Withdrawal by Subject|1|||
147359431|NCT04447040|531487999|FG002|Overall Study|Withdrawal by Subject|1|||
147359432|NCT04447040|531488000|FG003|Overall Study|Withdrawal by Subject|1|||
147359433|NCT04447040|531488001|FG004|Overall Study|Withdrawal by Subject|0|||
147359434|NCT04447040|531488002|FG005|Overall Study|Withdrawal by Subject|0|||
147453867|NCT05103332|531824078|FG005|SFU Period (6 Months=168 Days)|Death|0|||
147453868|NCT05103332|531824079|FG006|SFU Period (6 Months=168 Days)|Death|0|||
147453869|NCT05103332|531824080|FG007|SFU Period (6 Months=168 Days)|Death|0|||
147359438|NCT01208662|531488006|FG000|Induction and Consolidation|Disease Progression|23|||
147359439|NCT01208662|531488007|FG001|Induction and Consolidation|Disease Progression|13|||
147359440|NCT01208662|531488008|FG002|Induction and Consolidation|Disease Progression|0|||
147359441|NCT01208662|531488006|FG000|Induction and Consolidation|Adverse Event|16|||
147359442|NCT01208662|531488007|FG001|Induction and Consolidation|Adverse Event|18|||
147359443|NCT01208662|531488008|FG002|Induction and Consolidation|Adverse Event|2|||
147359444|NCT01208662|531488006|FG000|Induction and Consolidation|MD or Participant Decision|16|||
147359445|NCT01208662|531488007|FG001|Induction and Consolidation|MD or Participant Decision|34|||
147359446|NCT01208662|531488008|FG002|Induction and Consolidation|MD or Participant Decision|4|||
147359447|NCT01208662|531488006|FG000|Induction and Consolidation|Death|1|||
147359448|NCT01208662|531488007|FG001|Induction and Consolidation|Death|3|||
147359449|NCT01208662|531488008|FG002|Induction and Consolidation|Death|1|||
147359450|NCT01208662|531488006|FG000|Induction and Consolidation|Discontinued for other reasons|10|||
147359451|NCT01208662|531488007|FG001|Induction and Consolidation|Discontinued for other reasons|8|||
147359452|NCT01208662|531488008|FG002|Induction and Consolidation|Discontinued for other reasons|0|||
147359453|NCT01208662|531488006|FG000|Maintenance|Disease Progression|156|||
147359454|NCT01208662|531488007|FG001|Maintenance|Disease Progression|102|||
147359455|NCT01208662|531488008|FG002|Maintenance|Disease Progression|0|||
147359456|NCT01208662|531488006|FG000|Maintenance|Adverse Event|12|||
147359457|NCT01208662|531488007|FG001|Maintenance|Adverse Event|28|||
147359458|NCT01208662|531488008|FG002|Maintenance|Adverse Event|0|||
147359459|NCT01208662|531488006|FG000|Maintenance|MD or Participant Decision|24|||
147359460|NCT01208662|531488007|FG001|Maintenance|MD or Participant Decision|36|||
147453870|NCT05103332|531824081|FG008|SFU Period (6 Months=168 Days)|Death|0|||
147453871|NCT05103332|531824082|FG009|SFU Period (6 Months=168 Days)|Death|0|||
147453872|NCT05103332|531824083|FG010|SFU Period (6 Months=168 Days)|Death|0|||
147453873|NCT05103332|531824084|FG011|SFU Period (6 Months=168 Days)|Death|0|||
147453874|NCT05103332|531824085|FG012|SFU Period (6 Months=168 Days)|Death|0|||
147453875|NCT05103332|531824086|FG013|SFU Period (6 Months=168 Days)|Death|0|||
147453876|NCT05103332|531824087|FG014|SFU Period (6 Months=168 Days)|Death|1|||
147359461|NCT01208662|531488008|FG002|Maintenance|MD or Participant Decision|0|||
147359462|NCT01208662|531488006|FG000|Maintenance|Death|0|||
147359463|NCT01208662|531488007|FG001|Maintenance|Death|3|||
147359464|NCT01208662|531488008|FG002|Maintenance|Death|0|||
147359465|NCT01208662|531488006|FG000|Maintenance|Discontinued for other reasons|21|||
147359466|NCT01208662|531488007|FG001|Maintenance|Discontinued for other reasons|31|||
147359467|NCT01208662|531488008|FG002|Maintenance|Discontinued for other reasons|0|||
147359468|NCT01208662|531488006|FG000|Maintenance|Still on Treatment|78|||
147359469|NCT01208662|531488007|FG001|Maintenance|Still on Treatment|89|||
147359470|NCT01208662|531488008|FG002|Maintenance|Still on Treatment|0|||
147359471|NCT04076618|531488009|FG000|Overall Study|Lost to Follow-up|2|||
147359472|NCT04076618|531488010|FG001|Overall Study|Lost to Follow-up|1|||
147359473|NCT04076618|531488011|FG002|Overall Study|Lost to Follow-up|3|||
147359474|NCT04076618|531488009|FG000|Overall Study|Withdrawal by Subject|3|||
147359475|NCT04076618|531488010|FG001|Overall Study|Withdrawal by Subject|1|||
147359476|NCT04076618|531488011|FG002|Overall Study|Withdrawal by Subject|2|||
147359477|NCT04076618|531488009|FG000|Overall Study|Relocated out of state|0|||
147359478|NCT04076618|531488010|FG001|Overall Study|Relocated out of state|2|||
147359479|NCT04076618|531488011|FG002|Overall Study|Relocated out of state|0|||
147359480|NCT04076618|531488009|FG000|Overall Study|COVID concerns|0|||
147359481|NCT04076618|531488010|FG001|Overall Study|COVID concerns|1|||
147359482|NCT04076618|531488011|FG002|Overall Study|COVID concerns|0|||
147359483|NCT04076618|531488009|FG000|Overall Study|Adverse Event|0|||
147359484|NCT04076618|531488010|FG001|Overall Study|Adverse Event|0|||
147359485|NCT04076618|531488011|FG002|Overall Study|Adverse Event|2|||
147359486|NCT04778397|531488012|FG000|Overall Study|Death|59|||
147359487|NCT04778397|531488013|FG001|Overall Study|Death|54|||
147359488|NCT04778397|531488014|FG002|Overall Study|Death|11|||
147359489|NCT04778397|531488015|FG003|Overall Study|Death|9|||
147359490|NCT04778397|531488012|FG000|Overall Study|Study Terminated by Sponsor|34|||
147359491|NCT04778397|531488013|FG001|Overall Study|Study Terminated by Sponsor|42|||
147359492|NCT04778397|531488014|FG002|Overall Study|Study Terminated by Sponsor|15|||
147453877|NCT05103332|531824088|FG015|SFU Period (6 Months=168 Days)|Death|0|||
147453878|NCT05103332|531824089|FG016|SFU Period (6 Months=168 Days)|Death|0|||
147453879|NCT05103332|531824090|FG017|SFU Period (6 Months=168 Days)|Death|1|||
147453880|NCT04428476|531824091|FG000|Overall Study|Withdrawal by Subject|1|||
147453881|NCT04428476|531824091|FG000|Overall Study|Still on treatment|12|||
147453882|NCT04982250|531824093|FG000|Overall Study|Lost to Follow-up|0|||
147453883|NCT04982250|531824094|FG001|Overall Study|Lost to Follow-up|26|||
147453884|NCT04982250|531824095|FG002|Overall Study|Lost to Follow-up|0|||
147453885|NCT04982250|531824096|FG003|Overall Study|Lost to Follow-up|0|||
147453886|NCT04982250|531824097|FG004|Overall Study|Lost to Follow-up|72|||
147453887|NCT04982250|531824098|FG005|Overall Study|Lost to Follow-up|69|||
147453888|NCT04982250|531824093|FG000|Overall Study|Not Eligible to Enroll|0|||
147453889|NCT04982250|531824094|FG001|Overall Study|Not Eligible to Enroll|0|||
147453890|NCT04982250|531824095|FG002|Overall Study|Not Eligible to Enroll|0|||
147453891|NCT04982250|531824096|FG003|Overall Study|Not Eligible to Enroll|0|||
147453892|NCT04982250|531824097|FG004|Overall Study|Not Eligible to Enroll|10|||
147453893|NCT04982250|531824098|FG005|Overall Study|Not Eligible to Enroll|7|||
147453894|NCT01358864|531824108|FG000|Overall Study|Adverse Event|0|||
147453895|NCT01358864|531824109|FG001|Overall Study|Adverse Event|6|||
147453896|NCT01358864|531824110|FG002|Overall Study|Adverse Event|9|||
147453897|NCT01358864|531824111|FG003|Overall Study|Adverse Event|0|||
147453898|NCT01358864|531824112|FG004|Overall Study|Adverse Event|4|||
147453899|NCT01358864|531824113|FG005|Overall Study|Adverse Event|8|||
147453900|NCT01358864|531824114|FG006|Overall Study|Adverse Event|12|||
147453901|NCT01358864|531824115|FG007|Overall Study|Adverse Event|7|||
147453902|NCT01358864|531824108|FG000|Overall Study|Lack of Efficacy|26|||
147453903|NCT01358864|531824109|FG001|Overall Study|Lack of Efficacy|3|||
147453904|NCT01358864|531824110|FG002|Overall Study|Lack of Efficacy|4|||
147453905|NCT01358864|531824111|FG003|Overall Study|Lack of Efficacy|19|||
147453906|NCT01358864|531824112|FG004|Overall Study|Lack of Efficacy|7|||
147453907|NCT01358864|531824113|FG005|Overall Study|Lack of Efficacy|4|||
147453908|NCT01358864|531824114|FG006|Overall Study|Lack of Efficacy|49|||
147453909|NCT01358864|531824115|FG007|Overall Study|Lack of Efficacy|44|||
147453910|NCT01358864|531824108|FG000|Overall Study|Lost to Follow-up|0|||
147453911|NCT01358864|531824109|FG001|Overall Study|Lost to Follow-up|0|||
147453912|NCT01358864|531824110|FG002|Overall Study|Lost to Follow-up|1|||
147453913|NCT01358864|531824111|FG003|Overall Study|Lost to Follow-up|0|||
147453914|NCT01358864|531824112|FG004|Overall Study|Lost to Follow-up|0|||
147453915|NCT01358864|531824113|FG005|Overall Study|Lost to Follow-up|0|||
147453916|NCT01358864|531824114|FG006|Overall Study|Lost to Follow-up|0|||
147453917|NCT01358864|531824115|FG007|Overall Study|Lost to Follow-up|1|||
147453918|NCT01358864|531824108|FG000|Overall Study|Withdrawal by Subject|3|||
147453919|NCT01358864|531824109|FG001|Overall Study|Withdrawal by Subject|4|||
147453920|NCT01358864|531824110|FG002|Overall Study|Withdrawal by Subject|2|||
147453921|NCT01358864|531824111|FG003|Overall Study|Withdrawal by Subject|0|||
147453922|NCT01358864|531824112|FG004|Overall Study|Withdrawal by Subject|0|||
147453923|NCT01358864|531824113|FG005|Overall Study|Withdrawal by Subject|1|||
147359493|NCT04778397|531488015|FG003|Overall Study|Study Terminated by Sponsor|12|||
147359494|NCT04778397|531488012|FG000|Overall Study|Withdrew Consent|5|||
147359495|NCT04778397|531488013|FG001|Overall Study|Withdrew Consent|4|||
147359496|NCT04778397|531488014|FG002|Overall Study|Withdrew Consent|1|||
147359497|NCT04778397|531488015|FG003|Overall Study|Withdrew Consent|1|||
147359498|NCT04778397|531488012|FG000|Overall Study|Reason Not Specified|1|||
147359499|NCT04778397|531488013|FG001|Overall Study|Reason Not Specified|3|||
147359500|NCT04778397|531488014|FG002|Overall Study|Reason Not Specified|0|||
147359501|NCT04778397|531488015|FG003|Overall Study|Reason Not Specified|2|||
147359502|NCT04778397|531488012|FG000|Overall Study|Lost to Follow-up|2|||
147359503|NCT04778397|531488013|FG001|Overall Study|Lost to Follow-up|1|||
147359504|NCT04778397|531488014|FG002|Overall Study|Lost to Follow-up|0|||
147359505|NCT04778397|531488015|FG003|Overall Study|Lost to Follow-up|1|||
147359506|NCT01627574|531488016|FG000|Overall Study|Withdrawal by Subject|8|||
147359507|NCT01627574|531488017|FG001|Overall Study|Withdrawal by Subject|5|||
147359508|NCT01627574|531488016|FG000|Overall Study|Lost to Follow-up|13|||
147359509|NCT01627574|531488017|FG001|Overall Study|Lost to Follow-up|13|||
147359510|NCT03249090|531488027|FG000|Enrollment|Excluded after randomization for ineligibility|4|||
147359511|NCT03249090|531488028|FG001|Enrollment|Excluded after randomization for ineligibility|2|||
147359512|NCT03249090|531488027|FG000|3 Month Time Point|Death, hospice, discontinued therapy|41|||
147359513|NCT03249090|531488028|FG001|3 Month Time Point|Death, hospice, discontinued therapy|37|||
147359514|NCT03249090|531488027|FG000|3 Month Time Point|Voluntary withdrawal|6|||
147359515|NCT03249090|531488028|FG001|3 Month Time Point|Voluntary withdrawal|3|||
147359516|NCT03249090|531488027|FG000|3 Month Time Point|Changed oncology practice|4|||
147359517|NCT03249090|531488028|FG001|3 Month Time Point|Changed oncology practice|2|||
147359518|NCT03249090|531488027|FG000|12 Month Time Point|Death, hospice, discontinued therapy|172|||
147359519|NCT03249090|531488028|FG001|12 Month Time Point|Death, hospice, discontinued therapy|175|||
147359520|NCT03249090|531488027|FG000|12 Month Time Point|Voluntary withdrawal|35|||
147359521|NCT03249090|531488028|FG001|12 Month Time Point|Voluntary withdrawal|4|||
147359522|NCT03249090|531488027|FG000|12 Month Time Point|Changed oncology practice|20|||
147359523|NCT03249090|531488028|FG001|12 Month Time Point|Changed oncology practice|9|||
147359524|NCT04359654|531488031|FG000|Overall Study|Withdrawal by Subject|1|||
147359525|NCT04359654|531488032|FG001|Overall Study|Withdrawal by Subject|0|||
147359526|NCT04359654|531488031|FG000|Overall Study|Adverse Event|0|||
147359527|NCT04359654|531488032|FG001|Overall Study|Adverse Event|1|||
147359528|NCT06122194|531488033|FG000|Treatment Period 1 (3 Days)|Adverse Event|0|||
147359529|NCT06122194|531488034|FG001|Treatment Period 1 (3 Days)|Adverse Event|0|||
147359530|NCT06122194|531488035|FG002|Treatment Period 1 (3 Days)|Adverse Event|1|||
147359531|NCT06122194|531488036|FG003|Treatment Period 1 (3 Days)|Adverse Event|0|||
147359532|NCT04314778|531488037|FG000|Overall Study|Lost to Follow-up|5|||
147359533|NCT04314778|531488038|FG001|Overall Study|Lost to Follow-up|3|||
147359534|NCT05218096|531488039|FG000|Primary Evaluation|Withdrawal by Subject|0|||
147359535|NCT05218096|531488040|FG001|Primary Evaluation|Withdrawal by Subject|0|||
147359536|NCT05218096|531488041|FG002|Primary Evaluation|Withdrawal by Subject|2|||
147359537|NCT05218096|531488042|FG003|Primary Evaluation|Withdrawal by Subject|0|||
147359538|NCT05218096|531488043|FG004|Primary Evaluation|Withdrawal by Subject|0|||
147453924|NCT01358864|531824114|FG006|Overall Study|Withdrawal by Subject|1|||
147453925|NCT01358864|531824115|FG007|Overall Study|Withdrawal by Subject|3|||
147359539|NCT05218096|531488039|FG000|Primary Evaluation|Physician Decision|1|||
147359540|NCT05218096|531488040|FG001|Primary Evaluation|Physician Decision|0|||
147359541|NCT05218096|531488041|FG002|Primary Evaluation|Physician Decision|0|||
147359542|NCT05218096|531488042|FG003|Primary Evaluation|Physician Decision|0|||
147359543|NCT05218096|531488043|FG004|Primary Evaluation|Physician Decision|0|||
147359544|NCT05218096|531488039|FG000|Extended Treatment|Clinical Deterioration|1|||
147359545|NCT05218096|531488040|FG001|Extended Treatment|Clinical Deterioration|1|||
147453926|NCT01358864|531824108|FG000|Overall Study|Other reason not defined above|2|||
147453927|NCT01358864|531824109|FG001|Overall Study|Other reason not defined above|0|||
147453928|NCT01358864|531824110|FG002|Overall Study|Other reason not defined above|0|||
147453929|NCT01358864|531824111|FG003|Overall Study|Other reason not defined above|0|||
147453930|NCT01358864|531824112|FG004|Overall Study|Other reason not defined above|0|||
147453931|NCT01358864|531824113|FG005|Overall Study|Other reason not defined above|0|||
147453932|NCT01358864|531824114|FG006|Overall Study|Other reason not defined above|2|||
147453933|NCT01358864|531824115|FG007|Overall Study|Other reason not defined above|0|||
147453934|NCT01358864|531824108|FG000|Overall Study|Not treated|0|||
147453935|NCT01358864|531824109|FG001|Overall Study|Not treated|0|||
147453936|NCT01358864|531824110|FG002|Overall Study|Not treated|0|||
147453937|NCT01358864|531824111|FG003|Overall Study|Not treated|0|||
147453938|NCT01358864|531824112|FG004|Overall Study|Not treated|0|||
147453939|NCT01358864|531824113|FG005|Overall Study|Not treated|0|||
147453940|NCT01358864|531824114|FG006|Overall Study|Not treated|1|||
147453941|NCT01358864|531824115|FG007|Overall Study|Not treated|0|||
147453942|NCT04042103|531824121|FG000|Overall Study|Lost to Follow-up|1|||
147453943|NCT04042103|531824121|FG000|Overall Study|Withdrawal by Subject|1|||
147453944|NCT04209855|531824124|FG000|Overall Study|Death|161|||
147453945|NCT04209855|531824125|FG001|Overall Study|Death|177|||
147453946|NCT04209855|531824124|FG000|Overall Study|PI Discretion|1|||
147359546|NCT05218096|531488041|FG002|Extended Treatment|Clinical Deterioration|0|||
147359547|NCT05218096|531488042|FG003|Extended Treatment|Clinical Deterioration|0|||
147359548|NCT05218096|531488043|FG004|Extended Treatment|Clinical Deterioration|0|||
147359549|NCT05218096|531488039|FG000|Extended Treatment|Study Terminated by Sponsor|6|||
147359550|NCT05218096|531488040|FG001|Extended Treatment|Study Terminated by Sponsor|3|||
147359551|NCT05218096|531488041|FG002|Extended Treatment|Study Terminated by Sponsor|0|||
147359552|NCT05218096|531488042|FG003|Extended Treatment|Study Terminated by Sponsor|3|||
147359553|NCT05218096|531488043|FG004|Extended Treatment|Study Terminated by Sponsor|2|||
147359554|NCT05218096|531488039|FG000|Extended Treatment|Withdrawal by Subject|1|||
147359555|NCT05218096|531488040|FG001|Extended Treatment|Withdrawal by Subject|3|||
147359556|NCT05218096|531488041|FG002|Extended Treatment|Withdrawal by Subject|0|||
147359557|NCT05218096|531488042|FG003|Extended Treatment|Withdrawal by Subject|2|||
147359558|NCT05218096|531488043|FG004|Extended Treatment|Withdrawal by Subject|2|||
147359559|NCT05218096|531488039|FG000|Extended Treatment|Lack of Efficacy|3|||
147359560|NCT05218096|531488040|FG001|Extended Treatment|Lack of Efficacy|0|||
147359561|NCT05218096|531488041|FG002|Extended Treatment|Lack of Efficacy|0|||
147359562|NCT05218096|531488042|FG003|Extended Treatment|Lack of Efficacy|0|||
147359563|NCT05218096|531488043|FG004|Extended Treatment|Lack of Efficacy|0|||
147359564|NCT05218096|531488039|FG000|Extended Treatment|Physician Decision|0|||
147359565|NCT05218096|531488040|FG001|Extended Treatment|Physician Decision|1|||
147359566|NCT05218096|531488041|FG002|Extended Treatment|Physician Decision|0|||
147359567|NCT05218096|531488042|FG003|Extended Treatment|Physician Decision|0|||
147359568|NCT05218096|531488043|FG004|Extended Treatment|Physician Decision|0|||
147359569|NCT05218096|531488039|FG000|Open-label Extension|Adverse Event|1|||
147359570|NCT05218096|531488040|FG001|Open-label Extension|Adverse Event|0|||
147359571|NCT05218096|531488041|FG002|Open-label Extension|Adverse Event|0|||
147359572|NCT05218096|531488042|FG003|Open-label Extension|Adverse Event|0|||
147359573|NCT05218096|531488043|FG004|Open-label Extension|Adverse Event|1|||
147359574|NCT05218096|531488039|FG000|Open-label Extension|Pregnancy|0|||
147359575|NCT05218096|531488040|FG001|Open-label Extension|Pregnancy|0|||
147359576|NCT05218096|531488041|FG002|Open-label Extension|Pregnancy|0|||
147359577|NCT05218096|531488042|FG003|Open-label Extension|Pregnancy|0|||
147359578|NCT05218096|531488043|FG004|Open-label Extension|Pregnancy|1|||
147359579|NCT05218096|531488039|FG000|Open-label Extension|Lack of Efficacy|1|||
147359580|NCT05218096|531488040|FG001|Open-label Extension|Lack of Efficacy|2|||
147359581|NCT05218096|531488041|FG002|Open-label Extension|Lack of Efficacy|0|||
147359582|NCT05218096|531488042|FG003|Open-label Extension|Lack of Efficacy|0|||
147359583|NCT05218096|531488043|FG004|Open-label Extension|Lack of Efficacy|0|||
147359584|NCT05218096|531488039|FG000|Open-label Extension|Lost to Follow-up|1|||
147359585|NCT05218096|531488040|FG001|Open-label Extension|Lost to Follow-up|0|||
147359586|NCT05218096|531488041|FG002|Open-label Extension|Lost to Follow-up|0|||
147359587|NCT05218096|531488042|FG003|Open-label Extension|Lost to Follow-up|0|||
147359588|NCT05218096|531488043|FG004|Open-label Extension|Lost to Follow-up|0|||
147359589|NCT05218096|531488039|FG000|Open-label Extension|Death|0|||
147359590|NCT05218096|531488040|FG001|Open-label Extension|Death|0|||
147359591|NCT05218096|531488041|FG002|Open-label Extension|Death|0|||
147359592|NCT05218096|531488042|FG003|Open-label Extension|Death|1|||
147359593|NCT05218096|531488043|FG004|Open-label Extension|Death|0|||
147359594|NCT05218096|531488039|FG000|Open-label Extension|Study Terminated by Sponsor|13|||
147359595|NCT05218096|531488040|FG001|Open-label Extension|Study Terminated by Sponsor|4|||
147359596|NCT05218096|531488041|FG002|Open-label Extension|Study Terminated by Sponsor|0|||
147359597|NCT05218096|531488042|FG003|Open-label Extension|Study Terminated by Sponsor|7|||
147359598|NCT05218096|531488043|FG004|Open-label Extension|Study Terminated by Sponsor|7|||
147359599|NCT05863156|531488045|FG000|Overall Study|Failure to complete the electro-monitoring application in the appropriate position|21|||
147359600|NCT05863156|531488046|FG001|Overall Study|Failure to complete the electro-monitoring application in the appropriate position|21|||
147359601|NCT05863156|531488047|FG002|Overall Study|Failure to complete the electro-monitoring application in the appropriate position|23|||
147359602|NCT03655028|531488050|FG000|12-weeks Follow up|Death|1|||
147359603|NCT03655028|531488051|FG001|12-weeks Follow up|Death|0|||
147359604|NCT03655028|531488050|FG000|12-weeks Follow up|Physician Decision|3|||
147359605|NCT03655028|531488051|FG001|12-weeks Follow up|Physician Decision|3|||
147359606|NCT03655028|531488050|FG000|12-weeks Follow up|Withdrawal by Subject|2|||
147359607|NCT03655028|531488051|FG001|12-weeks Follow up|Withdrawal by Subject|0|||
147359608|NCT03655028|531488050|FG000|12-weeks Follow up|Lost to Follow-up|4|||
147359609|NCT03655028|531488051|FG001|12-weeks Follow up|Lost to Follow-up|4|||
147359610|NCT03655028|531488050|FG000|24-weeks|Lost to Follow-up|1|||
147359611|NCT03655028|531488051|FG001|24-weeks|Lost to Follow-up|1|||
147359612|NCT03655028|531488050|FG000|24-weeks|Death|0|||
147359613|NCT03655028|531488051|FG001|24-weeks|Death|1|||
147359614|NCT03513302|531488052|FG000|First Intervention (14 Days)|Screen failure|15|||
147359615|NCT03513302|531488053|FG001|First Intervention (14 Days)|Screen failure|16|||
147359616|NCT05256654|531488054|FG000|Overall Study|Adverse Event|0|||
147359617|NCT05256654|531488055|FG001|Overall Study|Adverse Event|0|||
147359618|NCT05256654|531488056|FG002|Overall Study|Adverse Event|1|||
147359619|NCT05256654|531488057|FG003|Overall Study|Adverse Event|0|||
147359620|NCT05256654|531488054|FG000|Overall Study|Lost to Follow-up|0|||
147359621|NCT05256654|531488055|FG001|Overall Study|Lost to Follow-up|0|||
147359622|NCT05256654|531488056|FG002|Overall Study|Lost to Follow-up|0|||
147359623|NCT05256654|531488057|FG003|Overall Study|Lost to Follow-up|1|||
147359624|NCT05256654|531488054|FG000|Overall Study|Withdrawal by Subject|1|||
147359625|NCT05256654|531488055|FG001|Overall Study|Withdrawal by Subject|2|||
147359626|NCT05256654|531488056|FG002|Overall Study|Withdrawal by Subject|1|||
147359627|NCT05256654|531488057|FG003|Overall Study|Withdrawal by Subject|3|||
147359628|NCT05256654|531488054|FG000|Overall Study|Earthquake at the Turkey site prevented participation in the study|0|||
147359629|NCT05256654|531488055|FG001|Overall Study|Earthquake at the Turkey site prevented participation in the study|1|||
147359630|NCT05256654|531488056|FG002|Overall Study|Earthquake at the Turkey site prevented participation in the study|1|||
147359631|NCT05256654|531488057|FG003|Overall Study|Earthquake at the Turkey site prevented participation in the study|0|||
147359632|NCT05256654|531488054|FG000|Overall Study|Other|0|||
147359633|NCT05256654|531488055|FG001|Overall Study|Other|0|||
147359634|NCT05256654|531488056|FG002|Overall Study|Other|0|||
147359635|NCT05256654|531488057|FG003|Overall Study|Other|1|||
147359636|NCT04862416|531488066|FG000|Overall Study|Withdrawal by Subject|0|||
147359637|NCT04862416|531488067|FG001|Overall Study|Withdrawal by Subject|1|||
147359638|NCT04862416|531488068|FG002|Overall Study|Withdrawal by Subject|0|||
147359639|NCT04862416|531488069|FG003|Overall Study|Withdrawal by Subject|1|||
147359640|NCT04862416|531488070|FG004|Overall Study|Withdrawal by Subject|0|||
147359641|NCT04862416|531488071|FG005|Overall Study|Withdrawal by Subject|0|||
147359642|NCT04862416|531488072|FG006|Overall Study|Withdrawal by Subject|0|||
147359643|NCT04862416|531488073|FG007|Overall Study|Withdrawal by Subject|0|||
147359644|NCT03852550|531488074|FG000|Overall Study|Lost to Follow-up|4|||
147359645|NCT03852550|531488075|FG001|Overall Study|Lost to Follow-up|3|||
147359646|NCT03852550|531488074|FG000|Overall Study|Only parent outcomes completed|0|||
147359647|NCT03852550|531488075|FG001|Overall Study|Only parent outcomes completed|1|||
147359648|NCT03852550|531488074|FG000|Overall Study|Withdrawal by Subject|1|||
147359649|NCT03852550|531488075|FG001|Overall Study|Withdrawal by Subject|0|||
147359650|NCT04295512|531488078|FG000|Overall Study|Lack of family response to schedule assessment|0|||
147359651|NCT04295512|531488079|FG001|Overall Study|Lack of family response to schedule assessment|0|||
147359652|NCT04295512|531488080|FG002|Overall Study|Lack of family response to schedule assessment|0|||
147359653|NCT04295512|531488081|FG003|Overall Study|Lack of family response to schedule assessment|2|||
147359654|NCT04295512|531488078|FG000|Overall Study|Therapist did not refer eligible family|7|||
147359655|NCT04295512|531488079|FG001|Overall Study|Therapist did not refer eligible family|7|||
147359656|NCT04295512|531488080|FG002|Overall Study|Therapist did not refer eligible family|0|||
147359657|NCT04295512|531488081|FG003|Overall Study|Therapist did not refer eligible family|0|||
147359658|NCT01009788|531488092|FG000|Overall Study|Withdrawal by Subject|1|||
147359659|NCT01009788|531488093|FG001|Overall Study|Withdrawal by Subject|0|||
147359660|NCT01309672|531488095|FG000|Overall Study|Lack of Efficacy|20|||
147359661|NCT01309672|531488095|FG000|Overall Study|Other|9|||
147359662|NCT01309672|531488095|FG000|Overall Study|Adverse Event|5|||
147359663|NCT01309672|531488095|FG000|Overall Study|Withdrawal by Subject|3|||
147359664|NCT01254864|531488098|FG000|Abiraterone Acetate+Prednisone(AP) Phase|Adverse Event|4|||
147359665|NCT01254864|531488099|FG001|Abiraterone Acetate+Prednisone(AP) Phase|Adverse Event|0|||
147359666|NCT01254864|531488100|FG002|Abiraterone Acetate+Prednisone(AP) Phase|Adverse Event|0|||
147359667|NCT01254864|531488098|FG000|Abiraterone Acetate+Prednisone(AP) Phase|Death|1|||
147359668|NCT01254864|531488099|FG001|Abiraterone Acetate+Prednisone(AP) Phase|Death|0|||
147359669|NCT01254864|531488100|FG002|Abiraterone Acetate+Prednisone(AP) Phase|Death|0|||
147359670|NCT01254864|531488098|FG000|Abiraterone Acetate+Prednisone(AP) Phase|Physician Decision|24|||
147359671|NCT01254864|531488099|FG001|Abiraterone Acetate+Prednisone(AP) Phase|Physician Decision|0|||
147359672|NCT01254864|531488100|FG002|Abiraterone Acetate+Prednisone(AP) Phase|Physician Decision|0|||
147359673|NCT01254864|531488098|FG000|Abiraterone Acetate+Prednisone(AP) Phase|Withdrawal by Subject|9|||
147359674|NCT01254864|531488099|FG001|Abiraterone Acetate+Prednisone(AP) Phase|Withdrawal by Subject|0|||
147359675|NCT01254864|531488100|FG002|Abiraterone Acetate+Prednisone(AP) Phase|Withdrawal by Subject|0|||
147359676|NCT01254864|531488098|FG000|Abiraterone Acetate+Prednisone(AP) Phase|Non-compliance|2|||
147359677|NCT01254864|531488099|FG001|Abiraterone Acetate+Prednisone(AP) Phase|Non-compliance|0|||
147359678|NCT01254864|531488100|FG002|Abiraterone Acetate+Prednisone(AP) Phase|Non-compliance|0|||
147359679|NCT01254864|531488098|FG000|Abiraterone Acetate+Prednisone(AP) Phase|Ongoing Response to Abiraterone|7|||
147359680|NCT01254864|531488099|FG001|Abiraterone Acetate+Prednisone(AP) Phase|Ongoing Response to Abiraterone|0|||
147359681|NCT01254864|531488100|FG002|Abiraterone Acetate+Prednisone(AP) Phase|Ongoing Response to Abiraterone|0|||
147359682|NCT01254864|531488098|FG000|Randomization Phase|Adverse Event|0|||
147359683|NCT01254864|531488099|FG001|Randomization Phase|Adverse Event|5|||
147359684|NCT01254864|531488100|FG002|Randomization Phase|Adverse Event|17|||
147359685|NCT01254864|531488098|FG000|Randomization Phase|Death|0|||
147359686|NCT01254864|531488099|FG001|Randomization Phase|Death|1|||
147359687|NCT01254864|531488100|FG002|Randomization Phase|Death|0|||
147608218|NCT00587860|532382569|FG000|Overall Study|Lost to Follow-up|2|||
147359688|NCT01254864|531488098|FG000|Randomization Phase|Lost to Follow-up|0|||
147359689|NCT01254864|531488099|FG001|Randomization Phase|Lost to Follow-up|0|||
147359690|NCT01254864|531488100|FG002|Randomization Phase|Lost to Follow-up|1|||
147359691|NCT01254864|531488098|FG000|Randomization Phase|Physician Decision|0|||
147359692|NCT01254864|531488099|FG001|Randomization Phase|Physician Decision|20|||
147359693|NCT01254864|531488100|FG002|Randomization Phase|Physician Decision|25|||
147359694|NCT01254864|531488098|FG000|Randomization Phase|Withdrawal by Subject|0|||
147359695|NCT01254864|531488099|FG001|Randomization Phase|Withdrawal by Subject|4|||
147359696|NCT01254864|531488100|FG002|Randomization Phase|Withdrawal by Subject|2|||
147359697|NCT01254864|531488098|FG000|Randomization Phase|Non-Compliance|0|||
147359698|NCT01254864|531488099|FG001|Randomization Phase|Non-Compliance|1|||
147359699|NCT01254864|531488100|FG002|Randomization Phase|Non-Compliance|0|||
147359700|NCT01254864|531488098|FG000|Randomization Phase|Comorbidities|0|||
147359701|NCT01254864|531488099|FG001|Randomization Phase|Comorbidities|2|||
147359702|NCT01254864|531488100|FG002|Randomization Phase|Comorbidities|1|||
147359703|NCT04141891|531488102|FG000|6 Month Follow-up (Drivers Only)|Missed interview|3|||
147359704|NCT04141891|531488103|FG001|6 Month Follow-up (Drivers Only)|Missed interview|8|||
147359705|NCT04141891|531488102|FG000|6 Month Follow-up (Drivers Only)|Withdrawal by Subject|4|||
147359706|NCT04141891|531488103|FG001|6 Month Follow-up (Drivers Only)|Withdrawal by Subject|4|||
147359707|NCT04141891|531488102|FG000|12 Month Follow-up (Drivers + SPs)|Missed interview|9|||
147359708|NCT04141891|531488103|FG001|12 Month Follow-up (Drivers + SPs)|Missed interview|20|||
147359709|NCT04141891|531488102|FG000|12 Month Follow-up (Drivers + SPs)|Death|1|||
147359710|NCT04141891|531488103|FG001|12 Month Follow-up (Drivers + SPs)|Death|4|||
147359711|NCT04141891|531488102|FG000|12 Month Follow-up (Drivers + SPs)|Withdrawal by Subject|11|||
147359712|NCT04141891|531488103|FG001|12 Month Follow-up (Drivers + SPs)|Withdrawal by Subject|8|||
147359713|NCT04141891|531488102|FG000|12 Month Follow-up (Drivers + SPs)|Withdrawn by team|0|||
147359714|NCT04141891|531488103|FG001|12 Month Follow-up (Drivers + SPs)|Withdrawn by team|2|||
147453947|NCT04209855|531824125|FG001|Overall Study|PI Discretion|1|||
147453948|NCT04209855|531824124|FG000|Overall Study|Lost to Follow-up|5|||
147453949|NCT04209855|531824125|FG001|Overall Study|Lost to Follow-up|2|||
147453950|NCT04209855|531824124|FG000|Overall Study|Withdrew consent|10|||
147453951|NCT04209855|531824125|FG001|Overall Study|Withdrew consent|24|||
147453952|NCT04209855|531824124|FG000|Overall Study|Sponsor decision|44|||
147453953|NCT04209855|531824125|FG001|Overall Study|Sponsor decision|18|||
147453954|NCT04209855|531824124|FG000|Overall Study|Other than specified|6|||
147453955|NCT04209855|531824125|FG001|Overall Study|Other than specified|4|||
147453956|NCT02289950|531824126|FG000|Overall Study|Progressive disease by RECIST 1.1|99|||
147453957|NCT02289950|531824127|FG001|Overall Study|Progressive disease by RECIST 1.1|52|||
147453958|NCT02289950|531824126|FG000|Overall Study|Progressive disease by Clinical Assessment|4|||
147453959|NCT02289950|531824127|FG001|Overall Study|Progressive disease by Clinical Assessment|4|||
147453960|NCT02289950|531824126|FG000|Overall Study|Lost to Follow-up|1|||
147453961|NCT02289950|531824127|FG001|Overall Study|Lost to Follow-up|0|||
147453962|NCT02289950|531824126|FG000|Overall Study|Physician Decision|9|||
147453963|NCT02289950|531824127|FG001|Overall Study|Physician Decision|3|||
147453964|NCT02289950|531824126|FG000|Overall Study|Subject chose to discontinue therapy but will continue to survival follow-up|9|||
147359715|NCT04141891|531488102|FG000|18 Month Follow-up (Drivers Only)|Missed interview|12|||
147359716|NCT04141891|531488103|FG001|18 Month Follow-up (Drivers Only)|Missed interview|14|||
147359717|NCT04141891|531488102|FG000|18 Month Follow-up (Drivers Only)|Death|1|||
147359718|NCT04141891|531488103|FG001|18 Month Follow-up (Drivers Only)|Death|2|||
147359719|NCT04141891|531488102|FG000|18 Month Follow-up (Drivers Only)|Withdrawal by Subject|1|||
147359720|NCT04141891|531488103|FG001|18 Month Follow-up (Drivers Only)|Withdrawal by Subject|3|||
147359721|NCT04141891|531488102|FG000|18 Month Follow-up (Drivers Only)|Withdrawn by team for health issues/hospitalization|0|||
147359722|NCT04141891|531488103|FG001|18 Month Follow-up (Drivers Only)|Withdrawn by team for health issues/hospitalization|1|||
147359723|NCT04141891|531488102|FG000|24 Month Follow-up (Drivers and SPs)|Missed interview|22|||
147359724|NCT04141891|531488103|FG001|24 Month Follow-up (Drivers and SPs)|Missed interview|18|||
147359725|NCT04141891|531488102|FG000|24 Month Follow-up (Drivers and SPs)|Death|2|||
147359726|NCT04141891|531488103|FG001|24 Month Follow-up (Drivers and SPs)|Death|3|||
147359727|NCT04141891|531488102|FG000|24 Month Follow-up (Drivers and SPs)|Withdrawal by Subject|5|||
147359728|NCT04141891|531488103|FG001|24 Month Follow-up (Drivers and SPs)|Withdrawal by Subject|6|||
147359729|NCT04141891|531488102|FG000|24 Month Follow-up (Drivers and SPs)|Withdrawn by team due to health issues|2|||
147359730|NCT04141891|531488103|FG001|24 Month Follow-up (Drivers and SPs)|Withdrawn by team due to health issues|0|||
147359731|NCT03626220|531488104|FG000|Overall Study|Withdrawal by Subject|2|||
147359732|NCT03626220|531488105|FG001|Overall Study|Withdrawal by Subject|0|||
147359733|NCT04625725|531488106|FG000|Provent Main Study|PARTICIPANT NOT FULFILLING INCLUSION CRITERIA|1|||
147359734|NCT04625725|531488107|FG001|Provent Main Study|PARTICIPANT NOT FULFILLING INCLUSION CRITERIA|0|||
147527266|NCT00421928|532084186|FG000|Overall Study|Withdrawal by Subject|50|||
147527267|NCT00421928|532084187|FG001|Overall Study|Withdrawal by Subject|48|||
147527268|NCT00421928|532084188|FG002|Overall Study|Withdrawal by Subject|43|||
147527269|NCT00421928|532084186|FG000|Overall Study|Lack of Efficacy|15|||
147527270|NCT00421928|532084187|FG001|Overall Study|Lack of Efficacy|7|||
147527271|NCT00421928|532084188|FG002|Overall Study|Lack of Efficacy|35|||
147527272|NCT00421928|532084186|FG000|Overall Study|Study drug non-compliant|6|||
147527273|NCT00421928|532084187|FG001|Overall Study|Study drug non-compliant|7|||
147359735|NCT04625725|531488108|FG002|Provent Main Study|PARTICIPANT NOT FULFILLING INCLUSION CRITERIA|0|||
147359736|NCT04625725|531488109|FG003|Provent Main Study|PARTICIPANT NOT FULFILLING INCLUSION CRITERIA|0|||
147359737|NCT04625725|531488110|FG004|Provent Main Study|PARTICIPANT NOT FULFILLING INCLUSION CRITERIA|0|||
147359738|NCT04625725|531488111|FG005|Provent Main Study|PARTICIPANT NOT FULFILLING INCLUSION CRITERIA|0|||
147359739|NCT04625725|531488106|FG000|Provent Main Study|Withdrawal by Subject|242|||
147359740|NCT04625725|531488107|FG001|Provent Main Study|Withdrawal by Subject|144|||
147359741|NCT04625725|531488108|FG002|Provent Main Study|Withdrawal by Subject|0|||
147359742|NCT04625725|531488109|FG003|Provent Main Study|Withdrawal by Subject|0|||
147359743|NCT04625725|531488110|FG004|Provent Main Study|Withdrawal by Subject|0|||
147359744|NCT04625725|531488111|FG005|Provent Main Study|Withdrawal by Subject|0|||
147359745|NCT04625725|531488106|FG000|Provent Main Study|Physician Decision|5|||
147359746|NCT04625725|531488107|FG001|Provent Main Study|Physician Decision|0|||
147359747|NCT04625725|531488108|FG002|Provent Main Study|Physician Decision|0|||
147359748|NCT04625725|531488109|FG003|Provent Main Study|Physician Decision|0|||
147359749|NCT04625725|531488110|FG004|Provent Main Study|Physician Decision|0|||
147359750|NCT04625725|531488111|FG005|Provent Main Study|Physician Decision|0|||
147359751|NCT04625725|531488106|FG000|Provent Main Study|Protocol Violation|1|||
147453965|NCT02289950|531824127|FG001|Overall Study|Subject chose to discontinue therapy but will continue to survival follow-up|2|||
147453966|NCT02289950|531824126|FG000|Overall Study|Withdrawal by Subject|1|||
147453967|NCT02289950|531824127|FG001|Overall Study|Withdrawal by Subject|3|||
147453968|NCT02289950|531824126|FG000|Overall Study|Test article held for greater than 28 days|0|||
147453969|NCT02289950|531824127|FG001|Overall Study|Test article held for greater than 28 days|1|||
147453970|NCT02289950|531824126|FG000|Overall Study|Adverse Event|11|||
147453971|NCT02289950|531824127|FG001|Overall Study|Adverse Event|3|||
147453972|NCT02289950|531824126|FG000|Overall Study|Death|1|||
147453973|NCT02289950|531824127|FG001|Overall Study|Death|1|||
147453974|NCT02289950|531824126|FG000|Overall Study|Other|5|||
147453975|NCT02289950|531824127|FG001|Overall Study|Other|2|||
147453976|NCT02289950|531824126|FG000|Overall Study|Not Treated|2|||
147453977|NCT02289950|531824127|FG001|Overall Study|Not Treated|1|||
147453978|NCT04518462|531824128|FG000|Overall Study|Withdrawal by Subject|0|||
147453979|NCT04518462|531824129|FG001|Overall Study|Withdrawal by Subject|0|||
147453980|NCT04518462|531824130|FG002|Overall Study|Withdrawal by Subject|1|||
147453981|NCT04518462|531824128|FG000|Overall Study|Physician Decision|1|||
147453982|NCT04518462|531824129|FG001|Overall Study|Physician Decision|1|||
147453983|NCT04518462|531824130|FG002|Overall Study|Physician Decision|0|||
147453984|NCT01003210|531824131|FG000|Overall Study|Lost to Follow-up|1|||
147453985|NCT01003210|531824132|FG001|Overall Study|Lost to Follow-up|3|||
147453986|NCT00271817|531824133|FG000|Part 1|Adverse Event|68|||
147453987|NCT00271817|531824134|FG001|Part 1|Adverse Event|25|||
147453988|NCT00271817|531824135|FG002|Part 1|Adverse Event|156|||
147453989|NCT00271817|531824133|FG000|Part 1|Lost to Follow-up|6|||
147453990|NCT00271817|531824134|FG001|Part 1|Lost to Follow-up|8|||
147453991|NCT00271817|531824135|FG002|Part 1|Lost to Follow-up|24|||
147453992|NCT00271817|531824133|FG000|Part 1|Protocol Violation|5|||
147453993|NCT00271817|531824134|FG001|Part 1|Protocol Violation|4|||
147453994|NCT00271817|531824135|FG002|Part 1|Protocol Violation|7|||
147453995|NCT00271817|531824133|FG000|Part 1|Patient Moved|3|||
147453996|NCT00271817|531824134|FG001|Part 1|Patient Moved|1|||
147453997|NCT00271817|531824135|FG002|Part 1|Patient Moved|5|||
147453998|NCT00271817|531824133|FG000|Part 1|Withdrawal by Subject|23|||
147453999|NCT00271817|531824134|FG001|Part 1|Withdrawal by Subject|17|||
147454000|NCT00271817|531824135|FG002|Part 1|Withdrawal by Subject|45|||
147454001|NCT00271817|531824133|FG000|Part 1|LDL < 50 mg/dL|1|||
147454002|NCT00271817|531824134|FG001|Part 1|LDL < 50 mg/dL|4|||
147454003|NCT00271817|531824135|FG002|Part 1|LDL < 50 mg/dL|48|||
147454004|NCT00271817|531824133|FG000|Part 2|Adverse Event|0|||
147454005|NCT00271817|531824134|FG001|Part 2|Adverse Event|17|||
147454006|NCT00271817|531824135|FG002|Part 2|Adverse Event|33|||
147454007|NCT00271817|531824133|FG000|Part 2|Lack of Efficacy|0|||
147359752|NCT04625725|531488107|FG001|Provent Main Study|Protocol Violation|0|||
147359753|NCT04625725|531488108|FG002|Provent Main Study|Protocol Violation|0|||
147359754|NCT04625725|531488109|FG003|Provent Main Study|Protocol Violation|0|||
147359755|NCT04625725|531488110|FG004|Provent Main Study|Protocol Violation|0|||
147454008|NCT00271817|531824134|FG001|Part 2|Lack of Efficacy|1|||
147454009|NCT00271817|531824135|FG002|Part 2|Lack of Efficacy|6|||
147454010|NCT00271817|531824133|FG000|Part 2|Lost to Follow-up|0|||
147454011|NCT00271817|531824134|FG001|Part 2|Lost to Follow-up|6|||
147359756|NCT04625725|531488111|FG005|Provent Main Study|Protocol Violation|0|||
147454012|NCT00271817|531824135|FG002|Part 2|Lost to Follow-up|18|||
147454013|NCT00271817|531824133|FG000|Part 2|Protocol Violation|0|||
147454014|NCT00271817|531824134|FG001|Part 2|Protocol Violation|3|||
147454015|NCT00271817|531824135|FG002|Part 2|Protocol Violation|5|||
147454016|NCT00271817|531824133|FG000|Part 2|Patient Moved|0|||
147454017|NCT00271817|531824134|FG001|Part 2|Patient Moved|0|||
147454018|NCT00271817|531824135|FG002|Part 2|Patient Moved|5|||
147454019|NCT00271817|531824133|FG000|Part 2|Withdrawal by Subject|0|||
147454020|NCT00271817|531824134|FG001|Part 2|Withdrawal by Subject|2|||
147454021|NCT00271817|531824135|FG002|Part 2|Withdrawal by Subject|13|||
147454022|NCT00271817|531824133|FG000|Part 2|LDL < 50 mg/dL|0|||
147454023|NCT00271817|531824134|FG001|Part 2|LDL < 50 mg/dL|3|||
147454024|NCT00271817|531824135|FG002|Part 2|LDL < 50 mg/dL|4|||
147454025|NCT04153188|531824140|FG000|Overall Study|Lost to Follow-up|1|||
147454026|NCT04153188|531824141|FG001|Overall Study|Lost to Follow-up|1|||
147454027|NCT04153188|531824140|FG000|Overall Study|Withdrawal by Subject|2|||
147454028|NCT04153188|531824141|FG001|Overall Study|Withdrawal by Subject|0|||
147454029|NCT04153188|531824140|FG000|Overall Study|Subject withdrew due to rebound erythema when Oxymetazoline wore off|0|||
147454030|NCT04153188|531824141|FG001|Overall Study|Subject withdrew due to rebound erythema when Oxymetazoline wore off|1|||
147454031|NCT01471782|531824142|FG000|Overall Study|Hematopoietic Stem Cell Transplantation|2|||
147454032|NCT01471782|531824143|FG001|Overall Study|Hematopoietic Stem Cell Transplantation|2|||
147454033|NCT01471782|531824144|FG002|Overall Study|Hematopoietic Stem Cell Transplantation|1|||
147454034|NCT01471782|531824145|FG003|Overall Study|Hematopoietic Stem Cell Transplantation|0|||
147454035|NCT01471782|531824146|FG004|Overall Study|Hematopoietic Stem Cell Transplantation|5|||
147454036|NCT01471782|531824147|FG005|Overall Study|Hematopoietic Stem Cell Transplantation|3|||
147454037|NCT01471782|531824142|FG000|Overall Study|Lack of Efficacy|1|||
147454038|NCT01471782|531824143|FG001|Overall Study|Lack of Efficacy|2|||
147454039|NCT01471782|531824144|FG002|Overall Study|Lack of Efficacy|1|||
147454040|NCT01471782|531824145|FG003|Overall Study|Lack of Efficacy|1|||
147454041|NCT01471782|531824146|FG004|Overall Study|Lack of Efficacy|5|||
147454042|NCT01471782|531824147|FG005|Overall Study|Lack of Efficacy|18|||
147454043|NCT01471782|531824142|FG000|Overall Study|Adverse Event|1|||
147454044|NCT01471782|531824143|FG001|Overall Study|Adverse Event|1|||
147454045|NCT01471782|531824144|FG002|Overall Study|Adverse Event|2|||
147454046|NCT01471782|531824145|FG003|Overall Study|Adverse Event|2|||
147454047|NCT01471782|531824146|FG004|Overall Study|Adverse Event|3|||
147454048|NCT01471782|531824147|FG005|Overall Study|Adverse Event|1|||
147454049|NCT01471782|531824142|FG000|Overall Study|Other|0|||
147454050|NCT01471782|531824143|FG001|Overall Study|Other|0|||
147454051|NCT01471782|531824144|FG002|Overall Study|Other|1|||
147454052|NCT01471782|531824145|FG003|Overall Study|Other|1|||
147454053|NCT01471782|531824146|FG004|Overall Study|Other|6|||
147454054|NCT01471782|531824147|FG005|Overall Study|Other|5|||
147454055|NCT01471782|531824142|FG000|Overall Study|Change of Chemotherapy|1|||
147454056|NCT01471782|531824143|FG001|Overall Study|Change of Chemotherapy|1|||
147454057|NCT01471782|531824144|FG002|Overall Study|Change of Chemotherapy|0|||
147454058|NCT01471782|531824145|FG003|Overall Study|Change of Chemotherapy|0|||
147454059|NCT01471782|531824146|FG004|Overall Study|Change of Chemotherapy|1|||
147454060|NCT01471782|531824147|FG005|Overall Study|Change of Chemotherapy|4|||
147454061|NCT01471782|531824142|FG000|Overall Study|Disease Relapse|0|||
147454062|NCT01471782|531824143|FG001|Overall Study|Disease Relapse|0|||
147359757|NCT04625725|531488106|FG000|Provent Main Study|Lost to Follow-up|357|||
147359758|NCT04625725|531488107|FG001|Provent Main Study|Lost to Follow-up|200|||
147359759|NCT04625725|531488108|FG002|Provent Main Study|Lost to Follow-up|0|||
147359760|NCT04625725|531488109|FG003|Provent Main Study|Lost to Follow-up|0|||
147359761|NCT04625725|531488110|FG004|Provent Main Study|Lost to Follow-up|0|||
147359762|NCT04625725|531488111|FG005|Provent Main Study|Lost to Follow-up|0|||
147359763|NCT04625725|531488106|FG000|Provent Main Study|Death|22|||
147359764|NCT04625725|531488107|FG001|Provent Main Study|Death|10|||
147359765|NCT04625725|531488108|FG002|Provent Main Study|Death|0|||
147359766|NCT04625725|531488109|FG003|Provent Main Study|Death|0|||
147359767|NCT04625725|531488110|FG004|Provent Main Study|Death|0|||
147359768|NCT04625725|531488111|FG005|Provent Main Study|Death|0|||
147359769|NCT04625725|531488106|FG000|Provent Main Study|Adverse Event|2|||
147359770|NCT04625725|531488107|FG001|Provent Main Study|Adverse Event|1|||
147359771|NCT04625725|531488108|FG002|Provent Main Study|Adverse Event|0|||
147359772|NCT04625725|531488109|FG003|Provent Main Study|Adverse Event|0|||
147359773|NCT04625725|531488110|FG004|Provent Main Study|Adverse Event|0|||
147359774|NCT04625725|531488111|FG005|Provent Main Study|Adverse Event|0|||
147359775|NCT04625725|531488106|FG000|Provent Main Study|Participants dosed in sub-study|310|||
147359776|NCT04625725|531488107|FG001|Provent Main Study|Participants dosed in sub-study|193|||
147359777|NCT04625725|531488108|FG002|Provent Main Study|Participants dosed in sub-study|0|||
147359778|NCT04625725|531488109|FG003|Provent Main Study|Participants dosed in sub-study|0|||
147359779|NCT04625725|531488110|FG004|Provent Main Study|Participants dosed in sub-study|0|||
147359780|NCT04625725|531488111|FG005|Provent Main Study|Participants dosed in sub-study|0|||
147359781|NCT04625725|531488106|FG000|Provent Main Study|PARTICIPANT NOT COMPLIANT|1|||
147359782|NCT04625725|531488107|FG001|Provent Main Study|PARTICIPANT NOT COMPLIANT|1|||
147359783|NCT04625725|531488108|FG002|Provent Main Study|PARTICIPANT NOT COMPLIANT|0|||
147359784|NCT04625725|531488109|FG003|Provent Main Study|PARTICIPANT NOT COMPLIANT|0|||
147359785|NCT04625725|531488110|FG004|Provent Main Study|PARTICIPANT NOT COMPLIANT|0|||
147359786|NCT04625725|531488111|FG005|Provent Main Study|PARTICIPANT NOT COMPLIANT|0|||
147359787|NCT04625725|531488106|FG000|Provent Main Study|PARTICIPANT COULD NOT BE REACHED PRIOR TO DBL|14|||
147454063|NCT01471782|531824144|FG002|Overall Study|Disease Relapse|0|||
147454064|NCT01471782|531824145|FG003|Overall Study|Disease Relapse|1|||
147454065|NCT01471782|531824146|FG004|Overall Study|Disease Relapse|2|||
147454066|NCT01471782|531824147|FG005|Overall Study|Disease Relapse|1|||
147454067|NCT01471782|531824142|FG000|Overall Study|Physician Decision|0|||
147359788|NCT04625725|531488107|FG001|Provent Main Study|PARTICIPANT COULD NOT BE REACHED PRIOR TO DBL|2|||
147359789|NCT04625725|531488108|FG002|Provent Main Study|PARTICIPANT COULD NOT BE REACHED PRIOR TO DBL|0|||
147359790|NCT04625725|531488109|FG003|Provent Main Study|PARTICIPANT COULD NOT BE REACHED PRIOR TO DBL|0|||
147359791|NCT04625725|531488110|FG004|Provent Main Study|PARTICIPANT COULD NOT BE REACHED PRIOR TO DBL|0|||
147359792|NCT04625725|531488111|FG005|Provent Main Study|PARTICIPANT COULD NOT BE REACHED PRIOR TO DBL|0|||
147359793|NCT04625725|531488106|FG000|Provent Main Study|INCARCERATION|3|||
147359794|NCT04625725|531488107|FG001|Provent Main Study|INCARCERATION|0|||
147359795|NCT04625725|531488108|FG002|Provent Main Study|INCARCERATION|0|||
147359796|NCT04625725|531488109|FG003|Provent Main Study|INCARCERATION|0|||
147359797|NCT04625725|531488110|FG004|Provent Main Study|INCARCERATION|0|||
147359798|NCT04625725|531488111|FG005|Provent Main Study|INCARCERATION|0|||
147359799|NCT04625725|531488106|FG000|Provent Main Study|WITHDRAWAL OF CONSENT|3|||
147359800|NCT04625725|531488107|FG001|Provent Main Study|WITHDRAWAL OF CONSENT|2|||
147359801|NCT04625725|531488108|FG002|Provent Main Study|WITHDRAWAL OF CONSENT|0|||
147359802|NCT04625725|531488109|FG003|Provent Main Study|WITHDRAWAL OF CONSENT|0|||
147359803|NCT04625725|531488110|FG004|Provent Main Study|WITHDRAWAL OF CONSENT|0|||
147359804|NCT04625725|531488111|FG005|Provent Main Study|WITHDRAWAL OF CONSENT|0|||
147359805|NCT04625725|531488106|FG000|Provent Main Study|MOVED ABROAD / LOCATION|7|||
147359806|NCT04625725|531488107|FG001|Provent Main Study|MOVED ABROAD / LOCATION|2|||
147359807|NCT04625725|531488108|FG002|Provent Main Study|MOVED ABROAD / LOCATION|0|||
147359808|NCT04625725|531488109|FG003|Provent Main Study|MOVED ABROAD / LOCATION|0|||
147359809|NCT04625725|531488110|FG004|Provent Main Study|MOVED ABROAD / LOCATION|0|||
147359810|NCT04625725|531488111|FG005|Provent Main Study|MOVED ABROAD / LOCATION|0|||
147359811|NCT04625725|531488106|FG000|Provent Main Study|PARTICIPANT DID NOT ATTEND VISIT|2|||
147359812|NCT04625725|531488107|FG001|Provent Main Study|PARTICIPANT DID NOT ATTEND VISIT|2|||
147359813|NCT04625725|531488108|FG002|Provent Main Study|PARTICIPANT DID NOT ATTEND VISIT|0|||
147359814|NCT04625725|531488109|FG003|Provent Main Study|PARTICIPANT DID NOT ATTEND VISIT|0|||
147359815|NCT04625725|531488110|FG004|Provent Main Study|PARTICIPANT DID NOT ATTEND VISIT|0|||
147359816|NCT04625725|531488111|FG005|Provent Main Study|PARTICIPANT DID NOT ATTEND VISIT|0|||
147359817|NCT04625725|531488106|FG000|Provent Main Study|MISSING REASON|0|||
147359818|NCT04625725|531488107|FG001|Provent Main Study|MISSING REASON|1|||
147359819|NCT04625725|531488108|FG002|Provent Main Study|MISSING REASON|0|||
147359820|NCT04625725|531488109|FG003|Provent Main Study|MISSING REASON|0|||
147359821|NCT04625725|531488110|FG004|Provent Main Study|MISSING REASON|0|||
147359822|NCT04625725|531488111|FG005|Provent Main Study|MISSING REASON|0|||
147359823|NCT04625725|531488106|FG000|Provent Sub Study|SUBJECT MOVED OUT OF AREA|0|||
147359824|NCT04625725|531488107|FG001|Provent Sub Study|SUBJECT MOVED OUT OF AREA|0|||
147454068|NCT01471782|531824143|FG001|Overall Study|Physician Decision|0|||
147454069|NCT01471782|531824144|FG002|Overall Study|Physician Decision|0|||
147454070|NCT01471782|531824145|FG003|Overall Study|Physician Decision|0|||
147454071|NCT01471782|531824146|FG004|Overall Study|Physician Decision|3|||
147454072|NCT01471782|531824147|FG005|Overall Study|Physician Decision|8|||
147608219|NCT00587860|532382570|FG001|Overall Study|Lost to Follow-up|2|||
147608220|NCT00587860|532382569|FG000|Overall Study|Withdrawal by Subject|3|||
147608221|NCT00587860|532382570|FG001|Overall Study|Withdrawal by Subject|3|||
147608222|NCT00261443|532382571|FG000|1: Confirmation of Partial Nonresponse|Adverse Event|33|||
147608223|NCT00261443|532382572|FG001|1: Confirmation of Partial Nonresponse|Adverse Event|0|||
147608224|NCT00261443|532382573|FG002|1: Confirmation of Partial Nonresponse|Adverse Event|0|||
147608225|NCT00261443|532382571|FG000|1: Confirmation of Partial Nonresponse|Withdrawal by Subject|93|||
147454073|NCT01471782|531824142|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
147454074|NCT01471782|531824143|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
147454075|NCT01471782|531824144|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
147454076|NCT01471782|531824145|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
147359825|NCT04625725|531488108|FG002|Provent Sub Study|SUBJECT MOVED OUT OF AREA|0|||
147359826|NCT04625725|531488109|FG003|Provent Sub Study|SUBJECT MOVED OUT OF AREA|1|||
147359827|NCT04625725|531488110|FG004|Provent Sub Study|SUBJECT MOVED OUT OF AREA|0|||
147359828|NCT04625725|531488111|FG005|Provent Sub Study|SUBJECT MOVED OUT OF AREA|0|||
147359829|NCT04625725|531488106|FG000|Provent Sub Study|SUBJECT WAS MOVING AWAY FROM THE STUDY CLINIC|0|||
147359830|NCT04625725|531488107|FG001|Provent Sub Study|SUBJECT WAS MOVING AWAY FROM THE STUDY CLINIC|0|||
147454077|NCT01471782|531824146|FG004|Overall Study|Withdrawal by Parent/Guardian|1|||
147454078|NCT01471782|531824147|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
147454079|NCT01471782|531824142|FG000|Overall Study|Death|0|||
147454080|NCT01471782|531824143|FG001|Overall Study|Death|0|||
147454081|NCT01471782|531824144|FG002|Overall Study|Death|0|||
147454082|NCT01471782|531824145|FG003|Overall Study|Death|0|||
147454083|NCT01471782|531824146|FG004|Overall Study|Death|0|||
147454084|NCT01471782|531824147|FG005|Overall Study|Death|1|||
147359831|NCT04625725|531488108|FG002|Provent Sub Study|SUBJECT WAS MOVING AWAY FROM THE STUDY CLINIC|1|||
147454085|NCT00936208|531824148|FG000|Overall Study|Protocol Violation|37|||
147454086|NCT00936208|531824149|FG001|Overall Study|Protocol Violation|22|||
147454087|NCT00861744|531824150|FG000|Overall Study|Adverse Event|0|||
147454088|NCT00861744|531824151|FG001|Overall Study|Adverse Event|0|||
147454089|NCT00861744|531824152|FG002|Overall Study|Adverse Event|0|||
147454090|NCT00861744|531824153|FG003|Overall Study|Adverse Event|1|||
147454091|NCT00861744|531824150|FG000|Overall Study|Lost to Follow-up|7|||
147454092|NCT00861744|531824151|FG001|Overall Study|Lost to Follow-up|19|||
147454093|NCT00861744|531824152|FG002|Overall Study|Lost to Follow-up|17|||
147454094|NCT00861744|531824153|FG003|Overall Study|Lost to Follow-up|12|||
147454095|NCT00861744|531824150|FG000|Overall Study|Withdrawal by Subject|10|||
147454096|NCT00861744|531824151|FG001|Overall Study|Withdrawal by Subject|6|||
147454097|NCT00861744|531824152|FG002|Overall Study|Withdrawal by Subject|6|||
147454098|NCT00861744|531824153|FG003|Overall Study|Withdrawal by Subject|19|||
147454099|NCT00861744|531824150|FG000|Overall Study|Protocol Violation|0|||
147454100|NCT00861744|531824151|FG001|Overall Study|Protocol Violation|1|||
147454101|NCT00861744|531824152|FG002|Overall Study|Protocol Violation|0|||
147454102|NCT00861744|531824153|FG003|Overall Study|Protocol Violation|0|||
147454103|NCT00861744|531824150|FG000|Overall Study|Migration from study area|0|||
147454104|NCT00861744|531824151|FG001|Overall Study|Migration from study area|3|||
147454105|NCT00861744|531824152|FG002|Overall Study|Migration from study area|1|||
147454106|NCT00861744|531824153|FG003|Overall Study|Migration from study area|0|||
147454107|NCT00861744|531824150|FG000|Overall Study|Blood draws|0|||
147454108|NCT00861744|531824151|FG001|Overall Study|Blood draws|0|||
147454109|NCT00861744|531824152|FG002|Overall Study|Blood draws|0|||
147454110|NCT00861744|531824153|FG003|Overall Study|Blood draws|1|||
147454111|NCT01411085|531824154|FG000|Overall Study|Physician Decision|1|||
147454112|NCT01411085|531824154|FG000|Overall Study|Protocol Violation|1|||
147454113|NCT01411085|531824154|FG000|Overall Study|Adverse Event|1|||
147454114|NCT04818593|531824155|FG000|Overall Study|Low Oocyte Yield|8|||
147454115|NCT04818593|531824156|FG001|Overall Study|Low Oocyte Yield|8|||
147454116|NCT04818593|531824155|FG000|Overall Study|Not ICSI Insemination|7|||
147454117|NCT04818593|531824156|FG001|Overall Study|Not ICSI Insemination|7|||
147454118|NCT04818593|531824155|FG000|Overall Study|Poor Sperm Quality|2|||
147454119|NCT04818593|531824156|FG001|Overall Study|Poor Sperm Quality|2|||
147454120|NCT04818593|531824155|FG000|Overall Study|Withdrawal by Subject|2|||
147454121|NCT04818593|531824156|FG001|Overall Study|Withdrawal by Subject|2|||
147454122|NCT04818593|531824155|FG000|Overall Study|Conversion to IUI due to low response|1|||
147454123|NCT04818593|531824156|FG001|Overall Study|Conversion to IUI due to low response|1|||
147454124|NCT01564862|531824157|FG000|Overall Study|Pretreatment Event or Adverse Event|6|||
147454125|NCT01564862|531824158|FG001|Overall Study|Pretreatment Event or Adverse Event|12|||
147454126|NCT01564862|531824159|FG002|Overall Study|Pretreatment Event or Adverse Event|6|||
147454127|NCT01564862|531824157|FG000|Overall Study|Major Protocol Deviation|3|||
147359832|NCT04625725|531488109|FG003|Provent Sub Study|SUBJECT WAS MOVING AWAY FROM THE STUDY CLINIC|0|||
147359833|NCT04625725|531488110|FG004|Provent Sub Study|SUBJECT WAS MOVING AWAY FROM THE STUDY CLINIC|0|||
147359834|NCT04625725|531488111|FG005|Provent Sub Study|SUBJECT WAS MOVING AWAY FROM THE STUDY CLINIC|0|||
147359835|NCT04625725|531488106|FG000|Provent Sub Study|Lost to Follow-up|0|||
147359836|NCT04625725|531488107|FG001|Provent Sub Study|Lost to Follow-up|0|||
147359837|NCT04625725|531488108|FG002|Provent Sub Study|Lost to Follow-up|20|||
147359838|NCT04625725|531488109|FG003|Provent Sub Study|Lost to Follow-up|10|||
147359839|NCT04625725|531488110|FG004|Provent Sub Study|Lost to Follow-up|6|||
147359840|NCT04625725|531488111|FG005|Provent Sub Study|Lost to Follow-up|4|||
147359841|NCT04625725|531488106|FG000|Provent Sub Study|Death|0|||
147359842|NCT04625725|531488107|FG001|Provent Sub Study|Death|0|||
147359843|NCT04625725|531488108|FG002|Provent Sub Study|Death|8|||
147359844|NCT04625725|531488109|FG003|Provent Sub Study|Death|5|||
147359845|NCT04625725|531488110|FG004|Provent Sub Study|Death|0|||
147359846|NCT04625725|531488111|FG005|Provent Sub Study|Death|1|||
147359847|NCT04625725|531488106|FG000|Provent Sub Study|Adverse Event|0|||
147359848|NCT04625725|531488107|FG001|Provent Sub Study|Adverse Event|0|||
147359849|NCT04625725|531488108|FG002|Provent Sub Study|Adverse Event|0|||
147359850|NCT04625725|531488109|FG003|Provent Sub Study|Adverse Event|0|||
147359851|NCT04625725|531488110|FG004|Provent Sub Study|Adverse Event|0|||
147359852|NCT04625725|531488111|FG005|Provent Sub Study|Adverse Event|1|||
147359853|NCT04625725|531488106|FG000|Provent Sub Study|DUE TO SUBJECT'S DECLINING HEALTH THE SUBJECT WILL NO LONGER BE ABLE TO PARTICIPATE IN THE STUDY|0|||
147359854|NCT04625725|531488107|FG001|Provent Sub Study|DUE TO SUBJECT'S DECLINING HEALTH THE SUBJECT WILL NO LONGER BE ABLE TO PARTICIPATE IN THE STUDY|0|||
147454128|NCT01564862|531824158|FG001|Overall Study|Major Protocol Deviation|3|||
147359855|NCT04625725|531488108|FG002|Provent Sub Study|DUE TO SUBJECT'S DECLINING HEALTH THE SUBJECT WILL NO LONGER BE ABLE TO PARTICIPATE IN THE STUDY|0|||
147359856|NCT04625725|531488109|FG003|Provent Sub Study|DUE TO SUBJECT'S DECLINING HEALTH THE SUBJECT WILL NO LONGER BE ABLE TO PARTICIPATE IN THE STUDY|0|||
147454129|NCT01564862|531824159|FG002|Overall Study|Major Protocol Deviation|4|||
147454130|NCT01564862|531824157|FG000|Overall Study|Lost to Follow-up|10|||
147454131|NCT01564862|531824158|FG001|Overall Study|Lost to Follow-up|8|||
147454132|NCT01564862|531824159|FG002|Overall Study|Lost to Follow-up|6|||
147454133|NCT01564862|531824157|FG000|Overall Study|Voluntary Withdrawal|9|||
147454134|NCT01564862|531824158|FG001|Overall Study|Voluntary Withdrawal|6|||
147359857|NCT04625725|531488110|FG004|Provent Sub Study|DUE TO SUBJECT'S DECLINING HEALTH THE SUBJECT WILL NO LONGER BE ABLE TO PARTICIPATE IN THE STUDY|1|||
147454135|NCT01564862|531824159|FG002|Overall Study|Voluntary Withdrawal|8|||
147454136|NCT01564862|531824157|FG000|Overall Study|Lack of Efficacy|1|||
147454137|NCT01564862|531824158|FG001|Overall Study|Lack of Efficacy|5|||
147608226|NCT00261443|532382572|FG001|1: Confirmation of Partial Nonresponse|Withdrawal by Subject|0|||
147608227|NCT00261443|532382573|FG002|1: Confirmation of Partial Nonresponse|Withdrawal by Subject|0|||
147608228|NCT00261443|532382571|FG000|1: Confirmation of Partial Nonresponse|Lost to Follow-up|111|||
147608229|NCT00261443|532382572|FG001|1: Confirmation of Partial Nonresponse|Lost to Follow-up|0|||
147608230|NCT00261443|532382573|FG002|1: Confirmation of Partial Nonresponse|Lost to Follow-up|0|||
147608231|NCT00261443|532382571|FG000|1: Confirmation of Partial Nonresponse|Poor/Noncompliance|23|||
147608232|NCT00261443|532382572|FG001|1: Confirmation of Partial Nonresponse|Poor/Noncompliance|0|||
147608233|NCT00261443|532382573|FG002|1: Confirmation of Partial Nonresponse|Poor/Noncompliance|0|||
147608234|NCT00261443|532382571|FG000|1: Confirmation of Partial Nonresponse|Pregnancy|1|||
147608235|NCT00261443|532382572|FG001|1: Confirmation of Partial Nonresponse|Pregnancy|0|||
147359858|NCT04625725|531488111|FG005|Provent Sub Study|DUE TO SUBJECT'S DECLINING HEALTH THE SUBJECT WILL NO LONGER BE ABLE TO PARTICIPATE IN THE STUDY|0|||
147608236|NCT00261443|532382573|FG002|1: Confirmation of Partial Nonresponse|Pregnancy|0|||
147608237|NCT00261443|532382571|FG000|1: Confirmation of Partial Nonresponse|Subject No Longer Met Study Criteria|307|||
147608238|NCT00261443|532382572|FG001|1: Confirmation of Partial Nonresponse|Subject No Longer Met Study Criteria|0|||
147608239|NCT00261443|532382573|FG002|1: Confirmation of Partial Nonresponse|Subject No Longer Met Study Criteria|0|||
147608240|NCT00261443|532382571|FG000|1: Confirmation of Partial Nonresponse|Other Reasons|16|||
147608241|NCT00261443|532382572|FG001|1: Confirmation of Partial Nonresponse|Other Reasons|0|||
147608242|NCT00261443|532382573|FG002|1: Confirmation of Partial Nonresponse|Other Reasons|0|||
147608243|NCT00261443|532382571|FG000|2: Stability & Maintenance of Stability|Lack of Efficacy|43|||
147608244|NCT00261443|532382572|FG001|2: Stability & Maintenance of Stability|Lack of Efficacy|0|||
147608245|NCT00261443|532382573|FG002|2: Stability & Maintenance of Stability|Lack of Efficacy|0|||
147608246|NCT00261443|532382571|FG000|2: Stability & Maintenance of Stability|Adverse Event|93|||
147608247|NCT00261443|532382572|FG001|2: Stability & Maintenance of Stability|Adverse Event|0|||
147608248|NCT00261443|532382573|FG002|2: Stability & Maintenance of Stability|Adverse Event|0|||
147608249|NCT00261443|532382571|FG000|2: Stability & Maintenance of Stability|Withdrawal by Subject|65|||
147608250|NCT00261443|532382572|FG001|2: Stability & Maintenance of Stability|Withdrawal by Subject|0|||
147608251|NCT00261443|532382573|FG002|2: Stability & Maintenance of Stability|Withdrawal by Subject|0|||
147608252|NCT00261443|532382571|FG000|2: Stability & Maintenance of Stability|Lost to Follow-up|59|||
147608253|NCT00261443|532382572|FG001|2: Stability & Maintenance of Stability|Lost to Follow-up|0|||
147608254|NCT00261443|532382573|FG002|2: Stability & Maintenance of Stability|Lost to Follow-up|0|||
147608255|NCT00261443|532382571|FG000|2: Stability & Maintenance of Stability|Poor/Noncompliance|33|||
147608256|NCT00261443|532382572|FG001|2: Stability & Maintenance of Stability|Poor/Noncompliance|0|||
147608257|NCT00261443|532382573|FG002|2: Stability & Maintenance of Stability|Poor/Noncompliance|0|||
147608258|NCT00261443|532382571|FG000|2: Stability & Maintenance of Stability|Pregnancy|1|||
147608259|NCT00261443|532382572|FG001|2: Stability & Maintenance of Stability|Pregnancy|0|||
147608260|NCT00261443|532382573|FG002|2: Stability & Maintenance of Stability|Pregnancy|0|||
147608261|NCT00261443|532382571|FG000|2: Stability & Maintenance of Stability|subject No Longer Met Study Criteria|32|||
147608262|NCT00261443|532382572|FG001|2: Stability & Maintenance of Stability|subject No Longer Met Study Criteria|0|||
147608263|NCT00261443|532382573|FG002|2: Stability & Maintenance of Stability|subject No Longer Met Study Criteria|0|||
147608264|NCT00261443|532382571|FG000|2: Stability & Maintenance of Stability|Administrative Reason by Sponsor|1|||
147608265|NCT00261443|532382572|FG001|2: Stability & Maintenance of Stability|Administrative Reason by Sponsor|0|||
147608266|NCT00261443|532382573|FG002|2: Stability & Maintenance of Stability|Administrative Reason by Sponsor|0|||
147608267|NCT00261443|532382571|FG000|2: Stability & Maintenance of Stability|Other Reasons|13|||
147608268|NCT00261443|532382572|FG001|2: Stability & Maintenance of Stability|Other Reasons|0|||
147608269|NCT00261443|532382573|FG002|2: Stability & Maintenance of Stability|Other Reasons|0|||
147608270|NCT00261443|532382571|FG000|3: Assessment of Relapse|Lack of Efficacy|0|||
147608271|NCT00261443|532382572|FG001|3: Assessment of Relapse|Lack of Efficacy|31|||
147608272|NCT00261443|532382573|FG002|3: Assessment of Relapse|Lack of Efficacy|14|||
147608273|NCT00261443|532382571|FG000|3: Assessment of Relapse|Adverse Event|0|||
147608274|NCT00261443|532382572|FG001|3: Assessment of Relapse|Adverse Event|15|||
147608275|NCT00261443|532382573|FG002|3: Assessment of Relapse|Adverse Event|19|||
147608276|NCT00261443|532382571|FG000|3: Assessment of Relapse|Withdrawal by Subject|0|||
147608277|NCT00261443|532382572|FG001|3: Assessment of Relapse|Withdrawal by Subject|14|||
147608278|NCT00261443|532382573|FG002|3: Assessment of Relapse|Withdrawal by Subject|15|||
147608279|NCT00261443|532382571|FG000|3: Assessment of Relapse|Death|0|||
147608280|NCT00261443|532382572|FG001|3: Assessment of Relapse|Death|0|||
147608281|NCT00261443|532382573|FG002|3: Assessment of Relapse|Death|1|||
147608282|NCT00261443|532382571|FG000|3: Assessment of Relapse|Lost to Follow-up|0|||
147608283|NCT00261443|532382572|FG001|3: Assessment of Relapse|Lost to Follow-up|7|||
147359859|NCT04625725|531488106|FG000|Provent Sub Study|Withdrawal by Subject|0|||
147359860|NCT04625725|531488107|FG001|Provent Sub Study|Withdrawal by Subject|0|||
147608284|NCT00261443|532382573|FG002|3: Assessment of Relapse|Lost to Follow-up|6|||
147608285|NCT00261443|532382571|FG000|3: Assessment of Relapse|Poor/Noncompliance|0|||
147359861|NCT04625725|531488108|FG002|Provent Sub Study|Withdrawal by Subject|11|||
147359862|NCT04625725|531488109|FG003|Provent Sub Study|Withdrawal by Subject|13|||
147359863|NCT04625725|531488110|FG004|Provent Sub Study|Withdrawal by Subject|5|||
147359864|NCT04625725|531488111|FG005|Provent Sub Study|Withdrawal by Subject|6|||
147359865|NCT04625725|531488106|FG000|Provent Sub Study|NON COMPLIANCE BY SUBJECT|0|||
147359866|NCT04625725|531488107|FG001|Provent Sub Study|NON COMPLIANCE BY SUBJECT|0|||
147359867|NCT04625725|531488108|FG002|Provent Sub Study|NON COMPLIANCE BY SUBJECT|0|||
147359868|NCT04625725|531488109|FG003|Provent Sub Study|NON COMPLIANCE BY SUBJECT|0|||
147359869|NCT04625725|531488110|FG004|Provent Sub Study|NON COMPLIANCE BY SUBJECT|0|||
147359870|NCT04625725|531488111|FG005|Provent Sub Study|NON COMPLIANCE BY SUBJECT|1|||
147359871|NCT05565820|531488119|FG000|7 Day Treatment Effectiveness|Withdrawal by Subject|2|||
147359872|NCT05565820|531488120|FG001|7 Day Treatment Effectiveness|Withdrawal by Subject|0|||
147359873|NCT05565820|531488119|FG000|14 Day Treatment Effectiveness|Withdrawal by Subject|2|||
147359874|NCT05565820|531488120|FG001|14 Day Treatment Effectiveness|Withdrawal by Subject|0|||
147359875|NCT03556293|531488123|FG000|Overall Study|Ineligible for analysis|1904|||
147359876|NCT03556293|531488124|FG001|Overall Study|Ineligible for analysis|1471|||
147359877|NCT03556293|531488125|FG002|Overall Study|Ineligible for analysis|1091|||
147359878|NCT03556293|531488126|FG003|Overall Study|Ineligible for analysis|1269|||
147359879|NCT05104463|531488127|FG000|Overall Study|Adverse Event|1|||
147359880|NCT05104463|531488128|FG001|Overall Study|Adverse Event|1|||
147359881|NCT05104463|531488127|FG000|Overall Study|Lost to Follow-up|1|||
147359882|NCT05104463|531488128|FG001|Overall Study|Lost to Follow-up|1|||
147359883|NCT05104463|531488127|FG000|Overall Study|Physician Decision|1|||
147359884|NCT05104463|531488128|FG001|Overall Study|Physician Decision|0|||
147359885|NCT05104463|531488127|FG000|Overall Study|Protocol Violation|0|||
147359886|NCT05104463|531488128|FG001|Overall Study|Protocol Violation|2|||
147359887|NCT05104463|531488127|FG000|Overall Study|Withdrawal by Subject|1|||
147359888|NCT05104463|531488128|FG001|Overall Study|Withdrawal by Subject|1|||
147359889|NCT04132518|531488133|FG000|Overall Study|Prematurely withdrawn from the study|0|||
147359890|NCT04132518|531488134|FG001|Overall Study|Prematurely withdrawn from the study|9|||
147359891|NCT04132518|531488135|FG002|Overall Study|Prematurely withdrawn from the study|1|||
147359892|NCT05425420|531488137|FG000|Overall Study|Physician Decision|1|||
147359893|NCT05425420|531488137|FG000|Overall Study|Failure to Meet Continuation Criteria|2|||
147359894|NCT04056611|531488138|FG000|Overall Study|Physician Decision|1|||
147359895|NCT02631746|531488141|FG000|Overall Study|Lack of Efficacy|3|||
147359896|NCT04183283|531489999|FG000|Period 1|Withdrawal by Subject|0|||
147359897|NCT04183283|531490000|FG001|Period 1|Withdrawal by Subject|1|||
147359898|NCT04183283|531490001|FG002|Period 1|Withdrawal by Subject|0|||
147359899|NCT04183283|531490002|FG003|Period 1|Withdrawal by Subject|0|||
147359900|NCT04183283|531489999|FG000|Washout 1(14 Days)|Positive Drug Screen|0|||
147359901|NCT04183283|531490000|FG001|Washout 1(14 Days)|Positive Drug Screen|0|||
147359902|NCT04183283|531490001|FG002|Washout 1(14 Days)|Positive Drug Screen|0|||
147359903|NCT04183283|531490002|FG003|Washout 1(14 Days)|Positive Drug Screen|1|||
147359904|NCT03220035|531490004|FG000|Overall Study|Adverse Event|1|||
147359905|NCT03220035|531490004|FG000|Overall Study|Protocol Violation|1|||
147359906|NCT03220035|531490004|FG000|Overall Study|Progressive Disease|2|||
147359907|NCT00696111|531490005|FG000|Overall Study|Withdrawal by Subject|17|||
147359908|NCT05299073|531490006|FG000|Overall Study|Withdrawal by Subject|0|||
147359909|NCT05299073|531490007|FG001|Overall Study|Withdrawal by Subject|0|||
147359910|NCT05299073|531490008|FG002|Overall Study|Withdrawal by Subject|1|||
147359911|NCT05299073|531490006|FG000|Overall Study|Adverse Event|0|||
147359912|NCT05299073|531490007|FG001|Overall Study|Adverse Event|1|||
147359913|NCT05299073|531490008|FG002|Overall Study|Adverse Event|0|||
147359914|NCT05299073|531490006|FG000|Overall Study|Lost to Follow-up|0|||
147359915|NCT05299073|531490007|FG001|Overall Study|Lost to Follow-up|1|||
147359916|NCT05299073|531490008|FG002|Overall Study|Lost to Follow-up|0|||
147359917|NCT05452460|531490009|FG000|Overall Study|Lost to Follow-up|3|||
147359918|NCT05452460|531490010|FG001|Overall Study|Lost to Follow-up|3|||
147359919|NCT05452460|531490009|FG000|Overall Study|Did not receive intervention|1|||
147359920|NCT05452460|531490010|FG001|Overall Study|Did not receive intervention|0|||
147359921|NCT04433208|531490011|FG000|Overall Study|Withdrawal by Subject|0|||
147359922|NCT04433208|531490012|FG001|Overall Study|Withdrawal by Subject|1|||
147359923|NCT04433208|531490013|FG002|Overall Study|Withdrawal by Subject|1|||
147359924|NCT04433208|531490014|FG003|Overall Study|Withdrawal by Subject|0|||
147359925|NCT04433208|531490015|FG004|Overall Study|Withdrawal by Subject|2|||
147359926|NCT04433208|531490016|FG005|Overall Study|Withdrawal by Subject|1|||
147359927|NCT04433208|531490011|FG000|Overall Study|Lost to Follow-up|0|||
147359928|NCT04433208|531490012|FG001|Overall Study|Lost to Follow-up|0|||
147359929|NCT04433208|531490013|FG002|Overall Study|Lost to Follow-up|0|||
147359930|NCT04433208|531490014|FG003|Overall Study|Lost to Follow-up|0|||
147359931|NCT04433208|531490015|FG004|Overall Study|Lost to Follow-up|0|||
147359932|NCT04433208|531490016|FG005|Overall Study|Lost to Follow-up|1|||
147359933|NCT03676192|531490021|FG000|Induction Study Period|Adverse Event|21|||
147359934|NCT03676192|531490022|FG001|Induction Study Period|Adverse Event|20|||
147359935|NCT03676192|531490021|FG000|Induction Study Period|Death|23|||
147359936|NCT03676192|531490022|FG001|Induction Study Period|Death|20|||
147359937|NCT03676192|531490021|FG000|Induction Study Period|Lost to Follow-up|3|||
147359938|NCT03676192|531490022|FG001|Induction Study Period|Lost to Follow-up|3|||
147359939|NCT03676192|531490021|FG000|Induction Study Period|Physician Decision|6|||
147359940|NCT03676192|531490022|FG001|Induction Study Period|Physician Decision|3|||
147359941|NCT03676192|531490021|FG000|Induction Study Period|Progressive Disease|32|||
147359942|NCT03676192|531490022|FG001|Induction Study Period|Progressive Disease|21|||
147359943|NCT03676192|531490021|FG000|Induction Study Period|Protocol Violation|1|||
147359944|NCT03676192|531490022|FG001|Induction Study Period|Protocol Violation|2|||
147359945|NCT03676192|531490021|FG000|Induction Study Period|Withdrawal by Subject|20|||
147359946|NCT03676192|531490022|FG001|Induction Study Period|Withdrawal by Subject|15|||
147359947|NCT03386578|531490024|FG000|PK Component|Lost to Follow-up|0|||
147359948|NCT03386578|531490025|FG001|PK Component|Lost to Follow-up|1|||
147359949|NCT03386578|531490026|FG002|PK Component|Lost to Follow-up|0|||
147359950|NCT03386578|531490027|FG003|PK Component|Lost to Follow-up|0|||
147359951|NCT03386578|531490028|FG004|PK Component|Lost to Follow-up|0|||
147359952|NCT03386578|531490029|FG005|PK Component|Lost to Follow-up|0|||
147359953|NCT03386578|531490030|FG006|PK Component|Lost to Follow-up|1|||
147359954|NCT03386578|531490031|FG007|PK Component|Lost to Follow-up|0|||
147359955|NCT03386578|531490032|FG008|PK Component|Lost to Follow-up|0|||
147359956|NCT03386578|531490033|FG009|PK Component|Lost to Follow-up|0|||
147359957|NCT03386578|531490024|FG000|PK Component|Stillbirth/Abortion|0|||
147359958|NCT03386578|531490025|FG001|PK Component|Stillbirth/Abortion|0|||
147359959|NCT03386578|531490026|FG002|PK Component|Stillbirth/Abortion|0|||
147359960|NCT03386578|531490027|FG003|PK Component|Stillbirth/Abortion|0|||
147359961|NCT03386578|531490028|FG004|PK Component|Stillbirth/Abortion|0|||
147359962|NCT03386578|531490029|FG005|PK Component|Stillbirth/Abortion|2|||
147359963|NCT03386578|531490030|FG006|PK Component|Stillbirth/Abortion|0|||
147359964|NCT03386578|531490031|FG007|PK Component|Stillbirth/Abortion|0|||
147359965|NCT03386578|531490032|FG008|PK Component|Stillbirth/Abortion|0|||
147359966|NCT03386578|531490033|FG009|PK Component|Stillbirth/Abortion|0|||
147359967|NCT03386578|531490024|FG000|PrEP Comparison Component Step 1|Lost to Follow-up|0|||
147359968|NCT03386578|531490025|FG001|PrEP Comparison Component Step 1|Lost to Follow-up|0|||
147359969|NCT03386578|531490026|FG002|PrEP Comparison Component Step 1|Lost to Follow-up|17|||
147359970|NCT03386578|531490027|FG003|PrEP Comparison Component Step 1|Lost to Follow-up|9|||
147359971|NCT03386578|531490028|FG004|PrEP Comparison Component Step 1|Lost to Follow-up|0|||
147359972|NCT03386578|531490029|FG005|PrEP Comparison Component Step 1|Lost to Follow-up|0|||
147359973|NCT03386578|531490030|FG006|PrEP Comparison Component Step 1|Lost to Follow-up|0|||
147359974|NCT03386578|531490031|FG007|PrEP Comparison Component Step 1|Lost to Follow-up|7|||
147359975|NCT03386578|531490032|FG008|PrEP Comparison Component Step 1|Lost to Follow-up|5|||
147359976|NCT03386578|531490033|FG009|PrEP Comparison Component Step 1|Lost to Follow-up|0|||
147359977|NCT03386578|531490024|FG000|PrEP Comparison Component Step 1|Withdrawal by Subject|0|||
147359978|NCT03386578|531490025|FG001|PrEP Comparison Component Step 1|Withdrawal by Subject|0|||
147359979|NCT03386578|531490026|FG002|PrEP Comparison Component Step 1|Withdrawal by Subject|9|||
147359980|NCT03386578|531490027|FG003|PrEP Comparison Component Step 1|Withdrawal by Subject|4|||
147359981|NCT03386578|531490028|FG004|PrEP Comparison Component Step 1|Withdrawal by Subject|0|||
147359982|NCT03386578|531490029|FG005|PrEP Comparison Component Step 1|Withdrawal by Subject|0|||
147359983|NCT03386578|531490030|FG006|PrEP Comparison Component Step 1|Withdrawal by Subject|0|||
147359984|NCT03386578|531490031|FG007|PrEP Comparison Component Step 1|Withdrawal by Subject|5|||
147359985|NCT03386578|531490032|FG008|PrEP Comparison Component Step 1|Withdrawal by Subject|1|||
147359986|NCT03386578|531490033|FG009|PrEP Comparison Component Step 1|Withdrawal by Subject|0|||
147359987|NCT03386578|531490024|FG000|PrEP Comparison Component Step 1|Death|0|||
147359988|NCT03386578|531490025|FG001|PrEP Comparison Component Step 1|Death|0|||
147359989|NCT03386578|531490026|FG002|PrEP Comparison Component Step 1|Death|1|||
147359990|NCT03386578|531490027|FG003|PrEP Comparison Component Step 1|Death|0|||
147359991|NCT03386578|531490028|FG004|PrEP Comparison Component Step 1|Death|0|||
147359992|NCT03386578|531490029|FG005|PrEP Comparison Component Step 1|Death|0|||
147359993|NCT03386578|531490030|FG006|PrEP Comparison Component Step 1|Death|0|||
147359994|NCT03386578|531490031|FG007|PrEP Comparison Component Step 1|Death|9|||
147359995|NCT03386578|531490032|FG008|PrEP Comparison Component Step 1|Death|5|||
147359996|NCT03386578|531490033|FG009|PrEP Comparison Component Step 1|Death|0|||
147359997|NCT03386578|531490024|FG000|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
147359998|NCT03386578|531490025|FG001|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
147359999|NCT03386578|531490026|FG002|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
147360000|NCT03386578|531490027|FG003|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|13|||
147360001|NCT03386578|531490028|FG004|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
147360002|NCT03386578|531490029|FG005|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
147360003|NCT03386578|531490030|FG006|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
147360004|NCT03386578|531490031|FG007|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
147360005|NCT03386578|531490032|FG008|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|13|||
147360006|NCT03386578|531490033|FG009|PrEP Comparison Component Step 1|Enrolled to Cohort 2/Step 2|0|||
147360007|NCT03386578|531490024|FG000|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
147360008|NCT03386578|531490025|FG001|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
147360009|NCT03386578|531490026|FG002|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
147608286|NCT00261443|532382572|FG001|3: Assessment of Relapse|Poor/Noncompliance|5|||
147360010|NCT03386578|531490027|FG003|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
147360011|NCT03386578|531490028|FG004|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
147360012|NCT03386578|531490029|FG005|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
147360013|NCT03386578|531490030|FG006|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
147360014|NCT03386578|531490031|FG007|PrEP Comparison Component Step 1|Stillbirth/Abortion|2|||
147360015|NCT03386578|531490032|FG008|PrEP Comparison Component Step 1|Stillbirth/Abortion|4|||
147360016|NCT03386578|531490033|FG009|PrEP Comparison Component Step 1|Stillbirth/Abortion|0|||
147360017|NCT03386578|531490024|FG000|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
147360018|NCT03386578|531490025|FG001|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
147360019|NCT03386578|531490026|FG002|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
147360020|NCT03386578|531490027|FG003|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
147360021|NCT03386578|531490028|FG004|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
147360022|NCT03386578|531490029|FG005|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
147360023|NCT03386578|531490030|FG006|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
147360024|NCT03386578|531490031|FG007|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|10|||
147360025|NCT03386578|531490032|FG008|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|5|||
147360026|NCT03386578|531490033|FG009|PrEP Comparison Component Step 1|Maternal Off-study During Pregnancy|0|||
147360027|NCT02424617|531490034|FG000|Overall Study|Adverse Event|0|||
147360028|NCT02424617|531490035|FG001|Overall Study|Adverse Event|1|||
147360029|NCT02424617|531490036|FG002|Overall Study|Adverse Event|0|||
147360030|NCT02424617|531490037|FG003|Overall Study|Adverse Event|0|||
147360031|NCT02424617|531490034|FG000|Overall Study|Investigator Decision|0|||
147360032|NCT02424617|531490035|FG001|Overall Study|Investigator Decision|0|||
147360033|NCT02424617|531490036|FG002|Overall Study|Investigator Decision|0|||
147360034|NCT02424617|531490037|FG003|Overall Study|Investigator Decision|1|||
147360035|NCT02424617|531490034|FG000|Overall Study|Withdrawal by Subject|1|||
147360036|NCT02424617|531490035|FG001|Overall Study|Withdrawal by Subject|1|||
147360037|NCT02424617|531490036|FG002|Overall Study|Withdrawal by Subject|0|||
147360038|NCT02424617|531490037|FG003|Overall Study|Withdrawal by Subject|1|||
147360039|NCT02424617|531490034|FG000|Overall Study|Progressive Disease|7|||
147360040|NCT02424617|531490035|FG001|Overall Study|Progressive Disease|6|||
147360041|NCT02424617|531490036|FG002|Overall Study|Progressive Disease|11|||
147360042|NCT02424617|531490037|FG003|Overall Study|Progressive Disease|10|||
147360043|NCT02424617|531490034|FG000|Overall Study|Other|0|||
147360044|NCT02424617|531490035|FG001|Overall Study|Other|0|||
147360045|NCT02424617|531490036|FG002|Overall Study|Other|0|||
147360046|NCT02424617|531490037|FG003|Overall Study|Other|1|||
147360047|NCT02694822|531490038|FG000|Phase 1|Death|2|||
147360048|NCT02694822|531490039|FG001|Phase 1|Death|1|||
147360049|NCT02694822|531490040|FG002|Phase 1|Death|6|||
147360050|NCT02694822|531490041|FG003|Phase 1|Death|6|||
147360051|NCT02694822|531490042|FG004|Phase 1|Death|3|||
147360052|NCT02694822|531490043|FG005|Phase 1|Death|0|||
147360053|NCT02694822|531490038|FG000|Phase 1|Withdrawal by Subject|2|||
147360054|NCT02694822|531490039|FG001|Phase 1|Withdrawal by Subject|2|||
147360055|NCT02694822|531490040|FG002|Phase 1|Withdrawal by Subject|4|||
147360056|NCT02694822|531490041|FG003|Phase 1|Withdrawal by Subject|8|||
147360057|NCT02694822|531490042|FG004|Phase 1|Withdrawal by Subject|1|||
147360058|NCT02694822|531490043|FG005|Phase 1|Withdrawal by Subject|0|||
147360059|NCT02694822|531490038|FG000|Phase 2|Death|0|||
147360060|NCT02694822|531490039|FG001|Phase 2|Death|0|||
147360061|NCT02694822|531490040|FG002|Phase 2|Death|0|||
147360062|NCT02694822|531490041|FG003|Phase 2|Death|0|||
147360063|NCT02694822|531490042|FG004|Phase 2|Death|0|||
147360064|NCT02694822|531490043|FG005|Phase 2|Death|26|||
147360065|NCT02694822|531490038|FG000|Phase 2|Withdrawal by Subject|0|||
147360066|NCT02694822|531490039|FG001|Phase 2|Withdrawal by Subject|0|||
147360067|NCT02694822|531490040|FG002|Phase 2|Withdrawal by Subject|0|||
147360068|NCT02694822|531490041|FG003|Phase 2|Withdrawal by Subject|0|||
147360069|NCT02694822|531490042|FG004|Phase 2|Withdrawal by Subject|0|||
147360070|NCT02694822|531490043|FG005|Phase 2|Withdrawal by Subject|13|||
147608287|NCT00261443|532382573|FG002|3: Assessment of Relapse|Poor/Noncompliance|3|||
147608288|NCT00261443|532382571|FG000|3: Assessment of Relapse|Pregnancy|0|||
147608289|NCT00261443|532382572|FG001|3: Assessment of Relapse|Pregnancy|2|||
147360071|NCT02694822|531490038|FG000|Phase 2|Administrative Study Closure|0|||
147608290|NCT00261443|532382573|FG002|3: Assessment of Relapse|Pregnancy|1|||
147608291|NCT00261443|532382571|FG000|3: Assessment of Relapse|Subject No Longer Meets Study Criteria|0|||
147608292|NCT00261443|532382572|FG001|3: Assessment of Relapse|Subject No Longer Meets Study Criteria|2|||
147360072|NCT02694822|531490039|FG001|Phase 2|Administrative Study Closure|0|||
147360073|NCT02694822|531490040|FG002|Phase 2|Administrative Study Closure|0|||
147360074|NCT02694822|531490041|FG003|Phase 2|Administrative Study Closure|0|||
147608293|NCT00261443|532382573|FG002|3: Assessment of Relapse|Subject No Longer Meets Study Criteria|1|||
147608294|NCT00261443|532382571|FG000|3: Assessment of Relapse|Administrative Reason By Sponsor|0|||
147360075|NCT02694822|531490042|FG004|Phase 2|Administrative Study Closure|0|||
147360076|NCT02694822|531490043|FG005|Phase 2|Administrative Study Closure|2|||
147360077|NCT02694822|531490038|FG000|Phase 2|Lost to Follow-up|0|||
147360078|NCT02694822|531490039|FG001|Phase 2|Lost to Follow-up|0|||
147360079|NCT02694822|531490040|FG002|Phase 2|Lost to Follow-up|0|||
147360080|NCT02694822|531490041|FG003|Phase 2|Lost to Follow-up|0|||
147360081|NCT02694822|531490042|FG004|Phase 2|Lost to Follow-up|0|||
147360082|NCT02694822|531490043|FG005|Phase 2|Lost to Follow-up|1|||
147360083|NCT02694822|531490038|FG000|Phase 2|Participant Transferred to Another Site|0|||
147360084|NCT02694822|531490039|FG001|Phase 2|Participant Transferred to Another Site|0|||
147360085|NCT02694822|531490040|FG002|Phase 2|Participant Transferred to Another Site|0|||
147360086|NCT02694822|531490041|FG003|Phase 2|Participant Transferred to Another Site|0|||
147360087|NCT02694822|531490042|FG004|Phase 2|Participant Transferred to Another Site|0|||
147360088|NCT02694822|531490043|FG005|Phase 2|Participant Transferred to Another Site|1|||
147360089|NCT01868997|531490044|FG000|Overall Study|Adverse Event|2|||
147360090|NCT01868997|531490045|FG001|Overall Study|Adverse Event|5|||
147360091|NCT01868997|531490044|FG000|Overall Study|Lack of Efficacy|2|||
147360092|NCT01868997|531490045|FG001|Overall Study|Lack of Efficacy|0|||
147360093|NCT01868997|531490044|FG000|Overall Study|Other|3|||
147360094|NCT01868997|531490045|FG001|Overall Study|Other|1|||
147360095|NCT01960452|531490046|FG000|Overall Study|Withdrawal by Subject|2|||
147360096|NCT01960452|531490047|FG001|Overall Study|Withdrawal by Subject|1|||
147360097|NCT01960452|531490046|FG000|Overall Study|Sleep apnea in Night 1|1|||
147360098|NCT01960452|531490047|FG001|Overall Study|Sleep apnea in Night 1|0|||
147360099|NCT01960452|531490046|FG000|Overall Study|Poor Sleep in Night 1|0|||
147360100|NCT01960452|531490047|FG001|Overall Study|Poor Sleep in Night 1|2|||
147360101|NCT01960452|531490046|FG000|Overall Study|No Sex/Age Match Night 1|1|||
147360102|NCT01960452|531490047|FG001|Overall Study|No Sex/Age Match Night 1|0|||
147360103|NCT01960452|531490046|FG000|Overall Study|No Sex/Age Match Night 2|0|||
147360104|NCT01960452|531490047|FG001|Overall Study|No Sex/Age Match Night 2|2|||
147360105|NCT01960452|531490046|FG000|Overall Study|Technical Difficulties Night 2|2|||
147360106|NCT01960452|531490047|FG001|Overall Study|Technical Difficulties Night 2|0|||
147454138|NCT01564862|531824159|FG002|Overall Study|Lack of Efficacy|6|||
147454139|NCT01564862|531824157|FG000|Overall Study|Other reason(s)|1|||
147454140|NCT01564862|531824158|FG001|Overall Study|Other reason(s)|0|||
147454141|NCT01564862|531824159|FG002|Overall Study|Other reason(s)|0|||
147454142|NCT03809611|531824160|FG000|Overall Study|Withdrawal by Subject|1|||
147454143|NCT03809611|531824161|FG001|Overall Study|Withdrawal by Subject|1|||
147454144|NCT02193074|531824164|FG000|Overall Study|Withdrawal by Subject|1|||
147454145|NCT02193074|531824165|FG001|Overall Study|Withdrawal by Subject|2|||
147454146|NCT02193074|531824164|FG000|Overall Study|Adverse Event|16|||
147454147|NCT02193074|531824165|FG001|Overall Study|Adverse Event|13|||
147360117|NCT04066205|531490052|FG000|T2 Immediate Post-Intervention|Did not respond during intervention or usual care|5|||
147360118|NCT04066205|531490053|FG001|T2 Immediate Post-Intervention|Did not respond during intervention or usual care|3|||
147360119|NCT04066205|531490052|FG000|T2 Immediate Post-Intervention|did not respond|5|||
147360120|NCT04066205|531490053|FG001|T2 Immediate Post-Intervention|did not respond|3|||
147360121|NCT04294641|531490055|FG000|Overall Study|Screen failure|4|||
147360122|NCT04730739|531490057|FG000|Overall Study|Death|1|||
147360123|NCT03308877|531490058|FG000|Overall Study|Lost to Follow-up|32|||
147360124|NCT03308877|531490059|FG001|Overall Study|Lost to Follow-up|28|||
147360125|NCT05646355|531490067|FG000|Overall Study|Lost to Follow-up|1|||
147360126|NCT05646355|531490068|FG001|Overall Study|Lost to Follow-up|0|||
147360127|NCT05646355|531490067|FG000|Overall Study|translated materials not available for pilot|2|||
147360128|NCT05646355|531490068|FG001|Overall Study|translated materials not available for pilot|0|||
147360129|NCT05646355|531490067|FG000|Overall Study|no longer screen eligible (completed screening prior to intervention)|6|||
147360130|NCT05646355|531490068|FG001|Overall Study|no longer screen eligible (completed screening prior to intervention)|0|||
147360131|NCT03523572|531490071|FG000|Dose Escalation|Progressive disease|1|||
147360132|NCT03523572|531490072|FG001|Dose Escalation|Progressive disease|0|||
147360133|NCT03523572|531490073|FG002|Dose Escalation|Progressive disease|0|||
147360134|NCT03523572|531490074|FG003|Dose Escalation|Progressive disease|0|||
147360135|NCT03523572|531490075|FG004|Dose Escalation|Progressive disease|0|||
147360136|NCT03523572|531490076|FG005|Dose Escalation|Progressive disease|0|||
147360137|NCT03523572|531490071|FG000|Dose Escalation|Clinical Progression|0|||
147360138|NCT03523572|531490072|FG001|Dose Escalation|Clinical Progression|1|||
147360139|NCT03523572|531490073|FG002|Dose Escalation|Clinical Progression|0|||
147360140|NCT03523572|531490074|FG003|Dose Escalation|Clinical Progression|0|||
147360141|NCT03523572|531490075|FG004|Dose Escalation|Clinical Progression|0|||
147360142|NCT03523572|531490076|FG005|Dose Escalation|Clinical Progression|0|||
147360143|NCT03523572|531490071|FG000|Dose Escalation|Adverse Event|2|||
147360144|NCT03523572|531490072|FG001|Dose Escalation|Adverse Event|0|||
147360145|NCT03523572|531490073|FG002|Dose Escalation|Adverse Event|0|||
147360146|NCT03523572|531490074|FG003|Dose Escalation|Adverse Event|0|||
147360147|NCT03523572|531490075|FG004|Dose Escalation|Adverse Event|0|||
147360148|NCT03523572|531490076|FG005|Dose Escalation|Adverse Event|0|||
147360149|NCT03523572|531490071|FG000|Dose Escalation|Physician Decision|1|||
147454148|NCT02600494|531824173|FG000|Part A (6 Week Double-Blind Treatment)|Adverse Event|13|||
147360150|NCT03523572|531490072|FG001|Dose Escalation|Physician Decision|1|||
147360151|NCT03523572|531490073|FG002|Dose Escalation|Physician Decision|0|||
147360152|NCT03523572|531490074|FG003|Dose Escalation|Physician Decision|0|||
147360153|NCT03523572|531490075|FG004|Dose Escalation|Physician Decision|0|||
147360154|NCT03523572|531490076|FG005|Dose Escalation|Physician Decision|0|||
147360155|NCT03523572|531490071|FG000|Dose Expansion|Progressive Disease|0|||
147360156|NCT03523572|531490072|FG001|Dose Expansion|Progressive Disease|0|||
147360157|NCT03523572|531490073|FG002|Dose Expansion|Progressive Disease|9|||
147360158|NCT03523572|531490074|FG003|Dose Expansion|Progressive Disease|11|||
147360159|NCT03523572|531490075|FG004|Dose Expansion|Progressive Disease|15|||
147360160|NCT03523572|531490076|FG005|Dose Expansion|Progressive Disease|2|||
147360161|NCT03523572|531490071|FG000|Dose Expansion|Clinical Progression|0|||
147360162|NCT03523572|531490072|FG001|Dose Expansion|Clinical Progression|0|||
147360163|NCT03523572|531490073|FG002|Dose Expansion|Clinical Progression|2|||
147360164|NCT03523572|531490074|FG003|Dose Expansion|Clinical Progression|2|||
147360165|NCT03523572|531490075|FG004|Dose Expansion|Clinical Progression|2|||
147360166|NCT03523572|531490076|FG005|Dose Expansion|Clinical Progression|0|||
147360167|NCT03523572|531490071|FG000|Dose Expansion|Adverse Event|0|||
147360168|NCT03523572|531490072|FG001|Dose Expansion|Adverse Event|0|||
147360169|NCT03523572|531490073|FG002|Dose Expansion|Adverse Event|10|||
147360170|NCT03523572|531490074|FG003|Dose Expansion|Adverse Event|1|||
147360171|NCT03523572|531490075|FG004|Dose Expansion|Adverse Event|5|||
147360172|NCT03523572|531490076|FG005|Dose Expansion|Adverse Event|2|||
147360173|NCT03523572|531490071|FG000|Dose Expansion|Withdrawal by Subject|0|||
147360174|NCT03523572|531490072|FG001|Dose Expansion|Withdrawal by Subject|0|||
147360175|NCT03523572|531490073|FG002|Dose Expansion|Withdrawal by Subject|1|||
147360176|NCT03523572|531490074|FG003|Dose Expansion|Withdrawal by Subject|1|||
147360177|NCT03523572|531490075|FG004|Dose Expansion|Withdrawal by Subject|0|||
147360178|NCT03523572|531490076|FG005|Dose Expansion|Withdrawal by Subject|0|||
147360179|NCT03523572|531490071|FG000|Dose Expansion|Physician Decision|0|||
147360180|NCT03523572|531490072|FG001|Dose Expansion|Physician Decision|0|||
147360181|NCT03523572|531490073|FG002|Dose Expansion|Physician Decision|1|||
147360182|NCT03523572|531490074|FG003|Dose Expansion|Physician Decision|0|||
147360183|NCT03523572|531490075|FG004|Dose Expansion|Physician Decision|1|||
147360184|NCT03523572|531490076|FG005|Dose Expansion|Physician Decision|0|||
147360185|NCT03523572|531490071|FG000|Dose Expansion|Miscellaneous|0|||
147360186|NCT03523572|531490072|FG001|Dose Expansion|Miscellaneous|0|||
147360187|NCT03523572|531490073|FG002|Dose Expansion|Miscellaneous|0|||
147360188|NCT03523572|531490074|FG003|Dose Expansion|Miscellaneous|0|||
147360189|NCT03523572|531490075|FG004|Dose Expansion|Miscellaneous|3|||
147360190|NCT03523572|531490076|FG005|Dose Expansion|Miscellaneous|0|||
147360191|NCT04685135|531490082|FG000|Overall Study|Death|126|||
147360192|NCT04685135|531490083|FG001|Overall Study|Death|53|||
147360193|NCT04685135|531490082|FG000|Overall Study|Withdrawal by Subject|12|||
147360194|NCT04685135|531490083|FG001|Overall Study|Withdrawal by Subject|16|||
147360195|NCT02315703|531490084|FG000|Main Study (From Week 0 up to Week 96)|Adverse Event|0|||
147360196|NCT02315703|531490085|FG001|Main Study (From Week 0 up to Week 96)|Adverse Event|0|||
147360197|NCT02315703|531490086|FG002|Main Study (From Week 0 up to Week 96)|Adverse Event|0|||
147360198|NCT02315703|531490087|FG003|Main Study (From Week 0 up to Week 96)|Adverse Event|1|||
147360199|NCT02315703|531490088|FG004|Main Study (From Week 0 up to Week 96)|Adverse Event|1|||
147360200|NCT02315703|531490089|FG005|Main Study (From Week 0 up to Week 96)|Adverse Event|0|||
147360201|NCT02315703|531490090|FG006|Main Study (From Week 0 up to Week 96)|Adverse Event|1|||
147360202|NCT02315703|531490091|FG007|Main Study (From Week 0 up to Week 96)|Adverse Event|0|||
147360203|NCT02315703|531490084|FG000|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|1|||
147360204|NCT02315703|531490085|FG001|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|5|||
147360205|NCT02315703|531490086|FG002|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|3|||
147360206|NCT02315703|531490087|FG003|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|3|||
147360207|NCT02315703|531490088|FG004|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|2|||
147360208|NCT02315703|531490089|FG005|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|1|||
147360209|NCT02315703|531490090|FG006|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|2|||
147360210|NCT02315703|531490091|FG007|Main Study (From Week 0 up to Week 96)|Lost to Follow-up|2|||
147360211|NCT02315703|531490084|FG000|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
147360212|NCT02315703|531490085|FG001|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
147360213|NCT02315703|531490086|FG002|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
147360214|NCT02315703|531490087|FG003|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
147360215|NCT02315703|531490088|FG004|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
147360216|NCT02315703|531490089|FG005|Main Study (From Week 0 up to Week 96)|Physician Decision|2|||
147360217|NCT02315703|531490090|FG006|Main Study (From Week 0 up to Week 96)|Physician Decision|1|||
147360218|NCT02315703|531490091|FG007|Main Study (From Week 0 up to Week 96)|Physician Decision|0|||
147360219|NCT02315703|531490084|FG000|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
147360220|NCT02315703|531490085|FG001|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
147360221|NCT02315703|531490086|FG002|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
147360222|NCT02315703|531490087|FG003|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
147360223|NCT02315703|531490088|FG004|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
147360224|NCT02315703|531490089|FG005|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
147360225|NCT02315703|531490090|FG006|Main Study (From Week 0 up to Week 96)|Pregnancy|0|||
147360226|NCT02315703|531490091|FG007|Main Study (From Week 0 up to Week 96)|Pregnancy|1|||
147360227|NCT02315703|531490084|FG000|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|1|||
147360228|NCT02315703|531490085|FG001|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|3|||
147360229|NCT02315703|531490086|FG002|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|0|||
147360230|NCT02315703|531490087|FG003|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|3|||
147360231|NCT02315703|531490088|FG004|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|4|||
147360232|NCT02315703|531490089|FG005|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|1|||
147360233|NCT02315703|531490090|FG006|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|1|||
147360234|NCT02315703|531490091|FG007|Main Study (From Week 0 up to Week 96)|Withdrawal by Subject|2|||
147360235|NCT02315703|531490084|FG000|Main Study (From Week 0 up to Week 96)|Other|4|||
147360236|NCT02315703|531490085|FG001|Main Study (From Week 0 up to Week 96)|Other|2|||
147360237|NCT02315703|531490086|FG002|Main Study (From Week 0 up to Week 96)|Other|2|||
147360238|NCT02315703|531490087|FG003|Main Study (From Week 0 up to Week 96)|Other|2|||
147360239|NCT02315703|531490088|FG004|Main Study (From Week 0 up to Week 96)|Other|1|||
147360240|NCT02315703|531490089|FG005|Main Study (From Week 0 up to Week 96)|Other|2|||
147360241|NCT02315703|531490090|FG006|Main Study (From Week 0 up to Week 96)|Other|8|||
147360242|NCT02315703|531490091|FG007|Main Study (From Week 0 up to Week 96)|Other|2|||
147360243|NCT02315703|531490084|FG000|LTE (After Week 96 up to Week 336)|Lost to Follow-up|1|||
147360244|NCT02315703|531490085|FG001|LTE (After Week 96 up to Week 336)|Lost to Follow-up|2|||
147360245|NCT02315703|531490086|FG002|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
147360246|NCT02315703|531490087|FG003|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
147360247|NCT02315703|531490088|FG004|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
147360248|NCT02315703|531490089|FG005|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
147360249|NCT02315703|531490090|FG006|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
147360250|NCT02315703|531490091|FG007|LTE (After Week 96 up to Week 336)|Lost to Follow-up|0|||
147360251|NCT02315703|531490084|FG000|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
147360252|NCT02315703|531490085|FG001|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|3|||
147360253|NCT02315703|531490086|FG002|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
147360254|NCT02315703|531490087|FG003|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
147360255|NCT02315703|531490088|FG004|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
147360256|NCT02315703|531490089|FG005|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
147360257|NCT02315703|531490090|FG006|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
147360258|NCT02315703|531490091|FG007|LTE (After Week 96 up to Week 336)|Withdrawal by Subject|0|||
147360259|NCT02315703|531490084|FG000|LTE (After Week 96 up to Week 336)|Other|1|||
147360260|NCT02315703|531490085|FG001|LTE (After Week 96 up to Week 336)|Other|0|||
147360261|NCT02315703|531490086|FG002|LTE (After Week 96 up to Week 336)|Other|0|||
147360262|NCT02315703|531490087|FG003|LTE (After Week 96 up to Week 336)|Other|0|||
147360263|NCT02315703|531490088|FG004|LTE (After Week 96 up to Week 336)|Other|0|||
147360264|NCT02315703|531490089|FG005|LTE (After Week 96 up to Week 336)|Other|0|||
147360265|NCT02315703|531490090|FG006|LTE (After Week 96 up to Week 336)|Other|0|||
147360266|NCT02315703|531490091|FG007|LTE (After Week 96 up to Week 336)|Other|0|||
147360267|NCT05974501|531490092|FG000|Overall Study|Physician Decision|0|||
147360268|NCT05974501|531490093|FG001|Overall Study|Physician Decision|1|||
147360269|NCT03625115|531490094|FG000|Overall Study|Withdrawal by Subject|4|||
147360270|NCT03625115|531490095|FG001|Overall Study|Withdrawal by Subject|7|||
147360271|NCT03625115|531490094|FG000|Overall Study|Lost to Follow-up|17|||
147360272|NCT03625115|531490095|FG001|Overall Study|Lost to Follow-up|24|||
147360273|NCT04197336|531490096|FG000|Overall Study|Withdrawal by Subject|1|||
147360274|NCT04304144|531490097|FG000|DLT Observation Period|Physician Decision|0|||
147360275|NCT04304144|531490098|FG001|DLT Observation Period|Physician Decision|1|||
147360276|NCT04304144|531490099|FG002|DLT Observation Period|Physician Decision|0|||
147360277|NCT04304144|531490100|FG003|DLT Observation Period|Physician Decision|0|||
147360278|NCT04304144|531490097|FG000|Continued Treatment Period|Adverse Event|0|||
147360279|NCT04304144|531490098|FG001|Continued Treatment Period|Adverse Event|1|||
147360280|NCT04304144|531490099|FG002|Continued Treatment Period|Adverse Event|0|||
147360281|NCT04304144|531490100|FG003|Continued Treatment Period|Adverse Event|0|||
147360282|NCT04304144|531490097|FG000|Continued Treatment Period|Death|0|||
147360283|NCT04304144|531490098|FG001|Continued Treatment Period|Death|0|||
147360284|NCT04304144|531490099|FG002|Continued Treatment Period|Death|1|||
147360285|NCT04304144|531490100|FG003|Continued Treatment Period|Death|2|||
147360286|NCT04304144|531490097|FG000|Continued Treatment Period|Withdrawal by Subject|1|||
147360287|NCT04304144|531490098|FG001|Continued Treatment Period|Withdrawal by Subject|0|||
147360288|NCT04304144|531490099|FG002|Continued Treatment Period|Withdrawal by Subject|0|||
147360289|NCT04304144|531490100|FG003|Continued Treatment Period|Withdrawal by Subject|3|||
147360290|NCT04304144|531490097|FG000|Continued Treatment Period|Other than specified|2|||
147360291|NCT04304144|531490098|FG001|Continued Treatment Period|Other than specified|0|||
147360292|NCT04304144|531490099|FG002|Continued Treatment Period|Other than specified|1|||
147360293|NCT04304144|531490100|FG003|Continued Treatment Period|Other than specified|1|||
147360294|NCT05868382|531490101|FG000|Overall Study|Lost to Follow-up|5|||
147360295|NCT05868382|531490102|FG001|Overall Study|Lost to Follow-up|0|||
147360296|NCT05868382|531490103|FG002|Overall Study|Lost to Follow-up|6|||
147608295|NCT00261443|532382572|FG001|3: Assessment of Relapse|Administrative Reason By Sponsor|0|||
147608296|NCT00261443|532382573|FG002|3: Assessment of Relapse|Administrative Reason By Sponsor|2|||
147360297|NCT05868382|531490104|FG003|Overall Study|Lost to Follow-up|4|||
147360298|NCT05868382|531490105|FG004|Overall Study|Lost to Follow-up|2|||
147360299|NCT05868382|531490106|FG005|Overall Study|Lost to Follow-up|6|||
147360300|NCT05868382|531490101|FG000|Overall Study|Withdrawal by Subject|1|||
147360301|NCT05868382|531490102|FG001|Overall Study|Withdrawal by Subject|0|||
147360302|NCT05868382|531490103|FG002|Overall Study|Withdrawal by Subject|0|||
147360303|NCT05868382|531490104|FG003|Overall Study|Withdrawal by Subject|0|||
147360304|NCT05868382|531490105|FG004|Overall Study|Withdrawal by Subject|1|||
147360305|NCT05868382|531490106|FG005|Overall Study|Withdrawal by Subject|0|||
147360306|NCT04585815|531490107|FG000|Sub-study A- Treatment Phase|Adverse Event|0|||
147360307|NCT04585815|531490108|FG001|Sub-study A- Treatment Phase|Adverse Event|1|||
147360308|NCT04585815|531490109|FG002|Sub-study A- Treatment Phase|Adverse Event|0|||
147360309|NCT04585815|531490110|FG003|Sub-study A- Treatment Phase|Adverse Event|0|||
147360310|NCT04585815|531490111|FG004|Sub-study A- Treatment Phase|Adverse Event|0|||
147360311|NCT04585815|531490112|FG005|Sub-study A- Treatment Phase|Adverse Event|0|||
147360312|NCT04585815|531490113|FG006|Sub-study A- Treatment Phase|Adverse Event|0|||
147360313|NCT04585815|531490107|FG000|Sub-study A- Treatment Phase|Death|0|||
147360314|NCT04585815|531490108|FG001|Sub-study A- Treatment Phase|Death|1|||
147360315|NCT04585815|531490109|FG002|Sub-study A- Treatment Phase|Death|0|||
147360316|NCT04585815|531490110|FG003|Sub-study A- Treatment Phase|Death|0|||
147360317|NCT04585815|531490111|FG004|Sub-study A- Treatment Phase|Death|0|||
147360318|NCT04585815|531490112|FG005|Sub-study A- Treatment Phase|Death|0|||
147360319|NCT04585815|531490113|FG006|Sub-study A- Treatment Phase|Death|0|||
147360320|NCT04585815|531490107|FG000|Sub-study A- Treatment Phase|Withdrawal by Subject|1|||
147360321|NCT04585815|531490108|FG001|Sub-study A- Treatment Phase|Withdrawal by Subject|0|||
147360322|NCT04585815|531490109|FG002|Sub-study A- Treatment Phase|Withdrawal by Subject|0|||
147360323|NCT04585815|531490110|FG003|Sub-study A- Treatment Phase|Withdrawal by Subject|0|||
147360324|NCT04585815|531490111|FG004|Sub-study A- Treatment Phase|Withdrawal by Subject|0|||
147360325|NCT04585815|531490112|FG005|Sub-study A- Treatment Phase|Withdrawal by Subject|0|||
147360326|NCT04585815|531490113|FG006|Sub-study A- Treatment Phase|Withdrawal by Subject|0|||
147360327|NCT04585815|531490107|FG000|Sub-study A- Treatment Phase|Global deterioration of health status|0|||
147360328|NCT04585815|531490108|FG001|Sub-study A- Treatment Phase|Global deterioration of health status|1|||
147360329|NCT04585815|531490109|FG002|Sub-study A- Treatment Phase|Global deterioration of health status|0|||
147360330|NCT04585815|531490110|FG003|Sub-study A- Treatment Phase|Global deterioration of health status|0|||
147360331|NCT04585815|531490111|FG004|Sub-study A- Treatment Phase|Global deterioration of health status|0|||
147360332|NCT04585815|531490112|FG005|Sub-study A- Treatment Phase|Global deterioration of health status|0|||
147360333|NCT04585815|531490113|FG006|Sub-study A- Treatment Phase|Global deterioration of health status|0|||
147360334|NCT04585815|531490107|FG000|Sub-study A- Treatment Phase|Other|1|||
147360335|NCT04585815|531490108|FG001|Sub-study A- Treatment Phase|Other|0|||
147360336|NCT04585815|531490109|FG002|Sub-study A- Treatment Phase|Other|0|||
147360337|NCT04585815|531490110|FG003|Sub-study A- Treatment Phase|Other|0|||
147360338|NCT04585815|531490111|FG004|Sub-study A- Treatment Phase|Other|0|||
147360339|NCT04585815|531490112|FG005|Sub-study A- Treatment Phase|Other|0|||
147360340|NCT04585815|531490113|FG006|Sub-study A- Treatment Phase|Other|0|||
147360341|NCT04585815|531490107|FG000|Sub-study A- Treatment Phase|Ongoing treatment|2|||
147360342|NCT04585815|531490108|FG001|Sub-study A- Treatment Phase|Ongoing treatment|6|||
147454149|NCT02600494|531824174|FG001|Part A (6 Week Double-Blind Treatment)|Adverse Event|15|||
147608297|NCT00261443|532382571|FG000|3: Assessment of Relapse|Other Reasons|0|||
147608298|NCT00261443|532382572|FG001|3: Assessment of Relapse|Other Reasons|4|||
147608299|NCT00261443|532382573|FG002|3: Assessment of Relapse|Other Reasons|3|||
147608300|NCT00261443|532382571|FG000|4: Extension Phase|Adverse Event|0|||
147608301|NCT00261443|532382572|FG001|4: Extension Phase|Adverse Event|1|||
147608302|NCT00261443|532382573|FG002|4: Extension Phase|Adverse Event|0|||
147608303|NCT00261443|532382571|FG000|4: Extension Phase|Withdrawal by Subject|0|||
147608304|NCT00261443|532382572|FG001|4: Extension Phase|Withdrawal by Subject|1|||
147608305|NCT00261443|532382573|FG002|4: Extension Phase|Withdrawal by Subject|2|||
147454150|NCT02600494|531824175|FG002|Part A (6 Week Double-Blind Treatment)|Adverse Event|4|||
147454151|NCT02600494|531824173|FG000|Part A (6 Week Double-Blind Treatment)|Lack of Efficacy|2|||
147454152|NCT02600494|531824174|FG001|Part A (6 Week Double-Blind Treatment)|Lack of Efficacy|4|||
147454153|NCT02600494|531824175|FG002|Part A (6 Week Double-Blind Treatment)|Lack of Efficacy|2|||
147454154|NCT02600494|531824173|FG000|Part A (6 Week Double-Blind Treatment)|Protocol Violation|13|||
147454155|NCT02600494|531824174|FG001|Part A (6 Week Double-Blind Treatment)|Protocol Violation|10|||
147454156|NCT02600494|531824175|FG002|Part A (6 Week Double-Blind Treatment)|Protocol Violation|14|||
147608306|NCT00261443|532382571|FG000|4: Extension Phase|Lost to Follow-up|0|||
147360343|NCT04585815|531490109|FG002|Sub-study A- Treatment Phase|Ongoing treatment|0|||
147360344|NCT04585815|531490110|FG003|Sub-study A- Treatment Phase|Ongoing treatment|0|||
147360345|NCT04585815|531490111|FG004|Sub-study A- Treatment Phase|Ongoing treatment|0|||
147360346|NCT04585815|531490112|FG005|Sub-study A- Treatment Phase|Ongoing treatment|0|||
147360347|NCT04585815|531490113|FG006|Sub-study A- Treatment Phase|Ongoing treatment|0|||
147360348|NCT04585815|531490107|FG000|Sub-study A- Follow-up Phase|Ongoing in study|0|||
147360349|NCT04585815|531490108|FG001|Sub-study A- Follow-up Phase|Ongoing in study|1|||
147360350|NCT04585815|531490109|FG002|Sub-study A- Follow-up Phase|Ongoing in study|0|||
147360351|NCT04585815|531490110|FG003|Sub-study A- Follow-up Phase|Ongoing in study|0|||
147360352|NCT04585815|531490111|FG004|Sub-study A- Follow-up Phase|Ongoing in study|0|||
147360353|NCT04585815|531490112|FG005|Sub-study A- Follow-up Phase|Ongoing in study|0|||
147360354|NCT04585815|531490113|FG006|Sub-study A- Follow-up Phase|Ongoing in study|0|||
147360355|NCT04585815|531490107|FG000|Sub-study B- Treatment Phase|Adverse Event|0|||
147360356|NCT04585815|531490108|FG001|Sub-study B- Treatment Phase|Adverse Event|0|||
147360357|NCT04585815|531490109|FG002|Sub-study B- Treatment Phase|Adverse Event|0|||
147360358|NCT04585815|531490110|FG003|Sub-study B- Treatment Phase|Adverse Event|0|||
147360359|NCT04585815|531490111|FG004|Sub-study B- Treatment Phase|Adverse Event|0|||
147360360|NCT04585815|531490112|FG005|Sub-study B- Treatment Phase|Adverse Event|0|||
147360361|NCT04585815|531490113|FG006|Sub-study B- Treatment Phase|Adverse Event|2|||
147360362|NCT04585815|531490107|FG000|Sub-study B- Treatment Phase|Death|0|||
147360363|NCT04585815|531490108|FG001|Sub-study B- Treatment Phase|Death|0|||
147360364|NCT04585815|531490109|FG002|Sub-study B- Treatment Phase|Death|0|||
147360365|NCT04585815|531490110|FG003|Sub-study B- Treatment Phase|Death|1|||
147360366|NCT04585815|531490111|FG004|Sub-study B- Treatment Phase|Death|0|||
147360367|NCT04585815|531490112|FG005|Sub-study B- Treatment Phase|Death|0|||
147360368|NCT04585815|531490113|FG006|Sub-study B- Treatment Phase|Death|0|||
147360369|NCT04585815|531490107|FG000|Sub-study B- Treatment Phase|Withdrawal by Subject|0|||
147360370|NCT04585815|531490108|FG001|Sub-study B- Treatment Phase|Withdrawal by Subject|0|||
147360371|NCT04585815|531490109|FG002|Sub-study B- Treatment Phase|Withdrawal by Subject|0|||
147360372|NCT04585815|531490110|FG003|Sub-study B- Treatment Phase|Withdrawal by Subject|1|||
147360373|NCT04585815|531490111|FG004|Sub-study B- Treatment Phase|Withdrawal by Subject|0|||
147360374|NCT04585815|531490112|FG005|Sub-study B- Treatment Phase|Withdrawal by Subject|1|||
147360375|NCT04585815|531490113|FG006|Sub-study B- Treatment Phase|Withdrawal by Subject|0|||
147360376|NCT04585815|531490107|FG000|Sub-study B- Treatment Phase|Global deterioration of health status|0|||
147360377|NCT04585815|531490108|FG001|Sub-study B- Treatment Phase|Global deterioration of health status|0|||
147360378|NCT04585815|531490109|FG002|Sub-study B- Treatment Phase|Global deterioration of health status|0|||
147360379|NCT04585815|531490110|FG003|Sub-study B- Treatment Phase|Global deterioration of health status|1|||
147360380|NCT04585815|531490111|FG004|Sub-study B- Treatment Phase|Global deterioration of health status|0|||
147360381|NCT04585815|531490112|FG005|Sub-study B- Treatment Phase|Global deterioration of health status|0|||
147360382|NCT04585815|531490113|FG006|Sub-study B- Treatment Phase|Global deterioration of health status|0|||
147360383|NCT04585815|531490107|FG000|Sub-study B- Treatment Phase|Ongoing treatment|0|||
147360384|NCT04585815|531490108|FG001|Sub-study B- Treatment Phase|Ongoing treatment|0|||
147360385|NCT04585815|531490109|FG002|Sub-study B- Treatment Phase|Ongoing treatment|0|||
147360386|NCT04585815|531490110|FG003|Sub-study B- Treatment Phase|Ongoing treatment|0|||
147360387|NCT04585815|531490111|FG004|Sub-study B- Treatment Phase|Ongoing treatment|0|||
147360388|NCT04585815|531490112|FG005|Sub-study B- Treatment Phase|Ongoing treatment|0|||
147360389|NCT04585815|531490113|FG006|Sub-study B- Treatment Phase|Ongoing treatment|1|||
147360390|NCT04585815|531490107|FG000|Sub-study B- Treatment Phase|Progressive disease|0|||
147360391|NCT04585815|531490108|FG001|Sub-study B- Treatment Phase|Progressive disease|0|||
147360392|NCT04585815|531490109|FG002|Sub-study B- Treatment Phase|Progressive disease|3|||
147360393|NCT04585815|531490110|FG003|Sub-study B- Treatment Phase|Progressive disease|2|||
147360394|NCT04585815|531490111|FG004|Sub-study B- Treatment Phase|Progressive disease|2|||
147360395|NCT04585815|531490112|FG005|Sub-study B- Treatment Phase|Progressive disease|0|||
147360396|NCT04585815|531490113|FG006|Sub-study B- Treatment Phase|Progressive disease|4|||
147360397|NCT04585815|531490107|FG000|Sub-study B- Treatment Phase|Physician Decision|0|||
147360398|NCT04585815|531490108|FG001|Sub-study B- Treatment Phase|Physician Decision|0|||
147360399|NCT04585815|531490109|FG002|Sub-study B- Treatment Phase|Physician Decision|0|||
147360400|NCT04585815|531490110|FG003|Sub-study B- Treatment Phase|Physician Decision|1|||
147360401|NCT04585815|531490111|FG004|Sub-study B- Treatment Phase|Physician Decision|1|||
147454157|NCT02600494|531824173|FG000|Part A (6 Week Double-Blind Treatment)|Physician Decision|2|||
147454158|NCT02600494|531824174|FG001|Part A (6 Week Double-Blind Treatment)|Physician Decision|3|||
147454159|NCT02600494|531824175|FG002|Part A (6 Week Double-Blind Treatment)|Physician Decision|4|||
147454160|NCT02600494|531824173|FG000|Part A (6 Week Double-Blind Treatment)|Withdrawal by Subject|15|||
147454161|NCT02600494|531824174|FG001|Part A (6 Week Double-Blind Treatment)|Withdrawal by Subject|11|||
147454162|NCT02600494|531824175|FG002|Part A (6 Week Double-Blind Treatment)|Withdrawal by Subject|14|||
147454163|NCT02600494|531824173|FG000|Part A (6 Week Double-Blind Treatment)|Lost to Follow-up|12|||
147454164|NCT02600494|531824174|FG001|Part A (6 Week Double-Blind Treatment)|Lost to Follow-up|28|||
147454165|NCT02600494|531824175|FG002|Part A (6 Week Double-Blind Treatment)|Lost to Follow-up|10|||
147608307|NCT00261443|532382572|FG001|4: Extension Phase|Lost to Follow-up|1|||
147608308|NCT00261443|532382573|FG002|4: Extension Phase|Lost to Follow-up|0|||
147360402|NCT04585815|531490112|FG005|Sub-study B- Treatment Phase|Physician Decision|1|||
147360403|NCT04585815|531490113|FG006|Sub-study B- Treatment Phase|Physician Decision|0|||
147360404|NCT04585815|531490107|FG000|Sub-study B- Follow-up Phase|Ongoing in study|0|||
147360405|NCT04585815|531490108|FG001|Sub-study B- Follow-up Phase|Ongoing in study|0|||
147360406|NCT04585815|531490109|FG002|Sub-study B- Follow-up Phase|Ongoing in study|0|||
147360407|NCT04585815|531490110|FG003|Sub-study B- Follow-up Phase|Ongoing in study|0|||
147360408|NCT04585815|531490111|FG004|Sub-study B- Follow-up Phase|Ongoing in study|1|||
147360409|NCT04585815|531490112|FG005|Sub-study B- Follow-up Phase|Ongoing in study|1|||
147360410|NCT04585815|531490113|FG006|Sub-study B- Follow-up Phase|Ongoing in study|3|||
147360411|NCT04585815|531490107|FG000|Sub-study B- Follow-up Phase|Death|0|||
147360412|NCT04585815|531490108|FG001|Sub-study B- Follow-up Phase|Death|0|||
147360413|NCT04585815|531490109|FG002|Sub-study B- Follow-up Phase|Death|1|||
147360414|NCT04585815|531490110|FG003|Sub-study B- Follow-up Phase|Death|3|||
147360415|NCT04585815|531490111|FG004|Sub-study B- Follow-up Phase|Death|0|||
147360416|NCT04585815|531490112|FG005|Sub-study B- Follow-up Phase|Death|0|||
147360417|NCT04585815|531490113|FG006|Sub-study B- Follow-up Phase|Death|1|||
147360418|NCT02497950|531490116|FG000|Overall Study|Death|209|||
147360419|NCT02497950|531490116|FG000|Overall Study|Transplanted|85|||
147360420|NCT02497950|531490116|FG000|Overall Study|Explanted|8|||
147360421|NCT02497950|531490116|FG000|Overall Study|Device Permanently Deactivated|4|||
147360422|NCT02497950|531490116|FG000|Overall Study|Implanted/Exchanged to an LVAD other than HM3|1|||
147360423|NCT02497950|531490116|FG000|Overall Study|Lost to Follow-up|6|||
147360424|NCT02497950|531490116|FG000|Overall Study|Withdrawal by Subject|2|||
147360425|NCT02497950|531490116|FG000|Overall Study|Center Did Not Participate in Long-Term FU|4|||
147360426|NCT02497950|531490116|FG000|Overall Study|Refused Consent to Long-Term FU|13|||
147360427|NCT04660539|531490117|FG000|Overall Study|Adverse Event|10|||
147360428|NCT04660539|531490117|FG000|Overall Study|Lack of Efficacy|4|||
147360429|NCT04660539|531490117|FG000|Overall Study|Lost to Follow-up|5|||
147360430|NCT04660539|531490117|FG000|Overall Study|Non-Compliance With Study Drug|3|||
147360431|NCT04660539|531490117|FG000|Overall Study|Reason not Specified|12|||
147360432|NCT04660539|531490117|FG000|Overall Study|Pregnancy|2|||
147360433|NCT04660539|531490117|FG000|Overall Study|Protocol Violation|2|||
147360434|NCT04660539|531490117|FG000|Overall Study|Switch To Commercial Satralizumab|1|||
147360435|NCT04660539|531490117|FG000|Overall Study|Withdrawal by Subject|21|||
147360436|NCT03756662|531490121|FG000|Overall Study|due to an SAE that was not related to the medical device or medical procedure.|1|||
147360437|NCT05207956|531490126|FG000|Overall Study|Lost to follow up|1|||
147360438|NCT05207956|531490127|FG001|Overall Study|Lost to follow up|2|||
147360439|NCT01828112|531490130|FG000|Treatment Phase|Adverse Event|7|||
147360440|NCT01828112|531490131|FG001|Treatment Phase|Adverse Event|8|||
147360441|NCT01828112|531490132|FG002|Treatment Phase|Adverse Event|0|||
147360442|NCT01828112|531490130|FG000|Treatment Phase|Death|9|||
147360443|NCT01828112|531490131|FG001|Treatment Phase|Death|5|||
147360444|NCT01828112|531490132|FG002|Treatment Phase|Death|0|||
147360445|NCT01828112|531490130|FG000|Treatment Phase|No longer required treatment|0|||
147360446|NCT01828112|531490131|FG001|Treatment Phase|No longer required treatment|1|||
147360447|NCT01828112|531490132|FG002|Treatment Phase|No longer required treatment|0|||
147360448|NCT01828112|531490130|FG000|Treatment Phase|Physician Decision|6|||
147360449|NCT01828112|531490131|FG001|Treatment Phase|Physician Decision|7|||
147360450|NCT01828112|531490132|FG002|Treatment Phase|Physician Decision|0|||
147360451|NCT01828112|531490130|FG000|Treatment Phase|Pregnancy|1|||
147360452|NCT01828112|531490131|FG001|Treatment Phase|Pregnancy|0|||
147360453|NCT01828112|531490132|FG002|Treatment Phase|Pregnancy|0|||
147360454|NCT01828112|531490130|FG000|Treatment Phase|Progressive disease|79|||
147360455|NCT01828112|531490131|FG001|Treatment Phase|Progressive disease|87|||
147360456|NCT01828112|531490132|FG002|Treatment Phase|Progressive disease|0|||
147608309|NCT01286753|532382574|FG000|Overall Study|Adverse Event|7|||
147360457|NCT01828112|531490130|FG000|Treatment Phase|Study terminated by sponsor|1|||
147360458|NCT01828112|531490131|FG001|Treatment Phase|Study terminated by sponsor|0|||
147360459|NCT01828112|531490132|FG002|Treatment Phase|Study terminated by sponsor|0|||
147360460|NCT01828112|531490130|FG000|Treatment Phase|Subject/guardian decision|12|||
147360461|NCT01828112|531490131|FG001|Treatment Phase|Subject/guardian decision|8|||
147360462|NCT01828112|531490132|FG002|Treatment Phase|Subject/guardian decision|0|||
147360463|NCT01828112|531490130|FG000|Extension Treatment Phase|Adverse Event|0|||
147360464|NCT01828112|531490131|FG001|Extension Treatment Phase|Adverse Event|0|||
147360465|NCT01828112|531490132|FG002|Extension Treatment Phase|Adverse Event|6|||
147360466|NCT01828112|531490130|FG000|Extension Treatment Phase|Death|0|||
147360467|NCT01828112|531490131|FG001|Extension Treatment Phase|Death|0|||
147360468|NCT01828112|531490132|FG002|Extension Treatment Phase|Death|17|||
147360469|NCT01828112|531490130|FG000|Extension Treatment Phase|Physician Decision|0|||
147608310|NCT01286753|532382575|FG001|Overall Study|Adverse Event|6|||
147360470|NCT01828112|531490131|FG001|Extension Treatment Phase|Physician Decision|0|||
147360471|NCT01828112|531490132|FG002|Extension Treatment Phase|Physician Decision|5|||
147360472|NCT01828112|531490130|FG000|Extension Treatment Phase|Progressive disease|0|||
147360473|NCT01828112|531490131|FG001|Extension Treatment Phase|Progressive disease|0|||
147360474|NCT01828112|531490132|FG002|Extension Treatment Phase|Progressive disease|46|||
147360475|NCT01828112|531490130|FG000|Extension Treatment Phase|Study terminated by sponsor|0|||
147360476|NCT01828112|531490131|FG001|Extension Treatment Phase|Study terminated by sponsor|0|||
147360477|NCT01828112|531490132|FG002|Extension Treatment Phase|Study terminated by sponsor|1|||
147360478|NCT01828112|531490130|FG000|Extension Treatment Phase|Subject/guardian decision|0|||
147360479|NCT01828112|531490131|FG001|Extension Treatment Phase|Subject/guardian decision|0|||
147360480|NCT01828112|531490132|FG002|Extension Treatment Phase|Subject/guardian decision|4|||
147360481|NCT04308681|531490138|FG000|Pre-Treatment|Not reported|1|||
147360482|NCT04308681|531490139|FG001|Pre-Treatment|Not reported|1|||
147360483|NCT04308681|531490140|FG002|Pre-Treatment|Not reported|0|||
147360484|NCT04308681|531490141|FG003|Pre-Treatment|Not reported|0|||
147360485|NCT04308681|531490142|FG004|Pre-Treatment|Not reported|0|||
147360486|NCT04308681|531490143|FG005|Pre-Treatment|Not reported|2|||
147360487|NCT04308681|531490144|FG006|Pre-Treatment|Not reported|0|||
147360488|NCT04308681|531490145|FG007|Pre-Treatment|Not reported|0|||
147360489|NCT04308681|531490138|FG000|Treatment up to Week 26|Withdrawal by participant|2|||
147360490|NCT04308681|531490139|FG001|Treatment up to Week 26|Withdrawal by participant|1|||
147360491|NCT04308681|531490140|FG002|Treatment up to Week 26|Withdrawal by participant|1|||
147360492|NCT04308681|531490141|FG003|Treatment up to Week 26|Withdrawal by participant|0|||
147360493|NCT04308681|531490142|FG004|Treatment up to Week 26|Withdrawal by participant|0|||
147360494|NCT04308681|531490143|FG005|Treatment up to Week 26|Withdrawal by participant|1|||
147360495|NCT04308681|531490144|FG006|Treatment up to Week 26|Withdrawal by participant|1|||
147360496|NCT04308681|531490145|FG007|Treatment up to Week 26|Withdrawal by participant|0|||
147360497|NCT04308681|531490138|FG000|Treatment up to Week 26|Other reasons|2|||
147360498|NCT04308681|531490139|FG001|Treatment up to Week 26|Other reasons|0|||
147360499|NCT04308681|531490140|FG002|Treatment up to Week 26|Other reasons|0|||
147360500|NCT04308681|531490141|FG003|Treatment up to Week 26|Other reasons|0|||
147360501|NCT04308681|531490142|FG004|Treatment up to Week 26|Other reasons|1|||
147360502|NCT04308681|531490143|FG005|Treatment up to Week 26|Other reasons|1|||
147360503|NCT04308681|531490144|FG006|Treatment up to Week 26|Other reasons|0|||
147360504|NCT04308681|531490145|FG007|Treatment up to Week 26|Other reasons|0|||
147360505|NCT04308681|531490138|FG000|Treatment up to Week 26|Participant no longer meets study criteria|0|||
147360506|NCT04308681|531490139|FG001|Treatment up to Week 26|Participant no longer meets study criteria|1|||
147360507|NCT04308681|531490140|FG002|Treatment up to Week 26|Participant no longer meets study criteria|2|||
147360508|NCT04308681|531490141|FG003|Treatment up to Week 26|Participant no longer meets study criteria|0|||
147360509|NCT04308681|531490142|FG004|Treatment up to Week 26|Participant no longer meets study criteria|1|||
147360510|NCT04308681|531490143|FG005|Treatment up to Week 26|Participant no longer meets study criteria|0|||
147360511|NCT04308681|531490144|FG006|Treatment up to Week 26|Participant no longer meets study criteria|1|||
147360512|NCT04308681|531490145|FG007|Treatment up to Week 26|Participant no longer meets study criteria|0|||
147360513|NCT04308681|531490138|FG000|Treatment up to Week 26|Adverse Event|6|||
147360514|NCT04308681|531490139|FG001|Treatment up to Week 26|Adverse Event|5|||
147360515|NCT04308681|531490140|FG002|Treatment up to Week 26|Adverse Event|5|||
147360516|NCT04308681|531490141|FG003|Treatment up to Week 26|Adverse Event|0|||
147360517|NCT04308681|531490142|FG004|Treatment up to Week 26|Adverse Event|6|||
147360518|NCT04308681|531490143|FG005|Treatment up to Week 26|Adverse Event|1|||
147360519|NCT04308681|531490144|FG006|Treatment up to Week 26|Adverse Event|0|||
147360520|NCT04308681|531490145|FG007|Treatment up to Week 26|Adverse Event|0|||
147360521|NCT04308681|531490138|FG000|Treatment up to Week 26|Adverse event unrelated to study drug|0|||
147360522|NCT04308681|531490139|FG001|Treatment up to Week 26|Adverse event unrelated to study drug|2|||
147360523|NCT04308681|531490140|FG002|Treatment up to Week 26|Adverse event unrelated to study drug|1|||
147527274|NCT00421928|532084188|FG002|Overall Study|Study drug non-compliant|4|||
147527275|NCT00421928|532084186|FG000|Overall Study|All other|26|||
147527276|NCT00421928|532084187|FG001|Overall Study|All other|21|||
147527277|NCT00421928|532084188|FG002|Overall Study|All other|27|||
147527278|NCT00421928|532084186|FG000|Overall Study|Death|0|||
147527279|NCT00421928|532084187|FG001|Overall Study|Death|1|||
147527280|NCT00421928|532084188|FG002|Overall Study|Death|0|||
147527281|NCT04120116|532084202|FG000|Overall Study|Lost to Follow-up|0|||
147527282|NCT04120116|532084203|FG001|Overall Study|Lost to Follow-up|1|||
147527283|NCT04120116|532084204|FG002|Overall Study|Lost to Follow-up|0|||
147527284|NCT04120116|532084205|FG003|Overall Study|Lost to Follow-up|2|||
147527285|NCT04120116|532084202|FG000|Overall Study|Withdrawal by Subject|1|||
147527286|NCT04120116|532084203|FG001|Overall Study|Withdrawal by Subject|0|||
147527287|NCT04120116|532084204|FG002|Overall Study|Withdrawal by Subject|1|||
147527288|NCT04120116|532084205|FG003|Overall Study|Withdrawal by Subject|1|||
147527289|NCT04120116|532084202|FG000|Overall Study|Subject was deemed to not meet the inclusion criteria for SNHL after dose was administered|0|||
147527290|NCT04120116|532084203|FG001|Overall Study|Subject was deemed to not meet the inclusion criteria for SNHL after dose was administered|0|||
147527291|NCT04120116|532084204|FG002|Overall Study|Subject was deemed to not meet the inclusion criteria for SNHL after dose was administered|1|||
147527359|NCT00682539|532084238|FG000|Ranibizumab vs Triamcinolone|Lost to Follow-up|0|||
147608311|NCT01286753|532382574|FG000|Overall Study|Progression|11|||
147360524|NCT04308681|531490141|FG003|Treatment up to Week 26|Adverse event unrelated to study drug|0|||
147360525|NCT04308681|531490142|FG004|Treatment up to Week 26|Adverse event unrelated to study drug|0|||
147360526|NCT04308681|531490143|FG005|Treatment up to Week 26|Adverse event unrelated to study drug|0|||
147360527|NCT04308681|531490144|FG006|Treatment up to Week 26|Adverse event unrelated to study drug|0|||
147360528|NCT04308681|531490145|FG007|Treatment up to Week 26|Adverse event unrelated to study drug|0|||
147360529|NCT04308681|531490138|FG000|OTE - 26 Weeks|Withdrawal by participant|0|||
147360530|NCT04308681|531490139|FG001|OTE - 26 Weeks|Withdrawal by participant|0|||
147360531|NCT04308681|531490140|FG002|OTE - 26 Weeks|Withdrawal by participant|4|||
147360532|NCT04308681|531490141|FG003|OTE - 26 Weeks|Withdrawal by participant|0|||
147360533|NCT04308681|531490142|FG004|OTE - 26 Weeks|Withdrawal by participant|0|||
147360534|NCT04308681|531490143|FG005|OTE - 26 Weeks|Withdrawal by participant|0|||
147360535|NCT04308681|531490144|FG006|OTE - 26 Weeks|Withdrawal by participant|1|||
147360536|NCT04308681|531490145|FG007|OTE - 26 Weeks|Withdrawal by participant|0|||
147360537|NCT04308681|531490138|FG000|OTE - 26 Weeks|Death|0|||
147360538|NCT04308681|531490139|FG001|OTE - 26 Weeks|Death|1|||
147360539|NCT04308681|531490140|FG002|OTE - 26 Weeks|Death|0|||
147360540|NCT04308681|531490141|FG003|OTE - 26 Weeks|Death|0|||
147360541|NCT04308681|531490142|FG004|OTE - 26 Weeks|Death|0|||
147360542|NCT04308681|531490143|FG005|OTE - 26 Weeks|Death|0|||
147360543|NCT04308681|531490144|FG006|OTE - 26 Weeks|Death|1|||
147360544|NCT04308681|531490145|FG007|OTE - 26 Weeks|Death|0|||
147360545|NCT04308681|531490138|FG000|OTE - 26 Weeks|Adverse Event|0|||
147360546|NCT04308681|531490139|FG001|OTE - 26 Weeks|Adverse Event|2|||
147360547|NCT04308681|531490140|FG002|OTE - 26 Weeks|Adverse Event|8|||
147360548|NCT04308681|531490141|FG003|OTE - 26 Weeks|Adverse Event|3|||
147360549|NCT04308681|531490142|FG004|OTE - 26 Weeks|Adverse Event|0|||
147360550|NCT04308681|531490143|FG005|OTE - 26 Weeks|Adverse Event|1|||
147608312|NCT01286753|532382575|FG001|Overall Study|Progression|13|||
147608313|NCT01286753|532382574|FG000|Overall Study|Refused Treatment|1|||
147608314|NCT01286753|532382575|FG001|Overall Study|Refused Treatment|0|||
147608315|NCT01286753|532382574|FG000|Overall Study|Withdrawal of Consent|0|||
147608316|NCT01286753|532382575|FG001|Overall Study|Withdrawal of Consent|2|||
147608317|NCT01286753|532382574|FG000|Overall Study|Discontinued to Join Extension Study|6|||
147608318|NCT01286753|532382575|FG001|Overall Study|Discontinued to Join Extension Study|4|||
147608319|NCT01286753|532382574|FG000|Overall Study|Participant to Receive Radiotherapy|1|||
147608320|NCT01286753|532382575|FG001|Overall Study|Participant to Receive Radiotherapy|0|||
147608321|NCT02126826|532382576|FG000|Overall Study|Withdrawal by Subject|0|||
147608322|NCT02126826|532382577|FG001|Overall Study|Withdrawal by Subject|0|||
147608323|NCT02126826|532382578|FG002|Overall Study|Withdrawal by Subject|0|||
147608324|NCT02126826|532382579|FG003|Overall Study|Withdrawal by Subject|1|||
147608325|NCT02126826|532382580|FG004|Overall Study|Withdrawal by Subject|0|||
147608326|NCT02126826|532382581|FG005|Overall Study|Withdrawal by Subject|0|||
147608327|NCT02126826|532382582|FG006|Overall Study|Withdrawal by Subject|0|||
147608328|NCT03092219|532382583|FG000|Overall Study|Protocol Violation|7|||
147608329|NCT03092219|532382584|FG001|Overall Study|Protocol Violation|4|||
147608330|NCT03278626|532382585|FG000|Overall Study|Death|2|||
147608331|NCT03278626|532382585|FG000|Overall Study|Toxicity|1|||
147608332|NCT03278626|532382585|FG000|Overall Study|Disease Progression|2|||
147608333|NCT04971187|532382586|FG000|Overall Study|Screen failures|2|||
147608334|NCT00591773|532382587|FG000|Overall Study|Adverse Event|9|||
147608335|NCT00591773|532382588|FG001|Overall Study|Adverse Event|9|||
147608336|NCT00591773|532382589|FG002|Overall Study|Adverse Event|6|||
147608337|NCT00591773|532382587|FG000|Overall Study|Protocol Violation|2|||
147608338|NCT00591773|532382588|FG001|Overall Study|Protocol Violation|3|||
147360551|NCT04308681|531490144|FG006|OTE - 26 Weeks|Adverse Event|2|||
147360552|NCT04308681|531490145|FG007|OTE - 26 Weeks|Adverse Event|0|||
147360553|NCT04308681|531490138|FG000|OTE - 26 Weeks|Adverse event unrelated to study drug|0|||
147360554|NCT04308681|531490139|FG001|OTE - 26 Weeks|Adverse event unrelated to study drug|1|||
147360555|NCT04308681|531490140|FG002|OTE - 26 Weeks|Adverse event unrelated to study drug|1|||
147608339|NCT00591773|532382589|FG002|Overall Study|Protocol Violation|0|||
147608340|NCT00591773|532382587|FG000|Overall Study|Lost to Follow-up|1|||
147608341|NCT00591773|532382588|FG001|Overall Study|Lost to Follow-up|4|||
147360556|NCT04308681|531490141|FG003|OTE - 26 Weeks|Adverse event unrelated to study drug|0|||
147360557|NCT04308681|531490142|FG004|OTE - 26 Weeks|Adverse event unrelated to study drug|0|||
147360558|NCT04308681|531490143|FG005|OTE - 26 Weeks|Adverse event unrelated to study drug|1|||
147360559|NCT04308681|531490144|FG006|OTE - 26 Weeks|Adverse event unrelated to study drug|0|||
147360560|NCT04308681|531490145|FG007|OTE - 26 Weeks|Adverse event unrelated to study drug|0|||
147360561|NCT05873556|531490146|FG000|Overall Study|Lost to Follow-up|4|||
147360562|NCT05873556|531490147|FG001|Overall Study|Lost to Follow-up|1|||
147360563|NCT03606408|531490148|FG000|Overall Study|Adverse Event|13|||
147360564|NCT03606408|531490148|FG000|Overall Study|Withdrawal by Subject|7|||
147608342|NCT00591773|532382589|FG002|Overall Study|Lost to Follow-up|1|||
147608343|NCT00591773|532382587|FG000|Overall Study|Withdrawal by Subject|2|||
147608344|NCT00591773|532382588|FG001|Overall Study|Withdrawal by Subject|5|||
147608345|NCT00591773|532382589|FG002|Overall Study|Withdrawal by Subject|3|||
147360565|NCT03606408|531490148|FG000|Overall Study|Physician Decision|4|||
147360566|NCT03606408|531490148|FG000|Overall Study|Lack of Efficacy|2|||
147360567|NCT03606408|531490148|FG000|Overall Study|Death|1|||
147360568|NCT03606408|531490148|FG000|Overall Study|new therapy for study indication|1|||
147360569|NCT04862234|531490154|FG000|Overall Study|Surgery cancellation|1|||
147360570|NCT04862234|531490155|FG001|Overall Study|Surgery cancellation|2|||
147360571|NCT04862234|531490154|FG000|Overall Study|Early discharge (<48 hours) - no CGM data collected|0|||
147360572|NCT04862234|531490155|FG001|Overall Study|Early discharge (<48 hours) - no CGM data collected|1|||
147360573|NCT04862234|531490154|FG000|Overall Study|Early discharge (<48 hours) - CGM data collected|0|||
147608346|NCT00591773|532382587|FG000|Overall Study|Lack of Efficacy|1|||
147608347|NCT00591773|532382588|FG001|Overall Study|Lack of Efficacy|2|||
147608348|NCT00591773|532382589|FG002|Overall Study|Lack of Efficacy|2|||
147608349|NCT00591773|532382587|FG000|Overall Study|Other|1|||
147608350|NCT00591773|532382588|FG001|Overall Study|Other|1|||
147608351|NCT00591773|532382589|FG002|Overall Study|Other|4|||
147608352|NCT02135614|532382590|FG000|Overall Study|Randomized but Not Treated|2|||
147608353|NCT02135614|532382591|FG001|Overall Study|Randomized but Not Treated|1|||
147608354|NCT02135614|532382590|FG000|Overall Study|Adverse Event|0|||
147608355|NCT02135614|532382591|FG001|Overall Study|Adverse Event|1|||
147608356|NCT02135614|532382590|FG000|Overall Study|Death|1|||
147608357|NCT02135614|532382591|FG001|Overall Study|Death|0|||
147608358|NCT02135614|532382590|FG000|Overall Study|Investigator's Discretion|0|||
147608359|NCT02135614|532382591|FG001|Overall Study|Investigator's Discretion|1|||
147608360|NCT02135614|532382590|FG000|Overall Study|Withdrew Consent|2|||
147360574|NCT04862234|531490155|FG001|Overall Study|Early discharge (<48 hours) - CGM data collected|1|||
147360575|NCT03292484|531490156|FG000|Overall Study|Participants did not have Disposition - Study Exit forms|415|||
147360576|NCT03292484|531490156|FG000|Overall Study|Withdrew consent (unrelated to adverse event [AE])|86|||
147360577|NCT03292484|531490156|FG000|Overall Study|Protocol Violation|2|||
147360578|NCT03292484|531490156|FG000|Overall Study|Investigator decision (unrelated to AE)|13|||
147360579|NCT03292484|531490156|FG000|Overall Study|Sponsor decision|349|||
147360580|NCT03292484|531490156|FG000|Overall Study|Lost to Follow-up|7|||
147360581|NCT03292484|531490156|FG000|Overall Study|Coronavirus Disease 2019|1|||
147360582|NCT03292484|531490156|FG000|Overall Study|Other|20|||
147360583|NCT05069896|531490158|FG000|Overall Study|Adverse Event|0|||
147360584|NCT05069896|531490159|FG001|Overall Study|Adverse Event|1|||
147360585|NCT05069896|531490160|FG002|Overall Study|Adverse Event|1|||
147360586|NCT05069896|531490161|FG003|Overall Study|Adverse Event|0|||
147360587|NCT05069896|531490162|FG004|Overall Study|Adverse Event|0|||
147360588|NCT05069896|531490163|FG005|Overall Study|Adverse Event|0|||
147360589|NCT05069896|531490158|FG000|Overall Study|Lost to Follow-up|0|||
147360590|NCT05069896|531490159|FG001|Overall Study|Lost to Follow-up|0|||
147360591|NCT05069896|531490160|FG002|Overall Study|Lost to Follow-up|1|||
147360592|NCT05069896|531490161|FG003|Overall Study|Lost to Follow-up|0|||
147360593|NCT05069896|531490162|FG004|Overall Study|Lost to Follow-up|1|||
147360594|NCT05069896|531490163|FG005|Overall Study|Lost to Follow-up|2|||
147360595|NCT04068831|531490164|FG000|Overall Study|Disease Progression|10|||
147360596|NCT04068831|531490165|FG001|Overall Study|Disease Progression|8|||
147360597|NCT02839265|531490167|FG000|Overall Study|Screen Failure|2|||
147360598|NCT02839265|531490167|FG000|Overall Study|Death|1|||
147360599|NCT02839265|531490167|FG000|Overall Study|Progression of SVC syndrome prior to treatment initiation|1|||
147360600|NCT04167553|531490170|FG000|Overall Study|Withdrawal by Subject|1|||
147360601|NCT04167553|531490171|FG001|Overall Study|Withdrawal by Subject|0|||
147360602|NCT04167553|531490172|FG002|Overall Study|Withdrawal by Subject|1|||
147360603|NCT04167553|531490173|FG003|Overall Study|Withdrawal by Subject|2|||
147360604|NCT04167553|531490174|FG004|Overall Study|Withdrawal by Subject|1|||
147360605|NCT04167553|531490175|FG005|Overall Study|Withdrawal by Subject|0|||
147360606|NCT04167553|531490176|FG006|Overall Study|Withdrawal by Subject|0|||
147360607|NCT04167553|531490170|FG000|Overall Study|Physician Decision|0|||
147360608|NCT04167553|531490171|FG001|Overall Study|Physician Decision|0|||
147360609|NCT04167553|531490172|FG002|Overall Study|Physician Decision|0|||
147360610|NCT04167553|531490173|FG003|Overall Study|Physician Decision|0|||
147608361|NCT02135614|532382591|FG001|Overall Study|Withdrew Consent|2|||
147608362|NCT02135614|532382590|FG000|Overall Study|Lost to Follow-up|3|||
147360611|NCT04167553|531490174|FG004|Overall Study|Physician Decision|2|||
147360612|NCT04167553|531490175|FG005|Overall Study|Physician Decision|2|||
147360613|NCT04167553|531490176|FG006|Overall Study|Physician Decision|0|||
147360614|NCT04167553|531490170|FG000|Overall Study|Lost to Follow-up|0|||
147360615|NCT04167553|531490171|FG001|Overall Study|Lost to Follow-up|0|||
147360616|NCT04167553|531490172|FG002|Overall Study|Lost to Follow-up|2|||
147360617|NCT04167553|531490173|FG003|Overall Study|Lost to Follow-up|0|||
147360618|NCT04167553|531490174|FG004|Overall Study|Lost to Follow-up|0|||
147360619|NCT04167553|531490175|FG005|Overall Study|Lost to Follow-up|0|||
147360620|NCT04167553|531490176|FG006|Overall Study|Lost to Follow-up|0|||
147608363|NCT02135614|532382591|FG001|Overall Study|Lost to Follow-up|0|||
147608364|NCT01207583|532382599|FG000|Overall Study|Withdrawal by Subject|0|||
147608365|NCT01207583|532382600|FG001|Overall Study|Withdrawal by Subject|3|||
147608366|NCT01207583|532382601|FG002|Overall Study|Withdrawal by Subject|1|||
147608367|NCT01207583|532382599|FG000|Overall Study|Participant failed to return|1|||
147608368|NCT01207583|532382600|FG001|Overall Study|Participant failed to return|0|||
147608369|NCT01207583|532382601|FG002|Overall Study|Participant failed to return|0|||
147360621|NCT05660434|531490178|FG000|Overall Study|Never obtained study materials|2|||
147360622|NCT05660434|531490179|FG001|Overall Study|Never obtained study materials|1|||
147360623|NCT04479761|531490194|FG000|Overall Study|could not perform the balance tasks|1|||
147360624|NCT04479761|531490195|FG001|Overall Study|could not perform the balance tasks|0|||
147360625|NCT04479761|531490196|FG002|Overall Study|could not perform the balance tasks|0|||
147360626|NCT04479761|531490194|FG000|Overall Study|Adverse Event|1|||
147360627|NCT04479761|531490195|FG001|Overall Study|Adverse Event|0|||
147360628|NCT04479761|531490196|FG002|Overall Study|Adverse Event|0|||
147608370|NCT01207583|532382599|FG000|Overall Study|Lost to Follow-up|0|||
147608371|NCT01207583|532382600|FG001|Overall Study|Lost to Follow-up|2|||
147608372|NCT01207583|532382601|FG002|Overall Study|Lost to Follow-up|0|||
147608373|NCT02679235|532382602|FG000|Overall Study|Withdrawal by Subject|3|||
147608374|NCT02679235|532382602|FG000|Overall Study|Adverse Event|1|||
147608375|NCT02540850|532382603|FG000|Overall Study|Lost to Follow-up|69|||
147608376|NCT02540850|532382604|FG001|Overall Study|Lost to Follow-up|66|||
147608377|NCT02540850|532382605|FG002|Overall Study|Lost to Follow-up|34|||
147608378|NCT00264550|532382606|FG000|Overall Study|Death|0|||
147608379|NCT00264550|532382607|FG001|Overall Study|Death|3|||
147608380|NCT00264550|532382608|FG002|Overall Study|Death|0|||
147360629|NCT04479761|531490194|FG000|Overall Study|one control did not meet screening criteria|0|||
147360630|NCT04479761|531490195|FG001|Overall Study|one control did not meet screening criteria|0|||
147360631|NCT04479761|531490196|FG002|Overall Study|one control did not meet screening criteria|1|||
147360632|NCT04479761|531490194|FG000|Overall Study|hearing loss recovered OR hearing loss too severe on the other side OR dizziness above 16 on DHI|0|||
147360633|NCT04479761|531490195|FG001|Overall Study|hearing loss recovered OR hearing loss too severe on the other side OR dizziness above 16 on DHI|3|||
147360634|NCT04479761|531490196|FG002|Overall Study|hearing loss recovered OR hearing loss too severe on the other side OR dizziness above 16 on DHI|0|||
147360635|NCT03106740|531491377|FG000|Overall Study|Lost to Follow-up|2|||
147360636|NCT03106740|531491378|FG001|Overall Study|Lost to Follow-up|2|||
147608381|NCT00264550|532382609|FG003|Overall Study|Death|0|||
147608382|NCT00264550|532382606|FG000|Overall Study|Lost to Follow-up|3|||
147608383|NCT00264550|532382607|FG001|Overall Study|Lost to Follow-up|1|||
147608384|NCT00264550|532382608|FG002|Overall Study|Lost to Follow-up|1|||
147608385|NCT00264550|532382609|FG003|Overall Study|Lost to Follow-up|1|||
147608386|NCT00264550|532382606|FG000|Overall Study|Adverse Event|23|||
147608387|NCT00264550|532382607|FG001|Overall Study|Adverse Event|18|||
147608388|NCT00264550|532382608|FG002|Overall Study|Adverse Event|9|||
147608389|NCT00264550|532382609|FG003|Overall Study|Adverse Event|14|||
147608390|NCT00264550|532382606|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
147608391|NCT00264550|532382607|FG001|Overall Study|Unsatisfactory therapeutic effect|11|||
147608392|NCT00264550|532382608|FG002|Overall Study|Unsatisfactory therapeutic effect|4|||
147608393|NCT00264550|532382609|FG003|Overall Study|Unsatisfactory therapeutic effect|6|||
147608394|NCT00264550|532382606|FG000|Overall Study|Discontinued oral study agent|0|||
147608395|NCT00264550|532382607|FG001|Overall Study|Discontinued oral study agent|1|||
147608396|NCT00264550|532382608|FG002|Overall Study|Discontinued oral study agent|0|||
147608397|NCT00264550|532382609|FG003|Overall Study|Discontinued oral study agent|0|||
147608398|NCT00264550|532382606|FG000|Overall Study|Other|13|||
147608399|NCT00264550|532382607|FG001|Overall Study|Other|7|||
147608400|NCT00264550|532382608|FG002|Overall Study|Other|3|||
147608401|NCT00264550|532382609|FG003|Overall Study|Other|9|||
147608402|NCT02246114|532382610|FG000|Overall Study|miscarriage|1|||
147608403|NCT02246114|532382611|FG001|Overall Study|miscarriage|0|||
147608404|NCT02473523|532382616|FG000|Overall Study|Death|1|||
147608405|NCT02473523|532382616|FG000|Overall Study|Lost to Follow-up|1|||
147608406|NCT02794246|532382617|FG000|Overall Study|Withdrawal by Subject|2|||
147360637|NCT03106740|531491377|FG000|Overall Study|Withdrawal by Subject|2|||
147360638|NCT03106740|531491378|FG001|Overall Study|Withdrawal by Subject|4|||
147360639|NCT03106740|531491377|FG000|Overall Study|Physician Decision|0|||
147608407|NCT02794246|532382617|FG000|Overall Study|Physician Decision|4|||
147608408|NCT00000620|532382620|FG000|Overall Study|Death|86|||
147608409|NCT00000620|532382621|FG001|Overall Study|Death|67|||
147608410|NCT00000620|532382622|FG002|Overall Study|Death|112|||
147608411|NCT00000620|532382623|FG003|Overall Study|Death|126|||
147608412|NCT00000620|532382624|FG004|Overall Study|Death|64|||
147608413|NCT00000620|532382625|FG005|Overall Study|Death|77|||
147608414|NCT00000620|532382626|FG006|Overall Study|Death|91|||
147608415|NCT00000620|532382627|FG007|Overall Study|Death|95|||
147608416|NCT00000620|532382620|FG000|Overall Study|Lost to Follow-up|14|||
147608417|NCT00000620|532382621|FG001|Overall Study|Lost to Follow-up|14|||
147608418|NCT00000620|532382622|FG002|Overall Study|Lost to Follow-up|14|||
147608419|NCT00000620|532382623|FG003|Overall Study|Lost to Follow-up|14|||
147608420|NCT00000620|532382624|FG004|Overall Study|Lost to Follow-up|15|||
147608421|NCT00000620|532382625|FG005|Overall Study|Lost to Follow-up|15|||
147608422|NCT00000620|532382626|FG006|Overall Study|Lost to Follow-up|13|||
147608423|NCT00000620|532382627|FG007|Overall Study|Lost to Follow-up|14|||
147608424|NCT00000620|532382620|FG000|Overall Study|Withdrawal by Subject|40|||
147360640|NCT03106740|531491378|FG001|Overall Study|Physician Decision|1|||
147360641|NCT03106740|531491377|FG000|Overall Study|Partial data|1|||
147360642|NCT03106740|531491378|FG001|Overall Study|Partial data|0|||
147360643|NCT04565990|531491379|FG000|Overall Study|Death|5|||
147360644|NCT04565990|531491379|FG000|Overall Study|Lost to Follow-up|1|||
147360645|NCT04565990|531491379|FG000|Overall Study|Withdrawal by Subject|1|||
147360646|NCT04797858|531491380|FG000|Overall Study|Withdrawal by Subject|0|||
147360647|NCT04797858|531491381|FG001|Overall Study|Withdrawal by Subject|1|||
147360648|NCT04797858|531491380|FG000|Overall Study|Excluded due to administrative error|7|||
147360649|NCT04797858|531491381|FG001|Overall Study|Excluded due to administrative error|8|||
147360650|NCT05269966|531491392|FG000|Overall Study|Adverse Event|4|||
147360651|NCT05269966|531491392|FG000|Overall Study|Withdrawal by Subject|1|||
147360652|NCT05269966|531491392|FG000|Overall Study|Lost to Follow-up|4|||
147360653|NCT05269966|531491392|FG000|Overall Study|Physician Decision|1|||
147360654|NCT03476343|531491408|FG000|Overall Study|Clinical exam moved to another scanner|7|||
147360655|NCT03476343|531491408|FG000|Overall Study|Clinical order cancelled|4|||
147360656|NCT03476343|531491408|FG000|Overall Study|Neonate did not settle down for the scan|1|||
147360657|NCT03711474|531491409|FG000|Overall Study|Physician Decision|2|||
147360658|NCT03711474|531491410|FG001|Overall Study|Physician Decision|0|||
147360659|NCT05147116|531491411|FG000|Overall Study|Withdrawal by Subject|0|||
147360660|NCT05147116|531491412|FG001|Overall Study|Withdrawal by Subject|1|||
147360661|NCT04101357|531491413|FG000|Overall Study|Death|1|||
147360662|NCT04101357|531491414|FG001|Overall Study|Death|1|||
147360663|NCT04101357|531491415|FG002|Overall Study|Death|1|||
147360664|NCT04101357|531491416|FG003|Overall Study|Death|2|||
147360665|NCT04101357|531491417|FG004|Overall Study|Death|4|||
147360666|NCT04101357|531491418|FG005|Overall Study|Death|11|||
147360667|NCT04101357|531491419|FG006|Overall Study|Death|4|||
147360668|NCT04101357|531491420|FG007|Overall Study|Death|4|||
147360669|NCT04101357|531491421|FG008|Overall Study|Death|5|||
147360670|NCT04101357|531491422|FG009|Overall Study|Death|2|||
147360671|NCT04101357|531491423|FG010|Overall Study|Death|3|||
147360672|NCT04101357|531491413|FG000|Overall Study|Trial closure|0|||
147360673|NCT04101357|531491414|FG001|Overall Study|Trial closure|0|||
147360674|NCT04101357|531491415|FG002|Overall Study|Trial closure|0|||
147360675|NCT04101357|531491416|FG003|Overall Study|Trial closure|0|||
147360676|NCT04101357|531491417|FG004|Overall Study|Trial closure|0|||
147360677|NCT04101357|531491418|FG005|Overall Study|Trial closure|2|||
147360678|NCT04101357|531491419|FG006|Overall Study|Trial closure|2|||
147360679|NCT04101357|531491420|FG007|Overall Study|Trial closure|0|||
147360680|NCT04101357|531491421|FG008|Overall Study|Trial closure|0|||
147360681|NCT04101357|531491422|FG009|Overall Study|Trial closure|0|||
147360682|NCT04101357|531491423|FG010|Overall Study|Trial closure|1|||
147360683|NCT04101357|531491413|FG000|Overall Study|Lost to Follow-up|0|||
147360684|NCT04101357|531491414|FG001|Overall Study|Lost to Follow-up|0|||
147360685|NCT04101357|531491415|FG002|Overall Study|Lost to Follow-up|0|||
147360686|NCT04101357|531491416|FG003|Overall Study|Lost to Follow-up|1|||
147360687|NCT04101357|531491417|FG004|Overall Study|Lost to Follow-up|0|||
147360688|NCT04101357|531491418|FG005|Overall Study|Lost to Follow-up|0|||
147360689|NCT04101357|531491419|FG006|Overall Study|Lost to Follow-up|0|||
147360690|NCT04101357|531491420|FG007|Overall Study|Lost to Follow-up|1|||
147360691|NCT04101357|531491421|FG008|Overall Study|Lost to Follow-up|0|||
147360692|NCT04101357|531491422|FG009|Overall Study|Lost to Follow-up|0|||
147360693|NCT04101357|531491423|FG010|Overall Study|Lost to Follow-up|0|||
147360694|NCT04101357|531491413|FG000|Overall Study|Withdrawal by Subject|1|||
147360695|NCT04101357|531491414|FG001|Overall Study|Withdrawal by Subject|0|||
147360696|NCT04101357|531491415|FG002|Overall Study|Withdrawal by Subject|0|||
147360697|NCT04101357|531491416|FG003|Overall Study|Withdrawal by Subject|0|||
147360698|NCT04101357|531491417|FG004|Overall Study|Withdrawal by Subject|0|||
147360699|NCT04101357|531491418|FG005|Overall Study|Withdrawal by Subject|0|||
147360700|NCT04101357|531491419|FG006|Overall Study|Withdrawal by Subject|0|||
147360701|NCT04101357|531491420|FG007|Overall Study|Withdrawal by Subject|0|||
147360702|NCT04101357|531491421|FG008|Overall Study|Withdrawal by Subject|1|||
147360703|NCT04101357|531491422|FG009|Overall Study|Withdrawal by Subject|1|||
147360704|NCT04101357|531491423|FG010|Overall Study|Withdrawal by Subject|0|||
147360705|NCT04101357|531491413|FG000|Overall Study|Other|0|||
147360706|NCT04101357|531491414|FG001|Overall Study|Other|0|||
147360707|NCT04101357|531491415|FG002|Overall Study|Other|0|||
147360708|NCT04101357|531491416|FG003|Overall Study|Other|0|||
147360709|NCT04101357|531491417|FG004|Overall Study|Other|0|||
147360710|NCT04101357|531491418|FG005|Overall Study|Other|1|||
147360711|NCT04101357|531491419|FG006|Overall Study|Other|2|||
147360712|NCT04101357|531491420|FG007|Overall Study|Other|1|||
147360713|NCT04101357|531491421|FG008|Overall Study|Other|0|||
147360714|NCT04101357|531491422|FG009|Overall Study|Other|0|||
147360715|NCT04101357|531491423|FG010|Overall Study|Other|0|||
147360716|NCT04101357|531491413|FG000|Overall Study|Enrolled but not treated|0|||
147360717|NCT04101357|531491414|FG001|Overall Study|Enrolled but not treated|0|||
147360718|NCT04101357|531491415|FG002|Overall Study|Enrolled but not treated|0|||
147360719|NCT04101357|531491416|FG003|Overall Study|Enrolled but not treated|0|||
147360720|NCT04101357|531491417|FG004|Overall Study|Enrolled but not treated|0|||
147360721|NCT04101357|531491418|FG005|Overall Study|Enrolled but not treated|1|||
147360722|NCT04101357|531491419|FG006|Overall Study|Enrolled but not treated|1|||
147360723|NCT04101357|531491420|FG007|Overall Study|Enrolled but not treated|0|||
147360724|NCT04101357|531491421|FG008|Overall Study|Enrolled but not treated|0|||
147360725|NCT04101357|531491422|FG009|Overall Study|Enrolled but not treated|0|||
147360726|NCT04101357|531491423|FG010|Overall Study|Enrolled but not treated|0|||
147360727|NCT05618587|531491424|FG000|Overall Study|Lost to Follow-up|2|||
147360728|NCT05618587|531491425|FG001|Overall Study|Lost to Follow-up|0|||
147360729|NCT05204654|531491428|FG000|Overall Study|Study terminated due to time restraint|2|||
147360730|NCT05204654|531491429|FG001|Overall Study|Study terminated due to time restraint|2|||
147360731|NCT01221948|531491430|FG000|Overall Study|Physician Decision|5|||
147360732|NCT01221948|531491430|FG000|Overall Study|Withdrawal by Subject|2|||
147360733|NCT01221948|531491430|FG000|Overall Study|not disclosed|2|||
147360734|NCT01221948|531491430|FG000|Overall Study|Death|1|||
147360735|NCT01221948|531491430|FG000|Overall Study|Protocol Violation|4|||
147360736|NCT02446236|531491433|FG000|Overall Study|Screen Failure|1|||
147360737|NCT02446236|531491434|FG001|Overall Study|Screen Failure|0|||
147360738|NCT02446236|531491435|FG002|Overall Study|Screen Failure|1|||
147360739|NCT02446236|531491433|FG000|Overall Study|Actively Receiving Therapy|0|||
147360740|NCT02446236|531491434|FG001|Overall Study|Actively Receiving Therapy|0|||
147360741|NCT02446236|531491435|FG002|Overall Study|Actively Receiving Therapy|1|||
147360742|NCT05290493|531491440|FG000|Overall Study|Withdrawal by Subject|2|||
147360743|NCT05290493|531491441|FG001|Overall Study|Withdrawal by Subject|2|||
147360744|NCT05290493|531491440|FG000|Overall Study|Adverse Event|1|||
147360745|NCT05290493|531491441|FG001|Overall Study|Adverse Event|0|||
147360746|NCT05012163|531491445|FG000|Overall Study|Protocol Violation|0|||
147360747|NCT05012163|531491446|FG001|Overall Study|Protocol Violation|0|||
147360748|NCT05012163|531491447|FG002|Overall Study|Protocol Violation|1|||
147360749|NCT05012163|531491448|FG003|Overall Study|Protocol Violation|1|||
147360750|NCT04003246|531491451|FG000|Overall Study|Death|9|||
147360751|NCT03673501|531491459|FG000|Overall Study|Participants ongoing.|36|||
147360752|NCT03673501|531491460|FG001|Overall Study|Participants ongoing.|24|||
147360753|NCT04599634|531491461|FG000|Overall Study|Dose limiting toxicity|0|||
147360754|NCT04599634|531491462|FG001|Overall Study|Dose limiting toxicity|0|||
147360755|NCT04599634|531491463|FG002|Overall Study|Dose limiting toxicity|2|||
147360756|NCT04599634|531491464|FG003|Overall Study|Dose limiting toxicity|0|||
147360757|NCT03714815|531491465|FG000|Overall Study|Physician Decision|2|||
147360758|NCT03714815|531491465|FG000|Overall Study|Withdrawal by Subject|2|||
147360759|NCT03714815|531491465|FG000|Overall Study|Death|11|||
147360760|NCT03733925|531491467|FG000|Overall Study|Lost to Follow-up|1|||
147360761|NCT03733925|531491467|FG000|Overall Study|Withdrawal by Subject|2|||
147360762|NCT03733925|531491467|FG000|Overall Study|Adverse Event|2|||
147360763|NCT03733925|531491467|FG000|Overall Study|Non-Compliance with Study Drug|1|||
147360764|NCT03213873|531491468|FG000|Overall Study|Withdrawal by Subject|8|||
147360765|NCT03213873|531491469|FG001|Overall Study|Withdrawal by Subject|9|||
147360766|NCT03213873|531491468|FG000|Overall Study|Diagnosed w atypical PD after randomization|0|||
147360767|NCT03213873|531491469|FG001|Overall Study|Diagnosed w atypical PD after randomization|1|||
147360768|NCT03213873|531491468|FG000|Overall Study|Lost to Follow-up|0|||
147360769|NCT03213873|531491469|FG001|Overall Study|Lost to Follow-up|2|||
147360770|NCT04709419|531491476|FG000|Overall Study|Physician Decision|1|||
147360771|NCT04709419|531491477|FG001|Overall Study|Physician Decision|0|||
147360772|NCT05683340|531491478|FG000|Overall Study|Adverse Event|1|||
147360773|NCT05683340|531491479|FG001|Overall Study|Adverse Event|1|||
147360774|NCT05683340|531491478|FG000|Overall Study|Protocol Violation|1|||
147360775|NCT05683340|531491479|FG001|Overall Study|Protocol Violation|0|||
147360776|NCT05683340|531491478|FG000|Overall Study|Withdrawal by Subject|0|||
147360777|NCT05683340|531491479|FG001|Overall Study|Withdrawal by Subject|2|||
147360778|NCT03824366|531491482|FG000|Overall Study|Death|1|||
147360779|NCT03824366|531491482|FG000|Overall Study|Previously unidentified metal artifact|1|||
147360780|NCT03824366|531491482|FG000|Overall Study|Unable to tolerate lying flat on MR table|1|||
147360781|NCT03824366|531491482|FG000|Overall Study|Withdrawal by Subject|1|||
147360782|NCT02988661|531491487|FG000|Overall Study|Death|2|||
147360783|NCT02988661|531491488|FG001|Overall Study|Death|18|||
147360784|NCT02988661|531491487|FG000|Overall Study|Lost to Follow-up|0|||
147360785|NCT02988661|531491488|FG001|Overall Study|Lost to Follow-up|33|||
147360786|NCT02988661|531491487|FG000|Overall Study|Withdrawal by Subject|0|||
147360787|NCT02988661|531491488|FG001|Overall Study|Withdrawal by Subject|6|||
147360788|NCT02988661|531491487|FG000|Overall Study|Unable to complete the 18-month survey|1|||
147360789|NCT02988661|531491488|FG001|Overall Study|Unable to complete the 18-month survey|27|||
147360790|NCT02323880|531491491|FG000|Overall Study|Adverse Event|2|||
147360791|NCT02323880|531491492|FG001|Overall Study|Adverse Event|0|||
147360792|NCT02323880|531491493|FG002|Overall Study|Adverse Event|1|||
147360793|NCT02323880|531491494|FG003|Overall Study|Adverse Event|1|||
147360794|NCT02323880|531491495|FG004|Overall Study|Adverse Event|1|||
147360795|NCT02323880|531491496|FG005|Overall Study|Adverse Event|0|||
147360796|NCT02323880|531491497|FG006|Overall Study|Adverse Event|1|||
147360797|NCT02323880|531491498|FG007|Overall Study|Adverse Event|0|||
147360798|NCT02323880|531491491|FG000|Overall Study|Death|0|||
147360799|NCT02323880|531491492|FG001|Overall Study|Death|0|||
147360800|NCT02323880|531491493|FG002|Overall Study|Death|0|||
147360801|NCT02323880|531491494|FG003|Overall Study|Death|0|||
147360802|NCT02323880|531491495|FG004|Overall Study|Death|0|||
147360803|NCT02323880|531491496|FG005|Overall Study|Death|1|||
147360804|NCT02323880|531491497|FG006|Overall Study|Death|0|||
147360805|NCT02323880|531491498|FG007|Overall Study|Death|0|||
147360806|NCT02323880|531491491|FG000|Overall Study|Lack of Efficacy|4|||
147360807|NCT02323880|531491492|FG001|Overall Study|Lack of Efficacy|11|||
147360808|NCT02323880|531491493|FG002|Overall Study|Lack of Efficacy|5|||
147360809|NCT02323880|531491494|FG003|Overall Study|Lack of Efficacy|5|||
147360810|NCT02323880|531491495|FG004|Overall Study|Lack of Efficacy|4|||
147360811|NCT02323880|531491496|FG005|Overall Study|Lack of Efficacy|8|||
147360812|NCT02323880|531491497|FG006|Overall Study|Lack of Efficacy|4|||
147360813|NCT02323880|531491498|FG007|Overall Study|Lack of Efficacy|6|||
147360814|NCT02323880|531491491|FG000|Overall Study|Physician Decision|0|||
147360815|NCT02323880|531491492|FG001|Overall Study|Physician Decision|0|||
147360816|NCT02323880|531491493|FG002|Overall Study|Physician Decision|0|||
147360817|NCT02323880|531491494|FG003|Overall Study|Physician Decision|0|||
147360818|NCT02323880|531491495|FG004|Overall Study|Physician Decision|1|||
147360819|NCT02323880|531491496|FG005|Overall Study|Physician Decision|1|||
147360820|NCT02323880|531491497|FG006|Overall Study|Physician Decision|1|||
147360821|NCT02323880|531491498|FG007|Overall Study|Physician Decision|0|||
147360822|NCT02323880|531491491|FG000|Overall Study|Withdrawal by Subject|0|||
147360823|NCT02323880|531491492|FG001|Overall Study|Withdrawal by Subject|2|||
147360824|NCT02323880|531491493|FG002|Overall Study|Withdrawal by Subject|0|||
147360825|NCT02323880|531491494|FG003|Overall Study|Withdrawal by Subject|0|||
147360826|NCT02323880|531491495|FG004|Overall Study|Withdrawal by Subject|0|||
147360827|NCT02323880|531491496|FG005|Overall Study|Withdrawal by Subject|0|||
147360828|NCT02323880|531491497|FG006|Overall Study|Withdrawal by Subject|0|||
147360829|NCT02323880|531491498|FG007|Overall Study|Withdrawal by Subject|0|||
147360830|NCT04766892|531492858|FG000|Overall Study|Withdrawal by Subject|1|||
147360831|NCT04766892|531492858|FG000|Overall Study|Lost to Follow-up|1|||
147360832|NCT04766892|531492858|FG000|Overall Study|Adverse Event|3|||
147360833|NCT04766892|531492858|FG000|Overall Study|Left ventricular ejection fraction (LVEF) Criteria Met|1|||
147360834|NCT03381586|531492863|FG000|Overall Study|Adverse Event|1|||
147360835|NCT03381586|531492864|FG001|Overall Study|Adverse Event|1|||
147360836|NCT03381586|531492863|FG000|Overall Study|Protocol Violation|1|||
147360837|NCT03381586|531492864|FG001|Overall Study|Protocol Violation|0|||
147360838|NCT03381586|531492863|FG000|Overall Study|Withdrawal by Subject|1|||
147360839|NCT03381586|531492864|FG001|Overall Study|Withdrawal by Subject|2|||
147360840|NCT05280574|531492870|FG000|Overall Study|Withdrawal by Subject|0|||
147360841|NCT05280574|531492871|FG001|Overall Study|Withdrawal by Subject|2|||
147360842|NCT05280574|531492872|FG002|Overall Study|Withdrawal by Subject|0|||
147360843|NCT05237284|531492877|FG000|Part A (Double-blind Period: 24 Weeks)|Other|0|||
147360844|NCT05237284|531492878|FG001|Part A (Double-blind Period: 24 Weeks)|Other|2|||
147360845|NCT05237284|531492879|FG002|Part A (Double-blind Period: 24 Weeks)|Other|0|||
147360846|NCT05237284|531492880|FG003|Part A (Double-blind Period: 24 Weeks)|Other|0|||
147360847|NCT05237284|531492877|FG000|Part A (Double-blind Period: 24 Weeks)|Withdrawal by Subject|8|||
147360848|NCT05237284|531492878|FG001|Part A (Double-blind Period: 24 Weeks)|Withdrawal by Subject|13|||
147360849|NCT05237284|531492879|FG002|Part A (Double-blind Period: 24 Weeks)|Withdrawal by Subject|0|||
147360850|NCT05237284|531492880|FG003|Part A (Double-blind Period: 24 Weeks)|Withdrawal by Subject|0|||
147360851|NCT05237284|531492877|FG000|Part A (Double-blind Period: 24 Weeks)|Poor compliance to protocol|0|||
147360852|NCT05237284|531492878|FG001|Part A (Double-blind Period: 24 Weeks)|Poor compliance to protocol|1|||
147360853|NCT05237284|531492879|FG002|Part A (Double-blind Period: 24 Weeks)|Poor compliance to protocol|0|||
147360854|NCT05237284|531492880|FG003|Part A (Double-blind Period: 24 Weeks)|Poor compliance to protocol|0|||
147608425|NCT00000620|532382621|FG001|Overall Study|Withdrawal by Subject|27|||
147360855|NCT05237284|531492877|FG000|Part A (Double-blind Period: 24 Weeks)|Adverse Event|6|||
147360856|NCT05237284|531492878|FG001|Part A (Double-blind Period: 24 Weeks)|Adverse Event|20|||
147360857|NCT05237284|531492879|FG002|Part A (Double-blind Period: 24 Weeks)|Adverse Event|0|||
147360858|NCT05237284|531492880|FG003|Part A (Double-blind Period: 24 Weeks)|Adverse Event|0|||
147360859|NCT05237284|531492877|FG000|Part B (Open-label Period: 80 Weeks)|Other|0|||
147360860|NCT05237284|531492878|FG001|Part B (Open-label Period: 80 Weeks)|Other|0|||
147360861|NCT05237284|531492879|FG002|Part B (Open-label Period: 80 Weeks)|Other|0|||
147360862|NCT05237284|531492880|FG003|Part B (Open-label Period: 80 Weeks)|Other|3|||
147360863|NCT05237284|531492877|FG000|Part B (Open-label Period: 80 Weeks)|Study terminated by sponsor|0|||
147360864|NCT05237284|531492878|FG001|Part B (Open-label Period: 80 Weeks)|Study terminated by sponsor|0|||
147360865|NCT05237284|531492879|FG002|Part B (Open-label Period: 80 Weeks)|Study terminated by sponsor|64|||
147360866|NCT05237284|531492880|FG003|Part B (Open-label Period: 80 Weeks)|Study terminated by sponsor|126|||
147360867|NCT05237284|531492877|FG000|Part B (Open-label Period: 80 Weeks)|Withdrawal by Subject|0|||
147360868|NCT05237284|531492878|FG001|Part B (Open-label Period: 80 Weeks)|Withdrawal by Subject|0|||
147360869|NCT05237284|531492879|FG002|Part B (Open-label Period: 80 Weeks)|Withdrawal by Subject|11|||
147360870|NCT05237284|531492880|FG003|Part B (Open-label Period: 80 Weeks)|Withdrawal by Subject|21|||
147360871|NCT05237284|531492877|FG000|Part B (Open-label Period: 80 Weeks)|Poor compliance to protocol|0|||
147360872|NCT05237284|531492878|FG001|Part B (Open-label Period: 80 Weeks)|Poor compliance to protocol|0|||
147360873|NCT05237284|531492879|FG002|Part B (Open-label Period: 80 Weeks)|Poor compliance to protocol|0|||
147360874|NCT05237284|531492880|FG003|Part B (Open-label Period: 80 Weeks)|Poor compliance to protocol|1|||
147360875|NCT05237284|531492877|FG000|Part B (Open-label Period: 80 Weeks)|Adverse Event|0|||
147360876|NCT05237284|531492878|FG001|Part B (Open-label Period: 80 Weeks)|Adverse Event|0|||
147360877|NCT05237284|531492879|FG002|Part B (Open-label Period: 80 Weeks)|Adverse Event|13|||
147360878|NCT05237284|531492880|FG003|Part B (Open-label Period: 80 Weeks)|Adverse Event|16|||
147360879|NCT02224144|531492884|FG000|Overall Study|Lost to Follow-up|3|||
147360880|NCT02224144|531492885|FG001|Overall Study|Lost to Follow-up|1|||
147360881|NCT02224144|531492884|FG000|Overall Study|Death|2|||
147360882|NCT02224144|531492885|FG001|Overall Study|Death|0|||
147360883|NCT02224144|531492884|FG000|Overall Study|Withdrawal by Subject|0|||
147360884|NCT02224144|531492885|FG001|Overall Study|Withdrawal by Subject|1|||
147360885|NCT03505008|531492886|FG000|Before Week 24 Randomization|Withdrawal by Subject|24|||
147360886|NCT03505008|531492887|FG001|Before Week 24 Randomization|Withdrawal by Subject|0|||
147360887|NCT03505008|531492888|FG002|Before Week 24 Randomization|Withdrawal by Subject|0|||
147360888|NCT03505008|531492889|FG003|Before Week 24 Randomization|Withdrawal by Subject|0|||
147360889|NCT03505008|531492886|FG000|Before Week 24 Randomization|Adverse Event|10|||
147360890|NCT03505008|531492887|FG001|Before Week 24 Randomization|Adverse Event|0|||
147360891|NCT03505008|531492888|FG002|Before Week 24 Randomization|Adverse Event|0|||
147360892|NCT03505008|531492889|FG003|Before Week 24 Randomization|Adverse Event|0|||
147360893|NCT03505008|531492886|FG000|Before Week 24 Randomization|Lack of Efficacy|8|||
147360894|NCT03505008|531492887|FG001|Before Week 24 Randomization|Lack of Efficacy|0|||
147360895|NCT03505008|531492888|FG002|Before Week 24 Randomization|Lack of Efficacy|0|||
147360896|NCT03505008|531492889|FG003|Before Week 24 Randomization|Lack of Efficacy|0|||
147360897|NCT03505008|531492886|FG000|Before Week 24 Randomization|Methotrexate <10 mg/week at Week 24|5|||
147360898|NCT03505008|531492887|FG001|Before Week 24 Randomization|Methotrexate <10 mg/week at Week 24|0|||
147360899|NCT03505008|531492888|FG002|Before Week 24 Randomization|Methotrexate <10 mg/week at Week 24|0|||
147360900|NCT03505008|531492889|FG003|Before Week 24 Randomization|Methotrexate <10 mg/week at Week 24|0|||
147360901|NCT03505008|531492886|FG000|Before Week 24 Randomization|Physician Decision|2|||
147360902|NCT03505008|531492887|FG001|Before Week 24 Randomization|Physician Decision|0|||
147360903|NCT03505008|531492888|FG002|Before Week 24 Randomization|Physician Decision|0|||
147360904|NCT03505008|531492889|FG003|Before Week 24 Randomization|Physician Decision|0|||
147360905|NCT03505008|531492886|FG000|Before Week 24 Randomization|Lost to Follow-up|1|||
147360906|NCT03505008|531492887|FG001|Before Week 24 Randomization|Lost to Follow-up|0|||
147360907|NCT03505008|531492888|FG002|Before Week 24 Randomization|Lost to Follow-up|0|||
147360908|NCT03505008|531492889|FG003|Before Week 24 Randomization|Lost to Follow-up|0|||
147360909|NCT03505008|531492886|FG000|Before Week 24 Randomization|Inadequate Methotrexate Adherence|1|||
147360910|NCT03505008|531492887|FG001|Before Week 24 Randomization|Inadequate Methotrexate Adherence|0|||
147360911|NCT03505008|531492888|FG002|Before Week 24 Randomization|Inadequate Methotrexate Adherence|0|||
147360912|NCT03505008|531492889|FG003|Before Week 24 Randomization|Inadequate Methotrexate Adherence|0|||
147360913|NCT03505008|531492886|FG000|Before Week 24 Randomization|Complication|1|||
147360914|NCT03505008|531492887|FG001|Before Week 24 Randomization|Complication|0|||
147360915|NCT03505008|531492888|FG002|Before Week 24 Randomization|Complication|0|||
147360916|NCT03505008|531492889|FG003|Before Week 24 Randomization|Complication|0|||
147360917|NCT03505008|531492886|FG000|After Week 24 Randomization|Withdrawal by Subject|0|||
147360918|NCT03505008|531492887|FG001|After Week 24 Randomization|Withdrawal by Subject|0|||
147360919|NCT03505008|531492888|FG002|After Week 24 Randomization|Withdrawal by Subject|3|||
147360920|NCT03505008|531492889|FG003|After Week 24 Randomization|Withdrawal by Subject|3|||
147360921|NCT03505008|531492886|FG000|After Week 24 Randomization|Lack of Efficacy|0|||
147360922|NCT03505008|531492887|FG001|After Week 24 Randomization|Lack of Efficacy|2|||
147360923|NCT03505008|531492888|FG002|After Week 24 Randomization|Lack of Efficacy|3|||
147360924|NCT03505008|531492889|FG003|After Week 24 Randomization|Lack of Efficacy|1|||
147360925|NCT03505008|531492886|FG000|After Week 24 Randomization|Adverse Event|0|||
147360926|NCT03505008|531492887|FG001|After Week 24 Randomization|Adverse Event|1|||
147360927|NCT03505008|531492888|FG002|After Week 24 Randomization|Adverse Event|2|||
147360928|NCT03505008|531492889|FG003|After Week 24 Randomization|Adverse Event|2|||
147360929|NCT03505008|531492886|FG000|After Week 24 Randomization|Lost to Follow-up|0|||
147360930|NCT03505008|531492887|FG001|After Week 24 Randomization|Lost to Follow-up|1|||
147360931|NCT03505008|531492888|FG002|After Week 24 Randomization|Lost to Follow-up|0|||
147360932|NCT03505008|531492889|FG003|After Week 24 Randomization|Lost to Follow-up|2|||
147360933|NCT03505008|531492886|FG000|After Week 24 Randomization|Protocol Violation|0|||
147360934|NCT03505008|531492887|FG001|After Week 24 Randomization|Protocol Violation|0|||
147360935|NCT03505008|531492888|FG002|After Week 24 Randomization|Protocol Violation|1|||
147360936|NCT03505008|531492889|FG003|After Week 24 Randomization|Protocol Violation|0|||
147360937|NCT03276676|531492890|FG000|Overall Study|Withdrawal by Subject|2|||
147360938|NCT03276676|531492891|FG001|Overall Study|Withdrawal by Subject|1|||
147360939|NCT02962076|531492893|FG000|Overall Study|MHED tracer not available|5|||
147360940|NCT02962076|531492893|FG000|Overall Study|Protocol Violation|1|||
147360941|NCT02962076|531492893|FG000|Overall Study|Physician Decision|1|||
147360942|NCT02780700|531492894|FG000|Overall Study|Progressive disease|1|||
147360943|NCT03926130|531492895|FG000|Overall Study|Adverse Event|9|||
147360944|NCT03926130|531492896|FG001|Overall Study|Adverse Event|11|||
147360945|NCT03926130|531492897|FG002|Overall Study|Adverse Event|2|||
147360946|NCT03926130|531492898|FG003|Overall Study|Adverse Event|0|||
147360947|NCT03926130|531492895|FG000|Overall Study|Death|2|||
147360948|NCT03926130|531492896|FG001|Overall Study|Death|0|||
147360949|NCT03926130|531492897|FG002|Overall Study|Death|1|||
147360950|NCT03926130|531492898|FG003|Overall Study|Death|0|||
147360951|NCT03926130|531492895|FG000|Overall Study|Lack of Efficacy|14|||
147360952|NCT03926130|531492896|FG001|Overall Study|Lack of Efficacy|11|||
147360953|NCT03926130|531492897|FG002|Overall Study|Lack of Efficacy|7|||
147360954|NCT03926130|531492898|FG003|Overall Study|Lack of Efficacy|1|||
147360955|NCT03926130|531492895|FG000|Overall Study|Lost to Follow-up|0|||
147360956|NCT03926130|531492896|FG001|Overall Study|Lost to Follow-up|7|||
147360957|NCT03926130|531492897|FG002|Overall Study|Lost to Follow-up|1|||
147360958|NCT03926130|531492898|FG003|Overall Study|Lost to Follow-up|0|||
147360959|NCT03926130|531492895|FG000|Overall Study|As Reported by Investigator|2|||
147360960|NCT03926130|531492896|FG001|Overall Study|As Reported by Investigator|6|||
147360961|NCT03926130|531492897|FG002|Overall Study|As Reported by Investigator|6|||
147360962|NCT03926130|531492898|FG003|Overall Study|As Reported by Investigator|0|||
147360963|NCT03926130|531492895|FG000|Overall Study|Physician Decision|3|||
147360964|NCT03926130|531492896|FG001|Overall Study|Physician Decision|2|||
147360965|NCT03926130|531492897|FG002|Overall Study|Physician Decision|1|||
147360966|NCT03926130|531492898|FG003|Overall Study|Physician Decision|0|||
147360967|NCT03926130|531492895|FG000|Overall Study|Pregnancy|2|||
147360968|NCT03926130|531492896|FG001|Overall Study|Pregnancy|2|||
147360969|NCT03926130|531492897|FG002|Overall Study|Pregnancy|1|||
147360970|NCT03926130|531492898|FG003|Overall Study|Pregnancy|0|||
147360971|NCT03926130|531492895|FG000|Overall Study|Withdrawal by Subject|20|||
147360972|NCT03926130|531492896|FG001|Overall Study|Withdrawal by Subject|28|||
147360973|NCT03926130|531492897|FG002|Overall Study|Withdrawal by Subject|18|||
147360974|NCT03926130|531492898|FG003|Overall Study|Withdrawal by Subject|1|||
147360975|NCT03926130|531492895|FG000|Overall Study|Non-Compliance|1|||
147360976|NCT03926130|531492896|FG001|Overall Study|Non-Compliance|1|||
147360977|NCT03926130|531492897|FG002|Overall Study|Non-Compliance|0|||
147360978|NCT03926130|531492898|FG003|Overall Study|Non-Compliance|0|||
147360979|NCT03926130|531492895|FG000|Overall Study|Disposition Not Captured|0|||
147360980|NCT03926130|531492896|FG001|Overall Study|Disposition Not Captured|2|||
147360981|NCT03926130|531492897|FG002|Overall Study|Disposition Not Captured|1|||
147360982|NCT03926130|531492898|FG003|Overall Study|Disposition Not Captured|0|||
147360983|NCT03583333|531492899|FG000|Overall Study|Participant Conducted Day 28 Visit Prior to the Required Time Window|8|||
147360984|NCT03583333|531492900|FG001|Overall Study|Participant Conducted Day 28 Visit Prior to the Required Time Window|6|||
147360985|NCT03583333|531492899|FG000|Overall Study|Withdrawal by Parent/Guardian|16|||
147360986|NCT03583333|531492900|FG001|Overall Study|Withdrawal by Parent/Guardian|10|||
147360987|NCT03583333|531492899|FG000|Overall Study|Withdrawal by Subject|9|||
147360988|NCT03583333|531492900|FG001|Overall Study|Withdrawal by Subject|5|||
147360989|NCT03583333|531492899|FG000|Overall Study|Physician Decision|3|||
147360990|NCT03583333|531492900|FG001|Overall Study|Physician Decision|2|||
147360991|NCT03583333|531492899|FG000|Overall Study|Death|12|||
147360992|NCT03583333|531492900|FG001|Overall Study|Death|7|||
147360993|NCT03640286|531492917|FG000|Overall Study|Adverse Event|6|||
147360994|NCT03640286|531492918|FG001|Overall Study|Adverse Event|6|||
147360995|NCT03640286|531492917|FG000|Overall Study|Lost to Follow-up|3|||
147360996|NCT03640286|531492918|FG001|Overall Study|Lost to Follow-up|6|||
147360997|NCT03640286|531492917|FG000|Overall Study|Pregnancy|1|||
147360998|NCT03640286|531492918|FG001|Overall Study|Pregnancy|0|||
147608426|NCT00000620|532382622|FG002|Overall Study|Withdrawal by Subject|28|||
147360999|NCT03640286|531492917|FG000|Overall Study|Withdrawal by Subject|10|||
147608427|NCT00000620|532382623|FG003|Overall Study|Withdrawal by Subject|27|||
147608428|NCT00000620|532382624|FG004|Overall Study|Withdrawal by Subject|30|||
147361000|NCT03640286|531492918|FG001|Overall Study|Withdrawal by Subject|10|||
147608429|NCT00000620|532382625|FG005|Overall Study|Withdrawal by Subject|32|||
147361001|NCT03640286|531492917|FG000|Overall Study|Non-compliance|4|||
147361002|NCT03640286|531492918|FG001|Overall Study|Non-compliance|10|||
147361003|NCT03640286|531492917|FG000|Overall Study|Medication change|1|||
147361004|NCT03640286|531492918|FG001|Overall Study|Medication change|0|||
147361005|NCT03640286|531492917|FG000|Overall Study|Other|1|||
147361006|NCT03640286|531492918|FG001|Overall Study|Other|2|||
147361007|NCT03640286|531492917|FG000|Overall Study|Joined another lifestyle program|0|||
147361008|NCT03640286|531492918|FG001|Overall Study|Joined another lifestyle program|1|||
147361009|NCT03181516|531492919|FG000|Overall Study|Withdrawal by Subject|14|||
147361010|NCT03181516|531492920|FG001|Overall Study|Withdrawal by Subject|7|||
147361011|NCT03181516|531492919|FG000|Overall Study|Lost to Follow-up|2|||
147608430|NCT00000620|532382626|FG006|Overall Study|Withdrawal by Subject|32|||
147361012|NCT03181516|531492920|FG001|Overall Study|Lost to Follow-up|2|||
147361013|NCT04580914|531492921|FG000|Overall Study|Withdrawal by Subject|6|||
147361014|NCT04580914|531492921|FG000|Overall Study|Lost to Follow-up|2|||
147361015|NCT04544007|531492922|FG000|Overall Study|Withdrawal by Subject|1|||
147361016|NCT04544007|531492922|FG000|Overall Study|Confirmed Progressive Disease|1|||
147361017|NCT02998528|531492930|FG000|Randomization Period|Adverse event unrelated to study drug|0|||
147361018|NCT02998528|531492931|FG001|Randomization Period|Adverse event unrelated to study drug|0|||
147361019|NCT02998528|531492932|FG002|Randomization Period|Adverse event unrelated to study drug|1|||
147361020|NCT02998528|531492930|FG000|Randomization Period|Participant withdrew consent|0|||
147361021|NCT02998528|531492931|FG001|Randomization Period|Participant withdrew consent|3|||
147361022|NCT02998528|531492932|FG002|Randomization Period|Participant withdrew consent|0|||
147361023|NCT02998528|531492930|FG000|Randomization Period|Participant no longer meets study criteria|1|||
147361024|NCT02998528|531492931|FG001|Randomization Period|Participant no longer meets study criteria|3|||
147361025|NCT02998528|531492932|FG002|Randomization Period|Participant no longer meets study criteria|2|||
147361026|NCT02998528|531492930|FG000|Neoadjuvant Treatment Period|Participant request to discontinue study treatment|0|||
147361027|NCT02998528|531492931|FG001|Neoadjuvant Treatment Period|Participant request to discontinue study treatment|7|||
147361028|NCT02998528|531492932|FG002|Neoadjuvant Treatment Period|Participant request to discontinue study treatment|0|||
147361029|NCT02998528|531492930|FG000|Neoadjuvant Treatment Period|Participant withdrew consent|0|||
147361030|NCT02998528|531492931|FG001|Neoadjuvant Treatment Period|Participant withdrew consent|4|||
147361031|NCT02998528|531492932|FG002|Neoadjuvant Treatment Period|Participant withdrew consent|0|||
147361032|NCT02998528|531492930|FG000|Neoadjuvant Treatment Period|Participant no longer meets study criteria|0|||
147361033|NCT02998528|531492931|FG001|Neoadjuvant Treatment Period|Participant no longer meets study criteria|1|||
147361034|NCT02998528|531492932|FG002|Neoadjuvant Treatment Period|Participant no longer meets study criteria|0|||
147361035|NCT02998528|531492930|FG000|Neoadjuvant Treatment Period|Disease progression|3|||
147361036|NCT02998528|531492931|FG001|Neoadjuvant Treatment Period|Disease progression|2|||
147361037|NCT02998528|531492932|FG002|Neoadjuvant Treatment Period|Disease progression|1|||
147361038|NCT02998528|531492930|FG000|Neoadjuvant Treatment Period|Study drug toxicity|6|||
147361039|NCT02998528|531492931|FG001|Neoadjuvant Treatment Period|Study drug toxicity|14|||
147361040|NCT02998528|531492932|FG002|Neoadjuvant Treatment Period|Study drug toxicity|10|||
147361041|NCT02998528|531492930|FG000|Neoadjuvant Treatment Period|Death|1|||
147361042|NCT02998528|531492931|FG001|Neoadjuvant Treatment Period|Death|0|||
147361043|NCT02998528|531492932|FG002|Neoadjuvant Treatment Period|Death|0|||
147361044|NCT02998528|531492930|FG000|Neoadjuvant Treatment Period|Adverse event unrelated to study treatment|0|||
147361045|NCT02998528|531492931|FG001|Neoadjuvant Treatment Period|Adverse event unrelated to study treatment|3|||
147361046|NCT02998528|531492932|FG002|Neoadjuvant Treatment Period|Adverse event unrelated to study treatment|0|||
147361047|NCT02998528|531492930|FG000|Systemic Adjuvant Treatment Period|Disease progression|1|||
147361048|NCT02998528|531492931|FG001|Systemic Adjuvant Treatment Period|Disease progression|0|||
147361049|NCT02998528|531492932|FG002|Systemic Adjuvant Treatment Period|Disease progression|0|||
147361050|NCT02998528|531492930|FG000|Systemic Adjuvant Treatment Period|Study drug toxicity|4|||
147361051|NCT02998528|531492931|FG001|Systemic Adjuvant Treatment Period|Study drug toxicity|5|||
147361052|NCT02998528|531492932|FG002|Systemic Adjuvant Treatment Period|Study drug toxicity|1|||
147361053|NCT02998528|531492930|FG000|Systemic Adjuvant Treatment Period|Adverse event unrelated to study drug|1|||
147361054|NCT02998528|531492931|FG001|Systemic Adjuvant Treatment Period|Adverse event unrelated to study drug|0|||
147361055|NCT02998528|531492932|FG002|Systemic Adjuvant Treatment Period|Adverse event unrelated to study drug|1|||
147361056|NCT02998528|531492930|FG000|Systemic Adjuvant Treatment Period|Participant request to discontinue treatment|3|||
147361057|NCT02998528|531492931|FG001|Systemic Adjuvant Treatment Period|Participant request to discontinue treatment|1|||
147361058|NCT02998528|531492932|FG002|Systemic Adjuvant Treatment Period|Participant request to discontinue treatment|1|||
147361059|NCT02998528|531492930|FG000|Systemic Adjuvant Treatment Period|Other reasons|0|||
147361060|NCT02998528|531492931|FG001|Systemic Adjuvant Treatment Period|Other reasons|0|||
147361061|NCT02998528|531492932|FG002|Systemic Adjuvant Treatment Period|Other reasons|1|||
147361062|NCT03485729|531492935|FG000|Overall Study|Withdrawal by Subject|0|||
147361063|NCT03485729|531492936|FG001|Overall Study|Withdrawal by Subject|0|||
147361064|NCT03485729|531492937|FG002|Overall Study|Withdrawal by Subject|1|||
147361065|NCT03485729|531492935|FG000|Overall Study|Disease progression|8|||
147361066|NCT03485729|531492936|FG001|Overall Study|Disease progression|13|||
147361067|NCT03485729|531492937|FG002|Overall Study|Disease progression|1|||
147361068|NCT03485729|531492935|FG000|Overall Study|Hospice care|1|||
147361069|NCT03485729|531492936|FG001|Overall Study|Hospice care|0|||
147361070|NCT03485729|531492937|FG002|Overall Study|Hospice care|0|||
147361071|NCT03485729|531492935|FG000|Overall Study|Poor performance status|1|||
147361072|NCT03485729|531492936|FG001|Overall Study|Poor performance status|0|||
147361073|NCT03485729|531492937|FG002|Overall Study|Poor performance status|0|||
147361074|NCT03485729|531492935|FG000|Overall Study|Illness|0|||
147361075|NCT03485729|531492936|FG001|Overall Study|Illness|1|||
147361076|NCT03485729|531492937|FG002|Overall Study|Illness|0|||
147361077|NCT05035654|531492938|FG000|Overall Study|Physician Decision|0|||
147361078|NCT05035654|531492939|FG001|Overall Study|Physician Decision|1|||
147361079|NCT05035654|531492940|FG002|Overall Study|Physician Decision|0|||
147361080|NCT05035654|531492938|FG000|Overall Study|Adverse Event|0|||
147361081|NCT05035654|531492939|FG001|Overall Study|Adverse Event|1|||
147361082|NCT05035654|531492940|FG002|Overall Study|Adverse Event|0|||
147361083|NCT05035654|531492938|FG000|Overall Study|Withdrawal by Subject|0|||
147361084|NCT05035654|531492939|FG001|Overall Study|Withdrawal by Subject|0|||
147361085|NCT05035654|531492940|FG002|Overall Study|Withdrawal by Subject|4|||
147361086|NCT05035654|531492938|FG000|Overall Study|Bilateral Dislodgement|1|||
147361087|NCT05035654|531492939|FG001|Overall Study|Bilateral Dislodgement|0|||
147361088|NCT05035654|531492940|FG002|Overall Study|Bilateral Dislodgement|0|||
147361089|NCT05856435|531492944|FG000|Overall Study|Lost to Follow-up|6|||
147361090|NCT04934072|531492945|FG000|Day 0 to Week 52|Withdrawal by Subject|17|||
147361091|NCT04934072|531492946|FG001|Day 0 to Week 52|Withdrawal by Subject|22|||
147361092|NCT04934072|531492947|FG002|Day 0 to Week 52|Withdrawal by Subject|0|||
147361093|NCT04934072|531492948|FG003|Day 0 to Week 52|Withdrawal by Subject|0|||
147361094|NCT04934072|531492949|FG004|Day 0 to Week 52|Withdrawal by Subject|0|||
147361095|NCT04934072|531492945|FG000|Day 0 to Week 52|Discontinued Treatment Prior to Week 52|4|||
147361096|NCT04934072|531492946|FG001|Day 0 to Week 52|Discontinued Treatment Prior to Week 52|1|||
147361097|NCT04934072|531492947|FG002|Day 0 to Week 52|Discontinued Treatment Prior to Week 52|0|||
147361098|NCT04934072|531492948|FG003|Day 0 to Week 52|Discontinued Treatment Prior to Week 52|0|||
147361099|NCT04934072|531492949|FG004|Day 0 to Week 52|Discontinued Treatment Prior to Week 52|0|||
147361100|NCT04934072|531492945|FG000|Day 0 to Week 52|Other|3|||
147361101|NCT04934072|531492946|FG001|Day 0 to Week 52|Other|1|||
147361102|NCT04934072|531492947|FG002|Day 0 to Week 52|Other|0|||
147361103|NCT04934072|531492948|FG003|Day 0 to Week 52|Other|0|||
147361104|NCT04934072|531492949|FG004|Day 0 to Week 52|Other|0|||
147361105|NCT04934072|531492945|FG000|Day 0 to Week 52|Adverse Event|1|||
147361106|NCT04934072|531492946|FG001|Day 0 to Week 52|Adverse Event|3|||
147361107|NCT04934072|531492947|FG002|Day 0 to Week 52|Adverse Event|0|||
147361108|NCT04934072|531492948|FG003|Day 0 to Week 52|Adverse Event|0|||
147361109|NCT04934072|531492949|FG004|Day 0 to Week 52|Adverse Event|0|||
147361110|NCT04934072|531492945|FG000|Week 52 to Week 78|Adverse Event|0|||
147361111|NCT04934072|531492946|FG001|Week 52 to Week 78|Adverse Event|0|||
147361112|NCT04934072|531492947|FG002|Week 52 to Week 78|Adverse Event|0|||
147361113|NCT04934072|531492948|FG003|Week 52 to Week 78|Adverse Event|1|||
147361114|NCT04934072|531492949|FG004|Week 52 to Week 78|Adverse Event|1|||
147361115|NCT04934072|531492945|FG000|Week 52 to Week 78|Withdrawal by Subject|0|||
147361116|NCT04934072|531492946|FG001|Week 52 to Week 78|Withdrawal by Subject|0|||
147361117|NCT04934072|531492947|FG002|Week 52 to Week 78|Withdrawal by Subject|6|||
147361118|NCT04934072|531492948|FG003|Week 52 to Week 78|Withdrawal by Subject|1|||
147361119|NCT04934072|531492949|FG004|Week 52 to Week 78|Withdrawal by Subject|2|||
147361120|NCT04934072|531492945|FG000|Week 52 to Week 78|Other|0|||
147361121|NCT04934072|531492946|FG001|Week 52 to Week 78|Other|0|||
147361122|NCT04934072|531492947|FG002|Week 52 to Week 78|Other|1|||
147361123|NCT04934072|531492948|FG003|Week 52 to Week 78|Other|0|||
147361124|NCT04934072|531492949|FG004|Week 52 to Week 78|Other|0|||
147361125|NCT02828358|531492952|FG000|Overall Study|Physician Decision|7|||
147361126|NCT02828358|531492953|FG001|Overall Study|Physician Decision|1|||
147361127|NCT02828358|531492952|FG000|Overall Study|Treatment Failure|6|||
147361128|NCT02828358|531492953|FG001|Overall Study|Treatment Failure|0|||
147361129|NCT02828358|531492952|FG000|Overall Study|Patients without KMT2A rearrangement|0|||
147361130|NCT02828358|531492953|FG001|Overall Study|Patients without KMT2A rearrangement|21|||
147361131|NCT02828358|531492952|FG000|Overall Study|Refusal of further protocol therapy|2|||
147361132|NCT02828358|531492953|FG001|Overall Study|Refusal of further protocol therapy|0|||
147361133|NCT02828358|531492952|FG000|Overall Study|Relapse|25|||
147361134|NCT02828358|531492953|FG001|Overall Study|Relapse|0|||
147361135|NCT02828358|531492952|FG000|Overall Study|Still on therapy|5|||
147361136|NCT02828358|531492953|FG001|Overall Study|Still on therapy|0|||
147361137|NCT02413489|531492954|FG000|Overall Study|Death|11|||
147361138|NCT02413489|531492955|FG001|Overall Study|Death|3|||
147361139|NCT02413489|531492956|FG002|Overall Study|Death|4|||
147361140|NCT02413489|531492954|FG000|Overall Study|Withdrawal by Subject|2|||
147361141|NCT02413489|531492955|FG001|Overall Study|Withdrawal by Subject|0|||
147361142|NCT02413489|531492956|FG002|Overall Study|Withdrawal by Subject|0|||
147361143|NCT02413489|531492954|FG000|Overall Study|Study Terminated By Sponsor|2|||
147361144|NCT02413489|531492955|FG001|Overall Study|Study Terminated By Sponsor|13|||
147361145|NCT02413489|531492956|FG002|Overall Study|Study Terminated By Sponsor|1|||
147361146|NCT05285137|531492957|FG000|Overall Study|Failure to Meet Continuation Criteria|0|||
147361147|NCT05285137|531492958|FG001|Overall Study|Failure to Meet Continuation Criteria|0|||
147361148|NCT05285137|531492959|FG002|Overall Study|Failure to Meet Continuation Criteria|0|||
147608431|NCT00000620|532382627|FG007|Overall Study|Withdrawal by Subject|21|||
147361149|NCT05285137|531492960|FG003|Overall Study|Failure to Meet Continuation Criteria|0|||
147361150|NCT05285137|531492961|FG004|Overall Study|Failure to Meet Continuation Criteria|0|||
147361151|NCT05285137|531492962|FG005|Overall Study|Failure to Meet Continuation Criteria|0|||
147361152|NCT05285137|531492963|FG006|Overall Study|Failure to Meet Continuation Criteria|2|||
147361153|NCT05285137|531492964|FG007|Overall Study|Failure to Meet Continuation Criteria|0|||
147361154|NCT05285137|531492965|FG008|Overall Study|Failure to Meet Continuation Criteria|1|||
147361155|NCT05285137|531492957|FG000|Overall Study|Lost to Follow-up|0|||
147361156|NCT05285137|531492958|FG001|Overall Study|Lost to Follow-up|0|||
147361157|NCT05285137|531492959|FG002|Overall Study|Lost to Follow-up|1|||
147361158|NCT05285137|531492960|FG003|Overall Study|Lost to Follow-up|3|||
147361159|NCT05285137|531492961|FG004|Overall Study|Lost to Follow-up|0|||
147361160|NCT05285137|531492962|FG005|Overall Study|Lost to Follow-up|0|||
147361161|NCT05285137|531492963|FG006|Overall Study|Lost to Follow-up|1|||
147361162|NCT05285137|531492964|FG007|Overall Study|Lost to Follow-up|0|||
147361163|NCT05285137|531492965|FG008|Overall Study|Lost to Follow-up|0|||
147361164|NCT05285137|531492957|FG000|Overall Study|Physician Decision|0|||
147361165|NCT05285137|531492958|FG001|Overall Study|Physician Decision|1|||
147361166|NCT05285137|531492959|FG002|Overall Study|Physician Decision|0|||
147361167|NCT05285137|531492960|FG003|Overall Study|Physician Decision|0|||
147361168|NCT05285137|531492961|FG004|Overall Study|Physician Decision|0|||
147361169|NCT05285137|531492962|FG005|Overall Study|Physician Decision|0|||
147361170|NCT05285137|531492963|FG006|Overall Study|Physician Decision|0|||
147361171|NCT05285137|531492964|FG007|Overall Study|Physician Decision|0|||
147361172|NCT05285137|531492965|FG008|Overall Study|Physician Decision|0|||
147361173|NCT05285137|531492957|FG000|Overall Study|Pregnancy|0|||
147361174|NCT05285137|531492958|FG001|Overall Study|Pregnancy|0|||
147361175|NCT05285137|531492959|FG002|Overall Study|Pregnancy|0|||
147361176|NCT05285137|531492960|FG003|Overall Study|Pregnancy|0|||
147361177|NCT05285137|531492961|FG004|Overall Study|Pregnancy|0|||
147361178|NCT05285137|531492962|FG005|Overall Study|Pregnancy|0|||
147361179|NCT05285137|531492963|FG006|Overall Study|Pregnancy|1|||
147361180|NCT05285137|531492964|FG007|Overall Study|Pregnancy|0|||
147361181|NCT05285137|531492965|FG008|Overall Study|Pregnancy|0|||
147361182|NCT05285137|531492957|FG000|Overall Study|Withdrawal by Subject|0|||
147361183|NCT05285137|531492958|FG001|Overall Study|Withdrawal by Subject|1|||
147361184|NCT05285137|531492959|FG002|Overall Study|Withdrawal by Subject|2|||
147361185|NCT05285137|531492960|FG003|Overall Study|Withdrawal by Subject|1|||
147361186|NCT05285137|531492961|FG004|Overall Study|Withdrawal by Subject|0|||
147361187|NCT05285137|531492962|FG005|Overall Study|Withdrawal by Subject|0|||
147361188|NCT05285137|531492963|FG006|Overall Study|Withdrawal by Subject|0|||
147361189|NCT05285137|531492964|FG007|Overall Study|Withdrawal by Subject|0|||
147361190|NCT05285137|531492965|FG008|Overall Study|Withdrawal by Subject|1|||
147454166|NCT02600494|531824173|FG000|Part A (6 Week Double-Blind Treatment)|non-compliant with site request|0|||
147454167|NCT02600494|531824174|FG001|Part A (6 Week Double-Blind Treatment)|non-compliant with site request|1|||
147454168|NCT02600494|531824175|FG002|Part A (6 Week Double-Blind Treatment)|non-compliant with site request|0|||
147454169|NCT02600494|531824173|FG000|Part B (6 Month Open-Label Treatment)|Adverse Event|0|||
147454170|NCT02600494|531824174|FG001|Part B (6 Month Open-Label Treatment)|Adverse Event|12|||
147454171|NCT02600494|531824175|FG002|Part B (6 Month Open-Label Treatment)|Adverse Event|0|||
147454172|NCT02600494|531824173|FG000|Part B (6 Month Open-Label Treatment)|Lack of Efficacy|0|||
147454173|NCT02600494|531824174|FG001|Part B (6 Month Open-Label Treatment)|Lack of Efficacy|4|||
147608432|NCT00000620|532382620|FG000|Overall Study|missed closeout visit|22|||
147608433|NCT00000620|532382621|FG001|Overall Study|missed closeout visit|28|||
147608434|NCT00000620|532382622|FG002|Overall Study|missed closeout visit|16|||
147608435|NCT00000620|532382623|FG003|Overall Study|missed closeout visit|11|||
147608436|NCT00000620|532382624|FG004|Overall Study|missed closeout visit|26|||
147608437|NCT00000620|532382625|FG005|Overall Study|missed closeout visit|28|||
147454174|NCT02600494|531824175|FG002|Part B (6 Month Open-Label Treatment)|Lack of Efficacy|0|||
147608438|NCT00000620|532382626|FG006|Overall Study|missed closeout visit|13|||
147608439|NCT00000620|532382627|FG007|Overall Study|missed closeout visit|16|||
147608440|NCT02368314|532382629|FG000|Overall Study|Withdrawal by Subject|2|||
147608441|NCT02368314|532382630|FG001|Overall Study|Withdrawal by Subject|1|||
147608442|NCT02368314|532382629|FG000|Overall Study|Adverse Event|1|||
147608443|NCT02368314|532382630|FG001|Overall Study|Adverse Event|2|||
147608444|NCT00958893|532382631|FG000|Overall Study|Study prematurely terminated|4|||
147361203|NCT03717935|531492974|FG000|Overall Study|Withdrawal by Subject|0|||
147361204|NCT03717935|531492975|FG001|Overall Study|Withdrawal by Subject|2|||
147361205|NCT01820611|531492976|FG000|Overall Study|Death|8|||
147361206|NCT01820611|531492976|FG000|Overall Study|Adverse Event|1|||
147361207|NCT01820611|531492976|FG000|Overall Study|Withdrawal by Subject|9|||
147361208|NCT05736458|531492977|FG000|Baseline MRI and Assessments|Lost to Follow-up|0|||
147361209|NCT05736458|531492978|FG001|Baseline MRI and Assessments|Lost to Follow-up|0|||
147608445|NCT01994850|532382633|FG000|Overall Study|Physician Decision|1|||
147361210|NCT05736458|531492979|FG002|Baseline MRI and Assessments|Lost to Follow-up|4|||
147361211|NCT05736458|531492977|FG000|Baseline MRI and Assessments|Withdrawal by Subject|2|||
147361212|NCT05736458|531492978|FG001|Baseline MRI and Assessments|Withdrawal by Subject|0|||
147361213|NCT05736458|531492979|FG002|Baseline MRI and Assessments|Withdrawal by Subject|0|||
147361214|NCT05736458|531492977|FG000|TMS/fMRI #1|Physician Decision|0|||
147361215|NCT05736458|531492978|FG001|TMS/fMRI #1|Physician Decision|0|||
147361216|NCT05736458|531492979|FG002|TMS/fMRI #1|Physician Decision|2|||
147361217|NCT05736458|531492977|FG000|Washout (at Least 7 Days)|Lost to Follow-up|0|||
147361218|NCT05736458|531492978|FG001|Washout (at Least 7 Days)|Lost to Follow-up|1|||
147361219|NCT05736458|531492979|FG002|Washout (at Least 7 Days)|Lost to Follow-up|0|||
147361220|NCT01199133|531492984|FG000|Year 1|Adverse Event|16|||
147361221|NCT01199133|531492985|FG001|Year 1|Adverse Event|4|||
147361222|NCT01199133|531492984|FG000|Year 1|Withdrawal by Subject|8|||
147361223|NCT01199133|531492985|FG001|Year 1|Withdrawal by Subject|4|||
147361224|NCT01199133|531492984|FG000|Year 1|Any other reason not above-mentioned|6|||
147361225|NCT01199133|531492985|FG001|Year 1|Any other reason not above-mentioned|7|||
147361226|NCT01199133|531492984|FG000|Year 2|Adverse Event|1|||
147361227|NCT01199133|531492985|FG001|Year 2|Adverse Event|0|||
147361228|NCT01199133|531492984|FG000|Year 2|Withdrawal by Subject|1|||
147361229|NCT01199133|531492985|FG001|Year 2|Withdrawal by Subject|1|||
147361230|NCT01199133|531492984|FG000|Year 2|Any other reason not above-mentioned|1|||
147361231|NCT01199133|531492985|FG001|Year 2|Any other reason not above-mentioned|2|||
147361232|NCT05100628|531492986|FG000|Overall Study|Progressive Disease|1|||
147361233|NCT05100628|531492987|FG001|Overall Study|Progressive Disease|0|||
147361234|NCT05100628|531492988|FG002|Overall Study|Progressive Disease|0|||
147361235|NCT05100628|531492989|FG003|Overall Study|Progressive Disease|0|||
147361236|NCT05100628|531492986|FG000|Overall Study|Study Terminated by Sponsor|0|||
147361237|NCT05100628|531492987|FG001|Overall Study|Study Terminated by Sponsor|0|||
147361238|NCT05100628|531492988|FG002|Overall Study|Study Terminated by Sponsor|3|||
147361239|NCT05100628|531492989|FG003|Overall Study|Study Terminated by Sponsor|0|||
147361240|NCT05100628|531492986|FG000|Overall Study|unkown|0|||
147361241|NCT05100628|531492987|FG001|Overall Study|unkown|1|||
147361242|NCT05100628|531492988|FG002|Overall Study|unkown|0|||
147361243|NCT05100628|531492989|FG003|Overall Study|unkown|0|||
147361244|NCT02575950|531492992|FG000|Overall Study|Withdrawal by Subject|0|||
147361245|NCT02575950|531492993|FG001|Overall Study|Withdrawal by Subject|0|||
147361246|NCT02575950|531492994|FG002|Overall Study|Withdrawal by Subject|0|||
147361247|NCT02575950|531492995|FG003|Overall Study|Withdrawal by Subject|2|||
147361248|NCT02575950|531492992|FG000|Overall Study|Lost to Follow-up|0|||
147361249|NCT02575950|531492993|FG001|Overall Study|Lost to Follow-up|1|||
147361250|NCT02575950|531492994|FG002|Overall Study|Lost to Follow-up|0|||
147361251|NCT02575950|531492995|FG003|Overall Study|Lost to Follow-up|3|||
147361252|NCT04271046|531492996|FG000|Overall Study|Death|0|||
147361253|NCT04271046|531492997|FG001|Overall Study|Death|2|||
147361254|NCT04271046|531492998|FG002|Overall Study|Death|0|||
147361255|NCT04271046|531492999|FG003|Overall Study|Death|2|||
147361256|NCT04271046|531492996|FG000|Overall Study|Lost to Follow-up|12|||
147361257|NCT04271046|531492997|FG001|Overall Study|Lost to Follow-up|12|||
147361258|NCT04271046|531492998|FG002|Overall Study|Lost to Follow-up|11|||
147361259|NCT04271046|531492999|FG003|Overall Study|Lost to Follow-up|11|||
147361260|NCT04271046|531492996|FG000|Overall Study|Patient with Dementia Died|2|||
147361261|NCT04271046|531492997|FG001|Overall Study|Patient with Dementia Died|0|||
147361262|NCT04271046|531492998|FG002|Overall Study|Patient with Dementia Died|2|||
147361263|NCT04271046|531492999|FG003|Overall Study|Patient with Dementia Died|0|||
147361264|NCT04271046|531492996|FG000|Overall Study|Patient with dementia were not administered surveys|0|||
147361265|NCT04271046|531492997|FG001|Overall Study|Patient with dementia were not administered surveys|18|||
147361266|NCT04271046|531492998|FG002|Overall Study|Patient with dementia were not administered surveys|0|||
147361267|NCT04271046|531492999|FG003|Overall Study|Patient with dementia were not administered surveys|22|||
147361268|NCT04230681|531493000|FG000|Overall Study|Physician Decision|2|||
147361269|NCT04230681|531493001|FG001|Overall Study|Physician Decision|3|||
147361270|NCT04230681|531493000|FG000|Overall Study|Investigational Pharmacy unable to provide medications in timely manner|1|||
147361271|NCT04230681|531493001|FG001|Overall Study|Investigational Pharmacy unable to provide medications in timely manner|1|||
147361272|NCT04230681|531493000|FG000|Overall Study|IV inadvertently removed|0|||
147361273|NCT04230681|531493001|FG001|Overall Study|IV inadvertently removed|1|||
147361274|NCT04414722|531494298|FG000|Overall Study|Lost to Follow-up|3|||
147361275|NCT04414722|531494299|FG001|Overall Study|Lost to Follow-up|4|||
147361276|NCT04414722|531494300|FG002|Overall Study|Lost to Follow-up|3|||
147361277|NCT04414722|531494301|FG003|Overall Study|Lost to Follow-up|2|||
147361278|NCT04414722|531494302|FG004|Overall Study|Lost to Follow-up|3|||
147361279|NCT04414722|531494298|FG000|Overall Study|Withdrawal by Subject|6|||
147361280|NCT04414722|531494299|FG001|Overall Study|Withdrawal by Subject|3|||
147361281|NCT04414722|531494300|FG002|Overall Study|Withdrawal by Subject|1|||
147361282|NCT04414722|531494301|FG003|Overall Study|Withdrawal by Subject|5|||
147361283|NCT04414722|531494302|FG004|Overall Study|Withdrawal by Subject|1|||
147361284|NCT04414722|531494298|FG000|Overall Study|Physician Decision|0|||
147361285|NCT04414722|531494299|FG001|Overall Study|Physician Decision|1|||
147361286|NCT04414722|531494300|FG002|Overall Study|Physician Decision|2|||
147361287|NCT04414722|531494301|FG003|Overall Study|Physician Decision|0|||
147361288|NCT04414722|531494302|FG004|Overall Study|Physician Decision|0|||
147361289|NCT04414722|531494298|FG000|Overall Study|Non-participatory|0|||
147361290|NCT04414722|531494299|FG001|Overall Study|Non-participatory|1|||
147361291|NCT04414722|531494300|FG002|Overall Study|Non-participatory|1|||
147361292|NCT04414722|531494301|FG003|Overall Study|Non-participatory|0|||
147361293|NCT04414722|531494302|FG004|Overall Study|Non-participatory|0|||
147361294|NCT05906784|531494304|FG000|Overall Study|Lost to Follow-up|2|||
147361295|NCT05906784|531494305|FG001|Overall Study|Lost to Follow-up|1|||
147361296|NCT05906784|531494306|FG002|Overall Study|Lost to Follow-up|1|||
147361297|NCT05906784|531494307|FG003|Overall Study|Lost to Follow-up|1|||
147361298|NCT02668692|531494308|FG000|Overall Study|Adverse Event|1|||
147361299|NCT02668692|531494309|FG001|Overall Study|Adverse Event|0|||
147361300|NCT03442309|531494310|FG000|Overall Study|Lost to Follow-up|1676|||
147361301|NCT03442309|531494311|FG001|Overall Study|Lost to Follow-up|1642|||
147454175|NCT02600494|531824173|FG000|Part B (6 Month Open-Label Treatment)|Protocol Violation|0|||
147454176|NCT02600494|531824174|FG001|Part B (6 Month Open-Label Treatment)|Protocol Violation|8|||
147454177|NCT02600494|531824175|FG002|Part B (6 Month Open-Label Treatment)|Protocol Violation|0|||
147454178|NCT02600494|531824173|FG000|Part B (6 Month Open-Label Treatment)|Physician Decision|0|||
147454179|NCT02600494|531824174|FG001|Part B (6 Month Open-Label Treatment)|Physician Decision|1|||
147454180|NCT02600494|531824175|FG002|Part B (6 Month Open-Label Treatment)|Physician Decision|0|||
147454181|NCT02600494|531824173|FG000|Part B (6 Month Open-Label Treatment)|Withdrawal by Subject|0|||
147454182|NCT02600494|531824174|FG001|Part B (6 Month Open-Label Treatment)|Withdrawal by Subject|17|||
147361310|NCT05524402|531494322|FG000|Overall Study|Withdrawal by Subject|3|||
147361311|NCT05524402|531494323|FG001|Overall Study|Withdrawal by Subject|1|||
147361312|NCT05524402|531494322|FG000|Overall Study|Lost to Follow-up|2|||
147361313|NCT05524402|531494323|FG001|Overall Study|Lost to Follow-up|1|||
147361314|NCT05976334|531494324|FG000|Part B|Death|0|||
147361315|NCT05976334|531494325|FG001|Part B|Death|1|||
147361316|NCT05976334|531494324|FG000|Part B|Study Terminated by Sponsor|0|||
147361317|NCT05976334|531494325|FG001|Part B|Study Terminated by Sponsor|1|||
147361318|NCT05976334|531494324|FG000|Part B|Reason Not Specified|0|||
147361319|NCT05976334|531494325|FG001|Part B|Reason Not Specified|1|||
147361320|NCT05363163|531494326|FG000|Overall Study|Withdrawal by Subject|13|||
147361321|NCT05838027|531494328|FG000|Overall Study|Lost to Follow-up|5|||
147361322|NCT05838027|531494329|FG001|Overall Study|Lost to Follow-up|1|||
147361323|NCT05838027|531494328|FG000|Overall Study|Withdrawal by Subject|1|||
147361324|NCT05838027|531494329|FG001|Overall Study|Withdrawal by Subject|0|||
147361325|NCT04820322|531494330|FG000|Overall Study|Adverse Event|1|||
147361326|NCT04820322|531494331|FG001|Overall Study|Adverse Event|0|||
147361327|NCT03156465|531494332|FG000|Overall Study|Withdrawal by Subject|2|||
147361328|NCT05715528|531494336|FG000|Overall Study|Randomized but never treated|11|||
147361329|NCT05715528|531494337|FG001|Overall Study|Randomized but never treated|13|||
147361330|NCT05715528|531494336|FG000|Overall Study|Withdrew consent|7|||
147361331|NCT05715528|531494337|FG001|Overall Study|Withdrew consent|15|||
147361332|NCT05715528|531494336|FG000|Overall Study|Lost to Follow-up|5|||
147361333|NCT05715528|531494337|FG001|Overall Study|Lost to Follow-up|13|||
147361334|NCT05715528|531494336|FG000|Overall Study|Investigator's discretion|3|||
147361335|NCT05715528|531494337|FG001|Overall Study|Investigator's discretion|1|||
147361336|NCT05715528|531494336|FG000|Overall Study|Protocol Violation|2|||
147361337|NCT05715528|531494337|FG001|Overall Study|Protocol Violation|0|||
147361338|NCT05715528|531494336|FG000|Overall Study|Non-compliance with study drug|0|||
147361339|NCT05715528|531494337|FG001|Overall Study|Non-compliance with study drug|1|||
147361340|NCT03118518|531494338|FG000|Overall Study|Early Exit after treatment|2|||
147361341|NCT03118518|531494339|FG001|Overall Study|Early Exit after treatment|8|||
147361342|NCT03118518|531494338|FG000|Overall Study|Early Exit after randomization but prior to treatment|4|||
147361343|NCT03118518|531494339|FG001|Overall Study|Early Exit after randomization but prior to treatment|3|||
147361344|NCT04880733|531494340|FG000|Participants in the RCT (Overall Study)|Data collection issue|3|||
147361345|NCT04880733|531494341|FG001|Participants in the RCT (Overall Study)|Data collection issue|5|||
147361346|NCT04880733|531494342|FG002|Participants in the RCT (Overall Study)|Data collection issue|0|||
147361347|NCT04880733|531494340|FG000|Participants in the RCT (Overall Study)|Withdrawal by Subject|3|||
147361348|NCT04880733|531494341|FG001|Participants in the RCT (Overall Study)|Withdrawal by Subject|1|||
147361349|NCT04880733|531494342|FG002|Participants in the RCT (Overall Study)|Withdrawal by Subject|0|||
147361350|NCT04880733|531494340|FG000|Participants in the RCT (Overall Study)|Delay due to ED imaging|1|||
147361351|NCT04880733|531494341|FG001|Participants in the RCT (Overall Study)|Delay due to ED imaging|0|||
147361352|NCT04880733|531494342|FG002|Participants in the RCT (Overall Study)|Delay due to ED imaging|0|||
147361353|NCT04880733|531494340|FG000|Participants in the RCT (Overall Study)|Early discharge|0|||
147361354|NCT04880733|531494341|FG001|Participants in the RCT (Overall Study)|Early discharge|1|||
147361355|NCT04880733|531494342|FG002|Participants in the RCT (Overall Study)|Early discharge|0|||
147361356|NCT04880733|531494340|FG000|ED Staff/Providers 6 Month Assessment|Skipped question 2|0|||
147361357|NCT04880733|531494341|FG001|ED Staff/Providers 6 Month Assessment|Skipped question 2|0|||
147361358|NCT04880733|531494342|FG002|ED Staff/Providers 6 Month Assessment|Skipped question 2|1|||
147361359|NCT05533190|531494344|FG000|Overall Study|Lost to Follow-up|19|||
147361360|NCT05533190|531494345|FG001|Overall Study|Lost to Follow-up|7|||
147361361|NCT05533190|531494344|FG000|Overall Study|Failed to download app|1|||
147361362|NCT05533190|531494345|FG001|Overall Study|Failed to download app|0|||
147361363|NCT05533190|531494344|FG000|Overall Study|Thought app was a scam|1|||
147361364|NCT05533190|531494345|FG001|Overall Study|Thought app was a scam|0|||
147361365|NCT05533190|531494344|FG000|Overall Study|Withdrawal by Subject|2|||
147361366|NCT05533190|531494345|FG001|Overall Study|Withdrawal by Subject|0|||
147361367|NCT03213678|531494353|FG000|Overall Study|Death|1|||
147361368|NCT03213678|531494353|FG000|Overall Study|Physician Decision|1|||
147361369|NCT03213678|531494353|FG000|Overall Study|Progressive disease|16|||
147361370|NCT04218851|531494354|FG000|Overall Study|Death|1|||
147361371|NCT04218851|531494355|FG001|Overall Study|Death|3|||
147361372|NCT03988621|531494360|FG000|Overall Study|Lost to Follow-up|16|||
147361373|NCT03988621|531494361|FG001|Overall Study|Lost to Follow-up|17|||
147361374|NCT03988621|531494360|FG000|Overall Study|Withdrawal by Subject|14|||
147361375|NCT03988621|531494361|FG001|Overall Study|Withdrawal by Subject|7|||
147361376|NCT03988621|531494360|FG000|Overall Study|Patient Lost to Follow Up|15|||
147361377|NCT03988621|531494361|FG001|Overall Study|Patient Lost to Follow Up|15|||
147361378|NCT03988621|531494360|FG000|Overall Study|Patient death|1|||
147361379|NCT03988621|531494361|FG001|Overall Study|Patient death|5|||
147361380|NCT05013385|531494362|FG000|Overall Study|Sponsor's decision to terminate the trial|5|||
147361381|NCT04247802|531494363|FG000|Overall Study|Withdrawal by Subject|1|||
147361382|NCT04247802|531494364|FG001|Overall Study|Withdrawal by Subject|3|||
147361383|NCT04247802|531494363|FG000|Overall Study|LTFU COVID lockdown restrictions|10|||
147361384|NCT04247802|531494364|FG001|Overall Study|LTFU COVID lockdown restrictions|7|||
147361385|NCT01447719|531494367|FG000|Overall Study|Image acquisition failure|2|||
147361386|NCT01447719|531494367|FG000|Overall Study|Invalid image or not imaged|3|||
147361387|NCT01447719|531494367|FG000|Overall Study|Subject still living at end of study|79|||
147361388|NCT01447719|531494367|FG000|Overall Study|Withdrawal by Subject|2|||
147361389|NCT01447719|531494367|FG000|Overall Study|Family withdrew autopsy consent|7|||
147361390|NCT03252288|531494369|FG000|Overall Study|Death|1|||
147361391|NCT03252288|531494370|FG001|Overall Study|Death|0|||
147361392|NCT03252288|531494371|FG002|Overall Study|Death|0|||
147361393|NCT03252288|531494369|FG000|Overall Study|Death|11|||
147361394|NCT03252288|531494370|FG001|Overall Study|Death|0|||
147361395|NCT03252288|531494371|FG002|Overall Study|Death|0|||
147361396|NCT03252288|531494369|FG000|Overall Study|Withdrawal by Subject|2|||
147361397|NCT03252288|531494370|FG001|Overall Study|Withdrawal by Subject|0|||
147361398|NCT03252288|531494371|FG002|Overall Study|Withdrawal by Subject|0|||
147361399|NCT03252288|531494369|FG000|Overall Study|Lost to Follow-up|79|||
147361400|NCT03252288|531494370|FG001|Overall Study|Lost to Follow-up|0|||
147361401|NCT03252288|531494371|FG002|Overall Study|Lost to Follow-up|0|||
147361402|NCT03252288|531494369|FG000|Overall Study|Loss of baseline data on tablets|6|||
147361403|NCT03252288|531494370|FG001|Overall Study|Loss of baseline data on tablets|0|||
147361404|NCT03252288|531494371|FG002|Overall Study|Loss of baseline data on tablets|0|||
147361405|NCT02641730|531494373|FG000|Placebo Controlled Period (Week 0 - 16)|Adverse Event|2|||
147361406|NCT02641730|531494374|FG001|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
147361407|NCT02641730|531494375|FG002|Placebo Controlled Period (Week 0 - 16)|Adverse Event|0|||
147361408|NCT02641730|531494376|FG003|Placebo Controlled Period (Week 0 - 16)|Adverse Event|1|||
147361409|NCT02641730|531494377|FG004|Placebo Controlled Period (Week 0 - 16)|Adverse Event|2|||
147361410|NCT02641730|531494373|FG000|After Controlled Period (Week 16 - 52)|Adverse Event|0|||
147361411|NCT02641730|531494374|FG001|After Controlled Period (Week 16 - 52)|Adverse Event|1|||
147361412|NCT02641730|531494375|FG002|After Controlled Period (Week 16 - 52)|Adverse Event|1|||
147361413|NCT02641730|531494376|FG003|After Controlled Period (Week 16 - 52)|Adverse Event|5|||
147361414|NCT02641730|531494377|FG004|After Controlled Period (Week 16 - 52)|Adverse Event|4|||
147361415|NCT02641730|531494373|FG000|After Controlled Period (Week 16 - 52)|Lack of Efficacy|0|||
147361416|NCT02641730|531494374|FG001|After Controlled Period (Week 16 - 52)|Lack of Efficacy|2|||
147361417|NCT02641730|531494375|FG002|After Controlled Period (Week 16 - 52)|Lack of Efficacy|0|||
147361418|NCT02641730|531494376|FG003|After Controlled Period (Week 16 - 52)|Lack of Efficacy|2|||
147361419|NCT02641730|531494377|FG004|After Controlled Period (Week 16 - 52)|Lack of Efficacy|0|||
147361420|NCT02641730|531494373|FG000|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
147361421|NCT02641730|531494374|FG001|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
147361422|NCT02641730|531494375|FG002|After Controlled Period (Week 16 - 52)|Pregnancy|0|||
147361423|NCT02641730|531494376|FG003|After Controlled Period (Week 16 - 52)|Pregnancy|1|||
147361424|NCT02641730|531494377|FG004|After Controlled Period (Week 16 - 52)|Pregnancy|1|||
147361425|NCT02641730|531494373|FG000|After Controlled Period (Week 16 - 52)|Other|0|||
147361426|NCT02641730|531494374|FG001|After Controlled Period (Week 16 - 52)|Other|1|||
147361427|NCT02641730|531494375|FG002|After Controlled Period (Week 16 - 52)|Other|1|||
147361428|NCT02641730|531494376|FG003|After Controlled Period (Week 16 - 52)|Other|0|||
147361429|NCT02641730|531494377|FG004|After Controlled Period (Week 16 - 52)|Other|1|||
147361430|NCT02641730|531494373|FG000|Observational Period (Week 60 - Week 84)|Other|0|||
147361431|NCT02641730|531494374|FG001|Observational Period (Week 60 - Week 84)|Other|0|||
147361432|NCT02641730|531494375|FG002|Observational Period (Week 60 - Week 84)|Other|0|||
147361433|NCT02641730|531494376|FG003|Observational Period (Week 60 - Week 84)|Other|0|||
147361434|NCT02641730|531494377|FG004|Observational Period (Week 60 - Week 84)|Other|1|||
147361435|NCT05460871|531494378|FG000|Overall Study|Withdrawal by Subject|1|||
147361436|NCT05460871|531494379|FG001|Overall Study|Withdrawal by Subject|2|||
147454183|NCT02600494|531824175|FG002|Part B (6 Month Open-Label Treatment)|Withdrawal by Subject|0|||
147454184|NCT02600494|531824173|FG000|Part B (6 Month Open-Label Treatment)|Lost to Follow-up|0|||
147361437|NCT00721149|531494380|FG000|Overall Study|Physician Decision|1|||
147361438|NCT05158504|531494381|FG000|Overall Study|Lost to Follow-up|2|||
147361439|NCT05158504|531494382|FG001|Overall Study|Lost to Follow-up|3|||
147361440|NCT03606512|531494385|FG000|Overall Study|Lost to Follow-up|0|||
147361441|NCT03606512|531494386|FG001|Overall Study|Lost to Follow-up|1|||
147361442|NCT03606512|531494385|FG000|Overall Study|'moved from study area|0|||
147361443|NCT03606512|531494386|FG001|Overall Study|'moved from study area|1|||
147361444|NCT05513937|531494387|FG000|Run in (-4 Week to 0) Monotherapy Phase|Newly developed or not previously recognized exclusion criteria|0|||
147361445|NCT05513937|531494388|FG001|Run in (-4 Week to 0) Monotherapy Phase|Newly developed or not previously recognized exclusion criteria|1|||
147361446|NCT05513937|531494389|FG002|Run in (-4 Week to 0) Monotherapy Phase|Newly developed or not previously recognized exclusion criteria|0|||
147361447|NCT05513937|531494390|FG003|Run in (-4 Week to 0) Monotherapy Phase|Newly developed or not previously recognized exclusion criteria|0|||
147361448|NCT05513937|531494387|FG000|Run in (-4 Week to 0) Monotherapy Phase|Protocol Violation|2|||
147361449|NCT05513937|531494388|FG001|Run in (-4 Week to 0) Monotherapy Phase|Protocol Violation|5|||
147361450|NCT05513937|531494389|FG002|Run in (-4 Week to 0) Monotherapy Phase|Protocol Violation|0|||
147361451|NCT05513937|531494390|FG003|Run in (-4 Week to 0) Monotherapy Phase|Protocol Violation|0|||
147361452|NCT05513937|531494387|FG000|Run in (-4 Week to 0) Monotherapy Phase|Physician Decision|1|||
147361453|NCT05513937|531494388|FG001|Run in (-4 Week to 0) Monotherapy Phase|Physician Decision|0|||
147361454|NCT05513937|531494389|FG002|Run in (-4 Week to 0) Monotherapy Phase|Physician Decision|0|||
147361455|NCT05513937|531494390|FG003|Run in (-4 Week to 0) Monotherapy Phase|Physician Decision|0|||
147361456|NCT05513937|531494387|FG000|Run in (-4 Week to 0) Monotherapy Phase|Withdrawal by Subject|1|||
147361457|NCT05513937|531494388|FG001|Run in (-4 Week to 0) Monotherapy Phase|Withdrawal by Subject|0|||
147361458|NCT05513937|531494389|FG002|Run in (-4 Week to 0) Monotherapy Phase|Withdrawal by Subject|0|||
147361459|NCT05513937|531494390|FG003|Run in (-4 Week to 0) Monotherapy Phase|Withdrawal by Subject|0|||
147361460|NCT05513937|531494387|FG000|Combination Therapy (4 to 8 Weeks)|Adverse Event|0|||
147361461|NCT05513937|531494388|FG001|Combination Therapy (4 to 8 Weeks)|Adverse Event|0|||
147361462|NCT05513937|531494389|FG002|Combination Therapy (4 to 8 Weeks)|Adverse Event|2|||
147361463|NCT05513937|531494390|FG003|Combination Therapy (4 to 8 Weeks)|Adverse Event|0|||
147361464|NCT05513937|531494387|FG000|Combination Therapy (4 to 8 Weeks)|Protocol Violation|0|||
147361465|NCT05513937|531494388|FG001|Combination Therapy (4 to 8 Weeks)|Protocol Violation|0|||
147361466|NCT05513937|531494389|FG002|Combination Therapy (4 to 8 Weeks)|Protocol Violation|1|||
147361467|NCT05513937|531494390|FG003|Combination Therapy (4 to 8 Weeks)|Protocol Violation|0|||
147361468|NCT02846545|531494391|FG000|Active Treatment Period: Week 0-52|Lost to Follow-up|1|||
147361469|NCT02846545|531494392|FG001|Active Treatment Period: Week 0-52|Lost to Follow-up|1|||
147361470|NCT02846545|531494391|FG000|Active Treatment Period: Week 0-52|Non-compliance with study drug|1|||
147361471|NCT02846545|531494392|FG001|Active Treatment Period: Week 0-52|Non-compliance with study drug|0|||
147361472|NCT02846545|531494391|FG000|Active Treatment Period: Week 0-52|Withdrawal by Subject|1|||
147361473|NCT02846545|531494392|FG001|Active Treatment Period: Week 0-52|Withdrawal by Subject|5|||
147361474|NCT02846545|531494391|FG000|Off-therapy FU:Wk 52-104 & OLE: Wk 0-60|Lost to Follow-up|1|||
147361475|NCT02846545|531494392|FG001|Off-therapy FU:Wk 52-104 & OLE: Wk 0-60|Lost to Follow-up|1|||
147361476|NCT02846545|531494391|FG000|Off-therapy FU:Wk 52-104 & OLE: Wk 0-60|Other|1|||
147361477|NCT02846545|531494392|FG001|Off-therapy FU:Wk 52-104 & OLE: Wk 0-60|Other|1|||
147361478|NCT03993392|531494397|FG000|Overall Study|Withdrawal by Subject|3|||
147361479|NCT03993392|531494397|FG000|Overall Study|Lost to Follow-up|2|||
147361480|NCT03993392|531494397|FG000|Overall Study|Did not meet Day 1 check-in criteria|1|||
147361481|NCT05654662|531494399|FG000|Overall Study|Withdrawal by Subject|1|||
147361482|NCT05654662|531494400|FG001|Overall Study|Withdrawal by Subject|0|||
147361483|NCT05654662|531494399|FG000|Overall Study|A death in the family|1|||
147361484|NCT05654662|531494400|FG001|Overall Study|A death in the family|0|||
147361485|NCT05962814|531494401|FG000|Overall Study|failed eligibility|1|||
147361486|NCT03057054|531494402|FG000|Overall Study|Death|4|||
147361487|NCT03057054|531494403|FG001|Overall Study|Death|4|||
147361488|NCT03057054|531494402|FG000|Overall Study|Withdrawal by Subject|6|||
147361489|NCT03057054|531494403|FG001|Overall Study|Withdrawal by Subject|3|||
147361490|NCT03057054|531494402|FG000|Overall Study|Ineligible|1|||
147361491|NCT03057054|531494403|FG001|Overall Study|Ineligible|1|||
147454185|NCT02600494|531824174|FG001|Part B (6 Month Open-Label Treatment)|Lost to Follow-up|11|||
147454186|NCT02600494|531824175|FG002|Part B (6 Month Open-Label Treatment)|Lost to Follow-up|0|||
147454187|NCT03124563|531824176|FG000|Overall Study|Lost to Follow-up|1|||
147454188|NCT03124563|531824177|FG001|Overall Study|Lost to Follow-up|1|||
147454189|NCT03124563|531824176|FG000|Overall Study|Withdrawal by Subject|1|||
147454190|NCT03124563|531824177|FG001|Overall Study|Withdrawal by Subject|1|||
147454191|NCT04179175|531825552|FG000|Overall Study|Ongoing at the time of the data cut-off date|94|||
147454192|NCT04179175|531825553|FG001|Overall Study|Ongoing at the time of the data cut-off date|54|||
147454193|NCT04179175|531825554|FG002|Overall Study|Ongoing at the time of the data cut-off date|95|||
147454194|NCT04179175|531825555|FG003|Overall Study|Ongoing at the time of the data cut-off date|43|||
147454195|NCT04179175|531825556|FG004|Overall Study|Ongoing at the time of the data cut-off date|98|||
147454196|NCT04179175|531825557|FG005|Overall Study|Ongoing at the time of the data cut-off date|105|||
147454197|NCT04179175|531825552|FG000|Overall Study|Adverse Event|5|||
147454198|NCT04179175|531825553|FG001|Overall Study|Adverse Event|3|||
147361492|NCT06262477|531496008|FG000|Overall Study|Withdrawal by Subject|1|||
147361493|NCT06262477|531496009|FG001|Overall Study|Withdrawal by Subject|0|||
147361494|NCT06262477|531496008|FG000|Overall Study|Adverse Event|0|||
147361495|NCT06262477|531496009|FG001|Overall Study|Adverse Event|1|||
147361496|NCT06262477|531496008|FG000|Overall Study|Lost to Follow-up|0|||
147361497|NCT06262477|531496009|FG001|Overall Study|Lost to Follow-up|1|||
147361498|NCT01064440|531496010|FG000|Overall Study|Lost to Follow-up|1|||
147361499|NCT01064440|531496011|FG001|Overall Study|Lost to Follow-up|1|||
147361500|NCT01064440|531496012|FG002|Overall Study|Lost to Follow-up|1|||
147361501|NCT01064440|531496010|FG000|Overall Study|Non-compliance|0|||
147361502|NCT01064440|531496011|FG001|Overall Study|Non-compliance|1|||
147361503|NCT01064440|531496012|FG002|Overall Study|Non-compliance|0|||
147361504|NCT01064440|531496010|FG000|Overall Study|Death|1|||
147361505|NCT01064440|531496011|FG001|Overall Study|Death|0|||
147361506|NCT01064440|531496012|FG002|Overall Study|Death|1|||
147361507|NCT01064440|531496010|FG000|Overall Study|Withdrawal by Subject|0|||
147361508|NCT01064440|531496011|FG001|Overall Study|Withdrawal by Subject|1|||
147361509|NCT01064440|531496012|FG002|Overall Study|Withdrawal by Subject|1|||
147361510|NCT01064440|531496010|FG000|Overall Study|Other: amputation|1|||
147361511|NCT01064440|531496011|FG001|Overall Study|Other: amputation|0|||
147361512|NCT01064440|531496012|FG002|Overall Study|Other: amputation|0|||
147361513|NCT04108130|531496013|FG000|Overall Study|Verbal Agreement Withdrawn|4|||
147361514|NCT04108130|531496014|FG001|Overall Study|Verbal Agreement Withdrawn|2|||
147361515|NCT04108130|531496013|FG000|Overall Study|Consent Withdrawn|9|||
147361516|NCT04108130|531496014|FG001|Overall Study|Consent Withdrawn|6|||
147361517|NCT04108130|531496013|FG000|Overall Study|Surgery Cancelled|4|||
147361518|NCT04108130|531496014|FG001|Overall Study|Surgery Cancelled|4|||
147361519|NCT04108130|531496013|FG000|Overall Study|Found Ineligible for Study|4|||
147361520|NCT04108130|531496014|FG001|Overall Study|Found Ineligible for Study|3|||
147361521|NCT04108130|531496013|FG000|Overall Study|Consent Not Obtained for Other Reasons|3|||
147361522|NCT04108130|531496014|FG001|Overall Study|Consent Not Obtained for Other Reasons|3|||
147361523|NCT04108130|531496013|FG000|Overall Study|Intervention Not Done and No Data Collected|0|||
147361524|NCT04108130|531496014|FG001|Overall Study|Intervention Not Done and No Data Collected|1|||
147361525|NCT05507333|531496015|FG000|Overall Study|Protocol Violation|1|||
147361526|NCT05247034|531496020|FG000|Overall Study|Lost to Follow-up|3|||
147361527|NCT05247034|531496021|FG001|Overall Study|Lost to Follow-up|2|||
147361528|NCT05247034|531496020|FG000|Overall Study|Organizational problems when attending appointments|1|||
147361529|NCT05247034|531496021|FG001|Overall Study|Organizational problems when attending appointments|0|||
147361530|NCT04136912|531496026|FG000|Overall Study|Operational reasons|0|||
147361531|NCT04136912|531496027|FG001|Overall Study|Operational reasons|0|||
147361532|NCT04136912|531496028|FG002|Overall Study|Operational reasons|2|||
147361533|NCT04615273|531496029|FG000|Overall Study|Withdrawal by Subject|3|||
147361534|NCT04615273|531496030|FG001|Overall Study|Withdrawal by Subject|1|||
147361535|NCT04615273|531496031|FG002|Overall Study|Withdrawal by Subject|2|||
147361536|NCT04615273|531496029|FG000|Overall Study|Adverse Event|1|||
147361537|NCT04615273|531496030|FG001|Overall Study|Adverse Event|0|||
147361538|NCT04615273|531496031|FG002|Overall Study|Adverse Event|1|||
147361539|NCT04615273|531496029|FG000|Overall Study|Lost to Follow-up|0|||
147361540|NCT04615273|531496030|FG001|Overall Study|Lost to Follow-up|1|||
147361541|NCT04615273|531496031|FG002|Overall Study|Lost to Follow-up|0|||
147361542|NCT04615273|531496029|FG000|Overall Study|Physician Decision|0|||
147361543|NCT04615273|531496030|FG001|Overall Study|Physician Decision|0|||
147361544|NCT04615273|531496031|FG002|Overall Study|Physician Decision|1|||
147361545|NCT04615273|531496029|FG000|Overall Study|Other|0|||
147361546|NCT04615273|531496030|FG001|Overall Study|Other|1|||
147361547|NCT04615273|531496031|FG002|Overall Study|Other|0|||
147361548|NCT04615273|531496029|FG000|Overall Study|Randomized but not treated|1|||
147361549|NCT04615273|531496030|FG001|Overall Study|Randomized but not treated|3|||
147361550|NCT04615273|531496031|FG002|Overall Study|Randomized but not treated|1|||
147361551|NCT04999111|531496036|FG000|Overall Study|Lost to Follow-up|21|||
147361552|NCT04999111|531496037|FG001|Overall Study|Lost to Follow-up|16|||
147361553|NCT04999111|531496038|FG002|Overall Study|Lost to Follow-up|2|||
147361554|NCT04999111|531496039|FG003|Overall Study|Lost to Follow-up|26|||
147361555|NCT04999111|531496040|FG004|Overall Study|Lost to Follow-up|30|||
147361556|NCT04999111|531496041|FG005|Overall Study|Lost to Follow-up|6|||
147361557|NCT04999111|531496036|FG000|Overall Study|Physician Decision|1|||
147361558|NCT04999111|531496037|FG001|Overall Study|Physician Decision|3|||
147361559|NCT04999111|531496038|FG002|Overall Study|Physician Decision|0|||
147361560|NCT04999111|531496039|FG003|Overall Study|Physician Decision|1|||
147361561|NCT04999111|531496040|FG004|Overall Study|Physician Decision|2|||
147361562|NCT04999111|531496041|FG005|Overall Study|Physician Decision|0|||
147361563|NCT04999111|531496036|FG000|Overall Study|Withdrawal by Subject|23|||
147361564|NCT04999111|531496037|FG001|Overall Study|Withdrawal by Subject|29|||
147361565|NCT04999111|531496038|FG002|Overall Study|Withdrawal by Subject|15|||
147361566|NCT04999111|531496039|FG003|Overall Study|Withdrawal by Subject|30|||
147361567|NCT04999111|531496040|FG004|Overall Study|Withdrawal by Subject|35|||
147361568|NCT04999111|531496041|FG005|Overall Study|Withdrawal by Subject|10|||
147361569|NCT04999111|531496036|FG000|Overall Study|Other|6|||
147361570|NCT04999111|531496037|FG001|Overall Study|Other|6|||
147608446|NCT01994850|532382633|FG000|Overall Study|Withdrawal by Subject|1|||
147608447|NCT00182325|532382638|FG000|Overall Study|Lost to Follow-up|7|||
147608448|NCT00182325|532382639|FG001|Overall Study|Lost to Follow-up|7|||
147608449|NCT00182325|532382638|FG000|Overall Study|Miscarriage|5|||
147608450|NCT00182325|532382639|FG001|Overall Study|Miscarriage|3|||
147608451|NCT00182325|532382638|FG000|Overall Study|Did not complete survey|22|||
147608452|NCT00182325|532382639|FG001|Overall Study|Did not complete survey|43|||
147608453|NCT01420965|532382643|FG000|Overall Study|Withdrawal by Subject|1|||
147608454|NCT01420965|532382644|FG001|Overall Study|Withdrawal by Subject|0|||
147361571|NCT04999111|531496038|FG002|Overall Study|Other|3|||
147361572|NCT04999111|531496039|FG003|Overall Study|Other|8|||
147361573|NCT04999111|531496040|FG004|Overall Study|Other|8|||
147361574|NCT04999111|531496041|FG005|Overall Study|Other|5|||
147361575|NCT04999111|531496036|FG000|Overall Study|Non-compliance with study schedule|1|||
147361576|NCT04999111|531496037|FG001|Overall Study|Non-compliance with study schedule|0|||
147361577|NCT04999111|531496038|FG002|Overall Study|Non-compliance with study schedule|0|||
147361578|NCT04999111|531496039|FG003|Overall Study|Non-compliance with study schedule|1|||
147361579|NCT04999111|531496040|FG004|Overall Study|Non-compliance with study schedule|1|||
147361580|NCT04999111|531496041|FG005|Overall Study|Non-compliance with study schedule|1|||
147361581|NCT04999111|531496036|FG000|Overall Study|Randomized but not vaccinated|1|||
147361582|NCT04999111|531496037|FG001|Overall Study|Randomized but not vaccinated|2|||
147361583|NCT04999111|531496038|FG002|Overall Study|Randomized but not vaccinated|0|||
147361584|NCT04999111|531496039|FG003|Overall Study|Randomized but not vaccinated|3|||
147361585|NCT04999111|531496040|FG004|Overall Study|Randomized but not vaccinated|3|||
147361586|NCT04999111|531496041|FG005|Overall Study|Randomized but not vaccinated|0|||
147361587|NCT04999111|531496036|FG000|Overall Study|Adverse Event|1|||
147361588|NCT04999111|531496037|FG001|Overall Study|Adverse Event|1|||
147361589|NCT04999111|531496038|FG002|Overall Study|Adverse Event|0|||
147361590|NCT04999111|531496039|FG003|Overall Study|Adverse Event|0|||
147361591|NCT04999111|531496040|FG004|Overall Study|Adverse Event|0|||
147361592|NCT04999111|531496041|FG005|Overall Study|Adverse Event|0|||
147361593|NCT04999111|531496036|FG000|Overall Study|Initiated prohibited medication|0|||
147361594|NCT04999111|531496037|FG001|Overall Study|Initiated prohibited medication|0|||
147361595|NCT04999111|531496038|FG002|Overall Study|Initiated prohibited medication|0|||
147361596|NCT04999111|531496039|FG003|Overall Study|Initiated prohibited medication|0|||
147361597|NCT04999111|531496040|FG004|Overall Study|Initiated prohibited medication|1|||
147361598|NCT04999111|531496041|FG005|Overall Study|Initiated prohibited medication|0|||
147361599|NCT02437136|531496047|FG000|Dose Escalation/Confirmation (Phase 1b)|Death|4|||
147361600|NCT02437136|531496048|FG001|Dose Escalation/Confirmation (Phase 1b)|Death|0|||
147361601|NCT02437136|531496049|FG002|Dose Escalation/Confirmation (Phase 1b)|Death|0|||
147361602|NCT02437136|531496050|FG003|Dose Escalation/Confirmation (Phase 1b)|Death|0|||
147361603|NCT02437136|531496051|FG004|Dose Escalation/Confirmation (Phase 1b)|Death|0|||
147361604|NCT02437136|531496052|FG005|Dose Escalation/Confirmation (Phase 1b)|Death|0|||
147361605|NCT02437136|531496053|FG006|Dose Escalation/Confirmation (Phase 1b)|Death|0|||
147361606|NCT02437136|531496047|FG000|Expansion (Phase 2)|Death|0|||
147361607|NCT02437136|531496048|FG001|Expansion (Phase 2)|Death|0|||
147361608|NCT02437136|531496049|FG002|Expansion (Phase 2)|Death|0|||
147361609|NCT02437136|531496050|FG003|Expansion (Phase 2)|Death|6|||
147361610|NCT02437136|531496051|FG004|Expansion (Phase 2)|Death|37|||
147361611|NCT02437136|531496052|FG005|Expansion (Phase 2)|Death|29|||
147361612|NCT02437136|531496053|FG006|Expansion (Phase 2)|Death|24|||
147361613|NCT02437136|531496047|FG000|Expansion (Phase 2)|Withdrawal by Subject|0|||
147361614|NCT02437136|531496048|FG001|Expansion (Phase 2)|Withdrawal by Subject|0|||
147361615|NCT02437136|531496049|FG002|Expansion (Phase 2)|Withdrawal by Subject|0|||
147361616|NCT02437136|531496050|FG003|Expansion (Phase 2)|Withdrawal by Subject|7|||
147361617|NCT02437136|531496051|FG004|Expansion (Phase 2)|Withdrawal by Subject|25|||
147361618|NCT02437136|531496052|FG005|Expansion (Phase 2)|Withdrawal by Subject|4|||
147361619|NCT02437136|531496053|FG006|Expansion (Phase 2)|Withdrawal by Subject|2|||
147361620|NCT02437136|531496047|FG000|Expansion (Phase 2)|Lost to Follow-up|0|||
147361621|NCT02437136|531496048|FG001|Expansion (Phase 2)|Lost to Follow-up|0|||
147361622|NCT02437136|531496049|FG002|Expansion (Phase 2)|Lost to Follow-up|0|||
147361623|NCT02437136|531496050|FG003|Expansion (Phase 2)|Lost to Follow-up|0|||
147361624|NCT02437136|531496051|FG004|Expansion (Phase 2)|Lost to Follow-up|3|||
147454199|NCT04179175|531825554|FG002|Overall Study|Adverse Event|3|||
147454200|NCT04179175|531825555|FG003|Overall Study|Adverse Event|4|||
147608455|NCT01420965|532382645|FG002|Overall Study|Withdrawal by Subject|0|||
147608456|NCT01420965|532382643|FG000|Overall Study|Adverse Event|0|||
147361625|NCT02437136|531496052|FG005|Expansion (Phase 2)|Lost to Follow-up|3|||
147361626|NCT02437136|531496053|FG006|Expansion (Phase 2)|Lost to Follow-up|2|||
147361627|NCT01314105|531496054|FG000|Overall Study|Progressive Disease|6|||
147608457|NCT01420965|532382644|FG001|Overall Study|Adverse Event|1|||
147361628|NCT01314105|531496055|FG001|Overall Study|Progressive Disease|10|||
147361629|NCT01314105|531496054|FG000|Overall Study|Refused to continue taking medication|0|||
147361630|NCT01314105|531496055|FG001|Overall Study|Refused to continue taking medication|1|||
147454201|NCT04179175|531825556|FG004|Overall Study|Adverse Event|6|||
147454202|NCT04179175|531825557|FG005|Overall Study|Adverse Event|6|||
147361631|NCT01314105|531496054|FG000|Overall Study|Other Adverse Event|1|||
147361632|NCT01314105|531496055|FG001|Overall Study|Other Adverse Event|1|||
147361633|NCT02056834|531496056|FG000|Overall Study|Lost to Follow-up|7|||
147361634|NCT04526886|531496060|FG000|Overall Study|Physician Decision|4|||
147361635|NCT03174275|531496071|FG000|Overall Study (Until End of Surgery)|Adverse Event|4|||
147361636|NCT03174275|531496071|FG000|Overall Study (Until End of Surgery)|Withdrawal by Subject|9|||
147361637|NCT03174275|531496071|FG000|Overall Study (Until End of Surgery)|Lack of Efficacy|1|||
147361638|NCT03174275|531496071|FG000|Adjuvant Chemotherapy|Withdrawal by Subject|6|||
147361639|NCT03174275|531496071|FG000|Adjuvant Chemotherapy|Progression|1|||
147361640|NCT03174275|531496071|FG000|Adjuvant Chemotherapy|Adverse Event|1|||
147361641|NCT03174275|531496071|FG000|Adjuvant Durvalumab|Withdrawal by Subject|6|||
147361642|NCT03174275|531496071|FG000|Adjuvant Durvalumab|Progression|1|||
147361643|NCT03174275|531496071|FG000|Adjuvant Durvalumab|Adverse Event|3|||
147361644|NCT03174275|531496071|FG000|Adjuvant Radiotherapy|Withdrawal by Subject|5|||
147361645|NCT03174275|531496071|FG000|Adjuvant Radiotherapy|Progression|1|||
147361646|NCT03174275|531496071|FG000|Adjuvant Radiotherapy|Adverse Event|1|||
147361647|NCT03484819|531496072|FG000|Overall Study|Death|2|||
147361648|NCT03484819|531496072|FG000|Overall Study|Adverse Event|2|||
147361649|NCT03484819|531496072|FG000|Overall Study|Physician Decision|1|||
147361650|NCT03484819|531496072|FG000|Overall Study|Withdrawal by Subject|2|||
147361651|NCT03484819|531496072|FG000|Overall Study|Disease Progression|4|||
147361652|NCT03484819|531496072|FG000|Overall Study|Complicating Condition|1|||
147361653|NCT05970861|531496073|FG000|Overall Study|Physician Decision|4|||
147361654|NCT05970861|531496074|FG001|Overall Study|Physician Decision|4|||
147361655|NCT05970861|531496073|FG000|Overall Study|Lost to Follow-up|4|||
147361656|NCT05970861|531496074|FG001|Overall Study|Lost to Follow-up|3|||
147361657|NCT04456296|531496075|FG000|Overall Study|Withdrawal by Subject|14|||
147361658|NCT04456296|531496076|FG001|Overall Study|Withdrawal by Subject|21|||
147361659|NCT04456296|531496077|FG002|Overall Study|Withdrawal by Subject|21|||
147361660|NCT04456296|531496075|FG000|Overall Study|Adverse Event|2|||
147361661|NCT04456296|531496076|FG001|Overall Study|Adverse Event|2|||
147361662|NCT04456296|531496077|FG002|Overall Study|Adverse Event|2|||
147361663|NCT04456296|531496075|FG000|Overall Study|Death|1|||
147361664|NCT04456296|531496076|FG001|Overall Study|Death|0|||
147361665|NCT04456296|531496077|FG002|Overall Study|Death|0|||
147361666|NCT04456296|531496075|FG000|Overall Study|Lost to Follow-up|3|||
147361667|NCT04456296|531496076|FG001|Overall Study|Lost to Follow-up|5|||
147361668|NCT04456296|531496077|FG002|Overall Study|Lost to Follow-up|6|||
147361669|NCT04456296|531496075|FG000|Overall Study|Other than specified|0|||
147361670|NCT04456296|531496076|FG001|Overall Study|Other than specified|1|||
147361671|NCT04456296|531496077|FG002|Overall Study|Other than specified|4|||
147361672|NCT04456296|531496075|FG000|Overall Study|Randomized, not treated|2|||
147361673|NCT04456296|531496076|FG001|Overall Study|Randomized, not treated|1|||
147361674|NCT04456296|531496077|FG002|Overall Study|Randomized, not treated|0|||
147361675|NCT02990338|531496078|FG000|Overall Study|Randomized and not treated|4|||
147361676|NCT02990338|531496079|FG001|Overall Study|Randomized and not treated|2|||
147361677|NCT02990338|531496078|FG000|Overall Study|Adverse Event|23|||
147361678|NCT02990338|531496079|FG001|Overall Study|Adverse Event|22|||
147361679|NCT02990338|531496078|FG000|Overall Study|Progressive disease|118|||
147361680|NCT02990338|531496079|FG001|Overall Study|Progressive disease|107|||
147361681|NCT02990338|531496078|FG000|Overall Study|Poor compliance to protocol|0|||
147361682|NCT02990338|531496079|FG001|Overall Study|Poor compliance to protocol|1|||
147361683|NCT02990338|531496078|FG000|Overall Study|Withdrawal by Subject|6|||
147361684|NCT02990338|531496079|FG001|Overall Study|Withdrawal by Subject|8|||
147361685|NCT02990338|531496078|FG000|Overall Study|Physician's decision|2|||
147361686|NCT02990338|531496079|FG001|Overall Study|Physician's decision|6|||
147361687|NCT02990338|531496078|FG000|Overall Study|Treatment extension study|0|||
147361688|NCT02990338|531496079|FG001|Overall Study|Treatment extension study|6|||
147361689|NCT02990338|531496078|FG000|Overall Study|Unconfirmed disease progression per investigator|0|||
147361690|NCT02990338|531496079|FG001|Overall Study|Unconfirmed disease progression per investigator|1|||
147361691|NCT02990338|531496078|FG000|Overall Study|Continue with therapy available commercially|0|||
147361692|NCT02990338|531496079|FG001|Overall Study|Continue with therapy available commercially|1|||
147361693|NCT04186819|531496080|FG000|Overall Study|Adverse Event|1|||
147361694|NCT04186819|531496080|FG000|Overall Study|Lost to Follow-up|1|||
147361695|NCT04186819|531496080|FG000|Overall Study|Opted for EBRT|1|||
147361696|NCT04186819|531496080|FG000|Overall Study|Opted SBRT|1|||
147361697|NCT04186819|531496080|FG000|Overall Study|Patient decided to have focal ablation and not surgery|2|||
147361698|NCT04186819|531496080|FG000|Overall Study|Physician Decision|1|||
147361699|NCT04186819|531496080|FG000|Overall Study|RP Delayed|1|||
147361700|NCT04186819|531496080|FG000|Overall Study|Sponsor Decision: Outdated FU Timeline|1|||
147361701|NCT04186819|531496080|FG000|Overall Study|Subject declined for financial reasons|1|||
147361702|NCT04186819|531496080|FG000|Overall Study|The subject declined any biopsy or surgery due to COVID-19 pandemic|1|||
147361703|NCT04186819|531496080|FG000|Overall Study|The subject declined for any biopsy or other imaging|2|||
147361704|NCT04186819|531496080|FG000|Overall Study|The subject opted for other treatment option|2|||
147361705|NCT04186819|531496080|FG000|Overall Study|The subject opted for other treatment options|1|||
147608458|NCT01420965|532382645|FG002|Overall Study|Adverse Event|0|||
147608459|NCT01890434|532382646|FG000|Overall Study|Adverse Event|8|||
147608460|NCT01890434|532382646|FG000|Overall Study|PCI at external hospital|1|||
147608461|NCT01890434|532382646|FG000|Overall Study|Assessment discrepancy|1|||
147361706|NCT04186819|531496080|FG000|Overall Study|Withdrawal by Subject|3|||
147361707|NCT04186819|531496080|FG000|Overall Study|Reason not specified|1|||
147361708|NCT05900154|531496081|FG000|Follow-Up Period|Lost to Follow-up|1|||
147361709|NCT05900154|531496082|FG001|Follow-Up Period|Lost to Follow-up|2|||
147361710|NCT05900154|531496083|FG002|Follow-Up Period|Lost to Follow-up|1|||
147361711|NCT05900154|531496084|FG003|Follow-Up Period|Lost to Follow-up|0|||
147361712|NCT05900154|531496085|FG004|Follow-Up Period|Lost to Follow-up|1|||
147361713|NCT05900154|531496086|FG005|Follow-Up Period|Lost to Follow-up|1|||
147361714|NCT02905331|531496088|FG000|Placebo Controlled Period(Week[wk] 0-16)|Adverse Event|1|||
147361715|NCT02905331|531496089|FG001|Placebo Controlled Period(Week[wk] 0-16)|Adverse Event|0|||
147361716|NCT02905331|531496090|FG002|Placebo Controlled Period(Week[wk] 0-16)|Adverse Event|0|||
147361717|NCT02905331|531496088|FG000|Placebo Controlled Period(Week[wk] 0-16)|Lack of Efficacy|2|||
147361718|NCT02905331|531496089|FG001|Placebo Controlled Period(Week[wk] 0-16)|Lack of Efficacy|0|||
147361719|NCT02905331|531496090|FG002|Placebo Controlled Period(Week[wk] 0-16)|Lack of Efficacy|0|||
147361720|NCT02905331|531496088|FG000|Placebo Controlled Period(Week[wk] 0-16)|Lost to Follow-up|0|||
147361721|NCT02905331|531496089|FG001|Placebo Controlled Period(Week[wk] 0-16)|Lost to Follow-up|1|||
147361722|NCT02905331|531496090|FG002|Placebo Controlled Period(Week[wk] 0-16)|Lost to Follow-up|0|||
147361723|NCT02905331|531496088|FG000|Active Treatment and Follow up (wk16-40)|Other|0|||
147361724|NCT02905331|531496089|FG001|Active Treatment and Follow up (wk16-40)|Other|6|||
147361725|NCT02905331|531496090|FG002|Active Treatment and Follow up (wk16-40)|Other|0|||
147361726|NCT02905331|531496088|FG000|Active Treatment and Follow up (wk16-40)|Withdrawal by Subject|0|||
147361727|NCT02905331|531496089|FG001|Active Treatment and Follow up (wk16-40)|Withdrawal by Subject|2|||
147361728|NCT02905331|531496090|FG002|Active Treatment and Follow up (wk16-40)|Withdrawal by Subject|0|||
147361729|NCT04102111|531496098|FG000|Overall Study|Withdrawal by Subject|2|||
147361730|NCT04102111|531496099|FG001|Overall Study|Withdrawal by Subject|3|||
147361731|NCT04102111|531496098|FG000|Overall Study|Adverse Event|1|||
147361732|NCT04102111|531496099|FG001|Overall Study|Adverse Event|1|||
147361733|NCT04102111|531496098|FG000|Overall Study|Study terminated by sponsor|1|||
147361734|NCT04102111|531496099|FG001|Overall Study|Study terminated by sponsor|3|||
147361735|NCT02542631|531496100|FG000|Overall Study|Adverse Event|1|||
147361736|NCT02542631|531496101|FG001|Overall Study|Adverse Event|1|||
147361737|NCT02542631|531496100|FG000|Overall Study|Sponsor Termination|1|||
147361738|NCT02542631|531496101|FG001|Overall Study|Sponsor Termination|0|||
147361739|NCT02542631|531496100|FG000|Overall Study|Withdrawal by Subject|11|||
147361740|NCT02542631|531496101|FG001|Overall Study|Withdrawal by Subject|16|||
147361741|NCT02542631|531496100|FG000|Overall Study|Protocol Violation|1|||
147361742|NCT02542631|531496101|FG001|Overall Study|Protocol Violation|1|||
147361743|NCT02542631|531496100|FG000|Overall Study|Physician Decision|6|||
147361744|NCT02542631|531496101|FG001|Overall Study|Physician Decision|4|||
147361745|NCT02542631|531496100|FG000|Overall Study|Lost to Follow-up|6|||
147361746|NCT02542631|531496101|FG001|Overall Study|Lost to Follow-up|5|||
147361747|NCT02542631|531496100|FG000|Overall Study|Death|1|||
147361748|NCT02542631|531496101|FG001|Overall Study|Death|2|||
147361749|NCT02542631|531496100|FG000|Overall Study|Other|2|||
147361750|NCT02542631|531496101|FG001|Overall Study|Other|1|||
147361751|NCT02542631|531496100|FG000|Overall Study|Used Prohibited Medication|2|||
147361752|NCT02542631|531496101|FG001|Overall Study|Used Prohibited Medication|1|||
147361753|NCT03334695|531496102|FG000|Overall Study|Lost to Follow-up|3|||
147361754|NCT03334695|531496103|FG001|Overall Study|Lost to Follow-up|3|||
147361755|NCT03334695|531496102|FG000|Overall Study|Physician Decision|1|||
147361756|NCT03334695|531496103|FG001|Overall Study|Physician Decision|2|||
147361757|NCT03334695|531496102|FG000|Overall Study|Protocol Violation|0|||
147361758|NCT03334695|531496103|FG001|Overall Study|Protocol Violation|1|||
147361759|NCT02938923|531496104|FG000|Overall Study|Death|1|||
147361760|NCT02938923|531496105|FG001|Overall Study|Death|0|||
147361761|NCT02938923|531496106|FG002|Overall Study|Death|0|||
147361762|NCT02938923|531496104|FG000|Overall Study|Physician Decision|0|||
147361763|NCT02938923|531496105|FG001|Overall Study|Physician Decision|2|||
147361764|NCT02938923|531496106|FG002|Overall Study|Physician Decision|0|||
147361765|NCT02938923|531496104|FG000|Overall Study|Withdrawal by Subject|0|||
147361766|NCT02938923|531496105|FG001|Overall Study|Withdrawal by Subject|1|||
147361767|NCT02938923|531496106|FG002|Overall Study|Withdrawal by Subject|1|||
147454203|NCT04179175|531825552|FG000|Overall Study|Lack of Efficacy|5|||
147454204|NCT04179175|531825553|FG001|Overall Study|Lack of Efficacy|1|||
147454205|NCT04179175|531825554|FG002|Overall Study|Lack of Efficacy|3|||
147608462|NCT01890434|532382646|FG000|Overall Study|CRC didn't contact participant for FU|1|||
147608463|NCT01890434|532382646|FG000|Overall Study|Could not get whole set of images|1|||
147361768|NCT04583280|531496109|FG000|Overall Study|Consent withdrawn by parent/caregiver|0|||
147361769|NCT04583280|531496110|FG001|Overall Study|Consent withdrawn by parent/caregiver|1|||
147361770|NCT04614948|531496111|FG000|DB Phase (Day 1 up to 7.2 Months)|Adverse Event|5|||
147454206|NCT04179175|531825555|FG003|Overall Study|Lack of Efficacy|2|||
147361771|NCT04614948|531496112|FG001|DB Phase (Day 1 up to 7.2 Months)|Adverse Event|10|||
147361772|NCT04614948|531496113|FG002|DB Phase (Day 1 up to 7.2 Months)|Adverse Event|0|||
147361773|NCT04614948|531496111|FG000|DB Phase (Day 1 up to 7.2 Months)|Death|6|||
147361774|NCT04614948|531496112|FG001|DB Phase (Day 1 up to 7.2 Months)|Death|13|||
147361775|NCT04614948|531496113|FG002|DB Phase (Day 1 up to 7.2 Months)|Death|0|||
147361776|NCT04614948|531496111|FG000|DB Phase (Day 1 up to 7.2 Months)|Lost to Follow-up|170|||
147361777|NCT04614948|531496112|FG001|DB Phase (Day 1 up to 7.2 Months)|Lost to Follow-up|219|||
147361778|NCT04614948|531496113|FG002|DB Phase (Day 1 up to 7.2 Months)|Lost to Follow-up|0|||
147361779|NCT04614948|531496111|FG000|DB Phase (Day 1 up to 7.2 Months)|Physician Decision|15|||
147361780|NCT04614948|531496112|FG001|DB Phase (Day 1 up to 7.2 Months)|Physician Decision|6|||
147361781|NCT04614948|531496113|FG002|DB Phase (Day 1 up to 7.2 Months)|Physician Decision|0|||
147361782|NCT04614948|531496111|FG000|DB Phase (Day 1 up to 7.2 Months)|Pregnancy|0|||
147361783|NCT04614948|531496112|FG001|DB Phase (Day 1 up to 7.2 Months)|Pregnancy|1|||
147361784|NCT04614948|531496113|FG002|DB Phase (Day 1 up to 7.2 Months)|Pregnancy|0|||
147361785|NCT04614948|531496111|FG000|DB Phase (Day 1 up to 7.2 Months)|Protocol Violation|1|||
147361786|NCT04614948|531496112|FG001|DB Phase (Day 1 up to 7.2 Months)|Protocol Violation|7|||
147361787|NCT04614948|531496113|FG002|DB Phase (Day 1 up to 7.2 Months)|Protocol Violation|0|||
147361788|NCT04614948|531496111|FG000|DB Phase (Day 1 up to 7.2 Months)|Withdrawal by Subject|468|||
147361789|NCT04614948|531496112|FG001|DB Phase (Day 1 up to 7.2 Months)|Withdrawal by Subject|1273|||
147361790|NCT04614948|531496113|FG002|DB Phase (Day 1 up to 7.2 Months)|Withdrawal by Subject|0|||
147361791|NCT04614948|531496111|FG000|DB Phase (Day 1 up to 7.2 Months)|Initiated Prohibited Medication|10|||
147361792|NCT04614948|531496112|FG001|DB Phase (Day 1 up to 7.2 Months)|Initiated Prohibited Medication|75|||
147361793|NCT04614948|531496113|FG002|DB Phase (Day 1 up to 7.2 Months)|Initiated Prohibited Medication|0|||
147361794|NCT04614948|531496111|FG000|DB Phase (Day 1 up to 7.2 Months)|Rolled Over into Different Clinical Trial|0|||
147361795|NCT04614948|531496112|FG001|DB Phase (Day 1 up to 7.2 Months)|Rolled Over into Different Clinical Trial|3|||
147361796|NCT04614948|531496113|FG002|DB Phase (Day 1 up to 7.2 Months)|Rolled Over into Different Clinical Trial|0|||
147361797|NCT04614948|531496111|FG000|DB Phase (Day 1 up to 7.2 Months)|Technical Problems|0|||
147361798|NCT04614948|531496112|FG001|DB Phase (Day 1 up to 7.2 Months)|Technical Problems|2|||
147361799|NCT04614948|531496113|FG002|DB Phase (Day 1 up to 7.2 Months)|Technical Problems|0|||
147361800|NCT04614948|531496111|FG000|DB Phase (Day 1 up to 7.2 Months)|Other|26|||
147361801|NCT04614948|531496112|FG001|DB Phase (Day 1 up to 7.2 Months)|Other|149|||
147361802|NCT04614948|531496113|FG002|DB Phase (Day 1 up to 7.2 Months)|Other|0|||
147361803|NCT04614948|531496111|FG000|DB + Open-label Phase (2 Years 6 Months)|Adverse Event|0|||
147361804|NCT04614948|531496112|FG001|DB + Open-label Phase (2 Years 6 Months)|Adverse Event|0|||
147361805|NCT04614948|531496113|FG002|DB + Open-label Phase (2 Years 6 Months)|Adverse Event|14|||
147361806|NCT04614948|531496111|FG000|DB + Open-label Phase (2 Years 6 Months)|Death|0|||
147361807|NCT04614948|531496112|FG001|DB + Open-label Phase (2 Years 6 Months)|Death|0|||
147361808|NCT04614948|531496113|FG002|DB + Open-label Phase (2 Years 6 Months)|Death|131|||
147361809|NCT04614948|531496111|FG000|DB + Open-label Phase (2 Years 6 Months)|Lost to Follow-up|0|||
147361810|NCT04614948|531496112|FG001|DB + Open-label Phase (2 Years 6 Months)|Lost to Follow-up|0|||
147361811|NCT04614948|531496113|FG002|DB + Open-label Phase (2 Years 6 Months)|Lost to Follow-up|3796|||
147361812|NCT04614948|531496111|FG000|DB + Open-label Phase (2 Years 6 Months)|Physician Decision|0|||
147608464|NCT01890434|532382646|FG000|Overall Study|Decline to return for GSPECT|1|||
147361813|NCT04614948|531496112|FG001|DB + Open-label Phase (2 Years 6 Months)|Physician Decision|0|||
147361814|NCT04614948|531496113|FG002|DB + Open-label Phase (2 Years 6 Months)|Physician Decision|178|||
147361815|NCT04614948|531496111|FG000|DB + Open-label Phase (2 Years 6 Months)|Pregnancy|0|||
147361816|NCT04614948|531496112|FG001|DB + Open-label Phase (2 Years 6 Months)|Pregnancy|0|||
147361817|NCT04614948|531496113|FG002|DB + Open-label Phase (2 Years 6 Months)|Pregnancy|2|||
147361818|NCT04614948|531496111|FG000|DB + Open-label Phase (2 Years 6 Months)|Protocol Violation|0|||
147361819|NCT04614948|531496112|FG001|DB + Open-label Phase (2 Years 6 Months)|Protocol Violation|0|||
147361820|NCT04614948|531496113|FG002|DB + Open-label Phase (2 Years 6 Months)|Protocol Violation|9|||
147361821|NCT04614948|531496111|FG000|DB + Open-label Phase (2 Years 6 Months)|Withdrawal by Subject|0|||
147361822|NCT04614948|531496112|FG001|DB + Open-label Phase (2 Years 6 Months)|Withdrawal by Subject|0|||
147361823|NCT04614948|531496113|FG002|DB + Open-label Phase (2 Years 6 Months)|Withdrawal by Subject|5922|||
147361824|NCT04614948|531496111|FG000|DB + Open-label Phase (2 Years 6 Months)|Initiated Prohibited Medication|0|||
147361825|NCT04614948|531496112|FG001|DB + Open-label Phase (2 Years 6 Months)|Initiated Prohibited Medication|0|||
147361826|NCT04614948|531496113|FG002|DB + Open-label Phase (2 Years 6 Months)|Initiated Prohibited Medication|92|||
147361827|NCT04614948|531496111|FG000|DB + Open-label Phase (2 Years 6 Months)|Rolled Over into Different Clinical Trial|0|||
147608465|NCT01890434|532382646|FG000|Overall Study|GSPECT at rest was not done|1|||
147361828|NCT04614948|531496112|FG001|DB + Open-label Phase (2 Years 6 Months)|Rolled Over into Different Clinical Trial|0|||
147361829|NCT04614948|531496113|FG002|DB + Open-label Phase (2 Years 6 Months)|Rolled Over into Different Clinical Trial|48|||
147361830|NCT04614948|531496111|FG000|DB + Open-label Phase (2 Years 6 Months)|Technical Problems|0|||
147361831|NCT04614948|531496112|FG001|DB + Open-label Phase (2 Years 6 Months)|Technical Problems|0|||
147608466|NCT01890434|532382646|FG000|Overall Study|Participant didn't complete MRI|1|||
147361832|NCT04614948|531496113|FG002|DB + Open-label Phase (2 Years 6 Months)|Technical Problems|17|||
147361833|NCT04614948|531496111|FG000|DB + Open-label Phase (2 Years 6 Months)|Sponsor Decision|0|||
147361834|NCT04614948|531496112|FG001|DB + Open-label Phase (2 Years 6 Months)|Sponsor Decision|0|||
147361835|NCT04614948|531496113|FG002|DB + Open-label Phase (2 Years 6 Months)|Sponsor Decision|1|||
147361836|NCT04614948|531496111|FG000|DB + Open-label Phase (2 Years 6 Months)|Other|0|||
147361837|NCT04614948|531496112|FG001|DB + Open-label Phase (2 Years 6 Months)|Other|0|||
147361838|NCT04614948|531496113|FG002|DB + Open-label Phase (2 Years 6 Months)|Other|477|||
147361839|NCT04129554|531496114|FG000|Overall Study|Withdrawal by Subject|4|||
147361840|NCT04129554|531496115|FG001|Overall Study|Withdrawal by Subject|3|||
147361841|NCT04129554|531496114|FG000|Overall Study|Other|0|||
147361842|NCT04129554|531496115|FG001|Overall Study|Other|2|||
147361843|NCT01570361|531496116|FG000|Overall Study|Subject discontinued|1|||
147361844|NCT01570361|531496117|FG001|Overall Study|Subject discontinued|2|||
147361845|NCT01570361|531496116|FG000|Overall Study|Sponsor closing the study|51|||
147361846|NCT01570361|531496117|FG001|Overall Study|Sponsor closing the study|50|||
147361847|NCT01570361|531496116|FG000|Overall Study|Subject excluded|5|||
147361848|NCT01570361|531496117|FG001|Overall Study|Subject excluded|3|||
147361849|NCT01570361|531496116|FG000|Overall Study|Subject withdrew consent|14|||
147361850|NCT01570361|531496117|FG001|Overall Study|Subject withdrew consent|9|||
147361851|NCT01570361|531496116|FG000|Overall Study|Adverse Event|2|||
147361852|NCT01570361|531496117|FG001|Overall Study|Adverse Event|1|||
147361853|NCT01570361|531496116|FG000|Overall Study|Lost to Follow-up|4|||
147361854|NCT01570361|531496117|FG001|Overall Study|Lost to Follow-up|4|||
147361855|NCT01570361|531496116|FG000|Overall Study|Death|5|||
147361856|NCT01570361|531496117|FG001|Overall Study|Death|4|||
147361857|NCT01570361|531496116|FG000|Overall Study|Other|0|||
147361858|NCT01570361|531496117|FG001|Overall Study|Other|2|||
147361859|NCT04633538|531496120|FG000|Overall Study|Death|1|||
147361860|NCT04633538|531496120|FG000|Overall Study|Lost to Follow-up|3|||
147361861|NCT04633538|531496120|FG000|Overall Study|Withdrawal by Subject|1|||
147361862|NCT02938520|531496121|FG000|Overall Study|On-going at the time of analysis|258|||
147361863|NCT02938520|531496122|FG001|Overall Study|On-going at the time of analysis|261|||
147361864|NCT02938520|531496121|FG000|Overall Study|Physician Decision|2|||
147361865|NCT02938520|531496122|FG001|Overall Study|Physician Decision|5|||
147361866|NCT02938520|531496121|FG000|Overall Study|Lost to Follow-up|2|||
147361867|NCT02938520|531496122|FG001|Overall Study|Lost to Follow-up|2|||
147361868|NCT02938520|531496121|FG000|Overall Study|Withdrawal by Subject|7|||
147361869|NCT02938520|531496122|FG001|Overall Study|Withdrawal by Subject|7|||
147361870|NCT02938520|531496121|FG000|Overall Study|Protocol Violation|0|||
147361871|NCT02938520|531496122|FG001|Overall Study|Protocol Violation|1|||
147361872|NCT02938520|531496121|FG000|Overall Study|Lack of Efficacy|5|||
147361873|NCT02938520|531496122|FG001|Overall Study|Lack of Efficacy|3|||
147361874|NCT02938520|531496121|FG000|Overall Study|Adverse Event|9|||
147361875|NCT02938520|531496122|FG001|Overall Study|Adverse Event|4|||
147361876|NCT03245840|531496123|FG000|Overall Study|Adverse Event|6|||
147361877|NCT03245840|531496124|FG001|Overall Study|Adverse Event|0|||
147361878|NCT03245840|531496123|FG000|Overall Study|Death|2|||
147361879|NCT03245840|531496124|FG001|Overall Study|Death|0|||
147361880|NCT03245840|531496123|FG000|Overall Study|Withdrawal by Subject|31|||
147361881|NCT03245840|531496124|FG001|Overall Study|Withdrawal by Subject|1|||
147361882|NCT03245840|531496123|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
147361883|NCT03245840|531496124|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
147361884|NCT03245840|531496123|FG000|Overall Study|Physician Decision|4|||
147361885|NCT03245840|531496124|FG001|Overall Study|Physician Decision|1|||
147361886|NCT03245840|531496123|FG000|Overall Study|Study Terminated by Sponsor|56|||
147361887|NCT03245840|531496124|FG001|Overall Study|Study Terminated by Sponsor|6|||
147361888|NCT03245840|531496123|FG000|Overall Study|Site Terminated by Sponsor|4|||
147361889|NCT03245840|531496124|FG001|Overall Study|Site Terminated by Sponsor|0|||
147361890|NCT03245840|531496123|FG000|Overall Study|Lost to Follow-up|12|||
147361891|NCT03245840|531496124|FG001|Overall Study|Lost to Follow-up|2|||
147361892|NCT03245840|531496123|FG000|Overall Study|Pregnancy|2|||
147361893|NCT03245840|531496124|FG001|Overall Study|Pregnancy|0|||
147361894|NCT03245840|531496123|FG000|Overall Study|Non-Compliance with Study Drug|2|||
147361895|NCT03245840|531496124|FG001|Overall Study|Non-Compliance with Study Drug|0|||
147361896|NCT03245840|531496123|FG000|Overall Study|Not treated|1|||
147361897|NCT03245840|531496124|FG001|Overall Study|Not treated|1|||
147361898|NCT02518048|531496129|FG000|Overall Study|Withdrawal by Subject|1|||
147361899|NCT02585323|531497355|FG000|Week 13 (RCT Period)|Withdrawal by Subject|2|||
147361900|NCT02585323|531497356|FG001|Week 13 (RCT Period)|Withdrawal by Subject|0|||
147361901|NCT02585323|531497355|FG000|Week 13 (RCT Period)|Participant refused assessment|0|||
147361902|NCT02585323|531497356|FG001|Week 13 (RCT Period)|Participant refused assessment|1|||
147361903|NCT02585323|531497355|FG000|Week 26 (All Received Intervention)|Withdrawal by Subject|2|||
147361904|NCT02585323|531497356|FG001|Week 26 (All Received Intervention)|Withdrawal by Subject|0|||
147361905|NCT02585323|531497355|FG000|Week 39 (All Received Intervention)|Withdrawal by Subject|2|||
147361906|NCT02585323|531497356|FG001|Week 39 (All Received Intervention)|Withdrawal by Subject|0|||
147361907|NCT01130883|531497357|FG000|Overall Study|Patient Noncompliance|6|||
147361908|NCT01130883|531497357|FG000|Overall Study|Reason Unknown|1|||
147361909|NCT01130883|531497357|FG000|Overall Study|Adverse Event|3|||
147361910|NCT01880515|531497360|FG000|Overall Study|Lost to Follow-up|3|||
147361911|NCT01880515|531497361|FG001|Overall Study|Lost to Follow-up|2|||
147361912|NCT01880515|531497360|FG000|Overall Study|Disease Progression|5|||
147361913|NCT01880515|531497361|FG001|Overall Study|Disease Progression|7|||
147361914|NCT03972150|531497362|FG000|Overall Study|Adverse Event|0|||
147361915|NCT03972150|531497363|FG001|Overall Study|Adverse Event|1|||
147361916|NCT03972150|531497364|FG002|Overall Study|Adverse Event|1|||
147361917|NCT03972150|531497365|FG003|Overall Study|Adverse Event|0|||
147361918|NCT03972150|531497366|FG004|Overall Study|Adverse Event|0|||
147361919|NCT03972150|531497362|FG000|Overall Study|Progressive disease|3|||
147361920|NCT03972150|531497363|FG001|Overall Study|Progressive disease|5|||
147361921|NCT03972150|531497364|FG002|Overall Study|Progressive disease|2|||
147361922|NCT03972150|531497365|FG003|Overall Study|Progressive disease|2|||
147361923|NCT03972150|531497366|FG004|Overall Study|Progressive disease|3|||
147361924|NCT03505710|531497367|FG000|Overall Study|Progressive Disease|24|||
147361925|NCT03505710|531497368|FG001|Overall Study|Progressive Disease|17|||
147361926|NCT03505710|531497369|FG002|Overall Study|Progressive Disease|43|||
147361927|NCT03505710|531497367|FG000|Overall Study|Clinical Progression|6|||
147361928|NCT03505710|531497368|FG001|Overall Study|Clinical Progression|8|||
147361929|NCT03505710|531497369|FG002|Overall Study|Clinical Progression|3|||
147361930|NCT03505710|531497367|FG000|Overall Study|Adverse Event|12|||
147361931|NCT03505710|531497368|FG001|Overall Study|Adverse Event|6|||
147361932|NCT03505710|531497369|FG002|Overall Study|Adverse Event|28|||
147361933|NCT03505710|531497367|FG000|Overall Study|Withdrawal by Subject|1|||
147361934|NCT03505710|531497368|FG001|Overall Study|Withdrawal by Subject|3|||
147361935|NCT03505710|531497369|FG002|Overall Study|Withdrawal by Subject|7|||
147361936|NCT03505710|531497367|FG000|Overall Study|Physician Decision|1|||
147361937|NCT03505710|531497368|FG001|Overall Study|Physician Decision|1|||
147361938|NCT03505710|531497369|FG002|Overall Study|Physician Decision|2|||
147361939|NCT03505710|531497367|FG000|Overall Study|Death|4|||
147361940|NCT03505710|531497368|FG001|Overall Study|Death|5|||
147361941|NCT03505710|531497369|FG002|Overall Study|Death|6|||
147361942|NCT03505710|531497367|FG000|Overall Study|Other Reasons|1|||
147361943|NCT03505710|531497368|FG001|Overall Study|Other Reasons|1|||
147361944|NCT03505710|531497369|FG002|Overall Study|Other Reasons|1|||
147361945|NCT03505710|531497367|FG000|Overall Study|Study Terminated by Sponsor|0|||
147361946|NCT03505710|531497368|FG001|Overall Study|Study Terminated by Sponsor|0|||
147361947|NCT03505710|531497369|FG002|Overall Study|Study Terminated by Sponsor|1|||
147361948|NCT03981926|531497372|FG000|Overall Study|Lost to Follow-up|5|||
147361949|NCT03981926|531497373|FG001|Overall Study|Lost to Follow-up|9|||
147361950|NCT06262347|531497374|FG000|Overall Study|Lost to Follow-up|4|||
147361951|NCT06262347|531497375|FG001|Overall Study|Lost to Follow-up|3|||
147361952|NCT06262347|531497374|FG000|Overall Study|Withdrawal by Subject|0|||
147361953|NCT06262347|531497375|FG001|Overall Study|Withdrawal by Subject|1|||
147361954|NCT03677141|531497376|FG000|Overall Study|Death|2|||
147361955|NCT03677141|531497377|FG001|Overall Study|Death|1|||
147361956|NCT03677141|531497378|FG002|Overall Study|Death|6|||
147361957|NCT03677141|531497379|FG003|Overall Study|Death|9|||
147361958|NCT03677141|531497380|FG004|Overall Study|Death|5|||
147361959|NCT03677141|531497381|FG005|Overall Study|Death|3|||
147361960|NCT03677141|531497376|FG000|Overall Study|Lost to Follow-up|0|||
147361961|NCT03677141|531497377|FG001|Overall Study|Lost to Follow-up|0|||
147361962|NCT03677141|531497378|FG002|Overall Study|Lost to Follow-up|0|||
147361963|NCT03677141|531497379|FG003|Overall Study|Lost to Follow-up|2|||
147361964|NCT03677141|531497380|FG004|Overall Study|Lost to Follow-up|0|||
147361965|NCT03677141|531497381|FG005|Overall Study|Lost to Follow-up|0|||
147361966|NCT03677141|531497376|FG000|Overall Study|Screen failure or enrolled in error|0|||
147361967|NCT03677141|531497377|FG001|Overall Study|Screen failure or enrolled in error|0|||
147361968|NCT03677141|531497378|FG002|Overall Study|Screen failure or enrolled in error|0|||
147361969|NCT03677141|531497379|FG003|Overall Study|Screen failure or enrolled in error|0|||
147361970|NCT03677141|531497380|FG004|Overall Study|Screen failure or enrolled in error|2|||
147361971|NCT03677141|531497381|FG005|Overall Study|Screen failure or enrolled in error|0|||
147361972|NCT03677141|531497376|FG000|Overall Study|Physician Decision|0|||
147361973|NCT03677141|531497377|FG001|Overall Study|Physician Decision|0|||
147361974|NCT03677141|531497378|FG002|Overall Study|Physician Decision|0|||
147361975|NCT03677141|531497379|FG003|Overall Study|Physician Decision|0|||
147361976|NCT03677141|531497380|FG004|Overall Study|Physician Decision|1|||
147608467|NCT01890434|532382646|FG000|Overall Study|Uncontactable by phone|1|||
147361977|NCT03677141|531497381|FG005|Overall Study|Physician Decision|0|||
147361978|NCT03677141|531497376|FG000|Overall Study|Withdrawal by Subject|0|||
147361979|NCT03677141|531497377|FG001|Overall Study|Withdrawal by Subject|0|||
147361980|NCT03677141|531497378|FG002|Overall Study|Withdrawal by Subject|1|||
147361981|NCT03677141|531497379|FG003|Overall Study|Withdrawal by Subject|1|||
147361982|NCT03677141|531497380|FG004|Overall Study|Withdrawal by Subject|1|||
147361983|NCT03677141|531497381|FG005|Overall Study|Withdrawal by Subject|0|||
147361984|NCT06106022|531497393|FG000|Overall Study|Lost to Follow-up|1|||
147608468|NCT01890434|532382646|FG000|Overall Study|Moved out of position|1|||
147361985|NCT06106022|531497394|FG001|Overall Study|Lost to Follow-up|0|||
147361986|NCT06106022|531497393|FG000|Overall Study|Voluntary Withdrawal|0|||
147361987|NCT06106022|531497394|FG001|Overall Study|Voluntary Withdrawal|2|||
147361988|NCT04089865|531497396|FG000|Overall Study|Withdrawal by Subject|2|||
147361989|NCT04089865|531497397|FG001|Overall Study|Withdrawal by Subject|2|||
147361990|NCT04089865|531497398|FG002|Overall Study|Withdrawal by Subject|7|||
147361991|NCT04089865|531497399|FG003|Overall Study|Withdrawal by Subject|2|||
147361992|NCT03580356|531497412|FG000|Treatment Period|Withdrawal by Subject|13|||
147361993|NCT03580356|531497413|FG001|Treatment Period|Withdrawal by Subject|0|||
147361994|NCT03580356|531497414|FG002|Treatment Period|Withdrawal by Subject|13|||
147361995|NCT03580356|531497415|FG003|Treatment Period|Withdrawal by Subject|1|||
147361996|NCT03580356|531497416|FG004|Treatment Period|Withdrawal by Subject|17|||
147361997|NCT03580356|531497417|FG005|Treatment Period|Withdrawal by Subject|0|||
147361998|NCT03580356|531497418|FG006|Treatment Period|Withdrawal by Subject|5|||
147361999|NCT03580356|531497419|FG007|Treatment Period|Withdrawal by Subject|0|||
147362000|NCT03580356|531497412|FG000|Treatment Period|Adverse Event|10|||
147362001|NCT03580356|531497413|FG001|Treatment Period|Adverse Event|0|||
147362002|NCT03580356|531497414|FG002|Treatment Period|Adverse Event|13|||
147362003|NCT03580356|531497415|FG003|Treatment Period|Adverse Event|0|||
147362004|NCT03580356|531497416|FG004|Treatment Period|Adverse Event|5|||
147362005|NCT03580356|531497417|FG005|Treatment Period|Adverse Event|0|||
147362006|NCT03580356|531497418|FG006|Treatment Period|Adverse Event|8|||
147362007|NCT03580356|531497419|FG007|Treatment Period|Adverse Event|0|||
147362008|NCT03580356|531497412|FG000|Treatment Period|Protocol Violation|5|||
147362009|NCT03580356|531497413|FG001|Treatment Period|Protocol Violation|0|||
147362010|NCT03580356|531497414|FG002|Treatment Period|Protocol Violation|6|||
147362011|NCT03580356|531497415|FG003|Treatment Period|Protocol Violation|1|||
147362012|NCT03580356|531497416|FG004|Treatment Period|Protocol Violation|9|||
147362013|NCT03580356|531497417|FG005|Treatment Period|Protocol Violation|1|||
147362014|NCT03580356|531497418|FG006|Treatment Period|Protocol Violation|1|||
147362015|NCT03580356|531497419|FG007|Treatment Period|Protocol Violation|0|||
147362016|NCT03580356|531497412|FG000|Treatment Period|Lack of Efficacy|6|||
147362017|NCT03580356|531497413|FG001|Treatment Period|Lack of Efficacy|0|||
147362018|NCT03580356|531497414|FG002|Treatment Period|Lack of Efficacy|2|||
147362019|NCT03580356|531497415|FG003|Treatment Period|Lack of Efficacy|0|||
147362020|NCT03580356|531497416|FG004|Treatment Period|Lack of Efficacy|3|||
147362021|NCT03580356|531497417|FG005|Treatment Period|Lack of Efficacy|0|||
147362022|NCT03580356|531497418|FG006|Treatment Period|Lack of Efficacy|3|||
147362023|NCT03580356|531497419|FG007|Treatment Period|Lack of Efficacy|0|||
147362024|NCT03580356|531497412|FG000|Treatment Period|Pregnancy|1|||
147362025|NCT03580356|531497413|FG001|Treatment Period|Pregnancy|0|||
147362026|NCT03580356|531497414|FG002|Treatment Period|Pregnancy|7|||
147362027|NCT03580356|531497415|FG003|Treatment Period|Pregnancy|0|||
147362028|NCT03580356|531497416|FG004|Treatment Period|Pregnancy|2|||
147362029|NCT03580356|531497417|FG005|Treatment Period|Pregnancy|0|||
147362030|NCT03580356|531497418|FG006|Treatment Period|Pregnancy|1|||
147362031|NCT03580356|531497419|FG007|Treatment Period|Pregnancy|0|||
147362032|NCT03580356|531497412|FG000|Treatment Period|Physician Decision|2|||
147362033|NCT03580356|531497413|FG001|Treatment Period|Physician Decision|0|||
147362034|NCT03580356|531497414|FG002|Treatment Period|Physician Decision|1|||
147362035|NCT03580356|531497415|FG003|Treatment Period|Physician Decision|0|||
147362036|NCT03580356|531497416|FG004|Treatment Period|Physician Decision|4|||
147362037|NCT03580356|531497417|FG005|Treatment Period|Physician Decision|0|||
147362038|NCT03580356|531497418|FG006|Treatment Period|Physician Decision|2|||
147362039|NCT03580356|531497419|FG007|Treatment Period|Physician Decision|0|||
147362040|NCT03580356|531497412|FG000|Treatment Period|Lost to Follow-up|1|||
147362041|NCT03580356|531497413|FG001|Treatment Period|Lost to Follow-up|1|||
147362042|NCT03580356|531497414|FG002|Treatment Period|Lost to Follow-up|1|||
147362043|NCT03580356|531497415|FG003|Treatment Period|Lost to Follow-up|0|||
147362044|NCT03580356|531497416|FG004|Treatment Period|Lost to Follow-up|3|||
147362045|NCT03580356|531497417|FG005|Treatment Period|Lost to Follow-up|0|||
147362046|NCT03580356|531497418|FG006|Treatment Period|Lost to Follow-up|1|||
147362047|NCT03580356|531497419|FG007|Treatment Period|Lost to Follow-up|0|||
147362048|NCT03580356|531497412|FG000|Treatment Period|Death|0|||
147362049|NCT03580356|531497413|FG001|Treatment Period|Death|0|||
147362050|NCT03580356|531497414|FG002|Treatment Period|Death|1|||
147362051|NCT03580356|531497415|FG003|Treatment Period|Death|0|||
147362052|NCT03580356|531497416|FG004|Treatment Period|Death|0|||
147362053|NCT03580356|531497417|FG005|Treatment Period|Death|0|||
147362054|NCT03580356|531497418|FG006|Treatment Period|Death|0|||
147362055|NCT03580356|531497419|FG007|Treatment Period|Death|0|||
147362056|NCT03580356|531497412|FG000|Treatment Period|Technical problems|0|||
147362057|NCT03580356|531497413|FG001|Treatment Period|Technical problems|0|||
147362058|NCT03580356|531497414|FG002|Treatment Period|Technical problems|0|||
147362059|NCT03580356|531497415|FG003|Treatment Period|Technical problems|0|||
147362060|NCT03580356|531497416|FG004|Treatment Period|Technical problems|1|||
147362061|NCT03580356|531497417|FG005|Treatment Period|Technical problems|0|||
147362062|NCT03580356|531497418|FG006|Treatment Period|Technical problems|0|||
147608469|NCT01890434|532382646|FG000|Overall Study|Unable to contact|1|||
147608470|NCT01890434|532382646|FG000|Overall Study|Withdrawal by PI for ICA not performed|2|||
147608471|NCT01267994|532382647|FG000|Overall Study|Adverse Event|2|||
147608472|NCT04868968|532382650|FG000|Overall Study|Lost to Follow-up|1|||
147608473|NCT03276078|532382651|FG000|Overall Study|Adverse Event|1|||
147608474|NCT02552732|532382652|FG000|Overall Study|Lost to Follow-up|2|||
147608475|NCT02552732|532382652|FG000|Overall Study|Physician Decision|1|||
147608476|NCT02552732|532382652|FG000|Overall Study|Day 1 SpO2 > 96%|1|||
147608477|NCT02552732|532382652|FG000|Overall Study|Withdrawal by Subject|6|||
147608478|NCT01275430|532382654|FG000|Overall Study|Adverse Event|1|||
147608479|NCT01275430|532382654|FG000|Overall Study|No Contrast Injection|6|||
147608480|NCT01275430|532382654|FG000|Overall Study|Device Malfunction|1|||
147608481|NCT01275430|532382654|FG000|Overall Study|Inability to achieve maximum p-wave|1|||
147608482|NCT02613182|532382655|FG000|Overall Study|Death|6|||
147608483|NCT02613182|532382655|FG000|Overall Study|Physician Decision|1|||
147608484|NCT02613182|532382655|FG000|Overall Study|Study Terminated by Sponsor|21|||
147608485|NCT02613182|532382655|FG000|Overall Study|Withdrawal by Subject|6|||
147608486|NCT00863772|532382659|FG000|Overall Study|Adverse Event|1|||
147608487|NCT00863772|532382660|FG001|Overall Study|Adverse Event|4|||
147608488|NCT00863772|532382661|FG002|Overall Study|Adverse Event|0|||
147608489|NCT00863772|532382659|FG000|Overall Study|Lack of Efficacy|4|||
147608490|NCT00863772|532382660|FG001|Overall Study|Lack of Efficacy|2|||
147608491|NCT00863772|532382661|FG002|Overall Study|Lack of Efficacy|4|||
147608492|NCT00863772|532382659|FG000|Overall Study|Lost to Follow-up|5|||
147608493|NCT00863772|532382660|FG001|Overall Study|Lost to Follow-up|1|||
147608494|NCT00863772|532382661|FG002|Overall Study|Lost to Follow-up|1|||
147608495|NCT00863772|532382659|FG000|Overall Study|Protocol Violation|2|||
147608496|NCT00863772|532382660|FG001|Overall Study|Protocol Violation|0|||
147608497|NCT00863772|532382661|FG002|Overall Study|Protocol Violation|2|||
147608498|NCT00863772|532382659|FG000|Overall Study|Withdrawal by Subject|4|||
147608499|NCT00863772|532382660|FG001|Overall Study|Withdrawal by Subject|7|||
147608500|NCT00863772|532382661|FG002|Overall Study|Withdrawal by Subject|5|||
147608501|NCT00863772|532382659|FG000|Overall Study|Study terminated by sponsor|44|||
147608502|NCT00863772|532382660|FG001|Overall Study|Study terminated by sponsor|45|||
147608503|NCT00863772|532382661|FG002|Overall Study|Study terminated by sponsor|36|||
147608504|NCT00863772|532382659|FG000|Overall Study|Entered extension study|6|||
147608505|NCT00863772|532382660|FG001|Overall Study|Entered extension study|4|||
147608506|NCT00863772|532382661|FG002|Overall Study|Entered extension study|9|||
147608507|NCT00863772|532382659|FG000|Overall Study|Other|1|||
147608508|NCT00863772|532382660|FG001|Overall Study|Other|2|||
147608509|NCT00863772|532382661|FG002|Overall Study|Other|4|||
147362063|NCT03580356|531497419|FG007|Treatment Period|Technical problems|0|||
147362064|NCT03580356|531497412|FG000|Treatment Period|Misrandomized, no treatment|0|||
147362065|NCT03580356|531497413|FG001|Treatment Period|Misrandomized, no treatment|0|||
147362066|NCT03580356|531497414|FG002|Treatment Period|Misrandomized, no treatment|1|||
147362067|NCT03580356|531497415|FG003|Treatment Period|Misrandomized, no treatment|0|||
147362068|NCT03580356|531497416|FG004|Treatment Period|Misrandomized, no treatment|2|||
147362069|NCT03580356|531497417|FG005|Treatment Period|Misrandomized, no treatment|0|||
147362070|NCT03580356|531497418|FG006|Treatment Period|Misrandomized, no treatment|0|||
147362071|NCT03580356|531497419|FG007|Treatment Period|Misrandomized, no treatment|0|||
147362072|NCT03580356|531497412|FG000|Post-treatment Follow Up Period|Withdrawal by Subject|6|||
147362073|NCT03580356|531497413|FG001|Post-treatment Follow Up Period|Withdrawal by Subject|0|||
147362074|NCT03580356|531497414|FG002|Post-treatment Follow Up Period|Withdrawal by Subject|12|||
147362075|NCT03580356|531497415|FG003|Post-treatment Follow Up Period|Withdrawal by Subject|1|||
147362076|NCT03580356|531497416|FG004|Post-treatment Follow Up Period|Withdrawal by Subject|4|||
147362077|NCT03580356|531497417|FG005|Post-treatment Follow Up Period|Withdrawal by Subject|0|||
147362078|NCT03580356|531497418|FG006|Post-treatment Follow Up Period|Withdrawal by Subject|6|||
147362079|NCT03580356|531497419|FG007|Post-treatment Follow Up Period|Withdrawal by Subject|1|||
147362080|NCT03580356|531497412|FG000|Post-treatment Follow Up Period|Lost to Follow-up|3|||
147362081|NCT03580356|531497413|FG001|Post-treatment Follow Up Period|Lost to Follow-up|0|||
147362082|NCT03580356|531497414|FG002|Post-treatment Follow Up Period|Lost to Follow-up|2|||
147362083|NCT03580356|531497415|FG003|Post-treatment Follow Up Period|Lost to Follow-up|0|||
147608510|NCT00863772|532382659|FG000|Overall Study|Randomized but not Treated|1|||
147608511|NCT00863772|532382660|FG001|Overall Study|Randomized but not Treated|0|||
147608512|NCT00863772|532382661|FG002|Overall Study|Randomized but not Treated|0|||
147362084|NCT03580356|531497416|FG004|Post-treatment Follow Up Period|Lost to Follow-up|1|||
147362085|NCT03580356|531497417|FG005|Post-treatment Follow Up Period|Lost to Follow-up|0|||
147608513|NCT00086281|532382662|FG000|Phase 1|Adverse Event|0|||
147608514|NCT00086281|532382663|FG001|Phase 1|Adverse Event|0|||
147608515|NCT00086281|532382664|FG002|Phase 1|Adverse Event|0|||
147608516|NCT00086281|532382665|FG003|Phase 1|Adverse Event|0|||
147608517|NCT00086281|532382666|FG004|Phase 1|Adverse Event|0|||
147608518|NCT00086281|532382667|FG005|Phase 1|Adverse Event|0|||
147608519|NCT00086281|532382668|FG006|Phase 1|Adverse Event|0|||
147608520|NCT00086281|532382669|FG007|Phase 1|Adverse Event|0|||
147608521|NCT00086281|532382670|FG008|Phase 1|Adverse Event|0|||
147608522|NCT00086281|532382671|FG009|Phase 1|Adverse Event|1|||
147608523|NCT00086281|532382672|FG010|Phase 1|Adverse Event|2|||
147608524|NCT00086281|532382673|FG011|Phase 1|Adverse Event|1|||
147608525|NCT00086281|532382674|FG012|Phase 1|Adverse Event|1|||
147608526|NCT00086281|532382675|FG013|Phase 1|Adverse Event|1|||
147608527|NCT00086281|532382676|FG014|Phase 1|Adverse Event|2|||
147608528|NCT00086281|532382662|FG000|Phase 1|Protocol Violation|0|||
147608529|NCT00086281|532382663|FG001|Phase 1|Protocol Violation|0|||
147608530|NCT00086281|532382664|FG002|Phase 1|Protocol Violation|0|||
147608531|NCT00086281|532382665|FG003|Phase 1|Protocol Violation|0|||
147608532|NCT00086281|532382666|FG004|Phase 1|Protocol Violation|0|||
147608533|NCT00086281|532382667|FG005|Phase 1|Protocol Violation|0|||
147608534|NCT00086281|532382668|FG006|Phase 1|Protocol Violation|0|||
147608535|NCT00086281|532382669|FG007|Phase 1|Protocol Violation|0|||
147608536|NCT00086281|532382670|FG008|Phase 1|Protocol Violation|0|||
147608537|NCT00086281|532382671|FG009|Phase 1|Protocol Violation|0|||
147608538|NCT00086281|532382672|FG010|Phase 1|Protocol Violation|1|||
147608539|NCT00086281|532382673|FG011|Phase 1|Protocol Violation|0|||
147608540|NCT00086281|532382674|FG012|Phase 1|Protocol Violation|0|||
147608541|NCT00086281|532382675|FG013|Phase 1|Protocol Violation|0|||
147608542|NCT00086281|532382676|FG014|Phase 1|Protocol Violation|0|||
147608543|NCT00086281|532382662|FG000|Phase 1|Serious Adverse Event|0|||
147608544|NCT00086281|532382663|FG001|Phase 1|Serious Adverse Event|0|||
147608545|NCT00086281|532382664|FG002|Phase 1|Serious Adverse Event|0|||
147608546|NCT00086281|532382665|FG003|Phase 1|Serious Adverse Event|0|||
147608547|NCT00086281|532382666|FG004|Phase 1|Serious Adverse Event|0|||
147608548|NCT00086281|532382667|FG005|Phase 1|Serious Adverse Event|0|||
147608549|NCT00086281|532382668|FG006|Phase 1|Serious Adverse Event|0|||
147608550|NCT00086281|532382669|FG007|Phase 1|Serious Adverse Event|0|||
147608551|NCT00086281|532382670|FG008|Phase 1|Serious Adverse Event|0|||
147608552|NCT00086281|532382671|FG009|Phase 1|Serious Adverse Event|0|||
147608553|NCT00086281|532382672|FG010|Phase 1|Serious Adverse Event|0|||
147608554|NCT00086281|532382673|FG011|Phase 1|Serious Adverse Event|0|||
147608555|NCT00086281|532382674|FG012|Phase 1|Serious Adverse Event|0|||
147608556|NCT00086281|532382675|FG013|Phase 1|Serious Adverse Event|0|||
147362086|NCT03580356|531497418|FG006|Post-treatment Follow Up Period|Lost to Follow-up|0|||
147362087|NCT03580356|531497419|FG007|Post-treatment Follow Up Period|Lost to Follow-up|0|||
147362088|NCT03580356|531497412|FG000|Post-treatment Follow Up Period|Adverse Event|1|||
147362089|NCT03580356|531497413|FG001|Post-treatment Follow Up Period|Adverse Event|0|||
147362090|NCT03580356|531497414|FG002|Post-treatment Follow Up Period|Adverse Event|3|||
147362091|NCT03580356|531497415|FG003|Post-treatment Follow Up Period|Adverse Event|0|||
147362092|NCT03580356|531497416|FG004|Post-treatment Follow Up Period|Adverse Event|0|||
147362093|NCT03580356|531497417|FG005|Post-treatment Follow Up Period|Adverse Event|0|||
147362094|NCT03580356|531497418|FG006|Post-treatment Follow Up Period|Adverse Event|0|||
147362095|NCT03580356|531497419|FG007|Post-treatment Follow Up Period|Adverse Event|0|||
147362096|NCT03580356|531497412|FG000|Post-treatment Follow Up Period|Lack of Efficacy|0|||
147362097|NCT03580356|531497413|FG001|Post-treatment Follow Up Period|Lack of Efficacy|0|||
147362098|NCT03580356|531497414|FG002|Post-treatment Follow Up Period|Lack of Efficacy|1|||
147362099|NCT03580356|531497415|FG003|Post-treatment Follow Up Period|Lack of Efficacy|0|||
147362100|NCT03580356|531497416|FG004|Post-treatment Follow Up Period|Lack of Efficacy|1|||
147362101|NCT03580356|531497417|FG005|Post-treatment Follow Up Period|Lack of Efficacy|0|||
147362102|NCT03580356|531497418|FG006|Post-treatment Follow Up Period|Lack of Efficacy|0|||
147362103|NCT03580356|531497419|FG007|Post-treatment Follow Up Period|Lack of Efficacy|0|||
147362104|NCT03580356|531497412|FG000|Post-treatment Follow Up Period|Protocol Violation|1|||
147362105|NCT03580356|531497413|FG001|Post-treatment Follow Up Period|Protocol Violation|0|||
147362106|NCT03580356|531497414|FG002|Post-treatment Follow Up Period|Protocol Violation|1|||
147362107|NCT03580356|531497415|FG003|Post-treatment Follow Up Period|Protocol Violation|0|||
147362108|NCT03580356|531497416|FG004|Post-treatment Follow Up Period|Protocol Violation|0|||
147362109|NCT03580356|531497417|FG005|Post-treatment Follow Up Period|Protocol Violation|0|||
147362110|NCT03580356|531497418|FG006|Post-treatment Follow Up Period|Protocol Violation|0|||
147362111|NCT03580356|531497419|FG007|Post-treatment Follow Up Period|Protocol Violation|0|||
147362112|NCT03580356|531497412|FG000|Post-treatment Follow Up Period|Physician Decision|0|||
147362113|NCT03580356|531497413|FG001|Post-treatment Follow Up Period|Physician Decision|0|||
147362114|NCT03580356|531497414|FG002|Post-treatment Follow Up Period|Physician Decision|0|||
147608557|NCT00086281|532382676|FG014|Phase 1|Serious Adverse Event|1|||
147608558|NCT00086281|532382662|FG000|Phase 2|Adverse Event|0|||
147608559|NCT00086281|532382663|FG001|Phase 2|Adverse Event|0|||
147608560|NCT00086281|532382664|FG002|Phase 2|Adverse Event|0|||
147454207|NCT04179175|531825556|FG004|Overall Study|Lack of Efficacy|18|||
147608561|NCT00086281|532382665|FG003|Phase 2|Adverse Event|0|||
147608562|NCT00086281|532382666|FG004|Phase 2|Adverse Event|0|||
147608563|NCT00086281|532382667|FG005|Phase 2|Adverse Event|0|||
147608564|NCT00086281|532382668|FG006|Phase 2|Adverse Event|0|||
147608565|NCT00086281|532382669|FG007|Phase 2|Adverse Event|0|||
147608566|NCT00086281|532382670|FG008|Phase 2|Adverse Event|0|||
147608567|NCT00086281|532382671|FG009|Phase 2|Adverse Event|0|||
147608568|NCT00086281|532382672|FG010|Phase 2|Adverse Event|0|||
147362115|NCT03580356|531497415|FG003|Post-treatment Follow Up Period|Physician Decision|0|||
147362116|NCT03580356|531497416|FG004|Post-treatment Follow Up Period|Physician Decision|0|||
147362117|NCT03580356|531497417|FG005|Post-treatment Follow Up Period|Physician Decision|0|||
147362118|NCT03580356|531497418|FG006|Post-treatment Follow Up Period|Physician Decision|1|||
147362119|NCT03580356|531497419|FG007|Post-treatment Follow Up Period|Physician Decision|0|||
147362120|NCT03580356|531497412|FG000|Post-treatment Follow Up Period|Pregnancy|1|||
147362121|NCT03580356|531497413|FG001|Post-treatment Follow Up Period|Pregnancy|0|||
147362122|NCT03580356|531497414|FG002|Post-treatment Follow Up Period|Pregnancy|0|||
147362123|NCT03580356|531497415|FG003|Post-treatment Follow Up Period|Pregnancy|0|||
147362124|NCT03580356|531497416|FG004|Post-treatment Follow Up Period|Pregnancy|0|||
147362125|NCT03580356|531497417|FG005|Post-treatment Follow Up Period|Pregnancy|0|||
147362126|NCT03580356|531497418|FG006|Post-treatment Follow Up Period|Pregnancy|0|||
147362127|NCT03580356|531497419|FG007|Post-treatment Follow Up Period|Pregnancy|0|||
147362128|NCT02834390|531497420|FG000|Induction Phase|Progressive disease|0|||
147362129|NCT02834390|531497421|FG001|Induction Phase|Progressive disease|1|||
147362130|NCT02834390|531497420|FG000|Induction Phase|CR, CRp, or CRi not achieved (Induction Cycle 2)|2|||
147362131|NCT02834390|531497421|FG001|Induction Phase|CR, CRp, or CRi not achieved (Induction Cycle 2)|0|||
147362132|NCT02834390|531497420|FG000|Induction Phase|Relapse after CR, CRp, or CRi|0|||
147362133|NCT02834390|531497421|FG001|Induction Phase|Relapse after CR, CRp, or CRi|1|||
147362134|NCT02834390|531497420|FG000|Consolidation Phase|Physician Decision|1|||
147362135|NCT02834390|531497421|FG001|Consolidation Phase|Physician Decision|1|||
147362136|NCT03536884|531497427|FG000|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|8|||
147362137|NCT03536884|531497428|FG001|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|6|||
147362138|NCT03536884|531497429|FG002|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
147362139|NCT03536884|531497430|FG003|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
147362140|NCT03536884|531497431|FG004|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
147362141|NCT03536884|531497432|FG005|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
147362142|NCT03536884|531497433|FG006|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
147362143|NCT03536884|531497434|FG007|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
147362144|NCT03536884|531497435|FG008|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
147362145|NCT03536884|531497436|FG009|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
147362146|NCT03536884|531497437|FG010|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
147362147|NCT03536884|531497438|FG011|Double-Blind (DB) Period: ITP Wk 0-16|Adverse Event|0|||
147362148|NCT03536884|531497427|FG000|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
147362149|NCT03536884|531497428|FG001|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|3|||
147362150|NCT03536884|531497429|FG002|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
147362151|NCT03536884|531497430|FG003|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
147362152|NCT03536884|531497431|FG004|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
147362153|NCT03536884|531497432|FG005|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
147362154|NCT03536884|531497433|FG006|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
147362155|NCT03536884|531497434|FG007|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
147362156|NCT03536884|531497435|FG008|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
147362157|NCT03536884|531497436|FG009|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
147362158|NCT03536884|531497437|FG010|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
147362159|NCT03536884|531497438|FG011|Double-Blind (DB) Period: ITP Wk 0-16|Lost to Follow-up|0|||
147362160|NCT03536884|531497427|FG000|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|3|||
147362161|NCT03536884|531497428|FG001|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|4|||
147362162|NCT03536884|531497429|FG002|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
147608569|NCT00086281|532382673|FG011|Phase 2|Adverse Event|0|||
147362163|NCT03536884|531497430|FG003|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
147362164|NCT03536884|531497431|FG004|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
147362165|NCT03536884|531497432|FG005|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
147362166|NCT03536884|531497433|FG006|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
147362167|NCT03536884|531497434|FG007|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
147362168|NCT03536884|531497435|FG008|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
147362169|NCT03536884|531497436|FG009|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
147362170|NCT03536884|531497437|FG010|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
147362171|NCT03536884|531497438|FG011|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawal by Subject|0|||
147362172|NCT03536884|531497427|FG000|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
147362173|NCT03536884|531497428|FG001|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|1|||
147362174|NCT03536884|531497429|FG002|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
147362175|NCT03536884|531497430|FG003|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
147362176|NCT03536884|531497431|FG004|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
147362177|NCT03536884|531497432|FG005|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
147608570|NCT00086281|532382674|FG012|Phase 2|Adverse Event|1|||
147608571|NCT00086281|532382675|FG013|Phase 2|Adverse Event|1|||
147608572|NCT00086281|532382676|FG014|Phase 2|Adverse Event|0|||
147608573|NCT03456453|532382679|FG000|Overall Study|Withdrawal by Subject|2|||
147608574|NCT03456453|532382680|FG001|Overall Study|Withdrawal by Subject|0|||
147608575|NCT03456453|532382679|FG000|Overall Study|Not released to community|1|||
147608576|NCT03456453|532382680|FG001|Overall Study|Not released to community|5|||
147608577|NCT03456453|532382679|FG000|Overall Study|Lost to Follow-up|0|||
147608578|NCT03456453|532382680|FG001|Overall Study|Lost to Follow-up|2|||
147608579|NCT00896480|532382681|FG000|Overall Study|Disease progression/recurrence|21|||
147608580|NCT04784533|532382682|FG000|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|6|||
147608581|NCT04784533|532382683|FG001|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|3|||
147608582|NCT04784533|532382684|FG002|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
147608583|NCT04784533|532382685|FG003|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
147608584|NCT04784533|532382686|FG004|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
147608585|NCT04784533|532382687|FG005|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
147608586|NCT04784533|532382688|FG006|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
147362178|NCT03536884|531497433|FG006|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
147362179|NCT03536884|531497434|FG007|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
147362180|NCT03536884|531497435|FG008|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
147362181|NCT03536884|531497436|FG009|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
147362182|NCT03536884|531497437|FG010|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
147362183|NCT03536884|531497438|FG011|Double-Blind (DB) Period: ITP Wk 0-16|Unblinding was reason for dropout|0|||
147362184|NCT03536884|531497427|FG000|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
147362185|NCT03536884|531497428|FG001|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|1|||
147362186|NCT03536884|531497429|FG002|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
147362187|NCT03536884|531497430|FG003|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
147362188|NCT03536884|531497431|FG004|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
147362189|NCT03536884|531497432|FG005|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
147362190|NCT03536884|531497433|FG006|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
147362191|NCT03536884|531497434|FG007|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
147362192|NCT03536884|531497435|FG008|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
147362193|NCT03536884|531497436|FG009|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
147362194|NCT03536884|531497437|FG010|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
147362195|NCT03536884|531497438|FG011|Double-Blind (DB) Period: ITP Wk 0-16|Withdrawn by Investigator for abnormal lab values|0|||
147362196|NCT03536884|531497427|FG000|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
147362197|NCT03536884|531497428|FG001|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|1|||
147362198|NCT03536884|531497429|FG002|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
147362199|NCT03536884|531497430|FG003|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
147362200|NCT03536884|531497431|FG004|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
147362201|NCT03536884|531497432|FG005|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
147362202|NCT03536884|531497433|FG006|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
147362203|NCT03536884|531497434|FG007|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
147362204|NCT03536884|531497435|FG008|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
147362205|NCT03536884|531497436|FG009|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
147362206|NCT03536884|531497437|FG010|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
147362207|NCT03536884|531497438|FG011|Double-Blind (DB) Period: ITP Wk 0-16|Unable to attend visits|0|||
147362208|NCT03536884|531497427|FG000|Double-Blind Period: MTP Wk 16-48|Death|0|||
147362209|NCT03536884|531497428|FG001|Double-Blind Period: MTP Wk 16-48|Death|0|||
147362210|NCT03536884|531497429|FG002|Double-Blind Period: MTP Wk 16-48|Death|1|||
147362211|NCT03536884|531497430|FG003|Double-Blind Period: MTP Wk 16-48|Death|0|||
147362212|NCT03536884|531497431|FG004|Double-Blind Period: MTP Wk 16-48|Death|1|||
147362213|NCT03536884|531497432|FG005|Double-Blind Period: MTP Wk 16-48|Death|0|||
147362214|NCT03536884|531497433|FG006|Double-Blind Period: MTP Wk 16-48|Death|0|||
147362215|NCT03536884|531497434|FG007|Double-Blind Period: MTP Wk 16-48|Death|0|||
147362216|NCT03536884|531497435|FG008|Double-Blind Period: MTP Wk 16-48|Death|0|||
147362217|NCT03536884|531497436|FG009|Double-Blind Period: MTP Wk 16-48|Death|0|||
147362218|NCT03536884|531497437|FG010|Double-Blind Period: MTP Wk 16-48|Death|0|||
147362219|NCT03536884|531497438|FG011|Double-Blind Period: MTP Wk 16-48|Death|0|||
147362220|NCT03536884|531497427|FG000|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
147362221|NCT03536884|531497428|FG001|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
147362222|NCT03536884|531497429|FG002|Double-Blind Period: MTP Wk 16-48|Adverse Event|1|||
147362223|NCT03536884|531497430|FG003|Double-Blind Period: MTP Wk 16-48|Adverse Event|3|||
147454208|NCT04179175|531825557|FG005|Overall Study|Lack of Efficacy|7|||
147362224|NCT03536884|531497431|FG004|Double-Blind Period: MTP Wk 16-48|Adverse Event|3|||
147362225|NCT03536884|531497432|FG005|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
147362226|NCT03536884|531497433|FG006|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
147362227|NCT03536884|531497434|FG007|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
147362228|NCT03536884|531497435|FG008|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
147362229|NCT03536884|531497436|FG009|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
147362230|NCT03536884|531497437|FG010|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
147362231|NCT03536884|531497438|FG011|Double-Blind Period: MTP Wk 16-48|Adverse Event|0|||
147362232|NCT03536884|531497427|FG000|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
147362233|NCT03536884|531497428|FG001|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
147362234|NCT03536884|531497429|FG002|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
147362235|NCT03536884|531497430|FG003|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|1|||
147362236|NCT03536884|531497431|FG004|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|4|||
147362237|NCT03536884|531497432|FG005|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
147362238|NCT03536884|531497433|FG006|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
147362239|NCT03536884|531497434|FG007|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
147362240|NCT03536884|531497435|FG008|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
147362241|NCT03536884|531497436|FG009|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
147362242|NCT03536884|531497437|FG010|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
147362243|NCT03536884|531497438|FG011|Double-Blind Period: MTP Wk 16-48|Lack of Efficacy|0|||
147362244|NCT03536884|531497427|FG000|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
147362245|NCT03536884|531497428|FG001|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
147362246|NCT03536884|531497429|FG002|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|1|||
147362247|NCT03536884|531497430|FG003|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|2|||
147362248|NCT03536884|531497431|FG004|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|9|||
147362249|NCT03536884|531497432|FG005|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
147362250|NCT03536884|531497433|FG006|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
147362251|NCT03536884|531497434|FG007|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
147362252|NCT03536884|531497435|FG008|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
147362253|NCT03536884|531497436|FG009|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
147362254|NCT03536884|531497437|FG010|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
147362255|NCT03536884|531497438|FG011|Double-Blind Period: MTP Wk 16-48|Lost to Follow-up|0|||
147362256|NCT03536884|531497427|FG000|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
147362257|NCT03536884|531497428|FG001|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
147362258|NCT03536884|531497429|FG002|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|7|||
147362259|NCT03536884|531497430|FG003|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|3|||
147362260|NCT03536884|531497431|FG004|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|12|||
147362261|NCT03536884|531497432|FG005|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
147362262|NCT03536884|531497433|FG006|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
147362263|NCT03536884|531497434|FG007|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
147362264|NCT03536884|531497435|FG008|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
147362265|NCT03536884|531497436|FG009|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
147362266|NCT03536884|531497437|FG010|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
147362267|NCT03536884|531497438|FG011|Double-Blind Period: MTP Wk 16-48|Withdrawal by Subject|0|||
147362268|NCT03536884|531497427|FG000|OLE Period: Wk48-Wk144|Adverse Event|0|||
147362269|NCT03536884|531497428|FG001|OLE Period: Wk48-Wk144|Adverse Event|0|||
147362270|NCT03536884|531497429|FG002|OLE Period: Wk48-Wk144|Adverse Event|0|||
147362271|NCT03536884|531497430|FG003|OLE Period: Wk48-Wk144|Adverse Event|0|||
147608587|NCT04784533|532382689|FG007|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
147608588|NCT04784533|532382690|FG008|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
147608589|NCT04784533|532382691|FG009|Part A: Period 1 (Day 1 to Week 24)|Treatment Emergent or Worsening Adverse Event|0|||
147608590|NCT04784533|532382682|FG000|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|1|||
147608591|NCT04784533|532382683|FG001|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|1|||
147608592|NCT04784533|532382684|FG002|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
147608593|NCT04784533|532382685|FG003|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
147608594|NCT04784533|532382686|FG004|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
147362272|NCT03536884|531497431|FG004|OLE Period: Wk48-Wk144|Adverse Event|0|||
147362273|NCT03536884|531497432|FG005|OLE Period: Wk48-Wk144|Adverse Event|10|||
147362274|NCT03536884|531497433|FG006|OLE Period: Wk48-Wk144|Adverse Event|8|||
147362275|NCT03536884|531497434|FG007|OLE Period: Wk48-Wk144|Adverse Event|6|||
147362276|NCT03536884|531497435|FG008|OLE Period: Wk48-Wk144|Adverse Event|13|||
147362277|NCT03536884|531497436|FG009|OLE Period: Wk48-Wk144|Adverse Event|0|||
147362278|NCT03536884|531497437|FG010|OLE Period: Wk48-Wk144|Adverse Event|0|||
147362279|NCT03536884|531497438|FG011|OLE Period: Wk48-Wk144|Adverse Event|0|||
147362280|NCT03536884|531497427|FG000|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
147362281|NCT03536884|531497428|FG001|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
147362282|NCT03536884|531497429|FG002|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
147362283|NCT03536884|531497430|FG003|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
147362284|NCT03536884|531497431|FG004|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
147362285|NCT03536884|531497432|FG005|OLE Period: Wk48-Wk144|Lack of Efficacy|1|||
147362286|NCT03536884|531497433|FG006|OLE Period: Wk48-Wk144|Lack of Efficacy|1|||
147362287|NCT03536884|531497434|FG007|OLE Period: Wk48-Wk144|Lack of Efficacy|1|||
147362288|NCT03536884|531497435|FG008|OLE Period: Wk48-Wk144|Lack of Efficacy|4|||
147362289|NCT03536884|531497436|FG009|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
147362290|NCT03536884|531497437|FG010|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
147362291|NCT03536884|531497438|FG011|OLE Period: Wk48-Wk144|Lack of Efficacy|0|||
147362292|NCT03536884|531497427|FG000|OLE Period: Wk48-Wk144|Protocol Violation|0|||
147362293|NCT03536884|531497428|FG001|OLE Period: Wk48-Wk144|Protocol Violation|0|||
147362294|NCT03536884|531497429|FG002|OLE Period: Wk48-Wk144|Protocol Violation|0|||
147362295|NCT03536884|531497430|FG003|OLE Period: Wk48-Wk144|Protocol Violation|0|||
147362296|NCT03536884|531497431|FG004|OLE Period: Wk48-Wk144|Protocol Violation|0|||
147362297|NCT03536884|531497432|FG005|OLE Period: Wk48-Wk144|Protocol Violation|1|||
147362298|NCT03536884|531497433|FG006|OLE Period: Wk48-Wk144|Protocol Violation|0|||
147362299|NCT03536884|531497434|FG007|OLE Period: Wk48-Wk144|Protocol Violation|2|||
147362300|NCT03536884|531497435|FG008|OLE Period: Wk48-Wk144|Protocol Violation|0|||
147362301|NCT03536884|531497436|FG009|OLE Period: Wk48-Wk144|Protocol Violation|0|||
147362302|NCT03536884|531497437|FG010|OLE Period: Wk48-Wk144|Protocol Violation|0|||
147362303|NCT03536884|531497438|FG011|OLE Period: Wk48-Wk144|Protocol Violation|0|||
147362304|NCT03536884|531497427|FG000|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
147362305|NCT03536884|531497428|FG001|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
147362306|NCT03536884|531497429|FG002|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
147362307|NCT03536884|531497430|FG003|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
147362308|NCT03536884|531497431|FG004|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
147362309|NCT03536884|531497432|FG005|OLE Period: Wk48-Wk144|Lost to Follow-up|7|||
147362310|NCT03536884|531497433|FG006|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
147362311|NCT03536884|531497434|FG007|OLE Period: Wk48-Wk144|Lost to Follow-up|1|||
147362312|NCT03536884|531497435|FG008|OLE Period: Wk48-Wk144|Lost to Follow-up|5|||
147362313|NCT03536884|531497436|FG009|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
147362314|NCT03536884|531497437|FG010|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
147362315|NCT03536884|531497438|FG011|OLE Period: Wk48-Wk144|Lost to Follow-up|0|||
147362316|NCT03536884|531497427|FG000|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
147362317|NCT03536884|531497428|FG001|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
147362318|NCT03536884|531497429|FG002|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
147362319|NCT03536884|531497430|FG003|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
147362320|NCT03536884|531497431|FG004|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
147362321|NCT03536884|531497432|FG005|OLE Period: Wk48-Wk144|Withdrawal by Subject|12|||
147362322|NCT03536884|531497433|FG006|OLE Period: Wk48-Wk144|Withdrawal by Subject|7|||
147362323|NCT03536884|531497434|FG007|OLE Period: Wk48-Wk144|Withdrawal by Subject|6|||
147362324|NCT03536884|531497435|FG008|OLE Period: Wk48-Wk144|Withdrawal by Subject|6|||
147362325|NCT03536884|531497436|FG009|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
147362326|NCT03536884|531497437|FG010|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
147362327|NCT03536884|531497438|FG011|OLE Period: Wk48-Wk144|Withdrawal by Subject|0|||
147362328|NCT03536884|531497427|FG000|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
147362329|NCT03536884|531497428|FG001|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
147362330|NCT03536884|531497429|FG002|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
147362331|NCT03536884|531497430|FG003|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
147362332|NCT03536884|531497431|FG004|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
147362333|NCT03536884|531497432|FG005|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|1|||
147362334|NCT03536884|531497433|FG006|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
147362335|NCT03536884|531497434|FG007|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
147362336|NCT03536884|531497435|FG008|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
147362337|NCT03536884|531497436|FG009|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
147362338|NCT03536884|531497437|FG010|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
147362339|NCT03536884|531497438|FG011|OLE Period: Wk48-Wk144|Not dosing for over 6 Months while out of country|0|||
147362340|NCT03536884|531497427|FG000|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
147362341|NCT03536884|531497428|FG001|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
147362342|NCT03536884|531497429|FG002|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
147362343|NCT03536884|531497430|FG003|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
147362344|NCT03536884|531497431|FG004|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
147362345|NCT03536884|531497432|FG005|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
147362346|NCT03536884|531497433|FG006|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|1|||
147362347|NCT03536884|531497434|FG007|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
147362348|NCT03536884|531497435|FG008|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
147362349|NCT03536884|531497436|FG009|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
147454209|NCT04179175|531825552|FG000|Overall Study|Lost to Follow-up|5|||
147362350|NCT03536884|531497437|FG010|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
147362351|NCT03536884|531497438|FG011|OLE Period: Wk48-Wk144|Patient held IP due to pandemic, not restarted|0|||
147362352|NCT03536884|531497427|FG000|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
147362353|NCT03536884|531497428|FG001|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
147362354|NCT03536884|531497429|FG002|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
147362355|NCT03536884|531497430|FG003|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
147362356|NCT03536884|531497431|FG004|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
147362357|NCT03536884|531497432|FG005|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
147362358|NCT03536884|531497433|FG006|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|1|||
147362359|NCT03536884|531497434|FG007|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
147362360|NCT03536884|531497435|FG008|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
147362361|NCT03536884|531497436|FG009|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
147362362|NCT03536884|531497437|FG010|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
147362363|NCT03536884|531497438|FG011|OLE Period: Wk48-Wk144|Went to jail, unable to continue study visits|0|||
147362364|NCT03536884|531497427|FG000|OLE Period: Wk48-Wk144|Non-compliance|0|||
147362365|NCT03536884|531497428|FG001|OLE Period: Wk48-Wk144|Non-compliance|0|||
147362366|NCT03536884|531497429|FG002|OLE Period: Wk48-Wk144|Non-compliance|0|||
147362367|NCT03536884|531497430|FG003|OLE Period: Wk48-Wk144|Non-compliance|0|||
147362368|NCT03536884|531497431|FG004|OLE Period: Wk48-Wk144|Non-compliance|0|||
147362369|NCT03536884|531497432|FG005|OLE Period: Wk48-Wk144|Non-compliance|1|||
147362370|NCT03536884|531497433|FG006|OLE Period: Wk48-Wk144|Non-compliance|0|||
147362371|NCT03536884|531497434|FG007|OLE Period: Wk48-Wk144|Non-compliance|0|||
147362372|NCT03536884|531497435|FG008|OLE Period: Wk48-Wk144|Non-compliance|0|||
147362373|NCT03536884|531497436|FG009|OLE Period: Wk48-Wk144|Non-compliance|0|||
147362374|NCT03536884|531497437|FG010|OLE Period: Wk48-Wk144|Non-compliance|0|||
147362375|NCT03536884|531497438|FG011|OLE Period: Wk48-Wk144|Non-compliance|0|||
147362376|NCT03536884|531497427|FG000|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
147362377|NCT03536884|531497428|FG001|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
147362378|NCT03536884|531497429|FG002|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
147362379|NCT03536884|531497430|FG003|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
147362380|NCT03536884|531497431|FG004|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
147362381|NCT03536884|531497432|FG005|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
147362382|NCT03536884|531497433|FG006|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
147362383|NCT03536884|531497434|FG007|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
147362384|NCT03536884|531497435|FG008|OLE Period: Wk48-Wk144|She wants to be pregnant|1|||
147362385|NCT03536884|531497436|FG009|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
147362386|NCT03536884|531497437|FG010|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
147362387|NCT03536884|531497438|FG011|OLE Period: Wk48-Wk144|She wants to be pregnant|0|||
147362388|NCT03536884|531497427|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
147362389|NCT03536884|531497428|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
147362390|NCT03536884|531497429|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
147362391|NCT03536884|531497430|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
147362392|NCT03536884|531497431|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
147362393|NCT03536884|531497432|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
147362394|NCT03536884|531497433|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
147362395|NCT03536884|531497434|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
147362396|NCT03536884|531497435|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
147362397|NCT03536884|531497436|FG009|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|1|||
147362398|NCT03536884|531497437|FG010|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|2|||
147362399|NCT03536884|531497438|FG011|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|1|||
147362400|NCT03536884|531497427|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
147362401|NCT03536884|531497428|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
147362402|NCT03536884|531497429|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
147362403|NCT03536884|531497430|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
147362404|NCT03536884|531497431|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
147362405|NCT03536884|531497432|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
147362406|NCT03536884|531497433|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
147362407|NCT03536884|531497434|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
147362408|NCT03536884|531497435|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
147362409|NCT03536884|531497436|FG009|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|2|||
147362410|NCT03536884|531497437|FG010|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|2|||
147362411|NCT03536884|531497438|FG011|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|2|||
147362412|NCT03536884|531497427|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
147362413|NCT03536884|531497428|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
147362414|NCT03536884|531497429|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
147362415|NCT03536884|531497430|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
147362416|NCT03536884|531497431|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
147362417|NCT03536884|531497432|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
147362418|NCT03536884|531497433|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
147362419|NCT03536884|531497434|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
147362420|NCT03536884|531497435|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
147362421|NCT03536884|531497436|FG009|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
147362422|NCT03536884|531497437|FG010|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|1|||
147362423|NCT03536884|531497438|FG011|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site's business is closing on 30 September 2022|0|||
147362424|NCT03536884|531497427|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
147362425|NCT03536884|531497428|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
147362426|NCT03536884|531497429|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
147362427|NCT03536884|531497430|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
147362428|NCT03536884|531497431|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
147362429|NCT03536884|531497432|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
147362430|NCT03536884|531497433|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
147362431|NCT03536884|531497434|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
147362432|NCT03536884|531497435|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
147362433|NCT03536884|531497436|FG009|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
147362434|NCT03536884|531497437|FG010|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|0|||
147362435|NCT03536884|531497438|FG011|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Site closure|3|||
147362436|NCT03536884|531497427|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
147362437|NCT03536884|531497428|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
147362438|NCT03536884|531497429|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
147362439|NCT03536884|531497430|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
147362440|NCT03536884|531497431|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
147362441|NCT03536884|531497432|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
147362442|NCT03536884|531497433|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
147362443|NCT03536884|531497434|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
147454210|NCT04179175|531825553|FG001|Overall Study|Lost to Follow-up|3|||
147454211|NCT04179175|531825554|FG002|Overall Study|Lost to Follow-up|2|||
147608595|NCT04784533|532382687|FG005|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
147608596|NCT04784533|532382688|FG006|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
147608597|NCT04784533|532382689|FG007|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
147608598|NCT04784533|532382690|FG008|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
147608599|NCT04784533|532382691|FG009|Part A: Period 1 (Day 1 to Week 24)|Lack of Efficacy|0|||
147608600|NCT04784533|532382682|FG000|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
147608601|NCT04784533|532382683|FG001|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|2|||
147608602|NCT04784533|532382684|FG002|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
147608603|NCT04784533|532382685|FG003|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
147608604|NCT04784533|532382686|FG004|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
147608605|NCT04784533|532382687|FG005|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
147608606|NCT04784533|532382688|FG006|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
147608607|NCT04784533|532382689|FG007|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
147608608|NCT04784533|532382690|FG008|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
147608609|NCT04784533|532382691|FG009|Part A: Period 1 (Day 1 to Week 24)|Non-compliance With Study Drug|0|||
147608610|NCT04784533|532382682|FG000|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|1|||
147608611|NCT04784533|532382683|FG001|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
147608612|NCT04784533|532382684|FG002|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
147608613|NCT04784533|532382685|FG003|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
147608614|NCT04784533|532382686|FG004|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
147608615|NCT04784533|532382687|FG005|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
147608616|NCT04784533|532382688|FG006|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
147608617|NCT04784533|532382689|FG007|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
147608618|NCT04784533|532382690|FG008|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
147608619|NCT04784533|532382691|FG009|Part A: Period 1 (Day 1 to Week 24)|Protocol Violation|0|||
147608620|NCT04784533|532382682|FG000|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|5|||
147608621|NCT04784533|532382683|FG001|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|7|||
147608622|NCT04784533|532382684|FG002|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
147608623|NCT04784533|532382685|FG003|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
147608624|NCT04784533|532382686|FG004|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
147608625|NCT04784533|532382687|FG005|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
147362444|NCT03536884|531497435|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
147362445|NCT03536884|531497436|FG009|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
147362446|NCT03536884|531497437|FG010|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|0|||
147362447|NCT03536884|531497438|FG011|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Subject had threatening behavior to site staff|1|||
147362448|NCT00844415|531497459|FG000|Overall Study|Withdrawal by Subject|1|||
147362449|NCT02473445|531497460|FG000|Overall Study|Withdrawal by Subject|2|||
147362450|NCT02473445|531497460|FG000|Overall Study|Sponsor Decision|20|||
147362451|NCT04778410|531497461|FG000|Safety Run-in Period|Death|5|||
147362452|NCT04778410|531497462|FG001|Safety Run-in Period|Death|6|||
147362453|NCT04778410|531497463|FG002|Safety Run-in Period|Death|0|||
147362454|NCT04778410|531497464|FG003|Safety Run-in Period|Death|0|||
147362455|NCT04778410|531497465|FG004|Safety Run-in Period|Death|0|||
147362456|NCT04778410|531497466|FG005|Safety Run-in Period|Death|0|||
147362457|NCT04778410|531497461|FG000|Phase 2 Period|Death|0|||
147362458|NCT04778410|531497462|FG001|Phase 2 Period|Death|0|||
147362459|NCT04778410|531497463|FG002|Phase 2 Period|Death|0|||
147362460|NCT04778410|531497464|FG003|Phase 2 Period|Death|5|||
147362461|NCT04778410|531497465|FG004|Phase 2 Period|Death|18|||
147362462|NCT04778410|531497466|FG005|Phase 2 Period|Death|0|||
147362463|NCT04778410|531497461|FG000|Phase 2 Period|Lost to Follow-up|0|||
147362464|NCT04778410|531497462|FG001|Phase 2 Period|Lost to Follow-up|0|||
147362465|NCT04778410|531497463|FG002|Phase 2 Period|Lost to Follow-up|0|||
147362466|NCT04778410|531497464|FG003|Phase 2 Period|Lost to Follow-up|1|||
147362467|NCT04778410|531497465|FG004|Phase 2 Period|Lost to Follow-up|1|||
147362468|NCT04778410|531497466|FG005|Phase 2 Period|Lost to Follow-up|0|||
147362469|NCT04778410|531497461|FG000|Phase 2 Period|Study Terminated By Sponsor|0|||
147362470|NCT04778410|531497462|FG001|Phase 2 Period|Study Terminated By Sponsor|0|||
147362471|NCT04778410|531497463|FG002|Phase 2 Period|Study Terminated By Sponsor|0|||
147362472|NCT04778410|531497464|FG003|Phase 2 Period|Study Terminated By Sponsor|1|||
147362473|NCT04778410|531497465|FG004|Phase 2 Period|Study Terminated By Sponsor|0|||
147362474|NCT04778410|531497466|FG005|Phase 2 Period|Study Terminated By Sponsor|0|||
147362475|NCT04778410|531497461|FG000|Phase 2 Period|Withdrew Consent|0|||
147362476|NCT04778410|531497462|FG001|Phase 2 Period|Withdrew Consent|0|||
147362477|NCT04778410|531497463|FG002|Phase 2 Period|Withdrew Consent|0|||
147362478|NCT04778410|531497464|FG003|Phase 2 Period|Withdrew Consent|0|||
147362479|NCT04778410|531497465|FG004|Phase 2 Period|Withdrew Consent|2|||
147362480|NCT04778410|531497466|FG005|Phase 2 Period|Withdrew Consent|0|||
147362481|NCT02944968|531497467|FG000|Overall Study|Subject excluded before study procedure|1|||
147362482|NCT02944968|531497467|FG000|Overall Study|Subject didn't meet eligibility criteria|2|||
147362483|NCT00631475|531497468|FG000|Overall Study|Death|18|||
147362484|NCT00631475|531497468|FG000|Overall Study|Adverse Event|14|||
147362485|NCT00631475|531497468|FG000|Overall Study|Withdrew consent|5|||
147362486|NCT00631475|531497468|FG000|Overall Study|Preparation for lung transplant|8|||
147362487|NCT00303459|531497469|FG000|Overall Study|Death|33|||
147362488|NCT00303459|531497470|FG001|Overall Study|Death|44|||
147362489|NCT00303459|531497469|FG000|Overall Study|Withdrawal of consent|32|||
147362490|NCT00303459|531497470|FG001|Overall Study|Withdrawal of consent|26|||
147362491|NCT00303459|531497469|FG000|Overall Study|Lost to Follow-up|5|||
147362492|NCT00303459|531497470|FG001|Overall Study|Lost to Follow-up|4|||
147362493|NCT00303459|531497469|FG000|Overall Study|Administrative reason|7|||
147362494|NCT00303459|531497470|FG001|Overall Study|Administrative reason|7|||
147362495|NCT00303459|531497469|FG000|Overall Study|Decision by the investigator|5|||
147362496|NCT00303459|531497470|FG001|Overall Study|Decision by the investigator|7|||
147362497|NCT00303459|531497469|FG000|Overall Study|Lung transplantation|1|||
147362498|NCT00303459|531497470|FG001|Overall Study|Lung transplantation|1|||
147362499|NCT03691298|531497473|FG000|Overall Study|Lost to Follow-up|8|||
147362500|NCT03691298|531497473|FG000|Overall Study|Sponsor terminated study|2|||
147362501|NCT02492711|531497477|FG000|Overall Study|Adverse Event|9|||
147362502|NCT02492711|531497478|FG001|Overall Study|Adverse Event|9|||
147362503|NCT02492711|531497479|FG002|Overall Study|Adverse Event|2|||
147362504|NCT02492711|531497477|FG000|Overall Study|Death|3|||
147608626|NCT04784533|532382688|FG006|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
147362505|NCT02492711|531497478|FG001|Overall Study|Death|3|||
147362506|NCT02492711|531497479|FG002|Overall Study|Death|0|||
147362507|NCT02492711|531497477|FG000|Overall Study|Withdrawal by Subject|10|||
147362508|NCT02492711|531497478|FG001|Overall Study|Withdrawal by Subject|16|||
147608627|NCT04784533|532382689|FG007|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
147608628|NCT04784533|532382690|FG008|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
147608629|NCT04784533|532382691|FG009|Part A: Period 1 (Day 1 to Week 24)|Reason not Specified|0|||
147362509|NCT02492711|531497479|FG002|Overall Study|Withdrawal by Subject|5|||
147362510|NCT02492711|531497477|FG000|Overall Study|Physician Decision|10|||
147362511|NCT02492711|531497478|FG001|Overall Study|Physician Decision|6|||
147362512|NCT02492711|531497479|FG002|Overall Study|Physician Decision|4|||
147362513|NCT02492711|531497477|FG000|Overall Study|Lost to Follow-up|0|||
147362514|NCT02492711|531497478|FG001|Overall Study|Lost to Follow-up|0|||
147362515|NCT02492711|531497479|FG002|Overall Study|Lost to Follow-up|1|||
147362516|NCT02492711|531497477|FG000|Overall Study|study treatment delay|2|||
147362517|NCT02492711|531497478|FG001|Overall Study|study treatment delay|1|||
147362518|NCT02492711|531497479|FG002|Overall Study|study treatment delay|0|||
147362519|NCT02492711|531497477|FG000|Overall Study|change in chemotherapy|0|||
147362520|NCT02492711|531497478|FG001|Overall Study|change in chemotherapy|1|||
147362521|NCT02492711|531497479|FG002|Overall Study|change in chemotherapy|0|||
147362522|NCT02492711|531497477|FG000|Overall Study|never treated|2|||
147362523|NCT02492711|531497478|FG001|Overall Study|never treated|4|||
147362524|NCT02492711|531497479|FG002|Overall Study|never treated|0|||
147362525|NCT02492711|531497477|FG000|Overall Study|Other|0|||
147362526|NCT02492711|531497478|FG001|Overall Study|Other|0|||
147362527|NCT02492711|531497479|FG002|Overall Study|Other|1|||
147362528|NCT03663205|531497480|FG000|Overall Study|Death|144|||
147362529|NCT03663205|531497481|FG001|Overall Study|Death|69|||
147362530|NCT03663205|531497480|FG000|Overall Study|Sponsor decision|53|||
147362531|NCT03663205|531497481|FG001|Overall Study|Sponsor decision|19|||
147362532|NCT03663205|531497480|FG000|Overall Study|Withdrawal by Subject|8|||
147362533|NCT03663205|531497481|FG001|Overall Study|Withdrawal by Subject|11|||
147362534|NCT03663205|531497480|FG000|Overall Study|Lost to Follow-up|7|||
147362535|NCT03663205|531497481|FG001|Overall Study|Lost to Follow-up|9|||
147362536|NCT03663205|531497480|FG000|Overall Study|Transferred to long term extension study|11|||
147362537|NCT03663205|531497481|FG001|Overall Study|Transferred to long term extension study|3|||
147362538|NCT05890105|531497484|FG000|Overall Study|Adverse Event|1|||
147362539|NCT05890105|531497485|FG001|Overall Study|Adverse Event|0|||
147362540|NCT05890105|531497486|FG002|Overall Study|Adverse Event|0|||
147362541|NCT05890105|531497484|FG000|Overall Study|Other|1|||
147362542|NCT05890105|531497485|FG001|Overall Study|Other|2|||
147362543|NCT05890105|531497486|FG002|Overall Study|Other|0|||
147362544|NCT04505410|531497487|FG000|Overall Study|Adverse Event|2|||
147362545|NCT04505410|531497488|FG001|Overall Study|Adverse Event|0|||
147362546|NCT04505410|531497487|FG000|Overall Study|abdominal pain after starting tofacitinib|1|||
147362547|NCT04505410|531497488|FG001|Overall Study|abdominal pain after starting tofacitinib|1|||
147362548|NCT04505410|531497487|FG000|Overall Study|did not want to follow diet|1|||
147362549|NCT04505410|531497488|FG001|Overall Study|did not want to follow diet|0|||
147362550|NCT04505410|531497487|FG000|Overall Study|flare up of ulcerative colitis|0|||
147362551|NCT04505410|531497488|FG001|Overall Study|flare up of ulcerative colitis|1|||
147362552|NCT04505410|531497487|FG000|Overall Study|Lost to Follow-up|0|||
147362553|NCT04505410|531497488|FG001|Overall Study|Lost to Follow-up|2|||
147362554|NCT04505410|531497487|FG000|Overall Study|Lost to Follow-up|1|||
147362555|NCT04505410|531497488|FG001|Overall Study|Lost to Follow-up|0|||
147362556|NCT04505410|531497487|FG000|Overall Study|initiated another diet on their own|0|||
147362557|NCT04505410|531497488|FG001|Overall Study|initiated another diet on their own|2|||
147362558|NCT05123027|531497493|FG000|Overall Study|Lost to Follow-up|17|||
147362559|NCT05123027|531497494|FG001|Overall Study|Lost to Follow-up|22|||
147362560|NCT05123027|531497493|FG000|Overall Study|Incarceration|3|||
147362561|NCT05123027|531497494|FG001|Overall Study|Incarceration|4|||
147362562|NCT05123027|531497493|FG000|Overall Study|Death|2|||
147362563|NCT05123027|531497494|FG001|Overall Study|Death|2|||
147362564|NCT05123027|531497493|FG000|Overall Study|Other|2|||
147362565|NCT05123027|531497494|FG001|Overall Study|Other|0|||
147362566|NCT05311176|531499490|FG000|Overall Study|Death|6|||
147362567|NCT05311176|531499490|FG000|Overall Study|Sponsor discontinued the study|1|||
147362568|NCT05464069|531499491|FG000|Overall Study|Protocol Violation|3|||
147362569|NCT05464069|531499492|FG001|Overall Study|Protocol Violation|2|||
147362570|NCT05524116|531499505|FG000|Baseline to Postintervention (Week 8)|Brain tumor flare up|0|||
147362571|NCT05524116|531499506|FG001|Baseline to Postintervention (Week 8)|Brain tumor flare up|1|||
147362572|NCT05524116|531499505|FG000|Baseline to Postintervention (Week 8)|concussion|0|||
147608630|NCT04784533|532382682|FG000|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|5|||
147608631|NCT04784533|532382683|FG001|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|6|||
147608632|NCT04784533|532382684|FG002|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
147362573|NCT05524116|531499506|FG001|Baseline to Postintervention (Week 8)|concussion|1|||
147362574|NCT05524116|531499505|FG000|Baseline to Postintervention (Week 8)|hernia surgery|0|||
147362575|NCT05524116|531499506|FG001|Baseline to Postintervention (Week 8)|hernia surgery|1|||
147362576|NCT05524116|531499505|FG000|Week 8 to Follow-up (Week 14)|Caregiver for sick family member|1|||
147362577|NCT05524116|531499506|FG001|Week 8 to Follow-up (Week 14)|Caregiver for sick family member|0|||
147362578|NCT05524116|531499505|FG000|Week 8 to Follow-up (Week 14)|Lost to Follow-up|0|||
147362579|NCT05524116|531499506|FG001|Week 8 to Follow-up (Week 14)|Lost to Follow-up|1|||
147362580|NCT05552508|531499510|FG000|Overall Study|Adverse Event|3|||
147362581|NCT04605159|531499511|FG000|Overall Study|Adverse Event|6|||
147362582|NCT04605159|531499512|FG001|Overall Study|Adverse Event|3|||
147362583|NCT04605159|531499513|FG002|Overall Study|Adverse Event|21|||
147362584|NCT04605159|531499514|FG003|Overall Study|Adverse Event|4|||
147362585|NCT04605159|531499511|FG000|Overall Study|Lost to Follow-up|74|||
147454212|NCT04179175|531825555|FG003|Overall Study|Lost to Follow-up|2|||
147362586|NCT04605159|531499512|FG001|Overall Study|Lost to Follow-up|45|||
147362587|NCT04605159|531499513|FG002|Overall Study|Lost to Follow-up|119|||
147362588|NCT04605159|531499514|FG003|Overall Study|Lost to Follow-up|80|||
147362589|NCT04605159|531499511|FG000|Overall Study|Protocol Violation|4|||
147362590|NCT04605159|531499512|FG001|Overall Study|Protocol Violation|5|||
147362591|NCT04605159|531499513|FG002|Overall Study|Protocol Violation|2|||
147362592|NCT04605159|531499514|FG003|Overall Study|Protocol Violation|0|||
147362593|NCT04605159|531499511|FG000|Overall Study|Withdrawal by Subject|66|||
147362594|NCT04605159|531499512|FG001|Overall Study|Withdrawal by Subject|37|||
147362595|NCT04605159|531499513|FG002|Overall Study|Withdrawal by Subject|68|||
147362596|NCT04605159|531499514|FG003|Overall Study|Withdrawal by Subject|50|||
147362597|NCT04605159|531499511|FG000|Overall Study|Migrated / moved from the study area|32|||
147362598|NCT04605159|531499512|FG001|Overall Study|Migrated / moved from the study area|22|||
147362599|NCT04605159|531499513|FG002|Overall Study|Migrated / moved from the study area|41|||
147362600|NCT04605159|531499514|FG003|Overall Study|Migrated / moved from the study area|21|||
147362601|NCT04605159|531499511|FG000|Overall Study|Other|1|||
147362602|NCT04605159|531499512|FG001|Overall Study|Other|2|||
147362603|NCT04605159|531499513|FG002|Overall Study|Other|7|||
147362604|NCT04605159|531499514|FG003|Overall Study|Other|3|||
147362605|NCT05424380|531499518|FG000|Part 1: Cohort 1: 12.5 ug (Days 1 to 28)|Death|1|||
147362606|NCT05424380|531499519|FG001|Part 1: Cohort 1: 12.5 ug (Days 1 to 28)|Death|0|||
147362607|NCT05424380|531499520|FG002|Part 1: Cohort 1: 12.5 ug (Days 1 to 28)|Death|0|||
147362608|NCT05424380|531499521|FG003|Part 1: Cohort 1: 12.5 ug (Days 1 to 28)|Death|0|||
147362609|NCT05424380|531499522|FG004|Part 1: Cohort 1: 12.5 ug (Days 1 to 28)|Death|0|||
147362610|NCT05424380|531499523|FG005|Part 1: Cohort 1: 12.5 ug (Days 1 to 28)|Death|0|||
147362611|NCT05424380|531499518|FG000|Part 1: Cohort 1: 25 ug (Days 29 to 57)|Death|1|||
147362612|NCT05424380|531499519|FG001|Part 1: Cohort 1: 25 ug (Days 29 to 57)|Death|0|||
147362613|NCT05424380|531499520|FG002|Part 1: Cohort 1: 25 ug (Days 29 to 57)|Death|0|||
147362614|NCT05424380|531499521|FG003|Part 1: Cohort 1: 25 ug (Days 29 to 57)|Death|0|||
147362615|NCT05424380|531499522|FG004|Part 1: Cohort 1: 25 ug (Days 29 to 57)|Death|0|||
147362616|NCT05424380|531499523|FG005|Part 1: Cohort 1: 25 ug (Days 29 to 57)|Death|0|||
147362617|NCT05424380|531499518|FG000|Part 1: Cohort 1: 50 ug (Days 58 to 86)|Death|1|||
147362618|NCT05424380|531499519|FG001|Part 1: Cohort 1: 50 ug (Days 58 to 86)|Death|0|||
147362619|NCT05424380|531499520|FG002|Part 1: Cohort 1: 50 ug (Days 58 to 86)|Death|0|||
147362620|NCT05424380|531499521|FG003|Part 1: Cohort 1: 50 ug (Days 58 to 86)|Death|0|||
147362621|NCT05424380|531499522|FG004|Part 1: Cohort 1: 50 ug (Days 58 to 86)|Death|0|||
147362622|NCT05424380|531499523|FG005|Part 1: Cohort 1: 50 ug (Days 58 to 86)|Death|0|||
147362623|NCT05424380|531499518|FG000|Part 1: Cohort 2: 25 ug (Days 1 to 28)|Death|0|||
147362624|NCT05424380|531499519|FG001|Part 1: Cohort 2: 25 ug (Days 1 to 28)|Death|1|||
147362625|NCT05424380|531499520|FG002|Part 1: Cohort 2: 25 ug (Days 1 to 28)|Death|0|||
147362626|NCT05424380|531499521|FG003|Part 1: Cohort 2: 25 ug (Days 1 to 28)|Death|0|||
147362627|NCT05424380|531499522|FG004|Part 1: Cohort 2: 25 ug (Days 1 to 28)|Death|0|||
147362628|NCT05424380|531499523|FG005|Part 1: Cohort 2: 25 ug (Days 1 to 28)|Death|0|||
147362629|NCT05424380|531499518|FG000|Part 1: Cohort 2: 100 ug (Days 58 to 86)|Death|0|||
147362630|NCT05424380|531499519|FG001|Part 1: Cohort 2: 100 ug (Days 58 to 86)|Death|1|||
147362631|NCT05424380|531499520|FG002|Part 1: Cohort 2: 100 ug (Days 58 to 86)|Death|0|||
147362632|NCT05424380|531499521|FG003|Part 1: Cohort 2: 100 ug (Days 58 to 86)|Death|0|||
147362633|NCT05424380|531499522|FG004|Part 1: Cohort 2: 100 ug (Days 58 to 86)|Death|0|||
147362634|NCT05424380|531499523|FG005|Part 1: Cohort 2: 100 ug (Days 58 to 86)|Death|0|||
147362635|NCT05424380|531499518|FG000|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Withdrawal by Subject|0|||
147362636|NCT05424380|531499519|FG001|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Withdrawal by Subject|0|||
147362637|NCT05424380|531499520|FG002|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Withdrawal by Subject|1|||
147362638|NCT05424380|531499521|FG003|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Withdrawal by Subject|0|||
147362639|NCT05424380|531499522|FG004|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Withdrawal by Subject|0|||
147362640|NCT05424380|531499523|FG005|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Withdrawal by Subject|0|||
147362641|NCT05424380|531499518|FG000|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Death|0|||
147362642|NCT05424380|531499519|FG001|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Death|0|||
147362643|NCT05424380|531499520|FG002|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Death|1|||
147362644|NCT05424380|531499521|FG003|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Death|0|||
147362645|NCT05424380|531499522|FG004|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Death|0|||
147362646|NCT05424380|531499523|FG005|Part 1: Cohort 3: 100 ug (Days 29 to 57)|Death|0|||
147362647|NCT05424380|531499518|FG000|Part 1: Cohort 3: 200 ug (Days 58 to 86)|Death|0|||
147362648|NCT05424380|531499519|FG001|Part 1: Cohort 3: 200 ug (Days 58 to 86)|Death|0|||
147362649|NCT05424380|531499520|FG002|Part 1: Cohort 3: 200 ug (Days 58 to 86)|Death|1|||
147362650|NCT05424380|531499521|FG003|Part 1: Cohort 3: 200 ug (Days 58 to 86)|Death|0|||
147362651|NCT05424380|531499522|FG004|Part 1: Cohort 3: 200 ug (Days 58 to 86)|Death|0|||
147362652|NCT05424380|531499523|FG005|Part 1: Cohort 3: 200 ug (Days 58 to 86)|Death|0|||
147362653|NCT05424380|531499518|FG000|Part 1: Cohort 4:100 ug (Days 1 to 28)|Withdrawal by Subject|0|||
147454213|NCT04179175|531825556|FG004|Overall Study|Lost to Follow-up|4|||
147454214|NCT04179175|531825557|FG005|Overall Study|Lost to Follow-up|5|||
147608633|NCT04784533|532382685|FG003|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
147362654|NCT05424380|531499519|FG001|Part 1: Cohort 4:100 ug (Days 1 to 28)|Withdrawal by Subject|0|||
147362655|NCT05424380|531499520|FG002|Part 1: Cohort 4:100 ug (Days 1 to 28)|Withdrawal by Subject|0|||
147362656|NCT05424380|531499521|FG003|Part 1: Cohort 4:100 ug (Days 1 to 28)|Withdrawal by Subject|1|||
147362657|NCT05424380|531499522|FG004|Part 1: Cohort 4:100 ug (Days 1 to 28)|Withdrawal by Subject|0|||
147362658|NCT05424380|531499523|FG005|Part 1: Cohort 4:100 ug (Days 1 to 28)|Withdrawal by Subject|0|||
147362659|NCT05424380|531499518|FG000|Part 1: Cohort 4: 200 ug (Days 29 to 57)|Death|0|||
147362660|NCT05424380|531499519|FG001|Part 1: Cohort 4: 200 ug (Days 29 to 57)|Death|0|||
147362661|NCT05424380|531499520|FG002|Part 1: Cohort 4: 200 ug (Days 29 to 57)|Death|0|||
147362662|NCT05424380|531499521|FG003|Part 1: Cohort 4: 200 ug (Days 29 to 57)|Death|1|||
147362663|NCT05424380|531499522|FG004|Part 1: Cohort 4: 200 ug (Days 29 to 57)|Death|0|||
147362664|NCT05424380|531499523|FG005|Part 1: Cohort 4: 200 ug (Days 29 to 57)|Death|0|||
147362665|NCT05424380|531499518|FG000|Part 1: Cohort 4: 300 ug (Days 58 to 86)|Withdrawal by Subject|0|||
147362666|NCT05424380|531499519|FG001|Part 1: Cohort 4: 300 ug (Days 58 to 86)|Withdrawal by Subject|0|||
147362667|NCT05424380|531499520|FG002|Part 1: Cohort 4: 300 ug (Days 58 to 86)|Withdrawal by Subject|0|||
147362668|NCT05424380|531499521|FG003|Part 1: Cohort 4: 300 ug (Days 58 to 86)|Withdrawal by Subject|1|||
147362669|NCT05424380|531499522|FG004|Part 1: Cohort 4: 300 ug (Days 58 to 86)|Withdrawal by Subject|0|||
147362670|NCT05424380|531499523|FG005|Part 1: Cohort 4: 300 ug (Days 58 to 86)|Withdrawal by Subject|0|||
147362671|NCT05424380|531499518|FG000|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Death|0|||
147362672|NCT05424380|531499519|FG001|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Death|0|||
147362673|NCT05424380|531499520|FG002|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Death|0|||
147362674|NCT05424380|531499521|FG003|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Death|0|||
147362675|NCT05424380|531499522|FG004|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Death|3|||
147362676|NCT05424380|531499523|FG005|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Death|0|||
147362677|NCT05424380|531499518|FG000|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Withdrawal by Subject|0|||
147362678|NCT05424380|531499519|FG001|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Withdrawal by Subject|0|||
147362679|NCT05424380|531499520|FG002|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Withdrawal by Subject|0|||
147362680|NCT05424380|531499521|FG003|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Withdrawal by Subject|0|||
147362681|NCT05424380|531499522|FG004|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Withdrawal by Subject|1|||
147362682|NCT05424380|531499523|FG005|Part 1: Cohort 5: 200 ug (Days 1 to 28)|Withdrawal by Subject|0|||
147362683|NCT05424380|531499518|FG000|Part 1: Cohort 5: 300 ug (Days 58 to 86)|Death|0|||
147362684|NCT05424380|531499519|FG001|Part 1: Cohort 5: 300 ug (Days 58 to 86)|Death|0|||
147362685|NCT05424380|531499520|FG002|Part 1: Cohort 5: 300 ug (Days 58 to 86)|Death|0|||
147362686|NCT05424380|531499521|FG003|Part 1: Cohort 5: 300 ug (Days 58 to 86)|Death|0|||
147362687|NCT05424380|531499522|FG004|Part 1: Cohort 5: 300 ug (Days 58 to 86)|Death|1|||
147362688|NCT05424380|531499523|FG005|Part 1: Cohort 5: 300 ug (Days 58 to 86)|Death|0|||
147362689|NCT02909686|531499528|FG000|Overall Study|Physician Decision|3|||
147362690|NCT02909686|531499528|FG000|Overall Study|Withdrawal by Subject|2|||
147362691|NCT03015532|531499531|FG000|Overall Study|Adverse Event|0|||
147362692|NCT03015532|531499532|FG001|Overall Study|Adverse Event|0|||
147362693|NCT03015532|531499533|FG002|Overall Study|Adverse Event|0|||
147362694|NCT03015532|531499534|FG003|Overall Study|Adverse Event|0|||
147362695|NCT03015532|531499535|FG004|Overall Study|Adverse Event|0|||
147362696|NCT03015532|531499536|FG005|Overall Study|Adverse Event|2|||
147362697|NCT03015532|531499537|FG006|Overall Study|Adverse Event|1|||
147362698|NCT03015532|531499538|FG007|Overall Study|Adverse Event|0|||
147362699|NCT03015532|531499531|FG000|Overall Study|Withdrawal by Subject|0|||
147362700|NCT03015532|531499532|FG001|Overall Study|Withdrawal by Subject|0|||
147362701|NCT03015532|531499533|FG002|Overall Study|Withdrawal by Subject|0|||
147362702|NCT03015532|531499534|FG003|Overall Study|Withdrawal by Subject|0|||
147362703|NCT03015532|531499535|FG004|Overall Study|Withdrawal by Subject|0|||
147362704|NCT03015532|531499536|FG005|Overall Study|Withdrawal by Subject|0|||
147362705|NCT03015532|531499537|FG006|Overall Study|Withdrawal by Subject|1|||
147362706|NCT03015532|531499538|FG007|Overall Study|Withdrawal by Subject|0|||
147362707|NCT03914469|531499539|FG000|Overall Study|Lost to Follow-up|1|||
147362708|NCT03914469|531499540|FG001|Overall Study|Lost to Follow-up|4|||
147362709|NCT00677365|531499545|FG000|Overall Study|Adverse Event|2|||
147362710|NCT00677365|531499546|FG001|Overall Study|Adverse Event|1|||
147362711|NCT00677365|531499547|FG002|Overall Study|Adverse Event|1|||
147362712|NCT00677365|531499548|FG003|Overall Study|Adverse Event|2|||
147362713|NCT00677365|531499545|FG000|Overall Study|Withdrawal by Subject|0|||
147362714|NCT00677365|531499546|FG001|Overall Study|Withdrawal by Subject|0|||
147362715|NCT00677365|531499547|FG002|Overall Study|Withdrawal by Subject|1|||
147362716|NCT00677365|531499548|FG003|Overall Study|Withdrawal by Subject|0|||
147608634|NCT04784533|532382686|FG004|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
147608635|NCT04784533|532382687|FG005|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
147362717|NCT00677365|531499545|FG000|Overall Study|Other reason|0|||
147362718|NCT00677365|531499546|FG001|Overall Study|Other reason|0|||
147362719|NCT00677365|531499547|FG002|Overall Study|Other reason|0|||
147362720|NCT00677365|531499548|FG003|Overall Study|Other reason|1|||
147362721|NCT05422885|531499549|FG000|Overall Study|Lost to Follow-up|1|||
147362722|NCT05422885|531499549|FG000|Overall Study|Withdrawal by Subject|2|||
147362723|NCT01121588|531499550|FG000|Overall Study|Death|5|||
147362724|NCT01121588|531499551|FG001|Overall Study|Death|3|||
147362725|NCT01121588|531499552|FG002|Overall Study|Death|13|||
147362726|NCT01121588|531499550|FG000|Overall Study|Study Terminated by Sponsor|1|||
147362727|NCT01121588|531499551|FG001|Overall Study|Study Terminated by Sponsor|1|||
147362728|NCT01121588|531499552|FG002|Overall Study|Study Terminated by Sponsor|0|||
147362729|NCT01121588|531499550|FG000|Overall Study|Participant Refused Further Followup|2|||
147362730|NCT01121588|531499551|FG001|Overall Study|Participant Refused Further Followup|0|||
147362731|NCT01121588|531499552|FG002|Overall Study|Participant Refused Further Followup|2|||
147362732|NCT01121588|531499550|FG000|Overall Study|Lost to Follow-up|0|||
147362733|NCT01121588|531499551|FG001|Overall Study|Lost to Follow-up|1|||
147362734|NCT01121588|531499552|FG002|Overall Study|Lost to Follow-up|1|||
147362735|NCT01121588|531499550|FG000|Overall Study|Non-Specified Reasons|9|||
147362736|NCT01121588|531499551|FG001|Overall Study|Non-Specified Reasons|4|||
147362737|NCT01121588|531499552|FG002|Overall Study|Non-Specified Reasons|2|||
147362738|NCT00942877|531499553|FG000|Overall Study|Refused further treatment|1|||
147362739|NCT00942877|531499554|FG001|Overall Study|Refused further treatment|1|||
147362740|NCT00942877|531499553|FG000|Overall Study|Patient was not treated|1|||
147362741|NCT00942877|531499554|FG001|Overall Study|Patient was not treated|0|||
147362742|NCT00942877|531499553|FG000|Overall Study|Adverse Event|1|||
147362743|NCT00942877|531499554|FG001|Overall Study|Adverse Event|0|||
147362744|NCT00942877|531499553|FG000|Overall Study|Progressive disease|42|||
147362745|NCT00942877|531499554|FG001|Overall Study|Progressive disease|3|||
147362746|NCT01385202|531499557|FG000|Overall Study|Lost to Follow-up|6|||
147362747|NCT01385202|531499557|FG000|Overall Study|Not Eligible|11|||
147362748|NCT01385202|531499557|FG000|Overall Study|Withdrawn|1|||
147362749|NCT02874742|531499558|FG000|Overall Study|Death|0|||
147362750|NCT02874742|531499559|FG001|Overall Study|Death|1|||
147362751|NCT02874742|531499560|FG002|Overall Study|Death|0|||
147362752|NCT02874742|531499558|FG000|Overall Study|Lost to Follow-up|5|||
147362753|NCT02874742|531499559|FG001|Overall Study|Lost to Follow-up|4|||
147362754|NCT02874742|531499560|FG002|Overall Study|Lost to Follow-up|1|||
147362755|NCT02874742|531499558|FG000|Overall Study|Withdrawal by Subject|17|||
147362756|NCT02874742|531499559|FG001|Overall Study|Withdrawal by Subject|8|||
147362757|NCT02874742|531499560|FG002|Overall Study|Withdrawal by Subject|0|||
147362758|NCT02874742|531499558|FG000|Overall Study|Other|4|||
147362759|NCT02874742|531499559|FG001|Overall Study|Other|1|||
147362760|NCT02874742|531499560|FG002|Overall Study|Other|0|||
147362761|NCT02874742|531499558|FG000|Overall Study|Progressive Disease|1|||
147362762|NCT02874742|531499559|FG001|Overall Study|Progressive Disease|0|||
147362763|NCT02874742|531499560|FG002|Overall Study|Progressive Disease|0|||
147362764|NCT02874742|531499558|FG000|Overall Study|Screen Failure|0|||
147362765|NCT02874742|531499559|FG001|Overall Study|Screen Failure|2|||
147362766|NCT02874742|531499560|FG002|Overall Study|Screen Failure|0|||
147362767|NCT04424316|531499572|FG000|Overall Study|Adverse Event|0|||
147362768|NCT04424316|531499573|FG001|Overall Study|Adverse Event|1|||
147362769|NCT04424316|531499574|FG002|Overall Study|Adverse Event|0|||
147362770|NCT04424316|531499575|FG003|Overall Study|Adverse Event|0|||
147362771|NCT04424316|531499572|FG000|Overall Study|Death|1|||
147362772|NCT04424316|531499573|FG001|Overall Study|Death|0|||
147362773|NCT04424316|531499574|FG002|Overall Study|Death|8|||
147362774|NCT04424316|531499575|FG003|Overall Study|Death|14|||
147362775|NCT04424316|531499572|FG000|Overall Study|Lost to Follow-up|93|||
147454215|NCT04179175|531825552|FG000|Overall Study|Physician Decision|2|||
147454216|NCT04179175|531825553|FG001|Overall Study|Physician Decision|0|||
147454217|NCT04179175|531825554|FG002|Overall Study|Physician Decision|2|||
147454218|NCT04179175|531825555|FG003|Overall Study|Physician Decision|3|||
147454219|NCT04179175|531825556|FG004|Overall Study|Physician Decision|1|||
147454220|NCT04179175|531825557|FG005|Overall Study|Physician Decision|1|||
147454221|NCT04179175|531825552|FG000|Overall Study|Pregnancy|3|||
147454222|NCT04179175|531825553|FG001|Overall Study|Pregnancy|0|||
147362776|NCT04424316|531499573|FG001|Overall Study|Lost to Follow-up|88|||
147362777|NCT04424316|531499574|FG002|Overall Study|Lost to Follow-up|224|||
147362778|NCT04424316|531499575|FG003|Overall Study|Lost to Follow-up|211|||
147362779|NCT04424316|531499572|FG000|Overall Study|No longer met eligibility criteria|1|||
147362780|NCT04424316|531499573|FG001|Overall Study|No longer met eligibility criteria|0|||
147362781|NCT04424316|531499574|FG002|Overall Study|No longer met eligibility criteria|0|||
147362782|NCT04424316|531499575|FG003|Overall Study|No longer met eligibility criteria|0|||
147454223|NCT04179175|531825554|FG002|Overall Study|Pregnancy|3|||
147362783|NCT04424316|531499572|FG000|Overall Study|Other|15|||
147454224|NCT04179175|531825555|FG003|Overall Study|Pregnancy|0|||
147362784|NCT04424316|531499573|FG001|Overall Study|Other|11|||
147454225|NCT04179175|531825556|FG004|Overall Study|Pregnancy|1|||
147362785|NCT04424316|531499574|FG002|Overall Study|Other|34|||
147362786|NCT04424316|531499575|FG003|Overall Study|Other|45|||
147362787|NCT04424316|531499572|FG000|Overall Study|Physician Decision|1|||
147362788|NCT04424316|531499573|FG001|Overall Study|Physician Decision|0|||
147362789|NCT04424316|531499574|FG002|Overall Study|Physician Decision|1|||
147362790|NCT04424316|531499575|FG003|Overall Study|Physician Decision|1|||
147454226|NCT04179175|531825557|FG005|Overall Study|Pregnancy|2|||
147362791|NCT04424316|531499572|FG000|Overall Study|Protocol Violation|0|||
147362792|NCT04424316|531499573|FG001|Overall Study|Protocol Violation|1|||
147362793|NCT04424316|531499574|FG002|Overall Study|Protocol Violation|0|||
147362794|NCT04424316|531499575|FG003|Overall Study|Protocol Violation|0|||
147362795|NCT04424316|531499572|FG000|Overall Study|Withdrawal by Subject|71|||
147362796|NCT04424316|531499573|FG001|Overall Study|Withdrawal by Subject|77|||
147362797|NCT04424316|531499574|FG002|Overall Study|Withdrawal by Subject|0|||
147362798|NCT04424316|531499575|FG003|Overall Study|Withdrawal by Subject|0|||
147362799|NCT04424316|531499572|FG000|Overall Study|Withdrawal by parent/guardian|0|||
147362800|NCT04424316|531499573|FG001|Overall Study|Withdrawal by parent/guardian|0|||
147362801|NCT04424316|531499574|FG002|Overall Study|Withdrawal by parent/guardian|74|||
147362802|NCT04424316|531499575|FG003|Overall Study|Withdrawal by parent/guardian|81|||
147362803|NCT04424316|531499572|FG000|Overall Study|Randomized but not vaccinated|13|||
147362804|NCT04424316|531499573|FG001|Overall Study|Randomized but not vaccinated|21|||
147362805|NCT04424316|531499574|FG002|Overall Study|Randomized but not vaccinated|0|||
147362806|NCT04424316|531499575|FG003|Overall Study|Randomized but not vaccinated|0|||
147362807|NCT04424316|531499572|FG000|Overall Study|Mother vaccinated but unblinded during study|1|||
147362808|NCT04424316|531499573|FG001|Overall Study|Mother vaccinated but unblinded during study|0|||
147362809|NCT04424316|531499574|FG002|Overall Study|Mother vaccinated but unblinded during study|2|||
147362810|NCT04424316|531499575|FG003|Overall Study|Mother vaccinated but unblinded during study|0|||
147362811|NCT05070741|531499576|FG000|Overall Study|Failed initial laboratory testing and was unable to progress to heat therapy treatment.|1|||
147362812|NCT03582033|531499577|FG000|Part A|Other|0|||
147362813|NCT03582033|531499578|FG001|Part A|Other|0|||
147362814|NCT03582033|531499579|FG002|Part A|Other|0|||
147362815|NCT03582033|531499580|FG003|Part A|Other|0|||
147362816|NCT03582033|531499581|FG004|Part A|Other|2|||
147362817|NCT03582033|531499582|FG005|Part A|Other|0|||
147362818|NCT03582033|531499583|FG006|Part A|Other|0|||
147362819|NCT03582033|531499584|FG007|Part A|Other|0|||
147362820|NCT03582033|531499585|FG008|Part A|Other|0|||
147362821|NCT03582033|531499586|FG009|Part A|Other|0|||
147362822|NCT03582033|531499577|FG000|Part A|Death|1|||
147362823|NCT03582033|531499578|FG001|Part A|Death|1|||
147362824|NCT03582033|531499579|FG002|Part A|Death|2|||
147362825|NCT03582033|531499580|FG003|Part A|Death|4|||
147362826|NCT03582033|531499581|FG004|Part A|Death|11|||
147362827|NCT03582033|531499582|FG005|Part A|Death|0|||
147362828|NCT03582033|531499583|FG006|Part A|Death|0|||
147362829|NCT03582033|531499584|FG007|Part A|Death|0|||
147362830|NCT03582033|531499585|FG008|Part A|Death|0|||
147362831|NCT03582033|531499586|FG009|Part A|Death|0|||
147362832|NCT03582033|531499577|FG000|Part A|Lost to Follow-up|0|||
147362833|NCT03582033|531499578|FG001|Part A|Lost to Follow-up|0|||
147362834|NCT03582033|531499579|FG002|Part A|Lost to Follow-up|0|||
147362835|NCT03582033|531499580|FG003|Part A|Lost to Follow-up|0|||
147362836|NCT03582033|531499581|FG004|Part A|Lost to Follow-up|1|||
147362837|NCT03582033|531499582|FG005|Part A|Lost to Follow-up|0|||
147362838|NCT03582033|531499583|FG006|Part A|Lost to Follow-up|0|||
147362839|NCT03582033|531499584|FG007|Part A|Lost to Follow-up|0|||
147362840|NCT03582033|531499585|FG008|Part A|Lost to Follow-up|0|||
147362841|NCT03582033|531499586|FG009|Part A|Lost to Follow-up|0|||
147362842|NCT03582033|531499577|FG000|Part A|Study terminated by sponsor|0|||
147362843|NCT03582033|531499578|FG001|Part A|Study terminated by sponsor|0|||
147362844|NCT03582033|531499579|FG002|Part A|Study terminated by sponsor|0|||
147362845|NCT03582033|531499580|FG003|Part A|Study terminated by sponsor|2|||
147362846|NCT03582033|531499581|FG004|Part A|Study terminated by sponsor|1|||
147362847|NCT03582033|531499582|FG005|Part A|Study terminated by sponsor|0|||
147362848|NCT03582033|531499583|FG006|Part A|Study terminated by sponsor|0|||
147362849|NCT03582033|531499584|FG007|Part A|Study terminated by sponsor|0|||
147362850|NCT03582033|531499585|FG008|Part A|Study terminated by sponsor|0|||
147362851|NCT03582033|531499586|FG009|Part A|Study terminated by sponsor|0|||
147362852|NCT03582033|531499577|FG000|Part A|Withdrawal by Subject|1|||
147362853|NCT03582033|531499578|FG001|Part A|Withdrawal by Subject|1|||
147362854|NCT03582033|531499579|FG002|Part A|Withdrawal by Subject|0|||
147362855|NCT03582033|531499580|FG003|Part A|Withdrawal by Subject|1|||
147362856|NCT03582033|531499581|FG004|Part A|Withdrawal by Subject|7|||
147362857|NCT03582033|531499582|FG005|Part A|Withdrawal by Subject|0|||
147362858|NCT03582033|531499583|FG006|Part A|Withdrawal by Subject|0|||
147362859|NCT03582033|531499584|FG007|Part A|Withdrawal by Subject|0|||
147362860|NCT03582033|531499585|FG008|Part A|Withdrawal by Subject|0|||
147362861|NCT03582033|531499586|FG009|Part A|Withdrawal by Subject|0|||
147362862|NCT03582033|531499577|FG000|Part B|Death|0|||
147362863|NCT03582033|531499578|FG001|Part B|Death|0|||
147362864|NCT03582033|531499579|FG002|Part B|Death|0|||
147362865|NCT03582033|531499580|FG003|Part B|Death|0|||
147362866|NCT03582033|531499581|FG004|Part B|Death|0|||
147362867|NCT03582033|531499582|FG005|Part B|Death|2|||
147362868|NCT03582033|531499583|FG006|Part B|Death|0|||
147362869|NCT03582033|531499584|FG007|Part B|Death|0|||
147362870|NCT03582033|531499585|FG008|Part B|Death|0|||
147362871|NCT03582033|531499586|FG009|Part B|Death|0|||
147362872|NCT03582033|531499577|FG000|Part B|Study terminated by sponsor|0|||
147362873|NCT03582033|531499578|FG001|Part B|Study terminated by sponsor|0|||
147362874|NCT03582033|531499579|FG002|Part B|Study terminated by sponsor|0|||
147362875|NCT03582033|531499580|FG003|Part B|Study terminated by sponsor|0|||
147362876|NCT03582033|531499581|FG004|Part B|Study terminated by sponsor|0|||
147362877|NCT03582033|531499582|FG005|Part B|Study terminated by sponsor|12|||
147362878|NCT03582033|531499583|FG006|Part B|Study terminated by sponsor|0|||
147362879|NCT03582033|531499584|FG007|Part B|Study terminated by sponsor|0|||
147362880|NCT03582033|531499585|FG008|Part B|Study terminated by sponsor|0|||
147362881|NCT03582033|531499586|FG009|Part B|Study terminated by sponsor|0|||
147362882|NCT03582033|531499577|FG000|Part B|Withdrawal by Subject|0|||
147362883|NCT03582033|531499578|FG001|Part B|Withdrawal by Subject|0|||
147362884|NCT03582033|531499579|FG002|Part B|Withdrawal by Subject|0|||
147362885|NCT03582033|531499580|FG003|Part B|Withdrawal by Subject|0|||
147362886|NCT03582033|531499581|FG004|Part B|Withdrawal by Subject|0|||
147362887|NCT03582033|531499582|FG005|Part B|Withdrawal by Subject|6|||
147362888|NCT03582033|531499583|FG006|Part B|Withdrawal by Subject|0|||
147362889|NCT03582033|531499584|FG007|Part B|Withdrawal by Subject|0|||
147362890|NCT03582033|531499585|FG008|Part B|Withdrawal by Subject|0|||
147362891|NCT03582033|531499586|FG009|Part B|Withdrawal by Subject|0|||
147362892|NCT03582033|531499577|FG000|Part C|Other|0|||
147362893|NCT03582033|531499578|FG001|Part C|Other|0|||
147362894|NCT03582033|531499579|FG002|Part C|Other|0|||
147362895|NCT03582033|531499580|FG003|Part C|Other|0|||
147362896|NCT03582033|531499581|FG004|Part C|Other|0|||
147362897|NCT03582033|531499582|FG005|Part C|Other|0|||
147362898|NCT03582033|531499583|FG006|Part C|Other|2|||
147362899|NCT03582033|531499584|FG007|Part C|Other|0|||
147362900|NCT03582033|531499585|FG008|Part C|Other|0|||
147362901|NCT03582033|531499586|FG009|Part C|Other|0|||
147362902|NCT03582033|531499577|FG000|Part C|Death|0|||
147362903|NCT03582033|531499578|FG001|Part C|Death|0|||
147362904|NCT03582033|531499579|FG002|Part C|Death|0|||
147362905|NCT03582033|531499580|FG003|Part C|Death|0|||
147362906|NCT03582033|531499581|FG004|Part C|Death|0|||
147362907|NCT03582033|531499582|FG005|Part C|Death|0|||
147362908|NCT03582033|531499583|FG006|Part C|Death|6|||
147362909|NCT03582033|531499584|FG007|Part C|Death|1|||
147362910|NCT03582033|531499585|FG008|Part C|Death|2|||
147362911|NCT03582033|531499586|FG009|Part C|Death|0|||
147362912|NCT03582033|531499577|FG000|Part C|Study terminated by sponsor|0|||
147362913|NCT03582033|531499578|FG001|Part C|Study terminated by sponsor|0|||
147362914|NCT03582033|531499579|FG002|Part C|Study terminated by sponsor|0|||
147362915|NCT03582033|531499580|FG003|Part C|Study terminated by sponsor|0|||
147362916|NCT03582033|531499581|FG004|Part C|Study terminated by sponsor|0|||
147362917|NCT03582033|531499582|FG005|Part C|Study terminated by sponsor|0|||
147362918|NCT03582033|531499583|FG006|Part C|Study terminated by sponsor|3|||
147362919|NCT03582033|531499584|FG007|Part C|Study terminated by sponsor|3|||
147362920|NCT03582033|531499585|FG008|Part C|Study terminated by sponsor|2|||
147362921|NCT03582033|531499586|FG009|Part C|Study terminated by sponsor|0|||
147362922|NCT03582033|531499577|FG000|Part C|Withdrawal by Subject|0|||
147362923|NCT03582033|531499578|FG001|Part C|Withdrawal by Subject|0|||
147362924|NCT03582033|531499579|FG002|Part C|Withdrawal by Subject|0|||
147362925|NCT03582033|531499580|FG003|Part C|Withdrawal by Subject|0|||
147362926|NCT03582033|531499581|FG004|Part C|Withdrawal by Subject|0|||
147362927|NCT03582033|531499582|FG005|Part C|Withdrawal by Subject|0|||
147362928|NCT03582033|531499583|FG006|Part C|Withdrawal by Subject|1|||
147362929|NCT03582033|531499584|FG007|Part C|Withdrawal by Subject|2|||
147362930|NCT03582033|531499585|FG008|Part C|Withdrawal by Subject|1|||
147362931|NCT03582033|531499586|FG009|Part C|Withdrawal by Subject|0|||
147362932|NCT03582033|531499577|FG000|Part D|Death|0|||
147362933|NCT03582033|531499578|FG001|Part D|Death|0|||
147362934|NCT03582033|531499579|FG002|Part D|Death|0|||
147362935|NCT03582033|531499580|FG003|Part D|Death|0|||
147362936|NCT03582033|531499581|FG004|Part D|Death|0|||
147362937|NCT03582033|531499582|FG005|Part D|Death|0|||
147362938|NCT03582033|531499583|FG006|Part D|Death|0|||
147362939|NCT03582033|531499584|FG007|Part D|Death|0|||
147454227|NCT04179175|531825552|FG000|Overall Study|Withdrawal by Subject|22|||
147362940|NCT03582033|531499585|FG008|Part D|Death|0|||
147362941|NCT03582033|531499586|FG009|Part D|Death|1|||
147362942|NCT03582033|531499577|FG000|Part D|Study terminated by sponsor|0|||
147362943|NCT03582033|531499578|FG001|Part D|Study terminated by sponsor|0|||
147362944|NCT03582033|531499579|FG002|Part D|Study terminated by sponsor|0|||
147362945|NCT03582033|531499580|FG003|Part D|Study terminated by sponsor|0|||
147362946|NCT03582033|531499581|FG004|Part D|Study terminated by sponsor|0|||
147454228|NCT04179175|531825553|FG001|Overall Study|Withdrawal by Subject|10|||
147454229|NCT04179175|531825554|FG002|Overall Study|Withdrawal by Subject|12|||
147454230|NCT04179175|531825555|FG003|Overall Study|Withdrawal by Subject|8|||
147454231|NCT04179175|531825556|FG004|Overall Study|Withdrawal by Subject|23|||
147454232|NCT04179175|531825557|FG005|Overall Study|Withdrawal by Subject|31|||
147454233|NCT04179175|531825552|FG000|Overall Study|Technical problems|0|||
147362947|NCT03582033|531499582|FG005|Part D|Study terminated by sponsor|0|||
147362948|NCT03582033|531499583|FG006|Part D|Study terminated by sponsor|0|||
147362949|NCT03582033|531499584|FG007|Part D|Study terminated by sponsor|0|||
147362950|NCT03582033|531499585|FG008|Part D|Study terminated by sponsor|0|||
147362951|NCT03582033|531499586|FG009|Part D|Study terminated by sponsor|4|||
147362952|NCT06010836|531499587|FG000|Overall Study|Lost to Follow-up|2|||
147362953|NCT06010836|531499588|FG001|Overall Study|Lost to Follow-up|2|||
147362954|NCT06010836|531499587|FG000|Overall Study|Case cancelled by surgeon, or reoperation after surgical complication|8|||
147362955|NCT06010836|531499588|FG001|Overall Study|Case cancelled by surgeon, or reoperation after surgical complication|2|||
147362956|NCT06010836|531499587|FG000|Overall Study|Poor or absent audio recording for data collection|1|||
147608636|NCT04784533|532382688|FG006|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
147608637|NCT04784533|532382689|FG007|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
147608638|NCT04784533|532382690|FG008|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
147362957|NCT06010836|531499588|FG001|Overall Study|Poor or absent audio recording for data collection|4|||
147362958|NCT06010836|531499587|FG000|Overall Study|Did not receive intervention discussion|0|||
147362959|NCT06010836|531499588|FG001|Overall Study|Did not receive intervention discussion|4|||
147362960|NCT05953740|531499596|FG000|Period 1|Physician Decision|0|||
147362961|NCT05953740|531499597|FG001|Period 1|Physician Decision|1|||
147362962|NCT05953740|531499598|FG002|Period 1|Physician Decision|0|||
147362963|NCT05953740|531499599|FG003|Period 1|Physician Decision|0|||
147362964|NCT05953740|531499600|FG004|Period 1|Physician Decision|0|||
147362965|NCT05953740|531499601|FG005|Period 1|Physician Decision|0|||
147362966|NCT05953740|531499602|FG006|Period 1|Physician Decision|0|||
147362967|NCT05953740|531499603|FG007|Period 1|Physician Decision|0|||
147362968|NCT05953740|531499596|FG000|Period 2|Withdrawal by Subject|0|||
147362969|NCT05953740|531499597|FG001|Period 2|Withdrawal by Subject|1|||
147362970|NCT05953740|531499598|FG002|Period 2|Withdrawal by Subject|1|||
147362971|NCT05953740|531499599|FG003|Period 2|Withdrawal by Subject|0|||
147362972|NCT05953740|531499600|FG004|Period 2|Withdrawal by Subject|0|||
147362973|NCT05953740|531499601|FG005|Period 2|Withdrawal by Subject|0|||
147362974|NCT05953740|531499602|FG006|Period 2|Withdrawal by Subject|0|||
147362975|NCT05953740|531499603|FG007|Period 2|Withdrawal by Subject|0|||
147362976|NCT04206787|531499604|FG000|Overall Study|Other than listed|2|||
147362977|NCT04206787|531499604|FG000|Overall Study|Investigator decision|1|||
147362978|NCT04206787|531499604|FG000|Overall Study|Death|25|||
147362979|NCT04206787|531499604|FG000|Overall Study|Lost to Follow-up|9|||
147362980|NCT04206787|531499604|FG000|Overall Study|Withdrawal of consent|9|||
147362981|NCT02865538|531499606|FG000|Overall Study|Withdrawal by Subject|0|||
147362982|NCT02865538|531499607|FG001|Overall Study|Withdrawal by Subject|0|||
147362983|NCT02865538|531499608|FG002|Overall Study|Withdrawal by Subject|1|||
147362984|NCT02865538|531499609|FG003|Overall Study|Withdrawal by Subject|0|||
147362985|NCT02865538|531499610|FG004|Overall Study|Withdrawal by Subject|0|||
147362986|NCT02865538|531499606|FG000|Overall Study|Lost to Follow-up|1|||
147362987|NCT02865538|531499607|FG001|Overall Study|Lost to Follow-up|0|||
147362988|NCT02865538|531499608|FG002|Overall Study|Lost to Follow-up|0|||
147362989|NCT02865538|531499609|FG003|Overall Study|Lost to Follow-up|0|||
147362990|NCT02865538|531499610|FG004|Overall Study|Lost to Follow-up|0|||
147362991|NCT04451772|531500965|FG000|Overall Study|Adverse Event|1|||
147362992|NCT04451772|531500966|FG001|Overall Study|Adverse Event|0|||
147362993|NCT04451772|531500967|FG002|Overall Study|Adverse Event|1|||
147362994|NCT04451772|531500968|FG003|Overall Study|Adverse Event|1|||
147362995|NCT04451772|531500969|FG004|Overall Study|Adverse Event|0|||
147362996|NCT04451772|531500970|FG005|Overall Study|Adverse Event|3|||
147362997|NCT04451772|531500965|FG000|Overall Study|Withdrawal by Subject|2|||
147362998|NCT04451772|531500966|FG001|Overall Study|Withdrawal by Subject|7|||
147362999|NCT04451772|531500967|FG002|Overall Study|Withdrawal by Subject|2|||
147363000|NCT04451772|531500968|FG003|Overall Study|Withdrawal by Subject|1|||
147363001|NCT04451772|531500969|FG004|Overall Study|Withdrawal by Subject|1|||
147363002|NCT04451772|531500970|FG005|Overall Study|Withdrawal by Subject|0|||
147363003|NCT04451772|531500965|FG000|Overall Study|Other, not specified|1|||
147363004|NCT04451772|531500966|FG001|Overall Study|Other, not specified|2|||
147363005|NCT04451772|531500967|FG002|Overall Study|Other, not specified|1|||
147363006|NCT04451772|531500968|FG003|Overall Study|Other, not specified|0|||
147363007|NCT04451772|531500969|FG004|Overall Study|Other, not specified|0|||
147363008|NCT04451772|531500970|FG005|Overall Study|Other, not specified|1|||
147363009|NCT04451772|531500965|FG000|Overall Study|Sponsor decision based on interim analysis data review|0|||
147363010|NCT04451772|531500966|FG001|Overall Study|Sponsor decision based on interim analysis data review|0|||
147363011|NCT04451772|531500967|FG002|Overall Study|Sponsor decision based on interim analysis data review|0|||
147454234|NCT04179175|531825553|FG001|Overall Study|Technical problems|0|||
147363012|NCT04451772|531500968|FG003|Overall Study|Sponsor decision based on interim analysis data review|11|||
147363013|NCT04451772|531500969|FG004|Overall Study|Sponsor decision based on interim analysis data review|23|||
147363014|NCT04451772|531500970|FG005|Overall Study|Sponsor decision based on interim analysis data review|9|||
147363015|NCT04311632|531500971|FG000|Overall Study|Withdrawal by Subject|0|||
147363016|NCT04311632|531500972|FG001|Overall Study|Withdrawal by Subject|0|||
147363017|NCT04311632|531500973|FG002|Overall Study|Withdrawal by Subject|1|||
147454235|NCT04179175|531825554|FG002|Overall Study|Technical problems|1|||
147363018|NCT04632225|531500974|FG000|Overall Study|Withdrawal by Subject|2|||
147363019|NCT04632225|531500975|FG001|Overall Study|Withdrawal by Subject|2|||
147363020|NCT02278211|531500976|FG000|Overall Study|Unable to analyse PET scan|2|||
147363021|NCT03858517|531500977|FG000|Overall Study|Adverse Event|1|||
147363022|NCT03858517|531500977|FG000|Overall Study|Lost to Follow-up|1|||
147363023|NCT03858517|531500977|FG000|Overall Study|removed for being incarcerated|1|||
147363024|NCT03858517|531500977|FG000|Overall Study|Sponsor Closure|48|||
147363025|NCT04804540|531500978|FG000|Overall Study|Adverse Event|26|||
147363026|NCT04804540|531500979|FG001|Overall Study|Adverse Event|13|||
147363027|NCT05172232|531500980|FG000|Overall Study|Lost to Follow-up|3|||
147363028|NCT02997202|531500982|FG000|Overall Study|Miscellaneous|2|||
147363029|NCT02997202|531500983|FG001|Overall Study|Miscellaneous|2|||
147363030|NCT02997202|531500982|FG000|Overall Study|Withdrawal by Subject|8|||
147363031|NCT02997202|531500983|FG001|Overall Study|Withdrawal by Subject|12|||
147363032|NCT02997202|531500982|FG000|Overall Study|Lost to Follow-up|5|||
147363033|NCT02997202|531500983|FG001|Overall Study|Lost to Follow-up|3|||
147363034|NCT02997202|531500982|FG000|Overall Study|Death|41|||
147363035|NCT02997202|531500983|FG001|Overall Study|Death|45|||
147363036|NCT04629339|531500989|FG000|Overall Study|Death|1|||
147363037|NCT04629339|531500990|FG001|Overall Study|Death|0|||
147363038|NCT04629339|531500991|FG002|Overall Study|Death|2|||
147363039|NCT04629339|531500992|FG003|Overall Study|Death|2|||
147363040|NCT04629339|531500993|FG004|Overall Study|Death|0|||
147363041|NCT04629339|531500989|FG000|Overall Study|Disease Progression|0|||
147363042|NCT04629339|531500990|FG001|Overall Study|Disease Progression|0|||
147363043|NCT04629339|531500991|FG002|Overall Study|Disease Progression|1|||
147363044|NCT04629339|531500992|FG003|Overall Study|Disease Progression|1|||
147363045|NCT04629339|531500993|FG004|Overall Study|Disease Progression|0|||
147363046|NCT04629339|531500989|FG000|Overall Study|Lost to Follow-up|0|||
147363047|NCT04629339|531500990|FG001|Overall Study|Lost to Follow-up|0|||
147363048|NCT04629339|531500991|FG002|Overall Study|Lost to Follow-up|0|||
147363049|NCT04629339|531500992|FG003|Overall Study|Lost to Follow-up|1|||
147363050|NCT04629339|531500993|FG004|Overall Study|Lost to Follow-up|0|||
147363051|NCT04629339|531500989|FG000|Overall Study|Physician Decision|0|||
147363052|NCT04629339|531500990|FG001|Overall Study|Physician Decision|1|||
147363053|NCT04629339|531500991|FG002|Overall Study|Physician Decision|0|||
147363054|NCT04629339|531500992|FG003|Overall Study|Physician Decision|0|||
147363055|NCT04629339|531500993|FG004|Overall Study|Physician Decision|0|||
147363056|NCT04629339|531500989|FG000|Overall Study|Study Terminated by Sponsor|0|||
147363057|NCT04629339|531500990|FG001|Overall Study|Study Terminated by Sponsor|0|||
147363058|NCT04629339|531500991|FG002|Overall Study|Study Terminated by Sponsor|0|||
147363059|NCT04629339|531500992|FG003|Overall Study|Study Terminated by Sponsor|1|||
147363060|NCT04629339|531500993|FG004|Overall Study|Study Terminated by Sponsor|0|||
147363061|NCT04629339|531500989|FG000|Overall Study|Withdrawal by Subject|0|||
147363062|NCT04629339|531500990|FG001|Overall Study|Withdrawal by Subject|0|||
147363063|NCT04629339|531500991|FG002|Overall Study|Withdrawal by Subject|2|||
147363064|NCT04629339|531500992|FG003|Overall Study|Withdrawal by Subject|2|||
147363065|NCT04629339|531500993|FG004|Overall Study|Withdrawal by Subject|0|||
147363066|NCT04158739|531500998|FG000|Overall Study|Adverse Event|1|||
147363067|NCT04158739|531500999|FG001|Overall Study|Adverse Event|0|||
147363068|NCT04158739|531500998|FG000|Overall Study|Death|0|||
147363069|NCT04158739|531500999|FG001|Overall Study|Death|1|||
147363070|NCT04158739|531500998|FG000|Overall Study|Lack of Efficacy|3|||
147363071|NCT04158739|531500999|FG001|Overall Study|Lack of Efficacy|7|||
147363072|NCT04158739|531500998|FG000|Overall Study|Physician Decision|0|||
147363073|NCT04158739|531500999|FG001|Overall Study|Physician Decision|1|||
147608639|NCT04784533|532382691|FG009|Part A: Period 1 (Day 1 to Week 24)|Lost to Follow-up|0|||
147608640|NCT04784533|532382682|FG000|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
147608641|NCT04784533|532382683|FG001|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
147608642|NCT04784533|532382684|FG002|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|1|||
147363074|NCT04158739|531500998|FG000|Overall Study|Withdrawal by Subject|3|||
147363075|NCT04158739|531500999|FG001|Overall Study|Withdrawal by Subject|0|||
147363076|NCT04084574|531501002|FG000|Overall Study|Lost to Follow-up|1|||
147608643|NCT04784533|532382685|FG003|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
147363077|NCT04084574|531501003|FG001|Overall Study|Lost to Follow-up|0|||
147363078|NCT04084574|531501002|FG000|Overall Study|Physician Decision|1|||
147363079|NCT04084574|531501003|FG001|Overall Study|Physician Decision|0|||
147363080|NCT04084574|531501002|FG000|Overall Study|Relocated out of state|1|||
147363081|NCT04084574|531501003|FG001|Overall Study|Relocated out of state|0|||
147363082|NCT02782676|531501004|FG000|Overall Study|Lost to Follow-up|0|||
147363083|NCT02782676|531501005|FG001|Overall Study|Lost to Follow-up|1|||
147363084|NCT00964392|531501006|FG000|Overall Study|Withdrawal by Subject|4|||
147363085|NCT00964392|531501007|FG001|Overall Study|Withdrawal by Subject|6|||
147363086|NCT00964392|531501006|FG000|Overall Study|Lost to Follow-up|4|||
147363087|NCT00964392|531501007|FG001|Overall Study|Lost to Follow-up|10|||
147363088|NCT00964392|531501006|FG000|Overall Study|Early Termination, non-study arrhythmia|1|||
147363089|NCT00964392|531501007|FG001|Overall Study|Early Termination, non-study arrhythmia|6|||
147363090|NCT00964392|531501006|FG000|Overall Study|Not completed|44|||
147363091|NCT00964392|531501007|FG001|Overall Study|Not completed|168|||
147363092|NCT04055012|531501008|FG000|Overall Study|Withdrawal by Subject|1|||
147363093|NCT04055012|531501009|FG001|Overall Study|Withdrawal by Subject|3|||
147363094|NCT04055012|531501010|FG002|Overall Study|Withdrawal by Subject|1|||
147363095|NCT04055012|531501011|FG003|Overall Study|Withdrawal by Subject|0|||
147363096|NCT04055012|531501008|FG000|Overall Study|Metformin Recall|1|||
147363097|NCT04055012|531501009|FG001|Overall Study|Metformin Recall|1|||
147363098|NCT04055012|531501010|FG002|Overall Study|Metformin Recall|1|||
147363099|NCT04055012|531501011|FG003|Overall Study|Metformin Recall|0|||
147363100|NCT03652272|531501012|FG000|3 Month|Withdrawal by Subject|1|||
147363101|NCT03652272|531501013|FG001|3 Month|Withdrawal by Subject|1|||
147363102|NCT03652272|531501012|FG000|3 Month|Lost to Follow-up|16|||
147363103|NCT03652272|531501013|FG001|3 Month|Lost to Follow-up|14|||
147363104|NCT02326974|531501014|FG000|Overall Study|Withdrawal by Subject|2|||
147363105|NCT02326974|531501014|FG000|Overall Study|failed heterogenity evaluation|5|||
147363106|NCT02577354|531501015|FG000|Overall Study|Lack of Efficacy|4|||
147363107|NCT02577354|531501016|FG001|Overall Study|Lack of Efficacy|4|||
147363108|NCT02577354|531501015|FG000|Overall Study|Lost to Follow-up|3|||
147363109|NCT02577354|531501016|FG001|Overall Study|Lost to Follow-up|1|||
147363110|NCT02577354|531501015|FG000|Overall Study|Missed Visit|4|||
147363111|NCT02577354|531501016|FG001|Overall Study|Missed Visit|3|||
147363112|NCT02577354|531501015|FG000|Overall Study|Adverse Event|4|||
147363113|NCT02577354|531501016|FG001|Overall Study|Adverse Event|5|||
147363114|NCT04214834|531501022|FG000|Overall Study|Withdrawal by Parent(s)/Legal Guardian(s)|4|||
147363115|NCT04214834|531501023|FG001|Overall Study|Withdrawal by Parent(s)/Legal Guardian(s)|0|||
147363116|NCT04924400|531501026|FG000|Overall Study|Lost to Follow-up|3|||
147363117|NCT04924400|531501027|FG001|Overall Study|Lost to Follow-up|0|||
147363118|NCT04109066|531501028|FG000|Pre-treatment|Participant withdrew consent|2|||
147363119|NCT04109066|531501029|FG001|Pre-treatment|Participant withdrew consent|0|||
147363120|NCT04109066|531501028|FG000|Pre-treatment|Participant no longer meets study criteria|1|||
147363121|NCT04109066|531501029|FG001|Pre-treatment|Participant no longer meets study criteria|1|||
147363122|NCT04109066|531501028|FG000|Treatment|Lack of Efficacy|2|||
147363123|NCT04109066|531501029|FG001|Treatment|Lack of Efficacy|4|||
147363124|NCT04109066|531501028|FG000|Treatment|Adverse Event|23|||
147363125|NCT04109066|531501029|FG001|Treatment|Adverse Event|7|||
147363126|NCT04109066|531501028|FG000|Treatment|Participant request to discontinue Study treatment|15|||
147363127|NCT04109066|531501029|FG001|Treatment|Participant request to discontinue Study treatment|14|||
147363128|NCT04109066|531501028|FG000|Treatment|Withdrawal by Subject|8|||
147363129|NCT04109066|531501029|FG001|Treatment|Withdrawal by Subject|8|||
147363130|NCT04109066|531501028|FG000|Treatment|Death|3|||
147363131|NCT04109066|531501029|FG001|Treatment|Death|0|||
147363132|NCT04109066|531501028|FG000|Treatment|Participant no longer meets study criteria|2|||
147363133|NCT04109066|531501029|FG001|Treatment|Participant no longer meets study criteria|2|||
147363134|NCT04109066|531501028|FG000|Treatment|Administrative reasons by sponsor|2|||
147363135|NCT04109066|531501029|FG001|Treatment|Administrative reasons by sponsor|3|||
147363136|NCT04109066|531501028|FG000|Treatment|Other reasons|17|||
147363137|NCT04109066|531501029|FG001|Treatment|Other reasons|23|||
147363138|NCT04109066|531501028|FG000|Treatment|Disease Progression|4|||
147363139|NCT04109066|531501029|FG001|Treatment|Disease Progression|7|||
147363140|NCT04109066|531501028|FG000|Treatment|Study drug toxicity|12|||
147363141|NCT04109066|531501029|FG001|Treatment|Study drug toxicity|5|||
147363142|NCT04109066|531501028|FG000|Treatment|Adverse Event unrelated to Study drug|1|||
147363143|NCT04109066|531501029|FG001|Treatment|Adverse Event unrelated to Study drug|0|||
147363144|NCT04109066|531501028|FG000|Treatment|Disease Recurrence|0|||
147363145|NCT04109066|531501029|FG001|Treatment|Disease Recurrence|2|||
147363146|NCT04109066|531501028|FG000|Treatment|Not reported|4|||
147363147|NCT04109066|531501029|FG001|Treatment|Not reported|8|||
147363148|NCT03812614|531501030|FG000|Intervention|Withdrawal by Subject|7|||
147363149|NCT03812614|531501031|FG001|Intervention|Withdrawal by Subject|2|||
147363150|NCT03812614|531501032|FG002|Intervention|Withdrawal by Subject|7|||
147363151|NCT03812614|531501033|FG003|Intervention|Withdrawal by Subject|2|||
147363152|NCT03812614|531501030|FG000|Intervention|Patient declined to participate in the introductory session intervention|1|||
147363153|NCT03812614|531501031|FG001|Intervention|Patient declined to participate in the introductory session intervention|5|||
147608644|NCT04784533|532382686|FG004|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
147363154|NCT03812614|531501032|FG002|Intervention|Patient declined to participate in the introductory session intervention|11|||
147363155|NCT03812614|531501033|FG003|Intervention|Patient declined to participate in the introductory session intervention|86|||
147363156|NCT03812614|531501030|FG000|6-month Follow-up|We were prevented from collecting A1c data from many patients due to pandemic-related restrictions|23|||
147608645|NCT04784533|532382687|FG005|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
147363157|NCT03812614|531501031|FG001|6-month Follow-up|We were prevented from collecting A1c data from many patients due to pandemic-related restrictions|20|||
147363158|NCT03812614|531501032|FG002|6-month Follow-up|We were prevented from collecting A1c data from many patients due to pandemic-related restrictions|0|||
147608646|NCT04784533|532382688|FG006|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
147608647|NCT04784533|532382689|FG007|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
147608648|NCT04784533|532382690|FG008|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
147608649|NCT04784533|532382691|FG009|Part A: Period 2 (Week 24 to Week 48)|Lost to Follow-up|0|||
147363159|NCT03812614|531501033|FG003|6-month Follow-up|We were prevented from collecting A1c data from many patients due to pandemic-related restrictions|0|||
147363160|NCT03812614|531501030|FG000|6-month Follow-up|Lost to Follow-up|0|||
147363161|NCT03812614|531501031|FG001|6-month Follow-up|Lost to Follow-up|0|||
147363162|NCT03812614|531501032|FG002|6-month Follow-up|Lost to Follow-up|12|||
147363163|NCT03812614|531501033|FG003|6-month Follow-up|Lost to Follow-up|8|||
147363164|NCT03812614|531501030|FG000|12-month Follow-up|Lost to Follow-up|18|||
147363165|NCT03812614|531501031|FG001|12-month Follow-up|Lost to Follow-up|17|||
147363166|NCT03812614|531501032|FG002|12-month Follow-up|Lost to Follow-up|5|||
147363167|NCT03812614|531501033|FG003|12-month Follow-up|Lost to Follow-up|2|||
147363168|NCT05205161|531501034|FG000|Overall Study|Study terminated by sponsor|3|||
147363169|NCT05205161|531501035|FG001|Overall Study|Study terminated by sponsor|3|||
147363170|NCT05205161|531501036|FG002|Overall Study|Study terminated by sponsor|1|||
147363171|NCT05652010|531501037|FG000|First Intervention|Withdrawal by Subject|0|||
147363172|NCT05652010|531501038|FG001|First Intervention|Withdrawal by Subject|1|||
147363173|NCT05652010|531501037|FG000|Second Intervention|Withdrawal by Subject|1|||
147363174|NCT05652010|531501038|FG001|Second Intervention|Withdrawal by Subject|0|||
147363175|NCT05741294|531501040|FG000|Overall Study|Lost to Follow-up|3|||
147363176|NCT05741294|531501040|FG000|Overall Study|Protocol deviation|3|||
147363177|NCT05741294|531501040|FG000|Overall Study|Withdrawal by Subject|1|||
147363178|NCT05451693|531501041|FG000|Overall Study|Withdrawal by Subject|1|||
147363179|NCT05451693|531501042|FG001|Overall Study|Withdrawal by Subject|1|||
147363180|NCT04707768|531501057|FG000|Overall Study|Adverse Event|9|||
147363181|NCT04707768|531501058|FG001|Overall Study|Adverse Event|18|||
147363182|NCT04707768|531501059|FG002|Overall Study|Adverse Event|3|||
147363183|NCT04707768|531501057|FG000|Overall Study|Investigator's Discretion|8|||
147363184|NCT04707768|531501058|FG001|Overall Study|Investigator's Discretion|4|||
147363185|NCT04707768|531501059|FG002|Overall Study|Investigator's Discretion|3|||
147363186|NCT04707768|531501057|FG000|Overall Study|Withdrawal by Subject|6|||
147363187|NCT04707768|531501058|FG001|Overall Study|Withdrawal by Subject|8|||
147363188|NCT04707768|531501059|FG002|Overall Study|Withdrawal by Subject|2|||
147363189|NCT04707768|531501057|FG000|Overall Study|Lack of Efficacy|1|||
147363190|NCT04707768|531501058|FG001|Overall Study|Lack of Efficacy|3|||
147363191|NCT04707768|531501059|FG002|Overall Study|Lack of Efficacy|0|||
147363192|NCT04707768|531501057|FG000|Overall Study|Lost to Follow-up|0|||
147363193|NCT04707768|531501058|FG001|Overall Study|Lost to Follow-up|0|||
147363194|NCT04707768|531501059|FG002|Overall Study|Lost to Follow-up|3|||
147363195|NCT04707768|531501057|FG000|Overall Study|Death|13|||
147363196|NCT04707768|531501058|FG001|Overall Study|Death|11|||
147363197|NCT04707768|531501059|FG002|Overall Study|Death|13|||
147363198|NCT04707768|531501057|FG000|Overall Study|Protocol Violation|2|||
147363199|NCT04707768|531501058|FG001|Overall Study|Protocol Violation|1|||
147363200|NCT04707768|531501059|FG002|Overall Study|Protocol Violation|0|||
147363201|NCT04707768|531501057|FG000|Overall Study|Non Compliance with Study Drug|1|||
147363202|NCT04707768|531501058|FG001|Overall Study|Non Compliance with Study Drug|0|||
147363203|NCT04707768|531501059|FG002|Overall Study|Non Compliance with Study Drug|0|||
147363204|NCT04707768|531501057|FG000|Overall Study|Transplant|4|||
147363205|NCT04707768|531501058|FG001|Overall Study|Transplant|4|||
147363206|NCT04707768|531501059|FG002|Overall Study|Transplant|8|||
147363207|NCT04707768|531501057|FG000|Overall Study|Other|9|||
147363208|NCT04707768|531501058|FG001|Overall Study|Other|5|||
147363209|NCT04707768|531501059|FG002|Overall Study|Other|2|||
147363210|NCT02510235|531501060|FG000|Overall Study|Withdrawal by Subject|1|||
147363211|NCT02510235|531501061|FG001|Overall Study|Withdrawal by Subject|0|||
147363212|NCT05008055|531501062|FG000|Overall Study|Patients ongoing treatment at data cut-off date of 22 August 2023.|3|||
147363213|NCT05008055|531501063|FG001|Overall Study|Patients ongoing treatment at data cut-off date of 22 August 2023.|1|||
147363214|NCT05008055|531501064|FG002|Overall Study|Patients ongoing treatment at data cut-off date of 22 August 2023.|1|||
147363215|NCT03011034|531501070|FG000|Overall Study|Adverse Event|1|||
147363216|NCT03011034|531501071|FG001|Overall Study|Adverse Event|0|||
147608650|NCT04784533|532382682|FG000|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
147608651|NCT04784533|532382683|FG001|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
147608652|NCT04784533|532382684|FG002|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
147363217|NCT03735979|531501075|FG000|Overall Study|Lost to Follow-up|1|||
147363218|NCT03735979|531501076|FG001|Overall Study|Lost to Follow-up|12|||
147363219|NCT03735979|531501077|FG002|Overall Study|Lost to Follow-up|14|||
147363220|NCT03735979|531501075|FG000|Overall Study|Withdrawal by Subject|1|||
147363221|NCT03735979|531501076|FG001|Overall Study|Withdrawal by Subject|5|||
147363222|NCT03735979|531501077|FG002|Overall Study|Withdrawal by Subject|2|||
147363223|NCT03735979|531501075|FG000|Overall Study|Not due to the above reasons|1|||
147363224|NCT03735979|531501076|FG001|Overall Study|Not due to the above reasons|0|||
147363225|NCT03735979|531501077|FG002|Overall Study|Not due to the above reasons|0|||
147363226|NCT01438853|531501080|FG000|Overall Study|Death|0|||
147363227|NCT01438853|531501081|FG001|Overall Study|Death|0|||
147363228|NCT01438853|531501082|FG002|Overall Study|Death|0|||
147363229|NCT01438853|531501083|FG003|Overall Study|Death|1|||
147363230|NCT01438853|531501080|FG000|Overall Study|Withdrawal by Subject|0|||
147363231|NCT01438853|531501081|FG001|Overall Study|Withdrawal by Subject|0|||
147363232|NCT01438853|531501082|FG002|Overall Study|Withdrawal by Subject|1|||
147363233|NCT01438853|531501083|FG003|Overall Study|Withdrawal by Subject|0|||
147363234|NCT03165955|531501084|FG000|Treatment|Withdrawal by Subject|3|||
147363235|NCT03165955|531501084|FG000|Treatment|Death|1|||
147363236|NCT03165955|531501084|FG000|Treatment|Adverse Event|1|||
147363237|NCT03165955|531501084|FG000|Treatment|Progressive disease|3|||
147363238|NCT04761198|531501087|FG000|Overall Study|Progressive Disease|1|||
147363239|NCT04761198|531501088|FG001|Overall Study|Progressive Disease|0|||
147363240|NCT04761198|531501089|FG002|Overall Study|Progressive Disease|0|||
147363241|NCT04761198|531501090|FG003|Overall Study|Progressive Disease|1|||
147363242|NCT04761198|531501091|FG004|Overall Study|Progressive Disease|4|||
147363243|NCT04761198|531501092|FG005|Overall Study|Progressive Disease|1|||
147363244|NCT04761198|531501093|FG006|Overall Study|Progressive Disease|2|||
147363245|NCT04761198|531501087|FG000|Overall Study|Protocol Violation|0|||
147363246|NCT04761198|531501088|FG001|Overall Study|Protocol Violation|0|||
147363247|NCT04761198|531501089|FG002|Overall Study|Protocol Violation|0|||
147363248|NCT04761198|531501090|FG003|Overall Study|Protocol Violation|0|||
147363249|NCT04761198|531501091|FG004|Overall Study|Protocol Violation|1|||
147363250|NCT04761198|531501092|FG005|Overall Study|Protocol Violation|0|||
147363251|NCT04761198|531501093|FG006|Overall Study|Protocol Violation|0|||
147363252|NCT04761198|531501087|FG000|Overall Study|Death|2|||
147363253|NCT04761198|531501088|FG001|Overall Study|Death|1|||
147363254|NCT04761198|531501089|FG002|Overall Study|Death|2|||
147363255|NCT04761198|531501090|FG003|Overall Study|Death|5|||
147363256|NCT04761198|531501091|FG004|Overall Study|Death|14|||
147363257|NCT04761198|531501092|FG005|Overall Study|Death|2|||
147363258|NCT04761198|531501093|FG006|Overall Study|Death|5|||
147363259|NCT04761198|531501087|FG000|Overall Study|Lost to Follow-up|0|||
147363260|NCT04761198|531501088|FG001|Overall Study|Lost to Follow-up|0|||
147363261|NCT04761198|531501089|FG002|Overall Study|Lost to Follow-up|0|||
147363262|NCT04761198|531501090|FG003|Overall Study|Lost to Follow-up|0|||
147363263|NCT04761198|531501091|FG004|Overall Study|Lost to Follow-up|1|||
147363264|NCT04761198|531501092|FG005|Overall Study|Lost to Follow-up|0|||
147363265|NCT04761198|531501093|FG006|Overall Study|Lost to Follow-up|0|||
147363266|NCT04761198|531501087|FG000|Overall Study|Withdrawal by Subject|2|||
147363267|NCT04761198|531501088|FG001|Overall Study|Withdrawal by Subject|0|||
147363268|NCT04761198|531501089|FG002|Overall Study|Withdrawal by Subject|1|||
147363269|NCT04761198|531501090|FG003|Overall Study|Withdrawal by Subject|0|||
147363270|NCT04761198|531501091|FG004|Overall Study|Withdrawal by Subject|2|||
147363271|NCT04761198|531501092|FG005|Overall Study|Withdrawal by Subject|0|||
147363272|NCT04761198|531501093|FG006|Overall Study|Withdrawal by Subject|1|||
147363273|NCT04761198|531501087|FG000|Overall Study|Study Terminated by Sponsor|6|||
147363274|NCT04761198|531501088|FG001|Overall Study|Study Terminated by Sponsor|0|||
147363275|NCT04761198|531501089|FG002|Overall Study|Study Terminated by Sponsor|5|||
147363276|NCT04761198|531501090|FG003|Overall Study|Study Terminated by Sponsor|3|||
147363277|NCT04761198|531501091|FG004|Overall Study|Study Terminated by Sponsor|10|||
147363278|NCT04761198|531501092|FG005|Overall Study|Study Terminated by Sponsor|1|||
147363279|NCT04761198|531501093|FG006|Overall Study|Study Terminated by Sponsor|2|||
147363280|NCT02994927|531501094|FG000|Overall Study|Withdrawal by parent/guardian|0|||
147363281|NCT02994927|531501095|FG001|Overall Study|Withdrawal by parent/guardian|1|||
147363282|NCT02994927|531501094|FG000|Overall Study|Did not meet eligibility criteria|0|||
147363283|NCT02994927|531501095|FG001|Overall Study|Did not meet eligibility criteria|1|||
147363284|NCT02994927|531501094|FG000|Overall Study|Physician Decision|4|||
147363285|NCT02994927|531501095|FG001|Overall Study|Physician Decision|3|||
147363286|NCT02994927|531501094|FG000|Overall Study|Death|4|||
147363287|NCT02994927|531501095|FG001|Overall Study|Death|2|||
147363288|NCT02994927|531501094|FG000|Overall Study|Adverse Event|2|||
147363289|NCT02994927|531501095|FG001|Overall Study|Adverse Event|1|||
147363290|NCT02994927|531501094|FG000|Overall Study|Withdrawal by Subject|3|||
147363291|NCT02994927|531501095|FG001|Overall Study|Withdrawal by Subject|6|||
147363292|NCT02994927|531501094|FG000|Overall Study|Lost to Follow-up|2|||
147363293|NCT02994927|531501095|FG001|Overall Study|Lost to Follow-up|1|||
147363294|NCT00626795|531501096|FG000|Open-label TD1414 Cream TID Treatment|Adverse Event|0|||
147363295|NCT00626795|531501097|FG001|Open-label TD1414 Cream TID Treatment|Adverse Event|1|||
147363296|NCT00626795|531501098|FG002|Open-label TD1414 Cream TID Treatment|Adverse Event|0|||
147363297|NCT00626795|531501096|FG000|Blinded Treatment|Lack of Efficacy|2|||
147363298|NCT00626795|531501097|FG001|Blinded Treatment|Lack of Efficacy|0|||
147363299|NCT00626795|531501098|FG002|Blinded Treatment|Lack of Efficacy|0|||
147363300|NCT00626795|531501096|FG000|Blinded Treatment|Unacceptable adverse event|0|||
147363301|NCT00626795|531501097|FG001|Blinded Treatment|Unacceptable adverse event|0|||
147363302|NCT00626795|531501098|FG002|Blinded Treatment|Unacceptable adverse event|1|||
147363303|NCT00626795|531501096|FG000|Blinded Treatment|Protocol Violation|0|||
147363304|NCT00626795|531501097|FG001|Blinded Treatment|Protocol Violation|1|||
147363305|NCT00626795|531501098|FG002|Blinded Treatment|Protocol Violation|1|||
147363306|NCT00626795|531501096|FG000|Blinded Treatment|Withdrawal by Subject|1|||
147363307|NCT00626795|531501097|FG001|Blinded Treatment|Withdrawal by Subject|1|||
147363308|NCT00626795|531501098|FG002|Blinded Treatment|Withdrawal by Subject|0|||
147363309|NCT00626795|531501096|FG000|Blinded Treatment|Other reasons|2|||
147363310|NCT00626795|531501097|FG001|Blinded Treatment|Other reasons|0|||
147363311|NCT00626795|531501098|FG002|Blinded Treatment|Other reasons|2|||
147363312|NCT00626795|531501096|FG000|Blinded Treatment|Missing reason for withdrawal|5|||
147363313|NCT00626795|531501097|FG001|Blinded Treatment|Missing reason for withdrawal|3|||
147363314|NCT00626795|531501098|FG002|Blinded Treatment|Missing reason for withdrawal|5|||
147363315|NCT03533257|531501106|FG000|Overall Study|Adverse Event|4|||
147363316|NCT03533257|531501107|FG001|Overall Study|Adverse Event|2|||
147363317|NCT03533257|531501106|FG000|Overall Study|Enrolled in other study, terminated by Sponsor, other|6|||
147363318|NCT03533257|531501107|FG001|Overall Study|Enrolled in other study, terminated by Sponsor, other|0|||
147363319|NCT05525104|531501108|FG000|Overall Study|Failed caudal analgesia|1|||
147363320|NCT05525104|531501109|FG001|Overall Study|Failed caudal analgesia|3|||
147363321|NCT05525104|531501108|FG000|Overall Study|Premedication needed|0|||
147363322|NCT05525104|531501109|FG001|Overall Study|Premedication needed|1|||
147363323|NCT05525104|531501108|FG000|Overall Study|Protocol Violation|10|||
147363324|NCT05525104|531501109|FG001|Overall Study|Protocol Violation|0|||
147363325|NCT05525104|531501108|FG000|Overall Study|Cancelled operation|1|||
147363326|NCT05525104|531501109|FG001|Overall Study|Cancelled operation|0|||
147363327|NCT02039401|531501110|FG000|Overall Study|Adverse Event|0|||
147363328|NCT02039401|531501111|FG001|Overall Study|Adverse Event|1|||
147363329|NCT04389957|531501853|FG000|Overall Study|Providers without data in the post intervention timeframe.|7|||
147363330|NCT04389957|531501854|FG001|Overall Study|Providers without data in the post intervention timeframe.|7|||
147363331|NCT04389957|531501855|FG002|Overall Study|Providers without data in the post intervention timeframe.|12|||
147363332|NCT04389957|531501856|FG003|Overall Study|Providers without data in the post intervention timeframe.|20|||
147363333|NCT04389957|531501857|FG004|Overall Study|Providers without data in the post intervention timeframe.|7|||
147363334|NCT05405985|531501860|FG000|Overall Study|Withdrawal by Subject|1|||
147363335|NCT05405985|531501861|FG001|Overall Study|Withdrawal by Subject|0|||
147363336|NCT01917084|531501862|FG000|Overall Study|Withdrawal by Subject|1|||
147363337|NCT03571386|531501863|FG000|Overall Study|scheduling conflict|4|||
147363338|NCT03571386|531501864|FG001|Overall Study|scheduling conflict|0|||
147363339|NCT03571386|531501863|FG000|Overall Study|Withdrawal by Subject|15|||
147363340|NCT03571386|531501864|FG001|Overall Study|Withdrawal by Subject|5|||
147363341|NCT06037668|531501871|FG000|Overall Study|Lost to Follow-up|1|||
147363342|NCT06037668|531501872|FG001|Overall Study|Lost to Follow-up|1|||
147363343|NCT06037668|531501871|FG000|Overall Study|Protocol Violation|1|||
147363344|NCT06037668|531501872|FG001|Overall Study|Protocol Violation|0|||
147363345|NCT06037668|531501871|FG000|Overall Study|Withdrawal by Subject|1|||
147363346|NCT06037668|531501872|FG001|Overall Study|Withdrawal by Subject|0|||
147363347|NCT06037668|531501871|FG000|Overall Study|Other Study Discontinuation Reason|1|||
147363348|NCT06037668|531501872|FG001|Overall Study|Other Study Discontinuation Reason|0|||
147363349|NCT05224544|531501873|FG000|V2, Catheterization and Visualization|Adverse Event|2|||
147363350|NCT05224544|531501874|FG001|V2, Catheterization and Visualization|Adverse Event|1|||
147363351|NCT01828021|531501875|FG000|Overall Study|Adverse Event|5|||
147363352|NCT01828021|531501875|FG000|Overall Study|Lack of Efficacy|17|||
147363353|NCT01828021|531501875|FG000|Overall Study|Withdrawal by Subject|2|||
147363354|NCT01828021|531501875|FG000|Overall Study|Ileal obstruction, unrelated|1|||
147363355|NCT04881461|531501876|FG000|Overall Study|Adverse Event|2|||
147363356|NCT04881461|531501877|FG001|Overall Study|Adverse Event|4|||
147363357|NCT04881461|531501876|FG000|Overall Study|Withdrawal by Subject|19|||
147363358|NCT04881461|531501877|FG001|Overall Study|Withdrawal by Subject|19|||
147363359|NCT04881461|531501876|FG000|Overall Study|Lost to Follow-up|4|||
147363360|NCT04881461|531501877|FG001|Overall Study|Lost to Follow-up|4|||
147363361|NCT04881461|531501876|FG000|Overall Study|Lack of Efficacy|1|||
147363362|NCT04881461|531501877|FG001|Overall Study|Lack of Efficacy|0|||
147363363|NCT04881461|531501876|FG000|Overall Study|"Reason stated as other in CRF"|1|||
147363364|NCT04881461|531501877|FG001|Overall Study|"Reason stated as other in CRF"|2|||
147363365|NCT03681262|531501884|FG000|Overall Study|Continuing on study|3|||
147363366|NCT03681262|531501885|FG001|Overall Study|Continuing on study|3|||
147363367|NCT03681262|531501884|FG000|Overall Study|Lost to Follow-up|1|||
147363368|NCT03681262|531501885|FG001|Overall Study|Lost to Follow-up|0|||
147363369|NCT03372057|531501897|FG000|Dose Optimization Phase|Withdrawal by Subject|1|||
147363370|NCT03372057|531501898|FG001|Dose Optimization Phase|Withdrawal by Subject|1|||
147363371|NCT03372057|531501899|FG002|Dose Optimization Phase|Withdrawal by Subject|0|||
147363372|NCT03372057|531501897|FG000|Dose Optimization Phase|Closure Of The Study By The Sponsor|3|||
147363373|NCT03372057|531501898|FG001|Dose Optimization Phase|Closure Of The Study By The Sponsor|1|||
147363374|NCT03372057|531501899|FG002|Dose Optimization Phase|Closure Of The Study By The Sponsor|0|||
147363375|NCT03372057|531501897|FG000|Dose Optimization Phase|Death|16|||
147363376|NCT03372057|531501898|FG001|Dose Optimization Phase|Death|11|||
147363377|NCT03372057|531501899|FG002|Dose Optimization Phase|Death|0|||
147363378|NCT03372057|531501897|FG000|Expansion Phase|Withdrawal by Subject|0|||
147363379|NCT03372057|531501898|FG001|Expansion Phase|Withdrawal by Subject|0|||
147454236|NCT04179175|531825555|FG003|Overall Study|Technical problems|1|||
147454237|NCT04179175|531825556|FG004|Overall Study|Technical problems|0|||
147363380|NCT03372057|531501899|FG002|Expansion Phase|Withdrawal by Subject|4|||
147363381|NCT03372057|531501897|FG000|Expansion Phase|Closure Of The Study By The Sponsor|0|||
147363382|NCT03372057|531501898|FG001|Expansion Phase|Closure Of The Study By The Sponsor|0|||
147363383|NCT03372057|531501899|FG002|Expansion Phase|Closure Of The Study By The Sponsor|39|||
147363384|NCT03372057|531501897|FG000|Expansion Phase|Death|0|||
147363385|NCT03372057|531501898|FG001|Expansion Phase|Death|0|||
147363386|NCT03372057|531501899|FG002|Expansion Phase|Death|78|||
147363387|NCT03372057|531501897|FG000|Expansion Phase|Progressive Disease|0|||
147363388|NCT03372057|531501898|FG001|Expansion Phase|Progressive Disease|0|||
147363389|NCT03372057|531501899|FG002|Expansion Phase|Progressive Disease|1|||
147363390|NCT03372057|531501897|FG000|Expansion Phase|Adverse Event|0|||
147363391|NCT03372057|531501898|FG001|Expansion Phase|Adverse Event|0|||
147363392|NCT03372057|531501899|FG002|Expansion Phase|Adverse Event|1|||
147363393|NCT00450216|531501900|FG000|Overall Study|Adverse Event|38|||
147363394|NCT00450216|531501901|FG001|Overall Study|Adverse Event|23|||
147363395|NCT00450216|531501900|FG000|Overall Study|Withdrawal by Subject|48|||
147363396|NCT00450216|531501901|FG001|Overall Study|Withdrawal by Subject|26|||
147363397|NCT00450216|531501900|FG000|Overall Study|Lost to Follow-up|16|||
147363398|NCT00450216|531501901|FG001|Overall Study|Lost to Follow-up|9|||
147363399|NCT00450216|531501900|FG000|Overall Study|upper gastrointestinal (UGI) ulcer|51|||
147363400|NCT00450216|531501901|FG001|Overall Study|upper gastrointestinal (UGI) ulcer|51|||
147363401|NCT00450216|531501900|FG000|Overall Study|misc|21|||
147363402|NCT00450216|531501901|FG001|Overall Study|misc|20|||
147363403|NCT05112900|531501905|FG000|Overall Study|Withdrawal by Subject|960|||
147363404|NCT05112900|531501906|FG001|Overall Study|Withdrawal by Subject|921|||
147363405|NCT05112900|531501907|FG002|Overall Study|Withdrawal by Subject|968|||
147363406|NCT00319111|531501908|FG000|Overall Study|Adverse Event|20|||
147363407|NCT00319111|531501908|FG000|Overall Study|Withdrawal of consent|11|||
147363408|NCT00319111|531501908|FG000|Overall Study|Death|9|||
147363409|NCT00319111|531501908|FG000|Overall Study|Lack of clinical improvement|4|||
147363410|NCT00319111|531501908|FG000|Overall Study|Administrative|2|||
147363411|NCT00319111|531501908|FG000|Overall Study|Treatment failure|1|||
147363412|NCT02919917|531501911|FG000|Overall Study|Withdrawal by Subject|4|||
147363413|NCT02919917|531501912|FG001|Overall Study|Withdrawal by Subject|8|||
147363414|NCT04743973|531501914|FG000|Overall Study|Withdrawal by Subject|5|||
147363415|NCT04330040|531501915|FG000|Overall Study|Other: Adverse event|5|||
147363416|NCT04330040|531501916|FG001|Overall Study|Other: Adverse event|0|||
147363417|NCT04330040|531501917|FG002|Overall Study|Other: Adverse event|0|||
147363418|NCT04330040|531501915|FG000|Overall Study|Disease progression|38|||
147363419|NCT04330040|531501916|FG001|Overall Study|Disease progression|10|||
147363420|NCT04330040|531501917|FG002|Overall Study|Disease progression|0|||
147363421|NCT04330040|531501915|FG000|Overall Study|Physician Decision|5|||
147363422|NCT04330040|531501916|FG001|Overall Study|Physician Decision|3|||
147363423|NCT04330040|531501917|FG002|Overall Study|Physician Decision|0|||
147363424|NCT04330040|531501915|FG000|Overall Study|Lost to Follow-up|1|||
147363425|NCT04330040|531501916|FG001|Overall Study|Lost to Follow-up|1|||
147363426|NCT04330040|531501917|FG002|Overall Study|Lost to Follow-up|0|||
147363427|NCT04330040|531501915|FG000|Overall Study|Death|2|||
147363428|NCT04330040|531501916|FG001|Overall Study|Death|1|||
147363429|NCT04330040|531501917|FG002|Overall Study|Death|0|||
147363430|NCT04330040|531501915|FG000|Overall Study|Withdrawal by Subject|3|||
147363431|NCT04330040|531501916|FG001|Overall Study|Withdrawal by Subject|3|||
147363432|NCT04330040|531501917|FG002|Overall Study|Withdrawal by Subject|0|||
147363433|NCT04330040|531501915|FG000|Overall Study|Other: Increased QTc interval and clinical progression found|0|||
147363434|NCT04330040|531501916|FG001|Overall Study|Other: Increased QTc interval and clinical progression found|1|||
147363435|NCT04330040|531501917|FG002|Overall Study|Other: Increased QTc interval and clinical progression found|0|||
147363436|NCT04330040|531501915|FG000|Overall Study|Other: Progressive disease (no confirming documents)|0|||
147363437|NCT04330040|531501916|FG001|Overall Study|Other: Progressive disease (no confirming documents)|1|||
147363438|NCT04330040|531501917|FG002|Overall Study|Other: Progressive disease (no confirming documents)|0|||
147363439|NCT04330040|531501915|FG000|Overall Study|Other: Disease progression|1|||
147363440|NCT04330040|531501916|FG001|Overall Study|Other: Disease progression|0|||
147363441|NCT04330040|531501917|FG002|Overall Study|Other: Disease progression|0|||
147363442|NCT04330040|531501915|FG000|Overall Study|Other: Due to anemia the investigator decided not to continue|1|||
147454238|NCT04179175|531825557|FG005|Overall Study|Technical problems|0|||
147363443|NCT04330040|531501916|FG001|Overall Study|Other: Due to anemia the investigator decided not to continue|0|||
147363444|NCT04330040|531501917|FG002|Overall Study|Other: Due to anemia the investigator decided not to continue|0|||
147454239|NCT05593016|531825558|FG000|Overall Study|Death|1|||
147454240|NCT05593016|531825559|FG001|Overall Study|Death|1|||
147454241|NCT05593016|531825560|FG002|Overall Study|Death|1|||
147454242|NCT05593016|531825561|FG003|Overall Study|Death|0|||
147363445|NCT04330040|531501915|FG000|Overall Study|Other: Due to disease progression and could not tolerate the dose|1|||
147363446|NCT04330040|531501916|FG001|Overall Study|Other: Due to disease progression and could not tolerate the dose|0|||
147608653|NCT04784533|532382685|FG003|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
147608654|NCT04784533|532382686|FG004|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
147608655|NCT04784533|532382687|FG005|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
147608656|NCT04784533|532382688|FG006|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
147608657|NCT04784533|532382689|FG007|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
147363447|NCT04330040|531501917|FG002|Overall Study|Other: Due to disease progression and could not tolerate the dose|0|||
147363448|NCT04330040|531501915|FG000|Overall Study|Enrolled and did not receive study drug (not included in Safety Analysis Set)|2|||
147363449|NCT04330040|531501916|FG001|Overall Study|Enrolled and did not receive study drug (not included in Safety Analysis Set)|0|||
147363450|NCT04330040|531501917|FG002|Overall Study|Enrolled and did not receive study drug (not included in Safety Analysis Set)|0|||
147363451|NCT02461134|531501919|FG000|Overall Study|Adverse Event|1|||
147363452|NCT04499521|531501922|FG000|Overall Study|Disease Progression|1|||
147363453|NCT04499521|531501923|FG001|Overall Study|Disease Progression|0|||
147363454|NCT04678856|531501924|FG000|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|3|||
147363455|NCT04678856|531501925|FG001|Overall Study|Not related to Coronavirus Disease-2019 (COVID-19)|0|||
147363456|NCT04678856|531501924|FG000|Overall Study|Withdrawal by Subject|5|||
147363457|NCT04678856|531501925|FG001|Overall Study|Withdrawal by Subject|1|||
147363458|NCT03734029|531501926|FG000|Overall Study|Progressive disease as per RECIST v1.1|220|||
147363459|NCT03734029|531501927|FG001|Overall Study|Progressive disease as per RECIST v1.1|130|||
147363460|NCT03734029|531501926|FG000|Overall Study|Adverse Event|60|||
147363461|NCT03734029|531501927|FG001|Overall Study|Adverse Event|14|||
147363462|NCT03734029|531501926|FG000|Overall Study|Withdrawal by Subject|12|||
147363463|NCT03734029|531501927|FG001|Overall Study|Withdrawal by Subject|11|||
147363464|NCT03734029|531501926|FG000|Overall Study|Clinical progression by investigator|10|||
147363465|NCT03734029|531501927|FG001|Overall Study|Clinical progression by investigator|8|||
147363466|NCT03734029|531501926|FG000|Overall Study|Death|5|||
147363467|NCT03734029|531501927|FG001|Overall Study|Death|2|||
147363468|NCT03734029|531501926|FG000|Overall Study|Physician Decision|4|||
147363469|NCT03734029|531501927|FG001|Overall Study|Physician Decision|3|||
147363470|NCT03734029|531501926|FG000|Overall Study|Other|2|||
147363471|NCT03734029|531501927|FG001|Overall Study|Other|0|||
147363472|NCT03734029|531501926|FG000|Overall Study|Lost to Follow-up|0|||
147363473|NCT03734029|531501927|FG001|Overall Study|Lost to Follow-up|1|||
147363474|NCT03734029|531501926|FG000|Overall Study|Randomized, but not treated|2|||
147363475|NCT03734029|531501927|FG001|Overall Study|Randomized, but not treated|12|||
147363476|NCT04427007|531502797|FG000|Overall Study|Unable to use the experimental liner due to suspension issues. Incomplete data collection.|0|||
147363477|NCT04427007|531502798|FG001|Overall Study|Unable to use the experimental liner due to suspension issues. Incomplete data collection.|1|||
147363478|NCT04165213|531502809|FG000|Clinician Enrollment|Did not deliver COPE to dyads|1|||
147363479|NCT04165213|531502810|FG001|Clinician Enrollment|Did not deliver COPE to dyads|2|||
147363480|NCT04165213|531502809|FG000|Clinician Enrollment|Withdrawal by Subject|6|||
147363481|NCT04165213|531502810|FG001|Clinician Enrollment|Withdrawal by Subject|0|||
147363482|NCT04165213|531502809|FG000|Clinician Enrollment|Termination from site|0|||
147363483|NCT04165213|531502810|FG001|Clinician Enrollment|Termination from site|1|||
147363484|NCT04165213|531502809|FG000|Caregiver Enrollment|Withdrawal by Subject|0|||
147363485|NCT04165213|531502810|FG001|Caregiver Enrollment|Withdrawal by Subject|5|||
147363486|NCT04165213|531502809|FG000|Caregiver Enrollment|Lost to Follow-up|1|||
147363487|NCT04165213|531502810|FG001|Caregiver Enrollment|Lost to Follow-up|1|||
147363488|NCT04165213|531502809|FG000|Caregiver Enrollment|Physician Decision|1|||
147363489|NCT04165213|531502810|FG001|Caregiver Enrollment|Physician Decision|0|||
147363490|NCT04165213|531502809|FG000|Caregiver Enrollment|PLWD entered long term care, no longer eligible|1|||
147363491|NCT04165213|531502810|FG001|Caregiver Enrollment|PLWD entered long term care, no longer eligible|0|||
147363492|NCT04165213|531502809|FG000|Caregiver Enrollment|PLWD death|2|||
147363493|NCT04165213|531502810|FG001|Caregiver Enrollment|PLWD death|0|||
147363494|NCT04165213|531502809|FG000|Caregiver Enrollment|Did not receive minimal dose of COPE|0|||
147363495|NCT04165213|531502810|FG001|Caregiver Enrollment|Did not receive minimal dose of COPE|4|||
147363496|NCT04165213|531502809|FG000|PLWD Enrollment|Withdrawal by Subject|0|||
147363497|NCT04165213|531502810|FG001|PLWD Enrollment|Withdrawal by Subject|5|||
147608658|NCT04784533|532382690|FG008|Part B (Day 1 to Week 24)|Lost to Follow-up|1|||
147608659|NCT04784533|532382691|FG009|Part B (Day 1 to Week 24)|Lost to Follow-up|0|||
147608660|NCT04784533|532382682|FG000|Part B (Day 1 to Week 24)|Reason not Specified|0|||
147363498|NCT04165213|531502809|FG000|PLWD Enrollment|Lost to Follow-up|1|||
147363499|NCT04165213|531502810|FG001|PLWD Enrollment|Lost to Follow-up|1|||
147363500|NCT04165213|531502809|FG000|PLWD Enrollment|Physician Decision|1|||
147363501|NCT04165213|531502810|FG001|PLWD Enrollment|Physician Decision|0|||
147363502|NCT04165213|531502809|FG000|PLWD Enrollment|Entered long term care, no longer eligible|1|||
147363503|NCT04165213|531502810|FG001|PLWD Enrollment|Entered long term care, no longer eligible|0|||
147363504|NCT04165213|531502809|FG000|PLWD Enrollment|Death|2|||
147363505|NCT04165213|531502810|FG001|PLWD Enrollment|Death|0|||
147363506|NCT04165213|531502809|FG000|PLWD Enrollment|Did not receive minimal dose of COPE|0|||
147363507|NCT04165213|531502810|FG001|PLWD Enrollment|Did not receive minimal dose of COPE|4|||
147363508|NCT04464564|531502811|FG000|Period A (Placebo lead-in)|Other|5|||
147363509|NCT04464564|531502812|FG001|Period A (Placebo lead-in)|Other|0|||
147363510|NCT04464564|531502813|FG002|Period A (Placebo lead-in)|Other|0|||
147363511|NCT04464564|531502814|FG003|Period A (Placebo lead-in)|Other|0|||
147363512|NCT04464564|531502811|FG000|Period B (Randomization Period)|Adverse Event|0|||
147363513|NCT04464564|531502812|FG001|Period B (Randomization Period)|Adverse Event|1|||
147363514|NCT04464564|531502813|FG002|Period B (Randomization Period)|Adverse Event|2|||
147363515|NCT04464564|531502814|FG003|Period B (Randomization Period)|Adverse Event|8|||
147363516|NCT04464564|531502811|FG000|Period B (Randomization Period)|Lack of Efficacy|0|||
147363517|NCT04464564|531502812|FG001|Period B (Randomization Period)|Lack of Efficacy|1|||
147363518|NCT04464564|531502813|FG002|Period B (Randomization Period)|Lack of Efficacy|0|||
147363519|NCT04464564|531502814|FG003|Period B (Randomization Period)|Lack of Efficacy|0|||
147363520|NCT04464564|531502811|FG000|Period B (Randomization Period)|Lost to Follow-up|0|||
147363521|NCT04464564|531502812|FG001|Period B (Randomization Period)|Lost to Follow-up|0|||
147363522|NCT04464564|531502813|FG002|Period B (Randomization Period)|Lost to Follow-up|0|||
147363523|NCT04464564|531502814|FG003|Period B (Randomization Period)|Lost to Follow-up|1|||
147363524|NCT04464564|531502811|FG000|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|0|||
147363525|NCT04464564|531502812|FG001|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|3|||
147363526|NCT04464564|531502813|FG002|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|3|||
147363527|NCT04464564|531502814|FG003|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|5|||
147363528|NCT04464564|531502811|FG000|Period B (Randomization Period)|Study Terminated by Sponsor|0|||
147363529|NCT04464564|531502812|FG001|Period B (Randomization Period)|Study Terminated by Sponsor|10|||
147363530|NCT04464564|531502813|FG002|Period B (Randomization Period)|Study Terminated by Sponsor|10|||
147363531|NCT04464564|531502814|FG003|Period B (Randomization Period)|Study Terminated by Sponsor|7|||
147363532|NCT04464564|531502811|FG000|Period B (Randomization Period)|Withdrawal by Subject|0|||
147363533|NCT04464564|531502812|FG001|Period B (Randomization Period)|Withdrawal by Subject|2|||
147363534|NCT04464564|531502813|FG002|Period B (Randomization Period)|Withdrawal by Subject|4|||
147363535|NCT04464564|531502814|FG003|Period B (Randomization Period)|Withdrawal by Subject|1|||
147363536|NCT04464564|531502811|FG000|Period B (Randomization Period)|Reason not Specified|0|||
147363537|NCT04464564|531502812|FG001|Period B (Randomization Period)|Reason not Specified|3|||
147363538|NCT04464564|531502813|FG002|Period B (Randomization Period)|Reason not Specified|3|||
147363539|NCT04464564|531502814|FG003|Period B (Randomization Period)|Reason not Specified|3|||
147363540|NCT04282980|531502817|FG000|Overall Study|Remained on treatment|6|||
147363541|NCT04282980|531502817|FG000|Overall Study|Survival follow-up|11|||
147363542|NCT04282980|531502817|FG000|Overall Study|Withdrawal of informed consent|1|||
147363543|NCT04282980|531502817|FG000|Overall Study|Lost to Follow-up|1|||
147363544|NCT05007080|531502818|FG000|Overall Study|Lost to Follow-up|0|||
147363545|NCT05007080|531502819|FG001|Overall Study|Lost to Follow-up|1|||
147363546|NCT05007080|531502820|FG002|Overall Study|Lost to Follow-up|0|||
147363547|NCT05007080|531502821|FG003|Overall Study|Lost to Follow-up|1|||
147363548|NCT05007080|531502822|FG004|Overall Study|Lost to Follow-up|1|||
147363549|NCT05007080|531502823|FG005|Overall Study|Lost to Follow-up|1|||
147363550|NCT05007080|531502818|FG000|Overall Study|Death|0|||
147363551|NCT05007080|531502819|FG001|Overall Study|Death|1|||
147363552|NCT05007080|531502820|FG002|Overall Study|Death|0|||
147363553|NCT05007080|531502821|FG003|Overall Study|Death|0|||
147363554|NCT05007080|531502822|FG004|Overall Study|Death|0|||
147363555|NCT05007080|531502823|FG005|Overall Study|Death|0|||
147363556|NCT05007080|531502818|FG000|Overall Study|Withdrawal by Subject|1|||
147363557|NCT05007080|531502819|FG001|Overall Study|Withdrawal by Subject|2|||
147363558|NCT05007080|531502820|FG002|Overall Study|Withdrawal by Subject|0|||
147363559|NCT05007080|531502821|FG003|Overall Study|Withdrawal by Subject|2|||
147363560|NCT05007080|531502822|FG004|Overall Study|Withdrawal by Subject|1|||
147363561|NCT05007080|531502823|FG005|Overall Study|Withdrawal by Subject|1|||
147363562|NCT05007080|531502818|FG000|Overall Study|Other|1|||
147363563|NCT05007080|531502819|FG001|Overall Study|Other|0|||
147363564|NCT05007080|531502820|FG002|Overall Study|Other|1|||
147363565|NCT05007080|531502821|FG003|Overall Study|Other|1|||
147363566|NCT05007080|531502822|FG004|Overall Study|Other|0|||
147363567|NCT05007080|531502823|FG005|Overall Study|Other|2|||
147363568|NCT05007080|531502818|FG000|Overall Study|Randomized not vaccinated|0|||
147363569|NCT05007080|531502819|FG001|Overall Study|Randomized not vaccinated|0|||
147363570|NCT05007080|531502820|FG002|Overall Study|Randomized not vaccinated|0|||
147363571|NCT05007080|531502821|FG003|Overall Study|Randomized not vaccinated|0|||
147363572|NCT05007080|531502822|FG004|Overall Study|Randomized not vaccinated|0|||
147454243|NCT05593016|531825562|FG004|Overall Study|Death|0|||
147454244|NCT05593016|531825558|FG000|Overall Study|Lost to Follow-up|1|||
147363573|NCT05007080|531502823|FG005|Overall Study|Randomized not vaccinated|1|||
147363574|NCT03370913|531502827|FG000|Overall Study|Death|1|||
147363575|NCT03370913|531502827|FG000|Overall Study|Lost to Follow-up|1|||
147363576|NCT04631016|531502832|FG000|Overall Study|Adverse Event|3|||
147363577|NCT04631016|531502833|FG001|Overall Study|Adverse Event|0|||
147363578|NCT04631016|531502832|FG000|Overall Study|Withdrawal by Subject|5|||
147363579|NCT04631016|531502833|FG001|Overall Study|Withdrawal by Subject|4|||
147363580|NCT04631016|531502832|FG000|Overall Study|Reason unspecified|1|||
147363581|NCT04631016|531502833|FG001|Overall Study|Reason unspecified|0|||
147363582|NCT04631016|531502832|FG000|Overall Study|Failure to meet randomization criteria|2|||
147363583|NCT04631016|531502833|FG001|Overall Study|Failure to meet randomization criteria|1|||
147363584|NCT04967599|531502834|FG000|Overall Study|Lost to Follow-up|35|||
147363585|NCT04967599|531502835|FG001|Overall Study|Lost to Follow-up|19|||
147363586|NCT04967599|531502836|FG002|Overall Study|Lost to Follow-up|23|||
147363587|NCT04490109|531502837|FG000|Overall Study|Lost to Follow-up|3|||
147363588|NCT04490109|531502838|FG001|Overall Study|Lost to Follow-up|10|||
147363589|NCT04490109|531502839|FG002|Overall Study|Lost to Follow-up|4|||
147363590|NCT04490109|531502837|FG000|Overall Study|Withdrawal by Subject|8|||
147363591|NCT04490109|531502838|FG001|Overall Study|Withdrawal by Subject|6|||
147363592|NCT04490109|531502839|FG002|Overall Study|Withdrawal by Subject|9|||
147363593|NCT04490109|531502837|FG000|Overall Study|Physician Decision|0|||
147363594|NCT04490109|531502838|FG001|Overall Study|Physician Decision|2|||
147363595|NCT04490109|531502839|FG002|Overall Study|Physician Decision|3|||
147363596|NCT04490109|531502837|FG000|Overall Study|Adverse Event|2|||
147363597|NCT04490109|531502838|FG001|Overall Study|Adverse Event|1|||
147363598|NCT04490109|531502839|FG002|Overall Study|Adverse Event|0|||
147363599|NCT04490109|531502837|FG000|Overall Study|Significant Non-Compliance|2|||
147363600|NCT04490109|531502838|FG001|Overall Study|Significant Non-Compliance|4|||
147363601|NCT04490109|531502839|FG002|Overall Study|Significant Non-Compliance|4|||
147363602|NCT04490109|531502837|FG000|Overall Study|Significant Clinical Event|0|||
147363603|NCT04490109|531502838|FG001|Overall Study|Significant Clinical Event|1|||
147363604|NCT04490109|531502839|FG002|Overall Study|Significant Clinical Event|0|||
147363605|NCT04490109|531502837|FG000|Overall Study|Other Reason|4|||
147363606|NCT04490109|531502838|FG001|Overall Study|Other Reason|1|||
147363607|NCT04490109|531502839|FG002|Overall Study|Other Reason|1|||
147363608|NCT04163991|531502840|FG000|Overall Study|Adverse Event|0|||
147363609|NCT04163991|531502841|FG001|Overall Study|Adverse Event|0|||
147363610|NCT04163991|531502842|FG002|Overall Study|Adverse Event|0|||
147363611|NCT04163991|531502843|FG003|Overall Study|Adverse Event|1|||
147363612|NCT04163991|531502844|FG004|Overall Study|Adverse Event|0|||
147363613|NCT04163991|531502840|FG000|Overall Study|Death|0|||
147363614|NCT04163991|531502841|FG001|Overall Study|Death|0|||
147363615|NCT04163991|531502842|FG002|Overall Study|Death|1|||
147363616|NCT04163991|531502843|FG003|Overall Study|Death|0|||
147363617|NCT04163991|531502844|FG004|Overall Study|Death|0|||
147363618|NCT04163991|531502840|FG000|Overall Study|Lost to Follow-up|0|||
147363619|NCT04163991|531502841|FG001|Overall Study|Lost to Follow-up|1|||
147363620|NCT04163991|531502842|FG002|Overall Study|Lost to Follow-up|0|||
147363621|NCT04163991|531502843|FG003|Overall Study|Lost to Follow-up|0|||
147363622|NCT04163991|531502844|FG004|Overall Study|Lost to Follow-up|0|||
147363623|NCT04163991|531502840|FG000|Overall Study|Withdrawal by Subject|1|||
147363624|NCT04163991|531502841|FG001|Overall Study|Withdrawal by Subject|1|||
147363625|NCT04163991|531502842|FG002|Overall Study|Withdrawal by Subject|3|||
147363626|NCT04163991|531502843|FG003|Overall Study|Withdrawal by Subject|1|||
147363627|NCT04163991|531502844|FG004|Overall Study|Withdrawal by Subject|1|||
147363628|NCT04163991|531502840|FG000|Overall Study|Other, Not Specified|0|||
147363629|NCT04163991|531502841|FG001|Overall Study|Other, Not Specified|1|||
147363630|NCT04163991|531502842|FG002|Overall Study|Other, Not Specified|1|||
147363631|NCT04163991|531502843|FG003|Overall Study|Other, Not Specified|1|||
147363632|NCT04163991|531502844|FG004|Overall Study|Other, Not Specified|0|||
147363633|NCT03880955|531502845|FG000|Overall Study|Adverse Event|1|||
147363634|NCT03880955|531502845|FG000|Overall Study|Death|1|||
147363635|NCT03880955|531502845|FG000|Overall Study|Lost to Follow-up|12|||
147363636|NCT03880955|531502845|FG000|Overall Study|Withdrawal by Subject|4|||
147363637|NCT03880955|531502845|FG000|Overall Study|Missing- Study Site Closed|27|||
147363638|NCT03817983|531502846|FG000|ProSpA-CD Assess Phase|MRI not performed|0|||
147363639|NCT03817983|531502847|FG001|ProSpA-CD Assess Phase|MRI not performed|0|||
147363640|NCT03817983|531502848|FG002|ProSpA-CD Assess Phase|MRI not performed|7|||
147363641|NCT03744676|531502849|FG000|Pre-Treatment Phase|Disease related complications|2|||
147363642|NCT03744676|531502849|FG000|Pre-Treatment Phase|No longer meets study criteria|4|||
147363643|NCT03744676|531502849|FG000|Pre-Treatment Phase|Death|7|||
147363644|NCT03744676|531502849|FG000|Pre-Treatment Phase|Other Reasons|7|||
147363645|NCT03744676|531502849|FG000|Treatment Phase|Participant withdrew consent|8|||
147363646|NCT03744676|531502849|FG000|Treatment Phase|Death|33|||
147363647|NCT03744676|531502849|FG000|Treatment Phase|other reasons|6|||
147363648|NCT04078152|531502850|FG000|Overall Study|Other|83|||
147608661|NCT04784533|532382683|FG001|Part B (Day 1 to Week 24)|Reason not Specified|0|||
147363649|NCT04078152|531502851|FG001|Overall Study|Other|22|||
147363650|NCT04078152|531502852|FG002|Overall Study|Other|25|||
147363651|NCT04078152|531502850|FG000|Overall Study|Development of study specific withdrawal criteria|1|||
147363652|NCT04078152|531502851|FG001|Overall Study|Development of study specific withdrawal criteria|1|||
147363653|NCT04078152|531502852|FG002|Overall Study|Development of study specific withdrawal criteria|0|||
147363654|NCT04078152|531502850|FG000|Overall Study|Withdrawal by Subject|5|||
147363655|NCT04078152|531502851|FG001|Overall Study|Withdrawal by Subject|0|||
147363656|NCT04078152|531502852|FG002|Overall Study|Withdrawal by Subject|1|||
147363657|NCT04078152|531502850|FG000|Overall Study|Death|10|||
147363658|NCT04078152|531502851|FG001|Overall Study|Death|2|||
147363659|NCT04078152|531502852|FG002|Overall Study|Death|12|||
147363660|NCT04078152|531502850|FG000|Overall Study|Adverse Event|1|||
147363661|NCT04078152|531502851|FG001|Overall Study|Adverse Event|0|||
147363662|NCT04078152|531502852|FG002|Overall Study|Adverse Event|0|||
147363663|NCT02624050|531502858|FG000|Overall Study|Physician Decision|4|||
147363664|NCT02624050|531502859|FG001|Overall Study|Physician Decision|0|||
147363665|NCT02624050|531502858|FG000|Overall Study|Protocol Violation|2|||
147363666|NCT02624050|531502859|FG001|Overall Study|Protocol Violation|0|||
147363667|NCT03279978|531502861|FG000|Overall Study|Withdrawal by Subject|0|||
147363668|NCT03279978|531502862|FG001|Overall Study|Withdrawal by Subject|1|||
147363669|NCT03279978|531502863|FG002|Overall Study|Withdrawal by Subject|0|||
147363670|NCT03279978|531502864|FG003|Overall Study|Withdrawal by Subject|0|||
147363671|NCT03279978|531502865|FG004|Overall Study|Withdrawal by Subject|0|||
147363672|NCT03279978|531502866|FG005|Overall Study|Withdrawal by Subject|0|||
147363673|NCT03279978|531502867|FG006|Overall Study|Withdrawal by Subject|0|||
147363674|NCT03279978|531502868|FG007|Overall Study|Withdrawal by Subject|0|||
147363675|NCT03279978|531502869|FG008|Overall Study|Withdrawal by Subject|0|||
147363676|NCT03279978|531502870|FG009|Overall Study|Withdrawal by Subject|1|||
147363677|NCT03279978|531502861|FG000|Overall Study|Lost to Follow-up|1|||
147363678|NCT03279978|531502862|FG001|Overall Study|Lost to Follow-up|0|||
147363679|NCT03279978|531502863|FG002|Overall Study|Lost to Follow-up|1|||
147363680|NCT03279978|531502864|FG003|Overall Study|Lost to Follow-up|0|||
147363681|NCT03279978|531502865|FG004|Overall Study|Lost to Follow-up|0|||
147363682|NCT03279978|531502866|FG005|Overall Study|Lost to Follow-up|0|||
147363683|NCT03279978|531502867|FG006|Overall Study|Lost to Follow-up|0|||
147363684|NCT03279978|531502868|FG007|Overall Study|Lost to Follow-up|0|||
147363685|NCT03279978|531502869|FG008|Overall Study|Lost to Follow-up|0|||
147363686|NCT03279978|531502870|FG009|Overall Study|Lost to Follow-up|0|||
147363687|NCT03279978|531502861|FG000|Overall Study|Other than stated above|0|||
147363688|NCT03279978|531502862|FG001|Overall Study|Other than stated above|0|||
147363689|NCT03279978|531502863|FG002|Overall Study|Other than stated above|0|||
147363690|NCT03279978|531502864|FG003|Overall Study|Other than stated above|0|||
147363691|NCT03279978|531502865|FG004|Overall Study|Other than stated above|0|||
147363692|NCT03279978|531502866|FG005|Overall Study|Other than stated above|0|||
147363693|NCT03279978|531502867|FG006|Overall Study|Other than stated above|1|||
147363694|NCT03279978|531502868|FG007|Overall Study|Other than stated above|0|||
147363695|NCT03279978|531502869|FG008|Overall Study|Other than stated above|0|||
147363696|NCT03279978|531502870|FG009|Overall Study|Other than stated above|0|||
147363697|NCT03493542|531502871|FG000|Base Study|Withdrawal by Subject|0|||
147363698|NCT03493542|531502872|FG001|Base Study|Withdrawal by Subject|4|||
147363699|NCT03493542|531502873|FG002|Base Study|Withdrawal by Subject|0|||
147363700|NCT03493542|531502871|FG000|Extension Study|Consent withdrawal by parent/guardian|0|||
147363701|NCT03493542|531502872|FG001|Extension Study|Consent withdrawal by parent/guardian|0|||
147363702|NCT03493542|531502873|FG002|Extension Study|Consent withdrawal by parent/guardian|2|||
147363703|NCT03493542|531502871|FG000|Extension Study|Withdrawal by Subject|0|||
147363704|NCT03493542|531502872|FG001|Extension Study|Withdrawal by Subject|0|||
147363705|NCT03493542|531502873|FG002|Extension Study|Withdrawal by Subject|25|||
147363706|NCT01756300|531502879|FG000|Overall Study|Death|1|||
147363707|NCT01756300|531502879|FG000|Overall Study|Withdrawal by Subject|1|||
147363708|NCT04244175|531503604|FG000|Overall Study|Adverse Event|3|||
147363709|NCT04244175|531503605|FG001|Overall Study|Adverse Event|2|||
147363710|NCT04244175|531503606|FG002|Overall Study|Adverse Event|5|||
147363711|NCT04244175|531503604|FG000|Overall Study|Lack of Efficacy|1|||
147363712|NCT04244175|531503605|FG001|Overall Study|Lack of Efficacy|0|||
147363713|NCT04244175|531503606|FG002|Overall Study|Lack of Efficacy|1|||
147363714|NCT04244175|531503604|FG000|Overall Study|Lost to Follow-up|1|||
147363715|NCT04244175|531503605|FG001|Overall Study|Lost to Follow-up|0|||
147363716|NCT04244175|531503606|FG002|Overall Study|Lost to Follow-up|0|||
147363717|NCT04244175|531503604|FG000|Overall Study|Non-compliance with study drug|1|||
147363718|NCT04244175|531503605|FG001|Overall Study|Non-compliance with study drug|0|||
147363719|NCT04244175|531503606|FG002|Overall Study|Non-compliance with study drug|1|||
147363720|NCT04244175|531503604|FG000|Overall Study|Protocol deviation|0|||
147363721|NCT04244175|531503605|FG001|Overall Study|Protocol deviation|1|||
147363722|NCT04244175|531503606|FG002|Overall Study|Protocol deviation|0|||
147363723|NCT04244175|531503604|FG000|Overall Study|Withdrawal by Subject|1|||
147363724|NCT04244175|531503605|FG001|Overall Study|Withdrawal by Subject|3|||
147363725|NCT04244175|531503606|FG002|Overall Study|Withdrawal by Subject|1|||
147363726|NCT04244175|531503604|FG000|Overall Study|Other, not specified|0|||
147363727|NCT04244175|531503605|FG001|Overall Study|Other, not specified|1|||
147363728|NCT04244175|531503606|FG002|Overall Study|Other, not specified|2|||
147363729|NCT02095691|531503607|FG000|Overall Study|Physician Decision|1|||
147363730|NCT00887198|531503608|FG000|Randomized Period|Ongoing|42|||
147363731|NCT00887198|531503609|FG001|Randomized Period|Ongoing|0|||
147363732|NCT00887198|531503610|FG002|Randomized Period|Ongoing|0|||
147363733|NCT00887198|531503608|FG000|Randomized Period|Adverse Event|50|||
147363734|NCT00887198|531503609|FG001|Randomized Period|Adverse Event|33|||
147454245|NCT05593016|531825559|FG001|Overall Study|Lost to Follow-up|1|||
147363735|NCT00887198|531503610|FG002|Randomized Period|Adverse Event|0|||
147363736|NCT00887198|531503608|FG000|Randomized Period|Lost to Follow-up|1|||
147363737|NCT00887198|531503609|FG001|Randomized Period|Lost to Follow-up|0|||
147363738|NCT00887198|531503610|FG002|Randomized Period|Lost to Follow-up|0|||
147363739|NCT00887198|531503608|FG000|Randomized Period|Cross-over to AA (under amendment 3)|0|||
147363740|NCT00887198|531503609|FG001|Randomized Period|Cross-over to AA (under amendment 3)|51|||
147363741|NCT00887198|531503610|FG002|Randomized Period|Cross-over to AA (under amendment 3)|0|||
147363742|NCT00887198|531503608|FG000|Randomized Period|Withdrawal by Subject|41|||
147363743|NCT00887198|531503609|FG001|Randomized Period|Withdrawal by Subject|56|||
147363744|NCT00887198|531503610|FG002|Randomized Period|Withdrawal by Subject|0|||
147363745|NCT00887198|531503608|FG000|Randomized Period|Progressive disease|366|||
147363746|NCT00887198|531503609|FG001|Randomized Period|Progressive disease|370|||
147363747|NCT00887198|531503610|FG002|Randomized Period|Progressive disease|0|||
147363748|NCT00887198|531503608|FG000|Randomized Period|Other|42|||
147363749|NCT00887198|531503609|FG001|Randomized Period|Other|30|||
147363750|NCT00887198|531503610|FG002|Randomized Period|Other|0|||
147363751|NCT00887198|531503608|FG000|Randomized Period|Randomized, Not treated|4|||
147363752|NCT00887198|531503609|FG001|Randomized Period|Randomized, Not treated|2|||
147363753|NCT00887198|531503610|FG002|Randomized Period|Randomized, Not treated|0|||
147363754|NCT00887198|531503608|FG000|Cross Over (Placebo to AA)|Started other prostate cancer treatment|0|||
147363755|NCT00887198|531503609|FG001|Cross Over (Placebo to AA)|Started other prostate cancer treatment|0|||
147363756|NCT00887198|531503610|FG002|Cross Over (Placebo to AA)|Started other prostate cancer treatment|8|||
147363757|NCT00887198|531503608|FG000|Cross Over (Placebo to AA)|Ongoing|0|||
147363758|NCT00887198|531503609|FG001|Cross Over (Placebo to AA)|Ongoing|0|||
147363759|NCT00887198|531503610|FG002|Cross Over (Placebo to AA)|Ongoing|35|||
147363760|NCT00887198|531503608|FG000|Cross Over (Placebo to AA)|Adverse Event|0|||
147363761|NCT00887198|531503609|FG001|Cross Over (Placebo to AA)|Adverse Event|0|||
147363762|NCT00887198|531503610|FG002|Cross Over (Placebo to AA)|Adverse Event|9|||
147363763|NCT00887198|531503608|FG000|Cross Over (Placebo to AA)|Withdrawal by Subject|0|||
147363764|NCT00887198|531503609|FG001|Cross Over (Placebo to AA)|Withdrawal by Subject|0|||
147363765|NCT00887198|531503610|FG002|Cross Over (Placebo to AA)|Withdrawal by Subject|2|||
147363766|NCT00887198|531503608|FG000|Cross Over (Placebo to AA)|Progressive disease|0|||
147363767|NCT00887198|531503609|FG001|Cross Over (Placebo to AA)|Progressive disease|0|||
147363768|NCT00887198|531503610|FG002|Cross Over (Placebo to AA)|Progressive disease|20|||
147363769|NCT00887198|531503608|FG000|Cross Over (Placebo to AA)|Other|0|||
147363770|NCT00887198|531503609|FG001|Cross Over (Placebo to AA)|Other|0|||
147363771|NCT00887198|531503610|FG002|Cross Over (Placebo to AA)|Other|19|||
147363772|NCT05147584|531503611|FG000|Overall Study|Subjects consented but did not fully meet inclusion /exclusion criteria|8|||
147363773|NCT05830799|531503617|FG000|Overall Study|Withdrawal by Subject|1|||
147363774|NCT04173247|531503618|FG000|Overall Study|Withdrawal by Subject|0|||
147363775|NCT04173247|531503619|FG001|Overall Study|Withdrawal by Subject|2|||
147363776|NCT04173247|531503618|FG000|Overall Study|Death|1|||
147363777|NCT04173247|531503619|FG001|Overall Study|Death|0|||
147363778|NCT04173247|531503618|FG000|Overall Study|Physician Decision|1|||
147363779|NCT04173247|531503619|FG001|Overall Study|Physician Decision|0|||
147363780|NCT02163694|531503620|FG000|Overall Study|Adverse event- related to progression|4|||
147363781|NCT02163694|531503621|FG001|Overall Study|Adverse event- related to progression|10|||
147363782|NCT02163694|531503620|FG000|Overall Study|Adverse event- not related to progression|7|||
147363783|NCT02163694|531503621|FG001|Overall Study|Adverse event- not related to progression|22|||
147363784|NCT02163694|531503620|FG000|Overall Study|Withdrew consent|13|||
147363785|NCT02163694|531503621|FG001|Overall Study|Withdrew consent|28|||
147363786|NCT02163694|531503620|FG000|Overall Study|Lost to Follow-up|2|||
147363787|NCT02163694|531503621|FG001|Overall Study|Lost to Follow-up|2|||
147363788|NCT02163694|531503620|FG000|Overall Study|Sponsor discontinued study|3|||
147363789|NCT02163694|531503621|FG001|Overall Study|Sponsor discontinued study|29|||
147363790|NCT02163694|531503620|FG000|Overall Study|Progressive disease per protocol|125|||
147363791|NCT02163694|531503621|FG001|Overall Study|Progressive disease per protocol|224|||
147363792|NCT02163694|531503620|FG000|Overall Study|Other, not specified|17|||
147363793|NCT02163694|531503621|FG001|Overall Study|Other, not specified|22|||
147363794|NCT02163694|531503620|FG000|Overall Study|Randomized but Not Treated|1|||
147608662|NCT04784533|532382684|FG002|Part B (Day 1 to Week 24)|Reason not Specified|0|||
147363795|NCT02163694|531503621|FG001|Overall Study|Randomized but Not Treated|0|||
147363796|NCT02163694|531503620|FG000|Overall Study|Determined not to have a suspected deleterious or deleterious mutation in BRCA1/2|2|||
147363797|NCT02163694|531503621|FG001|Overall Study|Determined not to have a suspected deleterious or deleterious mutation in BRCA1/2|2|||
147363798|NCT03884101|531503622|FG000|Overall Study|Participant Ongoing in Study|202|||
147363799|NCT03884101|531503623|FG001|Overall Study|Participant Ongoing in Study|186|||
147363800|NCT03884101|531503622|FG000|Overall Study|Death|212|||
147363801|NCT03884101|531503623|FG001|Overall Study|Death|224|||
147363802|NCT03884101|531503622|FG000|Overall Study|Lost to Follow-up|0|||
147608663|NCT04784533|532382685|FG003|Part B (Day 1 to Week 24)|Reason not Specified|0|||
147363803|NCT03884101|531503623|FG001|Overall Study|Lost to Follow-up|1|||
147363804|NCT03884101|531503622|FG000|Overall Study|Withdrawal by Subject|6|||
147608664|NCT04784533|532382686|FG004|Part B (Day 1 to Week 24)|Reason not Specified|0|||
147363805|NCT03884101|531503623|FG001|Overall Study|Withdrawal by Subject|11|||
147363806|NCT04369911|531503626|FG000|Overall Study|Lost to Follow-up|3|||
147363807|NCT04369911|531503627|FG001|Overall Study|Lost to Follow-up|3|||
147363808|NCT04369911|531503626|FG000|Overall Study|Withdrawal by Subject|1|||
147363809|NCT04369911|531503627|FG001|Overall Study|Withdrawal by Subject|2|||
147363810|NCT05454514|531503628|FG000|Overall Study|Withdrawal by Subject|4|||
147363811|NCT05541484|531503631|FG000|Overall Study|Withdrawal by Subject|1|||
147363812|NCT05541484|531503632|FG001|Overall Study|Withdrawal by Subject|0|||
147363813|NCT05785130|531503635|FG000|Overall Study|Withdrawal by Subject|1|||
147363814|NCT05785130|531503636|FG001|Overall Study|Withdrawal by Subject|0|||
147363815|NCT05785130|531503635|FG000|Overall Study|Lack of Efficacy|0|||
147363816|NCT05785130|531503636|FG001|Overall Study|Lack of Efficacy|1|||
147363817|NCT04157517|531503637|FG000|Overall Study|Death|1|||
147363818|NCT04157517|531503638|FG001|Overall Study|Death|2|||
147363819|NCT04157517|531503639|FG002|Overall Study|Death|2|||
147363820|NCT04157517|531503640|FG003|Overall Study|Death|3|||
147363821|NCT04157517|531503641|FG004|Overall Study|Death|3|||
147363822|NCT04157517|531503642|FG005|Overall Study|Death|4|||
147363823|NCT04157517|531503643|FG006|Overall Study|Death|1|||
147363824|NCT04157517|531503644|FG007|Overall Study|Death|2|||
147363825|NCT04157517|531503645|FG008|Overall Study|Death|4|||
147363826|NCT04157517|531503646|FG009|Overall Study|Death|0|||
147363827|NCT04157517|531503637|FG000|Overall Study|Withdrawal by Subject|1|||
147363828|NCT04157517|531503638|FG001|Overall Study|Withdrawal by Subject|1|||
147363829|NCT04157517|531503639|FG002|Overall Study|Withdrawal by Subject|1|||
147363830|NCT04157517|531503640|FG003|Overall Study|Withdrawal by Subject|0|||
147363831|NCT04157517|531503641|FG004|Overall Study|Withdrawal by Subject|0|||
147363832|NCT04157517|531503642|FG005|Overall Study|Withdrawal by Subject|1|||
147363833|NCT04157517|531503643|FG006|Overall Study|Withdrawal by Subject|0|||
147363834|NCT04157517|531503644|FG007|Overall Study|Withdrawal by Subject|0|||
147363835|NCT04157517|531503645|FG008|Overall Study|Withdrawal by Subject|1|||
147363836|NCT04157517|531503646|FG009|Overall Study|Withdrawal by Subject|0|||
147363837|NCT04157517|531503637|FG000|Overall Study|Other|1|||
147363838|NCT04157517|531503638|FG001|Overall Study|Other|0|||
147363839|NCT04157517|531503639|FG002|Overall Study|Other|0|||
147363840|NCT04157517|531503640|FG003|Overall Study|Other|0|||
147363841|NCT04157517|531503641|FG004|Overall Study|Other|0|||
147363842|NCT04157517|531503642|FG005|Overall Study|Other|1|||
147363843|NCT04157517|531503643|FG006|Overall Study|Other|2|||
147363844|NCT04157517|531503644|FG007|Overall Study|Other|7|||
147363845|NCT04157517|531503645|FG008|Overall Study|Other|7|||
147363846|NCT04157517|531503646|FG009|Overall Study|Other|0|||
147363847|NCT04159519|531503651|FG000|Overall Study|Adverse Event|1|||
147363848|NCT04159519|531503652|FG001|Overall Study|Adverse Event|1|||
147363849|NCT04159519|531503651|FG000|Overall Study|Lack of Efficacy|1|||
147363850|NCT04159519|531503652|FG001|Overall Study|Lack of Efficacy|0|||
147363851|NCT04159519|531503651|FG000|Overall Study|Discontinued from study|1|||
147363852|NCT04159519|531503652|FG001|Overall Study|Discontinued from study|0|||
147363853|NCT04159519|531503651|FG000|Overall Study|Protocol Violation|1|||
147363854|NCT04159519|531503652|FG001|Overall Study|Protocol Violation|1|||
147363855|NCT04159519|531503651|FG000|Overall Study|Withdrawal by Subject|4|||
147363856|NCT04159519|531503652|FG001|Overall Study|Withdrawal by Subject|4|||
147363857|NCT04780581|531503653|FG000|Full Modified Intention-to-treat Anal.|Protocol Violation|1|||
147363858|NCT04780581|531503654|FG001|Full Modified Intention-to-treat Anal.|Protocol Violation|2|||
147363859|NCT04780581|531503653|FG000|Overall Study (90 Days)|Lost to Follow-up|0|||
147363860|NCT04780581|531503654|FG001|Overall Study (90 Days)|Lost to Follow-up|2|||
147363861|NCT01651000|531503655|FG000|Overall Study|Adverse Event|2|||
147363862|NCT01651000|531503656|FG001|Overall Study|Adverse Event|8|||
147363863|NCT01651000|531503655|FG000|Overall Study|Lost to Follow-up|3|||
147363864|NCT01651000|531503656|FG001|Overall Study|Lost to Follow-up|2|||
147363865|NCT01651000|531503655|FG000|Overall Study|Protocol Violation|0|||
147363866|NCT01651000|531503656|FG001|Overall Study|Protocol Violation|3|||
147363867|NCT01651000|531503655|FG000|Overall Study|Withdrawal by Subject|2|||
147363868|NCT01651000|531503656|FG001|Overall Study|Withdrawal by Subject|10|||
147363869|NCT01651000|531503655|FG000|Overall Study|Subject noncompliance|0|||
147363870|NCT01651000|531503656|FG001|Overall Study|Subject noncompliance|3|||
147363871|NCT01651000|531503655|FG000|Overall Study|Lack of Efficacy|1|||
147363872|NCT01651000|531503656|FG001|Overall Study|Lack of Efficacy|1|||
147363873|NCT01651000|531503655|FG000|Overall Study|Physician Decision|1|||
147363874|NCT01651000|531503656|FG001|Overall Study|Physician Decision|0|||
147363875|NCT01651000|531503655|FG000|Overall Study|Administrative reason|1|||
147363876|NCT01651000|531503656|FG001|Overall Study|Administrative reason|0|||
147363877|NCT01651000|531503655|FG000|Overall Study|Serum Ca >/= 11.0 mg/dL, repeat confirm|0|||
147363878|NCT01651000|531503656|FG001|Overall Study|Serum Ca >/= 11.0 mg/dL, repeat confirm|1|||
147363879|NCT02765412|531503657|FG000|Overall Study|Death|482|||
147363880|NCT02765412|531503658|FG001|Overall Study|Death|855|||
147363881|NCT03781089|531504330|FG000|Overall Study|Constipation|1|||
147363882|NCT03781089|531504331|FG001|Overall Study|Constipation|0|||
147363883|NCT03781089|531504330|FG000|Overall Study|Positive pregnancy test|0|||
147363884|NCT03781089|531504331|FG001|Overall Study|Positive pregnancy test|1|||
147363885|NCT03417284|531504332|FG000|Overall Study|Inadequate supply on study drug|1|||
147363886|NCT03417284|531504333|FG001|Overall Study|Inadequate supply on study drug|0|||
147363887|NCT03417284|531504334|FG002|Overall Study|Inadequate supply on study drug|0|||
147363888|NCT03417284|531504335|FG003|Overall Study|Inadequate supply on study drug|0|||
147363889|NCT03417284|531504332|FG000|Overall Study|Disease Progression|0|||
147363890|NCT03417284|531504333|FG001|Overall Study|Disease Progression|0|||
147363891|NCT03417284|531504334|FG002|Overall Study|Disease Progression|1|||
147363892|NCT03417284|531504335|FG003|Overall Study|Disease Progression|0|||
147363893|NCT03636490|531504336|FG000|Overall Study|Dropped out or incomplete data|141|||
147363894|NCT02246127|531504337|FG000|First Course Treatment|Adverse Event|9|||
147363895|NCT02246127|531504338|FG001|First Course Treatment|Adverse Event|7|||
147363896|NCT02246127|531504337|FG000|First Course Treatment|Withdrawal by Subject|6|||
147363897|NCT02246127|531504338|FG001|First Course Treatment|Withdrawal by Subject|7|||
147363898|NCT02246127|531504337|FG000|First Course Treatment|Physician Decision|9|||
147363899|NCT02246127|531504338|FG001|First Course Treatment|Physician Decision|9|||
147363900|NCT02246127|531504337|FG000|First Course Treatment|Death|3|||
147363901|NCT02246127|531504338|FG001|First Course Treatment|Death|3|||
147363902|NCT02246127|531504337|FG000|First Course Treatment|Not reported reasons|6|||
147363903|NCT02246127|531504338|FG001|First Course Treatment|Not reported reasons|7|||
147363904|NCT02246127|531504337|FG000|First Course Treatment|Not treated|3|||
147363905|NCT02246127|531504338|FG001|First Course Treatment|Not treated|3|||
147363906|NCT03635567|531504339|FG000|Overall Study|Lost to Follow-up|4|||
147363907|NCT03635567|531504340|FG001|Overall Study|Lost to Follow-up|1|||
147363908|NCT03635567|531504339|FG000|Overall Study|Withdrawal by Subject|11|||
147363909|NCT03635567|531504340|FG001|Overall Study|Withdrawal by Subject|16|||
147363910|NCT03635567|531504339|FG000|Overall Study|Sponsor Decision|99|||
147363911|NCT03635567|531504340|FG001|Overall Study|Sponsor Decision|57|||
147363912|NCT03635567|531504339|FG000|Overall Study|Death|194|||
147363913|NCT03635567|531504340|FG001|Overall Study|Death|235|||
147363914|NCT04560179|531504345|FG000|Overall Study|Physician Decision|1|||
147363915|NCT04560179|531504346|FG001|Overall Study|Physician Decision|0|||
147363916|NCT04560179|531504347|FG002|Overall Study|Physician Decision|0|||
147363917|NCT04560179|531504348|FG003|Overall Study|Physician Decision|0|||
147363918|NCT04560179|531504349|FG004|Overall Study|Physician Decision|0|||
147363919|NCT04560179|531504345|FG000|Overall Study|Adverse Event|0|||
147363920|NCT04560179|531504346|FG001|Overall Study|Adverse Event|0|||
147363921|NCT04560179|531504347|FG002|Overall Study|Adverse Event|0|||
147363922|NCT04560179|531504348|FG003|Overall Study|Adverse Event|1|||
147363923|NCT04560179|531504349|FG004|Overall Study|Adverse Event|0|||
147363924|NCT04214418|531504352|FG000|Overall Study|Withdrawal by Subject|1|||
147363925|NCT04214418|531504353|FG001|Overall Study|Withdrawal by Subject|0|||
147363926|NCT04214418|531504354|FG002|Overall Study|Withdrawal by Subject|0|||
147363927|NCT04214418|531504355|FG003|Overall Study|Withdrawal by Subject|0|||
147363928|NCT04214418|531504356|FG004|Overall Study|Withdrawal by Subject|0|||
147363929|NCT04214418|531504357|FG005|Overall Study|Withdrawal by Subject|0|||
147363930|NCT04214418|531504352|FG000|Overall Study|Adverse Event|0|||
147363931|NCT04214418|531504353|FG001|Overall Study|Adverse Event|2|||
147363932|NCT04214418|531504354|FG002|Overall Study|Adverse Event|0|||
147363933|NCT04214418|531504355|FG003|Overall Study|Adverse Event|0|||
147363934|NCT04214418|531504356|FG004|Overall Study|Adverse Event|0|||
147363935|NCT04214418|531504357|FG005|Overall Study|Adverse Event|0|||
147363936|NCT04214418|531504352|FG000|Overall Study|Death|1|||
147363937|NCT04214418|531504353|FG001|Overall Study|Death|0|||
147363938|NCT04214418|531504354|FG002|Overall Study|Death|0|||
147363939|NCT04214418|531504355|FG003|Overall Study|Death|0|||
147363940|NCT04214418|531504356|FG004|Overall Study|Death|0|||
147363941|NCT04214418|531504357|FG005|Overall Study|Death|0|||
147363942|NCT03248479|531504360|FG000|Overall Study|Death|12|||
147454246|NCT05593016|531825560|FG002|Overall Study|Lost to Follow-up|1|||
147454247|NCT05593016|531825561|FG003|Overall Study|Lost to Follow-up|2|||
147454248|NCT05593016|531825562|FG004|Overall Study|Lost to Follow-up|0|||
147363943|NCT03248479|531504361|FG001|Overall Study|Death|44|||
147363944|NCT03248479|531504362|FG002|Overall Study|Death|1|||
147363945|NCT03248479|531504363|FG003|Overall Study|Death|72|||
147363946|NCT03248479|531504364|FG004|Overall Study|Death|17|||
147363947|NCT03248479|531504365|FG005|Overall Study|Death|6|||
147363948|NCT03248479|531504366|FG006|Overall Study|Death|1|||
147363949|NCT03248479|531504367|FG007|Overall Study|Death|14|||
147363950|NCT03248479|531504368|FG008|Overall Study|Death|3|||
147363951|NCT03248479|531504369|FG009|Overall Study|Death|7|||
147363952|NCT03248479|531504370|FG010|Overall Study|Death|3|||
147363953|NCT03248479|531504371|FG011|Overall Study|Death|1|||
147363954|NCT03248479|531504372|FG012|Overall Study|Death|1|||
147363955|NCT03248479|531504360|FG000|Overall Study|Study terminated by sponsor|12|||
147363956|NCT03248479|531504361|FG001|Overall Study|Study terminated by sponsor|15|||
147363957|NCT03248479|531504362|FG002|Overall Study|Study terminated by sponsor|0|||
147363958|NCT03248479|531504363|FG003|Overall Study|Study terminated by sponsor|5|||
147363959|NCT03248479|531504364|FG004|Overall Study|Study terminated by sponsor|0|||
147454249|NCT04705051|531825563|FG000|Overall Study|Enrolled but not treated|1|||
147363960|NCT03248479|531504365|FG005|Overall Study|Study terminated by sponsor|0|||
147363961|NCT03248479|531504366|FG006|Overall Study|Study terminated by sponsor|0|||
147363962|NCT03248479|531504367|FG007|Overall Study|Study terminated by sponsor|1|||
147363963|NCT03248479|531504368|FG008|Overall Study|Study terminated by sponsor|1|||
147363964|NCT03248479|531504369|FG009|Overall Study|Study terminated by sponsor|0|||
147363965|NCT03248479|531504370|FG010|Overall Study|Study terminated by sponsor|5|||
147363966|NCT03248479|531504371|FG011|Overall Study|Study terminated by sponsor|4|||
147363967|NCT03248479|531504372|FG012|Overall Study|Study terminated by sponsor|0|||
147363968|NCT03248479|531504360|FG000|Overall Study|Consent withdrawn|6|||
147363969|NCT03248479|531504361|FG001|Overall Study|Consent withdrawn|3|||
147363970|NCT03248479|531504362|FG002|Overall Study|Consent withdrawn|0|||
147608665|NCT04784533|532382687|FG005|Part B (Day 1 to Week 24)|Reason not Specified|0|||
147363971|NCT03248479|531504363|FG003|Overall Study|Consent withdrawn|9|||
147363972|NCT03248479|531504364|FG004|Overall Study|Consent withdrawn|1|||
147363973|NCT03248479|531504365|FG005|Overall Study|Consent withdrawn|0|||
147363974|NCT03248479|531504366|FG006|Overall Study|Consent withdrawn|0|||
147363975|NCT03248479|531504367|FG007|Overall Study|Consent withdrawn|1|||
147363976|NCT03248479|531504368|FG008|Overall Study|Consent withdrawn|0|||
147363977|NCT03248479|531504369|FG009|Overall Study|Consent withdrawn|3|||
147363978|NCT03248479|531504370|FG010|Overall Study|Consent withdrawn|1|||
147363979|NCT03248479|531504371|FG011|Overall Study|Consent withdrawn|0|||
147363980|NCT03248479|531504372|FG012|Overall Study|Consent withdrawn|1|||
147363981|NCT03248479|531504360|FG000|Overall Study|Lost to Follow-up|2|||
147363982|NCT03248479|531504361|FG001|Overall Study|Lost to Follow-up|1|||
147363983|NCT03248479|531504362|FG002|Overall Study|Lost to Follow-up|0|||
147363984|NCT03248479|531504363|FG003|Overall Study|Lost to Follow-up|0|||
147363985|NCT03248479|531504364|FG004|Overall Study|Lost to Follow-up|0|||
147363986|NCT03248479|531504365|FG005|Overall Study|Lost to Follow-up|0|||
147363987|NCT03248479|531504366|FG006|Overall Study|Lost to Follow-up|0|||
147363988|NCT03248479|531504367|FG007|Overall Study|Lost to Follow-up|0|||
147363989|NCT03248479|531504368|FG008|Overall Study|Lost to Follow-up|0|||
147363990|NCT03248479|531504369|FG009|Overall Study|Lost to Follow-up|0|||
147363991|NCT03248479|531504370|FG010|Overall Study|Lost to Follow-up|0|||
147363992|NCT03248479|531504371|FG011|Overall Study|Lost to Follow-up|0|||
147363993|NCT03248479|531504372|FG012|Overall Study|Lost to Follow-up|1|||
147363994|NCT03248479|531504360|FG000|Overall Study|Not reported|0|||
147363995|NCT03248479|531504361|FG001|Overall Study|Not reported|0|||
147363996|NCT03248479|531504362|FG002|Overall Study|Not reported|0|||
147363997|NCT03248479|531504363|FG003|Overall Study|Not reported|1|||
147363998|NCT03248479|531504364|FG004|Overall Study|Not reported|1|||
147363999|NCT03248479|531504365|FG005|Overall Study|Not reported|0|||
147364000|NCT03248479|531504366|FG006|Overall Study|Not reported|0|||
147608666|NCT04784533|532382688|FG006|Part B (Day 1 to Week 24)|Reason not Specified|0|||
147608667|NCT04784533|532382689|FG007|Part B (Day 1 to Week 24)|Reason not Specified|0|||
147608668|NCT04784533|532382690|FG008|Part B (Day 1 to Week 24)|Reason not Specified|1|||
147608669|NCT04784533|532382691|FG009|Part B (Day 1 to Week 24)|Reason not Specified|1|||
147608670|NCT04324073|532384019|FG000|Overall Study|withdrew consent|0|||
147608671|NCT04324073|532384020|FG001|Overall Study|withdrew consent|4|||
147608672|NCT04324073|532384021|FG002|Overall Study|withdrew consent|2|||
147608673|NCT04324073|532384022|FG003|Overall Study|withdrew consent|8|||
147608674|NCT00369486|532384024|FG000|4-Week Visit|Missed visit|2|||
147608675|NCT00369486|532384025|FG001|4-Week Visit|Missed visit|2|||
147608676|NCT00369486|532384026|FG002|4-Week Visit|Missed visit|0|||
147608677|NCT00369486|532384027|FG003|4-Week Visit|Missed visit|2|||
147608678|NCT00369486|532384028|FG004|4-Week Visit|Missed visit|1|||
147608679|NCT00369486|532384024|FG000|4-Week Visit|Dropped|0|||
147608680|NCT00369486|532384025|FG001|4-Week Visit|Dropped|0|||
147608681|NCT00369486|532384026|FG002|4-Week Visit|Dropped|1|||
147608682|NCT00369486|532384027|FG003|4-Week Visit|Dropped|0|||
147608683|NCT00369486|532384028|FG004|4-Week Visit|Dropped|0|||
147608684|NCT00369486|532384024|FG000|8-Week Visit|Missed visit|0|||
147608685|NCT00369486|532384025|FG001|8-Week Visit|Missed visit|1|||
147608686|NCT00369486|532384026|FG002|8-Week Visit|Missed visit|0|||
147608687|NCT00369486|532384027|FG003|8-Week Visit|Missed visit|0|||
147364001|NCT03248479|531504367|FG007|Overall Study|Not reported|1|||
147364002|NCT03248479|531504368|FG008|Overall Study|Not reported|1|||
147364003|NCT03248479|531504369|FG009|Overall Study|Not reported|0|||
147364004|NCT03248479|531504370|FG010|Overall Study|Not reported|0|||
147364005|NCT03248479|531504371|FG011|Overall Study|Not reported|0|||
147364006|NCT03248479|531504372|FG012|Overall Study|Not reported|0|||
147364007|NCT04679389|531504373|FG000|Overall Study|Adverse Event|1|||
147364008|NCT04679389|531504374|FG001|Overall Study|Adverse Event|0|||
147364009|NCT04679389|531504373|FG000|Overall Study|Protocol Violation|2|||
147364010|NCT04679389|531504374|FG001|Overall Study|Protocol Violation|0|||
147608688|NCT00369486|532384028|FG004|8-Week Visit|Missed visit|1|||
147608689|NCT00369486|532384024|FG000|8-Week Visit|Dropped|0|||
147608690|NCT00369486|532384025|FG001|8-Week Visit|Dropped|0|||
147608691|NCT00369486|532384026|FG002|8-Week Visit|Dropped|0|||
147608692|NCT00369486|532384027|FG003|8-Week Visit|Dropped|1|||
147364011|NCT04679389|531504373|FG000|Overall Study|Physician Decision|3|||
147608693|NCT00369486|532384028|FG004|8-Week Visit|Dropped|0|||
147364012|NCT04679389|531504374|FG001|Overall Study|Physician Decision|5|||
147364013|NCT04679389|531504373|FG000|Overall Study|Withdrawal by Subject|5|||
147364014|NCT04679389|531504374|FG001|Overall Study|Withdrawal by Subject|7|||
147364015|NCT01475786|531504403|FG000|Overall Study|Adverse Event|0|||
147364016|NCT01475786|531504404|FG001|Overall Study|Adverse Event|1|||
147364017|NCT01475786|531504405|FG002|Overall Study|Adverse Event|0|||
147364018|NCT01475786|531504403|FG000|Overall Study|Lost to Follow-up|1|||
147364019|NCT01475786|531504404|FG001|Overall Study|Lost to Follow-up|2|||
147364020|NCT01475786|531504405|FG002|Overall Study|Lost to Follow-up|1|||
147364021|NCT01475786|531504403|FG000|Overall Study|Withdrawal by Subject|0|||
147364022|NCT01475786|531504404|FG001|Overall Study|Withdrawal by Subject|1|||
147364023|NCT01475786|531504405|FG002|Overall Study|Withdrawal by Subject|1|||
147364024|NCT01475786|531504403|FG000|Overall Study|Subject discontinued prior to study treatment|1|||
147364025|NCT01475786|531504404|FG001|Overall Study|Subject discontinued prior to study treatment|0|||
147364026|NCT01475786|531504405|FG002|Overall Study|Subject discontinued prior to study treatment|0|||
147364027|NCT01897441|531504406|FG000|Overall Study|Lost to Follow-up|0|||
147364028|NCT01897441|531504407|FG001|Overall Study|Lost to Follow-up|0|||
147364029|NCT01897441|531504408|FG002|Overall Study|Lost to Follow-up|1|||
147364030|NCT01897441|531504409|FG003|Overall Study|Lost to Follow-up|0|||
147364031|NCT01897441|531504410|FG004|Overall Study|Lost to Follow-up|0|||
147364032|NCT01897441|531504411|FG005|Overall Study|Lost to Follow-up|0|||
147364033|NCT01897441|531504406|FG000|Overall Study|Withdrawal by Subject|0|||
147364034|NCT01897441|531504407|FG001|Overall Study|Withdrawal by Subject|0|||
147364035|NCT01897441|531504408|FG002|Overall Study|Withdrawal by Subject|0|||
147364036|NCT01897441|531504409|FG003|Overall Study|Withdrawal by Subject|0|||
147364037|NCT01897441|531504410|FG004|Overall Study|Withdrawal by Subject|1|||
147364038|NCT01897441|531504411|FG005|Overall Study|Withdrawal by Subject|0|||
147364039|NCT01897441|531504406|FG000|Overall Study|Withdrawn by Provider|0|||
147364040|NCT01897441|531504407|FG001|Overall Study|Withdrawn by Provider|2|||
147364041|NCT01897441|531504408|FG002|Overall Study|Withdrawn by Provider|0|||
147364042|NCT01897441|531504409|FG003|Overall Study|Withdrawn by Provider|0|||
147364043|NCT01897441|531504410|FG004|Overall Study|Withdrawn by Provider|0|||
147364044|NCT01897441|531504411|FG005|Overall Study|Withdrawn by Provider|0|||
147364045|NCT04633278|531505014|FG000|Overall Study|Adverse Event|1|||
147364046|NCT04633278|531505015|FG001|Overall Study|Adverse Event|0|||
147364047|NCT04633278|531505014|FG000|Overall Study|Withdrawal by Subject|1|||
147364048|NCT04633278|531505015|FG001|Overall Study|Withdrawal by Subject|0|||
147364049|NCT04633278|531505014|FG000|Overall Study|Death|11|||
147364050|NCT04633278|531505015|FG001|Overall Study|Death|7|||
147364051|NCT04633278|531505014|FG000|Overall Study|Sponsor Decision|3|||
147364052|NCT04633278|531505015|FG001|Overall Study|Sponsor Decision|0|||
147364053|NCT04633278|531505014|FG000|Overall Study|Not Listed|1|||
147364054|NCT04633278|531505015|FG001|Overall Study|Not Listed|0|||
147364055|NCT00942734|531505024|FG000|Overall Study|Adverse Event|2|||
147364056|NCT00942734|531505024|FG000|Overall Study|Protocol Violation|3|||
147364057|NCT00942734|531505024|FG000|Overall Study|Disease Progression|2|||
147364058|NCT00942734|531505024|FG000|Overall Study|Physician Decision|1|||
147364059|NCT04496752|531505035|FG000|Second Assessment|Lost to Follow-up|3|||
147364060|NCT04496752|531505036|FG001|Second Assessment|Lost to Follow-up|3|||
147364061|NCT04496752|531505035|FG000|Second Assessment|Adverse Event|2|||
147364062|NCT04496752|531505036|FG001|Second Assessment|Adverse Event|0|||
147364063|NCT03662022|531505037|FG000|Year 1 2019|prevalent case|83|||
147364064|NCT03662022|531505038|FG001|Year 1 2019|prevalent case|116|||
147364065|NCT03662022|531505039|FG002|Year 1 2019|prevalent case|158|||
147364066|NCT03662022|531505040|FG003|Year 1 2019|prevalent case|99|||
147364067|NCT03662022|531505037|FG000|Year 2 2020|incident case|18|||
147364068|NCT03662022|531505038|FG001|Year 2 2020|incident case|18|||
147364069|NCT03662022|531505039|FG002|Year 2 2020|incident case|16|||
147364070|NCT03662022|531505040|FG003|Year 2 2020|incident case|26|||
147608694|NCT00369486|532384024|FG000|17-Week Visit|Missed visit|0|||
147608695|NCT00369486|532384025|FG001|17-Week Visit|Missed visit|0|||
147608696|NCT00369486|532384026|FG002|17-Week Visit|Missed visit|1|||
147608697|NCT00369486|532384027|FG003|17-Week Visit|Missed visit|1|||
147608698|NCT00369486|532384028|FG004|17-Week Visit|Missed visit|1|||
147608699|NCT00369486|532384024|FG000|34-Week Visit|Dropped|0|||
147364071|NCT03662022|531505037|FG000|Year 2 2020|other case|18|||
147364072|NCT03662022|531505038|FG001|Year 2 2020|other case|16|||
147364073|NCT03662022|531505039|FG002|Year 2 2020|other case|16|||
147364074|NCT03662022|531505040|FG003|Year 2 2020|other case|24|||
147364075|NCT03662022|531505037|FG000|Year 2 2020|Lost to Follow-up|1633|||
147364076|NCT03662022|531505038|FG001|Year 2 2020|Lost to Follow-up|1183|||
147364077|NCT03662022|531505039|FG002|Year 2 2020|Lost to Follow-up|1381|||
147364078|NCT03662022|531505040|FG003|Year 2 2020|Lost to Follow-up|2858|||
147364079|NCT03662022|531505037|FG000|Year 3 2021|incident case|24|||
147364080|NCT03662022|531505038|FG001|Year 3 2021|incident case|27|||
147364081|NCT03662022|531505039|FG002|Year 3 2021|incident case|24|||
147364082|NCT03662022|531505040|FG003|Year 3 2021|incident case|11|||
147364083|NCT03662022|531505037|FG000|Year 3 2021|other case|4|||
147608700|NCT00369486|532384025|FG001|34-Week Visit|Dropped|1|||
147364084|NCT03662022|531505038|FG001|Year 3 2021|other case|15|||
147364085|NCT03662022|531505039|FG002|Year 3 2021|other case|10|||
147364086|NCT03662022|531505040|FG003|Year 3 2021|other case|14|||
147364087|NCT03662022|531505037|FG000|Year 3 2021|Lost to Follow-up|179|||
147364088|NCT03662022|531505038|FG001|Year 3 2021|Lost to Follow-up|244|||
147364089|NCT03662022|531505039|FG002|Year 3 2021|Lost to Follow-up|480|||
147364090|NCT03662022|531505040|FG003|Year 3 2021|Lost to Follow-up|477|||
147364091|NCT03662022|531505037|FG000|Year 4 2022|incident case|25|||
147364092|NCT03662022|531505038|FG001|Year 4 2022|incident case|41|||
147364093|NCT03662022|531505039|FG002|Year 4 2022|incident case|28|||
147364094|NCT03662022|531505040|FG003|Year 4 2022|incident case|7|||
147364095|NCT03662022|531505037|FG000|Year 4 2022|other case|8|||
147364096|NCT03662022|531505038|FG001|Year 4 2022|other case|19|||
147364097|NCT03662022|531505039|FG002|Year 4 2022|other case|13|||
147364098|NCT03662022|531505040|FG003|Year 4 2022|other case|7|||
147364099|NCT03662022|531505037|FG000|Year 4 2022|Lost to Follow-up|986|||
147364100|NCT03662022|531505038|FG001|Year 4 2022|Lost to Follow-up|1079|||
147364101|NCT03662022|531505039|FG002|Year 4 2022|Lost to Follow-up|1236|||
147364102|NCT03662022|531505040|FG003|Year 4 2022|Lost to Follow-up|1826|||
147364103|NCT03547271|531505047|FG000|Overall Study|Adverse Event|1|||
147364104|NCT03547271|531505048|FG001|Overall Study|Adverse Event|1|||
147364105|NCT03547271|531505049|FG002|Overall Study|Adverse Event|0|||
147364106|NCT03547271|531505050|FG003|Overall Study|Adverse Event|0|||
147364107|NCT03547271|531505047|FG000|Overall Study|Protocol deviation|5|||
147364108|NCT03547271|531505048|FG001|Overall Study|Protocol deviation|7|||
147364109|NCT03547271|531505049|FG002|Overall Study|Protocol deviation|3|||
147364110|NCT03547271|531505050|FG003|Overall Study|Protocol deviation|0|||
147364111|NCT03547271|531505047|FG000|Overall Study|Withdrawal by Parent/Guardian|24|||
147364112|NCT03547271|531505048|FG001|Overall Study|Withdrawal by Parent/Guardian|24|||
147364113|NCT03547271|531505049|FG002|Overall Study|Withdrawal by Parent/Guardian|2|||
147364114|NCT03547271|531505050|FG003|Overall Study|Withdrawal by Parent/Guardian|4|||
147364115|NCT03547271|531505047|FG000|Overall Study|Lost to Follow-up|3|||
147364116|NCT03547271|531505048|FG001|Overall Study|Lost to Follow-up|3|||
147364117|NCT03547271|531505049|FG002|Overall Study|Lost to Follow-up|1|||
147364118|NCT03547271|531505050|FG003|Overall Study|Lost to Follow-up|0|||
147364119|NCT04795245|531505055|FG000|Overall Study|Unkown reason|7|||
147364120|NCT04795245|531505055|FG000|Overall Study|Death|17|||
147364121|NCT04795245|531505055|FG000|Overall Study|Other than listed|19|||
147364122|NCT04795245|531505055|FG000|Overall Study|Adverse Event|143|||
147364123|NCT04795245|531505055|FG000|Overall Study|Progressive disease|512|||
147364124|NCT04795245|531505055|FG000|Overall Study|Unknown if patients were still on treatment at end of observation period|22|||
147364125|NCT03904576|531505056|FG000|Washout Period|Protocol Violation|1|||
147364126|NCT03904576|531505057|FG001|Washout Period|Protocol Violation|1|||
147364127|NCT05718687|531505058|FG000|Overall Study|Withdrawal by Subject|3|||
147364128|NCT03418740|531505059|FG000|Overall Study|Lost to Follow-up|13|||
147364129|NCT03418740|531505059|FG000|Overall Study|Scheduling Issues|7|||
147364130|NCT03418740|531505059|FG000|Overall Study|Withdrawal by Subject|2|||
147364131|NCT03418740|531505059|FG000|Overall Study|Unable to Continue Consent|1|||
147364132|NCT05215054|531505060|FG000|Overall Study|Lost to Follow-up|1|||
147364133|NCT05215054|531505061|FG001|Overall Study|Lost to Follow-up|1|||
147364134|NCT05215054|531505060|FG000|Overall Study|Protocol Violation|1|||
147364135|NCT05215054|531505061|FG001|Overall Study|Protocol Violation|1|||
147364136|NCT05215054|531505060|FG000|Overall Study|Withdrawal by Subject|4|||
147364137|NCT05215054|531505061|FG001|Overall Study|Withdrawal by Subject|4|||
147364138|NCT01499368|531505062|FG000|Overall Study|Did not meet I/E criteria|8|||
147364139|NCT01499368|531505063|FG001|Overall Study|Did not meet I/E criteria|4|||
147364140|NCT01499368|531505064|FG002|Overall Study|Did not meet I/E criteria|4|||
147364141|NCT01499368|531505062|FG000|Overall Study|Prohibited Concomitant medication|1|||
147364142|NCT01499368|531505063|FG001|Overall Study|Prohibited Concomitant medication|1|||
147364143|NCT01499368|531505064|FG002|Overall Study|Prohibited Concomitant medication|0|||
147364144|NCT01499368|531505062|FG000|Overall Study|Withdrawal by Subject|11|||
147364145|NCT01499368|531505063|FG001|Overall Study|Withdrawal by Subject|10|||
147364146|NCT01499368|531505064|FG002|Overall Study|Withdrawal by Subject|8|||
147364147|NCT01499368|531505062|FG000|Overall Study|Lost to Follow-up|3|||
147364148|NCT01499368|531505063|FG001|Overall Study|Lost to Follow-up|2|||
147608701|NCT00369486|532384026|FG002|34-Week Visit|Dropped|1|||
147364149|NCT01499368|531505064|FG002|Overall Study|Lost to Follow-up|5|||
147364150|NCT01499368|531505062|FG000|Overall Study|Adverse Event|4|||
147364151|NCT01499368|531505063|FG001|Overall Study|Adverse Event|0|||
147364152|NCT01499368|531505064|FG002|Overall Study|Adverse Event|2|||
147364153|NCT01499368|531505062|FG000|Overall Study|Physician Decision|0|||
147364154|NCT01499368|531505063|FG001|Overall Study|Physician Decision|1|||
147364155|NCT01499368|531505064|FG002|Overall Study|Physician Decision|0|||
147364156|NCT01499368|531505062|FG000|Overall Study|Deviation from visit window|0|||
147364157|NCT01499368|531505063|FG001|Overall Study|Deviation from visit window|0|||
147364158|NCT01499368|531505064|FG002|Overall Study|Deviation from visit window|1|||
147364159|NCT01499368|531505062|FG000|Overall Study|Error of Prescriptions|0|||
147364160|NCT01499368|531505063|FG001|Overall Study|Error of Prescriptions|0|||
147364161|NCT01499368|531505064|FG002|Overall Study|Error of Prescriptions|1|||
147364162|NCT03990883|531505065|FG000|Blinded Treatment Phase|Adverse Event|1|||
147364163|NCT03990883|531505066|FG001|Blinded Treatment Phase|Adverse Event|1|||
147364164|NCT03990883|531505067|FG002|Blinded Treatment Phase|Adverse Event|0|||
147364165|NCT03990883|531505065|FG000|Blinded Treatment Phase|Lost to Follow-up|7|||
147364166|NCT03990883|531505066|FG001|Blinded Treatment Phase|Lost to Follow-up|10|||
147608702|NCT00369486|532384027|FG003|34-Week Visit|Dropped|3|||
147608703|NCT00369486|532384028|FG004|34-Week Visit|Dropped|3|||
147608704|NCT01659125|532384029|FG000|Overall Study|Withdrawal by Subject|2|||
147608705|NCT01659125|532384029|FG000|Overall Study|Lost to Follow-up|7|||
147608706|NCT01659125|532384029|FG000|Overall Study|Technical Problem|1|||
147364167|NCT03990883|531505067|FG002|Blinded Treatment Phase|Lost to Follow-up|0|||
147364168|NCT03990883|531505065|FG000|Blinded Treatment Phase|Physician Decision|1|||
147364169|NCT03990883|531505066|FG001|Blinded Treatment Phase|Physician Decision|0|||
147364170|NCT03990883|531505067|FG002|Blinded Treatment Phase|Physician Decision|0|||
147364171|NCT03990883|531505065|FG000|Blinded Treatment Phase|Withdrawal by Subject|2|||
147364172|NCT03990883|531505066|FG001|Blinded Treatment Phase|Withdrawal by Subject|5|||
147364173|NCT03990883|531505067|FG002|Blinded Treatment Phase|Withdrawal by Subject|0|||
147364174|NCT03990883|531505065|FG000|Blinded Treatment Phase|COVID-19|3|||
147364175|NCT03990883|531505066|FG001|Blinded Treatment Phase|COVID-19|2|||
147364176|NCT03990883|531505067|FG002|Blinded Treatment Phase|COVID-19|0|||
147364177|NCT03990883|531505065|FG000|Blinded Treatment Phase|Personal Reasons|6|||
147364178|NCT03990883|531505066|FG001|Blinded Treatment Phase|Personal Reasons|3|||
147364179|NCT03990883|531505067|FG002|Blinded Treatment Phase|Personal Reasons|0|||
147364180|NCT03990883|531505065|FG000|Blinded Treatment Phase|Temporary Hold on Repeat Treatment|3|||
147364181|NCT03990883|531505066|FG001|Blinded Treatment Phase|Temporary Hold on Repeat Treatment|2|||
147364182|NCT03990883|531505067|FG002|Blinded Treatment Phase|Temporary Hold on Repeat Treatment|0|||
147364183|NCT03990883|531505065|FG000|Open Label Extension Phase|Lost to Follow-up|0|||
147364184|NCT03990883|531505066|FG001|Open Label Extension Phase|Lost to Follow-up|0|||
147364185|NCT03990883|531505067|FG002|Open Label Extension Phase|Lost to Follow-up|1|||
147364186|NCT03990883|531505065|FG000|Open Label Extension Phase|Withdrawal by Subject|0|||
147364187|NCT03990883|531505066|FG001|Open Label Extension Phase|Withdrawal by Subject|0|||
147364188|NCT03990883|531505067|FG002|Open Label Extension Phase|Withdrawal by Subject|1|||
147364189|NCT02076009|531505899|FG000|Overall Study|Death|172|||
147364190|NCT02076009|531505900|FG001|Overall Study|Death|153|||
147364191|NCT02076009|531505899|FG000|Overall Study|Withdrawal by Subject|16|||
147364192|NCT02076009|531505900|FG001|Overall Study|Withdrawal by Subject|12|||
147364193|NCT02076009|531505899|FG000|Overall Study|Lost to Follow-up|4|||
147364194|NCT02076009|531505900|FG001|Overall Study|Lost to Follow-up|2|||
147364195|NCT02076009|531505899|FG000|Overall Study|Progressive Disease|1|||
147364196|NCT02076009|531505900|FG001|Overall Study|Progressive Disease|0|||
147364197|NCT02076009|531505899|FG000|Overall Study|Physician Decision|0|||
147364198|NCT02076009|531505900|FG001|Overall Study|Physician Decision|1|||
147364199|NCT02076009|531505899|FG000|Overall Study|End of data collection|90|||
147364200|NCT02076009|531505900|FG001|Overall Study|End of data collection|118|||
147364201|NCT05988398|531505904|FG000|Overall Study|Lack of time|21|||
147364202|NCT05988398|531505905|FG001|Overall Study|Lack of time|0|||
147364203|NCT05988398|531505904|FG000|Overall Study|Absent from school|0|||
147364204|NCT05988398|531505905|FG001|Overall Study|Absent from school|38|||
147364205|NCT05988398|531505904|FG000|Overall Study|Chose not to participate|0|||
147364206|NCT05988398|531505905|FG001|Overall Study|Chose not to participate|42|||
147364207|NCT05988398|531505904|FG000|Overall Study|Other commitments (e.g., sports)|0|||
147364208|NCT05988398|531505905|FG001|Overall Study|Other commitments (e.g., sports)|25|||
147364209|NCT04408755|531505906|FG000|Period A (Placebo lead-in)|Other|11|||
147364210|NCT04408755|531505907|FG001|Period A (Placebo lead-in)|Other|0|||
147364211|NCT04408755|531505908|FG002|Period A (Placebo lead-in)|Other|0|||
147364212|NCT04408755|531505909|FG003|Period A (Placebo lead-in)|Other|0|||
147364213|NCT04408755|531505906|FG000|Period B (Randomization Period)|Adverse Event|0|||
147364214|NCT04408755|531505907|FG001|Period B (Randomization Period)|Adverse Event|3|||
147364215|NCT04408755|531505908|FG002|Period B (Randomization Period)|Adverse Event|0|||
147364216|NCT04408755|531505909|FG003|Period B (Randomization Period)|Adverse Event|1|||
147364217|NCT04408755|531505906|FG000|Period B (Randomization Period)|Death|0|||
147364218|NCT04408755|531505907|FG001|Period B (Randomization Period)|Death|0|||
147364219|NCT04408755|531505908|FG002|Period B (Randomization Period)|Death|1|||
147364220|NCT04408755|531505909|FG003|Period B (Randomization Period)|Death|0|||
147364221|NCT04408755|531505906|FG000|Period B (Randomization Period)|Lost to Follow-up|0|||
147364222|NCT04408755|531505907|FG001|Period B (Randomization Period)|Lost to Follow-up|1|||
147364223|NCT04408755|531505908|FG002|Period B (Randomization Period)|Lost to Follow-up|1|||
147364224|NCT04408755|531505909|FG003|Period B (Randomization Period)|Lost to Follow-up|0|||
147364225|NCT04408755|531505906|FG000|Period B (Randomization Period)|Physician Decision|0|||
147364226|NCT04408755|531505907|FG001|Period B (Randomization Period)|Physician Decision|0|||
147364227|NCT04408755|531505908|FG002|Period B (Randomization Period)|Physician Decision|1|||
147364228|NCT04408755|531505909|FG003|Period B (Randomization Period)|Physician Decision|0|||
147364229|NCT04408755|531505906|FG000|Period B (Randomization Period)|Protocol Deviation|0|||
147364230|NCT04408755|531505907|FG001|Period B (Randomization Period)|Protocol Deviation|1|||
147608707|NCT01659125|532384029|FG000|Overall Study|Time Constraints|2|||
147364231|NCT04408755|531505908|FG002|Period B (Randomization Period)|Protocol Deviation|0|||
147364232|NCT04408755|531505909|FG003|Period B (Randomization Period)|Protocol Deviation|0|||
147364233|NCT04408755|531505906|FG000|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|0|||
147364234|NCT04408755|531505907|FG001|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|2|||
147364235|NCT04408755|531505908|FG002|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|2|||
147364236|NCT04408755|531505909|FG003|Period B (Randomization Period)|Study Subject Withdrawal by Parent or Guardian|2|||
147364237|NCT04408755|531505906|FG000|Period B (Randomization Period)|Study Terminated by Sponsor|0|||
147364238|NCT04408755|531505907|FG001|Period B (Randomization Period)|Study Terminated by Sponsor|1|||
147364239|NCT04408755|531505908|FG002|Period B (Randomization Period)|Study Terminated by Sponsor|5|||
147364240|NCT04408755|531505909|FG003|Period B (Randomization Period)|Study Terminated by Sponsor|3|||
147364241|NCT04408755|531505906|FG000|Period B (Randomization Period)|Withdrawal by Subject|0|||
147364242|NCT04408755|531505907|FG001|Period B (Randomization Period)|Withdrawal by Subject|3|||
147364243|NCT04408755|531505908|FG002|Period B (Randomization Period)|Withdrawal by Subject|2|||
147364244|NCT04408755|531505909|FG003|Period B (Randomization Period)|Withdrawal by Subject|1|||
147364245|NCT04408755|531505906|FG000|Period B (Randomization Period)|Reason not Specified|0|||
147364246|NCT04408755|531505907|FG001|Period B (Randomization Period)|Reason not Specified|1|||
147364247|NCT04408755|531505908|FG002|Period B (Randomization Period)|Reason not Specified|0|||
147364248|NCT04408755|531505909|FG003|Period B (Randomization Period)|Reason not Specified|2|||
147364249|NCT06655818|531505910|FG000|Overall Study|Withdrawal by Subject|1|||
147364250|NCT00319046|531505911|FG000|Overall Study|withdrawal of subject's consent|7|||
147364251|NCT00319046|531505911|FG000|Overall Study|administrative reason|1|||
147364252|NCT00412607|531505912|FG000|Overall Study|Withdrawal by Subject|9|||
147364253|NCT00412607|531505912|FG000|Overall Study|Lost to Follow-up|19|||
147364254|NCT00412607|531505912|FG000|Overall Study|Death|61|||
147364255|NCT00412607|531505912|FG000|Overall Study|Not meet inclusion/exclusion Criteria|15|||
147364256|NCT04675034|531505915|FG000|Overall Study|Lost to Follow-up|1|||
147364257|NCT04675034|531505916|FG001|Overall Study|Lost to Follow-up|1|||
147364258|NCT04675034|531505917|FG002|Overall Study|Lost to Follow-up|0|||
147364259|NCT04675034|531505918|FG003|Overall Study|Lost to Follow-up|2|||
147364260|NCT04675034|531505919|FG004|Overall Study|Lost to Follow-up|0|||
147364261|NCT04675034|531505915|FG000|Overall Study|Protocol Violation|1|||
147364262|NCT04675034|531505916|FG001|Overall Study|Protocol Violation|0|||
147364263|NCT04675034|531505917|FG002|Overall Study|Protocol Violation|0|||
147364264|NCT04675034|531505918|FG003|Overall Study|Protocol Violation|1|||
147364265|NCT04675034|531505919|FG004|Overall Study|Protocol Violation|3|||
147364266|NCT04675034|531505915|FG000|Overall Study|Withdrawal by Subject|9|||
147364267|NCT04675034|531505916|FG001|Overall Study|Withdrawal by Subject|3|||
147364268|NCT04675034|531505917|FG002|Overall Study|Withdrawal by Subject|4|||
147364269|NCT04675034|531505918|FG003|Overall Study|Withdrawal by Subject|8|||
147364270|NCT04675034|531505919|FG004|Overall Study|Withdrawal by Subject|6|||
147364271|NCT05836012|531505922|FG000|Overall Study|Lost to Follow-up|1|||
147364272|NCT05836012|531505923|FG001|Overall Study|Lost to Follow-up|0|||
147364273|NCT05836012|531505922|FG000|Overall Study|Withdrawal by Subject|1|||
147364274|NCT05836012|531505923|FG001|Overall Study|Withdrawal by Subject|3|||
147364275|NCT05836012|531505922|FG000|Overall Study|Reason not included in pre-specified categories|2|||
147364276|NCT05836012|531505923|FG001|Overall Study|Reason not included in pre-specified categories|1|||
147364277|NCT05985395|531505924|FG000|Overall Study|Physician Decision|2|||
147364278|NCT05985395|531505925|FG001|Overall Study|Physician Decision|1|||
147364279|NCT05985395|531505924|FG000|Overall Study|Withdrawal by Subject|1|||
147364280|NCT05985395|531505925|FG001|Overall Study|Withdrawal by Subject|0|||
147364281|NCT04908930|531505928|FG000|Overall Study|Lost to Follow-up|1|||
147364282|NCT04908930|531505929|FG001|Overall Study|Lost to Follow-up|1|||
147364283|NCT04908930|531505930|FG002|Overall Study|Lost to Follow-up|0|||
147364284|NCT04908930|531505931|FG003|Overall Study|Lost to Follow-up|0|||
147364285|NCT04908930|531505932|FG004|Overall Study|Lost to Follow-up|0|||
147364286|NCT04908930|531505928|FG000|Overall Study|hardware in mouth|1|||
147364287|NCT04908930|531505929|FG001|Overall Study|hardware in mouth|1|||
147364288|NCT04908930|531505930|FG002|Overall Study|hardware in mouth|0|||
147364289|NCT04908930|531505931|FG003|Overall Study|hardware in mouth|0|||
147364290|NCT04908930|531505932|FG004|Overall Study|hardware in mouth|0|||
147364291|NCT04908930|531505928|FG000|Overall Study|wrong team|1|||
147364292|NCT04908930|531505929|FG001|Overall Study|wrong team|0|||
147364293|NCT04908930|531505930|FG002|Overall Study|wrong team|0|||
147364294|NCT04908930|531505931|FG003|Overall Study|wrong team|0|||
147364295|NCT04908930|531505932|FG004|Overall Study|wrong team|0|||
147454250|NCT04705051|531825563|FG000|Overall Study|Study terminated by sponsor|23|||
147364296|NCT04908930|531505928|FG000|Overall Study|quit team|2|||
147364297|NCT04908930|531505929|FG001|Overall Study|quit team|4|||
147364298|NCT04908930|531505930|FG002|Overall Study|quit team|0|||
147364299|NCT04908930|531505931|FG003|Overall Study|quit team|0|||
147364300|NCT04908930|531505932|FG004|Overall Study|quit team|0|||
147364301|NCT04908930|531505928|FG000|Overall Study|Withdrawal by Subject|1|||
147364302|NCT04908930|531505929|FG001|Overall Study|Withdrawal by Subject|2|||
147364303|NCT04908930|531505930|FG002|Overall Study|Withdrawal by Subject|0|||
147364304|NCT04908930|531505931|FG003|Overall Study|Withdrawal by Subject|0|||
147364305|NCT04908930|531505932|FG004|Overall Study|Withdrawal by Subject|0|||
147364306|NCT04908930|531505928|FG000|Overall Study|parent not liking program|0|||
147364307|NCT04908930|531505929|FG001|Overall Study|parent not liking program|1|||
147364308|NCT04908930|531505930|FG002|Overall Study|parent not liking program|0|||
147364309|NCT04908930|531505931|FG003|Overall Study|parent not liking program|0|||
147364310|NCT04908930|531505932|FG004|Overall Study|parent not liking program|0|||
147364311|NCT02777593|531505935|FG000|Overall Study|Still in study|1|||
147364312|NCT02777593|531505936|FG001|Overall Study|Still in study|32|||
147364313|NCT02777593|531505937|FG002|Overall Study|Still in study|3|||
147364314|NCT02777593|531505938|FG003|Overall Study|Still in study|6|||
147364315|NCT02777593|531505939|FG004|Overall Study|Still in study|5|||
147364316|NCT02777593|531505935|FG000|Overall Study|Death|21|||
147364317|NCT02777593|531505936|FG001|Overall Study|Death|28|||
147364318|NCT02777593|531505937|FG002|Overall Study|Death|0|||
147364319|NCT02777593|531505938|FG003|Overall Study|Death|5|||
147364320|NCT02777593|531505939|FG004|Overall Study|Death|0|||
147364321|NCT02777593|531505935|FG000|Overall Study|Withdrawal by Subject|8|||
147364322|NCT02777593|531505936|FG001|Overall Study|Withdrawal by Subject|4|||
147364323|NCT02777593|531505937|FG002|Overall Study|Withdrawal by Subject|1|||
147364324|NCT02777593|531505938|FG003|Overall Study|Withdrawal by Subject|1|||
147364325|NCT02777593|531505939|FG004|Overall Study|Withdrawal by Subject|0|||
147364326|NCT02777593|531505935|FG000|Overall Study|Lost to Follow-up|8|||
147364327|NCT02777593|531505936|FG001|Overall Study|Lost to Follow-up|16|||
147364328|NCT02777593|531505937|FG002|Overall Study|Lost to Follow-up|5|||
147364329|NCT02777593|531505938|FG003|Overall Study|Lost to Follow-up|0|||
147364330|NCT02777593|531505939|FG004|Overall Study|Lost to Follow-up|1|||
147364331|NCT02777593|531505935|FG000|Overall Study|Physician Decision|2|||
147364332|NCT02777593|531505936|FG001|Overall Study|Physician Decision|2|||
147364333|NCT02777593|531505937|FG002|Overall Study|Physician Decision|0|||
147364334|NCT02777593|531505938|FG003|Overall Study|Physician Decision|0|||
147364335|NCT02777593|531505939|FG004|Overall Study|Physician Decision|0|||
147364336|NCT02777593|531505935|FG000|Overall Study|Discontinued due to Other|1|||
147364337|NCT02777593|531505936|FG001|Overall Study|Discontinued due to Other|0|||
147364338|NCT02777593|531505937|FG002|Overall Study|Discontinued due to Other|0|||
147364339|NCT02777593|531505938|FG003|Overall Study|Discontinued due to Other|0|||
147364340|NCT02777593|531505939|FG004|Overall Study|Discontinued due to Other|0|||
147364341|NCT06065735|531505942|FG000|Paroxetine 20 mg (Days 1 to 7)|Adverse Event|2|||
147364342|NCT06065735|531505943|FG001|Paroxetine 20 mg (Days 1 to 7)|Adverse Event|0|||
147364343|NCT06065735|531505944|FG002|Paroxetine 20 mg (Days 1 to 7)|Adverse Event|0|||
147364344|NCT06065735|531505942|FG000|Paroxetine 20 mg (Days 1 to 7)|Physician Decision|2|||
147364345|NCT06065735|531505943|FG001|Paroxetine 20 mg (Days 1 to 7)|Physician Decision|0|||
147364346|NCT06065735|531505944|FG002|Paroxetine 20 mg (Days 1 to 7)|Physician Decision|0|||
147364347|NCT06065735|531505942|FG000|Paroxetine 20 mg (Days 1 to 7)|Withdrawal by Subject|1|||
147364348|NCT06065735|531505943|FG001|Paroxetine 20 mg (Days 1 to 7)|Withdrawal by Subject|0|||
147364349|NCT06065735|531505944|FG002|Paroxetine 20 mg (Days 1 to 7)|Withdrawal by Subject|0|||
147364350|NCT06065735|531505942|FG000|Paroxetine 40 mg (Days 8 to 14)|Adverse Event|0|||
147364351|NCT06065735|531505943|FG001|Paroxetine 40 mg (Days 8 to 14)|Adverse Event|1|||
147364352|NCT06065735|531505944|FG002|Paroxetine 40 mg (Days 8 to 14)|Adverse Event|0|||
147364353|NCT06065735|531505942|FG000|Paroxetine 60 mg (Days 15 to 21)|Adverse Event|0|||
147364354|NCT06065735|531505943|FG001|Paroxetine 60 mg (Days 15 to 21)|Adverse Event|0|||
147364355|NCT06065735|531505944|FG002|Paroxetine 60 mg (Days 15 to 21)|Adverse Event|1|||
147364356|NCT02532621|531505945|FG000|Overall Study|Death|3|||
147364357|NCT02532621|531505945|FG000|Overall Study|Lost to Follow-up|3|||
147364358|NCT02532621|531505945|FG000|Overall Study|Withdrawal by Subject|6|||
147364359|NCT02532621|531505945|FG000|Overall Study|implanted graft abandoned before 6 months|12|||
147364360|NCT02532621|531505945|FG000|Overall Study|last follow up performed outside window (<166 days) -censored|2|||
147364361|NCT03522298|531505946|FG000|Overall Study|Adverse Event|1|||
147364362|NCT03522298|531505947|FG001|Overall Study|Adverse Event|0|||
147364363|NCT03522298|531505948|FG002|Overall Study|Adverse Event|0|||
147364364|NCT03522298|531505949|FG003|Overall Study|Adverse Event|1|||
147364365|NCT03522298|531505946|FG000|Overall Study|Death|2|||
147364366|NCT03522298|531505947|FG001|Overall Study|Death|4|||
147364367|NCT03522298|531505948|FG002|Overall Study|Death|8|||
147364368|NCT03522298|531505949|FG003|Overall Study|Death|8|||
147364369|NCT03522298|531505946|FG000|Overall Study|Patient decision|0|||
147364370|NCT03522298|531505947|FG001|Overall Study|Patient decision|2|||
147364371|NCT03522298|531505948|FG002|Overall Study|Patient decision|2|||
147364372|NCT03522298|531505949|FG003|Overall Study|Patient decision|2|||
147364373|NCT02933489|531505952|FG000|Overall Study|Ineligible|3|||
147364374|NCT02933489|531505953|FG001|Overall Study|Ineligible|3|||
147364375|NCT02933489|531505952|FG000|Overall Study|Withdrawal by Subject|27|||
147364376|NCT02933489|531505953|FG001|Overall Study|Withdrawal by Subject|18|||
147364377|NCT02933489|531505952|FG000|Overall Study|Unable to complete exams (other)|14|||
147364378|NCT02933489|531505953|FG001|Overall Study|Unable to complete exams (other)|7|||
147364379|NCT05485935|531505954|FG000|Period 1 (V0, V1, T1, and V2)|Adverse Event|1|||
147364380|NCT05485935|531505955|FG001|Period 1 (V0, V1, T1, and V2)|Adverse Event|1|||
147364381|NCT05485935|531505954|FG000|Period 1 (V0, V1, T1, and V2)|Withdrawal by Subject|3|||
147364382|NCT05485935|531505955|FG001|Period 1 (V0, V1, T1, and V2)|Withdrawal by Subject|0|||
147364383|NCT05485935|531505954|FG000|Period 2 (T2 and V3)|Adverse Event|0|||
147364384|NCT05485935|531505955|FG001|Period 2 (T2 and V3)|Adverse Event|1|||
147364385|NCT05485935|531505954|FG000|Period 2 (T2 and V3)|loss of contact|0|||
147364386|NCT05485935|531505955|FG001|Period 2 (T2 and V3)|loss of contact|1|||
147364387|NCT03250676|531505960|FG000|Overall Study|Adverse Event|0|||
147364388|NCT03250676|531505961|FG001|Overall Study|Adverse Event|0|||
147364389|NCT03250676|531505962|FG002|Overall Study|Adverse Event|0|||
147364390|NCT03250676|531505963|FG003|Overall Study|Adverse Event|1|||
147364391|NCT03250676|531505964|FG004|Overall Study|Adverse Event|2|||
147364392|NCT03250676|531505965|FG005|Overall Study|Adverse Event|9|||
147364393|NCT03250676|531505960|FG000|Overall Study|Withdrawal by Subject|1|||
147364394|NCT03250676|531505961|FG001|Overall Study|Withdrawal by Subject|0|||
147364395|NCT03250676|531505962|FG002|Overall Study|Withdrawal by Subject|0|||
147364396|NCT03250676|531505963|FG003|Overall Study|Withdrawal by Subject|1|||
147364397|NCT03250676|531505964|FG004|Overall Study|Withdrawal by Subject|1|||
147364398|NCT03250676|531505965|FG005|Overall Study|Withdrawal by Subject|2|||
147364399|NCT03250676|531505960|FG000|Overall Study|Physician Decision|0|||
147364400|NCT03250676|531505961|FG001|Overall Study|Physician Decision|0|||
147364401|NCT03250676|531505962|FG002|Overall Study|Physician Decision|0|||
147364402|NCT03250676|531505963|FG003|Overall Study|Physician Decision|2|||
147364403|NCT03250676|531505964|FG004|Overall Study|Physician Decision|0|||
147364404|NCT03250676|531505965|FG005|Overall Study|Physician Decision|3|||
147364405|NCT03250676|531505960|FG000|Overall Study|Withdrawal of consent|0|||
147364406|NCT03250676|531505961|FG001|Overall Study|Withdrawal of consent|0|||
147364407|NCT03250676|531505962|FG002|Overall Study|Withdrawal of consent|2|||
147364408|NCT03250676|531505963|FG003|Overall Study|Withdrawal of consent|0|||
147364409|NCT03250676|531505964|FG004|Overall Study|Withdrawal of consent|0|||
147364410|NCT03250676|531505965|FG005|Overall Study|Withdrawal of consent|2|||
147364411|NCT03250676|531505960|FG000|Overall Study|Other|1|||
147364412|NCT03250676|531505961|FG001|Overall Study|Other|0|||
147364413|NCT03250676|531505962|FG002|Overall Study|Other|0|||
147364414|NCT03250676|531505963|FG003|Overall Study|Other|0|||
147364415|NCT03250676|531505964|FG004|Overall Study|Other|0|||
147364416|NCT03250676|531505965|FG005|Overall Study|Other|0|||
147364417|NCT03250676|531505960|FG000|Overall Study|Disease progression|4|||
147364418|NCT03250676|531505961|FG001|Overall Study|Disease progression|12|||
147364419|NCT03250676|531505962|FG002|Overall Study|Disease progression|9|||
147364420|NCT03250676|531505963|FG003|Overall Study|Disease progression|7|||
147364421|NCT03250676|531505964|FG004|Overall Study|Disease progression|4|||
147364422|NCT03250676|531505965|FG005|Overall Study|Disease progression|88|||
147364423|NCT04626427|531505966|FG000|Overall Study|Death|1|||
147364424|NCT04626427|531505966|FG000|Overall Study|Withdrawal by Subject|1|||
147364425|NCT04626427|531505966|FG000|Overall Study|Investigation Early Termination by Sponsor|11|||
147364426|NCT04626427|531505966|FG000|Overall Study|Participant Permanently Moved Abroad|1|||
147364427|NCT02325154|531505967|FG000|Overall Study|Physician Decision|1|||
147364428|NCT01265537|531505968|FG000|Overall Study|Adverse Event|2|||
147364429|NCT01265537|531505969|FG001|Overall Study|Adverse Event|1|||
147364430|NCT01265537|531505968|FG000|Overall Study|Physician Decision|0|||
147364431|NCT01265537|531505969|FG001|Overall Study|Physician Decision|1|||
147364432|NCT04595331|531506965|FG000|Overall Study|Withdrawal by Subject|0|||
147364433|NCT04595331|531506966|FG001|Overall Study|Withdrawal by Subject|1|||
147364434|NCT04595331|531506965|FG000|Overall Study|Lost to Follow-up|0|||
147364435|NCT04595331|531506966|FG001|Overall Study|Lost to Follow-up|5|||
147364436|NCT04595331|531506965|FG000|Overall Study|Medical reason|0|||
147364437|NCT04595331|531506966|FG001|Overall Study|Medical reason|1|||
147364438|NCT05412004|531506968|FG000|Overall Study|Adverse Event|0|||
147364439|NCT05412004|531506969|FG001|Overall Study|Adverse Event|2|||
147364440|NCT05412004|531506970|FG002|Overall Study|Adverse Event|1|||
147364441|NCT05412004|531506971|FG003|Overall Study|Adverse Event|5|||
147364442|NCT05412004|531506968|FG000|Overall Study|Assigned Treatment by Mistake|5|||
147364443|NCT05412004|531506969|FG001|Overall Study|Assigned Treatment by Mistake|10|||
147364444|NCT05412004|531506970|FG002|Overall Study|Assigned Treatment by Mistake|2|||
147364445|NCT05412004|531506971|FG003|Overall Study|Assigned Treatment by Mistake|5|||
147364446|NCT05412004|531506968|FG000|Overall Study|Lost to Follow-up|3|||
147364447|NCT05412004|531506969|FG001|Overall Study|Lost to Follow-up|0|||
147364448|NCT05412004|531506970|FG002|Overall Study|Lost to Follow-up|0|||
147364449|NCT05412004|531506971|FG003|Overall Study|Lost to Follow-up|0|||
147364450|NCT05412004|531506968|FG000|Overall Study|Patient could not travel to site|0|||
147364451|NCT05412004|531506969|FG001|Overall Study|Patient could not travel to site|1|||
147364452|NCT05412004|531506970|FG002|Overall Study|Patient could not travel to site|0|||
147364453|NCT05412004|531506971|FG003|Overall Study|Patient could not travel to site|0|||
147364454|NCT05412004|531506968|FG000|Overall Study|Physician Decision|0|||
147364455|NCT05412004|531506969|FG001|Overall Study|Physician Decision|1|||
147364456|NCT05412004|531506970|FG002|Overall Study|Physician Decision|0|||
147364457|NCT05412004|531506971|FG003|Overall Study|Physician Decision|0|||
147364458|NCT05412004|531506968|FG000|Overall Study|Pregnancy|0|||
147364459|NCT05412004|531506969|FG001|Overall Study|Pregnancy|1|||
147364460|NCT05412004|531506970|FG002|Overall Study|Pregnancy|0|||
147364461|NCT05412004|531506971|FG003|Overall Study|Pregnancy|0|||
147364462|NCT05412004|531506968|FG000|Overall Study|Protocol Violation|1|||
147364463|NCT05412004|531506969|FG001|Overall Study|Protocol Violation|0|||
147364464|NCT05412004|531506970|FG002|Overall Study|Protocol Violation|0|||
147364465|NCT05412004|531506971|FG003|Overall Study|Protocol Violation|0|||
147364466|NCT05412004|531506968|FG000|Overall Study|Withdrawal by Subject|4|||
147364467|NCT05412004|531506969|FG001|Overall Study|Withdrawal by Subject|19|||
147364468|NCT05412004|531506970|FG002|Overall Study|Withdrawal by Subject|4|||
147364469|NCT05412004|531506971|FG003|Overall Study|Withdrawal by Subject|14|||
147364470|NCT05412004|531506968|FG000|Overall Study|Screen Failure|0|||
147364471|NCT05412004|531506969|FG001|Overall Study|Screen Failure|0|||
147364472|NCT05412004|531506970|FG002|Overall Study|Screen Failure|0|||
147364473|NCT05412004|531506971|FG003|Overall Study|Screen Failure|1|||
147364474|NCT05412004|531506968|FG000|Overall Study|The participant quit treatment and study due to their schedule and the final V801 was done remotely|0|||
147364475|NCT05412004|531506969|FG001|Overall Study|The participant quit treatment and study due to their schedule and the final V801 was done remotely|0|||
147364476|NCT05412004|531506970|FG002|Overall Study|The participant quit treatment and study due to their schedule and the final V801 was done remotely|0|||
147364477|NCT05412004|531506971|FG003|Overall Study|The participant quit treatment and study due to their schedule and the final V801 was done remotely|1|||
147364478|NCT04644029|531506972|FG000|Overall Study|Death|1|||
147364479|NCT04644029|531506973|FG001|Overall Study|Death|0|||
147364480|NCT04644029|531506972|FG000|Overall Study|Physician Decision|1|||
147364481|NCT04644029|531506973|FG001|Overall Study|Physician Decision|2|||
147364482|NCT04644029|531506972|FG000|Overall Study|Withdrawal by Subject|21|||
147364483|NCT04644029|531506973|FG001|Overall Study|Withdrawal by Subject|19|||
147364484|NCT04644029|531506972|FG000|Overall Study|Lost to Follow-up|31|||
147364485|NCT04644029|531506973|FG001|Overall Study|Lost to Follow-up|34|||
147364486|NCT04644029|531506972|FG000|Overall Study|Study Terminated by Sponsor|308|||
147364487|NCT04644029|531506973|FG001|Overall Study|Study Terminated by Sponsor|309|||
147364488|NCT04644029|531506972|FG000|Overall Study|Randomized in Error|2|||
147364489|NCT04644029|531506973|FG001|Overall Study|Randomized in Error|1|||
147364490|NCT04644029|531506972|FG000|Overall Study|Other|0|||
147364491|NCT04644029|531506973|FG001|Overall Study|Other|1|||
147364492|NCT05020353|531506974|FG000|Overall Study|Protocol Violation|7|||
147364493|NCT05020353|531506974|FG000|Overall Study|Withdrawal by Subject|33|||
147364494|NCT05132400|531506975|FG000|Overall Study|Withdrawal by Subject|14|||
147364495|NCT05132400|531506976|FG001|Overall Study|Withdrawal by Subject|8|||
147364496|NCT05132400|531506975|FG000|Overall Study|Lost to Follow-up|132|||
147364497|NCT05132400|531506976|FG001|Overall Study|Lost to Follow-up|121|||
147364498|NCT02611687|531506978|FG000|Double-blind Period (0 to 8 Weeks)|Withdrawal by Subject|2|||
147364499|NCT02611687|531506979|FG001|Double-blind Period (0 to 8 Weeks)|Withdrawal by Subject|1|||
147364500|NCT03934931|531506980|FG000|Overall Study|Excluded as a duplicate enrollment|1|||
147364501|NCT03934931|531506981|FG001|Overall Study|Excluded as a duplicate enrollment|0|||
147364502|NCT03934931|531506982|FG002|Overall Study|Excluded as a duplicate enrollment|0|||
147364503|NCT03786926|531506990|FG000|Overall Study|Adverse Event|0|||
147364504|NCT03786926|531506991|FG001|Overall Study|Adverse Event|0|||
147364505|NCT03786926|531506992|FG002|Overall Study|Adverse Event|0|||
147364506|NCT03786926|531506993|FG003|Overall Study|Adverse Event|0|||
147364507|NCT03786926|531506994|FG004|Overall Study|Adverse Event|0|||
147364508|NCT03786926|531506995|FG005|Overall Study|Adverse Event|0|||
147364509|NCT03786926|531506996|FG006|Overall Study|Adverse Event|0|||
147364510|NCT03786926|531506997|FG007|Overall Study|Adverse Event|1|||
147364511|NCT03786926|531506998|FG008|Overall Study|Adverse Event|1|||
147364512|NCT03786926|531506999|FG009|Overall Study|Adverse Event|0|||
147364513|NCT03786926|531507000|FG010|Overall Study|Adverse Event|1|||
147364514|NCT03786926|531506990|FG000|Overall Study|Progressive disease|3|||
147364515|NCT03786926|531506991|FG001|Overall Study|Progressive disease|0|||
147364516|NCT03786926|531506992|FG002|Overall Study|Progressive disease|3|||
147364517|NCT03786926|531506993|FG003|Overall Study|Progressive disease|1|||
147364518|NCT03786926|531506994|FG004|Overall Study|Progressive disease|2|||
147364519|NCT03786926|531506995|FG005|Overall Study|Progressive disease|2|||
147364520|NCT03786926|531506996|FG006|Overall Study|Progressive disease|1|||
147364521|NCT03786926|531506997|FG007|Overall Study|Progressive disease|6|||
147364522|NCT03786926|531506998|FG008|Overall Study|Progressive disease|1|||
147364523|NCT03786926|531506999|FG009|Overall Study|Progressive disease|1|||
147364524|NCT03786926|531507000|FG010|Overall Study|Progressive disease|1|||
147364525|NCT03786926|531506990|FG000|Overall Study|Death|0|||
147364526|NCT03786926|531506991|FG001|Overall Study|Death|1|||
147364527|NCT03786926|531506992|FG002|Overall Study|Death|1|||
147364528|NCT03786926|531506993|FG003|Overall Study|Death|0|||
147364529|NCT03786926|531506994|FG004|Overall Study|Death|0|||
147364530|NCT03786926|531506995|FG005|Overall Study|Death|0|||
147364531|NCT03786926|531506996|FG006|Overall Study|Death|0|||
147364532|NCT03786926|531506997|FG007|Overall Study|Death|0|||
147364533|NCT03786926|531506998|FG008|Overall Study|Death|0|||
147364534|NCT03786926|531506999|FG009|Overall Study|Death|1|||
147364535|NCT03786926|531507000|FG010|Overall Study|Death|2|||
147364536|NCT03786926|531506990|FG000|Overall Study|Physician Decision|0|||
147364537|NCT03786926|531506991|FG001|Overall Study|Physician Decision|1|||
147364538|NCT03786926|531506992|FG002|Overall Study|Physician Decision|0|||
147608708|NCT01659125|532384029|FG000|Overall Study|Failed to Start Treatment|2|||
147608709|NCT05013008|532384033|FG000|Overall Study|Exclusion from mBFAS|5|||
147608710|NCT05013008|532384034|FG001|Overall Study|Exclusion from mBFAS|25|||
147608711|NCT01443728|532384035|FG000|Overall Study|Lost to Follow-up|2|||
147608712|NCT01443728|532384036|FG001|Overall Study|Lost to Follow-up|0|||
147608713|NCT01443728|532384035|FG000|Overall Study|Withdrawal by Subject|1|||
147608714|NCT01443728|532384036|FG001|Overall Study|Withdrawal by Subject|1|||
147608715|NCT01443728|532384035|FG000|Overall Study|Adverse Event|0|||
147608716|NCT01443728|532384036|FG001|Overall Study|Adverse Event|2|||
147608717|NCT04981717|532384037|FG000|Overall Study|Protocol Violation|0|||
147608718|NCT04981717|532384038|FG001|Overall Study|Protocol Violation|3|||
147608719|NCT04981717|532384037|FG000|Overall Study|Adverse Event|1|||
147608720|NCT04981717|532384038|FG001|Overall Study|Adverse Event|3|||
147608721|NCT04981717|532384037|FG000|Overall Study|Pregnancy|1|||
147608722|NCT04981717|532384038|FG001|Overall Study|Pregnancy|0|||
147608723|NCT04981717|532384037|FG000|Overall Study|Physician Decision|1|||
147608724|NCT04981717|532384038|FG001|Overall Study|Physician Decision|0|||
147608725|NCT04981717|532384037|FG000|Overall Study|Sponsor Request|157|||
147608726|NCT04981717|532384038|FG001|Overall Study|Sponsor Request|172|||
147608727|NCT04981717|532384037|FG000|Overall Study|Lost to Follow-up|4|||
147608728|NCT04981717|532384038|FG001|Overall Study|Lost to Follow-up|5|||
147608729|NCT04981717|532384037|FG000|Overall Study|Withdrawal by Subject|50|||
147608730|NCT04981717|532384038|FG001|Overall Study|Withdrawal by Subject|37|||
147608731|NCT03743415|532384039|FG000|Overall Study|Death|5|||
147608732|NCT03743415|532384040|FG001|Overall Study|Death|3|||
147608733|NCT03743415|532384041|FG002|Overall Study|Death|1|||
147608734|NCT03743415|532384042|FG003|Overall Study|Death|4|||
147608735|NCT03743415|532384043|FG004|Overall Study|Death|0|||
147608736|NCT03743415|532384044|FG005|Overall Study|Death|0|||
147608737|NCT03743415|532384045|FG006|Overall Study|Death|0|||
147608738|NCT03743415|532384046|FG007|Overall Study|Death|0|||
147608739|NCT03743415|532384047|FG008|Overall Study|Death|1|||
147364539|NCT03786926|531506993|FG003|Overall Study|Physician Decision|1|||
147364540|NCT03786926|531506994|FG004|Overall Study|Physician Decision|2|||
147364541|NCT03786926|531506995|FG005|Overall Study|Physician Decision|0|||
147364542|NCT03786926|531506996|FG006|Overall Study|Physician Decision|0|||
147364543|NCT03786926|531506997|FG007|Overall Study|Physician Decision|2|||
147364544|NCT03786926|531506998|FG008|Overall Study|Physician Decision|1|||
147364545|NCT03786926|531506999|FG009|Overall Study|Physician Decision|1|||
147364546|NCT03786926|531507000|FG010|Overall Study|Physician Decision|0|||
147364547|NCT03786926|531506990|FG000|Overall Study|Withdrawal by Subject|0|||
147364548|NCT03786926|531506991|FG001|Overall Study|Withdrawal by Subject|1|||
147364549|NCT03786926|531506992|FG002|Overall Study|Withdrawal by Subject|1|||
147364550|NCT03786926|531506993|FG003|Overall Study|Withdrawal by Subject|0|||
147364551|NCT03786926|531506994|FG004|Overall Study|Withdrawal by Subject|0|||
147364552|NCT03786926|531506995|FG005|Overall Study|Withdrawal by Subject|0|||
147364553|NCT03786926|531506996|FG006|Overall Study|Withdrawal by Subject|1|||
147364554|NCT03786926|531506997|FG007|Overall Study|Withdrawal by Subject|0|||
147364555|NCT03786926|531506998|FG008|Overall Study|Withdrawal by Subject|1|||
147364556|NCT03786926|531506999|FG009|Overall Study|Withdrawal by Subject|0|||
147364557|NCT03786926|531507000|FG010|Overall Study|Withdrawal by Subject|1|||
147364558|NCT03786926|531506990|FG000|Overall Study|Study terminated by Sponsor|0|||
147364559|NCT03786926|531506991|FG001|Overall Study|Study terminated by Sponsor|0|||
147364560|NCT03786926|531506992|FG002|Overall Study|Study terminated by Sponsor|0|||
147608740|NCT03743415|532384048|FG009|Overall Study|Death|0|||
147608741|NCT03743415|532384039|FG000|Overall Study|Withdrawal by Subject|1|||
147364561|NCT03786926|531506993|FG003|Overall Study|Study terminated by Sponsor|0|||
147364562|NCT03786926|531506994|FG004|Overall Study|Study terminated by Sponsor|1|||
147364563|NCT03786926|531506995|FG005|Overall Study|Study terminated by Sponsor|0|||
147364564|NCT03786926|531506996|FG006|Overall Study|Study terminated by Sponsor|0|||
147364565|NCT03786926|531506997|FG007|Overall Study|Study terminated by Sponsor|4|||
147608742|NCT03743415|532384040|FG001|Overall Study|Withdrawal by Subject|0|||
147608743|NCT03743415|532384041|FG002|Overall Study|Withdrawal by Subject|4|||
147608744|NCT03743415|532384042|FG003|Overall Study|Withdrawal by Subject|5|||
147608745|NCT03743415|532384043|FG004|Overall Study|Withdrawal by Subject|5|||
147364566|NCT03786926|531506998|FG008|Overall Study|Study terminated by Sponsor|0|||
147364567|NCT03786926|531506999|FG009|Overall Study|Study terminated by Sponsor|0|||
147364568|NCT03786926|531507000|FG010|Overall Study|Study terminated by Sponsor|0|||
147608746|NCT03743415|532384044|FG005|Overall Study|Withdrawal by Subject|2|||
147608747|NCT03743415|532384045|FG006|Overall Study|Withdrawal by Subject|2|||
147608748|NCT03743415|532384046|FG007|Overall Study|Withdrawal by Subject|5|||
147364569|NCT03786926|531506990|FG000|Overall Study|Anti-neoplasm treatment|0|||
147364570|NCT03786926|531506991|FG001|Overall Study|Anti-neoplasm treatment|0|||
147364571|NCT03786926|531506992|FG002|Overall Study|Anti-neoplasm treatment|0|||
147364572|NCT03786926|531506993|FG003|Overall Study|Anti-neoplasm treatment|0|||
147608749|NCT03743415|532384047|FG008|Overall Study|Withdrawal by Subject|9|||
147364573|NCT03786926|531506994|FG004|Overall Study|Anti-neoplasm treatment|1|||
147364574|NCT03786926|531506995|FG005|Overall Study|Anti-neoplasm treatment|0|||
147364575|NCT03786926|531506996|FG006|Overall Study|Anti-neoplasm treatment|1|||
147364576|NCT03786926|531506997|FG007|Overall Study|Anti-neoplasm treatment|0|||
147364577|NCT03786926|531506998|FG008|Overall Study|Anti-neoplasm treatment|0|||
147364578|NCT03786926|531506999|FG009|Overall Study|Anti-neoplasm treatment|0|||
147364579|NCT03786926|531507000|FG010|Overall Study|Anti-neoplasm treatment|0|||
147364580|NCT03786926|531506990|FG000|Overall Study|Other|0|||
147364581|NCT03786926|531506991|FG001|Overall Study|Other|0|||
147364582|NCT03786926|531506992|FG002|Overall Study|Other|0|||
147364583|NCT03786926|531506993|FG003|Overall Study|Other|1|||
147364584|NCT03786926|531506994|FG004|Overall Study|Other|0|||
147364585|NCT03786926|531506995|FG005|Overall Study|Other|1|||
147364586|NCT03786926|531506996|FG006|Overall Study|Other|0|||
147364587|NCT03786926|531506997|FG007|Overall Study|Other|0|||
147364588|NCT03786926|531506998|FG008|Overall Study|Other|2|||
147364589|NCT03786926|531506999|FG009|Overall Study|Other|0|||
147364590|NCT03786926|531507000|FG010|Overall Study|Other|0|||
147364591|NCT05875701|531507005|FG000|Overall Study|Lost to Follow-up|2|||
147364592|NCT05875701|531507006|FG001|Overall Study|Lost to Follow-up|0|||
147364593|NCT05875701|531507005|FG000|Overall Study|Withdrawal by Subject|1|||
147364594|NCT05875701|531507006|FG001|Overall Study|Withdrawal by Subject|1|||
147364595|NCT03884439|531507020|FG000|Overall Study|No informed consent for publication of study results|38|||
147364596|NCT03884439|531507020|FG000|Overall Study|Contract violation/deficiency|7|||
147364597|NCT04093869|531507029|FG000|Overall Study|Death|0|||
147364598|NCT04093869|531507030|FG001|Overall Study|Death|1|||
147364599|NCT04093869|531507029|FG000|Overall Study|Withdrawal by Subject|1|||
147364600|NCT04093869|531507030|FG001|Overall Study|Withdrawal by Subject|0|||
147364601|NCT02806726|531507031|FG000|Overall Study|Lost to Follow-up|1|||
147364602|NCT05129501|531507034|FG000|Overall Study|Lost to Follow-up|54|||
147364603|NCT05129501|531507035|FG001|Overall Study|Lost to Follow-up|41|||
147364604|NCT03092674|531507036|FG000|Overall Study|Adverse Event or Side Effects|1|||
147364605|NCT03092674|531507037|FG001|Overall Study|Adverse Event or Side Effects|4|||
147364606|NCT03092674|531507038|FG002|Overall Study|Adverse Event or Side Effects|4|||
147364607|NCT03092674|531507036|FG000|Overall Study|Refusal Unrelated to Adverse Event|5|||
147364608|NCT03092674|531507037|FG001|Overall Study|Refusal Unrelated to Adverse Event|1|||
147364609|NCT03092674|531507038|FG002|Overall Study|Refusal Unrelated to Adverse Event|3|||
147364610|NCT03092674|531507036|FG000|Overall Study|Progression/Relapse|5|||
147364611|NCT03092674|531507037|FG001|Overall Study|Progression/Relapse|4|||
147364612|NCT03092674|531507038|FG002|Overall Study|Progression/Relapse|8|||
147364613|NCT03092674|531507036|FG000|Overall Study|Death|4|||
147364614|NCT03092674|531507037|FG001|Overall Study|Death|8|||
147364615|NCT03092674|531507038|FG002|Overall Study|Death|2|||
147364616|NCT03092674|531507036|FG000|Overall Study|Other - Not Protocol Specified|11|||
147364617|NCT03092674|531507037|FG001|Overall Study|Other - Not Protocol Specified|8|||
147364618|NCT03092674|531507038|FG002|Overall Study|Other - Not Protocol Specified|8|||
147364619|NCT01527188|531507039|FG000|Overall Study|Adverse Event|5|||
147364620|NCT01527188|531507040|FG001|Overall Study|Adverse Event|5|||
147364621|NCT01527188|531507041|FG002|Overall Study|Adverse Event|11|||
147364622|NCT01527188|531507042|FG003|Overall Study|Adverse Event|0|||
147364623|NCT01527188|531507039|FG000|Overall Study|Withdrawal by Subject|3|||
147364624|NCT01527188|531507040|FG001|Overall Study|Withdrawal by Subject|6|||
147364625|NCT01527188|531507041|FG002|Overall Study|Withdrawal by Subject|4|||
147364626|NCT01527188|531507042|FG003|Overall Study|Withdrawal by Subject|4|||
147364627|NCT01527188|531507039|FG000|Overall Study|Any other reason not above-mentioned|6|||
147364628|NCT01527188|531507040|FG001|Overall Study|Any other reason not above-mentioned|7|||
147364629|NCT01527188|531507041|FG002|Overall Study|Any other reason not above-mentioned|8|||
147364630|NCT01527188|531507042|FG003|Overall Study|Any other reason not above-mentioned|8|||
147364631|NCT03982186|531507045|FG000|Overall Study|Lost to Follow-up|0|||
147364632|NCT03982186|531507046|FG001|Overall Study|Lost to Follow-up|1|||
147364633|NCT03982186|531507047|FG002|Overall Study|Lost to Follow-up|2|||
147364634|NCT03982186|531507048|FG003|Overall Study|Lost to Follow-up|1|||
147364635|NCT03982186|531507049|FG004|Overall Study|Lost to Follow-up|1|||
147364636|NCT03982186|531507050|FG005|Overall Study|Lost to Follow-up|0|||
147364637|NCT03982186|531507045|FG000|Overall Study|Physician Decision|0|||
147364638|NCT03982186|531507046|FG001|Overall Study|Physician Decision|1|||
147364639|NCT03982186|531507047|FG002|Overall Study|Physician Decision|0|||
147364640|NCT03982186|531507048|FG003|Overall Study|Physician Decision|0|||
147364641|NCT03982186|531507049|FG004|Overall Study|Physician Decision|0|||
147364642|NCT03982186|531507050|FG005|Overall Study|Physician Decision|0|||
147364643|NCT03982186|531507045|FG000|Overall Study|Withdrawal by Subject|3|||
147364644|NCT03982186|531507046|FG001|Overall Study|Withdrawal by Subject|4|||
147364645|NCT03982186|531507047|FG002|Overall Study|Withdrawal by Subject|1|||
147364646|NCT03982186|531507048|FG003|Overall Study|Withdrawal by Subject|7|||
147364647|NCT03982186|531507049|FG004|Overall Study|Withdrawal by Subject|2|||
147364648|NCT03982186|531507050|FG005|Overall Study|Withdrawal by Subject|0|||
147364649|NCT03982186|531507045|FG000|Overall Study|Randomized and not treated|0|||
147364650|NCT03982186|531507046|FG001|Overall Study|Randomized and not treated|0|||
147364651|NCT03982186|531507047|FG002|Overall Study|Randomized and not treated|0|||
147364652|NCT03982186|531507048|FG003|Overall Study|Randomized and not treated|1|||
147364653|NCT03982186|531507049|FG004|Overall Study|Randomized and not treated|0|||
147364654|NCT03982186|531507050|FG005|Overall Study|Randomized and not treated|0|||
147364655|NCT03512301|531507663|FG000|Overall Study|Protocol Violation|2|||
147364656|NCT03512301|531507663|FG000|Overall Study|Did Not Qualify|3|||
147364657|NCT03512301|531507663|FG000|Overall Study|Age-ineligible|1|||
147364658|NCT03512301|531507663|FG000|Overall Study|Inadequate fluency with the English language|3|||
147364659|NCT00739908|531507670|FG000|Overall Study|Adverse Event|5|||
147364660|NCT00739908|531507671|FG001|Overall Study|Adverse Event|6|||
147364661|NCT00739908|531507670|FG000|Overall Study|Withdrawal by Subject|4|||
147364662|NCT00739908|531507671|FG001|Overall Study|Withdrawal by Subject|2|||
147364663|NCT00739908|531507670|FG000|Overall Study|Lost to Follow-up|14|||
147364664|NCT00739908|531507671|FG001|Overall Study|Lost to Follow-up|9|||
147364665|NCT00739908|531507670|FG000|Overall Study|Non-Compliance With Study Procedures|2|||
147364666|NCT00739908|531507671|FG001|Overall Study|Non-Compliance With Study Procedures|3|||
147364667|NCT00739908|531507670|FG000|Overall Study|Non-Compliance With Study Medication|0|||
147364668|NCT00739908|531507671|FG001|Overall Study|Non-Compliance With Study Medication|3|||
147364669|NCT00739908|531507670|FG000|Overall Study|Lack of Efficacy|0|||
147364670|NCT00739908|531507671|FG001|Overall Study|Lack of Efficacy|1|||
147364671|NCT00739908|531507670|FG000|Overall Study|Relocation|0|||
147364672|NCT00739908|531507671|FG001|Overall Study|Relocation|1|||
147364673|NCT05157841|531507672|FG000|Part A (14 Days)|Withdrawal by Subject|0|||
147364674|NCT05157841|531507673|FG001|Part A (14 Days)|Withdrawal by Subject|1|||
147364675|NCT05157841|531507674|FG002|Part A (14 Days)|Withdrawal by Subject|2|||
147364676|NCT05157841|531507672|FG000|Part A (14 Days)|Adverse Event|1|||
147364677|NCT05157841|531507673|FG001|Part A (14 Days)|Adverse Event|0|||
147364678|NCT05157841|531507674|FG002|Part A (14 Days)|Adverse Event|0|||
147364679|NCT05157841|531507672|FG000|Part A (14 Days)|Failure to meet continuation criteria|0|||
147364680|NCT05157841|531507673|FG001|Part A (14 Days)|Failure to meet continuation criteria|0|||
147364681|NCT05157841|531507674|FG002|Part A (14 Days)|Failure to meet continuation criteria|1|||
147364682|NCT02075554|531507678|FG000|Overall Study|Lost to Follow-up|7|||
147364683|NCT02075554|531507678|FG000|Overall Study|Withdrawal by Subject|5|||
147364684|NCT02075554|531507678|FG000|Overall Study|Physician Decision|3|||
147364685|NCT04933474|531507684|FG000|Overall Study|Discontinued Intervention Prior to End of Follow-up|2|||
147364686|NCT04933474|531507685|FG001|Overall Study|Discontinued Intervention Prior to End of Follow-up|1|||
147364687|NCT04933474|531507684|FG000|Overall Study|Lost to Follow-up|19|||
147364688|NCT04933474|531507685|FG001|Overall Study|Lost to Follow-up|9|||
147364689|NCT04933474|531507684|FG000|Overall Study|Life Burden - unable to participate|6|||
147364690|NCT04933474|531507685|FG001|Overall Study|Life Burden - unable to participate|2|||
147364691|NCT04933474|531507684|FG000|Overall Study|Disease Burden - unable to participate|4|||
147364692|NCT04933474|531507685|FG001|Overall Study|Disease Burden - unable to participate|1|||
147364693|NCT04933474|531507684|FG000|Overall Study|Surgery/Hospitalization|1|||
147364694|NCT04933474|531507685|FG001|Overall Study|Surgery/Hospitalization|2|||
147364695|NCT04933474|531507684|FG000|Overall Study|Dissatisfied with Intervention|1|||
147364696|NCT04933474|531507685|FG001|Overall Study|Dissatisfied with Intervention|1|||
147364697|NCT04933474|531507684|FG000|Overall Study|Withdrew interest in participation|1|||
147364698|NCT04933474|531507685|FG001|Overall Study|Withdrew interest in participation|0|||
147364699|NCT04933474|531507684|FG000|Overall Study|Had previously enrolled in the study|0|||
147364700|NCT04933474|531507685|FG001|Overall Study|Had previously enrolled in the study|1|||
147364701|NCT01773993|531507686|FG000|Overall Study|No Visit After Treatment|35|||
147364702|NCT04993677|531507687|FG000|Overall Study|Lost to Follow-up|1|||
147364703|NCT04993677|531507688|FG001|Overall Study|Lost to Follow-up|0|||
147364704|NCT04993677|531507689|FG002|Overall Study|Lost to Follow-up|0|||
147364705|NCT04993677|531507690|FG003|Overall Study|Lost to Follow-up|0|||
147364706|NCT04993677|531507687|FG000|Overall Study|Death|11|||
147364707|NCT04993677|531507688|FG001|Overall Study|Death|8|||
147454251|NCT00598975|531825564|FG000|Overall Study|Adverse Event|1|||
147454252|NCT00598975|531825565|FG001|Overall Study|Adverse Event|1|||
147454253|NCT00598975|531825564|FG000|Overall Study|Brain metastases|1|||
147454254|NCT00598975|531825565|FG001|Overall Study|Brain metastases|0|||
147364708|NCT04993677|531507689|FG002|Overall Study|Death|3|||
147364709|NCT04993677|531507690|FG003|Overall Study|Death|1|||
147364710|NCT04993677|531507687|FG000|Overall Study|Subject withdrawal of consent|4|||
147364711|NCT04993677|531507688|FG001|Overall Study|Subject withdrawal of consent|3|||
147364712|NCT04993677|531507689|FG002|Overall Study|Subject withdrawal of consent|0|||
147364713|NCT04993677|531507690|FG003|Overall Study|Subject withdrawal of consent|2|||
147364714|NCT04993677|531507687|FG000|Overall Study|Study termination by sponsor|3|||
147364715|NCT04993677|531507688|FG001|Overall Study|Study termination by sponsor|25|||
147364716|NCT04993677|531507689|FG002|Overall Study|Study termination by sponsor|3|||
147364717|NCT04993677|531507690|FG003|Overall Study|Study termination by sponsor|3|||
147364718|NCT04993677|531507687|FG000|Overall Study|Other|2|||
147454255|NCT00598975|531825564|FG000|Overall Study|Withdrawal by Subject|1|||
147454256|NCT00598975|531825565|FG001|Overall Study|Withdrawal by Subject|1|||
147454257|NCT00598975|531825564|FG000|Overall Study|Withdrawal of consent|0|||
147364719|NCT04993677|531507688|FG001|Overall Study|Other|3|||
147364720|NCT04993677|531507689|FG002|Overall Study|Other|3|||
147364721|NCT04993677|531507690|FG003|Overall Study|Other|2|||
147364722|NCT04174170|531507691|FG000|Placebo Run-in Period|Not Randomized|38|||
147364723|NCT04174170|531507692|FG001|Placebo Run-in Period|Not Randomized|0|||
147364724|NCT04174170|531507693|FG002|Placebo Run-in Period|Not Randomized|0|||
147364725|NCT04174170|531507694|FG003|Placebo Run-in Period|Not Randomized|0|||
147364726|NCT04174170|531507691|FG000|Double Blind Treatment Period|Adverse Event|0|||
147364727|NCT04174170|531507692|FG001|Double Blind Treatment Period|Adverse Event|9|||
147364728|NCT04174170|531507693|FG002|Double Blind Treatment Period|Adverse Event|9|||
147364729|NCT04174170|531507694|FG003|Double Blind Treatment Period|Adverse Event|8|||
147364730|NCT04174170|531507691|FG000|Double Blind Treatment Period|Death|0|||
147364731|NCT04174170|531507692|FG001|Double Blind Treatment Period|Death|1|||
147608750|NCT03743415|532384048|FG009|Overall Study|Withdrawal by Subject|10|||
147608751|NCT03743415|532384039|FG000|Overall Study|Lost to Follow-up|2|||
147608752|NCT03743415|532384040|FG001|Overall Study|Lost to Follow-up|0|||
147608753|NCT03743415|532384041|FG002|Overall Study|Lost to Follow-up|2|||
147608754|NCT03743415|532384042|FG003|Overall Study|Lost to Follow-up|1|||
147608755|NCT03743415|532384043|FG004|Overall Study|Lost to Follow-up|1|||
147608756|NCT03743415|532384044|FG005|Overall Study|Lost to Follow-up|0|||
147608757|NCT03743415|532384045|FG006|Overall Study|Lost to Follow-up|1|||
147608758|NCT03743415|532384046|FG007|Overall Study|Lost to Follow-up|4|||
147608759|NCT03743415|532384047|FG008|Overall Study|Lost to Follow-up|13|||
147608760|NCT03743415|532384048|FG009|Overall Study|Lost to Follow-up|13|||
147608761|NCT00094861|532384049|FG000|Overall Study|Adverse Event|5|||
147608762|NCT00094861|532384050|FG001|Overall Study|Adverse Event|2|||
147608763|NCT00094861|532384049|FG000|Overall Study|Withdrawal by Subject|5|||
147608764|NCT00094861|532384050|FG001|Overall Study|Withdrawal by Subject|3|||
147608765|NCT00094861|532384049|FG000|Overall Study|Physician Decision|1|||
147608766|NCT00094861|532384050|FG001|Overall Study|Physician Decision|1|||
147608767|NCT00094861|532384049|FG000|Overall Study|Lost to Follow-up|0|||
147608768|NCT00094861|532384050|FG001|Overall Study|Lost to Follow-up|1|||
147608769|NCT00094861|532384049|FG000|Overall Study|Death|4|||
147608770|NCT00094861|532384050|FG001|Overall Study|Death|2|||
147608771|NCT00094861|532384049|FG000|Overall Study|Other|3|||
147608772|NCT00094861|532384050|FG001|Overall Study|Other|0|||
147608773|NCT00451204|532384053|FG000|Overall Study|Adverse Event|4|||
147608774|NCT00451204|532384054|FG001|Overall Study|Adverse Event|6|||
147608775|NCT00451204|532384053|FG000|Overall Study|Lack of Efficacy|4|||
147608776|NCT00451204|532384054|FG001|Overall Study|Lack of Efficacy|4|||
147608777|NCT00451204|532384053|FG000|Overall Study|Lost to Follow-up|4|||
147608778|NCT00451204|532384054|FG001|Overall Study|Lost to Follow-up|4|||
147608779|NCT00451204|532384053|FG000|Overall Study|Protocol Violation|1|||
147608780|NCT00451204|532384054|FG001|Overall Study|Protocol Violation|0|||
147608781|NCT00451204|532384053|FG000|Overall Study|Patient refusal|8|||
147608782|NCT00451204|532384054|FG001|Overall Study|Patient refusal|4|||
147608783|NCT00451204|532384053|FG000|Overall Study|Other|1|||
147608784|NCT00451204|532384054|FG001|Overall Study|Other|2|||
147608785|NCT03760185|532384055|FG000|Overall Study|Lost to Follow-up|1|||
147364732|NCT04174170|531507693|FG002|Double Blind Treatment Period|Death|0|||
147364733|NCT04174170|531507694|FG003|Double Blind Treatment Period|Death|0|||
147364734|NCT04174170|531507691|FG000|Double Blind Treatment Period|Lost to Follow-up|0|||
147364735|NCT04174170|531507692|FG001|Double Blind Treatment Period|Lost to Follow-up|22|||
147364736|NCT04174170|531507693|FG002|Double Blind Treatment Period|Lost to Follow-up|11|||
147364737|NCT04174170|531507694|FG003|Double Blind Treatment Period|Lost to Follow-up|25|||
147364738|NCT04174170|531507691|FG000|Double Blind Treatment Period|Non-Compliance With Study Drug|0|||
147364739|NCT04174170|531507692|FG001|Double Blind Treatment Period|Non-Compliance With Study Drug|4|||
147608786|NCT03760185|532384056|FG001|Overall Study|Lost to Follow-up|1|||
147608787|NCT02242045|532384057|FG000|Overall Study|Investigator's Discretion|1|||
147608788|NCT02242045|532384057|FG000|Overall Study|Progressive Disease|2|||
147608789|NCT02242045|532384057|FG000|Overall Study|Unable to tolerate rechallenge with idelalisib|1|||
147608790|NCT02242045|532384057|FG000|Overall Study|Initiated another anti-cancer or experimental therapy|2|||
147608791|NCT00976911|532384063|FG000|Overall Study|Withdrawal by Subject|4|||
147608792|NCT00976911|532384064|FG001|Overall Study|Withdrawal by Subject|6|||
147608793|NCT00976911|532384063|FG000|Overall Study|Death|138|||
147608794|NCT00976911|532384064|FG001|Overall Study|Death|126|||
147608795|NCT00976911|532384063|FG000|Overall Study|Adverse Event|0|||
147608796|NCT00976911|532384064|FG001|Overall Study|Adverse Event|1|||
147608797|NCT00976911|532384063|FG000|Overall Study|Protocol Violation|2|||
147364740|NCT04174170|531507693|FG002|Double Blind Treatment Period|Non-Compliance With Study Drug|4|||
147364741|NCT04174170|531507694|FG003|Double Blind Treatment Period|Non-Compliance With Study Drug|2|||
147364742|NCT04174170|531507691|FG000|Double Blind Treatment Period|Physician Decision|0|||
147608798|NCT00976911|532384064|FG001|Overall Study|Protocol Violation|0|||
147608799|NCT00976911|532384063|FG000|Overall Study|Other|8|||
147608800|NCT00976911|532384064|FG001|Overall Study|Other|9|||
147608801|NCT00976911|532384063|FG000|Overall Study|In Follow-Up as of 25 Jan 2013|30|||
147608802|NCT00976911|532384064|FG001|Overall Study|In Follow-Up as of 25 Jan 2013|37|||
147364743|NCT04174170|531507692|FG001|Double Blind Treatment Period|Physician Decision|1|||
147364744|NCT04174170|531507693|FG002|Double Blind Treatment Period|Physician Decision|0|||
147364745|NCT04174170|531507694|FG003|Double Blind Treatment Period|Physician Decision|1|||
147364746|NCT04174170|531507691|FG000|Double Blind Treatment Period|Pregnancy|0|||
147364747|NCT04174170|531507692|FG001|Double Blind Treatment Period|Pregnancy|1|||
147364748|NCT04174170|531507693|FG002|Double Blind Treatment Period|Pregnancy|0|||
147364749|NCT04174170|531507694|FG003|Double Blind Treatment Period|Pregnancy|1|||
147364750|NCT04174170|531507691|FG000|Double Blind Treatment Period|Protocol Deviation|0|||
147364751|NCT04174170|531507692|FG001|Double Blind Treatment Period|Protocol Deviation|7|||
147364752|NCT04174170|531507693|FG002|Double Blind Treatment Period|Protocol Deviation|6|||
147364753|NCT04174170|531507694|FG003|Double Blind Treatment Period|Protocol Deviation|4|||
147364754|NCT04174170|531507691|FG000|Double Blind Treatment Period|Withdrawal by Subject|0|||
147364755|NCT04174170|531507692|FG001|Double Blind Treatment Period|Withdrawal by Subject|19|||
147364756|NCT04174170|531507693|FG002|Double Blind Treatment Period|Withdrawal by Subject|29|||
147364757|NCT04174170|531507694|FG003|Double Blind Treatment Period|Withdrawal by Subject|14|||
147364758|NCT04174170|531507691|FG000|Double Blind Treatment Period|Reason Not Specified|0|||
147364759|NCT04174170|531507692|FG001|Double Blind Treatment Period|Reason Not Specified|1|||
147364760|NCT04174170|531507693|FG002|Double Blind Treatment Period|Reason Not Specified|3|||
147364761|NCT04174170|531507694|FG003|Double Blind Treatment Period|Reason Not Specified|6|||
147364762|NCT04664881|531507695|FG000|Overall Study|Withdrawal by Subject|1|||
147364763|NCT04664881|531507696|FG001|Overall Study|Withdrawal by Subject|8|||
147364764|NCT04664881|531507695|FG000|Overall Study|Physician Decision|0|||
147364765|NCT04664881|531507696|FG001|Overall Study|Physician Decision|5|||
147364766|NCT04664881|531507695|FG000|Overall Study|Lost to Follow-up|1|||
147364767|NCT04664881|531507696|FG001|Overall Study|Lost to Follow-up|0|||
147364768|NCT04772534|531507705|FG000|Overall Study|Physician Decision|1|||
147364769|NCT04772534|531507706|FG001|Overall Study|Physician Decision|0|||
147364770|NCT04772534|531507707|FG002|Overall Study|Physician Decision|0|||
147364771|NCT04772534|531507705|FG000|Overall Study|Withdrawal by Subject|3|||
147364772|NCT04772534|531507706|FG001|Overall Study|Withdrawal by Subject|0|||
147364773|NCT04772534|531507707|FG002|Overall Study|Withdrawal by Subject|1|||
147364774|NCT04194450|531507708|FG000|Overall Study|not eligible|1|||
147364775|NCT04194450|531507709|FG001|Overall Study|not eligible|0|||
147364776|NCT00308997|531507713|FG000|Overall Study|Subject feigned clinical data|0|||
147364777|NCT00308997|531507714|FG001|Overall Study|Subject feigned clinical data|1|||
147364778|NCT00308997|531507713|FG000|Overall Study|Unable to tolerate intervention|1|||
147364779|NCT00308997|531507714|FG001|Overall Study|Unable to tolerate intervention|0|||
147364780|NCT04490356|531507715|FG000|Overall Study|Lost to Follow-up|1|||
147364781|NCT03733626|531507716|FG000|Overall Study|Physician Decision|4|||
147364782|NCT03733626|531507717|FG001|Overall Study|Physician Decision|4|||
147364783|NCT03816397|531507718|FG000|Overall Study|Censored at interim analysis date.|13|||
147364784|NCT03816397|531507719|FG001|Overall Study|Censored at interim analysis date.|6|||
147364785|NCT03816397|531507718|FG000|Overall Study|Withdrawal by Subject|1|||
147364786|NCT03816397|531507719|FG001|Overall Study|Withdrawal by Subject|1|||
147364787|NCT01220531|531507728|FG000|Overall Study|Death|7|||
147364788|NCT01220531|531507728|FG000|Overall Study|Lost to Follow-up|1|||
147364789|NCT01553149|531507729|FG000|Overall Study|Adverse Event|0|||
147364790|NCT01553149|531507730|FG001|Overall Study|Adverse Event|9|||
147364791|NCT01553149|531507729|FG000|Overall Study|Physician Decision|5|||
147364792|NCT01553149|531507730|FG001|Overall Study|Physician Decision|10|||
147364793|NCT01553149|531507729|FG000|Overall Study|Ineligible|0|||
147364794|NCT01553149|531507730|FG001|Overall Study|Ineligible|1|||
147364795|NCT05866926|531507731|FG000|Overall Study|Death|16|||
147364796|NCT05866926|531507732|FG001|Overall Study|Death|9|||
147364797|NCT05866926|531507731|FG000|Overall Study|Lost to Follow-up|0|||
147364798|NCT05866926|531507732|FG001|Overall Study|Lost to Follow-up|1|||
147364799|NCT05866926|531507731|FG000|Overall Study|Adverse Event|1|||
147364800|NCT05866926|531507732|FG001|Overall Study|Adverse Event|0|||
147364801|NCT05866926|531507731|FG000|Overall Study|Withdrawal by Subject|5|||
147364802|NCT05866926|531507732|FG001|Overall Study|Withdrawal by Subject|1|||
147364803|NCT05866926|531507731|FG000|Overall Study|Disease progression|1|||
147364804|NCT05866926|531507732|FG001|Overall Study|Disease progression|0|||
147364805|NCT05866926|531507731|FG000|Overall Study|other causes|2|||
147364806|NCT05866926|531507732|FG001|Overall Study|other causes|1|||
147364807|NCT00709956|531507733|FG000|Overall Study|Withdrawal by Subject|1|||
147364808|NCT00709956|531507734|FG001|Overall Study|Withdrawal by Subject|1|||
147364809|NCT00709956|531507733|FG000|Overall Study|Inclusion/exclusion criteria violation|2|||
147364810|NCT00709956|531507734|FG001|Overall Study|Inclusion/exclusion criteria violation|3|||
147364811|NCT01105091|531507735|FG000|Overall Study|Death|2|||
147364812|NCT01105091|531507736|FG001|Overall Study|Death|0|||
147364813|NCT03215706|531507737|FG000|Randomization|Adverse Event unrelated to study drug|1|||
147364814|NCT03215706|531507738|FG001|Randomization|Adverse Event unrelated to study drug|0|||
147364815|NCT03215706|531507737|FG000|Randomization|participant withdrew consent|1|||
147364816|NCT03215706|531507738|FG001|Randomization|participant withdrew consent|3|||
147364817|NCT03215706|531507737|FG000|Randomization|no longer meets study criteria|1|||
147364818|NCT03215706|531507738|FG001|Randomization|no longer meets study criteria|4|||
147364819|NCT03215706|531507737|FG000|Randomization|other reasons|0|||
147364820|NCT03215706|531507738|FG001|Randomization|other reasons|2|||
147364821|NCT03215706|531507737|FG000|Treatment Period|Disease Progression|150|||
147364822|NCT03215706|531507738|FG001|Treatment Period|Disease Progression|142|||
147364823|NCT03215706|531507737|FG000|Treatment Period|Study Drug Toxicity|53|||
147364824|NCT03215706|531507738|FG001|Treatment Period|Study Drug Toxicity|21|||
147364825|NCT03215706|531507737|FG000|Treatment Period|Death|2|||
147364826|NCT03215706|531507738|FG001|Treatment Period|Death|1|||
147364827|NCT03215706|531507737|FG000|Treatment Period|Adverse event unrelated to study drug|24|||
147364828|NCT03215706|531507738|FG001|Treatment Period|Adverse event unrelated to study drug|23|||
147364829|NCT03215706|531507737|FG000|Treatment Period|Request to D/C treatment|1|||
147364830|NCT03215706|531507738|FG001|Treatment Period|Request to D/C treatment|6|||
147364831|NCT03215706|531507737|FG000|Treatment Period|Participant withdrew consent|3|||
147364832|NCT03215706|531507738|FG001|Treatment Period|Participant withdrew consent|4|||
147364833|NCT03215706|531507737|FG000|Treatment Period|Lost to Follow-up|0|||
147364834|NCT03215706|531507738|FG001|Treatment Period|Lost to Follow-up|1|||
147364835|NCT03215706|531507737|FG000|Treatment Period|Other Reasons|4|||
147364836|NCT03215706|531507738|FG001|Treatment Period|Other Reasons|5|||
147364837|NCT03215706|531507737|FG000|Treatment Period|Ongoing in the treatment period|105|||
147364838|NCT03215706|531507738|FG001|Treatment Period|Ongoing in the treatment period|43|||
147364839|NCT05267639|531508601|FG000|Overall Study|Withdrawal by Subject|1|||
147364840|NCT05267639|531508602|FG001|Overall Study|Withdrawal by Subject|0|||
147364841|NCT03705793|531508614|FG000|Overall Study|Lost to Follow-up|3|||
147364842|NCT03705793|531508615|FG001|Overall Study|Lost to Follow-up|4|||
147364843|NCT03705793|531508614|FG000|Overall Study|Withdrawal by Subject|2|||
147364844|NCT03705793|531508615|FG001|Overall Study|Withdrawal by Subject|1|||
147364845|NCT00447980|531508616|FG000|Overall Study|Withdrawal by Subject|1|||
147364846|NCT00447980|531508617|FG001|Overall Study|Withdrawal by Subject|1|||
147364847|NCT00447980|531508618|FG002|Overall Study|Withdrawal by Subject|4|||
147364848|NCT00447980|531508619|FG003|Overall Study|Withdrawal by Subject|4|||
147364849|NCT00447980|531508616|FG000|Overall Study|Lost to Follow-up|1|||
147364850|NCT00447980|531508617|FG001|Overall Study|Lost to Follow-up|1|||
147364851|NCT00447980|531508618|FG002|Overall Study|Lost to Follow-up|0|||
147364852|NCT00447980|531508619|FG003|Overall Study|Lost to Follow-up|0|||
147364853|NCT00447980|531508616|FG000|Overall Study|Did not proceed with surgery|3|||
147364854|NCT00447980|531508617|FG001|Overall Study|Did not proceed with surgery|3|||
147364855|NCT00447980|531508618|FG002|Overall Study|Did not proceed with surgery|2|||
147364856|NCT00447980|531508619|FG003|Overall Study|Did not proceed with surgery|2|||
147364857|NCT02720068|531508620|FG000|Overall Study|Adverse Event|0|||
147364858|NCT02720068|531508621|FG001|Overall Study|Adverse Event|0|||
147364859|NCT02720068|531508622|FG002|Overall Study|Adverse Event|0|||
147364860|NCT02720068|531508623|FG003|Overall Study|Adverse Event|0|||
147364861|NCT02720068|531508624|FG004|Overall Study|Adverse Event|0|||
147364862|NCT02720068|531508625|FG005|Overall Study|Adverse Event|0|||
147364863|NCT02720068|531508626|FG006|Overall Study|Adverse Event|0|||
147364864|NCT02720068|531508627|FG007|Overall Study|Adverse Event|0|||
147364865|NCT02720068|531508628|FG008|Overall Study|Adverse Event|0|||
147364866|NCT02720068|531508629|FG009|Overall Study|Adverse Event|0|||
147364867|NCT02720068|531508630|FG010|Overall Study|Adverse Event|0|||
147364868|NCT02720068|531508631|FG011|Overall Study|Adverse Event|1|||
147364869|NCT02720068|531508632|FG012|Overall Study|Adverse Event|0|||
147364870|NCT02720068|531508633|FG013|Overall Study|Adverse Event|0|||
147364871|NCT02720068|531508634|FG014|Overall Study|Adverse Event|0|||
147364872|NCT02720068|531508635|FG015|Overall Study|Adverse Event|0|||
147364873|NCT02720068|531508636|FG016|Overall Study|Adverse Event|0|||
147364874|NCT02720068|531508637|FG017|Overall Study|Adverse Event|0|||
147364875|NCT02720068|531508620|FG000|Overall Study|Death|1|||
147608803|NCT01191944|532384065|FG000|Overall Study|Adverse Event|11|||
147608804|NCT01191944|532384066|FG001|Overall Study|Adverse Event|12|||
147608805|NCT01191944|532384065|FG000|Overall Study|Protocol Violation|1|||
147364876|NCT02720068|531508621|FG001|Overall Study|Death|3|||
147364877|NCT02720068|531508622|FG002|Overall Study|Death|2|||
147364878|NCT02720068|531508623|FG003|Overall Study|Death|1|||
147364879|NCT02720068|531508624|FG004|Overall Study|Death|2|||
147454258|NCT00598975|531825565|FG001|Overall Study|Withdrawal of consent|1|||
147454259|NCT00598975|531825564|FG000|Overall Study|Disease progression|8|||
147454260|NCT00598975|531825565|FG001|Overall Study|Disease progression|3|||
147364880|NCT02720068|531508625|FG005|Overall Study|Death|1|||
147364881|NCT02720068|531508626|FG006|Overall Study|Death|2|||
147608806|NCT01191944|532384066|FG001|Overall Study|Protocol Violation|2|||
147364882|NCT02720068|531508627|FG007|Overall Study|Death|2|||
147364883|NCT02720068|531508628|FG008|Overall Study|Death|3|||
147364884|NCT02720068|531508629|FG009|Overall Study|Death|1|||
147364885|NCT02720068|531508630|FG010|Overall Study|Death|20|||
147364886|NCT02720068|531508631|FG011|Overall Study|Death|166|||
147364887|NCT02720068|531508632|FG012|Overall Study|Death|34|||
147364888|NCT02720068|531508633|FG013|Overall Study|Death|30|||
147454261|NCT00598975|531825564|FG000|Overall Study|Tx delayed >2 wks, hospitalized for AE|1|||
147364889|NCT02720068|531508634|FG014|Overall Study|Death|45|||
147364890|NCT02720068|531508635|FG015|Overall Study|Death|16|||
147364891|NCT02720068|531508636|FG016|Overall Study|Death|20|||
147364892|NCT02720068|531508637|FG017|Overall Study|Death|28|||
147364893|NCT02720068|531508620|FG000|Overall Study|Lost to Follow-up|0|||
147364894|NCT02720068|531508621|FG001|Overall Study|Lost to Follow-up|0|||
147364895|NCT02720068|531508622|FG002|Overall Study|Lost to Follow-up|0|||
147364896|NCT02720068|531508623|FG003|Overall Study|Lost to Follow-up|0|||
147364897|NCT02720068|531508624|FG004|Overall Study|Lost to Follow-up|0|||
147364898|NCT02720068|531508625|FG005|Overall Study|Lost to Follow-up|0|||
147364899|NCT02720068|531508626|FG006|Overall Study|Lost to Follow-up|0|||
147364900|NCT02720068|531508627|FG007|Overall Study|Lost to Follow-up|0|||
147364901|NCT02720068|531508628|FG008|Overall Study|Lost to Follow-up|0|||
147364902|NCT02720068|531508629|FG009|Overall Study|Lost to Follow-up|0|||
147364903|NCT02720068|531508630|FG010|Overall Study|Lost to Follow-up|0|||
147364904|NCT02720068|531508631|FG011|Overall Study|Lost to Follow-up|1|||
147364905|NCT02720068|531508632|FG012|Overall Study|Lost to Follow-up|0|||
147364906|NCT02720068|531508633|FG013|Overall Study|Lost to Follow-up|1|||
147364907|NCT02720068|531508634|FG014|Overall Study|Lost to Follow-up|2|||
147364908|NCT02720068|531508635|FG015|Overall Study|Lost to Follow-up|0|||
147364909|NCT02720068|531508636|FG016|Overall Study|Lost to Follow-up|0|||
147364910|NCT02720068|531508637|FG017|Overall Study|Lost to Follow-up|1|||
147364911|NCT02720068|531508620|FG000|Overall Study|Physician Decision|0|||
147364912|NCT02720068|531508621|FG001|Overall Study|Physician Decision|0|||
147364913|NCT02720068|531508622|FG002|Overall Study|Physician Decision|0|||
147364914|NCT02720068|531508623|FG003|Overall Study|Physician Decision|1|||
147364915|NCT02720068|531508624|FG004|Overall Study|Physician Decision|0|||
147364916|NCT02720068|531508625|FG005|Overall Study|Physician Decision|0|||
147364917|NCT02720068|531508626|FG006|Overall Study|Physician Decision|0|||
147364918|NCT02720068|531508627|FG007|Overall Study|Physician Decision|0|||
147454262|NCT00598975|531825565|FG001|Overall Study|Tx delayed >2 wks, hospitalized for AE|0|||
147454263|NCT01178138|531825566|FG000|Overall Study|Lost to Follow-up|8|||
147364919|NCT02720068|531508628|FG008|Overall Study|Physician Decision|0|||
147364920|NCT02720068|531508629|FG009|Overall Study|Physician Decision|0|||
147364921|NCT02720068|531508630|FG010|Overall Study|Physician Decision|0|||
147364922|NCT02720068|531508631|FG011|Overall Study|Physician Decision|1|||
147364923|NCT02720068|531508632|FG012|Overall Study|Physician Decision|0|||
147364924|NCT02720068|531508633|FG013|Overall Study|Physician Decision|0|||
147364925|NCT02720068|531508634|FG014|Overall Study|Physician Decision|0|||
147364926|NCT02720068|531508635|FG015|Overall Study|Physician Decision|0|||
147364927|NCT02720068|531508636|FG016|Overall Study|Physician Decision|0|||
147364928|NCT02720068|531508637|FG017|Overall Study|Physician Decision|1|||
147364929|NCT02720068|531508620|FG000|Overall Study|Progressive Disease|2|||
147364930|NCT02720068|531508621|FG001|Overall Study|Progressive Disease|3|||
147364931|NCT02720068|531508622|FG002|Overall Study|Progressive Disease|1|||
147364932|NCT02720068|531508623|FG003|Overall Study|Progressive Disease|1|||
147364933|NCT02720068|531508624|FG004|Overall Study|Progressive Disease|1|||
147364934|NCT02720068|531508625|FG005|Overall Study|Progressive Disease|2|||
147608807|NCT01191944|532384065|FG000|Overall Study|Withdrawal by Subject|4|||
147608808|NCT01191944|532384066|FG001|Overall Study|Withdrawal by Subject|2|||
147608809|NCT01191944|532384065|FG000|Overall Study|Other|1|||
147608810|NCT01191944|532384066|FG001|Overall Study|Other|3|||
147608811|NCT02954991|532384069|FG000|Overall Study|Death|92|||
147608812|NCT02954991|532384070|FG001|Overall Study|Death|11|||
147364935|NCT02720068|531508626|FG006|Overall Study|Progressive Disease|1|||
147454264|NCT01178138|531825566|FG000|Overall Study|Withdrawal by Subject|7|||
147454265|NCT01178138|531825566|FG000|Overall Study|Physician Decision|8|||
147454266|NCT01241708|531825567|FG000|Overall Study|Withdrawal by Subject|6|||
147608813|NCT02954991|532384071|FG002|Overall Study|Death|2|||
147608814|NCT02954991|532384069|FG000|Overall Study|Lost to Follow-up|3|||
147608815|NCT02954991|532384070|FG001|Overall Study|Lost to Follow-up|2|||
147608816|NCT02954991|532384071|FG002|Overall Study|Lost to Follow-up|0|||
147364936|NCT02720068|531508627|FG007|Overall Study|Progressive Disease|1|||
147454267|NCT01241708|531825567|FG000|Overall Study|Screen Failure|6|||
147608817|NCT02954991|532384069|FG000|Overall Study|Withdrawal by Subject|9|||
147364937|NCT02720068|531508628|FG008|Overall Study|Progressive Disease|0|||
147364938|NCT02720068|531508629|FG009|Overall Study|Progressive Disease|1|||
147364939|NCT02720068|531508630|FG010|Overall Study|Progressive Disease|0|||
147364940|NCT02720068|531508631|FG011|Overall Study|Progressive Disease|4|||
147364941|NCT02720068|531508632|FG012|Overall Study|Progressive Disease|1|||
147364942|NCT02720068|531508633|FG013|Overall Study|Progressive Disease|0|||
147364943|NCT02720068|531508634|FG014|Overall Study|Progressive Disease|0|||
147364944|NCT02720068|531508635|FG015|Overall Study|Progressive Disease|0|||
147364945|NCT02720068|531508636|FG016|Overall Study|Progressive Disease|0|||
147364946|NCT02720068|531508637|FG017|Overall Study|Progressive Disease|0|||
147364947|NCT02720068|531508620|FG000|Overall Study|Sponsor Decision|0|||
147364948|NCT02720068|531508621|FG001|Overall Study|Sponsor Decision|0|||
147364949|NCT02720068|531508622|FG002|Overall Study|Sponsor Decision|0|||
147364950|NCT02720068|531508623|FG003|Overall Study|Sponsor Decision|0|||
147454268|NCT01241708|531825567|FG000|Overall Study|Did not move forward with 2nd Transplant|39|||
147608818|NCT02954991|532384070|FG001|Overall Study|Withdrawal by Subject|8|||
147364951|NCT02720068|531508624|FG004|Overall Study|Sponsor Decision|0|||
147364952|NCT02720068|531508625|FG005|Overall Study|Sponsor Decision|0|||
147364953|NCT02720068|531508626|FG006|Overall Study|Sponsor Decision|0|||
147364954|NCT02720068|531508627|FG007|Overall Study|Sponsor Decision|0|||
147364955|NCT02720068|531508628|FG008|Overall Study|Sponsor Decision|0|||
147364956|NCT02720068|531508629|FG009|Overall Study|Sponsor Decision|0|||
147364957|NCT02720068|531508630|FG010|Overall Study|Sponsor Decision|0|||
147364958|NCT02720068|531508631|FG011|Overall Study|Sponsor Decision|6|||
147364959|NCT02720068|531508632|FG012|Overall Study|Sponsor Decision|3|||
147364960|NCT02720068|531508633|FG013|Overall Study|Sponsor Decision|2|||
147364961|NCT02720068|531508634|FG014|Overall Study|Sponsor Decision|4|||
147364962|NCT02720068|531508635|FG015|Overall Study|Sponsor Decision|4|||
147364963|NCT02720068|531508636|FG016|Overall Study|Sponsor Decision|0|||
147364964|NCT02720068|531508637|FG017|Overall Study|Sponsor Decision|8|||
147364965|NCT02720068|531508620|FG000|Overall Study|Withdrawal by Subject|0|||
147364966|NCT02720068|531508621|FG001|Overall Study|Withdrawal by Subject|0|||
147364967|NCT02720068|531508622|FG002|Overall Study|Withdrawal by Subject|0|||
147364968|NCT02720068|531508623|FG003|Overall Study|Withdrawal by Subject|0|||
147364969|NCT02720068|531508624|FG004|Overall Study|Withdrawal by Subject|0|||
147364970|NCT02720068|531508625|FG005|Overall Study|Withdrawal by Subject|0|||
147364971|NCT02720068|531508626|FG006|Overall Study|Withdrawal by Subject|0|||
147364972|NCT02720068|531508627|FG007|Overall Study|Withdrawal by Subject|0|||
147364973|NCT02720068|531508628|FG008|Overall Study|Withdrawal by Subject|0|||
147364974|NCT02720068|531508629|FG009|Overall Study|Withdrawal by Subject|1|||
147364975|NCT02720068|531508630|FG010|Overall Study|Withdrawal by Subject|0|||
147364976|NCT02720068|531508631|FG011|Overall Study|Withdrawal by Subject|27|||
147364977|NCT02720068|531508632|FG012|Overall Study|Withdrawal by Subject|2|||
147364978|NCT02720068|531508633|FG013|Overall Study|Withdrawal by Subject|8|||
147364979|NCT02720068|531508634|FG014|Overall Study|Withdrawal by Subject|7|||
147364980|NCT02720068|531508635|FG015|Overall Study|Withdrawal by Subject|0|||
147364981|NCT02720068|531508636|FG016|Overall Study|Withdrawal by Subject|0|||
147364982|NCT02720068|531508637|FG017|Overall Study|Withdrawal by Subject|2|||
147364983|NCT02720068|531508620|FG000|Overall Study|Protocol Violation|0|||
147364984|NCT02720068|531508621|FG001|Overall Study|Protocol Violation|0|||
147364985|NCT02720068|531508622|FG002|Overall Study|Protocol Violation|0|||
147364986|NCT02720068|531508623|FG003|Overall Study|Protocol Violation|0|||
147364987|NCT02720068|531508624|FG004|Overall Study|Protocol Violation|0|||
147364988|NCT02720068|531508625|FG005|Overall Study|Protocol Violation|0|||
147364989|NCT02720068|531508626|FG006|Overall Study|Protocol Violation|0|||
147364990|NCT02720068|531508627|FG007|Overall Study|Protocol Violation|0|||
147364991|NCT02720068|531508628|FG008|Overall Study|Protocol Violation|0|||
147364992|NCT02720068|531508629|FG009|Overall Study|Protocol Violation|0|||
147364993|NCT02720068|531508630|FG010|Overall Study|Protocol Violation|1|||
147364994|NCT02720068|531508631|FG011|Overall Study|Protocol Violation|0|||
147364995|NCT02720068|531508632|FG012|Overall Study|Protocol Violation|0|||
147364996|NCT02720068|531508633|FG013|Overall Study|Protocol Violation|0|||
147364997|NCT02720068|531508634|FG014|Overall Study|Protocol Violation|1|||
147364998|NCT02720068|531508635|FG015|Overall Study|Protocol Violation|0|||
147364999|NCT02720068|531508636|FG016|Overall Study|Protocol Violation|1|||
147365000|NCT02720068|531508637|FG017|Overall Study|Protocol Violation|0|||
147365001|NCT02467270|531508650|FG000|Overall Study|Participants Never Treated|0|||
147365002|NCT02467270|531508651|FG001|Overall Study|Participants Never Treated|1|||
147365003|NCT02467270|531508652|FG002|Overall Study|Participants Never Treated|0|||
147365004|NCT02467270|531508650|FG000|Overall Study|Ongoing|50|||
147365005|NCT02467270|531508651|FG001|Overall Study|Ongoing|41|||
147365006|NCT02467270|531508652|FG002|Overall Study|Ongoing|43|||
147365007|NCT02467270|531508650|FG000|Overall Study|Adverse Event|16|||
147365008|NCT02467270|531508651|FG001|Overall Study|Adverse Event|15|||
147365009|NCT02467270|531508652|FG002|Overall Study|Adverse Event|14|||
147365010|NCT02467270|531508650|FG000|Overall Study|Progressive Disease|7|||
147365011|NCT02467270|531508651|FG001|Overall Study|Progressive Disease|7|||
147365012|NCT02467270|531508652|FG002|Overall Study|Progressive Disease|4|||
147365013|NCT02467270|531508650|FG000|Overall Study|Death|2|||
147365014|NCT02467270|531508651|FG001|Overall Study|Death|0|||
147365015|NCT02467270|531508652|FG002|Overall Study|Death|2|||
147365016|NCT02467270|531508650|FG000|Overall Study|Lack of Efficacy|12|||
147365017|NCT02467270|531508651|FG001|Overall Study|Lack of Efficacy|18|||
147365018|NCT02467270|531508652|FG002|Overall Study|Lack of Efficacy|23|||
147365019|NCT02467270|531508650|FG000|Overall Study|Non-compliance With Study Drug|0|||
147365020|NCT02467270|531508651|FG001|Overall Study|Non-compliance With Study Drug|2|||
147365021|NCT02467270|531508652|FG002|Overall Study|Non-compliance With Study Drug|1|||
147365022|NCT02467270|531508650|FG000|Overall Study|Lost to Follow-up|2|||
147365023|NCT02467270|531508651|FG001|Overall Study|Lost to Follow-up|1|||
147365024|NCT02467270|531508652|FG002|Overall Study|Lost to Follow-up|0|||
147365025|NCT02467270|531508650|FG000|Overall Study|Pregnancy|0|||
147365026|NCT02467270|531508651|FG001|Overall Study|Pregnancy|1|||
147365027|NCT02467270|531508652|FG002|Overall Study|Pregnancy|0|||
147365028|NCT02467270|531508650|FG000|Overall Study|Physician Decision|0|||
147365029|NCT02467270|531508651|FG001|Overall Study|Physician Decision|4|||
147365030|NCT02467270|531508652|FG002|Overall Study|Physician Decision|1|||
147365031|NCT02467270|531508650|FG000|Overall Study|Withdrawal by Subject|4|||
147365032|NCT02467270|531508651|FG001|Overall Study|Withdrawal by Subject|3|||
147365033|NCT02467270|531508652|FG002|Overall Study|Withdrawal by Subject|5|||
147365034|NCT02467270|531508650|FG000|Overall Study|Reason not Specified|1|||
147365035|NCT02467270|531508651|FG001|Overall Study|Reason not Specified|2|||
147365036|NCT02467270|531508652|FG002|Overall Study|Reason not Specified|1|||
147365037|NCT04281498|531508687|FG000|Overall Study|Progression of disease|1|||
147365038|NCT04281498|531508687|FG000|Overall Study|Planned SCT|1|||
147365039|NCT04281498|531508687|FG000|Overall Study|Alternative Treatment|1|||
147365040|NCT03142009|531508690|FG000|Overall Study|Lost to Follow-up|45|||
147365041|NCT03142009|531508691|FG001|Overall Study|Lost to Follow-up|30|||
147365042|NCT03587805|531508692|FG000|Overall Study|Adverse Event|72|||
147365043|NCT03587805|531508692|FG000|Overall Study|Death|1|||
147365044|NCT03587805|531508692|FG000|Overall Study|Lost to Follow-up|78|||
147365045|NCT03587805|531508692|FG000|Overall Study|Withdrawal by Subject|105|||
147365046|NCT03587805|531508692|FG000|Overall Study|Lack of Efficacy|119|||
147365047|NCT03587805|531508692|FG000|Overall Study|Reason unknown|26|||
147365048|NCT03587805|531508692|FG000|Overall Study|COVID_19 pandemic|4|||
147365049|NCT03587805|531508692|FG000|Overall Study|Various reasons|121|||
147365050|NCT03587805|531508692|FG000|Overall Study|Withdrawal by parent/guardian|3|||
147365051|NCT03008382|531508693|FG000|Overall Study|Withdrawal by Subject|2|||
147365052|NCT03008382|531508694|FG001|Overall Study|Withdrawal by Subject|5|||
147365053|NCT03008382|531508695|FG002|Overall Study|Withdrawal by Subject|2|||
147365054|NCT03008382|531508696|FG003|Overall Study|Withdrawal by Subject|0|||
147365055|NCT03008382|531508693|FG000|Overall Study|Protocol Violation|1|||
147365056|NCT03008382|531508694|FG001|Overall Study|Protocol Violation|0|||
147365057|NCT03008382|531508695|FG002|Overall Study|Protocol Violation|0|||
147365058|NCT03008382|531508696|FG003|Overall Study|Protocol Violation|0|||
147365059|NCT03008382|531508693|FG000|Overall Study|Withdrew from study but did not withdraw consent|0|||
147365060|NCT03008382|531508694|FG001|Overall Study|Withdrew from study but did not withdraw consent|1|||
147365061|NCT03008382|531508695|FG002|Overall Study|Withdrew from study but did not withdraw consent|0|||
147365062|NCT03008382|531508696|FG003|Overall Study|Withdrew from study but did not withdraw consent|0|||
147365063|NCT03008382|531508693|FG000|Overall Study|Lost to Follow-up|0|||
147365064|NCT03008382|531508694|FG001|Overall Study|Lost to Follow-up|0|||
147365065|NCT03008382|531508695|FG002|Overall Study|Lost to Follow-up|1|||
147365066|NCT03008382|531508696|FG003|Overall Study|Lost to Follow-up|0|||
147365067|NCT03008382|531508693|FG000|Overall Study|Screenfail|0|||
147365068|NCT03008382|531508694|FG001|Overall Study|Screenfail|0|||
147365069|NCT03008382|531508695|FG002|Overall Study|Screenfail|2|||
147365070|NCT03008382|531508696|FG003|Overall Study|Screenfail|0|||
147365071|NCT05180539|531509329|FG000|Overall Study|Lost to Follow-up|27|||
147365072|NCT05180539|531509330|FG001|Overall Study|Lost to Follow-up|30|||
147365073|NCT00994643|531509333|FG000|Overall Study|Withdrawal by Subject|1|||
147365074|NCT04518943|531509335|FG000|Consent Through Baseline|Walked too many steps at baseline|3|||
147365075|NCT04518943|531509336|FG001|Consent Through Baseline|Walked too many steps at baseline|1|||
147365076|NCT04518943|531509337|FG002|Consent Through Baseline|Walked too many steps at baseline|4|||
147365077|NCT04518943|531509338|FG003|Consent Through Baseline|Walked too many steps at baseline|5|||
147365078|NCT04518943|531509339|FG004|Consent Through Baseline|Walked too many steps at baseline|3|||
147365079|NCT04518943|531509340|FG005|Consent Through Baseline|Walked too many steps at baseline|3|||
147365080|NCT04518943|531509341|FG006|Consent Through Baseline|Walked too many steps at baseline|4|||
147365081|NCT04518943|531509342|FG007|Consent Through Baseline|Walked too many steps at baseline|7|||
147365082|NCT04518943|531509343|FG008|Consent Through Baseline|Walked too many steps at baseline|4|||
147365083|NCT04518943|531509344|FG009|Consent Through Baseline|Walked too many steps at baseline|1|||
147365084|NCT04518943|531509345|FG010|Consent Through Baseline|Walked too many steps at baseline|3|||
147365085|NCT04518943|531509346|FG011|Consent Through Baseline|Walked too many steps at baseline|1|||
147365086|NCT04518943|531509347|FG012|Consent Through Baseline|Walked too many steps at baseline|4|||
147365087|NCT04518943|531509348|FG013|Consent Through Baseline|Walked too many steps at baseline|5|||
147365088|NCT04518943|531509349|FG014|Consent Through Baseline|Walked too many steps at baseline|4|||
147365089|NCT04518943|531509350|FG015|Consent Through Baseline|Walked too many steps at baseline|4|||
147365090|NCT00968149|531509351|FG000|Overall Study|Adverse Event|5|||
147365091|NCT00968149|531509352|FG001|Overall Study|Adverse Event|1|||
147365092|NCT00968149|531509351|FG000|Overall Study|Lack of Efficacy|0|||
147365093|NCT00968149|531509352|FG001|Overall Study|Lack of Efficacy|4|||
147365094|NCT00968149|531509351|FG000|Overall Study|Lost to Follow-up|0|||
147365095|NCT00968149|531509352|FG001|Overall Study|Lost to Follow-up|1|||
147365096|NCT00968149|531509351|FG000|Overall Study|Protocol Violation|4|||
147365097|NCT00968149|531509352|FG001|Overall Study|Protocol Violation|0|||
147365098|NCT00968149|531509351|FG000|Overall Study|Withdrawal by Subject|2|||
147365099|NCT00968149|531509352|FG001|Overall Study|Withdrawal by Subject|0|||
147365100|NCT04757753|531509353|FG000|Overall Study|Lost to Follow-up|7|||
147365101|NCT04757753|531509354|FG001|Overall Study|Lost to Follow-up|7|||
147365102|NCT04757753|531509353|FG000|Overall Study|Withdrawal by Subject|0|||
147365103|NCT04757753|531509354|FG001|Overall Study|Withdrawal by Subject|3|||
147365104|NCT04757753|531509353|FG000|Overall Study|Endodontic treatment failure|1|||
147608819|NCT02954991|532384071|FG002|Overall Study|Withdrawal by Subject|1|||
147608820|NCT02954991|532384069|FG000|Overall Study|Study Terminated by Sponsor|18|||
147608821|NCT02954991|532384070|FG001|Overall Study|Study Terminated by Sponsor|10|||
147608822|NCT02954991|532384071|FG002|Overall Study|Study Terminated by Sponsor|1|||
147608823|NCT02954991|532384069|FG000|Overall Study|Miscellaneous|2|||
147608824|NCT02954991|532384070|FG001|Overall Study|Miscellaneous|1|||
147608825|NCT02954991|532384071|FG002|Overall Study|Miscellaneous|1|||
147608826|NCT00576316|532384072|FG000|Overall Study|Adverse Event|9|||
147608827|NCT00576316|532384072|FG000|Overall Study|Withdrawal by Subject|2|||
147608828|NCT00576316|532384072|FG000|Overall Study|Protocol Violation|9|||
147608829|NCT02552303|532384077|FG000|Allocation|Withdrawal by Subject|2|||
147608830|NCT02552303|532384078|FG001|Allocation|Withdrawal by Subject|1|||
147608831|NCT02552303|532384079|FG002|Allocation|Withdrawal by Subject|1|||
147608832|NCT02552303|532384080|FG003|Allocation|Withdrawal by Subject|1|||
147608833|NCT02552303|532384077|FG000|Allocation|ineligible|1|||
147608834|NCT02552303|532384078|FG001|Allocation|ineligible|1|||
147608835|NCT02552303|532384079|FG002|Allocation|ineligible|0|||
147608836|NCT02552303|532384080|FG003|Allocation|ineligible|0|||
147608837|NCT02552303|532384077|FG000|Follow-Up|Lost to Follow-up|0|||
147608838|NCT02552303|532384078|FG001|Follow-Up|Lost to Follow-up|0|||
147608839|NCT02552303|532384079|FG002|Follow-Up|Lost to Follow-up|1|||
147608840|NCT02552303|532384080|FG003|Follow-Up|Lost to Follow-up|0|||
147608841|NCT02552303|532384077|FG000|Follow-Up|ineligible|0|||
147608842|NCT02552303|532384078|FG001|Follow-Up|ineligible|2|||
147608843|NCT02552303|532384079|FG002|Follow-Up|ineligible|0|||
147608844|NCT02552303|532384080|FG003|Follow-Up|ineligible|0|||
147608845|NCT04602546|532384081|FG000|Overall Study|Training|2|||
147608846|NCT04602546|532384082|FG001|Overall Study|Training|2|||
147608847|NCT04602546|532384083|FG002|Overall Study|Training|1|||
147608848|NCT04602546|532384084|FG003|Overall Study|Training|2|||
147608849|NCT04602546|532384085|FG004|Overall Study|Training|0|||
147608850|NCT04602546|532384081|FG000|Overall Study|Randomized with disqualified data|2|||
147608851|NCT04602546|532384082|FG001|Overall Study|Randomized with disqualified data|0|||
147608852|NCT04602546|532384083|FG002|Overall Study|Randomized with disqualified data|2|||
147608853|NCT04602546|532384084|FG003|Overall Study|Randomized with disqualified data|5|||
147608854|NCT04602546|532384085|FG004|Overall Study|Randomized with disqualified data|3|||
147608855|NCT00253448|532384086|FG000|Overall Study|Withdrawal by Subject|1|||
147608856|NCT02052011|532384088|FG000|Overall Study|Lost to Follow-up|3|||
147608857|NCT02052011|532384089|FG001|Overall Study|Lost to Follow-up|0|||
147365105|NCT04757753|531509354|FG001|Overall Study|Endodontic treatment failure|2|||
147365106|NCT04757753|531509353|FG000|Overall Study|Tooth fracture/extraction|3|||
147365107|NCT04757753|531509354|FG001|Overall Study|Tooth fracture/extraction|0|||
147365108|NCT03333915|531509357|FG000|Overall Study|Lost to Follow-up|0|||
147365109|NCT03333915|531509358|FG001|Overall Study|Lost to Follow-up|0|||
147365110|NCT03333915|531509359|FG002|Overall Study|Lost to Follow-up|1|||
147365111|NCT03333915|531509360|FG003|Overall Study|Lost to Follow-up|0|||
147365112|NCT03333915|531509361|FG004|Overall Study|Lost to Follow-up|0|||
147365113|NCT03333915|531509357|FG000|Overall Study|Disease Progression|0|||
147365114|NCT03333915|531509358|FG001|Overall Study|Disease Progression|1|||
147365115|NCT03333915|531509359|FG002|Overall Study|Disease Progression|0|||
147365116|NCT03333915|531509360|FG003|Overall Study|Disease Progression|0|||
147365117|NCT03333915|531509361|FG004|Overall Study|Disease Progression|0|||
147365118|NCT03333915|531509357|FG000|Overall Study|Death|0|||
147365119|NCT03333915|531509358|FG001|Overall Study|Death|0|||
147365120|NCT03333915|531509359|FG002|Overall Study|Death|0|||
147365121|NCT03333915|531509360|FG003|Overall Study|Death|37|||
147365122|NCT03333915|531509361|FG004|Overall Study|Death|18|||
147365123|NCT03333915|531509357|FG000|Overall Study|Sponsor's Decision|0|||
147365124|NCT03333915|531509358|FG001|Overall Study|Sponsor's Decision|0|||
147365125|NCT03333915|531509359|FG002|Overall Study|Sponsor's Decision|0|||
147365126|NCT03333915|531509360|FG003|Overall Study|Sponsor's Decision|48|||
147365127|NCT03333915|531509361|FG004|Overall Study|Sponsor's Decision|4|||
147365128|NCT03333915|531509357|FG000|Overall Study|Withdrawal by Subject|0|||
147365129|NCT03333915|531509358|FG001|Overall Study|Withdrawal by Subject|0|||
147454269|NCT01241708|531825567|FG000|Overall Study|Lost to Follow-up|5|||
147608858|NCT02052011|532384088|FG000|Overall Study|Withdrawal by Subject|1|||
147454270|NCT01790503|531825572|FG000|Overall Study|Adverse Event|1|||
147454271|NCT01790503|531825573|FG001|Overall Study|Adverse Event|0|||
147608859|NCT02052011|532384089|FG001|Overall Study|Withdrawal by Subject|2|||
147365130|NCT03333915|531509359|FG002|Overall Study|Withdrawal by Subject|0|||
147365131|NCT03333915|531509360|FG003|Overall Study|Withdrawal by Subject|5|||
147365132|NCT03333915|531509361|FG004|Overall Study|Withdrawal by Subject|1|||
147365133|NCT03872466|531509364|FG000|Overall Study|Withdrawal by Subject|1|||
147365134|NCT03872466|531509365|FG001|Overall Study|Withdrawal by Subject|0|||
147454272|NCT01790503|531825574|FG002|Overall Study|Adverse Event|0|||
147608860|NCT01851330|532384090|FG000|Overall Study|Lack of Efficacy|10|||
147608861|NCT01851330|532384091|FG001|Overall Study|Lack of Efficacy|9|||
147608862|NCT01851330|532384092|FG002|Overall Study|Lack of Efficacy|2|||
147608863|NCT01851330|532384090|FG000|Overall Study|Lost to Follow-up|1|||
147608864|NCT01851330|532384091|FG001|Overall Study|Lost to Follow-up|6|||
147608865|NCT01851330|532384092|FG002|Overall Study|Lost to Follow-up|9|||
147608866|NCT01851330|532384090|FG000|Overall Study|Withdrew Consent|2|||
147608867|NCT01851330|532384091|FG001|Overall Study|Withdrew Consent|1|||
147608868|NCT01851330|532384092|FG002|Overall Study|Withdrew Consent|0|||
147608869|NCT01851330|532384090|FG000|Overall Study|Investigator's Discretion|0|||
147608870|NCT01851330|532384091|FG001|Overall Study|Investigator's Discretion|0|||
147608871|NCT01851330|532384092|FG002|Overall Study|Investigator's Discretion|1|||
147608872|NCT02648932|532384093|FG000|Overall Study|No transplant|3|||
147608873|NCT02648932|532384094|FG001|Overall Study|No transplant|1|||
147608874|NCT01266031|532384095|FG000|Overall Study|Not treated|0|||
147608875|NCT01266031|532384096|FG001|Overall Study|Not treated|3|||
147608876|NCT01266031|532384097|FG002|Overall Study|Not treated|2|||
147608877|NCT03106987|532384100|FG000|Overall Study|Death|37|||
147608878|NCT03106987|532384101|FG001|Overall Study|Death|22|||
147608879|NCT03106987|532384102|FG002|Overall Study|Death|12|||
147608880|NCT03106987|532384103|FG003|Overall Study|Death|8|||
147608881|NCT03106987|532384100|FG000|Overall Study|Lost to Follow-up|2|||
147608882|NCT03106987|532384101|FG001|Overall Study|Lost to Follow-up|0|||
147608883|NCT03106987|532384102|FG002|Overall Study|Lost to Follow-up|2|||
147608884|NCT03106987|532384103|FG003|Overall Study|Lost to Follow-up|2|||
147608885|NCT03106987|532384100|FG000|Overall Study|Withdrawal by Subject|5|||
147608886|NCT03106987|532384101|FG001|Overall Study|Withdrawal by Subject|1|||
147365135|NCT03872466|531509364|FG000|Overall Study|Physician Decision|2|||
147365136|NCT03872466|531509365|FG001|Overall Study|Physician Decision|0|||
147365137|NCT01778686|531509366|FG000|Overall Study|Adverse Event|0|||
147365138|NCT01778686|531509367|FG001|Overall Study|Adverse Event|0|||
147365139|NCT01778686|531509368|FG002|Overall Study|Adverse Event|1|||
147365140|NCT04012567|531509369|FG000|Overall Study|Lost to Follow-up|0|||
147365141|NCT04012567|531509370|FG001|Overall Study|Lost to Follow-up|1|||
147365142|NCT04012567|531509369|FG000|Overall Study|Withdrawal by Subject|1|||
147365143|NCT04012567|531509370|FG001|Overall Study|Withdrawal by Subject|0|||
147365144|NCT06059443|531509371|FG000|Overall Study|Withdrawal by Subject|2|||
147365145|NCT06059443|531509372|FG001|Overall Study|Withdrawal by Subject|0|||
147365146|NCT06059443|531509371|FG000|Overall Study|Lost to Follow-up|2|||
147365147|NCT06059443|531509372|FG001|Overall Study|Lost to Follow-up|2|||
147365148|NCT05771467|531509373|FG000|Overall Study|Lost to Follow-up|6|||
147365149|NCT05771467|531509374|FG001|Overall Study|Lost to Follow-up|3|||
147365150|NCT04940624|531509380|FG000|Overall Study|Adverse Event|4|||
147365151|NCT04940624|531509381|FG001|Overall Study|Adverse Event|11|||
147365152|NCT04940624|531509380|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
147365153|NCT04940624|531509381|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
147365154|NCT04940624|531509380|FG000|Overall Study|Physician Decision|1|||
147365155|NCT04940624|531509381|FG001|Overall Study|Physician Decision|0|||
147365156|NCT04940624|531509380|FG000|Overall Study|Lost to Follow-up|1|||
147365157|NCT04940624|531509381|FG001|Overall Study|Lost to Follow-up|0|||
147365158|NCT04940624|531509380|FG000|Overall Study|Reason Not Specified|1|||
147365159|NCT04940624|531509381|FG001|Overall Study|Reason Not Specified|0|||
147365160|NCT02206828|531509382|FG000|Overall Study|Lost to Follow-up|7|||
147365161|NCT00113360|531509953|FG000|Overall Study|Adverse Event|3|||
147365162|NCT00113360|531509953|FG000|Overall Study|Subject required surgery|1|||
147365163|NCT00113360|531509953|FG000|Overall Study|Did not meet eligibility criteria|3|||
147365164|NCT02231749|531509959|FG000|Overall Study|Disease progression|229|||
147365165|NCT02231749|531509960|FG001|Overall Study|Disease progression|297|||
147365166|NCT02231749|531509959|FG000|Overall Study|Study Drug Toxicity|134|||
147365167|NCT02231749|531509960|FG001|Overall Study|Study Drug Toxicity|63|||
147365168|NCT02231749|531509959|FG000|Overall Study|Death|1|||
147365169|NCT02231749|531509960|FG001|Overall Study|Death|1|||
147365170|NCT02231749|531509959|FG000|Overall Study|AE unrelated to Study drug|32|||
147608887|NCT03106987|532384102|FG002|Overall Study|Withdrawal by Subject|4|||
147608888|NCT03106987|532384103|FG003|Overall Study|Withdrawal by Subject|1|||
147608889|NCT03336528|532384104|FG000|Overall Study|Protocol Violation|1|||
147608890|NCT03336528|532384105|FG001|Overall Study|Protocol Violation|1|||
147365171|NCT02231749|531509960|FG001|Overall Study|AE unrelated to Study drug|31|||
147365172|NCT02231749|531509959|FG000|Overall Study|Participant's request to discontinue|10|||
147365173|NCT02231749|531509960|FG001|Overall Study|Participant's request to discontinue|21|||
147365174|NCT02231749|531509959|FG000|Overall Study|Participant withdrew Consent|8|||
147365175|NCT02231749|531509960|FG001|Overall Study|Participant withdrew Consent|15|||
147365176|NCT02231749|531509959|FG000|Overall Study|Lost to Follow-up|1|||
147365177|NCT02231749|531509960|FG001|Overall Study|Lost to Follow-up|2|||
147365178|NCT02231749|531509959|FG000|Overall Study|Maximum Clinical Benefit|5|||
147365179|NCT02231749|531509960|FG001|Overall Study|Maximum Clinical Benefit|8|||
147365180|NCT02231749|531509959|FG000|Overall Study|Poor/Non-Compliance|0|||
147608891|NCT03336528|532384104|FG000|Overall Study|Discharged within 48 hours of study medication|8|||
147608892|NCT03336528|532384105|FG001|Overall Study|Discharged within 48 hours of study medication|6|||
147608893|NCT03336528|532384104|FG000|Overall Study|Did not receive study medication|1|||
147608894|NCT03336528|532384105|FG001|Overall Study|Did not receive study medication|2|||
147608895|NCT01307111|532384106|FG000|IUD Insertion|Lost to Follow-up|2|||
147608896|NCT01307111|532384107|FG001|IUD Insertion|Lost to Follow-up|0|||
147608897|NCT01307111|532384106|FG000|1-2 Week IUD Check up|IUD expulsion/removal|2|||
147608898|NCT01307111|532384107|FG001|1-2 Week IUD Check up|IUD expulsion/removal|2|||
147608899|NCT01275729|532384112|FG000|Overall Study|Death|3|||
147608900|NCT01275729|532384112|FG000|Overall Study|Withdrawal by Subject|1|||
147608901|NCT02252406|532384113|FG000|Starting Dose Ranolazine 500 mg BID|Lost to Follow-up|2|||
147608902|NCT02252406|532384114|FG001|Starting Dose Ranolazine 500 mg BID|Lost to Follow-up|3|||
147608903|NCT02252406|532384113|FG000|Starting Dose Ranolazine 500 mg BID|Withdrawal by Subject|1|||
147608904|NCT02252406|532384114|FG001|Starting Dose Ranolazine 500 mg BID|Withdrawal by Subject|0|||
147608905|NCT02252406|532384113|FG000|Starting Dose Ranolazine 500 mg BID|Adverse Event|1|||
147608906|NCT02252406|532384114|FG001|Starting Dose Ranolazine 500 mg BID|Adverse Event|0|||
147608907|NCT02252406|532384113|FG000|Titrated to Ranolazine 1000mg BID|Lost to Follow-up|1|||
147608908|NCT02252406|532384114|FG001|Titrated to Ranolazine 1000mg BID|Lost to Follow-up|1|||
147365181|NCT02231749|531509960|FG001|Overall Study|Poor/Non-Compliance|3|||
147365182|NCT02231749|531509959|FG000|Overall Study|Pregnancy|1|||
147365183|NCT02231749|531509960|FG001|Overall Study|Pregnancy|0|||
147365184|NCT02231749|531509959|FG000|Overall Study|other|0|||
147608909|NCT02252406|532384113|FG000|Titrated to Ranolazine 1000mg BID|Adverse Event|2|||
147365185|NCT02231749|531509960|FG001|Overall Study|other|8|||
147365186|NCT02231749|531509959|FG000|Overall Study|No longer meets Study Criteria|1|||
147365187|NCT02231749|531509960|FG001|Overall Study|No longer meets Study Criteria|0|||
147365188|NCT03705390|531509961|FG000|10 Week Initial Treatment Period|Trial suspended prior to completion|2|||
147365189|NCT03705390|531509961|FG000|Treatment Extension|Trial closed early due to COVID-19 pandemic|1|||
147365190|NCT02989662|531509963|FG000|Overall Study|Lost to Follow-up|0|||
147365191|NCT02989662|531509964|FG001|Overall Study|Lost to Follow-up|0|||
147365192|NCT02989662|531509965|FG002|Overall Study|Lost to Follow-up|0|||
147365193|NCT02989662|531509966|FG003|Overall Study|Lost to Follow-up|2|||
147365194|NCT02989662|531509963|FG000|Overall Study|Physician Decision|3|||
147365195|NCT02989662|531509964|FG001|Overall Study|Physician Decision|0|||
147365196|NCT02989662|531509965|FG002|Overall Study|Physician Decision|0|||
147365197|NCT02989662|531509966|FG003|Overall Study|Physician Decision|0|||
147365198|NCT02989662|531509963|FG000|Overall Study|Withdrawal by Subject|1|||
147365199|NCT02989662|531509964|FG001|Overall Study|Withdrawal by Subject|0|||
147365200|NCT02989662|531509965|FG002|Overall Study|Withdrawal by Subject|0|||
147365201|NCT02989662|531509966|FG003|Overall Study|Withdrawal by Subject|0|||
147365202|NCT00328783|531509967|FG000|Overall Study|Could not tolerate ABC|21|||
147365203|NCT00328783|531509967|FG000|Overall Study|No heart in RT field|4|||
147365204|NCT00328783|531509967|FG000|Overall Study|Withdrawal by Subject|1|||
147365205|NCT00357682|531509968|FG000|Overall Study|Did not receive allocated Treatment|10|||
147365206|NCT00357682|531509969|FG001|Overall Study|Did not receive allocated Treatment|9|||
147365207|NCT00357682|531509970|FG002|Overall Study|Did not receive allocated Treatment|9|||
147365208|NCT00357682|531509971|FG003|Overall Study|Did not receive allocated Treatment|10|||
147365209|NCT00357682|531509968|FG000|Overall Study|Withdrew consent|6|||
147365210|NCT00357682|531509969|FG001|Overall Study|Withdrew consent|6|||
147365211|NCT00357682|531509970|FG002|Overall Study|Withdrew consent|5|||
147365212|NCT00357682|531509971|FG003|Overall Study|Withdrew consent|5|||
147365213|NCT00357682|531509968|FG000|Overall Study|Lost to Follow-up|39|||
147365214|NCT00357682|531509969|FG001|Overall Study|Lost to Follow-up|33|||
147365215|NCT00357682|531509970|FG002|Overall Study|Lost to Follow-up|26|||
147365216|NCT00357682|531509971|FG003|Overall Study|Lost to Follow-up|35|||
147365217|NCT00357682|531509968|FG000|Overall Study|Adverse Event|24|||
147365218|NCT00357682|531509969|FG001|Overall Study|Adverse Event|32|||
147365219|NCT00357682|531509970|FG002|Overall Study|Adverse Event|22|||
147365220|NCT00357682|531509971|FG003|Overall Study|Adverse Event|27|||
147365221|NCT00357682|531509968|FG000|Overall Study|Physician Decision|32|||
147365222|NCT00357682|531509969|FG001|Overall Study|Physician Decision|20|||
147365223|NCT00357682|531509970|FG002|Overall Study|Physician Decision|24|||
147365224|NCT00357682|531509971|FG003|Overall Study|Physician Decision|30|||
147365225|NCT00357682|531509968|FG000|Overall Study|Patient decision|73|||
147365226|NCT00357682|531509969|FG001|Overall Study|Patient decision|80|||
147365227|NCT00357682|531509970|FG002|Overall Study|Patient decision|51|||
147365228|NCT00357682|531509971|FG003|Overall Study|Patient decision|59|||
147365229|NCT00357682|531509968|FG000|Overall Study|Other reason|157|||
147365230|NCT00357682|531509969|FG001|Overall Study|Other reason|130|||
147365231|NCT00357682|531509970|FG002|Overall Study|Other reason|114|||
147365232|NCT00357682|531509971|FG003|Overall Study|Other reason|99|||
147365233|NCT03660930|531509973|FG000|Overall Study|Adverse Event|0|||
147365234|NCT03660930|531509974|FG001|Overall Study|Adverse Event|0|||
147365235|NCT03660930|531509975|FG002|Overall Study|Adverse Event|0|||
147365236|NCT03660930|531509976|FG003|Overall Study|Adverse Event|2|||
147365237|NCT03660930|531509977|FG004|Overall Study|Adverse Event|0|||
147365238|NCT03660930|531509978|FG005|Overall Study|Adverse Event|1|||
147365239|NCT03660930|531509979|FG006|Overall Study|Adverse Event|0|||
147365240|NCT03660930|531509980|FG007|Overall Study|Adverse Event|0|||
147365241|NCT03660930|531509973|FG000|Overall Study|Withdrawal by Subject|0|||
147365242|NCT03660930|531509974|FG001|Overall Study|Withdrawal by Subject|0|||
147608910|NCT02252406|532384114|FG001|Titrated to Ranolazine 1000mg BID|Adverse Event|0|||
147608911|NCT00005957|532384119|FG000|Overall Study|No treated|3|||
147365243|NCT03660930|531509975|FG002|Overall Study|Withdrawal by Subject|0|||
147365244|NCT03660930|531509976|FG003|Overall Study|Withdrawal by Subject|0|||
147365245|NCT03660930|531509977|FG004|Overall Study|Withdrawal by Subject|0|||
147365246|NCT03660930|531509978|FG005|Overall Study|Withdrawal by Subject|1|||
147365247|NCT03660930|531509979|FG006|Overall Study|Withdrawal by Subject|0|||
147365248|NCT03660930|531509980|FG007|Overall Study|Withdrawal by Subject|0|||
147365249|NCT02656706|531509983|FG000|Overall Study|Insurance Denial|1|||
147365250|NCT03725332|531509984|FG000|Overall Study|Adverse Event|5|||
147365251|NCT03725332|531509985|FG001|Overall Study|Adverse Event|10|||
147365252|NCT03725332|531509984|FG000|Overall Study|Death|1|||
147365253|NCT03725332|531509985|FG001|Overall Study|Death|3|||
147365254|NCT03725332|531509984|FG000|Overall Study|Lost to Follow-up|43|||
147365255|NCT03725332|531509985|FG001|Overall Study|Lost to Follow-up|122|||
147365256|NCT03725332|531509984|FG000|Overall Study|Withdrawal by Subject|0|||
147365257|NCT03725332|531509985|FG001|Overall Study|Withdrawal by Subject|1|||
147365258|NCT03725332|531509984|FG000|Overall Study|Duplicate enrollment|0|||
147365259|NCT03725332|531509985|FG001|Overall Study|Duplicate enrollment|1|||
147365260|NCT03725332|531509984|FG000|Overall Study|Did not consent|0|||
147365261|NCT03725332|531509985|FG001|Overall Study|Did not consent|1|||
147365262|NCT03242915|531509992|FG000|Overall Study|Adverse Event|5|||
147365263|NCT03242915|531509993|FG001|Overall Study|Adverse Event|1|||
147365264|NCT03242915|531509992|FG000|Overall Study|Withdrawal by Subject|0|||
147365265|NCT03242915|531509993|FG001|Overall Study|Withdrawal by Subject|2|||
147365266|NCT03242915|531509992|FG000|Overall Study|Physician Decision|4|||
147454273|NCT01790503|531825575|FG003|Overall Study|Adverse Event|0|||
147454274|NCT01790503|531825576|FG004|Overall Study|Adverse Event|0|||
147454275|NCT01790503|531825577|FG005|Overall Study|Adverse Event|2|||
147365267|NCT03242915|531509993|FG001|Overall Study|Physician Decision|1|||
147365268|NCT02726386|531509994|FG000|Overall Study|Adverse Event|17|||
147365269|NCT02726386|531509995|FG001|Overall Study|Adverse Event|20|||
147365270|NCT02726386|531509994|FG000|Overall Study|Withdrawal by Subject|14|||
147365271|NCT02726386|531509995|FG001|Overall Study|Withdrawal by Subject|28|||
147365272|NCT02726386|531509994|FG000|Overall Study|Other reasons|7|||
147365273|NCT02726386|531509995|FG001|Overall Study|Other reasons|8|||
147365274|NCT03201939|531509998|FG000|Overall Study|Study was suspended by DSMB because of laboratory quality control issues.|32|||
147365275|NCT03201939|531509999|FG001|Overall Study|Study was suspended by DSMB because of laboratory quality control issues.|34|||
147365276|NCT05424718|531510013|FG000|Overall Study|Lost to Follow-up|5|||
147365277|NCT05424718|531510014|FG001|Overall Study|Lost to Follow-up|4|||
147365278|NCT04046549|531510015|FG000|Overall Study|Adverse Event|1|||
147365279|NCT04046549|531510015|FG000|Overall Study|Physician Decision|1|||
147365280|NCT04046549|531510015|FG000|Overall Study|Withdrawal by Subject|3|||
147365281|NCT04046549|531510015|FG000|Overall Study|Other, Not Specified|5|||
147365282|NCT04039113|531510028|FG000|Overall Study|Withdrawal by Subject|8|||
147365283|NCT04039113|531510029|FG001|Overall Study|Withdrawal by Subject|11|||
147365284|NCT04039113|531510028|FG000|Overall Study|Lost to Follow-up|1|||
147365285|NCT04039113|531510029|FG001|Overall Study|Lost to Follow-up|1|||
147365286|NCT04039113|531510028|FG000|Overall Study|Adverse Event|2|||
147365287|NCT04039113|531510029|FG001|Overall Study|Adverse Event|2|||
147365288|NCT04039113|531510028|FG000|Overall Study|Death|2|||
147365289|NCT04039113|531510029|FG001|Overall Study|Death|4|||
147365290|NCT04039113|531510028|FG000|Overall Study|Site Closure|6|||
147365291|NCT04039113|531510029|FG001|Overall Study|Site Closure|0|||
147365292|NCT04039113|531510028|FG000|Overall Study|Failure to meet randomisation criteria|4|||
147365293|NCT04039113|531510029|FG001|Overall Study|Failure to meet randomisation criteria|0|||
147365294|NCT00353496|531510030|FG000|Overall Study|Adverse Event|1|||
147365295|NCT00353496|531510031|FG001|Overall Study|Adverse Event|0|||
147365296|NCT00353496|531510030|FG000|Overall Study|Protocol Violation|2|||
147365297|NCT00353496|531510031|FG001|Overall Study|Protocol Violation|2|||
147365298|NCT00353496|531510030|FG000|Overall Study|Withdrawal by Subject|3|||
147365299|NCT00353496|531510031|FG001|Overall Study|Withdrawal by Subject|4|||
147365300|NCT00353496|531510030|FG000|Overall Study|Physician Decision|6|||
147365301|NCT00353496|531510031|FG001|Overall Study|Physician Decision|9|||
147365302|NCT00353496|531510030|FG000|Overall Study|Not otherwise specified|4|||
147365303|NCT00353496|531510031|FG001|Overall Study|Not otherwise specified|2|||
147365304|NCT00945724|531510033|FG000|Overall Study|Withdrawal by Subject|2|||
147365305|NCT00945724|531510033|FG000|Overall Study|Physician Decision|1|||
147365306|NCT00945724|531510033|FG000|Overall Study|Adverse Event|5|||
147454276|NCT01790503|531825578|FG006|Overall Study|Adverse Event|0|||
147454277|NCT01790503|531825579|FG007|Overall Study|Adverse Event|0|||
147454278|NCT01790503|531825580|FG008|Overall Study|Adverse Event|2|||
147454279|NCT01790503|531825581|FG009|Overall Study|Adverse Event|4|||
147454280|NCT01790503|531825582|FG010|Overall Study|Adverse Event|7|||
147454281|NCT01790503|531825572|FG000|Overall Study|Withdrawal by Subject|0|||
147454282|NCT01790503|531825573|FG001|Overall Study|Withdrawal by Subject|0|||
147454283|NCT01790503|531825574|FG002|Overall Study|Withdrawal by Subject|1|||
147454284|NCT01790503|531825575|FG003|Overall Study|Withdrawal by Subject|1|||
147454285|NCT01790503|531825576|FG004|Overall Study|Withdrawal by Subject|1|||
147454286|NCT01790503|531825577|FG005|Overall Study|Withdrawal by Subject|2|||
147365307|NCT00945724|531510033|FG000|Overall Study|Second malignancy|1|||
147608912|NCT00005957|532384120|FG001|Overall Study|No treated|9|||
147454287|NCT01790503|531825578|FG006|Overall Study|Withdrawal by Subject|1|||
147608913|NCT00005957|532384119|FG000|Overall Study|Crossover to the other arm|5|||
147608914|NCT00005957|532384120|FG001|Overall Study|Crossover to the other arm|19|||
147365409|NCT04732871|531512678|FG000|Overall Study|Adverse event (AE) requiring expedited reporting|9|||
147365410|NCT04732871|531512679|FG001|Overall Study|Adverse event (AE) requiring expedited reporting|1|||
147365411|NCT04732871|531512680|FG002|Overall Study|Adverse event (AE) requiring expedited reporting|3|||
147365412|NCT04732871|531512678|FG000|Overall Study|Lost to Follow-up|7|||
147365413|NCT04732871|531512679|FG001|Overall Study|Lost to Follow-up|4|||
147365414|NCT04732871|531512680|FG002|Overall Study|Lost to Follow-up|3|||
147365415|NCT04732871|531512678|FG000|Overall Study|Consent withdrawal, not due to a serious adverse event (SAE)|26|||
147365416|NCT04732871|531512679|FG001|Overall Study|Consent withdrawal, not due to a serious adverse event (SAE)|7|||
147365417|NCT04732871|531512680|FG002|Overall Study|Consent withdrawal, not due to a serious adverse event (SAE)|6|||
147365418|NCT04732871|531512678|FG000|Overall Study|Migrated / moved from the study area|5|||
147365419|NCT04732871|531512679|FG001|Overall Study|Migrated / moved from the study area|0|||
147365420|NCT04732871|531512680|FG002|Overall Study|Migrated / moved from the study area|0|||
147365421|NCT04732871|531512678|FG000|Overall Study|Other|1|||
147365422|NCT04732871|531512679|FG001|Overall Study|Other|0|||
147365423|NCT04732871|531512680|FG002|Overall Study|Other|1|||
147365424|NCT04732871|531512678|FG000|Overall Study|Ongoing|6|||
147365425|NCT04732871|531512679|FG001|Overall Study|Ongoing|0|||
147365426|NCT04732871|531512680|FG002|Overall Study|Ongoing|1|||
147365427|NCT04732871|531512678|FG000|Overall Study|Unsolicited non-serious adverse event|1|||
147365428|NCT04732871|531512679|FG001|Overall Study|Unsolicited non-serious adverse event|0|||
147365429|NCT04732871|531512680|FG002|Overall Study|Unsolicited non-serious adverse event|0|||
147608915|NCT02047734|532384121|FG000|Overall Study|Adverse Event|18|||
147608916|NCT02047734|532384122|FG001|Overall Study|Adverse Event|13|||
147608917|NCT02047734|532384123|FG002|Overall Study|Adverse Event|13|||
147608918|NCT02047734|532384121|FG000|Overall Study|Lack of Efficacy|4|||
147608919|NCT02047734|532384122|FG001|Overall Study|Lack of Efficacy|5|||
147608920|NCT02047734|532384123|FG002|Overall Study|Lack of Efficacy|1|||
147608921|NCT02047734|532384121|FG000|Overall Study|Protocol Violation|3|||
147608922|NCT02047734|532384122|FG001|Overall Study|Protocol Violation|1|||
147608923|NCT02047734|532384123|FG002|Overall Study|Protocol Violation|1|||
147608924|NCT02047734|532384121|FG000|Overall Study|Lost to Follow-up|1|||
147608925|NCT02047734|532384122|FG001|Overall Study|Lost to Follow-up|4|||
147608926|NCT02047734|532384123|FG002|Overall Study|Lost to Follow-up|0|||
147608927|NCT02047734|532384121|FG000|Overall Study|Death|0|||
147608928|NCT02047734|532384122|FG001|Overall Study|Death|1|||
147608929|NCT02047734|532384123|FG002|Overall Study|Death|0|||
147608930|NCT02047734|532384121|FG000|Overall Study|Withdrawal by Subject|30|||
147608931|NCT02047734|532384122|FG001|Overall Study|Withdrawal by Subject|31|||
147608932|NCT02047734|532384123|FG002|Overall Study|Withdrawal by Subject|19|||
147608933|NCT02047734|532384121|FG000|Overall Study|Physician Decision|7|||
147608934|NCT02047734|532384122|FG001|Overall Study|Physician Decision|6|||
147608935|NCT02047734|532384123|FG002|Overall Study|Physician Decision|5|||
147608936|NCT02047734|532384121|FG000|Overall Study|Miscellaneous|2|||
147608937|NCT02047734|532384122|FG001|Overall Study|Miscellaneous|4|||
147608938|NCT02047734|532384123|FG002|Overall Study|Miscellaneous|6|||
147608939|NCT02047734|532384121|FG000|Overall Study|Did Not Receive Study Drug|2|||
147608940|NCT02047734|532384122|FG001|Overall Study|Did Not Receive Study Drug|4|||
147608941|NCT02047734|532384123|FG002|Overall Study|Did Not Receive Study Drug|1|||
147608942|NCT01174043|532384124|FG000|Overall Study|Disease progression|5|||
147608943|NCT01174043|532384124|FG000|Overall Study|Adverse Event|3|||
147608944|NCT01174043|532384124|FG000|Overall Study|Death|1|||
147608945|NCT01174043|532384124|FG000|Overall Study|Withdrawal by Subject|2|||
147608946|NCT00582010|532384127|FG000|Overall Study|Death|0|||
147608947|NCT00582010|532384128|FG001|Overall Study|Death|1|||
147454288|NCT01790503|531825579|FG007|Overall Study|Withdrawal by Subject|0|||
147608948|NCT02289456|532384134|FG000|Induction Period|Death|2|||
147608949|NCT02289456|532384134|FG000|Induction Period|Adverse Event|11|||
147608950|NCT02289456|532384134|FG000|Induction Period|Progressive Disease (PD)|4|||
147608951|NCT02289456|532384134|FG000|Induction Period|Symptomatic Deterioration|4|||
147608952|NCT02289456|532384134|FG000|Induction Period|Withdrawal by Subject|2|||
147608953|NCT02289456|532384134|FG000|Induction Period|Miscellaneous|1|||
147608954|NCT02289456|532384134|FG000|Monotherapy Period|Death|1|||
147608955|NCT02289456|532384134|FG000|Monotherapy Period|Adverse Event|1|||
147454289|NCT01790503|531825580|FG008|Overall Study|Withdrawal by Subject|0|||
147608956|NCT02289456|532384134|FG000|Monotherapy Period|Progressive Disease (PD)|8|||
147608957|NCT02289456|532384134|FG000|Monotherapy Period|Symptomatic Deterioration|1|||
147608958|NCT02289456|532384134|FG000|Monotherapy Period|Withdrawal by Subject|2|||
147608959|NCT02289456|532384134|FG000|Monotherapy Period|Study Terminated by Sponsor|2|||
147608960|NCT02289456|532384134|FG000|Monotherapy Period|Miscellaneous|1|||
147608961|NCT02892149|532384135|FG000|Overall Study|Death|262|||
147608962|NCT02892149|532384136|FG001|Overall Study|Death|278|||
147608963|NCT02892149|532384135|FG000|Overall Study|Withdrawal by Subject|53|||
147454290|NCT01790503|531825581|FG009|Overall Study|Withdrawal by Subject|0|||
147454291|NCT01790503|531825582|FG010|Overall Study|Withdrawal by Subject|1|||
147454292|NCT01790503|531825572|FG000|Overall Study|Disease progression|2|||
147454293|NCT01790503|531825573|FG001|Overall Study|Disease progression|1|||
147454294|NCT01790503|531825574|FG002|Overall Study|Disease progression|0|||
147454295|NCT01790503|531825575|FG003|Overall Study|Disease progression|1|||
147454296|NCT01790503|531825576|FG004|Overall Study|Disease progression|2|||
147454297|NCT01790503|531825577|FG005|Overall Study|Disease progression|1|||
147454298|NCT01790503|531825578|FG006|Overall Study|Disease progression|0|||
147454299|NCT01790503|531825579|FG007|Overall Study|Disease progression|1|||
147454300|NCT01790503|531825580|FG008|Overall Study|Disease progression|0|||
147454301|NCT01790503|531825581|FG009|Overall Study|Disease progression|17|||
147454302|NCT01790503|531825582|FG010|Overall Study|Disease progression|7|||
147454303|NCT01790503|531825572|FG000|Overall Study|Protocol Violation|0|||
147454304|NCT01790503|531825573|FG001|Overall Study|Protocol Violation|0|||
147454305|NCT01790503|531825574|FG002|Overall Study|Protocol Violation|0|||
147454306|NCT01790503|531825575|FG003|Overall Study|Protocol Violation|0|||
147454307|NCT01790503|531825576|FG004|Overall Study|Protocol Violation|0|||
147454308|NCT01790503|531825577|FG005|Overall Study|Protocol Violation|0|||
147454309|NCT01790503|531825578|FG006|Overall Study|Protocol Violation|0|||
147454310|NCT01790503|531825579|FG007|Overall Study|Protocol Violation|0|||
147454311|NCT01790503|531825580|FG008|Overall Study|Protocol Violation|0|||
147454312|NCT01790503|531825581|FG009|Overall Study|Protocol Violation|1|||
147454313|NCT01790503|531825582|FG010|Overall Study|Protocol Violation|0|||
147454314|NCT01790503|531825572|FG000|Overall Study|Physician Decision|0|||
147454315|NCT01790503|531825573|FG001|Overall Study|Physician Decision|0|||
147608964|NCT02892149|532384136|FG001|Overall Study|Withdrawal by Subject|47|||
147608965|NCT02892149|532384135|FG000|Overall Study|Lost to Follow-up|37|||
147608966|NCT02892149|532384136|FG001|Overall Study|Lost to Follow-up|31|||
147608967|NCT03489109|532384137|FG000|Overall Study|Lost to Follow-up|1|||
147608968|NCT03489109|532384138|FG001|Overall Study|Lost to Follow-up|2|||
147608969|NCT01547130|532384139|FG000|Overall Study|Lost to Follow-up|9|||
147608970|NCT01547130|532384140|FG001|Overall Study|Lost to Follow-up|5|||
147608971|NCT03968978|532384141|FG000|Overall Study|Adverse Event|1|||
147608972|NCT03968978|532384142|FG001|Overall Study|Adverse Event|0|||
147608973|NCT02714426|532384143|FG000|Overall Study|Withdrawal by Subject|2|||
147608974|NCT02714426|532384144|FG001|Overall Study|Withdrawal by Subject|2|||
147608975|NCT00025259|532384146|FG000|Overall Study|Death|1|||
147608976|NCT00025259|532384147|FG001|Overall Study|Death|3|||
147608977|NCT00025259|532384148|FG002|Overall Study|Death|0|||
147608978|NCT00025259|532384149|FG003|Overall Study|Death|3|||
147608979|NCT00025259|532384150|FG004|Overall Study|Death|0|||
147608980|NCT00025259|532384151|FG005|Overall Study|Death|1|||
147608981|NCT00025259|532384152|FG006|Overall Study|Death|2|||
147608982|NCT00025259|532384146|FG000|Overall Study|Lack of Efficacy|2|||
147608983|NCT00025259|532384147|FG001|Overall Study|Lack of Efficacy|46|||
147608984|NCT00025259|532384148|FG002|Overall Study|Lack of Efficacy|60|||
147608985|NCT00025259|532384149|FG003|Overall Study|Lack of Efficacy|78|||
147608986|NCT00025259|532384150|FG004|Overall Study|Lack of Efficacy|11|||
147608987|NCT00025259|532384151|FG005|Overall Study|Lack of Efficacy|30|||
147608988|NCT00025259|532384152|FG006|Overall Study|Lack of Efficacy|38|||
147608989|NCT00025259|532384146|FG000|Overall Study|Lost to Follow-up|2|||
147608990|NCT00025259|532384147|FG001|Overall Study|Lost to Follow-up|9|||
147608991|NCT00025259|532384148|FG002|Overall Study|Lost to Follow-up|13|||
147608992|NCT00025259|532384149|FG003|Overall Study|Lost to Follow-up|13|||
147608993|NCT00025259|532384150|FG004|Overall Study|Lost to Follow-up|1|||
147608994|NCT00025259|532384151|FG005|Overall Study|Lost to Follow-up|3|||
147608995|NCT00025259|532384152|FG006|Overall Study|Lost to Follow-up|1|||
147608996|NCT00025259|532384146|FG000|Overall Study|Physician Decision|12|||
147608997|NCT00025259|532384147|FG001|Overall Study|Physician Decision|1|||
147608998|NCT00025259|532384148|FG002|Overall Study|Physician Decision|0|||
147608999|NCT00025259|532384149|FG003|Overall Study|Physician Decision|5|||
147609000|NCT00025259|532384150|FG004|Overall Study|Physician Decision|4|||
147609001|NCT00025259|532384151|FG005|Overall Study|Physician Decision|2|||
147609002|NCT00025259|532384152|FG006|Overall Study|Physician Decision|1|||
147609003|NCT00025259|532384146|FG000|Overall Study|Protocol Violation|3|||
147609004|NCT00025259|532384147|FG001|Overall Study|Protocol Violation|2|||
147609005|NCT00025259|532384148|FG002|Overall Study|Protocol Violation|2|||
147609006|NCT00025259|532384149|FG003|Overall Study|Protocol Violation|1|||
147609007|NCT00025259|532384150|FG004|Overall Study|Protocol Violation|2|||
147609008|NCT00025259|532384151|FG005|Overall Study|Protocol Violation|1|||
147609009|NCT00025259|532384152|FG006|Overall Study|Protocol Violation|3|||
147609010|NCT00025259|532384146|FG000|Overall Study|Withdrawal by Subject|9|||
147609011|NCT00025259|532384147|FG001|Overall Study|Withdrawal by Subject|27|||
147609012|NCT00025259|532384148|FG002|Overall Study|Withdrawal by Subject|6|||
147662809|NCT03811821|532587437|FG000|Overall Study|Withdrawal by Subject|5|||
147609013|NCT00025259|532384149|FG003|Overall Study|Withdrawal by Subject|14|||
147609014|NCT00025259|532384150|FG004|Overall Study|Withdrawal by Subject|11|||
147609015|NCT00025259|532384151|FG005|Overall Study|Withdrawal by Subject|8|||
147609016|NCT00025259|532384152|FG006|Overall Study|Withdrawal by Subject|3|||
147609017|NCT00025259|532384146|FG000|Overall Study|Ineligible|14|||
147609018|NCT00025259|532384147|FG001|Overall Study|Ineligible|1|||
147609019|NCT00025259|532384148|FG002|Overall Study|Ineligible|0|||
147609020|NCT00025259|532384149|FG003|Overall Study|Ineligible|0|||
147662810|NCT03811821|532587438|FG001|Overall Study|Withdrawal by Subject|4|||
147366075|NCT04974047|531512801|FG000|Overall Study|Sponsor Ended Study|20|||
147366076|NCT04974047|531512802|FG001|Overall Study|Sponsor Ended Study|22|||
147366077|NCT04974047|531512801|FG000|Overall Study|Death|8|||
147366078|NCT04974047|531512802|FG001|Overall Study|Death|17|||
147366079|NCT04974047|531512801|FG000|Overall Study|Lost to Follow-up|2|||
147366080|NCT04974047|531512802|FG001|Overall Study|Lost to Follow-up|0|||
147366081|NCT04974047|531512801|FG000|Overall Study|Withdrawal by Subject|0|||
147366082|NCT04974047|531512802|FG001|Overall Study|Withdrawal by Subject|1|||
147366085|NCT03391466|531512804|FG000|Overall Study|Death|84|||
147366086|NCT03391466|531512805|FG001|Overall Study|Death|91|||
147366087|NCT03391466|531512804|FG000|Overall Study|Rollover to Long-term Follow-up Study Criteria|80|||
147366088|NCT03391466|531512805|FG001|Overall Study|Rollover to Long-term Follow-up Study Criteria|0|||
147366089|NCT03391466|531512804|FG000|Overall Study|Subject Withdrawal of Consent from Further Follow-up|3|||
147366090|NCT03391466|531512805|FG001|Overall Study|Subject Withdrawal of Consent from Further Follow-up|13|||
147366091|NCT03391466|531512804|FG000|Overall Study|Lost to Follow-up|9|||
147366092|NCT03391466|531512805|FG001|Overall Study|Lost to Follow-up|5|||
147366093|NCT03391466|531512804|FG000|Overall Study|Reason Not Specified|2|||
147366094|NCT03391466|531512805|FG001|Overall Study|Reason Not Specified|2|||
147366095|NCT03391466|531512804|FG000|Overall Study|Investigator Decision|0|||
147366096|NCT03391466|531512805|FG001|Overall Study|Investigator Decision|1|||
147366139|NCT02502266|531512817|FG000|Overall Study|Adverse Event|0|||
147366140|NCT02502266|531512818|FG001|Overall Study|Adverse Event|0|||
147366141|NCT02502266|531512819|FG002|Overall Study|Adverse Event|0|||
147366142|NCT02502266|531512820|FG003|Overall Study|Adverse Event|0|||
147366143|NCT02502266|531512821|FG004|Overall Study|Adverse Event|1|||
147366144|NCT02502266|531512822|FG005|Overall Study|Adverse Event|1|||
147366145|NCT02502266|531512823|FG006|Overall Study|Adverse Event|1|||
147366146|NCT02502266|531512817|FG000|Overall Study|Withdrawal by Subject|30|||
147366147|NCT02502266|531512818|FG001|Overall Study|Withdrawal by Subject|15|||
147366148|NCT02502266|531512819|FG002|Overall Study|Withdrawal by Subject|16|||
147366149|NCT02502266|531512820|FG003|Overall Study|Withdrawal by Subject|0|||
147366150|NCT02502266|531512821|FG004|Overall Study|Withdrawal by Subject|0|||
147366151|NCT02502266|531512822|FG005|Overall Study|Withdrawal by Subject|0|||
147366152|NCT02502266|531512823|FG006|Overall Study|Withdrawal by Subject|0|||
147366153|NCT02502266|531512817|FG000|Overall Study|Still on Treatment|0|||
147366154|NCT02502266|531512818|FG001|Overall Study|Still on Treatment|0|||
147366155|NCT02502266|531512819|FG002|Overall Study|Still on Treatment|1|||
147366156|NCT02502266|531512820|FG003|Overall Study|Still on Treatment|0|||
147366157|NCT02502266|531512821|FG004|Overall Study|Still on Treatment|0|||
147366158|NCT02502266|531512822|FG005|Overall Study|Still on Treatment|0|||
147366159|NCT02502266|531512823|FG006|Overall Study|Still on Treatment|0|||
147366160|NCT02502266|531512817|FG000|Overall Study|Other Reasons|19|||
147366161|NCT02502266|531512818|FG001|Overall Study|Other Reasons|6|||
147366162|NCT02502266|531512819|FG002|Overall Study|Other Reasons|14|||
147366163|NCT02502266|531512820|FG003|Overall Study|Other Reasons|0|||
147366164|NCT02502266|531512821|FG004|Overall Study|Other Reasons|1|||
147366165|NCT02502266|531512822|FG005|Overall Study|Other Reasons|1|||
147366166|NCT02502266|531512823|FG006|Overall Study|Other Reasons|0|||
147366167|NCT02502266|531512817|FG000|Overall Study|Arm 4 Discontinued|0|||
147366168|NCT02502266|531512818|FG001|Overall Study|Arm 4 Discontinued|0|||
147366169|NCT02502266|531512819|FG002|Overall Study|Arm 4 Discontinued|0|||
147366170|NCT02502266|531512820|FG003|Overall Study|Arm 4 Discontinued|52|||
147366171|NCT02502266|531512821|FG004|Overall Study|Arm 4 Discontinued|0|||
147366172|NCT02502266|531512822|FG005|Overall Study|Arm 4 Discontinued|0|||
147366173|NCT02502266|531512823|FG006|Overall Study|Arm 4 Discontinued|0|||
147366174|NCT02502266|531512817|FG000|Overall Study|Never treated|0|||
147366175|NCT02502266|531512818|FG001|Overall Study|Never treated|0|||
147366176|NCT02502266|531512819|FG002|Overall Study|Never treated|0|||
147366177|NCT02502266|531512820|FG003|Overall Study|Never treated|0|||
147366178|NCT02502266|531512821|FG004|Overall Study|Never treated|0|||
147366179|NCT02502266|531512822|FG005|Overall Study|Never treated|1|||
147366180|NCT02502266|531512823|FG006|Overall Study|Never treated|0|||
147609021|NCT00025259|532384150|FG004|Overall Study|Ineligible|6|||
147609022|NCT00025259|532384151|FG005|Overall Study|Ineligible|0|||
147609023|NCT00025259|532384152|FG006|Overall Study|Ineligible|1|||
147454316|NCT01790503|531825574|FG002|Overall Study|Physician Decision|0|||
147609024|NCT00025259|532384146|FG000|Overall Study|Randomization error|1|||
147662811|NCT03811821|532587437|FG000|Overall Study|Lost to Follow-up|2|||
147662812|NCT03811821|532587438|FG001|Overall Study|Lost to Follow-up|2|||
147662813|NCT03811821|532587437|FG000|Overall Study|Contraindication for treatment|0|||
147662814|NCT03811821|532587438|FG001|Overall Study|Contraindication for treatment|1|||
147609025|NCT00025259|532384147|FG001|Overall Study|Randomization error|0|||
147609026|NCT00025259|532384148|FG002|Overall Study|Randomization error|0|||
147609027|NCT00025259|532384149|FG003|Overall Study|Randomization error|0|||
147609028|NCT00025259|532384150|FG004|Overall Study|Randomization error|1|||
147609029|NCT00025259|532384151|FG005|Overall Study|Randomization error|7|||
147609030|NCT00025259|532384152|FG006|Overall Study|Randomization error|2|||
147609031|NCT00025259|532384146|FG000|Overall Study|Adverse Event|1|||
147609032|NCT00025259|532384147|FG001|Overall Study|Adverse Event|0|||
147366378|NCT01976936|531512883|FG000|Overall Study|Did not receive at least 9 doses|9|||
147366379|NCT01976936|531512884|FG001|Overall Study|Did not receive at least 9 doses|4|||
147609033|NCT00025259|532384148|FG002|Overall Study|Adverse Event|0|||
147609034|NCT00025259|532384149|FG003|Overall Study|Adverse Event|0|||
147609035|NCT00025259|532384150|FG004|Overall Study|Adverse Event|0|||
147609036|NCT00025259|532384151|FG005|Overall Study|Adverse Event|0|||
147609037|NCT00025259|532384152|FG006|Overall Study|Adverse Event|0|||
147609038|NCT00908310|532384155|FG000|Overall Study|Death|37|||
147609039|NCT00908310|532384155|FG000|Overall Study|Withdrawal by Subject|7|||
147609040|NCT00908310|532384155|FG000|Overall Study|Lost to Follow-up|7|||
147366405|NCT06408870|531512890|FG000|Washout period|Withdrawal by Subject|1|||
147609041|NCT00908310|532384155|FG000|Overall Study|Screening failure|5|||
147609042|NCT00908310|532384155|FG000|Overall Study|Other reasons|4|||
147609043|NCT02071849|532384158|FG000|6-month Primary Endpoint|Did not receive device|4|||
147662815|NCT03811821|532587437|FG000|Overall Study|Tolerability|0|||
147366406|NCT06408870|531512891|FG001|Washout period|Withdrawal by Subject|0|||
147366407|NCT06408870|531512890|FG000|Washout period|Adverse Event|2|||
147366408|NCT06408870|531512891|FG001|Washout period|Adverse Event|0|||
147454317|NCT01790503|531825575|FG003|Overall Study|Physician Decision|0|||
147609044|NCT02071849|532384158|FG000|6-month Primary Endpoint|Adverse Event|1|||
147609045|NCT02071849|532384158|FG000|2-year Extended Follow-up|Adverse Event|1|||
147609046|NCT00103610|532384161|FG000|Overall Study|Entered Rescue Procedure|10|||
147609047|NCT00103610|532384162|FG001|Overall Study|Entered Rescue Procedure|52|||
147366441|NCT02306161|531513773|FG000|Overall Study|Death|1|||
147366442|NCT02306161|531513774|FG001|Overall Study|Death|3|||
147366443|NCT02306161|531513773|FG000|Overall Study|Lack of Efficacy|20|||
147366444|NCT02306161|531513774|FG001|Overall Study|Lack of Efficacy|43|||
147366445|NCT02306161|531513773|FG000|Overall Study|Physician Decision|30|||
147366446|NCT02306161|531513774|FG001|Overall Study|Physician Decision|18|||
147366447|NCT02306161|531513773|FG000|Overall Study|Withdrawal by Subject|4|||
147366448|NCT02306161|531513774|FG001|Overall Study|Withdrawal by Subject|0|||
147366449|NCT02306161|531513773|FG000|Overall Study|Ineligible|9|||
147366450|NCT02306161|531513774|FG001|Overall Study|Ineligible|5|||
147609048|NCT00103610|532384161|FG000|Overall Study|Death|16|||
147609049|NCT00103610|532384162|FG001|Overall Study|Death|12|||
147609050|NCT00103610|532384161|FG000|Overall Study|Elective Withdrawal|4|||
147609051|NCT00103610|532384162|FG001|Overall Study|Elective Withdrawal|0|||
147609052|NCT00103610|532384161|FG000|Overall Study|Lost to Follow-up|3|||
147609053|NCT00103610|532384162|FG001|Overall Study|Lost to Follow-up|1|||
147609054|NCT00103610|532384161|FG000|Overall Study|Adverse Event|2|||
147609055|NCT00103610|532384162|FG001|Overall Study|Adverse Event|2|||
147609056|NCT00103610|532384161|FG000|Overall Study|Other|2|||
147609057|NCT00103610|532384162|FG001|Overall Study|Other|7|||
147609058|NCT00103610|532384161|FG000|Overall Study|Failed mobilization|1|||
147609059|NCT00103610|532384162|FG001|Overall Study|Failed mobilization|5|||
147609060|NCT00103610|532384161|FG000|Overall Study|Noncompliance|0|||
147662816|NCT03811821|532587438|FG001|Overall Study|Tolerability|3|||
147662817|NCT03811821|532587437|FG000|Overall Study|Comorbidities|0|||
147662818|NCT03811821|532587438|FG001|Overall Study|Comorbidities|2|||
147662819|NCT05027815|532587441|FG000|Overall Study|Death|2|||
147662820|NCT05027815|532587442|FG001|Overall Study|Death|1|||
147662821|NCT00447902|532587447|FG000|Overall Study|Adverse Event|0|||
147662822|NCT00447902|532587448|FG001|Overall Study|Adverse Event|3|||
147662823|NCT00447902|532587447|FG000|Overall Study|Protocol Violation|1|||
147662824|NCT00447902|532587448|FG001|Overall Study|Protocol Violation|0|||
147662825|NCT00447902|532587447|FG000|Overall Study|Withdrawal by Subject|0|||
147662826|NCT00447902|532587448|FG001|Overall Study|Withdrawal by Subject|1|||
147662827|NCT00447902|532587447|FG000|Overall Study|included patients who discontinued|1|||
147662828|NCT00447902|532587448|FG001|Overall Study|included patients who discontinued|1|||
147662829|NCT00447902|532587447|FG000|Overall Study|Lack of Efficacy|2|||
147662830|NCT00447902|532587448|FG001|Overall Study|Lack of Efficacy|1|||
147662831|NCT01386606|532589103|FG000|Overall Study|Adverse Event|0|||
147662832|NCT01386606|532589104|FG001|Overall Study|Adverse Event|1|||
147662833|NCT01386606|532589105|FG002|Overall Study|Adverse Event|0|||
147662834|NCT01386606|532589106|FG003|Overall Study|Adverse Event|0|||
147662835|NCT01386606|532589103|FG000|Overall Study|Withdrawal by Subject|0|||
147662836|NCT01386606|532589104|FG001|Overall Study|Withdrawal by Subject|1|||
147662837|NCT01386606|532589105|FG002|Overall Study|Withdrawal by Subject|1|||
147662838|NCT01386606|532589106|FG003|Overall Study|Withdrawal by Subject|0|||
147662839|NCT01386606|532589103|FG000|Overall Study|Protocol Violation|1|||
147662840|NCT01386606|532589104|FG001|Overall Study|Protocol Violation|0|||
147662841|NCT01386606|532589105|FG002|Overall Study|Protocol Violation|1|||
147662842|NCT01386606|532589106|FG003|Overall Study|Protocol Violation|1|||
147662843|NCT01386606|532589103|FG000|Overall Study|Lost to Follow-up|2|||
147609061|NCT00103610|532384162|FG001|Overall Study|Noncompliance|1|||
147662844|NCT01386606|532589104|FG001|Overall Study|Lost to Follow-up|0|||
147662845|NCT01386606|532589105|FG002|Overall Study|Lost to Follow-up|0|||
147662846|NCT01386606|532589106|FG003|Overall Study|Lost to Follow-up|0|||
147662847|NCT01386606|532589103|FG000|Overall Study|Subject incarcerated|0|||
147662848|NCT01386606|532589104|FG001|Overall Study|Subject incarcerated|1|||
147662849|NCT01386606|532589105|FG002|Overall Study|Subject incarcerated|0|||
147609062|NCT00725205|532384166|FG000|Overall Study|Adverse Event|22|||
147609063|NCT00725205|532384166|FG000|Overall Study|Investigator Discontinued|1|||
147609064|NCT00725205|532384166|FG000|Overall Study|Non-compliance With Protocol|14|||
147609065|NCT00725205|532384166|FG000|Overall Study|Other|8|||
147662850|NCT01386606|532589106|FG003|Overall Study|Subject incarcerated|0|||
147609066|NCT00725205|532384166|FG000|Overall Study|Protocol Defined Clinical Event|1|||
147609067|NCT00725205|532384166|FG000|Overall Study|Treatment Failure|41|||
147609068|NCT01680497|532384167|FG000|Overall Study|Lost to Follow-up|2|||
147609069|NCT05819203|532384168|FG000|Overall Study|Protocol Violation|1|||
147609070|NCT05819203|532384169|FG001|Overall Study|Protocol Violation|2|||
147609071|NCT05819203|532384168|FG000|Overall Study|Withdrawal by Subject|1|||
147609072|NCT05819203|532384169|FG001|Overall Study|Withdrawal by Subject|0|||
147609073|NCT04123561|532384172|FG000|Overall Study|Lost to Follow-up|20|||
147609074|NCT04123561|532384173|FG001|Overall Study|Lost to Follow-up|12|||
147609075|NCT04123561|532384174|FG002|Overall Study|Lost to Follow-up|5|||
147609076|NCT04123561|532384172|FG000|Overall Study|Withdrawal by Subject|9|||
147609077|NCT04123561|532384173|FG001|Overall Study|Withdrawal by Subject|7|||
147609078|NCT04123561|532384174|FG002|Overall Study|Withdrawal by Subject|9|||
147609079|NCT04123561|532384172|FG000|Overall Study|Lack of Efficacy|7|||
147609080|NCT04123561|532384173|FG001|Overall Study|Lack of Efficacy|8|||
147609081|NCT04123561|532384174|FG002|Overall Study|Lack of Efficacy|6|||
147609082|NCT04123561|532384172|FG000|Overall Study|Adverse Event|5|||
147609083|NCT04123561|532384173|FG001|Overall Study|Adverse Event|2|||
147609084|NCT04123561|532384174|FG002|Overall Study|Adverse Event|3|||
147609085|NCT04123561|532384172|FG000|Overall Study|A surgical procedure or IA administration in the index knee|3|||
147609086|NCT04123561|532384173|FG001|Overall Study|A surgical procedure or IA administration in the index knee|0|||
147609087|NCT04123561|532384174|FG002|Overall Study|A surgical procedure or IA administration in the index knee|1|||
147609088|NCT04123561|532384172|FG000|Overall Study|Death|0|||
147609089|NCT04123561|532384173|FG001|Overall Study|Death|0|||
147609090|NCT04123561|532384174|FG002|Overall Study|Death|1|||
147609091|NCT04123561|532384172|FG000|Overall Study|Protocol Violation|0|||
147609092|NCT04123561|532384173|FG001|Overall Study|Protocol Violation|1|||
147609093|NCT04123561|532384174|FG002|Overall Study|Protocol Violation|0|||
147609094|NCT03654599|532384178|FG000|Overall Study|Lost to Follow-up|14|||
147609095|NCT03654599|532384179|FG001|Overall Study|Lost to Follow-up|12|||
147609096|NCT03654599|532384178|FG000|Overall Study|Death|8|||
147609097|NCT03654599|532384179|FG001|Overall Study|Death|6|||
147609098|NCT03654599|532384178|FG000|Overall Study|Withdrawal by Subject|6|||
147609099|NCT03654599|532384179|FG001|Overall Study|Withdrawal by Subject|4|||
147609100|NCT05833139|532386158|FG000|Study Period 2|Adverse Event|1|||
147609101|NCT00974922|532386163|FG000|Overall Study|study terminated|24|||
147609102|NCT00287586|532386164|FG000|Overall Study|Withdrew Consent|19|||
147609103|NCT00287586|532386165|FG001|Overall Study|Withdrew Consent|30|||
147609104|NCT00287586|532386164|FG000|Overall Study|Lost to Follow-up|5|||
147609105|NCT00287586|532386165|FG001|Overall Study|Lost to Follow-up|4|||
147609106|NCT00287586|532386164|FG000|Overall Study|Death|2|||
147454318|NCT01790503|531825576|FG004|Overall Study|Physician Decision|0|||
147609107|NCT00287586|532386165|FG001|Overall Study|Death|3|||
147609108|NCT00287586|532386164|FG000|Overall Study|Elevated Hematocrit|3|||
147609109|NCT00287586|532386165|FG001|Overall Study|Elevated Hematocrit|0|||
147609110|NCT00287586|532386164|FG000|Overall Study|Rash|3|||
147609111|NCT00287586|532386165|FG001|Overall Study|Rash|0|||
147609112|NCT00287586|532386164|FG000|Overall Study|Elevated Prostate Specific Antigen|2|||
147609113|NCT00287586|532386165|FG001|Overall Study|Elevated Prostate Specific Antigen|0|||
147609114|NCT00287586|532386164|FG000|Overall Study|Stroke|2|||
147609115|NCT00287586|532386165|FG001|Overall Study|Stroke|0|||
147609116|NCT00287586|532386164|FG000|Overall Study|Myocardial Infarction|1|||
147609117|NCT00287586|532386165|FG001|Overall Study|Myocardial Infarction|0|||
147609118|NCT00287586|532386164|FG000|Overall Study|Lower Urinary Tract Symptoms|1|||
147662851|NCT01386606|532589103|FG000|Overall Study|Unable to draw PK|1|||
147454319|NCT01790503|531825577|FG005|Overall Study|Physician Decision|0|||
147454320|NCT01790503|531825578|FG006|Overall Study|Physician Decision|0|||
147609119|NCT00287586|532386165|FG001|Overall Study|Lower Urinary Tract Symptoms|0|||
147609120|NCT00287586|532386164|FG000|Overall Study|Cognitive Impairment|1|||
147454321|NCT01790503|531825579|FG007|Overall Study|Physician Decision|0|||
147454322|NCT01790503|531825580|FG008|Overall Study|Physician Decision|0|||
147454323|NCT01790503|531825581|FG009|Overall Study|Physician Decision|1|||
147454324|NCT01790503|531825582|FG010|Overall Study|Physician Decision|1|||
147609121|NCT00287586|532386165|FG001|Overall Study|Cognitive Impairment|0|||
147609122|NCT00287586|532386164|FG000|Overall Study|Pancreatic Cancer|1|||
147366756|NCT05162586|531513817|FG000|Overall Study|Other|0|||
147366757|NCT05162586|531513818|FG001|Overall Study|Other|0|||
147366758|NCT05162586|531513819|FG002|Overall Study|Other|0|||
147366759|NCT05162586|531513820|FG003|Overall Study|Other|0|||
147366760|NCT05162586|531513821|FG004|Overall Study|Other|1|||
147366761|NCT05162586|531513822|FG005|Overall Study|Other|0|||
147366762|NCT05162586|531513823|FG006|Overall Study|Other|2|||
147366763|NCT05162586|531513824|FG007|Overall Study|Other|2|||
147366764|NCT05162586|531513817|FG000|Overall Study|Lack of Efficacy|0|||
147366765|NCT05162586|531513818|FG001|Overall Study|Lack of Efficacy|0|||
147366766|NCT05162586|531513819|FG002|Overall Study|Lack of Efficacy|0|||
147366767|NCT05162586|531513820|FG003|Overall Study|Lack of Efficacy|0|||
147366768|NCT05162586|531513821|FG004|Overall Study|Lack of Efficacy|1|||
147366769|NCT05162586|531513822|FG005|Overall Study|Lack of Efficacy|0|||
147366770|NCT05162586|531513823|FG006|Overall Study|Lack of Efficacy|0|||
147366771|NCT05162586|531513824|FG007|Overall Study|Lack of Efficacy|1|||
147366772|NCT05162586|531513817|FG000|Overall Study|Lost to Follow-up|0|||
147366773|NCT05162586|531513818|FG001|Overall Study|Lost to Follow-up|0|||
147366774|NCT05162586|531513819|FG002|Overall Study|Lost to Follow-up|0|||
147366775|NCT05162586|531513820|FG003|Overall Study|Lost to Follow-up|0|||
147366776|NCT05162586|531513821|FG004|Overall Study|Lost to Follow-up|2|||
147366777|NCT05162586|531513822|FG005|Overall Study|Lost to Follow-up|0|||
147366778|NCT05162586|531513823|FG006|Overall Study|Lost to Follow-up|0|||
147366779|NCT05162586|531513824|FG007|Overall Study|Lost to Follow-up|2|||
147366780|NCT05162586|531513817|FG000|Overall Study|Non-Compliance|0|||
147366781|NCT05162586|531513818|FG001|Overall Study|Non-Compliance|1|||
147366782|NCT05162586|531513819|FG002|Overall Study|Non-Compliance|0|||
147366783|NCT05162586|531513820|FG003|Overall Study|Non-Compliance|0|||
147454325|NCT01790503|531825572|FG000|Overall Study|Death|0|||
147609123|NCT00287586|532386165|FG001|Overall Study|Pancreatic Cancer|3|||
147609124|NCT00287586|532386164|FG000|Overall Study|Sleep Apnea|1|||
147609125|NCT00287586|532386165|FG001|Overall Study|Sleep Apnea|0|||
147609126|NCT00287586|532386164|FG000|Overall Study|Shoulder Pain|1|||
147609127|NCT00287586|532386165|FG001|Overall Study|Shoulder Pain|0|||
147609128|NCT00287586|532386164|FG000|Overall Study|Inappropriate Behaviour with Staff|1|||
147609129|NCT00287586|532386165|FG001|Overall Study|Inappropriate Behaviour with Staff|0|||
147609130|NCT00287586|532386164|FG000|Overall Study|Nonadherence|1|||
147609131|NCT00287586|532386165|FG001|Overall Study|Nonadherence|1|||
147609132|NCT00287586|532386164|FG000|Overall Study|Enrolled in Another Study|1|||
147609133|NCT00287586|532386165|FG001|Overall Study|Enrolled in Another Study|0|||
147609134|NCT00287586|532386164|FG000|Overall Study|Major Depression|0|||
147609135|NCT00287586|532386165|FG001|Overall Study|Major Depression|2|||
147609136|NCT00287586|532386164|FG000|Overall Study|Lung Cancer|0|||
147609137|NCT00287586|532386165|FG001|Overall Study|Lung Cancer|2|||
147609138|NCT00287586|532386164|FG000|Overall Study|Elevated IPSS Score|0|||
147609139|NCT00287586|532386165|FG001|Overall Study|Elevated IPSS Score|1|||
147609140|NCT00287586|532386164|FG000|Overall Study|Retroperitoneal Cancer|0|||
147609141|NCT00287586|532386165|FG001|Overall Study|Retroperitoneal Cancer|1|||
147609142|NCT00287586|532386164|FG000|Overall Study|Mastodynia and Gynecomastia|0|||
147609143|NCT00287586|532386165|FG001|Overall Study|Mastodynia and Gynecomastia|1|||
147609144|NCT00287586|532386164|FG000|Overall Study|Mood Swings and Irritability|0|||
147609145|NCT00287586|532386165|FG001|Overall Study|Mood Swings and Irritability|1|||
147609146|NCT00287586|532386164|FG000|Overall Study|Bradycardia|0|||
147609147|NCT00287586|532386165|FG001|Overall Study|Bradycardia|1|||
147609148|NCT00287586|532386164|FG000|Overall Study|Itchy Swollen Eyes|0|||
147609149|NCT00287586|532386165|FG001|Overall Study|Itchy Swollen Eyes|1|||
147609150|NCT00287586|532386164|FG000|Overall Study|Recurrent Melanoma|0|||
147609151|NCT00287586|532386165|FG001|Overall Study|Recurrent Melanoma|1|||
147609152|NCT02640482|532386166|FG000|Overall Study|Lost to Follow-up|3|||
147609153|NCT02640482|532386167|FG001|Overall Study|Lost to Follow-up|0|||
147609154|NCT00517881|532386168|FG000|Overall Study|Protocol Violation|2|||
147609155|NCT00517881|532386168|FG000|Overall Study|Adverse Event|1|||
147609156|NCT00517881|532386168|FG000|Overall Study|Renal transplantation|2|||
147609157|NCT00113763|532386169|FG000|Overall Study|Adverse Event|5|||
147609158|NCT00113763|532386170|FG001|Overall Study|Adverse Event|2|||
147609159|NCT00113763|532386169|FG000|Overall Study|Disease Progression|28|||
147609160|NCT00113763|532386170|FG001|Overall Study|Disease Progression|14|||
147609161|NCT00113763|532386169|FG000|Overall Study|Lost to Follow-up|10|||
147366784|NCT05162586|531513821|FG004|Overall Study|Non-Compliance|1|||
147454326|NCT01790503|531825573|FG001|Overall Study|Death|0|||
147609162|NCT00113763|532386170|FG001|Overall Study|Lost to Follow-up|0|||
147609163|NCT00113763|532386169|FG000|Overall Study|Withdrawal by Subject|1|||
147609164|NCT00113763|532386170|FG001|Overall Study|Withdrawal by Subject|4|||
147609165|NCT00113763|532386169|FG000|Overall Study|Other|27|||
147609166|NCT00113763|532386170|FG001|Overall Study|Other|6|||
147609167|NCT00113763|532386169|FG000|Overall Study|Non-compliance|1|||
147366785|NCT05162586|531513822|FG005|Overall Study|Non-Compliance|0|||
147366786|NCT05162586|531513823|FG006|Overall Study|Non-Compliance|0|||
147609168|NCT00113763|532386170|FG001|Overall Study|Non-compliance|0|||
147609169|NCT00113763|532386169|FG000|Overall Study|Ongoing|1|||
147609170|NCT00113763|532386170|FG001|Overall Study|Ongoing|0|||
147366787|NCT05162586|531513824|FG007|Overall Study|Non-Compliance|1|||
147366788|NCT05162586|531513817|FG000|Overall Study|Withdrawal by Subject|2|||
147366789|NCT05162586|531513818|FG001|Overall Study|Withdrawal by Subject|0|||
147366790|NCT05162586|531513819|FG002|Overall Study|Withdrawal by Subject|0|||
147366791|NCT05162586|531513820|FG003|Overall Study|Withdrawal by Subject|0|||
147366792|NCT05162586|531513821|FG004|Overall Study|Withdrawal by Subject|7|||
147366793|NCT05162586|531513822|FG005|Overall Study|Withdrawal by Subject|6|||
147366794|NCT05162586|531513823|FG006|Overall Study|Withdrawal by Subject|2|||
147366795|NCT05162586|531513824|FG007|Overall Study|Withdrawal by Subject|2|||
147366796|NCT05162586|531513817|FG000|Overall Study|Adverse Event|2|||
147366797|NCT05162586|531513818|FG001|Overall Study|Adverse Event|0|||
147366798|NCT05162586|531513819|FG002|Overall Study|Adverse Event|1|||
147366799|NCT05162586|531513820|FG003|Overall Study|Adverse Event|2|||
147366800|NCT05162586|531513821|FG004|Overall Study|Adverse Event|4|||
147366801|NCT05162586|531513822|FG005|Overall Study|Adverse Event|1|||
147366802|NCT05162586|531513823|FG006|Overall Study|Adverse Event|5|||
147366803|NCT05162586|531513824|FG007|Overall Study|Adverse Event|2|||
147609171|NCT02129608|532386175|FG000|Overall Study|Lost to Follow-up|0|||
147609172|NCT02129608|532386176|FG001|Overall Study|Lost to Follow-up|1|||
147609173|NCT02129608|532386177|FG002|Overall Study|Lost to Follow-up|1|||
147609174|NCT02129608|532386175|FG000|Overall Study|Withdrawal by Subject|0|||
147609175|NCT02129608|532386176|FG001|Overall Study|Withdrawal by Subject|0|||
147662852|NCT01386606|532589104|FG001|Overall Study|Unable to draw PK|0|||
147609176|NCT02129608|532386177|FG002|Overall Study|Withdrawal by Subject|2|||
147609177|NCT02114385|532386179|FG000|Overall Study|Withdrawal by Subject|3|||
147609178|NCT02114385|532386180|FG001|Overall Study|Withdrawal by Subject|2|||
147609179|NCT02114385|532386179|FG000|Overall Study|Lost to Follow-up|0|||
147609180|NCT02114385|532386180|FG001|Overall Study|Lost to Follow-up|6|||
147609181|NCT00230178|532386184|FG000|Overall Study|Adverse Event|1|||
147609182|NCT00230178|532386185|FG001|Overall Study|Adverse Event|5|||
147609183|NCT00230178|532386186|FG002|Overall Study|Adverse Event|2|||
147609184|NCT00230178|532386184|FG000|Overall Study|Withdrawal by Subject|0|||
147609185|NCT00230178|532386185|FG001|Overall Study|Withdrawal by Subject|0|||
147609186|NCT00230178|532386186|FG002|Overall Study|Withdrawal by Subject|1|||
147609187|NCT00230178|532386184|FG000|Overall Study|Various other reasons|3|||
147609188|NCT00230178|532386185|FG001|Overall Study|Various other reasons|2|||
147609189|NCT00230178|532386186|FG002|Overall Study|Various other reasons|4|||
147609190|NCT01753297|532386187|FG000|Overall Study|Lost to Follow-up|7|||
147609191|NCT01753297|532386188|FG001|Overall Study|Lost to Follow-up|2|||
147609192|NCT01753297|532386187|FG000|Overall Study|Withdrawal by Subject|26|||
147609193|NCT01753297|532386188|FG001|Overall Study|Withdrawal by Subject|23|||
147609194|NCT01753297|532386187|FG000|Overall Study|Adverse Event (up to Month 36)|1|||
147609195|NCT01753297|532386188|FG001|Overall Study|Adverse Event (up to Month 36)|1|||
147609196|NCT01753297|532386187|FG000|Overall Study|Death|0|||
147609197|NCT01753297|532386188|FG001|Overall Study|Death|2|||
147609198|NCT01753297|532386187|FG000|Overall Study|Did not attend end of study visit|7|||
147609199|NCT01753297|532386188|FG001|Overall Study|Did not attend end of study visit|8|||
147609200|NCT02533180|532386189|FG000|Overall Study|Death|0|||
147609201|NCT02533180|532386190|FG001|Overall Study|Death|2|||
147609202|NCT02533180|532386189|FG000|Overall Study|Lost to Follow-up|0|||
147609203|NCT02533180|532386190|FG001|Overall Study|Lost to Follow-up|1|||
147366929|NCT02567435|531515394|FG000|Overall Study|Death|1|||
147366930|NCT02567435|531515395|FG001|Overall Study|Death|1|||
147366931|NCT02567435|531515396|FG002|Overall Study|Death|0|||
147366932|NCT02567435|531515397|FG003|Overall Study|Death|0|||
147366933|NCT02567435|531515394|FG000|Overall Study|Ineligible|1|||
147366934|NCT02567435|531515395|FG001|Overall Study|Ineligible|3|||
147366935|NCT02567435|531515396|FG002|Overall Study|Ineligible|0|||
147366936|NCT02567435|531515397|FG003|Overall Study|Ineligible|0|||
147366937|NCT02567435|531515394|FG000|Overall Study|Withdrawal of consent for any further data submissions|4|||
147366938|NCT02567435|531515395|FG001|Overall Study|Withdrawal of consent for any further data submissions|5|||
147366939|NCT02567435|531515396|FG002|Overall Study|Withdrawal of consent for any further data submissions|0|||
147366940|NCT02567435|531515397|FG003|Overall Study|Withdrawal of consent for any further data submissions|1|||
147366941|NCT02166463|531515398|FG000|Overall Study|Lost to Follow-up|0|||
147366942|NCT02166463|531515399|FG001|Overall Study|Lost to Follow-up|1|||
147366943|NCT02166463|531515398|FG000|Overall Study|Physician Decision|10|||
147366944|NCT02166463|531515399|FG001|Overall Study|Physician Decision|10|||
147366945|NCT02166463|531515398|FG000|Overall Study|Ineligible|11|||
147366946|NCT02166463|531515399|FG001|Overall Study|Ineligible|2|||
147366947|NCT02166463|531515398|FG000|Overall Study|Progressive Disease|9|||
147366948|NCT02166463|531515399|FG001|Overall Study|Progressive Disease|6|||
147366949|NCT02166463|531515398|FG000|Overall Study|Repeat eligibility studies are outside the parameters required for eligibility|2|||
147366950|NCT02166463|531515399|FG001|Overall Study|Repeat eligibility studies are outside the parameters required for eligibility|2|||
147366951|NCT02166463|531515398|FG000|Overall Study|Patient enrollment onto another COG study with tumor therapeutic intent|1|||
147366952|NCT02166463|531515399|FG001|Overall Study|Patient enrollment onto another COG study with tumor therapeutic intent|0|||
147366953|NCT02166463|531515398|FG000|Overall Study|Refusal of further protocol therapy|5|||
147366954|NCT02166463|531515399|FG001|Overall Study|Refusal of further protocol therapy|6|||
147609204|NCT02533180|532386189|FG000|Overall Study|Physician Decision|0|||
147609205|NCT02533180|532386190|FG001|Overall Study|Physician Decision|1|||
147609206|NCT02533180|532386189|FG000|Overall Study|Withdrawal by Subject|2|||
147609207|NCT02533180|532386190|FG001|Overall Study|Withdrawal by Subject|5|||
147609208|NCT02533180|532386189|FG000|Overall Study|Screen Failure|37|||
147367041|NCT05030584|531515421|FG000|Overall Study|Adverse Event|17|||
147367042|NCT05030584|531515422|FG001|Overall Study|Adverse Event|2|||
147367043|NCT05030584|531515421|FG000|Overall Study|Lack of Efficacy|0|||
147367044|NCT05030584|531515422|FG001|Overall Study|Lack of Efficacy|6|||
147367045|NCT05030584|531515421|FG000|Overall Study|Lost to Follow-up|5|||
147367046|NCT05030584|531515422|FG001|Overall Study|Lost to Follow-up|2|||
147367047|NCT05030584|531515421|FG000|Overall Study|Non-Compliance with Study Drug|2|||
147367048|NCT05030584|531515422|FG001|Overall Study|Non-Compliance with Study Drug|3|||
147367049|NCT05030584|531515421|FG000|Overall Study|Other reason|4|||
147609209|NCT02533180|532386190|FG001|Overall Study|Screen Failure|0|||
147367050|NCT05030584|531515422|FG001|Overall Study|Other reason|3|||
147367051|NCT05030584|531515421|FG000|Overall Study|Physician Decision|1|||
147367052|NCT05030584|531515422|FG001|Overall Study|Physician Decision|4|||
147367053|NCT05030584|531515421|FG000|Overall Study|Protocol Violation|0|||
147367054|NCT05030584|531515422|FG001|Overall Study|Protocol Violation|2|||
147367055|NCT05030584|531515421|FG000|Overall Study|Randomized by Mistake|0|||
147367056|NCT05030584|531515422|FG001|Overall Study|Randomized by Mistake|2|||
147367057|NCT05030584|531515421|FG000|Overall Study|Withdrawal by Subject|21|||
147367058|NCT05030584|531515422|FG001|Overall Study|Withdrawal by Subject|28|||
147367059|NCT05030584|531515421|FG000|Overall Study|Technical Problems|0|||
147367060|NCT05030584|531515422|FG001|Overall Study|Technical Problems|1|||
147367061|NCT05030584|531515421|FG000|Overall Study|Completed post-treatment/FU visits|41|||
147367062|NCT05030584|531515422|FG001|Overall Study|Completed post-treatment/FU visits|31|||
147454327|NCT01790503|531825574|FG002|Overall Study|Death|0|||
147454328|NCT01790503|531825575|FG003|Overall Study|Death|0|||
147454329|NCT01790503|531825576|FG004|Overall Study|Death|0|||
147454330|NCT01790503|531825577|FG005|Overall Study|Death|0|||
147454331|NCT01790503|531825578|FG006|Overall Study|Death|0|||
147454332|NCT01790503|531825579|FG007|Overall Study|Death|0|||
147454333|NCT01790503|531825580|FG008|Overall Study|Death|0|||
147454334|NCT01790503|531825581|FG009|Overall Study|Death|1|||
147454335|NCT01790503|531825582|FG010|Overall Study|Death|0|||
147454336|NCT01790503|531825572|FG000|Overall Study|Non Compliance|0|||
147454337|NCT01790503|531825573|FG001|Overall Study|Non Compliance|0|||
147454338|NCT01790503|531825574|FG002|Overall Study|Non Compliance|0|||
147454339|NCT01790503|531825575|FG003|Overall Study|Non Compliance|0|||
147454340|NCT01790503|531825576|FG004|Overall Study|Non Compliance|1|||
147454341|NCT01790503|531825577|FG005|Overall Study|Non Compliance|0|||
147454342|NCT01790503|531825578|FG006|Overall Study|Non Compliance|0|||
147367260|NCT03047213|531515477|FG000|Overall Study|Withdrawal by Subject|2|||
147367261|NCT03047213|531515478|FG001|Overall Study|Withdrawal by Subject|0|||
147367262|NCT03047213|531515477|FG000|Overall Study|Adverse Event|2|||
147454343|NCT01790503|531825579|FG007|Overall Study|Non Compliance|0|||
147367263|NCT03047213|531515478|FG001|Overall Study|Adverse Event|0|||
147609210|NCT02533180|532386189|FG000|Overall Study|Protocol Deviation|0|||
147609211|NCT02533180|532386190|FG001|Overall Study|Protocol Deviation|1|||
147609212|NCT02533180|532386189|FG000|Overall Study|Non-compliance|0|||
147609213|NCT02533180|532386190|FG001|Overall Study|Non-compliance|1|||
147609214|NCT00447876|532386191|FG000|Overall Study|Withdrawal by Subject|1|||
147609215|NCT00447876|532386192|FG001|Overall Study|Withdrawal by Subject|4|||
147609216|NCT00447876|532386191|FG000|Overall Study|Lost to Follow-up|1|||
147609217|NCT00447876|532386192|FG001|Overall Study|Lost to Follow-up|0|||
147609218|NCT00447876|532386191|FG000|Overall Study|Deterioration of symptomology|1|||
147609219|NCT00447876|532386192|FG001|Overall Study|Deterioration of symptomology|0|||
147609220|NCT01609023|532386193|FG000|Overall Study|Lack of Efficacy|3|||
147609221|NCT01609023|532386193|FG000|Overall Study|Withdrawal by Subject|4|||
147609222|NCT01609023|532386193|FG000|Overall Study|Lost to Follow-up|8|||
147609223|NCT01609023|532386193|FG000|Overall Study|Toxicity|3|||
147609224|NCT01609023|532386193|FG000|Overall Study|Disease progression|10|||
147609225|NCT01609023|532386193|FG000|Overall Study|Physician Decision|2|||
147609226|NCT01609023|532386193|FG000|Overall Study|Death|2|||
147609227|NCT01609023|532386193|FG000|Overall Study|Personal reasons|1|||
147609228|NCT04172597|532386195|FG000|Overall Study|Disease Progression|0|||
147609229|NCT04172597|532386196|FG001|Overall Study|Disease Progression|0|||
147609230|NCT04172597|532386197|FG002|Overall Study|Disease Progression|0|||
147609231|NCT04172597|532386198|FG003|Overall Study|Disease Progression|0|||
147609232|NCT04172597|532386199|FG004|Overall Study|Disease Progression|1|||
147609233|NCT03717012|532386216|FG000|Overall Study|Due to trial termination|1|||
147609234|NCT03717012|532386217|FG001|Overall Study|Due to trial termination|2|||
147609235|NCT03717012|532386216|FG000|Overall Study|Protocol Violation|0|||
147609236|NCT03717012|532386217|FG001|Overall Study|Protocol Violation|2|||
147609237|NCT03717012|532386216|FG000|Overall Study|Adverse Event|0|||
147609238|NCT03717012|532386217|FG001|Overall Study|Adverse Event|1|||
147609239|NCT03717012|532386216|FG000|Overall Study|Lung transplant|0|||
147609240|NCT03717012|532386217|FG001|Overall Study|Lung transplant|1|||
147609241|NCT00789035|532386218|FG000|Overall Study|Adverse Event|0|||
147609242|NCT00789035|532386219|FG001|Overall Study|Adverse Event|2|||
147609243|NCT00789035|532386220|FG002|Overall Study|Adverse Event|0|||
147609244|NCT00789035|532386221|FG003|Overall Study|Adverse Event|1|||
147609245|NCT00789035|532386222|FG004|Overall Study|Adverse Event|3|||
147609246|NCT00789035|532386218|FG000|Overall Study|Lack of Efficacy|3|||
147609247|NCT00789035|532386219|FG001|Overall Study|Lack of Efficacy|0|||
147609248|NCT00789035|532386220|FG002|Overall Study|Lack of Efficacy|0|||
147609249|NCT00789035|532386221|FG003|Overall Study|Lack of Efficacy|0|||
147609250|NCT00789035|532386222|FG004|Overall Study|Lack of Efficacy|2|||
147609251|NCT00789035|532386218|FG000|Overall Study|Protocol Violation|1|||
147609252|NCT00789035|532386219|FG001|Overall Study|Protocol Violation|0|||
147609253|NCT00789035|532386220|FG002|Overall Study|Protocol Violation|0|||
147609254|NCT00789035|532386221|FG003|Overall Study|Protocol Violation|0|||
147609255|NCT00789035|532386222|FG004|Overall Study|Protocol Violation|0|||
147609256|NCT00789035|532386218|FG000|Overall Study|Withdrawal by Subject|0|||
147609257|NCT00789035|532386219|FG001|Overall Study|Withdrawal by Subject|2|||
147609258|NCT00789035|532386220|FG002|Overall Study|Withdrawal by Subject|0|||
147609259|NCT00789035|532386221|FG003|Overall Study|Withdrawal by Subject|0|||
147609260|NCT00789035|532386222|FG004|Overall Study|Withdrawal by Subject|0|||
147609261|NCT00789035|532386218|FG000|Overall Study|Other reason not defined above|2|||
147609262|NCT00789035|532386219|FG001|Overall Study|Other reason not defined above|3|||
147609263|NCT00789035|532386220|FG002|Overall Study|Other reason not defined above|1|||
147609264|NCT00789035|532386221|FG003|Overall Study|Other reason not defined above|0|||
147609265|NCT00789035|532386222|FG004|Overall Study|Other reason not defined above|1|||
147609266|NCT01520870|532386223|FG000|Overall Study|Withdrawal by Subject|2|||
147609267|NCT02463357|532386224|FG000|Overall Study|Withdrawal by Subject|1|||
147662853|NCT01386606|532589105|FG002|Overall Study|Unable to draw PK|0|||
147609268|NCT02463357|532386225|FG001|Overall Study|Withdrawal by Subject|0|||
147609269|NCT02463357|532386226|FG002|Overall Study|Withdrawal by Subject|0|||
147367394|NCT02115282|531515533|FG000|Overall Study|Disease progression during treatment|216|||
147367395|NCT02115282|531515534|FG001|Overall Study|Disease progression during treatment|229|||
147367396|NCT02115282|531515533|FG000|Overall Study|Adverse Event|49|||
147367397|NCT02115282|531515534|FG001|Overall Study|Adverse Event|23|||
147367398|NCT02115282|531515533|FG000|Overall Study|Death|1|||
147367399|NCT02115282|531515534|FG001|Overall Study|Death|3|||
147367400|NCT02115282|531515533|FG000|Overall Study|Alternative therapy|1|||
147367401|NCT02115282|531515534|FG001|Overall Study|Alternative therapy|1|||
147367402|NCT02115282|531515533|FG000|Overall Study|Complicating disease|0|||
147367403|NCT02115282|531515534|FG001|Overall Study|Complicating disease|3|||
147367404|NCT02115282|531515533|FG000|Overall Study|Withdrawal by Subject|12|||
147367405|NCT02115282|531515534|FG001|Overall Study|Withdrawal by Subject|10|||
147367406|NCT02115282|531515533|FG000|Overall Study|Symptomatic progression/deterioration|7|||
147367407|NCT02115282|531515534|FG001|Overall Study|Symptomatic progression/deterioration|18|||
147367408|NCT02115282|531515533|FG000|Overall Study|Non-compliance|5|||
147367409|NCT02115282|531515534|FG001|Overall Study|Non-compliance|1|||
147367410|NCT02115282|531515533|FG000|Overall Study|Protocol Violation|2|||
147367411|NCT02115282|531515534|FG001|Overall Study|Protocol Violation|2|||
147367412|NCT02115282|531515533|FG000|Overall Study|Study termination (stop treatment due to the release of the results)|3|||
147367413|NCT02115282|531515534|FG001|Overall Study|Study termination (stop treatment due to the release of the results)|3|||
147367414|NCT02115282|531515533|FG000|Overall Study|Not start protocol therapy|9|||
147367415|NCT02115282|531515534|FG001|Overall Study|Not start protocol therapy|10|||
147454344|NCT01790503|531825580|FG008|Overall Study|Non Compliance|0|||
147662854|NCT01386606|532589106|FG003|Overall Study|Unable to draw PK|0|||
147662855|NCT01386606|532589103|FG000|Overall Study|T levels too high|0|||
147662856|NCT01386606|532589104|FG001|Overall Study|T levels too high|1|||
147662857|NCT01386606|532589105|FG002|Overall Study|T levels too high|1|||
147662858|NCT01386606|532589106|FG003|Overall Study|T levels too high|0|||
147662859|NCT02357459|532589109|FG000|Overall Study|Adverse Event|0|||
147662860|NCT02357459|532589110|FG001|Overall Study|Adverse Event|1|||
147662861|NCT02357459|532589111|FG002|Overall Study|Adverse Event|1|||
147662862|NCT02357459|532589109|FG000|Overall Study|Withdrawal by Subject|5|||
147662863|NCT02357459|532589110|FG001|Overall Study|Withdrawal by Subject|3|||
147662864|NCT02357459|532589111|FG002|Overall Study|Withdrawal by Subject|3|||
147662865|NCT02357459|532589109|FG000|Overall Study|Physician Decision|0|||
147662866|NCT02357459|532589110|FG001|Overall Study|Physician Decision|2|||
147662867|NCT02357459|532589111|FG002|Overall Study|Physician Decision|0|||
147662868|NCT02357459|532589109|FG000|Overall Study|Protocol Violation|1|||
147662869|NCT02357459|532589110|FG001|Overall Study|Protocol Violation|1|||
147662870|NCT02357459|532589111|FG002|Overall Study|Protocol Violation|0|||
147662871|NCT02357459|532589109|FG000|Overall Study|Lost to Follow-up|1|||
147662872|NCT02357459|532589110|FG001|Overall Study|Lost to Follow-up|3|||
147662873|NCT02357459|532589111|FG002|Overall Study|Lost to Follow-up|0|||
147662874|NCT02357459|532589109|FG000|Overall Study|Lack of Efficacy|7|||
147662875|NCT02357459|532589110|FG001|Overall Study|Lack of Efficacy|4|||
147662876|NCT02357459|532589111|FG002|Overall Study|Lack of Efficacy|4|||
147662877|NCT02357459|532589109|FG000|Overall Study|Patient Relocated|2|||
147662878|NCT02357459|532589110|FG001|Overall Study|Patient Relocated|0|||
147662879|NCT02357459|532589111|FG002|Overall Study|Patient Relocated|0|||
147662880|NCT02357459|532589109|FG000|Overall Study|Instruction from PCP|1|||
147662881|NCT02357459|532589110|FG001|Overall Study|Instruction from PCP|0|||
147662882|NCT02357459|532589111|FG002|Overall Study|Instruction from PCP|0|||
147662883|NCT02357459|532589109|FG000|Overall Study|Incarceration|0|||
147662884|NCT02357459|532589110|FG001|Overall Study|Incarceration|0|||
147662885|NCT02357459|532589111|FG002|Overall Study|Incarceration|1|||
147662886|NCT02357459|532589109|FG000|Overall Study|Pre-planned Knee surgery|0|||
147662887|NCT02357459|532589110|FG001|Overall Study|Pre-planned Knee surgery|0|||
147662888|NCT02357459|532589111|FG002|Overall Study|Pre-planned Knee surgery|2|||
147662889|NCT02357459|532589109|FG000|Overall Study|Job Commitments|0|||
147662890|NCT02357459|532589110|FG001|Overall Study|Job Commitments|0|||
147662891|NCT02357459|532589111|FG002|Overall Study|Job Commitments|1|||
147367453|NCT06393127|531515546|FG000|Washout period|Withdrawal by Subject|1|||
147367454|NCT06393127|531515547|FG001|Washout period|Withdrawal by Subject|0|||
147367455|NCT06393127|531515546|FG000|Washout period|Non-compliance from subject with trial procedures|1|||
147367456|NCT06393127|531515547|FG001|Washout period|Non-compliance from subject with trial procedures|0|||
147367457|NCT02446600|531515548|FG000|Overall Study|Never treated|20|||
147367458|NCT02446600|531515549|FG001|Overall Study|Never treated|2|||
147367459|NCT02446600|531515550|FG002|Overall Study|Never treated|6|||
147662892|NCT03246347|532589112|FG000|Overall Study|On Study|23|||
147662893|NCT01548599|532589113|FG000|Overall Study|Lost to Follow-up|0|||
147662894|NCT01548599|532589114|FG001|Overall Study|Lost to Follow-up|1|||
147662895|NCT01548599|532589113|FG000|Overall Study|Withdrawal by Subject|4|||
147662896|NCT01548599|532589114|FG001|Overall Study|Withdrawal by Subject|0|||
147662897|NCT01548599|532589113|FG000|Overall Study|Death|2|||
147367460|NCT02446600|531515551|FG003|Overall Study|Never treated|0|||
147367461|NCT02446600|531515548|FG000|Overall Study|Withdrawal by Subject|19|||
147367462|NCT02446600|531515549|FG001|Overall Study|Withdrawal by Subject|5|||
147367463|NCT02446600|531515550|FG002|Overall Study|Withdrawal by Subject|17|||
147367464|NCT02446600|531515551|FG003|Overall Study|Withdrawal by Subject|0|||
147367465|NCT02446600|531515548|FG000|Overall Study|Ineligible|1|||
147367466|NCT02446600|531515549|FG001|Overall Study|Ineligible|4|||
147367467|NCT02446600|531515550|FG002|Overall Study|Ineligible|4|||
147367468|NCT02446600|531515551|FG003|Overall Study|Ineligible|1|||
147367469|NCT02446600|531515548|FG000|Overall Study|Duplicate Enrollment|0|||
147367470|NCT02446600|531515549|FG001|Overall Study|Duplicate Enrollment|1|||
147367471|NCT02446600|531515550|FG002|Overall Study|Duplicate Enrollment|0|||
147367472|NCT02446600|531515551|FG003|Overall Study|Duplicate Enrollment|0|||
147454345|NCT01790503|531825581|FG009|Overall Study|Non Compliance|0|||
147454346|NCT01790503|531825582|FG010|Overall Study|Non Compliance|0|||
147454347|NCT01790503|531825572|FG000|Overall Study|Other|0|||
147454348|NCT01790503|531825573|FG001|Overall Study|Other|0|||
147454349|NCT01790503|531825574|FG002|Overall Study|Other|0|||
147454350|NCT01790503|531825575|FG003|Overall Study|Other|0|||
147454351|NCT01790503|531825576|FG004|Overall Study|Other|1|||
147454352|NCT01790503|531825577|FG005|Overall Study|Other|0|||
147454353|NCT01790503|531825578|FG006|Overall Study|Other|0|||
147454354|NCT01790503|531825579|FG007|Overall Study|Other|0|||
147454355|NCT01790503|531825580|FG008|Overall Study|Other|1|||
147454356|NCT01790503|531825581|FG009|Overall Study|Other|2|||
147454357|NCT01790503|531825582|FG010|Overall Study|Other|0|||
147454358|NCT00049673|531825583|FG000|Overall Study|No receive treatment/lost to follow-up|1|||
147454359|NCT00049673|531825584|FG001|Overall Study|No receive treatment/lost to follow-up|3|||
147609270|NCT02463357|532386227|FG003|Overall Study|Withdrawal by Subject|0|||
147609271|NCT02463357|532386228|FG004|Overall Study|Withdrawal by Subject|0|||
147609272|NCT02463357|532386224|FG000|Overall Study|Withdrawal by Subject|0|||
147609273|NCT02463357|532386225|FG001|Overall Study|Withdrawal by Subject|0|||
147609274|NCT02463357|532386226|FG002|Overall Study|Withdrawal by Subject|0|||
147609275|NCT02463357|532386227|FG003|Overall Study|Withdrawal by Subject|0|||
147609276|NCT02463357|532386228|FG004|Overall Study|Withdrawal by Subject|1|||
147609277|NCT01371539|532386231|FG000|Period One: One Week|Lost to Follow-up|0|||
147609278|NCT01371539|532386232|FG001|Period One: One Week|Lost to Follow-up|1|||
147609279|NCT01371539|532386231|FG000|Period Two: One Week|Lost to Follow-up|0|||
147609280|NCT01371539|532386232|FG001|Period Two: One Week|Lost to Follow-up|1|||
147299996|NCT03286751|531264574|FG000|Washout Period 2|Personal Reasons|0|||
147299997|NCT03286751|531264575|FG001|Washout Period 2|Personal Reasons|1|||
147299998|NCT03286751|531264576|FG002|Washout Period 2|Personal Reasons|0|||
147299999|NCT03286751|531264577|FG003|Washout Period 2|Personal Reasons|0|||
147300000|NCT03286751|531264578|FG004|Washout Period 2|Personal Reasons|0|||
147300001|NCT03286751|531264579|FG005|Washout Period 2|Personal Reasons|0|||
147300002|NCT03286751|531264574|FG000|Washout Period 5|Adverse Event|0|||
147300003|NCT03286751|531264575|FG001|Washout Period 5|Adverse Event|0|||
147300004|NCT03286751|531264576|FG002|Washout Period 5|Adverse Event|0|||
147300005|NCT03286751|531264577|FG003|Washout Period 5|Adverse Event|0|||
147300006|NCT03286751|531264578|FG004|Washout Period 5|Adverse Event|1|||
147300007|NCT03286751|531264579|FG005|Washout Period 5|Adverse Event|0|||
147300008|NCT01119768|531264580|FG000|Treatment Period|Lack of Efficacy|18|||
147300009|NCT01119768|531264581|FG001|Treatment Period|Lack of Efficacy|25|||
147300010|NCT01059643|531264582|FG000|Overall Study|Adverse Event|3|||
147300011|NCT01059643|531264582|FG000|Overall Study|Withdrawal by Subject|2|||
147300012|NCT01059643|531264582|FG000|Overall Study|Physician Decision|1|||
147300013|NCT01820559|531264583|FG000|Overall Study|Adverse Event|4|||
147300014|NCT01820559|531264584|FG001|Overall Study|Adverse Event|6|||
147300015|NCT01820559|531264585|FG002|Overall Study|Adverse Event|13|||
147300016|NCT01820559|531264583|FG000|Overall Study|Withdrawal by Subject|1|||
147300017|NCT01820559|531264584|FG001|Overall Study|Withdrawal by Subject|2|||
147300018|NCT01820559|531264585|FG002|Overall Study|Withdrawal by Subject|5|||
147300019|NCT01820559|531264583|FG000|Overall Study|Protocol Violation|2|||
147300020|NCT01820559|531264584|FG001|Overall Study|Protocol Violation|1|||
147300021|NCT01820559|531264585|FG002|Overall Study|Protocol Violation|3|||
147300022|NCT01820559|531264583|FG000|Overall Study|Subject's non-compliance|1|||
147300023|NCT01820559|531264584|FG001|Overall Study|Subject's non-compliance|0|||
147300024|NCT01820559|531264585|FG002|Overall Study|Subject's non-compliance|2|||
147300025|NCT01820559|531264583|FG000|Overall Study|Lost to Follow-up|3|||
147300026|NCT01820559|531264584|FG001|Overall Study|Lost to Follow-up|2|||
147300027|NCT01820559|531264585|FG002|Overall Study|Lost to Follow-up|2|||
147300028|NCT01820559|531264583|FG000|Overall Study|At sponsor request|0|||
147300029|NCT01820559|531264584|FG001|Overall Study|At sponsor request|0|||
147300030|NCT01820559|531264585|FG002|Overall Study|At sponsor request|1|||
147300031|NCT01820559|531264583|FG000|Overall Study|Lack of Efficacy|3|||
147300032|NCT01820559|531264584|FG001|Overall Study|Lack of Efficacy|2|||
147300033|NCT01820559|531264585|FG002|Overall Study|Lack of Efficacy|3|||
147300034|NCT00166296|531264587|FG000|Overall Study|Withdrawal by Subject|1|||
147300035|NCT00166296|531264588|FG001|Overall Study|Withdrawal by Subject|3|||
147300036|NCT00166296|531264587|FG000|Overall Study|Adverse Event|2|||
147300037|NCT00166296|531264588|FG001|Overall Study|Adverse Event|4|||
147300038|NCT00166296|531264587|FG000|Overall Study|Lost to Follow-up|4|||
147300039|NCT00166296|531264588|FG001|Overall Study|Lost to Follow-up|2|||
147300040|NCT04035200|531264594|FG000|Overall Study|Lost to Follow-up|0|||
147300041|NCT04035200|531264595|FG001|Overall Study|Lost to Follow-up|1|||
147300042|NCT04035200|531264596|FG002|Overall Study|Lost to Follow-up|0|||
147300043|NCT04035200|531264594|FG000|Overall Study|Withdrawal by Subject|1|||
147300044|NCT04035200|531264595|FG001|Overall Study|Withdrawal by Subject|4|||
147300045|NCT04035200|531264596|FG002|Overall Study|Withdrawal by Subject|4|||
147300046|NCT04035200|531264594|FG000|Overall Study|COVID-19|1|||
147300047|NCT04035200|531264595|FG001|Overall Study|COVID-19|0|||
147367559|NCT02466971|531517169|FG000|Overall Study|eligible and never treated|14|||
147367560|NCT02466971|531517170|FG001|Overall Study|eligible and never treated|20|||
147367561|NCT02466971|531517169|FG000|Overall Study|too early for evaluation of treatment and toxicity|3|||
147367562|NCT02466971|531517170|FG001|Overall Study|too early for evaluation of treatment and toxicity|2|||
147367563|NCT02466971|531517169|FG000|Overall Study|ineligible and treated|1|||
147367564|NCT02466971|531517170|FG001|Overall Study|ineligible and treated|0|||
147367565|NCT02466971|531517169|FG000|Overall Study|ineligible and never treated|0|||
147367566|NCT02466971|531517170|FG001|Overall Study|ineligible and never treated|1|||
147609281|NCT01371539|532386231|FG000|Period Two: One Week|Unacceptable Objective Visual Acuity|0|||
147609282|NCT01371539|532386232|FG001|Period Two: One Week|Unacceptable Objective Visual Acuity|1|||
147609283|NCT01371539|532386231|FG000|Period Two: One Week|Time/job conflict|0|||
147609284|NCT01371539|532386232|FG001|Period Two: One Week|Time/job conflict|1|||
147609285|NCT01399658|532386233|FG000|Overall Study|Ineligible|1|||
147609286|NCT01399658|532386233|FG000|Overall Study|Machine Technical Issue|3|||
147609287|NCT01399658|532386233|FG000|Overall Study|Alternative therapy|1|||
147609288|NCT01399658|532386233|FG000|Overall Study|No reason given|1|||
147609289|NCT02620579|532386234|FG000|Overall Study|Physician Decision|0|||
147662898|NCT01548599|532589114|FG001|Overall Study|Death|1|||
147609290|NCT02620579|532386235|FG001|Overall Study|Physician Decision|0|||
147609291|NCT02620579|532386236|FG002|Overall Study|Physician Decision|0|||
147454360|NCT01535729|531825585|FG000|Overall Study|Withdrawal by Subject|2|||
147609292|NCT02620579|532386237|FG003|Overall Study|Physician Decision|1|||
147454361|NCT01535729|531825585|FG000|Overall Study|Disease progression|230|||
147454362|NCT01535729|531825585|FG000|Overall Study|Discontinued treatment|25|||
147609293|NCT02620579|532386234|FG000|Overall Study|Withdrawal by Subject|0|||
147609294|NCT02620579|532386235|FG001|Overall Study|Withdrawal by Subject|1|||
147609295|NCT02620579|532386236|FG002|Overall Study|Withdrawal by Subject|1|||
147609296|NCT02620579|532386237|FG003|Overall Study|Withdrawal by Subject|0|||
147609297|NCT00796107|532386243|FG000|Overall Study|Lack of Efficacy|1|||
147609298|NCT00796107|532386243|FG000|Overall Study|Progressive Disease|5|||
147609299|NCT02681510|532386244|FG000|Overall Study|Withdrawal by Subject|1|||
147609300|NCT02681510|532386244|FG000|Overall Study|Lost to Follow-up|9|||
147454363|NCT01535729|531825585|FG000|Overall Study|Lost to Follow-up|8|||
147454364|NCT01535729|531825585|FG000|Overall Study|Death|52|||
147609301|NCT01721317|532386246|FG000|Overall Study|Study Closed / Terminated|2|||
147454365|NCT01535729|531825585|FG000|Overall Study|Other|19|||
147454366|NCT01535729|531825585|FG000|Overall Study|Did not sign informed consent|1|||
147454367|NCT01535729|531825585|FG000|Overall Study|No previous chemotherapy|33|||
147454368|NCT01535729|531825585|FG000|Overall Study|NSCLC grade IV histology not confirmed|20|||
147454369|NCT01535729|531825585|FG000|Overall Study|Protocol Violation|11|||
147454370|NCT01535729|531825585|FG000|Overall Study|Screening failure|1|||
147454371|NCT01535729|531825585|FG000|Overall Study|Not treated|9|||
147454372|NCT01535729|531825585|FG000|Overall Study|No participant record available|5|||
147454373|NCT00494091|531825588|FG000|Overall Study|Death|5|||
147454374|NCT00494091|531825589|FG001|Overall Study|Death|54|||
147454375|NCT00494091|531825588|FG000|Overall Study|Lost to Follow-up|0|||
147454376|NCT00494091|531825589|FG001|Overall Study|Lost to Follow-up|4|||
147454377|NCT00494091|531825588|FG000|Overall Study|Other|1|||
147454378|NCT00494091|531825589|FG001|Overall Study|Other|11|||
147454379|NCT00494091|531825588|FG000|Overall Study|Withdrawal by Subject|0|||
147609302|NCT01721317|532386247|FG001|Overall Study|Study Closed / Terminated|2|||
147609303|NCT01721317|532386246|FG000|Overall Study|Physician Decision|0|||
147609304|NCT01721317|532386247|FG001|Overall Study|Physician Decision|1|||
147609305|NCT01721317|532386246|FG000|Overall Study|Withdrawal by Subject|0|||
147454380|NCT00494091|531825589|FG001|Overall Study|Withdrawal by Subject|7|||
147454381|NCT04161131|531825590|FG000|Overall Study|Ineligible|2|||
147454382|NCT04161131|531825590|FG000|Overall Study|Lost to Follow-up|4|||
147454383|NCT00984204|531825594|FG000|Overall Study|Death|1|||
147609306|NCT01721317|532386247|FG001|Overall Study|Withdrawal by Subject|1|||
147454384|NCT00984204|531825594|FG000|Overall Study|Lost to Follow-up|4|||
147454385|NCT00984204|531825594|FG000|Overall Study|Lack of Efficacy|10|||
147609307|NCT00378573|532386256|FG000|Treatment Period|Adverse Event|9|||
147609308|NCT00378573|532386256|FG000|Treatment Period|Physician Decision|1|||
147609309|NCT00378573|532386256|FG000|Treatment Period|Withdrawal by Subject|2|||
147609310|NCT00378573|532386256|FG000|Treatment Period|Disease Progression|4|||
147609311|NCT00378573|532386256|FG000|Treatment Period|Sponsor decision to close study|1|||
147609312|NCT00378573|532386256|FG000|Follow-up|Death|12|||
147609313|NCT00378573|532386256|FG000|Follow-up|Lost to Follow-up|1|||
147609314|NCT00378573|532386256|FG000|Follow-up|Withdrawal by Subject|1|||
147609315|NCT02806024|532386257|FG000|Overall Study|Night Delivery|1|||
147609316|NCT02806024|532386258|FG001|Overall Study|Night Delivery|1|||
147609317|NCT02806024|532386257|FG000|Overall Study|DVT during antepartum admission|0|||
147609318|NCT02806024|532386258|FG001|Overall Study|DVT during antepartum admission|1|||
147609319|NCT03837743|532386266|FG000|Overall Study|Adverse Event|1|||
147609320|NCT03837743|532386266|FG000|Overall Study|Withdrawal by Subject|2|||
147609321|NCT00252239|532386267|FG000|Overall Study|Withdrawal by Subject|1|||
147609322|NCT00252239|532386268|FG001|Overall Study|Withdrawal by Subject|0|||
147609323|NCT00252239|532386269|FG002|Overall Study|Withdrawal by Subject|0|||
147609324|NCT00252239|532386270|FG003|Overall Study|Withdrawal by Subject|1|||
147609325|NCT00252239|532386267|FG000|Overall Study|Lost to Follow-up|0|||
147609326|NCT00252239|532386268|FG001|Overall Study|Lost to Follow-up|0|||
147609327|NCT00252239|532386269|FG002|Overall Study|Lost to Follow-up|2|||
147609328|NCT00252239|532386270|FG003|Overall Study|Lost to Follow-up|0|||
147609329|NCT02257385|532386272|FG000|Overall Study|Adverse Event|12|||
147609330|NCT02257385|532386273|FG001|Overall Study|Adverse Event|8|||
147609331|NCT02257385|532386272|FG000|Overall Study|Lack of Efficacy|1|||
147609332|NCT02257385|532386273|FG001|Overall Study|Lack of Efficacy|2|||
147609333|NCT02257385|532386272|FG000|Overall Study|Protocol Violation|5|||
147609334|NCT02257385|532386273|FG001|Overall Study|Protocol Violation|7|||
147609335|NCT02257385|532386272|FG000|Overall Study|Lost to Follow-up|0|||
147609336|NCT02257385|532386273|FG001|Overall Study|Lost to Follow-up|1|||
147609337|NCT02257385|532386272|FG000|Overall Study|Withdrawal by Subject|4|||
147609338|NCT02257385|532386273|FG001|Overall Study|Withdrawal by Subject|4|||
147609339|NCT01822366|532386280|FG000|Overall Study|Lost to Follow-up|5|||
147454386|NCT02479802|531825603|FG000|Overall Study|Lost to Follow-up|1|||
147454387|NCT02479802|531825603|FG000|Overall Study|Adverse Event|1|||
147609340|NCT01822366|532386281|FG001|Overall Study|Lost to Follow-up|1|||
147609341|NCT01822366|532386282|FG002|Overall Study|Lost to Follow-up|5|||
147609342|NCT01822366|532386283|FG003|Overall Study|Lost to Follow-up|1|||
147609343|NCT01822366|532386280|FG000|Overall Study|Withdrawal by Subject|0|||
147609344|NCT01822366|532386281|FG001|Overall Study|Withdrawal by Subject|6|||
147609345|NCT01822366|532386282|FG002|Overall Study|Withdrawal by Subject|0|||
147454388|NCT03757988|531825604|FG000|Overall Study|Withdrawal by Subject|1|||
147454389|NCT03806127|531825605|FG000|Overall Study|Withdrawal by Subject|4|||
147454390|NCT03806127|531825606|FG001|Overall Study|Withdrawal by Subject|5|||
147454391|NCT03806127|531825605|FG000|Overall Study|Protocol Violation|3|||
147454392|NCT03806127|531825606|FG001|Overall Study|Protocol Violation|1|||
147454393|NCT03806127|531825605|FG000|Overall Study|Adverse Event|3|||
147454394|NCT03806127|531825606|FG001|Overall Study|Adverse Event|0|||
147454395|NCT03806127|531825605|FG000|Overall Study|Unable to Complete Procedures|0|||
147454396|NCT03806127|531825606|FG001|Overall Study|Unable to Complete Procedures|1|||
147454397|NCT03806127|531825605|FG000|Overall Study|Pregnancy|0|||
147454398|NCT03806127|531825606|FG001|Overall Study|Pregnancy|1|||
147454399|NCT03806127|531825605|FG000|Overall Study|Lost to Follow-up|5|||
147454400|NCT03806127|531825606|FG001|Overall Study|Lost to Follow-up|1|||
147454401|NCT03806127|531825605|FG000|Overall Study|Physician Decision|1|||
147454402|NCT03806127|531825606|FG001|Overall Study|Physician Decision|1|||
147454403|NCT03806127|531825605|FG000|Overall Study|Could Not Come Due to Covid|1|||
147454404|NCT03806127|531825606|FG001|Overall Study|Could Not Come Due to Covid|0|||
147662899|NCT02188160|532589115|FG000|Overall Study|Adverse Event|1|||
147662900|NCT02188160|532589116|FG001|Overall Study|Adverse Event|0|||
147662901|NCT02188160|532589115|FG000|Overall Study|Use of an excluded medication|0|||
147662902|NCT02188160|532589116|FG001|Overall Study|Use of an excluded medication|1|||
147662903|NCT04113694|532589117|FG000|Overall Study|Adverse Event|2|||
147662904|NCT04113694|532589117|FG000|Overall Study|Lost to Follow-up|2|||
147662905|NCT04113694|532589117|FG000|Overall Study|Withdrawal by Subject|6|||
147662906|NCT04113694|532589117|FG000|Overall Study|Withdrawal due to not meeting inclusion and exclusion criteria|1|||
147662907|NCT00916578|532589120|FG000|Overall Study|Physician Decision|2|||
147662908|NCT00916578|532589120|FG000|Overall Study|Withdrawal by Subject|3|||
147662909|NCT00916578|532589120|FG000|Overall Study|Insurance Denial|2|||
147662910|NCT00754741|532589121|FG000|Overall Study|Died or disenrolled|57|||
147662911|NCT00754741|532589122|FG001|Overall Study|Died or disenrolled|69|||
147662912|NCT00754741|532589123|FG002|Overall Study|Died or disenrolled|54|||
147662913|NCT04152200|532589125|FG000|Long-term Extension Period|Entered Long-term Extension Period after completion of the Primary Analysis Period|6|||
147662914|NCT04152200|532589126|FG001|Long-term Extension Period|Entered Long-term Extension Period after completion of the Primary Analysis Period|15|||
147662915|NCT04969289|532589127|FG000|Overall Study|Lost to Follow-up|13|||
147662916|NCT04969289|532589128|FG001|Overall Study|Lost to Follow-up|9|||
147609346|NCT01822366|532386283|FG003|Overall Study|Withdrawal by Subject|6|||
147609347|NCT01822366|532386280|FG000|Overall Study|Partial Intervention Completion|0|||
147609348|NCT01822366|532386281|FG001|Overall Study|Partial Intervention Completion|15|||
147609349|NCT01822366|532386282|FG002|Overall Study|Partial Intervention Completion|0|||
147609350|NCT01822366|532386283|FG003|Overall Study|Partial Intervention Completion|15|||
147609351|NCT00384930|532386286|FG000|Overall Study|Adverse Event|5|||
147609352|NCT00384930|532386287|FG001|Overall Study|Adverse Event|4|||
147609353|NCT00384930|532386288|FG002|Overall Study|Adverse Event|12|||
147609354|NCT00384930|532386289|FG003|Overall Study|Adverse Event|11|||
147609355|NCT00384930|532386290|FG004|Overall Study|Adverse Event|14|||
147609356|NCT00384930|532386286|FG000|Overall Study|Entry Criteria Not Met|2|||
147609357|NCT00384930|532386287|FG001|Overall Study|Entry Criteria Not Met|6|||
147609358|NCT00384930|532386288|FG002|Overall Study|Entry Criteria Not Met|7|||
147609359|NCT00384930|532386289|FG003|Overall Study|Entry Criteria Not Met|8|||
147609360|NCT00384930|532386290|FG004|Overall Study|Entry Criteria Not Met|4|||
147609361|NCT00384930|532386286|FG000|Overall Study|Lack of Efficacy|1|||
147609362|NCT00384930|532386287|FG001|Overall Study|Lack of Efficacy|1|||
147609363|NCT00384930|532386288|FG002|Overall Study|Lack of Efficacy|2|||
147609364|NCT00384930|532386289|FG003|Overall Study|Lack of Efficacy|1|||
147609365|NCT00384930|532386290|FG004|Overall Study|Lack of Efficacy|2|||
147609366|NCT00384930|532386286|FG000|Overall Study|Lost to Follow-up|5|||
147609367|NCT00384930|532386287|FG001|Overall Study|Lost to Follow-up|3|||
147609368|NCT00384930|532386288|FG002|Overall Study|Lost to Follow-up|0|||
147609369|NCT00384930|532386289|FG003|Overall Study|Lost to Follow-up|4|||
147609370|NCT00384930|532386290|FG004|Overall Study|Lost to Follow-up|6|||
147609371|NCT00384930|532386286|FG000|Overall Study|Physician Decision|0|||
147609372|NCT00384930|532386287|FG001|Overall Study|Physician Decision|1|||
147662917|NCT00593814|532589129|FG000|Overall Study|Death|7|||
147609373|NCT00384930|532386288|FG002|Overall Study|Physician Decision|1|||
147609374|NCT00384930|532386289|FG003|Overall Study|Physician Decision|0|||
147609375|NCT00384930|532386290|FG004|Overall Study|Physician Decision|1|||
147609376|NCT00384930|532386286|FG000|Overall Study|Protocol Violation|1|||
147609377|NCT00384930|532386287|FG001|Overall Study|Protocol Violation|0|||
147609378|NCT00384930|532386288|FG002|Overall Study|Protocol Violation|1|||
147662918|NCT00593814|532589130|FG001|Overall Study|Death|0|||
147662919|NCT00593814|532589129|FG000|Overall Study|Withdrawal by Subject|7|||
147662920|NCT00593814|532589130|FG001|Overall Study|Withdrawal by Subject|0|||
147662921|NCT00593814|532589129|FG000|Overall Study|Lost to Follow-up|7|||
147662922|NCT00593814|532589130|FG001|Overall Study|Lost to Follow-up|0|||
147662923|NCT00593814|532589129|FG000|Overall Study|Physician Decision|3|||
147662924|NCT00593814|532589130|FG001|Overall Study|Physician Decision|0|||
147662925|NCT02699996|532589131|FG000|Overall Study|Withdrawal by Subject|5|||
147662926|NCT02699996|532589132|FG001|Overall Study|Withdrawal by Subject|2|||
147662927|NCT01921517|532589133|FG000|Overall Study|Lost to Follow-up|5|||
147662928|NCT01921517|532589134|FG001|Overall Study|Lost to Follow-up|0|||
147662929|NCT01921517|532589133|FG000|Overall Study|Newly diagnosed health concern|2|||
147662930|NCT01921517|532589134|FG001|Overall Study|Newly diagnosed health concern|0|||
147662931|NCT01921517|532589133|FG000|Overall Study|Physician Decision|0|||
147662932|NCT01921517|532589134|FG001|Overall Study|Physician Decision|2|||
147662933|NCT01921517|532589133|FG000|Overall Study|Withdrawal by Subject|7|||
147662934|NCT01921517|532589134|FG001|Overall Study|Withdrawal by Subject|3|||
147662935|NCT01921517|532589133|FG000|Overall Study|Subject missed final imaging|1|||
147662936|NCT01921517|532589134|FG001|Overall Study|Subject missed final imaging|4|||
147662937|NCT01307787|532589136|FG000|Overall Study|Withdrawal by Subject|2|||
147662938|NCT01307787|532589137|FG001|Overall Study|Withdrawal by Subject|0|||
147662939|NCT01294423|532589138|FG000|Overall Study|Adverse Event|1|||
147662940|NCT01294423|532589139|FG001|Overall Study|Adverse Event|2|||
147662941|NCT01294423|532589140|FG002|Overall Study|Adverse Event|3|||
147662942|NCT01294423|532589138|FG000|Overall Study|Withdrawal by Subject|1|||
147662943|NCT01294423|532589139|FG001|Overall Study|Withdrawal by Subject|2|||
147662944|NCT01294423|532589140|FG002|Overall Study|Withdrawal by Subject|2|||
147662945|NCT01294423|532589138|FG000|Overall Study|subject no longer meets study criteria|2|||
147662946|NCT01294423|532589139|FG001|Overall Study|subject no longer meets study criteria|5|||
147662947|NCT01294423|532589140|FG002|Overall Study|subject no longer meets study criteria|2|||
147662948|NCT01294423|532589138|FG000|Overall Study|poor/non-compliance|1|||
147662949|NCT01294423|532589139|FG001|Overall Study|poor/non-compliance|0|||
147662950|NCT01294423|532589140|FG002|Overall Study|poor/non-compliance|1|||
147662951|NCT01405560|532589143|FG000|Overall Study|Physician Decision|1|||
147662952|NCT01699750|532589144|FG000|Overall Study|Withdrew Consent|0|||
147662953|NCT01699750|532589145|FG001|Overall Study|Withdrew Consent|1|||
147662954|NCT01699750|532589144|FG000|Overall Study|Other|0|||
147662955|NCT01699750|532589145|FG001|Overall Study|Other|2|||
147662956|NCT01484951|532589146|FG000|Overall Study|Adverse Event|3|||
147662957|NCT01484951|532589146|FG000|Overall Study|Personal Reasons|1|||
147662958|NCT01484951|532589146|FG000|Overall Study|Non-Compliance|1|||
147662959|NCT01831427|532589148|FG000|Overall Study|Adverse Event|0|||
147662960|NCT01831427|532589149|FG001|Overall Study|Adverse Event|1|||
147662961|NCT01831427|532589150|FG002|Overall Study|Adverse Event|0|||
147662962|NCT01831427|532589151|FG003|Overall Study|Adverse Event|0|||
147662963|NCT01831427|532589152|FG004|Overall Study|Adverse Event|0|||
147662964|NCT01831427|532589153|FG005|Overall Study|Adverse Event|1|||
147368054|NCT02101853|531517268|FG000|Block 1 Induction|Adverse Event|11|||
147368055|NCT02101853|531517269|FG001|Block 1 Induction|Adverse Event|0|||
147368056|NCT02101853|531517270|FG002|Block 1 Induction|Adverse Event|0|||
147368057|NCT02101853|531517271|FG003|Block 1 Induction|Adverse Event|0|||
147368058|NCT02101853|531517272|FG004|Block 1 Induction|Adverse Event|0|||
147662965|NCT01831427|532589154|FG006|Overall Study|Adverse Event|0|||
147662966|NCT01831427|532589155|FG007|Overall Study|Adverse Event|1|||
147662967|NCT01831427|532589156|FG008|Overall Study|Adverse Event|0|||
147662968|NCT01831427|532589157|FG009|Overall Study|Adverse Event|0|||
147368059|NCT02101853|531517273|FG005|Block 1 Induction|Adverse Event|0|||
147368060|NCT02101853|531517268|FG000|Block 1 Induction|Death|20|||
147368061|NCT02101853|531517269|FG001|Block 1 Induction|Death|0|||
147368062|NCT02101853|531517270|FG002|Block 1 Induction|Death|0|||
147368063|NCT02101853|531517271|FG003|Block 1 Induction|Death|0|||
147454405|NCT03806127|531825605|FG000|Overall Study|Prescribed Exclusionary Medication (Med)|1|||
147662969|NCT01831427|532589158|FG010|Overall Study|Adverse Event|2|||
147662970|NCT01831427|532589148|FG000|Overall Study|Investigator's Discretion|0|||
147662971|NCT01831427|532589149|FG001|Overall Study|Investigator's Discretion|0|||
147662972|NCT01831427|532589150|FG002|Overall Study|Investigator's Discretion|0|||
147662973|NCT01831427|532589151|FG003|Overall Study|Investigator's Discretion|1|||
147662974|NCT01831427|532589152|FG004|Overall Study|Investigator's Discretion|0|||
147662975|NCT01831427|532589153|FG005|Overall Study|Investigator's Discretion|0|||
147368064|NCT02101853|531517272|FG004|Block 1 Induction|Death|0|||
147662976|NCT01831427|532589154|FG006|Overall Study|Investigator's Discretion|0|||
147662977|NCT01831427|532589155|FG007|Overall Study|Investigator's Discretion|0|||
147368065|NCT02101853|531517273|FG005|Block 1 Induction|Death|0|||
147368066|NCT02101853|531517268|FG000|Block 1 Induction|Lack of Efficacy|6|||
147368067|NCT02101853|531517269|FG001|Block 1 Induction|Lack of Efficacy|0|||
147368068|NCT02101853|531517270|FG002|Block 1 Induction|Lack of Efficacy|0|||
147368069|NCT02101853|531517271|FG003|Block 1 Induction|Lack of Efficacy|0|||
147368070|NCT02101853|531517272|FG004|Block 1 Induction|Lack of Efficacy|0|||
147368071|NCT02101853|531517273|FG005|Block 1 Induction|Lack of Efficacy|0|||
147368072|NCT02101853|531517268|FG000|Block 1 Induction|Physician Decision|61|||
147368073|NCT02101853|531517269|FG001|Block 1 Induction|Physician Decision|0|||
147368074|NCT02101853|531517270|FG002|Block 1 Induction|Physician Decision|0|||
147368075|NCT02101853|531517271|FG003|Block 1 Induction|Physician Decision|0|||
147368076|NCT02101853|531517272|FG004|Block 1 Induction|Physician Decision|0|||
147368077|NCT02101853|531517273|FG005|Block 1 Induction|Physician Decision|0|||
147368078|NCT02101853|531517268|FG000|Block 1 Induction|Protocol Violation|2|||
147368079|NCT02101853|531517269|FG001|Block 1 Induction|Protocol Violation|0|||
147368080|NCT02101853|531517270|FG002|Block 1 Induction|Protocol Violation|0|||
147368081|NCT02101853|531517271|FG003|Block 1 Induction|Protocol Violation|0|||
147368082|NCT02101853|531517272|FG004|Block 1 Induction|Protocol Violation|0|||
147368083|NCT02101853|531517273|FG005|Block 1 Induction|Protocol Violation|0|||
147368084|NCT02101853|531517268|FG000|Block 1 Induction|Withdrawal by Subject|65|||
147368085|NCT02101853|531517269|FG001|Block 1 Induction|Withdrawal by Subject|0|||
147368086|NCT02101853|531517270|FG002|Block 1 Induction|Withdrawal by Subject|0|||
147368087|NCT02101853|531517271|FG003|Block 1 Induction|Withdrawal by Subject|0|||
147368088|NCT02101853|531517272|FG004|Block 1 Induction|Withdrawal by Subject|0|||
147368089|NCT02101853|531517273|FG005|Block 1 Induction|Withdrawal by Subject|0|||
147368090|NCT02101853|531517268|FG000|Block 1 Induction|Ineligible|8|||
147368091|NCT02101853|531517269|FG001|Block 1 Induction|Ineligible|0|||
147368092|NCT02101853|531517270|FG002|Block 1 Induction|Ineligible|0|||
147368093|NCT02101853|531517271|FG003|Block 1 Induction|Ineligible|0|||
147368094|NCT02101853|531517272|FG004|Block 1 Induction|Ineligible|0|||
147368095|NCT02101853|531517273|FG005|Block 1 Induction|Ineligible|0|||
147368096|NCT02101853|531517268|FG000|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|1|||
147368097|NCT02101853|531517269|FG001|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|0|||
147368098|NCT02101853|531517270|FG002|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|0|||
147368099|NCT02101853|531517271|FG003|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|0|||
147368100|NCT02101853|531517272|FG004|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|0|||
147368101|NCT02101853|531517273|FG005|Block 1 Induction|Development of significant central nervous system pathology pre-randomization|0|||
147368102|NCT02101853|531517268|FG000|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|1|||
147368103|NCT02101853|531517269|FG001|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|0|||
147368104|NCT02101853|531517270|FG002|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|0|||
147368105|NCT02101853|531517271|FG003|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|0|||
147368106|NCT02101853|531517272|FG004|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|0|||
147368107|NCT02101853|531517273|FG005|Block 1 Induction|Repeat eligibility studies are outside the parameters required for eligibility|0|||
147368108|NCT02101853|531517268|FG000|Post Induction Randomization|Adverse Event|0|||
147368109|NCT02101853|531517269|FG001|Post Induction Randomization|Adverse Event|3|||
147368110|NCT02101853|531517270|FG002|Post Induction Randomization|Adverse Event|8|||
147368111|NCT02101853|531517271|FG003|Post Induction Randomization|Adverse Event|4|||
147368112|NCT02101853|531517272|FG004|Post Induction Randomization|Adverse Event|4|||
147368113|NCT02101853|531517273|FG005|Post Induction Randomization|Adverse Event|0|||
147368114|NCT02101853|531517268|FG000|Post Induction Randomization|Death|0|||
147368115|NCT02101853|531517269|FG001|Post Induction Randomization|Death|9|||
147368116|NCT02101853|531517270|FG002|Post Induction Randomization|Death|2|||
147368117|NCT02101853|531517271|FG003|Post Induction Randomization|Death|2|||
147368118|NCT02101853|531517272|FG004|Post Induction Randomization|Death|0|||
147368119|NCT02101853|531517273|FG005|Post Induction Randomization|Death|0|||
147368120|NCT02101853|531517268|FG000|Post Induction Randomization|Lack of Efficacy|0|||
147368121|NCT02101853|531517269|FG001|Post Induction Randomization|Lack of Efficacy|14|||
147368122|NCT02101853|531517270|FG002|Post Induction Randomization|Lack of Efficacy|23|||
147368123|NCT02101853|531517271|FG003|Post Induction Randomization|Lack of Efficacy|18|||
147368124|NCT02101853|531517272|FG004|Post Induction Randomization|Lack of Efficacy|21|||
147368125|NCT02101853|531517273|FG005|Post Induction Randomization|Lack of Efficacy|0|||
147368126|NCT02101853|531517268|FG000|Post Induction Randomization|Physician Decision|0|||
147368127|NCT02101853|531517269|FG001|Post Induction Randomization|Physician Decision|43|||
147368128|NCT02101853|531517270|FG002|Post Induction Randomization|Physician Decision|23|||
147368129|NCT02101853|531517271|FG003|Post Induction Randomization|Physician Decision|14|||
147368130|NCT02101853|531517272|FG004|Post Induction Randomization|Physician Decision|14|||
147368131|NCT02101853|531517273|FG005|Post Induction Randomization|Physician Decision|0|||
147368132|NCT02101853|531517268|FG000|Post Induction Randomization|Protocol Violation|0|||
147454406|NCT03806127|531825606|FG001|Overall Study|Prescribed Exclusionary Medication (Med)|0|||
147454407|NCT03806127|531825605|FG000|Overall Study|Ran Out of Study Meds (Covid Quarantine)|1|||
147454408|NCT03806127|531825606|FG001|Overall Study|Ran Out of Study Meds (Covid Quarantine)|0|||
147454409|NCT03806127|531825605|FG000|Overall Study|Covid 19 Restrictions|2|||
147454410|NCT03806127|531825606|FG001|Overall Study|Covid 19 Restrictions|0|||
147454411|NCT03806127|531825605|FG000|Overall Study|Withdrawn Due to Work/School Schedule|0|||
147454412|NCT03806127|531825606|FG001|Overall Study|Withdrawn Due to Work/School Schedule|1|||
147454413|NCT03806127|531825605|FG000|Overall Study|Covid 19 Concern; Possible Site Closure|0|||
147454414|NCT03806127|531825606|FG001|Overall Study|Covid 19 Concern; Possible Site Closure|1|||
147454415|NCT01100944|531825607|FG000|Dose Escalation Phase 1 Dose Level 1|Adverse Event|2|||
147454416|NCT01100944|531825608|FG001|Dose Escalation Phase 1 Dose Level 1|Adverse Event|0|||
147454417|NCT01100944|531825609|FG002|Dose Escalation Phase 1 Dose Level 1|Adverse Event|0|||
147454418|NCT01100944|531825607|FG000|Dose Escalation Phase 1 Dose Level 1|Discontinued due to treatment delay|1|||
147454419|NCT01100944|531825608|FG001|Dose Escalation Phase 1 Dose Level 1|Discontinued due to treatment delay|0|||
147454420|NCT01100944|531825609|FG002|Dose Escalation Phase 1 Dose Level 1|Discontinued due to treatment delay|0|||
147454421|NCT01100944|531825607|FG000|Dose Escalation Phase 1 Dose Level 1|Progressive Disease|1|||
147454422|NCT01100944|531825608|FG001|Dose Escalation Phase 1 Dose Level 1|Progressive Disease|0|||
147454423|NCT01100944|531825609|FG002|Dose Escalation Phase 1 Dose Level 1|Progressive Disease|0|||
147454424|NCT01100944|531825607|FG000|Dose Escalation Phase 1 Dose Level 2|Adverse Event|0|||
147454425|NCT01100944|531825608|FG001|Dose Escalation Phase 1 Dose Level 2|Adverse Event|2|||
147454426|NCT01100944|531825609|FG002|Dose Escalation Phase 1 Dose Level 2|Adverse Event|0|||
147454427|NCT00577993|531825610|FG000|Overall Study|Adverse Event|1|||
147454428|NCT00577993|531825611|FG001|Overall Study|Adverse Event|0|||
147454429|NCT00577993|531825612|FG002|Overall Study|Adverse Event|0|||
147454430|NCT00577993|531825610|FG000|Overall Study|Death|0|||
147454431|NCT00577993|531825611|FG001|Overall Study|Death|1|||
147454432|NCT00577993|531825612|FG002|Overall Study|Death|1|||
147454433|NCT00577993|531825610|FG000|Overall Study|Lack of Efficacy|0|||
147454434|NCT00577993|531825611|FG001|Overall Study|Lack of Efficacy|1|||
147454435|NCT00577993|531825612|FG002|Overall Study|Lack of Efficacy|0|||
147454436|NCT00577993|531825610|FG000|Overall Study|Protocol Violation|2|||
147454437|NCT00577993|531825611|FG001|Overall Study|Protocol Violation|3|||
147454438|NCT00577993|531825612|FG002|Overall Study|Protocol Violation|0|||
147454439|NCT00577993|531825610|FG000|Overall Study|Withdrawal by Subject|1|||
147609379|NCT00384930|532386289|FG003|Overall Study|Protocol Violation|6|||
147609380|NCT00384930|532386290|FG004|Overall Study|Protocol Violation|4|||
147609381|NCT00384930|532386286|FG000|Overall Study|Sponsor Decision|3|||
147609382|NCT00384930|532386287|FG001|Overall Study|Sponsor Decision|4|||
147609383|NCT00384930|532386288|FG002|Overall Study|Sponsor Decision|0|||
147368133|NCT02101853|531517269|FG001|Post Induction Randomization|Protocol Violation|3|||
147368134|NCT02101853|531517270|FG002|Post Induction Randomization|Protocol Violation|0|||
147368135|NCT02101853|531517271|FG003|Post Induction Randomization|Protocol Violation|0|||
147368136|NCT02101853|531517272|FG004|Post Induction Randomization|Protocol Violation|0|||
147368137|NCT02101853|531517273|FG005|Post Induction Randomization|Protocol Violation|0|||
147368138|NCT02101853|531517268|FG000|Post Induction Randomization|Withdrawal by Subject|0|||
147368139|NCT02101853|531517269|FG001|Post Induction Randomization|Withdrawal by Subject|13|||
147368140|NCT02101853|531517270|FG002|Post Induction Randomization|Withdrawal by Subject|12|||
147368141|NCT02101853|531517271|FG003|Post Induction Randomization|Withdrawal by Subject|7|||
147368142|NCT02101853|531517272|FG004|Post Induction Randomization|Withdrawal by Subject|8|||
147368143|NCT02101853|531517273|FG005|Post Induction Randomization|Withdrawal by Subject|0|||
147368144|NCT02101853|531517268|FG000|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|0|||
147368145|NCT02101853|531517269|FG001|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|0|||
147368146|NCT02101853|531517270|FG002|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|0|||
147368147|NCT02101853|531517271|FG003|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|1|||
147609384|NCT00384930|532386289|FG003|Overall Study|Sponsor Decision|5|||
147609385|NCT00384930|532386290|FG004|Overall Study|Sponsor Decision|0|||
147609386|NCT00384930|532386286|FG000|Overall Study|Withdrawal by Subject|9|||
147609387|NCT00384930|532386287|FG001|Overall Study|Withdrawal by Subject|7|||
147454440|NCT00577993|531825611|FG001|Overall Study|Withdrawal by Subject|0|||
147609388|NCT00384930|532386288|FG002|Overall Study|Withdrawal by Subject|7|||
147609389|NCT00384930|532386289|FG003|Overall Study|Withdrawal by Subject|6|||
147609390|NCT00384930|532386290|FG004|Overall Study|Withdrawal by Subject|16|||
147609391|NCT00384930|532386286|FG000|Overall Study|Didn't Receive Double-Blind Study Drug|1|||
147454441|NCT00577993|531825612|FG002|Overall Study|Withdrawal by Subject|2|||
147609392|NCT00384930|532386287|FG001|Overall Study|Didn't Receive Double-Blind Study Drug|1|||
147609393|NCT00384930|532386288|FG002|Overall Study|Didn't Receive Double-Blind Study Drug|0|||
147454442|NCT00577993|531825610|FG000|Overall Study|Conversion|2|||
147609394|NCT00384930|532386289|FG003|Overall Study|Didn't Receive Double-Blind Study Drug|0|||
147609395|NCT00384930|532386290|FG004|Overall Study|Didn't Receive Double-Blind Study Drug|0|||
147609396|NCT01449370|532386293|FG000|Overall Study|Disease Progression|5|||
147609397|NCT01449370|532386294|FG001|Overall Study|Disease Progression|4|||
147609398|NCT01449370|532386295|FG002|Overall Study|Disease Progression|8|||
147609399|NCT01449370|532386296|FG003|Overall Study|Disease Progression|3|||
147609400|NCT01449370|532386297|FG004|Overall Study|Disease Progression|3|||
147609401|NCT01449370|532386298|FG005|Overall Study|Disease Progression|3|||
147609402|NCT01449370|532386299|FG006|Overall Study|Disease Progression|3|||
147609403|NCT01449370|532386300|FG007|Overall Study|Disease Progression|2|||
147609404|NCT01449370|532386301|FG008|Overall Study|Disease Progression|9|||
147609405|NCT01449370|532386302|FG009|Overall Study|Disease Progression|1|||
147609406|NCT01449370|532386303|FG010|Overall Study|Disease Progression|3|||
147609407|NCT01449370|532386304|FG011|Overall Study|Disease Progression|3|||
147609408|NCT01449370|532386305|FG012|Overall Study|Disease Progression|2|||
147609409|NCT01449370|532386306|FG013|Overall Study|Disease Progression|8|||
147609410|NCT01449370|532386307|FG014|Overall Study|Disease Progression|3|||
147609411|NCT01449370|532386308|FG015|Overall Study|Disease Progression|1|||
147609412|NCT01449370|532386309|FG016|Overall Study|Disease Progression|4|||
147609413|NCT01449370|532386310|FG017|Overall Study|Disease Progression|3|||
147609414|NCT01449370|532386311|FG018|Overall Study|Disease Progression|1|||
147609415|NCT01449370|532386312|FG019|Overall Study|Disease Progression|2|||
147609416|NCT01449370|532386313|FG020|Overall Study|Disease Progression|5|||
147609417|NCT01449370|532386314|FG021|Overall Study|Disease Progression|2|||
147609418|NCT01449370|532386315|FG022|Overall Study|Disease Progression|3|||
147609419|NCT01449370|532386316|FG023|Overall Study|Disease Progression|7|||
147609420|NCT01449370|532386317|FG024|Overall Study|Disease Progression|3|||
147609421|NCT01449370|532386293|FG000|Overall Study|Adverse Event|1|||
147609422|NCT01449370|532386294|FG001|Overall Study|Adverse Event|2|||
147609423|NCT01449370|532386295|FG002|Overall Study|Adverse Event|0|||
147609424|NCT01449370|532386296|FG003|Overall Study|Adverse Event|1|||
147609425|NCT01449370|532386297|FG004|Overall Study|Adverse Event|0|||
147609426|NCT01449370|532386298|FG005|Overall Study|Adverse Event|0|||
147609427|NCT01449370|532386299|FG006|Overall Study|Adverse Event|0|||
147609428|NCT01449370|532386300|FG007|Overall Study|Adverse Event|0|||
147609429|NCT01449370|532386301|FG008|Overall Study|Adverse Event|1|||
147609430|NCT01449370|532386302|FG009|Overall Study|Adverse Event|1|||
147609431|NCT01449370|532386303|FG010|Overall Study|Adverse Event|0|||
147609432|NCT01449370|532386304|FG011|Overall Study|Adverse Event|0|||
147609433|NCT01449370|532386305|FG012|Overall Study|Adverse Event|0|||
147609434|NCT01449370|532386306|FG013|Overall Study|Adverse Event|2|||
147609435|NCT01449370|532386307|FG014|Overall Study|Adverse Event|0|||
147609436|NCT01449370|532386308|FG015|Overall Study|Adverse Event|1|||
147609437|NCT01449370|532386309|FG016|Overall Study|Adverse Event|0|||
147609438|NCT01449370|532386310|FG017|Overall Study|Adverse Event|0|||
147609439|NCT01449370|532386311|FG018|Overall Study|Adverse Event|1|||
147609440|NCT01449370|532386312|FG019|Overall Study|Adverse Event|1|||
147609441|NCT01449370|532386313|FG020|Overall Study|Adverse Event|0|||
147609442|NCT01449370|532386314|FG021|Overall Study|Adverse Event|1|||
147609443|NCT01449370|532386315|FG022|Overall Study|Adverse Event|0|||
147609444|NCT01449370|532386316|FG023|Overall Study|Adverse Event|1|||
147609445|NCT01449370|532386317|FG024|Overall Study|Adverse Event|3|||
147609446|NCT01449370|532386293|FG000|Overall Study|Participant Decision|0|||
147609447|NCT01449370|532386294|FG001|Overall Study|Participant Decision|0|||
147609448|NCT01449370|532386295|FG002|Overall Study|Participant Decision|0|||
147609449|NCT01449370|532386296|FG003|Overall Study|Participant Decision|0|||
147368148|NCT02101853|531517272|FG004|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|0|||
147368149|NCT02101853|531517273|FG005|Post Induction Randomization|Repeat eligibility studies are outside the parameters required for eligibility|0|||
147609450|NCT01449370|532386297|FG004|Overall Study|Participant Decision|0|||
147609451|NCT01449370|532386298|FG005|Overall Study|Participant Decision|0|||
147609452|NCT01449370|532386299|FG006|Overall Study|Participant Decision|0|||
147609453|NCT01449370|532386300|FG007|Overall Study|Participant Decision|1|||
147609454|NCT01449370|532386301|FG008|Overall Study|Participant Decision|1|||
147609455|NCT01449370|532386302|FG009|Overall Study|Participant Decision|0|||
147609456|NCT01449370|532386303|FG010|Overall Study|Participant Decision|0|||
147609457|NCT01449370|532386304|FG011|Overall Study|Participant Decision|0|||
147609458|NCT01449370|532386305|FG012|Overall Study|Participant Decision|1|||
147609459|NCT01449370|532386306|FG013|Overall Study|Participant Decision|1|||
147609460|NCT01449370|532386307|FG014|Overall Study|Participant Decision|0|||
147609461|NCT01449370|532386308|FG015|Overall Study|Participant Decision|1|||
147609462|NCT01449370|532386309|FG016|Overall Study|Participant Decision|3|||
147609463|NCT01449370|532386310|FG017|Overall Study|Participant Decision|0|||
147609464|NCT01449370|532386311|FG018|Overall Study|Participant Decision|1|||
147609465|NCT01449370|532386312|FG019|Overall Study|Participant Decision|0|||
147609466|NCT01449370|532386313|FG020|Overall Study|Participant Decision|0|||
147609467|NCT01449370|532386314|FG021|Overall Study|Participant Decision|1|||
147609468|NCT01449370|532386315|FG022|Overall Study|Participant Decision|0|||
147662978|NCT01831427|532589156|FG008|Overall Study|Investigator's Discretion|0|||
147609469|NCT01449370|532386316|FG023|Overall Study|Participant Decision|0|||
147662979|NCT01831427|532589157|FG009|Overall Study|Investigator's Discretion|0|||
147368150|NCT02101853|531517268|FG000|Post Induction Randomization|Found to be ineligible for HSCT|0|||
147368151|NCT02101853|531517269|FG001|Post Induction Randomization|Found to be ineligible for HSCT|5|||
147368152|NCT02101853|531517270|FG002|Post Induction Randomization|Found to be ineligible for HSCT|8|||
147662980|NCT01831427|532589158|FG010|Overall Study|Investigator's Discretion|0|||
147662981|NCT01831427|532589148|FG000|Overall Study|Withdrew Consent|0|||
147662982|NCT01831427|532589149|FG001|Overall Study|Withdrew Consent|0|||
147662983|NCT01831427|532589150|FG002|Overall Study|Withdrew Consent|0|||
147662984|NCT01831427|532589151|FG003|Overall Study|Withdrew Consent|0|||
147662985|NCT01831427|532589152|FG004|Overall Study|Withdrew Consent|0|||
147662986|NCT01831427|532589153|FG005|Overall Study|Withdrew Consent|0|||
147662987|NCT01831427|532589154|FG006|Overall Study|Withdrew Consent|2|||
147662988|NCT01831427|532589155|FG007|Overall Study|Withdrew Consent|0|||
147662989|NCT01831427|532589156|FG008|Overall Study|Withdrew Consent|0|||
147662990|NCT01831427|532589157|FG009|Overall Study|Withdrew Consent|1|||
147662991|NCT01831427|532589158|FG010|Overall Study|Withdrew Consent|1|||
147662992|NCT02169505|532589159|FG000|Overall Study|Withdrawal by Subject|1|||
147662993|NCT02035553|532589160|FG000|Overall Study|Death (See All-Cause Mortality Table)|0|||
147662994|NCT02035553|532589161|FG001|Overall Study|Death (See All-Cause Mortality Table)|1|||
147662995|NCT02035553|532589160|FG000|Overall Study|Adverse Event|10|||
147662996|NCT02035553|532589161|FG001|Overall Study|Adverse Event|6|||
147662997|NCT02035553|532589160|FG000|Overall Study|Physician Decision|3|||
147662998|NCT02035553|532589161|FG001|Overall Study|Physician Decision|2|||
147662999|NCT02035553|532589160|FG000|Overall Study|Lack of Efficacy|1|||
147368153|NCT02101853|531517271|FG003|Post Induction Randomization|Found to be ineligible for HSCT|0|||
147368154|NCT02101853|531517272|FG004|Post Induction Randomization|Found to be ineligible for HSCT|0|||
147368155|NCT02101853|531517273|FG005|Post Induction Randomization|Found to be ineligible for HSCT|0|||
147368156|NCT02101853|531517268|FG000|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|0|||
147368157|NCT02101853|531517269|FG001|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|5|||
147368158|NCT02101853|531517270|FG002|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|0|||
147368159|NCT02101853|531517271|FG003|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|0|||
147368160|NCT02101853|531517272|FG004|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|0|||
147609470|NCT01449370|532386317|FG024|Overall Study|Participant Decision|1|||
147609471|NCT01449370|532386293|FG000|Overall Study|Lost to Follow-up|0|||
147609472|NCT01449370|532386294|FG001|Overall Study|Lost to Follow-up|0|||
147609473|NCT01449370|532386295|FG002|Overall Study|Lost to Follow-up|0|||
147609474|NCT01449370|532386296|FG003|Overall Study|Lost to Follow-up|0|||
147609475|NCT01449370|532386297|FG004|Overall Study|Lost to Follow-up|0|||
147609476|NCT01449370|532386298|FG005|Overall Study|Lost to Follow-up|0|||
147609477|NCT01449370|532386299|FG006|Overall Study|Lost to Follow-up|0|||
147609478|NCT01449370|532386300|FG007|Overall Study|Lost to Follow-up|0|||
147609479|NCT01449370|532386301|FG008|Overall Study|Lost to Follow-up|0|||
147609480|NCT01449370|532386302|FG009|Overall Study|Lost to Follow-up|0|||
147609481|NCT01449370|532386303|FG010|Overall Study|Lost to Follow-up|0|||
147609482|NCT01449370|532386304|FG011|Overall Study|Lost to Follow-up|0|||
147609483|NCT01449370|532386305|FG012|Overall Study|Lost to Follow-up|0|||
147609484|NCT01449370|532386306|FG013|Overall Study|Lost to Follow-up|0|||
147609485|NCT01449370|532386307|FG014|Overall Study|Lost to Follow-up|0|||
147609486|NCT01449370|532386308|FG015|Overall Study|Lost to Follow-up|0|||
147609487|NCT01449370|532386309|FG016|Overall Study|Lost to Follow-up|0|||
147609488|NCT01449370|532386310|FG017|Overall Study|Lost to Follow-up|0|||
147609489|NCT01449370|532386311|FG018|Overall Study|Lost to Follow-up|0|||
147609490|NCT01449370|532386312|FG019|Overall Study|Lost to Follow-up|0|||
147609491|NCT01449370|532386313|FG020|Overall Study|Lost to Follow-up|1|||
147609492|NCT01449370|532386314|FG021|Overall Study|Lost to Follow-up|0|||
147609493|NCT01449370|532386315|FG022|Overall Study|Lost to Follow-up|0|||
147609494|NCT01449370|532386316|FG023|Overall Study|Lost to Follow-up|0|||
147609495|NCT01449370|532386317|FG024|Overall Study|Lost to Follow-up|0|||
147609496|NCT01449370|532386293|FG000|Overall Study|Other|0|||
147609497|NCT01449370|532386294|FG001|Overall Study|Other|0|||
147609498|NCT01449370|532386295|FG002|Overall Study|Other|0|||
147609499|NCT01449370|532386296|FG003|Overall Study|Other|0|||
147663000|NCT02035553|532589161|FG001|Overall Study|Lack of Efficacy|1|||
147663001|NCT02035553|532589160|FG000|Overall Study|Withdrawal by Subject|4|||
147609500|NCT01449370|532386297|FG004|Overall Study|Other|0|||
147609501|NCT01449370|532386298|FG005|Overall Study|Other|0|||
147609502|NCT01449370|532386299|FG006|Overall Study|Other|0|||
147609503|NCT01449370|532386300|FG007|Overall Study|Other|0|||
147609504|NCT01449370|532386301|FG008|Overall Study|Other|1|||
147609505|NCT01449370|532386302|FG009|Overall Study|Other|1|||
147609506|NCT01449370|532386303|FG010|Overall Study|Other|0|||
147609507|NCT01449370|532386304|FG011|Overall Study|Other|0|||
147663002|NCT02035553|532589161|FG001|Overall Study|Withdrawal by Subject|7|||
147663003|NCT02035553|532589160|FG000|Overall Study|Non-compliance with Study Drug|0|||
147663004|NCT02035553|532589161|FG001|Overall Study|Non-compliance with Study Drug|1|||
147609508|NCT01449370|532386305|FG012|Overall Study|Other|0|||
147609509|NCT01449370|532386306|FG013|Overall Study|Other|0|||
147609510|NCT01449370|532386307|FG014|Overall Study|Other|0|||
147663005|NCT02035553|532589160|FG000|Overall Study|Lost to Follow-up|0|||
147663006|NCT02035553|532589161|FG001|Overall Study|Lost to Follow-up|1|||
147663007|NCT02035553|532589160|FG000|Overall Study|Other Reason|0|||
147663008|NCT02035553|532589161|FG001|Overall Study|Other Reason|4|||
147663009|NCT00917124|532589162|FG000|Overall Study|Protocol Violation|4|||
147663010|NCT00917124|532589163|FG001|Overall Study|Protocol Violation|6|||
147663011|NCT03191799|532589169|FG000|Overall Study|Withdrawal by Subject|4|||
147663012|NCT03191799|532589169|FG000|Overall Study|Physician Decision|2|||
147663013|NCT03191799|532589169|FG000|Overall Study|Lost to Follow-up|1|||
147663014|NCT03191799|532589169|FG000|Overall Study|Death|2|||
147663015|NCT00126594|532589171|FG000|Overall Study|Ineligible|2|||
147663016|NCT00126594|532589172|FG001|Overall Study|Ineligible|0|||
147663017|NCT00126594|532589171|FG000|Overall Study|Withdrawal by Subject|0|||
147368161|NCT02101853|531517273|FG005|Post Induction Randomization|Proceeded to Blinatumomab salvage therapy|0|||
147663018|NCT00126594|532589172|FG001|Overall Study|Withdrawal by Subject|4|||
147663019|NCT00126594|532589171|FG000|Overall Study|Physician Decision|1|||
147663020|NCT00126594|532589172|FG001|Overall Study|Physician Decision|3|||
147663021|NCT00126594|532589171|FG000|Overall Study|Adverse Event|7|||
147663022|NCT00126594|532589172|FG001|Overall Study|Adverse Event|5|||
147663023|NCT00126594|532589171|FG000|Overall Study|Non-compliance|0|||
147663024|NCT00126594|532589172|FG001|Overall Study|Non-compliance|1|||
147663025|NCT00126594|532589171|FG000|Overall Study|Disease Progression|29|||
147663026|NCT00126594|532589172|FG001|Overall Study|Disease Progression|24|||
147663027|NCT00468585|532589173|FG000|Overall Study|Patient not treated|1|||
147663028|NCT00468585|532589174|FG001|Overall Study|Patient not treated|0|||
147663029|NCT00468585|532589175|FG002|Overall Study|Patient not treated|1|||
147663030|NCT00468585|532589176|FG003|Overall Study|Patient not treated|0|||
147663031|NCT00468585|532589173|FG000|Overall Study|Patient found to be ineligible|0|||
147663032|NCT00468585|532589174|FG001|Overall Study|Patient found to be ineligible|0|||
147663033|NCT00468585|532589175|FG002|Overall Study|Patient found to be ineligible|1|||
147663034|NCT00468585|532589176|FG003|Overall Study|Patient found to be ineligible|0|||
147663035|NCT00468585|532589173|FG000|Overall Study|Adverse Event|0|||
147663036|NCT00468585|532589174|FG001|Overall Study|Adverse Event|0|||
147663037|NCT00468585|532589175|FG002|Overall Study|Adverse Event|1|||
147663038|NCT00468585|532589176|FG003|Overall Study|Adverse Event|0|||
147663039|NCT00468585|532589173|FG000|Overall Study|Withdrawal by Subject|0|||
147663040|NCT00468585|532589174|FG001|Overall Study|Withdrawal by Subject|0|||
147663041|NCT00468585|532589175|FG002|Overall Study|Withdrawal by Subject|2|||
147663042|NCT00468585|532589176|FG003|Overall Study|Withdrawal by Subject|1|||
147663043|NCT03769649|532589177|FG000|Overall Study|Lost to Follow-up|4|||
147663044|NCT00731822|532589181|FG000|Overall Study|Adverse Event|2|||
147663045|NCT00731822|532589182|FG001|Overall Study|Adverse Event|1|||
147663046|NCT00731822|532589181|FG000|Overall Study|Protocol Violation|1|||
147663047|NCT00731822|532589182|FG001|Overall Study|Protocol Violation|0|||
147663048|NCT00731822|532589181|FG000|Overall Study|Lost to Follow-up|1|||
147663049|NCT00731822|532589182|FG001|Overall Study|Lost to Follow-up|0|||
147663050|NCT02127658|532589183|FG000|Overall Study|Screen Fail (Not MRSA on culture check)|2|||
147663051|NCT02127658|532589184|FG001|Overall Study|Screen Fail (Not MRSA on culture check)|0|||
147663052|NCT02127658|532589183|FG000|Overall Study|Withdrawal by Subject|0|||
147663053|NCT02127658|532589184|FG001|Overall Study|Withdrawal by Subject|2|||
147663054|NCT02127658|532589183|FG000|Overall Study|Physician Decision|0|||
147663055|NCT02127658|532589184|FG001|Overall Study|Physician Decision|1|||
147663056|NCT03834493|532589185|FG000|Overall Study|Participants Ongoing|311|||
147663057|NCT03834493|532589186|FG001|Overall Study|Participants Ongoing|324|||
147663058|NCT03834493|532589185|FG000|Overall Study|Withdrawal by Subject|20|||
147663059|NCT03834493|532589186|FG001|Overall Study|Withdrawal by Subject|17|||
147663060|NCT03834493|532589185|FG000|Overall Study|Physician Decision|1|||
147663061|NCT03834493|532589186|FG001|Overall Study|Physician Decision|0|||
147663062|NCT03834493|532589185|FG000|Overall Study|Death|289|||
147663063|NCT03834493|532589186|FG001|Overall Study|Death|282|||
147368162|NCT02101853|531517268|FG000|Post Induction Randomization|Patient still receiving protocol therapy|0|||
147368163|NCT02101853|531517269|FG001|Post Induction Randomization|Patient still receiving protocol therapy|0|||
147368164|NCT02101853|531517270|FG002|Post Induction Randomization|Patient still receiving protocol therapy|0|||
147368165|NCT02101853|531517271|FG003|Post Induction Randomization|Patient still receiving protocol therapy|5|||
147663064|NCT04144322|532589188|FG000|Overall Study|Lack of Efficacy|2|||
147663065|NCT04144322|532589189|FG001|Overall Study|Lack of Efficacy|2|||
147663066|NCT02277028|532589190|FG000|Overall Study|Lost to Follow-up|1|||
147663067|NCT02277028|532589191|FG001|Overall Study|Lost to Follow-up|0|||
147663068|NCT02277028|532589190|FG000|Overall Study|Withdrawal by Subject|0|||
147663069|NCT02277028|532589191|FG001|Overall Study|Withdrawal by Subject|1|||
147663070|NCT02718911|532589192|FG000|Overall Study|Adverse Event|0|||
147663071|NCT02718911|532589193|FG001|Overall Study|Adverse Event|0|||
147663072|NCT02718911|532589194|FG002|Overall Study|Adverse Event|0|||
147663073|NCT02718911|532589195|FG003|Overall Study|Adverse Event|0|||
147663074|NCT02718911|532589196|FG004|Overall Study|Adverse Event|0|||
147663075|NCT02718911|532589197|FG005|Overall Study|Adverse Event|0|||
147663076|NCT02718911|532589198|FG006|Overall Study|Adverse Event|0|||
147454443|NCT00577993|531825611|FG001|Overall Study|Conversion|5|||
147454444|NCT00577993|531825612|FG002|Overall Study|Conversion|0|||
147454445|NCT00577993|531825610|FG000|Overall Study|Uninsured|1|||
147454446|NCT00577993|531825611|FG001|Overall Study|Uninsured|0|||
147454447|NCT00577993|531825612|FG002|Overall Study|Uninsured|0|||
147454448|NCT02217566|531825615|FG000|Overall Study|Lost to Follow-up|2|||
147454449|NCT02217566|531825615|FG000|Overall Study|Death|3|||
147454450|NCT02217566|531825615|FG000|Overall Study|Early study termination|6|||
147454451|NCT02296242|531825616|FG000|Overall Study|Death|1|||
147454452|NCT02296242|531825617|FG001|Overall Study|Death|1|||
147454453|NCT02296242|531825618|FG002|Overall Study|Death|1|||
147454454|NCT02296242|531825619|FG003|Overall Study|Death|1|||
147454455|NCT02296242|531825620|FG004|Overall Study|Death|1|||
147454456|NCT02296242|531825616|FG000|Overall Study|Withdrawal by Subject|0|||
147454457|NCT02296242|531825617|FG001|Overall Study|Withdrawal by Subject|0|||
147454458|NCT02296242|531825618|FG002|Overall Study|Withdrawal by Subject|1|||
147454459|NCT02296242|531825619|FG003|Overall Study|Withdrawal by Subject|1|||
147454460|NCT02296242|531825620|FG004|Overall Study|Withdrawal by Subject|3|||
147454461|NCT02296242|531825616|FG000|Overall Study|Disease Progression|1|||
147454462|NCT02296242|531825617|FG001|Overall Study|Disease Progression|3|||
147454463|NCT02296242|531825618|FG002|Overall Study|Disease Progression|2|||
147454464|NCT02296242|531825619|FG003|Overall Study|Disease Progression|8|||
147454465|NCT02296242|531825620|FG004|Overall Study|Disease Progression|11|||
147454466|NCT02296242|531825616|FG000|Overall Study|Unacceptable Toxicity|0|||
147454467|NCT02296242|531825617|FG001|Overall Study|Unacceptable Toxicity|0|||
147454468|NCT02296242|531825618|FG002|Overall Study|Unacceptable Toxicity|0|||
147454469|NCT02296242|531825619|FG003|Overall Study|Unacceptable Toxicity|0|||
147454470|NCT02296242|531825620|FG004|Overall Study|Unacceptable Toxicity|1|||
147454471|NCT02296242|531825616|FG000|Overall Study|Patient Condition Changed|0|||
147454472|NCT02296242|531825617|FG001|Overall Study|Patient Condition Changed|0|||
147454473|NCT02296242|531825618|FG002|Overall Study|Patient Condition Changed|2|||
147454474|NCT02296242|531825619|FG003|Overall Study|Patient Condition Changed|0|||
147454475|NCT02296242|531825620|FG004|Overall Study|Patient Condition Changed|1|||
147454476|NCT02296242|531825616|FG000|Overall Study|At Least 3 Drug Interruptions|0|||
147454477|NCT02296242|531825617|FG001|Overall Study|At Least 3 Drug Interruptions|0|||
147454478|NCT02296242|531825618|FG002|Overall Study|At Least 3 Drug Interruptions|1|||
147454479|NCT02296242|531825619|FG003|Overall Study|At Least 3 Drug Interruptions|1|||
147454480|NCT02296242|531825620|FG004|Overall Study|At Least 3 Drug Interruptions|1|||
147454481|NCT02296242|531825616|FG000|Overall Study|Lost to Follow-up|1|||
147454482|NCT02296242|531825617|FG001|Overall Study|Lost to Follow-up|0|||
147454483|NCT02296242|531825618|FG002|Overall Study|Lost to Follow-up|0|||
147454484|NCT02296242|531825619|FG003|Overall Study|Lost to Follow-up|0|||
147454485|NCT02296242|531825620|FG004|Overall Study|Lost to Follow-up|0|||
147454486|NCT02296242|531825616|FG000|Overall Study|Need for Hydroxyurea|2|||
147454487|NCT02296242|531825617|FG001|Overall Study|Need for Hydroxyurea|0|||
147454488|NCT02296242|531825618|FG002|Overall Study|Need for Hydroxyurea|0|||
147454489|NCT02296242|531825619|FG003|Overall Study|Need for Hydroxyurea|0|||
147454490|NCT02296242|531825620|FG004|Overall Study|Need for Hydroxyurea|0|||
147368166|NCT02101853|531517272|FG004|Post Induction Randomization|Patient still receiving protocol therapy|1|||
147368167|NCT02101853|531517273|FG005|Post Induction Randomization|Patient still receiving protocol therapy|0|||
147368168|NCT02101853|531517268|FG000|Blinatumomab Salvage Therapy|Death|0|||
147368169|NCT02101853|531517269|FG001|Blinatumomab Salvage Therapy|Death|0|||
147368170|NCT02101853|531517270|FG002|Blinatumomab Salvage Therapy|Death|0|||
147368171|NCT02101853|531517271|FG003|Blinatumomab Salvage Therapy|Death|0|||
147368172|NCT02101853|531517272|FG004|Blinatumomab Salvage Therapy|Death|0|||
147368173|NCT02101853|531517273|FG005|Blinatumomab Salvage Therapy|Death|2|||
147368174|NCT02101853|531517268|FG000|Blinatumomab Salvage Therapy|Lack of Efficacy|0|||
147368175|NCT02101853|531517269|FG001|Blinatumomab Salvage Therapy|Lack of Efficacy|0|||
147368176|NCT02101853|531517270|FG002|Blinatumomab Salvage Therapy|Lack of Efficacy|0|||
147368177|NCT02101853|531517271|FG003|Blinatumomab Salvage Therapy|Lack of Efficacy|0|||
147368178|NCT02101853|531517272|FG004|Blinatumomab Salvage Therapy|Lack of Efficacy|0|||
147368179|NCT02101853|531517273|FG005|Blinatumomab Salvage Therapy|Lack of Efficacy|7|||
147368180|NCT02101853|531517268|FG000|Blinatumomab Salvage Therapy|Physician Decision|0|||
147368181|NCT02101853|531517269|FG001|Blinatumomab Salvage Therapy|Physician Decision|0|||
147368182|NCT02101853|531517270|FG002|Blinatumomab Salvage Therapy|Physician Decision|0|||
147368183|NCT02101853|531517271|FG003|Blinatumomab Salvage Therapy|Physician Decision|0|||
147368184|NCT02101853|531517272|FG004|Blinatumomab Salvage Therapy|Physician Decision|0|||
147368185|NCT02101853|531517273|FG005|Blinatumomab Salvage Therapy|Physician Decision|14|||
147454491|NCT02296242|531825616|FG000|Overall Study|Screened for Other Protocol|0|||
147454492|NCT02296242|531825617|FG001|Overall Study|Screened for Other Protocol|1|||
147368186|NCT02101853|531517268|FG000|Blinatumomab Salvage Therapy|Withdrawal by Subject|0|||
147454493|NCT02296242|531825618|FG002|Overall Study|Screened for Other Protocol|0|||
147454494|NCT02296242|531825619|FG003|Overall Study|Screened for Other Protocol|0|||
147454495|NCT02296242|531825620|FG004|Overall Study|Screened for Other Protocol|0|||
147454496|NCT02296242|531825616|FG000|Overall Study|Physician Decision|0|||
147454497|NCT02296242|531825617|FG001|Overall Study|Physician Decision|1|||
147368187|NCT02101853|531517269|FG001|Blinatumomab Salvage Therapy|Withdrawal by Subject|0|||
147368188|NCT02101853|531517270|FG002|Blinatumomab Salvage Therapy|Withdrawal by Subject|0|||
147368189|NCT02101853|531517271|FG003|Blinatumomab Salvage Therapy|Withdrawal by Subject|0|||
147368190|NCT02101853|531517272|FG004|Blinatumomab Salvage Therapy|Withdrawal by Subject|0|||
147368191|NCT02101853|531517273|FG005|Blinatumomab Salvage Therapy|Withdrawal by Subject|2|||
147368192|NCT02112916|531517274|FG000|Overall Study|Adverse Event|6|||
147368193|NCT02112916|531517275|FG001|Overall Study|Adverse Event|9|||
147368194|NCT02112916|531517276|FG002|Overall Study|Adverse Event|3|||
147368195|NCT02112916|531517277|FG003|Overall Study|Adverse Event|2|||
147368196|NCT02112916|531517274|FG000|Overall Study|Death|9|||
147368197|NCT02112916|531517275|FG001|Overall Study|Death|9|||
147368198|NCT02112916|531517276|FG002|Overall Study|Death|3|||
147368199|NCT02112916|531517277|FG003|Overall Study|Death|4|||
147368200|NCT02112916|531517274|FG000|Overall Study|Lost to Follow-up|1|||
147368201|NCT02112916|531517275|FG001|Overall Study|Lost to Follow-up|0|||
147368202|NCT02112916|531517276|FG002|Overall Study|Lost to Follow-up|0|||
147368203|NCT02112916|531517277|FG003|Overall Study|Lost to Follow-up|0|||
147368204|NCT02112916|531517274|FG000|Overall Study|Physician Decision|94|||
147368205|NCT02112916|531517275|FG001|Overall Study|Physician Decision|72|||
147368206|NCT02112916|531517276|FG002|Overall Study|Physician Decision|24|||
147368207|NCT02112916|531517277|FG003|Overall Study|Physician Decision|15|||
147368208|NCT02112916|531517274|FG000|Overall Study|Withdrawal by Subject|5|||
147368209|NCT02112916|531517275|FG001|Overall Study|Withdrawal by Subject|3|||
147368210|NCT02112916|531517276|FG002|Overall Study|Withdrawal by Subject|1|||
147368211|NCT02112916|531517277|FG003|Overall Study|Withdrawal by Subject|1|||
147368212|NCT02112916|531517274|FG000|Overall Study|Ineligible|4|||
147368213|NCT02112916|531517275|FG001|Overall Study|Ineligible|8|||
147454498|NCT02296242|531825618|FG002|Overall Study|Physician Decision|0|||
147454499|NCT02296242|531825619|FG003|Overall Study|Physician Decision|1|||
147663077|NCT02718911|532589199|FG007|Overall Study|Adverse Event|0|||
147663078|NCT02718911|532589200|FG008|Overall Study|Adverse Event|0|||
147663079|NCT02718911|532589201|FG009|Overall Study|Adverse Event|2|||
147663080|NCT02718911|532589192|FG000|Overall Study|Death|2|||
147663081|NCT02718911|532589193|FG001|Overall Study|Death|3|||
147663082|NCT02718911|532589194|FG002|Overall Study|Death|1|||
147663083|NCT02718911|532589195|FG003|Overall Study|Death|0|||
147663084|NCT02718911|532589196|FG004|Overall Study|Death|1|||
147663085|NCT02718911|532589197|FG005|Overall Study|Death|3|||
147663086|NCT02718911|532589198|FG006|Overall Study|Death|1|||
147663087|NCT02718911|532589199|FG007|Overall Study|Death|1|||
147663088|NCT02718911|532589200|FG008|Overall Study|Death|4|||
147663089|NCT02718911|532589201|FG009|Overall Study|Death|3|||
147663090|NCT02718911|532589192|FG000|Overall Study|Lost to Follow-up|0|||
147663091|NCT02718911|532589193|FG001|Overall Study|Lost to Follow-up|0|||
147663092|NCT02718911|532589194|FG002|Overall Study|Lost to Follow-up|0|||
147663093|NCT02718911|532589195|FG003|Overall Study|Lost to Follow-up|0|||
147663094|NCT02718911|532589196|FG004|Overall Study|Lost to Follow-up|0|||
147663095|NCT02718911|532589197|FG005|Overall Study|Lost to Follow-up|0|||
147663096|NCT02718911|532589198|FG006|Overall Study|Lost to Follow-up|0|||
147663097|NCT02718911|532589199|FG007|Overall Study|Lost to Follow-up|0|||
147663098|NCT02718911|532589200|FG008|Overall Study|Lost to Follow-up|1|||
147663099|NCT02718911|532589201|FG009|Overall Study|Lost to Follow-up|0|||
147663100|NCT02718911|532589192|FG000|Overall Study|Physician Decision|2|||
147663101|NCT02718911|532589193|FG001|Overall Study|Physician Decision|0|||
147663102|NCT02718911|532589194|FG002|Overall Study|Physician Decision|1|||
147663103|NCT02718911|532589195|FG003|Overall Study|Physician Decision|1|||
147663104|NCT02718911|532589196|FG004|Overall Study|Physician Decision|0|||
147663105|NCT02718911|532589197|FG005|Overall Study|Physician Decision|0|||
147663106|NCT02718911|532589198|FG006|Overall Study|Physician Decision|0|||
147663107|NCT02718911|532589199|FG007|Overall Study|Physician Decision|1|||
147663108|NCT02718911|532589200|FG008|Overall Study|Physician Decision|2|||
147663109|NCT02718911|532589201|FG009|Overall Study|Physician Decision|1|||
147663110|NCT02718911|532589192|FG000|Overall Study|Withdrawal by Subject|0|||
147663111|NCT02718911|532589193|FG001|Overall Study|Withdrawal by Subject|0|||
147663112|NCT02718911|532589194|FG002|Overall Study|Withdrawal by Subject|0|||
147663113|NCT02718911|532589195|FG003|Overall Study|Withdrawal by Subject|0|||
147663114|NCT02718911|532589196|FG004|Overall Study|Withdrawal by Subject|1|||
147663115|NCT02718911|532589197|FG005|Overall Study|Withdrawal by Subject|0|||
147663116|NCT02718911|532589198|FG006|Overall Study|Withdrawal by Subject|0|||
147663117|NCT02718911|532589199|FG007|Overall Study|Withdrawal by Subject|0|||
147663118|NCT02718911|532589200|FG008|Overall Study|Withdrawal by Subject|1|||
147663119|NCT02718911|532589201|FG009|Overall Study|Withdrawal by Subject|4|||
147663120|NCT02718911|532589192|FG000|Overall Study|Reason Not Collected|0|||
147663121|NCT02718911|532589193|FG001|Overall Study|Reason Not Collected|0|||
147663122|NCT02718911|532589194|FG002|Overall Study|Reason Not Collected|1|||
147663123|NCT02718911|532589195|FG003|Overall Study|Reason Not Collected|0|||
147368214|NCT02112916|531517276|FG002|Overall Study|Ineligible|3|||
147368215|NCT02112916|531517277|FG003|Overall Study|Ineligible|8|||
147663124|NCT02718911|532589196|FG004|Overall Study|Reason Not Collected|0|||
147663125|NCT02718911|532589197|FG005|Overall Study|Reason Not Collected|0|||
147663126|NCT02718911|532589198|FG006|Overall Study|Reason Not Collected|2|||
147663127|NCT02718911|532589199|FG007|Overall Study|Reason Not Collected|1|||
147663128|NCT02718911|532589200|FG008|Overall Study|Reason Not Collected|4|||
147663129|NCT02718911|532589201|FG009|Overall Study|Reason Not Collected|9|||
147663130|NCT04817332|532589202|FG000|Overall Study|Lost to Follow-up|3|||
147663131|NCT04817332|532589203|FG001|Overall Study|Lost to Follow-up|3|||
147663132|NCT04817332|532589202|FG000|Overall Study|Protocol Violation|2|||
147368216|NCT02112916|531517274|FG000|Overall Study|Inevaluable|6|||
147368217|NCT02112916|531517275|FG001|Overall Study|Inevaluable|4|||
147368218|NCT02112916|531517276|FG002|Overall Study|Inevaluable|5|||
147609511|NCT01449370|532386308|FG015|Overall Study|Other|0|||
147609512|NCT01449370|532386309|FG016|Overall Study|Other|0|||
147609513|NCT01449370|532386310|FG017|Overall Study|Other|0|||
147609514|NCT01449370|532386311|FG018|Overall Study|Other|0|||
147609515|NCT01449370|532386312|FG019|Overall Study|Other|0|||
147609516|NCT01449370|532386313|FG020|Overall Study|Other|0|||
147609517|NCT01449370|532386314|FG021|Overall Study|Other|0|||
147609518|NCT01449370|532386315|FG022|Overall Study|Other|1|||
147609519|NCT01449370|532386316|FG023|Overall Study|Other|1|||
147609520|NCT01449370|532386317|FG024|Overall Study|Other|0|||
147609521|NCT01449370|532386293|FG000|Overall Study|Medication Prohibited by Protocol|0|||
147609522|NCT01449370|532386294|FG001|Overall Study|Medication Prohibited by Protocol|0|||
147609523|NCT01449370|532386295|FG002|Overall Study|Medication Prohibited by Protocol|0|||
147609524|NCT01449370|532386296|FG003|Overall Study|Medication Prohibited by Protocol|0|||
147609525|NCT01449370|532386297|FG004|Overall Study|Medication Prohibited by Protocol|0|||
147609526|NCT01449370|532386298|FG005|Overall Study|Medication Prohibited by Protocol|0|||
147609527|NCT01449370|532386299|FG006|Overall Study|Medication Prohibited by Protocol|0|||
147609528|NCT01449370|532386300|FG007|Overall Study|Medication Prohibited by Protocol|0|||
147609529|NCT01449370|532386301|FG008|Overall Study|Medication Prohibited by Protocol|0|||
147609530|NCT01449370|532386302|FG009|Overall Study|Medication Prohibited by Protocol|0|||
147609531|NCT01449370|532386303|FG010|Overall Study|Medication Prohibited by Protocol|0|||
147609532|NCT01449370|532386304|FG011|Overall Study|Medication Prohibited by Protocol|0|||
147609533|NCT01449370|532386305|FG012|Overall Study|Medication Prohibited by Protocol|0|||
147609534|NCT01449370|532386306|FG013|Overall Study|Medication Prohibited by Protocol|0|||
147609535|NCT01449370|532386307|FG014|Overall Study|Medication Prohibited by Protocol|0|||
147609536|NCT01449370|532386308|FG015|Overall Study|Medication Prohibited by Protocol|0|||
147609537|NCT01449370|532386309|FG016|Overall Study|Medication Prohibited by Protocol|0|||
147609538|NCT01449370|532386310|FG017|Overall Study|Medication Prohibited by Protocol|0|||
147609539|NCT01449370|532386311|FG018|Overall Study|Medication Prohibited by Protocol|0|||
147609540|NCT01449370|532386312|FG019|Overall Study|Medication Prohibited by Protocol|0|||
147609541|NCT01449370|532386313|FG020|Overall Study|Medication Prohibited by Protocol|0|||
147609542|NCT01449370|532386314|FG021|Overall Study|Medication Prohibited by Protocol|0|||
147609543|NCT01449370|532386315|FG022|Overall Study|Medication Prohibited by Protocol|0|||
147609544|NCT01449370|532386316|FG023|Overall Study|Medication Prohibited by Protocol|1|||
147609545|NCT01449370|532386317|FG024|Overall Study|Medication Prohibited by Protocol|0|||
147609546|NCT01449370|532386293|FG000|Overall Study|Death|0|||
147609547|NCT01449370|532386294|FG001|Overall Study|Death|0|||
147609548|NCT01449370|532386295|FG002|Overall Study|Death|0|||
147609549|NCT01449370|532386296|FG003|Overall Study|Death|0|||
147609550|NCT01449370|532386297|FG004|Overall Study|Death|0|||
147609551|NCT01449370|532386298|FG005|Overall Study|Death|0|||
147609552|NCT01449370|532386299|FG006|Overall Study|Death|0|||
147609553|NCT01449370|532386300|FG007|Overall Study|Death|0|||
147609554|NCT01449370|532386301|FG008|Overall Study|Death|0|||
147609555|NCT01449370|532386302|FG009|Overall Study|Death|0|||
147609556|NCT01449370|532386303|FG010|Overall Study|Death|0|||
147609557|NCT01449370|532386304|FG011|Overall Study|Death|0|||
147609558|NCT01449370|532386305|FG012|Overall Study|Death|0|||
147609559|NCT01449370|532386306|FG013|Overall Study|Death|0|||
147609560|NCT01449370|532386307|FG014|Overall Study|Death|0|||
147609561|NCT01449370|532386308|FG015|Overall Study|Death|0|||
147609562|NCT01449370|532386309|FG016|Overall Study|Death|0|||
147609563|NCT01449370|532386310|FG017|Overall Study|Death|0|||
147609564|NCT01449370|532386311|FG018|Overall Study|Death|0|||
147609565|NCT01449370|532386312|FG019|Overall Study|Death|0|||
147609566|NCT01449370|532386313|FG020|Overall Study|Death|0|||
147609567|NCT01449370|532386314|FG021|Overall Study|Death|0|||
147663133|NCT04817332|532589203|FG001|Overall Study|Protocol Violation|0|||
147609568|NCT01449370|532386315|FG022|Overall Study|Death|0|||
147609569|NCT01449370|532386316|FG023|Overall Study|Death|0|||
147609570|NCT01449370|532386317|FG024|Overall Study|Death|1|||
147609571|NCT00534404|532386318|FG000|Overall Study|Death|0|||
147609572|NCT00534404|532386319|FG001|Overall Study|Death|0|||
147609573|NCT00534404|532386320|FG002|Overall Study|Death|2|||
147609574|NCT00534404|532386318|FG000|Overall Study|Withdrawal by Subject|8|||
147609575|NCT00534404|532386319|FG001|Overall Study|Withdrawal by Subject|2|||
147609576|NCT00534404|532386320|FG002|Overall Study|Withdrawal by Subject|38|||
147368219|NCT02112916|531517277|FG003|Overall Study|Inevaluable|5|||
147609577|NCT00534404|532386318|FG000|Overall Study|Removed by study staff|2|||
147609578|NCT00534404|532386319|FG001|Overall Study|Removed by study staff|3|||
147609579|NCT00534404|532386320|FG002|Overall Study|Removed by study staff|1|||
147609580|NCT00534404|532386318|FG000|Overall Study|Lost to Follow-up|170|||
147609581|NCT00534404|532386319|FG001|Overall Study|Lost to Follow-up|138|||
147368220|NCT02112916|531517274|FG000|Overall Study|Refusal of further protocol therapy|19|||
147368221|NCT02112916|531517275|FG001|Overall Study|Refusal of further protocol therapy|16|||
147368222|NCT02112916|531517276|FG002|Overall Study|Refusal of further protocol therapy|1|||
147368223|NCT02112916|531517277|FG003|Overall Study|Refusal of further protocol therapy|7|||
147368224|NCT02112916|531517274|FG000|Overall Study|Development of SMN|1|||
147368225|NCT02112916|531517275|FG001|Overall Study|Development of SMN|0|||
147368226|NCT02112916|531517276|FG002|Overall Study|Development of SMN|0|||
147368227|NCT02112916|531517277|FG003|Overall Study|Development of SMN|1|||
147368228|NCT02112916|531517274|FG000|Overall Study|Relapse/Progression|10|||
147368229|NCT02112916|531517275|FG001|Overall Study|Relapse/Progression|18|||
147368230|NCT02112916|531517276|FG002|Overall Study|Relapse/Progression|15|||
147368231|NCT02112916|531517277|FG003|Overall Study|Relapse/Progression|2|||
147368232|NCT02112916|531517274|FG000|Overall Study|VHR T-ALL who have an M2/M3 marrow and/or detectable MRD by end of the 3 HR Intensification Blocks|5|||
147368233|NCT02112916|531517275|FG001|Overall Study|VHR T-ALL who have an M2/M3 marrow and/or detectable MRD by end of the 3 HR Intensification Blocks|5|||
147368234|NCT02112916|531517276|FG002|Overall Study|VHR T-ALL who have an M2/M3 marrow and/or detectable MRD by end of the 3 HR Intensification Blocks|0|||
147368235|NCT02112916|531517277|FG003|Overall Study|VHR T-ALL who have an M2/M3 marrow and/or detectable MRD by end of the 3 HR Intensification Blocks|0|||
147368236|NCT02112916|531517274|FG000|Overall Study|Still on Therapy|44|||
147368237|NCT02112916|531517275|FG001|Overall Study|Still on Therapy|47|||
147368238|NCT02112916|531517276|FG002|Overall Study|Still on Therapy|3|||
147368239|NCT02112916|531517277|FG003|Overall Study|Still on Therapy|2|||
147368240|NCT02112916|531517274|FG000|Overall Study|Identified to have Ph+ T-ALL|0|||
147368241|NCT02112916|531517275|FG001|Overall Study|Identified to have Ph+ T-ALL|1|||
147368242|NCT02112916|531517276|FG002|Overall Study|Identified to have Ph+ T-ALL|0|||
147368243|NCT02112916|531517277|FG003|Overall Study|Identified to have Ph+ T-ALL|0|||
147368244|NCT02112916|531517274|FG000|Overall Study|Identified to have Ph+ T-Lly|0|||
147368245|NCT02112916|531517275|FG001|Overall Study|Identified to have Ph+ T-Lly|0|||
147368246|NCT02112916|531517276|FG002|Overall Study|Identified to have Ph+ T-Lly|1|||
147368247|NCT02112916|531517277|FG003|Overall Study|Identified to have Ph+ T-Lly|0|||
147609582|NCT00534404|532386320|FG002|Overall Study|Lost to Follow-up|201|||
147609583|NCT02996487|532386321|FG000|Overall Study|Lost to Follow-up|1|||
147368399|NCT02890355|531517913|FG000|Overall Study|Adverse Event|5|||
147368400|NCT02890355|531517914|FG001|Overall Study|Adverse Event|5|||
147368401|NCT02890355|531517913|FG000|Overall Study|Refusal unrelated to adverse event|5|||
147368402|NCT02890355|531517914|FG001|Overall Study|Refusal unrelated to adverse event|10|||
147368403|NCT02890355|531517913|FG000|Overall Study|Progression/relapse|46|||
147368404|NCT02890355|531517914|FG001|Overall Study|Progression/relapse|39|||
147368405|NCT02890355|531517913|FG000|Overall Study|Not protocol specified|3|||
147368406|NCT02890355|531517914|FG001|Overall Study|Not protocol specified|4|||
147454500|NCT02296242|531825620|FG004|Overall Study|Physician Decision|0|||
147454501|NCT02296242|531825616|FG000|Overall Study|Alternative Treatment|0|||
147454502|NCT02296242|531825617|FG001|Overall Study|Alternative Treatment|0|||
147454503|NCT02296242|531825618|FG002|Overall Study|Alternative Treatment|0|||
147454504|NCT02296242|531825619|FG003|Overall Study|Alternative Treatment|1|||
147454505|NCT02296242|531825620|FG004|Overall Study|Alternative Treatment|0|||
147454506|NCT02296242|531825616|FG000|Overall Study|Adverse Event|0|||
147454507|NCT02296242|531825617|FG001|Overall Study|Adverse Event|0|||
147454508|NCT02296242|531825618|FG002|Overall Study|Adverse Event|0|||
147454509|NCT02296242|531825619|FG003|Overall Study|Adverse Event|1|||
147454510|NCT02296242|531825620|FG004|Overall Study|Adverse Event|0|||
147454511|NCT02296242|531825616|FG000|Overall Study|Lack of Efficacy|0|||
147609584|NCT02996487|532386322|FG001|Overall Study|Lost to Follow-up|1|||
147609585|NCT02996487|532386323|FG002|Overall Study|Lost to Follow-up|0|||
147609586|NCT02996487|532386321|FG000|Overall Study|Death|0|||
147609587|NCT02996487|532386322|FG001|Overall Study|Death|1|||
147609588|NCT02996487|532386323|FG002|Overall Study|Death|0|||
147609589|NCT02996487|532386321|FG000|Overall Study|Withdrawal by Subject|2|||
147609590|NCT02996487|532386322|FG001|Overall Study|Withdrawal by Subject|3|||
147609591|NCT02996487|532386323|FG002|Overall Study|Withdrawal by Subject|0|||
147609592|NCT02027428|532386324|FG000|Induction|Never treated|7|||
147609593|NCT02027428|532386325|FG001|Induction|Never treated|0|||
147609594|NCT02027428|532386326|FG002|Induction|Never treated|0|||
147609595|NCT02027428|532386324|FG000|Induction|Progressive disease|77|||
147609596|NCT02027428|532386325|FG001|Induction|Progressive disease|0|||
147609597|NCT02027428|532386326|FG002|Induction|Progressive disease|0|||
147609598|NCT02027428|532386324|FG000|Induction|Adverse Event|51|||
147609599|NCT02027428|532386325|FG001|Induction|Adverse Event|0|||
147609600|NCT02027428|532386326|FG002|Induction|Adverse Event|0|||
147609601|NCT02027428|532386324|FG000|Induction|Withdrawal by Subject|22|||
147609602|NCT02027428|532386325|FG001|Induction|Withdrawal by Subject|0|||
147609603|NCT02027428|532386326|FG002|Induction|Withdrawal by Subject|0|||
147609604|NCT02027428|532386324|FG000|Induction|Death|21|||
147609605|NCT02027428|532386325|FG001|Induction|Death|0|||
147609606|NCT02027428|532386326|FG002|Induction|Death|0|||
147609607|NCT02027428|532386324|FG000|Induction|Symptomatic deterioration|16|||
147609608|NCT02027428|532386325|FG001|Induction|Symptomatic deterioration|0|||
147609609|NCT02027428|532386326|FG002|Induction|Symptomatic deterioration|0|||
147609610|NCT02027428|532386324|FG000|Induction|Study terminated by sponsor|12|||
147609611|NCT02027428|532386325|FG001|Induction|Study terminated by sponsor|0|||
147609612|NCT02027428|532386326|FG002|Induction|Study terminated by sponsor|0|||
147609613|NCT02027428|532386324|FG000|Induction|Protocol Violation|1|||
147609614|NCT02027428|532386325|FG001|Induction|Protocol Violation|0|||
147368452|NCT02180867|531517934|FG000|Overall Study|Adverse Event|3|||
147368453|NCT02180867|531517935|FG001|Overall Study|Adverse Event|4|||
147368454|NCT02180867|531517936|FG002|Overall Study|Adverse Event|1|||
147368455|NCT02180867|531517937|FG003|Overall Study|Adverse Event|5|||
147368456|NCT02180867|531517938|FG004|Overall Study|Adverse Event|0|||
147368457|NCT02180867|531517939|FG005|Overall Study|Adverse Event|0|||
147368458|NCT02180867|531517940|FG006|Overall Study|Adverse Event|0|||
147368459|NCT02180867|531517934|FG000|Overall Study|Death|0|||
147368460|NCT02180867|531517935|FG001|Overall Study|Death|0|||
147368461|NCT02180867|531517936|FG002|Overall Study|Death|0|||
147368462|NCT02180867|531517937|FG003|Overall Study|Death|0|||
147368463|NCT02180867|531517938|FG004|Overall Study|Death|1|||
147368464|NCT02180867|531517939|FG005|Overall Study|Death|0|||
147368465|NCT02180867|531517940|FG006|Overall Study|Death|0|||
147609615|NCT02027428|532386326|FG002|Induction|Protocol Violation|0|||
147609616|NCT02027428|532386324|FG000|Induction|Miscellaneous|14|||
147609617|NCT02027428|532386325|FG001|Induction|Miscellaneous|0|||
147368466|NCT02180867|531517934|FG000|Overall Study|Lack of Efficacy|0|||
147609618|NCT02027428|532386326|FG002|Induction|Miscellaneous|0|||
147609619|NCT02027428|532386324|FG000|Induction|Induction Treatment Ongoing|4|||
147368467|NCT02180867|531517935|FG001|Overall Study|Lack of Efficacy|2|||
147609620|NCT02027428|532386325|FG001|Induction|Induction Treatment Ongoing|0|||
147454512|NCT02296242|531825617|FG001|Overall Study|Lack of Efficacy|0|||
147368468|NCT02180867|531517936|FG002|Overall Study|Lack of Efficacy|0|||
147368469|NCT02180867|531517937|FG003|Overall Study|Lack of Efficacy|1|||
147368470|NCT02180867|531517938|FG004|Overall Study|Lack of Efficacy|6|||
147454513|NCT02296242|531825618|FG002|Overall Study|Lack of Efficacy|0|||
147609621|NCT02027428|532386326|FG002|Induction|Induction Treatment Ongoing|0|||
147609622|NCT02027428|532386324|FG000|Maintenance|Death|0|||
147609623|NCT02027428|532386325|FG001|Maintenance|Death|3|||
147609624|NCT02027428|532386326|FG002|Maintenance|Death|2|||
147368471|NCT02180867|531517939|FG005|Overall Study|Lack of Efficacy|0|||
147368472|NCT02180867|531517940|FG006|Overall Study|Lack of Efficacy|1|||
147368473|NCT02180867|531517934|FG000|Overall Study|Physician Decision|1|||
147368474|NCT02180867|531517935|FG001|Overall Study|Physician Decision|3|||
147368475|NCT02180867|531517936|FG002|Overall Study|Physician Decision|1|||
147368476|NCT02180867|531517937|FG003|Overall Study|Physician Decision|10|||
147368477|NCT02180867|531517938|FG004|Overall Study|Physician Decision|9|||
147368478|NCT02180867|531517939|FG005|Overall Study|Physician Decision|3|||
147368479|NCT02180867|531517940|FG006|Overall Study|Physician Decision|4|||
147368480|NCT02180867|531517934|FG000|Overall Study|Withdrawal by Subject|0|||
147368481|NCT02180867|531517935|FG001|Overall Study|Withdrawal by Subject|0|||
147368482|NCT02180867|531517936|FG002|Overall Study|Withdrawal by Subject|0|||
147368483|NCT02180867|531517937|FG003|Overall Study|Withdrawal by Subject|1|||
147368484|NCT02180867|531517938|FG004|Overall Study|Withdrawal by Subject|1|||
147368485|NCT02180867|531517939|FG005|Overall Study|Withdrawal by Subject|0|||
147368486|NCT02180867|531517940|FG006|Overall Study|Withdrawal by Subject|0|||
147368487|NCT02180867|531517934|FG000|Overall Study|Ineligible|1|||
147368488|NCT02180867|531517935|FG001|Overall Study|Ineligible|2|||
147368489|NCT02180867|531517936|FG002|Overall Study|Ineligible|0|||
147368490|NCT02180867|531517937|FG003|Overall Study|Ineligible|3|||
147368491|NCT02180867|531517938|FG004|Overall Study|Ineligible|5|||
147368492|NCT02180867|531517939|FG005|Overall Study|Ineligible|0|||
147368493|NCT02180867|531517940|FG006|Overall Study|Ineligible|0|||
147368494|NCT02180867|531517934|FG000|Overall Study|Repeat Eligibility Studies|0|||
147368495|NCT02180867|531517935|FG001|Overall Study|Repeat Eligibility Studies|0|||
147368496|NCT02180867|531517936|FG002|Overall Study|Repeat Eligibility Studies|0|||
147368497|NCT02180867|531517937|FG003|Overall Study|Repeat Eligibility Studies|0|||
147368498|NCT02180867|531517938|FG004|Overall Study|Repeat Eligibility Studies|1|||
147368499|NCT02180867|531517939|FG005|Overall Study|Repeat Eligibility Studies|0|||
147368500|NCT02180867|531517940|FG006|Overall Study|Repeat Eligibility Studies|0|||
147368501|NCT02180867|531517934|FG000|Overall Study|Refusal of further protocol therapy|1|||
147368502|NCT02180867|531517935|FG001|Overall Study|Refusal of further protocol therapy|0|||
147368503|NCT02180867|531517936|FG002|Overall Study|Refusal of further protocol therapy|2|||
147368504|NCT02180867|531517937|FG003|Overall Study|Refusal of further protocol therapy|6|||
147368505|NCT02180867|531517938|FG004|Overall Study|Refusal of further protocol therapy|4|||
147368506|NCT02180867|531517939|FG005|Overall Study|Refusal of further protocol therapy|0|||
147368507|NCT02180867|531517940|FG006|Overall Study|Refusal of further protocol therapy|0|||
147454514|NCT02296242|531825619|FG003|Overall Study|Lack of Efficacy|0|||
147663134|NCT01867008|532589204|FG000|Overall Study|Withdrawal by Subject|1|||
147663135|NCT00983372|532589205|FG000|14 Day Washout Period|Withdrawal by Subject|1|||
147663136|NCT00983372|532589205|FG000|Diltiazem ER Alone|missed diltiazem dose|2|||
147663137|NCT00983372|532589205|FG000|Diltiazem ER Alone|Adverse Event|1|||
147663138|NCT02131064|532589212|FG000|Overall Study|Death|5|||
147663139|NCT02131064|532589213|FG001|Overall Study|Death|6|||
147663140|NCT02131064|532589212|FG000|Overall Study|Lost to Follow-up|4|||
147663141|NCT02131064|532589213|FG001|Overall Study|Lost to Follow-up|8|||
147663142|NCT02131064|532589212|FG000|Overall Study|Withdrawal by Subject|14|||
147663143|NCT02131064|532589213|FG001|Overall Study|Withdrawal by Subject|18|||
147609625|NCT02027428|532386324|FG000|Maintenance|Adverse Event|0|||
147609626|NCT02027428|532386325|FG001|Maintenance|Adverse Event|21|||
147609627|NCT02027428|532386326|FG002|Maintenance|Adverse Event|1|||
147609628|NCT02027428|532386324|FG000|Maintenance|Progressive disease|0|||
147609629|NCT02027428|532386325|FG001|Maintenance|Progressive disease|84|||
147609630|NCT02027428|532386326|FG002|Maintenance|Progressive disease|47|||
147609631|NCT02027428|532386324|FG000|Maintenance|Symptomatic deterioration|0|||
147609632|NCT02027428|532386325|FG001|Maintenance|Symptomatic deterioration|4|||
147609633|NCT02027428|532386326|FG002|Maintenance|Symptomatic deterioration|1|||
147609634|NCT02027428|532386324|FG000|Maintenance|Withdrawal by Subject|0|||
147609635|NCT02027428|532386325|FG001|Maintenance|Withdrawal by Subject|6|||
147609636|NCT02027428|532386326|FG002|Maintenance|Withdrawal by Subject|5|||
147609637|NCT02027428|532386324|FG000|Maintenance|Protocol Violation|0|||
147609638|NCT02027428|532386325|FG001|Maintenance|Protocol Violation|0|||
147609639|NCT02027428|532386326|FG002|Maintenance|Protocol Violation|1|||
147609640|NCT02027428|532386324|FG000|Maintenance|Other|0|||
147609641|NCT02027428|532386325|FG001|Maintenance|Other|6|||
147609642|NCT02027428|532386326|FG002|Maintenance|Other|3|||
147609643|NCT02027428|532386324|FG000|Survival Follow-up|Death|0|||
147609644|NCT02027428|532386325|FG001|Survival Follow-up|Death|78|||
147609645|NCT02027428|532386326|FG002|Survival Follow-up|Death|45|||
147609646|NCT02027428|532386324|FG000|Survival Follow-up|Lost to Follow-up|0|||
147609647|NCT02027428|532386325|FG001|Survival Follow-up|Lost to Follow-up|1|||
147609648|NCT02027428|532386326|FG002|Survival Follow-up|Lost to Follow-up|1|||
147609649|NCT01004003|532386327|FG000|Overall Study|Progressive disease|2|||
147609650|NCT01004003|532386328|FG001|Overall Study|Progressive disease|1|||
147609651|NCT01004003|532386329|FG002|Overall Study|Progressive disease|1|||
147609652|NCT01004003|532386330|FG003|Overall Study|Progressive disease|0|||
147609653|NCT01004003|532386331|FG004|Overall Study|Progressive disease|2|||
147609654|NCT01004003|532386332|FG005|Overall Study|Progressive disease|1|||
147609655|NCT01004003|532386333|FG006|Overall Study|Progressive disease|1|||
147609656|NCT01004003|532386334|FG007|Overall Study|Progressive disease|39|||
147609657|NCT01004003|532386335|FG008|Overall Study|Progressive disease|22|||
147609658|NCT01004003|532386327|FG000|Overall Study|Adverse Event|4|||
147609659|NCT01004003|532386328|FG001|Overall Study|Adverse Event|2|||
147609660|NCT01004003|532386329|FG002|Overall Study|Adverse Event|3|||
147609661|NCT01004003|532386330|FG003|Overall Study|Adverse Event|3|||
147609662|NCT01004003|532386331|FG004|Overall Study|Adverse Event|2|||
147609663|NCT01004003|532386332|FG005|Overall Study|Adverse Event|2|||
147609664|NCT01004003|532386333|FG006|Overall Study|Adverse Event|7|||
147609665|NCT01004003|532386334|FG007|Overall Study|Adverse Event|21|||
147609666|NCT01004003|532386335|FG008|Overall Study|Adverse Event|6|||
147609667|NCT01004003|532386327|FG000|Overall Study|Refused to continue taking trial med.|0|||
147609668|NCT01004003|532386328|FG001|Overall Study|Refused to continue taking trial med.|0|||
147609669|NCT01004003|532386329|FG002|Overall Study|Refused to continue taking trial med.|0|||
147609670|NCT01004003|532386330|FG003|Overall Study|Refused to continue taking trial med.|0|||
147609671|NCT01004003|532386331|FG004|Overall Study|Refused to continue taking trial med.|0|||
147609672|NCT01004003|532386332|FG005|Overall Study|Refused to continue taking trial med.|0|||
147609673|NCT01004003|532386333|FG006|Overall Study|Refused to continue taking trial med.|0|||
147609674|NCT01004003|532386334|FG007|Overall Study|Refused to continue taking trial med.|0|||
147609675|NCT01004003|532386335|FG008|Overall Study|Refused to continue taking trial med.|2|||
147609676|NCT01004003|532386327|FG000|Overall Study|Other|0|||
147609677|NCT01004003|532386328|FG001|Overall Study|Other|0|||
147663144|NCT02131064|532589212|FG000|Overall Study|Other|2|||
147609678|NCT01004003|532386329|FG002|Overall Study|Other|0|||
147609679|NCT01004003|532386330|FG003|Overall Study|Other|0|||
147609680|NCT01004003|532386331|FG004|Overall Study|Other|0|||
147609681|NCT01004003|532386332|FG005|Overall Study|Other|1|||
147609682|NCT01004003|532386333|FG006|Overall Study|Other|0|||
147663145|NCT02131064|532589213|FG001|Overall Study|Other|2|||
147663146|NCT00570401|532589224|FG000|Overall Study|Adverse Event|2|||
147663147|NCT00871234|532589225|FG000|Overall Study|Adverse Event|2|||
147663148|NCT00871234|532589225|FG000|Overall Study|Lost to Follow-up|3|||
147663149|NCT01710020|532589226|FG000|Period 1|Protocol Violation|1|||
147663150|NCT01764841|532589227|FG000|Overall Study|Logistical Difficulties|0|||
147663151|NCT01764841|532589228|FG001|Overall Study|Logistical Difficulties|1|||
147663152|NCT01764841|532589229|FG002|Overall Study|Logistical Difficulties|0|||
147663153|NCT01764841|532589230|FG003|Overall Study|Logistical Difficulties|0|||
147663154|NCT01764841|532589227|FG000|Overall Study|Death|3|||
147663155|NCT01764841|532589228|FG001|Overall Study|Death|0|||
147663156|NCT01764841|532589229|FG002|Overall Study|Death|1|||
147663157|NCT01764841|532589230|FG003|Overall Study|Death|4|||
147663158|NCT01764841|532589227|FG000|Overall Study|No Follow Up|1|||
147663159|NCT01764841|532589228|FG001|Overall Study|No Follow Up|0|||
147663160|NCT01764841|532589229|FG002|Overall Study|No Follow Up|1|||
147663161|NCT01764841|532589230|FG003|Overall Study|No Follow Up|0|||
147663162|NCT01764841|532589227|FG000|Overall Study|Protocol Violation|0|||
147663163|NCT01764841|532589228|FG001|Overall Study|Protocol Violation|1|||
147663164|NCT01764841|532589229|FG002|Overall Study|Protocol Violation|0|||
147663165|NCT01764841|532589230|FG003|Overall Study|Protocol Violation|0|||
147663166|NCT01764841|532589227|FG000|Overall Study|Withdrawal by Subject|16|||
147663167|NCT01764841|532589228|FG001|Overall Study|Withdrawal by Subject|24|||
147663168|NCT01764841|532589229|FG002|Overall Study|Withdrawal by Subject|11|||
147663169|NCT01764841|532589230|FG003|Overall Study|Withdrawal by Subject|15|||
147663170|NCT01764841|532589227|FG000|Overall Study|Lost to Follow-up|3|||
147663171|NCT01764841|532589228|FG001|Overall Study|Lost to Follow-up|0|||
147663172|NCT01764841|532589229|FG002|Overall Study|Lost to Follow-up|1|||
147663173|NCT01764841|532589230|FG003|Overall Study|Lost to Follow-up|0|||
147663174|NCT00549549|532589231|FG000|Overall Study|Adverse Event|5|||
147663175|NCT00549549|532589232|FG001|Overall Study|Adverse Event|3|||
147663176|NCT00549549|532589233|FG002|Overall Study|Adverse Event|1|||
147663177|NCT00549549|532589234|FG003|Overall Study|Adverse Event|9|||
147454515|NCT02296242|531825620|FG004|Overall Study|Lack of Efficacy|3|||
147609683|NCT01004003|532386334|FG007|Overall Study|Other|0|||
147609684|NCT01004003|532386335|FG008|Overall Study|Other|0|||
147609685|NCT00259272|532386336|FG000|Overall Study|Adverse Event|2|||
147609686|NCT00259272|532386337|FG001|Overall Study|Adverse Event|1|||
147609687|NCT00259272|532386338|FG002|Overall Study|Adverse Event|0|||
147609688|NCT00259272|532386339|FG003|Overall Study|Adverse Event|3|||
147609689|NCT00259272|532386336|FG000|Overall Study|Lack of Efficacy|5|||
147609690|NCT00259272|532386337|FG001|Overall Study|Lack of Efficacy|1|||
147609691|NCT00259272|532386338|FG002|Overall Study|Lack of Efficacy|2|||
147609692|NCT00259272|532386339|FG003|Overall Study|Lack of Efficacy|6|||
147609693|NCT00259272|532386336|FG000|Overall Study|Physician Decision|1|||
147609694|NCT00259272|532386337|FG001|Overall Study|Physician Decision|2|||
147609695|NCT00259272|532386338|FG002|Overall Study|Physician Decision|1|||
147609696|NCT00259272|532386339|FG003|Overall Study|Physician Decision|3|||
147609697|NCT00259272|532386336|FG000|Overall Study|Protocol Violation|2|||
147609698|NCT00259272|532386337|FG001|Overall Study|Protocol Violation|0|||
147609699|NCT00259272|532386338|FG002|Overall Study|Protocol Violation|0|||
147609700|NCT00259272|532386339|FG003|Overall Study|Protocol Violation|1|||
147609701|NCT00259272|532386336|FG000|Overall Study|Sponsor Decision|0|||
147609702|NCT00259272|532386337|FG001|Overall Study|Sponsor Decision|1|||
147609703|NCT00259272|532386338|FG002|Overall Study|Sponsor Decision|0|||
147609704|NCT00259272|532386339|FG003|Overall Study|Sponsor Decision|0|||
147609705|NCT00259272|532386336|FG000|Overall Study|Withdrawal by Subject|4|||
147609706|NCT00259272|532386337|FG001|Overall Study|Withdrawal by Subject|2|||
147609707|NCT00259272|532386338|FG002|Overall Study|Withdrawal by Subject|2|||
147609708|NCT00259272|532386339|FG003|Overall Study|Withdrawal by Subject|7|||
147609709|NCT00259272|532386336|FG000|Overall Study|Lost to Follow-up|1|||
147609710|NCT00259272|532386337|FG001|Overall Study|Lost to Follow-up|0|||
147609711|NCT00259272|532386338|FG002|Overall Study|Lost to Follow-up|0|||
147663178|NCT00549549|532589231|FG000|Overall Study|Lack of Efficacy|9|||
147663179|NCT00549549|532589232|FG001|Overall Study|Lack of Efficacy|6|||
147663180|NCT00549549|532589233|FG002|Overall Study|Lack of Efficacy|4|||
147663181|NCT00549549|532589234|FG003|Overall Study|Lack of Efficacy|2|||
147663182|NCT00549549|532589231|FG000|Overall Study|Lost to Follow-up|1|||
147663183|NCT00549549|532589232|FG001|Overall Study|Lost to Follow-up|0|||
147609712|NCT00259272|532386339|FG003|Overall Study|Lost to Follow-up|1|||
147609713|NCT00315731|532386342|FG000|Overall Study|Lost to Follow-up|1|||
147609714|NCT00315731|532386342|FG000|Overall Study|Death|5|||
147609715|NCT04614246|532386343|FG000|Overall Study|Adverse Event|0|||
147609716|NCT04614246|532386344|FG001|Overall Study|Adverse Event|1|||
147609717|NCT04614246|532386345|FG002|Overall Study|Adverse Event|1|||
147609718|NCT04614246|532386346|FG003|Overall Study|Adverse Event|2|||
147663184|NCT00549549|532589233|FG002|Overall Study|Lost to Follow-up|1|||
147663185|NCT00549549|532589234|FG003|Overall Study|Lost to Follow-up|2|||
147663186|NCT00549549|532589231|FG000|Overall Study|Withdrawal by Subject|0|||
147663187|NCT00549549|532589232|FG001|Overall Study|Withdrawal by Subject|4|||
147663188|NCT00549549|532589233|FG002|Overall Study|Withdrawal by Subject|1|||
147454516|NCT01639833|531825621|FG000|Overall Study|Death|4|||
147454517|NCT01639833|531825622|FG001|Overall Study|Death|2|||
147454518|NCT01639833|531825621|FG000|Overall Study|Withdrawal by Subject|2|||
147454519|NCT01639833|531825622|FG001|Overall Study|Withdrawal by Subject|2|||
147454520|NCT02499029|531825625|FG000|Overall Study|Lost to Follow-up|2|||
147454521|NCT02499029|531825626|FG001|Overall Study|Lost to Follow-up|2|||
147454522|NCT02499029|531825625|FG000|Overall Study|Physician Decision|2|||
147454523|NCT02499029|531825626|FG001|Overall Study|Physician Decision|1|||
147454524|NCT02499029|531825625|FG000|Overall Study|Death|1|||
147454525|NCT02499029|531825626|FG001|Overall Study|Death|0|||
147454526|NCT01999582|531825627|FG000|Overall Study|Withdrawal by Subject|0|||
147454527|NCT01999582|531825628|FG001|Overall Study|Withdrawal by Subject|0|||
147454528|NCT01999582|531825629|FG002|Overall Study|Withdrawal by Subject|0|||
147454529|NCT01999582|531825630|FG003|Overall Study|Withdrawal by Subject|1|||
147454530|NCT01999582|531825631|FG004|Overall Study|Withdrawal by Subject|0|||
147454531|NCT01999582|531825632|FG005|Overall Study|Withdrawal by Subject|0|||
147454532|NCT01999582|531825627|FG000|Overall Study|Adverse Event|0|||
147454533|NCT01999582|531825628|FG001|Overall Study|Adverse Event|0|||
147454534|NCT01999582|531825629|FG002|Overall Study|Adverse Event|3|||
147454535|NCT01999582|531825630|FG003|Overall Study|Adverse Event|0|||
147454536|NCT01999582|531825631|FG004|Overall Study|Adverse Event|1|||
147454537|NCT01999582|531825632|FG005|Overall Study|Adverse Event|0|||
147454538|NCT01999582|531825627|FG000|Overall Study|Other Reasons|1|||
147454539|NCT01999582|531825628|FG001|Overall Study|Other Reasons|0|||
147454540|NCT01999582|531825629|FG002|Overall Study|Other Reasons|3|||
147454541|NCT01999582|531825630|FG003|Overall Study|Other Reasons|1|||
147454542|NCT01999582|531825631|FG004|Overall Study|Other Reasons|1|||
147454543|NCT01999582|531825632|FG005|Overall Study|Other Reasons|2|||
147454544|NCT01999582|531825627|FG000|Overall Study|Protocol Violation|1|||
147454545|NCT01999582|531825628|FG001|Overall Study|Protocol Violation|0|||
147454546|NCT01999582|531825629|FG002|Overall Study|Protocol Violation|0|||
147454547|NCT01999582|531825630|FG003|Overall Study|Protocol Violation|0|||
147454548|NCT01999582|531825631|FG004|Overall Study|Protocol Violation|0|||
147454549|NCT01999582|531825632|FG005|Overall Study|Protocol Violation|1|||
147454550|NCT01999582|531825627|FG000|Overall Study|Lack of Efficacy|1|||
147454551|NCT01999582|531825628|FG001|Overall Study|Lack of Efficacy|3|||
147454552|NCT01999582|531825629|FG002|Overall Study|Lack of Efficacy|0|||
147454553|NCT01999582|531825630|FG003|Overall Study|Lack of Efficacy|1|||
147454554|NCT01999582|531825631|FG004|Overall Study|Lack of Efficacy|0|||
147454555|NCT01999582|531825632|FG005|Overall Study|Lack of Efficacy|0|||
147454556|NCT01081795|531825633|FG000|Overall Study|Adverse Event|18|||
147609719|NCT04614246|532386347|FG004|Overall Study|Adverse Event|1|||
147609720|NCT04614246|532386343|FG000|Overall Study|Lost to Follow-up|0|||
147609721|NCT04614246|532386344|FG001|Overall Study|Lost to Follow-up|1|||
147609722|NCT04614246|532386345|FG002|Overall Study|Lost to Follow-up|0|||
147609723|NCT04614246|532386346|FG003|Overall Study|Lost to Follow-up|1|||
147609724|NCT04614246|532386347|FG004|Overall Study|Lost to Follow-up|3|||
147609725|NCT04614246|532386343|FG000|Overall Study|Other reason|0|||
147609726|NCT04614246|532386344|FG001|Overall Study|Other reason|1|||
147609727|NCT04614246|532386345|FG002|Overall Study|Other reason|2|||
147609728|NCT04614246|532386346|FG003|Overall Study|Other reason|0|||
147609729|NCT04614246|532386347|FG004|Overall Study|Other reason|0|||
147609730|NCT04614246|532386343|FG000|Overall Study|Withdrawal by Subject|4|||
147609731|NCT04614246|532386344|FG001|Overall Study|Withdrawal by Subject|2|||
147609732|NCT04614246|532386345|FG002|Overall Study|Withdrawal by Subject|4|||
147609733|NCT04614246|532386346|FG003|Overall Study|Withdrawal by Subject|3|||
147609734|NCT04614246|532386347|FG004|Overall Study|Withdrawal by Subject|4|||
147609735|NCT04614246|532386343|FG000|Overall Study|Physician Decision|0|||
147609736|NCT04614246|532386344|FG001|Overall Study|Physician Decision|2|||
147609737|NCT04614246|532386345|FG002|Overall Study|Physician Decision|1|||
147609738|NCT04614246|532386346|FG003|Overall Study|Physician Decision|0|||
147609739|NCT04614246|532386347|FG004|Overall Study|Physician Decision|0|||
147609740|NCT04614246|532386343|FG000|Overall Study|Study terminated by sponsor|10|||
147609741|NCT04614246|532386344|FG001|Overall Study|Study terminated by sponsor|15|||
147609742|NCT04614246|532386345|FG002|Overall Study|Study terminated by sponsor|12|||
147609743|NCT04614246|532386346|FG003|Overall Study|Study terminated by sponsor|13|||
147609744|NCT04614246|532386347|FG004|Overall Study|Study terminated by sponsor|9|||
147609745|NCT04614246|532386343|FG000|Overall Study|Pregnancy|2|||
147609746|NCT04614246|532386344|FG001|Overall Study|Pregnancy|0|||
147609747|NCT04614246|532386345|FG002|Overall Study|Pregnancy|1|||
147609748|NCT04614246|532386346|FG003|Overall Study|Pregnancy|0|||
147609749|NCT04614246|532386347|FG004|Overall Study|Pregnancy|0|||
147609750|NCT03597464|532386350|FG000|Overall Study|Withdrawal by Subject|4|||
147609751|NCT03597464|532386351|FG001|Overall Study|Withdrawal by Subject|5|||
147609752|NCT03597464|532386350|FG000|Overall Study|Lost to Follow-up|3|||
147609753|NCT03597464|532386351|FG001|Overall Study|Lost to Follow-up|1|||
147609754|NCT03597464|532386350|FG000|Overall Study|Pregnancy|3|||
147609755|NCT03597464|532386351|FG001|Overall Study|Pregnancy|1|||
147609756|NCT03597464|532386350|FG000|Overall Study|Lack of Efficacy|2|||
147609757|NCT03597464|532386351|FG001|Overall Study|Lack of Efficacy|0|||
147609758|NCT03597464|532386350|FG000|Overall Study|Physician Decision|2|||
147609759|NCT03597464|532386351|FG001|Overall Study|Physician Decision|2|||
147609760|NCT03597464|532386350|FG000|Overall Study|Protocol Violation|1|||
147609761|NCT03597464|532386351|FG001|Overall Study|Protocol Violation|1|||
147609762|NCT03597464|532386350|FG000|Overall Study|Adverse Event|0|||
147609763|NCT03597464|532386351|FG001|Overall Study|Adverse Event|2|||
147609764|NCT03597464|532386350|FG000|Overall Study|Death|0|||
147609765|NCT03597464|532386351|FG001|Overall Study|Death|3|||
147609766|NCT01374269|532386353|FG000|Overall Study|Withdrawal by Subject|4|||
147609767|NCT01374269|532386354|FG001|Overall Study|Withdrawal by Subject|0|||
147609768|NCT01374269|532386353|FG000|Overall Study|Lost to Follow-up|1|||
147609769|NCT01374269|532386354|FG001|Overall Study|Lost to Follow-up|3|||
147609770|NCT01374269|532386353|FG000|Overall Study|closed research|1|||
147609771|NCT01374269|532386354|FG001|Overall Study|closed research|2|||
147609772|NCT00340678|532386360|FG000|Overall Study|Lost to Follow-up|1|||
147609773|NCT00340678|532386361|FG001|Overall Study|Lost to Follow-up|0|||
147609774|NCT00340678|532386362|FG002|Overall Study|Lost to Follow-up|0|||
147609775|NCT00340678|532386363|FG003|Overall Study|Lost to Follow-up|0|||
147609776|NCT00278889|532386364|FG000|Overall Study|Withdrawal by Subject|0|||
147609777|NCT00278889|532386365|FG001|Overall Study|Withdrawal by Subject|5|||
147609778|NCT00278889|532386366|FG002|Overall Study|Withdrawal by Subject|3|||
147609779|NCT00278889|532386364|FG000|Overall Study|Lost to Follow-up|1|||
147609780|NCT00278889|532386365|FG001|Overall Study|Lost to Follow-up|1|||
147609781|NCT00278889|532386366|FG002|Overall Study|Lost to Follow-up|0|||
147300048|NCT04035200|531264596|FG002|Overall Study|COVID-19|0|||
147609782|NCT00278889|532386364|FG000|Overall Study|Death|24|||
147609783|NCT00278889|532386365|FG001|Overall Study|Death|21|||
147609784|NCT00278889|532386366|FG002|Overall Study|Death|17|||
147609785|NCT04042376|532386367|FG000|Overall Study|Withdrawal by Subject|1|||
147300049|NCT04035200|531264594|FG000|Overall Study|Early Termination|0|||
147300050|NCT04035200|531264595|FG001|Overall Study|Early Termination|1|||
147300051|NCT04035200|531264596|FG002|Overall Study|Early Termination|0|||
147300052|NCT04035200|531264594|FG000|Overall Study|Non-compliance|0|||
147300053|NCT04035200|531264595|FG001|Overall Study|Non-compliance|1|||
147300054|NCT04035200|531264596|FG002|Overall Study|Non-compliance|0|||
147300055|NCT02277990|531264597|FG000|Overall Study|Death|170|||
147300056|NCT02277990|531264598|FG001|Overall Study|Death|188|||
147300057|NCT02277990|531264597|FG000|Overall Study|Withdrawal by Subject|64|||
147300058|NCT02277990|531264598|FG001|Overall Study|Withdrawal by Subject|53|||
147300059|NCT02277990|531264597|FG000|Overall Study|Physician Decision|40|||
147368632|NCT04129450|531517960|FG000|Overall Study|Lost to Follow-up|20|||
147368633|NCT04129450|531517961|FG001|Overall Study|Lost to Follow-up|10|||
147368634|NCT04129450|531517960|FG000|Overall Study|Withdrawal by Subject|9|||
147368635|NCT04129450|531517961|FG001|Overall Study|Withdrawal by Subject|5|||
147368636|NCT04129450|531517960|FG000|Overall Study|Work Family Obligations|2|||
147368637|NCT04129450|531517961|FG001|Overall Study|Work Family Obligations|0|||
147368638|NCT04129450|531517960|FG000|Overall Study|Other|3|||
147368639|NCT04129450|531517961|FG001|Overall Study|Other|0|||
147454557|NCT01081795|531825634|FG001|Overall Study|Adverse Event|23|||
147454558|NCT01081795|531825635|FG002|Overall Study|Adverse Event|6|||
147454559|NCT01081795|531825633|FG000|Overall Study|Lack of Efficacy|7|||
147454560|NCT01081795|531825634|FG001|Overall Study|Lack of Efficacy|5|||
147454561|NCT01081795|531825635|FG002|Overall Study|Lack of Efficacy|19|||
147454562|NCT01081795|531825633|FG000|Overall Study|Subject's schedule|1|||
147454563|NCT01081795|531825634|FG001|Overall Study|Subject's schedule|1|||
147454564|NCT01081795|531825635|FG002|Overall Study|Subject's schedule|2|||
147454565|NCT01081795|531825633|FG000|Overall Study|Revocation of informed consent|2|||
147609786|NCT04042376|532386367|FG000|Overall Study|Death|3|||
147663189|NCT00549549|532589234|FG003|Overall Study|Withdrawal by Subject|0|||
147663190|NCT00549549|532589231|FG000|Overall Study|Other|9|||
147663191|NCT00549549|532589232|FG001|Overall Study|Other|9|||
147663192|NCT00549549|532589233|FG002|Overall Study|Other|9|||
147663193|NCT00549549|532589234|FG003|Overall Study|Other|11|||
147663194|NCT00549549|532589231|FG000|Overall Study|Randomized but not treated|0|||
147663195|NCT00549549|532589232|FG001|Overall Study|Randomized but not treated|0|||
147663196|NCT00549549|532589233|FG002|Overall Study|Randomized but not treated|1|||
147663197|NCT00549549|532589234|FG003|Overall Study|Randomized but not treated|1|||
147663198|NCT02155699|532589235|FG000|Overall Study|Withdrawal by Subject|0|||
147663199|NCT02155699|532589236|FG001|Overall Study|Withdrawal by Subject|3|||
147663200|NCT02155699|532589237|FG002|Overall Study|Withdrawal by Subject|6|||
147663201|NCT02155699|532589238|FG003|Overall Study|Withdrawal by Subject|1|||
147663202|NCT02155699|532589235|FG000|Overall Study|Lost to Follow-up|0|||
147663203|NCT02155699|532589236|FG001|Overall Study|Lost to Follow-up|0|||
147663204|NCT02155699|532589237|FG002|Overall Study|Lost to Follow-up|0|||
147663205|NCT02155699|532589238|FG003|Overall Study|Lost to Follow-up|3|||
147663206|NCT02155699|532589235|FG000|Overall Study|Emergence of Psychosis or Substance disorder during protocol|0|||
147663207|NCT02155699|532589236|FG001|Overall Study|Emergence of Psychosis or Substance disorder during protocol|0|||
147663208|NCT02155699|532589237|FG002|Overall Study|Emergence of Psychosis or Substance disorder during protocol|2|||
147663209|NCT02155699|532589238|FG003|Overall Study|Emergence of Psychosis or Substance disorder during protocol|1|||
147368641|NCT04129164|531518465|FG000|Overall Study|Non-compliance with procedures|0|||
147368642|NCT04129164|531518466|FG001|Overall Study|Non-compliance with procedures|0|||
147368643|NCT04129164|531518467|FG002|Overall Study|Non-compliance with procedures|2|||
147368644|NCT04129164|531518468|FG003|Overall Study|Non-compliance with procedures|0|||
147368645|NCT04129164|531518465|FG000|Overall Study|Adverse Event|0|||
147368646|NCT04129164|531518466|FG001|Overall Study|Adverse Event|0|||
147368647|NCT04129164|531518467|FG002|Overall Study|Adverse Event|2|||
147368648|NCT04129164|531518468|FG003|Overall Study|Adverse Event|0|||
147368649|NCT04129164|531518465|FG000|Overall Study|Pregnancy|0|||
147368650|NCT04129164|531518466|FG001|Overall Study|Pregnancy|0|||
147368651|NCT04129164|531518467|FG002|Overall Study|Pregnancy|0|||
147368652|NCT04129164|531518468|FG003|Overall Study|Pregnancy|1|||
147368653|NCT04129164|531518465|FG000|Overall Study|Withdrawal by Subject|3|||
147368654|NCT04129164|531518466|FG001|Overall Study|Withdrawal by Subject|2|||
147368655|NCT04129164|531518467|FG002|Overall Study|Withdrawal by Subject|4|||
147368656|NCT04129164|531518468|FG003|Overall Study|Withdrawal by Subject|6|||
147368657|NCT04129164|531518465|FG000|Overall Study|Death|0|||
147368658|NCT04129164|531518466|FG001|Overall Study|Death|1|||
147368659|NCT04129164|531518467|FG002|Overall Study|Death|0|||
147368660|NCT04129164|531518468|FG003|Overall Study|Death|0|||
147368661|NCT04129164|531518465|FG000|Overall Study|Lost to Follow-up|0|||
147368662|NCT04129164|531518466|FG001|Overall Study|Lost to Follow-up|1|||
147368663|NCT04129164|531518467|FG002|Overall Study|Lost to Follow-up|0|||
147368664|NCT04129164|531518468|FG003|Overall Study|Lost to Follow-up|0|||
147368665|NCT04174560|531518481|FG000|Overall Study|Lost to Follow-up|1|||
147368666|NCT04174560|531518482|FG001|Overall Study|Lost to Follow-up|0|||
147368667|NCT04174560|531518483|FG002|Overall Study|Lost to Follow-up|0|||
147368668|NCT04174560|531518484|FG003|Overall Study|Lost to Follow-up|0|||
147368669|NCT04174560|531518481|FG000|Overall Study|Withdrawal by Subject|0|||
147368670|NCT04174560|531518482|FG001|Overall Study|Withdrawal by Subject|0|||
147368671|NCT04174560|531518483|FG002|Overall Study|Withdrawal by Subject|2|||
147368672|NCT04174560|531518484|FG003|Overall Study|Withdrawal by Subject|0|||
147368673|NCT03782116|531518492|FG000|Completed Intervetion|Lost to Follow-up|11|||
147368674|NCT03782116|531518493|FG001|Completed Intervetion|Lost to Follow-up|7|||
147368675|NCT03782116|531518492|FG000|Completed Intervetion|Withdrawal by Subject|6|||
147368676|NCT03782116|531518493|FG001|Completed Intervetion|Withdrawal by Subject|5|||
147368677|NCT03782116|531518492|FG000|Included in Analysis|Protocol Violation|5|||
147368678|NCT03782116|531518493|FG001|Included in Analysis|Protocol Violation|5|||
147368679|NCT05934292|531518494|FG000|Overall Study|Lost to Follow-up|0|||
147368680|NCT05934292|531518495|FG001|Overall Study|Lost to Follow-up|0|||
147368681|NCT05934292|531518496|FG002|Overall Study|Lost to Follow-up|1|||
147368682|NCT05934292|531518497|FG003|Overall Study|Lost to Follow-up|0|||
147368683|NCT04479787|531518498|FG000|Through 6 Months|Withdrawal by Subject|16|||
147368684|NCT04479787|531518499|FG001|Through 6 Months|Withdrawal by Subject|14|||
147368685|NCT04479787|531518498|FG000|Through 6 Months|Unsuccessful Trial|17|||
147368686|NCT04479787|531518499|FG001|Through 6 Months|Unsuccessful Trial|0|||
147368687|NCT04479787|531518498|FG000|Through 6 Months|Subject Participation Terminated By Investigator|12|||
147368688|NCT04479787|531518499|FG001|Through 6 Months|Subject Participation Terminated By Investigator|3|||
147368689|NCT04479787|531518498|FG000|Through 6 Months|IPG/Lead(s) Explanted But Not Replaced|2|||
147368690|NCT04479787|531518499|FG001|Through 6 Months|IPG/Lead(s) Explanted But Not Replaced|0|||
147368691|NCT04479787|531518498|FG000|Through 6 Months|Lost to Follow-up|3|||
147368692|NCT04479787|531518499|FG001|Through 6 Months|Lost to Follow-up|2|||
147368693|NCT04479787|531518498|FG000|Through 6 Months|Death|3|||
147368694|NCT04479787|531518499|FG001|Through 6 Months|Death|0|||
147368695|NCT04479787|531518498|FG000|Through 6 Months|Inclusion/Exclusion|2|||
147368696|NCT04479787|531518499|FG001|Through 6 Months|Inclusion/Exclusion|1|||
147368697|NCT04479787|531518498|FG000|Through 6 Months|Subject Became Pregnant|1|||
147368698|NCT04479787|531518499|FG001|Through 6 Months|Subject Became Pregnant|1|||
147368699|NCT04479787|531518498|FG000|Through 6 Months|Patient Diagnosed With Oral Cancer, Needs To Undergo Radiation And Chemo|0|||
147368700|NCT04479787|531518499|FG001|Through 6 Months|Patient Diagnosed With Oral Cancer, Needs To Undergo Radiation And Chemo|1|||
147368701|NCT04479787|531518498|FG000|Through 6 Months|Withdrawn At Sponsor's Request|1|||
147368702|NCT04479787|531518499|FG001|Through 6 Months|Withdrawn At Sponsor's Request|0|||
147368703|NCT04479787|531518498|FG000|Through 6 Months|Subject Failed To Comply With The Protocol Requirements|1|||
147368704|NCT04479787|531518499|FG001|Through 6 Months|Subject Failed To Comply With The Protocol Requirements|0|||
147368705|NCT04479787|531518498|FG000|After 6 Months|Withdrawal by Subject|3|||
147368706|NCT04479787|531518499|FG001|After 6 Months|Withdrawal by Subject|13|||
147609787|NCT01243775|532386368|FG000|Overall Study|Withdrawal by Subject|2|||
147609788|NCT02260570|532388862|FG000|Overall Study|Withdrawal by Subject|2|||
147609789|NCT02260570|532388863|FG001|Overall Study|Withdrawal by Subject|1|||
147609790|NCT02260570|532388862|FG000|Overall Study|Physician Decision|1|||
147609791|NCT02260570|532388863|FG001|Overall Study|Physician Decision|1|||
147609792|NCT03996447|532388864|FG000|First MRI Examination|Adverse Event|2|||
147609793|NCT03996447|532388865|FG001|First MRI Examination|Adverse Event|0|||
147609794|NCT03996447|532388864|FG000|First MRI Examination|Withdrawal by Subject|1|||
147609795|NCT03996447|532388865|FG001|First MRI Examination|Withdrawal by Subject|2|||
147609796|NCT03996447|532388864|FG000|First MRI Examination|Protocol Violation|0|||
147609797|NCT03996447|532388865|FG001|First MRI Examination|Protocol Violation|1|||
147609798|NCT03996447|532388864|FG000|Washout|Adverse Event|2|||
147609799|NCT03996447|532388865|FG001|Washout|Adverse Event|0|||
147609800|NCT03996447|532388864|FG000|Washout|Follow-up unavailable due to COVID-19 pandemic|2|||
147609801|NCT03996447|532388865|FG001|Washout|Follow-up unavailable due to COVID-19 pandemic|1|||
147609802|NCT03996447|532388864|FG000|Washout|Withdrawal by Subject|0|||
147609803|NCT03996447|532388865|FG001|Washout|Withdrawal by Subject|1|||
147609804|NCT03996447|532388864|FG000|Washout|Other reason|1|||
147609805|NCT03996447|532388865|FG001|Washout|Other reason|1|||
147609806|NCT01810302|532388873|FG000|Overall Study|Death|1|||
147609807|NCT01810302|532388874|FG001|Overall Study|Death|0|||
147609808|NCT01810302|532388873|FG000|Overall Study|Physician Decision|0|||
147609809|NCT01810302|532388874|FG001|Overall Study|Physician Decision|1|||
147609810|NCT03888066|532388875|FG000|Run-in Phase|Randomization Criterion #1|24|||
147609811|NCT03888066|532388876|FG001|Run-in Phase|Randomization Criterion #1|0|||
147609812|NCT03888066|532388875|FG000|Run-in Phase|Randomization Criteria #1, #2|5|||
147609813|NCT03888066|532388876|FG001|Run-in Phase|Randomization Criteria #1, #2|0|||
147609814|NCT03888066|532388875|FG000|Run-in Phase|Randomization Criteria #1, #2 #4; AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
147609815|NCT03888066|532388876|FG001|Run-in Phase|Randomization Criteria #1, #2 #4; AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
147609816|NCT03888066|532388875|FG000|Run-in Phase|Randomization Criteria #1, #3|1|||
147609817|NCT03888066|532388876|FG001|Run-in Phase|Randomization Criteria #1, #3|0|||
147609818|NCT03888066|532388875|FG000|Run-in Phase|Randomization Criteria #1, #4|1|||
147609819|NCT03888066|532388876|FG001|Run-in Phase|Randomization Criteria #1, #4|0|||
147609820|NCT03888066|532388875|FG000|Run-in Phase|Randomization Crit #1, #4; Withdraw By Subject; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
147609821|NCT03888066|532388876|FG001|Run-in Phase|Randomization Crit #1, #4; Withdraw By Subject; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
147609822|NCT03888066|532388875|FG000|Run-in Phase|Randomization Criteria #1, #4; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
147609823|NCT03888066|532388876|FG001|Run-in Phase|Randomization Criteria #1, #4; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
147609824|NCT03888066|532388875|FG000|Run-in Phase|Randomization Criterion #1; AE|4|||
147609825|NCT03888066|532388876|FG001|Run-in Phase|Randomization Criterion #1; AE|0|||
147609826|NCT03888066|532388875|FG000|Run-in Phase|Randomization Criterion #1; AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
147609827|NCT03888066|532388876|FG001|Run-in Phase|Randomization Criterion #1; AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
147368707|NCT04479787|531518498|FG000|After 6 Months|Unsuccessful Trial|0|||
147368708|NCT04479787|531518499|FG001|After 6 Months|Unsuccessful Trial|7|||
147368709|NCT04479787|531518498|FG000|After 6 Months|IPG/Lead(s) Explanted But Not Replaced|2|||
147368710|NCT04479787|531518499|FG001|After 6 Months|IPG/Lead(s) Explanted But Not Replaced|4|||
147368711|NCT04479787|531518498|FG000|After 6 Months|Subject Participation Terminated By Investigator|2|||
147368712|NCT04479787|531518499|FG001|After 6 Months|Subject Participation Terminated By Investigator|2|||
147368713|NCT04479787|531518498|FG000|After 6 Months|Death|2|||
147368714|NCT04479787|531518499|FG001|After 6 Months|Death|0|||
147609828|NCT03888066|532388875|FG000|Run-in Phase|Randomization Criterion #1; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|2|||
147609829|NCT03888066|532388876|FG001|Run-in Phase|Randomization Criterion #1; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
147368715|NCT04479787|531518498|FG000|After 6 Months|Lost to Follow-up|1|||
147368716|NCT04479787|531518499|FG001|After 6 Months|Lost to Follow-up|1|||
147368717|NCT04479787|531518498|FG000|After 6 Months|Patient Was Withdrawn Due To Study Timelines|0|||
147609830|NCT03888066|532388875|FG000|Run-in Phase|Randomization Criterion #2|5|||
147609831|NCT03888066|532388876|FG001|Run-in Phase|Randomization Criterion #2|0|||
147609832|NCT03888066|532388875|FG000|Run-in Phase|Randomization Criteria #2, #3|1|||
147663210|NCT02688933|532589241|FG000|Overall Study|Adverse Event|3|||
147663211|NCT02688933|532589242|FG001|Overall Study|Adverse Event|1|||
147663212|NCT02688933|532589241|FG000|Overall Study|Lack of Efficacy|2|||
147663213|NCT02688933|532589242|FG001|Overall Study|Lack of Efficacy|2|||
147663214|NCT02688933|532589241|FG000|Overall Study|Poor compliance to protocol|7|||
147663215|NCT02688933|532589242|FG001|Overall Study|Poor compliance to protocol|4|||
147663216|NCT02688933|532589241|FG000|Overall Study|Hypoglycemia|2|||
147368718|NCT04479787|531518499|FG001|After 6 Months|Patient Was Withdrawn Due To Study Timelines|1|||
147368719|NCT04479787|531518498|FG000|After 6 Months|Patient's Health Significantly Declined|0|||
147368720|NCT04479787|531518499|FG001|After 6 Months|Patient's Health Significantly Declined|1|||
147368721|NCT04479787|531518498|FG000|After 6 Months|Subject Had Back Surgery On March 1st|0|||
147368722|NCT04479787|531518499|FG001|After 6 Months|Subject Had Back Surgery On March 1st|1|||
147368723|NCT04479787|531518498|FG000|After 6 Months|Subject Failed To Comply With The Protocol Requirements|0|||
147368724|NCT04479787|531518499|FG001|After 6 Months|Subject Failed To Comply With The Protocol Requirements|1|||
147368725|NCT05714059|531518502|FG000|Overall Study|Withdrawal by Subject|2|||
147368726|NCT05714059|531518503|FG001|Overall Study|Withdrawal by Subject|2|||
147368727|NCT05714059|531518502|FG000|Overall Study|Adverse Event|0|||
147368728|NCT05714059|531518503|FG001|Overall Study|Adverse Event|1|||
147609833|NCT03888066|532388876|FG001|Run-in Phase|Randomization Criteria #2, #3|0|||
147609834|NCT03888066|532388875|FG000|Run-in Phase|Randomization Criteria #2, #3, #4|1|||
147609835|NCT03888066|532388876|FG001|Run-in Phase|Randomization Criteria #2, #3, #4|0|||
147609836|NCT03888066|532388875|FG000|Run-in Phase|Randomization Criteria #2, #4|4|||
147609837|NCT03888066|532388876|FG001|Run-in Phase|Randomization Criteria #2, #4|0|||
147609838|NCT03888066|532388875|FG000|Run-in Phase|Randomization Criterion #3|11|||
147609839|NCT03888066|532388876|FG001|Run-in Phase|Randomization Criterion #3|0|||
147609840|NCT03888066|532388875|FG000|Run-in Phase|Randomization Criteria #3, #4|1|||
147609841|NCT03888066|532388876|FG001|Run-in Phase|Randomization Criteria #3, #4|0|||
147609842|NCT03888066|532388875|FG000|Run-in Phase|Randomization Criteria #3, #4; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|2|||
147609843|NCT03888066|532388876|FG001|Run-in Phase|Randomization Criteria #3, #4; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|0|||
147609844|NCT03888066|532388875|FG000|Run-in Phase|Randomization Criterion #3; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
147609845|NCT03888066|532388876|FG001|Run-in Phase|Randomization Criterion #3; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
147609846|NCT03888066|532388875|FG000|Run-in Phase|Randomization Criterion #4|3|||
147609847|NCT03888066|532388876|FG001|Run-in Phase|Randomization Criterion #4|0|||
147609848|NCT03888066|532388875|FG000|Run-in Phase|Randomization Criterion #3; Physician Decision|1|||
147368729|NCT05714059|531518502|FG000|Overall Study|Lost to Follow-up|0|||
147368730|NCT05714059|531518503|FG001|Overall Study|Lost to Follow-up|1|||
147368731|NCT05714059|531518502|FG000|Overall Study|WITHDRAWAL BY PARENT/GUARDIAN|3|||
147368732|NCT05714059|531518503|FG001|Overall Study|WITHDRAWAL BY PARENT/GUARDIAN|0|||
147368733|NCT05714059|531518502|FG000|Overall Study|TECHNICAL PROBLEMS|0|||
147368734|NCT05714059|531518503|FG001|Overall Study|TECHNICAL PROBLEMS|1|||
147368735|NCT04899674|531518504|FG000|Test|Adverse Event|1|||
147368736|NCT03774472|531518505|FG000|Overall Study|Physician Decision|1|||
147368737|NCT03774472|531518506|FG001|Overall Study|Physician Decision|0|||
147368738|NCT03774472|531518507|FG002|Overall Study|Physician Decision|0|||
147368739|NCT03774472|531518505|FG000|Overall Study|Progression prior to 4 weeks|0|||
147368740|NCT03774472|531518506|FG001|Overall Study|Progression prior to 4 weeks|1|||
147368741|NCT03774472|531518507|FG002|Overall Study|Progression prior to 4 weeks|0|||
147368742|NCT03774472|531518505|FG000|Overall Study|Withdrawal by Subject|0|||
147368743|NCT03774472|531518506|FG001|Overall Study|Withdrawal by Subject|1|||
147368744|NCT03774472|531518507|FG002|Overall Study|Withdrawal by Subject|0|||
147368745|NCT03150862|531518509|FG000|Overall Study|Death|2|||
147368746|NCT03150862|531518510|FG001|Overall Study|Death|7|||
147368747|NCT03150862|531518511|FG002|Overall Study|Death|8|||
147368748|NCT03150862|531518512|FG003|Overall Study|Death|27|||
147368749|NCT03150862|531518513|FG004|Overall Study|Death|4|||
147368750|NCT03150862|531518514|FG005|Overall Study|Death|8|||
147368751|NCT03150862|531518515|FG006|Overall Study|Death|6|||
147368752|NCT03150862|531518516|FG007|Overall Study|Death|21|||
147368753|NCT03150862|531518509|FG000|Overall Study|Withdrawal by Subject|1|||
147368754|NCT03150862|531518510|FG001|Overall Study|Withdrawal by Subject|1|||
147368755|NCT03150862|531518511|FG002|Overall Study|Withdrawal by Subject|0|||
147454566|NCT01081795|531825634|FG001|Overall Study|Revocation of informed consent|0|||
147663217|NCT02688933|532589242|FG001|Overall Study|Hypoglycemia|0|||
147663218|NCT02688933|532589241|FG000|Overall Study|Other than Specified|14|||
147663219|NCT02688933|532589242|FG001|Overall Study|Other than Specified|25|||
147663220|NCT02688933|532589241|FG000|Overall Study|Lost to Follow-up|1|||
147663221|NCT02688933|532589242|FG001|Overall Study|Lost to Follow-up|5|||
147368756|NCT03150862|531518512|FG003|Overall Study|Withdrawal by Subject|3|||
147368757|NCT03150862|531518513|FG004|Overall Study|Withdrawal by Subject|1|||
147368758|NCT03150862|531518514|FG005|Overall Study|Withdrawal by Subject|1|||
147368759|NCT03150862|531518515|FG006|Overall Study|Withdrawal by Subject|1|||
147368760|NCT03150862|531518516|FG007|Overall Study|Withdrawal by Subject|3|||
147368761|NCT03150862|531518509|FG000|Overall Study|Lost to Follow-up|0|||
147368762|NCT03150862|531518510|FG001|Overall Study|Lost to Follow-up|0|||
147368763|NCT03150862|531518511|FG002|Overall Study|Lost to Follow-up|1|||
147368764|NCT03150862|531518512|FG003|Overall Study|Lost to Follow-up|0|||
147368765|NCT03150862|531518513|FG004|Overall Study|Lost to Follow-up|0|||
147368766|NCT03150862|531518514|FG005|Overall Study|Lost to Follow-up|0|||
147368767|NCT03150862|531518515|FG006|Overall Study|Lost to Follow-up|0|||
147368768|NCT03150862|531518516|FG007|Overall Study|Lost to Follow-up|2|||
147368769|NCT03150862|531518509|FG000|Overall Study|Sponsor's decision|0|||
147368770|NCT03150862|531518510|FG001|Overall Study|Sponsor's decision|0|||
147368771|NCT03150862|531518511|FG002|Overall Study|Sponsor's decision|0|||
147368772|NCT03150862|531518512|FG003|Overall Study|Sponsor's decision|10|||
147368773|NCT03150862|531518513|FG004|Overall Study|Sponsor's decision|3|||
147368774|NCT03150862|531518514|FG005|Overall Study|Sponsor's decision|0|||
147368775|NCT03150862|531518515|FG006|Overall Study|Sponsor's decision|1|||
147368776|NCT03150862|531518516|FG007|Overall Study|Sponsor's decision|1|||
147368777|NCT03150862|531518509|FG000|Overall Study|Change in Methylation status|0|||
147368778|NCT03150862|531518510|FG001|Overall Study|Change in Methylation status|0|||
147368779|NCT03150862|531518511|FG002|Overall Study|Change in Methylation status|0|||
147368780|NCT03150862|531518512|FG003|Overall Study|Change in Methylation status|0|||
147368781|NCT03150862|531518513|FG004|Overall Study|Change in Methylation status|1|||
147368782|NCT03150862|531518514|FG005|Overall Study|Change in Methylation status|0|||
147368783|NCT03150862|531518515|FG006|Overall Study|Change in Methylation status|0|||
147609849|NCT03888066|532388876|FG001|Run-in Phase|Randomization Criterion #3; Physician Decision|0|||
147609850|NCT03888066|532388875|FG000|Run-in Phase|Randomization Criterion #4; AE|4|||
147609851|NCT03888066|532388876|FG001|Run-in Phase|Randomization Criterion #4; AE|0|||
147609852|NCT03888066|532388875|FG000|Run-in Phase|Randomization Criterion #4; AE; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|1|||
147609853|NCT03888066|532388876|FG001|Run-in Phase|Randomization Criterion #4; AE; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|0|||
147609854|NCT03888066|532388875|FG000|Run-in Phase|Randomization Criterion #3; Exceeded 12 Weeks Of Run In|1|||
147609855|NCT03888066|532388876|FG001|Run-in Phase|Randomization Criterion #3; Exceeded 12 Weeks Of Run In|0|||
147609856|NCT03888066|532388875|FG000|Run-in Phase|Randomization Criterion #4; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|2|||
147609857|NCT03888066|532388876|FG001|Run-in Phase|Randomization Criterion #4; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
147609858|NCT03888066|532388875|FG000|Run-in Phase|Randomization Criterion #4; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|1|||
147609859|NCT03888066|532388876|FG001|Run-in Phase|Randomization Criterion #4; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|0|||
147609860|NCT03888066|532388875|FG000|Run-in Phase|AE (Adverse Event)|17|||
147609861|NCT03888066|532388876|FG001|Run-in Phase|AE (Adverse Event)|0|||
147609862|NCT03888066|532388875|FG000|Run-in Phase|AE; Withdrawal By Subject|3|||
147609863|NCT03888066|532388876|FG001|Run-in Phase|AE; Withdrawal By Subject|0|||
147609864|NCT03888066|532388875|FG000|Run-in Phase|AE; Withdrawal By Subject; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
147609865|NCT03888066|532388876|FG001|Run-in Phase|AE; Withdrawal By Subject; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
147609866|NCT03888066|532388875|FG000|Run-in Phase|AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|1|||
147609867|NCT03888066|532388876|FG001|Run-in Phase|AE; 1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
147609868|NCT03888066|532388875|FG000|Run-in Phase|AE; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|2|||
147609869|NCT03888066|532388876|FG001|Run-in Phase|AE; 2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|0|||
147609870|NCT03888066|532388875|FG000|Run-in Phase|Withdrawal by Subject|43|||
147609871|NCT03888066|532388876|FG001|Run-in Phase|Withdrawal by Subject|0|||
147609872|NCT03888066|532388875|FG000|Run-in Phase|AE; Physician Decision|1|||
147609873|NCT03888066|532388876|FG001|Run-in Phase|AE; Physician Decision|0|||
147609874|NCT03888066|532388875|FG000|Run-in Phase|1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|10|||
147609875|NCT03888066|532388876|FG001|Run-in Phase|1 Wk After 3 Patiromer Packets/Day, sK+ >5.0 Meq/L|0|||
147609876|NCT03888066|532388875|FG000|Run-in Phase|Withdrawal By Subject; Withdrawal Of Consent|1|||
147609877|NCT03888066|532388876|FG001|Run-in Phase|Withdrawal By Subject; Withdrawal Of Consent|0|||
147609878|NCT03888066|532388875|FG000|Run-in Phase|2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|6|||
147609879|NCT03888066|532388876|FG001|Run-in Phase|2 Wks After Taking Min 0 Packet/Day, sK+ Is < 4.0 Meq/L|0|||
147609880|NCT03888066|532388875|FG000|Run-in Phase|Death|1|||
147609881|NCT03888066|532388876|FG001|Run-in Phase|Death|0|||
147609882|NCT03888066|532388875|FG000|Run-in Phase|Non-Compliance With Study Drug|2|||
147609883|NCT03888066|532388876|FG001|Run-in Phase|Non-Compliance With Study Drug|0|||
147609884|NCT03888066|532388875|FG000|Run-in Phase|Physician Decision|1|||
147609885|NCT03888066|532388876|FG001|Run-in Phase|Physician Decision|0|||
147609886|NCT03888066|532388875|FG000|Run-in Phase|Protocol Violation|13|||
147609887|NCT03888066|532388876|FG001|Run-in Phase|Protocol Violation|0|||
147609888|NCT03888066|532388875|FG000|Run-in Phase|Sponsor Request|34|||
147609889|NCT03888066|532388876|FG001|Run-in Phase|Sponsor Request|0|||
147368784|NCT03150862|531518516|FG007|Overall Study|Change in Methylation status|0|||
147368785|NCT03150862|531518509|FG000|Overall Study|Roll over in to Long Term Extension|0|||
147368786|NCT03150862|531518510|FG001|Overall Study|Roll over in to Long Term Extension|0|||
147368787|NCT03150862|531518511|FG002|Overall Study|Roll over in to Long Term Extension|0|||
147368788|NCT03150862|531518512|FG003|Overall Study|Roll over in to Long Term Extension|0|||
147609890|NCT03888066|532388875|FG000|Run-in Phase|Study Terminated By Sponsor|71|||
147609891|NCT03888066|532388876|FG001|Run-in Phase|Study Terminated By Sponsor|0|||
147609892|NCT03888066|532388875|FG000|Run-in Phase|Withdrawal Of Consent|1|||
147609893|NCT03888066|532388876|FG001|Run-in Phase|Withdrawal Of Consent|0|||
147609894|NCT03888066|532388875|FG000|Run-in Phase|Exceeded 12 Weeks Of Run In|2|||
147609895|NCT03888066|532388876|FG001|Run-in Phase|Exceeded 12 Weeks Of Run In|0|||
147609896|NCT03888066|532388875|FG000|Run-in Phase|Not treated with Patiromer during Run-in|27|||
147609897|NCT03888066|532388876|FG001|Run-in Phase|Not treated with Patiromer during Run-in|0|||
147609898|NCT03888066|532388875|FG000|Treatment Phase (Overall Study)|Protocol Violation|0|||
147609899|NCT03888066|532388876|FG001|Treatment Phase (Overall Study)|Protocol Violation|1|||
147609900|NCT03888066|532388875|FG000|Treatment Phase (Overall Study)|Physician Decision|20|||
147609901|NCT03888066|532388876|FG001|Treatment Phase (Overall Study)|Physician Decision|13|||
147609902|NCT03888066|532388875|FG000|Treatment Phase (Overall Study)|Adverse Event|27|||
147609903|NCT03888066|532388876|FG001|Treatment Phase (Overall Study)|Adverse Event|21|||
147609904|NCT03888066|532388875|FG000|Treatment Phase (Overall Study)|Lost to Follow-up|1|||
147609905|NCT03888066|532388876|FG001|Treatment Phase (Overall Study)|Lost to Follow-up|0|||
147609906|NCT03888066|532388875|FG000|Treatment Phase (Overall Study)|Consent withdrawn by subject|21|||
147609907|NCT03888066|532388876|FG001|Treatment Phase (Overall Study)|Consent withdrawn by subject|25|||
147609908|NCT03888066|532388875|FG000|Treatment Phase (Overall Study)|End of study visit not completed/delayed|1|||
147609909|NCT03888066|532388876|FG001|Treatment Phase (Overall Study)|End of study visit not completed/delayed|3|||
147609910|NCT03888066|532388875|FG000|Treatment Phase (Overall Study)|Early study termination|0|||
147609911|NCT03888066|532388876|FG001|Treatment Phase (Overall Study)|Early study termination|1|||
147609912|NCT03888066|532388875|FG000|Treatment Phase (Overall Study)|Treatment discontinuation|2|||
147609913|NCT03888066|532388876|FG001|Treatment Phase (Overall Study)|Treatment discontinuation|2|||
147609914|NCT03888066|532388875|FG000|Treatment Phase (Overall Study)|Delayed visit and insufficient study|6|||
147609915|NCT03888066|532388876|FG001|Treatment Phase (Overall Study)|Delayed visit and insufficient study|6|||
147609916|NCT03888066|532388875|FG000|Treatment Phase (Overall Study)|Sponsor's decision|1|||
147609917|NCT03888066|532388876|FG001|Treatment Phase (Overall Study)|Sponsor's decision|0|||
147609918|NCT02207634|532388877|FG000|Overall Study|Withdrawal by Subject|21|||
147609919|NCT02207634|532388878|FG001|Overall Study|Withdrawal by Subject|31|||
147609920|NCT02207634|532388877|FG000|Overall Study|Lost to Follow-up|1|||
147609921|NCT02207634|532388878|FG001|Overall Study|Lost to Follow-up|0|||
147609922|NCT02077140|532388879|FG000|Overall Study|Lost to Follow-up|4|||
147609923|NCT02077140|532388880|FG001|Overall Study|Lost to Follow-up|1|||
147609924|NCT02077140|532388881|FG002|Overall Study|Lost to Follow-up|2|||
147609925|NCT02077140|532388882|FG003|Overall Study|Lost to Follow-up|2|||
147609926|NCT02077140|532388883|FG004|Overall Study|Lost to Follow-up|3|||
147609927|NCT02077140|532388879|FG000|Overall Study|Withdrawal by Subject|0|||
147609928|NCT02077140|532388880|FG001|Overall Study|Withdrawal by Subject|1|||
147609929|NCT02077140|532388881|FG002|Overall Study|Withdrawal by Subject|0|||
147609930|NCT02077140|532388882|FG003|Overall Study|Withdrawal by Subject|2|||
147609931|NCT02077140|532388883|FG004|Overall Study|Withdrawal by Subject|2|||
147609932|NCT00459355|532388884|FG000|Overall Study|Subject no longer met inc criteria|20|||
147609933|NCT00459355|532388885|FG001|Overall Study|Subject no longer met inc criteria|18|||
147609934|NCT01762800|532388888|FG000|Overall Study|Adverse Event|8|||
147609935|NCT01762800|532388889|FG001|Overall Study|Adverse Event|13|||
147609936|NCT01762800|532388888|FG000|Overall Study|Lack of Efficacy|3|||
147609937|NCT01762800|532388889|FG001|Overall Study|Lack of Efficacy|2|||
147609938|NCT01762800|532388888|FG000|Overall Study|Study Closed/Terminated|0|||
147609939|NCT01762800|532388889|FG001|Overall Study|Study Closed/Terminated|1|||
147609940|NCT01762800|532388888|FG000|Overall Study|Physician Decision|1|||
147609941|NCT01762800|532388889|FG001|Overall Study|Physician Decision|1|||
147663222|NCT00810199|532589243|FG000|Overall Study|Adverse Event|24|||
147663223|NCT00810199|532589244|FG001|Overall Study|Adverse Event|26|||
147609942|NCT01762800|532388888|FG000|Overall Study|Withdrawal by Subject|7|||
147609943|NCT01762800|532388889|FG001|Overall Study|Withdrawal by Subject|4|||
147609944|NCT01173120|532388891|FG000|Overall Study|Lack of Efficacy|2|||
147609945|NCT01173120|532388891|FG000|Overall Study|Lost to Follow-up|1|||
147609946|NCT01173120|532388891|FG000|Overall Study|Participant Decision|2|||
147609947|NCT01173120|532388891|FG000|Overall Study|Switch-Administrative Reason By Sponsor|33|||
147609948|NCT01173120|532388891|FG000|Overall Study|Switch-Participant Decision|12|||
147609949|NCT01173120|532388891|FG000|Overall Study|Switch-Difficulty With Device|12|||
147609950|NCT02847260|532388892|FG000|Overall Study|Adverse Event|3|||
147609951|NCT02847260|532388892|FG000|Overall Study|Withdrawal by Subject|2|||
147609952|NCT02847260|532388892|FG000|Overall Study|Clinical Deterioration|1|||
147663224|NCT00810199|532589243|FG000|Overall Study|Death|4|||
147609953|NCT02847260|532388892|FG000|Overall Study|Physician Decision|1|||
147609954|NCT02906358|532388893|FG000|Overall Study|Withdrawal by Subject|10|||
147609955|NCT02906358|532388894|FG001|Overall Study|Withdrawal by Subject|7|||
147609956|NCT02906358|532388893|FG000|Overall Study|Lost to Follow-up|12|||
147609957|NCT02906358|532388894|FG001|Overall Study|Lost to Follow-up|15|||
147663225|NCT00810199|532589244|FG001|Overall Study|Death|6|||
147663226|NCT00810199|532589243|FG000|Overall Study|Withdrew consent|9|||
147368789|NCT03150862|531518513|FG004|Overall Study|Roll over in to Long Term Extension|0|||
147368790|NCT03150862|531518514|FG005|Overall Study|Roll over in to Long Term Extension|0|||
147368791|NCT03150862|531518515|FG006|Overall Study|Roll over in to Long Term Extension|0|||
147368792|NCT03150862|531518516|FG007|Overall Study|Roll over in to Long Term Extension|1|||
147368793|NCT03150862|531518509|FG000|Overall Study|Progressive Disease|0|||
147368794|NCT03150862|531518510|FG001|Overall Study|Progressive Disease|0|||
147368795|NCT03150862|531518511|FG002|Overall Study|Progressive Disease|0|||
147368796|NCT03150862|531518512|FG003|Overall Study|Progressive Disease|0|||
147368797|NCT03150862|531518513|FG004|Overall Study|Progressive Disease|0|||
147368798|NCT03150862|531518514|FG005|Overall Study|Progressive Disease|0|||
147368799|NCT03150862|531518515|FG006|Overall Study|Progressive Disease|0|||
147368800|NCT03150862|531518516|FG007|Overall Study|Progressive Disease|2|||
147368801|NCT05039021|531518982|FG000|Overall Study|Death|1|||
147368802|NCT05039021|531518982|FG000|Overall Study|Lost to Follow-up|3|||
147368803|NCT02719574|531518983|FG000|Phase 1 (Dose Escalation)|Other|0|||
147368804|NCT02719574|531518984|FG001|Phase 1 (Dose Escalation)|Other|2|||
147368805|NCT02719574|531518985|FG002|Phase 1 (Dose Escalation)|Other|1|||
147368806|NCT02719574|531518986|FG003|Phase 1 (Dose Escalation)|Other|2|||
147368807|NCT02719574|531518987|FG004|Phase 1 (Dose Escalation)|Other|2|||
147368808|NCT02719574|531518988|FG005|Phase 1 (Dose Escalation)|Other|0|||
147368809|NCT02719574|531518989|FG006|Phase 1 (Dose Escalation)|Other|0|||
147368810|NCT02719574|531518990|FG007|Phase 1 (Dose Escalation)|Other|0|||
147368811|NCT02719574|531518991|FG008|Phase 1 (Dose Escalation)|Other|0|||
147368812|NCT02719574|531518992|FG009|Phase 1 (Dose Escalation)|Other|0|||
147368813|NCT02719574|531518993|FG010|Phase 1 (Dose Escalation)|Other|0|||
147368814|NCT02719574|531518994|FG011|Phase 1 (Dose Escalation)|Other|0|||
147368815|NCT02719574|531518995|FG012|Phase 1 (Dose Escalation)|Other|0|||
147368816|NCT02719574|531518996|FG013|Phase 1 (Dose Escalation)|Other|0|||
147368817|NCT02719574|531518997|FG014|Phase 1 (Dose Escalation)|Other|0|||
147368818|NCT02719574|531518998|FG015|Phase 1 (Dose Escalation)|Other|0|||
147368819|NCT02719574|531518999|FG016|Phase 1 (Dose Escalation)|Other|0|||
147368820|NCT02719574|531518983|FG000|Phase 1 (Dose Escalation)|Progressive Disease|1|||
147368821|NCT02719574|531518984|FG001|Phase 1 (Dose Escalation)|Progressive Disease|3|||
147368822|NCT02719574|531518985|FG002|Phase 1 (Dose Escalation)|Progressive Disease|2|||
147368823|NCT02719574|531518986|FG003|Phase 1 (Dose Escalation)|Progressive Disease|2|||
147368824|NCT02719574|531518987|FG004|Phase 1 (Dose Escalation)|Progressive Disease|1|||
147663227|NCT00810199|532589244|FG001|Overall Study|Withdrew consent|12|||
147663228|NCT00810199|532589243|FG000|Overall Study|Insufficient therapeutic response|5|||
147663229|NCT00810199|532589244|FG001|Overall Study|Insufficient therapeutic response|14|||
147663230|NCT00810199|532589243|FG000|Overall Study|Refused treatment/Did not cooperate|7|||
147663231|NCT00810199|532589244|FG001|Overall Study|Refused treatment/Did not cooperate|7|||
147663232|NCT00810199|532589243|FG000|Overall Study|Administrative/Other|5|||
147368825|NCT02719574|531518988|FG005|Phase 1 (Dose Escalation)|Progressive Disease|3|||
147368826|NCT02719574|531518989|FG006|Phase 1 (Dose Escalation)|Progressive Disease|0|||
147368827|NCT02719574|531518990|FG007|Phase 1 (Dose Escalation)|Progressive Disease|0|||
147368828|NCT02719574|531518991|FG008|Phase 1 (Dose Escalation)|Progressive Disease|0|||
147368829|NCT02719574|531518992|FG009|Phase 1 (Dose Escalation)|Progressive Disease|0|||
147368830|NCT02719574|531518993|FG010|Phase 1 (Dose Escalation)|Progressive Disease|0|||
147368831|NCT02719574|531518994|FG011|Phase 1 (Dose Escalation)|Progressive Disease|0|||
147368832|NCT02719574|531518995|FG012|Phase 1 (Dose Escalation)|Progressive Disease|0|||
147368833|NCT02719574|531518996|FG013|Phase 1 (Dose Escalation)|Progressive Disease|0|||
147368834|NCT02719574|531518997|FG014|Phase 1 (Dose Escalation)|Progressive Disease|0|||
147368835|NCT02719574|531518998|FG015|Phase 1 (Dose Escalation)|Progressive Disease|0|||
147368836|NCT02719574|531518999|FG016|Phase 1 (Dose Escalation)|Progressive Disease|0|||
147368837|NCT02719574|531518983|FG000|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
147368838|NCT02719574|531518984|FG001|Phase 1 (Dose Escalation)|HSCT Transplant|1|||
147368839|NCT02719574|531518985|FG002|Phase 1 (Dose Escalation)|HSCT Transplant|2|||
147368840|NCT02719574|531518986|FG003|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
147368841|NCT02719574|531518987|FG004|Phase 1 (Dose Escalation)|HSCT Transplant|2|||
147368842|NCT02719574|531518988|FG005|Phase 1 (Dose Escalation)|HSCT Transplant|2|||
147368843|NCT02719574|531518989|FG006|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
147368844|NCT02719574|531518990|FG007|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
147454567|NCT01081795|531825635|FG002|Overall Study|Revocation of informed consent|0|||
147663233|NCT00810199|532589244|FG001|Overall Study|Administrative/Other|6|||
147368845|NCT02719574|531518991|FG008|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
147368846|NCT02719574|531518992|FG009|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
147368847|NCT02719574|531518993|FG010|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
147368848|NCT02719574|531518994|FG011|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
147368849|NCT02719574|531518995|FG012|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
147368850|NCT02719574|531518996|FG013|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
147368851|NCT02719574|531518997|FG014|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
147368852|NCT02719574|531518998|FG015|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
147368853|NCT02719574|531518999|FG016|Phase 1 (Dose Escalation)|HSCT Transplant|0|||
147368854|NCT02719574|531518983|FG000|Phase 1 (Dose Escalation)|Death|2|||
147368855|NCT02719574|531518984|FG001|Phase 1 (Dose Escalation)|Death|1|||
147368856|NCT02719574|531518985|FG002|Phase 1 (Dose Escalation)|Death|1|||
147663234|NCT00810199|532589243|FG000|Overall Study|Protocol Violation|2|||
147663235|NCT00810199|532589244|FG001|Overall Study|Protocol Violation|6|||
147663236|NCT00810199|532589243|FG000|Overall Study|Failure to return|1|||
147663237|NCT00810199|532589244|FG001|Overall Study|Failure to return|4|||
147663238|NCT00810199|532589243|FG000|Overall Study|Did not receive study drug|2|||
147663239|NCT00810199|532589244|FG001|Overall Study|Did not receive study drug|1|||
147663240|NCT00992017|532589246|FG000|Overall Study|Lost to Follow-up|2|||
147663241|NCT00992017|532589246|FG000|Overall Study|Withdrawal by Subject|2|||
147663242|NCT00992017|532589246|FG000|Overall Study|Unable to get to clinic|5|||
147663243|NCT00992017|532589246|FG000|Overall Study|Not adhere to study requirements|1|||
147663244|NCT02864407|532589247|FG000|Overall Study|Protocol Violation|3|||
147663245|NCT02864407|532589247|FG000|Overall Study|Lost to Follow-up|115|||
147663246|NCT02864407|532589247|FG000|Overall Study|Not treated with Vahelva® Respimat®|1|||
147663247|NCT02864407|532589247|FG000|Overall Study|Were administered Vahelva® Respimat® prior to the consent date|3|||
147663248|NCT02864407|532589247|FG000|Overall Study|Consent prior to the contract date|1|||
147663249|NCT02287038|532589257|FG000|Overall Study|Stopped attending appointments|3|||
147663250|NCT02287038|532589258|FG001|Overall Study|Stopped attending appointments|2|||
147663251|NCT02287038|532589257|FG000|Overall Study|Anxiety after starting medication|0|||
147663252|NCT02287038|532589258|FG001|Overall Study|Anxiety after starting medication|1|||
147663253|NCT02287038|532589257|FG000|Overall Study|Nausea after starting medication|1|||
147663254|NCT02287038|532589258|FG001|Overall Study|Nausea after starting medication|0|||
147663255|NCT02287038|532589257|FG000|Overall Study|Abnormal ECG after starting medication|1|||
147663256|NCT02287038|532589258|FG001|Overall Study|Abnormal ECG after starting medication|0|||
147663257|NCT05502302|532589266|FG000|Overall Study|Lost to Follow-up|6|||
147663258|NCT05502302|532589266|FG000|Overall Study|Death|2|||
147663259|NCT02155985|532589270|FG000|Overall Study|Withdrawal by Subject|0|||
147663260|NCT02155985|532589271|FG001|Overall Study|Withdrawal by Subject|0|||
147663261|NCT02155985|532589272|FG002|Overall Study|Withdrawal by Subject|1|||
147368857|NCT02719574|531518986|FG003|Phase 1 (Dose Escalation)|Death|0|||
147368858|NCT02719574|531518987|FG004|Phase 1 (Dose Escalation)|Death|0|||
147368859|NCT02719574|531518988|FG005|Phase 1 (Dose Escalation)|Death|0|||
147368860|NCT02719574|531518989|FG006|Phase 1 (Dose Escalation)|Death|0|||
147368861|NCT02719574|531518990|FG007|Phase 1 (Dose Escalation)|Death|0|||
147368862|NCT02719574|531518991|FG008|Phase 1 (Dose Escalation)|Death|0|||
147368863|NCT02719574|531518992|FG009|Phase 1 (Dose Escalation)|Death|0|||
147368864|NCT02719574|531518993|FG010|Phase 1 (Dose Escalation)|Death|0|||
147368865|NCT02719574|531518994|FG011|Phase 1 (Dose Escalation)|Death|0|||
147368866|NCT02719574|531518995|FG012|Phase 1 (Dose Escalation)|Death|0|||
147368867|NCT02719574|531518996|FG013|Phase 1 (Dose Escalation)|Death|0|||
147368868|NCT02719574|531518997|FG014|Phase 1 (Dose Escalation)|Death|0|||
147368869|NCT02719574|531518998|FG015|Phase 1 (Dose Escalation)|Death|0|||
147368870|NCT02719574|531518999|FG016|Phase 1 (Dose Escalation)|Death|0|||
147368871|NCT02719574|531518983|FG000|Phase 1 (Dose Escalation)|Adverse Event|0|||
147368872|NCT02719574|531518984|FG001|Phase 1 (Dose Escalation)|Adverse Event|1|||
147368873|NCT02719574|531518985|FG002|Phase 1 (Dose Escalation)|Adverse Event|0|||
147368874|NCT02719574|531518986|FG003|Phase 1 (Dose Escalation)|Adverse Event|0|||
147368875|NCT02719574|531518987|FG004|Phase 1 (Dose Escalation)|Adverse Event|1|||
147368876|NCT02719574|531518988|FG005|Phase 1 (Dose Escalation)|Adverse Event|1|||
147368877|NCT02719574|531518989|FG006|Phase 1 (Dose Escalation)|Adverse Event|0|||
147368878|NCT02719574|531518990|FG007|Phase 1 (Dose Escalation)|Adverse Event|0|||
147368879|NCT02719574|531518991|FG008|Phase 1 (Dose Escalation)|Adverse Event|0|||
147368880|NCT02719574|531518992|FG009|Phase 1 (Dose Escalation)|Adverse Event|0|||
147368881|NCT02719574|531518993|FG010|Phase 1 (Dose Escalation)|Adverse Event|0|||
147368882|NCT02719574|531518994|FG011|Phase 1 (Dose Escalation)|Adverse Event|0|||
147368883|NCT02719574|531518995|FG012|Phase 1 (Dose Escalation)|Adverse Event|0|||
147368884|NCT02719574|531518996|FG013|Phase 1 (Dose Escalation)|Adverse Event|0|||
147368885|NCT02719574|531518997|FG014|Phase 1 (Dose Escalation)|Adverse Event|0|||
147368886|NCT02719574|531518998|FG015|Phase 1 (Dose Escalation)|Adverse Event|0|||
147368887|NCT02719574|531518999|FG016|Phase 1 (Dose Escalation)|Adverse Event|0|||
147368888|NCT02719574|531518983|FG000|Phase 1 (Dose Escalation)|Physician Decision|0|||
147368889|NCT02719574|531518984|FG001|Phase 1 (Dose Escalation)|Physician Decision|0|||
147368890|NCT02719574|531518985|FG002|Phase 1 (Dose Escalation)|Physician Decision|0|||
147368891|NCT02719574|531518986|FG003|Phase 1 (Dose Escalation)|Physician Decision|0|||
147368892|NCT02719574|531518987|FG004|Phase 1 (Dose Escalation)|Physician Decision|1|||
147368893|NCT02719574|531518988|FG005|Phase 1 (Dose Escalation)|Physician Decision|2|||
147368894|NCT02719574|531518989|FG006|Phase 1 (Dose Escalation)|Physician Decision|0|||
147368895|NCT02719574|531518990|FG007|Phase 1 (Dose Escalation)|Physician Decision|0|||
147368896|NCT02719574|531518991|FG008|Phase 1 (Dose Escalation)|Physician Decision|0|||
147368897|NCT02719574|531518992|FG009|Phase 1 (Dose Escalation)|Physician Decision|0|||
147368898|NCT02719574|531518993|FG010|Phase 1 (Dose Escalation)|Physician Decision|0|||
147663262|NCT02155985|532589270|FG000|Overall Study|Lost to Follow-up|1|||
147663263|NCT02155985|532589271|FG001|Overall Study|Lost to Follow-up|0|||
147663264|NCT02155985|532589272|FG002|Overall Study|Lost to Follow-up|0|||
147663265|NCT02998151|532589275|FG000|Overall Study|Withdrawal by Subject|3|||
147663266|NCT02998151|532589275|FG000|Overall Study|Participant declined to re-enroll for baclofen|8|||
147454568|NCT01081795|531825633|FG000|Overall Study|Ineligible for participation|1|||
147609958|NCT02699684|532388895|FG000|Period 2, Second 30 Days of Wear|Adverse Event|1|||
147609959|NCT02699684|532388896|FG001|Period 2, Second 30 Days of Wear|Adverse Event|0|||
147609960|NCT01145508|532388897|FG000|Overall Study|Adverse Event|1|||
147609961|NCT01145508|532388898|FG001|Overall Study|Adverse Event|0|||
147609962|NCT01145508|532388897|FG000|Overall Study|Death|1|||
147609963|NCT01145508|532388898|FG001|Overall Study|Death|0|||
147609964|NCT01145508|532388897|FG000|Overall Study|Physician Decision|2|||
147609965|NCT01145508|532388898|FG001|Overall Study|Physician Decision|1|||
147609966|NCT01145508|532388897|FG000|Overall Study|Never started treatment|1|||
147609967|NCT01145508|532388898|FG001|Overall Study|Never started treatment|1|||
147609968|NCT02111603|532388907|FG000|Overall Study|Withdrawal by Subject|1|||
147609969|NCT00799825|532388910|FG000|Overall Study|Adverse Event|1|||
147609970|NCT00799825|532388910|FG000|Overall Study|Withdrawal by Subject|6|||
147454569|NCT01081795|531825634|FG001|Overall Study|Ineligible for participation|0|||
147454570|NCT01081795|531825635|FG002|Overall Study|Ineligible for participation|0|||
147454571|NCT01081795|531825633|FG000|Overall Study|Use of a prohibited concomitant drug|1|||
147609971|NCT00799825|532388910|FG000|Overall Study|Lost to Follow-up|38|||
147609972|NCT00799825|532388910|FG000|Overall Study|Pregnancy|3|||
147609973|NCT00492778|532388914|FG000|Overall Study|Ineligible by Pathology Review|8|||
147609974|NCT00492778|532388915|FG001|Overall Study|Ineligible by Pathology Review|1|||
147609975|NCT01098474|532388920|FG000|Active Phase|Other|0|||
147300060|NCT02277990|531264598|FG001|Overall Study|Physician Decision|34|||
147300061|NCT02277990|531264597|FG000|Overall Study|Lost to Follow-up|66|||
147300062|NCT02277990|531264598|FG001|Overall Study|Lost to Follow-up|69|||
147300063|NCT02277990|531264597|FG000|Overall Study|Had other reason|26|||
147300064|NCT02277990|531264598|FG001|Overall Study|Had other reason|32|||
147300065|NCT03351738|531264599|FG000|Overall Study|Withdrawal by Subject|0|||
147300066|NCT03351738|531264600|FG001|Overall Study|Withdrawal by Subject|1|||
147300067|NCT03351738|531264601|FG002|Overall Study|Withdrawal by Subject|0|||
147300068|NCT03351738|531264602|FG003|Overall Study|Withdrawal by Subject|1|||
147300069|NCT03351738|531264603|FG004|Overall Study|Withdrawal by Subject|0|||
147300070|NCT03351738|531264604|FG005|Overall Study|Withdrawal by Subject|0|||
147300071|NCT05479604|531264609|FG000|Overall Study|Lost to Follow-up|1|||
147300072|NCT05479604|531264610|FG001|Overall Study|Lost to Follow-up|5|||
147300073|NCT03138733|531264613|FG000|Overall Study|Death|17|||
147300074|NCT03138733|531264614|FG001|Overall Study|Death|18|||
147300075|NCT03138733|531264613|FG000|Overall Study|Withdrawal by Subject|11|||
147300076|NCT03138733|531264614|FG001|Overall Study|Withdrawal by Subject|6|||
147300077|NCT03138733|531264613|FG000|Overall Study|Lost to Follow-up|3|||
147300078|NCT03138733|531264614|FG001|Overall Study|Lost to Follow-up|2|||
147300079|NCT03138733|531264613|FG000|Overall Study|Adverse Event|1|||
147300080|NCT03138733|531264614|FG001|Overall Study|Adverse Event|0|||
147300081|NCT03138733|531264613|FG000|Overall Study|Protocol Violation|1|||
147300082|NCT03138733|531264614|FG001|Overall Study|Protocol Violation|3|||
147300083|NCT03138733|531264613|FG000|Overall Study|Administrative or logistical reason|1|||
147300084|NCT03138733|531264614|FG001|Overall Study|Administrative or logistical reason|0|||
147300085|NCT03138733|531264613|FG000|Overall Study|The patient was transferred to another hospital|1|||
147300086|NCT03138733|531264614|FG001|Overall Study|The patient was transferred to another hospital|0|||
147300087|NCT03641313|531264620|FG000|Overall Study|Death|1|||
147300088|NCT03641313|531264620|FG000|Overall Study|Withdrawal by Subject|2|||
147300089|NCT03641313|531264620|FG000|Overall Study|Declining health|1|||
147300090|NCT03641313|531264620|FG000|Overall Study|Adverse Event|1|||
147300091|NCT03033225|531264621|FG000|Overall Study|Withdrawal by Subject|5|||
147300092|NCT00946296|531264622|FG000|Overall Study|Physician Decision|3|||
147300093|NCT00946296|531264623|FG001|Overall Study|Physician Decision|0|||
147300094|NCT03434678|531264626|FG000|Overall Study|Withdrawal by Subject|13|||
147300095|NCT03434678|531264627|FG001|Overall Study|Withdrawal by Subject|13|||
147300096|NCT03434678|531264626|FG000|Overall Study|Found to be ineligible post randomization|2|||
147300097|NCT03434678|531264627|FG001|Overall Study|Found to be ineligible post randomization|1|||
147300098|NCT06060457|531264630|FG000|Overall Study|Adverse Event|1|||
147300099|NCT06060457|531264631|FG001|Overall Study|Adverse Event|1|||
147300100|NCT06060457|531264630|FG000|Overall Study|Death|2|||
147300101|NCT06060457|531264631|FG001|Overall Study|Death|2|||
147300102|NCT06060457|531264630|FG000|Overall Study|Lost to Follow-up|17|||
147300103|NCT06060457|531264631|FG001|Overall Study|Lost to Follow-up|19|||
147300104|NCT06060457|531264630|FG000|Overall Study|Physician Decision|0|||
147300105|NCT06060457|531264631|FG001|Overall Study|Physician Decision|1|||
147300106|NCT06060457|531264630|FG000|Overall Study|Protocol Violation|1|||
147300107|NCT06060457|531264631|FG001|Overall Study|Protocol Violation|1|||
147300108|NCT06060457|531264630|FG000|Overall Study|Serious Adverse Reaction (SAR)/Reactogenicity Event|1|||
147300109|NCT06060457|531264631|FG001|Overall Study|Serious Adverse Reaction (SAR)/Reactogenicity Event|1|||
147300110|NCT06060457|531264630|FG000|Overall Study|Withdrawal by Subject|12|||
147300111|NCT06060457|531264631|FG001|Overall Study|Withdrawal by Subject|15|||
147300112|NCT06060457|531264630|FG000|Overall Study|Other Than Specified|2|||
147368899|NCT02719574|531518994|FG011|Phase 1 (Dose Escalation)|Physician Decision|0|||
147368900|NCT02719574|531518995|FG012|Phase 1 (Dose Escalation)|Physician Decision|0|||
147368901|NCT02719574|531518996|FG013|Phase 1 (Dose Escalation)|Physician Decision|0|||
147368902|NCT02719574|531518997|FG014|Phase 1 (Dose Escalation)|Physician Decision|0|||
147368903|NCT02719574|531518998|FG015|Phase 1 (Dose Escalation)|Physician Decision|0|||
147368904|NCT02719574|531518999|FG016|Phase 1 (Dose Escalation)|Physician Decision|0|||
147368905|NCT02719574|531518983|FG000|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
147368906|NCT02719574|531518984|FG001|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
147368907|NCT02719574|531518985|FG002|Phase 1 (Dose Escalation)|Withdrawal by Subject|1|||
147368908|NCT02719574|531518986|FG003|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
147609976|NCT01098474|532388921|FG001|Active Phase|Other|0|||
147609977|NCT01098474|532388922|FG002|Active Phase|Other|3|||
147609978|NCT01098474|532388923|FG003|Active Phase|Other|0|||
147609979|NCT01098474|532388924|FG004|Active Phase|Other|0|||
147609980|NCT01098474|532388925|FG005|Active Phase|Other|0|||
147609981|NCT01098474|532388920|FG000|Active Phase|Withdrawal by Subject|1|||
147609982|NCT01098474|532388921|FG001|Active Phase|Withdrawal by Subject|1|||
147609983|NCT01098474|532388922|FG002|Active Phase|Withdrawal by Subject|2|||
147609984|NCT01098474|532388923|FG003|Active Phase|Withdrawal by Subject|0|||
147609985|NCT01098474|532388924|FG004|Active Phase|Withdrawal by Subject|0|||
147609986|NCT01098474|532388925|FG005|Active Phase|Withdrawal by Subject|0|||
147609987|NCT01098474|532388920|FG000|Active Phase|Lost to Follow-up|1|||
147609988|NCT01098474|532388921|FG001|Active Phase|Lost to Follow-up|0|||
147609989|NCT01098474|532388922|FG002|Active Phase|Lost to Follow-up|0|||
147609990|NCT01098474|532388923|FG003|Active Phase|Lost to Follow-up|0|||
147609991|NCT01098474|532388924|FG004|Active Phase|Lost to Follow-up|0|||
147609992|NCT01098474|532388925|FG005|Active Phase|Lost to Follow-up|0|||
147609993|NCT01098474|532388920|FG000|Follow Up Phase|Travelled out of study area|0|||
147609994|NCT01098474|532388921|FG001|Follow Up Phase|Travelled out of study area|0|||
147609995|NCT01098474|532388922|FG002|Follow Up Phase|Travelled out of study area|0|||
147609996|NCT01098474|532388923|FG003|Follow Up Phase|Travelled out of study area|0|||
147609997|NCT01098474|532388924|FG004|Follow Up Phase|Travelled out of study area|1|||
147609998|NCT01098474|532388925|FG005|Follow Up Phase|Travelled out of study area|0|||
147609999|NCT01098474|532388920|FG000|Follow Up Phase|Other|0|||
147610000|NCT01098474|532388921|FG001|Follow Up Phase|Other|0|||
147610001|NCT01098474|532388922|FG002|Follow Up Phase|Other|0|||
147610002|NCT01098474|532388923|FG003|Follow Up Phase|Other|0|||
147610003|NCT01098474|532388924|FG004|Follow Up Phase|Other|0|||
147610004|NCT01098474|532388925|FG005|Follow Up Phase|Other|4|||
147610005|NCT01098474|532388920|FG000|Follow Up Phase|Withdrawal by Subject|0|||
147610006|NCT01098474|532388921|FG001|Follow Up Phase|Withdrawal by Subject|0|||
147610007|NCT01098474|532388922|FG002|Follow Up Phase|Withdrawal by Subject|0|||
147610008|NCT01098474|532388923|FG003|Follow Up Phase|Withdrawal by Subject|2|||
147610009|NCT01098474|532388924|FG004|Follow Up Phase|Withdrawal by Subject|0|||
147610010|NCT01098474|532388925|FG005|Follow Up Phase|Withdrawal by Subject|1|||
147610011|NCT01098474|532388920|FG000|Follow Up Phase|Lost to Follow-up|0|||
147610012|NCT01098474|532388921|FG001|Follow Up Phase|Lost to Follow-up|0|||
147610013|NCT01098474|532388922|FG002|Follow Up Phase|Lost to Follow-up|0|||
147610014|NCT01098474|532388923|FG003|Follow Up Phase|Lost to Follow-up|0|||
147610015|NCT01098474|532388924|FG004|Follow Up Phase|Lost to Follow-up|1|||
147610016|NCT01098474|532388925|FG005|Follow Up Phase|Lost to Follow-up|0|||
147610017|NCT03993379|532388926|FG000|Overall Study|The study was terminated early due to business decision.|0|||
147610018|NCT03993379|532388927|FG001|Overall Study|The study was terminated early due to business decision.|2|||
147610019|NCT03993379|532388928|FG002|Overall Study|The study was terminated early due to business decision.|0|||
147610020|NCT03993379|532388929|FG003|Overall Study|The study was terminated early due to business decision.|0|||
147610021|NCT03993379|532388926|FG000|Overall Study|Withdrawal by Subject|0|||
147610022|NCT03993379|532388927|FG001|Overall Study|Withdrawal by Subject|1|||
147610023|NCT03993379|532388928|FG002|Overall Study|Withdrawal by Subject|0|||
147610024|NCT03993379|532388929|FG003|Overall Study|Withdrawal by Subject|0|||
147610025|NCT00711880|532388932|FG000|Overall Study|Adverse Event|11|||
147610026|NCT00711880|532388933|FG001|Overall Study|Adverse Event|2|||
147610027|NCT00711880|532388932|FG000|Overall Study|Patient non-compliance|1|||
147610028|NCT00711880|532388933|FG001|Overall Study|Patient non-compliance|0|||
147610029|NCT00711880|532388932|FG000|Overall Study|Lack of Efficacy|1|||
147610030|NCT00711880|532388933|FG001|Overall Study|Lack of Efficacy|5|||
147610031|NCT00704132|532388934|FG000|Overall Study|Clinical Adverse Experience|1|||
147610032|NCT00704132|532388935|FG001|Overall Study|Clinical Adverse Experience|0|||
147610033|NCT00704132|532388934|FG000|Overall Study|Lack of Efficacy|0|||
147368909|NCT02719574|531518987|FG004|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
147610034|NCT00704132|532388935|FG001|Overall Study|Lack of Efficacy|1|||
147610035|NCT00704132|532388934|FG000|Overall Study|Withdrawal by Subject|0|||
147610036|NCT00704132|532388935|FG001|Overall Study|Withdrawal by Subject|1|||
147610037|NCT03348163|532388936|FG000|Overall Study|Withdrawal by Subject|2|||
147610038|NCT03348163|532388937|FG001|Overall Study|Withdrawal by Subject|0|||
147610039|NCT04841577|532388938|FG000|Overall Study|Adverse Event|5|||
147663267|NCT02998151|532589275|FG000|Overall Study|Participant was not offered acamprosate; acamprosate was discontinued and replaced with baclofen|13|||
147663268|NCT04414787|532589283|FG000|Overall Study|Patient Death|18|||
147663269|NCT04414787|532589284|FG001|Overall Study|Patient Death|18|||
147368910|NCT02719574|531518988|FG005|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
147368911|NCT02719574|531518989|FG006|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
147663270|NCT04414787|532589285|FG002|Overall Study|Patient Death|15|||
147663271|NCT04414787|532589286|FG003|Overall Study|Patient Death|15|||
147663272|NCT04414787|532589283|FG000|Overall Study|Patient Hospitalization|1|||
147663273|NCT04414787|532589284|FG001|Overall Study|Patient Hospitalization|1|||
147663274|NCT04414787|532589285|FG002|Overall Study|Patient Hospitalization|2|||
147663275|NCT04414787|532589286|FG003|Overall Study|Patient Hospitalization|2|||
147663276|NCT04414787|532589283|FG000|Overall Study|Lost to Follow-up|7|||
147663277|NCT04414787|532589284|FG001|Overall Study|Lost to Follow-up|7|||
147663278|NCT04414787|532589285|FG002|Overall Study|Lost to Follow-up|5|||
147663279|NCT04414787|532589286|FG003|Overall Study|Lost to Follow-up|5|||
147663280|NCT04414787|532589283|FG000|Overall Study|Residence in post-acute care facility|3|||
147663281|NCT04414787|532589284|FG001|Overall Study|Residence in post-acute care facility|3|||
147663282|NCT04414787|532589285|FG002|Overall Study|Residence in post-acute care facility|5|||
147663283|NCT04414787|532589286|FG003|Overall Study|Residence in post-acute care facility|5|||
147663284|NCT01022203|532591418|FG000|Post Treatment Assessment|Withdrawal by Subject|12|||
147663285|NCT01022203|532591419|FG001|Post Treatment Assessment|Withdrawal by Subject|12|||
147663286|NCT01022203|532591418|FG000|Post Treatment Assessment|Physician Decision|2|||
147663287|NCT01022203|532591419|FG001|Post Treatment Assessment|Physician Decision|0|||
147663288|NCT01022203|532591418|FG000|Post Treatment Assessment|Adverse Event|0|||
147663289|NCT01022203|532591419|FG001|Post Treatment Assessment|Adverse Event|2|||
147663290|NCT01022203|532591418|FG000|Follow-Up Assessment|Lost to Follow-up|2|||
147663291|NCT01022203|532591419|FG001|Follow-Up Assessment|Lost to Follow-up|2|||
147663292|NCT03163446|532591422|FG000|Overall Study|Unable to return for Day 180 visit|2|||
147663293|NCT03163446|532591423|FG001|Overall Study|Unable to return for Day 180 visit|0|||
147663294|NCT03163446|532591422|FG000|Overall Study|Withdrawal by Subject|2|||
147663295|NCT03163446|532591423|FG001|Overall Study|Withdrawal by Subject|6|||
147663296|NCT03163446|532591422|FG000|Overall Study|Death|16|||
147663297|NCT03163446|532591423|FG001|Overall Study|Death|5|||
147663298|NCT03163446|532591422|FG000|Overall Study|Lost to Follow-up|6|||
147663299|NCT03163446|532591423|FG001|Overall Study|Lost to Follow-up|5|||
147663300|NCT03163446|532591422|FG000|Overall Study|Physician Decision|1|||
147663301|NCT03163446|532591423|FG001|Overall Study|Physician Decision|1|||
147663302|NCT03163446|532591422|FG000|Overall Study|Patient randomized but went to surgery and was unable to be dosed.|1|||
147663303|NCT03163446|532591423|FG001|Overall Study|Patient randomized but went to surgery and was unable to be dosed.|0|||
147663304|NCT03638128|532591424|FG000|Overall Study|Withdrawal by Subject|1|||
147663305|NCT03638128|532591425|FG001|Overall Study|Withdrawal by Subject|7|||
147663306|NCT03638128|532591426|FG002|Overall Study|Withdrawal by Subject|6|||
147663307|NCT03638128|532591424|FG000|Overall Study|Sponsor Decision|15|||
147663308|NCT03638128|532591425|FG001|Overall Study|Sponsor Decision|12|||
147663309|NCT03638128|532591426|FG002|Overall Study|Sponsor Decision|19|||
147663310|NCT03638128|532591424|FG000|Overall Study|Lost to Follow-up|0|||
147663311|NCT03638128|532591425|FG001|Overall Study|Lost to Follow-up|0|||
147663312|NCT03638128|532591426|FG002|Overall Study|Lost to Follow-up|1|||
147663313|NCT00611806|532591427|FG000|Overall Study|Withdrawal by Subject|8|||
147663314|NCT00611806|532591428|FG001|Overall Study|Withdrawal by Subject|2|||
147663315|NCT00611806|532591427|FG000|Overall Study|Adverse Event|2|||
147663316|NCT00611806|532591428|FG001|Overall Study|Adverse Event|1|||
147368912|NCT02719574|531518990|FG007|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
147368913|NCT02719574|531518991|FG008|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
147368914|NCT02719574|531518992|FG009|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
147368915|NCT02719574|531518993|FG010|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
147368916|NCT02719574|531518994|FG011|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
147368917|NCT02719574|531518995|FG012|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
147663317|NCT00611806|532591427|FG000|Overall Study|Lost to Follow-up|6|||
147663318|NCT00611806|532591428|FG001|Overall Study|Lost to Follow-up|0|||
147663319|NCT00329108|532591430|FG000|Overall Study|Adverse Event|2|||
147663320|NCT00329108|532591431|FG001|Overall Study|Adverse Event|2|||
147663321|NCT00329108|532591430|FG000|Overall Study|Lack of Efficacy|3|||
147368918|NCT02719574|531518996|FG013|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
147368919|NCT02719574|531518997|FG014|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
147368920|NCT02719574|531518998|FG015|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
147368921|NCT02719574|531518999|FG016|Phase 1 (Dose Escalation)|Withdrawal by Subject|0|||
147663322|NCT00329108|532591431|FG001|Overall Study|Lack of Efficacy|3|||
147663323|NCT00329108|532591430|FG000|Overall Study|Withdrawal by Subject|0|||
147663324|NCT00329108|532591431|FG001|Overall Study|Withdrawal by Subject|2|||
147663325|NCT00329108|532591430|FG000|Overall Study|symptomatic deterioration|1|||
147663326|NCT00329108|532591431|FG001|Overall Study|symptomatic deterioration|1|||
147663327|NCT00329108|532591430|FG000|Overall Study|Subject no longer willing to participate|2|||
147663328|NCT00329108|532591431|FG001|Overall Study|Subject no longer willing to participate|2|||
147368922|NCT02719574|531518983|FG000|Phase 1 (Dose Expansion)|Progressive Disease|0|||
147368923|NCT02719574|531518984|FG001|Phase 1 (Dose Expansion)|Progressive Disease|0|||
147368924|NCT02719574|531518985|FG002|Phase 1 (Dose Expansion)|Progressive Disease|0|||
147368925|NCT02719574|531518986|FG003|Phase 1 (Dose Expansion)|Progressive Disease|0|||
147368926|NCT02719574|531518987|FG004|Phase 1 (Dose Expansion)|Progressive Disease|0|||
147368927|NCT02719574|531518988|FG005|Phase 1 (Dose Expansion)|Progressive Disease|0|||
147368928|NCT02719574|531518989|FG006|Phase 1 (Dose Expansion)|Progressive Disease|3|||
147368929|NCT02719574|531518990|FG007|Phase 1 (Dose Expansion)|Progressive Disease|10|||
147368930|NCT02719574|531518991|FG008|Phase 1 (Dose Expansion)|Progressive Disease|1|||
147368931|NCT02719574|531518992|FG009|Phase 1 (Dose Expansion)|Progressive Disease|0|||
147368932|NCT02719574|531518993|FG010|Phase 1 (Dose Expansion)|Progressive Disease|0|||
147368933|NCT02719574|531518994|FG011|Phase 1 (Dose Expansion)|Progressive Disease|0|||
147368934|NCT02719574|531518995|FG012|Phase 1 (Dose Expansion)|Progressive Disease|0|||
147368935|NCT02719574|531518996|FG013|Phase 1 (Dose Expansion)|Progressive Disease|0|||
147368936|NCT02719574|531518997|FG014|Phase 1 (Dose Expansion)|Progressive Disease|0|||
147368937|NCT02719574|531518998|FG015|Phase 1 (Dose Expansion)|Progressive Disease|0|||
147368938|NCT02719574|531518999|FG016|Phase 1 (Dose Expansion)|Progressive Disease|0|||
147368939|NCT02719574|531518983|FG000|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
147368940|NCT02719574|531518984|FG001|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
147368941|NCT02719574|531518985|FG002|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
147368942|NCT02719574|531518986|FG003|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
147368943|NCT02719574|531518987|FG004|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
147368944|NCT02719574|531518988|FG005|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
147368945|NCT02719574|531518989|FG006|Phase 1 (Dose Expansion)|HSCT Transplant|1|||
147368946|NCT02719574|531518990|FG007|Phase 1 (Dose Expansion)|HSCT Transplant|5|||
147368947|NCT02719574|531518991|FG008|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
147368948|NCT02719574|531518992|FG009|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
147368949|NCT02719574|531518993|FG010|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
147368950|NCT02719574|531518994|FG011|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
147368951|NCT02719574|531518995|FG012|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
147368952|NCT02719574|531518996|FG013|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
147368953|NCT02719574|531518997|FG014|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
147368954|NCT02719574|531518998|FG015|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
147368955|NCT02719574|531518999|FG016|Phase 1 (Dose Expansion)|HSCT Transplant|0|||
147368956|NCT02719574|531518983|FG000|Phase 1 (Dose Expansion)|Death|0|||
147368957|NCT02719574|531518984|FG001|Phase 1 (Dose Expansion)|Death|0|||
147368958|NCT02719574|531518985|FG002|Phase 1 (Dose Expansion)|Death|0|||
147368959|NCT02719574|531518986|FG003|Phase 1 (Dose Expansion)|Death|0|||
147368960|NCT02719574|531518987|FG004|Phase 1 (Dose Expansion)|Death|0|||
147610040|NCT04841577|532388939|FG001|Overall Study|Adverse Event|10|||
147610041|NCT04841577|532388938|FG000|Overall Study|Lost to Follow-up|8|||
147610042|NCT04841577|532388939|FG001|Overall Study|Lost to Follow-up|7|||
147610043|NCT04841577|532388938|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO A (S)AE|0|||
147610044|NCT04841577|532388939|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO A (S)AE|8|||
147610045|NCT04841577|532388938|FG000|Overall Study|Other|0|||
147610046|NCT04841577|532388939|FG001|Overall Study|Other|1|||
147610047|NCT00652340|532388942|FG000|Overall Study|Had not progressed.|4|||
147610048|NCT00652340|532388943|FG001|Overall Study|Had not progressed.|3|||
147610049|NCT03682107|532388944|FG000|Overall Study|Withdrawal by Subject|0|||
147610050|NCT03682107|532388945|FG001|Overall Study|Withdrawal by Subject|1|||
147610051|NCT03682107|532388946|FG002|Overall Study|Withdrawal by Subject|0|||
147610052|NCT03682107|532388947|FG003|Overall Study|Withdrawal by Subject|0|||
147610053|NCT03682107|532388948|FG004|Overall Study|Withdrawal by Subject|0|||
147610054|NCT00879411|532388949|FG000|Overall Study|lost to follow-up (non-AE)|162|||
147610055|NCT00710866|532388956|FG000|Overall Study|Protocol Violation|5|||
147610056|NCT00710866|532388957|FG001|Overall Study|Protocol Violation|4|||
147610057|NCT00710866|532388956|FG000|Overall Study|Withdrawal by Subject|2|||
147610058|NCT00710866|532388957|FG001|Overall Study|Withdrawal by Subject|1|||
147368961|NCT02719574|531518988|FG005|Phase 1 (Dose Expansion)|Death|0|||
147368962|NCT02719574|531518989|FG006|Phase 1 (Dose Expansion)|Death|1|||
147610059|NCT00710866|532388956|FG000|Overall Study|Lost to Follow-up|1|||
147610060|NCT00710866|532388957|FG001|Overall Study|Lost to Follow-up|0|||
147610061|NCT00710866|532388956|FG000|Overall Study|Failed to meet eligibility|1|||
147610062|NCT00710866|532388957|FG001|Overall Study|Failed to meet eligibility|1|||
147368963|NCT02719574|531518990|FG007|Phase 1 (Dose Expansion)|Death|6|||
147368964|NCT02719574|531518991|FG008|Phase 1 (Dose Expansion)|Death|0|||
147368965|NCT02719574|531518992|FG009|Phase 1 (Dose Expansion)|Death|0|||
147663329|NCT00329108|532591430|FG000|Overall Study|study terminated by sponsor|1|||
147368966|NCT02719574|531518993|FG010|Phase 1 (Dose Expansion)|Death|0|||
147368967|NCT02719574|531518994|FG011|Phase 1 (Dose Expansion)|Death|0|||
147368968|NCT02719574|531518995|FG012|Phase 1 (Dose Expansion)|Death|0|||
147368969|NCT02719574|531518996|FG013|Phase 1 (Dose Expansion)|Death|0|||
147368970|NCT02719574|531518997|FG014|Phase 1 (Dose Expansion)|Death|0|||
147610063|NCT02676765|532388963|FG000|Overall Study|Lost to Follow-up|0|||
147610064|NCT02676765|532388964|FG001|Overall Study|Lost to Follow-up|1|||
147663330|NCT00329108|532591431|FG001|Overall Study|study terminated by sponsor|0|||
147610065|NCT01128543|532388965|FG000|Overall Study|Withdrawal by Subject|3|||
147610066|NCT01128543|532388965|FG000|Overall Study|Protocol Violation|1|||
147610067|NCT04487067|532388969|FG000|Overall Study|Adverse Event|3|||
147610068|NCT04487067|532388969|FG000|Overall Study|Death Other Than Progressive Disease|60|||
147610069|NCT04487067|532388969|FG000|Overall Study|Death Due To Progressive Disease|40|||
147610070|NCT04487067|532388969|FG000|Overall Study|Lost to Follow-up|3|||
147610071|NCT04487067|532388969|FG000|Overall Study|Progressive Disease|1|||
147610072|NCT04487067|532388969|FG000|Overall Study|Protocol Violation|3|||
147610073|NCT04487067|532388969|FG000|Overall Study|Participant Discontinued From Study as per Protocol|6|||
147610074|NCT04487067|532388969|FG000|Overall Study|Withdrawal by Subject|15|||
147610075|NCT03097991|532388970|FG000|Overall Study|Didn't meet study criteria|8|||
147610076|NCT03097991|532388971|FG001|Overall Study|Didn't meet study criteria|0|||
147610077|NCT03097991|532388970|FG000|Overall Study|Withdrawal by Subject|12|||
147610078|NCT03097991|532388971|FG001|Overall Study|Withdrawal by Subject|6|||
147610079|NCT03097991|532388970|FG000|Overall Study|Death of Baby|3|||
147610080|NCT03097991|532388971|FG001|Overall Study|Death of Baby|1|||
147610081|NCT03097991|532388970|FG000|Overall Study|Lost to Follow-up|24|||
147610082|NCT03097991|532388971|FG001|Overall Study|Lost to Follow-up|38|||
147610083|NCT03097991|532388970|FG000|Overall Study|Adverse Event|3|||
147610084|NCT03097991|532388971|FG001|Overall Study|Adverse Event|5|||
147610085|NCT00246324|532388972|FG000|Overall Study|Withdrawal by Subject|1|||
147610086|NCT00299130|532388973|FG000|Treatment Period (up to 5 Years)|Adverse Event|13|||
147610087|NCT00299130|532388974|FG001|Treatment Period (up to 5 Years)|Adverse Event|8|||
147610088|NCT00299130|532388975|FG002|Treatment Period (up to 5 Years)|Adverse Event|13|||
147610089|NCT00299130|532388973|FG000|Treatment Period (up to 5 Years)|Death|1|||
147610090|NCT00299130|532388974|FG001|Treatment Period (up to 5 Years)|Death|3|||
147610091|NCT00299130|532388975|FG002|Treatment Period (up to 5 Years)|Death|1|||
147610092|NCT00299130|532388973|FG000|Treatment Period (up to 5 Years)|Insufficient Therapeutic Response|19|||
147610093|NCT00299130|532388974|FG001|Treatment Period (up to 5 Years)|Insufficient Therapeutic Response|6|||
147610094|NCT00299130|532388975|FG002|Treatment Period (up to 5 Years)|Insufficient Therapeutic Response|6|||
147610095|NCT00299130|532388973|FG000|Treatment Period (up to 5 Years)|Protocol Violation|0|||
147610096|NCT00299130|532388974|FG001|Treatment Period (up to 5 Years)|Protocol Violation|1|||
147610097|NCT00299130|532388975|FG002|Treatment Period (up to 5 Years)|Protocol Violation|0|||
147610098|NCT00299130|532388973|FG000|Treatment Period (up to 5 Years)|Refused Treatment|12|||
147610099|NCT00299130|532388974|FG001|Treatment Period (up to 5 Years)|Refused Treatment|12|||
147610100|NCT00299130|532388975|FG002|Treatment Period (up to 5 Years)|Refused Treatment|19|||
147610101|NCT00299130|532388973|FG000|Treatment Period (up to 5 Years)|Failure to Return|4|||
147610102|NCT00299130|532388974|FG001|Treatment Period (up to 5 Years)|Failure to Return|6|||
147610103|NCT00299130|532388975|FG002|Treatment Period (up to 5 Years)|Failure to Return|6|||
147610104|NCT00299130|532388973|FG000|Treatment Period (up to 5 Years)|Reason not Specified|4|||
147610105|NCT00299130|532388974|FG001|Treatment Period (up to 5 Years)|Reason not Specified|6|||
147610106|NCT00299130|532388975|FG002|Treatment Period (up to 5 Years)|Reason not Specified|4|||
147610107|NCT00299130|532388973|FG000|Treatment Period (up to 5 Years)|Withdrawal by Subject|0|||
147610108|NCT00299130|532388974|FG001|Treatment Period (up to 5 Years)|Withdrawal by Subject|1|||
147610109|NCT00299130|532388975|FG002|Treatment Period (up to 5 Years)|Withdrawal by Subject|1|||
147610110|NCT00299130|532388973|FG000|Safety Follow-up (SFU) (48 Weeks)|Administrative/Other|4|||
147610111|NCT00299130|532388974|FG001|Safety Follow-up (SFU) (48 Weeks)|Administrative/Other|9|||
147610112|NCT00299130|532388975|FG002|Safety Follow-up (SFU) (48 Weeks)|Administrative/Other|4|||
147663331|NCT00329108|532591430|FG000|Overall Study|withdrew patient after SAE resolved|1|||
147663332|NCT00329108|532591431|FG001|Overall Study|withdrew patient after SAE resolved|0|||
147663333|NCT00329108|532591430|FG000|Overall Study|Protocol Violation|0|||
147663334|NCT00329108|532591431|FG001|Overall Study|Protocol Violation|2|||
147663335|NCT02371616|532591432|FG000|Overall Study|Protocol Violation|2|||
147663336|NCT02371616|532591433|FG001|Overall Study|Protocol Violation|1|||
147663337|NCT02371616|532591432|FG000|Overall Study|Adverse Event|0|||
147663338|NCT02371616|532591433|FG001|Overall Study|Adverse Event|1|||
147663339|NCT02371616|532591432|FG000|Overall Study|Withdrawal of Consent|1|||
147663340|NCT02371616|532591433|FG001|Overall Study|Withdrawal of Consent|0|||
147663341|NCT02371616|532591432|FG000|Overall Study|Other (Not specified)|1|||
147663342|NCT02371616|532591433|FG001|Overall Study|Other (Not specified)|5|||
147368971|NCT02719574|531518998|FG015|Phase 1 (Dose Expansion)|Death|0|||
147368972|NCT02719574|531518999|FG016|Phase 1 (Dose Expansion)|Death|0|||
147610113|NCT00299130|532388973|FG000|Safety Follow-up (SFU) (48 Weeks)|Death|4|||
147610114|NCT00299130|532388974|FG001|Safety Follow-up (SFU) (48 Weeks)|Death|5|||
147663343|NCT04069715|532591438|FG000|Overall Study|Lost to Follow-up|1|||
147663344|NCT04069715|532591439|FG001|Overall Study|Lost to Follow-up|1|||
147663345|NCT04069715|532591438|FG000|Overall Study|Physician Decision|1|||
147368973|NCT02719574|531518983|FG000|Phase 1 (Dose Expansion)|Adverse Event|0|||
147368974|NCT02719574|531518984|FG001|Phase 1 (Dose Expansion)|Adverse Event|0|||
147368975|NCT02719574|531518985|FG002|Phase 1 (Dose Expansion)|Adverse Event|0|||
147663346|NCT04069715|532591439|FG001|Overall Study|Physician Decision|1|||
147610115|NCT00299130|532388975|FG002|Safety Follow-up (SFU) (48 Weeks)|Death|3|||
147663347|NCT04069715|532591438|FG000|Overall Study|Withdrawal by Subject|3|||
147663348|NCT04069715|532591439|FG001|Overall Study|Withdrawal by Subject|3|||
147663349|NCT03205150|532591440|FG000|Overall Study|Protocol deviation|1|||
147663350|NCT03205150|532591441|FG001|Overall Study|Protocol deviation|3|||
147663351|NCT03205150|532591442|FG002|Overall Study|Protocol deviation|0|||
147663352|NCT03205150|532591440|FG000|Overall Study|Patient/guardian decision|0|||
147663353|NCT03205150|532591441|FG001|Overall Study|Patient/guardian decision|3|||
147663354|NCT03205150|532591442|FG002|Overall Study|Patient/guardian decision|0|||
147663355|NCT03205150|532591440|FG000|Overall Study|Adverse Event|1|||
147663356|NCT03205150|532591441|FG001|Overall Study|Adverse Event|1|||
147663357|NCT03205150|532591442|FG002|Overall Study|Adverse Event|1|||
147663358|NCT03205150|532591440|FG000|Overall Study|Lost to Follow-up|0|||
147663359|NCT03205150|532591441|FG001|Overall Study|Lost to Follow-up|0|||
147663360|NCT03205150|532591442|FG002|Overall Study|Lost to Follow-up|1|||
147663361|NCT02723188|532591443|FG000|Overall Study|Withdrawal by Subject|1|||
147663362|NCT02723188|532591444|FG001|Overall Study|Withdrawal by Subject|0|||
147663363|NCT02723188|532591445|FG002|Overall Study|Withdrawal by Subject|0|||
147663364|NCT02486692|532591451|FG000|Overall Study|did not login for randomization|4|||
147663365|NCT02486692|532591452|FG001|Overall Study|did not login for randomization|7|||
147663366|NCT00116688|532591460|FG000|Overall Study|Protocol deviation|1|||
147663367|NCT00116688|532591461|FG001|Overall Study|Protocol deviation|0|||
147663368|NCT00116688|532591460|FG000|Overall Study|Noncompliance|3|||
147663369|NCT00116688|532591461|FG001|Overall Study|Noncompliance|1|||
147663370|NCT00116688|532591460|FG000|Overall Study|Adverse Event|11|||
147663371|NCT00116688|532591461|FG001|Overall Study|Adverse Event|0|||
147663372|NCT00116688|532591460|FG000|Overall Study|Withdrawal by Subject|26|||
147663373|NCT00116688|532591461|FG001|Overall Study|Withdrawal by Subject|2|||
147663374|NCT00116688|532591460|FG000|Overall Study|Requirement for alternative therapy|11|||
147663375|NCT00116688|532591461|FG001|Overall Study|Requirement for alternative therapy|1|||
147663376|NCT00116688|532591460|FG000|Overall Study|Physician Decision|7|||
147663377|NCT00116688|532591461|FG001|Overall Study|Physician Decision|0|||
147663378|NCT00116688|532591460|FG000|Overall Study|Lost to Follow-up|3|||
147663379|NCT00116688|532591461|FG001|Overall Study|Lost to Follow-up|0|||
147663380|NCT00116688|532591460|FG000|Overall Study|Death|15|||
147663381|NCT00116688|532591461|FG001|Overall Study|Death|0|||
147663382|NCT00116688|532591460|FG000|Overall Study|Protocol-specified criteria|3|||
147663383|NCT00116688|532591461|FG001|Overall Study|Protocol-specified criteria|0|||
147663384|NCT00116688|532591460|FG000|Overall Study|Pregnancy|1|||
147663385|NCT00116688|532591461|FG001|Overall Study|Pregnancy|0|||
147663386|NCT00116688|532591460|FG000|Overall Study|Other|11|||
147663387|NCT00116688|532591461|FG001|Overall Study|Other|0|||
147663388|NCT01775670|532591466|FG000|Overall Study|Lost to Follow-up|1|||
147663389|NCT01775670|532591467|FG001|Overall Study|Lost to Follow-up|1|||
147663390|NCT00643760|532591470|FG000|Overall Study|Adverse Event|11|||
147663391|NCT00643760|532591471|FG001|Overall Study|Adverse Event|5|||
147663392|NCT00643760|532591472|FG002|Overall Study|Adverse Event|12|||
147663393|NCT00643760|532591473|FG003|Overall Study|Adverse Event|21|||
147663394|NCT00643760|532591474|FG004|Overall Study|Adverse Event|6|||
147663395|NCT00643760|532591470|FG000|Overall Study|Lack of Efficacy|3|||
147663396|NCT00643760|532591471|FG001|Overall Study|Lack of Efficacy|1|||
147663397|NCT00643760|532591472|FG002|Overall Study|Lack of Efficacy|0|||
147663398|NCT00643760|532591473|FG003|Overall Study|Lack of Efficacy|4|||
147663399|NCT00643760|532591474|FG004|Overall Study|Lack of Efficacy|3|||
147663400|NCT00643760|532591470|FG000|Overall Study|Protocol Violation|7|||
147663401|NCT00643760|532591471|FG001|Overall Study|Protocol Violation|6|||
147663402|NCT00643760|532591472|FG002|Overall Study|Protocol Violation|4|||
147663403|NCT00643760|532591473|FG003|Overall Study|Protocol Violation|4|||
147663404|NCT00643760|532591474|FG004|Overall Study|Protocol Violation|6|||
147663405|NCT00643760|532591470|FG000|Overall Study|Lost to Follow-up|6|||
147663406|NCT00643760|532591471|FG001|Overall Study|Lost to Follow-up|2|||
147663407|NCT00643760|532591472|FG002|Overall Study|Lost to Follow-up|1|||
147663408|NCT00643760|532591473|FG003|Overall Study|Lost to Follow-up|3|||
147663409|NCT00643760|532591474|FG004|Overall Study|Lost to Follow-up|3|||
147663410|NCT00643760|532591470|FG000|Overall Study|Investigator Discretion|0|||
147663411|NCT00643760|532591471|FG001|Overall Study|Investigator Discretion|0|||
147663412|NCT00643760|532591472|FG002|Overall Study|Investigator Discretion|0|||
147454572|NCT01081795|531825634|FG001|Overall Study|Use of a prohibited concomitant drug|1|||
147454573|NCT01081795|531825635|FG002|Overall Study|Use of a prohibited concomitant drug|1|||
147454574|NCT01081795|531825633|FG000|Overall Study|Using drug with restricted days of use|2|||
147454575|NCT01081795|531825634|FG001|Overall Study|Using drug with restricted days of use|3|||
147663413|NCT00643760|532591473|FG003|Overall Study|Investigator Discretion|2|||
147663414|NCT00643760|532591474|FG004|Overall Study|Investigator Discretion|0|||
147663415|NCT00643760|532591470|FG000|Overall Study|Withdrawal by Subject|3|||
147663416|NCT00643760|532591471|FG001|Overall Study|Withdrawal by Subject|1|||
147663417|NCT00643760|532591472|FG002|Overall Study|Withdrawal by Subject|2|||
147663418|NCT00643760|532591473|FG003|Overall Study|Withdrawal by Subject|4|||
147663419|NCT00643760|532591474|FG004|Overall Study|Withdrawal by Subject|1|||
147663420|NCT03353792|532591481|FG000|Overall Study|Lost to Follow-up|1|||
147454576|NCT01081795|531825635|FG002|Overall Study|Using drug with restricted days of use|2|||
147454577|NCT01081795|531825633|FG000|Overall Study|Other|1|||
147454578|NCT01081795|531825634|FG001|Overall Study|Other|2|||
147454579|NCT01081795|531825635|FG002|Overall Study|Other|0|||
147454580|NCT02462473|531825636|FG000|Overall Study|Death|1|||
147454581|NCT02462473|531825636|FG000|Overall Study|Other|3|||
147454582|NCT00661271|531825637|FG000|Overall Study|Lost to Follow-up|28|||
147454583|NCT00661271|531825638|FG001|Overall Study|Lost to Follow-up|25|||
147454584|NCT01707693|531825640|FG000|Overall Study Allocation|Withdrawal by Subject|9|||
147454585|NCT01707693|531825641|FG001|Overall Study Allocation|Withdrawal by Subject|5|||
147454586|NCT01707693|531825640|FG000|Overall Study Allocation|Protocol Violation|4|||
147454587|NCT01707693|531825641|FG001|Overall Study Allocation|Protocol Violation|3|||
147454588|NCT01707693|531825640|FG000|Time 3 Measures @ 6 Mth|Lost to Follow-up|0|||
147454589|NCT01707693|531825641|FG001|Time 3 Measures @ 6 Mth|Lost to Follow-up|3|||
147454590|NCT01707693|531825640|FG000|Time 3 Measures @ 6 Mth|Withdrawal by Subject|0|||
147454591|NCT01707693|531825641|FG001|Time 3 Measures @ 6 Mth|Withdrawal by Subject|2|||
147454592|NCT00927095|531825642|FG000|Overall Study|Adverse Event|3|||
147454593|NCT00927095|531825643|FG001|Overall Study|Adverse Event|1|||
147454594|NCT00927095|531825644|FG002|Overall Study|Adverse Event|0|||
147454595|NCT00927095|531825642|FG000|Overall Study|Withdrawal by Subject|2|||
147454596|NCT00927095|531825643|FG001|Overall Study|Withdrawal by Subject|1|||
147454597|NCT00927095|531825644|FG002|Overall Study|Withdrawal by Subject|1|||
147454598|NCT00927095|531825642|FG000|Overall Study|Physician Decision|1|||
147454599|NCT00927095|531825643|FG001|Overall Study|Physician Decision|2|||
147454600|NCT00927095|531825644|FG002|Overall Study|Physician Decision|1|||
147454601|NCT03115151|531825649|FG000|Overall Study|Intervention discontinue due to clinical condition|2|||
147454602|NCT03115151|531825650|FG001|Overall Study|Intervention discontinue due to clinical condition|2|||
147454603|NCT03115151|531825649|FG000|Overall Study|Epidural catheter removal|1|||
147454604|NCT03115151|531825650|FG001|Overall Study|Epidural catheter removal|0|||
147454605|NCT03115151|531825649|FG000|Overall Study|Withdrawal by Subject|0|||
147454606|NCT03115151|531825650|FG001|Overall Study|Withdrawal by Subject|1|||
147454607|NCT03115151|531825649|FG000|Overall Study|Intervention not received according to the protocol.|1|||
147454608|NCT03115151|531825650|FG001|Overall Study|Intervention not received according to the protocol.|1|||
147454609|NCT03115151|531825649|FG000|Overall Study|Physician Decision|1|||
147454610|NCT03115151|531825650|FG001|Overall Study|Physician Decision|0|||
147454611|NCT03115151|531825649|FG000|Overall Study|Randomization not applied|1|||
147454612|NCT03115151|531825650|FG001|Overall Study|Randomization not applied|1|||
147454613|NCT05779072|531825651|FG000|Overall Study|Lost to Follow-up|0|||
147454614|NCT05779072|531825652|FG001|Overall Study|Lost to Follow-up|1|||
147454615|NCT05779072|531825651|FG000|Overall Study|Withdrawal by Subject|1|||
147454616|NCT05779072|531825652|FG001|Overall Study|Withdrawal by Subject|5|||
147454617|NCT03713944|531825653|FG000|Study Treatment|Patient non-compliance|1|||
147454618|NCT03713944|531825653|FG000|Study Treatment|Alternative Cancer Therapy|3|||
147454619|NCT03713944|531825653|FG000|Study Treatment|Disease Progression|18|||
147454620|NCT03713944|531825653|FG000|Study Treatment|AE/Side Effects/Complications|2|||
147454621|NCT03713944|531825653|FG000|Study Treatment|Death|2|||
147454622|NCT03713944|531825653|FG000|Study Treatment|Withdrawal by Subject|1|||
147454623|NCT03713944|531825653|FG000|Study Treatment|Subject decided to come off study due to hip replacement|1|||
147454624|NCT03713944|531825653|FG000|Study Treatment|Symptomatic Deterioration|2|||
147454625|NCT03713944|531825653|FG000|Follow up|Withdrawal by Subject|2|||
147454626|NCT03713944|531825653|FG000|Follow up|Death|11|||
147454627|NCT03713944|531825653|FG000|Follow up|Study Terminated|3|||
147454628|NCT03847610|531825654|FG000|Overall Study|Withdrawal by Subject|1|||
147610116|NCT00299130|532388973|FG000|Safety Follow-up (SFU) (48 Weeks)|Did not Co-operate|1|||
147454629|NCT03298022|531825655|FG000|Overall Study|Lack of Efficacy|4|||
147454630|NCT03298022|531825655|FG000|Overall Study|Withdrawal by Subject|7|||
147454631|NCT03298022|531825655|FG000|Overall Study|Adverse Event|1|||
147454632|NCT03298022|531825655|FG000|Overall Study|disease relapse|1|||
147454633|NCT00044512|531825656|FG000|Follow Up|Lost to Follow-up|2|||
147454634|NCT02508194|531825658|FG000|Overall Study|Death|5|||
147454635|NCT02508194|531825659|FG001|Overall Study|Death|3|||
147454636|NCT02508194|531825658|FG000|Overall Study|Lost to Follow-up|25|||
147454637|NCT02508194|531825659|FG001|Overall Study|Lost to Follow-up|18|||
147454638|NCT02508194|531825658|FG000|Overall Study|Withdrawal by Subject|20|||
147454639|NCT02508194|531825659|FG001|Overall Study|Withdrawal by Subject|18|||
147454640|NCT02508194|531825658|FG000|Overall Study|Error in Randomization|1|||
147454641|NCT02508194|531825659|FG001|Overall Study|Error in Randomization|3|||
147454642|NCT02508194|531825658|FG000|Overall Study|Principal Investigator Decision|1|||
147454643|NCT02508194|531825659|FG001|Overall Study|Principal Investigator Decision|2|||
147454644|NCT00511355|531825663|FG000|Overall Study|Adverse Event|4|||
147454645|NCT00511355|531825664|FG001|Overall Study|Adverse Event|4|||
147454646|NCT00511355|531825663|FG000|Overall Study|Pregnancy Wish|1|||
147454647|NCT00511355|531825664|FG001|Overall Study|Pregnancy Wish|0|||
147454648|NCT00511355|531825663|FG000|Overall Study|Lost to Follow-up|2|||
147454649|NCT00511355|531825664|FG001|Overall Study|Lost to Follow-up|1|||
147454650|NCT00511355|531825663|FG000|Overall Study|Other Reason|0|||
147610117|NCT00299130|532388974|FG001|Safety Follow-up (SFU) (48 Weeks)|Did not Co-operate|1|||
147610118|NCT00299130|532388975|FG002|Safety Follow-up (SFU) (48 Weeks)|Did not Co-operate|2|||
147610119|NCT00299130|532388973|FG000|Safety Follow-up (SFU) (48 Weeks)|Failure to Return|14|||
147610120|NCT00299130|532388974|FG001|Safety Follow-up (SFU) (48 Weeks)|Failure to Return|7|||
147610121|NCT00299130|532388975|FG002|Safety Follow-up (SFU) (48 Weeks)|Failure to Return|15|||
147610122|NCT00299130|532388973|FG000|Safety Follow-up (SFU) (48 Weeks)|No SFU Week 48 Date Recorded|0|||
147610123|NCT00299130|532388974|FG001|Safety Follow-up (SFU) (48 Weeks)|No SFU Week 48 Date Recorded|1|||
147368976|NCT02719574|531518986|FG003|Phase 1 (Dose Expansion)|Adverse Event|0|||
147368977|NCT02719574|531518987|FG004|Phase 1 (Dose Expansion)|Adverse Event|0|||
147368978|NCT02719574|531518988|FG005|Phase 1 (Dose Expansion)|Adverse Event|0|||
147368979|NCT02719574|531518989|FG006|Phase 1 (Dose Expansion)|Adverse Event|2|||
147368980|NCT02719574|531518990|FG007|Phase 1 (Dose Expansion)|Adverse Event|1|||
147368981|NCT02719574|531518991|FG008|Phase 1 (Dose Expansion)|Adverse Event|0|||
147368982|NCT02719574|531518992|FG009|Phase 1 (Dose Expansion)|Adverse Event|0|||
147368983|NCT02719574|531518993|FG010|Phase 1 (Dose Expansion)|Adverse Event|0|||
147368984|NCT02719574|531518994|FG011|Phase 1 (Dose Expansion)|Adverse Event|0|||
147368985|NCT02719574|531518995|FG012|Phase 1 (Dose Expansion)|Adverse Event|0|||
147368986|NCT02719574|531518996|FG013|Phase 1 (Dose Expansion)|Adverse Event|0|||
147368987|NCT02719574|531518997|FG014|Phase 1 (Dose Expansion)|Adverse Event|0|||
147368988|NCT02719574|531518998|FG015|Phase 1 (Dose Expansion)|Adverse Event|0|||
147368989|NCT02719574|531518999|FG016|Phase 1 (Dose Expansion)|Adverse Event|0|||
147368990|NCT02719574|531518983|FG000|Phase 1 (Dose Expansion)|Physician Decision|0|||
147368991|NCT02719574|531518984|FG001|Phase 1 (Dose Expansion)|Physician Decision|0|||
147368992|NCT02719574|531518985|FG002|Phase 1 (Dose Expansion)|Physician Decision|0|||
147368993|NCT02719574|531518986|FG003|Phase 1 (Dose Expansion)|Physician Decision|0|||
147368994|NCT02719574|531518987|FG004|Phase 1 (Dose Expansion)|Physician Decision|0|||
147368995|NCT02719574|531518988|FG005|Phase 1 (Dose Expansion)|Physician Decision|0|||
147368996|NCT02719574|531518989|FG006|Phase 1 (Dose Expansion)|Physician Decision|1|||
147368997|NCT02719574|531518990|FG007|Phase 1 (Dose Expansion)|Physician Decision|2|||
147368998|NCT02719574|531518991|FG008|Phase 1 (Dose Expansion)|Physician Decision|0|||
147368999|NCT02719574|531518992|FG009|Phase 1 (Dose Expansion)|Physician Decision|0|||
147369000|NCT02719574|531518993|FG010|Phase 1 (Dose Expansion)|Physician Decision|0|||
147369001|NCT02719574|531518994|FG011|Phase 1 (Dose Expansion)|Physician Decision|0|||
147369002|NCT02719574|531518995|FG012|Phase 1 (Dose Expansion)|Physician Decision|0|||
147369003|NCT02719574|531518996|FG013|Phase 1 (Dose Expansion)|Physician Decision|0|||
147369004|NCT02719574|531518997|FG014|Phase 1 (Dose Expansion)|Physician Decision|0|||
147369005|NCT02719574|531518998|FG015|Phase 1 (Dose Expansion)|Physician Decision|0|||
147369006|NCT02719574|531518999|FG016|Phase 1 (Dose Expansion)|Physician Decision|0|||
147369007|NCT02719574|531518983|FG000|Phase 1 (Dose Expansion)|Other|0|||
147369008|NCT02719574|531518984|FG001|Phase 1 (Dose Expansion)|Other|0|||
147369009|NCT02719574|531518985|FG002|Phase 1 (Dose Expansion)|Other|0|||
147369010|NCT02719574|531518986|FG003|Phase 1 (Dose Expansion)|Other|0|||
147369011|NCT02719574|531518987|FG004|Phase 1 (Dose Expansion)|Other|0|||
147369012|NCT02719574|531518988|FG005|Phase 1 (Dose Expansion)|Other|0|||
147369013|NCT02719574|531518989|FG006|Phase 1 (Dose Expansion)|Other|1|||
147369014|NCT02719574|531518990|FG007|Phase 1 (Dose Expansion)|Other|7|||
147369015|NCT02719574|531518991|FG008|Phase 1 (Dose Expansion)|Other|0|||
147369016|NCT02719574|531518992|FG009|Phase 1 (Dose Expansion)|Other|0|||
147369017|NCT02719574|531518993|FG010|Phase 1 (Dose Expansion)|Other|0|||
147369018|NCT02719574|531518994|FG011|Phase 1 (Dose Expansion)|Other|0|||
147369019|NCT02719574|531518995|FG012|Phase 1 (Dose Expansion)|Other|0|||
147369020|NCT02719574|531518996|FG013|Phase 1 (Dose Expansion)|Other|0|||
147369021|NCT02719574|531518997|FG014|Phase 1 (Dose Expansion)|Other|0|||
147369022|NCT02719574|531518998|FG015|Phase 1 (Dose Expansion)|Other|0|||
147369023|NCT02719574|531518999|FG016|Phase 1 (Dose Expansion)|Other|0|||
147369024|NCT02719574|531518983|FG000|Phase 2|Protocol Defined Disease Progression|0|||
147369025|NCT02719574|531518984|FG001|Phase 2|Protocol Defined Disease Progression|0|||
147369026|NCT02719574|531518985|FG002|Phase 2|Protocol Defined Disease Progression|0|||
147369027|NCT02719574|531518986|FG003|Phase 2|Protocol Defined Disease Progression|0|||
147369028|NCT02719574|531518987|FG004|Phase 2|Protocol Defined Disease Progression|0|||
147369029|NCT02719574|531518988|FG005|Phase 2|Protocol Defined Disease Progression|0|||
147369030|NCT02719574|531518989|FG006|Phase 2|Protocol Defined Disease Progression|0|||
147369031|NCT02719574|531518990|FG007|Phase 2|Protocol Defined Disease Progression|0|||
147369032|NCT02719574|531518991|FG008|Phase 2|Protocol Defined Disease Progression|0|||
147369033|NCT02719574|531518992|FG009|Phase 2|Protocol Defined Disease Progression|65|||
147369034|NCT02719574|531518993|FG010|Phase 2|Protocol Defined Disease Progression|8|||
147369035|NCT02719574|531518994|FG011|Phase 2|Protocol Defined Disease Progression|2|||
147369036|NCT02719574|531518995|FG012|Phase 2|Protocol Defined Disease Progression|4|||
147454651|NCT00511355|531825664|FG001|Overall Study|Other Reason|1|||
147369037|NCT02719574|531518996|FG013|Phase 2|Protocol Defined Disease Progression|9|||
147369038|NCT02719574|531518997|FG014|Phase 2|Protocol Defined Disease Progression|11|||
147369039|NCT02719574|531518998|FG015|Phase 2|Protocol Defined Disease Progression|3|||
147369040|NCT02719574|531518999|FG016|Phase 2|Protocol Defined Disease Progression|4|||
147369041|NCT02719574|531518983|FG000|Phase 2|Adverse Event|0|||
147369042|NCT02719574|531518984|FG001|Phase 2|Adverse Event|0|||
147610124|NCT00299130|532388975|FG002|Safety Follow-up (SFU) (48 Weeks)|No SFU Week 48 Date Recorded|0|||
147610125|NCT00299130|532388973|FG000|Safety Follow-up (SFU) (48 Weeks)|Withdrawal by Subject|22|||
147610126|NCT00299130|532388974|FG001|Safety Follow-up (SFU) (48 Weeks)|Withdrawal by Subject|22|||
147610127|NCT00299130|532388975|FG002|Safety Follow-up (SFU) (48 Weeks)|Withdrawal by Subject|21|||
147610128|NCT00299130|532388973|FG000|Extended SFU (ESFU) (up to 5.1 Years)|Death|0|||
147610129|NCT00299130|532388974|FG001|Extended SFU (ESFU) (up to 5.1 Years)|Death|3|||
147610130|NCT00299130|532388975|FG002|Extended SFU (ESFU) (up to 5.1 Years)|Death|0|||
147610131|NCT00299130|532388973|FG000|Extended SFU (ESFU) (up to 5.1 Years)|Failure to Return|0|||
147610132|NCT00299130|532388974|FG001|Extended SFU (ESFU) (up to 5.1 Years)|Failure to Return|2|||
147610133|NCT00299130|532388975|FG002|Extended SFU (ESFU) (up to 5.1 Years)|Failure to Return|2|||
147610134|NCT00299130|532388973|FG000|Extended SFU (ESFU) (up to 5.1 Years)|Did not Cooperate/Withdrew Consent|0|||
147610135|NCT00299130|532388974|FG001|Extended SFU (ESFU) (up to 5.1 Years)|Did not Cooperate/Withdrew Consent|3|||
147610136|NCT00299130|532388975|FG002|Extended SFU (ESFU) (up to 5.1 Years)|Did not Cooperate/Withdrew Consent|4|||
147610137|NCT01098487|532388977|FG000|Overall Study|Adverse Event|22|||
147610138|NCT01098487|532388977|FG000|Overall Study|Lack of Efficacy|11|||
147610139|NCT01098487|532388977|FG000|Overall Study|Withdrawal by Subject|7|||
147610140|NCT01098487|532388977|FG000|Overall Study|Lost to Follow-up|3|||
147610141|NCT01098487|532388977|FG000|Overall Study|Physician Decision|1|||
147610142|NCT03301623|532388982|FG000|Overall Study|Death|3|||
147610143|NCT03301623|532388983|FG001|Overall Study|Death|1|||
147610144|NCT03301623|532388982|FG000|Overall Study|Withdrawal by Subject|11|||
147610145|NCT03301623|532388983|FG001|Overall Study|Withdrawal by Subject|13|||
147610146|NCT03301623|532388982|FG000|Overall Study|Lost to Follow-up|3|||
147610147|NCT03301623|532388983|FG001|Overall Study|Lost to Follow-up|1|||
147610148|NCT02516553|532388984|FG000|Overall Study|Progressive disease|2|||
147610149|NCT02516553|532388985|FG001|Overall Study|Progressive disease|2|||
147610150|NCT02516553|532388986|FG002|Overall Study|Progressive disease|3|||
147610151|NCT02516553|532388987|FG003|Overall Study|Progressive disease|5|||
147610152|NCT02516553|532388988|FG004|Overall Study|Progressive disease|3|||
147610153|NCT02516553|532388989|FG005|Overall Study|Progressive disease|0|||
147610154|NCT02516553|532388990|FG006|Overall Study|Progressive disease|5|||
147610155|NCT02516553|532388991|FG007|Overall Study|Progressive disease|5|||
147610156|NCT02516553|532388992|FG008|Overall Study|Progressive disease|11|||
147610157|NCT02516553|532388993|FG009|Overall Study|Progressive disease|3|||
147610158|NCT02516553|532388994|FG010|Overall Study|Progressive disease|10|||
147610159|NCT02516553|532388995|FG011|Overall Study|Progressive disease|8|||
147610160|NCT02516553|532388996|FG012|Overall Study|Progressive disease|8|||
147610161|NCT02516553|532388997|FG013|Overall Study|Progressive disease|2|||
147610162|NCT02516553|532388998|FG014|Overall Study|Progressive disease|2|||
147610163|NCT02516553|532388999|FG015|Overall Study|Progressive disease|2|||
147610164|NCT02516553|532389000|FG016|Overall Study|Progressive disease|1|||
147610165|NCT02516553|532389001|FG017|Overall Study|Progressive disease|9|||
147610166|NCT02516553|532389002|FG018|Overall Study|Progressive disease|12|||
147610167|NCT02516553|532389003|FG019|Overall Study|Progressive disease|7|||
147610168|NCT02516553|532389004|FG020|Overall Study|Progressive disease|16|||
147610169|NCT02516553|532389005|FG021|Overall Study|Progressive disease|18|||
147610170|NCT02516553|532388984|FG000|Overall Study|Dose limiting toxicity|0|||
147610171|NCT02516553|532388985|FG001|Overall Study|Dose limiting toxicity|0|||
147610172|NCT02516553|532388986|FG002|Overall Study|Dose limiting toxicity|0|||
147610173|NCT02516553|532388987|FG003|Overall Study|Dose limiting toxicity|0|||
147610174|NCT02516553|532388988|FG004|Overall Study|Dose limiting toxicity|3|||
147369043|NCT02719574|531518985|FG002|Phase 2|Adverse Event|0|||
147610175|NCT02516553|532388989|FG005|Overall Study|Dose limiting toxicity|1|||
147610176|NCT02516553|532388990|FG006|Overall Study|Dose limiting toxicity|1|||
147610177|NCT02516553|532388991|FG007|Overall Study|Dose limiting toxicity|0|||
147610178|NCT02516553|532388992|FG008|Overall Study|Dose limiting toxicity|1|||
147610179|NCT02516553|532388993|FG009|Overall Study|Dose limiting toxicity|0|||
147610180|NCT02516553|532388994|FG010|Overall Study|Dose limiting toxicity|0|||
147610181|NCT02516553|532388995|FG011|Overall Study|Dose limiting toxicity|1|||
147610182|NCT02516553|532388996|FG012|Overall Study|Dose limiting toxicity|0|||
147610183|NCT02516553|532388997|FG013|Overall Study|Dose limiting toxicity|1|||
147610184|NCT02516553|532388998|FG014|Overall Study|Dose limiting toxicity|0|||
147610185|NCT02516553|532388999|FG015|Overall Study|Dose limiting toxicity|0|||
147610186|NCT02516553|532389000|FG016|Overall Study|Dose limiting toxicity|1|||
147610187|NCT02516553|532389001|FG017|Overall Study|Dose limiting toxicity|1|||
147610188|NCT02516553|532389002|FG018|Overall Study|Dose limiting toxicity|0|||
147610189|NCT02516553|532389003|FG019|Overall Study|Dose limiting toxicity|2|||
147610190|NCT02516553|532389004|FG020|Overall Study|Dose limiting toxicity|0|||
147610191|NCT02516553|532389005|FG021|Overall Study|Dose limiting toxicity|0|||
147369044|NCT02719574|531518986|FG003|Phase 2|Adverse Event|0|||
147610192|NCT02516553|532388984|FG000|Overall Study|Other Adverse Events|0|||
147610193|NCT02516553|532388985|FG001|Overall Study|Other Adverse Events|0|||
147610194|NCT02516553|532388986|FG002|Overall Study|Other Adverse Events|0|||
147369045|NCT02719574|531518987|FG004|Phase 2|Adverse Event|0|||
147369046|NCT02719574|531518988|FG005|Phase 2|Adverse Event|0|||
147369047|NCT02719574|531518989|FG006|Phase 2|Adverse Event|0|||
147369048|NCT02719574|531518990|FG007|Phase 2|Adverse Event|0|||
147369049|NCT02719574|531518991|FG008|Phase 2|Adverse Event|0|||
147369050|NCT02719574|531518992|FG009|Phase 2|Adverse Event|27|||
147369051|NCT02719574|531518993|FG010|Phase 2|Adverse Event|0|||
147369052|NCT02719574|531518994|FG011|Phase 2|Adverse Event|1|||
147369053|NCT02719574|531518995|FG012|Phase 2|Adverse Event|1|||
147610195|NCT02516553|532388987|FG003|Overall Study|Other Adverse Events|1|||
147610196|NCT02516553|532388988|FG004|Overall Study|Other Adverse Events|0|||
147610197|NCT02516553|532388989|FG005|Overall Study|Other Adverse Events|1|||
147610198|NCT02516553|532388990|FG006|Overall Study|Other Adverse Events|0|||
147610199|NCT02516553|532388991|FG007|Overall Study|Other Adverse Events|0|||
147610200|NCT02516553|532388992|FG008|Overall Study|Other Adverse Events|0|||
147610201|NCT02516553|532388993|FG009|Overall Study|Other Adverse Events|1|||
147610202|NCT02516553|532388994|FG010|Overall Study|Other Adverse Events|3|||
147610203|NCT02516553|532388995|FG011|Overall Study|Other Adverse Events|2|||
147610204|NCT02516553|532388996|FG012|Overall Study|Other Adverse Events|0|||
147610205|NCT02516553|532388997|FG013|Overall Study|Other Adverse Events|1|||
147610206|NCT02516553|532388998|FG014|Overall Study|Other Adverse Events|0|||
147610207|NCT02516553|532388999|FG015|Overall Study|Other Adverse Events|0|||
147610208|NCT02516553|532389000|FG016|Overall Study|Other Adverse Events|0|||
147610209|NCT02516553|532389001|FG017|Overall Study|Other Adverse Events|2|||
147610210|NCT02516553|532389002|FG018|Overall Study|Other Adverse Events|1|||
147610211|NCT02516553|532389003|FG019|Overall Study|Other Adverse Events|2|||
147610212|NCT02516553|532389004|FG020|Overall Study|Other Adverse Events|2|||
147610213|NCT02516553|532389005|FG021|Overall Study|Other Adverse Events|1|||
147610214|NCT02516553|532388984|FG000|Overall Study|Refused to continue trial medication|0|||
147610215|NCT02516553|532388985|FG001|Overall Study|Refused to continue trial medication|0|||
147610216|NCT02516553|532388986|FG002|Overall Study|Refused to continue trial medication|0|||
147610217|NCT02516553|532388987|FG003|Overall Study|Refused to continue trial medication|0|||
147610218|NCT02516553|532388988|FG004|Overall Study|Refused to continue trial medication|0|||
147610219|NCT02516553|532388989|FG005|Overall Study|Refused to continue trial medication|0|||
147610220|NCT02516553|532388990|FG006|Overall Study|Refused to continue trial medication|0|||
147610221|NCT02516553|532388991|FG007|Overall Study|Refused to continue trial medication|0|||
147610222|NCT02516553|532388992|FG008|Overall Study|Refused to continue trial medication|0|||
147610223|NCT02516553|532388993|FG009|Overall Study|Refused to continue trial medication|0|||
147610224|NCT02516553|532388994|FG010|Overall Study|Refused to continue trial medication|1|||
147369054|NCT02719574|531518996|FG013|Phase 2|Adverse Event|1|||
147369055|NCT02719574|531518997|FG014|Phase 2|Adverse Event|2|||
147369056|NCT02719574|531518998|FG015|Phase 2|Adverse Event|2|||
147369057|NCT02719574|531518999|FG016|Phase 2|Adverse Event|3|||
147369058|NCT02719574|531518983|FG000|Phase 2|Other|0|||
147369059|NCT02719574|531518984|FG001|Phase 2|Other|0|||
147369060|NCT02719574|531518985|FG002|Phase 2|Other|0|||
147369061|NCT02719574|531518986|FG003|Phase 2|Other|0|||
147369062|NCT02719574|531518987|FG004|Phase 2|Other|0|||
147369063|NCT02719574|531518988|FG005|Phase 2|Other|0|||
147369064|NCT02719574|531518989|FG006|Phase 2|Other|0|||
147369065|NCT02719574|531518990|FG007|Phase 2|Other|0|||
147369066|NCT02719574|531518991|FG008|Phase 2|Other|0|||
147369067|NCT02719574|531518992|FG009|Phase 2|Other|20|||
147369068|NCT02719574|531518993|FG010|Phase 2|Other|7|||
147369069|NCT02719574|531518994|FG011|Phase 2|Other|0|||
147369070|NCT02719574|531518995|FG012|Phase 2|Other|5|||
147369071|NCT02719574|531518996|FG013|Phase 2|Other|7|||
147369072|NCT02719574|531518997|FG014|Phase 2|Other|0|||
147369073|NCT02719574|531518998|FG015|Phase 2|Other|1|||
147369074|NCT02719574|531518999|FG016|Phase 2|Other|4|||
147610225|NCT02516553|532388995|FG011|Overall Study|Refused to continue trial medication|0|||
147610226|NCT02516553|532388996|FG012|Overall Study|Refused to continue trial medication|0|||
147369075|NCT02719574|531518983|FG000|Phase 2|Transplant|0|||
147610227|NCT02516553|532388997|FG013|Overall Study|Refused to continue trial medication|0|||
147610228|NCT02516553|532388998|FG014|Overall Study|Refused to continue trial medication|0|||
147610229|NCT02516553|532388999|FG015|Overall Study|Refused to continue trial medication|0|||
147610230|NCT02516553|532389000|FG016|Overall Study|Refused to continue trial medication|0|||
147610231|NCT02516553|532389001|FG017|Overall Study|Refused to continue trial medication|0|||
147610232|NCT02516553|532389002|FG018|Overall Study|Refused to continue trial medication|1|||
147610233|NCT02516553|532389003|FG019|Overall Study|Refused to continue trial medication|0|||
147369076|NCT02719574|531518984|FG001|Phase 2|Transplant|0|||
147369077|NCT02719574|531518985|FG002|Phase 2|Transplant|0|||
147369078|NCT02719574|531518986|FG003|Phase 2|Transplant|0|||
147369079|NCT02719574|531518987|FG004|Phase 2|Transplant|0|||
147610234|NCT02516553|532389004|FG020|Overall Study|Refused to continue trial medication|0|||
147369080|NCT02719574|531518988|FG005|Phase 2|Transplant|0|||
147369081|NCT02719574|531518989|FG006|Phase 2|Transplant|0|||
147369082|NCT02719574|531518990|FG007|Phase 2|Transplant|0|||
147369083|NCT02719574|531518991|FG008|Phase 2|Transplant|0|||
147369084|NCT02719574|531518992|FG009|Phase 2|Transplant|15|||
147610235|NCT02516553|532389005|FG021|Overall Study|Refused to continue trial medication|1|||
147610236|NCT02516553|532388984|FG000|Overall Study|other reasons than listed|0|||
147610237|NCT02516553|532388985|FG001|Overall Study|other reasons than listed|0|||
147610238|NCT02516553|532388986|FG002|Overall Study|other reasons than listed|0|||
147610239|NCT02516553|532388987|FG003|Overall Study|other reasons than listed|0|||
147610240|NCT02516553|532388988|FG004|Overall Study|other reasons than listed|0|||
147610241|NCT02516553|532388989|FG005|Overall Study|other reasons than listed|0|||
147610242|NCT02516553|532388990|FG006|Overall Study|other reasons than listed|0|||
147610243|NCT02516553|532388991|FG007|Overall Study|other reasons than listed|1|||
147610244|NCT02516553|532388992|FG008|Overall Study|other reasons than listed|1|||
147610245|NCT02516553|532388993|FG009|Overall Study|other reasons than listed|0|||
147610246|NCT02516553|532388994|FG010|Overall Study|other reasons than listed|1|||
147610247|NCT02516553|532388995|FG011|Overall Study|other reasons than listed|1|||
147610248|NCT02516553|532388996|FG012|Overall Study|other reasons than listed|0|||
147610249|NCT02516553|532388997|FG013|Overall Study|other reasons than listed|0|||
147610250|NCT02516553|532388998|FG014|Overall Study|other reasons than listed|0|||
147610251|NCT02516553|532388999|FG015|Overall Study|other reasons than listed|0|||
147610252|NCT02516553|532389000|FG016|Overall Study|other reasons than listed|0|||
147610253|NCT02516553|532389001|FG017|Overall Study|other reasons than listed|0|||
147610254|NCT02516553|532389002|FG018|Overall Study|other reasons than listed|0|||
147610255|NCT02516553|532389003|FG019|Overall Study|other reasons than listed|0|||
147610256|NCT02516553|532389004|FG020|Overall Study|other reasons than listed|2|||
147610257|NCT02516553|532389005|FG021|Overall Study|other reasons than listed|2|||
147610258|NCT03316547|532389009|FG000|Overall Study|Death|3|||
147610259|NCT03316547|532389010|FG001|Overall Study|Death|1|||
147610260|NCT03316547|532389009|FG000|Overall Study|Lost to Follow-up|6|||
147610261|NCT03316547|532389010|FG001|Overall Study|Lost to Follow-up|6|||
147610262|NCT03316547|532389009|FG000|Overall Study|Withdrawal by Subject|3|||
147610263|NCT03316547|532389010|FG001|Overall Study|Withdrawal by Subject|2|||
147610264|NCT03316547|532389009|FG000|Overall Study|Transfer to another hospital|6|||
147610265|NCT03316547|532389010|FG001|Overall Study|Transfer to another hospital|4|||
147610266|NCT00996892|532389011|FG000|Dose-Escalation Stage 1|Adverse Event|0|||
147610267|NCT00996892|532389012|FG001|Dose-Escalation Stage 1|Adverse Event|0|||
147610268|NCT00996892|532389013|FG002|Dose-Escalation Stage 1|Adverse Event|0|||
147610269|NCT00996892|532389014|FG003|Dose-Escalation Stage 1|Adverse Event|2|||
147610270|NCT00996892|532389015|FG004|Dose-Escalation Stage 1|Adverse Event|0|||
147610271|NCT00996892|532389016|FG005|Dose-Escalation Stage 1|Adverse Event|0|||
147610272|NCT00996892|532389017|FG006|Dose-Escalation Stage 1|Adverse Event|1|||
147369085|NCT02719574|531518993|FG010|Phase 2|Transplant|2|||
147369086|NCT02719574|531518994|FG011|Phase 2|Transplant|0|||
147369087|NCT02719574|531518995|FG012|Phase 2|Transplant|6|||
147369088|NCT02719574|531518996|FG013|Phase 2|Transplant|1|||
147610273|NCT00996892|532389018|FG007|Dose-Escalation Stage 1|Adverse Event|0|||
147369089|NCT02719574|531518997|FG014|Phase 2|Transplant|1|||
147369090|NCT02719574|531518998|FG015|Phase 2|Transplant|0|||
147369091|NCT02719574|531518999|FG016|Phase 2|Transplant|0|||
147610274|NCT00996892|532389019|FG008|Dose-Escalation Stage 1|Adverse Event|0|||
147610275|NCT00996892|532389020|FG009|Dose-Escalation Stage 1|Adverse Event|0|||
147610276|NCT00996892|532389021|FG010|Dose-Escalation Stage 1|Adverse Event|0|||
147610277|NCT00996892|532389022|FG011|Dose-Escalation Stage 1|Adverse Event|0|||
147610278|NCT00996892|532389023|FG012|Dose-Escalation Stage 1|Adverse Event|0|||
147610279|NCT00996892|532389024|FG013|Dose-Escalation Stage 1|Adverse Event|0|||
147610280|NCT00996892|532389025|FG014|Dose-Escalation Stage 1|Adverse Event|0|||
147610281|NCT00996892|532389026|FG015|Dose-Escalation Stage 1|Adverse Event|0|||
147369092|NCT02719574|531518983|FG000|Phase 2|Death|0|||
147369093|NCT02719574|531518984|FG001|Phase 2|Death|0|||
147369094|NCT02719574|531518985|FG002|Phase 2|Death|0|||
147369095|NCT02719574|531518986|FG003|Phase 2|Death|0|||
147369096|NCT02719574|531518987|FG004|Phase 2|Death|0|||
147369097|NCT02719574|531518988|FG005|Phase 2|Death|0|||
147369098|NCT02719574|531518989|FG006|Phase 2|Death|0|||
147369099|NCT02719574|531518990|FG007|Phase 2|Death|0|||
147369100|NCT02719574|531518991|FG008|Phase 2|Death|0|||
147369101|NCT02719574|531518992|FG009|Phase 2|Death|14|||
147369102|NCT02719574|531518993|FG010|Phase 2|Death|0|||
147369103|NCT02719574|531518994|FG011|Phase 2|Death|0|||
147369104|NCT02719574|531518995|FG012|Phase 2|Death|1|||
147369105|NCT02719574|531518996|FG013|Phase 2|Death|1|||
147369106|NCT02719574|531518997|FG014|Phase 2|Death|2|||
147369107|NCT02719574|531518998|FG015|Phase 2|Death|0|||
147369108|NCT02719574|531518999|FG016|Phase 2|Death|0|||
147610282|NCT00996892|532389027|FG016|Dose-Escalation Stage 1|Adverse Event|0|||
147610283|NCT00996892|532389028|FG017|Dose-Escalation Stage 1|Adverse Event|0|||
147369109|NCT02719574|531518983|FG000|Phase 2|Investigator Decision|0|||
147369110|NCT02719574|531518984|FG001|Phase 2|Investigator Decision|0|||
147610284|NCT00996892|532389029|FG018|Dose-Escalation Stage 1|Adverse Event|0|||
147663421|NCT03353792|532591482|FG001|Overall Study|Lost to Follow-up|0|||
147369111|NCT02719574|531518985|FG002|Phase 2|Investigator Decision|0|||
147369112|NCT02719574|531518986|FG003|Phase 2|Investigator Decision|0|||
147369113|NCT02719574|531518987|FG004|Phase 2|Investigator Decision|0|||
147369114|NCT02719574|531518988|FG005|Phase 2|Investigator Decision|0|||
147610285|NCT00996892|532389030|FG019|Dose-Escalation Stage 1|Adverse Event|0|||
147610286|NCT00996892|532389011|FG000|Dose-Escalation Stage 1|Death|1|||
147610287|NCT00996892|532389012|FG001|Dose-Escalation Stage 1|Death|0|||
147610288|NCT00996892|532389013|FG002|Dose-Escalation Stage 1|Death|0|||
147610289|NCT00996892|532389014|FG003|Dose-Escalation Stage 1|Death|0|||
147610290|NCT00996892|532389015|FG004|Dose-Escalation Stage 1|Death|0|||
147610291|NCT00996892|532389016|FG005|Dose-Escalation Stage 1|Death|1|||
147610292|NCT00996892|532389017|FG006|Dose-Escalation Stage 1|Death|0|||
147610293|NCT00996892|532389018|FG007|Dose-Escalation Stage 1|Death|0|||
147610294|NCT00996892|532389019|FG008|Dose-Escalation Stage 1|Death|0|||
147610295|NCT00996892|532389020|FG009|Dose-Escalation Stage 1|Death|0|||
147610296|NCT00996892|532389021|FG010|Dose-Escalation Stage 1|Death|0|||
147610297|NCT00996892|532389022|FG011|Dose-Escalation Stage 1|Death|0|||
147610298|NCT00996892|532389023|FG012|Dose-Escalation Stage 1|Death|0|||
147610299|NCT00996892|532389024|FG013|Dose-Escalation Stage 1|Death|0|||
147610300|NCT00996892|532389025|FG014|Dose-Escalation Stage 1|Death|0|||
147610301|NCT00996892|532389026|FG015|Dose-Escalation Stage 1|Death|0|||
147610302|NCT00996892|532389027|FG016|Dose-Escalation Stage 1|Death|0|||
147610303|NCT00996892|532389028|FG017|Dose-Escalation Stage 1|Death|0|||
147610304|NCT00996892|532389029|FG018|Dose-Escalation Stage 1|Death|0|||
147610305|NCT00996892|532389030|FG019|Dose-Escalation Stage 1|Death|0|||
147610306|NCT00996892|532389011|FG000|Dose-Escalation Stage 1|Physician Decision|1|||
147610307|NCT00996892|532389012|FG001|Dose-Escalation Stage 1|Physician Decision|0|||
147610308|NCT00996892|532389013|FG002|Dose-Escalation Stage 1|Physician Decision|0|||
147610309|NCT00996892|532389014|FG003|Dose-Escalation Stage 1|Physician Decision|1|||
147610310|NCT00996892|532389015|FG004|Dose-Escalation Stage 1|Physician Decision|0|||
147610311|NCT00996892|532389016|FG005|Dose-Escalation Stage 1|Physician Decision|1|||
147610312|NCT00996892|532389017|FG006|Dose-Escalation Stage 1|Physician Decision|2|||
147610313|NCT00996892|532389018|FG007|Dose-Escalation Stage 1|Physician Decision|0|||
147610314|NCT00996892|532389019|FG008|Dose-Escalation Stage 1|Physician Decision|0|||
147610315|NCT00996892|532389020|FG009|Dose-Escalation Stage 1|Physician Decision|0|||
147610316|NCT00996892|532389021|FG010|Dose-Escalation Stage 1|Physician Decision|0|||
147610317|NCT00996892|532389022|FG011|Dose-Escalation Stage 1|Physician Decision|0|||
147610318|NCT00996892|532389023|FG012|Dose-Escalation Stage 1|Physician Decision|0|||
147610319|NCT00996892|532389024|FG013|Dose-Escalation Stage 1|Physician Decision|0|||
147610320|NCT00996892|532389025|FG014|Dose-Escalation Stage 1|Physician Decision|0|||
147610321|NCT00996892|532389026|FG015|Dose-Escalation Stage 1|Physician Decision|0|||
147610322|NCT00996892|532389027|FG016|Dose-Escalation Stage 1|Physician Decision|0|||
147610323|NCT00996892|532389028|FG017|Dose-Escalation Stage 1|Physician Decision|0|||
147610324|NCT00996892|532389029|FG018|Dose-Escalation Stage 1|Physician Decision|0|||
147610325|NCT00996892|532389030|FG019|Dose-Escalation Stage 1|Physician Decision|0|||
147610326|NCT00996892|532389011|FG000|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
147610327|NCT00996892|532389012|FG001|Dose-Escalation Stage 1|Withdrawal by Subject|1|||
147610328|NCT00996892|532389013|FG002|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
147610329|NCT00996892|532389014|FG003|Dose-Escalation Stage 1|Withdrawal by Subject|2|||
147610330|NCT00996892|532389015|FG004|Dose-Escalation Stage 1|Withdrawal by Subject|1|||
147610331|NCT00996892|532389016|FG005|Dose-Escalation Stage 1|Withdrawal by Subject|1|||
147610332|NCT00996892|532389017|FG006|Dose-Escalation Stage 1|Withdrawal by Subject|1|||
147610333|NCT00996892|532389018|FG007|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
147610334|NCT00996892|532389019|FG008|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
147610335|NCT00996892|532389020|FG009|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
147610336|NCT00996892|532389021|FG010|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
147610337|NCT00996892|532389022|FG011|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
147610338|NCT00996892|532389023|FG012|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
147610339|NCT00996892|532389024|FG013|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
147610340|NCT00996892|532389025|FG014|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
147610341|NCT00996892|532389026|FG015|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
147610342|NCT00996892|532389027|FG016|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
147610343|NCT00996892|532389028|FG017|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
147610344|NCT00996892|532389029|FG018|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
147610345|NCT00996892|532389030|FG019|Dose-Escalation Stage 1|Withdrawal by Subject|0|||
147663422|NCT03353792|532591481|FG000|Overall Study|Participant Unable to Manage Device|1|||
147663423|NCT03353792|532591482|FG001|Overall Study|Participant Unable to Manage Device|0|||
147610346|NCT00996892|532389011|FG000|Dose-Escalation Stage 1|Disease Progression|2|||
147369115|NCT02719574|531518989|FG006|Phase 2|Investigator Decision|0|||
147610347|NCT00996892|532389012|FG001|Dose-Escalation Stage 1|Disease Progression|2|||
147610348|NCT00996892|532389013|FG002|Dose-Escalation Stage 1|Disease Progression|3|||
147610349|NCT00996892|532389014|FG003|Dose-Escalation Stage 1|Disease Progression|4|||
147610350|NCT00996892|532389015|FG004|Dose-Escalation Stage 1|Disease Progression|10|||
147610351|NCT00996892|532389016|FG005|Dose-Escalation Stage 1|Disease Progression|7|||
147610352|NCT00996892|532389017|FG006|Dose-Escalation Stage 1|Disease Progression|0|||
147610353|NCT00996892|532389018|FG007|Dose-Escalation Stage 1|Disease Progression|0|||
147369116|NCT02719574|531518990|FG007|Phase 2|Investigator Decision|0|||
147610354|NCT00996892|532389019|FG008|Dose-Escalation Stage 1|Disease Progression|0|||
147610355|NCT00996892|532389020|FG009|Dose-Escalation Stage 1|Disease Progression|0|||
147610356|NCT00996892|532389021|FG010|Dose-Escalation Stage 1|Disease Progression|0|||
147610357|NCT00996892|532389022|FG011|Dose-Escalation Stage 1|Disease Progression|0|||
147610358|NCT00996892|532389023|FG012|Dose-Escalation Stage 1|Disease Progression|0|||
147610359|NCT00996892|532389024|FG013|Dose-Escalation Stage 1|Disease Progression|0|||
147610360|NCT00996892|532389025|FG014|Dose-Escalation Stage 1|Disease Progression|0|||
147610361|NCT00996892|532389026|FG015|Dose-Escalation Stage 1|Disease Progression|0|||
147610362|NCT00996892|532389027|FG016|Dose-Escalation Stage 1|Disease Progression|0|||
147610363|NCT00996892|532389028|FG017|Dose-Escalation Stage 1|Disease Progression|0|||
147610364|NCT00996892|532389029|FG018|Dose-Escalation Stage 1|Disease Progression|0|||
147610365|NCT00996892|532389030|FG019|Dose-Escalation Stage 1|Disease Progression|0|||
147610366|NCT00996892|532389011|FG000|Dose-Escalation Stage 1A|Adverse Event|0|||
147610367|NCT00996892|532389012|FG001|Dose-Escalation Stage 1A|Adverse Event|0|||
147610368|NCT00996892|532389013|FG002|Dose-Escalation Stage 1A|Adverse Event|0|||
147610369|NCT00996892|532389014|FG003|Dose-Escalation Stage 1A|Adverse Event|0|||
147610370|NCT00996892|532389015|FG004|Dose-Escalation Stage 1A|Adverse Event|0|||
147610371|NCT00996892|532389016|FG005|Dose-Escalation Stage 1A|Adverse Event|0|||
147610372|NCT00996892|532389017|FG006|Dose-Escalation Stage 1A|Adverse Event|0|||
147610373|NCT00996892|532389018|FG007|Dose-Escalation Stage 1A|Adverse Event|0|||
147610374|NCT00996892|532389019|FG008|Dose-Escalation Stage 1A|Adverse Event|0|||
147610375|NCT00996892|532389020|FG009|Dose-Escalation Stage 1A|Adverse Event|0|||
147610376|NCT00996892|532389021|FG010|Dose-Escalation Stage 1A|Adverse Event|1|||
147610377|NCT00996892|532389022|FG011|Dose-Escalation Stage 1A|Adverse Event|0|||
147610378|NCT00996892|532389023|FG012|Dose-Escalation Stage 1A|Adverse Event|0|||
147610379|NCT00996892|532389024|FG013|Dose-Escalation Stage 1A|Adverse Event|1|||
147610380|NCT00996892|532389025|FG014|Dose-Escalation Stage 1A|Adverse Event|0|||
147610381|NCT00996892|532389026|FG015|Dose-Escalation Stage 1A|Adverse Event|0|||
147610382|NCT00996892|532389027|FG016|Dose-Escalation Stage 1A|Adverse Event|0|||
147610383|NCT00996892|532389028|FG017|Dose-Escalation Stage 1A|Adverse Event|0|||
147610384|NCT00996892|532389029|FG018|Dose-Escalation Stage 1A|Adverse Event|0|||
147610385|NCT00996892|532389030|FG019|Dose-Escalation Stage 1A|Adverse Event|0|||
147610386|NCT00996892|532389011|FG000|Dose-Escalation Stage 1A|Death|0|||
147663424|NCT00789321|532591483|FG000|Overall Study|Adverse Event|0|||
147663425|NCT00789321|532591484|FG001|Overall Study|Adverse Event|1|||
147663426|NCT00104052|532591485|FG000|Overall Study|Adverse Event|1|||
147663427|NCT00104052|532591485|FG000|Overall Study|Lack of Efficacy|26|||
147369117|NCT02719574|531518991|FG008|Phase 2|Investigator Decision|0|||
147369118|NCT02719574|531518992|FG009|Phase 2|Investigator Decision|6|||
147369119|NCT02719574|531518993|FG010|Phase 2|Investigator Decision|1|||
147369120|NCT02719574|531518994|FG011|Phase 2|Investigator Decision|2|||
147369121|NCT02719574|531518995|FG012|Phase 2|Investigator Decision|3|||
147369122|NCT02719574|531518996|FG013|Phase 2|Investigator Decision|1|||
147369123|NCT02719574|531518997|FG014|Phase 2|Investigator Decision|3|||
147369124|NCT02719574|531518998|FG015|Phase 2|Investigator Decision|2|||
147369125|NCT02719574|531518999|FG016|Phase 2|Investigator Decision|0|||
147369126|NCT02719574|531518983|FG000|Phase 2|Withdrawal by Subject|0|||
147369127|NCT02719574|531518984|FG001|Phase 2|Withdrawal by Subject|0|||
147369128|NCT02719574|531518985|FG002|Phase 2|Withdrawal by Subject|0|||
147369129|NCT02719574|531518986|FG003|Phase 2|Withdrawal by Subject|0|||
147369130|NCT02719574|531518987|FG004|Phase 2|Withdrawal by Subject|0|||
147369131|NCT02719574|531518988|FG005|Phase 2|Withdrawal by Subject|0|||
147369132|NCT02719574|531518989|FG006|Phase 2|Withdrawal by Subject|0|||
147369133|NCT02719574|531518990|FG007|Phase 2|Withdrawal by Subject|0|||
147369134|NCT02719574|531518991|FG008|Phase 2|Withdrawal by Subject|0|||
147369135|NCT02719574|531518992|FG009|Phase 2|Withdrawal by Subject|5|||
147369136|NCT02719574|531518993|FG010|Phase 2|Withdrawal by Subject|0|||
147369137|NCT02719574|531518994|FG011|Phase 2|Withdrawal by Subject|0|||
147369138|NCT02719574|531518995|FG012|Phase 2|Withdrawal by Subject|0|||
147369139|NCT02719574|531518996|FG013|Phase 2|Withdrawal by Subject|1|||
147369140|NCT02719574|531518997|FG014|Phase 2|Withdrawal by Subject|1|||
147369141|NCT02719574|531518998|FG015|Phase 2|Withdrawal by Subject|2|||
147369142|NCT02719574|531518999|FG016|Phase 2|Withdrawal by Subject|0|||
147369143|NCT02719574|531518983|FG000|Phase 2|Protocol Violation|0|||
147369144|NCT02719574|531518984|FG001|Phase 2|Protocol Violation|0|||
147369145|NCT02719574|531518985|FG002|Phase 2|Protocol Violation|0|||
147663428|NCT00104052|532591485|FG000|Overall Study|Discontinuation unrelated to treatment|2|||
147663429|NCT03652818|532591489|FG000|Overall Study|Adverse Event|1|||
147369146|NCT02719574|531518986|FG003|Phase 2|Protocol Violation|0|||
147369147|NCT02719574|531518987|FG004|Phase 2|Protocol Violation|0|||
147369148|NCT02719574|531518988|FG005|Phase 2|Protocol Violation|0|||
147369149|NCT02719574|531518989|FG006|Phase 2|Protocol Violation|0|||
147369150|NCT02719574|531518990|FG007|Phase 2|Protocol Violation|0|||
147369151|NCT02719574|531518991|FG008|Phase 2|Protocol Violation|0|||
147610387|NCT00996892|532389012|FG001|Dose-Escalation Stage 1A|Death|0|||
147610388|NCT00996892|532389013|FG002|Dose-Escalation Stage 1A|Death|0|||
147610389|NCT00996892|532389014|FG003|Dose-Escalation Stage 1A|Death|0|||
147369152|NCT02719574|531518992|FG009|Phase 2|Protocol Violation|1|||
147369153|NCT02719574|531518993|FG010|Phase 2|Protocol Violation|0|||
147369154|NCT02719574|531518994|FG011|Phase 2|Protocol Violation|0|||
147369155|NCT02719574|531518995|FG012|Phase 2|Protocol Violation|0|||
147369156|NCT02719574|531518996|FG013|Phase 2|Protocol Violation|0|||
147369157|NCT02719574|531518997|FG014|Phase 2|Protocol Violation|0|||
147610390|NCT00996892|532389015|FG004|Dose-Escalation Stage 1A|Death|0|||
147610391|NCT00996892|532389016|FG005|Dose-Escalation Stage 1A|Death|0|||
147610392|NCT00996892|532389017|FG006|Dose-Escalation Stage 1A|Death|0|||
147610393|NCT00996892|532389018|FG007|Dose-Escalation Stage 1A|Death|0|||
147610394|NCT00996892|532389019|FG008|Dose-Escalation Stage 1A|Death|0|||
147610395|NCT00996892|532389020|FG009|Dose-Escalation Stage 1A|Death|2|||
147610396|NCT00996892|532389021|FG010|Dose-Escalation Stage 1A|Death|0|||
147369158|NCT02719574|531518998|FG015|Phase 2|Protocol Violation|0|||
147610397|NCT00996892|532389022|FG011|Dose-Escalation Stage 1A|Death|1|||
147610398|NCT00996892|532389023|FG012|Dose-Escalation Stage 1A|Death|1|||
147610399|NCT00996892|532389024|FG013|Dose-Escalation Stage 1A|Death|0|||
147610400|NCT00996892|532389025|FG014|Dose-Escalation Stage 1A|Death|0|||
147610401|NCT00996892|532389026|FG015|Dose-Escalation Stage 1A|Death|0|||
147610402|NCT00996892|532389027|FG016|Dose-Escalation Stage 1A|Death|0|||
147610403|NCT00996892|532389028|FG017|Dose-Escalation Stage 1A|Death|0|||
147610404|NCT00996892|532389029|FG018|Dose-Escalation Stage 1A|Death|0|||
147610405|NCT00996892|532389030|FG019|Dose-Escalation Stage 1A|Death|0|||
147610406|NCT00996892|532389011|FG000|Dose-Escalation Stage 1A|Physician Decision|0|||
147610407|NCT00996892|532389012|FG001|Dose-Escalation Stage 1A|Physician Decision|0|||
147610408|NCT00996892|532389013|FG002|Dose-Escalation Stage 1A|Physician Decision|0|||
147610409|NCT00996892|532389014|FG003|Dose-Escalation Stage 1A|Physician Decision|0|||
147610410|NCT00996892|532389015|FG004|Dose-Escalation Stage 1A|Physician Decision|0|||
147610411|NCT00996892|532389016|FG005|Dose-Escalation Stage 1A|Physician Decision|0|||
147610412|NCT00996892|532389017|FG006|Dose-Escalation Stage 1A|Physician Decision|0|||
147610413|NCT00996892|532389018|FG007|Dose-Escalation Stage 1A|Physician Decision|1|||
147610414|NCT00996892|532389019|FG008|Dose-Escalation Stage 1A|Physician Decision|0|||
147610415|NCT00996892|532389020|FG009|Dose-Escalation Stage 1A|Physician Decision|0|||
147610416|NCT00996892|532389021|FG010|Dose-Escalation Stage 1A|Physician Decision|0|||
147610417|NCT00996892|532389022|FG011|Dose-Escalation Stage 1A|Physician Decision|0|||
147610418|NCT00996892|532389023|FG012|Dose-Escalation Stage 1A|Physician Decision|0|||
147610419|NCT00996892|532389024|FG013|Dose-Escalation Stage 1A|Physician Decision|0|||
147610420|NCT00996892|532389025|FG014|Dose-Escalation Stage 1A|Physician Decision|0|||
147610421|NCT00996892|532389026|FG015|Dose-Escalation Stage 1A|Physician Decision|0|||
147610422|NCT00996892|532389027|FG016|Dose-Escalation Stage 1A|Physician Decision|0|||
147610423|NCT00996892|532389028|FG017|Dose-Escalation Stage 1A|Physician Decision|0|||
147610424|NCT00996892|532389029|FG018|Dose-Escalation Stage 1A|Physician Decision|0|||
147610425|NCT00996892|532389030|FG019|Dose-Escalation Stage 1A|Physician Decision|0|||
147610426|NCT00996892|532389011|FG000|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
147610427|NCT00996892|532389012|FG001|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
147610428|NCT00996892|532389013|FG002|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
147610429|NCT00996892|532389014|FG003|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
147610430|NCT00996892|532389015|FG004|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
147610431|NCT00996892|532389016|FG005|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
147610432|NCT00996892|532389017|FG006|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
147610433|NCT00996892|532389018|FG007|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
147610434|NCT00996892|532389019|FG008|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
147610435|NCT00996892|532389020|FG009|Dose-Escalation Stage 1A|Withdrawal by Subject|1|||
147610436|NCT00996892|532389021|FG010|Dose-Escalation Stage 1A|Withdrawal by Subject|1|||
147610437|NCT00996892|532389022|FG011|Dose-Escalation Stage 1A|Withdrawal by Subject|1|||
147610438|NCT00996892|532389023|FG012|Dose-Escalation Stage 1A|Withdrawal by Subject|1|||
147610439|NCT00996892|532389024|FG013|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
147610440|NCT00996892|532389025|FG014|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
147610441|NCT00996892|532389026|FG015|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
147369159|NCT02719574|531518999|FG016|Phase 2|Protocol Violation|0|||
147369160|NCT00495677|531519004|FG000|Stage 1 (25 Days)|Adverse Event|0|||
147369161|NCT00495677|531519005|FG001|Stage 1 (25 Days)|Adverse Event|0|||
147610442|NCT00996892|532389027|FG016|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
147610443|NCT00996892|532389028|FG017|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
147610444|NCT00996892|532389029|FG018|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
147369162|NCT00495677|531519006|FG002|Stage 1 (25 Days)|Adverse Event|1|||
147369163|NCT00495677|531519007|FG003|Stage 1 (25 Days)|Adverse Event|0|||
147610445|NCT00996892|532389030|FG019|Dose-Escalation Stage 1A|Withdrawal by Subject|0|||
147610446|NCT00996892|532389011|FG000|Dose-Escalation Stage 1A|Disease Progression|0|||
147610447|NCT00996892|532389012|FG001|Dose-Escalation Stage 1A|Disease Progression|0|||
147610448|NCT00996892|532389013|FG002|Dose-Escalation Stage 1A|Disease Progression|0|||
147610449|NCT00996892|532389014|FG003|Dose-Escalation Stage 1A|Disease Progression|0|||
147610450|NCT00996892|532389015|FG004|Dose-Escalation Stage 1A|Disease Progression|0|||
147610451|NCT00996892|532389016|FG005|Dose-Escalation Stage 1A|Disease Progression|0|||
147610452|NCT00996892|532389017|FG006|Dose-Escalation Stage 1A|Disease Progression|0|||
147610453|NCT00996892|532389018|FG007|Dose-Escalation Stage 1A|Disease Progression|2|||
147610454|NCT00996892|532389019|FG008|Dose-Escalation Stage 1A|Disease Progression|3|||
147610455|NCT00996892|532389020|FG009|Dose-Escalation Stage 1A|Disease Progression|1|||
147610456|NCT00996892|532389021|FG010|Dose-Escalation Stage 1A|Disease Progression|5|||
147610457|NCT00996892|532389022|FG011|Dose-Escalation Stage 1A|Disease Progression|7|||
147610458|NCT00996892|532389023|FG012|Dose-Escalation Stage 1A|Disease Progression|6|||
147610459|NCT00996892|532389024|FG013|Dose-Escalation Stage 1A|Disease Progression|4|||
147610460|NCT00996892|532389025|FG014|Dose-Escalation Stage 1A|Disease Progression|0|||
147610461|NCT00996892|532389026|FG015|Dose-Escalation Stage 1A|Disease Progression|0|||
147610462|NCT00996892|532389027|FG016|Dose-Escalation Stage 1A|Disease Progression|0|||
147610463|NCT00996892|532389028|FG017|Dose-Escalation Stage 1A|Disease Progression|0|||
147610464|NCT00996892|532389029|FG018|Dose-Escalation Stage 1A|Disease Progression|0|||
147610465|NCT00996892|532389030|FG019|Dose-Escalation Stage 1A|Disease Progression|0|||
147610466|NCT00996892|532389011|FG000|Dose-Escalation Stage 1B|Physician Decision|0|||
147610467|NCT00996892|532389012|FG001|Dose-Escalation Stage 1B|Physician Decision|0|||
147610468|NCT00996892|532389013|FG002|Dose-Escalation Stage 1B|Physician Decision|0|||
147610469|NCT00996892|532389014|FG003|Dose-Escalation Stage 1B|Physician Decision|0|||
147610470|NCT00996892|532389015|FG004|Dose-Escalation Stage 1B|Physician Decision|0|||
147610471|NCT00996892|532389016|FG005|Dose-Escalation Stage 1B|Physician Decision|0|||
147610472|NCT00996892|532389017|FG006|Dose-Escalation Stage 1B|Physician Decision|0|||
147610473|NCT00996892|532389018|FG007|Dose-Escalation Stage 1B|Physician Decision|0|||
147610474|NCT00996892|532389019|FG008|Dose-Escalation Stage 1B|Physician Decision|0|||
147610475|NCT00996892|532389020|FG009|Dose-Escalation Stage 1B|Physician Decision|0|||
147610476|NCT00996892|532389021|FG010|Dose-Escalation Stage 1B|Physician Decision|0|||
147610477|NCT00996892|532389022|FG011|Dose-Escalation Stage 1B|Physician Decision|0|||
147610478|NCT00996892|532389023|FG012|Dose-Escalation Stage 1B|Physician Decision|0|||
147610479|NCT00996892|532389024|FG013|Dose-Escalation Stage 1B|Physician Decision|0|||
147610480|NCT00996892|532389025|FG014|Dose-Escalation Stage 1B|Physician Decision|0|||
147610481|NCT00996892|532389026|FG015|Dose-Escalation Stage 1B|Physician Decision|0|||
147610482|NCT00996892|532389027|FG016|Dose-Escalation Stage 1B|Physician Decision|0|||
147610483|NCT00996892|532389028|FG017|Dose-Escalation Stage 1B|Physician Decision|2|||
147610484|NCT00996892|532389029|FG018|Dose-Escalation Stage 1B|Physician Decision|0|||
147610485|NCT00996892|532389030|FG019|Dose-Escalation Stage 1B|Physician Decision|0|||
147610486|NCT00996892|532389011|FG000|Dose-Escalation Stage 1B|Disease Progression|0|||
147610487|NCT00996892|532389012|FG001|Dose-Escalation Stage 1B|Disease Progression|0|||
147610488|NCT00996892|532389013|FG002|Dose-Escalation Stage 1B|Disease Progression|0|||
147610489|NCT00996892|532389014|FG003|Dose-Escalation Stage 1B|Disease Progression|0|||
147610490|NCT00996892|532389015|FG004|Dose-Escalation Stage 1B|Disease Progression|0|||
147610491|NCT00996892|532389016|FG005|Dose-Escalation Stage 1B|Disease Progression|0|||
147610492|NCT00996892|532389017|FG006|Dose-Escalation Stage 1B|Disease Progression|0|||
147610493|NCT00996892|532389018|FG007|Dose-Escalation Stage 1B|Disease Progression|0|||
147610494|NCT00996892|532389019|FG008|Dose-Escalation Stage 1B|Disease Progression|0|||
147610495|NCT00996892|532389020|FG009|Dose-Escalation Stage 1B|Disease Progression|0|||
147610496|NCT00996892|532389021|FG010|Dose-Escalation Stage 1B|Disease Progression|0|||
147610497|NCT00996892|532389022|FG011|Dose-Escalation Stage 1B|Disease Progression|0|||
147610498|NCT00996892|532389023|FG012|Dose-Escalation Stage 1B|Disease Progression|0|||
147610499|NCT00996892|532389024|FG013|Dose-Escalation Stage 1B|Disease Progression|0|||
147610500|NCT00996892|532389025|FG014|Dose-Escalation Stage 1B|Disease Progression|4|||
147610501|NCT00996892|532389026|FG015|Dose-Escalation Stage 1B|Disease Progression|3|||
147610502|NCT00996892|532389027|FG016|Dose-Escalation Stage 1B|Disease Progression|3|||
147610503|NCT00996892|532389028|FG017|Dose-Escalation Stage 1B|Disease Progression|3|||
147369164|NCT00495677|531519008|FG004|Stage 1 (25 Days)|Adverse Event|0|||
147369165|NCT00495677|531519009|FG005|Stage 1 (25 Days)|Adverse Event|0|||
147369166|NCT00495677|531519010|FG006|Stage 1 (25 Days)|Adverse Event|0|||
147369167|NCT03653364|531519015|FG000|Overall Study|Withdrawal by Subject|1|||
147369168|NCT03653364|531519015|FG000|Overall Study|Enrolled in Error|1|||
147369169|NCT03653364|531519015|FG000|Overall Study|Death|1|||
147369170|NCT03983382|531519018|FG000|Overall Study|Death|1|||
147369171|NCT03983382|531519018|FG000|Overall Study|Lost to Follow-up|3|||
147369172|NCT03983382|531519018|FG000|Overall Study|Physician Decision|2|||
147610504|NCT00996892|532389029|FG018|Dose-Escalation Stage 1B|Disease Progression|0|||
147610505|NCT00996892|532389030|FG019|Dose-Escalation Stage 1B|Disease Progression|0|||
147610506|NCT00996892|532389011|FG000|Expansion Stage 2|Adverse Event|0|||
147610507|NCT00996892|532389012|FG001|Expansion Stage 2|Adverse Event|0|||
147369173|NCT03983382|531519018|FG000|Overall Study|Withdrawal by Subject|10|||
147610508|NCT00996892|532389013|FG002|Expansion Stage 2|Adverse Event|0|||
147610509|NCT00996892|532389014|FG003|Expansion Stage 2|Adverse Event|0|||
147610510|NCT00996892|532389015|FG004|Expansion Stage 2|Adverse Event|0|||
147610511|NCT00996892|532389016|FG005|Expansion Stage 2|Adverse Event|0|||
147610512|NCT00996892|532389017|FG006|Expansion Stage 2|Adverse Event|0|||
147369174|NCT03983382|531519018|FG000|Overall Study|Change in cancer treatment|2|||
147369175|NCT04908514|531519027|FG000|Overall Study|Lost to Follow-up|2|||
147369176|NCT04908514|531519027|FG000|Overall Study|Withdrawal by Subject|1|||
147369177|NCT02566889|531520184|FG000|Overall Study|Withdrawal by Subject|3|||
147369178|NCT02566889|531520185|FG001|Overall Study|Withdrawal by Subject|1|||
147369179|NCT02566889|531520184|FG000|Overall Study|Adverse Event|4|||
147610513|NCT00996892|532389018|FG007|Expansion Stage 2|Adverse Event|0|||
147610514|NCT00996892|532389019|FG008|Expansion Stage 2|Adverse Event|0|||
147610515|NCT00996892|532389020|FG009|Expansion Stage 2|Adverse Event|0|||
147610516|NCT00996892|532389021|FG010|Expansion Stage 2|Adverse Event|0|||
147610517|NCT00996892|532389022|FG011|Expansion Stage 2|Adverse Event|0|||
147610518|NCT00996892|532389023|FG012|Expansion Stage 2|Adverse Event|0|||
147610519|NCT00996892|532389024|FG013|Expansion Stage 2|Adverse Event|0|||
147610520|NCT00996892|532389025|FG014|Expansion Stage 2|Adverse Event|0|||
147610521|NCT00996892|532389026|FG015|Expansion Stage 2|Adverse Event|0|||
147610522|NCT00996892|532389027|FG016|Expansion Stage 2|Adverse Event|0|||
147610523|NCT00996892|532389028|FG017|Expansion Stage 2|Adverse Event|0|||
147610524|NCT00996892|532389029|FG018|Expansion Stage 2|Adverse Event|3|||
147610525|NCT00996892|532389030|FG019|Expansion Stage 2|Adverse Event|0|||
147610526|NCT00996892|532389011|FG000|Expansion Stage 2|Death|0|||
147610527|NCT00996892|532389012|FG001|Expansion Stage 2|Death|0|||
147610528|NCT00996892|532389013|FG002|Expansion Stage 2|Death|0|||
147610529|NCT00996892|532389014|FG003|Expansion Stage 2|Death|0|||
147610530|NCT00996892|532389015|FG004|Expansion Stage 2|Death|0|||
147610531|NCT00996892|532389016|FG005|Expansion Stage 2|Death|0|||
147610532|NCT00996892|532389017|FG006|Expansion Stage 2|Death|0|||
147610533|NCT00996892|532389018|FG007|Expansion Stage 2|Death|0|||
147610534|NCT00996892|532389019|FG008|Expansion Stage 2|Death|0|||
147610535|NCT00996892|532389020|FG009|Expansion Stage 2|Death|0|||
147610536|NCT00996892|532389021|FG010|Expansion Stage 2|Death|0|||
147610537|NCT00996892|532389022|FG011|Expansion Stage 2|Death|0|||
147610538|NCT00996892|532389023|FG012|Expansion Stage 2|Death|0|||
147610539|NCT00996892|532389024|FG013|Expansion Stage 2|Death|0|||
147610540|NCT00996892|532389025|FG014|Expansion Stage 2|Death|0|||
147610541|NCT00996892|532389026|FG015|Expansion Stage 2|Death|0|||
147610542|NCT00996892|532389027|FG016|Expansion Stage 2|Death|0|||
147610543|NCT00996892|532389028|FG017|Expansion Stage 2|Death|0|||
147610544|NCT00996892|532389029|FG018|Expansion Stage 2|Death|2|||
147610545|NCT00996892|532389030|FG019|Expansion Stage 2|Death|0|||
147610546|NCT00996892|532389011|FG000|Expansion Stage 2|Physician Decision|0|||
147610547|NCT00996892|532389012|FG001|Expansion Stage 2|Physician Decision|0|||
147610548|NCT00996892|532389013|FG002|Expansion Stage 2|Physician Decision|0|||
147369180|NCT02566889|531520185|FG001|Overall Study|Adverse Event|2|||
147369181|NCT02566889|531520184|FG000|Overall Study|Other|6|||
147369182|NCT02566889|531520185|FG001|Overall Study|Other|2|||
147369183|NCT03140670|531520186|FG000|Overall Study|Withdrawal by Subject|2|||
147369184|NCT03140670|531520186|FG000|Overall Study|Lost to Follow-up|1|||
147369185|NCT03140670|531520186|FG000|Overall Study|Physician Decision|1|||
147369186|NCT00220805|531520187|FG000|Overall Study|Adverse Event|1|||
147369187|NCT00220805|531520188|FG001|Overall Study|Adverse Event|3|||
147369188|NCT00220805|531520187|FG000|Overall Study|Withdrawal by Subject|3|||
147369189|NCT00220805|531520188|FG001|Overall Study|Withdrawal by Subject|0|||
147369190|NCT00220805|531520187|FG000|Overall Study|Lack of Efficacy|1|||
147369191|NCT00220805|531520188|FG001|Overall Study|Lack of Efficacy|0|||
147369192|NCT00220805|531520187|FG000|Overall Study|Develop. of choroidal neovascularization|3|||
147369193|NCT00220805|531520188|FG001|Overall Study|Develop. of choroidal neovascularization|8|||
147369194|NCT02325466|531520189|FG000|Period 1 Timeframe - Baseline to Week 4|Adverse Event|0|||
147369195|NCT02325466|531520190|FG001|Period 1 Timeframe - Baseline to Week 4|Adverse Event|0|||
147369196|NCT02325466|531520191|FG002|Period 1 Timeframe - Baseline to Week 4|Adverse Event|1|||
147369197|NCT02325466|531520189|FG000|Period 1 Timeframe - Baseline to Week 4|Withdrawal by Subject|0|||
147369198|NCT02325466|531520190|FG001|Period 1 Timeframe - Baseline to Week 4|Withdrawal by Subject|2|||
147369199|NCT02325466|531520191|FG002|Period 1 Timeframe - Baseline to Week 4|Withdrawal by Subject|0|||
147369200|NCT02325466|531520189|FG000|Period 1 Timeframe - Baseline to Week 4|urgent vascularization|1|||
147369201|NCT02325466|531520190|FG001|Period 1 Timeframe - Baseline to Week 4|urgent vascularization|0|||
147369202|NCT02325466|531520191|FG002|Period 1 Timeframe - Baseline to Week 4|urgent vascularization|2|||
147369203|NCT02325466|531520189|FG000|Period 2 - Timeframe Week 4 to Week 10|Protocol Violation|1|||
147369204|NCT02325466|531520190|FG001|Period 2 - Timeframe Week 4 to Week 10|Protocol Violation|0|||
147610549|NCT00996892|532389014|FG003|Expansion Stage 2|Physician Decision|0|||
147610550|NCT00996892|532389015|FG004|Expansion Stage 2|Physician Decision|0|||
147610551|NCT00996892|532389016|FG005|Expansion Stage 2|Physician Decision|0|||
147610552|NCT00996892|532389017|FG006|Expansion Stage 2|Physician Decision|0|||
147610553|NCT00996892|532389018|FG007|Expansion Stage 2|Physician Decision|0|||
147610554|NCT00996892|532389019|FG008|Expansion Stage 2|Physician Decision|0|||
147610555|NCT00996892|532389020|FG009|Expansion Stage 2|Physician Decision|0|||
147610556|NCT00996892|532389021|FG010|Expansion Stage 2|Physician Decision|0|||
147610557|NCT00996892|532389022|FG011|Expansion Stage 2|Physician Decision|0|||
147610558|NCT00996892|532389023|FG012|Expansion Stage 2|Physician Decision|0|||
147610559|NCT00996892|532389024|FG013|Expansion Stage 2|Physician Decision|0|||
147610560|NCT00996892|532389025|FG014|Expansion Stage 2|Physician Decision|0|||
147610561|NCT00996892|532389026|FG015|Expansion Stage 2|Physician Decision|0|||
147610562|NCT00996892|532389027|FG016|Expansion Stage 2|Physician Decision|0|||
147610563|NCT00996892|532389028|FG017|Expansion Stage 2|Physician Decision|0|||
147610564|NCT00996892|532389029|FG018|Expansion Stage 2|Physician Decision|1|||
147610565|NCT00996892|532389030|FG019|Expansion Stage 2|Physician Decision|0|||
147610566|NCT00996892|532389011|FG000|Expansion Stage 2|Withdrawal by Subject|0|||
147610567|NCT00996892|532389012|FG001|Expansion Stage 2|Withdrawal by Subject|0|||
147610568|NCT00996892|532389013|FG002|Expansion Stage 2|Withdrawal by Subject|0|||
147610569|NCT00996892|532389014|FG003|Expansion Stage 2|Withdrawal by Subject|0|||
147610570|NCT00996892|532389015|FG004|Expansion Stage 2|Withdrawal by Subject|0|||
147610571|NCT00996892|532389016|FG005|Expansion Stage 2|Withdrawal by Subject|0|||
147610572|NCT00996892|532389017|FG006|Expansion Stage 2|Withdrawal by Subject|0|||
147610573|NCT00996892|532389018|FG007|Expansion Stage 2|Withdrawal by Subject|0|||
147610574|NCT00996892|532389019|FG008|Expansion Stage 2|Withdrawal by Subject|0|||
147610575|NCT00996892|532389020|FG009|Expansion Stage 2|Withdrawal by Subject|0|||
147610576|NCT00996892|532389021|FG010|Expansion Stage 2|Withdrawal by Subject|0|||
147610577|NCT00996892|532389022|FG011|Expansion Stage 2|Withdrawal by Subject|0|||
147610578|NCT00996892|532389023|FG012|Expansion Stage 2|Withdrawal by Subject|0|||
147610579|NCT00996892|532389024|FG013|Expansion Stage 2|Withdrawal by Subject|0|||
147610580|NCT00996892|532389025|FG014|Expansion Stage 2|Withdrawal by Subject|0|||
147610581|NCT00996892|532389026|FG015|Expansion Stage 2|Withdrawal by Subject|0|||
147610582|NCT00996892|532389027|FG016|Expansion Stage 2|Withdrawal by Subject|0|||
147610583|NCT00996892|532389028|FG017|Expansion Stage 2|Withdrawal by Subject|0|||
147610584|NCT00996892|532389029|FG018|Expansion Stage 2|Withdrawal by Subject|1|||
147610585|NCT00996892|532389030|FG019|Expansion Stage 2|Withdrawal by Subject|0|||
147610586|NCT00996892|532389011|FG000|Expansion Stage 2|Disease Progression|0|||
147610587|NCT00996892|532389012|FG001|Expansion Stage 2|Disease Progression|0|||
147610588|NCT00996892|532389013|FG002|Expansion Stage 2|Disease Progression|0|||
147610589|NCT00996892|532389014|FG003|Expansion Stage 2|Disease Progression|0|||
147663430|NCT03652818|532591490|FG001|Overall Study|Adverse Event|0|||
147663431|NCT03652818|532591491|FG002|Overall Study|Adverse Event|0|||
147663432|NCT03652818|532591492|FG003|Overall Study|Adverse Event|0|||
147663433|NCT03652818|532591493|FG004|Overall Study|Adverse Event|0|||
147663434|NCT03652818|532591489|FG000|Overall Study|Physician Decision|1|||
147369205|NCT02325466|531520191|FG002|Period 2 - Timeframe Week 4 to Week 10|Protocol Violation|0|||
147369206|NCT02325466|531520189|FG000|Period 2 - Timeframe Week 4 to Week 10|Withdrawal by Subject|1|||
147369207|NCT02325466|531520190|FG001|Period 2 - Timeframe Week 4 to Week 10|Withdrawal by Subject|1|||
147369208|NCT02325466|531520191|FG002|Period 2 - Timeframe Week 4 to Week 10|Withdrawal by Subject|0|||
147369209|NCT02325466|531520189|FG000|Period 2 - Timeframe Week 4 to Week 10|urgent vascularization|1|||
147369210|NCT02325466|531520190|FG001|Period 2 - Timeframe Week 4 to Week 10|urgent vascularization|0|||
147369211|NCT02325466|531520191|FG002|Period 2 - Timeframe Week 4 to Week 10|urgent vascularization|0|||
147369212|NCT02325466|531520189|FG000|3rd Crossover - Week 10 to Week 16|Adverse Event|1|||
147369213|NCT02325466|531520190|FG001|3rd Crossover - Week 10 to Week 16|Adverse Event|0|||
147369214|NCT02325466|531520191|FG002|3rd Crossover - Week 10 to Week 16|Adverse Event|0|||
147369215|NCT02325466|531520189|FG000|3rd Crossover - Week 10 to Week 16|Protocol Violation|0|||
147369216|NCT02325466|531520190|FG001|3rd Crossover - Week 10 to Week 16|Protocol Violation|1|||
147369217|NCT02325466|531520191|FG002|3rd Crossover - Week 10 to Week 16|Protocol Violation|0|||
147369218|NCT02325466|531520189|FG000|3rd Crossover - Week 10 to Week 16|urgent vascularization|0|||
147369219|NCT02325466|531520190|FG001|3rd Crossover - Week 10 to Week 16|urgent vascularization|1|||
147369220|NCT02325466|531520191|FG002|3rd Crossover - Week 10 to Week 16|urgent vascularization|0|||
147369221|NCT03699163|531520192|FG000|Overall Study|Physician Decision|12|||
147369222|NCT03699163|531520193|FG001|Overall Study|Physician Decision|0|||
147369223|NCT03699163|531520192|FG000|Overall Study|failed QC measures|205|||
147369224|NCT03699163|531520193|FG001|Overall Study|failed QC measures|206|||
147369225|NCT01964300|531520199|FG000|Overall Study|Ineligible after enrollment|0|||
147369226|NCT01964300|531520200|FG001|Overall Study|Ineligible after enrollment|1|||
147369227|NCT01964300|531520199|FG000|Overall Study|Adverse Event|1|||
147369228|NCT01964300|531520200|FG001|Overall Study|Adverse Event|1|||
147369229|NCT01964300|531520199|FG000|Overall Study|Lack of Efficacy|3|||
147369230|NCT01964300|531520200|FG001|Overall Study|Lack of Efficacy|5|||
147369231|NCT01964300|531520199|FG000|Overall Study|Withdrawal by Subject|0|||
147369232|NCT01964300|531520200|FG001|Overall Study|Withdrawal by Subject|1|||
147369233|NCT01964300|531520199|FG000|Overall Study|To receive alternative therapy|1|||
147369234|NCT01964300|531520200|FG001|Overall Study|To receive alternative therapy|2|||
147369235|NCT01964300|531520199|FG000|Overall Study|Enlargement of cyst requiring drainage|1|||
147369236|NCT01964300|531520200|FG001|Overall Study|Enlargement of cyst requiring drainage|0|||
147369237|NCT01964300|531520199|FG000|Overall Study|Weight criteria not met|0|||
147610590|NCT00996892|532389015|FG004|Expansion Stage 2|Disease Progression|0|||
147610591|NCT00996892|532389016|FG005|Expansion Stage 2|Disease Progression|0|||
147610592|NCT00996892|532389017|FG006|Expansion Stage 2|Disease Progression|0|||
147610593|NCT00996892|532389018|FG007|Expansion Stage 2|Disease Progression|0|||
147610594|NCT00996892|532389019|FG008|Expansion Stage 2|Disease Progression|0|||
147663435|NCT03652818|532591490|FG001|Overall Study|Physician Decision|0|||
147454652|NCT00511355|531825663|FG000|Overall Study|Pre-treatment (serious) adverse event|0|||
147454653|NCT00511355|531825664|FG001|Overall Study|Pre-treatment (serious) adverse event|1|||
147454654|NCT00511355|531825663|FG000|Overall Study|Withdrawal of informed consent|0|||
147454655|NCT00511355|531825664|FG001|Overall Study|Withdrawal of informed consent|1|||
147454656|NCT00511355|531825663|FG000|Overall Study|Other reason pre-treatment|0|||
147454657|NCT00511355|531825664|FG001|Overall Study|Other reason pre-treatment|1|||
147454658|NCT00454805|531825665|FG000|Overall Study|Withdrawal by Subject|9|||
147454659|NCT00454805|531825666|FG001|Overall Study|Withdrawal by Subject|2|||
147454660|NCT00454805|531825665|FG000|Overall Study|Death|0|||
147454661|NCT00454805|531825666|FG001|Overall Study|Death|2|||
147454662|NCT00454805|531825665|FG000|Overall Study|Disease progression|16|||
147454663|NCT00454805|531825666|FG001|Overall Study|Disease progression|19|||
147454664|NCT00454805|531825665|FG000|Overall Study|In order to begin radiotherapy|1|||
147454665|NCT00454805|531825666|FG001|Overall Study|In order to begin radiotherapy|0|||
147454666|NCT00217087|531825667|FG000|Overall Study|decided to have esophagectomy|1|||
147454667|NCT00217087|531825668|FG001|Overall Study|decided to have esophagectomy|2|||
147454668|NCT00217087|531825667|FG000|Overall Study|completed less than 12 months return|10|||
147454669|NCT00217087|531825668|FG001|Overall Study|completed less than 12 months return|18|||
147454670|NCT03208231|531825671|FG000|Overall Study|Death|1|||
147454671|NCT03208231|531825672|FG001|Overall Study|Death|2|||
147454672|NCT03208231|531825671|FG000|Overall Study|Moved and unable to get to clinic|1|||
147454673|NCT03208231|531825672|FG001|Overall Study|Moved and unable to get to clinic|0|||
147454674|NCT03208231|531825671|FG000|Overall Study|Unwilling to adhere to study requirements|0|||
147454675|NCT03208231|531825672|FG001|Overall Study|Unwilling to adhere to study requirements|1|||
147454676|NCT04947800|531825678|FG000|Overall Study|1) Closure of pulm rehab program from which patients were recruited 2) recurrent IRB delays|8|||
147454677|NCT04947800|531825679|FG001|Overall Study|1) Closure of pulm rehab program from which patients were recruited 2) recurrent IRB delays|0|||
147454678|NCT04947800|531825680|FG002|Overall Study|1) Closure of pulm rehab program from which patients were recruited 2) recurrent IRB delays|0|||
147454679|NCT03977467|531825681|FG000|Overall Study|Disease Progression|1|||
147454680|NCT03977467|531825682|FG001|Overall Study|Disease Progression|1|||
147454681|NCT03977467|531825683|FG002|Overall Study|Disease Progression|30|||
147454682|NCT03977467|531825684|FG003|Overall Study|Disease Progression|0|||
147454683|NCT03977467|531825681|FG000|Overall Study|Adverse Event|0|||
147454684|NCT03977467|531825682|FG001|Overall Study|Adverse Event|1|||
147454685|NCT03977467|531825683|FG002|Overall Study|Adverse Event|0|||
147454686|NCT03977467|531825684|FG003|Overall Study|Adverse Event|0|||
147454687|NCT03977467|531825681|FG000|Overall Study|Death|0|||
147454688|NCT03977467|531825682|FG001|Overall Study|Death|0|||
147454689|NCT03977467|531825683|FG002|Overall Study|Death|3|||
147454690|NCT03977467|531825684|FG003|Overall Study|Death|0|||
147454691|NCT03977467|531825681|FG000|Overall Study|Lack of Efficacy|0|||
147454692|NCT03977467|531825682|FG001|Overall Study|Lack of Efficacy|0|||
147454693|NCT03977467|531825683|FG002|Overall Study|Lack of Efficacy|1|||
147454694|NCT03977467|531825684|FG003|Overall Study|Lack of Efficacy|0|||
147454695|NCT03977467|531825681|FG000|Overall Study|Withdrawal by Subject|2|||
147454696|NCT03977467|531825682|FG001|Overall Study|Withdrawal by Subject|1|||
147454697|NCT03977467|531825683|FG002|Overall Study|Withdrawal by Subject|4|||
147454698|NCT03977467|531825684|FG003|Overall Study|Withdrawal by Subject|0|||
147454699|NCT03977467|531825681|FG000|Overall Study|Study Terminated|1|||
147454700|NCT03977467|531825682|FG001|Overall Study|Study Terminated|0|||
147454701|NCT03977467|531825683|FG002|Overall Study|Study Terminated|0|||
147454702|NCT03977467|531825684|FG003|Overall Study|Study Terminated|1|||
147610595|NCT00996892|532389020|FG009|Expansion Stage 2|Disease Progression|0|||
147610596|NCT00996892|532389021|FG010|Expansion Stage 2|Disease Progression|0|||
147610597|NCT00996892|532389022|FG011|Expansion Stage 2|Disease Progression|0|||
147610598|NCT00996892|532389023|FG012|Expansion Stage 2|Disease Progression|0|||
147610599|NCT00996892|532389024|FG013|Expansion Stage 2|Disease Progression|0|||
147610600|NCT00996892|532389025|FG014|Expansion Stage 2|Disease Progression|0|||
147610601|NCT00996892|532389026|FG015|Expansion Stage 2|Disease Progression|0|||
147610602|NCT00996892|532389027|FG016|Expansion Stage 2|Disease Progression|0|||
147610603|NCT00996892|532389028|FG017|Expansion Stage 2|Disease Progression|0|||
147610604|NCT00996892|532389029|FG018|Expansion Stage 2|Disease Progression|28|||
147663436|NCT03652818|532591491|FG002|Overall Study|Physician Decision|0|||
147454703|NCT01314716|531825690|FG000|Double-Blind Phase|Randomized but not treated|1|||
147454704|NCT01314716|531825691|FG001|Double-Blind Phase|Randomized but not treated|1|||
147454705|NCT01314716|531825690|FG000|Double-Blind Phase|Adverse Event|10|||
147454706|NCT01314716|531825691|FG001|Double-Blind Phase|Adverse Event|4|||
147454707|NCT01314716|531825690|FG000|Double-Blind Phase|Withdrawal by Subject|5|||
147454708|NCT01314716|531825691|FG001|Double-Blind Phase|Withdrawal by Subject|6|||
147454709|NCT01314716|531825690|FG000|Double-Blind Phase|Lost to Follow-up|0|||
147610605|NCT00996892|532389030|FG019|Expansion Stage 2|Disease Progression|0|||
147610606|NCT00996892|532389011|FG000|Expansion Stage 2A|Adverse Event|0|||
147454710|NCT01314716|531825691|FG001|Double-Blind Phase|Lost to Follow-up|1|||
147610607|NCT00996892|532389012|FG001|Expansion Stage 2A|Adverse Event|0|||
147610608|NCT00996892|532389013|FG002|Expansion Stage 2A|Adverse Event|0|||
147610609|NCT00996892|532389014|FG003|Expansion Stage 2A|Adverse Event|0|||
147369238|NCT01964300|531520200|FG001|Overall Study|Weight criteria not met|1|||
147369239|NCT00557492|531520201|FG000|Overall Study|Change in health insurance|1|||
147369240|NCT02111096|531520203|FG000|Overall Study|Adverse Event|4|||
147369241|NCT02111096|531520204|FG001|Overall Study|Adverse Event|1|||
147369242|NCT02111096|531520205|FG002|Overall Study|Adverse Event|2|||
147369243|NCT02111096|531520203|FG000|Overall Study|Non-Compliance with Study Drug|1|||
147369244|NCT02111096|531520204|FG001|Overall Study|Non-Compliance with Study Drug|1|||
147369245|NCT02111096|531520205|FG002|Overall Study|Non-Compliance with Study Drug|0|||
147369246|NCT02111096|531520203|FG000|Overall Study|Lost to Follow Up|1|||
147369247|NCT02111096|531520204|FG001|Overall Study|Lost to Follow Up|1|||
147369248|NCT02111096|531520205|FG002|Overall Study|Lost to Follow Up|1|||
147369249|NCT02111096|531520203|FG000|Overall Study|Physician Decision|0|||
147369250|NCT02111096|531520204|FG001|Overall Study|Physician Decision|1|||
147369251|NCT02111096|531520205|FG002|Overall Study|Physician Decision|0|||
147369252|NCT02111096|531520203|FG000|Overall Study|Protocol Violation|1|||
147369253|NCT02111096|531520204|FG001|Overall Study|Protocol Violation|0|||
147369254|NCT02111096|531520205|FG002|Overall Study|Protocol Violation|1|||
147369255|NCT02111096|531520203|FG000|Overall Study|Terminated by Sponsor|53|||
147369256|NCT02111096|531520204|FG001|Overall Study|Terminated by Sponsor|35|||
147369257|NCT02111096|531520205|FG002|Overall Study|Terminated by Sponsor|54|||
147369258|NCT02111096|531520203|FG000|Overall Study|Withdrawal by Subject|4|||
147369259|NCT02111096|531520204|FG001|Overall Study|Withdrawal by Subject|2|||
147369260|NCT02111096|531520205|FG002|Overall Study|Withdrawal by Subject|8|||
147369261|NCT03621735|531520206|FG000|Overall Study|Withdrawal by Subject|13|||
147369262|NCT03621735|531520207|FG001|Overall Study|Withdrawal by Subject|13|||
147369263|NCT03875313|531520213|FG000|Overall Study|Withdrawal by Subject|1|||
147369264|NCT03875313|531520214|FG001|Overall Study|Withdrawal by Subject|3|||
147369265|NCT03875313|531520215|FG002|Overall Study|Withdrawal by Subject|0|||
147369266|NCT03875313|531520216|FG003|Overall Study|Withdrawal by Subject|0|||
147369267|NCT03875313|531520217|FG004|Overall Study|Withdrawal by Subject|0|||
147369268|NCT03875313|531520213|FG000|Overall Study|Death|0|||
147369269|NCT03875313|531520214|FG001|Overall Study|Death|0|||
147369270|NCT03875313|531520215|FG002|Overall Study|Death|0|||
147369271|NCT03875313|531520216|FG003|Overall Study|Death|0|||
147369272|NCT03875313|531520217|FG004|Overall Study|Death|1|||
147369273|NCT03875313|531520213|FG000|Overall Study|Lost to Follow-up|0|||
147369274|NCT03875313|531520214|FG001|Overall Study|Lost to Follow-up|0|||
147369275|NCT03875313|531520215|FG002|Overall Study|Lost to Follow-up|0|||
147369276|NCT03875313|531520216|FG003|Overall Study|Lost to Follow-up|0|||
147369277|NCT03875313|531520217|FG004|Overall Study|Lost to Follow-up|1|||
147369278|NCT03875313|531520213|FG000|Overall Study|Study Termination by Sponsor|0|||
147369279|NCT03875313|531520214|FG001|Overall Study|Study Termination by Sponsor|1|||
147369280|NCT03875313|531520215|FG002|Overall Study|Study Termination by Sponsor|1|||
147369281|NCT03875313|531520216|FG003|Overall Study|Study Termination by Sponsor|0|||
147369282|NCT03875313|531520217|FG004|Overall Study|Study Termination by Sponsor|1|||
147369283|NCT03875313|531520213|FG000|Overall Study|New Anticancer Treatment|0|||
147369284|NCT03875313|531520214|FG001|Overall Study|New Anticancer Treatment|1|||
147369285|NCT03875313|531520215|FG002|Overall Study|New Anticancer Treatment|2|||
147369286|NCT03875313|531520216|FG003|Overall Study|New Anticancer Treatment|1|||
147369287|NCT03875313|531520217|FG004|Overall Study|New Anticancer Treatment|0|||
147369288|NCT03875313|531520213|FG000|Overall Study|Other, Not Specified|2|||
147369289|NCT03875313|531520214|FG001|Overall Study|Other, Not Specified|11|||
147369290|NCT03875313|531520215|FG002|Overall Study|Other, Not Specified|3|||
147369291|NCT03875313|531520216|FG003|Overall Study|Other, Not Specified|3|||
147369292|NCT03875313|531520217|FG004|Overall Study|Other, Not Specified|1|||
147369293|NCT04121546|531520218|FG000|Overall Study|Lost to Follow-up|1|||
147369294|NCT04121546|531520219|FG001|Overall Study|Lost to Follow-up|3|||
147454711|NCT01314716|531825690|FG000|Double-Blind Phase|Sponsor request|1|||
147454712|NCT01314716|531825691|FG001|Double-Blind Phase|Sponsor request|2|||
147369295|NCT00686595|531520222|FG000|Overall Study|Adverse Event|3|||
147369296|NCT00686595|531520222|FG000|Overall Study|Protocol Violation|1|||
147369297|NCT00686595|531520222|FG000|Overall Study|Lost to Follow-up|1|||
147369298|NCT00686595|531520222|FG000|Overall Study|Lack of Efficacy|1|||
147369299|NCT00686595|531520222|FG000|Overall Study|Poor Compliance|1|||
147369300|NCT03286114|531520228|FG000|Overall Study|Adverse Event|6|||
147369301|NCT03286114|531520228|FG000|Overall Study|Death|3|||
147369302|NCT01260896|531520234|FG000|First Intervention|Withdrawn Due to Emesis|2|||
147369303|NCT01260896|531520235|FG001|First Intervention|Withdrawn Due to Emesis|0|||
147369304|NCT00982644|531520236|FG000|Main: Week 0 to 52 (NN1250-3579)|Adverse Event|20|||
147369305|NCT00982644|531520237|FG001|Main: Week 0 to 52 (NN1250-3579)|Adverse Event|5|||
147610610|NCT00996892|532389015|FG004|Expansion Stage 2A|Adverse Event|0|||
147610611|NCT00996892|532389016|FG005|Expansion Stage 2A|Adverse Event|0|||
147610612|NCT00996892|532389017|FG006|Expansion Stage 2A|Adverse Event|0|||
147610613|NCT00996892|532389018|FG007|Expansion Stage 2A|Adverse Event|0|||
147610614|NCT00996892|532389019|FG008|Expansion Stage 2A|Adverse Event|0|||
147610615|NCT00996892|532389020|FG009|Expansion Stage 2A|Adverse Event|0|||
147610616|NCT00996892|532389021|FG010|Expansion Stage 2A|Adverse Event|0|||
147369306|NCT00982644|531520236|FG000|Main: Week 0 to 52 (NN1250-3579)|Lack of Efficacy|7|||
147610617|NCT00996892|532389022|FG011|Expansion Stage 2A|Adverse Event|0|||
147610618|NCT00996892|532389023|FG012|Expansion Stage 2A|Adverse Event|0|||
147610619|NCT00996892|532389024|FG013|Expansion Stage 2A|Adverse Event|0|||
147610620|NCT00996892|532389025|FG014|Expansion Stage 2A|Adverse Event|0|||
147610621|NCT00996892|532389026|FG015|Expansion Stage 2A|Adverse Event|0|||
147610622|NCT00996892|532389027|FG016|Expansion Stage 2A|Adverse Event|0|||
147610623|NCT00996892|532389028|FG017|Expansion Stage 2A|Adverse Event|0|||
147610624|NCT00996892|532389029|FG018|Expansion Stage 2A|Adverse Event|0|||
147610625|NCT00996892|532389030|FG019|Expansion Stage 2A|Adverse Event|8|||
147610626|NCT00996892|532389011|FG000|Expansion Stage 2A|Physician Decision|0|||
147610627|NCT00996892|532389012|FG001|Expansion Stage 2A|Physician Decision|0|||
147610628|NCT00996892|532389013|FG002|Expansion Stage 2A|Physician Decision|0|||
147610629|NCT00996892|532389014|FG003|Expansion Stage 2A|Physician Decision|0|||
147610630|NCT00996892|532389015|FG004|Expansion Stage 2A|Physician Decision|0|||
147610631|NCT00996892|532389016|FG005|Expansion Stage 2A|Physician Decision|0|||
147610632|NCT00996892|532389017|FG006|Expansion Stage 2A|Physician Decision|0|||
147610633|NCT00996892|532389018|FG007|Expansion Stage 2A|Physician Decision|0|||
147610634|NCT00996892|532389019|FG008|Expansion Stage 2A|Physician Decision|0|||
147610635|NCT00996892|532389020|FG009|Expansion Stage 2A|Physician Decision|0|||
147610636|NCT00996892|532389021|FG010|Expansion Stage 2A|Physician Decision|0|||
147610637|NCT00996892|532389022|FG011|Expansion Stage 2A|Physician Decision|0|||
147610638|NCT00996892|532389023|FG012|Expansion Stage 2A|Physician Decision|0|||
147610639|NCT00996892|532389024|FG013|Expansion Stage 2A|Physician Decision|0|||
147610640|NCT00996892|532389025|FG014|Expansion Stage 2A|Physician Decision|0|||
147610641|NCT00996892|532389026|FG015|Expansion Stage 2A|Physician Decision|0|||
147610642|NCT00996892|532389027|FG016|Expansion Stage 2A|Physician Decision|0|||
147610643|NCT00996892|532389028|FG017|Expansion Stage 2A|Physician Decision|0|||
147610644|NCT00996892|532389029|FG018|Expansion Stage 2A|Physician Decision|0|||
147610645|NCT00996892|532389030|FG019|Expansion Stage 2A|Physician Decision|2|||
147610646|NCT00996892|532389011|FG000|Expansion Stage 2A|Withdrawal by Subject|0|||
147610647|NCT00996892|532389012|FG001|Expansion Stage 2A|Withdrawal by Subject|0|||
147610648|NCT00996892|532389013|FG002|Expansion Stage 2A|Withdrawal by Subject|0|||
147610649|NCT00996892|532389014|FG003|Expansion Stage 2A|Withdrawal by Subject|0|||
147610650|NCT00996892|532389015|FG004|Expansion Stage 2A|Withdrawal by Subject|0|||
147610651|NCT00996892|532389016|FG005|Expansion Stage 2A|Withdrawal by Subject|0|||
147610652|NCT00996892|532389017|FG006|Expansion Stage 2A|Withdrawal by Subject|0|||
147610653|NCT00996892|532389018|FG007|Expansion Stage 2A|Withdrawal by Subject|0|||
147610654|NCT00996892|532389019|FG008|Expansion Stage 2A|Withdrawal by Subject|0|||
147610655|NCT00996892|532389020|FG009|Expansion Stage 2A|Withdrawal by Subject|0|||
147610656|NCT00996892|532389021|FG010|Expansion Stage 2A|Withdrawal by Subject|0|||
147610657|NCT00996892|532389022|FG011|Expansion Stage 2A|Withdrawal by Subject|0|||
147610658|NCT00996892|532389023|FG012|Expansion Stage 2A|Withdrawal by Subject|0|||
147610659|NCT00996892|532389024|FG013|Expansion Stage 2A|Withdrawal by Subject|0|||
147610660|NCT00996892|532389025|FG014|Expansion Stage 2A|Withdrawal by Subject|0|||
147610661|NCT00996892|532389026|FG015|Expansion Stage 2A|Withdrawal by Subject|0|||
147610662|NCT00996892|532389027|FG016|Expansion Stage 2A|Withdrawal by Subject|0|||
147610663|NCT00996892|532389028|FG017|Expansion Stage 2A|Withdrawal by Subject|0|||
147610664|NCT00996892|532389029|FG018|Expansion Stage 2A|Withdrawal by Subject|0|||
147610665|NCT00996892|532389030|FG019|Expansion Stage 2A|Withdrawal by Subject|4|||
147610666|NCT00996892|532389011|FG000|Expansion Stage 2A|Disease Progression|0|||
147610667|NCT00996892|532389012|FG001|Expansion Stage 2A|Disease Progression|0|||
147610668|NCT00996892|532389013|FG002|Expansion Stage 2A|Disease Progression|0|||
147610669|NCT00996892|532389014|FG003|Expansion Stage 2A|Disease Progression|0|||
147610670|NCT00996892|532389015|FG004|Expansion Stage 2A|Disease Progression|0|||
147610671|NCT00996892|532389016|FG005|Expansion Stage 2A|Disease Progression|0|||
147610672|NCT00996892|532389017|FG006|Expansion Stage 2A|Disease Progression|0|||
147610673|NCT00996892|532389018|FG007|Expansion Stage 2A|Disease Progression|0|||
147610674|NCT00996892|532389019|FG008|Expansion Stage 2A|Disease Progression|0|||
147610675|NCT00996892|532389020|FG009|Expansion Stage 2A|Disease Progression|0|||
147610676|NCT00996892|532389021|FG010|Expansion Stage 2A|Disease Progression|0|||
147610677|NCT00996892|532389022|FG011|Expansion Stage 2A|Disease Progression|0|||
147610678|NCT00996892|532389023|FG012|Expansion Stage 2A|Disease Progression|0|||
147610679|NCT00996892|532389024|FG013|Expansion Stage 2A|Disease Progression|0|||
147610680|NCT00996892|532389025|FG014|Expansion Stage 2A|Disease Progression|0|||
147610681|NCT00996892|532389026|FG015|Expansion Stage 2A|Disease Progression|0|||
147610682|NCT00996892|532389027|FG016|Expansion Stage 2A|Disease Progression|0|||
147610683|NCT00996892|532389028|FG017|Expansion Stage 2A|Disease Progression|0|||
147610684|NCT00996892|532389029|FG018|Expansion Stage 2A|Disease Progression|0|||
147610685|NCT00996892|532389030|FG019|Expansion Stage 2A|Disease Progression|31|||
147610686|NCT01653912|532389031|FG000|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0|||
147610687|NCT01653912|532389032|FG001|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|1|||
147610688|NCT01653912|532389033|FG002|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0|||
147610689|NCT01653912|532389034|FG003|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0|||
147610690|NCT01653912|532389035|FG004|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0|||
147610691|NCT01653912|532389036|FG005|Phase 1-Cohort 1.5: GSK2110183 75 mg|Clinical Progression|0|||
147610692|NCT01653912|532389031|FG000|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0|||
147610693|NCT01653912|532389032|FG001|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0|||
147369307|NCT00982644|531520237|FG001|Main: Week 0 to 52 (NN1250-3579)|Lack of Efficacy|2|||
147369308|NCT00982644|531520236|FG000|Main: Week 0 to 52 (NN1250-3579)|Protocol Violation|46|||
147369309|NCT00982644|531520237|FG001|Main: Week 0 to 52 (NN1250-3579)|Protocol Violation|18|||
147369310|NCT00982644|531520236|FG000|Main: Week 0 to 52 (NN1250-3579)|Withdrawal criteria|9|||
147369311|NCT00982644|531520237|FG001|Main: Week 0 to 52 (NN1250-3579)|Withdrawal criteria|5|||
147369312|NCT00982644|531520236|FG000|Main: Week 0 to 52 (NN1250-3579)|Unclassified|84|||
147369313|NCT00982644|531520237|FG001|Main: Week 0 to 52 (NN1250-3579)|Unclassified|30|||
147369314|NCT00982644|531520236|FG000|Extension: Week 53 to 104 (NN1250-3643)|Adverse Event|12|||
147369315|NCT00982644|531520237|FG001|Extension: Week 53 to 104 (NN1250-3643)|Adverse Event|5|||
147369316|NCT00982644|531520236|FG000|Extension: Week 53 to 104 (NN1250-3643)|Lack of Efficacy|3|||
147369317|NCT00982644|531520237|FG001|Extension: Week 53 to 104 (NN1250-3643)|Lack of Efficacy|1|||
147369318|NCT00982644|531520236|FG000|Extension: Week 53 to 104 (NN1250-3643)|Protocol Violation|2|||
147369319|NCT00982644|531520237|FG001|Extension: Week 53 to 104 (NN1250-3643)|Protocol Violation|4|||
147369320|NCT00982644|531520236|FG000|Extension: Week 53 to 104 (NN1250-3643)|Withdrawal criteria|6|||
147369321|NCT00982644|531520237|FG001|Extension: Week 53 to 104 (NN1250-3643)|Withdrawal criteria|3|||
147369322|NCT00982644|531520236|FG000|Extension: Week 53 to 104 (NN1250-3643)|Unclassified|23|||
147369323|NCT00982644|531520237|FG001|Extension: Week 53 to 104 (NN1250-3643)|Unclassified|7|||
147369324|NCT00943917|531520240|FG000|Stage I|Adverse Event|1|||
147369325|NCT00943917|531520241|FG001|Stage I|Adverse Event|2|||
147369326|NCT00943917|531520242|FG002|Stage I|Adverse Event|2|||
147369327|NCT00943917|531520243|FG003|Stage I|Adverse Event|0|||
147369328|NCT00943917|531520244|FG004|Stage I|Adverse Event|0|||
147369329|NCT00943917|531520245|FG005|Stage I|Adverse Event|0|||
147369330|NCT00943917|531520246|FG006|Stage I|Adverse Event|0|||
147369331|NCT00943917|531520247|FG007|Stage I|Adverse Event|0|||
147369332|NCT00943917|531520248|FG008|Stage I|Adverse Event|0|||
147369333|NCT00943917|531520249|FG009|Stage I|Adverse Event|0|||
147369334|NCT00943917|531520250|FG010|Stage I|Adverse Event|0|||
147369335|NCT00943917|531520251|FG011|Stage I|Adverse Event|0|||
147369336|NCT00943917|531520252|FG012|Stage I|Adverse Event|0|||
147369337|NCT00943917|531520253|FG013|Stage I|Adverse Event|0|||
147369338|NCT00943917|531520254|FG014|Stage I|Adverse Event|0|||
147369339|NCT00943917|531520240|FG000|Stage I|Lost to Follow-up|0|||
147369340|NCT00943917|531520241|FG001|Stage I|Lost to Follow-up|0|||
147369341|NCT00943917|531520242|FG002|Stage I|Lost to Follow-up|1|||
147369342|NCT00943917|531520243|FG003|Stage I|Lost to Follow-up|0|||
147369343|NCT00943917|531520244|FG004|Stage I|Lost to Follow-up|0|||
147369344|NCT00943917|531520245|FG005|Stage I|Lost to Follow-up|0|||
147369345|NCT00943917|531520246|FG006|Stage I|Lost to Follow-up|0|||
147610694|NCT01653912|532389033|FG002|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|2|||
147610695|NCT01653912|532389034|FG003|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0|||
147610696|NCT01653912|532389035|FG004|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0|||
147610697|NCT01653912|532389036|FG005|Phase 1-Cohort 2: GSK2110183 100 mg|Adverse Event|0|||
147610698|NCT01653912|532389031|FG000|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0|||
147610699|NCT01653912|532389032|FG001|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0|||
147610700|NCT01653912|532389033|FG002|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0|||
147610701|NCT01653912|532389034|FG003|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|1|||
147610702|NCT01653912|532389035|FG004|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0|||
147610703|NCT01653912|532389036|FG005|Phase 1-Cohort 3: GSK2110183 125 mg|Clinical Progression|0|||
147369346|NCT00943917|531520247|FG007|Stage I|Lost to Follow-up|0|||
147369347|NCT00943917|531520248|FG008|Stage I|Lost to Follow-up|0|||
147369348|NCT00943917|531520249|FG009|Stage I|Lost to Follow-up|0|||
147369349|NCT00943917|531520250|FG010|Stage I|Lost to Follow-up|0|||
147369350|NCT00943917|531520251|FG011|Stage I|Lost to Follow-up|0|||
147369351|NCT00943917|531520252|FG012|Stage I|Lost to Follow-up|0|||
147369352|NCT00943917|531520253|FG013|Stage I|Lost to Follow-up|0|||
147369353|NCT00943917|531520254|FG014|Stage I|Lost to Follow-up|0|||
147369354|NCT00943917|531520240|FG000|Stage I|hyperglycemia|0|||
147369355|NCT00943917|531520241|FG001|Stage I|hyperglycemia|0|||
147610704|NCT01653912|532389031|FG000|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0|||
147610705|NCT01653912|532389032|FG001|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0|||
147610706|NCT01653912|532389033|FG002|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0|||
147610707|NCT01653912|532389034|FG003|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|1|||
147369356|NCT00943917|531520242|FG002|Stage I|hyperglycemia|1|||
147369357|NCT00943917|531520243|FG003|Stage I|hyperglycemia|0|||
147369358|NCT00943917|531520244|FG004|Stage I|hyperglycemia|0|||
147369359|NCT00943917|531520245|FG005|Stage I|hyperglycemia|0|||
147369360|NCT00943917|531520246|FG006|Stage I|hyperglycemia|0|||
147369361|NCT00943917|531520247|FG007|Stage I|hyperglycemia|0|||
147369362|NCT00943917|531520248|FG008|Stage I|hyperglycemia|0|||
147369363|NCT00943917|531520249|FG009|Stage I|hyperglycemia|0|||
147369364|NCT00943917|531520250|FG010|Stage I|hyperglycemia|0|||
147369365|NCT00943917|531520251|FG011|Stage I|hyperglycemia|0|||
147369366|NCT00943917|531520252|FG012|Stage I|hyperglycemia|0|||
147663437|NCT03652818|532591492|FG003|Overall Study|Physician Decision|0|||
147454713|NCT01314716|531825690|FG000|Double-Blind Phase|Physician Decision|0|||
147454714|NCT01314716|531825691|FG001|Double-Blind Phase|Physician Decision|1|||
147454715|NCT01314716|531825690|FG000|Open-Label Phase|Adverse Event|4|||
147454716|NCT01314716|531825691|FG001|Open-Label Phase|Adverse Event|6|||
147454717|NCT01314716|531825690|FG000|Open-Label Phase|Withdrawal by Subject|1|||
147454718|NCT01314716|531825691|FG001|Open-Label Phase|Withdrawal by Subject|2|||
147454719|NCT01314716|531825690|FG000|Open-Label Phase|Physician Decision|5|||
147454720|NCT01314716|531825691|FG001|Open-Label Phase|Physician Decision|4|||
147454721|NCT00700271|531825692|FG000|Overall Study|Adverse Event|4|||
147454722|NCT00700271|531825693|FG001|Overall Study|Adverse Event|6|||
147454723|NCT00700271|531825692|FG000|Overall Study|Protocol Violation|1|||
147454724|NCT00700271|531825693|FG001|Overall Study|Protocol Violation|0|||
147454725|NCT00700271|531825692|FG000|Overall Study|Administrative Reasons|1|||
147454726|NCT00700271|531825693|FG001|Overall Study|Administrative Reasons|0|||
147454727|NCT00700271|531825692|FG000|Overall Study|Withdrawal by Subject|6|||
147454728|NCT00700271|531825693|FG001|Overall Study|Withdrawal by Subject|4|||
147454729|NCT00700271|531825692|FG000|Overall Study|Lost to Follow-up|2|||
147454730|NCT00700271|531825693|FG001|Overall Study|Lost to Follow-up|2|||
147454731|NCT04440592|531825694|FG000|Overall Study|Adverse Event|8|||
147454732|NCT04440592|531825695|FG001|Overall Study|Adverse Event|0|||
147454733|NCT04440592|531825694|FG000|Overall Study|Lost to Follow-up|1|||
147454734|NCT04440592|531825695|FG001|Overall Study|Lost to Follow-up|0|||
147454735|NCT04440592|531825694|FG000|Overall Study|Withdrawal by Subject|1|||
147454736|NCT04440592|531825695|FG001|Overall Study|Withdrawal by Subject|1|||
147454737|NCT04440592|531825694|FG000|Overall Study|Other therapy needed|0|||
147454738|NCT04440592|531825695|FG001|Overall Study|Other therapy needed|1|||
147454739|NCT02028455|531825698|FG000|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
147454740|NCT02028455|531825699|FG001|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
147454741|NCT02028455|531825700|FG002|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
147454742|NCT02028455|531825701|FG003|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
147454743|NCT02028455|531825702|FG004|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
147454744|NCT02028455|531825703|FG005|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|0|||
147454745|NCT02028455|531825704|FG006|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|4|||
147454746|NCT02028455|531825705|FG007|Enrollment and Preliminary Assessments|Went off study without receiving CAR T cell infusion|17|||
147454747|NCT02028455|531825698|FG000|Treatment(T Cell Infusion) and Follow up|Death|4|||
147454748|NCT02028455|531825699|FG001|Treatment(T Cell Infusion) and Follow up|Death|9|||
147454749|NCT02028455|531825700|FG002|Treatment(T Cell Infusion) and Follow up|Death|3|||
147454750|NCT02028455|531825701|FG003|Treatment(T Cell Infusion) and Follow up|Death|5|||
147454751|NCT02028455|531825702|FG004|Treatment(T Cell Infusion) and Follow up|Death|3|||
147454752|NCT02028455|531825703|FG005|Treatment(T Cell Infusion) and Follow up|Death|2|||
147454753|NCT02028455|531825704|FG006|Treatment(T Cell Infusion) and Follow up|Death|0|||
147454754|NCT02028455|531825705|FG007|Treatment(T Cell Infusion) and Follow up|Death|40|||
147454755|NCT02028455|531825698|FG000|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
147454756|NCT02028455|531825699|FG001|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
147454757|NCT02028455|531825700|FG002|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
147454758|NCT02028455|531825701|FG003|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
147454759|NCT02028455|531825702|FG004|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
147454760|NCT02028455|531825703|FG005|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|1|||
147454761|NCT02028455|531825704|FG006|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|0|||
147454762|NCT02028455|531825705|FG007|Treatment(T Cell Infusion) and Follow up|Lost to Follow-up|2|||
147454763|NCT02028455|531825698|FG000|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|3|||
147454764|NCT02028455|531825699|FG001|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|3|||
147454765|NCT02028455|531825700|FG002|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|4|||
147454766|NCT02028455|531825701|FG003|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|0|||
147454767|NCT02028455|531825702|FG004|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|3|||
147454768|NCT02028455|531825703|FG005|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|3|||
147454769|NCT02028455|531825704|FG006|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|0|||
147454770|NCT02028455|531825705|FG007|Treatment(T Cell Infusion) and Follow up|Still in long-term follow up|61|||
147454771|NCT02396589|531825711|FG000|Intervention|Lost to Follow-up|1|||
147454772|NCT02396589|531825712|FG001|Intervention|Lost to Follow-up|0|||
147454773|NCT02396589|531825711|FG000|6 Month Follow-up|change in health status|0|||
147454774|NCT02396589|531825712|FG001|6 Month Follow-up|change in health status|1|||
147454775|NCT02396589|531825711|FG000|9 Month Follow-up|Death|0|||
147454776|NCT02396589|531825712|FG001|9 Month Follow-up|Death|1|||
147454777|NCT02396589|531825711|FG000|12 Month Follow up|Lost to Follow-up|0|||
147454778|NCT02396589|531825712|FG001|12 Month Follow up|Lost to Follow-up|2|||
147454779|NCT03087955|531827705|FG000|Overall Study|Death|4|||
147610708|NCT01653912|532389035|FG004|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0|||
147610709|NCT01653912|532389036|FG005|Phase 1-Cohort 3: GSK2110183 125 mg|Withdrawal by Subject|0|||
147610710|NCT01653912|532389031|FG000|Phase 2: GSK2110183 125 mg|Adverse Event|0|||
147610711|NCT01653912|532389032|FG001|Phase 2: GSK2110183 125 mg|Adverse Event|0|||
147610712|NCT01653912|532389033|FG002|Phase 2: GSK2110183 125 mg|Adverse Event|0|||
147610713|NCT01653912|532389034|FG003|Phase 2: GSK2110183 125 mg|Adverse Event|0|||
147610714|NCT01653912|532389035|FG004|Phase 2: GSK2110183 125 mg|Adverse Event|0|||
147610715|NCT01653912|532389036|FG005|Phase 2: GSK2110183 125 mg|Adverse Event|1|||
147610716|NCT01653912|532389031|FG000|Phase 2: GSK2110183 125 mg|Clinical Progression|0|||
147610717|NCT01653912|532389032|FG001|Phase 2: GSK2110183 125 mg|Clinical Progression|0|||
147610718|NCT01653912|532389033|FG002|Phase 2: GSK2110183 125 mg|Clinical Progression|0|||
147610719|NCT01653912|532389034|FG003|Phase 2: GSK2110183 125 mg|Clinical Progression|0|||
147610720|NCT01653912|532389035|FG004|Phase 2: GSK2110183 125 mg|Clinical Progression|0|||
147610721|NCT01653912|532389036|FG005|Phase 2: GSK2110183 125 mg|Clinical Progression|6|||
147610722|NCT01653912|532389031|FG000|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0|||
147610723|NCT01653912|532389032|FG001|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0|||
147610724|NCT01653912|532389033|FG002|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0|||
147610725|NCT01653912|532389034|FG003|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0|||
147610726|NCT01653912|532389035|FG004|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|0|||
147610727|NCT01653912|532389036|FG005|Phase 2: GSK2110183 125 mg|Withdrawal by Subject|1|||
147610728|NCT00708227|532389037|FG000|Overall Study|Physician Decision|0|||
147610729|NCT00708227|532389038|FG001|Overall Study|Physician Decision|3|||
147610730|NCT00708227|532389039|FG002|Overall Study|Physician Decision|1|||
147610731|NCT00708227|532389040|FG003|Overall Study|Physician Decision|2|||
147610732|NCT00708227|532389037|FG000|Overall Study|Withdrawal by Subject|1|||
147610733|NCT00708227|532389038|FG001|Overall Study|Withdrawal by Subject|2|||
147610734|NCT00708227|532389039|FG002|Overall Study|Withdrawal by Subject|0|||
147610735|NCT00708227|532389040|FG003|Overall Study|Withdrawal by Subject|1|||
147610736|NCT04007991|532389041|FG000|Overall Study|Withdrawal by Subject|1|||
147610737|NCT04007991|532389042|FG001|Overall Study|Withdrawal by Subject|1|||
147610738|NCT04007991|532389041|FG000|Overall Study|Physician Decision|1|||
147610739|NCT04007991|532389042|FG001|Overall Study|Physician Decision|1|||
147610740|NCT04007991|532389041|FG000|Overall Study|Non-compliance with Study Drug|0|||
147610741|NCT04007991|532389042|FG001|Overall Study|Non-compliance with Study Drug|1|||
147610742|NCT04007991|532389041|FG000|Overall Study|Withdrawal by Parent/Caregiver|1|||
147610743|NCT04007991|532389042|FG001|Overall Study|Withdrawal by Parent/Caregiver|2|||
147610744|NCT04007991|532389041|FG000|Overall Study|Adverse event, non-fatal|5|||
147610745|NCT04007991|532389042|FG001|Overall Study|Adverse event, non-fatal|0|||
147610746|NCT04007991|532389041|FG000|Overall Study|Lost to Follow-up|2|||
147610747|NCT04007991|532389042|FG001|Overall Study|Lost to Follow-up|1|||
147610748|NCT01987479|532389043|FG000|Overall Study|Protocol Violation|1|||
147610749|NCT01987479|532389043|FG000|Overall Study|Physician Decision|2|||
147610750|NCT01987479|532389043|FG000|Overall Study|Participant/legal guardian decision|1|||
147610751|NCT01987479|532389043|FG000|Overall Study|Other|5|||
147610752|NCT01987479|532389043|FG000|Overall Study|Lost to Follow-up|1|||
147610753|NCT01987479|532389043|FG000|Overall Study|Adverse Event|7|||
147610754|NCT05314816|532389044|FG000|Overall Study|Lost to Follow-up|5|||
147610755|NCT05314816|532389045|FG001|Overall Study|Lost to Follow-up|0|||
147610756|NCT05314816|532389046|FG002|Overall Study|Lost to Follow-up|1|||
147610757|NCT05314816|532389044|FG000|Overall Study|Protocol Violation|13|||
147610758|NCT05314816|532389045|FG001|Overall Study|Protocol Violation|8|||
147610759|NCT05314816|532389046|FG002|Overall Study|Protocol Violation|0|||
147663438|NCT03652818|532591493|FG004|Overall Study|Physician Decision|0|||
147663439|NCT03652818|532591489|FG000|Overall Study|Lost to Follow-up|0|||
147663440|NCT03652818|532591490|FG001|Overall Study|Lost to Follow-up|1|||
147663441|NCT03652818|532591491|FG002|Overall Study|Lost to Follow-up|2|||
147663442|NCT03652818|532591492|FG003|Overall Study|Lost to Follow-up|1|||
147663443|NCT03652818|532591493|FG004|Overall Study|Lost to Follow-up|1|||
147610760|NCT02017015|532390852|FG000|Overall Study|Adverse Event|9|||
147610761|NCT02017015|532390852|FG000|Overall Study|Withdrawal by Subject|21|||
147610762|NCT02017015|532390852|FG000|Overall Study|Death|4|||
147610763|NCT02017015|532390852|FG000|Overall Study|Progressive Disease|31|||
147610764|NCT02017015|532390852|FG000|Overall Study|Non-compliance with study drug|2|||
147610765|NCT02017015|532390852|FG000|Overall Study|Physician Decision|2|||
147610766|NCT03104400|532390855|FG000|Period 1 (Week 1 - 56)|Adverse Event|5|||
147610767|NCT03104400|532390856|FG001|Period 1 (Week 1 - 56)|Adverse Event|7|||
147610768|NCT03104400|532390857|FG002|Period 1 (Week 1 - 56)|Adverse Event|11|||
147610769|NCT03104400|532390858|FG003|Period 1 (Week 1 - 56)|Adverse Event|9|||
147610770|NCT03104400|532390859|FG004|Period 1 (Week 1 - 56)|Adverse Event|21|||
147610771|NCT03104400|532390860|FG005|Period 1 (Week 1 - 56)|Adverse Event|0|||
147610772|NCT03104400|532390861|FG006|Period 1 (Week 1 - 56)|Adverse Event|0|||
147610773|NCT03104400|532390862|FG007|Period 1 (Week 1 - 56)|Adverse Event|0|||
147610774|NCT03104400|532390863|FG008|Period 1 (Week 1 - 56)|Adverse Event|0|||
147610775|NCT03104400|532390864|FG009|Period 1 (Week 1 - 56)|Adverse Event|0|||
147610776|NCT03104400|532390855|FG000|Period 1 (Week 1 - 56)|Withdrawal by Subject|17|||
147663444|NCT03964207|532591494|FG000|First Treatment|Withdrawal by Subject|1|||
147610777|NCT03104400|532390856|FG001|Period 1 (Week 1 - 56)|Withdrawal by Subject|20|||
147610778|NCT03104400|532390857|FG002|Period 1 (Week 1 - 56)|Withdrawal by Subject|29|||
147610779|NCT03104400|532390858|FG003|Period 1 (Week 1 - 56)|Withdrawal by Subject|24|||
147610780|NCT03104400|532390859|FG004|Period 1 (Week 1 - 56)|Withdrawal by Subject|24|||
147610781|NCT03104400|532390860|FG005|Period 1 (Week 1 - 56)|Withdrawal by Subject|0|||
147610782|NCT03104400|532390861|FG006|Period 1 (Week 1 - 56)|Withdrawal by Subject|0|||
147610783|NCT03104400|532390862|FG007|Period 1 (Week 1 - 56)|Withdrawal by Subject|0|||
147610784|NCT03104400|532390863|FG008|Period 1 (Week 1 - 56)|Withdrawal by Subject|0|||
147610785|NCT03104400|532390864|FG009|Period 1 (Week 1 - 56)|Withdrawal by Subject|0|||
147610786|NCT03104400|532390855|FG000|Period 1 (Week 1 - 56)|Lost to Follow-up|4|||
147610787|NCT03104400|532390856|FG001|Period 1 (Week 1 - 56)|Lost to Follow-up|1|||
147610788|NCT03104400|532390857|FG002|Period 1 (Week 1 - 56)|Lost to Follow-up|4|||
147610789|NCT03104400|532390858|FG003|Period 1 (Week 1 - 56)|Lost to Follow-up|8|||
147610790|NCT03104400|532390859|FG004|Period 1 (Week 1 - 56)|Lost to Follow-up|7|||
147610791|NCT03104400|532390860|FG005|Period 1 (Week 1 - 56)|Lost to Follow-up|0|||
147610792|NCT03104400|532390861|FG006|Period 1 (Week 1 - 56)|Lost to Follow-up|0|||
147610793|NCT03104400|532390862|FG007|Period 1 (Week 1 - 56)|Lost to Follow-up|0|||
147610794|NCT03104400|532390863|FG008|Period 1 (Week 1 - 56)|Lost to Follow-up|0|||
147610795|NCT03104400|532390864|FG009|Period 1 (Week 1 - 56)|Lost to Follow-up|0|||
147610796|NCT03104400|532390855|FG000|Period 1 (Week 1 - 56)|Lack of Efficacy|6|||
147610797|NCT03104400|532390856|FG001|Period 1 (Week 1 - 56)|Lack of Efficacy|3|||
147610798|NCT03104400|532390857|FG002|Period 1 (Week 1 - 56)|Lack of Efficacy|8|||
147610799|NCT03104400|532390858|FG003|Period 1 (Week 1 - 56)|Lack of Efficacy|2|||
147610800|NCT03104400|532390859|FG004|Period 1 (Week 1 - 56)|Lack of Efficacy|1|||
147610801|NCT03104400|532390860|FG005|Period 1 (Week 1 - 56)|Lack of Efficacy|0|||
147610802|NCT03104400|532390861|FG006|Period 1 (Week 1 - 56)|Lack of Efficacy|0|||
147610803|NCT03104400|532390862|FG007|Period 1 (Week 1 - 56)|Lack of Efficacy|0|||
147610804|NCT03104400|532390863|FG008|Period 1 (Week 1 - 56)|Lack of Efficacy|0|||
147610805|NCT03104400|532390864|FG009|Period 1 (Week 1 - 56)|Lack of Efficacy|0|||
147610806|NCT03104400|532390855|FG000|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
147610807|NCT03104400|532390856|FG001|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
147610808|NCT03104400|532390857|FG002|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
147610809|NCT03104400|532390858|FG003|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|1|||
147610810|NCT03104400|532390859|FG004|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
147610811|NCT03104400|532390860|FG005|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
147610812|NCT03104400|532390861|FG006|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
147610813|NCT03104400|532390862|FG007|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
147610814|NCT03104400|532390863|FG008|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
147610815|NCT03104400|532390864|FG009|Period 1 (Week 1 - 56)|COVID-19 Logistical Restrictions|0|||
147610816|NCT03104400|532390855|FG000|Period 1 (Week 1 - 56)|Other, not specified|2|||
147610817|NCT03104400|532390856|FG001|Period 1 (Week 1 - 56)|Other, not specified|3|||
147610818|NCT03104400|532390857|FG002|Period 1 (Week 1 - 56)|Other, not specified|7|||
147610819|NCT03104400|532390858|FG003|Period 1 (Week 1 - 56)|Other, not specified|6|||
147610820|NCT03104400|532390859|FG004|Period 1 (Week 1 - 56)|Other, not specified|4|||
147610821|NCT03104400|532390860|FG005|Period 1 (Week 1 - 56)|Other, not specified|0|||
147610822|NCT03104400|532390861|FG006|Period 1 (Week 1 - 56)|Other, not specified|0|||
147610823|NCT03104400|532390862|FG007|Period 1 (Week 1 - 56)|Other, not specified|0|||
147610824|NCT03104400|532390863|FG008|Period 1 (Week 1 - 56)|Other, not specified|0|||
147610825|NCT03104400|532390864|FG009|Period 1 (Week 1 - 56)|Other, not specified|0|||
147610826|NCT03104400|532390855|FG000|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
147610827|NCT03104400|532390856|FG001|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
147610828|NCT03104400|532390857|FG002|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
147610829|NCT03104400|532390858|FG003|Period 1 (Week 1 - 56)|Did not receive study drug|1|||
147610830|NCT03104400|532390859|FG004|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
147610831|NCT03104400|532390860|FG005|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
147610832|NCT03104400|532390861|FG006|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
147610833|NCT03104400|532390862|FG007|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
147610834|NCT03104400|532390863|FG008|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
147610835|NCT03104400|532390864|FG009|Period 1 (Week 1 - 56)|Did not receive study drug|0|||
147610836|NCT03104400|532390855|FG000|Period 2 Week 56 - 260)|Adverse Event|0|||
147610837|NCT03104400|532390856|FG001|Period 2 Week 56 - 260)|Adverse Event|0|||
147610838|NCT03104400|532390857|FG002|Period 2 Week 56 - 260)|Adverse Event|0|||
147610839|NCT03104400|532390858|FG003|Period 2 Week 56 - 260)|Adverse Event|0|||
147610840|NCT03104400|532390859|FG004|Period 2 Week 56 - 260)|Adverse Event|0|||
147610841|NCT03104400|532390860|FG005|Period 2 Week 56 - 260)|Adverse Event|14|||
147610842|NCT03104400|532390861|FG006|Period 2 Week 56 - 260)|Adverse Event|17|||
147610843|NCT03104400|532390862|FG007|Period 2 Week 56 - 260)|Adverse Event|14|||
147610844|NCT03104400|532390863|FG008|Period 2 Week 56 - 260)|Adverse Event|28|||
147610845|NCT03104400|532390864|FG009|Period 2 Week 56 - 260)|Adverse Event|28|||
147610846|NCT03104400|532390855|FG000|Period 2 Week 56 - 260)|Withdrawal by Subject|0|||
147610847|NCT03104400|532390856|FG001|Period 2 Week 56 - 260)|Withdrawal by Subject|0|||
147663445|NCT03964207|532591495|FG001|First Treatment|Withdrawal by Subject|2|||
147663446|NCT03964207|532591494|FG000|First Treatment|Protocol Violation|1|||
147663447|NCT03964207|532591495|FG001|First Treatment|Protocol Violation|0|||
147663448|NCT03964207|532591494|FG000|First Treatment|Lost to Follow-up|1|||
147663449|NCT03964207|532591495|FG001|First Treatment|Lost to Follow-up|0|||
147663450|NCT03964207|532591494|FG000|Second Treatment|Lost to Follow-up|0|||
147663451|NCT03964207|532591495|FG001|Second Treatment|Lost to Follow-up|1|||
147663452|NCT03964207|532591494|FG000|Second Treatment|Adverse Event|1|||
147663453|NCT03964207|532591495|FG001|Second Treatment|Adverse Event|2|||
147663454|NCT00830219|532591496|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
147663455|NCT00830219|532591497|FG001|Washout of 7 Days|Withdrawal by Subject|1|||
147663456|NCT01241279|532591502|FG000|Overall Study|Lost to Follow-up|0|||
147663457|NCT01241279|532591503|FG001|Overall Study|Lost to Follow-up|1|||
147663458|NCT00239720|532591507|FG000|Overall Study|Adverse Event|1|||
147663459|NCT00239720|532591508|FG001|Overall Study|Adverse Event|0|||
147663460|NCT00239720|532591507|FG000|Overall Study|Lost to Follow-up|0|||
147663461|NCT00239720|532591508|FG001|Overall Study|Lost to Follow-up|1|||
147663462|NCT01811732|532591509|FG000|Overall Study|Lost to Follow-up|24|||
147663463|NCT01811732|532591510|FG001|Overall Study|Lost to Follow-up|30|||
147663464|NCT01811732|532591509|FG000|Overall Study|Withdrawal by Subject|16|||
147663465|NCT01811732|532591510|FG001|Overall Study|Withdrawal by Subject|10|||
147663466|NCT01811732|532591509|FG000|Overall Study|Adverse Event|3|||
147663467|NCT01811732|532591510|FG001|Overall Study|Adverse Event|9|||
147663468|NCT01811732|532591509|FG000|Overall Study|Lack of Efficacy|3|||
147663469|NCT01811732|532591510|FG001|Overall Study|Lack of Efficacy|1|||
147663470|NCT01811732|532591509|FG000|Overall Study|Non-compliance with study drug/procedure|3|||
147663471|NCT01811732|532591510|FG001|Overall Study|Non-compliance with study drug/procedure|3|||
147663472|NCT01811732|532591509|FG000|Overall Study|Physician Decision|2|||
147369367|NCT00943917|531520253|FG013|Stage I|hyperglycemia|0|||
147369368|NCT00943917|531520254|FG014|Stage I|hyperglycemia|0|||
147369369|NCT00943917|531520240|FG000|Stage I|A1C elevation|1|||
147369370|NCT00943917|531520241|FG001|Stage I|A1C elevation|0|||
147369371|NCT00943917|531520242|FG002|Stage I|A1C elevation|0|||
147369372|NCT00943917|531520243|FG003|Stage I|A1C elevation|0|||
147369373|NCT00943917|531520244|FG004|Stage I|A1C elevation|0|||
147369374|NCT00943917|531520245|FG005|Stage I|A1C elevation|0|||
147369375|NCT00943917|531520246|FG006|Stage I|A1C elevation|0|||
147369376|NCT00943917|531520247|FG007|Stage I|A1C elevation|0|||
147369377|NCT00943917|531520248|FG008|Stage I|A1C elevation|0|||
147369378|NCT00943917|531520249|FG009|Stage I|A1C elevation|0|||
147369379|NCT00943917|531520250|FG010|Stage I|A1C elevation|0|||
147369380|NCT00943917|531520251|FG011|Stage I|A1C elevation|0|||
147369381|NCT00943917|531520252|FG012|Stage I|A1C elevation|0|||
147369382|NCT00943917|531520253|FG013|Stage I|A1C elevation|0|||
147369383|NCT00943917|531520254|FG014|Stage I|A1C elevation|0|||
147369384|NCT00943917|531520240|FG000|Stage I|Withdrawal by Subject|2|||
147369385|NCT00943917|531520241|FG001|Stage I|Withdrawal by Subject|1|||
147369386|NCT00943917|531520242|FG002|Stage I|Withdrawal by Subject|2|||
147369387|NCT00943917|531520243|FG003|Stage I|Withdrawal by Subject|0|||
147369388|NCT00943917|531520244|FG004|Stage I|Withdrawal by Subject|0|||
147369389|NCT00943917|531520245|FG005|Stage I|Withdrawal by Subject|0|||
147369390|NCT00943917|531520246|FG006|Stage I|Withdrawal by Subject|0|||
147369391|NCT00943917|531520247|FG007|Stage I|Withdrawal by Subject|0|||
147369392|NCT00943917|531520248|FG008|Stage I|Withdrawal by Subject|0|||
147369393|NCT00943917|531520249|FG009|Stage I|Withdrawal by Subject|0|||
147663473|NCT01811732|532591510|FG001|Overall Study|Physician Decision|0|||
147369394|NCT00943917|531520250|FG010|Stage I|Withdrawal by Subject|0|||
147369395|NCT00943917|531520251|FG011|Stage I|Withdrawal by Subject|0|||
147369396|NCT00943917|531520252|FG012|Stage I|Withdrawal by Subject|0|||
147369397|NCT00943917|531520253|FG013|Stage I|Withdrawal by Subject|0|||
147369398|NCT00943917|531520254|FG014|Stage I|Withdrawal by Subject|0|||
147369399|NCT00943917|531520240|FG000|Stage II|Adverse Event|0|||
147663474|NCT01811732|532591509|FG000|Overall Study|Death|1|||
147369400|NCT00943917|531520241|FG001|Stage II|Adverse Event|0|||
147663475|NCT01811732|532591510|FG001|Overall Study|Death|1|||
147663476|NCT01811732|532591509|FG000|Overall Study|Insufficient venous access|0|||
147663477|NCT01811732|532591510|FG001|Overall Study|Insufficient venous access|1|||
147663478|NCT01811732|532591509|FG000|Overall Study|Protocol Violation|0|||
147369401|NCT00943917|531520242|FG002|Stage II|Adverse Event|0|||
147369402|NCT00943917|531520243|FG003|Stage II|Adverse Event|0|||
147369403|NCT00943917|531520244|FG004|Stage II|Adverse Event|0|||
147369404|NCT00943917|531520245|FG005|Stage II|Adverse Event|1|||
147369405|NCT00943917|531520246|FG006|Stage II|Adverse Event|3|||
147369406|NCT00943917|531520247|FG007|Stage II|Adverse Event|0|||
147369407|NCT00943917|531520248|FG008|Stage II|Adverse Event|1|||
147369408|NCT00943917|531520249|FG009|Stage II|Adverse Event|0|||
147369409|NCT00943917|531520250|FG010|Stage II|Adverse Event|0|||
147369410|NCT00943917|531520251|FG011|Stage II|Adverse Event|0|||
147369411|NCT00943917|531520252|FG012|Stage II|Adverse Event|0|||
147369412|NCT00943917|531520253|FG013|Stage II|Adverse Event|0|||
147663479|NCT01811732|532591510|FG001|Overall Study|Protocol Violation|1|||
147663480|NCT01811732|532591509|FG000|Overall Study|Subject incarcerated|1|||
147454780|NCT03087955|531827706|FG001|Overall Study|Death|0|||
147454781|NCT03087955|531827705|FG000|Overall Study|Lack of Efficacy|2|||
147454782|NCT03087955|531827706|FG001|Overall Study|Lack of Efficacy|0|||
147454783|NCT03087955|531827705|FG000|Overall Study|Lost to Follow-up|1|||
147454784|NCT03087955|531827706|FG001|Overall Study|Lost to Follow-up|0|||
147454785|NCT02392429|531827707|FG000|Screening|Screen failure|15|||
147454786|NCT02392429|531827707|FG000|Enrolled Participants|Ineligible due to disease|3|||
147454787|NCT02392429|531827707|FG000|Enrolled Participants|Withdrawal by Subject|4|||
147454788|NCT02392429|531827707|FG000|Enrolled Participants|Post-treatment FLT PET/CT scan not completed|9|||
147454789|NCT02392429|531827707|FG000|Evaluable|Death|5|||
147454790|NCT02392429|531827707|FG000|Evaluable|Withdrawal by Subject|1|||
147454791|NCT02392429|531827707|FG000|Evaluable|Adverse Event|1|||
147454792|NCT02392429|531827707|FG000|Evaluable|remission bone marrow biopsy|3|||
147454793|NCT02968810|531827711|FG000|Overall Study|Lost to Follow-up|1|||
147454794|NCT02968810|531827712|FG001|Overall Study|Lost to Follow-up|0|||
147454795|NCT02968810|531827711|FG000|Overall Study|Physician Decision|1|||
147454796|NCT02968810|531827712|FG001|Overall Study|Physician Decision|0|||
147454797|NCT02968810|531827711|FG000|Overall Study|Withdrawal by Subject|1|||
147454798|NCT02968810|531827712|FG001|Overall Study|Withdrawal by Subject|3|||
147454799|NCT02968810|531827711|FG000|Overall Study|Disease Progression|0|||
147454800|NCT02968810|531827712|FG001|Overall Study|Disease Progression|1|||
147454801|NCT04183335|531827713|FG000|Overall Study|Adverse Event|1|||
147454802|NCT04183335|531827714|FG001|Overall Study|Adverse Event|0|||
147454803|NCT04183335|531827713|FG000|Overall Study|Withdrawal by Subject|12|||
147454804|NCT04183335|531827714|FG001|Overall Study|Withdrawal by Subject|3|||
147454805|NCT02787850|531827715|FG000|Overall Study|Withdrawal by Subject|0|||
147454806|NCT02787850|531827716|FG001|Overall Study|Withdrawal by Subject|1|||
147454807|NCT02322710|531827719|FG000|Overall Study|No efficacy assessment post-baseline|0|||
147454808|NCT02322710|531827720|FG001|Overall Study|No efficacy assessment post-baseline|1|||
147454809|NCT02322710|531827719|FG000|Overall Study|Protocol Violation|20|||
147454810|NCT02322710|531827720|FG001|Overall Study|Protocol Violation|25|||
147454811|NCT03733392|531827721|FG000|Overall Study|Withdrawal by Subject|11|||
147454812|NCT03733392|531827722|FG001|Overall Study|Withdrawal by Subject|1|||
147454813|NCT03733392|531827721|FG000|Overall Study|Death|1|||
147454814|NCT03733392|531827722|FG001|Overall Study|Death|0|||
147454815|NCT03733392|531827721|FG000|Overall Study|Lost to Follow-up|5|||
147454816|NCT03733392|531827722|FG001|Overall Study|Lost to Follow-up|0|||
147454817|NCT03733392|531827721|FG000|Overall Study|Protocol Violation|0|||
147454818|NCT03733392|531827722|FG001|Overall Study|Protocol Violation|1|||
147454819|NCT03733392|531827721|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met or Non-eligibility|4|||
147454820|NCT03733392|531827722|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met or Non-eligibility|4|||
147454821|NCT03733392|531827721|FG000|Overall Study|Incomplete Ablation or Ablation not done|0|||
147454822|NCT03733392|531827722|FG001|Overall Study|Incomplete Ablation or Ablation not done|5|||
147454823|NCT03733392|531827721|FG000|Overall Study|Patient Non-Compliance|2|||
147454824|NCT03733392|531827722|FG001|Overall Study|Patient Non-Compliance|1|||
147454825|NCT03733392|531827721|FG000|Overall Study|Subject did not complete follow-up but did not meet criteria for lost-to-follow-up|12|||
147454826|NCT03733392|531827722|FG001|Overall Study|Subject did not complete follow-up but did not meet criteria for lost-to-follow-up|0|||
147454827|NCT03733392|531827721|FG000|Overall Study|Withdrawal prior to procedure|5|||
147454828|NCT03733392|531827722|FG001|Overall Study|Withdrawal prior to procedure|2|||
147454829|NCT00130832|531827723|FG000|Overall Study|Adverse Event|1|||
147454830|NCT00130832|531827724|FG001|Overall Study|Adverse Event|1|||
147454831|NCT00130832|531827723|FG000|Overall Study|Lost to Follow-up|1|||
147454832|NCT00130832|531827724|FG001|Overall Study|Lost to Follow-up|2|||
147454833|NCT00130832|531827723|FG000|Overall Study|Protocol Violation|6|||
147454834|NCT00130832|531827724|FG001|Overall Study|Protocol Violation|8|||
147454835|NCT00130832|531827723|FG000|Overall Study|Withdrawal by Subject|6|||
147454836|NCT00130832|531827724|FG001|Overall Study|Withdrawal by Subject|1|||
147454837|NCT00130832|531827723|FG000|Overall Study|Moved|2|||
147454838|NCT00130832|531827724|FG001|Overall Study|Moved|2|||
147454839|NCT00130832|531827723|FG000|Overall Study|Other|0|||
147454840|NCT00130832|531827724|FG001|Overall Study|Other|3|||
147454841|NCT03905863|531827725|FG000|Overall Study|Adverse Event|2|||
147454842|NCT03905863|531827726|FG001|Overall Study|Adverse Event|4|||
147454843|NCT03905863|531827725|FG000|Overall Study|Withdrawal by Subject|2|||
147454844|NCT03905863|531827726|FG001|Overall Study|Withdrawal by Subject|2|||
147454845|NCT03905863|531827725|FG000|Overall Study|Physician Decision|0|||
147610848|NCT03104400|532390857|FG002|Period 2 Week 56 - 260)|Withdrawal by Subject|0|||
147610849|NCT03104400|532390858|FG003|Period 2 Week 56 - 260)|Withdrawal by Subject|0|||
147610850|NCT03104400|532390859|FG004|Period 2 Week 56 - 260)|Withdrawal by Subject|0|||
147610851|NCT03104400|532390860|FG005|Period 2 Week 56 - 260)|Withdrawal by Subject|11|||
147610852|NCT03104400|532390861|FG006|Period 2 Week 56 - 260)|Withdrawal by Subject|21|||
147610853|NCT03104400|532390862|FG007|Period 2 Week 56 - 260)|Withdrawal by Subject|45|||
147610854|NCT03104400|532390863|FG008|Period 2 Week 56 - 260)|Withdrawal by Subject|44|||
147610855|NCT03104400|532390864|FG009|Period 2 Week 56 - 260)|Withdrawal by Subject|32|||
147610856|NCT03104400|532390855|FG000|Period 2 Week 56 - 260)|Lost to Follow-up|0|||
147610857|NCT03104400|532390856|FG001|Period 2 Week 56 - 260)|Lost to Follow-up|0|||
147610858|NCT03104400|532390857|FG002|Period 2 Week 56 - 260)|Lost to Follow-up|0|||
147610859|NCT03104400|532390858|FG003|Period 2 Week 56 - 260)|Lost to Follow-up|0|||
147610860|NCT03104400|532390859|FG004|Period 2 Week 56 - 260)|Lost to Follow-up|0|||
147610861|NCT03104400|532390860|FG005|Period 2 Week 56 - 260)|Lost to Follow-up|7|||
147610862|NCT03104400|532390861|FG006|Period 2 Week 56 - 260)|Lost to Follow-up|6|||
147610863|NCT03104400|532390862|FG007|Period 2 Week 56 - 260)|Lost to Follow-up|12|||
147369413|NCT00943917|531520254|FG014|Stage II|Adverse Event|0|||
147369414|NCT00943917|531520240|FG000|Stage II|Withdrawal by Subject|0|||
147369415|NCT00943917|531520241|FG001|Stage II|Withdrawal by Subject|0|||
147369416|NCT00943917|531520242|FG002|Stage II|Withdrawal by Subject|0|||
147369417|NCT00943917|531520243|FG003|Stage II|Withdrawal by Subject|0|||
147369418|NCT00943917|531520244|FG004|Stage II|Withdrawal by Subject|0|||
147610864|NCT03104400|532390863|FG008|Period 2 Week 56 - 260)|Lost to Follow-up|12|||
147369419|NCT00943917|531520245|FG005|Stage II|Withdrawal by Subject|1|||
147369420|NCT00943917|531520246|FG006|Stage II|Withdrawal by Subject|0|||
147369421|NCT00943917|531520247|FG007|Stage II|Withdrawal by Subject|0|||
147369422|NCT00943917|531520248|FG008|Stage II|Withdrawal by Subject|0|||
147369423|NCT00943917|531520249|FG009|Stage II|Withdrawal by Subject|0|||
147369424|NCT00943917|531520250|FG010|Stage II|Withdrawal by Subject|0|||
147369425|NCT00943917|531520251|FG011|Stage II|Withdrawal by Subject|0|||
147369426|NCT00943917|531520252|FG012|Stage II|Withdrawal by Subject|0|||
147369427|NCT00943917|531520253|FG013|Stage II|Withdrawal by Subject|0|||
147369428|NCT00943917|531520254|FG014|Stage II|Withdrawal by Subject|0|||
147369429|NCT00943917|531520240|FG000|Stage II|Pregnancy|0|||
147369430|NCT00943917|531520241|FG001|Stage II|Pregnancy|0|||
147369431|NCT00943917|531520242|FG002|Stage II|Pregnancy|0|||
147369432|NCT00943917|531520243|FG003|Stage II|Pregnancy|0|||
147369433|NCT00943917|531520244|FG004|Stage II|Pregnancy|0|||
147369434|NCT00943917|531520245|FG005|Stage II|Pregnancy|1|||
147369435|NCT00943917|531520246|FG006|Stage II|Pregnancy|0|||
147369436|NCT00943917|531520247|FG007|Stage II|Pregnancy|0|||
147369437|NCT00943917|531520248|FG008|Stage II|Pregnancy|0|||
147369438|NCT00943917|531520249|FG009|Stage II|Pregnancy|0|||
147369439|NCT00943917|531520250|FG010|Stage II|Pregnancy|0|||
147369440|NCT00943917|531520251|FG011|Stage II|Pregnancy|0|||
147369441|NCT00943917|531520252|FG012|Stage II|Pregnancy|0|||
147369442|NCT00943917|531520253|FG013|Stage II|Pregnancy|0|||
147369443|NCT00943917|531520254|FG014|Stage II|Pregnancy|0|||
147369444|NCT00943917|531520240|FG000|Stage II Continuation|Adverse Event|0|||
147369445|NCT00943917|531520241|FG001|Stage II Continuation|Adverse Event|0|||
147369446|NCT00943917|531520242|FG002|Stage II Continuation|Adverse Event|0|||
147369447|NCT00943917|531520243|FG003|Stage II Continuation|Adverse Event|0|||
147369448|NCT00943917|531520244|FG004|Stage II Continuation|Adverse Event|0|||
147369449|NCT00943917|531520245|FG005|Stage II Continuation|Adverse Event|0|||
147369450|NCT00943917|531520246|FG006|Stage II Continuation|Adverse Event|0|||
147369451|NCT00943917|531520247|FG007|Stage II Continuation|Adverse Event|0|||
147369452|NCT00943917|531520248|FG008|Stage II Continuation|Adverse Event|0|||
147369453|NCT00943917|531520249|FG009|Stage II Continuation|Adverse Event|0|||
147369454|NCT00943917|531520250|FG010|Stage II Continuation|Adverse Event|0|||
147369455|NCT00943917|531520251|FG011|Stage II Continuation|Adverse Event|1|||
147369456|NCT00943917|531520252|FG012|Stage II Continuation|Adverse Event|2|||
147369457|NCT00943917|531520253|FG013|Stage II Continuation|Adverse Event|1|||
147369458|NCT00943917|531520254|FG014|Stage II Continuation|Adverse Event|1|||
147369459|NCT00943917|531520240|FG000|Stage II Continuation|Withdrawal by Subject|0|||
147369460|NCT00943917|531520241|FG001|Stage II Continuation|Withdrawal by Subject|0|||
147369461|NCT00943917|531520242|FG002|Stage II Continuation|Withdrawal by Subject|0|||
147369462|NCT00943917|531520243|FG003|Stage II Continuation|Withdrawal by Subject|0|||
147369463|NCT00943917|531520244|FG004|Stage II Continuation|Withdrawal by Subject|0|||
147369464|NCT00943917|531520245|FG005|Stage II Continuation|Withdrawal by Subject|0|||
147369465|NCT00943917|531520246|FG006|Stage II Continuation|Withdrawal by Subject|0|||
147369466|NCT00943917|531520247|FG007|Stage II Continuation|Withdrawal by Subject|0|||
147369467|NCT00943917|531520248|FG008|Stage II Continuation|Withdrawal by Subject|0|||
147369468|NCT00943917|531520249|FG009|Stage II Continuation|Withdrawal by Subject|0|||
147369469|NCT00943917|531520250|FG010|Stage II Continuation|Withdrawal by Subject|0|||
147369470|NCT00943917|531520251|FG011|Stage II Continuation|Withdrawal by Subject|0|||
147369471|NCT00943917|531520252|FG012|Stage II Continuation|Withdrawal by Subject|0|||
147369472|NCT00943917|531520253|FG013|Stage II Continuation|Withdrawal by Subject|1|||
147369473|NCT00943917|531520254|FG014|Stage II Continuation|Withdrawal by Subject|3|||
147369474|NCT00943917|531520240|FG000|Stage II Continuation|Protocol Violation|0|||
147369475|NCT00943917|531520241|FG001|Stage II Continuation|Protocol Violation|0|||
147369476|NCT00943917|531520242|FG002|Stage II Continuation|Protocol Violation|0|||
147369477|NCT00943917|531520243|FG003|Stage II Continuation|Protocol Violation|0|||
147369478|NCT00943917|531520244|FG004|Stage II Continuation|Protocol Violation|0|||
147369479|NCT00943917|531520245|FG005|Stage II Continuation|Protocol Violation|0|||
147610865|NCT03104400|532390864|FG009|Period 2 Week 56 - 260)|Lost to Follow-up|7|||
147610866|NCT03104400|532390855|FG000|Period 2 Week 56 - 260)|Lack of Efficacy|0|||
147610867|NCT03104400|532390856|FG001|Period 2 Week 56 - 260)|Lack of Efficacy|0|||
147610868|NCT03104400|532390857|FG002|Period 2 Week 56 - 260)|Lack of Efficacy|0|||
147610869|NCT03104400|532390858|FG003|Period 2 Week 56 - 260)|Lack of Efficacy|0|||
147610870|NCT03104400|532390859|FG004|Period 2 Week 56 - 260)|Lack of Efficacy|0|||
147610871|NCT03104400|532390860|FG005|Period 2 Week 56 - 260)|Lack of Efficacy|4|||
147610872|NCT03104400|532390861|FG006|Period 2 Week 56 - 260)|Lack of Efficacy|4|||
147610873|NCT03104400|532390862|FG007|Period 2 Week 56 - 260)|Lack of Efficacy|9|||
147610874|NCT03104400|532390863|FG008|Period 2 Week 56 - 260)|Lack of Efficacy|6|||
147610875|NCT03104400|532390864|FG009|Period 2 Week 56 - 260)|Lack of Efficacy|7|||
147369480|NCT00943917|531520246|FG006|Stage II Continuation|Protocol Violation|0|||
147369481|NCT00943917|531520247|FG007|Stage II Continuation|Protocol Violation|0|||
147369482|NCT00943917|531520248|FG008|Stage II Continuation|Protocol Violation|0|||
147369483|NCT00943917|531520249|FG009|Stage II Continuation|Protocol Violation|1|||
147369484|NCT00943917|531520250|FG010|Stage II Continuation|Protocol Violation|0|||
147369485|NCT00943917|531520251|FG011|Stage II Continuation|Protocol Violation|1|||
147369486|NCT00943917|531520252|FG012|Stage II Continuation|Protocol Violation|0|||
147369487|NCT00943917|531520253|FG013|Stage II Continuation|Protocol Violation|0|||
147369488|NCT00943917|531520254|FG014|Stage II Continuation|Protocol Violation|0|||
147369489|NCT00943917|531520240|FG000|Stage II Continuation|hypoglycemia|0|||
147369490|NCT00943917|531520241|FG001|Stage II Continuation|hypoglycemia|0|||
147369491|NCT00943917|531520242|FG002|Stage II Continuation|hypoglycemia|0|||
147369492|NCT00943917|531520243|FG003|Stage II Continuation|hypoglycemia|0|||
147369493|NCT00943917|531520244|FG004|Stage II Continuation|hypoglycemia|0|||
147369494|NCT00943917|531520245|FG005|Stage II Continuation|hypoglycemia|0|||
147369495|NCT00943917|531520246|FG006|Stage II Continuation|hypoglycemia|0|||
147369496|NCT00943917|531520247|FG007|Stage II Continuation|hypoglycemia|0|||
147369497|NCT00943917|531520248|FG008|Stage II Continuation|hypoglycemia|0|||
147369498|NCT00943917|531520249|FG009|Stage II Continuation|hypoglycemia|0|||
147369499|NCT00943917|531520250|FG010|Stage II Continuation|hypoglycemia|0|||
147369500|NCT00943917|531520251|FG011|Stage II Continuation|hypoglycemia|0|||
147369501|NCT00943917|531520252|FG012|Stage II Continuation|hypoglycemia|1|||
147369502|NCT00943917|531520253|FG013|Stage II Continuation|hypoglycemia|0|||
147369503|NCT00943917|531520254|FG014|Stage II Continuation|hypoglycemia|0|||
147369504|NCT00943917|531520240|FG000|Stage II Continuation|A1C elevation|0|||
147369505|NCT00943917|531520241|FG001|Stage II Continuation|A1C elevation|0|||
147369506|NCT00943917|531520242|FG002|Stage II Continuation|A1C elevation|0|||
147369507|NCT00943917|531520243|FG003|Stage II Continuation|A1C elevation|0|||
147369508|NCT00943917|531520244|FG004|Stage II Continuation|A1C elevation|0|||
147369509|NCT00943917|531520245|FG005|Stage II Continuation|A1C elevation|0|||
147369510|NCT00943917|531520246|FG006|Stage II Continuation|A1C elevation|0|||
147369511|NCT00943917|531520247|FG007|Stage II Continuation|A1C elevation|0|||
147369512|NCT00943917|531520248|FG008|Stage II Continuation|A1C elevation|0|||
147369513|NCT00943917|531520249|FG009|Stage II Continuation|A1C elevation|0|||
147369514|NCT00943917|531520250|FG010|Stage II Continuation|A1C elevation|0|||
147369515|NCT00943917|531520251|FG011|Stage II Continuation|A1C elevation|0|||
147369516|NCT00943917|531520252|FG012|Stage II Continuation|A1C elevation|0|||
147369517|NCT00943917|531520253|FG013|Stage II Continuation|A1C elevation|1|||
147369518|NCT00943917|531520254|FG014|Stage II Continuation|A1C elevation|0|||
147369519|NCT01171976|531520255|FG000|Overall Study|Protocol Violation|0|||
147369520|NCT01171976|531520256|FG001|Overall Study|Protocol Violation|0|||
147369521|NCT01171976|531520257|FG002|Overall Study|Protocol Violation|1|||
147369522|NCT01171976|531520255|FG000|Overall Study|Death|2|||
147369523|NCT01171976|531520256|FG001|Overall Study|Death|4|||
147369524|NCT01171976|531520257|FG002|Overall Study|Death|1|||
147369525|NCT01171976|531520255|FG000|Overall Study|Lost to Follow-up|4|||
147369526|NCT01171976|531520256|FG001|Overall Study|Lost to Follow-up|0|||
147369527|NCT01171976|531520257|FG002|Overall Study|Lost to Follow-up|2|||
147369528|NCT01171976|531520255|FG000|Overall Study|Withdrawal by Subject|1|||
147369529|NCT01171976|531520256|FG001|Overall Study|Withdrawal by Subject|5|||
147369530|NCT01171976|531520257|FG002|Overall Study|Withdrawal by Subject|6|||
147369531|NCT01171976|531520255|FG000|Overall Study|Abnormal test result|1|||
147369532|NCT01171976|531520256|FG001|Overall Study|Abnormal test result|0|||
147369533|NCT01171976|531520257|FG002|Overall Study|Abnormal test result|0|||
147369534|NCT01171976|531520255|FG000|Overall Study|Adverse Event|6|||
147369535|NCT01171976|531520256|FG001|Overall Study|Adverse Event|2|||
147610876|NCT03104400|532390855|FG000|Period 2 Week 56 - 260)|COVIID-19 infection|0|||
147369536|NCT01171976|531520257|FG002|Overall Study|Adverse Event|5|||
147369537|NCT00003222|531520262|FG000|Overall Study|Physician Decision|0|||
147369538|NCT00003222|531520263|FG001|Overall Study|Physician Decision|1|||
147369539|NCT03767335|531520275|FG000|Overall Study|Physician Decision|1|||
147369540|NCT03767335|531520276|FG001|Overall Study|Physician Decision|1|||
147369541|NCT03767335|531520277|FG002|Overall Study|Physician Decision|0|||
147369542|NCT03767335|531520275|FG000|Overall Study|Withdrawal by Subject|0|||
147369543|NCT03767335|531520276|FG001|Overall Study|Withdrawal by Subject|0|||
147369544|NCT03767335|531520277|FG002|Overall Study|Withdrawal by Subject|6|||
147369545|NCT03767335|531520275|FG000|Overall Study|Participant excluded from efficacy population|0|||
147454846|NCT03905863|531827726|FG001|Overall Study|Physician Decision|3|||
147454847|NCT03905863|531827725|FG000|Overall Study|Lost to Follow-up|1|||
147454848|NCT03905863|531827726|FG001|Overall Study|Lost to Follow-up|0|||
147454849|NCT03905863|531827725|FG000|Overall Study|Protocol Violation|0|||
147454850|NCT03905863|531827726|FG001|Overall Study|Protocol Violation|2|||
147454851|NCT03905863|531827725|FG000|Overall Study|Death|0|||
147454852|NCT03905863|531827726|FG001|Overall Study|Death|1|||
147454853|NCT00618748|531827733|FG000|Overall Study|Adverse Event|4|||
147454854|NCT00618748|531827734|FG001|Overall Study|Adverse Event|3|||
147454855|NCT00618748|531827735|FG002|Overall Study|Adverse Event|8|||
147454856|NCT00618748|531827733|FG000|Overall Study|Physician Decision|3|||
147454857|NCT00618748|531827734|FG001|Overall Study|Physician Decision|1|||
147454858|NCT00618748|531827735|FG002|Overall Study|Physician Decision|1|||
147454859|NCT00618748|531827733|FG000|Overall Study|Withdrawal by Subject|4|||
147454860|NCT00618748|531827734|FG001|Overall Study|Withdrawal by Subject|1|||
147454861|NCT00618748|531827735|FG002|Overall Study|Withdrawal by Subject|5|||
147454862|NCT04401267|531827736|FG000|Overall Study|Death|0|||
147454863|NCT04401267|531827737|FG001|Overall Study|Death|1|||
147454864|NCT04401267|531827736|FG000|Overall Study|Discontinuation of TOT17 therapy|4|||
147454865|NCT04401267|531827737|FG001|Overall Study|Discontinuation of TOT17 therapy|2|||
147454866|NCT04401267|531827736|FG000|Overall Study|Found to be Ineligible|1|||
147454867|NCT04401267|531827737|FG001|Overall Study|Found to be Ineligible|0|||
147454868|NCT00559507|531827742|FG000|Overall Study|Not treated, patient ineligible|3|||
147454869|NCT02770326|531827743|FG000|Overall Study|Death|3|||
147454870|NCT02770326|531827743|FG000|Overall Study|Lost to Follow-up|1|||
147454871|NCT01191697|531827745|FG000|Overall Study|Death|1|||
147454872|NCT01191697|531827745|FG000|Overall Study|Physician Decision|2|||
147454873|NCT01191697|531827745|FG000|Overall Study|Pursue chemoradiation|2|||
147454874|NCT01191697|531827745|FG000|Overall Study|Break from chemotherapy|2|||
147454875|NCT01191697|531827745|FG000|Overall Study|Withdrawal by Subject|1|||
147454876|NCT01191697|531827745|FG000|Overall Study|Surveillance|1|||
147454877|NCT01191697|531827745|FG000|Overall Study|Adverse Event|2|||
147454878|NCT01191697|531827745|FG000|Overall Study|Subject never received treatment and wasn't analyzed.|1|||
147454879|NCT01191697|531827745|FG000|Overall Study|Not completed but analyzed|25|||
147454880|NCT04227899|531827746|FG000|Overall Study|Withdrawal by Subject|6|||
147454881|NCT04227899|531827747|FG001|Overall Study|Withdrawal by Subject|3|||
147454882|NCT04227899|531827746|FG000|Overall Study|Death|12|||
147454883|NCT04227899|531827747|FG001|Overall Study|Death|6|||
147454884|NCT04227899|531827746|FG000|Overall Study|Lost to Follow-up|2|||
147454885|NCT04227899|531827747|FG001|Overall Study|Lost to Follow-up|1|||
147454886|NCT02421887|531827748|FG000|Overall Study|Lost to Follow-up|5|||
147454887|NCT02421887|531827749|FG001|Overall Study|Lost to Follow-up|0|||
147454888|NCT02421887|531827748|FG000|Overall Study|Withdrawal by Subject|8|||
147610877|NCT03104400|532390856|FG001|Period 2 Week 56 - 260)|COVIID-19 infection|0|||
147610878|NCT03104400|532390857|FG002|Period 2 Week 56 - 260)|COVIID-19 infection|0|||
147610879|NCT03104400|532390858|FG003|Period 2 Week 56 - 260)|COVIID-19 infection|0|||
147610880|NCT03104400|532390859|FG004|Period 2 Week 56 - 260)|COVIID-19 infection|0|||
147610881|NCT03104400|532390860|FG005|Period 2 Week 56 - 260)|COVIID-19 infection|0|||
147610882|NCT03104400|532390861|FG006|Period 2 Week 56 - 260)|COVIID-19 infection|2|||
147610883|NCT03104400|532390862|FG007|Period 2 Week 56 - 260)|COVIID-19 infection|0|||
147610884|NCT03104400|532390863|FG008|Period 2 Week 56 - 260)|COVIID-19 infection|2|||
147610885|NCT03104400|532390864|FG009|Period 2 Week 56 - 260)|COVIID-19 infection|3|||
147610886|NCT03104400|532390855|FG000|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|0|||
147610887|NCT03104400|532390856|FG001|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|0|||
147610888|NCT03104400|532390857|FG002|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|0|||
147610889|NCT03104400|532390858|FG003|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|0|||
147610890|NCT03104400|532390859|FG004|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|0|||
147610891|NCT03104400|532390860|FG005|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|0|||
147610892|NCT03104400|532390861|FG006|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|0|||
147610893|NCT03104400|532390862|FG007|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|1|||
147610894|NCT03104400|532390863|FG008|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|1|||
147610895|NCT03104400|532390864|FG009|Period 2 Week 56 - 260)|COVID-19 Logistical Restrictions|0|||
147610896|NCT03104400|532390855|FG000|Period 2 Week 56 - 260)|Other, not specified|0|||
147610897|NCT03104400|532390856|FG001|Period 2 Week 56 - 260)|Other, not specified|0|||
147454889|NCT02421887|531827749|FG001|Overall Study|Withdrawal by Subject|5|||
147454890|NCT02421887|531827748|FG000|Overall Study|Physician Decision|2|||
147454891|NCT02421887|531827749|FG001|Overall Study|Physician Decision|4|||
147454892|NCT02421887|531827748|FG000|Overall Study|Adverse Event|2|||
147454893|NCT02421887|531827749|FG001|Overall Study|Adverse Event|0|||
147454894|NCT01882907|531827750|FG000|Overall Study|Adverse Event|3|||
147454895|NCT01882907|531827751|FG001|Overall Study|Adverse Event|1|||
147454896|NCT01882907|531827750|FG000|Overall Study|Lack of Efficacy|0|||
147454897|NCT01882907|531827751|FG001|Overall Study|Lack of Efficacy|3|||
147454898|NCT01882907|531827750|FG000|Overall Study|Lost to Follow-up|1|||
147454899|NCT01882907|531827751|FG001|Overall Study|Lost to Follow-up|4|||
147454900|NCT01882907|531827750|FG000|Overall Study|Protocol Violation|10|||
147454901|NCT01882907|531827751|FG001|Overall Study|Protocol Violation|14|||
147663481|NCT01811732|532591510|FG001|Overall Study|Subject incarcerated|2|||
147663482|NCT01811732|532591509|FG000|Overall Study|Admitted to another facility|1|||
147663483|NCT01811732|532591510|FG001|Overall Study|Admitted to another facility|0|||
147663484|NCT01811732|532591509|FG000|Overall Study|Correct study drug not available on site|1|||
147663485|NCT01811732|532591510|FG001|Overall Study|Correct study drug not available on site|0|||
147663486|NCT01783743|532591511|FG000|Screening of Subjects by CTA During MDA|Absent at MDA|3427|||
147663487|NCT01783743|532591512|FG001|Screening of Subjects by CTA During MDA|Absent at MDA|4439|||
147663488|NCT01783743|532591511|FG000|Rescreening of Subjects by Senior Grader|Lost to Follow-up|591|||
147663489|NCT01783743|532591512|FG001|Rescreening of Subjects by Senior Grader|Lost to Follow-up|684|||
147663490|NCT01783743|532591511|FG000|Rescreening of Subjects by Senior Grader|Not part of the random sample selected|10305|||
147663491|NCT01783743|532591512|FG001|Rescreening of Subjects by Senior Grader|Not part of the random sample selected|10236|||
147663492|NCT02771275|532591513|FG000|Overall Study|Reoperation|3|||
147663493|NCT02771275|532591513|FG000|Overall Study|Exit - subject did not reconsent to extended follow-up|1|||
147663494|NCT05556148|532591514|FG000|Overall Study|Early Termination|29|||
147663495|NCT05556148|532591514|FG000|Overall Study|Baseline Tasks Expired|4|||
147663496|NCT05556148|532591514|FG000|Overall Study|Family Emergency: Could no longer take part|1|||
147663497|NCT05556148|532591514|FG000|Overall Study|No Longer Wished to Participate|1|||
147663498|NCT05556148|532591514|FG000|Overall Study|Bacterial Conjunctivitis|1|||
147663499|NCT01290718|532591531|FG000|Overall Study|Early termination of the study|4|||
147663500|NCT02456727|532591534|FG000|Overall Study|Lost to Follow-up|63|||
147663501|NCT02456727|532591535|FG001|Overall Study|Lost to Follow-up|65|||
147663502|NCT02456727|532591534|FG000|Overall Study|Death|2|||
147663503|NCT02456727|532591535|FG001|Overall Study|Death|1|||
147663504|NCT02456727|532591534|FG000|Overall Study|Withdrawal by Subject|1|||
147663505|NCT02456727|532591535|FG001|Overall Study|Withdrawal by Subject|10|||
147663506|NCT02456727|532591534|FG000|Overall Study|Never Initiated Treatment|43|||
147663507|NCT02456727|532591535|FG001|Overall Study|Never Initiated Treatment|30|||
147663508|NCT02059239|532591536|FG000|Overall Study|Progressive Disease after Bendamustine|1|||
147663509|NCT02059239|532591537|FG001|Overall Study|Progressive Disease after Bendamustine|3|||
147663510|NCT02059239|532591536|FG000|Overall Study|Physician Decision|1|||
147663511|NCT02059239|532591537|FG001|Overall Study|Physician Decision|0|||
147663512|NCT01268267|532591539|FG000|Overall Study|Protocol Violation|1|||
147663513|NCT01222104|532591540|FG000|Overall Study|Lost to Follow-up|37|||
147663514|NCT01222104|532591540|FG000|Overall Study|Death|10|||
147663515|NCT01418339|532591541|FG000|Overall Study|Adverse Event|5|||
147663516|NCT01418339|532591542|FG001|Overall Study|Adverse Event|2|||
147663517|NCT01418339|532591541|FG000|Overall Study|Subject Withdrew Consent|1|||
147663518|NCT01418339|532591542|FG001|Overall Study|Subject Withdrew Consent|2|||
147663519|NCT01418339|532591541|FG000|Overall Study|Lack of Efficacy as Determined by the Investigator|6|||
147663520|NCT01418339|532591542|FG001|Overall Study|Lack of Efficacy as Determined by the Investigator|6|||
147663521|NCT02204917|532591545|FG000|Overall Study|Protocol Violation|1|||
147663522|NCT00909844|532591546|FG000|Overall Study|Adverse Event|1|||
147663523|NCT00909844|532591546|FG000|Overall Study|Withdrawal by Subject|1|||
147663524|NCT00909844|532591546|FG000|Overall Study|Lost to Follow-up|2|||
147663525|NCT02219685|532591547|FG000|Blinded Treatment Phase|Lost to Follow-up|1|||
147663526|NCT02219685|532591548|FG001|Blinded Treatment Phase|Lost to Follow-up|0|||
147663527|NCT02219685|532591547|FG000|Blinded Treatment Phase|Withdrew Consent|1|||
147663528|NCT02219685|532591548|FG001|Blinded Treatment Phase|Withdrew Consent|0|||
147663529|NCT00698815|532591549|FG000|Overall Study|Death|1|||
147663530|NCT00698815|532591550|FG001|Overall Study|Death|2|||
147663531|NCT00698815|532591551|FG002|Overall Study|Death|4|||
147663532|NCT00698815|532591549|FG000|Overall Study|Withdrawal by Subject|6|||
147663533|NCT00698815|532591550|FG001|Overall Study|Withdrawal by Subject|3|||
147663534|NCT00698815|532591551|FG002|Overall Study|Withdrawal by Subject|2|||
147663535|NCT00698815|532591549|FG000|Overall Study|MD discretion|2|||
147663536|NCT00698815|532591550|FG001|Overall Study|MD discretion|7|||
147663537|NCT00698815|532591551|FG002|Overall Study|MD discretion|2|||
147663538|NCT00698815|532591549|FG000|Overall Study|Did not receive protocol treatment|1|||
147369546|NCT03767335|531520276|FG001|Overall Study|Participant excluded from efficacy population|0|||
147369547|NCT03767335|531520277|FG002|Overall Study|Participant excluded from efficacy population|1|||
147369548|NCT03767335|531520275|FG000|Overall Study|Death|0|||
147369549|NCT03767335|531520276|FG001|Overall Study|Death|0|||
147369550|NCT03767335|531520277|FG002|Overall Study|Death|2|||
147369551|NCT03767335|531520275|FG000|Overall Study|Progressive Disease|2|||
147663539|NCT00698815|532591550|FG001|Overall Study|Did not receive protocol treatment|2|||
147663540|NCT00698815|532591551|FG002|Overall Study|Did not receive protocol treatment|2|||
147663541|NCT00706004|532591552|FG000|Overall Study|Did not meet eligibility criteria|2|||
147663542|NCT00485069|532591557|FG000|Overall Study|Adverse Event|10|||
147663543|NCT00485069|532591558|FG001|Overall Study|Adverse Event|4|||
147663544|NCT00485069|532591557|FG000|Overall Study|Lack of Efficacy|2|||
147663545|NCT00485069|532591558|FG001|Overall Study|Lack of Efficacy|1|||
147663546|NCT00485069|532591557|FG000|Overall Study|Protocol Violation|0|||
147369552|NCT03767335|531520276|FG001|Overall Study|Progressive Disease|2|||
147663547|NCT00485069|532591558|FG001|Overall Study|Protocol Violation|1|||
147369553|NCT03767335|531520277|FG002|Overall Study|Progressive Disease|2|||
147369554|NCT03767335|531520275|FG000|Overall Study|Disease progression needing additional medication|0|||
147369555|NCT03767335|531520276|FG001|Overall Study|Disease progression needing additional medication|0|||
147369556|NCT03767335|531520277|FG002|Overall Study|Disease progression needing additional medication|17|||
147369557|NCT03767335|531520275|FG000|Overall Study|Sponsor decision|0|||
147369558|NCT03767335|531520276|FG001|Overall Study|Sponsor decision|0|||
147369559|NCT03767335|531520277|FG002|Overall Study|Sponsor decision|2|||
147369560|NCT03767335|531520275|FG000|Overall Study|Other Medical Reasons|0|||
147369561|NCT03767335|531520276|FG001|Overall Study|Other Medical Reasons|0|||
147369562|NCT03767335|531520277|FG002|Overall Study|Other Medical Reasons|3|||
147369563|NCT01313559|531520278|FG000|Overall Study|Withdrawal by Subject|1|||
147369564|NCT01313559|531520279|FG001|Overall Study|Withdrawal by Subject|2|||
147369565|NCT01313559|531520278|FG000|Overall Study|Disease progression|1|||
147369566|NCT01313559|531520279|FG001|Overall Study|Disease progression|0|||
147369567|NCT01313559|531520278|FG000|Overall Study|Rising PSA|2|||
147369568|NCT01313559|531520279|FG001|Overall Study|Rising PSA|0|||
147369569|NCT02754596|531520280|FG000|Overall Study|Withdrawal by Subject|3|||
147369570|NCT02754596|531520281|FG001|Overall Study|Withdrawal by Subject|4|||
147369571|NCT02754596|531520282|FG002|Overall Study|Withdrawal by Subject|0|||
147369572|NCT02754596|531520280|FG000|Overall Study|Physician Decision|1|||
147369573|NCT02754596|531520281|FG001|Overall Study|Physician Decision|1|||
147369574|NCT02754596|531520282|FG002|Overall Study|Physician Decision|1|||
147369575|NCT02754596|531520280|FG000|Overall Study|Lost to Follow-up|1|||
147369576|NCT02754596|531520281|FG001|Overall Study|Lost to Follow-up|1|||
147369577|NCT02754596|531520282|FG002|Overall Study|Lost to Follow-up|2|||
147369578|NCT02754596|531520280|FG000|Overall Study|Death|0|||
147369579|NCT02754596|531520281|FG001|Overall Study|Death|2|||
147369580|NCT02754596|531520282|FG002|Overall Study|Death|0|||
147369581|NCT02754596|531520280|FG000|Overall Study|Adverse Event|1|||
147369582|NCT02754596|531520281|FG001|Overall Study|Adverse Event|0|||
147369583|NCT02754596|531520282|FG002|Overall Study|Adverse Event|1|||
147369584|NCT02754596|531520280|FG000|Overall Study|Other|1|||
147369585|NCT02754596|531520281|FG001|Overall Study|Other|0|||
147369586|NCT02754596|531520282|FG002|Overall Study|Other|0|||
147369587|NCT03213457|531520285|FG000|Screening Period|Withdrawal by Subject|0|||
147369588|NCT03213457|531520286|FG001|Screening Period|Withdrawal by Subject|1|||
147369589|NCT03213457|531520287|FG002|Screening Period|Withdrawal by Subject|0|||
147369590|NCT03213457|531520285|FG000|Screening Period|Other|1|||
147369591|NCT03213457|531520286|FG001|Screening Period|Other|0|||
147369592|NCT03213457|531520287|FG002|Screening Period|Other|0|||
147369593|NCT03213457|531520285|FG000|Double-Blind Period|Adverse Event|3|||
147369594|NCT03213457|531520286|FG001|Double-Blind Period|Adverse Event|2|||
147369595|NCT03213457|531520287|FG002|Double-Blind Period|Adverse Event|7|||
147369596|NCT03213457|531520285|FG000|Double-Blind Period|Withdrawal by Subject|14|||
147369597|NCT03213457|531520286|FG001|Double-Blind Period|Withdrawal by Subject|2|||
147369598|NCT03213457|531520287|FG002|Double-Blind Period|Withdrawal by Subject|14|||
147369599|NCT03213457|531520285|FG000|Double-Blind Period|Lost to Follow-up|2|||
147369600|NCT03213457|531520286|FG001|Double-Blind Period|Lost to Follow-up|3|||
147369601|NCT03213457|531520287|FG002|Double-Blind Period|Lost to Follow-up|9|||
147369602|NCT03213457|531520285|FG000|Double-Blind Period|Requires surgery or invasive intervention for treatment of endometriosis|2|||
147369603|NCT03213457|531520286|FG001|Double-Blind Period|Requires surgery or invasive intervention for treatment of endometriosis|0|||
147369604|NCT03213457|531520287|FG002|Double-Blind Period|Requires surgery or invasive intervention for treatment of endometriosis|1|||
147369605|NCT03213457|531520285|FG000|Double-Blind Period|Non-compliance with study procedures|0|||
147369606|NCT03213457|531520286|FG001|Double-Blind Period|Non-compliance with study procedures|2|||
147369607|NCT03213457|531520287|FG002|Double-Blind Period|Non-compliance with study procedures|4|||
147369608|NCT03213457|531520285|FG000|Double-Blind Period|Pregnancy|5|||
147369609|NCT03213457|531520286|FG001|Double-Blind Period|Pregnancy|0|||
147369610|NCT03213457|531520287|FG002|Double-Blind Period|Pregnancy|0|||
147369611|NCT03213457|531520285|FG000|Double-Blind Period|Other|10|||
147369612|NCT03213457|531520286|FG001|Double-Blind Period|Other|3|||
147369613|NCT03213457|531520287|FG002|Double-Blind Period|Other|17|||
147369614|NCT03213457|531520285|FG000|Open-Label Period|Adverse Event|1|||
147369615|NCT03213457|531520286|FG001|Open-Label Period|Adverse Event|2|||
147369616|NCT03213457|531520287|FG002|Open-Label Period|Adverse Event|2|||
147369617|NCT03213457|531520285|FG000|Open-Label Period|Withdrawal by Subject|12|||
147369618|NCT03213457|531520286|FG001|Open-Label Period|Withdrawal by Subject|5|||
147369619|NCT03213457|531520287|FG002|Open-Label Period|Withdrawal by Subject|24|||
147369620|NCT03213457|531520285|FG000|Open-Label Period|Lost to Follow-up|1|||
147369621|NCT03213457|531520286|FG001|Open-Label Period|Lost to Follow-up|2|||
147369622|NCT03213457|531520287|FG002|Open-Label Period|Lost to Follow-up|8|||
147369623|NCT03213457|531520285|FG000|Open-Label Period|Requires surgery or invasive intervention for treatment of endometriosis|0|||
147369624|NCT03213457|531520286|FG001|Open-Label Period|Requires surgery or invasive intervention for treatment of endometriosis|0|||
147369625|NCT03213457|531520287|FG002|Open-Label Period|Requires surgery or invasive intervention for treatment of endometriosis|2|||
147369626|NCT03213457|531520285|FG000|Open-Label Period|Non-compliance with study procedures|1|||
147369627|NCT03213457|531520286|FG001|Open-Label Period|Non-compliance with study procedures|1|||
147369628|NCT03213457|531520287|FG002|Open-Label Period|Non-compliance with study procedures|2|||
147369629|NCT03213457|531520285|FG000|Open-Label Period|Exclusionary medications|0|||
147369630|NCT03213457|531520286|FG001|Open-Label Period|Exclusionary medications|0|||
147369631|NCT03213457|531520287|FG002|Open-Label Period|Exclusionary medications|1|||
147369632|NCT03213457|531520285|FG000|Open-Label Period|Other|1|||
147369633|NCT03213457|531520286|FG001|Open-Label Period|Other|1|||
147369634|NCT03213457|531520287|FG002|Open-Label Period|Other|6|||
147369635|NCT03213457|531520285|FG000|Follow-Up Period|Adverse Event|16|||
147369636|NCT03213457|531520286|FG001|Follow-Up Period|Adverse Event|8|||
147369637|NCT03213457|531520287|FG002|Follow-Up Period|Adverse Event|37|||
147369638|NCT03213457|531520285|FG000|Follow-Up Period|Withdrawal by Subject|18|||
147369639|NCT03213457|531520286|FG001|Follow-Up Period|Withdrawal by Subject|11|||
147369640|NCT03213457|531520287|FG002|Follow-Up Period|Withdrawal by Subject|55|||
147369641|NCT03213457|531520285|FG000|Follow-Up Period|Lost to Follow-up|28|||
147369642|NCT03213457|531520286|FG001|Follow-Up Period|Lost to Follow-up|15|||
147369643|NCT03213457|531520287|FG002|Follow-Up Period|Lost to Follow-up|50|||
147369644|NCT03213457|531520285|FG000|Follow-Up Period|Requires surgery or invasive intervention for treatment of endometriosis|3|||
147369645|NCT03213457|531520286|FG001|Follow-Up Period|Requires surgery or invasive intervention for treatment of endometriosis|1|||
147369646|NCT03213457|531520287|FG002|Follow-Up Period|Requires surgery or invasive intervention for treatment of endometriosis|2|||
147369647|NCT03213457|531520285|FG000|Follow-Up Period|Non-compliance with study procedures|4|||
147369648|NCT03213457|531520286|FG001|Follow-Up Period|Non-compliance with study procedures|1|||
147369649|NCT03213457|531520287|FG002|Follow-Up Period|Non-compliance with study procedures|6|||
147369650|NCT03213457|531520285|FG000|Follow-Up Period|Pregnancy|7|||
147369651|NCT03213457|531520286|FG001|Follow-Up Period|Pregnancy|0|||
147369652|NCT03213457|531520287|FG002|Follow-Up Period|Pregnancy|18|||
147369653|NCT03213457|531520285|FG000|Follow-Up Period|Exclusionary medications|1|||
147369654|NCT03213457|531520286|FG001|Follow-Up Period|Exclusionary medications|1|||
147369655|NCT03213457|531520287|FG002|Follow-Up Period|Exclusionary medications|5|||
147369656|NCT03213457|531520285|FG000|Follow-Up Period|COVID-19 logistical restrictions|1|||
147369657|NCT03213457|531520286|FG001|Follow-Up Period|COVID-19 logistical restrictions|0|||
147369658|NCT03213457|531520287|FG002|Follow-Up Period|COVID-19 logistical restrictions|0|||
147369659|NCT03213457|531520285|FG000|Follow-Up Period|Other|14|||
147369660|NCT03213457|531520286|FG001|Follow-Up Period|Other|10|||
147369661|NCT03213457|531520287|FG002|Follow-Up Period|Other|31|||
147369662|NCT02951052|531520288|FG000|Overall Study|Adverse Event|13|||
147369663|NCT02951052|531520289|FG001|Overall Study|Adverse Event|5|||
147369664|NCT02951052|531520288|FG000|Overall Study|Withdrawal by Subject|1|||
147369665|NCT02951052|531520289|FG001|Overall Study|Withdrawal by Subject|5|||
147369666|NCT02951052|531520288|FG000|Overall Study|Physician Decision|2|||
147369667|NCT02951052|531520289|FG001|Overall Study|Physician Decision|0|||
147369668|NCT02951052|531520288|FG000|Overall Study|Lost to Follow-up|1|||
147369669|NCT02951052|531520289|FG001|Overall Study|Lost to Follow-up|1|||
147369670|NCT02951052|531520288|FG000|Overall Study|Protocol-specified withdrawal criterion|1|||
147369671|NCT02951052|531520289|FG001|Overall Study|Protocol-specified withdrawal criterion|0|||
147369672|NCT02951052|531520288|FG000|Overall Study|Protocol Violation|5|||
147369673|NCT02951052|531520289|FG001|Overall Study|Protocol Violation|3|||
147369674|NCT02951052|531520288|FG000|Overall Study|Lack of Efficacy|3|||
147369675|NCT02951052|531520289|FG001|Overall Study|Lack of Efficacy|4|||
147369676|NCT02951052|531520288|FG000|Overall Study|Ongoing|1|||
147369677|NCT02951052|531520289|FG001|Overall Study|Ongoing|0|||
147369678|NCT04059406|531520294|FG000|Overall Study|Early Treatment Termination|5|||
147369679|NCT04059406|531520295|FG001|Overall Study|Early Treatment Termination|5|||
147369680|NCT04059406|531520296|FG002|Overall Study|Early Treatment Termination|15|||
147369681|NCT04755595|531520298|FG000|Overall Study|Lost to Follow-up|1|||
147369682|NCT00319696|531520299|FG000|Overall Study|Adverse Event|36|||
147369683|NCT00319696|531520299|FG000|Overall Study|withdrawal of consent|14|||
147369684|NCT00319696|531520299|FG000|Overall Study|administrative|7|||
147369685|NCT00319696|531520299|FG000|Overall Study|Lost to Follow-up|3|||
147369686|NCT00655499|531520893|FG000|Overall Study|not eligible|4|||
147369687|NCT03248492|531520896|FG000|Overall Study|Progressive Disease|24|||
147369688|NCT03248492|531520897|FG001|Overall Study|Progressive Disease|23|||
147369689|NCT03248492|531520898|FG002|Overall Study|Progressive Disease|11|||
147369690|NCT03248492|531520899|FG003|Overall Study|Progressive Disease|66|||
147369691|NCT03248492|531520900|FG004|Overall Study|Progressive Disease|1|||
147369692|NCT03248492|531520896|FG000|Overall Study|Adverse Event|14|||
147369693|NCT03248492|531520897|FG001|Overall Study|Adverse Event|13|||
147369694|NCT03248492|531520898|FG002|Overall Study|Adverse Event|9|||
147369695|NCT03248492|531520899|FG003|Overall Study|Adverse Event|22|||
147369696|NCT03248492|531520900|FG004|Overall Study|Adverse Event|2|||
147369697|NCT03248492|531520896|FG000|Overall Study|Withdrawal by Subject|5|||
147369698|NCT03248492|531520897|FG001|Overall Study|Withdrawal by Subject|4|||
147369699|NCT03248492|531520898|FG002|Overall Study|Withdrawal by Subject|0|||
147369700|NCT03248492|531520899|FG003|Overall Study|Withdrawal by Subject|8|||
147369701|NCT03248492|531520900|FG004|Overall Study|Withdrawal by Subject|1|||
147369702|NCT03248492|531520896|FG000|Overall Study|Physician Decision|1|||
147663548|NCT00485069|532591557|FG000|Overall Study|Withdrawal by Subject|6|||
147663549|NCT00485069|532591558|FG001|Overall Study|Withdrawal by Subject|6|||
147663550|NCT00828113|532591559|FG000|Overall Study|Withdrawal by Subject|27|||
147663551|NCT00828113|532591560|FG001|Overall Study|Withdrawal by Subject|26|||
147663552|NCT00828113|532591559|FG000|Overall Study|Lost to Follow-up|3|||
147663553|NCT00828113|532591560|FG001|Overall Study|Lost to Follow-up|5|||
147663554|NCT01365130|532591561|FG000|Overall Study|Progression/worsening of Dx prior to txt|2|||
147663555|NCT05547386|532591562|FG000|Overall Study|Withdrawal by Subject|7|||
147663556|NCT04622969|532591563|FG000|Overall Study|Withdrawal by Subject|2|||
147663557|NCT04622969|532591564|FG001|Overall Study|Withdrawal by Subject|3|||
147663558|NCT05616013|532591565|FG000|Overall Study|Adverse Event|6|||
147663559|NCT05616013|532591566|FG001|Overall Study|Adverse Event|12|||
147663560|NCT05616013|532591567|FG002|Overall Study|Adverse Event|8|||
147663561|NCT05616013|532591568|FG003|Overall Study|Adverse Event|4|||
147663562|NCT05616013|532591569|FG004|Overall Study|Adverse Event|6|||
147663563|NCT05616013|532591570|FG005|Overall Study|Adverse Event|8|||
147663564|NCT05616013|532591571|FG006|Overall Study|Adverse Event|3|||
147663565|NCT05616013|532591572|FG007|Overall Study|Adverse Event|6|||
147663566|NCT05616013|532591573|FG008|Overall Study|Adverse Event|1|||
147663567|NCT05616013|532591565|FG000|Overall Study|Lost to Follow-up|5|||
147663568|NCT05616013|532591566|FG001|Overall Study|Lost to Follow-up|4|||
147663569|NCT05616013|532591567|FG002|Overall Study|Lost to Follow-up|3|||
147663570|NCT05616013|532591568|FG003|Overall Study|Lost to Follow-up|2|||
147663571|NCT05616013|532591569|FG004|Overall Study|Lost to Follow-up|0|||
147663572|NCT05616013|532591570|FG005|Overall Study|Lost to Follow-up|5|||
147663573|NCT05616013|532591571|FG006|Overall Study|Lost to Follow-up|2|||
147663574|NCT05616013|532591572|FG007|Overall Study|Lost to Follow-up|1|||
147663575|NCT05616013|532591573|FG008|Overall Study|Lost to Follow-up|2|||
147663576|NCT05616013|532591565|FG000|Overall Study|Non-compliance with study requirements|2|||
147663577|NCT05616013|532591566|FG001|Overall Study|Non-compliance with study requirements|2|||
147663578|NCT05616013|532591567|FG002|Overall Study|Non-compliance with study requirements|2|||
147663579|NCT05616013|532591568|FG003|Overall Study|Non-compliance with study requirements|3|||
147663580|NCT05616013|532591569|FG004|Overall Study|Non-compliance with study requirements|0|||
147663581|NCT05616013|532591570|FG005|Overall Study|Non-compliance with study requirements|2|||
147663582|NCT05616013|532591571|FG006|Overall Study|Non-compliance with study requirements|1|||
147663583|NCT05616013|532591572|FG007|Overall Study|Non-compliance with study requirements|1|||
147663584|NCT05616013|532591573|FG008|Overall Study|Non-compliance with study requirements|4|||
147663585|NCT05616013|532591565|FG000|Overall Study|Withdrawal by Subject|11|||
147663586|NCT05616013|532591566|FG001|Overall Study|Withdrawal by Subject|9|||
147663587|NCT05616013|532591567|FG002|Overall Study|Withdrawal by Subject|8|||
147663588|NCT05616013|532591568|FG003|Overall Study|Withdrawal by Subject|6|||
147663589|NCT05616013|532591569|FG004|Overall Study|Withdrawal by Subject|3|||
147663590|NCT05616013|532591570|FG005|Overall Study|Withdrawal by Subject|4|||
147663591|NCT05616013|532591571|FG006|Overall Study|Withdrawal by Subject|6|||
147663592|NCT05616013|532591572|FG007|Overall Study|Withdrawal by Subject|5|||
147663593|NCT05616013|532591573|FG008|Overall Study|Withdrawal by Subject|4|||
147663594|NCT05616013|532591565|FG000|Overall Study|Physician Decision|0|||
147663595|NCT05616013|532591566|FG001|Overall Study|Physician Decision|0|||
147663596|NCT05616013|532591567|FG002|Overall Study|Physician Decision|1|||
147663597|NCT05616013|532591568|FG003|Overall Study|Physician Decision|0|||
147663598|NCT05616013|532591569|FG004|Overall Study|Physician Decision|0|||
147663599|NCT05616013|532591570|FG005|Overall Study|Physician Decision|1|||
147663600|NCT05616013|532591571|FG006|Overall Study|Physician Decision|3|||
147663601|NCT05616013|532591572|FG007|Overall Study|Physician Decision|0|||
147663602|NCT05616013|532591573|FG008|Overall Study|Physician Decision|0|||
147663603|NCT05616013|532591565|FG000|Overall Study|Protocol Violation|0|||
147663604|NCT05616013|532591566|FG001|Overall Study|Protocol Violation|0|||
147663605|NCT05616013|532591567|FG002|Overall Study|Protocol Violation|0|||
147369703|NCT03248492|531520897|FG001|Overall Study|Physician Decision|1|||
147369704|NCT03248492|531520898|FG002|Overall Study|Physician Decision|1|||
147369705|NCT03248492|531520899|FG003|Overall Study|Physician Decision|7|||
147369706|NCT03248492|531520900|FG004|Overall Study|Physician Decision|0|||
147369707|NCT03248492|531520896|FG000|Overall Study|Death|1|||
147663606|NCT05616013|532591568|FG003|Overall Study|Protocol Violation|0|||
147369708|NCT03248492|531520897|FG001|Overall Study|Death|1|||
147369709|NCT03248492|531520898|FG002|Overall Study|Death|0|||
147454902|NCT01882907|531827750|FG000|Overall Study|Withdrawal by Subject|0|||
147663607|NCT05616013|532591569|FG004|Overall Study|Protocol Violation|0|||
147663608|NCT05616013|532591570|FG005|Overall Study|Protocol Violation|0|||
147663609|NCT05616013|532591571|FG006|Overall Study|Protocol Violation|1|||
147663610|NCT05616013|532591572|FG007|Overall Study|Protocol Violation|0|||
147663611|NCT05616013|532591573|FG008|Overall Study|Protocol Violation|2|||
147663612|NCT05616013|532591565|FG000|Overall Study|Did not Fulfill Enrollment criteria|1|||
147663613|NCT05616013|532591566|FG001|Overall Study|Did not Fulfill Enrollment criteria|0|||
147663614|NCT05616013|532591567|FG002|Overall Study|Did not Fulfill Enrollment criteria|0|||
147369710|NCT03248492|531520899|FG003|Overall Study|Death|6|||
147369711|NCT03248492|531520900|FG004|Overall Study|Death|0|||
147369712|NCT03248492|531520896|FG000|Overall Study|Study Terminated by Sponsor|3|||
147369713|NCT03248492|531520897|FG001|Overall Study|Study Terminated by Sponsor|1|||
147369714|NCT03248492|531520898|FG002|Overall Study|Study Terminated by Sponsor|0|||
147369715|NCT03248492|531520899|FG003|Overall Study|Study Terminated by Sponsor|7|||
147369716|NCT03248492|531520900|FG004|Overall Study|Study Terminated by Sponsor|0|||
147369717|NCT03248492|531520896|FG000|Overall Study|Other|2|||
147369718|NCT03248492|531520897|FG001|Overall Study|Other|5|||
147369719|NCT03248492|531520898|FG002|Overall Study|Other|0|||
147369720|NCT03248492|531520899|FG003|Overall Study|Other|14|||
147369721|NCT03248492|531520900|FG004|Overall Study|Other|0|||
147369722|NCT04495621|531520901|FG000|Overall Study|Withdrawal by Subject|0|||
147369723|NCT04495621|531520902|FG001|Overall Study|Withdrawal by Subject|3|||
147369724|NCT04495621|531520901|FG000|Overall Study|Death|7|||
147369725|NCT04495621|531520902|FG001|Overall Study|Death|11|||
147369726|NCT04495621|531520901|FG000|Overall Study|Investigator Decision|0|||
147369727|NCT04495621|531520902|FG001|Overall Study|Investigator Decision|7|||
147369728|NCT04495621|531520901|FG000|Overall Study|Lost to Follow-up|0|||
147369729|NCT04495621|531520902|FG001|Overall Study|Lost to Follow-up|1|||
147369730|NCT05707351|531520905|FG000|Overall Study|Withdrawal by Subject|2|||
147369731|NCT05707351|531520905|FG000|Overall Study|Reason Not Specified|1|||
147369732|NCT05155306|531520911|FG000|Wash-out Period 1 to 2|Adverse Event|0|||
147369733|NCT05155306|531520912|FG001|Wash-out Period 1 to 2|Adverse Event|0|||
147369734|NCT05155306|531520913|FG002|Wash-out Period 1 to 2|Adverse Event|0|||
147369735|NCT05155306|531520914|FG003|Wash-out Period 1 to 2|Adverse Event|2|||
147369736|NCT05155306|531520911|FG000|Wash-out Period 3 to 4|Temporal availability|3|||
147369737|NCT05155306|531520912|FG001|Wash-out Period 3 to 4|Temporal availability|1|||
147369738|NCT05155306|531520913|FG002|Wash-out Period 3 to 4|Temporal availability|1|||
147369739|NCT05155306|531520914|FG003|Wash-out Period 3 to 4|Temporal availability|1|||
147369740|NCT04158141|531520915|FG000|Step 1: Registration|Does not meet requirements for Step 2|1|||
147369741|NCT04158141|531520916|FG001|Step 1: Registration|Does not meet requirements for Step 2|0|||
147369742|NCT04158141|531520917|FG002|Step 1: Registration|Does not meet requirements for Step 2|0|||
147369743|NCT04158141|531520915|FG000|Step 1: Registration|Adverse Event|1|||
147369744|NCT04158141|531520916|FG001|Step 1: Registration|Adverse Event|0|||
147369745|NCT04158141|531520917|FG002|Step 1: Registration|Adverse Event|0|||
147369746|NCT04158141|531520915|FG000|Step 1: Registration|Withdrawal by Subject|1|||
147369747|NCT04158141|531520916|FG001|Step 1: Registration|Withdrawal by Subject|0|||
147369748|NCT04158141|531520917|FG002|Step 1: Registration|Withdrawal by Subject|0|||
147369749|NCT04158141|531520915|FG000|Step 1: Registration|Study terminated immediately after patient enrolled|2|||
147369750|NCT04158141|531520916|FG001|Step 1: Registration|Study terminated immediately after patient enrolled|0|||
147369751|NCT04158141|531520917|FG002|Step 1: Registration|Study terminated immediately after patient enrolled|0|||
147369752|NCT04121741|531520918|FG000|Overall Study|Protocol Violation|1|||
147369753|NCT04121741|531520919|FG001|Overall Study|Protocol Violation|0|||
147369754|NCT04121741|531520920|FG002|Overall Study|Protocol Violation|0|||
147369755|NCT04121741|531520921|FG003|Overall Study|Protocol Violation|0|||
147369756|NCT04121741|531520922|FG004|Overall Study|Protocol Violation|0|||
147369757|NCT04121741|531520923|FG005|Overall Study|Protocol Violation|0|||
147369758|NCT01084863|531520924|FG000|Main Study Treatment Period|Disease progression|11|||
147369759|NCT01084863|531520925|FG001|Main Study Treatment Period|Disease progression|7|||
147369760|NCT01084863|531520924|FG000|Main Study Treatment Period|Adverse Event|5|||
147369761|NCT01084863|531520925|FG001|Main Study Treatment Period|Adverse Event|3|||
147369762|NCT01084863|531520924|FG000|Main Study Treatment Period|Other Reason|0|||
147369763|NCT01084863|531520925|FG001|Main Study Treatment Period|Other Reason|1|||
147369764|NCT01084863|531520924|FG000|Treatment Period Beyond Cycle 8|Withdrawal by Subject|4|||
147369765|NCT01084863|531520925|FG001|Treatment Period Beyond Cycle 8|Withdrawal by Subject|4|||
147369766|NCT01084863|531520924|FG000|Treatment Period Beyond Cycle 8|Physician Decision|2|||
147369767|NCT01084863|531520925|FG001|Treatment Period Beyond Cycle 8|Physician Decision|4|||
147369768|NCT01084863|531520924|FG000|Treatment Period Beyond Cycle 8|Disease progression|51|||
147369769|NCT01084863|531520925|FG001|Treatment Period Beyond Cycle 8|Disease progression|45|||
147369770|NCT01084863|531520924|FG000|Treatment Period Beyond Cycle 8|Adverse Event|1|||
147369771|NCT01084863|531520925|FG001|Treatment Period Beyond Cycle 8|Adverse Event|0|||
147369772|NCT01084863|531520924|FG000|Treatment Period Beyond Cycle 8|Other|0|||
147369773|NCT01084863|531520925|FG001|Treatment Period Beyond Cycle 8|Other|1|||
147369774|NCT01084863|531520924|FG000|Treatment Period Beyond Cycle 8|Other reason|2|||
147369775|NCT01084863|531520925|FG001|Treatment Period Beyond Cycle 8|Other reason|2|||
147369776|NCT04505722|531520926|FG000|DB Phase (Day 1 up to 6 Months)|Adverse Event|1|||
147369777|NCT04505722|531520927|FG001|DB Phase (Day 1 up to 6 Months)|Adverse Event|2|||
147369778|NCT04505722|531520928|FG002|DB Phase (Day 1 up to 6 Months)|Adverse Event|0|||
147369779|NCT04505722|531520926|FG000|DB Phase (Day 1 up to 6 Months)|Death|34|||
147369780|NCT04505722|531520927|FG001|DB Phase (Day 1 up to 6 Months)|Death|63|||
147369781|NCT04505722|531520928|FG002|DB Phase (Day 1 up to 6 Months)|Death|0|||
147610898|NCT03104400|532390857|FG002|Period 2 Week 56 - 260)|Other, not specified|0|||
147369782|NCT04505722|531520926|FG000|DB Phase (Day 1 up to 6 Months)|Lost to Follow-up|271|||
147369783|NCT04505722|531520927|FG001|DB Phase (Day 1 up to 6 Months)|Lost to Follow-up|333|||
147369784|NCT04505722|531520928|FG002|DB Phase (Day 1 up to 6 Months)|Lost to Follow-up|0|||
147369785|NCT04505722|531520926|FG000|DB Phase (Day 1 up to 6 Months)|Physician Decision|17|||
147369786|NCT04505722|531520927|FG001|DB Phase (Day 1 up to 6 Months)|Physician Decision|17|||
147369787|NCT04505722|531520928|FG002|DB Phase (Day 1 up to 6 Months)|Physician Decision|0|||
147369788|NCT04505722|531520926|FG000|DB Phase (Day 1 up to 6 Months)|Protocol Violation|0|||
147369789|NCT04505722|531520927|FG001|DB Phase (Day 1 up to 6 Months)|Protocol Violation|1|||
147369790|NCT04505722|531520928|FG002|DB Phase (Day 1 up to 6 Months)|Protocol Violation|0|||
147369791|NCT04505722|531520926|FG000|DB Phase (Day 1 up to 6 Months)|Withdrawal by Subject|376|||
147369792|NCT04505722|531520927|FG001|DB Phase (Day 1 up to 6 Months)|Withdrawal by Subject|714|||
147369793|NCT04505722|531520928|FG002|DB Phase (Day 1 up to 6 Months)|Withdrawal by Subject|0|||
147369794|NCT04505722|531520926|FG000|DB Phase (Day 1 up to 6 Months)|Other|61|||
147369795|NCT04505722|531520927|FG001|DB Phase (Day 1 up to 6 Months)|Other|98|||
147369796|NCT04505722|531520928|FG002|DB Phase (Day 1 up to 6 Months)|Other|0|||
147369797|NCT04505722|531520926|FG000|DB Phase (Day 1 up to 6 Months)|Randomized not vaccinated|276|||
147369798|NCT04505722|531520927|FG001|DB Phase (Day 1 up to 6 Months)|Randomized not vaccinated|260|||
147369799|NCT04505722|531520928|FG002|DB Phase (Day 1 up to 6 Months)|Randomized not vaccinated|0|||
147369800|NCT04505722|531520926|FG000|DB + OL Phase (2 Years 6.5 Months)|Adverse Event|0|||
147369801|NCT04505722|531520927|FG001|DB + OL Phase (2 Years 6.5 Months)|Adverse Event|0|||
147369802|NCT04505722|531520928|FG002|DB + OL Phase (2 Years 6.5 Months)|Adverse Event|6|||
147369803|NCT04505722|531520926|FG000|DB + OL Phase (2 Years 6.5 Months)|Death|0|||
147369804|NCT04505722|531520927|FG001|DB + OL Phase (2 Years 6.5 Months)|Death|0|||
147369805|NCT04505722|531520928|FG002|DB + OL Phase (2 Years 6.5 Months)|Death|324|||
147369806|NCT04505722|531520926|FG000|DB + OL Phase (2 Years 6.5 Months)|Lost to Follow-up|0|||
147369807|NCT04505722|531520927|FG001|DB + OL Phase (2 Years 6.5 Months)|Lost to Follow-up|0|||
147369808|NCT04505722|531520928|FG002|DB + OL Phase (2 Years 6.5 Months)|Lost to Follow-up|4978|||
147369809|NCT04505722|531520926|FG000|DB + OL Phase (2 Years 6.5 Months)|Physician Decision|0|||
147369810|NCT04505722|531520927|FG001|DB + OL Phase (2 Years 6.5 Months)|Physician Decision|0|||
147369811|NCT04505722|531520928|FG002|DB + OL Phase (2 Years 6.5 Months)|Physician Decision|342|||
147369812|NCT04505722|531520926|FG000|DB + OL Phase (2 Years 6.5 Months)|Protocol Violation|0|||
147369813|NCT04505722|531520927|FG001|DB + OL Phase (2 Years 6.5 Months)|Protocol Violation|0|||
147369814|NCT04505722|531520928|FG002|DB + OL Phase (2 Years 6.5 Months)|Protocol Violation|2|||
147369815|NCT04505722|531520926|FG000|DB + OL Phase (2 Years 6.5 Months)|Withdrawal by Subject|0|||
147369816|NCT04505722|531520927|FG001|DB + OL Phase (2 Years 6.5 Months)|Withdrawal by Subject|0|||
147369817|NCT04505722|531520928|FG002|DB + OL Phase (2 Years 6.5 Months)|Withdrawal by Subject|4332|||
147369818|NCT04505722|531520926|FG000|DB + OL Phase (2 Years 6.5 Months)|Other|0|||
147369819|NCT04505722|531520927|FG001|DB + OL Phase (2 Years 6.5 Months)|Other|0|||
147369820|NCT04505722|531520928|FG002|DB + OL Phase (2 Years 6.5 Months)|Other|2211|||
147369821|NCT03473223|531520929|FG000|Overall Study|Lost to Follow-up|1|||
147369822|NCT03473223|531520930|FG001|Overall Study|Lost to Follow-up|1|||
147369823|NCT03473223|531520929|FG000|Overall Study|Withdrawal by Subject|47|||
147369824|NCT03473223|531520930|FG001|Overall Study|Withdrawal by Subject|42|||
147369825|NCT03473223|531520929|FG000|Overall Study|Indirect contact|32|||
147369826|NCT03473223|531520930|FG001|Overall Study|Indirect contact|29|||
147369827|NCT03473223|531520929|FG000|Overall Study|Other (Not specified)|32|||
147369828|NCT03473223|531520930|FG001|Overall Study|Other (Not specified)|20|||
147369829|NCT05827068|531520931|FG000|Overall Study|Lost to Follow-up|1|||
147369830|NCT05827068|531520932|FG001|Overall Study|Lost to Follow-up|4|||
147369831|NCT05827068|531520933|FG002|Overall Study|Lost to Follow-up|1|||
147369832|NCT05827068|531520934|FG003|Overall Study|Lost to Follow-up|1|||
147369833|NCT05827068|531520935|FG004|Overall Study|Lost to Follow-up|2|||
147369834|NCT05827068|531520936|FG005|Overall Study|Lost to Follow-up|4|||
147369835|NCT05827068|531520937|FG006|Overall Study|Lost to Follow-up|1|||
147369836|NCT05827068|531520931|FG000|Overall Study|Withdrawal by Subject|4|||
147369837|NCT05827068|531520932|FG001|Overall Study|Withdrawal by Subject|0|||
147369838|NCT05827068|531520933|FG002|Overall Study|Withdrawal by Subject|1|||
147610899|NCT03104400|532390858|FG003|Period 2 Week 56 - 260)|Other, not specified|0|||
147610900|NCT03104400|532390859|FG004|Period 2 Week 56 - 260)|Other, not specified|0|||
147610901|NCT03104400|532390860|FG005|Period 2 Week 56 - 260)|Other, not specified|10|||
147610902|NCT03104400|532390861|FG006|Period 2 Week 56 - 260)|Other, not specified|7|||
147610903|NCT03104400|532390862|FG007|Period 2 Week 56 - 260)|Other, not specified|17|||
147610904|NCT03104400|532390863|FG008|Period 2 Week 56 - 260)|Other, not specified|12|||
147610905|NCT03104400|532390864|FG009|Period 2 Week 56 - 260)|Other, not specified|18|||
147610906|NCT03104400|532390855|FG000|Period 2 Week 56 - 260)|Other|0|||
147610907|NCT03104400|532390856|FG001|Period 2 Week 56 - 260)|Other|0|||
147610908|NCT03104400|532390857|FG002|Period 2 Week 56 - 260)|Other|0|||
147610909|NCT03104400|532390858|FG003|Period 2 Week 56 - 260)|Other|0|||
147610910|NCT03104400|532390859|FG004|Period 2 Week 56 - 260)|Other|0|||
147663615|NCT05616013|532591568|FG003|Overall Study|Did not Fulfill Enrollment criteria|0|||
147369839|NCT05827068|531520934|FG003|Overall Study|Withdrawal by Subject|2|||
147369840|NCT05827068|531520935|FG004|Overall Study|Withdrawal by Subject|3|||
147610911|NCT03104400|532390860|FG005|Period 2 Week 56 - 260)|Other|0|||
147610912|NCT03104400|532390861|FG006|Period 2 Week 56 - 260)|Other|0|||
147369841|NCT05827068|531520936|FG005|Overall Study|Withdrawal by Subject|0|||
147369842|NCT05827068|531520937|FG006|Overall Study|Withdrawal by Subject|1|||
147369843|NCT05827068|531520931|FG000|Overall Study|Physician Decision|0|||
147369844|NCT05827068|531520932|FG001|Overall Study|Physician Decision|0|||
147369845|NCT05827068|531520933|FG002|Overall Study|Physician Decision|0|||
147369846|NCT05827068|531520934|FG003|Overall Study|Physician Decision|0|||
147369847|NCT05827068|531520935|FG004|Overall Study|Physician Decision|1|||
147369848|NCT05827068|531520936|FG005|Overall Study|Physician Decision|0|||
147369849|NCT05827068|531520937|FG006|Overall Study|Physician Decision|1|||
147369850|NCT05827068|531520931|FG000|Overall Study|Other Than Specified|0|||
147369851|NCT05827068|531520932|FG001|Overall Study|Other Than Specified|1|||
147369852|NCT05827068|531520933|FG002|Overall Study|Other Than Specified|0|||
147369853|NCT05827068|531520934|FG003|Overall Study|Other Than Specified|0|||
147369854|NCT05827068|531520935|FG004|Overall Study|Other Than Specified|0|||
147369855|NCT05827068|531520936|FG005|Overall Study|Other Than Specified|0|||
147369856|NCT05827068|531520937|FG006|Overall Study|Other Than Specified|0|||
147369857|NCT00319020|531520938|FG000|Overall Study|Death|2|||
147369858|NCT00319020|531520939|FG001|Overall Study|Death|2|||
147369859|NCT00319020|531520938|FG000|Overall Study|Withdrawal by Subject|4|||
147369860|NCT00319020|531520939|FG001|Overall Study|Withdrawal by Subject|1|||
147369861|NCT00319020|531520938|FG000|Overall Study|F-1 completed but not enrolled in F-2|1|||
147369862|NCT00319020|531520939|FG001|Overall Study|F-1 completed but not enrolled in F-2|0|||
147369863|NCT00319020|531520938|FG000|Overall Study|Administrative reason|0|||
147369864|NCT00319020|531520939|FG001|Overall Study|Administrative reason|5|||
147369865|NCT00319020|531520938|FG000|Overall Study|Disease progression|0|||
147369866|NCT00319020|531520939|FG001|Overall Study|Disease progression|2|||
147369867|NCT00319020|531520938|FG000|Overall Study|Transplant|0|||
147369868|NCT00319020|531520939|FG001|Overall Study|Transplant|1|||
147369869|NCT00319020|531520938|FG000|Overall Study|Treatment failure|0|||
147369870|NCT00319020|531520939|FG001|Overall Study|Treatment failure|1|||
147369871|NCT00319020|531520938|FG000|Overall Study|Adverse Event|0|||
147369872|NCT00319020|531520939|FG001|Overall Study|Adverse Event|1|||
147369873|NCT01288443|531521595|FG000|Overall Study|Adverse Event|0|||
147369874|NCT01288443|531521596|FG001|Overall Study|Adverse Event|0|||
147369875|NCT01288443|531521597|FG002|Overall Study|Adverse Event|1|||
147369876|NCT01288443|531521598|FG003|Overall Study|Adverse Event|1|||
147369877|NCT01288443|531521599|FG004|Overall Study|Adverse Event|3|||
147369878|NCT01288443|531521600|FG005|Overall Study|Adverse Event|1|||
147369879|NCT01288443|531521595|FG000|Overall Study|Poor compliance to protocol|0|||
147369880|NCT01288443|531521596|FG001|Overall Study|Poor compliance to protocol|0|||
147369881|NCT01288443|531521597|FG002|Overall Study|Poor compliance to protocol|0|||
147369882|NCT01288443|531521598|FG003|Overall Study|Poor compliance to protocol|0|||
147369883|NCT01288443|531521599|FG004|Overall Study|Poor compliance to protocol|0|||
147369884|NCT01288443|531521600|FG005|Overall Study|Poor compliance to protocol|1|||
147369885|NCT01288443|531521595|FG000|Overall Study|Participant Moved|0|||
147369886|NCT01288443|531521596|FG001|Overall Study|Participant Moved|0|||
147369887|NCT01288443|531521597|FG002|Overall Study|Participant Moved|0|||
147369888|NCT01288443|531521598|FG003|Overall Study|Participant Moved|1|||
147369889|NCT01288443|531521599|FG004|Overall Study|Participant Moved|2|||
147369890|NCT01288443|531521600|FG005|Overall Study|Participant Moved|1|||
147369891|NCT01288443|531521595|FG000|Overall Study|Consent withdrawn by Participant|0|||
147369892|NCT01288443|531521596|FG001|Overall Study|Consent withdrawn by Participant|0|||
147369893|NCT01288443|531521597|FG002|Overall Study|Consent withdrawn by Participant|0|||
147369894|NCT01288443|531521598|FG003|Overall Study|Consent withdrawn by Participant|0|||
147369895|NCT01288443|531521599|FG004|Overall Study|Consent withdrawn by Participant|0|||
147369896|NCT01288443|531521600|FG005|Overall Study|Consent withdrawn by Participant|1|||
147369897|NCT01288443|531521595|FG000|Overall Study|Lost to Follow-up|0|||
147369898|NCT01288443|531521596|FG001|Overall Study|Lost to Follow-up|1|||
147369899|NCT01288443|531521597|FG002|Overall Study|Lost to Follow-up|0|||
147369900|NCT01288443|531521598|FG003|Overall Study|Lost to Follow-up|0|||
147369901|NCT01288443|531521599|FG004|Overall Study|Lost to Follow-up|0|||
147369902|NCT01288443|531521600|FG005|Overall Study|Lost to Follow-up|0|||
147369903|NCT01288443|531521595|FG000|Overall Study|Study drug auto-injector administration|0|||
147369904|NCT01288443|531521596|FG001|Overall Study|Study drug auto-injector administration|0|||
147369905|NCT01288443|531521597|FG002|Overall Study|Study drug auto-injector administration|0|||
147369906|NCT01288443|531521598|FG003|Overall Study|Study drug auto-injector administration|0|||
147369907|NCT01288443|531521599|FG004|Overall Study|Study drug auto-injector administration|1|||
147369908|NCT01288443|531521600|FG005|Overall Study|Study drug auto-injector administration|1|||
147369909|NCT01288443|531521595|FG000|Overall Study|Other than above|0|||
147369910|NCT01288443|531521596|FG001|Overall Study|Other than above|0|||
147369911|NCT01288443|531521597|FG002|Overall Study|Other than above|0|||
147369912|NCT01288443|531521598|FG003|Overall Study|Other than above|2|||
147369913|NCT01288443|531521599|FG004|Overall Study|Other than above|1|||
147369914|NCT01288443|531521600|FG005|Overall Study|Other than above|0|||
147369915|NCT01596972|531521601|FG000|Overall Study|Physician Decision|1|||
147369916|NCT01596972|531521602|FG001|Overall Study|Physician Decision|9|||
147369917|NCT01596972|531521601|FG000|Overall Study|Lost to Follow-up|0|||
147369918|NCT01596972|531521602|FG001|Overall Study|Lost to Follow-up|4|||
147369919|NCT01596972|531521601|FG000|Overall Study|Withdrawal by Subject|0|||
147369920|NCT01596972|531521602|FG001|Overall Study|Withdrawal by Subject|1|||
147369921|NCT01639131|531521604|FG000|Overall Study|Disease Progression|6|||
147369922|NCT02285270|531521606|FG000|Overall Study|Lost to Follow-up|1|||
147369923|NCT02285270|531521606|FG000|Overall Study|Physician Decision|3|||
147369924|NCT02285270|531521606|FG000|Overall Study|Determined to be ineligible|1|||
147369925|NCT00439270|531521607|FG000|Phase 1 (18.1 Months)|Disease progression|3|||
147369926|NCT00439270|531521608|FG001|Phase 1 (18.1 Months)|Disease progression|2|||
147369927|NCT00439270|531521609|FG002|Phase 1 (18.1 Months)|Disease progression|3|||
147369928|NCT00439270|531521610|FG003|Phase 1 (18.1 Months)|Disease progression|0|||
147369929|NCT00439270|531521611|FG004|Phase 1 (18.1 Months)|Disease progression|3|||
147369930|NCT00439270|531521607|FG000|Phase 1 (18.1 Months)|Study drug toxicity|0|||
147369931|NCT00439270|531521608|FG001|Phase 1 (18.1 Months)|Study drug toxicity|1|||
147369932|NCT00439270|531521609|FG002|Phase 1 (18.1 Months)|Study drug toxicity|0|||
147369933|NCT00439270|531521610|FG003|Phase 1 (18.1 Months)|Study drug toxicity|0|||
147369934|NCT00439270|531521611|FG004|Phase 1 (18.1 Months)|Study drug toxicity|0|||
147369935|NCT00439270|531521607|FG000|Phase 2 (51.6 Months)|Disease progression|0|||
147369936|NCT00439270|531521608|FG001|Phase 2 (51.6 Months)|Disease progression|0|||
147369937|NCT00439270|531521609|FG002|Phase 2 (51.6 Months)|Disease progression|0|||
147369938|NCT00439270|531521610|FG003|Phase 2 (51.6 Months)|Disease progression|18|||
147369939|NCT00439270|531521611|FG004|Phase 2 (51.6 Months)|Disease progression|0|||
147369940|NCT00439270|531521607|FG000|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0|||
147369941|NCT00439270|531521608|FG001|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0|||
147369942|NCT00439270|531521609|FG002|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0|||
147369943|NCT00439270|531521610|FG003|Phase 2 (51.6 Months)|Poor compliance/noncompliance|1|||
147369944|NCT00439270|531521611|FG004|Phase 2 (51.6 Months)|Poor compliance/noncompliance|0|||
147369945|NCT00439270|531521607|FG000|Phase 2 (51.6 Months)|Study drug toxicity|0|||
147369946|NCT00439270|531521608|FG001|Phase 2 (51.6 Months)|Study drug toxicity|0|||
147369947|NCT00439270|531521609|FG002|Phase 2 (51.6 Months)|Study drug toxicity|0|||
147369948|NCT00439270|531521610|FG003|Phase 2 (51.6 Months)|Study drug toxicity|6|||
147369949|NCT00439270|531521611|FG004|Phase 2 (51.6 Months)|Study drug toxicity|0|||
147369950|NCT00439270|531521607|FG000|Phase 2 (51.6 Months)|Maximum clinical benefit|0|||
147369951|NCT00439270|531521608|FG001|Phase 2 (51.6 Months)|Maximum clinical benefit|0|||
147369952|NCT00439270|531521609|FG002|Phase 2 (51.6 Months)|Maximum clinical benefit|0|||
147369953|NCT00439270|531521610|FG003|Phase 2 (51.6 Months)|Maximum clinical benefit|3|||
147369954|NCT00439270|531521611|FG004|Phase 2 (51.6 Months)|Maximum clinical benefit|0|||
147369955|NCT00439270|531521607|FG000|Phase 2 (51.6 Months)|No longer meets study criteria|0|||
147369956|NCT00439270|531521608|FG001|Phase 2 (51.6 Months)|No longer meets study criteria|0|||
147369957|NCT00439270|531521609|FG002|Phase 2 (51.6 Months)|No longer meets study criteria|0|||
147369958|NCT00439270|531521610|FG003|Phase 2 (51.6 Months)|No longer meets study criteria|1|||
147369959|NCT00439270|531521611|FG004|Phase 2 (51.6 Months)|No longer meets study criteria|0|||
147369960|NCT00439270|531521607|FG000|Phase 2 (51.6 Months)|Withdrawal by Subject|0|||
147369961|NCT00439270|531521608|FG001|Phase 2 (51.6 Months)|Withdrawal by Subject|0|||
147369962|NCT00439270|531521609|FG002|Phase 2 (51.6 Months)|Withdrawal by Subject|0|||
147369963|NCT00439270|531521610|FG003|Phase 2 (51.6 Months)|Withdrawal by Subject|2|||
147369964|NCT00439270|531521611|FG004|Phase 2 (51.6 Months)|Withdrawal by Subject|0|||
147369965|NCT00439270|531521607|FG000|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0|||
147369966|NCT00439270|531521608|FG001|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0|||
147369967|NCT00439270|531521609|FG002|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0|||
147610913|NCT03104400|532390862|FG007|Period 2 Week 56 - 260)|Other|0|||
147610914|NCT03104400|532390863|FG008|Period 2 Week 56 - 260)|Other|1|||
147610915|NCT03104400|532390864|FG009|Period 2 Week 56 - 260)|Other|1|||
147610916|NCT02013817|532390865|FG000|Overall Study|Adverse Event|12|||
147610917|NCT02013817|532390865|FG000|Overall Study|Withdrawal by Subject|4|||
147610918|NCT02013817|532390865|FG000|Overall Study|Death|2|||
147610919|NCT02013817|532390865|FG000|Overall Study|Other|9|||
147610920|NCT01582152|532390869|FG000|Overall Study|Disease Progression|4|||
147663616|NCT05616013|532591569|FG004|Overall Study|Did not Fulfill Enrollment criteria|0|||
147663617|NCT05616013|532591570|FG005|Overall Study|Did not Fulfill Enrollment criteria|0|||
147369968|NCT00439270|531521610|FG003|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|2|||
147369969|NCT00439270|531521611|FG004|Phase 2 (51.6 Months)|Adverse event unrelated to study drug|0|||
147369970|NCT00439270|531521607|FG000|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0|||
147369971|NCT00439270|531521608|FG001|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0|||
147369972|NCT00439270|531521609|FG002|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0|||
147610921|NCT01582152|532390870|FG001|Overall Study|Disease Progression|5|||
147610922|NCT01582152|532390869|FG000|Overall Study|Adverse Event|2|||
147610923|NCT01582152|532390870|FG001|Overall Study|Adverse Event|1|||
147610924|NCT00794339|532390878|FG000|Overall Study|Withdrawal by Subject|3|||
147663618|NCT05616013|532591571|FG006|Overall Study|Did not Fulfill Enrollment criteria|0|||
147610925|NCT00794339|532390878|FG000|Overall Study|Ineligible|4|||
147610926|NCT00794339|532390878|FG000|Overall Study|Tx prior to ATSM|3|||
147369973|NCT00439270|531521610|FG003|Phase 2 (51.6 Months)|Insurance no longer covered patient care|1|||
147369974|NCT00439270|531521611|FG004|Phase 2 (51.6 Months)|Insurance no longer covered patient care|0|||
147369975|NCT04334317|531521612|FG000|Overall Study|Adverse Event|1|||
147369976|NCT04334317|531521613|FG001|Overall Study|Adverse Event|2|||
147369977|NCT04334317|531521614|FG002|Overall Study|Adverse Event|0|||
147369978|NCT04334317|531521615|FG003|Overall Study|Adverse Event|0|||
147369979|NCT04334317|531521612|FG000|Overall Study|Protocol Deviation|0|||
147369980|NCT04334317|531521613|FG001|Overall Study|Protocol Deviation|1|||
147369981|NCT04334317|531521614|FG002|Overall Study|Protocol Deviation|0|||
147369982|NCT04334317|531521615|FG003|Overall Study|Protocol Deviation|0|||
147454903|NCT01882907|531827751|FG001|Overall Study|Withdrawal by Subject|6|||
147369983|NCT04334317|531521612|FG000|Overall Study|Withdrawal by Subject|2|||
147369984|NCT04334317|531521613|FG001|Overall Study|Withdrawal by Subject|2|||
147454904|NCT03124784|531827752|FG000|Overall Study|Adverse Event|1|||
147454905|NCT03124784|531827752|FG000|Overall Study|Computer/Equip Malfunction|1|||
147454906|NCT05702515|531827753|FG000|Overall Study|7 patients were excluded due to the inability to complete a chest radiograph.|7|||
147454907|NCT01784965|531827754|FG000|Overall Study|Withdrawal by Subject|6|||
147454908|NCT01784965|531827755|FG001|Overall Study|Withdrawal by Subject|3|||
147454909|NCT01784965|531827754|FG000|Overall Study|Adverse Event|0|||
147454910|NCT01784965|531827755|FG001|Overall Study|Adverse Event|8|||
147454911|NCT01467492|531827758|FG000|Overall Study|Withdrawal by Subject|6|||
147454912|NCT01467492|531827759|FG001|Overall Study|Withdrawal by Subject|4|||
147454913|NCT01467492|531827758|FG000|Overall Study|Study Terminated by Sponsor|6|||
147454914|NCT01467492|531827759|FG001|Overall Study|Study Terminated by Sponsor|4|||
147454915|NCT01467492|531827758|FG000|Overall Study|Adverse Event|4|||
147454916|NCT01467492|531827759|FG001|Overall Study|Adverse Event|3|||
147454917|NCT01467492|531827758|FG000|Overall Study|Lost to Follow-up|3|||
147454918|NCT01467492|531827759|FG001|Overall Study|Lost to Follow-up|2|||
147454919|NCT01467492|531827758|FG000|Overall Study|Undefined|2|||
147454920|NCT01467492|531827759|FG001|Overall Study|Undefined|0|||
147454921|NCT01467492|531827758|FG000|Overall Study|Enrolled But Not Treated|1|||
147454922|NCT01467492|531827759|FG001|Overall Study|Enrolled But Not Treated|0|||
147454923|NCT02450487|531827760|FG000|Overall Study|Lost to Follow-up|3|||
147454924|NCT04269395|531827761|FG000|Overall Study|Lost to Follow-up|1|||
147454925|NCT04269395|531827762|FG001|Overall Study|Lost to Follow-up|0|||
147454926|NCT04269395|531827761|FG000|Overall Study|Study terminated by Sponsor|13|||
147454927|NCT04269395|531827762|FG001|Overall Study|Study terminated by Sponsor|10|||
147454928|NCT01491178|531827763|FG000|Overall Study|Adverse Event|1016|||
147454929|NCT01491178|531827763|FG000|Overall Study|Improvement of NVAF|210|||
147454930|NCT01491178|531827763|FG000|Overall Study|To conduct invasive treatment|59|||
147454931|NCT01491178|531827763|FG000|Overall Study|Lost to follow-up (unknown reason)|287|||
147454932|NCT01491178|531827763|FG000|Overall Study|Lost to follow-up (changing hospital)|545|||
147454933|NCT01491178|531827763|FG000|Overall Study|To take a contraindication|20|||
147454934|NCT01491178|531827763|FG000|Overall Study|Other than specified above|657|||
147454935|NCT03132636|531827764|FG000|Overall Study|Adverse Event|1|||
147454936|NCT03132636|531827765|FG001|Overall Study|Adverse Event|2|||
147454937|NCT03132636|531827764|FG000|Overall Study|Death|4|||
147454938|NCT03132636|531827765|FG001|Overall Study|Death|7|||
147454939|NCT03132636|531827764|FG000|Overall Study|Lost to Follow-up|3|||
147454940|NCT03132636|531827765|FG001|Overall Study|Lost to Follow-up|2|||
147454941|NCT03132636|531827764|FG000|Overall Study|Non compliance with protocol by participant|1|||
147454942|NCT03132636|531827765|FG001|Overall Study|Non compliance with protocol by participant|1|||
147454943|NCT03132636|531827764|FG000|Overall Study|Subject decision|1|||
147454944|NCT03132636|531827765|FG001|Overall Study|Subject decision|9|||
147454945|NCT03132636|531827764|FG000|Overall Study|Sponsor decision|0|||
147454946|NCT03132636|531827765|FG001|Overall Study|Sponsor decision|1|||
147454947|NCT03132636|531827764|FG000|Overall Study|Physician Decision|1|||
147454948|NCT03132636|531827765|FG001|Overall Study|Physician Decision|0|||
147454949|NCT03132636|531827764|FG000|Overall Study|Progressive disease|33|||
147454950|NCT03132636|531827765|FG001|Overall Study|Progressive disease|36|||
147454951|NCT03132636|531827764|FG000|Overall Study|Withdrawal of consent|2|||
147454952|NCT03132636|531827765|FG001|Overall Study|Withdrawal of consent|5|||
147454953|NCT03132636|531827764|FG000|Overall Study|Did not re-consent|1|||
147369985|NCT04334317|531521614|FG002|Overall Study|Withdrawal by Subject|0|||
147369986|NCT04334317|531521615|FG003|Overall Study|Withdrawal by Subject|0|||
147369987|NCT03183050|531521617|FG000|Overall Study|Lost to Follow-up|23|||
147454954|NCT03132636|531827765|FG001|Overall Study|Did not re-consent|0|||
147454955|NCT03132636|531827764|FG000|Overall Study|Lost insurance coverage|1|||
147454956|NCT03132636|531827765|FG001|Overall Study|Lost insurance coverage|0|||
147454957|NCT03132636|531827764|FG000|Overall Study|Related to radiological outcomes|0|||
147454958|NCT03132636|531827765|FG001|Overall Study|Related to radiological outcomes|1|||
147369988|NCT02797132|531521618|FG000|Part A (15 Days)|Adverse Event|1|||
147369989|NCT02797132|531521618|FG000|Part B (24 Weeks)|Adverse Event|3|||
147454959|NCT03132636|531827764|FG000|Overall Study|Unable to come to site for continued visits|0|||
147454960|NCT03132636|531827765|FG001|Overall Study|Unable to come to site for continued visits|1|||
147454961|NCT01415752|531827766|FG000|Induction (Step 1)|Ineligible|4|||
147369990|NCT01315132|531521619|FG000|Overall Study|not treated due to disease progression|1|||
147369991|NCT01371994|531521631|FG000|Overall Study|Adverse Event|3|||
147369992|NCT01371994|531521632|FG001|Overall Study|Adverse Event|6|||
147369993|NCT01371994|531521631|FG000|Overall Study|Lack of Efficacy|3|||
147369994|NCT01371994|531521632|FG001|Overall Study|Lack of Efficacy|0|||
147369995|NCT01371994|531521631|FG000|Overall Study|Withdrawal by Subject|13|||
147369996|NCT01371994|531521632|FG001|Overall Study|Withdrawal by Subject|7|||
147369997|NCT01371994|531521631|FG000|Overall Study|Lost to Follow-up|1|||
147369998|NCT01371994|531521632|FG001|Overall Study|Lost to Follow-up|1|||
147369999|NCT01371994|531521631|FG000|Overall Study|Protocol Violation|24|||
147370000|NCT01371994|531521632|FG001|Overall Study|Protocol Violation|17|||
147370001|NCT01371994|531521631|FG000|Overall Study|Randomized but Never Received Study Drug|6|||
147370002|NCT01371994|531521632|FG001|Overall Study|Randomized but Never Received Study Drug|6|||
147370003|NCT01371994|531521631|FG000|Overall Study|Physician Decision|1|||
147370004|NCT01371994|531521632|FG001|Overall Study|Physician Decision|1|||
147370005|NCT01371994|531521631|FG000|Overall Study|Miscellaneous Reasons|6|||
147370006|NCT01371994|531521632|FG001|Overall Study|Miscellaneous Reasons|4|||
147370007|NCT00087685|531521633|FG000|Overall Study|Adverse Event|5|||
147370008|NCT00087685|531521633|FG000|Overall Study|Non-Compliance|1|||
147370009|NCT00087685|531521633|FG000|Overall Study|Progressive Disease|5|||
147370010|NCT00087685|531521633|FG000|Overall Study|Withdrawal by Subject|3|||
147370011|NCT04018495|531521634|FG000|Overall Study|Physician Decision|1|||
147370012|NCT02500576|531521645|FG000|Overall Study|Adverse Event|0|||
147370013|NCT02500576|531521646|FG001|Overall Study|Adverse Event|1|||
147370014|NCT02500576|531521645|FG000|Overall Study|Death|2|||
147370015|NCT02500576|531521646|FG001|Overall Study|Death|1|||
147370016|NCT02500576|531521645|FG000|Overall Study|Lack of Efficacy|5|||
147370017|NCT02500576|531521646|FG001|Overall Study|Lack of Efficacy|5|||
147370018|NCT02500576|531521645|FG000|Overall Study|Withdrawal by Subject|1|||
147370019|NCT02500576|531521646|FG001|Overall Study|Withdrawal by Subject|1|||
147370020|NCT01983683|531521652|FG000|Overall Study|Withdrawal by Subject|14|||
147370021|NCT01983683|531521653|FG001|Overall Study|Withdrawal by Subject|18|||
147370022|NCT01983683|531521652|FG000|Overall Study|Death|11|||
147370023|NCT01983683|531521653|FG001|Overall Study|Death|15|||
147370024|NCT01983683|531521652|FG000|Overall Study|Physician Decision|8|||
147370025|NCT01983683|531521653|FG001|Overall Study|Physician Decision|9|||
147370026|NCT01983683|531521652|FG000|Overall Study|Lost to Follow-up|4|||
147370027|NCT01983683|531521653|FG001|Overall Study|Lost to Follow-up|8|||
147370028|NCT01983683|531521652|FG000|Overall Study|Sponsor Decision|1|||
147370029|NCT01983683|531521653|FG001|Overall Study|Sponsor Decision|1|||
147370030|NCT04926740|531521656|FG000|Overall Study|Ineligible: received >1L of pre-study fluid prior to enrolment|2|||
147370031|NCT04926740|531521657|FG001|Overall Study|Ineligible: received >1L of pre-study fluid prior to enrolment|1|||
147370032|NCT04926740|531521656|FG000|Overall Study|Ineligible: subsequently found to not have true DKA|7|||
147370033|NCT04926740|531521657|FG001|Overall Study|Ineligible: subsequently found to not have true DKA|4|||
147610927|NCT00794339|532390878|FG000|Overall Study|ATSM imaging not complete or inadequate|3|||
147610928|NCT00794339|532390878|FG000|Overall Study|Tx not per protocol|1|||
147610929|NCT01611857|532390879|FG000|Overall Study|Withdrawal by Subject|0|||
147610930|NCT01611857|532390880|FG001|Overall Study|Withdrawal by Subject|2|||
147610931|NCT02439970|532390881|FG000|Overall Study|Study Terminated|2|||
147610932|NCT02439970|532390882|FG001|Overall Study|Study Terminated|3|||
147610933|NCT02952586|532390885|FG000|Lead-In Phase (7 Days)|Death|0|||
147610934|NCT02952586|532390886|FG001|Lead-In Phase (7 Days)|Death|1|||
147610935|NCT02952586|532390885|FG000|Lead-In Phase (7 Days)|Adverse Event|3|||
147610936|NCT02952586|532390886|FG001|Lead-In Phase (7 Days)|Adverse Event|0|||
147610937|NCT02952586|532390885|FG000|Lead-In Phase (7 Days)|No Longer Met Eligibility Criteria|0|||
147610938|NCT02952586|532390886|FG001|Lead-In Phase (7 Days)|No Longer Met Eligibility Criteria|1|||
147610939|NCT02952586|532390885|FG000|Lead-In Phase (7 Days)|Withdrawal by Subject|2|||
147610940|NCT02952586|532390886|FG001|Lead-In Phase (7 Days)|Withdrawal by Subject|2|||
147610941|NCT02952586|532390885|FG000|CRT for Avelumab or Placebo (63 Days)|Death|5|||
147610942|NCT02952586|532390886|FG001|CRT for Avelumab or Placebo (63 Days)|Death|8|||
147610943|NCT02952586|532390885|FG000|CRT for Avelumab or Placebo (63 Days)|Adverse Event|12|||
147663619|NCT05616013|532591572|FG007|Overall Study|Did not Fulfill Enrollment criteria|0|||
147663620|NCT05616013|532591573|FG008|Overall Study|Did not Fulfill Enrollment criteria|0|||
147370034|NCT04980300|531521658|FG000|Baseline to 12 Weeks|Withdrawal by Subject|2|||
147370035|NCT04980300|531521659|FG001|Baseline to 12 Weeks|Withdrawal by Subject|1|||
147370036|NCT04980300|531521658|FG000|Baseline to 12 Weeks|Lost to Follow-up|4|||
147370037|NCT04980300|531521659|FG001|Baseline to 12 Weeks|Lost to Follow-up|0|||
147370038|NCT04980300|531521658|FG000|12 Weeks to 24 Weeks|Withdrawal by Subject|2|||
147370039|NCT04980300|531521659|FG001|12 Weeks to 24 Weeks|Withdrawal by Subject|1|||
147370040|NCT04980300|531521658|FG000|12 Weeks to 24 Weeks|Lost to Follow-up|2|||
147370041|NCT04980300|531521659|FG001|12 Weeks to 24 Weeks|Lost to Follow-up|4|||
147370042|NCT04530487|531522498|FG000|Overall Study|Death|1|||
147663621|NCT05616013|532591565|FG000|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|1|||
147610944|NCT02952586|532390886|FG001|CRT for Avelumab or Placebo (63 Days)|Adverse Event|12|||
147370043|NCT04977583|531522499|FG000|Overall Study|Lost to Follow-up|8|||
147370044|NCT04977583|531522500|FG001|Overall Study|Lost to Follow-up|4|||
147370045|NCT04977583|531522501|FG002|Overall Study|Lost to Follow-up|13|||
147370046|NCT04977583|531522499|FG000|Overall Study|Withdrawal by Subject|3|||
147370047|NCT04977583|531522500|FG001|Overall Study|Withdrawal by Subject|2|||
147370048|NCT04977583|531522501|FG002|Overall Study|Withdrawal by Subject|1|||
147370049|NCT01574716|531522505|FG000|Part 1|Death|3|||
147370050|NCT01574716|531522506|FG001|Part 1|Death|1|||
147370051|NCT01574716|531522507|FG002|Part 1|Death|8|||
147370052|NCT01574716|531522508|FG003|Part 1|Death|0|||
147370053|NCT01574716|531522509|FG004|Part 1|Death|0|||
147370054|NCT01574716|531522505|FG000|Part 1|Discontinuation of study by sponsor|0|||
147370055|NCT01574716|531522506|FG001|Part 1|Discontinuation of study by sponsor|0|||
147370056|NCT01574716|531522507|FG002|Part 1|Discontinuation of study by sponsor|1|||
147370057|NCT01574716|531522508|FG003|Part 1|Discontinuation of study by sponsor|0|||
147370058|NCT01574716|531522509|FG004|Part 1|Discontinuation of study by sponsor|0|||
147370059|NCT01574716|531522505|FG000|Part 1|Withdrawal by Subject|0|||
147370060|NCT01574716|531522506|FG001|Part 1|Withdrawal by Subject|2|||
147370061|NCT01574716|531522507|FG002|Part 1|Withdrawal by Subject|0|||
147370062|NCT01574716|531522508|FG003|Part 1|Withdrawal by Subject|0|||
147370063|NCT01574716|531522509|FG004|Part 1|Withdrawal by Subject|0|||
147370064|NCT01574716|531522505|FG000|Part 1|Lost to Follow-up|0|||
147370065|NCT01574716|531522506|FG001|Part 1|Lost to Follow-up|1|||
147370066|NCT01574716|531522507|FG002|Part 1|Lost to Follow-up|0|||
147370067|NCT01574716|531522508|FG003|Part 1|Lost to Follow-up|0|||
147370068|NCT01574716|531522509|FG004|Part 1|Lost to Follow-up|0|||
147370069|NCT01574716|531522505|FG000|Part 2|Progressive disease|0|||
147370070|NCT01574716|531522506|FG001|Part 2|Progressive disease|0|||
147370071|NCT01574716|531522507|FG002|Part 2|Progressive disease|0|||
147370072|NCT01574716|531522508|FG003|Part 2|Progressive disease|1|||
147370073|NCT01574716|531522509|FG004|Part 2|Progressive disease|0|||
147370074|NCT01574716|531522505|FG000|Part 2|Death|0|||
147370075|NCT01574716|531522506|FG001|Part 2|Death|0|||
147370076|NCT01574716|531522507|FG002|Part 2|Death|0|||
147370077|NCT01574716|531522508|FG003|Part 2|Death|76|||
147370078|NCT01574716|531522509|FG004|Part 2|Death|35|||
147370079|NCT01574716|531522505|FG000|Part 2|Discontinuation of study by sponsor|0|||
147370080|NCT01574716|531522506|FG001|Part 2|Discontinuation of study by sponsor|0|||
147370081|NCT01574716|531522507|FG002|Part 2|Discontinuation of study by sponsor|0|||
147370082|NCT01574716|531522508|FG003|Part 2|Discontinuation of study by sponsor|51|||
147370083|NCT01574716|531522509|FG004|Part 2|Discontinuation of study by sponsor|31|||
147370084|NCT01574716|531522505|FG000|Part 2|Withdrawal by Subject|0|||
147370085|NCT01574716|531522506|FG001|Part 2|Withdrawal by Subject|0|||
147370086|NCT01574716|531522507|FG002|Part 2|Withdrawal by Subject|0|||
147370087|NCT01574716|531522508|FG003|Part 2|Withdrawal by Subject|5|||
147370088|NCT01574716|531522509|FG004|Part 2|Withdrawal by Subject|4|||
147370089|NCT01574716|531522505|FG000|Part 2|Brain metastases|0|||
147370090|NCT01574716|531522506|FG001|Part 2|Brain metastases|0|||
147370091|NCT01574716|531522507|FG002|Part 2|Brain metastases|0|||
147370092|NCT01574716|531522508|FG003|Part 2|Brain metastases|1|||
147370093|NCT01574716|531522509|FG004|Part 2|Brain metastases|0|||
147370094|NCT01574716|531522505|FG000|Part 2|Lost to Follow-up|0|||
147370095|NCT01574716|531522506|FG001|Part 2|Lost to Follow-up|0|||
147370096|NCT01574716|531522507|FG002|Part 2|Lost to Follow-up|0|||
147370097|NCT01574716|531522508|FG003|Part 2|Lost to Follow-up|3|||
147370098|NCT01574716|531522509|FG004|Part 2|Lost to Follow-up|0|||
147370099|NCT01268306|531522513|FG000|Overall Study|Lost to Follow-up|1|||
147370100|NCT03709706|531522514|FG000|Overall Study|Adverse Event|0|||
147370101|NCT03709706|531522515|FG001|Overall Study|Adverse Event|1|||
147370102|NCT03709706|531522514|FG000|Overall Study|Physician Decision|14|||
147370103|NCT03709706|531522515|FG001|Overall Study|Physician Decision|8|||
147370104|NCT03709706|531522514|FG000|Overall Study|Withdrawal by Subject|2|||
147370105|NCT03709706|531522515|FG001|Overall Study|Withdrawal by Subject|1|||
147370106|NCT03709706|531522514|FG000|Overall Study|Death Prior to Lete-cel Infusion|1|||
147610945|NCT02952586|532390885|FG000|CRT for Avelumab or Placebo (63 Days)|Physician Decision|2|||
147610946|NCT02952586|532390886|FG001|CRT for Avelumab or Placebo (63 Days)|Physician Decision|1|||
147610947|NCT02952586|532390885|FG000|CRT for Avelumab or Placebo (63 Days)|Global Deterioration of Health Status|1|||
147370107|NCT03709706|531522515|FG001|Overall Study|Death Prior to Lete-cel Infusion|1|||
147370108|NCT01105975|531522516|FG000|Overall Study|Adverse Event|2|||
147370109|NCT01105975|531522517|FG001|Overall Study|Adverse Event|1|||
147370110|NCT01105975|531522518|FG002|Overall Study|Adverse Event|5|||
147370111|NCT01105975|531522519|FG003|Overall Study|Adverse Event|1|||
147370112|NCT01105975|531522520|FG004|Overall Study|Adverse Event|0|||
147370113|NCT01105975|531522521|FG005|Overall Study|Adverse Event|1|||
147370114|NCT01105975|531522522|FG006|Overall Study|Adverse Event|2|||
147370115|NCT01105975|531522523|FG007|Overall Study|Adverse Event|4|||
147370116|NCT01105975|531522524|FG008|Overall Study|Adverse Event|1|||
147370117|NCT01105975|531522525|FG009|Overall Study|Adverse Event|4|||
147370118|NCT01105975|531522516|FG000|Overall Study|Withdrawal by Subject|2|||
147370119|NCT01105975|531522517|FG001|Overall Study|Withdrawal by Subject|2|||
147370120|NCT01105975|531522518|FG002|Overall Study|Withdrawal by Subject|2|||
147370121|NCT01105975|531522519|FG003|Overall Study|Withdrawal by Subject|0|||
147370122|NCT01105975|531522520|FG004|Overall Study|Withdrawal by Subject|4|||
147370123|NCT01105975|531522521|FG005|Overall Study|Withdrawal by Subject|1|||
147370124|NCT01105975|531522522|FG006|Overall Study|Withdrawal by Subject|2|||
147370125|NCT01105975|531522523|FG007|Overall Study|Withdrawal by Subject|1|||
147370126|NCT01105975|531522524|FG008|Overall Study|Withdrawal by Subject|0|||
147370127|NCT01105975|531522525|FG009|Overall Study|Withdrawal by Subject|3|||
147370128|NCT01105975|531522516|FG000|Overall Study|Lost to Follow-up|1|||
147370129|NCT01105975|531522517|FG001|Overall Study|Lost to Follow-up|0|||
147370130|NCT01105975|531522518|FG002|Overall Study|Lost to Follow-up|0|||
147370131|NCT01105975|531522519|FG003|Overall Study|Lost to Follow-up|1|||
147370132|NCT01105975|531522520|FG004|Overall Study|Lost to Follow-up|1|||
147370133|NCT01105975|531522521|FG005|Overall Study|Lost to Follow-up|0|||
147370134|NCT01105975|531522522|FG006|Overall Study|Lost to Follow-up|0|||
147370135|NCT01105975|531522523|FG007|Overall Study|Lost to Follow-up|0|||
147370136|NCT01105975|531522524|FG008|Overall Study|Lost to Follow-up|1|||
147370137|NCT01105975|531522525|FG009|Overall Study|Lost to Follow-up|0|||
147370138|NCT01105975|531522516|FG000|Overall Study|Physician Decision|0|||
147370139|NCT01105975|531522517|FG001|Overall Study|Physician Decision|0|||
147370140|NCT01105975|531522518|FG002|Overall Study|Physician Decision|0|||
147370141|NCT01105975|531522519|FG003|Overall Study|Physician Decision|0|||
147370142|NCT01105975|531522520|FG004|Overall Study|Physician Decision|0|||
147370143|NCT01105975|531522521|FG005|Overall Study|Physician Decision|0|||
147370144|NCT01105975|531522522|FG006|Overall Study|Physician Decision|2|||
147370145|NCT01105975|531522523|FG007|Overall Study|Physician Decision|0|||
147370146|NCT01105975|531522524|FG008|Overall Study|Physician Decision|0|||
147370147|NCT01105975|531522525|FG009|Overall Study|Physician Decision|0|||
147370148|NCT01105975|531522516|FG000|Overall Study|Protocol Violation|0|||
147370149|NCT01105975|531522517|FG001|Overall Study|Protocol Violation|2|||
147370150|NCT01105975|531522518|FG002|Overall Study|Protocol Violation|2|||
147370151|NCT01105975|531522519|FG003|Overall Study|Protocol Violation|0|||
147370152|NCT01105975|531522520|FG004|Overall Study|Protocol Violation|1|||
147370153|NCT01105975|531522521|FG005|Overall Study|Protocol Violation|1|||
147370154|NCT01105975|531522522|FG006|Overall Study|Protocol Violation|1|||
147370155|NCT01105975|531522523|FG007|Overall Study|Protocol Violation|1|||
147370156|NCT01105975|531522524|FG008|Overall Study|Protocol Violation|2|||
147370157|NCT01105975|531522525|FG009|Overall Study|Protocol Violation|2|||
147370158|NCT01105975|531522516|FG000|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
147370159|NCT01105975|531522517|FG001|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
147370160|NCT01105975|531522518|FG002|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
147370161|NCT01105975|531522519|FG003|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
147370162|NCT01105975|531522520|FG004|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
147370163|NCT01105975|531522521|FG005|Overall Study|Abnormal Lab/Electrocardiogram Result|2|||
147370164|NCT01105975|531522522|FG006|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
147370165|NCT01105975|531522523|FG007|Overall Study|Abnormal Lab/Electrocardiogram Result|1|||
147370166|NCT01105975|531522524|FG008|Overall Study|Abnormal Lab/Electrocardiogram Result|2|||
147370167|NCT01105975|531522525|FG009|Overall Study|Abnormal Lab/Electrocardiogram Result|0|||
147370168|NCT02502526|531522527|FG000|Overall Study|Lost to Follow-up|2|||
147370169|NCT02502526|531522528|FG001|Overall Study|Lost to Follow-up|2|||
147370170|NCT02502526|531522529|FG002|Overall Study|Lost to Follow-up|3|||
147370171|NCT02502526|531522527|FG000|Overall Study|Withdrawal by Subject|0|||
147610948|NCT02952586|532390886|FG001|CRT for Avelumab or Placebo (63 Days)|Global Deterioration of Health Status|0|||
147610949|NCT02952586|532390885|FG000|CRT for Avelumab or Placebo (63 Days)|Withdrawal by Subject|10|||
147610950|NCT02952586|532390886|FG001|CRT for Avelumab or Placebo (63 Days)|Withdrawal by Subject|4|||
147610951|NCT02952586|532390885|FG000|CRT for Avelumab or Placebo (63 Days)|Lost to Follow-up|1|||
147610952|NCT02952586|532390886|FG001|CRT for Avelumab or Placebo (63 Days)|Lost to Follow-up|1|||
147610953|NCT02952586|532390885|FG000|CRT for Avelumab or Placebo (63 Days)|Other|2|||
147610954|NCT02952586|532390886|FG001|CRT for Avelumab or Placebo (63 Days)|Other|1|||
147610955|NCT02952586|532390885|FG000|CRT for Cisplatin (63 Days)|Death|3|||
147610956|NCT02952586|532390886|FG001|CRT for Cisplatin (63 Days)|Death|8|||
147610957|NCT02952586|532390885|FG000|CRT for Cisplatin (63 Days)|Adverse Event|82|||
147610958|NCT02952586|532390886|FG001|CRT for Cisplatin (63 Days)|Adverse Event|81|||
147610959|NCT02952586|532390885|FG000|CRT for Cisplatin (63 Days)|Physician Decision|12|||
147370172|NCT02502526|531522528|FG001|Overall Study|Withdrawal by Subject|1|||
147370173|NCT02502526|531522529|FG002|Overall Study|Withdrawal by Subject|1|||
147610960|NCT02952586|532390886|FG001|CRT for Cisplatin (63 Days)|Physician Decision|10|||
147610961|NCT02952586|532390885|FG000|CRT for Cisplatin (63 Days)|Global Deterioration of Health Status|1|||
147610962|NCT02952586|532390886|FG001|CRT for Cisplatin (63 Days)|Global Deterioration of Health Status|0|||
147370174|NCT02502526|531522527|FG000|Overall Study|Disqualified due to cataract grading|0|||
147370175|NCT02502526|531522528|FG001|Overall Study|Disqualified due to cataract grading|0|||
147370176|NCT02502526|531522529|FG002|Overall Study|Disqualified due to cataract grading|1|||
147370177|NCT02502526|531522527|FG000|Overall Study|Enrollment suspension|4|||
147370178|NCT02502526|531522528|FG001|Overall Study|Enrollment suspension|1|||
147454962|NCT01415752|531827767|FG001|Induction (Step 1)|Ineligible|3|||
147454963|NCT01415752|531827768|FG002|Induction (Step 1)|Ineligible|4|||
147454964|NCT01415752|531827769|FG003|Induction (Step 1)|Ineligible|4|||
147454965|NCT01415752|531827766|FG000|Maintenance (Step 2)|Lack of Efficacy|12|||
147454966|NCT01415752|531827767|FG001|Maintenance (Step 2)|Lack of Efficacy|10|||
147454967|NCT01415752|531827768|FG002|Maintenance (Step 2)|Lack of Efficacy|8|||
147454968|NCT01415752|531827769|FG003|Maintenance (Step 2)|Lack of Efficacy|3|||
147454969|NCT01415752|531827766|FG000|Maintenance (Step 2)|Adverse Event|3|||
147454970|NCT01415752|531827767|FG001|Maintenance (Step 2)|Adverse Event|4|||
147454971|NCT01415752|531827768|FG002|Maintenance (Step 2)|Adverse Event|9|||
147454972|NCT01415752|531827769|FG003|Maintenance (Step 2)|Adverse Event|6|||
147454973|NCT01415752|531827766|FG000|Maintenance (Step 2)|Death|1|||
147454974|NCT01415752|531827767|FG001|Maintenance (Step 2)|Death|1|||
147454975|NCT01415752|531827768|FG002|Maintenance (Step 2)|Death|2|||
147454976|NCT01415752|531827769|FG003|Maintenance (Step 2)|Death|0|||
147454977|NCT01415752|531827766|FG000|Maintenance (Step 2)|Withdrawal by Subject|2|||
147454978|NCT01415752|531827767|FG001|Maintenance (Step 2)|Withdrawal by Subject|1|||
147454979|NCT01415752|531827768|FG002|Maintenance (Step 2)|Withdrawal by Subject|3|||
147454980|NCT01415752|531827769|FG003|Maintenance (Step 2)|Withdrawal by Subject|3|||
147454981|NCT01415752|531827766|FG000|Maintenance (Step 2)|Alternative therapy|0|||
147454982|NCT01415752|531827767|FG001|Maintenance (Step 2)|Alternative therapy|1|||
147454983|NCT01415752|531827768|FG002|Maintenance (Step 2)|Alternative therapy|0|||
147454984|NCT01415752|531827769|FG003|Maintenance (Step 2)|Alternative therapy|0|||
147610963|NCT02952586|532390885|FG000|CRT for Cisplatin (63 Days)|Withdrawal by Subject|11|||
147610964|NCT02952586|532390886|FG001|CRT for Cisplatin (63 Days)|Withdrawal by Subject|3|||
147610965|NCT02952586|532390885|FG000|CRT for Cisplatin (63 Days)|Lost to Follow-up|1|||
147370179|NCT02502526|531522529|FG002|Overall Study|Enrollment suspension|1|||
147370180|NCT00640159|531522532|FG000|Overall Study|Lost to Follow-up|2|||
147370181|NCT00112359|531522533|FG000|Overall Study|Unrelated adverse event|16|||
147370182|NCT00112359|531522534|FG001|Overall Study|Unrelated adverse event|8|||
147370183|NCT00112359|531522533|FG000|Overall Study|Trial drug intolerance (adverse event)|2|||
147370184|NCT00112359|531522534|FG001|Overall Study|Trial drug intolerance (adverse event)|0|||
147370185|NCT00112359|531522533|FG000|Overall Study|Related adverse event|5|||
147370186|NCT00112359|531522534|FG001|Overall Study|Related adverse event|3|||
147370187|NCT00112359|531522533|FG000|Overall Study|Lost to Follow-up|0|||
147370188|NCT00112359|531522534|FG001|Overall Study|Lost to Follow-up|1|||
147370189|NCT00112359|531522533|FG000|Overall Study|Personal/administrative|1|||
147370190|NCT00112359|531522534|FG001|Overall Study|Personal/administrative|1|||
147370191|NCT00112359|531522533|FG000|Overall Study|Other|3|||
147370192|NCT00112359|531522534|FG001|Overall Study|Other|0|||
147370193|NCT01218009|531522535|FG000|Overall Study|Protocol Violation|2|||
147370194|NCT01218009|531522536|FG001|Overall Study|Protocol Violation|1|||
147370195|NCT01218009|531522535|FG000|Overall Study|Withdrawal by Subject|3|||
147370196|NCT01218009|531522536|FG001|Overall Study|Withdrawal by Subject|1|||
147370197|NCT01218009|531522535|FG000|Overall Study|Sponsor terminated study|161|||
147370198|NCT01218009|531522536|FG001|Overall Study|Sponsor terminated study|163|||
147370199|NCT03170882|531522537|FG000|Overall Study|Death|17|||
147370200|NCT03170882|531522538|FG001|Overall Study|Death|29|||
147370201|NCT03170882|531522537|FG000|Overall Study|Lost to Follow-up|0|||
147370202|NCT03170882|531522538|FG001|Overall Study|Lost to Follow-up|1|||
147370203|NCT03170882|531522537|FG000|Overall Study|Withdrawal by Subject|4|||
147370204|NCT03170882|531522538|FG001|Overall Study|Withdrawal by Subject|7|||
147370205|NCT03170882|531522537|FG000|Overall Study|Reason not Specified|28|||
147370206|NCT03170882|531522538|FG001|Overall Study|Reason not Specified|36|||
147370207|NCT05521516|531522544|FG000|Overall Study|Withdrawal by Subject|1|||
147370208|NCT05521516|531522545|FG001|Overall Study|Withdrawal by Subject|1|||
147370209|NCT04305327|531522546|FG000|Overall Study|Study early termination|2|||
147370210|NCT04305327|531522547|FG001|Overall Study|Study early termination|5|||
147370211|NCT04305327|531522548|FG002|Overall Study|Study early termination|2|||
147370212|NCT04305327|531522549|FG003|Overall Study|Study early termination|2|||
147610966|NCT02952586|532390886|FG001|CRT for Cisplatin (63 Days)|Lost to Follow-up|1|||
147610967|NCT02952586|532390885|FG000|CRT for Cisplatin (63 Days)|Other|1|||
147370213|NCT04305327|531522546|FG000|Overall Study|Withdrawal by Subject|0|||
147370214|NCT04305327|531522547|FG001|Overall Study|Withdrawal by Subject|1|||
147370215|NCT04305327|531522548|FG002|Overall Study|Withdrawal by Subject|0|||
147454985|NCT01415752|531827766|FG000|Maintenance (Step 2)|Other reasons|3|||
147454986|NCT01415752|531827767|FG001|Maintenance (Step 2)|Other reasons|6|||
147454987|NCT01415752|531827768|FG002|Maintenance (Step 2)|Other reasons|4|||
147454988|NCT01415752|531827769|FG003|Maintenance (Step 2)|Other reasons|6|||
147610968|NCT02952586|532390886|FG001|CRT for Cisplatin (63 Days)|Other|1|||
147454989|NCT01415752|531827766|FG000|Maintenance (Step 2)|Did not receive treatment|1|||
147370216|NCT04305327|531522549|FG003|Overall Study|Withdrawal by Subject|0|||
147370217|NCT03275285|531522550|FG000|Overall Study|Ongoing|45|||
147370218|NCT03275285|531522551|FG001|Overall Study|Ongoing|69|||
147370219|NCT00115934|531522552|FG000|Overall Study|Lost to Follow-up|1|||
147454990|NCT01415752|531827767|FG001|Maintenance (Step 2)|Did not receive treatment|0|||
147370220|NCT00115934|531522553|FG001|Overall Study|Lost to Follow-up|0|||
147370221|NCT00115934|531522552|FG000|Overall Study|Did not receive intervention|3|||
147370222|NCT00115934|531522553|FG001|Overall Study|Did not receive intervention|2|||
147370223|NCT00747565|531522554|FG000|Overall Study|Withdrawal by Subject|10|||
147370224|NCT00747565|531522555|FG001|Overall Study|Withdrawal by Subject|6|||
147370225|NCT00747565|531522554|FG000|Overall Study|Lost to Follow-up|4|||
147370226|NCT00747565|531522555|FG001|Overall Study|Lost to Follow-up|1|||
147370227|NCT04882917|531522563|FG000|Overall Study|Adverse Event|0|||
147370228|NCT04882917|531522564|FG001|Overall Study|Adverse Event|1|||
147370229|NCT04882917|531522565|FG002|Overall Study|Adverse Event|2|||
147370230|NCT04882917|531522566|FG003|Overall Study|Adverse Event|2|||
147370231|NCT04882917|531522563|FG000|Overall Study|Withdrawal by Subject|1|||
147370232|NCT04882917|531522564|FG001|Overall Study|Withdrawal by Subject|0|||
147370233|NCT04882917|531522565|FG002|Overall Study|Withdrawal by Subject|2|||
147370234|NCT04882917|531522566|FG003|Overall Study|Withdrawal by Subject|1|||
147370235|NCT04882917|531522563|FG000|Overall Study|COVID-19-related and COVID-19-non-related|1|||
147370236|NCT04882917|531522564|FG001|Overall Study|COVID-19-related and COVID-19-non-related|0|||
147370237|NCT04882917|531522565|FG002|Overall Study|COVID-19-related and COVID-19-non-related|0|||
147370238|NCT04882917|531522566|FG003|Overall Study|COVID-19-related and COVID-19-non-related|0|||
147370239|NCT00227266|531522567|FG000|Overall Study|Withdrawal by Subject|0|||
147370240|NCT00227266|531522568|FG001|Overall Study|Withdrawal by Subject|0|||
147370241|NCT00227266|531522569|FG002|Overall Study|Withdrawal by Subject|1|||
147370242|NCT00227266|531522567|FG000|Overall Study|Protocol Violation|1|||
147370243|NCT00227266|531522568|FG001|Overall Study|Protocol Violation|0|||
147370244|NCT00227266|531522569|FG002|Overall Study|Protocol Violation|1|||
147370245|NCT00227266|531522567|FG000|Overall Study|Excessive weight gain|0|||
147370246|NCT00227266|531522568|FG001|Overall Study|Excessive weight gain|0|||
147370247|NCT00227266|531522569|FG002|Overall Study|Excessive weight gain|2|||
147370248|NCT00210106|531523542|FG000|Overall Study|Death|1|||
147370249|NCT00210106|531523542|FG000|Overall Study|Protocol Violation|13|||
147610969|NCT02952586|532390885|FG000|CRT for IMRT (63 Days)|Death|5|||
147370250|NCT03876457|531523546|FG000|Overall Study|Lost to Follow-up|1|||
147370251|NCT03876457|531523547|FG001|Overall Study|Lost to Follow-up|3|||
147370252|NCT02422615|531523548|FG000|Treatment Period|Progressive disease|314|||
147370253|NCT02422615|531523549|FG001|Treatment Period|Progressive disease|200|||
147370254|NCT02422615|531523548|FG000|Treatment Period|Adverse Event|51|||
147370255|NCT02422615|531523549|FG001|Treatment Period|Adverse Event|9|||
147370256|NCT02422615|531523548|FG000|Treatment Period|Physician Decision|32|||
147370257|NCT02422615|531523549|FG001|Treatment Period|Physician Decision|8|||
147370258|NCT02422615|531523548|FG000|Treatment Period|Subject/guardian decision|38|||
147370259|NCT02422615|531523549|FG001|Treatment Period|Subject/guardian decision|8|||
147370260|NCT02422615|531523548|FG000|Treatment Period|Death|2|||
147610970|NCT02952586|532390886|FG001|CRT for IMRT (63 Days)|Death|8|||
147370261|NCT02422615|531523549|FG001|Treatment Period|Death|1|||
147370262|NCT02422615|531523548|FG000|Treatment Period|Technical problems|0|||
147370263|NCT02422615|531523549|FG001|Treatment Period|Technical problems|1|||
147370264|NCT02422615|531523548|FG000|Treatment Period|Protocol deviation|1|||
147370265|NCT02422615|531523549|FG001|Treatment Period|Protocol deviation|1|||
147370266|NCT02422615|531523548|FG000|Treatment Period|Study terminated as per protocol|46|||
147370267|NCT02422615|531523549|FG001|Treatment Period|Study terminated as per protocol|14|||
147370268|NCT02422615|531523548|FG000|Post-treatment Efficacy Follow-up|Adverse Event|1|||
147370269|NCT02422615|531523549|FG001|Post-treatment Efficacy Follow-up|Adverse Event|0|||
147370270|NCT02422615|531523548|FG000|Post-treatment Efficacy Follow-up|Death|2|||
147370271|NCT02422615|531523549|FG001|Post-treatment Efficacy Follow-up|Death|1|||
147370272|NCT02422615|531523548|FG000|Post-treatment Efficacy Follow-up|Physician Decision|0|||
147370273|NCT02422615|531523549|FG001|Post-treatment Efficacy Follow-up|Physician Decision|1|||
147370274|NCT02422615|531523548|FG000|Post-treatment Efficacy Follow-up|Progressive disease|23|||
147370275|NCT02422615|531523549|FG001|Post-treatment Efficacy Follow-up|Progressive disease|6|||
147370276|NCT02422615|531523548|FG000|Post-treatment Efficacy Follow-up|Study Terminated as per protocol|2|||
147370277|NCT02422615|531523549|FG001|Post-treatment Efficacy Follow-up|Study Terminated as per protocol|0|||
147610971|NCT02952586|532390885|FG000|CRT for IMRT (63 Days)|Adverse Event|5|||
147610972|NCT02952586|532390886|FG001|CRT for IMRT (63 Days)|Adverse Event|5|||
147370278|NCT02422615|531523548|FG000|Post-treatment Efficacy Follow-up|Subject/Guardian Decision|6|||
147370279|NCT02422615|531523549|FG001|Post-treatment Efficacy Follow-up|Subject/Guardian Decision|1|||
147370280|NCT01036724|531523550|FG000|Overall Study|Adverse Event|1|||
147454991|NCT01415752|531827768|FG002|Maintenance (Step 2)|Did not receive treatment|2|||
147370281|NCT01036724|531523551|FG001|Overall Study|Adverse Event|2|||
147370282|NCT01036724|531523550|FG000|Overall Study|Lack of Efficacy|1|||
147370283|NCT01036724|531523551|FG001|Overall Study|Lack of Efficacy|1|||
147370284|NCT01036724|531523550|FG000|Overall Study|Protocol Violation|4|||
147370285|NCT01036724|531523551|FG001|Overall Study|Protocol Violation|5|||
147454992|NCT01415752|531827769|FG003|Maintenance (Step 2)|Did not receive treatment|1|||
147370286|NCT00945321|531523553|FG000|Period 1|Adverse Event|0|||
147454993|NCT01415752|531827766|FG000|Maintenance (Step 2)|ineligible|1|||
147610973|NCT02952586|532390885|FG000|CRT for IMRT (63 Days)|Global Deterioration of Health Status|1|||
147610974|NCT02952586|532390886|FG001|CRT for IMRT (63 Days)|Global Deterioration of Health Status|0|||
147370287|NCT00945321|531523554|FG001|Period 1|Adverse Event|0|||
147370288|NCT00945321|531523555|FG002|Period 1|Adverse Event|0|||
147370289|NCT00945321|531523556|FG003|Period 1|Adverse Event|0|||
147370290|NCT00945321|531523557|FG004|Period 1|Adverse Event|1|||
147370291|NCT00945321|531523558|FG005|Period 1|Adverse Event|0|||
147370292|NCT00945321|531523553|FG000|Period 4|Lost to Follow-up|0|||
147370293|NCT00945321|531523554|FG001|Period 4|Lost to Follow-up|0|||
147370294|NCT00945321|531523555|FG002|Period 4|Lost to Follow-up|0|||
147370295|NCT00945321|531523556|FG003|Period 4|Lost to Follow-up|0|||
147370296|NCT00945321|531523557|FG004|Period 4|Lost to Follow-up|0|||
147370297|NCT00945321|531523558|FG005|Period 4|Lost to Follow-up|1|||
147370298|NCT02438137|531523559|FG000|Overall Study|Lost to Follow-up|3|||
147370299|NCT02438137|531523560|FG001|Overall Study|Lost to Follow-up|2|||
147370300|NCT02438137|531523559|FG000|Overall Study|Adverse Event|1|||
147370301|NCT02438137|531523560|FG001|Overall Study|Adverse Event|0|||
147370302|NCT02438137|531523559|FG000|Overall Study|Withdrawal by Subject|4|||
147370303|NCT02438137|531523560|FG001|Overall Study|Withdrawal by Subject|3|||
147370304|NCT02438137|531523559|FG000|Overall Study|Physician Decision|0|||
147370305|NCT02438137|531523560|FG001|Overall Study|Physician Decision|1|||
147370306|NCT04017611|531523561|FG000|Overall Study|Withdrawn prior to completion|1|||
147370307|NCT00692913|531523562|FG000|Overall Study|Adverse Event|8|||
147370308|NCT00692913|531523563|FG001|Overall Study|Adverse Event|4|||
147370309|NCT00692913|531523562|FG000|Overall Study|Lost to Follow-up|3|||
147370310|NCT00692913|531523563|FG001|Overall Study|Lost to Follow-up|5|||
147370311|NCT00692913|531523562|FG000|Overall Study|Physician Decision|2|||
147370312|NCT00692913|531523563|FG001|Overall Study|Physician Decision|0|||
147370313|NCT00692913|531523562|FG000|Overall Study|Protocol Violation|1|||
147370314|NCT00692913|531523563|FG001|Overall Study|Protocol Violation|1|||
147370315|NCT00692913|531523562|FG000|Overall Study|Withdrawal by Subject|15|||
147370316|NCT00692913|531523563|FG001|Overall Study|Withdrawal by Subject|20|||
147370317|NCT02291913|531523564|FG000|Overall Study|Progressive Disease|32|||
147370318|NCT02291913|531523564|FG000|Overall Study|Adverse Event|11|||
147370319|NCT02291913|531523564|FG000|Overall Study|Death|2|||
147370320|NCT02291913|531523564|FG000|Overall Study|Physician Decision|1|||
147370321|NCT02291913|531523564|FG000|Overall Study|Withdrawal by Subject|1|||
147370322|NCT02291913|531523564|FG000|Overall Study|Protocol Violation|1|||
147370323|NCT01637402|531523573|FG000|Standard Dose Regimen|Lack of Efficacy|2|||
147370324|NCT01637402|531523574|FG001|Standard Dose Regimen|Lack of Efficacy|0|||
147370325|NCT01637402|531523573|FG000|Standard Dose Regimen|Adverse Event|1|||
147370326|NCT01637402|531523574|FG001|Standard Dose Regimen|Adverse Event|0|||
147370327|NCT01637402|531523573|FG000|Week 12 Evaluation|Lack of Efficacy|6|||
147370328|NCT01637402|531523574|FG001|Week 12 Evaluation|Lack of Efficacy|0|||
147370329|NCT01637402|531523573|FG000|Treatment Regiments Post Week 12|Not evaluable for response after 12wks|0|||
147370330|NCT01637402|531523574|FG001|Treatment Regiments Post Week 12|Not evaluable for response after 12wks|4|||
147370331|NCT01637402|531523573|FG000|Treatment Regiments Post Week 12|Withdrawal by Subject|4|||
147370332|NCT01637402|531523574|FG001|Treatment Regiments Post Week 12|Withdrawal by Subject|0|||
147370333|NCT01637402|531523573|FG000|Treatment Regiments Post Week 12|Progression after escalation arm closed|5|||
147370334|NCT01637402|531523574|FG001|Treatment Regiments Post Week 12|Progression after escalation arm closed|0|||
147370335|NCT04876417|531523577|FG000|Overall Study|Lost to Follow-up|5|||
147370336|NCT04876417|531523578|FG001|Overall Study|Lost to Follow-up|8|||
147370337|NCT04876417|531523579|FG002|Overall Study|Lost to Follow-up|0|||
147370338|NCT04876417|531523580|FG003|Overall Study|Lost to Follow-up|0|||
147370339|NCT04868617|531523581|FG000|Overall Study|Death|1|||
147370340|NCT04868617|531523582|FG001|Overall Study|Death|0|||
147370341|NCT04868617|531523581|FG000|Overall Study|Adverse Event|1|||
147370342|NCT04868617|531523582|FG001|Overall Study|Adverse Event|0|||
147370343|NCT04868617|531523581|FG000|Overall Study|Withdrawal by Subject|1|||
147370344|NCT04868617|531523582|FG001|Overall Study|Withdrawal by Subject|0|||
147370345|NCT04868617|531523581|FG000|Overall Study|Device deficiency|1|||
147370346|NCT04868617|531523582|FG001|Overall Study|Device deficiency|0|||
147370347|NCT01342367|531523583|FG000|Overall Study|Death|1|||
147370348|NCT01342367|531523584|FG001|Overall Study|Death|0|||
147370349|NCT01342367|531523583|FG000|Overall Study|Withdrawal by Subject|1|||
147610975|NCT02952586|532390885|FG000|CRT for IMRT (63 Days)|Withdrawal by Subject|10|||
147610976|NCT02952586|532390886|FG001|CRT for IMRT (63 Days)|Withdrawal by Subject|6|||
147370350|NCT01342367|531523584|FG001|Overall Study|Withdrawal by Subject|2|||
147370351|NCT02964741|531523585|FG000|Overall Study|Protocol Violation|1|||
147370352|NCT02964741|531523586|FG001|Overall Study|Protocol Violation|0|||
147610977|NCT02952586|532390885|FG000|CRT for IMRT (63 Days)|Lost to Follow-up|1|||
147370353|NCT02964741|531523587|FG002|Overall Study|Protocol Violation|0|||
147370354|NCT02964741|531523585|FG000|Overall Study|Withdrawal by Subject|0|||
147610978|NCT02952586|532390886|FG001|CRT for IMRT (63 Days)|Lost to Follow-up|1|||
147370355|NCT02964741|531523586|FG001|Overall Study|Withdrawal by Subject|1|||
147370356|NCT02964741|531523587|FG002|Overall Study|Withdrawal by Subject|0|||
147370357|NCT02964741|531523585|FG000|Overall Study|claustrophobia|1|||
147370358|NCT02964741|531523586|FG001|Overall Study|claustrophobia|0|||
147370359|NCT02964741|531523587|FG002|Overall Study|claustrophobia|0|||
147370360|NCT01074294|531523591|FG000|Phase A (Day 1 to Week 5)|Lost to Follow-up|16|||
147370361|NCT01074294|531523592|FG001|Phase A (Day 1 to Week 5)|Lost to Follow-up|0|||
147370362|NCT01074294|531523593|FG002|Phase A (Day 1 to Week 5)|Lost to Follow-up|0|||
147370363|NCT01074294|531523594|FG003|Phase A (Day 1 to Week 5)|Lost to Follow-up|0|||
147370364|NCT01074294|531523591|FG000|Phase A (Day 1 to Week 5)|Adverse Event|51|||
147370365|NCT01074294|531523592|FG001|Phase A (Day 1 to Week 5)|Adverse Event|0|||
147370366|NCT01074294|531523593|FG002|Phase A (Day 1 to Week 5)|Adverse Event|0|||
147370367|NCT01074294|531523594|FG003|Phase A (Day 1 to Week 5)|Adverse Event|0|||
147370368|NCT01074294|531523591|FG000|Phase A (Day 1 to Week 5)|Protocol specified withdrawal criteria|47|||
147370369|NCT01074294|531523592|FG001|Phase A (Day 1 to Week 5)|Protocol specified withdrawal criteria|0|||
147370370|NCT01074294|531523593|FG002|Phase A (Day 1 to Week 5)|Protocol specified withdrawal criteria|0|||
147370371|NCT01074294|531523594|FG003|Phase A (Day 1 to Week 5)|Protocol specified withdrawal criteria|0|||
147370372|NCT01074294|531523591|FG000|Phase A (Day 1 to Week 5)|Withdrawn From Participation by the Investigator|3|||
147370373|NCT01074294|531523592|FG001|Phase A (Day 1 to Week 5)|Withdrawn From Participation by the Investigator|0|||
147370374|NCT01074294|531523593|FG002|Phase A (Day 1 to Week 5)|Withdrawn From Participation by the Investigator|0|||
147370375|NCT01074294|531523594|FG003|Phase A (Day 1 to Week 5)|Withdrawn From Participation by the Investigator|0|||
147370376|NCT01074294|531523591|FG000|Phase A (Day 1 to Week 5)|Withdrawal by Subject|32|||
147370377|NCT01074294|531523592|FG001|Phase A (Day 1 to Week 5)|Withdrawal by Subject|0|||
147370378|NCT01074294|531523593|FG002|Phase A (Day 1 to Week 5)|Withdrawal by Subject|0|||
147370379|NCT01074294|531523594|FG003|Phase A (Day 1 to Week 5)|Withdrawal by Subject|0|||
147370380|NCT01074294|531523591|FG000|Phase A (Day 1 to Week 5)|Protocol deviation|10|||
147370381|NCT01074294|531523592|FG001|Phase A (Day 1 to Week 5)|Protocol deviation|0|||
147370382|NCT01074294|531523593|FG002|Phase A (Day 1 to Week 5)|Protocol deviation|0|||
147370383|NCT01074294|531523594|FG003|Phase A (Day 1 to Week 5)|Protocol deviation|0|||
147370384|NCT01074294|531523591|FG000|Phase A (Day 1 to Week 5)|Participants not Dosed|7|||
147370385|NCT01074294|531523592|FG001|Phase A (Day 1 to Week 5)|Participants not Dosed|0|||
147370386|NCT01074294|531523593|FG002|Phase A (Day 1 to Week 5)|Participants not Dosed|0|||
147370387|NCT01074294|531523594|FG003|Phase A (Day 1 to Week 5)|Participants not Dosed|0|||
147370388|NCT01074294|531523591|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Lost to Follow-up|0|||
147370389|NCT01074294|531523592|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Lost to Follow-up|2|||
147370390|NCT01074294|531523593|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Lost to Follow-up|2|||
147370391|NCT01074294|531523594|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Lost to Follow-up|11|||
147370392|NCT01074294|531523591|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Adverse Event|0|||
147370393|NCT01074294|531523592|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Adverse Event|2|||
147370394|NCT01074294|531523593|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Adverse Event|3|||
147370395|NCT01074294|531523594|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Adverse Event|8|||
147370396|NCT01074294|531523591|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Protocol-Specified Withdrawal Criteria|0|||
147370397|NCT01074294|531523592|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Protocol-Specified Withdrawal Criteria|2|||
147370398|NCT01074294|531523593|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Protocol-Specified Withdrawal Criteria|0|||
147370399|NCT01074294|531523594|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Protocol-Specified Withdrawal Criteria|0|||
147370400|NCT01074294|531523591|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Withdrawal by Subject|0|||
147370401|NCT01074294|531523592|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Withdrawal by Subject|2|||
147370402|NCT01074294|531523593|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Withdrawal by Subject|2|||
147370403|NCT01074294|531523594|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Withdrawal by Subject|4|||
147370404|NCT01074294|531523591|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Protocol Violation|0|||
147370405|NCT01074294|531523592|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Protocol Violation|0|||
147370406|NCT01074294|531523593|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Protocol Violation|3|||
147370407|NCT01074294|531523594|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Protocol Violation|2|||
147370408|NCT01074294|531523591|FG000|Phase B and Phase A+ (Week 6 to Week 11)|Lack of Efficacy|0|||
147370409|NCT01074294|531523592|FG001|Phase B and Phase A+ (Week 6 to Week 11)|Lack of Efficacy|1|||
147370410|NCT01074294|531523593|FG002|Phase B and Phase A+ (Week 6 to Week 11)|Lack of Efficacy|0|||
147370411|NCT01074294|531523594|FG003|Phase B and Phase A+ (Week 6 to Week 11)|Lack of Efficacy|0|||
147370412|NCT00312208|531523601|FG000|Overall Study|Adverse Event|97|||
147370413|NCT00312208|531523602|FG001|Overall Study|Adverse Event|61|||
147370414|NCT00312208|531523601|FG000|Overall Study|Protocol Violation|5|||
147370415|NCT00312208|531523602|FG001|Overall Study|Protocol Violation|3|||
147370416|NCT00312208|531523601|FG000|Overall Study|Death|2|||
147610979|NCT02952586|532390885|FG000|CRT for IMRT (63 Days)|Other|1|||
147370417|NCT00312208|531523602|FG001|Overall Study|Death|1|||
147370418|NCT00312208|531523601|FG000|Overall Study|Lack of Efficacy|7|||
147370419|NCT00312208|531523602|FG001|Overall Study|Lack of Efficacy|4|||
147370420|NCT00312208|531523601|FG000|Overall Study|Lost to Follow-up|3|||
147454994|NCT01415752|531827767|FG001|Maintenance (Step 2)|ineligible|1|||
147454995|NCT01415752|531827768|FG002|Maintenance (Step 2)|ineligible|1|||
147454996|NCT01415752|531827769|FG003|Maintenance (Step 2)|ineligible|0|||
147454997|NCT01415752|531827766|FG000|Maintenance (Step 2)|Missing|4|||
147610980|NCT02952586|532390886|FG001|CRT for IMRT (63 Days)|Other|0|||
147610981|NCT02952586|532390885|FG000|Maintenance Phase (12 Months)|Death|17|||
147610982|NCT02952586|532390886|FG001|Maintenance Phase (12 Months)|Death|11|||
147610983|NCT02952586|532390885|FG000|Maintenance Phase (12 Months)|Progressive disease|60|||
147610984|NCT02952586|532390886|FG001|Maintenance Phase (12 Months)|Progressive disease|54|||
147610985|NCT02952586|532390885|FG000|Maintenance Phase (12 Months)|Adverse Event|24|||
147610986|NCT02952586|532390886|FG001|Maintenance Phase (12 Months)|Adverse Event|21|||
147610987|NCT02952586|532390885|FG000|Maintenance Phase (12 Months)|Non-compliance With Study Drug|1|||
147610988|NCT02952586|532390886|FG001|Maintenance Phase (12 Months)|Non-compliance With Study Drug|1|||
147610989|NCT02952586|532390885|FG000|Maintenance Phase (12 Months)|Physician Decision|1|||
147610990|NCT02952586|532390886|FG001|Maintenance Phase (12 Months)|Physician Decision|1|||
147610991|NCT02952586|532390885|FG000|Maintenance Phase (12 Months)|Global Deterioration of Health Status|14|||
147610992|NCT02952586|532390886|FG001|Maintenance Phase (12 Months)|Global Deterioration of Health Status|5|||
147610993|NCT02952586|532390885|FG000|Maintenance Phase (12 Months)|Withdrawal by Subject|31|||
147610994|NCT02952586|532390886|FG001|Maintenance Phase (12 Months)|Withdrawal by Subject|25|||
147610995|NCT02952586|532390885|FG000|Maintenance Phase (12 Months)|Lost to Follow-up|1|||
147610996|NCT02952586|532390886|FG001|Maintenance Phase (12 Months)|Lost to Follow-up|2|||
147610997|NCT02952586|532390885|FG000|Maintenance Phase (12 Months)|Other|2|||
147610998|NCT02952586|532390886|FG001|Maintenance Phase (12 Months)|Other|1|||
147610999|NCT02952586|532390885|FG000|Maintenance Phase (12 Months)|Study Terminated by Sponsor|1|||
147611000|NCT02952586|532390886|FG001|Maintenance Phase (12 Months)|Study Terminated by Sponsor|6|||
147611001|NCT02952586|532390885|FG000|Follow-Up Phase (90 Days)|Death|12|||
147611002|NCT02952586|532390886|FG001|Follow-Up Phase (90 Days)|Death|10|||
147611003|NCT02952586|532390885|FG000|Follow-Up Phase (90 Days)|Withdrawal by Subject|6|||
147611004|NCT02952586|532390886|FG001|Follow-Up Phase (90 Days)|Withdrawal by Subject|2|||
147370421|NCT00312208|531523602|FG001|Overall Study|Lost to Follow-up|5|||
147370422|NCT00312208|531523601|FG000|Overall Study|Withdrawal by Subject|53|||
147370423|NCT00312208|531523602|FG001|Overall Study|Withdrawal by Subject|42|||
147370424|NCT00312208|531523601|FG000|Overall Study|Other|5|||
147370425|NCT00312208|531523602|FG001|Overall Study|Other|7|||
147370426|NCT02284113|531523603|FG000|Overall Study|Adverse Event|1|||
147370427|NCT02284113|531523604|FG001|Overall Study|Adverse Event|0|||
147370428|NCT02284113|531523603|FG000|Overall Study|non-compliance|0|||
147370429|NCT02284113|531523604|FG001|Overall Study|non-compliance|1|||
147370430|NCT02284113|531523603|FG000|Overall Study|Withdrawal by Subject|0|||
147370431|NCT02284113|531523604|FG001|Overall Study|Withdrawal by Subject|1|||
147370432|NCT02284113|531523603|FG000|Overall Study|not provided|0|||
147370433|NCT02284113|531523604|FG001|Overall Study|not provided|1|||
147370434|NCT02284113|531523603|FG000|Overall Study|surgery cancelled|2|||
147370435|NCT02284113|531523604|FG001|Overall Study|surgery cancelled|0|||
147370436|NCT04191824|531523605|FG000|Overall Study|Death|13|||
147370437|NCT04191824|531523606|FG001|Overall Study|Death|12|||
147370438|NCT04191824|531523605|FG000|Overall Study|Lost to Follow-up|456|||
147370439|NCT04191824|531523606|FG001|Overall Study|Lost to Follow-up|435|||
147370440|NCT04191824|531523605|FG000|Overall Study|Physician Decision|2|||
147370441|NCT04191824|531523606|FG001|Overall Study|Physician Decision|1|||
147370442|NCT04191824|531523605|FG000|Overall Study|Protocol Violation|0|||
147370443|NCT04191824|531523606|FG001|Overall Study|Protocol Violation|2|||
147370444|NCT04191824|531523605|FG000|Overall Study|Withdrawal by Subject|16|||
147370445|NCT04191824|531523606|FG001|Overall Study|Withdrawal by Subject|18|||
147370446|NCT04191824|531523605|FG000|Overall Study|Early site closure|24|||
147370447|NCT04191824|531523606|FG001|Overall Study|Early site closure|22|||
147370448|NCT01324310|531523607|FG000|Overall Study|Adverse Event|1|||
147370449|NCT01324310|531523607|FG000|Overall Study|Disease Progression|1|||
147370450|NCT01830595|531523624|FG000|First Period|Withdrawal by Subject|1|||
147370451|NCT01830595|531523625|FG001|First Period|Withdrawal by Subject|3|||
147370452|NCT01830595|531523624|FG000|Washout|Withdrawal by Subject|2|||
147370453|NCT01830595|531523625|FG001|Washout|Withdrawal by Subject|2|||
147370454|NCT05018143|531523626|FG000|Overall Study|Lost to Follow-up|5|||
147370455|NCT05018143|531523627|FG001|Overall Study|Lost to Follow-up|4|||
147370456|NCT05018143|531523626|FG000|Overall Study|Withdrawal by Subject|0|||
147370457|NCT05018143|531523627|FG001|Overall Study|Withdrawal by Subject|1|||
147370458|NCT05116774|531523628|FG000|Part 1 (up to 24 Weeks)|Withdrawal by Subject|0|||
147370459|NCT05116774|531523629|FG001|Part 1 (up to 24 Weeks)|Withdrawal by Subject|1|||
147370460|NCT05116774|531523628|FG000|Part 1 (up to 24 Weeks)|Adverse Event|1|||
147370461|NCT05116774|531523629|FG001|Part 1 (up to 24 Weeks)|Adverse Event|0|||
147370462|NCT05116774|531523628|FG000|Part 2 (up to 52 Weeks)|Adverse Event|1|||
147370463|NCT05116774|531523629|FG001|Part 2 (up to 52 Weeks)|Adverse Event|0|||
147370464|NCT05116774|531523628|FG000|Part 2 (up to 52 Weeks)|Miscellaneous|3|||
147370465|NCT05116774|531523629|FG001|Part 2 (up to 52 Weeks)|Miscellaneous|1|||
147611005|NCT02952586|532390885|FG000|Follow-Up Phase (90 Days)|Lost to Follow-up|1|||
147611006|NCT02952586|532390886|FG001|Follow-Up Phase (90 Days)|Lost to Follow-up|1|||
147370466|NCT05601882|531523630|FG000|Period 1 (Baseline - Week 16)|Lost to Follow-up|2|||
147370467|NCT05601882|531523631|FG001|Period 1 (Baseline - Week 16)|Lost to Follow-up|0|||
147370468|NCT05601882|531523632|FG002|Period 1 (Baseline - Week 16)|Lost to Follow-up|0|||
147370469|NCT05601882|531523633|FG003|Period 1 (Baseline - Week 16)|Lost to Follow-up|0|||
147370470|NCT05601882|531523630|FG000|Period 1 (Baseline - Week 16)|Withdrawal by Subject|21|||
147370471|NCT05601882|531523631|FG001|Period 1 (Baseline - Week 16)|Withdrawal by Subject|24|||
147370472|NCT05601882|531523632|FG002|Period 1 (Baseline - Week 16)|Withdrawal by Subject|0|||
147370473|NCT05601882|531523633|FG003|Period 1 (Baseline - Week 16)|Withdrawal by Subject|0|||
147370474|NCT05601882|531523630|FG000|Period 1 (Baseline - Week 16)|Other, not specified|16|||
147370475|NCT05601882|531523631|FG001|Period 1 (Baseline - Week 16)|Other, not specified|16|||
147370476|NCT05601882|531523632|FG002|Period 1 (Baseline - Week 16)|Other, not specified|0|||
147370477|NCT05601882|531523633|FG003|Period 1 (Baseline - Week 16)|Other, not specified|0|||
147370478|NCT05601882|531523630|FG000|Period 2 (Week 16 - Week 32)|Lost to Follow-up|0|||
147370479|NCT05601882|531523631|FG001|Period 2 (Week 16 - Week 32)|Lost to Follow-up|0|||
147370480|NCT05601882|531523632|FG002|Period 2 (Week 16 - Week 32)|Lost to Follow-up|3|||
147370481|NCT05601882|531523633|FG003|Period 2 (Week 16 - Week 32)|Lost to Follow-up|1|||
147370482|NCT05601882|531523630|FG000|Period 2 (Week 16 - Week 32)|Withdrawal by Subject|0|||
147370483|NCT05601882|531523631|FG001|Period 2 (Week 16 - Week 32)|Withdrawal by Subject|0|||
147370484|NCT05601882|531523632|FG002|Period 2 (Week 16 - Week 32)|Withdrawal by Subject|3|||
147370485|NCT05601882|531523633|FG003|Period 2 (Week 16 - Week 32)|Withdrawal by Subject|4|||
147370486|NCT05601882|531523630|FG000|Period 2 (Week 16 - Week 32)|Other, not specified|0|||
147370487|NCT05601882|531523631|FG001|Period 2 (Week 16 - Week 32)|Other, not specified|0|||
147370488|NCT05601882|531523632|FG002|Period 2 (Week 16 - Week 32)|Other, not specified|4|||
147370489|NCT05601882|531523633|FG003|Period 2 (Week 16 - Week 32)|Other, not specified|11|||
147370490|NCT05464732|531523643|FG000|Overall Study|Lost to Follow-up|0|||
147370491|NCT05464732|531523644|FG001|Overall Study|Lost to Follow-up|1|||
147370492|NCT05464732|531523643|FG000|Overall Study|Adverse Event|1|||
147370493|NCT05464732|531523644|FG001|Overall Study|Adverse Event|0|||
147370494|NCT03959423|531523648|FG000|Overall Study|Withdrawal by Subject|2|||
147370495|NCT03959423|531523649|FG001|Overall Study|Withdrawal by Subject|3|||
147370496|NCT03959423|531523648|FG000|Overall Study|Physician Decision|0|||
147370497|NCT03959423|531523649|FG001|Overall Study|Physician Decision|1|||
147370498|NCT03959423|531523648|FG000|Overall Study|Lost to Follow-up|1|||
147370499|NCT03959423|531523649|FG001|Overall Study|Lost to Follow-up|0|||
147370500|NCT03959423|531523648|FG000|Overall Study|Withdrawal by Parent/Guardian|6|||
147370501|NCT03959423|531523649|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
147370502|NCT05864209|531524532|FG000|Overall Study|Lost to Follow-up|2|||
147370503|NCT05864209|531524533|FG001|Overall Study|Lost to Follow-up|3|||
147370504|NCT02722434|531524536|FG000|Overall Study|Withdrawal Prior to Beginning Treatment|1|||
147370505|NCT02722434|531524537|FG001|Overall Study|Withdrawal Prior to Beginning Treatment|0|||
147370506|NCT02722434|531524536|FG000|Overall Study|Withdrawal After Beginning Treatment|0|||
147370507|NCT02722434|531524537|FG001|Overall Study|Withdrawal After Beginning Treatment|3|||
147370508|NCT00146172|531524539|FG000|Overall Study|Adverse Event|0|||
147370509|NCT00146172|531524540|FG001|Overall Study|Adverse Event|0|||
147370510|NCT00146172|531524541|FG002|Overall Study|Adverse Event|1|||
147370511|NCT00146172|531524542|FG003|Overall Study|Adverse Event|1|||
147370512|NCT00146172|531524543|FG004|Overall Study|Adverse Event|0|||
147370513|NCT00146172|531524544|FG005|Overall Study|Adverse Event|2|||
147370514|NCT00146172|531524545|FG006|Overall Study|Adverse Event|3|||
147370515|NCT00146172|531524546|FG007|Overall Study|Adverse Event|10|||
147370516|NCT00146172|531524539|FG000|Overall Study|Lost to Follow-up|0|||
147370517|NCT00146172|531524540|FG001|Overall Study|Lost to Follow-up|0|||
147370518|NCT00146172|531524541|FG002|Overall Study|Lost to Follow-up|0|||
147611007|NCT02952586|532390885|FG000|Follow-Up Phase (90 Days)|Other|7|||
147370519|NCT00146172|531524542|FG003|Overall Study|Lost to Follow-up|0|||
147370520|NCT00146172|531524543|FG004|Overall Study|Lost to Follow-up|0|||
147370521|NCT00146172|531524544|FG005|Overall Study|Lost to Follow-up|0|||
147370522|NCT00146172|531524545|FG006|Overall Study|Lost to Follow-up|0|||
147370523|NCT00146172|531524546|FG007|Overall Study|Lost to Follow-up|1|||
147370524|NCT00146172|531524539|FG000|Overall Study|Disease Progression|2|||
147370525|NCT00146172|531524540|FG001|Overall Study|Disease Progression|4|||
147370526|NCT00146172|531524541|FG002|Overall Study|Disease Progression|2|||
147370527|NCT00146172|531524542|FG003|Overall Study|Disease Progression|5|||
147370528|NCT00146172|531524543|FG004|Overall Study|Disease Progression|2|||
147370529|NCT00146172|531524544|FG005|Overall Study|Disease Progression|2|||
147370530|NCT00146172|531524545|FG006|Overall Study|Disease Progression|1|||
147370531|NCT00146172|531524546|FG007|Overall Study|Disease Progression|22|||
147370532|NCT00146172|531524539|FG000|Overall Study|Death|0|||
147370533|NCT00146172|531524540|FG001|Overall Study|Death|0|||
147370534|NCT00146172|531524541|FG002|Overall Study|Death|0|||
147611008|NCT02952586|532390886|FG001|Follow-Up Phase (90 Days)|Other|5|||
147611009|NCT02952586|532390885|FG000|Follow-Up Phase (90 Days)|Study Terminated by Sponsor|32|||
147611010|NCT02952586|532390886|FG001|Follow-Up Phase (90 Days)|Study Terminated by Sponsor|50|||
147370535|NCT00146172|531524542|FG003|Overall Study|Death|0|||
147370536|NCT00146172|531524543|FG004|Overall Study|Death|0|||
147370537|NCT00146172|531524544|FG005|Overall Study|Death|0|||
147370538|NCT00146172|531524545|FG006|Overall Study|Death|1|||
147370539|NCT00146172|531524546|FG007|Overall Study|Death|0|||
147370540|NCT00146172|531524539|FG000|Overall Study|Physician Decision|0|||
147454998|NCT01415752|531827767|FG001|Maintenance (Step 2)|Missing|1|||
147370541|NCT00146172|531524540|FG001|Overall Study|Physician Decision|0|||
147370542|NCT00146172|531524541|FG002|Overall Study|Physician Decision|0|||
147370543|NCT00146172|531524542|FG003|Overall Study|Physician Decision|0|||
147370544|NCT00146172|531524543|FG004|Overall Study|Physician Decision|0|||
147370545|NCT00146172|531524544|FG005|Overall Study|Physician Decision|0|||
147370546|NCT00146172|531524545|FG006|Overall Study|Physician Decision|0|||
147370547|NCT00146172|531524546|FG007|Overall Study|Physician Decision|1|||
147370548|NCT00146172|531524539|FG000|Overall Study|Withdrawal by Subject|0|||
147370549|NCT00146172|531524540|FG001|Overall Study|Withdrawal by Subject|0|||
147370550|NCT00146172|531524541|FG002|Overall Study|Withdrawal by Subject|0|||
147370551|NCT00146172|531524542|FG003|Overall Study|Withdrawal by Subject|0|||
147370552|NCT00146172|531524543|FG004|Overall Study|Withdrawal by Subject|0|||
147370553|NCT00146172|531524544|FG005|Overall Study|Withdrawal by Subject|1|||
147370554|NCT00146172|531524545|FG006|Overall Study|Withdrawal by Subject|1|||
147370555|NCT00146172|531524546|FG007|Overall Study|Withdrawal by Subject|4|||
147370556|NCT00146172|531524539|FG000|Overall Study|Symptomatic Deterioration|1|||
147370557|NCT00146172|531524540|FG001|Overall Study|Symptomatic Deterioration|0|||
147370558|NCT00146172|531524541|FG002|Overall Study|Symptomatic Deterioration|1|||
147370559|NCT00146172|531524542|FG003|Overall Study|Symptomatic Deterioration|0|||
147370560|NCT00146172|531524543|FG004|Overall Study|Symptomatic Deterioration|1|||
147370561|NCT00146172|531524544|FG005|Overall Study|Symptomatic Deterioration|2|||
147370562|NCT00146172|531524545|FG006|Overall Study|Symptomatic Deterioration|0|||
147370563|NCT00146172|531524546|FG007|Overall Study|Symptomatic Deterioration|2|||
147370564|NCT00786864|531524547|FG000|Overall Study|Lost to Follow-up|0|||
147370565|NCT00786864|531524548|FG001|Overall Study|Lost to Follow-up|1|||
147370566|NCT00786864|531524547|FG000|Overall Study|Sustained serious back injury|1|||
147370567|NCT00786864|531524548|FG001|Overall Study|Sustained serious back injury|0|||
147370568|NCT01500200|531524560|FG000|Stage 1|Adverse Event|1|||
147370569|NCT01500200|531524561|FG001|Stage 1|Adverse Event|4|||
147370570|NCT01500200|531524562|FG002|Stage 1|Adverse Event|5|||
147370571|NCT01500200|531524563|FG003|Stage 1|Adverse Event|0|||
147370572|NCT01500200|531524564|FG004|Stage 1|Adverse Event|0|||
147370573|NCT01500200|531524565|FG005|Stage 1|Adverse Event|0|||
147370574|NCT01500200|531524560|FG000|Stage 1|Lost to Follow-up|2|||
147370575|NCT01500200|531524561|FG001|Stage 1|Lost to Follow-up|2|||
147370576|NCT01500200|531524562|FG002|Stage 1|Lost to Follow-up|1|||
147370577|NCT01500200|531524563|FG003|Stage 1|Lost to Follow-up|0|||
147370578|NCT01500200|531524564|FG004|Stage 1|Lost to Follow-up|0|||
147370579|NCT01500200|531524565|FG005|Stage 1|Lost to Follow-up|0|||
147370580|NCT01500200|531524560|FG000|Stage 1|Withdrawal by Subject|3|||
147370581|NCT01500200|531524561|FG001|Stage 1|Withdrawal by Subject|0|||
147370582|NCT01500200|531524562|FG002|Stage 1|Withdrawal by Subject|0|||
147370583|NCT01500200|531524563|FG003|Stage 1|Withdrawal by Subject|0|||
147370584|NCT01500200|531524564|FG004|Stage 1|Withdrawal by Subject|0|||
147370585|NCT01500200|531524565|FG005|Stage 1|Withdrawal by Subject|0|||
147370586|NCT01500200|531524560|FG000|Stage 1|Noncompliance with Study Drug|1|||
147370587|NCT01500200|531524561|FG001|Stage 1|Noncompliance with Study Drug|0|||
147370588|NCT01500200|531524562|FG002|Stage 1|Noncompliance with Study Drug|0|||
147370589|NCT01500200|531524563|FG003|Stage 1|Noncompliance with Study Drug|0|||
147370590|NCT01500200|531524564|FG004|Stage 1|Noncompliance with Study Drug|0|||
147370591|NCT01500200|531524565|FG005|Stage 1|Noncompliance with Study Drug|0|||
147370592|NCT01500200|531524560|FG000|Stage 1|Physician Decision|1|||
147370593|NCT01500200|531524561|FG001|Stage 1|Physician Decision|0|||
147370594|NCT01500200|531524562|FG002|Stage 1|Physician Decision|0|||
147370595|NCT01500200|531524563|FG003|Stage 1|Physician Decision|0|||
147370596|NCT01500200|531524564|FG004|Stage 1|Physician Decision|0|||
147370597|NCT01500200|531524565|FG005|Stage 1|Physician Decision|0|||
147370598|NCT01500200|531524560|FG000|Stage 2|Adverse Event|0|||
147370599|NCT01500200|531524561|FG001|Stage 2|Adverse Event|0|||
147370600|NCT01500200|531524562|FG002|Stage 2|Adverse Event|0|||
147370601|NCT01500200|531524563|FG003|Stage 2|Adverse Event|0|||
147370602|NCT01500200|531524564|FG004|Stage 2|Adverse Event|5|||
147370603|NCT01500200|531524565|FG005|Stage 2|Adverse Event|4|||
147370604|NCT00623194|531524566|FG000|Overall Study|Lack of Efficacy|1|||
147370605|NCT00623194|531524566|FG000|Overall Study|Protocol Violation|3|||
147370606|NCT00623194|531524566|FG000|Overall Study|Unclassified|1|||
147370607|NCT01952366|531524567|FG000|Overall Study|Death|22|||
147370608|NCT01952366|531524567|FG000|Overall Study|Withdrawal by Subject|9|||
147370609|NCT04860505|531524568|FG000|Overall Study|Lost to Follow-up|2|||
147370610|NCT00857766|531524569|FG000|Overall Study|Adverse Event|13|||
147370611|NCT00857766|531524570|FG001|Overall Study|Adverse Event|12|||
147370612|NCT00857766|531524569|FG000|Overall Study|Protocol Violation|11|||
147370613|NCT00857766|531524570|FG001|Overall Study|Protocol Violation|11|||
147370614|NCT00857766|531524569|FG000|Overall Study|Lost to Follow-up|1|||
147370615|NCT00857766|531524570|FG001|Overall Study|Lost to Follow-up|0|||
147370616|NCT00857766|531524569|FG000|Overall Study|Investigator Discretion|2|||
147370617|NCT00857766|531524570|FG001|Overall Study|Investigator Discretion|3|||
147370618|NCT00857766|531524569|FG000|Overall Study|Participant Withdrew Consent|4|||
147370619|NCT00857766|531524570|FG001|Overall Study|Participant Withdrew Consent|4|||
147370620|NCT01961609|531524571|FG000|Initiation|Missing|3|||
147370621|NCT01961609|531524572|FG001|Initiation|Missing|2|||
147370622|NCT01961609|531524573|FG002|Initiation|Missing|0|||
147370623|NCT01961609|531524574|FG003|Initiation|Missing|0|||
147370624|NCT01961609|531524571|FG000|Initiation|Protocol deviation|1|||
147370625|NCT01961609|531524572|FG001|Initiation|Protocol deviation|0|||
147370626|NCT01961609|531524573|FG002|Initiation|Protocol deviation|0|||
147370627|NCT01961609|531524574|FG003|Initiation|Protocol deviation|0|||
147370628|NCT01961609|531524571|FG000|Initiation|Death|0|||
147370629|NCT01961609|531524572|FG001|Initiation|Death|1|||
147370630|NCT01961609|531524573|FG002|Initiation|Death|0|||
147370631|NCT01961609|531524574|FG003|Initiation|Death|0|||
147370632|NCT01961609|531524571|FG000|Initiation|Administrative problems|1|||
147370633|NCT01961609|531524572|FG001|Initiation|Administrative problems|0|||
147370634|NCT01961609|531524573|FG002|Initiation|Administrative problems|0|||
147370635|NCT01961609|531524574|FG003|Initiation|Administrative problems|0|||
147370636|NCT01961609|531524571|FG000|Initiation|Withdrawal by Subject|1|||
147370637|NCT01961609|531524572|FG001|Initiation|Withdrawal by Subject|2|||
147370638|NCT01961609|531524573|FG002|Initiation|Withdrawal by Subject|0|||
147370639|NCT01961609|531524574|FG003|Initiation|Withdrawal by Subject|0|||
147370640|NCT01961609|531524571|FG000|Initiation|Lack of Efficacy|2|||
147370641|NCT01961609|531524572|FG001|Initiation|Lack of Efficacy|1|||
147370642|NCT01961609|531524573|FG002|Initiation|Lack of Efficacy|0|||
147370643|NCT01961609|531524574|FG003|Initiation|Lack of Efficacy|0|||
147370644|NCT01961609|531524571|FG000|Initiation|Abnormal lab values|0|||
147370645|NCT01961609|531524572|FG001|Initiation|Abnormal lab values|1|||
147370646|NCT01961609|531524573|FG002|Initiation|Abnormal lab values|0|||
147370647|NCT01961609|531524574|FG003|Initiation|Abnormal lab values|0|||
147370648|NCT01961609|531524571|FG000|Initiation|Adverse Event|3|||
147370649|NCT01961609|531524572|FG001|Initiation|Adverse Event|5|||
147370650|NCT01961609|531524573|FG002|Initiation|Adverse Event|0|||
147370651|NCT01961609|531524574|FG003|Initiation|Adverse Event|0|||
147370652|NCT01961609|531524571|FG000|Initiation|Randomized but not treated|1|||
147370653|NCT01961609|531524572|FG001|Initiation|Randomized but not treated|1|||
147370654|NCT01961609|531524573|FG002|Initiation|Randomized but not treated|0|||
147370655|NCT01961609|531524574|FG003|Initiation|Randomized but not treated|0|||
147370656|NCT01961609|531524571|FG000|Maintenance 1 (Weeks 17 - 48)|Reason for discontinuation is missing|1|||
147370657|NCT01961609|531524572|FG001|Maintenance 1 (Weeks 17 - 48)|Reason for discontinuation is missing|0|||
147370658|NCT01961609|531524573|FG002|Maintenance 1 (Weeks 17 - 48)|Reason for discontinuation is missing|3|||
147370659|NCT01961609|531524574|FG003|Maintenance 1 (Weeks 17 - 48)|Reason for discontinuation is missing|0|||
147370660|NCT01961609|531524571|FG000|Maintenance 1 (Weeks 17 - 48)|Protocol deviation|3|||
147370661|NCT01961609|531524572|FG001|Maintenance 1 (Weeks 17 - 48)|Protocol deviation|0|||
147370662|NCT01961609|531524573|FG002|Maintenance 1 (Weeks 17 - 48)|Protocol deviation|1|||
147370663|NCT01961609|531524574|FG003|Maintenance 1 (Weeks 17 - 48)|Protocol deviation|0|||
147370664|NCT01961609|531524571|FG000|Maintenance 1 (Weeks 17 - 48)|Withdrawal by Subject|0|||
147370665|NCT01961609|531524572|FG001|Maintenance 1 (Weeks 17 - 48)|Withdrawal by Subject|1|||
147370666|NCT01961609|531524573|FG002|Maintenance 1 (Weeks 17 - 48)|Withdrawal by Subject|1|||
147370667|NCT01961609|531524574|FG003|Maintenance 1 (Weeks 17 - 48)|Withdrawal by Subject|0|||
147370668|NCT01961609|531524571|FG000|Maintenance 1 (Weeks 17 - 48)|Lack of Efficacy|13|||
147370669|NCT01961609|531524572|FG001|Maintenance 1 (Weeks 17 - 48)|Lack of Efficacy|4|||
147370670|NCT01961609|531524573|FG002|Maintenance 1 (Weeks 17 - 48)|Lack of Efficacy|10|||
147370671|NCT01961609|531524574|FG003|Maintenance 1 (Weeks 17 - 48)|Lack of Efficacy|0|||
147370672|NCT01961609|531524571|FG000|Maintenance 1 (Weeks 17 - 48)|Adverse Event|6|||
147370673|NCT01961609|531524572|FG001|Maintenance 1 (Weeks 17 - 48)|Adverse Event|6|||
147370674|NCT01961609|531524573|FG002|Maintenance 1 (Weeks 17 - 48)|Adverse Event|3|||
147370675|NCT01961609|531524574|FG003|Maintenance 1 (Weeks 17 - 48)|Adverse Event|0|||
147370676|NCT01961609|531524571|FG000|Maintenance 1 (Weeks 17 - 48)|Abnormal laboratory value|0|||
147370677|NCT01961609|531524572|FG001|Maintenance 1 (Weeks 17 - 48)|Abnormal laboratory value|0|||
147370678|NCT01961609|531524573|FG002|Maintenance 1 (Weeks 17 - 48)|Abnormal laboratory value|1|||
147370679|NCT01961609|531524574|FG003|Maintenance 1 (Weeks 17 - 48)|Abnormal laboratory value|0|||
147370680|NCT01961609|531524571|FG000|Maintanence 2 (Weeks 49 - 72)|Reason for discontinuation is missing|7|||
147370681|NCT01961609|531524572|FG001|Maintanence 2 (Weeks 49 - 72)|Reason for discontinuation is missing|5|||
147370682|NCT01961609|531524573|FG002|Maintanence 2 (Weeks 49 - 72)|Reason for discontinuation is missing|0|||
147370683|NCT01961609|531524574|FG003|Maintanence 2 (Weeks 49 - 72)|Reason for discontinuation is missing|4|||
147611011|NCT02952586|532390885|FG000|LT Follow-up (up to 45 Months)|Death|51|||
147370684|NCT01961609|531524571|FG000|Maintanence 2 (Weeks 49 - 72)|Protocol deviation|0|||
147370685|NCT01961609|531524572|FG001|Maintanence 2 (Weeks 49 - 72)|Protocol deviation|0|||
147370686|NCT01961609|531524573|FG002|Maintanence 2 (Weeks 49 - 72)|Protocol deviation|1|||
147370687|NCT01961609|531524574|FG003|Maintanence 2 (Weeks 49 - 72)|Protocol deviation|0|||
147370688|NCT01961609|531524571|FG000|Maintanence 2 (Weeks 49 - 72)|Lost to Follow-up|1|||
147370689|NCT01961609|531524572|FG001|Maintanence 2 (Weeks 49 - 72)|Lost to Follow-up|0|||
147370690|NCT01961609|531524573|FG002|Maintanence 2 (Weeks 49 - 72)|Lost to Follow-up|0|||
147611012|NCT02952586|532390886|FG001|LT Follow-up (up to 45 Months)|Death|31|||
147370691|NCT01961609|531524574|FG003|Maintanence 2 (Weeks 49 - 72)|Lost to Follow-up|0|||
147370692|NCT01961609|531524571|FG000|Maintanence 2 (Weeks 49 - 72)|Withdrawal by Subject|0|||
147370693|NCT01961609|531524572|FG001|Maintanence 2 (Weeks 49 - 72)|Withdrawal by Subject|1|||
147370694|NCT01961609|531524573|FG002|Maintanence 2 (Weeks 49 - 72)|Withdrawal by Subject|0|||
147370695|NCT01961609|531524574|FG003|Maintanence 2 (Weeks 49 - 72)|Withdrawal by Subject|0|||
147370696|NCT01961609|531524571|FG000|Maintanence 2 (Weeks 49 - 72)|Lack of Efficacy|3|||
147370697|NCT01961609|531524572|FG001|Maintanence 2 (Weeks 49 - 72)|Lack of Efficacy|0|||
147370698|NCT01961609|531524573|FG002|Maintanence 2 (Weeks 49 - 72)|Lack of Efficacy|3|||
147370699|NCT01961609|531524574|FG003|Maintanence 2 (Weeks 49 - 72)|Lack of Efficacy|1|||
147370700|NCT01961609|531524571|FG000|Maintanence 2 (Weeks 49 - 72)|Adverse Event|1|||
147370701|NCT01961609|531524572|FG001|Maintanence 2 (Weeks 49 - 72)|Adverse Event|0|||
147370702|NCT01961609|531524573|FG002|Maintanence 2 (Weeks 49 - 72)|Adverse Event|0|||
147370703|NCT01961609|531524574|FG003|Maintanence 2 (Weeks 49 - 72)|Adverse Event|2|||
147370704|NCT01988402|531524575|FG000|Overall Study|Adverse Event|1|||
147370705|NCT01988402|531524576|FG001|Overall Study|Adverse Event|2|||
147370706|NCT01988402|531524575|FG000|Overall Study|Withdrawal by Subject|1|||
147370707|NCT01988402|531524576|FG001|Overall Study|Withdrawal by Subject|0|||
147370708|NCT01212744|531524579|FG000|Overall Study|Withdrawal by Subject|1|||
147370709|NCT02167451|531524581|FG000|Overall Study|Withdrawal by Subject|1|||
147370710|NCT00571649|531524582|FG000|Treatment Period|Adverse Event|438|||
147370711|NCT00571649|531524583|FG001|Treatment Period|Adverse Event|385|||
147370712|NCT00571649|531524582|FG000|Treatment Period|Clinical endpoint reached|50|||
147370713|NCT00571649|531524583|FG001|Treatment Period|Clinical endpoint reached|56|||
147370714|NCT00571649|531524582|FG000|Treatment Period|Withdrawal by Subject|285|||
147370715|NCT00571649|531524583|FG001|Treatment Period|Withdrawal by Subject|255|||
147370716|NCT00571649|531524582|FG000|Treatment Period|Death|76|||
147370717|NCT00571649|531524583|FG001|Treatment Period|Death|59|||
147370718|NCT00571649|531524582|FG000|Treatment Period|Physician Decision|8|||
147370719|NCT00571649|531524583|FG001|Treatment Period|Physician Decision|9|||
147370720|NCT00571649|531524582|FG000|Treatment Period|Lost to Follow-up|43|||
147370721|NCT00571649|531524583|FG001|Treatment Period|Lost to Follow-up|41|||
147370722|NCT00571649|531524582|FG000|Treatment Period|Non-compliant with study medication|88|||
147370723|NCT00571649|531524583|FG001|Treatment Period|Non-compliant with study medication|89|||
147370724|NCT00571649|531524582|FG000|Treatment Period|Patient convenience|11|||
147370725|NCT00571649|531524583|FG001|Treatment Period|Patient convenience|13|||
147370726|NCT00571649|531524582|FG000|Treatment Period|Protocol Violation|90|||
147370727|NCT00571649|531524583|FG001|Treatment Period|Protocol Violation|92|||
147370728|NCT00571649|531524582|FG000|Treatment Period|Technical problems|3|||
147370729|NCT00571649|531524583|FG001|Treatment Period|Technical problems|5|||
147370730|NCT00571649|531524582|FG000|Follow-up Period|Adverse Event|46|||
147370731|NCT00571649|531524583|FG001|Follow-up Period|Adverse Event|40|||
147370732|NCT00571649|531524582|FG000|Follow-up Period|Clinical endpoint reached|5|||
147370733|NCT00571649|531524583|FG001|Follow-up Period|Clinical endpoint reached|2|||
147370734|NCT00571649|531524582|FG000|Follow-up Period|Withdrawal by Subject|119|||
147370735|NCT00571649|531524583|FG001|Follow-up Period|Withdrawal by Subject|115|||
147370736|NCT00571649|531524582|FG000|Follow-up Period|Death|132|||
147370737|NCT00571649|531524583|FG001|Follow-up Period|Death|133|||
147370738|NCT00571649|531524582|FG000|Follow-up Period|Physician Decision|7|||
147370739|NCT00571649|531524583|FG001|Follow-up Period|Physician Decision|13|||
147370740|NCT00571649|531524582|FG000|Follow-up Period|Lost to Follow-up|95|||
147370741|NCT00571649|531524583|FG001|Follow-up Period|Lost to Follow-up|92|||
147370742|NCT00571649|531524582|FG000|Follow-up Period|Patient convenience|136|||
147370743|NCT00571649|531524583|FG001|Follow-up Period|Patient convenience|121|||
147370744|NCT00571649|531524582|FG000|Follow-up Period|Protocol Violation|5|||
147370745|NCT00571649|531524583|FG001|Follow-up Period|Protocol Violation|12|||
147370746|NCT01218659|531524584|FG000|18-Month Randomized Period|Withdrawal by Subject|2|||
147370747|NCT01218659|531524585|FG001|18-Month Randomized Period|Withdrawal by Subject|3|||
147370748|NCT01218659|531524586|FG002|18-Month Randomized Period|Withdrawal by Subject|0|||
147370749|NCT01218659|531524584|FG000|18-Month Randomized Period|Did not receive study drug|0|||
147370750|NCT01218659|531524585|FG001|18-Month Randomized Period|Did not receive study drug|3|||
147370751|NCT01218659|531524586|FG002|18-Month Randomized Period|Did not receive study drug|0|||
147370752|NCT01218659|531524584|FG000|12-Month OLE|Withdrawal by Subject|0|||
147370753|NCT01218659|531524585|FG001|12-Month OLE|Withdrawal by Subject|0|||
147370754|NCT01218659|531524586|FG002|12-Month OLE|Withdrawal by Subject|2|||
147370755|NCT01218659|531524584|FG000|12-Month OLE|Physician Decision|0|||
147370756|NCT01218659|531524585|FG001|12-Month OLE|Physician Decision|0|||
147370757|NCT01218659|531524586|FG002|12-Month OLE|Physician Decision|1|||
147370758|NCT01218659|531524584|FG000|12-Month OLE|Lost to Follow-up|0|||
147370759|NCT01218659|531524585|FG001|12-Month OLE|Lost to Follow-up|0|||
147370760|NCT01218659|531524586|FG002|12-Month OLE|Lost to Follow-up|1|||
147370761|NCT01218659|531524584|FG000|12-Month OLE|Pregnancy|0|||
147370762|NCT01218659|531524585|FG001|12-Month OLE|Pregnancy|0|||
147370763|NCT01218659|531524586|FG002|12-Month OLE|Pregnancy|1|||
147370764|NCT01218659|531524584|FG000|12-Month OLE|Lack of Efficacy|0|||
147370765|NCT01218659|531524585|FG001|12-Month OLE|Lack of Efficacy|0|||
147663622|NCT05616013|532591566|FG001|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|0|||
147663623|NCT05616013|532591567|FG002|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|0|||
147663624|NCT05616013|532591568|FG003|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|0|||
147663625|NCT05616013|532591569|FG004|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|0|||
147663626|NCT05616013|532591570|FG005|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|0|||
147663627|NCT05616013|532591571|FG006|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|0|||
147663628|NCT05616013|532591572|FG007|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|0|||
147663629|NCT05616013|532591573|FG008|Overall Study|Difficulty Attending Visits due to Personal/work Commitments|0|||
147663630|NCT05616013|532591565|FG000|Overall Study|Participant Withdrawal due to use of Restricted Medication|1|||
147663631|NCT05616013|532591566|FG001|Overall Study|Participant Withdrawal due to use of Restricted Medication|0|||
147663632|NCT05616013|532591567|FG002|Overall Study|Participant Withdrawal due to use of Restricted Medication|0|||
147663633|NCT05616013|532591568|FG003|Overall Study|Participant Withdrawal due to use of Restricted Medication|0|||
147663634|NCT05616013|532591569|FG004|Overall Study|Participant Withdrawal due to use of Restricted Medication|0|||
147663635|NCT05616013|532591570|FG005|Overall Study|Participant Withdrawal due to use of Restricted Medication|0|||
147663636|NCT05616013|532591571|FG006|Overall Study|Participant Withdrawal due to use of Restricted Medication|0|||
147663637|NCT05616013|532591572|FG007|Overall Study|Participant Withdrawal due to use of Restricted Medication|0|||
147663638|NCT05616013|532591573|FG008|Overall Study|Participant Withdrawal due to use of Restricted Medication|0|||
147370766|NCT01218659|531524586|FG002|12-Month OLE|Lack of Efficacy|1|||
147370767|NCT01218659|531524584|FG000|12-Month OLE|Declined to participate in the OLE|0|||
147370768|NCT01218659|531524585|FG001|12-Month OLE|Declined to participate in the OLE|0|||
147370769|NCT01218659|531524586|FG002|12-Month OLE|Declined to participate in the OLE|4|||
147370770|NCT00811941|531524587|FG000|All Randomised Patients|Did not receive placebo/nalmefene|2|||
147370771|NCT00811941|531524588|FG001|All Randomised Patients|Did not receive placebo/nalmefene|8|||
147370772|NCT00811941|531524587|FG000|All Treated Patients|Adverse Event|2|||
147370773|NCT00811941|531524588|FG001|All Treated Patients|Adverse Event|43|||
147370774|NCT00811941|531524587|FG000|All Treated Patients|Lack of Efficacy|2|||
147370775|NCT00811941|531524588|FG001|All Treated Patients|Lack of Efficacy|3|||
147370776|NCT00811941|531524587|FG000|All Treated Patients|Non-compliance|1|||
147370777|NCT00811941|531524588|FG001|All Treated Patients|Non-compliance|8|||
147370778|NCT00811941|531524587|FG000|All Treated Patients|Protocol Violation|5|||
147370779|NCT00811941|531524588|FG001|All Treated Patients|Protocol Violation|17|||
147370780|NCT00811941|531524587|FG000|All Treated Patients|Withdrawal by Subject|35|||
147370781|NCT00811941|531524588|FG001|All Treated Patients|Withdrawal by Subject|94|||
147370782|NCT00811941|531524587|FG000|All Treated Patients|Lost to Follow-up|3|||
147370783|NCT00811941|531524588|FG001|All Treated Patients|Lost to Follow-up|12|||
147370784|NCT00811941|531524587|FG000|All Treated Patients|Other Reason|4|||
147370785|NCT00811941|531524588|FG001|All Treated Patients|Other Reason|14|||
147370786|NCT03885232|531524589|FG000|Overall Study|Lost to Follow-up|74|||
147370787|NCT03885232|531524590|FG001|Overall Study|Lost to Follow-up|32|||
147370788|NCT03885232|531524589|FG000|Overall Study|Staff turnover at enrolled clinics|32|||
147370789|NCT03885232|531524590|FG001|Overall Study|Staff turnover at enrolled clinics|23|||
147370790|NCT02397096|531524591|FG000|Day 1 to Week 24|Adverse Event|7|||
147370791|NCT02397096|531524592|FG001|Day 1 to Week 24|Adverse Event|1|||
147370792|NCT02397096|531524591|FG000|Day 1 to Week 24|Death|1|||
147370793|NCT02397096|531524592|FG001|Day 1 to Week 24|Death|0|||
147370794|NCT02397096|531524591|FG000|Day 1 to Week 24|Lack of Efficacy|0|||
147370795|NCT02397096|531524592|FG001|Day 1 to Week 24|Lack of Efficacy|1|||
147370796|NCT02397096|531524591|FG000|Day 1 to Week 24|Lost to Follow-up|3|||
147370797|NCT02397096|531524592|FG001|Day 1 to Week 24|Lost to Follow-up|4|||
147370798|NCT02397096|531524591|FG000|Day 1 to Week 24|Physician Decision|2|||
147370799|NCT02397096|531524592|FG001|Day 1 to Week 24|Physician Decision|3|||
147370800|NCT02397096|531524591|FG000|Day 1 to Week 24|Protocol Violation|1|||
147370801|NCT02397096|531524592|FG001|Day 1 to Week 24|Protocol Violation|4|||
147370802|NCT02397096|531524591|FG000|Day 1 to Week 24|Withdrawal by Subject|6|||
147370803|NCT02397096|531524592|FG001|Day 1 to Week 24|Withdrawal by Subject|1|||
147370804|NCT02397096|531524591|FG000|Day 1 to Week 24|Randomized, not treated|3|||
147370805|NCT02397096|531524592|FG001|Day 1 to Week 24|Randomized, not treated|0|||
147370806|NCT02397096|531524591|FG000|Week 24 to Week 48|Adverse Event|6|||
147370807|NCT02397096|531524592|FG001|Week 24 to Week 48|Adverse Event|2|||
147370808|NCT02397096|531524591|FG000|Week 24 to Week 48|Lack of Efficacy|5|||
147370809|NCT02397096|531524592|FG001|Week 24 to Week 48|Lack of Efficacy|1|||
147370810|NCT02397096|531524591|FG000|Week 24 to Week 48|Non-Compliance With Study Drug|0|||
147663639|NCT05616013|532591565|FG000|Overall Study|Participant Cannot Continue study due to Work Commitments|0|||
147663640|NCT05616013|532591566|FG001|Overall Study|Participant Cannot Continue study due to Work Commitments|1|||
147370811|NCT02397096|531524592|FG001|Week 24 to Week 48|Non-Compliance With Study Drug|1|||
147370812|NCT02397096|531524591|FG000|Week 24 to Week 48|Physician Decision|2|||
147370813|NCT02397096|531524592|FG001|Week 24 to Week 48|Physician Decision|1|||
147370814|NCT02397096|531524591|FG000|Week 24 to Week 48|Withdrawal by Subject|5|||
147370815|NCT02397096|531524592|FG001|Week 24 to Week 48|Withdrawal by Subject|2|||
147370816|NCT02397096|531524591|FG000|Week 24 to Week 48|Lost to Follow-up|2|||
147370817|NCT02397096|531524592|FG001|Week 24 to Week 48|Lost to Follow-up|0|||
147370818|NCT02397096|531524591|FG000|Study Extension 1|Adverse Event|7|||
147370819|NCT02397096|531524592|FG001|Study Extension 1|Adverse Event|5|||
147370820|NCT02397096|531524591|FG000|Study Extension 1|Death|1|||
147370821|NCT02397096|531524592|FG001|Study Extension 1|Death|0|||
147370822|NCT02397096|531524591|FG000|Study Extension 1|Lack of Efficacy|2|||
147370823|NCT02397096|531524592|FG001|Study Extension 1|Lack of Efficacy|5|||
147370824|NCT02397096|531524591|FG000|Study Extension 1|Lost to Follow-up|2|||
147370825|NCT02397096|531524592|FG001|Study Extension 1|Lost to Follow-up|3|||
147370826|NCT02397096|531524591|FG000|Study Extension 1|Non-compliance with study drug|3|||
147370827|NCT02397096|531524592|FG001|Study Extension 1|Non-compliance with study drug|0|||
147370828|NCT02397096|531524591|FG000|Study Extension 1|Physician Decision|4|||
147370829|NCT02397096|531524592|FG001|Study Extension 1|Physician Decision|2|||
147370830|NCT02397096|531524591|FG000|Study Extension 1|Pregnancy|1|||
147370831|NCT02397096|531524592|FG001|Study Extension 1|Pregnancy|0|||
147370832|NCT02397096|531524591|FG000|Study Extension 1|Protocol Violation|0|||
147370833|NCT02397096|531524592|FG001|Study Extension 1|Protocol Violation|1|||
147370834|NCT02397096|531524591|FG000|Study Extension 1|Withdrawal by Subject|21|||
147370835|NCT02397096|531524592|FG001|Study Extension 1|Withdrawal by Subject|7|||
147370836|NCT02397096|531524591|FG000|Study Extension 2|Adverse Event|3|||
147370837|NCT02397096|531524592|FG001|Study Extension 2|Adverse Event|3|||
147370838|NCT02397096|531524591|FG000|Study Extension 2|Availability of study medication locally|152|||
147370839|NCT02397096|531524592|FG001|Study Extension 2|Availability of study medication locally|64|||
147370840|NCT02397096|531524591|FG000|Study Extension 2|Death|2|||
147370841|NCT02397096|531524592|FG001|Study Extension 2|Death|0|||
147370842|NCT02397096|531524591|FG000|Study Extension 2|Lack of Efficacy|1|||
147370843|NCT02397096|531524592|FG001|Study Extension 2|Lack of Efficacy|0|||
147370844|NCT02397096|531524591|FG000|Study Extension 2|Lost to Follow-up|2|||
147370845|NCT02397096|531524592|FG001|Study Extension 2|Lost to Follow-up|1|||
147370846|NCT02397096|531524591|FG000|Study Extension 2|Non-compliance with study drug|1|||
147370847|NCT02397096|531524592|FG001|Study Extension 2|Non-compliance with study drug|0|||
147370848|NCT02397096|531524591|FG000|Study Extension 2|Physician Decision|2|||
147370849|NCT02397096|531524592|FG001|Study Extension 2|Physician Decision|5|||
147370850|NCT02397096|531524591|FG000|Study Extension 2|Pregnancy|1|||
147370851|NCT02397096|531524592|FG001|Study Extension 2|Pregnancy|0|||
147370852|NCT02397096|531524591|FG000|Study Extension 2|Withdrawal by Subject|10|||
147370853|NCT02397096|531524592|FG001|Study Extension 2|Withdrawal by Subject|3|||
147370854|NCT02397096|531524591|FG000|Study Extension 3|Adverse Event|1|||
147370855|NCT02397096|531524592|FG001|Study Extension 3|Adverse Event|0|||
147370856|NCT02397096|531524591|FG000|Study Extension 3|Availability of study medication locally|11|||
147370857|NCT02397096|531524592|FG001|Study Extension 3|Availability of study medication locally|3|||
147370858|NCT02397096|531524591|FG000|Study Extension 3|Lost to Follow-up|1|||
147370859|NCT02397096|531524592|FG001|Study Extension 3|Lost to Follow-up|0|||
147370860|NCT02397096|531524591|FG000|Study Extension 3|Withdrawal by Subject|2|||
147370861|NCT02397096|531524592|FG001|Study Extension 3|Withdrawal by Subject|1|||
147370862|NCT03840902|531524593|FG000|Overall Study|Randomized but not treated|1|||
147370863|NCT03840902|531524594|FG001|Overall Study|Randomized but not treated|1|||
147370864|NCT06688357|531524598|FG000|Overall Study|Adverse Event|0|||
147370865|NCT06688357|531524599|FG001|Overall Study|Adverse Event|1|||
147370866|NCT03222609|531524602|FG000|Overall Study|Withdrew consent|2|||
147370867|NCT03222609|531524603|FG001|Overall Study|Withdrew consent|3|||
147370868|NCT03222609|531524604|FG002|Overall Study|Withdrew consent|4|||
147370869|NCT03222609|531524605|FG003|Overall Study|Withdrew consent|2|||
147370870|NCT03222609|531524602|FG000|Overall Study|Lost to Follow-up|1|||
147370871|NCT03222609|531524603|FG001|Overall Study|Lost to Follow-up|0|||
147370872|NCT03222609|531524604|FG002|Overall Study|Lost to Follow-up|0|||
147370873|NCT03222609|531524605|FG003|Overall Study|Lost to Follow-up|0|||
147370874|NCT03222609|531524602|FG000|Overall Study|Death|16|||
147370875|NCT03222609|531524603|FG001|Overall Study|Death|13|||
147454999|NCT01415752|531827768|FG002|Maintenance (Step 2)|Missing|4|||
147370876|NCT03222609|531524604|FG002|Overall Study|Death|9|||
147370877|NCT03222609|531524605|FG003|Overall Study|Death|6|||
147370878|NCT03222609|531524602|FG000|Overall Study|Remains on treatment or in study follow-up|15|||
147455000|NCT01415752|531827769|FG003|Maintenance (Step 2)|Missing|3|||
147455001|NCT01562548|531827772|FG000|Overall Study|Lost to Follow-up|0|||
147455002|NCT01562548|531827773|FG001|Overall Study|Lost to Follow-up|0|||
147370879|NCT03222609|531524603|FG001|Overall Study|Remains on treatment or in study follow-up|75|||
147370880|NCT03222609|531524604|FG002|Overall Study|Remains on treatment or in study follow-up|21|||
147370881|NCT03222609|531524605|FG003|Overall Study|Remains on treatment or in study follow-up|24|||
147455003|NCT01562548|531827774|FG002|Overall Study|Lost to Follow-up|1|||
147455004|NCT01562548|531827775|FG003|Overall Study|Lost to Follow-up|0|||
147370882|NCT05139992|531524606|FG000|Overall Study|Withdrawal by Subject|12|||
147370883|NCT05139992|531524606|FG000|Overall Study|Lost to Follow-up|6|||
147370884|NCT03834740|531524607|FG000|Ribo 600mg QD+Eve 70mg Once|Physician Decision|0|||
147370885|NCT03834740|531524608|FG001|Ribo 600mg QD+Eve 70mg Once|Physician Decision|1|||
147370886|NCT03834740|531524609|FG002|Ribo 600mg QD+Eve 70mg Once|Physician Decision|0|||
147370887|NCT03593226|531524610|FG000|Overall Study|Disease progression|6|||
147370888|NCT03593226|531524611|FG001|Overall Study|Disease progression|13|||
147370889|NCT03593226|531524612|FG002|Overall Study|Disease progression|5|||
147370890|NCT03593226|531524613|FG003|Overall Study|Disease progression|6|||
147370891|NCT03593226|531524610|FG000|Overall Study|Adverse Event|0|||
147370892|NCT03593226|531524611|FG001|Overall Study|Adverse Event|1|||
147370893|NCT03593226|531524612|FG002|Overall Study|Adverse Event|0|||
147370894|NCT03593226|531524613|FG003|Overall Study|Adverse Event|0|||
147370895|NCT03593226|531524610|FG000|Overall Study|Withdrawal by Subject|0|||
147370896|NCT03593226|531524611|FG001|Overall Study|Withdrawal by Subject|4|||
147370897|NCT03593226|531524612|FG002|Overall Study|Withdrawal by Subject|1|||
147370898|NCT03593226|531524613|FG003|Overall Study|Withdrawal by Subject|0|||
147370899|NCT03593226|531524610|FG000|Overall Study|Physician Decision|0|||
147370900|NCT03593226|531524611|FG001|Overall Study|Physician Decision|1|||
147370901|NCT03593226|531524612|FG002|Overall Study|Physician Decision|0|||
147370902|NCT03593226|531524613|FG003|Overall Study|Physician Decision|0|||
147370903|NCT03593226|531524610|FG000|Overall Study|Clinical disease progression|0|||
147370904|NCT03593226|531524611|FG001|Overall Study|Clinical disease progression|0|||
147370905|NCT03593226|531524612|FG002|Overall Study|Clinical disease progression|1|||
147370906|NCT03593226|531524613|FG003|Overall Study|Clinical disease progression|0|||
147370907|NCT03891758|531524614|FG000|Overall Study|Adverse Event|2|||
147370908|NCT03891758|531524615|FG001|Overall Study|Adverse Event|0|||
147370909|NCT03891758|531524614|FG000|Overall Study|Withdrawal by parent/guardian|0|||
147370910|NCT03891758|531524615|FG001|Overall Study|Withdrawal by parent/guardian|2|||
147370911|NCT03777657|531524616|FG000|Overall Study|Death|397|||
147370912|NCT03777657|531524617|FG001|Overall Study|Death|431|||
147370913|NCT03777657|531524616|FG000|Overall Study|Study Closed by Sponsor|77|||
147370914|NCT03777657|531524617|FG001|Overall Study|Study Closed by Sponsor|38|||
147370915|NCT03777657|531524616|FG000|Overall Study|Withdrawal by Subject|20|||
147370916|NCT03777657|531524617|FG001|Overall Study|Withdrawal by Subject|17|||
147370917|NCT03777657|531524616|FG000|Overall Study|Lost to Follow-up|6|||
147370918|NCT03777657|531524617|FG001|Overall Study|Lost to Follow-up|10|||
147370919|NCT03789110|531524618|FG000|Overall Study|Adverse Event|2|||
147370920|NCT03789110|531524618|FG000|Overall Study|Physician Decision|1|||
147370921|NCT03789110|531524618|FG000|Overall Study|Withdrawal by Subject|2|||
147370922|NCT03789110|531524618|FG000|Overall Study|Lack of Efficacy|22|||
147370923|NCT03789110|531524618|FG000|Overall Study|still on treatment|3|||
147370924|NCT03691493|531524619|FG000|Overall Study|Withdrawal by Subject|1|||
147370925|NCT02678689|531524621|FG000|Overall Study|Participant chose to receive commercial drug in their home country|1|||
147370926|NCT02678689|531524622|FG001|Overall Study|Participant chose to receive commercial drug in their home country|0|||
147370927|NCT02549352|531524623|FG000|3-day Treatment and 8-week Follow-up|Adverse Event|0|||
147370928|NCT02549352|531524624|FG001|3-day Treatment and 8-week Follow-up|Adverse Event|1|||
147370929|NCT02549352|531524623|FG000|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|2|||
147370930|NCT02549352|531524624|FG001|3-day Treatment and 8-week Follow-up|Withdrawal by Subject|3|||
147370931|NCT02549352|531524623|FG000|3-day Treatment and 8-week Follow-up|Other|0|||
147370932|NCT02549352|531524624|FG001|3-day Treatment and 8-week Follow-up|Other|2|||
147370933|NCT02549352|531524623|FG000|12-month Follow-up|Withdrawal by Subject|4|||
147370934|NCT02549352|531524624|FG001|12-month Follow-up|Withdrawal by Subject|5|||
147370935|NCT02549352|531524623|FG000|12-month Follow-up|Lost to Follow-up|3|||
147370936|NCT02549352|531524624|FG001|12-month Follow-up|Lost to Follow-up|2|||
147370937|NCT02549352|531524623|FG000|12-month Follow-up|Death|0|||
147370938|NCT02549352|531524624|FG001|12-month Follow-up|Death|1|||
147370939|NCT02549352|531524623|FG000|12-month Follow-up|Protocol Violation|0|||
147370940|NCT02549352|531524624|FG001|12-month Follow-up|Protocol Violation|1|||
147370941|NCT02549352|531524623|FG000|12-month Follow-up|Other|1|||
147370942|NCT02549352|531524624|FG001|12-month Follow-up|Other|3|||
147370943|NCT05704725|531524625|FG000|Overall Study|Lost to Follow-up|0|||
147370944|NCT05704725|531524626|FG001|Overall Study|Lost to Follow-up|1|||
147370945|NCT05704725|531524625|FG000|Overall Study|Withdrawal by Subject|1|||
147370946|NCT05704725|531524626|FG001|Overall Study|Withdrawal by Subject|0|||
147370947|NCT01470144|531524627|FG000|Overall Study|Adverse Event|2|||
147370948|NCT01470144|531524627|FG000|Overall Study|Death|1|||
147370949|NCT01470144|531524627|FG000|Overall Study|Lung transplant|6|||
147370950|NCT01470144|531524627|FG000|Overall Study|Patient's and investigator's decision|1|||
147370951|NCT00593840|531524628|FG000|Overall Study|Withdrawal by Subject|1|||
147370952|NCT04503681|531525764|FG000|Overall Study|Subjects did not complete outcome questionnaire|5|||
147370953|NCT04503681|531525765|FG001|Overall Study|Subjects did not complete outcome questionnaire|7|||
147370954|NCT03752684|531525766|FG000|Overall Study|Lost to Follow-up|4|||
147370955|NCT03352713|531525769|FG000|Overall Study|Lost to Follow-up|8|||
147370956|NCT03352713|531525769|FG000|Overall Study|Withdrawn by investigator|5|||
147370957|NCT03352713|531525769|FG000|Overall Study|Completed 0 EMAs|8|||
147370958|NCT03352713|531525769|FG000|Overall Study|Device incompatible/stolen|5|||
147370959|NCT01812759|531525770|FG000|Overall Study|Physician Decision|0|||
147370960|NCT01812759|531525771|FG001|Overall Study|Physician Decision|0|||
147370961|NCT01812759|531525772|FG002|Overall Study|Physician Decision|1|||
147370962|NCT00536120|531525773|FG000|Overall Study|Lost to Follow-up|1|||
147370963|NCT00536120|531525774|FG001|Overall Study|Lost to Follow-up|0|||
147370964|NCT00536120|531525773|FG000|Overall Study|Positive for Anti-natalizumab Antibodies|3|||
147370965|NCT00536120|531525774|FG001|Overall Study|Positive for Anti-natalizumab Antibodies|0|||
147370966|NCT00536120|531525773|FG000|Overall Study|Non-compliance|1|||
147370967|NCT00536120|531525774|FG001|Overall Study|Non-compliance|0|||
147370968|NCT00536120|531525773|FG000|Overall Study|Sponsor Decision Due to Lab Values|1|||
147370969|NCT00536120|531525774|FG001|Overall Study|Sponsor Decision Due to Lab Values|0|||
147370970|NCT00536120|531525773|FG000|Overall Study|Steroid Use|0|||
147370971|NCT00536120|531525774|FG001|Overall Study|Steroid Use|2|||
147370972|NCT00536120|531525773|FG000|Overall Study|Missed Study Visit|0|||
147370973|NCT00536120|531525774|FG001|Overall Study|Missed Study Visit|1|||
147370974|NCT04559698|531525775|FG000|Overall Study|Lost to Follow-up|14|||
147370975|NCT04559698|531525776|FG001|Overall Study|Lost to Follow-up|15|||
147370976|NCT04559698|531525775|FG000|Overall Study|Withdrawal by Subject|0|||
147370977|NCT04559698|531525776|FG001|Overall Study|Withdrawal by Subject|1|||
147370978|NCT03437733|531525777|FG000|Overall Study|Eligibility criteria not met|0|||
147370979|NCT03437733|531525778|FG001|Overall Study|Eligibility criteria not met|3|||
147370980|NCT01982682|531525779|FG000|Overall Study|Physician Decision|1|||
147370981|NCT02760654|531525780|FG000|Overall Study|Lost to Follow-up|3|||
147370982|NCT02760654|531525781|FG001|Overall Study|Lost to Follow-up|3|||
147370983|NCT02760654|531525780|FG000|Overall Study|Withdrawal by Subject|4|||
147370984|NCT02760654|531525781|FG001|Overall Study|Withdrawal by Subject|3|||
147370985|NCT01184326|531525782|FG000|Overall Study|Adverse Event|1|||
147370986|NCT01184326|531525783|FG001|Overall Study|Adverse Event|2|||
147370987|NCT01184326|531525784|FG002|Overall Study|Adverse Event|0|||
147370988|NCT01184326|531525782|FG000|Overall Study|Death|0|||
147370989|NCT01184326|531525783|FG001|Overall Study|Death|0|||
147370990|NCT01184326|531525784|FG002|Overall Study|Death|1|||
147370991|NCT01184326|531525782|FG000|Overall Study|Withdrawal by Subject|0|||
147370992|NCT01184326|531525783|FG001|Overall Study|Withdrawal by Subject|0|||
147370993|NCT01184326|531525784|FG002|Overall Study|Withdrawal by Subject|1|||
147370994|NCT01184326|531525782|FG000|Overall Study|Physician Decision|1|||
147370995|NCT01184326|531525783|FG001|Overall Study|Physician Decision|1|||
147370996|NCT01184326|531525784|FG002|Overall Study|Physician Decision|0|||
147370997|NCT01184326|531525782|FG000|Overall Study|Disease Progression|1|||
147370998|NCT01184326|531525783|FG001|Overall Study|Disease Progression|3|||
147370999|NCT01184326|531525784|FG002|Overall Study|Disease Progression|12|||
147371000|NCT01084694|531525785|FG000|Overall Study|Withdrawal by Subject|2|||
147371001|NCT01084694|531525786|FG001|Overall Study|Withdrawal by Subject|1|||
147371002|NCT01084694|531525785|FG000|Overall Study|Death|2|||
147371003|NCT01084694|531525786|FG001|Overall Study|Death|12|||
147371004|NCT01084694|531525785|FG000|Overall Study|eligibility not maintained|2|||
147371005|NCT01084694|531525786|FG001|Overall Study|eligibility not maintained|7|||
147371006|NCT00605306|531525787|FG000|Overall Study|Adverse Event|0|||
147371007|NCT00605306|531525788|FG001|Overall Study|Adverse Event|1|||
147371008|NCT01750684|531525789|FG000|Overall Study|Death|1|||
147371009|NCT01750684|531525790|FG001|Overall Study|Death|0|||
147371010|NCT01750684|531525789|FG000|Overall Study|Non-compliance with Study Drug|0|||
147371011|NCT01750684|531525790|FG001|Overall Study|Non-compliance with Study Drug|1|||
147371012|NCT01750684|531525789|FG000|Overall Study|Withdrawn by Sponsor|0|||
147371013|NCT01750684|531525790|FG001|Overall Study|Withdrawn by Sponsor|1|||
147371014|NCT01750684|531525789|FG000|Overall Study|Protocol Violation|1|||
147371015|NCT01750684|531525790|FG001|Overall Study|Protocol Violation|0|||
147371016|NCT02185794|531525793|FG000|Overall Study|Enrolled but Never Dosed|1|||
147371017|NCT02185794|531525794|FG001|Overall Study|Enrolled but Never Dosed|6|||
147371018|NCT02185794|531525795|FG002|Overall Study|Enrolled but Never Dosed|3|||
147371019|NCT02185794|531525796|FG003|Overall Study|Enrolled but Never Dosed|1|||
147611013|NCT02952586|532390885|FG000|LT Follow-up (up to 45 Months)|Withdrawal by Subject|7|||
147611014|NCT02952586|532390886|FG001|LT Follow-up (up to 45 Months)|Withdrawal by Subject|1|||
147611015|NCT02952586|532390885|FG000|LT Follow-up (up to 45 Months)|Lost to Follow-up|2|||
147611016|NCT02952586|532390886|FG001|LT Follow-up (up to 45 Months)|Lost to Follow-up|4|||
147611017|NCT02952586|532390885|FG000|LT Follow-up (up to 45 Months)|Study Terminated by Sponsor|187|||
147611018|NCT02952586|532390886|FG001|LT Follow-up (up to 45 Months)|Study Terminated by Sponsor|201|||
147611019|NCT04414618|532390891|FG000|Overall Study|Death|3|||
147611020|NCT04414618|532390892|FG001|Overall Study|Death|3|||
147611021|NCT04414618|532390891|FG000|Overall Study|Withdrawal by Subject|2|||
147611022|NCT04414618|532390892|FG001|Overall Study|Withdrawal by Subject|1|||
147611023|NCT04414618|532390891|FG000|Overall Study|Lost to Follow-up|2|||
147371020|NCT02185794|531525797|FG004|Overall Study|Enrolled but Never Dosed|1|||
147371021|NCT02185794|531525798|FG005|Overall Study|Enrolled but Never Dosed|0|||
147371022|NCT02185794|531525793|FG000|Overall Study|Investigator's Discretion|1|||
147371023|NCT02185794|531525794|FG001|Overall Study|Investigator's Discretion|0|||
147371024|NCT02185794|531525795|FG002|Overall Study|Investigator's Discretion|1|||
147611024|NCT04414618|532390892|FG001|Overall Study|Lost to Follow-up|3|||
147611025|NCT04414618|532390891|FG000|Overall Study|Physician Decision|1|||
147455005|NCT01285908|531827776|FG000|Baseline Measurement|unable to insert catheter|1|||
147371025|NCT02185794|531525796|FG003|Overall Study|Investigator's Discretion|2|||
147371026|NCT02185794|531525797|FG004|Overall Study|Investigator's Discretion|2|||
147371027|NCT02185794|531525798|FG005|Overall Study|Investigator's Discretion|15|||
147371028|NCT02185794|531525793|FG000|Overall Study|Withdrew Consent|2|||
147371029|NCT02185794|531525794|FG001|Overall Study|Withdrew Consent|5|||
147371030|NCT02185794|531525795|FG002|Overall Study|Withdrew Consent|10|||
147371031|NCT02185794|531525796|FG003|Overall Study|Withdrew Consent|2|||
147371032|NCT02185794|531525797|FG004|Overall Study|Withdrew Consent|0|||
147371033|NCT02185794|531525798|FG005|Overall Study|Withdrew Consent|0|||
147371034|NCT02185794|531525793|FG000|Overall Study|Lost to Follow-up|1|||
147371035|NCT02185794|531525794|FG001|Overall Study|Lost to Follow-up|2|||
147371036|NCT02185794|531525795|FG002|Overall Study|Lost to Follow-up|2|||
147371037|NCT02185794|531525796|FG003|Overall Study|Lost to Follow-up|3|||
147371038|NCT02185794|531525797|FG004|Overall Study|Lost to Follow-up|0|||
147371039|NCT02185794|531525798|FG005|Overall Study|Lost to Follow-up|1|||
147371040|NCT00336505|531525799|FG000|Overall Study|Adverse Event|10|||
147371041|NCT00336505|531525800|FG001|Overall Study|Adverse Event|9|||
147371042|NCT00336505|531525799|FG000|Overall Study|Lack of Efficacy|8|||
147371043|NCT00336505|531525800|FG001|Overall Study|Lack of Efficacy|4|||
147371044|NCT00336505|531525799|FG000|Overall Study|Lost to Follow-up|7|||
147455006|NCT01285908|531827777|FG001|Baseline Measurement|unable to insert catheter|0|||
147455007|NCT01285908|531827778|FG002|Baseline Measurement|unable to insert catheter|0|||
147455008|NCT01285908|531827776|FG000|Baseline Measurement|History of stroke, exclusion criteria|1|||
147455009|NCT01285908|531827777|FG001|Baseline Measurement|History of stroke, exclusion criteria|0|||
147455010|NCT01285908|531827778|FG002|Baseline Measurement|History of stroke, exclusion criteria|0|||
147455011|NCT01285908|531827776|FG000|Baseline Measurement|unable to tolerate procedure|1|||
147455012|NCT01285908|531827777|FG001|Baseline Measurement|unable to tolerate procedure|0|||
147455013|NCT01285908|531827778|FG002|Baseline Measurement|unable to tolerate procedure|0|||
147455014|NCT01239160|531827779|FG000|Overall Study|Lost to Follow-up|3|||
147455015|NCT01239160|531827780|FG001|Overall Study|Lost to Follow-up|5|||
147455016|NCT01239160|531827781|FG002|Overall Study|Lost to Follow-up|0|||
147455017|NCT01239160|531827779|FG000|Overall Study|Withdrawal by Subject|17|||
147455018|NCT01239160|531827780|FG001|Overall Study|Withdrawal by Subject|6|||
147455019|NCT01239160|531827781|FG002|Overall Study|Withdrawal by Subject|2|||
147455020|NCT01239160|531827779|FG000|Overall Study|Physician Decision|5|||
147455021|NCT01239160|531827780|FG001|Overall Study|Physician Decision|7|||
147455022|NCT01239160|531827781|FG002|Overall Study|Physician Decision|2|||
147455023|NCT01239160|531827779|FG000|Overall Study|Early Termination Due to Study Closure|0|||
147455024|NCT01239160|531827780|FG001|Overall Study|Early Termination Due to Study Closure|1|||
147455025|NCT01239160|531827781|FG002|Overall Study|Early Termination Due to Study Closure|6|||
147455026|NCT04781816|531827786|FG000|Overall Study|Adverse Event|0|||
147455027|NCT04781816|531827787|FG001|Overall Study|Adverse Event|1|||
147455028|NCT04781816|531827786|FG000|Overall Study|Withdrawal by Subject|1|||
147455029|NCT04781816|531827787|FG001|Overall Study|Withdrawal by Subject|1|||
147455030|NCT04781816|531827786|FG000|Overall Study|Not Related to Coronavirus Disease 2019|1|||
147455031|NCT04781816|531827787|FG001|Overall Study|Not Related to Coronavirus Disease 2019|1|||
147455032|NCT01121393|531827788|FG000|Overall Study|Progressive disease|201|||
147455033|NCT01121393|531827789|FG001|Overall Study|Progressive disease|20|||
147455034|NCT01121393|531827788|FG000|Overall Study|Other Adverse events|24|||
147455035|NCT01121393|531827789|FG001|Overall Study|Other Adverse events|45|||
147455036|NCT01121393|531827788|FG000|Overall Study|Non-compliant with protocol|0|||
147455037|NCT01121393|531827789|FG001|Overall Study|Non-compliant with protocol|3|||
147455038|NCT01121393|531827788|FG000|Overall Study|Lost to Follow-up|1|||
147455039|NCT01121393|531827789|FG001|Overall Study|Lost to Follow-up|0|||
147455040|NCT01121393|531827788|FG000|Overall Study|Refused cont. medication|7|||
147455041|NCT01121393|531827789|FG001|Overall Study|Refused cont. medication|7|||
147455042|NCT01121393|531827788|FG000|Overall Study|Not treated|3|||
147455043|NCT01121393|531827789|FG001|Overall Study|Not treated|9|||
147455044|NCT01121393|531827788|FG000|Overall Study|Other than listed|6|||
147455045|NCT01121393|531827789|FG001|Overall Study|Other than listed|0|||
147455046|NCT04372927|531827792|FG000|Overall Study|Death|1|||
147371045|NCT00336505|531525800|FG001|Overall Study|Lost to Follow-up|4|||
147371046|NCT00336505|531525799|FG000|Overall Study|Withdrawal by Subject|5|||
147455047|NCT00608985|531827798|FG000|Overall Study|Adverse Event|2|||
147455048|NCT00608985|531827799|FG001|Overall Study|Adverse Event|7|||
147455049|NCT00608985|531827800|FG002|Overall Study|Adverse Event|4|||
147455050|NCT00608985|531827801|FG003|Overall Study|Adverse Event|6|||
147455051|NCT00608985|531827798|FG000|Overall Study|Administrative/Other|7|||
147455052|NCT00608985|531827799|FG001|Overall Study|Administrative/Other|4|||
147371047|NCT00336505|531525800|FG001|Overall Study|Withdrawal by Subject|3|||
147371048|NCT00336505|531525799|FG000|Overall Study|Other|7|||
147371049|NCT00336505|531525800|FG001|Overall Study|Other|7|||
147371050|NCT01092416|531525801|FG000|Enrollment|Atherectomy device not inserted|3|||
147455053|NCT00608985|531827800|FG002|Overall Study|Administrative/Other|1|||
147455054|NCT00608985|531827801|FG003|Overall Study|Administrative/Other|2|||
147455055|NCT00608985|531827798|FG000|Overall Study|Withdrawal of Consent|5|||
147663641|NCT05616013|532591567|FG002|Overall Study|Participant Cannot Continue study due to Work Commitments|0|||
147663642|NCT05616013|532591568|FG003|Overall Study|Participant Cannot Continue study due to Work Commitments|0|||
147663643|NCT05616013|532591569|FG004|Overall Study|Participant Cannot Continue study due to Work Commitments|0|||
147663644|NCT05616013|532591570|FG005|Overall Study|Participant Cannot Continue study due to Work Commitments|0|||
147663645|NCT05616013|532591571|FG006|Overall Study|Participant Cannot Continue study due to Work Commitments|0|||
147663646|NCT05616013|532591572|FG007|Overall Study|Participant Cannot Continue study due to Work Commitments|0|||
147663647|NCT05616013|532591573|FG008|Overall Study|Participant Cannot Continue study due to Work Commitments|0|||
147663648|NCT05616013|532591565|FG000|Overall Study|Participant Decision, Time Constraints|0|||
147663649|NCT05616013|532591566|FG001|Overall Study|Participant Decision, Time Constraints|1|||
147663650|NCT05616013|532591567|FG002|Overall Study|Participant Decision, Time Constraints|0|||
147663651|NCT05616013|532591568|FG003|Overall Study|Participant Decision, Time Constraints|0|||
147663652|NCT05616013|532591569|FG004|Overall Study|Participant Decision, Time Constraints|0|||
147663653|NCT05616013|532591570|FG005|Overall Study|Participant Decision, Time Constraints|0|||
147663654|NCT05616013|532591571|FG006|Overall Study|Participant Decision, Time Constraints|0|||
147663655|NCT05616013|532591572|FG007|Overall Study|Participant Decision, Time Constraints|0|||
147663656|NCT05616013|532591573|FG008|Overall Study|Participant Decision, Time Constraints|0|||
147663657|NCT05616013|532591565|FG000|Overall Study|Prohibited Concomitant Medication|0|||
147663658|NCT05616013|532591566|FG001|Overall Study|Prohibited Concomitant Medication|0|||
147663659|NCT05616013|532591567|FG002|Overall Study|Prohibited Concomitant Medication|1|||
147663660|NCT05616013|532591568|FG003|Overall Study|Prohibited Concomitant Medication|0|||
147663661|NCT05616013|532591569|FG004|Overall Study|Prohibited Concomitant Medication|0|||
147663662|NCT05616013|532591570|FG005|Overall Study|Prohibited Concomitant Medication|0|||
147663663|NCT05616013|532591571|FG006|Overall Study|Prohibited Concomitant Medication|0|||
147371051|NCT01092416|531525801|FG000|30-Day Follow-up|Death|2|||
147371052|NCT01092416|531525801|FG000|30-Day Follow-up|Missed 30-day follow-up|3|||
147371053|NCT01092416|531525801|FG000|30-Day Follow-up|Data collected after close of 30D window|5|||
147371054|NCT01092416|531525801|FG000|12-Month Follow-up|Death|16|||
147371055|NCT01092416|531525801|FG000|12-Month Follow-up|Lost to Follow-up|4|||
147371056|NCT01092416|531525801|FG000|12-Month Follow-up|Withdrawal by Subject|2|||
147371057|NCT01092416|531525801|FG000|12-Month Follow-up|Missed 1-year follow-up|1|||
147371058|NCT01092416|531525801|FG000|12-Month Follow-up|Data collected after close of 1Y window|2|||
147371059|NCT00366249|531525802|FG000|Overall Study|Adverse Event|53|||
147371060|NCT00366249|531525803|FG001|Overall Study|Adverse Event|28|||
147371061|NCT00366249|531525802|FG000|Overall Study|Death|0|||
147371062|NCT00366249|531525803|FG001|Overall Study|Death|1|||
147371063|NCT00366249|531525802|FG000|Overall Study|Physician Decision|5|||
147371064|NCT00366249|531525803|FG001|Overall Study|Physician Decision|2|||
147371065|NCT00366249|531525802|FG000|Overall Study|Lost to Follow-up|2|||
147371066|NCT00366249|531525803|FG001|Overall Study|Lost to Follow-up|0|||
147371067|NCT00366249|531525802|FG000|Overall Study|Protocol Violation|1|||
147371068|NCT00366249|531525803|FG001|Overall Study|Protocol Violation|2|||
147371069|NCT00366249|531525802|FG000|Overall Study|Withdrawal by Subject|18|||
147371070|NCT00366249|531525803|FG001|Overall Study|Withdrawal by Subject|4|||
147371071|NCT00366249|531525802|FG000|Overall Study|Lack of Efficacy|21|||
147371072|NCT00366249|531525803|FG001|Overall Study|Lack of Efficacy|21|||
147371073|NCT00366249|531525802|FG000|Overall Study|Most due to osteomylitis status|31|||
147371074|NCT00366249|531525803|FG001|Overall Study|Most due to osteomylitis status|20|||
147371075|NCT01561300|531525804|FG000|Run in on Placebo|Adverse Event|1|||
147371076|NCT01561300|531525805|FG001|Run in on Placebo|Adverse Event|0|||
147371077|NCT00777049|531525806|FG000|Overall Study|Withdrawal by Subject|1|||
147371078|NCT00777049|531525807|FG001|Overall Study|Withdrawal by Subject|0|||
147371079|NCT00777049|531525806|FG000|Overall Study|No treatment (elevated liver enzymes)|0|||
147371080|NCT00777049|531525807|FG001|Overall Study|No treatment (elevated liver enzymes)|1|||
147371081|NCT00246805|531525808|FG000|Phase 1|Lost to Follow-up|1|||
147371082|NCT00246805|531525809|FG001|Phase 1|Lost to Follow-up|0|||
147371083|NCT03478969|531525810|FG000|Overall Study|Withdrawal by Subject|4|||
147371084|NCT03478969|531525811|FG001|Overall Study|Withdrawal by Subject|7|||
147371085|NCT03478969|531525812|FG002|Overall Study|Withdrawal by Subject|6|||
147371086|NCT03478969|531525810|FG000|Overall Study|Adverse Event|2|||
147371087|NCT03478969|531525811|FG001|Overall Study|Adverse Event|0|||
147371088|NCT03478969|531525812|FG002|Overall Study|Adverse Event|1|||
147371089|NCT03478969|531525810|FG000|Overall Study|Pregnancy|1|||
147371090|NCT03478969|531525811|FG001|Overall Study|Pregnancy|0|||
147371091|NCT03478969|531525812|FG002|Overall Study|Pregnancy|0|||
147371092|NCT03478969|531525810|FG000|Overall Study|Personal Reasons|1|||
147371093|NCT03478969|531525811|FG001|Overall Study|Personal Reasons|0|||
147371094|NCT03478969|531525812|FG002|Overall Study|Personal Reasons|1|||
147371095|NCT03478969|531525810|FG000|Overall Study|Covid-19|1|||
147371096|NCT03478969|531525811|FG001|Overall Study|Covid-19|4|||
147371097|NCT03478969|531525812|FG002|Overall Study|Covid-19|3|||
147371098|NCT03478969|531525810|FG000|Overall Study|Multiple Reasons|0|||
147371099|NCT03478969|531525811|FG001|Overall Study|Multiple Reasons|1|||
147371100|NCT03478969|531525812|FG002|Overall Study|Multiple Reasons|1|||
147371101|NCT03478969|531525810|FG000|Overall Study|Eligibility Criteria|0|||
147663664|NCT05616013|532591572|FG007|Overall Study|Prohibited Concomitant Medication|0|||
147663665|NCT05616013|532591573|FG008|Overall Study|Prohibited Concomitant Medication|0|||
147663666|NCT05616013|532591565|FG000|Overall Study|Medical history condition Requiring Further Treatment|0|||
147663667|NCT05616013|532591566|FG001|Overall Study|Medical history condition Requiring Further Treatment|0|||
147663668|NCT05616013|532591567|FG002|Overall Study|Medical history condition Requiring Further Treatment|1|||
147663669|NCT05616013|532591568|FG003|Overall Study|Medical history condition Requiring Further Treatment|0|||
147663670|NCT05616013|532591569|FG004|Overall Study|Medical history condition Requiring Further Treatment|0|||
147663671|NCT05616013|532591570|FG005|Overall Study|Medical history condition Requiring Further Treatment|0|||
147663672|NCT05616013|532591571|FG006|Overall Study|Medical history condition Requiring Further Treatment|0|||
147663673|NCT05616013|532591572|FG007|Overall Study|Medical history condition Requiring Further Treatment|0|||
147663674|NCT05616013|532591573|FG008|Overall Study|Medical history condition Requiring Further Treatment|0|||
147663675|NCT05616013|532591565|FG000|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|0|||
147663676|NCT05616013|532591566|FG001|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|0|||
147663677|NCT05616013|532591567|FG002|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|0|||
147663678|NCT05616013|532591568|FG003|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|1|||
147371102|NCT03478969|531525811|FG001|Overall Study|Eligibility Criteria|0|||
147371103|NCT03478969|531525812|FG002|Overall Study|Eligibility Criteria|5|||
147371104|NCT03478969|531525810|FG000|Overall Study|Lost to Follow-up|0|||
147371105|NCT03478969|531525811|FG001|Overall Study|Lost to Follow-up|0|||
147455056|NCT00608985|531827799|FG001|Overall Study|Withdrawal of Consent|1|||
147371106|NCT03478969|531525812|FG002|Overall Study|Lost to Follow-up|1|||
147371107|NCT01185600|531525813|FG000|Overall Study|Adverse Event|1|||
147371108|NCT01185600|531525814|FG001|Overall Study|Adverse Event|1|||
147371109|NCT01185600|531525813|FG000|Overall Study|Death|0|||
147371110|NCT01185600|531525814|FG001|Overall Study|Death|1|||
147371111|NCT01185600|531525813|FG000|Overall Study|Lost to Follow-up|0|||
147371112|NCT01185600|531525814|FG001|Overall Study|Lost to Follow-up|5|||
147371113|NCT01185600|531525813|FG000|Overall Study|Physician Decision|29|||
147371114|NCT01185600|531525814|FG001|Overall Study|Physician Decision|35|||
147371115|NCT01185600|531525813|FG000|Overall Study|Withdrawal by Subject|1|||
147371116|NCT01185600|531525814|FG001|Overall Study|Withdrawal by Subject|1|||
147371117|NCT01185600|531525813|FG000|Overall Study|Hold by DSMB|1|||
147371118|NCT01185600|531525814|FG001|Overall Study|Hold by DSMB|2|||
147371119|NCT00724126|531525815|FG000|Overall Study|Adverse Event|2|||
147371120|NCT00724126|531525816|FG001|Overall Study|Adverse Event|0|||
147371121|NCT00724126|531525815|FG000|Overall Study|Withdrawal by Subject|8|||
147371122|NCT00724126|531525816|FG001|Overall Study|Withdrawal by Subject|6|||
147371123|NCT00724126|531525815|FG000|Overall Study|Lost to Follow-up|6|||
147371124|NCT00724126|531525816|FG001|Overall Study|Lost to Follow-up|6|||
147371125|NCT00724126|531525815|FG000|Overall Study|Noncompliance|2|||
147371126|NCT00724126|531525816|FG001|Overall Study|Noncompliance|1|||
147371127|NCT00724126|531525815|FG000|Overall Study|Subject randomized although ineligible|1|||
147371128|NCT00724126|531525816|FG001|Overall Study|Subject randomized although ineligible|1|||
147371129|NCT00724126|531525815|FG000|Overall Study|Subject had to leave vicinity of site|0|||
147371130|NCT00724126|531525816|FG001|Overall Study|Subject had to leave vicinity of site|1|||
147371131|NCT00739934|531525818|FG000|Voriconazole IV|Adverse Event|6|||
147371132|NCT00739934|531525818|FG000|Voriconazole Oral|Other|3|||
147371133|NCT01579318|531525821|FG000|Overall Study|Disease Progression|1|||
147371134|NCT03066609|531525828|FG000|INDUCTION|Pregnancy|0|||
147371135|NCT03066609|531525829|FG001|INDUCTION|Pregnancy|0|||
147371136|NCT03066609|531525830|FG002|INDUCTION|Pregnancy|1|||
147371137|NCT03066609|531525831|FG003|INDUCTION|Pregnancy|0|||
147371138|NCT03066609|531525828|FG000|INDUCTION|Lack of Efficacy|0|||
147371139|NCT03066609|531525829|FG001|INDUCTION|Lack of Efficacy|0|||
147371140|NCT03066609|531525830|FG002|INDUCTION|Lack of Efficacy|1|||
147455057|NCT00608985|531827800|FG002|Overall Study|Withdrawal of Consent|1|||
147611026|NCT04414618|532390892|FG001|Overall Study|Physician Decision|0|||
147611027|NCT00362336|532390893|FG000|Overall Study|Serious Adverse Event|1|||
147611028|NCT00362336|532390894|FG001|Overall Study|Serious Adverse Event|0|||
147611029|NCT00362336|532390895|FG002|Overall Study|Serious Adverse Event|1|||
147611030|NCT00362336|532390893|FG000|Overall Study|Protocol Violation|0|||
147611031|NCT00362336|532390894|FG001|Overall Study|Protocol Violation|0|||
147611032|NCT00362336|532390895|FG002|Overall Study|Protocol Violation|1|||
147611033|NCT00362336|532390893|FG000|Overall Study|Lost to Follow-up|6|||
147611034|NCT00362336|532390894|FG001|Overall Study|Lost to Follow-up|4|||
147611035|NCT00362336|532390895|FG002|Overall Study|Lost to Follow-up|0|||
147611036|NCT00362336|532390893|FG000|Overall Study|Withdrawal by Subject|3|||
147611037|NCT00362336|532390894|FG001|Overall Study|Withdrawal by Subject|3|||
147611038|NCT00362336|532390895|FG002|Overall Study|Withdrawal by Subject|1|||
147371141|NCT03066609|531525831|FG003|INDUCTION|Lack of Efficacy|0|||
147371142|NCT03066609|531525828|FG000|INDUCTION|Adverse Event|2|||
147371143|NCT03066609|531525829|FG001|INDUCTION|Adverse Event|2|||
147371144|NCT03066609|531525830|FG002|INDUCTION|Adverse Event|0|||
147455058|NCT00608985|531827801|FG003|Overall Study|Withdrawal of Consent|1|||
147455059|NCT00608985|531827798|FG000|Overall Study|Lost to Follow-up|2|||
147455060|NCT00608985|531827799|FG001|Overall Study|Lost to Follow-up|1|||
147455061|NCT00608985|531827800|FG002|Overall Study|Lost to Follow-up|0|||
147455062|NCT00608985|531827801|FG003|Overall Study|Lost to Follow-up|0|||
147455063|NCT03033745|531827802|FG000|Overall Study|Protocol Violation|0|||
147455064|NCT03033745|531827803|FG001|Overall Study|Protocol Violation|0|||
147455065|NCT03033745|531827804|FG002|Overall Study|Protocol Violation|1|||
147455066|NCT03033745|531827802|FG000|Overall Study|Adverse Event|1|||
147455067|NCT03033745|531827803|FG001|Overall Study|Adverse Event|0|||
147455068|NCT03033745|531827804|FG002|Overall Study|Adverse Event|1|||
147455069|NCT03033745|531827802|FG000|Overall Study|Withdrawal by Subject|0|||
147455070|NCT03033745|531827803|FG001|Overall Study|Withdrawal by Subject|1|||
147455071|NCT03033745|531827804|FG002|Overall Study|Withdrawal by Subject|0|||
147455072|NCT02706730|531827806|FG000|Overall Study|Adverse Event|3|||
147455073|NCT02706730|531827806|FG000|Overall Study|Lack of Efficacy|5|||
147455074|NCT02706730|531827806|FG000|Overall Study|Withdrawal by Subject|11|||
147455075|NCT02706730|531827806|FG000|Overall Study|Study Terminated by Sponsor|11|||
147455076|NCT02706730|531827806|FG000|Overall Study|Subject chose not to receive injection|3|||
147455077|NCT00953758|531827810|FG000|Overall Study|Death|2|||
147455078|NCT00953758|531827811|FG001|Overall Study|Death|0|||
147455079|NCT00953758|531827812|FG002|Overall Study|Death|1|||
147455080|NCT00953758|531827813|FG003|Overall Study|Death|1|||
147455081|NCT00953758|531827814|FG004|Overall Study|Death|1|||
147455082|NCT00953758|531827815|FG005|Overall Study|Death|1|||
147455083|NCT00953758|531827816|FG006|Overall Study|Death|1|||
147455084|NCT00953758|531827817|FG007|Overall Study|Death|3|||
147455085|NCT00953758|531827818|FG008|Overall Study|Death|1|||
147455086|NCT00953758|531827819|FG009|Overall Study|Death|0|||
147455087|NCT00953758|531827810|FG000|Overall Study|Participant refused further follow-up|0|||
147455088|NCT00953758|531827811|FG001|Overall Study|Participant refused further follow-up|0|||
147455089|NCT00953758|531827812|FG002|Overall Study|Participant refused further follow-up|1|||
147455090|NCT00953758|531827813|FG003|Overall Study|Participant refused further follow-up|0|||
147455091|NCT00953758|531827814|FG004|Overall Study|Participant refused further follow-up|3|||
147455092|NCT00953758|531827815|FG005|Overall Study|Participant refused further follow-up|0|||
147455093|NCT00953758|531827816|FG006|Overall Study|Participant refused further follow-up|0|||
147455094|NCT00953758|531827817|FG007|Overall Study|Participant refused further follow-up|0|||
147455095|NCT00953758|531827818|FG008|Overall Study|Participant refused further follow-up|1|||
147455096|NCT00953758|531827819|FG009|Overall Study|Participant refused further follow-up|0|||
147455097|NCT00953758|531827810|FG000|Overall Study|Lost to Follow-up|0|||
147371145|NCT03066609|531525831|FG003|INDUCTION|Adverse Event|0|||
147371146|NCT03066609|531525828|FG000|MAINTENANCE|Adverse Event|0|||
147371147|NCT03066609|531525829|FG001|MAINTENANCE|Adverse Event|0|||
147371148|NCT03066609|531525830|FG002|MAINTENANCE|Adverse Event|0|||
147371149|NCT03066609|531525831|FG003|MAINTENANCE|Adverse Event|1|||
147371150|NCT03066609|531525828|FG000|MAINTENANCE|Withdrawal by Subject|4|||
147371151|NCT03066609|531525829|FG001|MAINTENANCE|Withdrawal by Subject|2|||
147371152|NCT03066609|531525830|FG002|MAINTENANCE|Withdrawal by Subject|1|||
147371153|NCT03066609|531525831|FG003|MAINTENANCE|Withdrawal by Subject|1|||
147371154|NCT03066609|531525828|FG000|MAINTENANCE|Lost to Follow-up|0|||
147371155|NCT03066609|531525829|FG001|MAINTENANCE|Lost to Follow-up|1|||
147371156|NCT03066609|531525830|FG002|MAINTENANCE|Lost to Follow-up|1|||
147371157|NCT03066609|531525831|FG003|MAINTENANCE|Lost to Follow-up|0|||
147371158|NCT03066609|531525828|FG000|MAINTENANCE|Pregnancy|1|||
147371159|NCT03066609|531525829|FG001|MAINTENANCE|Pregnancy|0|||
147371160|NCT03066609|531525830|FG002|MAINTENANCE|Pregnancy|0|||
147455098|NCT00953758|531827811|FG001|Overall Study|Lost to Follow-up|0|||
147455099|NCT00953758|531827812|FG002|Overall Study|Lost to Follow-up|0|||
147663679|NCT05616013|532591569|FG004|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|0|||
147371161|NCT03066609|531525831|FG003|MAINTENANCE|Pregnancy|0|||
147371162|NCT03066609|531525828|FG000|MAINTENANCE|Lack of Efficacy|2|||
147371163|NCT03066609|531525829|FG001|MAINTENANCE|Lack of Efficacy|1|||
147371164|NCT03066609|531525830|FG002|MAINTENANCE|Lack of Efficacy|0|||
147371165|NCT03066609|531525831|FG003|MAINTENANCE|Lack of Efficacy|1|||
147371166|NCT03066609|531525828|FG000|OVERALL STUDY|Adverse Event|2|||
147371167|NCT03066609|531525829|FG001|OVERALL STUDY|Adverse Event|2|||
147371168|NCT03066609|531525830|FG002|OVERALL STUDY|Adverse Event|0|||
147455100|NCT00953758|531827813|FG003|Overall Study|Lost to Follow-up|1|||
147455101|NCT00953758|531827814|FG004|Overall Study|Lost to Follow-up|0|||
147455102|NCT00953758|531827815|FG005|Overall Study|Lost to Follow-up|0|||
147455103|NCT00953758|531827816|FG006|Overall Study|Lost to Follow-up|0|||
147371169|NCT03066609|531525831|FG003|OVERALL STUDY|Adverse Event|1|||
147455104|NCT00953758|531827817|FG007|Overall Study|Lost to Follow-up|1|||
147455105|NCT00953758|531827818|FG008|Overall Study|Lost to Follow-up|0|||
147455106|NCT00953758|531827819|FG009|Overall Study|Lost to Follow-up|1|||
147455107|NCT00953758|531827810|FG000|Overall Study|Physician Decision|0|||
147371170|NCT03066609|531525828|FG000|OVERALL STUDY|Withdrawal by Subject|4|||
147455108|NCT00953758|531827811|FG001|Overall Study|Physician Decision|0|||
147455109|NCT00953758|531827812|FG002|Overall Study|Physician Decision|0|||
147371171|NCT03066609|531525829|FG001|OVERALL STUDY|Withdrawal by Subject|2|||
147371172|NCT03066609|531525830|FG002|OVERALL STUDY|Withdrawal by Subject|1|||
147371173|NCT03066609|531525831|FG003|OVERALL STUDY|Withdrawal by Subject|2|||
147371174|NCT03066609|531525828|FG000|OVERALL STUDY|Lost to Follow-up|1|||
147371175|NCT03066609|531525829|FG001|OVERALL STUDY|Lost to Follow-up|1|||
147371176|NCT03066609|531525830|FG002|OVERALL STUDY|Lost to Follow-up|1|||
147371177|NCT03066609|531525831|FG003|OVERALL STUDY|Lost to Follow-up|1|||
147371178|NCT03066609|531525828|FG000|OVERALL STUDY|Pregnancy|1|||
147371179|NCT03066609|531525829|FG001|OVERALL STUDY|Pregnancy|0|||
147371180|NCT03066609|531525830|FG002|OVERALL STUDY|Pregnancy|1|||
147371181|NCT03066609|531525831|FG003|OVERALL STUDY|Pregnancy|0|||
147371182|NCT03066609|531525828|FG000|OVERALL STUDY|Lack of Efficacy|2|||
147371183|NCT03066609|531525829|FG001|OVERALL STUDY|Lack of Efficacy|1|||
147371184|NCT03066609|531525830|FG002|OVERALL STUDY|Lack of Efficacy|1|||
147371185|NCT03066609|531525831|FG003|OVERALL STUDY|Lack of Efficacy|1|||
147371186|NCT03066609|531525828|FG000|OVERALL STUDY|discontinued follow up|0|||
147371187|NCT03066609|531525829|FG001|OVERALL STUDY|discontinued follow up|2|||
147371188|NCT03066609|531525830|FG002|OVERALL STUDY|discontinued follow up|0|||
147371189|NCT03066609|531525831|FG003|OVERALL STUDY|discontinued follow up|0|||
147371190|NCT03355573|531525832|FG000|Overall Study|Withdrew consent due to refused treatment to AE latent tuberculosis|1|||
147371191|NCT03355573|531525832|FG000|Overall Study|Sponsor's decision|1|||
147371192|NCT03355573|531525832|FG000|Overall Study|Participant withdrew consent due to AEs|1|||
147371193|NCT03355573|531525832|FG000|Overall Study|PI's decision|2|||
147371194|NCT03355573|531525832|FG000|Overall Study|Withdrawal by Subject|23|||
147371195|NCT03355573|531525832|FG000|Overall Study|Lost to Follow-up|4|||
147371196|NCT03355573|531525832|FG000|Overall Study|Lack of Efficacy|2|||
147371197|NCT03355573|531525832|FG000|Overall Study|Adverse Event, non-fatal|17|||
147371198|NCT03355573|531525832|FG000|Overall Study|Adverse Event, serious fatal|2|||
147371199|NCT01566890|531525833|FG000|Overall Study|Adverse Event|1|||
147371200|NCT01566890|531525834|FG001|Overall Study|Adverse Event|0|||
147371201|NCT01566890|531525835|FG002|Overall Study|Adverse Event|0|||
147371202|NCT01566890|531525836|FG003|Overall Study|Adverse Event|0|||
147371203|NCT01566890|531525837|FG004|Overall Study|Adverse Event|0|||
147371204|NCT01566890|531525833|FG000|Overall Study|Withdrawal by Subject|3|||
147371205|NCT01566890|531525834|FG001|Overall Study|Withdrawal by Subject|1|||
147371206|NCT01566890|531525835|FG002|Overall Study|Withdrawal by Subject|1|||
147371207|NCT01566890|531525836|FG003|Overall Study|Withdrawal by Subject|1|||
147371208|NCT01566890|531525837|FG004|Overall Study|Withdrawal by Subject|0|||
147371209|NCT01566890|531525833|FG000|Overall Study|Screen failure|6|||
147371210|NCT01566890|531525834|FG001|Overall Study|Screen failure|0|||
147371211|NCT01566890|531525835|FG002|Overall Study|Screen failure|1|||
147371212|NCT01566890|531525836|FG003|Overall Study|Screen failure|1|||
147371213|NCT01566890|531525837|FG004|Overall Study|Screen failure|0|||
147371214|NCT01566890|531525833|FG000|Overall Study|Incomplete CEU data|1|||
147371215|NCT01566890|531525834|FG001|Overall Study|Incomplete CEU data|3|||
147371216|NCT01566890|531525835|FG002|Overall Study|Incomplete CEU data|5|||
147371217|NCT01566890|531525836|FG003|Overall Study|Incomplete CEU data|8|||
147371218|NCT01566890|531525837|FG004|Overall Study|Incomplete CEU data|0|||
147371219|NCT01566890|531525833|FG000|Overall Study|Lost to Follow-up|0|||
147371220|NCT01566890|531525834|FG001|Overall Study|Lost to Follow-up|0|||
147371221|NCT01566890|531525835|FG002|Overall Study|Lost to Follow-up|4|||
147371222|NCT01566890|531525836|FG003|Overall Study|Lost to Follow-up|4|||
147371223|NCT01566890|531525837|FG004|Overall Study|Lost to Follow-up|0|||
147371224|NCT01566890|531525833|FG000|Overall Study|Other|0|||
147371225|NCT01566890|531525834|FG001|Overall Study|Other|0|||
147371226|NCT01566890|531525835|FG002|Overall Study|Other|0|||
147371227|NCT01566890|531525836|FG003|Overall Study|Other|0|||
147371228|NCT01566890|531525837|FG004|Overall Study|Other|7|||
147371229|NCT00523419|531525848|FG000|Overall Study|Adverse Event|1|||
147371230|NCT00523419|531525848|FG000|Overall Study|Withdrawal by Subject|1|||
147371231|NCT00523419|531525848|FG000|Overall Study|Physician Decision|2|||
147611039|NCT00658879|532390896|FG000|Overall Study|Protocol Violation|1|||
147371232|NCT00523419|531525848|FG000|Overall Study|Progressive Disease|22|||
147371233|NCT00523419|531525848|FG000|Overall Study|Death due to Study Disease|4|||
147371234|NCT00523419|531525848|FG000|Overall Study|Death due to Adverse Event|2|||
147371235|NCT01211184|531525849|FG000|Overall Study|Withdrawal by Subject|0|||
147371236|NCT01211184|531525850|FG001|Overall Study|Withdrawal by Subject|2|||
147371237|NCT01211184|531525851|FG002|Overall Study|Withdrawal by Subject|1|||
147371238|NCT01421667|531525852|FG000|Overall Study|Withdrawal by Subject|0|||
147371239|NCT01421667|531525853|FG001|Overall Study|Withdrawal by Subject|1|||
147371240|NCT01421667|531525854|FG002|Overall Study|Withdrawal by Subject|2|||
147371241|NCT01421667|531525855|FG003|Overall Study|Withdrawal by Subject|1|||
147371242|NCT01421667|531525852|FG000|Overall Study|Lost to Follow-up|0|||
147371243|NCT01421667|531525853|FG001|Overall Study|Lost to Follow-up|1|||
147371244|NCT01421667|531525854|FG002|Overall Study|Lost to Follow-up|0|||
147371245|NCT01421667|531525855|FG003|Overall Study|Lost to Follow-up|0|||
147371246|NCT00822120|531525856|FG000|Initial Registration|Adverse Event|1|||
147611040|NCT02640690|532390897|FG000|Overall Study|Lost to Follow-up|7|||
147611041|NCT02640690|532390898|FG001|Overall Study|Lost to Follow-up|7|||
147371247|NCT00822120|531525857|FG001|Initial Registration|Adverse Event|0|||
147371248|NCT00822120|531525858|FG002|Initial Registration|Adverse Event|0|||
147371249|NCT00822120|531525859|FG003|Initial Registration|Adverse Event|0|||
147371250|NCT00822120|531525860|FG004|Initial Registration|Adverse Event|0|||
147371251|NCT00822120|531525861|FG005|Initial Registration|Adverse Event|0|||
147371252|NCT00822120|531525856|FG000|Initial Registration|Refusal Unrelated to Adverse Event|1|||
147371253|NCT00822120|531525857|FG001|Initial Registration|Refusal Unrelated to Adverse Event|0|||
147371254|NCT00822120|531525858|FG002|Initial Registration|Refusal Unrelated to Adverse Event|0|||
147371255|NCT00822120|531525859|FG003|Initial Registration|Refusal Unrelated to Adverse Event|0|||
147371256|NCT00822120|531525860|FG004|Initial Registration|Refusal Unrelated to Adverse Event|0|||
147371257|NCT00822120|531525861|FG005|Initial Registration|Refusal Unrelated to Adverse Event|0|||
147371258|NCT00822120|531525856|FG000|Initial Registration|Reasons not Protocol Specified|2|||
147371259|NCT00822120|531525857|FG001|Initial Registration|Reasons not Protocol Specified|0|||
147371260|NCT00822120|531525858|FG002|Initial Registration|Reasons not Protocol Specified|0|||
147371261|NCT00822120|531525859|FG003|Initial Registration|Reasons not Protocol Specified|0|||
147371262|NCT00822120|531525860|FG004|Initial Registration|Reasons not Protocol Specified|0|||
147371263|NCT00822120|531525861|FG005|Initial Registration|Reasons not Protocol Specified|0|||
147371264|NCT00822120|531525856|FG000|Initial Registration|Ineligible|22|||
147371265|NCT00822120|531525857|FG001|Initial Registration|Ineligible|1|||
147371266|NCT00822120|531525858|FG002|Initial Registration|Ineligible|0|||
147371267|NCT00822120|531525859|FG003|Initial Registration|Ineligible|0|||
147371268|NCT00822120|531525860|FG004|Initial Registration|Ineligible|0|||
147371269|NCT00822120|531525861|FG005|Initial Registration|Ineligible|0|||
147371270|NCT00822120|531525856|FG000|PET-directed Therapy|Adverse Event|0|||
147371271|NCT00822120|531525857|FG001|PET-directed Therapy|Adverse Event|0|||
147371272|NCT00822120|531525858|FG002|PET-directed Therapy|Adverse Event|0|||
147371273|NCT00822120|531525859|FG003|PET-directed Therapy|Adverse Event|1|||
147371274|NCT00822120|531525860|FG004|PET-directed Therapy|Adverse Event|0|||
147371275|NCT00822120|531525861|FG005|PET-directed Therapy|Adverse Event|0|||
147371276|NCT00822120|531525856|FG000|PET-directed Therapy|Refusal Unrelated to Adverse Event|0|||
147371277|NCT00822120|531525857|FG001|PET-directed Therapy|Refusal Unrelated to Adverse Event|0|||
147371278|NCT00822120|531525858|FG002|PET-directed Therapy|Refusal Unrelated to Adverse Event|0|||
147371279|NCT00822120|531525859|FG003|PET-directed Therapy|Refusal Unrelated to Adverse Event|1|||
147371280|NCT00822120|531525860|FG004|PET-directed Therapy|Refusal Unrelated to Adverse Event|0|||
147371281|NCT00822120|531525861|FG005|PET-directed Therapy|Refusal Unrelated to Adverse Event|0|||
147371282|NCT00822120|531525856|FG000|PET-directed Therapy|Death|0|||
147371283|NCT00822120|531525857|FG001|PET-directed Therapy|Death|0|||
147371284|NCT00822120|531525858|FG002|PET-directed Therapy|Death|0|||
147371285|NCT00822120|531525859|FG003|PET-directed Therapy|Death|2|||
147371286|NCT00822120|531525860|FG004|PET-directed Therapy|Death|0|||
147371287|NCT00822120|531525861|FG005|PET-directed Therapy|Death|0|||
147371288|NCT00822120|531525856|FG000|PET-directed Therapy|Protocol Violation|0|||
147371289|NCT00822120|531525857|FG001|PET-directed Therapy|Protocol Violation|0|||
147371290|NCT00822120|531525858|FG002|PET-directed Therapy|Protocol Violation|0|||
147371291|NCT00822120|531525859|FG003|PET-directed Therapy|Protocol Violation|6|||
147371292|NCT00822120|531525860|FG004|PET-directed Therapy|Protocol Violation|0|||
147371293|NCT00822120|531525861|FG005|PET-directed Therapy|Protocol Violation|0|||
147371294|NCT04060212|531525863|FG000|Overall Study|Withdrawal by Subject|7|||
147371295|NCT03802994|531525867|FG000|Overall Study|Lost to Follow-up|0|||
147371296|NCT03802994|531525868|FG001|Overall Study|Lost to Follow-up|2|||
147371297|NCT03802994|531525869|FG002|Overall Study|Lost to Follow-up|3|||
147371298|NCT03802994|531525870|FG003|Overall Study|Lost to Follow-up|2|||
147371299|NCT03802994|531525871|FG004|Overall Study|Lost to Follow-up|2|||
147371300|NCT02646618|531525872|FG000|Overall Study|Lost to Follow-up|10|||
147371301|NCT02646618|531525873|FG001|Overall Study|Lost to Follow-up|14|||
147371302|NCT00918203|531525877|FG000|Treatment With or Without Olaratumab|Lost to Follow-up|1|||
147371303|NCT00918203|531525878|FG001|Treatment With or Without Olaratumab|Lost to Follow-up|1|||
147371304|NCT00918203|531525879|FG002|Treatment With or Without Olaratumab|Lost to Follow-up|0|||
147371305|NCT00918203|531525877|FG000|Treatment With or Without Olaratumab|Withdrawal by Subject|2|||
147371306|NCT00918203|531525878|FG001|Treatment With or Without Olaratumab|Withdrawal by Subject|8|||
147371307|NCT00918203|531525879|FG002|Treatment With or Without Olaratumab|Withdrawal by Subject|0|||
147371308|NCT00918203|531525877|FG000|Treatment With or Without Olaratumab|Other Therapy Started|2|||
147371309|NCT00918203|531525878|FG001|Treatment With or Without Olaratumab|Other Therapy Started|1|||
147371310|NCT00918203|531525879|FG002|Treatment With or Without Olaratumab|Other Therapy Started|0|||
147371311|NCT00918203|531525877|FG000|Treatment With or Without Olaratumab|Never Treated/Death|1|||
147371312|NCT00918203|531525878|FG001|Treatment With or Without Olaratumab|Never Treated/Death|0|||
147371313|NCT00918203|531525879|FG002|Treatment With or Without Olaratumab|Never Treated/Death|0|||
147371314|NCT00701701|531525880|FG000|Overall Study|Withdrawal by Subject|0|||
147371315|NCT00701701|531525881|FG001|Overall Study|Withdrawal by Subject|1|||
147371316|NCT00701701|531525880|FG000|Overall Study|Adverse Event|0|||
147371317|NCT00701701|531525881|FG001|Overall Study|Adverse Event|1|||
147371318|NCT00589875|531525882|FG000|Enrollment to Treatment Initiation|Patients ineligable for study.|9|||
147371319|NCT00589875|531525882|FG000|Treatment Initiation to Completion|Treatment discontinuation|7|||
147371320|NCT03357952|531525885|FG000|Overall Study|Withdrawal by Subject|0|||
147371321|NCT03357952|531525886|FG001|Overall Study|Withdrawal by Subject|1|||
147371322|NCT03357952|531525885|FG000|Overall Study|Sponsor Decision|9|||
147371323|NCT03357952|531525886|FG001|Overall Study|Sponsor Decision|0|||
147371324|NCT01208974|531525887|FG000|Post-Mastectomy Period (Weeks 1 to 4)|Physician Decision|1|||
147371325|NCT01208974|531525888|FG001|Post-Mastectomy Period (Weeks 1 to 4)|Physician Decision|0|||
147371326|NCT01208974|531525889|FG002|Post-Mastectomy Period (Weeks 1 to 4)|Physician Decision|0|||
147371327|NCT01208974|531525890|FG003|Post-Mastectomy Period (Weeks 1 to 4)|Physician Decision|0|||
147371328|NCT01208974|531525887|FG000|Post-Mastectomy Period (Weeks 1 to 4)|Withdrawal by Subject|1|||
147371329|NCT01208974|531525888|FG001|Post-Mastectomy Period (Weeks 1 to 4)|Withdrawal by Subject|0|||
147371330|NCT01208974|531525889|FG002|Post-Mastectomy Period (Weeks 1 to 4)|Withdrawal by Subject|0|||
147371331|NCT01208974|531525890|FG003|Post-Mastectomy Period (Weeks 1 to 4)|Withdrawal by Subject|0|||
147371332|NCT01208974|531525887|FG000|Post-Mastectomy Period (Weeks 1 to 4)|Adverse Event|1|||
147371333|NCT01208974|531525888|FG001|Post-Mastectomy Period (Weeks 1 to 4)|Adverse Event|0|||
147371334|NCT01208974|531525889|FG002|Post-Mastectomy Period (Weeks 1 to 4)|Adverse Event|0|||
147371335|NCT01208974|531525890|FG003|Post-Mastectomy Period (Weeks 1 to 4)|Adverse Event|0|||
147371336|NCT04517435|531525907|FG000|Overall Study|Withdrawal by Subject|0|||
147371337|NCT04517435|531525908|FG001|Overall Study|Withdrawal by Subject|0|||
147371338|NCT04517435|531525909|FG002|Overall Study|Withdrawal by Subject|1|||
147371339|NCT04517435|531525907|FG000|Overall Study|Pharmaceutical company discontinued the trial|3|||
147371340|NCT04517435|531525908|FG001|Overall Study|Pharmaceutical company discontinued the trial|6|||
147371341|NCT04517435|531525909|FG002|Overall Study|Pharmaceutical company discontinued the trial|3|||
147371342|NCT06191679|531525910|FG000|Baseline|Lost to Follow-up|1|||
147371343|NCT06191679|531525911|FG001|Baseline|Lost to Follow-up|0|||
147371344|NCT06191679|531525912|FG002|Baseline|Lost to Follow-up|1|||
147371345|NCT06191679|531525913|FG003|Baseline|Lost to Follow-up|0|||
147371346|NCT06191679|531525910|FG000|Allocation to Group|Withdrawal by Subject|0|||
147371347|NCT06191679|531525911|FG001|Allocation to Group|Withdrawal by Subject|1|||
147371348|NCT06191679|531525912|FG002|Allocation to Group|Withdrawal by Subject|2|||
147371349|NCT06191679|531525913|FG003|Allocation to Group|Withdrawal by Subject|0|||
147371350|NCT06191679|531525910|FG000|Post-Intervention Assessment|Lost to Follow-up|2|||
147371351|NCT06191679|531525911|FG001|Post-Intervention Assessment|Lost to Follow-up|3|||
147371352|NCT06191679|531525912|FG002|Post-Intervention Assessment|Lost to Follow-up|0|||
147371353|NCT06191679|531525913|FG003|Post-Intervention Assessment|Lost to Follow-up|0|||
147371354|NCT06191679|531525910|FG000|Post-Intervention Qualitative Interview|Lost to Follow-up|0|||
147371355|NCT06191679|531525911|FG001|Post-Intervention Qualitative Interview|Lost to Follow-up|7|||
147371356|NCT06191679|531525912|FG002|Post-Intervention Qualitative Interview|Lost to Follow-up|5|||
147371357|NCT06191679|531525913|FG003|Post-Intervention Qualitative Interview|Lost to Follow-up|0|||
147371358|NCT06191679|531525910|FG000|Post-Intervention Qualitative Interview|Started but did not finish due to time constraints.|0|||
147371359|NCT06191679|531525911|FG001|Post-Intervention Qualitative Interview|Started but did not finish due to time constraints.|0|||
147371360|NCT06191679|531525912|FG002|Post-Intervention Qualitative Interview|Started but did not finish due to time constraints.|0|||
147371361|NCT06191679|531525913|FG003|Post-Intervention Qualitative Interview|Started but did not finish due to time constraints.|2|||
147371362|NCT03459196|531527856|FG000|Overall Study|Subject didn't receive study catheter|2|||
147371363|NCT04989816|531527858|FG000|Overall Study|Death|77|||
147371364|NCT04989816|531527858|FG000|Overall Study|Lost to Follow-up|3|||
147371365|NCT04213807|531527864|FG000|Overall Study|Physician Decision|0|||
147371366|NCT04213807|531527865|FG001|Overall Study|Physician Decision|0|||
147371367|NCT04213807|531527866|FG002|Overall Study|Physician Decision|1|||
147371368|NCT01128595|531527869|FG000|Treatment Period 3|Withdrawal by Subject|0|||
147371369|NCT01128595|531527870|FG001|Treatment Period 3|Withdrawal by Subject|1|||
147371370|NCT01128595|531527871|FG002|Treatment Period 3|Withdrawal by Subject|0|||
147371371|NCT01128595|531527872|FG003|Treatment Period 3|Withdrawal by Subject|0|||
147371372|NCT00372775|531527873|FG000|Overall Study|Adverse Event|8|||
147371373|NCT00372775|531527873|FG000|Overall Study|Death|15|||
147371374|NCT00372775|531527873|FG000|Overall Study|Objective progression or relapse|30|||
147371375|NCT00372775|531527873|FG000|Overall Study|Global deterioration of health status|6|||
147371376|NCT00372775|531527873|FG000|Overall Study|Withdrawal by Subject|1|||
147371377|NCT00372775|531527873|FG000|Overall Study|Other|1|||
147371378|NCT00372775|531527873|FG000|Overall Study|Not Treated|2|||
147371379|NCT00890591|531527876|FG000|Overall Study|Lack of Efficacy|20|||
147371380|NCT01436175|531527879|FG000|Overall Study|Adverse Event|111|||
147371381|NCT01436175|531527879|FG000|Overall Study|Protocol Violation|49|||
147371382|NCT01436175|531527879|FG000|Overall Study|Withdrawal by Subject|108|||
147371383|NCT01436175|531527879|FG000|Overall Study|Lost to Follow-up|89|||
147371384|NCT01436175|531527879|FG000|Overall Study|Lack of Efficacy|24|||
147371385|NCT01436175|531527879|FG000|Overall Study|Met blood pressure or pulse withdrawal|63|||
147371386|NCT01436175|531527879|FG000|Overall Study|Other|826|||
147371387|NCT05405244|531527880|FG000|Washout (2 Weeks)|Lost to Follow-up|0|||
147371388|NCT05405244|531527881|FG001|Washout (2 Weeks)|Lost to Follow-up|1|||
147371389|NCT05405244|531527880|FG000|Washout (2 Weeks)|Adverse Event|2|||
147371390|NCT05405244|531527881|FG001|Washout (2 Weeks)|Adverse Event|0|||
147371391|NCT05405244|531527880|FG000|Washout (2 Weeks)|Withdrawal by Subject|2|||
147371392|NCT05405244|531527881|FG001|Washout (2 Weeks)|Withdrawal by Subject|0|||
147371393|NCT03418922|531527882|FG000|Overall Study|Withdrawal by Subject|0|||
147371394|NCT03418922|531527883|FG001|Overall Study|Withdrawal by Subject|2|||
147371395|NCT03418922|531527882|FG000|Overall Study|Adverse Event|2|||
147371396|NCT03418922|531527883|FG001|Overall Study|Adverse Event|2|||
147371397|NCT03418922|531527882|FG000|Overall Study|Death|0|||
147371398|NCT03418922|531527883|FG001|Overall Study|Death|1|||
147371399|NCT03418922|531527882|FG000|Overall Study|Physician Decision|0|||
147371400|NCT03418922|531527883|FG001|Overall Study|Physician Decision|1|||
147371401|NCT03577106|531527884|FG000|Overall Study|Withdrawal by Subject|3|||
147371402|NCT03601715|531527887|FG000|Second Intervention|Lost to Follow-up|1|||
147371403|NCT03601715|531527888|FG001|Second Intervention|Lost to Follow-up|1|||
147371404|NCT03601715|531527889|FG002|Second Intervention|Lost to Follow-up|0|||
147371405|NCT02347332|531527890|FG000|Overall Study|Not treated|5|||
147371406|NCT02347332|531527891|FG001|Overall Study|Not treated|2|||
147371407|NCT02347332|531527890|FG000|Overall Study|Progressive disease|141|||
147371408|NCT02347332|531527891|FG001|Overall Study|Progressive disease|159|||
147371409|NCT02347332|531527890|FG000|Overall Study|Adverse Event|50|||
147371410|NCT02347332|531527891|FG001|Overall Study|Adverse Event|41|||
147371411|NCT02347332|531527890|FG000|Overall Study|Death (Unknown, Various reasons)|6|||
147371412|NCT02347332|531527891|FG001|Overall Study|Death (Unknown, Various reasons)|6|||
147371413|NCT02347332|531527890|FG000|Overall Study|Protocol Violation|1|||
147371414|NCT02347332|531527891|FG001|Overall Study|Protocol Violation|1|||
147371415|NCT02347332|531527890|FG000|Overall Study|Lost to Follow-up|2|||
147371416|NCT02347332|531527891|FG001|Overall Study|Lost to Follow-up|1|||
147371417|NCT02347332|531527890|FG000|Overall Study|Physician Decision|4|||
147371418|NCT02347332|531527891|FG001|Overall Study|Physician Decision|3|||
147371419|NCT02347332|531527890|FG000|Overall Study|Withdrawal by Subject|20|||
147371420|NCT02347332|531527891|FG001|Overall Study|Withdrawal by Subject|14|||
147371421|NCT02347332|531527890|FG000|Overall Study|Protocol requirement|1|||
147371422|NCT02347332|531527891|FG001|Overall Study|Protocol requirement|1|||
147371423|NCT02347332|531527890|FG000|Overall Study|Switch Post-Trial program|0|||
147371424|NCT02347332|531527891|FG001|Overall Study|Switch Post-Trial program|1|||
147371425|NCT01478594|531527893|FG000|Overall Study|Randomized but Never Received Study Drug|0|||
147371426|NCT01478594|531527894|FG001|Overall Study|Randomized but Never Received Study Drug|1|||
147371427|NCT01478594|531527893|FG000|Overall Study|Death|45|||
147371428|NCT01478594|531527894|FG001|Overall Study|Death|18|||
147371429|NCT01478594|531527893|FG000|Overall Study|Lost to Follow-up|3|||
147371430|NCT01478594|531527894|FG001|Overall Study|Lost to Follow-up|1|||
147371431|NCT01478594|531527893|FG000|Overall Study|Withdrawal by Subject|9|||
147371432|NCT01478594|531527894|FG001|Overall Study|Withdrawal by Subject|3|||
147371433|NCT01478594|531527893|FG000|Overall Study|Study Closed by Sponsor|8|||
147371434|NCT01478594|531527894|FG001|Overall Study|Study Closed by Sponsor|5|||
147371435|NCT01313884|531527896|FG000|Overall Study|Per insurance pvdr, pt can't be on cl tr|1|||
147371436|NCT01970007|531527897|FG000|Overall Study|Death|5|||
147371437|NCT01970007|531527897|FG000|Overall Study|Withdrawal by Subject|23|||
147371438|NCT01970007|531527897|FG000|Overall Study|Lost to Follow-up|24|||
147371439|NCT01970007|531527897|FG000|Overall Study|"Other endpoint"|3|||
147371440|NCT02854436|531527898|FG000|Overall Study|Adverse Event|1|||
147371441|NCT02854436|531527898|FG000|Overall Study|Death|208|||
147371442|NCT02854436|531527898|FG000|Overall Study|Lost to Follow-up|5|||
147371443|NCT02854436|531527898|FG000|Overall Study|Withdrawal by Subject|24|||
147371444|NCT02854436|531527898|FG000|Overall Study|Other|45|||
147371445|NCT02854436|531527898|FG000|Overall Study|Physician Decision|6|||
147371446|NCT04250194|531527899|FG000|Overall Study|Declined to schedule biopsy|6|||
147371447|NCT04250194|531527900|FG001|Overall Study|Declined to schedule biopsy|10|||
147371448|NCT04250194|531527899|FG000|Overall Study|Medically Unfit for Biopsy|2|||
147371449|NCT04250194|531527900|FG001|Overall Study|Medically Unfit for Biopsy|1|||
147371450|NCT04250194|531527899|FG000|Overall Study|New data available meeting exclusion criterion: PET/CT with avid adenopathy|0|||
147371451|NCT04250194|531527900|FG001|Overall Study|New data available meeting exclusion criterion: PET/CT with avid adenopathy|2|||
147371452|NCT04250194|531527899|FG000|Overall Study|New data available meeting exclusion criterion: interim CT demonstrated rapid growth to >30 mm|0|||
147371453|NCT04250194|531527900|FG001|Overall Study|New data available meeting exclusion criterion: interim CT demonstrated rapid growth to >30 mm|2|||
147611042|NCT02640690|532390897|FG000|Overall Study|Withdrawal by Subject|16|||
147611043|NCT02640690|532390898|FG001|Overall Study|Withdrawal by Subject|20|||
147611044|NCT02640690|532390897|FG000|Overall Study|Partial completion (insufficient sessions)|2|||
147611045|NCT02640690|532390898|FG001|Overall Study|Partial completion (insufficient sessions)|5|||
147611046|NCT01118975|532390899|FG000|Overall Study|Adverse Event|0|||
147611047|NCT01118975|532390900|FG001|Overall Study|Adverse Event|1|||
147371454|NCT04250194|531527899|FG000|Overall Study|New data available meeting exclusion criterion: PET/CT with avid endobronchial lesion|0|||
147611048|NCT01645787|532390901|FG000|Washout (2 Weeks)|Adverse Event|1|||
147611049|NCT01645787|532390902|FG001|Washout (2 Weeks)|Adverse Event|0|||
147611050|NCT04315506|532390907|FG000|Overall Study|Lost to Follow-up|74|||
147371455|NCT04250194|531527900|FG001|Overall Study|New data available meeting exclusion criterion: PET/CT with avid endobronchial lesion|1|||
147371456|NCT01499849|531527903|FG000|Overall Study|Adverse Event|28|||
147371457|NCT01499849|531527904|FG001|Overall Study|Adverse Event|32|||
147371458|NCT01499849|531527903|FG000|Overall Study|Chemo completed or Change in Therapy|70|||
147371459|NCT01499849|531527904|FG001|Overall Study|Chemo completed or Change in Therapy|67|||
147371460|NCT01499849|531527903|FG000|Overall Study|Withdrawal by Subject|43|||
147371461|NCT01499849|531527904|FG001|Overall Study|Withdrawal by Subject|43|||
147371462|NCT01499849|531527903|FG000|Overall Study|Death|5|||
147371463|NCT01499849|531527904|FG001|Overall Study|Death|7|||
147371464|NCT01499849|531527903|FG000|Overall Study|Disease Progression|11|||
147371465|NCT01499849|531527904|FG001|Overall Study|Disease Progression|10|||
147371466|NCT01499849|531527903|FG000|Overall Study|Protocol Violation|11|||
147371467|NCT01499849|531527904|FG001|Overall Study|Protocol Violation|11|||
147371468|NCT01499849|531527903|FG000|Overall Study|Physician Decision|20|||
147371469|NCT01499849|531527904|FG001|Overall Study|Physician Decision|19|||
147371470|NCT01499849|531527903|FG000|Overall Study|Lack of Efficacy|3|||
147371471|NCT01499849|531527904|FG001|Overall Study|Lack of Efficacy|4|||
147371472|NCT01499849|531527903|FG000|Overall Study|Lost to Follow-up|6|||
147371473|NCT01499849|531527904|FG001|Overall Study|Lost to Follow-up|3|||
147371474|NCT01499849|531527903|FG000|Overall Study|Other Reasons|27|||
147371475|NCT01499849|531527904|FG001|Overall Study|Other Reasons|30|||
147371476|NCT00174252|531527905|FG000|Overall Study|Protocol Violation|2|||
147371477|NCT00622700|531527911|FG000|Core Treatment Period|Randomized but Not Treated|0|||
147371478|NCT00622700|531527912|FG001|Core Treatment Period|Randomized but Not Treated|2|||
147371479|NCT00622700|531527913|FG002|Core Treatment Period|Randomized but Not Treated|2|||
147371480|NCT00622700|531527914|FG003|Core Treatment Period|Randomized but Not Treated|0|||
147371481|NCT00622700|531527915|FG004|Core Treatment Period|Randomized but Not Treated|0|||
147371482|NCT00622700|531527916|FG005|Core Treatment Period|Randomized but Not Treated|0|||
147371483|NCT00622700|531527917|FG006|Core Treatment Period|Randomized but Not Treated|0|||
147371484|NCT00622700|531527911|FG000|Core Treatment Period|Adverse Event|18|||
147371485|NCT00622700|531527912|FG001|Core Treatment Period|Adverse Event|25|||
147371486|NCT00622700|531527913|FG002|Core Treatment Period|Adverse Event|18|||
147371487|NCT00622700|531527914|FG003|Core Treatment Period|Adverse Event|0|||
147371488|NCT00622700|531527915|FG004|Core Treatment Period|Adverse Event|0|||
147371489|NCT00622700|531527916|FG005|Core Treatment Period|Adverse Event|0|||
147371490|NCT00622700|531527917|FG006|Core Treatment Period|Adverse Event|0|||
147371491|NCT00622700|531527911|FG000|Core Treatment Period|Lack of Efficacy|19|||
147371492|NCT00622700|531527912|FG001|Core Treatment Period|Lack of Efficacy|6|||
147371493|NCT00622700|531527913|FG002|Core Treatment Period|Lack of Efficacy|12|||
147371494|NCT00622700|531527914|FG003|Core Treatment Period|Lack of Efficacy|0|||
147371495|NCT00622700|531527915|FG004|Core Treatment Period|Lack of Efficacy|0|||
147371496|NCT00622700|531527916|FG005|Core Treatment Period|Lack of Efficacy|0|||
147371497|NCT00622700|531527917|FG006|Core Treatment Period|Lack of Efficacy|0|||
147371498|NCT00622700|531527911|FG000|Core Treatment Period|Lost to Follow-up|1|||
147371499|NCT00622700|531527912|FG001|Core Treatment Period|Lost to Follow-up|1|||
147371500|NCT00622700|531527913|FG002|Core Treatment Period|Lost to Follow-up|1|||
147371501|NCT00622700|531527914|FG003|Core Treatment Period|Lost to Follow-up|0|||
147371502|NCT00622700|531527915|FG004|Core Treatment Period|Lost to Follow-up|0|||
147371503|NCT00622700|531527916|FG005|Core Treatment Period|Lost to Follow-up|0|||
147371504|NCT00622700|531527917|FG006|Core Treatment Period|Lost to Follow-up|0|||
147371505|NCT00622700|531527911|FG000|Core Treatment Period|Death|1|||
147371506|NCT00622700|531527912|FG001|Core Treatment Period|Death|0|||
147371507|NCT00622700|531527913|FG002|Core Treatment Period|Death|0|||
147371508|NCT00622700|531527914|FG003|Core Treatment Period|Death|0|||
147371509|NCT00622700|531527915|FG004|Core Treatment Period|Death|0|||
147371510|NCT00622700|531527916|FG005|Core Treatment Period|Death|0|||
147371511|NCT00622700|531527917|FG006|Core Treatment Period|Death|0|||
147371512|NCT00622700|531527911|FG000|Core Treatment Period|Progressive Disease|3|||
147371513|NCT00622700|531527912|FG001|Core Treatment Period|Progressive Disease|1|||
147371514|NCT00622700|531527913|FG002|Core Treatment Period|Progressive Disease|0|||
147371515|NCT00622700|531527914|FG003|Core Treatment Period|Progressive Disease|0|||
147371516|NCT00622700|531527915|FG004|Core Treatment Period|Progressive Disease|0|||
147371517|NCT00622700|531527916|FG005|Core Treatment Period|Progressive Disease|0|||
147371518|NCT00622700|531527917|FG006|Core Treatment Period|Progressive Disease|0|||
147371519|NCT00622700|531527911|FG000|Core Treatment Period|Withdrawal by Subject|12|||
147371520|NCT00622700|531527912|FG001|Core Treatment Period|Withdrawal by Subject|18|||
147371521|NCT00622700|531527913|FG002|Core Treatment Period|Withdrawal by Subject|15|||
147371522|NCT00622700|531527914|FG003|Core Treatment Period|Withdrawal by Subject|0|||
147371523|NCT00622700|531527915|FG004|Core Treatment Period|Withdrawal by Subject|0|||
147371524|NCT00622700|531527916|FG005|Core Treatment Period|Withdrawal by Subject|0|||
147371525|NCT00622700|531527917|FG006|Core Treatment Period|Withdrawal by Subject|0|||
147371526|NCT00622700|531527911|FG000|Core Treatment Period|Other than specified above|2|||
147371527|NCT00622700|531527912|FG001|Core Treatment Period|Other than specified above|2|||
147371528|NCT00622700|531527913|FG002|Core Treatment Period|Other than specified above|5|||
147663680|NCT05616013|532591570|FG005|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|0|||
147663681|NCT05616013|532591571|FG006|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|0|||
147663682|NCT05616013|532591572|FG007|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|0|||
147663683|NCT05616013|532591573|FG008|Overall Study|Difficulty Following Protocol Requirement, Dissatisfied with Amount of Weight Lost|0|||
147663684|NCT05616013|532591565|FG000|Overall Study|Withdrawn due to Elevated Blood Pressure|0|||
147663685|NCT05616013|532591566|FG001|Overall Study|Withdrawn due to Elevated Blood Pressure|0|||
147663686|NCT05616013|532591567|FG002|Overall Study|Withdrawn due to Elevated Blood Pressure|0|||
147663687|NCT05616013|532591568|FG003|Overall Study|Withdrawn due to Elevated Blood Pressure|0|||
147663688|NCT05616013|532591569|FG004|Overall Study|Withdrawn due to Elevated Blood Pressure|0|||
147663689|NCT05616013|532591570|FG005|Overall Study|Withdrawn due to Elevated Blood Pressure|0|||
147663690|NCT05616013|532591571|FG006|Overall Study|Withdrawn due to Elevated Blood Pressure|1|||
147663691|NCT05616013|532591572|FG007|Overall Study|Withdrawn due to Elevated Blood Pressure|0|||
147663692|NCT05616013|532591573|FG008|Overall Study|Withdrawn due to Elevated Blood Pressure|0|||
147663693|NCT05616013|532591565|FG000|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|0|||
147663694|NCT05616013|532591566|FG001|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|0|||
147663695|NCT05616013|532591567|FG002|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|0|||
147663696|NCT05616013|532591568|FG003|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|0|||
147663697|NCT05616013|532591569|FG004|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|0|||
147663698|NCT05616013|532591570|FG005|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|0|||
147663699|NCT05616013|532591571|FG006|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|0|||
147663700|NCT05616013|532591572|FG007|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|0|||
147663701|NCT05616013|532591573|FG008|Overall Study|Participant Reported Concerns About their fat Percentage Dropping too low|1|||
147663702|NCT05616013|532591565|FG000|Overall Study|Unable to Visit site as Participant Moved town|0|||
147663703|NCT05616013|532591566|FG001|Overall Study|Unable to Visit site as Participant Moved town|0|||
147663704|NCT05616013|532591567|FG002|Overall Study|Unable to Visit site as Participant Moved town|0|||
147663705|NCT05616013|532591568|FG003|Overall Study|Unable to Visit site as Participant Moved town|0|||
147663706|NCT05616013|532591569|FG004|Overall Study|Unable to Visit site as Participant Moved town|0|||
147663707|NCT05616013|532591570|FG005|Overall Study|Unable to Visit site as Participant Moved town|0|||
147663708|NCT05616013|532591571|FG006|Overall Study|Unable to Visit site as Participant Moved town|0|||
147663709|NCT05616013|532591572|FG007|Overall Study|Unable to Visit site as Participant Moved town|0|||
147663710|NCT05616013|532591573|FG008|Overall Study|Unable to Visit site as Participant Moved town|1|||
147663711|NCT05116202|532591574|FG000|Overall Study|Study Terminated by Sponsor|21|||
147663712|NCT05116202|532591575|FG001|Overall Study|Study Terminated by Sponsor|38|||
147663713|NCT05116202|532591576|FG002|Overall Study|Study Terminated by Sponsor|17|||
147663714|NCT05116202|532591577|FG003|Overall Study|Study Terminated by Sponsor|18|||
147663715|NCT05116202|532591578|FG004|Overall Study|Study Terminated by Sponsor|0|||
147663716|NCT05116202|532591574|FG000|Overall Study|Withdrawal by Subject|0|||
147663717|NCT05116202|532591575|FG001|Overall Study|Withdrawal by Subject|1|||
147663718|NCT05116202|532591576|FG002|Overall Study|Withdrawal by Subject|1|||
147663719|NCT05116202|532591577|FG003|Overall Study|Withdrawal by Subject|1|||
147663720|NCT05116202|532591578|FG004|Overall Study|Withdrawal by Subject|1|||
147663721|NCT05116202|532591574|FG000|Overall Study|Lost to Follow-up|0|||
147663722|NCT05116202|532591575|FG001|Overall Study|Lost to Follow-up|0|||
147663723|NCT05116202|532591576|FG002|Overall Study|Lost to Follow-up|0|||
147663724|NCT05116202|532591577|FG003|Overall Study|Lost to Follow-up|0|||
147663725|NCT05116202|532591578|FG004|Overall Study|Lost to Follow-up|2|||
147663726|NCT05116202|532591574|FG000|Overall Study|Death|1|||
147663727|NCT05116202|532591575|FG001|Overall Study|Death|1|||
147663728|NCT05116202|532591576|FG002|Overall Study|Death|2|||
147663729|NCT05116202|532591577|FG003|Overall Study|Death|1|||
147663730|NCT05116202|532591578|FG004|Overall Study|Death|5|||
147663731|NCT05067972|532591579|FG000|Part 1: Treatment|Global Deterioration of Health Status|0|||
147663732|NCT05067972|532591580|FG001|Part 1: Treatment|Global Deterioration of Health Status|1|||
147663733|NCT05067972|532591581|FG002|Part 1: Treatment|Global Deterioration of Health Status|0|||
147663734|NCT05067972|532591582|FG003|Part 1: Treatment|Global Deterioration of Health Status|1|||
147663735|NCT05067972|532591583|FG004|Part 1: Treatment|Global Deterioration of Health Status|0|||
147663736|NCT05067972|532591584|FG005|Part 1: Treatment|Global Deterioration of Health Status|0|||
147663737|NCT05067972|532591585|FG006|Part 1: Treatment|Global Deterioration of Health Status|1|||
147371529|NCT00622700|531527914|FG003|Core Treatment Period|Other than specified above|0|||
147371530|NCT00622700|531527915|FG004|Core Treatment Period|Other than specified above|0|||
147371531|NCT00622700|531527916|FG005|Core Treatment Period|Other than specified above|0|||
147371532|NCT00622700|531527917|FG006|Core Treatment Period|Other than specified above|0|||
147663738|NCT05067972|532591579|FG000|Part 1: Treatment|Withdrawal by Subject|0|||
147663739|NCT05067972|532591580|FG001|Part 1: Treatment|Withdrawal by Subject|0|||
147663740|NCT05067972|532591581|FG002|Part 1: Treatment|Withdrawal by Subject|0|||
147663741|NCT05067972|532591582|FG003|Part 1: Treatment|Withdrawal by Subject|0|||
147371533|NCT00622700|531527911|FG000|Extension Treatment Period|Adverse Event|0|||
147371534|NCT00622700|531527912|FG001|Extension Treatment Period|Adverse Event|0|||
147371535|NCT00622700|531527913|FG002|Extension Treatment Period|Adverse Event|0|||
147371536|NCT00622700|531527914|FG003|Extension Treatment Period|Adverse Event|5|||
147371537|NCT00622700|531527915|FG004|Extension Treatment Period|Adverse Event|9|||
147371538|NCT00622700|531527916|FG005|Extension Treatment Period|Adverse Event|6|||
147371539|NCT00622700|531527917|FG006|Extension Treatment Period|Adverse Event|8|||
147371540|NCT00622700|531527911|FG000|Extension Treatment Period|Lack of Efficacy|0|||
147371541|NCT00622700|531527912|FG001|Extension Treatment Period|Lack of Efficacy|0|||
147371542|NCT00622700|531527913|FG002|Extension Treatment Period|Lack of Efficacy|0|||
147371543|NCT00622700|531527914|FG003|Extension Treatment Period|Lack of Efficacy|2|||
147371544|NCT00622700|531527915|FG004|Extension Treatment Period|Lack of Efficacy|8|||
147371545|NCT00622700|531527916|FG005|Extension Treatment Period|Lack of Efficacy|1|||
147371546|NCT00622700|531527917|FG006|Extension Treatment Period|Lack of Efficacy|9|||
147371547|NCT00622700|531527911|FG000|Extension Treatment Period|Protocol Violation|0|||
147371548|NCT00622700|531527912|FG001|Extension Treatment Period|Protocol Violation|0|||
147371549|NCT00622700|531527913|FG002|Extension Treatment Period|Protocol Violation|0|||
147371550|NCT00622700|531527914|FG003|Extension Treatment Period|Protocol Violation|0|||
147371551|NCT00622700|531527915|FG004|Extension Treatment Period|Protocol Violation|0|||
147371552|NCT00622700|531527916|FG005|Extension Treatment Period|Protocol Violation|2|||
147371553|NCT00622700|531527917|FG006|Extension Treatment Period|Protocol Violation|0|||
147371554|NCT00622700|531527911|FG000|Extension Treatment Period|Lost to Follow-up|0|||
147371555|NCT00622700|531527912|FG001|Extension Treatment Period|Lost to Follow-up|0|||
147371556|NCT00622700|531527913|FG002|Extension Treatment Period|Lost to Follow-up|0|||
147371557|NCT00622700|531527914|FG003|Extension Treatment Period|Lost to Follow-up|0|||
147371558|NCT00622700|531527915|FG004|Extension Treatment Period|Lost to Follow-up|1|||
147371559|NCT00622700|531527916|FG005|Extension Treatment Period|Lost to Follow-up|0|||
147371560|NCT00622700|531527917|FG006|Extension Treatment Period|Lost to Follow-up|0|||
147371561|NCT00622700|531527911|FG000|Extension Treatment Period|Progressive Disease|0|||
147371562|NCT00622700|531527912|FG001|Extension Treatment Period|Progressive Disease|0|||
147371563|NCT00622700|531527913|FG002|Extension Treatment Period|Progressive Disease|0|||
147371564|NCT00622700|531527914|FG003|Extension Treatment Period|Progressive Disease|1|||
147371565|NCT00622700|531527915|FG004|Extension Treatment Period|Progressive Disease|2|||
147371566|NCT00622700|531527916|FG005|Extension Treatment Period|Progressive Disease|0|||
147371567|NCT00622700|531527917|FG006|Extension Treatment Period|Progressive Disease|2|||
147371568|NCT00622700|531527911|FG000|Extension Treatment Period|Withdrawal by Subject|0|||
147371569|NCT00622700|531527912|FG001|Extension Treatment Period|Withdrawal by Subject|0|||
147371570|NCT00622700|531527913|FG002|Extension Treatment Period|Withdrawal by Subject|0|||
147371571|NCT00622700|531527914|FG003|Extension Treatment Period|Withdrawal by Subject|11|||
147371572|NCT00622700|531527915|FG004|Extension Treatment Period|Withdrawal by Subject|16|||
147371573|NCT00622700|531527916|FG005|Extension Treatment Period|Withdrawal by Subject|6|||
147371574|NCT00622700|531527917|FG006|Extension Treatment Period|Withdrawal by Subject|10|||
147371575|NCT00622700|531527911|FG000|Extension Treatment Period|Missing|0|||
147371576|NCT00622700|531527912|FG001|Extension Treatment Period|Missing|0|||
147371577|NCT00622700|531527913|FG002|Extension Treatment Period|Missing|0|||
147371578|NCT00622700|531527914|FG003|Extension Treatment Period|Missing|2|||
147371579|NCT00622700|531527915|FG004|Extension Treatment Period|Missing|3|||
147371580|NCT00622700|531527916|FG005|Extension Treatment Period|Missing|1|||
147371581|NCT00622700|531527917|FG006|Extension Treatment Period|Missing|0|||
147371582|NCT00622700|531527911|FG000|Extension Treatment Period|Other than specified above|0|||
147371583|NCT00622700|531527912|FG001|Extension Treatment Period|Other than specified above|0|||
147371584|NCT00622700|531527913|FG002|Extension Treatment Period|Other than specified above|0|||
147371585|NCT00622700|531527914|FG003|Extension Treatment Period|Other than specified above|0|||
147371586|NCT00622700|531527915|FG004|Extension Treatment Period|Other than specified above|0|||
147371587|NCT00622700|531527916|FG005|Extension Treatment Period|Other than specified above|1|||
147371588|NCT00622700|531527917|FG006|Extension Treatment Period|Other than specified above|1|||
147371589|NCT00942266|531527918|FG000|Overall Study|Withdrawal by Subject|1|||
147371590|NCT00942266|531527919|FG001|Overall Study|Withdrawal by Subject|0|||
147371591|NCT00942266|531527918|FG000|Overall Study|Adverse Event|2|||
147371592|NCT00942266|531527919|FG001|Overall Study|Adverse Event|1|||
147371593|NCT00942266|531527918|FG000|Overall Study|Disease Progression|38|||
147371594|NCT00942266|531527919|FG001|Overall Study|Disease Progression|11|||
147371595|NCT00942266|531527918|FG000|Overall Study|Failure to thrive and pt withdrawal|0|||
147371596|NCT00942266|531527919|FG001|Overall Study|Failure to thrive and pt withdrawal|1|||
147371597|NCT00942266|531527918|FG000|Overall Study|Intercurrent illness|0|||
147371598|NCT00942266|531527919|FG001|Overall Study|Intercurrent illness|1|||
147371599|NCT00942266|531527918|FG000|Overall Study|Physician Decision|2|||
147371600|NCT00942266|531527919|FG001|Overall Study|Physician Decision|0|||
147371601|NCT00942266|531527918|FG000|Overall Study|medical deterioration (pneumonia)|0|||
147371602|NCT00942266|531527919|FG001|Overall Study|medical deterioration (pneumonia)|1|||
147371603|NCT03611556|531527920|FG000|Overall Study|Death|7|||
147371604|NCT03611556|531527921|FG001|Overall Study|Death|7|||
147371605|NCT03611556|531527922|FG002|Overall Study|Death|3|||
147371606|NCT03611556|531527923|FG003|Overall Study|Death|8|||
147371607|NCT03611556|531527924|FG004|Overall Study|Death|47|||
147371608|NCT03611556|531527925|FG005|Overall Study|Death|32|||
147371609|NCT03611556|531527926|FG006|Overall Study|Death|53|||
147371610|NCT03611556|531527920|FG000|Overall Study|Withdrawal by Subject|0|||
147371611|NCT03611556|531527921|FG001|Overall Study|Withdrawal by Subject|0|||
147371612|NCT03611556|531527922|FG002|Overall Study|Withdrawal by Subject|0|||
147371613|NCT03611556|531527923|FG003|Overall Study|Withdrawal by Subject|0|||
147371614|NCT03611556|531527924|FG004|Overall Study|Withdrawal by Subject|4|||
147371615|NCT03611556|531527925|FG005|Overall Study|Withdrawal by Subject|2|||
147371616|NCT03611556|531527926|FG006|Overall Study|Withdrawal by Subject|4|||
147371617|NCT03611556|531527920|FG000|Overall Study|Sponsor decision|0|||
147371618|NCT03611556|531527921|FG001|Overall Study|Sponsor decision|0|||
147371619|NCT03611556|531527922|FG002|Overall Study|Sponsor decision|0|||
147371620|NCT03611556|531527923|FG003|Overall Study|Sponsor decision|0|||
147371621|NCT03611556|531527924|FG004|Overall Study|Sponsor decision|9|||
147371622|NCT03611556|531527925|FG005|Overall Study|Sponsor decision|4|||
147371623|NCT03611556|531527926|FG006|Overall Study|Sponsor decision|12|||
147371624|NCT03611556|531527920|FG000|Overall Study|Reasons|0|||
147371625|NCT03611556|531527921|FG001|Overall Study|Reasons|0|||
147371626|NCT03611556|531527922|FG002|Overall Study|Reasons|0|||
147371627|NCT03611556|531527923|FG003|Overall Study|Reasons|0|||
147371628|NCT03611556|531527924|FG004|Overall Study|Reasons|2|||
147371629|NCT03611556|531527925|FG005|Overall Study|Reasons|0|||
147371630|NCT03611556|531527926|FG006|Overall Study|Reasons|1|||
147371631|NCT02844439|531527932|FG000|Overall Study|Withdrawal by Subject|1|||
147371632|NCT02844439|531527932|FG000|Overall Study|Lost to Follow-up|2|||
147371633|NCT02844439|531527932|FG000|Overall Study|Termination by Sponsor|4|||
147371634|NCT02844439|531527932|FG000|Overall Study|Death|28|||
147371635|NCT02844439|531527932|FG000|Overall Study|Other|5|||
147371636|NCT05580003|531527938|FG000|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
147371637|NCT05580003|531527939|FG001|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
147371638|NCT05580003|531527940|FG002|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
147371639|NCT05580003|531527941|FG003|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
147371640|NCT05580003|531527942|FG004|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
147371641|NCT05580003|531527943|FG005|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
147371642|NCT05580003|531527944|FG006|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|1|||
147371643|NCT05580003|531527945|FG007|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
147371644|NCT05580003|531527946|FG008|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
147371645|NCT05580003|531527947|FG009|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
147371646|NCT05580003|531527948|FG010|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
147371647|NCT05580003|531527949|FG011|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
147371648|NCT05580003|531527950|FG012|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
147371649|NCT05580003|531527951|FG013|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
147371650|NCT05580003|531527952|FG014|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
147371651|NCT05580003|531527953|FG015|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
147371652|NCT05580003|531527954|FG016|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
147371653|NCT05580003|531527955|FG017|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
147371654|NCT05580003|531527956|FG018|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
147371655|NCT05580003|531527957|FG019|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
147371656|NCT05580003|531527958|FG020|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
147371657|NCT05580003|531527959|FG021|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
147371658|NCT05580003|531527960|FG022|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
147371659|NCT05580003|531527961|FG023|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
147371660|NCT05580003|531527962|FG024|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
147371661|NCT05580003|531527963|FG025|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
147371662|NCT05580003|531527964|FG026|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
147371663|NCT05580003|531527965|FG027|Part (P) 1 Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
147371664|NCT05580003|531527938|FG000|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
147371665|NCT05580003|531527939|FG001|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
147371666|NCT05580003|531527940|FG002|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
147371667|NCT05580003|531527941|FG003|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
147371668|NCT05580003|531527942|FG004|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
147371669|NCT05580003|531527943|FG005|Part 1 Treatment Period 2 (Day 1)|Physician Decision|1|||
147371670|NCT05580003|531527944|FG006|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
147371671|NCT05580003|531527945|FG007|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
147371672|NCT05580003|531527946|FG008|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
147371673|NCT05580003|531527947|FG009|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
147371674|NCT05580003|531527948|FG010|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
147371675|NCT05580003|531527949|FG011|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
147371676|NCT05580003|531527950|FG012|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
147371677|NCT05580003|531527951|FG013|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
147371678|NCT05580003|531527952|FG014|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
147371679|NCT05580003|531527953|FG015|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
147371680|NCT05580003|531527954|FG016|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
147663742|NCT05067972|532591583|FG004|Part 1: Treatment|Withdrawal by Subject|1|||
147663743|NCT05067972|532591584|FG005|Part 1: Treatment|Withdrawal by Subject|2|||
147663744|NCT05067972|532591585|FG006|Part 1: Treatment|Withdrawal by Subject|1|||
147663745|NCT05067972|532591579|FG000|Part 1: Treatment|Progressive Disease|3|||
147663746|NCT05067972|532591580|FG001|Part 1: Treatment|Progressive Disease|3|||
147371681|NCT05580003|531527955|FG017|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
147371682|NCT05580003|531527956|FG018|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
147371683|NCT05580003|531527957|FG019|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
147371684|NCT05580003|531527958|FG020|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
147371685|NCT05580003|531527959|FG021|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
147371686|NCT05580003|531527960|FG022|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
147371687|NCT05580003|531527961|FG023|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
147371688|NCT05580003|531527962|FG024|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
147371689|NCT05580003|531527963|FG025|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
147371690|NCT05580003|531527964|FG026|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
147371691|NCT05580003|531527965|FG027|Part 1 Treatment Period 2 (Day 1)|Physician Decision|0|||
147371692|NCT05580003|531527938|FG000|Part 1 Treatment Period 2 (Day 1)|Other|0|||
147371693|NCT05580003|531527939|FG001|Part 1 Treatment Period 2 (Day 1)|Other|0|||
147371694|NCT05580003|531527940|FG002|Part 1 Treatment Period 2 (Day 1)|Other|0|||
147371695|NCT05580003|531527941|FG003|Part 1 Treatment Period 2 (Day 1)|Other|1|||
147371696|NCT05580003|531527942|FG004|Part 1 Treatment Period 2 (Day 1)|Other|0|||
147371697|NCT05580003|531527943|FG005|Part 1 Treatment Period 2 (Day 1)|Other|0|||
147371698|NCT05580003|531527944|FG006|Part 1 Treatment Period 2 (Day 1)|Other|0|||
147371699|NCT05580003|531527945|FG007|Part 1 Treatment Period 2 (Day 1)|Other|0|||
147371700|NCT05580003|531527946|FG008|Part 1 Treatment Period 2 (Day 1)|Other|0|||
147371701|NCT05580003|531527947|FG009|Part 1 Treatment Period 2 (Day 1)|Other|0|||
147371702|NCT05580003|531527948|FG010|Part 1 Treatment Period 2 (Day 1)|Other|0|||
147371703|NCT05580003|531527949|FG011|Part 1 Treatment Period 2 (Day 1)|Other|0|||
147371704|NCT05580003|531527950|FG012|Part 1 Treatment Period 2 (Day 1)|Other|0|||
147371705|NCT05580003|531527951|FG013|Part 1 Treatment Period 2 (Day 1)|Other|0|||
147371706|NCT05580003|531527952|FG014|Part 1 Treatment Period 2 (Day 1)|Other|0|||
147371707|NCT05580003|531527953|FG015|Part 1 Treatment Period 2 (Day 1)|Other|0|||
147371708|NCT05580003|531527954|FG016|Part 1 Treatment Period 2 (Day 1)|Other|0|||
147371709|NCT05580003|531527955|FG017|Part 1 Treatment Period 2 (Day 1)|Other|0|||
147371710|NCT05580003|531527956|FG018|Part 1 Treatment Period 2 (Day 1)|Other|0|||
147371711|NCT05580003|531527957|FG019|Part 1 Treatment Period 2 (Day 1)|Other|0|||
147371712|NCT05580003|531527958|FG020|Part 1 Treatment Period 2 (Day 1)|Other|0|||
147371713|NCT05580003|531527959|FG021|Part 1 Treatment Period 2 (Day 1)|Other|0|||
147371714|NCT05580003|531527960|FG022|Part 1 Treatment Period 2 (Day 1)|Other|0|||
147371715|NCT05580003|531527961|FG023|Part 1 Treatment Period 2 (Day 1)|Other|0|||
147371716|NCT05580003|531527962|FG024|Part 1 Treatment Period 2 (Day 1)|Other|0|||
147371717|NCT05580003|531527963|FG025|Part 1 Treatment Period 2 (Day 1)|Other|0|||
147371718|NCT05580003|531527964|FG026|Part 1 Treatment Period 2 (Day 1)|Other|0|||
147371719|NCT05580003|531527965|FG027|Part 1 Treatment Period 2 (Day 1)|Other|0|||
147371720|NCT05580003|531527938|FG000|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
147371721|NCT05580003|531527939|FG001|Part 1: Treatment Period 3 (Day 1)|Physician Decision|1|||
147371722|NCT05580003|531527940|FG002|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
147371723|NCT05580003|531527941|FG003|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
147371724|NCT05580003|531527942|FG004|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
147371725|NCT05580003|531527943|FG005|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
147371726|NCT05580003|531527944|FG006|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
147371727|NCT05580003|531527945|FG007|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
147371728|NCT05580003|531527946|FG008|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
147371729|NCT05580003|531527947|FG009|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
147371730|NCT05580003|531527948|FG010|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
147371731|NCT05580003|531527949|FG011|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
147371732|NCT05580003|531527950|FG012|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
147663747|NCT05067972|532591581|FG002|Part 1: Treatment|Progressive Disease|4|||
147371733|NCT05580003|531527951|FG013|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
147371734|NCT05580003|531527952|FG014|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
147371735|NCT05580003|531527953|FG015|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
147371736|NCT05580003|531527954|FG016|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
147371737|NCT05580003|531527955|FG017|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
147371738|NCT05580003|531527956|FG018|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
147371739|NCT05580003|531527957|FG019|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
147371740|NCT05580003|531527958|FG020|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
147371741|NCT05580003|531527959|FG021|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
147371742|NCT05580003|531527960|FG022|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
147371743|NCT05580003|531527961|FG023|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
147371744|NCT05580003|531527962|FG024|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
147371745|NCT05580003|531527963|FG025|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
147371746|NCT05580003|531527964|FG026|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
147371747|NCT05580003|531527965|FG027|Part 1: Treatment Period 3 (Day 1)|Physician Decision|0|||
147371748|NCT05580003|531527938|FG000|Part 2 (up to 10 Days)|Other|0|||
147371749|NCT05580003|531527939|FG001|Part 2 (up to 10 Days)|Other|0|||
147371750|NCT05580003|531527940|FG002|Part 2 (up to 10 Days)|Other|0|||
147371751|NCT05580003|531527941|FG003|Part 2 (up to 10 Days)|Other|0|||
147371752|NCT05580003|531527942|FG004|Part 2 (up to 10 Days)|Other|0|||
147371753|NCT05580003|531527943|FG005|Part 2 (up to 10 Days)|Other|0|||
147371754|NCT05580003|531527944|FG006|Part 2 (up to 10 Days)|Other|0|||
147371755|NCT05580003|531527945|FG007|Part 2 (up to 10 Days)|Other|0|||
147371756|NCT05580003|531527946|FG008|Part 2 (up to 10 Days)|Other|0|||
147371757|NCT05580003|531527947|FG009|Part 2 (up to 10 Days)|Other|1|||
147371758|NCT05580003|531527948|FG010|Part 2 (up to 10 Days)|Other|0|||
147371759|NCT05580003|531527949|FG011|Part 2 (up to 10 Days)|Other|0|||
147371760|NCT05580003|531527950|FG012|Part 2 (up to 10 Days)|Other|0|||
147371761|NCT05580003|531527951|FG013|Part 2 (up to 10 Days)|Other|0|||
147371762|NCT05580003|531527952|FG014|Part 2 (up to 10 Days)|Other|0|||
147371763|NCT05580003|531527953|FG015|Part 2 (up to 10 Days)|Other|0|||
147371764|NCT05580003|531527954|FG016|Part 2 (up to 10 Days)|Other|0|||
147371765|NCT05580003|531527955|FG017|Part 2 (up to 10 Days)|Other|0|||
147371766|NCT05580003|531527956|FG018|Part 2 (up to 10 Days)|Other|0|||
147371767|NCT05580003|531527957|FG019|Part 2 (up to 10 Days)|Other|0|||
147371768|NCT05580003|531527958|FG020|Part 2 (up to 10 Days)|Other|0|||
147371769|NCT05580003|531527959|FG021|Part 2 (up to 10 Days)|Other|0|||
147371770|NCT05580003|531527960|FG022|Part 2 (up to 10 Days)|Other|0|||
147371771|NCT05580003|531527961|FG023|Part 2 (up to 10 Days)|Other|0|||
147371772|NCT05580003|531527962|FG024|Part 2 (up to 10 Days)|Other|0|||
147371773|NCT05580003|531527963|FG025|Part 2 (up to 10 Days)|Other|0|||
147371774|NCT05580003|531527964|FG026|Part 2 (up to 10 Days)|Other|0|||
147371775|NCT05580003|531527965|FG027|Part 2 (up to 10 Days)|Other|0|||
147371776|NCT05580003|531527938|FG000|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
147371777|NCT05580003|531527939|FG001|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
147371778|NCT05580003|531527940|FG002|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
147371779|NCT05580003|531527941|FG003|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
147371780|NCT05580003|531527942|FG004|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
147371781|NCT05580003|531527943|FG005|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
147371782|NCT05580003|531527944|FG006|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
147371783|NCT05580003|531527945|FG007|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
147371784|NCT05580003|531527946|FG008|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
147371785|NCT05580003|531527947|FG009|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
147371786|NCT05580003|531527948|FG010|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
147371787|NCT05580003|531527949|FG011|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
147371788|NCT05580003|531527950|FG012|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
147371789|NCT05580003|531527951|FG013|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
147371790|NCT05580003|531527952|FG014|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
147371791|NCT05580003|531527953|FG015|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
147371792|NCT05580003|531527954|FG016|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
147371793|NCT05580003|531527955|FG017|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
147371794|NCT05580003|531527956|FG018|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
147371795|NCT05580003|531527957|FG019|Part 4 (Day 1 to Day 11)|Adverse Event|1|||
147371796|NCT05580003|531527958|FG020|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
147371797|NCT05580003|531527959|FG021|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
147371798|NCT05580003|531527960|FG022|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
147371799|NCT05580003|531527961|FG023|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
147371800|NCT05580003|531527962|FG024|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
147371801|NCT05580003|531527963|FG025|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
147371802|NCT05580003|531527964|FG026|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
147371803|NCT05580003|531527965|FG027|Part 4 (Day 1 to Day 11)|Adverse Event|0|||
147371804|NCT05580003|531527938|FG000|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
147371805|NCT05580003|531527939|FG001|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
147371806|NCT05580003|531527940|FG002|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
147371807|NCT05580003|531527941|FG003|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
147371808|NCT05580003|531527942|FG004|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
147371809|NCT05580003|531527943|FG005|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
147371810|NCT05580003|531527944|FG006|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
147371811|NCT05580003|531527945|FG007|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
147371812|NCT05580003|531527946|FG008|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
147455110|NCT00953758|531827813|FG003|Overall Study|Physician Decision|0|||
147371813|NCT05580003|531527947|FG009|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
147371814|NCT05580003|531527948|FG010|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
147371815|NCT05580003|531527949|FG011|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
147371816|NCT05580003|531527950|FG012|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
147371817|NCT05580003|531527951|FG013|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
147371818|NCT05580003|531527952|FG014|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
147371819|NCT05580003|531527953|FG015|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
147371820|NCT05580003|531527954|FG016|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
147371821|NCT05580003|531527955|FG017|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
147371822|NCT05580003|531527956|FG018|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
147371823|NCT05580003|531527957|FG019|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
147371824|NCT05580003|531527958|FG020|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|1|||
147371825|NCT05580003|531527959|FG021|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
147371826|NCT05580003|531527960|FG022|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
147371827|NCT05580003|531527961|FG023|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
147371828|NCT05580003|531527962|FG024|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
147371829|NCT05580003|531527963|FG025|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
147371830|NCT05580003|531527964|FG026|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
147371831|NCT05580003|531527965|FG027|Part 5: Sequence AB: Period 1 (Day 1)|Adverse Event|0|||
147371832|NCT05580003|531527938|FG000|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
147371833|NCT05580003|531527939|FG001|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
147371834|NCT05580003|531527940|FG002|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
147371835|NCT05580003|531527941|FG003|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
147371836|NCT05580003|531527942|FG004|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
147371837|NCT05580003|531527943|FG005|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
147371838|NCT05580003|531527944|FG006|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
147371839|NCT05580003|531527945|FG007|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
147371840|NCT05580003|531527946|FG008|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
147371841|NCT05580003|531527947|FG009|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
147371842|NCT05580003|531527948|FG010|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
147371843|NCT05580003|531527949|FG011|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
147371844|NCT05580003|531527950|FG012|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
147371845|NCT05580003|531527951|FG013|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
147371846|NCT05580003|531527952|FG014|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
147371847|NCT05580003|531527953|FG015|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
147371848|NCT05580003|531527954|FG016|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
147371849|NCT05580003|531527955|FG017|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
147371850|NCT05580003|531527956|FG018|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
147371851|NCT05580003|531527957|FG019|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
147371852|NCT05580003|531527958|FG020|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
147371853|NCT05580003|531527959|FG021|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|1|||
147371854|NCT05580003|531527960|FG022|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
147371855|NCT05580003|531527961|FG023|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
147371856|NCT05580003|531527962|FG024|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
147371857|NCT05580003|531527963|FG025|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
147371858|NCT05580003|531527964|FG026|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
147371859|NCT05580003|531527965|FG027|Part5:Sequence BA:Period1(up to 10 Days)|Adverse Event|0|||
147371860|NCT05580003|531527938|FG000|Part 6 Period 2 (Day 1)|Adverse Event|0|||
147371861|NCT05580003|531527939|FG001|Part 6 Period 2 (Day 1)|Adverse Event|0|||
147371862|NCT05580003|531527940|FG002|Part 6 Period 2 (Day 1)|Adverse Event|0|||
147371863|NCT05580003|531527941|FG003|Part 6 Period 2 (Day 1)|Adverse Event|0|||
147371864|NCT05580003|531527942|FG004|Part 6 Period 2 (Day 1)|Adverse Event|0|||
147371865|NCT05580003|531527943|FG005|Part 6 Period 2 (Day 1)|Adverse Event|0|||
147371866|NCT05580003|531527944|FG006|Part 6 Period 2 (Day 1)|Adverse Event|0|||
147371867|NCT05580003|531527945|FG007|Part 6 Period 2 (Day 1)|Adverse Event|0|||
147371868|NCT05580003|531527946|FG008|Part 6 Period 2 (Day 1)|Adverse Event|0|||
147371869|NCT05580003|531527947|FG009|Part 6 Period 2 (Day 1)|Adverse Event|0|||
147371870|NCT05580003|531527948|FG010|Part 6 Period 2 (Day 1)|Adverse Event|0|||
147371871|NCT05580003|531527949|FG011|Part 6 Period 2 (Day 1)|Adverse Event|0|||
147371872|NCT05580003|531527950|FG012|Part 6 Period 2 (Day 1)|Adverse Event|0|||
147371873|NCT05580003|531527951|FG013|Part 6 Period 2 (Day 1)|Adverse Event|0|||
147455111|NCT00953758|531827814|FG004|Overall Study|Physician Decision|1|||
147455112|NCT00953758|531827815|FG005|Overall Study|Physician Decision|0|||
147371874|NCT05580003|531527952|FG014|Part 6 Period 2 (Day 1)|Adverse Event|0|||
147371875|NCT05580003|531527953|FG015|Part 6 Period 2 (Day 1)|Adverse Event|0|||
147371876|NCT05580003|531527954|FG016|Part 6 Period 2 (Day 1)|Adverse Event|0|||
147371877|NCT05580003|531527955|FG017|Part 6 Period 2 (Day 1)|Adverse Event|0|||
147455113|NCT00953758|531827816|FG006|Overall Study|Physician Decision|0|||
147371878|NCT05580003|531527956|FG018|Part 6 Period 2 (Day 1)|Adverse Event|0|||
147371879|NCT05580003|531527957|FG019|Part 6 Period 2 (Day 1)|Adverse Event|0|||
147371880|NCT05580003|531527958|FG020|Part 6 Period 2 (Day 1)|Adverse Event|0|||
147371881|NCT05580003|531527959|FG021|Part 6 Period 2 (Day 1)|Adverse Event|0|||
147371882|NCT05580003|531527960|FG022|Part 6 Period 2 (Day 1)|Adverse Event|0|||
147371883|NCT05580003|531527961|FG023|Part 6 Period 2 (Day 1)|Adverse Event|0|||
147371884|NCT05580003|531527962|FG024|Part 6 Period 2 (Day 1)|Adverse Event|0|||
147371885|NCT05580003|531527963|FG025|Part 6 Period 2 (Day 1)|Adverse Event|0|||
147371886|NCT05580003|531527964|FG026|Part 6 Period 2 (Day 1)|Adverse Event|0|||
147371887|NCT05580003|531527965|FG027|Part 6 Period 2 (Day 1)|Adverse Event|1|||
147371888|NCT05580003|531527938|FG000|Part 6 Period 2 (Day 1)|Other|0|||
147371889|NCT05580003|531527939|FG001|Part 6 Period 2 (Day 1)|Other|0|||
147371890|NCT05580003|531527940|FG002|Part 6 Period 2 (Day 1)|Other|0|||
147371891|NCT05580003|531527941|FG003|Part 6 Period 2 (Day 1)|Other|0|||
147371892|NCT05580003|531527942|FG004|Part 6 Period 2 (Day 1)|Other|0|||
147371893|NCT05580003|531527943|FG005|Part 6 Period 2 (Day 1)|Other|0|||
147371894|NCT05580003|531527944|FG006|Part 6 Period 2 (Day 1)|Other|0|||
147371895|NCT05580003|531527945|FG007|Part 6 Period 2 (Day 1)|Other|0|||
147371896|NCT05580003|531527946|FG008|Part 6 Period 2 (Day 1)|Other|0|||
147371897|NCT05580003|531527947|FG009|Part 6 Period 2 (Day 1)|Other|0|||
147371898|NCT05580003|531527948|FG010|Part 6 Period 2 (Day 1)|Other|0|||
147371899|NCT05580003|531527949|FG011|Part 6 Period 2 (Day 1)|Other|0|||
147371900|NCT05580003|531527950|FG012|Part 6 Period 2 (Day 1)|Other|0|||
147371901|NCT05580003|531527951|FG013|Part 6 Period 2 (Day 1)|Other|0|||
147371902|NCT05580003|531527952|FG014|Part 6 Period 2 (Day 1)|Other|0|||
147371903|NCT05580003|531527953|FG015|Part 6 Period 2 (Day 1)|Other|0|||
147371904|NCT05580003|531527954|FG016|Part 6 Period 2 (Day 1)|Other|0|||
147371905|NCT05580003|531527955|FG017|Part 6 Period 2 (Day 1)|Other|0|||
147371906|NCT05580003|531527956|FG018|Part 6 Period 2 (Day 1)|Other|0|||
147371907|NCT05580003|531527957|FG019|Part 6 Period 2 (Day 1)|Other|0|||
147371908|NCT05580003|531527958|FG020|Part 6 Period 2 (Day 1)|Other|0|||
147371909|NCT05580003|531527959|FG021|Part 6 Period 2 (Day 1)|Other|0|||
147371910|NCT05580003|531527960|FG022|Part 6 Period 2 (Day 1)|Other|0|||
147371911|NCT05580003|531527961|FG023|Part 6 Period 2 (Day 1)|Other|0|||
147371912|NCT05580003|531527962|FG024|Part 6 Period 2 (Day 1)|Other|1|||
147371913|NCT05580003|531527963|FG025|Part 6 Period 2 (Day 1)|Other|0|||
147371914|NCT05580003|531527964|FG026|Part 6 Period 2 (Day 1)|Other|0|||
147371915|NCT05580003|531527965|FG027|Part 6 Period 2 (Day 1)|Other|0|||
147371916|NCT03500549|531527966|FG000|RCP (Day 1 - Week 16)|Adverse Event|3|||
147371917|NCT03500549|531527967|FG001|RCP (Day 1 - Week 16)|Adverse Event|0|||
147371918|NCT03500549|531527966|FG000|Open-label Period (Week 17 to Week 48)|Adverse Event|3|||
147371919|NCT03500549|531527967|FG001|Open-label Period (Week 17 to Week 48)|Adverse Event|7|||
147371920|NCT04337931|531527971|FG000|Overall Study|Death|4|||
147371921|NCT04337931|531527972|FG001|Overall Study|Death|1|||
147371922|NCT04337931|531527973|FG002|Overall Study|Death|7|||
147371923|NCT04337931|531527971|FG000|Overall Study|Withdrawal by Subject|0|||
147371924|NCT04337931|531527972|FG001|Overall Study|Withdrawal by Subject|1|||
147371925|NCT04337931|531527973|FG002|Overall Study|Withdrawal by Subject|0|||
147371926|NCT04337931|531527971|FG000|Overall Study|Initiation of subsequent anti-cancer treatment|1|||
147371927|NCT04337931|531527972|FG001|Overall Study|Initiation of subsequent anti-cancer treatment|0|||
147371928|NCT04337931|531527973|FG002|Overall Study|Initiation of subsequent anti-cancer treatment|9|||
147371929|NCT04337931|531527971|FG000|Overall Study|Study terminated by sponsor|3|||
147371930|NCT04337931|531527972|FG001|Overall Study|Study terminated by sponsor|6|||
147371931|NCT04337931|531527973|FG002|Overall Study|Study terminated by sponsor|2|||
147371932|NCT04337931|531527971|FG000|Overall Study|Initiated first treatment with anti-PD1/L1 therapy|3|||
147371933|NCT04337931|531527972|FG001|Overall Study|Initiated first treatment with anti-PD1/L1 therapy|5|||
147371934|NCT04337931|531527973|FG002|Overall Study|Initiated first treatment with anti-PD1/L1 therapy|1|||
147371935|NCT04337931|531527971|FG000|Overall Study|Colorectal cancer treatment|1|||
147371936|NCT04337931|531527972|FG001|Overall Study|Colorectal cancer treatment|0|||
147371937|NCT04337931|531527973|FG002|Overall Study|Colorectal cancer treatment|0|||
147371938|NCT04337931|531527971|FG000|Overall Study|Participant decision|0|||
147371939|NCT04337931|531527972|FG001|Overall Study|Participant decision|1|||
147371940|NCT04337931|531527973|FG002|Overall Study|Participant decision|0|||
147371941|NCT01738438|531527974|FG000|Overall Study|Disease Progression|32|||
147371942|NCT01738438|531527974|FG000|Overall Study|Adverse Event|3|||
147371943|NCT04436289|531527975|FG000|Overall Study|Death prior to hospital discharge|8|||
147371944|NCT04436289|531527976|FG001|Overall Study|Death prior to hospital discharge|5|||
147371945|NCT04436289|531527977|FG002|Overall Study|Death prior to hospital discharge|0|||
147371946|NCT04436289|531527978|FG003|Overall Study|Death prior to hospital discharge|1|||
147371947|NCT04436289|531527975|FG000|Overall Study|Withdrawal by Subject|0|||
147371948|NCT04436289|531527976|FG001|Overall Study|Withdrawal by Subject|1|||
147371949|NCT04436289|531527977|FG002|Overall Study|Withdrawal by Subject|4|||
147371950|NCT04436289|531527978|FG003|Overall Study|Withdrawal by Subject|0|||
147371951|NCT04436289|531527975|FG000|Overall Study|Extended hospital stay|0|||
147371952|NCT04436289|531527976|FG001|Overall Study|Extended hospital stay|1|||
147371953|NCT04436289|531527977|FG002|Overall Study|Extended hospital stay|0|||
147663748|NCT05067972|532591582|FG003|Part 1: Treatment|Progressive Disease|2|||
147663749|NCT05067972|532591583|FG004|Part 1: Treatment|Progressive Disease|3|||
147663750|NCT05067972|532591584|FG005|Part 1: Treatment|Progressive Disease|0|||
147663751|NCT05067972|532591585|FG006|Part 1: Treatment|Progressive Disease|2|||
147663752|NCT05067972|532591579|FG000|Part 1: Treatment|Physician Decision|0|||
147663753|NCT05067972|532591580|FG001|Part 1: Treatment|Physician Decision|0|||
147663754|NCT05067972|532591581|FG002|Part 1: Treatment|Physician Decision|0|||
147663755|NCT05067972|532591582|FG003|Part 1: Treatment|Physician Decision|1|||
147663756|NCT05067972|532591583|FG004|Part 1: Treatment|Physician Decision|0|||
147663757|NCT05067972|532591584|FG005|Part 1: Treatment|Physician Decision|0|||
147663758|NCT05067972|532591585|FG006|Part 1: Treatment|Physician Decision|0|||
147663759|NCT05067972|532591579|FG000|Part 1: Treatment|Death|0|||
147663760|NCT05067972|532591580|FG001|Part 1: Treatment|Death|0|||
147663761|NCT05067972|532591581|FG002|Part 1: Treatment|Death|0|||
147663762|NCT05067972|532591582|FG003|Part 1: Treatment|Death|2|||
147663763|NCT05067972|532591583|FG004|Part 1: Treatment|Death|0|||
147663764|NCT05067972|532591584|FG005|Part 1: Treatment|Death|0|||
147663765|NCT05067972|532591585|FG006|Part 1: Treatment|Death|0|||
147663766|NCT05067972|532591579|FG000|Part 1: Treatment|Adverse Event|0|||
147663767|NCT05067972|532591580|FG001|Part 1: Treatment|Adverse Event|0|||
147663768|NCT05067972|532591581|FG002|Part 1: Treatment|Adverse Event|0|||
147663769|NCT05067972|532591582|FG003|Part 1: Treatment|Adverse Event|0|||
147663770|NCT05067972|532591583|FG004|Part 1: Treatment|Adverse Event|0|||
147663771|NCT05067972|532591584|FG005|Part 1: Treatment|Adverse Event|2|||
147663772|NCT05067972|532591585|FG006|Part 1: Treatment|Adverse Event|1|||
147663773|NCT05067972|532591579|FG000|Part 1: Follow-up|Adverse Event|0|||
147663774|NCT05067972|532591580|FG001|Part 1: Follow-up|Adverse Event|0|||
147663775|NCT05067972|532591581|FG002|Part 1: Follow-up|Adverse Event|0|||
147663776|NCT05067972|532591582|FG003|Part 1: Follow-up|Adverse Event|0|||
147663777|NCT05067972|532591583|FG004|Part 1: Follow-up|Adverse Event|0|||
147663778|NCT05067972|532591584|FG005|Part 1: Follow-up|Adverse Event|1|||
147663779|NCT05067972|532591585|FG006|Part 1: Follow-up|Adverse Event|0|||
147663780|NCT05067972|532591579|FG000|Part 1: Follow-up|Withdrawal by Subject|0|||
147663781|NCT05067972|532591580|FG001|Part 1: Follow-up|Withdrawal by Subject|0|||
147663782|NCT05067972|532591581|FG002|Part 1: Follow-up|Withdrawal by Subject|0|||
147663783|NCT05067972|532591582|FG003|Part 1: Follow-up|Withdrawal by Subject|0|||
147663784|NCT05067972|532591583|FG004|Part 1: Follow-up|Withdrawal by Subject|0|||
147663785|NCT05067972|532591584|FG005|Part 1: Follow-up|Withdrawal by Subject|0|||
147663786|NCT05067972|532591585|FG006|Part 1: Follow-up|Withdrawal by Subject|1|||
147663787|NCT05067972|532591579|FG000|Part 1: Follow-up|Study Terminated by Sponsor|0|||
147663788|NCT05067972|532591580|FG001|Part 1: Follow-up|Study Terminated by Sponsor|0|||
147663789|NCT05067972|532591581|FG002|Part 1: Follow-up|Study Terminated by Sponsor|0|||
147371954|NCT04436289|531527978|FG003|Overall Study|Extended hospital stay|0|||
147371955|NCT04436289|531527975|FG000|Overall Study|Lost to Follow-up|0|||
147371956|NCT04436289|531527976|FG001|Overall Study|Lost to Follow-up|4|||
147371957|NCT04436289|531527977|FG002|Overall Study|Lost to Follow-up|1|||
147371958|NCT04436289|531527978|FG003|Overall Study|Lost to Follow-up|3|||
147371959|NCT01532999|531527979|FG000|Overall Study|Lost to Follow-up|14|||
147371960|NCT01532999|531527980|FG001|Overall Study|Lost to Follow-up|8|||
147371961|NCT01532999|531527979|FG000|Overall Study|Physician Decision|1|||
147371962|NCT01532999|531527980|FG001|Overall Study|Physician Decision|2|||
147371963|NCT01532999|531527979|FG000|Overall Study|Withdrawal by Subject|5|||
147371964|NCT01532999|531527980|FG001|Overall Study|Withdrawal by Subject|0|||
147371965|NCT01532999|531527979|FG000|Overall Study|Relocated|2|||
147371966|NCT01532999|531527980|FG001|Overall Study|Relocated|0|||
147371967|NCT01532999|531527979|FG000|Overall Study|should not have been randomized|1|||
147371968|NCT01532999|531527980|FG001|Overall Study|should not have been randomized|0|||
147371969|NCT01532999|531527979|FG000|Overall Study|substantial noncompliance|2|||
147371970|NCT01532999|531527980|FG001|Overall Study|substantial noncompliance|0|||
147371971|NCT01532999|531527979|FG000|Overall Study|no show for week 9 assessments|6|||
147371972|NCT01532999|531527980|FG001|Overall Study|no show for week 9 assessments|4|||
147663790|NCT05067972|532591582|FG003|Part 1: Follow-up|Study Terminated by Sponsor|0|||
147663791|NCT05067972|532591583|FG004|Part 1: Follow-up|Study Terminated by Sponsor|0|||
147663792|NCT05067972|532591584|FG005|Part 1: Follow-up|Study Terminated by Sponsor|1|||
147663793|NCT05067972|532591585|FG006|Part 1: Follow-up|Study Terminated by Sponsor|0|||
147663794|NCT05067972|532591579|FG000|Part 1: Follow-up|Physician Decision|0|||
147663795|NCT05067972|532591580|FG001|Part 1: Follow-up|Physician Decision|0|||
147663796|NCT05067972|532591581|FG002|Part 1: Follow-up|Physician Decision|0|||
147371973|NCT01532999|531527979|FG000|Overall Study|Adverse Event|0|||
147371974|NCT01532999|531527980|FG001|Overall Study|Adverse Event|1|||
147371975|NCT01532999|531527979|FG000|Overall Study|incarcerated|0|||
147371976|NCT01532999|531527980|FG001|Overall Study|incarcerated|1|||
147663797|NCT05067972|532591582|FG003|Part 1: Follow-up|Physician Decision|1|||
147663798|NCT05067972|532591583|FG004|Part 1: Follow-up|Physician Decision|0|||
147663799|NCT05067972|532591584|FG005|Part 1: Follow-up|Physician Decision|0|||
147663800|NCT05067972|532591585|FG006|Part 1: Follow-up|Physician Decision|0|||
147663801|NCT05067972|532591579|FG000|Part 1: Follow-up|Death|1|||
147663802|NCT05067972|532591580|FG001|Part 1: Follow-up|Death|2|||
147371977|NCT01532999|531527979|FG000|Overall Study|New job|0|||
147371978|NCT01532999|531527980|FG001|Overall Study|New job|2|||
147371979|NCT02928172|531527981|FG000|Overall Study|Device did not record data|1|||
147371980|NCT02016872|531527982|FG000|Overall Study|Withdrawal by Subject|10|||
147371981|NCT02016872|531527982|FG000|Overall Study|Death Progression|2|||
147371982|NCT02016872|531527982|FG000|Overall Study|No FMISO scan|1|||
147371983|NCT02016872|531527982|FG000|Overall Study|Ineligible|2|||
147371984|NCT03280030|531527983|FG000|Part 1 - Safety Evaluation|Physician Decision|2|||
147371985|NCT03280030|531527984|FG001|Part 1 - Safety Evaluation|Physician Decision|0|||
147371986|NCT03280030|531527985|FG002|Part 1 - Safety Evaluation|Physician Decision|0|||
147371987|NCT03280030|531527983|FG000|Part 1 - Safety Evaluation|Disease progression|1|||
147371988|NCT03280030|531527984|FG001|Part 1 - Safety Evaluation|Disease progression|0|||
147371989|NCT03280030|531527985|FG002|Part 1 - Safety Evaluation|Disease progression|0|||
147371990|NCT03280030|531527983|FG000|Part 1 - Safety Evaluation|Adverse Event|2|||
147371991|NCT03280030|531527984|FG001|Part 1 - Safety Evaluation|Adverse Event|0|||
147371992|NCT03280030|531527985|FG002|Part 1 - Safety Evaluation|Adverse Event|0|||
147371993|NCT03280030|531527983|FG000|Part 2 - Efficacy|Adverse Event|0|||
147455114|NCT00953758|531827817|FG007|Overall Study|Physician Decision|0|||
147455115|NCT00953758|531827818|FG008|Overall Study|Physician Decision|0|||
147455116|NCT00953758|531827819|FG009|Overall Study|Physician Decision|0|||
147455117|NCT00953758|531827810|FG000|Overall Study|Disease progression|0|||
147455118|NCT00953758|531827811|FG001|Overall Study|Disease progression|0|||
147455119|NCT00953758|531827812|FG002|Overall Study|Disease progression|0|||
147455120|NCT00953758|531827813|FG003|Overall Study|Disease progression|0|||
147455121|NCT00953758|531827814|FG004|Overall Study|Disease progression|1|||
147455122|NCT00953758|531827815|FG005|Overall Study|Disease progression|0|||
147455123|NCT00953758|531827816|FG006|Overall Study|Disease progression|0|||
147371994|NCT03280030|531527984|FG001|Part 2 - Efficacy|Adverse Event|4|||
147371995|NCT03280030|531527985|FG002|Part 2 - Efficacy|Adverse Event|6|||
147371996|NCT03280030|531527983|FG000|Part 2 - Efficacy|Death|0|||
147371997|NCT03280030|531527984|FG001|Part 2 - Efficacy|Death|3|||
147455124|NCT00953758|531827817|FG007|Overall Study|Disease progression|0|||
147455125|NCT00953758|531827818|FG008|Overall Study|Disease progression|0|||
147371998|NCT03280030|531527985|FG002|Part 2 - Efficacy|Death|0|||
147371999|NCT03280030|531527983|FG000|Part 2 - Efficacy|Physician Decision|0|||
147372000|NCT03280030|531527984|FG001|Part 2 - Efficacy|Physician Decision|10|||
147372001|NCT03280030|531527985|FG002|Part 2 - Efficacy|Physician Decision|16|||
147372002|NCT03280030|531527983|FG000|Part 2 - Efficacy|Withdrawal by Subject|0|||
147372003|NCT03280030|531527984|FG001|Part 2 - Efficacy|Withdrawal by Subject|2|||
147372004|NCT03280030|531527985|FG002|Part 2 - Efficacy|Withdrawal by Subject|1|||
147372005|NCT03280030|531527983|FG000|Part 2 - Efficacy|Progressive disease|0|||
147372006|NCT03280030|531527984|FG001|Part 2 - Efficacy|Progressive disease|7|||
147372007|NCT03280030|531527985|FG002|Part 2 - Efficacy|Progressive disease|5|||
147372008|NCT03211247|531527986|FG000|Overall Study|Adverse Event|8|||
147372009|NCT03211247|531527987|FG001|Overall Study|Adverse Event|0|||
147372010|NCT03211247|531527988|FG002|Overall Study|Adverse Event|1|||
147372011|NCT03211247|531527989|FG003|Overall Study|Adverse Event|0|||
147372012|NCT03211247|531527990|FG004|Overall Study|Adverse Event|0|||
147372013|NCT03211247|531527986|FG000|Overall Study|Lost to Follow-up|2|||
147372014|NCT03211247|531527987|FG001|Overall Study|Lost to Follow-up|1|||
147372015|NCT03211247|531527988|FG002|Overall Study|Lost to Follow-up|0|||
147372016|NCT03211247|531527989|FG003|Overall Study|Lost to Follow-up|0|||
147372017|NCT03211247|531527990|FG004|Overall Study|Lost to Follow-up|0|||
147455126|NCT00953758|531827819|FG009|Overall Study|Disease progression|0|||
147455127|NCT00953758|531827810|FG000|Overall Study|Participant went for transplant|0|||
147455128|NCT00953758|531827811|FG001|Overall Study|Participant went for transplant|0|||
147455129|NCT00953758|531827812|FG002|Overall Study|Participant went for transplant|0|||
147455130|NCT00953758|531827813|FG003|Overall Study|Participant went for transplant|0|||
147455131|NCT00953758|531827814|FG004|Overall Study|Participant went for transplant|0|||
147455132|NCT00953758|531827815|FG005|Overall Study|Participant went for transplant|0|||
147455133|NCT00953758|531827816|FG006|Overall Study|Participant went for transplant|0|||
147455134|NCT00953758|531827817|FG007|Overall Study|Participant went for transplant|0|||
147455135|NCT00953758|531827818|FG008|Overall Study|Participant went for transplant|1|||
147372018|NCT03211247|531527986|FG000|Overall Study|Physician Decision|1|||
147372019|NCT03211247|531527987|FG001|Overall Study|Physician Decision|2|||
147372020|NCT03211247|531527988|FG002|Overall Study|Physician Decision|0|||
147372021|NCT03211247|531527989|FG003|Overall Study|Physician Decision|0|||
147372022|NCT03211247|531527990|FG004|Overall Study|Physician Decision|0|||
147372023|NCT03211247|531527986|FG000|Overall Study|Non-compliance with study drug|2|||
147372024|NCT03211247|531527987|FG001|Overall Study|Non-compliance with study drug|0|||
147372025|NCT03211247|531527988|FG002|Overall Study|Non-compliance with study drug|0|||
147372026|NCT03211247|531527989|FG003|Overall Study|Non-compliance with study drug|0|||
147455136|NCT00953758|531827819|FG009|Overall Study|Participant went for transplant|0|||
147455137|NCT01536860|531827820|FG000|Washout Period (3 Days)|Lost to Follow-up|1|||
147455138|NCT01536860|531827821|FG001|Washout Period (3 Days)|Lost to Follow-up|0|||
147455139|NCT01536860|531827822|FG002|Washout Period (3 Days)|Lost to Follow-up|0|||
147372027|NCT03211247|531527990|FG004|Overall Study|Non-compliance with study drug|0|||
147455140|NCT01164722|531827823|FG000|Overall Study|Adverse Event|0|||
147663803|NCT05067972|532591581|FG002|Part 1: Follow-up|Death|1|||
147663804|NCT05067972|532591582|FG003|Part 1: Follow-up|Death|0|||
147372028|NCT03211247|531527986|FG000|Overall Study|Participant withdrawal by Parent or Caregiver|18|||
147372029|NCT03211247|531527987|FG001|Overall Study|Participant withdrawal by Parent or Caregiver|13|||
147372030|NCT03211247|531527988|FG002|Overall Study|Participant withdrawal by Parent or Caregiver|2|||
147372031|NCT03211247|531527989|FG003|Overall Study|Participant withdrawal by Parent or Caregiver|1|||
147372032|NCT03211247|531527990|FG004|Overall Study|Participant withdrawal by Parent or Caregiver|0|||
147372033|NCT03211247|531527986|FG000|Overall Study|Participant did not want to complete oral food challenge|5|||
147372034|NCT03211247|531527987|FG001|Overall Study|Participant did not want to complete oral food challenge|2|||
147372035|NCT03211247|531527988|FG002|Overall Study|Participant did not want to complete oral food challenge|1|||
147372036|NCT03211247|531527989|FG003|Overall Study|Participant did not want to complete oral food challenge|3|||
147455141|NCT01164722|531827824|FG001|Overall Study|Adverse Event|1|||
147455142|NCT01164722|531827823|FG000|Overall Study|Withdrawal by Subject|3|||
147611051|NCT04315506|532390908|FG001|Overall Study|Lost to Follow-up|82|||
147611052|NCT04315506|532390907|FG000|Overall Study|Withdrawal by Subject|8|||
147611053|NCT04315506|532390908|FG001|Overall Study|Withdrawal by Subject|8|||
147611054|NCT04315506|532390907|FG000|Overall Study|Physician Decision|0|||
147611055|NCT04315506|532390908|FG001|Overall Study|Physician Decision|1|||
147611056|NCT02661217|532390909|FG000|Overall Study|Physician Decision|12|||
147611057|NCT02661217|532390910|FG001|Overall Study|Physician Decision|15|||
147611058|NCT02661217|532390909|FG000|Overall Study|Lost to Follow-up|1|||
147611059|NCT02661217|532390910|FG001|Overall Study|Lost to Follow-up|4|||
147611060|NCT02661217|532390909|FG000|Overall Study|Protocol Deviation|0|||
147611061|NCT02661217|532390910|FG001|Overall Study|Protocol Deviation|4|||
147611062|NCT02661217|532390909|FG000|Overall Study|Non-compliance with study treatment|5|||
147611063|NCT02661217|532390910|FG001|Overall Study|Non-compliance with study treatment|5|||
147611064|NCT02661217|532390909|FG000|Overall Study|Death|21|||
147611065|NCT02661217|532390910|FG001|Overall Study|Death|15|||
147611066|NCT02661217|532390909|FG000|Overall Study|Adverse Event|10|||
147611067|NCT02661217|532390910|FG001|Overall Study|Adverse Event|8|||
147611068|NCT02661217|532390909|FG000|Overall Study|Withdrawal by Subject|15|||
147611069|NCT02661217|532390910|FG001|Overall Study|Withdrawal by Subject|19|||
147611070|NCT02661217|532390909|FG000|Overall Study|Did not enter follow-up epoch|7|||
147611071|NCT02661217|532390910|FG001|Overall Study|Did not enter follow-up epoch|10|||
147611072|NCT02661217|532390909|FG000|Overall Study|Death - no study drug received|1|||
147611073|NCT02661217|532390910|FG001|Overall Study|Death - no study drug received|2|||
147611074|NCT02661217|532390909|FG000|Overall Study|Mis-randomized (not in treatment epoch)|3|||
147611075|NCT02661217|532390910|FG001|Overall Study|Mis-randomized (not in treatment epoch)|1|||
147611076|NCT00626561|532390930|FG000|Overall Study|Withdrawal by Subject|2|||
147611077|NCT00626561|532390930|FG000|Overall Study|Disease Progression|2|||
147611078|NCT01372748|532390933|FG000|Overall Study|Lost to Follow-up|16|||
147611079|NCT01372748|532390934|FG001|Overall Study|Lost to Follow-up|34|||
147611080|NCT01372748|532390933|FG000|Overall Study|Withdrawal by Subject|7|||
147611081|NCT01372748|532390934|FG001|Overall Study|Withdrawal by Subject|5|||
147611082|NCT00134901|532390935|FG000|Overall Study|Lost to Follow-up|5|||
147611083|NCT00134901|532390936|FG001|Overall Study|Lost to Follow-up|5|||
147611084|NCT00134901|532390935|FG000|Overall Study|discontinued intervention|12|||
147611085|NCT00134901|532390936|FG001|Overall Study|discontinued intervention|10|||
147611086|NCT02604407|532390937|FG000|Overall Study|Adverse Event|0|||
147611087|NCT02604407|532390938|FG001|Overall Study|Adverse Event|7|||
147611088|NCT02604407|532390939|FG002|Overall Study|Adverse Event|5|||
147611089|NCT02604407|532390937|FG000|Overall Study|Protocol Violation|2|||
147611090|NCT02604407|532390938|FG001|Overall Study|Protocol Violation|0|||
147611091|NCT02604407|532390939|FG002|Overall Study|Protocol Violation|0|||
147611092|NCT02604407|532390937|FG000|Overall Study|Withdrawal by Subject|3|||
147611093|NCT02604407|532390938|FG001|Overall Study|Withdrawal by Subject|3|||
147611094|NCT02604407|532390939|FG002|Overall Study|Withdrawal by Subject|5|||
147611095|NCT02604407|532390937|FG000|Overall Study|Lost to Follow-up|2|||
147611096|NCT02604407|532390938|FG001|Overall Study|Lost to Follow-up|1|||
147663805|NCT05067972|532591583|FG004|Part 1: Follow-up|Death|1|||
147611097|NCT02604407|532390939|FG002|Overall Study|Lost to Follow-up|2|||
147611098|NCT02604407|532390937|FG000|Overall Study|Lack of Efficacy|1|||
147611099|NCT02604407|532390938|FG001|Overall Study|Lack of Efficacy|0|||
147611100|NCT02604407|532390939|FG002|Overall Study|Lack of Efficacy|0|||
147611101|NCT02604407|532390937|FG000|Overall Study|Other|3|||
147611102|NCT02604407|532390938|FG001|Overall Study|Other|1|||
147611103|NCT02604407|532390939|FG002|Overall Study|Other|4|||
147611104|NCT00606632|532390940|FG000|Overall Study|Withdrawal by Subject|13|||
147611105|NCT00606632|532390940|FG000|Overall Study|Miscellaneous reasons|9|||
147611106|NCT03908437|532390945|FG000|Overall Study|Death|0|||
147611107|NCT03908437|532390946|FG001|Overall Study|Death|1|||
147611108|NCT03908437|532390945|FG000|Overall Study|Lost to Follow-up|31|||
147611109|NCT03908437|532390946|FG001|Overall Study|Lost to Follow-up|24|||
147611110|NCT00442962|532390947|FG000|Overall Study|Pregnancy|1|||
147611111|NCT00442962|532390947|FG000|Overall Study|Lost to Follow-up|7|||
147372037|NCT03211247|531527990|FG004|Overall Study|Participant did not want to complete oral food challenge|1|||
147372038|NCT03211247|531527986|FG000|Overall Study|Protocol Violation|0|||
147372039|NCT03211247|531527987|FG001|Overall Study|Protocol Violation|1|||
147372040|NCT03211247|531527988|FG002|Overall Study|Protocol Violation|0|||
147372041|NCT03211247|531527989|FG003|Overall Study|Protocol Violation|0|||
147372042|NCT03211247|531527990|FG004|Overall Study|Protocol Violation|0|||
147372043|NCT02415127|531527991|FG000|Overall Study|Adverse Event|1|||
147372044|NCT02415127|531527992|FG001|Overall Study|Adverse Event|0|||
147372045|NCT00545545|531527993|FG000|Overall Study|Progressive Neoplastic Disease|1|||
147372046|NCT00545545|531527994|FG001|Overall Study|Progressive Neoplastic Disease|5|||
147372047|NCT00545545|531527995|FG002|Overall Study|Progressive Neoplastic Disease|0|||
147372048|NCT00545545|531527996|FG003|Overall Study|Progressive Neoplastic Disease|4|||
147372049|NCT00545545|531527997|FG004|Overall Study|Progressive Neoplastic Disease|8|||
147372050|NCT00545545|531527998|FG005|Overall Study|Progressive Neoplastic Disease|7|||
147372051|NCT00545545|531527993|FG000|Overall Study|Withdrawal by Subject|0|||
147372052|NCT00545545|531527994|FG001|Overall Study|Withdrawal by Subject|1|||
147372053|NCT00545545|531527995|FG002|Overall Study|Withdrawal by Subject|0|||
147372054|NCT00545545|531527996|FG003|Overall Study|Withdrawal by Subject|0|||
147372055|NCT00545545|531527997|FG004|Overall Study|Withdrawal by Subject|0|||
147372056|NCT00545545|531527998|FG005|Overall Study|Withdrawal by Subject|0|||
147372057|NCT00545545|531527993|FG000|Overall Study|Physician Decision|1|||
147372058|NCT00545545|531527994|FG001|Overall Study|Physician Decision|0|||
147372059|NCT00545545|531527995|FG002|Overall Study|Physician Decision|0|||
147372060|NCT00545545|531527996|FG003|Overall Study|Physician Decision|0|||
147372061|NCT00545545|531527997|FG004|Overall Study|Physician Decision|0|||
147372062|NCT00545545|531527998|FG005|Overall Study|Physician Decision|1|||
147372063|NCT00545545|531527993|FG000|Overall Study|Irinotecan intolerance|1|||
147372064|NCT00545545|531527994|FG001|Overall Study|Irinotecan intolerance|1|||
147372065|NCT00545545|531527995|FG002|Overall Study|Irinotecan intolerance|0|||
147372066|NCT00545545|531527996|FG003|Overall Study|Irinotecan intolerance|0|||
147372067|NCT00545545|531527997|FG004|Overall Study|Irinotecan intolerance|0|||
147372068|NCT00545545|531527998|FG005|Overall Study|Irinotecan intolerance|0|||
147372069|NCT00545545|531527993|FG000|Overall Study|No target lesions to track post surgery|0|||
147372070|NCT00545545|531527994|FG001|Overall Study|No target lesions to track post surgery|0|||
147372071|NCT00545545|531527995|FG002|Overall Study|No target lesions to track post surgery|0|||
147372072|NCT00545545|531527996|FG003|Overall Study|No target lesions to track post surgery|0|||
147372073|NCT00545545|531527997|FG004|Overall Study|No target lesions to track post surgery|1|||
147372074|NCT00545545|531527998|FG005|Overall Study|No target lesions to track post surgery|1|||
147372075|NCT02761187|531527999|FG000|Overall Study|Too ill to Participate|13|||
147372076|NCT02761187|531528000|FG001|Overall Study|Too ill to Participate|8|||
147372077|NCT02761187|531527999|FG000|Overall Study|Patient declined participation and declined follow-up for survival|34|||
147372078|NCT02761187|531528000|FG001|Overall Study|Patient declined participation and declined follow-up for survival|26|||
147372079|NCT02761187|531527999|FG000|Overall Study|Patient withdrew consent|64|||
147372080|NCT02761187|531528000|FG001|Overall Study|Patient withdrew consent|58|||
147455143|NCT01164722|531827824|FG001|Overall Study|Withdrawal by Subject|4|||
147455144|NCT01164722|531827823|FG000|Overall Study|Lost to Follow-up|3|||
147455145|NCT01164722|531827824|FG001|Overall Study|Lost to Follow-up|6|||
147455146|NCT01164722|531827823|FG000|Overall Study|met protocol criteria for non-treatment|11|||
147455147|NCT01164722|531827824|FG001|Overall Study|met protocol criteria for non-treatment|1|||
147455148|NCT01164722|531827823|FG000|Overall Study|enrolled on other study, concomitant med|1|||
147455149|NCT01164722|531827824|FG001|Overall Study|enrolled on other study, concomitant med|3|||
147455150|NCT02902120|531827825|FG000|Overall Study|Lack of Efficacy|1|||
147455151|NCT01445769|531827826|FG000|Overall Study|Consent Withdrawn|2|||
147455152|NCT01445769|531827826|FG000|Overall Study|Disease Progression|1|||
147455153|NCT01445769|531827826|FG000|Overall Study|Lost to Follow-up|5|||
147455154|NCT03694925|531827827|FG000|Overall Study|Inadequate laboratory testing|0|||
147455155|NCT03694925|531827828|FG001|Overall Study|Inadequate laboratory testing|3|||
147455156|NCT03694925|531827829|FG002|Overall Study|Inadequate laboratory testing|0|||
147455157|NCT02799069|531827834|FG000|Overall Study|Adverse Event|0|||
147455158|NCT02799069|531827835|FG001|Overall Study|Adverse Event|2|||
147455159|NCT02799069|531827836|FG002|Overall Study|Adverse Event|2|||
147455160|NCT02799069|531827834|FG000|Overall Study|Lack of Efficacy|2|||
147455161|NCT02799069|531827835|FG001|Overall Study|Lack of Efficacy|0|||
147455162|NCT02799069|531827836|FG002|Overall Study|Lack of Efficacy|0|||
147455163|NCT02799069|531827834|FG000|Overall Study|Lost to Follow-up|1|||
147455164|NCT02799069|531827835|FG001|Overall Study|Lost to Follow-up|1|||
147455165|NCT02799069|531827836|FG002|Overall Study|Lost to Follow-up|0|||
147455166|NCT02799069|531827834|FG000|Overall Study|Withdrawal by Subject|4|||
147455167|NCT02799069|531827835|FG001|Overall Study|Withdrawal by Subject|4|||
147455168|NCT02799069|531827836|FG002|Overall Study|Withdrawal by Subject|3|||
147455169|NCT02799069|531827834|FG000|Overall Study|Protocol Violation|1|||
147611112|NCT04238650|532390948|FG000|Overall Study|Withdrawal by Subject|0|||
147611113|NCT04238650|532390949|FG001|Overall Study|Withdrawal by Subject|1|||
147372081|NCT02761187|531527999|FG000|Overall Study|Physician discretion|4|||
147372082|NCT02761187|531528000|FG001|Overall Study|Physician discretion|8|||
147372083|NCT02761187|531527999|FG000|Overall Study|Change in physician or transferred to another treatment center|72|||
147372084|NCT02761187|531528000|FG001|Overall Study|Change in physician or transferred to another treatment center|62|||
147372085|NCT02761187|531527999|FG000|Overall Study|On Hospice|20|||
147372086|NCT02761187|531528000|FG001|Overall Study|On Hospice|26|||
147372087|NCT02761187|531527999|FG000|Overall Study|Deceased|474|||
147372088|NCT02761187|531528000|FG001|Overall Study|Deceased|642|||
147372089|NCT02761187|531527999|FG000|Overall Study|Lost to Follow-up|73|||
147372090|NCT02761187|531528000|FG001|Overall Study|Lost to Follow-up|63|||
147372091|NCT02761187|531527999|FG000|Overall Study|Due to study discontinued at site|100|||
147372092|NCT02761187|531528000|FG001|Overall Study|Due to study discontinued at site|85|||
147372093|NCT02761187|531527999|FG000|Overall Study|Reason not Specified|1484|||
147372094|NCT02761187|531528000|FG001|Overall Study|Reason not Specified|937|||
147372095|NCT04153890|531528001|FG000|Overall Study|Lost to Follow-up|9|||
147372096|NCT04153890|531528002|FG001|Overall Study|Lost to Follow-up|0|||
147372097|NCT04153890|531528003|FG002|Overall Study|Lost to Follow-up|9|||
147372098|NCT04153890|531528004|FG003|Overall Study|Lost to Follow-up|0|||
147372099|NCT04153890|531528001|FG000|Overall Study|Death|0|||
147372100|NCT04153890|531528002|FG001|Overall Study|Death|2|||
147372101|NCT04153890|531528003|FG002|Overall Study|Death|0|||
147372102|NCT04153890|531528004|FG003|Overall Study|Death|0|||
147372103|NCT04153890|531528001|FG000|Overall Study|Withdrawal by Subject|0|||
147372104|NCT04153890|531528002|FG001|Overall Study|Withdrawal by Subject|0|||
147372105|NCT04153890|531528003|FG002|Overall Study|Withdrawal by Subject|0|||
147372106|NCT04153890|531528004|FG003|Overall Study|Withdrawal by Subject|2|||
147372107|NCT03997474|531528007|FG000|Overall Study|Death|6|||
147372108|NCT03997474|531528008|FG001|Overall Study|Death|2|||
147372109|NCT03997474|531528009|FG002|Overall Study|Death|1|||
147372110|NCT03997474|531528007|FG000|Overall Study|Physician Decision|2|||
147372111|NCT03997474|531528008|FG001|Overall Study|Physician Decision|0|||
147372112|NCT03997474|531528009|FG002|Overall Study|Physician Decision|0|||
147372113|NCT03997474|531528007|FG000|Overall Study|study terminated by sponsor|1|||
147372114|NCT03997474|531528008|FG001|Overall Study|study terminated by sponsor|0|||
147372115|NCT03997474|531528009|FG002|Overall Study|study terminated by sponsor|1|||
147372116|NCT05630833|531528011|FG000|Overall Study|Adverse Event|3|||
147372117|NCT05630833|531528012|FG001|Overall Study|Adverse Event|0|||
147372118|NCT05630833|531528011|FG000|Overall Study|Lack of Efficacy|0|||
147372119|NCT05630833|531528012|FG001|Overall Study|Lack of Efficacy|1|||
147372120|NCT05630833|531528011|FG000|Overall Study|Lost to Follow-up|1|||
147372121|NCT05630833|531528012|FG001|Overall Study|Lost to Follow-up|0|||
147372122|NCT05630833|531528011|FG000|Overall Study|Withdrawal by Subject|3|||
147372123|NCT05630833|531528012|FG001|Overall Study|Withdrawal by Subject|1|||
147372124|NCT03277989|531528013|FG000|Overall Study|Lost to Follow-up|6|||
147372125|NCT03277989|531528013|FG000|Overall Study|Adverse Event|6|||
147372126|NCT03277989|531528013|FG000|Overall Study|Withdrawal by Subject|3|||
147372127|NCT03277989|531528013|FG000|Overall Study|Didn't Receive Study Device|7|||
147372128|NCT03277989|531528013|FG000|Overall Study|Site Closure|26|||
147372129|NCT03277989|531528013|FG000|Overall Study|Sponsor Closure|107|||
147372130|NCT02798471|531528016|FG000|Overall Study|Adverse Event|7|||
147372131|NCT02798471|531528017|FG001|Overall Study|Adverse Event|2|||
147372132|NCT02798471|531528016|FG000|Overall Study|Physician Decision|3|||
147372133|NCT02798471|531528017|FG001|Overall Study|Physician Decision|7|||
147372134|NCT02798471|531528016|FG000|Overall Study|Death|2|||
147372135|NCT02798471|531528017|FG001|Overall Study|Death|3|||
147372136|NCT02798471|531528016|FG000|Overall Study|Lost to Follow-up|0|||
147372137|NCT02798471|531528017|FG001|Overall Study|Lost to Follow-up|1|||
147372138|NCT02798471|531528016|FG000|Overall Study|Other|5|||
147372139|NCT02798471|531528017|FG001|Overall Study|Other|3|||
147372140|NCT02798471|531528016|FG000|Overall Study|Subject withdrew consent|0|||
147372141|NCT02798471|531528017|FG001|Overall Study|Subject withdrew consent|6|||
147372142|NCT02798471|531528016|FG000|Overall Study|Data entry error (reported as study completion and study discontinuation)|2|||
147372143|NCT02798471|531528017|FG001|Overall Study|Data entry error (reported as study completion and study discontinuation)|0|||
147372144|NCT02798471|531528016|FG000|Overall Study|Randomized, but not treated|0|||
147372145|NCT02798471|531528017|FG001|Overall Study|Randomized, but not treated|2|||
147372146|NCT03083366|531529410|FG000|Screening Period|Did not meet criteria (screen fail)|1|||
147663806|NCT05067972|532591584|FG005|Part 1: Follow-up|Death|0|||
147372147|NCT03083366|531529411|FG001|Screening Period|Did not meet criteria (screen fail)|0|||
147372148|NCT03083366|531529410|FG000|Enrollment Period|Lack of Efficacy|1|||
147372149|NCT03083366|531529411|FG001|Enrollment Period|Lack of Efficacy|0|||
147372150|NCT06056310|531529416|FG000|Overall Study|Other Reasons|2|||
147372151|NCT06056310|531529416|FG000|Overall Study|Sponsor Request|16|||
147372152|NCT02702843|531529417|FG000|Overall Study|Insufficient data to analyze|15|||
147372153|NCT02702843|531529418|FG001|Overall Study|Insufficient data to analyze|23|||
147372154|NCT00065182|531529423|FG000|Overall Study|Adverse Event|24|||
147372155|NCT00065182|531529424|FG001|Overall Study|Adverse Event|17|||
147372156|NCT00065182|531529423|FG000|Overall Study|Lost to Follow-up|0|||
147372157|NCT00065182|531529424|FG001|Overall Study|Lost to Follow-up|4|||
147372158|NCT00065182|531529423|FG000|Overall Study|Protocol Violation|3|||
147663807|NCT05067972|532591585|FG006|Part 1: Follow-up|Death|1|||
147663808|NCT04391842|532591586|FG000|Overall Study|Withdrawal by Subject|2|||
147663809|NCT02573259|532591595|FG000|Overall Study|Death|1|||
147663810|NCT02573259|532591596|FG001|Overall Study|Death|6|||
147663811|NCT02573259|532591597|FG002|Overall Study|Death|5|||
147663812|NCT02573259|532591598|FG003|Overall Study|Death|6|||
147663813|NCT02573259|532591599|FG004|Overall Study|Death|9|||
147663814|NCT02573259|532591600|FG005|Overall Study|Death|32|||
147663815|NCT02573259|532591601|FG006|Overall Study|Death|21|||
147663816|NCT02573259|532591595|FG000|Overall Study|Lost to Follow-up|0|||
147663817|NCT02573259|532591596|FG001|Overall Study|Lost to Follow-up|0|||
147663818|NCT02573259|532591597|FG002|Overall Study|Lost to Follow-up|0|||
147663819|NCT02573259|532591598|FG003|Overall Study|Lost to Follow-up|0|||
147663820|NCT02573259|532591599|FG004|Overall Study|Lost to Follow-up|0|||
147663821|NCT02573259|532591600|FG005|Overall Study|Lost to Follow-up|2|||
147663822|NCT02573259|532591601|FG006|Overall Study|Lost to Follow-up|1|||
147663823|NCT02573259|532591595|FG000|Overall Study|Participant refused further follow-up|0|||
147663824|NCT02573259|532591596|FG001|Overall Study|Participant refused further follow-up|2|||
147663825|NCT02573259|532591597|FG002|Overall Study|Participant refused further follow-up|1|||
147663826|NCT02573259|532591598|FG003|Overall Study|Participant refused further follow-up|0|||
147663827|NCT02573259|532591599|FG004|Overall Study|Participant refused further follow-up|3|||
147663828|NCT02573259|532591600|FG005|Overall Study|Participant refused further follow-up|20|||
147663829|NCT02573259|532591601|FG006|Overall Study|Participant refused further follow-up|7|||
147663830|NCT02573259|532591595|FG000|Overall Study|Other|0|||
147663831|NCT02573259|532591596|FG001|Overall Study|Other|0|||
147663832|NCT02573259|532591597|FG002|Overall Study|Other|0|||
147663833|NCT02573259|532591598|FG003|Overall Study|Other|0|||
147663834|NCT02573259|532591599|FG004|Overall Study|Other|1|||
147663835|NCT02573259|532591600|FG005|Overall Study|Other|4|||
147663836|NCT02573259|532591601|FG006|Overall Study|Other|5|||
147663837|NCT00751140|532591602|FG000|Overall Study|benign angioma excluded from analysis|1|||
147663838|NCT02667301|532591603|FG000|Overall Study|Adverse Event|1|||
147663839|NCT02667301|532591603|FG000|Overall Study|Lack of Efficacy|1|||
147663840|NCT01883895|532591607|FG000|Overall Study|Lost to Follow-up|2|||
147372159|NCT00065182|531529424|FG001|Overall Study|Protocol Violation|4|||
147372160|NCT00065182|531529423|FG000|Overall Study|Serious adverse events (SAE)|1|||
147372161|NCT00065182|531529424|FG001|Overall Study|Serious adverse events (SAE)|0|||
147372162|NCT00065182|531529423|FG000|Overall Study|Sponsor Decision|11|||
147372163|NCT00065182|531529424|FG001|Overall Study|Sponsor Decision|7|||
147372164|NCT00065182|531529423|FG000|Overall Study|Withdrawal by Subject|8|||
147372165|NCT00065182|531529424|FG001|Overall Study|Withdrawal by Subject|3|||
147372166|NCT00065182|531529423|FG000|Overall Study|No clinical benefit|1|||
147372167|NCT00065182|531529424|FG001|Overall Study|No clinical benefit|0|||
147372168|NCT00065182|531529423|FG000|Overall Study|Death|0|||
147372169|NCT00065182|531529424|FG001|Overall Study|Death|1|||
147372170|NCT00065182|531529423|FG000|Overall Study|Decline in Status|0|||
147372171|NCT00065182|531529424|FG001|Overall Study|Decline in Status|1|||
147372172|NCT02633215|531529425|FG000|Overall Study|Lost to Follow-up|2|||
147372173|NCT02633215|531529426|FG001|Overall Study|Lost to Follow-up|3|||
147372174|NCT00754325|531529427|FG000|Initial Treatment|Continuing Active Treatment|4|||
147372175|NCT00754325|531529428|FG001|Initial Treatment|Continuing Active Treatment|5|||
147372176|NCT00754325|531529427|FG000|Initial Treatment|Adverse Event|7|||
147372177|NCT00754325|531529428|FG001|Initial Treatment|Adverse Event|6|||
147372178|NCT00754325|531529427|FG000|Initial Treatment|Withdrawal by Subject|2|||
147372179|NCT00754325|531529428|FG001|Initial Treatment|Withdrawal by Subject|2|||
147372180|NCT00754325|531529427|FG000|Initial Treatment|Physician Decision|2|||
147372181|NCT00754325|531529428|FG001|Initial Treatment|Physician Decision|0|||
147372182|NCT00754325|531529427|FG000|Initial Treatment|Sponsor Request|0|||
147372183|NCT00754325|531529428|FG001|Initial Treatment|Sponsor Request|1|||
147663841|NCT02895295|532591608|FG000|Overall Study|Survey Non-response|71|||
147663842|NCT02895295|532591609|FG001|Overall Study|Survey Non-response|94|||
147663843|NCT02895295|532591610|FG002|Overall Study|Survey Non-response|92|||
147372184|NCT00754325|531529427|FG000|Initial Treatment|Disease Progression|35|||
147372185|NCT00754325|531529428|FG001|Initial Treatment|Disease Progression|35|||
147372186|NCT03442777|531529429|FG000|Overall Study|Not included in analysis as assessed only once and no pressure ulcer or category 1 at any site|8|||
147372187|NCT03442777|531529430|FG001|Overall Study|Not included in analysis as assessed only once and no pressure ulcer or category 1 at any site|13|||
147372188|NCT03442777|531529431|FG002|Overall Study|Not included in analysis as assessed only once and no pressure ulcer or category 1 at any site|7|||
147372189|NCT03801148|531529432|FG000|Period 1 (2 Days)|Adverse Event|1|||
147372190|NCT03801148|531529433|FG001|Period 1 (2 Days)|Adverse Event|1|||
147372191|NCT03801148|531529434|FG002|Period 1 (2 Days)|Adverse Event|0|||
147372192|NCT03801148|531529435|FG003|Period 1 (2 Days)|Adverse Event|0|||
147663844|NCT00490919|532591611|FG000|Open-label Run-in Period|Adverse Event|239|||
147663845|NCT00490919|532591612|FG001|Open-label Run-in Period|Adverse Event|0|||
147663846|NCT00490919|532591613|FG002|Open-label Run-in Period|Adverse Event|0|||
147663847|NCT00490919|532591611|FG000|Open-label Run-in Period|Withdrawal by Subject|37|||
147663848|NCT00490919|532591612|FG001|Open-label Run-in Period|Withdrawal by Subject|0|||
147372193|NCT03801148|531529432|FG000|Washout Period (at Least 5 Days)|Lost to Follow-up|0|||
147372194|NCT03801148|531529433|FG001|Washout Period (at Least 5 Days)|Lost to Follow-up|0|||
147372195|NCT03801148|531529434|FG002|Washout Period (at Least 5 Days)|Lost to Follow-up|0|||
147372196|NCT03801148|531529435|FG003|Washout Period (at Least 5 Days)|Lost to Follow-up|1|||
147372197|NCT03801148|531529432|FG000|Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
147372198|NCT03801148|531529433|FG001|Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
147372199|NCT03801148|531529434|FG002|Washout Period (at Least 5 Days)|Withdrawal by Subject|1|||
147372200|NCT03801148|531529435|FG003|Washout Period (at Least 5 Days)|Withdrawal by Subject|0|||
147372201|NCT03801148|531529432|FG000|Follow-Up (12 Days)|Lost to Follow-up|0|||
147372202|NCT03801148|531529433|FG001|Follow-Up (12 Days)|Lost to Follow-up|1|||
147372203|NCT03801148|531529434|FG002|Follow-Up (12 Days)|Lost to Follow-up|1|||
147372204|NCT03801148|531529435|FG003|Follow-Up (12 Days)|Lost to Follow-up|0|||
147372205|NCT00609869|531529436|FG000|Overall Study|Withdrawn, ischemic stroke|1|||
147372206|NCT00609869|531529436|FG000|Overall Study|Severe hematologic toxicity|1|||
147372207|NCT00609869|531529436|FG000|Overall Study|Withdrawal by Subject|1|||
147372208|NCT00609869|531529436|FG000|Overall Study|Seizures|1|||
147372209|NCT00609869|531529436|FG000|Overall Study|Severe tumor flare reaction|1|||
147372210|NCT00609869|531529436|FG000|Overall Study|Hepatitis B infection|1|||
147372211|NCT00609869|531529436|FG000|Overall Study|Rituximab reaction prior to lenalidomide|1|||
147372212|NCT00609869|531529436|FG000|Overall Study|Mantle cell: not evaluable|4|||
147372213|NCT01627561|531529437|FG000|Overall Study|Lost to Follow-up|1|||
147372214|NCT01627561|531529438|FG001|Overall Study|Lost to Follow-up|0|||
147372215|NCT01627561|531529437|FG000|Overall Study|Withdrawal by Subject|0|||
147372216|NCT01627561|531529438|FG001|Overall Study|Withdrawal by Subject|1|||
147372217|NCT01627561|531529437|FG000|Overall Study|Migrated/moved from study area|0|||
147372218|NCT01627561|531529438|FG001|Overall Study|Migrated/moved from study area|2|||
147372219|NCT00754065|531529449|FG000|Overall Study|Never received treatment|12|||
147372220|NCT00754065|531529450|FG001|Overall Study|Never received treatment|2|||
147372221|NCT00754065|531529449|FG000|Overall Study|Adverse Event|19|||
147372222|NCT00754065|531529450|FG001|Overall Study|Adverse Event|25|||
147372223|NCT00754065|531529449|FG000|Overall Study|Lost to Follow-up|7|||
147372224|NCT00754065|531529450|FG001|Overall Study|Lost to Follow-up|11|||
147372225|NCT00754065|531529449|FG000|Overall Study|Protocol Violation|12|||
147372226|NCT00754065|531529450|FG001|Overall Study|Protocol Violation|10|||
147372227|NCT00754065|531529449|FG000|Overall Study|Withdrawal by Subject|4|||
147372228|NCT00754065|531529450|FG001|Overall Study|Withdrawal by Subject|5|||
147372229|NCT00754065|531529449|FG000|Overall Study|Pregnancy|6|||
147372230|NCT00754065|531529450|FG001|Overall Study|Pregnancy|0|||
147372231|NCT00754065|531529449|FG000|Overall Study|Reason not specified or unknown, etc.|21|||
147372232|NCT00754065|531529450|FG001|Overall Study|Reason not specified or unknown, etc.|27|||
147372233|NCT04033445|531529451|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|2|||
147372234|NCT04033445|531529452|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|1|||
147372235|NCT04033445|531529453|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
147372236|NCT04033445|531529454|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
147372237|NCT04033445|531529455|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
147372238|NCT04033445|531529456|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|9|||
147372239|NCT04033445|531529457|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|7|||
147372240|NCT04033445|531529458|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
147372241|NCT04033445|531529459|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
147372242|NCT04033445|531529460|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
147372243|NCT04033445|531529461|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
147372244|NCT04033445|531529462|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
147372245|NCT04033445|531529463|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
147372246|NCT04033445|531529464|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Adverse Event|0|||
147372247|NCT04033445|531529451|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
147372248|NCT04033445|531529452|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
147372249|NCT04033445|531529453|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
147372250|NCT04033445|531529454|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
147372251|NCT04033445|531529455|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
147372252|NCT04033445|531529456|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|1|||
147372253|NCT04033445|531529457|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|1|||
147611114|NCT03633825|532390950|FG000|Enrollment|Did not post on network|5066|||
147611115|NCT03633825|532390951|FG001|Enrollment|Did not post on network|5080|||
147611116|NCT03633825|532390950|FG000|Enrollment|Post not classified as crisis|13967|||
147611117|NCT03633825|532390951|FG001|Enrollment|Post not classified as crisis|13757|||
147372254|NCT04033445|531529458|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
147611118|NCT03633825|532390950|FG000|Follow up|Lost to Follow-up|478|||
147372255|NCT04033445|531529459|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
147372256|NCT04033445|531529460|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
147372257|NCT04033445|531529461|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
147611119|NCT03633825|532390951|FG001|Follow up|Lost to Follow-up|450|||
147611120|NCT02756208|532390952|FG000|Overall Study|Withdrawal by Subject|1|||
147372258|NCT04033445|531529462|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
147372259|NCT04033445|531529463|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
147372260|NCT04033445|531529464|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Death|0|||
147372261|NCT04033445|531529451|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|2|||
147372262|NCT04033445|531529452|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
147372263|NCT04033445|531529453|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
147372264|NCT04033445|531529454|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
147372265|NCT04033445|531529455|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
147372266|NCT04033445|531529456|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
147372267|NCT04033445|531529457|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|2|||
147372268|NCT04033445|531529458|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
147372269|NCT04033445|531529459|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
147372270|NCT04033445|531529460|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
147372271|NCT04033445|531529461|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
147372272|NCT04033445|531529462|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
147372273|NCT04033445|531529463|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
147372274|NCT04033445|531529464|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Lack of Efficacy|0|||
147372275|NCT04033445|531529451|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
147372276|NCT04033445|531529452|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
147372277|NCT04033445|531529453|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
147372278|NCT04033445|531529454|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
147372279|NCT04033445|531529455|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
147372280|NCT04033445|531529456|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|2|||
147372281|NCT04033445|531529457|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|1|||
147372282|NCT04033445|531529458|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
147372283|NCT04033445|531529459|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
147372284|NCT04033445|531529460|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
147372285|NCT04033445|531529461|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
147372286|NCT04033445|531529462|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
147372287|NCT04033445|531529463|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
147372288|NCT04033445|531529464|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Physician Decision|0|||
147372289|NCT04033445|531529451|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
147372290|NCT04033445|531529452|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
147372291|NCT04033445|531529453|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
147372292|NCT04033445|531529454|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
147372293|NCT04033445|531529455|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
147372294|NCT04033445|531529456|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
147372295|NCT04033445|531529457|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|1|||
147455170|NCT02799069|531827835|FG001|Overall Study|Protocol Violation|0|||
147455171|NCT02799069|531827836|FG002|Overall Study|Protocol Violation|2|||
147455172|NCT03652662|531827839|FG000|Overall Study|Withdrawal by Subject|2|||
147455173|NCT03652662|531827840|FG001|Overall Study|Withdrawal by Subject|1|||
147455174|NCT03652662|531827839|FG000|Overall Study|Lost to Follow-up|1|||
147455175|NCT03652662|531827840|FG001|Overall Study|Lost to Follow-up|0|||
147455176|NCT00487539|531827841|FG000|Overall Study|Adverse Event|3|||
147455177|NCT00487539|531827842|FG001|Overall Study|Adverse Event|2|||
147455178|NCT00487539|531827843|FG002|Overall Study|Adverse Event|1|||
147455179|NCT00487539|531827844|FG003|Overall Study|Adverse Event|1|||
147455180|NCT00487539|531827841|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
147455181|NCT00487539|531827842|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
147455182|NCT00487539|531827843|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
147372296|NCT04033445|531529458|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
147372297|NCT04033445|531529459|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
147372298|NCT04033445|531529460|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
147372299|NCT04033445|531529461|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
147372300|NCT04033445|531529462|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
147372301|NCT04033445|531529463|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
147372302|NCT04033445|531529464|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Pregnancy|0|||
147455183|NCT00487539|531827844|FG003|Overall Study|Unsatisfactory therapeutic effect|1|||
147455184|NCT00487539|531827841|FG000|Overall Study|Other|3|||
147455185|NCT00487539|531827842|FG001|Overall Study|Other|1|||
147372303|NCT04033445|531529451|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|1|||
147372304|NCT04033445|531529452|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|1|||
147372305|NCT04033445|531529453|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|1|||
147372306|NCT04033445|531529454|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
147372307|NCT04033445|531529455|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
147455186|NCT00487539|531827843|FG002|Overall Study|Other|2|||
147455187|NCT00487539|531827844|FG003|Overall Study|Other|2|||
147455188|NCT02695628|531827845|FG000|Overall Study|Withdrawal by Subject|1|||
147455189|NCT02678390|531827846|FG000|AE (1 Day)|Withdrawal by Subject|0|||
147372308|NCT04033445|531529456|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|12|||
147372309|NCT04033445|531529457|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|6|||
147372310|NCT04033445|531529458|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
147372311|NCT04033445|531529459|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
147372312|NCT04033445|531529460|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
147372313|NCT04033445|531529461|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
147372314|NCT04033445|531529462|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
147372315|NCT04033445|531529463|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
147372316|NCT04033445|531529464|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Withdrawal by Subject|0|||
147372317|NCT04033445|531529451|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
147372318|NCT04033445|531529452|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|1|||
147372319|NCT04033445|531529453|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
147372320|NCT04033445|531529454|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
147372321|NCT04033445|531529455|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
147372322|NCT04033445|531529456|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|1|||
147372323|NCT04033445|531529457|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
147372324|NCT04033445|531529458|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
147372325|NCT04033445|531529459|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
147372326|NCT04033445|531529460|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
147372327|NCT04033445|531529461|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
147372328|NCT04033445|531529462|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
147372329|NCT04033445|531529463|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
147372330|NCT04033445|531529464|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Other|0|||
147372331|NCT04033445|531529451|FG000|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|1|||
147372332|NCT04033445|531529452|FG001|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
147372333|NCT04033445|531529453|FG002|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
147372334|NCT04033445|531529454|FG003|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
147372335|NCT04033445|531529455|FG004|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
147372336|NCT04033445|531529456|FG005|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|1|||
147372337|NCT04033445|531529457|FG006|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
147372338|NCT04033445|531529458|FG007|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
147372339|NCT04033445|531529459|FG008|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
147372340|NCT04033445|531529460|FG009|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
147372341|NCT04033445|531529461|FG010|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
147372342|NCT04033445|531529462|FG011|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
147372343|NCT04033445|531529463|FG012|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
147372344|NCT04033445|531529464|FG013|IS-1 and IS-2 Period 1 (Week 0 to 12)|Randomized but not treated|0|||
147372345|NCT04033445|531529451|FG000|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
147372346|NCT04033445|531529452|FG001|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
147372347|NCT04033445|531529453|FG002|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
147372348|NCT04033445|531529454|FG003|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|2|||
147372349|NCT04033445|531529455|FG004|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|2|||
147372350|NCT04033445|531529456|FG005|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
147372351|NCT04033445|531529457|FG006|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
147372352|NCT04033445|531529458|FG007|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|4|||
147372353|NCT04033445|531529459|FG008|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|6|||
147372354|NCT04033445|531529460|FG009|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
147372355|NCT04033445|531529461|FG010|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
147372356|NCT04033445|531529462|FG011|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
147372357|NCT04033445|531529463|FG012|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
147372358|NCT04033445|531529464|FG013|IS-1 and IS-2 Period 2 (Week 12 to 24)|Adverse Event|0|||
147372359|NCT04033445|531529451|FG000|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
147372360|NCT04033445|531529452|FG001|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
147372361|NCT04033445|531529453|FG002|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
147372362|NCT04033445|531529454|FG003|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
147372363|NCT04033445|531529455|FG004|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
147372364|NCT04033445|531529456|FG005|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
147372365|NCT04033445|531529457|FG006|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
147372366|NCT04033445|531529458|FG007|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|1|||
147372367|NCT04033445|531529459|FG008|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|3|||
147372368|NCT04033445|531529460|FG009|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
147372369|NCT04033445|531529461|FG010|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
147372370|NCT04033445|531529462|FG011|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
147372371|NCT04033445|531529463|FG012|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
147372372|NCT04033445|531529464|FG013|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lack of Efficacy|0|||
147372373|NCT04033445|531529451|FG000|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
147372374|NCT04033445|531529452|FG001|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
147372375|NCT04033445|531529453|FG002|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
147372376|NCT04033445|531529454|FG003|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
147372377|NCT04033445|531529455|FG004|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
147372378|NCT04033445|531529456|FG005|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
147372379|NCT04033445|531529457|FG006|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
147372380|NCT04033445|531529458|FG007|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
147372381|NCT04033445|531529459|FG008|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|1|||
147372382|NCT04033445|531529460|FG009|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
147372383|NCT04033445|531529461|FG010|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
147372384|NCT04033445|531529462|FG011|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
147372385|NCT04033445|531529463|FG012|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
147372386|NCT04033445|531529464|FG013|IS-1 and IS-2 Period 2 (Week 12 to 24)|Lost to Follow-up|0|||
147372387|NCT04033445|531529451|FG000|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
147372388|NCT04033445|531529452|FG001|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
147372389|NCT04033445|531529453|FG002|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
147372390|NCT04033445|531529454|FG003|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|1|||
147372391|NCT04033445|531529455|FG004|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
147372392|NCT04033445|531529456|FG005|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
147372393|NCT04033445|531529457|FG006|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
147372394|NCT04033445|531529458|FG007|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
147372395|NCT04033445|531529459|FG008|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
147372396|NCT04033445|531529460|FG009|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
147372397|NCT04033445|531529461|FG010|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
147372398|NCT04033445|531529462|FG011|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
147372399|NCT04033445|531529463|FG012|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
147372400|NCT04033445|531529464|FG013|IS-1 and IS-2 Period 2 (Week 12 to 24)|Protocol Violation|0|||
147372401|NCT04033445|531529451|FG000|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
147372402|NCT04033445|531529452|FG001|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
147372403|NCT04033445|531529453|FG002|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
147372404|NCT04033445|531529454|FG003|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
147372405|NCT04033445|531529455|FG004|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
147372406|NCT04033445|531529456|FG005|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
147372407|NCT04033445|531529457|FG006|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
147372408|NCT04033445|531529458|FG007|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|3|||
147372409|NCT04033445|531529459|FG008|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|2|||
147372410|NCT04033445|531529460|FG009|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
147372411|NCT04033445|531529461|FG010|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
147372412|NCT04033445|531529462|FG011|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
147372413|NCT04033445|531529463|FG012|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
147372414|NCT04033445|531529464|FG013|IS-1 and IS-2 Period 2 (Week 12 to 24)|Withdrawal by Subject|0|||
147372415|NCT04033445|531529451|FG000|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
147372416|NCT04033445|531529452|FG001|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
147372417|NCT04033445|531529453|FG002|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
147300113|NCT06060457|531264631|FG001|Overall Study|Other Than Specified|1|||
147300114|NCT02061202|531264632|FG000|Overall Study|Lost to Follow-up|1|||
147300115|NCT02061202|531264633|FG001|Overall Study|Lost to Follow-up|1|||
147300116|NCT01533493|531264634|FG000|Overall Study|Adverse Event|2|||
147300117|NCT01533493|531264635|FG001|Overall Study|Adverse Event|1|||
147300118|NCT01533493|531264634|FG000|Overall Study|Withdrawal by Subject|1|||
147300119|NCT01533493|531264635|FG001|Overall Study|Withdrawal by Subject|2|||
147300120|NCT01533493|531264634|FG000|Overall Study|Lost to Follow-up|2|||
147372418|NCT04033445|531529454|FG003|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
147372419|NCT04033445|531529455|FG004|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
147372420|NCT04033445|531529456|FG005|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
147372421|NCT04033445|531529457|FG006|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
147372422|NCT04033445|531529458|FG007|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|1|||
147455190|NCT02678390|531827847|FG001|AE (1 Day)|Withdrawal by Subject|1|||
147455191|NCT03499028|531827848|FG000|Overall Study|Lost to Follow-up|12|||
147372423|NCT04033445|531529459|FG008|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
147372424|NCT04033445|531529460|FG009|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
147372425|NCT04033445|531529461|FG010|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
147372426|NCT04033445|531529462|FG011|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
147372427|NCT04033445|531529463|FG012|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
147372428|NCT04033445|531529464|FG013|IS-1 and IS-2 Period 2 (Week 12 to 24)|Other|0|||
147372429|NCT04033445|531529451|FG000|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
147663849|NCT00490919|532591613|FG002|Open-label Run-in Period|Withdrawal by Subject|0|||
147663850|NCT00490919|532591611|FG000|Open-label Run-in Period|Lost to Follow-up|21|||
147663851|NCT00490919|532591612|FG001|Open-label Run-in Period|Lost to Follow-up|0|||
147663852|NCT00490919|532591613|FG002|Open-label Run-in Period|Lost to Follow-up|0|||
147663853|NCT00490919|532591611|FG000|Open-label Run-in Period|Lack of Efficacy|143|||
147663854|NCT00490919|532591612|FG001|Open-label Run-in Period|Lack of Efficacy|0|||
147663855|NCT00490919|532591613|FG002|Open-label Run-in Period|Lack of Efficacy|0|||
147663856|NCT00490919|532591611|FG000|Open-label Run-in Period|Administrative|40|||
147663857|NCT00490919|532591612|FG001|Open-label Run-in Period|Administrative|0|||
147663858|NCT00490919|532591613|FG002|Open-label Run-in Period|Administrative|0|||
147663859|NCT00490919|532591611|FG000|Open-label Run-in Period|Confirmed or suspected diversion|3|||
147663860|NCT00490919|532591612|FG001|Open-label Run-in Period|Confirmed or suspected diversion|0|||
147663861|NCT00490919|532591613|FG002|Open-label Run-in Period|Confirmed or suspected diversion|0|||
147663862|NCT00490919|532591611|FG000|Double-blind Phase|Adverse Event|0|||
147663863|NCT00490919|532591612|FG001|Double-blind Phase|Adverse Event|40|||
147663864|NCT00490919|532591613|FG002|Double-blind Phase|Adverse Event|20|||
147663865|NCT00490919|532591611|FG000|Double-blind Phase|Withdrawal by Subject|0|||
147663866|NCT00490919|532591612|FG001|Double-blind Phase|Withdrawal by Subject|10|||
147372430|NCT04033445|531529452|FG001|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
147372431|NCT04033445|531529453|FG002|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
147372432|NCT04033445|531529454|FG003|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
147372433|NCT04033445|531529455|FG004|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
147372434|NCT04033445|531529456|FG005|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
147372435|NCT04033445|531529457|FG006|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
147372436|NCT04033445|531529458|FG007|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|1|||
147372437|NCT04033445|531529459|FG008|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
147372438|NCT04033445|531529460|FG009|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
147372439|NCT04033445|531529461|FG010|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
147372440|NCT04033445|531529462|FG011|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
147372441|NCT04033445|531529463|FG012|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
147372442|NCT04033445|531529464|FG013|IS-1 and IS-2 Period 2 (Week 12 to 24)|Crossed over but not treated|0|||
147372443|NCT04033445|531529451|FG000|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
147372444|NCT04033445|531529452|FG001|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
147372445|NCT04033445|531529453|FG002|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
147372446|NCT04033445|531529454|FG003|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
147372447|NCT04033445|531529455|FG004|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
147372448|NCT04033445|531529456|FG005|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
147372449|NCT04033445|531529457|FG006|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
147372450|NCT04033445|531529458|FG007|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
147372451|NCT04033445|531529459|FG008|Maintenance Study (Week 0 to Week 44)|Adverse Event|0|||
147372452|NCT04033445|531529460|FG009|Maintenance Study (Week 0 to Week 44)|Adverse Event|12|||
147372453|NCT04033445|531529461|FG010|Maintenance Study (Week 0 to Week 44)|Adverse Event|9|||
147372454|NCT04033445|531529462|FG011|Maintenance Study (Week 0 to Week 44)|Adverse Event|10|||
147372455|NCT04033445|531529463|FG012|Maintenance Study (Week 0 to Week 44)|Adverse Event|11|||
147372456|NCT04033445|531529464|FG013|Maintenance Study (Week 0 to Week 44)|Adverse Event|5|||
147372457|NCT04033445|531529451|FG000|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
147372458|NCT04033445|531529452|FG001|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
147372459|NCT04033445|531529453|FG002|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
147372460|NCT04033445|531529454|FG003|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
147372461|NCT04033445|531529455|FG004|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
147372462|NCT04033445|531529456|FG005|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
147372463|NCT04033445|531529457|FG006|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
147372464|NCT04033445|531529458|FG007|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
147372465|NCT04033445|531529459|FG008|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|0|||
147372466|NCT04033445|531529460|FG009|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|6|||
147372467|NCT04033445|531529461|FG010|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|3|||
147455192|NCT03499028|531827849|FG001|Overall Study|Lost to Follow-up|9|||
147663867|NCT00490919|532591613|FG002|Double-blind Phase|Withdrawal by Subject|11|||
147663868|NCT00490919|532591611|FG000|Double-blind Phase|Lost to Follow-up|0|||
147663869|NCT00490919|532591612|FG001|Double-blind Phase|Lost to Follow-up|8|||
147663870|NCT00490919|532591613|FG002|Double-blind Phase|Lost to Follow-up|11|||
147663871|NCT00490919|532591611|FG000|Double-blind Phase|Lack of Efficacy|0|||
147663872|NCT00490919|532591612|FG001|Double-blind Phase|Lack of Efficacy|22|||
147663873|NCT00490919|532591613|FG002|Double-blind Phase|Lack of Efficacy|36|||
147663874|NCT00490919|532591611|FG000|Double-blind Phase|Administrative|0|||
147663875|NCT00490919|532591612|FG001|Double-blind Phase|Administrative|6|||
147663876|NCT00490919|532591613|FG002|Double-blind Phase|Administrative|6|||
147372468|NCT04033445|531529462|FG011|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|1|||
147372469|NCT04033445|531529463|FG012|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|5|||
147372470|NCT04033445|531529464|FG013|Maintenance Study (Week 0 to Week 44)|Lack of Efficacy|3|||
147372471|NCT04033445|531529451|FG000|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
147372472|NCT04033445|531529452|FG001|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
147372473|NCT04033445|531529453|FG002|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
147372474|NCT04033445|531529454|FG003|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
147372475|NCT04033445|531529455|FG004|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
147372476|NCT04033445|531529456|FG005|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
147372477|NCT04033445|531529457|FG006|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
147372478|NCT04033445|531529458|FG007|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
147372479|NCT04033445|531529459|FG008|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
147372480|NCT04033445|531529460|FG009|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
147372481|NCT04033445|531529461|FG010|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|1|||
147372482|NCT04033445|531529462|FG011|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|1|||
147372483|NCT04033445|531529463|FG012|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|0|||
147372484|NCT04033445|531529464|FG013|Maintenance Study (Week 0 to Week 44)|Lost to Follow-up|1|||
147372485|NCT04033445|531529451|FG000|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
147372486|NCT04033445|531529452|FG001|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
147372487|NCT04033445|531529453|FG002|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
147372488|NCT04033445|531529454|FG003|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
147372489|NCT04033445|531529455|FG004|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
147372490|NCT04033445|531529456|FG005|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
147372491|NCT04033445|531529457|FG006|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
147372492|NCT04033445|531529458|FG007|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
147372493|NCT04033445|531529459|FG008|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
147372494|NCT04033445|531529460|FG009|Maintenance Study (Week 0 to Week 44)|Physician Decision|0|||
147372495|NCT04033445|531529461|FG010|Maintenance Study (Week 0 to Week 44)|Physician Decision|4|||
147372496|NCT04033445|531529462|FG011|Maintenance Study (Week 0 to Week 44)|Physician Decision|1|||
147372497|NCT04033445|531529463|FG012|Maintenance Study (Week 0 to Week 44)|Physician Decision|2|||
147372498|NCT04033445|531529464|FG013|Maintenance Study (Week 0 to Week 44)|Physician Decision|1|||
147372499|NCT04033445|531529451|FG000|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
147372500|NCT04033445|531529452|FG001|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
147372501|NCT04033445|531529453|FG002|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
147372502|NCT04033445|531529454|FG003|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
147372503|NCT04033445|531529455|FG004|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
147372504|NCT04033445|531529456|FG005|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
147372505|NCT04033445|531529457|FG006|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
147372506|NCT04033445|531529458|FG007|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
147372507|NCT04033445|531529459|FG008|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|0|||
147372508|NCT04033445|531529460|FG009|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|8|||
147372509|NCT04033445|531529461|FG010|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|4|||
147372510|NCT04033445|531529462|FG011|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|7|||
147372511|NCT04033445|531529463|FG012|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|6|||
147372512|NCT04033445|531529464|FG013|Maintenance Study (Week 0 to Week 44)|Withdrawal by Subject|5|||
147372513|NCT04033445|531529451|FG000|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
147372514|NCT04033445|531529452|FG001|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
147372515|NCT04033445|531529453|FG002|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
147372516|NCT04033445|531529454|FG003|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
147372517|NCT04033445|531529455|FG004|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
147372518|NCT04033445|531529456|FG005|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
147372519|NCT04033445|531529457|FG006|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
147372520|NCT04033445|531529458|FG007|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
147372521|NCT04033445|531529459|FG008|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
147372522|NCT04033445|531529460|FG009|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
147372523|NCT04033445|531529461|FG010|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
147372524|NCT04033445|531529462|FG011|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
147372525|NCT04033445|531529463|FG012|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|0|||
147372526|NCT04033445|531529464|FG013|Maintenance Study (Week 0 to Week 44)|Non-Compliance With Study Drug|1|||
147372527|NCT04033445|531529451|FG000|Maintenance Study (Week 0 to Week 44)|Other|0|||
147372528|NCT04033445|531529452|FG001|Maintenance Study (Week 0 to Week 44)|Other|0|||
147372529|NCT04033445|531529453|FG002|Maintenance Study (Week 0 to Week 44)|Other|0|||
147372530|NCT04033445|531529454|FG003|Maintenance Study (Week 0 to Week 44)|Other|0|||
147372531|NCT04033445|531529455|FG004|Maintenance Study (Week 0 to Week 44)|Other|0|||
147372532|NCT04033445|531529456|FG005|Maintenance Study (Week 0 to Week 44)|Other|0|||
147372533|NCT04033445|531529457|FG006|Maintenance Study (Week 0 to Week 44)|Other|0|||
147372534|NCT04033445|531529458|FG007|Maintenance Study (Week 0 to Week 44)|Other|0|||
147372535|NCT04033445|531529459|FG008|Maintenance Study (Week 0 to Week 44)|Other|0|||
147372536|NCT04033445|531529460|FG009|Maintenance Study (Week 0 to Week 44)|Other|1|||
147372537|NCT04033445|531529461|FG010|Maintenance Study (Week 0 to Week 44)|Other|1|||
147372538|NCT04033445|531529462|FG011|Maintenance Study (Week 0 to Week 44)|Other|2|||
147372539|NCT04033445|531529463|FG012|Maintenance Study (Week 0 to Week 44)|Other|2|||
147372540|NCT04033445|531529464|FG013|Maintenance Study (Week 0 to Week 44)|Other|2|||
147372541|NCT04033445|531529451|FG000|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
147372542|NCT04033445|531529452|FG001|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
147372543|NCT04033445|531529453|FG002|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
147372544|NCT04033445|531529454|FG003|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
147372545|NCT04033445|531529455|FG004|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
147372546|NCT04033445|531529456|FG005|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
147372547|NCT04033445|531529457|FG006|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
147372548|NCT04033445|531529458|FG007|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
147372549|NCT04033445|531529459|FG008|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
147372550|NCT04033445|531529460|FG009|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|1|||
147372551|NCT04033445|531529461|FG010|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
147372552|NCT04033445|531529462|FG011|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|1|||
147372553|NCT04033445|531529463|FG012|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|1|||
147372554|NCT04033445|531529464|FG013|Maintenance Study (Week 0 to Week 44)|Site Closure in Ukraine|0|||
147372555|NCT04353492|531529467|FG000|Overall Study|Subject decision|24|||
147372556|NCT04353492|531529467|FG000|Overall Study|Physician Decision|5|||
147372557|NCT04353492|531529467|FG000|Overall Study|Adverse Event|3|||
147372558|NCT04353492|531529467|FG000|Overall Study|Pregnancy|3|||
147372559|NCT04353492|531529467|FG000|Overall Study|Lost to Follow-up|2|||
147372560|NCT04353492|531529467|FG000|Overall Study|Protocol deviation|1|||
147372561|NCT04353492|531529467|FG000|Overall Study|Technical problems|1|||
147372562|NCT00776009|531529468|FG000|Period 1: First Intervention|Withdrawal by Subject|0|||
147372563|NCT00776009|531529469|FG001|Period 1: First Intervention|Withdrawal by Subject|0|||
147372564|NCT00776009|531529470|FG002|Period 1: First Intervention|Withdrawal by Subject|1|||
147372565|NCT00776009|531529471|FG003|Period 1: First Intervention|Withdrawal by Subject|0|||
147372566|NCT00776009|531529472|FG004|Period 1: First Intervention|Withdrawal by Subject|1|||
147372567|NCT00776009|531529473|FG005|Period 1: First Intervention|Withdrawal by Subject|0|||
147372568|NCT00776009|531529468|FG000|Period 1: First Intervention|Protocol Violation|0|||
147372569|NCT00776009|531529469|FG001|Period 1: First Intervention|Protocol Violation|1|||
147372570|NCT00776009|531529470|FG002|Period 1: First Intervention|Protocol Violation|0|||
147372571|NCT00776009|531529471|FG003|Period 1: First Intervention|Protocol Violation|0|||
147372572|NCT00776009|531529472|FG004|Period 1: First Intervention|Protocol Violation|1|||
147372573|NCT00776009|531529473|FG005|Period 1: First Intervention|Protocol Violation|0|||
147372574|NCT00776009|531529468|FG000|Period 2: Second Intervention|Withdrawal by Subject|0|||
147372575|NCT00776009|531529469|FG001|Period 2: Second Intervention|Withdrawal by Subject|0|||
147372576|NCT00776009|531529470|FG002|Period 2: Second Intervention|Withdrawal by Subject|0|||
147372577|NCT00776009|531529471|FG003|Period 2: Second Intervention|Withdrawal by Subject|0|||
147372578|NCT00776009|531529472|FG004|Period 2: Second Intervention|Withdrawal by Subject|0|||
147372579|NCT00776009|531529473|FG005|Period 2: Second Intervention|Withdrawal by Subject|1|||
147372580|NCT00776009|531529468|FG000|Period 2: Second Intervention|Protocol Violation|1|||
147372581|NCT00776009|531529469|FG001|Period 2: Second Intervention|Protocol Violation|0|||
147372582|NCT00776009|531529470|FG002|Period 2: Second Intervention|Protocol Violation|1|||
147372583|NCT00776009|531529471|FG003|Period 2: Second Intervention|Protocol Violation|0|||
147372584|NCT00776009|531529472|FG004|Period 2: Second Intervention|Protocol Violation|0|||
147372585|NCT00776009|531529473|FG005|Period 2: Second Intervention|Protocol Violation|0|||
147611121|NCT02756208|532390953|FG001|Overall Study|Withdrawal by Subject|0|||
147611122|NCT02756208|532390954|FG002|Overall Study|Withdrawal by Subject|1|||
147611123|NCT02756208|532390955|FG003|Overall Study|Withdrawal by Subject|3|||
147611124|NCT02756208|532390952|FG000|Overall Study|Lost to Follow-up|3|||
147611125|NCT02756208|532390953|FG001|Overall Study|Lost to Follow-up|1|||
147611126|NCT02756208|532390954|FG002|Overall Study|Lost to Follow-up|1|||
147372586|NCT00776009|531529468|FG000|Period 3: Third Intervention|Withdrawal by Subject|1|||
147372587|NCT00776009|531529469|FG001|Period 3: Third Intervention|Withdrawal by Subject|0|||
147372588|NCT00776009|531529470|FG002|Period 3: Third Intervention|Withdrawal by Subject|0|||
147372589|NCT00776009|531529471|FG003|Period 3: Third Intervention|Withdrawal by Subject|0|||
147372590|NCT00776009|531529472|FG004|Period 3: Third Intervention|Withdrawal by Subject|0|||
147372591|NCT00776009|531529473|FG005|Period 3: Third Intervention|Withdrawal by Subject|0|||
147611127|NCT02756208|532390955|FG003|Overall Study|Lost to Follow-up|1|||
147611128|NCT02756208|532390952|FG000|Overall Study|Physician Decision|1|||
147372592|NCT00582972|531529474|FG000|Overall Study|Protocol Violation|2|||
147372593|NCT02101775|531529480|FG000|Overall Study|Adverse Event|4|||
147372594|NCT02101775|531529481|FG001|Overall Study|Adverse Event|0|||
147372595|NCT02101775|531529482|FG002|Overall Study|Adverse Event|0|||
147372596|NCT02101775|531529480|FG000|Overall Study|Admission to Hospital|0|||
147372597|NCT02101775|531529481|FG001|Overall Study|Admission to Hospital|1|||
147372598|NCT02101775|531529482|FG002|Overall Study|Admission to Hospital|0|||
147372599|NCT00293397|531529483|FG000|Overall Study|Death|2|||
147372600|NCT00503906|531529486|FG000|Overall Study|Withdrawal by Subject|1|||
147372601|NCT04035447|531529487|FG000|Treatment Period|Lost to Follow-up|6|||
147372602|NCT04035447|531529488|FG001|Treatment Period|Lost to Follow-up|5|||
147372603|NCT04035447|531529487|FG000|Treatment Period|Physician Decision|0|||
147372604|NCT04035447|531529488|FG001|Treatment Period|Physician Decision|2|||
147372605|NCT03304587|531529489|FG000|Overall Study|Headache after intervention|0|||
147372606|NCT03304587|531529490|FG001|Overall Study|Headache after intervention|1|||
147372607|NCT03304587|531529489|FG000|Overall Study|Withdrawal by Subject|1|||
147372608|NCT03304587|531529490|FG001|Overall Study|Withdrawal by Subject|0|||
147372609|NCT02029235|531529491|FG000|Overall Study|Non-compliance with study meds or diary|4|||
147372610|NCT02029235|531529492|FG001|Overall Study|Non-compliance with study meds or diary|1|||
147372611|NCT02107261|531529493|FG000|Washout: Weakness Back to Baseline|Lost to Follow-up|1|||
147372612|NCT02107261|531529494|FG001|Washout: Weakness Back to Baseline|Lost to Follow-up|0|||
147372613|NCT02107261|531529493|FG000|Cycle 2: Week 12-15|Withdrawal by Subject|0|||
147372614|NCT02107261|531529494|FG001|Cycle 2: Week 12-15|Withdrawal by Subject|1|||
147372615|NCT02408887|531529497|FG000|Overall Study|Participant was inevaluable due to advanced cancer|1|||
147372616|NCT02408887|531529498|FG001|Overall Study|Participant was inevaluable due to advanced cancer|0|||
147372617|NCT02408887|531529497|FG000|Overall Study|Participant was inevaluable due to benign pathology.|0|||
147372618|NCT02408887|531529498|FG001|Overall Study|Participant was inevaluable due to benign pathology.|1|||
147372619|NCT03333109|531529499|FG000|Double-blind Treatment Period (DBTP)|Adverse Event|0|||
147372620|NCT03333109|531529500|FG001|Double-blind Treatment Period (DBTP)|Adverse Event|0|||
147372621|NCT03333109|531529501|FG002|Double-blind Treatment Period (DBTP)|Adverse Event|2|||
147372622|NCT03333109|531529499|FG000|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
147372623|NCT03333109|531529500|FG001|Double-blind Treatment Period (DBTP)|Lost to Follow-up|0|||
147372624|NCT03333109|531529501|FG002|Double-blind Treatment Period (DBTP)|Lost to Follow-up|1|||
147372625|NCT03333109|531529499|FG000|Double-blind Treatment Period (DBTP)|Physician Decision|4|||
147372626|NCT03333109|531529500|FG001|Double-blind Treatment Period (DBTP)|Physician Decision|0|||
147372627|NCT03333109|531529501|FG002|Double-blind Treatment Period (DBTP)|Physician Decision|1|||
147372628|NCT03333109|531529499|FG000|Double-blind Treatment Period (DBTP)|Pregnancy|1|||
147372629|NCT03333109|531529500|FG001|Double-blind Treatment Period (DBTP)|Pregnancy|0|||
147372630|NCT03333109|531529501|FG002|Double-blind Treatment Period (DBTP)|Pregnancy|0|||
147372631|NCT03333109|531529499|FG000|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|9|||
147372632|NCT03333109|531529500|FG001|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|6|||
147372633|NCT03333109|531529501|FG002|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|5|||
147372634|NCT03333109|531529499|FG000|Double-blind Treatment Period (DBTP)|Randomized but not treated|3|||
147372635|NCT03333109|531529500|FG001|Double-blind Treatment Period (DBTP)|Randomized but not treated|0|||
147372636|NCT03333109|531529501|FG002|Double-blind Treatment Period (DBTP)|Randomized but not treated|3|||
147372637|NCT03333109|531529499|FG000|Safety Follow-up Period|Lost to Follow-up|6|||
147372638|NCT03333109|531529500|FG001|Safety Follow-up Period|Lost to Follow-up|2|||
147372639|NCT03333109|531529501|FG002|Safety Follow-up Period|Lost to Follow-up|1|||
147372640|NCT03333109|531529499|FG000|Safety Follow-up Period|Withdrawal by Subject|7|||
147372641|NCT03333109|531529500|FG001|Safety Follow-up Period|Withdrawal by Subject|2|||
147372642|NCT03333109|531529501|FG002|Safety Follow-up Period|Withdrawal by Subject|12|||
147372643|NCT04088227|531529502|FG000|Overall Study|Withdrawal by Subject|1|||
147372644|NCT04088227|531529503|FG001|Overall Study|Withdrawal by Subject|0|||
147372645|NCT04088227|531529502|FG000|Overall Study|Surgery postponed >5weeks|1|||
147372646|NCT04088227|531529503|FG001|Overall Study|Surgery postponed >5weeks|0|||
147372647|NCT03160885|531529506|FG000|Initial Treatment Period|Not dosed|2|||
147372648|NCT03160885|531529507|FG001|Initial Treatment Period|Not dosed|0|||
147372649|NCT03160885|531529508|FG002|Initial Treatment Period|Not dosed|0|||
147372650|NCT03160885|531529509|FG003|Initial Treatment Period|Not dosed|0|||
147372651|NCT03160885|531529510|FG004|Initial Treatment Period|Not dosed|0|||
147372652|NCT03160885|531529511|FG005|Initial Treatment Period|Not dosed|0|||
147372653|NCT03160885|531529512|FG006|Initial Treatment Period|Not dosed|0|||
147372654|NCT03160885|531529506|FG000|Initial Treatment Period|Discontinued IMP before Week 16|33|||
147372655|NCT03160885|531529507|FG001|Initial Treatment Period|Discontinued IMP before Week 16|22|||
147372656|NCT03160885|531529508|FG002|Initial Treatment Period|Discontinued IMP before Week 16|0|||
147372657|NCT03160885|531529509|FG003|Initial Treatment Period|Discontinued IMP before Week 16|0|||
147372658|NCT03160885|531529510|FG004|Initial Treatment Period|Discontinued IMP before Week 16|0|||
147372659|NCT03160885|531529511|FG005|Initial Treatment Period|Discontinued IMP before Week 16|0|||
147372660|NCT03160885|531529512|FG006|Initial Treatment Period|Discontinued IMP before Week 16|0|||
147372661|NCT03160885|531529506|FG000|Open-label Treatment|Not dosed|0|||
147455193|NCT03499028|531827848|FG000|Overall Study|Withdrawal by Subject|5|||
147372662|NCT03160885|531529507|FG001|Open-label Treatment|Not dosed|0|||
147372663|NCT03160885|531529508|FG002|Open-label Treatment|Not dosed|0|||
147372664|NCT03160885|531529509|FG003|Open-label Treatment|Not dosed|0|||
147372665|NCT03160885|531529510|FG004|Open-label Treatment|Not dosed|0|||
147372666|NCT03160885|531529511|FG005|Open-label Treatment|Not dosed|0|||
147372667|NCT03160885|531529512|FG006|Open-label Treatment|Not dosed|2|||
147372668|NCT03160885|531529506|FG000|Open-label Treatment|Discontinued IMP|0|||
147372669|NCT03160885|531529507|FG001|Open-label Treatment|Discontinued IMP|0|||
147372670|NCT03160885|531529508|FG002|Open-label Treatment|Discontinued IMP|0|||
147372671|NCT03160885|531529509|FG003|Open-label Treatment|Discontinued IMP|0|||
147372672|NCT03160885|531529510|FG004|Open-label Treatment|Discontinued IMP|0|||
147372673|NCT03160885|531529511|FG005|Open-label Treatment|Discontinued IMP|0|||
147372674|NCT03160885|531529512|FG006|Open-label Treatment|Discontinued IMP|131|||
147372675|NCT03160885|531529506|FG000|Open-label Treatment|Completed Week 50|0|||
147372676|NCT03160885|531529507|FG001|Open-label Treatment|Completed Week 50|0|||
147372677|NCT03160885|531529508|FG002|Open-label Treatment|Completed Week 50|0|||
147372678|NCT03160885|531529509|FG003|Open-label Treatment|Completed Week 50|0|||
147372679|NCT03160885|531529510|FG004|Open-label Treatment|Completed Week 50|0|||
147372680|NCT03160885|531529511|FG005|Open-label Treatment|Completed Week 50|0|||
147372681|NCT03160885|531529512|FG006|Open-label Treatment|Completed Week 50|4|||
147372682|NCT03160885|531529506|FG000|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
147372683|NCT03160885|531529507|FG001|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
147372684|NCT03160885|531529508|FG002|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
147372685|NCT03160885|531529509|FG003|Maintenance Treatment Period|Not dosed - transfer to open-label|1|||
147372686|NCT03160885|531529510|FG004|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
147372687|NCT03160885|531529511|FG005|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
147372688|NCT03160885|531529512|FG006|Maintenance Treatment Period|Not dosed - transfer to open-label|0|||
147372689|NCT03160885|531529506|FG000|Maintenance Treatment Period|Discontinued IMP|0|||
147372690|NCT03160885|531529507|FG001|Maintenance Treatment Period|Discontinued IMP|0|||
147372691|NCT03160885|531529508|FG002|Maintenance Treatment Period|Discontinued IMP|9|||
147372692|NCT03160885|531529509|FG003|Maintenance Treatment Period|Discontinued IMP|13|||
147372693|NCT03160885|531529510|FG004|Maintenance Treatment Period|Discontinued IMP|5|||
147372694|NCT03160885|531529511|FG005|Maintenance Treatment Period|Discontinued IMP|7|||
147372695|NCT03160885|531529512|FG006|Maintenance Treatment Period|Discontinued IMP|0|||
147372696|NCT03160885|531529506|FG000|Maintenance Treatment Period|Transfer to open-label treatment|0|||
147372697|NCT03160885|531529507|FG001|Maintenance Treatment Period|Transfer to open-label treatment|0|||
147372698|NCT03160885|531529508|FG002|Maintenance Treatment Period|Transfer to open-label treatment|29|||
147372699|NCT03160885|531529509|FG003|Maintenance Treatment Period|Transfer to open-label treatment|26|||
147372700|NCT03160885|531529510|FG004|Maintenance Treatment Period|Transfer to open-label treatment|26|||
147372701|NCT03160885|531529511|FG005|Maintenance Treatment Period|Transfer to open-label treatment|8|||
147372702|NCT03160885|531529512|FG006|Maintenance Treatment Period|Transfer to open-label treatment|0|||
147372703|NCT03160885|531529506|FG000|Maintenance Treatment Period|Completed Week 50|0|||
147372704|NCT03160885|531529507|FG001|Maintenance Treatment Period|Completed Week 50|0|||
147372705|NCT03160885|531529508|FG002|Maintenance Treatment Period|Completed Week 50|1|||
147372706|NCT03160885|531529509|FG003|Maintenance Treatment Period|Completed Week 50|0|||
147372707|NCT03160885|531529510|FG004|Maintenance Treatment Period|Completed Week 50|0|||
147372708|NCT03160885|531529511|FG005|Maintenance Treatment Period|Completed Week 50|0|||
147372709|NCT03160885|531529512|FG006|Maintenance Treatment Period|Completed Week 50|0|||
147372710|NCT05786612|531529513|FG000|Overall Study|Adverse Event|1|||
147372711|NCT05786612|531529514|FG001|Overall Study|Adverse Event|2|||
147372712|NCT05786612|531529513|FG000|Overall Study|one screening failure|0|||
147372713|NCT05786612|531529514|FG001|Overall Study|one screening failure|2|||
147372714|NCT05485805|531529520|FG000|Overall Study|Withdrawal by Subject|1|||
147372715|NCT05485805|531529521|FG001|Overall Study|Withdrawal by Subject|2|||
147372716|NCT05485805|531529522|FG002|Overall Study|Withdrawal by Subject|2|||
147372717|NCT05485805|531529523|FG003|Overall Study|Withdrawal by Subject|0|||
147372718|NCT05485805|531529524|FG004|Overall Study|Withdrawal by Subject|2|||
147372719|NCT05485805|531529520|FG000|Overall Study|Adverse Event|0|||
147372720|NCT05485805|531529521|FG001|Overall Study|Adverse Event|1|||
147455194|NCT03499028|531827849|FG001|Overall Study|Withdrawal by Subject|8|||
147455195|NCT03499028|531827848|FG000|Overall Study|Unplanned SNF discharge|5|||
147455196|NCT03499028|531827849|FG001|Overall Study|Unplanned SNF discharge|8|||
147372721|NCT05485805|531529522|FG002|Overall Study|Adverse Event|0|||
147372722|NCT05485805|531529523|FG003|Overall Study|Adverse Event|0|||
147372723|NCT05485805|531529524|FG004|Overall Study|Adverse Event|0|||
147372724|NCT05485805|531529520|FG000|Overall Study|Lost to Follow-up|1|||
147372725|NCT05485805|531529521|FG001|Overall Study|Lost to Follow-up|1|||
147372726|NCT05485805|531529522|FG002|Overall Study|Lost to Follow-up|3|||
147372727|NCT05485805|531529523|FG003|Overall Study|Lost to Follow-up|1|||
147372728|NCT05485805|531529524|FG004|Overall Study|Lost to Follow-up|0|||
147455197|NCT00720109|531827850|FG000|Induction Period|Did not meet eligibility criteria|3|||
147372729|NCT00490139|531529525|FG000|Overall Study|Lost to Follow-up|249|||
147372730|NCT00490139|531529526|FG001|Overall Study|Lost to Follow-up|216|||
147372731|NCT00490139|531529527|FG002|Overall Study|Lost to Follow-up|205|||
147372732|NCT00490139|531529528|FG003|Overall Study|Lost to Follow-up|229|||
147372733|NCT00490139|531529525|FG000|Overall Study|Withdrawal by Subject|333|||
147372734|NCT00490139|531529526|FG001|Overall Study|Withdrawal by Subject|322|||
147372735|NCT00490139|531529527|FG002|Overall Study|Withdrawal by Subject|396|||
147372736|NCT00490139|531529528|FG003|Overall Study|Withdrawal by Subject|295|||
147372737|NCT00490139|531529525|FG000|Overall Study|Patient did not sign ICF 12|169|||
147372738|NCT00490139|531529526|FG001|Overall Study|Patient did not sign ICF 12|176|||
147372739|NCT00490139|531529527|FG002|Overall Study|Patient did not sign ICF 12|139|||
147372740|NCT00490139|531529528|FG003|Overall Study|Patient did not sign ICF 12|167|||
147372741|NCT00490139|531529525|FG000|Overall Study|Data unavailable due to regulatory issues|98|||
147372742|NCT00490139|531529526|FG001|Overall Study|Data unavailable due to regulatory issues|96|||
147372743|NCT00490139|531529527|FG002|Overall Study|Data unavailable due to regulatory issues|85|||
147372744|NCT00490139|531529528|FG003|Overall Study|Data unavailable due to regulatory issues|95|||
147372745|NCT00490139|531529525|FG000|Overall Study|Data unavailable due to lapsed ethical consent|14|||
147372746|NCT00490139|531529526|FG001|Overall Study|Data unavailable due to lapsed ethical consent|13|||
147372747|NCT00490139|531529527|FG002|Overall Study|Data unavailable due to lapsed ethical consent|14|||
147372748|NCT00490139|531529528|FG003|Overall Study|Data unavailable due to lapsed ethical consent|14|||
147372749|NCT00490139|531529525|FG000|Overall Study|Other reasons as defined per protocol|98|||
147372750|NCT00490139|531529526|FG001|Overall Study|Other reasons as defined per protocol|84|||
147372751|NCT00490139|531529527|FG002|Overall Study|Other reasons as defined per protocol|82|||
147372752|NCT00490139|531529528|FG003|Overall Study|Other reasons as defined per protocol|105|||
147372753|NCT03664804|531529530|FG000|Overall Study|Withdrawal by Subject|7|||
147372754|NCT05529992|531529531|FG000|Overall Study|Withdrawal by Subject|1|||
147372755|NCT06140290|531529532|FG000|Period 1|Adverse Event|1|||
147372756|NCT06140290|531529533|FG001|Period 1|Adverse Event|0|||
147372757|NCT06140290|531529532|FG000|Period 2|Assigned but not treated|0|||
147372758|NCT06140290|531529533|FG001|Period 2|Assigned but not treated|1|||
147372759|NCT06140290|531529532|FG000|Period 2|Withdrawal by Subject|0|||
147372760|NCT06140290|531529533|FG001|Period 2|Withdrawal by Subject|1|||
147372761|NCT05250115|531530513|FG000|Overall Study|Premature study end|40|||
147372762|NCT05250115|531530513|FG000|Overall Study|Adverse Event|8|||
147372763|NCT05250115|531530513|FG000|Overall Study|Lost to Follow-up|7|||
147372764|NCT05250115|531530513|FG000|Overall Study|Withdrawal by Subject|6|||
147372765|NCT05250115|531530513|FG000|Overall Study|Withdrawal of informed consent|1|||
147372766|NCT05250115|531530513|FG000|Overall Study|Other|7|||
147372767|NCT03758638|531530514|FG000|Overall Study|Pregnancy|17|||
147372768|NCT03758638|531530515|FG001|Overall Study|Pregnancy|25|||
147372769|NCT03758638|531530514|FG000|Overall Study|Lost to Follow-up|60|||
147372770|NCT03758638|531530515|FG001|Overall Study|Lost to Follow-up|54|||
147372771|NCT03758638|531530514|FG000|Overall Study|Protocol Violation|2|||
147611129|NCT02756208|532390953|FG001|Overall Study|Physician Decision|0|||
147300121|NCT01533493|531264635|FG001|Overall Study|Lost to Follow-up|0|||
147300122|NCT05614089|531264641|FG000|Overall Study|Pregnancy|5|||
147300123|NCT05614089|531264642|FG001|Overall Study|Pregnancy|2|||
147300124|NCT05614089|531264641|FG000|Overall Study|Lost to Follow-up|5|||
147300125|NCT05614089|531264642|FG001|Overall Study|Lost to Follow-up|1|||
147300126|NCT05614089|531264641|FG000|Overall Study|Death|0|||
147300127|NCT05614089|531264642|FG001|Overall Study|Death|1|||
147300128|NCT05614089|531264641|FG000|Overall Study|Adverse Event|1|||
147300129|NCT05614089|531264642|FG001|Overall Study|Adverse Event|0|||
147300130|NCT05163522|531264643|FG000|Overall Study|Withdrawal by Subject|0|||
147300131|NCT05163522|531264644|FG001|Overall Study|Withdrawal by Subject|0|||
147300132|NCT05163522|531264645|FG002|Overall Study|Withdrawal by Subject|1|||
147300133|NCT05163522|531264646|FG003|Overall Study|Withdrawal by Subject|0|||
147300134|NCT05163522|531264647|FG004|Overall Study|Withdrawal by Subject|0|||
147300135|NCT05163522|531264648|FG005|Overall Study|Withdrawal by Subject|0|||
147300136|NCT05163522|531264649|FG006|Overall Study|Withdrawal by Subject|0|||
147300137|NCT05163522|531264650|FG007|Overall Study|Withdrawal by Subject|0|||
147300138|NCT05163522|531264651|FG008|Overall Study|Withdrawal by Subject|0|||
147300139|NCT05163522|531264652|FG009|Overall Study|Withdrawal by Subject|0|||
147300140|NCT05163522|531264653|FG010|Overall Study|Withdrawal by Subject|0|||
147300141|NCT02521285|531264655|FG000|Overall Study|Lost to Follow-up|1|||
147300142|NCT02521285|531264656|FG001|Overall Study|Lost to Follow-up|1|||
147300143|NCT02521285|531264655|FG000|Overall Study|Withdrawal by Subject|1|||
147300144|NCT02521285|531264656|FG001|Overall Study|Withdrawal by Subject|1|||
147300145|NCT02521285|531264655|FG000|Overall Study|Adverse Event|0|||
147300146|NCT02521285|531264656|FG001|Overall Study|Adverse Event|1|||
147300147|NCT05701995|531264658|FG000|Pre-Treatment|Randomization Error|1|||
147300148|NCT05701995|531264659|FG001|Pre-Treatment|Randomization Error|1|||
147300149|NCT05701995|531264658|FG000|Treatment|Withdrawal by Subject|8|||
147300150|NCT05701995|531264659|FG001|Treatment|Withdrawal by Subject|4|||
147300151|NCT05701995|531264658|FG000|Treatment|Lost to Follow-up|2|||
147372772|NCT03758638|531530515|FG001|Overall Study|Protocol Violation|0|||
147372773|NCT03758638|531530514|FG000|Overall Study|Withdrawal by Subject|8|||
147372774|NCT03758638|531530515|FG001|Overall Study|Withdrawal by Subject|2|||
147372775|NCT03758638|531530514|FG000|Overall Study|Providers not included in the primary outcome.|183|||
147372776|NCT03758638|531530515|FG001|Overall Study|Providers not included in the primary outcome.|128|||
147372777|NCT01314118|531530516|FG000|Overall Study|Adverse Event|9|||
147372778|NCT01314118|531530516|FG000|Overall Study|Progressive disease|27|||
147372779|NCT01314118|531530516|FG000|Overall Study|Physician Decision|11|||
147372780|NCT01314118|531530516|FG000|Overall Study|Death|4|||
147372781|NCT01314118|531530516|FG000|Overall Study|Protocol Violation|5|||
147372782|NCT01314118|531530516|FG000|Overall Study|Withdrawal by Subject|11|||
147372783|NCT01314118|531530516|FG000|Overall Study|Other|2|||
147372784|NCT01314118|531530516|FG000|Overall Study|Ongoing|62|||
147372785|NCT00790569|531530520|FG000|End of Treatment (6 Month Interview)|Lost to Follow-up|20|||
147372786|NCT00790569|531530521|FG001|End of Treatment (6 Month Interview)|Lost to Follow-up|8|||
147372787|NCT00790569|531530522|FG002|End of Treatment (6 Month Interview)|Lost to Follow-up|20|||
147372788|NCT00790569|531530520|FG000|End of Treatment (6 Month Interview)|Death|0|||
147372789|NCT00790569|531530521|FG001|End of Treatment (6 Month Interview)|Death|2|||
147372790|NCT00790569|531530522|FG002|End of Treatment (6 Month Interview)|Death|1|||
147372791|NCT00790569|531530520|FG000|End of Treatment (6 Month Interview)|Hospitalized|2|||
147372792|NCT00790569|531530521|FG001|End of Treatment (6 Month Interview)|Hospitalized|0|||
147372793|NCT00790569|531530522|FG002|End of Treatment (6 Month Interview)|Hospitalized|0|||
147372794|NCT00790569|531530520|FG000|End of Treatment (6 Month Interview)|Residential Treatment|0|||
147372795|NCT00790569|531530521|FG001|End of Treatment (6 Month Interview)|Residential Treatment|0|||
147372796|NCT00790569|531530522|FG002|End of Treatment (6 Month Interview)|Residential Treatment|2|||
147372797|NCT00790569|531530520|FG000|End of Treatment (6 Month Interview)|Incarcerated|0|||
147372798|NCT00790569|531530521|FG001|End of Treatment (6 Month Interview)|Incarcerated|0|||
147372799|NCT00790569|531530522|FG002|End of Treatment (6 Month Interview)|Incarcerated|3|||
147372800|NCT00790569|531530520|FG000|End of Study (12 Month Interview)|Lost to Follow-up|66|||
147372801|NCT00790569|531530521|FG001|End of Study (12 Month Interview)|Lost to Follow-up|19|||
147372802|NCT00790569|531530522|FG002|End of Study (12 Month Interview)|Lost to Follow-up|50|||
147372803|NCT03244800|531530523|FG000|Overall Study|Adverse Event|0|||
147372804|NCT03244800|531530524|FG001|Overall Study|Adverse Event|1|||
147372805|NCT03244800|531530525|FG002|Overall Study|Adverse Event|0|||
147372806|NCT03244800|531530526|FG003|Overall Study|Adverse Event|1|||
147372807|NCT03244800|531530523|FG000|Overall Study|Withdrew treatment|0|||
147372808|NCT03244800|531530524|FG001|Overall Study|Withdrew treatment|0|||
147372809|NCT03244800|531530525|FG002|Overall Study|Withdrew treatment|0|||
147372810|NCT03244800|531530526|FG003|Overall Study|Withdrew treatment|1|||
147372811|NCT02941549|531530527|FG000|Overall Study|Adverse Event|1|||
147372812|NCT02941549|531530528|FG001|Overall Study|Adverse Event|0|||
147372813|NCT02941549|531530529|FG002|Overall Study|Adverse Event|0|||
147372814|NCT02941549|531530527|FG000|Overall Study|Withdrawal by Subject|2|||
147372815|NCT02941549|531530528|FG001|Overall Study|Withdrawal by Subject|1|||
147372816|NCT02941549|531530529|FG002|Overall Study|Withdrawal by Subject|2|||
147372817|NCT03451422|531530533|FG000|Overall Study|Lost to Follow-up|0|||
147372818|NCT03451422|531530534|FG001|Overall Study|Lost to Follow-up|0|||
147372819|NCT03451422|531530535|FG002|Overall Study|Lost to Follow-up|0|||
147372820|NCT03451422|531530536|FG003|Overall Study|Lost to Follow-up|0|||
147372821|NCT03451422|531530537|FG004|Overall Study|Lost to Follow-up|0|||
147372822|NCT03451422|531530538|FG005|Overall Study|Lost to Follow-up|1|||
147372823|NCT03451422|531530533|FG000|Overall Study|Decision by sponsor|1|||
147372824|NCT03451422|531530534|FG001|Overall Study|Decision by sponsor|0|||
147372825|NCT03451422|531530535|FG002|Overall Study|Decision by sponsor|1|||
147372826|NCT03451422|531530536|FG003|Overall Study|Decision by sponsor|0|||
147372827|NCT03451422|531530537|FG004|Overall Study|Decision by sponsor|0|||
147372828|NCT03451422|531530538|FG005|Overall Study|Decision by sponsor|0|||
147372829|NCT03451422|531530533|FG000|Overall Study|Withdrawal by Subject|0|||
147372830|NCT03451422|531530534|FG001|Overall Study|Withdrawal by Subject|0|||
147372831|NCT03451422|531530535|FG002|Overall Study|Withdrawal by Subject|2|||
147372832|NCT03451422|531530536|FG003|Overall Study|Withdrawal by Subject|3|||
147611130|NCT02756208|532390954|FG002|Overall Study|Physician Decision|0|||
147611131|NCT02756208|532390955|FG003|Overall Study|Physician Decision|0|||
147372833|NCT03451422|531530537|FG004|Overall Study|Withdrawal by Subject|2|||
147372834|NCT03451422|531530538|FG005|Overall Study|Withdrawal by Subject|1|||
147611132|NCT02756208|532390952|FG000|Overall Study|Protocol Violation|0|||
147372835|NCT00918333|531530539|FG000|Overall Study|Drug not taken per protocol|1|||
147372836|NCT00918333|531530540|FG001|Overall Study|Drug not taken per protocol|0|||
147372837|NCT00918333|531530539|FG000|Overall Study|Inadequate amount of drugs provided|1|||
147372838|NCT00918333|531530540|FG001|Overall Study|Inadequate amount of drugs provided|4|||
147372839|NCT00918333|531530539|FG000|Overall Study|Ineligible|1|||
147372840|NCT00918333|531530540|FG001|Overall Study|Ineligible|0|||
147372841|NCT00918333|531530539|FG000|Overall Study|Withdrawal by Subject|0|||
147372842|NCT00918333|531530540|FG001|Overall Study|Withdrawal by Subject|1|||
147372843|NCT00263757|531530541|FG000|Overall Study|Withdrawal by Subject|5|||
147611133|NCT02756208|532390953|FG001|Overall Study|Protocol Violation|1|||
147611134|NCT02756208|532390954|FG002|Overall Study|Protocol Violation|0|||
147372844|NCT00263757|531530542|FG001|Overall Study|Withdrawal by Subject|4|||
147372845|NCT00263757|531530541|FG000|Overall Study|Screen failure|0|||
147372846|NCT00263757|531530542|FG001|Overall Study|Screen failure|1|||
147372847|NCT00263757|531530541|FG000|Overall Study|Adverse Event|3|||
147372848|NCT00263757|531530542|FG001|Overall Study|Adverse Event|3|||
147372849|NCT00713596|531530543|FG000|Overall Study|Study was terminated|2|||
147372850|NCT00713596|531530544|FG001|Overall Study|Study was terminated|3|||
147372851|NCT00713596|531530545|FG002|Overall Study|Study was terminated|2|||
147372852|NCT04545619|531530546|FG000|Overall Study|due to equipment challenges|1|||
147372853|NCT04384172|531530547|FG000|Overall Study|Lost to Follow-up|0|||
147372854|NCT04384172|531530548|FG001|Overall Study|Lost to Follow-up|2|||
147372855|NCT04384172|531530547|FG000|Overall Study|Pregnancy|1|||
147372856|NCT04384172|531530548|FG001|Overall Study|Pregnancy|0|||
147372857|NCT04384172|531530547|FG000|Overall Study|Withdrawal by Subject|0|||
147372858|NCT04384172|531530548|FG001|Overall Study|Withdrawal by Subject|1|||
147372859|NCT01759862|531530549|FG000|Overall Study|Physician Decision|3|||
147372860|NCT01759862|531530550|FG001|Overall Study|Physician Decision|1|||
147372861|NCT01759862|531530549|FG000|Overall Study|Adverse Event|0|||
147372862|NCT01759862|531530550|FG001|Overall Study|Adverse Event|1|||
147372863|NCT03631407|531530551|FG000|Overall Study|Withdrawal by Subject|3|||
147372864|NCT03631407|531530552|FG001|Overall Study|Withdrawal by Subject|2|||
147372865|NCT03631407|531530551|FG000|Overall Study|Sponsor Decision|0|||
147372866|NCT03631407|531530552|FG001|Overall Study|Sponsor Decision|2|||
147372867|NCT03631407|531530551|FG000|Overall Study|Death|16|||
147372868|NCT03631407|531530552|FG001|Overall Study|Death|16|||
147372869|NCT03631407|531530551|FG000|Overall Study|Randomized by mistake without study treatment|1|||
147372870|NCT03631407|531530552|FG001|Overall Study|Randomized by mistake without study treatment|0|||
147372871|NCT01437319|531530553|FG000|Phase I|Lost to Follow-up|2|||
147372872|NCT01437319|531530554|FG001|Phase I|Lost to Follow-up|0|||
147372873|NCT01437319|531530555|FG002|Phase I|Lost to Follow-up|0|||
147372874|NCT01437319|531530553|FG000|Phase I|Protocol Violation|1|||
147372875|NCT01437319|531530554|FG001|Phase I|Protocol Violation|0|||
147372876|NCT01437319|531530555|FG002|Phase I|Protocol Violation|0|||
147372877|NCT01437319|531530553|FG000|Phase I|Study related symptoms/complaints|27|||
147372878|NCT01437319|531530554|FG001|Phase I|Study related symptoms/complaints|0|||
147372879|NCT01437319|531530555|FG002|Phase I|Study related symptoms/complaints|0|||
147372880|NCT01437319|531530553|FG000|Phase I|Withdrawal by Subject|25|||
147372881|NCT01437319|531530554|FG001|Phase I|Withdrawal by Subject|0|||
147372882|NCT01437319|531530555|FG002|Phase I|Withdrawal by Subject|0|||
147372883|NCT01437319|531530553|FG000|Phase II|Withdrawal by Subject|0|||
147372884|NCT01437319|531530554|FG001|Phase II|Withdrawal by Subject|8|||
147372885|NCT01437319|531530555|FG002|Phase II|Withdrawal by Subject|16|||
147372886|NCT01437319|531530553|FG000|Phase II|Lost to Follow-up|0|||
147372887|NCT01437319|531530554|FG001|Phase II|Lost to Follow-up|7|||
147372888|NCT01437319|531530555|FG002|Phase II|Lost to Follow-up|2|||
147372889|NCT01437319|531530553|FG000|Phase II|Study related symptoms/complaints|0|||
147372890|NCT01437319|531530554|FG001|Phase II|Study related symptoms/complaints|28|||
147372891|NCT01437319|531530555|FG002|Phase II|Study related symptoms/complaints|19|||
147372892|NCT01437319|531530553|FG000|Phase II|Protocol Violation|0|||
147372893|NCT01437319|531530554|FG001|Phase II|Protocol Violation|1|||
147372894|NCT01437319|531530555|FG002|Phase II|Protocol Violation|0|||
147372895|NCT00983294|531530556|FG000|14 Day Washout Period|Withdrawal by Subject|2|||
147372896|NCT00983294|531530556|FG000|Colchicine With Azithromycin|Adverse Event|1|||
147372897|NCT03473743|531530557|FG000|Overall Study|Withdrawal by Subject|0|||
147372898|NCT03473743|531530558|FG001|Overall Study|Withdrawal by Subject|0|||
147372899|NCT03473743|531530559|FG002|Overall Study|Withdrawal by Subject|0|||
147372900|NCT03473743|531530560|FG003|Overall Study|Withdrawal by Subject|0|||
147372901|NCT03473743|531530561|FG004|Overall Study|Withdrawal by Subject|0|||
147372902|NCT03473743|531530562|FG005|Overall Study|Withdrawal by Subject|0|||
147372903|NCT03473743|531530563|FG006|Overall Study|Withdrawal by Subject|0|||
147372904|NCT03473743|531530564|FG007|Overall Study|Withdrawal by Subject|3|||
147372905|NCT03473743|531530557|FG000|Overall Study|Other|0|||
147372906|NCT03473743|531530558|FG001|Overall Study|Other|0|||
147611135|NCT02756208|532390955|FG003|Overall Study|Protocol Violation|0|||
147372907|NCT03473743|531530559|FG002|Overall Study|Other|0|||
147372908|NCT03473743|531530560|FG003|Overall Study|Other|1|||
147372909|NCT03473743|531530561|FG004|Overall Study|Other|0|||
147372910|NCT03473743|531530562|FG005|Overall Study|Other|0|||
147372911|NCT03473743|531530563|FG006|Overall Study|Other|0|||
147372912|NCT03473743|531530564|FG007|Overall Study|Other|0|||
147372913|NCT03473743|531530557|FG000|Overall Study|Ongoing|0|||
147372914|NCT03473743|531530558|FG001|Overall Study|Ongoing|0|||
147372915|NCT03473743|531530559|FG002|Overall Study|Ongoing|6|||
147372916|NCT03473743|531530560|FG003|Overall Study|Ongoing|8|||
147372917|NCT03473743|531530561|FG004|Overall Study|Ongoing|1|||
147372918|NCT03473743|531530562|FG005|Overall Study|Ongoing|1|||
147372919|NCT03473743|531530563|FG006|Overall Study|Ongoing|22|||
147372920|NCT03473743|531530564|FG007|Overall Study|Ongoing|24|||
147663877|NCT00728494|532594356|FG000|Overall Study|Adverse Event|7|||
147663878|NCT00728494|532594357|FG001|Overall Study|Adverse Event|0|||
147663879|NCT00728494|532594356|FG000|Overall Study|Withdrawal by Subject|0|||
147663880|NCT00728494|532594357|FG001|Overall Study|Withdrawal by Subject|2|||
147663881|NCT00728494|532594356|FG000|Overall Study|Lack of Efficacy|2|||
147663882|NCT00728494|532594357|FG001|Overall Study|Lack of Efficacy|4|||
147663883|NCT00728494|532594356|FG000|Overall Study|No data available|0|||
147663884|NCT00728494|532594357|FG001|Overall Study|No data available|1|||
147663885|NCT00853762|532594358|FG000|Overall Study|Premature Termination|16|||
147663886|NCT00853762|532594359|FG001|Overall Study|Premature Termination|15|||
147663887|NCT00853762|532594360|FG002|Overall Study|Premature Termination|14|||
147663888|NCT00853762|532594361|FG003|Overall Study|Premature Termination|21|||
147663889|NCT00853762|532594358|FG000|Overall Study|Protocol Violation|0|||
147663890|NCT00853762|532594359|FG001|Overall Study|Protocol Violation|0|||
147663891|NCT00853762|532594360|FG002|Overall Study|Protocol Violation|0|||
147663892|NCT00853762|532594361|FG003|Overall Study|Protocol Violation|1|||
147663893|NCT00853762|532594358|FG000|Overall Study|Withdrawal by Subject|0|||
147663894|NCT00853762|532594359|FG001|Overall Study|Withdrawal by Subject|0|||
147663895|NCT00853762|532594360|FG002|Overall Study|Withdrawal by Subject|1|||
147663896|NCT00853762|532594361|FG003|Overall Study|Withdrawal by Subject|0|||
147663897|NCT00853762|532594358|FG000|Overall Study|Other|0|||
147663898|NCT00853762|532594359|FG001|Overall Study|Other|2|||
147663899|NCT00853762|532594360|FG002|Overall Study|Other|0|||
147663900|NCT00853762|532594361|FG003|Overall Study|Other|0|||
147663901|NCT00853762|532594358|FG000|Overall Study|Randomised but not Treated|0|||
147663902|NCT00853762|532594359|FG001|Overall Study|Randomised but not Treated|2|||
147663903|NCT00853762|532594360|FG002|Overall Study|Randomised but not Treated|2|||
147663904|NCT00853762|532594361|FG003|Overall Study|Randomised but not Treated|0|||
147663905|NCT02000921|532594367|FG000|Overall Study|Withdrawal by Subject|3|||
147663906|NCT02000921|532594368|FG001|Overall Study|Withdrawal by Subject|10|||
147663907|NCT02000921|532594369|FG002|Overall Study|Withdrawal by Subject|5|||
147663908|NCT02000921|532594367|FG000|Overall Study|Lost to Follow-up|2|||
147663909|NCT02000921|532594368|FG001|Overall Study|Lost to Follow-up|4|||
147663910|NCT02000921|532594369|FG002|Overall Study|Lost to Follow-up|5|||
147663911|NCT02000921|532594367|FG000|Overall Study|Physician Decision|0|||
147663912|NCT02000921|532594368|FG001|Overall Study|Physician Decision|2|||
147663913|NCT02000921|532594369|FG002|Overall Study|Physician Decision|0|||
147663914|NCT02914834|532594370|FG000|Overall Study|Study halted due to COVID|1|||
147663915|NCT02914834|532594371|FG001|Overall Study|Study halted due to COVID|1|||
147663916|NCT02914834|532594370|FG000|Overall Study|1 subject withdrew|0|||
147372921|NCT03473743|531530557|FG000|Overall Study|Randomized but not treated|0|||
147372922|NCT03473743|531530558|FG001|Overall Study|Randomized but not treated|0|||
147372923|NCT03473743|531530559|FG002|Overall Study|Randomized but not treated|0|||
147372924|NCT03473743|531530560|FG003|Overall Study|Randomized but not treated|0|||
147372925|NCT03473743|531530561|FG004|Overall Study|Randomized but not treated|0|||
147372926|NCT03473743|531530562|FG005|Overall Study|Randomized but not treated|0|||
147372927|NCT03473743|531530563|FG006|Overall Study|Randomized but not treated|1|||
147372928|NCT03473743|531530564|FG007|Overall Study|Randomized but not treated|1|||
147372929|NCT00980954|531530565|FG000|Overall Study|Protocol Violation|9|||
147372930|NCT00980954|531530566|FG001|Overall Study|Protocol Violation|15|||
147372931|NCT01458366|531530572|FG000|Period 1: 70mg/m^2|Physician Decision|2|||
147372932|NCT01458366|531530573|FG001|Period 1: 70mg/m^2|Physician Decision|0|||
147372933|NCT01458366|531530574|FG002|Period 1: 70mg/m^2|Physician Decision|0|||
147372934|NCT01458366|531530575|FG003|Period 1: 70mg/m^2|Physician Decision|0|||
147372935|NCT01458366|531530576|FG004|Period 1: 70mg/m^2|Physician Decision|0|||
147372936|NCT01458366|531530572|FG000|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|0|||
147372937|NCT01458366|531530573|FG001|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|0|||
147372938|NCT01458366|531530574|FG002|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|0|||
147663917|NCT02914834|532594371|FG001|Overall Study|1 subject withdrew|1|||
147663918|NCT02631941|532594376|FG000|Overall Study|Physician Decision|0|||
147663919|NCT02631941|532594377|FG001|Overall Study|Physician Decision|1|||
147663920|NCT02631941|532594378|FG002|Overall Study|Physician Decision|0|||
147663921|NCT02631941|532594379|FG003|Overall Study|Physician Decision|0|||
147663922|NCT02631941|532594380|FG004|Overall Study|Physician Decision|0|||
147663923|NCT02631941|532594381|FG005|Overall Study|Physician Decision|0|||
147663924|NCT02631941|532594382|FG006|Overall Study|Physician Decision|0|||
147663925|NCT02631941|532594383|FG007|Overall Study|Physician Decision|0|||
147663926|NCT02631941|532594384|FG008|Overall Study|Physician Decision|0|||
147663927|NCT02631941|532594385|FG009|Overall Study|Physician Decision|0|||
147663928|NCT02631941|532594376|FG000|Overall Study|Adverse Event|0|||
147663929|NCT02631941|532594377|FG001|Overall Study|Adverse Event|1|||
147372939|NCT01458366|531530575|FG003|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|0|||
147372940|NCT01458366|531530576|FG004|Period 5: Maximum Tolerated Dose (MTD)|Withdrawal by Subject|1|||
147663930|NCT02631941|532594378|FG002|Overall Study|Adverse Event|0|||
147663931|NCT02631941|532594379|FG003|Overall Study|Adverse Event|0|||
147663932|NCT02631941|532594380|FG004|Overall Study|Adverse Event|0|||
147663933|NCT02631941|532594381|FG005|Overall Study|Adverse Event|0|||
147372941|NCT04647487|531530577|FG000|Overall Study|Protocol Deviation|0|||
147372942|NCT04647487|531530578|FG001|Overall Study|Protocol Deviation|0|||
147372943|NCT04647487|531530579|FG002|Overall Study|Protocol Deviation|1|||
147372944|NCT04647487|531530577|FG000|Overall Study|Withdrawal by Subject|1|||
147372945|NCT04647487|531530578|FG001|Overall Study|Withdrawal by Subject|0|||
147372946|NCT04647487|531530579|FG002|Overall Study|Withdrawal by Subject|2|||
147372947|NCT02787005|531530580|FG000|Overall Study|Adverse Event|24|||
147372948|NCT02787005|531530581|FG001|Overall Study|Adverse Event|9|||
147455198|NCT00720109|531827851|FG001|Induction Period|Did not meet eligibility criteria|0|||
147455199|NCT00720109|531827852|FG002|Induction Period|Did not meet eligibility criteria|0|||
147455200|NCT00720109|531827850|FG000|Induction Period|Bone Marrow Transplant|2|||
147455201|NCT00720109|531827851|FG001|Induction Period|Bone Marrow Transplant|0|||
147455202|NCT00720109|531827852|FG002|Induction Period|Bone Marrow Transplant|0|||
147455203|NCT00720109|531827850|FG000|Induction Period|Physician Decision|1|||
147455204|NCT00720109|531827851|FG001|Induction Period|Physician Decision|0|||
147455205|NCT00720109|531827852|FG002|Induction Period|Physician Decision|0|||
147455206|NCT00720109|531827850|FG000|Risk Stratification Period|Adverse Event|0|||
147455207|NCT00720109|531827851|FG001|Risk Stratification Period|Adverse Event|1|||
147455208|NCT00720109|531827852|FG002|Risk Stratification Period|Adverse Event|0|||
147455209|NCT00720109|531827850|FG000|Risk Stratification Period|Physician Decision|0|||
147455210|NCT00720109|531827851|FG001|Risk Stratification Period|Physician Decision|2|||
147455211|NCT00720109|531827852|FG002|Risk Stratification Period|Physician Decision|1|||
147455212|NCT00720109|531827850|FG000|Risk Stratification Period|Bone marrow transplant|0|||
147455213|NCT00720109|531827851|FG001|Risk Stratification Period|Bone marrow transplant|9|||
147455214|NCT00720109|531827852|FG002|Risk Stratification Period|Bone marrow transplant|7|||
147455215|NCT00720109|531827850|FG000|Risk Stratification Period|Disease progression or relapse|0|||
147455216|NCT00720109|531827851|FG001|Risk Stratification Period|Disease progression or relapse|2|||
147455217|NCT00720109|531827852|FG002|Risk Stratification Period|Disease progression or relapse|0|||
147455218|NCT00720109|531827850|FG000|Risk Stratification Period|Development of second malignant neoplasm|0|||
147455219|NCT00720109|531827851|FG001|Risk Stratification Period|Development of second malignant neoplasm|1|||
147455220|NCT00720109|531827852|FG002|Risk Stratification Period|Development of second malignant neoplasm|0|||
147455221|NCT01110200|531827853|FG000|Overall Study|Adverse Event|28|||
147455222|NCT01110200|531827854|FG001|Overall Study|Adverse Event|28|||
147455223|NCT01110200|531827853|FG000|Overall Study|Withdrawal by Subject|25|||
147455224|NCT01110200|531827854|FG001|Overall Study|Withdrawal by Subject|32|||
147455225|NCT01110200|531827853|FG000|Overall Study|Lack of Efficacy|16|||
147455226|NCT01110200|531827854|FG001|Overall Study|Lack of Efficacy|25|||
147455227|NCT01110200|531827853|FG000|Overall Study|Protocol Violation|14|||
147455228|NCT01110200|531827854|FG001|Overall Study|Protocol Violation|12|||
147455229|NCT01110200|531827853|FG000|Overall Study|Physician Decision|13|||
147455230|NCT01110200|531827854|FG001|Overall Study|Physician Decision|17|||
147455231|NCT01110200|531827853|FG000|Overall Study|Lost to Follow-up|10|||
147455232|NCT01110200|531827854|FG001|Overall Study|Lost to Follow-up|7|||
147455233|NCT03467958|531827855|FG000|Overall Study|Adverse Event|20|||
147455234|NCT03467958|531827856|FG001|Overall Study|Adverse Event|32|||
147455235|NCT03467958|531827857|FG002|Overall Study|Adverse Event|5|||
147455236|NCT03467958|531827858|FG003|Overall Study|Adverse Event|3|||
147455237|NCT03467958|531827859|FG004|Overall Study|Adverse Event|3|||
147455238|NCT03467958|531827860|FG005|Overall Study|Adverse Event|3|||
147455239|NCT03467958|531827861|FG006|Overall Study|Adverse Event|6|||
147455240|NCT03467958|531827862|FG007|Overall Study|Adverse Event|5|||
147455241|NCT03467958|531827863|FG008|Overall Study|Adverse Event|0|||
147455242|NCT03467958|531827855|FG000|Overall Study|Lack of Efficacy|59|||
147455243|NCT03467958|531827856|FG001|Overall Study|Lack of Efficacy|120|||
147455244|NCT03467958|531827857|FG002|Overall Study|Lack of Efficacy|6|||
147455245|NCT03467958|531827858|FG003|Overall Study|Lack of Efficacy|9|||
147455246|NCT03467958|531827859|FG004|Overall Study|Lack of Efficacy|8|||
147455247|NCT03467958|531827860|FG005|Overall Study|Lack of Efficacy|9|||
147455248|NCT03467958|531827861|FG006|Overall Study|Lack of Efficacy|11|||
147455249|NCT03467958|531827862|FG007|Overall Study|Lack of Efficacy|9|||
147455250|NCT03467958|531827863|FG008|Overall Study|Lack of Efficacy|3|||
147455251|NCT03467958|531827855|FG000|Overall Study|Lost to Follow-up|1|||
147455252|NCT03467958|531827856|FG001|Overall Study|Lost to Follow-up|2|||
147372949|NCT02787005|531530582|FG002|Overall Study|Adverse Event|9|||
147372950|NCT02787005|531530583|FG003|Overall Study|Adverse Event|7|||
147455253|NCT03467958|531827857|FG002|Overall Study|Lost to Follow-up|1|||
147372951|NCT02787005|531530584|FG004|Overall Study|Adverse Event|2|||
147455254|NCT03467958|531827858|FG003|Overall Study|Lost to Follow-up|0|||
147372952|NCT02787005|531530580|FG000|Overall Study|Death|100|||
147455255|NCT03467958|531827859|FG004|Overall Study|Lost to Follow-up|4|||
147455256|NCT03467958|531827860|FG005|Overall Study|Lost to Follow-up|0|||
147455257|NCT03467958|531827861|FG006|Overall Study|Lost to Follow-up|0|||
147455258|NCT03467958|531827862|FG007|Overall Study|Lost to Follow-up|0|||
147372953|NCT02787005|531530581|FG001|Overall Study|Death|53|||
147455259|NCT03467958|531827863|FG008|Overall Study|Lost to Follow-up|0|||
147455260|NCT03467958|531827855|FG000|Overall Study|Other reasons|8|||
147455261|NCT03467958|531827856|FG001|Overall Study|Other reasons|14|||
147372954|NCT02787005|531530582|FG002|Overall Study|Death|48|||
147455262|NCT03467958|531827857|FG002|Overall Study|Other reasons|2|||
147455263|NCT03467958|531827858|FG003|Overall Study|Other reasons|1|||
147455264|NCT03467958|531827859|FG004|Overall Study|Other reasons|4|||
147455265|NCT03467958|531827860|FG005|Overall Study|Other reasons|0|||
147455266|NCT03467958|531827861|FG006|Overall Study|Other reasons|1|||
147455267|NCT03467958|531827862|FG007|Overall Study|Other reasons|0|||
147455268|NCT03467958|531827863|FG008|Overall Study|Other reasons|1|||
147455269|NCT03467958|531827855|FG000|Overall Study|Pregnancy|1|||
147372955|NCT02787005|531530583|FG003|Overall Study|Death|69|||
147372956|NCT02787005|531530584|FG004|Overall Study|Death|38|||
147372957|NCT02787005|531530580|FG000|Overall Study|Sponsor Decision|7|||
147372958|NCT02787005|531530581|FG001|Overall Study|Sponsor Decision|4|||
147372959|NCT02787005|531530582|FG002|Overall Study|Sponsor Decision|0|||
147372960|NCT02787005|531530583|FG003|Overall Study|Sponsor Decision|4|||
147372961|NCT02787005|531530584|FG004|Overall Study|Sponsor Decision|5|||
147372962|NCT02787005|531530580|FG000|Overall Study|Withdrawal by Subject|2|||
147372963|NCT02787005|531530581|FG001|Overall Study|Withdrawal by Subject|1|||
147372964|NCT02787005|531530582|FG002|Overall Study|Withdrawal by Subject|1|||
147372965|NCT02787005|531530583|FG003|Overall Study|Withdrawal by Subject|0|||
147372966|NCT02787005|531530584|FG004|Overall Study|Withdrawal by Subject|1|||
147372967|NCT02787005|531530580|FG000|Overall Study|Screen Failure|0|||
147455270|NCT03467958|531827856|FG001|Overall Study|Pregnancy|0|||
147455271|NCT03467958|531827857|FG002|Overall Study|Pregnancy|0|||
147455272|NCT03467958|531827858|FG003|Overall Study|Pregnancy|0|||
147455273|NCT03467958|531827859|FG004|Overall Study|Pregnancy|0|||
147611136|NCT02585778|532390956|FG000|Overall Study|Adverse Event|17|||
147611137|NCT02585778|532390957|FG001|Overall Study|Adverse Event|4|||
147611138|NCT02585778|532390956|FG000|Overall Study|Participant did not wish to continue|9|||
147611139|NCT02585778|532390957|FG001|Overall Study|Participant did not wish to continue|4|||
147611140|NCT02585778|532390956|FG000|Overall Study|Poor compliance to study protocol|0|||
147611141|NCT02585778|532390957|FG001|Overall Study|Poor compliance to study protocol|2|||
147611142|NCT02585778|532390956|FG000|Overall Study|Death|0|||
147611143|NCT02585778|532390957|FG001|Overall Study|Death|1|||
147611144|NCT02585778|532390956|FG000|Overall Study|Randomized but not treated|1|||
147611145|NCT02585778|532390957|FG001|Overall Study|Randomized but not treated|2|||
147611146|NCT02585778|532390956|FG000|Overall Study|Other than specified above|6|||
147611147|NCT02585778|532390957|FG001|Overall Study|Other than specified above|2|||
147611148|NCT00356525|532390958|FG000|Overall Study|Progressive Disease|8|||
147611149|NCT00356525|532390959|FG001|Overall Study|Progressive Disease|5|||
147611150|NCT00356525|532390960|FG002|Overall Study|Progressive Disease|4|||
147611151|NCT00356525|532390961|FG003|Overall Study|Progressive Disease|2|||
147611152|NCT00356525|532390958|FG000|Overall Study|Adverse Event|1|||
147611153|NCT00356525|532390959|FG001|Overall Study|Adverse Event|3|||
147611154|NCT00356525|532390960|FG002|Overall Study|Adverse Event|1|||
147611155|NCT00356525|532390961|FG003|Overall Study|Adverse Event|1|||
147611156|NCT00356525|532390958|FG000|Overall Study|Lost to Follow-up|1|||
147611157|NCT00356525|532390959|FG001|Overall Study|Lost to Follow-up|0|||
147611158|NCT00356525|532390960|FG002|Overall Study|Lost to Follow-up|0|||
147611159|NCT00356525|532390961|FG003|Overall Study|Lost to Follow-up|0|||
147611160|NCT00356525|532390958|FG000|Overall Study|Physician Decision|2|||
147611161|NCT00356525|532390959|FG001|Overall Study|Physician Decision|2|||
147611162|NCT00356525|532390960|FG002|Overall Study|Physician Decision|2|||
147611163|NCT00356525|532390961|FG003|Overall Study|Physician Decision|1|||
147611164|NCT00356525|532390958|FG000|Overall Study|Protocol Entry Criteria Not Met|1|||
147611165|NCT00356525|532390959|FG001|Overall Study|Protocol Entry Criteria Not Met|0|||
147611166|NCT00356525|532390960|FG002|Overall Study|Protocol Entry Criteria Not Met|0|||
147611167|NCT00356525|532390961|FG003|Overall Study|Protocol Entry Criteria Not Met|0|||
147611168|NCT00356525|532390958|FG000|Overall Study|Withdrawal by Subject|1|||
147611169|NCT00356525|532390959|FG001|Overall Study|Withdrawal by Subject|1|||
147611170|NCT00356525|532390960|FG002|Overall Study|Withdrawal by Subject|0|||
147611171|NCT00356525|532390961|FG003|Overall Study|Withdrawal by Subject|3|||
147611172|NCT00356525|532390958|FG000|Overall Study|Death|0|||
147372968|NCT02787005|531530581|FG001|Overall Study|Screen Failure|2|||
147372969|NCT02787005|531530582|FG002|Overall Study|Screen Failure|0|||
147611173|NCT00356525|532390959|FG001|Overall Study|Death|0|||
147611174|NCT00356525|532390960|FG002|Overall Study|Death|0|||
147611175|NCT00356525|532390961|FG003|Overall Study|Death|1|||
147611176|NCT00356525|532390958|FG000|Overall Study|Sponsor Decision|0|||
147611177|NCT00356525|532390959|FG001|Overall Study|Sponsor Decision|0|||
147611178|NCT00356525|532390960|FG002|Overall Study|Sponsor Decision|0|||
147372970|NCT02787005|531530583|FG003|Overall Study|Screen Failure|0|||
147372971|NCT02787005|531530584|FG004|Overall Study|Screen Failure|1|||
147372972|NCT02787005|531530580|FG000|Overall Study|Lost to Follow-up|0|||
147372973|NCT02787005|531530581|FG001|Overall Study|Lost to Follow-up|0|||
147455274|NCT03467958|531827860|FG005|Overall Study|Pregnancy|1|||
147455275|NCT03467958|531827861|FG006|Overall Study|Pregnancy|0|||
147455276|NCT03467958|531827862|FG007|Overall Study|Pregnancy|0|||
147455277|NCT03467958|531827863|FG008|Overall Study|Pregnancy|0|||
147455278|NCT03467958|531827855|FG000|Overall Study|Study terminated by sponsor|65|||
147611179|NCT00356525|532390961|FG003|Overall Study|Sponsor Decision|1|||
147611180|NCT00214383|532390969|FG000|Overall Study|Lost to Follow-up|16|||
147611181|NCT00214383|532390970|FG001|Overall Study|Lost to Follow-up|26|||
147611182|NCT01038297|532390971|FG000|Part A: Skin Testing Phase (50 Days)|Withdrawal by Subject|1|||
147611183|NCT01038297|532390972|FG001|Part A: Skin Testing Phase (50 Days)|Withdrawal by Subject|0|||
147611184|NCT01038297|532390973|FG002|Part A: Skin Testing Phase (50 Days)|Withdrawal by Subject|0|||
147611185|NCT01685840|532390976|FG000|Overall Study|Death|77|||
147611186|NCT01685840|532390977|FG001|Overall Study|Death|66|||
147611187|NCT01685840|532390976|FG000|Overall Study|Lost to Follow-up|27|||
147611188|NCT01685840|532390977|FG001|Overall Study|Lost to Follow-up|25|||
147611189|NCT01685840|532390976|FG000|Overall Study|Physician Decision|3|||
147611190|NCT01685840|532390977|FG001|Overall Study|Physician Decision|7|||
147611191|NCT01685840|532390976|FG000|Overall Study|Withdrawal by Subject|14|||
147611192|NCT01685840|532390977|FG001|Overall Study|Withdrawal by Subject|17|||
147611193|NCT01685840|532390976|FG000|Overall Study|Futility|197|||
147611194|NCT01685840|532390977|FG001|Overall Study|Futility|200|||
147611195|NCT01685840|532390976|FG000|Overall Study|Had VAD, Dialysis or Transplant|11|||
147611196|NCT01685840|532390977|FG001|Overall Study|Had VAD, Dialysis or Transplant|17|||
147611197|NCT03340974|532390982|FG000|Completion of Study -Long Term Follow up|Death|8|||
147611198|NCT03340974|532390983|FG001|Completion of Study -Long Term Follow up|Death|5|||
147611199|NCT03340974|532390984|FG002|Completion of Study -Long Term Follow up|Death|5|||
147611200|NCT03340974|532390985|FG003|Completion of Study -Long Term Follow up|Death|7|||
147611201|NCT03340974|532390982|FG000|Completion of Study -Long Term Follow up|Withdrawal by Subject|2|||
147611202|NCT03340974|532390983|FG001|Completion of Study -Long Term Follow up|Withdrawal by Subject|0|||
147611203|NCT03340974|532390984|FG002|Completion of Study -Long Term Follow up|Withdrawal by Subject|0|||
147611204|NCT03340974|532390985|FG003|Completion of Study -Long Term Follow up|Withdrawal by Subject|1|||
147611205|NCT03340974|532390982|FG000|Completion of Study -Long Term Follow up|Lost to Follow-up|0|||
147611206|NCT03340974|532390983|FG001|Completion of Study -Long Term Follow up|Lost to Follow-up|1|||
147611207|NCT03340974|532390984|FG002|Completion of Study -Long Term Follow up|Lost to Follow-up|1|||
147611208|NCT03340974|532390985|FG003|Completion of Study -Long Term Follow up|Lost to Follow-up|2|||
147611209|NCT03340974|532390982|FG000|Completion of Study -Long Term Follow up|Last Know Alive|8|||
147611210|NCT03340974|532390983|FG001|Completion of Study -Long Term Follow up|Last Know Alive|0|||
147611211|NCT03340974|532390984|FG002|Completion of Study -Long Term Follow up|Last Know Alive|0|||
147611212|NCT03340974|532390985|FG003|Completion of Study -Long Term Follow up|Last Know Alive|2|||
147611213|NCT02374346|532390986|FG000|Overall Study|operated or discharged during weekend|48|||
147611214|NCT00396565|532390990|FG000|Overall Study|Physician Decision|3|||
147611215|NCT00396565|532390991|FG001|Overall Study|Physician Decision|1|||
147611216|NCT00396565|532390992|FG002|Overall Study|Physician Decision|2|||
147611217|NCT00396565|532390990|FG000|Overall Study|Adverse Event|5|||
147611218|NCT00396565|532390991|FG001|Overall Study|Adverse Event|13|||
147611219|NCT00396565|532390992|FG002|Overall Study|Adverse Event|3|||
147611220|NCT00396565|532390990|FG000|Overall Study|Withdrawal by Subject|8|||
147611221|NCT00396565|532390991|FG001|Overall Study|Withdrawal by Subject|13|||
147611222|NCT00396565|532390992|FG002|Overall Study|Withdrawal by Subject|1|||
147611223|NCT00396565|532390990|FG000|Overall Study|Lack of Efficacy|32|||
147611224|NCT00396565|532390991|FG001|Overall Study|Lack of Efficacy|64|||
147611225|NCT00396565|532390992|FG002|Overall Study|Lack of Efficacy|11|||
147611226|NCT00345631|532390993|FG000|Overall Study|Withdrawal by Subject|1|||
147611227|NCT00345631|532390994|FG001|Overall Study|Withdrawal by Subject|0|||
147372974|NCT02787005|531530582|FG002|Overall Study|Lost to Follow-up|0|||
147372975|NCT02787005|531530583|FG003|Overall Study|Lost to Follow-up|1|||
147372976|NCT02787005|531530584|FG004|Overall Study|Lost to Follow-up|0|||
147372977|NCT01753999|531530585|FG000|Period 1 - Initial Assignment|Physician Decision|2|||
147372978|NCT01753999|531530586|FG001|Period 1 - Initial Assignment|Physician Decision|3|||
147372979|NCT01753999|531530585|FG000|Period 1 - Initial Assignment|Withdrawal by Subject|19|||
147372980|NCT01753999|531530586|FG001|Period 1 - Initial Assignment|Withdrawal by Subject|20|||
147372981|NCT01753999|531530585|FG000|Period 1 - Initial Assignment|Lost to Follow-up|18|||
147372982|NCT01753999|531530586|FG001|Period 1 - Initial Assignment|Lost to Follow-up|27|||
147372983|NCT01753999|531530585|FG000|Period 2 -Cross to Alternate Arm|Lost to Follow-up|13|||
147372984|NCT01753999|531530586|FG001|Period 2 -Cross to Alternate Arm|Lost to Follow-up|17|||
147372985|NCT01753999|531530585|FG000|Period 2 -Cross to Alternate Arm|Withdrawal by Subject|3|||
147372986|NCT01753999|531530586|FG001|Period 2 -Cross to Alternate Arm|Withdrawal by Subject|5|||
147372987|NCT01753999|531530585|FG000|Period 2 -Cross to Alternate Arm|Physician Decision|1|||
147611228|NCT00345631|532390995|FG002|Overall Study|Withdrawal by Subject|1|||
147611229|NCT00345631|532390993|FG000|Overall Study|Adverse Event|0|||
147611230|NCT00345631|532390994|FG001|Overall Study|Adverse Event|1|||
147611231|NCT00345631|532390995|FG002|Overall Study|Adverse Event|0|||
147611232|NCT00345631|532390993|FG000|Overall Study|Lost to Follow-up|3|||
147611233|NCT00345631|532390994|FG001|Overall Study|Lost to Follow-up|7|||
147611234|NCT00345631|532390995|FG002|Overall Study|Lost to Follow-up|4|||
147611235|NCT00345631|532390993|FG000|Overall Study|Other reasons|0|||
147611236|NCT00345631|532390994|FG001|Overall Study|Other reasons|0|||
147611237|NCT00345631|532390995|FG002|Overall Study|Other reasons|1|||
147663934|NCT02631941|532594382|FG006|Overall Study|Adverse Event|0|||
147663935|NCT02631941|532594383|FG007|Overall Study|Adverse Event|0|||
147663936|NCT02631941|532594384|FG008|Overall Study|Adverse Event|0|||
147663937|NCT02631941|532594385|FG009|Overall Study|Adverse Event|0|||
147663938|NCT02631941|532594376|FG000|Overall Study|Withdrawal by Subject|0|||
147663939|NCT02631941|532594377|FG001|Overall Study|Withdrawal by Subject|0|||
147663940|NCT02631941|532594378|FG002|Overall Study|Withdrawal by Subject|0|||
147663941|NCT02631941|532594379|FG003|Overall Study|Withdrawal by Subject|0|||
147663942|NCT02631941|532594380|FG004|Overall Study|Withdrawal by Subject|1|||
147663943|NCT02631941|532594381|FG005|Overall Study|Withdrawal by Subject|0|||
147663944|NCT02631941|532594382|FG006|Overall Study|Withdrawal by Subject|0|||
147663945|NCT02631941|532594383|FG007|Overall Study|Withdrawal by Subject|1|||
147663946|NCT02631941|532594384|FG008|Overall Study|Withdrawal by Subject|0|||
147663947|NCT02631941|532594385|FG009|Overall Study|Withdrawal by Subject|0|||
147663948|NCT02631941|532594376|FG000|Overall Study|Lost to Follow-up|0|||
147663949|NCT02631941|532594377|FG001|Overall Study|Lost to Follow-up|0|||
147663950|NCT02631941|532594378|FG002|Overall Study|Lost to Follow-up|0|||
147663951|NCT02631941|532594379|FG003|Overall Study|Lost to Follow-up|0|||
147663952|NCT02631941|532594380|FG004|Overall Study|Lost to Follow-up|0|||
147663953|NCT02631941|532594381|FG005|Overall Study|Lost to Follow-up|0|||
147663954|NCT02631941|532594382|FG006|Overall Study|Lost to Follow-up|0|||
147663955|NCT02631941|532594383|FG007|Overall Study|Lost to Follow-up|0|||
147663956|NCT02631941|532594384|FG008|Overall Study|Lost to Follow-up|1|||
147663957|NCT02631941|532594385|FG009|Overall Study|Lost to Follow-up|0|||
147663958|NCT04456686|532594388|FG000|Overall Study|Adverse Event|2|||
147663959|NCT04456686|532594389|FG001|Overall Study|Adverse Event|1|||
147663960|NCT04456686|532594388|FG000|Overall Study|Lack of Efficacy|3|||
147663961|NCT04456686|532594389|FG001|Overall Study|Lack of Efficacy|1|||
147663962|NCT04456686|532594388|FG000|Overall Study|Withdrew consent|3|||
147663963|NCT04456686|532594389|FG001|Overall Study|Withdrew consent|1|||
147663964|NCT04456686|532594388|FG000|Overall Study|Physician Decision|2|||
147663965|NCT04456686|532594389|FG001|Overall Study|Physician Decision|2|||
147663966|NCT04456686|532594388|FG000|Overall Study|Withdrawal by Subject|5|||
147663967|NCT04456686|532594389|FG001|Overall Study|Withdrawal by Subject|1|||
147663968|NCT04456686|532594388|FG000|Overall Study|Protocol Violation|0|||
147663969|NCT04456686|532594389|FG001|Overall Study|Protocol Violation|1|||
147663970|NCT02858401|532594395|FG000|Overall Study|Withdrew Consent|0|||
147663971|NCT02858401|532594396|FG001|Overall Study|Withdrew Consent|0|||
147663972|NCT02858401|532594397|FG002|Overall Study|Withdrew Consent|0|||
147663973|NCT02858401|532594398|FG003|Overall Study|Withdrew Consent|0|||
147663974|NCT02858401|532594399|FG004|Overall Study|Withdrew Consent|0|||
147663975|NCT02858401|532594400|FG005|Overall Study|Withdrew Consent|1|||
147663976|NCT02858401|532594401|FG006|Overall Study|Withdrew Consent|0|||
147663977|NCT02858401|532594395|FG000|Overall Study|Lost to Follow-up|0|||
147663978|NCT02858401|532594396|FG001|Overall Study|Lost to Follow-up|1|||
147663979|NCT02858401|532594397|FG002|Overall Study|Lost to Follow-up|0|||
147663980|NCT02858401|532594398|FG003|Overall Study|Lost to Follow-up|0|||
147663981|NCT02858401|532594399|FG004|Overall Study|Lost to Follow-up|0|||
147663982|NCT02858401|532594400|FG005|Overall Study|Lost to Follow-up|0|||
147663983|NCT02858401|532594401|FG006|Overall Study|Lost to Follow-up|0|||
147663984|NCT03722576|532594402|FG000|Overall Study|Withdrawal by Subject|3|||
147663985|NCT03722576|532594402|FG000|Overall Study|Adverse Event|2|||
147663986|NCT03722576|532594402|FG000|Overall Study|Physician Decision|1|||
147372988|NCT01753999|531530586|FG001|Period 2 -Cross to Alternate Arm|Physician Decision|1|||
147372989|NCT02392234|531530587|FG000|Treatment Period 1 (8 Weeks)|Adverse Event|1|||
147372990|NCT02392234|531530588|FG001|Treatment Period 1 (8 Weeks)|Adverse Event|0|||
147372991|NCT02392234|531530589|FG002|Treatment Period 1 (8 Weeks)|Adverse Event|1|||
147372992|NCT02392234|531530590|FG003|Treatment Period 1 (8 Weeks)|Adverse Event|0|||
147372993|NCT02392234|531530591|FG004|Treatment Period 1 (8 Weeks)|Adverse Event|1|||
147372994|NCT02392234|531530592|FG005|Treatment Period 1 (8 Weeks)|Adverse Event|1|||
147372995|NCT02392234|531530587|FG000|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0|||
147372996|NCT02392234|531530588|FG001|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0|||
147372997|NCT02392234|531530589|FG002|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0|||
147372998|NCT02392234|531530590|FG003|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0|||
147372999|NCT02392234|531530591|FG004|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|2|||
147663987|NCT03722576|532594402|FG000|Overall Study|Lost to Follow-up|1|||
147663988|NCT00748241|532594403|FG000|Overall Study|Implant failure|1|||
147663989|NCT00748241|532594403|FG000|Overall Study|Lost to Follow-up|5|||
147663990|NCT00748241|532594403|FG000|Overall Study|Death|2|||
147373000|NCT02392234|531530592|FG005|Treatment Period 1 (8 Weeks)|Withdrawal by Subject|0|||
147663991|NCT01240382|532594404|FG000|Overall Study|Adverse Event|2|||
147663992|NCT01240382|532594405|FG001|Overall Study|Adverse Event|1|||
147663993|NCT01240382|532594404|FG000|Overall Study|Lack of Efficacy|0|||
147663994|NCT01240382|532594405|FG001|Overall Study|Lack of Efficacy|2|||
147663995|NCT01240382|532594404|FG000|Overall Study|Fear of adverse events|0|||
147663996|NCT01240382|532594405|FG001|Overall Study|Fear of adverse events|1|||
147663997|NCT01408706|532594406|FG000|Overall Study|Physician Decision|1|||
147663998|NCT01408706|532594407|FG001|Overall Study|Physician Decision|0|||
147663999|NCT00888654|532594408|FG000|Overall Study|Problems swallowing oral meds.|1|||
147664000|NCT00888654|532594408|FG000|Overall Study|Not enough oral meds before surgery|3|||
147664001|NCT00888654|532594408|FG000|Overall Study|Surgery aborted|2|||
147664002|NCT00888654|532594408|FG000|Overall Study|Withdrawal by Subject|1|||
147664003|NCT00888654|532594408|FG000|Overall Study|Inelig. due to contraindication of med|1|||
147664004|NCT00888654|532594408|FG000|Overall Study|Change in surg date|1|||
147664005|NCT00888654|532594408|FG000|Overall Study|Stopped meds due to headaches|1|||
147664006|NCT03885908|532594409|FG000|Overall Study|Patient deemed to be ineligible due to language preference|1|||
147664007|NCT03885908|532594410|FG001|Overall Study|Patient deemed to be ineligible due to language preference|0|||
147664008|NCT03885908|532594409|FG000|Overall Study|Patient became ineligible becasue she underwent neoaedjuvant chemotherapy before surgery.|1|||
147664009|NCT03885908|532594410|FG001|Overall Study|Patient became ineligible becasue she underwent neoaedjuvant chemotherapy before surgery.|0|||
147664010|NCT03885908|532594409|FG000|Overall Study|Patient did not undergo surgery within 2 months of consent.|1|||
147664011|NCT03885908|532594410|FG001|Overall Study|Patient did not undergo surgery within 2 months of consent.|1|||
147664012|NCT03885908|532594409|FG000|Overall Study|Patient unable to complete appointment - withdrawn from study|0|||
147664013|NCT03885908|532594410|FG001|Overall Study|Patient unable to complete appointment - withdrawn from study|1|||
147664014|NCT03669549|532594411|FG000|Overall Study|Adverse Event|4|||
147664015|NCT03669549|532594411|FG000|Overall Study|Withdrawal by Subject|1|||
147664016|NCT03669549|532594411|FG000|Overall Study|Study terminated by the Sponsor|1|||
147664017|NCT02974868|532594413|FG000|Initial 24-Week Treatment Period (TP)|Adverse Event|1|||
147664018|NCT02974868|532594414|FG001|Initial 24-Week Treatment Period (TP)|Adverse Event|1|||
147664019|NCT02974868|532594415|FG002|Initial 24-Week Treatment Period (TP)|Adverse Event|2|||
147664020|NCT02974868|532594416|FG003|Initial 24-Week Treatment Period (TP)|Adverse Event|4|||
147373001|NCT02392234|531530587|FG000|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
147373002|NCT02392234|531530588|FG001|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
147373003|NCT02392234|531530589|FG002|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
147373004|NCT02392234|531530590|FG003|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
147373005|NCT02392234|531530591|FG004|Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
147373006|NCT02392234|531530592|FG005|Treatment Period 1 (8 Weeks)|Lost to Follow-up|1|||
147373007|NCT02392234|531530587|FG000|Treatment Period 1 (8 Weeks)|Pregnancy|1|||
147373008|NCT02392234|531530588|FG001|Treatment Period 1 (8 Weeks)|Pregnancy|0|||
147373009|NCT02392234|531530589|FG002|Treatment Period 1 (8 Weeks)|Pregnancy|0|||
147373010|NCT02392234|531530590|FG003|Treatment Period 1 (8 Weeks)|Pregnancy|1|||
147373011|NCT02392234|531530591|FG004|Treatment Period 1 (8 Weeks)|Pregnancy|0|||
147373012|NCT02392234|531530592|FG005|Treatment Period 1 (8 Weeks)|Pregnancy|0|||
147373013|NCT02392234|531530587|FG000|Treatment Period 1 (8 Weeks)|Noncompliance|0|||
147373014|NCT02392234|531530588|FG001|Treatment Period 1 (8 Weeks)|Noncompliance|0|||
147373015|NCT02392234|531530589|FG002|Treatment Period 1 (8 Weeks)|Noncompliance|0|||
147373016|NCT02392234|531530590|FG003|Treatment Period 1 (8 Weeks)|Noncompliance|0|||
147373017|NCT02392234|531530591|FG004|Treatment Period 1 (8 Weeks)|Noncompliance|0|||
147373018|NCT02392234|531530592|FG005|Treatment Period 1 (8 Weeks)|Noncompliance|1|||
147373019|NCT02392234|531530587|FG000|Treatment Period 1 (8 Weeks)|Other|1|||
147373020|NCT02392234|531530588|FG001|Treatment Period 1 (8 Weeks)|Other|0|||
147373021|NCT02392234|531530589|FG002|Treatment Period 1 (8 Weeks)|Other|0|||
147373022|NCT02392234|531530590|FG003|Treatment Period 1 (8 Weeks)|Other|0|||
147373023|NCT02392234|531530591|FG004|Treatment Period 1 (8 Weeks)|Other|0|||
147373024|NCT02392234|531530592|FG005|Treatment Period 1 (8 Weeks)|Other|0|||
147373025|NCT02392234|531530587|FG000|Treatment Period 1 (8 Weeks)|Randomized but not treated|0|||
147373026|NCT02392234|531530588|FG001|Treatment Period 1 (8 Weeks)|Randomized but not treated|0|||
147373027|NCT02392234|531530589|FG002|Treatment Period 1 (8 Weeks)|Randomized but not treated|1|||
147373028|NCT02392234|531530590|FG003|Treatment Period 1 (8 Weeks)|Randomized but not treated|0|||
147373029|NCT02392234|531530591|FG004|Treatment Period 1 (8 Weeks)|Randomized but not treated|1|||
147373030|NCT02392234|531530592|FG005|Treatment Period 1 (8 Weeks)|Randomized but not treated|0|||
147373031|NCT02392234|531530587|FG000|Treatment Period 2 (8 Weeks)|Adverse Event|1|||
147373032|NCT02392234|531530588|FG001|Treatment Period 2 (8 Weeks)|Adverse Event|0|||
147373033|NCT02392234|531530589|FG002|Treatment Period 2 (8 Weeks)|Adverse Event|0|||
147373034|NCT02392234|531530590|FG003|Treatment Period 2 (8 Weeks)|Adverse Event|0|||
147373035|NCT02392234|531530591|FG004|Treatment Period 2 (8 Weeks)|Adverse Event|0|||
147373036|NCT02392234|531530592|FG005|Treatment Period 2 (8 Weeks)|Adverse Event|0|||
147373037|NCT01387516|531530593|FG000|Overall Study|Lost to Follow-up|4|||
147373038|NCT01387516|531530594|FG001|Overall Study|Lost to Follow-up|4|||
147373039|NCT01387516|531530595|FG002|Overall Study|Lost to Follow-up|2|||
147664021|NCT02974868|532594413|FG000|Initial 24-Week Treatment Period (TP)|others|3|||
147664022|NCT02974868|532594414|FG001|Initial 24-Week Treatment Period (TP)|others|8|||
147664023|NCT02974868|532594415|FG002|Initial 24-Week Treatment Period (TP)|others|1|||
147664024|NCT02974868|532594416|FG003|Initial 24-Week Treatment Period (TP)|others|8|||
147664025|NCT02974868|532594413|FG000|Single-Blind Extension (SBE) Period|AE & Withdraw by participants|2|||
147373040|NCT01387516|531530596|FG003|Overall Study|Lost to Follow-up|3|||
147373041|NCT01387516|531530593|FG000|Overall Study|Withdrawal by Subject|1|||
147373042|NCT01387516|531530594|FG001|Overall Study|Withdrawal by Subject|1|||
147373043|NCT01387516|531530595|FG002|Overall Study|Withdrawal by Subject|2|||
147373044|NCT01387516|531530596|FG003|Overall Study|Withdrawal by Subject|0|||
147373045|NCT01387516|531530593|FG000|Overall Study|Death|0|||
147373046|NCT01387516|531530594|FG001|Overall Study|Death|0|||
147373047|NCT01387516|531530595|FG002|Overall Study|Death|0|||
147373048|NCT01387516|531530596|FG003|Overall Study|Death|1|||
147373049|NCT03170648|531530599|FG000|Chemotherapy Education (Cycle 2)|schedule conflict|1|||
147373050|NCT03170648|531530599|FG000|Auricular Acupuncture (Cycle 3)|Adverse Event|1|||
147373051|NCT02052440|531530600|FG000|Overall Study|Withdrawal by Subject|0|||
147373052|NCT02052440|531530601|FG001|Overall Study|Withdrawal by Subject|1|||
147373053|NCT03509909|531530602|FG000|Overall Study|Withdrawal by Subject|16|||
147373054|NCT03509909|531530603|FG001|Overall Study|Withdrawal by Subject|9|||
147373055|NCT03509909|531530602|FG000|Overall Study|Lost to Follow-up|3|||
147373056|NCT03509909|531530603|FG001|Overall Study|Lost to Follow-up|4|||
147373057|NCT03509909|531530602|FG000|Overall Study|Adverse Event|2|||
147373058|NCT03509909|531530603|FG001|Overall Study|Adverse Event|0|||
147373059|NCT04325828|531530604|FG000|Overall Study|Ongoing|26|||
147373060|NCT05509816|531530605|FG000|Overall Study|Lost to Follow-up|1|||
147373061|NCT02130557|531530606|FG000|Overall Study|Withdrawal by Subject|12|||
147373062|NCT02130557|531530607|FG001|Overall Study|Withdrawal by Subject|12|||
147373063|NCT02130557|531530606|FG000|Overall Study|Investigator Request|0|||
147373064|NCT02130557|531530607|FG001|Overall Study|Investigator Request|2|||
147373065|NCT02130557|531530606|FG000|Overall Study|Deceased|14|||
147373066|NCT02130557|531530607|FG001|Overall Study|Deceased|14|||
147373067|NCT02130557|531530606|FG000|Overall Study|Lost to Follow-up|6|||
147373068|NCT02130557|531530607|FG001|Overall Study|Lost to Follow-up|7|||
147373069|NCT02130557|531530606|FG000|Overall Study|Other|2|||
147373070|NCT02130557|531530607|FG001|Overall Study|Other|1|||
147373071|NCT02130557|531530606|FG000|Overall Study|Missing|2|||
147373072|NCT02130557|531530607|FG001|Overall Study|Missing|1|||
147373073|NCT04066075|531530608|FG000|Overall Study|Lost to Follow-up|3|||
147373074|NCT04066075|531530609|FG001|Overall Study|Lost to Follow-up|3|||
147373075|NCT04066075|531530608|FG000|Overall Study|no longer eligible or technical issue with intervention or data|4|||
147373076|NCT04066075|531530609|FG001|Overall Study|no longer eligible or technical issue with intervention or data|0|||
147373077|NCT04066075|531530608|FG000|Overall Study|Withdrawal by Subject|2|||
147373078|NCT04066075|531530609|FG001|Overall Study|Withdrawal by Subject|2|||
147373079|NCT00309166|531530610|FG000|Overall Study|Adverse event, non-fatal|1|||
147373080|NCT00309166|531530611|FG001|Overall Study|Adverse event, non-fatal|0|||
147373081|NCT00309166|531530610|FG000|Overall Study|Withdrawal by Subject|4|||
147373082|NCT00309166|531530611|FG001|Overall Study|Withdrawal by Subject|3|||
147373083|NCT04801420|531530616|FG000|Overall Study|Other|1|||
147373084|NCT04801420|531530617|FG001|Overall Study|Other|2|||
147373085|NCT04801420|531530618|FG002|Overall Study|Other|1|||
147373086|NCT04801420|531530616|FG000|Overall Study|Lost to Follow-up|7|||
147373087|NCT04801420|531530617|FG001|Overall Study|Lost to Follow-up|9|||
147373088|NCT04801420|531530618|FG002|Overall Study|Lost to Follow-up|10|||
147373089|NCT04801420|531530616|FG000|Overall Study|Moved from study area|0|||
147373090|NCT04801420|531530617|FG001|Overall Study|Moved from study area|1|||
147373091|NCT04801420|531530618|FG002|Overall Study|Moved from study area|1|||
147373092|NCT04801420|531530616|FG000|Overall Study|Withdrawal by Subject|5|||
147373093|NCT04801420|531530617|FG001|Overall Study|Withdrawal by Subject|1|||
147373094|NCT04801420|531530618|FG002|Overall Study|Withdrawal by Subject|4|||
147373095|NCT04801420|531530616|FG000|Overall Study|Individual stopping criteria reached|0|||
147373096|NCT04801420|531530617|FG001|Overall Study|Individual stopping criteria reached|1|||
147373097|NCT04801420|531530618|FG002|Overall Study|Individual stopping criteria reached|0|||
147373098|NCT04801420|531530616|FG000|Overall Study|Ongoing in the study|195|||
147373099|NCT04801420|531530617|FG001|Overall Study|Ongoing in the study|195|||
147373100|NCT04801420|531530618|FG002|Overall Study|Ongoing in the study|192|||
147373101|NCT01675492|531530619|FG000|Overall Study|study completed early - product approval|42|||
147373102|NCT05349838|531530620|FG000|Overall Study|Virological Failure|1|||
147373103|NCT05349838|531530621|FG001|Overall Study|Virological Failure|2|||
147373104|NCT05349838|531530620|FG000|Overall Study|Withdrawal by Subject|2|||
147373105|NCT05349838|531530621|FG001|Overall Study|Withdrawal by Subject|3|||
147373106|NCT05349838|531530620|FG000|Overall Study|Adverse Event|3|||
147373107|NCT05349838|531530621|FG001|Overall Study|Adverse Event|1|||
147373108|NCT05349838|531530620|FG000|Overall Study|Lost to Follow-up|1|||
147373109|NCT05349838|531530621|FG001|Overall Study|Lost to Follow-up|2|||
147373110|NCT05349838|531530620|FG000|Overall Study|Other reasons|5|||
147373111|NCT05349838|531530621|FG001|Overall Study|Other reasons|1|||
147373112|NCT00092534|531532157|FG000|Base Study Vaccination Period|Randomized not Vaccinated|5|||
147373113|NCT00092534|531532158|FG001|Base Study Vaccination Period|Randomized not Vaccinated|5|||
147373114|NCT00092534|531532159|FG002|Base Study Vaccination Period|Randomized not Vaccinated|0|||
147373115|NCT00092534|531532160|FG003|Base Study Vaccination Period|Randomized not Vaccinated|0|||
147373116|NCT00092534|531532161|FG004|Base Study Vaccination Period|Randomized not Vaccinated|0|||
147373117|NCT00092534|531532157|FG000|Base Study Vaccination Period|Adverse Event|3|||
147373118|NCT00092534|531532158|FG001|Base Study Vaccination Period|Adverse Event|1|||
147373119|NCT00092534|531532159|FG002|Base Study Vaccination Period|Adverse Event|0|||
147373120|NCT00092534|531532160|FG003|Base Study Vaccination Period|Adverse Event|0|||
147373121|NCT00092534|531532161|FG004|Base Study Vaccination Period|Adverse Event|0|||
147373122|NCT00092534|531532157|FG000|Base Study Vaccination Period|Death|5|||
147373123|NCT00092534|531532158|FG001|Base Study Vaccination Period|Death|4|||
147373124|NCT00092534|531532159|FG002|Base Study Vaccination Period|Death|0|||
147373125|NCT00092534|531532160|FG003|Base Study Vaccination Period|Death|0|||
147373126|NCT00092534|531532161|FG004|Base Study Vaccination Period|Death|0|||
147373127|NCT00092534|531532157|FG000|Base Study Vaccination Period|Lost to Follow-up|41|||
147373128|NCT00092534|531532158|FG001|Base Study Vaccination Period|Lost to Follow-up|37|||
147373129|NCT00092534|531532159|FG002|Base Study Vaccination Period|Lost to Follow-up|0|||
147373130|NCT00092534|531532160|FG003|Base Study Vaccination Period|Lost to Follow-up|0|||
147373131|NCT00092534|531532161|FG004|Base Study Vaccination Period|Lost to Follow-up|0|||
147373132|NCT00092534|531532157|FG000|Base Study Vaccination Period|Physician Decision|1|||
147373133|NCT00092534|531532158|FG001|Base Study Vaccination Period|Physician Decision|0|||
147373134|NCT00092534|531532159|FG002|Base Study Vaccination Period|Physician Decision|0|||
147373135|NCT00092534|531532160|FG003|Base Study Vaccination Period|Physician Decision|0|||
147373136|NCT00092534|531532161|FG004|Base Study Vaccination Period|Physician Decision|0|||
147373137|NCT00092534|531532157|FG000|Base Study Vaccination Period|Pregnancy|9|||
147373138|NCT00092534|531532158|FG001|Base Study Vaccination Period|Pregnancy|7|||
147373139|NCT00092534|531532159|FG002|Base Study Vaccination Period|Pregnancy|0|||
147373140|NCT00092534|531532160|FG003|Base Study Vaccination Period|Pregnancy|0|||
147373141|NCT00092534|531532161|FG004|Base Study Vaccination Period|Pregnancy|0|||
147373142|NCT00092534|531532157|FG000|Base Study Vaccination Period|Protocol Violation|2|||
147373143|NCT00092534|531532158|FG001|Base Study Vaccination Period|Protocol Violation|1|||
147373144|NCT00092534|531532159|FG002|Base Study Vaccination Period|Protocol Violation|0|||
147373145|NCT00092534|531532160|FG003|Base Study Vaccination Period|Protocol Violation|0|||
147373146|NCT00092534|531532161|FG004|Base Study Vaccination Period|Protocol Violation|0|||
147373147|NCT00092534|531532157|FG000|Base Study Vaccination Period|Withdrawal by Subject|85|||
147373148|NCT00092534|531532158|FG001|Base Study Vaccination Period|Withdrawal by Subject|58|||
147373149|NCT00092534|531532159|FG002|Base Study Vaccination Period|Withdrawal by Subject|0|||
147373150|NCT00092534|531532160|FG003|Base Study Vaccination Period|Withdrawal by Subject|0|||
147373151|NCT00092534|531532161|FG004|Base Study Vaccination Period|Withdrawal by Subject|0|||
147373152|NCT00092534|531532157|FG000|Base Study Vaccination Period|Moved|14|||
147373153|NCT00092534|531532158|FG001|Base Study Vaccination Period|Moved|12|||
147373154|NCT00092534|531532159|FG002|Base Study Vaccination Period|Moved|0|||
147373155|NCT00092534|531532160|FG003|Base Study Vaccination Period|Moved|0|||
147373156|NCT00092534|531532161|FG004|Base Study Vaccination Period|Moved|0|||
147373157|NCT00092534|531532157|FG000|Base Study Vaccination Period|New Medical History (Not AEs)|5|||
147373158|NCT00092534|531532158|FG001|Base Study Vaccination Period|New Medical History (Not AEs)|0|||
147373159|NCT00092534|531532159|FG002|Base Study Vaccination Period|New Medical History (Not AEs)|0|||
147373160|NCT00092534|531532160|FG003|Base Study Vaccination Period|New Medical History (Not AEs)|0|||
147373161|NCT00092534|531532161|FG004|Base Study Vaccination Period|New Medical History (Not AEs)|0|||
147373162|NCT00092534|531532157|FG000|Base Study Vaccination Period|Travel|1|||
147373163|NCT00092534|531532158|FG001|Base Study Vaccination Period|Travel|0|||
147373164|NCT00092534|531532159|FG002|Base Study Vaccination Period|Travel|0|||
147373165|NCT00092534|531532160|FG003|Base Study Vaccination Period|Travel|0|||
147373166|NCT00092534|531532161|FG004|Base Study Vaccination Period|Travel|0|||
147373167|NCT00092534|531532157|FG000|Base Study Vaccination Period|Site Closed|0|||
147373168|NCT00092534|531532158|FG001|Base Study Vaccination Period|Site Closed|1|||
147373169|NCT00092534|531532159|FG002|Base Study Vaccination Period|Site Closed|0|||
147373170|NCT00092534|531532160|FG003|Base Study Vaccination Period|Site Closed|0|||
147373171|NCT00092534|531532161|FG004|Base Study Vaccination Period|Site Closed|0|||
147373172|NCT00092534|531532157|FG000|Base Study Follow-Up Period|Adverse Event|2|||
147373173|NCT00092534|531532158|FG001|Base Study Follow-Up Period|Adverse Event|4|||
147373174|NCT00092534|531532159|FG002|Base Study Follow-Up Period|Adverse Event|0|||
147373175|NCT00092534|531532160|FG003|Base Study Follow-Up Period|Adverse Event|0|||
147373176|NCT00092534|531532161|FG004|Base Study Follow-Up Period|Adverse Event|0|||
147373177|NCT00092534|531532157|FG000|Base Study Follow-Up Period|Death|2|||
147373178|NCT00092534|531532158|FG001|Base Study Follow-Up Period|Death|1|||
147373179|NCT00092534|531532159|FG002|Base Study Follow-Up Period|Death|0|||
147373180|NCT00092534|531532160|FG003|Base Study Follow-Up Period|Death|0|||
147373181|NCT00092534|531532161|FG004|Base Study Follow-Up Period|Death|0|||
147373182|NCT00092534|531532157|FG000|Base Study Follow-Up Period|Lost to Follow-up|120|||
147373183|NCT00092534|531532158|FG001|Base Study Follow-Up Period|Lost to Follow-up|146|||
147373184|NCT00092534|531532159|FG002|Base Study Follow-Up Period|Lost to Follow-up|0|||
147611238|NCT01885195|532390998|FG000|Overall Study|Adverse Event|29|||
147611239|NCT01885195|532390998|FG000|Overall Study|Death|1|||
147373185|NCT00092534|531532160|FG003|Base Study Follow-Up Period|Lost to Follow-up|0|||
147373186|NCT00092534|531532161|FG004|Base Study Follow-Up Period|Lost to Follow-up|0|||
147611240|NCT01885195|532390998|FG000|Overall Study|Disease Progression|67|||
147664026|NCT02974868|532594414|FG001|Single-Blind Extension (SBE) Period|AE & Withdraw by participants|1|||
147664027|NCT02974868|532594415|FG002|Single-Blind Extension (SBE) Period|AE & Withdraw by participants|11|||
147664028|NCT02974868|532594416|FG003|Single-Blind Extension (SBE) Period|AE & Withdraw by participants|6|||
147664029|NCT02974868|532594413|FG000|Cross-Over Extension (COE) Period|Withdrawal by Subject|2|||
147664030|NCT02974868|532594414|FG001|Cross-Over Extension (COE) Period|Withdrawal by Subject|1|||
147664031|NCT02974868|532594415|FG002|Cross-Over Extension (COE) Period|Withdrawal by Subject|3|||
147664032|NCT02974868|532594416|FG003|Cross-Over Extension (COE) Period|Withdrawal by Subject|0|||
147664033|NCT02674516|532594417|FG000|Overall Study|Lost to Follow-up|3|||
147664034|NCT02674516|532594418|FG001|Overall Study|Lost to Follow-up|0|||
147664035|NCT02674516|532594417|FG000|Overall Study|Protocol Violation|0|||
147664036|NCT02674516|532594418|FG001|Overall Study|Protocol Violation|4|||
147664037|NCT02674516|532594417|FG000|Overall Study|Knowledge of study hypothesis|1|||
147664038|NCT02674516|532594418|FG001|Overall Study|Knowledge of study hypothesis|0|||
147664039|NCT01064479|532594419|FG000|Overall Study|Death|10|||
147664040|NCT01064479|532594420|FG001|Overall Study|Death|11|||
147664041|NCT01064479|532594419|FG000|Overall Study|Withdrawal by Subject|2|||
147664042|NCT01064479|532594420|FG001|Overall Study|Withdrawal by Subject|2|||
147664043|NCT01064479|532594419|FG000|Overall Study|Disease progression|1|||
147664044|NCT01064479|532594420|FG001|Overall Study|Disease progression|1|||
147664045|NCT01064479|532594419|FG000|Overall Study|Toxicity|1|||
147664046|NCT01064479|532594420|FG001|Overall Study|Toxicity|1|||
147664047|NCT01064479|532594419|FG000|Overall Study|Other|1|||
147664048|NCT01064479|532594420|FG001|Overall Study|Other|2|||
147664049|NCT01663402|532594424|FG000|Overall Study|Randomized but not treated|19|||
147664050|NCT01663402|532594425|FG001|Overall Study|Randomized but not treated|11|||
147664051|NCT01663402|532594424|FG000|Overall Study|Adverse Event|347|||
147664052|NCT01663402|532594425|FG001|Overall Study|Adverse Event|362|||
147664053|NCT01663402|532594424|FG000|Overall Study|Two consecutive LDL-C <15 mg/dL|0|||
147664054|NCT01663402|532594425|FG001|Overall Study|Two consecutive LDL-C <15 mg/dL|730|||
147664055|NCT01663402|532594424|FG000|Overall Study|Poor compliance to protocol|529|||
147664056|NCT01663402|532594425|FG001|Overall Study|Poor compliance to protocol|454|||
147664057|NCT01663402|532594424|FG000|Overall Study|Physician Decision|77|||
147664058|NCT01663402|532594425|FG001|Overall Study|Physician Decision|62|||
147664059|NCT01663402|532594424|FG000|Overall Study|Site terminated by sponsor|1|||
147664060|NCT01663402|532594425|FG001|Overall Study|Site terminated by sponsor|3|||
147664061|NCT01663402|532594424|FG000|Overall Study|Participant moved|139|||
147664062|NCT01663402|532594425|FG001|Overall Study|Participant moved|104|||
147664063|NCT01663402|532594424|FG000|Overall Study|Withdrawal by Subject|118|||
147664064|NCT01663402|532594425|FG001|Overall Study|Withdrawal by Subject|91|||
147373187|NCT00092534|531532157|FG000|Base Study Follow-Up Period|Pregnancy|6|||
147373188|NCT00092534|531532158|FG001|Base Study Follow-Up Period|Pregnancy|10|||
147373189|NCT00092534|531532159|FG002|Base Study Follow-Up Period|Pregnancy|0|||
147373190|NCT00092534|531532160|FG003|Base Study Follow-Up Period|Pregnancy|0|||
147373191|NCT00092534|531532161|FG004|Base Study Follow-Up Period|Pregnancy|0|||
147373192|NCT00092534|531532157|FG000|Base Study Follow-Up Period|Protocol Violation|1|||
147373193|NCT00092534|531532158|FG001|Base Study Follow-Up Period|Protocol Violation|2|||
147373194|NCT00092534|531532159|FG002|Base Study Follow-Up Period|Protocol Violation|0|||
147373195|NCT00092534|531532160|FG003|Base Study Follow-Up Period|Protocol Violation|0|||
147373196|NCT00092534|531532161|FG004|Base Study Follow-Up Period|Protocol Violation|0|||
147373197|NCT00092534|531532157|FG000|Base Study Follow-Up Period|Withdrawal by Subject|71|||
147373198|NCT00092534|531532158|FG001|Base Study Follow-Up Period|Withdrawal by Subject|62|||
147373199|NCT00092534|531532159|FG002|Base Study Follow-Up Period|Withdrawal by Subject|0|||
147373200|NCT00092534|531532160|FG003|Base Study Follow-Up Period|Withdrawal by Subject|0|||
147373201|NCT00092534|531532161|FG004|Base Study Follow-Up Period|Withdrawal by Subject|0|||
147373202|NCT00092534|531532157|FG000|Base Study Follow-Up Period|Moved|62|||
147373203|NCT00092534|531532158|FG001|Base Study Follow-Up Period|Moved|58|||
147373204|NCT00092534|531532159|FG002|Base Study Follow-Up Period|Moved|0|||
147373205|NCT00092534|531532160|FG003|Base Study Follow-Up Period|Moved|0|||
147373206|NCT00092534|531532161|FG004|Base Study Follow-Up Period|Moved|0|||
147373207|NCT00092534|531532157|FG000|Base Study Follow-Up Period|Travel|10|||
147373208|NCT00092534|531532158|FG001|Base Study Follow-Up Period|Travel|7|||
147373209|NCT00092534|531532159|FG002|Base Study Follow-Up Period|Travel|0|||
147373210|NCT00092534|531532160|FG003|Base Study Follow-Up Period|Travel|0|||
147373211|NCT00092534|531532161|FG004|Base Study Follow-Up Period|Travel|0|||
147373212|NCT00092534|531532157|FG000|Base Study Follow-Up Period|Site Closed|0|||
147455279|NCT03467958|531827856|FG001|Overall Study|Study terminated by sponsor|117|||
147455280|NCT03467958|531827857|FG002|Overall Study|Study terminated by sponsor|45|||
147664065|NCT01663402|532594424|FG000|Overall Study|Related to study drug administration|96|||
147373213|NCT00092534|531532158|FG001|Base Study Follow-Up Period|Site Closed|2|||
147455281|NCT03467958|531827858|FG003|Overall Study|Study terminated by sponsor|64|||
147664066|NCT01663402|532594425|FG001|Overall Study|Related to study drug administration|105|||
147664067|NCT01663402|532594424|FG000|Overall Study|Lost to Follow-up|17|||
147664068|NCT01663402|532594425|FG001|Overall Study|Lost to Follow-up|15|||
147664069|NCT01663402|532594424|FG000|Overall Study|Other than specified above|172|||
147664070|NCT01663402|532594425|FG001|Overall Study|Other than specified above|147|||
147373214|NCT00092534|531532159|FG002|Base Study Follow-Up Period|Site Closed|0|||
147373215|NCT00092534|531532160|FG003|Base Study Follow-Up Period|Site Closed|0|||
147373216|NCT00092534|531532161|FG004|Base Study Follow-Up Period|Site Closed|0|||
147373217|NCT00092534|531532157|FG000|Base Study Follow-Up Period|Subjects continuing|27|||
147373218|NCT00092534|531532158|FG001|Base Study Follow-Up Period|Subjects continuing|31|||
147373219|NCT00092534|531532159|FG002|Base Study Follow-Up Period|Subjects continuing|0|||
147373220|NCT00092534|531532160|FG003|Base Study Follow-Up Period|Subjects continuing|0|||
147373221|NCT00092534|531532161|FG004|Base Study Follow-Up Period|Subjects continuing|0|||
147373222|NCT00092534|531532157|FG000|Base Study Follow-Up Period|Subjects in extension|15|||
147373223|NCT00092534|531532158|FG001|Base Study Follow-Up Period|Subjects in extension|371|||
147373224|NCT00092534|531532159|FG002|Base Study Follow-Up Period|Subjects in extension|0|||
147373225|NCT00092534|531532160|FG003|Base Study Follow-Up Period|Subjects in extension|0|||
147373226|NCT00092534|531532161|FG004|Base Study Follow-Up Period|Subjects in extension|0|||
147373227|NCT00092534|531532157|FG000|Base Study EXT|Lost to Follow-up|0|||
147373228|NCT00092534|531532158|FG001|Base Study EXT|Lost to Follow-up|0|||
147373229|NCT00092534|531532159|FG002|Base Study EXT|Lost to Follow-up|41|||
147373230|NCT00092534|531532160|FG003|Base Study EXT|Lost to Follow-up|0|||
147373231|NCT00092534|531532161|FG004|Base Study EXT|Lost to Follow-up|0|||
147373232|NCT00092534|531532157|FG000|Base Study EXT|Physician Decision|0|||
147373233|NCT00092534|531532158|FG001|Base Study EXT|Physician Decision|0|||
147373234|NCT00092534|531532159|FG002|Base Study EXT|Physician Decision|1|||
147373235|NCT00092534|531532160|FG003|Base Study EXT|Physician Decision|0|||
147373236|NCT00092534|531532161|FG004|Base Study EXT|Physician Decision|0|||
147373237|NCT00092534|531532157|FG000|Base Study EXT|Pregnancy|0|||
147373238|NCT00092534|531532158|FG001|Base Study EXT|Pregnancy|0|||
147373239|NCT00092534|531532159|FG002|Base Study EXT|Pregnancy|12|||
147373240|NCT00092534|531532160|FG003|Base Study EXT|Pregnancy|0|||
147373241|NCT00092534|531532161|FG004|Base Study EXT|Pregnancy|0|||
147373242|NCT00092534|531532157|FG000|Base Study EXT|Withdrawal by Subject|0|||
147373243|NCT00092534|531532158|FG001|Base Study EXT|Withdrawal by Subject|0|||
147373244|NCT00092534|531532159|FG002|Base Study EXT|Withdrawal by Subject|18|||
147373245|NCT00092534|531532160|FG003|Base Study EXT|Withdrawal by Subject|0|||
147373246|NCT00092534|531532161|FG004|Base Study EXT|Withdrawal by Subject|0|||
147373247|NCT00092534|531532157|FG000|Base Study EXT|Participant moved|0|||
147373248|NCT00092534|531532158|FG001|Base Study EXT|Participant moved|0|||
147373249|NCT00092534|531532159|FG002|Base Study EXT|Participant moved|6|||
147373250|NCT00092534|531532160|FG003|Base Study EXT|Participant moved|0|||
147373251|NCT00092534|531532161|FG004|Base Study EXT|Participant moved|0|||
147373252|NCT00092534|531532157|FG000|Base Study EXT|Travel|0|||
147373253|NCT00092534|531532158|FG001|Base Study EXT|Travel|0|||
147373254|NCT00092534|531532159|FG002|Base Study EXT|Travel|2|||
147373255|NCT00092534|531532160|FG003|Base Study EXT|Travel|0|||
147373256|NCT00092534|531532161|FG004|Base Study EXT|Travel|0|||
147373257|NCT00092534|531532157|FG000|Base Study EXT|Site closed|0|||
147373258|NCT00092534|531532158|FG001|Base Study EXT|Site closed|0|||
147373259|NCT00092534|531532159|FG002|Base Study EXT|Site closed|21|||
147373260|NCT00092534|531532160|FG003|Base Study EXT|Site closed|0|||
147373261|NCT00092534|531532161|FG004|Base Study EXT|Site closed|0|||
147373262|NCT00092534|531532157|FG000|Base Study EXT|Study ended|0|||
147373263|NCT00092534|531532158|FG001|Base Study EXT|Study ended|0|||
147373264|NCT00092534|531532159|FG002|Base Study EXT|Study ended|29|||
147373265|NCT00092534|531532160|FG003|Base Study EXT|Study ended|0|||
147373266|NCT00092534|531532161|FG004|Base Study EXT|Study ended|0|||
147373267|NCT00092534|531532157|FG000|Base Study EXT|Protocol Violation|0|||
147373268|NCT00092534|531532158|FG001|Base Study EXT|Protocol Violation|0|||
147373269|NCT00092534|531532159|FG002|Base Study EXT|Protocol Violation|15|||
147373270|NCT00092534|531532160|FG003|Base Study EXT|Protocol Violation|0|||
147373271|NCT00092534|531532161|FG004|Base Study EXT|Protocol Violation|0|||
147373272|NCT00092534|531532157|FG000|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|0|||
147373273|NCT00092534|531532158|FG001|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|0|||
147664071|NCT03575702|532594428|FG000|Overall Study|Withdrawal by Subject|1|||
147373274|NCT00092534|531532159|FG002|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|0|||
147664072|NCT03575702|532594429|FG001|Overall Study|Withdrawal by Subject|1|||
147664073|NCT03575702|532594428|FG000|Overall Study|Lost to Follow-up|1|||
147664074|NCT03575702|532594429|FG001|Overall Study|Lost to Follow-up|2|||
147373275|NCT00092534|531532160|FG003|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|1|||
147373276|NCT00092534|531532161|FG004|Long-Term Follow-Up (LTFU) Study|Withdrawal by Subject|0|||
147373277|NCT02036970|531532163|FG000|Part 1: Day 1 Through Week 16|Adverse Event|0|||
147373278|NCT02036970|531532164|FG001|Part 1: Day 1 Through Week 16|Adverse Event|0|||
147373279|NCT02036970|531532165|FG002|Part 1: Day 1 Through Week 16|Adverse Event|3|||
147373280|NCT02036970|531532166|FG003|Part 1: Day 1 Through Week 16|Adverse Event|2|||
147373281|NCT02036970|531532167|FG004|Part 1: Day 1 Through Week 16|Adverse Event|0|||
147373282|NCT02036970|531532168|FG005|Part 1: Day 1 Through Week 16|Adverse Event|1|||
147373283|NCT02036970|531532169|FG006|Part 1: Day 1 Through Week 16|Adverse Event|0|||
147373284|NCT02036970|531532170|FG007|Part 1: Day 1 Through Week 16|Adverse Event|1|||
147373285|NCT02036970|531532171|FG008|Part 1: Day 1 Through Week 16|Adverse Event|3|||
147373286|NCT02036970|531532172|FG009|Part 1: Day 1 Through Week 16|Adverse Event|1|||
147373287|NCT02036970|531532163|FG000|Part 1: Day 1 Through Week 16|Death|0|||
147373288|NCT02036970|531532164|FG001|Part 1: Day 1 Through Week 16|Death|0|||
147373289|NCT02036970|531532165|FG002|Part 1: Day 1 Through Week 16|Death|0|||
147373290|NCT02036970|531532166|FG003|Part 1: Day 1 Through Week 16|Death|0|||
147373291|NCT02036970|531532167|FG004|Part 1: Day 1 Through Week 16|Death|0|||
147373292|NCT02036970|531532168|FG005|Part 1: Day 1 Through Week 16|Death|0|||
147373293|NCT02036970|531532169|FG006|Part 1: Day 1 Through Week 16|Death|0|||
147373294|NCT02036970|531532170|FG007|Part 1: Day 1 Through Week 16|Death|0|||
147373295|NCT02036970|531532171|FG008|Part 1: Day 1 Through Week 16|Death|1|||
147373296|NCT02036970|531532172|FG009|Part 1: Day 1 Through Week 16|Death|0|||
147373297|NCT02036970|531532163|FG000|Part 1: Day 1 Through Week 16|Protocol Violation|1|||
147373298|NCT02036970|531532164|FG001|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
147373299|NCT02036970|531532165|FG002|Part 1: Day 1 Through Week 16|Protocol Violation|1|||
147373300|NCT02036970|531532166|FG003|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
147373301|NCT02036970|531532167|FG004|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
147373302|NCT02036970|531532168|FG005|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
147373303|NCT02036970|531532169|FG006|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
147373304|NCT02036970|531532170|FG007|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
147373305|NCT02036970|531532171|FG008|Part 1: Day 1 Through Week 16|Protocol Violation|2|||
147373306|NCT02036970|531532172|FG009|Part 1: Day 1 Through Week 16|Protocol Violation|0|||
147373307|NCT02036970|531532163|FG000|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
147373308|NCT02036970|531532164|FG001|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
147373309|NCT02036970|531532165|FG002|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
147373310|NCT02036970|531532166|FG003|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
147373311|NCT02036970|531532167|FG004|Part 1: Day 1 Through Week 16|Withdrawal by Subject|1|||
147373312|NCT02036970|531532168|FG005|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
147373313|NCT02036970|531532169|FG006|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
147373314|NCT02036970|531532170|FG007|Part 1: Day 1 Through Week 16|Withdrawal by Subject|0|||
147373315|NCT02036970|531532171|FG008|Part 1: Day 1 Through Week 16|Withdrawal by Subject|2|||
147373316|NCT02036970|531532172|FG009|Part 1: Day 1 Through Week 16|Withdrawal by Subject|4|||
147373317|NCT02036970|531532163|FG000|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
147373318|NCT02036970|531532164|FG001|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
147373319|NCT02036970|531532165|FG002|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
147373320|NCT02036970|531532166|FG003|Part 1: Day 1 Through Week 16|Progressive Disease|1|||
147373321|NCT02036970|531532167|FG004|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
147373322|NCT02036970|531532168|FG005|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
147373323|NCT02036970|531532169|FG006|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
147373324|NCT02036970|531532170|FG007|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
147373325|NCT02036970|531532171|FG008|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
147373326|NCT02036970|531532172|FG009|Part 1: Day 1 Through Week 16|Progressive Disease|0|||
147373327|NCT02036970|531532163|FG000|Part 2: Week 16 Onwards|Adverse Event|0|||
147373328|NCT02036970|531532164|FG001|Part 2: Week 16 Onwards|Adverse Event|2|||
147373329|NCT02036970|531532165|FG002|Part 2: Week 16 Onwards|Adverse Event|1|||
147373330|NCT02036970|531532166|FG003|Part 2: Week 16 Onwards|Adverse Event|1|||
147373331|NCT02036970|531532167|FG004|Part 2: Week 16 Onwards|Adverse Event|1|||
147373332|NCT02036970|531532168|FG005|Part 2: Week 16 Onwards|Adverse Event|0|||
147373333|NCT02036970|531532169|FG006|Part 2: Week 16 Onwards|Adverse Event|1|||
147373334|NCT02036970|531532170|FG007|Part 2: Week 16 Onwards|Adverse Event|0|||
147373335|NCT02036970|531532171|FG008|Part 2: Week 16 Onwards|Adverse Event|6|||
147373336|NCT02036970|531532172|FG009|Part 2: Week 16 Onwards|Adverse Event|3|||
147373337|NCT02036970|531532163|FG000|Part 2: Week 16 Onwards|Protocol Violation|0|||
147373338|NCT02036970|531532164|FG001|Part 2: Week 16 Onwards|Protocol Violation|0|||
147373339|NCT02036970|531532165|FG002|Part 2: Week 16 Onwards|Protocol Violation|0|||
147373340|NCT02036970|531532166|FG003|Part 2: Week 16 Onwards|Protocol Violation|0|||
147373341|NCT02036970|531532167|FG004|Part 2: Week 16 Onwards|Protocol Violation|0|||
147373342|NCT02036970|531532168|FG005|Part 2: Week 16 Onwards|Protocol Violation|0|||
147373343|NCT02036970|531532169|FG006|Part 2: Week 16 Onwards|Protocol Violation|0|||
147373344|NCT02036970|531532170|FG007|Part 2: Week 16 Onwards|Protocol Violation|1|||
147373345|NCT02036970|531532171|FG008|Part 2: Week 16 Onwards|Protocol Violation|0|||
147373346|NCT02036970|531532172|FG009|Part 2: Week 16 Onwards|Protocol Violation|0|||
147373347|NCT02036970|531532163|FG000|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
147373348|NCT02036970|531532164|FG001|Part 2: Week 16 Onwards|Withdrawal by Subject|1|||
147373349|NCT02036970|531532165|FG002|Part 2: Week 16 Onwards|Withdrawal by Subject|1|||
147373350|NCT02036970|531532166|FG003|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
147373351|NCT02036970|531532167|FG004|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
147373352|NCT02036970|531532168|FG005|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
147373353|NCT02036970|531532169|FG006|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
147373354|NCT02036970|531532170|FG007|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
147373355|NCT02036970|531532171|FG008|Part 2: Week 16 Onwards|Withdrawal by Subject|3|||
147373356|NCT02036970|531532172|FG009|Part 2: Week 16 Onwards|Withdrawal by Subject|0|||
147373357|NCT02036970|531532163|FG000|Part 2: Week 16 Onwards|Progressive Disease|0|||
147373358|NCT02036970|531532164|FG001|Part 2: Week 16 Onwards|Progressive Disease|2|||
147373359|NCT02036970|531532165|FG002|Part 2: Week 16 Onwards|Progressive Disease|1|||
147373360|NCT02036970|531532166|FG003|Part 2: Week 16 Onwards|Progressive Disease|1|||
147373361|NCT02036970|531532167|FG004|Part 2: Week 16 Onwards|Progressive Disease|0|||
147373362|NCT02036970|531532168|FG005|Part 2: Week 16 Onwards|Progressive Disease|0|||
147373363|NCT02036970|531532169|FG006|Part 2: Week 16 Onwards|Progressive Disease|0|||
147373364|NCT02036970|531532170|FG007|Part 2: Week 16 Onwards|Progressive Disease|0|||
147373365|NCT02036970|531532171|FG008|Part 2: Week 16 Onwards|Progressive Disease|0|||
147373366|NCT02036970|531532172|FG009|Part 2: Week 16 Onwards|Progressive Disease|2|||
147373367|NCT01171898|531532177|FG000|Overall Study|Death|0|||
147373368|NCT01171898|531532178|FG001|Overall Study|Death|0|||
147373369|NCT01171898|531532179|FG002|Overall Study|Death|2|||
147373370|NCT01171898|531532180|FG003|Overall Study|Death|0|||
147373371|NCT01171898|531532177|FG000|Overall Study|Lost to Follow-up|0|||
147373372|NCT01171898|531532178|FG001|Overall Study|Lost to Follow-up|1|||
147373373|NCT01171898|531532179|FG002|Overall Study|Lost to Follow-up|1|||
147373374|NCT01171898|531532180|FG003|Overall Study|Lost to Follow-up|1|||
147373375|NCT01171898|531532177|FG000|Overall Study|Withdrawal by Subject|1|||
147373376|NCT01171898|531532178|FG001|Overall Study|Withdrawal by Subject|4|||
147373377|NCT01171898|531532179|FG002|Overall Study|Withdrawal by Subject|6|||
147373378|NCT01171898|531532180|FG003|Overall Study|Withdrawal by Subject|3|||
147373379|NCT01171898|531532177|FG000|Overall Study|Terminated by Sponsor|1|||
147373380|NCT01171898|531532178|FG001|Overall Study|Terminated by Sponsor|0|||
147373381|NCT01171898|531532179|FG002|Overall Study|Terminated by Sponsor|0|||
147373382|NCT01171898|531532180|FG003|Overall Study|Terminated by Sponsor|0|||
147373383|NCT01171898|531532177|FG000|Overall Study|Ongoing|1|||
147373384|NCT01171898|531532178|FG001|Overall Study|Ongoing|9|||
147373385|NCT01171898|531532179|FG002|Overall Study|Ongoing|3|||
147373386|NCT01171898|531532180|FG003|Overall Study|Ongoing|0|||
147373387|NCT01171898|531532177|FG000|Overall Study|Other|1|||
147373388|NCT01171898|531532178|FG001|Overall Study|Other|5|||
147373389|NCT01171898|531532179|FG002|Overall Study|Other|0|||
147373390|NCT01171898|531532180|FG003|Overall Study|Other|2|||
147373391|NCT05802173|531532181|FG000|Overall Study|Withdrawal by Subject|2|||
147373392|NCT05802173|531532182|FG001|Overall Study|Withdrawal by Subject|0|||
147373393|NCT05802173|531532183|FG002|Overall Study|Withdrawal by Subject|0|||
147373394|NCT05802173|531532181|FG000|Overall Study|Protocol Violation|1|||
147373395|NCT05802173|531532182|FG001|Overall Study|Protocol Violation|0|||
147373396|NCT05802173|531532183|FG002|Overall Study|Protocol Violation|0|||
147373397|NCT05802173|531532181|FG000|Overall Study|Lost to Follow-up|0|||
147373398|NCT05802173|531532182|FG001|Overall Study|Lost to Follow-up|6|||
147373399|NCT05802173|531532183|FG002|Overall Study|Lost to Follow-up|4|||
147373400|NCT05802173|531532181|FG000|Overall Study|non-compliance|0|||
147373401|NCT05802173|531532182|FG001|Overall Study|non-compliance|1|||
147373402|NCT05802173|531532183|FG002|Overall Study|non-compliance|0|||
147373403|NCT02932410|531532184|FG000|Overall Study|Death|7|||
147373404|NCT02932410|531532185|FG001|Overall Study|Death|6|||
147373405|NCT02932410|531532186|FG002|Overall Study|Death|0|||
147373406|NCT02932410|531532187|FG003|Overall Study|Death|0|||
147373407|NCT02932410|531532184|FG000|Overall Study|Lost to Follow-up|1|||
147373408|NCT02932410|531532185|FG001|Overall Study|Lost to Follow-up|2|||
147373409|NCT02932410|531532186|FG002|Overall Study|Lost to Follow-up|0|||
147373410|NCT02932410|531532187|FG003|Overall Study|Lost to Follow-up|0|||
147373411|NCT02932410|531532184|FG000|Overall Study|Parent/Subjects decision|6|||
147373412|NCT02932410|531532185|FG001|Overall Study|Parent/Subjects decision|6|||
147373413|NCT02932410|531532186|FG002|Overall Study|Parent/Subjects decision|1|||
147373414|NCT02932410|531532187|FG003|Overall Study|Parent/Subjects decision|0|||
147373415|NCT02932410|531532184|FG000|Overall Study|Physician Decision|0|||
147373416|NCT02932410|531532185|FG001|Overall Study|Physician Decision|1|||
147373417|NCT02932410|531532186|FG002|Overall Study|Physician Decision|0|||
147373418|NCT02932410|531532187|FG003|Overall Study|Physician Decision|0|||
147373419|NCT00360269|531532188|FG000|Overall Study|Lost to Follow-up|7|||
147373420|NCT00360269|531532189|FG001|Overall Study|Lost to Follow-up|9|||
147373421|NCT00360269|531532188|FG000|Overall Study|Physician Decision|1|||
147373422|NCT00360269|531532189|FG001|Overall Study|Physician Decision|2|||
147373423|NCT00360269|531532188|FG000|Overall Study|Adverse Event|1|||
147373424|NCT00360269|531532189|FG001|Overall Study|Adverse Event|0|||
147373425|NCT00360269|531532188|FG000|Overall Study|Withdrawal by Subject|1|||
147373426|NCT00360269|531532189|FG001|Overall Study|Withdrawal by Subject|1|||
147373427|NCT00048932|531532192|FG000|Double Blind Period (DB)|Administrative Reason By Sponsor|1|||
147373428|NCT00048932|531532193|FG001|Double Blind Period (DB)|Administrative Reason By Sponsor|0|||
147373429|NCT00048932|531532194|FG002|Double Blind Period (DB)|Administrative Reason By Sponsor|0|||
147373430|NCT00048932|531532192|FG000|Double Blind Period (DB)|Adverse Event|51|||
147373431|NCT00048932|531532193|FG001|Double Blind Period (DB)|Adverse Event|19|||
147373432|NCT00048932|531532194|FG002|Double Blind Period (DB)|Adverse Event|0|||
147373433|NCT00048932|531532192|FG000|Double Blind Period (DB)|Death|5|||
147373434|NCT00048932|531532193|FG001|Double Blind Period (DB)|Death|3|||
147373435|NCT00048932|531532194|FG002|Double Blind Period (DB)|Death|0|||
147373436|NCT00048932|531532192|FG000|Double Blind Period (DB)|Lack of Efficacy|26|||
147373437|NCT00048932|531532193|FG001|Double Blind Period (DB)|Lack of Efficacy|44|||
147373438|NCT00048932|531532194|FG002|Double Blind Period (DB)|Lack of Efficacy|0|||
147373439|NCT00048932|531532192|FG000|Double Blind Period (DB)|Lost to Follow-up|3|||
147373440|NCT00048932|531532193|FG001|Double Blind Period (DB)|Lost to Follow-up|4|||
147373441|NCT00048932|531532194|FG002|Double Blind Period (DB)|Lost to Follow-up|0|||
147373442|NCT00048932|531532192|FG000|Double Blind Period (DB)|Relocation|1|||
147373443|NCT00048932|531532193|FG001|Double Blind Period (DB)|Relocation|0|||
147373444|NCT00048932|531532194|FG002|Double Blind Period (DB)|Relocation|0|||
147373445|NCT00048932|531532192|FG000|Double Blind Period (DB)|Uncontrolled hypertension|0|||
147373446|NCT00048932|531532193|FG001|Double Blind Period (DB)|Uncontrolled hypertension|1|||
147373447|NCT00048932|531532194|FG002|Double Blind Period (DB)|Uncontrolled hypertension|0|||
147373448|NCT00048932|531532192|FG000|Double Blind Period (DB)|Missed 2 doses while undergoing work-up|1|||
147373449|NCT00048932|531532193|FG001|Double Blind Period (DB)|Missed 2 doses while undergoing work-up|0|||
147373450|NCT00048932|531532194|FG002|Double Blind Period (DB)|Missed 2 doses while undergoing work-up|0|||
147373451|NCT00048932|531532192|FG000|Double Blind Period (DB)|Pregnancy|1|||
147373452|NCT00048932|531532193|FG001|Double Blind Period (DB)|Pregnancy|0|||
147373453|NCT00048932|531532194|FG002|Double Blind Period (DB)|Pregnancy|0|||
147373454|NCT00048932|531532192|FG000|Double Blind Period (DB)|No Longer Meets Study Criteria|8|||
147373455|NCT00048932|531532193|FG001|Double Blind Period (DB)|No Longer Meets Study Criteria|2|||
147373456|NCT00048932|531532194|FG002|Double Blind Period (DB)|No Longer Meets Study Criteria|0|||
147373457|NCT00048932|531532192|FG000|Double Blind Period (DB)|Withdrawal by Subject|24|||
147373458|NCT00048932|531532193|FG001|Double Blind Period (DB)|Withdrawal by Subject|10|||
147373459|NCT00048932|531532194|FG002|Double Blind Period (DB)|Withdrawal by Subject|0|||
147373460|NCT00048932|531532192|FG000|Double Blind Period (DB)|Poor/Non-Compliance|2|||
147373461|NCT00048932|531532193|FG001|Double Blind Period (DB)|Poor/Non-Compliance|4|||
147373462|NCT00048932|531532194|FG002|Double Blind Period (DB)|Poor/Non-Compliance|0|||
147373463|NCT00048932|531532192|FG000|Open Label Period (OL)|Death|0|||
147373464|NCT00048932|531532193|FG001|Open Label Period (OL)|Death|0|||
147373465|NCT00048932|531532194|FG002|Open Label Period (OL)|Death|25|||
147373466|NCT00048932|531532192|FG000|Open Label Period (OL)|Adverse Event|0|||
147373467|NCT00048932|531532193|FG001|Open Label Period (OL)|Adverse Event|0|||
147373468|NCT00048932|531532194|FG002|Open Label Period (OL)|Adverse Event|103|||
147373469|NCT00048932|531532192|FG000|Open Label Period (OL)|Lack of Efficacy|0|||
147373470|NCT00048932|531532193|FG001|Open Label Period (OL)|Lack of Efficacy|0|||
147373471|NCT00048932|531532194|FG002|Open Label Period (OL)|Lack of Efficacy|81|||
147373472|NCT00048932|531532192|FG000|Open Label Period (OL)|Lost to Follow-up|0|||
147373473|NCT00048932|531532193|FG001|Open Label Period (OL)|Lost to Follow-up|0|||
147373474|NCT00048932|531532194|FG002|Open Label Period (OL)|Lost to Follow-up|27|||
147373475|NCT00048932|531532192|FG000|Open Label Period (OL)|Withdrawal by Subject|0|||
147373476|NCT00048932|531532193|FG001|Open Label Period (OL)|Withdrawal by Subject|0|||
147373477|NCT00048932|531532194|FG002|Open Label Period (OL)|Withdrawal by Subject|117|||
147373478|NCT00048932|531532192|FG000|Open Label Period (OL)|No Longer Meets Study Criteria|0|||
147373479|NCT00048932|531532193|FG001|Open Label Period (OL)|No Longer Meets Study Criteria|0|||
147373480|NCT00048932|531532194|FG002|Open Label Period (OL)|No Longer Meets Study Criteria|5|||
147373481|NCT00048932|531532192|FG000|Open Label Period (OL)|Poor/Non-Compliance|0|||
147373482|NCT00048932|531532193|FG001|Open Label Period (OL)|Poor/Non-Compliance|0|||
147373483|NCT00048932|531532194|FG002|Open Label Period (OL)|Poor/Non-Compliance|13|||
147373484|NCT00048932|531532192|FG000|Open Label Period (OL)|Pregnancy|0|||
147373485|NCT00048932|531532193|FG001|Open Label Period (OL)|Pregnancy|0|||
147373486|NCT00048932|531532194|FG002|Open Label Period (OL)|Pregnancy|6|||
147373487|NCT00048932|531532192|FG000|Open Label Period (OL)|Administrative Reason By Sponsor|0|||
147373488|NCT00048932|531532193|FG001|Open Label Period (OL)|Administrative Reason By Sponsor|0|||
147373489|NCT00048932|531532194|FG002|Open Label Period (OL)|Administrative Reason By Sponsor|20|||
147373490|NCT00048932|531532192|FG000|Open Label Period (OL)|Investigator Retiring|0|||
147373491|NCT00048932|531532193|FG001|Open Label Period (OL)|Investigator Retiring|0|||
147373492|NCT00048932|531532194|FG002|Open Label Period (OL)|Investigator Retiring|2|||
147373493|NCT00048932|531532192|FG000|Open Label Period (OL)|Participant Transportation Issues|0|||
147373494|NCT00048932|531532193|FG001|Open Label Period (OL)|Participant Transportation Issues|0|||
147373495|NCT00048932|531532194|FG002|Open Label Period (OL)|Participant Transportation Issues|1|||
147373496|NCT00048932|531532192|FG000|Open Label Period (OL)|Participant Relocated|0|||
147373497|NCT00048932|531532193|FG001|Open Label Period (OL)|Participant Relocated|0|||
147373498|NCT00048932|531532194|FG002|Open Label Period (OL)|Participant Relocated|6|||
147373499|NCT00048932|531532192|FG000|Open Label Period (OL)|Investigator Dosing the Trial|0|||
147373500|NCT00048932|531532193|FG001|Open Label Period (OL)|Investigator Dosing the Trial|0|||
147455282|NCT03467958|531827859|FG004|Overall Study|Study terminated by sponsor|66|||
147373501|NCT00048932|531532194|FG002|Open Label Period (OL)|Investigator Dosing the Trial|1|||
147373502|NCT00048932|531532192|FG000|Open Label Period (OL)|Site Closure|0|||
147373503|NCT00048932|531532193|FG001|Open Label Period (OL)|Site Closure|0|||
147611241|NCT01885195|532390998|FG000|Overall Study|Protocol Deviation|2|||
147611242|NCT01885195|532390998|FG000|Overall Study|Physician Decision|3|||
147611243|NCT01885195|532390998|FG000|Overall Study|Patient/guardian decision|8|||
147455283|NCT03467958|531827860|FG005|Overall Study|Study terminated by sponsor|17|||
147455284|NCT03467958|531827861|FG006|Overall Study|Study terminated by sponsor|11|||
147455285|NCT03467958|531827862|FG007|Overall Study|Study terminated by sponsor|5|||
147455286|NCT03467958|531827863|FG008|Overall Study|Study terminated by sponsor|5|||
147455287|NCT03467958|531827855|FG000|Overall Study|Withdrawal by Subject|25|||
147455288|NCT03467958|531827856|FG001|Overall Study|Withdrawal by Subject|44|||
147455289|NCT03467958|531827857|FG002|Overall Study|Withdrawal by Subject|7|||
147455290|NCT03467958|531827858|FG003|Overall Study|Withdrawal by Subject|8|||
147455291|NCT03467958|531827859|FG004|Overall Study|Withdrawal by Subject|6|||
147455292|NCT03467958|531827860|FG005|Overall Study|Withdrawal by Subject|8|||
147455293|NCT03467958|531827861|FG006|Overall Study|Withdrawal by Subject|4|||
147455294|NCT03467958|531827862|FG007|Overall Study|Withdrawal by Subject|1|||
147455295|NCT03467958|531827863|FG008|Overall Study|Withdrawal by Subject|4|||
147455296|NCT02925156|531827865|FG000|Overall Study|Lost to Follow-up|27|||
147664075|NCT03575702|532594428|FG000|Overall Study|Protocol Violation|0|||
147373504|NCT00048932|531532194|FG002|Open Label Period (OL)|Site Closure|3|||
147373505|NCT00048932|531532192|FG000|Open Label Period (OL)|Trial Terminated|0|||
147373506|NCT00048932|531532193|FG001|Open Label Period (OL)|Trial Terminated|0|||
147373507|NCT00048932|531532194|FG002|Open Label Period (OL)|Trial Terminated|1|||
147373508|NCT00048932|531532192|FG000|Open Label Period (OL)|Difficult IV Access with Participant|0|||
147373509|NCT00048932|531532193|FG001|Open Label Period (OL)|Difficult IV Access with Participant|0|||
147373510|NCT00048932|531532194|FG002|Open Label Period (OL)|Difficult IV Access with Participant|1|||
147373511|NCT00048932|531532192|FG000|Open Label Period (OL)|Patient Decision|0|||
147373512|NCT00048932|531532193|FG001|Open Label Period (OL)|Patient Decision|0|||
147373513|NCT00048932|531532194|FG002|Open Label Period (OL)|Patient Decision|4|||
147373514|NCT00048932|531532192|FG000|Open Label Period (OL)|Participant Received Wrong Medication|0|||
147373515|NCT00048932|531532193|FG001|Open Label Period (OL)|Participant Received Wrong Medication|0|||
147373516|NCT00048932|531532194|FG002|Open Label Period (OL)|Participant Received Wrong Medication|1|||
147373517|NCT00048932|531532192|FG000|Open Label Period (OL)|Participant Desires Pregnancy|0|||
147373518|NCT00048932|531532193|FG001|Open Label Period (OL)|Participant Desires Pregnancy|0|||
147373519|NCT00048932|531532194|FG002|Open Label Period (OL)|Participant Desires Pregnancy|2|||
147373520|NCT00048932|531532192|FG000|Open Label Period (OL)|Participant Missed Consecutive Doses|0|||
147373521|NCT00048932|531532193|FG001|Open Label Period (OL)|Participant Missed Consecutive Doses|0|||
147373522|NCT00048932|531532194|FG002|Open Label Period (OL)|Participant Missed Consecutive Doses|5|||
147373523|NCT00048932|531532192|FG000|Open Label Period (OL)|Medication Lost Efficacy|0|||
147373524|NCT00048932|531532193|FG001|Open Label Period (OL)|Medication Lost Efficacy|0|||
147373525|NCT00048932|531532194|FG002|Open Label Period (OL)|Medication Lost Efficacy|1|||
147373526|NCT00048932|531532192|FG000|Open Label Period (OL)|Investigator Decision|0|||
147373527|NCT00048932|531532193|FG001|Open Label Period (OL)|Investigator Decision|0|||
147373528|NCT00048932|531532194|FG002|Open Label Period (OL)|Investigator Decision|4|||
147373529|NCT00048932|531532192|FG000|Open Label Period (OL)|Site Staff Issues|0|||
147373530|NCT00048932|531532193|FG001|Open Label Period (OL)|Site Staff Issues|0|||
147373531|NCT00048932|531532194|FG002|Open Label Period (OL)|Site Staff Issues|2|||
147373532|NCT00048932|531532192|FG000|Open Label Period (OL)|Site Not Participating in Open Label|0|||
147373533|NCT00048932|531532193|FG001|Open Label Period (OL)|Site Not Participating in Open Label|0|||
147373534|NCT00048932|531532194|FG002|Open Label Period (OL)|Site Not Participating in Open Label|9|||
147373535|NCT00048932|531532192|FG000|Open Label Period (OL)|Participant Surgery|0|||
147373536|NCT00048932|531532193|FG001|Open Label Period (OL)|Participant Surgery|0|||
147373537|NCT00048932|531532194|FG002|Open Label Period (OL)|Participant Surgery|1|||
147373538|NCT02232737|531532195|FG000|Overall Study|Lost to Follow-up|18|||
147373539|NCT02232737|531532196|FG001|Overall Study|Lost to Follow-up|28|||
147373540|NCT02232737|531532197|FG002|Overall Study|Lost to Follow-up|33|||
147373541|NCT02232737|531532195|FG000|Overall Study|Personal reasons|7|||
147373542|NCT02232737|531532196|FG001|Overall Study|Personal reasons|8|||
147373543|NCT02232737|531532197|FG002|Overall Study|Personal reasons|14|||
147373544|NCT02232737|531532195|FG000|Overall Study|Adverse Event|6|||
147373545|NCT02232737|531532196|FG001|Overall Study|Adverse Event|3|||
147373546|NCT02232737|531532197|FG002|Overall Study|Adverse Event|8|||
147373547|NCT02232737|531532195|FG000|Overall Study|Incarcerated|2|||
147373548|NCT02232737|531532196|FG001|Overall Study|Incarcerated|1|||
147373549|NCT02232737|531532197|FG002|Overall Study|Incarcerated|2|||
147373550|NCT02232737|531532195|FG000|Overall Study|Withdrawal by Subject|0|||
147373551|NCT02232737|531532196|FG001|Overall Study|Withdrawal by Subject|1|||
147373552|NCT02232737|531532197|FG002|Overall Study|Withdrawal by Subject|2|||
147373553|NCT02232737|531532195|FG000|Overall Study|Death|0|||
147455297|NCT02925156|531827866|FG001|Overall Study|Lost to Follow-up|53|||
147455298|NCT02925156|531827867|FG002|Overall Study|Lost to Follow-up|51|||
147455299|NCT02925156|531827868|FG003|Overall Study|Lost to Follow-up|59|||
147455300|NCT02925156|531827869|FG004|Overall Study|Lost to Follow-up|89|||
147373554|NCT02232737|531532196|FG001|Overall Study|Death|1|||
147455301|NCT02925156|531827870|FG005|Overall Study|Lost to Follow-up|107|||
147455302|NCT02925156|531827871|FG006|Overall Study|Lost to Follow-up|34|||
147455303|NCT02925156|531827872|FG007|Overall Study|Lost to Follow-up|36|||
147611244|NCT01589497|532390999|FG000|Overall Study|Withdrawal by Subject|0|||
147373555|NCT02232737|531532197|FG002|Overall Study|Death|1|||
147373556|NCT02232737|531532195|FG000|Overall Study|Physician Decision|1|||
147373557|NCT02232737|531532196|FG001|Overall Study|Physician Decision|3|||
147373558|NCT02232737|531532197|FG002|Overall Study|Physician Decision|1|||
147373559|NCT02232737|531532195|FG000|Overall Study|Protocol Violation|1|||
147373560|NCT02232737|531532196|FG001|Overall Study|Protocol Violation|0|||
147373561|NCT02232737|531532197|FG002|Overall Study|Protocol Violation|1|||
147373562|NCT02232737|531532195|FG000|Overall Study|Reason unknown|1|||
147373563|NCT02232737|531532196|FG001|Overall Study|Reason unknown|0|||
147373564|NCT02232737|531532197|FG002|Overall Study|Reason unknown|0|||
147373565|NCT02200705|531532200|FG000|Overall Study|Excluded|12|||
147373566|NCT02200705|531532200|FG000|Overall Study|Death|21|||
147373567|NCT02200705|531532200|FG000|Overall Study|Withdrawal by Subject|22|||
147373568|NCT02200705|531532200|FG000|Overall Study|Lost to Follow-up|13|||
147373569|NCT02200705|531532200|FG000|Overall Study|Physician Decision|5|||
147373570|NCT02200705|531532200|FG000|Overall Study|Adverse Event|2|||
147373571|NCT03738228|531532202|FG000|Overall Study|Never received study treatment|2|||
147373572|NCT03738228|531532203|FG001|Overall Study|Never received study treatment|2|||
147373573|NCT02866942|531532204|FG000|Overall Study|Invalid consent|1|||
147373574|NCT06212752|531532205|FG000|Overall Study|Death|5|||
147373575|NCT06212752|531532206|FG001|Overall Study|Death|3|||
147373576|NCT06212752|531532205|FG000|Overall Study|Participants ongoing|23|||
147373577|NCT06212752|531532206|FG001|Overall Study|Participants ongoing|8|||
147373578|NCT04162210|531532207|FG000|Overall Study|Lost to Follow-up|4|||
147373579|NCT04162210|531532208|FG001|Overall Study|Lost to Follow-up|1|||
147373580|NCT04162210|531532207|FG000|Overall Study|Withdrawal by Subject|17|||
147373581|NCT04162210|531532208|FG001|Overall Study|Withdrawal by Subject|9|||
147373582|NCT04162210|531532207|FG000|Overall Study|Ongoing|113|||
147373583|NCT04162210|531532208|FG001|Overall Study|Ongoing|59|||
147373584|NCT01641900|531532209|FG000|Overall Study|Withdrawal by Subject|2|||
147373585|NCT01641900|531532210|FG001|Overall Study|Withdrawal by Subject|2|||
147373586|NCT02568215|531532211|FG000|Overall Study|Death|1|||
147373587|NCT02568215|531532212|FG001|Overall Study|Death|2|||
147373588|NCT02568215|531532213|FG002|Overall Study|Death|0|||
147373589|NCT02568215|531532211|FG000|Overall Study|Physician Decision|2|||
147373590|NCT02568215|531532212|FG001|Overall Study|Physician Decision|2|||
147373591|NCT02568215|531532213|FG002|Overall Study|Physician Decision|2|||
147373592|NCT02568215|531532211|FG000|Overall Study|Lost to Follow-up|29|||
147373593|NCT02568215|531532212|FG001|Overall Study|Lost to Follow-up|32|||
147373594|NCT02568215|531532213|FG002|Overall Study|Lost to Follow-up|41|||
147373595|NCT02568215|531532211|FG000|Overall Study|Withdrawal by Subject|21|||
147373596|NCT02568215|531532212|FG001|Overall Study|Withdrawal by Subject|19|||
147373597|NCT02568215|531532213|FG002|Overall Study|Withdrawal by Subject|22|||
147373598|NCT02568215|531532211|FG000|Overall Study|Protocol Violation|1|||
147373599|NCT02568215|531532212|FG001|Overall Study|Protocol Violation|1|||
147373600|NCT02568215|531532213|FG002|Overall Study|Protocol Violation|0|||
147611245|NCT01589497|532391000|FG001|Overall Study|Withdrawal by Subject|1|||
147611246|NCT01589497|532391001|FG002|Overall Study|Withdrawal by Subject|0|||
147611247|NCT01589497|532391002|FG003|Overall Study|Withdrawal by Subject|1|||
147611248|NCT01589497|532390999|FG000|Overall Study|Death|1|||
147611249|NCT01589497|532391000|FG001|Overall Study|Death|0|||
147611250|NCT01589497|532391001|FG002|Overall Study|Death|0|||
147611251|NCT01589497|532391002|FG003|Overall Study|Death|0|||
147611252|NCT01589497|532390999|FG000|Overall Study|Pre-entry overnight sputum< 10ML|0|||
147611253|NCT01589497|532391000|FG001|Overall Study|Pre-entry overnight sputum< 10ML|0|||
147611254|NCT01589497|532391001|FG002|Overall Study|Pre-entry overnight sputum< 10ML|1|||
147611255|NCT01589497|532391002|FG003|Overall Study|Pre-entry overnight sputum< 10ML|0|||
147611256|NCT03390426|532391003|FG000|Overall Study|Protocol Violation|0|||
147611257|NCT03390426|532391004|FG001|Overall Study|Protocol Violation|1|||
147611258|NCT03052127|532391007|FG000|Overall Study|Withdrawal by Subject|0|||
147611259|NCT03052127|532391008|FG001|Overall Study|Withdrawal by Subject|0|||
147611260|NCT03052127|532391009|FG002|Overall Study|Withdrawal by Subject|0|||
147373601|NCT02568215|531532211|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|25|||
147373602|NCT02568215|531532212|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|23|||
147373603|NCT02568215|531532213|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|21|||
147373604|NCT02568215|531532211|FG000|Overall Study|Other|0|||
147373605|NCT02568215|531532212|FG001|Overall Study|Other|1|||
147373606|NCT02568215|531532213|FG002|Overall Study|Other|4|||
147373607|NCT00371345|531532214|FG000|Overall Study|Disease Progression|21|||
147373608|NCT00371345|531532215|FG001|Overall Study|Disease Progression|35|||
147373609|NCT00371345|531532214|FG000|Overall Study|Study Drug Toxicity|1|||
147373610|NCT00371345|531532215|FG001|Overall Study|Study Drug Toxicity|7|||
147373611|NCT00371345|531532214|FG000|Overall Study|Adverse event(AE Unrelated to Study Drug|1|||
147611261|NCT03052127|532391010|FG003|Overall Study|Withdrawal by Subject|0|||
147611262|NCT03052127|532391011|FG004|Overall Study|Withdrawal by Subject|0|||
147611263|NCT03052127|532391012|FG005|Overall Study|Withdrawal by Subject|0|||
147611264|NCT03052127|532391013|FG006|Overall Study|Withdrawal by Subject|0|||
147611265|NCT03052127|532391014|FG007|Overall Study|Withdrawal by Subject|1|||
147664076|NCT03575702|532594429|FG001|Overall Study|Protocol Violation|1|||
147664077|NCT03575702|532594428|FG000|Overall Study|Patient non compliance|4|||
147664078|NCT03575702|532594429|FG001|Overall Study|Patient non compliance|0|||
147664079|NCT03903172|532594430|FG000|Overall Study|screen fail|4|||
147664080|NCT03903172|532594431|FG001|Overall Study|screen fail|1|||
147664081|NCT01545388|532594432|FG000|Overall Study|Adverse Event|2|||
147664082|NCT01545388|532594433|FG001|Overall Study|Adverse Event|4|||
147664083|NCT01545388|532594434|FG002|Overall Study|Adverse Event|1|||
147664084|NCT01545388|532594432|FG000|Overall Study|Lack of Efficacy|3|||
147664085|NCT01545388|532594433|FG001|Overall Study|Lack of Efficacy|2|||
147664086|NCT01545388|532594434|FG002|Overall Study|Lack of Efficacy|5|||
147664087|NCT01545388|532594432|FG000|Overall Study|Participant moved or relocated|1|||
147664088|NCT01545388|532594433|FG001|Overall Study|Participant moved or relocated|0|||
147664089|NCT01545388|532594434|FG002|Overall Study|Participant moved or relocated|0|||
147664090|NCT01545388|532594432|FG000|Overall Study|Withdrawal by Subject|1|||
147664091|NCT01545388|532594433|FG001|Overall Study|Withdrawal by Subject|4|||
147664092|NCT01545388|532594434|FG002|Overall Study|Withdrawal by Subject|2|||
147664093|NCT01545388|532594432|FG000|Overall Study|Other|1|||
147664094|NCT01545388|532594433|FG001|Overall Study|Other|1|||
147664095|NCT01545388|532594434|FG002|Overall Study|Other|0|||
147664096|NCT01900444|532594435|FG000|Overall Study|Protocol Violation|2|||
147664097|NCT01900444|532594435|FG000|Overall Study|Lost to Follow-up|1|||
147664098|NCT00072384|532594436|FG000|Overall Study|Physician Decision|1|||
147664099|NCT00072384|532594436|FG000|Overall Study|Ineligible|8|||
147664100|NCT01825200|532594437|FG000|Overall Study|Lost to Follow-up|5|||
147664101|NCT01825200|532594438|FG001|Overall Study|Lost to Follow-up|6|||
147664102|NCT01825200|532594437|FG000|Overall Study|Withdrawal by Subject|0|||
147664103|NCT01825200|532594438|FG001|Overall Study|Withdrawal by Subject|1|||
147664104|NCT01255163|532594439|FG000|Overall Study|Withdrawal by Subject|1|||
147664105|NCT01255163|532594440|FG001|Overall Study|Withdrawal by Subject|0|||
147664106|NCT01255163|532594439|FG000|Overall Study|Lost to Follow-up|2|||
147664107|NCT01255163|532594440|FG001|Overall Study|Lost to Follow-up|0|||
147373612|NCT00371345|531532215|FG001|Overall Study|Adverse event(AE Unrelated to Study Drug|2|||
147373613|NCT00371345|531532214|FG000|Overall Study|Participant Request|1|||
147373614|NCT00371345|531532215|FG001|Overall Study|Participant Request|1|||
147373615|NCT00371345|531532214|FG000|Overall Study|Participant Withdrew Consent|0|||
147373616|NCT00371345|531532215|FG001|Overall Study|Participant Withdrew Consent|1|||
147664108|NCT01255163|532594439|FG000|Overall Study|Adverse Event|0|||
147664109|NCT01255163|532594440|FG001|Overall Study|Adverse Event|2|||
147664110|NCT01255163|532594439|FG000|Overall Study|AstraZeneca stopped support of the study|1|||
147664111|NCT01255163|532594440|FG001|Overall Study|AstraZeneca stopped support of the study|3|||
147664112|NCT00490035|532594441|FG000|Overall Study|AE, non-serious non-fatal|3|||
147373617|NCT02463448|531532219|FG000|Enrollment Through 6 Months|Withdrawal by Subject|3|||
147373618|NCT02463448|531532219|FG000|6 Months Through 12 Months|Lost to Follow-up|1|||
147373619|NCT02463448|531532219|FG000|6 Months Through 12 Months|Withdrawal by Subject|1|||
147373620|NCT02463448|531532219|FG000|12 Months Through End of Study|Lost to Follow-up|1|||
147373621|NCT01640951|531532220|FG000|Overall Study|Adverse Event|8|||
147373622|NCT01640951|531532221|FG001|Overall Study|Adverse Event|3|||
147373623|NCT01640951|531532222|FG002|Overall Study|Adverse Event|10|||
147373624|NCT01640951|531532223|FG003|Overall Study|Adverse Event|6|||
147373625|NCT01640951|531532224|FG004|Overall Study|Adverse Event|1|||
147373626|NCT01640951|531532225|FG005|Overall Study|Adverse Event|11|||
147373627|NCT01640951|531532226|FG006|Overall Study|Adverse Event|1|||
147373628|NCT01640951|531532227|FG007|Overall Study|Adverse Event|3|||
147373629|NCT01640951|531532220|FG000|Overall Study|Lack of Efficacy|20|||
147373630|NCT01640951|531532221|FG001|Overall Study|Lack of Efficacy|1|||
147373631|NCT01640951|531532222|FG002|Overall Study|Lack of Efficacy|7|||
147373632|NCT01640951|531532223|FG003|Overall Study|Lack of Efficacy|14|||
147373633|NCT01640951|531532224|FG004|Overall Study|Lack of Efficacy|0|||
147373634|NCT01640951|531532225|FG005|Overall Study|Lack of Efficacy|6|||
147373635|NCT01640951|531532226|FG006|Overall Study|Lack of Efficacy|5|||
147373636|NCT01640951|531532227|FG007|Overall Study|Lack of Efficacy|6|||
147373637|NCT01640951|531532220|FG000|Overall Study|Lost to Follow-up|1|||
147373638|NCT01640951|531532221|FG001|Overall Study|Lost to Follow-up|0|||
147664113|NCT00490035|532594442|FG001|Overall Study|AE, non-serious non-fatal|4|||
147664114|NCT00490035|532594443|FG002|Overall Study|AE, non-serious non-fatal|4|||
147664115|NCT00490035|532594444|FG003|Overall Study|AE, non-serious non-fatal|5|||
147664116|NCT00490035|532594441|FG000|Overall Study|Lost to Follow-up|2|||
147664117|NCT00490035|532594442|FG001|Overall Study|Lost to Follow-up|0|||
147664118|NCT00490035|532594443|FG002|Overall Study|Lost to Follow-up|1|||
147664119|NCT00490035|532594444|FG003|Overall Study|Lost to Follow-up|0|||
147664120|NCT00490035|532594441|FG000|Overall Study|Withdrawal by Subject|2|||
147664121|NCT00490035|532594442|FG001|Overall Study|Withdrawal by Subject|1|||
147373639|NCT01640951|531532222|FG002|Overall Study|Lost to Follow-up|6|||
147373640|NCT01640951|531532223|FG003|Overall Study|Lost to Follow-up|2|||
147455304|NCT02925156|531827873|FG008|Overall Study|Lost to Follow-up|73|||
147455305|NCT02925156|531827874|FG009|Overall Study|Lost to Follow-up|34|||
147664122|NCT00490035|532594443|FG002|Overall Study|Withdrawal by Subject|1|||
147664123|NCT00490035|532594444|FG003|Overall Study|Withdrawal by Subject|0|||
147664124|NCT00490035|532594441|FG000|Overall Study|Other reason|0|||
147664125|NCT00490035|532594442|FG001|Overall Study|Other reason|1|||
147664126|NCT00490035|532594443|FG002|Overall Study|Other reason|3|||
147664127|NCT00490035|532594444|FG003|Overall Study|Other reason|1|||
147664128|NCT00490035|532594441|FG000|Overall Study|AE, serious fatal|1|||
147664129|NCT00490035|532594442|FG001|Overall Study|AE, serious fatal|0|||
147664130|NCT00490035|532594443|FG002|Overall Study|AE, serious fatal|0|||
147664131|NCT00490035|532594444|FG003|Overall Study|AE, serious fatal|0|||
147664132|NCT00490035|532594441|FG000|Overall Study|Serious adverse event (SAE), non-fatal|0|||
147664133|NCT00490035|532594442|FG001|Overall Study|Serious adverse event (SAE), non-fatal|0|||
147664134|NCT00490035|532594443|FG002|Overall Study|Serious adverse event (SAE), non-fatal|1|||
147664135|NCT00490035|532594444|FG003|Overall Study|Serious adverse event (SAE), non-fatal|0|||
147664136|NCT00490035|532594441|FG000|Overall Study|AE of unknown type|0|||
147664137|NCT00490035|532594442|FG001|Overall Study|AE of unknown type|0|||
147664138|NCT00490035|532594443|FG002|Overall Study|AE of unknown type|2|||
147664139|NCT00490035|532594444|FG003|Overall Study|AE of unknown type|0|||
147664140|NCT06058390|532594445|FG000|Overall Study|Lost to Follow-up|0|||
147664141|NCT06058390|532594446|FG001|Overall Study|Lost to Follow-up|0|||
147664142|NCT06058390|532594447|FG002|Overall Study|Lost to Follow-up|2|||
147664143|NCT06058390|532594448|FG003|Overall Study|Lost to Follow-up|1|||
147664144|NCT06058390|532594445|FG000|Overall Study|Physician Decision|0|||
147373641|NCT01640951|531532224|FG004|Overall Study|Lost to Follow-up|2|||
147373642|NCT01640951|531532225|FG005|Overall Study|Lost to Follow-up|3|||
147373643|NCT01640951|531532226|FG006|Overall Study|Lost to Follow-up|1|||
147373644|NCT01640951|531532227|FG007|Overall Study|Lost to Follow-up|1|||
147373645|NCT01640951|531532220|FG000|Overall Study|Non-compliance with study treatment|0|||
147373646|NCT01640951|531532221|FG001|Overall Study|Non-compliance with study treatment|0|||
147373647|NCT01640951|531532222|FG002|Overall Study|Non-compliance with study treatment|1|||
147373648|NCT01640951|531532223|FG003|Overall Study|Non-compliance with study treatment|1|||
147373649|NCT01640951|531532224|FG004|Overall Study|Non-compliance with study treatment|1|||
147373650|NCT01640951|531532225|FG005|Overall Study|Non-compliance with study treatment|4|||
147373651|NCT01640951|531532226|FG006|Overall Study|Non-compliance with study treatment|1|||
147373652|NCT01640951|531532227|FG007|Overall Study|Non-compliance with study treatment|0|||
147373653|NCT01640951|531532220|FG000|Overall Study|Physician Decision|2|||
147373654|NCT01640951|531532221|FG001|Overall Study|Physician Decision|5|||
147373655|NCT01640951|531532222|FG002|Overall Study|Physician Decision|2|||
147373656|NCT01640951|531532223|FG003|Overall Study|Physician Decision|2|||
147373657|NCT01640951|531532224|FG004|Overall Study|Physician Decision|2|||
147373658|NCT01640951|531532225|FG005|Overall Study|Physician Decision|3|||
147373659|NCT01640951|531532226|FG006|Overall Study|Physician Decision|3|||
147373660|NCT01640951|531532227|FG007|Overall Study|Physician Decision|0|||
147373661|NCT01640951|531532220|FG000|Overall Study|Pregnancy|3|||
147373662|NCT01640951|531532221|FG001|Overall Study|Pregnancy|0|||
147373663|NCT01640951|531532222|FG002|Overall Study|Pregnancy|0|||
147373664|NCT01640951|531532223|FG003|Overall Study|Pregnancy|4|||
147373665|NCT01640951|531532224|FG004|Overall Study|Pregnancy|0|||
147373666|NCT01640951|531532225|FG005|Overall Study|Pregnancy|0|||
147373667|NCT01640951|531532226|FG006|Overall Study|Pregnancy|2|||
147373668|NCT01640951|531532227|FG007|Overall Study|Pregnancy|0|||
147373669|NCT01640951|531532220|FG000|Overall Study|Protocol Deviation|0|||
147373670|NCT01640951|531532221|FG001|Overall Study|Protocol Deviation|1|||
147373671|NCT01640951|531532222|FG002|Overall Study|Protocol Deviation|2|||
147373672|NCT01640951|531532223|FG003|Overall Study|Protocol Deviation|1|||
147455306|NCT00866307|531827875|FG000|Induction|Adverse Event|5|||
147455307|NCT00866307|531827876|FG001|Induction|Adverse Event|0|||
147455308|NCT00866307|531827877|FG002|Induction|Adverse Event|0|||
147455309|NCT00866307|531827875|FG000|Induction|Death|2|||
147455310|NCT00866307|531827876|FG001|Induction|Death|0|||
147373673|NCT01640951|531532224|FG004|Overall Study|Protocol Deviation|0|||
147373674|NCT01640951|531532225|FG005|Overall Study|Protocol Deviation|1|||
147373675|NCT01640951|531532226|FG006|Overall Study|Protocol Deviation|0|||
147455311|NCT00866307|531827877|FG002|Induction|Death|0|||
147455312|NCT00866307|531827875|FG000|Induction|Physician Decision|5|||
147455313|NCT00866307|531827876|FG001|Induction|Physician Decision|0|||
147664145|NCT06058390|532594446|FG001|Overall Study|Physician Decision|0|||
147664146|NCT06058390|532594447|FG002|Overall Study|Physician Decision|0|||
147664147|NCT06058390|532594448|FG003|Overall Study|Physician Decision|1|||
147664148|NCT06058390|532594445|FG000|Overall Study|Participants did not receive any study intervention|0|||
147664149|NCT06058390|532594446|FG001|Overall Study|Participants did not receive any study intervention|0|||
147664150|NCT06058390|532594447|FG002|Overall Study|Participants did not receive any study intervention|0|||
147664151|NCT06058390|532594448|FG003|Overall Study|Participants did not receive any study intervention|1|||
147664152|NCT02495389|532594449|FG000|Overall Study|Withdrawal by Subject|40|||
147373676|NCT01640951|531532227|FG007|Overall Study|Protocol Deviation|0|||
147373677|NCT01640951|531532220|FG000|Overall Study|Subject/Guardian decision|12|||
147455314|NCT00866307|531827877|FG002|Induction|Physician Decision|0|||
147664153|NCT01802385|532594453|FG000|Overall Study|Death|106|||
147455315|NCT00866307|531827875|FG000|Induction|Progressive Disease|1|||
147455316|NCT00866307|531827876|FG001|Induction|Progressive Disease|0|||
147373678|NCT01640951|531532221|FG001|Overall Study|Subject/Guardian decision|4|||
147373679|NCT01640951|531532222|FG002|Overall Study|Subject/Guardian decision|13|||
147373680|NCT01640951|531532223|FG003|Overall Study|Subject/Guardian decision|15|||
147373681|NCT01640951|531532224|FG004|Overall Study|Subject/Guardian decision|7|||
147373682|NCT01640951|531532225|FG005|Overall Study|Subject/Guardian decision|19|||
147373683|NCT01640951|531532226|FG006|Overall Study|Subject/Guardian decision|5|||
147373684|NCT01640951|531532227|FG007|Overall Study|Subject/Guardian decision|4|||
147373685|NCT01640951|531532220|FG000|Overall Study|Death|0|||
147373686|NCT01640951|531532221|FG001|Overall Study|Death|1|||
147373687|NCT01640951|531532222|FG002|Overall Study|Death|1|||
147373688|NCT01640951|531532223|FG003|Overall Study|Death|0|||
147455317|NCT00866307|531827877|FG002|Induction|Progressive Disease|0|||
147455318|NCT00866307|531827875|FG000|Induction|Identification of Patients with Day 29 M|3|||
147611266|NCT03052127|532391015|FG008|Overall Study|Withdrawal by Subject|1|||
147373689|NCT01640951|531532224|FG004|Overall Study|Death|0|||
147373690|NCT01640951|531532225|FG005|Overall Study|Death|0|||
147373691|NCT01640951|531532226|FG006|Overall Study|Death|0|||
147373692|NCT01640951|531532227|FG007|Overall Study|Death|2|||
147373693|NCT04949542|531532228|FG000|Overall Study|Lost to Follow-up|4|||
147373694|NCT04949542|531532229|FG001|Overall Study|Lost to Follow-up|1|||
147373695|NCT01536093|531532230|FG000|Overall Study|Death|1|||
147373696|NCT01536093|531532231|FG001|Overall Study|Death|2|||
147373697|NCT01536093|531532230|FG000|Overall Study|absence of maternal colostrum|2|||
147373698|NCT01536093|531532231|FG001|Overall Study|absence of maternal colostrum|0|||
147373699|NCT01536093|531532230|FG000|Overall Study|Withdrawal by Subject|0|||
147373700|NCT01536093|531532231|FG001|Overall Study|Withdrawal by Subject|1|||
147373701|NCT02365597|531532232|FG000|Overall Study|Lost to Follow-up|0|||
147373702|NCT02365597|531532233|FG001|Overall Study|Lost to Follow-up|1|||
147373703|NCT02365597|531532234|FG002|Overall Study|Lost to Follow-up|0|||
147373704|NCT02365597|531532235|FG003|Overall Study|Lost to Follow-up|1|||
147373705|NCT02365597|531532232|FG000|Overall Study|Withdrawal by Subject|1|||
147373706|NCT02365597|531532233|FG001|Overall Study|Withdrawal by Subject|8|||
147373707|NCT02365597|531532234|FG002|Overall Study|Withdrawal by Subject|5|||
147373708|NCT02365597|531532235|FG003|Overall Study|Withdrawal by Subject|1|||
147373709|NCT02365597|531532232|FG000|Overall Study|Sponsor's decision|1|||
147373710|NCT02365597|531532233|FG001|Overall Study|Sponsor's decision|3|||
147373711|NCT02365597|531532234|FG002|Overall Study|Sponsor's decision|13|||
147373712|NCT02365597|531532235|FG003|Overall Study|Sponsor's decision|0|||
147373713|NCT02365597|531532232|FG000|Overall Study|Other|0|||
147373714|NCT02365597|531532233|FG001|Overall Study|Other|4|||
147373715|NCT02365597|531532234|FG002|Overall Study|Other|0|||
147373716|NCT02365597|531532235|FG003|Overall Study|Other|0|||
147373717|NCT02365597|531532232|FG000|Overall Study|Enrolled but not treated|0|||
147373718|NCT02365597|531532233|FG001|Overall Study|Enrolled but not treated|1|||
147373719|NCT02365597|531532234|FG002|Overall Study|Enrolled but not treated|1|||
147373720|NCT02365597|531532235|FG003|Overall Study|Enrolled but not treated|0|||
147373721|NCT02365597|531532232|FG000|Overall Study|Ongoing|0|||
147373722|NCT02365597|531532233|FG001|Overall Study|Ongoing|0|||
147373723|NCT02365597|531532234|FG002|Overall Study|Ongoing|0|||
147373724|NCT02365597|531532235|FG003|Overall Study|Ongoing|17|||
147373725|NCT02275611|531532236|FG000|Inpatient Withdrawal|Withdrawal by Subject|1|||
147373726|NCT02275611|531532237|FG001|Inpatient Withdrawal|Withdrawal by Subject|0|||
147373727|NCT02275611|531532238|FG002|Inpatient Withdrawal|Withdrawal by Subject|0|||
147373728|NCT02275611|531532239|FG003|Inpatient Withdrawal|Withdrawal by Subject|0|||
147373729|NCT00390884|531532247|FG000|Overall Study|Withdrawal by Subject|2|||
147373730|NCT00390884|531532248|FG001|Overall Study|Withdrawal by Subject|2|||
147373731|NCT04622332|531532249|FG000|Overall Study|Withdrawal by Subject|4|||
147373732|NCT04622332|531532250|FG001|Overall Study|Withdrawal by Subject|2|||
147611267|NCT03052127|532391016|FG009|Overall Study|Withdrawal by Subject|1|||
147611268|NCT03052127|532391017|FG010|Overall Study|Withdrawal by Subject|0|||
147373733|NCT04622332|531532249|FG000|Overall Study|Physician Decision|1|||
147373734|NCT04622332|531532250|FG001|Overall Study|Physician Decision|1|||
147373735|NCT04622332|531532249|FG000|Overall Study|Adverse Event|0|||
147373736|NCT04622332|531532250|FG001|Overall Study|Adverse Event|2|||
147373737|NCT04622332|531532249|FG000|Overall Study|Protocol Violation|0|||
147373738|NCT04622332|531532250|FG001|Overall Study|Protocol Violation|1|||
147373739|NCT05966155|531532251|FG000|Overall Study|Death|1|||
147373740|NCT05966155|531532252|FG001|Overall Study|Death|2|||
147373741|NCT05966155|531532251|FG000|Overall Study|Lost to Follow-up|63|||
147373742|NCT05966155|531532252|FG001|Overall Study|Lost to Follow-up|67|||
147373743|NCT05966155|531532251|FG000|Overall Study|Protocol Violation|1|||
147373744|NCT05966155|531532252|FG001|Overall Study|Protocol Violation|0|||
147373745|NCT05966155|531532251|FG000|Overall Study|Withdrawal by Subject|8|||
147373746|NCT05966155|531532252|FG001|Overall Study|Withdrawal by Subject|9|||
147373747|NCT05966155|531532251|FG000|Overall Study|Enrolled Erroneously|0|||
147373748|NCT05966155|531532252|FG001|Overall Study|Enrolled Erroneously|1|||
147373749|NCT05966155|531532251|FG000|Overall Study|Follow-up Incorrectly Scheduled|0|||
147373750|NCT05966155|531532252|FG001|Overall Study|Follow-up Incorrectly Scheduled|1|||
147455319|NCT00866307|531827876|FG001|Induction|Identification of Patients with Day 29 M|0|||
147373751|NCT05036278|531532255|FG000|Overall Study|Withdrawal by Subject|1|||
147373752|NCT05036278|531532255|FG000|Overall Study|Adverse Event|1|||
147373753|NCT01946204|531532260|FG000|Overall Study|Death|38|||
147373754|NCT01946204|531532261|FG001|Overall Study|Death|59|||
147373755|NCT01946204|531532260|FG000|Overall Study|Withdrawal by Subject|37|||
147373756|NCT01946204|531532261|FG001|Overall Study|Withdrawal by Subject|50|||
147373757|NCT01946204|531532260|FG000|Overall Study|Lost to Follow-up|3|||
147373758|NCT01946204|531532261|FG001|Overall Study|Lost to Follow-up|7|||
147373759|NCT01946204|531532260|FG000|Overall Study|Ongoing|316|||
147373760|NCT01946204|531532261|FG001|Overall Study|Ongoing|687|||
147373761|NCT01946204|531532260|FG000|Overall Study|Other|7|||
147373762|NCT01946204|531532261|FG001|Overall Study|Other|3|||
147373763|NCT03466411|531532262|FG000|Overall Study|Lost to Follow-up|0|||
147373764|NCT03466411|531532263|FG001|Overall Study|Lost to Follow-up|1|||
147373765|NCT03466411|531532264|FG002|Overall Study|Lost to Follow-up|1|||
147373766|NCT03466411|531532265|FG003|Overall Study|Lost to Follow-up|0|||
147373767|NCT03466411|531532266|FG004|Overall Study|Lost to Follow-up|0|||
147373768|NCT03466411|531532267|FG005|Overall Study|Lost to Follow-up|0|||
147373769|NCT03466411|531532268|FG006|Overall Study|Lost to Follow-up|1|||
147373770|NCT03466411|531532269|FG007|Overall Study|Lost to Follow-up|1|||
147373771|NCT03466411|531532270|FG008|Overall Study|Lost to Follow-up|0|||
147373772|NCT03466411|531532271|FG009|Overall Study|Lost to Follow-up|1|||
147373773|NCT03466411|531532272|FG010|Overall Study|Lost to Follow-up|1|||
147373774|NCT03466411|531532273|FG011|Overall Study|Lost to Follow-up|1|||
147373775|NCT03466411|531532274|FG012|Overall Study|Lost to Follow-up|0|||
147373776|NCT03466411|531532262|FG000|Overall Study|Withdrawal by Subject|14|||
147373777|NCT03466411|531532263|FG001|Overall Study|Withdrawal by Subject|7|||
147373778|NCT03466411|531532264|FG002|Overall Study|Withdrawal by Subject|8|||
147373779|NCT03466411|531532265|FG003|Overall Study|Withdrawal by Subject|4|||
147373780|NCT03466411|531532266|FG004|Overall Study|Withdrawal by Subject|6|||
147373781|NCT03466411|531532267|FG005|Overall Study|Withdrawal by Subject|3|||
147373782|NCT03466411|531532268|FG006|Overall Study|Withdrawal by Subject|6|||
147373783|NCT03466411|531532269|FG007|Overall Study|Withdrawal by Subject|9|||
147373784|NCT03466411|531532270|FG008|Overall Study|Withdrawal by Subject|6|||
147373785|NCT03466411|531532271|FG009|Overall Study|Withdrawal by Subject|11|||
147373786|NCT03466411|531532272|FG010|Overall Study|Withdrawal by Subject|14|||
147373787|NCT03466411|531532273|FG011|Overall Study|Withdrawal by Subject|12|||
147373788|NCT03466411|531532274|FG012|Overall Study|Withdrawal by Subject|7|||
147373789|NCT03466411|531532262|FG000|Overall Study|Other|1|||
147373790|NCT03466411|531532263|FG001|Overall Study|Other|1|||
147373791|NCT03466411|531532264|FG002|Overall Study|Other|0|||
147373792|NCT03466411|531532265|FG003|Overall Study|Other|1|||
147373793|NCT03466411|531532266|FG004|Overall Study|Other|2|||
147373794|NCT03466411|531532267|FG005|Overall Study|Other|0|||
147373795|NCT03466411|531532268|FG006|Overall Study|Other|0|||
147373796|NCT03466411|531532269|FG007|Overall Study|Other|0|||
147373797|NCT03466411|531532270|FG008|Overall Study|Other|0|||
147373798|NCT03466411|531532271|FG009|Overall Study|Other|1|||
147373799|NCT03466411|531532272|FG010|Overall Study|Other|2|||
147373800|NCT03466411|531532273|FG011|Overall Study|Other|0|||
147373801|NCT03466411|531532274|FG012|Overall Study|Other|0|||
147373802|NCT03466411|531532262|FG000|Overall Study|Randomized but not Treated|0|||
147373803|NCT03466411|531532263|FG001|Overall Study|Randomized but not Treated|0|||
147373804|NCT03466411|531532264|FG002|Overall Study|Randomized but not Treated|0|||
147373805|NCT03466411|531532265|FG003|Overall Study|Randomized but not Treated|0|||
147373806|NCT03466411|531532266|FG004|Overall Study|Randomized but not Treated|0|||
147373807|NCT03466411|531532267|FG005|Overall Study|Randomized but not Treated|0|||
147373808|NCT03466411|531532268|FG006|Overall Study|Randomized but not Treated|1|||
147373809|NCT03466411|531532269|FG007|Overall Study|Randomized but not Treated|0|||
147373810|NCT03466411|531532270|FG008|Overall Study|Randomized but not Treated|0|||
147611269|NCT03052127|532391018|FG011|Overall Study|Withdrawal by Subject|0|||
147611270|NCT03052127|532391007|FG000|Overall Study|Discontinuation by Sponsor|0|||
147611271|NCT03052127|532391008|FG001|Overall Study|Discontinuation by Sponsor|0|||
147373811|NCT03466411|531532271|FG009|Overall Study|Randomized but not Treated|0|||
147373812|NCT03466411|531532272|FG010|Overall Study|Randomized but not Treated|0|||
147373813|NCT03466411|531532273|FG011|Overall Study|Randomized but not Treated|0|||
147373814|NCT03466411|531532274|FG012|Overall Study|Randomized but not Treated|0|||
147373815|NCT00274261|531532287|FG000|Overall Study|Adverse Event|19|||
147373816|NCT00274261|531532288|FG001|Overall Study|Adverse Event|11|||
147373817|NCT00274261|531532287|FG000|Overall Study|Pregnancy|114|||
147373818|NCT00274261|531532288|FG001|Overall Study|Pregnancy|83|||
147373819|NCT00274261|531532287|FG000|Overall Study|Withdrawal by Subject|179|||
147373820|NCT00274261|531532288|FG001|Overall Study|Withdrawal by Subject|126|||
147611272|NCT03052127|532391009|FG002|Overall Study|Discontinuation by Sponsor|0|||
147611273|NCT03052127|532391010|FG003|Overall Study|Discontinuation by Sponsor|0|||
147373821|NCT00274261|531532287|FG000|Overall Study|Protocol Violation|71|||
147373822|NCT00274261|531532288|FG001|Overall Study|Protocol Violation|42|||
147373823|NCT00274261|531532287|FG000|Overall Study|Lost to Follow-up|106|||
147373824|NCT00274261|531532288|FG001|Overall Study|Lost to Follow-up|75|||
147373825|NCT03582475|531532289|FG000|Treatment Period|Withdrawal by Subject|0|||
147664154|NCT01802385|532594454|FG001|Overall Study|Death|120|||
147664155|NCT05559905|532594455|FG000|Overall Study|Withdrawal by Subject|1|||
147664156|NCT05559905|532594456|FG001|Overall Study|Withdrawal by Subject|0|||
147664157|NCT05559905|532594457|FG002|Overall Study|Withdrawal by Subject|0|||
147664158|NCT05559905|532594455|FG000|Overall Study|Not Reported|1|||
147664159|NCT05559905|532594456|FG001|Overall Study|Not Reported|0|||
147664160|NCT05559905|532594457|FG002|Overall Study|Not Reported|0|||
147373826|NCT03582475|531532290|FG001|Treatment Period|Withdrawal by Subject|1|||
147373827|NCT03582475|531532289|FG000|Follow-up Period|Withdrawal by Subject|0|||
147373828|NCT03582475|531532290|FG001|Follow-up Period|Withdrawal by Subject|1|||
147373829|NCT02257736|531532291|FG000|Overall Study|Progressive disease|365|||
147373830|NCT02257736|531532292|FG001|Overall Study|Progressive disease|327|||
147373831|NCT02257736|531532291|FG000|Overall Study|Adverse Event|45|||
147373832|NCT02257736|531532292|FG001|Overall Study|Adverse Event|56|||
147373833|NCT02257736|531532291|FG000|Overall Study|Withdrawal by Subject|21|||
147373834|NCT02257736|531532292|FG001|Overall Study|Withdrawal by Subject|38|||
147373835|NCT02257736|531532291|FG000|Overall Study|Death|11|||
147373836|NCT02257736|531532292|FG001|Overall Study|Death|6|||
147373837|NCT02257736|531532291|FG000|Overall Study|Physician Decision|5|||
147373838|NCT02257736|531532292|FG001|Overall Study|Physician Decision|9|||
147373839|NCT02257736|531532291|FG000|Overall Study|Non-Compliance with study drug|1|||
147373840|NCT02257736|531532292|FG001|Overall Study|Non-Compliance with study drug|2|||
147373841|NCT02257736|531532291|FG000|Overall Study|Protocol Violation|1|||
147373842|NCT02257736|531532292|FG001|Overall Study|Protocol Violation|0|||
147373843|NCT02257736|531532291|FG000|Overall Study|Other|1|||
147373844|NCT02257736|531532292|FG001|Overall Study|Other|7|||
147373845|NCT02257736|531532291|FG000|Overall Study|Randomized, not treated|1|||
147373846|NCT02257736|531532292|FG001|Overall Study|Randomized, not treated|2|||
147373847|NCT03431350|531532293|FG000|Overall Study|ONGOING|0|||
147373848|NCT03431350|531532294|FG001|Overall Study|ONGOING|0|||
147373849|NCT03431350|531532295|FG002|Overall Study|ONGOING|2|||
147373850|NCT03431350|531532296|FG003|Overall Study|ONGOING|0|||
147373851|NCT03431350|531532297|FG004|Overall Study|ONGOING|1|||
147373852|NCT03431350|531532298|FG005|Overall Study|ONGOING|3|||
147373853|NCT03431350|531532299|FG006|Overall Study|ONGOING|0|||
147373854|NCT03431350|531532300|FG007|Overall Study|ONGOING|1|||
147373855|NCT03431350|531532301|FG008|Overall Study|ONGOING|3|||
147373856|NCT03431350|531532302|FG009|Overall Study|ONGOING|4|||
147373857|NCT03431350|531532303|FG010|Overall Study|ONGOING|2|||
147373858|NCT03431350|531532304|FG011|Overall Study|ONGOING|1|||
147373859|NCT03431350|531532293|FG000|Overall Study|Death|6|||
147373860|NCT03431350|531532294|FG001|Overall Study|Death|5|||
147373861|NCT03431350|531532295|FG002|Overall Study|Death|18|||
147373862|NCT03431350|531532296|FG003|Overall Study|Death|7|||
147373863|NCT03431350|531532297|FG004|Overall Study|Death|4|||
147373864|NCT03431350|531532298|FG005|Overall Study|Death|3|||
147373865|NCT03431350|531532299|FG006|Overall Study|Death|2|||
147373866|NCT03431350|531532300|FG007|Overall Study|Death|0|||
147373867|NCT03431350|531532301|FG008|Overall Study|Death|0|||
147373868|NCT03431350|531532302|FG009|Overall Study|Death|0|||
147373869|NCT03431350|531532303|FG010|Overall Study|Death|4|||
147373870|NCT03431350|531532304|FG011|Overall Study|Death|0|||
147373871|NCT03431350|531532293|FG000|Overall Study|Lost to Follow-up|0|||
147373872|NCT03431350|531532294|FG001|Overall Study|Lost to Follow-up|1|||
147373873|NCT03431350|531532295|FG002|Overall Study|Lost to Follow-up|0|||
147373874|NCT03431350|531532296|FG003|Overall Study|Lost to Follow-up|0|||
147373875|NCT03431350|531532297|FG004|Overall Study|Lost to Follow-up|0|||
147373876|NCT03431350|531532298|FG005|Overall Study|Lost to Follow-up|0|||
147373877|NCT03431350|531532299|FG006|Overall Study|Lost to Follow-up|0|||
147373878|NCT03431350|531532300|FG007|Overall Study|Lost to Follow-up|0|||
147373879|NCT03431350|531532301|FG008|Overall Study|Lost to Follow-up|0|||
147373880|NCT03431350|531532302|FG009|Overall Study|Lost to Follow-up|0|||
147373881|NCT03431350|531532303|FG010|Overall Study|Lost to Follow-up|0|||
147373882|NCT03431350|531532304|FG011|Overall Study|Lost to Follow-up|0|||
147373883|NCT03431350|531532293|FG000|Overall Study|Withdrawal by Subject|0|||
147373884|NCT03431350|531532294|FG001|Overall Study|Withdrawal by Subject|0|||
147373885|NCT03431350|531532295|FG002|Overall Study|Withdrawal by Subject|0|||
147373886|NCT03431350|531532296|FG003|Overall Study|Withdrawal by Subject|1|||
147373887|NCT03431350|531532297|FG004|Overall Study|Withdrawal by Subject|1|||
147373888|NCT03431350|531532298|FG005|Overall Study|Withdrawal by Subject|1|||
147664161|NCT04003103|532594458|FG000|Overall Study|Death|1|||
147373889|NCT03431350|531532299|FG006|Overall Study|Withdrawal by Subject|0|||
147373890|NCT03431350|531532300|FG007|Overall Study|Withdrawal by Subject|0|||
147373891|NCT03431350|531532301|FG008|Overall Study|Withdrawal by Subject|0|||
147373892|NCT03431350|531532302|FG009|Overall Study|Withdrawal by Subject|2|||
147373893|NCT03431350|531532303|FG010|Overall Study|Withdrawal by Subject|0|||
147373894|NCT03431350|531532304|FG011|Overall Study|Withdrawal by Subject|1|||
147664162|NCT04003103|532594459|FG001|Overall Study|Death|0|||
147664163|NCT04003103|532594460|FG002|Overall Study|Death|0|||
147373895|NCT03431350|531532293|FG000|Overall Study|Other|0|||
147373896|NCT03431350|531532294|FG001|Overall Study|Other|0|||
147373897|NCT03431350|531532295|FG002|Overall Study|Other|1|||
147664164|NCT04003103|532594458|FG000|Overall Study|Lost to Follow-up|4|||
147664165|NCT04003103|532594459|FG001|Overall Study|Lost to Follow-up|3|||
147664166|NCT04003103|532594460|FG002|Overall Study|Lost to Follow-up|2|||
147664167|NCT04003103|532594458|FG000|Overall Study|Withdrawal by Subject|10|||
147664168|NCT04003103|532594459|FG001|Overall Study|Withdrawal by Subject|1|||
147664169|NCT04003103|532594460|FG002|Overall Study|Withdrawal by Subject|1|||
147664170|NCT04003103|532594458|FG000|Overall Study|Status not recorded|0|||
147664171|NCT04003103|532594459|FG001|Overall Study|Status not recorded|2|||
147664172|NCT04003103|532594460|FG002|Overall Study|Status not recorded|0|||
147664173|NCT05518539|532594464|FG000|Overall Study|Lost to Follow-up|6|||
147664174|NCT03589807|532594467|FG000|Overall Study|Lost to Follow-up|0|||
147664175|NCT03589807|532594468|FG001|Overall Study|Lost to Follow-up|2|||
147664176|NCT03589807|532594469|FG002|Overall Study|Lost to Follow-up|2|||
147664177|NCT03589807|532594470|FG003|Overall Study|Lost to Follow-up|3|||
147664178|NCT03589807|532594471|FG004|Overall Study|Lost to Follow-up|1|||
147664179|NCT03589807|532594472|FG005|Overall Study|Lost to Follow-up|1|||
147664180|NCT03589807|532594467|FG000|Overall Study|Withdrawal by Subject|0|||
147664181|NCT03589807|532594468|FG001|Overall Study|Withdrawal by Subject|5|||
147664182|NCT03589807|532594469|FG002|Overall Study|Withdrawal by Subject|0|||
147664183|NCT03589807|532594470|FG003|Overall Study|Withdrawal by Subject|0|||
147664184|NCT03589807|532594471|FG004|Overall Study|Withdrawal by Subject|0|||
147664185|NCT03589807|532594472|FG005|Overall Study|Withdrawal by Subject|0|||
147664186|NCT03589807|532594467|FG000|Overall Study|Protocol Violation|0|||
147664187|NCT03589807|532594468|FG001|Overall Study|Protocol Violation|0|||
147664188|NCT03589807|532594469|FG002|Overall Study|Protocol Violation|0|||
147664189|NCT03589807|532594470|FG003|Overall Study|Protocol Violation|1|||
147664190|NCT03589807|532594471|FG004|Overall Study|Protocol Violation|0|||
147664191|NCT03589807|532594472|FG005|Overall Study|Protocol Violation|0|||
147664192|NCT03589807|532594467|FG000|Overall Study|Enrolled but treatment not administered|0|||
147664193|NCT03589807|532594468|FG001|Overall Study|Enrolled but treatment not administered|0|||
147664194|NCT03589807|532594469|FG002|Overall Study|Enrolled but treatment not administered|0|||
147664195|NCT03589807|532594470|FG003|Overall Study|Enrolled but treatment not administered|0|||
147373898|NCT03431350|531532296|FG003|Overall Study|Other|3|||
147373899|NCT03431350|531532297|FG004|Overall Study|Other|2|||
147373900|NCT03431350|531532298|FG005|Overall Study|Other|2|||
147373901|NCT03431350|531532299|FG006|Overall Study|Other|4|||
147373902|NCT03431350|531532300|FG007|Overall Study|Other|0|||
147373903|NCT03431350|531532301|FG008|Overall Study|Other|14|||
147373904|NCT03431350|531532302|FG009|Overall Study|Other|11|||
147373905|NCT03431350|531532303|FG010|Overall Study|Other|11|||
147373906|NCT03431350|531532304|FG011|Overall Study|Other|15|||
147373907|NCT03414684|531532305|FG000|First-course Treatment|Complete response|0|||
147373908|NCT03414684|531532306|FG001|First-course Treatment|Complete response|1|||
147373909|NCT03414684|531532305|FG000|First-course Treatment|Intercurrent illness|1|||
147373910|NCT03414684|531532306|FG001|First-course Treatment|Intercurrent illness|0|||
147373911|NCT03414684|531532305|FG000|First-course Treatment|Progressive Disease|31|||
147373912|NCT03414684|531532306|FG001|First-course Treatment|Progressive Disease|32|||
147373913|NCT03414684|531532305|FG000|First-course Treatment|Adverse Event|1|||
147373914|NCT03414684|531532306|FG001|First-course Treatment|Adverse Event|2|||
147373915|NCT03414684|531532305|FG000|First-course Treatment|Physician Decision|0|||
147373916|NCT03414684|531532306|FG001|First-course Treatment|Physician Decision|1|||
147373917|NCT03414684|531532305|FG000|First-course Treatment|Withdrawal by Subject|0|||
147373918|NCT03414684|531532306|FG001|First-course Treatment|Withdrawal by Subject|1|||
147373919|NCT03414684|531532305|FG000|First-course Treatment|"Patient proceeded with chest wall excision"|1|||
147373920|NCT03414684|531532306|FG001|First-course Treatment|"Patient proceeded with chest wall excision"|0|||
147373921|NCT03414684|531532305|FG000|First-course Treatment|"Participant needed palliative radiation, which is not permitted on study"|0|||
147373922|NCT03414684|531532306|FG001|First-course Treatment|"Participant needed palliative radiation, which is not permitted on study"|1|||
147373923|NCT03414684|531532305|FG000|First-course Treatment|Still on treatment|3|||
147373924|NCT03414684|531532306|FG001|First-course Treatment|Still on treatment|0|||
147373925|NCT03414684|531532305|FG000|First-course Treatment|Never started protocol therapy|2|||
147373926|NCT03414684|531532306|FG001|First-course Treatment|Never started protocol therapy|1|||
147373927|NCT03414684|531532305|FG000|Crossover Treatment|Progressive disease|0|||
147373928|NCT03414684|531532306|FG001|Crossover Treatment|Progressive disease|12|||
147373929|NCT03414684|531532305|FG000|Crossover Treatment|Adverse Event|0|||
147373930|NCT03414684|531532306|FG001|Crossover Treatment|Adverse Event|3|||
147373931|NCT03414684|531532305|FG000|Crossover Treatment|Physician Decision|0|||
147373932|NCT03414684|531532306|FG001|Crossover Treatment|Physician Decision|1|||
147373933|NCT03414684|531532305|FG000|Crossover Treatment|Still on treatment|0|||
147373934|NCT03414684|531532306|FG001|Crossover Treatment|Still on treatment|2|||
147373935|NCT02078648|531532307|FG000|Overall Study|Unequivocal Evidence of Disease Progression|36|||
147373936|NCT02078648|531532308|FG001|Overall Study|Unequivocal Evidence of Disease Progression|13|||
147373937|NCT02078648|531532307|FG000|Overall Study|Adverse Event|0|||
147455320|NCT00866307|531827877|FG002|Induction|Identification of Patients with Day 29 M|0|||
147664196|NCT03589807|532594471|FG004|Overall Study|Enrolled but treatment not administered|1|||
147455321|NCT00866307|531827875|FG000|Induction|Inadequate cytognetic samples th|1|||
147455322|NCT00866307|531827876|FG001|Induction|Inadequate cytognetic samples th|0|||
147455323|NCT00866307|531827877|FG002|Induction|Inadequate cytognetic samples th|0|||
147455324|NCT00866307|531827875|FG000|Induction|Improper post-induction consent|2|||
147455325|NCT00866307|531827876|FG001|Induction|Improper post-induction consent|0|||
147455326|NCT00866307|531827877|FG002|Induction|Improper post-induction consent|0|||
147455327|NCT00866307|531827875|FG000|Induction|Study was closed at the time|1|||
147455328|NCT00866307|531827876|FG001|Induction|Study was closed at the time|0|||
147455329|NCT00866307|531827877|FG002|Induction|Study was closed at the time|0|||
147455330|NCT00866307|531827875|FG000|Consolidation/Maintenance|Adverse Event|0|||
147455331|NCT00866307|531827876|FG001|Consolidation/Maintenance|Adverse Event|0|||
147455332|NCT00866307|531827877|FG002|Consolidation/Maintenance|Adverse Event|8|||
147455333|NCT00866307|531827875|FG000|Consolidation/Maintenance|Death|0|||
147455334|NCT00866307|531827876|FG001|Consolidation/Maintenance|Death|0|||
147455335|NCT00866307|531827877|FG002|Consolidation/Maintenance|Death|1|||
147455336|NCT00866307|531827875|FG000|Consolidation/Maintenance|Physician Decision|0|||
147455337|NCT00866307|531827876|FG001|Consolidation/Maintenance|Physician Decision|3|||
147455338|NCT00866307|531827877|FG002|Consolidation/Maintenance|Physician Decision|2|||
147455339|NCT00866307|531827875|FG000|Consolidation/Maintenance|Withdrawal by Subject|0|||
147455340|NCT00866307|531827876|FG001|Consolidation/Maintenance|Withdrawal by Subject|1|||
147611274|NCT03052127|532391011|FG004|Overall Study|Discontinuation by Sponsor|0|||
147611275|NCT03052127|532391012|FG005|Overall Study|Discontinuation by Sponsor|0|||
147611276|NCT03052127|532391013|FG006|Overall Study|Discontinuation by Sponsor|0|||
147373938|NCT02078648|531532308|FG001|Overall Study|Adverse Event|1|||
147373939|NCT02078648|531532307|FG000|Overall Study|General Deterioration in Performance Status Without Radiographic Evidence of Disease Progression|1|||
147373940|NCT02078648|531532308|FG001|Overall Study|General Deterioration in Performance Status Without Radiographic Evidence of Disease Progression|4|||
147373941|NCT02078648|531532307|FG000|Overall Study|Withdrawal by Subject|3|||
147373942|NCT02078648|531532308|FG001|Overall Study|Withdrawal by Subject|1|||
147373943|NCT02078648|531532307|FG000|Overall Study|Investigator Decision|5|||
147373944|NCT02078648|531532308|FG001|Overall Study|Investigator Decision|7|||
147373945|NCT02078648|531532307|FG000|Overall Study|Death|1|||
147373946|NCT02078648|531532308|FG001|Overall Study|Death|1|||
147373947|NCT02078648|531532307|FG000|Overall Study|Undefined|0|||
147373948|NCT02078648|531532308|FG001|Overall Study|Undefined|1|||
147373949|NCT05379270|531532309|FG000|Overall Study|Withdrawal by Subject|1|||
147373950|NCT05379270|531532310|FG001|Overall Study|Withdrawal by Subject|1|||
147373951|NCT04306367|531532316|FG000|Overall Study|Progression of Disease|9|||
147373952|NCT04306367|531532316|FG000|Overall Study|Adverse Event|3|||
147373953|NCT04306367|531532316|FG000|Overall Study|Withdrawal by Subject|1|||
147373954|NCT02401815|531532319|FG000|Dose Escalation (up to 670 Days)|Adverse Event|0|||
147373955|NCT02401815|531532320|FG001|Dose Escalation (up to 670 Days)|Adverse Event|0|||
147373956|NCT02401815|531532321|FG002|Dose Escalation (up to 670 Days)|Adverse Event|0|||
147373957|NCT02401815|531532322|FG003|Dose Escalation (up to 670 Days)|Adverse Event|1|||
147373958|NCT02401815|531532323|FG004|Dose Escalation (up to 670 Days)|Adverse Event|0|||
147455341|NCT00866307|531827877|FG002|Consolidation/Maintenance|Withdrawal by Subject|1|||
147455342|NCT00866307|531827875|FG000|Consolidation/Maintenance|Development of 2nd malignant neoplasm|0|||
147455343|NCT00866307|531827876|FG001|Consolidation/Maintenance|Development of 2nd malignant neoplasm|0|||
147455344|NCT00866307|531827877|FG002|Consolidation/Maintenance|Development of 2nd malignant neoplasm|2|||
147611277|NCT03052127|532391014|FG007|Overall Study|Discontinuation by Sponsor|0|||
147611278|NCT03052127|532391015|FG008|Overall Study|Discontinuation by Sponsor|4|||
147611279|NCT03052127|532391016|FG009|Overall Study|Discontinuation by Sponsor|2|||
147611280|NCT03052127|532391017|FG010|Overall Study|Discontinuation by Sponsor|5|||
147611281|NCT03052127|532391018|FG011|Overall Study|Discontinuation by Sponsor|13|||
147611282|NCT03052127|532391007|FG000|Overall Study|Inability to comply with trial requirements|0|||
147611283|NCT03052127|532391008|FG001|Overall Study|Inability to comply with trial requirements|0|||
147611284|NCT03052127|532391009|FG002|Overall Study|Inability to comply with trial requirements|1|||
147611285|NCT03052127|532391010|FG003|Overall Study|Inability to comply with trial requirements|0|||
147611286|NCT03052127|532391011|FG004|Overall Study|Inability to comply with trial requirements|0|||
147611287|NCT03052127|532391012|FG005|Overall Study|Inability to comply with trial requirements|0|||
147611288|NCT03052127|532391013|FG006|Overall Study|Inability to comply with trial requirements|0|||
147611289|NCT03052127|532391014|FG007|Overall Study|Inability to comply with trial requirements|0|||
147373959|NCT02401815|531532324|FG005|Dose Escalation (up to 670 Days)|Adverse Event|0|||
147373960|NCT02401815|531532325|FG006|Dose Escalation (up to 670 Days)|Adverse Event|0|||
147455345|NCT00866307|531827875|FG000|Consolidation/Maintenance|Recurrent leukemia following remission|0|||
147455346|NCT00866307|531827876|FG001|Consolidation/Maintenance|Recurrent leukemia following remission|3|||
147455347|NCT00866307|531827877|FG002|Consolidation/Maintenance|Recurrent leukemia following remission|1|||
147611290|NCT03052127|532391015|FG008|Overall Study|Inability to comply with trial requirements|0|||
147611291|NCT03052127|532391016|FG009|Overall Study|Inability to comply with trial requirements|0|||
147611292|NCT03052127|532391017|FG010|Overall Study|Inability to comply with trial requirements|0|||
147373961|NCT02401815|531532326|FG007|Dose Escalation (up to 670 Days)|Adverse Event|0|||
147455348|NCT00866307|531827875|FG000|Consolidation/Maintenance|Therapy error|0|||
147373962|NCT02401815|531532327|FG008|Dose Escalation (up to 670 Days)|Adverse Event|0|||
147373963|NCT02401815|531532328|FG009|Dose Escalation (up to 670 Days)|Adverse Event|0|||
147373964|NCT02401815|531532319|FG000|Dose Escalation (up to 670 Days)|Clinical Progression|1|||
147373965|NCT02401815|531532320|FG001|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
147373966|NCT02401815|531532321|FG002|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
147373967|NCT02401815|531532322|FG003|Dose Escalation (up to 670 Days)|Clinical Progression|1|||
147373968|NCT02401815|531532323|FG004|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
147373969|NCT02401815|531532324|FG005|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
147373970|NCT02401815|531532325|FG006|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
147373971|NCT02401815|531532326|FG007|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
147373972|NCT02401815|531532327|FG008|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
147373973|NCT02401815|531532328|FG009|Dose Escalation (up to 670 Days)|Clinical Progression|0|||
147373974|NCT02401815|531532319|FG000|Dose Escalation (up to 670 Days)|Death|1|||
147373975|NCT02401815|531532320|FG001|Dose Escalation (up to 670 Days)|Death|2|||
147373976|NCT02401815|531532321|FG002|Dose Escalation (up to 670 Days)|Death|3|||
147373977|NCT02401815|531532322|FG003|Dose Escalation (up to 670 Days)|Death|5|||
147373978|NCT02401815|531532323|FG004|Dose Escalation (up to 670 Days)|Death|4|||
147373979|NCT02401815|531532324|FG005|Dose Escalation (up to 670 Days)|Death|0|||
147373980|NCT02401815|531532325|FG006|Dose Escalation (up to 670 Days)|Death|0|||
147373981|NCT02401815|531532326|FG007|Dose Escalation (up to 670 Days)|Death|0|||
147373982|NCT02401815|531532327|FG008|Dose Escalation (up to 670 Days)|Death|0|||
147373983|NCT02401815|531532328|FG009|Dose Escalation (up to 670 Days)|Death|0|||
147373984|NCT02401815|531532319|FG000|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
147373985|NCT02401815|531532320|FG001|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|2|||
147373986|NCT02401815|531532321|FG002|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
147373987|NCT02401815|531532322|FG003|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
147373988|NCT02401815|531532323|FG004|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|2|||
147373989|NCT02401815|531532324|FG005|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
147373990|NCT02401815|531532325|FG006|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
147373991|NCT02401815|531532326|FG007|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
147373992|NCT02401815|531532327|FG008|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
147373993|NCT02401815|531532328|FG009|Dose Escalation (up to 670 Days)|Progressive Disease (Per RECIST)|0|||
147373994|NCT02401815|531532319|FG000|Dose Escalation (up to 670 Days)|Withdrawal by Subject|1|||
147373995|NCT02401815|531532320|FG001|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
147373996|NCT02401815|531532321|FG002|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
147373997|NCT02401815|531532322|FG003|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
147373998|NCT02401815|531532323|FG004|Dose Escalation (up to 670 Days)|Withdrawal by Subject|1|||
147373999|NCT02401815|531532324|FG005|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
147374000|NCT02401815|531532325|FG006|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
147374001|NCT02401815|531532326|FG007|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
147374002|NCT02401815|531532327|FG008|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
147374003|NCT02401815|531532328|FG009|Dose Escalation (up to 670 Days)|Withdrawal by Subject|0|||
147374004|NCT02401815|531532319|FG000|Dose Extension Part 2b (up to 868 Days)|Death|0|||
147374005|NCT02401815|531532320|FG001|Dose Extension Part 2b (up to 868 Days)|Death|0|||
147374006|NCT02401815|531532321|FG002|Dose Extension Part 2b (up to 868 Days)|Death|0|||
147374007|NCT02401815|531532322|FG003|Dose Extension Part 2b (up to 868 Days)|Death|0|||
147374008|NCT02401815|531532323|FG004|Dose Extension Part 2b (up to 868 Days)|Death|0|||
147374009|NCT02401815|531532324|FG005|Dose Extension Part 2b (up to 868 Days)|Death|2|||
147374010|NCT02401815|531532325|FG006|Dose Extension Part 2b (up to 868 Days)|Death|0|||
147374011|NCT02401815|531532326|FG007|Dose Extension Part 2b (up to 868 Days)|Death|0|||
147374012|NCT02401815|531532327|FG008|Dose Extension Part 2b (up to 868 Days)|Death|0|||
147374013|NCT02401815|531532328|FG009|Dose Extension Part 2b (up to 868 Days)|Death|0|||
147374014|NCT02401815|531532319|FG000|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
147374015|NCT02401815|531532320|FG001|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
147374016|NCT02401815|531532321|FG002|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
147374017|NCT02401815|531532322|FG003|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
147374018|NCT02401815|531532323|FG004|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
147374019|NCT02401815|531532324|FG005|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
147374020|NCT02401815|531532325|FG006|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|5|||
147374021|NCT02401815|531532326|FG007|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
147374022|NCT02401815|531532327|FG008|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
147611293|NCT03052127|532391018|FG011|Overall Study|Inability to comply with trial requirements|0|||
147611294|NCT03052127|532391007|FG000|Overall Study|COVID-19 restrictions and Investigator discretion|1|||
147374023|NCT02401815|531532328|FG009|Dose Extension Part 2b (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
147374024|NCT02401815|531532319|FG000|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
147374025|NCT02401815|531532320|FG001|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
147374026|NCT02401815|531532321|FG002|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
147374027|NCT02401815|531532322|FG003|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
147374028|NCT02401815|531532323|FG004|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
147374029|NCT02401815|531532324|FG005|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|1|||
147374030|NCT02401815|531532325|FG006|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|3|||
147374031|NCT02401815|531532326|FG007|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
147374032|NCT02401815|531532327|FG008|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
147611295|NCT03052127|532391008|FG001|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
147374033|NCT02401815|531532328|FG009|Dose Extension Part 2b (up to 868 Days)|Withdrawal by Subject|0|||
147374034|NCT02401815|531532319|FG000|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
147374035|NCT02401815|531532320|FG001|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
147374036|NCT02401815|531532321|FG002|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
147374037|NCT02401815|531532322|FG003|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
147374038|NCT02401815|531532323|FG004|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
147374039|NCT02401815|531532324|FG005|Dose Extension Part 2b (up to 868 Days)|Other than specified|1|||
147374040|NCT02401815|531532325|FG006|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
147374041|NCT02401815|531532326|FG007|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
147374042|NCT02401815|531532327|FG008|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
147374043|NCT02401815|531532328|FG009|Dose Extension Part 2b (up to 868 Days)|Other than specified|0|||
147374044|NCT02401815|531532319|FG000|Dose Extension Part 2e (up to 868 Days)|Death|0|||
147374045|NCT02401815|531532320|FG001|Dose Extension Part 2e (up to 868 Days)|Death|0|||
147374046|NCT02401815|531532321|FG002|Dose Extension Part 2e (up to 868 Days)|Death|0|||
147374047|NCT02401815|531532322|FG003|Dose Extension Part 2e (up to 868 Days)|Death|0|||
147374048|NCT02401815|531532323|FG004|Dose Extension Part 2e (up to 868 Days)|Death|0|||
147374049|NCT02401815|531532324|FG005|Dose Extension Part 2e (up to 868 Days)|Death|0|||
147374050|NCT02401815|531532325|FG006|Dose Extension Part 2e (up to 868 Days)|Death|0|||
147374051|NCT02401815|531532326|FG007|Dose Extension Part 2e (up to 868 Days)|Death|1|||
147374052|NCT02401815|531532327|FG008|Dose Extension Part 2e (up to 868 Days)|Death|2|||
147374053|NCT02401815|531532328|FG009|Dose Extension Part 2e (up to 868 Days)|Death|4|||
147374054|NCT02401815|531532319|FG000|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
147374055|NCT02401815|531532320|FG001|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
147374056|NCT02401815|531532321|FG002|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
147374057|NCT02401815|531532322|FG003|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
147374058|NCT02401815|531532323|FG004|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
147374059|NCT02401815|531532324|FG005|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
147374060|NCT02401815|531532325|FG006|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
147374061|NCT02401815|531532326|FG007|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|0|||
147374062|NCT02401815|531532327|FG008|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|2|||
147374063|NCT02401815|531532328|FG009|Dose Extension Part 2e (up to 868 Days)|Progressive Disease (Per RECIST)|1|||
147374064|NCT02401815|531532319|FG000|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
147374065|NCT02401815|531532320|FG001|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
147374066|NCT02401815|531532321|FG002|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
147374067|NCT02401815|531532322|FG003|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
147374068|NCT02401815|531532323|FG004|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
147374069|NCT02401815|531532324|FG005|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
147374070|NCT02401815|531532325|FG006|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
147374071|NCT02401815|531532326|FG007|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
147374072|NCT02401815|531532327|FG008|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|0|||
147374073|NCT02401815|531532328|FG009|Dose Extension Part 2e (up to 868 Days)|Withdrawal by Subject|2|||
147374074|NCT02401815|531532319|FG000|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
147374075|NCT02401815|531532320|FG001|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
147374076|NCT02401815|531532321|FG002|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
147374077|NCT02401815|531532322|FG003|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
147374078|NCT02401815|531532323|FG004|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
147374079|NCT02401815|531532324|FG005|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
147374080|NCT02401815|531532325|FG006|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
147374081|NCT02401815|531532326|FG007|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
147374082|NCT02401815|531532327|FG008|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|1|||
147374083|NCT02401815|531532328|FG009|Dose Extension Part 2e (up to 868 Days)|Clinical Progression|0|||
147374084|NCT02401815|531532319|FG000|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
147374085|NCT02401815|531532320|FG001|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
147374086|NCT02401815|531532321|FG002|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
147374087|NCT02401815|531532322|FG003|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
147374088|NCT02401815|531532323|FG004|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
147374089|NCT02401815|531532324|FG005|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
147374090|NCT02401815|531532325|FG006|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
147374091|NCT02401815|531532326|FG007|Dose Extension Part 2e (up to 868 Days)|Other than specified|2|||
147374092|NCT02401815|531532327|FG008|Dose Extension Part 2e (up to 868 Days)|Other than specified|0|||
147374093|NCT02401815|531532328|FG009|Dose Extension Part 2e (up to 868 Days)|Other than specified|3|||
147374094|NCT00748709|531532329|FG000|Overall Study|Progressive disease|15|||
147374095|NCT00748709|531532329|FG000|Overall Study|Drug reducing Toxity|2|||
147374096|NCT00748709|531532329|FG000|Overall Study|Other Adverse Event|1|||
147374097|NCT00748709|531532329|FG000|Overall Study|Withdrawal by Subject|1|||
147374098|NCT00748709|531532329|FG000|Overall Study|Other Reasons|1|||
147374099|NCT02751528|531532334|FG000|Overall Study|Withdrawal by Subject|1|||
147374100|NCT02751528|531532334|FG000|Overall Study|Adverse Event|1|||
147374101|NCT04218357|531532335|FG000|1st Allocation|Withdrawal by Subject|1|||
147374102|NCT04218357|531532336|FG001|1st Allocation|Withdrawal by Subject|0|||
147374103|NCT04484623|531532338|FG000|Overall Study|Lost to Follow-up|0|||
147374104|NCT04484623|531532339|FG001|Overall Study|Lost to Follow-up|1|||
147374105|NCT04484623|531532338|FG000|Overall Study|Protocol Deviation|1|||
147374106|NCT04484623|531532339|FG001|Overall Study|Protocol Deviation|0|||
147374107|NCT04484623|531532338|FG000|Overall Study|Physician Decision|1|||
147374108|NCT04484623|531532339|FG001|Overall Study|Physician Decision|0|||
147374109|NCT04484623|531532338|FG000|Overall Study|Withdrawal by Subject|11|||
147374110|NCT04484623|531532339|FG001|Overall Study|Withdrawal by Subject|8|||
147374111|NCT04484623|531532338|FG000|Overall Study|Ongoing|94|||
147374112|NCT04484623|531532339|FG001|Overall Study|Ongoing|84|||
147374113|NCT05199571|531533853|FG000|Treatment Period|Participant decision|3|||
147374114|NCT05199571|531533853|FG000|Treatment Period|Physician Decision|1|||
147374115|NCT05199571|531533853|FG000|Post-treatment Follow up Period|Participant decision|3|||
147374116|NCT03367156|531533854|FG000|Overall Study|Lack of interest|3|||
147374117|NCT03367156|531533855|FG001|Overall Study|Lack of interest|1|||
147374118|NCT03367156|531533854|FG000|Overall Study|Death|2|||
147374119|NCT03367156|531533855|FG001|Overall Study|Death|0|||
147374120|NCT03367156|531533854|FG000|Overall Study|Lost to Follow-up|2|||
147374121|NCT03367156|531533855|FG001|Overall Study|Lost to Follow-up|1|||
147374122|NCT03367156|531533854|FG000|Overall Study|Became ineligible|1|||
147374123|NCT03367156|531533855|FG001|Overall Study|Became ineligible|2|||
147374124|NCT03367156|531533854|FG000|Overall Study|Hospitalization|1|||
147611296|NCT03052127|532391009|FG002|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
147611297|NCT03052127|532391010|FG003|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
147611298|NCT03052127|532391011|FG004|Overall Study|COVID-19 restrictions and Investigator discretion|1|||
147611299|NCT03052127|532391012|FG005|Overall Study|COVID-19 restrictions and Investigator discretion|1|||
147611300|NCT03052127|532391013|FG006|Overall Study|COVID-19 restrictions and Investigator discretion|1|||
147611301|NCT03052127|532391014|FG007|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
147611302|NCT03052127|532391015|FG008|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
147611303|NCT03052127|532391016|FG009|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
147611304|NCT03052127|532391017|FG010|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
147611305|NCT03052127|532391018|FG011|Overall Study|COVID-19 restrictions and Investigator discretion|0|||
147611306|NCT02521376|532391019|FG000|Overall Study|Enrolled, But Not Treated|1|||
147611307|NCT02521376|532391020|FG001|Overall Study|Enrolled, But Not Treated|0|||
147611308|NCT02521376|532391021|FG002|Overall Study|Enrolled, But Not Treated|0|||
147611309|NCT02521376|532391022|FG003|Overall Study|Enrolled, But Not Treated|0|||
147611310|NCT02759692|532391024|FG000|Period 1|Test article no longer available|1|||
147611311|NCT02759692|532391025|FG001|Period 1|Test article no longer available|1|||
147611312|NCT02759692|532391024|FG000|Period 1|No longer meets eligibility criteria.|1|||
147611313|NCT02759692|532391025|FG001|Period 1|No longer meets eligibility criteria.|0|||
147611314|NCT02759692|532391024|FG000|Period 1|Miss-Randomized|1|||
147611315|NCT02759692|532391025|FG001|Period 1|Miss-Randomized|1|||
147611316|NCT02759692|532391024|FG000|Period 2|Lost to Follow-up|1|||
147374125|NCT03367156|531533855|FG001|Overall Study|Hospitalization|0|||
147374126|NCT03367156|531533854|FG000|Overall Study|Concerned about Treatment|11|||
147374127|NCT03367156|531533855|FG001|Overall Study|Concerned about Treatment|3|||
147374128|NCT03367156|531533854|FG000|Overall Study|Started new treatment|4|||
147374129|NCT03367156|531533855|FG001|Overall Study|Started new treatment|1|||
147374130|NCT03762850|531533856|FG000|Overall Study|Death|0|||
147374131|NCT03762850|531533857|FG001|Overall Study|Death|1|||
147374132|NCT03762850|531533856|FG000|Overall Study|Lost to Follow-up|0|||
147611317|NCT02759692|532391025|FG001|Period 2|Lost to Follow-up|0|||
147611318|NCT02759692|532391024|FG000|Period 2|Test article no longer available|0|||
147611319|NCT02759692|532391025|FG001|Period 2|Test article no longer available|1|||
147374133|NCT03762850|531533857|FG001|Overall Study|Lost to Follow-up|1|||
147374134|NCT03762850|531533856|FG000|Overall Study|Physician Decision|0|||
147374135|NCT03762850|531533857|FG001|Overall Study|Physician Decision|1|||
147374136|NCT03762850|531533856|FG000|Overall Study|Withdrawal by Subject|4|||
147374137|NCT03762850|531533857|FG001|Overall Study|Withdrawal by Subject|9|||
147374138|NCT03002194|531533860|FG000|Overall Study|Lost to Follow-up|6|||
147455349|NCT00866307|531827876|FG001|Consolidation/Maintenance|Therapy error|1|||
147455350|NCT00866307|531827877|FG002|Consolidation/Maintenance|Therapy error|0|||
147455351|NCT00866307|531827875|FG000|Consolidation/Maintenance|Non-compliance|0|||
147374139|NCT03002194|531533860|FG000|Overall Study|Adverse Event|1|||
147374140|NCT03002194|531533860|FG000|Overall Study|Lack of Efficacy|1|||
147374141|NCT03002194|531533860|FG000|Overall Study|Withdrawal by Subject|2|||
147374142|NCT00442104|531533861|FG000|Overall Study|Adverse Event|5|||
147374143|NCT00442104|531533861|FG000|Overall Study|Death|2|||
147374144|NCT00442104|531533861|FG000|Overall Study|Lost to Follow-up|3|||
147374145|NCT00442104|531533861|FG000|Overall Study|Withdrawal by Subject|5|||
147374146|NCT00442104|531533861|FG000|Overall Study|Insufficient Clinical Response|10|||
147374147|NCT00442104|531533861|FG000|Overall Study|Other|21|||
147374148|NCT00442104|531533861|FG000|Overall Study|Discretion of the Investigator/Sponsor|1|||
147374149|NCT04497415|531533864|FG000|Overall Study|Lost to Follow-up|43|||
147374150|NCT04497415|531533865|FG001|Overall Study|Lost to Follow-up|27|||
147455352|NCT00866307|531827876|FG001|Consolidation/Maintenance|Non-compliance|0|||
147455353|NCT00866307|531827877|FG002|Consolidation/Maintenance|Non-compliance|1|||
147455354|NCT00866307|531827875|FG000|Consolidation/Maintenance|Patient moved to non-participating inst|0|||
147455355|NCT00866307|531827876|FG001|Consolidation/Maintenance|Patient moved to non-participating inst|1|||
147455356|NCT00866307|531827877|FG002|Consolidation/Maintenance|Patient moved to non-participating inst|0|||
147455357|NCT01687712|531827878|FG000|Cycle 1|Not Biochemically Pregnant|386|||
147455358|NCT01687712|531827879|FG001|Cycle 1|Not Biochemically Pregnant|348|||
147455359|NCT01687712|531827878|FG000|Cycle 1|Early Pregnancy Loss|43|||
147455360|NCT01687712|531827879|FG001|Cycle 1|Early Pregnancy Loss|60|||
147455361|NCT01687712|531827878|FG000|Cycle 1|Ectopic Pregnancy|5|||
147374151|NCT03021993|531533866|FG000|Overall Study|Withdrawal by Subject|4|||
147374152|NCT03021993|531533866|FG000|Overall Study|Physician Decision|1|||
147374153|NCT03021993|531533866|FG000|Overall Study|enrolled but were not treated|1|||
147374154|NCT03021993|531533866|FG000|Overall Study|Death|3|||
147374155|NCT00756574|531533867|FG000|Overall Study|Withdrawal by Subject|9|||
147374156|NCT00756574|531533868|FG001|Overall Study|Withdrawal by Subject|7|||
147374157|NCT00756574|531533867|FG000|Overall Study|Lost to Follow-up|4|||
147374158|NCT00756574|531533868|FG001|Overall Study|Lost to Follow-up|4|||
147374159|NCT03516812|531533871|FG000|Overall Study|Adverse Event|4|||
147374160|NCT03516812|531533871|FG000|Overall Study|Lack of Efficacy|2|||
147374161|NCT04795167|531533872|FG000|Overall Study|Death|1|||
147374162|NCT04795167|531533873|FG001|Overall Study|Death|18|||
147374163|NCT04795167|531533874|FG002|Overall Study|Death|1|||
147374164|NCT04795167|531533872|FG000|Overall Study|Remained in-hospital for >/= 45 Days|4|||
147374165|NCT04795167|531533873|FG001|Overall Study|Remained in-hospital for >/= 45 Days|0|||
147374166|NCT04795167|531533874|FG002|Overall Study|Remained in-hospital for >/= 45 Days|0|||
147374167|NCT03683576|531533880|FG000|Overall Study|Withdrawal by Subject|2|||
147374168|NCT03683576|531533881|FG001|Overall Study|Withdrawal by Subject|0|||
147374169|NCT03683576|531533882|FG002|Overall Study|Withdrawal by Subject|8|||
147374170|NCT03683576|531533883|FG003|Overall Study|Withdrawal by Subject|3|||
147374171|NCT03683576|531533880|FG000|Overall Study|Adverse Event|3|||
147374172|NCT03683576|531533881|FG001|Overall Study|Adverse Event|0|||
147374173|NCT03683576|531533882|FG002|Overall Study|Adverse Event|0|||
147374174|NCT03683576|531533883|FG003|Overall Study|Adverse Event|4|||
147374175|NCT03683576|531533880|FG000|Overall Study|Lack of Efficacy|1|||
147374176|NCT03683576|531533881|FG001|Overall Study|Lack of Efficacy|0|||
147374177|NCT03683576|531533882|FG002|Overall Study|Lack of Efficacy|1|||
147374178|NCT03683576|531533883|FG003|Overall Study|Lack of Efficacy|1|||
147374179|NCT03683576|531533880|FG000|Overall Study|Lost to Follow-up|0|||
147374180|NCT03683576|531533881|FG001|Overall Study|Lost to Follow-up|1|||
147374181|NCT03683576|531533882|FG002|Overall Study|Lost to Follow-up|2|||
147374182|NCT03683576|531533883|FG003|Overall Study|Lost to Follow-up|0|||
147374183|NCT03683576|531533880|FG000|Overall Study|Other, Not Specified|0|||
147455362|NCT01687712|531827879|FG001|Cycle 1|Ectopic Pregnancy|5|||
147455363|NCT01687712|531827878|FG000|Cycle 1|Heterotropic Pregnancy|1|||
147455364|NCT01687712|531827879|FG001|Cycle 1|Heterotropic Pregnancy|0|||
147455365|NCT01687712|531827878|FG000|Cycle 1|Miscarriage/Spontaneous Abortion|9|||
147374184|NCT03683576|531533881|FG001|Overall Study|Other, Not Specified|2|||
147374185|NCT03683576|531533882|FG002|Overall Study|Other, Not Specified|0|||
147374186|NCT03683576|531533883|FG003|Overall Study|Other, Not Specified|0|||
147374187|NCT03683576|531533880|FG000|Overall Study|Protocol Violation|0|||
147374188|NCT03683576|531533881|FG001|Overall Study|Protocol Violation|1|||
147374189|NCT03683576|531533882|FG002|Overall Study|Protocol Violation|1|||
147374190|NCT03683576|531533883|FG003|Overall Study|Protocol Violation|0|||
147374191|NCT02628626|531533885|FG000|Overall Study|Withdrawal by Subject|2|||
147374192|NCT02628626|531533886|FG001|Overall Study|Withdrawal by Subject|2|||
147455366|NCT01687712|531827879|FG001|Cycle 1|Miscarriage/Spontaneous Abortion|14|||
147455367|NCT01687712|531827878|FG000|Cycle 1|Abortion|3|||
147374193|NCT02744066|531533887|FG000|Overall Study|Withdrawal by parent|0|||
147374194|NCT02744066|531533888|FG001|Overall Study|Withdrawal by parent|1|||
147374195|NCT02744066|531533887|FG000|Overall Study|Discharged from NICU prior to completion|0|||
147374196|NCT02744066|531533888|FG001|Overall Study|Discharged from NICU prior to completion|4|||
147374197|NCT05628103|531533889|FG000|Overall Study|Adverse Event|7|||
147374198|NCT05628103|531533889|FG000|Overall Study|Withdrawal by Subject|3|||
147374199|NCT05628103|531533889|FG000|Overall Study|Lost to Follow-up|3|||
147374200|NCT05628103|531533889|FG000|Overall Study|Lack of Efficacy|1|||
147374201|NCT05628103|531533889|FG000|Overall Study|Non-Compliance With Study Drug|4|||
147611320|NCT01954745|532391031|FG000|Overall Study|Radiological Progression|11|||
147374202|NCT03492177|531533891|FG000|Overall Study|Adverse Event|1|||
147374203|NCT03492177|531533892|FG001|Overall Study|Adverse Event|0|||
147374204|NCT03492177|531533893|FG002|Overall Study|Adverse Event|0|||
147374205|NCT03492177|531533891|FG000|Overall Study|Death|3|||
147374206|NCT03492177|531533892|FG001|Overall Study|Death|0|||
147374207|NCT03492177|531533893|FG002|Overall Study|Death|3|||
147374208|NCT03492177|531533891|FG000|Overall Study|Lack of Efficacy|1|||
147374209|NCT03492177|531533892|FG001|Overall Study|Lack of Efficacy|2|||
147374210|NCT03492177|531533893|FG002|Overall Study|Lack of Efficacy|0|||
147374211|NCT03492177|531533891|FG000|Overall Study|Other|1|||
147374212|NCT03492177|531533892|FG001|Overall Study|Other|0|||
147374213|NCT03492177|531533893|FG002|Overall Study|Other|0|||
147374214|NCT03492177|531533891|FG000|Overall Study|Ongoing|16|||
147374215|NCT03492177|531533892|FG001|Overall Study|Ongoing|19|||
147455368|NCT01687712|531827879|FG001|Cycle 1|Abortion|0|||
147611321|NCT01954745|532391031|FG000|Overall Study|Clinical Progression|5|||
147611322|NCT01954745|532391031|FG000|Overall Study|Adverse Event|2|||
147611323|NCT01954745|532391031|FG000|Overall Study|Death|1|||
147611324|NCT04034927|532393578|FG000|Overall Study|Adverse Event|4|||
147611325|NCT04034927|532393579|FG001|Overall Study|Adverse Event|9|||
147611326|NCT04034927|532393578|FG000|Overall Study|Death|0|||
147611327|NCT04034927|532393579|FG001|Overall Study|Death|1|||
147611328|NCT04034927|532393578|FG000|Overall Study|Withdrawal by Subject|0|||
147611329|NCT04034927|532393579|FG001|Overall Study|Withdrawal by Subject|3|||
147611330|NCT04034927|532393578|FG000|Overall Study|Still on Treatment|2|||
147611331|NCT04034927|532393579|FG001|Overall Study|Still on Treatment|1|||
147611332|NCT04034927|532393578|FG000|Overall Study|Other|1|||
147611333|NCT04034927|532393579|FG001|Overall Study|Other|1|||
147611334|NCT02291510|532393580|FG000|Overall Study|Adverse Event|0|||
147611335|NCT02291510|532393581|FG001|Overall Study|Adverse Event|0|||
147611336|NCT02291510|532393582|FG002|Overall Study|Adverse Event|0|||
147611337|NCT02291510|532393583|FG003|Overall Study|Adverse Event|1|||
147611338|NCT04856930|532393587|FG000|Placebo-controlled Period (16 Weeks)|Withdrawal by Subject|6|||
147611339|NCT04856930|532393588|FG001|Placebo-controlled Period (16 Weeks)|Withdrawal by Subject|5|||
147611340|NCT04856930|532393589|FG002|Placebo-controlled Period (16 Weeks)|Withdrawal by Subject|4|||
147611341|NCT04856930|532393587|FG000|Placebo-controlled Period (16 Weeks)|Lost to Follow-up|3|||
147611342|NCT04856930|532393588|FG001|Placebo-controlled Period (16 Weeks)|Lost to Follow-up|1|||
147611343|NCT04856930|532393589|FG002|Placebo-controlled Period (16 Weeks)|Lost to Follow-up|0|||
147611344|NCT04856930|532393587|FG000|Placebo-controlled Period (16 Weeks)|Pregnancy|0|||
147611345|NCT04856930|532393588|FG001|Placebo-controlled Period (16 Weeks)|Pregnancy|1|||
147611346|NCT04856930|532393589|FG002|Placebo-controlled Period (16 Weeks)|Pregnancy|0|||
147611347|NCT04856930|532393587|FG000|Placebo-controlled Period (16 Weeks)|Protocol Violation|0|||
147611348|NCT04856930|532393588|FG001|Placebo-controlled Period (16 Weeks)|Protocol Violation|0|||
147611349|NCT04856930|532393589|FG002|Placebo-controlled Period (16 Weeks)|Protocol Violation|1|||
147611350|NCT04856930|532393587|FG000|Placebo-controlled Period (16 Weeks)|Adverse Event|0|||
147611351|NCT04856930|532393588|FG001|Placebo-controlled Period (16 Weeks)|Adverse Event|0|||
147611352|NCT04856930|532393589|FG002|Placebo-controlled Period (16 Weeks)|Adverse Event|1|||
147611353|NCT04856930|532393587|FG000|Placebo-controlled Period (16 Weeks)|Use of Any Prohibited Medication or Treatment|0|||
147611354|NCT04856930|532393588|FG001|Placebo-controlled Period (16 Weeks)|Use of Any Prohibited Medication or Treatment|1|||
147611355|NCT04856930|532393589|FG002|Placebo-controlled Period (16 Weeks)|Use of Any Prohibited Medication or Treatment|0|||
147611356|NCT04856930|532393587|FG000|Extension Period (16 Weeks)|Withdrawal by Subject|9|||
147611357|NCT04856930|532393588|FG001|Extension Period (16 Weeks)|Withdrawal by Subject|5|||
147611358|NCT04856930|532393589|FG002|Extension Period (16 Weeks)|Withdrawal by Subject|1|||
147611359|NCT04856930|532393587|FG000|Extension Period (16 Weeks)|Lost to Follow-up|2|||
147611360|NCT04856930|532393588|FG001|Extension Period (16 Weeks)|Lost to Follow-up|5|||
147611361|NCT04856930|532393589|FG002|Extension Period (16 Weeks)|Lost to Follow-up|1|||
147611362|NCT04856930|532393587|FG000|Extension Period (16 Weeks)|Adverse Event|1|||
147611363|NCT04856930|532393588|FG001|Extension Period (16 Weeks)|Adverse Event|0|||
147374216|NCT03492177|531533893|FG002|Overall Study|Ongoing|17|||
147374217|NCT02499328|531533894|FG000|Overall Study|Withdrawal by Subject|1|||
147374218|NCT02499328|531533895|FG001|Overall Study|Withdrawal by Subject|1|||
147374219|NCT02499328|531533896|FG002|Overall Study|Withdrawal by Subject|5|||
147374220|NCT02499328|531533897|FG003|Overall Study|Withdrawal by Subject|3|||
147374221|NCT02499328|531533898|FG004|Overall Study|Withdrawal by Subject|5|||
147374222|NCT02499328|531533899|FG005|Overall Study|Withdrawal by Subject|0|||
147374223|NCT02499328|531533900|FG006|Overall Study|Withdrawal by Subject|0|||
147374224|NCT02499328|531533901|FG007|Overall Study|Withdrawal by Subject|0|||
147374225|NCT02499328|531533902|FG008|Overall Study|Withdrawal by Subject|2|||
147374226|NCT02499328|531533903|FG009|Overall Study|Withdrawal by Subject|2|||
147374227|NCT02499328|531533904|FG010|Overall Study|Withdrawal by Subject|0|||
147374228|NCT02499328|531533905|FG011|Overall Study|Withdrawal by Subject|3|||
147374229|NCT02499328|531533906|FG012|Overall Study|Withdrawal by Subject|7|||
147374230|NCT02499328|531533907|FG013|Overall Study|Withdrawal by Subject|3|||
147374231|NCT02499328|531533908|FG014|Overall Study|Withdrawal by Subject|1|||
147374232|NCT02499328|531533909|FG015|Overall Study|Withdrawal by Subject|0|||
147374233|NCT02499328|531533910|FG016|Overall Study|Withdrawal by Subject|0|||
147374234|NCT02499328|531533911|FG017|Overall Study|Withdrawal by Subject|3|||
147374235|NCT02499328|531533912|FG018|Overall Study|Withdrawal by Subject|0|||
147374236|NCT02499328|531533894|FG000|Overall Study|Lost to Follow-up|0|||
147374237|NCT02499328|531533895|FG001|Overall Study|Lost to Follow-up|1|||
147374238|NCT02499328|531533896|FG002|Overall Study|Lost to Follow-up|1|||
147374239|NCT02499328|531533897|FG003|Overall Study|Lost to Follow-up|2|||
147374240|NCT02499328|531533898|FG004|Overall Study|Lost to Follow-up|0|||
147374241|NCT02499328|531533899|FG005|Overall Study|Lost to Follow-up|0|||
147374242|NCT02499328|531533900|FG006|Overall Study|Lost to Follow-up|0|||
147374243|NCT02499328|531533901|FG007|Overall Study|Lost to Follow-up|2|||
147374244|NCT02499328|531533902|FG008|Overall Study|Lost to Follow-up|3|||
147374245|NCT02499328|531533903|FG009|Overall Study|Lost to Follow-up|0|||
147374246|NCT02499328|531533904|FG010|Overall Study|Lost to Follow-up|0|||
147374247|NCT02499328|531533905|FG011|Overall Study|Lost to Follow-up|0|||
147374248|NCT02499328|531533906|FG012|Overall Study|Lost to Follow-up|0|||
147374249|NCT02499328|531533907|FG013|Overall Study|Lost to Follow-up|0|||
147374250|NCT02499328|531533908|FG014|Overall Study|Lost to Follow-up|0|||
147374251|NCT02499328|531533909|FG015|Overall Study|Lost to Follow-up|0|||
147374252|NCT02499328|531533910|FG016|Overall Study|Lost to Follow-up|0|||
147374253|NCT02499328|531533911|FG017|Overall Study|Lost to Follow-up|0|||
147374254|NCT02499328|531533912|FG018|Overall Study|Lost to Follow-up|1|||
147374255|NCT02499328|531533894|FG000|Overall Study|Death|0|||
147374256|NCT02499328|531533895|FG001|Overall Study|Death|3|||
147374257|NCT02499328|531533896|FG002|Overall Study|Death|3|||
147374258|NCT02499328|531533897|FG003|Overall Study|Death|2|||
147374259|NCT02499328|531533898|FG004|Overall Study|Death|4|||
147374260|NCT02499328|531533899|FG005|Overall Study|Death|7|||
147374261|NCT02499328|531533900|FG006|Overall Study|Death|3|||
147374262|NCT02499328|531533901|FG007|Overall Study|Death|0|||
147374263|NCT02499328|531533902|FG008|Overall Study|Death|2|||
147374264|NCT02499328|531533903|FG009|Overall Study|Death|6|||
147374265|NCT02499328|531533904|FG010|Overall Study|Death|6|||
147374266|NCT02499328|531533905|FG011|Overall Study|Death|20|||
147374267|NCT02499328|531533906|FG012|Overall Study|Death|9|||
147374268|NCT02499328|531533907|FG013|Overall Study|Death|7|||
147374269|NCT02499328|531533908|FG014|Overall Study|Death|3|||
147374270|NCT02499328|531533909|FG015|Overall Study|Death|1|||
147374271|NCT02499328|531533910|FG016|Overall Study|Death|1|||
147374272|NCT02499328|531533911|FG017|Overall Study|Death|16|||
147374273|NCT02499328|531533912|FG018|Overall Study|Death|5|||
147374274|NCT02499328|531533894|FG000|Overall Study|"Other"|2|||
147374275|NCT02499328|531533895|FG001|Overall Study|"Other"|2|||
147374276|NCT02499328|531533896|FG002|Overall Study|"Other"|1|||
147374277|NCT02499328|531533897|FG003|Overall Study|"Other"|3|||
147374278|NCT02499328|531533898|FG004|Overall Study|"Other"|6|||
147374279|NCT02499328|531533899|FG005|Overall Study|"Other"|2|||
147374280|NCT02499328|531533900|FG006|Overall Study|"Other"|3|||
147374281|NCT02499328|531533901|FG007|Overall Study|"Other"|4|||
147664197|NCT03589807|532594472|FG005|Overall Study|Enrolled but treatment not administered|0|||
147374282|NCT02499328|531533902|FG008|Overall Study|"Other"|6|||
147374283|NCT02499328|531533903|FG009|Overall Study|"Other"|16|||
147374284|NCT02499328|531533904|FG010|Overall Study|"Other"|13|||
147374285|NCT02499328|531533905|FG011|Overall Study|"Other"|31|||
147374286|NCT02499328|531533906|FG012|Overall Study|"Other"|8|||
147374287|NCT02499328|531533907|FG013|Overall Study|"Other"|7|||
147374288|NCT02499328|531533908|FG014|Overall Study|"Other"|6|||
147374289|NCT02499328|531533909|FG015|Overall Study|"Other"|0|||
147374290|NCT02499328|531533910|FG016|Overall Study|"Other"|0|||
147374291|NCT02499328|531533911|FG017|Overall Study|"Other"|34|||
147374292|NCT02499328|531533912|FG018|Overall Study|"Other"|43|||
147664198|NCT00338741|532594473|FG000|Overall Study|Lost to Follow-up|2|||
147374293|NCT02499328|531533894|FG000|Overall Study|Disease Progression|0|||
147374294|NCT02499328|531533895|FG001|Overall Study|Disease Progression|0|||
147374295|NCT02499328|531533896|FG002|Overall Study|Disease Progression|0|||
147374296|NCT02499328|531533897|FG003|Overall Study|Disease Progression|0|||
147374297|NCT02499328|531533898|FG004|Overall Study|Disease Progression|0|||
147374298|NCT02499328|531533899|FG005|Overall Study|Disease Progression|0|||
147374299|NCT02499328|531533900|FG006|Overall Study|Disease Progression|1|||
147374300|NCT02499328|531533901|FG007|Overall Study|Disease Progression|0|||
147374301|NCT02499328|531533902|FG008|Overall Study|Disease Progression|1|||
147374302|NCT02499328|531533903|FG009|Overall Study|Disease Progression|0|||
147374303|NCT02499328|531533904|FG010|Overall Study|Disease Progression|1|||
147664199|NCT00338741|532594474|FG001|Overall Study|Lost to Follow-up|0|||
147664200|NCT01534273|532594475|FG000|Period 1|Physician Decision|0|||
147664201|NCT01534273|532594476|FG001|Period 1|Physician Decision|0|||
147664202|NCT01534273|532594477|FG002|Period 1|Physician Decision|0|||
147664203|NCT01534273|532594478|FG003|Period 1|Physician Decision|1|||
147664204|NCT01534273|532594479|FG004|Period 1|Physician Decision|0|||
147664205|NCT01534273|532594480|FG005|Period 1|Physician Decision|0|||
147664206|NCT01534273|532594481|FG006|Period 1|Physician Decision|0|||
147664207|NCT01619865|532594482|FG000|Overall Study|Adverse Event|1|||
147664208|NCT01619865|532594482|FG000|Overall Study|Death|2|||
147664209|NCT01619865|532594482|FG000|Overall Study|subject not able to comply|1|||
147664210|NCT03586050|532594483|FG000|Overall Study|Death|3|||
147664211|NCT03586050|532594483|FG000|Overall Study|Withdrawal by Subject|2|||
147664212|NCT01494818|532594484|FG000|Overall Study|Relocation|1|||
147664213|NCT01494818|532594485|FG001|Overall Study|Relocation|2|||
147664214|NCT01494818|532594484|FG000|Overall Study|Lost to Follow-up|1|||
147664215|NCT01494818|532594485|FG001|Overall Study|Lost to Follow-up|0|||
147664216|NCT00593918|532594486|FG000|Overall Study|Withdrawal by Subject|5|||
147664217|NCT00593918|532594487|FG001|Overall Study|Withdrawal by Subject|24|||
147664218|NCT01211145|532594491|FG000|Overall Study|Reason not specified|3|||
147664219|NCT01211145|532594492|FG001|Overall Study|Reason not specified|2|||
147664220|NCT01211145|532594493|FG002|Overall Study|Reason not specified|2|||
147664221|NCT01211145|532594494|FG003|Overall Study|Reason not specified|1|||
147664222|NCT01211145|532594491|FG000|Overall Study|Lost to Follow-up|3|||
147664223|NCT01211145|532594492|FG001|Overall Study|Lost to Follow-up|2|||
147664224|NCT01211145|532594493|FG002|Overall Study|Lost to Follow-up|1|||
147664225|NCT01211145|532594494|FG003|Overall Study|Lost to Follow-up|2|||
147664226|NCT01211145|532594491|FG000|Overall Study|Study-specific withdrawal criteria|1|||
147664227|NCT01211145|532594492|FG001|Overall Study|Study-specific withdrawal criteria|0|||
147664228|NCT01211145|532594493|FG002|Overall Study|Study-specific withdrawal criteria|0|||
147664229|NCT01211145|532594494|FG003|Overall Study|Study-specific withdrawal criteria|0|||
147664230|NCT01211145|532594491|FG000|Overall Study|Severe noncompliance to protocol|1|||
147664231|NCT01211145|532594492|FG001|Overall Study|Severe noncompliance to protocol|0|||
147664232|NCT01211145|532594493|FG002|Overall Study|Severe noncompliance to protocol|0|||
147664233|NCT01211145|532594494|FG003|Overall Study|Severe noncompliance to protocol|0|||
147664234|NCT01211145|532594491|FG000|Overall Study|Eligibility criteria not fulfilled|16|||
147664235|NCT01211145|532594492|FG001|Overall Study|Eligibility criteria not fulfilled|12|||
147664236|NCT01211145|532594493|FG002|Overall Study|Eligibility criteria not fulfilled|10|||
147664237|NCT01211145|532594494|FG003|Overall Study|Eligibility criteria not fulfilled|15|||
147664238|NCT01211145|532594491|FG000|Overall Study|Patient decision|2|||
147664239|NCT01211145|532594492|FG001|Overall Study|Patient decision|1|||
147664240|NCT01211145|532594493|FG002|Overall Study|Patient decision|0|||
147664241|NCT01211145|532594494|FG003|Overall Study|Patient decision|2|||
147664242|NCT00791999|532594495|FG000|Overall Study|Protocol planed withdrawal|14|||
147664243|NCT00791999|532594496|FG001|Overall Study|Protocol planed withdrawal|11|||
147664244|NCT00791999|532594497|FG002|Overall Study|Protocol planed withdrawal|11|||
147664245|NCT00791999|532594498|FG003|Overall Study|Protocol planed withdrawal|45|||
147664246|NCT00791999|532594495|FG000|Overall Study|Withdrawal by Subject|0|||
147664247|NCT00791999|532594496|FG001|Overall Study|Withdrawal by Subject|1|||
147664248|NCT00791999|532594497|FG002|Overall Study|Withdrawal by Subject|0|||
147664249|NCT00791999|532594498|FG003|Overall Study|Withdrawal by Subject|2|||
147664250|NCT00791999|532594495|FG000|Overall Study|Protocol Violation|3|||
147664251|NCT00791999|532594496|FG001|Overall Study|Protocol Violation|0|||
147664252|NCT00791999|532594497|FG002|Overall Study|Protocol Violation|1|||
147664253|NCT00791999|532594498|FG003|Overall Study|Protocol Violation|0|||
147664254|NCT00791999|532594495|FG000|Overall Study|Adverse Event|3|||
147455369|NCT01687712|531827878|FG000|Cycle 1|Intrauterine Fetal Death|0|||
147455370|NCT01687712|531827879|FG001|Cycle 1|Intrauterine Fetal Death|1|||
147455371|NCT01687712|531827878|FG000|Cycle 1|Lost to Follow-up|1|||
147664255|NCT00791999|532594496|FG001|Overall Study|Adverse Event|3|||
147664256|NCT00791999|532594497|FG002|Overall Study|Adverse Event|7|||
147664257|NCT00791999|532594498|FG003|Overall Study|Adverse Event|3|||
147664258|NCT00791999|532594495|FG000|Overall Study|Lack of Efficacy|0|||
147664259|NCT00791999|532594496|FG001|Overall Study|Lack of Efficacy|1|||
147664260|NCT00791999|532594497|FG002|Overall Study|Lack of Efficacy|0|||
147455372|NCT01687712|531827879|FG001|Cycle 1|Lost to Follow-up|1|||
147455373|NCT01687712|531827878|FG000|Cycle 2|Not Biochemically Pregnant|74|||
147664261|NCT00791999|532594498|FG003|Overall Study|Lack of Efficacy|2|||
147664262|NCT00791999|532594495|FG000|Overall Study|Reason other than those above|1|||
147300152|NCT05701995|531264659|FG001|Treatment|Lost to Follow-up|3|||
147455374|NCT01687712|531827879|FG001|Cycle 2|Not Biochemically Pregnant|77|||
147664263|NCT00791999|532594496|FG001|Overall Study|Reason other than those above|0|||
147664264|NCT00791999|532594497|FG002|Overall Study|Reason other than those above|1|||
147664265|NCT00791999|532594498|FG003|Overall Study|Reason other than those above|0|||
147664266|NCT00617357|532594503|FG000|Overall Study|Lost to Follow-up|7|||
147664267|NCT00617357|532594503|FG000|Overall Study|Death|5|||
147664268|NCT00617357|532594503|FG000|Overall Study|insurance concerns|2|||
147664269|NCT00617357|532594503|FG000|Overall Study|Withdrawal by Subject|1|||
147455375|NCT01687712|531827878|FG000|Cycle 2|Early Pregnancy Loss|18|||
147455376|NCT01687712|531827879|FG001|Cycle 2|Early Pregnancy Loss|16|||
147455377|NCT01687712|531827878|FG000|Cycle 2|Ectopic Pregnancy|0|||
147455378|NCT01687712|531827879|FG001|Cycle 2|Ectopic Pregnancy|1|||
147455379|NCT01687712|531827878|FG000|Cycle 2|Still Birth|1|||
147455380|NCT01687712|531827879|FG001|Cycle 2|Still Birth|0|||
147455381|NCT01687712|531827878|FG000|Cycle 2|Miscarriage/Spontaneous Abortion|0|||
147455382|NCT01687712|531827879|FG001|Cycle 2|Miscarriage/Spontaneous Abortion|1|||
147455383|NCT01687712|531827878|FG000|Cycle 3|Not Biochemically Pregnant|21|||
147455384|NCT01687712|531827879|FG001|Cycle 3|Not Biochemically Pregnant|22|||
147455385|NCT01687712|531827878|FG000|Cycle 3|Early Pregnancy Loss|1|||
147455386|NCT01687712|531827879|FG001|Cycle 3|Early Pregnancy Loss|2|||
147455387|NCT01687712|531827878|FG000|Cycle 3|Ectopic Pregnancy|1|||
147455388|NCT01687712|531827879|FG001|Cycle 3|Ectopic Pregnancy|0|||
147455389|NCT01687712|531827878|FG000|Cycle 3|Miscarriage/Spontaneous Abortion|1|||
147455390|NCT01687712|531827879|FG001|Cycle 3|Miscarriage/Spontaneous Abortion|0|||
147455391|NCT01681433|531827880|FG000|Overall Study|Lack of Efficacy|23|||
147455392|NCT01681433|531827881|FG001|Overall Study|Lack of Efficacy|23|||
147455393|NCT01681433|531827880|FG000|Overall Study|Withdrawal by Subject|5|||
147455394|NCT01681433|531827881|FG001|Overall Study|Withdrawal by Subject|5|||
147455395|NCT01681433|531827880|FG000|Overall Study|Protocol Violation|2|||
147455396|NCT01681433|531827881|FG001|Overall Study|Protocol Violation|0|||
147455397|NCT01681433|531827880|FG000|Overall Study|Adverse Event|2|||
147455398|NCT01681433|531827881|FG001|Overall Study|Adverse Event|4|||
147455399|NCT01681433|531827880|FG000|Overall Study|Lost to Follow-up|0|||
147455400|NCT01681433|531827881|FG001|Overall Study|Lost to Follow-up|1|||
147455401|NCT00730639|531827882|FG000|Overall Study|Adverse Event|3|||
147455402|NCT00730639|531827883|FG001|Overall Study|Adverse Event|0|||
147455403|NCT00730639|531827884|FG002|Overall Study|Adverse Event|9|||
147455404|NCT00730639|531827885|FG003|Overall Study|Adverse Event|8|||
147455405|NCT00730639|531827886|FG004|Overall Study|Adverse Event|23|||
147455406|NCT00730639|531827882|FG000|Overall Study|Complete Response|0|||
147455407|NCT00730639|531827883|FG001|Overall Study|Complete Response|0|||
147455408|NCT00730639|531827884|FG002|Overall Study|Complete Response|2|||
147455409|NCT00730639|531827885|FG003|Overall Study|Complete Response|2|||
147455410|NCT00730639|531827886|FG004|Overall Study|Complete Response|1|||
147455411|NCT00730639|531827882|FG000|Overall Study|Completed Maximum Cycles|0|||
147455412|NCT00730639|531827883|FG001|Overall Study|Completed Maximum Cycles|0|||
147455413|NCT00730639|531827884|FG002|Overall Study|Completed Maximum Cycles|11|||
147455414|NCT00730639|531827885|FG003|Overall Study|Completed Maximum Cycles|3|||
147455415|NCT00730639|531827886|FG004|Overall Study|Completed Maximum Cycles|6|||
147455416|NCT00730639|531827882|FG000|Overall Study|Death|0|||
147455417|NCT00730639|531827883|FG001|Overall Study|Death|0|||
147455418|NCT00730639|531827884|FG002|Overall Study|Death|0|||
147455419|NCT00730639|531827885|FG003|Overall Study|Death|0|||
147455420|NCT00730639|531827886|FG004|Overall Study|Death|2|||
147455421|NCT00730639|531827882|FG000|Overall Study|Disease Progression|12|||
147455422|NCT00730639|531827883|FG001|Overall Study|Disease Progression|13|||
147455423|NCT00730639|531827884|FG002|Overall Study|Disease Progression|48|||
147455424|NCT00730639|531827885|FG003|Overall Study|Disease Progression|32|||
147455425|NCT00730639|531827886|FG004|Overall Study|Disease Progression|88|||
147455426|NCT00730639|531827882|FG000|Overall Study|non-specified|0|||
147455427|NCT00730639|531827883|FG001|Overall Study|non-specified|0|||
147455428|NCT00730639|531827884|FG002|Overall Study|non-specified|4|||
147455429|NCT00730639|531827885|FG003|Overall Study|non-specified|2|||
147455430|NCT00730639|531827886|FG004|Overall Study|non-specified|3|||
147455431|NCT00730639|531827882|FG000|Overall Study|Protocol Violation|0|||
147455432|NCT00730639|531827883|FG001|Overall Study|Protocol Violation|0|||
147455433|NCT00730639|531827884|FG002|Overall Study|Protocol Violation|1|||
147455434|NCT00730639|531827885|FG003|Overall Study|Protocol Violation|0|||
147455435|NCT00730639|531827886|FG004|Overall Study|Protocol Violation|0|||
147455436|NCT00730639|531827882|FG000|Overall Study|Withdrawal by Subject|0|||
147455437|NCT00730639|531827883|FG001|Overall Study|Withdrawal by Subject|0|||
147455438|NCT00730639|531827884|FG002|Overall Study|Withdrawal by Subject|6|||
147455439|NCT00730639|531827885|FG003|Overall Study|Withdrawal by Subject|3|||
147455440|NCT00730639|531827886|FG004|Overall Study|Withdrawal by Subject|4|||
147455441|NCT00730639|531827882|FG000|Overall Study|Treatment on-going|2|||
147455442|NCT00730639|531827883|FG001|Overall Study|Treatment on-going|5|||
147455443|NCT00730639|531827884|FG002|Overall Study|Treatment on-going|5|||
147455444|NCT00730639|531827885|FG003|Overall Study|Treatment on-going|4|||
147455445|NCT00730639|531827886|FG004|Overall Study|Treatment on-going|4|||
147455446|NCT00903929|531827887|FG000|Overall Study|Withdrawal by Subject|0|||
147611364|NCT04856930|532393589|FG002|Extension Period (16 Weeks)|Adverse Event|1|||
147455447|NCT00903929|531827888|FG001|Overall Study|Withdrawal by Subject|0|||
147455448|NCT00903929|531827889|FG002|Overall Study|Withdrawal by Subject|1|||
147455449|NCT00903929|531827890|FG003|Overall Study|Withdrawal by Subject|2|||
147455450|NCT00903929|531827887|FG000|Overall Study|Adverse Event|0|||
147455451|NCT00903929|531827888|FG001|Overall Study|Adverse Event|0|||
147455452|NCT00903929|531827889|FG002|Overall Study|Adverse Event|0|||
147455453|NCT00903929|531827890|FG003|Overall Study|Adverse Event|1|||
147455454|NCT01844895|531827893|FG000|Day 1 to Day 28 - Pre-filled Syringe|Adverse Event|1|||
147455455|NCT01844895|531827893|FG000|Day 1 to Day 28 - Pre-filled Syringe|Withdrawal by Subject|1|||
147455456|NCT01844895|531827893|FG000|Day 1 to Day 28 - Pre-filled Syringe|Clinic Closed|1|||
147455457|NCT01844895|531827893|FG000|Day 29 - Day113 - Autoinjector|Adverse Event|1|||
147455458|NCT01844895|531827893|FG000|Day 29 - Day113 - Autoinjector|Withdrawal by Subject|1|||
147455459|NCT01844895|531827893|FG000|Day 29 - Day113 - Autoinjector|Difficulty using device|3|||
147455460|NCT01844895|531827893|FG000|Day 29 - Day113 - Autoinjector|planned surgery|1|||
147455461|NCT05061719|531827898|FG000|Overall Study|Adverse Event|60|||
147455462|NCT05061719|531827898|FG000|Overall Study|Death|1|||
147455463|NCT05061719|531827898|FG000|Overall Study|Lack of Efficacy|7|||
147455464|NCT05061719|531827898|FG000|Overall Study|Lost to Follow-up|5|||
147455465|NCT05061719|531827898|FG000|Overall Study|Pregnancy|1|||
147455466|NCT05061719|531827898|FG000|Overall Study|Protocol Violation|8|||
147455467|NCT05061719|531827898|FG000|Overall Study|Withdrawal by Subject|41|||
147455468|NCT05061719|531827898|FG000|Overall Study|Site Closure|2|||
147455469|NCT04341948|531827899|FG000|Overall Study|Adverse Event|0|||
147455470|NCT04341948|531827900|FG001|Overall Study|Adverse Event|1|||
147455471|NCT04341948|531827899|FG000|Overall Study|Lost to Follow-up|6|||
147455472|NCT04341948|531827900|FG001|Overall Study|Lost to Follow-up|1|||
147455473|NCT04341948|531827899|FG000|Overall Study|Physician Decision|1|||
147455474|NCT04341948|531827900|FG001|Overall Study|Physician Decision|2|||
147455475|NCT04341948|531827899|FG000|Overall Study|Withdrawal by Participant|6|||
147455476|NCT04341948|531827900|FG001|Overall Study|Withdrawal by Participant|3|||
147455477|NCT04341948|531827899|FG000|Overall Study|Lack of compliance by Participant|1|||
147455478|NCT04341948|531827900|FG001|Overall Study|Lack of compliance by Participant|0|||
147455479|NCT00482014|531829836|FG000|Overall Study|Withdrawal by Subject|1|||
147455480|NCT00482014|531829837|FG001|Overall Study|Withdrawal by Subject|2|||
147374304|NCT02499328|531533905|FG011|Overall Study|Disease Progression|0|||
147374305|NCT02499328|531533906|FG012|Overall Study|Disease Progression|0|||
147374306|NCT02499328|531533907|FG013|Overall Study|Disease Progression|0|||
147374307|NCT02499328|531533908|FG014|Overall Study|Disease Progression|0|||
147374308|NCT02499328|531533909|FG015|Overall Study|Disease Progression|0|||
147374309|NCT02499328|531533910|FG016|Overall Study|Disease Progression|0|||
147374310|NCT02499328|531533911|FG017|Overall Study|Disease Progression|2|||
147374311|NCT02499328|531533912|FG018|Overall Study|Disease Progression|0|||
147374312|NCT02499328|531533894|FG000|Overall Study|Adverse Event|1|||
147374313|NCT02499328|531533895|FG001|Overall Study|Adverse Event|0|||
147374314|NCT02499328|531533896|FG002|Overall Study|Adverse Event|0|||
147374315|NCT02499328|531533897|FG003|Overall Study|Adverse Event|1|||
147374316|NCT02499328|531533898|FG004|Overall Study|Adverse Event|0|||
147374317|NCT02499328|531533899|FG005|Overall Study|Adverse Event|0|||
147374318|NCT02499328|531533900|FG006|Overall Study|Adverse Event|0|||
147374319|NCT02499328|531533901|FG007|Overall Study|Adverse Event|0|||
147374320|NCT02499328|531533902|FG008|Overall Study|Adverse Event|0|||
147374321|NCT02499328|531533903|FG009|Overall Study|Adverse Event|0|||
147374322|NCT02499328|531533904|FG010|Overall Study|Adverse Event|0|||
147374323|NCT02499328|531533905|FG011|Overall Study|Adverse Event|0|||
147374324|NCT02499328|531533906|FG012|Overall Study|Adverse Event|1|||
147374325|NCT02499328|531533907|FG013|Overall Study|Adverse Event|0|||
147374326|NCT02499328|531533908|FG014|Overall Study|Adverse Event|0|||
147374327|NCT02499328|531533909|FG015|Overall Study|Adverse Event|0|||
147374328|NCT02499328|531533910|FG016|Overall Study|Adverse Event|0|||
147374329|NCT02499328|531533911|FG017|Overall Study|Adverse Event|0|||
147374330|NCT02499328|531533912|FG018|Overall Study|Adverse Event|0|||
147374331|NCT01400958|531533915|FG000|Overall Study|Physician Decision|0|||
147374332|NCT01400958|531533916|FG001|Overall Study|Physician Decision|1|||
147374333|NCT01400958|531533915|FG000|Overall Study|Withdrawal by Subject|0|||
147374334|NCT01400958|531533916|FG001|Overall Study|Withdrawal by Subject|1|||
147374335|NCT01400958|531533915|FG000|Overall Study|Adverse Event|1|||
147374336|NCT01400958|531533916|FG001|Overall Study|Adverse Event|0|||
147374337|NCT03102034|531533917|FG000|Overall Study|Withdrawal by Subject|1|||
147374338|NCT03102034|531533918|FG001|Overall Study|Withdrawal by Subject|0|||
147374339|NCT05663866|531533923|FG000|Overall Study|Adverse Event|0|||
147374340|NCT05663866|531533924|FG001|Overall Study|Adverse Event|0|||
147455481|NCT00482014|531829838|FG002|Overall Study|Withdrawal by Subject|3|||
147455482|NCT00482014|531829839|FG003|Overall Study|Withdrawal by Subject|4|||
147455483|NCT00482014|531829836|FG000|Overall Study|Adverse Event|3|||
147374341|NCT05663866|531533925|FG002|Overall Study|Adverse Event|1|||
147374342|NCT05663866|531533926|FG003|Overall Study|Adverse Event|0|||
147374343|NCT05663866|531533923|FG000|Overall Study|Physician Decision|0|||
147374344|NCT05663866|531533924|FG001|Overall Study|Physician Decision|0|||
147374345|NCT05663866|531533925|FG002|Overall Study|Physician Decision|0|||
147374346|NCT05663866|531533926|FG003|Overall Study|Physician Decision|1|||
147374347|NCT05663866|531533923|FG000|Overall Study|Withdrawal by Subject|0|||
147374348|NCT05663866|531533924|FG001|Overall Study|Withdrawal by Subject|2|||
147374349|NCT05663866|531533925|FG002|Overall Study|Withdrawal by Subject|1|||
147374350|NCT05663866|531533926|FG003|Overall Study|Withdrawal by Subject|2|||
147374351|NCT05663866|531533923|FG000|Overall Study|Progressive disease|4|||
147374352|NCT05663866|531533924|FG001|Overall Study|Progressive disease|8|||
147374353|NCT05663866|531533925|FG002|Overall Study|Progressive disease|5|||
147374354|NCT05663866|531533926|FG003|Overall Study|Progressive disease|2|||
147374355|NCT05663866|531533923|FG000|Overall Study|Other|1|||
147374356|NCT05663866|531533924|FG001|Overall Study|Other|0|||
147374357|NCT05663866|531533925|FG002|Overall Study|Other|0|||
147374358|NCT05663866|531533926|FG003|Overall Study|Other|0|||
147374359|NCT05663866|531533923|FG000|Overall Study|Ongoing|1|||
147374360|NCT05663866|531533924|FG001|Overall Study|Ongoing|27|||
147374361|NCT05663866|531533925|FG002|Overall Study|Ongoing|6|||
147374362|NCT05663866|531533926|FG003|Overall Study|Ongoing|1|||
147374363|NCT03598907|531533929|FG000|Overall Study|Physician Decision|14|||
147374364|NCT03598907|531533930|FG001|Overall Study|Physician Decision|19|||
147374365|NCT05741528|531533931|FG000|Overall Study|Withdrawal by Subject|11|||
147374366|NCT05741528|531533931|FG000|Overall Study|Lost to Follow-up|3|||
147374367|NCT05741528|531533931|FG000|Overall Study|Adverse Event|2|||
147374368|NCT05741528|531533931|FG000|Overall Study|Non-Compliance With Study Drug|2|||
147374369|NCT05741528|531533931|FG000|Overall Study|Reason Not Specified|1|||
147374370|NCT03656718|531533934|FG000|Treatment Period Parts A, B, D, and E|Disease progression|8|||
147374371|NCT03656718|531533935|FG001|Treatment Period Parts A, B, D, and E|Disease progression|11|||
147374372|NCT03656718|531533936|FG002|Treatment Period Parts A, B, D, and E|Disease progression|4|||
147374373|NCT03656718|531533937|FG003|Treatment Period Parts A, B, D, and E|Disease progression|6|||
147374374|NCT03656718|531533938|FG004|Treatment Period Parts A, B, D, and E|Disease progression|0|||
147374375|NCT03656718|531533939|FG005|Treatment Period Parts A, B, D, and E|Disease progression|20|||
147374376|NCT03656718|531533940|FG006|Treatment Period Parts A, B, D, and E|Disease progression|21|||
147374377|NCT03656718|531533934|FG000|Treatment Period Parts A, B, D, and E|Study drug toxicity|2|||
147374378|NCT03656718|531533935|FG001|Treatment Period Parts A, B, D, and E|Study drug toxicity|1|||
147374379|NCT03656718|531533936|FG002|Treatment Period Parts A, B, D, and E|Study drug toxicity|1|||
147374380|NCT03656718|531533937|FG003|Treatment Period Parts A, B, D, and E|Study drug toxicity|2|||
147374381|NCT03656718|531533938|FG004|Treatment Period Parts A, B, D, and E|Study drug toxicity|0|||
147374382|NCT03656718|531533939|FG005|Treatment Period Parts A, B, D, and E|Study drug toxicity|4|||
147374383|NCT03656718|531533940|FG006|Treatment Period Parts A, B, D, and E|Study drug toxicity|1|||
147611365|NCT04856930|532393587|FG000|Extension Period (16 Weeks)|Pregnancy|0|||
147611366|NCT04856930|532393588|FG001|Extension Period (16 Weeks)|Pregnancy|0|||
147611367|NCT04856930|532393589|FG002|Extension Period (16 Weeks)|Pregnancy|2|||
147611368|NCT04856930|532393587|FG000|Extension Period (16 Weeks)|Use of Any Prohibited Medication or Treatment|1|||
147611369|NCT04856930|532393588|FG001|Extension Period (16 Weeks)|Use of Any Prohibited Medication or Treatment|0|||
147611370|NCT04856930|532393589|FG002|Extension Period (16 Weeks)|Use of Any Prohibited Medication or Treatment|0|||
147611371|NCT04856930|532393587|FG000|Extension Period (16 Weeks)|Stopped participation by Sponsor|0|||
147611372|NCT04856930|532393588|FG001|Extension Period (16 Weeks)|Stopped participation by Sponsor|0|||
147611373|NCT04856930|532393589|FG002|Extension Period (16 Weeks)|Stopped participation by Sponsor|2|||
147611374|NCT04856930|532393587|FG000|Extension Period (16 Weeks)|Other than specified|0|||
147611375|NCT04856930|532393588|FG001|Extension Period (16 Weeks)|Other than specified|0|||
147611376|NCT04856930|532393589|FG002|Extension Period (16 Weeks)|Other than specified|1|||
147611377|NCT04856930|532393587|FG000|Follow-up Period (8 Weeks)|Withdrawal by Subject|3|||
147611378|NCT04856930|532393588|FG001|Follow-up Period (8 Weeks)|Withdrawal by Subject|2|||
147611379|NCT04856930|532393589|FG002|Follow-up Period (8 Weeks)|Withdrawal by Subject|3|||
147611380|NCT04856930|532393587|FG000|Follow-up Period (8 Weeks)|Lost to Follow-up|0|||
147611381|NCT04856930|532393588|FG001|Follow-up Period (8 Weeks)|Lost to Follow-up|0|||
147611382|NCT04856930|532393589|FG002|Follow-up Period (8 Weeks)|Lost to Follow-up|1|||
147611383|NCT04856930|532393587|FG000|Follow-up Period (8 Weeks)|Adverse Event|0|||
147611384|NCT04856930|532393588|FG001|Follow-up Period (8 Weeks)|Adverse Event|0|||
147611385|NCT04856930|532393589|FG002|Follow-up Period (8 Weeks)|Adverse Event|1|||
147611386|NCT04856930|532393587|FG000|Follow-up Period (8 Weeks)|Stopped participation by Sponsor|12|||
147611387|NCT04856930|532393588|FG001|Follow-up Period (8 Weeks)|Stopped participation by Sponsor|12|||
147611388|NCT04856930|532393589|FG002|Follow-up Period (8 Weeks)|Stopped participation by Sponsor|17|||
147611389|NCT01009814|532393592|FG000|Overall Study|No longer met study criteria|1|||
147611390|NCT01009814|532393593|FG001|Overall Study|No longer met study criteria|1|||
147611391|NCT01009814|532393594|FG002|Overall Study|No longer met study criteria|0|||
147611392|NCT01009814|532393595|FG003|Overall Study|No longer met study criteria|0|||
147611393|NCT01009814|532393596|FG004|Overall Study|No longer met study criteria|0|||
147611394|NCT00618371|532393597|FG000|Overall Study|Withdrawal by Subject|2|||
147611395|NCT03055624|532393598|FG000|Overall Study|Study closed|9|||
147611396|NCT01434810|532393599|FG000|Overall Study|Did not receive treatment|11|||
147611397|NCT01434810|532393600|FG001|Overall Study|Did not receive treatment|3|||
147374384|NCT03656718|531533934|FG000|Treatment Period Parts A, B, D, and E|Death|1|||
147374385|NCT03656718|531533935|FG001|Treatment Period Parts A, B, D, and E|Death|0|||
147374386|NCT03656718|531533936|FG002|Treatment Period Parts A, B, D, and E|Death|0|||
147374387|NCT03656718|531533937|FG003|Treatment Period Parts A, B, D, and E|Death|0|||
147374388|NCT03656718|531533938|FG004|Treatment Period Parts A, B, D, and E|Death|0|||
147455484|NCT00482014|531829837|FG001|Overall Study|Adverse Event|0|||
147374389|NCT03656718|531533939|FG005|Treatment Period Parts A, B, D, and E|Death|0|||
147374390|NCT03656718|531533940|FG006|Treatment Period Parts A, B, D, and E|Death|2|||
147374391|NCT03656718|531533934|FG000|Treatment Period Parts A, B, D, and E|Adverse event unrelated to study drug|0|||
147374392|NCT03656718|531533935|FG001|Treatment Period Parts A, B, D, and E|Adverse event unrelated to study drug|0|||
147374393|NCT03656718|531533936|FG002|Treatment Period Parts A, B, D, and E|Adverse event unrelated to study drug|0|||
147374394|NCT03656718|531533937|FG003|Treatment Period Parts A, B, D, and E|Adverse event unrelated to study drug|0|||
147374395|NCT03656718|531533938|FG004|Treatment Period Parts A, B, D, and E|Adverse event unrelated to study drug|0|||
147374396|NCT03656718|531533939|FG005|Treatment Period Parts A, B, D, and E|Adverse event unrelated to study drug|4|||
147374397|NCT03656718|531533940|FG006|Treatment Period Parts A, B, D, and E|Adverse event unrelated to study drug|1|||
147374398|NCT03656718|531533934|FG000|Treatment Period Parts A, B, D, and E|Participant requested to discontinue study treatment|1|||
147374399|NCT03656718|531533935|FG001|Treatment Period Parts A, B, D, and E|Participant requested to discontinue study treatment|0|||
147374400|NCT03656718|531533936|FG002|Treatment Period Parts A, B, D, and E|Participant requested to discontinue study treatment|0|||
147374401|NCT03656718|531533937|FG003|Treatment Period Parts A, B, D, and E|Participant requested to discontinue study treatment|0|||
147374402|NCT03656718|531533938|FG004|Treatment Period Parts A, B, D, and E|Participant requested to discontinue study treatment|0|||
147374403|NCT03656718|531533939|FG005|Treatment Period Parts A, B, D, and E|Participant requested to discontinue study treatment|0|||
147374404|NCT03656718|531533940|FG006|Treatment Period Parts A, B, D, and E|Participant requested to discontinue study treatment|2|||
147374405|NCT03656718|531533934|FG000|Treatment Period Parts A, B, D, and E|Other reasons|0|||
147374406|NCT03656718|531533935|FG001|Treatment Period Parts A, B, D, and E|Other reasons|0|||
147374407|NCT03656718|531533936|FG002|Treatment Period Parts A, B, D, and E|Other reasons|0|||
147374408|NCT03656718|531533937|FG003|Treatment Period Parts A, B, D, and E|Other reasons|0|||
147374409|NCT03656718|531533938|FG004|Treatment Period Parts A, B, D, and E|Other reasons|0|||
147374410|NCT03656718|531533939|FG005|Treatment Period Parts A, B, D, and E|Other reasons|1|||
147374411|NCT03656718|531533940|FG006|Treatment Period Parts A, B, D, and E|Other reasons|3|||
147374412|NCT03656718|531533934|FG000|Treatment Period Part C|Disease progression|0|||
147374413|NCT03656718|531533935|FG001|Treatment Period Part C|Disease progression|0|||
147374414|NCT03656718|531533936|FG002|Treatment Period Part C|Disease progression|0|||
147374415|NCT03656718|531533937|FG003|Treatment Period Part C|Disease progression|0|||
147374416|NCT03656718|531533938|FG004|Treatment Period Part C|Disease progression|12|||
147374417|NCT03656718|531533939|FG005|Treatment Period Part C|Disease progression|0|||
147374418|NCT03656718|531533940|FG006|Treatment Period Part C|Disease progression|0|||
147374419|NCT03656718|531533934|FG000|Treatment Period Part C|Death|0|||
147374420|NCT03656718|531533935|FG001|Treatment Period Part C|Death|0|||
147374421|NCT03656718|531533936|FG002|Treatment Period Part C|Death|0|||
147374422|NCT03656718|531533937|FG003|Treatment Period Part C|Death|0|||
147374423|NCT03656718|531533938|FG004|Treatment Period Part C|Death|1|||
147374424|NCT03656718|531533939|FG005|Treatment Period Part C|Death|0|||
147374425|NCT03656718|531533940|FG006|Treatment Period Part C|Death|0|||
147374426|NCT03656718|531533934|FG000|Treatment Period Part C|Participant requested to discontinue study treatment|0|||
147374427|NCT03656718|531533935|FG001|Treatment Period Part C|Participant requested to discontinue study treatment|0|||
147374428|NCT03656718|531533936|FG002|Treatment Period Part C|Participant requested to discontinue study treatment|0|||
147374429|NCT03656718|531533937|FG003|Treatment Period Part C|Participant requested to discontinue study treatment|0|||
147374430|NCT03656718|531533938|FG004|Treatment Period Part C|Participant requested to discontinue study treatment|1|||
147374431|NCT03656718|531533939|FG005|Treatment Period Part C|Participant requested to discontinue study treatment|0|||
147374432|NCT03656718|531533940|FG006|Treatment Period Part C|Participant requested to discontinue study treatment|0|||
147374433|NCT03656718|531533934|FG000|Treatment Period Part C|Other reasons|0|||
147374434|NCT03656718|531533935|FG001|Treatment Period Part C|Other reasons|0|||
147374435|NCT03656718|531533936|FG002|Treatment Period Part C|Other reasons|0|||
147374436|NCT03656718|531533937|FG003|Treatment Period Part C|Other reasons|0|||
147374437|NCT03656718|531533938|FG004|Treatment Period Part C|Other reasons|1|||
147374438|NCT03656718|531533939|FG005|Treatment Period Part C|Other reasons|0|||
147374439|NCT03656718|531533940|FG006|Treatment Period Part C|Other reasons|0|||
147374440|NCT03656718|531533934|FG000|Treatment Period Part C|Maximum clinical benefit|0|||
147374441|NCT03656718|531533935|FG001|Treatment Period Part C|Maximum clinical benefit|0|||
147374442|NCT03656718|531533936|FG002|Treatment Period Part C|Maximum clinical benefit|0|||
147374443|NCT03656718|531533937|FG003|Treatment Period Part C|Maximum clinical benefit|0|||
147374444|NCT03656718|531533938|FG004|Treatment Period Part C|Maximum clinical benefit|1|||
147374445|NCT03656718|531533939|FG005|Treatment Period Part C|Maximum clinical benefit|0|||
147374446|NCT03656718|531533940|FG006|Treatment Period Part C|Maximum clinical benefit|0|||
147374447|NCT00489307|531533943|FG000|Overall Study|Death|1|||
147374448|NCT00489307|531533944|FG001|Overall Study|Death|1|||
147374449|NCT00489307|531533943|FG000|Overall Study|Lost to Follow-up|2|||
147455485|NCT00482014|531829838|FG002|Overall Study|Adverse Event|2|||
147455486|NCT00482014|531829839|FG003|Overall Study|Adverse Event|8|||
147455487|NCT00482014|531829836|FG000|Overall Study|Death|1|||
147455488|NCT00482014|531829837|FG001|Overall Study|Death|2|||
147455489|NCT00482014|531829838|FG002|Overall Study|Death|1|||
147374450|NCT00489307|531533944|FG001|Overall Study|Lost to Follow-up|2|||
147374451|NCT00489307|531533943|FG000|Overall Study|Physician Decision|1|||
147374452|NCT00489307|531533944|FG001|Overall Study|Physician Decision|0|||
147374453|NCT00489307|531533943|FG000|Overall Study|Withdrawal by Subject|2|||
147374454|NCT00489307|531533944|FG001|Overall Study|Withdrawal by Subject|4|||
147374455|NCT00489307|531533943|FG000|Overall Study|Hospitalization unrelated to treatment|10|||
147374456|NCT00489307|531533944|FG001|Overall Study|Hospitalization unrelated to treatment|7|||
147374457|NCT00489307|531533943|FG000|Overall Study|Surgery after assignment|1|||
147374458|NCT00489307|531533944|FG001|Overall Study|Surgery after assignment|0|||
147374459|NCT00489307|531533943|FG000|Overall Study|Did not fill up the forms|2|||
147374460|NCT00489307|531533944|FG001|Overall Study|Did not fill up the forms|1|||
147374461|NCT00489307|531533943|FG000|Overall Study|Patient or family refusal|5|||
147374462|NCT00489307|531533944|FG001|Overall Study|Patient or family refusal|9|||
147374463|NCT02307682|531533945|FG000|Overall Study|Adverse Event|9|||
147374464|NCT02307682|531533946|FG001|Overall Study|Adverse Event|8|||
147374465|NCT02307682|531533947|FG002|Overall Study|Adverse Event|12|||
147374466|NCT02307682|531533945|FG000|Overall Study|Lack of Efficacy|1|||
147374467|NCT02307682|531533946|FG001|Overall Study|Lack of Efficacy|0|||
147374468|NCT02307682|531533947|FG002|Overall Study|Lack of Efficacy|1|||
147374469|NCT02307682|531533945|FG000|Overall Study|Physician Decision|2|||
147374470|NCT02307682|531533946|FG001|Overall Study|Physician Decision|2|||
147374471|NCT02307682|531533947|FG002|Overall Study|Physician Decision|8|||
147374472|NCT02307682|531533945|FG000|Overall Study|Progressive Disease|1|||
147374473|NCT02307682|531533946|FG001|Overall Study|Progressive Disease|0|||
147374474|NCT02307682|531533947|FG002|Overall Study|Progressive Disease|0|||
147374475|NCT02307682|531533945|FG000|Overall Study|Withdrawal by Subject|26|||
147374476|NCT02307682|531533946|FG001|Overall Study|Withdrawal by Subject|34|||
147374477|NCT02307682|531533947|FG002|Overall Study|Withdrawal by Subject|23|||
147374478|NCT02307682|531533945|FG000|Overall Study|Death|9|||
147374479|NCT02307682|531533946|FG001|Overall Study|Death|7|||
147374480|NCT02307682|531533947|FG002|Overall Study|Death|12|||
147374481|NCT02307682|531533945|FG000|Overall Study|Lost to Follow-up|1|||
147374482|NCT02307682|531533946|FG001|Overall Study|Lost to Follow-up|5|||
147374483|NCT02307682|531533947|FG002|Overall Study|Lost to Follow-up|6|||
147374484|NCT02307682|531533945|FG000|Overall Study|Protocol Deviation|0|||
147374485|NCT02307682|531533946|FG001|Overall Study|Protocol Deviation|0|||
147374486|NCT02307682|531533947|FG002|Overall Study|Protocol Deviation|2|||
147374487|NCT02307682|531533945|FG000|Overall Study|Other|1|||
147374488|NCT02307682|531533946|FG001|Overall Study|Other|1|||
147374489|NCT02307682|531533947|FG002|Overall Study|Other|0|||
147374490|NCT02517268|531533950|FG000|Overall Study|Withdrawal by Subject|1|||
147374491|NCT02517268|531533951|FG001|Overall Study|Withdrawal by Subject|0|||
147374492|NCT04686266|531533952|FG000|Overall Study|Withdrawal by Subject|0|||
147374493|NCT04686266|531533953|FG001|Overall Study|Withdrawal by Subject|1|||
147374494|NCT03227861|531533956|FG000|Main Study Period (Week 0 to Week 48)|Lost to Follow-up|4|||
147374495|NCT03227861|531533956|FG000|Main Study Period (Week 0 to Week 48)|Withdrawal by Subject|1|||
147374496|NCT03227861|531533956|FG000|Main Study Period (Week 0 to Week 48)|Adverse Event|1|||
147374497|NCT03227861|531533956|FG000|Main Study Period (Week 0 to Week 48)|Protocol Violation|1|||
147374498|NCT03227861|531533956|FG000|Main Study Period (Week 0 to Week 48)|Other|5|||
147374499|NCT03227861|531533956|FG000|Extension Period (Week 48 to Week 96)|Transition to Commercial D/C/F/TAF|55|||
147374500|NCT03227861|531533956|FG000|Extension Period (Week 48 to Week 96)|Transition to Other ARV Treatment|16|||
147374501|NCT03227861|531533956|FG000|Extension Period (Week 48 to Week 96)|Lost to Follow-up|6|||
147374502|NCT03227861|531533956|FG000|Extension Period (Week 48 to Week 96)|Adverse Event|1|||
147374503|NCT03227861|531533956|FG000|Extension Period (Week 48 to Week 96)|Other|2|||
147374504|NCT05071430|531533958|FG000|Overall Study|Adverse Event|1|||
147374505|NCT05071430|531533959|FG001|Overall Study|Adverse Event|2|||
147374506|NCT05071430|531533958|FG000|Overall Study|Lost to Follow-up|4|||
147374507|NCT05071430|531533959|FG001|Overall Study|Lost to Follow-up|4|||
147374508|NCT05071430|531533958|FG000|Overall Study|Protocol Violation|1|||
147374509|NCT05071430|531533959|FG001|Overall Study|Protocol Violation|0|||
147374510|NCT05071430|531533958|FG000|Overall Study|Withdrawal by Subject|3|||
147374511|NCT05071430|531533959|FG001|Overall Study|Withdrawal by Subject|2|||
147374512|NCT05071430|531533958|FG000|Overall Study|Other|1|||
147374513|NCT05071430|531533959|FG001|Overall Study|Other|1|||
147374514|NCT01958021|531533960|FG000|Treatment|Progressive disease|206|||
147374515|NCT01958021|531533961|FG001|Treatment|Progressive disease|265|||
147374516|NCT01958021|531533960|FG000|Treatment|Adverse Event|38|||
147374517|NCT01958021|531533961|FG001|Treatment|Adverse Event|10|||
147374518|NCT01958021|531533960|FG000|Treatment|Subject/guardian decision|29|||
147374519|NCT01958021|531533961|FG001|Treatment|Subject/guardian decision|25|||
147374520|NCT01958021|531533960|FG000|Treatment|Physician Decision|28|||
147374521|NCT01958021|531533961|FG001|Treatment|Physician Decision|21|||
147374522|NCT01958021|531533960|FG000|Treatment|Death|6|||
147374523|NCT01958021|531533961|FG001|Treatment|Death|1|||
147374524|NCT01958021|531533960|FG000|Treatment|Protocol deviation|3|||
147374525|NCT01958021|531533961|FG001|Treatment|Protocol deviation|1|||
147374526|NCT01958021|531533960|FG000|Treatment|Sponsor decision|24|||
147374527|NCT01958021|531533961|FG001|Treatment|Sponsor decision|11|||
147664270|NCT00617357|532594503|FG000|Overall Study|Physician Decision|1|||
147664271|NCT00427908|532594504|FG000|Primary Phase|Lost to Follow-up|4|||
147664272|NCT00427908|532594505|FG001|Primary Phase|Lost to Follow-up|0|||
147664273|NCT00427908|532594506|FG002|Primary Phase|Lost to Follow-up|2|||
147664274|NCT00427908|532594507|FG003|Primary Phase|Lost to Follow-up|0|||
147664275|NCT00427908|532594504|FG000|Primary Phase|Withdrawal by Subject|1|||
147664276|NCT00427908|532594505|FG001|Primary Phase|Withdrawal by Subject|2|||
147664277|NCT00427908|532594506|FG002|Primary Phase|Withdrawal by Subject|1|||
147664278|NCT00427908|532594507|FG003|Primary Phase|Withdrawal by Subject|0|||
147664279|NCT00427908|532594504|FG000|Primary Phase|Adverse Event|0|||
147664280|NCT00427908|532594505|FG001|Primary Phase|Adverse Event|1|||
147664281|NCT00427908|532594506|FG002|Primary Phase|Adverse Event|0|||
147664282|NCT00427908|532594507|FG003|Primary Phase|Adverse Event|0|||
147664283|NCT04202497|532594511|FG000|Baseline Scan (Day-1)|Metabolites of [18F]MNI-1054 could not be analyzed|1|||
147664284|NCT04202497|532594512|FG001|Baseline Scan (Day-1)|Metabolites of [18F]MNI-1054 could not be analyzed|0|||
147664285|NCT04202497|532594513|FG002|Baseline Scan (Day-1)|Metabolites of [18F]MNI-1054 could not be analyzed|0|||
147664286|NCT04202497|532594514|FG003|Baseline Scan (Day-1)|Metabolites of [18F]MNI-1054 could not be analyzed|0|||
147374528|NCT01958021|531533960|FG000|Post-treatment Efficacy Follow-up|Adverse Event|1|||
147374529|NCT01958021|531533961|FG001|Post-treatment Efficacy Follow-up|Adverse Event|0|||
147374530|NCT01958021|531533960|FG000|Post-treatment Efficacy Follow-up|Death|1|||
147374531|NCT01958021|531533961|FG001|Post-treatment Efficacy Follow-up|Death|0|||
147374532|NCT01958021|531533960|FG000|Post-treatment Efficacy Follow-up|Lost to Follow-up|1|||
147374533|NCT01958021|531533961|FG001|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
147374534|NCT01958021|531533960|FG000|Post-treatment Efficacy Follow-up|Physician Decision|1|||
147374535|NCT01958021|531533961|FG001|Post-treatment Efficacy Follow-up|Physician Decision|2|||
147374536|NCT01958021|531533960|FG000|Post-treatment Efficacy Follow-up|Progressive disease|12|||
147374537|NCT01958021|531533961|FG001|Post-treatment Efficacy Follow-up|Progressive disease|3|||
147374538|NCT01958021|531533960|FG000|Post-treatment Efficacy Follow-up|Sponsor decision|5|||
147374539|NCT01958021|531533961|FG001|Post-treatment Efficacy Follow-up|Sponsor decision|2|||
147374540|NCT01958021|531533960|FG000|Post-treatment Efficacy Follow-up|Subject/Guardian decision|4|||
147374541|NCT01958021|531533961|FG001|Post-treatment Efficacy Follow-up|Subject/Guardian decision|2|||
147374542|NCT05810285|531533962|FG000|Overall Study|Death|4|||
147374543|NCT05810285|531533963|FG001|Overall Study|Death|21|||
147374544|NCT05810285|531533962|FG000|Overall Study|Adverse Event|18|||
147374545|NCT05810285|531533963|FG001|Overall Study|Adverse Event|16|||
147374546|NCT04649047|531533964|FG000|Overall Study|Withdrawal by Subject|3|||
147374547|NCT02488408|531533965|FG000|Part A|Adverse Event|2|||
147374548|NCT02488408|531533966|FG001|Part A|Adverse Event|0|||
147374549|NCT02488408|531533967|FG002|Part A|Adverse Event|0|||
147374550|NCT02488408|531533968|FG003|Part A|Adverse Event|0|||
147374551|NCT02488408|531533969|FG004|Part A|Adverse Event|0|||
147374552|NCT02488408|531533970|FG005|Part A|Adverse Event|0|||
147374553|NCT02488408|531533971|FG006|Part A|Adverse Event|0|||
147374554|NCT02488408|531533972|FG007|Part A|Adverse Event|0|||
147374555|NCT02488408|531533973|FG008|Part A|Adverse Event|0|||
147374556|NCT02488408|531533974|FG009|Part A|Adverse Event|0|||
147374557|NCT02488408|531533965|FG000|Part A|Death|1|||
147374558|NCT02488408|531533966|FG001|Part A|Death|5|||
147374559|NCT02488408|531533967|FG002|Part A|Death|0|||
147374560|NCT02488408|531533968|FG003|Part A|Death|0|||
147374561|NCT02488408|531533969|FG004|Part A|Death|3|||
147374562|NCT02488408|531533970|FG005|Part A|Death|0|||
147374563|NCT02488408|531533971|FG006|Part A|Death|0|||
147374564|NCT02488408|531533972|FG007|Part A|Death|0|||
147374565|NCT02488408|531533973|FG008|Part A|Death|0|||
147374566|NCT02488408|531533974|FG009|Part A|Death|0|||
147374567|NCT02488408|531533965|FG000|Part A|Disease Progression|2|||
147374568|NCT02488408|531533966|FG001|Part A|Disease Progression|8|||
147374569|NCT02488408|531533967|FG002|Part A|Disease Progression|2|||
147664287|NCT04344301|532594515|FG000|Overall Study|Withdrawal by Subject|1|||
147664288|NCT04344301|532594516|FG001|Overall Study|Withdrawal by Subject|0|||
147664289|NCT04344301|532594515|FG000|Overall Study|Death|0|||
147374570|NCT02488408|531533968|FG003|Part A|Disease Progression|3|||
147374571|NCT02488408|531533969|FG004|Part A|Disease Progression|4|||
147374572|NCT02488408|531533970|FG005|Part A|Disease Progression|0|||
147374573|NCT02488408|531533971|FG006|Part A|Disease Progression|0|||
147374574|NCT02488408|531533972|FG007|Part A|Disease Progression|0|||
147374575|NCT02488408|531533973|FG008|Part A|Disease Progression|0|||
147664290|NCT04344301|532594516|FG001|Overall Study|Death|1|||
147374576|NCT02488408|531533974|FG009|Part A|Disease Progression|0|||
147374577|NCT02488408|531533965|FG000|Part A|Initiation of Alternative Cancer Therapy|0|||
147374578|NCT02488408|531533966|FG001|Part A|Initiation of Alternative Cancer Therapy|0|||
147374579|NCT02488408|531533967|FG002|Part A|Initiation of Alternative Cancer Therapy|0|||
147374580|NCT02488408|531533968|FG003|Part A|Initiation of Alternative Cancer Therapy|1|||
147374581|NCT02488408|531533969|FG004|Part A|Initiation of Alternative Cancer Therapy|0|||
147374582|NCT02488408|531533970|FG005|Part A|Initiation of Alternative Cancer Therapy|0|||
147374583|NCT02488408|531533971|FG006|Part A|Initiation of Alternative Cancer Therapy|0|||
147664291|NCT01747499|532594517|FG000|Overall Study|Steroid refractory aGvHD|1|||
147611398|NCT01434810|532393599|FG000|Overall Study|Missing data/received <5hr phototherapy|12|||
147611399|NCT01434810|532393600|FG001|Overall Study|Missing data/received <5hr phototherapy|7|||
147611400|NCT02437903|532393605|FG000|Overall Study|Adverse Event|1|||
147611401|NCT02437903|532393605|FG000|Overall Study|Withdrawal by Subject|1|||
147611402|NCT02437903|532393605|FG000|Overall Study|Lost to Follow-up|3|||
147611403|NCT04974749|532393606|FG000|Overall Study|Withdrawal by Subject|2|||
147611404|NCT04974749|532393606|FG000|Overall Study|Gestation|1|||
147611405|NCT02075515|532393613|FG000|Overall Study|Serious Adverse Event|1|||
147611406|NCT02075515|532393614|FG001|Overall Study|Serious Adverse Event|1|||
147611407|NCT02075515|532393615|FG002|Overall Study|Serious Adverse Event|1|||
147611408|NCT02075515|532393613|FG000|Overall Study|Non-Serious Adverse Event|0|||
147611409|NCT02075515|532393614|FG001|Overall Study|Non-Serious Adverse Event|1|||
147611410|NCT02075515|532393615|FG002|Overall Study|Non-Serious Adverse Event|0|||
147611411|NCT02075515|532393613|FG000|Overall Study|Withdrawal by Subject|2|||
147374584|NCT02488408|531533972|FG007|Part A|Initiation of Alternative Cancer Therapy|0|||
147374585|NCT02488408|531533973|FG008|Part A|Initiation of Alternative Cancer Therapy|0|||
147374586|NCT02488408|531533974|FG009|Part A|Initiation of Alternative Cancer Therapy|0|||
147374587|NCT02488408|531533965|FG000|Part A|Investigator Decision|0|||
147374588|NCT02488408|531533966|FG001|Part A|Investigator Decision|1|||
147374589|NCT02488408|531533967|FG002|Part A|Investigator Decision|1|||
147374590|NCT02488408|531533968|FG003|Part A|Investigator Decision|0|||
147374591|NCT02488408|531533969|FG004|Part A|Investigator Decision|0|||
147374592|NCT02488408|531533970|FG005|Part A|Investigator Decision|0|||
147374593|NCT02488408|531533971|FG006|Part A|Investigator Decision|0|||
147374594|NCT02488408|531533972|FG007|Part A|Investigator Decision|0|||
147374595|NCT02488408|531533973|FG008|Part A|Investigator Decision|0|||
147374596|NCT02488408|531533974|FG009|Part A|Investigator Decision|0|||
147374597|NCT02488408|531533965|FG000|Part A|Withdrawal by Subject|0|||
147374598|NCT02488408|531533966|FG001|Part A|Withdrawal by Subject|0|||
147374599|NCT02488408|531533967|FG002|Part A|Withdrawal by Subject|2|||
147374600|NCT02488408|531533968|FG003|Part A|Withdrawal by Subject|0|||
147374601|NCT02488408|531533969|FG004|Part A|Withdrawal by Subject|0|||
147374602|NCT02488408|531533970|FG005|Part A|Withdrawal by Subject|0|||
147374603|NCT02488408|531533971|FG006|Part A|Withdrawal by Subject|0|||
147374604|NCT02488408|531533972|FG007|Part A|Withdrawal by Subject|0|||
147374605|NCT02488408|531533973|FG008|Part A|Withdrawal by Subject|0|||
147374606|NCT02488408|531533974|FG009|Part A|Withdrawal by Subject|0|||
147374607|NCT02488408|531533965|FG000|Part A|Other|1|||
147374608|NCT02488408|531533966|FG001|Part A|Other|0|||
147300153|NCT05701995|531264658|FG000|Treatment|Adverse Event|3|||
147300154|NCT05701995|531264659|FG001|Treatment|Adverse Event|1|||
147300155|NCT05701995|531264658|FG000|Treatment|Other Reason|1|||
147300156|NCT05701995|531264659|FG001|Treatment|Other Reason|1|||
147300157|NCT05701995|531264658|FG000|Treatment|Death|1|||
147300158|NCT05701995|531264659|FG001|Treatment|Death|0|||
147300159|NCT05701995|531264658|FG000|Treatment|Physician Decision|0|||
147300160|NCT05701995|531264659|FG001|Treatment|Physician Decision|1|||
147374609|NCT02488408|531533967|FG002|Part A|Other|0|||
147374610|NCT02488408|531533968|FG003|Part A|Other|0|||
147374611|NCT02488408|531533969|FG004|Part A|Other|0|||
147374612|NCT02488408|531533970|FG005|Part A|Other|0|||
147374613|NCT02488408|531533971|FG006|Part A|Other|0|||
147374614|NCT02488408|531533972|FG007|Part A|Other|0|||
147374615|NCT02488408|531533973|FG008|Part A|Other|0|||
147374616|NCT02488408|531533974|FG009|Part A|Other|0|||
147374617|NCT02488408|531533965|FG000|Part B|Adverse Event|0|||
147374618|NCT02488408|531533966|FG001|Part B|Adverse Event|0|||
147374619|NCT02488408|531533967|FG002|Part B|Adverse Event|0|||
147374620|NCT02488408|531533968|FG003|Part B|Adverse Event|0|||
147374621|NCT02488408|531533969|FG004|Part B|Adverse Event|0|||
147374622|NCT02488408|531533970|FG005|Part B|Adverse Event|2|||
147611412|NCT02075515|532393614|FG001|Overall Study|Withdrawal by Subject|0|||
147611413|NCT02075515|532393615|FG002|Overall Study|Withdrawal by Subject|1|||
147611414|NCT02075515|532393613|FG000|Overall Study|Lost to Follow-up|1|||
147664292|NCT01747499|532594518|FG001|Overall Study|Steroid refractory aGvHD|0|||
147664293|NCT01747499|532594519|FG002|Overall Study|Steroid refractory aGvHD|0|||
147664294|NCT01747499|532594520|FG003|Overall Study|Steroid refractory aGvHD|1|||
147374623|NCT02488408|531533971|FG006|Part B|Adverse Event|2|||
147374624|NCT02488408|531533972|FG007|Part B|Adverse Event|7|||
147374625|NCT02488408|531533973|FG008|Part B|Adverse Event|2|||
147374626|NCT02488408|531533974|FG009|Part B|Adverse Event|2|||
147374627|NCT02488408|531533965|FG000|Part B|Death|0|||
147374628|NCT02488408|531533966|FG001|Part B|Death|0|||
147374629|NCT02488408|531533967|FG002|Part B|Death|0|||
147374630|NCT02488408|531533968|FG003|Part B|Death|0|||
147374631|NCT02488408|531533969|FG004|Part B|Death|0|||
147300161|NCT00689026|531264672|FG000|Overall Study|Withdrawal by Subject|13|||
147300162|NCT00689026|531264673|FG001|Overall Study|Withdrawal by Subject|6|||
147374632|NCT02488408|531533970|FG005|Part B|Death|3|||
147374633|NCT02488408|531533971|FG006|Part B|Death|1|||
147374634|NCT02488408|531533972|FG007|Part B|Death|2|||
147374635|NCT02488408|531533973|FG008|Part B|Death|2|||
147611415|NCT02075515|532393614|FG001|Overall Study|Lost to Follow-up|3|||
147664295|NCT01747499|532594521|FG004|Overall Study|Steroid refractory aGvHD|4|||
147664296|NCT01747499|532594517|FG000|Overall Study|Physician Decision|0|||
147664297|NCT01747499|532594518|FG001|Overall Study|Physician Decision|1|||
147664298|NCT01747499|532594519|FG002|Overall Study|Physician Decision|0|||
147664299|NCT01747499|532594520|FG003|Overall Study|Physician Decision|0|||
147664300|NCT01747499|532594521|FG004|Overall Study|Physician Decision|2|||
147664301|NCT01747499|532594517|FG000|Overall Study|Death|0|||
147664302|NCT01747499|532594518|FG001|Overall Study|Death|0|||
147664303|NCT01747499|532594519|FG002|Overall Study|Death|0|||
147664304|NCT01747499|532594520|FG003|Overall Study|Death|1|||
147664305|NCT01747499|532594521|FG004|Overall Study|Death|1|||
147664306|NCT01747499|532594517|FG000|Overall Study|Withdrawal by Subject|0|||
147664307|NCT01747499|532594518|FG001|Overall Study|Withdrawal by Subject|0|||
147664308|NCT01747499|532594519|FG002|Overall Study|Withdrawal by Subject|0|||
147664309|NCT01747499|532594520|FG003|Overall Study|Withdrawal by Subject|0|||
147664310|NCT01747499|532594521|FG004|Overall Study|Withdrawal by Subject|6|||
147664311|NCT01747499|532594517|FG000|Overall Study|Developed AML and death|0|||
147664312|NCT01747499|532594518|FG001|Overall Study|Developed AML and death|0|||
147664313|NCT01747499|532594519|FG002|Overall Study|Developed AML and death|0|||
147664314|NCT01747499|532594520|FG003|Overall Study|Developed AML and death|0|||
147664315|NCT01747499|532594521|FG004|Overall Study|Developed AML and death|1|||
147664316|NCT01747499|532594517|FG000|Overall Study|Determined not to be eligible|0|||
147664317|NCT01747499|532594518|FG001|Overall Study|Determined not to be eligible|0|||
147664318|NCT01747499|532594519|FG002|Overall Study|Determined not to be eligible|0|||
147664319|NCT01747499|532594520|FG003|Overall Study|Determined not to be eligible|0|||
147664320|NCT01747499|532594521|FG004|Overall Study|Determined not to be eligible|1|||
147664321|NCT00072410|532594522|FG000|Overall Study|Progressive disease|0|||
147664322|NCT00072410|532594523|FG001|Overall Study|Progressive disease|3|||
147664323|NCT00248651|532594526|FG000|Overall Study|Withdrawal by Subject|28|||
147664324|NCT00248651|532594527|FG001|Overall Study|Withdrawal by Subject|40|||
147664325|NCT00248651|532594528|FG002|Overall Study|Withdrawal by Subject|32|||
147664326|NCT03834506|532594529|FG000|Overall Study|Death|336|||
147664327|NCT03834506|532594530|FG001|Overall Study|Death|326|||
147664328|NCT03834506|532594529|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
147664329|NCT03834506|532594530|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
147664330|NCT03834506|532594529|FG000|Overall Study|Withdrawal by Subject|10|||
147664331|NCT03834506|532594530|FG001|Overall Study|Withdrawal by Subject|8|||
147664332|NCT03834506|532594529|FG000|Overall Study|Sponsor decision|165|||
147664333|NCT03834506|532594530|FG001|Overall Study|Sponsor decision|178|||
147664334|NCT03834506|532594529|FG000|Overall Study|Physician Decision|3|||
147664335|NCT03834506|532594530|FG001|Overall Study|Physician Decision|1|||
147664336|NCT03834506|532594529|FG000|Overall Study|Lost to Follow-up|0|||
147664337|NCT03834506|532594530|FG001|Overall Study|Lost to Follow-up|1|||
147664338|NCT03160716|532594531|FG000|Overall Study|Lost to Follow-up|1|||
147664339|NCT01628848|532594532|FG000|Overall Study|Adverse Event|9|||
147664340|NCT01628848|532594533|FG001|Overall Study|Adverse Event|7|||
147664341|NCT01628848|532594532|FG000|Overall Study|Lack of Efficacy|0|||
147664342|NCT01628848|532594533|FG001|Overall Study|Lack of Efficacy|4|||
147664343|NCT01628848|532594532|FG000|Overall Study|Withdrawal by Subject|0|||
147664344|NCT01628848|532594533|FG001|Overall Study|Withdrawal by Subject|2|||
147664345|NCT01628848|532594532|FG000|Overall Study|Physician Decision|3|||
147664346|NCT01628848|532594533|FG001|Overall Study|Physician Decision|1|||
147664347|NCT01939314|532594534|FG000|Overall Study|Withdrawal by Subject|3|||
147664348|NCT01939314|532594535|FG001|Overall Study|Withdrawal by Subject|1|||
147664349|NCT01939314|532594534|FG000|Overall Study|Protocol Violation|1|||
147664350|NCT01939314|532594535|FG001|Overall Study|Protocol Violation|0|||
147664351|NCT01939314|532594534|FG000|Overall Study|Pregnancy|0|||
147664352|NCT01939314|532594535|FG001|Overall Study|Pregnancy|1|||
147664353|NCT01939314|532594534|FG000|Overall Study|Lost to Follow-up|5|||
147664354|NCT01939314|532594535|FG001|Overall Study|Lost to Follow-up|6|||
147664355|NCT01107925|532594540|FG000|Period 1-Randomization up Through Day 12|Withdrawal by Subject|1|||
147664356|NCT01107925|532594541|FG001|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0|||
147664357|NCT01107925|532594542|FG002|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0|||
147300163|NCT01666808|531264674|FG000|Overall Study|Lost to Follow-up|9|||
147300164|NCT01666808|531264675|FG001|Overall Study|Lost to Follow-up|15|||
147300165|NCT01666808|531264674|FG000|Overall Study|Withdrawal by Subject|3|||
147300166|NCT01666808|531264675|FG001|Overall Study|Withdrawal by Subject|1|||
147664358|NCT01107925|532594543|FG003|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0|||
147664359|NCT01107925|532594544|FG004|Period 1-Randomization up Through Day 12|Withdrawal by Subject|1|||
147664360|NCT01107925|532594545|FG005|Period 1-Randomization up Through Day 12|Withdrawal by Subject|0|||
147664361|NCT01107925|532594540|FG000|Period 2|Withdrawal by Subject|0|||
147664362|NCT01107925|532594541|FG001|Period 2|Withdrawal by Subject|1|||
147664363|NCT01107925|532594542|FG002|Period 2|Withdrawal by Subject|0|||
147664364|NCT01107925|532594543|FG003|Period 2|Withdrawal by Subject|0|||
147664365|NCT01107925|532594544|FG004|Period 2|Withdrawal by Subject|0|||
147664366|NCT01107925|532594545|FG005|Period 2|Withdrawal by Subject|1|||
147664367|NCT04877990|532594546|FG000|Treatment|Other reasons|3|||
147374636|NCT02488408|531533974|FG009|Part B|Death|2|||
147374637|NCT02488408|531533965|FG000|Part B|Death due to Disease Progression|0|||
147374638|NCT02488408|531533966|FG001|Part B|Death due to Disease Progression|0|||
147374639|NCT02488408|531533967|FG002|Part B|Death due to Disease Progression|0|||
147374640|NCT02488408|531533968|FG003|Part B|Death due to Disease Progression|0|||
147374641|NCT02488408|531533969|FG004|Part B|Death due to Disease Progression|0|||
147374642|NCT02488408|531533970|FG005|Part B|Death due to Disease Progression|2|||
147374643|NCT02488408|531533971|FG006|Part B|Death due to Disease Progression|2|||
147374644|NCT02488408|531533972|FG007|Part B|Death due to Disease Progression|1|||
147374645|NCT02488408|531533973|FG008|Part B|Death due to Disease Progression|1|||
147374646|NCT02488408|531533974|FG009|Part B|Death due to Disease Progression|1|||
147374647|NCT02488408|531533965|FG000|Part B|Disease Progression|0|||
147374648|NCT02488408|531533966|FG001|Part B|Disease Progression|0|||
147374649|NCT02488408|531533967|FG002|Part B|Disease Progression|0|||
147374650|NCT02488408|531533968|FG003|Part B|Disease Progression|0|||
147374651|NCT02488408|531533969|FG004|Part B|Disease Progression|0|||
147374652|NCT02488408|531533970|FG005|Part B|Disease Progression|6|||
147374653|NCT02488408|531533971|FG006|Part B|Disease Progression|9|||
147374654|NCT02488408|531533972|FG007|Part B|Disease Progression|7|||
147374655|NCT02488408|531533973|FG008|Part B|Disease Progression|9|||
147374656|NCT02488408|531533974|FG009|Part B|Disease Progression|11|||
147374657|NCT02488408|531533965|FG000|Part B|Initiation of Alternative Cancer Therapy|0|||
147374658|NCT02488408|531533966|FG001|Part B|Initiation of Alternative Cancer Therapy|0|||
147374659|NCT02488408|531533967|FG002|Part B|Initiation of Alternative Cancer Therapy|0|||
147374660|NCT02488408|531533968|FG003|Part B|Initiation of Alternative Cancer Therapy|0|||
147374661|NCT02488408|531533969|FG004|Part B|Initiation of Alternative Cancer Therapy|0|||
147374662|NCT02488408|531533970|FG005|Part B|Initiation of Alternative Cancer Therapy|1|||
147374663|NCT02488408|531533971|FG006|Part B|Initiation of Alternative Cancer Therapy|1|||
147374664|NCT02488408|531533972|FG007|Part B|Initiation of Alternative Cancer Therapy|1|||
147374665|NCT02488408|531533973|FG008|Part B|Initiation of Alternative Cancer Therapy|2|||
147374666|NCT02488408|531533974|FG009|Part B|Initiation of Alternative Cancer Therapy|3|||
147374667|NCT02488408|531533965|FG000|Part B|Investigator Decision|0|||
147374668|NCT02488408|531533966|FG001|Part B|Investigator Decision|0|||
147374669|NCT02488408|531533967|FG002|Part B|Investigator Decision|0|||
147374670|NCT02488408|531533968|FG003|Part B|Investigator Decision|0|||
147374671|NCT02488408|531533969|FG004|Part B|Investigator Decision|0|||
147374672|NCT02488408|531533970|FG005|Part B|Investigator Decision|0|||
147374673|NCT02488408|531533971|FG006|Part B|Investigator Decision|1|||
147374674|NCT02488408|531533972|FG007|Part B|Investigator Decision|0|||
147374675|NCT02488408|531533973|FG008|Part B|Investigator Decision|2|||
147374676|NCT02488408|531533974|FG009|Part B|Investigator Decision|1|||
147374677|NCT05037513|531533975|FG000|Intervention Period|Lost to Follow-up|1|||
147300167|NCT01666808|531264674|FG000|Overall Study|No radiotherapy given, due to extrapelvic uptake on PET scan|4|||
147300168|NCT01666808|531264675|FG001|Overall Study|No radiotherapy given, due to extrapelvic uptake on PET scan|0|||
147300169|NCT03933826|531264676|FG000|Overall Study|Withdrawal by Subject|8|||
147300170|NCT03933826|531264677|FG001|Overall Study|Withdrawal by Subject|1|||
147300171|NCT03933826|531264676|FG000|Overall Study|Death|19|||
147300172|NCT03933826|531264677|FG001|Overall Study|Death|11|||
147300173|NCT03933826|531264676|FG000|Overall Study|Lost to Follow-up|41|||
147300174|NCT03933826|531264677|FG001|Overall Study|Lost to Follow-up|13|||
147300175|NCT04992546|531264678|FG000|Double-Blinded Treatment Period|Withdrawal by Subject|1|||
147300176|NCT04992546|531264678|FG000|Double-Blinded Treatment Period|Doses missed due to Covid-19 pandemic circumstances at the site|1|||
147300177|NCT04992546|531264678|FG000|Open-Label Treatment Period|Adverse Event|3|||
147300178|NCT04992546|531264678|FG000|Open-Label Treatment Period|Withdrawal by Subject|1|||
147300179|NCT00500903|531264682|FG000|Overall Study|Occurrence of Adverse Event(s)|10|||
147300180|NCT00500903|531264683|FG001|Overall Study|Occurrence of Adverse Event(s)|0|||
147300181|NCT00500903|531264684|FG002|Overall Study|Occurrence of Adverse Event(s)|0|||
147300182|NCT00500903|531264682|FG000|Overall Study|Unsatisfactory Therapeutic Response|2|||
147300183|NCT00500903|531264683|FG001|Overall Study|Unsatisfactory Therapeutic Response|0|||
147300184|NCT00500903|531264684|FG002|Overall Study|Unsatisfactory Therapeutic Response|0|||
147300185|NCT00500903|531264682|FG000|Overall Study|Progressive Disease|41|||
147300186|NCT00500903|531264683|FG001|Overall Study|Progressive Disease|2|||
147300187|NCT00500903|531264684|FG002|Overall Study|Progressive Disease|15|||
147300188|NCT00500903|531264682|FG000|Overall Study|Patient Declined Further Treatment|0|||
147300189|NCT00500903|531264683|FG001|Overall Study|Patient Declined Further Treatment|0|||
147300190|NCT00500903|531264684|FG002|Overall Study|Patient Declined Further Treatment|3|||
147300191|NCT00500903|531264682|FG000|Overall Study|Symptomatic Deterioration|2|||
147300192|NCT00500903|531264683|FG001|Overall Study|Symptomatic Deterioration|0|||
147300193|NCT00500903|531264684|FG002|Overall Study|Symptomatic Deterioration|0|||
147300194|NCT00500903|531264682|FG000|Overall Study|Reason Not Specified|10|||
147300195|NCT00500903|531264683|FG001|Overall Study|Reason Not Specified|0|||
147300196|NCT00500903|531264684|FG002|Overall Study|Reason Not Specified|2|||
147300197|NCT01648348|531264686|FG000|Overall Study|Cancel|1|||
147300198|NCT01648348|531264687|FG001|Overall Study|Cancel|0|||
147374678|NCT05037513|531533976|FG001|Intervention Period|Lost to Follow-up|2|||
147374679|NCT05037513|531533975|FG000|Follow Up Period|Lost to Follow-up|16|||
147374680|NCT05037513|531533976|FG001|Follow Up Period|Lost to Follow-up|21|||
147374681|NCT05037513|531533975|FG000|Follow Up Period|Death|0|||
147374682|NCT05037513|531533976|FG001|Follow Up Period|Death|1|||
147374683|NCT05037513|531533975|FG000|Follow Up Period|Incarcerated|4|||
147374684|NCT05037513|531533976|FG001|Follow Up Period|Incarcerated|2|||
147374685|NCT05886777|531533977|FG000|Overall Study|Lost to Follow-up|1|||
147374686|NCT05886777|531533978|FG001|Overall Study|Lost to Follow-up|0|||
147374687|NCT05886777|531533979|FG002|Overall Study|Lost to Follow-up|2|||
147374688|NCT05886777|531533980|FG003|Overall Study|Lost to Follow-up|1|||
147374689|NCT05886777|531533981|FG004|Overall Study|Lost to Follow-up|0|||
147374690|NCT05886777|531533982|FG005|Overall Study|Lost to Follow-up|2|||
147374691|NCT05886777|531533983|FG006|Overall Study|Lost to Follow-up|0|||
147374692|NCT05886777|531533977|FG000|Overall Study|Other|0|||
147374693|NCT05886777|531533978|FG001|Overall Study|Other|2|||
147374694|NCT05886777|531533979|FG002|Overall Study|Other|1|||
147374695|NCT05886777|531533980|FG003|Overall Study|Other|0|||
147374696|NCT05886777|531533981|FG004|Overall Study|Other|0|||
147374697|NCT05886777|531533982|FG005|Overall Study|Other|0|||
147374698|NCT05886777|531533983|FG006|Overall Study|Other|0|||
147374699|NCT05886777|531533977|FG000|Overall Study|Withdrawal by Subject|1|||
147374700|NCT05886777|531533978|FG001|Overall Study|Withdrawal by Subject|0|||
147374701|NCT05886777|531533979|FG002|Overall Study|Withdrawal by Subject|1|||
147374702|NCT05886777|531533980|FG003|Overall Study|Withdrawal by Subject|4|||
147374703|NCT05886777|531533981|FG004|Overall Study|Withdrawal by Subject|3|||
147374704|NCT05886777|531533982|FG005|Overall Study|Withdrawal by Subject|1|||
147374705|NCT05886777|531533983|FG006|Overall Study|Withdrawal by Subject|1|||
147374706|NCT05886777|531533977|FG000|Overall Study|Protocol Violation|0|||
147374707|NCT05886777|531533978|FG001|Overall Study|Protocol Violation|0|||
147374708|NCT05886777|531533979|FG002|Overall Study|Protocol Violation|1|||
147374709|NCT05886777|531533980|FG003|Overall Study|Protocol Violation|0|||
147374710|NCT05886777|531533981|FG004|Overall Study|Protocol Violation|0|||
147374711|NCT05886777|531533982|FG005|Overall Study|Protocol Violation|0|||
147374712|NCT05886777|531533983|FG006|Overall Study|Protocol Violation|0|||
147374713|NCT05886777|531533977|FG000|Overall Study|No longer met eligibility criteria|0|||
147374714|NCT05886777|531533978|FG001|Overall Study|No longer met eligibility criteria|1|||
147374715|NCT05886777|531533979|FG002|Overall Study|No longer met eligibility criteria|0|||
147374716|NCT05886777|531533980|FG003|Overall Study|No longer met eligibility criteria|0|||
147374717|NCT05886777|531533981|FG004|Overall Study|No longer met eligibility criteria|0|||
147374718|NCT05886777|531533982|FG005|Overall Study|No longer met eligibility criteria|0|||
147374719|NCT05886777|531533983|FG006|Overall Study|No longer met eligibility criteria|0|||
147374720|NCT03773107|531533984|FG000|Overall Study|Participant currently on study and in follow up status.|1|||
147374721|NCT03773107|531533985|FG001|Overall Study|Participant currently on study and in follow up status.|0|||
147374722|NCT03773107|531533986|FG002|Overall Study|Participant currently on study and in follow up status.|0|||
147374723|NCT03773107|531533987|FG003|Overall Study|Participant currently on study and in follow up status.|1|||
147374724|NCT07204444|531533990|FG000|Overall Study|Medical/Hospitalization|6|||
147374725|NCT07204444|531533991|FG001|Overall Study|Medical/Hospitalization|9|||
147374726|NCT07204444|531533992|FG002|Overall Study|Medical/Hospitalization|6|||
147374727|NCT07204444|531533990|FG000|Overall Study|Treatment Provider Issue|1|||
147374728|NCT07204444|531533991|FG001|Overall Study|Treatment Provider Issue|3|||
147374729|NCT07204444|531533992|FG002|Overall Study|Treatment Provider Issue|0|||
147374730|NCT07204444|531533990|FG000|Overall Study|Withdrawal by Subject|11|||
147374731|NCT07204444|531533991|FG001|Overall Study|Withdrawal by Subject|5|||
147374732|NCT07204444|531533992|FG002|Overall Study|Withdrawal by Subject|5|||
147374733|NCT07204444|531533990|FG000|Overall Study|Death|3|||
147374734|NCT07204444|531533991|FG001|Overall Study|Death|6|||
147374735|NCT07204444|531533992|FG002|Overall Study|Death|1|||
147374736|NCT07204444|531533990|FG000|Overall Study|Unable To Reach|29|||
147374737|NCT07204444|531533991|FG001|Overall Study|Unable To Reach|26|||
147455490|NCT00482014|531829839|FG003|Overall Study|Death|4|||
147455491|NCT00482014|531829836|FG000|Overall Study|Lack of Efficacy|1|||
147455492|NCT00482014|531829837|FG001|Overall Study|Lack of Efficacy|0|||
147374738|NCT07204444|531533992|FG002|Overall Study|Unable To Reach|17|||
147374739|NCT07204444|531533990|FG000|Overall Study|Protocol Deviation|3|||
147455493|NCT00482014|531829838|FG002|Overall Study|Lack of Efficacy|4|||
147374740|NCT07204444|531533991|FG001|Overall Study|Protocol Deviation|2|||
147374741|NCT07204444|531533992|FG002|Overall Study|Protocol Deviation|0|||
147374742|NCT02386098|531535084|FG000|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|30|||
147455494|NCT00482014|531829839|FG003|Overall Study|Lack of Efficacy|6|||
147455495|NCT00482014|531829836|FG000|Overall Study|Sponsor Decision|1|||
147374743|NCT02386098|531535085|FG001|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|29|||
147374744|NCT02386098|531535086|FG002|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|0|||
147374745|NCT02386098|531535087|FG003|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|0|||
147374746|NCT02386098|531535088|FG004|Stage 1 (96 Weeks)|Other: Administrative reason by sponsor|0|||
147374747|NCT02386098|531535084|FG000|Stage 1 (96 Weeks)|Adverse Event|2|||
147374748|NCT02386098|531535085|FG001|Stage 1 (96 Weeks)|Adverse Event|1|||
147374749|NCT02386098|531535086|FG002|Stage 1 (96 Weeks)|Adverse Event|0|||
147374750|NCT02386098|531535087|FG003|Stage 1 (96 Weeks)|Adverse Event|0|||
147374751|NCT02386098|531535088|FG004|Stage 1 (96 Weeks)|Adverse Event|0|||
147374752|NCT02386098|531535084|FG000|Stage 1 (96 Weeks)|Lost to Follow-up|2|||
147374753|NCT02386098|531535085|FG001|Stage 1 (96 Weeks)|Lost to Follow-up|2|||
147374754|NCT02386098|531535086|FG002|Stage 1 (96 Weeks)|Lost to Follow-up|0|||
147374755|NCT02386098|531535087|FG003|Stage 1 (96 Weeks)|Lost to Follow-up|0|||
147374756|NCT02386098|531535088|FG004|Stage 1 (96 Weeks)|Lost to Follow-up|0|||
147374757|NCT02386098|531535084|FG000|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|0|||
147374758|NCT02386098|531535085|FG001|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|2|||
147374759|NCT02386098|531535086|FG002|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|0|||
147374760|NCT02386098|531535087|FG003|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|0|||
147374761|NCT02386098|531535088|FG004|Stage 1 (96 Weeks)|Other:Protocol defined stopping criteria|0|||
147374762|NCT02386098|531535084|FG000|Stage 1 (96 Weeks)|Withdrawal by Subject|3|||
147374763|NCT02386098|531535085|FG001|Stage 1 (96 Weeks)|Withdrawal by Subject|1|||
147374764|NCT02386098|531535086|FG002|Stage 1 (96 Weeks)|Withdrawal by Subject|0|||
147374765|NCT02386098|531535087|FG003|Stage 1 (96 Weeks)|Withdrawal by Subject|0|||
147374766|NCT02386098|531535088|FG004|Stage 1 (96 Weeks)|Withdrawal by Subject|0|||
147374767|NCT02386098|531535084|FG000|Stage 1 (96 Weeks)|Other|1|||
147374768|NCT02386098|531535085|FG001|Stage 1 (96 Weeks)|Other|0|||
147374769|NCT02386098|531535086|FG002|Stage 1 (96 Weeks)|Other|0|||
147374770|NCT02386098|531535087|FG003|Stage 1 (96 Weeks)|Other|0|||
147374771|NCT02386098|531535088|FG004|Stage 1 (96 Weeks)|Other|0|||
147374772|NCT02386098|531535084|FG000|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|5|||
147374773|NCT02386098|531535085|FG001|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|8|||
147374774|NCT02386098|531535086|FG002|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|0|||
147374775|NCT02386098|531535087|FG003|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|0|||
147374776|NCT02386098|531535088|FG004|Stage 1 (96 Weeks)|Other: Breach of good clinical practice|0|||
147374777|NCT04083976|531535093|FG000|Overall Study|Lost to Follow-up|3|||
147374778|NCT04083976|531535094|FG001|Overall Study|Lost to Follow-up|0|||
147374779|NCT04083976|531535095|FG002|Overall Study|Lost to Follow-up|0|||
147374780|NCT04083976|531535096|FG003|Overall Study|Lost to Follow-up|1|||
147374781|NCT04083976|531535093|FG000|Overall Study|Withdrawal by Subject|16|||
147374782|NCT04083976|531535094|FG001|Overall Study|Withdrawal by Subject|1|||
147374783|NCT04083976|531535095|FG002|Overall Study|Withdrawal by Subject|9|||
147374784|NCT04083976|531535096|FG003|Overall Study|Withdrawal by Subject|0|||
147374785|NCT04083976|531535093|FG000|Overall Study|Sponsor Decision|14|||
147374786|NCT04083976|531535094|FG001|Overall Study|Sponsor Decision|0|||
147374787|NCT04083976|531535095|FG002|Overall Study|Sponsor Decision|0|||
147374788|NCT04083976|531535096|FG003|Overall Study|Sponsor Decision|7|||
147374789|NCT04083976|531535093|FG000|Overall Study|Other|1|||
147374790|NCT04083976|531535094|FG001|Overall Study|Other|0|||
147374791|NCT04083976|531535095|FG002|Overall Study|Other|1|||
147374792|NCT04083976|531535096|FG003|Overall Study|Other|0|||
147374793|NCT00512252|531535102|FG000|Overall Study|Lost to Follow-up|0|||
147374794|NCT00512252|531535103|FG001|Overall Study|Lost to Follow-up|0|||
147374795|NCT00512252|531535104|FG002|Overall Study|Lost to Follow-up|1|||
147374796|NCT00512252|531535102|FG000|Overall Study|Protocol Violation|0|||
147374797|NCT00512252|531535103|FG001|Overall Study|Protocol Violation|0|||
147374798|NCT00512252|531535104|FG002|Overall Study|Protocol Violation|1|||
147374799|NCT00512252|531535102|FG000|Overall Study|Death|0|||
147374800|NCT00512252|531535103|FG001|Overall Study|Death|0|||
147374801|NCT00512252|531535104|FG002|Overall Study|Death|1|||
147374802|NCT02357966|531535105|FG000|Overall Study|Death|0|||
147374803|NCT02357966|531535106|FG001|Overall Study|Death|0|||
147374804|NCT02357966|531535107|FG002|Overall Study|Death|1|||
147374805|NCT02357966|531535108|FG003|Overall Study|Death|0|||
147374806|NCT02357966|531535109|FG004|Overall Study|Death|2|||
147374807|NCT02357966|531535110|FG005|Overall Study|Death|0|||
147374808|NCT02357966|531535105|FG000|Overall Study|Physician Decision|1|||
147374809|NCT02357966|531535106|FG001|Overall Study|Physician Decision|0|||
147374810|NCT02357966|531535107|FG002|Overall Study|Physician Decision|0|||
147611416|NCT02075515|532393615|FG002|Overall Study|Lost to Follow-up|6|||
147611417|NCT00741338|532393618|FG000|Overall Study|Adverse Event|0|||
147611418|NCT00741338|532393619|FG001|Overall Study|Adverse Event|1|||
147611419|NCT03593395|532393620|FG000|Overall Study|Lost to Follow-up|48|||
147611420|NCT03593395|532393621|FG001|Overall Study|Lost to Follow-up|3|||
147611421|NCT03593395|532393620|FG000|Overall Study|Withdrawal by Subject|5|||
147374811|NCT02357966|531535108|FG003|Overall Study|Physician Decision|0|||
147374812|NCT02357966|531535109|FG004|Overall Study|Physician Decision|1|||
147374813|NCT02357966|531535110|FG005|Overall Study|Physician Decision|0|||
147374814|NCT01779700|531535111|FG000|Overall Study|Adverse Event|4|||
147374815|NCT01779700|531535112|FG001|Overall Study|Adverse Event|3|||
147374816|NCT01779700|531535111|FG000|Overall Study|Withdrawal by Subject|0|||
147374817|NCT01779700|531535112|FG001|Overall Study|Withdrawal by Subject|2|||
147374818|NCT04608409|531535116|FG000|Overall Study|Physician Decision|1|||
147374819|NCT04608409|531535117|FG001|Overall Study|Physician Decision|1|||
147611422|NCT03593395|532393621|FG001|Overall Study|Withdrawal by Subject|24|||
147374820|NCT04608409|531535118|FG002|Overall Study|Physician Decision|2|||
147374821|NCT00683800|531535121|FG000|Overall Study|Adverse Event|195|||
147374822|NCT00683800|531535122|FG001|Overall Study|Adverse Event|102|||
147374823|NCT00683800|531535121|FG000|Overall Study|Death|0|||
147374824|NCT00683800|531535122|FG001|Overall Study|Death|1|||
147374825|NCT00683800|531535121|FG000|Overall Study|Lost to Follow-up|57|||
147374826|NCT00683800|531535122|FG001|Overall Study|Lost to Follow-up|44|||
147374827|NCT00683800|531535121|FG000|Overall Study|Other|5|||
147374828|NCT00683800|531535122|FG001|Overall Study|Other|2|||
147374829|NCT00683800|531535121|FG000|Overall Study|Protocol Violation|13|||
147374830|NCT00683800|531535122|FG001|Overall Study|Protocol Violation|16|||
147374831|NCT00683800|531535121|FG000|Overall Study|Withdrawal by Subject|66|||
147374832|NCT00683800|531535122|FG001|Overall Study|Withdrawal by Subject|64|||
147374833|NCT00683800|531535121|FG000|Overall Study|Lack of Efficacy|61|||
147374834|NCT00683800|531535122|FG001|Overall Study|Lack of Efficacy|104|||
147374835|NCT00683800|531535121|FG000|Overall Study|Randomized, not treated|35|||
147374836|NCT00683800|531535122|FG001|Overall Study|Randomized, not treated|33|||
147374837|NCT03041233|531535125|FG000|Overall Study|Death|5|||
147374838|NCT03041233|531535125|FG000|Overall Study|Physician Decision|1|||
147374839|NCT03041233|531535125|FG000|Overall Study|Lost to Follow-up|16|||
147374840|NCT03041233|531535125|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|7|||
147374841|NCT03041233|531535125|FG000|Overall Study|Sponsor Request|1|||
147374842|NCT03041233|531535125|FG000|Overall Study|Duplicate subject|1|||
147374843|NCT03041233|531535125|FG000|Overall Study|Re-ablation|1|||
147374844|NCT01588951|531535138|FG000|Overall Study|Ineligible in retrospect|0|||
147374845|NCT01588951|531535139|FG001|Overall Study|Ineligible in retrospect|0|||
147374846|NCT01588951|531535140|FG002|Overall Study|Ineligible in retrospect|1|||
147374847|NCT01593020|531535141|FG000|Overall Study|Adverse Event|1|||
147374848|NCT01593020|531535142|FG001|Overall Study|Adverse Event|1|||
147374849|NCT01593020|531535141|FG000|Overall Study|Death|0|||
147374850|NCT01593020|531535142|FG001|Overall Study|Death|1|||
147374851|NCT01593020|531535141|FG000|Overall Study|Ineligible|1|||
147374852|NCT01593020|531535142|FG001|Overall Study|Ineligible|0|||
147374853|NCT02350634|531535143|FG000|Overall Study|subject survived greater than 6 months following dosing|1|||
147374854|NCT02972359|531535159|FG000|Overall Study|Incl. criteria not met/Exclusion met|2|||
147374855|NCT02972359|531535159|FG000|Overall Study|Lack of Efficacy|1|||
147374856|NCT02972359|531535159|FG000|Overall Study|Adverse Event|4|||
147374857|NCT02972359|531535159|FG000|Overall Study|Death|1|||
147374858|NCT02972359|531535159|FG000|Overall Study|Withdrawal by Subject|30|||
147374859|NCT02972359|531535159|FG000|Overall Study|Protocol Violation|1|||
147374860|NCT02972359|531535159|FG000|Overall Study|Lost to Follow-up|26|||
147374861|NCT02972359|531535159|FG000|Overall Study|Other reasons|5|||
147374862|NCT02972359|531535159|FG000|Overall Study|Missing|1|||
147374863|NCT02063659|531535160|FG000|Double-Blind Treatment Period|Adverse Event|1|||
147374864|NCT02063659|531535161|FG001|Double-Blind Treatment Period|Adverse Event|2|||
147374865|NCT02063659|531535162|FG002|Double-Blind Treatment Period|Adverse Event|0|||
147374866|NCT02063659|531535163|FG003|Double-Blind Treatment Period|Adverse Event|0|||
147374867|NCT02063659|531535160|FG000|Double-Blind Treatment Period|Physician Decision|1|||
147374868|NCT02063659|531535161|FG001|Double-Blind Treatment Period|Physician Decision|0|||
147374869|NCT02063659|531535162|FG002|Double-Blind Treatment Period|Physician Decision|0|||
147374870|NCT02063659|531535163|FG003|Double-Blind Treatment Period|Physician Decision|0|||
147374871|NCT02063659|531535160|FG000|Double-Blind Treatment Period|Withdrawal of consent|0|||
147374872|NCT02063659|531535161|FG001|Double-Blind Treatment Period|Withdrawal of consent|1|||
147374873|NCT02063659|531535162|FG002|Double-Blind Treatment Period|Withdrawal of consent|3|||
147374874|NCT02063659|531535163|FG003|Double-Blind Treatment Period|Withdrawal of consent|0|||
147374875|NCT02063659|531535160|FG000|Open-Label Extension Period (OLE)|Physician Decision|0|||
147374876|NCT02063659|531535161|FG001|Open-Label Extension Period (OLE)|Physician Decision|0|||
147374877|NCT02063659|531535162|FG002|Open-Label Extension Period (OLE)|Physician Decision|0|||
147374878|NCT02063659|531535163|FG003|Open-Label Extension Period (OLE)|Physician Decision|1|||
147374879|NCT02063659|531535160|FG000|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
147374880|NCT02063659|531535161|FG001|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
147374881|NCT02063659|531535162|FG002|Open-Label Extension Period (OLE)|Withdrawal of Consent|0|||
147374882|NCT02063659|531535163|FG003|Open-Label Extension Period (OLE)|Withdrawal of Consent|9|||
147374883|NCT02063659|531535160|FG000|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
147374884|NCT02063659|531535161|FG001|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
147374885|NCT02063659|531535162|FG002|Open-Label Extension Period (OLE)|Lack of Efficacy|0|||
147374886|NCT02063659|531535163|FG003|Open-Label Extension Period (OLE)|Lack of Efficacy|1|||
147374887|NCT02063659|531535160|FG000|Open-Label Extension Period (OLE)|Adverse Event|0|||
147374888|NCT02063659|531535161|FG001|Open-Label Extension Period (OLE)|Adverse Event|0|||
147374889|NCT02063659|531535162|FG002|Open-Label Extension Period (OLE)|Adverse Event|0|||
147374890|NCT02063659|531535163|FG003|Open-Label Extension Period (OLE)|Adverse Event|7|||
147374891|NCT02063659|531535160|FG000|Open-Label Extension Period (OLE)|Reason not Specified|0|||
147374892|NCT02063659|531535161|FG001|Open-Label Extension Period (OLE)|Reason not Specified|0|||
147374893|NCT02063659|531535162|FG002|Open-Label Extension Period (OLE)|Reason not Specified|0|||
147611423|NCT03593395|532393620|FG000|Overall Study|Death|2|||
147611424|NCT03593395|532393621|FG001|Overall Study|Death|3|||
147611425|NCT03593395|532393620|FG000|Overall Study|Physician Decision|0|||
147611426|NCT03593395|532393621|FG001|Overall Study|Physician Decision|6|||
147611427|NCT03593395|532393620|FG000|Overall Study|Participant Relocated|19|||
147611428|NCT03593395|532393621|FG001|Overall Study|Participant Relocated|3|||
147611429|NCT03593395|532393620|FG000|Overall Study|No Information|1|||
147611430|NCT03593395|532393621|FG001|Overall Study|No Information|7|||
147611431|NCT03713632|532393622|FG000|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|6|||
147611432|NCT03713632|532393623|FG001|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|6|||
147611433|NCT03713632|532393624|FG002|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|8|||
147611434|NCT03713632|532393625|FG003|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|0|||
147611435|NCT03713632|532393626|FG004|Treatment Period 1 (Until Week 16)|Withdrawal by Subject|0|||
147611436|NCT03713632|532393622|FG000|Treatment Period 1 (Until Week 16)|Adverse Event|1|||
147611437|NCT03713632|532393623|FG001|Treatment Period 1 (Until Week 16)|Adverse Event|4|||
147611438|NCT03713632|532393624|FG002|Treatment Period 1 (Until Week 16)|Adverse Event|4|||
147611439|NCT03713632|532393625|FG003|Treatment Period 1 (Until Week 16)|Adverse Event|0|||
147611440|NCT03713632|532393626|FG004|Treatment Period 1 (Until Week 16)|Adverse Event|0|||
147611441|NCT03713632|532393622|FG000|Treatment Period 1 (Until Week 16)|Lost to Follow-up|1|||
147611442|NCT03713632|532393623|FG001|Treatment Period 1 (Until Week 16)|Lost to Follow-up|1|||
147611443|NCT03713632|532393624|FG002|Treatment Period 1 (Until Week 16)|Lost to Follow-up|1|||
147611444|NCT03713632|532393625|FG003|Treatment Period 1 (Until Week 16)|Lost to Follow-up|0|||
147611445|NCT03713632|532393626|FG004|Treatment Period 1 (Until Week 16)|Lost to Follow-up|0|||
147611446|NCT03713632|532393622|FG000|Treatment Period 1 (Until Week 16)|Lack of Efficacy|1|||
147611447|NCT03713632|532393623|FG001|Treatment Period 1 (Until Week 16)|Lack of Efficacy|0|||
147611448|NCT03713632|532393624|FG002|Treatment Period 1 (Until Week 16)|Lack of Efficacy|1|||
147611449|NCT03713632|532393625|FG003|Treatment Period 1 (Until Week 16)|Lack of Efficacy|0|||
147611450|NCT03713632|532393626|FG004|Treatment Period 1 (Until Week 16)|Lack of Efficacy|0|||
147611451|NCT03713632|532393622|FG000|Treatment Period 1 (Until Week 16)|Technical problems|1|||
147611452|NCT03713632|532393623|FG001|Treatment Period 1 (Until Week 16)|Technical problems|0|||
147611453|NCT03713632|532393624|FG002|Treatment Period 1 (Until Week 16)|Technical problems|1|||
147611454|NCT03713632|532393625|FG003|Treatment Period 1 (Until Week 16)|Technical problems|0|||
147611455|NCT03713632|532393626|FG004|Treatment Period 1 (Until Week 16)|Technical problems|0|||
147611456|NCT03713632|532393622|FG000|Treatment Period 1 (Until Week 16)|Pregnancy|0|||
147611457|NCT03713632|532393623|FG001|Treatment Period 1 (Until Week 16)|Pregnancy|0|||
147611458|NCT03713632|532393624|FG002|Treatment Period 1 (Until Week 16)|Pregnancy|1|||
147611459|NCT03713632|532393625|FG003|Treatment Period 1 (Until Week 16)|Pregnancy|0|||
147611460|NCT03713632|532393626|FG004|Treatment Period 1 (Until Week 16)|Pregnancy|0|||
147611461|NCT03713632|532393622|FG000|Treatment Period 1 (Until Week 16)|Misrandomized Subject|1|||
147611462|NCT03713632|532393623|FG001|Treatment Period 1 (Until Week 16)|Misrandomized Subject|0|||
147611463|NCT03713632|532393624|FG002|Treatment Period 1 (Until Week 16)|Misrandomized Subject|0|||
147611464|NCT03713632|532393625|FG003|Treatment Period 1 (Until Week 16)|Misrandomized Subject|0|||
147611465|NCT03713632|532393626|FG004|Treatment Period 1 (Until Week 16)|Misrandomized Subject|0|||
147611466|NCT03713632|532393622|FG000|Treatment Period 2 (After Week 16)|Withdrawal by Subject|9|||
147611467|NCT03713632|532393623|FG001|Treatment Period 2 (After Week 16)|Withdrawal by Subject|18|||
147611468|NCT03713632|532393624|FG002|Treatment Period 2 (After Week 16)|Withdrawal by Subject|0|||
147611469|NCT03713632|532393625|FG003|Treatment Period 2 (After Week 16)|Withdrawal by Subject|9|||
147664368|NCT04877990|532594547|FG001|Treatment|Other reasons|1|||
147664369|NCT04877990|532594546|FG000|Treatment|Administrative reasons by sponsor|17|||
147664370|NCT04877990|532594547|FG001|Treatment|Administrative reasons by sponsor|33|||
147664371|NCT04877990|532594546|FG000|Treatment|Withdrawal by Subject|2|||
147374894|NCT02063659|531535163|FG003|Open-Label Extension Period (OLE)|Reason not Specified|2|||
147374895|NCT00914966|531535164|FG000|Step 1: 1500 Units|Withdrawal by Subject|1|||
147374896|NCT00914966|531535164|FG000|Step 1: 1500 Units|Physician Decision|1|||
147374897|NCT00914966|531535164|FG000|Step 2: 2000 Units|Withdrawal by Subject|1|||
147374898|NCT03488719|531535165|FG000|Overall Study|Adverse Event|0|||
147374899|NCT03488719|531535166|FG001|Overall Study|Adverse Event|4|||
147374900|NCT03488719|531535167|FG002|Overall Study|Adverse Event|2|||
147374901|NCT03488719|531535165|FG000|Overall Study|Other|0|||
147374902|NCT03488719|531535166|FG001|Overall Study|Other|0|||
147374903|NCT03488719|531535167|FG002|Overall Study|Other|5|||
147374904|NCT03477175|531535170|FG000|Overall Study|Unable to travel due to COVID-19|0|||
147374905|NCT03477175|531535171|FG001|Overall Study|Unable to travel due to COVID-19|1|||
147374906|NCT03477175|531535170|FG000|Overall Study|Physician Decision|1|||
147374907|NCT03477175|531535171|FG001|Overall Study|Physician Decision|0|||
147374908|NCT03477175|531535170|FG000|Overall Study|Transitioned to commercial drug|6|||
147374909|NCT03477175|531535171|FG001|Overall Study|Transitioned to commercial drug|6|||
147374910|NCT03477175|531535170|FG000|Overall Study|Lost to Follow-up|1|||
147374911|NCT03477175|531535171|FG001|Overall Study|Lost to Follow-up|1|||
147374912|NCT03477175|531535170|FG000|Overall Study|Withdrawal by Subject|3|||
147374913|NCT03477175|531535171|FG001|Overall Study|Withdrawal by Subject|1|||
147374914|NCT03477175|531535170|FG000|Overall Study|Adverse Event|1|||
147374915|NCT03477175|531535171|FG001|Overall Study|Adverse Event|5|||
147374916|NCT03477175|531535170|FG000|Overall Study|Disease Progression|7|||
147374917|NCT03477175|531535171|FG001|Overall Study|Disease Progression|7|||
147374918|NCT03371017|531535172|FG000|Overall Study|Physician Decision|0|||
147374919|NCT03371017|531535173|FG001|Overall Study|Physician Decision|1|||
147374920|NCT03371017|531535172|FG000|Overall Study|Reason not Specified|0|||
147374921|NCT03371017|531535173|FG001|Overall Study|Reason not Specified|1|||
147374922|NCT03371017|531535172|FG000|Overall Study|Lost to Follow-up|13|||
147374923|NCT03371017|531535173|FG001|Overall Study|Lost to Follow-up|16|||
147374924|NCT03371017|531535172|FG000|Overall Study|Death|228|||
147374925|NCT03371017|531535173|FG001|Overall Study|Death|215|||
147374926|NCT03371017|531535172|FG000|Overall Study|Withdrawal by Subject|20|||
147374927|NCT03371017|531535173|FG001|Overall Study|Withdrawal by Subject|25|||
147374928|NCT03371017|531535172|FG000|Overall Study|Study Ended by Sponsor|37|||
147374929|NCT03371017|531535173|FG001|Overall Study|Study Ended by Sponsor|38|||
147374930|NCT03371017|531535172|FG000|Overall Study|Protocol Deviation|0|||
147374931|NCT03371017|531535173|FG001|Overall Study|Protocol Deviation|1|||
147374932|NCT01855750|531535174|FG000|Overall Study|Death|78|||
147374933|NCT01855750|531535175|FG001|Overall Study|Death|78|||
147374934|NCT01855750|531535174|FG000|Overall Study|Lost to Follow-up|9|||
147374935|NCT01855750|531535175|FG001|Overall Study|Lost to Follow-up|23|||
147374936|NCT01855750|531535174|FG000|Overall Study|Withdrawal by Subject|35|||
147374937|NCT01855750|531535175|FG001|Overall Study|Withdrawal by Subject|28|||
147374938|NCT01855750|531535174|FG000|Overall Study|Sponsor ends the study|297|||
147374939|NCT01855750|531535175|FG001|Overall Study|Sponsor ends the study|290|||
147374940|NCT04300023|531535176|FG000|Before Crossover to Social Group|Withdrawal by Subject|0|||
147374941|NCT04300023|531535177|FG001|Before Crossover to Social Group|Withdrawal by Subject|1|||
147374942|NCT05525572|531535178|FG000|Overall Study|Lost to Follow-up|2|||
147374943|NCT05025384|531535185|FG000|Overall Study|Physician Decision|5|||
147374944|NCT05025384|531535186|FG001|Overall Study|Physician Decision|6|||
147374945|NCT03425682|531535187|FG000|Overall Study|Lost to Follow-up|2|||
147374946|NCT03425682|531535188|FG001|Overall Study|Lost to Follow-up|4|||
147374947|NCT03425682|531535187|FG000|Overall Study|Withdrawal by Subject|0|||
147374948|NCT03425682|531535188|FG001|Overall Study|Withdrawal by Subject|3|||
147374949|NCT03425682|531535187|FG000|Overall Study|Subject did not meet I/E|4|||
147374950|NCT03425682|531535188|FG001|Overall Study|Subject did not meet I/E|10|||
147374951|NCT03610581|531535189|FG000|Overall Study|Study terminated by sponsor|2|||
147374952|NCT03610581|531535190|FG001|Overall Study|Study terminated by sponsor|0|||
147374953|NCT03610581|531535189|FG000|Overall Study|Other|0|||
147374954|NCT03610581|531535190|FG001|Overall Study|Other|1|||
147374955|NCT03610581|531535189|FG000|Overall Study|Withdrawal by Subject|1|||
147374956|NCT03610581|531535190|FG001|Overall Study|Withdrawal by Subject|0|||
147374957|NCT05470114|531535194|FG000|Overall Study|Withdrawal by Subject|1|||
147374958|NCT05470114|531535195|FG001|Overall Study|Withdrawal by Subject|0|||
147374959|NCT05470114|531535194|FG000|Overall Study|Lost to Follow-up|1|||
147374960|NCT05470114|531535195|FG001|Overall Study|Lost to Follow-up|0|||
147374961|NCT00719888|531535196|FG000|Overall Study|Death|24|||
147374962|NCT00719888|531535197|FG001|Overall Study|Death|9|||
147374963|NCT00719888|531535196|FG000|Overall Study|Relapse|8|||
147374964|NCT00719888|531535197|FG001|Overall Study|Relapse|3|||
147374965|NCT00719888|531535196|FG000|Overall Study|Physician Decision|1|||
147374966|NCT00719888|531535197|FG001|Overall Study|Physician Decision|0|||
147374967|NCT00719888|531535196|FG000|Overall Study|Withdrawal by Subject|1|||
147374968|NCT00719888|531535197|FG001|Overall Study|Withdrawal by Subject|0|||
147374969|NCT04577651|531535198|FG000|Overall Study|Screen Failure|7|||
147374970|NCT04577651|531535198|FG000|Overall Study|Adverse Event|1|||
147374971|NCT04577651|531535198|FG000|Overall Study|Death|1|||
147374972|NCT04577651|531535198|FG000|Overall Study|Physician Decision|1|||
147374973|NCT04577651|531535198|FG000|Overall Study|Withdrawal by Subject|3|||
147611470|NCT03713632|532393626|FG004|Treatment Period 2 (After Week 16)|Withdrawal by Subject|12|||
147611471|NCT03713632|532393622|FG000|Treatment Period 2 (After Week 16)|Adverse Event|6|||
147611472|NCT03713632|532393623|FG001|Treatment Period 2 (After Week 16)|Adverse Event|3|||
147374974|NCT03861052|531536350|FG000|Overall Study|Adverse Event|1|||
147374975|NCT03861052|531536351|FG001|Overall Study|Adverse Event|1|||
147374976|NCT03861052|531536352|FG002|Overall Study|Adverse Event|2|||
147374977|NCT03861052|531536353|FG003|Overall Study|Adverse Event|4|||
147374978|NCT03861052|531536350|FG000|Overall Study|Lost to Follow-up|0|||
147374979|NCT03861052|531536351|FG001|Overall Study|Lost to Follow-up|0|||
147374980|NCT03861052|531536352|FG002|Overall Study|Lost to Follow-up|0|||
147374981|NCT03861052|531536353|FG003|Overall Study|Lost to Follow-up|1|||
147611473|NCT03713632|532393624|FG002|Treatment Period 2 (After Week 16)|Adverse Event|0|||
147611474|NCT03713632|532393625|FG003|Treatment Period 2 (After Week 16)|Adverse Event|2|||
147374982|NCT03861052|531536350|FG000|Overall Study|Physician Decision|0|||
147374983|NCT03861052|531536351|FG001|Overall Study|Physician Decision|1|||
147374984|NCT03861052|531536352|FG002|Overall Study|Physician Decision|0|||
147374985|NCT03861052|531536353|FG003|Overall Study|Physician Decision|0|||
147374986|NCT03861052|531536350|FG000|Overall Study|Withdrawal by Subject|2|||
147374987|NCT03861052|531536351|FG001|Overall Study|Withdrawal by Subject|5|||
147374988|NCT03861052|531536352|FG002|Overall Study|Withdrawal by Subject|3|||
147374989|NCT03861052|531536353|FG003|Overall Study|Withdrawal by Subject|0|||
147374990|NCT03861052|531536350|FG000|Overall Study|Relocation to other city|1|||
147374991|NCT03861052|531536351|FG001|Overall Study|Relocation to other city|0|||
147374992|NCT03861052|531536352|FG002|Overall Study|Relocation to other city|0|||
147374993|NCT03861052|531536353|FG003|Overall Study|Relocation to other city|0|||
147374994|NCT00705406|531536356|FG000|Overall Study|Lost to Follow-up|3|||
147374995|NCT00705406|531536357|FG001|Overall Study|Lost to Follow-up|3|||
147374996|NCT00705406|531536356|FG000|Overall Study|Did not receive study drug|1|||
147374997|NCT00705406|531536357|FG001|Overall Study|Did not receive study drug|2|||
147374998|NCT03712371|531536360|FG000|Overall Study|Lack of Efficacy|0|||
147374999|NCT03712371|531536361|FG001|Overall Study|Lack of Efficacy|0|||
147375000|NCT03712371|531536362|FG002|Overall Study|Lack of Efficacy|0|||
147375001|NCT03712371|531536363|FG003|Overall Study|Lack of Efficacy|1|||
147375002|NCT02362035|531536366|FG000|Overall Study|Death|67|||
147375003|NCT02362035|531536366|FG000|Overall Study|Lost to Follow-up|3|||
147375004|NCT02362035|531536366|FG000|Overall Study|Adverse Event|1|||
147375005|NCT02362035|531536366|FG000|Overall Study|Physician Decision|1|||
147375006|NCT02362035|531536366|FG000|Overall Study|Subject started another cancer therapy|10|||
147375007|NCT02362035|531536366|FG000|Overall Study|Study terminated by sponsor|45|||
147375008|NCT02362035|531536366|FG000|Overall Study|Decision by subject not related to AE/SAE|2|||
147375009|NCT02362035|531536366|FG000|Overall Study|Decision by PI not related to AE/SAE|1|||
147375010|NCT02362035|531536366|FG000|Overall Study|Disease progression|11|||
147375011|NCT02362035|531536366|FG000|Overall Study|Withdrawal by Subject|20|||
147375012|NCT00229658|531536376|FG000|Overall Study|Administrative|2|||
147375013|NCT00229658|531536377|FG001|Overall Study|Administrative|1|||
147375014|NCT00229658|531536376|FG000|Overall Study|Investigator decision|13|||
147375015|NCT00229658|531536377|FG001|Overall Study|Investigator decision|10|||
147375016|NCT00229658|531536376|FG000|Overall Study|Other|80|||
147375017|NCT00229658|531536377|FG001|Overall Study|Other|60|||
147375018|NCT00229658|531536376|FG000|Overall Study|Lost to Follow-up|82|||
147375019|NCT00229658|531536377|FG001|Overall Study|Lost to Follow-up|55|||
147375020|NCT00229658|531536376|FG000|Overall Study|Serious Adverse Event|2|||
147375021|NCT00229658|531536377|FG001|Overall Study|Serious Adverse Event|2|||
147375022|NCT00229658|531536376|FG000|Overall Study|Withdrawal of consent|46|||
147375023|NCT00229658|531536377|FG001|Overall Study|Withdrawal of consent|39|||
147375024|NCT02157116|531536378|FG000|Overall Study|Withdrawal by Subject|4|||
147375025|NCT02157116|531536378|FG000|Overall Study|Physician Decision|3|||
147375026|NCT02157116|531536378|FG000|Overall Study|Failed Screening|2|||
147375027|NCT00975585|531536379|FG000|Overall Study|Adverse Event|0|||
147375028|NCT00975585|531536380|FG001|Overall Study|Adverse Event|4|||
147375029|NCT00975585|531536379|FG000|Overall Study|Lost to Follow-up|3|||
147375030|NCT00975585|531536380|FG001|Overall Study|Lost to Follow-up|5|||
147375031|NCT00975585|531536379|FG000|Overall Study|Withdrawal by Subject|2|||
147375032|NCT00975585|531536380|FG001|Overall Study|Withdrawal by Subject|1|||
147375033|NCT00975585|531536379|FG000|Overall Study|Lens issue|2|||
147375034|NCT00975585|531536380|FG001|Overall Study|Lens issue|2|||
147375035|NCT01953224|531536381|FG000|Overall Study|Lost to Follow-up|1|||
147375036|NCT01953224|531536382|FG001|Overall Study|Lost to Follow-up|1|||
147375037|NCT01953224|531536381|FG000|Overall Study|Withdrawal by Subject|1|||
147375038|NCT01953224|531536382|FG001|Overall Study|Withdrawal by Subject|2|||
147375039|NCT00205179|531536385|FG000|Overall Study|Death|0|||
147375040|NCT00205179|531536386|FG001|Overall Study|Death|2|||
147375041|NCT00205179|531536385|FG000|Overall Study|Physician Decision|1|||
147375042|NCT00205179|531536386|FG001|Overall Study|Physician Decision|1|||
147375043|NCT00205179|531536385|FG000|Overall Study|Adverse Event|1|||
147375044|NCT00205179|531536386|FG001|Overall Study|Adverse Event|1|||
147375045|NCT00463229|531536387|FG000|Overall Study|Lost to Follow-up|5|||
147375046|NCT00463229|531536388|FG001|Overall Study|Lost to Follow-up|7|||
147375047|NCT00463229|531536387|FG000|Overall Study|Death|4|||
147611475|NCT03713632|532393626|FG004|Treatment Period 2 (After Week 16)|Adverse Event|1|||
147611476|NCT03713632|532393622|FG000|Treatment Period 2 (After Week 16)|Lack of Efficacy|3|||
147611477|NCT03713632|532393623|FG001|Treatment Period 2 (After Week 16)|Lack of Efficacy|3|||
147375048|NCT00463229|531536388|FG001|Overall Study|Death|3|||
147375049|NCT01767467|531536395|FG000|Vaccination Phase (up to Month 2)|Adverse Event|8|||
147375050|NCT01767467|531536396|FG001|Vaccination Phase (up to Month 2)|Adverse Event|8|||
147375051|NCT01767467|531536395|FG000|Vaccination Phase (up to Month 2)|Protocol Violation|1|||
147375052|NCT01767467|531536396|FG001|Vaccination Phase (up to Month 2)|Protocol Violation|0|||
147375053|NCT01767467|531536395|FG000|Vaccination Phase (up to Month 2)|Withdrawal by Subject|7|||
147375054|NCT01767467|531536396|FG001|Vaccination Phase (up to Month 2)|Withdrawal by Subject|10|||
147375055|NCT01767467|531536395|FG000|Vaccination Phase (up to Month 2)|Suspected Herpes Zoster episode|0|||
147375056|NCT01767467|531536396|FG001|Vaccination Phase (up to Month 2)|Suspected Herpes Zoster episode|1|||
147375057|NCT01767467|531536395|FG000|Vaccination Phase (up to Month 2)|Physician Decision|1|||
147375058|NCT01767467|531536396|FG001|Vaccination Phase (up to Month 2)|Physician Decision|0|||
147375059|NCT01767467|531536395|FG000|Vaccination Phase (up to Month 2)|Subject unavailable|0|||
147375060|NCT01767467|531536396|FG001|Vaccination Phase (up to Month 2)|Subject unavailable|1|||
147611478|NCT03713632|532393624|FG002|Treatment Period 2 (After Week 16)|Lack of Efficacy|0|||
147611479|NCT03713632|532393625|FG003|Treatment Period 2 (After Week 16)|Lack of Efficacy|1|||
147611480|NCT03713632|532393626|FG004|Treatment Period 2 (After Week 16)|Lack of Efficacy|2|||
147375061|NCT01767467|531536395|FG000|End of Study Phase (up to Month 13)|Adverse Event|29|||
147375062|NCT01767467|531536396|FG001|End of Study Phase (up to Month 13)|Adverse Event|39|||
147375063|NCT01767467|531536395|FG000|End of Study Phase (up to Month 13)|Protocol Violation|2|||
147375064|NCT01767467|531536396|FG001|End of Study Phase (up to Month 13)|Protocol Violation|0|||
147375065|NCT01767467|531536395|FG000|End of Study Phase (up to Month 13)|Withdrawal by Subject|9|||
147375066|NCT01767467|531536396|FG001|End of Study Phase (up to Month 13)|Withdrawal by Subject|14|||
147375067|NCT01767467|531536395|FG000|End of Study Phase (up to Month 13)|Migrated/Moved from study area|0|||
147375068|NCT01767467|531536396|FG001|End of Study Phase (up to Month 13)|Migrated/Moved from study area|3|||
147375069|NCT01767467|531536395|FG000|End of Study Phase (up to Month 13)|Lost to Follow-up|6|||
147375070|NCT01767467|531536396|FG001|End of Study Phase (up to Month 13)|Lost to Follow-up|4|||
147375071|NCT01767467|531536395|FG000|End of Study Phase (up to Month 13)|Suspected Herpes Zoster episode|0|||
147375072|NCT01767467|531536396|FG001|End of Study Phase (up to Month 13)|Suspected Herpes Zoster episode|1|||
147375073|NCT01767467|531536395|FG000|End of Study Phase (up to Month 13)|Physician Decision|1|||
147375074|NCT01767467|531536396|FG001|End of Study Phase (up to Month 13)|Physician Decision|0|||
147375075|NCT01767467|531536395|FG000|End of Study Phase (up to Month 13)|Subject Unavailable|0|||
147375076|NCT01767467|531536396|FG001|End of Study Phase (up to Month 13)|Subject Unavailable|2|||
147375077|NCT01359150|531536397|FG000|Overall Study|Lack of Efficacy|1|||
147375078|NCT01359150|531536398|FG001|Overall Study|Lack of Efficacy|1|||
147375079|NCT01359150|531536397|FG000|Overall Study|Withdrawal by Subject|1|||
147375080|NCT01359150|531536398|FG001|Overall Study|Withdrawal by Subject|1|||
147375081|NCT01359150|531536397|FG000|Overall Study|Adverse Event|4|||
147375082|NCT01359150|531536398|FG001|Overall Study|Adverse Event|3|||
147375083|NCT01359150|531536397|FG000|Overall Study|Other|1|||
147375084|NCT01359150|531536398|FG001|Overall Study|Other|0|||
147375085|NCT01787032|531536401|FG000|Overall Study|Protocol Violation|0|||
147375086|NCT01787032|531536402|FG001|Overall Study|Protocol Violation|0|||
147375087|NCT01787032|531536403|FG002|Overall Study|Protocol Violation|0|||
147375088|NCT01787032|531536404|FG003|Overall Study|Protocol Violation|0|||
147375089|NCT01787032|531536405|FG004|Overall Study|Protocol Violation|1|||
147375090|NCT01787032|531536406|FG005|Overall Study|Protocol Violation|1|||
147375091|NCT02040870|531536407|FG000|Overall Study|Completed treatment phase|6|||
147375092|NCT02040870|531536407|FG000|Overall Study|Adverse Event|7|||
147375093|NCT02040870|531536407|FG000|Overall Study|Progressive disease|58|||
147375094|NCT02040870|531536407|FG000|Overall Study|Physician Decision|6|||
147375095|NCT02040870|531536407|FG000|Overall Study|Subject/guardian decision|10|||
147375096|NCT02040870|531536407|FG000|Overall Study|Lost to Follow-up|3|||
147375097|NCT02040870|531536407|FG000|Overall Study|Death|13|||
147375098|NCT04971733|531536408|FG000|Overall Study|Adverse Event|1|||
147375099|NCT04971733|531536409|FG001|Overall Study|Adverse Event|1|||
147375100|NCT04971733|531536408|FG000|Overall Study|Subject choice|2|||
147375101|NCT04971733|531536409|FG001|Overall Study|Subject choice|0|||
147375102|NCT04971733|531536408|FG000|Overall Study|Withdrawal by Subject|1|||
147375103|NCT04971733|531536409|FG001|Overall Study|Withdrawal by Subject|0|||
147375104|NCT04971733|531536408|FG000|Overall Study|Other|1|||
147375105|NCT04971733|531536409|FG001|Overall Study|Other|0|||
147375106|NCT02406092|531536418|FG000|Overall Study|Screen failure|10|||
147375107|NCT02406092|531536419|FG001|Overall Study|Screen failure|7|||
147375108|NCT02406092|531536418|FG000|Overall Study|Death|22|||
147375109|NCT02406092|531536419|FG001|Overall Study|Death|5|||
147375110|NCT02406092|531536418|FG000|Overall Study|Lost to Follow-up|4|||
147375111|NCT02406092|531536419|FG001|Overall Study|Lost to Follow-up|1|||
147375112|NCT02406092|531536418|FG000|Overall Study|Adverse Event|1|||
147375113|NCT02406092|531536419|FG001|Overall Study|Adverse Event|0|||
147375114|NCT02406092|531536418|FG000|Overall Study|Withdrawal by Subject|1|||
147375115|NCT02406092|531536419|FG001|Overall Study|Withdrawal by Subject|0|||
147375116|NCT00853593|531536423|FG000|Overall Study|Subjects did not receive a 4396 lead|12|||
147375117|NCT00853593|531536423|FG000|Overall Study|Model 4396 lead not attempted|29|||
147375118|NCT00853593|531536423|FG000|Overall Study|Implant not attempted|4|||
147375119|NCT03890289|531536424|FG000|Overall Study|Adverse Event|1|||
147375120|NCT03890289|531536424|FG000|Overall Study|Physician Decision|1|||
147375121|NCT03890289|531536424|FG000|Overall Study|Lack of Efficacy|2|||
147375122|NCT02816398|531536425|FG000|Overall Study|Death|5|||
147611481|NCT03713632|532393622|FG000|Treatment Period 2 (After Week 16)|Lost to Follow-up|1|||
147375123|NCT02816398|531536425|FG000|Overall Study|Lack of Efficacy|8|||
147375124|NCT02816398|531536425|FG000|Overall Study|Lost to Follow-up|1|||
147375125|NCT03362190|531536426|FG000|Overall Study|Adverse Event|0|||
147375126|NCT03362190|531536427|FG001|Overall Study|Adverse Event|0|||
147375127|NCT03362190|531536428|FG002|Overall Study|Adverse Event|0|||
147375128|NCT03362190|531536429|FG003|Overall Study|Adverse Event|1|||
147375129|NCT03362190|531536426|FG000|Overall Study|Withdrawal by Subject|0|||
147375130|NCT03362190|531536427|FG001|Overall Study|Withdrawal by Subject|0|||
147375131|NCT03362190|531536428|FG002|Overall Study|Withdrawal by Subject|0|||
147375132|NCT03362190|531536429|FG003|Overall Study|Withdrawal by Subject|1|||
147375133|NCT00687219|531536430|FG000|Overall Study|Adverse Event|8|||
147375134|NCT00687219|531536430|FG000|Overall Study|Discontinuance criteria met|7|||
147375135|NCT00687219|531536430|FG000|Overall Study|HCV-RNA positive conversion|34|||
147375136|NCT00687219|531536430|FG000|Overall Study|Withdrawal by Subject|1|||
147375137|NCT00687219|531536430|FG000|Overall Study|Lack of Efficacy|1|||
147375138|NCT01367236|531536438|FG000|Overall Study|Withdrawal by Subject|3|||
147375139|NCT01367236|531536439|FG001|Overall Study|Withdrawal by Subject|1|||
147375140|NCT02235298|531536440|FG000|Overall Study|Lost to Follow-up|6|||
147375141|NCT02235298|531536441|FG001|Overall Study|Lost to Follow-up|5|||
147375142|NCT02235298|531536440|FG000|Overall Study|Adverse Event|2|||
147375143|NCT02235298|531536441|FG001|Overall Study|Adverse Event|2|||
147375144|NCT02235298|531536440|FG000|Overall Study|Withdrawal by Subject|0|||
147375145|NCT02235298|531536441|FG001|Overall Study|Withdrawal by Subject|1|||
147375146|NCT04038580|531536454|FG000|Washout 1|Death|0|||
147375147|NCT04038580|531536455|FG001|Washout 1|Death|0|||
147375148|NCT04038580|531536456|FG002|Washout 1|Death|0|||
147375149|NCT04038580|531536457|FG003|Washout 1|Death|1|||
147375150|NCT04038580|531536458|FG004|Washout 1|Death|0|||
147375151|NCT04038580|531536459|FG005|Washout 1|Death|0|||
147375152|NCT04038580|531536454|FG000|Washout 1|Withdrawal by Subject|0|||
147375153|NCT04038580|531536455|FG001|Washout 1|Withdrawal by Subject|0|||
147375154|NCT04038580|531536456|FG002|Washout 1|Withdrawal by Subject|0|||
147375155|NCT04038580|531536457|FG003|Washout 1|Withdrawal by Subject|0|||
147375156|NCT04038580|531536458|FG004|Washout 1|Withdrawal by Subject|1|||
147375157|NCT04038580|531536459|FG005|Washout 1|Withdrawal by Subject|0|||
147375158|NCT04038580|531536454|FG000|Wash-out 2|Withdrawal by Subject|1|||
147375159|NCT04038580|531536455|FG001|Wash-out 2|Withdrawal by Subject|0|||
147375160|NCT04038580|531536456|FG002|Wash-out 2|Withdrawal by Subject|0|||
147375161|NCT04038580|531536457|FG003|Wash-out 2|Withdrawal by Subject|2|||
147375162|NCT04038580|531536458|FG004|Wash-out 2|Withdrawal by Subject|0|||
147375163|NCT04038580|531536459|FG005|Wash-out 2|Withdrawal by Subject|1|||
147375164|NCT04038580|531536454|FG000|Experimental Socket #2|Withdrawal by Subject|0|||
147375165|NCT04038580|531536455|FG001|Experimental Socket #2|Withdrawal by Subject|1|||
147375166|NCT04038580|531536456|FG002|Experimental Socket #2|Withdrawal by Subject|0|||
147375167|NCT04038580|531536457|FG003|Experimental Socket #2|Withdrawal by Subject|0|||
147375168|NCT04038580|531536458|FG004|Experimental Socket #2|Withdrawal by Subject|0|||
147375169|NCT04038580|531536459|FG005|Experimental Socket #2|Withdrawal by Subject|0|||
147375170|NCT04038580|531536454|FG000|Wash-out 3|Withdrawal by Subject|1|||
147375171|NCT04038580|531536455|FG001|Wash-out 3|Withdrawal by Subject|0|||
147375172|NCT04038580|531536456|FG002|Wash-out 3|Withdrawal by Subject|2|||
147375173|NCT04038580|531536457|FG003|Wash-out 3|Withdrawal by Subject|0|||
147375174|NCT04038580|531536458|FG004|Wash-out 3|Withdrawal by Subject|0|||
147375175|NCT04038580|531536459|FG005|Wash-out 3|Withdrawal by Subject|0|||
147375176|NCT05251363|531536460|FG000|Implant|Subject did not meet LBBA implant criteria|8|||
147375177|NCT05251363|531536460|FG000|Overall Study After Implant Period|Death|9|||
147375178|NCT05251363|531536460|FG000|Overall Study After Implant Period|Solia S lead in LBBA Position Extracted|4|||
147375179|NCT05251363|531536460|FG000|Overall Study After Implant Period|Withdrawal by Subject|4|||
147375180|NCT05251363|531536460|FG000|Overall Study After Implant Period|Lost to Follow-up|2|||
147375181|NCT05251363|531536460|FG000|Overall Study After Implant Period|Physician Decision|1|||
147375182|NCT05251363|531536460|FG000|Overall Study After Implant Period|Subject Moved from Investigational Center|3|||
147375183|NCT02328014|531537669|FG000|Overall Study|Adverse Event|1|||
147375184|NCT02328014|531537670|FG001|Overall Study|Adverse Event|0|||
147375185|NCT02328014|531537671|FG002|Overall Study|Adverse Event|0|||
147375186|NCT02328014|531537672|FG003|Overall Study|Adverse Event|1|||
147375187|NCT02328014|531537669|FG000|Overall Study|Death|0|||
147375188|NCT02328014|531537670|FG001|Overall Study|Death|0|||
147375189|NCT02328014|531537671|FG002|Overall Study|Death|0|||
147375190|NCT02328014|531537672|FG003|Overall Study|Death|4|||
147375191|NCT02328014|531537669|FG000|Overall Study|Physician Decision|0|||
147375192|NCT02328014|531537670|FG001|Overall Study|Physician Decision|0|||
147375193|NCT02328014|531537671|FG002|Overall Study|Physician Decision|0|||
147375194|NCT02328014|531537672|FG003|Overall Study|Physician Decision|1|||
147375195|NCT02328014|531537669|FG000|Overall Study|Disease Progression|1|||
147375196|NCT02328014|531537670|FG001|Overall Study|Disease Progression|0|||
147375197|NCT02328014|531537671|FG002|Overall Study|Disease Progression|1|||
147375198|NCT02328014|531537672|FG003|Overall Study|Disease Progression|3|||
147375199|NCT02328014|531537669|FG000|Overall Study|Study Terminated by Sponsor|4|||
147375200|NCT02328014|531537670|FG001|Overall Study|Study Terminated by Sponsor|1|||
147375201|NCT02328014|531537671|FG002|Overall Study|Study Terminated by Sponsor|1|||
147375202|NCT02328014|531537672|FG003|Overall Study|Study Terminated by Sponsor|0|||
147375203|NCT02328014|531537669|FG000|Overall Study|Subject Started Another Cancer Therapy|0|||
147375204|NCT02328014|531537670|FG001|Overall Study|Subject Started Another Cancer Therapy|5|||
147375205|NCT02328014|531537671|FG002|Overall Study|Subject Started Another Cancer Therapy|4|||
147375206|NCT02328014|531537672|FG003|Overall Study|Subject Started Another Cancer Therapy|12|||
147375207|NCT02328014|531537669|FG000|Overall Study|Withdrawal by Subject|0|||
147375208|NCT02328014|531537670|FG001|Overall Study|Withdrawal by Subject|0|||
147375209|NCT02328014|531537671|FG002|Overall Study|Withdrawal by Subject|0|||
147375210|NCT02328014|531537672|FG003|Overall Study|Withdrawal by Subject|1|||
147375211|NCT00093496|531537675|FG000|Overall Study|Protocol Violation|1|||
147375212|NCT00093496|531537676|FG001|Overall Study|Protocol Violation|3|||
147375213|NCT01932970|531537677|FG000|Overall Study|Withdrawal by Subject|5|||
147375214|NCT01932970|531537677|FG000|Overall Study|Death|1|||
147375215|NCT01932970|531537677|FG000|Overall Study|Lost to Follow-up|2|||
147375216|NCT01932970|531537677|FG000|Overall Study|Protocol Specified Criteria|10|||
147375217|NCT00853580|531537678|FG000|Overall Study|Lost to Follow-up|3|||
147375218|NCT00853580|531537679|FG001|Overall Study|Lost to Follow-up|5|||
147375219|NCT00853580|531537678|FG000|Overall Study|Protocol Violation|2|||
147375220|NCT00853580|531537679|FG001|Overall Study|Protocol Violation|1|||
147375221|NCT00853580|531537678|FG000|Overall Study|Withdrawal by Subject|2|||
147375222|NCT00853580|531537679|FG001|Overall Study|Withdrawal by Subject|8|||
147375223|NCT00853580|531537678|FG000|Overall Study|Commenced contraindicated therapy|0|||
147375224|NCT00853580|531537679|FG001|Overall Study|Commenced contraindicated therapy|2|||
147375225|NCT01700205|531537680|FG000|Overall Study|Withdrawal by Subject|13|||
147375226|NCT01700205|531537681|FG001|Overall Study|Withdrawal by Subject|13|||
147375227|NCT01700205|531537680|FG000|Overall Study|Protocol Violation|2|||
147375228|NCT01700205|531537681|FG001|Overall Study|Protocol Violation|2|||
147375229|NCT01728324|531537682|FG000|Termination of DBV|Adverse Event|14|||
147375230|NCT01728324|531537683|FG001|Termination of DBV|Adverse Event|13|||
147375231|NCT01728324|531537684|FG002|Termination of DBV|Adverse Event|4|||
147375232|NCT01728324|531537682|FG000|Termination of DBV|Lack of Efficacy|14|||
147375233|NCT01728324|531537683|FG001|Termination of DBV|Lack of Efficacy|12|||
147375234|NCT01728324|531537684|FG002|Termination of DBV|Lack of Efficacy|8|||
147375235|NCT01728324|531537682|FG000|Termination of DBV|Withdrawal by Subject|9|||
147375236|NCT01728324|531537683|FG001|Termination of DBV|Withdrawal by Subject|6|||
147375237|NCT01728324|531537684|FG002|Termination of DBV|Withdrawal by Subject|2|||
147375238|NCT01728324|531537682|FG000|Termination of DBV|Other than stated|1|||
147375239|NCT01728324|531537683|FG001|Termination of DBV|Other than stated|3|||
147375240|NCT01728324|531537684|FG002|Termination of DBV|Other than stated|0|||
147375241|NCT01728324|531537682|FG000|Termination of DBV|Adverse Event (Placebo Period)|0|||
147375242|NCT01728324|531537683|FG001|Termination of DBV|Adverse Event (Placebo Period)|1|||
147375243|NCT01728324|531537684|FG002|Termination of DBV|Adverse Event (Placebo Period)|0|||
147375244|NCT01728324|531537682|FG000|Termination of DBV|Protocol Violation (Placebo Period)|0|||
147375245|NCT01728324|531537683|FG001|Termination of DBV|Protocol Violation (Placebo Period)|1|||
147375246|NCT01728324|531537684|FG002|Termination of DBV|Protocol Violation (Placebo Period)|0|||
147375247|NCT01728324|531537682|FG000|Termination of FDV|Adverse Event|14|||
147375248|NCT01728324|531537683|FG001|Termination of FDV|Adverse Event|13|||
147375249|NCT01728324|531537684|FG002|Termination of FDV|Adverse Event|4|||
147375250|NCT01728324|531537682|FG000|Termination of FDV|Lack of Efficacy|14|||
147375251|NCT01728324|531537683|FG001|Termination of FDV|Lack of Efficacy|12|||
147375252|NCT01728324|531537684|FG002|Termination of FDV|Lack of Efficacy|8|||
147375253|NCT01728324|531537682|FG000|Termination of FDV|Withdrawal by Subject|9|||
147375254|NCT01728324|531537683|FG001|Termination of FDV|Withdrawal by Subject|6|||
147375255|NCT01728324|531537684|FG002|Termination of FDV|Withdrawal by Subject|2|||
147375256|NCT01728324|531537682|FG000|Termination of FDV|Other than stated|1|||
147375257|NCT01728324|531537683|FG001|Termination of FDV|Other than stated|3|||
147375258|NCT01728324|531537684|FG002|Termination of FDV|Other than stated|0|||
147375259|NCT01728324|531537682|FG000|Termination of FDV|Adverse Event (Placebo Period)|0|||
147375260|NCT01728324|531537683|FG001|Termination of FDV|Adverse Event (Placebo Period)|1|||
147375261|NCT01728324|531537684|FG002|Termination of FDV|Adverse Event (Placebo Period)|0|||
147375262|NCT01728324|531537682|FG000|Termination of FDV|Protocol Violation (Placebo Period)|0|||
147375263|NCT01728324|531537683|FG001|Termination of FDV|Protocol Violation (Placebo Period)|1|||
147375264|NCT01728324|531537684|FG002|Termination of FDV|Protocol Violation (Placebo Period)|0|||
147375265|NCT01728324|531537682|FG000|Termination of RBV|Adverse Event|15|||
147375266|NCT01728324|531537683|FG001|Termination of RBV|Adverse Event|16|||
147375267|NCT01728324|531537684|FG002|Termination of RBV|Adverse Event|5|||
147375268|NCT01728324|531537682|FG000|Termination of RBV|Lack of Efficacy|14|||
147375269|NCT01728324|531537683|FG001|Termination of RBV|Lack of Efficacy|11|||
147375270|NCT01728324|531537684|FG002|Termination of RBV|Lack of Efficacy|7|||
147375271|NCT01728324|531537682|FG000|Termination of RBV|Withdrawal by Subject|9|||
147375272|NCT01728324|531537683|FG001|Termination of RBV|Withdrawal by Subject|5|||
147375273|NCT01728324|531537684|FG002|Termination of RBV|Withdrawal by Subject|2|||
147375274|NCT01728324|531537682|FG000|Termination of RBV|Other than stated|1|||
147375275|NCT01728324|531537683|FG001|Termination of RBV|Other than stated|3|||
147375276|NCT01728324|531537684|FG002|Termination of RBV|Other than stated|1|||
147375277|NCT01728324|531537682|FG000|Termination of RBV|Adverse Event (Placebo Period)|0|||
147375278|NCT01728324|531537683|FG001|Termination of RBV|Adverse Event (Placebo Period)|1|||
147375279|NCT01728324|531537684|FG002|Termination of RBV|Adverse Event (Placebo Period)|0|||
147375280|NCT01728324|531537682|FG000|Termination of RBV|Protocol Violation (Placebo Period)|0|||
147375281|NCT01728324|531537683|FG001|Termination of RBV|Protocol Violation (Placebo Period)|1|||
147455496|NCT00482014|531829837|FG001|Overall Study|Sponsor Decision|2|||
147664372|NCT04877990|532594547|FG001|Treatment|Withdrawal by Subject|6|||
147300199|NCT01648348|531264688|FG002|Overall Study|Cancel|0|||
147455497|NCT00482014|531829838|FG002|Overall Study|Sponsor Decision|1|||
147611482|NCT03713632|532393623|FG001|Treatment Period 2 (After Week 16)|Lost to Follow-up|8|||
147611483|NCT03713632|532393624|FG002|Treatment Period 2 (After Week 16)|Lost to Follow-up|0|||
147611484|NCT03713632|532393625|FG003|Treatment Period 2 (After Week 16)|Lost to Follow-up|1|||
147611485|NCT03713632|532393626|FG004|Treatment Period 2 (After Week 16)|Lost to Follow-up|0|||
147611486|NCT03713632|532393622|FG000|Treatment Period 2 (After Week 16)|Physician Decision|1|||
147611487|NCT03713632|532393623|FG001|Treatment Period 2 (After Week 16)|Physician Decision|2|||
147611488|NCT03713632|532393624|FG002|Treatment Period 2 (After Week 16)|Physician Decision|0|||
147611489|NCT03713632|532393625|FG003|Treatment Period 2 (After Week 16)|Physician Decision|0|||
147611490|NCT03713632|532393626|FG004|Treatment Period 2 (After Week 16)|Physician Decision|2|||
147611491|NCT03713632|532393622|FG000|Treatment Period 2 (After Week 16)|Technical Problems|1|||
147611492|NCT03713632|532393623|FG001|Treatment Period 2 (After Week 16)|Technical Problems|0|||
147611493|NCT03713632|532393624|FG002|Treatment Period 2 (After Week 16)|Technical Problems|0|||
147611494|NCT03713632|532393625|FG003|Treatment Period 2 (After Week 16)|Technical Problems|0|||
147611495|NCT03713632|532393626|FG004|Treatment Period 2 (After Week 16)|Technical Problems|0|||
147611496|NCT03713632|532393622|FG000|Treatment Period 2 (After Week 16)|Death|0|||
147611497|NCT03713632|532393623|FG001|Treatment Period 2 (After Week 16)|Death|1|||
147611498|NCT03713632|532393624|FG002|Treatment Period 2 (After Week 16)|Death|0|||
147611499|NCT03713632|532393625|FG003|Treatment Period 2 (After Week 16)|Death|0|||
147611500|NCT03713632|532393626|FG004|Treatment Period 2 (After Week 16)|Death|0|||
147611501|NCT03713632|532393622|FG000|Treatment Period 2 (After Week 16)|Pregnancy|0|||
147611502|NCT03713632|532393623|FG001|Treatment Period 2 (After Week 16)|Pregnancy|1|||
147611503|NCT03713632|532393624|FG002|Treatment Period 2 (After Week 16)|Pregnancy|0|||
147611504|NCT03713632|532393625|FG003|Treatment Period 2 (After Week 16)|Pregnancy|0|||
147611505|NCT03713632|532393626|FG004|Treatment Period 2 (After Week 16)|Pregnancy|0|||
147611506|NCT01524978|532393627|FG000|Overall Study|Other|16|||
147611507|NCT01524978|532393628|FG001|Overall Study|Other|2|||
147611508|NCT01524978|532393629|FG002|Overall Study|Other|1|||
147611509|NCT01524978|532393630|FG003|Overall Study|Other|2|||
147300200|NCT01648348|531264689|FG003|Overall Study|Cancel|0|||
147300201|NCT01648348|531264690|FG004|Overall Study|Cancel|3|||
147300202|NCT01648348|531264691|FG005|Overall Study|Cancel|6|||
147300203|NCT01648348|531264686|FG000|Overall Study|Replaced for MTD analysis|1|||
147300204|NCT01648348|531264687|FG001|Overall Study|Replaced for MTD analysis|0|||
147300205|NCT01648348|531264688|FG002|Overall Study|Replaced for MTD analysis|1|||
147300206|NCT01648348|531264689|FG003|Overall Study|Replaced for MTD analysis|0|||
147300207|NCT01648348|531264690|FG004|Overall Study|Replaced for MTD analysis|0|||
147300208|NCT01648348|531264691|FG005|Overall Study|Replaced for MTD analysis|0|||
147300209|NCT03419364|531264701|FG000|Overall Study|Delivery due to maternal condition|2|||
147300210|NCT03419364|531264702|FG001|Overall Study|Delivery due to maternal condition|0|||
147300211|NCT03419364|531264703|FG002|Overall Study|Delivery due to maternal condition|0|||
147300212|NCT00552084|531264704|FG000|Overall Study|Adverse Event|2|||
147300213|NCT00552084|531264705|FG001|Overall Study|Adverse Event|3|||
147300214|NCT00552084|531264704|FG000|Overall Study|Withdrawal by Subject|4|||
147300215|NCT00552084|531264705|FG001|Overall Study|Withdrawal by Subject|5|||
147300216|NCT00552084|531264704|FG000|Overall Study|Protocol Violation|1|||
147300217|NCT00552084|531264705|FG001|Overall Study|Protocol Violation|0|||
147300218|NCT00552084|531264704|FG000|Overall Study|change in anti-arrythmic drug|1|||
147300219|NCT00552084|531264705|FG001|Overall Study|change in anti-arrythmic drug|1|||
147300220|NCT01338025|531264706|FG000|Overall Study|Unexpected closure of study|10|||
147300221|NCT01338025|531264707|FG001|Overall Study|Unexpected closure of study|9|||
147300222|NCT01338025|531264706|FG000|Overall Study|Withdrawal by Subject|0|||
147300223|NCT01338025|531264707|FG001|Overall Study|Withdrawal by Subject|2|||
147300224|NCT01338025|531264706|FG000|Overall Study|Found ineligible after starting|1|||
147300225|NCT01338025|531264707|FG001|Overall Study|Found ineligible after starting|0|||
147300226|NCT03779906|531264710|FG000|Overall Study|Lost to Follow-up|7|||
147300227|NCT03779906|531264710|FG000|Overall Study|COVID pandemic|1|||
147300228|NCT02553460|531264711|FG000|Overall Study|Death|3|||
147300229|NCT02553460|531264711|FG000|Overall Study|Withdrawal by Subject|1|||
147300230|NCT02553460|531264711|FG000|Overall Study|Development of unacceptable toxicity during treatment|1|||
147300231|NCT02553460|531264711|FG000|Overall Study|Relapse or Transplant|14|||
147300232|NCT02553460|531264711|FG000|Overall Study|No response to treatment|2|||
147300233|NCT02553460|531264711|FG000|Overall Study|CAR T cells|2|||
147300234|NCT04737109|531265989|FG000|Study Treatment|Disease Progression|5|||
147300235|NCT04737109|531265990|FG001|Study Treatment|Disease Progression|0|||
147300236|NCT04737109|531265991|FG002|Study Treatment|Disease Progression|0|||
147300237|NCT04737109|531265992|FG003|Study Treatment|Disease Progression|0|||
147300238|NCT04737109|531265989|FG000|Study Treatment|Death on study|1|||
147300239|NCT04737109|531265990|FG001|Study Treatment|Death on study|0|||
147300240|NCT04737109|531265991|FG002|Study Treatment|Death on study|0|||
147300241|NCT04737109|531265992|FG003|Study Treatment|Death on study|0|||
147300242|NCT01582789|531265994|FG000|Second Intervention (14 Days)|Withdrawal by Subject|1|||
147455498|NCT00482014|531829839|FG003|Overall Study|Sponsor Decision|1|||
147664373|NCT04877990|532594546|FG000|Treatment|Adverse Event|2|||
147455499|NCT01934140|531829843|FG000|Persistence Phase (Year 6-10)|Other|24|||
147455500|NCT01934140|531829844|FG001|Persistence Phase (Year 6-10)|Other|6|||
147455501|NCT01934140|531829843|FG000|Persistence Phase (Year 6-10)|Lost to Follow-up|5|||
147455502|NCT01934140|531829844|FG001|Persistence Phase (Year 6-10)|Lost to Follow-up|2|||
147455503|NCT01934140|531829843|FG000|Persistence Phase (Year 6-10)|Migrated/moved from study area|31|||
147455504|NCT01934140|531829844|FG001|Persistence Phase (Year 6-10)|Migrated/moved from study area|10|||
147455505|NCT01934140|531829843|FG000|Persistence Phase (Year 6-10)|Eligibility criteria not fulfilled|2|||
147455506|NCT01934140|531829844|FG001|Persistence Phase (Year 6-10)|Eligibility criteria not fulfilled|0|||
147455507|NCT01934140|531829843|FG000|Persistence Phase (Year 6-10)|Missed at least 1 persistence visit|21|||
147455508|NCT01934140|531829844|FG001|Persistence Phase (Year 6-10)|Missed at least 1 persistence visit|7|||
147455509|NCT01934140|531829843|FG000|Booster Phase (6 Months)|Lost to Follow-up|1|||
147455510|NCT01934140|531829844|FG001|Booster Phase (6 Months)|Lost to Follow-up|0|||
147455511|NCT01934140|531829843|FG000|Booster Phase (6 Months)|Missed at least 1 booster visit|2|||
147455512|NCT01934140|531829844|FG001|Booster Phase (6 Months)|Missed at least 1 booster visit|1|||
147455513|NCT01934140|531829843|FG000|Booster Phase (6 Months)|Migrated/moved from study area|2|||
147455514|NCT01934140|531829844|FG001|Booster Phase (6 Months)|Migrated/moved from study area|2|||
147455515|NCT00808444|531829845|FG000|Overall Study|Withdrawal by Subject|1|||
147455516|NCT00808444|531829846|FG001|Overall Study|Withdrawal by Subject|0|||
147455517|NCT00808444|531829845|FG000|Overall Study|Lost to Follow-up|0|||
147455518|NCT00808444|531829846|FG001|Overall Study|Lost to Follow-up|1|||
147455519|NCT00122135|531829847|FG000|Overall Study|Withdrawal by Subject|3|||
147455520|NCT00122135|531829848|FG001|Overall Study|Withdrawal by Subject|0|||
147455521|NCT03269344|531829849|FG000|Overall Study|Protocol Violation|4|||
147455522|NCT03269344|531829850|FG001|Overall Study|Protocol Violation|3|||
147455523|NCT01449708|531829856|FG000|Overall Study|Protocol Violation|0|||
147455524|NCT01449708|531829857|FG001|Overall Study|Protocol Violation|1|||
147455525|NCT01449708|531829856|FG000|Overall Study|surgical complication|1|||
147455526|NCT01449708|531829857|FG001|Overall Study|surgical complication|2|||
147455527|NCT01449708|531829856|FG000|Overall Study|respiratory failure|1|||
147455528|NCT01449708|531829857|FG001|Overall Study|respiratory failure|0|||
147455529|NCT05499559|531829858|FG000|Overall Study|Lost to Follow-up|467|||
147455530|NCT02889796|531829861|FG000|Overall Study|Withdrew Consent|18|||
147455531|NCT02889796|531829862|FG001|Overall Study|Withdrew Consent|29|||
147455532|NCT02889796|531829863|FG002|Overall Study|Withdrew Consent|20|||
147455533|NCT02889796|531829864|FG003|Overall Study|Withdrew Consent|1|||
147455534|NCT02889796|531829865|FG004|Overall Study|Withdrew Consent|2|||
147455535|NCT02889796|531829866|FG005|Overall Study|Withdrew Consent|35|||
147455536|NCT02889796|531829861|FG000|Overall Study|Investigator's Discretion|10|||
147455537|NCT02889796|531829862|FG001|Overall Study|Investigator's Discretion|9|||
147455538|NCT02889796|531829863|FG002|Overall Study|Investigator's Discretion|10|||
147455539|NCT02889796|531829864|FG003|Overall Study|Investigator's Discretion|3|||
147455540|NCT02889796|531829865|FG004|Overall Study|Investigator's Discretion|0|||
147455541|NCT02889796|531829866|FG005|Overall Study|Investigator's Discretion|15|||
147455542|NCT02889796|531829861|FG000|Overall Study|Adverse Event|17|||
147455543|NCT02889796|531829862|FG001|Overall Study|Adverse Event|8|||
147455544|NCT02889796|531829863|FG002|Overall Study|Adverse Event|8|||
147455545|NCT02889796|531829864|FG003|Overall Study|Adverse Event|4|||
147455546|NCT02889796|531829865|FG004|Overall Study|Adverse Event|1|||
147455547|NCT02889796|531829866|FG005|Overall Study|Adverse Event|7|||
147455548|NCT02889796|531829861|FG000|Overall Study|Lost to Follow-up|5|||
147455549|NCT02889796|531829862|FG001|Overall Study|Lost to Follow-up|7|||
147455550|NCT02889796|531829863|FG002|Overall Study|Lost to Follow-up|2|||
147455551|NCT02889796|531829864|FG003|Overall Study|Lost to Follow-up|0|||
147455552|NCT02889796|531829865|FG004|Overall Study|Lost to Follow-up|2|||
147455553|NCT02889796|531829866|FG005|Overall Study|Lost to Follow-up|6|||
147455554|NCT02889796|531829861|FG000|Overall Study|Protocol Violation|0|||
147455555|NCT02889796|531829862|FG001|Overall Study|Protocol Violation|1|||
147455556|NCT02889796|531829863|FG002|Overall Study|Protocol Violation|3|||
147455557|NCT02889796|531829864|FG003|Overall Study|Protocol Violation|0|||
147455558|NCT02889796|531829865|FG004|Overall Study|Protocol Violation|0|||
147455559|NCT02889796|531829866|FG005|Overall Study|Protocol Violation|4|||
147455560|NCT02889796|531829861|FG000|Overall Study|Non-compliance With Study Drug|0|||
147455561|NCT02889796|531829862|FG001|Overall Study|Non-compliance With Study Drug|2|||
147455562|NCT02889796|531829863|FG002|Overall Study|Non-compliance With Study Drug|0|||
147455563|NCT02889796|531829864|FG003|Overall Study|Non-compliance With Study Drug|0|||
147455564|NCT02889796|531829865|FG004|Overall Study|Non-compliance With Study Drug|1|||
147664374|NCT04877990|532594547|FG001|Treatment|Adverse Event|1|||
147455565|NCT02889796|531829866|FG005|Overall Study|Non-compliance With Study Drug|2|||
147455566|NCT02889796|531829861|FG000|Overall Study|Death|1|||
147455567|NCT02889796|531829862|FG001|Overall Study|Death|1|||
147455568|NCT02889796|531829863|FG002|Overall Study|Death|0|||
147455569|NCT02889796|531829864|FG003|Overall Study|Death|1|||
147455570|NCT02889796|531829865|FG004|Overall Study|Death|0|||
147455571|NCT02889796|531829866|FG005|Overall Study|Death|1|||
147664375|NCT01949142|532594548|FG000|Overall Study|Withdrawal of consent|1|||
147375282|NCT01728324|531537684|FG002|Termination of RBV|Protocol Violation (Placebo Period)|0|||
147375283|NCT03113409|531537687|FG000|Overall Study|Withdrawal by Subject|5|||
147375284|NCT03113409|531537688|FG001|Overall Study|Withdrawal by Subject|0|||
147375285|NCT03113409|531537689|FG002|Overall Study|Withdrawal by Subject|0|||
147375286|NCT03335488|531537694|FG000|Maintenance Period|Withdrawal by Parent/Guardian|1|||
147375287|NCT03335488|531537695|FG001|Maintenance Period|Withdrawal by Parent/Guardian|0|||
147375288|NCT03335488|531537694|FG000|Safety Extension Period|Adverse Event|1|||
147375289|NCT03335488|531537695|FG001|Safety Extension Period|Adverse Event|0|||
147375290|NCT03335488|531537694|FG000|Safety Extension Period|Did Not Return to Study Visit|1|||
147375291|NCT03335488|531537695|FG001|Safety Extension Period|Did Not Return to Study Visit|0|||
147375292|NCT00388726|531537696|FG000|Overall Study|Adverse Event|50|||
147375293|NCT00388726|531537697|FG001|Overall Study|Adverse Event|24|||
147375294|NCT00388726|531537696|FG000|Overall Study|Progressive Disease|336|||
147375295|NCT00388726|531537697|FG001|Overall Study|Progressive Disease|153|||
147375296|NCT00388726|531537696|FG000|Overall Study|Clinical Progression|61|||
147375297|NCT00388726|531537697|FG001|Overall Study|Clinical Progression|36|||
147375298|NCT00388726|531537696|FG000|Overall Study|Withdrawal by Subject|10|||
147375299|NCT00388726|531537697|FG001|Overall Study|Withdrawal by Subject|7|||
147375300|NCT00388726|531537696|FG000|Overall Study|Administrative|6|||
147375301|NCT00388726|531537697|FG001|Overall Study|Administrative|9|||
147375302|NCT00388726|531537696|FG000|Overall Study|Physician Decision|18|||
147375303|NCT00388726|531537697|FG001|Overall Study|Physician Decision|13|||
147375304|NCT00388726|531537696|FG000|Overall Study|Death|3|||
147375305|NCT00388726|531537697|FG001|Overall Study|Death|2|||
147375306|NCT00600353|531537699|FG000|Overall Study|history of malignancy within 5 years|1|||
147375307|NCT00600353|531537700|FG001|Overall Study|history of malignancy within 5 years|0|||
147375308|NCT00600353|531537699|FG000|Overall Study|History of prepartive regimen|0|||
147375309|NCT00600353|531537700|FG001|Overall Study|History of prepartive regimen|1|||
147375310|NCT04941482|531537701|FG000|Overall Study|At the time of confirming dropout, the dropout patients had not experienced any SAEs or fatalities.|9|||
147375311|NCT04941482|531537702|FG001|Overall Study|At the time of confirming dropout, the dropout patients had not experienced any SAEs or fatalities.|3|||
147375312|NCT03229408|531537703|FG000|Overall Study|Withdrawal by Subject|4|||
147375313|NCT03229408|531537704|FG001|Overall Study|Withdrawal by Subject|1|||
147375314|NCT03229408|531537703|FG000|Overall Study|Adverse Event|2|||
147375315|NCT03229408|531537704|FG001|Overall Study|Adverse Event|0|||
147375316|NCT03229408|531537703|FG000|Overall Study|Pregnancy|0|||
147375317|NCT03229408|531537704|FG001|Overall Study|Pregnancy|1|||
147375318|NCT03229408|531537703|FG000|Overall Study|Required to stopped during intermittent COVID-19 person-to-person human research suspensions|2|||
147375319|NCT03229408|531537704|FG001|Overall Study|Required to stopped during intermittent COVID-19 person-to-person human research suspensions|2|||
147375320|NCT04200664|531537705|FG000|Overall Study|Withdrawal by Subject|1|||
147375321|NCT04200664|531537706|FG001|Overall Study|Withdrawal by Subject|0|||
147375322|NCT04200664|531537707|FG002|Overall Study|Withdrawal by Subject|0|||
147375323|NCT03745313|531537712|FG000|At 30 Days Follow-up|Death|2|||
147375324|NCT03745313|531537712|FG000|At 6 Months Follow-up|Death|1|||
147375325|NCT03745313|531537712|FG000|At 6 Months Follow-up|Missed Visit|1|||
147375326|NCT03745313|531537712|FG000|At 6 Months Follow-up|Exited for Other Reason Within Window|1|||
147375327|NCT03745313|531537712|FG000|At 1 Year Follow-up|Death|2|||
147375328|NCT03745313|531537712|FG000|At 1 Year Follow-up|Missed Visit|2|||
147375329|NCT03745313|531537712|FG000|At 2 Year Follow-up|Missed Visit|1|||
147375330|NCT03611075|531537714|FG000|Overall Study|Physician Decision|0|||
147375331|NCT03611075|531537715|FG001|Overall Study|Physician Decision|1|||
147375332|NCT03611075|531537716|FG002|Overall Study|Physician Decision|1|||
147375333|NCT03611075|531537717|FG003|Overall Study|Physician Decision|0|||
147375334|NCT03611075|531537718|FG004|Overall Study|Physician Decision|0|||
147375335|NCT03611075|531537719|FG005|Overall Study|Physician Decision|0|||
147375336|NCT03611075|531537720|FG006|Overall Study|Physician Decision|0|||
147375337|NCT03611075|531537721|FG007|Overall Study|Physician Decision|0|||
147375338|NCT03611075|531537722|FG008|Overall Study|Physician Decision|0|||
147375339|NCT03611075|531537714|FG000|Overall Study|Lost to Follow-up|1|||
147375340|NCT03611075|531537715|FG001|Overall Study|Lost to Follow-up|0|||
147455572|NCT02889796|531829861|FG000|Overall Study|Pregnancy|0|||
147455573|NCT02889796|531829862|FG001|Overall Study|Pregnancy|1|||
147455574|NCT02889796|531829863|FG002|Overall Study|Pregnancy|1|||
147455575|NCT02889796|531829864|FG003|Overall Study|Pregnancy|0|||
147664376|NCT01949142|532594549|FG001|Overall Study|Withdrawal of consent|0|||
147375341|NCT03611075|531537716|FG002|Overall Study|Lost to Follow-up|0|||
147375342|NCT03611075|531537717|FG003|Overall Study|Lost to Follow-up|2|||
147375343|NCT03611075|531537718|FG004|Overall Study|Lost to Follow-up|0|||
147375344|NCT03611075|531537719|FG005|Overall Study|Lost to Follow-up|0|||
147375345|NCT03611075|531537720|FG006|Overall Study|Lost to Follow-up|0|||
147375346|NCT03611075|531537721|FG007|Overall Study|Lost to Follow-up|0|||
147375347|NCT03611075|531537722|FG008|Overall Study|Lost to Follow-up|0|||
147375348|NCT03611075|531537714|FG000|Overall Study|Withdrawal by Subject|0|||
147375349|NCT03611075|531537715|FG001|Overall Study|Withdrawal by Subject|1|||
147455576|NCT02889796|531829865|FG004|Overall Study|Pregnancy|0|||
147455577|NCT02889796|531829866|FG005|Overall Study|Pregnancy|0|||
147375350|NCT03611075|531537716|FG002|Overall Study|Withdrawal by Subject|1|||
147375351|NCT03611075|531537717|FG003|Overall Study|Withdrawal by Subject|1|||
147375352|NCT03611075|531537718|FG004|Overall Study|Withdrawal by Subject|0|||
147375353|NCT03611075|531537719|FG005|Overall Study|Withdrawal by Subject|0|||
147375354|NCT03611075|531537720|FG006|Overall Study|Withdrawal by Subject|1|||
147375355|NCT03611075|531537721|FG007|Overall Study|Withdrawal by Subject|0|||
147375356|NCT03611075|531537722|FG008|Overall Study|Withdrawal by Subject|0|||
147375357|NCT03611075|531537714|FG000|Overall Study|Reason unknown|0|||
147375358|NCT03611075|531537715|FG001|Overall Study|Reason unknown|0|||
147375359|NCT03611075|531537716|FG002|Overall Study|Reason unknown|0|||
147375360|NCT03611075|531537717|FG003|Overall Study|Reason unknown|1|||
147375361|NCT03611075|531537718|FG004|Overall Study|Reason unknown|0|||
147375362|NCT03611075|531537719|FG005|Overall Study|Reason unknown|0|||
147375363|NCT03611075|531537720|FG006|Overall Study|Reason unknown|1|||
147375364|NCT03611075|531537721|FG007|Overall Study|Reason unknown|0|||
147375365|NCT03611075|531537722|FG008|Overall Study|Reason unknown|0|||
147375366|NCT01701401|531537723|FG000|Overall Study|Randomized But Not Treated|3|||
147375367|NCT01701401|531537724|FG001|Overall Study|Randomized But Not Treated|1|||
147375368|NCT01701401|531537725|FG002|Overall Study|Randomized But Not Treated|0|||
147375369|NCT01701401|531537726|FG003|Overall Study|Randomized But Not Treated|1|||
147375370|NCT01701401|531537723|FG000|Overall Study|Lost to Follow-up|5|||
147375371|NCT01701401|531537724|FG001|Overall Study|Lost to Follow-up|5|||
147375372|NCT01701401|531537725|FG002|Overall Study|Lost to Follow-up|1|||
147375373|NCT01701401|531537726|FG003|Overall Study|Lost to Follow-up|3|||
147375374|NCT01701401|531537723|FG000|Overall Study|Withdrew Consent|0|||
147375375|NCT01701401|531537724|FG001|Overall Study|Withdrew Consent|3|||
147375376|NCT01701401|531537725|FG002|Overall Study|Withdrew Consent|1|||
147375377|NCT01701401|531537726|FG003|Overall Study|Withdrew Consent|2|||
147375378|NCT01701401|531537723|FG000|Overall Study|Lack of Efficacy|1|||
147375379|NCT01701401|531537724|FG001|Overall Study|Lack of Efficacy|0|||
147375380|NCT01701401|531537725|FG002|Overall Study|Lack of Efficacy|2|||
147375381|NCT01701401|531537726|FG003|Overall Study|Lack of Efficacy|0|||
147375382|NCT01701401|531537723|FG000|Overall Study|Adverse Event|1|||
147375383|NCT01701401|531537724|FG001|Overall Study|Adverse Event|0|||
147375384|NCT01701401|531537725|FG002|Overall Study|Adverse Event|0|||
147375385|NCT01701401|531537726|FG003|Overall Study|Adverse Event|0|||
147375386|NCT01701401|531537723|FG000|Overall Study|Protocol Violation|0|||
147375387|NCT01701401|531537724|FG001|Overall Study|Protocol Violation|0|||
147375388|NCT01701401|531537725|FG002|Overall Study|Protocol Violation|1|||
147375389|NCT01701401|531537726|FG003|Overall Study|Protocol Violation|0|||
147375390|NCT04827732|531537730|FG000|Overall Study|Did not start treatment|0|||
147375391|NCT04827732|531537731|FG001|Overall Study|Did not start treatment|1|||
147375392|NCT04827732|531537732|FG002|Overall Study|Did not start treatment|0|||
147375393|NCT04827732|531537733|FG003|Overall Study|Did not start treatment|1|||
147375394|NCT04021862|531537734|FG000|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|0|||
147375395|NCT04021862|531537735|FG001|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|1|||
147375396|NCT04021862|531537736|FG002|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|0|||
147375397|NCT04021862|531537737|FG003|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|0|||
147375398|NCT04021862|531537738|FG004|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|0|||
147375399|NCT04021862|531537739|FG005|Placebo Controlled Period (Week 0-16)|Withdrawal by Subject|0|||
147375400|NCT04021862|531537734|FG000|Placebo Controlled Period (Week 0-16)|Adverse Event|2|||
147375401|NCT04021862|531537735|FG001|Placebo Controlled Period (Week 0-16)|Adverse Event|0|||
147375402|NCT04021862|531537736|FG002|Placebo Controlled Period (Week 0-16)|Adverse Event|0|||
147375403|NCT04021862|531537737|FG003|Placebo Controlled Period (Week 0-16)|Adverse Event|0|||
147375404|NCT04021862|531537738|FG004|Placebo Controlled Period (Week 0-16)|Adverse Event|0|||
147375405|NCT04021862|531537739|FG005|Placebo Controlled Period (Week 0-16)|Adverse Event|0|||
147375406|NCT04021862|531537734|FG000|Placebo Controlled Period (Week 0-16)|Pregnancy|0|||
147375407|NCT04021862|531537735|FG001|Placebo Controlled Period (Week 0-16)|Pregnancy|0|||
147375408|NCT04021862|531537736|FG002|Placebo Controlled Period (Week 0-16)|Pregnancy|1|||
147375409|NCT04021862|531537737|FG003|Placebo Controlled Period (Week 0-16)|Pregnancy|0|||
147611510|NCT01524978|532393631|FG004|Overall Study|Other|1|||
147611511|NCT01524978|532393632|FG005|Overall Study|Other|3|||
147375410|NCT04021862|531537738|FG004|Placebo Controlled Period (Week 0-16)|Pregnancy|0|||
147375411|NCT04021862|531537739|FG005|Placebo Controlled Period (Week 0-16)|Pregnancy|0|||
147375412|NCT04021862|531537734|FG000|Placebo Controlled Period (Week 0-16)|Other|0|||
147375413|NCT04021862|531537735|FG001|Placebo Controlled Period (Week 0-16)|Other|0|||
147375414|NCT04021862|531537736|FG002|Placebo Controlled Period (Week 0-16)|Other|1|||
147375415|NCT04021862|531537737|FG003|Placebo Controlled Period (Week 0-16)|Other|0|||
147375416|NCT04021862|531537738|FG004|Placebo Controlled Period (Week 0-16)|Other|0|||
147375417|NCT04021862|531537739|FG005|Placebo Controlled Period (Week 0-16)|Other|0|||
147375418|NCT04021862|531537734|FG000|Active Treatment Period (Week 16-32)|Withdrawal by Subject|0|||
147375419|NCT04021862|531537735|FG001|Active Treatment Period (Week 16-32)|Withdrawal by Subject|0|||
147611512|NCT01524978|532393633|FG006|Overall Study|Other|17|||
147611513|NCT01524978|532393634|FG007|Overall Study|Other|1|||
147611514|NCT01524978|532393635|FG008|Overall Study|Other|2|||
147611515|NCT01524978|532393636|FG009|Overall Study|Other|2|||
147611516|NCT01524978|532393637|FG010|Overall Study|Other|5|||
147611517|NCT01524978|532393627|FG000|Overall Study|Withdrawal by Subject|12|||
147611518|NCT01524978|532393628|FG001|Overall Study|Withdrawal by Subject|0|||
147611519|NCT01524978|532393629|FG002|Overall Study|Withdrawal by Subject|1|||
147611520|NCT01524978|532393630|FG003|Overall Study|Withdrawal by Subject|1|||
147611521|NCT01524978|532393631|FG004|Overall Study|Withdrawal by Subject|3|||
147611522|NCT01524978|532393632|FG005|Overall Study|Withdrawal by Subject|1|||
147611523|NCT01524978|532393633|FG006|Overall Study|Withdrawal by Subject|6|||
147611524|NCT01524978|532393634|FG007|Overall Study|Withdrawal by Subject|2|||
147611525|NCT01524978|532393635|FG008|Overall Study|Withdrawal by Subject|4|||
147611526|NCT01524978|532393636|FG009|Overall Study|Withdrawal by Subject|0|||
147611527|NCT01524978|532393637|FG010|Overall Study|Withdrawal by Subject|5|||
147611528|NCT01524978|532393627|FG000|Overall Study|Lost to Follow-up|0|||
147611529|NCT01524978|532393628|FG001|Overall Study|Lost to Follow-up|0|||
147611530|NCT01524978|532393629|FG002|Overall Study|Lost to Follow-up|3|||
147611531|NCT01524978|532393630|FG003|Overall Study|Lost to Follow-up|0|||
147611532|NCT01524978|532393631|FG004|Overall Study|Lost to Follow-up|1|||
147611533|NCT01524978|532393632|FG005|Overall Study|Lost to Follow-up|1|||
147611534|NCT01524978|532393633|FG006|Overall Study|Lost to Follow-up|2|||
147611535|NCT01524978|532393634|FG007|Overall Study|Lost to Follow-up|0|||
147611536|NCT01524978|532393635|FG008|Overall Study|Lost to Follow-up|1|||
147611537|NCT01524978|532393636|FG009|Overall Study|Lost to Follow-up|1|||
147611538|NCT01524978|532393637|FG010|Overall Study|Lost to Follow-up|1|||
147611539|NCT01524978|532393627|FG000|Overall Study|Death|34|||
147611540|NCT01524978|532393628|FG001|Overall Study|Death|2|||
147611541|NCT01524978|532393629|FG002|Overall Study|Death|5|||
147611542|NCT01524978|532393630|FG003|Overall Study|Death|24|||
147611543|NCT01524978|532393631|FG004|Overall Study|Death|4|||
147611544|NCT01524978|532393632|FG005|Overall Study|Death|4|||
147611545|NCT01524978|532393633|FG006|Overall Study|Death|1|||
147611546|NCT01524978|532393634|FG007|Overall Study|Death|9|||
147611547|NCT01524978|532393635|FG008|Overall Study|Death|5|||
147611548|NCT01524978|532393636|FG009|Overall Study|Death|6|||
147611549|NCT01524978|532393637|FG010|Overall Study|Death|17|||
147611550|NCT03066258|532393643|FG000|Overall Study|Death|1|||
147611551|NCT03066258|532393644|FG001|Overall Study|Death|0|||
147611552|NCT03066258|532393645|FG002|Overall Study|Death|0|||
147611553|NCT03066258|532393646|FG003|Overall Study|Death|0|||
147611554|NCT03066258|532393647|FG004|Overall Study|Death|1|||
147611555|NCT02165735|532393648|FG000|Overall Study|Lost to Follow-up|12|||
147611556|NCT02165735|532393649|FG001|Overall Study|Lost to Follow-up|10|||
147611557|NCT02165735|532393648|FG000|Overall Study|Withdrawal by Subject|3|||
147611558|NCT02165735|532393649|FG001|Overall Study|Withdrawal by Subject|0|||
147611559|NCT02165735|532393648|FG000|Overall Study|Participant indicated lack of time|1|||
147611560|NCT02165735|532393649|FG001|Overall Study|Participant indicated lack of time|3|||
147611561|NCT02165735|532393648|FG000|Overall Study|Protocol Violation|0|||
147611562|NCT02165735|532393649|FG001|Overall Study|Protocol Violation|1|||
147611563|NCT02784795|532393650|FG000|Overall Study|Progressive Disease|2|||
147611564|NCT02784795|532393651|FG001|Overall Study|Progressive Disease|1|||
147611565|NCT02784795|532393652|FG002|Overall Study|Progressive Disease|1|||
147611566|NCT02784795|532393653|FG003|Overall Study|Progressive Disease|0|||
147611567|NCT02784795|532393654|FG004|Overall Study|Progressive Disease|2|||
147611568|NCT02784795|532393655|FG005|Overall Study|Progressive Disease|0|||
147611569|NCT02784795|532393656|FG006|Overall Study|Progressive Disease|2|||
147611570|NCT02784795|532393657|FG007|Overall Study|Progressive Disease|0|||
147611571|NCT02784795|532393658|FG008|Overall Study|Progressive Disease|0|||
147611572|NCT02784795|532393659|FG009|Overall Study|Progressive Disease|0|||
147611573|NCT02784795|532393660|FG010|Overall Study|Progressive Disease|1|||
147611574|NCT02784795|532393661|FG011|Overall Study|Progressive Disease|0|||
147611575|NCT02784795|532393650|FG000|Overall Study|Adverse Event|1|||
147611576|NCT02784795|532393651|FG001|Overall Study|Adverse Event|0|||
147611577|NCT02784795|532393652|FG002|Overall Study|Adverse Event|0|||
147611578|NCT02784795|532393653|FG003|Overall Study|Adverse Event|1|||
147611579|NCT02784795|532393654|FG004|Overall Study|Adverse Event|0|||
147611580|NCT02784795|532393655|FG005|Overall Study|Adverse Event|0|||
147611581|NCT02784795|532393656|FG006|Overall Study|Adverse Event|1|||
147611582|NCT02784795|532393657|FG007|Overall Study|Adverse Event|0|||
147611583|NCT02784795|532393658|FG008|Overall Study|Adverse Event|0|||
147611584|NCT02784795|532393659|FG009|Overall Study|Adverse Event|0|||
147611585|NCT02784795|532393660|FG010|Overall Study|Adverse Event|0|||
147611586|NCT02784795|532393661|FG011|Overall Study|Adverse Event|2|||
147611587|NCT02784795|532393650|FG000|Overall Study|Withdrawal by Subject|1|||
147611588|NCT02784795|532393651|FG001|Overall Study|Withdrawal by Subject|0|||
147611589|NCT02784795|532393652|FG002|Overall Study|Withdrawal by Subject|2|||
147611590|NCT02784795|532393653|FG003|Overall Study|Withdrawal by Subject|1|||
147611591|NCT02784795|532393654|FG004|Overall Study|Withdrawal by Subject|3|||
147611592|NCT02784795|532393655|FG005|Overall Study|Withdrawal by Subject|0|||
147611593|NCT02784795|532393656|FG006|Overall Study|Withdrawal by Subject|0|||
147611594|NCT02784795|532393657|FG007|Overall Study|Withdrawal by Subject|1|||
147664377|NCT01949142|532594548|FG000|Overall Study|Lost to Follow-up|1|||
147664378|NCT01949142|532594549|FG001|Overall Study|Lost to Follow-up|1|||
147664379|NCT01949142|532594548|FG000|Overall Study|Parent changed their mind|1|||
147664380|NCT01949142|532594549|FG001|Overall Study|Parent changed their mind|0|||
147664381|NCT00903201|532596233|FG000|Overall Study|Adverse Event|1|||
147664382|NCT00903201|532596234|FG001|Overall Study|Adverse Event|4|||
147664383|NCT00903201|532596235|FG002|Overall Study|Adverse Event|0|||
147664384|NCT00903201|532596233|FG000|Overall Study|Protocol Violation|2|||
147664385|NCT00903201|532596234|FG001|Overall Study|Protocol Violation|1|||
147664386|NCT00903201|532596235|FG002|Overall Study|Protocol Violation|0|||
147664387|NCT00903201|532596233|FG000|Overall Study|Lost to Follow-up|0|||
147664388|NCT00903201|532596234|FG001|Overall Study|Lost to Follow-up|1|||
147664389|NCT00903201|532596235|FG002|Overall Study|Lost to Follow-up|0|||
147664390|NCT00903201|532596233|FG000|Overall Study|Physician Decision|1|||
147664391|NCT00903201|532596234|FG001|Overall Study|Physician Decision|0|||
147664392|NCT00903201|532596235|FG002|Overall Study|Physician Decision|1|||
147664393|NCT00903201|532596233|FG000|Overall Study|Withdrawal by Subject|1|||
147664394|NCT00903201|532596234|FG001|Overall Study|Withdrawal by Subject|0|||
147664395|NCT00903201|532596235|FG002|Overall Study|Withdrawal by Subject|1|||
147664396|NCT01094288|532596236|FG000|Overall Study|Adverse Event|0|||
147664397|NCT01094288|532596237|FG001|Overall Study|Adverse Event|3|||
147664398|NCT01094288|532596238|FG002|Overall Study|Adverse Event|1|||
147664399|NCT01094288|532596239|FG003|Overall Study|Adverse Event|1|||
147664400|NCT01094288|532596240|FG004|Overall Study|Adverse Event|0|||
147664401|NCT01094288|532596241|FG005|Overall Study|Adverse Event|0|||
147664402|NCT01094288|532596242|FG006|Overall Study|Adverse Event|0|||
147664403|NCT01094288|532596243|FG007|Overall Study|Adverse Event|0|||
147664404|NCT01094288|532596236|FG000|Overall Study|Withdrawal by Subject|0|||
147664405|NCT01094288|532596237|FG001|Overall Study|Withdrawal by Subject|1|||
147664406|NCT01094288|532596238|FG002|Overall Study|Withdrawal by Subject|2|||
147664407|NCT01094288|532596239|FG003|Overall Study|Withdrawal by Subject|0|||
147664408|NCT01094288|532596240|FG004|Overall Study|Withdrawal by Subject|0|||
147664409|NCT01094288|532596241|FG005|Overall Study|Withdrawal by Subject|0|||
147375420|NCT04021862|531537736|FG002|Active Treatment Period (Week 16-32)|Withdrawal by Subject|0|||
147375421|NCT04021862|531537737|FG003|Active Treatment Period (Week 16-32)|Withdrawal by Subject|1|||
147375422|NCT04021862|531537738|FG004|Active Treatment Period (Week 16-32)|Withdrawal by Subject|0|||
147375423|NCT04021862|531537739|FG005|Active Treatment Period (Week 16-32)|Withdrawal by Subject|0|||
147375424|NCT04057131|531537740|FG000|Overall Study|Protocol Violation|24|||
147375425|NCT03835754|531537741|FG000|Overall Study|Death|4|||
147375426|NCT02830204|531537742|FG000|Overall Study|Death|9|||
147375427|NCT02830204|531537742|FG000|Overall Study|Withdrawal by Subject|1|||
147375428|NCT04445831|531537745|FG000|Overall Study|Withdrawal by Subject|2|||
147375429|NCT04445831|531537746|FG001|Overall Study|Withdrawal by Subject|1|||
147375430|NCT04445831|531537747|FG002|Overall Study|Withdrawal by Subject|1|||
147375431|NCT04445831|531537748|FG003|Overall Study|Withdrawal by Subject|0|||
147375432|NCT04445831|531537749|FG004|Overall Study|Withdrawal by Subject|0|||
147375433|NCT04445831|531537750|FG005|Overall Study|Withdrawal by Subject|0|||
147375434|NCT04445831|531537751|FG006|Overall Study|Withdrawal by Subject|0|||
147375435|NCT04445831|531537745|FG000|Overall Study|Subject withdrawal by caregiver|0|||
147375436|NCT04445831|531537746|FG001|Overall Study|Subject withdrawal by caregiver|1|||
147375437|NCT04445831|531537747|FG002|Overall Study|Subject withdrawal by caregiver|0|||
147375438|NCT04445831|531537748|FG003|Overall Study|Subject withdrawal by caregiver|0|||
147375439|NCT04445831|531537749|FG004|Overall Study|Subject withdrawal by caregiver|0|||
147375440|NCT04445831|531537750|FG005|Overall Study|Subject withdrawal by caregiver|0|||
147375441|NCT04445831|531537751|FG006|Overall Study|Subject withdrawal by caregiver|0|||
147375442|NCT05613907|531537755|FG000|Overall Study|Lost to Follow-up|5|||
147375443|NCT05613907|531537755|FG000|Overall Study|Death|3|||
147375444|NCT05613907|531537755|FG000|Overall Study|Withdrawal by Subject|2|||
147375445|NCT04701203|531537774|FG000|Blinded Period (Weeks 0 to 26)|Death|1|||
147375446|NCT04701203|531537775|FG001|Blinded Period (Weeks 0 to 26)|Death|0|||
147375447|NCT04701203|531537776|FG002|Blinded Period (Weeks 0 to 26)|Death|0|||
147375448|NCT04701203|531537774|FG000|Blinded Period (Weeks 0 to 26)|Withdrawal by Subject|0|||
147664410|NCT01094288|532596242|FG006|Overall Study|Withdrawal by Subject|0|||
147375449|NCT04701203|531537775|FG001|Blinded Period (Weeks 0 to 26)|Withdrawal by Subject|1|||
147375450|NCT04701203|531537776|FG002|Blinded Period (Weeks 0 to 26)|Withdrawal by Subject|0|||
147375451|NCT04701203|531537774|FG000|Blinded Period (Weeks 0 to 26)|Adverse Event|0|||
147375452|NCT04701203|531537775|FG001|Blinded Period (Weeks 0 to 26)|Adverse Event|1|||
147664411|NCT01094288|532596243|FG007|Overall Study|Withdrawal by Subject|2|||
147664412|NCT01094288|532596236|FG000|Overall Study|Initiation of Alternative Therapy|0|||
147664413|NCT01094288|532596237|FG001|Overall Study|Initiation of Alternative Therapy|0|||
147664414|NCT01094288|532596238|FG002|Overall Study|Initiation of Alternative Therapy|1|||
147664415|NCT01094288|532596239|FG003|Overall Study|Initiation of Alternative Therapy|0|||
147664416|NCT01094288|532596240|FG004|Overall Study|Initiation of Alternative Therapy|0|||
147664417|NCT01094288|532596241|FG005|Overall Study|Initiation of Alternative Therapy|0|||
147664418|NCT01094288|532596242|FG006|Overall Study|Initiation of Alternative Therapy|0|||
147664419|NCT01094288|532596243|FG007|Overall Study|Initiation of Alternative Therapy|0|||
147664420|NCT01094288|532596236|FG000|Overall Study|Reason not Specified|2|||
147664421|NCT01094288|532596237|FG001|Overall Study|Reason not Specified|3|||
147664422|NCT01094288|532596238|FG002|Overall Study|Reason not Specified|0|||
147664423|NCT01094288|532596239|FG003|Overall Study|Reason not Specified|1|||
147664424|NCT01094288|532596240|FG004|Overall Study|Reason not Specified|0|||
147664425|NCT01094288|532596241|FG005|Overall Study|Reason not Specified|0|||
147664426|NCT01094288|532596242|FG006|Overall Study|Reason not Specified|0|||
147664427|NCT01094288|532596243|FG007|Overall Study|Reason not Specified|0|||
147664428|NCT01094288|532596236|FG000|Overall Study|Ongoing Participants|0|||
147664429|NCT01094288|532596237|FG001|Overall Study|Ongoing Participants|3|||
147664430|NCT01094288|532596238|FG002|Overall Study|Ongoing Participants|0|||
147664431|NCT01094288|532596239|FG003|Overall Study|Ongoing Participants|0|||
147664432|NCT01094288|532596240|FG004|Overall Study|Ongoing Participants|0|||
147664433|NCT01094288|532596241|FG005|Overall Study|Ongoing Participants|0|||
147664434|NCT01094288|532596242|FG006|Overall Study|Ongoing Participants|0|||
147664435|NCT01094288|532596243|FG007|Overall Study|Ongoing Participants|0|||
147664436|NCT02611882|532596246|FG000|Overall Study|Did not complete prostatectomy per protocol stipulation|33|||
147664437|NCT02611882|532596247|FG001|Overall Study|Did not complete prostatectomy per protocol stipulation|0|||
147664438|NCT02611882|532596248|FG002|Overall Study|Did not complete prostatectomy per protocol stipulation|0|||
147664439|NCT01389232|532596249|FG000|Overall Study|Had scaffold removed|15|||
147664440|NCT01389232|532596249|FG000|Overall Study|Personal reasons|2|||
147664441|NCT01389232|532596249|FG000|Overall Study|Adverse Event|1|||
147664442|NCT01389232|532596249|FG000|Overall Study|Death|1|||
147664443|NCT01317940|532596250|FG000|Overall Study|Death|1|||
147664444|NCT01317940|532596251|FG001|Overall Study|Death|0|||
147664445|NCT01317940|532596252|FG002|Overall Study|Death|1|||
147664446|NCT01317940|532596253|FG003|Overall Study|Death|0|||
147664447|NCT01317940|532596254|FG004|Overall Study|Death|0|||
147664448|NCT01317940|532596255|FG005|Overall Study|Death|0|||
147664449|NCT01317940|532596250|FG000|Overall Study|Lost to Follow-up|0|||
147664450|NCT01317940|532596251|FG001|Overall Study|Lost to Follow-up|0|||
147664451|NCT01317940|532596252|FG002|Overall Study|Lost to Follow-up|1|||
147664452|NCT01317940|532596253|FG003|Overall Study|Lost to Follow-up|1|||
147664453|NCT01317940|532596254|FG004|Overall Study|Lost to Follow-up|1|||
147664454|NCT01317940|532596255|FG005|Overall Study|Lost to Follow-up|0|||
147664455|NCT01317940|532596250|FG000|Overall Study|Change in therapy plan|0|||
147664456|NCT01317940|532596251|FG001|Overall Study|Change in therapy plan|0|||
147664457|NCT01317940|532596252|FG002|Overall Study|Change in therapy plan|3|||
147664458|NCT01317940|532596253|FG003|Overall Study|Change in therapy plan|0|||
147664459|NCT01317940|532596254|FG004|Overall Study|Change in therapy plan|0|||
147664460|NCT01317940|532596255|FG005|Overall Study|Change in therapy plan|0|||
147664461|NCT00945243|532596257|FG000|Overall Study|Study Terminated: Subjects Dispositioned|3|||
147664462|NCT03256578|532596258|FG000|Overall Study|Excluded Post Randomization|66|||
147664463|NCT03256578|532596259|FG001|Overall Study|Excluded Post Randomization|56|||
147664464|NCT01198002|532596260|FG000|Treatment Period 1 (Weeks 0-52)|Adverse Event|18|||
147664465|NCT01198002|532596261|FG001|Treatment Period 1 (Weeks 0-52)|Adverse Event|11|||
147664466|NCT01198002|532596262|FG002|Treatment Period 1 (Weeks 0-52)|Adverse Event|11|||
147664467|NCT01198002|532596260|FG000|Treatment Period 1 (Weeks 0-52)|Death|2|||
147664468|NCT01198002|532596261|FG001|Treatment Period 1 (Weeks 0-52)|Death|0|||
147664469|NCT01198002|532596262|FG002|Treatment Period 1 (Weeks 0-52)|Death|1|||
147664470|NCT01198002|532596260|FG000|Treatment Period 1 (Weeks 0-52)|Lack of Efficacy|10|||
147664471|NCT01198002|532596261|FG001|Treatment Period 1 (Weeks 0-52)|Lack of Efficacy|9|||
147664472|NCT01198002|532596262|FG002|Treatment Period 1 (Weeks 0-52)|Lack of Efficacy|6|||
147664473|NCT01198002|532596260|FG000|Treatment Period 1 (Weeks 0-52)|Entry Criteria Not Met|1|||
147664474|NCT01198002|532596261|FG001|Treatment Period 1 (Weeks 0-52)|Entry Criteria Not Met|3|||
147664475|NCT01198002|532596262|FG002|Treatment Period 1 (Weeks 0-52)|Entry Criteria Not Met|3|||
147664476|NCT01198002|532596260|FG000|Treatment Period 1 (Weeks 0-52)|Lost to Follow-up|0|||
147664477|NCT01198002|532596261|FG001|Treatment Period 1 (Weeks 0-52)|Lost to Follow-up|2|||
147664478|NCT01198002|532596262|FG002|Treatment Period 1 (Weeks 0-52)|Lost to Follow-up|0|||
147375453|NCT04701203|531537776|FG002|Blinded Period (Weeks 0 to 26)|Adverse Event|0|||
147375454|NCT04701203|531537774|FG000|Open-Label Period (Weeks 26 to 182)|Study Ongoing|0|||
147375455|NCT04701203|531537775|FG001|Open-Label Period (Weeks 26 to 182)|Study Ongoing|0|||
147375456|NCT04701203|531537776|FG002|Open-Label Period (Weeks 26 to 182)|Study Ongoing|79|||
147375457|NCT00491894|531537778|FG000|Overall Study|Adverse Event|14|||
147664479|NCT01198002|532596260|FG000|Treatment Period 1 (Weeks 0-52)|Withdrawal by Subject|16|||
147664480|NCT01198002|532596261|FG001|Treatment Period 1 (Weeks 0-52)|Withdrawal by Subject|21|||
147664481|NCT01198002|532596262|FG002|Treatment Period 1 (Weeks 0-52)|Withdrawal by Subject|12|||
147664482|NCT01198002|532596260|FG000|Treatment Period 1 (Weeks 0-52)|Physician Decision|1|||
147664483|NCT01198002|532596261|FG001|Treatment Period 1 (Weeks 0-52)|Physician Decision|2|||
147664484|NCT01198002|532596262|FG002|Treatment Period 1 (Weeks 0-52)|Physician Decision|2|||
147664485|NCT01198002|532596260|FG000|Treatment Period 1 (Weeks 0-52)|Protocol Violation|14|||
147375458|NCT00491894|531537778|FG000|Overall Study|Withdrawal by Subject|5|||
147375459|NCT00491894|531537778|FG000|Overall Study|Death|3|||
147375460|NCT00491894|531537778|FG000|Overall Study|Lost to Follow-up|3|||
147375461|NCT00491894|531537778|FG000|Overall Study|Lack of Efficacy|2|||
147375462|NCT00491894|531537778|FG000|Overall Study|Other-Failed to meet any criteria|2|||
147611595|NCT02784795|532393658|FG008|Overall Study|Withdrawal by Subject|0|||
147611596|NCT02784795|532393659|FG009|Overall Study|Withdrawal by Subject|0|||
147611597|NCT02784795|532393660|FG010|Overall Study|Withdrawal by Subject|0|||
147611598|NCT02784795|532393661|FG011|Overall Study|Withdrawal by Subject|2|||
147611599|NCT02784795|532393650|FG000|Overall Study|Death|0|||
147611600|NCT02784795|532393651|FG001|Overall Study|Death|0|||
147611601|NCT02784795|532393652|FG002|Overall Study|Death|0|||
147611602|NCT02784795|532393653|FG003|Overall Study|Death|0|||
147611603|NCT02784795|532393654|FG004|Overall Study|Death|1|||
147611604|NCT02784795|532393655|FG005|Overall Study|Death|0|||
147611605|NCT02784795|532393656|FG006|Overall Study|Death|0|||
147611606|NCT02784795|532393657|FG007|Overall Study|Death|0|||
147611607|NCT02784795|532393658|FG008|Overall Study|Death|0|||
147611608|NCT02784795|532393659|FG009|Overall Study|Death|0|||
147611609|NCT02784795|532393660|FG010|Overall Study|Death|0|||
147611610|NCT02784795|532393661|FG011|Overall Study|Death|0|||
147611611|NCT02784795|532393650|FG000|Overall Study|Physician Decision|0|||
147611612|NCT02784795|532393651|FG001|Overall Study|Physician Decision|0|||
147611613|NCT02784795|532393652|FG002|Overall Study|Physician Decision|0|||
147611614|NCT02784795|532393653|FG003|Overall Study|Physician Decision|0|||
147611615|NCT02784795|532393654|FG004|Overall Study|Physician Decision|0|||
147611616|NCT02784795|532393655|FG005|Overall Study|Physician Decision|0|||
147611617|NCT02784795|532393656|FG006|Overall Study|Physician Decision|1|||
147611618|NCT02784795|532393657|FG007|Overall Study|Physician Decision|0|||
147611619|NCT02784795|532393658|FG008|Overall Study|Physician Decision|0|||
147611620|NCT02784795|532393659|FG009|Overall Study|Physician Decision|0|||
147611621|NCT02784795|532393660|FG010|Overall Study|Physician Decision|0|||
147611622|NCT02784795|532393661|FG011|Overall Study|Physician Decision|0|||
147611623|NCT00101283|532393662|FG000|Overall Study|Withdrawal by Subject|0|||
147611624|NCT00101283|532393663|FG001|Overall Study|Withdrawal by Subject|1|||
147611625|NCT00101283|532393662|FG000|Overall Study|Insurance Refusal|0|||
147611626|NCT00101283|532393663|FG001|Overall Study|Insurance Refusal|1|||
147611627|NCT00101283|532393662|FG000|Overall Study|Prostate Cancer Recurrence|0|||
147611628|NCT00101283|532393663|FG001|Overall Study|Prostate Cancer Recurrence|1|||
147611629|NCT02540083|532393664|FG000|Overall Study|Withdrawal by Subject|16|||
147611630|NCT02797171|532393665|FG000|Overall Study|Lost to Follow-up|2|||
147611631|NCT02797171|532393666|FG001|Overall Study|Lost to Follow-up|0|||
147611632|NCT02797171|532393667|FG002|Overall Study|Lost to Follow-up|2|||
147611633|NCT02797171|532393668|FG003|Overall Study|Lost to Follow-up|1|||
147611634|NCT02797171|532393669|FG004|Overall Study|Lost to Follow-up|2|||
147611635|NCT02797171|532393670|FG005|Overall Study|Lost to Follow-up|0|||
147611636|NCT02797171|532393665|FG000|Overall Study|Withdrawal by Subject|1|||
147611637|NCT02797171|532393666|FG001|Overall Study|Withdrawal by Subject|1|||
147611638|NCT02797171|532393667|FG002|Overall Study|Withdrawal by Subject|0|||
147611639|NCT02797171|532393668|FG003|Overall Study|Withdrawal by Subject|0|||
147611640|NCT02797171|532393669|FG004|Overall Study|Withdrawal by Subject|0|||
147611641|NCT02797171|532393670|FG005|Overall Study|Withdrawal by Subject|0|||
147611642|NCT02797171|532393665|FG000|Overall Study|Protocol Violation|1|||
147611643|NCT02797171|532393666|FG001|Overall Study|Protocol Violation|0|||
147611644|NCT02797171|532393667|FG002|Overall Study|Protocol Violation|0|||
147611645|NCT02797171|532393668|FG003|Overall Study|Protocol Violation|0|||
147611646|NCT02797171|532393669|FG004|Overall Study|Protocol Violation|0|||
147611647|NCT02797171|532393670|FG005|Overall Study|Protocol Violation|0|||
147611648|NCT02797171|532393665|FG000|Overall Study|Participant unable to adhere|0|||
147611649|NCT02797171|532393666|FG001|Overall Study|Participant unable to adhere|1|||
147611650|NCT02797171|532393667|FG002|Overall Study|Participant unable to adhere|0|||
147611651|NCT02797171|532393668|FG003|Overall Study|Participant unable to adhere|0|||
147375463|NCT00491894|531537778|FG000|Overall Study|Physician Decision|2|||
147375464|NCT00491894|531537778|FG000|Overall Study|Protocol Violation|2|||
147611652|NCT02797171|532393669|FG004|Overall Study|Participant unable to adhere|0|||
147611653|NCT02797171|532393670|FG005|Overall Study|Participant unable to adhere|0|||
147611654|NCT02797171|532393665|FG000|Overall Study|Not Randomized|0|||
147611655|NCT02797171|532393666|FG001|Overall Study|Not Randomized|0|||
147611656|NCT02797171|532393667|FG002|Overall Study|Not Randomized|0|||
147611657|NCT02797171|532393668|FG003|Overall Study|Not Randomized|0|||
147611658|NCT02797171|532393669|FG004|Overall Study|Not Randomized|0|||
147611659|NCT02797171|532393670|FG005|Overall Study|Not Randomized|1|||
147611660|NCT00595309|532393671|FG000|Overall Study|Lost to Follow-up|1|||
147611661|NCT00595309|532393671|FG000|Overall Study|planned vaccination against yellow fever|1|||
147375465|NCT00491894|531537778|FG000|Overall Study|Other-Intake of prohibited medication|1|||
147375466|NCT01563185|531537779|FG000|Overall Study|Withdrawal by Subject|1|||
147611662|NCT00595309|532393671|FG000|Overall Study|acute infection after V0|1|||
147611663|NCT00595309|532393671|FG000|Overall Study|personal reason|1|||
147611664|NCT02301390|532393676|FG000|Overall Study|Withdrawal by Subject|3|||
147611665|NCT02301390|532393677|FG001|Overall Study|Withdrawal by Subject|5|||
147375467|NCT01563185|531537779|FG000|Overall Study|Non-Compliance with study drug|1|||
147375468|NCT05293717|531537781|FG000|Overall Study|Physician Decision|1|||
147375469|NCT05422339|531539161|FG000|Overall Study|Withdrawal by Subject|17|||
147375470|NCT05422339|531539162|FG001|Overall Study|Withdrawal by Subject|15|||
147375471|NCT04172675|531539163|FG000|Overall Study|Withdrawal by Subject|7|||
147375472|NCT04172675|531539164|FG001|Overall Study|Withdrawal by Subject|5|||
147375473|NCT04172675|531539165|FG002|Overall Study|Withdrawal by Subject|1|||
147375474|NCT04172675|531539166|FG003|Overall Study|Withdrawal by Subject|4|||
147375475|NCT05029284|531539173|FG000|Overall Study|Lost to Follow-up|1|||
147375476|NCT03070392|531539174|FG000|Overall Study|Not Treated|7|||
147375477|NCT03070392|531539175|FG001|Overall Study|Not Treated|0|||
147375478|NCT03070392|531539176|FG002|Overall Study|Not Treated|3|||
147375479|NCT03070392|531539177|FG003|Overall Study|Not Treated|12|||
147375480|NCT03070392|531539174|FG000|Overall Study|Death|3|||
147375481|NCT03070392|531539175|FG001|Overall Study|Death|0|||
147375482|NCT03070392|531539176|FG002|Overall Study|Death|0|||
147375483|NCT03070392|531539177|FG003|Overall Study|Death|1|||
147375484|NCT03070392|531539174|FG000|Overall Study|Withdrawal by Subject|7|||
147375485|NCT03070392|531539175|FG001|Overall Study|Withdrawal by Subject|0|||
147375486|NCT03070392|531539176|FG002|Overall Study|Withdrawal by Subject|0|||
147375487|NCT03070392|531539177|FG003|Overall Study|Withdrawal by Subject|3|||
147375488|NCT03070392|531539174|FG000|Overall Study|Physician Decision|1|||
147375489|NCT03070392|531539175|FG001|Overall Study|Physician Decision|0|||
147375490|NCT03070392|531539176|FG002|Overall Study|Physician Decision|0|||
147375491|NCT03070392|531539177|FG003|Overall Study|Physician Decision|2|||
147375492|NCT03070392|531539174|FG000|Overall Study|Progressive Disease|154|||
147375493|NCT03070392|531539175|FG001|Overall Study|Progressive Disease|6|||
147375494|NCT03070392|531539176|FG002|Overall Study|Progressive Disease|2|||
147375495|NCT03070392|531539177|FG003|Overall Study|Progressive Disease|70|||
147375496|NCT03070392|531539174|FG000|Overall Study|Adverse Event|6|||
147375497|NCT03070392|531539175|FG001|Overall Study|Adverse Event|1|||
147375498|NCT03070392|531539176|FG002|Overall Study|Adverse Event|1|||
147375499|NCT03070392|531539177|FG003|Overall Study|Adverse Event|3|||
147375500|NCT03070392|531539174|FG000|Overall Study|Alternate anticancer treatment|1|||
147375501|NCT03070392|531539175|FG001|Overall Study|Alternate anticancer treatment|0|||
147375502|NCT03070392|531539176|FG002|Overall Study|Alternate anticancer treatment|0|||
147375503|NCT03070392|531539177|FG003|Overall Study|Alternate anticancer treatment|1|||
147375504|NCT03070392|531539174|FG000|Overall Study|Ongoing|73|||
147375505|NCT03070392|531539175|FG001|Overall Study|Ongoing|0|||
147375506|NCT03070392|531539176|FG002|Overall Study|Ongoing|0|||
147375507|NCT03070392|531539177|FG003|Overall Study|Ongoing|11|||
147375508|NCT02972034|531539178|FG000|Overall Study|Death|11|||
147375509|NCT02972034|531539179|FG001|Overall Study|Death|1|||
147375510|NCT02972034|531539180|FG002|Overall Study|Death|3|||
147375511|NCT02972034|531539181|FG003|Overall Study|Death|3|||
147375512|NCT02972034|531539182|FG004|Overall Study|Death|2|||
147375513|NCT02972034|531539183|FG005|Overall Study|Death|2|||
147375514|NCT02972034|531539184|FG006|Overall Study|Death|3|||
147375515|NCT02972034|531539185|FG007|Overall Study|Death|4|||
147375516|NCT02972034|531539186|FG008|Overall Study|Death|8|||
147375517|NCT02972034|531539187|FG009|Overall Study|Death|11|||
147375518|NCT02972034|531539188|FG010|Overall Study|Death|3|||
147375519|NCT02972034|531539189|FG011|Overall Study|Death|2|||
147375520|NCT02972034|531539190|FG012|Overall Study|Death|11|||
147375521|NCT02972034|531539191|FG013|Overall Study|Death|10|||
147375522|NCT02972034|531539192|FG014|Overall Study|Death|9|||
147375523|NCT02972034|531539178|FG000|Overall Study|Lost to Follow-up|0|||
147375524|NCT02972034|531539179|FG001|Overall Study|Lost to Follow-up|0|||
147375525|NCT02972034|531539180|FG002|Overall Study|Lost to Follow-up|0|||
147375526|NCT02972034|531539181|FG003|Overall Study|Lost to Follow-up|0|||
147375527|NCT02972034|531539182|FG004|Overall Study|Lost to Follow-up|1|||
147375528|NCT02972034|531539183|FG005|Overall Study|Lost to Follow-up|0|||
147375529|NCT02972034|531539184|FG006|Overall Study|Lost to Follow-up|0|||
147375530|NCT02972034|531539185|FG007|Overall Study|Lost to Follow-up|1|||
147455578|NCT02889796|531829861|FG000|Overall Study|Randomized but not Dosed|2|||
147375531|NCT02972034|531539186|FG008|Overall Study|Lost to Follow-up|0|||
147375532|NCT02972034|531539187|FG009|Overall Study|Lost to Follow-up|0|||
147455579|NCT02889796|531829862|FG001|Overall Study|Randomized but not Dosed|0|||
147375533|NCT02972034|531539188|FG010|Overall Study|Lost to Follow-up|0|||
147375534|NCT02972034|531539189|FG011|Overall Study|Lost to Follow-up|0|||
147375535|NCT02972034|531539190|FG012|Overall Study|Lost to Follow-up|0|||
147375536|NCT02972034|531539191|FG013|Overall Study|Lost to Follow-up|0|||
147375537|NCT02972034|531539192|FG014|Overall Study|Lost to Follow-up|1|||
147375538|NCT02972034|531539178|FG000|Overall Study|Physician Decision|0|||
147375539|NCT02972034|531539179|FG001|Overall Study|Physician Decision|0|||
147375540|NCT02972034|531539180|FG002|Overall Study|Physician Decision|0|||
147375541|NCT02972034|531539181|FG003|Overall Study|Physician Decision|0|||
147375542|NCT02972034|531539182|FG004|Overall Study|Physician Decision|0|||
147375543|NCT02972034|531539183|FG005|Overall Study|Physician Decision|0|||
147375544|NCT02972034|531539184|FG006|Overall Study|Physician Decision|0|||
147375545|NCT02972034|531539185|FG007|Overall Study|Physician Decision|1|||
147455580|NCT02889796|531829863|FG002|Overall Study|Randomized but not Dosed|0|||
147375546|NCT02972034|531539186|FG008|Overall Study|Physician Decision|0|||
147375547|NCT02972034|531539187|FG009|Overall Study|Physician Decision|0|||
147375548|NCT02972034|531539188|FG010|Overall Study|Physician Decision|1|||
147375549|NCT02972034|531539189|FG011|Overall Study|Physician Decision|0|||
147375550|NCT02972034|531539190|FG012|Overall Study|Physician Decision|0|||
147375551|NCT02972034|531539191|FG013|Overall Study|Physician Decision|0|||
147375552|NCT02972034|531539192|FG014|Overall Study|Physician Decision|0|||
147375553|NCT02972034|531539178|FG000|Overall Study|Sponsor Decision|0|||
147375554|NCT02972034|531539179|FG001|Overall Study|Sponsor Decision|0|||
147375555|NCT02972034|531539180|FG002|Overall Study|Sponsor Decision|0|||
147375556|NCT02972034|531539181|FG003|Overall Study|Sponsor Decision|1|||
147375557|NCT02972034|531539182|FG004|Overall Study|Sponsor Decision|0|||
147375558|NCT02972034|531539183|FG005|Overall Study|Sponsor Decision|0|||
147375559|NCT02972034|531539184|FG006|Overall Study|Sponsor Decision|1|||
147375560|NCT02972034|531539185|FG007|Overall Study|Sponsor Decision|1|||
147375561|NCT02972034|531539186|FG008|Overall Study|Sponsor Decision|1|||
147375562|NCT02972034|531539187|FG009|Overall Study|Sponsor Decision|2|||
147375563|NCT02972034|531539188|FG010|Overall Study|Sponsor Decision|2|||
147375564|NCT02972034|531539189|FG011|Overall Study|Sponsor Decision|0|||
147375565|NCT02972034|531539190|FG012|Overall Study|Sponsor Decision|1|||
147375566|NCT02972034|531539191|FG013|Overall Study|Sponsor Decision|0|||
147375567|NCT02972034|531539192|FG014|Overall Study|Sponsor Decision|1|||
147375568|NCT02972034|531539178|FG000|Overall Study|Withdrawal by Subject|3|||
147375569|NCT02972034|531539179|FG001|Overall Study|Withdrawal by Subject|0|||
147375570|NCT02972034|531539180|FG002|Overall Study|Withdrawal by Subject|0|||
147375571|NCT02972034|531539181|FG003|Overall Study|Withdrawal by Subject|0|||
147375572|NCT02972034|531539182|FG004|Overall Study|Withdrawal by Subject|1|||
147375573|NCT02972034|531539183|FG005|Overall Study|Withdrawal by Subject|1|||
147375574|NCT02972034|531539184|FG006|Overall Study|Withdrawal by Subject|0|||
147375575|NCT02972034|531539185|FG007|Overall Study|Withdrawal by Subject|0|||
147375576|NCT02972034|531539186|FG008|Overall Study|Withdrawal by Subject|1|||
147375577|NCT02972034|531539187|FG009|Overall Study|Withdrawal by Subject|1|||
147375578|NCT02972034|531539188|FG010|Overall Study|Withdrawal by Subject|2|||
147375579|NCT02972034|531539189|FG011|Overall Study|Withdrawal by Subject|1|||
147375580|NCT02972034|531539190|FG012|Overall Study|Withdrawal by Subject|1|||
147375581|NCT02972034|531539191|FG013|Overall Study|Withdrawal by Subject|1|||
147375582|NCT02972034|531539192|FG014|Overall Study|Withdrawal by Subject|0|||
147375583|NCT02972034|531539178|FG000|Overall Study|Screen Failure|0|||
147375584|NCT02972034|531539179|FG001|Overall Study|Screen Failure|0|||
147375585|NCT02972034|531539180|FG002|Overall Study|Screen Failure|0|||
147375586|NCT02972034|531539181|FG003|Overall Study|Screen Failure|0|||
147375587|NCT02972034|531539182|FG004|Overall Study|Screen Failure|0|||
147375588|NCT02972034|531539183|FG005|Overall Study|Screen Failure|0|||
147375589|NCT02972034|531539184|FG006|Overall Study|Screen Failure|0|||
147375590|NCT02972034|531539185|FG007|Overall Study|Screen Failure|0|||
147375591|NCT02972034|531539186|FG008|Overall Study|Screen Failure|0|||
147375592|NCT02972034|531539187|FG009|Overall Study|Screen Failure|0|||
147611666|NCT02301390|532393676|FG000|Overall Study|Protocol Violation|1|||
147611667|NCT02301390|532393677|FG001|Overall Study|Protocol Violation|0|||
147611668|NCT02301390|532393676|FG000|Overall Study|Physician Decision|1|||
147611669|NCT02301390|532393677|FG001|Overall Study|Physician Decision|0|||
147611670|NCT02301390|532393676|FG000|Overall Study|Lost to Follow-up|0|||
147611671|NCT02301390|532393677|FG001|Overall Study|Lost to Follow-up|1|||
147611672|NCT02301390|532393676|FG000|Overall Study|Death|2|||
147611673|NCT02301390|532393677|FG001|Overall Study|Death|2|||
147611674|NCT02301390|532393676|FG000|Overall Study|Procedure not completed|0|||
147611675|NCT02301390|532393677|FG001|Overall Study|Procedure not completed|4|||
147611676|NCT02301390|532393676|FG000|Overall Study|Missed multiple visits|1|||
147611677|NCT02301390|532393677|FG001|Overall Study|Missed multiple visits|1|||
147611678|NCT02301390|532393676|FG000|Overall Study|study terminated|2|||
147611679|NCT02301390|532393677|FG001|Overall Study|study terminated|0|||
147611680|NCT00185588|532393678|FG000|Overall Study|Adverse Event|3|||
147611681|NCT00185588|532393679|FG001|Overall Study|Adverse Event|1|||
147611682|NCT00185588|532393680|FG002|Overall Study|Adverse Event|4|||
147611683|NCT00185588|532393681|FG003|Overall Study|Adverse Event|2|||
147375593|NCT02972034|531539188|FG010|Overall Study|Screen Failure|0|||
147375594|NCT02972034|531539189|FG011|Overall Study|Screen Failure|0|||
147375595|NCT02972034|531539190|FG012|Overall Study|Screen Failure|1|||
147611684|NCT00185588|532393678|FG000|Overall Study|Lost to Follow-up|0|||
147611685|NCT00185588|532393679|FG001|Overall Study|Lost to Follow-up|0|||
147611686|NCT00185588|532393680|FG002|Overall Study|Lost to Follow-up|1|||
147375596|NCT02972034|531539191|FG013|Overall Study|Screen Failure|0|||
147375597|NCT02972034|531539192|FG014|Overall Study|Screen Failure|0|||
147375598|NCT03009344|531539193|FG000|Overall Study|Lack of Efficacy|5|||
147375599|NCT03009344|531539193|FG000|Overall Study|Withdrawal by Subject|1|||
147375600|NCT03009344|531539193|FG000|Overall Study|Adverse Event|1|||
147375601|NCT00378898|531539194|FG000|Overall Study|Withdrawal by Subject|10|||
147611687|NCT00185588|532393681|FG003|Overall Study|Lost to Follow-up|2|||
147611688|NCT00185588|532393678|FG000|Overall Study|Withdrawal by Subject|0|||
147611689|NCT00185588|532393679|FG001|Overall Study|Withdrawal by Subject|1|||
147375602|NCT00378898|531539195|FG001|Overall Study|Withdrawal by Subject|5|||
147375603|NCT00378898|531539194|FG000|Overall Study|Protocol Violation|1|||
147375604|NCT00378898|531539195|FG001|Overall Study|Protocol Violation|1|||
147375605|NCT02534233|531539201|FG000|Overall Study|2 participants with protocol deviations didn't complete|2|||
147375606|NCT01278030|531539205|FG000|Overall Study|Withdrawal by Subject|8|||
147375607|NCT01278030|531539206|FG001|Overall Study|Withdrawal by Subject|4|||
147375608|NCT00458783|531539208|FG000|Overall Study|Protocol Violation|1228|||
147375609|NCT00458783|531539209|FG001|Overall Study|Protocol Violation|1220|||
147375610|NCT01737398|531539210|FG000|Overall Study|Adverse event or SAE|16|||
147375611|NCT01737398|531539211|FG001|Overall Study|Adverse event or SAE|1|||
147611690|NCT00185588|532393680|FG002|Overall Study|Withdrawal by Subject|0|||
147611691|NCT00185588|532393681|FG003|Overall Study|Withdrawal by Subject|0|||
147611692|NCT00185588|532393678|FG000|Overall Study|Physician Decision|0|||
147611693|NCT00185588|532393679|FG001|Overall Study|Physician Decision|0|||
147375612|NCT01737398|531539210|FG000|Overall Study|Stopping rule met|2|||
147375613|NCT01737398|531539211|FG001|Overall Study|Stopping rule met|1|||
147375614|NCT01737398|531539210|FG000|Overall Study|Voluntary withdrawal|2|||
147375615|NCT01737398|531539211|FG001|Overall Study|Voluntary withdrawal|3|||
147375616|NCT01737398|531539210|FG000|Overall Study|Ineligibility|1|||
147375617|NCT01737398|531539211|FG001|Overall Study|Ineligibility|0|||
147375618|NCT01737398|531539210|FG000|Overall Study|Liver transplant|1|||
147375619|NCT01737398|531539211|FG001|Overall Study|Liver transplant|0|||
147375620|NCT01737398|531539210|FG000|Overall Study|Disease progression|2|||
147375621|NCT01737398|531539211|FG001|Overall Study|Disease progression|3|||
147375622|NCT01737398|531539210|FG000|Overall Study|Sponsor's decision|2|||
147375623|NCT01737398|531539211|FG001|Overall Study|Sponsor's decision|0|||
147375624|NCT03220724|531539213|FG000|Overall Study|Lost to Follow-up|2|||
147375625|NCT03220724|531539214|FG001|Overall Study|Lost to Follow-up|2|||
147375626|NCT03220724|531539215|FG002|Overall Study|Lost to Follow-up|0|||
147375627|NCT03220724|531539216|FG003|Overall Study|Lost to Follow-up|3|||
147375628|NCT03220724|531539217|FG004|Overall Study|Lost to Follow-up|1|||
147375629|NCT03220724|531539218|FG005|Overall Study|Lost to Follow-up|0|||
147375630|NCT03220724|531539219|FG006|Overall Study|Lost to Follow-up|2|||
147375631|NCT03220724|531539220|FG007|Overall Study|Lost to Follow-up|1|||
147375632|NCT03220724|531539221|FG008|Overall Study|Lost to Follow-up|0|||
147375633|NCT03220724|531539213|FG000|Overall Study|Withdrawal by Subject|1|||
147375634|NCT03220724|531539214|FG001|Overall Study|Withdrawal by Subject|0|||
147375635|NCT03220724|531539215|FG002|Overall Study|Withdrawal by Subject|1|||
147375636|NCT03220724|531539216|FG003|Overall Study|Withdrawal by Subject|0|||
147375637|NCT03220724|531539217|FG004|Overall Study|Withdrawal by Subject|0|||
147375638|NCT03220724|531539218|FG005|Overall Study|Withdrawal by Subject|0|||
147375639|NCT03220724|531539219|FG006|Overall Study|Withdrawal by Subject|0|||
147375640|NCT03220724|531539220|FG007|Overall Study|Withdrawal by Subject|0|||
147375641|NCT03220724|531539221|FG008|Overall Study|Withdrawal by Subject|0|||
147375642|NCT00019604|531539222|FG000|Overall Study|Death|1|||
147375643|NCT00019604|531539222|FG000|Overall Study|Progressive disease|23|||
147375644|NCT00019604|531539222|FG000|Overall Study|Refused treatment|1|||
147375645|NCT00019604|531539222|FG000|Overall Study|Carcinoid tumor, not treatable|1|||
147375646|NCT00019604|531539222|FG000|Overall Study|Going to have liver transplant|1|||
147611694|NCT00185588|532393680|FG002|Overall Study|Physician Decision|1|||
147611695|NCT00185588|532393681|FG003|Overall Study|Physician Decision|0|||
147611696|NCT00398866|532393682|FG000|Overall Study|Adverse Event|1|||
147611697|NCT00398866|532393683|FG001|Overall Study|Adverse Event|0|||
147611698|NCT00398866|532393684|FG002|Overall Study|Adverse Event|0|||
147611699|NCT00398866|532393682|FG000|Overall Study|Lack of Efficacy|0|||
147611700|NCT00398866|532393683|FG001|Overall Study|Lack of Efficacy|0|||
147611701|NCT00398866|532393684|FG002|Overall Study|Lack of Efficacy|1|||
147611702|NCT00398866|532393682|FG000|Overall Study|Lost to Follow-up|7|||
147611703|NCT00398866|532393683|FG001|Overall Study|Lost to Follow-up|6|||
147611704|NCT00398866|532393684|FG002|Overall Study|Lost to Follow-up|4|||
147375647|NCT00019604|531539222|FG000|Overall Study|Move to a different study|1|||
147375648|NCT00019604|531539222|FG000|Overall Study|Non compliant on systemic CH|1|||
147375649|NCT00019604|531539222|FG000|Overall Study|Non compliant|1|||
147375650|NCT00019604|531539222|FG000|Overall Study|Resectable disease|1|||
147375651|NCT00019604|531539222|FG000|Overall Study|Started new chemo regimen|1|||
147375652|NCT00019604|531539222|FG000|Overall Study|Pt going to immunotherapy study|1|||
147375653|NCT00019604|531539222|FG000|Overall Study|Too much disease|1|||
147375654|NCT00019604|531539222|FG000|Overall Study|Unable to evaluate|1|||
147375655|NCT00019604|531539222|FG000|Overall Study|Details for other not available|4|||
147375656|NCT00454194|531539237|FG000|Overall Study|Adverse Event|7|||
147375657|NCT00454194|531539238|FG001|Overall Study|Adverse Event|2|||
147375658|NCT00454194|531539237|FG000|Overall Study|Withdrawal by Subject|12|||
147375659|NCT00454194|531539238|FG001|Overall Study|Withdrawal by Subject|8|||
147375660|NCT00454194|531539237|FG000|Overall Study|Other Medical Problems|1|||
147611705|NCT00398866|532393682|FG000|Overall Study|Withdrawal by Subject|5|||
147611706|NCT00398866|532393683|FG001|Overall Study|Withdrawal by Subject|1|||
147611707|NCT00398866|532393684|FG002|Overall Study|Withdrawal by Subject|2|||
147611708|NCT00398866|532393682|FG000|Overall Study|Unable to complete requirements of study|1|||
147375661|NCT00454194|531539238|FG001|Overall Study|Other Medical Problems|2|||
147375662|NCT00454194|531539237|FG000|Overall Study|Other Unspecified Reason|2|||
147375663|NCT00454194|531539238|FG001|Overall Study|Other Unspecified Reason|2|||
147375664|NCT00586313|531539246|FG000|Overall Study|Lack of Efficacy|2|||
147611709|NCT00398866|532393683|FG001|Overall Study|Unable to complete requirements of study|1|||
147611710|NCT00398866|532393684|FG002|Overall Study|Unable to complete requirements of study|1|||
147611711|NCT02481869|532393685|FG000|Overall Study|Lost to Follow-up|3|||
147611712|NCT02481869|532393686|FG001|Overall Study|Lost to Follow-up|4|||
147611713|NCT02481869|532393685|FG000|Overall Study|Withdrawal by Subject|2|||
147611714|NCT02481869|532393686|FG001|Overall Study|Withdrawal by Subject|0|||
147611715|NCT00191191|532393687|FG000|Overall Study|Entry Criteria Exclusion|2|||
147611716|NCT00191191|532393688|FG001|Overall Study|Entry Criteria Exclusion|0|||
147611717|NCT00191191|532393687|FG000|Overall Study|Treated with Another Systemic Agent|1|||
147611718|NCT00191191|532393688|FG001|Overall Study|Treated with Another Systemic Agent|1|||
147611719|NCT00191191|532393687|FG000|Overall Study|Adverse Event|11|||
147611720|NCT00191191|532393688|FG001|Overall Study|Adverse Event|21|||
147611721|NCT00191191|532393687|FG000|Overall Study|Progressive Disease|84|||
147611722|NCT00191191|532393688|FG001|Overall Study|Progressive Disease|72|||
147611723|NCT00191191|532393687|FG000|Overall Study|Toxicity After Dose Reduction|7|||
147611724|NCT00191191|532393688|FG001|Overall Study|Toxicity After Dose Reduction|8|||
147611725|NCT00191191|532393687|FG000|Overall Study|Family/Caregiver Decision|5|||
147611726|NCT00191191|532393688|FG001|Overall Study|Family/Caregiver Decision|7|||
147611727|NCT00191191|532393687|FG000|Overall Study|Lost to Follow-up|1|||
147611728|NCT00191191|532393688|FG001|Overall Study|Lost to Follow-up|0|||
147611729|NCT00191191|532393687|FG000|Overall Study|Physician Decision|3|||
147611730|NCT00191191|532393688|FG001|Overall Study|Physician Decision|2|||
147611731|NCT00191191|532393687|FG000|Overall Study|Good Clinical Practice Violation|0|||
147611732|NCT00191191|532393688|FG001|Overall Study|Good Clinical Practice Violation|1|||
147611733|NCT05246670|532393689|FG000|Overall Study|Withdrawal by Subject|2|||
147611734|NCT05246670|532393690|FG001|Overall Study|Withdrawal by Subject|3|||
147611735|NCT05246670|532393691|FG002|Overall Study|Withdrawal by Subject|0|||
147611736|NCT05246670|532393692|FG003|Overall Study|Withdrawal by Subject|1|||
147611737|NCT05246670|532393689|FG000|Overall Study|Adverse Event|0|||
147611738|NCT05246670|532393690|FG001|Overall Study|Adverse Event|0|||
147611739|NCT05246670|532393691|FG002|Overall Study|Adverse Event|1|||
147611740|NCT05246670|532393692|FG003|Overall Study|Adverse Event|0|||
147611741|NCT05246670|532393689|FG000|Overall Study|Physician Decision|1|||
147611742|NCT05246670|532393690|FG001|Overall Study|Physician Decision|0|||
147611743|NCT05246670|532393691|FG002|Overall Study|Physician Decision|0|||
147611744|NCT05246670|532393692|FG003|Overall Study|Physician Decision|0|||
147611745|NCT05246670|532393689|FG000|Overall Study|Protocol Violation|1|||
147611746|NCT05246670|532393690|FG001|Overall Study|Protocol Violation|0|||
147611747|NCT05246670|532393691|FG002|Overall Study|Protocol Violation|0|||
147611748|NCT05246670|532393692|FG003|Overall Study|Protocol Violation|0|||
147611749|NCT04152291|532393693|FG000|Overall Study|Covid-19 restrictions|27|||
147611750|NCT04152291|532393693|FG000|Overall Study|Withdrawal by Subject|3|||
147611751|NCT03597295|532393694|FG000|Overall Study|Death|70|||
147611752|NCT03597295|532393694|FG000|Overall Study|Lost to Follow-up|7|||
147611753|NCT05124691|532393695|FG000|Phase II|Eligibility criteria|0|||
147611754|NCT05124691|532393696|FG001|Phase II|Eligibility criteria|1|||
147611755|NCT05124691|532393697|FG002|Phase II|Eligibility criteria|0|||
147611756|NCT05124691|532393695|FG000|Phase II|Withdrawal by Subject|6|||
147611757|NCT05124691|532393696|FG001|Phase II|Withdrawal by Subject|2|||
147611758|NCT05124691|532393697|FG002|Phase II|Withdrawal by Subject|3|||
147611759|NCT05124691|532393695|FG000|Phase III|Withdrawal by Subject|6|||
147375665|NCT03205566|531539248|FG000|Phase 1|Protocol Violation|1|||
147375666|NCT03205566|531539249|FG001|Phase 1|Protocol Violation|1|||
147375667|NCT03184987|531539250|FG000|Overall Study|Withdrawal by Subject|0|||
147611760|NCT05124691|532393696|FG001|Phase III|Withdrawal by Subject|4|||
147611761|NCT05124691|532393697|FG002|Phase III|Withdrawal by Subject|4|||
147611762|NCT05124691|532393695|FG000|Phase III|Lost to Follow-up|1|||
147611763|NCT05124691|532393696|FG001|Phase III|Lost to Follow-up|0|||
147611764|NCT05124691|532393697|FG002|Phase III|Lost to Follow-up|0|||
147611765|NCT05211726|532393698|FG000|Overall Study|Withdrawal by Subject|2|||
147611766|NCT05211726|532393699|FG001|Overall Study|Withdrawal by Subject|3|||
147611767|NCT05211726|532393698|FG000|Overall Study|Protocol Violation|0|||
147611768|NCT05211726|532393699|FG001|Overall Study|Protocol Violation|1|||
147611769|NCT03509467|532393700|FG000|Overall Study|Withdrawal by Subject|5|||
147611770|NCT03509467|532393701|FG001|Overall Study|Withdrawal by Subject|1|||
147611771|NCT03509467|532393702|FG002|Overall Study|Withdrawal by Subject|6|||
147611772|NCT03509467|532393703|FG003|Overall Study|Withdrawal by Subject|7|||
147611773|NCT03509467|532393704|FG004|Overall Study|Withdrawal by Subject|10|||
147611774|NCT03509467|532393705|FG005|Overall Study|Withdrawal by Subject|10|||
147611775|NCT03509467|532393706|FG006|Overall Study|Withdrawal by Subject|10|||
147611776|NCT03509467|532393707|FG007|Overall Study|Withdrawal by Subject|10|||
147611777|NCT03509467|532393700|FG000|Overall Study|Death|0|||
147611778|NCT03509467|532393701|FG001|Overall Study|Death|0|||
147611779|NCT03509467|532393702|FG002|Overall Study|Death|2|||
147375668|NCT03184987|531539251|FG001|Overall Study|Withdrawal by Subject|1|||
147375669|NCT03184987|531539252|FG002|Overall Study|Withdrawal by Subject|2|||
147375670|NCT03184987|531539250|FG000|Overall Study|Physician Decision|0|||
147375671|NCT03184987|531539251|FG001|Overall Study|Physician Decision|0|||
147375672|NCT03184987|531539252|FG002|Overall Study|Physician Decision|1|||
147375673|NCT03184987|531539250|FG000|Overall Study|Adverse Event|1|||
147375674|NCT03184987|531539251|FG001|Overall Study|Adverse Event|0|||
147375675|NCT03184987|531539252|FG002|Overall Study|Adverse Event|1|||
147375676|NCT01619059|531539259|FG000|Short-Term (ST) Treatment Period|Adverse Event|1|||
147375677|NCT01619059|531539260|FG001|Short-Term (ST) Treatment Period|Adverse Event|0|||
147375678|NCT01619059|531539259|FG000|Short-Term (ST) Treatment Period|Withdrawal by Subject|2|||
147375679|NCT01619059|531539260|FG001|Short-Term (ST) Treatment Period|Withdrawal by Subject|5|||
147375680|NCT01619059|531539259|FG000|Short-Term (ST) Treatment Period|Lost to Follow-up|2|||
147375681|NCT01619059|531539260|FG001|Short-Term (ST) Treatment Period|Lost to Follow-up|4|||
147375682|NCT01619059|531539259|FG000|Short-Term (ST) Treatment Period|Non-compliance, not Met Study Criteria|1|||
147375683|NCT01619059|531539260|FG001|Short-Term (ST) Treatment Period|Non-compliance, not Met Study Criteria|2|||
147375684|NCT01619059|531539259|FG000|Long-Term (LT) Treatment Period|Lack of Efficacy|0|||
147375685|NCT01619059|531539260|FG001|Long-Term (LT) Treatment Period|Lack of Efficacy|1|||
147375686|NCT01619059|531539259|FG000|Long-Term (LT) Treatment Period|Adverse Event|2|||
147375687|NCT01619059|531539260|FG001|Long-Term (LT) Treatment Period|Adverse Event|3|||
147375688|NCT01619059|531539259|FG000|Long-Term (LT) Treatment Period|Withdrawal by Subject|3|||
147375689|NCT01619059|531539260|FG001|Long-Term (LT) Treatment Period|Withdrawal by Subject|2|||
147375690|NCT01619059|531539259|FG000|Long-Term (LT) Treatment Period|Death|1|||
147375691|NCT01619059|531539260|FG001|Long-Term (LT) Treatment Period|Death|0|||
147375692|NCT01619059|531539259|FG000|Long-Term (LT) Treatment Period|Lost to Follow-up|2|||
147375693|NCT01619059|531539260|FG001|Long-Term (LT) Treatment Period|Lost to Follow-up|2|||
147375694|NCT01619059|531539259|FG000|Long-Term (LT) Treatment Period|Not Met Study Criteria|0|||
147375695|NCT01619059|531539260|FG001|Long-Term (LT) Treatment Period|Not Met Study Criteria|1|||
147375696|NCT01170208|531539261|FG000|Overall Study|Withdrawal by Subject|5|||
147375697|NCT01170208|531539262|FG001|Overall Study|Withdrawal by Subject|0|||
147375698|NCT01170208|531539263|FG002|Overall Study|Withdrawal by Subject|1|||
147375699|NCT01170208|531539261|FG000|Overall Study|Protocol Violation|1|||
147375700|NCT01170208|531539262|FG001|Overall Study|Protocol Violation|0|||
147375701|NCT01170208|531539263|FG002|Overall Study|Protocol Violation|1|||
147375702|NCT01160354|531539270|FG000|Overall Study|Death|0|||
147375703|NCT01160354|531539271|FG001|Overall Study|Death|1|||
147375704|NCT01160354|531539272|FG002|Overall Study|Death|1|||
147375705|NCT02743819|531539274|FG000|Overall Study|Lack of Efficacy|5|||
147375706|NCT02743819|531539274|FG000|Overall Study|Death|2|||
147375707|NCT02743819|531539274|FG000|Overall Study|Adverse Event|1|||
147375708|NCT03389802|531539275|FG000|Overall Study|Lack of Efficacy|3|||
147375709|NCT03389802|531539276|FG001|Overall Study|Lack of Efficacy|3|||
147375710|NCT03389802|531539277|FG002|Overall Study|Lack of Efficacy|13|||
147375711|NCT03389802|531539278|FG003|Overall Study|Lack of Efficacy|6|||
147375712|NCT03389802|531539279|FG004|Overall Study|Lack of Efficacy|1|||
147375713|NCT03389802|531539275|FG000|Overall Study|Adverse Event|0|||
147375714|NCT03389802|531539276|FG001|Overall Study|Adverse Event|0|||
147375715|NCT03389802|531539277|FG002|Overall Study|Adverse Event|1|||
147375716|NCT03389802|531539278|FG003|Overall Study|Adverse Event|0|||
147375717|NCT03389802|531539279|FG004|Overall Study|Adverse Event|4|||
147375718|NCT03389802|531539275|FG000|Overall Study|Subject deemed ineligible after enrollment|0|||
147375719|NCT03389802|531539276|FG001|Overall Study|Subject deemed ineligible after enrollment|0|||
147375720|NCT03389802|531539277|FG002|Overall Study|Subject deemed ineligible after enrollment|1|||
147375721|NCT03389802|531539278|FG003|Overall Study|Subject deemed ineligible after enrollment|0|||
147375722|NCT03389802|531539279|FG004|Overall Study|Subject deemed ineligible after enrollment|0|||
147375723|NCT01706159|531539280|FG000|Overall Study|Withdrawal Criteria|2|||
147375724|NCT01706159|531539281|FG001|Overall Study|Withdrawal Criteria|1|||
147375725|NCT01706159|531539280|FG000|Overall Study|Unclassified|6|||
147375726|NCT01706159|531539281|FG001|Overall Study|Unclassified|1|||
147375727|NCT02454959|531539283|FG000|Overall Study|Protocol-Specified Criteria|3|||
147375728|NCT02454959|531539283|FG000|Overall Study|Physician Decision|1|||
147375729|NCT02454959|531539283|FG000|Overall Study|Withdrawal by Subject|3|||
147375730|NCT02454959|531539283|FG000|Overall Study|Adverse Event|2|||
147375731|NCT00989196|531539284|FG000|Treatment Period|Lost to Follow-up|1|||
147375732|NCT00989196|531539285|FG001|Treatment Period|Lost to Follow-up|0|||
147375733|NCT02409680|531539286|FG000|Overall Study|Lost to Follow-up|15|||
147375734|NCT02409680|531539287|FG001|Overall Study|Lost to Follow-up|30|||
147375735|NCT03789656|531539288|FG000|Treatment Period: up to 13 Weeks|Prohibited Medication|1|||
147375736|NCT03789656|531539289|FG001|Treatment Period: up to 13 Weeks|Prohibited Medication|0|||
147375737|NCT03789656|531539290|FG002|Treatment Period: up to 13 Weeks|Prohibited Medication|0|||
147375738|NCT03789656|531539291|FG003|Treatment Period: up to 13 Weeks|Prohibited Medication|1|||
147375739|NCT03789656|531539292|FG004|Treatment Period: up to 13 Weeks|Prohibited Medication|0|||
147375740|NCT03789656|531539288|FG000|Treatment Period: up to 13 Weeks|COVID-19 Lockdown|0|||
147375741|NCT03789656|531539289|FG001|Treatment Period: up to 13 Weeks|COVID-19 Lockdown|0|||
147611780|NCT03509467|532393703|FG003|Overall Study|Death|2|||
147611781|NCT03509467|532393704|FG004|Overall Study|Death|1|||
147611782|NCT03509467|532393705|FG005|Overall Study|Death|0|||
147611783|NCT03509467|532393706|FG006|Overall Study|Death|1|||
147611784|NCT03509467|532393707|FG007|Overall Study|Death|0|||
147611785|NCT03509467|532393700|FG000|Overall Study|Proxy Withdrawal|0|||
147611786|NCT03509467|532393701|FG001|Overall Study|Proxy Withdrawal|0|||
147611787|NCT03509467|532393702|FG002|Overall Study|Proxy Withdrawal|0|||
147611788|NCT03509467|532393703|FG003|Overall Study|Proxy Withdrawal|0|||
147611789|NCT03509467|532393704|FG004|Overall Study|Proxy Withdrawal|0|||
147611790|NCT03509467|532393705|FG005|Overall Study|Proxy Withdrawal|0|||
147611791|NCT03509467|532393706|FG006|Overall Study|Proxy Withdrawal|0|||
147611792|NCT03509467|532393707|FG007|Overall Study|Proxy Withdrawal|1|||
147611793|NCT00428116|532393708|FG000|Overall Study|Death|1|||
147611794|NCT00428116|532393709|FG001|Overall Study|Death|0|||
147611795|NCT00428116|532393708|FG000|Overall Study|Withdrawal by Subject|1|||
147611796|NCT00428116|532393709|FG001|Overall Study|Withdrawal by Subject|0|||
147611797|NCT00428116|532393708|FG000|Overall Study|Lost to Follow-up|1|||
147611798|NCT00428116|532393709|FG001|Overall Study|Lost to Follow-up|0|||
147375742|NCT03789656|531539290|FG002|Treatment Period: up to 13 Weeks|COVID-19 Lockdown|1|||
147375743|NCT03789656|531539291|FG003|Treatment Period: up to 13 Weeks|COVID-19 Lockdown|0|||
147375744|NCT03789656|531539292|FG004|Treatment Period: up to 13 Weeks|COVID-19 Lockdown|0|||
147375745|NCT03789656|531539288|FG000|Treatment Period: up to 13 Weeks|Unable to Travel|1|||
147375746|NCT03789656|531539289|FG001|Treatment Period: up to 13 Weeks|Unable to Travel|0|||
147375747|NCT03789656|531539290|FG002|Treatment Period: up to 13 Weeks|Unable to Travel|0|||
147375748|NCT03789656|531539291|FG003|Treatment Period: up to 13 Weeks|Unable to Travel|0|||
147375749|NCT03789656|531539292|FG004|Treatment Period: up to 13 Weeks|Unable to Travel|0|||
147375750|NCT03789656|531539288|FG000|Follow-up Period: up to 4 Weeks|Withdrawal by Subject|1|||
147375751|NCT03789656|531539289|FG001|Follow-up Period: up to 4 Weeks|Withdrawal by Subject|0|||
147375752|NCT03789656|531539290|FG002|Follow-up Period: up to 4 Weeks|Withdrawal by Subject|0|||
147375753|NCT03789656|531539291|FG003|Follow-up Period: up to 4 Weeks|Withdrawal by Subject|0|||
147375754|NCT03789656|531539292|FG004|Follow-up Period: up to 4 Weeks|Withdrawal by Subject|0|||
147375755|NCT05325294|531539297|FG000|Overall Study|Adverse Event|3|||
147375756|NCT05325294|531539298|FG001|Overall Study|Adverse Event|3|||
147375757|NCT05325294|531539297|FG000|Overall Study|Physician Decision|0|||
147375758|NCT05325294|531539298|FG001|Overall Study|Physician Decision|1|||
147375759|NCT05325294|531539297|FG000|Overall Study|Withdrawal by Subject|0|||
147375760|NCT05325294|531539298|FG001|Overall Study|Withdrawal by Subject|3|||
147375761|NCT05325294|531539297|FG000|Overall Study|Lost to Follow-up|1|||
147375762|NCT05325294|531539298|FG001|Overall Study|Lost to Follow-up|0|||
147375763|NCT05325294|531539297|FG000|Overall Study|Sponsor Request|0|||
147375764|NCT05325294|531539298|FG001|Overall Study|Sponsor Request|2|||
147375765|NCT02434328|531539300|FG000|Overall Study|Adverse Event|9|||
147375766|NCT02434328|531539301|FG001|Overall Study|Adverse Event|4|||
147375767|NCT02434328|531539300|FG000|Overall Study|Lack of Efficacy|0|||
147375768|NCT02434328|531539301|FG001|Overall Study|Lack of Efficacy|2|||
147375769|NCT02434328|531539300|FG000|Overall Study|Physician Decision|0|||
147375770|NCT02434328|531539301|FG001|Overall Study|Physician Decision|1|||
147375771|NCT02434328|531539300|FG000|Overall Study|Withdrawal by Subject|12|||
147375772|NCT02434328|531539301|FG001|Overall Study|Withdrawal by Subject|21|||
147375773|NCT02434328|531539300|FG000|Overall Study|Death|4|||
147375774|NCT02434328|531539301|FG001|Overall Study|Death|7|||
147375775|NCT02434328|531539300|FG000|Overall Study|Lost to Follow-up|1|||
147375776|NCT02434328|531539301|FG001|Overall Study|Lost to Follow-up|6|||
147375777|NCT02434328|531539300|FG000|Overall Study|Other|4|||
147375778|NCT02434328|531539301|FG001|Overall Study|Other|1|||
147375779|NCT03147287|531539304|FG000|Overall Study|Randomized Not Treated|2|||
147375780|NCT03147287|531539305|FG001|Overall Study|Randomized Not Treated|1|||
147375781|NCT03147287|531539306|FG002|Overall Study|Randomized Not Treated|1|||
147375782|NCT03147287|531539304|FG000|Overall Study|Progressive Disease RECIST|31|||
147375783|NCT03147287|531539305|FG001|Overall Study|Progressive Disease RECIST|72|||
147375784|NCT03147287|531539306|FG002|Overall Study|Progressive Disease RECIST|32|||
147455581|NCT02889796|531829864|FG003|Overall Study|Randomized but not Dosed|0|||
147375785|NCT03147287|531539304|FG000|Overall Study|Progressive Disease not RECIST|13|||
147375786|NCT03147287|531539305|FG001|Overall Study|Progressive Disease not RECIST|21|||
147375787|NCT03147287|531539306|FG002|Overall Study|Progressive Disease not RECIST|13|||
147375788|NCT03147287|531539304|FG000|Overall Study|Physician Decision|1|||
147375789|NCT03147287|531539305|FG001|Overall Study|Physician Decision|2|||
147375790|NCT03147287|531539306|FG002|Overall Study|Physician Decision|1|||
147611799|NCT01141205|532393710|FG000|Overall Study|Physician Decision|1|||
147611800|NCT01141205|532393711|FG001|Overall Study|Physician Decision|1|||
147611801|NCT01141205|532393710|FG000|Overall Study|Lost to Follow-up|1|||
147611802|NCT01141205|532393711|FG001|Overall Study|Lost to Follow-up|0|||
147455582|NCT02889796|531829865|FG004|Overall Study|Randomized but not Dosed|0|||
147611803|NCT01141205|532393710|FG000|Overall Study|Withdrawal by Subject|1|||
147611804|NCT01141205|532393711|FG001|Overall Study|Withdrawal by Subject|1|||
147611805|NCT04759768|532393718|FG000|Washout (7 Days)|Withdrawal by Subject|0|||
147611806|NCT04759768|532393719|FG001|Washout (7 Days)|Withdrawal by Subject|1|||
147611807|NCT04759768|532393718|FG000|Washout (7 Days)|Physician Decision|0|||
147375791|NCT03147287|531539304|FG000|Overall Study|Intercurrent illness|0|||
147375792|NCT03147287|531539305|FG001|Overall Study|Intercurrent illness|1|||
147375793|NCT03147287|531539306|FG002|Overall Study|Intercurrent illness|0|||
147375794|NCT03147287|531539304|FG000|Overall Study|Withdrawal by Subject|2|||
147375795|NCT03147287|531539305|FG001|Overall Study|Withdrawal by Subject|3|||
147375796|NCT03147287|531539306|FG002|Overall Study|Withdrawal by Subject|2|||
147375797|NCT03147287|531539304|FG000|Overall Study|Patient Non-Compliance|0|||
147375798|NCT03147287|531539305|FG001|Overall Study|Patient Non-Compliance|2|||
147375799|NCT03147287|531539306|FG002|Overall Study|Patient Non-Compliance|0|||
147375800|NCT03147287|531539304|FG000|Overall Study|Patient moved|0|||
147375801|NCT03147287|531539305|FG001|Overall Study|Patient moved|1|||
147375802|NCT03147287|531539306|FG002|Overall Study|Patient moved|0|||
147375803|NCT03147287|531539304|FG000|Overall Study|Arm A crossover without PD|1|||
147375804|NCT03147287|531539305|FG001|Overall Study|Arm A crossover without PD|0|||
147375805|NCT03147287|531539306|FG002|Overall Study|Arm A crossover without PD|0|||
147375806|NCT03147287|531539304|FG000|Overall Study|Ongoing at date of cut-off (11 Jul 2022)|5|||
147375807|NCT03147287|531539305|FG001|Overall Study|Ongoing at date of cut-off (11 Jul 2022)|8|||
147375808|NCT03147287|531539306|FG002|Overall Study|Ongoing at date of cut-off (11 Jul 2022)|5|||
147375809|NCT00925548|531540894|FG000|Overall Study|Discontinuation of trial by sponsor|10|||
147375810|NCT00925548|531540895|FG001|Overall Study|Discontinuation of trial by sponsor|5|||
147375811|NCT02278796|531540896|FG000|Overall Study|Death|2|||
147375812|NCT02278796|531540897|FG001|Overall Study|Death|3|||
147375813|NCT03214081|531540898|FG000|Overall Study|Case Report Forms Uncollected|9|||
147375814|NCT03214081|531540898|FG000|Overall Study|Protocol Deviation|54|||
147375815|NCT02962284|531540899|FG000|Overall Study|Death|2|||
147375816|NCT02962284|531540900|FG001|Overall Study|Death|0|||
147375817|NCT02962284|531540899|FG000|Overall Study|Progressive disease|2|||
147375818|NCT02962284|531540900|FG001|Overall Study|Progressive disease|3|||
147375819|NCT02962284|531540899|FG000|Overall Study|Withdrawal by Subject|1|||
147375820|NCT02962284|531540900|FG001|Overall Study|Withdrawal by Subject|0|||
147375821|NCT02372799|531540903|FG000|Treatment Period|Adverse Event|3|||
147375822|NCT02372799|531540904|FG001|Treatment Period|Adverse Event|10|||
147375823|NCT02372799|531540905|FG002|Treatment Period|Adverse Event|6|||
147375824|NCT02372799|531540903|FG000|Treatment Period|Insufficient therapeutic response|2|||
147375825|NCT02372799|531540904|FG001|Treatment Period|Insufficient therapeutic response|2|||
147375826|NCT02372799|531540905|FG002|Treatment Period|Insufficient therapeutic response|0|||
147375827|NCT02372799|531540903|FG000|Treatment Period|Withdrawal by Subject|10|||
147375828|NCT02372799|531540904|FG001|Treatment Period|Withdrawal by Subject|10|||
147375829|NCT02372799|531540905|FG002|Treatment Period|Withdrawal by Subject|2|||
147375830|NCT02372799|531540903|FG000|Treatment Period|Lost to Follow-up|11|||
147375831|NCT02372799|531540904|FG001|Treatment Period|Lost to Follow-up|5|||
147375832|NCT02372799|531540905|FG002|Treatment Period|Lost to Follow-up|3|||
147375833|NCT02372799|531540903|FG000|Treatment Period|Protocol Violation|3|||
147375834|NCT02372799|531540904|FG001|Treatment Period|Protocol Violation|0|||
147375835|NCT02372799|531540905|FG002|Treatment Period|Protocol Violation|0|||
147375836|NCT02372799|531540903|FG000|Treatment Period|Non-compliance with study drug|4|||
147375837|NCT02372799|531540904|FG001|Treatment Period|Non-compliance with study drug|4|||
147375838|NCT02372799|531540905|FG002|Treatment Period|Non-compliance with study drug|4|||
147375839|NCT02372799|531540903|FG000|Treatment Period|Miscellaneous Reasons|1|||
147375840|NCT02372799|531540904|FG001|Treatment Period|Miscellaneous Reasons|1|||
147375841|NCT02372799|531540905|FG002|Treatment Period|Miscellaneous Reasons|0|||
147375842|NCT02372799|531540903|FG000|Down-taper Period|Lost to Follow-up|1|||
147375843|NCT02372799|531540904|FG001|Down-taper Period|Lost to Follow-up|2|||
147375844|NCT02372799|531540905|FG002|Down-taper Period|Lost to Follow-up|2|||
147375845|NCT00089609|531540906|FG000|Overall Study|Withdrawal by Subject|3|||
147375846|NCT00089609|531540907|FG001|Overall Study|Withdrawal by Subject|1|||
147375847|NCT05815342|531540909|FG000|Baseline, Standard Therapy (2 Weeks)|Ineligible|4|||
147375848|NCT05815342|531540909|FG000|Baseline, Standard Therapy (2 Weeks)|Withdrawal by Subject|9|||
147375849|NCT05815342|531540909|FG000|Baseline, Standard Therapy (2 Weeks)|Lost to Follow-up|2|||
147375850|NCT05815342|531540909|FG000|Treatment Phase (13 Weeks)|Withdrawal by Subject|14|||
147375851|NCT05815342|531540909|FG000|Treatment Phase (13 Weeks)|Lost to Follow-up|2|||
147375852|NCT03116464|531540910|FG000|Overall Study|Insufficient enrollment for intervention development|4|||
147375853|NCT00747006|531540911|FG000|Overall Study|Adverse Event|1|||
147375854|NCT00747006|531540912|FG001|Overall Study|Adverse Event|0|||
147375855|NCT00747006|531540913|FG002|Overall Study|Adverse Event|0|||
147375856|NCT00747006|531540911|FG000|Overall Study|Lost to Follow-up|0|||
147375857|NCT00747006|531540912|FG001|Overall Study|Lost to Follow-up|1|||
147375858|NCT00747006|531540913|FG002|Overall Study|Lost to Follow-up|0|||
147375859|NCT00747006|531540911|FG000|Overall Study|Physician Decision|2|||
147375860|NCT00747006|531540912|FG001|Overall Study|Physician Decision|0|||
147375861|NCT00747006|531540913|FG002|Overall Study|Physician Decision|1|||
147375862|NCT00357994|531540914|FG000|Overall Study|Adverse Event|1|||
147611808|NCT04759768|532393719|FG001|Washout (7 Days)|Physician Decision|1|||
147375863|NCT00357994|531540915|FG001|Overall Study|Adverse Event|2|||
147375864|NCT00357994|531540914|FG000|Overall Study|Lack of Efficacy|0|||
147375865|NCT00357994|531540915|FG001|Overall Study|Lack of Efficacy|1|||
147375866|NCT00357994|531540914|FG000|Overall Study|Protocol Violation|1|||
147375867|NCT00357994|531540915|FG001|Overall Study|Protocol Violation|0|||
147375868|NCT00345046|531540918|FG000|Overall Study|Protocol Violation|1|||
147375869|NCT00345046|531540919|FG001|Overall Study|Protocol Violation|1|||
147375870|NCT00345046|531540920|FG002|Overall Study|Protocol Violation|2|||
147375871|NCT04652869|531540925|FG000|Overall Study|Withdrawal by Subject|0|||
147375872|NCT04652869|531540926|FG001|Overall Study|Withdrawal by Subject|2|||
147375873|NCT04652869|531540927|FG002|Overall Study|Withdrawal by Subject|0|||
147375874|NCT01372085|531540928|FG000|Washout Period 2|Physician Decision|0|||
147375875|NCT01372085|531540929|FG001|Washout Period 2|Physician Decision|0|||
147375876|NCT01372085|531540930|FG002|Washout Period 2|Physician Decision|0|||
147375877|NCT01372085|531540931|FG003|Washout Period 2|Physician Decision|0|||
147375878|NCT01372085|531540932|FG004|Washout Period 2|Physician Decision|1|||
147375879|NCT01372085|531540933|FG005|Washout Period 2|Physician Decision|0|||
147375880|NCT01372085|531540934|FG006|Washout Period 2|Physician Decision|0|||
147375881|NCT01372085|531540935|FG007|Washout Period 2|Physician Decision|0|||
147375882|NCT01372085|531540936|FG008|Washout Period 2|Physician Decision|0|||
147375883|NCT01372085|531540937|FG009|Washout Period 2|Physician Decision|0|||
147375884|NCT01372085|531540928|FG000|Washout Period 3|Withdrawal by Subject|0|||
147375885|NCT01372085|531540929|FG001|Washout Period 3|Withdrawal by Subject|0|||
147375886|NCT01372085|531540930|FG002|Washout Period 3|Withdrawal by Subject|0|||
147375887|NCT01372085|531540931|FG003|Washout Period 3|Withdrawal by Subject|0|||
147375888|NCT01372085|531540932|FG004|Washout Period 3|Withdrawal by Subject|0|||
147375889|NCT01372085|531540933|FG005|Washout Period 3|Withdrawal by Subject|2|||
147375890|NCT01372085|531540934|FG006|Washout Period 3|Withdrawal by Subject|0|||
147375891|NCT01372085|531540935|FG007|Washout Period 3|Withdrawal by Subject|0|||
147375892|NCT01372085|531540936|FG008|Washout Period 3|Withdrawal by Subject|0|||
147375893|NCT01372085|531540937|FG009|Washout Period 3|Withdrawal by Subject|0|||
147375894|NCT00562094|531540938|FG000|Overall Study|Lost to Follow-up|62|||
147375895|NCT03689946|531540939|FG000|Overall Study|Withdrawal by Subject|3|||
147375896|NCT03689946|531540939|FG000|Overall Study|Lost to Follow-up|3|||
147375897|NCT03689946|531540939|FG000|Overall Study|Data corruption|2|||
147375898|NCT01555138|531540940|FG000|Overall Study|Death|0|||
147375899|NCT01555138|531540941|FG001|Overall Study|Death|1|||
147375900|NCT01555138|531540940|FG000|Overall Study|Lost to Follow-up|1|||
147375901|NCT01555138|531540941|FG001|Overall Study|Lost to Follow-up|0|||
147375902|NCT01555138|531540940|FG000|Overall Study|Abnormal Lab reults|1|||
147375903|NCT01555138|531540941|FG001|Overall Study|Abnormal Lab reults|3|||
147375904|NCT01555138|531540940|FG000|Overall Study|Lack of Efficacy|2|||
147375905|NCT01555138|531540941|FG001|Overall Study|Lack of Efficacy|2|||
147375906|NCT01555138|531540940|FG000|Overall Study|Protocol Violation|5|||
147375907|NCT01555138|531540941|FG001|Overall Study|Protocol Violation|3|||
147375908|NCT01555138|531540940|FG000|Overall Study|Administrative problems|8|||
147375909|NCT01555138|531540941|FG001|Overall Study|Administrative problems|0|||
147375910|NCT01555138|531540940|FG000|Overall Study|Withdrawal by Subject|16|||
147375911|NCT01555138|531540941|FG001|Overall Study|Withdrawal by Subject|15|||
147375912|NCT01555138|531540940|FG000|Overall Study|Adverse Event|14|||
147375913|NCT01555138|531540941|FG001|Overall Study|Adverse Event|14|||
147375914|NCT01613417|531540942|FG000|Washout (no Second Injection/MRI)|Withdrawal by Subject|13|||
147375915|NCT01613417|531540943|FG001|Washout (no Second Injection/MRI)|Withdrawal by Subject|7|||
147375916|NCT03732807|531540947|FG000|Treatment Period (up to Week 24)|Adverse Event|3|||
147375917|NCT03732807|531540948|FG001|Treatment Period (up to Week 24)|Adverse Event|0|||
147375918|NCT03732807|531540949|FG002|Treatment Period (up to Week 24)|Adverse Event|2|||
147375919|NCT03732807|531540950|FG003|Treatment Period (up to Week 24)|Adverse Event|4|||
147375920|NCT03732807|531540951|FG004|Treatment Period (up to Week 24)|Adverse Event|2|||
147375921|NCT03732807|531540952|FG005|Treatment Period (up to Week 24)|Adverse Event|0|||
147375922|NCT03732807|531540953|FG006|Treatment Period (up to Week 24)|Adverse Event|1|||
147375923|NCT03732807|531540947|FG000|Treatment Period (up to Week 24)|Lost to Follow-up|1|||
147375924|NCT03732807|531540948|FG001|Treatment Period (up to Week 24)|Lost to Follow-up|0|||
147375925|NCT03732807|531540949|FG002|Treatment Period (up to Week 24)|Lost to Follow-up|1|||
147375926|NCT03732807|531540950|FG003|Treatment Period (up to Week 24)|Lost to Follow-up|2|||
147375927|NCT03732807|531540951|FG004|Treatment Period (up to Week 24)|Lost to Follow-up|1|||
147375928|NCT03732807|531540952|FG005|Treatment Period (up to Week 24)|Lost to Follow-up|0|||
147375929|NCT03732807|531540953|FG006|Treatment Period (up to Week 24)|Lost to Follow-up|0|||
147375930|NCT03732807|531540947|FG000|Treatment Period (up to Week 24)|Physician Decision|0|||
147375931|NCT03732807|531540948|FG001|Treatment Period (up to Week 24)|Physician Decision|1|||
147375932|NCT03732807|531540949|FG002|Treatment Period (up to Week 24)|Physician Decision|2|||
147611809|NCT04324021|532393723|FG000|Overall Study|Adverse Event|1|||
147611810|NCT04324021|532393724|FG001|Overall Study|Adverse Event|0|||
147611811|NCT04324021|532393725|FG002|Overall Study|Adverse Event|0|||
147611812|NCT04324021|532393723|FG000|Overall Study|Lack of Efficacy|0|||
147611813|NCT04324021|532393724|FG001|Overall Study|Lack of Efficacy|0|||
147375933|NCT03732807|531540950|FG003|Treatment Period (up to Week 24)|Physician Decision|5|||
147375934|NCT03732807|531540951|FG004|Treatment Period (up to Week 24)|Physician Decision|0|||
147375935|NCT03732807|531540952|FG005|Treatment Period (up to Week 24)|Physician Decision|0|||
147375936|NCT03732807|531540953|FG006|Treatment Period (up to Week 24)|Physician Decision|1|||
147375937|NCT03732807|531540947|FG000|Treatment Period (up to Week 24)|Pregnancy|1|||
147375938|NCT03732807|531540948|FG001|Treatment Period (up to Week 24)|Pregnancy|0|||
147375939|NCT03732807|531540949|FG002|Treatment Period (up to Week 24)|Pregnancy|0|||
147375940|NCT03732807|531540950|FG003|Treatment Period (up to Week 24)|Pregnancy|0|||
147375941|NCT03732807|531540951|FG004|Treatment Period (up to Week 24)|Pregnancy|1|||
147375942|NCT03732807|531540952|FG005|Treatment Period (up to Week 24)|Pregnancy|0|||
147375943|NCT03732807|531540953|FG006|Treatment Period (up to Week 24)|Pregnancy|1|||
147375944|NCT03732807|531540947|FG000|Treatment Period (up to Week 24)|Protocol Violation|1|||
147375945|NCT03732807|531540948|FG001|Treatment Period (up to Week 24)|Protocol Violation|1|||
147375946|NCT03732807|531540949|FG002|Treatment Period (up to Week 24)|Protocol Violation|0|||
147375947|NCT03732807|531540950|FG003|Treatment Period (up to Week 24)|Protocol Violation|0|||
147375948|NCT03732807|531540951|FG004|Treatment Period (up to Week 24)|Protocol Violation|0|||
147375949|NCT03732807|531540952|FG005|Treatment Period (up to Week 24)|Protocol Violation|0|||
147375950|NCT03732807|531540953|FG006|Treatment Period (up to Week 24)|Protocol Violation|0|||
147375951|NCT03732807|531540947|FG000|Treatment Period (up to Week 24)|Withdrawal by Subject|4|||
147375952|NCT03732807|531540948|FG001|Treatment Period (up to Week 24)|Withdrawal by Subject|4|||
147375953|NCT03732807|531540949|FG002|Treatment Period (up to Week 24)|Withdrawal by Subject|4|||
147375954|NCT03732807|531540950|FG003|Treatment Period (up to Week 24)|Withdrawal by Subject|4|||
147375955|NCT03732807|531540951|FG004|Treatment Period (up to Week 24)|Withdrawal by Subject|1|||
147375956|NCT03732807|531540952|FG005|Treatment Period (up to Week 24)|Withdrawal by Subject|1|||
147375957|NCT03732807|531540953|FG006|Treatment Period (up to Week 24)|Withdrawal by Subject|2|||
147375958|NCT03732807|531540947|FG000|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
147375959|NCT03732807|531540948|FG001|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
147375960|NCT03732807|531540949|FG002|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
147375961|NCT03732807|531540950|FG003|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
147375962|NCT03732807|531540951|FG004|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
147375963|NCT03732807|531540952|FG005|Treatment Period (up to Week 24)|Lack of Efficacy|1|||
147375964|NCT03732807|531540953|FG006|Treatment Period (up to Week 24)|Lack of Efficacy|0|||
147375965|NCT03732807|531540947|FG000|Treatment Extension (Week 25 up to 48)|Adverse Event|0|||
147375966|NCT03732807|531540948|FG001|Treatment Extension (Week 25 up to 48)|Adverse Event|2|||
147375967|NCT03732807|531540949|FG002|Treatment Extension (Week 25 up to 48)|Adverse Event|2|||
147375968|NCT03732807|531540950|FG003|Treatment Extension (Week 25 up to 48)|Adverse Event|1|||
147375969|NCT03732807|531540951|FG004|Treatment Extension (Week 25 up to 48)|Adverse Event|0|||
147375970|NCT03732807|531540952|FG005|Treatment Extension (Week 25 up to 48)|Adverse Event|0|||
147375971|NCT03732807|531540953|FG006|Treatment Extension (Week 25 up to 48)|Adverse Event|2|||
147375972|NCT03732807|531540947|FG000|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|2|||
147375973|NCT03732807|531540948|FG001|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|1|||
147375974|NCT03732807|531540949|FG002|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|0|||
147375975|NCT03732807|531540950|FG003|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|3|||
147375976|NCT03732807|531540951|FG004|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|3|||
147375977|NCT03732807|531540952|FG005|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|0|||
147375978|NCT03732807|531540953|FG006|Treatment Extension (Week 25 up to 48)|Lack of Efficacy|1|||
147375979|NCT03732807|531540947|FG000|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|0|||
147375980|NCT03732807|531540948|FG001|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|0|||
147375981|NCT03732807|531540949|FG002|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|2|||
147375982|NCT03732807|531540950|FG003|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|1|||
147375983|NCT03732807|531540951|FG004|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|1|||
147375984|NCT03732807|531540952|FG005|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|2|||
147375985|NCT03732807|531540953|FG006|Treatment Extension (Week 25 up to 48)|Lost to Follow-up|0|||
147375986|NCT03732807|531540947|FG000|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
147375987|NCT03732807|531540948|FG001|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|1|||
147375988|NCT03732807|531540949|FG002|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
147375989|NCT03732807|531540950|FG003|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
147375990|NCT03732807|531540951|FG004|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
147375991|NCT03732807|531540952|FG005|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
147375992|NCT03732807|531540953|FG006|Treatment Extension (Week 25 up to 48)|Non-Compliant with study drug|0|||
147375993|NCT03732807|531540947|FG000|Treatment Extension (Week 25 up to 48)|Physician Decision|0|||
147375994|NCT03732807|531540948|FG001|Treatment Extension (Week 25 up to 48)|Physician Decision|1|||
147375995|NCT03732807|531540949|FG002|Treatment Extension (Week 25 up to 48)|Physician Decision|0|||
147664486|NCT01198002|532596261|FG001|Treatment Period 1 (Weeks 0-52)|Protocol Violation|10|||
147664487|NCT01198002|532596262|FG002|Treatment Period 1 (Weeks 0-52)|Protocol Violation|10|||
147375996|NCT03732807|531540950|FG003|Treatment Extension (Week 25 up to 48)|Physician Decision|1|||
147375997|NCT03732807|531540951|FG004|Treatment Extension (Week 25 up to 48)|Physician Decision|1|||
147375998|NCT03732807|531540952|FG005|Treatment Extension (Week 25 up to 48)|Physician Decision|0|||
147375999|NCT03732807|531540953|FG006|Treatment Extension (Week 25 up to 48)|Physician Decision|0|||
147376000|NCT03732807|531540947|FG000|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|3|||
147376001|NCT03732807|531540948|FG001|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|2|||
147376002|NCT03732807|531540949|FG002|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|1|||
147376003|NCT03732807|531540950|FG003|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|1|||
147376004|NCT03732807|531540951|FG004|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|0|||
147376005|NCT03732807|531540952|FG005|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|1|||
147376006|NCT03732807|531540953|FG006|Treatment Extension (Week 25 up to 48)|Withdrawal by Subject|1|||
147376007|NCT03732807|531540947|FG000|Treatment Extension (Week 25 up to 48)|Other|1|||
147376008|NCT03732807|531540948|FG001|Treatment Extension (Week 25 up to 48)|Other|4|||
147376009|NCT03732807|531540949|FG002|Treatment Extension (Week 25 up to 48)|Other|0|||
147376010|NCT03732807|531540950|FG003|Treatment Extension (Week 25 up to 48)|Other|2|||
147376011|NCT03732807|531540951|FG004|Treatment Extension (Week 25 up to 48)|Other|0|||
147376012|NCT03732807|531540952|FG005|Treatment Extension (Week 25 up to 48)|Other|0|||
147376013|NCT03732807|531540953|FG006|Treatment Extension (Week 25 up to 48)|Other|0|||
147376014|NCT00599196|531540954|FG000|Overall Study|Lack of Efficacy|22|||
147376015|NCT00599196|531540954|FG000|Overall Study|Adverse Event|93|||
147376016|NCT00599196|531540954|FG000|Overall Study|Unsatisfactory compliance of subject|3|||
147376017|NCT00599196|531540954|FG000|Overall Study|Subject withdrew consent|43|||
147376018|NCT00599196|531540954|FG000|Overall Study|Study ended per sponsor|197|||
147376019|NCT00599196|531540954|FG000|Overall Study|Lost to Follow-up|17|||
147376020|NCT00599196|531540954|FG000|Overall Study|Other: Patient Leaving For Israel|1|||
147376021|NCT00599196|531540954|FG000|Overall Study|Other: Spouse Withdrew Consent|1|||
147376022|NCT00599196|531540954|FG000|Overall Study|Other: Diagnosis No Longer Idiopathic Pd|1|||
147376023|NCT00599196|531540954|FG000|Overall Study|Other: Pt Moved To Australia|1|||
147376024|NCT00599196|531540954|FG000|Overall Study|Other: Patient Stopped Due To Moving|1|||
147376025|NCT00599196|531540954|FG000|Overall Study|Other: Inv Switched Dopamine Agonist|1|||
147376026|NCT03274076|531540957|FG000|24 Weeks Double Blind|Withdrawal by Subject|0|||
147376027|NCT03274076|531540958|FG001|24 Weeks Double Blind|Withdrawal by Subject|1|||
147376028|NCT03274076|531540959|FG002|24 Weeks Double Blind|Withdrawal by Subject|0|||
147376029|NCT03274076|531540960|FG003|24 Weeks Double Blind|Withdrawal by Subject|0|||
147376030|NCT03274076|531540957|FG000|24 Weeks Open Label|Adverse Event|0|||
147376031|NCT03274076|531540958|FG001|24 Weeks Open Label|Adverse Event|0|||
147376032|NCT03274076|531540959|FG002|24 Weeks Open Label|Adverse Event|2|||
147376033|NCT03274076|531540960|FG003|24 Weeks Open Label|Adverse Event|0|||
147376034|NCT03274076|531540957|FG000|24 Weeks Open Label|Withdrawal by Subject|0|||
147376035|NCT03274076|531540958|FG001|24 Weeks Open Label|Withdrawal by Subject|0|||
147376036|NCT03274076|531540959|FG002|24 Weeks Open Label|Withdrawal by Subject|0|||
147376037|NCT03274076|531540960|FG003|24 Weeks Open Label|Withdrawal by Subject|1|||
147376038|NCT00641537|531540984|FG000|96-week Period|Adverse Event|0|||
147376039|NCT00641537|531540985|FG001|96-week Period|Adverse Event|1|||
147376040|NCT00641537|531540986|FG002|96-week Period|Adverse Event|3|||
147376041|NCT00641537|531540987|FG003|96-week Period|Adverse Event|0|||
147376042|NCT00641537|531540988|FG004|96-week Period|Adverse Event|2|||
147376043|NCT00641537|531540989|FG005|96-week Period|Adverse Event|0|||
147376044|NCT00641537|531540990|FG006|96-week Period|Adverse Event|0|||
147376045|NCT00641537|531540991|FG007|96-week Period|Adverse Event|0|||
147376046|NCT00641537|531540984|FG000|96-week Period|Lost to Follow-up|3|||
147376047|NCT00641537|531540985|FG001|96-week Period|Lost to Follow-up|1|||
147376048|NCT00641537|531540986|FG002|96-week Period|Lost to Follow-up|2|||
147376049|NCT00641537|531540987|FG003|96-week Period|Lost to Follow-up|2|||
147376050|NCT00641537|531540988|FG004|96-week Period|Lost to Follow-up|4|||
147376051|NCT00641537|531540989|FG005|96-week Period|Lost to Follow-up|0|||
147376052|NCT00641537|531540990|FG006|96-week Period|Lost to Follow-up|1|||
147376053|NCT00641537|531540991|FG007|96-week Period|Lost to Follow-up|0|||
147376054|NCT00641537|531540984|FG000|96-week Period|Protocol Violation|0|||
147376055|NCT00641537|531540985|FG001|96-week Period|Protocol Violation|1|||
147376056|NCT00641537|531540986|FG002|96-week Period|Protocol Violation|0|||
147376057|NCT00641537|531540987|FG003|96-week Period|Protocol Violation|1|||
147376058|NCT00641537|531540988|FG004|96-week Period|Protocol Violation|0|||
147376059|NCT00641537|531540989|FG005|96-week Period|Protocol Violation|1|||
147376060|NCT00641537|531540990|FG006|96-week Period|Protocol Violation|0|||
147376061|NCT00641537|531540991|FG007|96-week Period|Protocol Violation|0|||
147376062|NCT00641537|531540984|FG000|96-week Period|Death|2|||
147376063|NCT00641537|531540985|FG001|96-week Period|Death|0|||
147376064|NCT00641537|531540986|FG002|96-week Period|Death|1|||
147376065|NCT00641537|531540987|FG003|96-week Period|Death|0|||
147376066|NCT00641537|531540988|FG004|96-week Period|Death|0|||
147376067|NCT00641537|531540989|FG005|96-week Period|Death|0|||
147376068|NCT00641537|531540990|FG006|96-week Period|Death|0|||
147376069|NCT00641537|531540991|FG007|96-week Period|Death|0|||
147376070|NCT00641537|531540984|FG000|96-week Period|Other|4|||
147664488|NCT01198002|532596260|FG000|Treatment Period 1 (Weeks 0-52)|Sponsor Decision|213|||
147664489|NCT01198002|532596261|FG001|Treatment Period 1 (Weeks 0-52)|Sponsor Decision|216|||
147664490|NCT01198002|532596262|FG002|Treatment Period 1 (Weeks 0-52)|Sponsor Decision|224|||
147664491|NCT01198002|532596260|FG000|Treatment Period 2 (Weeks 52-100)|Adverse Event|2|||
147664492|NCT01198002|532596261|FG001|Treatment Period 2 (Weeks 52-100)|Adverse Event|0|||
147664493|NCT01198002|532596262|FG002|Treatment Period 2 (Weeks 52-100)|Adverse Event|1|||
147664494|NCT01198002|532596260|FG000|Treatment Period 2 (Weeks 52-100)|Lack of Efficacy|3|||
147664495|NCT01198002|532596261|FG001|Treatment Period 2 (Weeks 52-100)|Lack of Efficacy|1|||
147664496|NCT01198002|532596262|FG002|Treatment Period 2 (Weeks 52-100)|Lack of Efficacy|1|||
147664497|NCT01198002|532596260|FG000|Treatment Period 2 (Weeks 52-100)|Entry Criteria Not Met|1|||
147664498|NCT01198002|532596261|FG001|Treatment Period 2 (Weeks 52-100)|Entry Criteria Not Met|0|||
147664499|NCT01198002|532596262|FG002|Treatment Period 2 (Weeks 52-100)|Entry Criteria Not Met|0|||
147664500|NCT01198002|532596260|FG000|Treatment Period 2 (Weeks 52-100)|Lost to Follow-up|0|||
147664501|NCT01198002|532596261|FG001|Treatment Period 2 (Weeks 52-100)|Lost to Follow-up|2|||
147664502|NCT01198002|532596262|FG002|Treatment Period 2 (Weeks 52-100)|Lost to Follow-up|0|||
147664503|NCT01198002|532596260|FG000|Treatment Period 2 (Weeks 52-100)|Physician Decision|1|||
147664504|NCT01198002|532596261|FG001|Treatment Period 2 (Weeks 52-100)|Physician Decision|0|||
147664505|NCT01198002|532596262|FG002|Treatment Period 2 (Weeks 52-100)|Physician Decision|1|||
147664506|NCT01198002|532596260|FG000|Treatment Period 2 (Weeks 52-100)|Sponsor Decision|62|||
147664507|NCT01198002|532596261|FG001|Treatment Period 2 (Weeks 52-100)|Sponsor Decision|70|||
147664508|NCT01198002|532596262|FG002|Treatment Period 2 (Weeks 52-100)|Sponsor Decision|75|||
147664509|NCT00536510|532596269|FG000|Overall Study|Adverse Event|27|||
147664510|NCT00536510|532596270|FG001|Overall Study|Adverse Event|4|||
147664511|NCT00536510|532596269|FG000|Overall Study|Lost to Follow-up|11|||
147664512|NCT00536510|532596270|FG001|Overall Study|Lost to Follow-up|8|||
147664513|NCT00536510|532596269|FG000|Overall Study|Protocol Violation|4|||
147664514|NCT00536510|532596270|FG001|Overall Study|Protocol Violation|5|||
147664515|NCT00536510|532596269|FG000|Overall Study|Withdrawal by Subject|16|||
147664516|NCT00536510|532596270|FG001|Overall Study|Withdrawal by Subject|9|||
147664517|NCT00536510|532596269|FG000|Overall Study|Flushing with Product|20|||
147664518|NCT00536510|532596270|FG001|Overall Study|Flushing with Product|0|||
147664519|NCT00536510|532596269|FG000|Overall Study|Laboratory Adverse Event|2|||
147664520|NCT00536510|532596270|FG001|Overall Study|Laboratory Adverse Event|1|||
147664521|NCT00536510|532596269|FG000|Overall Study|Patient Discontinued for Other Reasons|2|||
147664522|NCT00536510|532596270|FG001|Overall Study|Patient Discontinued for Other Reasons|2|||
147664523|NCT01249417|532596271|FG000|Randomised Population|Study treatment not received|0|||
147664524|NCT01249417|532596272|FG001|Randomised Population|Study treatment not received|0|||
147664525|NCT01249417|532596273|FG002|Randomised Population|Study treatment not received|2|||
147664526|NCT01249417|532596271|FG000|Randomised Population|No MAS score at baseline and/or Week 4|1|||
147664527|NCT01249417|532596272|FG001|Randomised Population|No MAS score at baseline and/or Week 4|1|||
147664528|NCT01249417|532596273|FG002|Randomised Population|No MAS score at baseline and/or Week 4|2|||
147664529|NCT01249417|532596271|FG000|Treatment Phase - ITT Population|Other|0|||
147664530|NCT01249417|532596272|FG001|Treatment Phase - ITT Population|Other|0|||
147664531|NCT01249417|532596273|FG002|Treatment Phase - ITT Population|Other|1|||
147664532|NCT01249417|532596271|FG000|Treatment Phase - ITT Population|Adverse Event|0|||
147664533|NCT01249417|532596272|FG001|Treatment Phase - ITT Population|Adverse Event|0|||
147664534|NCT01249417|532596273|FG002|Treatment Phase - ITT Population|Adverse Event|1|||
147664535|NCT01249417|532596271|FG000|Treatment Phase - ITT Population|Withdrawal by Subject|1|||
147611814|NCT04324021|532393725|FG002|Overall Study|Lack of Efficacy|1|||
147611815|NCT04324021|532393723|FG000|Overall Study|Death|1|||
147611816|NCT04324021|532393724|FG001|Overall Study|Death|1|||
147611817|NCT04324021|532393725|FG002|Overall Study|Death|0|||
147611818|NCT02006732|532393726|FG000|Overall Study|Adverse Event|10|||
147611819|NCT02006732|532393727|FG001|Overall Study|Adverse Event|7|||
147611820|NCT02006732|532393728|FG002|Overall Study|Adverse Event|4|||
147611821|NCT02006732|532393729|FG003|Overall Study|Adverse Event|2|||
147611822|NCT02006732|532393726|FG000|Overall Study|Lack of Efficacy|6|||
147611823|NCT02006732|532393727|FG001|Overall Study|Lack of Efficacy|3|||
147611824|NCT02006732|532393728|FG002|Overall Study|Lack of Efficacy|1|||
147664536|NCT01249417|532596272|FG001|Treatment Phase - ITT Population|Withdrawal by Subject|3|||
147664537|NCT01249417|532596273|FG002|Treatment Phase - ITT Population|Withdrawal by Subject|1|||
147664538|NCT01249417|532596271|FG000|Treatment Phase - ITT Population|Lost to Follow-up|0|||
147664539|NCT01249417|532596272|FG001|Treatment Phase - ITT Population|Lost to Follow-up|1|||
147664540|NCT01249417|532596273|FG002|Treatment Phase - ITT Population|Lost to Follow-up|1|||
147664541|NCT03102762|532596274|FG000|Overall Study|Lost to Follow-up|1|||
147664542|NCT03102762|532596275|FG001|Overall Study|Lost to Follow-up|0|||
147664543|NCT03074695|532596280|FG000|Overall Study|Delivered with caesarean before request for analgesia|1|||
147611825|NCT02006732|532393729|FG003|Overall Study|Lack of Efficacy|1|||
147611826|NCT02006732|532393726|FG000|Overall Study|Protocol Violation|1|||
147611827|NCT02006732|532393727|FG001|Overall Study|Protocol Violation|1|||
147611828|NCT02006732|532393728|FG002|Overall Study|Protocol Violation|0|||
147376071|NCT00641537|531540985|FG001|96-week Period|Other|7|||
147376072|NCT00641537|531540986|FG002|96-week Period|Other|14|||
147376073|NCT00641537|531540987|FG003|96-week Period|Other|9|||
147376074|NCT00641537|531540988|FG004|96-week Period|Other|11|||
147376075|NCT00641537|531540989|FG005|96-week Period|Other|6|||
147376076|NCT00641537|531540990|FG006|96-week Period|Other|4|||
147376077|NCT00641537|531540991|FG007|96-week Period|Other|6|||
147376078|NCT00641537|531540984|FG000|24-Week Supplemental Follow-up Period|Lost to Follow-up|0|||
147376079|NCT00641537|531540985|FG001|24-Week Supplemental Follow-up Period|Lost to Follow-up|1|||
147376080|NCT00641537|531540986|FG002|24-Week Supplemental Follow-up Period|Lost to Follow-up|1|||
147376081|NCT00641537|531540987|FG003|24-Week Supplemental Follow-up Period|Lost to Follow-up|3|||
147376082|NCT00641537|531540988|FG004|24-Week Supplemental Follow-up Period|Lost to Follow-up|2|||
147376083|NCT00641537|531540989|FG005|24-Week Supplemental Follow-up Period|Lost to Follow-up|1|||
147376084|NCT00641537|531540990|FG006|24-Week Supplemental Follow-up Period|Lost to Follow-up|0|||
147376085|NCT00641537|531540991|FG007|24-Week Supplemental Follow-up Period|Lost to Follow-up|0|||
147376086|NCT00641537|531540984|FG000|24-Week Supplemental Follow-up Period|Other|0|||
147376087|NCT00641537|531540985|FG001|24-Week Supplemental Follow-up Period|Other|2|||
147376088|NCT00641537|531540986|FG002|24-Week Supplemental Follow-up Period|Other|2|||
147376089|NCT00641537|531540987|FG003|24-Week Supplemental Follow-up Period|Other|1|||
147376090|NCT00641537|531540988|FG004|24-Week Supplemental Follow-up Period|Other|3|||
147376091|NCT00641537|531540989|FG005|24-Week Supplemental Follow-up Period|Other|0|||
147376092|NCT00641537|531540990|FG006|24-Week Supplemental Follow-up Period|Other|1|||
147376093|NCT00641537|531540991|FG007|24-Week Supplemental Follow-up Period|Other|1|||
147376094|NCT01801007|531540992|FG000|Overall Study|Adverse Event|2|||
147376095|NCT01801007|531540992|FG000|Overall Study|Lost to Follow-up|4|||
147376096|NCT01801007|531540992|FG000|Overall Study|Withdrawal by Subject|5|||
147376097|NCT00665392|531540993|FG000|Overall Study|not treated|1|||
147376098|NCT02426138|531540994|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
147376099|NCT02426138|531540995|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
147376100|NCT00553332|531541001|FG000|Overall Study|ineligible, incorrect diagnosis|1|||
147376101|NCT03520036|531541004|FG000|Overall Study|Adverse Event|1|||
147376102|NCT03520036|531541005|FG001|Overall Study|Adverse Event|2|||
147376103|NCT03520036|531541006|FG002|Overall Study|Adverse Event|0|||
147376104|NCT03520036|531541004|FG000|Overall Study|Protocol Violation|1|||
147376105|NCT03520036|531541005|FG001|Overall Study|Protocol Violation|0|||
147376106|NCT03520036|531541006|FG002|Overall Study|Protocol Violation|0|||
147376107|NCT03520036|531541004|FG000|Overall Study|Withdrawal by Subject|0|||
147376108|NCT03520036|531541005|FG001|Overall Study|Withdrawal by Subject|1|||
147376109|NCT03520036|531541006|FG002|Overall Study|Withdrawal by Subject|4|||
147376110|NCT03520036|531541004|FG000|Overall Study|CS Adverse Findings from Post- Baseline Nevi Evaluation|0|||
147376111|NCT03520036|531541005|FG001|Overall Study|CS Adverse Findings from Post- Baseline Nevi Evaluation|1|||
147376112|NCT03520036|531541006|FG002|Overall Study|CS Adverse Findings from Post- Baseline Nevi Evaluation|0|||
147376113|NCT00467272|531541010|FG000|Overall Study|Pneumonia|2|||
147376114|NCT00467272|531541010|FG000|Overall Study|Thrombophlebitis|1|||
147376115|NCT00145470|531541013|FG000|Overall Study|Adverse Event|19|||
147376116|NCT00145470|531541014|FG001|Overall Study|Adverse Event|25|||
147376117|NCT00145470|531541013|FG000|Overall Study|Lack of Efficacy|27|||
147376118|NCT00145470|531541014|FG001|Overall Study|Lack of Efficacy|13|||
147376119|NCT00145470|531541013|FG000|Overall Study|Withdrawal by Subject|36|||
147376120|NCT00145470|531541014|FG001|Overall Study|Withdrawal by Subject|34|||
147376121|NCT00145470|531541013|FG000|Overall Study|Lost to Follow-up|21|||
147376122|NCT00145470|531541014|FG001|Overall Study|Lost to Follow-up|17|||
147376123|NCT00145470|531541013|FG000|Overall Study|Reason Not Reported|9|||
147376124|NCT00145470|531541014|FG001|Overall Study|Reason Not Reported|9|||
147376125|NCT03924869|531541022|FG000|Overall Study|Death|66|||
147376126|NCT03924869|531541023|FG001|Overall Study|Death|53|||
147376127|NCT03924869|531541022|FG000|Overall Study|Lost to Follow-up|2|||
147376128|NCT03924869|531541023|FG001|Overall Study|Lost to Follow-up|0|||
147376129|NCT03924869|531541022|FG000|Overall Study|Physician Decision|0|||
147376130|NCT03924869|531541023|FG001|Overall Study|Physician Decision|3|||
147376131|NCT03924869|531541022|FG000|Overall Study|Withdrawal by Subject|5|||
147376132|NCT03924869|531541023|FG001|Overall Study|Withdrawal by Subject|1|||
147376133|NCT03924869|531541022|FG000|Overall Study|Participants Ongoing|154|||
147376134|NCT03924869|531541023|FG001|Overall Study|Participants Ongoing|164|||
147376135|NCT04762277|531541026|FG000|Overall Study|Withdrawal by Subject|0|||
147376136|NCT04762277|531541027|FG001|Overall Study|Withdrawal by Subject|2|||
147376137|NCT04762277|531541026|FG000|Overall Study|Protocol Violation|0|||
147376138|NCT04762277|531541027|FG001|Overall Study|Protocol Violation|1|||
147376139|NCT04762277|531541026|FG000|Overall Study|Adverse Event|1|||
147376140|NCT04762277|531541027|FG001|Overall Study|Adverse Event|0|||
147376141|NCT05824559|531541028|FG000|Overall Study|Adverse Event|2|||
147376142|NCT05824559|531541028|FG000|Overall Study|Physician Decision|2|||
147376143|NCT05824559|531541028|FG000|Overall Study|Progressive Disease|16|||
147376144|NCT05824559|531541028|FG000|Overall Study|Study Terminated by Sponsor|1|||
147376145|NCT05824559|531541028|FG000|Overall Study|Withdrawal by Subject|2|||
147376146|NCT05366751|531541029|FG000|Overall Study|Adverse Event|25|||
147611829|NCT02006732|532393729|FG003|Overall Study|Protocol Violation|0|||
147611830|NCT02006732|532393726|FG000|Overall Study|Lost to Follow-up|0|||
147611831|NCT02006732|532393727|FG001|Overall Study|Lost to Follow-up|1|||
147611832|NCT02006732|532393728|FG002|Overall Study|Lost to Follow-up|0|||
147611833|NCT02006732|532393729|FG003|Overall Study|Lost to Follow-up|0|||
147611834|NCT02006732|532393726|FG000|Overall Study|Withdrawal by Subject|3|||
147611835|NCT02006732|532393727|FG001|Overall Study|Withdrawal by Subject|0|||
147611836|NCT02006732|532393728|FG002|Overall Study|Withdrawal by Subject|4|||
147611837|NCT02006732|532393729|FG003|Overall Study|Withdrawal by Subject|1|||
147611838|NCT03516513|532393732|FG000|Overall Study|Withdrawal by Subject|2|||
147611839|NCT03516513|532393733|FG001|Overall Study|Withdrawal by Subject|2|||
147611840|NCT03516513|532393734|FG002|Overall Study|Withdrawal by Subject|0|||
147611841|NCT03516513|532393735|FG003|Overall Study|Withdrawal by Subject|0|||
147611842|NCT01130597|532393741|FG000|Overall Study|Protocol-specified (High K+)|1|||
147611843|NCT01130597|532393741|FG000|Overall Study|Adverse Event|4|||
147611844|NCT01130597|532393741|FG000|Overall Study|Death|1|||
147611845|NCT01130597|532393741|FG000|Overall Study|Protocol Violation|1|||
147611846|NCT03371459|532393742|FG000|Washout|Lost to Follow-up|0|||
147611847|NCT03371459|532393743|FG001|Washout|Lost to Follow-up|1|||
147611848|NCT03694327|532393746|FG000|Overall Study|Lost to Follow-up|13|||
147611849|NCT03694327|532393747|FG001|Overall Study|Lost to Follow-up|23|||
147611850|NCT02185053|532393748|FG000|Solifenacin Dose Escalation Phase|Cardiac symptoms|1|||
147611851|NCT02185053|532393749|FG001|Solifenacin Dose Escalation Phase|Cardiac symptoms|0|||
147611852|NCT02185053|532393750|FG002|Solifenacin Dose Escalation Phase|Cardiac symptoms|0|||
147611853|NCT02185053|532393748|FG000|Solifenacin Dose Escalation Phase|No longer meeting eligibility criteria|2|||
147611854|NCT02185053|532393749|FG001|Solifenacin Dose Escalation Phase|No longer meeting eligibility criteria|0|||
147611855|NCT02185053|532393750|FG002|Solifenacin Dose Escalation Phase|No longer meeting eligibility criteria|0|||
147611856|NCT02185053|532393748|FG000|Donepezil Dose Escalation Phase|Cardiac symptoms|0|||
147611857|NCT02185053|532393749|FG001|Donepezil Dose Escalation Phase|Cardiac symptoms|1|||
147611858|NCT02185053|532393750|FG002|Donepezil Dose Escalation Phase|Cardiac symptoms|0|||
147611859|NCT02185053|532393748|FG000|Donepezil Dose Escalation Phase|Adverse Event|0|||
147611860|NCT02185053|532393749|FG001|Donepezil Dose Escalation Phase|Adverse Event|1|||
147611861|NCT02185053|532393750|FG002|Donepezil Dose Escalation Phase|Adverse Event|0|||
147611862|NCT02185053|532393748|FG000|Donepezil Dose Escalation Phase|No longer meeting eligibility criteria|0|||
147611863|NCT02185053|532393749|FG001|Donepezil Dose Escalation Phase|No longer meeting eligibility criteria|2|||
147611864|NCT02185053|532393750|FG002|Donepezil Dose Escalation Phase|No longer meeting eligibility criteria|0|||
147611865|NCT02185053|532393748|FG000|Donepezil Dose Escalation Phase|Withdrawal by Subject|0|||
147611866|NCT02185053|532393749|FG001|Donepezil Dose Escalation Phase|Withdrawal by Subject|1|||
147611867|NCT02185053|532393750|FG002|Donepezil Dose Escalation Phase|Withdrawal by Subject|0|||
147611868|NCT02185053|532393748|FG000|Donepezil Dose Maintenance Phase|Cardiac symptoms|0|||
147611869|NCT02185053|532393749|FG001|Donepezil Dose Maintenance Phase|Cardiac symptoms|0|||
147611870|NCT02185053|532393750|FG002|Donepezil Dose Maintenance Phase|Cardiac symptoms|1|||
147611871|NCT02185053|532393748|FG000|Donepezil Dose Maintenance Phase|Withdrawal by Subject|0|||
147611872|NCT02185053|532393749|FG001|Donepezil Dose Maintenance Phase|Withdrawal by Subject|0|||
147611873|NCT02185053|532393750|FG002|Donepezil Dose Maintenance Phase|Withdrawal by Subject|2|||
147611874|NCT00307437|532393751|FG000|Controlled Period|Adverse Event|7|||
147611875|NCT00307437|532393752|FG001|Controlled Period|Adverse Event|2|||
147611876|NCT00307437|532393753|FG002|Controlled Period|Adverse Event|5|||
147611877|NCT00307437|532393754|FG003|Controlled Period|Adverse Event|0|||
147611878|NCT00307437|532393755|FG004|Controlled Period|Adverse Event|0|||
147611879|NCT00307437|532393756|FG005|Controlled Period|Adverse Event|0|||
147611880|NCT00307437|532393757|FG006|Controlled Period|Adverse Event|0|||
147611881|NCT00307437|532393751|FG000|Controlled Period|Death|0|||
147611882|NCT00307437|532393752|FG001|Controlled Period|Death|0|||
147611883|NCT00307437|532393753|FG002|Controlled Period|Death|1|||
147611884|NCT00307437|532393754|FG003|Controlled Period|Death|0|||
147611885|NCT00307437|532393755|FG004|Controlled Period|Death|0|||
147611886|NCT00307437|532393756|FG005|Controlled Period|Death|0|||
147611887|NCT00307437|532393757|FG006|Controlled Period|Death|0|||
147611888|NCT00307437|532393751|FG000|Controlled Period|Lack of Efficacy|2|||
147611889|NCT00307437|532393752|FG001|Controlled Period|Lack of Efficacy|0|||
147376147|NCT05366751|531541029|FG000|Overall Study|Physician Decision|3|||
147376148|NCT05366751|531541029|FG000|Overall Study|Lost to Follow-up|2|||
147376149|NCT05366751|531541029|FG000|Overall Study|Withdrawal by Subject|14|||
147376150|NCT05366751|531541029|FG000|Overall Study|Study Terminated by Sponsor|50|||
147611890|NCT00307437|532393753|FG002|Controlled Period|Lack of Efficacy|0|||
147611891|NCT00307437|532393754|FG003|Controlled Period|Lack of Efficacy|0|||
147664544|NCT03074695|532596281|FG001|Overall Study|Delivered with caesarean before request for analgesia|1|||
147664545|NCT03074695|532596280|FG000|Overall Study|Research staff not available|1|||
147376151|NCT05366751|531541029|FG000|Overall Study|Site Terminated by Sponsor|3|||
147611892|NCT00307437|532393755|FG004|Controlled Period|Lack of Efficacy|0|||
147611893|NCT00307437|532393756|FG005|Controlled Period|Lack of Efficacy|0|||
147611894|NCT00307437|532393757|FG006|Controlled Period|Lack of Efficacy|0|||
147611895|NCT00307437|532393751|FG000|Controlled Period|Lost to Follow-up|2|||
147611896|NCT00307437|532393752|FG001|Controlled Period|Lost to Follow-up|3|||
147611897|NCT00307437|532393753|FG002|Controlled Period|Lost to Follow-up|0|||
147611898|NCT00307437|532393754|FG003|Controlled Period|Lost to Follow-up|0|||
147611899|NCT00307437|532393755|FG004|Controlled Period|Lost to Follow-up|0|||
147611900|NCT00307437|532393756|FG005|Controlled Period|Lost to Follow-up|0|||
147611901|NCT00307437|532393757|FG006|Controlled Period|Lost to Follow-up|0|||
147611902|NCT00307437|532393751|FG000|Controlled Period|Other|5|||
147611903|NCT00307437|532393752|FG001|Controlled Period|Other|1|||
147611904|NCT00307437|532393753|FG002|Controlled Period|Other|3|||
147611905|NCT00307437|532393754|FG003|Controlled Period|Other|0|||
147611906|NCT00307437|532393755|FG004|Controlled Period|Other|0|||
147611907|NCT00307437|532393756|FG005|Controlled Period|Other|0|||
147611908|NCT00307437|532393757|FG006|Controlled Period|Other|0|||
147611909|NCT00307437|532393751|FG000|After Controlled Period|Adverse Event|0|||
147611910|NCT00307437|532393752|FG001|After Controlled Period|Adverse Event|0|||
147611911|NCT00307437|532393753|FG002|After Controlled Period|Adverse Event|0|||
147611912|NCT00307437|532393754|FG003|After Controlled Period|Adverse Event|18|||
147611913|NCT00307437|532393755|FG004|After Controlled Period|Adverse Event|16|||
147611914|NCT00307437|532393756|FG005|After Controlled Period|Adverse Event|31|||
147611915|NCT00307437|532393757|FG006|After Controlled Period|Adverse Event|40|||
147611916|NCT00307437|532393751|FG000|After Controlled Period|Death|0|||
147611917|NCT00307437|532393752|FG001|After Controlled Period|Death|0|||
147611918|NCT00307437|532393753|FG002|After Controlled Period|Death|0|||
147611919|NCT00307437|532393754|FG003|After Controlled Period|Death|3|||
147611920|NCT00307437|532393755|FG004|After Controlled Period|Death|1|||
147611921|NCT00307437|532393756|FG005|After Controlled Period|Death|1|||
147611922|NCT00307437|532393757|FG006|After Controlled Period|Death|3|||
147611923|NCT00307437|532393751|FG000|After Controlled Period|Lack of Efficacy|0|||
147611924|NCT00307437|532393752|FG001|After Controlled Period|Lack of Efficacy|0|||
147611925|NCT00307437|532393753|FG002|After Controlled Period|Lack of Efficacy|0|||
147611926|NCT00307437|532393754|FG003|After Controlled Period|Lack of Efficacy|15|||
147611927|NCT00307437|532393755|FG004|After Controlled Period|Lack of Efficacy|17|||
147611928|NCT00307437|532393756|FG005|After Controlled Period|Lack of Efficacy|37|||
147611929|NCT00307437|532393757|FG006|After Controlled Period|Lack of Efficacy|24|||
147611930|NCT00307437|532393751|FG000|After Controlled Period|Lost to Follow-up|0|||
147611931|NCT00307437|532393752|FG001|After Controlled Period|Lost to Follow-up|0|||
147611932|NCT00307437|532393753|FG002|After Controlled Period|Lost to Follow-up|0|||
147611933|NCT00307437|532393754|FG003|After Controlled Period|Lost to Follow-up|7|||
147611934|NCT00307437|532393755|FG004|After Controlled Period|Lost to Follow-up|12|||
147611935|NCT00307437|532393756|FG005|After Controlled Period|Lost to Follow-up|13|||
147611936|NCT00307437|532393757|FG006|After Controlled Period|Lost to Follow-up|18|||
147611937|NCT00307437|532393751|FG000|After Controlled Period|Other|0|||
147611938|NCT00307437|532393752|FG001|After Controlled Period|Other|0|||
147611939|NCT00307437|532393753|FG002|After Controlled Period|Other|0|||
147611940|NCT00307437|532393754|FG003|After Controlled Period|Other|15|||
147611941|NCT00307437|532393755|FG004|After Controlled Period|Other|9|||
147611942|NCT00307437|532393756|FG005|After Controlled Period|Other|40|||
147611943|NCT00307437|532393757|FG006|After Controlled Period|Other|28|||
147376152|NCT01690624|531541032|FG000|Overall Study|PD based on IWG criteria or clinical PD|8|||
147376153|NCT01690624|531541033|FG001|Overall Study|PD based on IWG criteria or clinical PD|5|||
147376154|NCT01690624|531541034|FG002|Overall Study|PD based on IWG criteria or clinical PD|2|||
147376155|NCT01690624|531541035|FG003|Overall Study|PD based on IWG criteria or clinical PD|0|||
147376156|NCT01690624|531541032|FG000|Overall Study|Adverse event (other than DLT)|3|||
147376157|NCT01690624|531541033|FG001|Overall Study|Adverse event (other than DLT)|1|||
147376158|NCT01690624|531541034|FG002|Overall Study|Adverse event (other than DLT)|1|||
147376159|NCT01690624|531541035|FG003|Overall Study|Adverse event (other than DLT)|1|||
147376160|NCT01690624|531541032|FG000|Overall Study|Withdrawal by Subject|0|||
147376161|NCT01690624|531541033|FG001|Overall Study|Withdrawal by Subject|0|||
147376162|NCT01690624|531541034|FG002|Overall Study|Withdrawal by Subject|1|||
147376163|NCT01690624|531541035|FG003|Overall Study|Withdrawal by Subject|0|||
147376164|NCT01690624|531541032|FG000|Overall Study|Sponsor is ending trial|0|||
147376165|NCT01690624|531541033|FG001|Overall Study|Sponsor is ending trial|0|||
147376166|NCT01690624|531541034|FG002|Overall Study|Sponsor is ending trial|0|||
147376167|NCT01690624|531541035|FG003|Overall Study|Sponsor is ending trial|1|||
147376168|NCT01690624|531541032|FG000|Overall Study|Physician Decision|0|||
147376169|NCT01690624|531541033|FG001|Overall Study|Physician Decision|0|||
147376170|NCT01690624|531541034|FG002|Overall Study|Physician Decision|0|||
147611944|NCT00338728|532393763|FG000|Overall Study|Screen Failure|14|||
147611945|NCT02933255|532393768|FG000|Overall Study|Discontinued due to study closure.|1|||
147611946|NCT02933255|532393769|FG001|Overall Study|Discontinued due to study closure.|0|||
147611947|NCT04803305|532393770|FG000|Part A: 6-week Double-blind Treatment|Death|0|||
147611948|NCT04803305|532393771|FG001|Part A: 6-week Double-blind Treatment|Death|2|||
147611949|NCT04803305|532393770|FG000|Part A: 6-week Double-blind Treatment|Withdrawal by Subject|0|||
147611950|NCT04803305|532393771|FG001|Part A: 6-week Double-blind Treatment|Withdrawal by Subject|1|||
147611951|NCT04803305|532393770|FG000|Part A: 6-week Double-blind Treatment|Physician Decision|1|||
147611952|NCT04803305|532393771|FG001|Part A: 6-week Double-blind Treatment|Physician Decision|0|||
147611953|NCT04803305|532393770|FG000|Part B: OLT Period up to 18 Weeks|Other|0|||
147611954|NCT04803305|532393771|FG001|Part B: OLT Period up to 18 Weeks|Other|1|||
147611955|NCT04803305|532393770|FG000|Part B: OLT Period up to 18 Weeks|Withdrawal by Subject|1|||
147611956|NCT04803305|532393771|FG001|Part B: OLT Period up to 18 Weeks|Withdrawal by Subject|0|||
147611957|NCT04803305|532393770|FG000|Part B: OLT Period up to 18 Weeks|Physician Decision|0|||
147611958|NCT04803305|532393771|FG001|Part B: OLT Period up to 18 Weeks|Physician Decision|1|||
147611959|NCT04803305|532393770|FG000|Part B: OLT Period up to 18 Weeks|Death|1|||
147611960|NCT04803305|532393771|FG001|Part B: OLT Period up to 18 Weeks|Death|2|||
147611961|NCT04803305|532393770|FG000|Part B: OLT Period up to 18 Weeks|Adverse Event|1|||
147611962|NCT04803305|532393771|FG001|Part B: OLT Period up to 18 Weeks|Adverse Event|0|||
147611963|NCT01862484|532393773|FG000|Overall Study|Lack of Efficacy|1|||
147611964|NCT01862484|532393774|FG001|Overall Study|Lack of Efficacy|1|||
147611965|NCT01862484|532393773|FG000|Overall Study|Lost to Follow-up|1|||
147611966|NCT01862484|532393774|FG001|Overall Study|Lost to Follow-up|2|||
147611967|NCT01862484|532393773|FG000|Overall Study|Protocol Violation|0|||
147611968|NCT01862484|532393774|FG001|Overall Study|Protocol Violation|2|||
147611969|NCT01862484|532393773|FG000|Overall Study|Withdrawal by Subject|0|||
147611970|NCT01862484|532393774|FG001|Overall Study|Withdrawal by Subject|3|||
147611971|NCT00721227|532393775|FG000|Overall Study|Lost to Follow-up|3|||
147611972|NCT00721227|532393776|FG001|Overall Study|Lost to Follow-up|0|||
147611973|NCT00721227|532393775|FG000|Overall Study|Noncompliance with scheduled visits.|1|||
147611974|NCT00721227|532393776|FG001|Overall Study|Noncompliance with scheduled visits.|0|||
147611975|NCT03207867|532393777|FG000|Overall Study|Adverse Event|1|||
147611976|NCT03207867|532393778|FG001|Overall Study|Adverse Event|0|||
147611977|NCT03207867|532393779|FG002|Overall Study|Adverse Event|1|||
147611978|NCT03207867|532393780|FG003|Overall Study|Adverse Event|0|||
147611979|NCT03207867|532393781|FG004|Overall Study|Adverse Event|0|||
147611980|NCT03207867|532393782|FG005|Overall Study|Adverse Event|2|||
147611981|NCT03207867|532393783|FG006|Overall Study|Adverse Event|1|||
147611982|NCT03207867|532393784|FG007|Overall Study|Adverse Event|1|||
147611983|NCT03207867|532393785|FG008|Overall Study|Adverse Event|2|||
147611984|NCT03207867|532393786|FG009|Overall Study|Adverse Event|2|||
147611985|NCT03207867|532393787|FG010|Overall Study|Adverse Event|0|||
147611986|NCT03207867|532393788|FG011|Overall Study|Adverse Event|0|||
147611987|NCT03207867|532393789|FG012|Overall Study|Adverse Event|0|||
147611988|NCT03207867|532393790|FG013|Overall Study|Adverse Event|0|||
147611989|NCT03207867|532393791|FG014|Overall Study|Adverse Event|0|||
147611990|NCT03207867|532393792|FG015|Overall Study|Adverse Event|0|||
147611991|NCT03207867|532393793|FG016|Overall Study|Adverse Event|3|||
147611992|NCT03207867|532393794|FG017|Overall Study|Adverse Event|1|||
147611993|NCT03207867|532393795|FG018|Overall Study|Adverse Event|2|||
147611994|NCT03207867|532393796|FG019|Overall Study|Adverse Event|1|||
147611995|NCT03207867|532393797|FG020|Overall Study|Adverse Event|0|||
147611996|NCT03207867|532393798|FG021|Overall Study|Adverse Event|0|||
147611997|NCT03207867|532393799|FG022|Overall Study|Adverse Event|0|||
147611998|NCT03207867|532393800|FG023|Overall Study|Adverse Event|0|||
147611999|NCT03207867|532393777|FG000|Overall Study|Death|0|||
147612000|NCT03207867|532393778|FG001|Overall Study|Death|0|||
147612001|NCT03207867|532393779|FG002|Overall Study|Death|0|||
147612002|NCT03207867|532393780|FG003|Overall Study|Death|0|||
147612003|NCT03207867|532393781|FG004|Overall Study|Death|0|||
147612004|NCT03207867|532393782|FG005|Overall Study|Death|1|||
147612005|NCT03207867|532393783|FG006|Overall Study|Death|0|||
147612006|NCT03207867|532393784|FG007|Overall Study|Death|3|||
147612007|NCT03207867|532393785|FG008|Overall Study|Death|1|||
147612008|NCT03207867|532393786|FG009|Overall Study|Death|2|||
147376171|NCT01690624|531541035|FG003|Overall Study|Physician Decision|1|||
147376172|NCT01690624|531541032|FG000|Overall Study|Withdrawal by Subject|0|||
147376173|NCT01690624|531541033|FG001|Overall Study|Withdrawal by Subject|1|||
147376174|NCT01690624|531541034|FG002|Overall Study|Withdrawal by Subject|0|||
147376175|NCT01690624|531541035|FG003|Overall Study|Withdrawal by Subject|0|||
147376176|NCT01690624|531541032|FG000|Overall Study|Lack of Efficacy|1|||
147376177|NCT01690624|531541033|FG001|Overall Study|Lack of Efficacy|1|||
147376178|NCT01690624|531541034|FG002|Overall Study|Lack of Efficacy|3|||
147612009|NCT03207867|532393787|FG010|Overall Study|Death|0|||
147612010|NCT03207867|532393788|FG011|Overall Study|Death|1|||
147612011|NCT03207867|532393789|FG012|Overall Study|Death|0|||
147612012|NCT03207867|532393790|FG013|Overall Study|Death|1|||
147612013|NCT03207867|532393791|FG014|Overall Study|Death|0|||
147612014|NCT03207867|532393792|FG015|Overall Study|Death|0|||
147612015|NCT03207867|532393793|FG016|Overall Study|Death|0|||
147612016|NCT03207867|532393794|FG017|Overall Study|Death|2|||
147612017|NCT03207867|532393795|FG018|Overall Study|Death|0|||
147612018|NCT03207867|532393796|FG019|Overall Study|Death|1|||
147612019|NCT03207867|532393797|FG020|Overall Study|Death|0|||
147612020|NCT03207867|532393798|FG021|Overall Study|Death|0|||
147612021|NCT03207867|532393799|FG022|Overall Study|Death|0|||
147612022|NCT03207867|532393800|FG023|Overall Study|Death|0|||
147612023|NCT03207867|532393777|FG000|Overall Study|Physician Decision|3|||
147612024|NCT03207867|532393778|FG001|Overall Study|Physician Decision|5|||
147612025|NCT03207867|532393779|FG002|Overall Study|Physician Decision|0|||
147376179|NCT01690624|531541035|FG003|Overall Study|Lack of Efficacy|0|||
147376180|NCT04912856|531541039|FG000|Overall Study|Sponsor Decision; not due to safety reasons|4|||
147376181|NCT04912856|531541040|FG001|Overall Study|Sponsor Decision; not due to safety reasons|2|||
147376182|NCT04912856|531541039|FG000|Overall Study|Not reported in synoptic CSR.|0|||
147376183|NCT04912856|531541040|FG001|Overall Study|Not reported in synoptic CSR.|1|||
147376184|NCT00647387|531541041|FG000|Overall Study|Lost to Follow-up|6|||
147376185|NCT00647387|531541041|FG000|Overall Study|Unsuccessful implant|5|||
147376186|NCT00647387|531541041|FG000|Overall Study|Device explanted|3|||
147376187|NCT00647387|531541041|FG000|Overall Study|Other Reason|3|||
147376188|NCT00647387|531541041|FG000|Overall Study|Death|2|||
147376189|NCT03678688|531542651|FG000|Overall Study|Reason not Specified|0|||
147376190|NCT03678688|531542652|FG001|Overall Study|Reason not Specified|0|||
147376191|NCT03678688|531542653|FG002|Overall Study|Reason not Specified|3|||
147376192|NCT03678688|531542654|FG003|Overall Study|Reason not Specified|0|||
147376193|NCT03678688|531542655|FG004|Overall Study|Reason not Specified|1|||
147376194|NCT03678688|531542656|FG005|Overall Study|Reason not Specified|0|||
147376195|NCT03678688|531542657|FG006|Overall Study|Reason not Specified|0|||
147376196|NCT03678688|531542658|FG007|Overall Study|Reason not Specified|0|||
147376197|NCT03678688|531542659|FG008|Overall Study|Reason not Specified|0|||
147376198|NCT03678688|531542651|FG000|Overall Study|Non-Covid Related Adverse Event|0|||
147376199|NCT03678688|531542652|FG001|Overall Study|Non-Covid Related Adverse Event|0|||
147376200|NCT03678688|531542653|FG002|Overall Study|Non-Covid Related Adverse Event|0|||
147376201|NCT03678688|531542654|FG003|Overall Study|Non-Covid Related Adverse Event|1|||
147376202|NCT03678688|531542655|FG004|Overall Study|Non-Covid Related Adverse Event|0|||
147376203|NCT03678688|531542656|FG005|Overall Study|Non-Covid Related Adverse Event|0|||
147376204|NCT03678688|531542657|FG006|Overall Study|Non-Covid Related Adverse Event|2|||
147376205|NCT03678688|531542658|FG007|Overall Study|Non-Covid Related Adverse Event|1|||
147376206|NCT03678688|531542659|FG008|Overall Study|Non-Covid Related Adverse Event|0|||
147376207|NCT03678688|531542651|FG000|Overall Study|Covid Related Adverse Event|0|||
147376208|NCT03678688|531542652|FG001|Overall Study|Covid Related Adverse Event|0|||
147376209|NCT03678688|531542653|FG002|Overall Study|Covid Related Adverse Event|0|||
147376210|NCT03678688|531542654|FG003|Overall Study|Covid Related Adverse Event|0|||
147376211|NCT03678688|531542655|FG004|Overall Study|Covid Related Adverse Event|0|||
147376212|NCT03678688|531542656|FG005|Overall Study|Covid Related Adverse Event|3|||
147376213|NCT03678688|531542657|FG006|Overall Study|Covid Related Adverse Event|1|||
147376214|NCT03678688|531542658|FG007|Overall Study|Covid Related Adverse Event|1|||
147376215|NCT03678688|531542659|FG008|Overall Study|Covid Related Adverse Event|0|||
147376216|NCT03678688|531542651|FG000|Overall Study|Physician Decision|0|||
147376217|NCT03678688|531542652|FG001|Overall Study|Physician Decision|0|||
147376218|NCT03678688|531542653|FG002|Overall Study|Physician Decision|0|||
147376219|NCT03678688|531542654|FG003|Overall Study|Physician Decision|0|||
147376220|NCT03678688|531542655|FG004|Overall Study|Physician Decision|0|||
147376221|NCT03678688|531542656|FG005|Overall Study|Physician Decision|1|||
147376222|NCT03678688|531542657|FG006|Overall Study|Physician Decision|0|||
147376223|NCT03678688|531542658|FG007|Overall Study|Physician Decision|0|||
147376224|NCT03678688|531542659|FG008|Overall Study|Physician Decision|0|||
147376225|NCT03678688|531542651|FG000|Overall Study|Withdrawal by Subject|0|||
147376226|NCT03678688|531542652|FG001|Overall Study|Withdrawal by Subject|0|||
147376227|NCT03678688|531542653|FG002|Overall Study|Withdrawal by Subject|0|||
147376228|NCT03678688|531542654|FG003|Overall Study|Withdrawal by Subject|0|||
147376229|NCT03678688|531542655|FG004|Overall Study|Withdrawal by Subject|0|||
147376230|NCT03678688|531542656|FG005|Overall Study|Withdrawal by Subject|0|||
147376231|NCT03678688|531542657|FG006|Overall Study|Withdrawal by Subject|2|||
147376232|NCT03678688|531542658|FG007|Overall Study|Withdrawal by Subject|1|||
147376233|NCT03678688|531542659|FG008|Overall Study|Withdrawal by Subject|0|||
147376234|NCT01583166|531542662|FG000|Overall Study|Withdrawal by Subject|4|||
147376235|NCT01583166|531542663|FG001|Overall Study|Withdrawal by Subject|6|||
147376236|NCT02000752|531542666|FG000|Overall Study|Dystocic delivery|19|||
147376237|NCT02000752|531542667|FG001|Overall Study|Dystocic delivery|8|||
147376238|NCT02000752|531542666|FG000|Overall Study|Shift Changes|12|||
147376239|NCT02000752|531542667|FG001|Overall Study|Shift Changes|5|||
147376240|NCT00047385|531542673|FG000|Overall Study|Death before any screening|2|||
147376241|NCT00047385|531542674|FG001|Overall Study|Death before any screening|5|||
147376242|NCT00047385|531542673|FG000|Overall Study|Lung Cancer diagnosed before screening|5|||
147376243|NCT00047385|531542674|FG001|Overall Study|Lung Cancer diagnosed before screening|3|||
147376244|NCT00047385|531542673|FG000|Overall Study|Eligible for screening but had no screen|260|||
147376245|NCT00047385|531542674|FG001|Overall Study|Eligible for screening but had no screen|492|||
147376246|NCT03392194|531542675|FG000|Overall Study|Withdrawal by Subject|1|||
147376247|NCT03392194|531542676|FG001|Overall Study|Withdrawal by Subject|2|||
147376248|NCT03392194|531542675|FG000|Overall Study|Conflicts with personal schedule|1|||
147376249|NCT03392194|531542676|FG001|Overall Study|Conflicts with personal schedule|0|||
147376250|NCT03865732|531542677|FG000|Overall Study|Adverse Event|0|||
147376251|NCT03865732|531542678|FG001|Overall Study|Adverse Event|1|||
147376252|NCT01009645|531542682|FG000|Overall Study|Lost to Follow-up|2|||
147376253|NCT01009645|531542683|FG001|Overall Study|Lost to Follow-up|8|||
147376254|NCT01009645|531542684|FG002|Overall Study|Lost to Follow-up|4|||
147376255|NCT01009645|531542685|FG003|Overall Study|Lost to Follow-up|5|||
147376256|NCT00620854|531542686|FG000|Washout 1|Withdrawal by Subject|0|||
147376257|NCT00620854|531542687|FG001|Washout 1|Withdrawal by Subject|0|||
147376258|NCT00620854|531542688|FG002|Washout 1|Withdrawal by Subject|1|||
147612026|NCT03207867|532393780|FG003|Overall Study|Physician Decision|3|||
147612027|NCT03207867|532393781|FG004|Overall Study|Physician Decision|2|||
147612028|NCT03207867|532393782|FG005|Overall Study|Physician Decision|0|||
147612029|NCT03207867|532393783|FG006|Overall Study|Physician Decision|0|||
147612030|NCT03207867|532393784|FG007|Overall Study|Physician Decision|0|||
147612031|NCT03207867|532393785|FG008|Overall Study|Physician Decision|4|||
147612032|NCT03207867|532393786|FG009|Overall Study|Physician Decision|2|||
147612033|NCT03207867|532393787|FG010|Overall Study|Physician Decision|0|||
147612034|NCT03207867|532393788|FG011|Overall Study|Physician Decision|4|||
147612035|NCT03207867|532393789|FG012|Overall Study|Physician Decision|0|||
147612036|NCT03207867|532393790|FG013|Overall Study|Physician Decision|0|||
147612037|NCT03207867|532393791|FG014|Overall Study|Physician Decision|2|||
147612038|NCT03207867|532393792|FG015|Overall Study|Physician Decision|1|||
147612039|NCT03207867|532393793|FG016|Overall Study|Physician Decision|1|||
147612040|NCT03207867|532393794|FG017|Overall Study|Physician Decision|2|||
147612041|NCT03207867|532393795|FG018|Overall Study|Physician Decision|1|||
147612042|NCT03207867|532393796|FG019|Overall Study|Physician Decision|3|||
147612043|NCT03207867|532393797|FG020|Overall Study|Physician Decision|0|||
147612044|NCT03207867|532393798|FG021|Overall Study|Physician Decision|0|||
147612045|NCT03207867|532393799|FG022|Overall Study|Physician Decision|0|||
147612046|NCT03207867|532393800|FG023|Overall Study|Physician Decision|0|||
147612047|NCT03207867|532393777|FG000|Overall Study|Progressive Disease|7|||
147612048|NCT03207867|532393778|FG001|Overall Study|Progressive Disease|7|||
147612049|NCT03207867|532393779|FG002|Overall Study|Progressive Disease|9|||
147612050|NCT03207867|532393780|FG003|Overall Study|Progressive Disease|10|||
147612051|NCT03207867|532393781|FG004|Overall Study|Progressive Disease|11|||
147612052|NCT03207867|532393782|FG005|Overall Study|Progressive Disease|10|||
147612053|NCT03207867|532393783|FG006|Overall Study|Progressive Disease|9|||
147612054|NCT03207867|532393784|FG007|Overall Study|Progressive Disease|8|||
147612055|NCT03207867|532393785|FG008|Overall Study|Progressive Disease|19|||
147612056|NCT03207867|532393786|FG009|Overall Study|Progressive Disease|23|||
147612057|NCT03207867|532393787|FG010|Overall Study|Progressive Disease|2|||
147612058|NCT03207867|532393788|FG011|Overall Study|Progressive Disease|24|||
147612059|NCT03207867|532393789|FG012|Overall Study|Progressive Disease|3|||
147612060|NCT03207867|532393790|FG013|Overall Study|Progressive Disease|11|||
147612061|NCT03207867|532393791|FG014|Overall Study|Progressive Disease|9|||
147612062|NCT03207867|532393792|FG015|Overall Study|Progressive Disease|5|||
147612063|NCT03207867|532393793|FG016|Overall Study|Progressive Disease|10|||
147612064|NCT03207867|532393794|FG017|Overall Study|Progressive Disease|14|||
147612065|NCT03207867|532393795|FG018|Overall Study|Progressive Disease|13|||
147612066|NCT03207867|532393796|FG019|Overall Study|Progressive Disease|14|||
147612067|NCT03207867|532393797|FG020|Overall Study|Progressive Disease|6|||
147612068|NCT03207867|532393798|FG021|Overall Study|Progressive Disease|3|||
147612069|NCT03207867|532393799|FG022|Overall Study|Progressive Disease|3|||
147612070|NCT03207867|532393800|FG023|Overall Study|Progressive Disease|3|||
147612071|NCT03207867|532393777|FG000|Overall Study|Patient/guardian Decision|0|||
147612072|NCT03207867|532393778|FG001|Overall Study|Patient/guardian Decision|0|||
147612073|NCT03207867|532393779|FG002|Overall Study|Patient/guardian Decision|1|||
147612074|NCT03207867|532393780|FG003|Overall Study|Patient/guardian Decision|1|||
147612075|NCT03207867|532393781|FG004|Overall Study|Patient/guardian Decision|1|||
147612076|NCT03207867|532393782|FG005|Overall Study|Patient/guardian Decision|2|||
147612077|NCT03207867|532393783|FG006|Overall Study|Patient/guardian Decision|1|||
147612078|NCT03207867|532393784|FG007|Overall Study|Patient/guardian Decision|0|||
147612079|NCT03207867|532393785|FG008|Overall Study|Patient/guardian Decision|1|||
147612080|NCT03207867|532393786|FG009|Overall Study|Patient/guardian Decision|0|||
147612081|NCT03207867|532393787|FG010|Overall Study|Patient/guardian Decision|0|||
147612082|NCT03207867|532393788|FG011|Overall Study|Patient/guardian Decision|1|||
147612083|NCT03207867|532393789|FG012|Overall Study|Patient/guardian Decision|0|||
147612084|NCT03207867|532393790|FG013|Overall Study|Patient/guardian Decision|1|||
147612085|NCT03207867|532393791|FG014|Overall Study|Patient/guardian Decision|2|||
147612086|NCT03207867|532393792|FG015|Overall Study|Patient/guardian Decision|0|||
147612087|NCT03207867|532393793|FG016|Overall Study|Patient/guardian Decision|1|||
147612088|NCT03207867|532393794|FG017|Overall Study|Patient/guardian Decision|3|||
147612089|NCT03207867|532393795|FG018|Overall Study|Patient/guardian Decision|4|||
147612090|NCT03207867|532393796|FG019|Overall Study|Patient/guardian Decision|1|||
147612091|NCT03207867|532393797|FG020|Overall Study|Patient/guardian Decision|0|||
147612092|NCT03207867|532393798|FG021|Overall Study|Patient/guardian Decision|0|||
147612093|NCT03207867|532393799|FG022|Overall Study|Patient/guardian Decision|0|||
147612094|NCT03207867|532393800|FG023|Overall Study|Patient/guardian Decision|0|||
147612095|NCT05292183|532395386|FG000|Overall Study|Adverse Event|1|||
147612096|NCT03922529|532395391|FG000|Overall Study|Withdrawal by Subject|13|||
147612097|NCT03922529|532395392|FG001|Overall Study|Withdrawal by Subject|12|||
147612098|NCT03922529|532395391|FG000|Overall Study|Death|7|||
147612099|NCT03922529|532395392|FG001|Overall Study|Death|12|||
147612100|NCT03922529|532395391|FG000|Overall Study|Lost to Follow-up|12|||
147612101|NCT03922529|532395392|FG001|Overall Study|Lost to Follow-up|19|||
147612102|NCT03922529|532395391|FG000|Overall Study|Adverse Event|1|||
147612103|NCT03922529|532395392|FG001|Overall Study|Adverse Event|0|||
147612104|NCT03922529|532395391|FG000|Overall Study|Death after withdrawal|1|||
147612105|NCT03922529|532395392|FG001|Overall Study|Death after withdrawal|0|||
147612106|NCT03922529|532395391|FG000|Overall Study|Participant was contacted for final visit and declined to complete|1|||
147612107|NCT03922529|532395392|FG001|Overall Study|Participant was contacted for final visit and declined to complete|0|||
147612108|NCT03922529|532395391|FG000|Overall Study|Moved to assisted living and was unreachable for follow-up assessments|1|||
147612109|NCT03922529|532395392|FG001|Overall Study|Moved to assisted living and was unreachable for follow-up assessments|0|||
147612110|NCT01277601|532395393|FG000|Overall Study|Adverse Event|5|||
147612111|NCT01277601|532395394|FG001|Overall Study|Adverse Event|3|||
147612112|NCT01277601|532395395|FG002|Overall Study|Adverse Event|0|||
147612113|NCT01277601|532395396|FG003|Overall Study|Adverse Event|7|||
147612114|NCT01277601|532395393|FG000|Overall Study|Withdrawal by Subject|18|||
147612115|NCT01277601|532395394|FG001|Overall Study|Withdrawal by Subject|21|||
147612116|NCT01277601|532395395|FG002|Overall Study|Withdrawal by Subject|8|||
147612117|NCT01277601|532395396|FG003|Overall Study|Withdrawal by Subject|17|||
147612118|NCT01277601|532395393|FG000|Overall Study|Lost to Follow-up|7|||
147612119|NCT01277601|532395394|FG001|Overall Study|Lost to Follow-up|9|||
147376259|NCT00620854|531542689|FG003|Washout 1|Withdrawal by Subject|1|||
147376260|NCT00620854|531542690|FG004|Washout 1|Withdrawal by Subject|0|||
147376261|NCT00620854|531542691|FG005|Washout 1|Withdrawal by Subject|0|||
147376262|NCT03345979|531542692|FG000|Overall Study|Withdrawal by Subject|20|||
147376263|NCT03345979|531542693|FG001|Overall Study|Withdrawal by Subject|31|||
147376264|NCT03345979|531542692|FG000|Overall Study|Adverse Event|10|||
147376265|NCT03345979|531542693|FG001|Overall Study|Adverse Event|11|||
147376266|NCT03345979|531542692|FG000|Overall Study|Lost to Follow-up|8|||
147376267|NCT03345979|531542693|FG001|Overall Study|Lost to Follow-up|9|||
147376268|NCT03345979|531542692|FG000|Overall Study|Lack of Efficacy|4|||
147376269|NCT03345979|531542693|FG001|Overall Study|Lack of Efficacy|2|||
147376270|NCT03345979|531542692|FG000|Overall Study|Protocol Violation|1|||
147376271|NCT03345979|531542693|FG001|Overall Study|Protocol Violation|3|||
147376272|NCT03345979|531542692|FG000|Overall Study|Physician Decision|0|||
147376273|NCT03345979|531542693|FG001|Overall Study|Physician Decision|2|||
147376274|NCT00734578|531542695|FG000|Overall Study|Adverse Event|4|||
147376275|NCT00734578|531542696|FG001|Overall Study|Adverse Event|6|||
147376276|NCT00734578|531542697|FG002|Overall Study|Adverse Event|1|||
147376277|NCT00734578|531542695|FG000|Overall Study|Protocol Violation|8|||
147376278|NCT00734578|531542696|FG001|Overall Study|Protocol Violation|6|||
147376279|NCT00734578|531542697|FG002|Overall Study|Protocol Violation|3|||
147376280|NCT00734578|531542695|FG000|Overall Study|Withdrawal by Subject|7|||
147376281|NCT00734578|531542696|FG001|Overall Study|Withdrawal by Subject|8|||
147376282|NCT00734578|531542697|FG002|Overall Study|Withdrawal by Subject|11|||
147376283|NCT00734578|531542695|FG000|Overall Study|Lost to Follow-up|9|||
147376284|NCT00734578|531542696|FG001|Overall Study|Lost to Follow-up|3|||
147376285|NCT00734578|531542697|FG002|Overall Study|Lost to Follow-up|5|||
147376286|NCT00734578|531542695|FG000|Overall Study|Lack of Efficacy|3|||
147376287|NCT00734578|531542696|FG001|Overall Study|Lack of Efficacy|2|||
147376288|NCT00734578|531542697|FG002|Overall Study|Lack of Efficacy|5|||
147376289|NCT00734578|531542695|FG000|Overall Study|Randomized in error|1|||
147376290|NCT00734578|531542696|FG001|Overall Study|Randomized in error|0|||
147376291|NCT00734578|531542697|FG002|Overall Study|Randomized in error|0|||
147376292|NCT00734578|531542695|FG000|Overall Study|Exclusion criteria|1|||
147376293|NCT00734578|531542696|FG001|Overall Study|Exclusion criteria|0|||
147376294|NCT00734578|531542697|FG002|Overall Study|Exclusion criteria|0|||
147376295|NCT00999596|531542698|FG000|Overall Study|Statistical population not required|101|||
147376296|NCT02095145|531542699|FG000|Overall Study|Withdrawal by Subject|1|||
147376297|NCT02095145|531542700|FG001|Overall Study|Withdrawal by Subject|0|||
147376298|NCT02085941|531542701|FG000|Overall Study|Lack of Efficacy|1|||
147376299|NCT02085941|531542702|FG001|Overall Study|Lack of Efficacy|0|||
147376300|NCT02085941|531542701|FG000|Overall Study|Death|6|||
147376301|NCT02085941|531542702|FG001|Overall Study|Death|1|||
147376302|NCT02085941|531542701|FG000|Overall Study|Lost to Follow-up|1|||
147376303|NCT02085941|531542702|FG001|Overall Study|Lost to Follow-up|0|||
147376304|NCT02085941|531542701|FG000|Overall Study|Physician Decision|0|||
147376305|NCT02085941|531542702|FG001|Overall Study|Physician Decision|2|||
147376306|NCT01079806|531542708|FG000|Day 1 to Week 96|Adverse Event|0|||
147376307|NCT01079806|531542709|FG001|Day 1 to Week 96|Adverse Event|3|||
147376308|NCT01079806|531542708|FG000|Day 1 to Week 96|Withdrawal by Subject|3|||
147376309|NCT01079806|531542709|FG001|Day 1 to Week 96|Withdrawal by Subject|2|||
147376310|NCT01079806|531542708|FG000|Day 1 to Week 96|Pregnancy|0|||
147612120|NCT01277601|532395395|FG002|Overall Study|Lost to Follow-up|4|||
147612121|NCT01277601|532395396|FG003|Overall Study|Lost to Follow-up|2|||
147612122|NCT01277601|532395393|FG000|Overall Study|Physician Decision|3|||
147612123|NCT01277601|532395394|FG001|Overall Study|Physician Decision|5|||
147612124|NCT01277601|532395395|FG002|Overall Study|Physician Decision|1|||
147612125|NCT01277601|532395396|FG003|Overall Study|Physician Decision|6|||
147376311|NCT01079806|531542709|FG001|Day 1 to Week 96|Pregnancy|1|||
147376312|NCT01079806|531542708|FG000|Day 1 to Week 96|Poor compliance or noncompliance|2|||
147376313|NCT01079806|531542709|FG001|Day 1 to Week 96|Poor compliance or noncompliance|0|||
147376314|NCT01079806|531542708|FG000|Day 1 to Week 96|Lost to Follow-up|1|||
147376315|NCT01079806|531542709|FG001|Day 1 to Week 96|Lost to Follow-up|0|||
147376316|NCT01079806|531542708|FG000|Day 1 to Week 96|Subject request to stop study treatment|1|||
147376317|NCT01079806|531542709|FG001|Day 1 to Week 96|Subject request to stop study treatment|0|||
147376318|NCT01079806|531542708|FG000|Day 1 to Week 96|Removal by Medical Monitor|0|||
147376319|NCT01079806|531542709|FG001|Day 1 to Week 96|Removal by Medical Monitor|1|||
147376320|NCT01079806|531542708|FG000|Long-term Follow-up: Day 1-End of Study|Withdrawal by Subject|13|||
147376321|NCT01079806|531542709|FG001|Long-term Follow-up: Day 1-End of Study|Withdrawal by Subject|8|||
147376322|NCT01079806|531542708|FG000|Long-term Follow-up: Day 1-End of Study|Investigator Left Institution|0|||
147376323|NCT01079806|531542709|FG001|Long-term Follow-up: Day 1-End of Study|Investigator Left Institution|1|||
147376324|NCT01079806|531542708|FG000|Long-term Follow-up: Day 1-End of Study|Lost to Follow-up|6|||
147376325|NCT01079806|531542709|FG001|Long-term Follow-up: Day 1-End of Study|Lost to Follow-up|6|||
147376326|NCT02788981|531542712|FG000|Overall Study|Patient chose to pursue alternative treatment|0|||
147376327|NCT02788981|531542713|FG001|Overall Study|Patient chose to pursue alternative treatment|1|||
147376328|NCT00249769|531542714|FG000|Overall Study|Withdrawal by Subject|1|||
147376329|NCT00249769|531542715|FG001|Overall Study|Withdrawal by Subject|10|||
147376330|NCT00249769|531542716|FG002|Overall Study|Withdrawal by Subject|6|||
147376331|NCT00249769|531542714|FG000|Overall Study|Migration from Study Area|1|||
147376332|NCT00249769|531542715|FG001|Overall Study|Migration from Study Area|3|||
147376333|NCT00249769|531542716|FG002|Overall Study|Migration from Study Area|14|||
147376334|NCT00249769|531542714|FG000|Overall Study|Miscellaneous|0|||
147376335|NCT00249769|531542715|FG001|Overall Study|Miscellaneous|2|||
147376336|NCT00249769|531542716|FG002|Overall Study|Miscellaneous|2|||
147376337|NCT00249769|531542714|FG000|Overall Study|Adverse Event|0|||
147376338|NCT00249769|531542715|FG001|Overall Study|Adverse Event|0|||
147376339|NCT00249769|531542716|FG002|Overall Study|Adverse Event|1|||
147376340|NCT00249769|531542714|FG000|Overall Study|Physician Decision|0|||
147376341|NCT00249769|531542715|FG001|Overall Study|Physician Decision|0|||
147376342|NCT00249769|531542716|FG002|Overall Study|Physician Decision|2|||
147376343|NCT00249769|531542714|FG000|Overall Study|Lost to Follow-up|0|||
147376344|NCT00249769|531542715|FG001|Overall Study|Lost to Follow-up|0|||
147376345|NCT00249769|531542716|FG002|Overall Study|Lost to Follow-up|3|||
147376346|NCT02022657|531542717|FG000|Overall Study|Withdrawal by Subject|2|||
147376347|NCT02022657|531542718|FG001|Overall Study|Withdrawal by Subject|0|||
147376348|NCT02022657|531542719|FG002|Overall Study|Withdrawal by Subject|1|||
147376349|NCT02022657|531542720|FG003|Overall Study|Withdrawal by Subject|0|||
147376350|NCT02022657|531542721|FG004|Overall Study|Withdrawal by Subject|0|||
147376351|NCT02022657|531542722|FG005|Overall Study|Withdrawal by Subject|0|||
147376352|NCT02022657|531542717|FG000|Overall Study|Physician Decision|0|||
147376353|NCT02022657|531542718|FG001|Overall Study|Physician Decision|0|||
147376354|NCT02022657|531542719|FG002|Overall Study|Physician Decision|0|||
147376355|NCT02022657|531542720|FG003|Overall Study|Physician Decision|0|||
147376356|NCT02022657|531542721|FG004|Overall Study|Physician Decision|0|||
147376357|NCT02022657|531542722|FG005|Overall Study|Physician Decision|1|||
147376358|NCT03739866|531542729|FG000|Overall Study|Lost to Follow-up|0|||
147376359|NCT03739866|531542730|FG001|Overall Study|Lost to Follow-up|0|||
147376360|NCT03739866|531542731|FG002|Overall Study|Lost to Follow-up|0|||
147376361|NCT03739866|531542732|FG003|Overall Study|Lost to Follow-up|1|||
147376362|NCT03739866|531542733|FG004|Overall Study|Lost to Follow-up|0|||
147376363|NCT03739866|531542734|FG005|Overall Study|Lost to Follow-up|0|||
147376364|NCT03739866|531542735|FG006|Overall Study|Lost to Follow-up|0|||
147376365|NCT03739866|531542736|FG007|Overall Study|Lost to Follow-up|0|||
147376366|NCT03739866|531542729|FG000|Overall Study|Enrolled but not treated|0|||
147376367|NCT03739866|531542730|FG001|Overall Study|Enrolled but not treated|0|||
147376368|NCT03739866|531542731|FG002|Overall Study|Enrolled but not treated|1|||
147376369|NCT03739866|531542732|FG003|Overall Study|Enrolled but not treated|0|||
147376370|NCT03739866|531542733|FG004|Overall Study|Enrolled but not treated|1|||
147376371|NCT03739866|531542734|FG005|Overall Study|Enrolled but not treated|0|||
147376372|NCT03739866|531542735|FG006|Overall Study|Enrolled but not treated|0|||
147612126|NCT01277601|532395393|FG000|Overall Study|Pregnancy|2|||
147612127|NCT01277601|532395394|FG001|Overall Study|Pregnancy|2|||
147612128|NCT01277601|532395395|FG002|Overall Study|Pregnancy|4|||
147376373|NCT03739866|531542736|FG007|Overall Study|Enrolled but not treated|0|||
147376374|NCT03057600|531542737|FG000|Overall Study|Adverse Event|0|||
147376375|NCT03057600|531542738|FG001|Overall Study|Adverse Event|0|||
147376376|NCT03057600|531542739|FG002|Overall Study|Adverse Event|4|||
147376377|NCT03057600|531542740|FG003|Overall Study|Adverse Event|0|||
147376378|NCT03057600|531542737|FG000|Overall Study|Radiologic Disease Progression|8|||
147376379|NCT03057600|531542738|FG001|Overall Study|Radiologic Disease Progression|7|||
147376380|NCT03057600|531542739|FG002|Overall Study|Radiologic Disease Progression|13|||
147376381|NCT03057600|531542740|FG003|Overall Study|Radiologic Disease Progression|10|||
147612129|NCT01277601|532395396|FG003|Overall Study|Pregnancy|1|||
147376382|NCT03057600|531542737|FG000|Overall Study|Symptomatic Deterioration|0|||
147376383|NCT03057600|531542738|FG001|Overall Study|Symptomatic Deterioration|1|||
147376384|NCT03057600|531542739|FG002|Overall Study|Symptomatic Deterioration|1|||
147376385|NCT03057600|531542740|FG003|Overall Study|Symptomatic Deterioration|0|||
147376386|NCT03057600|531542737|FG000|Overall Study|Investigator Decision|0|||
147376387|NCT03057600|531542738|FG001|Overall Study|Investigator Decision|0|||
147376388|NCT03057600|531542739|FG002|Overall Study|Investigator Decision|1|||
147376389|NCT03057600|531542740|FG003|Overall Study|Investigator Decision|0|||
147376390|NCT03057600|531542737|FG000|Overall Study|Study Termination by Sponsor|0|||
147376391|NCT03057600|531542738|FG001|Overall Study|Study Termination by Sponsor|0|||
147376392|NCT03057600|531542739|FG002|Overall Study|Study Termination by Sponsor|0|||
147376393|NCT03057600|531542740|FG003|Overall Study|Study Termination by Sponsor|2|||
147376394|NCT03057600|531542737|FG000|Overall Study|Withdrawal by Subject|0|||
147376395|NCT03057600|531542738|FG001|Overall Study|Withdrawal by Subject|1|||
147376396|NCT03057600|531542739|FG002|Overall Study|Withdrawal by Subject|0|||
147376397|NCT03057600|531542740|FG003|Overall Study|Withdrawal by Subject|0|||
147376398|NCT03057600|531542737|FG000|Overall Study|Other, Not Specified|1|||
147376399|NCT03057600|531542738|FG001|Overall Study|Other, Not Specified|1|||
147376400|NCT03057600|531542739|FG002|Overall Study|Other, Not Specified|1|||
147376401|NCT03057600|531542740|FG003|Overall Study|Other, Not Specified|1|||
147376402|NCT02203799|531542741|FG000|Overall Study|Withdrawal by Subject|3|||
147376403|NCT01953692|531542744|FG000|Overall Study|Adverse Event|5|||
147376404|NCT01953692|531542745|FG001|Overall Study|Adverse Event|2|||
147376405|NCT01953692|531542746|FG002|Overall Study|Adverse Event|4|||
147376406|NCT01953692|531542747|FG003|Overall Study|Adverse Event|2|||
147376407|NCT01953692|531542748|FG004|Overall Study|Adverse Event|1|||
147376408|NCT01953692|531542749|FG005|Overall Study|Adverse Event|2|||
147376409|NCT01953692|531542750|FG006|Overall Study|Adverse Event|0|||
147376410|NCT01953692|531542751|FG007|Overall Study|Adverse Event|0|||
147376411|NCT01953692|531542752|FG008|Overall Study|Adverse Event|0|||
147376412|NCT01953692|531542744|FG000|Overall Study|Clinical Progression|0|||
147376413|NCT01953692|531542745|FG001|Overall Study|Clinical Progression|15|||
147376414|NCT01953692|531542746|FG002|Overall Study|Clinical Progression|7|||
147376415|NCT01953692|531542747|FG003|Overall Study|Clinical Progression|5|||
147376416|NCT01953692|531542748|FG004|Overall Study|Clinical Progression|0|||
147376417|NCT01953692|531542749|FG005|Overall Study|Clinical Progression|7|||
147376418|NCT01953692|531542750|FG006|Overall Study|Clinical Progression|20|||
147376419|NCT01953692|531542751|FG007|Overall Study|Clinical Progression|3|||
147376420|NCT01953692|531542752|FG008|Overall Study|Clinical Progression|3|||
147376421|NCT01953692|531542744|FG000|Overall Study|Death|5|||
147376422|NCT01953692|531542745|FG001|Overall Study|Death|0|||
147376423|NCT01953692|531542746|FG002|Overall Study|Death|2|||
147376424|NCT01953692|531542747|FG003|Overall Study|Death|2|||
147376425|NCT01953692|531542748|FG004|Overall Study|Death|1|||
147376426|NCT01953692|531542749|FG005|Overall Study|Death|3|||
147376427|NCT01953692|531542750|FG006|Overall Study|Death|6|||
147376428|NCT01953692|531542751|FG007|Overall Study|Death|2|||
147376429|NCT01953692|531542752|FG008|Overall Study|Death|1|||
147376430|NCT01953692|531542744|FG000|Overall Study|Excluded Medication|1|||
147376431|NCT01953692|531542745|FG001|Overall Study|Excluded Medication|0|||
147376432|NCT01953692|531542746|FG002|Overall Study|Excluded Medication|0|||
147376433|NCT01953692|531542747|FG003|Overall Study|Excluded Medication|0|||
147376434|NCT01953692|531542748|FG004|Overall Study|Excluded Medication|0|||
147376435|NCT01953692|531542749|FG005|Overall Study|Excluded Medication|0|||
147376436|NCT01953692|531542750|FG006|Overall Study|Excluded Medication|0|||
147376437|NCT01953692|531542751|FG007|Overall Study|Excluded Medication|0|||
147376438|NCT01953692|531542752|FG008|Overall Study|Excluded Medication|0|||
147376439|NCT01953692|531542744|FG000|Overall Study|Lost to Follow-up|1|||
147376440|NCT01953692|531542745|FG001|Overall Study|Lost to Follow-up|0|||
147376441|NCT01953692|531542746|FG002|Overall Study|Lost to Follow-up|3|||
147376442|NCT01953692|531542747|FG003|Overall Study|Lost to Follow-up|1|||
147376443|NCT01953692|531542748|FG004|Overall Study|Lost to Follow-up|0|||
147376444|NCT01953692|531542749|FG005|Overall Study|Lost to Follow-up|1|||
147376445|NCT01953692|531542750|FG006|Overall Study|Lost to Follow-up|0|||
147376446|NCT01953692|531542751|FG007|Overall Study|Lost to Follow-up|0|||
147376447|NCT01953692|531542752|FG008|Overall Study|Lost to Follow-up|0|||
147376448|NCT01953692|531542744|FG000|Overall Study|Physician Decision|11|||
147376449|NCT01953692|531542745|FG001|Overall Study|Physician Decision|4|||
147376450|NCT01953692|531542746|FG002|Overall Study|Physician Decision|2|||
147376451|NCT01953692|531542747|FG003|Overall Study|Physician Decision|2|||
147376452|NCT01953692|531542748|FG004|Overall Study|Physician Decision|1|||
147376453|NCT01953692|531542749|FG005|Overall Study|Physician Decision|2|||
147376454|NCT01953692|531542750|FG006|Overall Study|Physician Decision|4|||
147376455|NCT01953692|531542751|FG007|Overall Study|Physician Decision|1|||
147376456|NCT01953692|531542752|FG008|Overall Study|Physician Decision|0|||
147376457|NCT01953692|531542744|FG000|Overall Study|Protocol Violation|0|||
147376458|NCT01953692|531542745|FG001|Overall Study|Protocol Violation|2|||
147376459|NCT01953692|531542746|FG002|Overall Study|Protocol Violation|1|||
147376460|NCT01953692|531542747|FG003|Overall Study|Protocol Violation|0|||
147612130|NCT01277601|532395393|FG000|Overall Study|Noncompliance with Study Drug|1|||
147612131|NCT01277601|532395394|FG001|Overall Study|Noncompliance with Study Drug|3|||
147612132|NCT01277601|532395395|FG002|Overall Study|Noncompliance with Study Drug|2|||
147612133|NCT01277601|532395396|FG003|Overall Study|Noncompliance with Study Drug|0|||
147612134|NCT01277601|532395393|FG000|Overall Study|Subject Never Dosed with Study Drug|1|||
147612135|NCT01277601|532395394|FG001|Overall Study|Subject Never Dosed with Study Drug|2|||
147612136|NCT01277601|532395395|FG002|Overall Study|Subject Never Dosed with Study Drug|3|||
147612137|NCT01277601|532395396|FG003|Overall Study|Subject Never Dosed with Study Drug|1|||
147612138|NCT01277601|532395393|FG000|Overall Study|Protocol Violation|0|||
147612139|NCT01277601|532395394|FG001|Overall Study|Protocol Violation|2|||
147612140|NCT01277601|532395395|FG002|Overall Study|Protocol Violation|5|||
147612141|NCT01277601|532395396|FG003|Overall Study|Protocol Violation|0|||
147612142|NCT01277601|532395393|FG000|Overall Study|Subject Terminated from Study by Sponsor|0|||
147612143|NCT01277601|532395394|FG001|Overall Study|Subject Terminated from Study by Sponsor|1|||
147612144|NCT01277601|532395395|FG002|Overall Study|Subject Terminated from Study by Sponsor|0|||
147612145|NCT01277601|532395396|FG003|Overall Study|Subject Terminated from Study by Sponsor|2|||
147612146|NCT05929651|532395400|FG000|Overall Study|Protocol Deviation|1|||
147612147|NCT05929651|532395400|FG000|Overall Study|Withdrawal by participant's parents/legally acceptable representatives|2|||
147612148|NCT02731638|532395401|FG000|Overall Study|Lost to Follow-up|6|||
147612149|NCT02731638|532395402|FG001|Overall Study|Lost to Follow-up|9|||
147612150|NCT04158245|532395403|FG000|Overall Study|Lost to Follow-up|1|||
147612151|NCT02454608|532395404|FG000|Double-Blind Period|Lack of Efficacy|0|||
147612152|NCT02454608|532395405|FG001|Double-Blind Period|Lack of Efficacy|2|||
147612153|NCT02454608|532395406|FG002|Double-Blind Period|Lack of Efficacy|0|||
147612154|NCT02454608|532395404|FG000|Open Label Period|Lost to Follow-up|0|||
147612155|NCT02454608|532395405|FG001|Open Label Period|Lost to Follow-up|0|||
147612156|NCT02454608|532395406|FG002|Open Label Period|Lost to Follow-up|11|||
147612157|NCT02454608|532395404|FG000|Open Label Period|Withdrawal by Subject|0|||
147612158|NCT02454608|532395405|FG001|Open Label Period|Withdrawal by Subject|0|||
147612159|NCT02454608|532395406|FG002|Open Label Period|Withdrawal by Subject|8|||
147612160|NCT01433055|532395411|FG000|Overall Study|Diagnosed with cancer unrelated to study|1|||
147612161|NCT01433055|532395412|FG001|Overall Study|Diagnosed with cancer unrelated to study|0|||
147612162|NCT01433055|532395411|FG000|Overall Study|Severely elevated triglycerides at entry|1|||
147612163|NCT01433055|532395412|FG001|Overall Study|Severely elevated triglycerides at entry|0|||
147612164|NCT00678210|532395418|FG000|Overall Study|Adverse Event|1|||
147612165|NCT00678210|532395419|FG001|Overall Study|Adverse Event|2|||
147612166|NCT00678210|532395420|FG002|Overall Study|Adverse Event|3|||
147612167|NCT00678210|532395421|FG003|Overall Study|Adverse Event|3|||
147612168|NCT00678210|532395418|FG000|Overall Study|Lack of Efficacy|2|||
147612169|NCT00678210|532395419|FG001|Overall Study|Lack of Efficacy|3|||
147612170|NCT00678210|532395420|FG002|Overall Study|Lack of Efficacy|1|||
147612171|NCT00678210|532395421|FG003|Overall Study|Lack of Efficacy|9|||
147612172|NCT00678210|532395418|FG000|Overall Study|Lost to Follow-up|4|||
147612173|NCT00678210|532395419|FG001|Overall Study|Lost to Follow-up|2|||
147612174|NCT00678210|532395420|FG002|Overall Study|Lost to Follow-up|0|||
147612175|NCT00678210|532395421|FG003|Overall Study|Lost to Follow-up|1|||
147612176|NCT00678210|532395418|FG000|Overall Study|Withdrawal by Subject|3|||
147376461|NCT01953692|531542748|FG004|Overall Study|Protocol Violation|0|||
147376462|NCT01953692|531542749|FG005|Overall Study|Protocol Violation|0|||
147376463|NCT01953692|531542750|FG006|Overall Study|Protocol Violation|0|||
147376464|NCT01953692|531542751|FG007|Overall Study|Protocol Violation|1|||
147376465|NCT01953692|531542752|FG008|Overall Study|Protocol Violation|0|||
147376466|NCT01953692|531542744|FG000|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
147376467|NCT01953692|531542745|FG001|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
147376468|NCT01953692|531542746|FG002|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
147376469|NCT01953692|531542747|FG003|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
147376470|NCT01953692|531542748|FG004|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
147376471|NCT01953692|531542749|FG005|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
147376472|NCT01953692|531542750|FG006|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
147376473|NCT01953692|531542751|FG007|Overall Study|Study for Cohort 5 Terminated by Sponsor|2|||
147376474|NCT01953692|531542752|FG008|Overall Study|Study for Cohort 5 Terminated by Sponsor|0|||
147376475|NCT01953692|531542744|FG000|Overall Study|Withdrawal by Subject|4|||
147376476|NCT01953692|531542745|FG001|Overall Study|Withdrawal by Subject|2|||
147376477|NCT01953692|531542746|FG002|Overall Study|Withdrawal by Subject|1|||
147376478|NCT01953692|531542747|FG003|Overall Study|Withdrawal by Subject|2|||
147376479|NCT01953692|531542748|FG004|Overall Study|Withdrawal by Subject|0|||
147376480|NCT01953692|531542749|FG005|Overall Study|Withdrawal by Subject|3|||
147376481|NCT01953692|531542750|FG006|Overall Study|Withdrawal by Subject|2|||
147376482|NCT01953692|531542751|FG007|Overall Study|Withdrawal by Subject|1|||
147376483|NCT01953692|531542752|FG008|Overall Study|Withdrawal by Subject|1|||
147376484|NCT02022670|531542753|FG000|Overall Study|Adverse Event|1|||
147376485|NCT02022670|531542754|FG001|Overall Study|Adverse Event|0|||
147376486|NCT02022670|531542755|FG002|Overall Study|Adverse Event|1|||
147376487|NCT02630966|531542764|FG000|Overall Study|Adverse Event|1|||
147376488|NCT02630966|531542765|FG001|Overall Study|Adverse Event|3|||
147376489|NCT02630966|531542764|FG000|Overall Study|Significant Protocol Deviation|0|||
147376490|NCT02630966|531542765|FG001|Overall Study|Significant Protocol Deviation|2|||
147376491|NCT02630966|531542764|FG000|Overall Study|Voluntary Withdrawal|1|||
147376492|NCT02630966|531542765|FG001|Overall Study|Voluntary Withdrawal|1|||
147376493|NCT02630966|531542764|FG000|Overall Study|Lack of Efficacy|0|||
147376494|NCT02630966|531542765|FG001|Overall Study|Lack of Efficacy|2|||
147376495|NCT04677738|531542766|FG000|Overall Study|Withdrawal by Subject|4|||
147376496|NCT04677738|531542767|FG001|Overall Study|Withdrawal by Subject|2|||
147376497|NCT03697603|531542770|FG000|Overall Study|Adverse Event|3|||
147376498|NCT03697603|531542771|FG001|Overall Study|Adverse Event|18|||
147376499|NCT03697603|531542772|FG002|Overall Study|Adverse Event|3|||
147376500|NCT03697603|531542770|FG000|Overall Study|Physician Decision|1|||
147376501|NCT03697603|531542771|FG001|Overall Study|Physician Decision|0|||
147376502|NCT03697603|531542772|FG002|Overall Study|Physician Decision|2|||
147376503|NCT03697603|531542770|FG000|Overall Study|Protocol Violation|3|||
147376504|NCT03697603|531542771|FG001|Overall Study|Protocol Violation|8|||
147376505|NCT03697603|531542772|FG002|Overall Study|Protocol Violation|5|||
147376506|NCT03697603|531542770|FG000|Overall Study|Withdrawal by Subject|5|||
147376507|NCT03697603|531542771|FG001|Overall Study|Withdrawal by Subject|1|||
147376508|NCT03697603|531542772|FG002|Overall Study|Withdrawal by Subject|1|||
147376509|NCT03697603|531542770|FG000|Overall Study|Protocol Violation|0|||
147376510|NCT03697603|531542771|FG001|Overall Study|Protocol Violation|0|||
147376511|NCT03697603|531542772|FG002|Overall Study|Protocol Violation|1|||
147376512|NCT01683409|531542775|FG000|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0|||
147376513|NCT01683409|531542776|FG001|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0|||
147376514|NCT01683409|531542777|FG002|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|1|||
147376515|NCT01683409|531542778|FG003|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0|||
147376516|NCT01683409|531542779|FG004|Treatment Period (Weeks 1-24)|Inappropriately Enrolled|0|||
147376517|NCT01683409|531542775|FG000|Treatment Period (Weeks 1-24)|Adverse Event|0|||
147376518|NCT01683409|531542776|FG001|Treatment Period (Weeks 1-24)|Adverse Event|3|||
147376519|NCT01683409|531542777|FG002|Treatment Period (Weeks 1-24)|Adverse Event|0|||
147376520|NCT01683409|531542778|FG003|Treatment Period (Weeks 1-24)|Adverse Event|1|||
147376521|NCT01683409|531542779|FG004|Treatment Period (Weeks 1-24)|Adverse Event|1|||
147376522|NCT01683409|531542775|FG000|Treatment Period (Weeks 1-24)|Lost to Follow-up|0|||
147376523|NCT01683409|531542776|FG001|Treatment Period (Weeks 1-24)|Lost to Follow-up|1|||
147376524|NCT01683409|531542777|FG002|Treatment Period (Weeks 1-24)|Lost to Follow-up|0|||
147376525|NCT01683409|531542778|FG003|Treatment Period (Weeks 1-24)|Lost to Follow-up|0|||
147376526|NCT01683409|531542779|FG004|Treatment Period (Weeks 1-24)|Lost to Follow-up|0|||
147376527|NCT01683409|531542775|FG000|Treatment Period (Weeks 1-24)|Withdrawal by Subject|0|||
147376528|NCT01683409|531542776|FG001|Treatment Period (Weeks 1-24)|Withdrawal by Subject|0|||
147376529|NCT01683409|531542777|FG002|Treatment Period (Weeks 1-24)|Withdrawal by Subject|0|||
147376530|NCT01683409|531542778|FG003|Treatment Period (Weeks 1-24)|Withdrawal by Subject|1|||
147376531|NCT01683409|531542779|FG004|Treatment Period (Weeks 1-24)|Withdrawal by Subject|1|||
147376532|NCT01683409|531542775|FG000|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0|||
147376533|NCT01683409|531542776|FG001|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0|||
147376534|NCT01683409|531542777|FG002|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|1|||
147376535|NCT01683409|531542778|FG003|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0|||
147376536|NCT01683409|531542779|FG004|Washout Period 1 (Weeks 25-28)|Lost to Follow-up|0|||
147376537|NCT01683409|531542775|FG000|Washout Period 1 (Weeks 25-28)|Protocol Violation|1|||
147376538|NCT01683409|531542776|FG001|Washout Period 1 (Weeks 25-28)|Protocol Violation|0|||
147376539|NCT01683409|531542777|FG002|Washout Period 1 (Weeks 25-28)|Protocol Violation|0|||
147376540|NCT01683409|531542778|FG003|Washout Period 1 (Weeks 25-28)|Protocol Violation|1|||
147376541|NCT01683409|531542779|FG004|Washout Period 1 (Weeks 25-28)|Protocol Violation|0|||
147376542|NCT01683409|531542775|FG000|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|1|||
147376543|NCT01683409|531542776|FG001|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|0|||
147376544|NCT01683409|531542777|FG002|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|0|||
147376545|NCT01683409|531542778|FG003|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|0|||
147376546|NCT01683409|531542779|FG004|Washout Period 1 (Weeks 25-28)|Withdrawal by Subject|1|||
147376547|NCT01683409|531542775|FG000|Washout Period 1 (Weeks 25-28)|Physician Decision|1|||
147376548|NCT01683409|531542776|FG001|Washout Period 1 (Weeks 25-28)|Physician Decision|0|||
147612177|NCT00678210|532395419|FG001|Overall Study|Withdrawal by Subject|4|||
147376549|NCT01683409|531542777|FG002|Washout Period 1 (Weeks 25-28)|Physician Decision|0|||
147376550|NCT01683409|531542778|FG003|Washout Period 1 (Weeks 25-28)|Physician Decision|0|||
147376551|NCT01683409|531542779|FG004|Washout Period 1 (Weeks 25-28)|Physician Decision|0|||
147376552|NCT01683409|531542775|FG000|Washout Period 1 (Weeks 25-28)|Adverse Event|0|||
147376553|NCT01683409|531542776|FG001|Washout Period 1 (Weeks 25-28)|Adverse Event|4|||
147612178|NCT00678210|532395420|FG002|Overall Study|Withdrawal by Subject|1|||
147376554|NCT01683409|531542777|FG002|Washout Period 1 (Weeks 25-28)|Adverse Event|0|||
147376555|NCT01683409|531542778|FG003|Washout Period 1 (Weeks 25-28)|Adverse Event|1|||
147376556|NCT01683409|531542779|FG004|Washout Period 1 (Weeks 25-28)|Adverse Event|2|||
147612179|NCT00678210|532395421|FG003|Overall Study|Withdrawal by Subject|7|||
147664546|NCT03074695|532596281|FG001|Overall Study|Research staff not available|2|||
147664547|NCT03074695|532596280|FG000|Overall Study|Did not receive neuraxial block|2|||
147664548|NCT03074695|532596281|FG001|Overall Study|Did not receive neuraxial block|2|||
147664549|NCT01774981|532596282|FG000|Overall Study|Adverse Event|0|||
147664550|NCT01774981|532596283|FG001|Overall Study|Adverse Event|0|||
147664551|NCT01774981|532596284|FG002|Overall Study|Adverse Event|0|||
147664552|NCT01774981|532596285|FG003|Overall Study|Adverse Event|0|||
147664553|NCT01774981|532596286|FG004|Overall Study|Adverse Event|0|||
147664554|NCT01774981|532596287|FG005|Overall Study|Adverse Event|1|||
147664555|NCT01774981|532596288|FG006|Overall Study|Adverse Event|0|||
147664556|NCT01774981|532596289|FG007|Overall Study|Adverse Event|0|||
147664557|NCT01774981|532596282|FG000|Overall Study|Withdrawal by Subject|0|||
147664558|NCT01774981|532596283|FG001|Overall Study|Withdrawal by Subject|0|||
147664559|NCT01774981|532596284|FG002|Overall Study|Withdrawal by Subject|0|||
147664560|NCT01774981|532596285|FG003|Overall Study|Withdrawal by Subject|0|||
147664561|NCT01774981|532596286|FG004|Overall Study|Withdrawal by Subject|0|||
147664562|NCT01774981|532596287|FG005|Overall Study|Withdrawal by Subject|0|||
147664563|NCT01774981|532596288|FG006|Overall Study|Withdrawal by Subject|0|||
147664564|NCT01774981|532596289|FG007|Overall Study|Withdrawal by Subject|1|||
147664565|NCT01774981|532596282|FG000|Overall Study|Death|0|||
147664566|NCT01774981|532596283|FG001|Overall Study|Death|0|||
147664567|NCT01774981|532596284|FG002|Overall Study|Death|0|||
147664568|NCT01774981|532596285|FG003|Overall Study|Death|0|||
147664569|NCT01774981|532596286|FG004|Overall Study|Death|1|||
147664570|NCT01774981|532596287|FG005|Overall Study|Death|0|||
147664571|NCT01774981|532596288|FG006|Overall Study|Death|0|||
147664572|NCT01774981|532596289|FG007|Overall Study|Death|0|||
147664573|NCT00902577|532596294|FG000|Overall Study|Withdrawal by Subject|6|||
147664574|NCT00902577|532596294|FG000|Overall Study|FMISO production failure|2|||
147664575|NCT01232790|532596297|FG000|Randomization|Withdrawal by Subject|2|||
147664576|NCT01232790|532596298|FG001|Randomization|Withdrawal by Subject|0|||
147664577|NCT01232790|532596297|FG000|Randomization|Protocol Violation|0|||
147664578|NCT01232790|532596298|FG001|Randomization|Protocol Violation|1|||
147664579|NCT01232790|532596297|FG000|Randomization|Physician Decision|0|||
147664580|NCT01232790|532596298|FG001|Randomization|Physician Decision|1|||
147664581|NCT01232790|532596297|FG000|Initial Assessment|Withdrawal by Subject|0|||
147664582|NCT01232790|532596298|FG001|Initial Assessment|Withdrawal by Subject|1|||
147664583|NCT01232790|532596297|FG000|First Crossover|Withdrawal by Subject|1|||
147664584|NCT01232790|532596298|FG001|First Crossover|Withdrawal by Subject|0|||
147664585|NCT01232790|532596297|FG000|Second Crossover|Withdrawal by Subject|1|||
147664586|NCT01232790|532596298|FG001|Second Crossover|Withdrawal by Subject|2|||
147664587|NCT03322293|532596299|FG000|Overall Study|Lost to Follow-up|0|||
147664588|NCT03322293|532596300|FG001|Overall Study|Lost to Follow-up|0|||
147664589|NCT03322293|532596301|FG002|Overall Study|Lost to Follow-up|1|||
147664590|NCT00083915|532596302|FG000|Overall Study|Death|6|||
147664591|NCT00083915|532596303|FG001|Overall Study|Death|3|||
147664592|NCT00083915|532596302|FG000|Overall Study|Physician Decision|11|||
147664593|NCT00083915|532596303|FG001|Overall Study|Physician Decision|6|||
147664594|NCT00083915|532596302|FG000|Overall Study|Withdrawal by Subject|8|||
147664595|NCT00083915|532596303|FG001|Overall Study|Withdrawal by Subject|3|||
147664596|NCT00083915|532596302|FG000|Overall Study|disease progression|18|||
147664597|NCT00083915|532596303|FG001|Overall Study|disease progression|23|||
147664598|NCT00083915|532596302|FG000|Overall Study|Failure to collect|3|||
147664599|NCT00083915|532596303|FG001|Overall Study|Failure to collect|0|||
147664600|NCT00083915|532596302|FG000|Overall Study|No response|3|||
147664601|NCT00083915|532596303|FG001|Overall Study|No response|1|||
147664602|NCT00083915|532596302|FG000|Overall Study|Insurance issues|1|||
147664603|NCT00083915|532596303|FG001|Overall Study|Insurance issues|1|||
147664604|NCT01239797|532596304|FG000|Randomized Participants|Participant no longer meets study criteria|1|||
147664605|NCT01239797|532596305|FG001|Randomized Participants|Participant no longer meets study criteria|1|||
147664606|NCT01239797|532596304|FG000|Randomized Participants|Participant withdrew consent|1|||
147664607|NCT01239797|532596305|FG001|Randomized Participants|Participant withdrew consent|7|||
147664608|NCT01239797|532596304|FG000|Randomized Participants|Adverse event unrelated to study drug|0|||
147664609|NCT01239797|532596305|FG001|Randomized Participants|Adverse event unrelated to study drug|1|||
147664610|NCT01239797|532596304|FG000|Treated Participants|Disease progression|185|||
147664611|NCT01239797|532596305|FG001|Treated Participants|Disease progression|185|||
147664612|NCT01239797|532596304|FG000|Treated Participants|Study drug toxicity|39|||
147664613|NCT01239797|532596305|FG001|Treated Participants|Study drug toxicity|45|||
147664614|NCT01239797|532596304|FG000|Treated Participants|Adverse event unrelated to study drug|31|||
147664615|NCT01239797|532596305|FG001|Treated Participants|Adverse event unrelated to study drug|37|||
147664616|NCT01239797|532596304|FG000|Treated Participants|Participants request to discontinue study treatment|28|||
147664617|NCT01239797|532596305|FG001|Treated Participants|Participants request to discontinue study treatment|18|||
147664618|NCT01239797|532596304|FG000|Treated Participants|Administrative reason by sponsor|13|||
147664619|NCT01239797|532596305|FG001|Treated Participants|Administrative reason by sponsor|4|||
147664620|NCT01239797|532596304|FG000|Treated Participants|Other reasons|14|||
147664621|NCT01239797|532596305|FG001|Treated Participants|Other reasons|14|||
147376557|NCT01683409|531542775|FG000|Washout Period 2 (Weeks 29-32)|Adverse Event|0|||
147376558|NCT01683409|531542776|FG001|Washout Period 2 (Weeks 29-32)|Adverse Event|0|||
147376559|NCT01683409|531542777|FG002|Washout Period 2 (Weeks 29-32)|Adverse Event|0|||
147376560|NCT01683409|531542778|FG003|Washout Period 2 (Weeks 29-32)|Adverse Event|0|||
147376561|NCT01683409|531542779|FG004|Washout Period 2 (Weeks 29-32)|Adverse Event|3|||
147376562|NCT01683409|531542775|FG000|Washout Period 2 (Weeks 29-32)|Physician Decision|0|||
147376563|NCT01683409|531542776|FG001|Washout Period 2 (Weeks 29-32)|Physician Decision|0|||
147376564|NCT01683409|531542777|FG002|Washout Period 2 (Weeks 29-32)|Physician Decision|1|||
147376565|NCT01683409|531542778|FG003|Washout Period 2 (Weeks 29-32)|Physician Decision|0|||
147376566|NCT01683409|531542779|FG004|Washout Period 2 (Weeks 29-32)|Physician Decision|0|||
147376567|NCT04218864|531542780|FG000|Overall Study|Lost to Follow-up|8|||
147376568|NCT04218864|531542781|FG001|Overall Study|Lost to Follow-up|4|||
147376569|NCT04218864|531542780|FG000|Overall Study|Withdrawal by Subject|1|||
147376570|NCT04218864|531542781|FG001|Overall Study|Withdrawal by Subject|3|||
147376571|NCT00676091|531542782|FG000|Infant Series|Parent or legal guardian request|10|||
147376572|NCT00676091|531542783|FG001|Infant Series|Parent or legal guardian request|8|||
147376573|NCT00676091|531542782|FG000|Infant Series|Protocol Violation|6|||
147376574|NCT00676091|531542783|FG001|Infant Series|Protocol Violation|3|||
147376575|NCT00676091|531542782|FG000|Infant Series|Adverse Event|2|||
147376576|NCT00676091|531542783|FG001|Infant Series|Adverse Event|3|||
147376577|NCT00676091|531542782|FG000|Infant Series|Failed to return|1|||
147376578|NCT00676091|531542783|FG001|Infant Series|Failed to return|3|||
147376579|NCT00676091|531542782|FG000|Infant Series|Lost to Follow-up|1|||
147376580|NCT00676091|531542783|FG001|Infant Series|Lost to Follow-up|0|||
147376581|NCT00676091|531542782|FG000|Infant Series|Died prior to receiving 7vPnC|0|||
147376582|NCT00676091|531542783|FG001|Infant Series|Died prior to receiving 7vPnC|1|||
147376583|NCT00676091|531542782|FG000|After Infant Series|Adverse Event|0|||
147376584|NCT00676091|531542783|FG001|After Infant Series|Adverse Event|1|||
147376585|NCT00676091|531542782|FG000|After Infant Series|Protocol Violation|0|||
147376586|NCT00676091|531542783|FG001|After Infant Series|Protocol Violation|1|||
147376587|NCT00676091|531542782|FG000|After Infant Series|Failed to return|1|||
147376588|NCT00676091|531542783|FG001|After Infant Series|Failed to return|1|||
147376589|NCT00676091|531542782|FG000|Toddler Dose|Failed to return|2|||
147376590|NCT00676091|531542783|FG001|Toddler Dose|Failed to return|0|||
147376591|NCT00676091|531542782|FG000|Toddler Dose|Parent or legal guardian request|1|||
147376592|NCT00676091|531542783|FG001|Toddler Dose|Parent or legal guardian request|0|||
147376593|NCT00933270|531542786|FG000|Overall Study|Withdrawal by Subject|26|||
147376594|NCT00933270|531542786|FG000|Overall Study|Insufficient Follow-up|10|||
147376595|NCT00933270|531542786|FG000|Overall Study|Lost to Follow-up|14|||
147376596|NCT00933270|531542786|FG000|Overall Study|Adverse Event|1|||
147376597|NCT00933270|531542786|FG000|Overall Study|Missed Visit|2|||
147376598|NCT00933270|531542786|FG000|Overall Study|Death|24|||
147376599|NCT00933270|531542786|FG000|Overall Study|Moved or would not return|10|||
147376600|NCT03343704|531542787|FG000|Overall Study|Refused to complete follow up|0|||
147376601|NCT03343704|531542788|FG001|Overall Study|Refused to complete follow up|1|||
147376602|NCT03343704|531542787|FG000|Overall Study|Death|0|||
147376603|NCT03343704|531542788|FG001|Overall Study|Death|1|||
147376604|NCT03343704|531542787|FG000|Overall Study|Reluctant to collect blood and received telephone follow up|1|||
147376605|NCT03343704|531542788|FG001|Overall Study|Reluctant to collect blood and received telephone follow up|0|||
147376606|NCT00302211|531542791|FG000|Double Blind Period (New Patients)|Withdrawal by Subject|2|||
147376607|NCT00302211|531542792|FG001|Double Blind Period (New Patients)|Withdrawal by Subject|1|||
147376608|NCT00302211|531542793|FG002|Double Blind Period (New Patients)|Withdrawal by Subject|0|||
147376609|NCT00302211|531542794|FG003|Double Blind Period (New Patients)|Withdrawal by Subject|0|||
147376610|NCT00302211|531542795|FG004|Double Blind Period (New Patients)|Withdrawal by Subject|0|||
147376611|NCT00302211|531542791|FG000|Double Blind Period (New Patients)|Adverse Event|0|||
147376612|NCT00302211|531542792|FG001|Double Blind Period (New Patients)|Adverse Event|0|||
147376613|NCT00302211|531542793|FG002|Double Blind Period (New Patients)|Adverse Event|3|||
147376614|NCT00302211|531542794|FG003|Double Blind Period (New Patients)|Adverse Event|0|||
147376615|NCT00302211|531542795|FG004|Double Blind Period (New Patients)|Adverse Event|0|||
147376616|NCT00302211|531542791|FG000|Double Blind Period (New Patients)|Investigator's judgement|1|||
147376617|NCT00302211|531542792|FG001|Double Blind Period (New Patients)|Investigator's judgement|0|||
147376618|NCT00302211|531542793|FG002|Double Blind Period (New Patients)|Investigator's judgement|0|||
147376619|NCT00302211|531542794|FG003|Double Blind Period (New Patients)|Investigator's judgement|0|||
147376620|NCT00302211|531542795|FG004|Double Blind Period (New Patients)|Investigator's judgement|0|||
147376621|NCT00302211|531542791|FG000|Double Blind Period (New Patients)|Disease progression|0|||
147376622|NCT00302211|531542792|FG001|Double Blind Period (New Patients)|Disease progression|1|||
147376623|NCT00302211|531542793|FG002|Double Blind Period (New Patients)|Disease progression|1|||
147376624|NCT00302211|531542794|FG003|Double Blind Period (New Patients)|Disease progression|0|||
147376625|NCT00302211|531542795|FG004|Double Blind Period (New Patients)|Disease progression|0|||
147376626|NCT00302211|531542791|FG000|Open Label-Patients From Double-Blind|Withdrawal by Subject|0|||
147376627|NCT00302211|531542792|FG001|Open Label-Patients From Double-Blind|Withdrawal by Subject|0|||
147612180|NCT00678210|532395418|FG000|Overall Study|Other|1|||
147376628|NCT00302211|531542793|FG002|Open Label-Patients From Double-Blind|Withdrawal by Subject|0|||
147376629|NCT00302211|531542794|FG003|Open Label-Patients From Double-Blind|Withdrawal by Subject|3|||
147376630|NCT00302211|531542795|FG004|Open Label-Patients From Double-Blind|Withdrawal by Subject|3|||
147376631|NCT00302211|531542791|FG000|Open Label-Patients From Double-Blind|Adverse Event|0|||
147376632|NCT00302211|531542792|FG001|Open Label-Patients From Double-Blind|Adverse Event|0|||
147376633|NCT00302211|531542793|FG002|Open Label-Patients From Double-Blind|Adverse Event|0|||
147376634|NCT00302211|531542794|FG003|Open Label-Patients From Double-Blind|Adverse Event|1|||
147376635|NCT00302211|531542795|FG004|Open Label-Patients From Double-Blind|Adverse Event|0|||
147376636|NCT00302211|531542791|FG000|Open Label-Patients From Double-Blind|Investigator's judgement|0|||
147376637|NCT00302211|531542792|FG001|Open Label-Patients From Double-Blind|Investigator's judgement|0|||
147376638|NCT00302211|531542793|FG002|Open Label-Patients From Double-Blind|Investigator's judgement|0|||
147376639|NCT00302211|531542794|FG003|Open Label-Patients From Double-Blind|Investigator's judgement|1|||
147376640|NCT00302211|531542795|FG004|Open Label-Patients From Double-Blind|Investigator's judgement|0|||
147376641|NCT00302211|531542791|FG000|Open Label-Patients From Double-Blind|Disease progression|0|||
147376642|NCT00302211|531542792|FG001|Open Label-Patients From Double-Blind|Disease progression|0|||
147376643|NCT00302211|531542793|FG002|Open Label-Patients From Double-Blind|Disease progression|0|||
147376644|NCT00302211|531542794|FG003|Open Label-Patients From Double-Blind|Disease progression|1|||
147376645|NCT00302211|531542795|FG004|Open Label-Patients From Double-Blind|Disease progression|2|||
147376646|NCT00302211|531542791|FG000|Open Label-Patients From Double-Blind|Death|0|||
147376647|NCT00302211|531542792|FG001|Open Label-Patients From Double-Blind|Death|0|||
147376648|NCT00302211|531542793|FG002|Open Label-Patients From Double-Blind|Death|0|||
147376649|NCT00302211|531542794|FG003|Open Label-Patients From Double-Blind|Death|1|||
147376650|NCT00302211|531542795|FG004|Open Label-Patients From Double-Blind|Death|1|||
147376651|NCT00302211|531542791|FG000|Open Label-Patients From Double-Blind|Lost to Follow-up|0|||
147376652|NCT00302211|531542792|FG001|Open Label-Patients From Double-Blind|Lost to Follow-up|0|||
147376653|NCT00302211|531542793|FG002|Open Label-Patients From Double-Blind|Lost to Follow-up|0|||
147376654|NCT00302211|531542794|FG003|Open Label-Patients From Double-Blind|Lost to Follow-up|0|||
147376655|NCT00302211|531542795|FG004|Open Label-Patients From Double-Blind|Lost to Follow-up|1|||
147376656|NCT00302211|531542791|FG000|Open Label-Patients From Double-Blind|PH requiring lung transplant|0|||
147376657|NCT00302211|531542792|FG001|Open Label-Patients From Double-Blind|PH requiring lung transplant|0|||
147376658|NCT00302211|531542793|FG002|Open Label-Patients From Double-Blind|PH requiring lung transplant|0|||
147376659|NCT00302211|531542794|FG003|Open Label-Patients From Double-Blind|PH requiring lung transplant|0|||
147376660|NCT00302211|531542795|FG004|Open Label-Patients From Double-Blind|PH requiring lung transplant|1|||
147376661|NCT00302211|531542791|FG000|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0|||
147376662|NCT00302211|531542792|FG001|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0|||
147376663|NCT00302211|531542793|FG002|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0|||
147376664|NCT00302211|531542794|FG003|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|1|||
147376665|NCT00302211|531542795|FG004|Open Label-Patients From Double-Blind|Termination of the study by the sponsor|0|||
147376666|NCT05349721|531544486|FG000|Part A (24 Weeks)|Adverse Event|9|||
147376667|NCT05349721|531544487|FG001|Part A (24 Weeks)|Adverse Event|2|||
147376668|NCT05349721|531544486|FG000|Part A (24 Weeks)|Death|8|||
147376669|NCT05349721|531544487|FG001|Part A (24 Weeks)|Death|3|||
147376670|NCT05349721|531544486|FG000|Part A (24 Weeks)|Disease Progression|1|||
147376671|NCT05349721|531544487|FG001|Part A (24 Weeks)|Disease Progression|1|||
147376672|NCT05349721|531544486|FG000|Part A (24 Weeks)|Screen Failure|2|||
147376673|NCT05349721|531544487|FG001|Part A (24 Weeks)|Screen Failure|0|||
147376674|NCT05349721|531544486|FG000|Part A (24 Weeks)|Withdrawal by Subject|18|||
147376675|NCT05349721|531544487|FG001|Part A (24 Weeks)|Withdrawal by Subject|7|||
147376676|NCT05349721|531544486|FG000|Part A (24 Weeks)|Other Than Specified|5|||
147376677|NCT05349721|531544487|FG001|Part A (24 Weeks)|Other Than Specified|1|||
147376678|NCT05349721|531544486|FG000|Part B (28 Weeks)|Adverse Event|3|||
147376679|NCT05349721|531544487|FG001|Part B (28 Weeks)|Adverse Event|0|||
147376680|NCT05349721|531544486|FG000|Part B (28 Weeks)|Death|21|||
147376681|NCT05349721|531544487|FG001|Part B (28 Weeks)|Death|11|||
147376682|NCT05349721|531544486|FG000|Part B (28 Weeks)|Disease Progression|2|||
147376683|NCT05349721|531544487|FG001|Part B (28 Weeks)|Disease Progression|1|||
147376684|NCT05349721|531544486|FG000|Part B (28 Weeks)|Lost to Follow-up|2|||
147376685|NCT05349721|531544487|FG001|Part B (28 Weeks)|Lost to Follow-up|1|||
147376686|NCT05349721|531544486|FG000|Part B (28 Weeks)|Physician Decision|1|||
147376687|NCT05349721|531544487|FG001|Part B (28 Weeks)|Physician Decision|0|||
147376688|NCT05349721|531544486|FG000|Part B (28 Weeks)|Study terminated by sponsor|85|||
147376689|NCT05349721|531544487|FG001|Part B (28 Weeks)|Study terminated by sponsor|53|||
147376690|NCT05349721|531544486|FG000|Part B (28 Weeks)|Withdrawal by Subject|17|||
147376691|NCT05349721|531544487|FG001|Part B (28 Weeks)|Withdrawal by Subject|5|||
147376692|NCT05349721|531544486|FG000|Part B (28 Weeks)|Other Than Specified|4|||
147376693|NCT05349721|531544487|FG001|Part B (28 Weeks)|Other Than Specified|2|||
147376694|NCT05349721|531544486|FG000|Part C (108 Weeks)|Death|0|||
147664622|NCT01239797|532596304|FG000|Treated Participants|Participant withdrew consent|6|||
147455583|NCT02889796|531829866|FG005|Overall Study|Randomized but not Dosed|2|||
147455584|NCT04294459|531829867|FG000|Overall Study|Adverse Event|0|||
147455585|NCT04294459|531829868|FG001|Overall Study|Adverse Event|1|||
147455586|NCT04033367|531829869|FG000|DB Period (Up to Week 12)|Adverse Event|1|||
147455587|NCT04033367|531829870|FG001|DB Period (Up to Week 12)|Adverse Event|1|||
147455588|NCT04033367|531829869|FG000|DB Period (Up to Week 12)|Withdrawal by Subject|4|||
147455589|NCT04033367|531829870|FG001|DB Period (Up to Week 12)|Withdrawal by Subject|0|||
147455590|NCT04033367|531829869|FG000|OLE Period (Week 12 to Week 24)|Withdrawal by Subject|4|||
147455591|NCT04033367|531829870|FG001|OLE Period (Week 12 to Week 24)|Withdrawal by Subject|1|||
147455592|NCT04033367|531829869|FG000|OLE Period (Week 12 to Week 24)|Other-unspecified|1|||
147455593|NCT04033367|531829870|FG001|OLE Period (Week 12 to Week 24)|Other-unspecified|0|||
147455594|NCT02908880|531829871|FG000|Overall Study|Lost to Follow-up|4|||
147455595|NCT02908880|531829871|FG000|Overall Study|Explantation of the device|1|||
147455596|NCT02908880|531829871|FG000|Overall Study|Withdrawal by Subject|17|||
147455597|NCT02908880|531829871|FG000|Overall Study|Death|5|||
147455598|NCT01604512|531829874|FG000|Overall Study|Withdrawal by Subject|3|||
147455599|NCT01604512|531829874|FG000|Overall Study|Not treated|4|||
147455600|NCT03286842|531829875|FG000|Overall Study|Patients rolled over to another study|80|||
147455601|NCT01391507|531829879|FG000|Overall Study|Death|0|||
147455602|NCT01391507|531829880|FG001|Overall Study|Death|0|||
147455603|NCT01391507|531829881|FG002|Overall Study|Death|0|||
147455604|NCT01391507|531829882|FG003|Overall Study|Death|1|||
147612181|NCT00678210|532395419|FG001|Overall Study|Other|0|||
147612182|NCT00678210|532395420|FG002|Overall Study|Other|1|||
147612183|NCT00678210|532395421|FG003|Overall Study|Other|0|||
147612184|NCT04825912|532395422|FG000|Overall Study|Death|3|||
147612185|NCT04825912|532395422|FG000|Overall Study|Withdrawal by Subject|1|||
147612186|NCT03965689|532395423|FG000|Overall Study|Too sick to get study intervention|2|||
147612187|NCT01214655|532395424|FG000|Part A|Progressive Disease|7|||
147612188|NCT01214655|532395425|FG001|Part A|Progressive Disease|0|||
147612189|NCT01214655|532395426|FG002|Part A|Progressive Disease|0|||
147612190|NCT01214655|532395424|FG000|Part A|Physician Decision|1|||
147612191|NCT01214655|532395425|FG001|Part A|Physician Decision|0|||
147612192|NCT01214655|532395426|FG002|Part A|Physician Decision|0|||
147612193|NCT01214655|532395424|FG000|Part B|Progressive disease|0|||
147612194|NCT01214655|532395425|FG001|Part B|Progressive disease|10|||
147612195|NCT01214655|532395426|FG002|Part B|Progressive disease|0|||
147612196|NCT01214655|532395424|FG000|Part B|Death|0|||
147612197|NCT01214655|532395425|FG001|Part B|Death|1|||
147612198|NCT01214655|532395426|FG002|Part B|Death|0|||
147455605|NCT01391507|531829879|FG000|Overall Study|Adverse Event|1|||
147455606|NCT01391507|531829880|FG001|Overall Study|Adverse Event|1|||
147455607|NCT01391507|531829881|FG002|Overall Study|Adverse Event|2|||
147455608|NCT01391507|531829882|FG003|Overall Study|Adverse Event|2|||
147455609|NCT01391507|531829879|FG000|Overall Study|Withdrawal by Subject|1|||
147455610|NCT01391507|531829880|FG001|Overall Study|Withdrawal by Subject|2|||
147455611|NCT01391507|531829881|FG002|Overall Study|Withdrawal by Subject|1|||
147455612|NCT01391507|531829882|FG003|Overall Study|Withdrawal by Subject|1|||
147455613|NCT01391507|531829879|FG000|Overall Study|Lack of Efficacy|0|||
147455614|NCT01391507|531829880|FG001|Overall Study|Lack of Efficacy|0|||
147612199|NCT01214655|532395424|FG000|Part B|Withdrawal by Subject|0|||
147612200|NCT01214655|532395425|FG001|Part B|Withdrawal by Subject|2|||
147612201|NCT01214655|532395426|FG002|Part B|Withdrawal by Subject|0|||
147612202|NCT01214655|532395424|FG000|Part C|Progressive Disease|0|||
147612203|NCT01214655|532395425|FG001|Part C|Progressive Disease|0|||
147612204|NCT01214655|532395426|FG002|Part C|Progressive Disease|5|||
147612205|NCT01214655|532395424|FG000|Part C|Death|0|||
147612206|NCT01214655|532395425|FG001|Part C|Death|0|||
147612207|NCT01214655|532395426|FG002|Part C|Death|1|||
147612208|NCT01214655|532395424|FG000|Part C|Physician Decision|0|||
147612209|NCT01214655|532395425|FG001|Part C|Physician Decision|0|||
147612210|NCT01214655|532395426|FG002|Part C|Physician Decision|1|||
147612211|NCT01383707|532395437|FG000|Overall Study|Consent withdrawal|6|||
147612212|NCT01383707|532395437|FG000|Overall Study|Death|19|||
147612213|NCT01383707|532395437|FG000|Overall Study|Other|8|||
147612214|NCT01383707|532395437|FG000|Overall Study|Sponsor's decision|2|||
147612215|NCT01383707|532395437|FG000|Overall Study|Adverse Event|14|||
147612216|NCT01383707|532395437|FG000|Overall Study|Progressive disease|23|||
147612217|NCT00855894|532395438|FG000|Overall Study|Death|31|||
147612218|NCT00855894|532395438|FG000|Overall Study|Patient's decision|1|||
147612219|NCT00855894|532395438|FG000|Overall Study|Disease progression|1|||
147612220|NCT01121562|532395441|FG000|Overall Study|Objective progression or relapse|8|||
147455615|NCT01391507|531829881|FG002|Overall Study|Lack of Efficacy|0|||
147455616|NCT01391507|531829882|FG003|Overall Study|Lack of Efficacy|1|||
147455617|NCT01391507|531829879|FG000|Overall Study|Protocol Violation|2|||
147455618|NCT01391507|531829880|FG001|Overall Study|Protocol Violation|1|||
147455619|NCT01391507|531829881|FG002|Overall Study|Protocol Violation|1|||
147455620|NCT01391507|531829882|FG003|Overall Study|Protocol Violation|2|||
147612221|NCT01121562|532395441|FG000|Overall Study|Withdrawal by Subject|1|||
147612222|NCT01121562|532395441|FG000|Overall Study|Adverse Event|1|||
147612223|NCT01121562|532395441|FG000|Overall Study|Sponsor Decision|1|||
147376695|NCT05349721|531544487|FG001|Part C (108 Weeks)|Death|1|||
147376696|NCT05349721|531544486|FG000|Part C (108 Weeks)|Lost to Follow-up|0|||
147376697|NCT05349721|531544487|FG001|Part C (108 Weeks)|Lost to Follow-up|1|||
147376698|NCT05349721|531544486|FG000|Part C (108 Weeks)|Study terminated by sponsor|34|||
147376699|NCT05349721|531544487|FG001|Part C (108 Weeks)|Study terminated by sponsor|23|||
147376700|NCT05349721|531544486|FG000|Part C (108 Weeks)|Withdrawal by Subject|1|||
147376701|NCT05349721|531544487|FG001|Part C (108 Weeks)|Withdrawal by Subject|1|||
147376702|NCT03136159|531544489|FG000|Overall Study|chorioamnionitis|2|||
147376703|NCT03136159|531544490|FG001|Overall Study|chorioamnionitis|0|||
147376704|NCT03136159|531544489|FG000|Overall Study|vertical skin incision|1|||
147376705|NCT03136159|531544490|FG001|Overall Study|vertical skin incision|0|||
147376706|NCT03136159|531544489|FG000|Overall Study|additional dressing|1|||
147376707|NCT03136159|531544490|FG001|Overall Study|additional dressing|0|||
147376708|NCT03136159|531544489|FG000|Overall Study|never got dressing placed|1|||
147376709|NCT03136159|531544490|FG001|Overall Study|never got dressing placed|0|||
147376710|NCT03823703|531544491|FG000|Overall Study|Sponsor request|0|||
147376711|NCT03823703|531544492|FG001|Overall Study|Sponsor request|3|||
147376712|NCT03823703|531544493|FG002|Overall Study|Sponsor request|4|||
147376713|NCT03823703|531544491|FG000|Overall Study|Adverse Event|3|||
147376714|NCT03823703|531544492|FG001|Overall Study|Adverse Event|1|||
147376715|NCT03823703|531544493|FG002|Overall Study|Adverse Event|0|||
147376716|NCT03823703|531544491|FG000|Overall Study|Withdrawal by Subject|0|||
147376717|NCT03823703|531544492|FG001|Overall Study|Withdrawal by Subject|1|||
147376718|NCT03823703|531544493|FG002|Overall Study|Withdrawal by Subject|0|||
147376719|NCT03137459|531544494|FG000|2-month Assessment|Withdrawal by Subject|13|||
147376720|NCT03137459|531544495|FG001|2-month Assessment|Withdrawal by Subject|3|||
147376721|NCT03137459|531544494|FG000|2-month Assessment|Unable to reach|42|||
147376722|NCT03137459|531544495|FG001|2-month Assessment|Unable to reach|32|||
147376723|NCT03137459|531544494|FG000|2-month Assessment|Refused assessment|7|||
147376724|NCT03137459|531544495|FG001|2-month Assessment|Refused assessment|5|||
147376725|NCT03137459|531544494|FG000|2-month Assessment|Acutely ill|6|||
147376726|NCT03137459|531544495|FG001|2-month Assessment|Acutely ill|2|||
147376727|NCT03137459|531544494|FG000|4-month Assessment|Death|4|||
147376728|NCT03137459|531544495|FG001|4-month Assessment|Death|2|||
147376729|NCT03137459|531544494|FG000|4-month Assessment|Withdrawal by Subject|4|||
147376730|NCT03137459|531544495|FG001|4-month Assessment|Withdrawal by Subject|2|||
147376731|NCT03137459|531544494|FG000|4-month Assessment|Unable to reach|44|||
147376732|NCT03137459|531544495|FG001|4-month Assessment|Unable to reach|29|||
147376733|NCT03137459|531544494|FG000|4-month Assessment|Refused assessment|24|||
147376734|NCT03137459|531544495|FG001|4-month Assessment|Refused assessment|10|||
147376735|NCT03137459|531544494|FG000|4-month Assessment|Acutely ill|2|||
147376736|NCT03137459|531544495|FG001|4-month Assessment|Acutely ill|3|||
147376737|NCT03137459|531544494|FG000|6-months|Lost to Follow-up|14|||
147376738|NCT03137459|531544495|FG001|6-months|Lost to Follow-up|11|||
147376739|NCT03137459|531544494|FG000|6-months|Death|0|||
147376740|NCT03137459|531544495|FG001|6-months|Death|2|||
147376741|NCT03137459|531544494|FG000|6-months|Refused assessment|6|||
147376742|NCT03137459|531544495|FG001|6-months|Refused assessment|3|||
147376743|NCT03137459|531544494|FG000|6-months|Acutely ill|1|||
147376744|NCT03137459|531544495|FG001|6-months|Acutely ill|1|||
147376745|NCT00985088|531544496|FG000|Overall Study|Serious Adverse Event|1|||
147376746|NCT00985088|531544497|FG001|Overall Study|Serious Adverse Event|1|||
147376747|NCT00985088|531544498|FG002|Overall Study|Serious Adverse Event|0|||
147376748|NCT00985088|531544499|FG003|Overall Study|Serious Adverse Event|0|||
147376749|NCT00985088|531544500|FG004|Overall Study|Serious Adverse Event|0|||
147376750|NCT00985088|531544501|FG005|Overall Study|Serious Adverse Event|0|||
147376751|NCT00985088|531544502|FG006|Overall Study|Serious Adverse Event|0|||
147376752|NCT00985088|531544503|FG007|Overall Study|Serious Adverse Event|1|||
147376753|NCT00985088|531544496|FG000|Overall Study|Adverse Event|0|||
147376754|NCT00985088|531544497|FG001|Overall Study|Adverse Event|0|||
147376755|NCT00985088|531544498|FG002|Overall Study|Adverse Event|1|||
147376756|NCT00985088|531544499|FG003|Overall Study|Adverse Event|0|||
147376757|NCT00985088|531544500|FG004|Overall Study|Adverse Event|0|||
147376758|NCT00985088|531544501|FG005|Overall Study|Adverse Event|0|||
147376759|NCT00985088|531544502|FG006|Overall Study|Adverse Event|0|||
147376760|NCT00985088|531544503|FG007|Overall Study|Adverse Event|0|||
147376761|NCT00985088|531544496|FG000|Overall Study|Withdrawal by Subject|4|||
147376762|NCT00985088|531544497|FG001|Overall Study|Withdrawal by Subject|0|||
147376763|NCT00985088|531544498|FG002|Overall Study|Withdrawal by Subject|0|||
147376764|NCT00985088|531544499|FG003|Overall Study|Withdrawal by Subject|1|||
147376765|NCT00985088|531544500|FG004|Overall Study|Withdrawal by Subject|3|||
147376766|NCT00985088|531544501|FG005|Overall Study|Withdrawal by Subject|2|||
147376767|NCT00985088|531544502|FG006|Overall Study|Withdrawal by Subject|1|||
147376768|NCT00985088|531544503|FG007|Overall Study|Withdrawal by Subject|2|||
147376769|NCT00985088|531544496|FG000|Overall Study|Migrated/moved from study area|0|||
147376770|NCT00985088|531544497|FG001|Overall Study|Migrated/moved from study area|0|||
147376771|NCT00985088|531544498|FG002|Overall Study|Migrated/moved from study area|1|||
147376772|NCT00985088|531544499|FG003|Overall Study|Migrated/moved from study area|0|||
147664623|NCT01239797|532596305|FG001|Treated Participants|Participant withdrew consent|11|||
147612224|NCT01121562|532395441|FG000|Overall Study|Met study discontinuation criteria|1|||
147664624|NCT01239797|532596304|FG000|Treated Participants|Death|1|||
147664625|NCT01239797|532596305|FG001|Treated Participants|Death|1|||
147664626|NCT01239797|532596304|FG000|Treated Participants|Participant no longer meets study criteria|1|||
147664627|NCT01239797|532596305|FG001|Treated Participants|Participant no longer meets study criteria|1|||
147664628|NCT01239797|532596304|FG000|Treated Participants|Poor/non-compliance|0|||
147664629|NCT01239797|532596305|FG001|Treated Participants|Poor/non-compliance|1|||
147664630|NCT00719901|532596306|FG000|Overall Study|Adverse Event|5|||
147664631|NCT00719901|532596306|FG000|Overall Study|Withdrawal by Subject|1|||
147664632|NCT00719901|532596306|FG000|Overall Study|Alternate Treatment|1|||
147664633|NCT00719901|532596306|FG000|Overall Study|Disease Progression|3|||
147664634|NCT00719901|532596306|FG000|Overall Study|Availability of Study Drug|1|||
147376773|NCT00985088|531544500|FG004|Overall Study|Migrated/moved from study area|0|||
147376774|NCT00985088|531544501|FG005|Overall Study|Migrated/moved from study area|0|||
147376775|NCT00985088|531544502|FG006|Overall Study|Migrated/moved from study area|0|||
147376776|NCT00985088|531544503|FG007|Overall Study|Migrated/moved from study area|1|||
147376777|NCT00985088|531544496|FG000|Overall Study|Lost to Follow-up|6|||
147376778|NCT00985088|531544497|FG001|Overall Study|Lost to Follow-up|1|||
147376779|NCT00985088|531544498|FG002|Overall Study|Lost to Follow-up|2|||
147376780|NCT00985088|531544499|FG003|Overall Study|Lost to Follow-up|6|||
147376781|NCT00985088|531544500|FG004|Overall Study|Lost to Follow-up|6|||
147376782|NCT00985088|531544501|FG005|Overall Study|Lost to Follow-up|5|||
147376783|NCT00985088|531544502|FG006|Overall Study|Lost to Follow-up|3|||
147376784|NCT00985088|531544503|FG007|Overall Study|Lost to Follow-up|2|||
147376785|NCT01732757|531544504|FG000|Overall Study|Lost to Follow-up|1|||
147376786|NCT01732757|531544505|FG001|Overall Study|Lost to Follow-up|0|||
147376787|NCT01732757|531544506|FG002|Overall Study|Lost to Follow-up|0|||
147376788|NCT04926857|531544507|FG000|Overall Study|Withdrawal by Subject|40|||
147376789|NCT04926857|531544507|FG000|Overall Study|Death|9|||
147376790|NCT04926857|531544507|FG000|Overall Study|Study product no longer in use|44|||
147376791|NCT04926857|531544507|FG000|Overall Study|Inadequate data to address primary objective|16|||
147376792|NCT00491400|531544508|FG000|Overall Study|Withdrawal by Subject|5|||
147376793|NCT00491400|531544509|FG001|Overall Study|Withdrawal by Subject|4|||
147376794|NCT02132949|531544514|FG000|Overall Study|Death|7|||
147376795|NCT02132949|531544515|FG001|Overall Study|Death|13|||
147376796|NCT02132949|531544514|FG000|Overall Study|Lost to Follow-up|14|||
147376797|NCT02132949|531544515|FG001|Overall Study|Lost to Follow-up|4|||
147376798|NCT02132949|531544514|FG000|Overall Study|Withdrawal by Subject|6|||
147376799|NCT02132949|531544515|FG001|Overall Study|Withdrawal by Subject|5|||
147376800|NCT02132949|531544514|FG000|Overall Study|Noncompliance|5|||
147376801|NCT02132949|531544515|FG001|Overall Study|Noncompliance|1|||
147376802|NCT02132949|531544514|FG000|Overall Study|Physician Decision|3|||
147376803|NCT02132949|531544515|FG001|Overall Study|Physician Decision|1|||
147376804|NCT02132949|531544514|FG000|Overall Study|Disease Progression|3|||
147376805|NCT02132949|531544515|FG001|Overall Study|Disease Progression|0|||
147376806|NCT02132949|531544514|FG000|Overall Study|Adverse Event|2|||
147376807|NCT02132949|531544515|FG001|Overall Study|Adverse Event|1|||
147376808|NCT02132949|531544514|FG000|Overall Study|Withdrew Prior to Treatment|1|||
147376809|NCT02132949|531544515|FG001|Overall Study|Withdrew Prior to Treatment|2|||
147376810|NCT02132949|531544514|FG000|Overall Study|Reason Unspecified|0|||
147376811|NCT02132949|531544515|FG001|Overall Study|Reason Unspecified|1|||
147376812|NCT00887224|531544518|FG000|Open-label Response (OLR) Phase|Adverse Event|46|||
147376813|NCT00887224|531544519|FG001|Open-label Response (OLR) Phase|Adverse Event|0|||
147376814|NCT00887224|531544520|FG002|Open-label Response (OLR) Phase|Adverse Event|0|||
147376815|NCT00887224|531544518|FG000|Open-label Response (OLR) Phase|Failed to return|6|||
147376816|NCT00887224|531544519|FG001|Open-label Response (OLR) Phase|Failed to return|0|||
147376817|NCT00887224|531544520|FG002|Open-label Response (OLR) Phase|Failed to return|0|||
147376818|NCT00887224|531544518|FG000|Open-label Response (OLR) Phase|Lack of Efficacy|26|||
147612225|NCT04289363|532395442|FG000|Overall Study|Lost to Follow-up|14|||
147612226|NCT04289363|532395443|FG001|Overall Study|Lost to Follow-up|0|||
147612227|NCT03790657|532395444|FG000|Overall Study|Adverse Event|1|||
147612228|NCT03790657|532395445|FG001|Overall Study|Adverse Event|1|||
147612229|NCT03790657|532395444|FG000|Overall Study|Withdrawal by Subject|1|||
147612230|NCT03790657|532395445|FG001|Overall Study|Withdrawal by Subject|1|||
147612231|NCT03971474|532395446|FG000|Overall Study|Adverse Event|11|||
147664635|NCT02643693|532596307|FG000|Overall Study|Physician Decision|0|||
147376819|NCT00887224|531544519|FG001|Open-label Response (OLR) Phase|Lack of Efficacy|0|||
147664636|NCT02643693|532596308|FG001|Overall Study|Physician Decision|1|||
147664637|NCT02643693|532596309|FG002|Overall Study|Physician Decision|0|||
147376820|NCT00887224|531544520|FG002|Open-label Response (OLR) Phase|Lack of Efficacy|0|||
147376821|NCT00887224|531544518|FG000|Open-label Response (OLR) Phase|Lost to Follow-up|16|||
147376822|NCT00887224|531544519|FG001|Open-label Response (OLR) Phase|Lost to Follow-up|0|||
147376823|NCT00887224|531544520|FG002|Open-label Response (OLR) Phase|Lost to Follow-up|0|||
147376824|NCT00887224|531544518|FG000|Open-label Response (OLR) Phase|Other|1|||
147376825|NCT00887224|531544519|FG001|Open-label Response (OLR) Phase|Other|0|||
147612232|NCT03971474|532395447|FG001|Overall Study|Adverse Event|7|||
147612233|NCT03971474|532395446|FG000|Overall Study|Refusal unrelated to adverse event|5|||
147612234|NCT03971474|532395447|FG001|Overall Study|Refusal unrelated to adverse event|1|||
147612235|NCT03971474|532395446|FG000|Overall Study|Progression/relapse|40|||
147612236|NCT03971474|532395447|FG001|Overall Study|Progression/relapse|47|||
147612237|NCT03971474|532395446|FG000|Overall Study|Death|6|||
147612238|NCT03971474|532395447|FG001|Overall Study|Death|3|||
147612239|NCT03971474|532395446|FG000|Overall Study|Other - not protocol specified|5|||
147612240|NCT03971474|532395447|FG001|Overall Study|Other - not protocol specified|4|||
147612241|NCT03971474|532395446|FG000|Overall Study|On treatment|0|||
147612242|NCT03971474|532395447|FG001|Overall Study|On treatment|7|||
147612243|NCT02370238|532395448|FG000|Overall Study|Death|42|||
147612244|NCT02370238|532395449|FG001|Overall Study|Death|35|||
147612245|NCT02370238|532395448|FG000|Overall Study|Lost to Follow-up|1|||
147612246|NCT02370238|532395449|FG001|Overall Study|Lost to Follow-up|3|||
147612247|NCT02370238|532395448|FG000|Overall Study|Withdrawal by Subject|2|||
147612248|NCT02370238|532395449|FG001|Overall Study|Withdrawal by Subject|6|||
147612249|NCT02370238|532395448|FG000|Overall Study|Other|2|||
147612250|NCT02370238|532395449|FG001|Overall Study|Other|1|||
147612251|NCT01807065|532395450|FG000|Overall Study|Receive no sip-T due to IV access|1|||
147612252|NCT01807065|532395451|FG001|Overall Study|Receive no sip-T due to IV access|1|||
147612253|NCT01153425|532395452|FG000|Overall Study|Withdrawal by Subject|3|||
147612254|NCT01153425|532395453|FG001|Overall Study|Withdrawal by Subject|3|||
147612255|NCT01482312|532395454|FG000|Period 1, 90 Minutes of Wear|Other|1|||
147612256|NCT01482312|532395455|FG001|Period 1, 90 Minutes of Wear|Other|0|||
147612257|NCT01482312|532395456|FG002|Period 1, 90 Minutes of Wear|Other|0|||
147612258|NCT01482312|532395454|FG000|Period 2, 90 Minutes of Wear|Other|1|||
147612259|NCT01482312|532395455|FG001|Period 2, 90 Minutes of Wear|Other|0|||
147612260|NCT01482312|532395456|FG002|Period 2, 90 Minutes of Wear|Other|0|||
147612261|NCT01699815|532395457|FG000|Overall Study|Protocol Violation|4|||
147612262|NCT01699815|532395458|FG001|Overall Study|Protocol Violation|7|||
147612263|NCT01699815|532395457|FG000|Overall Study|record could not be located|1|||
147612264|NCT01699815|532395458|FG001|Overall Study|record could not be located|0|||
147612265|NCT01699815|532395457|FG000|Overall Study|Adverse Event|0|||
147612266|NCT01699815|532395458|FG001|Overall Study|Adverse Event|1|||
147612267|NCT01295320|532395459|FG000|Overall Study|Adverse Event|2|||
147612268|NCT01295320|532395459|FG000|Overall Study|Lost to Follow-up|4|||
147612269|NCT01295320|532395459|FG000|Overall Study|Withdrawal by Subject|2|||
147612270|NCT01295320|532395459|FG000|Overall Study|Subject was bedridden|1|||
147612271|NCT01295320|532395459|FG000|Overall Study|Unable to travel|1|||
147612272|NCT04877457|532395462|FG000|Overall Study|Early termination of study due to low enrollment|2|||
147612273|NCT04877457|532395463|FG001|Overall Study|Early termination of study due to low enrollment|1|||
147612274|NCT02211417|532395464|FG000|Overall Study|Withdrawal by Subject|11|||
147612275|NCT02211417|532395465|FG001|Overall Study|Withdrawal by Subject|8|||
147612276|NCT02211417|532395464|FG000|Overall Study|Protocol Violation|1|||
147612277|NCT02211417|532395465|FG001|Overall Study|Protocol Violation|0|||
147612278|NCT02211417|532395464|FG000|Overall Study|Pregnancy|0|||
147612279|NCT02211417|532395465|FG001|Overall Study|Pregnancy|1|||
147612280|NCT02211417|532395464|FG000|Overall Study|Lost to Follow-up|2|||
147612281|NCT02211417|532395465|FG001|Overall Study|Lost to Follow-up|3|||
147612282|NCT02211417|532395464|FG000|Overall Study|Adverse Event|1|||
147612283|NCT02211417|532395465|FG001|Overall Study|Adverse Event|4|||
147664638|NCT02643693|532596310|FG003|Overall Study|Physician Decision|0|||
147376826|NCT00887224|531544520|FG002|Open-label Response (OLR) Phase|Other|0|||
147376827|NCT00887224|531544518|FG000|Open-label Response (OLR) Phase|Protocol Violation|12|||
147376828|NCT00887224|531544519|FG001|Open-label Response (OLR) Phase|Protocol Violation|0|||
147376829|NCT00887224|531544520|FG002|Open-label Response (OLR) Phase|Protocol Violation|0|||
147376830|NCT00887224|531544518|FG000|Open-label Response (OLR) Phase|Withdrawal by Subject|15|||
147376831|NCT00887224|531544519|FG001|Open-label Response (OLR) Phase|Withdrawal by Subject|0|||
147376832|NCT00887224|531544520|FG002|Open-label Response (OLR) Phase|Withdrawal by Subject|0|||
147376833|NCT00887224|531544518|FG000|Open-label Stability (OLS) Phase|Adverse Event|22|||
147376834|NCT00887224|531544519|FG001|Open-label Stability (OLS) Phase|Adverse Event|0|||
147376835|NCT00887224|531544520|FG002|Open-label Stability (OLS) Phase|Adverse Event|0|||
147376836|NCT00887224|531544518|FG000|Open-label Stability (OLS) Phase|Failed to return|3|||
147376837|NCT00887224|531544519|FG001|Open-label Stability (OLS) Phase|Failed to return|0|||
147376838|NCT00887224|531544520|FG002|Open-label Stability (OLS) Phase|Failed to return|0|||
147376839|NCT00887224|531544518|FG000|Open-label Stability (OLS) Phase|Lack of Efficacy|16|||
147376840|NCT00887224|531544519|FG001|Open-label Stability (OLS) Phase|Lack of Efficacy|0|||
147376841|NCT00887224|531544520|FG002|Open-label Stability (OLS) Phase|Lack of Efficacy|0|||
147376842|NCT00887224|531544518|FG000|Open-label Stability (OLS) Phase|Lost to Follow-up|9|||
147376843|NCT00887224|531544519|FG001|Open-label Stability (OLS) Phase|Lost to Follow-up|0|||
147376844|NCT00887224|531544520|FG002|Open-label Stability (OLS) Phase|Lost to Follow-up|0|||
147612284|NCT01198132|532395466|FG000|Overall Study|Withdrawal by Subject|4|||
147612285|NCT01198132|532395467|FG001|Overall Study|Withdrawal by Subject|5|||
147612286|NCT01198132|532395466|FG000|Overall Study|Physician Decision|5|||
147376845|NCT00887224|531544518|FG000|Open-label Stability (OLS) Phase|Other|1|||
147376846|NCT00887224|531544519|FG001|Open-label Stability (OLS) Phase|Other|0|||
147376847|NCT00887224|531544520|FG002|Open-label Stability (OLS) Phase|Other|0|||
147376848|NCT00887224|531544518|FG000|Open-label Stability (OLS) Phase|Protocol Violation|13|||
147376849|NCT00887224|531544519|FG001|Open-label Stability (OLS) Phase|Protocol Violation|0|||
147376850|NCT00887224|531544520|FG002|Open-label Stability (OLS) Phase|Protocol Violation|0|||
147376851|NCT00887224|531544518|FG000|Open-label Stability (OLS) Phase|Withdrawal by Subject|19|||
147376852|NCT00887224|531544519|FG001|Open-label Stability (OLS) Phase|Withdrawal by Subject|0|||
147376853|NCT00887224|531544520|FG002|Open-label Stability (OLS) Phase|Withdrawal by Subject|0|||
147376854|NCT00887224|531544518|FG000|OL Taper Phase / OL Follow Up|Adverse Event|28|||
147376855|NCT00887224|531544519|FG001|OL Taper Phase / OL Follow Up|Adverse Event|0|||
147376856|NCT00887224|531544520|FG002|OL Taper Phase / OL Follow Up|Adverse Event|0|||
147376857|NCT00887224|531544518|FG000|OL Taper Phase / OL Follow Up|Failed to return|17|||
147376858|NCT00887224|531544519|FG001|OL Taper Phase / OL Follow Up|Failed to return|0|||
147376859|NCT00887224|531544520|FG002|OL Taper Phase / OL Follow Up|Failed to return|0|||
147376860|NCT00887224|531544518|FG000|OL Taper Phase / OL Follow Up|Physician Decision|10|||
147376861|NCT00887224|531544519|FG001|OL Taper Phase / OL Follow Up|Physician Decision|0|||
147376862|NCT00887224|531544520|FG002|OL Taper Phase / OL Follow Up|Physician Decision|0|||
147376863|NCT00887224|531544518|FG000|OL Taper Phase / OL Follow Up|Lost to Follow-up|8|||
147376864|NCT00887224|531544519|FG001|OL Taper Phase / OL Follow Up|Lost to Follow-up|0|||
147376865|NCT00887224|531544520|FG002|OL Taper Phase / OL Follow Up|Lost to Follow-up|0|||
147376866|NCT00887224|531544518|FG000|OL Taper Phase / OL Follow Up|Other|30|||
147376867|NCT00887224|531544519|FG001|OL Taper Phase / OL Follow Up|Other|0|||
147376868|NCT00887224|531544520|FG002|OL Taper Phase / OL Follow Up|Other|0|||
147376869|NCT00887224|531544518|FG000|OL Taper Phase / OL Follow Up|Protocol Violation|3|||
147376870|NCT00887224|531544519|FG001|OL Taper Phase / OL Follow Up|Protocol Violation|0|||
147376871|NCT00887224|531544520|FG002|OL Taper Phase / OL Follow Up|Protocol Violation|0|||
147376872|NCT00887224|531544518|FG000|OL Taper Phase / OL Follow Up|Withdrawal by Subject|48|||
147376873|NCT00887224|531544519|FG001|OL Taper Phase / OL Follow Up|Withdrawal by Subject|0|||
147376874|NCT00887224|531544520|FG002|OL Taper Phase / OL Follow Up|Withdrawal by Subject|0|||
147376875|NCT00887224|531544518|FG000|Double-blind (DB) Phase|Adverse Event|0|||
147376876|NCT00887224|531544519|FG001|Double-blind (DB) Phase|Adverse Event|7|||
147376877|NCT00887224|531544520|FG002|Double-blind (DB) Phase|Adverse Event|2|||
147376878|NCT00887224|531544518|FG000|Double-blind (DB) Phase|Failed to return|0|||
147376879|NCT00887224|531544519|FG001|Double-blind (DB) Phase|Failed to return|2|||
147376880|NCT00887224|531544520|FG002|Double-blind (DB) Phase|Failed to return|2|||
147376881|NCT00887224|531544518|FG000|Double-blind (DB) Phase|Lack of Efficacy|0|||
147376882|NCT00887224|531544519|FG001|Double-blind (DB) Phase|Lack of Efficacy|67|||
147376883|NCT00887224|531544520|FG002|Double-blind (DB) Phase|Lack of Efficacy|33|||
147376884|NCT00887224|531544518|FG000|Double-blind (DB) Phase|Lost to Follow-up|0|||
147376885|NCT00887224|531544519|FG001|Double-blind (DB) Phase|Lost to Follow-up|8|||
147376886|NCT00887224|531544520|FG002|Double-blind (DB) Phase|Lost to Follow-up|8|||
147376887|NCT00887224|531544518|FG000|Double-blind (DB) Phase|Other|0|||
147376888|NCT00887224|531544519|FG001|Double-blind (DB) Phase|Other|2|||
147376889|NCT00887224|531544520|FG002|Double-blind (DB) Phase|Other|0|||
147376890|NCT00887224|531544518|FG000|Double-blind (DB) Phase|Protocol Violation|0|||
147376891|NCT00887224|531544519|FG001|Double-blind (DB) Phase|Protocol Violation|8|||
147376892|NCT00887224|531544520|FG002|Double-blind (DB) Phase|Protocol Violation|5|||
147376893|NCT00887224|531544518|FG000|Double-blind (DB) Phase|Withdrawal by Subject|0|||
147376894|NCT00887224|531544519|FG001|Double-blind (DB) Phase|Withdrawal by Subject|6|||
147376895|NCT00887224|531544520|FG002|Double-blind (DB) Phase|Withdrawal by Subject|12|||
147376896|NCT00887224|531544518|FG000|DB Taper Phase / Post Study Follow Up|Adverse Event|0|||
147376897|NCT00887224|531544519|FG001|DB Taper Phase / Post Study Follow Up|Adverse Event|5|||
147376898|NCT00887224|531544520|FG002|DB Taper Phase / Post Study Follow Up|Adverse Event|0|||
147376899|NCT00887224|531544518|FG000|DB Taper Phase / Post Study Follow Up|Failed to return|0|||
147376900|NCT00887224|531544519|FG001|DB Taper Phase / Post Study Follow Up|Failed to return|5|||
147376901|NCT00887224|531544520|FG002|DB Taper Phase / Post Study Follow Up|Failed to return|4|||
147376902|NCT00887224|531544518|FG000|DB Taper Phase / Post Study Follow Up|Physician Decision|0|||
147376903|NCT00887224|531544519|FG001|DB Taper Phase / Post Study Follow Up|Physician Decision|6|||
147376904|NCT00887224|531544520|FG002|DB Taper Phase / Post Study Follow Up|Physician Decision|0|||
147376905|NCT00887224|531544518|FG000|DB Taper Phase / Post Study Follow Up|Lost to Follow-up|0|||
147376906|NCT00887224|531544519|FG001|DB Taper Phase / Post Study Follow Up|Lost to Follow-up|2|||
147376907|NCT00887224|531544520|FG002|DB Taper Phase / Post Study Follow Up|Lost to Follow-up|2|||
147376908|NCT00887224|531544518|FG000|DB Taper Phase / Post Study Follow Up|Other|0|||
147376909|NCT00887224|531544519|FG001|DB Taper Phase / Post Study Follow Up|Other|11|||
147376910|NCT00887224|531544520|FG002|DB Taper Phase / Post Study Follow Up|Other|12|||
147376911|NCT00887224|531544518|FG000|DB Taper Phase / Post Study Follow Up|Protocol Violation|0|||
147376912|NCT00887224|531544519|FG001|DB Taper Phase / Post Study Follow Up|Protocol Violation|4|||
147376913|NCT00887224|531544520|FG002|DB Taper Phase / Post Study Follow Up|Protocol Violation|1|||
147455621|NCT01453855|531829883|FG000|Overall Study|Adverse Event|3|||
147376914|NCT00887224|531544518|FG000|DB Taper Phase / Post Study Follow Up|Withdrawal by Subject|0|||
147376915|NCT00887224|531544519|FG001|DB Taper Phase / Post Study Follow Up|Withdrawal by Subject|8|||
147376916|NCT00887224|531544520|FG002|DB Taper Phase / Post Study Follow Up|Withdrawal by Subject|11|||
147376917|NCT01698918|531544523|FG000|First Line Treatment (Core+Extension)|Adverse Event|33|||
147376918|NCT01698918|531544523|FG000|First Line Treatment (Core+Extension)|Withdrawal by Subject|11|||
147376919|NCT01698918|531544523|FG000|First Line Treatment (Core+Extension)|Death|2|||
147376920|NCT01698918|531544523|FG000|First Line Treatment (Core+Extension)|Disease progression|120|||
147376921|NCT01698918|531544523|FG000|First Line Treatment (Core+Extension)|Physician Decision|7|||
147376922|NCT01698918|531544523|FG000|Second Line Treatment (Core+Extension)|Adverse Event|3|||
147376923|NCT01698918|531544523|FG000|Second Line Treatment (Core+Extension)|Withdrawal by Subject|1|||
147376924|NCT01698918|531544523|FG000|Second Line Treatment (Core+Extension)|Death|1|||
147376925|NCT01698918|531544523|FG000|Second Line Treatment (Core+Extension)|Disease progression|38|||
147376926|NCT01698918|531544523|FG000|Second Line Treatment (Core+Extension)|Physician Decision|3|||
147376927|NCT04693637|531544527|FG000|Overall Study|Death|4|||
147376928|NCT04693637|531544527|FG000|Overall Study|Withdrawal by Subject|3|||
147376929|NCT04693637|531544527|FG000|Overall Study|Physician Decision|2|||
147376930|NCT04693637|531544527|FG000|Overall Study|Lost to Follow-up|1|||
147376931|NCT05553366|531544530|FG000|Overall Study|Withdrawal of Consent (not due to AE|4|||
147376932|NCT05553366|531544531|FG001|Overall Study|Withdrawal of Consent (not due to AE|8|||
147376933|NCT05553366|531544532|FG002|Overall Study|Withdrawal of Consent (not due to AE|5|||
147376934|NCT05553366|531544530|FG000|Overall Study|Lost to Follow-up|3|||
147376935|NCT05553366|531544531|FG001|Overall Study|Lost to Follow-up|3|||
147376936|NCT05553366|531544532|FG002|Overall Study|Lost to Follow-up|3|||
147376937|NCT05553366|531544530|FG000|Overall Study|Other non-compliance|1|||
147376938|NCT05553366|531544531|FG001|Overall Study|Other non-compliance|1|||
147376939|NCT05553366|531544532|FG002|Overall Study|Other non-compliance|0|||
147376940|NCT05553366|531544530|FG000|Overall Study|Randomized but not dosed|0|||
147376941|NCT05553366|531544531|FG001|Overall Study|Randomized but not dosed|0|||
147376942|NCT05553366|531544532|FG002|Overall Study|Randomized but not dosed|2|||
147376943|NCT00795184|531544538|FG000|Overall Study|Tissue sampling incomplete/conclusive|8|||
147376944|NCT00795184|531544539|FG001|Overall Study|Tissue sampling incomplete/conclusive|13|||
147376945|NCT03781375|531544540|FG000|Double-blind Phase|Adverse Event|0|||
147376946|NCT03781375|531544541|FG001|Double-blind Phase|Adverse Event|1|||
147376947|NCT03781375|531544540|FG000|Double-blind Phase|Lack of Response|6|||
147612287|NCT01198132|532395467|FG001|Overall Study|Physician Decision|4|||
147612288|NCT01198132|532395466|FG000|Overall Study|Other Unspecified|3|||
147612289|NCT01198132|532395467|FG001|Overall Study|Other Unspecified|6|||
147376948|NCT03781375|531544541|FG001|Double-blind Phase|Lack of Response|2|||
147376949|NCT03781375|531544540|FG000|Double-blind Phase|Other|1|||
147612290|NCT01198132|532395466|FG000|Overall Study|Lack of Efficacy|2|||
147612291|NCT01198132|532395467|FG001|Overall Study|Lack of Efficacy|3|||
147376950|NCT03781375|531544541|FG001|Double-blind Phase|Other|3|||
147376951|NCT03781375|531544540|FG000|Open-label Phase|Protocol Issues|0|||
147376952|NCT03781375|531544541|FG001|Open-label Phase|Protocol Issues|1|||
147376953|NCT03781375|531544540|FG000|Open-label Phase|Suboptimal Clinical Response|1|||
147376954|NCT03781375|531544541|FG001|Open-label Phase|Suboptimal Clinical Response|0|||
147376955|NCT03781375|531544540|FG000|Open-label Phase|Other|2|||
147376956|NCT03781375|531544541|FG001|Open-label Phase|Other|2|||
147376957|NCT02079649|531544542|FG000|Overall Study|Lost to Follow-up|0|||
147376958|NCT02079649|531544543|FG001|Overall Study|Lost to Follow-up|0|||
147376959|NCT02079649|531544544|FG002|Overall Study|Lost to Follow-up|0|||
147376960|NCT02079649|531544545|FG003|Overall Study|Lost to Follow-up|1|||
147376961|NCT02079649|531544542|FG000|Overall Study|Withdrawal by Subject|0|||
147376962|NCT02079649|531544543|FG001|Overall Study|Withdrawal by Subject|0|||
147376963|NCT02079649|531544544|FG002|Overall Study|Withdrawal by Subject|0|||
147376964|NCT02079649|531544545|FG003|Overall Study|Withdrawal by Subject|1|||
147376965|NCT02079649|531544542|FG000|Overall Study|Randomization error (prior to treatment)|1|||
147376966|NCT02079649|531544543|FG001|Overall Study|Randomization error (prior to treatment)|0|||
147376967|NCT02079649|531544544|FG002|Overall Study|Randomization error (prior to treatment)|1|||
147455622|NCT01453855|531829884|FG001|Overall Study|Adverse Event|4|||
147612292|NCT01198132|532395466|FG000|Overall Study|Sign/symptoms of underlying disease|2|||
147612293|NCT01198132|532395467|FG001|Overall Study|Sign/symptoms of underlying disease|1|||
147612294|NCT01198132|532395466|FG000|Overall Study|Abnormal/clinically significant biologic|1|||
147612295|NCT01198132|532395467|FG001|Overall Study|Abnormal/clinically significant biologic|1|||
147612296|NCT01198132|532395466|FG000|Overall Study|Adverse Event|0|||
147612297|NCT01198132|532395467|FG001|Overall Study|Adverse Event|1|||
147612298|NCT01198132|532395466|FG000|Overall Study|Protocol Violation|1|||
147612299|NCT01198132|532395467|FG001|Overall Study|Protocol Violation|0|||
147612300|NCT01755091|532395468|FG000|Overall Study|Withdrawal by Subject|6|||
147612301|NCT01755091|532395469|FG001|Overall Study|Withdrawal by Subject|1|||
147612302|NCT01755091|532395470|FG002|Overall Study|Withdrawal by Subject|3|||
147612303|NCT01755091|532395468|FG000|Overall Study|Adverse Event|1|||
147612304|NCT01755091|532395469|FG001|Overall Study|Adverse Event|1|||
147612305|NCT01755091|532395470|FG002|Overall Study|Adverse Event|1|||
147376968|NCT02079649|531544545|FG003|Overall Study|Randomization error (prior to treatment)|0|||
147376969|NCT01034306|531544546|FG000|Overall Study|Adverse Event|1|||
147376970|NCT01034306|531544547|FG001|Overall Study|Adverse Event|0|||
147376971|NCT01034306|531544546|FG000|Overall Study|Lost to Follow-up|0|||
147376972|NCT01034306|531544547|FG001|Overall Study|Lost to Follow-up|1|||
147376973|NCT01034306|531544546|FG000|Overall Study|Withdrawal by Subject|2|||
147376974|NCT01034306|531544547|FG001|Overall Study|Withdrawal by Subject|2|||
147376975|NCT01034306|531544546|FG000|Overall Study|hospitalized and decided to stop|1|||
147376976|NCT01034306|531544547|FG001|Overall Study|hospitalized and decided to stop|0|||
147376977|NCT01034306|531544546|FG000|Overall Study|Noncomplience|1|||
147376978|NCT01034306|531544547|FG001|Overall Study|Noncomplience|0|||
147376979|NCT00836498|531544548|FG000|Overall Study|Adverse Event|1|||
147376980|NCT00836498|531544549|FG001|Overall Study|Adverse Event|0|||
147376981|NCT00836498|531544548|FG000|Overall Study|Lost to Follow-up|1|||
147376982|NCT00836498|531544549|FG001|Overall Study|Lost to Follow-up|0|||
147376983|NCT00836498|531544548|FG000|Overall Study|Withdrawal by Subject|2|||
147376984|NCT00836498|531544549|FG001|Overall Study|Withdrawal by Subject|1|||
147376985|NCT01968967|531544550|FG000|Treatment Period|Other|22|||
147376986|NCT01968967|531544551|FG001|Treatment Period|Other|22|||
147376987|NCT01968967|531544552|FG002|Treatment Period|Other|0|||
147376988|NCT01968967|531544553|FG003|Treatment Period|Other|0|||
147376989|NCT01968967|531544554|FG004|Treatment Period|Other|0|||
147376990|NCT01968967|531544550|FG000|Treatment Period|Withdrawal by Subject|71|||
147376991|NCT01968967|531544551|FG001|Treatment Period|Withdrawal by Subject|61|||
147376992|NCT01968967|531544552|FG002|Treatment Period|Withdrawal by Subject|0|||
147376993|NCT01968967|531544553|FG003|Treatment Period|Withdrawal by Subject|0|||
147376994|NCT01968967|531544554|FG004|Treatment Period|Withdrawal by Subject|0|||
147376995|NCT01968967|531544550|FG000|Treatment Period|Did Not Meet Entrance Criteria|2|||
147376996|NCT01968967|531544551|FG001|Treatment Period|Did Not Meet Entrance Criteria|3|||
147376997|NCT01968967|531544552|FG002|Treatment Period|Did Not Meet Entrance Criteria|0|||
147376998|NCT01968967|531544553|FG003|Treatment Period|Did Not Meet Entrance Criteria|0|||
147376999|NCT01968967|531544554|FG004|Treatment Period|Did Not Meet Entrance Criteria|0|||
147377000|NCT01968967|531544550|FG000|Treatment Period|Lost to Follow-up|26|||
147377001|NCT01968967|531544551|FG001|Treatment Period|Lost to Follow-up|31|||
147377002|NCT01968967|531544552|FG002|Treatment Period|Lost to Follow-up|0|||
147377003|NCT01968967|531544553|FG003|Treatment Period|Lost to Follow-up|0|||
147377004|NCT01968967|531544554|FG004|Treatment Period|Lost to Follow-up|0|||
147377005|NCT01968967|531544550|FG000|Treatment Period|Protocol Violation|1|||
147377006|NCT01968967|531544551|FG001|Treatment Period|Protocol Violation|2|||
147377007|NCT01968967|531544552|FG002|Treatment Period|Protocol Violation|0|||
147377008|NCT01968967|531544553|FG003|Treatment Period|Protocol Violation|0|||
147377009|NCT01968967|531544554|FG004|Treatment Period|Protocol Violation|0|||
147377010|NCT01968967|531544550|FG000|Treatment Period|Adverse Event|9|||
147377011|NCT01968967|531544551|FG001|Treatment Period|Adverse Event|8|||
147377012|NCT01968967|531544552|FG002|Treatment Period|Adverse Event|0|||
147377013|NCT01968967|531544553|FG003|Treatment Period|Adverse Event|0|||
147377014|NCT01968967|531544554|FG004|Treatment Period|Adverse Event|0|||
147377015|NCT01968967|531544550|FG000|Treatment Period|Death|9|||
147377016|NCT01968967|531544551|FG001|Treatment Period|Death|2|||
147377017|NCT01968967|531544552|FG002|Treatment Period|Death|0|||
147377018|NCT01968967|531544553|FG003|Treatment Period|Death|0|||
147377019|NCT01968967|531544554|FG004|Treatment Period|Death|0|||
147377020|NCT01968967|531544550|FG000|Treatment Period|Randomized Not Treated|6|||
147377021|NCT01968967|531544551|FG001|Treatment Period|Randomized Not Treated|5|||
147377022|NCT01968967|531544552|FG002|Treatment Period|Randomized Not Treated|0|||
147377023|NCT01968967|531544553|FG003|Treatment Period|Randomized Not Treated|0|||
147377024|NCT01968967|531544554|FG004|Treatment Period|Randomized Not Treated|0|||
147377025|NCT01968967|531544550|FG000|Extension Period|Withdrew Consent|0|||
147377026|NCT01968967|531544551|FG001|Extension Period|Withdrew Consent|0|||
147377027|NCT01968967|531544552|FG002|Extension Period|Withdrew Consent|2|||
147377028|NCT01968967|531544553|FG003|Extension Period|Withdrew Consent|0|||
147377029|NCT01968967|531544554|FG004|Extension Period|Withdrew Consent|5|||
147455623|NCT01453855|531829883|FG000|Overall Study|Lost to Follow-up|2|||
147455624|NCT01453855|531829884|FG001|Overall Study|Lost to Follow-up|1|||
147377030|NCT03489369|531544555|FG000|Overall Study|Documented Progressive Disease|3|||
147377031|NCT03489369|531544556|FG001|Overall Study|Documented Progressive Disease|2|||
147377032|NCT03489369|531544557|FG002|Overall Study|Documented Progressive Disease|3|||
147377033|NCT03489369|531544558|FG003|Overall Study|Documented Progressive Disease|6|||
147377034|NCT03489369|531544555|FG000|Overall Study|Clinical Progression (Worsening of Clini|0|||
147455625|NCT01453855|531829883|FG000|Overall Study|Patient Decision Unrel to Adverse Event|3|||
147455626|NCT01453855|531829884|FG001|Overall Study|Patient Decision Unrel to Adverse Event|3|||
147455627|NCT01453855|531829883|FG000|Overall Study|Noncompliance|1|||
147612306|NCT01755091|532395468|FG000|Overall Study|Lost to Follow-up|1|||
147377035|NCT03489369|531544556|FG001|Overall Study|Clinical Progression (Worsening of Clini|1|||
147377036|NCT03489369|531544557|FG002|Overall Study|Clinical Progression (Worsening of Clini|0|||
147377037|NCT03489369|531544558|FG003|Overall Study|Clinical Progression (Worsening of Clini|0|||
147455628|NCT01453855|531829884|FG001|Overall Study|Noncompliance|0|||
147455629|NCT01453855|531829883|FG000|Overall Study|Inadequate Control of IOP|1|||
147455630|NCT01453855|531829884|FG001|Overall Study|Inadequate Control of IOP|5|||
147455631|NCT01453855|531829883|FG000|Overall Study|Other|0|||
147455632|NCT01453855|531829884|FG001|Overall Study|Other|1|||
147455633|NCT01496066|531829890|FG000|Overall Study|Lost to Follow-up|8|||
147455634|NCT01496066|531829891|FG001|Overall Study|Lost to Follow-up|5|||
147455635|NCT01496066|531829890|FG000|Overall Study|Explant|3|||
147455636|NCT01496066|531829891|FG001|Overall Study|Explant|0|||
147455637|NCT01496066|531829890|FG000|Overall Study|Death|1|||
147455638|NCT01496066|531829891|FG001|Overall Study|Death|4|||
147455639|NCT02926209|531829892|FG000|Study Cohort|Poor Bowel Preparation|1|||
147455640|NCT02926209|531829893|FG001|Study Cohort|Poor Bowel Preparation|0|||
147455641|NCT01587079|531829894|FG000|Overall Study|Protocol-specified criteria|9|||
147455642|NCT01587079|531829894|FG000|Overall Study|Protocol Violation|5|||
147455643|NCT01587079|531829894|FG000|Overall Study|Lost to Follow-up|2|||
147612307|NCT01755091|532395469|FG001|Overall Study|Lost to Follow-up|0|||
147612308|NCT01755091|532395470|FG002|Overall Study|Lost to Follow-up|1|||
147612309|NCT01755091|532395468|FG000|Overall Study|Physician Decision|1|||
147377038|NCT02384382|531544565|FG000|Overall Study|Transitioned to study-NCT02960022|5|||
147377039|NCT02384382|531544565|FG000|Overall Study|Death|1|||
147377040|NCT02384382|531544565|FG000|Overall Study|Adverse Event|1|||
147377041|NCT02384382|531544565|FG000|Overall Study|Disease progression|16|||
147377042|NCT02113449|531544566|FG000|Overall Study|Adverse Event|4|||
147377043|NCT01328496|531544567|FG000|Overall Study|Significant Change in Health Status|1|||
147377044|NCT01328496|531544568|FG001|Overall Study|Significant Change in Health Status|0|||
147377045|NCT02091752|531544571|FG000|Overall Study|Study terminated by Sponsor|2|||
147377046|NCT02091752|531544571|FG000|Overall Study|Adverse Event|1|||
147377047|NCT04029090|531544572|FG000|Overall Study|Protocol Violation|1|||
147377048|NCT04029090|531544573|FG001|Overall Study|Protocol Violation|0|||
147377049|NCT04029090|531544574|FG002|Overall Study|Protocol Violation|0|||
147377050|NCT04029090|531544572|FG000|Overall Study|Withdrawal by Subject|0|||
147377051|NCT04029090|531544573|FG001|Overall Study|Withdrawal by Subject|1|||
147377052|NCT04029090|531544574|FG002|Overall Study|Withdrawal by Subject|0|||
147377053|NCT01065779|531544575|FG000|Overall Study|Duplicate Investigation|1|||
147377054|NCT01065779|531544575|FG000|Overall Study|Investigation Before Contract Date|37|||
147377055|NCT01065779|531544575|FG000|Overall Study|Non-enrollment Period Administration|10|||
147377056|NCT01065779|531544575|FG000|Overall Study|Not Administered With Study Drug|17|||
147377057|NCT01065779|531544575|FG000|Overall Study|Failed to Follow-up|10|||
147377058|NCT01065779|531544575|FG000|Overall Study|Inclusion Criteria Violation|7|||
147377059|NCT02157948|531544576|FG000|Overall Study|Withdrawal by Subject|4|||
147377060|NCT02157948|531544577|FG001|Overall Study|Withdrawal by Subject|5|||
147377061|NCT02157948|531544576|FG000|Overall Study|Lost to Follow-up|3|||
147377062|NCT02157948|531544577|FG001|Overall Study|Lost to Follow-up|2|||
147377063|NCT02157948|531544576|FG000|Overall Study|Protocol Specified Criteria|2|||
147377064|NCT02157948|531544577|FG001|Overall Study|Protocol Specified Criteria|1|||
147377065|NCT02157948|531544576|FG000|Overall Study|Decision by Sponsor|0|||
147377066|NCT02157948|531544577|FG001|Overall Study|Decision by Sponsor|1|||
147377067|NCT01604824|531544579|FG000|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0|||
147377068|NCT01604824|531544580|FG001|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0|||
147377069|NCT01604824|531544581|FG002|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0|||
147377070|NCT01604824|531544582|FG003|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0|||
147377071|NCT01604824|531544583|FG004|Open-label Extension (OLE) Period|Chose not to enter OLE Period|2|||
147612310|NCT01755091|532395469|FG001|Overall Study|Physician Decision|1|||
147612311|NCT01755091|532395470|FG002|Overall Study|Physician Decision|2|||
147612312|NCT03071276|532395471|FG000|Overall Study|Adverse Event|1|||
147612313|NCT03071276|532395471|FG000|Overall Study|Lack of Efficacy|14|||
147612314|NCT05794503|532395472|FG000|Overall Study|Operation Cancelled|2|||
147612315|NCT05794503|532395473|FG001|Overall Study|Operation Cancelled|0|||
147612316|NCT05794503|532395472|FG000|Overall Study|Received Neostigmine + Sugammadex|2|||
147612317|NCT05794503|532395473|FG001|Overall Study|Received Neostigmine + Sugammadex|0|||
147612318|NCT05794503|532395472|FG000|Overall Study|Protocol Violation|1|||
147612319|NCT05794503|532395473|FG001|Overall Study|Protocol Violation|0|||
147612320|NCT00509795|532395474|FG000|Overall Study|Adverse Event|4|||
147612321|NCT00509795|532395475|FG001|Overall Study|Adverse Event|3|||
147612322|NCT00509795|532395476|FG002|Overall Study|Adverse Event|5|||
147612323|NCT00509795|532395477|FG003|Overall Study|Adverse Event|4|||
147612324|NCT00509795|532395474|FG000|Overall Study|Death|3|||
147612325|NCT00509795|532395475|FG001|Overall Study|Death|1|||
147612326|NCT00509795|532395476|FG002|Overall Study|Death|2|||
147612327|NCT00509795|532395477|FG003|Overall Study|Death|7|||
147377072|NCT01604824|531544584|FG005|Open-label Extension (OLE) Period|Chose not to enter OLE Period|0|||
147377073|NCT01604824|531544579|FG000|Open-label Extension (OLE) Period|Refused to come into office|0|||
147377074|NCT01604824|531544580|FG001|Open-label Extension (OLE) Period|Refused to come into office|0|||
147455644|NCT01587079|531829894|FG000|Overall Study|Physician Decision|2|||
147455645|NCT01587079|531829894|FG000|Overall Study|Withdrawal by Subject|7|||
147455646|NCT01587079|531829894|FG000|Overall Study|Adverse Event|14|||
147455647|NCT01764633|531829896|FG000|Overall Study|Withdrawal by Subject|105|||
147455648|NCT01764633|531829897|FG001|Overall Study|Withdrawal by Subject|88|||
147455649|NCT01764633|531829896|FG000|Overall Study|Lost to Follow-up|13|||
147455650|NCT01764633|531829897|FG001|Overall Study|Lost to Follow-up|5|||
147455651|NCT04142983|531829899|FG000|Overall Study|Lost to Follow-up|73|||
147455652|NCT04142983|531829899|FG000|Overall Study|Withdrawal by Subject|10|||
147455653|NCT04142983|531829899|FG000|Overall Study|Physician Decision|1|||
147455654|NCT04142983|531829899|FG000|Overall Study|Adverse Event|1|||
147455655|NCT04142983|531829899|FG000|Overall Study|No longer eligible|4|||
147455656|NCT04142983|531829899|FG000|Overall Study|Screen Failure|10|||
147455657|NCT02062658|531829901|FG000|Overall Study|Withdrawal by Subject|1|||
147455658|NCT02062658|531829901|FG000|Overall Study|Lack of Efficacy|1|||
147455659|NCT01789970|531829902|FG000|Open-label Titration Period|Adverse Event|68|||
147455660|NCT01789970|531829903|FG001|Open-label Titration Period|Adverse Event|0|||
147455661|NCT01789970|531829904|FG002|Open-label Titration Period|Adverse Event|0|||
147455662|NCT01789970|531829902|FG000|Open-label Titration Period|Lack of Efficacy|31|||
147455663|NCT01789970|531829903|FG001|Open-label Titration Period|Lack of Efficacy|0|||
147455664|NCT01789970|531829904|FG002|Open-label Titration Period|Lack of Efficacy|0|||
147455665|NCT01789970|531829902|FG000|Open-label Titration Period|Withdrawal by Subject|31|||
147455666|NCT01789970|531829903|FG001|Open-label Titration Period|Withdrawal by Subject|0|||
147455667|NCT01789970|531829904|FG002|Open-label Titration Period|Withdrawal by Subject|0|||
147455668|NCT01789970|531829902|FG000|Open-label Titration Period|Protocol Violation|18|||
147455669|NCT01789970|531829903|FG001|Open-label Titration Period|Protocol Violation|0|||
147455670|NCT01789970|531829904|FG002|Open-label Titration Period|Protocol Violation|0|||
147455671|NCT01789970|531829902|FG000|Open-label Titration Period|Lost to Follow-up|5|||
147455672|NCT01789970|531829903|FG001|Open-label Titration Period|Lost to Follow-up|0|||
147455673|NCT01789970|531829904|FG002|Open-label Titration Period|Lost to Follow-up|0|||
147455674|NCT01789970|531829902|FG000|Open-label Titration Period|Noncompliance to study drug admin|11|||
147455675|NCT01789970|531829903|FG001|Open-label Titration Period|Noncompliance to study drug admin|0|||
147455676|NCT01789970|531829904|FG002|Open-label Titration Period|Noncompliance to study drug admin|0|||
147455677|NCT01789970|531829902|FG000|Open-label Titration Period|Noncompliance with study rescue meds|2|||
147455678|NCT01789970|531829903|FG001|Open-label Titration Period|Noncompliance with study rescue meds|0|||
147455679|NCT01789970|531829904|FG002|Open-label Titration Period|Noncompliance with study rescue meds|0|||
147455680|NCT01789970|531829902|FG000|Open-label Titration Period|Noncompliance with study procedures|8|||
147455681|NCT01789970|531829903|FG001|Open-label Titration Period|Noncompliance with study procedures|0|||
147455682|NCT01789970|531829904|FG002|Open-label Titration Period|Noncompliance with study procedures|0|||
147455683|NCT01789970|531829902|FG000|Open-label Titration Period|Pregnancy|2|||
147455684|NCT01789970|531829903|FG001|Open-label Titration Period|Pregnancy|0|||
147455685|NCT01789970|531829904|FG002|Open-label Titration Period|Pregnancy|0|||
147377075|NCT01604824|531544581|FG002|Open-label Extension (OLE) Period|Refused to come into office|0|||
147377076|NCT01604824|531544582|FG003|Open-label Extension (OLE) Period|Refused to come into office|0|||
147377077|NCT01604824|531544583|FG004|Open-label Extension (OLE) Period|Refused to come into office|1|||
147377078|NCT01604824|531544584|FG005|Open-label Extension (OLE) Period|Refused to come into office|0|||
147377079|NCT03822832|531544589|FG000|Period 1 - Double Blind Period|Withdrawal by Subject|3|||
147377080|NCT03822832|531544590|FG001|Period 1 - Double Blind Period|Withdrawal by Subject|3|||
147377081|NCT03822832|531544589|FG000|Period 1 - Double Blind Period|Lost to Follow-up|1|||
147377082|NCT03822832|531544590|FG001|Period 1 - Double Blind Period|Lost to Follow-up|1|||
147377083|NCT03822832|531544589|FG000|Period 1 - Double Blind Period|Protocol Violation|1|||
147377084|NCT03822832|531544590|FG001|Period 1 - Double Blind Period|Protocol Violation|1|||
147377085|NCT03822832|531544589|FG000|Period 1 - Double Blind Period|Lack of Efficacy|2|||
147377086|NCT03822832|531544590|FG001|Period 1 - Double Blind Period|Lack of Efficacy|1|||
147377087|NCT03822832|531544589|FG000|Period 1 - Double Blind Period|Adverse Event|3|||
147377088|NCT03822832|531544590|FG001|Period 1 - Double Blind Period|Adverse Event|5|||
147377089|NCT03822832|531544589|FG000|Re-allocation|Not re-allocated to open label period|2|||
147377090|NCT03822832|531544590|FG001|Re-allocation|Not re-allocated to open label period|6|||
147377091|NCT03822832|531544589|FG000|Period 2 - Open Label Period|Lost to Follow-up|1|||
147377092|NCT03822832|531544590|FG001|Period 2 - Open Label Period|Lost to Follow-up|0|||
147377093|NCT03822832|531544589|FG000|Period 2 - Open Label Period|Adverse Event|0|||
147377094|NCT03822832|531544590|FG001|Period 2 - Open Label Period|Adverse Event|3|||
147377095|NCT04248803|531544595|FG000|Overall Study|Lost to Follow-up|7|||
147377096|NCT04248803|531544596|FG001|Overall Study|Lost to Follow-up|7|||
147377097|NCT04248803|531544597|FG002|Overall Study|Lost to Follow-up|7|||
147377098|NCT04248803|531544598|FG003|Overall Study|Lost to Follow-up|7|||
147377099|NCT04248803|531544599|FG004|Overall Study|Lost to Follow-up|7|||
147377100|NCT04248803|531544600|FG005|Overall Study|Lost to Follow-up|7|||
147377101|NCT05352230|531544601|FG000|First Intervention (3 Months)|study terminated|2|||
147455686|NCT01789970|531829902|FG000|Open-label Titration Period|Other|76|||
147455687|NCT01789970|531829903|FG001|Open-label Titration Period|Other|0|||
147455688|NCT01789970|531829904|FG002|Open-label Titration Period|Other|0|||
147455689|NCT01789970|531829902|FG000|Open-label Titration Period|Dropped out prior to dosing|2|||
147455690|NCT01789970|531829903|FG001|Open-label Titration Period|Dropped out prior to dosing|0|||
147455691|NCT01789970|531829904|FG002|Open-label Titration Period|Dropped out prior to dosing|0|||
147377102|NCT05352230|531544602|FG001|First Intervention (3 Months)|study terminated|2|||
147377103|NCT04399837|531544604|FG000|Overall Study|Other than listed|0|||
147377104|NCT04399837|531544605|FG001|Overall Study|Other than listed|2|||
147377105|NCT04399837|531544606|FG002|Overall Study|Other than listed|2|||
147377106|NCT04399837|531544607|FG003|Overall Study|Other than listed|3|||
147664639|NCT02643693|532596311|FG004|Overall Study|Physician Decision|0|||
147664640|NCT02643693|532596312|FG005|Overall Study|Physician Decision|0|||
147664641|NCT02643693|532596307|FG000|Overall Study|Withdrawal by Subject|0|||
147664642|NCT02643693|532596308|FG001|Overall Study|Withdrawal by Subject|1|||
147664643|NCT02643693|532596309|FG002|Overall Study|Withdrawal by Subject|0|||
147664644|NCT02643693|532596310|FG003|Overall Study|Withdrawal by Subject|0|||
147664645|NCT02643693|532596311|FG004|Overall Study|Withdrawal by Subject|0|||
147664646|NCT02643693|532596312|FG005|Overall Study|Withdrawal by Subject|0|||
147664647|NCT02643693|532596307|FG000|Overall Study|Protocol Adherence Issues|2|||
147377107|NCT04399837|531544604|FG000|Overall Study|Withdrawal by Subject|1|||
147377108|NCT04399837|531544605|FG001|Overall Study|Withdrawal by Subject|2|||
147377109|NCT04399837|531544606|FG002|Overall Study|Withdrawal by Subject|1|||
147377110|NCT04399837|531544607|FG003|Overall Study|Withdrawal by Subject|1|||
147377111|NCT00614614|531544614|FG000|Primary Vaccination Phase|Adverse Event|6|||
147377112|NCT00614614|531544615|FG001|Primary Vaccination Phase|Adverse Event|0|||
147377113|NCT00614614|531544616|FG002|Primary Vaccination Phase|Adverse Event|0|||
147377114|NCT00614614|531544617|FG003|Primary Vaccination Phase|Adverse Event|0|||
147377115|NCT00614614|531544618|FG004|Primary Vaccination Phase|Adverse Event|0|||
147377116|NCT00614614|531544614|FG000|Primary Vaccination Phase|Withdrawal by Subject|45|||
147377117|NCT00614614|531544615|FG001|Primary Vaccination Phase|Withdrawal by Subject|6|||
147377118|NCT00614614|531544616|FG002|Primary Vaccination Phase|Withdrawal by Subject|0|||
147377119|NCT00614614|531544617|FG003|Primary Vaccination Phase|Withdrawal by Subject|0|||
147377120|NCT00614614|531544618|FG004|Primary Vaccination Phase|Withdrawal by Subject|0|||
147377121|NCT00614614|531544614|FG000|Primary Vaccination Phase|Lost to Follow-up|26|||
147377122|NCT00614614|531544615|FG001|Primary Vaccination Phase|Lost to Follow-up|8|||
147377123|NCT00614614|531544616|FG002|Primary Vaccination Phase|Lost to Follow-up|0|||
147377124|NCT00614614|531544617|FG003|Primary Vaccination Phase|Lost to Follow-up|0|||
147377125|NCT00614614|531544618|FG004|Primary Vaccination Phase|Lost to Follow-up|0|||
147377126|NCT00614614|531544614|FG000|Primary Vaccination Phase|Protocol Violation|9|||
147377127|NCT00614614|531544615|FG001|Primary Vaccination Phase|Protocol Violation|3|||
147377128|NCT00614614|531544616|FG002|Primary Vaccination Phase|Protocol Violation|0|||
147377129|NCT00614614|531544617|FG003|Primary Vaccination Phase|Protocol Violation|0|||
147377130|NCT00614614|531544618|FG004|Primary Vaccination Phase|Protocol Violation|0|||
147377131|NCT00614614|531544614|FG000|Primary Vaccination Phase|Other|4|||
147377132|NCT00614614|531544615|FG001|Primary Vaccination Phase|Other|0|||
147377133|NCT00614614|531544616|FG002|Primary Vaccination Phase|Other|0|||
147377134|NCT00614614|531544617|FG003|Primary Vaccination Phase|Other|0|||
147377135|NCT00614614|531544618|FG004|Primary Vaccination Phase|Other|0|||
147377136|NCT00614614|531544614|FG000|Booster Vaccination Phase|Adverse Event|0|||
147377137|NCT00614614|531544615|FG001|Booster Vaccination Phase|Adverse Event|0|||
147377138|NCT00614614|531544616|FG002|Booster Vaccination Phase|Adverse Event|1|||
147377139|NCT00614614|531544617|FG003|Booster Vaccination Phase|Adverse Event|1|||
147377140|NCT00614614|531544618|FG004|Booster Vaccination Phase|Adverse Event|0|||
147377141|NCT00614614|531544614|FG000|Booster Vaccination Phase|Withdrawal by Subject|0|||
147377142|NCT00614614|531544615|FG001|Booster Vaccination Phase|Withdrawal by Subject|0|||
147377143|NCT00614614|531544616|FG002|Booster Vaccination Phase|Withdrawal by Subject|4|||
147377144|NCT00614614|531544617|FG003|Booster Vaccination Phase|Withdrawal by Subject|3|||
147377145|NCT00614614|531544618|FG004|Booster Vaccination Phase|Withdrawal by Subject|4|||
147377146|NCT00614614|531544614|FG000|Booster Vaccination Phase|Lost to Follow-up|0|||
147377147|NCT00614614|531544615|FG001|Booster Vaccination Phase|Lost to Follow-up|5|||
147377148|NCT00614614|531544616|FG002|Booster Vaccination Phase|Lost to Follow-up|17|||
147377149|NCT00614614|531544617|FG003|Booster Vaccination Phase|Lost to Follow-up|10|||
147377150|NCT00614614|531544618|FG004|Booster Vaccination Phase|Lost to Follow-up|8|||
147377151|NCT00614614|531544614|FG000|Booster Vaccination Phase|Protocol Violation|0|||
147377152|NCT00614614|531544615|FG001|Booster Vaccination Phase|Protocol Violation|0|||
147377153|NCT00614614|531544616|FG002|Booster Vaccination Phase|Protocol Violation|2|||
147377154|NCT00614614|531544617|FG003|Booster Vaccination Phase|Protocol Violation|3|||
147377155|NCT00614614|531544618|FG004|Booster Vaccination Phase|Protocol Violation|0|||
147377156|NCT00614614|531544614|FG000|Booster Vaccination Phase|Other|0|||
147377157|NCT00614614|531544615|FG001|Booster Vaccination Phase|Other|1|||
147377158|NCT00614614|531544616|FG002|Booster Vaccination Phase|Other|3|||
147377159|NCT00614614|531544617|FG003|Booster Vaccination Phase|Other|2|||
147377160|NCT00614614|531544618|FG004|Booster Vaccination Phase|Other|1|||
147377161|NCT04745676|531544619|FG000|Overall Study|Death|1|||
147377162|NCT04745676|531544620|FG001|Overall Study|Death|0|||
147377163|NCT04745676|531544621|FG002|Overall Study|Death|0|||
147377164|NCT05212285|531544622|FG000|Overall Study|Lack of Efficacy|12|||
147377165|NCT05212285|531544623|FG001|Overall Study|Lack of Efficacy|8|||
147664648|NCT02643693|532596308|FG001|Overall Study|Protocol Adherence Issues|0|||
147664649|NCT02643693|532596309|FG002|Overall Study|Protocol Adherence Issues|1|||
147377166|NCT05212285|531544622|FG000|Overall Study|Withdrawal by Subject|8|||
147377167|NCT05212285|531544623|FG001|Overall Study|Withdrawal by Subject|1|||
147377168|NCT05212285|531544622|FG000|Overall Study|Lost to Follow-up|13|||
147377169|NCT05212285|531544623|FG001|Overall Study|Lost to Follow-up|1|||
147377170|NCT05212285|531544622|FG000|Overall Study|miss data|21|||
147377171|NCT05212285|531544623|FG001|Overall Study|miss data|2|||
147377172|NCT03683030|531544624|FG000|Overall Study|Enrolled but screen failures|12|||
147377173|NCT03683030|531544625|FG001|Overall Study|Enrolled but screen failures|7|||
147377174|NCT03683030|531544624|FG000|Overall Study|Enrolled but no catheter inserted|11|||
147377175|NCT03683030|531544625|FG001|Overall Study|Enrolled but no catheter inserted|13|||
147377176|NCT03683030|531544624|FG000|Overall Study|Withdrawal by Subject|0|||
147377177|NCT03683030|531544625|FG001|Overall Study|Withdrawal by Subject|2|||
147377178|NCT03683030|531544624|FG000|Overall Study|Early termination by subject|1|||
147377179|NCT03683030|531544625|FG001|Overall Study|Early termination by subject|0|||
147377180|NCT03683030|531544624|FG000|Overall Study|Lost to Follow-up|0|||
147377181|NCT03683030|531544625|FG001|Overall Study|Lost to Follow-up|6|||
147377182|NCT03683030|531544624|FG000|Overall Study|Death|0|||
147377183|NCT03683030|531544625|FG001|Overall Study|Death|2|||
147377184|NCT03683030|531544624|FG000|Overall Study|Catheter inserted but did not undergo ablation|0|||
147377185|NCT03683030|531544625|FG001|Overall Study|Catheter inserted but did not undergo ablation|1|||
147377186|NCT02222493|531544628|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Death|2|||
147377187|NCT02222493|531544629|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Death|2|||
147377188|NCT02222493|531544628|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Lost to Follow-up|0|||
147377189|NCT02222493|531544629|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Lost to Follow-up|1|||
147377190|NCT02222493|531544628|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Withdrawal by Subject|11|||
147377191|NCT02222493|531544629|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Withdrawal by Subject|9|||
147377192|NCT02222493|531544628|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Protocol Violation|5|||
147377193|NCT02222493|531544629|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Protocol Violation|1|||
147377194|NCT02222493|531544628|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Insufficient clinical response|0|||
147377195|NCT02222493|531544629|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Insufficient clinical response|7|||
147377196|NCT02222493|531544628|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Non-compliance with study treatment|1|||
147377197|NCT02222493|531544629|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Non-compliance with study treatment|0|||
147377198|NCT02222493|531544628|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Pregnancy|2|||
147377199|NCT02222493|531544629|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Pregnancy|0|||
147377200|NCT02222493|531544628|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Adverse Event|18|||
147377201|NCT02222493|531544629|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Adverse Event|20|||
147377202|NCT02222493|531544628|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Other|4|||
147377203|NCT02222493|531544629|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Other|0|||
147377204|NCT02222493|531544628|FG000|Period 1: First Dose-Week 30 (Pre-dose)|Randomized but not treated|1|||
147377205|NCT02222493|531544629|FG001|Period 1: First Dose-Week 30 (Pre-dose)|Randomized but not treated|0|||
147377206|NCT02222493|531544628|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Death|1|||
147377207|NCT02222493|531544629|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Death|0|||
147377208|NCT02222493|531544628|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Adverse Event|22|||
147377209|NCT02222493|531544629|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Adverse Event|9|||
147377210|NCT02222493|531544628|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Other|3|||
147377211|NCT02222493|531544629|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Other|0|||
147377212|NCT02222493|531544628|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Non-compliance with study treatment|1|||
147377213|NCT02222493|531544629|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Non-compliance with study treatment|0|||
147377214|NCT02222493|531544628|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Withdrawal by Subject|6|||
147377215|NCT02222493|531544629|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Withdrawal by Subject|4|||
147377216|NCT02222493|531544628|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Lost to Follow-up|1|||
147377217|NCT02222493|531544629|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Lost to Follow-up|1|||
147377218|NCT02222493|531544628|FG000|Period 2: Week30 Dosing-Week54(Pre-dose)|Insufficient clinical response|9|||
147377219|NCT02222493|531544629|FG001|Period 2: Week30 Dosing-Week54(Pre-dose)|Insufficient clinical response|3|||
147377220|NCT02222493|531544628|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Insufficient clinical response|3|||
147377221|NCT02222493|531544629|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Insufficient clinical response|0|||
147377222|NCT02222493|531544628|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Adverse Event|14|||
147377223|NCT02222493|531544629|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Adverse Event|0|||
147377224|NCT02222493|531544628|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Other|4|||
147377225|NCT02222493|531544629|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Other|0|||
147377226|NCT02222493|531544628|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Non-compliance with study treatment|1|||
147377227|NCT02222493|531544629|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Non-compliance with study treatment|0|||
147455692|NCT01789970|531829902|FG000|Double-blind Treatment Period (12 Weeks)|Adverse Event|0|||
147455693|NCT01789970|531829903|FG001|Double-blind Treatment Period (12 Weeks)|Adverse Event|9|||
147455694|NCT01789970|531829904|FG002|Double-blind Treatment Period (12 Weeks)|Adverse Event|15|||
147455695|NCT01789970|531829902|FG000|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|0|||
147377228|NCT02222493|531544628|FG000|Period 3: Week 54 Dosing-Week 78 Visit|Withdrawal by Subject|9|||
147377229|NCT02222493|531544629|FG001|Period 3: Week 54 Dosing-Week 78 Visit|Withdrawal by Subject|0|||
147377230|NCT01000805|531544633|FG000|Overall Study|Adverse Event|21|||
147377231|NCT01000805|531544634|FG001|Overall Study|Adverse Event|9|||
147377232|NCT01000805|531544633|FG000|Overall Study|Lack of Efficacy|5|||
147377233|NCT01000805|531544634|FG001|Overall Study|Lack of Efficacy|16|||
147377234|NCT01000805|531544633|FG000|Overall Study|Lost to Follow-up|16|||
147377235|NCT01000805|531544634|FG001|Overall Study|Lost to Follow-up|21|||
147377236|NCT01000805|531544633|FG000|Overall Study|Physician Decision|0|||
147664650|NCT02643693|532596310|FG003|Overall Study|Protocol Adherence Issues|0|||
147664651|NCT02643693|532596311|FG004|Overall Study|Protocol Adherence Issues|0|||
147664652|NCT02643693|532596312|FG005|Overall Study|Protocol Adherence Issues|1|||
147377237|NCT01000805|531544634|FG001|Overall Study|Physician Decision|1|||
147377238|NCT01000805|531544633|FG000|Overall Study|Protocol Violation|12|||
147377239|NCT01000805|531544634|FG001|Overall Study|Protocol Violation|8|||
147377240|NCT01000805|531544633|FG000|Overall Study|Withdrawal by Subject|16|||
147377241|NCT01000805|531544634|FG001|Overall Study|Withdrawal by Subject|6|||
147377242|NCT01000805|531544633|FG000|Overall Study|Sponsor Decision|0|||
147377243|NCT01000805|531544634|FG001|Overall Study|Sponsor Decision|1|||
147377244|NCT05432986|531544640|FG000|Overall Study|Withdrawal by Subject|2|||
147377245|NCT05432986|531544640|FG000|Overall Study|incomplete measurement|7|||
147377246|NCT00551421|531546213|FG000|Amended Protocol (Cetuximab-refr. mCRC)|Withdrawal by Subject|1|||
147377247|NCT00799409|531546215|FG000|Overall Study|Withdrawal by Subject|1|||
147377248|NCT00799409|531546216|FG001|Overall Study|Withdrawal by Subject|0|||
147377249|NCT00799409|531546217|FG002|Overall Study|Withdrawal by Subject|0|||
147377250|NCT00799409|531546215|FG000|Overall Study|Lost to Follow-up|1|||
147377251|NCT00799409|531546216|FG001|Overall Study|Lost to Follow-up|0|||
147377252|NCT00799409|531546217|FG002|Overall Study|Lost to Follow-up|0|||
147377253|NCT00799409|531546215|FG000|Overall Study|Optimal Dose Not Achieved|2|||
147377254|NCT00799409|531546216|FG001|Overall Study|Optimal Dose Not Achieved|0|||
147377255|NCT00799409|531546217|FG002|Overall Study|Optimal Dose Not Achieved|0|||
147377256|NCT00799409|531546215|FG000|Overall Study|Failure to follow study protocol)|1|||
147377257|NCT00799409|531546216|FG001|Overall Study|Failure to follow study protocol)|0|||
147377258|NCT00799409|531546217|FG002|Overall Study|Failure to follow study protocol)|0|||
147377259|NCT00799409|531546215|FG000|Overall Study|Did not attend lab school day 1|1|||
147377260|NCT00799409|531546216|FG001|Overall Study|Did not attend lab school day 1|0|||
147377261|NCT00799409|531546217|FG002|Overall Study|Did not attend lab school day 1|0|||
147377262|NCT00799409|531546215|FG000|Overall Study|medication compliance|1|||
147377263|NCT00799409|531546216|FG001|Overall Study|medication compliance|0|||
147377264|NCT00799409|531546217|FG002|Overall Study|medication compliance|0|||
147377265|NCT01970878|531546219|FG000|Overall Study|Withdrawal by Subject|11|||
147377266|NCT01970878|531546220|FG001|Overall Study|Withdrawal by Subject|10|||
147377267|NCT01970878|531546221|FG002|Overall Study|Withdrawal by Subject|14|||
147377268|NCT01970878|531546222|FG003|Overall Study|Withdrawal by Subject|7|||
147377269|NCT01970878|531546219|FG000|Overall Study|Lost to Follow-up|1|||
147377270|NCT01970878|531546220|FG001|Overall Study|Lost to Follow-up|3|||
147377271|NCT01970878|531546221|FG002|Overall Study|Lost to Follow-up|2|||
147377272|NCT01970878|531546222|FG003|Overall Study|Lost to Follow-up|4|||
147377273|NCT01970878|531546219|FG000|Overall Study|Administrative Reasons|1|||
147377274|NCT01970878|531546220|FG001|Overall Study|Administrative Reasons|0|||
147377275|NCT01970878|531546221|FG002|Overall Study|Administrative Reasons|0|||
147377276|NCT01970878|531546222|FG003|Overall Study|Administrative Reasons|4|||
147377277|NCT01970878|531546219|FG000|Overall Study|Lack of Efficacy|2|||
147377278|NCT01970878|531546220|FG001|Overall Study|Lack of Efficacy|1|||
147377279|NCT01970878|531546221|FG002|Overall Study|Lack of Efficacy|2|||
147377280|NCT01970878|531546222|FG003|Overall Study|Lack of Efficacy|0|||
147377281|NCT01970878|531546219|FG000|Overall Study|Adverse Event|12|||
147377282|NCT01970878|531546220|FG001|Overall Study|Adverse Event|7|||
147377283|NCT01970878|531546221|FG002|Overall Study|Adverse Event|4|||
147377284|NCT01970878|531546222|FG003|Overall Study|Adverse Event|3|||
147377285|NCT01970878|531546219|FG000|Overall Study|Protocol Specified Criteria|10|||
147377286|NCT01970878|531546220|FG001|Overall Study|Protocol Specified Criteria|4|||
147377287|NCT01970878|531546221|FG002|Overall Study|Protocol Specified Criteria|3|||
147377288|NCT01970878|531546222|FG003|Overall Study|Protocol Specified Criteria|6|||
147377289|NCT01970878|531546219|FG000|Overall Study|Physician Decision|0|||
147377290|NCT01970878|531546220|FG001|Overall Study|Physician Decision|1|||
147377291|NCT01970878|531546221|FG002|Overall Study|Physician Decision|1|||
147377292|NCT01970878|531546222|FG003|Overall Study|Physician Decision|0|||
147377293|NCT01970878|531546219|FG000|Overall Study|No Completion Status|0|||
147377294|NCT01970878|531546220|FG001|Overall Study|No Completion Status|1|||
147377295|NCT01970878|531546221|FG002|Overall Study|No Completion Status|0|||
147377296|NCT01970878|531546222|FG003|Overall Study|No Completion Status|0|||
147377297|NCT04323800|531546223|FG000|Overall Study|Withdrawal by Subject|4|||
147377298|NCT04323800|531546224|FG001|Overall Study|Withdrawal by Subject|4|||
147377299|NCT04323800|531546223|FG000|Overall Study|Incomplete transfusion|1|||
147377300|NCT04323800|531546224|FG001|Overall Study|Incomplete transfusion|0|||
147664653|NCT00492297|532596313|FG000|Treatment|Death|2|||
147455696|NCT01789970|531829903|FG001|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|17|||
147455697|NCT01789970|531829904|FG002|Double-blind Treatment Period (12 Weeks)|Lack of Efficacy|5|||
147455698|NCT01789970|531829902|FG000|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|0|||
147455699|NCT01789970|531829903|FG001|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|7|||
147455700|NCT01789970|531829904|FG002|Double-blind Treatment Period (12 Weeks)|Withdrawal by Subject|9|||
147455701|NCT01789970|531829902|FG000|Double-blind Treatment Period (12 Weeks)|Protocol Violation|0|||
147455702|NCT01789970|531829903|FG001|Double-blind Treatment Period (12 Weeks)|Protocol Violation|9|||
147455703|NCT01789970|531829904|FG002|Double-blind Treatment Period (12 Weeks)|Protocol Violation|7|||
147455704|NCT01789970|531829902|FG000|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|0|||
147455705|NCT01789970|531829903|FG001|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|2|||
147455706|NCT01789970|531829904|FG002|Double-blind Treatment Period (12 Weeks)|Noncompliance to study drug admin|2|||
147455707|NCT01789970|531829902|FG000|Double-blind Treatment Period (12 Weeks)|Noncompliance with study procedures|0|||
147455708|NCT01789970|531829903|FG001|Double-blind Treatment Period (12 Weeks)|Noncompliance with study procedures|2|||
147455709|NCT01789970|531829904|FG002|Double-blind Treatment Period (12 Weeks)|Noncompliance with study procedures|1|||
147455710|NCT01789970|531829902|FG000|Double-blind Treatment Period (12 Weeks)|Lost to Follow-up|0|||
147455711|NCT01789970|531829903|FG001|Double-blind Treatment Period (12 Weeks)|Lost to Follow-up|1|||
147455712|NCT01789970|531829904|FG002|Double-blind Treatment Period (12 Weeks)|Lost to Follow-up|2|||
147455713|NCT01789970|531829902|FG000|Double-blind Treatment Period (12 Weeks)|Pregnancy|0|||
147455714|NCT01789970|531829903|FG001|Double-blind Treatment Period (12 Weeks)|Pregnancy|1|||
147455715|NCT01789970|531829904|FG002|Double-blind Treatment Period (12 Weeks)|Pregnancy|0|||
147455716|NCT01789970|531829902|FG000|Double-blind Treatment Period (12 Weeks)|Other|0|||
147455717|NCT01789970|531829903|FG001|Double-blind Treatment Period (12 Weeks)|Other|1|||
147455718|NCT01789970|531829904|FG002|Double-blind Treatment Period (12 Weeks)|Other|3|||
147455719|NCT01789970|531829902|FG000|Double-blind Treatment Period (12 Weeks)|Dropped out prior to dosing|0|||
147455720|NCT01789970|531829903|FG001|Double-blind Treatment Period (12 Weeks)|Dropped out prior to dosing|1|||
147455721|NCT01789970|531829904|FG002|Double-blind Treatment Period (12 Weeks)|Dropped out prior to dosing|0|||
147455722|NCT00643994|531829905|FG000|Overall Study|Death|24|||
147455723|NCT00643994|531829905|FG000|Overall Study|Lost to Follow-up|72|||
147455724|NCT01847885|531829913|FG000|Initial Enrollment (Consented)|Protocol Violation|1|||
147455725|NCT01847885|531829914|FG001|Initial Enrollment (Consented)|Protocol Violation|0|||
147455726|NCT01847885|531829915|FG002|Initial Enrollment (Consented)|Protocol Violation|0|||
147455727|NCT01847885|531829913|FG000|Initial Enrollment (Consented)|Withdrawal by Subject|2|||
147455728|NCT01847885|531829914|FG001|Initial Enrollment (Consented)|Withdrawal by Subject|0|||
147455729|NCT01847885|531829915|FG002|Initial Enrollment (Consented)|Withdrawal by Subject|0|||
147455730|NCT01847885|531829913|FG000|Initial Enrollment (Consented)|Screen failure|39|||
147455731|NCT01847885|531829914|FG001|Initial Enrollment (Consented)|Screen failure|0|||
147455732|NCT01847885|531829915|FG002|Initial Enrollment (Consented)|Screen failure|0|||
147455733|NCT01847885|531829913|FG000|Initial Enrollment (Consented)|Pending prior to enrollment stop|6|||
147455734|NCT01847885|531829914|FG001|Initial Enrollment (Consented)|Pending prior to enrollment stop|0|||
147455735|NCT01847885|531829915|FG002|Initial Enrollment (Consented)|Pending prior to enrollment stop|0|||
147455736|NCT01847885|531829913|FG000|Randomization|Protocol Violation|0|||
147455737|NCT01847885|531829914|FG001|Randomization|Protocol Violation|1|||
147455738|NCT01847885|531829915|FG002|Randomization|Protocol Violation|0|||
147455739|NCT01847885|531829913|FG000|Randomization|Withdrawal by Subject|0|||
147455740|NCT01847885|531829914|FG001|Randomization|Withdrawal by Subject|0|||
147455741|NCT01847885|531829915|FG002|Randomization|Withdrawal by Subject|2|||
147455742|NCT01847885|531829913|FG000|Randomization|Screen Failure|0|||
147455743|NCT01847885|531829914|FG001|Randomization|Screen Failure|3|||
147455744|NCT01847885|531829915|FG002|Randomization|Screen Failure|0|||
147455745|NCT02574637|531829918|FG000|Double-blind Period|Adverse Event|1|||
147455746|NCT02574637|531829919|FG001|Double-blind Period|Adverse Event|0|||
147455747|NCT02574637|531829920|FG002|Double-blind Period|Adverse Event|0|||
147455748|NCT02574637|531829921|FG003|Double-blind Period|Adverse Event|0|||
147455749|NCT02574637|531829922|FG004|Double-blind Period|Adverse Event|0|||
147455750|NCT02574637|531829923|FG005|Double-blind Period|Adverse Event|0|||
147455751|NCT02574637|531829924|FG006|Double-blind Period|Adverse Event|0|||
147377301|NCT04323800|531546223|FG000|Overall Study|Other|0|||
147377302|NCT04323800|531546224|FG001|Overall Study|Other|1|||
147377303|NCT04323800|531546223|FG000|Overall Study|Positive RT-PCR at transfusion|1|||
147377304|NCT04323800|531546224|FG001|Overall Study|Positive RT-PCR at transfusion|1|||
147377305|NCT00489554|531546225|FG000|Overall Study|Adverse Event|2|||
147377306|NCT00489554|531546225|FG000|Overall Study|Withdrawal by Subject|1|||
147377307|NCT00489554|531546225|FG000|Overall Study|Lost to Follow-up|1|||
147377308|NCT00731692|531546226|FG000|Core Study (36 Months)|Lack of Efficacy|11|||
147377309|NCT00731692|531546227|FG001|Core Study (36 Months)|Lack of Efficacy|23|||
147377310|NCT00731692|531546228|FG002|Core Study (36 Months)|Lack of Efficacy|64|||
147377311|NCT00731692|531546226|FG000|Core Study (36 Months)|Physician Decision|1|||
147455752|NCT02574637|531829925|FG007|Double-blind Period|Adverse Event|0|||
147455753|NCT02574637|531829926|FG008|Double-blind Period|Adverse Event|0|||
147377312|NCT00731692|531546227|FG001|Core Study (36 Months)|Physician Decision|0|||
147377313|NCT00731692|531546228|FG002|Core Study (36 Months)|Physician Decision|2|||
147377314|NCT00731692|531546226|FG000|Core Study (36 Months)|Death|2|||
147377315|NCT00731692|531546227|FG001|Core Study (36 Months)|Death|1|||
147377316|NCT00731692|531546228|FG002|Core Study (36 Months)|Death|2|||
147377317|NCT00731692|531546226|FG000|Core Study (36 Months)|Lost to Follow-up|1|||
147377318|NCT00731692|531546227|FG001|Core Study (36 Months)|Lost to Follow-up|3|||
147377319|NCT00731692|531546228|FG002|Core Study (36 Months)|Lost to Follow-up|3|||
147377320|NCT00731692|531546226|FG000|Core Study (36 Months)|Administrative|2|||
147300243|NCT01582789|531265995|FG001|Second Intervention (14 Days)|Withdrawal by Subject|0|||
147300244|NCT02276066|531265996|FG000|Overall Study|Lost to Follow-up|21|||
147300245|NCT02276066|531265997|FG001|Overall Study|Lost to Follow-up|11|||
147300246|NCT05050578|531265998|FG000|Period 1, 30 Days|Lost to Follow-up|1|||
147300247|NCT05050578|531265999|FG001|Period 1, 30 Days|Lost to Follow-up|1|||
147300248|NCT05050578|531265998|FG000|Period 1, 30 Days|Withdrawal by Subject|1|||
147300249|NCT05050578|531265999|FG001|Period 1, 30 Days|Withdrawal by Subject|0|||
147300250|NCT05050578|531265998|FG000|Period 2, 30 Days|Protocol Violation|0|||
147300251|NCT05050578|531265999|FG001|Period 2, 30 Days|Protocol Violation|1|||
147300252|NCT03386032|531266001|FG000|Overall Study|Lack of Efficacy|6|||
147300253|NCT03386032|531266002|FG001|Overall Study|Lack of Efficacy|2|||
147300254|NCT03386032|531266003|FG002|Overall Study|Lack of Efficacy|0|||
147300255|NCT03386032|531266001|FG000|Overall Study|Adverse Event|2|||
147300256|NCT03386032|531266002|FG001|Overall Study|Adverse Event|2|||
147300257|NCT03386032|531266003|FG002|Overall Study|Adverse Event|0|||
147300258|NCT03386032|531266001|FG000|Overall Study|Withdrawal by Subject|1|||
147300259|NCT03386032|531266002|FG001|Overall Study|Withdrawal by Subject|0|||
147300260|NCT03386032|531266003|FG002|Overall Study|Withdrawal by Subject|0|||
147300261|NCT03386032|531266001|FG000|Overall Study|Lost to Follow-up|9|||
147300262|NCT03386032|531266002|FG001|Overall Study|Lost to Follow-up|3|||
147300263|NCT03386032|531266003|FG002|Overall Study|Lost to Follow-up|0|||
147300264|NCT02710292|531266008|FG000|Period 1, First 10 Days of Wear|Adverse Event|0|||
147300265|NCT02710292|531266009|FG001|Period 1, First 10 Days of Wear|Adverse Event|1|||
147300266|NCT02710292|531266008|FG000|Period 1, First 10 Days of Wear|Withdrawal by Subject|1|||
147300267|NCT02710292|531266009|FG001|Period 1, First 10 Days of Wear|Withdrawal by Subject|2|||
147300268|NCT03122119|531266010|FG000|Overall Study|Did not meet eligibility critria|1|||
147300269|NCT02364180|531266016|FG000|Overall Study|Screen Fail|1|||
147300270|NCT01783418|531266017|FG000|Overall Study|Withdrawal by Subject|1|||
147300271|NCT01783418|531266018|FG001|Overall Study|Withdrawal by Subject|0|||
147300272|NCT00089141|531266019|FG000|Overall Study|Termination of trial|18|||
147300273|NCT00089141|531266020|FG001|Overall Study|Termination of trial|24|||
147300274|NCT00508261|531266021|FG000|Overall Study|Other|0|||
147300275|NCT00508261|531266022|FG001|Overall Study|Other|1|||
147300276|NCT00508261|531266023|FG002|Overall Study|Other|1|||
147300277|NCT00508261|531266024|FG003|Overall Study|Other|0|||
147300278|NCT00508261|531266021|FG000|Overall Study|Serious Adverse Event|0|||
147300279|NCT00508261|531266022|FG001|Overall Study|Serious Adverse Event|1|||
147300280|NCT00508261|531266023|FG002|Overall Study|Serious Adverse Event|0|||
147300281|NCT00508261|531266024|FG003|Overall Study|Serious Adverse Event|0|||
147300282|NCT00508261|531266021|FG000|Overall Study|Withdrawal by Subject|3|||
147300283|NCT00508261|531266022|FG001|Overall Study|Withdrawal by Subject|4|||
147300284|NCT00508261|531266023|FG002|Overall Study|Withdrawal by Subject|4|||
147300285|NCT00508261|531266024|FG003|Overall Study|Withdrawal by Subject|0|||
147300286|NCT00508261|531266021|FG000|Overall Study|Migrated/ moved from study area|0|||
147300287|NCT00508261|531266022|FG001|Overall Study|Migrated/ moved from study area|1|||
147300288|NCT00508261|531266023|FG002|Overall Study|Migrated/ moved from study area|0|||
147300289|NCT00508261|531266024|FG003|Overall Study|Migrated/ moved from study area|0|||
147300290|NCT00508261|531266021|FG000|Overall Study|Lost to Follow-up|0|||
147300291|NCT00508261|531266022|FG001|Overall Study|Lost to Follow-up|1|||
147300292|NCT00508261|531266023|FG002|Overall Study|Lost to Follow-up|1|||
147300293|NCT00508261|531266024|FG003|Overall Study|Lost to Follow-up|1|||
147300294|NCT02901626|531266025|FG000|Overall Study|Lost to Follow-up|1|||
147300295|NCT02901626|531266026|FG001|Overall Study|Lost to Follow-up|1|||
147300296|NCT04082884|531266027|FG000|Overall Study|Withdrawal by Subject|1|||
147300297|NCT04857034|531266029|FG000|Placebo-Controlled Period|Request to discontinue|2|||
147300298|NCT04857034|531266030|FG001|Placebo-Controlled Period|Request to discontinue|2|||
147300299|NCT04857034|531266031|FG002|Placebo-Controlled Period|Request to discontinue|0|||
147300300|NCT04857034|531266032|FG003|Placebo-Controlled Period|Request to discontinue|0|||
147300301|NCT04857034|531266033|FG004|Placebo-Controlled Period|Request to discontinue|0|||
147300302|NCT04857034|531266029|FG000|Placebo-Controlled Period|withdrew consent|1|||
147300303|NCT04857034|531266030|FG001|Placebo-Controlled Period|withdrew consent|1|||
147300304|NCT04857034|531266031|FG002|Placebo-Controlled Period|withdrew consent|2|||
147300305|NCT04857034|531266032|FG003|Placebo-Controlled Period|withdrew consent|0|||
147300306|NCT04857034|531266033|FG004|Placebo-Controlled Period|withdrew consent|0|||
147300307|NCT04857034|531266029|FG000|Placebo-Controlled Period|Pregnancy|1|||
147300308|NCT04857034|531266030|FG001|Placebo-Controlled Period|Pregnancy|1|||
147455754|NCT02574637|531829927|FG009|Double-blind Period|Adverse Event|0|||
147455755|NCT02574637|531829918|FG000|Double-blind Period|Lack of Efficacy|0|||
147455756|NCT02574637|531829919|FG001|Double-blind Period|Lack of Efficacy|0|||
147455757|NCT02574637|531829920|FG002|Double-blind Period|Lack of Efficacy|2|||
147455758|NCT02574637|531829921|FG003|Double-blind Period|Lack of Efficacy|0|||
147455759|NCT02574637|531829922|FG004|Double-blind Period|Lack of Efficacy|0|||
147455760|NCT02574637|531829923|FG005|Double-blind Period|Lack of Efficacy|0|||
147455761|NCT02574637|531829924|FG006|Double-blind Period|Lack of Efficacy|0|||
147455762|NCT02574637|531829925|FG007|Double-blind Period|Lack of Efficacy|0|||
147455763|NCT02574637|531829926|FG008|Double-blind Period|Lack of Efficacy|0|||
147455764|NCT02574637|531829927|FG009|Double-blind Period|Lack of Efficacy|0|||
147455765|NCT02574637|531829918|FG000|Double-blind Period|Protocol Deviation|1|||
147455766|NCT02574637|531829919|FG001|Double-blind Period|Protocol Deviation|0|||
147455767|NCT02574637|531829920|FG002|Double-blind Period|Protocol Deviation|0|||
147455768|NCT02574637|531829921|FG003|Double-blind Period|Protocol Deviation|0|||
147455769|NCT02574637|531829922|FG004|Double-blind Period|Protocol Deviation|0|||
147455770|NCT02574637|531829923|FG005|Double-blind Period|Protocol Deviation|0|||
147455771|NCT02574637|531829924|FG006|Double-blind Period|Protocol Deviation|0|||
147455772|NCT02574637|531829925|FG007|Double-blind Period|Protocol Deviation|0|||
147455773|NCT02574637|531829926|FG008|Double-blind Period|Protocol Deviation|0|||
147455774|NCT02574637|531829927|FG009|Double-blind Period|Protocol Deviation|0|||
147455775|NCT02574637|531829918|FG000|Double-blind Period|Non-Compliance With Study Drug|0|||
147455776|NCT02574637|531829919|FG001|Double-blind Period|Non-Compliance With Study Drug|0|||
147455777|NCT02574637|531829920|FG002|Double-blind Period|Non-Compliance With Study Drug|0|||
147455778|NCT02574637|531829921|FG003|Double-blind Period|Non-Compliance With Study Drug|1|||
147455779|NCT02574637|531829922|FG004|Double-blind Period|Non-Compliance With Study Drug|0|||
147455780|NCT02574637|531829923|FG005|Double-blind Period|Non-Compliance With Study Drug|0|||
147455781|NCT02574637|531829924|FG006|Double-blind Period|Non-Compliance With Study Drug|0|||
147455782|NCT02574637|531829925|FG007|Double-blind Period|Non-Compliance With Study Drug|0|||
147455783|NCT02574637|531829926|FG008|Double-blind Period|Non-Compliance With Study Drug|0|||
147455784|NCT02574637|531829927|FG009|Double-blind Period|Non-Compliance With Study Drug|0|||
147455785|NCT02574637|531829918|FG000|Double-blind Period|Study Terminated By Sponsor|1|||
147455786|NCT02574637|531829919|FG001|Double-blind Period|Study Terminated By Sponsor|1|||
147455787|NCT02574637|531829920|FG002|Double-blind Period|Study Terminated By Sponsor|5|||
147455788|NCT02574637|531829921|FG003|Double-blind Period|Study Terminated By Sponsor|2|||
147455789|NCT02574637|531829922|FG004|Double-blind Period|Study Terminated By Sponsor|2|||
147455790|NCT02574637|531829923|FG005|Double-blind Period|Study Terminated By Sponsor|0|||
147455791|NCT02574637|531829924|FG006|Double-blind Period|Study Terminated By Sponsor|0|||
147455792|NCT02574637|531829925|FG007|Double-blind Period|Study Terminated By Sponsor|0|||
147455793|NCT02574637|531829926|FG008|Double-blind Period|Study Terminated By Sponsor|0|||
147377321|NCT00731692|531546227|FG001|Core Study (36 Months)|Administrative|2|||
147377322|NCT00731692|531546228|FG002|Core Study (36 Months)|Administrative|6|||
147377323|NCT00731692|531546226|FG000|Core Study (36 Months)|Abnormal Test Procedure Result|4|||
147377324|NCT00731692|531546227|FG001|Core Study (36 Months)|Abnormal Test Procedure Result|3|||
147377325|NCT00731692|531546228|FG002|Core Study (36 Months)|Abnormal Test Procedure Result|5|||
147377326|NCT00731692|531546226|FG000|Core Study (36 Months)|Protocol Violation|4|||
147377327|NCT00731692|531546227|FG001|Core Study (36 Months)|Protocol Violation|5|||
147377328|NCT00731692|531546228|FG002|Core Study (36 Months)|Protocol Violation|8|||
147377329|NCT00731692|531546226|FG000|Core Study (36 Months)|Abnormal Lab values|6|||
147377330|NCT00731692|531546227|FG001|Core Study (36 Months)|Abnormal Lab values|19|||
147377331|NCT00731692|531546228|FG002|Core Study (36 Months)|Abnormal Lab values|5|||
147377332|NCT00731692|531546226|FG000|Core Study (36 Months)|Adverse Event|25|||
147377333|NCT00731692|531546227|FG001|Core Study (36 Months)|Adverse Event|28|||
147377334|NCT00731692|531546228|FG002|Core Study (36 Months)|Adverse Event|29|||
147377335|NCT00731692|531546226|FG000|Core Study (36 Months)|Withdrawal by Subject|12|||
147377336|NCT00731692|531546227|FG001|Core Study (36 Months)|Withdrawal by Subject|32|||
147377337|NCT00731692|531546228|FG002|Core Study (36 Months)|Withdrawal by Subject|46|||
147377338|NCT00731692|531546226|FG000|Extension Phase|Admin Problems: Terminated # patients|69|||
147377339|NCT00731692|531546227|FG001|Extension Phase|Admin Problems: Terminated # patients|189|||
147377340|NCT00731692|531546228|FG002|Extension Phase|Admin Problems: Terminated # patients|277|||
147377341|NCT00731692|531546226|FG000|Extension Phase|Abnormal test procedure|0|||
147377342|NCT00731692|531546227|FG001|Extension Phase|Abnormal test procedure|0|||
147455794|NCT02574637|531829927|FG009|Double-blind Period|Study Terminated By Sponsor|0|||
147455795|NCT02574637|531829918|FG000|Double-blind Period|Reason Not Specified|0|||
147377343|NCT00731692|531546228|FG002|Extension Phase|Abnormal test procedure|1|||
147377344|NCT00731692|531546226|FG000|Extension Phase|Abnormal lab values|0|||
147455796|NCT02574637|531829919|FG001|Double-blind Period|Reason Not Specified|0|||
147612328|NCT00509795|532395474|FG000|Overall Study|Lack of Efficacy|0|||
147455797|NCT02574637|531829920|FG002|Double-blind Period|Reason Not Specified|0|||
147455798|NCT02574637|531829921|FG003|Double-blind Period|Reason Not Specified|1|||
147612329|NCT00509795|532395475|FG001|Overall Study|Lack of Efficacy|0|||
147455799|NCT02574637|531829922|FG004|Double-blind Period|Reason Not Specified|0|||
147377345|NCT00731692|531546227|FG001|Extension Phase|Abnormal lab values|0|||
147377346|NCT00731692|531546228|FG002|Extension Phase|Abnormal lab values|1|||
147377347|NCT00731692|531546226|FG000|Extension Phase|Lost to Follow-up|0|||
147377348|NCT00731692|531546227|FG001|Extension Phase|Lost to Follow-up|1|||
147377349|NCT00731692|531546228|FG002|Extension Phase|Lost to Follow-up|4|||
147377350|NCT00731692|531546226|FG000|Extension Phase|Withdrawal by Subject|4|||
147377351|NCT00731692|531546227|FG001|Extension Phase|Withdrawal by Subject|5|||
147377352|NCT00731692|531546228|FG002|Extension Phase|Withdrawal by Subject|3|||
147377353|NCT00731692|531546226|FG000|Extension Phase|Adverse Event|1|||
147377354|NCT00731692|531546227|FG001|Extension Phase|Adverse Event|1|||
147377355|NCT00731692|531546228|FG002|Extension Phase|Adverse Event|15|||
147377356|NCT06571695|531546229|FG000|Overall Study|Lost to Follow-up|1|||
147377357|NCT06571695|531546230|FG001|Overall Study|Lost to Follow-up|6|||
147377358|NCT04921358|531546231|FG000|Overall Study|Withdrawal by Subject|6|||
147377359|NCT04921358|531546232|FG001|Overall Study|Withdrawal by Subject|13|||
147377360|NCT04921358|531546231|FG000|Overall Study|Lost to Follow-up|3|||
147377361|NCT04921358|531546232|FG001|Overall Study|Lost to Follow-up|6|||
147377362|NCT04921358|531546231|FG000|Overall Study|Study Terminated by Sponsor|86|||
147377363|NCT04921358|531546232|FG001|Overall Study|Study Terminated by Sponsor|89|||
147377364|NCT04921358|531546231|FG000|Overall Study|Death|92|||
147377365|NCT04921358|531546232|FG001|Overall Study|Death|82|||
147377366|NCT02637063|531546233|FG000|Overall Study|Lost to Follow-up|3|||
147377367|NCT02637063|531546234|FG001|Overall Study|Lost to Follow-up|2|||
147377368|NCT02637063|531546235|FG002|Overall Study|Lost to Follow-up|3|||
147377369|NCT02637063|531546233|FG000|Overall Study|Withdrawal by Subject|2|||
147377370|NCT02637063|531546234|FG001|Overall Study|Withdrawal by Subject|2|||
147377371|NCT02637063|531546235|FG002|Overall Study|Withdrawal by Subject|3|||
147377372|NCT00745875|531546239|FG000|Overall Study|Continuing study treatment|4|||
147377373|NCT00745875|531546240|FG001|Overall Study|Continuing study treatment|4|||
147377374|NCT02310581|531546241|FG000|Overall Study|Adverse Event|1|||
147377375|NCT02310581|531546242|FG001|Overall Study|Adverse Event|1|||
147377376|NCT02310581|531546243|FG002|Overall Study|Adverse Event|1|||
147377377|NCT02310581|531546244|FG003|Overall Study|Adverse Event|0|||
147377378|NCT02310581|531546241|FG000|Overall Study|Withdrawal by Subject|2|||
147377379|NCT02310581|531546242|FG001|Overall Study|Withdrawal by Subject|1|||
147377380|NCT02310581|531546243|FG002|Overall Study|Withdrawal by Subject|0|||
147377381|NCT02310581|531546244|FG003|Overall Study|Withdrawal by Subject|1|||
147377382|NCT02824198|531546245|FG000|Overall Study|Non-compliance with the protocol|5|||
147377383|NCT02824198|531546246|FG001|Overall Study|Non-compliance with the protocol|1|||
147377384|NCT02824198|531546245|FG000|Overall Study|Lost to Follow-up|5|||
147377385|NCT02824198|531546246|FG001|Overall Study|Lost to Follow-up|2|||
147377386|NCT02824198|531546245|FG000|Overall Study|Withdrawal by Subject|5|||
147377387|NCT02824198|531546246|FG001|Overall Study|Withdrawal by Subject|0|||
147377388|NCT01833455|531546247|FG000|Overall Study|Withdrawal by Subject|1|||
147377389|NCT01833455|531546248|FG001|Overall Study|Withdrawal by Subject|0|||
147377390|NCT03883828|531546249|FG000|Overall Study|Did not start radiotherapy|1|||
147377391|NCT03883828|531546250|FG001|Overall Study|Did not start radiotherapy|2|||
147377392|NCT01256359|531546251|FG000|Overall Study|Randomised, later found to be ineligible and did not start treatment|1|||
147377393|NCT01256359|531546252|FG001|Overall Study|Randomised, later found to be ineligible and did not start treatment|1|||
147377394|NCT01256359|531546251|FG000|Overall Study|Randomised and found to be too unwell to start treatment|2|||
147377395|NCT01256359|531546252|FG001|Overall Study|Randomised and found to be too unwell to start treatment|0|||
147377396|NCT00487240|531546253|FG000|Overall Study|Withdrawal by Subject|12|||
147377397|NCT00487240|531546254|FG001|Overall Study|Withdrawal by Subject|6|||
147377398|NCT00487240|531546253|FG000|Overall Study|Lost to Follow-up|7|||
147377399|NCT00487240|531546254|FG001|Overall Study|Lost to Follow-up|6|||
147377400|NCT00487240|531546253|FG000|Overall Study|Adverse Event|0|||
147377401|NCT00487240|531546254|FG001|Overall Study|Adverse Event|4|||
147377402|NCT00487240|531546253|FG000|Overall Study|Protocol Violation|5|||
147377403|NCT00487240|531546254|FG001|Overall Study|Protocol Violation|5|||
147377404|NCT00487240|531546253|FG000|Overall Study|Entry Criteria Not Met|3|||
147377405|NCT00487240|531546254|FG001|Overall Study|Entry Criteria Not Met|4|||
147377406|NCT00487240|531546253|FG000|Overall Study|Sponsor Decision|2|||
147377407|NCT00487240|531546254|FG001|Overall Study|Sponsor Decision|1|||
147377408|NCT00487240|531546253|FG000|Overall Study|Physician Decision|2|||
147377409|NCT00487240|531546254|FG001|Overall Study|Physician Decision|0|||
147377410|NCT01019135|531546255|FG000|Overall Study|Did not receive allocated intervention|12|||
147377411|NCT01019135|531546256|FG001|Overall Study|Did not receive allocated intervention|6|||
147377412|NCT01019135|531546257|FG002|Overall Study|Did not receive allocated intervention|25|||
147377413|NCT01019135|531546255|FG000|Overall Study|Did not attend CR|8|||
147377414|NCT01019135|531546256|FG001|Overall Study|Did not attend CR|13|||
147377415|NCT01019135|531546257|FG002|Overall Study|Did not attend CR|6|||
147377416|NCT04237792|531546259|FG000|Treatment (Day 1)|Adverse Event|1|||
147377417|NCT04237792|531546260|FG001|Treatment (Day 1)|Adverse Event|0|||
147377418|NCT04237792|531546261|FG002|Treatment (Day 1)|Adverse Event|0|||
147377419|NCT04237792|531546262|FG003|Treatment (Day 1)|Adverse Event|0|||
147377420|NCT04237792|531546263|FG004|Treatment (Day 1)|Adverse Event|1|||
147377421|NCT04237792|531546264|FG005|Treatment (Day 1)|Adverse Event|1|||
147377422|NCT04237792|531546259|FG000|Treatment (Day 1)|Other|0|||
147377423|NCT04237792|531546260|FG001|Treatment (Day 1)|Other|0|||
147377424|NCT04237792|531546261|FG002|Treatment (Day 1)|Other|1|||
147377425|NCT04237792|531546262|FG003|Treatment (Day 1)|Other|0|||
147377426|NCT04237792|531546263|FG004|Treatment (Day 1)|Other|0|||
147377427|NCT04237792|531546264|FG005|Treatment (Day 1)|Other|1|||
147377428|NCT04237792|531546259|FG000|Treatment (Day 1)|Not treated|1|||
147377429|NCT04237792|531546260|FG001|Treatment (Day 1)|Not treated|1|||
147377430|NCT04237792|531546261|FG002|Treatment (Day 1)|Not treated|2|||
147377431|NCT04237792|531546262|FG003|Treatment (Day 1)|Not treated|1|||
147377432|NCT04237792|531546263|FG004|Treatment (Day 1)|Not treated|0|||
147377433|NCT04237792|531546264|FG005|Treatment (Day 1)|Not treated|1|||
147377434|NCT04885998|531546265|FG000|Overall Study|Withdrawal by Subject|0|||
147377435|NCT04885998|531546266|FG001|Overall Study|Withdrawal by Subject|2|||
147377436|NCT04885998|531546267|FG002|Overall Study|Withdrawal by Subject|0|||
147377437|NCT04885998|531546268|FG003|Overall Study|Withdrawal by Subject|3|||
147377438|NCT04885998|531546265|FG000|Overall Study|Lost to Follow-up|1|||
147377439|NCT04885998|531546266|FG001|Overall Study|Lost to Follow-up|1|||
147377440|NCT04885998|531546267|FG002|Overall Study|Lost to Follow-up|0|||
147377441|NCT04885998|531546268|FG003|Overall Study|Lost to Follow-up|0|||
147377442|NCT04885998|531546265|FG000|Overall Study|Death|2|||
147377443|NCT04885998|531546266|FG001|Overall Study|Death|1|||
147377444|NCT04885998|531546267|FG002|Overall Study|Death|2|||
147377445|NCT04885998|531546268|FG003|Overall Study|Death|2|||
147377446|NCT04885998|531546265|FG000|Overall Study|Decision by sponsor|1|||
147377447|NCT04885998|531546266|FG001|Overall Study|Decision by sponsor|1|||
147377448|NCT04885998|531546267|FG002|Overall Study|Decision by sponsor|0|||
147377449|NCT04885998|531546268|FG003|Overall Study|Decision by sponsor|0|||
147377450|NCT00910962|531546269|FG000|Overall Study|Adverse Event|5|||
147377451|NCT00910962|531546270|FG001|Overall Study|Adverse Event|20|||
147377452|NCT00910962|531546271|FG002|Overall Study|Adverse Event|17|||
147377453|NCT00910962|531546269|FG000|Overall Study|Protocol Violation|1|||
147377454|NCT00910962|531546270|FG001|Overall Study|Protocol Violation|3|||
147377455|NCT00910962|531546271|FG002|Overall Study|Protocol Violation|3|||
147377456|NCT00910962|531546269|FG000|Overall Study|Lost to Follow-up|0|||
147377457|NCT00910962|531546270|FG001|Overall Study|Lost to Follow-up|3|||
147377458|NCT00910962|531546271|FG002|Overall Study|Lost to Follow-up|1|||
147377459|NCT00910962|531546269|FG000|Overall Study|Physician Decision|0|||
147377460|NCT00910962|531546270|FG001|Overall Study|Physician Decision|6|||
147377461|NCT00910962|531546271|FG002|Overall Study|Physician Decision|6|||
147377462|NCT00910962|531546269|FG000|Overall Study|Withdrawal by Subject|25|||
147377463|NCT00910962|531546270|FG001|Overall Study|Withdrawal by Subject|32|||
147377464|NCT00910962|531546271|FG002|Overall Study|Withdrawal by Subject|32|||
147377465|NCT00910962|531546269|FG000|Overall Study|Reached defined stopping criteria|12|||
147377466|NCT00910962|531546270|FG001|Overall Study|Reached defined stopping criteria|14|||
147377467|NCT00910962|531546271|FG002|Overall Study|Reached defined stopping criteria|17|||
147377468|NCT01485887|531546273|FG000|Overall Study|Withdrawal by Subject|2|||
147377469|NCT01485887|531546273|FG000|Overall Study|Adverse Event|8|||
147377470|NCT01485887|531546273|FG000|Overall Study|Deterioration of primary disease|1|||
147377471|NCT01485887|531546273|FG000|Overall Study|Primary disease markedly improved|1|||
147377472|NCT02106884|531546278|FG000|Overall Study|Change of diagnosis/exclusion|0|||
147377473|NCT02106884|531546279|FG001|Overall Study|Change of diagnosis/exclusion|1|||
147377474|NCT04638816|531546285|FG000|Overall Study|Withdrawal by Subject|0|||
147377475|NCT04638816|531546286|FG001|Overall Study|Withdrawal by Subject|1|||
147377476|NCT04638816|531546285|FG000|Overall Study|Lost to Follow-up|0|||
147377477|NCT04638816|531546286|FG001|Overall Study|Lost to Follow-up|1|||
147377478|NCT01822756|531546289|FG000|Overall Study|Adverse Event|0|||
147377479|NCT01822756|531546290|FG001|Overall Study|Adverse Event|0|||
147377480|NCT01822756|531546291|FG002|Overall Study|Adverse Event|0|||
147377481|NCT01822756|531546292|FG003|Overall Study|Adverse Event|2|||
147377482|NCT01822756|531546293|FG004|Overall Study|Adverse Event|0|||
147377483|NCT01822756|531546289|FG000|Overall Study|Disease progression|11|||
147377484|NCT01822756|531546290|FG001|Overall Study|Disease progression|1|||
147377485|NCT01822756|531546291|FG002|Overall Study|Disease progression|7|||
147377486|NCT01822756|531546292|FG003|Overall Study|Disease progression|2|||
147377487|NCT01822756|531546293|FG004|Overall Study|Disease progression|6|||
147664654|NCT00492297|532596313|FG000|Treatment|Study terminated by sponsor|3|||
147377488|NCT01822756|531546289|FG000|Overall Study|Death|2|||
147377489|NCT01822756|531546290|FG001|Overall Study|Death|2|||
147377490|NCT01822756|531546291|FG002|Overall Study|Death|1|||
147377491|NCT01822756|531546292|FG003|Overall Study|Death|0|||
147377492|NCT01822756|531546293|FG004|Overall Study|Death|0|||
147377493|NCT01822756|531546289|FG000|Overall Study|Lost to Follow-up|1|||
147377494|NCT01822756|531546290|FG001|Overall Study|Lost to Follow-up|0|||
147377495|NCT01822756|531546291|FG002|Overall Study|Lost to Follow-up|1|||
147377496|NCT01822756|531546292|FG003|Overall Study|Lost to Follow-up|0|||
147377497|NCT01822756|531546293|FG004|Overall Study|Lost to Follow-up|1|||
147377498|NCT01822756|531546289|FG000|Overall Study|Physician Decision|0|||
147377499|NCT01822756|531546290|FG001|Overall Study|Physician Decision|1|||
147377500|NCT01822756|531546291|FG002|Overall Study|Physician Decision|0|||
147377501|NCT01822756|531546292|FG003|Overall Study|Physician Decision|0|||
147377502|NCT01822756|531546293|FG004|Overall Study|Physician Decision|0|||
147377503|NCT01822756|531546289|FG000|Overall Study|disease progression & patient preference|2|||
147377504|NCT01822756|531546290|FG001|Overall Study|disease progression & patient preference|0|||
147377505|NCT01822756|531546291|FG002|Overall Study|disease progression & patient preference|1|||
147377506|NCT01822756|531546292|FG003|Overall Study|disease progression & patient preference|0|||
147377507|NCT01822756|531546293|FG004|Overall Study|disease progression & patient preference|0|||
147377508|NCT02060487|531546309|FG000|Overall Study|Other|1|||
147377509|NCT02060487|531546310|FG001|Overall Study|Other|2|||
147377510|NCT02060487|531546311|FG002|Overall Study|Other|1|||
147377511|NCT02060487|531546309|FG000|Overall Study|Lack of Efficacy|0|||
147377512|NCT02060487|531546310|FG001|Overall Study|Lack of Efficacy|1|||
147377513|NCT02060487|531546311|FG002|Overall Study|Lack of Efficacy|0|||
147377514|NCT02060487|531546309|FG000|Overall Study|Withdrawal by Subject|3|||
147377515|NCT02060487|531546310|FG001|Overall Study|Withdrawal by Subject|10|||
147377516|NCT02060487|531546311|FG002|Overall Study|Withdrawal by Subject|4|||
147377517|NCT02060487|531546309|FG000|Overall Study|Study Terminated By Sponsor|87|||
147377518|NCT02060487|531546310|FG001|Overall Study|Study Terminated By Sponsor|89|||
147377519|NCT02060487|531546311|FG002|Overall Study|Study Terminated By Sponsor|100|||
147377520|NCT02060487|531546309|FG000|Overall Study|Randomized in error|1|||
147377521|NCT02060487|531546310|FG001|Overall Study|Randomized in error|0|||
147377522|NCT02060487|531546311|FG002|Overall Study|Randomized in error|0|||
147377523|NCT02060487|531546309|FG000|Overall Study|Protocol Violation|0|||
147377524|NCT02060487|531546310|FG001|Overall Study|Protocol Violation|1|||
147377525|NCT02060487|531546311|FG002|Overall Study|Protocol Violation|1|||
147377526|NCT02060487|531546309|FG000|Overall Study|Lost to Follow-up|3|||
147377527|NCT02060487|531546310|FG001|Overall Study|Lost to Follow-up|0|||
147377528|NCT02060487|531546311|FG002|Overall Study|Lost to Follow-up|2|||
147377529|NCT02060487|531546309|FG000|Overall Study|Death|34|||
147377530|NCT02060487|531546310|FG001|Overall Study|Death|25|||
147377531|NCT02060487|531546311|FG002|Overall Study|Death|19|||
147377532|NCT02060487|531546309|FG000|Overall Study|Adverse Event|0|||
147377533|NCT02060487|531546310|FG001|Overall Study|Adverse Event|0|||
147377534|NCT02060487|531546311|FG002|Overall Study|Adverse Event|1|||
147377535|NCT02309294|531546312|FG000|Overall Study|Withdrawal by Subject|2|||
147377536|NCT01227421|531546313|FG000|Overall Study|Lost to Follow-up|6|||
147377537|NCT01227421|531546314|FG001|Overall Study|Lost to Follow-up|7|||
147377538|NCT01227421|531546315|FG002|Overall Study|Lost to Follow-up|5|||
147377539|NCT01227421|531546313|FG000|Overall Study|Adverse Event|2|||
147377540|NCT01227421|531546314|FG001|Overall Study|Adverse Event|7|||
147377541|NCT01227421|531546315|FG002|Overall Study|Adverse Event|2|||
147377542|NCT01227421|531546313|FG000|Overall Study|Withdrawal by Subject|1|||
147377543|NCT01227421|531546314|FG001|Overall Study|Withdrawal by Subject|2|||
147377544|NCT01227421|531546315|FG002|Overall Study|Withdrawal by Subject|1|||
147377545|NCT01227421|531546313|FG000|Overall Study|Protocol Violation|1|||
147377546|NCT01227421|531546314|FG001|Overall Study|Protocol Violation|1|||
147377547|NCT01227421|531546315|FG002|Overall Study|Protocol Violation|2|||
147377548|NCT01227421|531546313|FG000|Overall Study|Randomized in error|1|||
147377549|NCT01227421|531546314|FG001|Overall Study|Randomized in error|1|||
147377550|NCT01227421|531546315|FG002|Overall Study|Randomized in error|0|||
147377551|NCT01827839|531546318|FG000|Overall Study|Adverse Event|1|||
147377552|NCT01827839|531546318|FG000|Overall Study|Consent Withdrawal|2|||
147377553|NCT05426109|531546319|FG000|Overall Study|Withdrawal by Subject|0|||
147377554|NCT05426109|531546320|FG001|Overall Study|Withdrawal by Subject|1|||
147377555|NCT02542943|531546321|FG000|Overall Study|Lost to Follow-up|1|||
147377556|NCT02542943|531546322|FG001|Overall Study|Lost to Follow-up|0|||
147377557|NCT02542943|531546323|FG002|Overall Study|Lost to Follow-up|0|||
147377558|NCT02542943|531546321|FG000|Overall Study|Withdrawal by Subject|0|||
147377559|NCT02542943|531546322|FG001|Overall Study|Withdrawal by Subject|1|||
147377560|NCT02542943|531546323|FG002|Overall Study|Withdrawal by Subject|0|||
147377561|NCT03476798|531546324|FG000|Overall Study|Death|1|||
147377562|NCT03476798|531546324|FG000|Overall Study|Withdrawal by Subject|2|||
147377563|NCT03476798|531546324|FG000|Overall Study|Protocol Violation|2|||
147377564|NCT06269003|531546325|FG000|Overall Study|One participant was excluded for being outside the eligible age range.|0|||
147377565|NCT06269003|531546326|FG001|Overall Study|One participant was excluded for being outside the eligible age range.|0|||
147377566|NCT06269003|531546327|FG002|Overall Study|One participant was excluded for being outside the eligible age range.|1|||
147377567|NCT06269003|531546328|FG003|Overall Study|One participant was excluded for being outside the eligible age range.|0|||
147377568|NCT05865392|531546332|FG000|Overall Study|Withdrawal by Subject|4|||
147664655|NCT00492297|532596313|FG000|Active Follow-up 30(+4) Days Duration|Death|17|||
147377569|NCT05865392|531546333|FG001|Overall Study|Withdrawal by Subject|0|||
147377570|NCT05865392|531546332|FG000|Overall Study|Didn't meet inclusion criteria|4|||
147377571|NCT05865392|531546333|FG001|Overall Study|Didn't meet inclusion criteria|0|||
147377572|NCT04447027|531546336|FG000|Dose Escalation|Withdrawal by Subject|1|||
147377573|NCT04447027|531546337|FG001|Dose Escalation|Withdrawal by Subject|4|||
147377574|NCT04447027|531546338|FG002|Dose Escalation|Withdrawal by Subject|3|||
147664656|NCT00492297|532596313|FG000|Active Follow-up 30(+4) Days Duration|Study terminated by sponsor|2|||
147664657|NCT00492297|532596313|FG000|Survival Only Follow-up|Death|46|||
147664658|NCT00492297|532596313|FG000|Survival Only Follow-up|Lack of Efficacy|1|||
147664659|NCT00492297|532596313|FG000|Survival Only Follow-up|Study terminated by sponsor|12|||
147664660|NCT03585270|532596318|FG000|Overall Study|Withdrawal by Subject|2|||
147664661|NCT03585270|532596319|FG001|Overall Study|Withdrawal by Subject|6|||
147664662|NCT03585270|532596318|FG000|Overall Study|Withdrawal by proxy/legal representative|1|||
147664663|NCT03585270|532596319|FG001|Overall Study|Withdrawal by proxy/legal representative|0|||
147664664|NCT03585270|532596318|FG000|Overall Study|Adverse Event|5|||
147664665|NCT03585270|532596319|FG001|Overall Study|Adverse Event|2|||
147664666|NCT03585270|532596318|FG000|Overall Study|Lost to Follow-up|1|||
147664667|NCT03585270|532596319|FG001|Overall Study|Lost to Follow-up|4|||
147664668|NCT03585270|532596318|FG000|Overall Study|Death|5|||
147664669|NCT03585270|532596319|FG001|Overall Study|Death|3|||
147664670|NCT03585270|532596318|FG000|Overall Study|Other reasons|2|||
147664671|NCT03585270|532596319|FG001|Overall Study|Other reasons|2|||
147664672|NCT05002972|532596322|FG000|Overall Study|Withdrawal by Subject|2|||
147664673|NCT01664091|532596323|FG000|Overall Study|Death|1|||
147377575|NCT04447027|531546339|FG003|Dose Escalation|Withdrawal by Subject|3|||
147377576|NCT04447027|531546340|FG004|Dose Escalation|Withdrawal by Subject|1|||
147377577|NCT04447027|531546341|FG005|Dose Escalation|Withdrawal by Subject|0|||
147377578|NCT04447027|531546342|FG006|Dose Escalation|Withdrawal by Subject|0|||
147377579|NCT04447027|531546343|FG007|Dose Escalation|Withdrawal by Subject|0|||
147377580|NCT04447027|531546344|FG008|Dose Escalation|Withdrawal by Subject|0|||
147377581|NCT04447027|531546336|FG000|Dose Escalation|Refused further treatment|0|||
147377582|NCT04447027|531546337|FG001|Dose Escalation|Refused further treatment|1|||
147377583|NCT04447027|531546338|FG002|Dose Escalation|Refused further treatment|1|||
147377584|NCT04447027|531546339|FG003|Dose Escalation|Refused further treatment|0|||
147377585|NCT04447027|531546340|FG004|Dose Escalation|Refused further treatment|0|||
147377586|NCT04447027|531546341|FG005|Dose Escalation|Refused further treatment|0|||
147377587|NCT04447027|531546342|FG006|Dose Escalation|Refused further treatment|0|||
147377588|NCT04447027|531546343|FG007|Dose Escalation|Refused further treatment|0|||
147377589|NCT04447027|531546344|FG008|Dose Escalation|Refused further treatment|0|||
147377590|NCT04447027|531546336|FG000|Dose Expansion|Withdrawal by Subject|0|||
147377591|NCT04447027|531546337|FG001|Dose Expansion|Withdrawal by Subject|0|||
147377592|NCT04447027|531546338|FG002|Dose Expansion|Withdrawal by Subject|0|||
147377593|NCT04447027|531546339|FG003|Dose Expansion|Withdrawal by Subject|0|||
147377594|NCT04447027|531546340|FG004|Dose Expansion|Withdrawal by Subject|0|||
147377595|NCT04447027|531546341|FG005|Dose Expansion|Withdrawal by Subject|2|||
147612330|NCT00509795|532395476|FG002|Overall Study|Lack of Efficacy|2|||
147612331|NCT00509795|532395477|FG003|Overall Study|Lack of Efficacy|2|||
147612332|NCT00509795|532395474|FG000|Overall Study|Lost to Follow-up|1|||
147612333|NCT00509795|532395475|FG001|Overall Study|Lost to Follow-up|2|||
147612334|NCT00509795|532395476|FG002|Overall Study|Lost to Follow-up|4|||
147612335|NCT00509795|532395477|FG003|Overall Study|Lost to Follow-up|4|||
147612336|NCT00509795|532395474|FG000|Overall Study|OTHER|1|||
147612337|NCT00509795|532395475|FG001|Overall Study|OTHER|0|||
147612338|NCT00509795|532395476|FG002|Overall Study|OTHER|4|||
147612339|NCT00509795|532395477|FG003|Overall Study|OTHER|1|||
147612340|NCT00509795|532395474|FG000|Overall Study|Protocol Violation|3|||
147612341|NCT00509795|532395475|FG001|Overall Study|Protocol Violation|0|||
147612342|NCT00509795|532395476|FG002|Overall Study|Protocol Violation|3|||
147612343|NCT00509795|532395477|FG003|Overall Study|Protocol Violation|1|||
147612344|NCT00509795|532395474|FG000|Overall Study|Withdrawal by Subject|10|||
147612345|NCT00509795|532395475|FG001|Overall Study|Withdrawal by Subject|5|||
147612346|NCT00509795|532395476|FG002|Overall Study|Withdrawal by Subject|7|||
147612347|NCT00509795|532395477|FG003|Overall Study|Withdrawal by Subject|8|||
147612348|NCT00143247|532395479|FG000|Overall Study|Death|8|||
147612349|NCT00143247|532395479|FG000|Overall Study|Adverse Event|19|||
147612350|NCT00143247|532395479|FG000|Overall Study|Lack of Efficacy|3|||
147612351|NCT00143247|532395479|FG000|Overall Study|Withdrawal by Subject|55|||
147612352|NCT00143247|532395479|FG000|Overall Study|Study terminated by sponsor|31|||
147612353|NCT00143247|532395479|FG000|Overall Study|Protocol Violation|15|||
147612354|NCT00143247|532395479|FG000|Overall Study|Lost to Follow-up|12|||
147612355|NCT00143247|532395479|FG000|Overall Study|following inaccurate lab adverse event|1|||
147612356|NCT00143247|532395479|FG000|Overall Study|Other|12|||
147612357|NCT02766283|532395482|FG000|Overall Study|Lost to Follow-up|27|||
147612358|NCT00805961|532395483|FG000|Modality Therapy|Withdrawal by Subject|1|||
147612359|NCT00805961|532395483|FG000|Modality Therapy|Adverse Event|1|||
147612360|NCT00805961|532395483|FG000|Modality Therapy|Disease Progression|2|||
147612361|NCT00805961|532395483|FG000|Treatment-Free Interval|Adverse Event|3|||
147612362|NCT00805961|532395483|FG000|Treatment-Free Interval|Intercurrent Illness|2|||
147612363|NCT00805961|532395483|FG000|Treatment-Free Interval|Physician Decision|1|||
147612364|NCT00805961|532395483|FG000|Treatment-Free Interval|Lack of Efficacy|1|||
147664674|NCT01664091|532596323|FG000|Overall Study|Disease Progression|2|||
147664675|NCT01664091|532596323|FG000|Overall Study|Lost to Follow-up|2|||
147664676|NCT01664091|532596323|FG000|Overall Study|Withdrawal by Subject|1|||
147377596|NCT04447027|531546342|FG006|Dose Expansion|Withdrawal by Subject|0|||
147377597|NCT04447027|531546343|FG007|Dose Expansion|Withdrawal by Subject|2|||
147377598|NCT04447027|531546344|FG008|Dose Expansion|Withdrawal by Subject|0|||
147377599|NCT04118894|531546347|FG000|Overall Study|Lost to Follow-up|21|||
147377600|NCT04118894|531546347|FG000|Overall Study|Withdrawal by Subject|10|||
147377601|NCT04118894|531546347|FG000|Overall Study|Adverse Event|4|||
147377602|NCT00597376|531547497|FG000|Overall Study|Withdrawal by Subject|4|||
147377603|NCT00597376|531547498|FG001|Overall Study|Withdrawal by Subject|3|||
147377604|NCT00597376|531547497|FG000|Overall Study|Adverse Event|4|||
147377605|NCT00597376|531547498|FG001|Overall Study|Adverse Event|1|||
147377606|NCT02634307|531547499|FG000|Overall Study|Adverse Event|50|||
147377607|NCT02634307|531547500|FG001|Overall Study|Adverse Event|24|||
147377608|NCT02634307|531547501|FG002|Overall Study|Adverse Event|14|||
147377609|NCT02634307|531547499|FG000|Overall Study|Lost to Follow-up|21|||
147377610|NCT02634307|531547500|FG001|Overall Study|Lost to Follow-up|5|||
147377611|NCT02634307|531547501|FG002|Overall Study|Lost to Follow-up|6|||
147377612|NCT02634307|531547499|FG000|Overall Study|Pregnancy|5|||
147377613|NCT02634307|531547500|FG001|Overall Study|Pregnancy|1|||
147377614|NCT02634307|531547501|FG002|Overall Study|Pregnancy|3|||
147377615|NCT02634307|531547499|FG000|Overall Study|Withdrawal by Subject|38|||
147377616|NCT02634307|531547500|FG001|Overall Study|Withdrawal by Subject|24|||
147377617|NCT02634307|531547501|FG002|Overall Study|Withdrawal by Subject|18|||
147455800|NCT02574637|531829923|FG005|Double-blind Period|Reason Not Specified|0|||
147455801|NCT02574637|531829924|FG006|Double-blind Period|Reason Not Specified|0|||
147455802|NCT02574637|531829925|FG007|Double-blind Period|Reason Not Specified|0|||
147455803|NCT02574637|531829926|FG008|Double-blind Period|Reason Not Specified|0|||
147455804|NCT02574637|531829927|FG009|Double-blind Period|Reason Not Specified|0|||
147455805|NCT02574637|531829918|FG000|Open-label (OL) Period|Adverse Event|0|||
147455806|NCT02574637|531829919|FG001|Open-label (OL) Period|Adverse Event|0|||
147455807|NCT02574637|531829920|FG002|Open-label (OL) Period|Adverse Event|0|||
147455808|NCT02574637|531829921|FG003|Open-label (OL) Period|Adverse Event|0|||
147455809|NCT02574637|531829922|FG004|Open-label (OL) Period|Adverse Event|0|||
147455810|NCT02574637|531829923|FG005|Open-label (OL) Period|Adverse Event|0|||
147455811|NCT02574637|531829924|FG006|Open-label (OL) Period|Adverse Event|0|||
147455812|NCT02574637|531829925|FG007|Open-label (OL) Period|Adverse Event|0|||
147455813|NCT02574637|531829926|FG008|Open-label (OL) Period|Adverse Event|1|||
147455814|NCT02574637|531829927|FG009|Open-label (OL) Period|Adverse Event|0|||
147455815|NCT02574637|531829918|FG000|Open-label (OL) Period|Withdrawal by Subject|0|||
147455816|NCT02574637|531829919|FG001|Open-label (OL) Period|Withdrawal by Subject|0|||
147455817|NCT02574637|531829920|FG002|Open-label (OL) Period|Withdrawal by Subject|0|||
147455818|NCT02574637|531829921|FG003|Open-label (OL) Period|Withdrawal by Subject|0|||
147455819|NCT02574637|531829922|FG004|Open-label (OL) Period|Withdrawal by Subject|0|||
147455820|NCT02574637|531829923|FG005|Open-label (OL) Period|Withdrawal by Subject|1|||
147455821|NCT02574637|531829924|FG006|Open-label (OL) Period|Withdrawal by Subject|0|||
147455822|NCT02574637|531829925|FG007|Open-label (OL) Period|Withdrawal by Subject|0|||
147455823|NCT02574637|531829926|FG008|Open-label (OL) Period|Withdrawal by Subject|0|||
147455824|NCT02574637|531829927|FG009|Open-label (OL) Period|Withdrawal by Subject|1|||
147455825|NCT02574637|531829918|FG000|Open-label (OL) Period|Study Terminated By Sponsor|0|||
147455826|NCT02574637|531829919|FG001|Open-label (OL) Period|Study Terminated By Sponsor|0|||
147455827|NCT02574637|531829920|FG002|Open-label (OL) Period|Study Terminated By Sponsor|0|||
147455828|NCT02574637|531829921|FG003|Open-label (OL) Period|Study Terminated By Sponsor|0|||
147455829|NCT02574637|531829922|FG004|Open-label (OL) Period|Study Terminated By Sponsor|0|||
147455830|NCT02574637|531829923|FG005|Open-label (OL) Period|Study Terminated By Sponsor|1|||
147455831|NCT02574637|531829924|FG006|Open-label (OL) Period|Study Terminated By Sponsor|2|||
147455832|NCT02574637|531829925|FG007|Open-label (OL) Period|Study Terminated By Sponsor|1|||
147455833|NCT02574637|531829926|FG008|Open-label (OL) Period|Study Terminated By Sponsor|1|||
147455834|NCT02574637|531829927|FG009|Open-label (OL) Period|Study Terminated By Sponsor|0|||
147455835|NCT04016311|531829928|FG000|Overall Study|Withdrawal by Subject|1|||
147455836|NCT04016311|531829929|FG001|Overall Study|Withdrawal by Subject|0|||
147455837|NCT04029519|531829932|FG000|Overall Study|Protocol Violation|1|||
147455838|NCT04029519|531829932|FG000|Overall Study|Withdrawal by Subject|3|||
147455839|NCT04029519|531829932|FG000|Overall Study|Lost to Follow-up|1|||
147455840|NCT00094055|531829939|FG000|Overall Study|Adverse Event|11|||
147455841|NCT00094055|531829939|FG000|Overall Study|Death|4|||
147455842|NCT00094055|531829939|FG000|Overall Study|Lack of Efficacy|17|||
147377618|NCT02634307|531547499|FG000|Overall Study|Non-Compliance with Study Drug|0|||
147377619|NCT02634307|531547500|FG001|Overall Study|Non-Compliance with Study Drug|2|||
147377620|NCT02634307|531547501|FG002|Overall Study|Non-Compliance with Study Drug|2|||
147455843|NCT00094055|531829939|FG000|Overall Study|Lost to Follow-up|2|||
147455844|NCT00094055|531829939|FG000|Overall Study|progressive disease|2|||
147455845|NCT00094055|531829939|FG000|Overall Study|clinical progression|1|||
147455846|NCT00094055|531829939|FG000|Overall Study|roll-over to another study|14|||
147455847|NCT00094055|531829939|FG000|Overall Study|Withdrawal by Subject|9|||
147455848|NCT04823949|531829940|FG000|Overall Study|Withdrawal by Subject|0|||
147377621|NCT02634307|531547499|FG000|Overall Study|Lack of Efficacy|1|||
147377622|NCT02634307|531547500|FG001|Overall Study|Lack of Efficacy|5|||
147377623|NCT02634307|531547501|FG002|Overall Study|Lack of Efficacy|3|||
147377624|NCT02634307|531547499|FG000|Overall Study|Physician Decision|7|||
147377625|NCT02634307|531547500|FG001|Overall Study|Physician Decision|5|||
147377626|NCT02634307|531547501|FG002|Overall Study|Physician Decision|5|||
147377627|NCT02634307|531547499|FG000|Overall Study|Reason not Specified|3|||
147377628|NCT02634307|531547500|FG001|Overall Study|Reason not Specified|5|||
147377629|NCT02634307|531547501|FG002|Overall Study|Reason not Specified|10|||
147377630|NCT01214200|531547506|FG000|Overall Study|Did not meet inclusion/exclusion|9|||
147377631|NCT01214200|531547506|FG000|Overall Study|Withdrawal by Subject|2|||
147377632|NCT00667017|531547507|FG000|Overall Study|Withdrawal by Subject|1|||
147377633|NCT01823224|531547508|FG000|Overall Study|Lost to Follow-up|5|||
147377634|NCT01823224|531547509|FG001|Overall Study|Lost to Follow-up|6|||
147377635|NCT01823224|531547508|FG000|Overall Study|didn't qualify|1|||
147377636|NCT01823224|531547509|FG001|Overall Study|didn't qualify|2|||
147377637|NCT01823224|531547508|FG000|Overall Study|pharmacy error|0|||
147377638|NCT01823224|531547509|FG001|Overall Study|pharmacy error|1|||
147377639|NCT01823224|531547508|FG000|Overall Study|missed med dose|0|||
147377640|NCT01823224|531547509|FG001|Overall Study|missed med dose|1|||
147377641|NCT01823224|531547508|FG000|Overall Study|Withdrawal by Subject|0|||
147377642|NCT01823224|531547509|FG001|Overall Study|Withdrawal by Subject|1|||
147377643|NCT01532648|531547510|FG000|Overall Study|Lost to Follow-up|3|||
147377644|NCT01532648|531547511|FG001|Overall Study|Lost to Follow-up|4|||
147377645|NCT01532648|531547510|FG000|Overall Study|Lack of Efficacy|4|||
147377646|NCT01532648|531547511|FG001|Overall Study|Lack of Efficacy|1|||
147377647|NCT01532648|531547510|FG000|Overall Study|Protocol Violation|1|||
147377648|NCT01532648|531547511|FG001|Overall Study|Protocol Violation|1|||
147377649|NCT01532648|531547510|FG000|Overall Study|Adverse Event|12|||
147377650|NCT01532648|531547511|FG001|Overall Study|Adverse Event|9|||
147377651|NCT01532648|531547510|FG000|Overall Study|Withdrawal by Subject|16|||
147377652|NCT01532648|531547511|FG001|Overall Study|Withdrawal by Subject|2|||
147377653|NCT03960645|531547512|FG000|Overall Study|Protocol Violation|1|||
147377654|NCT03960645|531547513|FG001|Overall Study|Protocol Violation|0|||
147377655|NCT04938453|531547516|FG000|Washout Period 1|Adverse Event|1|||
147377656|NCT04938453|531547517|FG001|Washout Period 1|Adverse Event|0|||
147455849|NCT04823949|531829941|FG001|Overall Study|Withdrawal by Subject|4|||
147377657|NCT04938453|531547516|FG000|Washout Period 1|Physician Decision|0|||
147377658|NCT04938453|531547517|FG001|Washout Period 1|Physician Decision|1|||
147455850|NCT04823949|531829940|FG000|Overall Study|Physician Decision|0|||
147455851|NCT04823949|531829941|FG001|Overall Study|Physician Decision|1|||
147455852|NCT02347176|531829944|FG000|Overall Study|Lost to Follow-up|2|||
147455853|NCT02347176|531829945|FG001|Overall Study|Lost to Follow-up|3|||
147455854|NCT02347176|531829946|FG002|Overall Study|Lost to Follow-up|1|||
147455855|NCT02347176|531829947|FG003|Overall Study|Lost to Follow-up|1|||
147455856|NCT02347176|531829944|FG000|Overall Study|Withdrawal by Subject|9|||
147455857|NCT02347176|531829945|FG001|Overall Study|Withdrawal by Subject|5|||
147455858|NCT02347176|531829946|FG002|Overall Study|Withdrawal by Subject|5|||
147455859|NCT02347176|531829947|FG003|Overall Study|Withdrawal by Subject|3|||
147455860|NCT02347176|531829944|FG000|Overall Study|Other|1|||
147455861|NCT02347176|531829945|FG001|Overall Study|Other|2|||
147455862|NCT02347176|531829946|FG002|Overall Study|Other|2|||
147455863|NCT02347176|531829947|FG003|Overall Study|Other|0|||
147455864|NCT02556255|531829948|FG000|Overall Study|Lost to Follow-up|4|||
147455865|NCT04673786|531829949|FG000|Treatment Period I (Weeks 0 to 16)|Withdrawal by Subject|3|||
147455866|NCT04673786|531829950|FG001|Treatment Period I (Weeks 0 to 16)|Withdrawal by Subject|3|||
147455867|NCT04673786|531829951|FG002|Treatment Period I (Weeks 0 to 16)|Withdrawal by Subject|0|||
147377659|NCT03292406|531547518|FG000|Overall Study|Progressive Disease|6|||
147377660|NCT03292406|531547519|FG001|Overall Study|Progressive Disease|3|||
147377661|NCT03292406|531547520|FG002|Overall Study|Progressive Disease|4|||
147377662|NCT03292406|531547518|FG000|Overall Study|Adverse Event|7|||
147377663|NCT03292406|531547519|FG001|Overall Study|Adverse Event|1|||
147377664|NCT03292406|531547520|FG002|Overall Study|Adverse Event|4|||
147377665|NCT03292406|531547518|FG000|Overall Study|Withdrawal by Subject|0|||
147377666|NCT03292406|531547519|FG001|Overall Study|Withdrawal by Subject|7|||
147377667|NCT03292406|531547520|FG002|Overall Study|Withdrawal by Subject|2|||
147377668|NCT03292406|531547518|FG000|Overall Study|Protocol Violation|0|||
147455868|NCT04673786|531829949|FG000|Treatment Period I (Weeks 0 to 16)|Lost to Follow-up|0|||
147377669|NCT03292406|531547519|FG001|Overall Study|Protocol Violation|1|||
147377670|NCT03292406|531547520|FG002|Overall Study|Protocol Violation|1|||
147377671|NCT03292406|531547518|FG000|Overall Study|Other|0|||
147377672|NCT03292406|531547519|FG001|Overall Study|Other|1|||
147377673|NCT03292406|531547520|FG002|Overall Study|Other|2|||
147377674|NCT00022672|531547522|FG000|Main Phase: 24 Months|Adverse Event|6|||
147377675|NCT00022672|531547523|FG001|Main Phase: 24 Months|Adverse Event|0|||
147377676|NCT00022672|531547522|FG000|Main Phase: 24 Months|Death|0|||
147455869|NCT04673786|531829950|FG001|Treatment Period I (Weeks 0 to 16)|Lost to Follow-up|1|||
147455870|NCT04673786|531829951|FG002|Treatment Period I (Weeks 0 to 16)|Lost to Follow-up|0|||
147377677|NCT00022672|531547523|FG001|Main Phase: 24 Months|Death|3|||
147377678|NCT00022672|531547522|FG000|Main Phase: 24 Months|Insufficient Therapeutic Response|75|||
147377679|NCT00022672|531547523|FG001|Main Phase: 24 Months|Insufficient Therapeutic Response|91|||
147377680|NCT00022672|531547522|FG000|Main Phase: 24 Months|Violation of Selection Criteria at Entry|0|||
147377681|NCT00022672|531547523|FG001|Main Phase: 24 Months|Violation of Selection Criteria at Entry|1|||
147377682|NCT00022672|531547522|FG000|Main Phase: 24 Months|Other Protocol Violation|1|||
147377683|NCT00022672|531547523|FG001|Main Phase: 24 Months|Other Protocol Violation|0|||
147377684|NCT00022672|531547522|FG000|Main Phase: 24 Months|Refused Treatment|3|||
147377685|NCT00022672|531547523|FG001|Main Phase: 24 Months|Refused Treatment|4|||
147377686|NCT00022672|531547522|FG000|Main Phase: 24 Months|Failure to Return|1|||
147377687|NCT00022672|531547523|FG001|Main Phase: 24 Months|Failure to Return|1|||
147377688|NCT00022672|531547522|FG000|Main Phase: 24 Months|Other|1|||
147377689|NCT00022672|531547523|FG001|Main Phase: 24 Months|Other|0|||
147377690|NCT00022672|531547522|FG000|Extension Phase|Adverse Event|1|||
147377691|NCT00022672|531547523|FG001|Extension Phase|Adverse Event|3|||
147377692|NCT00022672|531547522|FG000|Extension Phase|Death|0|||
147377693|NCT00022672|531547523|FG001|Extension Phase|Death|1|||
147377694|NCT00022672|531547522|FG000|Extension Phase|Insufficient Therapeutic Response|1|||
147377695|NCT00022672|531547523|FG001|Extension Phase|Insufficient Therapeutic Response|44|||
147377696|NCT00022672|531547522|FG000|Extension Phase|Refused Treatment|0|||
147377697|NCT00022672|531547523|FG001|Extension Phase|Refused Treatment|2|||
147377698|NCT00022672|531547522|FG000|Extension Phase|Other|1|||
147377699|NCT00022672|531547523|FG001|Extension Phase|Other|1|||
147377700|NCT00403494|531547524|FG000|Overall Study|Adverse Event|10|||
147377701|NCT00403494|531547525|FG001|Overall Study|Adverse Event|8|||
147377702|NCT00403494|531547524|FG000|Overall Study|Withdrew Consent|3|||
147377703|NCT00403494|531547525|FG001|Overall Study|Withdrew Consent|2|||
147377704|NCT00403494|531547524|FG000|Overall Study|Inappropriately enrolled|0|||
147377705|NCT00403494|531547525|FG001|Overall Study|Inappropriately enrolled|1|||
147377706|NCT00403494|531547524|FG000|Overall Study|Lost to Follow-up|0|||
147377707|NCT00403494|531547525|FG001|Overall Study|Lost to Follow-up|2|||
147377708|NCT00403494|531547524|FG000|Overall Study|Protocol noncompliance|0|||
147377709|NCT00403494|531547525|FG001|Overall Study|Protocol noncompliance|1|||
147377710|NCT00403494|531547524|FG000|Overall Study|Death|1|||
147377711|NCT00403494|531547525|FG001|Overall Study|Death|0|||
147377712|NCT00403494|531547524|FG000|Overall Study|Sponsor Request|1|||
147377713|NCT00403494|531547525|FG001|Overall Study|Sponsor Request|0|||
147377714|NCT04658784|531547532|FG000|6-month Follow-up|Lost to Follow-up|2|||
147377715|NCT04658784|531547533|FG001|6-month Follow-up|Lost to Follow-up|5|||
147377716|NCT02575365|531547534|FG000|Overall Study|Lost to Follow-up|4|||
147377717|NCT00670488|531547539|FG000|Overall Study|Adverse Event|0|||
147377718|NCT00670488|531547540|FG001|Overall Study|Adverse Event|7|||
147377719|NCT00670488|531547541|FG002|Overall Study|Adverse Event|0|||
147377720|NCT00670488|531547542|FG003|Overall Study|Adverse Event|3|||
147377721|NCT00670488|531547543|FG004|Overall Study|Adverse Event|1|||
147377722|NCT00670488|531547544|FG005|Overall Study|Adverse Event|1|||
147377723|NCT00670488|531547545|FG006|Overall Study|Adverse Event|5|||
147377724|NCT00670488|531547546|FG007|Overall Study|Adverse Event|1|||
147377725|NCT00670488|531547547|FG008|Overall Study|Adverse Event|0|||
147377726|NCT00670488|531547548|FG009|Overall Study|Adverse Event|1|||
147377727|NCT00670488|531547539|FG000|Overall Study|Physician Decision|1|||
147377728|NCT00670488|531547540|FG001|Overall Study|Physician Decision|9|||
147377729|NCT00670488|531547541|FG002|Overall Study|Physician Decision|0|||
147377730|NCT00670488|531547542|FG003|Overall Study|Physician Decision|1|||
147377731|NCT00670488|531547543|FG004|Overall Study|Physician Decision|0|||
147377732|NCT00670488|531547544|FG005|Overall Study|Physician Decision|0|||
147377733|NCT00670488|531547545|FG006|Overall Study|Physician Decision|0|||
147377734|NCT00670488|531547546|FG007|Overall Study|Physician Decision|0|||
147377735|NCT00670488|531547547|FG008|Overall Study|Physician Decision|0|||
147377736|NCT00670488|531547548|FG009|Overall Study|Physician Decision|0|||
147377737|NCT00670488|531547539|FG000|Overall Study|Progressive Disease|2|||
147377738|NCT00670488|531547540|FG001|Overall Study|Progressive Disease|41|||
147377739|NCT00670488|531547541|FG002|Overall Study|Progressive Disease|3|||
147377740|NCT00670488|531547542|FG003|Overall Study|Progressive Disease|2|||
147377741|NCT00670488|531547543|FG004|Overall Study|Progressive Disease|2|||
147377742|NCT00670488|531547544|FG005|Overall Study|Progressive Disease|4|||
147377743|NCT00670488|531547545|FG006|Overall Study|Progressive Disease|11|||
147377744|NCT00670488|531547546|FG007|Overall Study|Progressive Disease|2|||
147377745|NCT00670488|531547547|FG008|Overall Study|Progressive Disease|2|||
147377746|NCT00670488|531547548|FG009|Overall Study|Progressive Disease|1|||
147377747|NCT00670488|531547539|FG000|Overall Study|Withdrawal by Subject|0|||
147377748|NCT00670488|531547540|FG001|Overall Study|Withdrawal by Subject|1|||
147377749|NCT00670488|531547541|FG002|Overall Study|Withdrawal by Subject|0|||
147377750|NCT00670488|531547542|FG003|Overall Study|Withdrawal by Subject|1|||
147377751|NCT00670488|531547543|FG004|Overall Study|Withdrawal by Subject|0|||
147377752|NCT00670488|531547544|FG005|Overall Study|Withdrawal by Subject|0|||
147377753|NCT00670488|531547545|FG006|Overall Study|Withdrawal by Subject|1|||
147377754|NCT00670488|531547546|FG007|Overall Study|Withdrawal by Subject|0|||
147455871|NCT04673786|531829949|FG000|Treatment Period II (Weeks 16 to 52)|Withdrawal by Subject|9|||
147455872|NCT04673786|531829950|FG001|Treatment Period II (Weeks 16 to 52)|Withdrawal by Subject|3|||
147455873|NCT04673786|531829951|FG002|Treatment Period II (Weeks 16 to 52)|Withdrawal by Subject|1|||
147377755|NCT00670488|531547547|FG008|Overall Study|Withdrawal by Subject|1|||
147377756|NCT00670488|531547548|FG009|Overall Study|Withdrawal by Subject|0|||
147377757|NCT02708498|531547549|FG000|Overall Study|Death|20|||
147377758|NCT02708498|531547550|FG001|Overall Study|Death|19|||
147377759|NCT02708498|531547551|FG002|Overall Study|Death|0|||
147377760|NCT02708498|531547552|FG003|Overall Study|Death|0|||
147377761|NCT02708498|531547553|FG004|Overall Study|Death|1|||
147377762|NCT02708498|531547554|FG005|Overall Study|Death|0|||
147377763|NCT02708498|531547555|FG006|Overall Study|Death|0|||
147377764|NCT02708498|531547556|FG007|Overall Study|Death|0|||
147377765|NCT02708498|531547549|FG000|Overall Study|Unknown reason, missing data|0|||
147377766|NCT02708498|531547550|FG001|Overall Study|Unknown reason, missing data|0|||
147377767|NCT02708498|531547551|FG002|Overall Study|Unknown reason, missing data|62|||
147377768|NCT02708498|531547552|FG003|Overall Study|Unknown reason, missing data|51|||
147377769|NCT02708498|531547553|FG004|Overall Study|Unknown reason, missing data|195|||
147377770|NCT02708498|531547554|FG005|Overall Study|Unknown reason, missing data|132|||
147377771|NCT02708498|531547555|FG006|Overall Study|Unknown reason, missing data|0|||
147377772|NCT02708498|531547556|FG007|Overall Study|Unknown reason, missing data|0|||
147377773|NCT00195819|531547557|FG000|Double-Blind|Withdrawal by Subject|1|||
147377774|NCT00195819|531547558|FG001|Double-Blind|Withdrawal by Subject|0|||
147377775|NCT00195819|531547557|FG000|Double-Blind|Moved|1|||
147377776|NCT00195819|531547558|FG001|Double-Blind|Moved|0|||
147377777|NCT00195819|531547557|FG000|Open-label|Adverse Event|0|||
147377778|NCT00195819|531547558|FG001|Open-label|Adverse Event|9|||
147377779|NCT00195819|531547557|FG000|Open-label|Lack of Efficacy|0|||
147377780|NCT00195819|531547558|FG001|Open-label|Lack of Efficacy|2|||
147377781|NCT00195819|531547557|FG000|Open-label|Pregnancy|0|||
147377782|NCT00195819|531547558|FG001|Open-label|Pregnancy|1|||
147377783|NCT00195819|531547557|FG000|Open-label|Protocol Violation|0|||
147377784|NCT00195819|531547558|FG001|Open-label|Protocol Violation|2|||
147377785|NCT00195819|531547557|FG000|Open-label|Moved|0|||
147377786|NCT00195819|531547558|FG001|Open-label|Moved|1|||
147377787|NCT00195819|531547557|FG000|Open-label|Withdrawal by Subject|0|||
147377788|NCT00195819|531547558|FG001|Open-label|Withdrawal by Subject|5|||
147377789|NCT01124045|531547559|FG000|Overall Study|Lost to Follow-up|0|||
147377790|NCT01124045|531547560|FG001|Overall Study|Lost to Follow-up|1|||
147377791|NCT01124045|531547559|FG000|Overall Study|Physician Decision|0|||
147377792|NCT01124045|531547560|FG001|Overall Study|Physician Decision|2|||
147377793|NCT03298087|531547561|FG000|Overall Study|Withdrawal by Subject|4|||
147377794|NCT01629589|531547562|FG000|Overall Study|Protocol Violation|4|||
147377795|NCT01629589|531547563|FG001|Overall Study|Protocol Violation|2|||
147377796|NCT01629589|531547562|FG000|Overall Study|Lost to Follow-up|2|||
147377797|NCT01629589|531547563|FG001|Overall Study|Lost to Follow-up|1|||
147377798|NCT01629589|531547562|FG000|Overall Study|Withdrawal by Subject|2|||
147377799|NCT01629589|531547563|FG001|Overall Study|Withdrawal by Subject|3|||
147377800|NCT01629589|531547562|FG000|Overall Study|Did not receive study vaccine|0|||
147377801|NCT01629589|531547563|FG001|Overall Study|Did not receive study vaccine|1|||
147377802|NCT00822900|531547564|FG000|Overall Study|Withdrawal by Subject|14|||
147377803|NCT00822900|531547565|FG001|Overall Study|Withdrawal by Subject|14|||
147377804|NCT00822900|531547564|FG000|Overall Study|Lost to Follow-up|9|||
147377805|NCT00822900|531547565|FG001|Overall Study|Lost to Follow-up|9|||
147377806|NCT00822900|531547564|FG000|Overall Study|Death|83|||
147377807|NCT00822900|531547565|FG001|Overall Study|Death|69|||
147377808|NCT00822900|531547564|FG000|Overall Study|Became a ward of the state|2|||
147377809|NCT00822900|531547565|FG001|Overall Study|Became a ward of the state|1|||
147377810|NCT02234141|531547566|FG000|Treatment Period (24 Weeks)|Protocol Violation|0|||
147377811|NCT02234141|531547567|FG001|Treatment Period (24 Weeks)|Protocol Violation|0|||
147377812|NCT02234141|531547568|FG002|Treatment Period (24 Weeks)|Protocol Violation|0|||
147377813|NCT02234141|531547569|FG003|Treatment Period (24 Weeks)|Protocol Violation|1|||
147377814|NCT02234141|531547570|FG004|Treatment Period (24 Weeks)|Protocol Violation|0|||
147377815|NCT02234141|531547571|FG005|Treatment Period (24 Weeks)|Protocol Violation|0|||
147377816|NCT02234141|531547572|FG006|Treatment Period (24 Weeks)|Protocol Violation|0|||
147377817|NCT02234141|531547566|FG000|Treatment Period (24 Weeks)|Investigator's discretion|0|||
147377818|NCT02234141|531547567|FG001|Treatment Period (24 Weeks)|Investigator's discretion|2|||
147455874|NCT04673786|531829949|FG000|Treatment Period II (Weeks 16 to 52)|Lost to Follow-up|2|||
147455875|NCT04673786|531829950|FG001|Treatment Period II (Weeks 16 to 52)|Lost to Follow-up|0|||
147377819|NCT02234141|531547568|FG002|Treatment Period (24 Weeks)|Investigator's discretion|0|||
147377820|NCT02234141|531547569|FG003|Treatment Period (24 Weeks)|Investigator's discretion|0|||
147455876|NCT04673786|531829951|FG002|Treatment Period II (Weeks 16 to 52)|Lost to Follow-up|0|||
147455877|NCT04673786|531829949|FG000|Treatment Period II (Weeks 16 to 52)|Death|1|||
147377821|NCT02234141|531547570|FG004|Treatment Period (24 Weeks)|Investigator's discretion|0|||
147377822|NCT02234141|531547571|FG005|Treatment Period (24 Weeks)|Investigator's discretion|0|||
147377823|NCT02234141|531547572|FG006|Treatment Period (24 Weeks)|Investigator's discretion|0|||
147455878|NCT04673786|531829950|FG001|Treatment Period II (Weeks 16 to 52)|Death|0|||
147455879|NCT04673786|531829951|FG002|Treatment Period II (Weeks 16 to 52)|Death|0|||
147455880|NCT04673786|531829949|FG000|Treatment Period II (Weeks 16 to 52)|Adverse Event|2|||
147455881|NCT04673786|531829950|FG001|Treatment Period II (Weeks 16 to 52)|Adverse Event|0|||
147455882|NCT04673786|531829951|FG002|Treatment Period II (Weeks 16 to 52)|Adverse Event|1|||
147455883|NCT01422239|531829955|FG000|Overall Study|Lost to Follow-up|4|||
147455884|NCT01422239|531829956|FG001|Overall Study|Lost to Follow-up|3|||
147455885|NCT01250379|531829972|FG000|Overall Study|Death|141|||
147455886|NCT01250379|531829973|FG001|Overall Study|Death|148|||
147455887|NCT01250379|531829972|FG000|Overall Study|Withdrawal by Subject|32|||
147455888|NCT01250379|531829973|FG001|Overall Study|Withdrawal by Subject|20|||
147455889|NCT01250379|531829972|FG000|Overall Study|Physician Decision|11|||
147455890|NCT01250379|531829973|FG001|Overall Study|Physician Decision|3|||
147455891|NCT01250379|531829972|FG000|Overall Study|Protocol Violation|2|||
147455892|NCT01250379|531829973|FG001|Overall Study|Protocol Violation|8|||
147455893|NCT01250379|531829972|FG000|Overall Study|Lost to Follow-up|9|||
147455894|NCT01250379|531829973|FG001|Overall Study|Lost to Follow-up|6|||
147455895|NCT01250379|531829972|FG000|Overall Study|Adverse Event|5|||
147455896|NCT01250379|531829973|FG001|Overall Study|Adverse Event|4|||
147455897|NCT01250379|531829972|FG000|Overall Study|Other|0|||
147455898|NCT01250379|531829973|FG001|Overall Study|Other|4|||
147455899|NCT01250379|531829972|FG000|Overall Study|Participant noncompliance|2|||
147455900|NCT01250379|531829973|FG001|Overall Study|Participant noncompliance|0|||
147455901|NCT01489527|531829974|FG000|Overall Study|Pregnancy|9|||
147455902|NCT01489527|531829975|FG001|Overall Study|Pregnancy|14|||
147455903|NCT01489527|531829974|FG000|Overall Study|Participant moved|6|||
147455904|NCT01489527|531829975|FG001|Overall Study|Participant moved|7|||
147455905|NCT01489527|531829974|FG000|Overall Study|Withdrawal by Subject|0|||
147455906|NCT01489527|531829975|FG001|Overall Study|Withdrawal by Subject|4|||
147455907|NCT01489527|531829974|FG000|Overall Study|Lost to Follow-up|5|||
147455908|NCT01489527|531829975|FG001|Overall Study|Lost to Follow-up|1|||
147455909|NCT01489527|531829974|FG000|Overall Study|Procedures|1|||
147455910|NCT01489527|531829975|FG001|Overall Study|Procedures|0|||
147455911|NCT01489527|531829974|FG000|Overall Study|Not compliant|1|||
147455912|NCT01489527|531829975|FG001|Overall Study|Not compliant|0|||
147455913|NCT01984268|531829976|FG000|Overall Study|Study Terminated|15|||
147455914|NCT04899232|531829977|FG000|Screening Period|Physician Decision|1|||
147455915|NCT04899232|531829978|FG001|Screening Period|Physician Decision|0|||
147455916|NCT04899232|531829979|FG002|Screening Period|Physician Decision|0|||
147455917|NCT04899232|531829977|FG000|Screening Period|Withdrawal by Subject|1|||
147455918|NCT04899232|531829978|FG001|Screening Period|Withdrawal by Subject|0|||
147455919|NCT04899232|531829979|FG002|Screening Period|Withdrawal by Subject|0|||
147455920|NCT04899232|531829977|FG000|Screening Period|Participant discharged before receiving intervention|3|||
147455921|NCT04899232|531829978|FG001|Screening Period|Participant discharged before receiving intervention|0|||
147455922|NCT04899232|531829979|FG002|Screening Period|Participant discharged before receiving intervention|0|||
147455923|NCT02926950|531829983|FG000|Overall Study|Adverse Event|4|||
147455924|NCT02926950|531829984|FG001|Overall Study|Adverse Event|6|||
147455925|NCT02926950|531829983|FG000|Overall Study|At the participant's own request|21|||
147455926|NCT02926950|531829984|FG001|Overall Study|At the participant's own request|25|||
147455927|NCT02926950|531829983|FG000|Overall Study|Reason not Specified|17|||
147455928|NCT02926950|531829984|FG001|Overall Study|Reason not Specified|9|||
147455929|NCT02926950|531829983|FG000|Overall Study|Lost to Follow-up|7|||
147455930|NCT02926950|531829984|FG001|Overall Study|Lost to Follow-up|8|||
147455931|NCT05036083|531829985|FG000|Overall Study|Physician Decision|1|||
147455932|NCT05036083|531829985|FG000|Overall Study|Withdrawal by Subject|1|||
147455933|NCT05036083|531829985|FG000|Overall Study|Labs outside instition parameter, eGFR|3|||
147455934|NCT05036083|531829985|FG000|Overall Study|IV not sustainable|1|||
147455935|NCT04622046|531829986|FG000|Intervention Period|Adverse Event|1|||
147612365|NCT00805961|532395483|FG000|Maintenance Treatment|Lack of Efficacy|13|||
147612366|NCT00805961|532395483|FG000|Maintenance Treatment|Intercurrent Illness|7|||
147612367|NCT00805961|532395483|FG000|Maintenance Treatment|Adverse Event|6|||
147612368|NCT00805961|532395483|FG000|Maintenance Treatment|Withdrawal by Subject|5|||
147612369|NCT00805961|532395483|FG000|Maintenance Treatment|Symptomatic Deterioration|2|||
147455936|NCT04622046|531829986|FG000|Intervention Period|Withdrawal by Subject|2|||
147455937|NCT04622046|531829986|FG000|Extension Period|Ongoing in the Extension Period|21|||
147455938|NCT03505021|531829987|FG000|Overall Study|Protocol Violation|1|||
147612370|NCT00805961|532395483|FG000|Maintenance Treatment|Withdrawn Consent|1|||
147612371|NCT04380961|532395484|FG000|Overall Study|Lost to Follow-up|17|||
147612372|NCT04380961|532395485|FG001|Overall Study|Lost to Follow-up|11|||
147612373|NCT04380961|532395484|FG000|Overall Study|Withdrawal by Subject|3|||
147455939|NCT03505021|531829988|FG001|Overall Study|Protocol Violation|0|||
147455940|NCT03505021|531829987|FG000|Overall Study|Death|9|||
147455941|NCT03505021|531829988|FG001|Overall Study|Death|8|||
147455942|NCT03505021|531829987|FG000|Overall Study|Consent withdrawn by subject|6|||
147455943|NCT03505021|531829988|FG001|Overall Study|Consent withdrawn by subject|1|||
147455944|NCT03505021|531829987|FG000|Overall Study|Lost to Follow-up|5|||
147455945|NCT03505021|531829988|FG001|Overall Study|Lost to Follow-up|3|||
147664677|NCT01172873|532596324|FG000|Overall Study|Withdrawal by Subject|3|||
147377824|NCT02234141|531547566|FG000|Treatment Period (24 Weeks)|Death|1|||
147377825|NCT02234141|531547567|FG001|Treatment Period (24 Weeks)|Death|2|||
147377826|NCT02234141|531547568|FG002|Treatment Period (24 Weeks)|Death|0|||
147377827|NCT02234141|531547569|FG003|Treatment Period (24 Weeks)|Death|1|||
147377828|NCT02234141|531547570|FG004|Treatment Period (24 Weeks)|Death|0|||
147377829|NCT02234141|531547571|FG005|Treatment Period (24 Weeks)|Death|0|||
147377830|NCT02234141|531547572|FG006|Treatment Period (24 Weeks)|Death|0|||
147377831|NCT02234141|531547566|FG000|Treatment Period (24 Weeks)|Adverse Event|3|||
147377832|NCT02234141|531547567|FG001|Treatment Period (24 Weeks)|Adverse Event|1|||
147377833|NCT02234141|531547568|FG002|Treatment Period (24 Weeks)|Adverse Event|2|||
147377834|NCT02234141|531547569|FG003|Treatment Period (24 Weeks)|Adverse Event|3|||
147377835|NCT02234141|531547570|FG004|Treatment Period (24 Weeks)|Adverse Event|0|||
147377836|NCT02234141|531547571|FG005|Treatment Period (24 Weeks)|Adverse Event|0|||
147377837|NCT02234141|531547572|FG006|Treatment Period (24 Weeks)|Adverse Event|0|||
147664678|NCT01172873|532596325|FG001|Overall Study|Withdrawal by Subject|2|||
147664679|NCT02053493|532596326|FG000|Overall Study|Withdrawal by Subject|1|||
147664680|NCT02053493|532596327|FG001|Overall Study|Withdrawal by Subject|1|||
147664681|NCT01076543|532596328|FG000|Overall Study|Withdrawal by Subject|2|||
147664682|NCT01076543|532596329|FG001|Overall Study|Withdrawal by Subject|0|||
147664683|NCT01076543|532596330|FG002|Overall Study|Withdrawal by Subject|0|||
147664684|NCT01076543|532596331|FG003|Overall Study|Withdrawal by Subject|0|||
147664685|NCT01076543|532596332|FG004|Overall Study|Withdrawal by Subject|0|||
147664686|NCT01076543|532596333|FG005|Overall Study|Withdrawal by Subject|0|||
147664687|NCT01791985|532596334|FG000|Overall Study|Adverse Event|7|||
147664688|NCT01791985|532596334|FG000|Overall Study|Withdrawal by Subject|1|||
147664689|NCT00086190|532596347|FG000|Overall Study|Adverse Event|6|||
147664690|NCT00086190|532596348|FG001|Overall Study|Adverse Event|2|||
147664691|NCT00086190|532596349|FG002|Overall Study|Adverse Event|2|||
147664692|NCT00086190|532596347|FG000|Overall Study|Withdrawal by Subject|0|||
147664693|NCT00086190|532596348|FG001|Overall Study|Withdrawal by Subject|2|||
147664694|NCT00086190|532596349|FG002|Overall Study|Withdrawal by Subject|2|||
147664695|NCT00086190|532596347|FG000|Overall Study|Protocol Violation|1|||
147664696|NCT00086190|532596348|FG001|Overall Study|Protocol Violation|0|||
147377838|NCT02234141|531547566|FG000|Treatment Period (24 Weeks)|Randomized but not treated|0|||
147377839|NCT02234141|531547567|FG001|Treatment Period (24 Weeks)|Randomized but not treated|1|||
147377840|NCT02234141|531547568|FG002|Treatment Period (24 Weeks)|Randomized but not treated|0|||
147377841|NCT02234141|531547569|FG003|Treatment Period (24 Weeks)|Randomized but not treated|0|||
147377842|NCT02234141|531547570|FG004|Treatment Period (24 Weeks)|Randomized but not treated|0|||
147377843|NCT02234141|531547571|FG005|Treatment Period (24 Weeks)|Randomized but not treated|0|||
147377844|NCT02234141|531547572|FG006|Treatment Period (24 Weeks)|Randomized but not treated|0|||
147377845|NCT02234141|531547566|FG000|Long-Term Treatment Period|Death|0|||
147377846|NCT02234141|531547567|FG001|Long-Term Treatment Period|Death|0|||
147377847|NCT02234141|531547568|FG002|Long-Term Treatment Period|Death|0|||
147377848|NCT02234141|531547569|FG003|Long-Term Treatment Period|Death|0|||
147377849|NCT02234141|531547570|FG004|Long-Term Treatment Period|Death|0|||
147377850|NCT02234141|531547571|FG005|Long-Term Treatment Period|Death|1|||
147377851|NCT02234141|531547572|FG006|Long-Term Treatment Period|Death|0|||
147377852|NCT02234141|531547566|FG000|Long-Term Treatment Period|Investigator's discretion|1|||
147377853|NCT02234141|531547567|FG001|Long-Term Treatment Period|Investigator's discretion|3|||
147377854|NCT02234141|531547568|FG002|Long-Term Treatment Period|Investigator's discretion|2|||
147377855|NCT02234141|531547569|FG003|Long-Term Treatment Period|Investigator's discretion|0|||
147377856|NCT02234141|531547570|FG004|Long-Term Treatment Period|Investigator's discretion|0|||
147377857|NCT02234141|531547571|FG005|Long-Term Treatment Period|Investigator's discretion|0|||
147377858|NCT02234141|531547572|FG006|Long-Term Treatment Period|Investigator's discretion|1|||
147377859|NCT02234141|531547566|FG000|Long-Term Treatment Period|Adverse Event|4|||
147377860|NCT02234141|531547567|FG001|Long-Term Treatment Period|Adverse Event|0|||
147377861|NCT02234141|531547568|FG002|Long-Term Treatment Period|Adverse Event|5|||
147377862|NCT02234141|531547569|FG003|Long-Term Treatment Period|Adverse Event|0|||
147377863|NCT02234141|531547570|FG004|Long-Term Treatment Period|Adverse Event|1|||
147377864|NCT02234141|531547571|FG005|Long-Term Treatment Period|Adverse Event|1|||
147377865|NCT02234141|531547572|FG006|Long-Term Treatment Period|Adverse Event|1|||
147664697|NCT00086190|532596349|FG002|Overall Study|Protocol Violation|0|||
147664698|NCT00086190|532596347|FG000|Overall Study|Moved|1|||
147377866|NCT02234141|531547566|FG000|Long-Term Treatment Period|Withdrew Consent|0|||
147377867|NCT02234141|531547567|FG001|Long-Term Treatment Period|Withdrew Consent|1|||
147377868|NCT02234141|531547568|FG002|Long-Term Treatment Period|Withdrew Consent|1|||
147377869|NCT02234141|531547569|FG003|Long-Term Treatment Period|Withdrew Consent|0|||
147377870|NCT02234141|531547570|FG004|Long-Term Treatment Period|Withdrew Consent|0|||
147377871|NCT02234141|531547571|FG005|Long-Term Treatment Period|Withdrew Consent|0|||
147664699|NCT00086190|532596348|FG001|Overall Study|Moved|0|||
147664700|NCT00086190|532596349|FG002|Overall Study|Moved|0|||
147664701|NCT00086190|532596347|FG000|Overall Study|Worsening depression|0|||
147664702|NCT00086190|532596348|FG001|Overall Study|Worsening depression|0|||
147664703|NCT00086190|532596349|FG002|Overall Study|Worsening depression|2|||
147612374|NCT04380961|532395485|FG001|Overall Study|Withdrawal by Subject|0|||
147612375|NCT04380961|532395484|FG000|Overall Study|Death|22|||
147612376|NCT04380961|532395485|FG001|Overall Study|Death|16|||
147612377|NCT04380961|532395484|FG000|Overall Study|Other|1|||
147612378|NCT04380961|532395485|FG001|Overall Study|Other|0|||
147612379|NCT04380961|532395484|FG000|Overall Study|Randomized but Not Treated|1|||
147377872|NCT02234141|531547572|FG006|Long-Term Treatment Period|Withdrew Consent|0|||
147377873|NCT02234141|531547566|FG000|Long-Term Treatment Period|Study Discontinued by Sponsor|28|||
147377874|NCT02234141|531547567|FG001|Long-Term Treatment Period|Study Discontinued by Sponsor|27|||
147377875|NCT02234141|531547568|FG002|Long-Term Treatment Period|Study Discontinued by Sponsor|25|||
147377876|NCT02234141|531547569|FG003|Long-Term Treatment Period|Study Discontinued by Sponsor|0|||
147377877|NCT02234141|531547570|FG004|Long-Term Treatment Period|Study Discontinued by Sponsor|9|||
147377878|NCT02234141|531547571|FG005|Long-Term Treatment Period|Study Discontinued by Sponsor|10|||
147377879|NCT02234141|531547572|FG006|Long-Term Treatment Period|Study Discontinued by Sponsor|8|||
147377880|NCT03418545|531547573|FG000|Overall Study|Withdrawal by Participant|2|||
147377881|NCT03418545|531547574|FG001|Overall Study|Withdrawal by Participant|4|||
147377882|NCT03418545|531547573|FG000|Overall Study|Lost to Follow-up|3|||
147377883|NCT03418545|531547574|FG001|Overall Study|Lost to Follow-up|5|||
147377884|NCT03418545|531547573|FG000|Overall Study|Reason Not Specified|0|||
147377885|NCT03418545|531547574|FG001|Overall Study|Reason Not Specified|1|||
147377886|NCT03418545|531547573|FG000|Overall Study|Missing Completion Status|0|||
147377887|NCT03418545|531547574|FG001|Overall Study|Missing Completion Status|1|||
147377888|NCT02251652|531547575|FG000|Overall Study|Withdrawal by Subject|1|||
147377889|NCT01074242|531547576|FG000|Overall Study|Case report before date of contract|40|||
147377890|NCT01074242|531547576|FG000|Overall Study|Lost to Follow-up|1|||
147377891|NCT01074242|531547576|FG000|Overall Study|Case report unclear|6|||
147377892|NCT01074242|531547576|FG000|Overall Study|Violation of vaccine dose or dosage|351|||
147377893|NCT01074242|531547576|FG000|Overall Study|Duplicate Case Report Form|5|||
147377894|NCT00109031|531547577|FG000|Overall Study|Adverse Event|0|||
147377895|NCT00109031|531547578|FG001|Overall Study|Adverse Event|0|||
147377896|NCT00109031|531547579|FG002|Overall Study|Adverse Event|1|||
147377897|NCT00109031|531547580|FG003|Overall Study|Adverse Event|0|||
147377898|NCT00109031|531547577|FG000|Overall Study|Withdrawal by Subject|0|||
147377899|NCT00109031|531547578|FG001|Overall Study|Withdrawal by Subject|1|||
147377900|NCT00109031|531547579|FG002|Overall Study|Withdrawal by Subject|0|||
147377901|NCT00109031|531547580|FG003|Overall Study|Withdrawal by Subject|0|||
147377902|NCT00109031|531547577|FG000|Overall Study|Physician Decision|0|||
147377903|NCT00109031|531547578|FG001|Overall Study|Physician Decision|1|||
147377904|NCT00109031|531547579|FG002|Overall Study|Physician Decision|0|||
147377905|NCT00109031|531547580|FG003|Overall Study|Physician Decision|0|||
147377906|NCT00109031|531547577|FG000|Overall Study|Protocol Violation|0|||
147377907|NCT00109031|531547578|FG001|Overall Study|Protocol Violation|0|||
147377908|NCT00109031|531547579|FG002|Overall Study|Protocol Violation|1|||
147377909|NCT00109031|531547580|FG003|Overall Study|Protocol Violation|0|||
147377910|NCT01957163|531547581|FG000|Overall Study|Adverse Event|5|||
147377911|NCT01957163|531547582|FG001|Overall Study|Adverse Event|2|||
147377912|NCT01957163|531547583|FG002|Overall Study|Adverse Event|4|||
147377913|NCT01957163|531547581|FG000|Overall Study|Lack of Efficacy|5|||
147377914|NCT01957163|531547582|FG001|Overall Study|Lack of Efficacy|4|||
147377915|NCT01957163|531547583|FG002|Overall Study|Lack of Efficacy|9|||
147377916|NCT01957163|531547581|FG000|Overall Study|Protocol Violation|1|||
147377917|NCT01957163|531547582|FG001|Overall Study|Protocol Violation|2|||
147377918|NCT01957163|531547583|FG002|Overall Study|Protocol Violation|0|||
147377919|NCT01957163|531547581|FG000|Overall Study|Met Protocol-Defined Stopping Criteria|0|||
147377920|NCT01957163|531547582|FG001|Overall Study|Met Protocol-Defined Stopping Criteria|0|||
147377921|NCT01957163|531547583|FG002|Overall Study|Met Protocol-Defined Stopping Criteria|1|||
147377922|NCT01957163|531547581|FG000|Overall Study|Lost to Follow-up|0|||
147377923|NCT01957163|531547582|FG001|Overall Study|Lost to Follow-up|1|||
147377924|NCT01957163|531547583|FG002|Overall Study|Lost to Follow-up|0|||
147377925|NCT01957163|531547581|FG000|Overall Study|Withdrawal by Subject|4|||
147377926|NCT01957163|531547582|FG001|Overall Study|Withdrawal by Subject|2|||
147377927|NCT01957163|531547583|FG002|Overall Study|Withdrawal by Subject|4|||
147377928|NCT00243867|531547588|FG000|Overall Study|Adverse Event|24|||
147377929|NCT00243867|531547589|FG001|Overall Study|Adverse Event|34|||
147612380|NCT04380961|532395485|FG001|Overall Study|Randomized but Not Treated|2|||
147612381|NCT00306995|532395486|FG000|Study Part I|Withdrawal by Subject|0|||
147377930|NCT00243867|531547588|FG000|Overall Study|Lack of Efficacy|115|||
147377931|NCT00243867|531547589|FG001|Overall Study|Lack of Efficacy|78|||
147377932|NCT00243867|531547588|FG000|Overall Study|Withdrawal by Subject|11|||
147377933|NCT00243867|531547589|FG001|Overall Study|Withdrawal by Subject|23|||
147377934|NCT00243867|531547588|FG000|Overall Study|Lost to Follow-up|2|||
147377935|NCT00243867|531547589|FG001|Overall Study|Lost to Follow-up|1|||
147377936|NCT00243867|531547588|FG000|Overall Study|Physician Decision|2|||
147377937|NCT00243867|531547589|FG001|Overall Study|Physician Decision|7|||
147377938|NCT00243867|531547588|FG000|Overall Study|Delayed treatment, omission of treatment, peripheral neuropathy, intercurrent illness|22|||
147455946|NCT03505021|531829987|FG000|Overall Study|Adverse Event|26|||
147664704|NCT03217591|532596350|FG000|Overall Study|Adverse Event|1|||
147664705|NCT03217591|532596351|FG001|Overall Study|Adverse Event|2|||
147664706|NCT03217591|532596352|FG002|Overall Study|Adverse Event|6|||
147664707|NCT03217591|532596350|FG000|Overall Study|Withdrawal by Subject|0|||
147664708|NCT03217591|532596351|FG001|Overall Study|Withdrawal by Subject|1|||
147664709|NCT03217591|532596352|FG002|Overall Study|Withdrawal by Subject|3|||
147664710|NCT03217591|532596350|FG000|Overall Study|Lost to Follow-up|1|||
147664711|NCT03217591|532596351|FG001|Overall Study|Lost to Follow-up|0|||
147664712|NCT03217591|532596352|FG002|Overall Study|Lost to Follow-up|0|||
147664713|NCT03217591|532596350|FG000|Overall Study|Protocol Violation|1|||
147664714|NCT03217591|532596351|FG001|Overall Study|Protocol Violation|0|||
147664715|NCT03217591|532596352|FG002|Overall Study|Protocol Violation|1|||
147664716|NCT03902613|532596355|FG000|Overall Study|Physician Decision|1|||
147664717|NCT04467515|532596359|FG000|Overall Study|Lost to Follow-up|1|||
147664718|NCT04467515|532596360|FG001|Overall Study|Lost to Follow-up|0|||
147664719|NCT04467515|532596361|FG002|Overall Study|Lost to Follow-up|0|||
147664720|NCT04467515|532596359|FG000|Overall Study|Withdrawal by Subject|1|||
147664721|NCT04467515|532596360|FG001|Overall Study|Withdrawal by Subject|0|||
147664722|NCT04467515|532596361|FG002|Overall Study|Withdrawal by Subject|1|||
147664723|NCT04467515|532596359|FG000|Overall Study|Progressive Disease|0|||
147664724|NCT04467515|532596360|FG001|Overall Study|Progressive Disease|1|||
147664725|NCT04467515|532596361|FG002|Overall Study|Progressive Disease|3|||
147664726|NCT04467515|532596359|FG000|Overall Study|Death|0|||
147664727|NCT04467515|532596360|FG001|Overall Study|Death|1|||
147664728|NCT04467515|532596361|FG002|Overall Study|Death|0|||
147664729|NCT03014206|532596364|FG000|Overall Study|Registration Violation|12|||
147664730|NCT01091246|532596365|FG000|Overall Study|Lost to Follow-up|23|||
147377939|NCT00243867|531547589|FG001|Overall Study|Delayed treatment, omission of treatment, peripheral neuropathy, intercurrent illness|31|||
147377940|NCT05182606|531547599|FG000|Post-implementation (12 Months After)|Did not participate in the post-implementation survey|30|||
147612382|NCT00306995|532395487|FG001|Study Part I|Withdrawal by Subject|0|||
147612383|NCT00306995|532395488|FG002|Study Part I|Withdrawal by Subject|0|||
147612384|NCT00306995|532395489|FG003|Study Part I|Withdrawal by Subject|0|||
147612385|NCT00306995|532395490|FG004|Study Part I|Withdrawal by Subject|0|||
147612386|NCT00306995|532395491|FG005|Study Part I|Withdrawal by Subject|0|||
147612387|NCT00306995|532395492|FG006|Study Part I|Withdrawal by Subject|1|||
147612388|NCT00306995|532395486|FG000|Study Part II for Subset 2|Serious Adverse Event|0|||
147612389|NCT00306995|532395487|FG001|Study Part II for Subset 2|Serious Adverse Event|1|||
147612390|NCT00306995|532395488|FG002|Study Part II for Subset 2|Serious Adverse Event|0|||
147612391|NCT00306995|532395489|FG003|Study Part II for Subset 2|Serious Adverse Event|0|||
147612392|NCT00306995|532395490|FG004|Study Part II for Subset 2|Serious Adverse Event|0|||
147612393|NCT00306995|532395491|FG005|Study Part II for Subset 2|Serious Adverse Event|0|||
147612394|NCT00306995|532395492|FG006|Study Part II for Subset 2|Serious Adverse Event|0|||
147612395|NCT01496976|532397074|FG000|Overall Study|Withdrew - received stem cell transplant|1|||
147612396|NCT03598790|532397075|FG000|Treatment Period (TP): Wk0-Wk144|Adverse Event|24|||
147612397|NCT03598790|532397076|FG001|Treatment Period (TP): Wk0-Wk144|Adverse Event|33|||
147612398|NCT03598790|532397077|FG002|Treatment Period (TP): Wk0-Wk144|Adverse Event|24|||
147612399|NCT03598790|532397078|FG003|Treatment Period (TP): Wk0-Wk144|Adverse Event|0|||
147612400|NCT03598790|532397079|FG004|Treatment Period (TP): Wk0-Wk144|Adverse Event|0|||
147612401|NCT03598790|532397080|FG005|Treatment Period (TP): Wk0-Wk144|Adverse Event|0|||
147612402|NCT03598790|532397081|FG006|Treatment Period (TP): Wk0-Wk144|Adverse Event|3|||
147612403|NCT03598790|532397082|FG007|Treatment Period (TP): Wk0-Wk144|Adverse Event|1|||
147612404|NCT03598790|532397083|FG008|Treatment Period (TP): Wk0-Wk144|Adverse Event|2|||
147612405|NCT03598790|532397075|FG000|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|4|||
147612406|NCT03598790|532397076|FG001|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|7|||
147612407|NCT03598790|532397077|FG002|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|5|||
147612408|NCT03598790|532397078|FG003|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|0|||
147612409|NCT03598790|532397079|FG004|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|0|||
147377941|NCT02686658|531547601|FG000|Overall Study|Adverse Event|0|||
147377942|NCT02686658|531547602|FG001|Overall Study|Adverse Event|0|||
147377943|NCT02686658|531547603|FG002|Overall Study|Adverse Event|1|||
147377944|NCT02686658|531547604|FG003|Overall Study|Adverse Event|1|||
147377945|NCT02686658|531547605|FG004|Overall Study|Adverse Event|2|||
147377946|NCT02686658|531547606|FG005|Overall Study|Adverse Event|1|||
147612410|NCT03598790|532397080|FG005|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|0|||
147612411|NCT03598790|532397081|FG006|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|2|||
147612412|NCT03598790|532397082|FG007|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|0|||
147612413|NCT03598790|532397083|FG008|Treatment Period (TP): Wk0-Wk144|Lack of Efficacy|0|||
147612414|NCT03598790|532397075|FG000|Treatment Period (TP): Wk0-Wk144|Protocol Violation|1|||
147612415|NCT03598790|532397076|FG001|Treatment Period (TP): Wk0-Wk144|Protocol Violation|2|||
147664731|NCT01091246|532596366|FG001|Overall Study|Lost to Follow-up|11|||
147664732|NCT01091246|532596367|FG002|Overall Study|Lost to Follow-up|7|||
147664733|NCT01091246|532596365|FG000|Overall Study|Adverse Event|1|||
147664734|NCT01091246|532596366|FG001|Overall Study|Adverse Event|0|||
147664735|NCT01091246|532596367|FG002|Overall Study|Adverse Event|1|||
147377947|NCT02686658|531547601|FG000|Overall Study|Investigator decision|0|||
147377948|NCT02686658|531547602|FG001|Overall Study|Investigator decision|0|||
147377949|NCT02686658|531547603|FG002|Overall Study|Investigator decision|0|||
147377950|NCT02686658|531547604|FG003|Overall Study|Investigator decision|1|||
147377951|NCT02686658|531547605|FG004|Overall Study|Investigator decision|2|||
147377952|NCT02686658|531547606|FG005|Overall Study|Investigator decision|1|||
147377953|NCT02686658|531547601|FG000|Overall Study|Sponsor decision|1|||
147377954|NCT02686658|531547602|FG001|Overall Study|Sponsor decision|2|||
147377955|NCT02686658|531547603|FG002|Overall Study|Sponsor decision|1|||
147377956|NCT02686658|531547604|FG003|Overall Study|Sponsor decision|5|||
147377957|NCT02686658|531547605|FG004|Overall Study|Sponsor decision|13|||
147377958|NCT02686658|531547606|FG005|Overall Study|Sponsor decision|2|||
147377959|NCT02686658|531547601|FG000|Overall Study|Lost to Follow-up|0|||
147377960|NCT02686658|531547602|FG001|Overall Study|Lost to Follow-up|0|||
147377961|NCT02686658|531547603|FG002|Overall Study|Lost to Follow-up|2|||
147377962|NCT02686658|531547604|FG003|Overall Study|Lost to Follow-up|0|||
147377963|NCT02686658|531547605|FG004|Overall Study|Lost to Follow-up|0|||
147377964|NCT02686658|531547606|FG005|Overall Study|Lost to Follow-up|1|||
147377965|NCT02686658|531547601|FG000|Overall Study|Death|1|||
147377966|NCT02686658|531547602|FG001|Overall Study|Death|0|||
147377967|NCT02686658|531547603|FG002|Overall Study|Death|0|||
147377968|NCT02686658|531547604|FG003|Overall Study|Death|1|||
147377969|NCT02686658|531547605|FG004|Overall Study|Death|1|||
147377970|NCT02686658|531547606|FG005|Overall Study|Death|1|||
147377971|NCT02686658|531547601|FG000|Overall Study|Withdrawal by Subject|2|||
147377972|NCT02686658|531547602|FG001|Overall Study|Withdrawal by Subject|5|||
147377973|NCT02686658|531547603|FG002|Overall Study|Withdrawal by Subject|4|||
147377974|NCT02686658|531547604|FG003|Overall Study|Withdrawal by Subject|4|||
147377975|NCT02686658|531547605|FG004|Overall Study|Withdrawal by Subject|17|||
147377976|NCT02686658|531547606|FG005|Overall Study|Withdrawal by Subject|8|||
147377977|NCT02686658|531547601|FG000|Overall Study|Placed in hospice care|0|||
147377978|NCT02686658|531547602|FG001|Overall Study|Placed in hospice care|0|||
147377979|NCT02686658|531547603|FG002|Overall Study|Placed in hospice care|1|||
147377980|NCT02686658|531547604|FG003|Overall Study|Placed in hospice care|0|||
147377981|NCT02686658|531547605|FG004|Overall Study|Placed in hospice care|0|||
147377982|NCT02686658|531547606|FG005|Overall Study|Placed in hospice care|0|||
147377983|NCT02686658|531547601|FG000|Overall Study|Participant non-compliance|0|||
147377984|NCT02686658|531547602|FG001|Overall Study|Participant non-compliance|0|||
147377985|NCT02686658|531547603|FG002|Overall Study|Participant non-compliance|0|||
147377986|NCT02686658|531547604|FG003|Overall Study|Participant non-compliance|0|||
147377987|NCT02686658|531547605|FG004|Overall Study|Participant non-compliance|0|||
147377988|NCT02686658|531547606|FG005|Overall Study|Participant non-compliance|1|||
147377989|NCT02686658|531547601|FG000|Overall Study|Concern over coronavirus disease care|0|||
147377990|NCT02686658|531547602|FG001|Overall Study|Concern over coronavirus disease care|0|||
147377991|NCT02686658|531547603|FG002|Overall Study|Concern over coronavirus disease care|0|||
147377992|NCT02686658|531547604|FG003|Overall Study|Concern over coronavirus disease care|0|||
147377993|NCT02686658|531547605|FG004|Overall Study|Concern over coronavirus disease care|2|||
147377994|NCT02686658|531547606|FG005|Overall Study|Concern over coronavirus disease care|1|||
147377995|NCT02969356|531547618|FG000|Overall Study|Adverse Event|7|||
147377996|NCT02969356|531547618|FG000|Overall Study|Consent withdrawn|2|||
147377997|NCT02969356|531547618|FG000|Overall Study|Lost to Follow-up|3|||
147377998|NCT02969356|531547618|FG000|Overall Study|Did not need to be reinjected|6|||
147377999|NCT02969356|531547618|FG000|Overall Study|Personal reasons|5|||
147378000|NCT02556918|531549140|FG000|Overall Study|Protocol Violation|5|||
147378001|NCT02556918|531549141|FG001|Overall Study|Protocol Violation|6|||
147378002|NCT02556918|531549140|FG000|Overall Study|Withdrawal by Subject|4|||
147378003|NCT02556918|531549141|FG001|Overall Study|Withdrawal by Subject|4|||
147378004|NCT04511702|531549147|FG000|Overall Study|Lost to Follow-up|3|||
147378005|NCT04511702|531549148|FG001|Overall Study|Lost to Follow-up|0|||
147378006|NCT04511702|531549149|FG002|Overall Study|Lost to Follow-up|4|||
147378007|NCT04511702|531549147|FG000|Overall Study|Withdrawal by Subject|17|||
147378008|NCT04511702|531549148|FG001|Overall Study|Withdrawal by Subject|1|||
147378009|NCT04511702|531549149|FG002|Overall Study|Withdrawal by Subject|8|||
147378010|NCT04493424|531549150|FG000|Overall Study|Termination of the trial by the sponsor|89|||
147378011|NCT04493424|531549150|FG000|Overall Study|Withdrawal by Subject|9|||
147378012|NCT04493424|531549150|FG000|Overall Study|Lost to Follow-up|2|||
147378013|NCT04493424|531549150|FG000|Overall Study|Lack of Efficacy|3|||
147378014|NCT04493424|531549150|FG000|Overall Study|Adverse Event|5|||
147378015|NCT00108355|531549154|FG000|Overall Study|Peritonitis at index paracentesis|1|||
147378016|NCT00108355|531549155|FG001|Overall Study|Peritonitis at index paracentesis|1|||
147378017|NCT00108355|531549154|FG000|Overall Study|Loculated ascites, limiting paracentesis|1|||
147378018|NCT00108355|531549155|FG001|Overall Study|Loculated ascites, limiting paracentesis|1|||
147378019|NCT04992273|531549156|FG000|Overall Study|Lost to Follow-up|0|||
147378020|NCT04992273|531549157|FG001|Overall Study|Lost to Follow-up|1|||
147378021|NCT01364597|531549158|FG000|Overall Study|Adverse Event|4|||
147378022|NCT01364597|531549159|FG001|Overall Study|Adverse Event|5|||
147378023|NCT01364597|531549160|FG002|Overall Study|Adverse Event|16|||
147378024|NCT01364597|531549161|FG003|Overall Study|Adverse Event|7|||
147378025|NCT01364597|531549158|FG000|Overall Study|Lack of Efficacy|4|||
147378026|NCT01364597|531549159|FG001|Overall Study|Lack of Efficacy|4|||
147378027|NCT01364597|531549160|FG002|Overall Study|Lack of Efficacy|23|||
147378028|NCT01364597|531549161|FG003|Overall Study|Lack of Efficacy|8|||
147378029|NCT01364597|531549158|FG000|Overall Study|Protocol Violation|0|||
147378030|NCT01364597|531549159|FG001|Overall Study|Protocol Violation|0|||
147378031|NCT01364597|531549160|FG002|Overall Study|Protocol Violation|2|||
147378032|NCT01364597|531549161|FG003|Overall Study|Protocol Violation|0|||
147378033|NCT01364597|531549158|FG000|Overall Study|Lost to Follow-up|0|||
147378034|NCT01364597|531549159|FG001|Overall Study|Lost to Follow-up|0|||
147378035|NCT01364597|531549160|FG002|Overall Study|Lost to Follow-up|5|||
147378036|NCT01364597|531549161|FG003|Overall Study|Lost to Follow-up|3|||
147378037|NCT01364597|531549158|FG000|Overall Study|Withdrawal by Subject|4|||
147378038|NCT01364597|531549159|FG001|Overall Study|Withdrawal by Subject|1|||
147378039|NCT01364597|531549160|FG002|Overall Study|Withdrawal by Subject|18|||
147378040|NCT01364597|531549161|FG003|Overall Study|Withdrawal by Subject|6|||
147378041|NCT01364597|531549158|FG000|Overall Study|Non compliance|1|||
147378042|NCT01364597|531549159|FG001|Overall Study|Non compliance|0|||
147378043|NCT01364597|531549160|FG002|Overall Study|Non compliance|1|||
147378044|NCT01364597|531549161|FG003|Overall Study|Non compliance|0|||
147378045|NCT01364597|531549158|FG000|Overall Study|Lack of compliance|1|||
147378046|NCT01364597|531549159|FG001|Overall Study|Lack of compliance|0|||
147378047|NCT01364597|531549160|FG002|Overall Study|Lack of compliance|0|||
147378048|NCT01364597|531549161|FG003|Overall Study|Lack of compliance|0|||
147378049|NCT01364597|531549158|FG000|Overall Study|End of treatment epilepsy|1|||
147378050|NCT01364597|531549159|FG001|Overall Study|End of treatment epilepsy|0|||
147378051|NCT01364597|531549160|FG002|Overall Study|End of treatment epilepsy|0|||
147378052|NCT01364597|531549161|FG003|Overall Study|End of treatment epilepsy|0|||
147378053|NCT01364597|531549158|FG000|Overall Study|No Seizures|1|||
147378054|NCT01364597|531549159|FG001|Overall Study|No Seizures|0|||
147378055|NCT01364597|531549160|FG002|Overall Study|No Seizures|0|||
147378056|NCT01364597|531549161|FG003|Overall Study|No Seizures|0|||
147378057|NCT01364597|531549158|FG000|Overall Study|Lack of reliability from the subject's caregiver|1|||
147378058|NCT01364597|531549159|FG001|Overall Study|Lack of reliability from the subject's caregiver|0|||
147378059|NCT01364597|531549160|FG002|Overall Study|Lack of reliability from the subject's caregiver|0|||
147378060|NCT01364597|531549161|FG003|Overall Study|Lack of reliability from the subject's caregiver|0|||
147378061|NCT01364597|531549158|FG000|Overall Study|Cure|1|||
147378062|NCT01364597|531549159|FG001|Overall Study|Cure|0|||
147378063|NCT01364597|531549160|FG002|Overall Study|Cure|0|||
147378064|NCT01364597|531549161|FG003|Overall Study|Cure|0|||
147378065|NCT01364597|531549158|FG000|Overall Study|Patient was moving|0|||
147378066|NCT01364597|531549159|FG001|Overall Study|Patient was moving|1|||
147378067|NCT01364597|531549160|FG002|Overall Study|Patient was moving|0|||
147378068|NCT01364597|531549161|FG003|Overall Study|Patient was moving|0|||
147378069|NCT01364597|531549158|FG000|Overall Study|Seizures resolved|0|||
147378070|NCT01364597|531549159|FG001|Overall Study|Seizures resolved|0|||
147378071|NCT01364597|531549160|FG002|Overall Study|Seizures resolved|1|||
147378072|NCT01364597|531549161|FG003|Overall Study|Seizures resolved|0|||
147378073|NCT01364597|531549158|FG000|Overall Study|Patient became seizure-free after surgery|0|||
147378074|NCT01364597|531549159|FG001|Overall Study|Patient became seizure-free after surgery|0|||
147378075|NCT01364597|531549160|FG002|Overall Study|Patient became seizure-free after surgery|1|||
147378076|NCT01364597|531549161|FG003|Overall Study|Patient became seizure-free after surgery|0|||
147378077|NCT01364597|531549158|FG000|Overall Study|5 year without seizures. Treatment is finish|0|||
147378078|NCT01364597|531549159|FG001|Overall Study|5 year without seizures. Treatment is finish|0|||
147378079|NCT01364597|531549160|FG002|Overall Study|5 year without seizures. Treatment is finish|1|||
147378080|NCT01364597|531549161|FG003|Overall Study|5 year without seizures. Treatment is finish|0|||
147378081|NCT01364597|531549158|FG000|Overall Study|Patient cured from Epilepsy|0|||
147378082|NCT01364597|531549159|FG001|Overall Study|Patient cured from Epilepsy|0|||
147378083|NCT01364597|531549160|FG002|Overall Study|Patient cured from Epilepsy|1|||
147378084|NCT01364597|531549161|FG003|Overall Study|Patient cured from Epilepsy|0|||
147378085|NCT01364597|531549158|FG000|Overall Study|Investigator decision|0|||
147378086|NCT01364597|531549159|FG001|Overall Study|Investigator decision|0|||
147378087|NCT01364597|531549160|FG002|Overall Study|Investigator decision|1|||
147378088|NCT01364597|531549161|FG003|Overall Study|Investigator decision|0|||
147378089|NCT01364597|531549158|FG000|Overall Study|Sponsor recommended discontinuation|0|||
147378090|NCT01364597|531549159|FG001|Overall Study|Sponsor recommended discontinuation|0|||
147378091|NCT01364597|531549160|FG002|Overall Study|Sponsor recommended discontinuation|0|||
147378092|NCT01364597|531549161|FG003|Overall Study|Sponsor recommended discontinuation|1|||
147378093|NCT01364597|531549158|FG000|Overall Study|Parents went abroad with the patient|0|||
147378094|NCT01364597|531549159|FG001|Overall Study|Parents went abroad with the patient|0|||
147378095|NCT01364597|531549160|FG002|Overall Study|Parents went abroad with the patient|1|||
147378096|NCT01364597|531549161|FG003|Overall Study|Parents went abroad with the patient|0|||
147378097|NCT01364597|531549158|FG000|Overall Study|BRV discontinued as no seizures during 2 years|0|||
147378098|NCT01364597|531549159|FG001|Overall Study|BRV discontinued as no seizures during 2 years|0|||
147612416|NCT03598790|532397077|FG002|Treatment Period (TP): Wk0-Wk144|Protocol Violation|4|||
147612417|NCT03598790|532397078|FG003|Treatment Period (TP): Wk0-Wk144|Protocol Violation|0|||
147612418|NCT03598790|532397079|FG004|Treatment Period (TP): Wk0-Wk144|Protocol Violation|0|||
147612419|NCT03598790|532397080|FG005|Treatment Period (TP): Wk0-Wk144|Protocol Violation|0|||
147455947|NCT03505021|531829988|FG001|Overall Study|Adverse Event|9|||
147455948|NCT03505021|531829987|FG000|Overall Study|Disease progression|33|||
147455949|NCT03505021|531829988|FG001|Overall Study|Disease progression|17|||
147455950|NCT03505021|531829987|FG000|Overall Study|Other|11|||
147455951|NCT03505021|531829988|FG001|Overall Study|Other|5|||
147455952|NCT03505021|531829987|FG000|Overall Study|Personal reason|21|||
147455953|NCT03505021|531829988|FG001|Overall Study|Personal reason|12|||
147455954|NCT03686397|531831643|FG000|Overall Study|Lack of Efficacy|3|||
147455955|NCT03686397|531831644|FG001|Overall Study|Lack of Efficacy|5|||
147455956|NCT03686397|531831643|FG000|Overall Study|Adverse Event|0|||
147455957|NCT03686397|531831644|FG001|Overall Study|Adverse Event|1|||
147612420|NCT03598790|532397081|FG006|Treatment Period (TP): Wk0-Wk144|Protocol Violation|0|||
147612421|NCT03598790|532397082|FG007|Treatment Period (TP): Wk0-Wk144|Protocol Violation|0|||
147378099|NCT01364597|531549160|FG002|Overall Study|BRV discontinued as no seizures during 2 years|1|||
147378100|NCT01364597|531549161|FG003|Overall Study|BRV discontinued as no seizures during 2 years|0|||
147378101|NCT01364597|531549158|FG000|Overall Study|BRV administration dropout|0|||
147378102|NCT01364597|531549159|FG001|Overall Study|BRV administration dropout|0|||
147378103|NCT01364597|531549160|FG002|Overall Study|BRV administration dropout|1|||
147378104|NCT01364597|531549161|FG003|Overall Study|BRV administration dropout|0|||
147378105|NCT01364597|531549158|FG000|Overall Study|Dropout|0|||
147378106|NCT01364597|531549159|FG001|Overall Study|Dropout|0|||
147378107|NCT01364597|531549160|FG002|Overall Study|Dropout|3|||
147378108|NCT01364597|531549161|FG003|Overall Study|Dropout|1|||
147378109|NCT01364597|531549158|FG000|Overall Study|Unreliable subject|0|||
147378110|NCT01364597|531549159|FG001|Overall Study|Unreliable subject|0|||
147378111|NCT01364597|531549160|FG002|Overall Study|Unreliable subject|0|||
147378112|NCT01364597|531549161|FG003|Overall Study|Unreliable subject|1|||
147378113|NCT01364597|531549158|FG000|Overall Study|Other|0|||
147378114|NCT01364597|531549159|FG001|Overall Study|Other|0|||
147378115|NCT01364597|531549160|FG002|Overall Study|Other|0|||
147378116|NCT01364597|531549161|FG003|Overall Study|Other|1|||
147378117|NCT03493282|531549165|FG000|Primary Double-blind Study (180 Days)|Adverse Event|2|||
147378118|NCT03493282|531549166|FG001|Primary Double-blind Study (180 Days)|Adverse Event|2|||
147378119|NCT03493282|531549167|FG002|Primary Double-blind Study (180 Days)|Adverse Event|1|||
147378120|NCT03493282|531549165|FG000|Primary Double-blind Study (180 Days)|Subject Moved|1|||
147378121|NCT03493282|531549166|FG001|Primary Double-blind Study (180 Days)|Subject Moved|0|||
147378122|NCT03493282|531549167|FG002|Primary Double-blind Study (180 Days)|Subject Moved|0|||
147378123|NCT01380145|531549168|FG000|Overall Study|Progressive disease|4|||
147378124|NCT02698475|531549169|FG000|Main Study Period|Lack of Efficacy|1|||
147378125|NCT02698475|531549169|FG000|Main Study Period|Protocol Violation|2|||
147378126|NCT02698475|531549169|FG000|Long-Term Extension Period|Lost to Follow-up|1|||
147378127|NCT02698475|531549169|FG000|Long-Term Extension Period|Trial Site Terminated by Sponsor|1|||
147378128|NCT02698475|531549169|FG000|Long-Term Extension Period|Withdrawal by Subject|3|||
147378129|NCT02698475|531549169|FG000|Long-Term Extension Period|Due to Long Term Extension Protocol-Specified Criteria|22|||
147378130|NCT02698475|531549169|FG000|Long-Term Extension Period|Other|1|||
147378131|NCT02038049|531549170|FG000|Overall Study|Lost to Follow-up|1|||
147378132|NCT02038049|531549171|FG001|Overall Study|Lost to Follow-up|0|||
147378133|NCT02771366|531549172|FG000|Period 1|Withdrawal by Subject|0|||
147378134|NCT02771366|531549173|FG001|Period 1|Withdrawal by Subject|2|||
147378135|NCT02771366|531549172|FG000|Period 2 (Crossover)|Withdrawal by Subject|2|||
147378136|NCT02771366|531549173|FG001|Period 2 (Crossover)|Withdrawal by Subject|0|||
147378137|NCT00587171|531549176|FG000|Overall Study|Lost to Follow-up|1|||
147378138|NCT00587171|531549177|FG001|Overall Study|Lost to Follow-up|1|||
147378139|NCT02148705|531549181|FG000|Overall Study|Death|2|||
147378140|NCT02148705|531549182|FG001|Overall Study|Death|0|||
147378141|NCT02148705|531549183|FG002|Overall Study|Death|0|||
147378142|NCT02148705|531549181|FG000|Overall Study|Lost to Follow-up|13|||
147455958|NCT03686397|531831643|FG000|Overall Study|Protocol Violation|0|||
147612422|NCT03598790|532397083|FG008|Treatment Period (TP): Wk0-Wk144|Protocol Violation|0|||
147612423|NCT03598790|532397075|FG000|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|7|||
147612424|NCT03598790|532397076|FG001|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|11|||
147378143|NCT02148705|531549182|FG001|Overall Study|Lost to Follow-up|4|||
147612425|NCT03598790|532397077|FG002|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|14|||
147378144|NCT02148705|531549183|FG002|Overall Study|Lost to Follow-up|10|||
147378145|NCT02148705|531549181|FG000|Overall Study|Withdrawal by Subject|3|||
147378146|NCT02148705|531549182|FG001|Overall Study|Withdrawal by Subject|0|||
147378147|NCT02148705|531549183|FG002|Overall Study|Withdrawal by Subject|2|||
147378148|NCT02148705|531549181|FG000|Overall Study|Not Treated|0|||
147378149|NCT02148705|531549182|FG001|Overall Study|Not Treated|1|||
147378150|NCT02148705|531549183|FG002|Overall Study|Not Treated|5|||
147455959|NCT03686397|531831644|FG001|Overall Study|Protocol Violation|1|||
147455960|NCT03686397|531831643|FG000|Overall Study|Withdrawal by Subject|0|||
147378151|NCT01737021|531549186|FG000|Overall Study|Lost to Follow-up|5|||
147378152|NCT01737021|531549187|FG001|Overall Study|Lost to Follow-up|3|||
147378153|NCT01673594|531549188|FG000|Overall Study|Adverse Event|3|||
147378154|NCT01673594|531549189|FG001|Overall Study|Adverse Event|1|||
147378155|NCT01673594|531549188|FG000|Overall Study|Lost to Follow-up|1|||
147378156|NCT01673594|531549189|FG001|Overall Study|Lost to Follow-up|0|||
147378157|NCT01673594|531549188|FG000|Overall Study|Physician Decision|2|||
147378158|NCT01673594|531549189|FG001|Overall Study|Physician Decision|4|||
147378159|NCT01673594|531549188|FG000|Overall Study|Withdrawal by Subject|0|||
147378160|NCT01673594|531549189|FG001|Overall Study|Withdrawal by Subject|1|||
147378161|NCT02605174|531549193|FG000|Overall Study|Adverse Event|0|||
147378162|NCT02605174|531549194|FG001|Overall Study|Adverse Event|0|||
147378163|NCT02605174|531549195|FG002|Overall Study|Adverse Event|1|||
147378164|NCT02605174|531549196|FG003|Overall Study|Adverse Event|0|||
147378165|NCT02605174|531549197|FG004|Overall Study|Adverse Event|4|||
147378166|NCT02605174|531549198|FG005|Overall Study|Adverse Event|0|||
147378167|NCT02605174|531549199|FG006|Overall Study|Adverse Event|0|||
147378168|NCT02605174|531549193|FG000|Overall Study|Lost to Follow-up|20|||
147378169|NCT02605174|531549194|FG001|Overall Study|Lost to Follow-up|7|||
147378170|NCT02605174|531549195|FG002|Overall Study|Lost to Follow-up|27|||
147378171|NCT02605174|531549196|FG003|Overall Study|Lost to Follow-up|10|||
147378172|NCT02605174|531549197|FG004|Overall Study|Lost to Follow-up|20|||
147378173|NCT02605174|531549198|FG005|Overall Study|Lost to Follow-up|10|||
147378174|NCT02605174|531549199|FG006|Overall Study|Lost to Follow-up|29|||
147378175|NCT02605174|531549193|FG000|Overall Study|Protocol Violation|10|||
147378176|NCT02605174|531549194|FG001|Overall Study|Protocol Violation|4|||
147378177|NCT02605174|531549195|FG002|Overall Study|Protocol Violation|14|||
147378178|NCT02605174|531549196|FG003|Overall Study|Protocol Violation|6|||
147378179|NCT02605174|531549197|FG004|Overall Study|Protocol Violation|7|||
147378180|NCT02605174|531549198|FG005|Overall Study|Protocol Violation|7|||
147378181|NCT02605174|531549199|FG006|Overall Study|Protocol Violation|12|||
147378182|NCT02605174|531549193|FG000|Overall Study|Pregnancy|1|||
147378183|NCT02605174|531549194|FG001|Overall Study|Pregnancy|0|||
147378184|NCT02605174|531549195|FG002|Overall Study|Pregnancy|0|||
147378185|NCT02605174|531549196|FG003|Overall Study|Pregnancy|2|||
147378186|NCT02605174|531549197|FG004|Overall Study|Pregnancy|0|||
147378187|NCT02605174|531549198|FG005|Overall Study|Pregnancy|0|||
147378188|NCT02605174|531549199|FG006|Overall Study|Pregnancy|0|||
147378189|NCT02605174|531549193|FG000|Overall Study|Withdrawal by Subject|9|||
147378190|NCT02605174|531549194|FG001|Overall Study|Withdrawal by Subject|6|||
147378191|NCT02605174|531549195|FG002|Overall Study|Withdrawal by Subject|14|||
147378192|NCT02605174|531549196|FG003|Overall Study|Withdrawal by Subject|11|||
147378193|NCT02605174|531549197|FG004|Overall Study|Withdrawal by Subject|6|||
147378194|NCT02605174|531549198|FG005|Overall Study|Withdrawal by Subject|4|||
147378195|NCT02605174|531549199|FG006|Overall Study|Withdrawal by Subject|15|||
147378196|NCT02605174|531549193|FG000|Overall Study|Physician Decision|2|||
147378197|NCT02605174|531549194|FG001|Overall Study|Physician Decision|0|||
147378198|NCT02605174|531549195|FG002|Overall Study|Physician Decision|0|||
147378199|NCT02605174|531549196|FG003|Overall Study|Physician Decision|0|||
147378200|NCT02605174|531549197|FG004|Overall Study|Physician Decision|0|||
147378201|NCT02605174|531549198|FG005|Overall Study|Physician Decision|0|||
147378202|NCT02605174|531549199|FG006|Overall Study|Physician Decision|3|||
147378203|NCT02605174|531549193|FG000|Overall Study|Randomization Failure|22|||
147378204|NCT02605174|531549194|FG001|Overall Study|Randomization Failure|6|||
147378205|NCT02605174|531549195|FG002|Overall Study|Randomization Failure|20|||
147378206|NCT02605174|531549196|FG003|Overall Study|Randomization Failure|7|||
147378207|NCT02605174|531549197|FG004|Overall Study|Randomization Failure|16|||
147378208|NCT02605174|531549198|FG005|Overall Study|Randomization Failure|11|||
147378209|NCT02605174|531549199|FG006|Overall Study|Randomization Failure|30|||
147378210|NCT04250636|531549200|FG000|Overall Study|Lost to Follow-up|2|||
147378211|NCT01779050|531549202|FG000|Overall Study|Withdrawal by Subject|1|||
147378212|NCT01779050|531549203|FG001|Overall Study|Withdrawal by Subject|0|||
147378213|NCT01353274|531549204|FG000|Overall Study|No case report form (CRF) collected|28|||
147378214|NCT03737110|531549207|FG000|Run-in (RI) Period|Lack of Efficacy|3|||
147378215|NCT03737110|531549208|FG001|Run-in (RI) Period|Lack of Efficacy|0|||
147378216|NCT03737110|531549209|FG002|Run-in (RI) Period|Lack of Efficacy|0|||
147378217|NCT03737110|531549210|FG003|Run-in (RI) Period|Lack of Efficacy|0|||
147612426|NCT03598790|532397078|FG003|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|0|||
147612427|NCT03598790|532397079|FG004|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|0|||
147378218|NCT03737110|531549211|FG004|Run-in (RI) Period|Lack of Efficacy|0|||
147378219|NCT03737110|531549212|FG005|Run-in (RI) Period|Lack of Efficacy|0|||
147378220|NCT03737110|531549207|FG000|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|3|||
147378221|NCT03737110|531549208|FG001|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|0|||
147378222|NCT03737110|531549209|FG002|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|0|||
147378223|NCT03737110|531549210|FG003|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|0|||
147378224|NCT03737110|531549211|FG004|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|0|||
147378225|NCT03737110|531549212|FG005|Run-in (RI) Period|Did Not Meet Clinical Response Criteria|0|||
147612428|NCT03598790|532397080|FG005|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|0|||
147612429|NCT03598790|532397081|FG006|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|0|||
147612430|NCT03598790|532397082|FG007|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|0|||
147612431|NCT03598790|532397083|FG008|Treatment Period (TP): Wk0-Wk144|Lost to Follow-up|0|||
147612432|NCT03598790|532397075|FG000|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|14|||
147612433|NCT03598790|532397076|FG001|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|26|||
147612434|NCT03598790|532397077|FG002|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|17|||
147612435|NCT03598790|532397078|FG003|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|0|||
147612436|NCT03598790|532397079|FG004|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|0|||
147612437|NCT03598790|532397080|FG005|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|0|||
147612438|NCT03598790|532397081|FG006|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|1|||
147612439|NCT03598790|532397082|FG007|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|0|||
147612440|NCT03598790|532397083|FG008|Treatment Period (TP): Wk0-Wk144|Consent withdrawn by subject|0|||
147612441|NCT03598790|532397075|FG000|Treatment Period (TP): Wk0-Wk144|Pregnancy|1|||
147612442|NCT03598790|532397076|FG001|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
147612443|NCT03598790|532397077|FG002|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
147612444|NCT03598790|532397078|FG003|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
147612445|NCT03598790|532397079|FG004|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
147612446|NCT03598790|532397080|FG005|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
147612447|NCT03598790|532397081|FG006|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
147612448|NCT03598790|532397082|FG007|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
147612449|NCT03598790|532397083|FG008|Treatment Period (TP): Wk0-Wk144|Pregnancy|0|||
147612450|NCT03598790|532397075|FG000|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
147612451|NCT03598790|532397076|FG001|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|1|||
147612452|NCT03598790|532397077|FG002|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
147612453|NCT03598790|532397078|FG003|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
147612454|NCT03598790|532397079|FG004|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
147612455|NCT03598790|532397080|FG005|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
147612456|NCT03598790|532397081|FG006|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
147612457|NCT03598790|532397082|FG007|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
147612458|NCT03598790|532397083|FG008|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
147612459|NCT03598790|532397075|FG000|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
147612460|NCT03598790|532397076|FG001|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
147612461|NCT03598790|532397077|FG002|Treatment Period (TP): Wk0-Wk144|Physician Decision|1|||
147612462|NCT03598790|532397078|FG003|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
147612463|NCT03598790|532397079|FG004|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
147612464|NCT03598790|532397080|FG005|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
147612465|NCT03598790|532397081|FG006|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
147612466|NCT03598790|532397082|FG007|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
147612467|NCT03598790|532397083|FG008|Treatment Period (TP): Wk0-Wk144|Physician Decision|0|||
147612468|NCT03598790|532397075|FG000|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|1|||
147612469|NCT03598790|532397076|FG001|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
147612470|NCT03598790|532397077|FG002|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
147612471|NCT03598790|532397078|FG003|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
147612472|NCT03598790|532397079|FG004|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
147612473|NCT03598790|532397080|FG005|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
147612474|NCT03598790|532397081|FG006|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
147612475|NCT03598790|532397082|FG007|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
147612476|NCT03598790|532397083|FG008|Treatment Period (TP): Wk0-Wk144|Long IP pause; Investigator decided termination|0|||
147612477|NCT03598790|532397075|FG000|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|1|||
147612478|NCT03598790|532397076|FG001|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
147612479|NCT03598790|532397077|FG002|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
147612480|NCT03598790|532397078|FG003|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
147612481|NCT03598790|532397079|FG004|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
147612482|NCT03598790|532397080|FG005|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
147612483|NCT03598790|532397081|FG006|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
147612484|NCT03598790|532397082|FG007|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
147612485|NCT03598790|532397083|FG008|Treatment Period (TP): Wk0-Wk144|Withdrawn By Sponsor|0|||
147612486|NCT03598790|532397075|FG000|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|1|||
147612487|NCT03598790|532397076|FG001|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
147612488|NCT03598790|532397077|FG002|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
147612489|NCT03598790|532397078|FG003|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
147664736|NCT01091246|532596365|FG000|Overall Study|Withdrawal by Subject|9|||
147664737|NCT01091246|532596366|FG001|Overall Study|Withdrawal by Subject|5|||
147664738|NCT01091246|532596367|FG002|Overall Study|Withdrawal by Subject|4|||
147664739|NCT01091246|532596365|FG000|Overall Study|Subject not dosed|2|||
147664740|NCT01091246|532596366|FG001|Overall Study|Subject not dosed|0|||
147664741|NCT01091246|532596367|FG002|Overall Study|Subject not dosed|1|||
147664742|NCT04577794|532596368|FG000|Overall Study|Adverse Event|1|||
147664743|NCT04577794|532596369|FG001|Overall Study|Adverse Event|1|||
147664744|NCT01676012|532596371|FG000|Overall Study|Adverse Event|2|||
147664745|NCT01676012|532596371|FG000|Overall Study|incomplete set of videos|1|||
147664746|NCT01819727|532596378|FG000|Overall Study|Adverse Event|8|||
147664747|NCT01819727|532596379|FG001|Overall Study|Adverse Event|9|||
147455961|NCT03686397|531831644|FG001|Overall Study|Withdrawal by Subject|1|||
147455962|NCT03686397|531831643|FG000|Overall Study|covid pandemic, bacterial ear culture|2|||
147612490|NCT03598790|532397079|FG004|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
147612491|NCT03598790|532397080|FG005|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
147612492|NCT03598790|532397081|FG006|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
147612493|NCT03598790|532397082|FG007|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
147612494|NCT03598790|532397083|FG008|Treatment Period (TP): Wk0-Wk144|Patient Did Not Comply With Safety Precautions|0|||
147612495|NCT03598790|532397075|FG000|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
147612496|NCT03598790|532397076|FG001|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|2|||
147612497|NCT03598790|532397077|FG002|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|1|||
147664748|NCT01819727|532596378|FG000|Overall Study|Death|1|||
147664749|NCT01819727|532596379|FG001|Overall Study|Death|0|||
147664750|NCT01819727|532596378|FG000|Overall Study|Lost to Follow-up|1|||
147664751|NCT01819727|532596379|FG001|Overall Study|Lost to Follow-up|1|||
147455963|NCT03686397|531831644|FG001|Overall Study|covid pandemic, bacterial ear culture|0|||
147455964|NCT00403260|531831645|FG000|Overall Study|Adverse Event|5|||
147455965|NCT00403260|531831646|FG001|Overall Study|Adverse Event|4|||
147455966|NCT00403260|531831645|FG000|Overall Study|Withdrawal by Subject|5|||
147455967|NCT00403260|531831646|FG001|Overall Study|Withdrawal by Subject|6|||
147455968|NCT00403260|531831645|FG000|Overall Study|Lost to Follow-up|49|||
147664752|NCT01819727|532596378|FG000|Overall Study|Physician Decision|3|||
147378226|NCT03737110|531549207|FG000|Run-in (RI) Period|Adverse Event|4|||
147455969|NCT00403260|531831646|FG001|Overall Study|Lost to Follow-up|25|||
147455970|NCT00403260|531831645|FG000|Overall Study|Re-appearance of P. falciparum|34|||
147455971|NCT00403260|531831646|FG001|Overall Study|Re-appearance of P. falciparum|25|||
147455972|NCT00403260|531831645|FG000|Overall Study|P. vivax infection|26|||
147455973|NCT00403260|531831646|FG001|Overall Study|P. vivax infection|4|||
147664753|NCT01819727|532596379|FG001|Overall Study|Physician Decision|2|||
147664754|NCT01819727|532596378|FG000|Overall Study|Pregnancy|1|||
147378227|NCT03737110|531549208|FG001|Run-in (RI) Period|Adverse Event|0|||
147378228|NCT03737110|531549209|FG002|Run-in (RI) Period|Adverse Event|0|||
147378229|NCT03737110|531549210|FG003|Run-in (RI) Period|Adverse Event|0|||
147378230|NCT03737110|531549211|FG004|Run-in (RI) Period|Adverse Event|0|||
147378231|NCT03737110|531549212|FG005|Run-in (RI) Period|Adverse Event|0|||
147378232|NCT03737110|531549207|FG000|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|0|||
147378233|NCT03737110|531549208|FG001|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|1|||
147378234|NCT03737110|531549209|FG002|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|0|||
147378235|NCT03737110|531549210|FG003|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|0|||
147378236|NCT03737110|531549211|FG004|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|0|||
147378237|NCT03737110|531549212|FG005|Randomized Withdrawal (RW) Period|Completed, Not Continuing into LTE|0|||
147378238|NCT03737110|531549207|FG000|Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
147378239|NCT03737110|531549208|FG001|Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
147378240|NCT03737110|531549209|FG002|Randomized Withdrawal (RW) Period|Withdrawal by Subject|1|||
147378241|NCT03737110|531549210|FG003|Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
147378242|NCT03737110|531549211|FG004|Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
147378243|NCT03737110|531549212|FG005|Randomized Withdrawal (RW) Period|Withdrawal by Subject|0|||
147378244|NCT03737110|531549207|FG000|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
147378245|NCT03737110|531549208|FG001|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
147378246|NCT03737110|531549209|FG002|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
147378247|NCT03737110|531549210|FG003|Long-Term Extension (LTE) Period|Lost to Follow-up|1|||
147378248|NCT03737110|531549211|FG004|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
147378249|NCT03737110|531549212|FG005|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
147378250|NCT03737110|531549207|FG000|Long-Term Extension (LTE) Period|Withdrawal by Subject|0|||
147378251|NCT03737110|531549208|FG001|Long-Term Extension (LTE) Period|Withdrawal by Subject|0|||
147455974|NCT00403260|531831645|FG000|Overall Study|Mixed infection with P. vivax|2|||
147455975|NCT00403260|531831646|FG001|Overall Study|Mixed infection with P. vivax|0|||
147455976|NCT00403260|531831645|FG000|Overall Study|Mixed infection with P. falciparum|1|||
147664755|NCT01819727|532596379|FG001|Overall Study|Pregnancy|0|||
147664756|NCT01819727|532596378|FG000|Overall Study|Protocol Violation|0|||
147612498|NCT03598790|532397078|FG003|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
147612499|NCT03598790|532397079|FG004|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
147612500|NCT03598790|532397080|FG005|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
147612501|NCT03598790|532397081|FG006|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
147612502|NCT03598790|532397082|FG007|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
147612503|NCT03598790|532397083|FG008|Treatment Period (TP): Wk0-Wk144|Covid-19 Pandemic Circumstances|0|||
147612504|NCT03598790|532397075|FG000|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|1|||
147612505|NCT03598790|532397076|FG001|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|2|||
147612506|NCT03598790|532397077|FG002|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|0|||
147612507|NCT03598790|532397078|FG003|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|0|||
147612508|NCT03598790|532397079|FG004|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|0|||
147612509|NCT03598790|532397080|FG005|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|0|||
147612510|NCT03598790|532397081|FG006|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|0|||
147612511|NCT03598790|532397082|FG007|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|0|||
147612512|NCT03598790|532397083|FG008|Treatment Period (TP): Wk0-Wk144|Sponsor's Decision|0|||
147612513|NCT03598790|532397075|FG000|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
147612514|NCT03598790|532397076|FG001|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|1|||
147612515|NCT03598790|532397077|FG002|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
147612516|NCT03598790|532397078|FG003|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
147612517|NCT03598790|532397079|FG004|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
147612518|NCT03598790|532397080|FG005|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
147612519|NCT03598790|532397081|FG006|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
147612520|NCT03598790|532397082|FG007|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
147612521|NCT03598790|532397083|FG008|Treatment Period (TP): Wk0-Wk144|Unplanned Elective Surgery|0|||
147612522|NCT03598790|532397075|FG000|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
147612523|NCT03598790|532397076|FG001|Treatment Period (TP): Wk0-Wk144|Non-Compliance|1|||
147612524|NCT03598790|532397077|FG002|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
147612525|NCT03598790|532397078|FG003|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
147612526|NCT03598790|532397079|FG004|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
147612527|NCT03598790|532397080|FG005|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
147612528|NCT03598790|532397081|FG006|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
147612529|NCT03598790|532397082|FG007|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
147612530|NCT03598790|532397083|FG008|Treatment Period (TP): Wk0-Wk144|Non-Compliance|0|||
147612531|NCT03598790|532397075|FG000|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
147612532|NCT03598790|532397076|FG001|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
147612533|NCT03598790|532397077|FG002|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|1|||
147612534|NCT03598790|532397078|FG003|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
147612535|NCT03598790|532397079|FG004|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
147612536|NCT03598790|532397080|FG005|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
147612537|NCT03598790|532397081|FG006|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
147612538|NCT03598790|532397082|FG007|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
147612539|NCT03598790|532397083|FG008|Treatment Period (TP): Wk0-Wk144|Site Closure; Subject did not want to transfer|0|||
147612540|NCT03598790|532397075|FG000|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
147612541|NCT03598790|532397076|FG001|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
147612542|NCT03598790|532397077|FG002|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|1|||
147612543|NCT03598790|532397078|FG003|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
147612544|NCT03598790|532397079|FG004|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
147612545|NCT03598790|532397080|FG005|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
147612546|NCT03598790|532397081|FG006|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
147612547|NCT03598790|532397082|FG007|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
147612548|NCT03598790|532397083|FG008|Treatment Period (TP): Wk0-Wk144|COVID-19 restrictions; Subject unable to return|0|||
147612549|NCT03598790|532397075|FG000|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
147612550|NCT03598790|532397076|FG001|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
147612551|NCT03598790|532397077|FG002|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|1|||
147612552|NCT03598790|532397078|FG003|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
147612553|NCT03598790|532397079|FG004|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
147612554|NCT03598790|532397080|FG005|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
147643995|NCT01447446|532516687|FG001|Overall Study|Administrative/Other|9|||
147643996|NCT01447446|532516688|FG002|Overall Study|Administrative/Other|10|||
147378252|NCT03737110|531549209|FG002|Long-Term Extension (LTE) Period|Withdrawal by Subject|0|||
147643997|NCT01447446|532516689|FG003|Overall Study|Administrative/Other|2|||
147664757|NCT01819727|532596379|FG001|Overall Study|Protocol Violation|2|||
147664758|NCT01819727|532596378|FG000|Overall Study|Study Terminated by Sponsor|0|||
147664759|NCT01819727|532596379|FG001|Overall Study|Study Terminated by Sponsor|1|||
147664760|NCT01819727|532596378|FG000|Overall Study|Withdrawal by Subject|6|||
147664761|NCT01819727|532596379|FG001|Overall Study|Withdrawal by Subject|11|||
147664762|NCT01819727|532596378|FG000|Overall Study|Unable to demostrate ability self-inject|0|||
147664763|NCT01819727|532596379|FG001|Overall Study|Unable to demostrate ability self-inject|1|||
147664764|NCT01819727|532596378|FG000|Overall Study|Quit due to lack of health benifits|0|||
147664765|NCT01819727|532596379|FG001|Overall Study|Quit due to lack of health benifits|1|||
147664766|NCT04460326|532596380|FG000|Completed at Least 4 Meals|Early discharge|5|||
147664767|NCT04460326|532596381|FG001|Completed at Least 4 Meals|Early discharge|5|||
147664768|NCT04460326|532596380|FG000|Completed at Least 4 Meals|Started oral antihyperglycemic|1|||
147664769|NCT04460326|532596381|FG001|Completed at Least 4 Meals|Started oral antihyperglycemic|1|||
147664770|NCT04460326|532596380|FG000|Completed at Least 4 Meals|Nutrition method changed|1|||
147664771|NCT04460326|532596381|FG001|Completed at Least 4 Meals|Nutrition method changed|0|||
147664772|NCT04460326|532596380|FG000|Completed at Least 4 Meals|Transfer to ICU|0|||
147664773|NCT04460326|532596381|FG001|Completed at Least 4 Meals|Transfer to ICU|1|||
147664774|NCT04460326|532596380|FG000|Completed at Least 4 Meals|Bleeding at CGM site|0|||
147664775|NCT04460326|532596381|FG001|Completed at Least 4 Meals|Bleeding at CGM site|1|||
147664776|NCT04460326|532596380|FG000|Insulin Boluses & Postprandial CGM Data|Postprandial or CGM data not available|5|||
147664777|NCT04460326|532596381|FG001|Insulin Boluses & Postprandial CGM Data|Postprandial or CGM data not available|12|||
147664778|NCT04794751|532596382|FG000|Period 1|incorrect fitting guide was used to fit subject|2|||
147664779|NCT04794751|532596383|FG001|Period 1|incorrect fitting guide was used to fit subject|1|||
147664780|NCT04794751|532596382|FG000|Period 1|Subject no longer meets eligibility criteria|0|||
147664781|NCT04794751|532596383|FG001|Period 1|Subject no longer meets eligibility criteria|1|||
147664782|NCT04794751|532596382|FG000|Period 1|Protocol Violation|0|||
147664783|NCT04794751|532596383|FG001|Period 1|Protocol Violation|2|||
147664784|NCT04794751|532596382|FG000|Period 1|Withdrawal by Subject|0|||
147664785|NCT04794751|532596383|FG001|Period 1|Withdrawal by Subject|1|||
147664786|NCT04794751|532596382|FG000|Period 2|Withdrawal by Subject|0|||
147664787|NCT04794751|532596383|FG001|Period 2|Withdrawal by Subject|1|||
147664788|NCT04794751|532596382|FG000|Period 2|incorrect fitting guide was used to fit subject|0|||
147664789|NCT04794751|532596383|FG001|Period 2|incorrect fitting guide was used to fit subject|2|||
147664790|NCT04794751|532596382|FG000|Period 2|Protocol Violation|1|||
147664791|NCT04794751|532596383|FG001|Period 2|Protocol Violation|0|||
147664792|NCT00969228|532596384|FG000|Overall Study|Adverse Event|1|||
147664793|NCT00969228|532596385|FG001|Overall Study|Adverse Event|0|||
147664794|NCT00969228|532596384|FG000|Overall Study|Withdrawal by Subject|4|||
147664795|NCT00969228|532596385|FG001|Overall Study|Withdrawal by Subject|0|||
147664796|NCT00969228|532596384|FG000|Overall Study|Porcine circovirus detection in vaccine|38|||
147664797|NCT00969228|532596385|FG001|Overall Study|Porcine circovirus detection in vaccine|14|||
147664798|NCT02007720|532596393|FG000|Overall Study|Withdrawal by Subject|9|||
147664799|NCT02007720|532596394|FG001|Overall Study|Withdrawal by Subject|11|||
147664800|NCT02007720|532596393|FG000|Overall Study|study terminated by sponsor|58|||
147664801|NCT02007720|532596394|FG001|Overall Study|study terminated by sponsor|54|||
147664802|NCT02007720|532596393|FG000|Overall Study|technical problem|4|||
147664803|NCT02007720|532596394|FG001|Overall Study|technical problem|2|||
147664804|NCT02007720|532596393|FG000|Overall Study|patient followd less than 165 days|11|||
147612555|NCT03598790|532397081|FG006|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
147612556|NCT03598790|532397082|FG007|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
147612557|NCT03598790|532397083|FG008|Treatment Period (TP): Wk0-Wk144|Subject Withdraw Consent (Fear Of Another Ae)|0|||
147612558|NCT03598790|532397075|FG000|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
147612559|NCT03598790|532397076|FG001|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
147612560|NCT03598790|532397077|FG002|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
147612561|NCT03598790|532397078|FG003|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
147612562|NCT03598790|532397079|FG004|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
147612563|NCT03598790|532397080|FG005|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
147664805|NCT02007720|532596394|FG001|Overall Study|patient followd less than 165 days|5|||
147664806|NCT05630196|532597912|FG000|Overall Study|Adverse Event|2|||
147664807|NCT05630196|532597913|FG001|Overall Study|Adverse Event|1|||
147664808|NCT05630196|532597912|FG000|Overall Study|Lost to Follow-up|1|||
147664809|NCT05630196|532597913|FG001|Overall Study|Lost to Follow-up|1|||
147378253|NCT03737110|531549210|FG003|Long-Term Extension (LTE) Period|Withdrawal by Subject|1|||
147378254|NCT03737110|531549211|FG004|Long-Term Extension (LTE) Period|Withdrawal by Subject|0|||
147612564|NCT03598790|532397081|FG006|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|1|||
147664810|NCT05630196|532597912|FG000|Overall Study|Protocol Violation|2|||
147664811|NCT05630196|532597913|FG001|Overall Study|Protocol Violation|3|||
147664812|NCT05630196|532597912|FG000|Overall Study|Physician Decision|1|||
147664813|NCT05630196|532597913|FG001|Overall Study|Physician Decision|0|||
147378255|NCT03737110|531549212|FG005|Long-Term Extension (LTE) Period|Withdrawal by Subject|2|||
147378256|NCT03737110|531549207|FG000|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|0|||
147378257|NCT03737110|531549208|FG001|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|0|||
147378258|NCT03737110|531549209|FG002|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|0|||
147378259|NCT03737110|531549210|FG003|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|0|||
147378260|NCT03737110|531549211|FG004|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|1|||
147378261|NCT03737110|531549212|FG005|Long-Term Extension (LTE) Period|Investigator Decision due to Serious Adverse Event|0|||
147378262|NCT03648541|531549213|FG000|Re-induction Period Only|Withdrawal by Subject|1|||
147378263|NCT03648541|531549214|FG001|Re-induction Period Only|Withdrawal by Subject|0|||
147378264|NCT03648541|531549213|FG000|Re-induction Period Only|Lack of Efficacy|7|||
147378265|NCT03648541|531549214|FG001|Re-induction Period Only|Lack of Efficacy|0|||
147378266|NCT03648541|531549213|FG000|Maintenance Period Only|Missing|0|||
147378267|NCT03648541|531549214|FG001|Maintenance Period Only|Missing|1|||
147378268|NCT03648541|531549213|FG000|Maintenance Period Only|Other not listed below|0|||
147378269|NCT03648541|531549214|FG001|Maintenance Period Only|Other not listed below|4|||
147378270|NCT03648541|531549213|FG000|Maintenance Period Only|Withdrawal by Subject|0|||
147378271|NCT03648541|531549214|FG001|Maintenance Period Only|Withdrawal by Subject|3|||
147378272|NCT03648541|531549213|FG000|Maintenance Period Only|Protocol Violation|0|||
147378273|NCT03648541|531549214|FG001|Maintenance Period Only|Protocol Violation|1|||
147378274|NCT03648541|531549213|FG000|Maintenance Period Only|Lack of Efficacy|0|||
147378275|NCT03648541|531549214|FG001|Maintenance Period Only|Lack of Efficacy|18|||
147378276|NCT03648541|531549213|FG000|Maintenance Period Only|Adverse Event|0|||
147378277|NCT03648541|531549214|FG001|Maintenance Period Only|Adverse Event|4|||
147378278|NCT03648541|531549213|FG000|Maintenance Period Only|Stopped maintenance treatment due to study stop|0|||
147378279|NCT03648541|531549214|FG001|Maintenance Period Only|Stopped maintenance treatment due to study stop|3|||
147378280|NCT01852045|531549215|FG000|Overall Study|Adverse Event|1|||
147378281|NCT01852045|531549216|FG001|Overall Study|Adverse Event|0|||
147378282|NCT01852045|531549217|FG002|Overall Study|Adverse Event|0|||
147378283|NCT01852045|531549215|FG000|Overall Study|Lack of Efficacy|3|||
147378284|NCT01852045|531549216|FG001|Overall Study|Lack of Efficacy|0|||
147378285|NCT01852045|531549217|FG002|Overall Study|Lack of Efficacy|0|||
147378286|NCT01852045|531549215|FG000|Overall Study|Lost to Follow-up|0|||
147378287|NCT01852045|531549216|FG001|Overall Study|Lost to Follow-up|1|||
147378288|NCT01852045|531549217|FG002|Overall Study|Lost to Follow-up|1|||
147378289|NCT01852045|531549215|FG000|Overall Study|Withdrawal by Subject|1|||
147378290|NCT01852045|531549216|FG001|Overall Study|Withdrawal by Subject|0|||
147378291|NCT01852045|531549217|FG002|Overall Study|Withdrawal by Subject|1|||
147378292|NCT01852045|531549215|FG000|Overall Study|Other Miscellaneous Reasons|1|||
147378293|NCT01852045|531549216|FG001|Overall Study|Other Miscellaneous Reasons|3|||
147378294|NCT01852045|531549217|FG002|Overall Study|Other Miscellaneous Reasons|2|||
147378295|NCT02827201|531549218|FG000|Overall Study|Death|1|||
147378296|NCT02827201|531549219|FG001|Overall Study|Death|2|||
147378297|NCT02827201|531549218|FG000|Overall Study|Patients not treated|1|||
147378298|NCT02827201|531549219|FG001|Overall Study|Patients not treated|1|||
147378299|NCT00638456|531549224|FG000|Overall Study|Withdrawal by Subject|6|||
147378300|NCT00638456|531549225|FG001|Overall Study|Withdrawal by Subject|2|||
147378301|NCT03052517|531549228|FG000|Overall Study|Study Terminated By Sponsor|928|||
147378302|NCT03052517|531549229|FG001|Overall Study|Study Terminated By Sponsor|938|||
147378303|NCT03052517|531549230|FG002|Overall Study|Study Terminated By Sponsor|296|||
147378304|NCT03052517|531549228|FG000|Overall Study|Subject/Guardian Decision|50|||
147378305|NCT03052517|531549229|FG001|Overall Study|Subject/Guardian Decision|45|||
147378306|NCT03052517|531549230|FG002|Overall Study|Subject/Guardian Decision|22|||
147378307|NCT03052517|531549228|FG000|Overall Study|Lack of Efficacy|23|||
147378308|NCT03052517|531549229|FG001|Overall Study|Lack of Efficacy|14|||
147378309|NCT03052517|531549230|FG002|Overall Study|Lack of Efficacy|7|||
147378310|NCT03052517|531549228|FG000|Overall Study|Adverse Event|6|||
147378311|NCT03052517|531549229|FG001|Overall Study|Adverse Event|5|||
147378312|NCT03052517|531549230|FG002|Overall Study|Adverse Event|0|||
147378313|NCT03052517|531549228|FG000|Overall Study|Physician Decision|4|||
147378314|NCT03052517|531549229|FG001|Overall Study|Physician Decision|5|||
147378315|NCT03052517|531549230|FG002|Overall Study|Physician Decision|1|||
147378316|NCT03052517|531549228|FG000|Overall Study|Death|3|||
147378317|NCT03052517|531549229|FG001|Overall Study|Death|0|||
147378318|NCT03052517|531549230|FG002|Overall Study|Death|1|||
147378319|NCT03052517|531549228|FG000|Overall Study|Lost to Follow-up|2|||
147378320|NCT03052517|531549229|FG001|Overall Study|Lost to Follow-up|4|||
147378321|NCT03052517|531549230|FG002|Overall Study|Lost to Follow-up|0|||
147378322|NCT03052517|531549228|FG000|Overall Study|Pregnancy|1|||
147378323|NCT03052517|531549229|FG001|Overall Study|Pregnancy|0|||
147378324|NCT03052517|531549230|FG002|Overall Study|Pregnancy|1|||
147378325|NCT03052517|531549228|FG000|Overall Study|Non-Compliance With Study Treatment|0|||
147378326|NCT03052517|531549229|FG001|Overall Study|Non-Compliance With Study Treatment|2|||
147378327|NCT03052517|531549230|FG002|Overall Study|Non-Compliance With Study Treatment|0|||
147378328|NCT03052517|531549228|FG000|Overall Study|Technical Problems|0|||
147378329|NCT03052517|531549229|FG001|Overall Study|Technical Problems|1|||
147378330|NCT03052517|531549230|FG002|Overall Study|Technical Problems|0|||
147378331|NCT05260437|531549233|FG000|Overall Study|Lost to Follow-up|5|||
147378332|NCT05260437|531549234|FG001|Overall Study|Lost to Follow-up|2|||
147378333|NCT05260437|531549235|FG002|Overall Study|Lost to Follow-up|1|||
147378334|NCT05260437|531549236|FG003|Overall Study|Lost to Follow-up|2|||
147378335|NCT05260437|531549237|FG004|Overall Study|Lost to Follow-up|2|||
147378336|NCT05260437|531549233|FG000|Overall Study|Withdrawal by Subject|3|||
147378337|NCT05260437|531549234|FG001|Overall Study|Withdrawal by Subject|0|||
147378338|NCT05260437|531549235|FG002|Overall Study|Withdrawal by Subject|4|||
147378339|NCT05260437|531549236|FG003|Overall Study|Withdrawal by Subject|5|||
147378340|NCT05260437|531549237|FG004|Overall Study|Withdrawal by Subject|0|||
147378341|NCT05260437|531549233|FG000|Overall Study|Vaccine Not Administered|0|||
147378342|NCT05260437|531549234|FG001|Overall Study|Vaccine Not Administered|1|||
147378343|NCT05260437|531549235|FG002|Overall Study|Vaccine Not Administered|0|||
147378344|NCT05260437|531549236|FG003|Overall Study|Vaccine Not Administered|0|||
147378345|NCT05260437|531549237|FG004|Overall Study|Vaccine Not Administered|0|||
147378346|NCT01858688|531549238|FG000|Overall Study|Withdrawal by Subject|8|||
147378347|NCT01858688|531549238|FG000|Overall Study|Participant began another therapy|3|||
147378348|NCT01858688|531549238|FG000|Overall Study|Physician Decision|2|||
147378349|NCT01858688|531549238|FG000|Overall Study|Progressive Disease|2|||
147378350|NCT01858688|531549238|FG000|Overall Study|Reason not reproted|5|||
147378351|NCT01530334|531549240|FG000|Overall Study|Adverse Event|3|||
147378352|NCT01530334|531549240|FG000|Overall Study|unknown reason|1|||
147378353|NCT01530334|531549240|FG000|Overall Study|Progressive disease|47|||
147378354|NCT01303510|531549241|FG000|Overall Study|Lost to Follow-up|1|||
147378355|NCT01303510|531549242|FG001|Overall Study|Lost to Follow-up|0|||
147378356|NCT00701415|531549243|FG000|Overall Study|Adverse Event|0|||
147378357|NCT00701415|531549244|FG001|Overall Study|Adverse Event|1|||
147378358|NCT00701415|531549243|FG000|Overall Study|Social/family issues and needle phobia|1|||
147378359|NCT00701415|531549244|FG001|Overall Study|Social/family issues and needle phobia|0|||
147378360|NCT01972776|531549255|FG000|Part 1|Withdrawal by Subject|0|||
147378361|NCT01972776|531549256|FG001|Part 1|Withdrawal by Subject|0|||
147378362|NCT01972776|531549257|FG002|Part 1|Withdrawal by Subject|1|||
147378363|NCT01972776|531549258|FG003|Part 1|Withdrawal by Subject|0|||
147378364|NCT01972776|531549259|FG004|Part 1|Withdrawal by Subject|0|||
147378365|NCT01972776|531549260|FG005|Part 1|Withdrawal by Subject|0|||
147378366|NCT01972776|531549255|FG000|Part 1|Adverse Event|0|||
147378367|NCT01972776|531549256|FG001|Part 1|Adverse Event|0|||
147378368|NCT01972776|531549257|FG002|Part 1|Adverse Event|1|||
147378369|NCT01972776|531549258|FG003|Part 1|Adverse Event|1|||
147378370|NCT01972776|531549259|FG004|Part 1|Adverse Event|0|||
147378371|NCT01972776|531549260|FG005|Part 1|Adverse Event|0|||
147378372|NCT01972776|531549255|FG000|Part 2|Adverse Event|0|||
147378373|NCT01972776|531549256|FG001|Part 2|Adverse Event|0|||
147378374|NCT01972776|531549257|FG002|Part 2|Adverse Event|0|||
147378375|NCT01972776|531549258|FG003|Part 2|Adverse Event|0|||
147378376|NCT01972776|531549259|FG004|Part 2|Adverse Event|3|||
147378377|NCT01972776|531549260|FG005|Part 2|Adverse Event|0|||
147378378|NCT01972776|531549255|FG000|Part 2|Administrative problems|0|||
147378379|NCT01972776|531549256|FG001|Part 2|Administrative problems|0|||
147378380|NCT01972776|531549257|FG002|Part 2|Administrative problems|0|||
147378381|NCT01972776|531549258|FG003|Part 2|Administrative problems|0|||
147378382|NCT01972776|531549259|FG004|Part 2|Administrative problems|10|||
147378383|NCT01972776|531549260|FG005|Part 2|Administrative problems|7|||
147378384|NCT03162614|531549265|FG000|Overall Study|Lost to Follow-up|2|||
147612565|NCT03598790|532397082|FG007|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
147612566|NCT03598790|532397083|FG008|Treatment Period (TP): Wk0-Wk144|The Subject Can't Visit the Hospital Anymore|0|||
147612567|NCT03598790|532397075|FG000|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|3|||
147612568|NCT03598790|532397076|FG001|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|1|||
147612569|NCT03598790|532397077|FG002|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|0|||
147612570|NCT03598790|532397078|FG003|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|0|||
147612571|NCT03598790|532397079|FG004|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|0|||
147643998|NCT01447446|532516690|FG004|Overall Study|Administrative/Other|33|||
147378385|NCT03162614|531549266|FG001|Overall Study|Lost to Follow-up|1|||
147378386|NCT03162614|531549267|FG002|Overall Study|Lost to Follow-up|1|||
147378387|NCT03162614|531549268|FG003|Overall Study|Lost to Follow-up|1|||
147378388|NCT03162614|531549269|FG004|Overall Study|Lost to Follow-up|2|||
147378389|NCT03162614|531549270|FG005|Overall Study|Lost to Follow-up|0|||
147378390|NCT03162614|531549265|FG000|Overall Study|Protocol Violation|0|||
147378391|NCT03162614|531549266|FG001|Overall Study|Protocol Violation|1|||
147378392|NCT03162614|531549267|FG002|Overall Study|Protocol Violation|0|||
147378393|NCT03162614|531549268|FG003|Overall Study|Protocol Violation|1|||
147378394|NCT03162614|531549269|FG004|Overall Study|Protocol Violation|0|||
147378395|NCT03162614|531549270|FG005|Overall Study|Protocol Violation|0|||
147378396|NCT03162614|531549265|FG000|Overall Study|Withdrawal by Subject|2|||
147378397|NCT03162614|531549266|FG001|Overall Study|Withdrawal by Subject|1|||
147612572|NCT03598790|532397080|FG005|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|0|||
147612573|NCT03598790|532397081|FG006|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|0|||
147612574|NCT03598790|532397082|FG007|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|0|||
147612575|NCT03598790|532397083|FG008|Treatment Period (TP): Wk0-Wk144|Completed treatment but missed Week 144 visit|0|||
147612576|NCT03598790|532397075|FG000|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
147612577|NCT03598790|532397076|FG001|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
147612578|NCT03598790|532397077|FG002|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|1|||
147612579|NCT03598790|532397078|FG003|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
147612580|NCT03598790|532397079|FG004|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
147612581|NCT03598790|532397080|FG005|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
147612582|NCT03598790|532397081|FG006|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
147612583|NCT03598790|532397082|FG007|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
147612584|NCT03598790|532397083|FG008|Treatment Period (TP): Wk0-Wk144|Non-Compliance-PI early terminated the subject|0|||
147612585|NCT03598790|532397075|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
147612586|NCT03598790|532397076|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
147612587|NCT03598790|532397077|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
147612588|NCT03598790|532397078|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|2|||
147612589|NCT03598790|532397079|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|1|||
147612590|NCT03598790|532397080|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|2|||
147612591|NCT03598790|532397081|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
147612592|NCT03598790|532397082|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
147612593|NCT03598790|532397083|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Adverse Event|0|||
147612594|NCT03598790|532397075|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
147612595|NCT03598790|532397076|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
147612596|NCT03598790|532397077|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
147612597|NCT03598790|532397078|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|2|||
147612598|NCT03598790|532397079|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
147612599|NCT03598790|532397080|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
147612600|NCT03598790|532397081|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
147612601|NCT03598790|532397082|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
147612602|NCT03598790|532397083|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lack of Efficacy|0|||
147612603|NCT03598790|532397075|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
147612604|NCT03598790|532397076|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
147612605|NCT03598790|532397077|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
147612606|NCT03598790|532397078|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|4|||
147612607|NCT03598790|532397079|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
147612608|NCT03598790|532397080|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
147612609|NCT03598790|532397081|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
147612610|NCT03598790|532397082|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
147612611|NCT03598790|532397083|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Lost to Follow-up|0|||
147612612|NCT03598790|532397075|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|0|||
147612613|NCT03598790|532397076|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|0|||
147612614|NCT03598790|532397077|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|0|||
147378398|NCT03162614|531549267|FG002|Overall Study|Withdrawal by Subject|1|||
147378399|NCT03162614|531549268|FG003|Overall Study|Withdrawal by Subject|1|||
147378400|NCT03162614|531549269|FG004|Overall Study|Withdrawal by Subject|0|||
147378401|NCT03162614|531549270|FG005|Overall Study|Withdrawal by Subject|0|||
147378402|NCT03162614|531549265|FG000|Overall Study|Missed vaccination, exclusion criteria|2|||
147378403|NCT03162614|531549266|FG001|Overall Study|Missed vaccination, exclusion criteria|2|||
147378404|NCT03162614|531549267|FG002|Overall Study|Missed vaccination, exclusion criteria|2|||
147378405|NCT03162614|531549268|FG003|Overall Study|Missed vaccination, exclusion criteria|4|||
147378406|NCT03162614|531549269|FG004|Overall Study|Missed vaccination, exclusion criteria|3|||
147378407|NCT03162614|531549270|FG005|Overall Study|Missed vaccination, exclusion criteria|0|||
147378408|NCT02208843|531549271|FG000|Overall Study|Clinical symptoms of progression|2|||
147378409|NCT02208843|531549271|FG000|Overall Study|Progression disease according to RECIST|24|||
147378410|NCT02208843|531549271|FG000|Overall Study|Adverse Event|12|||
147378411|NCT02208843|531549271|FG000|Overall Study|Protocol Violation|1|||
147612615|NCT03598790|532397078|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|1|||
147612616|NCT03598790|532397079|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|1|||
147612617|NCT03598790|532397080|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|0|||
147612618|NCT03598790|532397081|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|0|||
147378412|NCT02208843|531549271|FG000|Overall Study|Withdrawal by Subject|1|||
147378413|NCT02208843|531549271|FG000|Overall Study|Switched to commercial afatinib|20|||
147378414|NCT01321073|531549272|FG000|Overall Study|Did not attempt implant|4|||
147664814|NCT05630196|532597912|FG000|Overall Study|Withdrawal by Subject|3|||
147664815|NCT05630196|532597913|FG001|Overall Study|Withdrawal by Subject|4|||
147664816|NCT01655901|532597917|FG000|Third Intervention (Hour 3)|Lost to Follow-up|1|||
147664817|NCT01655901|532597918|FG001|Third Intervention (Hour 3)|Lost to Follow-up|1|||
147664818|NCT01655901|532597919|FG002|Third Intervention (Hour 3)|Lost to Follow-up|1|||
147664819|NCT01655901|532597920|FG003|Third Intervention (Hour 3)|Lost to Follow-up|0|||
147664820|NCT01655901|532597921|FG004|Third Intervention (Hour 3)|Lost to Follow-up|1|||
147664821|NCT01655901|532597922|FG005|Third Intervention (Hour 3)|Lost to Follow-up|0|||
147378415|NCT01321073|531549272|FG000|Overall Study|Death|3|||
147612619|NCT03598790|532397082|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|0|||
147612620|NCT03598790|532397083|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Consent withdrawn|0|||
147612621|NCT03598790|532397075|FG000|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
147612622|NCT03598790|532397076|FG001|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
147612623|NCT03598790|532397077|FG002|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
147612624|NCT03598790|532397078|FG003|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|1|||
147612625|NCT03598790|532397079|FG004|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
147612626|NCT03598790|532397080|FG005|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
147612627|NCT03598790|532397081|FG006|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
147612628|NCT03598790|532397082|FG007|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
147612629|NCT03598790|532397083|FG008|OLE2 Period: Wk 144/OLE2 BL- OLE2 Wk 48|Pt Cannot Commit To Study Schedule|0|||
147612630|NCT01059786|532397084|FG000|Overall Study|Did not receive 6 cycles.|0|||
147612631|NCT01059786|532397085|FG001|Overall Study|Did not receive 6 cycles.|0|||
147612632|NCT01059786|532397086|FG002|Overall Study|Did not receive 6 cycles.|4|||
147612633|NCT01059786|532397087|FG003|Overall Study|Did not receive 6 cycles.|1|||
147612634|NCT01059786|532397088|FG004|Overall Study|Did not receive 6 cycles.|0|||
147612635|NCT05026177|532397093|FG000|Overall Study|Adverse Event|33|||
147612636|NCT05026177|532397094|FG001|Overall Study|Adverse Event|33|||
147612637|NCT05026177|532397095|FG002|Overall Study|Adverse Event|17|||
147612638|NCT05026177|532397093|FG000|Overall Study|Lost to Follow-up|7|||
147612639|NCT05026177|532397094|FG001|Overall Study|Lost to Follow-up|6|||
147612640|NCT05026177|532397095|FG002|Overall Study|Lost to Follow-up|8|||
147612641|NCT05026177|532397093|FG000|Overall Study|Noncompliance with study drug|6|||
147612642|NCT05026177|532397094|FG001|Overall Study|Noncompliance with study drug|2|||
147612643|NCT05026177|532397095|FG002|Overall Study|Noncompliance with study drug|1|||
147612644|NCT05026177|532397093|FG000|Overall Study|Physician Decision|4|||
147664822|NCT00352118|532597923|FG000|Overall Study|Physician Decision|4|||
147378416|NCT04224272|531549279|FG000|Part 1 - Dose Finding|Death|4|||
147378417|NCT04224272|531549279|FG000|Part 1 - Dose Finding|Withdrawal by Subject|2|||
147378418|NCT04224272|531549279|FG000|Part 1 - Dose Finding|Lost to Follow-up|1|||
147378419|NCT04224272|531549279|FG000|Part 2 - Dose Expansion|Death|10|||
147378420|NCT04224272|531549279|FG000|Part 2 - Dose Expansion|Withdrawal by Subject|3|||
147378421|NCT02609048|531549280|FG000|Overall Study|Adverse Event|3|||
147378422|NCT02609048|531549281|FG001|Overall Study|Adverse Event|0|||
147378423|NCT02609048|531549282|FG002|Overall Study|Adverse Event|0|||
147378424|NCT02609048|531549280|FG000|Overall Study|Randomized but never treated|1|||
147378425|NCT02609048|531549281|FG001|Overall Study|Randomized but never treated|1|||
147378426|NCT02609048|531549282|FG002|Overall Study|Randomized but never treated|1|||
147378427|NCT02609048|531549280|FG000|Overall Study|Withdrawal of informed consent|1|||
147378428|NCT02609048|531549281|FG001|Overall Study|Withdrawal of informed consent|0|||
147378429|NCT02609048|531549282|FG002|Overall Study|Withdrawal of informed consent|0|||
147378430|NCT02609048|531549280|FG000|Overall Study|Reason not specified|6|||
147378431|NCT02609048|531549281|FG001|Overall Study|Reason not specified|9|||
147378432|NCT02609048|531549282|FG002|Overall Study|Reason not specified|9|||
147378433|NCT04186247|531549283|FG000|Standard of Care (Week 0 to Week 4)|Withdrawal by Subject|2|||
147378434|NCT04186247|531549284|FG001|Standard of Care (Week 0 to Week 4)|Withdrawal by Subject|0|||
147378435|NCT04186247|531549285|FG002|Standard of Care (Week 0 to Week 4)|Withdrawal by Subject|0|||
147378436|NCT04186247|531549286|FG003|Standard of Care (Week 0 to Week 4)|Withdrawal by Subject|0|||
147378437|NCT04186247|531549287|FG004|Standard of Care (Week 0 to Week 4)|Withdrawal by Subject|0|||
147664823|NCT00870727|532597924|FG000|Overall Study|Lost to Follow-up|0|||
147664824|NCT00870727|532597925|FG001|Overall Study|Lost to Follow-up|1|||
147378438|NCT03769090|531550658|FG000|Overall Study|Randomized and did not receive randomized study treatment|1|||
147612645|NCT05026177|532397094|FG001|Overall Study|Physician Decision|1|||
147612646|NCT05026177|532397095|FG002|Overall Study|Physician Decision|0|||
147612647|NCT05026177|532397093|FG000|Overall Study|Sponsor requests subject to be withdrawn|0|||
147612648|NCT05026177|532397094|FG001|Overall Study|Sponsor requests subject to be withdrawn|0|||
147612649|NCT05026177|532397095|FG002|Overall Study|Sponsor requests subject to be withdrawn|3|||
147612650|NCT05026177|532397093|FG000|Overall Study|Withdrawal by Subject|53|||
147612651|NCT05026177|532397094|FG001|Overall Study|Withdrawal by Subject|51|||
147664825|NCT00870727|532597924|FG000|Overall Study|Lack of Efficacy|1|||
147378439|NCT03769090|531550659|FG001|Overall Study|Randomized and did not receive randomized study treatment|2|||
147664826|NCT00870727|532597925|FG001|Overall Study|Lack of Efficacy|3|||
147664827|NCT00870727|532597924|FG000|Overall Study|Adverse Event|0|||
147664828|NCT00870727|532597925|FG001|Overall Study|Adverse Event|1|||
147664829|NCT01712516|532597926|FG000|Overall Study|Technical problems|0|||
147664830|NCT01712516|532597927|FG001|Overall Study|Technical problems|0|||
147664831|NCT01712516|532597928|FG002|Overall Study|Technical problems|0|||
147664832|NCT01712516|532597929|FG003|Overall Study|Technical problems|2|||
147664833|NCT01712516|532597926|FG000|Overall Study|Lost to Follow-up|0|||
147664834|NCT01712516|532597927|FG001|Overall Study|Lost to Follow-up|0|||
147664835|NCT01712516|532597928|FG002|Overall Study|Lost to Follow-up|2|||
147664836|NCT01712516|532597929|FG003|Overall Study|Lost to Follow-up|1|||
147664837|NCT01712516|532597926|FG000|Overall Study|Death|0|||
147664838|NCT01712516|532597927|FG001|Overall Study|Death|1|||
147664839|NCT01712516|532597928|FG002|Overall Study|Death|0|||
147664840|NCT01712516|532597929|FG003|Overall Study|Death|0|||
147664841|NCT01712516|532597926|FG000|Overall Study|Protocol deviation|1|||
147664842|NCT01712516|532597927|FG001|Overall Study|Protocol deviation|0|||
147664843|NCT01712516|532597928|FG002|Overall Study|Protocol deviation|1|||
147664844|NCT01712516|532597929|FG003|Overall Study|Protocol deviation|0|||
147664845|NCT01712516|532597926|FG000|Overall Study|Physician Decision|2|||
147664846|NCT01712516|532597927|FG001|Overall Study|Physician Decision|0|||
147664847|NCT01712516|532597928|FG002|Overall Study|Physician Decision|0|||
147664848|NCT01712516|532597929|FG003|Overall Study|Physician Decision|1|||
147664849|NCT01712516|532597926|FG000|Overall Study|Withdrawal by Subject|3|||
147664850|NCT01712516|532597927|FG001|Overall Study|Withdrawal by Subject|9|||
147664851|NCT01712516|532597928|FG002|Overall Study|Withdrawal by Subject|3|||
147664852|NCT01712516|532597929|FG003|Overall Study|Withdrawal by Subject|9|||
147664853|NCT01251952|532597932|FG000|Overall Study|Adverse Event|1|||
147664854|NCT00496769|532597933|FG000|Double Blind|>=1 reason assigned per patient|558|||
147664855|NCT00496769|532597934|FG001|Double Blind|>=1 reason assigned per patient|649|||
147664856|NCT00496769|532597935|FG002|Double Blind|>=1 reason assigned per patient|0|||
147664857|NCT00496769|532597933|FG000|Open Label|>=1 reason assigned per patient|0|||
147664858|NCT00496769|532597934|FG001|Open Label|>=1 reason assigned per patient|0|||
147664859|NCT00496769|532597935|FG002|Open Label|>=1 reason assigned per patient|1011|||
147664860|NCT03028142|532597936|FG000|Overall Study|Adverse Event|1|||
147664861|NCT03028142|532597937|FG001|Overall Study|Adverse Event|1|||
147664862|NCT03028142|532597938|FG002|Overall Study|Adverse Event|0|||
147664863|NCT03028142|532597939|FG003|Overall Study|Adverse Event|0|||
147664864|NCT03028142|532597940|FG004|Overall Study|Adverse Event|0|||
147378440|NCT03769090|531550660|FG002|Overall Study|Randomized and did not receive randomized study treatment|2|||
147378441|NCT03769090|531550658|FG000|Overall Study|Withdrawal by Subject|52|||
147378442|NCT03769090|531550659|FG001|Overall Study|Withdrawal by Subject|62|||
147378443|NCT03769090|531550660|FG002|Overall Study|Withdrawal by Subject|74|||
147378444|NCT03769090|531550658|FG000|Overall Study|Death|4|||
147378445|NCT03769090|531550659|FG001|Overall Study|Death|2|||
147378446|NCT03769090|531550660|FG002|Overall Study|Death|2|||
147378447|NCT03769090|531550658|FG000|Overall Study|Adverse Event|7|||
147378448|NCT03769090|531550659|FG001|Overall Study|Adverse Event|7|||
147378449|NCT03769090|531550660|FG002|Overall Study|Adverse Event|8|||
147378450|NCT03769090|531550658|FG000|Overall Study|A single severe exacerbation event lasting >20 days|0|||
147378451|NCT03769090|531550659|FG001|Overall Study|A single severe exacerbation event lasting >20 days|1|||
147378452|NCT03769090|531550660|FG002|Overall Study|A single severe exacerbation event lasting >20 days|2|||
147378453|NCT03769090|531550658|FG000|Overall Study|>= 3 severe exacerbation events within a 3 month period|1|||
147378454|NCT03769090|531550659|FG001|Overall Study|>= 3 severe exacerbation events within a 3 month period|4|||
147378455|NCT03769090|531550660|FG002|Overall Study|>= 3 severe exacerbation events within a 3 month period|4|||
147378456|NCT03769090|531550658|FG000|Overall Study|>= 5 total severe exacerbation events|0|||
147378457|NCT03769090|531550659|FG001|Overall Study|>= 5 total severe exacerbation events|1|||
147378458|NCT03769090|531550660|FG002|Overall Study|>= 5 total severe exacerbation events|1|||
147378459|NCT03769090|531550658|FG000|Overall Study|Protocol Violation|5|||
147378460|NCT03769090|531550659|FG001|Overall Study|Protocol Violation|6|||
147378461|NCT03769090|531550660|FG002|Overall Study|Protocol Violation|8|||
147378462|NCT03769090|531550658|FG000|Overall Study|Pregnancy|1|||
147378463|NCT03769090|531550659|FG001|Overall Study|Pregnancy|0|||
147378464|NCT03769090|531550660|FG002|Overall Study|Pregnancy|3|||
147378465|NCT03769090|531550658|FG000|Overall Study|Lost to Follow-up|19|||
147664865|NCT03028142|532597941|FG005|Overall Study|Adverse Event|1|||
147664866|NCT03028142|532597936|FG000|Overall Study|Withdrawal by Subject|0|||
147664867|NCT03028142|532597937|FG001|Overall Study|Withdrawal by Subject|0|||
147664868|NCT03028142|532597938|FG002|Overall Study|Withdrawal by Subject|0|||
147664869|NCT03028142|532597939|FG003|Overall Study|Withdrawal by Subject|0|||
147664870|NCT03028142|532597940|FG004|Overall Study|Withdrawal by Subject|1|||
147664871|NCT03028142|532597941|FG005|Overall Study|Withdrawal by Subject|0|||
147664872|NCT02810418|532597945|FG000|Arm A Dose Escalation|Adverse Event|2|||
147664873|NCT02810418|532597946|FG001|Arm A Dose Escalation|Adverse Event|1|||
147664874|NCT02810418|532597947|FG002|Arm A Dose Escalation|Adverse Event|0|||
147378466|NCT03769090|531550659|FG001|Overall Study|Lost to Follow-up|25|||
147378467|NCT03769090|531550660|FG002|Overall Study|Lost to Follow-up|21|||
147378468|NCT03769090|531550658|FG000|Overall Study|Condition under investigation worsened|2|||
147378469|NCT03769090|531550659|FG001|Overall Study|Condition under investigation worsened|0|||
147378470|NCT03769090|531550660|FG002|Overall Study|Condition under investigation worsened|1|||
147378471|NCT03769090|531550658|FG000|Overall Study|Lack of Efficacy|1|||
147378472|NCT03769090|531550659|FG001|Overall Study|Lack of Efficacy|2|||
147378473|NCT03769090|531550660|FG002|Overall Study|Lack of Efficacy|2|||
147378474|NCT03769090|531550658|FG000|Overall Study|Other reasons|8|||
147378475|NCT03769090|531550659|FG001|Overall Study|Other reasons|12|||
147612652|NCT05026177|532397095|FG002|Overall Study|Withdrawal by Subject|55|||
147612653|NCT05026177|532397093|FG000|Overall Study|Protocol Violation|0|||
147612654|NCT05026177|532397094|FG001|Overall Study|Protocol Violation|1|||
147612655|NCT05026177|532397095|FG002|Overall Study|Protocol Violation|0|||
147612656|NCT05026177|532397093|FG000|Overall Study|Study terminated by sponsor|70|||
147612657|NCT05026177|532397094|FG001|Overall Study|Study terminated by sponsor|74|||
147612658|NCT05026177|532397095|FG002|Overall Study|Study terminated by sponsor|67|||
147612659|NCT05026177|532397093|FG000|Overall Study|Unavailability/noncompliance of study partner|2|||
147612660|NCT05026177|532397094|FG001|Overall Study|Unavailability/noncompliance of study partner|1|||
147612661|NCT05026177|532397095|FG002|Overall Study|Unavailability/noncompliance of study partner|1|||
147612662|NCT05026177|532397093|FG000|Overall Study|Starting alternative treatment|0|||
147612663|NCT05026177|532397094|FG001|Overall Study|Starting alternative treatment|1|||
147612664|NCT05026177|532397095|FG002|Overall Study|Starting alternative treatment|1|||
147612665|NCT05026177|532397093|FG000|Overall Study|Noncompliance with study procedures|0|||
147612666|NCT05026177|532397094|FG001|Overall Study|Noncompliance with study procedures|1|||
147612667|NCT05026177|532397095|FG002|Overall Study|Noncompliance with study procedures|1|||
147612668|NCT05026177|532397093|FG000|Overall Study|Met stopping criteria|0|||
147612669|NCT05026177|532397094|FG001|Overall Study|Met stopping criteria|0|||
147612670|NCT05026177|532397095|FG002|Overall Study|Met stopping criteria|1|||
147378476|NCT03769090|531550660|FG002|Overall Study|Other reasons|15|||
147378477|NCT03964974|531550661|FG000|Overall Study|Lost to Follow-up|3|||
147378478|NCT03964974|531550662|FG001|Overall Study|Lost to Follow-up|2|||
147378479|NCT03964974|531550661|FG000|Overall Study|Withdrawal by Subject|0|||
147378480|NCT03964974|531550662|FG001|Overall Study|Withdrawal by Subject|3|||
147378481|NCT02713594|531550663|FG000|Overall Study|Withdrawal by Subject|32|||
147378482|NCT02713594|531550664|FG001|Overall Study|Withdrawal by Subject|22|||
147378483|NCT02713594|531550663|FG000|Overall Study|Lost to Follow-up|358|||
147378484|NCT02713594|531550664|FG001|Overall Study|Lost to Follow-up|374|||
147378485|NCT02660086|531550665|FG000|Overall Study- 12-month|Withdrawal by Subject|5|||
147378486|NCT02660086|531550666|FG001|Overall Study- 12-month|Withdrawal by Subject|5|||
147378487|NCT02660086|531550665|FG000|Overall Study- 12-month|Left full-time employment|12|||
147378488|NCT02660086|531550666|FG001|Overall Study- 12-month|Left full-time employment|20|||
147378489|NCT02660086|531550665|FG000|Overall Study- 12-month|Missed 12-month follow-up visit|8|||
147378490|NCT02660086|531550666|FG001|Overall Study- 12-month|Missed 12-month follow-up visit|4|||
147378491|NCT02660086|531550665|FG000|Overall Study- 12-month|Became ineligible: new job in cafeteria|1|||
147378492|NCT02660086|531550666|FG001|Overall Study- 12-month|Became ineligible: new job in cafeteria|0|||
147378493|NCT02660086|531550665|FG000|Overall Study: 24-month Follow-up|Left employment after 12 months|17|||
147378494|NCT02660086|531550666|FG001|Overall Study: 24-month Follow-up|Left employment after 12 months|8|||
147378495|NCT02660086|531550665|FG000|Overall Study: 24-month Follow-up|Missed 24-month follow-up|9|||
147378496|NCT02660086|531550666|FG001|Overall Study: 24-month Follow-up|Missed 24-month follow-up|16|||
147378497|NCT05005247|531550672|FG000|Overall Study|Withdrawal by Subject|0|||
147378498|NCT05005247|531550673|FG001|Overall Study|Withdrawal by Subject|1|||
147378499|NCT05005247|531550674|FG002|Overall Study|Withdrawal by Subject|0|||
147378500|NCT01450007|531550675|FG000|Overall Study|Late exclusion before treatment|2|||
147378501|NCT01450007|531550676|FG001|Overall Study|Late exclusion before treatment|3|||
147378502|NCT01450007|531550677|FG002|Overall Study|Late exclusion before treatment|2|||
147378503|NCT01450007|531550675|FG000|Overall Study|Protocol Violation|0|||
147378504|NCT01450007|531550676|FG001|Overall Study|Protocol Violation|1|||
147378505|NCT01450007|531550677|FG002|Overall Study|Protocol Violation|1|||
147378506|NCT01450007|531550675|FG000|Overall Study|Adverse Event|0|||
147378507|NCT01450007|531550676|FG001|Overall Study|Adverse Event|1|||
147378508|NCT01450007|531550677|FG002|Overall Study|Adverse Event|0|||
147455977|NCT00403260|531831646|FG001|Overall Study|Mixed infection with P. falciparum|0|||
147612671|NCT05026177|532397093|FG000|Overall Study|Health issues preventing continuation|0|||
147612672|NCT05026177|532397094|FG001|Overall Study|Health issues preventing continuation|0|||
147612673|NCT05026177|532397095|FG002|Overall Study|Health issues preventing continuation|1|||
147612674|NCT05026177|532397093|FG000|Overall Study|Randomized in error, not treated|0|||
147612675|NCT05026177|532397094|FG001|Overall Study|Randomized in error, not treated|0|||
147612676|NCT05026177|532397095|FG002|Overall Study|Randomized in error, not treated|2|||
147378509|NCT02958553|531550678|FG000|Phase I, 3rd Visit -2 Week emPOWER FU|Withdrawal by Subject|1|||
147378510|NCT02958553|531550678|FG000|Phase II, 6th Visit -6 Month emPOWER FU|Adverse Event|2|||
147378511|NCT00273052|531550692|FG000|Overall Study|Withdrawal by Subject|16|||
147378512|NCT00273052|531550693|FG001|Overall Study|Withdrawal by Subject|19|||
147378513|NCT00273052|531550692|FG000|Overall Study|Adverse Event|21|||
147378514|NCT00273052|531550693|FG001|Overall Study|Adverse Event|19|||
147378515|NCT00273052|531550692|FG000|Overall Study|Protocol Violation|14|||
147612677|NCT03816878|532397102|FG000|Overall Study|Taken off study after Day 28 due to unrelated serious adverse event requiring hospitalization|1|||
147612678|NCT03816878|532397103|FG001|Overall Study|Taken off study after Day 28 due to unrelated serious adverse event requiring hospitalization|0|||
147612679|NCT03816878|532397102|FG000|Overall Study|Volunteer taken off study due to incarceration|0|||
147378516|NCT00273052|531550693|FG001|Overall Study|Protocol Violation|18|||
147378517|NCT00273052|531550692|FG000|Overall Study|Lost to Follow-up|7|||
147378518|NCT00273052|531550693|FG001|Overall Study|Lost to Follow-up|25|||
147378519|NCT00273052|531550692|FG000|Overall Study|Lack of Efficacy|6|||
147378520|NCT00273052|531550693|FG001|Overall Study|Lack of Efficacy|4|||
147612680|NCT03816878|532397103|FG001|Overall Study|Volunteer taken off study due to incarceration|1|||
147612681|NCT03355469|532397104|FG000|Overall Study|COVID-19|3|||
147612682|NCT03355469|532397105|FG001|Overall Study|COVID-19|2|||
147612683|NCT03355469|532397106|FG002|Overall Study|COVID-19|3|||
147378521|NCT00273052|531550692|FG000|Overall Study|Non-Compliance|3|||
147378522|NCT00273052|531550693|FG001|Overall Study|Non-Compliance|1|||
147378523|NCT00273052|531550692|FG000|Overall Study|Other|2|||
147378524|NCT00273052|531550693|FG001|Overall Study|Other|0|||
147378525|NCT00273052|531550692|FG000|Overall Study|Worsening serum lipid levels|0|||
147378526|NCT00273052|531550693|FG001|Overall Study|Worsening serum lipid levels|2|||
147378527|NCT02224755|531550694|FG000|Randomization to Device Implant|Withdrawn prior to implant|7|||
147612684|NCT03355469|532397107|FG003|Overall Study|COVID-19|3|||
147612685|NCT03355469|532397104|FG000|Overall Study|Lost to Follow-up|1|||
147612686|NCT03355469|532397105|FG001|Overall Study|Lost to Follow-up|0|||
147612687|NCT03355469|532397106|FG002|Overall Study|Lost to Follow-up|1|||
147612688|NCT03355469|532397107|FG003|Overall Study|Lost to Follow-up|0|||
147612689|NCT03355469|532397104|FG000|Overall Study|Withdrawal by Subject|2|||
147612690|NCT03355469|532397105|FG001|Overall Study|Withdrawal by Subject|1|||
147612691|NCT03355469|532397106|FG002|Overall Study|Withdrawal by Subject|0|||
147612692|NCT03355469|532397107|FG003|Overall Study|Withdrawal by Subject|3|||
147612693|NCT05626231|532397108|FG000|Provider Enrollment|Worked part-time|4|||
147612694|NCT05626231|532397108|FG000|Provider Enrollment|On leave (e.g., parental leave)|3|||
147612695|NCT05626231|532397108|FG000|Provider Enrollment|Non-clinical employee|1|||
147612696|NCT05626231|532397108|FG000|Provider Enrollment|Provider does not see clients|3|||
147612697|NCT05626231|532397108|FG000|Provider Enrollment|Other|5|||
147612698|NCT03765788|532397110|FG000|Overall Study|Subject decision|2|||
147612699|NCT03765788|532397111|FG001|Overall Study|Subject decision|3|||
147612700|NCT03765788|532397110|FG000|Overall Study|Physician Decision|2|||
147612701|NCT03765788|532397111|FG001|Overall Study|Physician Decision|4|||
147378528|NCT02224755|531550695|FG001|Randomization to Device Implant|Withdrawn prior to implant|1|||
147378529|NCT02224755|531550694|FG000|Two Year Follow up Post-implant|Death|103|||
147378530|NCT02224755|531550695|FG001|Two Year Follow up Post-implant|Death|98|||
147378531|NCT02224755|531550694|FG000|Two Year Follow up Post-implant|Heart transplant|137|||
147378532|NCT02224755|531550695|FG001|Two Year Follow up Post-implant|Heart transplant|119|||
147378533|NCT02224755|531550694|FG000|Two Year Follow up Post-implant|Device explant or permanent deactivation|3|||
147378534|NCT02224755|531550695|FG001|Two Year Follow up Post-implant|Device explant or permanent deactivation|3|||
147378535|NCT02224755|531550694|FG000|Two Year Follow up Post-implant|Withdrawn post-implant|15|||
147455978|NCT00403260|531831645|FG000|Overall Study|P. vivax infection at screening|1|||
147455979|NCT00403260|531831646|FG001|Overall Study|P. vivax infection at screening|0|||
147455980|NCT00403260|531831645|FG000|Overall Study|P. ovale infection|1|||
147455981|NCT00403260|531831646|FG001|Overall Study|P. ovale infection|0|||
147455982|NCT00403260|531831645|FG000|Overall Study|Gametocyte re-appearance|1|||
147455983|NCT00403260|531831646|FG001|Overall Study|Gametocyte re-appearance|1|||
147455984|NCT00403260|531831645|FG000|Overall Study|Withdrawn from study accidentally|0|||
147455985|NCT00403260|531831646|FG001|Overall Study|Withdrawn from study accidentally|1|||
147455986|NCT04137887|531831649|FG000|Overall Study|Death|102|||
147455987|NCT04137887|531831650|FG001|Overall Study|Death|92|||
147455988|NCT04137887|531831649|FG000|Overall Study|Withdrawal by Subject|2|||
147455989|NCT04137887|531831650|FG001|Overall Study|Withdrawal by Subject|3|||
147455990|NCT04137887|531831649|FG000|Overall Study|Randomized but not treated|0|||
147455991|NCT04137887|531831650|FG001|Overall Study|Randomized but not treated|1|||
147612702|NCT03765788|532397110|FG000|Overall Study|Death|0|||
147612703|NCT03765788|532397111|FG001|Overall Study|Death|1|||
147612704|NCT03765788|532397110|FG000|Overall Study|Lost to Follow-up|1|||
147612705|NCT03765788|532397111|FG001|Overall Study|Lost to Follow-up|0|||
147612706|NCT03203850|532397112|FG000|Overall Study|Subject/guardian decision|4|||
147612707|NCT03203850|532397113|FG001|Overall Study|Subject/guardian decision|3|||
147612708|NCT03203850|532397112|FG000|Overall Study|Adverse Event|3|||
147378536|NCT02224755|531550695|FG001|Two Year Follow up Post-implant|Withdrawn post-implant|6|||
147378537|NCT01951703|531550696|FG000|First Intervention|Withdrawal by Subject|1|||
147378538|NCT01951703|531550697|FG001|First Intervention|Withdrawal by Subject|0|||
147612709|NCT03203850|532397113|FG001|Overall Study|Adverse Event|0|||
147612710|NCT03203850|532397112|FG000|Overall Study|Death|1|||
147612711|NCT03203850|532397113|FG001|Overall Study|Death|0|||
147378539|NCT01951703|531550696|FG000|First Intervention|Subject was not compliant|1|||
147378540|NCT01951703|531550697|FG001|First Intervention|Subject was not compliant|1|||
147378541|NCT01951703|531550696|FG000|First Intervention|Physician Decision|1|||
147378542|NCT01951703|531550697|FG001|First Intervention|Physician Decision|0|||
147378543|NCT01951703|531550696|FG000|Second Intervention|Protocol Violation|0|||
147378544|NCT01951703|531550697|FG001|Second Intervention|Protocol Violation|1|||
147378545|NCT01951703|531550696|FG000|Second Intervention|Unsatisfactory Lens fitting|0|||
147378546|NCT01951703|531550697|FG001|Second Intervention|Unsatisfactory Lens fitting|1|||
147378547|NCT02736188|531550700|FG000|Overall Study|Discontinuation of Study by Sponsor|134|||
147378548|NCT02736188|531550700|FG000|Overall Study|Adverse Event|1|||
147378549|NCT02736188|531550700|FG000|Overall Study|Withdrawal by Subject|1|||
147378550|NCT02736188|531550700|FG000|Overall Study|Other|6|||
147378551|NCT00240994|531550701|FG000|Overall Study|Lost to Follow-up|1|||
147378552|NCT00240994|531550701|FG000|Overall Study|Protocol Violation|1|||
147378553|NCT00240994|531550701|FG000|Overall Study|Graft failure|1|||
147378554|NCT02630186|531550702|FG000|Overall Study|Withdrawal by Subject|1|||
147378555|NCT00439218|531550703|FG000|Cohort 1 (500 mg/kg/Day)|Less than 80% study drug compliance|1|||
147378556|NCT03176407|531550704|FG000|Overall Study|Protocol Violation|1|||
147378557|NCT03176407|531550704|FG000|Overall Study|human failure|1|||
147378558|NCT03176407|531550704|FG000|Overall Study|EGD showed esophageal varices=excl. crit|1|||
147378559|NCT01428583|531550705|FG000|Overall Study|Adverse Event|75|||
147378560|NCT01428583|531550705|FG000|Overall Study|Withdrawal by Subject|51|||
147378561|NCT01428583|531550705|FG000|Overall Study|Lack of Efficacy|37|||
147378562|NCT01428583|531550705|FG000|Overall Study|Lost to Follow-up|17|||
147378563|NCT01428583|531550705|FG000|Overall Study|Death|1|||
147378564|NCT01428583|531550705|FG000|Overall Study|Pregnancy|1|||
147378565|NCT01428583|531550705|FG000|Overall Study|Protocol Violation|1|||
147378566|NCT01428583|531550705|FG000|Overall Study|Physician Decision|12|||
147378567|NCT01428583|531550705|FG000|Overall Study|Non-compliant|25|||
147378568|NCT01428583|531550705|FG000|Overall Study|Confirmed positive urine drug test|8|||
147378569|NCT01428583|531550705|FG000|Overall Study|Sponsor's request|3|||
147378570|NCT01428583|531550705|FG000|Overall Study|Other|6|||
147378571|NCT05124210|531550706|FG000|Overall Study|Lost to Follow-up|1|||
147378572|NCT05124210|531550707|FG001|Overall Study|Lost to Follow-up|0|||
147378573|NCT05124210|531550706|FG000|Overall Study|Withdrawal by Subject|1|||
147378574|NCT05124210|531550707|FG001|Overall Study|Withdrawal by Subject|0|||
147378575|NCT00768755|531550708|FG000|Phase 1|Death|6|||
147378576|NCT00768755|531550709|FG001|Phase 1|Death|0|||
147378577|NCT00768755|531550710|FG002|Phase 1|Death|0|||
147378578|NCT00768755|531550711|FG003|Phase 1|Death|0|||
147378579|NCT00768755|531550708|FG000|Phase 1|Other|4|||
147378580|NCT00768755|531550709|FG001|Phase 1|Other|0|||
147378581|NCT00768755|531550710|FG002|Phase 1|Other|0|||
147378582|NCT00768755|531550711|FG003|Phase 1|Other|0|||
147378583|NCT00768755|531550708|FG000|Phase 2|Death|0|||
147378584|NCT00768755|531550709|FG001|Phase 2|Death|37|||
147378585|NCT00768755|531550710|FG002|Phase 2|Death|48|||
147378586|NCT00768755|531550711|FG003|Phase 2|Death|31|||
147378587|NCT00768755|531550708|FG000|Phase 2|Protocol Violation|0|||
147378588|NCT00768755|531550709|FG001|Phase 2|Protocol Violation|2|||
147378589|NCT00768755|531550710|FG002|Phase 2|Protocol Violation|0|||
147378590|NCT00768755|531550711|FG003|Phase 2|Protocol Violation|1|||
147378591|NCT00768755|531550708|FG000|Phase 2|Lost to Follow-up|0|||
147378592|NCT00768755|531550709|FG001|Phase 2|Lost to Follow-up|1|||
147378593|NCT00768755|531550710|FG002|Phase 2|Lost to Follow-up|1|||
147378594|NCT00768755|531550711|FG003|Phase 2|Lost to Follow-up|4|||
147378595|NCT00768755|531550708|FG000|Phase 2|Withdrawal by Subject|0|||
147378596|NCT00768755|531550709|FG001|Phase 2|Withdrawal by Subject|1|||
147378597|NCT00768755|531550710|FG002|Phase 2|Withdrawal by Subject|0|||
147378598|NCT00768755|531550711|FG003|Phase 2|Withdrawal by Subject|1|||
147378599|NCT00768755|531550708|FG000|Phase 2|Other|0|||
147378600|NCT00768755|531550709|FG001|Phase 2|Other|1|||
147378601|NCT00768755|531550710|FG002|Phase 2|Other|2|||
147378602|NCT00768755|531550711|FG003|Phase 2|Other|4|||
147378603|NCT00768755|531550708|FG000|Phase 2|Study Terminated by Sponsor|0|||
147378604|NCT00768755|531550709|FG001|Phase 2|Study Terminated by Sponsor|13|||
147378605|NCT00768755|531550710|FG002|Phase 2|Study Terminated by Sponsor|7|||
147378606|NCT00768755|531550711|FG003|Phase 2|Study Terminated by Sponsor|14|||
147378607|NCT00768755|531550708|FG000|Phase 2|Randomized but not treated|0|||
147378608|NCT00768755|531550709|FG001|Phase 2|Randomized but not treated|0|||
147378609|NCT00768755|531550710|FG002|Phase 2|Randomized but not treated|0|||
147378610|NCT00768755|531550711|FG003|Phase 2|Randomized but not treated|2|||
147378611|NCT03142932|531550712|FG000|Overall Study|Lost to Follow-up|2|||
147378612|NCT03142932|531550713|FG001|Overall Study|Lost to Follow-up|11|||
147378613|NCT02128269|531550714|FG000|Treatment Period|Adverse Event|1|||
147378614|NCT02128269|531550714|FG000|Treatment Period|Physician Decision|1|||
147378615|NCT00878189|531550715|FG000|Overall Study|Death|0|||
147378616|NCT00878189|531550716|FG001|Overall Study|Death|1|||
147378617|NCT00878189|531550717|FG002|Overall Study|Death|0|||
147378618|NCT00878189|531550718|FG003|Overall Study|Death|1|||
147378619|NCT00878189|531550719|FG004|Overall Study|Death|0|||
147378620|NCT00878189|531550720|FG005|Overall Study|Death|0|||
147378621|NCT00878189|531550721|FG006|Overall Study|Death|0|||
147378622|NCT00878189|531550722|FG007|Overall Study|Death|0|||
147378623|NCT00878189|531550723|FG008|Overall Study|Death|1|||
147378624|NCT00878189|531550715|FG000|Overall Study|Participant Refused to Follow-up|0|||
147378625|NCT00878189|531550716|FG001|Overall Study|Participant Refused to Follow-up|0|||
147378626|NCT00878189|531550717|FG002|Overall Study|Participant Refused to Follow-up|0|||
147378627|NCT00878189|531550718|FG003|Overall Study|Participant Refused to Follow-up|0|||
147378628|NCT00878189|531550719|FG004|Overall Study|Participant Refused to Follow-up|0|||
147378629|NCT00878189|531550720|FG005|Overall Study|Participant Refused to Follow-up|4|||
147378630|NCT00878189|531550721|FG006|Overall Study|Participant Refused to Follow-up|0|||
147378631|NCT00878189|531550722|FG007|Overall Study|Participant Refused to Follow-up|0|||
147378632|NCT00878189|531550723|FG008|Overall Study|Participant Refused to Follow-up|0|||
147378633|NCT00878189|531550715|FG000|Overall Study|Other|3|||
147378634|NCT00878189|531550716|FG001|Overall Study|Other|2|||
147378635|NCT00878189|531550717|FG002|Overall Study|Other|4|||
147378636|NCT00878189|531550718|FG003|Overall Study|Other|7|||
147378637|NCT00878189|531550719|FG004|Overall Study|Other|4|||
147378638|NCT00878189|531550720|FG005|Overall Study|Other|18|||
147378639|NCT00878189|531550721|FG006|Overall Study|Other|15|||
147378640|NCT00878189|531550722|FG007|Overall Study|Other|3|||
147378641|NCT00878189|531550723|FG008|Overall Study|Other|4|||
147378642|NCT00878189|531550715|FG000|Overall Study|Lost to Follow-up|0|||
147378643|NCT00878189|531550716|FG001|Overall Study|Lost to Follow-up|0|||
147378644|NCT00878189|531550717|FG002|Overall Study|Lost to Follow-up|0|||
147378645|NCT00878189|531550718|FG003|Overall Study|Lost to Follow-up|0|||
147378646|NCT00878189|531550719|FG004|Overall Study|Lost to Follow-up|0|||
147378647|NCT00878189|531550720|FG005|Overall Study|Lost to Follow-up|1|||
147378648|NCT00878189|531550721|FG006|Overall Study|Lost to Follow-up|1|||
147378649|NCT00878189|531550722|FG007|Overall Study|Lost to Follow-up|0|||
147378650|NCT00878189|531550723|FG008|Overall Study|Lost to Follow-up|0|||
147378651|NCT00878189|531550715|FG000|Overall Study|Objection Progression or Relapse|0|||
147378652|NCT00878189|531550716|FG001|Overall Study|Objection Progression or Relapse|0|||
147378653|NCT00878189|531550717|FG002|Overall Study|Objection Progression or Relapse|0|||
147378654|NCT00878189|531550718|FG003|Overall Study|Objection Progression or Relapse|0|||
147378655|NCT00878189|531550719|FG004|Overall Study|Objection Progression or Relapse|0|||
147378656|NCT00878189|531550720|FG005|Overall Study|Objection Progression or Relapse|0|||
147378657|NCT00878189|531550721|FG006|Overall Study|Objection Progression or Relapse|0|||
147378658|NCT00878189|531550722|FG007|Overall Study|Objection Progression or Relapse|0|||
147378659|NCT00878189|531550723|FG008|Overall Study|Objection Progression or Relapse|3|||
147378660|NCT01640288|531550724|FG000|Overall Study|Equipment Failure or Poor Image Quality|4|||
147378661|NCT01640288|531550725|FG001|Overall Study|Equipment Failure or Poor Image Quality|5|||
147378662|NCT01640288|531550724|FG000|Overall Study|Screen Failure|20|||
147378663|NCT01640288|531550725|FG001|Overall Study|Screen Failure|18|||
147378664|NCT01640288|531550724|FG000|Overall Study|Withdrawn by PI|5|||
147378665|NCT01640288|531550725|FG001|Overall Study|Withdrawn by PI|0|||
147378666|NCT01640288|531550724|FG000|Overall Study|Withdrawal by Subject|1|||
147455992|NCT05064059|531831652|FG000|Overall Study|Death|199|||
147455993|NCT05064059|531831653|FG001|Overall Study|Death|196|||
147455994|NCT05064059|531831652|FG000|Overall Study|Physician Decision|4|||
147455995|NCT05064059|531831653|FG001|Overall Study|Physician Decision|2|||
147455996|NCT05064059|531831652|FG000|Overall Study|Sponsor Decision|14|||
147455997|NCT05064059|531831653|FG001|Overall Study|Sponsor Decision|11|||
147455998|NCT05064059|531831652|FG000|Overall Study|Withdrawal by Subject|4|||
147455999|NCT05064059|531831653|FG001|Overall Study|Withdrawal by Subject|11|||
147456000|NCT02740478|531831654|FG000|Overall Study|Withdrawal by Subject|1|||
147456001|NCT02615990|531831656|FG000|Overall Study|study terminated|1|||
147456002|NCT02615990|531831657|FG001|Overall Study|study terminated|1|||
147456003|NCT04316585|531831658|FG000|Overall Study|Adverse Event|2|||
147378667|NCT01640288|531550725|FG001|Overall Study|Withdrawal by Subject|0|||
147378668|NCT00787176|531550727|FG000|Overall Study|Low quality fetal heart rate tracing|7|||
147378669|NCT00787176|531550728|FG001|Overall Study|Low quality fetal heart rate tracing|3|||
147378670|NCT00787176|531550729|FG002|Overall Study|Low quality fetal heart rate tracing|6|||
147456004|NCT04316585|531831659|FG001|Overall Study|Adverse Event|1|||
147456005|NCT04316585|531831658|FG000|Overall Study|Lost to Follow-up|1|||
147456006|NCT04316585|531831659|FG001|Overall Study|Lost to Follow-up|0|||
147456007|NCT04316585|531831658|FG000|Overall Study|Withdrawal by Subject|2|||
147664875|NCT02810418|532597948|FG003|Arm A Dose Escalation|Adverse Event|0|||
147378671|NCT00787176|531550730|FG003|Overall Study|Low quality fetal heart rate tracing|5|||
147378672|NCT00895245|531550736|FG000|Overall Study|Lack of Efficacy|6|||
147378673|NCT02095678|531550737|FG000|Overall Study|Withdrawal by Subject|0|||
147378674|NCT02095678|531550738|FG001|Overall Study|Withdrawal by Subject|1|||
147378675|NCT02095678|531550737|FG000|Overall Study|Omitted for Severe Image Artifacts or Patient Non-compliance|11|||
147378676|NCT02095678|531550738|FG001|Overall Study|Omitted for Severe Image Artifacts or Patient Non-compliance|12|||
147378677|NCT02095678|531550737|FG000|Overall Study|lesion impacted by previous treatment|1|||
147456008|NCT04316585|531831659|FG001|Overall Study|Withdrawal by Subject|3|||
147378678|NCT02095678|531550738|FG001|Overall Study|lesion impacted by previous treatment|1|||
147378679|NCT02095678|531550737|FG000|Overall Study|No Confirmed Diagnosis|0|||
147378680|NCT02095678|531550738|FG001|Overall Study|No Confirmed Diagnosis|3|||
147378681|NCT02095678|531550737|FG000|Overall Study|Malignant lesions not HCC nor Metastatic|1|||
147378682|NCT02095678|531550738|FG001|Overall Study|Malignant lesions not HCC nor Metastatic|1|||
147378683|NCT02095678|531550737|FG000|Overall Study|No Visible Lesion or Pathological Finding|4|||
147378684|NCT02095678|531550738|FG001|Overall Study|No Visible Lesion or Pathological Finding|0|||
147378685|NCT00681109|531550739|FG000|Overall Study|Lost to Follow-up|2|||
147378686|NCT00681109|531550740|FG001|Overall Study|Lost to Follow-up|6|||
147378687|NCT00681109|531550741|FG002|Overall Study|Lost to Follow-up|0|||
147378688|NCT02706483|531550742|FG000|Overall Study|Adverse Event|97|||
147378689|NCT02706483|531550742|FG000|Overall Study|Death|1|||
147378690|NCT02706483|531550742|FG000|Overall Study|Lack of Efficacy|39|||
147378691|NCT02706483|531550742|FG000|Overall Study|Lost to Follow-up|101|||
147378692|NCT02706483|531550742|FG000|Overall Study|Non-compliance with study drug|15|||
147378693|NCT02706483|531550742|FG000|Overall Study|Physician Decision|6|||
147378694|NCT02706483|531550742|FG000|Overall Study|Pregnancy|6|||
147378695|NCT02706483|531550742|FG000|Overall Study|Protocol Violation|18|||
147378696|NCT02706483|531550742|FG000|Overall Study|Withdrawal by Subject|136|||
147378697|NCT02706483|531550742|FG000|Overall Study|Non-compliance with visits|6|||
147378698|NCT02706483|531550742|FG000|Overall Study|Site closure|4|||
147378699|NCT02706483|531550742|FG000|Overall Study|Subject moved|1|||
147378700|NCT04660799|531550743|FG000|Overall Study|Progressive Disease|1|||
147378701|NCT04660799|531550744|FG001|Overall Study|Progressive Disease|1|||
147378702|NCT04660799|531550743|FG000|Overall Study|Death|2|||
147378703|NCT04660799|531550744|FG001|Overall Study|Death|1|||
147378704|NCT04660799|531550743|FG000|Overall Study|Adverse Event|2|||
147378705|NCT04660799|531550744|FG001|Overall Study|Adverse Event|1|||
147378706|NCT04660799|531550743|FG000|Overall Study|Withdrawal by Subject|2|||
147378707|NCT04660799|531550744|FG001|Overall Study|Withdrawal by Subject|5|||
147378708|NCT03131713|531550747|FG000|Overall Study|Lost to Follow-up|5|||
147378709|NCT03131713|531550748|FG001|Overall Study|Lost to Follow-up|0|||
147378710|NCT02382640|531550758|FG000|Intervention Period 4 (3 Days)|Laboratory Abnormality|1|||
147378711|NCT02382640|531550759|FG001|Intervention Period 4 (3 Days)|Laboratory Abnormality|0|||
147378712|NCT02382640|531550760|FG002|Intervention Period 4 (3 Days)|Laboratory Abnormality|0|||
147378713|NCT02382640|531550761|FG003|Intervention Period 4 (3 Days)|Laboratory Abnormality|0|||
147378714|NCT01560429|531550762|FG000|Overall Study|Protocol Violation|3|||
147378715|NCT01560429|531550763|FG001|Overall Study|Protocol Violation|6|||
147378716|NCT01638000|531550767|FG000|Overall Study|Randomized but Never Received Drug|7|||
147378717|NCT01638000|531550768|FG001|Overall Study|Randomized but Never Received Drug|10|||
147378718|NCT01638000|531550767|FG000|Overall Study|Adverse Event|14|||
147378719|NCT01638000|531550768|FG001|Overall Study|Adverse Event|16|||
147378720|NCT01638000|531550767|FG000|Overall Study|Lack of Efficacy|5|||
147378721|NCT01638000|531550768|FG001|Overall Study|Lack of Efficacy|6|||
147378722|NCT01638000|531550767|FG000|Overall Study|Protocol Violation|11|||
147378723|NCT01638000|531550768|FG001|Overall Study|Protocol Violation|13|||
147378724|NCT01638000|531550767|FG000|Overall Study|Withdrawal by Subject|21|||
147378725|NCT01638000|531550768|FG001|Overall Study|Withdrawal by Subject|24|||
147378726|NCT01638000|531550767|FG000|Overall Study|Miscellaneous|2|||
147378727|NCT01638000|531550768|FG001|Overall Study|Miscellaneous|2|||
147378728|NCT05484661|531550769|FG000|Overall Study|Withdrawal by Subject|1|||
147378729|NCT05484661|531550770|FG001|Overall Study|Withdrawal by Subject|0|||
147378730|NCT00570505|531550773|FG000|Overall Study|Adverse Event|7|||
147378731|NCT00570505|531550773|FG000|Overall Study|Withdrawal by Subject|7|||
147378732|NCT00570505|531550773|FG000|Overall Study|Lost to Follow-up|23|||
147378733|NCT00570505|531550773|FG000|Overall Study|Other loss to follow-up|4|||
147378734|NCT03905642|531550777|FG000|Overall Study|Withdrawal by Subject|3|||
147378735|NCT03905642|531550777|FG000|Overall Study|Pregnancy|1|||
147378736|NCT03905642|531550777|FG000|Overall Study|Adverse Event|1|||
147378737|NCT03905642|531550777|FG000|Overall Study|Lack of Efficacy|1|||
147378738|NCT03905642|531550777|FG000|Overall Study|Completed study but not 24 of 28 days|2|||
147378739|NCT02159989|531550778|FG000|Overall Study|Adverse Event|1|||
147378740|NCT02159989|531550779|FG001|Overall Study|Adverse Event|0|||
147378741|NCT02159989|531550780|FG002|Overall Study|Adverse Event|0|||
147378742|NCT02159989|531550781|FG003|Overall Study|Adverse Event|0|||
147378743|NCT02159989|531550782|FG004|Overall Study|Adverse Event|1|||
147378744|NCT02159989|531550783|FG005|Overall Study|Adverse Event|0|||
147378745|NCT02159989|531550784|FG006|Overall Study|Adverse Event|1|||
147378746|NCT02159989|531550785|FG007|Overall Study|Adverse Event|2|||
147378747|NCT02159989|531550786|FG008|Overall Study|Adverse Event|0|||
147378748|NCT02159989|531550787|FG009|Overall Study|Adverse Event|2|||
147378749|NCT02159989|531550788|FG010|Overall Study|Adverse Event|1|||
147378750|NCT02159989|531550778|FG000|Overall Study|Death|0|||
147378751|NCT02159989|531550779|FG001|Overall Study|Death|0|||
147378752|NCT02159989|531550780|FG002|Overall Study|Death|0|||
147378753|NCT02159989|531550781|FG003|Overall Study|Death|0|||
147378754|NCT02159989|531550782|FG004|Overall Study|Death|0|||
147378755|NCT02159989|531550783|FG005|Overall Study|Death|0|||
147378756|NCT02159989|531550784|FG006|Overall Study|Death|0|||
147378757|NCT02159989|531550785|FG007|Overall Study|Death|0|||
147378758|NCT02159989|531550786|FG008|Overall Study|Death|0|||
147378759|NCT02159989|531550787|FG009|Overall Study|Death|0|||
147378760|NCT02159989|531550788|FG010|Overall Study|Death|1|||
147378761|NCT02159989|531550778|FG000|Overall Study|Lack of Efficacy|2|||
147378762|NCT02159989|531550779|FG001|Overall Study|Lack of Efficacy|3|||
147378763|NCT02159989|531550780|FG002|Overall Study|Lack of Efficacy|3|||
147378764|NCT02159989|531550781|FG003|Overall Study|Lack of Efficacy|0|||
147378765|NCT02159989|531550782|FG004|Overall Study|Lack of Efficacy|2|||
147378766|NCT02159989|531550783|FG005|Overall Study|Lack of Efficacy|3|||
147378767|NCT02159989|531550784|FG006|Overall Study|Lack of Efficacy|3|||
147378768|NCT02159989|531550785|FG007|Overall Study|Lack of Efficacy|1|||
147378769|NCT02159989|531550786|FG008|Overall Study|Lack of Efficacy|3|||
147378770|NCT02159989|531550787|FG009|Overall Study|Lack of Efficacy|6|||
147378771|NCT02159989|531550788|FG010|Overall Study|Lack of Efficacy|7|||
147378772|NCT02159989|531550778|FG000|Overall Study|Lost to Follow-up|0|||
147378773|NCT02159989|531550779|FG001|Overall Study|Lost to Follow-up|0|||
147378774|NCT02159989|531550780|FG002|Overall Study|Lost to Follow-up|0|||
147378775|NCT02159989|531550781|FG003|Overall Study|Lost to Follow-up|1|||
147378776|NCT02159989|531550782|FG004|Overall Study|Lost to Follow-up|0|||
147378777|NCT02159989|531550783|FG005|Overall Study|Lost to Follow-up|0|||
147378778|NCT02159989|531550784|FG006|Overall Study|Lost to Follow-up|0|||
147378779|NCT02159989|531550785|FG007|Overall Study|Lost to Follow-up|0|||
147378780|NCT02159989|531550786|FG008|Overall Study|Lost to Follow-up|0|||
147378781|NCT02159989|531550787|FG009|Overall Study|Lost to Follow-up|0|||
147378782|NCT02159989|531550788|FG010|Overall Study|Lost to Follow-up|1|||
147378783|NCT02159989|531550778|FG000|Overall Study|Withdrawal by Subject|2|||
147378784|NCT02159989|531550779|FG001|Overall Study|Withdrawal by Subject|0|||
147378785|NCT02159989|531550780|FG002|Overall Study|Withdrawal by Subject|0|||
147378786|NCT02159989|531550781|FG003|Overall Study|Withdrawal by Subject|2|||
147378787|NCT02159989|531550782|FG004|Overall Study|Withdrawal by Subject|1|||
147378788|NCT02159989|531550783|FG005|Overall Study|Withdrawal by Subject|0|||
147378789|NCT02159989|531550784|FG006|Overall Study|Withdrawal by Subject|3|||
147378790|NCT02159989|531550785|FG007|Overall Study|Withdrawal by Subject|1|||
147378791|NCT02159989|531550786|FG008|Overall Study|Withdrawal by Subject|0|||
147378792|NCT02159989|531550787|FG009|Overall Study|Withdrawal by Subject|0|||
147378793|NCT02159989|531550788|FG010|Overall Study|Withdrawal by Subject|0|||
147378794|NCT02159989|531550778|FG000|Overall Study|New treatment|0|||
147378795|NCT02159989|531550779|FG001|Overall Study|New treatment|1|||
147378796|NCT02159989|531550780|FG002|Overall Study|New treatment|0|||
147378797|NCT02159989|531550781|FG003|Overall Study|New treatment|0|||
147378798|NCT02159989|531550782|FG004|Overall Study|New treatment|0|||
147378799|NCT02159989|531550783|FG005|Overall Study|New treatment|0|||
147378800|NCT02159989|531550784|FG006|Overall Study|New treatment|0|||
147378801|NCT02159989|531550785|FG007|Overall Study|New treatment|0|||
147378802|NCT02159989|531550786|FG008|Overall Study|New treatment|0|||
147378803|NCT02159989|531550787|FG009|Overall Study|New treatment|0|||
147378804|NCT02159989|531550788|FG010|Overall Study|New treatment|0|||
147378805|NCT02159989|531550778|FG000|Overall Study|Insurance Issues|0|||
147378806|NCT02159989|531550779|FG001|Overall Study|Insurance Issues|0|||
147378807|NCT02159989|531550780|FG002|Overall Study|Insurance Issues|0|||
147378808|NCT02159989|531550781|FG003|Overall Study|Insurance Issues|0|||
147378809|NCT02159989|531550782|FG004|Overall Study|Insurance Issues|0|||
147378810|NCT02159989|531550783|FG005|Overall Study|Insurance Issues|0|||
147378811|NCT02159989|531550784|FG006|Overall Study|Insurance Issues|0|||
147378812|NCT02159989|531550785|FG007|Overall Study|Insurance Issues|0|||
147378813|NCT02159989|531550786|FG008|Overall Study|Insurance Issues|0|||
147378814|NCT02159989|531550787|FG009|Overall Study|Insurance Issues|1|||
147378815|NCT02159989|531550788|FG010|Overall Study|Insurance Issues|0|||
147378816|NCT05338476|531550790|FG000|Period 2|Adverse Event|0|||
147378817|NCT05338476|531550791|FG001|Period 2|Adverse Event|1|||
147378818|NCT02485925|531550792|FG000|Overall Study|Withdrawal by Subject|3|||
147378819|NCT02485925|531550792|FG000|Overall Study|Death|1|||
147378820|NCT02485925|531550792|FG000|Overall Study|Lost to Follow-up|11|||
147378821|NCT04924608|531553050|FG000|Overall Study|Adverse Event|10|||
147378822|NCT04924608|531553051|FG001|Overall Study|Adverse Event|6|||
147378823|NCT04924608|531553050|FG000|Overall Study|Lost to Follow-up|1|||
147378824|NCT04924608|531553051|FG001|Overall Study|Lost to Follow-up|1|||
147378825|NCT04924608|531553050|FG000|Overall Study|Ongoing at the data cut-off date|54|||
147378826|NCT04924608|531553051|FG001|Overall Study|Ongoing at the data cut-off date|60|||
147378827|NCT04924608|531553050|FG000|Overall Study|Progressive Disease|2|||
147378828|NCT04924608|531553051|FG001|Overall Study|Progressive Disease|0|||
147378829|NCT04924608|531553050|FG000|Overall Study|Withdrawal by Subject|3|||
147378830|NCT04924608|531553051|FG001|Overall Study|Withdrawal by Subject|6|||
147378831|NCT04924608|531553050|FG000|Overall Study|Other reason|1|||
147378832|NCT04924608|531553051|FG001|Overall Study|Other reason|1|||
147378833|NCT00949117|531553052|FG000|Overall Study|Lack of Efficacy|2|||
147378834|NCT00949117|531553053|FG001|Overall Study|Lack of Efficacy|3|||
147378835|NCT00949117|531553052|FG000|Overall Study|Protocol Violation|1|||
147378836|NCT00949117|531553053|FG001|Overall Study|Protocol Violation|1|||
147378837|NCT00949117|531553052|FG000|Overall Study|Adverse Event|0|||
147378838|NCT00949117|531553053|FG001|Overall Study|Adverse Event|1|||
147378839|NCT02014402|531553054|FG000|Overall Study|Adverse Event|1|||
147378840|NCT02014402|531553055|FG001|Overall Study|Adverse Event|0|||
147378841|NCT02014402|531553056|FG002|Overall Study|Adverse Event|0|||
147378842|NCT02014402|531553057|FG003|Overall Study|Adverse Event|0|||
147378843|NCT02014402|531553054|FG000|Overall Study|Withdrawal by Subject|1|||
147378844|NCT02014402|531553055|FG001|Overall Study|Withdrawal by Subject|2|||
147378845|NCT02014402|531553056|FG002|Overall Study|Withdrawal by Subject|2|||
147378846|NCT02014402|531553057|FG003|Overall Study|Withdrawal by Subject|1|||
147378847|NCT02014402|531553054|FG000|Overall Study|Subject did not have transportation|0|||
147378848|NCT02014402|531553055|FG001|Overall Study|Subject did not have transportation|1|||
147378849|NCT02014402|531553056|FG002|Overall Study|Subject did not have transportation|0|||
147378850|NCT02014402|531553057|FG003|Overall Study|Subject did not have transportation|0|||
147378851|NCT02014402|531553054|FG000|Overall Study|Lost to Follow-up|0|||
147612712|NCT02717455|532397114|FG000|Overall Study|Adverse Event|1|||
147612713|NCT02717455|532397115|FG001|Overall Study|Adverse Event|0|||
147612714|NCT02717455|532397116|FG002|Overall Study|Adverse Event|0|||
147612715|NCT02717455|532397117|FG003|Overall Study|Adverse Event|2|||
147612716|NCT02717455|532397118|FG004|Overall Study|Adverse Event|2|||
147612717|NCT02717455|532397119|FG005|Overall Study|Adverse Event|2|||
147612718|NCT02717455|532397114|FG000|Overall Study|Withdrawal by Subject|1|||
147612719|NCT02717455|532397115|FG001|Overall Study|Withdrawal by Subject|1|||
147612720|NCT02717455|532397116|FG002|Overall Study|Withdrawal by Subject|0|||
147612721|NCT02717455|532397117|FG003|Overall Study|Withdrawal by Subject|2|||
147612722|NCT02717455|532397118|FG004|Overall Study|Withdrawal by Subject|2|||
147612723|NCT02717455|532397119|FG005|Overall Study|Withdrawal by Subject|1|||
147612724|NCT02717455|532397114|FG000|Overall Study|Death|1|||
147612725|NCT02717455|532397115|FG001|Overall Study|Death|0|||
147612726|NCT02717455|532397116|FG002|Overall Study|Death|0|||
147612727|NCT02717455|532397117|FG003|Overall Study|Death|0|||
147612728|NCT02717455|532397118|FG004|Overall Study|Death|1|||
147612729|NCT02717455|532397119|FG005|Overall Study|Death|0|||
147612730|NCT02717455|532397114|FG000|Overall Study|Did not receive study drug|0|||
147612731|NCT02717455|532397115|FG001|Overall Study|Did not receive study drug|0|||
147612732|NCT02717455|532397116|FG002|Overall Study|Did not receive study drug|0|||
147612733|NCT02717455|532397117|FG003|Overall Study|Did not receive study drug|1|||
147612734|NCT02717455|532397118|FG004|Overall Study|Did not receive study drug|0|||
147612735|NCT02717455|532397119|FG005|Overall Study|Did not receive study drug|1|||
147612736|NCT02717455|532397114|FG000|Overall Study|Extended delay in start of next cycle for reasons unrelated to treatment|0|||
147612737|NCT02717455|532397115|FG001|Overall Study|Extended delay in start of next cycle for reasons unrelated to treatment|0|||
147612738|NCT02717455|532397116|FG002|Overall Study|Extended delay in start of next cycle for reasons unrelated to treatment|0|||
147612739|NCT02717455|532397117|FG003|Overall Study|Extended delay in start of next cycle for reasons unrelated to treatment|0|||
147612740|NCT02717455|532397118|FG004|Overall Study|Extended delay in start of next cycle for reasons unrelated to treatment|0|||
147612741|NCT02717455|532397119|FG005|Overall Study|Extended delay in start of next cycle for reasons unrelated to treatment|1|||
147612742|NCT02717455|532397114|FG000|Overall Study|Patient off-treatment for other complicating disease|0|||
147612743|NCT02717455|532397115|FG001|Overall Study|Patient off-treatment for other complicating disease|0|||
147612744|NCT02717455|532397116|FG002|Overall Study|Patient off-treatment for other complicating disease|0|||
147612745|NCT02717455|532397117|FG003|Overall Study|Patient off-treatment for other complicating disease|1|||
147612746|NCT02717455|532397118|FG004|Overall Study|Patient off-treatment for other complicating disease|0|||
147612747|NCT02717455|532397119|FG005|Overall Study|Patient off-treatment for other complicating disease|0|||
147612748|NCT00733005|532397122|FG000|Overall Study|Adverse Event|0|||
147612749|NCT00733005|532397123|FG001|Overall Study|Adverse Event|1|||
147612750|NCT00733005|532397122|FG000|Overall Study|Treatment Failure|0|||
147612751|NCT00733005|532397123|FG001|Overall Study|Treatment Failure|1|||
147612752|NCT00733005|532397122|FG000|Overall Study|Withdrawal by Subject|0|||
147612753|NCT00733005|532397123|FG001|Overall Study|Withdrawal by Subject|1|||
147612754|NCT00733005|532397122|FG000|Overall Study|Protocol Violation|2|||
147612755|NCT00733005|532397123|FG001|Overall Study|Protocol Violation|0|||
147612756|NCT01769456|532397124|FG000|Overall Study|Lost to Follow-up|19|||
147612757|NCT01769456|532397124|FG000|Overall Study|Withdrawal by Subject|3|||
147612758|NCT01769456|532397124|FG000|Overall Study|Did not receive PCC intervention|6|||
147612759|NCT01769456|532397124|FG000|Overall Study|Moved out of the area|3|||
147612760|NCT01769456|532397124|FG000|Overall Study|No wk 0 visit w/in 30 days of screening|5|||
147612761|NCT01769456|532397124|FG000|Overall Study|Parental request to youth to withdraw|1|||
147612762|NCT02465398|532397131|FG000|Overall Study|Death|7|||
147612763|NCT02465398|532397131|FG000|Overall Study|Revision|7|||
147612764|NCT02465398|532397131|FG000|Overall Study|did not receive study device|1|||
147612765|NCT02465398|532397131|FG000|Overall Study|Withdrawal by Subject|1|||
147612766|NCT02465398|532397131|FG000|Overall Study|Lost to Follow-up|14|||
147612767|NCT05244122|532397136|FG000|Overall Study|Withdrawal by Subject|318|||
147612768|NCT02969382|532397139|FG000|Overall Study|Adverse Event|8|||
147378852|NCT02014402|531553055|FG001|Overall Study|Lost to Follow-up|0|||
147378853|NCT02014402|531553056|FG002|Overall Study|Lost to Follow-up|1|||
147378854|NCT02014402|531553057|FG003|Overall Study|Lost to Follow-up|2|||
147378855|NCT00670449|531553061|FG000|Overall Study|Adverse Event|6|||
147378856|NCT00670449|531553062|FG001|Overall Study|Adverse Event|2|||
147378857|NCT00670449|531553063|FG002|Overall Study|Adverse Event|8|||
147378858|NCT00670449|531553064|FG003|Overall Study|Adverse Event|5|||
147378859|NCT00670449|531553061|FG000|Overall Study|Protocol Deviation|1|||
147378860|NCT00670449|531553062|FG001|Overall Study|Protocol Deviation|2|||
147378861|NCT00670449|531553063|FG002|Overall Study|Protocol Deviation|0|||
147378862|NCT00670449|531553064|FG003|Overall Study|Protocol Deviation|1|||
147378863|NCT00670449|531553061|FG000|Overall Study|Administrative Problems|0|||
147378864|NCT00670449|531553062|FG001|Overall Study|Administrative Problems|2|||
147378865|NCT00670449|531553063|FG002|Overall Study|Administrative Problems|0|||
147378866|NCT00670449|531553064|FG003|Overall Study|Administrative Problems|1|||
147378867|NCT00670449|531553061|FG000|Overall Study|Subject Withdrew Consent|0|||
147378868|NCT00670449|531553062|FG001|Overall Study|Subject Withdrew Consent|2|||
147378869|NCT00670449|531553063|FG002|Overall Study|Subject Withdrew Consent|0|||
147378870|NCT00670449|531553064|FG003|Overall Study|Subject Withdrew Consent|1|||
147378871|NCT00670449|531553061|FG000|Overall Study|Unsatisfactory Therapeutic Effect|2|||
147378872|NCT00670449|531553062|FG001|Overall Study|Unsatisfactory Therapeutic Effect|0|||
147378873|NCT00670449|531553063|FG002|Overall Study|Unsatisfactory Therapeutic Effect|1|||
147378874|NCT00670449|531553064|FG003|Overall Study|Unsatisfactory Therapeutic Effect|0|||
147378875|NCT00670449|531553061|FG000|Overall Study|Abnormal Laboratory Value(s)|0|||
147378876|NCT00670449|531553062|FG001|Overall Study|Abnormal Laboratory Value(s)|2|||
147378877|NCT00670449|531553063|FG002|Overall Study|Abnormal Laboratory Value(s)|0|||
147378878|NCT00670449|531553064|FG003|Overall Study|Abnormal Laboratory Value(s)|0|||
147378879|NCT00413283|531553065|FG000|Overall Study|Withdrawal by Subject|1|||
147378880|NCT00413283|531553066|FG001|Overall Study|Withdrawal by Subject|0|||
147378881|NCT00413283|531553067|FG002|Overall Study|Withdrawal by Subject|0|||
147378882|NCT00413283|531553068|FG003|Overall Study|Withdrawal by Subject|1|||
147378883|NCT00413283|531553065|FG000|Overall Study|Death|0|||
147378884|NCT00413283|531553066|FG001|Overall Study|Death|0|||
147378885|NCT00413283|531553067|FG002|Overall Study|Death|1|||
147378886|NCT00413283|531553068|FG003|Overall Study|Death|1|||
147378887|NCT00413283|531553065|FG000|Overall Study|Adverse Event|0|||
147378888|NCT00413283|531553066|FG001|Overall Study|Adverse Event|0|||
147378889|NCT00413283|531553067|FG002|Overall Study|Adverse Event|0|||
147378890|NCT00413283|531553068|FG003|Overall Study|Adverse Event|1|||
147378891|NCT00413283|531553065|FG000|Overall Study|Ineligibility determined|0|||
147378892|NCT00413283|531553066|FG001|Overall Study|Ineligibility determined|0|||
147378893|NCT00413283|531553067|FG002|Overall Study|Ineligibility determined|0|||
147378894|NCT00413283|531553068|FG003|Overall Study|Ineligibility determined|1|||
147378895|NCT00413283|531553065|FG000|Overall Study|Protocol deviation|0|||
147378896|NCT00413283|531553066|FG001|Overall Study|Protocol deviation|1|||
147378897|NCT00413283|531553067|FG002|Overall Study|Protocol deviation|0|||
147378898|NCT00413283|531553068|FG003|Overall Study|Protocol deviation|0|||
147378899|NCT00413283|531553065|FG000|Overall Study|Requirement for alternative therapy|0|||
147378900|NCT00413283|531553066|FG001|Overall Study|Requirement for alternative therapy|2|||
147378901|NCT00413283|531553067|FG002|Overall Study|Requirement for alternative therapy|0|||
147378902|NCT00413283|531553068|FG003|Overall Study|Requirement for alternative therapy|0|||
147378903|NCT00413283|531553065|FG000|Overall Study|Other|0|||
147378904|NCT00413283|531553066|FG001|Overall Study|Other|0|||
147378905|NCT00413283|531553067|FG002|Overall Study|Other|1|||
147378906|NCT00413283|531553068|FG003|Overall Study|Other|0|||
147378907|NCT02002689|531553069|FG000|Overall Study|Disease Progression|7|||
147378908|NCT02002689|531553069|FG000|Overall Study|Adverse Event|3|||
147378909|NCT00671853|531553070|FG000|Overall Study|Lack of Efficacy|3|||
147378910|NCT00671853|531553071|FG001|Overall Study|Lack of Efficacy|7|||
147378911|NCT00671853|531553070|FG000|Overall Study|Adverse Event|7|||
147378912|NCT00671853|531553071|FG001|Overall Study|Adverse Event|1|||
147378913|NCT00671853|531553070|FG000|Overall Study|Withdrawal by Subject|1|||
147378914|NCT00671853|531553071|FG001|Overall Study|Withdrawal by Subject|5|||
147378915|NCT00671853|531553070|FG000|Overall Study|Lost to Follow-up|8|||
147378916|NCT00671853|531553071|FG001|Overall Study|Lost to Follow-up|8|||
147378917|NCT00671853|531553070|FG000|Overall Study|Physician Decision|0|||
147378918|NCT00671853|531553071|FG001|Overall Study|Physician Decision|2|||
147378919|NCT00671853|531553070|FG000|Overall Study|Non-adherence with study procedures|1|||
147378920|NCT00671853|531553071|FG001|Overall Study|Non-adherence with study procedures|4|||
147378921|NCT03928743|531553072|FG000|Double-Blind Treatment Period:Weeks 1-16|Due To COVID-19 Pandemic and Site Restrictions|1|||
147378922|NCT03928743|531553073|FG001|Double-Blind Treatment Period:Weeks 1-16|Due To COVID-19 Pandemic and Site Restrictions|1|||
147378923|NCT03928743|531553074|FG002|Double-Blind Treatment Period:Weeks 1-16|Due To COVID-19 Pandemic and Site Restrictions|0|||
147378924|NCT03928743|531553072|FG000|Double-Blind Treatment Period:Weeks 1-16|Withdrawal by Subject|1|||
147378925|NCT03928743|531553073|FG001|Double-Blind Treatment Period:Weeks 1-16|Withdrawal by Subject|3|||
147378926|NCT03928743|531553074|FG002|Double-Blind Treatment Period:Weeks 1-16|Withdrawal by Subject|0|||
147612769|NCT02969382|532397140|FG001|Overall Study|Adverse Event|10|||
147612770|NCT02969382|532397139|FG000|Overall Study|Lack of Efficacy|4|||
147612771|NCT02969382|532397140|FG001|Overall Study|Lack of Efficacy|5|||
147612772|NCT02969382|532397139|FG000|Overall Study|Death|0|||
147612773|NCT02969382|532397140|FG001|Overall Study|Death|1|||
147612774|NCT02969382|532397139|FG000|Overall Study|PROTOCOL DEVIATION|0|||
147612775|NCT02969382|532397140|FG001|Overall Study|PROTOCOL DEVIATION|1|||
147612776|NCT02969382|532397139|FG000|Overall Study|Withdrawal by Subject|14|||
147612777|NCT02969382|532397140|FG001|Overall Study|Withdrawal by Subject|9|||
147612778|NCT02090725|532397141|FG000|Overall Study|Withdrawal by Subject|1|||
147612779|NCT02090725|532397141|FG000|Overall Study|participants moved from area|3|||
147612780|NCT05256134|532397143|FG000|Overall Study|Study Terminated by Sponsor|11|||
147612781|NCT05256134|532397144|FG001|Overall Study|Study Terminated by Sponsor|10|||
147612782|NCT05256134|532397143|FG000|Overall Study|Withdrawal by Subject|1|||
147612783|NCT05256134|532397144|FG001|Overall Study|Withdrawal by Subject|3|||
147612784|NCT01977417|532397146|FG000|Overall Study|Adverse Event|1|||
147612785|NCT01977417|532397147|FG001|Overall Study|Adverse Event|0|||
147612786|NCT01977417|532397146|FG000|Overall Study|Withdrawal by Subject|2|||
147612787|NCT01977417|532397147|FG001|Overall Study|Withdrawal by Subject|4|||
147612788|NCT01977417|532397146|FG000|Overall Study|Female enrollment goal met|0|||
147612789|NCT01977417|532397147|FG001|Overall Study|Female enrollment goal met|2|||
147612790|NCT01692626|532397148|FG000|Overall Study|Death|0|||
147612791|NCT01692626|532397149|FG001|Overall Study|Death|1|||
147612792|NCT01692626|532397148|FG000|Overall Study|Adverse Event|2|||
147612793|NCT01692626|532397149|FG001|Overall Study|Adverse Event|3|||
147612794|NCT01692626|532397148|FG000|Overall Study|Protocol Violation|1|||
147612795|NCT01692626|532397149|FG001|Overall Study|Protocol Violation|2|||
147612796|NCT01692626|532397148|FG000|Overall Study|Withdrawal by Subject|1|||
147612797|NCT01692626|532397149|FG001|Overall Study|Withdrawal by Subject|0|||
147612798|NCT02794870|532397156|FG000|Overall Study|Withdrawal by Subject|2|||
147612799|NCT02794870|532397157|FG001|Overall Study|Withdrawal by Subject|0|||
147612800|NCT01495702|532397158|FG000|Randomized Phase|Randomized But Not Treated|1|||
147612801|NCT01495702|532397159|FG001|Randomized Phase|Randomized But Not Treated|4|||
147612802|NCT01495702|532397158|FG000|Randomized Phase|Adverse Event|2|||
147612803|NCT01495702|532397159|FG001|Randomized Phase|Adverse Event|2|||
147612804|NCT01495702|532397158|FG000|Randomized Phase|Death|1|||
147612805|NCT01495702|532397159|FG001|Randomized Phase|Death|0|||
147612806|NCT01495702|532397158|FG000|Randomized Phase|Lack of Efficacy|2|||
147612807|NCT01495702|532397159|FG001|Randomized Phase|Lack of Efficacy|0|||
147612808|NCT01495702|532397158|FG000|Randomized Phase|Investigators Discretion|2|||
147612809|NCT01495702|532397159|FG001|Randomized Phase|Investigators Discretion|0|||
147612810|NCT01495702|532397158|FG000|Randomized Phase|Withdrew Consent|10|||
147612811|NCT01495702|532397159|FG001|Randomized Phase|Withdrew Consent|18|||
147612812|NCT01495702|532397158|FG000|Randomized Phase|Lost to Follow-up|4|||
147612813|NCT01495702|532397159|FG001|Randomized Phase|Lost to Follow-up|3|||
147612814|NCT01495702|532397158|FG000|Randomized Phase|Participant Noncompliance|1|||
147612815|NCT01495702|532397159|FG001|Randomized Phase|Participant Noncompliance|0|||
147612816|NCT01495702|532397158|FG000|Randomized Phase|Protocol Violation|3|||
147612817|NCT01495702|532397159|FG001|Randomized Phase|Protocol Violation|1|||
147612818|NCT00616421|532397160|FG000|Overall Study|Withdrawal by Subject|9|||
147664876|NCT02810418|532597949|FG004|Arm A Dose Escalation|Adverse Event|0|||
147664877|NCT02810418|532597950|FG005|Arm A Dose Escalation|Adverse Event|0|||
147664878|NCT02810418|532597951|FG006|Arm A Dose Escalation|Adverse Event|0|||
147664879|NCT02810418|532597945|FG000|Dose Expansion|Adverse Event|0|||
147664880|NCT02810418|532597946|FG001|Dose Expansion|Adverse Event|1|||
147664881|NCT02810418|532597947|FG002|Dose Expansion|Adverse Event|1|||
147664882|NCT02810418|532597948|FG003|Dose Expansion|Adverse Event|0|||
147664883|NCT02810418|532597949|FG004|Dose Expansion|Adverse Event|0|||
147378927|NCT03928743|531553072|FG000|Double-Blind Treatment Period:Weeks 1-16|Lack of Efficacy|0|||
147612819|NCT00616421|532397161|FG001|Overall Study|Withdrawal by Subject|11|||
147612820|NCT00616421|532397162|FG002|Overall Study|Withdrawal by Subject|8|||
147612821|NCT00616421|532397160|FG000|Overall Study|Lost to Follow-up|12|||
147612822|NCT00616421|532397161|FG001|Overall Study|Lost to Follow-up|26|||
147612823|NCT00616421|532397162|FG002|Overall Study|Lost to Follow-up|30|||
147612824|NCT00616421|532397160|FG000|Overall Study|Inappropriate enrollment|3|||
147612825|NCT00616421|532397161|FG001|Overall Study|Inappropriate enrollment|0|||
147612826|NCT00616421|532397162|FG002|Overall Study|Inappropriate enrollment|1|||
147612827|NCT00616421|532397160|FG000|Overall Study|Administrative reason|1|||
147612828|NCT00616421|532397161|FG001|Overall Study|Administrative reason|0|||
147612829|NCT00616421|532397162|FG002|Overall Study|Administrative reason|0|||
147612830|NCT00616421|532397160|FG000|Overall Study|Protocol Violation|0|||
147612831|NCT00616421|532397161|FG001|Overall Study|Protocol Violation|1|||
147612832|NCT00616421|532397162|FG002|Overall Study|Protocol Violation|2|||
147664884|NCT02810418|532597950|FG005|Dose Expansion|Adverse Event|0|||
147664885|NCT02810418|532597951|FG006|Dose Expansion|Adverse Event|0|||
147612833|NCT00616421|532397160|FG000|Overall Study|Unable to classify|1|||
147612834|NCT00616421|532397161|FG001|Overall Study|Unable to classify|0|||
147612835|NCT00616421|532397162|FG002|Overall Study|Unable to classify|0|||
147612836|NCT01427608|532397163|FG000|Overall Study|Death|1|||
147612837|NCT01427608|532397164|FG001|Overall Study|Death|0|||
147612838|NCT01427608|532397163|FG000|Overall Study|Withdrawal by Subject|7|||
147612839|NCT01427608|532397164|FG001|Overall Study|Withdrawal by Subject|3|||
147612840|NCT01427608|532397163|FG000|Overall Study|Relapsed-all cause|13|||
147612841|NCT01427608|532397164|FG001|Overall Study|Relapsed-all cause|34|||
147612842|NCT01427608|532397163|FG000|Overall Study|Events not attributed to study meds|0|||
147612843|NCT01427608|532397164|FG001|Overall Study|Events not attributed to study meds|1|||
147612844|NCT02422797|532397165|FG000|Early Switch Phase (Up to Week 52)|Adverse Event|11|||
147612845|NCT02422797|532397166|FG001|Early Switch Phase (Up to Week 52)|Adverse Event|1|||
147612846|NCT02422797|532397165|FG000|Early Switch Phase (Up to Week 52)|Physician Decision|0|||
147612847|NCT02422797|532397166|FG001|Early Switch Phase (Up to Week 52)|Physician Decision|1|||
147612848|NCT02422797|532397165|FG000|Early Switch Phase (Up to Week 52)|Lack of Efficacy|1|||
147612849|NCT02422797|532397166|FG001|Early Switch Phase (Up to Week 52)|Lack of Efficacy|2|||
147612850|NCT02422797|532397165|FG000|Early Switch Phase (Up to Week 52)|Lost to Follow-up|1|||
147612851|NCT02422797|532397166|FG001|Early Switch Phase (Up to Week 52)|Lost to Follow-up|1|||
147612852|NCT02422797|532397165|FG000|Early Switch Phase (Up to Week 52)|Protocol Violation|0|||
147612853|NCT02422797|532397166|FG001|Early Switch Phase (Up to Week 52)|Protocol Violation|3|||
147612854|NCT02422797|532397165|FG000|Early Switch Phase (Up to Week 52)|Reached stopping criteria|1|||
147612855|NCT02422797|532397166|FG001|Early Switch Phase (Up to Week 52)|Reached stopping criteria|1|||
147612856|NCT02422797|532397165|FG000|Early Switch Phase (Up to Week 52)|Withdrawal by Subject|2|||
147612857|NCT02422797|532397166|FG001|Early Switch Phase (Up to Week 52)|Withdrawal by Subject|7|||
147612858|NCT02422797|532397165|FG000|Late Switch Phase (Week 52 to Week 148)|Physician Decision|0|||
147612859|NCT02422797|532397166|FG001|Late Switch Phase (Week 52 to Week 148)|Physician Decision|1|||
147612860|NCT02422797|532397165|FG000|Late Switch Phase (Week 52 to Week 148)|Adverse Event|10|||
147612861|NCT02422797|532397166|FG001|Late Switch Phase (Week 52 to Week 148)|Adverse Event|6|||
147612862|NCT02422797|532397165|FG000|Late Switch Phase (Week 52 to Week 148)|Lack of Efficacy|5|||
147612863|NCT02422797|532397166|FG001|Late Switch Phase (Week 52 to Week 148)|Lack of Efficacy|3|||
147612864|NCT02422797|532397165|FG000|Late Switch Phase (Week 52 to Week 148)|Lost to Follow-up|2|||
147612865|NCT02422797|532397166|FG001|Late Switch Phase (Week 52 to Week 148)|Lost to Follow-up|2|||
147612866|NCT02422797|532397165|FG000|Late Switch Phase (Week 52 to Week 148)|Withdrawal by Subject|2|||
147612867|NCT02422797|532397166|FG001|Late Switch Phase (Week 52 to Week 148)|Withdrawal by Subject|6|||
147612868|NCT02422797|532397165|FG000|Late Switch Phase (Week 52 to Week 148)|Reached stopping criteria|1|||
147612869|NCT02422797|532397166|FG001|Late Switch Phase (Week 52 to Week 148)|Reached stopping criteria|0|||
147612870|NCT02422797|532397165|FG000|Late Switch Phase (Week 52 to Week 148)|Protocol Violation|3|||
147612871|NCT02422797|532397166|FG001|Late Switch Phase (Week 52 to Week 148)|Protocol Violation|0|||
147612872|NCT02422797|532397165|FG000|Continuation Phase(Week 148 to Week 410)|Investigator discretion|1|||
147612873|NCT02422797|532397166|FG001|Continuation Phase(Week 148 to Week 410)|Investigator discretion|2|||
147612874|NCT02422797|532397165|FG000|Continuation Phase(Week 148 to Week 410)|Lost to Follow-up|0|||
147612875|NCT02422797|532397166|FG001|Continuation Phase(Week 148 to Week 410)|Lost to Follow-up|3|||
147612876|NCT02422797|532397165|FG000|Continuation Phase(Week 148 to Week 410)|Subject reached protocol-defined stopping criteria|1|||
147612877|NCT02422797|532397166|FG001|Continuation Phase(Week 148 to Week 410)|Subject reached protocol-defined stopping criteria|0|||
147612878|NCT02422797|532397165|FG000|Continuation Phase(Week 148 to Week 410)|Withdrawal by Subject|4|||
147612879|NCT02422797|532397166|FG001|Continuation Phase(Week 148 to Week 410)|Withdrawal by Subject|1|||
147612880|NCT02422797|532397165|FG000|Continuation Phase(Week 148 to Week 410)|Protocol Violation|0|||
147612881|NCT02422797|532397166|FG001|Continuation Phase(Week 148 to Week 410)|Protocol Violation|1|||
147612882|NCT02422797|532397165|FG000|Continuation Phase(Week 148 to Week 410)|Lack of Efficacy|1|||
147612883|NCT02422797|532397166|FG001|Continuation Phase(Week 148 to Week 410)|Lack of Efficacy|1|||
147612884|NCT02422797|532397165|FG000|Continuation Phase(Week 148 to Week 410)|Adverse Event|0|||
147612885|NCT02422797|532397166|FG001|Continuation Phase(Week 148 to Week 410)|Adverse Event|2|||
147612886|NCT04071405|532397167|FG000|Overall Study|Protocol Violation|3|||
147456009|NCT04316585|531831658|FG000|Overall Study|SUBJECT REACHED PROTOCOL-DEFINED STOPPING CRITERIA|0|||
147612887|NCT05445492|532397170|FG000|Overall Study|Physician Decision|1|||
147612888|NCT03126435|532397177|FG000|Overall Study|Death|90|||
147612889|NCT03126435|532397178|FG001|Overall Study|Death|84|||
147612890|NCT03126435|532397177|FG000|Overall Study|Lost to Follow-up|4|||
147612891|NCT03126435|532397178|FG001|Overall Study|Lost to Follow-up|3|||
147612892|NCT03126435|532397177|FG000|Overall Study|Physician Decision|0|||
147612893|NCT03126435|532397178|FG001|Overall Study|Physician Decision|1|||
147612894|NCT03126435|532397177|FG000|Overall Study|Withdrawal by Subject|6|||
147612895|NCT03126435|532397178|FG001|Overall Study|Withdrawal by Subject|12|||
147612896|NCT03126435|532397177|FG000|Overall Study|e.g. Sponsor Decision, General Deterioration...|6|||
147612897|NCT03126435|532397178|FG001|Overall Study|e.g. Sponsor Decision, General Deterioration...|4|||
147612898|NCT01937871|532397186|FG000|Overall Study|Adverse Event|6|||
147612899|NCT01937871|532397187|FG001|Overall Study|Adverse Event|6|||
147612900|NCT01937871|532397188|FG002|Overall Study|Adverse Event|2|||
147612901|NCT01937871|532397186|FG000|Overall Study|Lost to Follow-up|8|||
147612902|NCT01937871|532397187|FG001|Overall Study|Lost to Follow-up|2|||
147612903|NCT01937871|532397188|FG002|Overall Study|Lost to Follow-up|4|||
147378928|NCT03928743|531553073|FG001|Double-Blind Treatment Period:Weeks 1-16|Lack of Efficacy|1|||
147378929|NCT03928743|531553074|FG002|Double-Blind Treatment Period:Weeks 1-16|Lack of Efficacy|0|||
147378930|NCT03928743|531553072|FG000|Double-Blind Treatment Period:Weeks 1-16|Adverse Event|0|||
147378931|NCT03928743|531553073|FG001|Double-Blind Treatment Period:Weeks 1-16|Adverse Event|2|||
147378932|NCT03928743|531553074|FG002|Double-Blind Treatment Period:Weeks 1-16|Adverse Event|0|||
147378933|NCT03928743|531553072|FG000|Double-Blind Treatment Period:Weeks 1-16|Adverse Event, serious non-fatal|0|||
147378934|NCT03928743|531553073|FG001|Double-Blind Treatment Period:Weeks 1-16|Adverse Event, serious non-fatal|1|||
147378935|NCT03928743|531553074|FG002|Double-Blind Treatment Period:Weeks 1-16|Adverse Event, serious non-fatal|0|||
147378936|NCT03928743|531553072|FG000|Maintenance Period: Weeks 16-52|PI Decision Due To Non-Compliance and COVID 19|0|||
147378937|NCT03928743|531553073|FG001|Maintenance Period: Weeks 16-52|PI Decision Due To Non-Compliance and COVID 19|0|||
147378938|NCT03928743|531553074|FG002|Maintenance Period: Weeks 16-52|PI Decision Due To Non-Compliance and COVID 19|1|||
147378939|NCT03928743|531553072|FG000|Maintenance Period: Weeks 16-52|Withdrawal by Subject|0|||
147378940|NCT03928743|531553073|FG001|Maintenance Period: Weeks 16-52|Withdrawal by Subject|0|||
147378941|NCT03928743|531553074|FG002|Maintenance Period: Weeks 16-52|Withdrawal by Subject|4|||
147378942|NCT03928743|531553072|FG000|Maintenance Period: Weeks 16-52|Lost to Follow-up|0|||
147378943|NCT03928743|531553073|FG001|Maintenance Period: Weeks 16-52|Lost to Follow-up|0|||
147378944|NCT03928743|531553074|FG002|Maintenance Period: Weeks 16-52|Lost to Follow-up|2|||
147378945|NCT03928743|531553072|FG000|Maintenance Period: Weeks 16-52|Lack of Efficacy|0|||
147378946|NCT03928743|531553073|FG001|Maintenance Period: Weeks 16-52|Lack of Efficacy|0|||
147378947|NCT03928743|531553074|FG002|Maintenance Period: Weeks 16-52|Lack of Efficacy|3|||
147378948|NCT03928743|531553072|FG000|Maintenance Period: Weeks 16-52|Adverse Event|0|||
147378949|NCT03928743|531553073|FG001|Maintenance Period: Weeks 16-52|Adverse Event|0|||
147378950|NCT03928743|531553074|FG002|Maintenance Period: Weeks 16-52|Adverse Event|9|||
147378951|NCT03928743|531553072|FG000|Maintenance Period: Weeks 16-52|Adverse event, serious non-fatal|0|||
147378952|NCT03928743|531553073|FG001|Maintenance Period: Weeks 16-52|Adverse event, serious non-fatal|0|||
147378953|NCT03928743|531553074|FG002|Maintenance Period: Weeks 16-52|Adverse event, serious non-fatal|2|||
147378954|NCT02007070|531553078|FG000|Overall Study|Adverse Event|4|||
147378955|NCT02007070|531553078|FG000|Overall Study|Clinical Progression|4|||
147378956|NCT02007070|531553078|FG000|Overall Study|Death|1|||
147378957|NCT02007070|531553078|FG000|Overall Study|Protocol Violation|2|||
147378958|NCT02007070|531553078|FG000|Overall Study|Physician Decision|1|||
147378959|NCT02007070|531553078|FG000|Overall Study|Progressive Disease|21|||
147378960|NCT00703092|531553079|FG000|Overall Study|Withdrawal by Subject|2|||
147378961|NCT01480258|531553080|FG000|Infant Series|Protocol Violation|2|||
147378962|NCT01480258|531553081|FG001|Infant Series|Protocol Violation|0|||
147378963|NCT01480258|531553080|FG000|Infant Series|Physician Decision|0|||
147378964|NCT01480258|531553081|FG001|Infant Series|Physician Decision|1|||
147378965|NCT01480258|531553080|FG000|Infant Series|Not Vaccinated|3|||
147378966|NCT01480258|531553081|FG001|Infant Series|Not Vaccinated|0|||
147378967|NCT01480258|531553080|FG000|Infant Series|Adverse Event|1|||
147378968|NCT01480258|531553081|FG001|Infant Series|Adverse Event|1|||
147378969|NCT01480258|531553080|FG000|Infant Series|Withdrawal by Subject|1|||
147378970|NCT01480258|531553081|FG001|Infant Series|Withdrawal by Subject|6|||
147378971|NCT01480258|531553080|FG000|Interim Period|Lost to Follow-up|0|||
147378972|NCT01480258|531553081|FG001|Interim Period|Lost to Follow-up|2|||
147378973|NCT01480258|531553080|FG000|Interim Period|Physician Decision|1|||
147378974|NCT01480258|531553081|FG001|Interim Period|Physician Decision|0|||
147378975|NCT01480258|531553080|FG000|Interim Period|Protocol Violation|0|||
147378976|NCT01480258|531553081|FG001|Interim Period|Protocol Violation|1|||
147612904|NCT01937871|532397186|FG000|Overall Study|Withdrawal by Subject|9|||
147612905|NCT01937871|532397187|FG001|Overall Study|Withdrawal by Subject|6|||
147612906|NCT01937871|532397188|FG002|Overall Study|Withdrawal by Subject|4|||
147612907|NCT01937871|532397186|FG000|Overall Study|Physician Decision|0|||
147612908|NCT01937871|532397187|FG001|Overall Study|Physician Decision|1|||
147378977|NCT01480258|531553080|FG000|Interim Period|Withdrawal by Subject|9|||
147378978|NCT01480258|531553081|FG001|Interim Period|Withdrawal by Subject|6|||
147378979|NCT01228734|531553083|FG000|Overall Study|Randomized, but not treated|0|||
147378980|NCT01228734|531553084|FG001|Overall Study|Randomized, but not treated|4|||
147378981|NCT00659373|531553085|FG000|Overall Study|Withdrawal by Subject|3|||
147378982|NCT00659373|531553086|FG001|Overall Study|Withdrawal by Subject|5|||
147456010|NCT04316585|531831659|FG001|Overall Study|SUBJECT REACHED PROTOCOL-DEFINED STOPPING CRITERIA|1|||
147456011|NCT04316585|531831658|FG000|Overall Study|INVESTIGATOR DISCRETION|1|||
147456012|NCT04316585|531831659|FG001|Overall Study|INVESTIGATOR DISCRETION|0|||
147612909|NCT01937871|532397188|FG002|Overall Study|Physician Decision|0|||
147612910|NCT01937871|532397186|FG000|Overall Study|Entry Criteria Not Met|1|||
147612911|NCT01937871|532397187|FG001|Overall Study|Entry Criteria Not Met|2|||
147378983|NCT00659373|531553085|FG000|Overall Study|Assessment Missed|2|||
147378984|NCT00659373|531553086|FG001|Overall Study|Assessment Missed|2|||
147378985|NCT03042767|531553087|FG000|Overall Study|Lost to Follow-up|1|||
147378986|NCT03042767|531553088|FG001|Overall Study|Lost to Follow-up|2|||
147378987|NCT01543204|531553091|FG000|Overall Study|Non-compliance|1|||
147378988|NCT01543204|531553091|FG000|Overall Study|Adverse Event|1|||
147456013|NCT01072344|531831661|FG000|Overall Study|Relasped-reached end point|7|||
147612912|NCT01937871|532397188|FG002|Overall Study|Entry Criteria Not Met|1|||
147612913|NCT03154125|532397189|FG000|Overall Study|Lost to Follow-up|11|||
147612914|NCT03154125|532397190|FG001|Overall Study|Lost to Follow-up|11|||
147612915|NCT03154125|532397191|FG002|Overall Study|Lost to Follow-up|0|||
147612916|NCT03154125|532397189|FG000|Overall Study|Withdrawal by Subject|49|||
147612917|NCT03154125|532397190|FG001|Overall Study|Withdrawal by Subject|55|||
147612918|NCT03154125|532397191|FG002|Overall Study|Withdrawal by Subject|8|||
147612919|NCT03154125|532397189|FG000|Overall Study|Physician Decision|13|||
147612920|NCT03154125|532397190|FG001|Overall Study|Physician Decision|6|||
147612921|NCT03154125|532397191|FG002|Overall Study|Physician Decision|0|||
147612922|NCT03154125|532397189|FG000|Overall Study|Protocol Violation|3|||
147612923|NCT03154125|532397190|FG001|Overall Study|Protocol Violation|5|||
147612924|NCT03154125|532397191|FG002|Overall Study|Protocol Violation|0|||
147612925|NCT00799058|532397192|FG000|Overall Study|Withdrawal by Subject|2|||
147612926|NCT00799058|532397193|FG001|Overall Study|Withdrawal by Subject|2|||
147612927|NCT00799058|532397194|FG002|Overall Study|Withdrawal by Subject|2|||
147612928|NCT00799058|532397192|FG000|Overall Study|Lost to Follow-up|1|||
147612929|NCT00799058|532397193|FG001|Overall Study|Lost to Follow-up|2|||
147612930|NCT00799058|532397194|FG002|Overall Study|Lost to Follow-up|1|||
147612931|NCT00799058|532397192|FG000|Overall Study|Adverse Event|0|||
147612932|NCT00799058|532397193|FG001|Overall Study|Adverse Event|2|||
147612933|NCT00799058|532397194|FG002|Overall Study|Adverse Event|0|||
147612934|NCT00799058|532397192|FG000|Overall Study|Pregnancy|1|||
147612935|NCT00799058|532397193|FG001|Overall Study|Pregnancy|0|||
147612936|NCT00799058|532397194|FG002|Overall Study|Pregnancy|0|||
147612937|NCT00799058|532397192|FG000|Overall Study|Not adherent|3|||
147612938|NCT00799058|532397193|FG001|Overall Study|Not adherent|2|||
147612939|NCT00799058|532397194|FG002|Overall Study|Not adherent|1|||
147612940|NCT00799058|532397192|FG000|Overall Study|discontinued use of IP due to AE, but completed visits|0|||
147612941|NCT00799058|532397193|FG001|Overall Study|discontinued use of IP due to AE, but completed visits|0|||
147612942|NCT00799058|532397194|FG002|Overall Study|discontinued use of IP due to AE, but completed visits|1|||
147612943|NCT00799058|532397192|FG000|Overall Study|IP dispensing error|1|||
147612944|NCT00799058|532397193|FG001|Overall Study|IP dispensing error|0|||
147612945|NCT00799058|532397194|FG002|Overall Study|IP dispensing error|0|||
147612946|NCT00799058|532397192|FG000|Overall Study|not enough IP to complete trial due to IP dispending error|0|||
147612947|NCT00799058|532397193|FG001|Overall Study|not enough IP to complete trial due to IP dispending error|1|||
147612948|NCT00799058|532397194|FG002|Overall Study|not enough IP to complete trial due to IP dispending error|0|||
147612949|NCT00799058|532397192|FG000|Overall Study|IP discontinued too long during BV treatment|1|||
147612950|NCT00799058|532397193|FG001|Overall Study|IP discontinued too long during BV treatment|0|||
147612951|NCT00799058|532397194|FG002|Overall Study|IP discontinued too long during BV treatment|0|||
147612952|NCT00799058|532397192|FG000|Overall Study|lost 2 IP kits and did not have enough remaining to complete trial|0|||
147612953|NCT00799058|532397193|FG001|Overall Study|lost 2 IP kits and did not have enough remaining to complete trial|0|||
147612954|NCT00799058|532397194|FG002|Overall Study|lost 2 IP kits and did not have enough remaining to complete trial|1|||
147612955|NCT00799058|532397192|FG000|Overall Study|participant did not attend clinic visit 6 (final visit)|1|||
147612956|NCT00799058|532397193|FG001|Overall Study|participant did not attend clinic visit 6 (final visit)|0|||
147612957|NCT00799058|532397194|FG002|Overall Study|participant did not attend clinic visit 6 (final visit)|0|||
147612958|NCT00810511|532397195|FG000|Overall Study|Protocol Violation|0|||
147612959|NCT00810511|532397196|FG001|Overall Study|Protocol Violation|1|||
147612960|NCT00810511|532397195|FG000|Overall Study|Lack of Efficacy|9|||
147612961|NCT00810511|532397196|FG001|Overall Study|Lack of Efficacy|1|||
147664886|NCT02810418|532597945|FG000|Dose Expansion|Physician Decision|0|||
147664887|NCT02810418|532597946|FG001|Dose Expansion|Physician Decision|0|||
147664888|NCT02810418|532597947|FG002|Dose Expansion|Physician Decision|2|||
147378989|NCT01543204|531553091|FG000|Overall Study|Withdrawal by Subject|4|||
147664889|NCT02810418|532597948|FG003|Dose Expansion|Physician Decision|0|||
147378990|NCT01543204|531553091|FG000|Overall Study|Requirement for Alternative Therapy|1|||
147378991|NCT01543204|531553091|FG000|Overall Study|Lost to Follow-up|1|||
147378992|NCT01220999|531553092|FG000|Overall Study|Progressive disease|0|||
147378993|NCT01220999|531553093|FG001|Overall Study|Progressive disease|0|||
147378994|NCT01220999|531553094|FG002|Overall Study|Progressive disease|1|||
147378995|NCT01220999|531553095|FG003|Overall Study|Progressive disease|0|||
147378996|NCT01220999|531553096|FG004|Overall Study|Progressive disease|0|||
147378997|NCT02449902|531553098|FG000|Overall Study|Adverse Event|0|||
147378998|NCT02449902|531553099|FG001|Overall Study|Adverse Event|1|||
147378999|NCT02449902|531553098|FG000|Overall Study|Withdrawal by Subject|0|||
147379000|NCT02449902|531553099|FG001|Overall Study|Withdrawal by Subject|1|||
147379001|NCT01365546|531553100|FG000|Overall Study|Withdrawal by Subject|1|||
147456014|NCT01072344|531831662|FG001|Overall Study|Relasped-reached end point|12|||
147379002|NCT01365546|531553100|FG000|Overall Study|Screen failure|9|||
147612962|NCT00810511|532397195|FG000|Overall Study|death in the family|0|||
147379003|NCT01365546|531553100|FG000|Overall Study|Study termination|1|||
147379004|NCT03326856|531553101|FG000|Overall Study|Lost to Follow-up|1|||
147379005|NCT03326856|531553102|FG001|Overall Study|Lost to Follow-up|1|||
147612963|NCT00810511|532397196|FG001|Overall Study|death in the family|1|||
147379006|NCT03326856|531553103|FG002|Overall Study|Lost to Follow-up|0|||
147379007|NCT03326856|531553104|FG003|Overall Study|Lost to Follow-up|0|||
147379008|NCT03326856|531553105|FG004|Overall Study|Lost to Follow-up|0|||
147379009|NCT02037568|531553106|FG000|Overall Study|Withdrawal by Subject|17|||
147379010|NCT02037568|531553107|FG001|Overall Study|Withdrawal by Subject|24|||
147379011|NCT02037568|531553106|FG000|Overall Study|Lost to Follow-up|16|||
147379012|NCT02037568|531553107|FG001|Overall Study|Lost to Follow-up|13|||
147379013|NCT02037568|531553106|FG000|Overall Study|Screen Failure|3|||
147379014|NCT02037568|531553107|FG001|Overall Study|Screen Failure|1|||
147379015|NCT02037568|531553106|FG000|Overall Study|Patient did not receive transplant|0|||
147379016|NCT02037568|531553107|FG001|Overall Study|Patient did not receive transplant|1|||
147379017|NCT00721734|531553110|FG000|Overall Study|Progressive Disease|3|||
147379018|NCT00721734|531553111|FG001|Overall Study|Progressive Disease|10|||
147379019|NCT00721734|531553112|FG002|Overall Study|Progressive Disease|4|||
147379020|NCT00721734|531553113|FG003|Overall Study|Progressive Disease|5|||
147379021|NCT00721734|531553114|FG004|Overall Study|Progressive Disease|2|||
147379022|NCT00721734|531553110|FG000|Overall Study|Adverse Event|3|||
147379023|NCT00721734|531553111|FG001|Overall Study|Adverse Event|1|||
147379024|NCT00721734|531553112|FG002|Overall Study|Adverse Event|4|||
147379025|NCT00721734|531553113|FG003|Overall Study|Adverse Event|0|||
147379026|NCT00721734|531553114|FG004|Overall Study|Adverse Event|3|||
147379027|NCT00721734|531553110|FG000|Overall Study|Withdrawal by Subject|2|||
147379028|NCT00721734|531553111|FG001|Overall Study|Withdrawal by Subject|1|||
147379029|NCT00721734|531553112|FG002|Overall Study|Withdrawal by Subject|0|||
147379030|NCT00721734|531553113|FG003|Overall Study|Withdrawal by Subject|0|||
147379031|NCT00721734|531553114|FG004|Overall Study|Withdrawal by Subject|1|||
147379032|NCT00721734|531553110|FG000|Overall Study|Other|0|||
147379033|NCT00721734|531553111|FG001|Overall Study|Other|0|||
147379034|NCT00721734|531553112|FG002|Overall Study|Other|0|||
147379035|NCT00721734|531553113|FG003|Overall Study|Other|1|||
147379036|NCT00721734|531553114|FG004|Overall Study|Other|0|||
147379037|NCT03861234|531553115|FG000|Overall Study|Not treated|0|||
147379038|NCT03861234|531553116|FG001|Overall Study|Not treated|0|||
147379039|NCT03861234|531553117|FG002|Overall Study|Not treated|0|||
147379040|NCT03861234|531553118|FG003|Overall Study|Not treated|0|||
147379041|NCT03861234|531553119|FG004|Overall Study|Not treated|0|||
147379042|NCT03861234|531553120|FG005|Overall Study|Not treated|1|||
147379043|NCT03861234|531553121|FG006|Overall Study|Not treated|0|||
147379044|NCT03861234|531553122|FG007|Overall Study|Not treated|0|||
147379045|NCT03861234|531553115|FG000|Overall Study|Adverse Event|0|||
147379046|NCT03861234|531553116|FG001|Overall Study|Adverse Event|0|||
147379047|NCT03861234|531553117|FG002|Overall Study|Adverse Event|0|||
147379048|NCT03861234|531553118|FG003|Overall Study|Adverse Event|0|||
147379049|NCT03861234|531553119|FG004|Overall Study|Adverse Event|0|||
147379050|NCT03861234|531553120|FG005|Overall Study|Adverse Event|1|||
147379051|NCT03861234|531553121|FG006|Overall Study|Adverse Event|0|||
147379052|NCT03861234|531553122|FG007|Overall Study|Adverse Event|0|||
147379053|NCT03861234|531553115|FG000|Overall Study|Study medication discontinued due to safety notification|0|||
147379054|NCT03861234|531553116|FG001|Overall Study|Study medication discontinued due to safety notification|0|||
147379055|NCT03861234|531553117|FG002|Overall Study|Study medication discontinued due to safety notification|0|||
147379056|NCT03861234|531553118|FG003|Overall Study|Study medication discontinued due to safety notification|0|||
147379057|NCT03861234|531553119|FG004|Overall Study|Study medication discontinued due to safety notification|0|||
147379058|NCT03861234|531553120|FG005|Overall Study|Study medication discontinued due to safety notification|1|||
147379059|NCT03861234|531553121|FG006|Overall Study|Study medication discontinued due to safety notification|0|||
147379060|NCT03861234|531553122|FG007|Overall Study|Study medication discontinued due to safety notification|0|||
147379061|NCT03861234|531553115|FG000|Overall Study|As per sponsor decision|0|||
147379062|NCT03861234|531553116|FG001|Overall Study|As per sponsor decision|0|||
147379063|NCT03861234|531553117|FG002|Overall Study|As per sponsor decision|0|||
147379064|NCT03861234|531553118|FG003|Overall Study|As per sponsor decision|0|||
147379065|NCT03861234|531553119|FG004|Overall Study|As per sponsor decision|0|||
147379066|NCT03861234|531553120|FG005|Overall Study|As per sponsor decision|0|||
147379067|NCT03861234|531553121|FG006|Overall Study|As per sponsor decision|1|||
147379068|NCT03861234|531553122|FG007|Overall Study|As per sponsor decision|0|||
147379069|NCT03861234|531553115|FG000|Overall Study|IMP on hold as per sponsor instructions|0|||
147379070|NCT03861234|531553116|FG001|Overall Study|IMP on hold as per sponsor instructions|0|||
147612964|NCT00810511|532397195|FG000|Overall Study|Lost to Follow-up|1|||
147379071|NCT03861234|531553117|FG002|Overall Study|IMP on hold as per sponsor instructions|0|||
147379072|NCT03861234|531553118|FG003|Overall Study|IMP on hold as per sponsor instructions|0|||
147379073|NCT03861234|531553119|FG004|Overall Study|IMP on hold as per sponsor instructions|0|||
147379074|NCT03861234|531553120|FG005|Overall Study|IMP on hold as per sponsor instructions|0|||
147612965|NCT00810511|532397196|FG001|Overall Study|Lost to Follow-up|0|||
147612966|NCT00810511|532397195|FG000|Overall Study|deposits on contact lens|0|||
147379075|NCT03861234|531553121|FG006|Overall Study|IMP on hold as per sponsor instructions|2|||
147379076|NCT03861234|531553122|FG007|Overall Study|IMP on hold as per sponsor instructions|0|||
147379077|NCT01989689|531553126|FG000|Treatment Period 1 ( 3 Months)|Lost to Follow-up|0|||
147379078|NCT01989689|531553127|FG001|Treatment Period 1 ( 3 Months)|Lost to Follow-up|2|||
147379079|NCT01989689|531553126|FG000|Treatment Period 1 ( 3 Months)|Withdrawal by Subject|0|||
147379080|NCT01989689|531553127|FG001|Treatment Period 1 ( 3 Months)|Withdrawal by Subject|1|||
147379081|NCT02066636|531553128|FG000|Overall Study|Disease progression|51|||
147612967|NCT00810511|532397196|FG001|Overall Study|deposits on contact lens|1|||
147612968|NCT02088697|532397197|FG000|Period I|Physician Decision|1|||
147612969|NCT02088697|532397198|FG001|Period I|Physician Decision|4|||
147612970|NCT02088697|532397197|FG000|Wash-out Period (at Least 10 Days)|Adverse Event|1|||
147612971|NCT02088697|532397198|FG001|Wash-out Period (at Least 10 Days)|Adverse Event|0|||
147612972|NCT00462904|532397199|FG000|Overall Study|Lost to Follow-up|1|||
147612973|NCT02652949|532397200|FG000|30-Day Follow-up for Primary Endpoint|Death|1|||
147612974|NCT02652949|532397200|FG000|30-Day Follow-up for Secondary Endpoint|Death|1|||
147612975|NCT02652949|532397200|FG000|6-Month Follow-up Secondary Endpoint|Death|5|||
147612976|NCT02652949|532397200|FG000|6-Month Follow-up Secondary Endpoint|Withdrawal by Subject|2|||
147612977|NCT02652949|532397200|FG000|6-Month Follow-up Secondary Endpoint|Lost to Follow-up|1|||
147612978|NCT02652949|532397200|FG000|12-Month Follow-up Secondary Endpoint|Death|4|||
147612979|NCT02652949|532397200|FG000|24-Month Follow-up Secondary Endpoint|Death|2|||
147612980|NCT02652949|532397200|FG000|24-Month Follow-up Secondary Endpoint|Withdrawal by Subject|3|||
147612981|NCT02652949|532397200|FG000|24-Month Follow-up Secondary Endpoint|Lost to Follow-up|2|||
147612982|NCT02652949|532397200|FG000|24-Month Follow-up Secondary Endpoint|Subject declined reconsenting to extended follow-up out to 5 years|28|||
147612983|NCT02652949|532397200|FG000|36-Month Follow-up Secondary Endpoint|Death|2|||
147612984|NCT02652949|532397200|FG000|36-Month Follow-up Secondary Endpoint|Withdrawal by Subject|2|||
147612985|NCT02652949|532397200|FG000|48-Month Follow-up Secondary Endpoint|Death|4|||
147612986|NCT02652949|532397200|FG000|48-Month Follow-up Secondary Endpoint|Lost to Follow-up|1|||
147612987|NCT02652949|532397200|FG000|48-Month Follow-up Secondary Endpoint|Withdrawal by Subject|1|||
147612988|NCT02652949|532397200|FG000|60-Month Follow-up Secondary Endpoint|Death|5|||
147612989|NCT02652949|532397200|FG000|60-Month Follow-up Secondary Endpoint|Withdrawal by Subject|1|||
147612990|NCT00699816|532397201|FG000|Overall Study|Protocol Violation|1|||
147612991|NCT00699816|532397202|FG001|Overall Study|Protocol Violation|3|||
147612992|NCT01569295|532397203|FG000|Overall Study|Progressive Disease|75|||
147612993|NCT01569295|532397204|FG001|Overall Study|Progressive Disease|139|||
147612994|NCT01569295|532397203|FG000|Overall Study|Adverse Event|39|||
147612995|NCT01569295|532397204|FG001|Overall Study|Adverse Event|14|||
147612996|NCT01569295|532397203|FG000|Overall Study|Withdrawal by Subject|25|||
147612997|NCT01569295|532397204|FG001|Overall Study|Withdrawal by Subject|12|||
147612998|NCT01569295|532397203|FG000|Overall Study|Death|19|||
147612999|NCT01569295|532397204|FG001|Overall Study|Death|15|||
147613000|NCT01569295|532397203|FG000|Overall Study|Physician Decision|13|||
147613001|NCT01569295|532397204|FG001|Overall Study|Physician Decision|18|||
147613002|NCT01569295|532397203|FG000|Overall Study|Study Terminated by Sponsor|24|||
147613003|NCT01569295|532397204|FG001|Overall Study|Study Terminated by Sponsor|2|||
147613004|NCT01569295|532397203|FG000|Overall Study|Other Reason not Specified|3|||
147613005|NCT01569295|532397204|FG001|Overall Study|Other Reason not Specified|5|||
147613006|NCT01569295|532397203|FG000|Overall Study|Non-Compliance with Study Drug|6|||
147613007|NCT01569295|532397204|FG001|Overall Study|Non-Compliance with Study Drug|1|||
147613008|NCT01569295|532397203|FG000|Overall Study|Other Anticancer/Experimental Therapy|2|||
147613009|NCT01569295|532397204|FG001|Overall Study|Other Anticancer/Experimental Therapy|2|||
147613010|NCT01569295|532397203|FG000|Overall Study|Lost to Follow-up|1|||
147613011|NCT01569295|532397204|FG001|Overall Study|Lost to Follow-up|1|||
147613012|NCT02508935|532397205|FG000|Overall Study|Withdrawal by Subject|1|||
147613013|NCT02508935|532397205|FG000|Overall Study|Withdrawal by Caregiver|8|||
147613014|NCT02508935|532397205|FG000|Overall Study|Pain Score <4|1|||
147613015|NCT02508935|532397205|FG000|Overall Study|Emesis|3|||
147613016|NCT02508935|532397205|FG000|Overall Study|Adverse Event|3|||
147613017|NCT02508935|532397205|FG000|Overall Study|Protocol Violation|1|||
147613018|NCT02508935|532397205|FG000|Overall Study|Physician Decision|1|||
147613019|NCT02508935|532397205|FG000|Overall Study|Trial terminated by sponsor|5|||
147613020|NCT02125877|532397206|FG000|Overall Study|Physician Decision|1|||
147613021|NCT02125877|532397207|FG001|Overall Study|Physician Decision|0|||
147613022|NCT02125877|532397206|FG000|Overall Study|Death|0|||
147613023|NCT02125877|532397207|FG001|Overall Study|Death|1|||
147613024|NCT02125877|532397206|FG000|Overall Study|Administrative problems|0|||
147613025|NCT02125877|532397207|FG001|Overall Study|Administrative problems|1|||
147613026|NCT02125877|532397206|FG000|Overall Study|Participant/guardian decision|0|||
147613027|NCT02125877|532397207|FG001|Overall Study|Participant/guardian decision|2|||
147613028|NCT02125877|532397206|FG000|Overall Study|Withdrawal by Subject|2|||
147613029|NCT02125877|532397207|FG001|Overall Study|Withdrawal by Subject|1|||
147613030|NCT02125877|532397206|FG000|Overall Study|Protocol deviation|4|||
147613031|NCT02125877|532397207|FG001|Overall Study|Protocol deviation|1|||
147613032|NCT02125877|532397206|FG000|Overall Study|Adverse Event|6|||
147613033|NCT02125877|532397207|FG001|Overall Study|Adverse Event|4|||
147613034|NCT01973595|532397208|FG000|Washout|Withdrawal by Subject|1|||
147613035|NCT01973595|532397209|FG001|Washout|Withdrawal by Subject|0|||
147613036|NCT01973595|532397210|FG002|Washout|Withdrawal by Subject|1|||
147456015|NCT01072344|531831661|FG000|Overall Study|Protocol Violation|1|||
147379082|NCT02066636|531553129|FG001|Overall Study|Disease progression|60|||
147379083|NCT02066636|531553130|FG002|Overall Study|Disease progression|700|||
147379084|NCT02066636|531553128|FG000|Overall Study|Study drug toxicity|13|||
147379085|NCT02066636|531553129|FG001|Overall Study|Study drug toxicity|2|||
147379086|NCT02066636|531553130|FG002|Overall Study|Study drug toxicity|58|||
147379087|NCT02066636|531553128|FG000|Overall Study|Death|4|||
147379088|NCT02066636|531553129|FG001|Overall Study|Death|2|||
147379089|NCT02066636|531553130|FG002|Overall Study|Death|158|||
147379090|NCT02066636|531553128|FG000|Overall Study|Adverse event unrelated to study drug|6|||
147379091|NCT02066636|531553129|FG001|Overall Study|Adverse event unrelated to study drug|4|||
147379092|NCT02066636|531553130|FG002|Overall Study|Adverse event unrelated to study drug|45|||
147379093|NCT02066636|531553128|FG000|Overall Study|Participant request to discontinue treatment|12|||
147379094|NCT02066636|531553129|FG001|Overall Study|Participant request to discontinue treatment|12|||
147379095|NCT02066636|531553130|FG002|Overall Study|Participant request to discontinue treatment|70|||
147379096|NCT02066636|531553128|FG000|Overall Study|Participant withdrew consent|10|||
147379097|NCT02066636|531553129|FG001|Overall Study|Participant withdrew consent|18|||
147379098|NCT02066636|531553130|FG002|Overall Study|Participant withdrew consent|61|||
147379099|NCT02066636|531553128|FG000|Overall Study|Lost to Follow-up|0|||
147379100|NCT02066636|531553129|FG001|Overall Study|Lost to Follow-up|2|||
147379101|NCT02066636|531553130|FG002|Overall Study|Lost to Follow-up|2|||
147379102|NCT02066636|531553128|FG000|Overall Study|Maximum clinical benefit|2|||
147379103|NCT02066636|531553129|FG001|Overall Study|Maximum clinical benefit|2|||
147379104|NCT02066636|531553130|FG002|Overall Study|Maximum clinical benefit|3|||
147379105|NCT02066636|531553128|FG000|Overall Study|Poor/non-compliance|2|||
147379106|NCT02066636|531553129|FG001|Overall Study|Poor/non-compliance|1|||
147379107|NCT02066636|531553130|FG002|Overall Study|Poor/non-compliance|1|||
147379108|NCT02066636|531553128|FG000|Overall Study|Participant no loner meets study criteria|3|||
147379109|NCT02066636|531553129|FG001|Overall Study|Participant no loner meets study criteria|2|||
147379110|NCT02066636|531553130|FG002|Overall Study|Participant no loner meets study criteria|28|||
147379111|NCT02066636|531553128|FG000|Overall Study|Administrative reasons by sponsor|8|||
147456016|NCT01072344|531831662|FG001|Overall Study|Protocol Violation|2|||
147456017|NCT01072344|531831661|FG000|Overall Study|Lost to Follow-up|3|||
147456018|NCT01072344|531831662|FG001|Overall Study|Lost to Follow-up|4|||
147379112|NCT02066636|531553129|FG001|Overall Study|Administrative reasons by sponsor|5|||
147379113|NCT02066636|531553130|FG002|Overall Study|Administrative reasons by sponsor|0|||
147379114|NCT02066636|531553128|FG000|Overall Study|Other reasons|16|||
147456019|NCT02944448|531831672|FG000|Overall Study|Adverse Event|37|||
147456020|NCT02944448|531831673|FG001|Overall Study|Adverse Event|6|||
147456021|NCT02944448|531831672|FG000|Overall Study|Lack of Efficacy|8|||
147613037|NCT01973595|532397211|FG003|Washout|Withdrawal by Subject|0|||
147613038|NCT02800642|532397220|FG000|Overall Study|Death|3|||
147613039|NCT02800642|532397220|FG000|Overall Study|Other|10|||
147613040|NCT02800642|532397220|FG000|Overall Study|Physician Decision|2|||
147613041|NCT02800642|532397220|FG000|Overall Study|Adverse Event|6|||
147613042|NCT02800642|532397220|FG000|Overall Study|Withdrawal by Subject|3|||
147613043|NCT02800642|532397220|FG000|Overall Study|Lost to Follow-up|1|||
147613044|NCT04868500|532397221|FG000|Overall Study|Participants and Clinical Site Staff terminated early|3|||
147613045|NCT04868500|532397222|FG001|Overall Study|Participants and Clinical Site Staff terminated early|1|||
147613046|NCT04868500|532397221|FG000|Overall Study|Participants and Clinical Site Staff never opened App|1|||
147613047|NCT04868500|532397222|FG001|Overall Study|Participants and Clinical Site Staff never opened App|0|||
147613048|NCT01941498|532397226|FG000|Overall Study|Relocated out of state|1|||
147613049|NCT05299528|532397227|FG000|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|0|||
147613050|NCT05299528|532397228|FG001|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|4|||
147613051|NCT05299528|532397229|FG002|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|0|||
147613052|NCT05299528|532397230|FG003|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|0|||
147613053|NCT05299528|532397231|FG004|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|0|||
147613054|NCT05299528|532397232|FG005|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|0|||
147613055|NCT05299528|532397233|FG006|Phase 1 Patient Recruitment|4 patient participants were not eligible after consent.|0|||
147613056|NCT05299528|532397227|FG000|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|0|||
147613057|NCT05299528|532397228|FG001|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|0|||
147613058|NCT05299528|532397229|FG002|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|0|||
147613059|NCT05299528|532397230|FG003|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|0|||
147613060|NCT05299528|532397231|FG004|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|0|||
147613061|NCT05299528|532397232|FG005|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|1|||
147613062|NCT05299528|532397233|FG006|Phase 2 Patient Recruitment|Participant was determined to be ineligible after consent|0|||
147613063|NCT05299528|532397227|FG000|Surgeon Follow-up|Lost to Follow-up|0|||
147613064|NCT05299528|532397228|FG001|Surgeon Follow-up|Lost to Follow-up|0|||
147379115|NCT02066636|531553129|FG001|Overall Study|Other reasons|15|||
147379116|NCT02066636|531553130|FG002|Overall Study|Other reasons|50|||
147379117|NCT00391170|531553133|FG000|Overall Study|Withdrawal by Subject|1|||
147379118|NCT00391170|531553134|FG001|Overall Study|Withdrawal by Subject|0|||
147379119|NCT00391170|531553133|FG000|Overall Study|Adverse Event|3|||
147379120|NCT00391170|531553134|FG001|Overall Study|Adverse Event|2|||
147379121|NCT00391170|531553133|FG000|Overall Study|Physician Decision|2|||
147379122|NCT00391170|531553134|FG001|Overall Study|Physician Decision|2|||
147379123|NCT03567616|531553139|FG000|Overall Study|Disease progression|4|||
147379124|NCT03567616|531553139|FG000|Overall Study|Withdrawal by Subject|1|||
147379125|NCT03567616|531553139|FG000|Overall Study|Physician Decision|1|||
147379126|NCT03567616|531553139|FG000|Overall Study|Death|1|||
147379127|NCT03567616|531553139|FG000|Overall Study|Adverse Event|1|||
147379128|NCT00526994|531553144|FG000|Overall Study|Lost to Follow-up|98|||
147379129|NCT00526994|531553145|FG001|Overall Study|Lost to Follow-up|108|||
147379130|NCT00526994|531553146|FG002|Overall Study|Lost to Follow-up|96|||
147379131|NCT00526994|531553144|FG000|Overall Study|Death|4|||
147379132|NCT00526994|531553145|FG001|Overall Study|Death|3|||
147379133|NCT00526994|531553146|FG002|Overall Study|Death|3|||
147379134|NCT00526994|531553144|FG000|Overall Study|Withdrawal by Subject|2|||
147379135|NCT00526994|531553145|FG001|Overall Study|Withdrawal by Subject|7|||
147379136|NCT00526994|531553146|FG002|Overall Study|Withdrawal by Subject|5|||
147379137|NCT00526994|531553144|FG000|Overall Study|incarcerated, impaired, incomplete|4|||
147379138|NCT00526994|531553145|FG001|Overall Study|incarcerated, impaired, incomplete|3|||
147379139|NCT00526994|531553146|FG002|Overall Study|incarcerated, impaired, incomplete|3|||
147379140|NCT02833948|531553149|FG000|Overall Study|Death|2|||
147379141|NCT02833948|531553150|FG001|Overall Study|Death|3|||
147379142|NCT02833948|531553149|FG000|Overall Study|were not scanned|8|||
147379143|NCT02833948|531553150|FG001|Overall Study|were not scanned|13|||
147379144|NCT02833948|531553149|FG000|Overall Study|scans could not be evaluated|5|||
147379145|NCT02833948|531553150|FG001|Overall Study|scans could not be evaluated|2|||
147379146|NCT05169684|531553154|FG000|Overall Study|Adverse Event|1|||
147379147|NCT05169684|531553155|FG001|Overall Study|Adverse Event|3|||
147379148|NCT05169684|531553154|FG000|Overall Study|Physician Decision|0|||
147379149|NCT05169684|531553155|FG001|Overall Study|Physician Decision|1|||
147379150|NCT05169684|531553154|FG000|Overall Study|Progressive Disease|1|||
147379151|NCT05169684|531553155|FG001|Overall Study|Progressive Disease|1|||
147379152|NCT05169684|531553154|FG000|Overall Study|Participant request to discontinue treatment|0|||
147379153|NCT05169684|531553155|FG001|Overall Study|Participant request to discontinue treatment|1|||
147379154|NCT05169684|531553154|FG000|Overall Study|Other Reason|0|||
147379155|NCT05169684|531553155|FG001|Overall Study|Other Reason|1|||
147379156|NCT03539055|531553156|FG000|Overall Study|Death|4|||
147379157|NCT03539055|531553156|FG000|Overall Study|Lost to Follow-up|1|||
147379158|NCT03539055|531553156|FG000|Overall Study|Withdrawal by Subject|2|||
147613065|NCT05299528|532397229|FG002|Surgeon Follow-up|Lost to Follow-up|1|||
147613066|NCT05299528|532397230|FG003|Surgeon Follow-up|Lost to Follow-up|0|||
147613067|NCT05299528|532397231|FG004|Surgeon Follow-up|Lost to Follow-up|0|||
147613068|NCT05299528|532397232|FG005|Surgeon Follow-up|Lost to Follow-up|0|||
147613069|NCT05299528|532397233|FG006|Surgeon Follow-up|Lost to Follow-up|0|||
147613070|NCT00490841|532397234|FG000|Overall Study|Death|5|||
147613071|NCT00490841|532397234|FG000|Overall Study|Withdrawal by Subject|4|||
147613072|NCT00490841|532397234|FG000|Overall Study|Lost to Follow-up|1|||
147613073|NCT00490841|532397234|FG000|Overall Study|30 day f/u, only non-study stent used|3|||
147613074|NCT04697069|532397235|FG000|Overall Study|Withdrew consent due to possible/perceived lack of efficacy by participants|0|||
147613075|NCT04697069|532397236|FG001|Overall Study|Withdrew consent due to possible/perceived lack of efficacy by participants|1|||
147613076|NCT04697069|532397235|FG000|Overall Study|Study termination|2|||
147613077|NCT04697069|532397236|FG001|Overall Study|Study termination|1|||
147613078|NCT02779855|532397237|FG000|Overall Study|Withdrawal by patient prior to treatment|1|||
147613079|NCT02779855|532397238|FG001|Overall Study|Withdrawal by patient prior to treatment|0|||
147613080|NCT02779855|532397239|FG002|Overall Study|Withdrawal by patient prior to treatment|0|||
147613081|NCT01301729|532397240|FG000|Overall Study|Withdrawal by Subject|2|||
147379159|NCT03539055|531553156|FG000|Overall Study|Screen Fail|7|||
147379160|NCT03539055|531553156|FG000|Overall Study|Drug Intolerance|2|||
147613082|NCT01301729|532397240|FG000|Overall Study|Participant did not Return for Treatment|1|||
147613083|NCT01301729|532397240|FG000|Overall Study|Violated Selection Criteria|1|||
147379161|NCT00875706|531553160|FG000|Overall Study|Withdrawal by Subject|1|||
147379162|NCT00875706|531553161|FG001|Overall Study|Withdrawal by Subject|0|||
147379163|NCT00875706|531553162|FG002|Overall Study|Withdrawal by Subject|0|||
147379164|NCT03775213|531553163|FG000|Overall Study|Withdrawal by Subject|51|||
147379165|NCT03775213|531553164|FG001|Overall Study|Withdrawal by Subject|53|||
147613084|NCT00912912|532397241|FG000|Overall Study|Withdrawal by Subject|1|||
147613085|NCT00912912|532397241|FG000|Overall Study|Disease Progression|3|||
147379166|NCT03775213|531553163|FG000|Overall Study|Incomplete Survey|7|||
147379167|NCT03775213|531553164|FG001|Overall Study|Incomplete Survey|7|||
147379168|NCT00786188|531553165|FG000|Overall Study|Adverse Event|3|||
147379169|NCT00786188|531553166|FG001|Overall Study|Adverse Event|1|||
147379170|NCT00786188|531553165|FG000|Overall Study|Withdrawal by Subject|2|||
147379171|NCT00786188|531553166|FG001|Overall Study|Withdrawal by Subject|0|||
147379172|NCT05163353|531553170|FG000|Overall Study|Adverse Event|1|||
147379173|NCT05163353|531553171|FG001|Overall Study|Adverse Event|0|||
147379174|NCT05163353|531553170|FG000|Overall Study|Withdrawal by Subject|21|||
147379175|NCT05163353|531553171|FG001|Overall Study|Withdrawal by Subject|6|||
147379176|NCT05163353|531553170|FG000|Overall Study|Protocol Violation|0|||
147379177|NCT05163353|531553171|FG001|Overall Study|Protocol Violation|1|||
147379178|NCT05163353|531553170|FG000|Overall Study|Lost to Follow-up|13|||
147379179|NCT05163353|531553171|FG001|Overall Study|Lost to Follow-up|2|||
147379180|NCT06086028|531553173|FG000|Overall Study|Withdrawal by Subject|1|||
147379181|NCT06086028|531553174|FG001|Overall Study|Withdrawal by Subject|1|||
147379182|NCT06086028|531553173|FG000|Overall Study|Lost to Follow-up|2|||
147379183|NCT06086028|531553174|FG001|Overall Study|Lost to Follow-up|3|||
147379184|NCT00824408|531553175|FG000|Run-in Phase|Progressive disease|4|||
147379185|NCT00824408|531553176|FG001|Run-in Phase|Progressive disease|4|||
147379186|NCT00824408|531553177|FG002|Run-in Phase|Progressive disease|0|||
147379187|NCT00824408|531553178|FG003|Run-in Phase|Progressive disease|0|||
147379188|NCT00824408|531553179|FG004|Run-in Phase|Progressive disease|0|||
147379189|NCT00824408|531553175|FG000|Run-in Phase|Adverse Event|1|||
147379190|NCT00824408|531553176|FG001|Run-in Phase|Adverse Event|1|||
147379191|NCT00824408|531553177|FG002|Run-in Phase|Adverse Event|0|||
147379192|NCT00824408|531553178|FG003|Run-in Phase|Adverse Event|0|||
147379193|NCT00824408|531553179|FG004|Run-in Phase|Adverse Event|0|||
147379194|NCT00824408|531553175|FG000|Run-in Phase|Refused to continue medication|1|||
147379195|NCT00824408|531553176|FG001|Run-in Phase|Refused to continue medication|0|||
147379196|NCT00824408|531553177|FG002|Run-in Phase|Refused to continue medication|0|||
147379197|NCT00824408|531553178|FG003|Run-in Phase|Refused to continue medication|0|||
147379198|NCT00824408|531553179|FG004|Run-in Phase|Refused to continue medication|0|||
147379199|NCT00824408|531553175|FG000|Run-in Phase|Other reason not defined above|0|||
147379200|NCT00824408|531553176|FG001|Run-in Phase|Other reason not defined above|1|||
147379201|NCT00824408|531553177|FG002|Run-in Phase|Other reason not defined above|0|||
147379202|NCT00824408|531553178|FG003|Run-in Phase|Other reason not defined above|0|||
147379203|NCT00824408|531553179|FG004|Run-in Phase|Other reason not defined above|0|||
147379204|NCT00824408|531553175|FG000|Randomized Phase|Not treated|0|||
147379205|NCT00824408|531553176|FG001|Randomized Phase|Not treated|0|||
147379206|NCT00824408|531553177|FG002|Randomized Phase|Not treated|1|||
147379207|NCT00824408|531553178|FG003|Randomized Phase|Not treated|1|||
147379208|NCT00824408|531553179|FG004|Randomized Phase|Not treated|1|||
147379209|NCT00824408|531553175|FG000|Randomized Phase|Progressive disease|0|||
147379210|NCT00824408|531553176|FG001|Randomized Phase|Progressive disease|0|||
147379211|NCT00824408|531553177|FG002|Randomized Phase|Progressive disease|25|||
147379212|NCT00824408|531553178|FG003|Randomized Phase|Progressive disease|36|||
147379213|NCT00824408|531553179|FG004|Randomized Phase|Progressive disease|34|||
147379214|NCT00824408|531553175|FG000|Randomized Phase|Adverse Event|0|||
147379215|NCT00824408|531553176|FG001|Randomized Phase|Adverse Event|0|||
147379216|NCT00824408|531553177|FG002|Randomized Phase|Adverse Event|4|||
147379217|NCT00824408|531553178|FG003|Randomized Phase|Adverse Event|5|||
147379218|NCT00824408|531553179|FG004|Randomized Phase|Adverse Event|5|||
147379219|NCT00824408|531553175|FG000|Randomized Phase|Refused to continue medication|0|||
147379220|NCT00824408|531553176|FG001|Randomized Phase|Refused to continue medication|0|||
147379221|NCT00824408|531553177|FG002|Randomized Phase|Refused to continue medication|2|||
147379222|NCT00824408|531553178|FG003|Randomized Phase|Refused to continue medication|2|||
147379223|NCT00824408|531553179|FG004|Randomized Phase|Refused to continue medication|2|||
147379224|NCT00824408|531553175|FG000|Randomized Phase|Other reason not defined above|0|||
147379225|NCT00824408|531553176|FG001|Randomized Phase|Other reason not defined above|0|||
147379226|NCT00824408|531553177|FG002|Randomized Phase|Other reason not defined above|4|||
147379227|NCT00824408|531553178|FG003|Randomized Phase|Other reason not defined above|2|||
147379228|NCT00824408|531553179|FG004|Randomized Phase|Other reason not defined above|4|||
147379229|NCT04821271|531553180|FG000|Period 1|Withdrawal by Subject|2|||
147379230|NCT04821271|531553181|FG001|Period 1|Withdrawal by Subject|0|||
147379231|NCT02521493|531553183|FG000|Overall Study|Death|3|||
147379232|NCT02521493|531553184|FG001|Overall Study|Death|4|||
147379233|NCT02521493|531553185|FG002|Overall Study|Death|1|||
147379234|NCT02521493|531553183|FG000|Overall Study|Physician Decision|19|||
147379235|NCT02521493|531553184|FG001|Overall Study|Physician Decision|1|||
147379236|NCT02521493|531553185|FG002|Overall Study|Physician Decision|2|||
147379237|NCT02521493|531553183|FG000|Overall Study|Withdrawal by Subject|3|||
147379238|NCT02521493|531553184|FG001|Overall Study|Withdrawal by Subject|0|||
147379239|NCT02521493|531553185|FG002|Overall Study|Withdrawal by Subject|0|||
147379240|NCT02521493|531553183|FG000|Overall Study|Ineligible|0|||
147379241|NCT02521493|531553184|FG001|Overall Study|Ineligible|1|||
147379242|NCT02521493|531553185|FG002|Overall Study|Ineligible|0|||
147379243|NCT02521493|531553183|FG000|Overall Study|Post Amd4A (MRD < 0.05%)|0|||
147379244|NCT02521493|531553184|FG001|Overall Study|Post Amd4A (MRD < 0.05%)|0|||
147379245|NCT02521493|531553185|FG002|Overall Study|Post Amd4A (MRD < 0.05%)|115|||
147379246|NCT02521493|531553183|FG000|Overall Study|No MRD result|0|||
147379247|NCT02521493|531553184|FG001|Overall Study|No MRD result|0|||
147379248|NCT02521493|531553185|FG002|Overall Study|No MRD result|4|||
147379249|NCT04083781|531553186|FG000|Main Part|Physician Decision|0|||
147379250|NCT04083781|531553187|FG001|Main Part|Physician Decision|1|||
147379251|NCT04083781|531553188|FG002|Main Part|Physician Decision|2|||
147379252|NCT04083781|531553189|FG003|Main Part|Physician Decision|0|||
147379253|NCT04083781|531553186|FG000|Main Part|Death|1|||
147379254|NCT04083781|531553187|FG001|Main Part|Death|3|||
147379255|NCT04083781|531553188|FG002|Main Part|Death|1|||
147379256|NCT04083781|531553189|FG003|Main Part|Death|0|||
147379257|NCT04083781|531553186|FG000|Main Part|Withdrawal by Subject|5|||
147379258|NCT04083781|531553187|FG001|Main Part|Withdrawal by Subject|2|||
147379259|NCT04083781|531553188|FG002|Main Part|Withdrawal by Subject|3|||
147379260|NCT04083781|531553189|FG003|Main Part|Withdrawal by Subject|7|||
147379261|NCT04083781|531553186|FG000|Extension Part|Physician Decision|0|||
147379262|NCT04083781|531553187|FG001|Extension Part|Physician Decision|0|||
147379263|NCT04083781|531553188|FG002|Extension Part|Physician Decision|0|||
147379264|NCT04083781|531553189|FG003|Extension Part|Physician Decision|1|||
147379265|NCT04083781|531553186|FG000|Extension Part|Death|0|||
147379266|NCT04083781|531553187|FG001|Extension Part|Death|1|||
147379267|NCT04083781|531553188|FG002|Extension Part|Death|0|||
147379268|NCT04083781|531553189|FG003|Extension Part|Death|1|||
147379269|NCT04083781|531553186|FG000|Extension Part|Withdrawal by Subject|0|||
147379270|NCT04083781|531553187|FG001|Extension Part|Withdrawal by Subject|1|||
147379271|NCT04083781|531553188|FG002|Extension Part|Withdrawal by Subject|0|||
147379272|NCT04083781|531553189|FG003|Extension Part|Withdrawal by Subject|0|||
147379273|NCT04083781|531553186|FG000|Extension Part|Ongoing|13|||
147613086|NCT05422625|532397242|FG000|Overall Study|Withdrawal by Subject|1|||
147613087|NCT05422625|532397243|FG001|Overall Study|Withdrawal by Subject|0|||
147613088|NCT05938621|532398819|FG000|Overall Study|Lost to Follow-up|1|||
147613089|NCT05938621|532398820|FG001|Overall Study|Lost to Follow-up|5|||
147613090|NCT05938621|532398821|FG002|Overall Study|Lost to Follow-up|2|||
147613091|NCT05938621|532398822|FG003|Overall Study|Lost to Follow-up|2|||
147613092|NCT04205812|532398824|FG000|Randomized Treatment Period|Ongoing|28|||
147613093|NCT04205812|532398825|FG001|Randomized Treatment Period|Ongoing|138|||
147613094|NCT04205812|532398824|FG000|Randomized Treatment Period|Death|94|||
147613095|NCT04205812|532398825|FG001|Randomized Treatment Period|Death|226|||
147613096|NCT04205812|532398824|FG000|Randomized Treatment Period|Lost to Follow-up|5|||
147613097|NCT04205812|532398825|FG001|Randomized Treatment Period|Lost to Follow-up|11|||
147613098|NCT04205812|532398824|FG000|Randomized Treatment Period|Physician Decision|1|||
147613099|NCT04205812|532398825|FG001|Randomized Treatment Period|Physician Decision|4|||
147613100|NCT04205812|532398824|FG000|Randomized Treatment Period|Withdrawal by Subject|4|||
147613101|NCT04205812|532398825|FG001|Randomized Treatment Period|Withdrawal by Subject|11|||
147613102|NCT04205812|532398824|FG000|Randomized Treatment Period|Progressive Disease|0|||
147613103|NCT04205812|532398825|FG001|Randomized Treatment Period|Progressive Disease|1|||
147613104|NCT04205812|532398824|FG000|Randomized Treatment Period|Met Exclusion Criteria|1|||
147613105|NCT04205812|532398825|FG001|Randomized Treatment Period|Met Exclusion Criteria|0|||
147613106|NCT04205812|532398824|FG000|Monotherapy Treatment Period|Ongoing|17|||
147613107|NCT04205812|532398825|FG001|Monotherapy Treatment Period|Ongoing|0|||
147613108|NCT04205812|532398824|FG000|Monotherapy Treatment Period|Death|39|||
147613109|NCT04205812|532398825|FG001|Monotherapy Treatment Period|Death|0|||
147613110|NCT04205812|532398824|FG000|Monotherapy Treatment Period|Lost to Follow-up|2|||
147613111|NCT04205812|532398825|FG001|Monotherapy Treatment Period|Lost to Follow-up|0|||
147613112|NCT04205812|532398824|FG000|Monotherapy Treatment Period|Withdrawal by Subject|1|||
147613113|NCT04205812|532398825|FG001|Monotherapy Treatment Period|Withdrawal by Subject|0|||
147613114|NCT04559347|532398826|FG000|Overall Study|Death|1|||
147613115|NCT04559347|532398827|FG001|Overall Study|Death|0|||
147613116|NCT04559347|532398826|FG000|Overall Study|Thoracotomy conversion|1|||
147613117|NCT04559347|532398827|FG001|Overall Study|Thoracotomy conversion|1|||
147613118|NCT04559347|532398826|FG000|Overall Study|Provider unavailable|2|||
147613119|NCT04559347|532398827|FG001|Overall Study|Provider unavailable|1|||
147613120|NCT04559347|532398826|FG000|Overall Study|Other|2|||
147613121|NCT04559347|532398827|FG001|Overall Study|Other|1|||
147613122|NCT00371033|532398828|FG000|Overall Study|Lost to Follow-up|3|||
147613123|NCT00371033|532398829|FG001|Overall Study|Lost to Follow-up|2|||
147613124|NCT00371033|532398828|FG000|Overall Study|No longer interested|2|||
147379274|NCT04083781|531553187|FG001|Extension Part|Ongoing|25|||
147379275|NCT04083781|531553188|FG002|Extension Part|Ongoing|15|||
147379276|NCT04083781|531553189|FG003|Extension Part|Ongoing|51|||
147379277|NCT02334215|531553192|FG000|Overall Study|Death|1|||
147379278|NCT02334215|531553193|FG001|Overall Study|Death|1|||
147613125|NCT00371033|532398829|FG001|Overall Study|No longer interested|0|||
147613126|NCT00371033|532398828|FG000|Overall Study|Uknown|3|||
147613127|NCT00371033|532398829|FG001|Overall Study|Uknown|1|||
147613128|NCT01625988|532398841|FG000|Overall Study|Lost to Follow-up|5|||
147613129|NCT01625988|532398842|FG001|Overall Study|Lost to Follow-up|6|||
147379279|NCT02334215|531553194|FG002|Overall Study|Death|0|||
147379280|NCT02334215|531553192|FG000|Overall Study|Lost to Follow-up|1|||
147379281|NCT02334215|531553193|FG001|Overall Study|Lost to Follow-up|0|||
147613130|NCT01625988|532398841|FG000|Overall Study|Withdrawal by Subject|8|||
147613131|NCT01625988|532398842|FG001|Overall Study|Withdrawal by Subject|3|||
147613132|NCT01625988|532398841|FG000|Overall Study|Adverse Event|0|||
147613133|NCT01625988|532398842|FG001|Overall Study|Adverse Event|1|||
147613134|NCT01625988|532398841|FG000|Overall Study|Lack of Efficacy|0|||
147613135|NCT01625988|532398842|FG001|Overall Study|Lack of Efficacy|1|||
147613136|NCT01625988|532398841|FG000|Overall Study|Randomized Inappropriately|1|||
147613137|NCT01625988|532398842|FG001|Overall Study|Randomized Inappropriately|0|||
147613138|NCT01625988|532398841|FG000|Overall Study|Protocol Violation|0|||
147613139|NCT01625988|532398842|FG001|Overall Study|Protocol Violation|2|||
147613140|NCT04152863|532398843|FG000|Overall Study|Death|13|||
147613141|NCT04152863|532398844|FG001|Overall Study|Death|12|||
147613142|NCT04152863|532398845|FG002|Overall Study|Death|7|||
147613143|NCT04152863|532398843|FG000|Overall Study|Physician Decision|1|||
147613144|NCT04152863|532398844|FG001|Overall Study|Physician Decision|1|||
147613145|NCT04152863|532398845|FG002|Overall Study|Physician Decision|1|||
147613146|NCT04152863|532398843|FG000|Overall Study|Participation in Study Terminated by Sponsor|12|||
147613147|NCT04152863|532398844|FG001|Overall Study|Participation in Study Terminated by Sponsor|14|||
147613148|NCT04152863|532398845|FG002|Overall Study|Participation in Study Terminated by Sponsor|18|||
147613149|NCT04152863|532398843|FG000|Overall Study|Withdrawal by Subject|2|||
147613150|NCT04152863|532398844|FG001|Overall Study|Withdrawal by Subject|1|||
147613151|NCT04152863|532398845|FG002|Overall Study|Withdrawal by Subject|3|||
147613152|NCT01644617|532398846|FG000|Overall Study|Withdrawal by Subject|3|||
147613153|NCT01644617|532398847|FG001|Overall Study|Withdrawal by Subject|4|||
147613154|NCT01644617|532398848|FG002|Overall Study|Withdrawal by Subject|1|||
147613155|NCT01644617|532398846|FG000|Overall Study|Lost to Follow-up|0|||
147613156|NCT01644617|532398847|FG001|Overall Study|Lost to Follow-up|1|||
147613157|NCT01644617|532398848|FG002|Overall Study|Lost to Follow-up|0|||
147613158|NCT01644617|532398846|FG000|Overall Study|Adverse Event|3|||
147613159|NCT01644617|532398847|FG001|Overall Study|Adverse Event|0|||
147613160|NCT01644617|532398848|FG002|Overall Study|Adverse Event|6|||
147613161|NCT02276807|532398849|FG000|Overall Study|Withdrawal by Subject|8|||
147613162|NCT02276807|532398850|FG001|Overall Study|Withdrawal by Subject|7|||
147613163|NCT02276807|532398849|FG000|Overall Study|Lost to Follow-up|10|||
147613164|NCT02276807|532398850|FG001|Overall Study|Lost to Follow-up|10|||
147613165|NCT04342819|532398858|FG000|Overall Study|Declined|4|||
147613166|NCT04342819|532398858|FG000|Overall Study|Not meeeting selection criteria|1|||
147613167|NCT02287922|532398859|FG000|Overall Study|Adverse Event|1|||
147613168|NCT02287922|532398860|FG001|Overall Study|Adverse Event|1|||
147613169|NCT02287922|532398861|FG002|Overall Study|Adverse Event|3|||
147613170|NCT02287922|532398862|FG003|Overall Study|Adverse Event|4|||
147613171|NCT02287922|532398859|FG000|Overall Study|Withdrawal by Subject|1|||
147613172|NCT02287922|532398860|FG001|Overall Study|Withdrawal by Subject|1|||
147613173|NCT02287922|532398861|FG002|Overall Study|Withdrawal by Subject|1|||
147613174|NCT02287922|532398862|FG003|Overall Study|Withdrawal by Subject|2|||
147613175|NCT02287922|532398859|FG000|Overall Study|Lost to Follow-up|0|||
147613176|NCT02287922|532398860|FG001|Overall Study|Lost to Follow-up|0|||
147613177|NCT02287922|532398861|FG002|Overall Study|Lost to Follow-up|1|||
147613178|NCT02287922|532398862|FG003|Overall Study|Lost to Follow-up|0|||
147613179|NCT02287922|532398859|FG000|Overall Study|Sponsor's decision|0|||
147613180|NCT02287922|532398860|FG001|Overall Study|Sponsor's decision|0|||
147613181|NCT02287922|532398861|FG002|Overall Study|Sponsor's decision|0|||
147613182|NCT02287922|532398862|FG003|Overall Study|Sponsor's decision|1|||
147613183|NCT02287922|532398859|FG000|Overall Study|Other|1|||
147613184|NCT02287922|532398860|FG001|Overall Study|Other|0|||
147613185|NCT02287922|532398861|FG002|Overall Study|Other|2|||
147613186|NCT02287922|532398862|FG003|Overall Study|Other|0|||
147613187|NCT00668317|532398863|FG000|Overall Study|Adverse Event|2|||
147613188|NCT03607487|532398876|FG000|Overall Study|Withdrawal by Subject|2|||
147613189|NCT03607487|532398877|FG001|Overall Study|Withdrawal by Subject|0|||
147613190|NCT03607487|532398878|FG002|Overall Study|Withdrawal by Subject|0|||
147613191|NCT03607487|532398879|FG003|Overall Study|Withdrawal by Subject|1|||
147613192|NCT01884337|532398880|FG000|Treatment|Adverse Event|2|||
147613193|NCT01884337|532398881|FG001|Treatment|Adverse Event|2|||
147613194|NCT01884337|532398880|FG000|Treatment|Subj. request to discont. treatment|2|||
147613195|NCT01884337|532398881|FG001|Treatment|Subj. request to discont. treatment|0|||
147613196|NCT01884337|532398880|FG000|Follow-up Period|Lost to Follow-up|1|||
147613197|NCT01884337|532398881|FG001|Follow-up Period|Lost to Follow-up|1|||
147613198|NCT02455518|532398882|FG000|Overall Study|Protocol Violation|0|||
147613199|NCT02455518|532398883|FG001|Overall Study|Protocol Violation|1|||
147613200|NCT02455518|532398884|FG002|Overall Study|Protocol Violation|1|||
147613201|NCT02455518|532398885|FG003|Overall Study|Protocol Violation|3|||
147613202|NCT04223752|532398891|FG000|Overall Study|Participant enrolled in error|0|||
147613203|NCT04223752|532398892|FG001|Overall Study|Participant enrolled in error|0|||
147613204|NCT04223752|532398893|FG002|Overall Study|Participant enrolled in error|0|||
147613205|NCT04223752|532398894|FG003|Overall Study|Participant enrolled in error|0|||
147613206|NCT04223752|532398895|FG004|Overall Study|Participant enrolled in error|1|||
147613207|NCT04223752|532398891|FG000|Overall Study|Death|0|||
147379282|NCT02334215|531553194|FG002|Overall Study|Lost to Follow-up|4|||
147379283|NCT02334215|531553192|FG000|Overall Study|Withdrawal by Subject|2|||
147379284|NCT02334215|531553193|FG001|Overall Study|Withdrawal by Subject|2|||
147379285|NCT02334215|531553194|FG002|Overall Study|Withdrawal by Subject|1|||
147379286|NCT02334215|531553192|FG000|Overall Study|Not released from incarceration on time|3|||
147379287|NCT02334215|531553193|FG001|Overall Study|Not released from incarceration on time|3|||
147379288|NCT02334215|531553194|FG002|Overall Study|Not released from incarceration on time|3|||
147379289|NCT02334215|531553192|FG000|Overall Study|Incarcerated|0|||
147379290|NCT02334215|531553193|FG001|Overall Study|Incarcerated|0|||
147379291|NCT02334215|531553194|FG002|Overall Study|Incarcerated|7|||
147379292|NCT05615363|531553195|FG000|Overall Study|Adverse Event|0|||
147613208|NCT04223752|532398892|FG001|Overall Study|Death|0|||
147613209|NCT04223752|532398893|FG002|Overall Study|Death|0|||
147613210|NCT04223752|532398894|FG003|Overall Study|Death|2|||
147613211|NCT04223752|532398895|FG004|Overall Study|Death|1|||
147613212|NCT04759703|532398896|FG000|Overall Study|Withdrawal by Subject|4|||
147613213|NCT04759703|532398897|FG001|Overall Study|Withdrawal by Subject|9|||
147613214|NCT04759703|532398896|FG000|Overall Study|Adverse Event|1|||
147613215|NCT04759703|532398897|FG001|Overall Study|Adverse Event|0|||
147613216|NCT04759703|532398896|FG000|Overall Study|Lost to Follow-up|2|||
147613217|NCT04759703|532398897|FG001|Overall Study|Lost to Follow-up|0|||
147613218|NCT04186845|532398905|FG000|Overall Study|Death|2|||
147613219|NCT04186845|532398905|FG000|Overall Study|Lost to Follow-up|1|||
147613220|NCT04186845|532398905|FG000|Overall Study|Physician Decision|1|||
147613221|NCT04186845|532398905|FG000|Overall Study|Protocol Violation|1|||
147613222|NCT04186845|532398905|FG000|Overall Study|Biopsy ordered but area too small to biopsy|1|||
147613223|NCT04186845|532398905|FG000|Overall Study|Biopsy ordered but not done|1|||
147613224|NCT04186845|532398905|FG000|Overall Study|It was previously confirmed|1|||
147613225|NCT04186845|532398905|FG000|Overall Study|Patient cancelled scheduled scans|2|||
147613226|NCT04186845|532398905|FG000|Overall Study|PSMA PET/CT scan show disease within previously Bx area|1|||
147613227|NCT04186845|532398905|FG000|Overall Study|Subject refused confirmatory imaging|1|||
147613228|NCT04186845|532398905|FG000|Overall Study|Too small to biopsy|1|||
147613229|NCT05061420|532398906|FG000|Overall Study|Adverse event: Not related to Coronavirus Disease 2019 (COVID-19)|4|||
147613230|NCT05061420|532398907|FG001|Overall Study|Adverse event: Not related to Coronavirus Disease 2019 (COVID-19)|3|||
147613231|NCT05061420|532398908|FG002|Overall Study|Adverse event: Not related to Coronavirus Disease 2019 (COVID-19)|3|||
147613232|NCT05061420|532398906|FG000|Overall Study|Progressive disease|11|||
147613233|NCT05061420|532398907|FG001|Overall Study|Progressive disease|15|||
147613234|NCT05061420|532398908|FG002|Overall Study|Progressive disease|14|||
147379293|NCT05615363|531553196|FG001|Overall Study|Adverse Event|4|||
147379294|NCT05615363|531553197|FG002|Overall Study|Adverse Event|4|||
147379295|NCT05615363|531553198|FG003|Overall Study|Adverse Event|3|||
147613235|NCT05061420|532398906|FG000|Overall Study|Withdrawal by Subject|2|||
147613236|NCT05061420|532398907|FG001|Overall Study|Withdrawal by Subject|0|||
147613237|NCT05061420|532398908|FG002|Overall Study|Withdrawal by Subject|1|||
147613238|NCT05061420|532398906|FG000|Overall Study|Not related to COVID-19|2|||
147613239|NCT05061420|532398907|FG001|Overall Study|Not related to COVID-19|0|||
147613240|NCT05061420|532398908|FG002|Overall Study|Not related to COVID-19|0|||
147613241|NCT01814553|532398912|FG000|Overall Study|PD per clinical progression|6|||
147379296|NCT05615363|531553199|FG004|Overall Study|Adverse Event|1|||
147379297|NCT05615363|531553195|FG000|Overall Study|Physician Decision|2|||
147379298|NCT05615363|531553196|FG001|Overall Study|Physician Decision|0|||
147379299|NCT05615363|531553197|FG002|Overall Study|Physician Decision|4|||
147379300|NCT05615363|531553198|FG003|Overall Study|Physician Decision|1|||
147379301|NCT05615363|531553199|FG004|Overall Study|Physician Decision|3|||
147379302|NCT05615363|531553195|FG000|Overall Study|Protocol Violation|2|||
147379303|NCT05615363|531553196|FG001|Overall Study|Protocol Violation|0|||
147379304|NCT05615363|531553197|FG002|Overall Study|Protocol Violation|0|||
147613242|NCT01814553|532398913|FG001|Overall Study|PD per clinical progression|8|||
147613243|NCT01814553|532398912|FG000|Overall Study|Other Adverse Event|4|||
147613244|NCT01814553|532398913|FG001|Overall Study|Other Adverse Event|5|||
147613245|NCT01814553|532398912|FG000|Overall Study|Withdrawal by Subject|1|||
147379305|NCT05615363|531553198|FG003|Overall Study|Protocol Violation|0|||
147379306|NCT05615363|531553199|FG004|Overall Study|Protocol Violation|1|||
147379307|NCT05615363|531553195|FG000|Overall Study|Withdrawal by Subject|0|||
147379308|NCT05615363|531553196|FG001|Overall Study|Withdrawal by Subject|0|||
147613246|NCT01814553|532398913|FG001|Overall Study|Withdrawal by Subject|1|||
147613247|NCT01814553|532398912|FG000|Overall Study|Other than stated|7|||
147613248|NCT01814553|532398913|FG001|Overall Study|Other than stated|8|||
147613249|NCT03138655|532398914|FG000|Overall Study|Adverse Event|2|||
147613250|NCT03138655|532398915|FG001|Overall Study|Adverse Event|1|||
147613251|NCT03138655|532398916|FG002|Overall Study|Adverse Event|2|||
147613252|NCT03138655|532398917|FG003|Overall Study|Adverse Event|1|||
147613253|NCT03138655|532398918|FG004|Overall Study|Adverse Event|1|||
147613254|NCT03138655|532398919|FG005|Overall Study|Adverse Event|4|||
147379309|NCT05615363|531553197|FG002|Overall Study|Withdrawal by Subject|1|||
147379310|NCT05615363|531553198|FG003|Overall Study|Withdrawal by Subject|0|||
147456022|NCT02944448|531831673|FG001|Overall Study|Lack of Efficacy|5|||
147379311|NCT05615363|531553199|FG004|Overall Study|Withdrawal by Subject|0|||
147379312|NCT04602728|531553202|FG000|Overall Study|Lost to Follow-up|4|||
147379313|NCT04602728|531553203|FG001|Overall Study|Lost to Follow-up|4|||
147379314|NCT05289037|531553206|FG000|Overall Study|Withdrawal by Subject|7|||
147379315|NCT05289037|531553207|FG001|Overall Study|Withdrawal by Subject|0|||
147379316|NCT05289037|531553208|FG002|Overall Study|Withdrawal by Subject|3|||
147379317|NCT05289037|531553209|FG003|Overall Study|Withdrawal by Subject|3|||
147379318|NCT05289037|531553210|FG004|Overall Study|Withdrawal by Subject|1|||
147379319|NCT05289037|531553211|FG005|Overall Study|Withdrawal by Subject|5|||
147379320|NCT05289037|531553212|FG006|Overall Study|Withdrawal by Subject|2|||
147379321|NCT05289037|531553213|FG007|Overall Study|Withdrawal by Subject|1|||
147379322|NCT05289037|531553214|FG008|Overall Study|Withdrawal by Subject|2|||
147379323|NCT05289037|531553215|FG009|Overall Study|Withdrawal by Subject|2|||
147379324|NCT05289037|531553216|FG010|Overall Study|Withdrawal by Subject|1|||
147379325|NCT05289037|531553217|FG011|Overall Study|Withdrawal by Subject|0|||
147379326|NCT05289037|531553218|FG012|Overall Study|Withdrawal by Subject|1|||
147379327|NCT05289037|531553219|FG013|Overall Study|Withdrawal by Subject|2|||
147379328|NCT05289037|531553220|FG014|Overall Study|Withdrawal by Subject|0|||
147379329|NCT05289037|531553221|FG015|Overall Study|Withdrawal by Subject|3|||
147379330|NCT05289037|531553222|FG016|Overall Study|Withdrawal by Subject|3|||
147379331|NCT05289037|531553206|FG000|Overall Study|Lost to Follow-up|1|||
147379332|NCT05289037|531553207|FG001|Overall Study|Lost to Follow-up|4|||
147379333|NCT05289037|531553208|FG002|Overall Study|Lost to Follow-up|3|||
147379334|NCT05289037|531553209|FG003|Overall Study|Lost to Follow-up|3|||
147379335|NCT05289037|531553210|FG004|Overall Study|Lost to Follow-up|3|||
147379336|NCT05289037|531553211|FG005|Overall Study|Lost to Follow-up|2|||
147379337|NCT05289037|531553212|FG006|Overall Study|Lost to Follow-up|3|||
147379338|NCT05289037|531553213|FG007|Overall Study|Lost to Follow-up|2|||
147379339|NCT05289037|531553214|FG008|Overall Study|Lost to Follow-up|2|||
147379340|NCT05289037|531553215|FG009|Overall Study|Lost to Follow-up|1|||
147379341|NCT05289037|531553216|FG010|Overall Study|Lost to Follow-up|3|||
147379342|NCT05289037|531553217|FG011|Overall Study|Lost to Follow-up|4|||
147379343|NCT05289037|531553218|FG012|Overall Study|Lost to Follow-up|2|||
147379344|NCT05289037|531553219|FG013|Overall Study|Lost to Follow-up|7|||
147379345|NCT05289037|531553220|FG014|Overall Study|Lost to Follow-up|4|||
147379346|NCT05289037|531553221|FG015|Overall Study|Lost to Follow-up|6|||
147379347|NCT05289037|531553222|FG016|Overall Study|Lost to Follow-up|4|||
147379348|NCT05289037|531553206|FG000|Overall Study|Death|0|||
147379349|NCT05289037|531553207|FG001|Overall Study|Death|0|||
147379350|NCT05289037|531553208|FG002|Overall Study|Death|0|||
147379351|NCT05289037|531553209|FG003|Overall Study|Death|0|||
147379352|NCT05289037|531553210|FG004|Overall Study|Death|0|||
147379353|NCT05289037|531553211|FG005|Overall Study|Death|1|||
147379354|NCT05289037|531553212|FG006|Overall Study|Death|0|||
147379355|NCT05289037|531553213|FG007|Overall Study|Death|0|||
147379356|NCT05289037|531553214|FG008|Overall Study|Death|0|||
147379357|NCT05289037|531553215|FG009|Overall Study|Death|0|||
147613255|NCT03138655|532398920|FG006|Overall Study|Adverse Event|2|||
147379358|NCT05289037|531553216|FG010|Overall Study|Death|0|||
147379359|NCT05289037|531553217|FG011|Overall Study|Death|0|||
147379360|NCT05289037|531553218|FG012|Overall Study|Death|0|||
147379361|NCT05289037|531553219|FG013|Overall Study|Death|0|||
147379362|NCT05289037|531553220|FG014|Overall Study|Death|1|||
147379363|NCT05289037|531553221|FG015|Overall Study|Death|0|||
147379364|NCT05289037|531553222|FG016|Overall Study|Death|0|||
147379365|NCT05289037|531553206|FG000|Overall Study|Did not receive vaccine|0|||
147379366|NCT05289037|531553207|FG001|Overall Study|Did not receive vaccine|3|||
147379367|NCT05289037|531553208|FG002|Overall Study|Did not receive vaccine|0|||
147379368|NCT05289037|531553209|FG003|Overall Study|Did not receive vaccine|0|||
147379369|NCT05289037|531553210|FG004|Overall Study|Did not receive vaccine|1|||
147379370|NCT05289037|531553211|FG005|Overall Study|Did not receive vaccine|1|||
147379371|NCT05289037|531553212|FG006|Overall Study|Did not receive vaccine|1|||
147379372|NCT05289037|531553213|FG007|Overall Study|Did not receive vaccine|0|||
147379373|NCT05289037|531553214|FG008|Overall Study|Did not receive vaccine|0|||
147613256|NCT03138655|532398921|FG007|Overall Study|Adverse Event|2|||
147379374|NCT05289037|531553215|FG009|Overall Study|Did not receive vaccine|0|||
147379375|NCT05289037|531553216|FG010|Overall Study|Did not receive vaccine|0|||
147379376|NCT05289037|531553217|FG011|Overall Study|Did not receive vaccine|0|||
147379377|NCT05289037|531553218|FG012|Overall Study|Did not receive vaccine|0|||
147379378|NCT05289037|531553219|FG013|Overall Study|Did not receive vaccine|0|||
147379379|NCT05289037|531553220|FG014|Overall Study|Did not receive vaccine|1|||
147379380|NCT05289037|531553221|FG015|Overall Study|Did not receive vaccine|0|||
147379381|NCT05289037|531553222|FG016|Overall Study|Did not receive vaccine|0|||
147379382|NCT05289037|531553206|FG000|Overall Study|Unable to make last visit|0|||
147379383|NCT05289037|531553207|FG001|Overall Study|Unable to make last visit|0|||
147379384|NCT05289037|531553208|FG002|Overall Study|Unable to make last visit|1|||
147379385|NCT05289037|531553209|FG003|Overall Study|Unable to make last visit|0|||
147613257|NCT03138655|532398914|FG000|Overall Study|Withdrawal by Subject|0|||
147613258|NCT03138655|532398915|FG001|Overall Study|Withdrawal by Subject|1|||
147379386|NCT05289037|531553210|FG004|Overall Study|Unable to make last visit|0|||
147379387|NCT05289037|531553211|FG005|Overall Study|Unable to make last visit|0|||
147379388|NCT05289037|531553212|FG006|Overall Study|Unable to make last visit|0|||
147379389|NCT05289037|531553213|FG007|Overall Study|Unable to make last visit|0|||
147379390|NCT05289037|531553214|FG008|Overall Study|Unable to make last visit|0|||
147379391|NCT05289037|531553215|FG009|Overall Study|Unable to make last visit|0|||
147379392|NCT05289037|531553216|FG010|Overall Study|Unable to make last visit|0|||
147379393|NCT05289037|531553217|FG011|Overall Study|Unable to make last visit|0|||
147379394|NCT05289037|531553218|FG012|Overall Study|Unable to make last visit|0|||
147379395|NCT05289037|531553219|FG013|Overall Study|Unable to make last visit|0|||
147379396|NCT05289037|531553220|FG014|Overall Study|Unable to make last visit|0|||
147379397|NCT05289037|531553221|FG015|Overall Study|Unable to make last visit|0|||
147379398|NCT05289037|531553222|FG016|Overall Study|Unable to make last visit|0|||
147379399|NCT05289037|531553206|FG000|Overall Study|Protocol deviation|0|||
147379400|NCT05289037|531553207|FG001|Overall Study|Protocol deviation|0|||
147379401|NCT05289037|531553208|FG002|Overall Study|Protocol deviation|0|||
147379402|NCT05289037|531553209|FG003|Overall Study|Protocol deviation|0|||
147379403|NCT05289037|531553210|FG004|Overall Study|Protocol deviation|0|||
147379404|NCT05289037|531553211|FG005|Overall Study|Protocol deviation|0|||
147379405|NCT05289037|531553212|FG006|Overall Study|Protocol deviation|0|||
147379406|NCT05289037|531553213|FG007|Overall Study|Protocol deviation|0|||
147379407|NCT05289037|531553214|FG008|Overall Study|Protocol deviation|0|||
147379408|NCT05289037|531553215|FG009|Overall Study|Protocol deviation|0|||
147379409|NCT05289037|531553216|FG010|Overall Study|Protocol deviation|0|||
147379410|NCT05289037|531553217|FG011|Overall Study|Protocol deviation|0|||
147379411|NCT05289037|531553218|FG012|Overall Study|Protocol deviation|0|||
147379412|NCT05289037|531553219|FG013|Overall Study|Protocol deviation|0|||
147379413|NCT05289037|531553220|FG014|Overall Study|Protocol deviation|0|||
147379414|NCT05289037|531553221|FG015|Overall Study|Protocol deviation|1|||
147379415|NCT05289037|531553222|FG016|Overall Study|Protocol deviation|0|||
147379416|NCT04937504|531553223|FG000|15 Weeks Assessment|Lost to Follow-up|5|||
147379417|NCT04937504|531553224|FG001|15 Weeks Assessment|Lost to Follow-up|9|||
147379418|NCT04937504|531553223|FG000|9 Months Assessment|Lost to Follow-up|3|||
147379419|NCT04937504|531553224|FG001|9 Months Assessment|Lost to Follow-up|2|||
147379420|NCT00070707|531555229|FG000|Overall Study|Adverse Event|1|||
147379421|NCT00070707|531555230|FG001|Overall Study|Adverse Event|2|||
147379422|NCT00070707|531555229|FG000|Overall Study|Lack of Efficacy|4|||
147379423|NCT00070707|531555230|FG001|Overall Study|Lack of Efficacy|1|||
147379424|NCT00070707|531555229|FG000|Overall Study|Protocol Violation|8|||
147379425|NCT00070707|531555230|FG001|Overall Study|Protocol Violation|4|||
147379426|NCT00070707|531555229|FG000|Overall Study|Unrelated to Study Medication|1|||
147379427|NCT00070707|531555230|FG001|Overall Study|Unrelated to Study Medication|0|||
147379428|NCT03690219|531555231|FG000|Overall Study|no injuries|9|||
147379429|NCT03690219|531555232|FG001|Overall Study|no injuries|20|||
147379430|NCT03690219|531555231|FG000|Overall Study|missing information|7|||
147379431|NCT03690219|531555232|FG001|Overall Study|missing information|7|||
147379432|NCT04809623|531555233|FG000|Overall Study|Study Terminated by Sponsor|1|||
147379433|NCT04809623|531555234|FG001|Overall Study|Study Terminated by Sponsor|0|||
147379434|NCT01185340|531555237|FG000|Confirmation (CF) Phase, 3 Weeks|Adverse Event|24|||
147379435|NCT01185340|531555238|FG001|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
147379436|NCT01185340|531555239|FG002|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
147379437|NCT01185340|531555240|FG003|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
147379438|NCT01185340|531555237|FG000|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|6|||
147379439|NCT01185340|531555238|FG001|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
147379440|NCT01185340|531555239|FG002|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
147379441|NCT01185340|531555240|FG003|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
147379442|NCT01185340|531555237|FG000|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|5|||
147379443|NCT01185340|531555238|FG001|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
147379444|NCT01185340|531555239|FG002|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
147379445|NCT01185340|531555240|FG003|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
147379446|NCT01185340|531555237|FG000|Confirmation (CF) Phase, 3 Weeks|Physician Decision|2|||
147379447|NCT01185340|531555238|FG001|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
147456023|NCT02944448|531831672|FG000|Overall Study|Lost to Follow-up|3|||
147456024|NCT02944448|531831673|FG001|Overall Study|Lost to Follow-up|1|||
147456025|NCT02944448|531831672|FG000|Overall Study|Protocol Violation|25|||
147379448|NCT01185340|531555239|FG002|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
147379449|NCT01185340|531555240|FG003|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
147379450|NCT01185340|531555237|FG000|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|16|||
147379451|NCT01185340|531555238|FG001|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
147379452|NCT01185340|531555239|FG002|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
147456026|NCT02944448|531831673|FG001|Overall Study|Protocol Violation|7|||
147456027|NCT02944448|531831672|FG000|Overall Study|Withdrawal by Subject|14|||
147456028|NCT02944448|531831673|FG001|Overall Study|Withdrawal by Subject|4|||
147379453|NCT01185340|531555240|FG003|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
147456029|NCT02944448|531831672|FG000|Overall Study|Sponsor did not supply drug in time|0|||
147613259|NCT03138655|532398916|FG002|Overall Study|Withdrawal by Subject|0|||
147613260|NCT03138655|532398917|FG003|Overall Study|Withdrawal by Subject|0|||
147613261|NCT03138655|532398918|FG004|Overall Study|Withdrawal by Subject|0|||
147613262|NCT03138655|532398919|FG005|Overall Study|Withdrawal by Subject|0|||
147613263|NCT03138655|532398920|FG006|Overall Study|Withdrawal by Subject|1|||
147613264|NCT03138655|532398921|FG007|Overall Study|Withdrawal by Subject|0|||
147613265|NCT03138655|532398914|FG000|Overall Study|Reason not Specified|1|||
147613266|NCT03138655|532398915|FG001|Overall Study|Reason not Specified|0|||
147613267|NCT03138655|532398916|FG002|Overall Study|Reason not Specified|0|||
147613268|NCT03138655|532398917|FG003|Overall Study|Reason not Specified|2|||
147613269|NCT03138655|532398918|FG004|Overall Study|Reason not Specified|1|||
147613270|NCT03138655|532398919|FG005|Overall Study|Reason not Specified|1|||
147613271|NCT03138655|532398920|FG006|Overall Study|Reason not Specified|0|||
147613272|NCT03138655|532398921|FG007|Overall Study|Reason not Specified|0|||
147613273|NCT02859142|532398922|FG000|Overall Study|Adverse Event|1|||
147613274|NCT02859142|532398923|FG001|Overall Study|Adverse Event|2|||
147613275|NCT02859142|532398922|FG000|Overall Study|Lost to Follow-up|1|||
147613276|NCT02859142|532398923|FG001|Overall Study|Lost to Follow-up|4|||
147613277|NCT02859142|532398922|FG000|Overall Study|Withdrawal by Subject|2|||
147613278|NCT02859142|532398923|FG001|Overall Study|Withdrawal by Subject|0|||
147613279|NCT02859142|532398922|FG000|Overall Study|Scheduling difficulties|0|||
147613280|NCT02859142|532398923|FG001|Overall Study|Scheduling difficulties|3|||
147613281|NCT03290079|532398924|FG000|Overall Study|Death|2|||
147613282|NCT01277211|532398927|FG000|Overall Study|Adverse Event|60|||
147613283|NCT01277211|532398928|FG001|Overall Study|Adverse Event|22|||
147613284|NCT01277211|532398927|FG000|Overall Study|Pregnancy|9|||
147613285|NCT01277211|532398928|FG001|Overall Study|Pregnancy|4|||
147613286|NCT01277211|532398927|FG000|Overall Study|Lost to Follow-up|14|||
147613287|NCT01277211|532398928|FG001|Overall Study|Lost to Follow-up|9|||
147613288|NCT01277211|532398927|FG000|Overall Study|Did not wish to continue|17|||
147613289|NCT01277211|532398928|FG001|Overall Study|Did not wish to continue|0|||
147613290|NCT01277211|532398927|FG000|Overall Study|Withdrew Consent|9|||
147613291|NCT01277211|532398928|FG001|Overall Study|Withdrew Consent|9|||
147613292|NCT01277211|532398927|FG000|Overall Study|Non-compliance with protocol|13|||
147613293|NCT01277211|532398928|FG001|Overall Study|Non-compliance with protocol|4|||
147613294|NCT01277211|532398927|FG000|Overall Study|Did not meet protocol eligibility|1|||
147613295|NCT01277211|532398928|FG001|Overall Study|Did not meet protocol eligibility|0|||
147613296|NCT01277211|532398927|FG000|Overall Study|Administrative|3|||
147613297|NCT01277211|532398928|FG001|Overall Study|Administrative|0|||
147613298|NCT01277211|532398927|FG000|Overall Study|Pregnancy wish|0|||
147613299|NCT01277211|532398928|FG001|Overall Study|Pregnancy wish|2|||
147613300|NCT01277211|532398927|FG000|Overall Study|Discontinued prior to treatment|24|||
147613301|NCT01277211|532398928|FG001|Overall Study|Discontinued prior to treatment|13|||
147613302|NCT03452943|532398929|FG000|Titration Period (7 Weeks)|Adverse Event|1|||
147613303|NCT03452943|532398930|FG001|Titration Period (7 Weeks)|Adverse Event|1|||
147613304|NCT03452943|532398929|FG000|Titration Period (7 Weeks)|Protocol Violation|0|||
147613305|NCT03452943|532398930|FG001|Titration Period (7 Weeks)|Protocol Violation|1|||
147379454|NCT01185340|531555237|FG000|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|32|||
147379455|NCT01185340|531555238|FG001|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
147379456|NCT01185340|531555239|FG002|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
147379457|NCT01185340|531555240|FG003|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
147379458|NCT01185340|531555237|FG000|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|3|||
147379459|NCT01185340|531555238|FG001|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
147379460|NCT01185340|531555239|FG002|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
147379461|NCT01185340|531555240|FG003|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
147379462|NCT01185340|531555237|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|0|||
147379463|NCT01185340|531555238|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|13|||
147379464|NCT01185340|531555239|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|8|||
147379465|NCT01185340|531555240|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|13|||
147379466|NCT01185340|531555237|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|0|||
147379467|NCT01185340|531555238|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|4|||
147379468|NCT01185340|531555239|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|7|||
147613306|NCT03452943|532398929|FG000|Titration Period (7 Weeks)|Withdrawal by Subject|3|||
147613307|NCT03452943|532398930|FG001|Titration Period (7 Weeks)|Withdrawal by Subject|2|||
147613308|NCT03452943|532398929|FG000|Titration Period (7 Weeks)|Lost to Follow-up|1|||
147613309|NCT03452943|532398930|FG001|Titration Period (7 Weeks)|Lost to Follow-up|0|||
147613310|NCT03452943|532398929|FG000|Maintenance Period (5 Weeks)|Adverse Event|1|||
147613311|NCT03452943|532398930|FG001|Maintenance Period (5 Weeks)|Adverse Event|0|||
147613312|NCT03452943|532398929|FG000|Maintenance Period (5 Weeks)|Withdrawal by Subject|2|||
147613313|NCT03452943|532398930|FG001|Maintenance Period (5 Weeks)|Withdrawal by Subject|0|||
147613314|NCT01107197|532398935|FG000|Overall Study|Death|12|||
147613315|NCT01107197|532398936|FG001|Overall Study|Death|10|||
147613316|NCT01107197|532398935|FG000|Overall Study|Lost to Follow-up|5|||
147613317|NCT01107197|532398936|FG001|Overall Study|Lost to Follow-up|8|||
147379469|NCT01185340|531555240|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|4|||
147379470|NCT01185340|531555237|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0|||
147379471|NCT01185340|531555238|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|4|||
147379472|NCT01185340|531555239|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|5|||
147379473|NCT01185340|531555240|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|7|||
147379474|NCT01185340|531555237|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
147379475|NCT01185340|531555238|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1|||
147379476|NCT01185340|531555239|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
147379477|NCT01185340|531555240|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1|||
147379478|NCT01185340|531555237|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|0|||
147379479|NCT01185340|531555238|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5|||
147379480|NCT01185340|531555239|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|2|||
147379481|NCT01185340|531555240|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5|||
147379482|NCT01185340|531555237|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|0|||
147379483|NCT01185340|531555238|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|8|||
147379484|NCT01185340|531555239|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|8|||
147379485|NCT01185340|531555240|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|24|||
147379486|NCT01185340|531555237|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
147379487|NCT01185340|531555238|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
147379488|NCT01185340|531555239|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|3|||
147379489|NCT01185340|531555240|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|7|||
147379490|NCT01719172|531555241|FG000|Overall Study|Lost to Follow-up|1|||
147379491|NCT01719172|531555241|FG000|Overall Study|Death|1|||
147379492|NCT01148017|531555242|FG000|Overall Study|Withdrawal by Subject|31|||
147379493|NCT01148017|531555243|FG001|Overall Study|Withdrawal by Subject|14|||
147379494|NCT01148017|531555244|FG002|Overall Study|Withdrawal by Subject|0|||
147379495|NCT01148017|531555245|FG003|Overall Study|Withdrawal by Subject|0|||
147379496|NCT01148017|531555242|FG000|Overall Study|Lost to Follow-up|23|||
147379497|NCT01148017|531555243|FG001|Overall Study|Lost to Follow-up|10|||
147379498|NCT01148017|531555244|FG002|Overall Study|Lost to Follow-up|0|||
147379499|NCT01148017|531555245|FG003|Overall Study|Lost to Follow-up|0|||
147379500|NCT01148017|531555242|FG000|Overall Study|Inappropriate enrollment|1|||
147379501|NCT01148017|531555243|FG001|Overall Study|Inappropriate enrollment|0|||
147379502|NCT01148017|531555244|FG002|Overall Study|Inappropriate enrollment|0|||
147379503|NCT01148017|531555245|FG003|Overall Study|Inappropriate enrollment|0|||
147379504|NCT01148017|531555242|FG000|Overall Study|Administrative reason|22|||
147379505|NCT01148017|531555243|FG001|Overall Study|Administrative reason|9|||
147379506|NCT01148017|531555244|FG002|Overall Study|Administrative reason|0|||
147379507|NCT01148017|531555245|FG003|Overall Study|Administrative reason|0|||
147379508|NCT01148017|531555242|FG000|Overall Study|Unable to classify|3|||
147379509|NCT01148017|531555243|FG001|Overall Study|Unable to classify|1|||
147379510|NCT01148017|531555244|FG002|Overall Study|Unable to classify|0|||
147379511|NCT01148017|531555245|FG003|Overall Study|Unable to classify|0|||
147379512|NCT01848483|531555246|FG000|Overall Study|Death|2|||
147379513|NCT01848483|531555247|FG001|Overall Study|Death|1|||
147379514|NCT01848483|531555246|FG000|Overall Study|Lost to Follow-up|6|||
147379515|NCT01848483|531555247|FG001|Overall Study|Lost to Follow-up|8|||
147379516|NCT01848483|531555246|FG000|Overall Study|Withdrawal by Subject|1|||
147379517|NCT01848483|531555247|FG001|Overall Study|Withdrawal by Subject|0|||
147613318|NCT01107197|532398935|FG000|Overall Study|Withdrawal by Subject|3|||
147613319|NCT01107197|532398936|FG001|Overall Study|Withdrawal by Subject|5|||
147613320|NCT05180227|532398937|FG000|Overall Study|Hypertension at screening|1|||
147613321|NCT05180227|532398937|FG000|Overall Study|Lost to Follow-up|1|||
147613322|NCT00447993|532398940|FG000|Overall Study|Lost to Follow-up|0|||
147379518|NCT01848483|531555246|FG000|Overall Study|Incarceration|2|||
147379519|NCT01848483|531555247|FG001|Overall Study|Incarceration|2|||
147379520|NCT00246129|531555252|FG000|Overall Study|Lost to Follow-up|1|||
147379521|NCT00246129|531555253|FG001|Overall Study|Lost to Follow-up|0|||
147379522|NCT00246129|531555252|FG000|Overall Study|Death|2|||
147379523|NCT00246129|531555253|FG001|Overall Study|Death|1|||
147379524|NCT00246129|531555252|FG000|Overall Study|suffered primary non-function|1|||
147379525|NCT00246129|531555253|FG001|Overall Study|suffered primary non-function|0|||
147379526|NCT00246129|531555252|FG000|Overall Study|grafts failed|3|||
147379527|NCT00246129|531555253|FG001|Overall Study|grafts failed|1|||
147379528|NCT03740737|531555254|FG000|Overall Study|Protocol deviation|13|||
147379529|NCT03740737|531555255|FG001|Overall Study|Protocol deviation|0|||
147379530|NCT03740737|531555254|FG000|Overall Study|Adverse Event|2|||
147456030|NCT02944448|531831673|FG001|Overall Study|Sponsor did not supply drug in time|1|||
147613323|NCT00447993|532398941|FG001|Overall Study|Lost to Follow-up|0|||
147379531|NCT03740737|531555255|FG001|Overall Study|Adverse Event|0|||
147379532|NCT03740737|531555254|FG000|Overall Study|Lost to Follow-up|1|||
147379533|NCT03740737|531555255|FG001|Overall Study|Lost to Follow-up|0|||
147379534|NCT03740737|531555254|FG000|Overall Study|Randomization failure|1|||
147379535|NCT03740737|531555255|FG001|Overall Study|Randomization failure|0|||
147379536|NCT03740737|531555254|FG000|Overall Study|Participant withdrew consent|1|||
147379537|NCT03740737|531555255|FG001|Overall Study|Participant withdrew consent|0|||
147379538|NCT03740737|531555254|FG000|Overall Study|Participant withdrew from trial|2|||
147379539|NCT03740737|531555255|FG001|Overall Study|Participant withdrew from trial|1|||
147379540|NCT03469258|531555256|FG000|Overall Study|Upon surgery, did not meet criteria|4|||
147379541|NCT02236611|531555259|FG000|Overall Study|Adverse Event|10|||
147613324|NCT00447993|532398942|FG002|Overall Study|Lost to Follow-up|2|||
147613325|NCT00447993|532398943|FG003|Overall Study|Lost to Follow-up|2|||
147613326|NCT00447993|532398940|FG000|Overall Study|Withdrawal by Subject|0|||
147613327|NCT00447993|532398941|FG001|Overall Study|Withdrawal by Subject|0|||
147613328|NCT00447993|532398942|FG002|Overall Study|Withdrawal by Subject|2|||
147613329|NCT00447993|532398943|FG003|Overall Study|Withdrawal by Subject|2|||
147613330|NCT04700137|532398948|FG000|Overall Study|Lost to Follow-up|1|||
147613331|NCT04700137|532398949|FG001|Overall Study|Lost to Follow-up|6|||
147613332|NCT04700137|532398950|FG002|Overall Study|Lost to Follow-up|1|||
147613333|NCT04700137|532398951|FG003|Overall Study|Lost to Follow-up|1|||
147613334|NCT04700137|532398948|FG000|Overall Study|Withdrawal by Subject|0|||
147613335|NCT04700137|532398949|FG001|Overall Study|Withdrawal by Subject|0|||
147613336|NCT04700137|532398950|FG002|Overall Study|Withdrawal by Subject|1|||
147613337|NCT04700137|532398951|FG003|Overall Study|Withdrawal by Subject|0|||
147613338|NCT04700137|532398948|FG000|Overall Study|Death|0|||
147613339|NCT04700137|532398949|FG001|Overall Study|Death|0|||
147613340|NCT04700137|532398950|FG002|Overall Study|Death|1|||
147613341|NCT04700137|532398951|FG003|Overall Study|Death|0|||
147613342|NCT02503787|532398952|FG000|Enrollment|Withdrawal by Subject|6|||
147613343|NCT02503787|532398952|FG000|Enrollment|Inclusion/exclusion criteria not met|4|||
147613344|NCT02503787|532398952|FG000|Enrollment|Physician Decision|2|||
147613345|NCT02503787|532398952|FG000|Enrollment|Insurance issue|2|||
147613346|NCT02503787|532398952|FG000|Enrollment|Lost to Follow-up|1|||
147613347|NCT02503787|532398952|FG000|Enrollment|Study closure|1|||
147613348|NCT02503787|532398952|FG000|Enrollment|Adverse Event|1|||
147613349|NCT02503787|532398952|FG000|Enrollment|Protocol Violation|1|||
147613350|NCT02503787|532398952|FG000|Enrollment|Inability to implant system|1|||
147613351|NCT02503787|532398952|FG000|Enrollment|Unable to be programmed|1|||
147613352|NCT02503787|532398952|FG000|Device Trial (HD Programming Trial)|Lack of Efficacy|6|||
147613353|NCT02503787|532398952|FG000|Device Trial (HD Programming Trial)|Withdrawal by Subject|1|||
147613354|NCT02503787|532398952|FG000|Successful Trial (≥50% Pain Relief)|Withdrawal by Subject|3|||
147613355|NCT02503787|532398952|FG000|Successful Trial (≥50% Pain Relief)|Physician Decision|2|||
147613356|NCT02503787|532398952|FG000|Implant to 3 Month Endpoint|Adverse Event|2|||
147613357|NCT02503787|532398952|FG000|Implant to 3 Month Endpoint|Withdrawal by Subject|1|||
147613358|NCT04787627|532398953|FG000|Overall Study|Withdrawal by Subject|3|||
147613359|NCT04787627|532398954|FG001|Overall Study|Withdrawal by Subject|0|||
147613360|NCT04787627|532398953|FG000|Overall Study|Physician Decision|2|||
147613361|NCT04787627|532398954|FG001|Overall Study|Physician Decision|0|||
147613362|NCT04787627|532398953|FG000|Overall Study|Excluded|0|||
147613363|NCT04787627|532398954|FG001|Overall Study|Excluded|1|||
147613364|NCT00548093|532398955|FG000|Overall Study|Death|33|||
147613365|NCT00548093|532398956|FG001|Overall Study|Death|13|||
147613366|NCT00548093|532398955|FG000|Overall Study|Lost to Follow-up|3|||
147613367|NCT00548093|532398956|FG001|Overall Study|Lost to Follow-up|1|||
147613368|NCT00548093|532398955|FG000|Overall Study|Objective progression or relapse|1|||
147613369|NCT00548093|532398956|FG001|Overall Study|Objective progression or relapse|1|||
147613370|NCT00548093|532398955|FG000|Overall Study|Other|11|||
147613371|NCT00548093|532398956|FG001|Overall Study|Other|1|||
147613372|NCT00548093|532398955|FG000|Overall Study|Withdrawal by Subject|1|||
147613373|NCT00548093|532398956|FG001|Overall Study|Withdrawal by Subject|0|||
147613374|NCT00548093|532398955|FG000|Overall Study|Completed post-treatment follow-up|1|||
147379542|NCT02236611|531555260|FG001|Overall Study|Adverse Event|16|||
147456031|NCT02944448|531831672|FG000|Overall Study|Noncompliant with dosing|1|||
147456032|NCT02944448|531831673|FG001|Overall Study|Noncompliant with dosing|0|||
147379543|NCT02236611|531555259|FG000|Overall Study|Lack of Efficacy|4|||
147613375|NCT00548093|532398956|FG001|Overall Study|Completed post-treatment follow-up|0|||
147613376|NCT02924727|532398961|FG000|Overall Study|Withdrawal by Subject|2|||
147613377|NCT02924727|532398962|FG001|Overall Study|Withdrawal by Subject|4|||
147613378|NCT02924727|532398961|FG000|Overall Study|Lost to Follow-up|2|||
147613379|NCT02924727|532398962|FG001|Overall Study|Lost to Follow-up|5|||
147613380|NCT02924727|532398961|FG000|Overall Study|Death|221|||
147613381|NCT02924727|532398962|FG001|Overall Study|Death|247|||
147613382|NCT02924727|532398961|FG000|Overall Study|Mis-randomized (one mis-randomized patient in the Ramipril group also died)|4|||
147613383|NCT02924727|532398962|FG001|Overall Study|Mis-randomized (one mis-randomized patient in the Ramipril group also died)|3|||
147613384|NCT01464931|532398963|FG000|Overall Study|Withdrawal by Subject|1|||
147613385|NCT01464931|532398964|FG001|Overall Study|Withdrawal by Subject|0|||
147613386|NCT01982812|532398967|FG000|Overall Study|Death|1|||
147613387|NCT01982812|532398968|FG001|Overall Study|Death|5|||
147613388|NCT01982812|532398967|FG000|Overall Study|Adverse Event|0|||
147613389|NCT01982812|532398968|FG001|Overall Study|Adverse Event|5|||
147613390|NCT00174954|532398969|FG000|Overall Study|Adverse Event|2|||
147613391|NCT00174954|532398969|FG000|Overall Study|No tophi found in MRI|1|||
147379544|NCT02236611|531555260|FG001|Overall Study|Lack of Efficacy|7|||
147379545|NCT02236611|531555259|FG000|Overall Study|Lost to Follow-up|0|||
147379546|NCT02236611|531555260|FG001|Overall Study|Lost to Follow-up|2|||
147379547|NCT02236611|531555259|FG000|Overall Study|Protocol deviation|3|||
147379548|NCT02236611|531555260|FG001|Overall Study|Protocol deviation|5|||
147379549|NCT02236611|531555259|FG000|Overall Study|Withdrew consent|9|||
147379550|NCT02236611|531555260|FG001|Overall Study|Withdrew consent|4|||
147379551|NCT03041090|531555261|FG000|Overall Study|technical error|0|||
147379552|NCT03041090|531555262|FG001|Overall Study|technical error|3|||
147379553|NCT03403036|531555263|FG000|Overall Study|Lack of Efficacy|5|||
147379554|NCT01128959|531555264|FG000|Lead in Period|Adverse Event|3|||
147379555|NCT01128959|531555264|FG000|Treatment Period|Adverse Event|3|||
147379556|NCT01128959|531555264|FG000|Treatment Period|Withdrawal by Subject|1|||
147379557|NCT02338999|531555265|FG000|First Intervention|Withdrawal by Subject|3|||
147379558|NCT02338999|531555266|FG001|First Intervention|Withdrawal by Subject|1|||
147379559|NCT02338999|531555265|FG000|Washout Period|Withdrawal by Subject|0|||
147379560|NCT02338999|531555266|FG001|Washout Period|Withdrawal by Subject|2|||
147379561|NCT02338999|531555265|FG000|Second Intervention|Withdrawal by Subject|0|||
147379562|NCT02338999|531555266|FG001|Second Intervention|Withdrawal by Subject|2|||
147379563|NCT02701296|531555267|FG000|Overall Study|Incomplete Data|0|||
147379564|NCT02701296|531555268|FG001|Overall Study|Incomplete Data|2|||
147379565|NCT01409837|531555269|FG000|Overall Study|Withdrawal by Subject|2|||
147379566|NCT01409837|531555270|FG001|Overall Study|Withdrawal by Subject|1|||
147379567|NCT01409837|531555269|FG000|Overall Study|Lost to Follow-up|1|||
147379568|NCT01409837|531555270|FG001|Overall Study|Lost to Follow-up|0|||
147379569|NCT01409837|531555269|FG000|Overall Study|Physician Decision|0|||
147379570|NCT01409837|531555270|FG001|Overall Study|Physician Decision|1|||
147379571|NCT03490032|531555274|FG000|Overall Study|family issue (child custody)|1|||
147379572|NCT03490032|531555275|FG001|Overall Study|family issue (child custody)|0|||
147379573|NCT03490032|531555276|FG002|Overall Study|family issue (child custody)|0|||
147379574|NCT00308308|531555277|FG000|Overall Study|Adverse Event|17|||
147379575|NCT00308308|531555278|FG001|Overall Study|Adverse Event|2|||
147379576|NCT00308308|531555277|FG000|Overall Study|Lost to Follow-up|5|||
147379577|NCT00308308|531555278|FG001|Overall Study|Lost to Follow-up|5|||
147379578|NCT00308308|531555277|FG000|Overall Study|Physician Decision|15|||
147379579|NCT00308308|531555278|FG001|Overall Study|Physician Decision|7|||
147379580|NCT00308308|531555277|FG000|Overall Study|Protocol Violation|3|||
147379581|NCT00308308|531555278|FG001|Overall Study|Protocol Violation|14|||
147379582|NCT00308308|531555277|FG000|Overall Study|Withdrawal by Subject|47|||
147379583|NCT00308308|531555278|FG001|Overall Study|Withdrawal by Subject|19|||
147379584|NCT00308308|531555277|FG000|Overall Study|Various|7|||
147379585|NCT00308308|531555278|FG001|Overall Study|Various|5|||
147379586|NCT00308308|531555277|FG000|Overall Study|Randomized but not dosed|8|||
147379587|NCT00308308|531555278|FG001|Overall Study|Randomized but not dosed|16|||
147379588|NCT00308308|531555277|FG000|Overall Study|Other|1|||
147379589|NCT00308308|531555278|FG001|Overall Study|Other|0|||
147379590|NCT01021748|531555281|FG000|Overall Study|Adverse Event|2|||
147379591|NCT01021748|531555282|FG001|Overall Study|Adverse Event|1|||
147379592|NCT01021748|531555283|FG002|Overall Study|Adverse Event|2|||
147379593|NCT01021748|531555284|FG003|Overall Study|Adverse Event|0|||
147379594|NCT01021748|531555285|FG004|Overall Study|Adverse Event|2|||
147379595|NCT01021748|531555286|FG005|Overall Study|Adverse Event|0|||
147379596|NCT01021748|531555287|FG006|Overall Study|Adverse Event|1|||
147379597|NCT01021748|531555288|FG007|Overall Study|Adverse Event|0|||
147379598|NCT01021748|531555289|FG008|Overall Study|Adverse Event|7|||
147379599|NCT01021748|531555281|FG000|Overall Study|Physician Decision|1|||
147379600|NCT01021748|531555282|FG001|Overall Study|Physician Decision|0|||
147613392|NCT00174954|532398969|FG000|Overall Study|Physician Decision|1|||
147613393|NCT00993421|532398970|FG000|Overall Study|Adverse Event|2|||
147613394|NCT00993421|532398971|FG001|Overall Study|Adverse Event|7|||
147613395|NCT00993421|532398972|FG002|Overall Study|Adverse Event|6|||
147613396|NCT00993421|532398973|FG003|Overall Study|Adverse Event|9|||
147379601|NCT01021748|531555283|FG002|Overall Study|Physician Decision|1|||
147379602|NCT01021748|531555284|FG003|Overall Study|Physician Decision|1|||
147379603|NCT01021748|531555285|FG004|Overall Study|Physician Decision|0|||
147379604|NCT01021748|531555286|FG005|Overall Study|Physician Decision|0|||
147379605|NCT01021748|531555287|FG006|Overall Study|Physician Decision|1|||
147379606|NCT01021748|531555288|FG007|Overall Study|Physician Decision|1|||
147613397|NCT00993421|532398974|FG004|Overall Study|Adverse Event|5|||
147613398|NCT00993421|532398975|FG005|Overall Study|Adverse Event|7|||
147613399|NCT00993421|532398976|FG006|Overall Study|Adverse Event|1|||
147379607|NCT01021748|531555289|FG008|Overall Study|Physician Decision|2|||
147379608|NCT01021748|531555281|FG000|Overall Study|Progressive Disease|3|||
147379609|NCT01021748|531555282|FG001|Overall Study|Progressive Disease|3|||
147379610|NCT01021748|531555283|FG002|Overall Study|Progressive Disease|4|||
147379611|NCT01021748|531555284|FG003|Overall Study|Progressive Disease|6|||
147379612|NCT01021748|531555285|FG004|Overall Study|Progressive Disease|7|||
147379613|NCT01021748|531555286|FG005|Overall Study|Progressive Disease|3|||
147379614|NCT01021748|531555287|FG006|Overall Study|Progressive Disease|0|||
147379615|NCT01021748|531555288|FG007|Overall Study|Progressive Disease|5|||
147379616|NCT01021748|531555289|FG008|Overall Study|Progressive Disease|6|||
147379617|NCT01021748|531555281|FG000|Overall Study|Withdrawal by Subject|0|||
147379618|NCT01021748|531555282|FG001|Overall Study|Withdrawal by Subject|0|||
147379619|NCT01021748|531555283|FG002|Overall Study|Withdrawal by Subject|0|||
147379620|NCT01021748|531555284|FG003|Overall Study|Withdrawal by Subject|0|||
147379621|NCT01021748|531555285|FG004|Overall Study|Withdrawal by Subject|0|||
147379622|NCT01021748|531555286|FG005|Overall Study|Withdrawal by Subject|0|||
147379623|NCT01021748|531555287|FG006|Overall Study|Withdrawal by Subject|1|||
147379624|NCT01021748|531555288|FG007|Overall Study|Withdrawal by Subject|0|||
147379625|NCT01021748|531555289|FG008|Overall Study|Withdrawal by Subject|1|||
147379626|NCT01021748|531555281|FG000|Overall Study|Not Treated|0|||
147379627|NCT01021748|531555282|FG001|Overall Study|Not Treated|1|||
147379628|NCT01021748|531555283|FG002|Overall Study|Not Treated|0|||
147379629|NCT01021748|531555284|FG003|Overall Study|Not Treated|0|||
147379630|NCT01021748|531555285|FG004|Overall Study|Not Treated|0|||
147379631|NCT01021748|531555286|FG005|Overall Study|Not Treated|0|||
147379632|NCT01021748|531555287|FG006|Overall Study|Not Treated|0|||
147379633|NCT01021748|531555288|FG007|Overall Study|Not Treated|0|||
147379634|NCT01021748|531555289|FG008|Overall Study|Not Treated|0|||
147379635|NCT01829711|531555290|FG000|Overall Study|Lost to Follow-up|2|||
147379636|NCT01829711|531555290|FG000|Overall Study|Withdrawal by Subject|3|||
147379637|NCT01829711|531555290|FG000|Overall Study|Death|4|||
147379638|NCT01829711|531555290|FG000|Overall Study|Started new therapies|17|||
147379639|NCT01829711|531555290|FG000|Overall Study|Adverse Event|3|||
147379640|NCT01829711|531555290|FG000|Overall Study|Due to progression of disease|13|||
147379641|NCT01829711|531555290|FG000|Overall Study|Due to lack of response|1|||
147379642|NCT02935673|531555293|FG000|Overall Study|Adverse Event|0|||
147379643|NCT02935673|531555294|FG001|Overall Study|Adverse Event|1|||
147379644|NCT02935673|531555295|FG002|Overall Study|Adverse Event|0|||
147379645|NCT02935673|531555293|FG000|Overall Study|Withdrawal by Subject|1|||
147379646|NCT02935673|531555294|FG001|Overall Study|Withdrawal by Subject|2|||
147379647|NCT02935673|531555295|FG002|Overall Study|Withdrawal by Subject|0|||
147379648|NCT04679675|531555296|FG000|Overall Study|Excluded from analysis, recent Papanicolaou test prior to randomization date|356|||
147379649|NCT04679675|531555297|FG001|Overall Study|Excluded from analysis, recent Papanicolaou test prior to randomization date|261|||
147379650|NCT04679675|531555298|FG002|Overall Study|Excluded from analysis, recent Papanicolaou test prior to randomization date|50|||
147379651|NCT04679675|531555299|FG003|Overall Study|Excluded from analysis, recent Papanicolaou test prior to randomization date|210|||
147379652|NCT04679675|531555296|FG000|Overall Study|Excluded from analysis, recent disenrollment from KPWA|211|||
147379653|NCT04679675|531555297|FG001|Overall Study|Excluded from analysis, recent disenrollment from KPWA|164|||
147379654|NCT04679675|531555298|FG002|Overall Study|Excluded from analysis, recent disenrollment from KPWA|27|||
147379655|NCT04679675|531555299|FG003|Overall Study|Excluded from analysis, recent disenrollment from KPWA|137|||
147379656|NCT03909100|531555303|FG000|Overall Study|Protocol Deviation|2|||
147379657|NCT03909100|531555303|FG000|Overall Study|Technical Problems|4|||
147379658|NCT03909100|531555303|FG000|Overall Study|Withdrawal by Subject|4|||
147379659|NCT03909100|531555303|FG000|Overall Study|Lost to Follow-up|1|||
147379660|NCT03909100|531555303|FG000|Overall Study|Reason not Specified|4|||
147379661|NCT03259568|531555304|FG000|Overall Study|Participant performance was low|3|||
147379662|NCT04248868|531555305|FG000|Overall Study|Death|1|||
147379663|NCT04248868|531555305|FG000|Overall Study|Lost to Follow-up|3|||
147379664|NCT04248868|531555305|FG000|Overall Study|Protocol Violation|2|||
147379665|NCT03128099|531555308|FG000|Overall Study|High dose task was too long|0|||
147379666|NCT03128099|531555309|FG001|Overall Study|High dose task was too long|4|||
147379667|NCT03128099|531555310|FG002|Overall Study|High dose task was too long|0|||
147456033|NCT02944448|531831672|FG000|Overall Study|Abnormal laboratory values|1|||
147379668|NCT03128099|531555308|FG000|Overall Study|Participant got a full time job.|1|||
147456034|NCT02944448|531831673|FG001|Overall Study|Abnormal laboratory values|0|||
147456035|NCT00200850|531831676|FG000|Overall Study|relocation|1|||
147456036|NCT00200850|531831677|FG001|Overall Study|relocation|0|||
147456037|NCT00200850|531831678|FG002|Overall Study|relocation|1|||
147456038|NCT00200850|531831676|FG000|Overall Study|too busy|1|||
147613400|NCT00993421|532398970|FG000|Overall Study|Sponsor Decision|36|||
147379669|NCT03128099|531555309|FG001|Overall Study|Participant got a full time job.|0|||
147379670|NCT03128099|531555310|FG002|Overall Study|Participant got a full time job.|0|||
147379671|NCT03128099|531555308|FG000|Overall Study|Became homeless and lost contact|1|||
147379672|NCT03128099|531555309|FG001|Overall Study|Became homeless and lost contact|0|||
147379673|NCT03128099|531555310|FG002|Overall Study|Became homeless and lost contact|0|||
147379674|NCT03128099|531555308|FG000|Overall Study|Did not complete all the assessments|0|||
147379675|NCT03128099|531555309|FG001|Overall Study|Did not complete all the assessments|0|||
147379676|NCT03128099|531555310|FG002|Overall Study|Did not complete all the assessments|1|||
147379677|NCT00089791|531555311|FG000|Overall Study|Physician Decision|6|||
147379678|NCT00089791|531555312|FG001|Overall Study|Physician Decision|3|||
147379679|NCT00089791|531555311|FG000|Overall Study|Adverse Event|81|||
147456039|NCT00200850|531831677|FG001|Overall Study|too busy|0|||
147456040|NCT00200850|531831678|FG002|Overall Study|too busy|0|||
147379680|NCT00089791|531555312|FG001|Overall Study|Adverse Event|93|||
147379681|NCT00089791|531555311|FG000|Overall Study|Withdrawal by Subject|403|||
147379682|NCT00089791|531555312|FG001|Overall Study|Withdrawal by Subject|344|||
147379683|NCT00089791|531555311|FG000|Overall Study|Death|78|||
147379684|NCT00089791|531555312|FG001|Overall Study|Death|62|||
147379685|NCT00089791|531555311|FG000|Overall Study|Disease progression|7|||
147379686|NCT00089791|531555312|FG001|Overall Study|Disease progression|3|||
147379687|NCT00089791|531555311|FG000|Overall Study|Ineligibility determined|12|||
147379688|NCT00089791|531555312|FG001|Overall Study|Ineligibility determined|9|||
147379689|NCT00089791|531555311|FG000|Overall Study|Lost to Follow-up|57|||
147379690|NCT00089791|531555312|FG001|Overall Study|Lost to Follow-up|57|||
147379691|NCT00089791|531555311|FG000|Overall Study|Noncompliance|17|||
147379692|NCT00089791|531555312|FG001|Overall Study|Noncompliance|13|||
147379693|NCT00089791|531555311|FG000|Overall Study|Other|20|||
147379694|NCT00089791|531555312|FG001|Overall Study|Other|32|||
147379695|NCT00089791|531555311|FG000|Overall Study|Protocol deviation|12|||
147379696|NCT00089791|531555312|FG001|Overall Study|Protocol deviation|10|||
147379697|NCT00089791|531555311|FG000|Overall Study|Requirement for alternative therapy|7|||
147379698|NCT00089791|531555312|FG001|Overall Study|Requirement for alternative therapy|4|||
147379699|NCT02362789|531555318|FG000|Run-in Phase (Week 0 to 16)|Death unrelated to study treatment|1|||
147379700|NCT02362789|531555319|FG001|Run-in Phase (Week 0 to 16)|Death unrelated to study treatment|0|||
147379701|NCT02362789|531555320|FG002|Run-in Phase (Week 0 to 16)|Death unrelated to study treatment|0|||
147379702|NCT02362789|531555318|FG000|Run-in Phase (Week 0 to 16)|Adverse Event|1|||
147379703|NCT02362789|531555319|FG001|Run-in Phase (Week 0 to 16)|Adverse Event|0|||
147379704|NCT02362789|531555320|FG002|Run-in Phase (Week 0 to 16)|Adverse Event|0|||
147379705|NCT02362789|531555318|FG000|Randomized Withdrawal (Wk 16 to 32)|Lack of Efficacy|0|||
147379706|NCT02362789|531555319|FG001|Randomized Withdrawal (Wk 16 to 32)|Lack of Efficacy|2|||
147379707|NCT02362789|531555320|FG002|Randomized Withdrawal (Wk 16 to 32)|Lack of Efficacy|6|||
147379708|NCT02362789|531555318|FG000|Randomized Withdrawal (Wk 16 to 32)|Withdrawal by Subject|0|||
147379709|NCT02362789|531555319|FG001|Randomized Withdrawal (Wk 16 to 32)|Withdrawal by Subject|1|||
147379710|NCT02362789|531555320|FG002|Randomized Withdrawal (Wk 16 to 32)|Withdrawal by Subject|4|||
147379711|NCT02362789|531555318|FG000|Randomized Withdrawal (Wk 16 to 32)|Subject/guardian decision|0|||
147379712|NCT02362789|531555319|FG001|Randomized Withdrawal (Wk 16 to 32)|Subject/guardian decision|1|||
147379713|NCT02362789|531555320|FG002|Randomized Withdrawal (Wk 16 to 32)|Subject/guardian decision|2|||
147379714|NCT00621842|531555322|FG000|Overall Study|Adverse Event|6|||
147379715|NCT00621842|531555322|FG000|Overall Study|Withdrawal by Subject|7|||
147379716|NCT00621842|531555322|FG000|Overall Study|Protocol Violation|4|||
147379717|NCT00621842|531555322|FG000|Overall Study|Lack of Efficacy|2|||
147379718|NCT05074433|531555323|FG000|Overall Study|Adverse Event|0|||
147379719|NCT05074433|531555324|FG001|Overall Study|Adverse Event|2|||
147379720|NCT05074433|531555325|FG002|Overall Study|Adverse Event|0|||
147379721|NCT05074433|531555326|FG003|Overall Study|Adverse Event|1|||
147379722|NCT05074433|531555323|FG000|Overall Study|Sponsor Request|0|||
147379723|NCT05074433|531555324|FG001|Overall Study|Sponsor Request|1|||
147379724|NCT05074433|531555325|FG002|Overall Study|Sponsor Request|1|||
147379725|NCT05074433|531555326|FG003|Overall Study|Sponsor Request|0|||
147379726|NCT05074433|531555323|FG000|Overall Study|Death|1|||
147379727|NCT05074433|531555324|FG001|Overall Study|Death|0|||
147379728|NCT05074433|531555325|FG002|Overall Study|Death|0|||
147379729|NCT05074433|531555326|FG003|Overall Study|Death|0|||
147379730|NCT05074433|531555323|FG000|Overall Study|Lost to Follow-up|0|||
147379731|NCT05074433|531555324|FG001|Overall Study|Lost to Follow-up|0|||
147379732|NCT05074433|531555325|FG002|Overall Study|Lost to Follow-up|2|||
147379733|NCT05074433|531555326|FG003|Overall Study|Lost to Follow-up|0|||
147379734|NCT05074433|531555323|FG000|Overall Study|Subject Decision|8|||
147379735|NCT05074433|531555324|FG001|Overall Study|Subject Decision|6|||
147379736|NCT05074433|531555325|FG002|Overall Study|Subject Decision|4|||
147379737|NCT05074433|531555326|FG003|Overall Study|Subject Decision|5|||
147379738|NCT04397263|531555327|FG000|Overall Study|Withdrawal by Subject|2|||
147379739|NCT00705159|531555338|FG000|Overall Study|Withdrawal by Subject|0|||
147379740|NCT00705159|531555339|FG001|Overall Study|Withdrawal by Subject|1|||
147379741|NCT00705159|531555340|FG002|Overall Study|Withdrawal by Subject|1|||
147379742|NCT00705159|531555341|FG003|Overall Study|Withdrawal by Subject|1|||
147379743|NCT00705159|531555338|FG000|Overall Study|Protocol Violation|0|||
147379744|NCT00705159|531555339|FG001|Overall Study|Protocol Violation|1|||
147379745|NCT00705159|531555340|FG002|Overall Study|Protocol Violation|0|||
147379746|NCT00705159|531555341|FG003|Overall Study|Protocol Violation|0|||
147379747|NCT00705159|531555338|FG000|Overall Study|Adverse Event|0|||
147379748|NCT00705159|531555339|FG001|Overall Study|Adverse Event|0|||
147379749|NCT00705159|531555340|FG002|Overall Study|Adverse Event|1|||
147379750|NCT00705159|531555341|FG003|Overall Study|Adverse Event|0|||
147379751|NCT00705159|531555338|FG000|Overall Study|Lost to Follow-up|0|||
147379752|NCT00705159|531555339|FG001|Overall Study|Lost to Follow-up|0|||
147379753|NCT00705159|531555340|FG002|Overall Study|Lost to Follow-up|3|||
147379754|NCT00705159|531555341|FG003|Overall Study|Lost to Follow-up|2|||
147379755|NCT00705159|531555338|FG000|Overall Study|Screen Failure|0|||
147379756|NCT00705159|531555339|FG001|Overall Study|Screen Failure|0|||
147613401|NCT00993421|532398971|FG001|Overall Study|Sponsor Decision|31|||
147613402|NCT00993421|532398972|FG002|Overall Study|Sponsor Decision|28|||
147613403|NCT00993421|532398973|FG003|Overall Study|Sponsor Decision|30|||
147613404|NCT00993421|532398974|FG004|Overall Study|Sponsor Decision|38|||
147613405|NCT00993421|532398975|FG005|Overall Study|Sponsor Decision|30|||
147613406|NCT00993421|532398976|FG006|Overall Study|Sponsor Decision|29|||
147613407|NCT00993421|532398970|FG000|Overall Study|Lost to Follow-up|3|||
147613408|NCT00993421|532398971|FG001|Overall Study|Lost to Follow-up|5|||
147613409|NCT00993421|532398972|FG002|Overall Study|Lost to Follow-up|5|||
147613410|NCT00993421|532398973|FG003|Overall Study|Lost to Follow-up|0|||
147613411|NCT00993421|532398974|FG004|Overall Study|Lost to Follow-up|0|||
147613412|NCT00993421|532398975|FG005|Overall Study|Lost to Follow-up|0|||
147613413|NCT00993421|532398976|FG006|Overall Study|Lost to Follow-up|6|||
147379757|NCT00705159|531555340|FG002|Overall Study|Screen Failure|0|||
147379758|NCT00705159|531555341|FG003|Overall Study|Screen Failure|1|||
147379759|NCT03026166|531555342|FG000|Overall Study|Death|22|||
147379760|NCT03026166|531555343|FG001|Overall Study|Death|7|||
147379761|NCT03026166|531555342|FG000|Overall Study|Physician Decision|2|||
147379762|NCT03026166|531555343|FG001|Overall Study|Physician Decision|0|||
147379763|NCT03026166|531555342|FG000|Overall Study|Withdrawal by Subject|1|||
147379764|NCT03026166|531555343|FG001|Overall Study|Withdrawal by Subject|2|||
147379765|NCT03026166|531555342|FG000|Overall Study|Lost to Follow-up|1|||
147379766|NCT03026166|531555343|FG001|Overall Study|Lost to Follow-up|0|||
147379767|NCT03026166|531555342|FG000|Overall Study|Study Terminated by Sponsor|3|||
147379768|NCT03026166|531555343|FG001|Overall Study|Study Terminated by Sponsor|3|||
147379769|NCT03026166|531555342|FG000|Overall Study|Other|1|||
147379770|NCT03026166|531555343|FG001|Overall Study|Other|0|||
147379771|NCT05270460|531555344|FG000|Overall Study|Adverse Event|0|||
147379772|NCT05270460|531555345|FG001|Overall Study|Adverse Event|1|||
147379773|NCT05270460|531555346|FG002|Overall Study|Adverse Event|0|||
147379774|NCT05270460|531555344|FG000|Overall Study|Early Termination|0|||
147379775|NCT05270460|531555345|FG001|Overall Study|Early Termination|1|||
147379776|NCT05270460|531555346|FG002|Overall Study|Early Termination|0|||
147379777|NCT00380250|531555347|FG000|Overall Study|Withdrawal by Subject|39|||
147379778|NCT00380250|531555348|FG001|Overall Study|Withdrawal by Subject|28|||
147379779|NCT00380250|531555347|FG000|Overall Study|Adverse Event|20|||
147379780|NCT00380250|531555348|FG001|Overall Study|Adverse Event|9|||
147379781|NCT00380250|531555347|FG000|Overall Study|Lack of Efficacy|10|||
147379782|NCT00380250|531555348|FG001|Overall Study|Lack of Efficacy|8|||
147379783|NCT00380250|531555347|FG000|Overall Study|Protocol Violation|15|||
147379784|NCT00380250|531555348|FG001|Overall Study|Protocol Violation|5|||
147379785|NCT00380250|531555347|FG000|Overall Study|Lost to Follow-up|14|||
147379786|NCT00380250|531555348|FG001|Overall Study|Lost to Follow-up|5|||
147379787|NCT00380250|531555347|FG000|Overall Study|Physician Decision|1|||
147379788|NCT00380250|531555348|FG001|Overall Study|Physician Decision|0|||
147379789|NCT00680771|531555351|FG000|Overall Study|Withdrawal by Subject|1|||
147379790|NCT00680771|531555352|FG001|Overall Study|Withdrawal by Subject|0|||
147379791|NCT00680771|531555351|FG000|Overall Study|Sleep Apnea suspected after PSG|1|||
147379792|NCT00680771|531555352|FG001|Overall Study|Sleep Apnea suspected after PSG|0|||
147379793|NCT00680771|531555351|FG000|Overall Study|Prior Exposure to Hepatitus B Vaccine|4|||
147379794|NCT00680771|531555352|FG001|Overall Study|Prior Exposure to Hepatitus B Vaccine|2|||
147379795|NCT02691702|531555353|FG000|Overall Study|Adverse Event|1|||
147379796|NCT02691702|531555354|FG001|Overall Study|Adverse Event|0|||
147613414|NCT00993421|532398970|FG000|Overall Study|Withdrawal by Subject|3|||
147613415|NCT00993421|532398971|FG001|Overall Study|Withdrawal by Subject|2|||
147613416|NCT00993421|532398972|FG002|Overall Study|Withdrawal by Subject|3|||
147613417|NCT00993421|532398973|FG003|Overall Study|Withdrawal by Subject|3|||
147379797|NCT02691702|531555355|FG002|Overall Study|Adverse Event|0|||
147379798|NCT02691702|531555356|FG003|Overall Study|Adverse Event|0|||
147379799|NCT02691702|531555357|FG004|Overall Study|Adverse Event|0|||
147379800|NCT02691702|531555358|FG005|Overall Study|Adverse Event|0|||
147379801|NCT02691702|531555359|FG006|Overall Study|Adverse Event|0|||
147379802|NCT02691702|531555360|FG007|Overall Study|Adverse Event|0|||
147379803|NCT02691702|531555361|FG008|Overall Study|Adverse Event|1|||
147379804|NCT02691702|531555362|FG009|Overall Study|Adverse Event|0|||
147379805|NCT02691702|531555363|FG010|Overall Study|Adverse Event|1|||
147613418|NCT00993421|532398974|FG004|Overall Study|Withdrawal by Subject|3|||
147613419|NCT00993421|532398975|FG005|Overall Study|Withdrawal by Subject|5|||
147613420|NCT00993421|532398976|FG006|Overall Study|Withdrawal by Subject|3|||
147379806|NCT02691702|531555353|FG000|Overall Study|Lost to Follow-up|0|||
147379807|NCT02691702|531555354|FG001|Overall Study|Lost to Follow-up|0|||
147379808|NCT02691702|531555355|FG002|Overall Study|Lost to Follow-up|1|||
147379809|NCT02691702|531555356|FG003|Overall Study|Lost to Follow-up|0|||
147613421|NCT00993421|532398970|FG000|Overall Study|Death|0|||
147379810|NCT02691702|531555357|FG004|Overall Study|Lost to Follow-up|0|||
147379811|NCT02691702|531555358|FG005|Overall Study|Lost to Follow-up|2|||
147379812|NCT02691702|531555359|FG006|Overall Study|Lost to Follow-up|0|||
147379813|NCT02691702|531555360|FG007|Overall Study|Lost to Follow-up|0|||
147379814|NCT02691702|531555361|FG008|Overall Study|Lost to Follow-up|0|||
147379815|NCT02691702|531555362|FG009|Overall Study|Lost to Follow-up|0|||
147613422|NCT00993421|532398971|FG001|Overall Study|Death|0|||
147613423|NCT00993421|532398972|FG002|Overall Study|Death|0|||
147613424|NCT00993421|532398973|FG003|Overall Study|Death|0|||
147613425|NCT00993421|532398974|FG004|Overall Study|Death|0|||
147379816|NCT02691702|531555363|FG010|Overall Study|Lost to Follow-up|1|||
147379817|NCT02691702|531555353|FG000|Overall Study|Withdrawal by Subject|1|||
147379818|NCT02691702|531555354|FG001|Overall Study|Withdrawal by Subject|1|||
147379819|NCT02691702|531555355|FG002|Overall Study|Withdrawal by Subject|0|||
147613426|NCT00993421|532398975|FG005|Overall Study|Death|0|||
147613427|NCT00993421|532398976|FG006|Overall Study|Death|1|||
147613428|NCT00993421|532398970|FG000|Overall Study|Entry Criteria Exclusion|0|||
147613429|NCT00993421|532398971|FG001|Overall Study|Entry Criteria Exclusion|0|||
147613430|NCT00993421|532398972|FG002|Overall Study|Entry Criteria Exclusion|1|||
147613431|NCT00993421|532398973|FG003|Overall Study|Entry Criteria Exclusion|3|||
147613432|NCT00993421|532398974|FG004|Overall Study|Entry Criteria Exclusion|0|||
147613433|NCT00993421|532398975|FG005|Overall Study|Entry Criteria Exclusion|1|||
147613434|NCT00993421|532398976|FG006|Overall Study|Entry Criteria Exclusion|0|||
147613435|NCT00993421|532398970|FG000|Overall Study|Physician Decision|0|||
147613436|NCT00993421|532398971|FG001|Overall Study|Physician Decision|0|||
147613437|NCT00993421|532398972|FG002|Overall Study|Physician Decision|0|||
147613438|NCT00993421|532398973|FG003|Overall Study|Physician Decision|0|||
147613439|NCT00993421|532398974|FG004|Overall Study|Physician Decision|0|||
147613440|NCT00993421|532398975|FG005|Overall Study|Physician Decision|1|||
147613441|NCT00993421|532398976|FG006|Overall Study|Physician Decision|1|||
147613442|NCT00993421|532398970|FG000|Overall Study|Protocol Violation|0|||
147613443|NCT00993421|532398971|FG001|Overall Study|Protocol Violation|0|||
147613444|NCT00993421|532398972|FG002|Overall Study|Protocol Violation|0|||
147613445|NCT00993421|532398973|FG003|Overall Study|Protocol Violation|0|||
147613446|NCT00993421|532398974|FG004|Overall Study|Protocol Violation|0|||
147613447|NCT00993421|532398975|FG005|Overall Study|Protocol Violation|2|||
147613448|NCT00993421|532398976|FG006|Overall Study|Protocol Violation|1|||
147613449|NCT02215967|532398977|FG000|Overall Study|Patient became ineligible for treatment|0|||
147613450|NCT02215967|532398978|FG001|Overall Study|Patient became ineligible for treatment|0|||
147613451|NCT02215967|532398979|FG002|Overall Study|Patient became ineligible for treatment|0|||
147613452|NCT02215967|532398980|FG003|Overall Study|Patient became ineligible for treatment|3|||
147613453|NCT02215967|532398977|FG000|Overall Study|Patient did not get CAR T-Cells|0|||
147613454|NCT02215967|532398978|FG001|Overall Study|Patient did not get CAR T-Cells|0|||
147613455|NCT02215967|532398979|FG002|Overall Study|Patient did not get CAR T-Cells|1|||
147613456|NCT02215967|532398980|FG003|Overall Study|Patient did not get CAR T-Cells|0|||
147613457|NCT03514017|532398981|FG000|Overall Study|Death|1|||
147379820|NCT02691702|531555356|FG003|Overall Study|Withdrawal by Subject|0|||
147379821|NCT02691702|531555357|FG004|Overall Study|Withdrawal by Subject|0|||
147379822|NCT02691702|531555358|FG005|Overall Study|Withdrawal by Subject|1|||
147379823|NCT02691702|531555359|FG006|Overall Study|Withdrawal by Subject|2|||
147379824|NCT02691702|531555360|FG007|Overall Study|Withdrawal by Subject|0|||
147379825|NCT02691702|531555361|FG008|Overall Study|Withdrawal by Subject|0|||
147379826|NCT02691702|531555362|FG009|Overall Study|Withdrawal by Subject|0|||
147379827|NCT02691702|531555363|FG010|Overall Study|Withdrawal by Subject|0|||
147379828|NCT02691702|531555353|FG000|Overall Study|Other|0|||
147379829|NCT02691702|531555354|FG001|Overall Study|Other|0|||
147379830|NCT02691702|531555355|FG002|Overall Study|Other|0|||
147379831|NCT02691702|531555356|FG003|Overall Study|Other|0|||
147379832|NCT02691702|531555357|FG004|Overall Study|Other|0|||
147613458|NCT03514017|532398981|FG000|Overall Study|Adverse Event|1|||
147613459|NCT00352417|532398985|FG000|Overall Study|Adverse Event|1|||
147613460|NCT00352417|532398986|FG001|Overall Study|Adverse Event|0|||
147613461|NCT00352417|532398985|FG000|Overall Study|Protocol Violation|0|||
147613462|NCT00352417|532398986|FG001|Overall Study|Protocol Violation|2|||
147379833|NCT02691702|531555358|FG005|Overall Study|Other|0|||
147379834|NCT02691702|531555359|FG006|Overall Study|Other|1|||
147456041|NCT00200850|531831676|FG000|Overall Study|Pregnancy|0|||
147456042|NCT00200850|531831677|FG001|Overall Study|Pregnancy|0|||
147456043|NCT00200850|531831678|FG002|Overall Study|Pregnancy|1|||
147613463|NCT00352417|532398985|FG000|Overall Study|Withdrawal by Subject|1|||
147613464|NCT00352417|532398986|FG001|Overall Study|Withdrawal by Subject|2|||
147613465|NCT00352417|532398985|FG000|Overall Study|Lost to Follow-up|1|||
147613466|NCT00352417|532398986|FG001|Overall Study|Lost to Follow-up|0|||
147379835|NCT02691702|531555360|FG007|Overall Study|Other|0|||
147379836|NCT02691702|531555361|FG008|Overall Study|Other|1|||
147456044|NCT00200850|531831676|FG000|Overall Study|Poor adherence|0|||
147613467|NCT00352417|532398985|FG000|Overall Study|Schedule Change|2|||
147613468|NCT00352417|532398986|FG001|Overall Study|Schedule Change|1|||
147613469|NCT02447744|532398987|FG000|Overall Study|Withdrawal by Subject|3|||
147613470|NCT02447744|532398988|FG001|Overall Study|Withdrawal by Subject|1|||
147379837|NCT02691702|531555362|FG009|Overall Study|Other|0|||
147379838|NCT02691702|531555363|FG010|Overall Study|Other|0|||
147456045|NCT00200850|531831677|FG001|Overall Study|Poor adherence|0|||
147613471|NCT02447744|532398987|FG000|Overall Study|Data not collected b/c logistic reasons|3|||
147379839|NCT02691702|531555353|FG000|Overall Study|Protocol Violation|0|||
147379840|NCT02691702|531555354|FG001|Overall Study|Protocol Violation|0|||
147379841|NCT02691702|531555355|FG002|Overall Study|Protocol Violation|0|||
147379842|NCT02691702|531555356|FG003|Overall Study|Protocol Violation|0|||
147379843|NCT02691702|531555357|FG004|Overall Study|Protocol Violation|0|||
147379844|NCT02691702|531555358|FG005|Overall Study|Protocol Violation|0|||
147379845|NCT02691702|531555359|FG006|Overall Study|Protocol Violation|0|||
147379846|NCT02691702|531555360|FG007|Overall Study|Protocol Violation|0|||
147379847|NCT02691702|531555361|FG008|Overall Study|Protocol Violation|0|||
147379848|NCT02691702|531555362|FG009|Overall Study|Protocol Violation|2|||
147379849|NCT02691702|531555363|FG010|Overall Study|Protocol Violation|0|||
147379850|NCT05613088|531555364|FG000|Treatment|Ongoing Study Treatment|9|||
147379851|NCT05613088|531555365|FG001|Treatment|Ongoing Study Treatment|2|||
147379852|NCT05613088|531555364|FG000|Treatment|Adverse Event|3|||
147379853|NCT05613088|531555365|FG001|Treatment|Adverse Event|1|||
147379854|NCT05613088|531555364|FG000|Treatment|Other Reasons|0|||
147379855|NCT05613088|531555365|FG001|Treatment|Other Reasons|1|||
147379856|NCT05613088|531555364|FG000|Treatment|Progressive Disease|58|||
147379857|NCT05613088|531555365|FG001|Treatment|Progressive Disease|26|||
147379858|NCT05613088|531555364|FG000|Treatment|Withdrawal by Subject|0|||
147379859|NCT05613088|531555365|FG001|Treatment|Withdrawal by Subject|4|||
147379860|NCT01668719|531555366|FG000|Phase I|On treatment|1|||
147379861|NCT01668719|531555367|FG001|Phase I|On treatment|0|||
147379862|NCT01668719|531555368|FG002|Phase I|On treatment|0|||
147379863|NCT01668719|531555366|FG000|Phase I|Adverse Event|2|||
147379864|NCT01668719|531555367|FG001|Phase I|Adverse Event|0|||
147379865|NCT01668719|531555368|FG002|Phase I|Adverse Event|0|||
147379866|NCT01668719|531555366|FG000|Phase I|Progression/relapse|1|||
147379867|NCT01668719|531555367|FG001|Phase I|Progression/relapse|0|||
147379868|NCT01668719|531555368|FG002|Phase I|Progression/relapse|0|||
147379869|NCT01668719|531555366|FG000|Phase I|not protocol specified|2|||
147379870|NCT01668719|531555367|FG001|Phase I|not protocol specified|0|||
147379871|NCT01668719|531555368|FG002|Phase I|not protocol specified|0|||
147379872|NCT01668719|531555366|FG000|Phase II|On treatment|0|||
147379873|NCT01668719|531555367|FG001|Phase II|On treatment|4|||
147379874|NCT01668719|531555368|FG002|Phase II|On treatment|3|||
147379875|NCT01668719|531555366|FG000|Phase II|Adverse Event|0|||
147379876|NCT01668719|531555367|FG001|Phase II|Adverse Event|18|||
147379877|NCT01668719|531555368|FG002|Phase II|Adverse Event|18|||
147379878|NCT01668719|531555366|FG000|Phase II|Refusal unrelated to adverse event|0|||
147379879|NCT01668719|531555367|FG001|Phase II|Refusal unrelated to adverse event|4|||
147379880|NCT01668719|531555368|FG002|Phase II|Refusal unrelated to adverse event|1|||
147379881|NCT01668719|531555366|FG000|Phase II|Progression/relapse|0|||
147379882|NCT01668719|531555367|FG001|Phase II|Progression/relapse|13|||
147379883|NCT01668719|531555368|FG002|Phase II|Progression/relapse|17|||
147379884|NCT01668719|531555366|FG000|Phase II|Death|0|||
147379885|NCT01668719|531555367|FG001|Phase II|Death|0|||
147379886|NCT01668719|531555368|FG002|Phase II|Death|2|||
147379887|NCT01668719|531555366|FG000|Phase II|not protocol specified|0|||
147379888|NCT01668719|531555367|FG001|Phase II|not protocol specified|13|||
147379889|NCT01668719|531555368|FG002|Phase II|not protocol specified|7|||
147379890|NCT03205488|531555371|FG000|Overall Study|Adverse Event|1|||
147379891|NCT03205488|531555372|FG001|Overall Study|Adverse Event|2|||
147379892|NCT03205488|531555373|FG002|Overall Study|Adverse Event|4|||
147379893|NCT03205488|531555371|FG000|Overall Study|Protocol Violation|0|||
147379894|NCT03205488|531555372|FG001|Overall Study|Protocol Violation|0|||
147379895|NCT03205488|531555373|FG002|Overall Study|Protocol Violation|1|||
147379896|NCT03652610|531555374|FG000|Overall Study|Lost to Follow-up|1|||
147379897|NCT03652610|531555375|FG001|Overall Study|Lost to Follow-up|0|||
147379898|NCT03652610|531555374|FG000|Overall Study|Withdrawal by Subject|3|||
147379899|NCT03652610|531555375|FG001|Overall Study|Withdrawal by Subject|5|||
147379900|NCT00326183|531555376|FG000|Overall Study|Lost to Follow-up|104|||
147379901|NCT00326183|531555377|FG001|Overall Study|Lost to Follow-up|56|||
147379902|NCT00326183|531555376|FG000|Overall Study|Protocol Violation|6|||
147379903|NCT00326183|531555377|FG001|Overall Study|Protocol Violation|3|||
147379904|NCT00326183|531555376|FG000|Overall Study|Withdrawal by Subject|35|||
147379905|NCT00326183|531555377|FG001|Overall Study|Withdrawal by Subject|7|||
147379906|NCT00326183|531555376|FG000|Overall Study|Subject Moved|7|||
147379907|NCT00326183|531555377|FG001|Overall Study|Subject Moved|4|||
147379908|NCT00326183|531555376|FG000|Overall Study|Other|47|||
147379909|NCT00326183|531555377|FG001|Overall Study|Other|13|||
147379910|NCT00326183|531555376|FG000|Overall Study|Adverse Event|1|||
147379911|NCT00326183|531555377|FG001|Overall Study|Adverse Event|0|||
147379912|NCT01218594|531555378|FG000|Overall Study|Death|1|||
147379913|NCT01218594|531555378|FG000|Overall Study|Withdrawal by Subject|3|||
147379914|NCT01218594|531555378|FG000|Overall Study|Adverse Event|2|||
147379915|NCT01218594|531555378|FG000|Overall Study|Physician Decision|6|||
147379916|NCT02203032|531555380|FG000|Open Label Run-in (Week 0 to Week 16)|Adverse Event|2|||
147379917|NCT02203032|531555381|FG001|Open Label Run-in (Week 0 to Week 16)|Adverse Event|0|||
147379918|NCT02203032|531555382|FG002|Open Label Run-in (Week 0 to Week 16)|Adverse Event|0|||
147379919|NCT02203032|531555383|FG003|Open Label Run-in (Week 0 to Week 16)|Adverse Event|0|||
147379920|NCT02203032|531555380|FG000|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|1|||
147379921|NCT02203032|531555381|FG001|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|0|||
147379922|NCT02203032|531555382|FG002|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|0|||
147379923|NCT02203032|531555383|FG003|Open Label Run-in (Week 0 to Week 16)|Lack of Efficacy|0|||
147379924|NCT02203032|531555380|FG000|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|3|||
147379925|NCT02203032|531555381|FG001|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|0|||
147379926|NCT02203032|531555382|FG002|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|0|||
147379927|NCT02203032|531555383|FG003|Open Label Run-in (Week 0 to Week 16)|Lost to Follow-up|0|||
147379928|NCT02203032|531555380|FG000|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|6|||
147379929|NCT02203032|531555381|FG001|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|0|||
147379930|NCT02203032|531555382|FG002|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|0|||
147379931|NCT02203032|531555383|FG003|Open Label Run-in (Week 0 to Week 16)|Withdrawal by Subject|0|||
147379932|NCT02203032|531555380|FG000|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|4|||
147379933|NCT02203032|531555381|FG001|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|0|||
147379934|NCT02203032|531555382|FG002|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|0|||
147379935|NCT02203032|531555383|FG003|Open Label Run-in (Week 0 to Week 16)|Protocol Violation|0|||
147379936|NCT02203032|531555380|FG000|Open Label Run-in (Week 0 to Week 16)|Other|2|||
147379937|NCT02203032|531555381|FG001|Open Label Run-in (Week 0 to Week 16)|Other|0|||
147379938|NCT02203032|531555382|FG002|Open Label Run-in (Week 0 to Week 16)|Other|0|||
147379939|NCT02203032|531555383|FG003|Open Label Run-in (Week 0 to Week 16)|Other|0|||
147379940|NCT02203032|531555380|FG000|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|1|||
147379941|NCT02203032|531555381|FG001|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|0|||
147379942|NCT02203032|531555382|FG002|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|0|||
147379943|NCT02203032|531555383|FG003|Open Label Run-in (Week 0 to Week 16)|Enrolled but not treated|0|||
147379944|NCT02203032|531555380|FG000|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|0|||
147379945|NCT02203032|531555381|FG001|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|2|||
147379946|NCT02203032|531555382|FG002|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|3|||
147379947|NCT02203032|531555383|FG003|Blinded Phase (Week 16 to Week 44)|Lost to Follow-up|8|||
147379948|NCT02203032|531555380|FG000|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|0|||
147379949|NCT02203032|531555381|FG001|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|8|||
147379950|NCT02203032|531555382|FG002|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|19|||
147379951|NCT02203032|531555383|FG003|Blinded Phase (Week 16 to Week 44)|Withdrawal by Subject|20|||
147379952|NCT02203032|531555380|FG000|Blinded Phase (Week 16 to Week 44)|Other|0|||
147379953|NCT02203032|531555381|FG001|Blinded Phase (Week 16 to Week 44)|Other|4|||
147379954|NCT02203032|531555382|FG002|Blinded Phase (Week 16 to Week 44)|Other|1|||
147379955|NCT02203032|531555383|FG003|Blinded Phase (Week 16 to Week 44)|Other|15|||
147379956|NCT02203032|531555380|FG000|Blinded Phase (Week 16 to Week 44)|Death|0|||
147379957|NCT02203032|531555381|FG001|Blinded Phase (Week 16 to Week 44)|Death|0|||
147379958|NCT02203032|531555382|FG002|Blinded Phase (Week 16 to Week 44)|Death|0|||
147379959|NCT02203032|531555383|FG003|Blinded Phase (Week 16 to Week 44)|Death|1|||
147379960|NCT02203032|531555380|FG000|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|0|||
147379961|NCT02203032|531555381|FG001|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|1|||
147379962|NCT02203032|531555382|FG002|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|3|||
147379963|NCT02203032|531555383|FG003|Blinded Phase (Week 16 to Week 44)|Completed Safety follow-up|2|||
147379964|NCT02241785|531555384|FG000|Overall Study|Sponsor Termination|43|||
147379965|NCT02241785|531555384|FG000|Overall Study|Withdrawal by Subject|1|||
147379966|NCT02241785|531555384|FG000|Overall Study|Lost to Follow-up|2|||
147379967|NCT02241785|531555384|FG000|Overall Study|Adverse Event|1|||
147379968|NCT04748341|531555387|FG000|Overall Study|Lost to Follow-up|1|||
147379969|NCT04748341|531555388|FG001|Overall Study|Lost to Follow-up|1|||
147379970|NCT00452114|531555389|FG000|Overall Study|Physician Decision|3|||
147379971|NCT00452114|531555390|FG001|Overall Study|Physician Decision|3|||
147379972|NCT04197713|531555391|FG000|Overall Study|Not evaluable for DLT per protocol (dosing less than 70% of the study drug in first cycle)|0|||
147379973|NCT04197713|531555392|FG001|Overall Study|Not evaluable for DLT per protocol (dosing less than 70% of the study drug in first cycle)|1|||
147379974|NCT02831049|531555406|FG000|Overall Study|Lost to Follow-up|0|||
147379975|NCT02831049|531555407|FG001|Overall Study|Lost to Follow-up|0|||
147379976|NCT02831049|531555408|FG002|Overall Study|Lost to Follow-up|1|||
147379977|NCT02831049|531555406|FG000|Overall Study|Withdrawal by Subject|0|||
147379978|NCT02831049|531555407|FG001|Overall Study|Withdrawal by Subject|1|||
147379979|NCT02831049|531555408|FG002|Overall Study|Withdrawal by Subject|1|||
147379980|NCT02831049|531555406|FG000|Overall Study|Pandemic shutdown|1|||
147379981|NCT02831049|531555407|FG001|Overall Study|Pandemic shutdown|0|||
147379982|NCT02831049|531555408|FG002|Overall Study|Pandemic shutdown|0|||
147379983|NCT04535414|531555410|FG000|Overall Study|Taken off study due to principal investigator (PI) discretion.|1|||
147379984|NCT04535414|531555411|FG001|Overall Study|Taken off study due to principal investigator (PI) discretion.|0|||
147379985|NCT04535414|531555410|FG000|Overall Study|Cancelled appointment|1|||
147379986|NCT04535414|531555411|FG001|Overall Study|Cancelled appointment|0|||
147379987|NCT04535414|531555410|FG000|Overall Study|cancelled - food in stomach|2|||
147379988|NCT04535414|531555411|FG001|Overall Study|cancelled - food in stomach|0|||
147379989|NCT04535414|531555410|FG000|Overall Study|Study closed per PI decision prior to scheduled intervention|5|||
147379990|NCT04535414|531555411|FG001|Overall Study|Study closed per PI decision prior to scheduled intervention|5|||
147379991|NCT04535414|531555410|FG000|Overall Study|Withdrawal by Subject|0|||
147379992|NCT04535414|531555411|FG001|Overall Study|Withdrawal by Subject|1|||
147379993|NCT03662659|531555412|FG000|Pre-treatment|Participant no longer met study criteria|1|||
147379994|NCT03662659|531555413|FG001|Pre-treatment|Participant no longer met study criteria|1|||
147379995|NCT03662659|531555412|FG000|Pre-treatment|Other reasons|1|||
147379996|NCT03662659|531555413|FG001|Pre-treatment|Other reasons|0|||
147379997|NCT03662659|531555412|FG000|Treatment|Completed Treatment|0|||
147379998|NCT03662659|531555413|FG001|Treatment|Completed Treatment|2|||
147379999|NCT03662659|531555412|FG000|Treatment|Disease Progression|85|||
147380000|NCT03662659|531555413|FG001|Treatment|Disease Progression|97|||
147380001|NCT03662659|531555412|FG000|Treatment|Study Drug Toxicity|19|||
147380002|NCT03662659|531555413|FG001|Treatment|Study Drug Toxicity|9|||
147380003|NCT03662659|531555412|FG000|Treatment|Death|11|||
147380004|NCT03662659|531555413|FG001|Treatment|Death|9|||
147380005|NCT03662659|531555412|FG000|Treatment|Adverse Event unrelated to Study Drug|7|||
147380006|NCT03662659|531555413|FG001|Treatment|Adverse Event unrelated to Study Drug|6|||
147380007|NCT03662659|531555412|FG000|Treatment|Withdrawal by Subject|1|||
147380008|NCT03662659|531555413|FG001|Treatment|Withdrawal by Subject|1|||
147380009|NCT03662659|531555412|FG000|Treatment|Poor/Non-compliance|1|||
147380010|NCT03662659|531555413|FG001|Treatment|Poor/Non-compliance|0|||
147380011|NCT03662659|531555412|FG000|Treatment|Participant no longer meets study criteria|1|||
147380012|NCT03662659|531555413|FG001|Treatment|Participant no longer meets study criteria|0|||
147380013|NCT03662659|531555412|FG000|Treatment|Other reasons|10|||
147380014|NCT03662659|531555413|FG001|Treatment|Other reasons|8|||
147380015|NCT03662659|531555412|FG000|Treatment|Administrative reasons by sponsor|1|||
147380016|NCT03662659|531555413|FG001|Treatment|Administrative reasons by sponsor|0|||
147380017|NCT03662659|531555412|FG000|Treatment|maximum clinical benefit|0|||
147380018|NCT03662659|531555413|FG001|Treatment|maximum clinical benefit|2|||
147380019|NCT01668355|531557005|FG000|Overall Study|Death|3|||
147380020|NCT01668355|531557006|FG001|Overall Study|Death|1|||
147380021|NCT01668355|531557005|FG000|Overall Study|Withdrawal by Subject|6|||
147380022|NCT01668355|531557006|FG001|Overall Study|Withdrawal by Subject|1|||
147380023|NCT01277302|531557010|FG000|7-Month Fixed Treatment Period|Subject Decision to Withdraw|0|||
147380024|NCT01277302|531557011|FG001|7-Month Fixed Treatment Period|Subject Decision to Withdraw|0|||
147380025|NCT01277302|531557012|FG002|7-Month Fixed Treatment Period|Subject Decision to Withdraw|8|||
147380026|NCT01277302|531557010|FG000|7-Month Fixed Treatment Period|Lost to Follow-up|0|||
147380027|NCT01277302|531557011|FG001|7-Month Fixed Treatment Period|Lost to Follow-up|0|||
147380028|NCT01277302|531557012|FG002|7-Month Fixed Treatment Period|Lost to Follow-up|2|||
147380029|NCT01277302|531557010|FG000|7-Month Fixed Treatment Period|Subject Required Other Drug Therapy|0|||
147380030|NCT01277302|531557011|FG001|7-Month Fixed Treatment Period|Subject Required Other Drug Therapy|0|||
147380031|NCT01277302|531557012|FG002|7-Month Fixed Treatment Period|Subject Required Other Drug Therapy|1|||
147380032|NCT01277302|531557010|FG000|7-Month Fixed Treatment Period|Subject Non-compliance|0|||
147380033|NCT01277302|531557011|FG001|7-Month Fixed Treatment Period|Subject Non-compliance|0|||
147380034|NCT01277302|531557012|FG002|7-Month Fixed Treatment Period|Subject Non-compliance|1|||
147380035|NCT01277302|531557010|FG000|8-Month Alternate Dose Regimen Period|Death|0|||
147380036|NCT01277302|531557011|FG001|8-Month Alternate Dose Regimen Period|Death|1|||
147380037|NCT01277302|531557012|FG002|8-Month Alternate Dose Regimen Period|Death|0|||
147380038|NCT01277302|531557010|FG000|8-Month Alternate Dose Regimen Period|Lost to Follow-up|1|||
147380039|NCT01277302|531557011|FG001|8-Month Alternate Dose Regimen Period|Lost to Follow-up|1|||
147380040|NCT01277302|531557012|FG002|8-Month Alternate Dose Regimen Period|Lost to Follow-up|3|||
147380041|NCT01277302|531557010|FG000|8-Month Alternate Dose Regimen Period|Subject Decision to Withdraw|3|||
147380042|NCT01277302|531557011|FG001|8-Month Alternate Dose Regimen Period|Subject Decision to Withdraw|0|||
147380043|NCT01277302|531557012|FG002|8-Month Alternate Dose Regimen Period|Subject Decision to Withdraw|1|||
147380044|NCT01277302|531557010|FG000|8-Month Alternate Dose Regimen Period|Subject Non-compliance|0|||
147380045|NCT01277302|531557011|FG001|8-Month Alternate Dose Regimen Period|Subject Non-compliance|2|||
147380046|NCT01277302|531557012|FG002|8-Month Alternate Dose Regimen Period|Subject Non-compliance|1|||
147380047|NCT01277302|531557010|FG000|8-Month Alternate Dose Regimen Period|Relocation|1|||
147380048|NCT01277302|531557011|FG001|8-Month Alternate Dose Regimen Period|Relocation|0|||
147380049|NCT01277302|531557012|FG002|8-Month Alternate Dose Regimen Period|Relocation|1|||
147380050|NCT02710669|531557015|FG000|Overall Study|Physician Decision|2|||
147380051|NCT02710669|531557016|FG001|Overall Study|Physician Decision|1|||
147380052|NCT02710669|531557017|FG002|Overall Study|Physician Decision|0|||
147380053|NCT02710669|531557015|FG000|Overall Study|Institutional delays (including COVID)|2|||
147380054|NCT02710669|531557016|FG001|Overall Study|Institutional delays (including COVID)|2|||
147380055|NCT02710669|531557017|FG002|Overall Study|Institutional delays (including COVID)|0|||
147380056|NCT02710669|531557015|FG000|Overall Study|arrived in afib/aflutter|10|||
147380057|NCT02710669|531557016|FG001|Overall Study|arrived in afib/aflutter|8|||
147380058|NCT02710669|531557017|FG002|Overall Study|arrived in afib/aflutter|2|||
147380059|NCT01190124|531557019|FG000|Overall Study|Death|3|||
147380060|NCT01190124|531557020|FG001|Overall Study|Death|0|||
147380061|NCT01190124|531557021|FG002|Overall Study|Death|0|||
147380062|NCT01190124|531557019|FG000|Overall Study|Therapeutic Failure|12|||
147380063|NCT01190124|531557020|FG001|Overall Study|Therapeutic Failure|0|||
147380064|NCT01190124|531557021|FG002|Overall Study|Therapeutic Failure|1|||
147380065|NCT01190124|531557019|FG000|Overall Study|Lost to Follow-up|2|||
147380066|NCT01190124|531557020|FG001|Overall Study|Lost to Follow-up|0|||
147380067|NCT01190124|531557021|FG002|Overall Study|Lost to Follow-up|0|||
147380068|NCT01523392|531557022|FG000|Treatment Period 1|Withdrawal by Subject|2|||
147380069|NCT01523392|531557023|FG001|Treatment Period 1|Withdrawal by Subject|0|||
147380070|NCT01523392|531557022|FG000|Treatment Period 1|Did not complete 7-9 days of treatment.|1|||
147380071|NCT01523392|531557023|FG001|Treatment Period 1|Did not complete 7-9 days of treatment.|0|||
147380072|NCT01523392|531557022|FG000|Washout Period - 10 to 14 Days|Adverse Event|1|||
147380073|NCT01523392|531557023|FG001|Washout Period - 10 to 14 Days|Adverse Event|0|||
147380074|NCT02354417|531557024|FG000|Overall Study|Physician Decision|1|||
147380075|NCT03851094|531557027|FG000|Overall Study|Withdrawal by Subject|0|||
147380076|NCT03851094|531557028|FG001|Overall Study|Withdrawal by Subject|1|||
147380077|NCT03851094|531557027|FG000|Overall Study|Participant lost device|0|||
147380078|NCT03851094|531557028|FG001|Overall Study|Participant lost device|1|||
147380079|NCT03851094|531557027|FG000|Overall Study|Participant returned device|0|||
147380080|NCT03851094|531557028|FG001|Overall Study|Participant returned device|2|||
147380081|NCT00484198|531557029|FG000|Overall Study|Participant Withdrew Consent|12|||
147380082|NCT00484198|531557030|FG001|Overall Study|Participant Withdrew Consent|21|||
147380083|NCT00484198|531557031|FG002|Overall Study|Participant Withdrew Consent|47|||
147380084|NCT00484198|531557032|FG003|Overall Study|Participant Withdrew Consent|59|||
147380085|NCT00484198|531557029|FG000|Overall Study|Hyperglycemia Meeting Discontinuation Criteria|16|||
147380086|NCT00484198|531557030|FG001|Overall Study|Hyperglycemia Meeting Discontinuation Criteria|17|||
147380087|NCT00484198|531557031|FG002|Overall Study|Hyperglycemia Meeting Discontinuation Criteria|29|||
147380088|NCT00484198|531557032|FG003|Overall Study|Hyperglycemia Meeting Discontinuation Criteria|38|||
147380089|NCT00484198|531557029|FG000|Overall Study|Therapeutic failure/ lack of efficacy|3|||
147380090|NCT00484198|531557030|FG001|Overall Study|Therapeutic failure/ lack of efficacy|2|||
147380091|NCT00484198|531557031|FG002|Overall Study|Therapeutic failure/ lack of efficacy|6|||
147380092|NCT00484198|531557032|FG003|Overall Study|Therapeutic failure/ lack of efficacy|8|||
147380093|NCT00484198|531557029|FG000|Overall Study|Adverse Event|3|||
147380094|NCT00484198|531557030|FG001|Overall Study|Adverse Event|11|||
147380095|NCT00484198|531557031|FG002|Overall Study|Adverse Event|32|||
147380096|NCT00484198|531557032|FG003|Overall Study|Adverse Event|31|||
147380097|NCT00484198|531557029|FG000|Overall Study|Protocol Violation|0|||
147380098|NCT00484198|531557030|FG001|Overall Study|Protocol Violation|5|||
147380099|NCT00484198|531557031|FG002|Overall Study|Protocol Violation|6|||
147380100|NCT00484198|531557032|FG003|Overall Study|Protocol Violation|8|||
147380101|NCT00484198|531557029|FG000|Overall Study|Other|7|||
147380102|NCT00484198|531557030|FG001|Overall Study|Other|10|||
147380103|NCT00484198|531557031|FG002|Overall Study|Other|31|||
147380104|NCT00484198|531557032|FG003|Overall Study|Other|28|||
147380105|NCT01332266|531557033|FG000|Phase 1b|Death|3|||
147380106|NCT01332266|531557034|FG001|Phase 1b|Death|3|||
147380107|NCT01332266|531557035|FG002|Phase 1b|Death|2|||
147380108|NCT01332266|531557036|FG003|Phase 1b|Death|0|||
147380109|NCT01332266|531557037|FG004|Phase 1b|Death|0|||
147380110|NCT01332266|531557033|FG000|Phase 1b|Lost to Follow-up|0|||
147380111|NCT01332266|531557034|FG001|Phase 1b|Lost to Follow-up|1|||
147380112|NCT01332266|531557035|FG002|Phase 1b|Lost to Follow-up|0|||
147380113|NCT01332266|531557036|FG003|Phase 1b|Lost to Follow-up|0|||
147380114|NCT01332266|531557037|FG004|Phase 1b|Lost to Follow-up|0|||
147380115|NCT01332266|531557033|FG000|Phase 1b|Withdrawal by Subject|1|||
147380116|NCT01332266|531557034|FG001|Phase 1b|Withdrawal by Subject|1|||
147380117|NCT01332266|531557035|FG002|Phase 1b|Withdrawal by Subject|1|||
147380118|NCT01332266|531557036|FG003|Phase 1b|Withdrawal by Subject|0|||
147380119|NCT01332266|531557037|FG004|Phase 1b|Withdrawal by Subject|0|||
147380120|NCT01332266|531557033|FG000|Phase 2|Death|0|||
147380121|NCT01332266|531557034|FG001|Phase 2|Death|0|||
147613472|NCT02447744|532398988|FG001|Overall Study|Data not collected b/c logistic reasons|0|||
147380122|NCT01332266|531557035|FG002|Phase 2|Death|0|||
147380123|NCT01332266|531557036|FG003|Phase 2|Death|33|||
147613473|NCT01290302|532400843|FG000|Overall Study|Adverse Event|2|||
147613474|NCT01290302|532400844|FG001|Overall Study|Adverse Event|0|||
147380124|NCT01332266|531557037|FG004|Phase 2|Death|36|||
147380125|NCT01332266|531557033|FG000|Phase 2|Lost to Follow-up|0|||
147380126|NCT01332266|531557034|FG001|Phase 2|Lost to Follow-up|0|||
147380127|NCT01332266|531557035|FG002|Phase 2|Lost to Follow-up|0|||
147380128|NCT01332266|531557036|FG003|Phase 2|Lost to Follow-up|2|||
147380129|NCT01332266|531557037|FG004|Phase 2|Lost to Follow-up|0|||
147613475|NCT01290302|532400843|FG000|Overall Study|Withdrawal by Subject|1|||
147380130|NCT01332266|531557033|FG000|Phase 2|Physician Decision|0|||
147380131|NCT01332266|531557034|FG001|Phase 2|Physician Decision|0|||
147380132|NCT01332266|531557035|FG002|Phase 2|Physician Decision|0|||
147380133|NCT01332266|531557036|FG003|Phase 2|Physician Decision|3|||
147380134|NCT01332266|531557037|FG004|Phase 2|Physician Decision|1|||
147380135|NCT01332266|531557033|FG000|Phase 2|Symptomatic deterioration|0|||
147380136|NCT01332266|531557034|FG001|Phase 2|Symptomatic deterioration|0|||
147380137|NCT01332266|531557035|FG002|Phase 2|Symptomatic deterioration|0|||
147380138|NCT01332266|531557036|FG003|Phase 2|Symptomatic deterioration|0|||
147380139|NCT01332266|531557037|FG004|Phase 2|Symptomatic deterioration|1|||
147380140|NCT01332266|531557033|FG000|Phase 2|Progression Disease|0|||
147380141|NCT01332266|531557034|FG001|Phase 2|Progression Disease|0|||
147380142|NCT01332266|531557035|FG002|Phase 2|Progression Disease|0|||
147380143|NCT01332266|531557036|FG003|Phase 2|Progression Disease|2|||
147380144|NCT01332266|531557037|FG004|Phase 2|Progression Disease|1|||
147380145|NCT01332266|531557033|FG000|Phase 2|Withdrawal by Subject|0|||
147380146|NCT01332266|531557034|FG001|Phase 2|Withdrawal by Subject|0|||
147380147|NCT01332266|531557035|FG002|Phase 2|Withdrawal by Subject|0|||
147380148|NCT01332266|531557036|FG003|Phase 2|Withdrawal by Subject|2|||
147380149|NCT01332266|531557037|FG004|Phase 2|Withdrawal by Subject|2|||
147380150|NCT01536704|531557040|FG000|Washout Period 1|Withdrawal by Subject|1|||
147380151|NCT01536704|531557041|FG001|Washout Period 1|Withdrawal by Subject|2|||
147380152|NCT01536704|531557042|FG002|Washout Period 1|Withdrawal by Subject|0|||
147380153|NCT01536704|531557043|FG003|Washout Period 1|Withdrawal by Subject|0|||
147380154|NCT01536704|531557040|FG000|Washout Period 2|Adverse Event|1|||
147380155|NCT01536704|531557041|FG001|Washout Period 2|Adverse Event|0|||
147380156|NCT01536704|531557042|FG002|Washout Period 2|Adverse Event|0|||
147380157|NCT01536704|531557043|FG003|Washout Period 2|Adverse Event|0|||
147380158|NCT01536704|531557040|FG000|Washout Period 2|Withdrawal by Subject|0|||
147380159|NCT01536704|531557041|FG001|Washout Period 2|Withdrawal by Subject|0|||
147380160|NCT01536704|531557042|FG002|Washout Period 2|Withdrawal by Subject|0|||
147380161|NCT01536704|531557043|FG003|Washout Period 2|Withdrawal by Subject|1|||
147380162|NCT01536704|531557040|FG000|Period 3|Adverse Event|0|||
147380163|NCT01536704|531557041|FG001|Period 3|Adverse Event|0|||
147380164|NCT01536704|531557042|FG002|Period 3|Adverse Event|0|||
147380165|NCT01536704|531557043|FG003|Period 3|Adverse Event|1|||
147380166|NCT01536704|531557040|FG000|Washout Period 3|Adverse Event|0|||
147380167|NCT01536704|531557041|FG001|Washout Period 3|Adverse Event|0|||
147380168|NCT01536704|531557042|FG002|Washout Period 3|Adverse Event|1|||
147380169|NCT01536704|531557043|FG003|Washout Period 3|Adverse Event|0|||
147380170|NCT02392507|531557044|FG000|Induction Regimen|Death|3|||
147380171|NCT02392507|531557044|FG000|Induction Regimen|On Study Treatment at Study Conclusion|1|||
147380172|NCT02392507|531557044|FG000|Induction Regimen|Physician Decision|1|||
147380173|NCT02392507|531557044|FG000|Induction Regimen|Withdrawal by Subject|2|||
147380174|NCT02392507|531557044|FG000|Maintenance Regimen|Death|1|||
147380175|NCT02392507|531557044|FG000|Maintenance Regimen|On Study Treatment at Study Conclusion|1|||
147380176|NCT01802333|531557045|FG000|Overall Study|Ineligible|2|||
147380177|NCT01802333|531557046|FG001|Overall Study|Ineligible|6|||
147380178|NCT01802333|531557047|FG002|Overall Study|Ineligible|8|||
147380179|NCT01802333|531557045|FG000|Overall Study|Adverse Event|1|||
147380180|NCT01802333|531557046|FG001|Overall Study|Adverse Event|8|||
147380181|NCT01802333|531557047|FG002|Overall Study|Adverse Event|8|||
147380182|NCT01802333|531557045|FG000|Overall Study|Withdrawal by Subject|6|||
147380183|NCT01802333|531557046|FG001|Overall Study|Withdrawal by Subject|6|||
147380184|NCT01802333|531557047|FG002|Overall Study|Withdrawal by Subject|5|||
147380185|NCT01802333|531557045|FG000|Overall Study|Progression/relapse|1|||
147380186|NCT01802333|531557046|FG001|Overall Study|Progression/relapse|3|||
147380187|NCT01802333|531557047|FG002|Overall Study|Progression/relapse|0|||
147380188|NCT01802333|531557045|FG000|Overall Study|Death|7|||
147380189|NCT01802333|531557046|FG001|Overall Study|Death|14|||
147380190|NCT01802333|531557047|FG002|Overall Study|Death|13|||
147380191|NCT01802333|531557045|FG000|Overall Study|Other - not protocol specified|32|||
147380192|NCT01802333|531557046|FG001|Overall Study|Other - not protocol specified|22|||
147380193|NCT01802333|531557047|FG002|Overall Study|Other - not protocol specified|24|||
147380194|NCT01802333|531557045|FG000|Overall Study|Did not start treatment|0|||
147380195|NCT01802333|531557046|FG001|Overall Study|Did not start treatment|2|||
147380196|NCT01802333|531557047|FG002|Overall Study|Did not start treatment|5|||
147380197|NCT02067663|531557049|FG000|Overall Study|Lost to Follow-up|13|||
147380198|NCT02067663|531557050|FG001|Overall Study|Lost to Follow-up|14|||
147380199|NCT00486954|531557055|FG000|Pilot Part|Adverse Event|4|||
147380200|NCT00486954|531557056|FG001|Pilot Part|Adverse Event|0|||
147380201|NCT00486954|531557057|FG002|Pilot Part|Adverse Event|5|||
147380202|NCT00486954|531557058|FG003|Pilot Part|Adverse Event|0|||
147380203|NCT00486954|531557059|FG004|Pilot Part|Adverse Event|0|||
147380204|NCT00486954|531557055|FG000|Pilot Part|Disease Progression|2|||
147380205|NCT00486954|531557056|FG001|Pilot Part|Disease Progression|0|||
147380206|NCT00486954|531557057|FG002|Pilot Part|Disease Progression|1|||
147380207|NCT00486954|531557058|FG003|Pilot Part|Disease Progression|0|||
147380208|NCT00486954|531557059|FG004|Pilot Part|Disease Progression|0|||
147380209|NCT00486954|531557055|FG000|Randomized Part|Lost to Follow-up|0|||
147380210|NCT00486954|531557056|FG001|Randomized Part|Lost to Follow-up|0|||
147380211|NCT00486954|531557057|FG002|Randomized Part|Lost to Follow-up|0|||
147380212|NCT00486954|531557058|FG003|Randomized Part|Lost to Follow-up|0|||
147380213|NCT00486954|531557059|FG004|Randomized Part|Lost to Follow-up|1|||
147380214|NCT00486954|531557055|FG000|Randomized Part|Withdrawal by Subject|0|||
147380215|NCT00486954|531557056|FG001|Randomized Part|Withdrawal by Subject|0|||
147380216|NCT00486954|531557057|FG002|Randomized Part|Withdrawal by Subject|0|||
147380217|NCT00486954|531557058|FG003|Randomized Part|Withdrawal by Subject|1|||
147380218|NCT00486954|531557059|FG004|Randomized Part|Withdrawal by Subject|0|||
147380219|NCT00486954|531557055|FG000|Randomized Part|Sponsor Terminated Study|0|||
147380220|NCT00486954|531557056|FG001|Randomized Part|Sponsor Terminated Study|0|||
147380221|NCT00486954|531557057|FG002|Randomized Part|Sponsor Terminated Study|0|||
147380222|NCT00486954|531557058|FG003|Randomized Part|Sponsor Terminated Study|19|||
147380223|NCT00486954|531557059|FG004|Randomized Part|Sponsor Terminated Study|13|||
147380224|NCT03236779|531557060|FG000|Overall Study|Lost to Follow-up|13|||
147380225|NCT03236779|531557061|FG001|Overall Study|Lost to Follow-up|21|||
147380226|NCT01836523|531557066|FG000|Overall Study|Adverse Event|15|||
147380227|NCT01836523|531557067|FG001|Overall Study|Adverse Event|41|||
147380228|NCT01836523|531557068|FG002|Overall Study|Adverse Event|49|||
147380229|NCT01836523|531557069|FG003|Overall Study|Adverse Event|14|||
147380230|NCT01836523|531557066|FG000|Overall Study|Protocol Violation|6|||
147380231|NCT01836523|531557067|FG001|Overall Study|Protocol Violation|3|||
147380232|NCT01836523|531557068|FG002|Overall Study|Protocol Violation|2|||
147380233|NCT01836523|531557069|FG003|Overall Study|Protocol Violation|4|||
147380234|NCT01836523|531557066|FG000|Overall Study|Met Withdrawal Criteria|13|||
147380235|NCT01836523|531557067|FG001|Overall Study|Met Withdrawal Criteria|13|||
147380236|NCT01836523|531557068|FG002|Overall Study|Met Withdrawal Criteria|21|||
147380237|NCT01836523|531557069|FG003|Overall Study|Met Withdrawal Criteria|27|||
147380238|NCT01836523|531557066|FG000|Overall Study|Unclassified|17|||
147380239|NCT01836523|531557067|FG001|Overall Study|Unclassified|28|||
147380240|NCT01836523|531557068|FG002|Overall Study|Unclassified|19|||
147380241|NCT01836523|531557069|FG003|Overall Study|Unclassified|29|||
147380242|NCT02309515|531557070|FG000|Overall Study|Withdrawal by Subject|0|||
147380243|NCT02309515|531557071|FG001|Overall Study|Withdrawal by Subject|1|||
147380244|NCT04070105|531557075|FG000|Overall Study|Lost to Follow-up|0|||
147380245|NCT04070105|531557076|FG001|Overall Study|Lost to Follow-up|0|||
147380246|NCT04070105|531557077|FG002|Overall Study|Lost to Follow-up|0|||
147380247|NCT04070105|531557078|FG003|Overall Study|Lost to Follow-up|0|||
147380248|NCT04070105|531557079|FG004|Overall Study|Lost to Follow-up|0|||
147380249|NCT04070105|531557080|FG005|Overall Study|Lost to Follow-up|1|||
147380250|NCT00624377|531557086|FG000|Overall Study|Lost to Follow-up|355|||
147380251|NCT00624377|531557086|FG000|Overall Study|Withdrawal by Subject|100|||
147380252|NCT00624377|531557086|FG000|Overall Study|Adverse Event|14|||
147380253|NCT00624377|531557086|FG000|Overall Study|Other|91|||
147380254|NCT00624377|531557086|FG000|Overall Study|Non-evaluable population|84|||
147380255|NCT02245620|531557090|FG000|Overall Study|Physician Decision|1|||
147380256|NCT02245620|531557091|FG001|Overall Study|Physician Decision|1|||
147380257|NCT01102426|531557092|FG000|Overall Study|Randomized but not treated|4|||
147380258|NCT01102426|531557093|FG001|Overall Study|Randomized but not treated|1|||
147380259|NCT01102426|531557092|FG000|Overall Study|Adverse Events (treatment-related)|15|||
147380260|NCT01102426|531557093|FG001|Overall Study|Adverse Events (treatment-related)|8|||
147380261|NCT01102426|531557092|FG000|Overall Study|Physician Decision|9|||
147380262|NCT01102426|531557093|FG001|Overall Study|Physician Decision|6|||
147380263|NCT01102426|531557092|FG000|Overall Study|Progressive Disease|85|||
147380264|NCT01102426|531557093|FG001|Overall Study|Progressive Disease|44|||
147380265|NCT01102426|531557092|FG000|Overall Study|Adverse Events (unrelated to|9|||
147380266|NCT01102426|531557093|FG001|Overall Study|Adverse Events (unrelated to|1|||
147380267|NCT01102426|531557092|FG000|Overall Study|Patient Refusal|24|||
147380268|NCT01102426|531557093|FG001|Overall Study|Patient Refusal|12|||
147456046|NCT00200850|531831678|FG002|Overall Study|Poor adherence|1|||
147456047|NCT00200850|531831676|FG000|Overall Study|optic neuritis|0|||
147456048|NCT00200850|531831677|FG001|Overall Study|optic neuritis|0|||
147456049|NCT00200850|531831678|FG002|Overall Study|optic neuritis|1|||
147456050|NCT00200850|531831676|FG000|Overall Study|Adverse Event|1|||
147456051|NCT00200850|531831677|FG001|Overall Study|Adverse Event|1|||
147380269|NCT01102426|531557092|FG000|Overall Study|Death (due to adverse events|0|||
147380270|NCT01102426|531557093|FG001|Overall Study|Death (due to adverse events|1|||
147380271|NCT01102426|531557092|FG000|Overall Study|Death (non-related to the study|19|||
147380272|NCT01102426|531557093|FG001|Overall Study|Death (non-related to the study|8|||
147380273|NCT01393964|531557094|FG000|Overall Study|Disease Progression|4|||
147380274|NCT01393964|531557095|FG001|Overall Study|Disease Progression|3|||
147380275|NCT01393964|531557096|FG002|Overall Study|Disease Progression|5|||
147380276|NCT01393964|531557094|FG000|Overall Study|Study drug toxicity|1|||
147380277|NCT01393964|531557095|FG001|Overall Study|Study drug toxicity|0|||
147380278|NCT01393964|531557096|FG002|Overall Study|Study drug toxicity|0|||
147380279|NCT01393964|531557094|FG000|Overall Study|Withdrawal by Subject|0|||
147380280|NCT01393964|531557095|FG001|Overall Study|Withdrawal by Subject|0|||
147380281|NCT01393964|531557096|FG002|Overall Study|Withdrawal by Subject|1|||
147380282|NCT01393964|531557094|FG000|Overall Study|Adverse event unrelated to study drug|0|||
147380283|NCT01393964|531557095|FG001|Overall Study|Adverse event unrelated to study drug|3|||
147380284|NCT01393964|531557096|FG002|Overall Study|Adverse event unrelated to study drug|0|||
147380285|NCT01393964|531557094|FG000|Overall Study|Subject request stop study treatment|0|||
147380286|NCT01393964|531557095|FG001|Overall Study|Subject request stop study treatment|1|||
147380287|NCT01393964|531557096|FG002|Overall Study|Subject request stop study treatment|0|||
147380288|NCT01393964|531557094|FG000|Overall Study|Subject decided to move to transplant|1|||
147380289|NCT01393964|531557095|FG001|Overall Study|Subject decided to move to transplant|0|||
147380290|NCT01393964|531557096|FG002|Overall Study|Subject decided to move to transplant|0|||
147380291|NCT01393964|531557094|FG000|Overall Study|Subject switched to commercial supply|1|||
147380292|NCT01393964|531557095|FG001|Overall Study|Subject switched to commercial supply|0|||
147380293|NCT01393964|531557096|FG002|Overall Study|Subject switched to commercial supply|2|||
147380294|NCT01393964|531557094|FG000|Overall Study|Subject plateaued in terms of effect|1|||
147380295|NCT01393964|531557095|FG001|Overall Study|Subject plateaued in terms of effect|0|||
147380296|NCT01393964|531557096|FG002|Overall Study|Subject plateaued in terms of effect|0|||
147380297|NCT01393964|531557094|FG000|Overall Study|Investigator removed subject from study|0|||
147380298|NCT01393964|531557095|FG001|Overall Study|Investigator removed subject from study|1|||
147380299|NCT01393964|531557096|FG002|Overall Study|Investigator removed subject from study|0|||
147380300|NCT01393964|531557094|FG000|Overall Study|Subject converted to roll-over study|0|||
147380301|NCT01393964|531557095|FG001|Overall Study|Subject converted to roll-over study|1|||
147380302|NCT01393964|531557096|FG002|Overall Study|Subject converted to roll-over study|0|||
147380303|NCT01393964|531557094|FG000|Overall Study|Subject to receive non-protocol therapy|0|||
147380304|NCT01393964|531557095|FG001|Overall Study|Subject to receive non-protocol therapy|0|||
147380305|NCT01393964|531557096|FG002|Overall Study|Subject to receive non-protocol therapy|1|||
147380306|NCT00148122|531557097|FG000|Overall Study|Withdrawal by Subject|2|||
147380307|NCT00274287|531557098|FG000|Overall Study|Withdrawal by Subject|1|||
147380308|NCT00274287|531557098|FG000|Overall Study|subject non-compliance|1|||
147380309|NCT03200574|531557099|FG000|Overall Study|Death|4|||
147380310|NCT03200574|531557099|FG000|Overall Study|Withdrawal by Subject|8|||
147380311|NCT03200574|531557099|FG000|Overall Study|Long-Term need for anticoagulation|1|||
147380312|NCT03200574|531557099|FG000|Overall Study|Relocation|2|||
147380313|NCT03200574|531557099|FG000|Overall Study|Lost to Follow-up|2|||
147380314|NCT03035942|531557100|FG000|Overall Study|Adverse Event|8|||
147380315|NCT03035942|531557101|FG001|Overall Study|Adverse Event|4|||
147380316|NCT03035942|531557102|FG002|Overall Study|Adverse Event|5|||
147380317|NCT02538094|531557103|FG000|Intervention 1 (5 Days Per Participant)|Withdrawal by Subject|0|||
147380318|NCT02538094|531557104|FG001|Intervention 1 (5 Days Per Participant)|Withdrawal by Subject|1|||
147380319|NCT02538094|531557103|FG000|Washout (4 Weeks)|Withdrawal by Subject|0|||
147380320|NCT02538094|531557104|FG001|Washout (4 Weeks)|Withdrawal by Subject|1|||
147380321|NCT01989104|531557105|FG000|Overall Study|Withdrawal by Subject|3|||
147380322|NCT01989104|531557106|FG001|Overall Study|Withdrawal by Subject|0|||
147380323|NCT01989104|531557107|FG002|Overall Study|Withdrawal by Subject|0|||
147380324|NCT01989104|531557108|FG003|Overall Study|Withdrawal by Subject|0|||
147380325|NCT01989104|531557109|FG004|Overall Study|Withdrawal by Subject|0|||
147380326|NCT01860079|531557110|FG000|Overall Study|Physician Decision|14|||
147380327|NCT01860079|531557111|FG001|Overall Study|Physician Decision|22|||
147380328|NCT03803475|531557118|FG000|Overall Study|Physician Decision|1|||
147380329|NCT01880736|531557119|FG000|Overall Study|Adverse Event|0|||
147380330|NCT01880736|531557120|FG001|Overall Study|Adverse Event|0|||
147380331|NCT01880736|531557121|FG002|Overall Study|Adverse Event|0|||
147456052|NCT00200850|531831678|FG002|Overall Study|Adverse Event|2|||
147456053|NCT00805740|531831679|FG000|Overall Study|Death|7|||
147456054|NCT00805740|531831680|FG001|Overall Study|Death|4|||
147456055|NCT00805740|531831679|FG000|Overall Study|Withdrawal by Subject|1|||
147456056|NCT00805740|531831680|FG001|Overall Study|Withdrawal by Subject|0|||
147456057|NCT00805740|531831679|FG000|Overall Study|Lost to Follow-up|1|||
147456058|NCT00805740|531831680|FG001|Overall Study|Lost to Follow-up|0|||
147380332|NCT01880736|531557122|FG003|Overall Study|Adverse Event|1|||
147380333|NCT01880736|531557119|FG000|Overall Study|Withdrawal Criteria|1|||
147380334|NCT01880736|531557120|FG001|Overall Study|Withdrawal Criteria|2|||
147380335|NCT01880736|531557121|FG002|Overall Study|Withdrawal Criteria|1|||
147380336|NCT01880736|531557122|FG003|Overall Study|Withdrawal Criteria|5|||
147380337|NCT01263496|531557126|FG000|Enrolled - Long-Term Extension Study|Protocol Violation|1|||
147380338|NCT01263496|531557127|FG001|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
147380339|NCT01263496|531557128|FG002|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
147380340|NCT01263496|531557129|FG003|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
147380341|NCT01263496|531557130|FG004|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
147380342|NCT01263496|531557131|FG005|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
147380343|NCT01263496|531557132|FG006|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
147380344|NCT01263496|531557133|FG007|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
147380345|NCT01263496|531557134|FG008|Enrolled - Long-Term Extension Study|Protocol Violation|0|||
147380346|NCT01263496|531557126|FG000|Enrolled - Long-Term Extension Study|Adverse Event|0|||
147380347|NCT01263496|531557127|FG001|Enrolled - Long-Term Extension Study|Adverse Event|0|||
147380348|NCT01263496|531557128|FG002|Enrolled - Long-Term Extension Study|Adverse Event|0|||
147380349|NCT01263496|531557129|FG003|Enrolled - Long-Term Extension Study|Adverse Event|1|||
147456059|NCT00805740|531831679|FG000|Overall Study|Randomized, but not treated|2|||
147456060|NCT00805740|531831680|FG001|Overall Study|Randomized, but not treated|0|||
147456061|NCT05227690|531831692|FG000|Overall Study|Adverse Event|5|||
147456062|NCT05227690|531831693|FG001|Overall Study|Adverse Event|6|||
147456063|NCT05227690|531831694|FG002|Overall Study|Adverse Event|10|||
147456064|NCT05227690|531831692|FG000|Overall Study|Lack of Efficacy|2|||
147456065|NCT05227690|531831693|FG001|Overall Study|Lack of Efficacy|4|||
147456066|NCT05227690|531831694|FG002|Overall Study|Lack of Efficacy|1|||
147456067|NCT05227690|531831692|FG000|Overall Study|Physician Decision|6|||
147456068|NCT05227690|531831693|FG001|Overall Study|Physician Decision|0|||
147456069|NCT05227690|531831694|FG002|Overall Study|Physician Decision|4|||
147456070|NCT05227690|531831692|FG000|Overall Study|Withdrawal of consent|28|||
147456071|NCT05227690|531831693|FG001|Overall Study|Withdrawal of consent|27|||
147456072|NCT05227690|531831694|FG002|Overall Study|Withdrawal of consent|21|||
147456073|NCT05227690|531831692|FG000|Overall Study|Other, not specified|2|||
147456074|NCT05227690|531831693|FG001|Overall Study|Other, not specified|2|||
147456075|NCT05227690|531831694|FG002|Overall Study|Other, not specified|1|||
147613476|NCT01290302|532400844|FG001|Overall Study|Withdrawal by Subject|0|||
147613477|NCT01290302|532400843|FG000|Overall Study|Physician Decision|0|||
147613478|NCT01290302|532400844|FG001|Overall Study|Physician Decision|2|||
147613479|NCT01290302|532400843|FG000|Overall Study|Expiration of time for screening window|1|||
147613480|NCT01290302|532400844|FG001|Overall Study|Expiration of time for screening window|0|||
147613481|NCT00615199|532400847|FG000|Overall Study|Adverse Event|3|||
147613482|NCT00615199|532400848|FG001|Overall Study|Adverse Event|1|||
147613483|NCT00615199|532400849|FG002|Overall Study|Adverse Event|1|||
147613484|NCT00615199|532400850|FG003|Overall Study|Adverse Event|0|||
147613485|NCT00615199|532400847|FG000|Overall Study|Lack of Efficacy|2|||
147613486|NCT00615199|532400848|FG001|Overall Study|Lack of Efficacy|0|||
147613487|NCT00615199|532400849|FG002|Overall Study|Lack of Efficacy|0|||
147613488|NCT00615199|532400850|FG003|Overall Study|Lack of Efficacy|1|||
147613489|NCT00615199|532400847|FG000|Overall Study|Lost to Follow-up|1|||
147613490|NCT00615199|532400848|FG001|Overall Study|Lost to Follow-up|0|||
147613491|NCT00615199|532400849|FG002|Overall Study|Lost to Follow-up|0|||
147613492|NCT00615199|532400850|FG003|Overall Study|Lost to Follow-up|0|||
147613493|NCT00615199|532400847|FG000|Overall Study|Other|0|||
147613494|NCT00615199|532400848|FG001|Overall Study|Other|0|||
147613495|NCT00615199|532400849|FG002|Overall Study|Other|0|||
147380350|NCT01263496|531557130|FG004|Enrolled - Long-Term Extension Study|Adverse Event|2|||
147380351|NCT01263496|531557131|FG005|Enrolled - Long-Term Extension Study|Adverse Event|0|||
147380352|NCT01263496|531557132|FG006|Enrolled - Long-Term Extension Study|Adverse Event|0|||
147380353|NCT01263496|531557133|FG007|Enrolled - Long-Term Extension Study|Adverse Event|0|||
147380354|NCT01263496|531557134|FG008|Enrolled - Long-Term Extension Study|Adverse Event|0|||
147380355|NCT01263496|531557126|FG000|Entered - Long-Term Extension Study|Adverse Event|0|||
147380356|NCT01263496|531557127|FG001|Entered - Long-Term Extension Study|Adverse Event|5|||
147380357|NCT01263496|531557128|FG002|Entered - Long-Term Extension Study|Adverse Event|6|||
147380358|NCT01263496|531557129|FG003|Entered - Long-Term Extension Study|Adverse Event|3|||
147380359|NCT01263496|531557130|FG004|Entered - Long-Term Extension Study|Adverse Event|1|||
147380360|NCT01263496|531557131|FG005|Entered - Long-Term Extension Study|Adverse Event|0|||
147380361|NCT01263496|531557132|FG006|Entered - Long-Term Extension Study|Adverse Event|0|||
147380362|NCT01263496|531557133|FG007|Entered - Long-Term Extension Study|Adverse Event|0|||
147380363|NCT01263496|531557134|FG008|Entered - Long-Term Extension Study|Adverse Event|1|||
147380364|NCT01263496|531557126|FG000|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
147380365|NCT01263496|531557127|FG001|Entered - Long-Term Extension Study|Lost to Follow-up|2|||
147380366|NCT01263496|531557128|FG002|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
147380367|NCT01263496|531557129|FG003|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
147380368|NCT01263496|531557130|FG004|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
147380369|NCT01263496|531557131|FG005|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
147380370|NCT01263496|531557132|FG006|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
147456076|NCT00223496|531831695|FG000|Overall Study|screen failure|9|||
147456077|NCT00223496|531831695|FG000|Overall Study|Lost to Follow-up|4|||
147456078|NCT00223496|531831695|FG000|Overall Study|Lack of Efficacy|6|||
147613496|NCT00615199|532400850|FG003|Overall Study|Other|1|||
147613497|NCT00615199|532400847|FG000|Overall Study|Withdrawal by Subject|2|||
147613498|NCT00615199|532400848|FG001|Overall Study|Withdrawal by Subject|1|||
147613499|NCT00615199|532400849|FG002|Overall Study|Withdrawal by Subject|0|||
147380371|NCT01263496|531557133|FG007|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
147380372|NCT01263496|531557134|FG008|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
147380373|NCT01263496|531557126|FG000|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
147456079|NCT00223496|531831695|FG000|Overall Study|Withdrawal by Subject|1|||
147456080|NCT00223496|531831695|FG000|Overall Study|Physician Decision|2|||
147613500|NCT00615199|532400850|FG003|Overall Study|Withdrawal by Subject|0|||
147613501|NCT02653625|532400853|FG000|Overall Study|Adverse Event|1|||
147613502|NCT02653625|532400853|FG000|Overall Study|Non-compliance with Study Drug|1|||
147613503|NCT02653625|532400853|FG000|Overall Study|Protocol Violation|1|||
147613504|NCT02653625|532400853|FG000|Overall Study|Suspected Drug Induced Liver Injury|1|||
147613505|NCT00064987|532400854|FG000|Overall Study|Physician Decision|3|||
147380374|NCT01263496|531557127|FG001|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
147380375|NCT01263496|531557128|FG002|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
147380376|NCT01263496|531557129|FG003|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
147380377|NCT01263496|531557130|FG004|Entered - Long-Term Extension Study|Withdrawal by Subject|4|||
147380378|NCT01263496|531557131|FG005|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
147380379|NCT01263496|531557132|FG006|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
147380380|NCT01263496|531557133|FG007|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
147380381|NCT01263496|531557134|FG008|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
147380382|NCT01263496|531557126|FG000|Entered - Long-Term Extension Study|Lack of Efficacy|8|||
147380383|NCT01263496|531557127|FG001|Entered - Long-Term Extension Study|Lack of Efficacy|4|||
147380384|NCT01263496|531557128|FG002|Entered - Long-Term Extension Study|Lack of Efficacy|4|||
147380385|NCT01263496|531557129|FG003|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
147380386|NCT01263496|531557130|FG004|Entered - Long-Term Extension Study|Lack of Efficacy|5|||
147380387|NCT01263496|531557131|FG005|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
147380388|NCT01263496|531557132|FG006|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
147380389|NCT01263496|531557133|FG007|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
147380390|NCT01263496|531557134|FG008|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
147380391|NCT01263496|531557126|FG000|Entered - Long-Term Extension Study|Participant Unavailability|0|||
147380392|NCT01263496|531557127|FG001|Entered - Long-Term Extension Study|Participant Unavailability|0|||
147380393|NCT01263496|531557128|FG002|Entered - Long-Term Extension Study|Participant Unavailability|0|||
147380394|NCT01263496|531557129|FG003|Entered - Long-Term Extension Study|Participant Unavailability|0|||
147380395|NCT01263496|531557130|FG004|Entered - Long-Term Extension Study|Participant Unavailability|0|||
147380396|NCT01263496|531557131|FG005|Entered - Long-Term Extension Study|Participant Unavailability|0|||
147380397|NCT01263496|531557132|FG006|Entered - Long-Term Extension Study|Participant Unavailability|0|||
147380398|NCT01263496|531557133|FG007|Entered - Long-Term Extension Study|Participant Unavailability|1|||
147380399|NCT01263496|531557134|FG008|Entered - Long-Term Extension Study|Participant Unavailability|0|||
147380400|NCT05995977|531557138|FG000|Overall Study|Withdrawal by Subject|1|||
147380401|NCT05995977|531557139|FG001|Overall Study|Withdrawal by Subject|4|||
147380402|NCT05995977|531557138|FG000|Overall Study|Lost to Follow-up|2|||
147380403|NCT05995977|531557139|FG001|Overall Study|Lost to Follow-up|0|||
147380404|NCT04181788|531557140|FG000|TREATMENT|Adverse Event|0|||
147380405|NCT04181788|531557141|FG001|TREATMENT|Adverse Event|2|||
147380406|NCT04181788|531557142|FG002|TREATMENT|Adverse Event|1|||
147380407|NCT04181788|531557143|FG003|TREATMENT|Adverse Event|0|||
147380408|NCT04181788|531557144|FG004|TREATMENT|Adverse Event|1|||
147380409|NCT04181788|531557145|FG005|TREATMENT|Adverse Event|3|||
147380410|NCT04181788|531557140|FG000|TREATMENT|Death|0|||
147380411|NCT04181788|531557141|FG001|TREATMENT|Death|0|||
147380412|NCT04181788|531557142|FG002|TREATMENT|Death|0|||
147380413|NCT04181788|531557143|FG003|TREATMENT|Death|0|||
147380414|NCT04181788|531557144|FG004|TREATMENT|Death|8|||
147380415|NCT04181788|531557145|FG005|TREATMENT|Death|8|||
147380416|NCT04181788|531557140|FG000|TREATMENT|Physician Decision|0|||
147380417|NCT04181788|531557141|FG001|TREATMENT|Physician Decision|0|||
147380418|NCT04181788|531557142|FG002|TREATMENT|Physician Decision|0|||
147380419|NCT04181788|531557143|FG003|TREATMENT|Physician Decision|0|||
147380420|NCT04181788|531557144|FG004|TREATMENT|Physician Decision|0|||
147380421|NCT04181788|531557145|FG005|TREATMENT|Physician Decision|1|||
147380422|NCT04181788|531557140|FG000|TREATMENT|Progressive disease|3|||
147380423|NCT04181788|531557141|FG001|TREATMENT|Progressive disease|3|||
147380424|NCT04181788|531557142|FG002|TREATMENT|Progressive disease|5|||
147380425|NCT04181788|531557143|FG003|TREATMENT|Progressive disease|7|||
147380426|NCT04181788|531557144|FG004|TREATMENT|Progressive disease|20|||
147456081|NCT02723201|531831698|FG000|Second Intervention Period|Protocol Violation|1|||
147456082|NCT02723201|531831699|FG001|Second Intervention Period|Protocol Violation|0|||
147456083|NCT02723201|531831700|FG002|Second Intervention Period|Protocol Violation|0|||
147456084|NCT02723201|531831698|FG000|Second Intervention Period|Adverse Event|1|||
147456085|NCT02723201|531831699|FG001|Second Intervention Period|Adverse Event|0|||
147456086|NCT02723201|531831700|FG002|Second Intervention Period|Adverse Event|0|||
147456087|NCT02634580|531831706|FG000|Double-blind Treatment Period|Subject Request|1|||
147456088|NCT02634580|531831707|FG001|Double-blind Treatment Period|Subject Request|0|||
147456089|NCT02634580|531831708|FG002|Double-blind Treatment Period|Subject Request|1|||
147456090|NCT02634580|531831709|FG003|Double-blind Treatment Period|Subject Request|1|||
147456091|NCT02634580|531831706|FG000|Open-label Extension Period|Withdrawal by Subject|0|||
147456092|NCT02634580|531831707|FG001|Open-label Extension Period|Withdrawal by Subject|1|||
147456093|NCT02634580|531831708|FG002|Open-label Extension Period|Withdrawal by Subject|0|||
147380427|NCT04181788|531557145|FG005|TREATMENT|Progressive disease|38|||
147380428|NCT04181788|531557140|FG000|TREATMENT|Global deterioration of health status|0|||
147380429|NCT04181788|531557141|FG001|TREATMENT|Global deterioration of health status|2|||
147380430|NCT04181788|531557142|FG002|TREATMENT|Global deterioration of health status|0|||
147456094|NCT02634580|531831709|FG003|Open-label Extension Period|Withdrawal by Subject|1|||
147456095|NCT01978093|531831711|FG000|Overall Study|Death|1|||
147456096|NCT01978093|531831712|FG001|Overall Study|Death|0|||
147613506|NCT00064987|532400855|FG001|Overall Study|Physician Decision|0|||
147613507|NCT00196326|532400856|FG000|Overall Study|Did not meet protocol requirements|64|||
147613508|NCT00196326|532400856|FG000|Overall Study|Non-compliance with the protocol|81|||
147613509|NCT00196326|532400856|FG000|Overall Study|Physician Decision|3|||
147613510|NCT00196326|532400856|FG000|Overall Study|Withdrawal by Subject|225|||
147613511|NCT00196326|532400856|FG000|Overall Study|Adverse Event|253|||
147613512|NCT00196326|532400856|FG000|Overall Study|Pregnancy|34|||
147613513|NCT00196326|532400856|FG000|Overall Study|Lost to Follow-up|304|||
147613514|NCT00196326|532400856|FG000|Overall Study|Other|22|||
147613515|NCT01473407|532400857|FG000|Overall Study|Physician Decision|1|||
147613516|NCT01473407|532400858|FG001|Overall Study|Physician Decision|4|||
147613517|NCT01473407|532400857|FG000|Overall Study|Lost to Follow-up|10|||
147613518|NCT01473407|532400858|FG001|Overall Study|Lost to Follow-up|4|||
147613519|NCT01473407|532400857|FG000|Overall Study|Adverse Event|8|||
147613520|NCT01473407|532400858|FG001|Overall Study|Adverse Event|8|||
147613521|NCT01473407|532400857|FG000|Overall Study|Randomization Error|3|||
147613522|NCT01473407|532400858|FG001|Overall Study|Randomization Error|1|||
147613523|NCT01473407|532400857|FG000|Overall Study|Withdrawal by Subject|4|||
147613524|NCT01473407|532400858|FG001|Overall Study|Withdrawal by Subject|7|||
147613525|NCT01473407|532400857|FG000|Overall Study|Kidney Transplant|7|||
147613526|NCT01473407|532400858|FG001|Overall Study|Kidney Transplant|6|||
147613527|NCT01473407|532400857|FG000|Overall Study|Vacation/Travel|1|||
147613528|NCT01473407|532400858|FG001|Overall Study|Vacation/Travel|1|||
147613529|NCT01473407|532400857|FG000|Overall Study|Elevated Hemoglobin|1|||
147613530|NCT01473407|532400858|FG001|Overall Study|Elevated Hemoglobin|0|||
147613531|NCT01473407|532400857|FG000|Overall Study|Patient Received Aranesp|1|||
147613532|NCT01473407|532400858|FG001|Overall Study|Patient Received Aranesp|0|||
147613533|NCT01473407|532400857|FG000|Overall Study|Patient Lost Green Card Status|1|||
147613534|NCT01473407|532400858|FG001|Overall Study|Patient Lost Green Card Status|0|||
147613535|NCT01473407|532400857|FG000|Overall Study|Temperature Excursion|2|||
147613536|NCT01473407|532400858|FG001|Overall Study|Temperature Excursion|3|||
147613537|NCT01473407|532400857|FG000|Overall Study|Transfer to Another Facility/Unit|4|||
147613538|NCT01473407|532400858|FG001|Overall Study|Transfer to Another Facility/Unit|3|||
147613539|NCT01473407|532400857|FG000|Overall Study|Sponsor's Decision|10|||
147613540|NCT01473407|532400858|FG001|Overall Study|Sponsor's Decision|10|||
147613541|NCT01473407|532400857|FG000|Overall Study|Site Closure|1|||
147613542|NCT01473407|532400858|FG001|Overall Study|Site Closure|0|||
147613543|NCT05223920|532400859|FG000|Overall Study|Adverse Event|6|||
147613544|NCT05223920|532400860|FG001|Overall Study|Adverse Event|3|||
147613545|NCT05223920|532400859|FG000|Overall Study|Death|2|||
147380431|NCT04181788|531557143|FG003|TREATMENT|Global deterioration of health status|0|||
147380432|NCT04181788|531557144|FG004|TREATMENT|Global deterioration of health status|2|||
147380433|NCT04181788|531557145|FG005|TREATMENT|Global deterioration of health status|8|||
147380434|NCT04181788|531557140|FG000|TREATMENT|Withdrawal by Subject|1|||
147380435|NCT04181788|531557141|FG001|TREATMENT|Withdrawal by Subject|2|||
147380436|NCT04181788|531557142|FG002|TREATMENT|Withdrawal by Subject|0|||
147380437|NCT04181788|531557143|FG003|TREATMENT|Withdrawal by Subject|0|||
147380438|NCT04181788|531557144|FG004|TREATMENT|Withdrawal by Subject|3|||
147380439|NCT04181788|531557145|FG005|TREATMENT|Withdrawal by Subject|5|||
147380440|NCT04181788|531557140|FG000|TREATMENT|Other unspecified|0|||
147380441|NCT04181788|531557141|FG001|TREATMENT|Other unspecified|0|||
147380442|NCT04181788|531557142|FG002|TREATMENT|Other unspecified|0|||
147380443|NCT04181788|531557143|FG003|TREATMENT|Other unspecified|0|||
147380444|NCT04181788|531557144|FG004|TREATMENT|Other unspecified|0|||
147613546|NCT05223920|532400860|FG001|Overall Study|Death|0|||
147613547|NCT05223920|532400859|FG000|Overall Study|Disease Progression|1|||
147613548|NCT05223920|532400860|FG001|Overall Study|Disease Progression|2|||
147613549|NCT05223920|532400859|FG000|Overall Study|Physician Decision|1|||
147613550|NCT05223920|532400860|FG001|Overall Study|Physician Decision|2|||
147613551|NCT05223920|532400859|FG000|Overall Study|Sponsor decision|11|||
147613552|NCT05223920|532400860|FG001|Overall Study|Sponsor decision|9|||
147613553|NCT05223920|532400859|FG000|Overall Study|Transferred to Extension Study MK-3543-017 (NCT06351631)|29|||
147613554|NCT05223920|532400860|FG001|Overall Study|Transferred to Extension Study MK-3543-017 (NCT06351631)|7|||
147613555|NCT05223920|532400859|FG000|Overall Study|Subject decision|1|||
147613556|NCT05223920|532400860|FG001|Overall Study|Subject decision|0|||
147613557|NCT05223920|532400859|FG000|Overall Study|Withdrawal by Subject|1|||
147613558|NCT05223920|532400860|FG001|Overall Study|Withdrawal by Subject|6|||
147613559|NCT00369941|532400861|FG000|Overall Study|Never Treated|1|||
147613560|NCT00369941|532400862|FG001|Overall Study|Never Treated|2|||
147380445|NCT04181788|531557145|FG005|TREATMENT|Other unspecified|2|||
147380446|NCT04181788|531557140|FG000|TREATMENT|Ongoing|0|||
147380447|NCT04181788|531557141|FG001|TREATMENT|Ongoing|3|||
147613561|NCT00369941|532400861|FG000|Overall Study|Adverse Event|14|||
147613562|NCT00369941|532400862|FG001|Overall Study|Adverse Event|28|||
147380448|NCT04181788|531557142|FG002|TREATMENT|Ongoing|0|||
147380449|NCT04181788|531557143|FG003|TREATMENT|Ongoing|5|||
147613563|NCT00369941|532400861|FG000|Overall Study|Lack of Efficacy|6|||
147613564|NCT00369941|532400862|FG001|Overall Study|Lack of Efficacy|10|||
147613565|NCT00369941|532400861|FG000|Overall Study|Lost to Follow-up|12|||
147380450|NCT04181788|531557144|FG004|TREATMENT|Ongoing|7|||
147380451|NCT04181788|531557145|FG005|TREATMENT|Ongoing|15|||
147380452|NCT04181788|531557140|FG000|FOLLOW-UP|Death|0|||
147380453|NCT04181788|531557141|FG001|FOLLOW-UP|Death|0|||
147380454|NCT04181788|531557142|FG002|FOLLOW-UP|Death|1|||
147380455|NCT04181788|531557143|FG003|FOLLOW-UP|Death|2|||
147380456|NCT04181788|531557144|FG004|FOLLOW-UP|Death|8|||
147380457|NCT04181788|531557145|FG005|FOLLOW-UP|Death|20|||
147380458|NCT04181788|531557140|FG000|FOLLOW-UP|Lost to Follow-up|0|||
147380459|NCT04181788|531557141|FG001|FOLLOW-UP|Lost to Follow-up|0|||
147380460|NCT04181788|531557142|FG002|FOLLOW-UP|Lost to Follow-up|0|||
147380461|NCT04181788|531557143|FG003|FOLLOW-UP|Lost to Follow-up|0|||
147380462|NCT04181788|531557144|FG004|FOLLOW-UP|Lost to Follow-up|0|||
147380463|NCT04181788|531557145|FG005|FOLLOW-UP|Lost to Follow-up|2|||
147380464|NCT04181788|531557140|FG000|FOLLOW-UP|Withdrawal by Subject|0|||
147380465|NCT04181788|531557141|FG001|FOLLOW-UP|Withdrawal by Subject|0|||
147380466|NCT04181788|531557142|FG002|FOLLOW-UP|Withdrawal by Subject|0|||
147613566|NCT00369941|532400862|FG001|Overall Study|Lost to Follow-up|22|||
147613567|NCT00369941|532400861|FG000|Overall Study|Protocol Violation|5|||
147613568|NCT00369941|532400862|FG001|Overall Study|Protocol Violation|3|||
147613569|NCT00369941|532400861|FG000|Overall Study|Withdrawal by Subject|5|||
147613570|NCT00369941|532400862|FG001|Overall Study|Withdrawal by Subject|18|||
147613571|NCT00369941|532400861|FG000|Overall Study|Pregnancy|4|||
147613572|NCT00369941|532400862|FG001|Overall Study|Pregnancy|2|||
147613573|NCT00369941|532400861|FG000|Overall Study|Completed, Did Not Enter Extension|5|||
147613574|NCT00369941|532400862|FG001|Overall Study|Completed, Did Not Enter Extension|6|||
147613575|NCT00369941|532400861|FG000|Overall Study|Moved|11|||
147613576|NCT00369941|532400862|FG001|Overall Study|Moved|5|||
147613577|NCT00369941|532400861|FG000|Overall Study|Treatment with Prohibited Medication|3|||
147613578|NCT00369941|532400862|FG001|Overall Study|Treatment with Prohibited Medication|1|||
147613579|NCT00369941|532400861|FG000|Overall Study|Employment Interfered with Study Visits|1|||
147613580|NCT00369941|532400862|FG001|Overall Study|Employment Interfered with Study Visits|0|||
147613581|NCT00369941|532400861|FG000|Overall Study|Study Site Terminated|2|||
147613582|NCT00369941|532400862|FG001|Overall Study|Study Site Terminated|0|||
147613583|NCT00369941|532400861|FG000|Overall Study|Miscellaneous|3|||
147613584|NCT00369941|532400862|FG001|Overall Study|Miscellaneous|3|||
147613585|NCT01027702|532400863|FG000|Overall Study|Received subsequent therapy|1|||
147613586|NCT01027702|532400864|FG001|Overall Study|Received subsequent therapy|2|||
147613587|NCT01027702|532400865|FG002|Overall Study|Received subsequent therapy|0|||
147613588|NCT01027702|532400866|FG003|Overall Study|Received subsequent therapy|4|||
147613589|NCT01027702|532400867|FG004|Overall Study|Received subsequent therapy|1|||
147613590|NCT01027702|532400868|FG005|Overall Study|Received subsequent therapy|0|||
147613591|NCT01027702|532400869|FG006|Overall Study|Received subsequent therapy|1|||
147613592|NCT01027702|532400863|FG000|Overall Study|Death|0|||
147613593|NCT01027702|532400864|FG001|Overall Study|Death|0|||
147613594|NCT01027702|532400865|FG002|Overall Study|Death|1|||
147613595|NCT01027702|532400866|FG003|Overall Study|Death|0|||
147613596|NCT01027702|532400867|FG004|Overall Study|Death|0|||
147613597|NCT01027702|532400868|FG005|Overall Study|Death|0|||
147613598|NCT01027702|532400869|FG006|Overall Study|Death|0|||
147613599|NCT00403585|532400870|FG000|Initial Treatment Phase|Lost to Follow-up|2|||
147613600|NCT00403585|532400870|FG000|Open-Label Phase; Extension Study|Withdrawal by Subject|2|||
147613601|NCT00403585|532400870|FG000|Open-Label Phase; Extension Study|HBV DNA Mutation Positive|4|||
147613602|NCT02964312|532400873|FG000|Overall Study|Lost to Follow-up|28|||
147613603|NCT02964312|532400873|FG000|Overall Study|Withdrawal by Subject|11|||
147613604|NCT02964312|532400873|FG000|Overall Study|Lack of Efficacy|10|||
147613605|NCT02964312|532400873|FG000|Overall Study|Did not consent to long-term FU|14|||
147613606|NCT02964312|532400873|FG000|Overall Study|Death|1|||
147380467|NCT04181788|531557143|FG003|FOLLOW-UP|Withdrawal by Subject|0|||
147380468|NCT04181788|531557144|FG004|FOLLOW-UP|Withdrawal by Subject|1|||
147613607|NCT02862730|532400882|FG000|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
147613608|NCT02862730|532400883|FG001|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
147613609|NCT02862730|532400884|FG002|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|1|||
147613610|NCT02862730|532400885|FG003|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
147613611|NCT02862730|532400886|FG004|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
147613612|NCT02862730|532400887|FG005|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
147380469|NCT04181788|531557145|FG005|FOLLOW-UP|Withdrawal by Subject|0|||
147380470|NCT04181788|531557140|FG000|FOLLOW-UP|Other unspecified|0|||
147380471|NCT04181788|531557141|FG001|FOLLOW-UP|Other unspecified|1|||
147380472|NCT04181788|531557142|FG002|FOLLOW-UP|Other unspecified|0|||
147380473|NCT04181788|531557143|FG003|FOLLOW-UP|Other unspecified|0|||
147380474|NCT04181788|531557144|FG004|FOLLOW-UP|Other unspecified|0|||
147613613|NCT02862730|532400888|FG006|Tslim Training Visit (2 Weeks)|Withdrawal by Subject|0|||
147613614|NCT02862730|532400882|FG000|Second Intervention (84 Hours)|Withdrawal by Subject|1|||
147613615|NCT02862730|532400883|FG001|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
147613616|NCT02862730|532400884|FG002|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
147613617|NCT02862730|532400885|FG003|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
147613618|NCT02862730|532400886|FG004|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
147613619|NCT02862730|532400887|FG005|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
147380475|NCT04181788|531557145|FG005|FOLLOW-UP|Other unspecified|3|||
147380476|NCT04181788|531557140|FG000|FOLLOW-UP|Ongoing|0|||
147380477|NCT04181788|531557141|FG001|FOLLOW-UP|Ongoing|0|||
147380478|NCT04181788|531557142|FG002|FOLLOW-UP|Ongoing|1|||
147380479|NCT04181788|531557143|FG003|FOLLOW-UP|Ongoing|3|||
147380480|NCT04181788|531557144|FG004|FOLLOW-UP|Ongoing|2|||
147380481|NCT04181788|531557145|FG005|FOLLOW-UP|Ongoing|2|||
147380482|NCT01276509|531559067|FG000|Overall Study|Adverse Event|9|||
147380483|NCT01276509|531559068|FG001|Overall Study|Adverse Event|8|||
147380484|NCT01276509|531559069|FG002|Overall Study|Adverse Event|4|||
147380485|NCT01276509|531559070|FG003|Overall Study|Adverse Event|3|||
147380486|NCT01276509|531559067|FG000|Overall Study|Lack of Efficacy|2|||
147380487|NCT01276509|531559068|FG001|Overall Study|Lack of Efficacy|1|||
147380488|NCT01276509|531559069|FG002|Overall Study|Lack of Efficacy|1|||
147380489|NCT01276509|531559070|FG003|Overall Study|Lack of Efficacy|2|||
147380490|NCT01276509|531559067|FG000|Overall Study|Pregnancy|1|||
147380491|NCT01276509|531559068|FG001|Overall Study|Pregnancy|0|||
147380492|NCT01276509|531559069|FG002|Overall Study|Pregnancy|0|||
147380493|NCT01276509|531559070|FG003|Overall Study|Pregnancy|0|||
147380494|NCT01276509|531559067|FG000|Overall Study|Withdrawal by Subject|1|||
147380495|NCT01276509|531559068|FG001|Overall Study|Withdrawal by Subject|2|||
147380496|NCT01276509|531559069|FG002|Overall Study|Withdrawal by Subject|0|||
147380497|NCT01276509|531559070|FG003|Overall Study|Withdrawal by Subject|0|||
147380498|NCT01276509|531559067|FG000|Overall Study|Other|0|||
147380499|NCT01276509|531559068|FG001|Overall Study|Other|1|||
147380500|NCT01276509|531559069|FG002|Overall Study|Other|0|||
147380501|NCT01276509|531559070|FG003|Overall Study|Other|0|||
147380502|NCT00535626|531559074|FG000|Overall Study|Death|15|||
147380503|NCT00535626|531559074|FG000|Overall Study|Lost to Follow-up|29|||
147380504|NCT00535626|531559074|FG000|Overall Study|Withdrawal by Subject|20|||
147380505|NCT00535626|531559074|FG000|Overall Study|Removal/revision of study component|8|||
147380506|NCT00535626|531559074|FG000|Overall Study|Subject terminated|31|||
147380507|NCT00535626|531559074|FG000|Overall Study|Unable to return|2|||
147380508|NCT02830893|531559075|FG000|Overall Study|Relocation to out of the country|1|||
147380509|NCT02830893|531559076|FG001|Overall Study|Relocation to out of the country|0|||
147380510|NCT02830893|531559075|FG000|Overall Study|Lost to Follow-up|0|||
147380511|NCT02830893|531559076|FG001|Overall Study|Lost to Follow-up|2|||
147380512|NCT02830893|531559075|FG000|Overall Study|Discharged to SNF, no transportation.|0|||
147380513|NCT02830893|531559076|FG001|Overall Study|Discharged to SNF, no transportation.|1|||
147380514|NCT01567852|531559077|FG000|Overall Study|Withdrawal by Subject|3|||
147380515|NCT01567852|531559078|FG001|Overall Study|Withdrawal by Subject|6|||
147380516|NCT01567852|531559077|FG000|Overall Study|ECT discontinued|1|||
147380517|NCT01567852|531559078|FG001|Overall Study|ECT discontinued|1|||
147380518|NCT03332589|531559079|FG000|Overall Study|Lack of Efficacy|2|||
147380519|NCT03332589|531559080|FG001|Overall Study|Lack of Efficacy|0|||
147380520|NCT03332589|531559081|FG002|Overall Study|Lack of Efficacy|0|||
147380521|NCT03332589|531559079|FG000|Overall Study|Adverse Event|1|||
147380522|NCT03332589|531559080|FG001|Overall Study|Adverse Event|0|||
147380523|NCT03332589|531559081|FG002|Overall Study|Adverse Event|0|||
147380524|NCT03332589|531559079|FG000|Overall Study|Death|1|||
147380525|NCT03332589|531559080|FG001|Overall Study|Death|0|||
147380526|NCT03332589|531559081|FG002|Overall Study|Death|0|||
147380527|NCT00443820|531559082|FG000|Overall Study|Adverse Event|1|||
147380528|NCT00443820|531559083|FG001|Overall Study|Adverse Event|1|||
147380529|NCT00443820|531559084|FG002|Overall Study|Adverse Event|0|||
147380530|NCT00443820|531559085|FG003|Overall Study|Adverse Event|0|||
147613620|NCT02862730|532400888|FG006|Second Intervention (84 Hours)|Withdrawal by Subject|0|||
147613621|NCT02862730|532400882|FG000|Third Rest Period (7-45 Days)|Withdrawal by Subject|0|||
147613622|NCT02862730|532400883|FG001|Third Rest Period (7-45 Days)|Withdrawal by Subject|0|||
147613623|NCT02862730|532400884|FG002|Third Rest Period (7-45 Days)|Withdrawal by Subject|1|||
147613624|NCT02862730|532400885|FG003|Third Rest Period (7-45 Days)|Withdrawal by Subject|0|||
147613625|NCT02862730|532400886|FG004|Third Rest Period (7-45 Days)|Withdrawal by Subject|1|||
147613626|NCT02862730|532400887|FG005|Third Rest Period (7-45 Days)|Withdrawal by Subject|0|||
147380531|NCT00443820|531559082|FG000|Overall Study|Lack of Efficacy|3|||
147380532|NCT00443820|531559083|FG001|Overall Study|Lack of Efficacy|2|||
147380533|NCT00443820|531559084|FG002|Overall Study|Lack of Efficacy|1|||
147380534|NCT00443820|531559085|FG003|Overall Study|Lack of Efficacy|1|||
147380535|NCT00443820|531559082|FG000|Overall Study|Protocol Violation|2|||
147380536|NCT00443820|531559083|FG001|Overall Study|Protocol Violation|1|||
147380537|NCT00443820|531559084|FG002|Overall Study|Protocol Violation|2|||
147380538|NCT00443820|531559085|FG003|Overall Study|Protocol Violation|1|||
147380539|NCT00443820|531559082|FG000|Overall Study|Withdrawal by Subject|6|||
147380540|NCT00443820|531559083|FG001|Overall Study|Withdrawal by Subject|7|||
147380541|NCT00443820|531559084|FG002|Overall Study|Withdrawal by Subject|8|||
147380542|NCT00443820|531559085|FG003|Overall Study|Withdrawal by Subject|9|||
147380543|NCT00443820|531559082|FG000|Overall Study|Lost to Follow-up|9|||
147380544|NCT00443820|531559083|FG001|Overall Study|Lost to Follow-up|8|||
147380545|NCT00443820|531559084|FG002|Overall Study|Lost to Follow-up|6|||
147380546|NCT00443820|531559085|FG003|Overall Study|Lost to Follow-up|5|||
147380547|NCT00443820|531559082|FG000|Overall Study|Administrative problems|0|||
147380548|NCT00443820|531559083|FG001|Overall Study|Administrative problems|0|||
147380549|NCT00443820|531559084|FG002|Overall Study|Administrative problems|0|||
147380550|NCT00443820|531559085|FG003|Overall Study|Administrative problems|1|||
147380551|NCT00443820|531559082|FG000|Overall Study|Death|0|||
147380552|NCT00443820|531559083|FG001|Overall Study|Death|0|||
147380553|NCT00443820|531559084|FG002|Overall Study|Death|1|||
147380554|NCT00443820|531559085|FG003|Overall Study|Death|0|||
147380555|NCT01808534|531559095|FG000|Overall Study|Disease progression|3|||
147380556|NCT01808534|531559095|FG000|Overall Study|Physician Decision|1|||
147380557|NCT01377844|531559096|FG000|Overall Study|Withdrawal by Subject|25|||
147380558|NCT01377844|531559097|FG001|Overall Study|Withdrawal by Subject|28|||
147380559|NCT01377844|531559096|FG000|Overall Study|Protocol Violation|2|||
147380560|NCT01377844|531559097|FG001|Overall Study|Protocol Violation|3|||
147380561|NCT01377844|531559096|FG000|Overall Study|Adverse Event|3|||
147380562|NCT01377844|531559097|FG001|Overall Study|Adverse Event|0|||
147380563|NCT01377844|531559096|FG000|Overall Study|Physician Decision|6|||
147380564|NCT01377844|531559097|FG001|Overall Study|Physician Decision|3|||
147380565|NCT01377844|531559096|FG000|Overall Study|Study terminated by Sponsor|0|||
147380566|NCT01377844|531559097|FG001|Overall Study|Study terminated by Sponsor|1|||
147380567|NCT02202317|531559103|FG000|Overall Study|Lost to Follow-up|1|||
147380568|NCT00569166|531559105|FG000|Overall Study|Withdrawal by Subject|7|||
147380569|NCT00569166|531559106|FG001|Overall Study|Withdrawal by Subject|5|||
147380570|NCT00569166|531559107|FG002|Overall Study|Withdrawal by Subject|3|||
147380571|NCT00569166|531559105|FG000|Overall Study|Lost to Follow-up|2|||
147380572|NCT00569166|531559106|FG001|Overall Study|Lost to Follow-up|1|||
147380573|NCT00569166|531559107|FG002|Overall Study|Lost to Follow-up|1|||
147380574|NCT01853384|531559109|FG000|Randomized|Adverse Event|5|||
147380575|NCT01853384|531559110|FG001|Randomized|Adverse Event|3|||
147380576|NCT01853384|531559109|FG000|Randomized|Death|1|||
147380577|NCT01853384|531559110|FG001|Randomized|Death|2|||
147380578|NCT01853384|531559109|FG000|Randomized|Lost to Follow-up|1|||
147380579|NCT01853384|531559110|FG001|Randomized|Lost to Follow-up|1|||
147380580|NCT01853384|531559109|FG000|Randomized|Withdrawal by Subject|5|||
147380581|NCT01853384|531559110|FG001|Randomized|Withdrawal by Subject|3|||
147380582|NCT01853384|531559109|FG000|Randomized|Sponsor Decision|47|||
147380583|NCT01853384|531559110|FG001|Randomized|Sponsor Decision|34|||
147380584|NCT01853384|531559109|FG000|Randomized|Other|3|||
147380585|NCT01853384|531559110|FG001|Randomized|Other|3|||
147380586|NCT01853384|531559109|FG000|Completed Follow up Visit 1|Early Termination|13|||
147380587|NCT01853384|531559110|FG001|Completed Follow up Visit 1|Early Termination|9|||
147380588|NCT01853384|531559109|FG000|Completed Follow up Visit 1|Withdrawal by Subject|1|||
147380589|NCT01853384|531559110|FG001|Completed Follow up Visit 1|Withdrawal by Subject|0|||
147380590|NCT01853384|531559109|FG000|Completed Follow up Visit 2|Adverse Event|1|||
147380591|NCT01853384|531559110|FG001|Completed Follow up Visit 2|Adverse Event|0|||
147380592|NCT01853384|531559109|FG000|Completed Follow up Visit 2|Withdrawal by Subject|1|||
147380593|NCT01853384|531559110|FG001|Completed Follow up Visit 2|Withdrawal by Subject|2|||
147380594|NCT01853384|531559109|FG000|Completed Follow up Visit 2|Death|1|||
147380595|NCT01853384|531559110|FG001|Completed Follow up Visit 2|Death|0|||
147380596|NCT01853384|531559109|FG000|Completed Follow up Visit 2|Lost to Follow-up|0|||
147380597|NCT01853384|531559110|FG001|Completed Follow up Visit 2|Lost to Follow-up|1|||
147380598|NCT01947491|531559111|FG000|Overall Study|Lost to Follow-up|5|||
147380599|NCT01947491|531559112|FG001|Overall Study|Lost to Follow-up|3|||
147380600|NCT01947491|531559113|FG002|Overall Study|Lost to Follow-up|1|||
147380601|NCT01947491|531559114|FG003|Overall Study|Lost to Follow-up|2|||
147380602|NCT01947491|531559111|FG000|Overall Study|Lack of Efficacy|1|||
147380603|NCT01947491|531559112|FG001|Overall Study|Lack of Efficacy|0|||
147380604|NCT01947491|531559113|FG002|Overall Study|Lack of Efficacy|0|||
147380605|NCT01947491|531559114|FG003|Overall Study|Lack of Efficacy|1|||
147380606|NCT01947491|531559111|FG000|Overall Study|Protocol Violation|1|||
147456097|NCT01978093|531831711|FG000|Overall Study|Adverse Event|0|||
147380607|NCT01947491|531559112|FG001|Overall Study|Protocol Violation|0|||
147456098|NCT01978093|531831712|FG001|Overall Study|Adverse Event|5|||
147456099|NCT01978093|531831711|FG000|Overall Study|Protocol Violation|8|||
147380608|NCT01947491|531559113|FG002|Overall Study|Protocol Violation|0|||
147380609|NCT01947491|531559114|FG003|Overall Study|Protocol Violation|0|||
147380610|NCT01947491|531559111|FG000|Overall Study|Withdrawal by Subject|1|||
147380611|NCT01947491|531559112|FG001|Overall Study|Withdrawal by Subject|1|||
147380612|NCT01947491|531559113|FG002|Overall Study|Withdrawal by Subject|1|||
147380613|NCT01947491|531559114|FG003|Overall Study|Withdrawal by Subject|0|||
147380614|NCT01947491|531559111|FG000|Overall Study|Worsening of condition|0|||
147380615|NCT01947491|531559112|FG001|Overall Study|Worsening of condition|1|||
147380616|NCT01947491|531559113|FG002|Overall Study|Worsening of condition|0|||
147380617|NCT01947491|531559114|FG003|Overall Study|Worsening of condition|0|||
147380618|NCT01947491|531559111|FG000|Overall Study|Adverse Event|0|||
147380619|NCT01947491|531559112|FG001|Overall Study|Adverse Event|1|||
147456100|NCT01978093|531831712|FG001|Overall Study|Protocol Violation|2|||
147380620|NCT01947491|531559113|FG002|Overall Study|Adverse Event|0|||
147380621|NCT01947491|531559114|FG003|Overall Study|Adverse Event|2|||
147380622|NCT00704340|531559115|FG000|Overall Study|Lost to Follow-up|2|||
147380623|NCT00704340|531559116|FG001|Overall Study|Lost to Follow-up|1|||
147380624|NCT00704340|531559115|FG000|Overall Study|Death|0|||
147380625|NCT00704340|531559116|FG001|Overall Study|Death|1|||
147380626|NCT00929526|531559117|FG000|Overall Study|Withdrawal by Subject|1|||
147380627|NCT00929526|531559118|FG001|Overall Study|Withdrawal by Subject|11|||
147380628|NCT00929526|531559117|FG000|Overall Study|Lost to Follow-up|8|||
147380629|NCT00929526|531559118|FG001|Overall Study|Lost to Follow-up|12|||
147380630|NCT00929526|531559117|FG000|Overall Study|Other|8|||
147380631|NCT00929526|531559118|FG001|Overall Study|Other|6|||
147380632|NCT00403845|531559119|FG000|Treatment Period 1|Subject withdrew consent|1|||
147380633|NCT00403845|531559120|FG001|Treatment Period 1|Subject withdrew consent|0|||
147380634|NCT00403845|531559121|FG002|Treatment Period 1|Subject withdrew consent|0|||
147380635|NCT00403845|531559122|FG003|Treatment Period 1|Subject withdrew consent|0|||
147380636|NCT00403845|531559119|FG000|Treatment Period 1|Subject no longer needs study drug|0|||
147380637|NCT00403845|531559120|FG001|Treatment Period 1|Subject no longer needs study drug|0|||
147380638|NCT00403845|531559121|FG002|Treatment Period 1|Subject no longer needs study drug|0|||
147380639|NCT00403845|531559122|FG003|Treatment Period 1|Subject no longer needs study drug|1|||
147380640|NCT00403845|531559119|FG000|Treatment Period 2|Subject withdrew consent|1|||
147380641|NCT00403845|531559120|FG001|Treatment Period 2|Subject withdrew consent|0|||
147380642|NCT00403845|531559121|FG002|Treatment Period 2|Subject withdrew consent|0|||
147456101|NCT01978093|531831711|FG000|Overall Study|Withdrawal by Subject|29|||
147456102|NCT01978093|531831712|FG001|Overall Study|Withdrawal by Subject|25|||
147456103|NCT01978093|531831711|FG000|Overall Study|Lost to Follow-up|11|||
147456104|NCT01978093|531831712|FG001|Overall Study|Lost to Follow-up|15|||
147456105|NCT01978093|531831711|FG000|Overall Study|Migrated/moved from study area|11|||
147456106|NCT01978093|531831712|FG001|Overall Study|Migrated/moved from study area|13|||
147456107|NCT01978093|531831711|FG000|Overall Study|Loss of kaiser coverage|4|||
147456108|NCT01978093|531831712|FG001|Overall Study|Loss of kaiser coverage|10|||
147456109|NCT01978093|531831711|FG000|Overall Study|Lost kaiser health plan unable to contac|1|||
147456110|NCT01978093|531831712|FG001|Overall Study|Lost kaiser health plan unable to contac|0|||
147456111|NCT01978093|531831711|FG000|Overall Study|Mother lost custody of child|0|||
147456112|NCT01978093|531831712|FG001|Overall Study|Mother lost custody of child|1|||
147456113|NCT01978093|531831711|FG000|Overall Study|Child was in care of grandmother|0|||
147456114|NCT01978093|531831712|FG001|Overall Study|Child was in care of grandmother|1|||
147456115|NCT01978093|531831711|FG000|Overall Study|N/A for vaccine administration|0|||
147456116|NCT01978093|531831712|FG001|Overall Study|N/A for vaccine administration|1|||
147456117|NCT01396005|531831713|FG000|Overall Study|Withdrawal by Subject|0|||
147456118|NCT01396005|531831714|FG001|Overall Study|Withdrawal by Subject|1|||
147456119|NCT01396005|531831713|FG000|Overall Study|Non-compliance with protocol|0|||
147456120|NCT01396005|531831714|FG001|Overall Study|Non-compliance with protocol|1|||
147456121|NCT00491179|531831715|FG000|Overall Study|Adverse Event|5|||
147456122|NCT00491179|531831716|FG001|Overall Study|Adverse Event|1|||
147456123|NCT00491179|531831715|FG000|Overall Study|Withdrawal by Subject|2|||
147456124|NCT00491179|531831716|FG001|Overall Study|Withdrawal by Subject|1|||
147456125|NCT00159432|531831717|FG000|Overall Study|Adverse Event|1|||
147456126|NCT00159432|531831717|FG000|Overall Study|Death|1|||
147456127|NCT00159432|531831717|FG000|Overall Study|Lack of Efficacy|8|||
147456128|NCT03529773|531831720|FG000|Overall Study|Adverse Event|0|||
147456129|NCT03529773|531831721|FG001|Overall Study|Adverse Event|0|||
147456130|NCT03529773|531831722|FG002|Overall Study|Adverse Event|0|||
147456131|NCT03529773|531831723|FG003|Overall Study|Adverse Event|0|||
147456132|NCT03529773|531831724|FG004|Overall Study|Adverse Event|0|||
147456133|NCT03529773|531831725|FG005|Overall Study|Adverse Event|0|||
147456134|NCT03529773|531831726|FG006|Overall Study|Adverse Event|0|||
147456135|NCT03529773|531831727|FG007|Overall Study|Adverse Event|0|||
147456136|NCT03529773|531831728|FG008|Overall Study|Adverse Event|0|||
147456137|NCT03529773|531831729|FG009|Overall Study|Adverse Event|0|||
147380643|NCT00403845|531559122|FG003|Treatment Period 2|Subject withdrew consent|0|||
147380644|NCT00403845|531559119|FG000|Treatment Period 3|Subject withdrew consent|0|||
147456138|NCT03529773|531831730|FG010|Overall Study|Adverse Event|0|||
147456139|NCT03529773|531831731|FG011|Overall Study|Adverse Event|0|||
147456140|NCT03529773|531831732|FG012|Overall Study|Adverse Event|0|||
147456141|NCT03529773|531831733|FG013|Overall Study|Adverse Event|0|||
147456142|NCT03529773|531831734|FG014|Overall Study|Adverse Event|0|||
147613627|NCT02862730|532400888|FG006|Third Rest Period (7-45 Days)|Withdrawal by Subject|0|||
147380645|NCT00403845|531559120|FG001|Treatment Period 3|Subject withdrew consent|0|||
147456143|NCT03529773|531831735|FG015|Overall Study|Adverse Event|0|||
147456144|NCT03529773|531831736|FG016|Overall Study|Adverse Event|0|||
147456145|NCT03529773|531831737|FG017|Overall Study|Adverse Event|0|||
147456146|NCT03529773|531831738|FG018|Overall Study|Adverse Event|0|||
147456147|NCT03529773|531831739|FG019|Overall Study|Adverse Event|0|||
147456148|NCT03529773|531831740|FG020|Overall Study|Adverse Event|0|||
147456149|NCT03529773|531831741|FG021|Overall Study|Adverse Event|0|||
147613628|NCT02862730|532400882|FG000|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
147380646|NCT00403845|531559121|FG002|Treatment Period 3|Subject withdrew consent|0|||
147380647|NCT00403845|531559122|FG003|Treatment Period 3|Subject withdrew consent|1|||
147380648|NCT00403845|531559119|FG000|Treatment Period 3|Adverse Event|0|||
147380649|NCT00403845|531559120|FG001|Treatment Period 3|Adverse Event|0|||
147380650|NCT00403845|531559121|FG002|Treatment Period 3|Adverse Event|0|||
147380651|NCT00403845|531559122|FG003|Treatment Period 3|Adverse Event|1|||
147380652|NCT03316170|531559123|FG000|Overall Study|Death|1|||
147380653|NCT03316170|531559124|FG001|Overall Study|Death|0|||
147380654|NCT03316170|531559123|FG000|Overall Study|Lost to Follow-up|6|||
147380655|NCT03316170|531559124|FG001|Overall Study|Lost to Follow-up|7|||
147380656|NCT00578344|531559125|FG000|Overall Study|Insurance problems|1|||
147380657|NCT00578344|531559125|FG000|Overall Study|Graft failure|1|||
147380658|NCT02169414|531559126|FG000|Overall Study|Withdrawal by Subject|1|||
147380659|NCT02169414|531559127|FG001|Overall Study|Withdrawal by Subject|0|||
147380660|NCT02169414|531559128|FG002|Overall Study|Withdrawal by Subject|0|||
147380661|NCT02169414|531559129|FG003|Overall Study|Withdrawal by Subject|0|||
147380662|NCT02169414|531559126|FG000|Overall Study|Adverse Event|0|||
147380663|NCT02169414|531559127|FG001|Overall Study|Adverse Event|1|||
147380664|NCT02169414|531559128|FG002|Overall Study|Adverse Event|0|||
147613629|NCT02862730|532400883|FG001|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
147380665|NCT02169414|531559129|FG003|Overall Study|Adverse Event|0|||
147380666|NCT03374254|531559132|FG000|Overall Study|Death|5|||
147380667|NCT03374254|531559133|FG001|Overall Study|Death|16|||
147380668|NCT03374254|531559134|FG002|Overall Study|Death|13|||
147380669|NCT03374254|531559135|FG003|Overall Study|Death|11|||
147380670|NCT03374254|531559136|FG004|Overall Study|Death|9|||
147380671|NCT03374254|531559137|FG005|Overall Study|Death|12|||
147380672|NCT03374254|531559138|FG006|Overall Study|Death|11|||
147380673|NCT03374254|531559139|FG007|Overall Study|Death|6|||
147380674|NCT03374254|531559140|FG008|Overall Study|Death|7|||
147380675|NCT03374254|531559132|FG000|Overall Study|Lost to Follow-up|0|||
147380676|NCT03374254|531559133|FG001|Overall Study|Lost to Follow-up|0|||
147380677|NCT03374254|531559134|FG002|Overall Study|Lost to Follow-up|0|||
147380678|NCT03374254|531559135|FG003|Overall Study|Lost to Follow-up|0|||
147380679|NCT03374254|531559136|FG004|Overall Study|Lost to Follow-up|0|||
147613630|NCT02862730|532400884|FG002|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
147456150|NCT03529773|531831742|FG022|Overall Study|Adverse Event|0|||
147456151|NCT03529773|531831743|FG023|Overall Study|Adverse Event|0|||
147613631|NCT02862730|532400885|FG003|Third Intervention (84 Hours)|diagnosis of gastroparesis|1|||
147613632|NCT02862730|532400886|FG004|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
147613633|NCT02862730|532400887|FG005|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
147613634|NCT02862730|532400888|FG006|Third Intervention (84 Hours)|diagnosis of gastroparesis|0|||
147613635|NCT03685344|532400889|FG000|Overall Study|Withdrawal by Subject|1|||
147613636|NCT03685344|532400890|FG001|Overall Study|Withdrawal by Subject|1|||
147380680|NCT03374254|531559137|FG005|Overall Study|Lost to Follow-up|0|||
147380681|NCT03374254|531559138|FG006|Overall Study|Lost to Follow-up|2|||
147380682|NCT03374254|531559139|FG007|Overall Study|Lost to Follow-up|0|||
147380683|NCT03374254|531559140|FG008|Overall Study|Lost to Follow-up|0|||
147380684|NCT03374254|531559132|FG000|Overall Study|Sponsor Decision|1|||
147380685|NCT03374254|531559133|FG001|Overall Study|Sponsor Decision|0|||
147380686|NCT03374254|531559134|FG002|Overall Study|Sponsor Decision|2|||
147380687|NCT03374254|531559135|FG003|Overall Study|Sponsor Decision|3|||
147380688|NCT03374254|531559136|FG004|Overall Study|Sponsor Decision|2|||
147613637|NCT03685344|532400891|FG002|Overall Study|Withdrawal by Subject|2|||
147613638|NCT03685344|532400892|FG003|Overall Study|Withdrawal by Subject|0|||
147613639|NCT03685344|532400889|FG000|Overall Study|Physician Decision|1|||
147380689|NCT03374254|531559137|FG005|Overall Study|Sponsor Decision|3|||
147380690|NCT03374254|531559138|FG006|Overall Study|Sponsor Decision|3|||
147380691|NCT03374254|531559139|FG007|Overall Study|Sponsor Decision|3|||
147380692|NCT03374254|531559140|FG008|Overall Study|Sponsor Decision|4|||
147380693|NCT03374254|531559132|FG000|Overall Study|Withdrawal by Subject|0|||
147380694|NCT03374254|531559133|FG001|Overall Study|Withdrawal by Subject|0|||
147613640|NCT03685344|532400890|FG001|Overall Study|Physician Decision|1|||
147613641|NCT03685344|532400891|FG002|Overall Study|Physician Decision|5|||
147613642|NCT03685344|532400892|FG003|Overall Study|Physician Decision|0|||
147613643|NCT03685344|532400889|FG000|Overall Study|Death|1|||
147613644|NCT03685344|532400890|FG001|Overall Study|Death|1|||
147380695|NCT03374254|531559134|FG002|Overall Study|Withdrawal by Subject|0|||
147380696|NCT03374254|531559135|FG003|Overall Study|Withdrawal by Subject|2|||
147380697|NCT03374254|531559136|FG004|Overall Study|Withdrawal by Subject|0|||
147380698|NCT03374254|531559137|FG005|Overall Study|Withdrawal by Subject|1|||
147380699|NCT03374254|531559138|FG006|Overall Study|Withdrawal by Subject|0|||
147380700|NCT03374254|531559139|FG007|Overall Study|Withdrawal by Subject|0|||
147380701|NCT03374254|531559140|FG008|Overall Study|Withdrawal by Subject|0|||
147380702|NCT04803734|531559141|FG000|Overall Study|Withdrawal by Subject|0|||
147380703|NCT04803734|531559142|FG001|Overall Study|Withdrawal by Subject|1|||
147380704|NCT04803734|531559141|FG000|Overall Study|Protocol Violation|0|||
147380705|NCT04803734|531559142|FG001|Overall Study|Protocol Violation|1|||
147456152|NCT03529773|531831744|FG024|Overall Study|Adverse Event|0|||
147380706|NCT00749944|531559148|FG000|Overall Study|Lost to Follow-up|2|||
147380707|NCT00749944|531559149|FG001|Overall Study|Lost to Follow-up|1|||
147380708|NCT00749944|531559148|FG000|Overall Study|Other|1|||
147380709|NCT00749944|531559149|FG001|Overall Study|Other|0|||
147380710|NCT00749944|531559148|FG000|Overall Study|Withdrawal by Subject|2|||
147380711|NCT00749944|531559149|FG001|Overall Study|Withdrawal by Subject|0|||
147380712|NCT02547974|531559150|FG000|Overall Study|Withdrawal by Subject|1|||
147380713|NCT02547974|531559151|FG001|Overall Study|Withdrawal by Subject|0|||
147380714|NCT02547974|531559152|FG002|Overall Study|Withdrawal by Subject|0|||
147380715|NCT02547974|531559153|FG003|Overall Study|Withdrawal by Subject|0|||
147380716|NCT00923078|531559154|FG000|First Intervention (Weeks 1-4)|Withdrawal by Subject|1|||
147380717|NCT00923078|531559155|FG001|First Intervention (Weeks 1-4)|Withdrawal by Subject|1|||
147380718|NCT00923078|531559156|FG002|First Intervention (Weeks 1-4)|Withdrawal by Subject|0|||
147380719|NCT00923078|531559154|FG000|First Intervention (Weeks 1-4)|No intervention per protocol|0|||
147380720|NCT00923078|531559155|FG001|First Intervention (Weeks 1-4)|No intervention per protocol|0|||
147380721|NCT00923078|531559156|FG002|First Intervention (Weeks 1-4)|No intervention per protocol|20|||
147380722|NCT01999335|531559160|FG000|Overall Study|Discontinued before receiving treatment|0|||
147380723|NCT01999335|531559161|FG001|Overall Study|Discontinued before receiving treatment|0|||
147380724|NCT01999335|531559162|FG002|Overall Study|Discontinued before receiving treatment|0|||
147380725|NCT01999335|531559163|FG003|Overall Study|Discontinued before receiving treatment|0|||
147380726|NCT01999335|531559164|FG004|Overall Study|Discontinued before receiving treatment|2|||
147380727|NCT04766996|531559165|FG000|Overall Study|Withdrawal by Subject|1|||
147380728|NCT04766996|531559166|FG001|Overall Study|Withdrawal by Subject|0|||
147380729|NCT04766996|531559167|FG002|Overall Study|Withdrawal by Subject|13|||
147380730|NCT00080119|531559168|FG000|Overall Study|Discontinued because of study closure|0|||
147380731|NCT00080119|531559169|FG001|Overall Study|Discontinued because of study closure|0|||
147380732|NCT00080119|531559170|FG002|Overall Study|Discontinued because of study closure|130|||
147380733|NCT00080119|531559171|FG003|Overall Study|Discontinued because of study closure|141|||
147380734|NCT00080119|531559168|FG000|Overall Study|Unable to get to clinic|24|||
147380735|NCT00080119|531559169|FG001|Overall Study|Unable to get to clinic|24|||
147380736|NCT00080119|531559170|FG002|Overall Study|Unable to get to clinic|7|||
147380737|NCT00080119|531559171|FG003|Overall Study|Unable to get to clinic|1|||
147380738|NCT00080119|531559168|FG000|Overall Study|Consent withdrawn|13|||
147380739|NCT00080119|531559169|FG001|Overall Study|Consent withdrawn|17|||
147380740|NCT00080119|531559170|FG002|Overall Study|Consent withdrawn|4|||
147380741|NCT00080119|531559171|FG003|Overall Study|Consent withdrawn|6|||
147380742|NCT00080119|531559168|FG000|Overall Study|Unwilling to adhere to study requirement|3|||
147380743|NCT00080119|531559169|FG001|Overall Study|Unwilling to adhere to study requirement|2|||
147380744|NCT00080119|531559170|FG002|Overall Study|Unwilling to adhere to study requirement|5|||
147380745|NCT00080119|531559171|FG003|Overall Study|Unwilling to adhere to study requirement|1|||
147380746|NCT00080119|531559168|FG000|Overall Study|Lost to Follow-up|16|||
147380747|NCT00080119|531559169|FG001|Overall Study|Lost to Follow-up|19|||
147380748|NCT00080119|531559170|FG002|Overall Study|Lost to Follow-up|19|||
147380749|NCT00080119|531559171|FG003|Overall Study|Lost to Follow-up|14|||
147380750|NCT02988713|531559186|FG000|Overall Study|Withdrawal by Subject|1|||
147380751|NCT02988713|531559186|FG000|Overall Study|Subject's failure to meet study inclusion or exclusion criteria after enrollment|2|||
147380752|NCT03265132|531559187|FG000|Overall Study|Adverse Event|0|||
147380753|NCT03265132|531559188|FG001|Overall Study|Adverse Event|1|||
147380754|NCT03265132|531559187|FG000|Overall Study|Lack of Efficacy|0|||
147380755|NCT03265132|531559188|FG001|Overall Study|Lack of Efficacy|2|||
147380756|NCT03265132|531559187|FG000|Overall Study|Progressive disease|0|||
147380757|NCT03265132|531559188|FG001|Overall Study|Progressive disease|2|||
147380758|NCT03265132|531559187|FG000|Overall Study|Withdrawal by Subject|0|||
147380759|NCT03265132|531559188|FG001|Overall Study|Withdrawal by Subject|1|||
147380760|NCT04492475|531559189|FG000|Overall Study|Enrolled but not treated|8|||
147380761|NCT04492475|531559190|FG001|Overall Study|Enrolled but not treated|8|||
147380762|NCT04492475|531559189|FG000|Overall Study|Withdrawal by Subject|4|||
147380763|NCT04492475|531559190|FG001|Overall Study|Withdrawal by Subject|0|||
147380764|NCT04492475|531559189|FG000|Overall Study|Became ineligible after enrollment|2|||
147380765|NCT04492475|531559190|FG001|Overall Study|Became ineligible after enrollment|0|||
147380766|NCT03938272|531559199|FG000|Overall Study|Withdrawal by Subject|1|||
147380767|NCT03938272|531559200|FG001|Overall Study|Withdrawal by Subject|0|||
147380768|NCT03938272|531559199|FG000|Overall Study|Physician Decision|0|||
147380769|NCT03938272|531559200|FG001|Overall Study|Physician Decision|2|||
147380770|NCT03938272|531559199|FG000|Overall Study|Study termination by sponsor|10|||
147380771|NCT03938272|531559200|FG001|Overall Study|Study termination by sponsor|8|||
147380772|NCT01323790|531559208|FG000|Overall Study|Other|3|||
147380773|NCT01323790|531559209|FG001|Overall Study|Other|2|||
147380774|NCT01323790|531559210|FG002|Overall Study|Other|1|||
147380775|NCT01323790|531559208|FG000|Overall Study|Lost to Follow-up|11|||
147380776|NCT01323790|531559209|FG001|Overall Study|Lost to Follow-up|9|||
147380777|NCT01323790|531559210|FG002|Overall Study|Lost to Follow-up|9|||
147380778|NCT01323790|531559208|FG000|Overall Study|Study-Specific Withdrawal Criteria|0|||
147456153|NCT03529773|531831745|FG025|Overall Study|Adverse Event|0|||
147380779|NCT01323790|531559209|FG001|Overall Study|Study-Specific Withdrawal Criteria|3|||
147380780|NCT01323790|531559210|FG002|Overall Study|Study-Specific Withdrawal Criteria|3|||
147380781|NCT01323790|531559208|FG000|Overall Study|Lack of Efficacy|3|||
147380782|NCT01323790|531559209|FG001|Overall Study|Lack of Efficacy|0|||
147380783|NCT01323790|531559210|FG002|Overall Study|Lack of Efficacy|3|||
147380784|NCT01323790|531559208|FG000|Overall Study|Adverse Event|11|||
147380785|NCT01323790|531559209|FG001|Overall Study|Adverse Event|24|||
147380786|NCT01323790|531559210|FG002|Overall Study|Adverse Event|12|||
147380787|NCT01323790|531559208|FG000|Overall Study|Eligibility Criteria Not Fulfilled|0|||
147380788|NCT01323790|531559209|FG001|Overall Study|Eligibility Criteria Not Fulfilled|0|||
147380789|NCT01323790|531559210|FG002|Overall Study|Eligibility Criteria Not Fulfilled|1|||
147380790|NCT01323790|531559208|FG000|Overall Study|Withdrawal by Subject|23|||
147380791|NCT01323790|531559209|FG001|Overall Study|Withdrawal by Subject|20|||
147380792|NCT01323790|531559210|FG002|Overall Study|Withdrawal by Subject|13|||
147380793|NCT01323790|531559208|FG000|Overall Study|Did Not Receive Treatment|2|||
147380794|NCT01323790|531559209|FG001|Overall Study|Did Not Receive Treatment|0|||
147380795|NCT01323790|531559210|FG002|Overall Study|Did Not Receive Treatment|1|||
147380796|NCT01323790|531559208|FG000|Overall Study|Severe non-compliance with protocol|2|||
147380797|NCT01323790|531559209|FG001|Overall Study|Severe non-compliance with protocol|2|||
147380798|NCT01323790|531559210|FG002|Overall Study|Severe non-compliance with protocol|2|||
147380799|NCT00266656|531559214|FG000|Overall Study|Death|1|||
147380800|NCT00266656|531559215|FG001|Overall Study|Death|0|||
147380801|NCT00266656|531559214|FG000|Overall Study|Lost to Follow-up|4|||
147380802|NCT00266656|531559215|FG001|Overall Study|Lost to Follow-up|1|||
147380803|NCT00266656|531559214|FG000|Overall Study|Withdrawal by Subject|4|||
147380804|NCT00266656|531559215|FG001|Overall Study|Withdrawal by Subject|2|||
147380805|NCT00266656|531559214|FG000|Overall Study|Did Not Reach Final Height|4|||
147380806|NCT00266656|531559215|FG001|Overall Study|Did Not Reach Final Height|8|||
147380807|NCT00266656|531559214|FG000|Overall Study|Parent/Caregiver Decision|1|||
147380808|NCT00266656|531559215|FG001|Overall Study|Parent/Caregiver Decision|2|||
147380809|NCT02114515|531559218|FG000|Overall Study|Lost to Follow-up|52|||
147380810|NCT02114515|531559219|FG001|Overall Study|Lost to Follow-up|55|||
147380811|NCT02114515|531559218|FG000|Overall Study|Death|12|||
147380812|NCT02114515|531559219|FG001|Overall Study|Death|12|||
147380813|NCT02114515|531559218|FG000|Overall Study|Withdrawal by Subject|4|||
147380814|NCT02114515|531559219|FG001|Overall Study|Withdrawal by Subject|22|||
147380815|NCT02114515|531559218|FG000|Overall Study|Other|65|||
147380816|NCT02114515|531559219|FG001|Overall Study|Other|61|||
147380817|NCT00667732|531559220|FG000|Run -In (8 Weeks)|Adverse Event|4|||
147380818|NCT00667732|531559221|FG001|Run -In (8 Weeks)|Adverse Event|0|||
147380819|NCT00667732|531559222|FG002|Run -In (8 Weeks)|Adverse Event|0|||
147380820|NCT00667732|531559220|FG000|Run -In (8 Weeks)|Withdrawal by Subject|3|||
147380821|NCT00667732|531559221|FG001|Run -In (8 Weeks)|Withdrawal by Subject|0|||
147380822|NCT00667732|531559222|FG002|Run -In (8 Weeks)|Withdrawal by Subject|0|||
147380823|NCT00667732|531559220|FG000|Randomization (24 Weeks)|Withdrawal by Subject|0|||
147380824|NCT00667732|531559221|FG001|Randomization (24 Weeks)|Withdrawal by Subject|1|||
147380825|NCT00667732|531559222|FG002|Randomization (24 Weeks)|Withdrawal by Subject|0|||
147380826|NCT02106325|531559227|FG000|Phase 1|Lost to Follow-up|2|||
147380827|NCT02106325|531559228|FG001|Phase 1|Lost to Follow-up|2|||
147380828|NCT02106325|531559227|FG000|Phase 2|Lost to Follow-up|2|||
147380829|NCT02106325|531559228|FG001|Phase 2|Lost to Follow-up|3|||
147380830|NCT02106325|531559227|FG000|Phase 3|Lost to Follow-up|2|||
147380831|NCT02106325|531559228|FG001|Phase 3|Lost to Follow-up|1|||
147380832|NCT03242863|531559230|FG000|Study Week 1|Withdrawal by Subject|0|||
147380833|NCT03242863|531559231|FG001|Study Week 1|Withdrawal by Subject|1|||
147380834|NCT03242863|531559232|FG002|Study Week 1|Withdrawal by Subject|0|||
147380835|NCT03242863|531559233|FG003|Study Week 1|Withdrawal by Subject|0|||
147380836|NCT03242863|531559234|FG004|Study Week 1|Withdrawal by Subject|3|||
147380837|NCT03242863|531559235|FG005|Study Week 1|Withdrawal by Subject|0|||
147380838|NCT04852978|531559236|FG000|Overall Study|Physician Decision|0|||
147380839|NCT04852978|531559237|FG001|Overall Study|Physician Decision|1|||
147380840|NCT04852978|531559238|FG002|Overall Study|Physician Decision|0|||
147380841|NCT04852978|531559239|FG003|Overall Study|Physician Decision|0|||
147380842|NCT04852978|531559240|FG004|Overall Study|Physician Decision|0|||
147380843|NCT04852978|531559241|FG005|Overall Study|Physician Decision|0|||
147380844|NCT04852978|531559242|FG006|Overall Study|Physician Decision|0|||
147380845|NCT04852978|531559243|FG007|Overall Study|Physician Decision|2|||
147380846|NCT04852978|531559244|FG008|Overall Study|Physician Decision|0|||
147380847|NCT04852978|531559236|FG000|Overall Study|Sponsor request|0|||
147380848|NCT04852978|531559237|FG001|Overall Study|Sponsor request|0|||
147380849|NCT04852978|531559238|FG002|Overall Study|Sponsor request|1|||
147380850|NCT04852978|531559239|FG003|Overall Study|Sponsor request|0|||
147380851|NCT04852978|531559240|FG004|Overall Study|Sponsor request|0|||
147380852|NCT04852978|531559241|FG005|Overall Study|Sponsor request|0|||
147380853|NCT04852978|531559242|FG006|Overall Study|Sponsor request|0|||
147380854|NCT04852978|531559243|FG007|Overall Study|Sponsor request|0|||
147380855|NCT04852978|531559244|FG008|Overall Study|Sponsor request|0|||
147380856|NCT04852978|531559236|FG000|Overall Study|Death|0|||
147380857|NCT04852978|531559237|FG001|Overall Study|Death|0|||
147380858|NCT04852978|531559238|FG002|Overall Study|Death|0|||
147380859|NCT04852978|531559239|FG003|Overall Study|Death|0|||
147380860|NCT04852978|531559240|FG004|Overall Study|Death|0|||
147380861|NCT04852978|531559241|FG005|Overall Study|Death|0|||
147380862|NCT04852978|531559242|FG006|Overall Study|Death|1|||
147380863|NCT04852978|531559243|FG007|Overall Study|Death|0|||
147380864|NCT04852978|531559244|FG008|Overall Study|Death|0|||
147613645|NCT03685344|532400891|FG002|Overall Study|Death|0|||
147613646|NCT03685344|532400892|FG003|Overall Study|Death|0|||
147613647|NCT02121652|532400895|FG000|Overall Study|Lost to Follow-up|2|||
147613648|NCT02121652|532400896|FG001|Overall Study|Lost to Follow-up|1|||
147380865|NCT04852978|531559236|FG000|Overall Study|Lost to Follow-up|3|||
147380866|NCT04852978|531559237|FG001|Overall Study|Lost to Follow-up|2|||
147380867|NCT04852978|531559238|FG002|Overall Study|Lost to Follow-up|2|||
147380868|NCT04852978|531559239|FG003|Overall Study|Lost to Follow-up|0|||
147380869|NCT04852978|531559240|FG004|Overall Study|Lost to Follow-up|2|||
147380870|NCT04852978|531559241|FG005|Overall Study|Lost to Follow-up|4|||
147380871|NCT04852978|531559242|FG006|Overall Study|Lost to Follow-up|1|||
147380872|NCT04852978|531559243|FG007|Overall Study|Lost to Follow-up|2|||
147380873|NCT04852978|531559244|FG008|Overall Study|Lost to Follow-up|2|||
147380874|NCT04852978|531559236|FG000|Overall Study|Withdrawal by Subject|4|||
147380875|NCT04852978|531559237|FG001|Overall Study|Withdrawal by Subject|2|||
147380876|NCT04852978|531559238|FG002|Overall Study|Withdrawal by Subject|2|||
147380877|NCT04852978|531559239|FG003|Overall Study|Withdrawal by Subject|1|||
147380878|NCT04852978|531559240|FG004|Overall Study|Withdrawal by Subject|5|||
147380879|NCT04852978|531559241|FG005|Overall Study|Withdrawal by Subject|3|||
147380880|NCT04852978|531559242|FG006|Overall Study|Withdrawal by Subject|2|||
147380881|NCT04852978|531559243|FG007|Overall Study|Withdrawal by Subject|2|||
147380882|NCT04852978|531559244|FG008|Overall Study|Withdrawal by Subject|1|||
147380883|NCT04369664|531560511|FG000|Overall Study|Physician Decision|1|||
147380884|NCT04369664|531560512|FG001|Overall Study|Physician Decision|0|||
147380885|NCT00215943|531560516|FG000|Overall Study|Disease Progression|3|||
147380886|NCT00215943|531560517|FG001|Overall Study|Disease Progression|5|||
147380887|NCT00215943|531560516|FG000|Overall Study|Alternate therapy|0|||
147380888|NCT00215943|531560517|FG001|Overall Study|Alternate therapy|1|||
147380889|NCT00215943|531560516|FG000|Overall Study|Adverse Event|3|||
147380890|NCT00215943|531560517|FG001|Overall Study|Adverse Event|6|||
147380891|NCT00215943|531560516|FG000|Overall Study|Other disease|0|||
147380892|NCT00215943|531560517|FG001|Overall Study|Other disease|1|||
147380893|NCT00215943|531560516|FG000|Overall Study|Other complications|3|||
147380894|NCT00215943|531560517|FG001|Overall Study|Other complications|1|||
147380895|NCT04633200|531560518|FG000|Overall Study|Lost to Follow-up|3|||
147380896|NCT04633200|531560519|FG001|Overall Study|Lost to Follow-up|5|||
147380897|NCT02507297|531560520|FG000|Overall Study|Withdrawal by Subject|1|||
147380898|NCT02507297|531560521|FG001|Overall Study|Withdrawal by Subject|0|||
147380899|NCT02507297|531560520|FG000|Overall Study|Lost to Follow-up|0|||
147380900|NCT02507297|531560521|FG001|Overall Study|Lost to Follow-up|1|||
147380901|NCT02489799|531560522|FG000|Overall Study|Lost to Follow-up|4|||
147380902|NCT02489799|531560523|FG001|Overall Study|Lost to Follow-up|1|||
147613649|NCT02121652|532400895|FG000|Overall Study|Death|1|||
147613650|NCT02121652|532400896|FG001|Overall Study|Death|0|||
147613651|NCT02121652|532400895|FG000|Overall Study|Withdrawal by Subject|3|||
147613652|NCT02121652|532400896|FG001|Overall Study|Withdrawal by Subject|3|||
147613653|NCT00261950|532400898|FG000|Overall Study|Lost to Follow-up|2|||
147613654|NCT00261950|532400898|FG000|Overall Study|Death|6|||
147613655|NCT00261950|532400898|FG000|Overall Study|Withdrawal by Subject|5|||
147380903|NCT02489799|531560522|FG000|Overall Study|Failure to Maintain Eligibility|4|||
147380904|NCT02489799|531560523|FG001|Overall Study|Failure to Maintain Eligibility|6|||
147380905|NCT02489799|531560522|FG000|Overall Study|Withdrawal by Subject|1|||
147380906|NCT02489799|531560523|FG001|Overall Study|Withdrawal by Subject|1|||
147380907|NCT02489799|531560522|FG000|Overall Study|Death|0|||
147613656|NCT00261950|532400898|FG000|Overall Study|Other|1|||
147613657|NCT00261950|532400898|FG000|Overall Study|Physician Decision|1|||
147613658|NCT00261950|532400898|FG000|Overall Study|Protocol specified Criteria|11|||
147380908|NCT02489799|531560523|FG001|Overall Study|Death|1|||
147380909|NCT02092285|531560524|FG000|Induction Phase|Adverse Event|7|||
147380910|NCT02092285|531560524|FG000|Induction Phase|Physician Decision|4|||
147380911|NCT02092285|531560524|FG000|Induction Phase|Pregnancy|1|||
147380912|NCT02092285|531560524|FG000|Induction Phase|Relapse/Recurrence|7|||
147380913|NCT02092285|531560524|FG000|Induction Phase|Withdrawal by Subject|2|||
147380914|NCT02092285|531560524|FG000|Induction Phase|Lack of Efficacy|14|||
147380915|NCT02092285|531560524|FG000|Maintenance Phase & Follow-up|Adverse Event|22|||
147380916|NCT02092285|531560524|FG000|Maintenance Phase & Follow-up|Lost to Follow-up|1|||
147380917|NCT02092285|531560524|FG000|Maintenance Phase & Follow-up|Non-compliance with study drug|2|||
147380918|NCT02092285|531560524|FG000|Maintenance Phase & Follow-up|Physician Decision|10|||
147380919|NCT02092285|531560524|FG000|Maintenance Phase & Follow-up|Pregnancy|1|||
147613659|NCT01023035|532400899|FG000|Treatment Period|Adverse Event|27|||
147613660|NCT01023035|532400900|FG001|Treatment Period|Adverse Event|32|||
147613661|NCT01023035|532400901|FG002|Treatment Period|Adverse Event|50|||
147613662|NCT01023035|532400899|FG000|Treatment Period|Non-Medical Reasons|19|||
147380920|NCT02092285|531560524|FG000|Maintenance Phase & Follow-up|Protocol Violation|11|||
147380921|NCT02092285|531560524|FG000|Maintenance Phase & Follow-up|Relapse/recurrence|29|||
147380922|NCT02092285|531560524|FG000|Maintenance Phase & Follow-up|Withdrawal by Subject|11|||
147380923|NCT02092285|531560524|FG000|Maintenance Phase & Follow-up|Lack of Efficacy|23|||
147380924|NCT00087516|531560525|FG000|Overall Study|Adverse Event|10|||
147380925|NCT00087516|531560526|FG001|Overall Study|Adverse Event|10|||
147380926|NCT00087516|531560527|FG002|Overall Study|Adverse Event|3|||
147380927|NCT00087516|531560528|FG003|Overall Study|Adverse Event|6|||
147380928|NCT00087516|531560525|FG000|Overall Study|Lack of Efficacy|82|||
147380929|NCT00087516|531560526|FG001|Overall Study|Lack of Efficacy|80|||
147380930|NCT00087516|531560527|FG002|Overall Study|Lack of Efficacy|39|||
147380931|NCT00087516|531560528|FG003|Overall Study|Lack of Efficacy|29|||
147380932|NCT00087516|531560525|FG000|Overall Study|Lost to Follow-up|8|||
147380933|NCT00087516|531560526|FG001|Overall Study|Lost to Follow-up|6|||
147380934|NCT00087516|531560527|FG002|Overall Study|Lost to Follow-up|5|||
147380935|NCT00087516|531560528|FG003|Overall Study|Lost to Follow-up|5|||
147380936|NCT00087516|531560525|FG000|Overall Study|Protocol Violation|4|||
147380937|NCT00087516|531560526|FG001|Overall Study|Protocol Violation|8|||
147380938|NCT00087516|531560527|FG002|Overall Study|Protocol Violation|3|||
147380939|NCT00087516|531560528|FG003|Overall Study|Protocol Violation|6|||
147380940|NCT00087516|531560525|FG000|Overall Study|Withdrawal by Subject|16|||
147380941|NCT00087516|531560526|FG001|Overall Study|Withdrawal by Subject|27|||
147380942|NCT00087516|531560527|FG002|Overall Study|Withdrawal by Subject|11|||
147380943|NCT00087516|531560528|FG003|Overall Study|Withdrawal by Subject|12|||
147380944|NCT00087516|531560525|FG000|Overall Study|Site terminated|0|||
147380945|NCT00087516|531560526|FG001|Overall Study|Site terminated|2|||
147380946|NCT00087516|531560527|FG002|Overall Study|Site terminated|1|||
147380947|NCT00087516|531560528|FG003|Overall Study|Site terminated|0|||
147380948|NCT00087516|531560525|FG000|Overall Study|Protocol specified discontinuation|35|||
147380949|NCT00087516|531560526|FG001|Overall Study|Protocol specified discontinuation|33|||
147380950|NCT00087516|531560527|FG002|Overall Study|Protocol specified discontinuation|33|||
147380951|NCT00087516|531560528|FG003|Overall Study|Protocol specified discontinuation|26|||
147380952|NCT00087516|531560525|FG000|Overall Study|Patient moved|3|||
147380953|NCT00087516|531560526|FG001|Overall Study|Patient moved|2|||
147380954|NCT00087516|531560527|FG002|Overall Study|Patient moved|1|||
147380955|NCT00087516|531560528|FG003|Overall Study|Patient moved|0|||
147380956|NCT00087516|531560525|FG000|Overall Study|Patient was non-compliant|3|||
147380957|NCT00087516|531560526|FG001|Overall Study|Patient was non-compliant|1|||
147380958|NCT00087516|531560527|FG002|Overall Study|Patient was non-compliant|0|||
147380959|NCT00087516|531560528|FG003|Overall Study|Patient was non-compliant|0|||
147380960|NCT00087516|531560525|FG000|Overall Study|Recommendation of Primary Care Physician|0|||
147380961|NCT00087516|531560526|FG001|Overall Study|Recommendation of Primary Care Physician|0|||
147380962|NCT00087516|531560527|FG002|Overall Study|Recommendation of Primary Care Physician|0|||
147380963|NCT00087516|531560528|FG003|Overall Study|Recommendation of Primary Care Physician|1|||
147380964|NCT00087516|531560525|FG000|Overall Study|Other|0|||
147380965|NCT00087516|531560526|FG001|Overall Study|Other|0|||
147380966|NCT00087516|531560527|FG002|Overall Study|Other|1|||
147380967|NCT00087516|531560528|FG003|Overall Study|Other|0|||
147380968|NCT00278395|531560529|FG000|Overall Study|Adverse Event|2|||
147380969|NCT00278395|531560529|FG000|Overall Study|Nonevaluable|1|||
147380970|NCT01686152|531560532|FG000|Overall Study|Withdrawal by Subject|11|||
147380971|NCT01686152|531560533|FG001|Overall Study|Withdrawal by Subject|11|||
147380972|NCT01686152|531560534|FG002|Overall Study|Withdrawal by Subject|3|||
147380973|NCT01686152|531560532|FG000|Overall Study|Drug Code Unblinded|0|||
147380974|NCT01686152|531560533|FG001|Overall Study|Drug Code Unblinded|1|||
147380975|NCT01686152|531560534|FG002|Overall Study|Drug Code Unblinded|0|||
147380976|NCT01686152|531560532|FG000|Overall Study|Protocol Violation|6|||
147380977|NCT01686152|531560533|FG001|Overall Study|Protocol Violation|1|||
147380978|NCT01686152|531560534|FG002|Overall Study|Protocol Violation|0|||
147380979|NCT01686152|531560532|FG000|Overall Study|Adverse Event|12|||
147380980|NCT01686152|531560533|FG001|Overall Study|Adverse Event|11|||
147380981|NCT01686152|531560534|FG002|Overall Study|Adverse Event|0|||
147380982|NCT01686152|531560532|FG000|Overall Study|Lack of Efficacy|0|||
147380983|NCT01686152|531560533|FG001|Overall Study|Lack of Efficacy|0|||
147380984|NCT01686152|531560534|FG002|Overall Study|Lack of Efficacy|1|||
147380985|NCT01686152|531560532|FG000|Overall Study|IP Non-compliance|5|||
147380986|NCT01686152|531560533|FG001|Overall Study|IP Non-compliance|5|||
147380987|NCT01686152|531560534|FG002|Overall Study|IP Non-compliance|0|||
147380988|NCT01686152|531560532|FG000|Overall Study|Lost to Follow-up|7|||
147380989|NCT01686152|531560533|FG001|Overall Study|Lost to Follow-up|6|||
147380990|NCT01686152|531560534|FG002|Overall Study|Lost to Follow-up|5|||
147380991|NCT02784834|531560538|FG000|Overall Study|Lack of Efficacy|1|||
147380992|NCT02143713|531560539|FG000|Treatment Period (6 Months)|Withdrawal by Subject|1|||
147380993|NCT02143713|531560540|FG001|Treatment Period (6 Months)|Withdrawal by Subject|2|||
147380994|NCT02143713|531560541|FG002|Treatment Period (6 Months)|Withdrawal by Subject|5|||
147380995|NCT02143713|531560542|FG003|Treatment Period (6 Months)|Withdrawal by Subject|4|||
147380996|NCT02143713|531560539|FG000|Treatment Period (6 Months)|Adverse Event|7|||
147380997|NCT02143713|531560540|FG001|Treatment Period (6 Months)|Adverse Event|8|||
147380998|NCT02143713|531560541|FG002|Treatment Period (6 Months)|Adverse Event|8|||
147380999|NCT02143713|531560542|FG003|Treatment Period (6 Months)|Adverse Event|9|||
147381000|NCT02143713|531560539|FG000|Treatment Period (6 Months)|Lost to Follow-up|3|||
147381001|NCT02143713|531560540|FG001|Treatment Period (6 Months)|Lost to Follow-up|0|||
147381002|NCT02143713|531560541|FG002|Treatment Period (6 Months)|Lost to Follow-up|4|||
147381003|NCT02143713|531560542|FG003|Treatment Period (6 Months)|Lost to Follow-up|3|||
147381004|NCT02143713|531560539|FG000|Treatment Period (6 Months)|Surgery or Invasive Intervention|2|||
147381005|NCT02143713|531560540|FG001|Treatment Period (6 Months)|Surgery or Invasive Intervention|0|||
147381006|NCT02143713|531560541|FG002|Treatment Period (6 Months)|Surgery or Invasive Intervention|0|||
147381007|NCT02143713|531560542|FG003|Treatment Period (6 Months)|Surgery or Invasive Intervention|2|||
147381008|NCT02143713|531560539|FG000|Treatment Period (6 Months)|Pregnancy|0|||
147381009|NCT02143713|531560540|FG001|Treatment Period (6 Months)|Pregnancy|2|||
147381010|NCT02143713|531560541|FG002|Treatment Period (6 Months)|Pregnancy|2|||
147381011|NCT02143713|531560542|FG003|Treatment Period (6 Months)|Pregnancy|0|||
147381012|NCT02143713|531560539|FG000|Treatment Period (6 Months)|Non-compliance|1|||
147381013|NCT02143713|531560540|FG001|Treatment Period (6 Months)|Non-compliance|0|||
147381014|NCT02143713|531560541|FG002|Treatment Period (6 Months)|Non-compliance|0|||
147381015|NCT02143713|531560542|FG003|Treatment Period (6 Months)|Non-compliance|3|||
147381016|NCT02143713|531560539|FG000|Treatment Period (6 Months)|Other|3|||
147381017|NCT02143713|531560540|FG001|Treatment Period (6 Months)|Other|0|||
147381018|NCT02143713|531560541|FG002|Treatment Period (6 Months)|Other|3|||
147381019|NCT02143713|531560542|FG003|Treatment Period (6 Months)|Other|2|||
147381020|NCT02143713|531560539|FG000|Treatment Period (6 Months)|Bone Mineral Density (BMD) Decrease|0|||
147381021|NCT02143713|531560540|FG001|Treatment Period (6 Months)|Bone Mineral Density (BMD) Decrease|0|||
147381022|NCT02143713|531560541|FG002|Treatment Period (6 Months)|Bone Mineral Density (BMD) Decrease|0|||
147381023|NCT02143713|531560542|FG003|Treatment Period (6 Months)|Bone Mineral Density (BMD) Decrease|4|||
147381024|NCT02143713|531560539|FG000|Treatment Period (6 Months)|Exclusionary Medication|2|||
147381025|NCT02143713|531560540|FG001|Treatment Period (6 Months)|Exclusionary Medication|0|||
147381026|NCT02143713|531560541|FG002|Treatment Period (6 Months)|Exclusionary Medication|0|||
147381027|NCT02143713|531560542|FG003|Treatment Period (6 Months)|Exclusionary Medication|0|||
147381028|NCT02143713|531560539|FG000|Treatment Period (6 Months)|Lack of Efficacy|1|||
147381029|NCT02143713|531560540|FG001|Treatment Period (6 Months)|Lack of Efficacy|0|||
147381030|NCT02143713|531560541|FG002|Treatment Period (6 Months)|Lack of Efficacy|0|||
147381031|NCT02143713|531560542|FG003|Treatment Period (6 Months)|Lack of Efficacy|1|||
147381032|NCT02143713|531560539|FG000|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|4|||
147381033|NCT02143713|531560540|FG001|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|7|||
147381034|NCT02143713|531560541|FG002|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|6|||
147381035|NCT02143713|531560542|FG003|Post-treatment Follow-up (12 Months)|Withdrawal by Subject|10|||
147381036|NCT02143713|531560539|FG000|Post-treatment Follow-up (12 Months)|Adverse Event|0|||
147381037|NCT02143713|531560540|FG001|Post-treatment Follow-up (12 Months)|Adverse Event|0|||
147381038|NCT02143713|531560541|FG002|Post-treatment Follow-up (12 Months)|Adverse Event|1|||
147381039|NCT02143713|531560542|FG003|Post-treatment Follow-up (12 Months)|Adverse Event|0|||
147381040|NCT02143713|531560539|FG000|Post-treatment Follow-up (12 Months)|Lost to Follow-up|3|||
147381041|NCT02143713|531560540|FG001|Post-treatment Follow-up (12 Months)|Lost to Follow-up|8|||
147381042|NCT02143713|531560541|FG002|Post-treatment Follow-up (12 Months)|Lost to Follow-up|11|||
147381043|NCT02143713|531560542|FG003|Post-treatment Follow-up (12 Months)|Lost to Follow-up|8|||
147381044|NCT02143713|531560539|FG000|Post-treatment Follow-up (12 Months)|Surgery or Invasive Intervention|2|||
147381045|NCT02143713|531560540|FG001|Post-treatment Follow-up (12 Months)|Surgery or Invasive Intervention|4|||
147381046|NCT02143713|531560541|FG002|Post-treatment Follow-up (12 Months)|Surgery or Invasive Intervention|4|||
147381047|NCT02143713|531560542|FG003|Post-treatment Follow-up (12 Months)|Surgery or Invasive Intervention|1|||
147381048|NCT02143713|531560539|FG000|Post-treatment Follow-up (12 Months)|Exclusionary Medication|0|||
147381049|NCT02143713|531560540|FG001|Post-treatment Follow-up (12 Months)|Exclusionary Medication|1|||
147381050|NCT02143713|531560541|FG002|Post-treatment Follow-up (12 Months)|Exclusionary Medication|0|||
147381051|NCT02143713|531560542|FG003|Post-treatment Follow-up (12 Months)|Exclusionary Medication|1|||
147381052|NCT02143713|531560539|FG000|Post-treatment Follow-up (12 Months)|Other|3|||
147381053|NCT02143713|531560540|FG001|Post-treatment Follow-up (12 Months)|Other|4|||
147381054|NCT02143713|531560541|FG002|Post-treatment Follow-up (12 Months)|Other|7|||
147381055|NCT02143713|531560542|FG003|Post-treatment Follow-up (12 Months)|Other|7|||
147381056|NCT01768572|531560545|FG000|Overall Study|Adverse Event|7|||
147381057|NCT01768572|531560546|FG001|Overall Study|Adverse Event|8|||
147381058|NCT01768572|531560547|FG002|Overall Study|Adverse Event|4|||
147381059|NCT01768572|531560545|FG000|Overall Study|Lack of Efficacy|1|||
147381060|NCT01768572|531560546|FG001|Overall Study|Lack of Efficacy|3|||
147381061|NCT01768572|531560547|FG002|Overall Study|Lack of Efficacy|1|||
147381062|NCT01768572|531560545|FG000|Overall Study|Other, Not due to an adverse event|1|||
147381063|NCT01768572|531560546|FG001|Overall Study|Other, Not due to an adverse event|1|||
147381064|NCT01768572|531560547|FG002|Overall Study|Other, Not due to an adverse event|1|||
147613663|NCT01023035|532400900|FG001|Treatment Period|Non-Medical Reasons|22|||
147613664|NCT01023035|532400901|FG002|Treatment Period|Non-Medical Reasons|44|||
147613665|NCT01023035|532400899|FG000|Treatment Period|Treatment Failure|26|||
147613666|NCT01023035|532400900|FG001|Treatment Period|Treatment Failure|31|||
147613667|NCT01023035|532400901|FG002|Treatment Period|Treatment Failure|24|||
147613668|NCT01023035|532400899|FG000|Follow-up Period (up to Week 72)|Adverse Event|2|||
147613669|NCT01023035|532400900|FG001|Follow-up Period (up to Week 72)|Adverse Event|0|||
147613670|NCT01023035|532400901|FG002|Follow-up Period (up to Week 72)|Adverse Event|1|||
147613671|NCT01023035|532400899|FG000|Follow-up Period (up to Week 72)|Non-medical Reason|26|||
147613672|NCT01023035|532400900|FG001|Follow-up Period (up to Week 72)|Non-medical Reason|28|||
147613673|NCT01023035|532400901|FG002|Follow-up Period (up to Week 72)|Non-medical Reason|38|||
147613674|NCT02789137|532400906|FG000|Overall Study|Dropped out/Died|58|||
147613675|NCT00445432|532400907|FG000|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|1|||
147613676|NCT00445432|532400908|FG001|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|2|||
147613677|NCT00445432|532400909|FG002|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|7|||
147613678|NCT00445432|532400910|FG003|Through Week 52 of NCT00445432 (M06-837)|Adverse Event|0|||
147613679|NCT00445432|532400907|FG000|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|0|||
147613680|NCT00445432|532400908|FG001|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|0|||
147613681|NCT00445432|532400909|FG002|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|2|||
147613682|NCT00445432|532400910|FG003|Through Week 52 of NCT00445432 (M06-837)|Withdrawal by Subject|0|||
147613683|NCT00445432|532400907|FG000|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|14|||
147613684|NCT00445432|532400908|FG001|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|20|||
147613685|NCT00445432|532400909|FG002|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|0|||
147613686|NCT00445432|532400910|FG003|Through Week 52 of NCT00445432 (M06-837)|Moved to open-label|0|||
147613687|NCT00445432|532400907|FG000|Through Week 52 of NCT00445432 (M06-837)|Other|0|||
147613688|NCT00445432|532400908|FG001|Through Week 52 of NCT00445432 (M06-837)|Other|1|||
147613689|NCT00445432|532400909|FG002|Through Week 52 of NCT00445432 (M06-837)|Other|2|||
147613690|NCT00445432|532400910|FG003|Through Week 52 of NCT00445432 (M06-837)|Other|0|||
147613691|NCT00445432|532400907|FG000|148 Weeks of Adalimumab Treatment|Adverse Event|0|||
147613692|NCT00445432|532400908|FG001|148 Weeks of Adalimumab Treatment|Adverse Event|0|||
147613693|NCT00445432|532400909|FG002|148 Weeks of Adalimumab Treatment|Adverse Event|0|||
147613694|NCT00445432|532400910|FG003|148 Weeks of Adalimumab Treatment|Adverse Event|32|||
147456154|NCT03529773|531831746|FG026|Overall Study|Adverse Event|0|||
147456155|NCT03529773|531831747|FG027|Overall Study|Adverse Event|0|||
147456156|NCT03529773|531831748|FG028|Overall Study|Adverse Event|0|||
147456157|NCT03529773|531831749|FG029|Overall Study|Adverse Event|0|||
147456158|NCT03529773|531831750|FG030|Overall Study|Adverse Event|1|||
147456159|NCT03529773|531831751|FG031|Overall Study|Adverse Event|0|||
147613695|NCT00445432|532400907|FG000|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|0|||
147613696|NCT00445432|532400908|FG001|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|0|||
147613697|NCT00445432|532400909|FG002|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|0|||
147613698|NCT00445432|532400910|FG003|148 Weeks of Adalimumab Treatment|Withdrawal by Subject|3|||
147613699|NCT00445432|532400907|FG000|148 Weeks of Adalimumab Treatment|Other|0|||
147613700|NCT00445432|532400908|FG001|148 Weeks of Adalimumab Treatment|Other|0|||
147613701|NCT00445432|532400909|FG002|148 Weeks of Adalimumab Treatment|Other|0|||
147613702|NCT00445432|532400910|FG003|148 Weeks of Adalimumab Treatment|Other|9|||
147613703|NCT01090414|532400911|FG000|Study 101-99|Progressive Disease|28|||
147613704|NCT01090414|532400912|FG001|Study 101-99|Progressive Disease|48|||
147613705|NCT01090414|532400913|FG002|Study 101-99|Progressive Disease|10|||
147613706|NCT01090414|532400914|FG003|Study 101-99|Progressive Disease|4|||
147613707|NCT01090414|532400911|FG000|Study 101-99|Adverse Event|10|||
147613708|NCT01090414|532400912|FG001|Study 101-99|Adverse Event|28|||
147613709|NCT01090414|532400913|FG002|Study 101-99|Adverse Event|18|||
147613710|NCT01090414|532400914|FG003|Study 101-99|Adverse Event|0|||
147613711|NCT01090414|532400911|FG000|Study 101-99|Investigator Request|1|||
147613712|NCT01090414|532400912|FG001|Study 101-99|Investigator Request|11|||
147613713|NCT01090414|532400913|FG002|Study 101-99|Investigator Request|4|||
147613714|NCT01090414|532400914|FG003|Study 101-99|Investigator Request|0|||
147613715|NCT01090414|532400911|FG000|Study 101-99|Death|3|||
147613716|NCT01090414|532400912|FG001|Study 101-99|Death|8|||
147613717|NCT01090414|532400913|FG002|Study 101-99|Death|1|||
147613718|NCT01090414|532400914|FG003|Study 101-99|Death|0|||
147456160|NCT03529773|531831752|FG032|Overall Study|Adverse Event|0|||
147456161|NCT03529773|531831753|FG033|Overall Study|Adverse Event|0|||
147456162|NCT03529773|531831754|FG034|Overall Study|Adverse Event|0|||
147456163|NCT03529773|531831755|FG035|Overall Study|Adverse Event|1|||
147456164|NCT03529773|531831756|FG036|Overall Study|Adverse Event|0|||
147613719|NCT01090414|532400911|FG000|Study 101-99|Sponsor Discontinued Study|0|||
147613720|NCT01090414|532400912|FG001|Study 101-99|Sponsor Discontinued Study|7|||
147456165|NCT03529773|531831757|FG037|Overall Study|Adverse Event|0|||
147613721|NCT01090414|532400913|FG002|Study 101-99|Sponsor Discontinued Study|5|||
147613722|NCT01090414|532400914|FG003|Study 101-99|Sponsor Discontinued Study|0|||
147613723|NCT01090414|532400911|FG000|Study 101-99|Other (Unknown Reasons)|3|||
147613724|NCT01090414|532400912|FG001|Study 101-99|Other (Unknown Reasons)|3|||
147613725|NCT01090414|532400913|FG002|Study 101-99|Other (Unknown Reasons)|0|||
147613726|NCT01090414|532400914|FG003|Study 101-99|Other (Unknown Reasons)|0|||
147613727|NCT01090414|532400911|FG000|Study 101-99|Withdrew Consent|0|||
147613728|NCT01090414|532400912|FG001|Study 101-99|Withdrew Consent|2|||
147613729|NCT01090414|532400913|FG002|Study 101-99|Withdrew Consent|3|||
147613730|NCT01090414|532400914|FG003|Study 101-99|Withdrew Consent|1|||
147613731|NCT01090414|532400911|FG000|Study 101-99|Participant Request|3|||
147613732|NCT01090414|532400912|FG001|Study 101-99|Participant Request|1|||
147613733|NCT01090414|532400913|FG002|Study 101-99|Participant Request|0|||
147613734|NCT01090414|532400914|FG003|Study 101-99|Participant Request|0|||
147613735|NCT00247676|532400919|FG000|Overall Study|Death|5|||
147613736|NCT00247676|532400919|FG000|Overall Study|Adverse Event|11|||
147613737|NCT00247676|532400919|FG000|Overall Study|Lack of Efficacy|15|||
147613738|NCT00247676|532400919|FG000|Overall Study|Other|3|||
147613739|NCT00247676|532400919|FG000|Overall Study|Withdrawal by Subject|2|||
147613740|NCT03594071|532400920|FG000|Overall Study|Re-operation|3|||
147613741|NCT03594071|532400920|FG000|Overall Study|Missed visit|2|||
147613742|NCT05219448|532400921|FG000|Overall Study|Lost to Follow-up|9|||
147613743|NCT05219448|532400922|FG001|Overall Study|Lost to Follow-up|0|||
147613744|NCT00911300|532400924|FG000|Overall Study|Primary Endpoint Component Occurred|1|||
147613745|NCT00911300|532400925|FG001|Overall Study|Primary Endpoint Component Occurred|2|||
147613746|NCT00911300|532400924|FG000|Overall Study|Death|1|||
147381065|NCT01322386|531560548|FG000|Overall Study|Protocol Violation|0|||
147381066|NCT01322386|531560549|FG001|Overall Study|Protocol Violation|1|||
147381067|NCT01322386|531560548|FG000|Overall Study|Physician Decision|0|||
147381068|NCT01322386|531560549|FG001|Overall Study|Physician Decision|1|||
147381069|NCT00871494|531560554|FG000|Overall Study|Protocol Violation|5|||
147381070|NCT00871494|531560554|FG000|Overall Study|Lack of Efficacy|4|||
147381071|NCT00871494|531560554|FG000|Overall Study|Adverse Event|4|||
147381072|NCT00871494|531560554|FG000|Overall Study|Lost to Follow-up|1|||
147381073|NCT00889863|531560558|FG000|Part I: Open Label|Death|1|||
147381074|NCT00889863|531560559|FG001|Part I: Open Label|Death|0|||
147381075|NCT00889863|531560558|FG000|Part I: Open Label|Adverse Event|4|||
147381076|NCT00889863|531560559|FG001|Part I: Open Label|Adverse Event|0|||
147381077|NCT00889863|531560558|FG000|Part I: Open Label|Unsatisfactory therapeutic effect|72|||
147381078|NCT00889863|531560559|FG001|Part I: Open Label|Unsatisfactory therapeutic effect|0|||
147381079|NCT00889863|531560558|FG000|Part II: Randomized Double Blind|Adverse Event|0|||
147381080|NCT00889863|531560559|FG001|Part II: Randomized Double Blind|Adverse Event|4|||
147381081|NCT00889863|531560558|FG000|Part II: Randomized Double Blind|Unsatisfactory therapeutic effect|11|||
147381082|NCT00889863|531560559|FG001|Part II: Randomized Double Blind|Unsatisfactory therapeutic effect|20|||
147381083|NCT00889863|531560558|FG000|Part II: Randomized Double Blind|Withdrawal by Subject|0|||
147381084|NCT00889863|531560559|FG001|Part II: Randomized Double Blind|Withdrawal by Subject|1|||
147381085|NCT00889863|531560558|FG000|Part II: Randomized Double Blind|Protocol deviation|0|||
147381086|NCT00889863|531560559|FG001|Part II: Randomized Double Blind|Protocol deviation|1|||
147381087|NCT02404441|531560563|FG000|Phase 1 Part|Adverse Event|1|||
147381088|NCT02404441|531560564|FG001|Phase 1 Part|Adverse Event|0|||
147381089|NCT02404441|531560565|FG002|Phase 1 Part|Adverse Event|0|||
147381090|NCT02404441|531560566|FG003|Phase 1 Part|Adverse Event|0|||
147381091|NCT02404441|531560567|FG004|Phase 1 Part|Adverse Event|0|||
147381092|NCT02404441|531560568|FG005|Phase 1 Part|Adverse Event|0|||
147381093|NCT02404441|531560569|FG006|Phase 1 Part|Adverse Event|0|||
147381094|NCT02404441|531560570|FG007|Phase 1 Part|Adverse Event|0|||
147381095|NCT02404441|531560571|FG008|Phase 1 Part|Adverse Event|0|||
147381096|NCT02404441|531560572|FG009|Phase 1 Part|Adverse Event|0|||
147381097|NCT02404441|531560563|FG000|Phase 1 Part|Physician Decision|0|||
147381098|NCT02404441|531560564|FG001|Phase 1 Part|Physician Decision|1|||
147381099|NCT02404441|531560565|FG002|Phase 1 Part|Physician Decision|0|||
147381100|NCT02404441|531560566|FG003|Phase 1 Part|Physician Decision|0|||
147381101|NCT02404441|531560567|FG004|Phase 1 Part|Physician Decision|0|||
147381102|NCT02404441|531560568|FG005|Phase 1 Part|Physician Decision|0|||
147613747|NCT00911300|532400925|FG001|Overall Study|Death|0|||
147613748|NCT00911300|532400924|FG000|Overall Study|Thrombus Persistant in Second TEE|3|||
147613749|NCT00911300|532400925|FG001|Overall Study|Thrombus Persistant in Second TEE|7|||
147664890|NCT02810418|532597949|FG004|Dose Expansion|Physician Decision|0|||
147381103|NCT02404441|531560569|FG006|Phase 1 Part|Physician Decision|0|||
147381104|NCT02404441|531560570|FG007|Phase 1 Part|Physician Decision|0|||
147381105|NCT02404441|531560571|FG008|Phase 1 Part|Physician Decision|0|||
147381106|NCT02404441|531560572|FG009|Phase 1 Part|Physician Decision|0|||
147381107|NCT02404441|531560563|FG000|Phase 1 Part|Progressive Disease|14|||
147613750|NCT00911300|532400924|FG000|Overall Study|Adverse Event|14|||
147613751|NCT00911300|532400925|FG001|Overall Study|Adverse Event|6|||
147613752|NCT00911300|532400924|FG000|Overall Study|Protocol Violation|3|||
147613753|NCT00911300|532400925|FG001|Overall Study|Protocol Violation|2|||
147381108|NCT02404441|531560564|FG001|Phase 1 Part|Progressive Disease|11|||
147381109|NCT02404441|531560565|FG002|Phase 1 Part|Progressive Disease|7|||
147381110|NCT02404441|531560566|FG003|Phase 1 Part|Progressive Disease|6|||
147613754|NCT00911300|532400924|FG000|Overall Study|Consent Withdrawn|4|||
147613755|NCT00911300|532400925|FG001|Overall Study|Consent Withdrawn|12|||
147381111|NCT02404441|531560567|FG004|Phase 1 Part|Progressive Disease|9|||
147381112|NCT02404441|531560568|FG005|Phase 1 Part|Progressive Disease|0|||
147381113|NCT02404441|531560569|FG006|Phase 1 Part|Progressive Disease|0|||
147381114|NCT02404441|531560570|FG007|Phase 1 Part|Progressive Disease|0|||
147381115|NCT02404441|531560571|FG008|Phase 1 Part|Progressive Disease|0|||
147381116|NCT02404441|531560572|FG009|Phase 1 Part|Progressive Disease|0|||
147381117|NCT02404441|531560563|FG000|Phase 1 Part|Subject/Guardian Decision|0|||
147381118|NCT02404441|531560564|FG001|Phase 1 Part|Subject/Guardian Decision|2|||
147381119|NCT02404441|531560565|FG002|Phase 1 Part|Subject/Guardian Decision|3|||
147381120|NCT02404441|531560566|FG003|Phase 1 Part|Subject/Guardian Decision|0|||
147381121|NCT02404441|531560567|FG004|Phase 1 Part|Subject/Guardian Decision|0|||
147381122|NCT02404441|531560568|FG005|Phase 1 Part|Subject/Guardian Decision|0|||
147381123|NCT02404441|531560569|FG006|Phase 1 Part|Subject/Guardian Decision|0|||
147381124|NCT02404441|531560570|FG007|Phase 1 Part|Subject/Guardian Decision|0|||
147381125|NCT02404441|531560571|FG008|Phase 1 Part|Subject/Guardian Decision|0|||
147381126|NCT02404441|531560572|FG009|Phase 1 Part|Subject/Guardian Decision|0|||
147381127|NCT02404441|531560563|FG000|Phase 1 Part|Death|1|||
147456166|NCT03529773|531831758|FG038|Overall Study|Adverse Event|1|||
147456167|NCT03529773|531831759|FG039|Overall Study|Adverse Event|1|||
147456168|NCT03529773|531831720|FG000|Overall Study|Death|0|||
147456169|NCT03529773|531831721|FG001|Overall Study|Death|0|||
147456170|NCT03529773|531831722|FG002|Overall Study|Death|0|||
147613756|NCT00911300|532400924|FG000|Overall Study|Coronary Angiography Performed|1|||
147613757|NCT00911300|532400925|FG001|Overall Study|Coronary Angiography Performed|0|||
147613758|NCT00911300|532400924|FG000|Overall Study|Atrial Fibrillation (AF) Recurrence|3|||
147613759|NCT00911300|532400925|FG001|Overall Study|Atrial Fibrillation (AF) Recurrence|3|||
147613760|NCT00911300|532400924|FG000|Overall Study|Received Commercial Treatment|1|||
147613761|NCT00911300|532400925|FG001|Overall Study|Received Commercial Treatment|0|||
147613762|NCT00911300|532400924|FG000|Overall Study|Recurrent Tachyarrhythmia|1|||
147613763|NCT00911300|532400925|FG001|Overall Study|Recurrent Tachyarrhythmia|1|||
147613764|NCT00911300|532400924|FG000|Overall Study|Recurrent Tachy-Arrhythmia Absoluta|1|||
147613765|NCT00911300|532400925|FG001|Overall Study|Recurrent Tachy-Arrhythmia Absoluta|1|||
147613766|NCT00911300|532400924|FG000|Overall Study|Nurse Unavailable in Participant's City|1|||
147613767|NCT00911300|532400925|FG001|Overall Study|Nurse Unavailable in Participant's City|0|||
147613768|NCT00911300|532400924|FG000|Overall Study|CV Unsuccessful; Phenprocoumon Received|1|||
147613769|NCT00911300|532400925|FG001|Overall Study|CV Unsuccessful; Phenprocoumon Received|0|||
147613770|NCT00911300|532400924|FG000|Overall Study|Participant Could Not Stay in Hospital|0|||
147613771|NCT00911300|532400925|FG001|Overall Study|Participant Could Not Stay in Hospital|1|||
147613772|NCT00911300|532400924|FG000|Overall Study|Investigator's Decision; New AF Episode|0|||
147613773|NCT00911300|532400925|FG001|Overall Study|Investigator's Decision; New AF Episode|1|||
147613774|NCT00911300|532400924|FG000|Overall Study|International Normalized Ratio Too High|0|||
147613775|NCT00911300|532400925|FG001|Overall Study|International Normalized Ratio Too High|1|||
147613776|NCT00911300|532400924|FG000|Overall Study|Participant Refused Hospital Consulation|0|||
147613777|NCT00911300|532400925|FG001|Overall Study|Participant Refused Hospital Consulation|1|||
147613778|NCT00911300|532400924|FG000|Overall Study|Underlying Disease (Myocarditis)|0|||
147613779|NCT00911300|532400925|FG001|Overall Study|Underlying Disease (Myocarditis)|1|||
147456171|NCT03529773|531831723|FG003|Overall Study|Death|0|||
147456172|NCT03529773|531831724|FG004|Overall Study|Death|0|||
147456173|NCT03529773|531831725|FG005|Overall Study|Death|0|||
147456174|NCT03529773|531831726|FG006|Overall Study|Death|0|||
147456175|NCT03529773|531831727|FG007|Overall Study|Death|0|||
147456176|NCT03529773|531831728|FG008|Overall Study|Death|0|||
147456177|NCT03529773|531831729|FG009|Overall Study|Death|0|||
147456178|NCT03529773|531831730|FG010|Overall Study|Death|0|||
147456179|NCT03529773|531831731|FG011|Overall Study|Death|0|||
147613780|NCT00911300|532400924|FG000|Overall Study|Physician Decision|0|||
147381128|NCT02404441|531560564|FG001|Phase 1 Part|Death|1|||
147381129|NCT02404441|531560565|FG002|Phase 1 Part|Death|1|||
147456180|NCT03529773|531831732|FG012|Overall Study|Death|1|||
147456181|NCT03529773|531831733|FG013|Overall Study|Death|0|||
147456182|NCT03529773|531831734|FG014|Overall Study|Death|0|||
147456183|NCT03529773|531831735|FG015|Overall Study|Death|0|||
147456184|NCT03529773|531831736|FG016|Overall Study|Death|0|||
147456185|NCT03529773|531831737|FG017|Overall Study|Death|0|||
147613781|NCT00911300|532400925|FG001|Overall Study|Physician Decision|1|||
147613782|NCT00911300|532400924|FG000|Overall Study|Treatment Stopped by Mistake|0|||
147613783|NCT00911300|532400925|FG001|Overall Study|Treatment Stopped by Mistake|1|||
147613784|NCT00911300|532400924|FG000|Overall Study|Randomized; No Study Medication Received|0|||
147613785|NCT00911300|532400925|FG001|Overall Study|Randomized; No Study Medication Received|2|||
147664891|NCT02810418|532597950|FG005|Dose Expansion|Physician Decision|0|||
147664892|NCT02810418|532597951|FG006|Dose Expansion|Physician Decision|0|||
147456186|NCT03529773|531831738|FG018|Overall Study|Death|0|||
147381130|NCT02404441|531560566|FG003|Phase 1 Part|Death|0|||
147381131|NCT02404441|531560567|FG004|Phase 1 Part|Death|1|||
147456187|NCT03529773|531831739|FG019|Overall Study|Death|1|||
147456188|NCT03529773|531831740|FG020|Overall Study|Death|0|||
147456189|NCT03529773|531831741|FG021|Overall Study|Death|0|||
147381132|NCT02404441|531560568|FG005|Phase 1 Part|Death|0|||
147381133|NCT02404441|531560569|FG006|Phase 1 Part|Death|0|||
147381134|NCT02404441|531560570|FG007|Phase 1 Part|Death|0|||
147381135|NCT02404441|531560571|FG008|Phase 1 Part|Death|0|||
147381136|NCT02404441|531560572|FG009|Phase 1 Part|Death|0|||
147381137|NCT02404441|531560563|FG000|Phase 2 Part|Adverse Event|0|||
147381138|NCT02404441|531560564|FG001|Phase 2 Part|Adverse Event|0|||
147381139|NCT02404441|531560565|FG002|Phase 2 Part|Adverse Event|0|||
147381140|NCT02404441|531560566|FG003|Phase 2 Part|Adverse Event|0|||
147381141|NCT02404441|531560567|FG004|Phase 2 Part|Adverse Event|0|||
147381142|NCT02404441|531560568|FG005|Phase 2 Part|Adverse Event|2|||
147381143|NCT02404441|531560569|FG006|Phase 2 Part|Adverse Event|3|||
147381144|NCT02404441|531560570|FG007|Phase 2 Part|Adverse Event|3|||
147381145|NCT02404441|531560571|FG008|Phase 2 Part|Adverse Event|6|||
147381146|NCT02404441|531560572|FG009|Phase 2 Part|Adverse Event|1|||
147381147|NCT02404441|531560563|FG000|Phase 2 Part|Physician Decision|0|||
147381148|NCT02404441|531560564|FG001|Phase 2 Part|Physician Decision|0|||
147381149|NCT02404441|531560565|FG002|Phase 2 Part|Physician Decision|0|||
147381150|NCT02404441|531560566|FG003|Phase 2 Part|Physician Decision|0|||
147381151|NCT02404441|531560567|FG004|Phase 2 Part|Physician Decision|0|||
147381152|NCT02404441|531560568|FG005|Phase 2 Part|Physician Decision|7|||
147381153|NCT02404441|531560569|FG006|Phase 2 Part|Physician Decision|9|||
147381154|NCT02404441|531560570|FG007|Phase 2 Part|Physician Decision|2|||
147381155|NCT02404441|531560571|FG008|Phase 2 Part|Physician Decision|1|||
147381156|NCT02404441|531560572|FG009|Phase 2 Part|Physician Decision|3|||
147381157|NCT02404441|531560563|FG000|Phase 2 Part|Progressive disease|0|||
147381158|NCT02404441|531560564|FG001|Phase 2 Part|Progressive disease|0|||
147381159|NCT02404441|531560565|FG002|Phase 2 Part|Progressive disease|0|||
147381160|NCT02404441|531560566|FG003|Phase 2 Part|Progressive disease|0|||
147381161|NCT02404441|531560567|FG004|Phase 2 Part|Progressive disease|0|||
147381162|NCT02404441|531560568|FG005|Phase 2 Part|Progressive disease|43|||
147381163|NCT02404441|531560569|FG006|Phase 2 Part|Progressive disease|32|||
147381164|NCT02404441|531560570|FG007|Phase 2 Part|Progressive disease|31|||
147381165|NCT02404441|531560571|FG008|Phase 2 Part|Progressive disease|39|||
147381166|NCT02404441|531560572|FG009|Phase 2 Part|Progressive disease|27|||
147381167|NCT02404441|531560563|FG000|Phase 2 Part|Subject/guardian decision|0|||
147381168|NCT02404441|531560564|FG001|Phase 2 Part|Subject/guardian decision|0|||
147381169|NCT02404441|531560565|FG002|Phase 2 Part|Subject/guardian decision|0|||
147381170|NCT02404441|531560566|FG003|Phase 2 Part|Subject/guardian decision|0|||
147381171|NCT02404441|531560567|FG004|Phase 2 Part|Subject/guardian decision|0|||
147381172|NCT02404441|531560568|FG005|Phase 2 Part|Subject/guardian decision|3|||
147381173|NCT02404441|531560569|FG006|Phase 2 Part|Subject/guardian decision|9|||
147381174|NCT02404441|531560570|FG007|Phase 2 Part|Subject/guardian decision|0|||
147381175|NCT02404441|531560571|FG008|Phase 2 Part|Subject/guardian decision|3|||
147381176|NCT02404441|531560572|FG009|Phase 2 Part|Subject/guardian decision|2|||
147381177|NCT02404441|531560563|FG000|Phase 2 Part|Death|0|||
147381178|NCT02404441|531560564|FG001|Phase 2 Part|Death|0|||
147381179|NCT02404441|531560565|FG002|Phase 2 Part|Death|0|||
147381180|NCT02404441|531560566|FG003|Phase 2 Part|Death|0|||
147381181|NCT02404441|531560567|FG004|Phase 2 Part|Death|0|||
147381182|NCT02404441|531560568|FG005|Phase 2 Part|Death|4|||
147381183|NCT02404441|531560569|FG006|Phase 2 Part|Death|8|||
147381184|NCT02404441|531560570|FG007|Phase 2 Part|Death|4|||
147381185|NCT02404441|531560571|FG008|Phase 2 Part|Death|10|||
147381186|NCT02404441|531560572|FG009|Phase 2 Part|Death|9|||
147381187|NCT01918033|531560573|FG000|Overall Study|Adverse Event|1|||
147381188|NCT01918033|531560574|FG001|Overall Study|Adverse Event|0|||
147381189|NCT01918033|531560575|FG002|Overall Study|Adverse Event|2|||
147381190|NCT01918033|531560573|FG000|Overall Study|Lost to Follow-up|0|||
147381191|NCT01918033|531560574|FG001|Overall Study|Lost to Follow-up|1|||
147381192|NCT01918033|531560575|FG002|Overall Study|Lost to Follow-up|0|||
147381193|NCT01918033|531560573|FG000|Overall Study|Protocol Violation|2|||
147381194|NCT01918033|531560574|FG001|Overall Study|Protocol Violation|0|||
147381195|NCT01918033|531560575|FG002|Overall Study|Protocol Violation|1|||
147381196|NCT01918033|531560573|FG000|Overall Study|Withdrawal by Subject|2|||
147381197|NCT01918033|531560574|FG001|Overall Study|Withdrawal by Subject|1|||
147381198|NCT01918033|531560575|FG002|Overall Study|Withdrawal by Subject|0|||
147381199|NCT01976507|531560579|FG000|Overall Study|Adverse Event|6|||
147381200|NCT01976507|531560579|FG000|Overall Study|ablation not done, drug not given|1|||
147381201|NCT01794299|531560581|FG000|Overall Study|ATIR manufacturing not possible|1|||
147381202|NCT01794299|531560581|FG000|Overall Study|Death|14|||
147381203|NCT01794299|531560581|FG000|Overall Study|Graft failure|1|||
147381204|NCT01794299|531560581|FG000|Overall Study|ATIR batch rejected|2|||
147381205|NCT01794299|531560581|FG000|Overall Study|Relapse|2|||
147381206|NCT01794299|531560581|FG000|Overall Study|Discontinued from active follow-up|1|||
147381207|NCT01794299|531560581|FG000|Overall Study|Relapse and rejection of ATIR batch|1|||
147381208|NCT03006393|531560582|FG000|Overall Study|Withdrawal by Subject|1|||
147381209|NCT03006393|531560583|FG001|Overall Study|Withdrawal by Subject|1|||
147381210|NCT03006393|531560582|FG000|Overall Study|Pregnancy|0|||
147381211|NCT03006393|531560583|FG001|Overall Study|Pregnancy|1|||
147381212|NCT03006393|531560582|FG000|Overall Study|Lost to Follow-up|0|||
147456190|NCT03529773|531831742|FG022|Overall Study|Death|1|||
147456191|NCT03529773|531831743|FG023|Overall Study|Death|0|||
147456192|NCT03529773|531831744|FG024|Overall Study|Death|0|||
147456193|NCT03529773|531831745|FG025|Overall Study|Death|0|||
147456194|NCT03529773|531831746|FG026|Overall Study|Death|0|||
147456195|NCT03529773|531831747|FG027|Overall Study|Death|0|||
147456196|NCT03529773|531831748|FG028|Overall Study|Death|0|||
147456197|NCT03529773|531831749|FG029|Overall Study|Death|0|||
147456198|NCT03529773|531831750|FG030|Overall Study|Death|0|||
147456199|NCT03529773|531831751|FG031|Overall Study|Death|0|||
147456200|NCT03529773|531831752|FG032|Overall Study|Death|0|||
147456201|NCT03529773|531831753|FG033|Overall Study|Death|1|||
147456202|NCT03529773|531831754|FG034|Overall Study|Death|1|||
147456203|NCT03529773|531831755|FG035|Overall Study|Death|0|||
147456204|NCT03529773|531831756|FG036|Overall Study|Death|1|||
147456205|NCT03529773|531831757|FG037|Overall Study|Death|0|||
147456206|NCT03529773|531831758|FG038|Overall Study|Death|0|||
147456207|NCT03529773|531831759|FG039|Overall Study|Death|0|||
147456208|NCT03529773|531831720|FG000|Overall Study|Lost to Follow-up|0|||
147456209|NCT03529773|531831721|FG001|Overall Study|Lost to Follow-up|0|||
147456210|NCT03529773|531831722|FG002|Overall Study|Lost to Follow-up|1|||
147456211|NCT03529773|531831723|FG003|Overall Study|Lost to Follow-up|0|||
147456212|NCT03529773|531831724|FG004|Overall Study|Lost to Follow-up|1|||
147381213|NCT03006393|531560583|FG001|Overall Study|Lost to Follow-up|1|||
147381214|NCT02161458|531560584|FG000|Overall Study|Withdrawal by Subject|0|||
147381215|NCT02161458|531560585|FG001|Overall Study|Withdrawal by Subject|4|||
147381216|NCT02161458|531560586|FG002|Overall Study|Withdrawal by Subject|4|||
147381217|NCT02161458|531560587|FG003|Overall Study|Withdrawal by Subject|0|||
147381218|NCT02161458|531560584|FG000|Overall Study|Lost to Follow-up|0|||
147381219|NCT02161458|531560585|FG001|Overall Study|Lost to Follow-up|2|||
147381220|NCT02161458|531560586|FG002|Overall Study|Lost to Follow-up|1|||
147381221|NCT02161458|531560587|FG003|Overall Study|Lost to Follow-up|0|||
147381222|NCT03136861|531560591|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|3|||
147381223|NCT03136861|531560592|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|2|||
147381224|NCT03136861|531560593|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0|||
147381225|NCT03136861|531560594|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0|||
147381226|NCT03136861|531560595|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0|||
147381227|NCT03136861|531560596|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0|||
147381228|NCT03136861|531560597|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Adverse Event|0|||
147381229|NCT03136861|531560591|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|1|||
147381230|NCT03136861|531560592|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|1|||
147381231|NCT03136861|531560593|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0|||
147381232|NCT03136861|531560594|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0|||
147381233|NCT03136861|531560595|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0|||
147381234|NCT03136861|531560596|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0|||
147381235|NCT03136861|531560597|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Lost to Follow-up|0|||
147381236|NCT03136861|531560591|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|2|||
147381237|NCT03136861|531560592|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|1|||
147381238|NCT03136861|531560593|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0|||
147381239|NCT03136861|531560594|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0|||
147381240|NCT03136861|531560595|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0|||
147381241|NCT03136861|531560596|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0|||
147381242|NCT03136861|531560597|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Protocol Deviation|0|||
147381243|NCT03136861|531560591|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
147381244|NCT03136861|531560592|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|1|||
147381245|NCT03136861|531560593|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
147381246|NCT03136861|531560594|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
147381247|NCT03136861|531560595|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
147381248|NCT03136861|531560596|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
147381249|NCT03136861|531560597|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Subject/Guardian Decision|0|||
147381250|NCT03136861|531560591|FG000|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|1|||
147456213|NCT03529773|531831725|FG005|Overall Study|Lost to Follow-up|1|||
147456214|NCT03529773|531831726|FG006|Overall Study|Lost to Follow-up|0|||
147456215|NCT03529773|531831727|FG007|Overall Study|Lost to Follow-up|0|||
147456216|NCT03529773|531831728|FG008|Overall Study|Lost to Follow-up|0|||
147456217|NCT03529773|531831729|FG009|Overall Study|Lost to Follow-up|0|||
147456218|NCT03529773|531831730|FG010|Overall Study|Lost to Follow-up|0|||
147456219|NCT03529773|531831731|FG011|Overall Study|Lost to Follow-up|0|||
147456220|NCT03529773|531831732|FG012|Overall Study|Lost to Follow-up|0|||
147456221|NCT03529773|531831733|FG013|Overall Study|Lost to Follow-up|1|||
147456222|NCT03529773|531831734|FG014|Overall Study|Lost to Follow-up|4|||
147456223|NCT03529773|531831735|FG015|Overall Study|Lost to Follow-up|1|||
147456224|NCT03529773|531831736|FG016|Overall Study|Lost to Follow-up|1|||
147456225|NCT03529773|531831737|FG017|Overall Study|Lost to Follow-up|0|||
147456226|NCT03529773|531831738|FG018|Overall Study|Lost to Follow-up|1|||
147456227|NCT03529773|531831739|FG019|Overall Study|Lost to Follow-up|1|||
147456228|NCT03529773|531831740|FG020|Overall Study|Lost to Follow-up|2|||
147456229|NCT03529773|531831741|FG021|Overall Study|Lost to Follow-up|4|||
147456230|NCT03529773|531831742|FG022|Overall Study|Lost to Follow-up|3|||
147456231|NCT03529773|531831743|FG023|Overall Study|Lost to Follow-up|4|||
147456232|NCT03529773|531831744|FG024|Overall Study|Lost to Follow-up|3|||
147456233|NCT03529773|531831745|FG025|Overall Study|Lost to Follow-up|5|||
147456234|NCT03529773|531831746|FG026|Overall Study|Lost to Follow-up|5|||
147456235|NCT03529773|531831747|FG027|Overall Study|Lost to Follow-up|0|||
147456236|NCT03529773|531831748|FG028|Overall Study|Lost to Follow-up|0|||
147456237|NCT03529773|531831749|FG029|Overall Study|Lost to Follow-up|0|||
147456238|NCT03529773|531831750|FG030|Overall Study|Lost to Follow-up|1|||
147381251|NCT03136861|531560592|FG001|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|1|||
147381252|NCT03136861|531560593|FG002|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0|||
147381253|NCT03136861|531560594|FG003|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0|||
147381254|NCT03136861|531560595|FG004|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0|||
147381255|NCT03136861|531560596|FG005|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0|||
147381256|NCT03136861|531560597|FG006|Treatment Period 1 (TP1)(Baseline-Wk 8)|Withdrawal of Informed Consent|0|||
147381257|NCT03136861|531560591|FG000|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|0|||
147381258|NCT03136861|531560592|FG001|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|0|||
147381259|NCT03136861|531560593|FG002|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|0|||
147381260|NCT03136861|531560594|FG003|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|1|||
147381261|NCT03136861|531560595|FG004|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|2|||
147381262|NCT03136861|531560596|FG005|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|0|||
147381263|NCT03136861|531560597|FG006|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Adverse Event|1|||
147381264|NCT03136861|531560591|FG000|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
147381265|NCT03136861|531560592|FG001|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
147381266|NCT03136861|531560593|FG002|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|1|||
147381267|NCT03136861|531560594|FG003|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
147456239|NCT03529773|531831751|FG031|Overall Study|Lost to Follow-up|0|||
147456240|NCT03529773|531831752|FG032|Overall Study|Lost to Follow-up|0|||
147456241|NCT03529773|531831753|FG033|Overall Study|Lost to Follow-up|1|||
147456242|NCT03529773|531831754|FG034|Overall Study|Lost to Follow-up|1|||
147456243|NCT03529773|531831755|FG035|Overall Study|Lost to Follow-up|0|||
147456244|NCT03529773|531831756|FG036|Overall Study|Lost to Follow-up|0|||
147456245|NCT03529773|531831757|FG037|Overall Study|Lost to Follow-up|3|||
147456246|NCT03529773|531831758|FG038|Overall Study|Lost to Follow-up|1|||
147456247|NCT03529773|531831759|FG039|Overall Study|Lost to Follow-up|1|||
147456248|NCT03529773|531831720|FG000|Overall Study|No longer meets eligibility criteria|0|||
147456249|NCT03529773|531831721|FG001|Overall Study|No longer meets eligibility criteria|0|||
147456250|NCT03529773|531831722|FG002|Overall Study|No longer meets eligibility criteria|0|||
147456251|NCT03529773|531831723|FG003|Overall Study|No longer meets eligibility criteria|0|||
147456252|NCT03529773|531831724|FG004|Overall Study|No longer meets eligibility criteria|0|||
147456253|NCT03529773|531831725|FG005|Overall Study|No longer meets eligibility criteria|0|||
147456254|NCT03529773|531831726|FG006|Overall Study|No longer meets eligibility criteria|0|||
147456255|NCT03529773|531831727|FG007|Overall Study|No longer meets eligibility criteria|0|||
147456256|NCT03529773|531831728|FG008|Overall Study|No longer meets eligibility criteria|0|||
147456257|NCT03529773|531831729|FG009|Overall Study|No longer meets eligibility criteria|0|||
147456258|NCT03529773|531831730|FG010|Overall Study|No longer meets eligibility criteria|0|||
147456259|NCT03529773|531831731|FG011|Overall Study|No longer meets eligibility criteria|0|||
147456260|NCT03529773|531831732|FG012|Overall Study|No longer meets eligibility criteria|0|||
147456261|NCT03529773|531831733|FG013|Overall Study|No longer meets eligibility criteria|0|||
147613786|NCT03022370|532400926|FG000|Overall Study|Death|6|||
147613787|NCT03022370|532400927|FG001|Overall Study|Death|12|||
147456262|NCT03529773|531831734|FG014|Overall Study|No longer meets eligibility criteria|0|||
147456263|NCT03529773|531831735|FG015|Overall Study|No longer meets eligibility criteria|0|||
147456264|NCT03529773|531831736|FG016|Overall Study|No longer meets eligibility criteria|0|||
147456265|NCT03529773|531831737|FG017|Overall Study|No longer meets eligibility criteria|0|||
147456266|NCT03529773|531831738|FG018|Overall Study|No longer meets eligibility criteria|0|||
147456267|NCT03529773|531831739|FG019|Overall Study|No longer meets eligibility criteria|0|||
147456268|NCT03529773|531831740|FG020|Overall Study|No longer meets eligibility criteria|0|||
147456269|NCT03529773|531831741|FG021|Overall Study|No longer meets eligibility criteria|0|||
147456270|NCT03529773|531831742|FG022|Overall Study|No longer meets eligibility criteria|1|||
147456271|NCT03529773|531831743|FG023|Overall Study|No longer meets eligibility criteria|0|||
147456272|NCT03529773|531831744|FG024|Overall Study|No longer meets eligibility criteria|0|||
147456273|NCT03529773|531831745|FG025|Overall Study|No longer meets eligibility criteria|0|||
147456274|NCT03529773|531831746|FG026|Overall Study|No longer meets eligibility criteria|0|||
147456275|NCT03529773|531831747|FG027|Overall Study|No longer meets eligibility criteria|0|||
147613788|NCT03022370|532400926|FG000|Overall Study|Lost to Follow-up|174|||
147613789|NCT03022370|532400927|FG001|Overall Study|Lost to Follow-up|109|||
147613790|NCT00560391|532400930|FG000|Overall Study|Still on treatment|0|||
147613791|NCT00560391|532400931|FG001|Overall Study|Still on treatment|0|||
147613792|NCT00560391|532400932|FG002|Overall Study|Still on treatment|0|||
147613793|NCT00560391|532400933|FG003|Overall Study|Still on treatment|1|||
147613794|NCT00560391|532400934|FG004|Overall Study|Still on treatment|2|||
147613795|NCT03668808|532400935|FG000|First Intervention|Withdrawal by Subject|2|||
147613796|NCT03668808|532400936|FG001|First Intervention|Withdrawal by Subject|2|||
147613797|NCT01526655|532400939|FG000|Overall Study|Withdrawal by Subject|0|||
147613798|NCT01526655|532400940|FG001|Overall Study|Withdrawal by Subject|1|||
147613799|NCT00280735|532400941|FG000|Overall Study|Adverse Event|5|||
147613800|NCT00280735|532400941|FG000|Overall Study|Lack of Efficacy|3|||
147613801|NCT00280735|532400941|FG000|Overall Study|Withdrawal by Subject|8|||
147613802|NCT00280735|532400941|FG000|Overall Study|Intercurrent Illness|2|||
147613803|NCT02001987|532400943|FG000|Core Study Period (24 Weeks)|Adverse Event|9|||
147613804|NCT02001987|532400943|FG000|Core Study Period (24 Weeks)|Death|1|||
147381268|NCT03136861|531560595|FG004|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
147381269|NCT03136861|531560596|FG005|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
147381270|NCT03136861|531560597|FG006|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Lost to Follow-up|0|||
147381271|NCT03136861|531560591|FG000|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
147381272|NCT03136861|531560592|FG001|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
147381273|NCT03136861|531560593|FG002|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|1|||
147381274|NCT03136861|531560594|FG003|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
147381275|NCT03136861|531560595|FG004|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
147381276|NCT03136861|531560596|FG005|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
147381277|NCT03136861|531560597|FG006|Treatment Period 2 (TP2) (Wk 8-Wk 24)|Withdrawal of Informed Consent|0|||
147381278|NCT03390166|531560598|FG000|Overall Study|Death|0|||
147381279|NCT03390166|531560599|FG001|Overall Study|Death|1|||
147381280|NCT03390166|531560598|FG000|Overall Study|Lost to Follow-up|6|||
147381281|NCT03390166|531560599|FG001|Overall Study|Lost to Follow-up|4|||
147381282|NCT03390166|531560598|FG000|Overall Study|Physician Decision|2|||
147381283|NCT03390166|531560599|FG001|Overall Study|Physician Decision|1|||
147381284|NCT03390166|531560598|FG000|Overall Study|Move from study area|3|||
147381285|NCT03390166|531560599|FG001|Overall Study|Move from study area|2|||
147381286|NCT03390166|531560598|FG000|Overall Study|To militarycamp for conscript|1|||
147381287|NCT03390166|531560599|FG001|Overall Study|To militarycamp for conscript|0|||
147381288|NCT03390166|531560598|FG000|Overall Study|To drug therapy course|0|||
147381289|NCT03390166|531560599|FG001|Overall Study|To drug therapy course|1|||
147381290|NCT03390166|531560598|FG000|Overall Study|Move to work oversea|0|||
147381291|NCT03390166|531560599|FG001|Overall Study|Move to work oversea|1|||
147381292|NCT03692871|531560606|FG000|Overall Study|Death|1|||
147381293|NCT03692871|531560607|FG001|Overall Study|Death|1|||
147381294|NCT03692871|531560606|FG000|Overall Study|Lost to Follow-up|24|||
147381295|NCT03692871|531560607|FG001|Overall Study|Lost to Follow-up|9|||
147381296|NCT03692871|531560606|FG000|Overall Study|Physician Decision|22|||
147381297|NCT03692871|531560607|FG001|Overall Study|Physician Decision|7|||
147381298|NCT03692871|531560606|FG000|Overall Study|Protocol Deviation|1|||
147381299|NCT03692871|531560607|FG001|Overall Study|Protocol Deviation|0|||
147381300|NCT03692871|531560606|FG000|Overall Study|Withdrawal by Parent/Guardian|77|||
147381301|NCT03692871|531560607|FG001|Overall Study|Withdrawal by Parent/Guardian|20|||
147381302|NCT02852824|531560608|FG000|Overall Study|Withdrawal by Subject|1|||
147381303|NCT02852824|531560609|FG001|Overall Study|Withdrawal by Subject|0|||
147381304|NCT02852824|531560610|FG002|Overall Study|Withdrawal by Subject|0|||
147381305|NCT02852824|531560611|FG003|Overall Study|Withdrawal by Subject|0|||
147381306|NCT02852824|531560612|FG004|Overall Study|Withdrawal by Subject|0|||
147381307|NCT02852824|531560613|FG005|Overall Study|Withdrawal by Subject|0|||
147381308|NCT02852824|531560614|FG006|Overall Study|Withdrawal by Subject|0|||
147381309|NCT02852824|531560608|FG000|Overall Study|Adverse Event|0|||
147381310|NCT02852824|531560609|FG001|Overall Study|Adverse Event|0|||
147381311|NCT02852824|531560610|FG002|Overall Study|Adverse Event|0|||
147381312|NCT02852824|531560611|FG003|Overall Study|Adverse Event|0|||
147381313|NCT02852824|531560612|FG004|Overall Study|Adverse Event|2|||
147381314|NCT02852824|531560613|FG005|Overall Study|Adverse Event|0|||
147381315|NCT02852824|531560614|FG006|Overall Study|Adverse Event|0|||
147381316|NCT01316913|531560615|FG000|Overall Study|Adverse Event|17|||
147381317|NCT01316913|531560616|FG001|Overall Study|Adverse Event|20|||
147613805|NCT02001987|532400943|FG000|Core Study Period (24 Weeks)|Non-Serious Hypersensitivity Reaction|2|||
147613806|NCT02001987|532400943|FG000|Core Study Period (24 Weeks)|Physician Decision|1|||
147613807|NCT02001987|532400943|FG000|Core Study Period (24 Weeks)|Withdrawal by Subject|4|||
147381318|NCT01316913|531560617|FG002|Overall Study|Adverse Event|15|||
147381319|NCT01316913|531560618|FG003|Overall Study|Adverse Event|11|||
147613808|NCT02001987|532400943|FG000|Core Study Period (24 Weeks)|Protocol Violation|3|||
147613809|NCT02001987|532400943|FG000|Core Study Period (24 Weeks)|Lack of Efficacy|3|||
147613810|NCT02001987|532400943|FG000|LTE Period (52 Weeks)|Lost to Follow-up|2|||
147613811|NCT02001987|532400943|FG000|LTE Period (52 Weeks)|Physician Decision|2|||
147613812|NCT02001987|532400943|FG000|LTE Period (52 Weeks)|Withdrawal by Subject|1|||
147613813|NCT02001987|532400943|FG000|LTE Period (52 Weeks)|Lack of Efficacy|1|||
147381320|NCT01316913|531560615|FG000|Overall Study|Lack of Efficacy|22|||
147381321|NCT01316913|531560616|FG001|Overall Study|Lack of Efficacy|12|||
147381322|NCT01316913|531560617|FG002|Overall Study|Lack of Efficacy|9|||
147381323|NCT01316913|531560618|FG003|Overall Study|Lack of Efficacy|13|||
147381324|NCT01316913|531560615|FG000|Overall Study|Protocol Violation|1|||
147381325|NCT01316913|531560616|FG001|Overall Study|Protocol Violation|4|||
147381326|NCT01316913|531560617|FG002|Overall Study|Protocol Violation|4|||
147381327|NCT01316913|531560618|FG003|Overall Study|Protocol Violation|1|||
147381328|NCT01316913|531560615|FG000|Overall Study|Protocol-defined Stopping Criteria|7|||
147381329|NCT01316913|531560616|FG001|Overall Study|Protocol-defined Stopping Criteria|8|||
147381330|NCT01316913|531560617|FG002|Overall Study|Protocol-defined Stopping Criteria|11|||
147381331|NCT01316913|531560618|FG003|Overall Study|Protocol-defined Stopping Criteria|6|||
147381332|NCT01316913|531560615|FG000|Overall Study|Lost to Follow-up|0|||
147381333|NCT01316913|531560616|FG001|Overall Study|Lost to Follow-up|1|||
147381334|NCT01316913|531560617|FG002|Overall Study|Lost to Follow-up|0|||
147381335|NCT01316913|531560618|FG003|Overall Study|Lost to Follow-up|2|||
147381336|NCT01316913|531560615|FG000|Overall Study|Withdrawal by Subject|10|||
147381337|NCT01316913|531560616|FG001|Overall Study|Withdrawal by Subject|9|||
147381338|NCT01316913|531560617|FG002|Overall Study|Withdrawal by Subject|10|||
147381339|NCT01316913|531560618|FG003|Overall Study|Withdrawal by Subject|6|||
147381340|NCT05445557|531560619|FG000|Double Blind Part|Lost to Follow-up|1|||
147381341|NCT02915783|531560621|FG000|Overall Study|Death|21|||
147381342|NCT02915783|531560621|FG000|Overall Study|Lost to Follow-up|1|||
147381343|NCT02915783|531560621|FG000|Overall Study|Withdrawal by Subject|2|||
147381344|NCT02950961|531560622|FG000|Overall Study|Study had to stop due to COVID.|7|||
147381345|NCT03055988|531560623|FG000|Period 1|Adverse Event|0|||
147381346|NCT03055988|531560624|FG001|Period 1|Adverse Event|1|||
147381347|NCT03055988|531560623|FG000|Period 1|Lost to Follow-up|1|||
147381348|NCT03055988|531560624|FG001|Period 1|Lost to Follow-up|0|||
147381349|NCT03055988|531560623|FG000|Period 1|Withdrawal by Subject|0|||
147381350|NCT03055988|531560624|FG001|Period 1|Withdrawal by Subject|4|||
147381351|NCT03055988|531560623|FG000|Period 2|Adverse Event|0|||
147381352|NCT03055988|531560624|FG001|Period 2|Adverse Event|1|||
147381353|NCT03055988|531560623|FG000|Period 2|Other than listed|1|||
147381354|NCT03055988|531560624|FG001|Period 2|Other than listed|1|||
147381355|NCT01915914|531560627|FG000|Acute Phase|Withdrawal by Subject|4|||
147381356|NCT01915914|531560628|FG001|Acute Phase|Withdrawal by Subject|0|||
147381357|NCT01915914|531560629|FG002|Acute Phase|Withdrawal by Subject|0|||
147381358|NCT01915914|531560630|FG003|Acute Phase|Withdrawal by Subject|0|||
147381359|NCT01915914|531560627|FG000|Acute Phase|Lost to Follow-up|4|||
147381360|NCT01915914|531560628|FG001|Acute Phase|Lost to Follow-up|0|||
147381361|NCT01915914|531560629|FG002|Acute Phase|Lost to Follow-up|0|||
147381362|NCT01915914|531560630|FG003|Acute Phase|Lost to Follow-up|0|||
147381363|NCT01915914|531560627|FG000|Acute Phase|Physician Decision|1|||
147381364|NCT01915914|531560628|FG001|Acute Phase|Physician Decision|0|||
147381365|NCT01915914|531560629|FG002|Acute Phase|Physician Decision|0|||
147381366|NCT01915914|531560630|FG003|Acute Phase|Physician Decision|0|||
147381367|NCT01915914|531560627|FG000|Acute Phase|Accepted Other Topic Therapies|1|||
147381368|NCT01915914|531560628|FG001|Acute Phase|Accepted Other Topic Therapies|0|||
147381369|NCT01915914|531560629|FG002|Acute Phase|Accepted Other Topic Therapies|0|||
147381370|NCT01915914|531560630|FG003|Acute Phase|Accepted Other Topic Therapies|0|||
147381371|NCT01915914|531560627|FG000|Acute Phase|"Not Achieved treatment success"|1|||
147381372|NCT01915914|531560628|FG001|Acute Phase|"Not Achieved treatment success"|0|||
147381373|NCT01915914|531560629|FG002|Acute Phase|"Not Achieved treatment success"|0|||
147381374|NCT01915914|531560630|FG003|Acute Phase|"Not Achieved treatment success"|0|||
147381375|NCT01915914|531560627|FG000|Acute Phase|Missing|1|||
147381376|NCT01915914|531560628|FG001|Acute Phase|Missing|0|||
147381377|NCT01915914|531560629|FG002|Acute Phase|Missing|0|||
147381378|NCT01915914|531560630|FG003|Acute Phase|Missing|0|||
147381379|NCT01915914|531560627|FG000|Maintenance Phase|Withdrawal by Subject|0|||
147381380|NCT01915914|531560628|FG001|Maintenance Phase|Withdrawal by Subject|1|||
147381381|NCT01915914|531560629|FG002|Maintenance Phase|Withdrawal by Subject|1|||
147381382|NCT01915914|531560630|FG003|Maintenance Phase|Withdrawal by Subject|0|||
147381383|NCT01915914|531560627|FG000|Maintenance Phase|Lost to Follow-up|0|||
147381384|NCT01915914|531560628|FG001|Maintenance Phase|Lost to Follow-up|4|||
147381385|NCT01915914|531560629|FG002|Maintenance Phase|Lost to Follow-up|1|||
147381386|NCT01915914|531560630|FG003|Maintenance Phase|Lost to Follow-up|0|||
147381387|NCT01915914|531560627|FG000|Maintenance Phase|Missing|0|||
147613814|NCT02001987|532400943|FG000|LTE Period (52 Weeks)|Other|3|||
147613815|NCT01965860|532400944|FG000|Overall Study|Pregnancy|1|||
147381388|NCT01915914|531560628|FG001|Maintenance Phase|Missing|1|||
147381389|NCT01915914|531560629|FG002|Maintenance Phase|Missing|0|||
147381390|NCT01915914|531560630|FG003|Maintenance Phase|Missing|0|||
147381391|NCT01915914|531560627|FG000|Follow-up Phase|Withdrawal by Subject|0|||
147381392|NCT01915914|531560628|FG001|Follow-up Phase|Withdrawal by Subject|0|||
147381393|NCT01915914|531560629|FG002|Follow-up Phase|Withdrawal by Subject|0|||
147381394|NCT01915914|531560630|FG003|Follow-up Phase|Withdrawal by Subject|1|||
147381395|NCT01915914|531560627|FG000|Follow-up Phase|Physician Decision|0|||
147381396|NCT01915914|531560628|FG001|Follow-up Phase|Physician Decision|0|||
147381397|NCT01915914|531560629|FG002|Follow-up Phase|Physician Decision|0|||
147381398|NCT01915914|531560630|FG003|Follow-up Phase|Physician Decision|1|||
147381399|NCT00428714|531560632|FG000|Overall Study|Progressive Disease|28|||
147381400|NCT00428714|531560633|FG001|Overall Study|Progressive Disease|36|||
147381401|NCT00428714|531560632|FG000|Overall Study|Withdrawal by Subject|0|||
147381402|NCT00428714|531560633|FG001|Overall Study|Withdrawal by Subject|3|||
147381403|NCT00428714|531560632|FG000|Overall Study|Adverse Event|0|||
147381404|NCT00428714|531560633|FG001|Overall Study|Adverse Event|2|||
147613816|NCT01965860|532400945|FG001|Overall Study|Pregnancy|0|||
147613817|NCT01965860|532400946|FG002|Overall Study|Pregnancy|1|||
147613818|NCT01965860|532400944|FG000|Overall Study|Logistics|1|||
147613819|NCT01965860|532400945|FG001|Overall Study|Logistics|0|||
147613820|NCT01965860|532400946|FG002|Overall Study|Logistics|0|||
147613821|NCT02064296|532400950|FG000|Eligibility to Baseline Data Collection|Withdrawal by Subject|1|||
147613822|NCT02064296|532400951|FG001|Eligibility to Baseline Data Collection|Withdrawal by Subject|0|||
147613823|NCT02064296|532400952|FG002|Eligibility to Baseline Data Collection|Withdrawal by Subject|0|||
147613824|NCT02064296|532400950|FG000|Intervention|Withdrawal by Subject|0|||
147613825|NCT02064296|532400951|FG001|Intervention|Withdrawal by Subject|1|||
147613826|NCT02064296|532400952|FG002|Intervention|Withdrawal by Subject|2|||
147613827|NCT02288325|532400958|FG000|Run-in Period|Adverse Event|48|||
147613828|NCT02288325|532400959|FG001|Run-in Period|Adverse Event|0|||
147613829|NCT02288325|532400960|FG002|Run-in Period|Adverse Event|0|||
147613830|NCT02288325|532400958|FG000|Run-in Period|Lack of Efficacy|16|||
147613831|NCT02288325|532400959|FG001|Run-in Period|Lack of Efficacy|0|||
147613832|NCT02288325|532400960|FG002|Run-in Period|Lack of Efficacy|0|||
147613833|NCT02288325|532400958|FG000|Run-in Period|Withdrawal of Consent|28|||
147613834|NCT02288325|532400959|FG001|Run-in Period|Withdrawal of Consent|0|||
147613835|NCT02288325|532400960|FG002|Run-in Period|Withdrawal of Consent|0|||
147613836|NCT02288325|532400958|FG000|Run-in Period|Lost to Follow-up|25|||
147613837|NCT02288325|532400959|FG001|Run-in Period|Lost to Follow-up|0|||
147613838|NCT02288325|532400960|FG002|Run-in Period|Lost to Follow-up|0|||
147613839|NCT02288325|532400958|FG000|Run-in Period|Protocol Violation|17|||
147613840|NCT02288325|532400959|FG001|Run-in Period|Protocol Violation|0|||
147613841|NCT02288325|532400960|FG002|Run-in Period|Protocol Violation|0|||
147613842|NCT02288325|532400958|FG000|Run-in Period|Non-Compliance With Study Drug|3|||
147613843|NCT02288325|532400959|FG001|Run-in Period|Non-Compliance With Study Drug|0|||
147613844|NCT02288325|532400960|FG002|Run-in Period|Non-Compliance With Study Drug|0|||
147613845|NCT02288325|532400958|FG000|Run-in Period|Reason not Specified|8|||
147613846|NCT02288325|532400959|FG001|Run-in Period|Reason not Specified|0|||
147613847|NCT02288325|532400960|FG002|Run-in Period|Reason not Specified|0|||
147613848|NCT02288325|532400958|FG000|Stabilization Period|Adverse Event|13|||
147613849|NCT02288325|532400959|FG001|Stabilization Period|Adverse Event|0|||
147613850|NCT02288325|532400960|FG002|Stabilization Period|Adverse Event|0|||
147613851|NCT02288325|532400958|FG000|Stabilization Period|Lack of Efficacy|22|||
147381405|NCT00428714|531560632|FG000|Overall Study|Physician Decision|1|||
147381406|NCT00428714|531560633|FG001|Overall Study|Physician Decision|1|||
147381407|NCT00428714|531560632|FG000|Overall Study|Death due to Progressive Disease (PD)|1|||
147381408|NCT00428714|531560633|FG001|Overall Study|Death due to Progressive Disease (PD)|0|||
147381409|NCT00428714|531560632|FG000|Overall Study|Death due to other then PD|1|||
147381410|NCT00428714|531560633|FG001|Overall Study|Death due to other then PD|0|||
147381411|NCT01736475|531560636|FG000|Overall Study|Adverse Event|4|||
147381412|NCT01736475|531560637|FG001|Overall Study|Adverse Event|0|||
147381413|NCT01736475|531560636|FG000|Overall Study|Withdrawal by Subject|2|||
147381414|NCT01736475|531560637|FG001|Overall Study|Withdrawal by Subject|0|||
147381415|NCT01736475|531560636|FG000|Overall Study|Protocol Violation|4|||
147381416|NCT01736475|531560637|FG001|Overall Study|Protocol Violation|0|||
147381417|NCT01736475|531560636|FG000|Overall Study|Other - Screen failure|1|||
147381418|NCT01736475|531560637|FG001|Overall Study|Other - Screen failure|0|||
147613852|NCT02288325|532400959|FG001|Stabilization Period|Lack of Efficacy|0|||
147613853|NCT02288325|532400960|FG002|Stabilization Period|Lack of Efficacy|0|||
147613854|NCT02288325|532400958|FG000|Stabilization Period|Withdrawal of Consent|23|||
147613855|NCT02288325|532400959|FG001|Stabilization Period|Withdrawal of Consent|0|||
147613856|NCT02288325|532400960|FG002|Stabilization Period|Withdrawal of Consent|0|||
147613857|NCT02288325|532400958|FG000|Stabilization Period|Lost to Follow-up|12|||
147613858|NCT02288325|532400959|FG001|Stabilization Period|Lost to Follow-up|0|||
147613859|NCT02288325|532400960|FG002|Stabilization Period|Lost to Follow-up|0|||
147613860|NCT02288325|532400958|FG000|Stabilization Period|Protocol Violation|8|||
147613861|NCT02288325|532400959|FG001|Stabilization Period|Protocol Violation|0|||
147613862|NCT02288325|532400960|FG002|Stabilization Period|Protocol Violation|0|||
147613863|NCT02288325|532400958|FG000|Stabilization Period|Non-Compliance With Study Drug|5|||
147613864|NCT02288325|532400959|FG001|Stabilization Period|Non-Compliance With Study Drug|0|||
147381419|NCT01736475|531560636|FG000|Overall Study|Other - Surgical procedure|1|||
147381420|NCT01736475|531560637|FG001|Overall Study|Other - Surgical procedure|0|||
147381421|NCT00513071|531560638|FG000|Overall Study|Adverse Event|1|||
147381422|NCT00513071|531560638|FG000|Overall Study|Withdrawal by Subject|1|||
147381423|NCT00513071|531560638|FG000|Overall Study|Physician Decision|3|||
147381424|NCT00824850|531560640|FG000|Overall Study|Withdrawal by Subject|0|||
147381425|NCT00824850|531560641|FG001|Overall Study|Withdrawal by Subject|1|||
147381426|NCT04820491|531560642|FG000|Overall Study|Withdrawal by Subject|1|||
147381427|NCT04820491|531560643|FG001|Overall Study|Withdrawal by Subject|0|||
147381428|NCT04909593|531561943|FG000|Overall Study|Withdrawal by Subject|1|||
147381429|NCT01018992|531561944|FG000|Overall Study|Adverse Event|8|||
147381430|NCT01018992|531561945|FG001|Overall Study|Adverse Event|3|||
147381431|NCT01018992|531561944|FG000|Overall Study|Withdrawal by Subject|3|||
147381432|NCT01018992|531561945|FG001|Overall Study|Withdrawal by Subject|8|||
147381433|NCT01018992|531561944|FG000|Overall Study|Protocol Violation|0|||
147381434|NCT01018992|531561945|FG001|Overall Study|Protocol Violation|4|||
147381435|NCT01018992|531561944|FG000|Overall Study|Lost to Follow-up|5|||
147381436|NCT01018992|531561945|FG001|Overall Study|Lost to Follow-up|1|||
147381437|NCT01825785|531561946|FG000|Overall Study|Adverse Event|0|||
147381438|NCT01825785|531561947|FG001|Overall Study|Adverse Event|0|||
147381439|NCT01825785|531561948|FG002|Overall Study|Adverse Event|0|||
147381440|NCT01825785|531561949|FG003|Overall Study|Adverse Event|0|||
147381441|NCT01825785|531561950|FG004|Overall Study|Adverse Event|1|||
147381442|NCT01825785|531561951|FG005|Overall Study|Adverse Event|0|||
147381443|NCT01825785|531561952|FG006|Overall Study|Adverse Event|0|||
147381444|NCT01825785|531561946|FG000|Overall Study|Withdrawal by Subject|0|||
147381445|NCT01825785|531561947|FG001|Overall Study|Withdrawal by Subject|0|||
147381446|NCT01825785|531561948|FG002|Overall Study|Withdrawal by Subject|0|||
147381447|NCT01825785|531561949|FG003|Overall Study|Withdrawal by Subject|0|||
147381448|NCT01825785|531561950|FG004|Overall Study|Withdrawal by Subject|1|||
147381449|NCT01825785|531561951|FG005|Overall Study|Withdrawal by Subject|1|||
147381450|NCT01825785|531561952|FG006|Overall Study|Withdrawal by Subject|0|||
147381451|NCT01304940|531561954|FG000|Overall Study|not meet symptom severity requirement|3|||
147381452|NCT01304940|531561955|FG001|Overall Study|not meet symptom severity requirement|0|||
147381453|NCT02065895|531561956|FG000|Overall Study|Protocol Violation|1|||
147381454|NCT02065895|531561957|FG001|Overall Study|Protocol Violation|0|||
147381455|NCT02065895|531561958|FG002|Overall Study|Protocol Violation|0|||
147381456|NCT02065895|531561959|FG003|Overall Study|Protocol Violation|1|||
147381457|NCT02065895|531561960|FG004|Overall Study|Protocol Violation|0|||
147381458|NCT02065895|531561961|FG005|Overall Study|Protocol Violation|0|||
147381459|NCT02065895|531561956|FG000|Overall Study|Scheduling conflicts|0|||
147381460|NCT02065895|531561957|FG001|Overall Study|Scheduling conflicts|1|||
147381461|NCT02065895|531561958|FG002|Overall Study|Scheduling conflicts|0|||
147381462|NCT02065895|531561959|FG003|Overall Study|Scheduling conflicts|0|||
147381463|NCT02065895|531561960|FG004|Overall Study|Scheduling conflicts|0|||
147381464|NCT02065895|531561961|FG005|Overall Study|Scheduling conflicts|0|||
147381465|NCT03137784|531561962|FG000|Overall Study|Adverse Event|1|||
147381466|NCT03137784|531561963|FG001|Overall Study|Adverse Event|1|||
147381467|NCT03137784|531561964|FG002|Overall Study|Adverse Event|0|||
147381468|NCT03137784|531561965|FG003|Overall Study|Adverse Event|0|||
147381469|NCT03137784|531561966|FG004|Overall Study|Adverse Event|0|||
147381470|NCT03137784|531561967|FG005|Overall Study|Adverse Event|0|||
147381471|NCT03137784|531561962|FG000|Overall Study|Subject/guardian decision|1|||
147381472|NCT03137784|531561963|FG001|Overall Study|Subject/guardian decision|0|||
147381473|NCT03137784|531561964|FG002|Overall Study|Subject/guardian decision|0|||
147381474|NCT03137784|531561965|FG003|Overall Study|Subject/guardian decision|0|||
147381475|NCT03137784|531561966|FG004|Overall Study|Subject/guardian decision|0|||
147381476|NCT03137784|531561967|FG005|Overall Study|Subject/guardian decision|0|||
147381477|NCT03137784|531561962|FG000|Overall Study|Non-compliance with study treatment|0|||
147381478|NCT03137784|531561963|FG001|Overall Study|Non-compliance with study treatment|0|||
147381479|NCT03137784|531561964|FG002|Overall Study|Non-compliance with study treatment|0|||
147381480|NCT03137784|531561965|FG003|Overall Study|Non-compliance with study treatment|0|||
147381481|NCT03137784|531561966|FG004|Overall Study|Non-compliance with study treatment|1|||
147381482|NCT03137784|531561967|FG005|Overall Study|Non-compliance with study treatment|0|||
147381483|NCT01205126|531561968|FG000|Titration Phase|Adverse Event|5|||
147381484|NCT01205126|531561969|FG001|Titration Phase|Adverse Event|3|||
147381485|NCT01205126|531561968|FG000|Titration Phase|Withdrawal by Subject|5|||
147381486|NCT01205126|531561969|FG001|Titration Phase|Withdrawal by Subject|5|||
147381487|NCT01205126|531561968|FG000|Titration Phase|Lost to Follow-up|2|||
147381488|NCT01205126|531561969|FG001|Titration Phase|Lost to Follow-up|2|||
147381489|NCT01205126|531561968|FG000|Titration Phase|No stable titration dose|1|||
147381490|NCT01205126|531561969|FG001|Titration Phase|No stable titration dose|0|||
147381491|NCT01205126|531561968|FG000|Titration Phase|More than maximum dosage required|2|||
147381492|NCT01205126|531561969|FG001|Titration Phase|More than maximum dosage required|3|||
147381493|NCT01205126|531561968|FG000|Titration Phase|Other|8|||
147381494|NCT01205126|531561969|FG001|Titration Phase|Other|6|||
147381495|NCT01205126|531561968|FG000|Between Titration & Maintenance Phase|Other|0|||
147381496|NCT01205126|531561969|FG001|Between Titration & Maintenance Phase|Other|4|||
147381497|NCT01205126|531561968|FG000|Maintenance Phase|Adverse Event|3|||
147613865|NCT02288325|532400960|FG002|Stabilization Period|Non-Compliance With Study Drug|0|||
147613866|NCT02288325|532400958|FG000|Stabilization Period|Reason not Specified|15|||
147613867|NCT02288325|532400959|FG001|Stabilization Period|Reason not Specified|0|||
147613868|NCT02288325|532400960|FG002|Stabilization Period|Reason not Specified|0|||
147613869|NCT02288325|532400958|FG000|Double-blind Treatment Period|Adverse Event|0|||
147613870|NCT02288325|532400959|FG001|Double-blind Treatment Period|Adverse Event|2|||
147613871|NCT02288325|532400960|FG002|Double-blind Treatment Period|Adverse Event|5|||
147613872|NCT02288325|532400958|FG000|Double-blind Treatment Period|Withdrawal of Consent|0|||
147613873|NCT02288325|532400959|FG001|Double-blind Treatment Period|Withdrawal of Consent|8|||
147613874|NCT02288325|532400960|FG002|Double-blind Treatment Period|Withdrawal of Consent|8|||
147613875|NCT02288325|532400958|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
147613876|NCT02288325|532400959|FG001|Double-blind Treatment Period|Lost to Follow-up|4|||
147613877|NCT02288325|532400960|FG002|Double-blind Treatment Period|Lost to Follow-up|5|||
147613878|NCT02288325|532400958|FG000|Double-blind Treatment Period|Protocol Violation|0|||
147613879|NCT02288325|532400959|FG001|Double-blind Treatment Period|Protocol Violation|1|||
147613880|NCT02288325|532400960|FG002|Double-blind Treatment Period|Protocol Violation|2|||
147613881|NCT02288325|532400958|FG000|Double-blind Treatment Period|Non-Compliance With Study Drug|0|||
147613882|NCT02288325|532400959|FG001|Double-blind Treatment Period|Non-Compliance With Study Drug|1|||
147613883|NCT02288325|532400960|FG002|Double-blind Treatment Period|Non-Compliance With Study Drug|4|||
147613884|NCT02288325|532400958|FG000|Double-blind Treatment Period|Multiple Reasons|0|||
147613885|NCT02288325|532400959|FG001|Double-blind Treatment Period|Multiple Reasons|8|||
147613886|NCT02288325|532400960|FG002|Double-blind Treatment Period|Multiple Reasons|2|||
147613887|NCT04138823|532400970|FG000|Overall Study|Clinical disease progression|0|||
147613888|NCT04138823|532400971|FG001|Overall Study|Clinical disease progression|0|||
147613889|NCT04138823|532400972|FG002|Overall Study|Clinical disease progression|1|||
147613890|NCT04138823|532400970|FG000|Overall Study|Objective disease progression|3|||
147381498|NCT01205126|531561969|FG001|Maintenance Phase|Adverse Event|7|||
147381499|NCT01205126|531561968|FG000|Maintenance Phase|Death|4|||
147381500|NCT01205126|531561969|FG001|Maintenance Phase|Death|4|||
147381501|NCT01205126|531561968|FG000|Maintenance Phase|More than the maximum dosage required|5|||
147381502|NCT01205126|531561969|FG001|Maintenance Phase|More than the maximum dosage required|5|||
147381503|NCT01205126|531561968|FG000|Maintenance Phase|Prohibited drugs used|1|||
147381504|NCT01205126|531561969|FG001|Maintenance Phase|Prohibited drugs used|0|||
147381505|NCT01205126|531561968|FG000|Maintenance Phase|Other|11|||
147381506|NCT01205126|531561969|FG001|Maintenance Phase|Other|8|||
147381507|NCT01205126|531561968|FG000|Maintenance Phase|Lost to Follow-up|5|||
147381508|NCT01205126|531561969|FG001|Maintenance Phase|Lost to Follow-up|5|||
147381509|NCT01205126|531561968|FG000|Maintenance Phase|Withdrawal by Subject|8|||
147381510|NCT01205126|531561969|FG001|Maintenance Phase|Withdrawal by Subject|11|||
147381511|NCT00805792|531561972|FG000|Overall Study|Death|3|||
147381512|NCT00805792|531561972|FG000|Overall Study|Lost to Follow-up|2|||
147381513|NCT04328467|531561975|FG000|Overall Study|Did not meet inclusion criteria after randomization|4|||
147381514|NCT04328467|531561976|FG001|Overall Study|Did not meet inclusion criteria after randomization|2|||
147381515|NCT04328467|531561977|FG002|Overall Study|Did not meet inclusion criteria after randomization|1|||
147381516|NCT01655498|531561978|FG000|Overall Study|Unrelated health issue|2|||
147381517|NCT01655498|531561978|FG000|Overall Study|Protocol Violation|2|||
147381518|NCT01655498|531561978|FG000|Overall Study|Withdrawal by Subject|1|||
147381519|NCT01393600|531561981|FG000|Treatment Period 1 (Day 1 to 14)|Protocol Violation|0|||
147381520|NCT01393600|531561982|FG001|Treatment Period 1 (Day 1 to 14)|Protocol Violation|1|||
147381521|NCT01393600|531561983|FG002|Treatment Period 1 (Day 1 to 14)|Protocol Violation|0|||
147381522|NCT01393600|531561984|FG003|Treatment Period 1 (Day 1 to 14)|Protocol Violation|0|||
147381523|NCT01393600|531561981|FG000|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|0|||
147381524|NCT01393600|531561982|FG001|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|0|||
147381525|NCT01393600|531561983|FG002|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|1|||
147381526|NCT01393600|531561984|FG003|Treatment Period 1 (Day 1 to 14)|Withdrawal by Subject|0|||
147381527|NCT01393600|531561981|FG000|Treatment Period 1 (Day 1 to 14)|Adverse Event|0|||
147381528|NCT01393600|531561982|FG001|Treatment Period 1 (Day 1 to 14)|Adverse Event|0|||
147381529|NCT01393600|531561983|FG002|Treatment Period 1 (Day 1 to 14)|Adverse Event|0|||
147381530|NCT01393600|531561984|FG003|Treatment Period 1 (Day 1 to 14)|Adverse Event|1|||
147381531|NCT01393600|531561981|FG000|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|0|||
147381532|NCT01393600|531561982|FG001|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|0|||
147381533|NCT01393600|531561983|FG002|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|0|||
147613891|NCT04138823|532400971|FG001|Overall Study|Objective disease progression|2|||
147613892|NCT04138823|532400972|FG002|Overall Study|Objective disease progression|5|||
147613893|NCT04036110|532400973|FG000|Overall Study|Lost to Follow-up|3|||
147613894|NCT04036110|532400974|FG001|Overall Study|Lost to Follow-up|2|||
147613895|NCT04036110|532400975|FG002|Overall Study|Lost to Follow-up|1|||
147613896|NCT04036110|532400973|FG000|Overall Study|Study Suspended|4|||
147613897|NCT04036110|532400974|FG001|Overall Study|Study Suspended|5|||
147613898|NCT04036110|532400975|FG002|Overall Study|Study Suspended|1|||
147381534|NCT01393600|531561984|FG003|Treatment Period 2 (Day 15 to 28)|Withdrawal by Subject|1|||
147381535|NCT01393600|531561981|FG000|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|0|||
147381536|NCT01393600|531561982|FG001|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|0|||
147381537|NCT01393600|531561983|FG002|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|1|||
147381538|NCT01393600|531561984|FG003|Treatment Period 2 (Day 15 to 28)|Lost to Follow-up|0|||
147381539|NCT01393600|531561981|FG000|Treatment Period 2 (Day 15 to 28)|Physician Decision|0|||
147381540|NCT01393600|531561982|FG001|Treatment Period 2 (Day 15 to 28)|Physician Decision|0|||
147381541|NCT01393600|531561983|FG002|Treatment Period 2 (Day 15 to 28)|Physician Decision|1|||
147381542|NCT01393600|531561984|FG003|Treatment Period 2 (Day 15 to 28)|Physician Decision|0|||
147381543|NCT01393600|531561981|FG000|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|0|||
147381544|NCT01393600|531561982|FG001|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|0|||
147381545|NCT01393600|531561983|FG002|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|1|||
147381546|NCT01393600|531561984|FG003|Follow-up Period (Day 29 to 35)|Withdrawal by Subject|0|||
147381547|NCT01072149|531561985|FG000|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
147381548|NCT01072149|531561986|FG001|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
147381549|NCT01072149|531561987|FG002|Treatment Period 1 (28 Days)|Withdrawal by Subject|1|||
147381550|NCT01072149|531561988|FG003|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
147381551|NCT01072149|531561989|FG004|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
147381552|NCT01072149|531561990|FG005|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
147381553|NCT01072149|531561991|FG006|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
147381554|NCT01072149|531561992|FG007|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
147381555|NCT01072149|531561993|FG008|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
147381556|NCT01072149|531561994|FG009|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
147381557|NCT01072149|531561995|FG010|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
147381558|NCT01072149|531561996|FG011|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
147381559|NCT01072149|531561997|FG012|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
147381560|NCT01072149|531561998|FG013|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
147381561|NCT01072149|531561999|FG014|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
147381562|NCT01072149|531562000|FG015|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
147381563|NCT01072149|531562001|FG016|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
147381564|NCT01072149|531562002|FG017|Treatment Period 1 (28 Days)|Withdrawal by Subject|0|||
147381565|NCT01072149|531561985|FG000|Treatment Period 1 (28 Days)|Protocol Violation|0|||
147381566|NCT01072149|531561986|FG001|Treatment Period 1 (28 Days)|Protocol Violation|0|||
147381567|NCT01072149|531561987|FG002|Treatment Period 1 (28 Days)|Protocol Violation|0|||
147381568|NCT01072149|531561988|FG003|Treatment Period 1 (28 Days)|Protocol Violation|0|||
147381569|NCT01072149|531561989|FG004|Treatment Period 1 (28 Days)|Protocol Violation|0|||
147381570|NCT01072149|531561990|FG005|Treatment Period 1 (28 Days)|Protocol Violation|0|||
147381571|NCT01072149|531561991|FG006|Treatment Period 1 (28 Days)|Protocol Violation|0|||
147381572|NCT01072149|531561992|FG007|Treatment Period 1 (28 Days)|Protocol Violation|0|||
147381573|NCT01072149|531561993|FG008|Treatment Period 1 (28 Days)|Protocol Violation|0|||
147381574|NCT01072149|531561994|FG009|Treatment Period 1 (28 Days)|Protocol Violation|0|||
147381575|NCT01072149|531561995|FG010|Treatment Period 1 (28 Days)|Protocol Violation|0|||
147381576|NCT01072149|531561996|FG011|Treatment Period 1 (28 Days)|Protocol Violation|0|||
147381577|NCT01072149|531561997|FG012|Treatment Period 1 (28 Days)|Protocol Violation|0|||
147381578|NCT01072149|531561998|FG013|Treatment Period 1 (28 Days)|Protocol Violation|0|||
147381579|NCT01072149|531561999|FG014|Treatment Period 1 (28 Days)|Protocol Violation|0|||
147381580|NCT01072149|531562000|FG015|Treatment Period 1 (28 Days)|Protocol Violation|0|||
147381581|NCT01072149|531562001|FG016|Treatment Period 1 (28 Days)|Protocol Violation|0|||
147381582|NCT01072149|531562002|FG017|Treatment Period 1 (28 Days)|Protocol Violation|1|||
147381583|NCT01072149|531561985|FG000|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
147381584|NCT01072149|531561986|FG001|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
147381585|NCT01072149|531561987|FG002|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
147381586|NCT01072149|531561988|FG003|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
147381587|NCT01072149|531561989|FG004|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
147381588|NCT01072149|531561990|FG005|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
147381589|NCT01072149|531561991|FG006|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
147381590|NCT01072149|531561992|FG007|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
147381591|NCT01072149|531561993|FG008|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
147381592|NCT01072149|531561994|FG009|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
147381593|NCT01072149|531561995|FG010|Treatment Period 1 (28 Days)|Lost to Follow-up|1|||
147381594|NCT01072149|531561996|FG011|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
147381595|NCT01072149|531561997|FG012|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
147381596|NCT01072149|531561998|FG013|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
147381597|NCT01072149|531561999|FG014|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
147381598|NCT01072149|531562000|FG015|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
147381599|NCT01072149|531562001|FG016|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
147381600|NCT01072149|531562002|FG017|Treatment Period 1 (28 Days)|Lost to Follow-up|0|||
147456276|NCT03529773|531831748|FG028|Overall Study|No longer meets eligibility criteria|0|||
147456277|NCT03529773|531831749|FG029|Overall Study|No longer meets eligibility criteria|0|||
147381601|NCT01072149|531561985|FG000|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
147381602|NCT01072149|531561986|FG001|Treatment Period 2 (28 Days)|Lost to Follow-up|1|||
147381603|NCT01072149|531561987|FG002|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
147381604|NCT01072149|531561988|FG003|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
147381605|NCT01072149|531561989|FG004|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
147381606|NCT01072149|531561990|FG005|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
147381607|NCT01072149|531561991|FG006|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
147381608|NCT01072149|531561992|FG007|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
147381609|NCT01072149|531561993|FG008|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
147381610|NCT01072149|531561994|FG009|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
147381611|NCT01072149|531561995|FG010|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
147381612|NCT01072149|531561996|FG011|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
147381613|NCT01072149|531561997|FG012|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
147381614|NCT01072149|531561998|FG013|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
147381615|NCT01072149|531561999|FG014|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
147381616|NCT01072149|531562000|FG015|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
147381617|NCT01072149|531562001|FG016|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
147381618|NCT01072149|531562002|FG017|Treatment Period 2 (28 Days)|Lost to Follow-up|0|||
147381619|NCT01072149|531561985|FG000|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
147381620|NCT01072149|531561986|FG001|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
147381621|NCT01072149|531561987|FG002|Treatment Period 2 (28 Days)|Withdrawal by Subject|1|||
147381622|NCT01072149|531561988|FG003|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
147381623|NCT01072149|531561989|FG004|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
147381624|NCT01072149|531561990|FG005|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
147381625|NCT01072149|531561991|FG006|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
147381626|NCT01072149|531561992|FG007|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
147381627|NCT01072149|531561993|FG008|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
147381628|NCT01072149|531561994|FG009|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
147381629|NCT01072149|531561995|FG010|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
147381630|NCT01072149|531561996|FG011|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
147381631|NCT01072149|531561997|FG012|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
147381632|NCT01072149|531561998|FG013|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
147381633|NCT01072149|531561999|FG014|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
147381634|NCT01072149|531562000|FG015|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
147381635|NCT01072149|531562001|FG016|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
147381636|NCT01072149|531562002|FG017|Treatment Period 2 (28 Days)|Withdrawal by Subject|0|||
147381637|NCT01072149|531561985|FG000|Treatment Period 2 (28 Days)|Physician Decision|0|||
147381638|NCT01072149|531561986|FG001|Treatment Period 2 (28 Days)|Physician Decision|0|||
147381639|NCT01072149|531561987|FG002|Treatment Period 2 (28 Days)|Physician Decision|0|||
147381640|NCT01072149|531561988|FG003|Treatment Period 2 (28 Days)|Physician Decision|0|||
147381641|NCT01072149|531561989|FG004|Treatment Period 2 (28 Days)|Physician Decision|0|||
147381642|NCT01072149|531561990|FG005|Treatment Period 2 (28 Days)|Physician Decision|0|||
147381643|NCT01072149|531561991|FG006|Treatment Period 2 (28 Days)|Physician Decision|0|||
147381644|NCT01072149|531561992|FG007|Treatment Period 2 (28 Days)|Physician Decision|1|||
147381645|NCT01072149|531561993|FG008|Treatment Period 2 (28 Days)|Physician Decision|0|||
147381646|NCT01072149|531561994|FG009|Treatment Period 2 (28 Days)|Physician Decision|0|||
147381647|NCT01072149|531561995|FG010|Treatment Period 2 (28 Days)|Physician Decision|0|||
147381648|NCT01072149|531561996|FG011|Treatment Period 2 (28 Days)|Physician Decision|0|||
147381649|NCT01072149|531561997|FG012|Treatment Period 2 (28 Days)|Physician Decision|0|||
147381650|NCT01072149|531561998|FG013|Treatment Period 2 (28 Days)|Physician Decision|0|||
147381651|NCT01072149|531561999|FG014|Treatment Period 2 (28 Days)|Physician Decision|0|||
147381652|NCT01072149|531562000|FG015|Treatment Period 2 (28 Days)|Physician Decision|0|||
147381653|NCT01072149|531562001|FG016|Treatment Period 2 (28 Days)|Physician Decision|0|||
147381654|NCT01072149|531562002|FG017|Treatment Period 2 (28 Days)|Physician Decision|0|||
147381655|NCT01072149|531561985|FG000|Washout Period 2 (14 Days)|Physician Decision|1|||
147381656|NCT01072149|531561986|FG001|Washout Period 2 (14 Days)|Physician Decision|0|||
147381657|NCT01072149|531561987|FG002|Washout Period 2 (14 Days)|Physician Decision|0|||
147613899|NCT02466685|532400976|FG000|Overall Study|Adverse Event|5|||
147613900|NCT02466685|532400977|FG001|Overall Study|Adverse Event|2|||
147613901|NCT02466685|532400976|FG000|Overall Study|Lost to Follow-up|1|||
147613902|NCT02466685|532400977|FG001|Overall Study|Lost to Follow-up|1|||
147381658|NCT01072149|531561988|FG003|Washout Period 2 (14 Days)|Physician Decision|0|||
147381659|NCT01072149|531561989|FG004|Washout Period 2 (14 Days)|Physician Decision|0|||
147456278|NCT03529773|531831750|FG030|Overall Study|No longer meets eligibility criteria|0|||
147456279|NCT03529773|531831751|FG031|Overall Study|No longer meets eligibility criteria|0|||
147613903|NCT02466685|532400976|FG000|Overall Study|Withdrawal by Subject|1|||
147613904|NCT02466685|532400977|FG001|Overall Study|Withdrawal by Subject|0|||
147613905|NCT02466685|532400976|FG000|Overall Study|Physician Decision|1|||
147613906|NCT02466685|532400977|FG001|Overall Study|Physician Decision|1|||
147613907|NCT02593110|532400978|FG000|Overall Study|Withdrawal by Subject|0|||
147381660|NCT01072149|531561990|FG005|Washout Period 2 (14 Days)|Physician Decision|0|||
147381661|NCT01072149|531561991|FG006|Washout Period 2 (14 Days)|Physician Decision|0|||
147381662|NCT01072149|531561992|FG007|Washout Period 2 (14 Days)|Physician Decision|0|||
147381663|NCT01072149|531561993|FG008|Washout Period 2 (14 Days)|Physician Decision|0|||
147381664|NCT01072149|531561994|FG009|Washout Period 2 (14 Days)|Physician Decision|0|||
147381665|NCT01072149|531561995|FG010|Washout Period 2 (14 Days)|Physician Decision|0|||
147381666|NCT01072149|531561996|FG011|Washout Period 2 (14 Days)|Physician Decision|0|||
147381667|NCT01072149|531561997|FG012|Washout Period 2 (14 Days)|Physician Decision|0|||
147381668|NCT01072149|531561998|FG013|Washout Period 2 (14 Days)|Physician Decision|0|||
147381669|NCT01072149|531561999|FG014|Washout Period 2 (14 Days)|Physician Decision|0|||
147381670|NCT01072149|531562000|FG015|Washout Period 2 (14 Days)|Physician Decision|0|||
147381671|NCT01072149|531562001|FG016|Washout Period 2 (14 Days)|Physician Decision|0|||
147381672|NCT01072149|531562002|FG017|Washout Period 2 (14 Days)|Physician Decision|0|||
147381673|NCT01072149|531561985|FG000|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
147381674|NCT01072149|531561986|FG001|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
147381675|NCT01072149|531561987|FG002|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
147381676|NCT01072149|531561988|FG003|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
147381677|NCT01072149|531561989|FG004|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
147381678|NCT01072149|531561990|FG005|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
147381679|NCT01072149|531561991|FG006|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
147381680|NCT01072149|531561992|FG007|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
147381681|NCT01072149|531561993|FG008|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
147381682|NCT01072149|531561994|FG009|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
147381683|NCT01072149|531561995|FG010|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
147381684|NCT01072149|531561996|FG011|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
147381685|NCT01072149|531561997|FG012|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
147381686|NCT01072149|531561998|FG013|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
147381687|NCT01072149|531561999|FG014|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
147381688|NCT01072149|531562000|FG015|Washout Period 2 (14 Days)|Withdrawal by Subject|1|||
147381689|NCT01072149|531562001|FG016|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
147381690|NCT01072149|531562002|FG017|Washout Period 2 (14 Days)|Withdrawal by Subject|0|||
147381691|NCT01072149|531561985|FG000|Washout Period 2 (14 Days)|Adverse Event|0|||
147381692|NCT01072149|531561986|FG001|Washout Period 2 (14 Days)|Adverse Event|0|||
147381693|NCT01072149|531561987|FG002|Washout Period 2 (14 Days)|Adverse Event|0|||
147381694|NCT01072149|531561988|FG003|Washout Period 2 (14 Days)|Adverse Event|0|||
147381695|NCT01072149|531561989|FG004|Washout Period 2 (14 Days)|Adverse Event|0|||
147613908|NCT02593110|532400979|FG001|Overall Study|Withdrawal by Subject|3|||
147613909|NCT02593110|532400980|FG002|Overall Study|Withdrawal by Subject|3|||
147381696|NCT01072149|531561990|FG005|Washout Period 2 (14 Days)|Adverse Event|0|||
147381697|NCT01072149|531561991|FG006|Washout Period 2 (14 Days)|Adverse Event|0|||
147381698|NCT01072149|531561992|FG007|Washout Period 2 (14 Days)|Adverse Event|0|||
147613910|NCT02593110|532400981|FG003|Overall Study|Withdrawal by Subject|2|||
147613911|NCT02593110|532400978|FG000|Overall Study|Death|0|||
147613912|NCT02593110|532400979|FG001|Overall Study|Death|0|||
147613913|NCT02593110|532400980|FG002|Overall Study|Death|1|||
147613914|NCT02593110|532400981|FG003|Overall Study|Death|0|||
147613915|NCT03548337|532400982|FG000|Infant Series|Withdrawal by Parent/Guardian|8|||
147613916|NCT03548337|532400983|FG001|Infant Series|Withdrawal by Parent/Guardian|8|||
147613917|NCT03548337|532400982|FG000|Infant Series|No Longer Met Eligibility Criteria|1|||
147613918|NCT03548337|532400983|FG001|Infant Series|No Longer Met Eligibility Criteria|0|||
147613919|NCT03548337|532400982|FG000|Infant Series|Lost to Follow-up|2|||
147381699|NCT01072149|531561993|FG008|Washout Period 2 (14 Days)|Adverse Event|0|||
147381700|NCT01072149|531561994|FG009|Washout Period 2 (14 Days)|Adverse Event|0|||
147381701|NCT01072149|531561995|FG010|Washout Period 2 (14 Days)|Adverse Event|0|||
147381702|NCT01072149|531561996|FG011|Washout Period 2 (14 Days)|Adverse Event|0|||
147381703|NCT01072149|531561997|FG012|Washout Period 2 (14 Days)|Adverse Event|0|||
147381704|NCT01072149|531561998|FG013|Washout Period 2 (14 Days)|Adverse Event|0|||
147381705|NCT01072149|531561999|FG014|Washout Period 2 (14 Days)|Adverse Event|0|||
147613920|NCT03548337|532400983|FG001|Infant Series|Lost to Follow-up|1|||
147613921|NCT03548337|532400982|FG000|Infant Series|Adverse Event|0|||
147613922|NCT03548337|532400983|FG001|Infant Series|Adverse Event|2|||
147613923|NCT03548337|532400982|FG000|Infant Series|Randomized but Not Vaccinated|1|||
147613924|NCT03548337|532400983|FG001|Infant Series|Randomized but Not Vaccinated|0|||
147613925|NCT03548337|532400982|FG000|Toddler Dose|Withdrawal by parent/guardian|1|||
147613926|NCT03548337|532400983|FG001|Toddler Dose|Withdrawal by parent/guardian|1|||
147613927|NCT01911273|532400986|FG000|Overall Study|Progression of Disease|1|||
147613928|NCT01911273|532400987|FG001|Overall Study|Progression of Disease|0|||
147613929|NCT01911273|532400986|FG000|Overall Study|Withdrawal by Subject|0|||
147381706|NCT01072149|531562000|FG015|Washout Period 2 (14 Days)|Adverse Event|1|||
147381707|NCT01072149|531562001|FG016|Washout Period 2 (14 Days)|Adverse Event|0|||
147613930|NCT01911273|532400987|FG001|Overall Study|Withdrawal by Subject|2|||
147381708|NCT01072149|531562002|FG017|Washout Period 2 (14 Days)|Adverse Event|0|||
147381709|NCT01072149|531561985|FG000|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
147381710|NCT01072149|531561986|FG001|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
147381711|NCT01072149|531561987|FG002|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
147381712|NCT01072149|531561988|FG003|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
147381713|NCT01072149|531561989|FG004|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
147381714|NCT01072149|531561990|FG005|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
147381715|NCT01072149|531561991|FG006|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
147381716|NCT01072149|531561992|FG007|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
147381717|NCT01072149|531561993|FG008|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
147381718|NCT01072149|531561994|FG009|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
147381719|NCT01072149|531561995|FG010|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
147381720|NCT01072149|531561996|FG011|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
147381721|NCT01072149|531561997|FG012|Washout Period 2 (14 Days)|Lack of Efficacy|1|||
147381722|NCT01072149|531561998|FG013|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
147381723|NCT01072149|531561999|FG014|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
147381724|NCT01072149|531562000|FG015|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
147381725|NCT01072149|531562001|FG016|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
147381726|NCT01072149|531562002|FG017|Washout Period 2 (14 Days)|Lack of Efficacy|0|||
147381727|NCT01072149|531561985|FG000|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
147381728|NCT01072149|531561986|FG001|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
147381729|NCT01072149|531561987|FG002|Treatment Period 3 (28 Days)|Withdrawal by Subject|1|||
147381730|NCT01072149|531561988|FG003|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
147381731|NCT01072149|531561989|FG004|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
147381732|NCT01072149|531561990|FG005|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
147381733|NCT01072149|531561991|FG006|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
147381734|NCT01072149|531561992|FG007|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
147381735|NCT01072149|531561993|FG008|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
147381736|NCT01072149|531561994|FG009|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
147381737|NCT01072149|531561995|FG010|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
147381738|NCT01072149|531561996|FG011|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
147381739|NCT01072149|531561997|FG012|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
147381740|NCT01072149|531561998|FG013|Treatment Period 3 (28 Days)|Withdrawal by Subject|1|||
147381741|NCT01072149|531561999|FG014|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
147381742|NCT01072149|531562000|FG015|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
147381743|NCT01072149|531562001|FG016|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
147381744|NCT01072149|531562002|FG017|Treatment Period 3 (28 Days)|Withdrawal by Subject|0|||
147381745|NCT01090739|531562008|FG000|Enrollment|Withdrawal by Subject|24|||
147381746|NCT01090739|531562008|FG000|Enrollment|Protocol Violation|14|||
147381747|NCT01090739|531562008|FG000|Enrollment|Lost to Follow-up|5|||
147381748|NCT01090739|531562008|FG000|Enrollment|Physician Decision|5|||
147381749|NCT01090739|531562008|FG000|Enrollment|Sponsor termination of site|4|||
147381750|NCT01090739|531562008|FG000|Enrollment|Study implant limit reached|2|||
147381751|NCT01090739|531562008|FG000|Enrollment|Adverse Event|1|||
147381752|NCT01090739|531562008|FG000|12 Month Follow-up|Withdrawal by Subject|2|||
147381753|NCT01090739|531562008|FG000|12 Month Follow-up|Lost to Follow-up|1|||
147381754|NCT01090739|531562008|FG000|12 Month Follow-up|Physician Decision|1|||
147381755|NCT01090739|531562008|FG000|12 Month Follow-up|Death|1|||
147381756|NCT01090739|531562008|FG000|24 Month Follow-up|Withdrawal by Subject|7|||
147381757|NCT01090739|531562008|FG000|24 Month Follow-up|Lost to Follow-up|1|||
147381758|NCT01090739|531562008|FG000|24 Month Follow-up|Death|1|||
147381759|NCT01090739|531562008|FG000|36 Month Follow-up|Withdrawal by Subject|6|||
147381760|NCT01090739|531562008|FG000|36 Month Follow-up|Visit still pending|17|||
147381761|NCT00988429|531562009|FG000|Overall Study|Adverse Event|9|||
147381762|NCT00988429|531562010|FG001|Overall Study|Adverse Event|21|||
147381763|NCT00988429|531562011|FG002|Overall Study|Adverse Event|45|||
147381764|NCT00988429|531562009|FG000|Overall Study|Lack of Efficacy|0|||
147381765|NCT00988429|531562010|FG001|Overall Study|Lack of Efficacy|0|||
147381766|NCT00988429|531562011|FG002|Overall Study|Lack of Efficacy|1|||
147381767|NCT00988429|531562009|FG000|Overall Study|Non-Compliance with Study Drug|5|||
147381768|NCT00988429|531562010|FG001|Overall Study|Non-Compliance with Study Drug|1|||
147381769|NCT00988429|531562011|FG002|Overall Study|Non-Compliance with Study Drug|3|||
147381770|NCT00988429|531562009|FG000|Overall Study|Physician Decision|1|||
147381771|NCT00988429|531562010|FG001|Overall Study|Physician Decision|0|||
147381772|NCT00988429|531562011|FG002|Overall Study|Physician Decision|3|||
147381773|NCT00988429|531562009|FG000|Overall Study|Pregnancy|2|||
147381774|NCT00988429|531562010|FG001|Overall Study|Pregnancy|1|||
147456280|NCT03529773|531831752|FG032|Overall Study|No longer meets eligibility criteria|0|||
147381775|NCT00988429|531562011|FG002|Overall Study|Pregnancy|0|||
147381776|NCT00988429|531562009|FG000|Overall Study|Protocol Violation|4|||
147381777|NCT00988429|531562010|FG001|Overall Study|Protocol Violation|3|||
147381778|NCT00988429|531562011|FG002|Overall Study|Protocol Violation|3|||
147381779|NCT00988429|531562009|FG000|Overall Study|Withdrawal by Subject|7|||
147381780|NCT00988429|531562010|FG001|Overall Study|Withdrawal by Subject|7|||
147381781|NCT00988429|531562011|FG002|Overall Study|Withdrawal by Subject|12|||
147381782|NCT00988429|531562009|FG000|Overall Study|Administrative Reasons|1|||
147613931|NCT03017612|532400988|FG000|Overall Study|Adverse Event|2|||
147613932|NCT04895982|532400989|FG000|Overall Study|Withdrawal by Subject|0|||
147613933|NCT04895982|532400990|FG001|Overall Study|Withdrawal by Subject|0|||
147613934|NCT04895982|532400991|FG002|Overall Study|Withdrawal by Subject|0|||
147613935|NCT04895982|532400992|FG003|Overall Study|Withdrawal by Subject|0|||
147613936|NCT04895982|532400993|FG004|Overall Study|Withdrawal by Subject|0|||
147613937|NCT04895982|532400994|FG005|Overall Study|Withdrawal by Subject|1|||
147613938|NCT04895982|532400995|FG006|Overall Study|Withdrawal by Subject|1|||
147613939|NCT04895982|532400996|FG007|Overall Study|Withdrawal by Subject|0|||
147613940|NCT04895982|532400997|FG008|Overall Study|Withdrawal by Subject|0|||
147613941|NCT04895982|532400998|FG009|Overall Study|Withdrawal by Subject|1|||
147613942|NCT04895982|532400999|FG010|Overall Study|Withdrawal by Subject|0|||
147613943|NCT04895982|532401000|FG011|Overall Study|Withdrawal by Subject|1|||
147613944|NCT04895982|532400989|FG000|Overall Study|Withdrawal by parent/guardian|2|||
147613945|NCT04895982|532400990|FG001|Overall Study|Withdrawal by parent/guardian|3|||
147613946|NCT04895982|532400991|FG002|Overall Study|Withdrawal by parent/guardian|3|||
147613947|NCT04895982|532400992|FG003|Overall Study|Withdrawal by parent/guardian|1|||
147613948|NCT04895982|532400993|FG004|Overall Study|Withdrawal by parent/guardian|3|||
147613949|NCT04895982|532400994|FG005|Overall Study|Withdrawal by parent/guardian|2|||
147613950|NCT04895982|532400995|FG006|Overall Study|Withdrawal by parent/guardian|1|||
147664893|NCT02810418|532597945|FG000|Arm B Dose Escalation|Adverse Event|0|||
147381783|NCT00988429|531562010|FG001|Overall Study|Administrative Reasons|2|||
147381784|NCT00988429|531562011|FG002|Overall Study|Administrative Reasons|1|||
147381785|NCT00988429|531562009|FG000|Overall Study|other reasons|8|||
147381786|NCT00988429|531562010|FG001|Overall Study|other reasons|8|||
147381787|NCT00988429|531562011|FG002|Overall Study|other reasons|1|||
147381788|NCT00441168|531562012|FG000|Treatment Period|Death|3|||
147381789|NCT00441168|531562013|FG001|Treatment Period|Death|0|||
147613951|NCT04895982|532400996|FG007|Overall Study|Withdrawal by parent/guardian|0|||
147613952|NCT04895982|532400997|FG008|Overall Study|Withdrawal by parent/guardian|3|||
147613953|NCT04895982|532400998|FG009|Overall Study|Withdrawal by parent/guardian|0|||
147613954|NCT04895982|532400999|FG010|Overall Study|Withdrawal by parent/guardian|0|||
147613955|NCT04895982|532401000|FG011|Overall Study|Withdrawal by parent/guardian|0|||
147613956|NCT04895982|532400989|FG000|Overall Study|Other|0|||
147613957|NCT04895982|532400990|FG001|Overall Study|Other|0|||
147613958|NCT04895982|532400991|FG002|Overall Study|Other|1|||
147613959|NCT04895982|532400992|FG003|Overall Study|Other|1|||
147613960|NCT04895982|532400993|FG004|Overall Study|Other|0|||
147381790|NCT00441168|531562012|FG000|Treatment Period|Adverse Event|1|||
147381791|NCT00441168|531562013|FG001|Treatment Period|Adverse Event|2|||
147381792|NCT00441168|531562012|FG000|Treatment Period|Progressive Disease|0|||
147381793|NCT00441168|531562013|FG001|Treatment Period|Progressive Disease|2|||
147381794|NCT00441168|531562012|FG000|Treatment Period|Protocol Violation|0|||
147381795|NCT00441168|531562013|FG001|Treatment Period|Protocol Violation|1|||
147381796|NCT00441168|531562012|FG000|Treatment Period|Lost to Follow-up|0|||
147381797|NCT00441168|531562013|FG001|Treatment Period|Lost to Follow-up|1|||
147381798|NCT00441168|531562012|FG000|Treatment Period|Withdrawal by Subject|3|||
147381799|NCT00441168|531562013|FG001|Treatment Period|Withdrawal by Subject|0|||
147381800|NCT00441168|531562012|FG000|Treatment Period|qualified for stem-cell transplantation|3|||
147381801|NCT00441168|531562013|FG001|Treatment Period|qualified for stem-cell transplantation|0|||
147381802|NCT00441168|531562012|FG000|Treatment Period|refractory disease|1|||
147381803|NCT00441168|531562013|FG001|Treatment Period|refractory disease|0|||
147381804|NCT00441168|531562012|FG000|Follow-up Period|Death|3|||
147381805|NCT00441168|531562013|FG001|Follow-up Period|Death|0|||
147381806|NCT00441168|531562012|FG000|Follow-up Period|Lost to Follow-up|5|||
147381807|NCT00441168|531562013|FG001|Follow-up Period|Lost to Follow-up|6|||
147381808|NCT00441168|531562012|FG000|Follow-up Period|Withdrawal by Subject|3|||
147613961|NCT04895982|532400994|FG005|Overall Study|Other|0|||
147613962|NCT04895982|532400995|FG006|Overall Study|Other|0|||
147613963|NCT04895982|532400996|FG007|Overall Study|Other|0|||
147613964|NCT04895982|532400997|FG008|Overall Study|Other|0|||
147613965|NCT04895982|532400998|FG009|Overall Study|Other|1|||
147613966|NCT04895982|532400999|FG010|Overall Study|Other|0|||
147613967|NCT04895982|532401000|FG011|Overall Study|Other|0|||
147664894|NCT02810418|532597946|FG001|Arm B Dose Escalation|Adverse Event|0|||
147381809|NCT00441168|531562013|FG001|Follow-up Period|Withdrawal by Subject|0|||
147381810|NCT00441168|531562012|FG000|Follow-up Period|Other|1|||
147613968|NCT04895982|532400989|FG000|Overall Study|Protocol Violation|0|||
147613969|NCT04895982|532400990|FG001|Overall Study|Protocol Violation|0|||
147613970|NCT04895982|532400991|FG002|Overall Study|Protocol Violation|1|||
147613971|NCT04895982|532400992|FG003|Overall Study|Protocol Violation|1|||
147613972|NCT04895982|532400993|FG004|Overall Study|Protocol Violation|1|||
147613973|NCT04895982|532400994|FG005|Overall Study|Protocol Violation|0|||
147664895|NCT02810418|532597947|FG002|Arm B Dose Escalation|Adverse Event|0|||
147381811|NCT00441168|531562013|FG001|Follow-up Period|Other|3|||
147381812|NCT02964234|531562014|FG000|Overall Study|Lost to Follow-up|22|||
147381813|NCT02964234|531562015|FG001|Overall Study|Lost to Follow-up|13|||
147381814|NCT01799993|531562017|FG000|Overall Study|"Didn't complete CRF page End of FU"|30|||
147381815|NCT01799993|531562018|FG001|Overall Study|"Didn't complete CRF page End of FU"|40|||
147381816|NCT01799993|531562017|FG000|Overall Study|Death|61|||
147381817|NCT01799993|531562018|FG001|Overall Study|Death|45|||
147381818|NCT01799993|531562017|FG000|Overall Study|Withdrawal by Subject|23|||
147381819|NCT01799993|531562018|FG001|Overall Study|Withdrawal by Subject|24|||
147381820|NCT01799993|531562017|FG000|Overall Study|Lost to Follow-up|5|||
147381821|NCT01799993|531562018|FG001|Overall Study|Lost to Follow-up|8|||
147381822|NCT01799993|531562017|FG000|Overall Study|Withdrawal by parent/guardian/LAR|5|||
147381823|NCT01799993|531562018|FG001|Overall Study|Withdrawal by parent/guardian/LAR|3|||
147381824|NCT01799993|531562017|FG000|Overall Study|Protocol driven decision point|0|||
147381825|NCT01799993|531562018|FG001|Overall Study|Protocol driven decision point|3|||
147381826|NCT01799993|531562017|FG000|Overall Study|Protocol Violation|1|||
147381827|NCT01799993|531562018|FG001|Overall Study|Protocol Violation|1|||
147381828|NCT01799993|531562017|FG000|Overall Study|Deterioration of general conditions|2|||
147381829|NCT01799993|531562018|FG001|Overall Study|Deterioration of general conditions|0|||
147381830|NCT01799993|531562017|FG000|Overall Study|Screen failure|0|||
147381831|NCT01799993|531562018|FG001|Overall Study|Screen failure|1|||
147381832|NCT01799993|531562017|FG000|Overall Study|Adverse Event|1|||
147381833|NCT01799993|531562018|FG001|Overall Study|Adverse Event|0|||
147381834|NCT01799993|531562017|FG000|Overall Study|Lack of Efficacy|1|||
147381835|NCT01799993|531562018|FG001|Overall Study|Lack of Efficacy|0|||
147381836|NCT01799993|531562017|FG000|Overall Study|Recovery|0|||
147381837|NCT01799993|531562018|FG001|Overall Study|Recovery|1|||
147381838|NCT01799993|531562017|FG000|Overall Study|Logistical difficulties|1|||
147381839|NCT01799993|531562018|FG001|Overall Study|Logistical difficulties|0|||
147381840|NCT01799993|531562017|FG000|Overall Study|Protocol deviation|1|||
147381841|NCT01799993|531562018|FG001|Overall Study|Protocol deviation|0|||
147381842|NCT01799993|531562017|FG000|Overall Study|Non-compliance with medical device|1|||
147381843|NCT01799993|531562018|FG001|Overall Study|Non-compliance with medical device|0|||
147381844|NCT01799993|531562017|FG000|Overall Study|Withdrawal by parent/guardian|0|||
147381845|NCT01799993|531562018|FG001|Overall Study|Withdrawal by parent/guardian|1|||
147381846|NCT01799993|531562017|FG000|Overall Study|Other|1|||
147381847|NCT01799993|531562018|FG001|Overall Study|Other|0|||
147381848|NCT01799993|531562017|FG000|Overall Study|Subject didn't return for follow-up|0|||
147381849|NCT01799993|531562018|FG001|Overall Study|Subject didn't return for follow-up|1|||
147381850|NCT04410445|531562019|FG000|Overall Study|Lost to Follow-up|3|||
147381851|NCT04410445|531562020|FG001|Overall Study|Lost to Follow-up|9|||
147381852|NCT04410445|531562019|FG000|Overall Study|Withdrawal by Subject|27|||
147381853|NCT04410445|531562020|FG001|Overall Study|Withdrawal by Subject|15|||
147381854|NCT01320683|531562021|FG000|Overall Study|Positive antibody response|1|||
147381855|NCT02291861|531562022|FG000|Overall Study|Adverse Event|2|||
147381856|NCT02291861|531562023|FG001|Overall Study|Adverse Event|4|||
147381857|NCT02291861|531562024|FG002|Overall Study|Adverse Event|1|||
147381858|NCT02291861|531562025|FG003|Overall Study|Adverse Event|2|||
147381859|NCT02291861|531562022|FG000|Overall Study|Death|0|||
147381860|NCT02291861|531562023|FG001|Overall Study|Death|0|||
147381861|NCT02291861|531562024|FG002|Overall Study|Death|1|||
147381862|NCT02291861|531562025|FG003|Overall Study|Death|1|||
147381863|NCT02291861|531562022|FG000|Overall Study|Protocol Violation|1|||
147381864|NCT02291861|531562023|FG001|Overall Study|Protocol Violation|0|||
147381865|NCT02291861|531562024|FG002|Overall Study|Protocol Violation|0|||
147381866|NCT02291861|531562025|FG003|Overall Study|Protocol Violation|1|||
147381867|NCT02291861|531562022|FG000|Overall Study|Withdrawal by Subject|1|||
147381868|NCT02291861|531562023|FG001|Overall Study|Withdrawal by Subject|2|||
147381869|NCT02291861|531562024|FG002|Overall Study|Withdrawal by Subject|1|||
147381870|NCT02291861|531562025|FG003|Overall Study|Withdrawal by Subject|4|||
147381871|NCT02291861|531562022|FG000|Overall Study|Noncompliance|1|||
147381872|NCT02291861|531562023|FG001|Overall Study|Noncompliance|1|||
147381873|NCT02291861|531562024|FG002|Overall Study|Noncompliance|2|||
147381874|NCT02291861|531562025|FG003|Overall Study|Noncompliance|1|||
147381875|NCT02291861|531562022|FG000|Overall Study|Lost to Follow-up|2|||
147381876|NCT02291861|531562023|FG001|Overall Study|Lost to Follow-up|1|||
147381877|NCT02291861|531562024|FG002|Overall Study|Lost to Follow-up|4|||
147381878|NCT02291861|531562025|FG003|Overall Study|Lost to Follow-up|0|||
147381879|NCT02291861|531562022|FG000|Overall Study|Other|0|||
147381880|NCT02291861|531562023|FG001|Overall Study|Other|0|||
147381881|NCT02291861|531562024|FG002|Overall Study|Other|0|||
147381882|NCT02291861|531562025|FG003|Overall Study|Other|1|||
147381883|NCT03547154|531562030|FG000|Overall Study|Disease Progression/Recurrence|6|||
147381884|NCT03547154|531562031|FG001|Overall Study|Disease Progression/Recurrence|14|||
147381885|NCT03547154|531562030|FG000|Overall Study|Adverse Event|26|||
147381886|NCT03547154|531562031|FG001|Overall Study|Adverse Event|31|||
147381887|NCT03547154|531562030|FG000|Overall Study|Protocol Violation|6|||
147381888|NCT03547154|531562031|FG001|Overall Study|Protocol Violation|1|||
147381889|NCT03547154|531562030|FG000|Overall Study|Physician Decision|4|||
147381890|NCT03547154|531562031|FG001|Overall Study|Physician Decision|3|||
147381891|NCT03547154|531562030|FG000|Overall Study|Insufficient Therapeutic Response|13|||
147613974|NCT04895982|532400995|FG006|Overall Study|Protocol Violation|0|||
147381892|NCT03547154|531562031|FG001|Overall Study|Insufficient Therapeutic Response|10|||
147381893|NCT03547154|531562030|FG000|Overall Study|Withdrawal by Subject|10|||
147381894|NCT03547154|531562031|FG001|Overall Study|Withdrawal by Subject|6|||
147381895|NCT03547154|531562030|FG000|Overall Study|Not Selected|0|||
147381896|NCT03547154|531562031|FG001|Overall Study|Not Selected|1|||
147381897|NCT03547154|531562030|FG000|Overall Study|Continued treatment beyond 12 mo.|58|||
147381898|NCT03547154|531562031|FG001|Overall Study|Continued treatment beyond 12 mo.|50|||
147381899|NCT00088166|531562036|FG000|Overall Study|Adverse Event|11|||
147381900|NCT00088166|531562037|FG001|Overall Study|Adverse Event|9|||
147381901|NCT00088166|531562036|FG000|Overall Study|Death|3|||
147381902|NCT00088166|531562037|FG001|Overall Study|Death|1|||
147381903|NCT00088166|531562036|FG000|Overall Study|Lost to Follow-up|0|||
147381904|NCT00088166|531562037|FG001|Overall Study|Lost to Follow-up|1|||
147381905|NCT00088166|531562036|FG000|Overall Study|Physician Decision|4|||
147381906|NCT00088166|531562037|FG001|Overall Study|Physician Decision|1|||
147381907|NCT00088166|531562036|FG000|Overall Study|Protocol Violation|1|||
147381908|NCT00088166|531562037|FG001|Overall Study|Protocol Violation|5|||
147381909|NCT00088166|531562036|FG000|Overall Study|Patient deterioration|29|||
147381910|NCT00088166|531562037|FG001|Overall Study|Patient deterioration|39|||
147381911|NCT00088166|531562036|FG000|Overall Study|Withdrawal by Subject|5|||
147381912|NCT00088166|531562037|FG001|Overall Study|Withdrawal by Subject|5|||
147381913|NCT02671266|531562038|FG000|Overall Study|Withdrawal by Subject|1|||
147613975|NCT04895982|532400996|FG007|Overall Study|Protocol Violation|1|||
147381914|NCT02671266|531562039|FG001|Overall Study|Withdrawal by Subject|1|||
147381915|NCT00666705|531562043|FG000|Overall Study|Withdrawal by Subject|1|||
147381916|NCT01029704|531562047|FG000|Overall Study|Adverse Event|0|||
147381917|NCT01029704|531562048|FG001|Overall Study|Adverse Event|0|||
147381918|NCT01029704|531562049|FG002|Overall Study|Adverse Event|0|||
147381919|NCT01029704|531562050|FG003|Overall Study|Adverse Event|0|||
147381920|NCT01029704|531562051|FG004|Overall Study|Adverse Event|0|||
147381921|NCT01029704|531562052|FG005|Overall Study|Adverse Event|0|||
147381922|NCT01029704|531562053|FG006|Overall Study|Adverse Event|1|||
147381923|NCT01029704|531562054|FG007|Overall Study|Adverse Event|1|||
147381924|NCT01029704|531562055|FG008|Overall Study|Adverse Event|0|||
147381925|NCT01029704|531562047|FG000|Overall Study|Withdrawal by Subject|0|||
147381926|NCT01029704|531562048|FG001|Overall Study|Withdrawal by Subject|0|||
147381927|NCT01029704|531562049|FG002|Overall Study|Withdrawal by Subject|0|||
147381928|NCT01029704|531562050|FG003|Overall Study|Withdrawal by Subject|0|||
147381929|NCT01029704|531562051|FG004|Overall Study|Withdrawal by Subject|2|||
147381930|NCT01029704|531562052|FG005|Overall Study|Withdrawal by Subject|1|||
147381931|NCT01029704|531562053|FG006|Overall Study|Withdrawal by Subject|1|||
147381932|NCT01029704|531562054|FG007|Overall Study|Withdrawal by Subject|1|||
147381933|NCT01029704|531562055|FG008|Overall Study|Withdrawal by Subject|0|||
147381934|NCT01029704|531562047|FG000|Overall Study|Lost to Follow-up|0|||
147613976|NCT04895982|532400997|FG008|Overall Study|Protocol Violation|0|||
147613977|NCT04895982|532400998|FG009|Overall Study|Protocol Violation|0|||
147613978|NCT04895982|532400999|FG010|Overall Study|Protocol Violation|0|||
147613979|NCT04895982|532401000|FG011|Overall Study|Protocol Violation|0|||
147613980|NCT04895982|532400989|FG000|Overall Study|Lost to Follow-up|0|||
147613981|NCT04895982|532400990|FG001|Overall Study|Lost to Follow-up|0|||
147613982|NCT04895982|532400991|FG002|Overall Study|Lost to Follow-up|1|||
147613983|NCT04895982|532400992|FG003|Overall Study|Lost to Follow-up|0|||
147613984|NCT04895982|532400993|FG004|Overall Study|Lost to Follow-up|0|||
147613985|NCT04895982|532400994|FG005|Overall Study|Lost to Follow-up|1|||
147613986|NCT04895982|532400995|FG006|Overall Study|Lost to Follow-up|0|||
147613987|NCT04895982|532400996|FG007|Overall Study|Lost to Follow-up|0|||
147613988|NCT04895982|532400997|FG008|Overall Study|Lost to Follow-up|1|||
147613989|NCT04895982|532400998|FG009|Overall Study|Lost to Follow-up|0|||
147613990|NCT04895982|532400999|FG010|Overall Study|Lost to Follow-up|0|||
147613991|NCT04895982|532401000|FG011|Overall Study|Lost to Follow-up|0|||
147613992|NCT04895982|532400989|FG000|Overall Study|Refused further study procedures|0|||
147613993|NCT04895982|532400990|FG001|Overall Study|Refused further study procedures|0|||
147613994|NCT04895982|532400991|FG002|Overall Study|Refused further study procedures|1|||
147613995|NCT04895982|532400992|FG003|Overall Study|Refused further study procedures|0|||
147613996|NCT04895982|532400993|FG004|Overall Study|Refused further study procedures|0|||
147613997|NCT04895982|532400994|FG005|Overall Study|Refused further study procedures|0|||
147613998|NCT04895982|532400995|FG006|Overall Study|Refused further study procedures|0|||
147613999|NCT04895982|532400996|FG007|Overall Study|Refused further study procedures|0|||
147381935|NCT01029704|531562048|FG001|Overall Study|Lost to Follow-up|0|||
147381936|NCT01029704|531562049|FG002|Overall Study|Lost to Follow-up|0|||
147381937|NCT01029704|531562050|FG003|Overall Study|Lost to Follow-up|0|||
147381938|NCT01029704|531562051|FG004|Overall Study|Lost to Follow-up|0|||
147381939|NCT01029704|531562052|FG005|Overall Study|Lost to Follow-up|0|||
147381940|NCT01029704|531562053|FG006|Overall Study|Lost to Follow-up|1|||
147381941|NCT01029704|531562054|FG007|Overall Study|Lost to Follow-up|1|||
147381942|NCT01029704|531562055|FG008|Overall Study|Lost to Follow-up|1|||
147381943|NCT01029704|531562047|FG000|Overall Study|Lack of Efficacy|0|||
147381944|NCT01029704|531562048|FG001|Overall Study|Lack of Efficacy|0|||
147381945|NCT01029704|531562049|FG002|Overall Study|Lack of Efficacy|0|||
147381946|NCT01029704|531562050|FG003|Overall Study|Lack of Efficacy|0|||
147381947|NCT01029704|531562051|FG004|Overall Study|Lack of Efficacy|2|||
147381948|NCT01029704|531562052|FG005|Overall Study|Lack of Efficacy|3|||
147381949|NCT01029704|531562053|FG006|Overall Study|Lack of Efficacy|1|||
147381950|NCT01029704|531562054|FG007|Overall Study|Lack of Efficacy|2|||
147381951|NCT01029704|531562055|FG008|Overall Study|Lack of Efficacy|0|||
147381952|NCT01029704|531562047|FG000|Overall Study|Withdrawn due to major protocol violation|0|||
147381953|NCT01029704|531562048|FG001|Overall Study|Withdrawn due to major protocol violation|0|||
147381954|NCT01029704|531562049|FG002|Overall Study|Withdrawn due to major protocol violation|0|||
147381955|NCT01029704|531562050|FG003|Overall Study|Withdrawn due to major protocol violation|0|||
147381956|NCT01029704|531562051|FG004|Overall Study|Withdrawn due to major protocol violation|1|||
147381957|NCT01029704|531562052|FG005|Overall Study|Withdrawn due to major protocol violation|0|||
147381958|NCT01029704|531562053|FG006|Overall Study|Withdrawn due to major protocol violation|0|||
147381959|NCT01029704|531562054|FG007|Overall Study|Withdrawn due to major protocol violation|1|||
147381960|NCT01029704|531562055|FG008|Overall Study|Withdrawn due to major protocol violation|0|||
147381961|NCT03845517|531562056|FG000|Treatment Period (52 Weeks)|Adverse Event|12|||
147381962|NCT03845517|531562057|FG001|Treatment Period (52 Weeks)|Adverse Event|7|||
147381963|NCT03845517|531562058|FG002|Treatment Period (52 Weeks)|Adverse Event|10|||
147381964|NCT03845517|531562059|FG003|Treatment Period (52 Weeks)|Adverse Event|17|||
147381965|NCT03845517|531562056|FG000|Treatment Period (52 Weeks)|Death|0|||
147381966|NCT03845517|531562057|FG001|Treatment Period (52 Weeks)|Death|0|||
147381967|NCT03845517|531562058|FG002|Treatment Period (52 Weeks)|Death|1|||
147381968|NCT03845517|531562059|FG003|Treatment Period (52 Weeks)|Death|0|||
147381969|NCT03845517|531562056|FG000|Treatment Period (52 Weeks)|Lack of Efficacy|8|||
147381970|NCT03845517|531562057|FG001|Treatment Period (52 Weeks)|Lack of Efficacy|1|||
147381971|NCT03845517|531562058|FG002|Treatment Period (52 Weeks)|Lack of Efficacy|3|||
147381972|NCT03845517|531562059|FG003|Treatment Period (52 Weeks)|Lack of Efficacy|4|||
147456281|NCT03529773|531831753|FG033|Overall Study|No longer meets eligibility criteria|0|||
147456282|NCT03529773|531831754|FG034|Overall Study|No longer meets eligibility criteria|0|||
147456283|NCT03529773|531831755|FG035|Overall Study|No longer meets eligibility criteria|0|||
147456284|NCT03529773|531831756|FG036|Overall Study|No longer meets eligibility criteria|0|||
147456285|NCT03529773|531831757|FG037|Overall Study|No longer meets eligibility criteria|0|||
147456286|NCT03529773|531831758|FG038|Overall Study|No longer meets eligibility criteria|1|||
147456287|NCT03529773|531831759|FG039|Overall Study|No longer meets eligibility criteria|0|||
147456288|NCT03529773|531831720|FG000|Overall Study|Other|0|||
147456289|NCT03529773|531831721|FG001|Overall Study|Other|0|||
147456290|NCT03529773|531831722|FG002|Overall Study|Other|0|||
147456291|NCT03529773|531831723|FG003|Overall Study|Other|0|||
147456292|NCT03529773|531831724|FG004|Overall Study|Other|0|||
147456293|NCT03529773|531831725|FG005|Overall Study|Other|0|||
147456294|NCT03529773|531831726|FG006|Overall Study|Other|0|||
147456295|NCT03529773|531831727|FG007|Overall Study|Other|0|||
147456296|NCT03529773|531831728|FG008|Overall Study|Other|0|||
147456297|NCT03529773|531831729|FG009|Overall Study|Other|0|||
147456298|NCT03529773|531831730|FG010|Overall Study|Other|0|||
147456299|NCT03529773|531831731|FG011|Overall Study|Other|0|||
147456300|NCT03529773|531831732|FG012|Overall Study|Other|1|||
147456301|NCT03529773|531831733|FG013|Overall Study|Other|0|||
147456302|NCT03529773|531831734|FG014|Overall Study|Other|2|||
147456303|NCT03529773|531831735|FG015|Overall Study|Other|0|||
147456304|NCT03529773|531831736|FG016|Overall Study|Other|0|||
147456305|NCT03529773|531831737|FG017|Overall Study|Other|3|||
147456306|NCT03529773|531831738|FG018|Overall Study|Other|0|||
147456307|NCT03529773|531831739|FG019|Overall Study|Other|0|||
147456308|NCT03529773|531831740|FG020|Overall Study|Other|1|||
147456309|NCT03529773|531831741|FG021|Overall Study|Other|0|||
147456310|NCT03529773|531831742|FG022|Overall Study|Other|1|||
147456311|NCT03529773|531831743|FG023|Overall Study|Other|0|||
147456312|NCT03529773|531831744|FG024|Overall Study|Other|3|||
147456313|NCT03529773|531831745|FG025|Overall Study|Other|2|||
147456314|NCT03529773|531831746|FG026|Overall Study|Other|2|||
147456315|NCT03529773|531831747|FG027|Overall Study|Other|0|||
147614000|NCT04895982|532400997|FG008|Overall Study|Refused further study procedures|0|||
147614001|NCT04895982|532400998|FG009|Overall Study|Refused further study procedures|0|||
147381973|NCT03845517|531562056|FG000|Treatment Period (52 Weeks)|Lost to Follow-up|2|||
147381974|NCT03845517|531562057|FG001|Treatment Period (52 Weeks)|Lost to Follow-up|0|||
147456316|NCT03529773|531831748|FG028|Overall Study|Other|0|||
147456317|NCT03529773|531831749|FG029|Overall Study|Other|0|||
147456318|NCT03529773|531831750|FG030|Overall Study|Other|0|||
147456319|NCT03529773|531831751|FG031|Overall Study|Other|0|||
147456320|NCT03529773|531831752|FG032|Overall Study|Other|0|||
147456321|NCT03529773|531831753|FG033|Overall Study|Other|0|||
147456322|NCT03529773|531831754|FG034|Overall Study|Other|1|||
147381975|NCT03845517|531562058|FG002|Treatment Period (52 Weeks)|Lost to Follow-up|1|||
147381976|NCT03845517|531562059|FG003|Treatment Period (52 Weeks)|Lost to Follow-up|0|||
147456323|NCT03529773|531831755|FG035|Overall Study|Other|1|||
147456324|NCT03529773|531831756|FG036|Overall Study|Other|0|||
147456325|NCT03529773|531831757|FG037|Overall Study|Other|0|||
147381977|NCT03845517|531562056|FG000|Treatment Period (52 Weeks)|Non-compliance with study drug|1|||
147381978|NCT03845517|531562057|FG001|Treatment Period (52 Weeks)|Non-compliance with study drug|0|||
147381979|NCT03845517|531562058|FG002|Treatment Period (52 Weeks)|Non-compliance with study drug|0|||
147381980|NCT03845517|531562059|FG003|Treatment Period (52 Weeks)|Non-compliance with study drug|0|||
147381981|NCT03845517|531562056|FG000|Treatment Period (52 Weeks)|Physician's decision|0|||
147381982|NCT03845517|531562057|FG001|Treatment Period (52 Weeks)|Physician's decision|0|||
147381983|NCT03845517|531562058|FG002|Treatment Period (52 Weeks)|Physician's decision|1|||
147381984|NCT03845517|531562059|FG003|Treatment Period (52 Weeks)|Physician's decision|0|||
147381985|NCT03845517|531562056|FG000|Treatment Period (52 Weeks)|Site Terminated by Sponsor|2|||
147381986|NCT03845517|531562057|FG001|Treatment Period (52 Weeks)|Site Terminated by Sponsor|0|||
147381987|NCT03845517|531562058|FG002|Treatment Period (52 Weeks)|Site Terminated by Sponsor|0|||
147381988|NCT03845517|531562059|FG003|Treatment Period (52 Weeks)|Site Terminated by Sponsor|0|||
147381989|NCT03845517|531562056|FG000|Treatment Period (52 Weeks)|Other|2|||
147381990|NCT03845517|531562057|FG001|Treatment Period (52 Weeks)|Other|0|||
147381991|NCT03845517|531562058|FG002|Treatment Period (52 Weeks)|Other|0|||
147381992|NCT03845517|531562059|FG003|Treatment Period (52 Weeks)|Other|0|||
147381993|NCT03845517|531562056|FG000|Treatment Period (52 Weeks)|Pregnancy|1|||
147381994|NCT03845517|531562057|FG001|Treatment Period (52 Weeks)|Pregnancy|0|||
147381995|NCT03845517|531562058|FG002|Treatment Period (52 Weeks)|Pregnancy|0|||
147381996|NCT03845517|531562059|FG003|Treatment Period (52 Weeks)|Pregnancy|1|||
147381997|NCT03845517|531562056|FG000|Treatment Period (52 Weeks)|Protocol Violation|0|||
147381998|NCT03845517|531562057|FG001|Treatment Period (52 Weeks)|Protocol Violation|0|||
147381999|NCT03845517|531562058|FG002|Treatment Period (52 Weeks)|Protocol Violation|1|||
147382000|NCT03845517|531562059|FG003|Treatment Period (52 Weeks)|Protocol Violation|1|||
147382001|NCT03845517|531562056|FG000|Treatment Period (52 Weeks)|Withdrawal by Subject|4|||
147456326|NCT03529773|531831758|FG038|Overall Study|Other|0|||
147456327|NCT03529773|531831759|FG039|Overall Study|Other|0|||
147456328|NCT03529773|531831720|FG000|Overall Study|Physician Decision|0|||
147456329|NCT03529773|531831721|FG001|Overall Study|Physician Decision|0|||
147456330|NCT03529773|531831722|FG002|Overall Study|Physician Decision|0|||
147456331|NCT03529773|531831723|FG003|Overall Study|Physician Decision|0|||
147456332|NCT03529773|531831724|FG004|Overall Study|Physician Decision|0|||
147456333|NCT03529773|531831725|FG005|Overall Study|Physician Decision|0|||
147456334|NCT03529773|531831726|FG006|Overall Study|Physician Decision|0|||
147456335|NCT03529773|531831727|FG007|Overall Study|Physician Decision|0|||
147456336|NCT03529773|531831728|FG008|Overall Study|Physician Decision|0|||
147456337|NCT03529773|531831729|FG009|Overall Study|Physician Decision|0|||
147456338|NCT03529773|531831730|FG010|Overall Study|Physician Decision|0|||
147456339|NCT03529773|531831731|FG011|Overall Study|Physician Decision|0|||
147456340|NCT03529773|531831732|FG012|Overall Study|Physician Decision|0|||
147456341|NCT03529773|531831733|FG013|Overall Study|Physician Decision|0|||
147456342|NCT03529773|531831734|FG014|Overall Study|Physician Decision|0|||
147456343|NCT03529773|531831735|FG015|Overall Study|Physician Decision|0|||
147456344|NCT03529773|531831736|FG016|Overall Study|Physician Decision|0|||
147456345|NCT03529773|531831737|FG017|Overall Study|Physician Decision|0|||
147456346|NCT03529773|531831738|FG018|Overall Study|Physician Decision|0|||
147456347|NCT03529773|531831739|FG019|Overall Study|Physician Decision|1|||
147456348|NCT03529773|531831740|FG020|Overall Study|Physician Decision|1|||
147456349|NCT03529773|531831741|FG021|Overall Study|Physician Decision|0|||
147456350|NCT03529773|531831742|FG022|Overall Study|Physician Decision|0|||
147456351|NCT03529773|531831743|FG023|Overall Study|Physician Decision|0|||
147456352|NCT03529773|531831744|FG024|Overall Study|Physician Decision|0|||
147456353|NCT03529773|531831745|FG025|Overall Study|Physician Decision|0|||
147456354|NCT03529773|531831746|FG026|Overall Study|Physician Decision|0|||
147456355|NCT03529773|531831747|FG027|Overall Study|Physician Decision|0|||
147456356|NCT03529773|531831748|FG028|Overall Study|Physician Decision|0|||
147456357|NCT03529773|531831749|FG029|Overall Study|Physician Decision|0|||
147456358|NCT03529773|531831750|FG030|Overall Study|Physician Decision|0|||
147456359|NCT03529773|531831751|FG031|Overall Study|Physician Decision|0|||
147382002|NCT03845517|531562057|FG001|Treatment Period (52 Weeks)|Withdrawal by Subject|6|||
147382003|NCT03845517|531562058|FG002|Treatment Period (52 Weeks)|Withdrawal by Subject|6|||
147382004|NCT03845517|531562059|FG003|Treatment Period (52 Weeks)|Withdrawal by Subject|5|||
147382005|NCT03845517|531562056|FG000|Follow-up Period (4 Weeks)|Adverse Event|4|||
147382006|NCT03845517|531562057|FG001|Follow-up Period (4 Weeks)|Adverse Event|2|||
147382007|NCT03845517|531562058|FG002|Follow-up Period (4 Weeks)|Adverse Event|0|||
147382008|NCT03845517|531562059|FG003|Follow-up Period (4 Weeks)|Adverse Event|2|||
147456360|NCT03529773|531831752|FG032|Overall Study|Physician Decision|0|||
147456361|NCT03529773|531831753|FG033|Overall Study|Physician Decision|0|||
147456362|NCT03529773|531831754|FG034|Overall Study|Physician Decision|0|||
147456363|NCT03529773|531831755|FG035|Overall Study|Physician Decision|0|||
147456364|NCT03529773|531831756|FG036|Overall Study|Physician Decision|0|||
147456365|NCT03529773|531831757|FG037|Overall Study|Physician Decision|0|||
147456366|NCT03529773|531831758|FG038|Overall Study|Physician Decision|0|||
147456367|NCT03529773|531831759|FG039|Overall Study|Physician Decision|0|||
147456368|NCT03529773|531831720|FG000|Overall Study|Protocol Violation|0|||
147456369|NCT03529773|531831721|FG001|Overall Study|Protocol Violation|0|||
147614002|NCT04895982|532400999|FG010|Overall Study|Refused further study procedures|0|||
147614003|NCT04895982|532401000|FG011|Overall Study|Refused further study procedures|0|||
147614004|NCT02498613|532403154|FG000|Overall Study|Tx Initiation Criteria Not Met|2|||
147614005|NCT02498613|532403155|FG001|Overall Study|Tx Initiation Criteria Not Met|1|||
147614006|NCT02498613|532403156|FG002|Overall Study|Tx Initiation Criteria Not Met|5|||
147614007|NCT02498613|532403157|FG003|Overall Study|Tx Initiation Criteria Not Met|1|||
147614008|NCT02498613|532403154|FG000|Overall Study|Withdrawal by Subject|3|||
147614009|NCT02498613|532403155|FG001|Overall Study|Withdrawal by Subject|1|||
147614010|NCT02498613|532403156|FG002|Overall Study|Withdrawal by Subject|0|||
147614011|NCT02498613|532403157|FG003|Overall Study|Withdrawal by Subject|0|||
147614012|NCT05109611|532403159|FG000|Overall Study|Adverse Event|13|||
147614013|NCT05109611|532403160|FG001|Overall Study|Adverse Event|10|||
147614014|NCT05109611|532403159|FG000|Overall Study|Withdrawal by Subject|1|||
147614015|NCT05109611|532403160|FG001|Overall Study|Withdrawal by Subject|0|||
147614016|NCT05109611|532403159|FG000|Overall Study|Lost to Follow-up|1|||
147614017|NCT05109611|532403160|FG001|Overall Study|Lost to Follow-up|2|||
147614018|NCT05109611|532403159|FG000|Overall Study|Protocol Violation|0|||
147614019|NCT05109611|532403160|FG001|Overall Study|Protocol Violation|4|||
147614020|NCT05109611|532403159|FG000|Overall Study|Information unavailable|1|||
147614021|NCT05109611|532403160|FG001|Overall Study|Information unavailable|1|||
147614022|NCT00233948|532403163|FG000|Overall Study|Adverse Event|1|||
147614023|NCT00233948|532403164|FG001|Overall Study|Adverse Event|0|||
147614024|NCT00233948|532403165|FG002|Overall Study|Adverse Event|0|||
147614025|NCT00233948|532403166|FG003|Overall Study|Adverse Event|0|||
147614026|NCT00233948|532403167|FG004|Overall Study|Adverse Event|0|||
147614027|NCT00233948|532403168|FG005|Overall Study|Adverse Event|0|||
147614028|NCT03573830|532403169|FG000|Overall Study|Dropped without completing treatment|0|||
147614029|NCT03573830|532403170|FG001|Overall Study|Dropped without completing treatment|7|||
147614030|NCT03573830|532403169|FG000|Overall Study|Lost to Follow-up|4|||
147614031|NCT03573830|532403170|FG001|Overall Study|Lost to Follow-up|0|||
147614032|NCT03284723|532403171|FG000|Overall Study|Death|0|||
147614033|NCT03284723|532403172|FG001|Overall Study|Death|0|||
147614034|NCT03284723|532403173|FG002|Overall Study|Death|0|||
147614035|NCT03284723|532403174|FG003|Overall Study|Death|1|||
147614036|NCT03284723|532403175|FG004|Overall Study|Death|0|||
147614037|NCT03284723|532403176|FG005|Overall Study|Death|0|||
147614038|NCT03284723|532403177|FG006|Overall Study|Death|1|||
147614039|NCT03284723|532403178|FG007|Overall Study|Death|0|||
147614040|NCT03284723|532403179|FG008|Overall Study|Death|0|||
147614041|NCT03284723|532403180|FG009|Overall Study|Death|2|||
147614042|NCT03284723|532403181|FG010|Overall Study|Death|1|||
147614043|NCT03284723|532403182|FG011|Overall Study|Death|0|||
147614044|NCT03284723|532403171|FG000|Overall Study|Lost to Follow-up|0|||
147614045|NCT03284723|532403172|FG001|Overall Study|Lost to Follow-up|0|||
147614046|NCT03284723|532403173|FG002|Overall Study|Lost to Follow-up|0|||
147614047|NCT03284723|532403174|FG003|Overall Study|Lost to Follow-up|0|||
147614048|NCT03284723|532403175|FG004|Overall Study|Lost to Follow-up|0|||
147614049|NCT03284723|532403176|FG005|Overall Study|Lost to Follow-up|2|||
147614050|NCT03284723|532403177|FG006|Overall Study|Lost to Follow-up|1|||
147614051|NCT03284723|532403178|FG007|Overall Study|Lost to Follow-up|0|||
147614052|NCT03284723|532403179|FG008|Overall Study|Lost to Follow-up|0|||
147382009|NCT03845517|531562056|FG000|Follow-up Period (4 Weeks)|Death|0|||
147382010|NCT03845517|531562057|FG001|Follow-up Period (4 Weeks)|Death|0|||
147382011|NCT03845517|531562058|FG002|Follow-up Period (4 Weeks)|Death|1|||
147382012|NCT03845517|531562059|FG003|Follow-up Period (4 Weeks)|Death|1|||
147382013|NCT03845517|531562056|FG000|Follow-up Period (4 Weeks)|Lost to Follow-up|2|||
147382014|NCT03845517|531562057|FG001|Follow-up Period (4 Weeks)|Lost to Follow-up|1|||
147382015|NCT03845517|531562058|FG002|Follow-up Period (4 Weeks)|Lost to Follow-up|2|||
147382016|NCT03845517|531562059|FG003|Follow-up Period (4 Weeks)|Lost to Follow-up|0|||
147382017|NCT03845517|531562056|FG000|Follow-up Period (4 Weeks)|Physician's decision|0|||
147382018|NCT03845517|531562057|FG001|Follow-up Period (4 Weeks)|Physician's decision|0|||
147382019|NCT03845517|531562058|FG002|Follow-up Period (4 Weeks)|Physician's decision|1|||
147382020|NCT03845517|531562059|FG003|Follow-up Period (4 Weeks)|Physician's decision|1|||
147382021|NCT03845517|531562056|FG000|Follow-up Period (4 Weeks)|Study terminated by sponsor|0|||
147456370|NCT03529773|531831722|FG002|Overall Study|Protocol Violation|0|||
147456371|NCT03529773|531831723|FG003|Overall Study|Protocol Violation|0|||
147614053|NCT03284723|532403180|FG009|Overall Study|Lost to Follow-up|2|||
147614054|NCT03284723|532403181|FG010|Overall Study|Lost to Follow-up|0|||
147614055|NCT03284723|532403182|FG011|Overall Study|Lost to Follow-up|0|||
147614056|NCT03284723|532403171|FG000|Overall Study|Study Terminated By Sponsor|0|||
147614057|NCT03284723|532403172|FG001|Overall Study|Study Terminated By Sponsor|0|||
147614058|NCT03284723|532403173|FG002|Overall Study|Study Terminated By Sponsor|0|||
147614059|NCT03284723|532403174|FG003|Overall Study|Study Terminated By Sponsor|0|||
147614060|NCT03284723|532403175|FG004|Overall Study|Study Terminated By Sponsor|1|||
147614061|NCT03284723|532403176|FG005|Overall Study|Study Terminated By Sponsor|0|||
147614062|NCT03284723|532403177|FG006|Overall Study|Study Terminated By Sponsor|0|||
147614063|NCT03284723|532403178|FG007|Overall Study|Study Terminated By Sponsor|0|||
147614064|NCT03284723|532403179|FG008|Overall Study|Study Terminated By Sponsor|1|||
147382022|NCT03845517|531562057|FG001|Follow-up Period (4 Weeks)|Study terminated by sponsor|0|||
147382023|NCT03845517|531562058|FG002|Follow-up Period (4 Weeks)|Study terminated by sponsor|0|||
147382024|NCT03845517|531562059|FG003|Follow-up Period (4 Weeks)|Study terminated by sponsor|1|||
147382025|NCT03845517|531562056|FG000|Follow-up Period (4 Weeks)|Other|1|||
147382026|NCT03845517|531562057|FG001|Follow-up Period (4 Weeks)|Other|0|||
147382027|NCT03845517|531562058|FG002|Follow-up Period (4 Weeks)|Other|1|||
147382028|NCT03845517|531562059|FG003|Follow-up Period (4 Weeks)|Other|0|||
147382029|NCT03845517|531562056|FG000|Follow-up Period (4 Weeks)|Pregnancy|1|||
147382030|NCT03845517|531562057|FG001|Follow-up Period (4 Weeks)|Pregnancy|0|||
147382031|NCT03845517|531562058|FG002|Follow-up Period (4 Weeks)|Pregnancy|0|||
147382032|NCT03845517|531562059|FG003|Follow-up Period (4 Weeks)|Pregnancy|0|||
147382033|NCT03845517|531562056|FG000|Follow-up Period (4 Weeks)|Protocol Violation|0|||
147382034|NCT03845517|531562057|FG001|Follow-up Period (4 Weeks)|Protocol Violation|0|||
147382035|NCT03845517|531562058|FG002|Follow-up Period (4 Weeks)|Protocol Violation|0|||
147382036|NCT03845517|531562059|FG003|Follow-up Period (4 Weeks)|Protocol Violation|1|||
147382037|NCT03845517|531562056|FG000|Follow-up Period (4 Weeks)|Withdrawal by Subject|3|||
147382038|NCT03845517|531562057|FG001|Follow-up Period (4 Weeks)|Withdrawal by Subject|5|||
147382039|NCT03845517|531562058|FG002|Follow-up Period (4 Weeks)|Withdrawal by Subject|7|||
147382040|NCT03845517|531562059|FG003|Follow-up Period (4 Weeks)|Withdrawal by Subject|1|||
147382041|NCT01109979|531562060|FG000|Overall Study|Physician Decision|2|||
147382042|NCT01109979|531562061|FG001|Overall Study|Physician Decision|0|||
147382043|NCT01109979|531562060|FG000|Overall Study|Withdrawal by Subject|0|||
147382044|NCT01109979|531562061|FG001|Overall Study|Withdrawal by Subject|1|||
147382045|NCT00807599|531562065|FG000|Overall Study|Not treated on protocol study|0|||
147382046|NCT00807599|531562066|FG001|Overall Study|Not treated on protocol study|0|||
147382047|NCT00807599|531562067|FG002|Overall Study|Not treated on protocol study|2|||
147382048|NCT00807599|531562065|FG000|Overall Study|Adverse Event|0|||
147382049|NCT00807599|531562066|FG001|Overall Study|Adverse Event|0|||
147382050|NCT00807599|531562067|FG002|Overall Study|Adverse Event|5|||
147382051|NCT00807599|531562065|FG000|Overall Study|Inadequate response to induction|0|||
147382052|NCT00807599|531562066|FG001|Overall Study|Inadequate response to induction|0|||
147382053|NCT00807599|531562067|FG002|Overall Study|Inadequate response to induction|9|||
147382054|NCT00807599|531562065|FG000|Overall Study|Withdrawal by Subject|0|||
147382055|NCT00807599|531562066|FG001|Overall Study|Withdrawal by Subject|0|||
147382056|NCT00807599|531562067|FG002|Overall Study|Withdrawal by Subject|1|||
147382057|NCT01328756|531562068|FG000|Overall Study|Protocol Violation|4|||
147382058|NCT01328756|531562068|FG000|Overall Study|Adverse Event|39|||
147382059|NCT01328756|531562068|FG000|Overall Study|Lack of Efficacy|5|||
147382060|NCT01328756|531562068|FG000|Overall Study|Withdrawal by Subject|41|||
147382061|NCT01328756|531562068|FG000|Overall Study|Lost to Follow-up|5|||
147382062|NCT01328756|531562068|FG000|Overall Study|Other|29|||
147382063|NCT01262456|531562069|FG000|3-Month Double-Blind Period|Withdrawal by Subject|6|||
147382064|NCT01262456|531562070|FG001|3-Month Double-Blind Period|Withdrawal by Subject|8|||
147382065|NCT01262456|531562071|FG002|3-Month Double-Blind Period|Withdrawal by Subject|9|||
147382066|NCT01262456|531562069|FG000|3-Month Double-Blind Period|Lost to Follow-up|4|||
147382067|NCT01262456|531562070|FG001|3-Month Double-Blind Period|Lost to Follow-up|5|||
147382068|NCT01262456|531562071|FG002|3-Month Double-Blind Period|Lost to Follow-up|3|||
147382069|NCT01262456|531562069|FG000|3-Month Double-Blind Period|Adverse Event|6|||
147382070|NCT01262456|531562070|FG001|3-Month Double-Blind Period|Adverse Event|4|||
147382071|NCT01262456|531562071|FG002|3-Month Double-Blind Period|Adverse Event|8|||
147382072|NCT01262456|531562069|FG000|3-Month Double-Blind Period|Protocol Violation|3|||
147382073|NCT01262456|531562070|FG001|3-Month Double-Blind Period|Protocol Violation|6|||
147382074|NCT01262456|531562071|FG002|3-Month Double-Blind Period|Protocol Violation|6|||
147382075|NCT01262456|531562069|FG000|1-Month Open-Label Extension Period|Withdrawal by Subject|1|||
147614065|NCT03284723|532403180|FG009|Overall Study|Study Terminated By Sponsor|1|||
147614066|NCT03284723|532403181|FG010|Overall Study|Study Terminated By Sponsor|1|||
147614067|NCT03284723|532403182|FG011|Overall Study|Study Terminated By Sponsor|1|||
147614068|NCT03284723|532403171|FG000|Overall Study|Withdrawal by Subject|0|||
147382076|NCT01262456|531562070|FG001|1-Month Open-Label Extension Period|Withdrawal by Subject|1|||
147382077|NCT01262456|531562071|FG002|1-Month Open-Label Extension Period|Withdrawal by Subject|1|||
147382078|NCT01262456|531562069|FG000|1-Month Open-Label Extension Period|Lost to Follow-up|0|||
147382079|NCT01262456|531562070|FG001|1-Month Open-Label Extension Period|Lost to Follow-up|1|||
147382080|NCT01262456|531562071|FG002|1-Month Open-Label Extension Period|Lost to Follow-up|0|||
147382081|NCT01262456|531562069|FG000|1-Month Open-Label Extension Period|Adverse Event|2|||
147382082|NCT01262456|531562070|FG001|1-Month Open-Label Extension Period|Adverse Event|0|||
147382083|NCT01262456|531562071|FG002|1-Month Open-Label Extension Period|Adverse Event|2|||
147382084|NCT01262456|531562069|FG000|1-Month Open-Label Extension Period|Protocol Violation|1|||
147382085|NCT01262456|531562070|FG001|1-Month Open-Label Extension Period|Protocol Violation|0|||
147382086|NCT01262456|531562071|FG002|1-Month Open-Label Extension Period|Protocol Violation|2|||
147382087|NCT01262456|531562069|FG000|1-Month Open-Label Extension Period|Other Reason|0|||
147614069|NCT03284723|532403172|FG001|Overall Study|Withdrawal by Subject|0|||
147614070|NCT03284723|532403173|FG002|Overall Study|Withdrawal by Subject|0|||
147614071|NCT03284723|532403174|FG003|Overall Study|Withdrawal by Subject|0|||
147614072|NCT03284723|532403175|FG004|Overall Study|Withdrawal by Subject|5|||
147614073|NCT03284723|532403176|FG005|Overall Study|Withdrawal by Subject|3|||
147614074|NCT03284723|532403177|FG006|Overall Study|Withdrawal by Subject|1|||
147614075|NCT03284723|532403178|FG007|Overall Study|Withdrawal by Subject|0|||
147614076|NCT03284723|532403179|FG008|Overall Study|Withdrawal by Subject|6|||
147614077|NCT03284723|532403180|FG009|Overall Study|Withdrawal by Subject|0|||
147614078|NCT03284723|532403181|FG010|Overall Study|Withdrawal by Subject|3|||
147614079|NCT03284723|532403182|FG011|Overall Study|Withdrawal by Subject|1|||
147614080|NCT03284723|532403171|FG000|Overall Study|Other|1|||
147614081|NCT03284723|532403172|FG001|Overall Study|Other|0|||
147614082|NCT03284723|532403173|FG002|Overall Study|Other|1|||
147614083|NCT03284723|532403174|FG003|Overall Study|Other|0|||
147614084|NCT03284723|532403175|FG004|Overall Study|Other|1|||
147614085|NCT03284723|532403176|FG005|Overall Study|Other|0|||
147614086|NCT03284723|532403177|FG006|Overall Study|Other|0|||
147614087|NCT03284723|532403178|FG007|Overall Study|Other|0|||
147614088|NCT03284723|532403179|FG008|Overall Study|Other|0|||
147614089|NCT03284723|532403180|FG009|Overall Study|Other|0|||
147614090|NCT03284723|532403181|FG010|Overall Study|Other|1|||
147614091|NCT03284723|532403182|FG011|Overall Study|Other|0|||
147614092|NCT03284723|532403171|FG000|Overall Study|Adverse Event|0|||
147614093|NCT03284723|532403172|FG001|Overall Study|Adverse Event|0|||
147614094|NCT03284723|532403173|FG002|Overall Study|Adverse Event|0|||
147614095|NCT03284723|532403174|FG003|Overall Study|Adverse Event|0|||
147614096|NCT03284723|532403175|FG004|Overall Study|Adverse Event|0|||
147614097|NCT03284723|532403176|FG005|Overall Study|Adverse Event|0|||
147614098|NCT03284723|532403177|FG006|Overall Study|Adverse Event|0|||
147614099|NCT03284723|532403178|FG007|Overall Study|Adverse Event|0|||
147614100|NCT03284723|532403179|FG008|Overall Study|Adverse Event|1|||
147614101|NCT03284723|532403180|FG009|Overall Study|Adverse Event|0|||
147614102|NCT03284723|532403181|FG010|Overall Study|Adverse Event|0|||
147614103|NCT03284723|532403182|FG011|Overall Study|Adverse Event|0|||
147614104|NCT00764881|532403186|FG000|Overall Study|Adverse Event|5|||
147614105|NCT00764881|532403187|FG001|Overall Study|Adverse Event|1|||
147614106|NCT00764881|532403186|FG000|Overall Study|Withdrawal by Subject|1|||
147614107|NCT00764881|532403187|FG001|Overall Study|Withdrawal by Subject|3|||
147614108|NCT00764881|532403186|FG000|Overall Study|Protocol Violation|2|||
147614109|NCT00764881|532403187|FG001|Overall Study|Protocol Violation|2|||
147614110|NCT00764881|532403186|FG000|Overall Study|Lost to Follow-up|2|||
147614111|NCT00764881|532403187|FG001|Overall Study|Lost to Follow-up|0|||
147614112|NCT00764881|532403186|FG000|Overall Study|Noncompliant|1|||
147614113|NCT00764881|532403187|FG001|Overall Study|Noncompliant|0|||
147614114|NCT00764881|532403186|FG000|Overall Study|Accidentally discontinued study drug|1|||
147614115|NCT00764881|532403187|FG001|Overall Study|Accidentally discontinued study drug|0|||
147614116|NCT00764881|532403186|FG000|Overall Study|Wished to become pregnant|1|||
147614117|NCT00764881|532403187|FG001|Overall Study|Wished to become pregnant|0|||
147614118|NCT00764881|532403186|FG000|Overall Study|Carcinoma detected|1|||
147614119|NCT00764881|532403187|FG001|Overall Study|Carcinoma detected|0|||
147614120|NCT00764881|532403186|FG000|Overall Study|Possibly noncompliant (study drug)|0|||
147614121|NCT00764881|532403187|FG001|Overall Study|Possibly noncompliant (study drug)|2|||
147614122|NCT00764881|532403186|FG000|Overall Study|no treatment or no observation|2|||
147614123|NCT00764881|532403187|FG001|Overall Study|no treatment or no observation|2|||
147614124|NCT01567462|532403188|FG000|Overall Study|Withdrawal by Subject|4|||
147614125|NCT01567462|532403189|FG001|Overall Study|Withdrawal by Subject|7|||
147614126|NCT00886015|532403192|FG000|Overall Study|Death|0|||
147614127|NCT00886015|532403193|FG001|Overall Study|Death|2|||
147382088|NCT01262456|531562070|FG001|1-Month Open-Label Extension Period|Other Reason|1|||
147382089|NCT01262456|531562071|FG002|1-Month Open-Label Extension Period|Other Reason|0|||
147382090|NCT00800176|531562074|FG000|Overall Study|Adverse Event|2|||
147614128|NCT02548156|532403198|FG000|Washout Period 1|Lost to Follow-up|0|||
147614129|NCT02548156|532403199|FG001|Washout Period 1|Lost to Follow-up|0|||
147382091|NCT00800176|531562075|FG001|Overall Study|Adverse Event|1|||
147382092|NCT00800176|531562076|FG002|Overall Study|Adverse Event|0|||
147614130|NCT02548156|532403200|FG002|Washout Period 1|Lost to Follow-up|0|||
147614131|NCT02548156|532403201|FG003|Washout Period 1|Lost to Follow-up|0|||
147614132|NCT02548156|532403202|FG004|Washout Period 1|Lost to Follow-up|1|||
147614133|NCT02548156|532403203|FG005|Washout Period 1|Lost to Follow-up|0|||
147614134|NCT00444587|532403214|FG000|Overall Study|Death|2|||
147614135|NCT00444587|532403215|FG001|Overall Study|Death|1|||
147614136|NCT00444587|532403214|FG000|Overall Study|Progression of the disease|73|||
147614137|NCT00444587|532403215|FG001|Overall Study|Progression of the disease|8|||
147614138|NCT00444587|532403214|FG000|Overall Study|Refused treatment/did not cooperate|4|||
147614139|NCT00444587|532403215|FG001|Overall Study|Refused treatment/did not cooperate|1|||
147614140|NCT00444587|532403214|FG000|Overall Study|Investigator decision|3|||
147614141|NCT00444587|532403215|FG001|Overall Study|Investigator decision|0|||
147614142|NCT00444587|532403214|FG000|Overall Study|Protocol Violation|1|||
147614143|NCT00444587|532403215|FG001|Overall Study|Protocol Violation|0|||
147614144|NCT00444587|532403214|FG000|Overall Study|Missing|0|||
147382093|NCT00800176|531562077|FG003|Overall Study|Adverse Event|2|||
147382094|NCT00800176|531562078|FG004|Overall Study|Adverse Event|1|||
147382095|NCT00800176|531562079|FG005|Overall Study|Adverse Event|1|||
147382096|NCT00800176|531562074|FG000|Overall Study|Refused treatment|3|||
147382097|NCT00800176|531562075|FG001|Overall Study|Refused treatment|2|||
147382098|NCT00800176|531562076|FG002|Overall Study|Refused treatment|0|||
147382099|NCT00800176|531562077|FG003|Overall Study|Refused treatment|0|||
147382100|NCT00800176|531562078|FG004|Overall Study|Refused treatment|1|||
147382101|NCT00800176|531562079|FG005|Overall Study|Refused treatment|4|||
147382102|NCT00800176|531562074|FG000|Overall Study|Failure to return|3|||
147382103|NCT00800176|531562075|FG001|Overall Study|Failure to return|3|||
147382104|NCT00800176|531562076|FG002|Overall Study|Failure to return|0|||
147382105|NCT00800176|531562077|FG003|Overall Study|Failure to return|2|||
147382106|NCT00800176|531562078|FG004|Overall Study|Failure to return|0|||
147382107|NCT00800176|531562079|FG005|Overall Study|Failure to return|0|||
147382108|NCT00800176|531562074|FG000|Overall Study|Other|1|||
147382109|NCT00800176|531562075|FG001|Overall Study|Other|0|||
147382110|NCT00800176|531562076|FG002|Overall Study|Other|0|||
147382111|NCT00800176|531562077|FG003|Overall Study|Other|0|||
147382112|NCT00800176|531562078|FG004|Overall Study|Other|2|||
147382113|NCT00800176|531562079|FG005|Overall Study|Other|0|||
147382114|NCT02326220|531562082|FG000|Double-blind Treatment Period|Adverse Event|1|||
147382115|NCT02326220|531562083|FG001|Double-blind Treatment Period|Adverse Event|2|||
147382116|NCT02326220|531562084|FG002|Double-blind Treatment Period|Adverse Event|0|||
147382117|NCT02326220|531562082|FG000|Double-blind Treatment Period|Protocol Violation|0|||
147382118|NCT02326220|531562083|FG001|Double-blind Treatment Period|Protocol Violation|1|||
147382119|NCT02326220|531562084|FG002|Double-blind Treatment Period|Protocol Violation|0|||
147382120|NCT02326220|531562082|FG000|Double-blind Treatment Period|Withdrawal by Subject|0|||
147382121|NCT02326220|531562083|FG001|Double-blind Treatment Period|Withdrawal by Subject|1|||
147382122|NCT02326220|531562084|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
147382123|NCT02326220|531562082|FG000|Open-label Treatment Period|Withdrawal by Subject|0|||
147382124|NCT02326220|531562083|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
147382125|NCT02326220|531562084|FG002|Open-label Treatment Period|Withdrawal by Subject|1|||
147382126|NCT02326220|531562082|FG000|Open-label Treatment Period|Lost to Follow-up|0|||
147382127|NCT02326220|531562083|FG001|Open-label Treatment Period|Lost to Follow-up|0|||
147382128|NCT02326220|531562084|FG002|Open-label Treatment Period|Lost to Follow-up|1|||
147382129|NCT02699099|531562085|FG000|Overall Study|Adverse Event|1|||
147382130|NCT02699099|531562086|FG001|Overall Study|Adverse Event|0|||
147382131|NCT02699099|531562087|FG002|Overall Study|Adverse Event|2|||
147382132|NCT02699099|531562085|FG000|Overall Study|Lost to Follow-up|0|||
147382133|NCT02699099|531562086|FG001|Overall Study|Lost to Follow-up|1|||
147382134|NCT02699099|531562087|FG002|Overall Study|Lost to Follow-up|0|||
147382135|NCT02699099|531562085|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|7|||
147382136|NCT02699099|531562086|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|2|||
147382137|NCT02699099|531562087|FG002|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|4|||
147382138|NCT02659540|531562088|FG000|Overall Study|Adverse Event|3|||
147382139|NCT02659540|531562089|FG001|Overall Study|Adverse Event|2|||
147382140|NCT02659540|531562088|FG000|Overall Study|Death|1|||
147382141|NCT02659540|531562089|FG001|Overall Study|Death|0|||
147382142|NCT02659540|531562088|FG000|Overall Study|Progressive disease|2|||
147382143|NCT02659540|531562089|FG001|Overall Study|Progressive disease|6|||
147382144|NCT05184062|531562092|FG000|Overall Study|Lost to Follow-up|5|||
147382145|NCT05184062|531562093|FG001|Overall Study|Lost to Follow-up|1|||
147382146|NCT05184062|531562092|FG000|Overall Study|Withdrawal by Subject|1|||
147382147|NCT05184062|531562093|FG001|Overall Study|Withdrawal by Subject|0|||
147382148|NCT00747149|531563816|FG000|Overall Study|Adverse Event|0|||
147614145|NCT00444587|532403215|FG001|Overall Study|Missing|5|||
147614146|NCT02738138|532403230|FG000|Overall Study|Adverse Event|0|||
147382149|NCT00747149|531563817|FG001|Overall Study|Adverse Event|15|||
147382150|NCT00747149|531563816|FG000|Overall Study|Lost to Follow-up|0|||
147382151|NCT00747149|531563817|FG001|Overall Study|Lost to Follow-up|10|||
147382152|NCT00747149|531563816|FG000|Overall Study|Withdrawal by Subject|0|||
147382153|NCT00747149|531563817|FG001|Overall Study|Withdrawal by Subject|6|||
147382154|NCT00747149|531563816|FG000|Overall Study|Did not receive treatment|0|||
147382155|NCT00747149|531563817|FG001|Overall Study|Did not receive treatment|1|||
147382156|NCT00747149|531563816|FG000|Overall Study|Incorrect enrollment|0|||
147382157|NCT00747149|531563817|FG001|Overall Study|Incorrect enrollment|6|||
147382158|NCT00747149|531563816|FG000|Overall Study|Severe non-compliance to protocol|0|||
147382159|NCT00747149|531563817|FG001|Overall Study|Severe non-compliance to protocol|1|||
147382160|NCT00747149|531563816|FG000|Overall Study|Not reported|1|||
147382161|NCT00747149|531563817|FG001|Overall Study|Not reported|4|||
147382162|NCT03840200|531563822|FG000|Overall Study|Death|6|||
147382163|NCT03840200|531563823|FG001|Overall Study|Death|3|||
147382164|NCT03840200|531563824|FG002|Overall Study|Death|6|||
147382165|NCT03840200|531563825|FG003|Overall Study|Death|10|||
147382166|NCT03840200|531563822|FG000|Overall Study|Reason Not Specified|2|||
147382167|NCT03840200|531563823|FG001|Overall Study|Reason Not Specified|2|||
147382168|NCT03840200|531563824|FG002|Overall Study|Reason Not Specified|1|||
147382169|NCT03840200|531563825|FG003|Overall Study|Reason Not Specified|15|||
147382170|NCT03840200|531563822|FG000|Overall Study|Physician Decision|0|||
147382171|NCT03840200|531563823|FG001|Overall Study|Physician Decision|0|||
147382172|NCT03840200|531563824|FG002|Overall Study|Physician Decision|0|||
147382173|NCT03840200|531563825|FG003|Overall Study|Physician Decision|2|||
147382174|NCT03840200|531563822|FG000|Overall Study|Progressive Disease|0|||
147382175|NCT03840200|531563823|FG001|Overall Study|Progressive Disease|0|||
147382176|NCT03840200|531563824|FG002|Overall Study|Progressive Disease|0|||
147382177|NCT03840200|531563825|FG003|Overall Study|Progressive Disease|1|||
147382178|NCT03840200|531563822|FG000|Overall Study|Withdrawal by Subject|0|||
147382179|NCT03840200|531563823|FG001|Overall Study|Withdrawal by Subject|1|||
147382180|NCT03840200|531563824|FG002|Overall Study|Withdrawal by Subject|0|||
147382181|NCT03840200|531563825|FG003|Overall Study|Withdrawal by Subject|2|||
147382182|NCT05522777|531563826|FG000|Overall Study|Lack of Efficacy|1|||
147382183|NCT05522777|531563826|FG000|Overall Study|Withdrawal by Subject|1|||
147382184|NCT05487300|531563829|FG000|Overall Study|Withdrawal by Subject|1|||
147382185|NCT05487300|531563830|FG001|Overall Study|Withdrawal by Subject|0|||
147382186|NCT03141177|531563831|FG000|Overall Study|Death|62|||
147382187|NCT03141177|531563832|FG001|Overall Study|Death|13|||
147382188|NCT03141177|531563833|FG002|Overall Study|Death|84|||
147382189|NCT03141177|531563831|FG000|Overall Study|Participant withdrew consent|9|||
147382190|NCT03141177|531563832|FG001|Overall Study|Participant withdrew consent|2|||
147382191|NCT03141177|531563833|FG002|Overall Study|Participant withdrew consent|13|||
147382192|NCT03141177|531563831|FG000|Overall Study|Not reported|1|||
147382193|NCT03141177|531563832|FG001|Overall Study|Not reported|0|||
147382194|NCT03141177|531563833|FG002|Overall Study|Not reported|1|||
147382195|NCT03141177|531563831|FG000|Overall Study|Lost to Follow-up|2|||
147382196|NCT03141177|531563832|FG001|Overall Study|Lost to Follow-up|1|||
147382197|NCT03141177|531563833|FG002|Overall Study|Lost to Follow-up|1|||
147382198|NCT03141177|531563831|FG000|Overall Study|Other reasons|4|||
147382199|NCT03141177|531563832|FG001|Overall Study|Other reasons|0|||
147382200|NCT03141177|531563833|FG002|Overall Study|Other reasons|11|||
147382201|NCT03141177|531563831|FG000|Overall Study|Participants did not start treatment period|3|||
147382202|NCT03141177|531563832|FG001|Overall Study|Participants did not start treatment period|0|||
147382203|NCT03141177|531563833|FG002|Overall Study|Participants did not start treatment period|8|||
147382204|NCT05006703|531563834|FG000|Overall Study|Withdrawal by Subject|1|||
147382205|NCT05006703|531563835|FG001|Overall Study|Withdrawal by Subject|0|||
147382206|NCT05006703|531563834|FG000|Overall Study|Lost to Follow-up|13|||
147382207|NCT05006703|531563835|FG001|Overall Study|Lost to Follow-up|5|||
147382208|NCT02196259|531563840|FG000|Overall Study|Researcher choice|0|||
147382209|NCT02196259|531563841|FG001|Overall Study|Researcher choice|0|||
147382210|NCT02196259|531563842|FG002|Overall Study|Researcher choice|1|||
147382211|NCT02196259|531563840|FG000|Overall Study|Partial data analysis|0|||
147382212|NCT02196259|531563841|FG001|Overall Study|Partial data analysis|3|||
147382213|NCT02196259|531563842|FG002|Overall Study|Partial data analysis|0|||
147382214|NCT00264576|531563843|FG000|Overall Study|Lost to Follow-up|1|||
147382215|NCT00264576|531563844|FG001|Overall Study|Lost to Follow-up|1|||
147382216|NCT02659059|531563845|FG000|Overall Study|Other reasons|6|||
147382217|NCT02659059|531563846|FG001|Overall Study|Other reasons|1|||
147382218|NCT02659059|531563845|FG000|Overall Study|Disease Progression|143|||
147382219|NCT02659059|531563846|FG001|Overall Study|Disease Progression|16|||
147382220|NCT02659059|531563845|FG000|Overall Study|Study Drug toxicity|56|||
147382221|NCT02659059|531563846|FG001|Overall Study|Study Drug toxicity|9|||
147382222|NCT02659059|531563845|FG000|Overall Study|Death|3|||
147382223|NCT02659059|531563846|FG001|Overall Study|Death|1|||
147382224|NCT02659059|531563845|FG000|Overall Study|Adverse Event unrelated to Study drug|32|||
147382225|NCT02659059|531563846|FG001|Overall Study|Adverse Event unrelated to Study drug|4|||
147382226|NCT02659059|531563845|FG000|Overall Study|Participant request to discontinue study treatment|5|||
147382227|NCT02659059|531563846|FG001|Overall Study|Participant request to discontinue study treatment|0|||
147382228|NCT02659059|531563845|FG000|Overall Study|Participant withdrew consent|6|||
147382229|NCT02659059|531563846|FG001|Overall Study|Participant withdrew consent|1|||
147382230|NCT00092456|531563847|FG000|Overall Study|Adverse Event|0|||
147382231|NCT00092456|531563848|FG001|Overall Study|Adverse Event|0|||
147382232|NCT00092456|531563849|FG002|Overall Study|Adverse Event|1|||
147456372|NCT03529773|531831724|FG004|Overall Study|Protocol Violation|0|||
147382233|NCT00092456|531563850|FG003|Overall Study|Adverse Event|1|||
147382234|NCT00092456|531563847|FG000|Overall Study|Lost to Follow-up|2|||
147382235|NCT00092456|531563848|FG001|Overall Study|Lost to Follow-up|2|||
147382236|NCT00092456|531563849|FG002|Overall Study|Lost to Follow-up|1|||
147382237|NCT00092456|531563850|FG003|Overall Study|Lost to Follow-up|2|||
147382238|NCT00092456|531563847|FG000|Overall Study|Protocol Violation|5|||
147382239|NCT00092456|531563848|FG001|Overall Study|Protocol Violation|7|||
147382240|NCT00092456|531563849|FG002|Overall Study|Protocol Violation|8|||
147382241|NCT00092456|531563850|FG003|Overall Study|Protocol Violation|6|||
147382242|NCT00092456|531563847|FG000|Overall Study|Withdrawal by Subject|13|||
147382243|NCT00092456|531563848|FG001|Overall Study|Withdrawal by Subject|5|||
147382244|NCT00092456|531563849|FG002|Overall Study|Withdrawal by Subject|16|||
147456373|NCT03529773|531831725|FG005|Overall Study|Protocol Violation|0|||
147614147|NCT02738138|532403231|FG001|Overall Study|Adverse Event|1|||
147614148|NCT02738138|532403230|FG000|Overall Study|Lost to Follow-up|2|||
147614149|NCT02738138|532403231|FG001|Overall Study|Lost to Follow-up|0|||
147614150|NCT02738138|532403230|FG000|Overall Study|Other - not further specified|1|||
147614151|NCT02738138|532403231|FG001|Overall Study|Other - not further specified|0|||
147614152|NCT03639779|532403239|FG000|Overall Study|Lost to Follow-up|1|||
147614153|NCT02413229|532403240|FG000|Overall Study|Adverse Event|0|||
147614154|NCT02413229|532403241|FG001|Overall Study|Adverse Event|0|||
147614155|NCT02413229|532403242|FG002|Overall Study|Adverse Event|0|||
147614156|NCT02413229|532403243|FG003|Overall Study|Adverse Event|1|||
147614157|NCT02413229|532403244|FG004|Overall Study|Adverse Event|0|||
147614158|NCT02413229|532403245|FG005|Overall Study|Adverse Event|0|||
147614159|NCT02413229|532403246|FG006|Overall Study|Adverse Event|0|||
147614160|NCT02413229|532403247|FG007|Overall Study|Adverse Event|1|||
147614161|NCT02413229|532403240|FG000|Overall Study|Lost to Follow-up|0|||
147614162|NCT02413229|532403241|FG001|Overall Study|Lost to Follow-up|0|||
147614163|NCT02413229|532403242|FG002|Overall Study|Lost to Follow-up|1|||
147614164|NCT02413229|532403243|FG003|Overall Study|Lost to Follow-up|0|||
147614165|NCT02413229|532403244|FG004|Overall Study|Lost to Follow-up|2|||
147614166|NCT02413229|532403245|FG005|Overall Study|Lost to Follow-up|0|||
147614167|NCT02413229|532403246|FG006|Overall Study|Lost to Follow-up|0|||
147614168|NCT02413229|532403247|FG007|Overall Study|Lost to Follow-up|0|||
147614169|NCT02413229|532403240|FG000|Overall Study|Withdrawal by Subject|1|||
147614170|NCT02413229|532403241|FG001|Overall Study|Withdrawal by Subject|1|||
147614171|NCT02413229|532403242|FG002|Overall Study|Withdrawal by Subject|0|||
147614172|NCT02413229|532403243|FG003|Overall Study|Withdrawal by Subject|0|||
147614173|NCT02413229|532403244|FG004|Overall Study|Withdrawal by Subject|1|||
147614174|NCT02413229|532403245|FG005|Overall Study|Withdrawal by Subject|0|||
147614175|NCT02413229|532403246|FG006|Overall Study|Withdrawal by Subject|0|||
147614176|NCT02413229|532403247|FG007|Overall Study|Withdrawal by Subject|2|||
147614177|NCT02413229|532403240|FG000|Overall Study|Progressive Disease|0|||
147614178|NCT02413229|532403241|FG001|Overall Study|Progressive Disease|0|||
147614179|NCT02413229|532403242|FG002|Overall Study|Progressive Disease|0|||
147614180|NCT02413229|532403243|FG003|Overall Study|Progressive Disease|0|||
147614181|NCT02413229|532403244|FG004|Overall Study|Progressive Disease|0|||
147614182|NCT02413229|532403245|FG005|Overall Study|Progressive Disease|0|||
147614183|NCT02413229|532403246|FG006|Overall Study|Progressive Disease|0|||
147614184|NCT02413229|532403247|FG007|Overall Study|Progressive Disease|1|||
147614185|NCT02932462|532403248|FG000|Overall Study|Adverse Event|1|||
147614186|NCT02932462|532403249|FG001|Overall Study|Adverse Event|2|||
147614187|NCT02932462|532403248|FG000|Overall Study|Lost to Follow-up|4|||
147614188|NCT02932462|532403249|FG001|Overall Study|Lost to Follow-up|1|||
147614189|NCT02932462|532403248|FG000|Overall Study|Protocol Violation|0|||
147614190|NCT02932462|532403249|FG001|Overall Study|Protocol Violation|5|||
147614191|NCT02932462|532403248|FG000|Overall Study|Withdrawal by Subject|1|||
147614192|NCT02932462|532403249|FG001|Overall Study|Withdrawal by Subject|4|||
147614193|NCT02932462|532403248|FG000|Overall Study|Non-Compliance With Study Drug|0|||
147382245|NCT00092456|531563850|FG003|Overall Study|Withdrawal by Subject|6|||
147382246|NCT00092456|531563847|FG000|Overall Study|Moved|1|||
147382247|NCT00092456|531563848|FG001|Overall Study|Moved|1|||
147382248|NCT00092456|531563849|FG002|Overall Study|Moved|0|||
147382249|NCT00092456|531563850|FG003|Overall Study|Moved|1|||
147382250|NCT00092456|531563847|FG000|Overall Study|Other|4|||
147382251|NCT00092456|531563848|FG001|Overall Study|Other|2|||
147382252|NCT00092456|531563849|FG002|Overall Study|Other|3|||
147382253|NCT00092456|531563850|FG003|Overall Study|Other|0|||
147382254|NCT04783389|531563851|FG000|Overall Study|Withdrawal by Subject|2|||
147382255|NCT04783389|531563852|FG001|Overall Study|Withdrawal by Subject|0|||
147382256|NCT04783389|531563853|FG002|Overall Study|Withdrawal by Subject|0|||
147382257|NCT04783389|531563851|FG000|Overall Study|Termination of Study by Sponsor|10|||
147382258|NCT04783389|531563852|FG001|Overall Study|Termination of Study by Sponsor|12|||
147382259|NCT04783389|531563853|FG002|Overall Study|Termination of Study by Sponsor|14|||
147382260|NCT01241448|531563854|FG000|Overall Study|Adverse Event|1|||
147614194|NCT02932462|532403249|FG001|Overall Study|Non-Compliance With Study Drug|1|||
147614195|NCT02932462|532403248|FG000|Overall Study|Progressive Disease|1|||
147614196|NCT02932462|532403249|FG001|Overall Study|Progressive Disease|0|||
147614197|NCT01995513|532403250|FG000|Period 1: First Open Label Treatment|Other|34|||
147382261|NCT01241448|531563855|FG001|Overall Study|Adverse Event|0|||
147382262|NCT01241448|531563856|FG002|Overall Study|Adverse Event|2|||
147382263|NCT01241448|531563857|FG003|Overall Study|Adverse Event|2|||
147382264|NCT01241448|531563854|FG000|Overall Study|Lost to Follow-up|2|||
147614198|NCT01995513|532403251|FG001|Period 1: First Open Label Treatment|Other|0|||
147614199|NCT01995513|532403252|FG002|Period 1: First Open Label Treatment|Other|0|||
147614200|NCT01995513|532403253|FG003|Period 1: First Open Label Treatment|Other|0|||
147614201|NCT01995513|532403250|FG000|Period 1: First Open Label Treatment|Death|14|||
147614202|NCT01995513|532403251|FG001|Period 1: First Open Label Treatment|Death|0|||
147614203|NCT01995513|532403252|FG002|Period 1: First Open Label Treatment|Death|0|||
147614204|NCT01995513|532403253|FG003|Period 1: First Open Label Treatment|Death|0|||
147614205|NCT01995513|532403250|FG000|Period 1: First Open Label Treatment|Adverse Event|40|||
147614206|NCT01995513|532403251|FG001|Period 1: First Open Label Treatment|Adverse Event|0|||
147614207|NCT01995513|532403252|FG002|Period 1: First Open Label Treatment|Adverse Event|0|||
147614208|NCT01995513|532403253|FG003|Period 1: First Open Label Treatment|Adverse Event|0|||
147614209|NCT01995513|532403250|FG000|Period 1: First Open Label Treatment|Failure to Achieve PSA response at Week 13|43|||
147614210|NCT01995513|532403251|FG001|Period 1: First Open Label Treatment|Failure to Achieve PSA response at Week 13|0|||
147614211|NCT01995513|532403252|FG002|Period 1: First Open Label Treatment|Failure to Achieve PSA response at Week 13|0|||
147614212|NCT01995513|532403253|FG003|Period 1: First Open Label Treatment|Failure to Achieve PSA response at Week 13|0|||
147614213|NCT01995513|532403250|FG000|Period 1: First Open Label Treatment|Disease Progression|92|||
147614214|NCT01995513|532403251|FG001|Period 1: First Open Label Treatment|Disease Progression|0|||
147614215|NCT01995513|532403252|FG002|Period 1: First Open Label Treatment|Disease Progression|0|||
147614216|NCT01995513|532403253|FG003|Period 1: First Open Label Treatment|Disease Progression|0|||
147614217|NCT01995513|532403250|FG000|Period 1: First Open Label Treatment|Protocol Non-Compliance|2|||
147614218|NCT01995513|532403251|FG001|Period 1: First Open Label Treatment|Protocol Non-Compliance|0|||
147614219|NCT01995513|532403252|FG002|Period 1: First Open Label Treatment|Protocol Non-Compliance|0|||
147614220|NCT01995513|532403253|FG003|Period 1: First Open Label Treatment|Protocol Non-Compliance|0|||
147614221|NCT01995513|532403250|FG000|Period 1: First Open Label Treatment|Withdrawal by Subject|20|||
147614222|NCT01995513|532403251|FG001|Period 1: First Open Label Treatment|Withdrawal by Subject|0|||
147614223|NCT01995513|532403252|FG002|Period 1: First Open Label Treatment|Withdrawal by Subject|0|||
147614224|NCT01995513|532403253|FG003|Period 1: First Open Label Treatment|Withdrawal by Subject|0|||
147614225|NCT01995513|532403250|FG000|Period 1: Second Open Label Treatment|Other|0|||
147614226|NCT01995513|532403251|FG001|Period 1: Second Open Label Treatment|Other|2|||
147614227|NCT01995513|532403252|FG002|Period 1: Second Open Label Treatment|Other|0|||
147614228|NCT01995513|532403253|FG003|Period 1: Second Open Label Treatment|Other|0|||
147614229|NCT01995513|532403250|FG000|Period 1: Second Open Label Treatment|Disease Progression|0|||
147614230|NCT01995513|532403251|FG001|Period 1: Second Open Label Treatment|Disease Progression|11|||
147614231|NCT01995513|532403252|FG002|Period 1: Second Open Label Treatment|Disease Progression|0|||
147614232|NCT01995513|532403253|FG003|Period 1: Second Open Label Treatment|Disease Progression|0|||
147614233|NCT01995513|532403250|FG000|Period 2: Double Blind Treatment|Death|0|||
147614234|NCT01995513|532403251|FG001|Period 2: Double Blind Treatment|Death|0|||
147614235|NCT01995513|532403252|FG002|Period 2: Double Blind Treatment|Death|0|||
147614236|NCT01995513|532403253|FG003|Period 2: Double Blind Treatment|Death|1|||
147614237|NCT01995513|532403250|FG000|Period 2: Double Blind Treatment|Other|0|||
147614238|NCT01995513|532403251|FG001|Period 2: Double Blind Treatment|Other|0|||
147614239|NCT01995513|532403252|FG002|Period 2: Double Blind Treatment|Other|3|||
147614240|NCT01995513|532403253|FG003|Period 2: Double Blind Treatment|Other|3|||
147614241|NCT01995513|532403250|FG000|Period 2: Double Blind Treatment|Disease Progression|0|||
147614242|NCT01995513|532403251|FG001|Period 2: Double Blind Treatment|Disease Progression|0|||
147614243|NCT01995513|532403252|FG002|Period 2: Double Blind Treatment|Disease Progression|104|||
147382265|NCT01241448|531563855|FG001|Overall Study|Lost to Follow-up|1|||
147382266|NCT01241448|531563856|FG002|Overall Study|Lost to Follow-up|1|||
147382267|NCT01241448|531563857|FG003|Overall Study|Lost to Follow-up|1|||
147382268|NCT01241448|531563854|FG000|Overall Study|Physician Decision|0|||
147382269|NCT01241448|531563855|FG001|Overall Study|Physician Decision|2|||
147382270|NCT01241448|531563856|FG002|Overall Study|Physician Decision|0|||
147382271|NCT01241448|531563857|FG003|Overall Study|Physician Decision|0|||
147382272|NCT01241448|531563854|FG000|Overall Study|Protocol Violation|10|||
147382273|NCT01241448|531563855|FG001|Overall Study|Protocol Violation|5|||
147382274|NCT01241448|531563856|FG002|Overall Study|Protocol Violation|3|||
147614244|NCT01995513|532403253|FG003|Period 2: Double Blind Treatment|Disease Progression|107|||
147614245|NCT01995513|532403250|FG000|Period 2: Double Blind Treatment|Adverse Event|0|||
147614246|NCT01995513|532403251|FG001|Period 2: Double Blind Treatment|Adverse Event|0|||
147614247|NCT01995513|532403252|FG002|Period 2: Double Blind Treatment|Adverse Event|14|||
147614248|NCT01995513|532403253|FG003|Period 2: Double Blind Treatment|Adverse Event|5|||
147614249|NCT01995513|532403250|FG000|Period 2: Double Blind Treatment|Withdrawal by Subject|0|||
147614250|NCT01995513|532403251|FG001|Period 2: Double Blind Treatment|Withdrawal by Subject|0|||
147614251|NCT01995513|532403252|FG002|Period 2: Double Blind Treatment|Withdrawal by Subject|5|||
147614252|NCT01995513|532403253|FG003|Period 2: Double Blind Treatment|Withdrawal by Subject|8|||
147614253|NCT01995513|532403250|FG000|Period 2: Double Blind Treatment|Protocol Non-Compliance|0|||
147614254|NCT01995513|532403251|FG001|Period 2: Double Blind Treatment|Protocol Non-Compliance|0|||
147614255|NCT01995513|532403252|FG002|Period 2: Double Blind Treatment|Protocol Non-Compliance|0|||
147614256|NCT01995513|532403253|FG003|Period 2: Double Blind Treatment|Protocol Non-Compliance|1|||
147382275|NCT01241448|531563857|FG003|Overall Study|Protocol Violation|6|||
147382276|NCT01241448|531563854|FG000|Overall Study|Sponsor Decision|17|||
147382277|NCT01241448|531563855|FG001|Overall Study|Sponsor Decision|14|||
147382278|NCT01241448|531563856|FG002|Overall Study|Sponsor Decision|12|||
147382279|NCT01241448|531563857|FG003|Overall Study|Sponsor Decision|6|||
147382280|NCT01241448|531563854|FG000|Overall Study|Withdrawal by Subject|4|||
147382281|NCT01241448|531563855|FG001|Overall Study|Withdrawal by Subject|5|||
147614257|NCT01232452|532403254|FG000|Overall Study|Adverse Event|17|||
147614258|NCT01232452|532403255|FG001|Overall Study|Adverse Event|15|||
147614259|NCT01232452|532403254|FG000|Overall Study|Withdrawal by Subject|11|||
147614260|NCT01232452|532403255|FG001|Overall Study|Withdrawal by Subject|8|||
147614261|NCT01232452|532403254|FG000|Overall Study|Physician Decision|8|||
147614262|NCT01232452|532403255|FG001|Overall Study|Physician Decision|12|||
147614263|NCT01232452|532403254|FG000|Overall Study|Protocol entry criterion not met|0|||
147614264|NCT01232452|532403255|FG001|Overall Study|Protocol entry criterion not met|2|||
147614265|NCT01232452|532403254|FG000|Overall Study|Sponsor Decision|3|||
147614266|NCT01232452|532403255|FG001|Overall Study|Sponsor Decision|1|||
147614267|NCT01232452|532403254|FG000|Overall Study|Protocol Violation|0|||
147614268|NCT01232452|532403255|FG001|Overall Study|Protocol Violation|1|||
147614269|NCT02454933|532403256|FG000|Overall Study|Progressive disease|10|||
147614270|NCT02454933|532403257|FG001|Overall Study|Progressive disease|7|||
147614271|NCT02454933|532403256|FG000|Overall Study|Adverse Event|1|||
147614272|NCT02454933|532403257|FG001|Overall Study|Adverse Event|1|||
147614273|NCT02454933|532403256|FG000|Overall Study|Withdrawal by Subject|0|||
147614274|NCT02454933|532403257|FG001|Overall Study|Withdrawal by Subject|3|||
147614275|NCT02454933|532403256|FG000|Overall Study|Lost to Follow-up|1|||
147614276|NCT02454933|532403257|FG001|Overall Study|Lost to Follow-up|0|||
147614277|NCT04753216|532403263|FG000|Screening - 1st Response Assessment|Adverse Event|1|||
147614278|NCT04753216|532403263|FG000|Cycle 3 - 2nd Response Assessment|Disease Progression|1|||
147614279|NCT04753216|532403263|FG000|Cycle 5 - 3rd Response Assessment|Withdrawal by Subject|1|||
147614280|NCT01895777|532403264|FG000|Overall Study|Adverse Event|1|||
147614281|NCT01895777|532403265|FG001|Overall Study|Adverse Event|2|||
147614282|NCT01895777|532403264|FG000|Overall Study|Lost to Follow-up|2|||
147614283|NCT01895777|532403265|FG001|Overall Study|Lost to Follow-up|0|||
147614284|NCT01895777|532403264|FG000|Overall Study|Not treated|1|||
147614285|NCT01895777|532403265|FG001|Overall Study|Not treated|0|||
147614286|NCT01895777|532403264|FG000|Overall Study|Other reasons|3|||
147614287|NCT01895777|532403265|FG001|Overall Study|Other reasons|2|||
147614288|NCT01895777|532403264|FG000|Overall Study|Non-compliance with the CTP|2|||
147614289|NCT01895777|532403265|FG001|Overall Study|Non-compliance with the CTP|1|||
147382282|NCT01241448|531563856|FG002|Overall Study|Withdrawal by Subject|3|||
147382283|NCT01241448|531563857|FG003|Overall Study|Withdrawal by Subject|6|||
147382284|NCT01241448|531563854|FG000|Overall Study|Excluded due to data integrity issues|3|||
147382285|NCT01241448|531563855|FG001|Overall Study|Excluded due to data integrity issues|2|||
147382286|NCT01241448|531563856|FG002|Overall Study|Excluded due to data integrity issues|2|||
147382287|NCT01241448|531563857|FG003|Overall Study|Excluded due to data integrity issues|2|||
147382288|NCT03340961|531563858|FG000|Overall Study|Adverse Event|1|||
147382289|NCT03340961|531563859|FG001|Overall Study|Adverse Event|3|||
147382290|NCT03340961|531563860|FG002|Overall Study|Adverse Event|2|||
147382291|NCT03340961|531563861|FG003|Overall Study|Adverse Event|4|||
147382292|NCT03340961|531563858|FG000|Overall Study|Lost to Follow-up|0|||
147382293|NCT03340961|531563859|FG001|Overall Study|Lost to Follow-up|1|||
147382294|NCT03340961|531563860|FG002|Overall Study|Lost to Follow-up|0|||
147382295|NCT03340961|531563861|FG003|Overall Study|Lost to Follow-up|1|||
147382296|NCT03340961|531563858|FG000|Overall Study|Withdrawal by Subject|3|||
147382297|NCT03340961|531563859|FG001|Overall Study|Withdrawal by Subject|2|||
147382298|NCT03340961|531563860|FG002|Overall Study|Withdrawal by Subject|4|||
147382299|NCT03340961|531563861|FG003|Overall Study|Withdrawal by Subject|7|||
147382300|NCT03340961|531563858|FG000|Overall Study|Use of prohibited treatment|0|||
147456374|NCT03529773|531831726|FG006|Overall Study|Protocol Violation|0|||
147456375|NCT03529773|531831727|FG007|Overall Study|Protocol Violation|0|||
147614290|NCT01342081|532403266|FG000|Overall Study|Did not receive allocated intervention|0|||
147614291|NCT01342081|532403267|FG001|Overall Study|Did not receive allocated intervention|0|||
147614292|NCT01342081|532403268|FG002|Overall Study|Did not receive allocated intervention|1|||
147614293|NCT01342081|532403266|FG000|Overall Study|Adverse Event|1|||
147614294|NCT01342081|532403267|FG001|Overall Study|Adverse Event|0|||
147614295|NCT01342081|532403268|FG002|Overall Study|Adverse Event|0|||
147614296|NCT01342081|532403266|FG000|Overall Study|Physician Decision|0|||
147614297|NCT01342081|532403267|FG001|Overall Study|Physician Decision|1|||
147614298|NCT01342081|532403268|FG002|Overall Study|Physician Decision|0|||
147614299|NCT01342081|532403266|FG000|Overall Study|Withdrawal by Subject|1|||
147614300|NCT01342081|532403267|FG001|Overall Study|Withdrawal by Subject|1|||
147382301|NCT03340961|531563859|FG001|Overall Study|Use of prohibited treatment|3|||
147382302|NCT03340961|531563860|FG002|Overall Study|Use of prohibited treatment|2|||
147382303|NCT03340961|531563861|FG003|Overall Study|Use of prohibited treatment|4|||
147382304|NCT03340961|531563858|FG000|Overall Study|Wrongful enrollment (I/E criteria not me|0|||
147382305|NCT03340961|531563859|FG001|Overall Study|Wrongful enrollment (I/E criteria not me|1|||
147614301|NCT01342081|532403268|FG002|Overall Study|Withdrawal by Subject|0|||
147456376|NCT03529773|531831728|FG008|Overall Study|Protocol Violation|0|||
147614302|NCT00839254|532403277|FG000|Overall Study|Protocol Violation|0|||
147614303|NCT00839254|532403278|FG001|Overall Study|Protocol Violation|1|||
147614304|NCT00839254|532403279|FG002|Overall Study|Protocol Violation|1|||
147614305|NCT00839254|532403280|FG003|Overall Study|Protocol Violation|1|||
147614306|NCT00839254|532403281|FG004|Overall Study|Protocol Violation|0|||
147614307|NCT00839254|532403282|FG005|Overall Study|Protocol Violation|0|||
147614308|NCT00839254|532403283|FG006|Overall Study|Protocol Violation|1|||
147614309|NCT00839254|532403284|FG007|Overall Study|Protocol Violation|2|||
147614310|NCT00839254|532403277|FG000|Overall Study|Physician Decision|0|||
147614311|NCT00839254|532403278|FG001|Overall Study|Physician Decision|1|||
147614312|NCT00839254|532403279|FG002|Overall Study|Physician Decision|0|||
147614313|NCT00839254|532403280|FG003|Overall Study|Physician Decision|0|||
147614314|NCT00839254|532403281|FG004|Overall Study|Physician Decision|0|||
147614315|NCT00839254|532403282|FG005|Overall Study|Physician Decision|0|||
147614316|NCT00839254|532403283|FG006|Overall Study|Physician Decision|0|||
147614317|NCT00839254|532403284|FG007|Overall Study|Physician Decision|1|||
147614318|NCT00839254|532403277|FG000|Overall Study|Wrong treatment number allocation|0|||
147614319|NCT00839254|532403278|FG001|Overall Study|Wrong treatment number allocation|1|||
147614320|NCT00839254|532403279|FG002|Overall Study|Wrong treatment number allocation|0|||
147614321|NCT00839254|532403280|FG003|Overall Study|Wrong treatment number allocation|0|||
147614322|NCT00839254|532403281|FG004|Overall Study|Wrong treatment number allocation|0|||
147614323|NCT00839254|532403282|FG005|Overall Study|Wrong treatment number allocation|1|||
147614324|NCT00839254|532403283|FG006|Overall Study|Wrong treatment number allocation|0|||
147614325|NCT00839254|532403284|FG007|Overall Study|Wrong treatment number allocation|0|||
147614326|NCT00839254|532403277|FG000|Overall Study|Adverse Event|12|||
147614327|NCT00839254|532403278|FG001|Overall Study|Adverse Event|6|||
147614328|NCT00839254|532403279|FG002|Overall Study|Adverse Event|3|||
147614329|NCT00839254|532403280|FG003|Overall Study|Adverse Event|5|||
147614330|NCT00839254|532403281|FG004|Overall Study|Adverse Event|2|||
147614331|NCT00839254|532403282|FG005|Overall Study|Adverse Event|1|||
147614332|NCT00839254|532403283|FG006|Overall Study|Adverse Event|0|||
147614333|NCT00839254|532403284|FG007|Overall Study|Adverse Event|1|||
147614334|NCT00839254|532403277|FG000|Overall Study|Withdrawal by Subject|87|||
147614335|NCT00839254|532403278|FG001|Overall Study|Withdrawal by Subject|53|||
147614336|NCT00839254|532403279|FG002|Overall Study|Withdrawal by Subject|54|||
147614337|NCT00839254|532403280|FG003|Overall Study|Withdrawal by Subject|32|||
147614338|NCT00839254|532403281|FG004|Overall Study|Withdrawal by Subject|27|||
147614339|NCT00839254|532403282|FG005|Overall Study|Withdrawal by Subject|15|||
147614340|NCT00839254|532403283|FG006|Overall Study|Withdrawal by Subject|22|||
147614341|NCT00839254|532403284|FG007|Overall Study|Withdrawal by Subject|9|||
147614342|NCT00839254|532403277|FG000|Overall Study|Wrong group allocation|0|||
147614343|NCT00839254|532403278|FG001|Overall Study|Wrong group allocation|0|||
147614344|NCT00839254|532403279|FG002|Overall Study|Wrong group allocation|0|||
147614345|NCT00839254|532403280|FG003|Overall Study|Wrong group allocation|0|||
147614346|NCT00839254|532403281|FG004|Overall Study|Wrong group allocation|0|||
147614347|NCT00839254|532403282|FG005|Overall Study|Wrong group allocation|0|||
147614348|NCT00839254|532403283|FG006|Overall Study|Wrong group allocation|1|||
147614349|NCT00839254|532403284|FG007|Overall Study|Wrong group allocation|0|||
147614350|NCT00839254|532403277|FG000|Overall Study|Parents wanted pneumococcal vaccine|1|||
147614351|NCT00839254|532403278|FG001|Overall Study|Parents wanted pneumococcal vaccine|0|||
147614352|NCT00839254|532403279|FG002|Overall Study|Parents wanted pneumococcal vaccine|0|||
147614353|NCT00839254|532403280|FG003|Overall Study|Parents wanted pneumococcal vaccine|0|||
147382306|NCT03340961|531563860|FG002|Overall Study|Wrongful enrollment (I/E criteria not me|0|||
147382307|NCT03340961|531563861|FG003|Overall Study|Wrongful enrollment (I/E criteria not me|1|||
147382308|NCT03340961|531563858|FG000|Overall Study|Subject developed an exclusion criterion|0|||
147382309|NCT03340961|531563859|FG001|Overall Study|Subject developed an exclusion criterion|1|||
147382310|NCT03340961|531563860|FG002|Overall Study|Subject developed an exclusion criterion|0|||
147382311|NCT03340961|531563861|FG003|Overall Study|Subject developed an exclusion criterion|0|||
147382312|NCT03340961|531563858|FG000|Overall Study|Protocol Violation|1|||
147382313|NCT03340961|531563859|FG001|Overall Study|Protocol Violation|0|||
147382314|NCT03340961|531563860|FG002|Overall Study|Protocol Violation|1|||
147382315|NCT03340961|531563861|FG003|Overall Study|Protocol Violation|0|||
147382316|NCT03340961|531563858|FG000|Overall Study|Adverse Event|1|||
147382317|NCT03340961|531563859|FG001|Overall Study|Adverse Event|1|||
147382318|NCT03340961|531563860|FG002|Overall Study|Adverse Event|0|||
147382319|NCT03340961|531563861|FG003|Overall Study|Adverse Event|0|||
147382320|NCT03340961|531563858|FG000|Overall Study|Lack of Efficacy|0|||
147382321|NCT03340961|531563859|FG001|Overall Study|Lack of Efficacy|0|||
147382322|NCT03340961|531563860|FG002|Overall Study|Lack of Efficacy|0|||
147382323|NCT03340961|531563861|FG003|Overall Study|Lack of Efficacy|1|||
147382324|NCT04311983|531563862|FG000|Overall Study|Lost to Follow-up|421|||
147382325|NCT04311983|531563863|FG001|Overall Study|Lost to Follow-up|456|||
147382326|NCT04311983|531563862|FG000|Overall Study|Incomplete survey|7|||
147382327|NCT04311983|531563863|FG001|Overall Study|Incomplete survey|9|||
147614354|NCT00839254|532403281|FG004|Overall Study|Parents wanted pneumococcal vaccine|0|||
147382328|NCT04311983|531563862|FG000|Overall Study|Death|1|||
147382329|NCT04311983|531563863|FG001|Overall Study|Death|0|||
147382330|NCT00990184|531563869|FG000|Overall Study|Physician Decision|1|||
147614355|NCT00839254|532403282|FG005|Overall Study|Parents wanted pneumococcal vaccine|1|||
147614356|NCT00839254|532403283|FG006|Overall Study|Parents wanted pneumococcal vaccine|0|||
147614357|NCT00839254|532403284|FG007|Overall Study|Parents wanted pneumococcal vaccine|0|||
147382331|NCT02446015|531563870|FG000|Overall Study|Adverse Event|0|||
147382332|NCT02446015|531563871|FG001|Overall Study|Adverse Event|1|||
147382333|NCT02446015|531563870|FG000|Overall Study|Withdrawal by Subject|1|||
147382334|NCT02446015|531563871|FG001|Overall Study|Withdrawal by Subject|0|||
147382335|NCT00687297|531563872|FG000|Randomization|Withdrawal by Subject|2|||
147382336|NCT00687297|531563873|FG001|Randomization|Withdrawal by Subject|0|||
147382337|NCT00687297|531563872|FG000|Randomization|Withdrew before treatment, ineligible|1|||
147382338|NCT00687297|531563873|FG001|Randomization|Withdrew before treatment, ineligible|1|||
147382339|NCT00687297|531563872|FG000|Induction|Withdrawal by Subject|4|||
147614358|NCT00839254|532403277|FG000|Overall Study|Withdrawn due to non-compliance|2|||
147614359|NCT00839254|532403278|FG001|Overall Study|Withdrawn due to non-compliance|0|||
147614360|NCT00839254|532403279|FG002|Overall Study|Withdrawn due to non-compliance|0|||
147614361|NCT00839254|532403280|FG003|Overall Study|Withdrawn due to non-compliance|0|||
147382340|NCT00687297|531563873|FG001|Induction|Withdrawal by Subject|4|||
147382341|NCT00687297|531563872|FG000|Induction|Adverse Event|16|||
147382342|NCT00687297|531563873|FG001|Induction|Adverse Event|15|||
147382343|NCT00687297|531563872|FG000|Induction|Death|7|||
147382344|NCT00687297|531563873|FG001|Induction|Death|11|||
147382345|NCT00687297|531563872|FG000|Induction|Lack of Efficacy|17|||
147382346|NCT00687297|531563873|FG001|Induction|Lack of Efficacy|21|||
147382347|NCT00687297|531563872|FG000|Induction|Ineligible|0|||
147382348|NCT00687297|531563873|FG001|Induction|Ineligible|1|||
147382349|NCT00687297|531563872|FG000|Induction|Patient Noncompliance|1|||
147382350|NCT00687297|531563873|FG001|Induction|Patient Noncompliance|0|||
147382351|NCT00687297|531563872|FG000|Induction|Physician Decision|0|||
147382352|NCT00687297|531563873|FG001|Induction|Physician Decision|2|||
147382353|NCT00687297|531563872|FG000|Induction|Other|0|||
147382354|NCT00687297|531563873|FG001|Induction|Other|1|||
147382355|NCT03695185|531563874|FG000|Induction Period (Week 0 to Week 12)|Adverse Event|1|||
147382356|NCT03695185|531563874|FG000|Induction Period (Week 0 to Week 12)|Withdrew consent|2|||
147382357|NCT03695185|531563874|FG000|Induction Period (Week 0 to Week 12)|Lack of Efficacy|10|||
147382358|NCT03695185|531563874|FG000|Maintenance Period (Week 12 to Week 102)|Withdrew consent|3|||
147382359|NCT03695185|531563874|FG000|Maintenance Period (Week 12 to Week 102)|Lack of Efficacy|2|||
147382360|NCT03695185|531563874|FG000|Maintenance Period (Week 12 to Week 102)|Reason not specified|23|||
147382361|NCT05376397|531563877|FG000|Overall Study|Lost to Follow-up|1|||
147382362|NCT01535261|531563880|FG000|Overall Study|Physician Decision|8|||
147382363|NCT01535261|531563880|FG000|Overall Study|Protocol Violation|3|||
147382364|NCT01535261|531563880|FG000|Overall Study|Death|5|||
147382365|NCT01535261|531563880|FG000|Overall Study|Lost to Follow-up|8|||
147382366|NCT01535261|531563880|FG000|Overall Study|Withdrawal by Subject|14|||
147382367|NCT01535261|531563880|FG000|Overall Study|Adverse Event|12|||
147382368|NCT01137682|531563881|FG000|Overall Study|Adverse Event-CORE|2|||
147382369|NCT01137682|531563882|FG001|Overall Study|Adverse Event-CORE|4|||
147382370|NCT01137682|531563883|FG002|Overall Study|Adverse Event-CORE|0|||
147382371|NCT01137682|531563881|FG000|Overall Study|Withdrawal by Subject-CORE|2|||
147382372|NCT01137682|531563882|FG001|Overall Study|Withdrawal by Subject-CORE|2|||
147382373|NCT01137682|531563883|FG002|Overall Study|Withdrawal by Subject-CORE|2|||
147382374|NCT01137682|531563881|FG000|Overall Study|Administrative problems-CORE|2|||
147382375|NCT01137682|531563882|FG001|Overall Study|Administrative problems-CORE|1|||
147382376|NCT01137682|531563883|FG002|Overall Study|Administrative problems-CORE|0|||
147382377|NCT01137682|531563881|FG000|Overall Study|Protocol Violation-CORE|0|||
147382378|NCT01137682|531563882|FG001|Overall Study|Protocol Violation-CORE|1|||
147382379|NCT01137682|531563883|FG002|Overall Study|Protocol Violation-CORE|1|||
147382380|NCT01137682|531563881|FG000|Overall Study|Adverse Event-Extension|4|||
147382381|NCT01137682|531563882|FG001|Overall Study|Adverse Event-Extension|8|||
147382382|NCT01137682|531563883|FG002|Overall Study|Adverse Event-Extension|7|||
147382383|NCT01137682|531563881|FG000|Overall Study|Lack of Efficacy-Extension|15|||
147382384|NCT01137682|531563882|FG001|Overall Study|Lack of Efficacy-Extension|9|||
147382385|NCT01137682|531563883|FG002|Overall Study|Lack of Efficacy-Extension|13|||
147382386|NCT01137682|531563881|FG000|Overall Study|Withdrawal by Subject-Extension|6|||
147382387|NCT01137682|531563882|FG001|Overall Study|Withdrawal by Subject-Extension|8|||
147614362|NCT00839254|532403281|FG004|Overall Study|Withdrawn due to non-compliance|0|||
147614363|NCT00839254|532403282|FG005|Overall Study|Withdrawn due to non-compliance|0|||
147614364|NCT00839254|532403283|FG006|Overall Study|Withdrawn due to non-compliance|0|||
147382388|NCT01137682|531563883|FG002|Overall Study|Withdrawal by Subject-Extension|8|||
147382389|NCT01137682|531563881|FG000|Overall Study|Lost to Follow Up-Extension|0|||
147382390|NCT01137682|531563882|FG001|Overall Study|Lost to Follow Up-Extension|1|||
147382391|NCT01137682|531563883|FG002|Overall Study|Lost to Follow Up-Extension|0|||
147382392|NCT01137682|531563881|FG000|Overall Study|Administrative problems-Extension|0|||
147382393|NCT01137682|531563882|FG001|Overall Study|Administrative problems-Extension|2|||
147382394|NCT01137682|531563883|FG002|Overall Study|Administrative problems-Extension|0|||
147382395|NCT01137682|531563881|FG000|Overall Study|Death-Extension|2|||
147382396|NCT01137682|531563882|FG001|Overall Study|Death-Extension|0|||
147382397|NCT01137682|531563883|FG002|Overall Study|Death-Extension|0|||
147382398|NCT01137682|531563881|FG000|Overall Study|Protocol Violation-Extension|2|||
147382399|NCT01137682|531563882|FG001|Overall Study|Protocol Violation-Extension|1|||
147382400|NCT01137682|531563883|FG002|Overall Study|Protocol Violation-Extension|0|||
147382401|NCT01137682|531563881|FG000|Overall Study|Did not enter extension|2|||
147382402|NCT01137682|531563882|FG001|Overall Study|Did not enter extension|3|||
147382403|NCT01137682|531563883|FG002|Overall Study|Did not enter extension|2|||
147382404|NCT01137682|531563881|FG000|Overall Study|Did not receive treatment in extension|0|||
147382405|NCT01137682|531563882|FG001|Overall Study|Did not receive treatment in extension|0|||
147382406|NCT01137682|531563883|FG002|Overall Study|Did not receive treatment in extension|1|||
147382407|NCT02525744|531563887|FG000|Period 1|Physician Decision|0|||
147382408|NCT02525744|531563888|FG001|Period 1|Physician Decision|0|||
147382409|NCT02525744|531563889|FG002|Period 1|Physician Decision|1|||
147382410|NCT02525744|531563890|FG003|Period 1|Physician Decision|0|||
147382411|NCT02525744|531563887|FG000|Period 3|Adverse Event|0|||
147382412|NCT02525744|531563888|FG001|Period 3|Adverse Event|1|||
147382413|NCT02525744|531563889|FG002|Period 3|Adverse Event|0|||
147382414|NCT02525744|531563890|FG003|Period 3|Adverse Event|0|||
147382415|NCT02525744|531563887|FG000|Period 4|Withdrawal by Subject|1|||
147382416|NCT02525744|531563888|FG001|Period 4|Withdrawal by Subject|0|||
147382417|NCT02525744|531563889|FG002|Period 4|Withdrawal by Subject|0|||
147382418|NCT02525744|531563890|FG003|Period 4|Withdrawal by Subject|0|||
147382419|NCT02525744|531563887|FG000|Period 5|Physician Decision|1|||
147382420|NCT02525744|531563888|FG001|Period 5|Physician Decision|0|||
147382421|NCT02525744|531563889|FG002|Period 5|Physician Decision|0|||
147382422|NCT02525744|531563890|FG003|Period 5|Physician Decision|0|||
147382423|NCT00472082|531563891|FG000|Overall Study|Study prematurely terminated|5|||
147382424|NCT02069379|531563892|FG000|Baseline Measurements|Lost to Follow-up|1|||
147382425|NCT02069379|531563893|FG001|Baseline Measurements|Lost to Follow-up|0|||
147382426|NCT02069379|531563894|FG002|Baseline Measurements|Lost to Follow-up|0|||
147382427|NCT02069379|531563895|FG003|Baseline Measurements|Lost to Follow-up|0|||
147382428|NCT02069379|531563892|FG000|Baseline Measurements|Ineligible based on initial assessments|2|||
147382429|NCT02069379|531563893|FG001|Baseline Measurements|Ineligible based on initial assessments|0|||
147382430|NCT02069379|531563894|FG002|Baseline Measurements|Ineligible based on initial assessments|0|||
147382431|NCT02069379|531563895|FG003|Baseline Measurements|Ineligible based on initial assessments|2|||
147382432|NCT02069379|531563892|FG000|First Treatment Arm|Lost to Follow-up|0|||
147382433|NCT02069379|531563893|FG001|First Treatment Arm|Lost to Follow-up|1|||
147382434|NCT02069379|531563894|FG002|First Treatment Arm|Lost to Follow-up|1|||
147382435|NCT02069379|531563895|FG003|First Treatment Arm|Lost to Follow-up|0|||
147382436|NCT02069379|531563892|FG000|Washout Period (4 Weeks)|Lost to Follow-up|0|||
147382437|NCT02069379|531563893|FG001|Washout Period (4 Weeks)|Lost to Follow-up|1|||
147382438|NCT02069379|531563894|FG002|Washout Period (4 Weeks)|Lost to Follow-up|0|||
147382439|NCT02069379|531563895|FG003|Washout Period (4 Weeks)|Lost to Follow-up|0|||
147382440|NCT02069379|531563892|FG000|Washout Period (4 Weeks)|Unrelated event|0|||
147382441|NCT02069379|531563893|FG001|Washout Period (4 Weeks)|Unrelated event|1|||
147382442|NCT02069379|531563894|FG002|Washout Period (4 Weeks)|Unrelated event|0|||
147382443|NCT02069379|531563895|FG003|Washout Period (4 Weeks)|Unrelated event|0|||
147382444|NCT02069379|531563892|FG000|Second Treatment Arm|Lost to Follow-up|0|||
147382445|NCT02069379|531563893|FG001|Second Treatment Arm|Lost to Follow-up|0|||
147382446|NCT02069379|531563894|FG002|Second Treatment Arm|Lost to Follow-up|1|||
147382447|NCT02069379|531563895|FG003|Second Treatment Arm|Lost to Follow-up|0|||
147382448|NCT04421456|531563896|FG000|Randomized Placebo Run-in Period|Placebo Run-in Failures|0|||
147382449|NCT04421456|531563897|FG001|Randomized Placebo Run-in Period|Placebo Run-in Failures|0|||
147382450|NCT04421456|531563898|FG002|Randomized Placebo Run-in Period|Placebo Run-in Failures|18|||
147382451|NCT04421456|531563896|FG000|Randomized Treatment Period|Adverse Event|0|||
147382452|NCT04421456|531563897|FG001|Randomized Treatment Period|Adverse Event|1|||
147382453|NCT04421456|531563898|FG002|Randomized Treatment Period|Adverse Event|0|||
147382454|NCT04421456|531563896|FG000|Randomized Treatment Period|Withdrawal of parent/legal representative consent|1|||
147382455|NCT04421456|531563897|FG001|Randomized Treatment Period|Withdrawal of parent/legal representative consent|0|||
147382456|NCT04421456|531563898|FG002|Randomized Treatment Period|Withdrawal of parent/legal representative consent|1|||
147382457|NCT04421456|531563896|FG000|Randomized Treatment Period|Lost to Follow-up|2|||
147382458|NCT04421456|531563897|FG001|Randomized Treatment Period|Lost to Follow-up|2|||
147382459|NCT04421456|531563898|FG002|Randomized Treatment Period|Lost to Follow-up|1|||
147382460|NCT04421456|531563896|FG000|Randomized Treatment Period|Participant non-compliance|1|||
147382461|NCT04421456|531563897|FG001|Randomized Treatment Period|Participant non-compliance|1|||
147382462|NCT04421456|531563898|FG002|Randomized Treatment Period|Participant non-compliance|2|||
147382463|NCT04421456|531563896|FG000|Randomized Treatment Period|Other|0|||
147382464|NCT04421456|531563897|FG001|Randomized Treatment Period|Other|1|||
147382465|NCT04421456|531563898|FG002|Randomized Treatment Period|Other|3|||
147382466|NCT04617847|531563899|FG000|Overall Study|Withdrawal by Subject|1|||
147382467|NCT04617847|531563900|FG001|Overall Study|Withdrawal by Subject|0|||
147382468|NCT04617847|531563899|FG000|Overall Study|Adverse Event|0|||
147382469|NCT04617847|531563900|FG001|Overall Study|Adverse Event|2|||
147382470|NCT04617847|531563899|FG000|Overall Study|Death|0|||
147382471|NCT04617847|531563900|FG001|Overall Study|Death|1|||
147382472|NCT04617847|531563899|FG000|Overall Study|Termination of Study by Sponsor|2|||
147382473|NCT04617847|531563900|FG001|Overall Study|Termination of Study by Sponsor|21|||
147382474|NCT02206607|531563901|FG000|Open-Label Run-In|Withdrawal by Subject|3|||
147382475|NCT02206607|531563902|FG001|Open-Label Run-In|Withdrawal by Subject|0|||
147382476|NCT02206607|531563903|FG002|Open-Label Run-In|Withdrawal by Subject|0|||
147382477|NCT02206607|531563904|FG003|Open-Label Run-In|Withdrawal by Subject|0|||
147382478|NCT02206607|531563905|FG004|Open-Label Run-In|Withdrawal by Subject|0|||
147382479|NCT02206607|531563901|FG000|Second Intervention Period|Insufficient Clinical Response|0|||
147382480|NCT02206607|531563902|FG001|Second Intervention Period|Insufficient Clinical Response|0|||
147382481|NCT02206607|531563903|FG002|Second Intervention Period|Insufficient Clinical Response|0|||
147382482|NCT02206607|531563904|FG003|Second Intervention Period|Insufficient Clinical Response|1|||
147382483|NCT02206607|531563905|FG004|Second Intervention Period|Insufficient Clinical Response|0|||
147382484|NCT04183491|531563910|FG000|Overall Study|Withdrawal by Subject|0|||
147382485|NCT04183491|531563911|FG001|Overall Study|Withdrawal by Subject|0|||
147382486|NCT04183491|531563912|FG002|Overall Study|Withdrawal by Subject|1|||
147382487|NCT04183491|531563913|FG003|Overall Study|Withdrawal by Subject|0|||
147382488|NCT04183491|531563914|FG004|Overall Study|Withdrawal by Subject|0|||
147382489|NCT04183491|531563915|FG005|Overall Study|Withdrawal by Subject|1|||
147382490|NCT04183491|531563916|FG006|Overall Study|Withdrawal by Subject|0|||
147382491|NCT03989232|531563920|FG000|Overall Study|Lost to Follow-up|3|||
147382492|NCT03989232|531563921|FG001|Overall Study|Lost to Follow-up|10|||
147382493|NCT03989232|531563920|FG000|Overall Study|Withdrawal by Subject|6|||
147382494|NCT03989232|531563921|FG001|Overall Study|Withdrawal by Subject|6|||
147382495|NCT03989232|531563920|FG000|Overall Study|Death|1|||
147382496|NCT03989232|531563921|FG001|Overall Study|Death|2|||
147382497|NCT01930188|531563922|FG000|Overall Study|unclassified|4|||
147382498|NCT01930188|531563923|FG001|Overall Study|unclassified|5|||
147382499|NCT01930188|531563924|FG002|Overall Study|unclassified|3|||
147382500|NCT01930188|531563922|FG000|Overall Study|Missing follow-up information|2|||
147382501|NCT01930188|531563923|FG001|Overall Study|Missing follow-up information|2|||
147382502|NCT01930188|531563924|FG002|Overall Study|Missing follow-up information|3|||
147382503|NCT01930188|531563922|FG000|Overall Study|Lost to Follow-up|5|||
147382504|NCT01930188|531563923|FG001|Overall Study|Lost to Follow-up|2|||
147382505|NCT01930188|531563924|FG002|Overall Study|Lost to Follow-up|2|||
147382506|NCT01930188|531563922|FG000|Overall Study|Death|2|||
147382507|NCT01930188|531563923|FG001|Overall Study|Death|1|||
147382508|NCT01930188|531563924|FG002|Overall Study|Death|3|||
147382509|NCT01930188|531563922|FG000|Overall Study|Withdrawal by Subject|9|||
147382510|NCT01930188|531563923|FG001|Overall Study|Withdrawal by Subject|11|||
147382511|NCT01930188|531563924|FG002|Overall Study|Withdrawal by Subject|8|||
147382512|NCT00337610|531563927|FG000|Overall Study|Adverse Event|2|||
147382513|NCT00337610|531563928|FG001|Overall Study|Adverse Event|2|||
147382514|NCT00337610|531563927|FG000|Overall Study|Death|0|||
147382515|NCT00337610|531563928|FG001|Overall Study|Death|1|||
147382516|NCT00337610|531563927|FG000|Overall Study|Lack of Efficacy|6|||
147382517|NCT00337610|531563928|FG001|Overall Study|Lack of Efficacy|3|||
147382518|NCT00337610|531563927|FG000|Overall Study|Lost to Follow-up|3|||
147382519|NCT00337610|531563928|FG001|Overall Study|Lost to Follow-up|3|||
147382520|NCT00337610|531563927|FG000|Overall Study|Withdrawal by Subject|6|||
147382521|NCT00337610|531563928|FG001|Overall Study|Withdrawal by Subject|5|||
147382522|NCT04867382|531563931|FG000|Overall Study|Did not complete the survey|2|||
147382523|NCT04867382|531563932|FG001|Overall Study|Did not complete the survey|1|||
147382524|NCT02102724|531563937|FG000|Overall Study|Lost to Follow-up|1|||
147382525|NCT02102724|531563938|FG001|Overall Study|Lost to Follow-up|0|||
147382526|NCT02102724|531563937|FG000|Overall Study|surgery for brain aneurysm|1|||
147382527|NCT02102724|531563938|FG001|Overall Study|surgery for brain aneurysm|1|||
147382528|NCT02203513|531563942|FG000|Overall Study|Refused further treatment|2|||
147382529|NCT02203513|531563943|FG001|Overall Study|Refused further treatment|0|||
147382530|NCT02203513|531563944|FG002|Overall Study|Refused further treatment|1|||
147382531|NCT02203513|531563945|FG003|Overall Study|Refused further treatment|0|||
147382532|NCT02203513|531563946|FG004|Overall Study|Refused further treatment|0|||
147382533|NCT02203513|531563942|FG000|Overall Study|Switched to alternative treatment|3|||
147382534|NCT02203513|531563943|FG001|Overall Study|Switched to alternative treatment|4|||
147382535|NCT02203513|531563944|FG002|Overall Study|Switched to alternative treatment|0|||
147382536|NCT02203513|531563945|FG003|Overall Study|Switched to alternative treatment|0|||
147382537|NCT02203513|531563946|FG004|Overall Study|Switched to alternative treatment|4|||
147382538|NCT02203513|531563942|FG000|Overall Study|Did not receive investigational product (IP)|0|||
147382539|NCT02203513|531563943|FG001|Overall Study|Did not receive investigational product (IP)|1|||
147382540|NCT02203513|531563944|FG002|Overall Study|Did not receive investigational product (IP)|0|||
147382541|NCT02203513|531563945|FG003|Overall Study|Did not receive investigational product (IP)|0|||
147382542|NCT02203513|531563946|FG004|Overall Study|Did not receive investigational product (IP)|0|||
147382543|NCT02203513|531563942|FG000|Overall Study|Death (unrelated to study therapy)|1|||
147382544|NCT02203513|531563943|FG001|Overall Study|Death (unrelated to study therapy)|3|||
147382545|NCT02203513|531563944|FG002|Overall Study|Death (unrelated to study therapy)|1|||
147382546|NCT02203513|531563945|FG003|Overall Study|Death (unrelated to study therapy)|0|||
147456377|NCT03529773|531831729|FG009|Overall Study|Protocol Violation|0|||
147614365|NCT00839254|532403284|FG007|Overall Study|Withdrawn due to non-compliance|0|||
147382547|NCT02203513|531563946|FG004|Overall Study|Death (unrelated to study therapy)|2|||
147382548|NCT02203513|531563942|FG000|Overall Study|Lost to Follow-up|0|||
147382549|NCT02203513|531563943|FG001|Overall Study|Lost to Follow-up|0|||
147382550|NCT02203513|531563944|FG002|Overall Study|Lost to Follow-up|1|||
147382551|NCT02203513|531563945|FG003|Overall Study|Lost to Follow-up|1|||
147382552|NCT02203513|531563946|FG004|Overall Study|Lost to Follow-up|0|||
147382553|NCT01441596|531563947|FG000|Overall Study|Other reason not defined below|0|||
147382554|NCT01441596|531563948|FG001|Overall Study|Other reason not defined below|2|||
147382555|NCT01441596|531563949|FG002|Overall Study|Other reason not defined below|1|||
147382556|NCT01441596|531563947|FG000|Overall Study|Withdrawal by Subject|4|||
147382557|NCT01441596|531563948|FG001|Overall Study|Withdrawal by Subject|0|||
147382558|NCT01441596|531563949|FG002|Overall Study|Withdrawal by Subject|2|||
147382559|NCT01441596|531563947|FG000|Overall Study|Not treated|0|||
147382560|NCT01441596|531563948|FG001|Overall Study|Not treated|1|||
147382561|NCT01441596|531563949|FG002|Overall Study|Not treated|1|||
147382562|NCT02008916|531563950|FG000|Primary Assessment (up to Week 16)|Withdrawal by Subject|0|||
147382563|NCT02008916|531563951|FG001|Primary Assessment (up to Week 16)|Withdrawal by Subject|1|||
147382564|NCT02008916|531563952|FG002|Primary Assessment (up to Week 16)|Withdrawal by Subject|3|||
147382565|NCT02008916|531563950|FG000|Week 16 - 156|Adverse Event|4|||
147382566|NCT02008916|531563951|FG001|Week 16 - 156|Adverse Event|2|||
147382567|NCT02008916|531563952|FG002|Week 16 - 156|Adverse Event|3|||
147382568|NCT02008916|531563950|FG000|Week 16 - 156|Withdrawal by Subject|7|||
147382569|NCT02008916|531563951|FG001|Week 16 - 156|Withdrawal by Subject|3|||
147382570|NCT02008916|531563952|FG002|Week 16 - 156|Withdrawal by Subject|5|||
147382571|NCT02008916|531563950|FG000|Week 16 - 156|No longer requires treatment|0|||
147382572|NCT02008916|531563951|FG001|Week 16 - 156|No longer requires treatment|1|||
147382573|NCT02008916|531563952|FG002|Week 16 - 156|No longer requires treatment|0|||
147382574|NCT02008916|531563950|FG000|Week 16 - 156|Lost to Follow-up|5|||
147382575|NCT02008916|531563951|FG001|Week 16 - 156|Lost to Follow-up|0|||
147382576|NCT02008916|531563952|FG002|Week 16 - 156|Lost to Follow-up|0|||
147382577|NCT02008916|531563950|FG000|Week 16 - 156|Lack of Efficacy|3|||
147382578|NCT02008916|531563951|FG001|Week 16 - 156|Lack of Efficacy|5|||
147382579|NCT02008916|531563952|FG002|Week 16 - 156|Lack of Efficacy|2|||
147382580|NCT02008916|531563950|FG000|Week 16 - 156|Pregnancy|0|||
147382581|NCT02008916|531563951|FG001|Week 16 - 156|Pregnancy|1|||
147382582|NCT02008916|531563952|FG002|Week 16 - 156|Pregnancy|0|||
147382583|NCT02008916|531563950|FG000|Week 16 - 156|Physician Decision|0|||
147382584|NCT02008916|531563951|FG001|Week 16 - 156|Physician Decision|1|||
147382585|NCT02008916|531563952|FG002|Week 16 - 156|Physician Decision|0|||
147382586|NCT01528605|531563953|FG000|Overall Study|Lost to Follow-up|1|||
147382587|NCT01528605|531563954|FG001|Overall Study|Lost to Follow-up|0|||
147382588|NCT01528605|531563955|FG002|Overall Study|Lost to Follow-up|1|||
147382589|NCT01528605|531563956|FG003|Overall Study|Lost to Follow-up|1|||
147382590|NCT01528605|531563957|FG004|Overall Study|Lost to Follow-up|0|||
147382591|NCT01528605|531563958|FG005|Overall Study|Lost to Follow-up|0|||
147382592|NCT01528605|531563953|FG000|Overall Study|Death|1|||
147382593|NCT01528605|531563954|FG001|Overall Study|Death|0|||
147382594|NCT01528605|531563955|FG002|Overall Study|Death|0|||
147382595|NCT01528605|531563956|FG003|Overall Study|Death|0|||
147382596|NCT01528605|531563957|FG004|Overall Study|Death|0|||
147382597|NCT01528605|531563958|FG005|Overall Study|Death|0|||
147382598|NCT01681511|531563959|FG000|Overall Study|No Treatment Received|1|||
147382599|NCT01681511|531563960|FG001|Overall Study|No Treatment Received|3|||
147382600|NCT01681511|531563959|FG000|Overall Study|Failed Inclusion/Exclusion|3|||
147382601|NCT01681511|531563960|FG001|Overall Study|Failed Inclusion/Exclusion|0|||
147614366|NCT00839254|532403277|FG000|Overall Study|Lost to Follow-up|51|||
147614367|NCT00839254|532403278|FG001|Overall Study|Lost to Follow-up|30|||
147614368|NCT00839254|532403279|FG002|Overall Study|Lost to Follow-up|32|||
147614369|NCT00839254|532403280|FG003|Overall Study|Lost to Follow-up|24|||
147382602|NCT01681511|531563959|FG000|Overall Study|No Baseline Dips Stick & Urine Culture|3|||
147382603|NCT01681511|531563960|FG001|Overall Study|No Baseline Dips Stick & Urine Culture|6|||
147382604|NCT01681511|531563959|FG000|Overall Study|No Daily Urine Sample Collected|0|||
147382605|NCT01681511|531563960|FG001|Overall Study|No Daily Urine Sample Collected|1|||
147382606|NCT01681511|531563959|FG000|Overall Study|No post-catheter sample collected|11|||
147382607|NCT01681511|531563960|FG001|Overall Study|No post-catheter sample collected|4|||
147382608|NCT01156675|531563961|FG000|Overall Study|Death|5|||
147382609|NCT01156675|531563962|FG001|Overall Study|Death|3|||
147382610|NCT01156675|531563963|FG002|Overall Study|Death|0|||
147382611|NCT01156675|531563961|FG000|Overall Study|No data|29|||
147382612|NCT01156675|531563962|FG001|Overall Study|No data|22|||
147382613|NCT01156675|531563963|FG002|Overall Study|No data|2|||
147382614|NCT02432274|531563977|FG000|Overall Study|Death|2|||
147382615|NCT02432274|531563978|FG001|Overall Study|Death|6|||
147382616|NCT02432274|531563979|FG002|Overall Study|Death|7|||
147382617|NCT02432274|531563980|FG003|Overall Study|Death|0|||
147382618|NCT02432274|531563981|FG004|Overall Study|Death|27|||
147382619|NCT02432274|531563982|FG005|Overall Study|Death|7|||
147382620|NCT02432274|531563983|FG006|Overall Study|Death|9|||
147456378|NCT03529773|531831730|FG010|Overall Study|Protocol Violation|0|||
147456379|NCT03529773|531831731|FG011|Overall Study|Protocol Violation|0|||
147456380|NCT03529773|531831732|FG012|Overall Study|Protocol Violation|0|||
147456381|NCT03529773|531831733|FG013|Overall Study|Protocol Violation|0|||
147456382|NCT03529773|531831734|FG014|Overall Study|Protocol Violation|0|||
147456383|NCT03529773|531831735|FG015|Overall Study|Protocol Violation|0|||
147456384|NCT03529773|531831736|FG016|Overall Study|Protocol Violation|0|||
147456385|NCT03529773|531831737|FG017|Overall Study|Protocol Violation|0|||
147456386|NCT03529773|531831738|FG018|Overall Study|Protocol Violation|0|||
147456387|NCT03529773|531831739|FG019|Overall Study|Protocol Violation|0|||
147456388|NCT03529773|531831740|FG020|Overall Study|Protocol Violation|0|||
147456389|NCT03529773|531831741|FG021|Overall Study|Protocol Violation|0|||
147456390|NCT03529773|531831742|FG022|Overall Study|Protocol Violation|0|||
147456391|NCT03529773|531831743|FG023|Overall Study|Protocol Violation|0|||
147456392|NCT03529773|531831744|FG024|Overall Study|Protocol Violation|0|||
147456393|NCT03529773|531831745|FG025|Overall Study|Protocol Violation|0|||
147456394|NCT03529773|531831746|FG026|Overall Study|Protocol Violation|0|||
147456395|NCT03529773|531831747|FG027|Overall Study|Protocol Violation|0|||
147456396|NCT03529773|531831748|FG028|Overall Study|Protocol Violation|0|||
147456397|NCT03529773|531831749|FG029|Overall Study|Protocol Violation|0|||
147456398|NCT03529773|531831750|FG030|Overall Study|Protocol Violation|1|||
147456399|NCT03529773|531831751|FG031|Overall Study|Protocol Violation|0|||
147456400|NCT03529773|531831752|FG032|Overall Study|Protocol Violation|0|||
147456401|NCT03529773|531831753|FG033|Overall Study|Protocol Violation|0|||
147456402|NCT03529773|531831754|FG034|Overall Study|Protocol Violation|0|||
147456403|NCT03529773|531831755|FG035|Overall Study|Protocol Violation|0|||
147456404|NCT03529773|531831756|FG036|Overall Study|Protocol Violation|0|||
147456405|NCT03529773|531831757|FG037|Overall Study|Protocol Violation|0|||
147456406|NCT03529773|531831758|FG038|Overall Study|Protocol Violation|0|||
147456407|NCT03529773|531831759|FG039|Overall Study|Protocol Violation|0|||
147456408|NCT03529773|531831720|FG000|Overall Study|Withdrawal by Subject|0|||
147456409|NCT03529773|531831721|FG001|Overall Study|Withdrawal by Subject|0|||
147456410|NCT03529773|531831722|FG002|Overall Study|Withdrawal by Subject|0|||
147456411|NCT03529773|531831723|FG003|Overall Study|Withdrawal by Subject|0|||
147456412|NCT03529773|531831724|FG004|Overall Study|Withdrawal by Subject|0|||
147456413|NCT03529773|531831725|FG005|Overall Study|Withdrawal by Subject|0|||
147456414|NCT03529773|531831726|FG006|Overall Study|Withdrawal by Subject|0|||
147382621|NCT02432274|531563984|FG007|Overall Study|Death|14|||
147382622|NCT02432274|531563977|FG000|Overall Study|Withdrawal of Consent|0|||
147382623|NCT02432274|531563978|FG001|Overall Study|Withdrawal of Consent|0|||
147382624|NCT02432274|531563979|FG002|Overall Study|Withdrawal of Consent|0|||
147382625|NCT02432274|531563980|FG003|Overall Study|Withdrawal of Consent|0|||
147382626|NCT02432274|531563981|FG004|Overall Study|Withdrawal of Consent|2|||
147382627|NCT02432274|531563982|FG005|Overall Study|Withdrawal of Consent|0|||
147456415|NCT03529773|531831727|FG007|Overall Study|Withdrawal by Subject|1|||
147456416|NCT03529773|531831728|FG008|Overall Study|Withdrawal by Subject|0|||
147456417|NCT03529773|531831729|FG009|Overall Study|Withdrawal by Subject|1|||
147456418|NCT03529773|531831730|FG010|Overall Study|Withdrawal by Subject|1|||
147456419|NCT03529773|531831731|FG011|Overall Study|Withdrawal by Subject|0|||
147456420|NCT03529773|531831732|FG012|Overall Study|Withdrawal by Subject|0|||
147456421|NCT03529773|531831733|FG013|Overall Study|Withdrawal by Subject|0|||
147456422|NCT03529773|531831734|FG014|Overall Study|Withdrawal by Subject|0|||
147456423|NCT03529773|531831735|FG015|Overall Study|Withdrawal by Subject|3|||
147456424|NCT03529773|531831736|FG016|Overall Study|Withdrawal by Subject|0|||
147456425|NCT03529773|531831737|FG017|Overall Study|Withdrawal by Subject|2|||
147456426|NCT03529773|531831738|FG018|Overall Study|Withdrawal by Subject|3|||
147456427|NCT03529773|531831739|FG019|Overall Study|Withdrawal by Subject|1|||
147456428|NCT03529773|531831740|FG020|Overall Study|Withdrawal by Subject|3|||
147456429|NCT03529773|531831741|FG021|Overall Study|Withdrawal by Subject|1|||
147456430|NCT03529773|531831742|FG022|Overall Study|Withdrawal by Subject|1|||
147456431|NCT03529773|531831743|FG023|Overall Study|Withdrawal by Subject|2|||
147456432|NCT03529773|531831744|FG024|Overall Study|Withdrawal by Subject|2|||
147456433|NCT03529773|531831745|FG025|Overall Study|Withdrawal by Subject|4|||
147456434|NCT03529773|531831746|FG026|Overall Study|Withdrawal by Subject|2|||
147456435|NCT03529773|531831747|FG027|Overall Study|Withdrawal by Subject|1|||
147456436|NCT03529773|531831748|FG028|Overall Study|Withdrawal by Subject|1|||
147456437|NCT03529773|531831749|FG029|Overall Study|Withdrawal by Subject|0|||
147456438|NCT03529773|531831750|FG030|Overall Study|Withdrawal by Subject|0|||
147456439|NCT03529773|531831751|FG031|Overall Study|Withdrawal by Subject|0|||
147456440|NCT03529773|531831752|FG032|Overall Study|Withdrawal by Subject|0|||
147456441|NCT03529773|531831753|FG033|Overall Study|Withdrawal by Subject|0|||
147456442|NCT03529773|531831754|FG034|Overall Study|Withdrawal by Subject|1|||
147456443|NCT03529773|531831755|FG035|Overall Study|Withdrawal by Subject|2|||
147456444|NCT03529773|531831756|FG036|Overall Study|Withdrawal by Subject|0|||
147456445|NCT03529773|531831757|FG037|Overall Study|Withdrawal by Subject|2|||
147382628|NCT02432274|531563983|FG006|Overall Study|Withdrawal of Consent|1|||
147382629|NCT02432274|531563984|FG007|Overall Study|Withdrawal of Consent|2|||
147382630|NCT00090519|531563985|FG000|Overall Study|Adverse Event|5|||
147382631|NCT00090519|531563986|FG001|Overall Study|Adverse Event|4|||
147382632|NCT00090519|531563985|FG000|Overall Study|Death|9|||
147382633|NCT00090519|531563986|FG001|Overall Study|Death|9|||
147382634|NCT00090519|531563985|FG000|Overall Study|Lost to Follow-up|26|||
147382635|NCT00090519|531563986|FG001|Overall Study|Lost to Follow-up|29|||
147382636|NCT00090519|531563985|FG000|Overall Study|Withdrawal by Subject|28|||
147382637|NCT00090519|531563986|FG001|Overall Study|Withdrawal by Subject|29|||
147614370|NCT00839254|532403281|FG004|Overall Study|Lost to Follow-up|8|||
147614371|NCT00839254|532403282|FG005|Overall Study|Lost to Follow-up|8|||
147614372|NCT00839254|532403283|FG006|Overall Study|Lost to Follow-up|4|||
147614373|NCT00839254|532403284|FG007|Overall Study|Lost to Follow-up|2|||
147614374|NCT02359994|532403288|FG000|Overall Population Study|Adverse Event|1|||
147614375|NCT02359994|532403289|FG001|Overall Population Study|Adverse Event|1|||
147614376|NCT02359994|532403288|FG000|Overall Population Study|Death|1|||
147614377|NCT02359994|532403289|FG001|Overall Population Study|Death|5|||
147614378|NCT02359994|532403288|FG000|Overall Population Study|Lost to Follow-up|1|||
147614379|NCT02359994|532403289|FG001|Overall Population Study|Lost to Follow-up|1|||
147614380|NCT02359994|532403288|FG000|Overall Population Study|Withdrawal by Subject|1|||
147614381|NCT02359994|532403289|FG001|Overall Population Study|Withdrawal by Subject|0|||
147614382|NCT02359994|532403288|FG000|Overall Population Study|Canceled appointment and followed up with their primary care physician instead.|1|||
147614383|NCT02359994|532403289|FG001|Overall Population Study|Canceled appointment and followed up with their primary care physician instead.|0|||
147614384|NCT02359994|532403288|FG000|Overall Population Study|Remained in the long term care facility to which the subject was discharged.|0|||
147614385|NCT02359994|532403289|FG001|Overall Population Study|Remained in the long term care facility to which the subject was discharged.|1|||
147382638|NCT00090519|531563985|FG000|Overall Study|Physician Decision|2|||
147382639|NCT00090519|531563986|FG001|Overall Study|Physician Decision|3|||
147382640|NCT00090519|531563985|FG000|Overall Study|Sponsor Decision|3|||
147382641|NCT00090519|531563986|FG001|Overall Study|Sponsor Decision|1|||
147382642|NCT00116649|531563987|FG000|Overall Study|Adverse Event|20|||
147382643|NCT00116649|531563987|FG000|Overall Study|Lack of Efficacy|1|||
147382644|NCT00116649|531563987|FG000|Overall Study|Lost to Follow-up|32|||
147382645|NCT00116649|531563987|FG000|Overall Study|Withdrawal by Subject|68|||
147382646|NCT00116649|531563987|FG000|Overall Study|Local Skin Reaction|9|||
147382647|NCT00116649|531563987|FG000|Overall Study|Various Reasons|18|||
147382648|NCT00116649|531563987|FG000|Overall Study|Protocol Specified|7|||
147382649|NCT02161146|531563988|FG000|Overall Study|Adverse Event|1|||
147382650|NCT02161146|531563989|FG001|Overall Study|Adverse Event|1|||
147382651|NCT02161146|531563990|FG002|Overall Study|Adverse Event|0|||
147382652|NCT02161146|531563991|FG003|Overall Study|Adverse Event|1|||
147382653|NCT02161146|531563992|FG004|Overall Study|Adverse Event|0|||
147382654|NCT02161146|531563988|FG000|Overall Study|Lost to Follow-up|0|||
147382655|NCT02161146|531563989|FG001|Overall Study|Lost to Follow-up|1|||
147382656|NCT02161146|531563990|FG002|Overall Study|Lost to Follow-up|0|||
147382657|NCT02161146|531563991|FG003|Overall Study|Lost to Follow-up|0|||
147382658|NCT02161146|531563992|FG004|Overall Study|Lost to Follow-up|0|||
147382659|NCT02161146|531563988|FG000|Overall Study|Personal Reasons|0|||
147382660|NCT02161146|531563989|FG001|Overall Study|Personal Reasons|1|||
147382661|NCT02161146|531563990|FG002|Overall Study|Personal Reasons|0|||
147382662|NCT02161146|531563991|FG003|Overall Study|Personal Reasons|2|||
147382663|NCT02161146|531563992|FG004|Overall Study|Personal Reasons|1|||
147382664|NCT02161146|531563988|FG000|Overall Study|Other Miscellaneous Reasons|0|||
147382665|NCT02161146|531563989|FG001|Overall Study|Other Miscellaneous Reasons|1|||
147382666|NCT02161146|531563990|FG002|Overall Study|Other Miscellaneous Reasons|0|||
147382667|NCT02161146|531563991|FG003|Overall Study|Other Miscellaneous Reasons|0|||
147382668|NCT02161146|531563992|FG004|Overall Study|Other Miscellaneous Reasons|0|||
147382669|NCT00845520|531563993|FG000|Overall Study|Death|1|||
147382670|NCT00845520|531563994|FG001|Overall Study|Death|2|||
147382671|NCT00845520|531563995|FG002|Overall Study|Death|0|||
147614386|NCT02359994|532403288|FG000|Extended Oncology 24-Month Survival|Death|19|||
147614387|NCT02359994|532403289|FG001|Extended Oncology 24-Month Survival|Death|21|||
147382672|NCT00845520|531563993|FG000|Overall Study|Lost to Follow-up|1|||
147382673|NCT00845520|531563994|FG001|Overall Study|Lost to Follow-up|0|||
147382674|NCT00845520|531563995|FG002|Overall Study|Lost to Follow-up|0|||
147382675|NCT00845520|531563993|FG000|Overall Study|Adverse Event|0|||
147382676|NCT00845520|531563994|FG001|Overall Study|Adverse Event|0|||
147382677|NCT00845520|531563995|FG002|Overall Study|Adverse Event|1|||
147382678|NCT02613403|531563996|FG000|Overall Study|Lost to Follow-up|0|||
147382679|NCT02613403|531563997|FG001|Overall Study|Lost to Follow-up|1|||
147382680|NCT02613403|531563998|FG002|Overall Study|Lost to Follow-up|0|||
147382681|NCT02613403|531563999|FG003|Overall Study|Lost to Follow-up|0|||
147382682|NCT02613403|531564000|FG004|Overall Study|Lost to Follow-up|0|||
147382683|NCT02613403|531563996|FG000|Overall Study|Withdrawal by Subject|2|||
147382684|NCT02613403|531563997|FG001|Overall Study|Withdrawal by Subject|0|||
147382685|NCT02613403|531563998|FG002|Overall Study|Withdrawal by Subject|0|||
147382686|NCT02613403|531563999|FG003|Overall Study|Withdrawal by Subject|0|||
147382687|NCT02613403|531564000|FG004|Overall Study|Withdrawal by Subject|0|||
147382688|NCT02807857|531564001|FG000|Enrolled Set|Patients not suitable for follow-up.|551|||
147382689|NCT02807857|531564001|FG000|Follow-Up Set|Study Terminated By Sponsor|131|||
147382690|NCT02807857|531564001|FG000|Follow-Up Set|Withdrawal by Subject|8|||
147382691|NCT02807857|531564001|FG000|Follow-Up Set|Lost to Follow-up|7|||
147382692|NCT02807857|531564001|FG000|Follow-Up Set|Physician Decision|6|||
147382693|NCT02807857|531564001|FG000|Follow-Up Set|Adverse Event|3|||
147382694|NCT02807857|531564001|FG000|Follow-Up Set|Death|27|||
147382695|NCT02807857|531564001|FG000|Follow-Up Set|Relocation|2|||
147382696|NCT01240590|531564004|FG000|Phase I|Refused further treatment|0|||
147382697|NCT01240590|531564005|FG001|Phase I|Refused further treatment|0|||
147382698|NCT01240590|531564006|FG002|Phase I|Refused further treatment|3|||
147382699|NCT01240590|531564007|FG003|Phase I|Refused further treatment|0|||
147382700|NCT01240590|531564008|FG004|Phase I|Refused further treatment|0|||
147382701|NCT01240590|531564004|FG000|Phase II|Refused further treatment|0|||
147382702|NCT01240590|531564005|FG001|Phase II|Refused further treatment|0|||
147382703|NCT01240590|531564006|FG002|Phase II|Refused further treatment|0|||
147382704|NCT01240590|531564007|FG003|Phase II|Refused further treatment|2|||
147382705|NCT01240590|531564008|FG004|Phase II|Refused further treatment|1|||
147382706|NCT01075152|531564010|FG000|Overall Study|Withdrawal by Subject|1|||
147382707|NCT01075152|531564011|FG001|Overall Study|Withdrawal by Subject|0|||
147382708|NCT01079949|531564012|FG000|Overall Study|Withdrawal before r-hCG administration|2|||
147382709|NCT01079949|531564013|FG001|Overall Study|Withdrawal before r-hCG administration|3|||
147382710|NCT01079949|531564012|FG000|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|4|||
147382711|NCT01079949|531564013|FG001|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|8|||
147382712|NCT01079949|531564012|FG000|Overall Study|Withdrawal between OPU - embryo transfer|8|||
147382713|NCT01079949|531564013|FG001|Overall Study|Withdrawal between OPU - embryo transfer|2|||
147382714|NCT01079949|531564012|FG000|Overall Study|Randomized but not treated|1|||
147382715|NCT01079949|531564013|FG001|Overall Study|Randomized but not treated|0|||
147382716|NCT02144285|531564014|FG000|Overall Study|Withdrawal by Subject|0|||
147382717|NCT02144285|531564015|FG001|Overall Study|Withdrawal by Subject|0|||
147382718|NCT02144285|531564016|FG002|Overall Study|Withdrawal by Subject|0|||
147382719|NCT02144285|531564017|FG003|Overall Study|Withdrawal by Subject|0|||
147382720|NCT02144285|531564018|FG004|Overall Study|Withdrawal by Subject|1|||
147382721|NCT02144285|531564019|FG005|Overall Study|Withdrawal by Subject|0|||
147382722|NCT02144285|531564020|FG006|Overall Study|Withdrawal by Subject|0|||
147382723|NCT02144285|531564021|FG007|Overall Study|Withdrawal by Subject|0|||
147382724|NCT02144285|531564022|FG008|Overall Study|Withdrawal by Subject|0|||
147382725|NCT02144285|531564023|FG009|Overall Study|Withdrawal by Subject|0|||
147382726|NCT01529632|531564024|FG000|Overall Study|Administrative problem|2|||
147382727|NCT01529632|531564025|FG001|Overall Study|Administrative problem|1|||
147382728|NCT01529632|531564024|FG000|Overall Study|Protocol Violation|0|||
147382729|NCT01529632|531564025|FG001|Overall Study|Protocol Violation|1|||
147382730|NCT01529632|531564024|FG000|Overall Study|Adverse Event|1|||
147382731|NCT01529632|531564025|FG001|Overall Study|Adverse Event|1|||
147382732|NCT00452452|531564026|FG000|Overall Study|Protocol Violation|0|||
147382733|NCT00452452|531564027|FG001|Overall Study|Protocol Violation|0|||
147382734|NCT00452452|531564028|FG002|Overall Study|Protocol Violation|1|||
147382735|NCT00452452|531564026|FG000|Overall Study|Withdrawal by Subject|1|||
147382736|NCT00452452|531564027|FG001|Overall Study|Withdrawal by Subject|0|||
147382737|NCT00452452|531564028|FG002|Overall Study|Withdrawal by Subject|0|||
147382738|NCT00452452|531564026|FG000|Overall Study|Lost to Follow-up|1|||
147382739|NCT00452452|531564027|FG001|Overall Study|Lost to Follow-up|0|||
147382740|NCT00452452|531564028|FG002|Overall Study|Lost to Follow-up|0|||
147382741|NCT04620733|531565399|FG000|Overall Study|Adverse Event|4|||
147382742|NCT04620733|531565400|FG001|Overall Study|Adverse Event|3|||
147382743|NCT04620733|531565399|FG000|Overall Study|Withdrawal by Subject|2|||
147382744|NCT04620733|531565400|FG001|Overall Study|Withdrawal by Subject|5|||
147382745|NCT04620733|531565399|FG000|Overall Study|Lost to Follow-up|1|||
147382746|NCT04620733|531565400|FG001|Overall Study|Lost to Follow-up|1|||
147382747|NCT04620733|531565399|FG000|Overall Study|Protocol Deviation|1|||
147382748|NCT04620733|531565400|FG001|Overall Study|Protocol Deviation|1|||
147382749|NCT04620733|531565399|FG000|Overall Study|Reason Not Specified|0|||
147382750|NCT04620733|531565400|FG001|Overall Study|Reason Not Specified|1|||
147382751|NCT00451906|531565411|FG000|Overall Study|Adverse Event|515|||
147382752|NCT00451906|531565411|FG000|Overall Study|Lost to Follow-up|31|||
147382753|NCT00451906|531565411|FG000|Overall Study|Withdrawal by Subject|111|||
147382754|NCT00451906|531565411|FG000|Overall Study|Protocol Violation|21|||
147382755|NCT00451906|531565411|FG000|Overall Study|Progressive disease|1328|||
147382756|NCT00451906|531565411|FG000|Overall Study|Termination of the study|108|||
147382757|NCT00451906|531565411|FG000|Overall Study|Other Reasons|121|||
147382758|NCT00451906|531565411|FG000|Overall Study|Did not complete final visit|4|||
147382759|NCT02121808|531565417|FG000|Overall Study|Technical problem|3|||
147382760|NCT02164578|531565418|FG000|Treatment Period|Withdrawal by Subject|3|||
147382761|NCT02164578|531565419|FG001|Treatment Period|Withdrawal by Subject|3|||
147382762|NCT02164578|531565418|FG000|Treatment Period|Adverse Event|13|||
147382763|NCT02164578|531565419|FG001|Treatment Period|Adverse Event|6|||
147382764|NCT02164578|531565418|FG000|Treatment Period|Early termination due to expiry of study medication|1|||
147614388|NCT02359994|532403288|FG000|Extended Oncology 24-Month Survival|Lost to Follow-up|1|||
147614389|NCT02359994|532403289|FG001|Extended Oncology 24-Month Survival|Lost to Follow-up|0|||
147614390|NCT04597632|532403290|FG000|Overall Study|Withdrawal by Subject|10|||
147614391|NCT04597632|532403290|FG000|Overall Study|Lost to Follow-up|1|||
147614392|NCT04597632|532403290|FG000|Overall Study|Death|1|||
147614393|NCT04597632|532403290|FG000|Overall Study|Adverse Event|5|||
147614394|NCT01823835|532403291|FG000|Overall Study|Adverse Event|0|||
147614395|NCT01823835|532403292|FG001|Overall Study|Adverse Event|0|||
147614396|NCT01823835|532403293|FG002|Overall Study|Adverse Event|0|||
147614397|NCT01823835|532403294|FG003|Overall Study|Adverse Event|0|||
147614398|NCT01823835|532403295|FG004|Overall Study|Adverse Event|1|||
147614399|NCT01823835|532403296|FG005|Overall Study|Adverse Event|0|||
147614400|NCT01823835|532403297|FG006|Overall Study|Adverse Event|1|||
147614401|NCT01823835|532403298|FG007|Overall Study|Adverse Event|0|||
147614402|NCT01823835|532403299|FG008|Overall Study|Adverse Event|0|||
147614403|NCT01823835|532403300|FG009|Overall Study|Adverse Event|0|||
147614404|NCT01823835|532403301|FG010|Overall Study|Adverse Event|1|||
147614405|NCT01823835|532403302|FG011|Overall Study|Adverse Event|2|||
147614406|NCT01823835|532403303|FG012|Overall Study|Adverse Event|0|||
147614407|NCT01823835|532403304|FG013|Overall Study|Adverse Event|0|||
147614408|NCT01823835|532403305|FG014|Overall Study|Adverse Event|0|||
147614409|NCT01823835|532403291|FG000|Overall Study|Physician Decision|0|||
147614410|NCT01823835|532403292|FG001|Overall Study|Physician Decision|0|||
147614411|NCT01823835|532403293|FG002|Overall Study|Physician Decision|0|||
147614412|NCT01823835|532403294|FG003|Overall Study|Physician Decision|0|||
147614413|NCT01823835|532403295|FG004|Overall Study|Physician Decision|0|||
147614414|NCT01823835|532403296|FG005|Overall Study|Physician Decision|0|||
147614415|NCT01823835|532403297|FG006|Overall Study|Physician Decision|0|||
147614416|NCT01823835|532403298|FG007|Overall Study|Physician Decision|0|||
147614417|NCT01823835|532403299|FG008|Overall Study|Physician Decision|0|||
147614418|NCT01823835|532403300|FG009|Overall Study|Physician Decision|0|||
147614419|NCT01823835|532403301|FG010|Overall Study|Physician Decision|0|||
147614420|NCT01823835|532403302|FG011|Overall Study|Physician Decision|2|||
147614421|NCT01823835|532403303|FG012|Overall Study|Physician Decision|0|||
147614422|NCT01823835|532403304|FG013|Overall Study|Physician Decision|0|||
147614423|NCT01823835|532403305|FG014|Overall Study|Physician Decision|0|||
147614424|NCT01823835|532403291|FG000|Overall Study|Progressive Disease|3|||
147614425|NCT01823835|532403292|FG001|Overall Study|Progressive Disease|4|||
147614426|NCT01823835|532403293|FG002|Overall Study|Progressive Disease|3|||
147614427|NCT01823835|532403294|FG003|Overall Study|Progressive Disease|6|||
147614428|NCT01823835|532403295|FG004|Overall Study|Progressive Disease|4|||
147614429|NCT01823835|532403296|FG005|Overall Study|Progressive Disease|6|||
147382765|NCT02164578|531565419|FG001|Treatment Period|Early termination due to expiry of study medication|0|||
147382766|NCT02164578|531565418|FG000|Treatment Period|Protocol Violation|0|||
147382767|NCT02164578|531565419|FG001|Treatment Period|Protocol Violation|2|||
147614430|NCT01823835|532403297|FG006|Overall Study|Progressive Disease|5|||
147614431|NCT01823835|532403298|FG007|Overall Study|Progressive Disease|3|||
147614432|NCT01823835|532403299|FG008|Overall Study|Progressive Disease|3|||
147382768|NCT02164578|531565418|FG000|Extension Period|Withdrawal by Subject|2|||
147382769|NCT02164578|531565419|FG001|Extension Period|Withdrawal by Subject|0|||
147382770|NCT02164578|531565418|FG000|Extension Period|Adverse Event|4|||
147382771|NCT02164578|531565419|FG001|Extension Period|Adverse Event|0|||
147382772|NCT02164578|531565418|FG000|Extension Period|Expiry of study medication|1|||
147382773|NCT02164578|531565419|FG001|Extension Period|Expiry of study medication|0|||
147382774|NCT02164578|531565418|FG000|Extension Period|Protocol Violation|0|||
147382775|NCT02164578|531565419|FG001|Extension Period|Protocol Violation|1|||
147382776|NCT03924193|531565420|FG000|Overall Study|Adverse Event|10|||
147382777|NCT03924193|531565421|FG001|Overall Study|Adverse Event|0|||
147382778|NCT03924193|531565422|FG002|Overall Study|Adverse Event|10|||
147614433|NCT01823835|532403300|FG009|Overall Study|Progressive Disease|18|||
147614434|NCT01823835|532403301|FG010|Overall Study|Progressive Disease|8|||
147614435|NCT01823835|532403302|FG011|Overall Study|Progressive Disease|46|||
147614436|NCT01823835|532403303|FG012|Overall Study|Progressive Disease|18|||
147614437|NCT01823835|532403304|FG013|Overall Study|Progressive Disease|4|||
147664896|NCT02810418|532597948|FG003|Arm B Dose Escalation|Adverse Event|0|||
147664897|NCT02810418|532597949|FG004|Arm B Dose Escalation|Adverse Event|1|||
147382779|NCT03924193|531565420|FG000|Overall Study|Withdrawal by Subject|5|||
147382780|NCT03924193|531565421|FG001|Overall Study|Withdrawal by Subject|10|||
147614438|NCT01823835|532403305|FG014|Overall Study|Progressive Disease|6|||
147614439|NCT01823835|532403291|FG000|Overall Study|Study Termination|0|||
147614440|NCT01823835|532403292|FG001|Overall Study|Study Termination|0|||
147614441|NCT01823835|532403293|FG002|Overall Study|Study Termination|0|||
147382781|NCT03924193|531565422|FG002|Overall Study|Withdrawal by Subject|2|||
147382782|NCT00647699|531565423|FG000|Overall Study|Lost to Follow-up|5|||
147382783|NCT00647699|531565424|FG001|Overall Study|Lost to Follow-up|4|||
147382784|NCT00647699|531565423|FG000|Overall Study|Withdrawal by Subject|3|||
147614442|NCT01823835|532403294|FG003|Overall Study|Study Termination|0|||
147614443|NCT01823835|532403295|FG004|Overall Study|Study Termination|1|||
147614444|NCT01823835|532403296|FG005|Overall Study|Study Termination|0|||
147382785|NCT00647699|531565424|FG001|Overall Study|Withdrawal by Subject|8|||
147382786|NCT03029585|531565425|FG000|Overall Study|Death|1|||
147382787|NCT03029585|531565426|FG001|Overall Study|Death|1|||
147382788|NCT03029585|531565425|FG000|Overall Study|Withdrawal by Subject|1|||
147382789|NCT03029585|531565426|FG001|Overall Study|Withdrawal by Subject|0|||
147382790|NCT02165202|531565427|FG000|Oral Phase|Refused further participation|5|||
147382791|NCT02165202|531565428|FG001|Oral Phase|Refused further participation|1|||
147382792|NCT02165202|531565427|FG000|Oral Phase|Study product Related Toxicity|1|||
147382793|NCT02165202|531565428|FG001|Oral Phase|Study product Related Toxicity|0|||
147382794|NCT02165202|531565427|FG000|Oral Phase|Unable to contact Participant|1|||
147382795|NCT02165202|531565428|FG001|Oral Phase|Unable to contact Participant|1|||
147382796|NCT02165202|531565427|FG000|Oral Phase|Clinical reasons|1|||
147382797|NCT02165202|531565428|FG001|Oral Phase|Clinical reasons|0|||
147382798|NCT02165202|531565427|FG000|Oral Phase|QTcF>500 ms or increase of>60 ms|1|||
147382799|NCT02165202|531565428|FG001|Oral Phase|QTcF>500 ms or increase of>60 ms|0|||
147382800|NCT02165202|531565427|FG000|Oral Phase|CMC advised termination|1|||
147382801|NCT02165202|531565428|FG001|Oral Phase|CMC advised termination|0|||
147382802|NCT02165202|531565427|FG000|Oral Phase|Relocated, no follow-up planned|1|||
147382803|NCT02165202|531565428|FG001|Oral Phase|Relocated, no follow-up planned|0|||
147382804|NCT02165202|531565427|FG000|Oral Phase|Abnormal EKG|0|||
147382805|NCT02165202|531565428|FG001|Oral Phase|Abnormal EKG|1|||
147382806|NCT02165202|531565427|FG000|Injection Phase|Abnormal Lab Value|5|||
147382807|NCT02165202|531565428|FG001|Injection Phase|Abnormal Lab Value|1|||
147382808|NCT02165202|531565427|FG000|Injection Phase|Reactive HIV or HIV Suspected|0|||
147382809|NCT02165202|531565428|FG001|Injection Phase|Reactive HIV or HIV Suspected|2|||
147382810|NCT02165202|531565427|FG000|Injection Phase|Unable to attend within Visit Window|1|||
147382811|NCT02165202|531565428|FG001|Injection Phase|Unable to attend within Visit Window|0|||
147382812|NCT02165202|531565427|FG000|Injection Phase|QTcF>500 ms or increase of>60 ms|0|||
147382813|NCT02165202|531565428|FG001|Injection Phase|QTcF>500 ms or increase of>60 ms|1|||
147382814|NCT02165202|531565427|FG000|Injection Phase|End of Study|2|||
147382815|NCT02165202|531565428|FG001|Injection Phase|End of Study|1|||
147382816|NCT02165202|531565427|FG000|Injection Phase|Study Product related Toxicity|1|||
147382817|NCT02165202|531565428|FG001|Injection Phase|Study Product related Toxicity|0|||
147382818|NCT02165202|531565427|FG000|Injection Phase|No longer interested|0|||
147382819|NCT02165202|531565428|FG001|Injection Phase|No longer interested|1|||
147382820|NCT02165202|531565427|FG000|Injection Phase|Participant unwilling to comply|1|||
147382821|NCT02165202|531565428|FG001|Injection Phase|Participant unwilling to comply|0|||
147382822|NCT01975701|531565436|FG000|Overall Study|Lost to Follow-up|1|||
147382823|NCT01975701|531565436|FG000|Overall Study|Death|23|||
147382824|NCT01975701|531565436|FG000|Overall Study|Physician Decision|1|||
147382825|NCT02753075|531565437|FG000|Overall Study|Adverse Event|2|||
147382826|NCT02753075|531565438|FG001|Overall Study|Adverse Event|1|||
147382827|NCT02753075|531565439|FG002|Overall Study|Adverse Event|0|||
147382828|NCT02753075|531565437|FG000|Overall Study|Lost to Follow-up|2|||
147382829|NCT02753075|531565438|FG001|Overall Study|Lost to Follow-up|0|||
147382830|NCT02753075|531565439|FG002|Overall Study|Lost to Follow-up|0|||
147382831|NCT02753075|531565437|FG000|Overall Study|Withdrawal of Consent|1|||
147382832|NCT02753075|531565438|FG001|Overall Study|Withdrawal of Consent|1|||
147382833|NCT02753075|531565439|FG002|Overall Study|Withdrawal of Consent|3|||
147382834|NCT02753075|531565437|FG000|Overall Study|Physician Decision|3|||
147382835|NCT02753075|531565438|FG001|Overall Study|Physician Decision|1|||
147382836|NCT02753075|531565439|FG002|Overall Study|Physician Decision|0|||
147382837|NCT02152384|531565442|FG000|Period 1|Withdrawal by Subject|0|||
147382838|NCT02152384|531565443|FG001|Period 1|Withdrawal by Subject|1|||
147382839|NCT02152384|531565442|FG000|Period 1|Adverse Event|1|||
147382840|NCT02152384|531565443|FG001|Period 1|Adverse Event|1|||
147382841|NCT00603798|531565446|FG000|Overall Study|Adverse Event|4|||
147382842|NCT00603798|531565447|FG001|Overall Study|Adverse Event|2|||
147614445|NCT01823835|532403297|FG006|Overall Study|Study Termination|0|||
147382843|NCT00603798|531565448|FG002|Overall Study|Adverse Event|1|||
147382844|NCT00603798|531565446|FG000|Overall Study|Withdrawal by Subject|4|||
147382845|NCT00603798|531565447|FG001|Overall Study|Withdrawal by Subject|3|||
147382846|NCT00603798|531565448|FG002|Overall Study|Withdrawal by Subject|4|||
147382847|NCT00603798|531565446|FG000|Overall Study|Lost to Follow-up|1|||
147382848|NCT00603798|531565447|FG001|Overall Study|Lost to Follow-up|0|||
147382849|NCT00603798|531565448|FG002|Overall Study|Lost to Follow-up|1|||
147382850|NCT00603798|531565446|FG000|Overall Study|Non-compliance with study procedures|0|||
147382851|NCT00603798|531565447|FG001|Overall Study|Non-compliance with study procedures|1|||
147382852|NCT00603798|531565448|FG002|Overall Study|Non-compliance with study procedures|0|||
147382853|NCT00603798|531565446|FG000|Overall Study|Not due to AE|1|||
147382854|NCT00603798|531565447|FG001|Overall Study|Not due to AE|1|||
147382855|NCT00603798|531565448|FG002|Overall Study|Not due to AE|4|||
147382856|NCT04361617|531565452|FG000|Overall Study|Withdrawal by Subject|0|||
147382857|NCT04361617|531565453|FG001|Overall Study|Withdrawal by Subject|1|||
147382858|NCT02005484|531565455|FG000|Overall Study|Death|1|||
147382859|NCT02005484|531565455|FG000|Overall Study|Disease progression|1|||
147382860|NCT02005484|531565455|FG000|Overall Study|Changed to a Different Study|1|||
147382861|NCT02005484|531565455|FG000|Overall Study|Sponsor decision|1|||
147382862|NCT02584257|531565461|FG000|Period 1|Withdrawal by Subject|0|||
147382863|NCT02584257|531565462|FG001|Period 1|Withdrawal by Subject|0|||
147382864|NCT02584257|531565463|FG002|Period 1|Withdrawal by Subject|0|||
147382865|NCT02584257|531565464|FG003|Period 1|Withdrawal by Subject|0|||
147382866|NCT02584257|531565465|FG004|Period 1|Withdrawal by Subject|0|||
147382867|NCT02584257|531565466|FG005|Period 1|Withdrawal by Subject|0|||
147382868|NCT02584257|531565467|FG006|Period 1|Withdrawal by Subject|1|||
147382869|NCT02584257|531565468|FG007|Period 1|Withdrawal by Subject|0|||
147382870|NCT02584257|531565469|FG008|Period 1|Withdrawal by Subject|0|||
147382871|NCT02584257|531565461|FG000|Period 2|Physician Decision|1|||
147382872|NCT02584257|531565462|FG001|Period 2|Physician Decision|0|||
147382873|NCT02584257|531565463|FG002|Period 2|Physician Decision|0|||
147382874|NCT02584257|531565464|FG003|Period 2|Physician Decision|0|||
147382875|NCT02584257|531565465|FG004|Period 2|Physician Decision|0|||
147382876|NCT02584257|531565466|FG005|Period 2|Physician Decision|0|||
147382877|NCT02584257|531565467|FG006|Period 2|Physician Decision|0|||
147382878|NCT02584257|531565468|FG007|Period 2|Physician Decision|0|||
147382879|NCT02584257|531565469|FG008|Period 2|Physician Decision|0|||
147382880|NCT02584257|531565461|FG000|Period 2|Adverse Event|0|||
147382881|NCT02584257|531565462|FG001|Period 2|Adverse Event|1|||
147382882|NCT02584257|531565463|FG002|Period 2|Adverse Event|0|||
147382883|NCT02584257|531565464|FG003|Period 2|Adverse Event|0|||
147382884|NCT02584257|531565465|FG004|Period 2|Adverse Event|0|||
147382885|NCT02584257|531565466|FG005|Period 2|Adverse Event|0|||
147382886|NCT02584257|531565467|FG006|Period 2|Adverse Event|0|||
147382887|NCT02584257|531565468|FG007|Period 2|Adverse Event|0|||
147382888|NCT02584257|531565469|FG008|Period 2|Adverse Event|0|||
147382889|NCT02137785|531565470|FG000|Overall Study|Lost to Follow-up|1|||
147382890|NCT02137785|531565471|FG001|Overall Study|Lost to Follow-up|0|||
147382891|NCT02137785|531565470|FG000|Overall Study|Withdrawal by Subject|1|||
147382892|NCT02137785|531565471|FG001|Overall Study|Withdrawal by Subject|4|||
147382893|NCT02137785|531565470|FG000|Overall Study|subject moved out of state|1|||
147382894|NCT02137785|531565471|FG001|Overall Study|subject moved out of state|0|||
147382895|NCT01670877|531565472|FG000|Part I and Part 2|Grade 2 vomiting and progressive disease|0|||
147382896|NCT01670877|531565473|FG001|Part I and Part 2|Grade 2 vomiting and progressive disease|1|||
147382897|NCT01670877|531565474|FG002|Part I and Part 2|Grade 2 vomiting and progressive disease|0|||
147382898|NCT01670877|531565475|FG003|Part I and Part 2|Grade 2 vomiting and progressive disease|0|||
147382899|NCT01670877|531565476|FG004|Part I and Part 2|Grade 2 vomiting and progressive disease|0|||
147382900|NCT01670877|531565477|FG005|Part I and Part 2|Grade 2 vomiting and progressive disease|0|||
147382901|NCT01670877|531565472|FG000|Part I and Part 2|Grade 3 diarrhea and withdrawal|0|||
147382902|NCT01670877|531565473|FG001|Part I and Part 2|Grade 3 diarrhea and withdrawal|0|||
147382903|NCT01670877|531565474|FG002|Part I and Part 2|Grade 3 diarrhea and withdrawal|1|||
147382904|NCT01670877|531565475|FG003|Part I and Part 2|Grade 3 diarrhea and withdrawal|0|||
147382905|NCT01670877|531565476|FG004|Part I and Part 2|Grade 3 diarrhea and withdrawal|0|||
147382906|NCT01670877|531565477|FG005|Part I and Part 2|Grade 3 diarrhea and withdrawal|0|||
147382907|NCT01670877|531565472|FG000|Part I and Part 2|Grade 2 vomiting|0|||
147382908|NCT01670877|531565473|FG001|Part I and Part 2|Grade 2 vomiting|0|||
147382909|NCT01670877|531565474|FG002|Part I and Part 2|Grade 2 vomiting|0|||
147382910|NCT01670877|531565475|FG003|Part I and Part 2|Grade 2 vomiting|1|||
147382911|NCT01670877|531565476|FG004|Part I and Part 2|Grade 2 vomiting|0|||
147382912|NCT01670877|531565477|FG005|Part I and Part 2|Grade 2 vomiting|0|||
147382913|NCT01670877|531565472|FG000|Part I and Part 2|Grade 3 dizziness and progressive disease|0|||
147382914|NCT01670877|531565473|FG001|Part I and Part 2|Grade 3 dizziness and progressive disease|0|||
147382915|NCT01670877|531565474|FG002|Part I and Part 2|Grade 3 dizziness and progressive disease|0|||
147382916|NCT01670877|531565475|FG003|Part I and Part 2|Grade 3 dizziness and progressive disease|1|||
147382917|NCT01670877|531565476|FG004|Part I and Part 2|Grade 3 dizziness and progressive disease|0|||
147382918|NCT01670877|531565477|FG005|Part I and Part 2|Grade 3 dizziness and progressive disease|0|||
147614446|NCT01823835|532403298|FG007|Overall Study|Study Termination|0|||
147614447|NCT01823835|532403299|FG008|Overall Study|Study Termination|0|||
147614448|NCT01823835|532403300|FG009|Overall Study|Study Termination|0|||
147382919|NCT01670877|531565472|FG000|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0|||
147382920|NCT01670877|531565473|FG001|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0|||
147382921|NCT01670877|531565474|FG002|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0|||
147382922|NCT01670877|531565475|FG003|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|1|||
147382923|NCT01670877|531565476|FG004|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0|||
147382924|NCT01670877|531565477|FG005|Part I and Part 2|Grade 3 diarrhea and duodenal ulcer|0|||
147382925|NCT00417885|531565478|FG000|Overall Study|Adverse Event|1|||
147382926|NCT00417885|531565478|FG000|Overall Study|Objective Progression or Relapse|3|||
147382927|NCT00417885|531565478|FG000|Overall Study|Transferred to Another Sunitinib Study|2|||
147382928|NCT02309892|531565479|FG000|Overall Study|Physician Decision|1|||
147382929|NCT02309892|531565480|FG001|Overall Study|Physician Decision|0|||
147382930|NCT02309892|531565481|FG002|Overall Study|Physician Decision|0|||
147382931|NCT02309892|531565482|FG003|Overall Study|Physician Decision|0|||
147382932|NCT02309892|531565483|FG004|Overall Study|Physician Decision|0|||
147382933|NCT02309892|531565484|FG005|Overall Study|Physician Decision|0|||
147382934|NCT02309892|531565485|FG006|Overall Study|Physician Decision|0|||
147382935|NCT02309892|531565479|FG000|Overall Study|Adverse Event|1|||
147382936|NCT02309892|531565480|FG001|Overall Study|Adverse Event|0|||
147382937|NCT02309892|531565481|FG002|Overall Study|Adverse Event|1|||
147382938|NCT02309892|531565482|FG003|Overall Study|Adverse Event|0|||
147382939|NCT02309892|531565483|FG004|Overall Study|Adverse Event|0|||
147382940|NCT02309892|531565484|FG005|Overall Study|Adverse Event|0|||
147382941|NCT02309892|531565485|FG006|Overall Study|Adverse Event|0|||
147382942|NCT02309892|531565479|FG000|Overall Study|Progressive Disease|0|||
147456446|NCT03529773|531831758|FG038|Overall Study|Withdrawal by Subject|1|||
147456447|NCT03529773|531831759|FG039|Overall Study|Withdrawal by Subject|1|||
147456448|NCT03529773|531831720|FG000|Overall Study|Screen Failure|0|||
147614449|NCT01823835|532403301|FG010|Overall Study|Study Termination|0|||
147614450|NCT01823835|532403302|FG011|Overall Study|Study Termination|1|||
147614451|NCT01823835|532403303|FG012|Overall Study|Study Termination|0|||
147614452|NCT01823835|532403304|FG013|Overall Study|Study Termination|0|||
147614453|NCT01823835|532403305|FG014|Overall Study|Study Termination|0|||
147614454|NCT01823835|532403291|FG000|Overall Study|Withdrawal by Subject|0|||
147614455|NCT01823835|532403292|FG001|Overall Study|Withdrawal by Subject|0|||
147614456|NCT01823835|532403293|FG002|Overall Study|Withdrawal by Subject|1|||
147614457|NCT01823835|532403294|FG003|Overall Study|Withdrawal by Subject|0|||
147614458|NCT01823835|532403295|FG004|Overall Study|Withdrawal by Subject|0|||
147614459|NCT01823835|532403296|FG005|Overall Study|Withdrawal by Subject|0|||
147614460|NCT01823835|532403297|FG006|Overall Study|Withdrawal by Subject|0|||
147614461|NCT01823835|532403298|FG007|Overall Study|Withdrawal by Subject|0|||
147614462|NCT01823835|532403299|FG008|Overall Study|Withdrawal by Subject|0|||
147614463|NCT01823835|532403300|FG009|Overall Study|Withdrawal by Subject|1|||
147614464|NCT01823835|532403301|FG010|Overall Study|Withdrawal by Subject|1|||
147614465|NCT01823835|532403302|FG011|Overall Study|Withdrawal by Subject|2|||
147614466|NCT01823835|532403303|FG012|Overall Study|Withdrawal by Subject|1|||
147614467|NCT01823835|532403304|FG013|Overall Study|Withdrawal by Subject|0|||
147614468|NCT01823835|532403305|FG014|Overall Study|Withdrawal by Subject|0|||
147456449|NCT03529773|531831721|FG001|Overall Study|Screen Failure|0|||
147456450|NCT03529773|531831722|FG002|Overall Study|Screen Failure|0|||
147456451|NCT03529773|531831723|FG003|Overall Study|Screen Failure|0|||
147614469|NCT01320150|532403308|FG000|Overall Study|Protocol Violation|15|||
147614470|NCT01320150|532403308|FG000|Overall Study|Withdrawal by Subject|5|||
147614471|NCT01320150|532403308|FG000|Overall Study|Death|2|||
147614472|NCT01320150|532403308|FG000|Overall Study|Lost to Follow-up|44|||
147614473|NCT00919854|532403309|FG000|Overall Study|Adverse Event|1|||
147614474|NCT00985491|532403312|FG000|Overall Study|Adverse Event|8|||
147614475|NCT00985491|532403312|FG000|Overall Study|device migration|7|||
147614476|NCT00985491|532403312|FG000|Overall Study|Withdrawal by Subject|1|||
147614477|NCT00985491|532403312|FG000|Overall Study|implant failure|3|||
147614478|NCT01893346|532403313|FG000|Overall Study|Lost to Follow-up|0|||
147614479|NCT01893346|532403314|FG001|Overall Study|Lost to Follow-up|1|||
147614480|NCT01893346|532403315|FG002|Overall Study|Lost to Follow-up|0|||
147614481|NCT01893346|532403316|FG003|Overall Study|Lost to Follow-up|0|||
147614482|NCT01893346|532403313|FG000|Overall Study|Protocol Violation|1|||
147614483|NCT01893346|532403314|FG001|Overall Study|Protocol Violation|0|||
147614484|NCT01893346|532403315|FG002|Overall Study|Protocol Violation|0|||
147614485|NCT01893346|532403316|FG003|Overall Study|Protocol Violation|0|||
147614486|NCT01893346|532403313|FG000|Overall Study|Withdrawal by Subject|2|||
147614487|NCT01893346|532403314|FG001|Overall Study|Withdrawal by Subject|0|||
147614488|NCT01893346|532403315|FG002|Overall Study|Withdrawal by Subject|0|||
147614489|NCT01893346|532403316|FG003|Overall Study|Withdrawal by Subject|0|||
147614490|NCT02296931|532403323|FG000|Overall Study|Protocol Violation|0|||
147614491|NCT02296931|532403324|FG001|Overall Study|Protocol Violation|2|||
147614492|NCT01590277|532403325|FG000|Overall Study|Withdrawal by Subject|3|||
147614493|NCT01590277|532403325|FG000|Overall Study|Withdrawal by Subject|2|||
147382943|NCT02309892|531565480|FG001|Overall Study|Progressive Disease|1|||
147456452|NCT03529773|531831724|FG004|Overall Study|Screen Failure|0|||
147456453|NCT03529773|531831725|FG005|Overall Study|Screen Failure|0|||
147614494|NCT01590277|532403325|FG000|Overall Study|Withdrawal by Subject|1|||
147614495|NCT01590277|532403325|FG000|Overall Study|Withdrawal by Subject|1|||
147614496|NCT04386616|532403326|FG000|Overall Study|Death|22|||
147614497|NCT04386616|532403327|FG001|Overall Study|Death|22|||
147382944|NCT02309892|531565481|FG002|Overall Study|Progressive Disease|0|||
147456454|NCT03529773|531831726|FG006|Overall Study|Screen Failure|0|||
147614498|NCT04386616|532403328|FG002|Overall Study|Death|21|||
147614499|NCT04386616|532403326|FG000|Overall Study|Lost to Follow-up|5|||
147614500|NCT04386616|532403327|FG001|Overall Study|Lost to Follow-up|8|||
147382945|NCT02309892|531565482|FG003|Overall Study|Progressive Disease|0|||
147382946|NCT02309892|531565483|FG004|Overall Study|Progressive Disease|1|||
147456455|NCT03529773|531831727|FG007|Overall Study|Screen Failure|0|||
147614501|NCT04386616|532403328|FG002|Overall Study|Lost to Follow-up|6|||
147614502|NCT04386616|532403326|FG000|Overall Study|Withdrawal by Subject|2|||
147382947|NCT02309892|531565484|FG005|Overall Study|Progressive Disease|0|||
147382948|NCT02309892|531565485|FG006|Overall Study|Progressive Disease|0|||
147382949|NCT02309892|531565479|FG000|Overall Study|Death|0|||
147382950|NCT02309892|531565480|FG001|Overall Study|Death|0|||
147382951|NCT02309892|531565481|FG002|Overall Study|Death|0|||
147382952|NCT02309892|531565482|FG003|Overall Study|Death|0|||
147382953|NCT02309892|531565483|FG004|Overall Study|Death|0|||
147382954|NCT02309892|531565484|FG005|Overall Study|Death|1|||
147382955|NCT02309892|531565485|FG006|Overall Study|Death|0|||
147382956|NCT01584648|531565486|FG000|Overall Study|Death|136|||
147382957|NCT01584648|531565487|FG001|Overall Study|Death|146|||
147382958|NCT01584648|531565486|FG000|Overall Study|Lost to Follow-up|9|||
147382959|NCT01584648|531565487|FG001|Overall Study|Lost to Follow-up|9|||
147382960|NCT01584648|531565486|FG000|Overall Study|Investigator discretion|3|||
147382961|NCT01584648|531565487|FG001|Overall Study|Investigator discretion|2|||
147382962|NCT01584648|531565486|FG000|Overall Study|Withdrew consent|13|||
147382963|NCT01584648|531565487|FG001|Overall Study|Withdrew consent|4|||
147382964|NCT01584648|531565486|FG000|Overall Study|Study closed/terminated|50|||
147382965|NCT01584648|531565487|FG001|Overall Study|Study closed/terminated|23|||
147382966|NCT01584648|531565486|FG000|Overall Study|Crossover to Dabrafenib + Trametinib|0|||
147382967|NCT01584648|531565487|FG001|Overall Study|Crossover to Dabrafenib + Trametinib|28|||
147382968|NCT02009332|531565490|FG000|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0|||
147382969|NCT02009332|531565491|FG001|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|1|||
147382970|NCT02009332|531565492|FG002|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0|||
147382971|NCT02009332|531565493|FG003|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0|||
147382972|NCT02009332|531565494|FG004|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0|||
147382973|NCT02009332|531565495|FG005|Phase 1: Dose Level 2/2b (Wks 11-29)|Physician Decision|0|||
147382974|NCT02009332|531565490|FG000|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0|||
147382975|NCT02009332|531565491|FG001|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0|||
147382976|NCT02009332|531565492|FG002|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0|||
147382977|NCT02009332|531565493|FG003|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0|||
147382978|NCT02009332|531565494|FG004|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|1|||
147382979|NCT02009332|531565495|FG005|Phase 1: Dose Level 4 (Weeks 48-77)|Withdrawal by Subject|0|||
147382980|NCT02009332|531565490|FG000|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0|||
147382981|NCT02009332|531565491|FG001|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0|||
147382982|NCT02009332|531565492|FG002|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0|||
147382983|NCT02009332|531565493|FG003|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0|||
147382984|NCT02009332|531565494|FG004|Phase 2 (Weeks 206-252)|Withdrawal by Subject|0|||
147382985|NCT02009332|531565495|FG005|Phase 2 (Weeks 206-252)|Withdrawal by Subject|1|||
147382986|NCT01912599|531565496|FG000|Overall Study|Withdrawal by Subject|0|||
147382987|NCT01912599|531565497|FG001|Overall Study|Withdrawal by Subject|1|||
147382988|NCT00042939|531565499|FG000|Overall Study|Adverse Event|6|||
147382989|NCT00042939|531565500|FG001|Overall Study|Adverse Event|7|||
147382990|NCT00042939|531565499|FG000|Overall Study|Death|3|||
147382991|NCT00042939|531565500|FG001|Overall Study|Death|2|||
147614503|NCT04386616|532403327|FG001|Overall Study|Withdrawal by Subject|4|||
147614504|NCT04386616|532403328|FG002|Overall Study|Withdrawal by Subject|1|||
147614505|NCT04386616|532403326|FG000|Overall Study|Adverse Event|1|||
147614506|NCT04386616|532403327|FG001|Overall Study|Adverse Event|1|||
147614507|NCT04386616|532403328|FG002|Overall Study|Adverse Event|0|||
147614508|NCT01377012|532403329|FG000|Core Study|Study terminated by Sponsor|47|||
147614509|NCT01377012|532403330|FG001|Core Study|Study terminated by Sponsor|54|||
147614510|NCT01377012|532403331|FG002|Core Study|Study terminated by Sponsor|46|||
147614511|NCT01377012|532403329|FG000|Core Study|Technical problems|1|||
147614512|NCT01377012|532403330|FG001|Core Study|Technical problems|0|||
147614513|NCT01377012|532403331|FG002|Core Study|Technical problems|0|||
147614514|NCT01377012|532403329|FG000|Core Study|Withdrawal by Subject|15|||
147614515|NCT01377012|532403330|FG001|Core Study|Withdrawal by Subject|23|||
147614516|NCT01377012|532403331|FG002|Core Study|Withdrawal by Subject|18|||
147614517|NCT01377012|532403329|FG000|Core Study|Protocol Violation|7|||
147614518|NCT01377012|532403330|FG001|Core Study|Protocol Violation|3|||
147614519|NCT01377012|532403331|FG002|Core Study|Protocol Violation|2|||
147614520|NCT01377012|532403329|FG000|Core Study|Pregnancy|0|||
147614521|NCT01377012|532403330|FG001|Core Study|Pregnancy|0|||
147614522|NCT01377012|532403331|FG002|Core Study|Pregnancy|1|||
147382992|NCT00042939|531565499|FG000|Overall Study|Withdrawal by Subject|3|||
147382993|NCT00042939|531565500|FG001|Overall Study|Withdrawal by Subject|4|||
147382994|NCT00042939|531565499|FG000|Overall Study|Other disease|1|||
147382995|NCT00042939|531565500|FG001|Overall Study|Other disease|0|||
147382996|NCT00042939|531565499|FG000|Overall Study|Ineligible|2|||
147382997|NCT00042939|531565500|FG001|Overall Study|Ineligible|2|||
147382998|NCT00042939|531565499|FG000|Overall Study|Deterioration of health|3|||
147382999|NCT00042939|531565500|FG001|Overall Study|Deterioration of health|4|||
147383000|NCT00042939|531565499|FG000|Overall Study|QOL diminished|1|||
147383001|NCT00042939|531565500|FG001|Overall Study|QOL diminished|0|||
147614523|NCT01377012|532403329|FG000|Core Study|Physician Decision|5|||
147614524|NCT01377012|532403330|FG001|Core Study|Physician Decision|4|||
147383002|NCT00042939|531565499|FG000|Overall Study|Rising ca 19-9|1|||
147383003|NCT00042939|531565500|FG001|Overall Study|Rising ca 19-9|0|||
147383004|NCT00042939|531565499|FG000|Overall Study|Patient non-compliance|1|||
147383005|NCT00042939|531565500|FG001|Overall Study|Patient non-compliance|0|||
147383006|NCT00042939|531565499|FG000|Overall Study|Still on treatment|1|||
147383007|NCT00042939|531565500|FG001|Overall Study|Still on treatment|0|||
147383008|NCT00042939|531565499|FG000|Overall Study|Treatment break > 4 weeks|0|||
147383009|NCT00042939|531565500|FG001|Overall Study|Treatment break > 4 weeks|1|||
147383010|NCT00042939|531565499|FG000|Overall Study|Did not start treatment|2|||
147383011|NCT00042939|531565500|FG001|Overall Study|Did not start treatment|1|||
147383012|NCT00795639|531565501|FG000|Overall Study|Death|1|||
147383013|NCT00795639|531565502|FG001|Overall Study|Death|6|||
147383014|NCT00795639|531565501|FG000|Overall Study|Withdrawal by Subject|1|||
147383015|NCT00795639|531565502|FG001|Overall Study|Withdrawal by Subject|3|||
147383016|NCT00795639|531565501|FG000|Overall Study|Pregnancy|1|||
147383017|NCT00795639|531565502|FG001|Overall Study|Pregnancy|0|||
147383018|NCT00795639|531565501|FG000|Overall Study|Adverse Event|5|||
147383019|NCT00795639|531565502|FG001|Overall Study|Adverse Event|2|||
147383020|NCT00795639|531565501|FG000|Overall Study|Other|0|||
147383021|NCT00795639|531565502|FG001|Overall Study|Other|2|||
147383022|NCT00795639|531565501|FG000|Overall Study|Terminated by sponsor|13|||
147383023|NCT00795639|531565502|FG001|Overall Study|Terminated by sponsor|12|||
147383024|NCT00795639|531565501|FG000|Overall Study|Randomized and not treated|0|||
147383025|NCT00795639|531565502|FG001|Overall Study|Randomized and not treated|1|||
147383026|NCT03349476|531565503|FG000|Overall Study|Physician Decision|3|||
147383027|NCT00248794|531565510|FG000|Overall Study|Lost to Follow-up|6|||
147383028|NCT00248794|531565511|FG001|Overall Study|Lost to Follow-up|8|||
147383029|NCT00248794|531565512|FG002|Overall Study|Lost to Follow-up|3|||
147383030|NCT03449979|531565513|FG000|Overall Study|Technical difficulty|0|||
147383031|NCT03449979|531565514|FG001|Overall Study|Technical difficulty|0|||
147383032|NCT03449979|531565515|FG002|Overall Study|Technical difficulty|0|||
147383033|NCT03449979|531565516|FG003|Overall Study|Technical difficulty|1|||
147383034|NCT01762345|531565519|FG000|Overall Study|Adverse Event|5|||
147383035|NCT01762345|531565519|FG000|Overall Study|Protocol Violation|2|||
147383036|NCT00244751|531565520|FG000|Overall Study|Adverse Event|7|||
147383037|NCT00244751|531565521|FG001|Overall Study|Adverse Event|7|||
147383038|NCT00244751|531565522|FG002|Overall Study|Adverse Event|5|||
147383039|NCT00244751|531565520|FG000|Overall Study|Lost to Follow-up|0|||
147383040|NCT00244751|531565521|FG001|Overall Study|Lost to Follow-up|1|||
147383041|NCT00244751|531565522|FG002|Overall Study|Lost to Follow-up|0|||
147383042|NCT00244751|531565520|FG000|Overall Study|Protocol Violation|1|||
147383043|NCT00244751|531565521|FG001|Overall Study|Protocol Violation|0|||
147383044|NCT00244751|531565522|FG002|Overall Study|Protocol Violation|1|||
147383045|NCT00244751|531565520|FG000|Overall Study|Withdrawal by Subject|7|||
147383046|NCT00244751|531565521|FG001|Overall Study|Withdrawal by Subject|5|||
147383047|NCT00244751|531565522|FG002|Overall Study|Withdrawal by Subject|3|||
147383048|NCT00244751|531565520|FG000|Overall Study|Elevated liver enzymes|1|||
147383049|NCT00244751|531565521|FG001|Overall Study|Elevated liver enzymes|0|||
147383050|NCT00244751|531565522|FG002|Overall Study|Elevated liver enzymes|0|||
147383051|NCT00244751|531565520|FG000|Overall Study|Lack of compliance with protocol|0|||
147383052|NCT00244751|531565521|FG001|Overall Study|Lack of compliance with protocol|1|||
147383053|NCT00244751|531565522|FG002|Overall Study|Lack of compliance with protocol|0|||
147383054|NCT00244751|531565520|FG000|Overall Study|Safety reasons|0|||
147383055|NCT00244751|531565521|FG001|Overall Study|Safety reasons|1|||
147383056|NCT00244751|531565522|FG002|Overall Study|Safety reasons|0|||
147456456|NCT03529773|531831728|FG008|Overall Study|Screen Failure|0|||
147456457|NCT03529773|531831729|FG009|Overall Study|Screen Failure|0|||
147614525|NCT01377012|532403331|FG002|Core Study|Physician Decision|10|||
147614526|NCT01377012|532403329|FG000|Core Study|Non-Compliant with study treatment|0|||
147614527|NCT01377012|532403330|FG001|Core Study|Non-Compliant with study treatment|0|||
147614528|NCT01377012|532403331|FG002|Core Study|Non-Compliant with study treatment|1|||
147383057|NCT00244751|531565520|FG000|Overall Study|Participant randomized by mistake|0|||
147383058|NCT00244751|531565521|FG001|Overall Study|Participant randomized by mistake|0|||
147614529|NCT01377012|532403329|FG000|Core Study|No Longer require treatment|0|||
147383059|NCT00244751|531565522|FG002|Overall Study|Participant randomized by mistake|1|||
147383060|NCT00068107|531565523|FG000|Overall Study|end-stage renal disease|6|||
147383061|NCT00068107|531565523|FG000|Overall Study|Death|2|||
147383062|NCT00068107|531565523|FG000|Overall Study|Withdrawal by Subject|1|||
147383063|NCT03288506|531565524|FG000|Overall Study|Withdrawal by Subject|52|||
147383064|NCT02644122|531565528|FG000|Overall Study|Withdrawal by Subject|1|||
147383065|NCT00805441|531565535|FG000|Overall Study|Adverse Event|5|||
147383066|NCT00805441|531565536|FG001|Overall Study|Adverse Event|2|||
147383067|NCT00805441|531565535|FG000|Overall Study|Lack of Efficacy|0|||
147383068|NCT00805441|531565536|FG001|Overall Study|Lack of Efficacy|2|||
147383069|NCT00805441|531565535|FG000|Overall Study|Protocol Violation|4|||
147383070|NCT00805441|531565536|FG001|Overall Study|Protocol Violation|8|||
147383071|NCT00805441|531565535|FG000|Overall Study|Lost to Follow-up|10|||
147456458|NCT03529773|531831730|FG010|Overall Study|Screen Failure|0|||
147383072|NCT00805441|531565536|FG001|Overall Study|Lost to Follow-up|13|||
147383073|NCT00805441|531565535|FG000|Overall Study|Withdrawal by Subject|15|||
147383074|NCT00805441|531565536|FG001|Overall Study|Withdrawal by Subject|9|||
147383075|NCT00805441|531565535|FG000|Overall Study|Physician Decision|0|||
147383076|NCT00805441|531565536|FG001|Overall Study|Physician Decision|1|||
147383077|NCT00805441|531565535|FG000|Overall Study|Acute Alcohol Withdrawal|0|||
147383078|NCT00805441|531565536|FG001|Overall Study|Acute Alcohol Withdrawal|1|||
147383079|NCT02935894|531565538|FG000|Overall Study|Subject dismissed|1|||
147383080|NCT03659136|531565541|FG000|Overall Study|Not treated|2|||
147383081|NCT03659136|531565542|FG001|Overall Study|Not treated|0|||
147383082|NCT03659136|531565541|FG000|Overall Study|Covid-19 related|1|||
147383083|NCT03659136|531565542|FG001|Overall Study|Covid-19 related|1|||
147383084|NCT03659136|531565541|FG000|Overall Study|Withdrawal by Subject|1|||
147383085|NCT03659136|531565542|FG001|Overall Study|Withdrawal by Subject|6|||
147383086|NCT03659136|531565541|FG000|Overall Study|Adverse Event|4|||
147383087|NCT03659136|531565542|FG001|Overall Study|Adverse Event|6|||
147383088|NCT03659136|531565541|FG000|Overall Study|Progressive disease|37|||
147383089|NCT03659136|531565542|FG001|Overall Study|Progressive disease|31|||
147383090|NCT03659136|531565541|FG000|Overall Study|Study closure|2|||
147614530|NCT01377012|532403330|FG001|Core Study|No Longer require treatment|0|||
147383091|NCT03659136|531565542|FG001|Overall Study|Study closure|2|||
147383092|NCT03659136|531565541|FG000|Overall Study|Sponsor decision/recommendation|3|||
147383093|NCT03659136|531565542|FG001|Overall Study|Sponsor decision/recommendation|2|||
147383094|NCT03659136|531565541|FG000|Overall Study|Switched to other drug/therapy|2|||
147383095|NCT03659136|531565542|FG001|Overall Study|Switched to other drug/therapy|2|||
147614531|NCT01377012|532403331|FG002|Core Study|No Longer require treatment|1|||
147614532|NCT01377012|532403329|FG000|Core Study|Lost to Follow-up|7|||
147614533|NCT01377012|532403330|FG001|Core Study|Lost to Follow-up|5|||
147614534|NCT01377012|532403331|FG002|Core Study|Lost to Follow-up|4|||
147614535|NCT01377012|532403329|FG000|Core Study|Lack of Efficacy|41|||
147614536|NCT01377012|532403330|FG001|Core Study|Lack of Efficacy|28|||
147614537|NCT01377012|532403331|FG002|Core Study|Lack of Efficacy|37|||
147383096|NCT03659136|531565541|FG000|Overall Study|Lack of clinical benefit|0|||
147383097|NCT03659136|531565542|FG001|Overall Study|Lack of clinical benefit|1|||
147383098|NCT03786471|531565543|FG000|Overall Study|Death|254|||
147383099|NCT03786471|531565544|FG001|Overall Study|Death|223|||
147383100|NCT03786471|531565545|FG002|Overall Study|Death|37|||
147383101|NCT03786471|531565543|FG000|Overall Study|Lost to Follow-up|63|||
147383102|NCT03786471|531565544|FG001|Overall Study|Lost to Follow-up|50|||
147383103|NCT03786471|531565545|FG002|Overall Study|Lost to Follow-up|15|||
147383104|NCT03786471|531565543|FG000|Overall Study|Withdrawal by Subject|99|||
147383105|NCT03786471|531565544|FG001|Overall Study|Withdrawal by Subject|81|||
147383106|NCT03786471|531565545|FG002|Overall Study|Withdrawal by Subject|11|||
147383107|NCT03976102|531567247|FG000|Overall Study|Withdrawal by Subject|4|||
147383108|NCT03976102|531567248|FG001|Overall Study|Withdrawal by Subject|4|||
147383109|NCT03976102|531567247|FG000|Overall Study|Adverse Event|2|||
147383110|NCT03976102|531567248|FG001|Overall Study|Adverse Event|4|||
147383111|NCT03976102|531567247|FG000|Overall Study|Not related to Covid-19|9|||
147383112|NCT03976102|531567248|FG001|Overall Study|Not related to Covid-19|13|||
147383113|NCT03976102|531567247|FG000|Overall Study|Lost to Follow-up|0|||
147383114|NCT03976102|531567248|FG001|Overall Study|Lost to Follow-up|2|||
147383115|NCT03976102|531567247|FG000|Overall Study|Death|3|||
147383116|NCT03976102|531567248|FG001|Overall Study|Death|2|||
147383117|NCT03976102|531567247|FG000|Overall Study|Physician Decision|1|||
147383118|NCT03976102|531567248|FG001|Overall Study|Physician Decision|1|||
147383119|NCT05066230|531567251|FG000|Primary Study (Through Week 48)|Adverse Event|1|||
147383120|NCT05066230|531567252|FG001|Primary Study (Through Week 48)|Adverse Event|4|||
147383121|NCT05066230|531567251|FG000|Primary Study (Through Week 48)|Non-compliance with study schedule|0|||
147614538|NCT01377012|532403329|FG000|Core Study|Death|1|||
147614539|NCT01377012|532403330|FG001|Core Study|Death|1|||
147614540|NCT01377012|532403331|FG002|Core Study|Death|1|||
147614541|NCT01377012|532403329|FG000|Core Study|Adverse Event|10|||
147664898|NCT02810418|532597950|FG005|Arm B Dose Escalation|Adverse Event|2|||
147614542|NCT01377012|532403330|FG001|Core Study|Adverse Event|14|||
147664899|NCT02810418|532597951|FG006|Arm B Dose Escalation|Adverse Event|0|||
147383122|NCT05066230|531567252|FG001|Primary Study (Through Week 48)|Non-compliance with study schedule|1|||
147383123|NCT05066230|531567251|FG000|Primary Study (Through Week 48)|Withdrawal by Subject|4|||
147383124|NCT05066230|531567252|FG001|Primary Study (Through Week 48)|Withdrawal by Subject|2|||
147383125|NCT05066230|531567251|FG000|Primary Study (Through Week 48)|Lost to Follow-up|2|||
147383126|NCT05066230|531567252|FG001|Primary Study (Through Week 48)|Lost to Follow-up|3|||
147383127|NCT05066230|531567251|FG000|Primary Study (Through Week 48)|Participant relocated|1|||
147383128|NCT05066230|531567252|FG001|Primary Study (Through Week 48)|Participant relocated|0|||
147383129|NCT05066230|531567251|FG000|After Week 48|Adverse Event|1|||
147383130|NCT05066230|531567252|FG001|After Week 48|Adverse Event|0|||
147383131|NCT05066230|531567251|FG000|After Week 48|Non-compliance with study schedule|1|||
147383132|NCT05066230|531567252|FG001|After Week 48|Non-compliance with study schedule|0|||
147614543|NCT01377012|532403331|FG002|Core Study|Adverse Event|13|||
147664900|NCT02224625|532597952|FG000|Irritation|Adverse Event|6|||
147614544|NCT01377012|532403329|FG000|Extension Study, Weeks 104-260|Lack of Efficacy|3|||
147614545|NCT01377012|532403330|FG001|Extension Study, Weeks 104-260|Lack of Efficacy|0|||
147614546|NCT01377012|532403331|FG002|Extension Study, Weeks 104-260|Lack of Efficacy|0|||
147614547|NCT01377012|532403329|FG000|Extension Study, Weeks 104-260|Study terminated by sponsor|52|||
147614548|NCT01377012|532403330|FG001|Extension Study, Weeks 104-260|Study terminated by sponsor|69|||
147614549|NCT01377012|532403331|FG002|Extension Study, Weeks 104-260|Study terminated by sponsor|63|||
147614550|NCT01377012|532403329|FG000|Extension Study, Weeks 104-260|Withdrawal by Subject|1|||
147614551|NCT01377012|532403330|FG001|Extension Study, Weeks 104-260|Withdrawal by Subject|0|||
147614552|NCT01377012|532403331|FG002|Extension Study, Weeks 104-260|Withdrawal by Subject|3|||
147614553|NCT01377012|532403329|FG000|Extension Study, Weeks 104-260|Physician Decision|1|||
147614554|NCT01377012|532403330|FG001|Extension Study, Weeks 104-260|Physician Decision|0|||
147614555|NCT01377012|532403331|FG002|Extension Study, Weeks 104-260|Physician Decision|0|||
147614556|NCT01377012|532403329|FG000|Extension Study, Weeks 104-260|Lost to Follow-up|0|||
147614557|NCT01377012|532403330|FG001|Extension Study, Weeks 104-260|Lost to Follow-up|0|||
147614558|NCT01377012|532403331|FG002|Extension Study, Weeks 104-260|Lost to Follow-up|1|||
147614559|NCT01377012|532403329|FG000|Extension Study, Weeks 104-260|Adverse Event|0|||
147614560|NCT01377012|532403330|FG001|Extension Study, Weeks 104-260|Adverse Event|2|||
147614561|NCT01377012|532403331|FG002|Extension Study, Weeks 104-260|Adverse Event|1|||
147614562|NCT01632280|532403349|FG000|Overall Study|Withdrawal by Subject|1|||
147614563|NCT01632280|532403350|FG001|Overall Study|Withdrawal by Subject|0|||
147614564|NCT03086551|532403358|FG000|First Intervention|Failure to meet inclusion criterion|1|||
147614565|NCT03086551|532403359|FG001|First Intervention|Failure to meet inclusion criterion|0|||
147614566|NCT03086551|532403358|FG000|First Intervention|Lost to Follow-up|0|||
147614567|NCT03086551|532403359|FG001|First Intervention|Lost to Follow-up|1|||
147614568|NCT03086551|532403358|FG000|Washout|Lost to Follow-up|1|||
147614569|NCT03086551|532403359|FG001|Washout|Lost to Follow-up|2|||
147614570|NCT03086551|532403358|FG000|Washout|Withdrawal by Subject|2|||
147614571|NCT03086551|532403359|FG001|Washout|Withdrawal by Subject|1|||
147614572|NCT03736031|532403360|FG000|Overall Study|Death|2|||
147614573|NCT03736031|532403361|FG001|Overall Study|Death|4|||
147614574|NCT03736031|532403360|FG000|Overall Study|Lost to Follow-up|21|||
147614575|NCT03736031|532403361|FG001|Overall Study|Lost to Follow-up|2|||
147614576|NCT03736031|532403360|FG000|Overall Study|Withdrawal by Subject|9|||
147614577|NCT03736031|532403361|FG001|Overall Study|Withdrawal by Subject|0|||
147614578|NCT00451178|532403362|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Adverse Event|6|||
147614579|NCT00451178|532403363|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Adverse Event|6|||
147614580|NCT00451178|532403362|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Withdrawal by Subject|4|||
147614581|NCT00451178|532403363|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Withdrawal by Subject|3|||
147614582|NCT00451178|532403362|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Protocol Violation|2|||
147614583|NCT00451178|532403363|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Protocol Violation|1|||
147614584|NCT00451178|532403362|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Physician Decision|1|||
147614585|NCT00451178|532403363|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Physician Decision|2|||
147614586|NCT00451178|532403362|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Death|4|||
147614587|NCT00451178|532403363|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Death|3|||
147614588|NCT00451178|532403362|FG000|Chemotherapy (Up To Six 21-Day Cycles)|Progressive Disease (PD)|1|||
147614589|NCT00451178|532403363|FG001|Chemotherapy (Up To Six 21-Day Cycles)|Progressive Disease (PD)|2|||
147614590|NCT00451178|532403362|FG000|Prior to Maintenance Therapy|Physician Decision|2|||
147614591|NCT00451178|532403363|FG001|Prior to Maintenance Therapy|Physician Decision|0|||
147614592|NCT00451178|532403362|FG000|Prior to Maintenance Therapy|PD|2|||
147614593|NCT00451178|532403363|FG001|Prior to Maintenance Therapy|PD|0|||
147614594|NCT00451178|532403362|FG000|Maintenance Therapy (up to 3 Years)|Adverse Event|4|||
147614595|NCT00451178|532403363|FG001|Maintenance Therapy (up to 3 Years)|Adverse Event|0|||
147614596|NCT00451178|532403362|FG000|Maintenance Therapy (up to 3 Years)|Withdrawal by Subject|5|||
147614597|NCT00451178|532403363|FG001|Maintenance Therapy (up to 3 Years)|Withdrawal by Subject|0|||
147664901|NCT02224625|532597952|FG000|Sensitization|Adverse Event|55|||
147383133|NCT05066230|531567251|FG000|After Week 48|Withdrawal by Subject|0|||
147383134|NCT05066230|531567252|FG001|After Week 48|Withdrawal by Subject|1|||
147383135|NCT05066230|531567251|FG000|After Week 48|Lost to Follow-up|3|||
147383136|NCT05066230|531567252|FG001|After Week 48|Lost to Follow-up|3|||
147383137|NCT05066230|531567251|FG000|After Week 48|Sponsor Request|115|||
147383138|NCT05066230|531567252|FG001|After Week 48|Sponsor Request|111|||
147383139|NCT03072238|531567253|FG000|Overall Study|Withdrawal by Subject|44|||
147383140|NCT03072238|531567254|FG001|Overall Study|Withdrawal by Subject|64|||
147614598|NCT00451178|532403362|FG000|Maintenance Therapy (up to 3 Years)|Physician Decision|1|||
147614599|NCT00451178|532403363|FG001|Maintenance Therapy (up to 3 Years)|Physician Decision|0|||
147614600|NCT00451178|532403362|FG000|Maintenance Therapy (up to 3 Years)|Death|1|||
147614601|NCT00451178|532403363|FG001|Maintenance Therapy (up to 3 Years)|Death|0|||
147614602|NCT00451178|532403362|FG000|Maintenance Therapy (up to 3 Years)|PD|10|||
147614603|NCT00451178|532403363|FG001|Maintenance Therapy (up to 3 Years)|PD|0|||
147614604|NCT00451178|532403362|FG000|Maintenance Therapy (up to 3 Years)|Continuing Maintenance|9|||
147383141|NCT03072238|531567253|FG000|Overall Study|Lost to Follow-up|14|||
147614605|NCT00451178|532403363|FG001|Maintenance Therapy (up to 3 Years)|Continuing Maintenance|0|||
147614606|NCT00451178|532403362|FG000|Long-Term Follow-Up (Up to 2 Years)|Continuing Follow-Up|6|||
147614607|NCT00451178|532403363|FG001|Long-Term Follow-Up (Up to 2 Years)|Continuing Follow-Up|26|||
147383142|NCT03072238|531567254|FG001|Overall Study|Lost to Follow-up|5|||
147383143|NCT03072238|531567253|FG000|Overall Study|Physician Decision|4|||
147383144|NCT03072238|531567254|FG001|Overall Study|Physician Decision|6|||
147383145|NCT03072238|531567253|FG000|Overall Study|Death|351|||
147383146|NCT03072238|531567254|FG001|Overall Study|Death|318|||
147383147|NCT03072238|531567253|FG000|Overall Study|Progressive Disease|3|||
147383148|NCT03072238|531567254|FG001|Overall Study|Progressive Disease|4|||
147383149|NCT03072238|531567253|FG000|Overall Study|Reason Not Specified|138|||
147383150|NCT03072238|531567254|FG001|Overall Study|Reason Not Specified|150|||
147383151|NCT01562275|531567260|FG000|Stage 1|Adverse Event|0|||
147383152|NCT01562275|531567261|FG001|Stage 1|Adverse Event|0|||
147383153|NCT01562275|531567262|FG002|Stage 1|Adverse Event|0|||
147383154|NCT01562275|531567263|FG003|Stage 1|Adverse Event|1|||
147383155|NCT01562275|531567264|FG004|Stage 1|Adverse Event|1|||
147383156|NCT01562275|531567265|FG005|Stage 1|Adverse Event|0|||
147383157|NCT01562275|531567266|FG006|Stage 1|Adverse Event|0|||
147383158|NCT01562275|531567267|FG007|Stage 1|Adverse Event|0|||
147383159|NCT01562275|531567268|FG008|Stage 1|Adverse Event|0|||
147383160|NCT01562275|531567269|FG009|Stage 1|Adverse Event|1|||
147383161|NCT01562275|531567270|FG010|Stage 1|Adverse Event|0|||
147383162|NCT01562275|531567271|FG011|Stage 1|Adverse Event|0|||
147383163|NCT01562275|531567272|FG012|Stage 1|Adverse Event|0|||
147383164|NCT01562275|531567260|FG000|Stage 1|Death|1|||
147383165|NCT01562275|531567261|FG001|Stage 1|Death|0|||
147383166|NCT01562275|531567262|FG002|Stage 1|Death|0|||
147383167|NCT01562275|531567263|FG003|Stage 1|Death|0|||
147383168|NCT01562275|531567264|FG004|Stage 1|Death|0|||
147383169|NCT01562275|531567265|FG005|Stage 1|Death|0|||
147383170|NCT01562275|531567266|FG006|Stage 1|Death|0|||
147383171|NCT01562275|531567267|FG007|Stage 1|Death|0|||
147383172|NCT01562275|531567268|FG008|Stage 1|Death|0|||
147383173|NCT01562275|531567269|FG009|Stage 1|Death|0|||
147383174|NCT01562275|531567270|FG010|Stage 1|Death|0|||
147383175|NCT01562275|531567271|FG011|Stage 1|Death|0|||
147383176|NCT01562275|531567272|FG012|Stage 1|Death|0|||
147383177|NCT01562275|531567260|FG000|Stage 1|Non Compliance|0|||
147383178|NCT01562275|531567261|FG001|Stage 1|Non Compliance|0|||
147383179|NCT01562275|531567262|FG002|Stage 1|Non Compliance|1|||
147383180|NCT01562275|531567263|FG003|Stage 1|Non Compliance|0|||
147383181|NCT01562275|531567264|FG004|Stage 1|Non Compliance|0|||
147383182|NCT01562275|531567265|FG005|Stage 1|Non Compliance|0|||
147383183|NCT01562275|531567266|FG006|Stage 1|Non Compliance|0|||
147383184|NCT01562275|531567267|FG007|Stage 1|Non Compliance|0|||
147383185|NCT01562275|531567268|FG008|Stage 1|Non Compliance|0|||
147383186|NCT01562275|531567269|FG009|Stage 1|Non Compliance|0|||
147383187|NCT01562275|531567270|FG010|Stage 1|Non Compliance|0|||
147383188|NCT01562275|531567271|FG011|Stage 1|Non Compliance|0|||
147383189|NCT01562275|531567272|FG012|Stage 1|Non Compliance|0|||
147383190|NCT01562275|531567260|FG000|Stage 1|Physician Decision|0|||
147383191|NCT01562275|531567261|FG001|Stage 1|Physician Decision|0|||
147383192|NCT01562275|531567262|FG002|Stage 1|Physician Decision|0|||
147383193|NCT01562275|531567263|FG003|Stage 1|Physician Decision|0|||
147383194|NCT01562275|531567264|FG004|Stage 1|Physician Decision|1|||
147383195|NCT01562275|531567265|FG005|Stage 1|Physician Decision|0|||
147383196|NCT01562275|531567266|FG006|Stage 1|Physician Decision|1|||
147383197|NCT01562275|531567267|FG007|Stage 1|Physician Decision|0|||
147383198|NCT01562275|531567268|FG008|Stage 1|Physician Decision|1|||
147383199|NCT01562275|531567269|FG009|Stage 1|Physician Decision|0|||
147383200|NCT01562275|531567270|FG010|Stage 1|Physician Decision|0|||
147383201|NCT01562275|531567271|FG011|Stage 1|Physician Decision|0|||
147383202|NCT01562275|531567272|FG012|Stage 1|Physician Decision|0|||
147383203|NCT01562275|531567260|FG000|Stage 1|Progression of Disease|2|||
147383204|NCT01562275|531567261|FG001|Stage 1|Progression of Disease|6|||
147383205|NCT01562275|531567262|FG002|Stage 1|Progression of Disease|2|||
147456459|NCT03529773|531831731|FG011|Overall Study|Screen Failure|0|||
147383206|NCT01562275|531567263|FG003|Stage 1|Progression of Disease|1|||
147383207|NCT01562275|531567264|FG004|Stage 1|Progression of Disease|2|||
147383208|NCT01562275|531567265|FG005|Stage 1|Progression of Disease|4|||
147456460|NCT03529773|531831732|FG012|Overall Study|Screen Failure|0|||
147614608|NCT01260701|532403364|FG000|Overall Study|Adverse Event|9|||
147383209|NCT01562275|531567266|FG006|Stage 1|Progression of Disease|1|||
147383210|NCT01562275|531567267|FG007|Stage 1|Progression of Disease|7|||
147383211|NCT01562275|531567268|FG008|Stage 1|Progression of Disease|2|||
147383212|NCT01562275|531567269|FG009|Stage 1|Progression of Disease|5|||
147383213|NCT01562275|531567270|FG010|Stage 1|Progression of Disease|3|||
147383214|NCT01562275|531567271|FG011|Stage 1|Progression of Disease|0|||
147383215|NCT01562275|531567272|FG012|Stage 1|Progression of Disease|0|||
147383216|NCT01562275|531567260|FG000|Stage 1|Withdrawal by Subject|0|||
147383217|NCT01562275|531567261|FG001|Stage 1|Withdrawal by Subject|1|||
147383218|NCT01562275|531567262|FG002|Stage 1|Withdrawal by Subject|0|||
147383219|NCT01562275|531567263|FG003|Stage 1|Withdrawal by Subject|2|||
147383220|NCT01562275|531567264|FG004|Stage 1|Withdrawal by Subject|0|||
147614609|NCT01260701|532403364|FG000|Overall Study|Withdrawal by Subject|2|||
147614610|NCT01260701|532403364|FG000|Overall Study|Progression|53|||
147614611|NCT01260701|532403364|FG000|Overall Study|Death|2|||
147614612|NCT01260701|532403364|FG000|Overall Study|Not protocol specified|3|||
147614613|NCT01260701|532403364|FG000|Overall Study|Under review|1|||
147614614|NCT01260701|532403364|FG000|Overall Study|Ineligible|4|||
147614615|NCT01260701|532403364|FG000|Overall Study|Did not begin protocol therapy|1|||
147614616|NCT03631199|532404798|FG000|Overall Study|Progressive disease|9|||
147614617|NCT03631199|532404799|FG001|Overall Study|Progressive disease|5|||
147614618|NCT03631199|532404800|FG002|Overall Study|Progressive disease|5|||
147614619|NCT03631199|532404801|FG003|Overall Study|Progressive disease|149|||
147614620|NCT03631199|532404802|FG004|Overall Study|Progressive disease|148|||
147456461|NCT03529773|531831733|FG013|Overall Study|Screen Failure|0|||
147456462|NCT03529773|531831734|FG014|Overall Study|Screen Failure|0|||
147456463|NCT03529773|531831735|FG015|Overall Study|Screen Failure|0|||
147383221|NCT01562275|531567265|FG005|Stage 1|Withdrawal by Subject|0|||
147456464|NCT03529773|531831736|FG016|Overall Study|Screen Failure|0|||
147456465|NCT03529773|531831737|FG017|Overall Study|Screen Failure|0|||
147456466|NCT03529773|531831738|FG018|Overall Study|Screen Failure|0|||
147456467|NCT03529773|531831739|FG019|Overall Study|Screen Failure|0|||
147456468|NCT03529773|531831740|FG020|Overall Study|Screen Failure|0|||
147456469|NCT03529773|531831741|FG021|Overall Study|Screen Failure|0|||
147456470|NCT03529773|531831742|FG022|Overall Study|Screen Failure|0|||
147614621|NCT03631199|532404798|FG000|Overall Study|Physician Decision|0|||
147383222|NCT01562275|531567266|FG006|Stage 1|Withdrawal by Subject|1|||
147383223|NCT01562275|531567267|FG007|Stage 1|Withdrawal by Subject|0|||
147383224|NCT01562275|531567268|FG008|Stage 1|Withdrawal by Subject|0|||
147614622|NCT03631199|532404799|FG001|Overall Study|Physician Decision|2|||
147614623|NCT03631199|532404800|FG002|Overall Study|Physician Decision|3|||
147614624|NCT03631199|532404801|FG003|Overall Study|Physician Decision|19|||
147614625|NCT03631199|532404802|FG004|Overall Study|Physician Decision|13|||
147614626|NCT03631199|532404798|FG000|Overall Study|Adverse Event|1|||
147614627|NCT03631199|532404799|FG001|Overall Study|Adverse Event|1|||
147614628|NCT03631199|532404800|FG002|Overall Study|Adverse Event|0|||
147614629|NCT03631199|532404801|FG003|Overall Study|Adverse Event|28|||
147614630|NCT03631199|532404802|FG004|Overall Study|Adverse Event|29|||
147614631|NCT03631199|532404798|FG000|Overall Study|Death|0|||
147614632|NCT03631199|532404799|FG001|Overall Study|Death|1|||
147614633|NCT03631199|532404800|FG002|Overall Study|Death|0|||
147614634|NCT03631199|532404801|FG003|Overall Study|Death|35|||
147614635|NCT03631199|532404802|FG004|Overall Study|Death|48|||
147614636|NCT03631199|532404798|FG000|Overall Study|Subject decision|0|||
147614637|NCT03631199|532404799|FG001|Overall Study|Subject decision|1|||
147614638|NCT03631199|532404800|FG002|Overall Study|Subject decision|0|||
147614639|NCT03631199|532404801|FG003|Overall Study|Subject decision|12|||
147614640|NCT03631199|532404802|FG004|Overall Study|Subject decision|12|||
147383225|NCT01562275|531567269|FG009|Stage 1|Withdrawal by Subject|1|||
147383226|NCT01562275|531567270|FG010|Stage 1|Withdrawal by Subject|0|||
147383227|NCT01562275|531567271|FG011|Stage 1|Withdrawal by Subject|0|||
147383228|NCT01562275|531567272|FG012|Stage 1|Withdrawal by Subject|0|||
147383229|NCT01562275|531567260|FG000|Stage 2|Death|0|||
147383230|NCT01562275|531567261|FG001|Stage 2|Death|0|||
147383231|NCT01562275|531567262|FG002|Stage 2|Death|0|||
147383232|NCT01562275|531567263|FG003|Stage 2|Death|0|||
147383233|NCT01562275|531567264|FG004|Stage 2|Death|0|||
147614641|NCT03631199|532404798|FG000|Overall Study|No treated|0|||
147614642|NCT03631199|532404799|FG001|Overall Study|No treated|0|||
147614643|NCT03631199|532404800|FG002|Overall Study|No treated|0|||
147614644|NCT03631199|532404801|FG003|Overall Study|No treated|0|||
147614645|NCT03631199|532404802|FG004|Overall Study|No treated|1|||
147614646|NCT03631199|532404798|FG000|Overall Study|Treatment ongoing|0|||
147614647|NCT03631199|532404799|FG001|Overall Study|Treatment ongoing|1|||
147614648|NCT03631199|532404800|FG002|Overall Study|Treatment ongoing|1|||
147456471|NCT03529773|531831743|FG023|Overall Study|Screen Failure|0|||
147456472|NCT03529773|531831744|FG024|Overall Study|Screen Failure|0|||
147456473|NCT03529773|531831745|FG025|Overall Study|Screen Failure|0|||
147614649|NCT03631199|532404801|FG003|Overall Study|Treatment ongoing|76|||
147614650|NCT03631199|532404802|FG004|Overall Study|Treatment ongoing|71|||
147614651|NCT03631199|532404798|FG000|Overall Study|Guardian decision|0|||
147383234|NCT01562275|531567265|FG005|Stage 2|Death|0|||
147383235|NCT01562275|531567266|FG006|Stage 2|Death|0|||
147383236|NCT01562275|531567267|FG007|Stage 2|Death|0|||
147383237|NCT01562275|531567268|FG008|Stage 2|Death|0|||
147383238|NCT01562275|531567269|FG009|Stage 2|Death|0|||
147383239|NCT01562275|531567270|FG010|Stage 2|Death|0|||
147456474|NCT03529773|531831746|FG026|Overall Study|Screen Failure|0|||
147614652|NCT03631199|532404799|FG001|Overall Study|Guardian decision|0|||
147614653|NCT03631199|532404800|FG002|Overall Study|Guardian decision|0|||
147614654|NCT03631199|532404801|FG003|Overall Study|Guardian decision|1|||
147614655|NCT03631199|532404802|FG004|Overall Study|Guardian decision|1|||
147614656|NCT00577863|532404803|FG000|Overall Study|Adverse Event|4|||
147614657|NCT00577863|532404804|FG001|Overall Study|Adverse Event|2|||
147614658|NCT00577863|532404803|FG000|Overall Study|Death|1|||
147614659|NCT00577863|532404804|FG001|Overall Study|Death|0|||
147383240|NCT01562275|531567271|FG011|Stage 2|Death|2|||
147383241|NCT01562275|531567272|FG012|Stage 2|Death|1|||
147383242|NCT01562275|531567260|FG000|Stage 2|Progression of Disease|0|||
147383243|NCT01562275|531567261|FG001|Stage 2|Progression of Disease|0|||
147383244|NCT01562275|531567262|FG002|Stage 2|Progression of Disease|0|||
147383245|NCT01562275|531567263|FG003|Stage 2|Progression of Disease|0|||
147383246|NCT01562275|531567264|FG004|Stage 2|Progression of Disease|0|||
147383247|NCT01562275|531567265|FG005|Stage 2|Progression of Disease|0|||
147383248|NCT01562275|531567266|FG006|Stage 2|Progression of Disease|0|||
147383249|NCT01562275|531567267|FG007|Stage 2|Progression of Disease|0|||
147383250|NCT01562275|531567268|FG008|Stage 2|Progression of Disease|0|||
147383251|NCT01562275|531567269|FG009|Stage 2|Progression of Disease|0|||
147383252|NCT01562275|531567270|FG010|Stage 2|Progression of Disease|0|||
147383253|NCT01562275|531567271|FG011|Stage 2|Progression of Disease|12|||
147383254|NCT01562275|531567272|FG012|Stage 2|Progression of Disease|4|||
147383255|NCT01863368|531567273|FG000|Phase I, Day 0 to Day 35|Adverse Event|2|||
147383256|NCT01863368|531567274|FG001|Phase I, Day 0 to Day 35|Adverse Event|4|||
147383257|NCT01863368|531567273|FG000|Phase I, Day 0 to Day 35|Lost to Follow-up|1|||
147383258|NCT01863368|531567274|FG001|Phase I, Day 0 to Day 35|Lost to Follow-up|0|||
147383259|NCT01863368|531567273|FG000|Phase I, Day 0 to Day 35|Withdrawal by subject prior to treatment|0|||
147383260|NCT01863368|531567274|FG001|Phase I, Day 0 to Day 35|Withdrawal by subject prior to treatment|1|||
147383261|NCT01863368|531567273|FG000|Phase I, Day 0 to Day 35|Withdrawal by Subject|0|||
147383262|NCT01863368|531567274|FG001|Phase I, Day 0 to Day 35|Withdrawal by Subject|2|||
147383263|NCT01863368|531567273|FG000|Phase II, Day 35 to Day 90|Adverse Event|1|||
147383264|NCT01863368|531567274|FG001|Phase II, Day 35 to Day 90|Adverse Event|0|||
147383265|NCT01863368|531567273|FG000|Phase II, Day 35 to Day 90|Lost to Follow-up|1|||
147383266|NCT01863368|531567274|FG001|Phase II, Day 35 to Day 90|Lost to Follow-up|0|||
147383267|NCT00515112|531567276|FG000|Overall Study|Death|0|||
147383268|NCT00515112|531567277|FG001|Overall Study|Death|1|||
147383269|NCT00515112|531567276|FG000|Overall Study|The study was terminated|3|||
147383270|NCT00515112|531567277|FG001|Overall Study|The study was terminated|2|||
147383271|NCT00307489|531567280|FG000|Baseline Through Week 48|Lost to Follow-up|0|||
147383272|NCT00307489|531567281|FG001|Baseline Through Week 48|Lost to Follow-up|1|||
147383273|NCT00307489|531567280|FG000|Baseline Through Week 48|Physician Decision|1|||
147383274|NCT00307489|531567281|FG001|Baseline Through Week 48|Physician Decision|0|||
147383275|NCT00307489|531567280|FG000|Baseline Through Week 48|Withdrawal by Subject|0|||
147383276|NCT00307489|531567281|FG001|Baseline Through Week 48|Withdrawal by Subject|1|||
147383277|NCT00307489|531567280|FG000|Week 48 Through Week 168|Adverse Event|1|||
147383278|NCT00307489|531567281|FG001|Week 48 Through Week 168|Adverse Event|0|||
147383279|NCT00307489|531567280|FG000|Week 48 Through Week 168|Physician Decision|1|||
147383280|NCT00307489|531567281|FG001|Week 48 Through Week 168|Physician Decision|0|||
147383281|NCT00307489|531567280|FG000|Week 48 Through Week 168|Withdrawal by Subject|1|||
147383282|NCT00307489|531567281|FG001|Week 48 Through Week 168|Withdrawal by Subject|2|||
147383283|NCT00307489|531567280|FG000|Week 48 Through Week 168|Lack of Efficacy|2|||
147383284|NCT00307489|531567281|FG001|Week 48 Through Week 168|Lack of Efficacy|2|||
147383285|NCT00307489|531567280|FG000|Week 48 Through Week 168|Death|0|||
147383286|NCT00307489|531567281|FG001|Week 48 Through Week 168|Death|1|||
147383287|NCT00307489|531567280|FG000|Week 48 Through Week 168|Lost to Follow-up|0|||
147614660|NCT00577863|532404803|FG000|Overall Study|Lost to Follow-up|2|||
147614661|NCT00577863|532404804|FG001|Overall Study|Lost to Follow-up|2|||
147614662|NCT00577863|532404803|FG000|Overall Study|Entry Criteria Exclusion|1|||
147614663|NCT00577863|532404804|FG001|Overall Study|Entry Criteria Exclusion|0|||
147614664|NCT00577863|532404803|FG000|Overall Study|Withdrawal by Subject|0|||
147614665|NCT00577863|532404804|FG001|Overall Study|Withdrawal by Subject|2|||
147614666|NCT00577863|532404803|FG000|Overall Study|Sponsor Decision|2|||
147614667|NCT00577863|532404804|FG001|Overall Study|Sponsor Decision|7|||
147614668|NCT00577863|532404803|FG000|Overall Study|Did Not Receive at Least One Injection|0|||
147614669|NCT00577863|532404804|FG001|Overall Study|Did Not Receive at Least One Injection|1|||
147614670|NCT01750190|532404811|FG000|Overall Study|Adverse Event|47|||
147614671|NCT01750190|532404812|FG001|Overall Study|Adverse Event|19|||
147614672|NCT01750190|532404811|FG000|Overall Study|Death|38|||
147383288|NCT00307489|531567281|FG001|Week 48 Through Week 168|Lost to Follow-up|1|||
147383289|NCT00307489|531567280|FG000|Week 48 Through Week 168|Seroconversion|1|||
147383290|NCT00307489|531567281|FG001|Week 48 Through Week 168|Seroconversion|0|||
147383291|NCT04425252|531567282|FG000|Overall Study|Withdrawal by Subject|2|||
147383292|NCT04425252|531567283|FG001|Overall Study|Withdrawal by Subject|1|||
147383293|NCT04425252|531567282|FG000|Overall Study|Lost to Follow-up|1|||
147383294|NCT04425252|531567283|FG001|Overall Study|Lost to Follow-up|0|||
147383295|NCT04425252|531567282|FG000|Overall Study|Subject did not return due to COVID-19 restrictions.|1|||
147383296|NCT04425252|531567283|FG001|Overall Study|Subject did not return due to COVID-19 restrictions.|1|||
147614673|NCT01750190|532404812|FG001|Overall Study|Death|11|||
147614674|NCT01750190|532404811|FG000|Overall Study|Lack of Efficacy (Including Erythropoiesis-Stimulating Agent Rescue)|2|||
147383297|NCT00304278|531567285|FG000|Overall Study|lack of insurance coverage for chemoRT|1|||
147383298|NCT00304278|531567285|FG000|Overall Study|PT had medical condition preventing TX|1|||
147383299|NCT04025762|531567288|FG000|Crossover Study Period 1 (16 Weeks)|Death|0|||
147383300|NCT04025762|531567289|FG001|Crossover Study Period 1 (16 Weeks)|Death|1|||
147383301|NCT01286311|531567291|FG000|Overall Study|Physician did not want outreach sent|14|||
147383302|NCT01286311|531567292|FG001|Overall Study|Physician did not want outreach sent|0|||
147383303|NCT01381549|531567295|FG000|Overall Study|Ineligible: No organisms isolated|0|||
147383304|NCT01381549|531567296|FG001|Overall Study|Ineligible: No organisms isolated|0|||
147383305|NCT01381549|531567297|FG002|Overall Study|Ineligible: No organisms isolated|1|||
147383306|NCT02981953|531567298|FG000|Overall Study|Death|9|||
147383307|NCT02981953|531567298|FG000|Overall Study|Withdrawal by Subject|1|||
147614675|NCT01750190|532404812|FG001|Overall Study|Lack of Efficacy (Including Erythropoiesis-Stimulating Agent Rescue)|43|||
147614676|NCT01750190|532404811|FG000|Overall Study|Lost to Follow-up|28|||
147614677|NCT01750190|532404812|FG001|Overall Study|Lost to Follow-up|7|||
147614678|NCT01750190|532404811|FG000|Overall Study|Physician Decision|16|||
147614679|NCT01750190|532404812|FG001|Overall Study|Physician Decision|17|||
147614680|NCT01750190|532404811|FG000|Overall Study|Protocol Violation|6|||
147614681|NCT01750190|532404812|FG001|Overall Study|Protocol Violation|5|||
147614682|NCT01750190|532404811|FG000|Overall Study|Study/Site Terminated by Sponsor|4|||
147614683|NCT01750190|532404812|FG001|Overall Study|Study/Site Terminated by Sponsor|1|||
147614684|NCT01750190|532404811|FG000|Overall Study|Withdrawal by Subject|83|||
147614685|NCT01750190|532404812|FG001|Overall Study|Withdrawal by Subject|89|||
147614686|NCT01750190|532404811|FG000|Overall Study|Kidney Transplant|8|||
147614687|NCT01750190|532404812|FG001|Overall Study|Kidney Transplant|4|||
147614688|NCT01750190|532404811|FG000|Overall Study|Dialysis|22|||
147614689|NCT01750190|532404812|FG001|Overall Study|Dialysis|8|||
147614690|NCT01750190|532404811|FG000|Overall Study|Other than Specified|13|||
147614691|NCT01750190|532404812|FG001|Overall Study|Other than Specified|4|||
147614692|NCT02955212|532404813|FG000|Period 1: Double-blind Treatment Period|Adverse Event|4|||
147614693|NCT02955212|532404814|FG001|Period 1: Double-blind Treatment Period|Adverse Event|7|||
147614694|NCT02955212|532404813|FG000|Period 1: Double-blind Treatment Period|Withdrawal by Subject|8|||
147614695|NCT02955212|532404814|FG001|Period 1: Double-blind Treatment Period|Withdrawal by Subject|3|||
147614696|NCT02955212|532404813|FG000|Period 1: Double-blind Treatment Period|Lost to Follow-up|1|||
147614697|NCT02955212|532404814|FG001|Period 1: Double-blind Treatment Period|Lost to Follow-up|0|||
147614698|NCT02955212|532404813|FG000|Period 1: Double-blind Treatment Period|Other|3|||
147614699|NCT02955212|532404814|FG001|Period 1: Double-blind Treatment Period|Other|2|||
147614700|NCT02955212|532404813|FG000|Period 2: Open-label Extension|Adverse Event|11|||
147614701|NCT02955212|532404814|FG001|Period 2: Open-label Extension|Adverse Event|7|||
147614702|NCT02955212|532404813|FG000|Period 2: Open-label Extension|Withdrawal by Subject|1|||
147614703|NCT02955212|532404814|FG001|Period 2: Open-label Extension|Withdrawal by Subject|4|||
147614704|NCT02955212|532404813|FG000|Period 2: Open-label Extension|Lack of Efficacy|3|||
147614705|NCT02955212|532404814|FG001|Period 2: Open-label Extension|Lack of Efficacy|2|||
147614706|NCT02955212|532404813|FG000|Period 2: Open-label Extension|COVID-19 Logistical Restrictions|0|||
147614707|NCT02955212|532404814|FG001|Period 2: Open-label Extension|COVID-19 Logistical Restrictions|1|||
147614708|NCT02955212|532404813|FG000|Period 2: Open-label Extension|Other|2|||
147614709|NCT02955212|532404814|FG001|Period 2: Open-label Extension|Other|4|||
147614710|NCT02009722|532404815|FG000|Overall Study|Protocol Violation|1|||
147383308|NCT02981953|531567298|FG000|Overall Study|Withdrawal to non-compliance|1|||
147383309|NCT02889900|531567299|FG000|Overall Study|Adverse Event|11|||
147383310|NCT02889900|531567299|FG000|Overall Study|Condition under investigation worsened|32|||
147383311|NCT02889900|531567299|FG000|Overall Study|Other|5|||
147383312|NCT02889900|531567299|FG000|Overall Study|Withdrawal by Subject|7|||
147383313|NCT02889900|531567299|FG000|Overall Study|Not treated|2|||
147383314|NCT00813709|531567310|FG000|Double Blind Period|Adverse Event|4|||
147383315|NCT00813709|531567311|FG001|Double Blind Period|Adverse Event|1|||
147383316|NCT00813709|531567312|FG002|Double Blind Period|Adverse Event|4|||
147383317|NCT00813709|531567313|FG003|Double Blind Period|Adverse Event|0|||
147383318|NCT00813709|531567314|FG004|Double Blind Period|Adverse Event|0|||
147383319|NCT00813709|531567315|FG005|Double Blind Period|Adverse Event|0|||
147383320|NCT00813709|531567310|FG000|Double Blind Period|Lost to Follow-up|3|||
147383321|NCT00813709|531567311|FG001|Double Blind Period|Lost to Follow-up|2|||
147383322|NCT00813709|531567312|FG002|Double Blind Period|Lost to Follow-up|2|||
147383323|NCT00813709|531567313|FG003|Double Blind Period|Lost to Follow-up|0|||
147383324|NCT00813709|531567314|FG004|Double Blind Period|Lost to Follow-up|0|||
147614711|NCT02009722|532404816|FG001|Overall Study|Protocol Violation|2|||
147614712|NCT02009722|532404815|FG000|Overall Study|Did not receive intervention|0|||
147383325|NCT00813709|531567315|FG005|Double Blind Period|Lost to Follow-up|0|||
147383326|NCT00813709|531567310|FG000|Double Blind Period|Switched to open label phase|9|||
147614713|NCT02009722|532404816|FG001|Overall Study|Did not receive intervention|1|||
147383327|NCT00813709|531567311|FG001|Double Blind Period|Switched to open label phase|26|||
147383328|NCT00813709|531567312|FG002|Double Blind Period|Switched to open label phase|18|||
147383329|NCT00813709|531567313|FG003|Double Blind Period|Switched to open label phase|0|||
147383330|NCT00813709|531567314|FG004|Double Blind Period|Switched to open label phase|0|||
147614714|NCT02071225|532404825|FG000|Overall Study|Withdrawal of Consent|2|||
147614715|NCT02071225|532404825|FG000|Overall Study|Protocol Deviation|1|||
147383331|NCT00813709|531567315|FG005|Double Blind Period|Switched to open label phase|0|||
147383332|NCT00813709|531567310|FG000|Double Blind Period|Randomized but not treated|1|||
147383333|NCT00813709|531567311|FG001|Double Blind Period|Randomized but not treated|3|||
147383334|NCT00813709|531567312|FG002|Double Blind Period|Randomized but not treated|1|||
147383335|NCT00813709|531567313|FG003|Double Blind Period|Randomized but not treated|0|||
147383336|NCT00813709|531567314|FG004|Double Blind Period|Randomized but not treated|0|||
147383337|NCT00813709|531567315|FG005|Double Blind Period|Randomized but not treated|0|||
147383338|NCT00813709|531567310|FG000|Double Blind Period|Other|14|||
147383339|NCT00813709|531567311|FG001|Double Blind Period|Other|9|||
147383340|NCT00813709|531567312|FG002|Double Blind Period|Other|6|||
147383341|NCT00813709|531567313|FG003|Double Blind Period|Other|0|||
147383342|NCT00813709|531567314|FG004|Double Blind Period|Other|0|||
147383343|NCT00813709|531567315|FG005|Double Blind Period|Other|0|||
147383344|NCT00813709|531567310|FG000|Open Label Period|Adverse Event|0|||
147383345|NCT00813709|531567311|FG001|Open Label Period|Adverse Event|0|||
147383346|NCT00813709|531567312|FG002|Open Label Period|Adverse Event|0|||
147383347|NCT00813709|531567313|FG003|Open Label Period|Adverse Event|5|||
147383348|NCT00813709|531567314|FG004|Open Label Period|Adverse Event|4|||
147383349|NCT00813709|531567315|FG005|Open Label Period|Adverse Event|3|||
147383350|NCT00813709|531567310|FG000|Open Label Period|Lack of Efficacy|0|||
147383351|NCT00813709|531567311|FG001|Open Label Period|Lack of Efficacy|0|||
147383352|NCT00813709|531567312|FG002|Open Label Period|Lack of Efficacy|0|||
147383353|NCT00813709|531567313|FG003|Open Label Period|Lack of Efficacy|3|||
147383354|NCT00813709|531567314|FG004|Open Label Period|Lack of Efficacy|1|||
147383355|NCT00813709|531567315|FG005|Open Label Period|Lack of Efficacy|1|||
147383356|NCT00813709|531567310|FG000|Open Label Period|Randomized but not treated|0|||
147383357|NCT00813709|531567311|FG001|Open Label Period|Randomized but not treated|0|||
147383358|NCT00813709|531567312|FG002|Open Label Period|Randomized but not treated|0|||
147383359|NCT00813709|531567313|FG003|Open Label Period|Randomized but not treated|1|||
147383360|NCT00813709|531567314|FG004|Open Label Period|Randomized but not treated|0|||
147383361|NCT00813709|531567315|FG005|Open Label Period|Randomized but not treated|1|||
147383362|NCT00813709|531567310|FG000|Open Label Period|Other|0|||
147383363|NCT00813709|531567311|FG001|Open Label Period|Other|0|||
147383364|NCT00813709|531567312|FG002|Open Label Period|Other|0|||
147383365|NCT00813709|531567313|FG003|Open Label Period|Other|11|||
147383366|NCT00813709|531567314|FG004|Open Label Period|Other|5|||
147383367|NCT00813709|531567315|FG005|Open Label Period|Other|6|||
147383368|NCT01215253|531567316|FG000|Overall Study|Withdrawal by Subject|57|||
147383369|NCT01215253|531567317|FG001|Overall Study|Withdrawal by Subject|35|||
147383370|NCT01215253|531567316|FG000|Overall Study|Physician Decision|9|||
147383371|NCT01215253|531567317|FG001|Overall Study|Physician Decision|12|||
147383372|NCT01215253|531567316|FG000|Overall Study|Lost to Follow-up|6|||
147383373|NCT01215253|531567317|FG001|Overall Study|Lost to Follow-up|4|||
147383374|NCT01215253|531567316|FG000|Overall Study|Other|14|||
147383375|NCT01215253|531567317|FG001|Overall Study|Other|12|||
147383376|NCT00759681|531567318|FG000|Overall Study|Death|2|||
147383377|NCT00759681|531567319|FG001|Overall Study|Death|5|||
147383378|NCT00759681|531567318|FG000|Overall Study|Lost to Follow-up|8|||
147383379|NCT00759681|531567319|FG001|Overall Study|Lost to Follow-up|5|||
147383380|NCT03146845|531567321|FG000|Overall Study|Reference ulcer healed|1|||
147383381|NCT03146845|531567322|FG001|Overall Study|Reference ulcer healed|0|||
147383382|NCT03146845|531567321|FG000|Overall Study|Physician Decision|1|||
147383383|NCT03146845|531567322|FG001|Overall Study|Physician Decision|0|||
147383384|NCT03146845|531567321|FG000|Overall Study|Adverse Event|1|||
147383385|NCT03146845|531567322|FG001|Overall Study|Adverse Event|0|||
147383386|NCT03146845|531567321|FG000|Overall Study|Withdrawal by Subject|2|||
147383387|NCT03146845|531567322|FG001|Overall Study|Withdrawal by Subject|0|||
147383388|NCT03146845|531567321|FG000|Overall Study|Noncompliance|0|||
147383389|NCT03146845|531567322|FG001|Overall Study|Noncompliance|1|||
147383390|NCT03146845|531567321|FG000|Overall Study|Protocol Violation|0|||
147383391|NCT03146845|531567322|FG001|Overall Study|Protocol Violation|2|||
147383392|NCT03146845|531567321|FG000|Overall Study|Surgeon applied a graft with non-removable dressing; discharged to surgeon's care|0|||
147614716|NCT02071225|532404825|FG000|Overall Study|Lost to Follow-up|2|||
147383393|NCT03146845|531567322|FG001|Overall Study|Surgeon applied a graft with non-removable dressing; discharged to surgeon's care|1|||
147383394|NCT02721147|531567325|FG000|Overall Study|Lost to Follow-up|2|||
147383395|NCT02721147|531567326|FG001|Overall Study|Lost to Follow-up|0|||
147383396|NCT02721147|531567327|FG002|Overall Study|Lost to Follow-up|0|||
147614717|NCT02071225|532404825|FG000|Overall Study|Death|25|||
147614718|NCT03571828|532404827|FG000|Overall Study|Withdrawal by Subject|1|||
147614719|NCT03571828|532404828|FG001|Overall Study|Withdrawal by Subject|0|||
147383397|NCT01722097|531567329|FG000|Overall Study|Patient sheets not returned|6|||
147383398|NCT01722097|531567330|FG001|Overall Study|Patient sheets not returned|5|||
147383399|NCT01757288|531567332|FG000|Overall Study|Consent withdrawal|0|||
147383400|NCT01757288|531567333|FG001|Overall Study|Consent withdrawal|4|||
147383401|NCT01757288|531567334|FG002|Overall Study|Consent withdrawal|4|||
147614720|NCT03571828|532404827|FG000|Overall Study|Decision by sponsor|5|||
147383402|NCT01757288|531567332|FG000|Overall Study|Patient off study, IRB hold.|0|||
147383403|NCT01757288|531567333|FG001|Overall Study|Patient off study, IRB hold.|0|||
147383404|NCT01757288|531567334|FG002|Overall Study|Patient off study, IRB hold.|1|||
147383405|NCT01757288|531567332|FG000|Overall Study|Patient death prior to starting treatment|0|||
147383406|NCT01757288|531567333|FG001|Overall Study|Patient death prior to starting treatment|0|||
147383407|NCT01757288|531567334|FG002|Overall Study|Patient death prior to starting treatment|1|||
147383408|NCT01757288|531567332|FG000|Overall Study|Wrong medication administered|0|||
147383409|NCT01757288|531567333|FG001|Overall Study|Wrong medication administered|1|||
147383410|NCT01757288|531567334|FG002|Overall Study|Wrong medication administered|0|||
147383411|NCT01757288|531567332|FG000|Overall Study|Liver metastasis identified at CT simulation|0|||
147383412|NCT01757288|531567333|FG001|Overall Study|Liver metastasis identified at CT simulation|1|||
147383413|NCT01757288|531567334|FG002|Overall Study|Liver metastasis identified at CT simulation|0|||
147383414|NCT01757288|531567332|FG000|Overall Study|Not meeting protocol constraints|0|||
147383415|NCT01757288|531567333|FG001|Overall Study|Not meeting protocol constraints|1|||
147383416|NCT01757288|531567334|FG002|Overall Study|Not meeting protocol constraints|1|||
147383417|NCT01757288|531567332|FG000|Overall Study|Multiple missed appointments|0|||
147383418|NCT01757288|531567333|FG001|Overall Study|Multiple missed appointments|1|||
147383419|NCT01757288|531567334|FG002|Overall Study|Multiple missed appointments|0|||
147383420|NCT01757288|531567332|FG000|Overall Study|Mulitple hospitalization ( after first week of CRT)|0|||
147383421|NCT01757288|531567333|FG001|Overall Study|Mulitple hospitalization ( after first week of CRT)|0|||
147383422|NCT01757288|531567334|FG002|Overall Study|Mulitple hospitalization ( after first week of CRT)|1|||
147383423|NCT01757288|531567332|FG000|Overall Study|>2 weeks treatment break|0|||
147383424|NCT01757288|531567333|FG001|Overall Study|>2 weeks treatment break|0|||
147383425|NCT01757288|531567334|FG002|Overall Study|>2 weeks treatment break|1|||
147383426|NCT02825550|531567336|FG000|Overall Study|Physician Decision|1|||
147383427|NCT00700999|531567337|FG000|Overall Study|Lost to Follow-up|7|||
147383428|NCT00700999|531567338|FG001|Overall Study|Lost to Follow-up|7|||
147383429|NCT00700999|531567337|FG000|Overall Study|Excluded - did not meet study criteria|0|||
147383430|NCT00700999|531567338|FG001|Overall Study|Excluded - did not meet study criteria|1|||
147383431|NCT00700999|531567337|FG000|Overall Study|Withdrawal by Subject|8|||
147383432|NCT00700999|531567338|FG001|Overall Study|Withdrawal by Subject|1|||
147383433|NCT02379078|531567339|FG000|Overall Study|Lost to Follow-up|33|||
147383434|NCT02379078|531567340|FG001|Overall Study|Lost to Follow-up|30|||
147383435|NCT02379078|531567339|FG000|Overall Study|Withdrawal by Subject|6|||
147383436|NCT02379078|531567340|FG001|Overall Study|Withdrawal by Subject|5|||
147383437|NCT00761267|531567345|FG000|Overall Study|Death|1|||
147383438|NCT00761267|531567346|FG001|Overall Study|Death|2|||
147383439|NCT00761267|531567347|FG002|Overall Study|Death|5|||
147383440|NCT00761267|531567345|FG000|Overall Study|Lost to Follow-up|0|||
147383441|NCT00761267|531567346|FG001|Overall Study|Lost to Follow-up|0|||
147383442|NCT00761267|531567347|FG002|Overall Study|Lost to Follow-up|1|||
147383443|NCT00761267|531567345|FG000|Overall Study|Randomized but not treated|1|||
147383444|NCT00761267|531567346|FG001|Overall Study|Randomized but not treated|1|||
147383445|NCT00761267|531567347|FG002|Overall Study|Randomized but not treated|0|||
147383446|NCT00761267|531567345|FG000|Overall Study|Withdrawal by Subject|0|||
147383447|NCT00761267|531567346|FG001|Overall Study|Withdrawal by Subject|1|||
147383448|NCT00761267|531567347|FG002|Overall Study|Withdrawal by Subject|0|||
147383449|NCT01777932|531567351|FG000|Overall Study|Disease progression|136|||
147383450|NCT01777932|531567351|FG000|Overall Study|Death|3|||
147383451|NCT01777932|531567351|FG000|Overall Study|Adverse Event|34|||
147383452|NCT01777932|531567351|FG000|Overall Study|Lost to Follow-up|3|||
147383453|NCT01777932|531567351|FG000|Overall Study|Investigator decision|10|||
147383454|NCT01777932|531567351|FG000|Overall Study|Reimbursement limit|9|||
147383455|NCT01777932|531567351|FG000|Overall Study|Patient refused further treatment|10|||
147383456|NCT01419184|531567355|FG000|Overall Study|Site data not available|3|||
147383457|NCT01419184|531567356|FG001|Overall Study|Site data not available|2|||
147383458|NCT01419184|531567355|FG000|Overall Study|No IRLOS-No in-patient end date reported|3|||
147383459|NCT01419184|531567356|FG001|Overall Study|No IRLOS-No in-patient end date reported|6|||
147383460|NCT01419184|531567355|FG000|Overall Study|No IRLOS-randomized, not treated|2|||
147383461|NCT01419184|531567356|FG001|Overall Study|No IRLOS-randomized, not treated|4|||
147383462|NCT01419184|531567355|FG000|Overall Study|No IRLOS-non trial antibiotic used|1|||
147383463|NCT01419184|531567356|FG001|Overall Study|No IRLOS-non trial antibiotic used|2|||
147383464|NCT01419184|531567355|FG000|Overall Study|No IRLOS-No adverse event treatment date|0|||
147383465|NCT01419184|531567356|FG001|Overall Study|No IRLOS-No adverse event treatment date|1|||
147383466|NCT01419184|531567355|FG000|Overall Study|Participant randomized, not treated|1|||
147383467|NCT01419184|531567356|FG001|Overall Study|Participant randomized, not treated|0|||
147383468|NCT03031782|531567365|FG000|Treatment Period 1|Lack of Efficacy|3|||
147383469|NCT03031782|531567366|FG001|Treatment Period 1|Lack of Efficacy|0|||
147383470|NCT03031782|531567367|FG002|Treatment Period 1|Lack of Efficacy|0|||
147383471|NCT03031782|531567368|FG003|Treatment Period 1|Lack of Efficacy|0|||
147383472|NCT03031782|531567369|FG004|Treatment Period 1|Lack of Efficacy|0|||
147383473|NCT03031782|531567365|FG000|Treatment Period 2|Physician Decision|0|||
147383474|NCT03031782|531567366|FG001|Treatment Period 2|Physician Decision|1|||
147383475|NCT03031782|531567367|FG002|Treatment Period 2|Physician Decision|0|||
147383476|NCT03031782|531567368|FG003|Treatment Period 2|Physician Decision|0|||
147383477|NCT03031782|531567369|FG004|Treatment Period 2|Physician Decision|3|||
147383478|NCT03031782|531567365|FG000|Treatment Period 2|Lack of Efficacy|0|||
147383479|NCT03031782|531567366|FG001|Treatment Period 2|Lack of Efficacy|1|||
147383480|NCT03031782|531567367|FG002|Treatment Period 2|Lack of Efficacy|0|||
147383481|NCT03031782|531567368|FG003|Treatment Period 2|Lack of Efficacy|0|||
147383482|NCT03031782|531567369|FG004|Treatment Period 2|Lack of Efficacy|1|||
147383483|NCT03031782|531567365|FG000|Treatment Period 2|Withdrawal by Subject|0|||
147383484|NCT03031782|531567366|FG001|Treatment Period 2|Withdrawal by Subject|3|||
147383485|NCT03031782|531567367|FG002|Treatment Period 2|Withdrawal by Subject|0|||
147383486|NCT03031782|531567368|FG003|Treatment Period 2|Withdrawal by Subject|0|||
147383487|NCT03031782|531567369|FG004|Treatment Period 2|Withdrawal by Subject|1|||
147383488|NCT03031782|531567365|FG000|Treatment Period 2|Adverse Event|0|||
147383489|NCT03031782|531567366|FG001|Treatment Period 2|Adverse Event|1|||
147383490|NCT03031782|531567367|FG002|Treatment Period 2|Adverse Event|2|||
147383491|NCT03031782|531567368|FG003|Treatment Period 2|Adverse Event|0|||
147383492|NCT03031782|531567369|FG004|Treatment Period 2|Adverse Event|0|||
147383493|NCT03031782|531567365|FG000|Treatment Period 3|Withdrawal by Subject|0|||
147383494|NCT03031782|531567366|FG001|Treatment Period 3|Withdrawal by Subject|0|||
147383495|NCT03031782|531567367|FG002|Treatment Period 3|Withdrawal by Subject|0|||
147383496|NCT03031782|531567368|FG003|Treatment Period 3|Withdrawal by Subject|1|||
147383497|NCT03031782|531567369|FG004|Treatment Period 3|Withdrawal by Subject|0|||
147383498|NCT00424476|531567370|FG000|Overall Study|Withdrawal by Subject|7|||
147383499|NCT00424476|531567371|FG001|Overall Study|Withdrawal by Subject|6|||
147383500|NCT00424476|531567372|FG002|Overall Study|Withdrawal by Subject|3|||
147383501|NCT00424476|531567370|FG000|Overall Study|Adverse Event|19|||
147383502|NCT00424476|531567371|FG001|Overall Study|Adverse Event|16|||
147383503|NCT00424476|531567372|FG002|Overall Study|Adverse Event|15|||
147383504|NCT00424476|531567370|FG000|Overall Study|Lack of Efficacy|16|||
147383505|NCT00424476|531567371|FG001|Overall Study|Lack of Efficacy|12|||
147383506|NCT00424476|531567372|FG002|Overall Study|Lack of Efficacy|12|||
147383507|NCT00424476|531567370|FG000|Overall Study|Lack of Compliance|1|||
147383508|NCT00424476|531567371|FG001|Overall Study|Lack of Compliance|1|||
147383509|NCT00424476|531567372|FG002|Overall Study|Lack of Compliance|1|||
147383510|NCT00424476|531567370|FG000|Overall Study|Lost to Follow-up|4|||
147383511|NCT00424476|531567371|FG001|Overall Study|Lost to Follow-up|6|||
147383512|NCT00424476|531567372|FG002|Overall Study|Lost to Follow-up|3|||
147383513|NCT00424476|531567370|FG000|Overall Study|Protocol Violation|7|||
147383514|NCT00424476|531567371|FG001|Overall Study|Protocol Violation|2|||
147383515|NCT00424476|531567372|FG002|Overall Study|Protocol Violation|3|||
147383516|NCT00424476|531567370|FG000|Overall Study|Physician Decision|3|||
147383517|NCT00424476|531567371|FG001|Overall Study|Physician Decision|2|||
147383518|NCT00424476|531567372|FG002|Overall Study|Physician Decision|3|||
147383519|NCT00424476|531567370|FG000|Overall Study|Other|4|||
147383520|NCT00424476|531567371|FG001|Overall Study|Other|3|||
147383521|NCT00424476|531567372|FG002|Overall Study|Other|9|||
147383522|NCT03979040|531567373|FG000|Overall Study|Withdrawal by Subject|24|||
147383523|NCT03979040|531567374|FG001|Overall Study|Withdrawal by Subject|32|||
147383524|NCT03979040|531567373|FG000|Overall Study|randomized but never started treatment|32|||
147383525|NCT03979040|531567374|FG001|Overall Study|randomized but never started treatment|39|||
147383526|NCT03979040|531567373|FG000|Overall Study|withdrawn by study team due to poor fit/lack of efficacy|0|||
147383527|NCT03979040|531567374|FG001|Overall Study|withdrawn by study team due to poor fit/lack of efficacy|1|||
147383528|NCT03541369|531567377|FG000|Overall Study|Death|0|||
147383529|NCT03541369|531567378|FG001|Overall Study|Death|0|||
147383530|NCT03541369|531567379|FG002|Overall Study|Death|0|||
147383531|NCT03541369|531567380|FG003|Overall Study|Death|0|||
147383532|NCT03541369|531567381|FG004|Overall Study|Death|1|||
147383533|NCT03541369|531567382|FG005|Overall Study|Death|1|||
147456475|NCT03529773|531831747|FG027|Overall Study|Screen Failure|0|||
147456476|NCT03529773|531831748|FG028|Overall Study|Screen Failure|0|||
147456477|NCT03529773|531831749|FG029|Overall Study|Screen Failure|0|||
147614721|NCT03571828|532404828|FG001|Overall Study|Decision by sponsor|1|||
147383534|NCT03541369|531567383|FG006|Overall Study|Death|0|||
147383535|NCT03541369|531567384|FG007|Overall Study|Death|2|||
147383536|NCT03541369|531567385|FG008|Overall Study|Death|1|||
147383537|NCT03541369|531567386|FG009|Overall Study|Death|2|||
147383538|NCT03541369|531567387|FG010|Overall Study|Death|1|||
147383539|NCT03541369|531567388|FG011|Overall Study|Death|0|||
147383540|NCT03541369|531567389|FG012|Overall Study|Death|2|||
147614722|NCT03571828|532404827|FG000|Overall Study|Death|2|||
147383541|NCT03541369|531567390|FG013|Overall Study|Death|1|||
147383542|NCT03541369|531567391|FG014|Overall Study|Death|1|||
147383543|NCT03541369|531567392|FG015|Overall Study|Death|1|||
147383544|NCT03541369|531567393|FG016|Overall Study|Death|0|||
147383545|NCT03541369|531567394|FG017|Overall Study|Death|1|||
147383546|NCT03541369|531567377|FG000|Overall Study|Decision by sponsor|0|||
147383547|NCT03541369|531567378|FG001|Overall Study|Decision by sponsor|0|||
147383548|NCT03541369|531567379|FG002|Overall Study|Decision by sponsor|0|||
147383549|NCT03541369|531567380|FG003|Overall Study|Decision by sponsor|1|||
147383550|NCT03541369|531567381|FG004|Overall Study|Decision by sponsor|0|||
147383551|NCT03541369|531567382|FG005|Overall Study|Decision by sponsor|2|||
147383552|NCT03541369|531567383|FG006|Overall Study|Decision by sponsor|0|||
147383553|NCT03541369|531567384|FG007|Overall Study|Decision by sponsor|1|||
147383554|NCT03541369|531567385|FG008|Overall Study|Decision by sponsor|2|||
147383555|NCT03541369|531567386|FG009|Overall Study|Decision by sponsor|0|||
147383556|NCT03541369|531567387|FG010|Overall Study|Decision by sponsor|0|||
147383557|NCT03541369|531567388|FG011|Overall Study|Decision by sponsor|0|||
147383558|NCT03541369|531567389|FG012|Overall Study|Decision by sponsor|2|||
147383559|NCT03541369|531567390|FG013|Overall Study|Decision by sponsor|2|||
147383560|NCT03541369|531567391|FG014|Overall Study|Decision by sponsor|0|||
147383561|NCT03541369|531567392|FG015|Overall Study|Decision by sponsor|1|||
147383562|NCT03541369|531567393|FG016|Overall Study|Decision by sponsor|1|||
147383563|NCT03541369|531567394|FG017|Overall Study|Decision by sponsor|1|||
147383564|NCT03541369|531567377|FG000|Overall Study|Withdrawal by Subject|0|||
147383565|NCT03541369|531567378|FG001|Overall Study|Withdrawal by Subject|0|||
147383566|NCT03541369|531567379|FG002|Overall Study|Withdrawal by Subject|0|||
147383567|NCT03541369|531567380|FG003|Overall Study|Withdrawal by Subject|0|||
147383568|NCT03541369|531567381|FG004|Overall Study|Withdrawal by Subject|0|||
147383569|NCT03541369|531567382|FG005|Overall Study|Withdrawal by Subject|0|||
147383570|NCT03541369|531567383|FG006|Overall Study|Withdrawal by Subject|1|||
147383571|NCT03541369|531567384|FG007|Overall Study|Withdrawal by Subject|0|||
147383572|NCT03541369|531567385|FG008|Overall Study|Withdrawal by Subject|0|||
147383573|NCT03541369|531567386|FG009|Overall Study|Withdrawal by Subject|0|||
147383574|NCT03541369|531567387|FG010|Overall Study|Withdrawal by Subject|0|||
147383575|NCT03541369|531567388|FG011|Overall Study|Withdrawal by Subject|1|||
147383576|NCT03541369|531567389|FG012|Overall Study|Withdrawal by Subject|0|||
147383577|NCT03541369|531567390|FG013|Overall Study|Withdrawal by Subject|0|||
147383578|NCT03541369|531567391|FG014|Overall Study|Withdrawal by Subject|3|||
147383579|NCT03541369|531567392|FG015|Overall Study|Withdrawal by Subject|0|||
147383580|NCT03541369|531567393|FG016|Overall Study|Withdrawal by Subject|4|||
147383581|NCT03541369|531567394|FG017|Overall Study|Withdrawal by Subject|2|||
147383582|NCT03541369|531567377|FG000|Overall Study|Lost to Follow-up|0|||
147383583|NCT03541369|531567378|FG001|Overall Study|Lost to Follow-up|0|||
147383584|NCT03541369|531567379|FG002|Overall Study|Lost to Follow-up|0|||
147383585|NCT03541369|531567380|FG003|Overall Study|Lost to Follow-up|0|||
147383586|NCT03541369|531567381|FG004|Overall Study|Lost to Follow-up|1|||
147383587|NCT03541369|531567382|FG005|Overall Study|Lost to Follow-up|0|||
147383588|NCT03541369|531567383|FG006|Overall Study|Lost to Follow-up|0|||
147383589|NCT03541369|531567384|FG007|Overall Study|Lost to Follow-up|0|||
147383590|NCT03541369|531567385|FG008|Overall Study|Lost to Follow-up|1|||
147383591|NCT03541369|531567386|FG009|Overall Study|Lost to Follow-up|0|||
147383592|NCT03541369|531567387|FG010|Overall Study|Lost to Follow-up|0|||
147383593|NCT03541369|531567388|FG011|Overall Study|Lost to Follow-up|0|||
147383594|NCT03541369|531567389|FG012|Overall Study|Lost to Follow-up|1|||
147383595|NCT03541369|531567390|FG013|Overall Study|Lost to Follow-up|0|||
147383596|NCT03541369|531567391|FG014|Overall Study|Lost to Follow-up|0|||
147383597|NCT03541369|531567392|FG015|Overall Study|Lost to Follow-up|0|||
147456478|NCT03529773|531831750|FG030|Overall Study|Screen Failure|0|||
147456479|NCT03529773|531831751|FG031|Overall Study|Screen Failure|0|||
147456480|NCT03529773|531831752|FG032|Overall Study|Screen Failure|0|||
147383598|NCT03541369|531567393|FG016|Overall Study|Lost to Follow-up|0|||
147383599|NCT03541369|531567394|FG017|Overall Study|Lost to Follow-up|0|||
147383600|NCT02279732|531567397|FG000|Overall Study|Death|23|||
147383601|NCT02279732|531567398|FG001|Overall Study|Death|20|||
147383602|NCT02279732|531567397|FG000|Overall Study|Disease Progression|13|||
147456481|NCT03529773|531831753|FG033|Overall Study|Screen Failure|0|||
147456482|NCT03529773|531831754|FG034|Overall Study|Screen Failure|0|||
147456483|NCT03529773|531831755|FG035|Overall Study|Screen Failure|0|||
147456484|NCT03529773|531831756|FG036|Overall Study|Screen Failure|1|||
147456485|NCT03529773|531831757|FG037|Overall Study|Screen Failure|1|||
147456486|NCT03529773|531831758|FG038|Overall Study|Screen Failure|0|||
147456487|NCT03529773|531831759|FG039|Overall Study|Screen Failure|1|||
147456488|NCT03529773|531831720|FG000|Overall Study|Randomized but not vaccinated|0|||
147456489|NCT03529773|531831721|FG001|Overall Study|Randomized but not vaccinated|0|||
147456490|NCT03529773|531831722|FG002|Overall Study|Randomized but not vaccinated|0|||
147456491|NCT03529773|531831723|FG003|Overall Study|Randomized but not vaccinated|0|||
147456492|NCT03529773|531831724|FG004|Overall Study|Randomized but not vaccinated|0|||
147456493|NCT03529773|531831725|FG005|Overall Study|Randomized but not vaccinated|0|||
147456494|NCT03529773|531831726|FG006|Overall Study|Randomized but not vaccinated|0|||
147456495|NCT03529773|531831727|FG007|Overall Study|Randomized but not vaccinated|0|||
147456496|NCT03529773|531831728|FG008|Overall Study|Randomized but not vaccinated|0|||
147456497|NCT03529773|531831729|FG009|Overall Study|Randomized but not vaccinated|0|||
147456498|NCT03529773|531831730|FG010|Overall Study|Randomized but not vaccinated|0|||
147456499|NCT03529773|531831731|FG011|Overall Study|Randomized but not vaccinated|0|||
147456500|NCT03529773|531831732|FG012|Overall Study|Randomized but not vaccinated|0|||
147456501|NCT03529773|531831733|FG013|Overall Study|Randomized but not vaccinated|0|||
147456502|NCT03529773|531831734|FG014|Overall Study|Randomized but not vaccinated|0|||
147614723|NCT03571828|532404828|FG001|Overall Study|Death|0|||
147383603|NCT02279732|531567398|FG001|Overall Study|Disease Progression|3|||
147383604|NCT02279732|531567397|FG000|Overall Study|Withdrawal by Subject|2|||
147383605|NCT02279732|531567398|FG001|Overall Study|Withdrawal by Subject|7|||
147383606|NCT02279732|531567397|FG000|Overall Study|Adverse Event|1|||
147383607|NCT02279732|531567398|FG001|Overall Study|Adverse Event|2|||
147383608|NCT02279732|531567397|FG000|Overall Study|Administrative Reason By Sponsor|0|||
147383609|NCT02279732|531567398|FG001|Overall Study|Administrative Reason By Sponsor|2|||
147383610|NCT02279732|531567397|FG000|Overall Study|Study Drug Toxicity|2|||
147383611|NCT02279732|531567398|FG001|Overall Study|Study Drug Toxicity|0|||
147383612|NCT02279732|531567397|FG000|Overall Study|Lost to Follow-up|0|||
147383613|NCT02279732|531567398|FG001|Overall Study|Lost to Follow-up|1|||
147383614|NCT02279732|531567397|FG000|Overall Study|Maximum Clinical Benefit|1|||
147383615|NCT02279732|531567398|FG001|Overall Study|Maximum Clinical Benefit|0|||
147383616|NCT02279732|531567397|FG000|Overall Study|Subject Requested to Discontinue|0|||
147383617|NCT02279732|531567398|FG001|Overall Study|Subject Requested to Discontinue|1|||
147383618|NCT02279732|531567397|FG000|Overall Study|Other|53|||
147383619|NCT02279732|531567398|FG001|Overall Study|Other|67|||
147383620|NCT02279732|531567397|FG000|Overall Study|Other|3|||
147383621|NCT02279732|531567398|FG001|Overall Study|Other|3|||
147383622|NCT03072862|531567402|FG000|Overall Study|Withdrawal by Subject|4|||
147383623|NCT03072862|531567402|FG000|Overall Study|Lost to Follow-up|6|||
147383624|NCT03072862|531567402|FG000|Overall Study|Protocol Violation|4|||
147383625|NCT03072862|531567402|FG000|Overall Study|Physician Decision|2|||
147383626|NCT03072862|531567402|FG000|Overall Study|Death|1|||
147383627|NCT03072862|531567402|FG000|Overall Study|Adverse Event|1|||
147383628|NCT02513667|531567403|FG000|Overall Study|Withdrawal by Subject|0|||
147383629|NCT02513667|531567404|FG001|Overall Study|Withdrawal by Subject|1|||
147383630|NCT03347396|531567405|FG000|Part A (26 Weeks)|Adverse Event|1|||
147383631|NCT03347396|531567406|FG001|Part A (26 Weeks)|Adverse Event|0|||
147383632|NCT03347396|531567405|FG000|Part A (26 Weeks)|Death|0|||
147383633|NCT03347396|531567406|FG001|Part A (26 Weeks)|Death|1|||
147383634|NCT03347396|531567405|FG000|Part B (149 Weeks)|Adverse Event|1|||
147383635|NCT03347396|531567406|FG001|Part B (149 Weeks)|Adverse Event|1|||
147383636|NCT03347396|531567405|FG000|Part B (149 Weeks)|Death|1|||
147383637|NCT03347396|531567406|FG001|Part B (149 Weeks)|Death|0|||
147383638|NCT01670526|531567413|FG000|Overall Study|Withdrawal by Subject|3|||
147383639|NCT01670526|531567414|FG001|Overall Study|Withdrawal by Subject|1|||
147383640|NCT01670526|531567413|FG000|Overall Study|Lost to Follow-up|9|||
147383641|NCT01670526|531567414|FG001|Overall Study|Lost to Follow-up|5|||
147383642|NCT00392197|531567415|FG000|Overall Study|Adverse Event|4|||
147383643|NCT00392197|531567416|FG001|Overall Study|Adverse Event|12|||
147383644|NCT00392197|531567415|FG000|Overall Study|Lack of Efficacy|3|||
147383645|NCT00392197|531567416|FG001|Overall Study|Lack of Efficacy|4|||
147383646|NCT00392197|531567415|FG000|Overall Study|Lost to Follow-up|0|||
147383647|NCT00392197|531567416|FG001|Overall Study|Lost to Follow-up|1|||
147383648|NCT00392197|531567415|FG000|Overall Study|Physician Decision|3|||
147383649|NCT00392197|531567416|FG001|Overall Study|Physician Decision|2|||
147383650|NCT00392197|531567415|FG000|Overall Study|Protocol Violation|7|||
147383651|NCT00392197|531567416|FG001|Overall Study|Protocol Violation|5|||
147383652|NCT00392197|531567415|FG000|Overall Study|Withdrawal by Subject|4|||
147383653|NCT00392197|531567416|FG001|Overall Study|Withdrawal by Subject|6|||
147383654|NCT01970527|531567418|FG000|Pre-treatment/Baseline|Screen fail- participant had brain mets|1|||
147383655|NCT01970527|531567419|FG001|Pre-treatment/Baseline|Screen fail- participant had brain mets|0|||
147383656|NCT01970527|531567418|FG000|Treatment|Disease progression|0|||
147383657|NCT01970527|531567419|FG001|Treatment|Disease progression|1|||
147383658|NCT01970527|531567418|FG000|Treatment|Participant did not tolerate Ipilimumab|0|||
147383659|NCT01970527|531567419|FG001|Treatment|Participant did not tolerate Ipilimumab|1|||
147383660|NCT01970527|531567418|FG000|Treatment|Death|0|||
147383661|NCT01970527|531567419|FG001|Treatment|Death|1|||
147456503|NCT03529773|531831735|FG015|Overall Study|Randomized but not vaccinated|0|||
147383662|NCT01970527|531567418|FG000|Follow-up Clinic Visit|Disease progression|1|||
147383663|NCT01970527|531567419|FG001|Follow-up Clinic Visit|Disease progression|1|||
147383664|NCT01970527|531567418|FG000|Follow-up Clinic Visit|Withdrawal by Subject|0|||
147383665|NCT01970527|531567419|FG001|Follow-up Clinic Visit|Withdrawal by Subject|1|||
147383666|NCT01970527|531567418|FG000|Follow-up Clinic Visit|Lost to Follow-up|0|||
147383667|NCT01970527|531567419|FG001|Follow-up Clinic Visit|Lost to Follow-up|1|||
147383668|NCT04914897|531569551|FG000|Overall Study|Withdrawal by Subject|3|||
147383669|NCT04914897|531569552|FG001|Overall Study|Withdrawal by Subject|1|||
147383670|NCT04914897|531569553|FG002|Overall Study|Withdrawal by Subject|1|||
147383671|NCT04914897|531569554|FG003|Overall Study|Withdrawal by Subject|1|||
147383672|NCT04914897|531569551|FG000|Overall Study|Poor compliance to protocol|0|||
147383673|NCT04914897|531569552|FG001|Overall Study|Poor compliance to protocol|0|||
147383674|NCT04914897|531569553|FG002|Overall Study|Poor compliance to protocol|1|||
147383675|NCT04914897|531569554|FG003|Overall Study|Poor compliance to protocol|0|||
147383676|NCT04914897|531569551|FG000|Overall Study|Progressive disease|5|||
147383677|NCT04914897|531569552|FG001|Overall Study|Progressive disease|14|||
147383678|NCT04914897|531569553|FG002|Overall Study|Progressive disease|30|||
147383679|NCT04914897|531569554|FG003|Overall Study|Progressive disease|21|||
147383680|NCT04914897|531569551|FG000|Overall Study|Adverse event: Not related to Coronavirus Disease 2019 (COVID-19)|3|||
147383681|NCT04914897|531569552|FG001|Overall Study|Adverse event: Not related to Coronavirus Disease 2019 (COVID-19)|4|||
147383682|NCT04914897|531569553|FG002|Overall Study|Adverse event: Not related to Coronavirus Disease 2019 (COVID-19)|7|||
147383683|NCT04914897|531569554|FG003|Overall Study|Adverse event: Not related to Coronavirus Disease 2019 (COVID-19)|6|||
147383684|NCT04914897|531569551|FG000|Overall Study|Other|1|||
147383685|NCT04914897|531569552|FG001|Overall Study|Other|0|||
147383686|NCT04914897|531569553|FG002|Overall Study|Other|0|||
147383687|NCT04914897|531569554|FG003|Overall Study|Other|1|||
147383688|NCT03020914|531569555|FG000|Overall Study|Surgery Cancelled|1|||
147383689|NCT03020914|531569556|FG001|Overall Study|Surgery Cancelled|0|||
147383690|NCT01131325|531569559|FG000|Overall Study|Adverse Event|1|||
147383691|NCT01131325|531569559|FG000|Overall Study|The participants discontinued the study as the study got terminated|2|||
147383692|NCT03761849|531569560|FG000|Overall Study|transferred to OpenLabelExtension|35|||
147383693|NCT03761849|531569561|FG001|Overall Study|transferred to OpenLabelExtension|34|||
147383694|NCT03761849|531569562|FG002|Overall Study|transferred to OpenLabelExtension|36|||
147383695|NCT03761849|531569563|FG003|Overall Study|transferred to OpenLabelExtension|0|||
147383696|NCT03761849|531569564|FG004|Overall Study|transferred to OpenLabelExtension|0|||
147383697|NCT03761849|531569565|FG005|Overall Study|transferred to OpenLabelExtension|0|||
147383698|NCT03761849|531569560|FG000|Overall Study|Adverse Event|1|||
147383699|NCT03761849|531569561|FG001|Overall Study|Adverse Event|0|||
147383700|NCT03761849|531569562|FG002|Overall Study|Adverse Event|0|||
147383701|NCT03761849|531569563|FG003|Overall Study|Adverse Event|0|||
147383702|NCT03761849|531569564|FG004|Overall Study|Adverse Event|2|||
147383703|NCT03761849|531569565|FG005|Overall Study|Adverse Event|3|||
147383704|NCT03761849|531569560|FG000|Overall Study|Withdrawal by Subject|0|||
147383705|NCT03761849|531569561|FG001|Overall Study|Withdrawal by Subject|0|||
147383706|NCT03761849|531569562|FG002|Overall Study|Withdrawal by Subject|0|||
147383707|NCT03761849|531569563|FG003|Overall Study|Withdrawal by Subject|41|||
147383708|NCT03761849|531569564|FG004|Overall Study|Withdrawal by Subject|43|||
147383709|NCT03761849|531569565|FG005|Overall Study|Withdrawal by Subject|35|||
147383710|NCT03761849|531569560|FG000|Overall Study|Lost to Follow-up|0|||
147383711|NCT03761849|531569561|FG001|Overall Study|Lost to Follow-up|1|||
147383712|NCT03761849|531569562|FG002|Overall Study|Lost to Follow-up|0|||
147383713|NCT03761849|531569563|FG003|Overall Study|Lost to Follow-up|2|||
147383714|NCT03761849|531569564|FG004|Overall Study|Lost to Follow-up|4|||
147383715|NCT03761849|531569565|FG005|Overall Study|Lost to Follow-up|5|||
147383716|NCT03761849|531569560|FG000|Overall Study|Repeated MRI dId not pass QC.|0|||
147383717|NCT03761849|531569561|FG001|Overall Study|Repeated MRI dId not pass QC.|1|||
147383718|NCT03761849|531569562|FG002|Overall Study|Repeated MRI dId not pass QC.|0|||
147383719|NCT03761849|531569563|FG003|Overall Study|Repeated MRI dId not pass QC.|0|||
147383720|NCT03761849|531569564|FG004|Overall Study|Repeated MRI dId not pass QC.|0|||
147383721|NCT03761849|531569565|FG005|Overall Study|Repeated MRI dId not pass QC.|0|||
147383722|NCT03761849|531569560|FG000|Overall Study|Physician Decision|0|||
147383723|NCT03761849|531569561|FG001|Overall Study|Physician Decision|0|||
147383724|NCT03761849|531569562|FG002|Overall Study|Physician Decision|0|||
147383725|NCT03761849|531569563|FG003|Overall Study|Physician Decision|1|||
147383726|NCT03761849|531569564|FG004|Overall Study|Physician Decision|4|||
147383727|NCT03761849|531569565|FG005|Overall Study|Physician Decision|4|||
147383728|NCT03761849|531569560|FG000|Overall Study|Death|0|||
147383729|NCT03761849|531569561|FG001|Overall Study|Death|0|||
147383730|NCT03761849|531569562|FG002|Overall Study|Death|0|||
147383731|NCT03761849|531569563|FG003|Overall Study|Death|1|||
147383732|NCT03761849|531569564|FG004|Overall Study|Death|1|||
147383733|NCT03761849|531569565|FG005|Overall Study|Death|3|||
147383734|NCT03761849|531569560|FG000|Overall Study|Protocol Violation|0|||
147383735|NCT03761849|531569561|FG001|Overall Study|Protocol Violation|0|||
147383736|NCT03761849|531569562|FG002|Overall Study|Protocol Violation|0|||
147383737|NCT03761849|531569563|FG003|Overall Study|Protocol Violation|2|||
147383738|NCT03761849|531569564|FG004|Overall Study|Protocol Violation|2|||
147383739|NCT03761849|531569565|FG005|Overall Study|Protocol Violation|1|||
147383740|NCT03761849|531569560|FG000|Overall Study|Participant could not come to site|0|||
147383741|NCT03761849|531569561|FG001|Overall Study|Participant could not come to site|0|||
147383742|NCT03761849|531569562|FG002|Overall Study|Participant could not come to site|0|||
147383743|NCT03761849|531569563|FG003|Overall Study|Participant could not come to site|0|||
147383744|NCT03761849|531569564|FG004|Overall Study|Participant could not come to site|1|||
147383745|NCT03761849|531569565|FG005|Overall Study|Participant could not come to site|0|||
147383746|NCT03761849|531569560|FG000|Overall Study|SF- safety Finding|0|||
147383747|NCT03761849|531569561|FG001|Overall Study|SF- safety Finding|0|||
147614724|NCT00666328|532404829|FG000|Overall Study|Death|2|||
147383748|NCT03761849|531569562|FG002|Overall Study|SF- safety Finding|0|||
147383749|NCT03761849|531569563|FG003|Overall Study|SF- safety Finding|0|||
147383750|NCT03761849|531569564|FG004|Overall Study|SF- safety Finding|0|||
147383751|NCT03761849|531569565|FG005|Overall Study|SF- safety Finding|1|||
147383752|NCT03761849|531569560|FG000|Overall Study|Patient did not attend visit|0|||
147383753|NCT03761849|531569561|FG001|Overall Study|Patient did not attend visit|0|||
147383754|NCT03761849|531569562|FG002|Overall Study|Patient did not attend visit|0|||
147383755|NCT03761849|531569563|FG003|Overall Study|Patient did not attend visit|0|||
147383756|NCT03761849|531569564|FG004|Overall Study|Patient did not attend visit|0|||
147383757|NCT03761849|531569565|FG005|Overall Study|Patient did not attend visit|1|||
147383758|NCT03840993|531569566|FG000|Overall Study|Adverse Event|1|||
147383759|NCT03840993|531569567|FG001|Overall Study|Adverse Event|0|||
147383760|NCT03840993|531569566|FG000|Overall Study|Lost to Follow-up|4|||
147383761|NCT03840993|531569567|FG001|Overall Study|Lost to Follow-up|0|||
147383762|NCT03840993|531569566|FG000|Overall Study|Physician Decision|0|||
147383763|NCT03840993|531569567|FG001|Overall Study|Physician Decision|1|||
147383764|NCT03840993|531569566|FG000|Overall Study|Pregnancy|0|||
147383765|NCT03840993|531569567|FG001|Overall Study|Pregnancy|1|||
147383766|NCT03840993|531569566|FG000|Overall Study|Withdrawal by Subject|1|||
147383767|NCT03840993|531569567|FG001|Overall Study|Withdrawal by Subject|3|||
147383768|NCT03840993|531569566|FG000|Overall Study|Neutrophil count decrease, COVID-19|3|||
147383769|NCT03840993|531569567|FG001|Overall Study|Neutrophil count decrease, COVID-19|2|||
147383770|NCT04271254|531569568|FG000|Overall Study|Withdrawal by Subject|3|||
147383771|NCT00473512|531569569|FG000|Period 1 (Phase 1)|Adverse Event|0|||
147383772|NCT00473512|531569570|FG001|Period 1 (Phase 1)|Adverse Event|0|||
147383773|NCT00473512|531569571|FG002|Period 1 (Phase 1)|Adverse Event|0|||
147383774|NCT00473512|531569572|FG003|Period 1 (Phase 1)|Adverse Event|5|||
147383775|NCT00473512|531569573|FG004|Period 1 (Phase 1)|Adverse Event|0|||
147383776|NCT00473512|531569569|FG000|Period 1 (Phase 1)|Death|0|||
147383777|NCT00473512|531569570|FG001|Period 1 (Phase 1)|Death|0|||
147383778|NCT00473512|531569571|FG002|Period 1 (Phase 1)|Death|0|||
147383779|NCT00473512|531569572|FG003|Period 1 (Phase 1)|Death|1|||
147383780|NCT00473512|531569573|FG004|Period 1 (Phase 1)|Death|0|||
147383781|NCT00473512|531569569|FG000|Period 1 (Phase 1)|Disease Progression|1|||
147383782|NCT00473512|531569570|FG001|Period 1 (Phase 1)|Disease Progression|1|||
147383783|NCT00473512|531569571|FG002|Period 1 (Phase 1)|Disease Progression|0|||
147383784|NCT00473512|531569572|FG003|Period 1 (Phase 1)|Disease Progression|10|||
147383785|NCT00473512|531569573|FG004|Period 1 (Phase 1)|Disease Progression|1|||
147383786|NCT00473512|531569569|FG000|Period 1 (Phase 1)|Other|0|||
147383787|NCT00473512|531569570|FG001|Period 1 (Phase 1)|Other|0|||
147383788|NCT00473512|531569571|FG002|Period 1 (Phase 1)|Other|0|||
147383789|NCT00473512|531569572|FG003|Period 1 (Phase 1)|Other|1|||
147383790|NCT00473512|531569573|FG004|Period 1 (Phase 1)|Other|0|||
147383791|NCT00473512|531569569|FG000|Period 2 (Phase 2)|Adverse Event|0|||
147383792|NCT00473512|531569570|FG001|Period 2 (Phase 2)|Adverse Event|0|||
147383793|NCT00473512|531569571|FG002|Period 2 (Phase 2)|Adverse Event|0|||
147383794|NCT00473512|531569572|FG003|Period 2 (Phase 2)|Adverse Event|1|||
147383795|NCT00473512|531569573|FG004|Period 2 (Phase 2)|Adverse Event|0|||
147383796|NCT00473512|531569569|FG000|Period 2 (Phase 2)|Death|0|||
147383797|NCT00473512|531569570|FG001|Period 2 (Phase 2)|Death|0|||
147383798|NCT00473512|531569571|FG002|Period 2 (Phase 2)|Death|0|||
147383799|NCT00473512|531569572|FG003|Period 2 (Phase 2)|Death|1|||
147383800|NCT00473512|531569573|FG004|Period 2 (Phase 2)|Death|1|||
147383801|NCT00473512|531569569|FG000|Period 2 (Phase 2)|Disease Progression|0|||
147383802|NCT00473512|531569570|FG001|Period 2 (Phase 2)|Disease Progression|2|||
147383803|NCT00473512|531569571|FG002|Period 2 (Phase 2)|Disease Progression|2|||
147383804|NCT00473512|531569572|FG003|Period 2 (Phase 2)|Disease Progression|17|||
147383805|NCT00473512|531569573|FG004|Period 2 (Phase 2)|Disease Progression|1|||
147383806|NCT00473512|531569569|FG000|Period 2 (Phase 2)|Symptomatic Deterioration|0|||
147383807|NCT00473512|531569570|FG001|Period 2 (Phase 2)|Symptomatic Deterioration|0|||
147383808|NCT00473512|531569571|FG002|Period 2 (Phase 2)|Symptomatic Deterioration|0|||
147383809|NCT00473512|531569572|FG003|Period 2 (Phase 2)|Symptomatic Deterioration|1|||
147383810|NCT00473512|531569573|FG004|Period 2 (Phase 2)|Symptomatic Deterioration|0|||
147383811|NCT00473512|531569569|FG000|Period 2 (Phase 2)|Other|1|||
147614725|NCT00666328|532404829|FG000|Overall Study|Lost to Follow-up|2|||
147614726|NCT00666328|532404829|FG000|Overall Study|No longer met eligibility criteria|1|||
147614727|NCT02829918|532404834|FG000|Overall Study|Death|2|||
147614728|NCT02829918|532404834|FG000|Overall Study|Withdrawal by Subject|4|||
147383812|NCT00473512|531569570|FG001|Period 2 (Phase 2)|Other|0|||
147383813|NCT00473512|531569571|FG002|Period 2 (Phase 2)|Other|0|||
147383814|NCT00473512|531569572|FG003|Period 2 (Phase 2)|Other|3|||
147383815|NCT00473512|531569573|FG004|Period 2 (Phase 2)|Other|0|||
147383816|NCT00267956|531569578|FG000|Controlled Period|Adverse Event|4|||
147383817|NCT00267956|531569579|FG001|Controlled Period|Adverse Event|1|||
147383818|NCT00267956|531569580|FG002|Controlled Period|Adverse Event|0|||
147383819|NCT00267956|531569581|FG003|Controlled Period|Adverse Event|0|||
147383820|NCT00267956|531569578|FG000|Controlled Period|Lack of Efficacy|4|||
147383821|NCT00267956|531569579|FG001|Controlled Period|Lack of Efficacy|2|||
147383822|NCT00267956|531569580|FG002|Controlled Period|Lack of Efficacy|0|||
147383823|NCT00267956|531569581|FG003|Controlled Period|Lack of Efficacy|0|||
147383824|NCT00267956|531569578|FG000|Controlled Period|Lost to Follow-up|2|||
147383825|NCT00267956|531569579|FG001|Controlled Period|Lost to Follow-up|0|||
147383826|NCT00267956|531569580|FG002|Controlled Period|Lost to Follow-up|0|||
147383827|NCT00267956|531569581|FG003|Controlled Period|Lost to Follow-up|0|||
147383828|NCT00267956|531569578|FG000|Controlled Period|Withdrew consent|3|||
147383829|NCT00267956|531569579|FG001|Controlled Period|Withdrew consent|1|||
147383830|NCT00267956|531569580|FG002|Controlled Period|Withdrew consent|0|||
147383831|NCT00267956|531569581|FG003|Controlled Period|Withdrew consent|0|||
147383832|NCT00267956|531569578|FG000|After Controlled Period|Adverse Event|0|||
147383833|NCT00267956|531569579|FG001|After Controlled Period|Adverse Event|0|||
147383834|NCT00267956|531569580|FG002|After Controlled Period|Adverse Event|2|||
147383835|NCT00267956|531569581|FG003|After Controlled Period|Adverse Event|1|||
147383836|NCT00267956|531569578|FG000|After Controlled Period|Lack of Efficacy|0|||
147383837|NCT00267956|531569579|FG001|After Controlled Period|Lack of Efficacy|0|||
147383838|NCT00267956|531569580|FG002|After Controlled Period|Lack of Efficacy|1|||
147383839|NCT00267956|531569581|FG003|After Controlled Period|Lack of Efficacy|1|||
147383840|NCT00267956|531569578|FG000|After Controlled Period|Lost to Follow-up|0|||
147383841|NCT00267956|531569579|FG001|After Controlled Period|Lost to Follow-up|0|||
147383842|NCT00267956|531569580|FG002|After Controlled Period|Lost to Follow-up|1|||
147383843|NCT00267956|531569581|FG003|After Controlled Period|Lost to Follow-up|0|||
147383844|NCT00267956|531569578|FG000|After Controlled Period|Withdrew consent|0|||
147383845|NCT00267956|531569579|FG001|After Controlled Period|Withdrew consent|0|||
147383846|NCT00267956|531569580|FG002|After Controlled Period|Withdrew consent|1|||
147383847|NCT00267956|531569581|FG003|After Controlled Period|Withdrew consent|0|||
147383848|NCT01263223|531569582|FG000|Period 2|Withdrawal by Subject|0|||
147383849|NCT01263223|531569583|FG001|Period 2|Withdrawal by Subject|1|||
147383850|NCT01263223|531569582|FG000|7-day Follow-up|Withdrawal by Subject|0|||
147383851|NCT01263223|531569583|FG001|7-day Follow-up|Withdrawal by Subject|1|||
147383852|NCT01263223|531569582|FG000|7-day Follow-up|Lost to Follow-up|1|||
147383853|NCT01263223|531569583|FG001|7-day Follow-up|Lost to Follow-up|0|||
147383854|NCT02246647|531569584|FG000|Overall Study|Withdrawal by Subject|1|||
147383855|NCT02246647|531569585|FG001|Overall Study|Withdrawal by Subject|1|||
147383856|NCT01113541|531569589|FG000|Overall Study|Withdrawal by Subject|1|||
147383857|NCT01113541|531569589|FG000|Overall Study|Protocol Violation|1|||
147383858|NCT01113541|531569589|FG000|Overall Study|Study Terminated by Sponsor|7|||
147383859|NCT01113541|531569589|FG000|Overall Study|Adverse Event|4|||
147383860|NCT01494467|531569596|FG000|Part A Vehicle Control (12 Weeks)|Pregnancy|1|||
147383861|NCT01494467|531569597|FG001|Part A Vehicle Control (12 Weeks)|Pregnancy|0|||
147383862|NCT01494467|531569596|FG000|Part A Vehicle Control (12 Weeks)|Adverse Event|6|||
147383863|NCT01494467|531569597|FG001|Part A Vehicle Control (12 Weeks)|Adverse Event|4|||
147383864|NCT01494467|531569596|FG000|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|9|||
147383865|NCT01494467|531569597|FG001|Part A Vehicle Control (12 Weeks)|Withdrawal by Subject|8|||
147383866|NCT01494467|531569596|FG000|Part A Vehicle Control (12 Weeks)|Protocol Violation|4|||
147383867|NCT01494467|531569597|FG001|Part A Vehicle Control (12 Weeks)|Protocol Violation|0|||
147383868|NCT01494467|531569596|FG000|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|8|||
147383869|NCT01494467|531569597|FG001|Part A Vehicle Control (12 Weeks)|Lost to Follow-up|8|||
147383870|NCT01494467|531569596|FG000|Part A Vehicle Control (12 Weeks)|Other|1|||
147383871|NCT01494467|531569597|FG001|Part A Vehicle Control (12 Weeks)|Other|1|||
147383872|NCT01494467|531569596|FG000|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|1|||
147383873|NCT01494467|531569597|FG001|Part A Vehicle Control (12 Weeks)|Lack of Efficacy|0|||
147456504|NCT03529773|531831736|FG016|Overall Study|Randomized but not vaccinated|0|||
147614729|NCT02829918|532404834|FG000|Overall Study|Adverse Event|1|||
147614730|NCT02829918|532404834|FG000|Overall Study|Progression|1|||
147614731|NCT02441686|532404838|FG000|Induction|Adverse Event|4|||
147614732|NCT02441686|532404838|FG000|Induction|Complicating disease|1|||
147614733|NCT02441686|532404838|FG000|Induction|Physician Decision|1|||
147614734|NCT02441686|532404838|FG000|Induction|Withdrawal by Subject|1|||
147614735|NCT02441686|532404838|FG000|Induction|Did not receive treatment|1|||
147614736|NCT02441686|532404838|FG000|Maintenance|Remaining on Treatment|23|||
147614737|NCT02441686|532404838|FG000|Maintenance|Physician Decision|1|||
147614738|NCT02441686|532404838|FG000|Maintenance|Adverse Event|3|||
147614739|NCT02441686|532404838|FG000|Maintenance|Progressive Disease|10|||
147614740|NCT02441686|532404838|FG000|Maintenance|Withdrawal by Subject|1|||
147614741|NCT03762239|532404839|FG000|Overall Study|Appointment to the doctor|1|||
147614742|NCT03762239|532404840|FG001|Overall Study|Appointment to the doctor|1|||
147614743|NCT04471428|532404841|FG000|Overall Study|Withdrawal by Subject|29|||
147614744|NCT04471428|532404842|FG001|Overall Study|Withdrawal by Subject|1|||
147614745|NCT04471428|532404841|FG000|Overall Study|Physician Decision|0|||
147614746|NCT04471428|532404842|FG001|Overall Study|Physician Decision|1|||
147614747|NCT04471428|532404841|FG000|Overall Study|Reason Not Specified|0|||
147383874|NCT01494467|531569596|FG000|Part B Long Term Active Control 40 Weeks|Pregnancy|2|||
147383875|NCT01494467|531569597|FG001|Part B Long Term Active Control 40 Weeks|Pregnancy|0|||
147383876|NCT01494467|531569596|FG000|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|1|||
147383877|NCT01494467|531569597|FG001|Part B Long Term Active Control 40 Weeks|Lack of Efficacy|3|||
147383878|NCT01494467|531569596|FG000|Part B Long Term Active Control 40 Weeks|Adverse Event|3|||
147383879|NCT01494467|531569597|FG001|Part B Long Term Active Control 40 Weeks|Adverse Event|5|||
147383880|NCT01494467|531569596|FG000|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|32|||
147383881|NCT01494467|531569597|FG001|Part B Long Term Active Control 40 Weeks|Withdrawal by Subject|24|||
147456505|NCT03529773|531831737|FG017|Overall Study|Randomized but not vaccinated|1|||
147614748|NCT04471428|532404842|FG001|Overall Study|Reason Not Specified|2|||
147383882|NCT01494467|531569596|FG000|Part B Long Term Active Control 40 Weeks|Protocol Violation|3|||
147383883|NCT01494467|531569597|FG001|Part B Long Term Active Control 40 Weeks|Protocol Violation|5|||
147383884|NCT01494467|531569596|FG000|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|26|||
147383885|NCT01494467|531569597|FG001|Part B Long Term Active Control 40 Weeks|Lost to Follow-up|10|||
147383886|NCT01494467|531569596|FG000|Part B Long Term Active Control 40 Weeks|Other (noted in eCRF)|8|||
147383887|NCT01494467|531569597|FG001|Part B Long Term Active Control 40 Weeks|Other (noted in eCRF)|2|||
147383888|NCT03386344|531569600|FG000|Overall Study|Adverse Event|6|||
147383889|NCT03386344|531569601|FG001|Overall Study|Adverse Event|3|||
147383890|NCT03386344|531569602|FG002|Overall Study|Adverse Event|1|||
147383891|NCT03386344|531569600|FG000|Overall Study|Poor Compliance to Protocol|0|||
147383892|NCT03386344|531569601|FG001|Overall Study|Poor Compliance to Protocol|1|||
147383893|NCT03386344|531569602|FG002|Overall Study|Poor Compliance to Protocol|0|||
147383894|NCT03386344|531569600|FG000|Overall Study|Study Terminated by Sponsor|101|||
147383895|NCT03386344|531569601|FG001|Overall Study|Study Terminated by Sponsor|102|||
147383896|NCT03386344|531569602|FG002|Overall Study|Study Terminated by Sponsor|106|||
147383897|NCT03386344|531569600|FG000|Overall Study|Lost to Follow-up|3|||
147383898|NCT03386344|531569601|FG001|Overall Study|Lost to Follow-up|2|||
147383899|NCT03386344|531569602|FG002|Overall Study|Lost to Follow-up|1|||
147383900|NCT03386344|531569600|FG000|Overall Study|At the Participant's own Request|7|||
147383901|NCT03386344|531569601|FG001|Overall Study|At the Participant's own Request|7|||
147383902|NCT03386344|531569602|FG002|Overall Study|At the Participant's own Request|8|||
147383903|NCT03386344|531569600|FG000|Overall Study|Reason not Specified|0|||
147383904|NCT03386344|531569601|FG001|Overall Study|Reason not Specified|1|||
147383905|NCT03386344|531569602|FG002|Overall Study|Reason not Specified|0|||
147383906|NCT01280721|531569605|FG000|Overall Study|Adverse Event|4|||
147383907|NCT01280721|531569605|FG000|Overall Study|Physician Decision|3|||
147383908|NCT01280721|531569605|FG000|Overall Study|Withdrawal by Subject|6|||
147383909|NCT01280721|531569605|FG000|Overall Study|eGFR under the withdrawal criteria|7|||
147383910|NCT01280721|531569605|FG000|Overall Study|No tolerability for the lowest dose|2|||
147383911|NCT01180400|531569606|FG000|Overall Study|Withdrawal by Subject|5|||
147383912|NCT01180400|531569607|FG001|Overall Study|Withdrawal by Subject|6|||
147383913|NCT01180400|531569606|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
147383914|NCT01180400|531569607|FG001|Overall Study|Eligibility criteria not fulfilled|2|||
147383915|NCT01180400|531569606|FG000|Overall Study|Adverse Event|12|||
147383916|NCT01180400|531569607|FG001|Overall Study|Adverse Event|10|||
147383917|NCT01180400|531569606|FG000|Overall Study|Severe non-compliance to protocol|1|||
147383918|NCT01180400|531569607|FG001|Overall Study|Severe non-compliance to protocol|2|||
147383919|NCT01180400|531569606|FG000|Overall Study|Condition under investigation worsened|2|||
147383920|NCT01180400|531569607|FG001|Overall Study|Condition under investigation worsened|1|||
147383921|NCT01180400|531569606|FG000|Overall Study|Lack of Efficacy|2|||
147383922|NCT01180400|531569607|FG001|Overall Study|Lack of Efficacy|0|||
147383923|NCT01180400|531569606|FG000|Overall Study|Study-specific withdrawal criteria|1|||
147383924|NCT01180400|531569607|FG001|Overall Study|Study-specific withdrawal criteria|2|||
147383925|NCT01180400|531569606|FG000|Overall Study|Lost to Follow-up|2|||
147383926|NCT01180400|531569607|FG001|Overall Study|Lost to Follow-up|3|||
147383927|NCT01180400|531569606|FG000|Overall Study|Other|0|||
147383928|NCT01180400|531569607|FG001|Overall Study|Other|1|||
147383929|NCT01182285|531569609|FG000|First Intervention Week 1-10|Disease progression|1|||
147383930|NCT01182285|531569610|FG001|First Intervention Week 1-10|Disease progression|0|||
147383931|NCT01182285|531569611|FG002|First Intervention Week 1-10|Disease progression|0|||
147383932|NCT01182285|531569609|FG000|First Intervention Week 1-10|Adverse Event|1|||
147383933|NCT01182285|531569610|FG001|First Intervention Week 1-10|Adverse Event|0|||
147383934|NCT01182285|531569611|FG002|First Intervention Week 1-10|Adverse Event|0|||
147383935|NCT01182285|531569609|FG000|First Intervention Week 1-10|Non-compliance|1|||
147383936|NCT01182285|531569610|FG001|First Intervention Week 1-10|Non-compliance|0|||
147383937|NCT01182285|531569611|FG002|First Intervention Week 1-10|Non-compliance|0|||
147383938|NCT01182285|531569609|FG000|Third Intervention Week 11-52|Disease Progression|0|||
147383939|NCT01182285|531569610|FG001|Third Intervention Week 11-52|Disease Progression|0|||
147383940|NCT01182285|531569611|FG002|Third Intervention Week 11-52|Disease Progression|6|||
147383941|NCT01182285|531569609|FG000|Third Intervention Week 11-52|Other|0|||
147383942|NCT01182285|531569610|FG001|Third Intervention Week 11-52|Other|0|||
147383943|NCT01182285|531569611|FG002|Third Intervention Week 11-52|Other|2|||
147383944|NCT03209492|531569612|FG000|Overall Study|Case Report Forms Uncollected|5|||
147383945|NCT01525875|531569613|FG000|Placebo-controlled Period|Withdrawal by Subject|1|||
147383946|NCT01525875|531569614|FG001|Placebo-controlled Period|Withdrawal by Subject|2|||
147383947|NCT01525875|531569613|FG000|Open-label Period|Lost to Follow-up|0|||
147383948|NCT01525875|531569614|FG001|Open-label Period|Lost to Follow-up|2|||
147383949|NCT03481725|531569615|FG000|Overall Study|Withdrawal by Subject|1|||
147383950|NCT03481725|531569616|FG001|Overall Study|Withdrawal by Subject|0|||
147383951|NCT01894620|531569617|FG000|Overall Study|Withdrawal by Subject|0|||
147383952|NCT01894620|531569618|FG001|Overall Study|Withdrawal by Subject|1|||
147383953|NCT02877680|531569619|FG000|Overall Study|Lost to Follow-up|1|||
147383954|NCT02877680|531569620|FG001|Overall Study|Lost to Follow-up|1|||
147383955|NCT01133678|531569621|FG000|Overall Study|Death|1|||
147383956|NCT01133678|531569622|FG001|Overall Study|Death|1|||
147383957|NCT00879710|531569629|FG000|Phase 1 - 6 Weeks|Lost to Follow-up|2|||
147383958|NCT00879710|531569630|FG001|Phase 1 - 6 Weeks|Lost to Follow-up|3|||
147383959|NCT00879710|531569631|FG002|Phase 1 - 6 Weeks|Lost to Follow-up|1|||
147383960|NCT00879710|531569632|FG003|Phase 1 - 6 Weeks|Lost to Follow-up|4|||
147383961|NCT00879710|531569629|FG000|Phase 1 - 6 Weeks|Adverse Event|0|||
147383962|NCT00879710|531569630|FG001|Phase 1 - 6 Weeks|Adverse Event|0|||
147383963|NCT00879710|531569631|FG002|Phase 1 - 6 Weeks|Adverse Event|1|||
147383964|NCT00879710|531569632|FG003|Phase 1 - 6 Weeks|Adverse Event|0|||
147383965|NCT01864200|531569633|FG000|Overall Study|Lost to Follow-up|1|||
147383966|NCT01864200|531569634|FG001|Overall Study|Lost to Follow-up|3|||
147383967|NCT01864200|531569633|FG000|Overall Study|Protocol Violation|1|||
147383968|NCT01864200|531569634|FG001|Overall Study|Protocol Violation|0|||
147383969|NCT02077374|531569635|FG000|Overall Study|Withdrawal by Subject|0|||
147383970|NCT02077374|531569636|FG001|Overall Study|Withdrawal by Subject|1|||
147383971|NCT02077374|531569635|FG000|Overall Study|Protocol Violation|0|||
147383972|NCT02077374|531569636|FG001|Overall Study|Protocol Violation|1|||
147664902|NCT01573000|532597953|FG000|Dosimetric and Therapeutic Treatment|Lack of Efficacy|27|||
147664903|NCT01573000|532597954|FG001|Dosimetric and Therapeutic Treatment|Lack of Efficacy|32|||
147664904|NCT01573000|532597953|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|4|||
147664905|NCT01573000|532597954|FG001|Dosimetric and Therapeutic Treatment|Lost to Follow-up|2|||
147664906|NCT01573000|532597953|FG000|Dosimetric and Therapeutic Treatment|Death|0|||
147664907|NCT01573000|532597954|FG001|Dosimetric and Therapeutic Treatment|Death|1|||
147664908|NCT01573000|532597953|FG000|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|2|||
147664909|NCT01573000|532597954|FG001|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|0|||
147383973|NCT02514824|531569637|FG000|Overall Study|Withdrawal by Subject|1|||
147383974|NCT02514824|531569638|FG001|Overall Study|Withdrawal by Subject|0|||
147383975|NCT02514824|531569639|FG002|Overall Study|Withdrawal by Subject|0|||
147383976|NCT02514824|531569640|FG003|Overall Study|Withdrawal by Subject|0|||
147383977|NCT02514824|531569637|FG000|Overall Study|Dose-Limiting Toxicity|0|||
147383978|NCT02514824|531569638|FG001|Overall Study|Dose-Limiting Toxicity|1|||
147383979|NCT02514824|531569639|FG002|Overall Study|Dose-Limiting Toxicity|0|||
147383980|NCT02514824|531569640|FG003|Overall Study|Dose-Limiting Toxicity|0|||
147383981|NCT02170207|531569643|FG000|Overall Study|Case report forms unavailable|5|||
147383982|NCT03122860|531569644|FG000|Overall Study|Discontinued Before Treatment|1|||
147383983|NCT03122860|531569645|FG001|Overall Study|Discontinued Before Treatment|1|||
147383984|NCT03122860|531569646|FG002|Overall Study|Discontinued Before Treatment|2|||
147383985|NCT03122860|531569647|FG003|Overall Study|Discontinued Before Treatment|0|||
147383986|NCT03122860|531569648|FG004|Overall Study|Discontinued Before Treatment|1|||
147383987|NCT03122860|531569649|FG005|Overall Study|Discontinued Before Treatment|0|||
147383988|NCT03122860|531569644|FG000|Overall Study|Adverse Event|1|||
147383989|NCT03122860|531569645|FG001|Overall Study|Adverse Event|0|||
147383990|NCT03122860|531569646|FG002|Overall Study|Adverse Event|1|||
147383991|NCT03122860|531569647|FG003|Overall Study|Adverse Event|1|||
147383992|NCT03122860|531569648|FG004|Overall Study|Adverse Event|0|||
147383993|NCT03122860|531569649|FG005|Overall Study|Adverse Event|0|||
147383994|NCT03122860|531569644|FG000|Overall Study|Lost to Follow-up|5|||
147383995|NCT03122860|531569645|FG001|Overall Study|Lost to Follow-up|2|||
147383996|NCT03122860|531569646|FG002|Overall Study|Lost to Follow-up|3|||
147383997|NCT03122860|531569647|FG003|Overall Study|Lost to Follow-up|3|||
147383998|NCT03122860|531569648|FG004|Overall Study|Lost to Follow-up|5|||
147383999|NCT03122860|531569649|FG005|Overall Study|Lost to Follow-up|4|||
147384000|NCT03122860|531569644|FG000|Overall Study|Subject Non-Compliance|0|||
147664910|NCT01573000|532597953|FG000|Dosimetric and Therapeutic Treatment|Received Other Treatment|2|||
147664911|NCT01573000|532597954|FG001|Dosimetric and Therapeutic Treatment|Received Other Treatment|0|||
147384001|NCT03122860|531569645|FG001|Overall Study|Subject Non-Compliance|0|||
147384002|NCT03122860|531569646|FG002|Overall Study|Subject Non-Compliance|1|||
147384003|NCT03122860|531569647|FG003|Overall Study|Subject Non-Compliance|0|||
147384004|NCT03122860|531569648|FG004|Overall Study|Subject Non-Compliance|0|||
147384005|NCT03122860|531569649|FG005|Overall Study|Subject Non-Compliance|0|||
147384006|NCT03122860|531569644|FG000|Overall Study|Withdrawal by Subject|3|||
147384007|NCT03122860|531569645|FG001|Overall Study|Withdrawal by Subject|2|||
147384008|NCT03122860|531569646|FG002|Overall Study|Withdrawal by Subject|5|||
147384009|NCT03122860|531569647|FG003|Overall Study|Withdrawal by Subject|7|||
147456506|NCT03529773|531831738|FG018|Overall Study|Randomized but not vaccinated|0|||
147456507|NCT03529773|531831739|FG019|Overall Study|Randomized but not vaccinated|0|||
147456508|NCT03529773|531831740|FG020|Overall Study|Randomized but not vaccinated|0|||
147456509|NCT03529773|531831741|FG021|Overall Study|Randomized but not vaccinated|0|||
147456510|NCT03529773|531831742|FG022|Overall Study|Randomized but not vaccinated|0|||
147456511|NCT03529773|531831743|FG023|Overall Study|Randomized but not vaccinated|0|||
147456512|NCT03529773|531831744|FG024|Overall Study|Randomized but not vaccinated|0|||
147456513|NCT03529773|531831745|FG025|Overall Study|Randomized but not vaccinated|0|||
147456514|NCT03529773|531831746|FG026|Overall Study|Randomized but not vaccinated|0|||
147384010|NCT03122860|531569648|FG004|Overall Study|Withdrawal by Subject|9|||
147384011|NCT03122860|531569649|FG005|Overall Study|Withdrawal by Subject|8|||
147384012|NCT01138657|531569650|FG000|Overall Study|Adverse Event|3|||
147384013|NCT01138657|531569651|FG001|Overall Study|Adverse Event|10|||
147384014|NCT01138657|531569650|FG000|Overall Study|Lack of Efficacy|2|||
147384015|NCT01138657|531569651|FG001|Overall Study|Lack of Efficacy|1|||
147384016|NCT01138657|531569650|FG000|Overall Study|Lost to Follow-up|0|||
147384017|NCT01138657|531569651|FG001|Overall Study|Lost to Follow-up|3|||
147384018|NCT01138657|531569650|FG000|Overall Study|Miscellaneous Reasons|3|||
147384019|NCT01138657|531569651|FG001|Overall Study|Miscellaneous Reasons|4|||
147384020|NCT02159352|531569654|FG000|Overall Study|Adverse Event|3|||
147384021|NCT02159352|531569655|FG001|Overall Study|Adverse Event|1|||
147384022|NCT02159352|531569654|FG000|Overall Study|Withdrawal by Subject|0|||
147384023|NCT02159352|531569655|FG001|Overall Study|Withdrawal by Subject|1|||
147384024|NCT00529529|531569656|FG000|Overall Study|Adverse Event|12|||
147384025|NCT00529529|531569657|FG001|Overall Study|Adverse Event|17|||
147384026|NCT00529529|531569658|FG002|Overall Study|Adverse Event|8|||
147384027|NCT00529529|531569656|FG000|Overall Study|Subject withdrew consent|12|||
147384028|NCT00529529|531569657|FG001|Overall Study|Subject withdrew consent|9|||
147384029|NCT00529529|531569658|FG002|Overall Study|Subject withdrew consent|12|||
147384030|NCT00529529|531569656|FG000|Overall Study|Protocol deviation|8|||
147384031|NCT00529529|531569657|FG001|Overall Study|Protocol deviation|12|||
147384032|NCT00529529|531569658|FG002|Overall Study|Protocol deviation|5|||
147384033|NCT00529529|531569656|FG000|Overall Study|Lost to Follow-up|5|||
147384034|NCT00529529|531569657|FG001|Overall Study|Lost to Follow-up|3|||
147384035|NCT00529529|531569658|FG002|Overall Study|Lost to Follow-up|1|||
147384036|NCT00529529|531569656|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
147384037|NCT00529529|531569657|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
147384038|NCT00529529|531569658|FG002|Overall Study|Unsatisfactory therapeutic effect|2|||
147384039|NCT00529529|531569656|FG000|Overall Study|Death|2|||
147384040|NCT00529529|531569657|FG001|Overall Study|Death|0|||
147384041|NCT00529529|531569658|FG002|Overall Study|Death|0|||
147384042|NCT00529529|531569656|FG000|Overall Study|Abnormal test procedure result(s)|1|||
147384043|NCT00529529|531569657|FG001|Overall Study|Abnormal test procedure result(s)|0|||
147384044|NCT00529529|531569658|FG002|Overall Study|Abnormal test procedure result(s)|0|||
147384045|NCT00529529|531569656|FG000|Overall Study|Administrative problems|1|||
147384046|NCT00529529|531569657|FG001|Overall Study|Administrative problems|0|||
147384047|NCT00529529|531569658|FG002|Overall Study|Administrative problems|3|||
147384048|NCT01020435|531569663|FG000|Overall Study|Lost to Follow-up|0|||
147384049|NCT01020435|531569664|FG001|Overall Study|Lost to Follow-up|1|||
147384050|NCT01000649|531569665|FG000|Overall Study|Adverse Event|5|||
147384051|NCT01000649|531569666|FG001|Overall Study|Adverse Event|1|||
147384052|NCT01000649|531569667|FG002|Overall Study|Adverse Event|2|||
147384053|NCT01000649|531569668|FG003|Overall Study|Adverse Event|4|||
147384054|NCT01000649|531569665|FG000|Overall Study|Lost to Follow-up|0|||
147384055|NCT01000649|531569666|FG001|Overall Study|Lost to Follow-up|2|||
147384056|NCT01000649|531569667|FG002|Overall Study|Lost to Follow-up|0|||
147384057|NCT01000649|531569668|FG003|Overall Study|Lost to Follow-up|2|||
147384058|NCT00346398|531569671|FG000|Overall Study|Lost to Follow-up|3|||
147384059|NCT00346398|531569672|FG001|Overall Study|Lost to Follow-up|0|||
147384060|NCT00346398|531569671|FG000|Overall Study|Withdrawal by Subject|0|||
147384061|NCT00346398|531569672|FG001|Overall Study|Withdrawal by Subject|2|||
147384062|NCT02607956|531569673|FG000|Double-Blinded Phase|Withdrew Consent|17|||
147384063|NCT02607956|531569674|FG001|Double-Blinded Phase|Withdrew Consent|19|||
147384064|NCT02607956|531569675|FG002|Double-Blinded Phase|Withdrew Consent|0|||
147384065|NCT02607956|531569676|FG003|Double-Blinded Phase|Withdrew Consent|0|||
147384066|NCT02607956|531569673|FG000|Double-Blinded Phase|Lost to Follow-up|19|||
147384067|NCT02607956|531569674|FG001|Double-Blinded Phase|Lost to Follow-up|16|||
147384068|NCT02607956|531569675|FG002|Double-Blinded Phase|Lost to Follow-up|0|||
147384069|NCT02607956|531569676|FG003|Double-Blinded Phase|Lost to Follow-up|0|||
147384070|NCT02607956|531569673|FG000|Double-Blinded Phase|Randomized but never treated|7|||
147384071|NCT02607956|531569674|FG001|Double-Blinded Phase|Randomized but never treated|5|||
147384072|NCT02607956|531569675|FG002|Double-Blinded Phase|Randomized but never treated|0|||
147384073|NCT02607956|531569676|FG003|Double-Blinded Phase|Randomized but never treated|0|||
147384074|NCT02607956|531569673|FG000|Double-Blinded Phase|Investigator's Discretion|7|||
147384075|NCT02607956|531569674|FG001|Double-Blinded Phase|Investigator's Discretion|2|||
147384076|NCT02607956|531569675|FG002|Double-Blinded Phase|Investigator's Discretion|0|||
147384077|NCT02607956|531569676|FG003|Double-Blinded Phase|Investigator's Discretion|0|||
147384078|NCT02607956|531569673|FG000|Double-Blinded Phase|Death|4|||
147384079|NCT02607956|531569674|FG001|Double-Blinded Phase|Death|4|||
147384080|NCT02607956|531569675|FG002|Double-Blinded Phase|Death|0|||
147384081|NCT02607956|531569676|FG003|Double-Blinded Phase|Death|0|||
147384082|NCT02607956|531569673|FG000|Double-Blinded Phase|Adverse Event|4|||
147384083|NCT02607956|531569674|FG001|Double-Blinded Phase|Adverse Event|3|||
147384084|NCT02607956|531569675|FG002|Double-Blinded Phase|Adverse Event|0|||
147384085|NCT02607956|531569676|FG003|Double-Blinded Phase|Adverse Event|0|||
147384086|NCT02607956|531569673|FG000|Double-Blinded Phase|Protocol Violation|3|||
147384087|NCT02607956|531569674|FG001|Double-Blinded Phase|Protocol Violation|1|||
147384088|NCT02607956|531569675|FG002|Double-Blinded Phase|Protocol Violation|0|||
147384089|NCT02607956|531569676|FG003|Double-Blinded Phase|Protocol Violation|0|||
147384090|NCT02607956|531569673|FG000|Double-Blinded Phase|Non-Compliance with Study Drug|0|||
147384091|NCT02607956|531569674|FG001|Double-Blinded Phase|Non-Compliance with Study Drug|3|||
147384092|NCT02607956|531569675|FG002|Double-Blinded Phase|Non-Compliance with Study Drug|0|||
147384093|NCT02607956|531569676|FG003|Double-Blinded Phase|Non-Compliance with Study Drug|0|||
147384094|NCT02607956|531569673|FG000|Open-Label Extension Phase|Withdrew Consent|0|||
147384095|NCT02607956|531569674|FG001|Open-Label Extension Phase|Withdrew Consent|0|||
147384096|NCT02607956|531569675|FG002|Open-Label Extension Phase|Withdrew Consent|10|||
147384097|NCT02607956|531569676|FG003|Open-Label Extension Phase|Withdrew Consent|16|||
147664912|NCT01573000|532597953|FG000|Crossover Phase|Lack of Efficacy|0|||
147384098|NCT02607956|531569673|FG000|Open-Label Extension Phase|Lost to Follow-up|0|||
147456515|NCT03529773|531831747|FG027|Overall Study|Randomized but not vaccinated|1|||
147456516|NCT03529773|531831748|FG028|Overall Study|Randomized but not vaccinated|0|||
147456517|NCT03529773|531831749|FG029|Overall Study|Randomized but not vaccinated|0|||
147384099|NCT02607956|531569674|FG001|Open-Label Extension Phase|Lost to Follow-up|0|||
147384100|NCT02607956|531569675|FG002|Open-Label Extension Phase|Lost to Follow-up|14|||
147384101|NCT02607956|531569676|FG003|Open-Label Extension Phase|Lost to Follow-up|6|||
147384102|NCT02607956|531569673|FG000|Open-Label Extension Phase|Death|0|||
147384103|NCT02607956|531569674|FG001|Open-Label Extension Phase|Death|0|||
147384104|NCT02607956|531569675|FG002|Open-Label Extension Phase|Death|1|||
147384105|NCT02607956|531569676|FG003|Open-Label Extension Phase|Death|3|||
147384106|NCT02607956|531569673|FG000|Open-Label Extension Phase|Investigator's Discretion|0|||
147384107|NCT02607956|531569674|FG001|Open-Label Extension Phase|Investigator's Discretion|0|||
147384108|NCT02607956|531569675|FG002|Open-Label Extension Phase|Investigator's Discretion|2|||
147384109|NCT02607956|531569676|FG003|Open-Label Extension Phase|Investigator's Discretion|2|||
147384110|NCT02607956|531569673|FG000|Open-Label Extension Phase|Non Compliance with Study Drug|0|||
147384111|NCT02607956|531569674|FG001|Open-Label Extension Phase|Non Compliance with Study Drug|0|||
147384112|NCT02607956|531569675|FG002|Open-Label Extension Phase|Non Compliance with Study Drug|2|||
147384113|NCT02607956|531569676|FG003|Open-Label Extension Phase|Non Compliance with Study Drug|0|||
147384114|NCT02607956|531569673|FG000|Open-Label Extension Phase|Protocol Violation|0|||
147384115|NCT02607956|531569674|FG001|Open-Label Extension Phase|Protocol Violation|0|||
147384116|NCT02607956|531569675|FG002|Open-Label Extension Phase|Protocol Violation|0|||
147384117|NCT02607956|531569676|FG003|Open-Label Extension Phase|Protocol Violation|2|||
147384118|NCT02607956|531569673|FG000|Open-Label Extension Phase|Pregnancy|0|||
147384119|NCT02607956|531569674|FG001|Open-Label Extension Phase|Pregnancy|0|||
147384120|NCT02607956|531569675|FG002|Open-Label Extension Phase|Pregnancy|0|||
147384121|NCT02607956|531569676|FG003|Open-Label Extension Phase|Pregnancy|1|||
147384122|NCT01916109|531569677|FG000|Overall Study|Withdrawal by Subject|1|||
147384123|NCT00103857|531569680|FG000|54-Week Base Study|Adverse Event|12|||
147384124|NCT00103857|531569681|FG001|54-Week Base Study|Adverse Event|9|||
147384125|NCT00103857|531569682|FG002|54-Week Base Study|Adverse Event|11|||
147456518|NCT03529773|531831750|FG030|Overall Study|Randomized but not vaccinated|0|||
147456519|NCT03529773|531831751|FG031|Overall Study|Randomized but not vaccinated|0|||
147456520|NCT03529773|531831752|FG032|Overall Study|Randomized but not vaccinated|0|||
147456521|NCT03529773|531831753|FG033|Overall Study|Randomized but not vaccinated|0|||
147456522|NCT03529773|531831754|FG034|Overall Study|Randomized but not vaccinated|0|||
147456523|NCT03529773|531831755|FG035|Overall Study|Randomized but not vaccinated|0|||
147456524|NCT03529773|531831756|FG036|Overall Study|Randomized but not vaccinated|0|||
147456525|NCT03529773|531831757|FG037|Overall Study|Randomized but not vaccinated|0|||
147456526|NCT03529773|531831758|FG038|Overall Study|Randomized but not vaccinated|0|||
147456527|NCT03529773|531831759|FG039|Overall Study|Randomized but not vaccinated|0|||
147456528|NCT00756938|531831760|FG000|12-week Base Study|Protocol-specific Criteria Met|1|||
147456529|NCT00756938|531831761|FG001|12-week Base Study|Protocol-specific Criteria Met|0|||
147456530|NCT00756938|531831762|FG002|12-week Base Study|Protocol-specific Criteria Met|1|||
147384126|NCT00103857|531569683|FG003|54-Week Base Study|Adverse Event|6|||
147456531|NCT00756938|531831763|FG003|12-week Base Study|Protocol-specific Criteria Met|0|||
147456532|NCT00756938|531831760|FG000|12-week Base Study|Protocol Violation|0|||
147456533|NCT00756938|531831761|FG001|12-week Base Study|Protocol Violation|0|||
147456534|NCT00756938|531831762|FG002|12-week Base Study|Protocol Violation|1|||
147456535|NCT00756938|531831763|FG003|12-week Base Study|Protocol Violation|0|||
147456536|NCT00756938|531831760|FG000|12-week Base Study|Lost to Follow-up|1|||
147456537|NCT00756938|531831761|FG001|12-week Base Study|Lost to Follow-up|0|||
147456538|NCT00756938|531831762|FG002|12-week Base Study|Lost to Follow-up|0|||
147456539|NCT00756938|531831763|FG003|12-week Base Study|Lost to Follow-up|0|||
147456540|NCT00756938|531831760|FG000|Optional Extension|Lack of Efficacy|0|||
147456541|NCT00756938|531831761|FG001|Optional Extension|Lack of Efficacy|0|||
147456542|NCT00756938|531831762|FG002|Optional Extension|Lack of Efficacy|0|||
147456543|NCT00756938|531831763|FG003|Optional Extension|Lack of Efficacy|1|||
147456544|NCT00756938|531831760|FG000|Optional Extension|End of Study|0|||
147456545|NCT00756938|531831761|FG001|Optional Extension|End of Study|0|||
147384127|NCT00103857|531569684|FG004|54-Week Base Study|Adverse Event|5|||
147384128|NCT00103857|531569685|FG005|54-Week Base Study|Adverse Event|11|||
147384129|NCT00103857|531569686|FG006|54-Week Base Study|Adverse Event|3|||
147384130|NCT00103857|531569680|FG000|54-Week Base Study|Death|0|||
147384131|NCT00103857|531569681|FG001|54-Week Base Study|Death|0|||
147384132|NCT00103857|531569682|FG002|54-Week Base Study|Death|0|||
147384133|NCT00103857|531569683|FG003|54-Week Base Study|Death|0|||
147384134|NCT00103857|531569684|FG004|54-Week Base Study|Death|1|||
147384135|NCT00103857|531569685|FG005|54-Week Base Study|Death|1|||
147384136|NCT00103857|531569686|FG006|54-Week Base Study|Death|0|||
147384137|NCT00103857|531569680|FG000|54-Week Base Study|Lack of Efficacy|11|||
147384138|NCT00103857|531569681|FG001|54-Week Base Study|Lack of Efficacy|14|||
147384139|NCT00103857|531569682|FG002|54-Week Base Study|Lack of Efficacy|8|||
147384140|NCT00103857|531569683|FG003|54-Week Base Study|Lack of Efficacy|4|||
147384141|NCT00103857|531569684|FG004|54-Week Base Study|Lack of Efficacy|3|||
147384142|NCT00103857|531569685|FG005|54-Week Base Study|Lack of Efficacy|14|||
147384143|NCT00103857|531569686|FG006|54-Week Base Study|Lack of Efficacy|19|||
147384144|NCT00103857|531569680|FG000|54-Week Base Study|Lost to Follow-up|5|||
147384145|NCT00103857|531569681|FG001|54-Week Base Study|Lost to Follow-up|4|||
147384146|NCT00103857|531569682|FG002|54-Week Base Study|Lost to Follow-up|7|||
147384147|NCT00103857|531569683|FG003|54-Week Base Study|Lost to Follow-up|5|||
147384148|NCT00103857|531569684|FG004|54-Week Base Study|Lost to Follow-up|10|||
147384149|NCT00103857|531569685|FG005|54-Week Base Study|Lost to Follow-up|9|||
147384150|NCT00103857|531569686|FG006|54-Week Base Study|Lost to Follow-up|3|||
147384151|NCT00103857|531569680|FG000|54-Week Base Study|Physician Decision|1|||
147384152|NCT00103857|531569681|FG001|54-Week Base Study|Physician Decision|1|||
147384153|NCT00103857|531569682|FG002|54-Week Base Study|Physician Decision|0|||
147384154|NCT00103857|531569683|FG003|54-Week Base Study|Physician Decision|0|||
147384155|NCT00103857|531569684|FG004|54-Week Base Study|Physician Decision|1|||
147384156|NCT00103857|531569685|FG005|54-Week Base Study|Physician Decision|0|||
147384157|NCT00103857|531569686|FG006|54-Week Base Study|Physician Decision|0|||
147384158|NCT00103857|531569680|FG000|54-Week Base Study|Pregnancy|1|||
147384159|NCT00103857|531569681|FG001|54-Week Base Study|Pregnancy|0|||
147384160|NCT00103857|531569682|FG002|54-Week Base Study|Pregnancy|0|||
147384161|NCT00103857|531569683|FG003|54-Week Base Study|Pregnancy|0|||
147384162|NCT00103857|531569684|FG004|54-Week Base Study|Pregnancy|1|||
147384163|NCT00103857|531569685|FG005|54-Week Base Study|Pregnancy|0|||
147384164|NCT00103857|531569686|FG006|54-Week Base Study|Pregnancy|1|||
147384165|NCT00103857|531569680|FG000|54-Week Base Study|Protocol Violation|6|||
147384166|NCT00103857|531569681|FG001|54-Week Base Study|Protocol Violation|4|||
147384167|NCT00103857|531569682|FG002|54-Week Base Study|Protocol Violation|2|||
147384168|NCT00103857|531569683|FG003|54-Week Base Study|Protocol Violation|4|||
147384169|NCT00103857|531569684|FG004|54-Week Base Study|Protocol Violation|0|||
147384170|NCT00103857|531569685|FG005|54-Week Base Study|Protocol Violation|3|||
147384171|NCT00103857|531569686|FG006|54-Week Base Study|Protocol Violation|3|||
147384172|NCT00103857|531569680|FG000|54-Week Base Study|Withdrawal by Subject|17|||
147384173|NCT00103857|531569681|FG001|54-Week Base Study|Withdrawal by Subject|16|||
147384174|NCT00103857|531569682|FG002|54-Week Base Study|Withdrawal by Subject|16|||
147384175|NCT00103857|531569683|FG003|54-Week Base Study|Withdrawal by Subject|15|||
147384176|NCT00103857|531569684|FG004|54-Week Base Study|Withdrawal by Subject|10|||
147384177|NCT00103857|531569685|FG005|54-Week Base Study|Withdrawal by Subject|15|||
147384178|NCT00103857|531569686|FG006|54-Week Base Study|Withdrawal by Subject|4|||
147384179|NCT00103857|531569680|FG000|54-Week Base Study|protocol discontinuation criteria|2|||
147384180|NCT00103857|531569681|FG001|54-Week Base Study|protocol discontinuation criteria|5|||
147384181|NCT00103857|531569682|FG002|54-Week Base Study|protocol discontinuation criteria|2|||
147384182|NCT00103857|531569683|FG003|54-Week Base Study|protocol discontinuation criteria|6|||
147384183|NCT00103857|531569684|FG004|54-Week Base Study|protocol discontinuation criteria|5|||
147384184|NCT00103857|531569685|FG005|54-Week Base Study|protocol discontinuation criteria|3|||
147384185|NCT00103857|531569686|FG006|54-Week Base Study|protocol discontinuation criteria|5|||
147384186|NCT00103857|531569680|FG000|54-Week Base Study|patient moved|0|||
147384187|NCT00103857|531569681|FG001|54-Week Base Study|patient moved|1|||
147384188|NCT00103857|531569682|FG002|54-Week Base Study|patient moved|1|||
147384189|NCT00103857|531569683|FG003|54-Week Base Study|patient moved|2|||
147384190|NCT00103857|531569684|FG004|54-Week Base Study|patient moved|3|||
147384191|NCT00103857|531569685|FG005|54-Week Base Study|patient moved|1|||
147384192|NCT00103857|531569686|FG006|54-Week Base Study|patient moved|0|||
147384193|NCT00103857|531569680|FG000|54-Week Base Study|non-compliance with study procedures|1|||
147614749|NCT04471428|532404841|FG000|Overall Study|Death|106|||
147384194|NCT00103857|531569681|FG001|54-Week Base Study|non-compliance with study procedures|2|||
147384195|NCT00103857|531569682|FG002|54-Week Base Study|non-compliance with study procedures|0|||
147384196|NCT00103857|531569683|FG003|54-Week Base Study|non-compliance with study procedures|0|||
147384197|NCT00103857|531569684|FG004|54-Week Base Study|non-compliance with study procedures|0|||
147384198|NCT00103857|531569685|FG005|54-Week Base Study|non-compliance with study procedures|2|||
147384199|NCT00103857|531569686|FG006|54-Week Base Study|non-compliance with study procedures|0|||
147614750|NCT04471428|532404842|FG001|Overall Study|Death|114|||
147614751|NCT04471428|532404841|FG000|Overall Study|Ongoing in the study|45|||
147384200|NCT00103857|531569680|FG000|54-Week Base Study|patient incarcerated|0|||
147384201|NCT00103857|531569681|FG001|54-Week Base Study|patient incarcerated|0|||
147384202|NCT00103857|531569682|FG002|54-Week Base Study|patient incarcerated|0|||
147384203|NCT00103857|531569683|FG003|54-Week Base Study|patient incarcerated|0|||
147384204|NCT00103857|531569684|FG004|54-Week Base Study|patient incarcerated|1|||
147384205|NCT00103857|531569685|FG005|54-Week Base Study|patient incarcerated|1|||
147384206|NCT00103857|531569686|FG006|54-Week Base Study|patient incarcerated|0|||
147384207|NCT00103857|531569680|FG000|54-Week Base Study|laboratory reporting error|0|||
147384208|NCT00103857|531569681|FG001|54-Week Base Study|laboratory reporting error|0|||
147384209|NCT00103857|531569682|FG002|54-Week Base Study|laboratory reporting error|0|||
147384210|NCT00103857|531569683|FG003|54-Week Base Study|laboratory reporting error|0|||
147384211|NCT00103857|531569684|FG004|54-Week Base Study|laboratory reporting error|1|||
147384212|NCT00103857|531569685|FG005|54-Week Base Study|laboratory reporting error|0|||
147384213|NCT00103857|531569686|FG006|54-Week Base Study|laboratory reporting error|0|||
147384214|NCT00103857|531569680|FG000|54-Week Base Study|site error|0|||
147384215|NCT00103857|531569681|FG001|54-Week Base Study|site error|0|||
147384216|NCT00103857|531569682|FG002|54-Week Base Study|site error|0|||
147384217|NCT00103857|531569683|FG003|54-Week Base Study|site error|0|||
147384218|NCT00103857|531569684|FG004|54-Week Base Study|site error|0|||
147384219|NCT00103857|531569685|FG005|54-Week Base Study|site error|1|||
147384220|NCT00103857|531569686|FG006|54-Week Base Study|site error|0|||
147384221|NCT00103857|531569680|FG000|54-Week Base Study|patient intolerance to rescue therapy|1|||
147384222|NCT00103857|531569681|FG001|54-Week Base Study|patient intolerance to rescue therapy|0|||
147384223|NCT00103857|531569682|FG002|54-Week Base Study|patient intolerance to rescue therapy|0|||
147384224|NCT00103857|531569683|FG003|54-Week Base Study|patient intolerance to rescue therapy|0|||
147384225|NCT00103857|531569684|FG004|54-Week Base Study|patient intolerance to rescue therapy|0|||
147384226|NCT00103857|531569685|FG005|54-Week Base Study|patient intolerance to rescue therapy|0|||
147384227|NCT00103857|531569686|FG006|54-Week Base Study|patient intolerance to rescue therapy|0|||
147384228|NCT00103857|531569680|FG000|50-Week Extension Study|Adverse Event|2|||
147384229|NCT00103857|531569681|FG001|50-Week Extension Study|Adverse Event|3|||
147384230|NCT00103857|531569682|FG002|50-Week Extension Study|Adverse Event|2|||
147384231|NCT00103857|531569683|FG003|50-Week Extension Study|Adverse Event|0|||
147384232|NCT00103857|531569684|FG004|50-Week Extension Study|Adverse Event|1|||
147384233|NCT00103857|531569685|FG005|50-Week Extension Study|Adverse Event|1|||
147384234|NCT00103857|531569686|FG006|50-Week Extension Study|Adverse Event|0|||
147384235|NCT00103857|531569680|FG000|50-Week Extension Study|Death|0|||
147384236|NCT00103857|531569681|FG001|50-Week Extension Study|Death|0|||
147384237|NCT00103857|531569682|FG002|50-Week Extension Study|Death|0|||
147384238|NCT00103857|531569683|FG003|50-Week Extension Study|Death|1|||
147384239|NCT00103857|531569684|FG004|50-Week Extension Study|Death|0|||
147384240|NCT00103857|531569685|FG005|50-Week Extension Study|Death|1|||
147384241|NCT00103857|531569686|FG006|50-Week Extension Study|Death|0|||
147384242|NCT00103857|531569680|FG000|50-Week Extension Study|Lack of Efficacy|26|||
147384243|NCT00103857|531569681|FG001|50-Week Extension Study|Lack of Efficacy|15|||
147384244|NCT00103857|531569682|FG002|50-Week Extension Study|Lack of Efficacy|13|||
147384245|NCT00103857|531569683|FG003|50-Week Extension Study|Lack of Efficacy|16|||
147384246|NCT00103857|531569684|FG004|50-Week Extension Study|Lack of Efficacy|8|||
147384247|NCT00103857|531569685|FG005|50-Week Extension Study|Lack of Efficacy|8|||
147614752|NCT04471428|532404842|FG001|Overall Study|Ongoing in the study|68|||
147614753|NCT03151304|532404843|FG000|Overall Study|Termination of study by Sponsor|23|||
147614754|NCT03151304|532404843|FG000|Overall Study|missing|3|||
147384248|NCT00103857|531569686|FG006|50-Week Extension Study|Lack of Efficacy|0|||
147384249|NCT00103857|531569680|FG000|50-Week Extension Study|Lost to Follow-up|4|||
147384250|NCT00103857|531569681|FG001|50-Week Extension Study|Lost to Follow-up|0|||
147384251|NCT00103857|531569682|FG002|50-Week Extension Study|Lost to Follow-up|1|||
147384252|NCT00103857|531569683|FG003|50-Week Extension Study|Lost to Follow-up|4|||
147384253|NCT00103857|531569684|FG004|50-Week Extension Study|Lost to Follow-up|3|||
147384254|NCT00103857|531569685|FG005|50-Week Extension Study|Lost to Follow-up|3|||
147384255|NCT00103857|531569686|FG006|50-Week Extension Study|Lost to Follow-up|0|||
147384256|NCT00103857|531569680|FG000|50-Week Extension Study|Physician Decision|0|||
147384257|NCT00103857|531569681|FG001|50-Week Extension Study|Physician Decision|1|||
147384258|NCT00103857|531569682|FG002|50-Week Extension Study|Physician Decision|1|||
147384259|NCT00103857|531569683|FG003|50-Week Extension Study|Physician Decision|0|||
147384260|NCT00103857|531569684|FG004|50-Week Extension Study|Physician Decision|0|||
147384261|NCT00103857|531569685|FG005|50-Week Extension Study|Physician Decision|0|||
147384262|NCT00103857|531569686|FG006|50-Week Extension Study|Physician Decision|0|||
147384263|NCT00103857|531569680|FG000|50-Week Extension Study|Pregnancy|0|||
147384264|NCT00103857|531569681|FG001|50-Week Extension Study|Pregnancy|0|||
147614755|NCT03151304|532404843|FG000|Overall Study|Withdrawal by Subject|8|||
147384265|NCT00103857|531569682|FG002|50-Week Extension Study|Pregnancy|1|||
147384266|NCT00103857|531569683|FG003|50-Week Extension Study|Pregnancy|0|||
147384267|NCT00103857|531569684|FG004|50-Week Extension Study|Pregnancy|1|||
147384268|NCT00103857|531569685|FG005|50-Week Extension Study|Pregnancy|0|||
147384269|NCT00103857|531569686|FG006|50-Week Extension Study|Pregnancy|0|||
147614756|NCT03151304|532404843|FG000|Overall Study|multiple reasons|30|||
147384270|NCT00103857|531569680|FG000|50-Week Extension Study|Protocol Violation|1|||
147384271|NCT00103857|531569681|FG001|50-Week Extension Study|Protocol Violation|1|||
147384272|NCT00103857|531569682|FG002|50-Week Extension Study|Protocol Violation|1|||
147384273|NCT00103857|531569683|FG003|50-Week Extension Study|Protocol Violation|2|||
147384274|NCT00103857|531569684|FG004|50-Week Extension Study|Protocol Violation|0|||
147384275|NCT00103857|531569685|FG005|50-Week Extension Study|Protocol Violation|1|||
147384276|NCT00103857|531569686|FG006|50-Week Extension Study|Protocol Violation|0|||
147384277|NCT00103857|531569680|FG000|50-Week Extension Study|Withdrawal by Subject|2|||
147384278|NCT00103857|531569681|FG001|50-Week Extension Study|Withdrawal by Subject|5|||
147384279|NCT00103857|531569682|FG002|50-Week Extension Study|Withdrawal by Subject|2|||
147384280|NCT00103857|531569683|FG003|50-Week Extension Study|Withdrawal by Subject|8|||
147384281|NCT00103857|531569684|FG004|50-Week Extension Study|Withdrawal by Subject|3|||
147384282|NCT00103857|531569685|FG005|50-Week Extension Study|Withdrawal by Subject|3|||
147384283|NCT00103857|531569686|FG006|50-Week Extension Study|Withdrawal by Subject|0|||
147384284|NCT00103857|531569680|FG000|50-Week Extension Study|protocol discontinuation criteria|2|||
147384285|NCT00103857|531569681|FG001|50-Week Extension Study|protocol discontinuation criteria|2|||
147384286|NCT00103857|531569682|FG002|50-Week Extension Study|protocol discontinuation criteria|3|||
147384287|NCT00103857|531569683|FG003|50-Week Extension Study|protocol discontinuation criteria|2|||
147384288|NCT00103857|531569684|FG004|50-Week Extension Study|protocol discontinuation criteria|3|||
147384289|NCT00103857|531569685|FG005|50-Week Extension Study|protocol discontinuation criteria|3|||
147384290|NCT00103857|531569686|FG006|50-Week Extension Study|protocol discontinuation criteria|0|||
147384291|NCT00103857|531569680|FG000|50-Week Extension Study|non-compliance with study procedures|1|||
147384292|NCT00103857|531569681|FG001|50-Week Extension Study|non-compliance with study procedures|0|||
147384293|NCT00103857|531569682|FG002|50-Week Extension Study|non-compliance with study procedures|0|||
147384294|NCT00103857|531569683|FG003|50-Week Extension Study|non-compliance with study procedures|1|||
147384295|NCT00103857|531569684|FG004|50-Week Extension Study|non-compliance with study procedures|1|||
147384296|NCT00103857|531569685|FG005|50-Week Extension Study|non-compliance with study procedures|0|||
147384297|NCT00103857|531569686|FG006|50-Week Extension Study|non-compliance with study procedures|0|||
147384298|NCT00103857|531569680|FG000|50-Week Extension Study|patient moved|0|||
147384299|NCT00103857|531569681|FG001|50-Week Extension Study|patient moved|0|||
147384300|NCT00103857|531569682|FG002|50-Week Extension Study|patient moved|1|||
147384301|NCT00103857|531569683|FG003|50-Week Extension Study|patient moved|2|||
147384302|NCT00103857|531569684|FG004|50-Week Extension Study|patient moved|0|||
147384303|NCT00103857|531569685|FG005|50-Week Extension Study|patient moved|0|||
147384304|NCT00103857|531569686|FG006|50-Week Extension Study|patient moved|0|||
147384305|NCT00103857|531569680|FG000|50-Week Extension Study|patient scheduled for elective surgery|0|||
147384306|NCT00103857|531569681|FG001|50-Week Extension Study|patient scheduled for elective surgery|0|||
147384307|NCT00103857|531569682|FG002|50-Week Extension Study|patient scheduled for elective surgery|1|||
147384308|NCT00103857|531569683|FG003|50-Week Extension Study|patient scheduled for elective surgery|0|||
147384309|NCT00103857|531569684|FG004|50-Week Extension Study|patient scheduled for elective surgery|0|||
147384310|NCT00103857|531569685|FG005|50-Week Extension Study|patient scheduled for elective surgery|0|||
147384311|NCT00103857|531569686|FG006|50-Week Extension Study|patient scheduled for elective surgery|0|||
147384312|NCT00103857|531569680|FG000|50-Week Extension Study|reason unspecified|0|||
147614757|NCT02565511|532404845|FG000|Overall Study|Study terminated by Sponsor|35|||
147614758|NCT02565511|532404846|FG001|Overall Study|Study terminated by Sponsor|22|||
147614759|NCT02565511|532404847|FG002|Overall Study|Study terminated by Sponsor|235|||
147614760|NCT02565511|532404848|FG003|Overall Study|Study terminated by Sponsor|156|||
147614761|NCT02565511|532404845|FG000|Overall Study|Withdrawal by Subject|3|||
147614762|NCT02565511|532404846|FG001|Overall Study|Withdrawal by Subject|0|||
147614763|NCT02565511|532404847|FG002|Overall Study|Withdrawal by Subject|12|||
147614764|NCT02565511|532404848|FG003|Overall Study|Withdrawal by Subject|5|||
147614765|NCT02565511|532404845|FG000|Overall Study|Adverse Event|0|||
147614766|NCT02565511|532404846|FG001|Overall Study|Adverse Event|0|||
147384313|NCT00103857|531569681|FG001|50-Week Extension Study|reason unspecified|0|||
147384314|NCT00103857|531569682|FG002|50-Week Extension Study|reason unspecified|0|||
147384315|NCT00103857|531569683|FG003|50-Week Extension Study|reason unspecified|0|||
147384316|NCT00103857|531569684|FG004|50-Week Extension Study|reason unspecified|1|||
147384317|NCT00103857|531569685|FG005|50-Week Extension Study|reason unspecified|0|||
147384318|NCT00103857|531569686|FG006|50-Week Extension Study|reason unspecified|0|||
147456546|NCT00756938|531831762|FG002|Optional Extension|End of Study|0|||
147614767|NCT02565511|532404847|FG002|Overall Study|Adverse Event|1|||
147384319|NCT01856569|531569687|FG000|Overall Study|Other|1|||
147384320|NCT01856569|531569687|FG000|Overall Study|Changed Site/Structure|1|||
147384321|NCT01856569|531569687|FG000|Overall Study|Lost to Follow-up|3|||
147384322|NCT01856569|531569687|FG000|Overall Study|Did not met inclusion criteria|8|||
147384323|NCT02707952|531569688|FG000|Overall Study|Adverse Event|1|||
147384324|NCT02707952|531569689|FG001|Overall Study|Adverse Event|0|||
147384325|NCT02707952|531569690|FG002|Overall Study|Adverse Event|0|||
147614768|NCT02565511|532404848|FG003|Overall Study|Adverse Event|1|||
147614769|NCT02565511|532404845|FG000|Overall Study|Lost to Follow-up|4|||
147384326|NCT02707952|531569691|FG003|Overall Study|Adverse Event|0|||
147384327|NCT02707952|531569688|FG000|Overall Study|Lost to Follow-up|1|||
147384328|NCT02707952|531569689|FG001|Overall Study|Lost to Follow-up|0|||
147384329|NCT02707952|531569690|FG002|Overall Study|Lost to Follow-up|0|||
147384330|NCT02707952|531569691|FG003|Overall Study|Lost to Follow-up|0|||
147384331|NCT02707952|531569688|FG000|Overall Study|Withdrawal by Subject|0|||
147384332|NCT02707952|531569689|FG001|Overall Study|Withdrawal by Subject|1|||
147384333|NCT02707952|531569690|FG002|Overall Study|Withdrawal by Subject|2|||
147384334|NCT02707952|531569691|FG003|Overall Study|Withdrawal by Subject|0|||
147384335|NCT00696241|531569692|FG000|Overall Study|Adverse Event|11|||
147384336|NCT00696241|531569693|FG001|Overall Study|Adverse Event|3|||
147384337|NCT00696241|531569694|FG002|Overall Study|Adverse Event|6|||
147384338|NCT00696241|531569695|FG003|Overall Study|Adverse Event|4|||
147384339|NCT00696241|531569696|FG004|Overall Study|Adverse Event|5|||
147384340|NCT00696241|531569692|FG000|Overall Study|Protocol Violation|1|||
147384341|NCT00696241|531569693|FG001|Overall Study|Protocol Violation|1|||
147384342|NCT00696241|531569694|FG002|Overall Study|Protocol Violation|2|||
147384343|NCT00696241|531569695|FG003|Overall Study|Protocol Violation|0|||
147384344|NCT00696241|531569696|FG004|Overall Study|Protocol Violation|3|||
147384345|NCT00696241|531569692|FG000|Overall Study|Lost to Follow-up|1|||
147384346|NCT00696241|531569693|FG001|Overall Study|Lost to Follow-up|4|||
147384347|NCT00696241|531569694|FG002|Overall Study|Lost to Follow-up|1|||
147384348|NCT00696241|531569695|FG003|Overall Study|Lost to Follow-up|2|||
147384349|NCT00696241|531569696|FG004|Overall Study|Lost to Follow-up|0|||
147384350|NCT00696241|531569692|FG000|Overall Study|Withdrawal by Subject|4|||
147384351|NCT00696241|531569693|FG001|Overall Study|Withdrawal by Subject|8|||
147384352|NCT00696241|531569694|FG002|Overall Study|Withdrawal by Subject|6|||
147384353|NCT00696241|531569695|FG003|Overall Study|Withdrawal by Subject|1|||
147384354|NCT00696241|531569696|FG004|Overall Study|Withdrawal by Subject|0|||
147384355|NCT00696241|531569692|FG000|Overall Study|Lack of Efficacy|1|||
147384356|NCT00696241|531569693|FG001|Overall Study|Lack of Efficacy|5|||
147384357|NCT00696241|531569694|FG002|Overall Study|Lack of Efficacy|4|||
147384358|NCT00696241|531569695|FG003|Overall Study|Lack of Efficacy|5|||
147384359|NCT00696241|531569696|FG004|Overall Study|Lack of Efficacy|3|||
147384360|NCT00696241|531569692|FG000|Overall Study|Other|6|||
147384361|NCT00696241|531569693|FG001|Overall Study|Other|1|||
147384362|NCT00696241|531569694|FG002|Overall Study|Other|5|||
147384363|NCT00696241|531569695|FG003|Overall Study|Other|2|||
147384364|NCT00696241|531569696|FG004|Overall Study|Other|1|||
147384365|NCT03065400|531569697|FG000|Overall Study|Adverse Event|1|||
147384366|NCT03065400|531569697|FG000|Overall Study|Physician Decision|3|||
147384367|NCT03065400|531569697|FG000|Overall Study|Withdrawal by Subject|1|||
147384368|NCT03065400|531569697|FG000|Overall Study|Completed 6 cycles but did not meet criteria to continue past cycle 6|5|||
147384369|NCT03060525|531569698|FG000|Overall Study|moved out of state|1|||
147384370|NCT03060525|531569699|FG001|Overall Study|moved out of state|1|||
147384371|NCT03060525|531569700|FG002|Overall Study|moved out of state|1|||
147384372|NCT03060525|531569701|FG003|Overall Study|moved out of state|1|||
147384373|NCT03060525|531569698|FG000|Overall Study|unable to meet time commitment required of study|2|||
147384374|NCT03060525|531569699|FG001|Overall Study|unable to meet time commitment required of study|3|||
147384375|NCT03060525|531569700|FG002|Overall Study|unable to meet time commitment required of study|3|||
147384376|NCT03060525|531569701|FG003|Overall Study|unable to meet time commitment required of study|1|||
147384377|NCT03060525|531569698|FG000|Overall Study|no longer interested in doing intervention|0|||
147456547|NCT00756938|531831763|FG003|Optional Extension|End of Study|11|||
147384378|NCT03060525|531569699|FG001|Overall Study|no longer interested in doing intervention|0|||
147384379|NCT03060525|531569700|FG002|Overall Study|no longer interested in doing intervention|0|||
147384380|NCT03060525|531569701|FG003|Overall Study|no longer interested in doing intervention|1|||
147384381|NCT02147093|531569702|FG000|Period 1|Lost to Follow-up|0|||
147384382|NCT02147093|531569703|FG001|Period 1|Lost to Follow-up|1|||
147384383|NCT02147093|531569702|FG000|Period 2|Protocol Violation|2|||
147384384|NCT02147093|531569703|FG001|Period 2|Protocol Violation|0|||
147384385|NCT02189759|531569709|FG000|Overall Study|Lost to Follow-up|0|||
147384386|NCT02189759|531569710|FG001|Overall Study|Lost to Follow-up|0|||
147384387|NCT02189759|531569711|FG002|Overall Study|Lost to Follow-up|2|||
147384388|NCT02189759|531569712|FG003|Overall Study|Lost to Follow-up|5|||
147384389|NCT01147471|531569713|FG000|Post-discharge Follow Up (Approx 2 Wks)|Lost to Follow-up|0|||
147384390|NCT01147471|531569714|FG001|Post-discharge Follow Up (Approx 2 Wks)|Lost to Follow-up|1|||
147384391|NCT01147471|531569713|FG000|Post-discharge Follow Up (Approx 2 Wks)|Withdrawal by Subject|0|||
147384392|NCT01147471|531569714|FG001|Post-discharge Follow Up (Approx 2 Wks)|Withdrawal by Subject|1|||
147384393|NCT01147471|531569713|FG000|Post-discharge Follow Up (Approx 2 Wks)|incarcerated|0|||
147384394|NCT01147471|531569714|FG001|Post-discharge Follow Up (Approx 2 Wks)|incarcerated|1|||
147384395|NCT01147471|531569713|FG000|3 Month Follow Up|Lost to Follow-up|1|||
147384396|NCT01147471|531569714|FG001|3 Month Follow Up|Lost to Follow-up|1|||
147384397|NCT01147471|531569713|FG000|3 Month Follow Up|Physician Decision|0|||
147384398|NCT01147471|531569714|FG001|3 Month Follow Up|Physician Decision|1|||
147384399|NCT01147471|531569713|FG000|6 Month Follow Up|Lost to Follow-up|4|||
147384400|NCT01147471|531569714|FG001|6 Month Follow Up|Lost to Follow-up|2|||
147384401|NCT03890484|531569720|FG000|Overall Study|Lost to Follow-up|1|||
147384402|NCT03890484|531569721|FG001|Overall Study|Lost to Follow-up|1|||
147384403|NCT00518206|531569722|FG000|Overall Study|Disease Progression Requiring Therapy|6|||
147384404|NCT00518206|531569723|FG001|Overall Study|Disease Progression Requiring Therapy|6|||
147384405|NCT00518206|531569722|FG000|Overall Study|Withdrawal by Subject|2|||
147384406|NCT00518206|531569723|FG001|Overall Study|Withdrawal by Subject|0|||
147384407|NCT00518206|531569722|FG000|Overall Study|Drug Supply Issue|1|||
147384408|NCT00518206|531569723|FG001|Overall Study|Drug Supply Issue|0|||
147384409|NCT00518206|531569722|FG000|Overall Study|Reason Unknown|1|||
147384410|NCT00518206|531569723|FG001|Overall Study|Reason Unknown|0|||
147384411|NCT00518206|531569722|FG000|Overall Study|Completion Status Unknown|1|||
147384412|NCT00518206|531569723|FG001|Overall Study|Completion Status Unknown|0|||
147384413|NCT01294644|531569724|FG000|Overall Study|Adverse Event|2|||
147384414|NCT01294644|531569725|FG001|Overall Study|Adverse Event|0|||
147384415|NCT01294644|531569726|FG002|Overall Study|Adverse Event|1|||
147384416|NCT01294644|531569724|FG000|Overall Study|Withdrawal by Subject|3|||
147384417|NCT01294644|531569725|FG001|Overall Study|Withdrawal by Subject|7|||
147384418|NCT01294644|531569726|FG002|Overall Study|Withdrawal by Subject|4|||
147384419|NCT01294644|531569724|FG000|Overall Study|Lost to Follow-up|3|||
147384420|NCT01294644|531569725|FG001|Overall Study|Lost to Follow-up|2|||
147384421|NCT01294644|531569726|FG002|Overall Study|Lost to Follow-up|5|||
147384422|NCT01294644|531569724|FG000|Overall Study|Miscellaneous Reason|2|||
147384423|NCT01294644|531569725|FG001|Overall Study|Miscellaneous Reason|1|||
147384424|NCT01294644|531569726|FG002|Overall Study|Miscellaneous Reason|4|||
147384425|NCT02188459|531569727|FG000|Overall Study|Lost to Follow-up|3|||
147384426|NCT02188459|531569728|FG001|Overall Study|Lost to Follow-up|4|||
147384427|NCT02188459|531569727|FG000|Overall Study|Early Termination|0|||
147384428|NCT02188459|531569728|FG001|Overall Study|Early Termination|3|||
147384429|NCT02548585|531569729|FG000|Overall Study|Withdrawal by Subject|0|||
147384430|NCT02548585|531569730|FG001|Overall Study|Withdrawal by Subject|0|||
147384431|NCT02548585|531569731|FG002|Overall Study|Withdrawal by Subject|0|||
147384432|NCT02548585|531569732|FG003|Overall Study|Withdrawal by Subject|0|||
147384433|NCT02548585|531569733|FG004|Overall Study|Withdrawal by Subject|0|||
147384434|NCT02548585|531569734|FG005|Overall Study|Withdrawal by Subject|1|||
147384435|NCT02548585|531569735|FG006|Overall Study|Withdrawal by Subject|0|||
147384436|NCT02548585|531569729|FG000|Overall Study|Lost to Follow-up|1|||
147384437|NCT02548585|531569730|FG001|Overall Study|Lost to Follow-up|0|||
147384438|NCT02548585|531569731|FG002|Overall Study|Lost to Follow-up|0|||
147384439|NCT02548585|531569732|FG003|Overall Study|Lost to Follow-up|0|||
147384440|NCT02548585|531569733|FG004|Overall Study|Lost to Follow-up|0|||
147384441|NCT02548585|531569734|FG005|Overall Study|Lost to Follow-up|0|||
147384442|NCT02548585|531569735|FG006|Overall Study|Lost to Follow-up|0|||
147384443|NCT02548585|531569729|FG000|Overall Study|Other|1|||
147384444|NCT02548585|531569730|FG001|Overall Study|Other|0|||
147384445|NCT02548585|531569731|FG002|Overall Study|Other|0|||
147384446|NCT02548585|531569732|FG003|Overall Study|Other|2|||
147384447|NCT02548585|531569733|FG004|Overall Study|Other|3|||
147384448|NCT02548585|531569734|FG005|Overall Study|Other|0|||
147384449|NCT02548585|531569735|FG006|Overall Study|Other|1|||
147384450|NCT02548585|531569729|FG000|Overall Study|Randomized but not treated|0|||
147384451|NCT02548585|531569730|FG001|Overall Study|Randomized but not treated|0|||
147384452|NCT02548585|531569731|FG002|Overall Study|Randomized but not treated|0|||
147384453|NCT02548585|531569732|FG003|Overall Study|Randomized but not treated|0|||
147384454|NCT02548585|531569733|FG004|Overall Study|Randomized but not treated|0|||
147384455|NCT02548585|531569734|FG005|Overall Study|Randomized but not treated|1|||
147384456|NCT02548585|531569735|FG006|Overall Study|Randomized but not treated|0|||
147384457|NCT02612285|531569736|FG000|Overall Study|Withdrawal by Subject|1|||
147384458|NCT00853957|531569741|FG000|Overall Study|Adverse Event|9|||
147384459|NCT00853957|531569742|FG001|Overall Study|Adverse Event|3|||
147384460|NCT00853957|531569741|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
147384461|NCT00853957|531569742|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
147384462|NCT00853957|531569741|FG000|Overall Study|Subject withdrew consent|4|||
147384463|NCT00853957|531569742|FG001|Overall Study|Subject withdrew consent|5|||
147384464|NCT00853957|531569741|FG000|Overall Study|Lost to Follow-up|1|||
147384465|NCT00853957|531569742|FG001|Overall Study|Lost to Follow-up|6|||
147384466|NCT00853957|531569741|FG000|Overall Study|Protocol deviation|0|||
147384467|NCT00853957|531569742|FG001|Overall Study|Protocol deviation|3|||
147384468|NCT02942771|531569743|FG000|Overall Study|Adverse Event|1|||
147384469|NCT02942771|531569744|FG001|Overall Study|Adverse Event|0|||
147384470|NCT02942771|531569745|FG002|Overall Study|Adverse Event|0|||
147384471|NCT02942771|531569746|FG003|Overall Study|Adverse Event|0|||
147384472|NCT02942771|531569747|FG004|Overall Study|Adverse Event|2|||
147384473|NCT02942771|531569743|FG000|Overall Study|Lost to Follow-up|1|||
147384474|NCT02942771|531569744|FG001|Overall Study|Lost to Follow-up|0|||
147384475|NCT02942771|531569745|FG002|Overall Study|Lost to Follow-up|0|||
147384476|NCT02942771|531569746|FG003|Overall Study|Lost to Follow-up|0|||
147384477|NCT02942771|531569747|FG004|Overall Study|Lost to Follow-up|0|||
147384478|NCT02942771|531569743|FG000|Overall Study|Withdrawal by Subject|1|||
147384479|NCT02942771|531569744|FG001|Overall Study|Withdrawal by Subject|0|||
147384480|NCT02942771|531569745|FG002|Overall Study|Withdrawal by Subject|0|||
147384481|NCT02942771|531569746|FG003|Overall Study|Withdrawal by Subject|0|||
147384482|NCT02942771|531569747|FG004|Overall Study|Withdrawal by Subject|2|||
147384483|NCT04919499|531569748|FG000|Overall Study|Adverse Event|0|||
147384484|NCT04919499|531569749|FG001|Overall Study|Adverse Event|0|||
147384485|NCT04919499|531569750|FG002|Overall Study|Adverse Event|0|||
147384486|NCT04919499|531569751|FG003|Overall Study|Adverse Event|0|||
147384487|NCT04919499|531569752|FG004|Overall Study|Adverse Event|2|||
147384488|NCT04919499|531569748|FG000|Overall Study|Not treated|0|||
147384489|NCT04919499|531569749|FG001|Overall Study|Not treated|0|||
147384490|NCT04919499|531569750|FG002|Overall Study|Not treated|0|||
147384491|NCT04919499|531569751|FG003|Overall Study|Not treated|1|||
147384492|NCT04919499|531569752|FG004|Overall Study|Not treated|0|||
147384493|NCT01437540|531571755|FG000|Overall Study|Not listed below|7|||
147384494|NCT01437540|531571756|FG001|Overall Study|Not listed below|6|||
147384495|NCT01437540|531571755|FG000|Overall Study|COPD exacerbation|13|||
147384496|NCT01437540|531571756|FG001|Overall Study|COPD exacerbation|3|||
147384497|NCT01437540|531571755|FG000|Overall Study|Lost to Follow-up|3|||
147384498|NCT01437540|531571756|FG001|Overall Study|Lost to Follow-up|5|||
147384499|NCT01437540|531571755|FG000|Overall Study|Lack of Efficacy|23|||
147384500|NCT01437540|531571756|FG001|Overall Study|Lack of Efficacy|11|||
147384501|NCT01437540|531571755|FG000|Overall Study|Protocol Violation|24|||
147384502|NCT01437540|531571756|FG001|Overall Study|Protocol Violation|12|||
147384503|NCT01437540|531571755|FG000|Overall Study|Adverse Event|26|||
147384504|NCT01437540|531571756|FG001|Overall Study|Adverse Event|13|||
147384505|NCT01437540|531571755|FG000|Overall Study|Withdrawal by Subject|31|||
147384506|NCT01437540|531571756|FG001|Overall Study|Withdrawal by Subject|15|||
147384507|NCT00608959|531571757|FG000|Part 1|Did not meet eligibility criteria|1|||
147384508|NCT01416285|531571758|FG000|Overall Study|owing to the care model or moving to other cities of the country|0|||
147384509|NCT01416285|531571759|FG001|Overall Study|owing to the care model or moving to other cities of the country|9|||
147384510|NCT01005602|531571760|FG000|Overall Study|Excluded due to unreliable clinical data|1|||
147384511|NCT01005602|531571761|FG001|Overall Study|Excluded due to unreliable clinical data|0|||
147384512|NCT01248715|531571762|FG000|Overall Study|Not influenza positive|501|||
147384513|NCT01248715|531571763|FG001|Overall Study|Not influenza positive|510|||
147384514|NCT01919489|531571767|FG000|Overall Study|Rejected the need of injections|4|||
147384515|NCT01919489|531571768|FG001|Overall Study|Rejected the need of injections|7|||
147384516|NCT01919489|531571767|FG000|Overall Study|Adverse Event|10|||
147384517|NCT01919489|531571768|FG001|Overall Study|Adverse Event|0|||
147384518|NCT01919489|531571767|FG000|Overall Study|Hospital readmission|2|||
147384519|NCT01919489|531571768|FG001|Overall Study|Hospital readmission|9|||
147384520|NCT01919489|531571767|FG000|Overall Study|Death|2|||
147384521|NCT01919489|531571768|FG001|Overall Study|Death|1|||
147384522|NCT01919489|531571767|FG000|Overall Study|Lost to Follow-up|38|||
147384523|NCT01919489|531571768|FG001|Overall Study|Lost to Follow-up|27|||
147384524|NCT01540474|531571769|FG000|Vaccination Period|Lost to Follow-up|0|||
147384525|NCT01540474|531571770|FG001|Vaccination Period|Lost to Follow-up|1|||
147384526|NCT01540474|531571771|FG002|Vaccination Period|Lost to Follow-up|0|||
147384527|NCT01540474|531571772|FG003|Vaccination Period|Lost to Follow-up|0|||
147384528|NCT00857311|531571773|FG000|Overall Study|Lost to Follow-up|1|||
147384529|NCT00857311|531571774|FG001|Overall Study|Lost to Follow-up|0|||
147384530|NCT00857311|531571775|FG002|Overall Study|Lost to Follow-up|0|||
147384531|NCT00857311|531571776|FG003|Overall Study|Lost to Follow-up|0|||
147384532|NCT01587703|531571777|FG000|Part1 QD(Median Exposure of 1.38months)|Physician Decision|1|||
147384533|NCT01587703|531571778|FG001|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
147384534|NCT01587703|531571779|FG002|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
147384535|NCT01587703|531571780|FG003|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
147384536|NCT01587703|531571781|FG004|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
147384537|NCT01587703|531571782|FG005|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
147384538|NCT01587703|531571783|FG006|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
147384539|NCT01587703|531571784|FG007|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
147384540|NCT01587703|531571785|FG008|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
147384541|NCT01587703|531571786|FG009|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
147384542|NCT01587703|531571787|FG010|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
147384543|NCT01587703|531571788|FG011|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
147384544|NCT01587703|531571789|FG012|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
147384545|NCT01587703|531571790|FG013|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
147384546|NCT01587703|531571791|FG014|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
147384547|NCT01587703|531571792|FG015|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
147384548|NCT01587703|531571793|FG016|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
147384549|NCT01587703|531571794|FG017|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
147384550|NCT01587703|531571795|FG018|Part1 QD(Median Exposure of 1.38months)|Physician Decision|0|||
147384551|NCT01587703|531571777|FG000|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
147614770|NCT02565511|532404846|FG001|Overall Study|Lost to Follow-up|1|||
147384552|NCT01587703|531571778|FG001|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
147384553|NCT01587703|531571779|FG002|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
147384554|NCT01587703|531571780|FG003|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
147384555|NCT01587703|531571781|FG004|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
147384556|NCT01587703|531571782|FG005|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|1|||
147384557|NCT01587703|531571783|FG006|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
147384558|NCT01587703|531571784|FG007|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|2|||
147384559|NCT01587703|531571785|FG008|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
147384560|NCT01587703|531571786|FG009|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
147384561|NCT01587703|531571787|FG010|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
147384562|NCT01587703|531571788|FG011|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
147384563|NCT01587703|531571789|FG012|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
147384564|NCT01587703|531571790|FG013|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
147384565|NCT01587703|531571791|FG014|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
147384566|NCT01587703|531571792|FG015|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
147384567|NCT01587703|531571793|FG016|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
147384568|NCT01587703|531571794|FG017|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
147384569|NCT01587703|531571795|FG018|Part1 QD(Median Exposure of 1.38months)|Lost to Follow-up|0|||
147384570|NCT01587703|531571777|FG000|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
147384571|NCT01587703|531571778|FG001|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
147384572|NCT01587703|531571779|FG002|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
147384573|NCT01587703|531571780|FG003|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
147384574|NCT01587703|531571781|FG004|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
147384575|NCT01587703|531571782|FG005|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
147384576|NCT01587703|531571783|FG006|Part1 QD(Median Exposure of 1.38months)|Site closed|2|||
147384577|NCT01587703|531571784|FG007|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
147384578|NCT01587703|531571785|FG008|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
147384579|NCT01587703|531571786|FG009|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
147384580|NCT01587703|531571787|FG010|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
147384581|NCT01587703|531571788|FG011|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
147384582|NCT01587703|531571789|FG012|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
147384583|NCT01587703|531571790|FG013|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
147384584|NCT01587703|531571791|FG014|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
147384585|NCT01587703|531571792|FG015|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
147384586|NCT01587703|531571793|FG016|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
147384587|NCT01587703|531571794|FG017|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
147384588|NCT01587703|531571795|FG018|Part1 QD(Median Exposure of 1.38months)|Site closed|0|||
147384589|NCT01587703|531571777|FG000|Part1 QD(Median Exposure of 1.38months)|Death|2|||
147384590|NCT01587703|531571778|FG001|Part1 QD(Median Exposure of 1.38months)|Death|4|||
147384591|NCT01587703|531571779|FG002|Part1 QD(Median Exposure of 1.38months)|Death|1|||
147384592|NCT01587703|531571780|FG003|Part1 QD(Median Exposure of 1.38months)|Death|3|||
147384593|NCT01587703|531571781|FG004|Part1 QD(Median Exposure of 1.38months)|Death|4|||
147384594|NCT01587703|531571782|FG005|Part1 QD(Median Exposure of 1.38months)|Death|7|||
147384595|NCT01587703|531571783|FG006|Part1 QD(Median Exposure of 1.38months)|Death|30|||
147384596|NCT01587703|531571784|FG007|Part1 QD(Median Exposure of 1.38months)|Death|7|||
147384597|NCT01587703|531571785|FG008|Part1 QD(Median Exposure of 1.38months)|Death|0|||
147384598|NCT01587703|531571786|FG009|Part1 QD(Median Exposure of 1.38months)|Death|0|||
147384599|NCT01587703|531571787|FG010|Part1 QD(Median Exposure of 1.38months)|Death|0|||
147384600|NCT01587703|531571788|FG011|Part1 QD(Median Exposure of 1.38months)|Death|0|||
147384601|NCT01587703|531571789|FG012|Part1 QD(Median Exposure of 1.38months)|Death|0|||
147384602|NCT01587703|531571790|FG013|Part1 QD(Median Exposure of 1.38months)|Death|0|||
147384603|NCT01587703|531571791|FG014|Part1 QD(Median Exposure of 1.38months)|Death|0|||
147384604|NCT01587703|531571792|FG015|Part1 QD(Median Exposure of 1.38months)|Death|0|||
147384605|NCT01587703|531571793|FG016|Part1 QD(Median Exposure of 1.38months)|Death|0|||
147456548|NCT00756938|531831760|FG000|Optional Extension|Protocol-specific criteria met|0|||
147384606|NCT01587703|531571794|FG017|Part1 QD(Median Exposure of 1.38months)|Death|0|||
147384607|NCT01587703|531571795|FG018|Part1 QD(Median Exposure of 1.38months)|Death|0|||
147384608|NCT01587703|531571777|FG000|Part1 BID(Median Exposure of 1.41months)|Death|0|||
147384609|NCT01587703|531571778|FG001|Part1 BID(Median Exposure of 1.41months)|Death|0|||
147384610|NCT01587703|531571779|FG002|Part1 BID(Median Exposure of 1.41months)|Death|0|||
147384611|NCT01587703|531571780|FG003|Part1 BID(Median Exposure of 1.41months)|Death|0|||
147384612|NCT01587703|531571781|FG004|Part1 BID(Median Exposure of 1.41months)|Death|0|||
147384613|NCT01587703|531571782|FG005|Part1 BID(Median Exposure of 1.41months)|Death|0|||
147384614|NCT01587703|531571783|FG006|Part1 BID(Median Exposure of 1.41months)|Death|0|||
147384615|NCT01587703|531571784|FG007|Part1 BID(Median Exposure of 1.41months)|Death|0|||
147384616|NCT01587703|531571785|FG008|Part1 BID(Median Exposure of 1.41months)|Death|1|||
147456549|NCT00756938|531831761|FG001|Optional Extension|Protocol-specific criteria met|0|||
147384617|NCT01587703|531571786|FG009|Part1 BID(Median Exposure of 1.41months)|Death|9|||
147384618|NCT01587703|531571787|FG010|Part1 BID(Median Exposure of 1.41months)|Death|3|||
147384619|NCT01587703|531571788|FG011|Part1 BID(Median Exposure of 1.41months)|Death|0|||
147384620|NCT01587703|531571789|FG012|Part1 BID(Median Exposure of 1.41months)|Death|0|||
147384621|NCT01587703|531571790|FG013|Part1 BID(Median Exposure of 1.41months)|Death|0|||
147384622|NCT01587703|531571791|FG014|Part1 BID(Median Exposure of 1.41months)|Death|0|||
147384623|NCT01587703|531571792|FG015|Part1 BID(Median Exposure of 1.41months)|Death|0|||
147384624|NCT01587703|531571793|FG016|Part1 BID(Median Exposure of 1.41months)|Death|0|||
147384625|NCT01587703|531571794|FG017|Part1 BID(Median Exposure of 1.41months)|Death|0|||
147384626|NCT01587703|531571795|FG018|Part1 BID(Median Exposure of 1.41months)|Death|0|||
147384627|NCT01587703|531571777|FG000|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
147384628|NCT01587703|531571778|FG001|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
147384629|NCT01587703|531571779|FG002|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
147384630|NCT01587703|531571780|FG003|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
147384631|NCT01587703|531571781|FG004|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
147384632|NCT01587703|531571782|FG005|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
147384633|NCT01587703|531571783|FG006|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
147384634|NCT01587703|531571784|FG007|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
147384635|NCT01587703|531571785|FG008|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|1|||
147384636|NCT01587703|531571786|FG009|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
147384637|NCT01587703|531571787|FG010|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|1|||
147384638|NCT01587703|531571788|FG011|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
147384639|NCT01587703|531571789|FG012|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
147384640|NCT01587703|531571790|FG013|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
147384641|NCT01587703|531571791|FG014|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
147384642|NCT01587703|531571792|FG015|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
147384643|NCT01587703|531571793|FG016|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
147384644|NCT01587703|531571794|FG017|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
147384645|NCT01587703|531571795|FG018|Part1 BID(Median Exposure of 1.41months)|Withdrawal by Subject|0|||
147384646|NCT01587703|531571777|FG000|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
147384647|NCT01587703|531571778|FG001|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
147384648|NCT01587703|531571779|FG002|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
147384649|NCT01587703|531571780|FG003|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
147384650|NCT01587703|531571781|FG004|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
147384651|NCT01587703|531571782|FG005|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
147384652|NCT01587703|531571783|FG006|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
147384653|NCT01587703|531571784|FG007|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
147384654|NCT01587703|531571785|FG008|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
147384655|NCT01587703|531571786|FG009|Part1 BID(Median Exposure of 1.41months)|Site closed|1|||
147384656|NCT01587703|531571787|FG010|Part1 BID(Median Exposure of 1.41months)|Site closed|1|||
147384657|NCT01587703|531571788|FG011|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
147384658|NCT01587703|531571789|FG012|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
147384659|NCT01587703|531571790|FG013|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
147384660|NCT01587703|531571791|FG014|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
147384661|NCT01587703|531571792|FG015|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
147384662|NCT01587703|531571793|FG016|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
147384663|NCT01587703|531571794|FG017|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
147384664|NCT01587703|531571795|FG018|Part1 BID(Median Exposure of 1.41months)|Site closed|0|||
147384665|NCT01587703|531571777|FG000|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
147384666|NCT01587703|531571778|FG001|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
147384667|NCT01587703|531571779|FG002|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
147384668|NCT01587703|531571780|FG003|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
147384669|NCT01587703|531571781|FG004|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
147384670|NCT01587703|531571782|FG005|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
147384671|NCT01587703|531571783|FG006|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
147384672|NCT01587703|531571784|FG007|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
147384673|NCT01587703|531571785|FG008|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|1|||
147384674|NCT01587703|531571786|FG009|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
147384675|NCT01587703|531571787|FG010|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
147384676|NCT01587703|531571788|FG011|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
147384677|NCT01587703|531571789|FG012|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
147384678|NCT01587703|531571790|FG013|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
147384679|NCT01587703|531571791|FG014|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
147384680|NCT01587703|531571792|FG015|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
147384681|NCT01587703|531571793|FG016|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
147384682|NCT01587703|531571794|FG017|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
147384683|NCT01587703|531571795|FG018|Part1 BID(Median Exposure of 1.41months)|Lost to Follow-up|0|||
147384684|NCT01587703|531571777|FG000|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
147384685|NCT01587703|531571778|FG001|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
147384686|NCT01587703|531571779|FG002|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
147384687|NCT01587703|531571780|FG003|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
147384688|NCT01587703|531571781|FG004|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
147384689|NCT01587703|531571782|FG005|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
147384690|NCT01587703|531571783|FG006|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
147384691|NCT01587703|531571784|FG007|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
147384692|NCT01587703|531571785|FG008|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
147384693|NCT01587703|531571786|FG009|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
147384694|NCT01587703|531571787|FG010|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
147384695|NCT01587703|531571788|FG011|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
147384696|NCT01587703|531571789|FG012|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
147384697|NCT01587703|531571790|FG013|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
147384698|NCT01587703|531571791|FG014|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
147384699|NCT01587703|531571792|FG015|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
147384700|NCT01587703|531571793|FG016|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
147384701|NCT01587703|531571794|FG017|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|0|||
147384702|NCT01587703|531571795|FG018|Substudy-P4,Maximum Exposure of 5.5month|Withdrawal by Subject|1|||
147384703|NCT01587703|531571777|FG000|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
147384704|NCT01587703|531571778|FG001|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
147384705|NCT01587703|531571779|FG002|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
147384706|NCT01587703|531571780|FG003|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
147384707|NCT01587703|531571781|FG004|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
147384708|NCT01587703|531571782|FG005|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
147384709|NCT01587703|531571783|FG006|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
147384710|NCT01587703|531571784|FG007|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
147384711|NCT01587703|531571785|FG008|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
147384712|NCT01587703|531571786|FG009|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
147384713|NCT01587703|531571787|FG010|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
147384714|NCT01587703|531571788|FG011|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
147384715|NCT01587703|531571789|FG012|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
147384716|NCT01587703|531571790|FG013|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
147384717|NCT01587703|531571791|FG014|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
147384718|NCT01587703|531571792|FG015|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
147384719|NCT01587703|531571793|FG016|Substudy-P4,Maximum Exposure of 5.5month|Death|0|||
147384720|NCT01587703|531571794|FG017|Substudy-P4,Maximum Exposure of 5.5month|Death|5|||
147384721|NCT01587703|531571795|FG018|Substudy-P4,Maximum Exposure of 5.5month|Death|4|||
147384722|NCT01587703|531571777|FG000|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
147384723|NCT01587703|531571778|FG001|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
147384724|NCT01587703|531571779|FG002|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
147384725|NCT01587703|531571780|FG003|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
147384726|NCT01587703|531571781|FG004|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
147384727|NCT01587703|531571782|FG005|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
147384728|NCT01587703|531571783|FG006|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
147384729|NCT01587703|531571784|FG007|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
147384730|NCT01587703|531571785|FG008|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
147384731|NCT01587703|531571786|FG009|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
147384732|NCT01587703|531571787|FG010|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
147384733|NCT01587703|531571788|FG011|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
147384734|NCT01587703|531571789|FG012|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
147384735|NCT01587703|531571790|FG013|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
147384736|NCT01587703|531571791|FG014|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
147384737|NCT01587703|531571792|FG015|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|1|||
147384738|NCT01587703|531571793|FG016|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
147384739|NCT01587703|531571794|FG017|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
147384740|NCT01587703|531571795|FG018|Part2(Median Exposure of 1.41 Months)|Withdrawal by Subject|0|||
147384741|NCT01587703|531571777|FG000|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
147384742|NCT01587703|531571778|FG001|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
147384743|NCT01587703|531571779|FG002|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
147384744|NCT01587703|531571780|FG003|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
147384745|NCT01587703|531571781|FG004|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
147384746|NCT01587703|531571782|FG005|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
147384747|NCT01587703|531571783|FG006|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
147384748|NCT01587703|531571784|FG007|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
147384749|NCT01587703|531571785|FG008|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
147384750|NCT01587703|531571786|FG009|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
147384751|NCT01587703|531571787|FG010|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
147384752|NCT01587703|531571788|FG011|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|1|||
147384753|NCT01587703|531571789|FG012|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
147384754|NCT01587703|531571790|FG013|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
147384755|NCT01587703|531571791|FG014|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|2|||
147384756|NCT01587703|531571792|FG015|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
147384757|NCT01587703|531571793|FG016|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
147384758|NCT01587703|531571794|FG017|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
147384759|NCT01587703|531571795|FG018|Part2(Median Exposure of 1.41 Months)|Lost to Follow-up|0|||
147384760|NCT01587703|531571777|FG000|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
147384761|NCT01587703|531571778|FG001|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
147384762|NCT01587703|531571779|FG002|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
147384763|NCT01587703|531571780|FG003|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
147384764|NCT01587703|531571781|FG004|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
147384765|NCT01587703|531571782|FG005|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
147384766|NCT01587703|531571783|FG006|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
147384767|NCT01587703|531571784|FG007|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
147384768|NCT01587703|531571785|FG008|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
147384769|NCT01587703|531571786|FG009|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
147384770|NCT01587703|531571787|FG010|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
147384771|NCT01587703|531571788|FG011|Part2(Median Exposure of 1.41 Months)|Site closed|2|||
147384772|NCT01587703|531571789|FG012|Part2(Median Exposure of 1.41 Months)|Site closed|2|||
147384773|NCT01587703|531571790|FG013|Part2(Median Exposure of 1.41 Months)|Site closed|1|||
147384774|NCT01587703|531571791|FG014|Part2(Median Exposure of 1.41 Months)|Site closed|1|||
147384775|NCT01587703|531571792|FG015|Part2(Median Exposure of 1.41 Months)|Site closed|3|||
147384776|NCT01587703|531571793|FG016|Part2(Median Exposure of 1.41 Months)|Site closed|8|||
147384777|NCT01587703|531571794|FG017|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
147384778|NCT01587703|531571795|FG018|Part2(Median Exposure of 1.41 Months)|Site closed|0|||
147384779|NCT01587703|531571777|FG000|Part2(Median Exposure of 1.41 Months)|Death|0|||
147384780|NCT01587703|531571778|FG001|Part2(Median Exposure of 1.41 Months)|Death|0|||
147384781|NCT01587703|531571779|FG002|Part2(Median Exposure of 1.41 Months)|Death|0|||
147384782|NCT01587703|531571780|FG003|Part2(Median Exposure of 1.41 Months)|Death|0|||
147384783|NCT01587703|531571781|FG004|Part2(Median Exposure of 1.41 Months)|Death|0|||
147384784|NCT01587703|531571782|FG005|Part2(Median Exposure of 1.41 Months)|Death|0|||
147384785|NCT01587703|531571783|FG006|Part2(Median Exposure of 1.41 Months)|Death|0|||
147384786|NCT01587703|531571784|FG007|Part2(Median Exposure of 1.41 Months)|Death|0|||
147384787|NCT01587703|531571785|FG008|Part2(Median Exposure of 1.41 Months)|Death|0|||
147384788|NCT01587703|531571786|FG009|Part2(Median Exposure of 1.41 Months)|Death|0|||
147384789|NCT01587703|531571787|FG010|Part2(Median Exposure of 1.41 Months)|Death|0|||
147384790|NCT01587703|531571788|FG011|Part2(Median Exposure of 1.41 Months)|Death|8|||
147384791|NCT01587703|531571789|FG012|Part2(Median Exposure of 1.41 Months)|Death|12|||
147384792|NCT01587703|531571790|FG013|Part2(Median Exposure of 1.41 Months)|Death|21|||
147384793|NCT01587703|531571791|FG014|Part2(Median Exposure of 1.41 Months)|Death|16|||
147384794|NCT01587703|531571792|FG015|Part2(Median Exposure of 1.41 Months)|Death|17|||
147384795|NCT01587703|531571793|FG016|Part2(Median Exposure of 1.41 Months)|Death|5|||
147384796|NCT01587703|531571794|FG017|Part2(Median Exposure of 1.41 Months)|Death|0|||
147384797|NCT01587703|531571795|FG018|Part2(Median Exposure of 1.41 Months)|Death|0|||
147384798|NCT01587703|531571777|FG000|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
147384799|NCT01587703|531571778|FG001|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
147384800|NCT01587703|531571779|FG002|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
147384801|NCT01587703|531571780|FG003|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
147384802|NCT01587703|531571781|FG004|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
147384803|NCT01587703|531571782|FG005|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
147384804|NCT01587703|531571783|FG006|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
147384805|NCT01587703|531571784|FG007|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
147384806|NCT01587703|531571785|FG008|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
147384807|NCT01587703|531571786|FG009|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
147384808|NCT01587703|531571787|FG010|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
147384809|NCT01587703|531571788|FG011|Part2(Median Exposure of 1.41 Months)|Physician Decision|1|||
147384810|NCT01587703|531571789|FG012|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
147384811|NCT01587703|531571790|FG013|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
147384812|NCT01587703|531571791|FG014|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
147384813|NCT01587703|531571792|FG015|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
147384814|NCT01587703|531571793|FG016|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
147384815|NCT01587703|531571794|FG017|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
147384816|NCT01587703|531571795|FG018|Part2(Median Exposure of 1.41 Months)|Physician Decision|0|||
147384817|NCT00828139|531571796|FG000|Overall Study|Adverse Event|8|||
147384818|NCT00828139|531571797|FG001|Overall Study|Adverse Event|1|||
147384819|NCT00828139|531571798|FG002|Overall Study|Adverse Event|10|||
147384820|NCT00828139|531571799|FG003|Overall Study|Adverse Event|5|||
147384821|NCT00828139|531571796|FG000|Overall Study|Death|2|||
147384822|NCT00828139|531571797|FG001|Overall Study|Death|1|||
147384823|NCT00828139|531571798|FG002|Overall Study|Death|0|||
147384824|NCT00828139|531571799|FG003|Overall Study|Death|2|||
147384825|NCT00828139|531571796|FG000|Overall Study|Refusal unrelated to toxicity|3|||
147384826|NCT00828139|531571797|FG001|Overall Study|Refusal unrelated to toxicity|4|||
147384827|NCT00828139|531571798|FG002|Overall Study|Refusal unrelated to toxicity|5|||
147384828|NCT00828139|531571799|FG003|Overall Study|Refusal unrelated to toxicity|3|||
147384829|NCT00828139|531571796|FG000|Overall Study|Disease Progression|24|||
147384830|NCT00828139|531571797|FG001|Overall Study|Disease Progression|33|||
147384831|NCT00828139|531571798|FG002|Overall Study|Disease Progression|35|||
147384832|NCT00828139|531571799|FG003|Overall Study|Disease Progression|39|||
147384833|NCT00828139|531571796|FG000|Overall Study|Other|4|||
147384834|NCT00828139|531571797|FG001|Overall Study|Other|2|||
147384835|NCT00828139|531571798|FG002|Overall Study|Other|5|||
147384836|NCT00828139|531571799|FG003|Overall Study|Other|2|||
147384837|NCT01714947|531571800|FG000|Part B|Progressive Disease|3|||
147384838|NCT04751929|531571801|FG000|Overall Study|Withdrawal by Subject|2|||
147384839|NCT04751929|531571802|FG001|Overall Study|Withdrawal by Subject|0|||
147384840|NCT04751929|531571803|FG002|Overall Study|Withdrawal by Subject|0|||
147384841|NCT04751929|531571804|FG003|Overall Study|Withdrawal by Subject|0|||
147384842|NCT04751929|531571801|FG000|Overall Study|Rising PSA|0|||
147384843|NCT04751929|531571802|FG001|Overall Study|Rising PSA|1|||
147384844|NCT04751929|531571803|FG002|Overall Study|Rising PSA|0|||
147384845|NCT04751929|531571804|FG003|Overall Study|Rising PSA|0|||
147384846|NCT04751929|531571801|FG000|Overall Study|Adverse Event|1|||
147384847|NCT04751929|531571802|FG001|Overall Study|Adverse Event|2|||
147384848|NCT04751929|531571803|FG002|Overall Study|Adverse Event|0|||
147384849|NCT04751929|531571804|FG003|Overall Study|Adverse Event|0|||
147384850|NCT04751929|531571801|FG000|Overall Study|Progressive Disease|3|||
147384851|NCT04751929|531571802|FG001|Overall Study|Progressive Disease|4|||
147384852|NCT04751929|531571803|FG002|Overall Study|Progressive Disease|4|||
147384853|NCT04751929|531571804|FG003|Overall Study|Progressive Disease|0|||
147384854|NCT04751929|531571801|FG000|Overall Study|Death|1|||
147384855|NCT04751929|531571802|FG001|Overall Study|Death|1|||
147384856|NCT04751929|531571803|FG002|Overall Study|Death|0|||
147384857|NCT04751929|531571804|FG003|Overall Study|Death|0|||
147384858|NCT01123356|531571805|FG000|Overall Study|Adverse Event|2|||
147384859|NCT01123356|531571805|FG000|Overall Study|Lack of Efficacy|4|||
147384860|NCT01123356|531571805|FG000|Overall Study|Withdrawal by Subject|1|||
147384861|NCT00376259|531571808|FG000|Overall Study|Sponsor request - study termination|21|||
147384862|NCT00376259|531571809|FG001|Overall Study|Sponsor request - study termination|21|||
147384863|NCT00376259|531571808|FG000|Overall Study|Patient request|1|||
147384864|NCT00376259|531571809|FG001|Overall Study|Patient request|0|||
147384865|NCT00930644|531571811|FG000|Overall Study|Withdrawal by Subject|4|||
147384866|NCT00930644|531571811|FG000|Overall Study|Physician Decision|2|||
147384867|NCT00930644|531571811|FG000|Overall Study|Death|1|||
147384868|NCT00930644|531571811|FG000|Overall Study|Adverse Event|16|||
147384869|NCT01877720|531571812|FG000|Overall Study|Adverse Event|1|||
147384870|NCT01877720|531571813|FG001|Overall Study|Adverse Event|0|||
147384871|NCT02068352|531571816|FG000|Overall Study|Lost to Follow-up|0|||
147384872|NCT02068352|531571817|FG001|Overall Study|Lost to Follow-up|2|||
147384873|NCT02068352|531571818|FG002|Overall Study|Lost to Follow-up|0|||
147384874|NCT02068352|531571816|FG000|Overall Study|Adverse Event|4|||
147384875|NCT02068352|531571817|FG001|Overall Study|Adverse Event|2|||
147384876|NCT02068352|531571818|FG002|Overall Study|Adverse Event|7|||
147384877|NCT02068352|531571816|FG000|Overall Study|Participant met (Protocol Specified) Withdrawal Criteria|0|||
147384878|NCT02068352|531571817|FG001|Overall Study|Participant met (Protocol Specified) Withdrawal Criteria|1|||
147384879|NCT02068352|531571818|FG002|Overall Study|Participant met (Protocol Specified) Withdrawal Criteria|0|||
147384880|NCT02068352|531571816|FG000|Overall Study|Participant Withdrew Consent to Participate|6|||
147384881|NCT02068352|531571817|FG001|Overall Study|Participant Withdrew Consent to Participate|3|||
147456550|NCT00756938|531831762|FG002|Optional Extension|Protocol-specific criteria met|0|||
147456551|NCT00756938|531831763|FG003|Optional Extension|Protocol-specific criteria met|9|||
147384882|NCT02068352|531571818|FG002|Overall Study|Participant Withdrew Consent to Participate|1|||
147384883|NCT02068352|531571816|FG000|Overall Study|Protocol Deviation|0|||
147456552|NCT00756938|531831760|FG000|Optional Extension|Physician Decision|0|||
147456553|NCT00756938|531831761|FG001|Optional Extension|Physician Decision|0|||
147456554|NCT00756938|531831762|FG002|Optional Extension|Physician Decision|0|||
147456555|NCT00756938|531831763|FG003|Optional Extension|Physician Decision|3|||
147456556|NCT00756938|531831760|FG000|Optional Extension|Lost to Follow-up|0|||
147614771|NCT02565511|532404847|FG002|Overall Study|Lost to Follow-up|0|||
147614772|NCT02565511|532404848|FG003|Overall Study|Lost to Follow-up|1|||
147614773|NCT02565511|532404845|FG000|Overall Study|Physician Decision|0|||
147614774|NCT02565511|532404846|FG001|Overall Study|Physician Decision|0|||
147614775|NCT02565511|532404847|FG002|Overall Study|Physician Decision|0|||
147614776|NCT02565511|532404848|FG003|Overall Study|Physician Decision|1|||
147614777|NCT02565511|532404845|FG000|Overall Study|Protocol deviation|0|||
147614778|NCT02565511|532404846|FG001|Overall Study|Protocol deviation|0|||
147614779|NCT02565511|532404847|FG002|Overall Study|Protocol deviation|3|||
147614780|NCT02565511|532404848|FG003|Overall Study|Protocol deviation|0|||
147614781|NCT01137071|532404849|FG000|Overall Study|Disease Progression|11|||
147614782|NCT01137071|532404849|FG000|Overall Study|Withdrawal by Subject|2|||
147614783|NCT01137071|532404849|FG000|Overall Study|Wrongly Included|1|||
147614784|NCT04807400|532404850|FG000|Overall Study|Adverse Event|2|||
147614785|NCT04807400|532404851|FG001|Overall Study|Adverse Event|3|||
147614786|NCT04807400|532404852|FG002|Overall Study|Adverse Event|3|||
147614787|NCT04807400|532404850|FG000|Overall Study|Death|2|||
147614788|NCT04807400|532404851|FG001|Overall Study|Death|0|||
147614789|NCT04807400|532404852|FG002|Overall Study|Death|0|||
147614790|NCT04807400|532404850|FG000|Overall Study|Lost to Follow-up|8|||
147614791|NCT04807400|532404851|FG001|Overall Study|Lost to Follow-up|6|||
147614792|NCT04807400|532404852|FG002|Overall Study|Lost to Follow-up|6|||
147614793|NCT04807400|532404850|FG000|Overall Study|Non-Compliance With Study Drug|0|||
147614794|NCT04807400|532404851|FG001|Overall Study|Non-Compliance With Study Drug|4|||
147614795|NCT04807400|532404852|FG002|Overall Study|Non-Compliance With Study Drug|1|||
147614796|NCT04807400|532404850|FG000|Overall Study|Participant Decision|20|||
147614797|NCT04807400|532404851|FG001|Overall Study|Participant Decision|19|||
147614798|NCT04807400|532404852|FG002|Overall Study|Participant Decision|26|||
147614799|NCT04807400|532404850|FG000|Overall Study|Physician Decision|0|||
147614800|NCT04807400|532404851|FG001|Overall Study|Physician Decision|1|||
147614801|NCT04807400|532404852|FG002|Overall Study|Physician Decision|0|||
147614802|NCT04807400|532404850|FG000|Overall Study|Protocol Violation|4|||
147614803|NCT04807400|532404851|FG001|Overall Study|Protocol Violation|3|||
147614804|NCT04807400|532404852|FG002|Overall Study|Protocol Violation|7|||
147614805|NCT04807400|532404850|FG000|Overall Study|Withdrawal by Subject|13|||
147614806|NCT04807400|532404851|FG001|Overall Study|Withdrawal by Subject|9|||
147614807|NCT04807400|532404852|FG002|Overall Study|Withdrawal by Subject|20|||
147614808|NCT04807400|532404850|FG000|Overall Study|Mis-randomized|1|||
147614809|NCT04807400|532404851|FG001|Overall Study|Mis-randomized|0|||
147614810|NCT04807400|532404852|FG002|Overall Study|Mis-randomized|0|||
147614811|NCT03656744|532404853|FG000|Overall Study|Adverse Event|1|||
147614812|NCT03656744|532404854|FG001|Overall Study|Adverse Event|4|||
147614813|NCT03656744|532404855|FG002|Overall Study|Adverse Event|1|||
147614814|NCT03656744|532404853|FG000|Overall Study|Protocol Violation|1|||
147614815|NCT03656744|532404854|FG001|Overall Study|Protocol Violation|0|||
147614816|NCT03656744|532404855|FG002|Overall Study|Protocol Violation|0|||
147614817|NCT03656744|532404853|FG000|Overall Study|Lost to Follow-up|2|||
147614818|NCT03656744|532404854|FG001|Overall Study|Lost to Follow-up|2|||
147614819|NCT03656744|532404855|FG002|Overall Study|Lost to Follow-up|0|||
147614820|NCT03656744|532404853|FG000|Overall Study|Withdrawal by Subject|0|||
147614821|NCT03656744|532404854|FG001|Overall Study|Withdrawal by Subject|1|||
147614822|NCT03656744|532404855|FG002|Overall Study|Withdrawal by Subject|0|||
147614823|NCT03656744|532404853|FG000|Overall Study|Randomized in error. Did not start investigational product. Considered an ET.|1|||
147614824|NCT03656744|532404854|FG001|Overall Study|Randomized in error. Did not start investigational product. Considered an ET.|0|||
147614825|NCT03656744|532404855|FG002|Overall Study|Randomized in error. Did not start investigational product. Considered an ET.|0|||
147614826|NCT01332292|532404859|FG000|Treatment Period 1 (14 Days)|Adverse Event|1|||
147614827|NCT01332292|532404860|FG001|Treatment Period 1 (14 Days)|Adverse Event|0|||
147614828|NCT01332292|532404859|FG000|Treatment Period 1 (14 Days)|Protocol Violation|1|||
147614829|NCT01332292|532404860|FG001|Treatment Period 1 (14 Days)|Protocol Violation|1|||
147614830|NCT01332292|532404859|FG000|Treatment Period 2 (14 Days)|Physician Decision|1|||
147614831|NCT01332292|532404860|FG001|Treatment Period 2 (14 Days)|Physician Decision|1|||
147614832|NCT03910673|532404862|FG000|Overall Study|Adverse Event|0|||
147664913|NCT01573000|532597954|FG001|Crossover Phase|Lack of Efficacy|13|||
147614833|NCT03910673|532404863|FG001|Overall Study|Adverse Event|0|||
147614834|NCT03910673|532404864|FG002|Overall Study|Adverse Event|0|||
147614835|NCT03910673|532404865|FG003|Overall Study|Adverse Event|2|||
147664914|NCT01573000|532597953|FG000|Crossover Phase|Lost to Follow-up|0|||
147664915|NCT01573000|532597954|FG001|Crossover Phase|Lost to Follow-up|2|||
147664916|NCT01573000|532597953|FG000|Crossover Phase|Death|0|||
147614836|NCT03910673|532404866|FG004|Overall Study|Adverse Event|0|||
147614837|NCT00098774|532404867|FG000|Overall Study|Adverse Event|2|||
147614838|NCT00098774|532404867|FG000|Overall Study|Disease Progression|9|||
147614839|NCT00098774|532404867|FG000|Overall Study|Withdrawal by Subject|1|||
147614840|NCT00098774|532404867|FG000|Overall Study|Failed (to respond) during induction|4|||
147614841|NCT00098774|532404867|FG000|Overall Study|Physician Decision|2|||
147614842|NCT00796757|532404868|FG000|Overall Study|Withdrawal by Subject|14|||
147664917|NCT01573000|532597954|FG001|Crossover Phase|Death|3|||
147614843|NCT00796757|532404868|FG000|Overall Study|Death|61|||
147614844|NCT00796757|532404868|FG000|Overall Study|Protocol Violation|1|||
147614845|NCT00796757|532404868|FG000|Overall Study|Participant noncompliance|1|||
147614846|NCT00796757|532404868|FG000|Overall Study|Investigator's decision|2|||
147614847|NCT00796757|532404868|FG000|Overall Study|Other|7|||
147614848|NCT03142191|532404869|FG000|Placebo Controlled Period|Death|0|||
147614849|NCT03142191|532404870|FG001|Placebo Controlled Period|Death|1|||
147614850|NCT03142191|532404871|FG002|Placebo Controlled Period|Death|1|||
147614851|NCT03142191|532404872|FG003|Placebo Controlled Period|Death|0|||
147614852|NCT03142191|532404873|FG004|Placebo Controlled Period|Death|0|||
147614853|NCT03142191|532404869|FG000|Placebo Controlled Period|Adverse Event|4|||
147614854|NCT03142191|532404870|FG001|Placebo Controlled Period|Adverse Event|5|||
147614855|NCT03142191|532404871|FG002|Placebo Controlled Period|Adverse Event|1|||
147614856|NCT03142191|532404872|FG003|Placebo Controlled Period|Adverse Event|0|||
147614857|NCT03142191|532404873|FG004|Placebo Controlled Period|Adverse Event|0|||
147614858|NCT03142191|532404869|FG000|Placebo Controlled Period|Progressive Disease|1|||
147614859|NCT03142191|532404870|FG001|Placebo Controlled Period|Progressive Disease|0|||
147614860|NCT03142191|532404871|FG002|Placebo Controlled Period|Progressive Disease|1|||
147614861|NCT03142191|532404872|FG003|Placebo Controlled Period|Progressive Disease|0|||
147614862|NCT03142191|532404873|FG004|Placebo Controlled Period|Progressive Disease|0|||
147614863|NCT03142191|532404869|FG000|Placebo Controlled Period|Withdrawal by participant|1|||
147614864|NCT03142191|532404870|FG001|Placebo Controlled Period|Withdrawal by participant|3|||
147614865|NCT03142191|532404871|FG002|Placebo Controlled Period|Withdrawal by participant|2|||
147614866|NCT03142191|532404872|FG003|Placebo Controlled Period|Withdrawal by participant|0|||
147614867|NCT03142191|532404873|FG004|Placebo Controlled Period|Withdrawal by participant|1|||
147614868|NCT03142191|532404869|FG000|Placebo Controlled Period|Other Reasons|1|||
147614869|NCT03142191|532404870|FG001|Placebo Controlled Period|Other Reasons|0|||
147614870|NCT03142191|532404871|FG002|Placebo Controlled Period|Other Reasons|0|||
147384884|NCT02068352|531571817|FG001|Overall Study|Protocol Deviation|0|||
147384885|NCT02068352|531571818|FG002|Overall Study|Protocol Deviation|1|||
147384886|NCT01129011|531571824|FG000|Overall Study|Adverse Event|20|||
147384887|NCT01129011|531571825|FG001|Overall Study|Adverse Event|30|||
147384888|NCT01129011|531571824|FG000|Overall Study|Withdrawal by Subject|24|||
147384889|NCT01129011|531571825|FG001|Overall Study|Withdrawal by Subject|8|||
147384890|NCT01129011|531571824|FG000|Overall Study|Lost to Follow-up|6|||
147384891|NCT01129011|531571825|FG001|Overall Study|Lost to Follow-up|7|||
147384892|NCT01129011|531571824|FG000|Overall Study|Duodenal Ulcer|2|||
147384893|NCT01129011|531571825|FG001|Overall Study|Duodenal Ulcer|8|||
147384894|NCT01129011|531571824|FG000|Overall Study|misc|7|||
147384895|NCT01129011|531571825|FG001|Overall Study|misc|4|||
147384896|NCT01012999|531571826|FG000|Overall Study|Protocol Violation|1|||
147384897|NCT03745651|531571827|FG000|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|1|||
147384898|NCT03745651|531571828|FG001|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|1|||
147384899|NCT03745651|531571829|FG002|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
147384900|NCT03745651|531571830|FG003|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
147384901|NCT03745651|531571831|FG004|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
147384902|NCT03745651|531571832|FG005|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
147384903|NCT03745651|531571833|FG006|Vehicle Control Period (Day 1 to Week 8)|Adverse Event|0|||
147384904|NCT03745651|531571827|FG000|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|3|||
147384905|NCT03745651|531571828|FG001|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|13|||
147384906|NCT03745651|531571829|FG002|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|4|||
147384907|NCT03745651|531571830|FG003|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
147384908|NCT03745651|531571831|FG004|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
147384909|NCT03745651|531571832|FG005|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
147384910|NCT03745651|531571833|FG006|Vehicle Control Period (Day 1 to Week 8)|Lost to Follow-up|0|||
147384911|NCT03745651|531571827|FG000|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|3|||
147384912|NCT03745651|531571828|FG001|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
147384913|NCT03745651|531571829|FG002|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|1|||
147614871|NCT03142191|532404872|FG003|Placebo Controlled Period|Other Reasons|0|||
147614872|NCT03142191|532404873|FG004|Placebo Controlled Period|Other Reasons|0|||
147614873|NCT03142191|532404869|FG000|Active Treatment Extension Period|Death|2|||
147614874|NCT03142191|532404870|FG001|Active Treatment Extension Period|Death|1|||
147614875|NCT03142191|532404871|FG002|Active Treatment Extension Period|Death|1|||
147614876|NCT03142191|532404872|FG003|Active Treatment Extension Period|Death|1|||
147614877|NCT03142191|532404873|FG004|Active Treatment Extension Period|Death|0|||
147384914|NCT03745651|531571830|FG003|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
147384915|NCT03745651|531571831|FG004|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
147614878|NCT03142191|532404869|FG000|Active Treatment Extension Period|Adverse Event|6|||
147614879|NCT03142191|532404870|FG001|Active Treatment Extension Period|Adverse Event|5|||
147614880|NCT03142191|532404871|FG002|Active Treatment Extension Period|Adverse Event|4|||
147664918|NCT01573000|532597953|FG000|Long-Term Follow-Up|Death|3|||
147384916|NCT03745651|531571832|FG005|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
147384917|NCT03745651|531571833|FG006|Vehicle Control Period (Day 1 to Week 8)|Physician Decision|0|||
147384918|NCT03745651|531571827|FG000|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
147384919|NCT03745651|531571828|FG001|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|2|||
147384920|NCT03745651|531571829|FG002|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
147384921|NCT03745651|531571830|FG003|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
147384922|NCT03745651|531571831|FG004|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
147384923|NCT03745651|531571832|FG005|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
147384924|NCT03745651|531571833|FG006|Vehicle Control Period (Day 1 to Week 8)|Protocol Violation|0|||
147384925|NCT03745651|531571827|FG000|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|11|||
147384926|NCT03745651|531571828|FG001|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|21|||
147384927|NCT03745651|531571829|FG002|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|15|||
147384928|NCT03745651|531571830|FG003|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
147384929|NCT03745651|531571831|FG004|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
147384930|NCT03745651|531571832|FG005|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
147384931|NCT03745651|531571833|FG006|Vehicle Control Period (Day 1 to Week 8)|Withdrawal by Subject|0|||
147384932|NCT03745651|531571827|FG000|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|1|||
147384933|NCT03745651|531571828|FG001|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|2|||
147384934|NCT03745651|531571829|FG002|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|2|||
147384935|NCT03745651|531571830|FG003|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|0|||
147384936|NCT03745651|531571831|FG004|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|0|||
147384937|NCT03745651|531571832|FG005|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|0|||
147384938|NCT03745651|531571833|FG006|Vehicle Control Period (Day 1 to Week 8)|Reason not Specified|0|||
147384939|NCT03745651|531571827|FG000|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
147384940|NCT03745651|531571828|FG001|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
147384941|NCT03745651|531571829|FG002|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
147384942|NCT03745651|531571830|FG003|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
147384943|NCT03745651|531571831|FG004|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
147384944|NCT03745651|531571832|FG005|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|4|||
147384945|NCT03745651|531571833|FG006|Long-Term Safety Period (Weeks 8 to 52)|Adverse Event|0|||
147384946|NCT03745651|531571827|FG000|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
147384947|NCT03745651|531571828|FG001|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
147384948|NCT03745651|531571829|FG002|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
147384949|NCT03745651|531571830|FG003|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|1|||
147384950|NCT03745651|531571831|FG004|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|0|||
147384951|NCT03745651|531571832|FG005|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|4|||
147384952|NCT03745651|531571833|FG006|Long-Term Safety Period (Weeks 8 to 52)|Lack of Efficacy|4|||
147384953|NCT03745651|531571827|FG000|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
147384954|NCT03745651|531571828|FG001|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
147384955|NCT03745651|531571829|FG002|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|0|||
147384956|NCT03745651|531571830|FG003|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|4|||
147384957|NCT03745651|531571831|FG004|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|2|||
147384958|NCT03745651|531571832|FG005|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|13|||
147384959|NCT03745651|531571833|FG006|Long-Term Safety Period (Weeks 8 to 52)|Lost to Follow-up|10|||
147384960|NCT03745651|531571827|FG000|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
147384961|NCT03745651|531571828|FG001|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
147384962|NCT03745651|531571829|FG002|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
147384963|NCT03745651|531571830|FG003|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|1|||
147384964|NCT03745651|531571831|FG004|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|0|||
147384965|NCT03745651|531571832|FG005|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|4|||
147384966|NCT03745651|531571833|FG006|Long-Term Safety Period (Weeks 8 to 52)|Physician Decision|2|||
147384967|NCT03745651|531571827|FG000|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0|||
147384968|NCT03745651|531571828|FG001|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0|||
147384969|NCT03745651|531571829|FG002|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0|||
147384970|NCT03745651|531571830|FG003|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|1|||
147384971|NCT03745651|531571831|FG004|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0|||
147384972|NCT03745651|531571832|FG005|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|0|||
147384973|NCT03745651|531571833|FG006|Long-Term Safety Period (Weeks 8 to 52)|Pregnancy|1|||
147384974|NCT03745651|531571827|FG000|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
147384975|NCT03745651|531571828|FG001|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
147384976|NCT03745651|531571829|FG002|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
147384977|NCT03745651|531571830|FG003|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
147614881|NCT03142191|532404872|FG003|Active Treatment Extension Period|Adverse Event|1|||
147614882|NCT03142191|532404873|FG004|Active Treatment Extension Period|Adverse Event|0|||
147614883|NCT03142191|532404869|FG000|Active Treatment Extension Period|Progressive Disease|10|||
147384978|NCT03745651|531571831|FG004|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
147384979|NCT03745651|531571832|FG005|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|1|||
147384980|NCT03745651|531571833|FG006|Long-Term Safety Period (Weeks 8 to 52)|Protocol Violation|0|||
147384981|NCT03745651|531571827|FG000|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
147384982|NCT03745651|531571828|FG001|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
147384983|NCT03745651|531571829|FG002|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|0|||
147384984|NCT03745651|531571830|FG003|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|12|||
147384985|NCT03745651|531571831|FG004|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|8|||
147384986|NCT03745651|531571832|FG005|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|26|||
147384987|NCT03745651|531571833|FG006|Long-Term Safety Period (Weeks 8 to 52)|Withdrawal by Subject|34|||
147384988|NCT03745651|531571827|FG000|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|0|||
147384989|NCT03745651|531571828|FG001|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|0|||
147384990|NCT03745651|531571829|FG002|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|0|||
147384991|NCT03745651|531571830|FG003|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|1|||
147384992|NCT03745651|531571831|FG004|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|1|||
147384993|NCT03745651|531571832|FG005|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|1|||
147384994|NCT03745651|531571833|FG006|Long-Term Safety Period (Weeks 8 to 52)|Reason not Specified|0|||
147384995|NCT04175834|531571834|FG000|Overall Study|Withdrawal by Subject|1|||
147384996|NCT04175834|531571835|FG001|Overall Study|Withdrawal by Subject|0|||
147384997|NCT01322347|531571836|FG000|Overall Study|Adverse Event|7|||
147384998|NCT01322347|531571837|FG001|Overall Study|Adverse Event|2|||
147384999|NCT01322347|531571836|FG000|Overall Study|Death|5|||
147385000|NCT01322347|531571837|FG001|Overall Study|Death|3|||
147385001|NCT01322347|531571836|FG000|Overall Study|Physician Decision|2|||
147385002|NCT01322347|531571837|FG001|Overall Study|Physician Decision|1|||
147385003|NCT01322347|531571836|FG000|Overall Study|Protocol Violation|5|||
147385004|NCT01322347|531571837|FG001|Overall Study|Protocol Violation|2|||
147385005|NCT01322347|531571836|FG000|Overall Study|Withdrawal by Subject|1|||
147385006|NCT01322347|531571837|FG001|Overall Study|Withdrawal by Subject|4|||
147385007|NCT01322347|531571836|FG000|Overall Study|non-protocol change to ESA or IV iron|14|||
147385008|NCT01322347|531571837|FG001|Overall Study|non-protocol change to ESA or IV iron|6|||
147385009|NCT01322347|531571836|FG000|Overall Study|blood transfusion|5|||
147385010|NCT01322347|531571837|FG001|Overall Study|blood transfusion|5|||
147385011|NCT01322347|531571836|FG000|Overall Study|sponsor decision|1|||
147385012|NCT01322347|531571837|FG001|Overall Study|sponsor decision|3|||
147385013|NCT01322347|531571836|FG000|Overall Study|ineligible|6|||
147385014|NCT01322347|531571837|FG001|Overall Study|ineligible|3|||
147385015|NCT01322347|531571836|FG000|Overall Study|kidney transplant|3|||
147385016|NCT01322347|531571837|FG001|Overall Study|kidney transplant|1|||
147385017|NCT01322347|531571836|FG000|Overall Study|study drug withheld > 12 wks|0|||
147385018|NCT01322347|531571837|FG001|Overall Study|study drug withheld > 12 wks|1|||
147385019|NCT01322347|531571836|FG000|Overall Study|moved/changed dialysis|2|||
147385020|NCT01322347|531571837|FG001|Overall Study|moved/changed dialysis|4|||
147385021|NCT04883541|531571838|FG000|Overall Study|Not attending regular yoga class|16|||
147385022|NCT04883541|531571839|FG001|Overall Study|Not attending regular yoga class|0|||
147385023|NCT04883541|531571838|FG000|Overall Study|Not attending the pregnancy school|0|||
147385024|NCT04883541|531571839|FG001|Overall Study|Not attending the pregnancy school|9|||
147385025|NCT01369147|531571840|FG000|Overall Study|All collected data were unintentionally destroyed|0|||
147385026|NCT01369147|531571841|FG001|Overall Study|All collected data were unintentionally destroyed|1|||
147385027|NCT01369147|531571842|FG002|Overall Study|All collected data were unintentionally destroyed|0|||
147385028|NCT02823574|531571843|FG000|Randomization|Disease Progression|0|||
147385029|NCT02823574|531571844|FG001|Randomization|Disease Progression|0|||
147385030|NCT02823574|531571845|FG002|Randomization|Disease Progression|1|||
147385031|NCT02823574|531571846|FG003|Randomization|Disease Progression|0|||
147385032|NCT02823574|531571843|FG000|Randomization|AE unrelated to Study Drug|1|||
147385033|NCT02823574|531571844|FG001|Randomization|AE unrelated to Study Drug|0|||
147385034|NCT02823574|531571845|FG002|Randomization|AE unrelated to Study Drug|0|||
147385035|NCT02823574|531571846|FG003|Randomization|AE unrelated to Study Drug|0|||
147385036|NCT02823574|531571843|FG000|Treatment Period|Poor/Non Compliance|1|||
147385037|NCT02823574|531571844|FG001|Treatment Period|Poor/Non Compliance|0|||
147385038|NCT02823574|531571845|FG002|Treatment Period|Poor/Non Compliance|0|||
147385039|NCT02823574|531571846|FG003|Treatment Period|Poor/Non Compliance|1|||
147385040|NCT02823574|531571843|FG000|Treatment Period|Maximum Clinical Benefit|8|||
147385041|NCT02823574|531571844|FG001|Treatment Period|Maximum Clinical Benefit|4|||
147385042|NCT02823574|531571845|FG002|Treatment Period|Maximum Clinical Benefit|7|||
147385043|NCT02823574|531571846|FG003|Treatment Period|Maximum Clinical Benefit|1|||
147385044|NCT02823574|531571843|FG000|Treatment Period|Lost to Follow-up|1|||
147385045|NCT02823574|531571844|FG001|Treatment Period|Lost to Follow-up|1|||
147385046|NCT02823574|531571845|FG002|Treatment Period|Lost to Follow-up|0|||
147385047|NCT02823574|531571846|FG003|Treatment Period|Lost to Follow-up|0|||
147664919|NCT01573000|532597954|FG001|Long-Term Follow-Up|Death|0|||
147385048|NCT02823574|531571843|FG000|Treatment Period|Participant withdrew consent|4|||
147614884|NCT03142191|532404870|FG001|Active Treatment Extension Period|Progressive Disease|5|||
147385049|NCT02823574|531571844|FG001|Treatment Period|Participant withdrew consent|0|||
147385050|NCT02823574|531571845|FG002|Treatment Period|Participant withdrew consent|0|||
147385051|NCT02823574|531571846|FG003|Treatment Period|Participant withdrew consent|1|||
147385052|NCT02823574|531571843|FG000|Treatment Period|Participant request to discontinue|5|||
147385053|NCT02823574|531571844|FG001|Treatment Period|Participant request to discontinue|0|||
147385054|NCT02823574|531571845|FG002|Treatment Period|Participant request to discontinue|3|||
147385055|NCT02823574|531571846|FG003|Treatment Period|Participant request to discontinue|2|||
147385056|NCT02823574|531571843|FG000|Treatment Period|Adverse Event unrelated to to study Drug|10|||
147385057|NCT02823574|531571844|FG001|Treatment Period|Adverse Event unrelated to to study Drug|2|||
147385058|NCT02823574|531571845|FG002|Treatment Period|Adverse Event unrelated to to study Drug|9|||
147385059|NCT02823574|531571846|FG003|Treatment Period|Adverse Event unrelated to to study Drug|2|||
147385060|NCT02823574|531571843|FG000|Treatment Period|Study Drug Toxicity|11|||
147385061|NCT02823574|531571844|FG001|Treatment Period|Study Drug Toxicity|2|||
147385062|NCT02823574|531571845|FG002|Treatment Period|Study Drug Toxicity|14|||
147385063|NCT02823574|531571846|FG003|Treatment Period|Study Drug Toxicity|4|||
147385064|NCT02823574|531571843|FG000|Treatment Period|Disease Progression|113|||
147385065|NCT02823574|531571844|FG001|Treatment Period|Disease Progression|64|||
147385066|NCT02823574|531571845|FG002|Treatment Period|Disease Progression|82|||
147385067|NCT02823574|531571846|FG003|Treatment Period|Disease Progression|43|||
147385068|NCT02823574|531571843|FG000|Treatment Period|Other reasons|5|||
147385069|NCT02823574|531571844|FG001|Treatment Period|Other reasons|9|||
147385070|NCT02823574|531571845|FG002|Treatment Period|Other reasons|3|||
147385071|NCT02823574|531571846|FG003|Treatment Period|Other reasons|6|||
147385072|NCT02823574|531571843|FG000|Treatment Period|Participant no longer meets study criteria|0|||
147385073|NCT02823574|531571844|FG001|Treatment Period|Participant no longer meets study criteria|0|||
147385074|NCT02823574|531571845|FG002|Treatment Period|Participant no longer meets study criteria|1|||
147385075|NCT02823574|531571846|FG003|Treatment Period|Participant no longer meets study criteria|0|||
147385076|NCT02823574|531571843|FG000|Treatment Period|Death|0|||
147385077|NCT02823574|531571844|FG001|Treatment Period|Death|0|||
147385078|NCT02823574|531571845|FG002|Treatment Period|Death|3|||
147385079|NCT02823574|531571846|FG003|Treatment Period|Death|1|||
147385080|NCT00590759|531571847|FG000|Overall Study|Death|52|||
147385081|NCT00590759|531571847|FG000|Overall Study|Lost to Follow-up|28|||
147385082|NCT02542696|531571852|FG000|Overall Study|Adverse Event|167|||
147385083|NCT02542696|531571852|FG000|Overall Study|Lack of Efficacy|26|||
147385084|NCT02542696|531571852|FG000|Overall Study|Lost to Follow-up|6|||
147385085|NCT02542696|531571852|FG000|Overall Study|Withdrawal by Subject|104|||
147385086|NCT02542696|531571852|FG000|Overall Study|Protocol Violation|5|||
147385087|NCT02542696|531571852|FG000|Overall Study|Death|8|||
147385088|NCT02542696|531571852|FG000|Overall Study|DECREASED OFF TIME|1|||
147385089|NCT02542696|531571852|FG000|Overall Study|DID NOT MEET CRITERIA FOR CONTINUATION|1|||
147385090|NCT02542696|531571852|FG000|Overall Study|ELIGIBILITY CRITERIA NOT MET|8|||
147385091|NCT02542696|531571852|FG000|Overall Study|MEDICAL HISTORY|1|||
147385092|NCT02542696|531571852|FG000|Overall Study|"PATIENT WITHDRAWN DURING TITRATION AS COULD NOT TITRATE DRUG TO GET RESPONSE OF ON FROM PATIENT"|1|||
147385093|NCT02542696|531571852|FG000|Overall Study|PROGRESSION OF PARKINSON'S DISEASE|5|||
147385094|NCT02542696|531571852|FG000|Overall Study|SITE UNABLE TO COMPLY WITH PROTOCOL|2|||
147385095|NCT02542696|531571852|FG000|Overall Study|SPONSOR DECISION|3|||
147385096|NCT02542696|531571852|FG000|Overall Study|STUDY TERMINATED BY SPONSOR|36|||
147385097|NCT02542696|531571852|FG000|Overall Study|SUBJECT DECISION|2|||
147385098|NCT02410278|531571853|FG000|Run-in Period|Adverse Event|5|||
147385099|NCT02410278|531571854|FG001|Run-in Period|Adverse Event|0|||
147385100|NCT02410278|531571855|FG002|Run-in Period|Adverse Event|0|||
147614885|NCT03142191|532404871|FG002|Active Treatment Extension Period|Progressive Disease|4|||
147614886|NCT03142191|532404872|FG003|Active Treatment Extension Period|Progressive Disease|1|||
147614887|NCT03142191|532404873|FG004|Active Treatment Extension Period|Progressive Disease|2|||
147614888|NCT03142191|532404869|FG000|Active Treatment Extension Period|Withdrawal by participant|2|||
147614889|NCT03142191|532404870|FG001|Active Treatment Extension Period|Withdrawal by participant|0|||
147614890|NCT03142191|532404871|FG002|Active Treatment Extension Period|Withdrawal by participant|3|||
147614891|NCT03142191|532404872|FG003|Active Treatment Extension Period|Withdrawal by participant|1|||
147614892|NCT03142191|532404873|FG004|Active Treatment Extension Period|Withdrawal by participant|1|||
147614893|NCT03142191|532404869|FG000|Active Treatment Extension Period|Physician Decision|2|||
147614894|NCT03142191|532404870|FG001|Active Treatment Extension Period|Physician Decision|0|||
147614895|NCT03142191|532404871|FG002|Active Treatment Extension Period|Physician Decision|0|||
147385101|NCT02410278|531571853|FG000|Run-in Period|GSRS Threshold Not Met|30|||
147385102|NCT02410278|531571854|FG001|Run-in Period|GSRS Threshold Not Met|0|||
147385103|NCT02410278|531571855|FG002|Run-in Period|GSRS Threshold Not Met|0|||
147385104|NCT02410278|531571853|FG000|Run-in Period|Lost to Follow-up|1|||
147385105|NCT02410278|531571854|FG001|Run-in Period|Lost to Follow-up|0|||
147385106|NCT02410278|531571855|FG002|Run-in Period|Lost to Follow-up|0|||
147385107|NCT02410278|531571853|FG000|Run-in Period|Withdrawal by Subject|1|||
147385108|NCT02410278|531571854|FG001|Run-in Period|Withdrawal by Subject|0|||
147385109|NCT02410278|531571855|FG002|Run-in Period|Withdrawal by Subject|0|||
147614896|NCT03142191|532404872|FG003|Active Treatment Extension Period|Physician Decision|0|||
147614897|NCT03142191|532404873|FG004|Active Treatment Extension Period|Physician Decision|0|||
147614898|NCT03142191|532404869|FG000|Active Treatment Extension Period|Other Reasons|3|||
147614899|NCT03142191|532404870|FG001|Active Treatment Extension Period|Other Reasons|3|||
147614900|NCT03142191|532404871|FG002|Active Treatment Extension Period|Other Reasons|3|||
147614901|NCT03142191|532404872|FG003|Active Treatment Extension Period|Other Reasons|8|||
147614902|NCT03142191|532404873|FG004|Active Treatment Extension Period|Other Reasons|3|||
147456557|NCT00756938|531831761|FG001|Optional Extension|Lost to Follow-up|0|||
147456558|NCT00756938|531831762|FG002|Optional Extension|Lost to Follow-up|0|||
147456559|NCT00756938|531831763|FG003|Optional Extension|Lost to Follow-up|1|||
147456560|NCT00756938|531831760|FG000|Optional Extension|Protocol Violation|0|||
147456561|NCT00756938|531831761|FG001|Optional Extension|Protocol Violation|0|||
147614903|NCT03142191|532404869|FG000|Active Treatment Extension Period|Unknown, participant missing|1|||
147614904|NCT03142191|532404870|FG001|Active Treatment Extension Period|Unknown, participant missing|0|||
147614905|NCT03142191|532404871|FG002|Active Treatment Extension Period|Unknown, participant missing|0|||
147614906|NCT03142191|532404872|FG003|Active Treatment Extension Period|Unknown, participant missing|0|||
147614907|NCT03142191|532404873|FG004|Active Treatment Extension Period|Unknown, participant missing|0|||
147614908|NCT01130493|532404878|FG000|Open-label Dose Conversion to IPX066|Adverse Event|1|||
147614909|NCT01130493|532404879|FG001|Open-label Dose Conversion to IPX066|Adverse Event|0|||
147614910|NCT01130493|532404880|FG002|Open-label Dose Conversion to IPX066|Adverse Event|0|||
147614911|NCT01130493|532404878|FG000|Open-label Dose Conversion to IPX066|Protocol Violation|3|||
147614912|NCT01130493|532404879|FG001|Open-label Dose Conversion to IPX066|Protocol Violation|0|||
147614913|NCT01130493|532404880|FG002|Open-label Dose Conversion to IPX066|Protocol Violation|0|||
147614914|NCT01130493|532404878|FG000|Open-label Dose Conversion to IPX066|Lack of Efficacy|7|||
147614915|NCT01130493|532404879|FG001|Open-label Dose Conversion to IPX066|Lack of Efficacy|0|||
147614916|NCT01130493|532404880|FG002|Open-label Dose Conversion to IPX066|Lack of Efficacy|0|||
147614917|NCT01130493|532404878|FG000|Open-label Dose Conversion to IPX066|Withdrawal by Subject|7|||
147614918|NCT01130493|532404879|FG001|Open-label Dose Conversion to IPX066|Withdrawal by Subject|0|||
147614919|NCT01130493|532404880|FG002|Open-label Dose Conversion to IPX066|Withdrawal by Subject|0|||
147614920|NCT01130493|532404878|FG000|Open-label Dose Conversion to IPX066|Diary imcomplete|1|||
147614921|NCT01130493|532404879|FG001|Open-label Dose Conversion to IPX066|Diary imcomplete|0|||
147614922|NCT01130493|532404880|FG002|Open-label Dose Conversion to IPX066|Diary imcomplete|0|||
147614923|NCT01130493|532404878|FG000|Part 1: Double-blind Treatment Period 1|Protocol Violation|0|||
147664920|NCT01573000|532597953|FG000|Long-Term Follow-Up|Lost to Follow-up|0|||
147385110|NCT02410278|531571853|FG000|Run-in Period|Pregnancy|1|||
147385111|NCT02410278|531571854|FG001|Run-in Period|Pregnancy|0|||
147385112|NCT02410278|531571855|FG002|Run-in Period|Pregnancy|0|||
147385113|NCT02410278|531571853|FG000|Study Treatment Period|Adverse Event|0|||
147385114|NCT02410278|531571854|FG001|Study Treatment Period|Adverse Event|6|||
147385115|NCT02410278|531571855|FG002|Study Treatment Period|Adverse Event|3|||
147385116|NCT02410278|531571853|FG000|Study Treatment Period|Physician Decision|0|||
147385117|NCT02410278|531571854|FG001|Study Treatment Period|Physician Decision|0|||
147385118|NCT02410278|531571855|FG002|Study Treatment Period|Physician Decision|1|||
147385119|NCT02410278|531571853|FG000|Study Treatment Period|Withdrawal by Subject|0|||
147385120|NCT02410278|531571854|FG001|Study Treatment Period|Withdrawal by Subject|1|||
147385121|NCT02410278|531571855|FG002|Study Treatment Period|Withdrawal by Subject|0|||
147385122|NCT02410278|531571853|FG000|Study Treatment Period|Other|0|||
147385123|NCT02410278|531571854|FG001|Study Treatment Period|Other|3|||
147385124|NCT02410278|531571855|FG002|Study Treatment Period|Other|0|||
147385125|NCT02410278|531571853|FG000|Study Treatment Period|GSRS Threshold Not Met|0|||
147385126|NCT02410278|531571854|FG001|Study Treatment Period|GSRS Threshold Not Met|1|||
147385127|NCT02410278|531571855|FG002|Study Treatment Period|GSRS Threshold Not Met|0|||
147385128|NCT03693989|531571856|FG000|Overall Study|Protocol Violation|3|||
147385129|NCT03693989|531571857|FG001|Overall Study|Protocol Violation|4|||
147385130|NCT01190436|531571858|FG000|Overall Study|Lost to Follow-up|35|||
147385131|NCT01190436|531571858|FG000|Overall Study|Other|4|||
147385132|NCT00113529|531571859|FG000|Overall Study|Adverse Event|4|||
147385133|NCT00113529|531571859|FG000|Overall Study|Lack of Efficacy|20|||
147385134|NCT00113529|531571859|FG000|Overall Study|Decision of sponsor|6|||
147385135|NCT00113529|531571859|FG000|Overall Study|Withdrawal by Subject|4|||
147385136|NCT00648895|531571860|FG000|Overall Study|Lack of Efficacy|0|||
147385137|NCT00648895|531571861|FG001|Overall Study|Lack of Efficacy|1|||
147385138|NCT01077284|531571862|FG000|Overall Study|Adverse Event|2|||
147385139|NCT01077284|531571863|FG001|Overall Study|Adverse Event|0|||
147385140|NCT01077284|531571864|FG002|Overall Study|Adverse Event|1|||
147385141|NCT01077284|531571862|FG000|Overall Study|Lost to Follow-up|1|||
147385142|NCT01077284|531571863|FG001|Overall Study|Lost to Follow-up|2|||
147385143|NCT01077284|531571864|FG002|Overall Study|Lost to Follow-up|0|||
147385144|NCT01077284|531571862|FG000|Overall Study|Withdrawal by Subject|2|||
147456562|NCT00756938|531831762|FG002|Optional Extension|Protocol Violation|0|||
147456563|NCT00756938|531831763|FG003|Optional Extension|Protocol Violation|1|||
147614924|NCT01130493|532404879|FG001|Part 1: Double-blind Treatment Period 1|Protocol Violation|1|||
147614925|NCT01130493|532404880|FG002|Part 1: Double-blind Treatment Period 1|Protocol Violation|0|||
147614926|NCT01130493|532404878|FG000|Part 1: Double-blind Treatment Period 1|Lack of Efficacy|0|||
147614927|NCT01130493|532404879|FG001|Part 1: Double-blind Treatment Period 1|Lack of Efficacy|1|||
147614928|NCT01130493|532404880|FG002|Part 1: Double-blind Treatment Period 1|Lack of Efficacy|0|||
147614929|NCT01130493|532404878|FG000|Part 1: Open-Label IPX066 Washout|Lack of Efficacy|0|||
147614930|NCT01130493|532404879|FG001|Part 1: Open-Label IPX066 Washout|Lack of Efficacy|1|||
147614931|NCT01130493|532404880|FG002|Part 1: Open-Label IPX066 Washout|Lack of Efficacy|0|||
147614932|NCT01130493|532404878|FG000|Part 1: Open-Label IPX066 Washout|Adverse Event|0|||
147614933|NCT01130493|532404879|FG001|Part 1: Open-Label IPX066 Washout|Adverse Event|0|||
147614934|NCT01130493|532404880|FG002|Part 1: Open-Label IPX066 Washout|Adverse Event|1|||
147614935|NCT01130493|532404878|FG000|Part 1: Open-Label IPX066 Washout|Withdrawal by Subject|0|||
147614936|NCT01130493|532404879|FG001|Part 1: Open-Label IPX066 Washout|Withdrawal by Subject|0|||
147614937|NCT01130493|532404880|FG002|Part 1: Open-Label IPX066 Washout|Withdrawal by Subject|1|||
147614938|NCT01130493|532404878|FG000|Part 1: Double-blind Treatment Period 2|Withdrawal by Subject|0|||
147614939|NCT01130493|532404879|FG001|Part 1: Double-blind Treatment Period 2|Withdrawal by Subject|0|||
147614940|NCT01130493|532404880|FG002|Part 1: Double-blind Treatment Period 2|Withdrawal by Subject|1|||
147614941|NCT01130493|532404878|FG000|Part 1: Double-blind Treatment Period 2|Noncompliance|0|||
147614942|NCT01130493|532404879|FG001|Part 1: Double-blind Treatment Period 2|Noncompliance|0|||
147614943|NCT01130493|532404880|FG002|Part 1: Double-blind Treatment Period 2|Noncompliance|1|||
147614944|NCT01130493|532404878|FG000|Part 2: OLE|Adverse Event|0|||
147614945|NCT01130493|532404879|FG001|Part 2: OLE|Adverse Event|2|||
147614946|NCT01130493|532404880|FG002|Part 2: OLE|Adverse Event|1|||
147614947|NCT01130493|532404878|FG000|Part 2: OLE|Withdrawal by Subject|0|||
147614948|NCT01130493|532404879|FG001|Part 2: OLE|Withdrawal by Subject|1|||
147614949|NCT01130493|532404880|FG002|Part 2: OLE|Withdrawal by Subject|4|||
147614950|NCT02969044|532404883|FG000|Overall Study|Withdrawal by Subject|2|||
147614951|NCT02969044|532404884|FG001|Overall Study|Withdrawal by Subject|6|||
147614952|NCT02969044|532404883|FG000|Overall Study|Adverse Event|3|||
147614953|NCT02969044|532404884|FG001|Overall Study|Adverse Event|0|||
147614954|NCT00879086|532404885|FG000|Overall Study|Adverse Event|3|||
147614955|NCT00879086|532404886|FG001|Overall Study|Adverse Event|15|||
147614956|NCT00879086|532404885|FG000|Overall Study|Participant choice|2|||
147614957|NCT00879086|532404886|FG001|Overall Study|Participant choice|2|||
147614958|NCT00879086|532404885|FG000|Overall Study|Progression of disease|40|||
147614959|NCT00879086|532404886|FG001|Overall Study|Progression of disease|26|||
147614960|NCT00879086|532404885|FG000|Overall Study|Withdrawal of consent|2|||
147614961|NCT00879086|532404886|FG001|Overall Study|Withdrawal of consent|1|||
147614962|NCT00879086|532404885|FG000|Overall Study|Other|4|||
147614963|NCT00879086|532404886|FG001|Overall Study|Other|6|||
147614964|NCT00879086|532404885|FG000|Overall Study|Death|1|||
147614965|NCT00879086|532404886|FG001|Overall Study|Death|2|||
147614966|NCT04728802|532404887|FG000|Overall Study|Withdrawal by Subject|4|||
147614967|NCT04728802|532404888|FG001|Overall Study|Withdrawal by Subject|20|||
147614968|NCT04728802|532404887|FG000|Overall Study|Physician Decision|7|||
147614969|NCT04728802|532404888|FG001|Overall Study|Physician Decision|7|||
147385145|NCT01077284|531571863|FG001|Overall Study|Withdrawal by Subject|3|||
147385146|NCT01077284|531571864|FG002|Overall Study|Withdrawal by Subject|1|||
147385147|NCT01077284|531571862|FG000|Overall Study|Other|0|||
147385148|NCT01077284|531571863|FG001|Overall Study|Other|0|||
147385149|NCT01077284|531571864|FG002|Overall Study|Other|1|||
147385150|NCT04626128|531571865|FG000|Overall Study|Withdrawal by Subject|0|||
147614970|NCT04728802|532404887|FG000|Overall Study|Protocol Violation|10|||
147614971|NCT04728802|532404888|FG001|Overall Study|Protocol Violation|4|||
147614972|NCT04728802|532404887|FG000|Overall Study|Transfer|1|||
147614973|NCT04728802|532404888|FG001|Overall Study|Transfer|0|||
147614974|NCT04728802|532404887|FG000|Overall Study|Death|4|||
147614975|NCT04728802|532404888|FG001|Overall Study|Death|5|||
147614976|NCT04728802|532404887|FG000|Overall Study|Other|3|||
147614977|NCT04728802|532404888|FG001|Overall Study|Other|0|||
147614978|NCT04650204|532404889|FG000|Overall Study|Study was Terminated|2|||
147614979|NCT04650204|532404890|FG001|Overall Study|Study was Terminated|1|||
147614980|NCT01330303|532404891|FG000|Period 1|Adverse Event|1|||
147385151|NCT04626128|531571866|FG001|Overall Study|Withdrawal by Subject|1|||
147614981|NCT01330303|532404892|FG001|Period 1|Adverse Event|0|||
147614982|NCT01330303|532404891|FG000|Period 1|Protocol Violation|0|||
147614983|NCT01330303|532404892|FG001|Period 1|Protocol Violation|1|||
147614984|NCT01330303|532404891|FG000|Period 1|Withdrawal by Subject|0|||
147614985|NCT01330303|532404892|FG001|Period 1|Withdrawal by Subject|1|||
147614986|NCT02123446|532404894|FG000|Washout Period (1 Day)|Physician Decision|1|||
147614987|NCT02123446|532404895|FG001|Washout Period (1 Day)|Physician Decision|0|||
147614988|NCT04388553|532404896|FG000|Overall Study|Protocol Violation|1|||
147614989|NCT04388553|532404897|FG001|Overall Study|Protocol Violation|0|||
147614990|NCT01070953|532404902|FG000|Participants for Safety Evaluation|Violation of inclusion criteria|612|||
147614991|NCT01070953|532404902|FG000|Participants for Safety Evaluation|Off-label use|283|||
147614992|NCT01070953|532404902|FG000|Participants for Safety Evaluation|Duplicated participants|22|||
147385152|NCT04626128|531571867|FG002|Overall Study|Withdrawal by Subject|0|||
147385153|NCT04626128|531571868|FG003|Overall Study|Withdrawal by Subject|0|||
147385154|NCT00841321|531571869|FG000|Overall Study|Lost to Follow-up|1|||
147385155|NCT00841321|531571870|FG001|Overall Study|Lost to Follow-up|1|||
147385156|NCT00841321|531571869|FG000|Overall Study|Adverse Event|0|||
147385157|NCT00841321|531571870|FG001|Overall Study|Adverse Event|2|||
147385158|NCT02632747|531571873|FG000|Wash-out Period|Adverse Event|1|||
147385159|NCT02632747|531571874|FG001|Wash-out Period|Adverse Event|0|||
147385160|NCT00379210|531571875|FG000|Overall Study|Withdrawal by Subject|10|||
147385161|NCT00379210|531571876|FG001|Overall Study|Withdrawal by Subject|7|||
147385162|NCT03444155|531571877|FG000|First Intervention (6 Weeks)|Adverse Event|1|||
147385163|NCT03444155|531571878|FG001|First Intervention (6 Weeks)|Adverse Event|0|||
147385164|NCT02574286|531571879|FG000|Overall Study|Adverse Event|3|||
147385165|NCT02574286|531571879|FG000|Overall Study|Withdrawal by Subject|2|||
147385166|NCT03875729|531571880|FG000|Overall Study|Adverse Event|0|||
147385167|NCT03875729|531571881|FG001|Overall Study|Adverse Event|5|||
147385168|NCT03875729|531571880|FG000|Overall Study|Withdrawal by Subject|8|||
147385169|NCT03875729|531571881|FG001|Overall Study|Withdrawal by Subject|11|||
147385170|NCT03875729|531571880|FG000|Overall Study|Pregnancy|0|||
147385171|NCT03875729|531571881|FG001|Overall Study|Pregnancy|1|||
147385172|NCT03875729|531571880|FG000|Overall Study|Lost to Follow-up|0|||
147385173|NCT03875729|531571881|FG001|Overall Study|Lost to Follow-up|5|||
147385174|NCT03875729|531571880|FG000|Overall Study|Personal reasons|2|||
147385175|NCT03875729|531571881|FG001|Overall Study|Personal reasons|0|||
147385176|NCT04085614|531571884|FG000|Overall Study|Protocol Violation|9|||
147385177|NCT04085614|531571885|FG001|Overall Study|Protocol Violation|6|||
147385178|NCT00952523|531571886|FG000|Overall Study|Withdrawal by Subject|7|||
147385179|NCT01029925|531571887|FG000|Completion of Cycle 1 (28 Days)|Death|2|||
147385180|NCT01029925|531571887|FG000|Completion of Cycle 1 (28 Days)|Withdrawal by Subject|2|||
147385181|NCT01029925|531571887|FG000|Completion of Cycle 2 (56 Days)|off study due to disease progression|1|||
147385182|NCT05265247|531571888|FG000|Washout Period (7 Days)|Positive Result for Coronavirus (COVID)-19|1|||
147385183|NCT05265247|531571889|FG001|Washout Period (7 Days)|Positive Result for Coronavirus (COVID)-19|3|||
147385184|NCT05265247|531571888|FG000|Washout Period (7 Days)|Withdrawal by Subject|0|||
147385185|NCT05265247|531571889|FG001|Washout Period (7 Days)|Withdrawal by Subject|1|||
147385186|NCT05265247|531571888|FG000|Washout Period (7 Days)|Non-compliance with study requirements|3|||
147385187|NCT05265247|531571889|FG001|Washout Period (7 Days)|Non-compliance with study requirements|3|||
147385188|NCT02399449|531571890|FG000|Overall Study|Withdrawal by Subject|3|||
147385189|NCT02399449|531571891|FG001|Overall Study|Withdrawal by Subject|9|||
147385190|NCT02399449|531571890|FG000|Overall Study|Physician Decision|0|||
147385191|NCT02399449|531571891|FG001|Overall Study|Physician Decision|1|||
147385192|NCT02516202|531571892|FG000|Overall Study|Withdrawal by Subject|1|||
147385193|NCT02516202|531571893|FG001|Overall Study|Withdrawal by Subject|0|||
147385194|NCT02516202|531571894|FG002|Overall Study|Withdrawal by Subject|1|||
147385195|NCT02516202|531571892|FG000|Overall Study|Lost to Follow-up|1|||
147385196|NCT02516202|531571893|FG001|Overall Study|Lost to Follow-up|1|||
147385197|NCT02516202|531571894|FG002|Overall Study|Lost to Follow-up|1|||
147385198|NCT02516202|531571892|FG000|Overall Study|Stopped Follow-up|0|||
147385199|NCT02516202|531571893|FG001|Overall Study|Stopped Follow-up|0|||
147385200|NCT02516202|531571894|FG002|Overall Study|Stopped Follow-up|1|||
147385201|NCT00871715|531571895|FG000|Overall Study|Withdrawal by Subject|6|||
147385202|NCT00871715|531571896|FG001|Overall Study|Withdrawal by Subject|10|||
147385203|NCT00871715|531571897|FG002|Overall Study|Withdrawal by Subject|15|||
147385204|NCT00871715|531571895|FG000|Overall Study|Physician Decision|6|||
147385205|NCT00871715|531571896|FG001|Overall Study|Physician Decision|0|||
147385206|NCT00871715|531571897|FG002|Overall Study|Physician Decision|2|||
147385207|NCT00871715|531571895|FG000|Overall Study|Lost to Follow-up|3|||
147385208|NCT00871715|531571896|FG001|Overall Study|Lost to Follow-up|6|||
147385209|NCT00871715|531571897|FG002|Overall Study|Lost to Follow-up|9|||
147385210|NCT01794689|531571898|FG000|Intervention 1 (2 Nights)|Withdrawal by Subject|3|||
147385211|NCT01794689|531571899|FG001|Intervention 1 (2 Nights)|Withdrawal by Subject|0|||
147385212|NCT01794689|531571900|FG002|Intervention 1 (2 Nights)|Withdrawal by Subject|2|||
147385213|NCT01794689|531571901|FG003|Intervention 1 (2 Nights)|Withdrawal by Subject|4|||
147385214|NCT01794689|531571898|FG000|Intervention 1 (2 Nights)|Protocol Violation|1|||
147385215|NCT01794689|531571899|FG001|Intervention 1 (2 Nights)|Protocol Violation|0|||
147385216|NCT01794689|531571900|FG002|Intervention 1 (2 Nights)|Protocol Violation|1|||
147385217|NCT01794689|531571901|FG003|Intervention 1 (2 Nights)|Protocol Violation|0|||
147385218|NCT01794689|531571898|FG000|Intervention 1 (2 Nights)|Physician Decision|1|||
147385219|NCT01794689|531571899|FG001|Intervention 1 (2 Nights)|Physician Decision|1|||
147385220|NCT01794689|531571900|FG002|Intervention 1 (2 Nights)|Physician Decision|0|||
147385221|NCT01794689|531571901|FG003|Intervention 1 (2 Nights)|Physician Decision|0|||
147385222|NCT01794689|531571898|FG000|Intervention 1 (2 Nights)|Adverse Event|0|||
147385223|NCT01794689|531571899|FG001|Intervention 1 (2 Nights)|Adverse Event|1|||
147385224|NCT01794689|531571900|FG002|Intervention 1 (2 Nights)|Adverse Event|0|||
147385225|NCT01794689|531571901|FG003|Intervention 1 (2 Nights)|Adverse Event|0|||
147385226|NCT01697956|531571902|FG000|Overall Study|Protocol Violation|1|||
147385227|NCT01697956|531571903|FG001|Overall Study|Protocol Violation|1|||
147385228|NCT01964547|531571904|FG000|Overall Study|Adverse Event|8|||
147385229|NCT01964547|531571905|FG001|Overall Study|Adverse Event|2|||
147385230|NCT01964547|531571904|FG000|Overall Study|Withdrawal by Subject|4|||
147385231|NCT01964547|531571905|FG001|Overall Study|Withdrawal by Subject|7|||
147385232|NCT01964547|531571904|FG000|Overall Study|Lost to Follow-up|0|||
147385233|NCT01964547|531571905|FG001|Overall Study|Lost to Follow-up|1|||
147385234|NCT01964547|531571904|FG000|Overall Study|Withdrawal by Investigator|0|||
147385235|NCT01964547|531571905|FG001|Overall Study|Withdrawal by Investigator|1|||
147385236|NCT01115309|531571906|FG000|Procedure Safety (1-Month)|Lost to Follow-up|2|||
147385237|NCT01115309|531571906|FG000|Procedure Safety (1-Month)|Withdrawal by Subject|1|||
147385238|NCT01115309|531571906|FG000|Long-term Follow-up|Lost to Follow-up|6|||
147385239|NCT05700851|531571907|FG000|Overall Study|Received a kidney transplant|1|||
147385240|NCT05700851|531571907|FG000|Overall Study|Hospitalisation before starting baseline assessments|1|||
147385241|NCT05700851|531571907|FG000|Overall Study|Withdrawal by Subject|1|||
147385242|NCT03246724|531571908|FG000|Overall Study|Withdrawal by Subject|5|||
147385243|NCT03246724|531571909|FG001|Overall Study|Withdrawal by Subject|2|||
147385244|NCT03246724|531571910|FG002|Overall Study|Withdrawal by Subject|4|||
147385245|NCT03246724|531571911|FG003|Overall Study|Withdrawal by Subject|2|||
147385246|NCT03246724|531571908|FG000|Overall Study|Ineligible on day of surgery|7|||
147385247|NCT03246724|531571909|FG001|Overall Study|Ineligible on day of surgery|2|||
147385248|NCT03246724|531571910|FG002|Overall Study|Ineligible on day of surgery|0|||
147385249|NCT03246724|531571911|FG003|Overall Study|Ineligible on day of surgery|3|||
147385250|NCT03246724|531571908|FG000|Overall Study|Study completed before surgical date|2|||
147385251|NCT03246724|531571909|FG001|Overall Study|Study completed before surgical date|1|||
147385252|NCT03246724|531571910|FG002|Overall Study|Study completed before surgical date|8|||
147385253|NCT03246724|531571911|FG003|Overall Study|Study completed before surgical date|1|||
147385254|NCT03246724|531571908|FG000|Overall Study|Transferred to other arm|0|||
147385255|NCT03246724|531571909|FG001|Overall Study|Transferred to other arm|0|||
147385256|NCT03246724|531571910|FG002|Overall Study|Transferred to other arm|1|||
147385257|NCT03246724|531571911|FG003|Overall Study|Transferred to other arm|0|||
147385258|NCT03246724|531571908|FG000|Overall Study|Unable to obtain medication timely|0|||
147385259|NCT03246724|531571909|FG001|Overall Study|Unable to obtain medication timely|2|||
147385260|NCT03246724|531571910|FG002|Overall Study|Unable to obtain medication timely|2|||
147385261|NCT03246724|531571911|FG003|Overall Study|Unable to obtain medication timely|1|||
147385262|NCT03246724|531571908|FG000|Overall Study|Re-consented to participate|0|||
147385263|NCT03246724|531571909|FG001|Overall Study|Re-consented to participate|0|||
147385264|NCT03246724|531571910|FG002|Overall Study|Re-consented to participate|0|||
147385265|NCT03246724|531571911|FG003|Overall Study|Re-consented to participate|1|||
147385266|NCT02978716|531571912|FG000|Overall Study|Death|25|||
147385267|NCT02978716|531571913|FG001|Overall Study|Death|13|||
147385268|NCT02978716|531571914|FG002|Overall Study|Death|20|||
147385269|NCT02978716|531571912|FG000|Overall Study|Lost to Follow-up|0|||
147385270|NCT02978716|531571913|FG001|Overall Study|Lost to Follow-up|0|||
147385271|NCT02978716|531571914|FG002|Overall Study|Lost to Follow-up|1|||
147385272|NCT02978716|531571912|FG000|Overall Study|Withdrawal by Subject|6|||
147385273|NCT02978716|531571913|FG001|Overall Study|Withdrawal by Subject|4|||
147385274|NCT02978716|531571914|FG002|Overall Study|Withdrawal by Subject|5|||
147385275|NCT02978716|531571912|FG000|Overall Study|Sponsor terminated|2|||
147385276|NCT02978716|531571913|FG001|Overall Study|Sponsor terminated|13|||
147385277|NCT02978716|531571914|FG002|Overall Study|Sponsor terminated|9|||
147385278|NCT02978716|531571912|FG000|Overall Study|Other|1|||
147385279|NCT02978716|531571913|FG001|Overall Study|Other|3|||
147385280|NCT02978716|531571914|FG002|Overall Study|Other|0|||
147385281|NCT00589628|531571915|FG000|Overall Study|Lost to Follow-up|0|||
147385282|NCT00589628|531571916|FG001|Overall Study|Lost to Follow-up|1|||
147385283|NCT00689351|531571920|FG000|Infant Series of Dosing|Parent/legal guardian request|5|||
147385284|NCT00689351|531571921|FG001|Infant Series of Dosing|Parent/legal guardian request|0|||
147385285|NCT00689351|531571920|FG000|Infant Series of Dosing|Adverse Event|1|||
147385286|NCT00689351|531571921|FG001|Infant Series of Dosing|Adverse Event|0|||
147385287|NCT00689351|531571920|FG000|Infant Series of Dosing|Lost to Follow-up|0|||
147385288|NCT00689351|531571921|FG001|Infant Series of Dosing|Lost to Follow-up|1|||
147385289|NCT00689351|531571920|FG000|After Infant Series|Parent/legal guardian request|1|||
147385290|NCT00689351|531571921|FG001|After Infant Series|Parent/legal guardian request|0|||
147385291|NCT03075878|531571922|FG000|Overall Study|Physician Decision|1|||
147385292|NCT01986348|531571923|FG000|Overall Study|Death|8|||
147385293|NCT01986348|531571924|FG001|Overall Study|Death|22|||
147385294|NCT01986348|531571925|FG002|Overall Study|Death|10|||
147385295|NCT01986348|531571926|FG003|Overall Study|Death|21|||
147385296|NCT01986348|531571923|FG000|Overall Study|Lost to Follow-up|0|||
147385297|NCT01986348|531571924|FG001|Overall Study|Lost to Follow-up|0|||
147385298|NCT01986348|531571925|FG002|Overall Study|Lost to Follow-up|0|||
147385299|NCT01986348|531571926|FG003|Overall Study|Lost to Follow-up|2|||
147385300|NCT01986348|531571923|FG000|Overall Study|Physician Decision|0|||
147385301|NCT01986348|531571924|FG001|Overall Study|Physician Decision|0|||
147385302|NCT01986348|531571925|FG002|Overall Study|Physician Decision|0|||
147614993|NCT01070953|532404902|FG000|Participants for Safety Evaluation|Treatment prior to date of contract|8|||
147614994|NCT01070953|532404902|FG000|Participants for Safety Evaluation|Uncontracted participants|4|||
147614995|NCT01070953|532404902|FG000|Participants for Safety Evaluation|Violation of inclusions & off label use|1|||
147614996|NCT01070953|532404902|FG000|Participants for Safety Evaluation|Duplicated participants & off-label use|1|||
147614997|NCT01070953|532404902|FG000|Participants for Efficacy Evaluation|No efficacy evaluation|119|||
147614998|NCT01070953|532404902|FG000|Participants for Efficacy Evaluation|Lack of treatment period (<28 days)|106|||
147614999|NCT01070953|532404902|FG000|Participants for Efficacy Evaluation|Unknown date of efficacy evaluation|2|||
147615000|NCT01957176|532404903|FG000|Overall Study|Adverse Event|2|||
147615001|NCT01957176|532404904|FG001|Overall Study|Adverse Event|0|||
147615002|NCT01957176|532404903|FG000|Overall Study|Physician Decision|2|||
147615003|NCT01957176|532404904|FG001|Overall Study|Physician Decision|1|||
147615004|NCT01957176|532404903|FG000|Overall Study|Withdrawal by Subject|1|||
147615005|NCT01957176|532404904|FG001|Overall Study|Withdrawal by Subject|0|||
147615006|NCT00489827|532404906|FG000|Overall Study|Intraoperative exclusion criteria|1|||
147615007|NCT00489827|532404907|FG001|Overall Study|Intraoperative exclusion criteria|1|||
147615008|NCT00489827|532404906|FG000|Overall Study|Intraoperative exclusion criteria|1|||
147615009|NCT00489827|532404907|FG001|Overall Study|Intraoperative exclusion criteria|1|||
147615010|NCT05022212|532404912|FG000|Overall Study|Lost to Follow-up|0|||
147615011|NCT05022212|532404913|FG001|Overall Study|Lost to Follow-up|2|||
147615012|NCT02729909|532404914|FG000|Overall Study|Lost to Follow-up|0|||
147385303|NCT01986348|531571926|FG003|Overall Study|Physician Decision|1|||
147385304|NCT01986348|531571923|FG000|Overall Study|Progressive Disease|0|||
147385305|NCT01986348|531571924|FG001|Overall Study|Progressive Disease|0|||
147385306|NCT01986348|531571925|FG002|Overall Study|Progressive Disease|2|||
147385307|NCT01986348|531571926|FG003|Overall Study|Progressive Disease|0|||
147385308|NCT01986348|531571923|FG000|Overall Study|Withdrawal by Participant|0|||
147385309|NCT01986348|531571924|FG001|Overall Study|Withdrawal by Participant|1|||
147385310|NCT01986348|531571925|FG002|Overall Study|Withdrawal by Participant|2|||
147385311|NCT01986348|531571926|FG003|Overall Study|Withdrawal by Participant|1|||
147385312|NCT01986348|531571923|FG000|Overall Study|Study Terminated by Sponsor|0|||
147385313|NCT01986348|531571924|FG001|Overall Study|Study Terminated by Sponsor|0|||
147385314|NCT01986348|531571925|FG002|Overall Study|Study Terminated by Sponsor|0|||
147385315|NCT01986348|531571926|FG003|Overall Study|Study Terminated by Sponsor|3|||
147385316|NCT01986348|531571923|FG000|Overall Study|Other-unspecified|0|||
147385317|NCT01986348|531571924|FG001|Overall Study|Other-unspecified|1|||
147385318|NCT01986348|531571925|FG002|Overall Study|Other-unspecified|0|||
147385319|NCT01986348|531571926|FG003|Overall Study|Other-unspecified|2|||
147385320|NCT02158806|531571927|FG000|Overall Study|Death|2|||
147385321|NCT02158806|531571928|FG001|Overall Study|Death|0|||
147385322|NCT02158806|531571927|FG000|Overall Study|Withdrawal by Subject|2|||
147385323|NCT02158806|531571928|FG001|Overall Study|Withdrawal by Subject|0|||
147385324|NCT02158806|531571927|FG000|Overall Study|Lost to Follow-up|0|||
147385325|NCT02158806|531571928|FG001|Overall Study|Lost to Follow-up|3|||
147385326|NCT02158806|531571927|FG000|Overall Study|Moved out of area|0|||
147385327|NCT02158806|531571928|FG001|Overall Study|Moved out of area|1|||
147385328|NCT02158806|531571927|FG000|Overall Study|Transferred to palliative care|0|||
147385329|NCT02158806|531571928|FG001|Overall Study|Transferred to palliative care|1|||
147385330|NCT01898299|531571929|FG000|Post Treatment (One Month)|Lost to Follow-up|3|||
147385331|NCT01898299|531571930|FG001|Post Treatment (One Month)|Lost to Follow-up|4|||
147615013|NCT02729909|532404915|FG001|Overall Study|Lost to Follow-up|1|||
147615014|NCT02729909|532404914|FG000|Overall Study|Lack of Efficacy|0|||
147615015|NCT02729909|532404915|FG001|Overall Study|Lack of Efficacy|2|||
147615016|NCT02729909|532404914|FG000|Overall Study|Significant Protocol Deviation|0|||
147615017|NCT02729909|532404915|FG001|Overall Study|Significant Protocol Deviation|2|||
147385332|NCT00760877|531573253|FG000|Overall Study|Protocol Violation|1|||
147385333|NCT00760877|531573254|FG001|Overall Study|Protocol Violation|0|||
147385334|NCT00760877|531573253|FG000|Overall Study|Non-compliance with protocol treatment|2|||
147385335|NCT00760877|531573254|FG001|Overall Study|Non-compliance with protocol treatment|1|||
147385336|NCT00760877|531573253|FG000|Overall Study|Pregnancy|1|||
147385337|NCT00760877|531573254|FG001|Overall Study|Pregnancy|4|||
147385338|NCT00760877|531573253|FG000|Overall Study|Death|2|||
147385339|NCT00760877|531573254|FG001|Overall Study|Death|1|||
147385340|NCT00760877|531573253|FG000|Overall Study|Withdrawal by Subject|7|||
147385341|NCT00760877|531573254|FG001|Overall Study|Withdrawal by Subject|3|||
147385342|NCT00760877|531573253|FG000|Overall Study|Adverse Event|19|||
147385343|NCT00760877|531573254|FG001|Overall Study|Adverse Event|12|||
147385344|NCT00760877|531573253|FG000|Overall Study|Participant diagnosed with AML|0|||
147385345|NCT00760877|531573254|FG001|Overall Study|Participant diagnosed with AML|1|||
147385346|NCT00760877|531573253|FG000|Overall Study|Participant not eligible to cross-over|0|||
147385347|NCT00760877|531573254|FG001|Overall Study|Participant not eligible to cross-over|1|||
147385348|NCT00760877|531573253|FG000|Overall Study|Physician Decision|1|||
147385349|NCT00760877|531573254|FG001|Overall Study|Physician Decision|2|||
147385350|NCT00760877|531573253|FG000|Overall Study|Participants transferred to AMN107A2408|11|||
147385351|NCT00760877|531573254|FG001|Overall Study|Participants transferred to AMN107A2408|1|||
147456564|NCT00756938|531831760|FG000|Optional Extension|Withdrawal by Subject|0|||
147456565|NCT00756938|531831761|FG001|Optional Extension|Withdrawal by Subject|0|||
147456566|NCT00756938|531831762|FG002|Optional Extension|Withdrawal by Subject|0|||
147456567|NCT00756938|531831763|FG003|Optional Extension|Withdrawal by Subject|10|||
147456568|NCT00756938|531831760|FG000|Optional Extension|Adverse Event|0|||
147456569|NCT00756938|531831761|FG001|Optional Extension|Adverse Event|0|||
147456570|NCT00756938|531831762|FG002|Optional Extension|Adverse Event|0|||
147456571|NCT00756938|531831763|FG003|Optional Extension|Adverse Event|1|||
147456572|NCT00699907|531831765|FG000|Overall Study|Withdrawal by Subject|2|||
147456573|NCT00699907|531831766|FG001|Overall Study|Withdrawal by Subject|1|||
147456574|NCT00699907|531831767|FG002|Overall Study|Withdrawal by Subject|0|||
147456575|NCT00699907|531831765|FG000|Overall Study|No usable sample|0|||
147456576|NCT00699907|531831766|FG001|Overall Study|No usable sample|9|||
147456577|NCT00699907|531831767|FG002|Overall Study|No usable sample|8|||
147456578|NCT00430508|531831768|FG000|Overall Study|Adverse Event|2|||
147456579|NCT00430508|531831769|FG001|Overall Study|Adverse Event|3|||
147456580|NCT00430508|531831770|FG002|Overall Study|Adverse Event|5|||
147456581|NCT00430508|531831771|FG003|Overall Study|Adverse Event|3|||
147456582|NCT00430508|531831768|FG000|Overall Study|Withdrawal by Subject|0|||
147456583|NCT00430508|531831769|FG001|Overall Study|Withdrawal by Subject|1|||
147456584|NCT00430508|531831770|FG002|Overall Study|Withdrawal by Subject|1|||
147456585|NCT00430508|531831771|FG003|Overall Study|Withdrawal by Subject|1|||
147456586|NCT00430508|531831768|FG000|Overall Study|responder at visit 4|0|||
147456587|NCT00430508|531831769|FG001|Overall Study|responder at visit 4|0|||
147456588|NCT00430508|531831770|FG002|Overall Study|responder at visit 4|2|||
147456589|NCT00430508|531831771|FG003|Overall Study|responder at visit 4|0|||
147456590|NCT00430508|531831768|FG000|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|0|||
147456591|NCT00430508|531831769|FG001|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|1|||
147456592|NCT00430508|531831770|FG002|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|2|||
147456593|NCT00430508|531831771|FG003|Overall Study|conmed-BP-pulse-ABPM withdrawal criteria|1|||
147456594|NCT00430508|531831768|FG000|Overall Study|Other|1|||
147456595|NCT00430508|531831769|FG001|Overall Study|Other|1|||
147456596|NCT00430508|531831770|FG002|Overall Study|Other|3|||
147456597|NCT00430508|531831771|FG003|Overall Study|Other|0|||
147456598|NCT03889639|531831774|FG000|Overall Study|Withdrawal by Subject|0|||
147456599|NCT03889639|531831775|FG001|Overall Study|Withdrawal by Subject|0|||
147456600|NCT03889639|531831776|FG002|Overall Study|Withdrawal by Subject|0|||
147456601|NCT03889639|531831777|FG003|Overall Study|Withdrawal by Subject|0|||
147456602|NCT03889639|531831778|FG004|Overall Study|Withdrawal by Subject|0|||
147456603|NCT03889639|531831779|FG005|Overall Study|Withdrawal by Subject|0|||
147456604|NCT03889639|531831780|FG006|Overall Study|Withdrawal by Subject|0|||
147456605|NCT03889639|531831781|FG007|Overall Study|Withdrawal by Subject|1|||
147456606|NCT01703858|531831782|FG000|Overall Study|Withdrawal by Subject|0|||
147456607|NCT01703858|531831783|FG001|Overall Study|Withdrawal by Subject|1|||
147456608|NCT01703858|531831784|FG002|Overall Study|Withdrawal by Subject|0|||
147456609|NCT01543087|531831788|FG000|Stage 1 (48 Months)|Lost to Follow-up|3|||
147456610|NCT01543087|531831789|FG001|Stage 1 (48 Months)|Lost to Follow-up|4|||
147456611|NCT01543087|531831790|FG002|Stage 1 (48 Months)|Lost to Follow-up|12|||
147456612|NCT01543087|531831791|FG003|Stage 1 (48 Months)|Lost to Follow-up|0|||
147456613|NCT01543087|531831792|FG004|Stage 1 (48 Months)|Lost to Follow-up|0|||
147456614|NCT01543087|531831793|FG005|Stage 1 (48 Months)|Lost to Follow-up|0|||
147456615|NCT01543087|531831788|FG000|Stage 1 (48 Months)|No longer met eligibility criteria|1|||
147456616|NCT01543087|531831789|FG001|Stage 1 (48 Months)|No longer met eligibility criteria|0|||
147456617|NCT01543087|531831790|FG002|Stage 1 (48 Months)|No longer met eligibility criteria|1|||
147456618|NCT01543087|531831791|FG003|Stage 1 (48 Months)|No longer met eligibility criteria|2|||
147456619|NCT01543087|531831792|FG004|Stage 1 (48 Months)|No longer met eligibility criteria|0|||
147385352|NCT00760877|531573253|FG000|Overall Study|Treatment failure|1|||
147385353|NCT00760877|531573254|FG001|Overall Study|Treatment failure|0|||
147385354|NCT00711555|531573257|FG000|Overall Study|Adverse Event|3|||
147385355|NCT04820023|531573264|FG000|Overall Study|Death|0|||
147385356|NCT04820023|531573265|FG001|Overall Study|Death|0|||
147385357|NCT04820023|531573266|FG002|Overall Study|Death|0|||
147385358|NCT04820023|531573267|FG003|Overall Study|Death|0|||
147385359|NCT04820023|531573268|FG004|Overall Study|Death|0|||
147385360|NCT04820023|531573269|FG005|Overall Study|Death|0|||
147385361|NCT04820023|531573270|FG006|Overall Study|Death|1|||
147456620|NCT01543087|531831793|FG005|Stage 1 (48 Months)|No longer met eligibility criteria|0|||
147456621|NCT01543087|531831788|FG000|Stage 1 (48 Months)|No longer willing to participate|5|||
147456622|NCT01543087|531831789|FG001|Stage 1 (48 Months)|No longer willing to participate|3|||
147456623|NCT01543087|531831790|FG002|Stage 1 (48 Months)|No longer willing to participate|18|||
147456624|NCT01543087|531831791|FG003|Stage 1 (48 Months)|No longer willing to participate|6|||
147456625|NCT01543087|531831792|FG004|Stage 1 (48 Months)|No longer willing to participate|3|||
147456626|NCT01543087|531831793|FG005|Stage 1 (48 Months)|No longer willing to participate|0|||
147385362|NCT04820023|531573271|FG007|Overall Study|Death|0|||
147385363|NCT04820023|531573272|FG008|Overall Study|Death|1|||
147385364|NCT04820023|531573264|FG000|Overall Study|Withdrawal by Subject|1|||
147385365|NCT04820023|531573265|FG001|Overall Study|Withdrawal by Subject|2|||
147385366|NCT04820023|531573266|FG002|Overall Study|Withdrawal by Subject|2|||
147385367|NCT04820023|531573267|FG003|Overall Study|Withdrawal by Subject|1|||
147385368|NCT04820023|531573268|FG004|Overall Study|Withdrawal by Subject|4|||
147385369|NCT04820023|531573269|FG005|Overall Study|Withdrawal by Subject|3|||
147385370|NCT04820023|531573270|FG006|Overall Study|Withdrawal by Subject|3|||
147385371|NCT04820023|531573271|FG007|Overall Study|Withdrawal by Subject|6|||
147385372|NCT04820023|531573272|FG008|Overall Study|Withdrawal by Subject|5|||
147385373|NCT04820023|531573264|FG000|Overall Study|Progressive Disease|3|||
147385374|NCT04820023|531573265|FG001|Overall Study|Progressive Disease|0|||
147385375|NCT04820023|531573266|FG002|Overall Study|Progressive Disease|2|||
147385376|NCT04820023|531573267|FG003|Overall Study|Progressive Disease|2|||
147385377|NCT04820023|531573268|FG004|Overall Study|Progressive Disease|2|||
147385378|NCT04820023|531573269|FG005|Overall Study|Progressive Disease|0|||
147385379|NCT04820023|531573270|FG006|Overall Study|Progressive Disease|1|||
147385380|NCT04820023|531573271|FG007|Overall Study|Progressive Disease|1|||
147385381|NCT04820023|531573272|FG008|Overall Study|Progressive Disease|0|||
147385382|NCT04820023|531573264|FG000|Overall Study|New anti-cancer therapy|0|||
147385383|NCT04820023|531573265|FG001|Overall Study|New anti-cancer therapy|0|||
147385384|NCT04820023|531573266|FG002|Overall Study|New anti-cancer therapy|0|||
147385385|NCT04820023|531573267|FG003|Overall Study|New anti-cancer therapy|0|||
147385386|NCT04820023|531573268|FG004|Overall Study|New anti-cancer therapy|2|||
147385387|NCT04820023|531573269|FG005|Overall Study|New anti-cancer therapy|0|||
147456627|NCT01543087|531831788|FG000|Stage 1 (48 Months)|Other than specified|5|||
147456628|NCT01543087|531831789|FG001|Stage 1 (48 Months)|Other than specified|0|||
147456629|NCT01543087|531831790|FG002|Stage 1 (48 Months)|Other than specified|9|||
147456630|NCT01543087|531831791|FG003|Stage 1 (48 Months)|Other than specified|0|||
147456631|NCT01543087|531831792|FG004|Stage 1 (48 Months)|Other than specified|0|||
147456632|NCT01543087|531831793|FG005|Stage 1 (48 Months)|Other than specified|0|||
147456633|NCT01543087|531831788|FG000|Stage 1 (48 Months)|Protocol Violation|0|||
147456634|NCT01543087|531831789|FG001|Stage 1 (48 Months)|Protocol Violation|3|||
147456635|NCT01543087|531831790|FG002|Stage 1 (48 Months)|Protocol Violation|0|||
147456636|NCT01543087|531831791|FG003|Stage 1 (48 Months)|Protocol Violation|0|||
147456637|NCT01543087|531831792|FG004|Stage 1 (48 Months)|Protocol Violation|0|||
147456638|NCT01543087|531831793|FG005|Stage 1 (48 Months)|Protocol Violation|0|||
147456639|NCT01543087|531831788|FG000|Booster Stage (26 Months)|Withdrawal before booster vaccination|0|||
147385388|NCT04820023|531573270|FG006|Overall Study|New anti-cancer therapy|0|||
147385389|NCT04820023|531573271|FG007|Overall Study|New anti-cancer therapy|0|||
147385390|NCT04820023|531573272|FG008|Overall Study|New anti-cancer therapy|0|||
147385391|NCT04820023|531573264|FG000|Overall Study|Other|0|||
147385392|NCT04820023|531573265|FG001|Overall Study|Other|1|||
147385393|NCT04820023|531573266|FG002|Overall Study|Other|0|||
147385394|NCT04820023|531573267|FG003|Overall Study|Other|0|||
147385395|NCT04820023|531573268|FG004|Overall Study|Other|0|||
147385396|NCT04820023|531573269|FG005|Overall Study|Other|0|||
147385397|NCT04820023|531573270|FG006|Overall Study|Other|0|||
147385398|NCT04820023|531573271|FG007|Overall Study|Other|2|||
147385399|NCT04820023|531573272|FG008|Overall Study|Other|0|||
147385400|NCT01020487|531573273|FG000|Part 2 Double-blind Treatment Period|Adverse Event|0|||
147385401|NCT01020487|531573274|FG001|Part 2 Double-blind Treatment Period|Adverse Event|2|||
147385402|NCT01020487|531573275|FG002|Part 2 Double-blind Treatment Period|Adverse Event|1|||
147385403|NCT01020487|531573273|FG000|Part 2 Double-blind Treatment Period|Withdrawal by Subject|0|||
147385404|NCT01020487|531573274|FG001|Part 2 Double-blind Treatment Period|Withdrawal by Subject|0|||
147385405|NCT01020487|531573275|FG002|Part 2 Double-blind Treatment Period|Withdrawal by Subject|1|||
147385406|NCT01020487|531573273|FG000|Part 2 Double-blind Treatment Period|Required a Dose Reduction|0|||
147385407|NCT01020487|531573274|FG001|Part 2 Double-blind Treatment Period|Required a Dose Reduction|0|||
147385408|NCT01020487|531573275|FG002|Part 2 Double-blind Treatment Period|Required a Dose Reduction|3|||
147385409|NCT01020487|531573273|FG000|Part 2 Double-blind Treatment Period|Randomized in Error|0|||
147385410|NCT01020487|531573274|FG001|Part 2 Double-blind Treatment Period|Randomized in Error|0|||
147385411|NCT01020487|531573275|FG002|Part 2 Double-blind Treatment Period|Randomized in Error|1|||
147385412|NCT01020487|531573273|FG000|Part 2 Open-label Period|Adverse Event|0|||
147385413|NCT01020487|531573274|FG001|Part 2 Open-label Period|Adverse Event|4|||
147385414|NCT01020487|531573275|FG002|Part 2 Open-label Period|Adverse Event|1|||
147385415|NCT04049578|531573276|FG000|Overall Study|Physician Decision|1|||
147385416|NCT02400749|531573277|FG000|Week 0 -16|Withdrawal by Subject|5|||
147385417|NCT02400749|531573278|FG001|Week 0 -16|Withdrawal by Subject|5|||
147385418|NCT02400749|531573277|FG000|Week 0 -16|Adverse Event|3|||
147385419|NCT02400749|531573278|FG001|Week 0 -16|Adverse Event|1|||
147385420|NCT02400749|531573277|FG000|Week 0 -16|Lost to Follow-up|2|||
147385421|NCT02400749|531573278|FG001|Week 0 -16|Lost to Follow-up|0|||
147456640|NCT01543087|531831789|FG001|Booster Stage (26 Months)|Withdrawal before booster vaccination|1|||
147456641|NCT01543087|531831790|FG002|Booster Stage (26 Months)|Withdrawal before booster vaccination|0|||
147385422|NCT02400749|531573277|FG000|Week 0 -16|Protocol Violation|1|||
147385423|NCT02400749|531573278|FG001|Week 0 -16|Protocol Violation|0|||
147385424|NCT02400749|531573277|FG000|Week 17 - 32|Withdrawal by Subject|3|||
147385425|NCT02400749|531573278|FG001|Week 17 - 32|Withdrawal by Subject|2|||
147385426|NCT02400749|531573277|FG000|Week 17 - 32|Adverse Event|2|||
147385427|NCT02400749|531573278|FG001|Week 17 - 32|Adverse Event|1|||
147385428|NCT01945593|531573281|FG000|Overall Study|Adverse Event|0|||
147385429|NCT01945593|531573282|FG001|Overall Study|Adverse Event|0|||
147456642|NCT01543087|531831791|FG003|Booster Stage (26 Months)|Withdrawal before booster vaccination|0|||
147456643|NCT01543087|531831792|FG004|Booster Stage (26 Months)|Withdrawal before booster vaccination|2|||
147456644|NCT01543087|531831793|FG005|Booster Stage (26 Months)|Withdrawal before booster vaccination|0|||
147456645|NCT01543087|531831788|FG000|Booster Stage (26 Months)|Lost to Follow-up|0|||
147456646|NCT01543087|531831789|FG001|Booster Stage (26 Months)|Lost to Follow-up|0|||
147456647|NCT01543087|531831790|FG002|Booster Stage (26 Months)|Lost to Follow-up|1|||
147456648|NCT01543087|531831791|FG003|Booster Stage (26 Months)|Lost to Follow-up|0|||
147456649|NCT01543087|531831792|FG004|Booster Stage (26 Months)|Lost to Follow-up|0|||
147456650|NCT01543087|531831793|FG005|Booster Stage (26 Months)|Lost to Follow-up|0|||
147456651|NCT00143455|531831797|FG000|Cohort 1|Adverse Event|8|||
147456652|NCT00143455|531831798|FG001|Cohort 1|Adverse Event|4|||
147456653|NCT00143455|531831799|FG002|Cohort 1|Adverse Event|0|||
147456654|NCT00143455|531831800|FG003|Cohort 1|Adverse Event|0|||
147456655|NCT00143455|531831797|FG000|Cohort 1|Death|5|||
147456656|NCT00143455|531831798|FG001|Cohort 1|Death|2|||
147456657|NCT00143455|531831799|FG002|Cohort 1|Death|0|||
147456658|NCT00143455|531831800|FG003|Cohort 1|Death|0|||
147456659|NCT00143455|531831797|FG000|Cohort 1|Progressive Disease|0|||
147456660|NCT00143455|531831798|FG001|Cohort 1|Progressive Disease|6|||
147456661|NCT00143455|531831799|FG002|Cohort 1|Progressive Disease|0|||
147456662|NCT00143455|531831800|FG003|Cohort 1|Progressive Disease|0|||
147456663|NCT00143455|531831797|FG000|Cohort 1|Withdrawal by Subject|1|||
147664921|NCT01573000|532597954|FG001|Long-Term Follow-Up|Lost to Follow-up|1|||
147664922|NCT01100853|532597960|FG000|Overall Study|Lost to Follow-up|11|||
147664923|NCT01100853|532597961|FG001|Overall Study|Lost to Follow-up|6|||
147664924|NCT01100853|532597960|FG000|Overall Study|Received <4 study injections|10|||
147664925|NCT01100853|532597961|FG001|Overall Study|Received <4 study injections|13|||
147664926|NCT01100853|532597960|FG000|Overall Study|Withdrawal by Subject|6|||
147664927|NCT01100853|532597961|FG001|Overall Study|Withdrawal by Subject|4|||
147664928|NCT01384877|532597962|FG000|Treatment 2|Lost to Follow-up|2|||
147664929|NCT01384877|532597963|FG001|Treatment 2|Lost to Follow-up|2|||
147664930|NCT04161391|532597964|FG000|Overall Study|Adverse Event|0|||
147664931|NCT04161391|532597965|FG001|Overall Study|Adverse Event|1|||
147664932|NCT04161391|532597966|FG002|Overall Study|Adverse Event|0|||
147664933|NCT04161391|532597967|FG003|Overall Study|Adverse Event|1|||
147664934|NCT04161391|532597968|FG004|Overall Study|Adverse Event|0|||
147385430|NCT01945593|531573283|FG002|Overall Study|Adverse Event|0|||
147385431|NCT01945593|531573284|FG003|Overall Study|Adverse Event|5|||
147385432|NCT01945593|531573281|FG000|Overall Study|Physician Decision|0|||
147385433|NCT01945593|531573282|FG001|Overall Study|Physician Decision|0|||
147385434|NCT01945593|531573283|FG002|Overall Study|Physician Decision|1|||
147385435|NCT01945593|531573284|FG003|Overall Study|Physician Decision|1|||
147385436|NCT01945593|531573281|FG000|Overall Study|Withdrawal by Subject|0|||
147385437|NCT01945593|531573282|FG001|Overall Study|Withdrawal by Subject|2|||
147385438|NCT01945593|531573283|FG002|Overall Study|Withdrawal by Subject|0|||
147385439|NCT01945593|531573284|FG003|Overall Study|Withdrawal by Subject|4|||
147385440|NCT01945593|531573281|FG000|Overall Study|Protocol Violation|0|||
147385441|NCT01945593|531573282|FG001|Overall Study|Protocol Violation|2|||
147385442|NCT01945593|531573283|FG002|Overall Study|Protocol Violation|1|||
147385443|NCT01945593|531573284|FG003|Overall Study|Protocol Violation|3|||
147385444|NCT01945593|531573281|FG000|Overall Study|Death|0|||
147385445|NCT01945593|531573282|FG001|Overall Study|Death|0|||
147385446|NCT01945593|531573283|FG002|Overall Study|Death|1|||
147385447|NCT01945593|531573284|FG003|Overall Study|Death|0|||
147385448|NCT01945593|531573281|FG000|Overall Study|Other: Terminated|0|||
147456664|NCT00143455|531831798|FG001|Cohort 1|Withdrawal by Subject|4|||
147456665|NCT00143455|531831799|FG002|Cohort 1|Withdrawal by Subject|0|||
147664935|NCT04161391|532597969|FG005|Overall Study|Adverse Event|0|||
147664936|NCT04161391|532597970|FG006|Overall Study|Adverse Event|0|||
147456666|NCT00143455|531831800|FG003|Cohort 1|Withdrawal by Subject|0|||
147456667|NCT00143455|531831797|FG000|Cohort 1|Randomized But Not Treated|0|||
147664937|NCT04161391|532597971|FG007|Overall Study|Adverse Event|3|||
147664938|NCT04161391|532597972|FG008|Overall Study|Adverse Event|0|||
147385449|NCT01945593|531573282|FG001|Overall Study|Other: Terminated|0|||
147385450|NCT01945593|531573283|FG002|Overall Study|Other: Terminated|0|||
147385451|NCT01945593|531573284|FG003|Overall Study|Other: Terminated|1|||
147385452|NCT01945593|531573281|FG000|Overall Study|Other: Surgical Procedure|0|||
147385453|NCT01945593|531573282|FG001|Overall Study|Other: Surgical Procedure|2|||
147456668|NCT00143455|531831798|FG001|Cohort 1|Randomized But Not Treated|1|||
147385454|NCT01945593|531573283|FG002|Overall Study|Other: Surgical Procedure|0|||
147456669|NCT00143455|531831799|FG002|Cohort 1|Randomized But Not Treated|0|||
147456670|NCT00143455|531831800|FG003|Cohort 1|Randomized But Not Treated|0|||
147664939|NCT04161391|532597964|FG000|Overall Study|Death|0|||
147456671|NCT00143455|531831797|FG000|Cohort 2|Adverse Event|0|||
147456672|NCT00143455|531831798|FG001|Cohort 2|Adverse Event|0|||
147456673|NCT00143455|531831799|FG002|Cohort 2|Adverse Event|42|||
147456674|NCT00143455|531831800|FG003|Cohort 2|Adverse Event|30|||
147456675|NCT00143455|531831797|FG000|Cohort 2|No Longer Required Study Treatment|0|||
147456676|NCT00143455|531831798|FG001|Cohort 2|No Longer Required Study Treatment|0|||
147456677|NCT00143455|531831799|FG002|Cohort 2|No Longer Required Study Treatment|1|||
147456678|NCT00143455|531831800|FG003|Cohort 2|No Longer Required Study Treatment|0|||
147456679|NCT00143455|531831797|FG000|Cohort 2|Protocol Violation|0|||
147456680|NCT00143455|531831798|FG001|Cohort 2|Protocol Violation|0|||
147456681|NCT00143455|531831799|FG002|Cohort 2|Protocol Violation|1|||
147456682|NCT00143455|531831800|FG003|Cohort 2|Protocol Violation|1|||
147456683|NCT00143455|531831797|FG000|Cohort 2|Lost to Follow-up|0|||
147456684|NCT00143455|531831798|FG001|Cohort 2|Lost to Follow-up|0|||
147456685|NCT00143455|531831799|FG002|Cohort 2|Lost to Follow-up|1|||
147456686|NCT00143455|531831800|FG003|Cohort 2|Lost to Follow-up|4|||
147456687|NCT00143455|531831797|FG000|Cohort 2|Death|0|||
147456688|NCT00143455|531831798|FG001|Cohort 2|Death|0|||
147456689|NCT00143455|531831799|FG002|Cohort 2|Death|20|||
147456690|NCT00143455|531831800|FG003|Cohort 2|Death|12|||
147456691|NCT00143455|531831797|FG000|Cohort 2|Progressive Disease|0|||
147456692|NCT00143455|531831798|FG001|Cohort 2|Progressive Disease|0|||
147456693|NCT00143455|531831799|FG002|Cohort 2|Progressive Disease|20|||
147456694|NCT00143455|531831800|FG003|Cohort 2|Progressive Disease|27|||
147456695|NCT00143455|531831797|FG000|Cohort 2|Withdrawal by Subject|0|||
147456696|NCT00143455|531831798|FG001|Cohort 2|Withdrawal by Subject|0|||
147456697|NCT00143455|531831799|FG002|Cohort 2|Withdrawal by Subject|13|||
147456698|NCT00143455|531831800|FG003|Cohort 2|Withdrawal by Subject|12|||
147456699|NCT00143455|531831797|FG000|Cohort 2|Other|0|||
147456700|NCT00143455|531831798|FG001|Cohort 2|Other|0|||
147456701|NCT00143455|531831799|FG002|Cohort 2|Other|7|||
147456702|NCT00143455|531831800|FG003|Cohort 2|Other|6|||
147456703|NCT00143455|531831797|FG000|Cohort 2|Randomized But Not Treated|0|||
147456704|NCT00143455|531831798|FG001|Cohort 2|Randomized But Not Treated|0|||
147456705|NCT00143455|531831799|FG002|Cohort 2|Randomized But Not Treated|1|||
147456706|NCT00143455|531831800|FG003|Cohort 2|Randomized But Not Treated|1|||
147456707|NCT01325428|531831801|FG000|Part A|Progressive disease according to RECIST|9|||
147456708|NCT01325428|531831801|FG000|Part A|Clinical signs, symptoms of progression|2|||
147456709|NCT01325428|531831801|FG000|Part A|Other adverse event|1|||
147456710|NCT01325428|531831801|FG000|Part A|Refused continue taking trial medication|2|||
147456711|NCT01325428|531831801|FG000|Part A|Other reason not defined above|2|||
147456712|NCT01325428|531831801|FG000|Part B|Refused continue taking trial medication|2|||
147456713|NCT01325428|531831801|FG000|Part B|Other reason not defined above|1|||
147456714|NCT01298492|531831802|FG000|Overall Study|Death|2|||
147456715|NCT01298492|531831802|FG000|Overall Study|Insufficient Clinical Response|22|||
147456716|NCT01298492|531831802|FG000|Overall Study|Lost to Follow-up|12|||
147456717|NCT01298492|531831802|FG000|Overall Study|Withdrawal by Subject|47|||
147456718|NCT01298492|531831802|FG000|Overall Study|Other (Unspecified)|7|||
147456719|NCT01298492|531831802|FG000|Overall Study|Withdrawn Due to Pregnancy|1|||
147456720|NCT01298492|531831802|FG000|Overall Study|Protocol Violation|2|||
147456721|NCT01298492|531831802|FG000|Overall Study|Adverse Event(Related to Study Drug)|8|||
147456722|NCT01298492|531831802|FG000|Overall Study|Adverse Event(Not Related to Study Drug)|18|||
147456723|NCT03870555|531831803|FG000|Period 3 (2 Days)|Adverse Event|1|||
147456724|NCT03870555|531831804|FG001|Period 3 (2 Days)|Adverse Event|0|||
147456725|NCT03870555|531831805|FG002|Period 3 (2 Days)|Adverse Event|0|||
147456726|NCT02340663|531831806|FG000|Overall Study|Lost to Follow-up|1|||
147456727|NCT02340663|531831807|FG001|Overall Study|Lost to Follow-up|0|||
147456728|NCT02340663|531831806|FG000|Overall Study|Protocol Violation|1|||
147456729|NCT02340663|531831807|FG001|Overall Study|Protocol Violation|0|||
147456730|NCT02340663|531831806|FG000|Overall Study|Withdrawal by Subject|3|||
147456731|NCT02340663|531831807|FG001|Overall Study|Withdrawal by Subject|1|||
147615018|NCT02729909|532404914|FG000|Overall Study|Voluntary Withdrawal|1|||
147615019|NCT02729909|532404915|FG001|Overall Study|Voluntary Withdrawal|0|||
147615020|NCT06419907|532406570|FG000|Overall Study|Protocol Violation|0|||
147615021|NCT06419907|532406571|FG001|Overall Study|Protocol Violation|3|||
147615022|NCT06419907|532406572|FG002|Overall Study|Protocol Violation|0|||
147456732|NCT02004873|531831808|FG000|Overall Study|Implant unsuccessful|6|||
147456733|NCT02004873|531831808|FG000|Overall Study|Awaiting 6-month visit|390|||
147456734|NCT02004873|531831808|FG000|Overall Study|Missed 6-month visit|4|||
147615023|NCT06419907|532406573|FG003|Overall Study|Protocol Violation|1|||
147615024|NCT06419907|532406570|FG000|Overall Study|Lost to Follow-up|0|||
147456735|NCT02004873|531831808|FG000|Overall Study|Death|23|||
147456736|NCT02004873|531831808|FG000|Overall Study|Withdrawal by Subject|1|||
147456737|NCT01353703|531831809|FG000|Overall Study|Migrated/moved from study area|1|||
147456738|NCT01353703|531831810|FG001|Overall Study|Migrated/moved from study area|0|||
147456739|NCT02665286|531831818|FG000|Overall Study|Lost to Follow-up|3|||
147456740|NCT02665286|531831819|FG001|Overall Study|Lost to Follow-up|2|||
147456741|NCT02665286|531831820|FG002|Overall Study|Lost to Follow-up|1|||
147456742|NCT00512798|531831821|FG000|Overall Study|Death|0|||
147456743|NCT00512798|531831822|FG001|Overall Study|Death|3|||
147385455|NCT01945593|531573284|FG003|Overall Study|Other: Surgical Procedure|6|||
147385456|NCT01945593|531573281|FG000|Overall Study|Other: Screen Failure|0|||
147385457|NCT01945593|531573282|FG001|Overall Study|Other: Screen Failure|2|||
147385458|NCT01945593|531573283|FG002|Overall Study|Other: Screen Failure|0|||
147456744|NCT00512798|531831821|FG000|Overall Study|Adverse Event|2|||
147456745|NCT00512798|531831822|FG001|Overall Study|Adverse Event|4|||
147456746|NCT00512798|531831821|FG000|Overall Study|Progression of disease|14|||
147456747|NCT00512798|531831822|FG001|Overall Study|Progression of disease|20|||
147456748|NCT00512798|531831821|FG000|Overall Study|Withdrawal by Subject|3|||
147456749|NCT00512798|531831822|FG001|Overall Study|Withdrawal by Subject|0|||
147456750|NCT03718143|531833402|FG000|Overall Study|Death|1|||
147456751|NCT03718143|531833403|FG001|Overall Study|Death|0|||
147456752|NCT03718143|531833404|FG002|Overall Study|Death|0|||
147456753|NCT03718143|531833402|FG000|Overall Study|Progression of Disease|1|||
147456754|NCT03718143|531833403|FG001|Overall Study|Progression of Disease|0|||
147456755|NCT03718143|531833404|FG002|Overall Study|Progression of Disease|0|||
147456756|NCT03718143|531833402|FG000|Overall Study|Withdrawal of Informed Consent|1|||
147456757|NCT03718143|531833403|FG001|Overall Study|Withdrawal of Informed Consent|2|||
147456758|NCT03718143|531833404|FG002|Overall Study|Withdrawal of Informed Consent|1|||
147456759|NCT01461044|531833405|FG000|Overall Study|Death|58|||
147456760|NCT01461044|531833406|FG001|Overall Study|Death|35|||
147456761|NCT01461044|531833405|FG000|Overall Study|Lost to Follow-up|12|||
147456762|NCT01461044|531833406|FG001|Overall Study|Lost to Follow-up|5|||
147456763|NCT00716976|531833407|FG000|Overall Study|Adverse Event|2|||
147456764|NCT00716976|531833408|FG001|Overall Study|Adverse Event|0|||
147456765|NCT00716976|531833407|FG000|Overall Study|Death|1|||
147456766|NCT00716976|531833408|FG001|Overall Study|Death|0|||
147456767|NCT00716976|531833407|FG000|Overall Study|Physician Decision|2|||
147456768|NCT00716976|531833408|FG001|Overall Study|Physician Decision|2|||
147456769|NCT00716976|531833407|FG000|Overall Study|Withdrawal by Subject|5|||
147456770|NCT00716976|531833408|FG001|Overall Study|Withdrawal by Subject|1|||
147456771|NCT00716976|531833407|FG000|Overall Study|Premature discontinuation cisplatin|5|||
147456772|NCT00716976|531833408|FG001|Overall Study|Premature discontinuation cisplatin|4|||
147385459|NCT01945593|531573284|FG003|Overall Study|Other: Screen Failure|0|||
147385460|NCT00228813|531573285|FG000|Overall Study|Death|4|||
147385461|NCT00507429|531573286|FG000|Treatment Phase|Disease Progression|12|||
147385462|NCT00507429|531573287|FG001|Treatment Phase|Disease Progression|5|||
147385463|NCT00507429|531573286|FG000|Treatment Phase|Adverse Event|12|||
147385464|NCT00507429|531573287|FG001|Treatment Phase|Adverse Event|5|||
147385465|NCT00507429|531573286|FG000|Treatment Phase|Withdrawal by Subject|3|||
147385466|NCT00507429|531573287|FG001|Treatment Phase|Withdrawal by Subject|3|||
147385467|NCT00507429|531573286|FG000|Treatment Phase|Physician Decision|4|||
147385468|NCT00507429|531573287|FG001|Treatment Phase|Physician Decision|2|||
147385469|NCT00507429|531573286|FG000|Treatment Phase|Other|6|||
147385470|NCT00507429|531573287|FG001|Treatment Phase|Other|3|||
147385471|NCT00507429|531573286|FG000|Maintenance Phase|Progressive Disease|14|||
147385472|NCT00507429|531573287|FG001|Maintenance Phase|Progressive Disease|0|||
147385473|NCT03884478|531573294|FG000|Baseline to 2 Months Post-intervention|Lost to Follow-up|30|||
147385474|NCT03884478|531573295|FG001|Baseline to 2 Months Post-intervention|Lost to Follow-up|33|||
147385475|NCT03884478|531573296|FG002|Baseline to 2 Months Post-intervention|Lost to Follow-up|36|||
147385476|NCT03884478|531573294|FG000|Baseline to 2 Months Post-intervention|Withdrawn by research team|1|||
147385477|NCT03884478|531573295|FG001|Baseline to 2 Months Post-intervention|Withdrawn by research team|0|||
147385478|NCT03884478|531573296|FG002|Baseline to 2 Months Post-intervention|Withdrawn by research team|0|||
147385479|NCT03884478|531573294|FG000|Baseline to 4 Months Post-intervention|Lost to Follow-up|42|||
147385480|NCT03884478|531573295|FG001|Baseline to 4 Months Post-intervention|Lost to Follow-up|50|||
147385481|NCT03884478|531573296|FG002|Baseline to 4 Months Post-intervention|Lost to Follow-up|51|||
147385482|NCT03884478|531573294|FG000|Baseline to 4 Months Post-intervention|Withdrawn by research team|1|||
147385483|NCT03884478|531573295|FG001|Baseline to 4 Months Post-intervention|Withdrawn by research team|0|||
147385484|NCT03884478|531573296|FG002|Baseline to 4 Months Post-intervention|Withdrawn by research team|0|||
147385485|NCT02213094|531573297|FG000|Overall Study|Adverse Event|1|||
147615025|NCT06419907|532406571|FG001|Overall Study|Lost to Follow-up|0|||
147615026|NCT06419907|532406572|FG002|Overall Study|Lost to Follow-up|2|||
147615027|NCT06419907|532406573|FG003|Overall Study|Lost to Follow-up|1|||
147385486|NCT02213094|531573298|FG001|Overall Study|Adverse Event|0|||
147385487|NCT01807234|531573299|FG000|Overall Study|Lost to Follow-up|2|||
147456773|NCT00716976|531833407|FG000|Overall Study|Radiation during protocol|1|||
147456774|NCT00716976|531833408|FG001|Overall Study|Radiation during protocol|0|||
147456775|NCT00716976|531833407|FG000|Overall Study|Ineligibles|4|||
147615028|NCT03130777|532406574|FG000|Overall Study|Death|0|||
147385488|NCT01807234|531573300|FG001|Overall Study|Lost to Follow-up|5|||
147385489|NCT01807234|531573301|FG002|Overall Study|Lost to Follow-up|1|||
147385490|NCT01807234|531573302|FG003|Overall Study|Lost to Follow-up|1|||
147385491|NCT01807234|531573303|FG004|Overall Study|Lost to Follow-up|1|||
147456776|NCT00716976|531833408|FG001|Overall Study|Ineligibles|2|||
147456777|NCT02971202|531833409|FG000|Overall Study|Pregnancy|1|||
147456778|NCT02971202|531833410|FG001|Overall Study|Pregnancy|0|||
147385492|NCT01807234|531573304|FG005|Overall Study|Lost to Follow-up|2|||
147385493|NCT01807234|531573299|FG000|Overall Study|Withdrawal by Subject|3|||
147385494|NCT01807234|531573300|FG001|Overall Study|Withdrawal by Subject|1|||
147385495|NCT01807234|531573301|FG002|Overall Study|Withdrawal by Subject|1|||
147385496|NCT01807234|531573302|FG003|Overall Study|Withdrawal by Subject|1|||
147385497|NCT01807234|531573303|FG004|Overall Study|Withdrawal by Subject|2|||
147385498|NCT01807234|531573304|FG005|Overall Study|Withdrawal by Subject|1|||
147385499|NCT01807234|531573299|FG000|Overall Study|Lack of Efficacy|0|||
147385500|NCT01807234|531573300|FG001|Overall Study|Lack of Efficacy|0|||
147385501|NCT01807234|531573301|FG002|Overall Study|Lack of Efficacy|0|||
147385502|NCT01807234|531573302|FG003|Overall Study|Lack of Efficacy|0|||
147385503|NCT01807234|531573303|FG004|Overall Study|Lack of Efficacy|1|||
147385504|NCT01807234|531573304|FG005|Overall Study|Lack of Efficacy|1|||
147385505|NCT01074229|531573305|FG000|Overall Study|Lost to Follow-up|1|||
147385506|NCT01074229|531573306|FG001|Overall Study|Lost to Follow-up|0|||
147385507|NCT01074229|531573307|FG002|Overall Study|Lost to Follow-up|0|||
147385508|NCT01074229|531573305|FG000|Overall Study|Change to open surgical procedure|1|||
147385509|NCT01074229|531573306|FG001|Overall Study|Change to open surgical procedure|3|||
147385510|NCT01074229|531573307|FG002|Overall Study|Change to open surgical procedure|4|||
147385511|NCT02163499|531573308|FG000|Acute Phase: ZS 10 g TID|Participant's Compliance|1|||
147385512|NCT02163499|531573308|FG000|Acute Phase: ZS 10 g TID|Hypo- or Hyperkalemia|1|||
147385513|NCT02163499|531573308|FG000|Acute Phase: ZS 10 g TID|Protocol Violation|1|||
147385514|NCT02163499|531573308|FG000|Acute Phase: ZS 10 g TID|Physician Decision|1|||
147385515|NCT02163499|531573308|FG000|Acute Phase: ZS 10 g TID|Withdrawal by Subject|1|||
147385516|NCT02163499|531573308|FG000|Extended Dosing Phase: ZS|Adverse Event|51|||
147385517|NCT02163499|531573308|FG000|Extended Dosing Phase: ZS|Expected Progression of CKD|40|||
147385518|NCT02163499|531573308|FG000|Extended Dosing Phase: ZS|Hypokalemia|9|||
147385519|NCT02163499|531573308|FG000|Extended Dosing Phase: ZS|Sponsor's Decision|5|||
147385520|NCT02163499|531573308|FG000|Extended Dosing Phase: ZS|Met ECG Withdrawal Criteria|7|||
147385521|NCT02163499|531573308|FG000|Extended Dosing Phase: ZS|Withdrawal by Subject|81|||
147385522|NCT02163499|531573308|FG000|Extended Dosing Phase: ZS|Physician Decision|8|||
147385523|NCT02163499|531573308|FG000|Extended Dosing Phase: ZS|Lost to Follow-up|31|||
147385524|NCT02163499|531573308|FG000|Extended Dosing Phase: ZS|Protocol Violation|2|||
147385525|NCT02163499|531573308|FG000|Extended Dosing Phase: ZS|Death|8|||
147385526|NCT02163499|531573308|FG000|Extended Dosing Phase: ZS|Subject Compliance|17|||
147385527|NCT02163499|531573308|FG000|Extended Dosing Phase: ZS|Hyperkalemia|5|||
147385528|NCT02163499|531573308|FG000|Extended Dosing Phase: ZS|Various reasons|16|||
147385529|NCT02991118|531573309|FG000|Overall Study|Death|3|||
147385530|NCT02991118|531573310|FG001|Overall Study|Death|8|||
147385531|NCT02991118|531573309|FG000|Overall Study|Protocol Violation|0|||
147456779|NCT02971202|531833411|FG002|Overall Study|Pregnancy|0|||
147456780|NCT02971202|531833409|FG000|Overall Study|screen fail after consent|1|||
147456781|NCT02971202|531833410|FG001|Overall Study|screen fail after consent|0|||
147456782|NCT02971202|531833411|FG002|Overall Study|screen fail after consent|1|||
147456783|NCT01414257|531833412|FG000|Overall Study|No Visit After First Day of Treatment|12|||
147456784|NCT01414257|531833412|FG000|Overall Study|Protocol Violation|10|||
147456785|NCT01534676|531833413|FG000|Overall Study|Study closed due to poor enrollment|2|||
147456786|NCT01534676|531833414|FG001|Overall Study|Study closed due to poor enrollment|1|||
147456787|NCT00424827|531833419|FG000|Overall Study|Adverse Event|1|||
147456788|NCT02009878|531833422|FG000|Overall Study|Participant Met Withdrawal Criteria|0|||
147456789|NCT02009878|531833423|FG001|Overall Study|Participant Met Withdrawal Criteria|1|||
147456790|NCT02009878|531833424|FG002|Overall Study|Participant Met Withdrawal Criteria|0|||
147456791|NCT01790048|531833426|FG000|Overall Study|Incorrect Age|9|||
147456792|NCT01790048|531833427|FG001|Overall Study|Incorrect Age|14|||
147456793|NCT01790048|531833426|FG000|Overall Study|data entry error|0|||
147456794|NCT01790048|531833427|FG001|Overall Study|data entry error|1|||
147456795|NCT01790048|531833426|FG000|Overall Study|Other|0|||
147385532|NCT02991118|531573310|FG001|Overall Study|Protocol Violation|3|||
147385533|NCT02991118|531573309|FG000|Overall Study|Physician Decision|0|||
147456796|NCT01790048|531833427|FG001|Overall Study|Other|2|||
147385534|NCT02991118|531573310|FG001|Overall Study|Physician Decision|1|||
147385535|NCT02991118|531573309|FG000|Overall Study|Moved out of the country|0|||
147385536|NCT02991118|531573310|FG001|Overall Study|Moved out of the country|1|||
147385537|NCT02991118|531573309|FG000|Overall Study|Adverse Event|2|||
147385538|NCT02991118|531573310|FG001|Overall Study|Adverse Event|2|||
147456797|NCT01790048|531833426|FG000|Overall Study|SAM at Enrollment|2|||
147456798|NCT01790048|531833427|FG001|Overall Study|SAM at Enrollment|0|||
147456799|NCT01790048|531833426|FG000|Overall Study|Measurement error|1|||
147615029|NCT03130777|532406575|FG001|Overall Study|Death|1|||
147615030|NCT03130777|532406574|FG000|Overall Study|Did not meet eligibility criteria|1|||
147615031|NCT03130777|532406575|FG001|Overall Study|Did not meet eligibility criteria|0|||
147385539|NCT02991118|531573309|FG000|Overall Study|Withdrawal by Subject|1|||
147385540|NCT02991118|531573310|FG001|Overall Study|Withdrawal by Subject|7|||
147456800|NCT01790048|531833427|FG001|Overall Study|Measurement error|0|||
147456801|NCT05689047|531833430|FG000|Overall Study|Lost to Follow-up|0|||
147456802|NCT05689047|531833431|FG001|Overall Study|Lost to Follow-up|1|||
147385541|NCT02991118|531573309|FG000|Overall Study|Could not attend study visits|0|||
147385542|NCT02991118|531573310|FG001|Overall Study|Could not attend study visits|1|||
147385543|NCT02991118|531573309|FG000|Overall Study|Lost to Follow-up|1|||
147385544|NCT02991118|531573310|FG001|Overall Study|Lost to Follow-up|9|||
147385545|NCT00963924|531573315|FG000|Overall Study|Adverse Event|1|||
147385546|NCT00963924|531573316|FG001|Overall Study|Adverse Event|0|||
147385547|NCT00963924|531573315|FG000|Overall Study|Withdrawal by Subject|0|||
147385548|NCT00963924|531573316|FG001|Overall Study|Withdrawal by Subject|1|||
147385549|NCT00963924|531573315|FG000|Overall Study|Changed antipsychotic|0|||
147385550|NCT00963924|531573316|FG001|Overall Study|Changed antipsychotic|1|||
147385551|NCT00963924|531573315|FG000|Overall Study|Lost to Follow-up|0|||
147385552|NCT00963924|531573316|FG001|Overall Study|Lost to Follow-up|1|||
147385553|NCT00446095|531573317|FG000|Phase II (8 Weeks)|Lost to Follow-up|1|||
147385554|NCT00446095|531573318|FG001|Phase II (8 Weeks)|Lost to Follow-up|0|||
147385555|NCT00446095|531573319|FG002|Phase II (8 Weeks)|Lost to Follow-up|0|||
147385556|NCT00446095|531573320|FG003|Phase II (8 Weeks)|Lost to Follow-up|0|||
147385557|NCT00446095|531573321|FG004|Phase II (8 Weeks)|Lost to Follow-up|0|||
147385558|NCT00446095|531573317|FG000|Phase II (8 Weeks)|Adverse Event|0|||
147385559|NCT00446095|531573318|FG001|Phase II (8 Weeks)|Adverse Event|1|||
147385560|NCT00446095|531573319|FG002|Phase II (8 Weeks)|Adverse Event|1|||
147385561|NCT00446095|531573320|FG003|Phase II (8 Weeks)|Adverse Event|0|||
147385562|NCT00446095|531573321|FG004|Phase II (8 Weeks)|Adverse Event|0|||
147385563|NCT00446095|531573317|FG000|Phase II (8 Weeks)|Withdrawal by Subject|1|||
147385564|NCT00446095|531573318|FG001|Phase II (8 Weeks)|Withdrawal by Subject|0|||
147385565|NCT00446095|531573319|FG002|Phase II (8 Weeks)|Withdrawal by Subject|0|||
147385566|NCT00446095|531573320|FG003|Phase II (8 Weeks)|Withdrawal by Subject|0|||
147385567|NCT00446095|531573321|FG004|Phase II (8 Weeks)|Withdrawal by Subject|0|||
147385568|NCT00446095|531573317|FG000|Phase II (8 Weeks)|Physician Decision|1|||
147385569|NCT00446095|531573318|FG001|Phase II (8 Weeks)|Physician Decision|0|||
147385570|NCT00446095|531573319|FG002|Phase II (8 Weeks)|Physician Decision|0|||
147385571|NCT00446095|531573320|FG003|Phase II (8 Weeks)|Physician Decision|0|||
147385572|NCT00446095|531573321|FG004|Phase II (8 Weeks)|Physician Decision|0|||
147385573|NCT00446095|531573317|FG000|Phase II (8 Weeks)|Lack of Efficacy|9|||
147385574|NCT00446095|531573318|FG001|Phase II (8 Weeks)|Lack of Efficacy|2|||
147385575|NCT00446095|531573319|FG002|Phase II (8 Weeks)|Lack of Efficacy|1|||
147385576|NCT00446095|531573320|FG003|Phase II (8 Weeks)|Lack of Efficacy|0|||
147385577|NCT00446095|531573321|FG004|Phase II (8 Weeks)|Lack of Efficacy|0|||
147385578|NCT00446095|531573317|FG000|Phase II (8 Weeks)|Ongoing|0|||
147385579|NCT00446095|531573318|FG001|Phase II (8 Weeks)|Ongoing|0|||
147385580|NCT00446095|531573319|FG002|Phase II (8 Weeks)|Ongoing|1|||
147385581|NCT00446095|531573320|FG003|Phase II (8 Weeks)|Ongoing|0|||
147385582|NCT00446095|531573321|FG004|Phase II (8 Weeks)|Ongoing|0|||
147385583|NCT00446095|531573317|FG000|Phase I (28 Days)|Adverse Event|0|||
147385584|NCT00446095|531573318|FG001|Phase I (28 Days)|Adverse Event|0|||
147385585|NCT00446095|531573319|FG002|Phase I (28 Days)|Adverse Event|0|||
147385586|NCT00446095|531573320|FG003|Phase I (28 Days)|Adverse Event|1|||
147385587|NCT00446095|531573321|FG004|Phase I (28 Days)|Adverse Event|0|||
147385588|NCT00446095|531573317|FG000|Phase I (28 Days)|Lack of Efficacy|0|||
147385589|NCT00446095|531573318|FG001|Phase I (28 Days)|Lack of Efficacy|0|||
147385590|NCT00446095|531573319|FG002|Phase I (28 Days)|Lack of Efficacy|0|||
147385591|NCT00446095|531573320|FG003|Phase I (28 Days)|Lack of Efficacy|0|||
147385592|NCT00446095|531573321|FG004|Phase I (28 Days)|Lack of Efficacy|3|||
147385593|NCT00657709|531573323|FG000|Overall Study|AE or Death|7|||
147385594|NCT00657709|531573324|FG001|Overall Study|AE or Death|7|||
147385595|NCT00657709|531573325|FG002|Overall Study|AE or Death|6|||
147385596|NCT00657709|531573326|FG003|Overall Study|AE or Death|7|||
147385597|NCT00657709|531573327|FG004|Overall Study|AE or Death|1|||
147385598|NCT00657709|531573323|FG000|Overall Study|Withdrawal by Subject|7|||
147385599|NCT00657709|531573324|FG001|Overall Study|Withdrawal by Subject|15|||
147385600|NCT00657709|531573325|FG002|Overall Study|Withdrawal by Subject|15|||
147385601|NCT00657709|531573326|FG003|Overall Study|Withdrawal by Subject|5|||
147385602|NCT00657709|531573327|FG004|Overall Study|Withdrawal by Subject|9|||
147385603|NCT00657709|531573323|FG000|Overall Study|Lost to Follow-up|9|||
147385604|NCT00657709|531573324|FG001|Overall Study|Lost to Follow-up|9|||
147385605|NCT00657709|531573325|FG002|Overall Study|Lost to Follow-up|7|||
147385606|NCT00657709|531573326|FG003|Overall Study|Lost to Follow-up|1|||
147385607|NCT00657709|531573327|FG004|Overall Study|Lost to Follow-up|21|||
147385608|NCT00657709|531573323|FG000|Overall Study|Protocol Violation|0|||
147385609|NCT00657709|531573324|FG001|Overall Study|Protocol Violation|2|||
147385610|NCT00657709|531573325|FG002|Overall Study|Protocol Violation|0|||
147385611|NCT00657709|531573326|FG003|Overall Study|Protocol Violation|1|||
147385612|NCT00657709|531573327|FG004|Overall Study|Protocol Violation|2|||
147385613|NCT00886834|531573328|FG000|Overall Study|Protocol Violation|0|||
147385614|NCT00886834|531573329|FG001|Overall Study|Protocol Violation|3|||
147385615|NCT02764320|531573330|FG000|Overall Study|Withdrawal by Subject|35|||
147385616|NCT02764320|531573331|FG001|Overall Study|Withdrawal by Subject|38|||
147385617|NCT02764320|531573330|FG000|Overall Study|Protocol Violation|11|||
147385618|NCT02764320|531573331|FG001|Overall Study|Protocol Violation|6|||
147385619|NCT02764320|531573330|FG000|Overall Study|Adverse Event|2|||
147385620|NCT02764320|531573331|FG001|Overall Study|Adverse Event|0|||
147385621|NCT02764320|531573330|FG000|Overall Study|Health Issues unable to continue|2|||
147385622|NCT02764320|531573331|FG001|Overall Study|Health Issues unable to continue|0|||
147385623|NCT02764320|531573330|FG000|Overall Study|Did not meet inclusion criteria|1|||
147385624|NCT02764320|531573331|FG001|Overall Study|Did not meet inclusion criteria|0|||
147385625|NCT02764320|531573330|FG000|Overall Study|Subject moved|0|||
147385626|NCT02764320|531573331|FG001|Overall Study|Subject moved|2|||
147385627|NCT02764320|531573330|FG000|Overall Study|Overused medication unavailable|0|||
147385628|NCT02764320|531573331|FG001|Overall Study|Overused medication unavailable|1|||
147385629|NCT02764320|531573330|FG000|Overall Study|Seeking care outside site|0|||
147385630|NCT02764320|531573331|FG001|Overall Study|Seeking care outside site|1|||
147385631|NCT02764320|531573330|FG000|Overall Study|Technology barriers|0|||
147385632|NCT02764320|531573331|FG001|Overall Study|Technology barriers|1|||
147385633|NCT00753896|531573332|FG000|Overall Study|Adverse Event|4|||
147385634|NCT00753896|531573332|FG000|Overall Study|Death|1|||
147385635|NCT00753896|531573332|FG000|Overall Study|Lost to Follow-up|2|||
147385636|NCT00753896|531573332|FG000|Overall Study|Protocol Violation|1|||
147385637|NCT00753896|531573332|FG000|Overall Study|Withdrawal by Subject|4|||
147385638|NCT00753896|531573332|FG000|Overall Study|Entry Criteria Not Met|4|||
147385639|NCT01280656|531573333|FG000|Overall Study|Adverse Event|1|||
147385640|NCT01280656|531573334|FG001|Overall Study|Adverse Event|14|||
147385641|NCT01280656|531573335|FG002|Overall Study|Adverse Event|13|||
147385642|NCT01280656|531573333|FG000|Overall Study|Lack of Efficacy|1|||
147385643|NCT01280656|531573334|FG001|Overall Study|Lack of Efficacy|22|||
147385644|NCT01280656|531573335|FG002|Overall Study|Lack of Efficacy|38|||
147385645|NCT01280656|531573333|FG000|Overall Study|Treatment shortening (RGT)|0|||
147385646|NCT01280656|531573334|FG001|Overall Study|Treatment shortening (RGT)|4|||
147385647|NCT01280656|531573335|FG002|Overall Study|Treatment shortening (RGT)|5|||
147385648|NCT01280656|531573333|FG000|Overall Study|Other|1|||
147385649|NCT01280656|531573334|FG001|Overall Study|Other|7|||
147385650|NCT01280656|531573335|FG002|Overall Study|Other|7|||
147385651|NCT02959866|531573336|FG000|Overall Study|Withdrawal by Subject|1|||
147385652|NCT03150589|531573337|FG000|Overall Study|Withdrawal by Subject|16|||
147385653|NCT03150589|531573338|FG001|Overall Study|Withdrawal by Subject|9|||
147385654|NCT03150589|531573337|FG000|Overall Study|Adverse Event|7|||
147385655|NCT03150589|531573338|FG001|Overall Study|Adverse Event|6|||
147385656|NCT03150589|531573337|FG000|Overall Study|Protocol Violation|4|||
147385657|NCT03150589|531573338|FG001|Overall Study|Protocol Violation|3|||
147385658|NCT03150589|531573337|FG000|Overall Study|Lost to Follow-up|3|||
147385659|NCT03150589|531573338|FG001|Overall Study|Lost to Follow-up|3|||
147385660|NCT03150589|531573337|FG000|Overall Study|Death|2|||
147385661|NCT03150589|531573338|FG001|Overall Study|Death|3|||
147385662|NCT03150589|531573337|FG000|Overall Study|IP non-compliance and other reasons|12|||
147385663|NCT03150589|531573338|FG001|Overall Study|IP non-compliance and other reasons|3|||
147385664|NCT01405508|531573339|FG000|Overall Study|AE, non-serious non-fatal|1|||
147385665|NCT01405508|531573340|FG001|Overall Study|AE, non-serious non-fatal|1|||
147385666|NCT01405508|531573341|FG002|Overall Study|AE, non-serious non-fatal|0|||
147385667|NCT01405508|531573342|FG003|Overall Study|AE, non-serious non-fatal|0|||
147456803|NCT05689047|531833430|FG000|Overall Study|Protocol Deviation|1|||
147456804|NCT05689047|531833431|FG001|Overall Study|Protocol Deviation|0|||
147385668|NCT00476957|531573343|FG000|Overall Study|Lost to Follow-up|176|||
147385669|NCT00476957|531573344|FG001|Overall Study|Lost to Follow-up|193|||
147385670|NCT00409747|531573349|FG000|Overall Study|Withdrawal by Subject|1|||
147385671|NCT02006641|531573351|FG000|Overall Study|Withdrawal before treatment|2|||
147385672|NCT02006641|531573352|FG001|Overall Study|Withdrawal before treatment|5|||
147385673|NCT02006641|531573353|FG002|Overall Study|Withdrawal before treatment|3|||
147385674|NCT02006641|531573351|FG000|Overall Study|Adverse Event|15|||
147385675|NCT02006641|531573352|FG001|Overall Study|Adverse Event|11|||
147385676|NCT02006641|531573353|FG002|Overall Study|Adverse Event|15|||
147385677|NCT02006641|531573351|FG000|Overall Study|Protocol Violation|0|||
147385678|NCT02006641|531573352|FG001|Overall Study|Protocol Violation|2|||
147385679|NCT02006641|531573353|FG002|Overall Study|Protocol Violation|2|||
147385680|NCT02006641|531573351|FG000|Overall Study|Lost to Follow-up|0|||
147385681|NCT02006641|531573352|FG001|Overall Study|Lost to Follow-up|1|||
147385682|NCT02006641|531573353|FG002|Overall Study|Lost to Follow-up|0|||
147385683|NCT02006641|531573351|FG000|Overall Study|Withdrawal by Subject|7|||
147385684|NCT02006641|531573352|FG001|Overall Study|Withdrawal by Subject|12|||
147385685|NCT02006641|531573353|FG002|Overall Study|Withdrawal by Subject|11|||
147385686|NCT02006641|531573351|FG000|Overall Study|Other reason: patient didn't show up|1|||
147385687|NCT02006641|531573352|FG001|Overall Study|Other reason: patient didn't show up|0|||
147385688|NCT02006641|531573353|FG002|Overall Study|Other reason: patient didn't show up|0|||
147385689|NCT02006641|531573351|FG000|Overall Study|Other reason:patient didn't want to come|0|||
147385690|NCT02006641|531573352|FG001|Overall Study|Other reason:patient didn't want to come|0|||
147385691|NCT02006641|531573353|FG002|Overall Study|Other reason:patient didn't want to come|1|||
147456805|NCT03083886|531833432|FG000|Overall Study|Withdrawal by Subject|51|||
147385692|NCT02006641|531573351|FG000|Overall Study|Other reason: patient has moved|1|||
147385693|NCT02006641|531573352|FG001|Overall Study|Other reason: patient has moved|0|||
147385694|NCT02006641|531573353|FG002|Overall Study|Other reason: patient has moved|1|||
147385695|NCT02006641|531573351|FG000|Overall Study|Other reason: caregiver in hospital|0|||
147385696|NCT02006641|531573352|FG001|Overall Study|Other reason: caregiver in hospital|1|||
147385697|NCT02006641|531573353|FG002|Overall Study|Other reason: caregiver in hospital|0|||
147385698|NCT02006641|531573351|FG000|Overall Study|Other reason: patient's wife has died|0|||
147385699|NCT02006641|531573352|FG001|Overall Study|Other reason: patient's wife has died|0|||
147385700|NCT02006641|531573353|FG002|Overall Study|Other reason: patient's wife has died|1|||
147385701|NCT02006641|531573351|FG000|Overall Study|Other reason: hospitalisation|0|||
147385702|NCT02006641|531573352|FG001|Overall Study|Other reason: hospitalisation|1|||
147385703|NCT02006641|531573353|FG002|Overall Study|Other reason: hospitalisation|0|||
147385704|NCT02006641|531573351|FG000|Overall Study|Other reason: caregiver impossibility|0|||
147385705|NCT02006641|531573352|FG001|Overall Study|Other reason: caregiver impossibility|0|||
147385706|NCT02006641|531573353|FG002|Overall Study|Other reason: caregiver impossibility|1|||
147385707|NCT02006641|531573351|FG000|Overall Study|Other reason: protocol non-compliance|0|||
147385708|NCT02006641|531573352|FG001|Overall Study|Other reason: protocol non-compliance|0|||
147385709|NCT02006641|531573353|FG002|Overall Study|Other reason: protocol non-compliance|1|||
147385710|NCT02132195|531573354|FG000|Initial Assignment|Relapsed|14|||
147385711|NCT02132195|531573355|FG001|Initial Assignment|Relapsed|0|||
147385712|NCT02132195|531573356|FG002|Initial Assignment|Relapsed|0|||
147385713|NCT02132195|531573354|FG000|Rescue Therapy|Relapsed|0|||
147385714|NCT02132195|531573355|FG001|Rescue Therapy|Relapsed|0|||
147385715|NCT02132195|531573356|FG002|Rescue Therapy|Relapsed|7|||
147385716|NCT02132195|531573354|FG000|Rescue Therapy|Physician Decision|0|||
147385717|NCT02132195|531573355|FG001|Rescue Therapy|Physician Decision|0|||
147385718|NCT02132195|531573356|FG002|Rescue Therapy|Physician Decision|1|||
147385719|NCT02132195|531573354|FG000|Rescue Therapy|Withdrawal by Subject|0|||
147385720|NCT02132195|531573355|FG001|Rescue Therapy|Withdrawal by Subject|0|||
147385721|NCT02132195|531573356|FG002|Rescue Therapy|Withdrawal by Subject|1|||
147385722|NCT02132195|531573354|FG000|Rescue Therapy|Adverse Event|0|||
147385723|NCT02132195|531573355|FG001|Rescue Therapy|Adverse Event|0|||
147385724|NCT02132195|531573356|FG002|Rescue Therapy|Adverse Event|2|||
147385725|NCT01287832|531573357|FG000|Overall Study|Adverse Event|1|||
147385726|NCT01287832|531573358|FG001|Overall Study|Adverse Event|0|||
147385727|NCT01287832|531573357|FG000|Overall Study|Death|0|||
147385728|NCT01287832|531573358|FG001|Overall Study|Death|1|||
147385729|NCT04749797|531573359|FG000|Overall Study|Did not meet I/E criteria after surgery|1|||
147385730|NCT04749797|531573360|FG001|Overall Study|Did not meet I/E criteria after surgery|0|||
147385731|NCT04749797|531573361|FG002|Overall Study|Did not meet I/E criteria after surgery|0|||
147385732|NCT00632736|531573362|FG000|Overall Study|Adverse Event|104|||
147385733|NCT00632736|531573362|FG000|Overall Study|Lost to Follow-up|15|||
147385734|NCT00632736|531573362|FG000|Overall Study|Protocol Violation|14|||
147385735|NCT00632736|531573362|FG000|Overall Study|Withdrawal by Subject|99|||
147385736|NCT00632736|531573362|FG000|Overall Study|Lack of Efficacy|5|||
147385737|NCT00632736|531573362|FG000|Overall Study|Sponsor terminated study|5|||
147385738|NCT00632736|531573362|FG000|Overall Study|Non-compliance|10|||
147385739|NCT00632736|531573362|FG000|Overall Study|Other|16|||
147385740|NCT00537914|531573363|FG000|Overall Study|Death|1|||
147385741|NCT00537914|531573363|FG000|Overall Study|Adverse Event|7|||
147385742|NCT00537914|531573363|FG000|Overall Study|Treatment failure|10|||
147385743|NCT00537914|531573363|FG000|Overall Study|patients documented other as reason for study discontinuation|16|||
147456806|NCT03083886|531833433|FG001|Overall Study|Withdrawal by Subject|73|||
147456807|NCT03083886|531833434|FG002|Overall Study|Withdrawal by Subject|104|||
147456808|NCT03083886|531833432|FG000|Overall Study|Missing Baseline data|43|||
147456809|NCT03083886|531833433|FG001|Overall Study|Missing Baseline data|42|||
147456810|NCT03083886|531833434|FG002|Overall Study|Missing Baseline data|31|||
147456811|NCT03083886|531833432|FG000|Overall Study|Investigator terminated|1|||
147385744|NCT00537914|531573363|FG000|Overall Study|Lost to Follow-up|19|||
147385745|NCT00537914|531573363|FG000|Overall Study|Withdrawal of informed consent|59|||
147385746|NCT02312258|531573364|FG000|Overall Study|Lost to Follow-up|8|||
147385747|NCT02312258|531573365|FG001|Overall Study|Lost to Follow-up|8|||
147385748|NCT02312258|531573364|FG000|Overall Study|Withdrawal by Patient|49|||
147385749|NCT02312258|531573365|FG001|Overall Study|Withdrawal by Patient|76|||
147385750|NCT02312258|531573364|FG000|Overall Study|Reason not Specified|107|||
147385751|NCT02312258|531573365|FG001|Overall Study|Reason not Specified|159|||
147385752|NCT02312258|531573364|FG000|Overall Study|Missing|2|||
147385753|NCT02312258|531573365|FG001|Overall Study|Missing|1|||
147385754|NCT02312258|531573364|FG000|Overall Study|Death|115|||
147385755|NCT02312258|531573365|FG001|Overall Study|Death|181|||
147385756|NCT01766206|531573366|FG000|Overall Study|Withdrawal by Subject|22|||
147385757|NCT01766206|531573366|FG000|Overall Study|Lost to Follow-up|10|||
147385758|NCT01766206|531573366|FG000|Overall Study|Inappropriate enrollment|18|||
147385759|NCT01766206|531573366|FG000|Overall Study|Withdrawal and inappropriate enrollment|1|||
147385760|NCT01662505|531573367|FG000|Overall Study|Progressive disease|6|||
147385761|NCT01662505|531573368|FG001|Overall Study|Progressive disease|1|||
147385762|NCT01662505|531573369|FG002|Overall Study|Progressive disease|5|||
147385763|NCT01662505|531573367|FG000|Overall Study|Refused cont. medication|0|||
147385764|NCT01662505|531573368|FG001|Overall Study|Refused cont. medication|0|||
147385765|NCT01662505|531573369|FG002|Overall Study|Refused cont. medication|1|||
147385766|NCT01662505|531573367|FG000|Overall Study|Not specified above|1|||
147385767|NCT01662505|531573368|FG001|Overall Study|Not specified above|3|||
147385768|NCT01662505|531573369|FG002|Overall Study|Not specified above|2|||
147385769|NCT01313663|531573370|FG000|Overall Study|Study Closed/Terminated|2|||
147385770|NCT01313663|531573371|FG001|Overall Study|Study Closed/Terminated|4|||
147385771|NCT01313663|531573370|FG000|Overall Study|Lost to Follow-up|0|||
147385772|NCT01313663|531573371|FG001|Overall Study|Lost to Follow-up|1|||
147385773|NCT01313663|531573370|FG000|Overall Study|Physician Decision|0|||
147385774|NCT01313663|531573371|FG001|Overall Study|Physician Decision|2|||
147385775|NCT01313663|531573370|FG000|Overall Study|Withdrawal by Subject|2|||
147385776|NCT01313663|531573371|FG001|Overall Study|Withdrawal by Subject|1|||
147385777|NCT01661972|531573374|FG000|Overall Study|Adverse Event|1|||
147385778|NCT01661972|531573375|FG001|Overall Study|Adverse Event|2|||
147385779|NCT01661972|531573374|FG000|Overall Study|Death during Treatment period|1|||
147385780|NCT01661972|531573375|FG001|Overall Study|Death during Treatment period|1|||
147385781|NCT01661972|531573374|FG000|Overall Study|Withdrawal by Subject|0|||
147385782|NCT01661972|531573375|FG001|Overall Study|Withdrawal by Subject|1|||
147385783|NCT02367794|531573380|FG000|Overall Study|Death|252|||
147385784|NCT02367794|531573381|FG001|Overall Study|Death|245|||
147385785|NCT02367794|531573382|FG002|Overall Study|Death|243|||
147385786|NCT02367794|531573380|FG000|Overall Study|Lost to Follow-up|1|||
147385787|NCT02367794|531573381|FG001|Overall Study|Lost to Follow-up|2|||
147385788|NCT02367794|531573382|FG002|Overall Study|Lost to Follow-up|2|||
147385789|NCT02367794|531573380|FG000|Overall Study|Physician Decision|0|||
147385790|NCT02367794|531573381|FG001|Overall Study|Physician Decision|5|||
147385791|NCT02367794|531573382|FG002|Overall Study|Physician Decision|3|||
147385792|NCT02367794|531573380|FG000|Overall Study|Protocol Violation|1|||
147385793|NCT02367794|531573381|FG001|Overall Study|Protocol Violation|0|||
147385794|NCT02367794|531573382|FG002|Overall Study|Protocol Violation|1|||
147385795|NCT02367794|531573380|FG000|Overall Study|Withdrawal by Subject|25|||
147385796|NCT02367794|531573381|FG001|Overall Study|Withdrawal by Subject|12|||
147385797|NCT02367794|531573382|FG002|Overall Study|Withdrawal by Subject|20|||
147385798|NCT02367794|531573380|FG000|Overall Study|Brain metastasis|1|||
147385799|NCT02367794|531573381|FG001|Overall Study|Brain metastasis|0|||
147385800|NCT02367794|531573382|FG002|Overall Study|Brain metastasis|0|||
147385801|NCT02367794|531573380|FG000|Overall Study|Randomized in error|0|||
147385802|NCT02367794|531573381|FG001|Overall Study|Randomized in error|0|||
147385803|NCT02367794|531573382|FG002|Overall Study|Randomized in error|1|||
147385804|NCT02367794|531573380|FG000|Overall Study|Patient unable to receive carboplatin|0|||
147385805|NCT02367794|531573381|FG001|Overall Study|Patient unable to receive carboplatin|0|||
147385806|NCT02367794|531573382|FG002|Overall Study|Patient unable to receive carboplatin|1|||
147385807|NCT02367794|531573380|FG000|Overall Study|Hypercalcemia prior to C1D1|0|||
147385808|NCT02367794|531573381|FG001|Overall Study|Hypercalcemia prior to C1D1|0|||
147385809|NCT02367794|531573382|FG002|Overall Study|Hypercalcemia prior to C1D1|1|||
147385810|NCT02367794|531573380|FG000|Overall Study|Adverse Event|0|||
147385811|NCT02367794|531573381|FG001|Overall Study|Adverse Event|0|||
147385812|NCT02367794|531573382|FG002|Overall Study|Adverse Event|2|||
147385813|NCT02367794|531573380|FG000|Overall Study|Study Terminated By Sponsor|0|||
147385814|NCT02367794|531573381|FG001|Overall Study|Study Terminated By Sponsor|1|||
147385815|NCT02367794|531573382|FG002|Overall Study|Study Terminated By Sponsor|1|||
147385816|NCT02367794|531573380|FG000|Overall Study|Moved to Roll-Over Study|0|||
147385817|NCT02367794|531573381|FG001|Overall Study|Moved to Roll-Over Study|15|||
147385818|NCT02367794|531573382|FG002|Overall Study|Moved to Roll-Over Study|13|||
147385819|NCT02367794|531573380|FG000|Overall Study|Sponsor Request|60|||
147385820|NCT02367794|531573381|FG001|Overall Study|Sponsor Request|57|||
147385821|NCT02367794|531573382|FG002|Overall Study|Sponsor Request|45|||
147385822|NCT02367794|531573380|FG000|Overall Study|Moved into PTAP Study|0|||
147385823|NCT02367794|531573381|FG001|Overall Study|Moved into PTAP Study|2|||
147385824|NCT02367794|531573382|FG002|Overall Study|Moved into PTAP Study|3|||
147385825|NCT02367794|531573380|FG000|Overall Study|Moved to Commercial Atezolizumab Use|0|||
147385826|NCT02367794|531573381|FG001|Overall Study|Moved to Commercial Atezolizumab Use|2|||
147385827|NCT02367794|531573382|FG002|Overall Study|Moved to Commercial Atezolizumab Use|1|||
147385828|NCT02367794|531573380|FG000|Overall Study|Investigational Product Availability in Commercial Stock|0|||
147385829|NCT02367794|531573381|FG001|Overall Study|Investigational Product Availability in Commercial Stock|1|||
147456812|NCT03083886|531833433|FG001|Overall Study|Investigator terminated|6|||
147456813|NCT03083886|531833434|FG002|Overall Study|Investigator terminated|3|||
147615032|NCT02586688|532406576|FG000|Overall Study|Lost to Follow-up|2|||
147615033|NCT02586688|532406577|FG001|Overall Study|Lost to Follow-up|1|||
147385830|NCT02367794|531573382|FG002|Overall Study|Investigational Product Availability in Commercial Stock|0|||
147385831|NCT02367794|531573380|FG000|Overall Study|Participant Enrolled in Extended Protocol|0|||
147385832|NCT02367794|531573381|FG001|Overall Study|Participant Enrolled in Extended Protocol|1|||
147385833|NCT02367794|531573382|FG002|Overall Study|Participant Enrolled in Extended Protocol|0|||
147456814|NCT03178487|531833435|FG000|Period 1|Adverse Event|1|||
147385834|NCT02367794|531573380|FG000|Overall Study|Discontinuation Matched Treatment Discontinuation|0|||
147385835|NCT02367794|531573381|FG001|Overall Study|Discontinuation Matched Treatment Discontinuation|0|||
147385836|NCT02367794|531573382|FG002|Overall Study|Discontinuation Matched Treatment Discontinuation|1|||
147385837|NCT02340806|531573384|FG000|Overall Study|Protocol Violation|2|||
147385838|NCT02340806|531573385|FG001|Overall Study|Protocol Violation|0|||
147385839|NCT02340806|531573384|FG000|Overall Study|epidural catheter replaced|2|||
147385840|NCT02340806|531573385|FG001|Overall Study|epidural catheter replaced|1|||
147385841|NCT02340806|531573384|FG000|Overall Study|history of chronic pain medication|1|||
147385842|NCT02340806|531573385|FG001|Overall Study|history of chronic pain medication|0|||
147385843|NCT02340806|531573384|FG000|Overall Study|re-dose < 90 min of CSE|1|||
147385844|NCT02340806|531573385|FG001|Overall Study|re-dose < 90 min of CSE|3|||
147385845|NCT01186809|531573386|FG000|Overall Study|Death|30|||
147385846|NCT04895085|531573387|FG000|Overall Study|Death|1|||
147385847|NCT04895085|531573387|FG000|Overall Study|Withdrawal by Subject|1|||
147385848|NCT04895085|531573387|FG000|Overall Study|No longer eligible: Moved from area|1|||
147385849|NCT05379400|531574921|FG000|Overall Study|Lost to Follow-up|1|||
147385850|NCT05379400|531574922|FG001|Overall Study|Lost to Follow-up|1|||
147385851|NCT01922102|531574923|FG000|Overall Study|Withdrawal by Subject|7|||
147385852|NCT01922102|531574924|FG001|Overall Study|Withdrawal by Subject|3|||
147385853|NCT01922102|531574925|FG002|Overall Study|Withdrawal by Subject|7|||
147385854|NCT01922102|531574923|FG000|Overall Study|Physician Decision|0|||
147385855|NCT01922102|531574924|FG001|Overall Study|Physician Decision|2|||
147385856|NCT01922102|531574925|FG002|Overall Study|Physician Decision|1|||
147385857|NCT01922102|531574923|FG000|Overall Study|Adverse Event|1|||
147385858|NCT01922102|531574924|FG001|Overall Study|Adverse Event|2|||
147385859|NCT01922102|531574925|FG002|Overall Study|Adverse Event|0|||
147385860|NCT01922102|531574923|FG000|Overall Study|Lost to Follow-up|1|||
147385861|NCT01922102|531574924|FG001|Overall Study|Lost to Follow-up|0|||
147385862|NCT01922102|531574925|FG002|Overall Study|Lost to Follow-up|0|||
147385863|NCT01922102|531574923|FG000|Overall Study|Administrative problems|0|||
147385864|NCT01922102|531574924|FG001|Overall Study|Administrative problems|2|||
147385865|NCT01922102|531574925|FG002|Overall Study|Administrative problems|0|||
147385866|NCT01345253|531574930|FG000|Double-blind (DB) Phase (52 Weeks)|Adverse Event|22|||
147385867|NCT01345253|531574931|FG001|Double-blind (DB) Phase (52 Weeks)|Adverse Event|27|||
147385868|NCT01345253|531574930|FG000|Double-blind (DB) Phase (52 Weeks)|Lack of Efficacy|11|||
147385869|NCT01345253|531574931|FG001|Double-blind (DB) Phase (52 Weeks)|Lack of Efficacy|7|||
147385870|NCT01345253|531574930|FG000|Double-blind (DB) Phase (52 Weeks)|Protocol Violation|1|||
147385871|NCT01345253|531574931|FG001|Double-blind (DB) Phase (52 Weeks)|Protocol Violation|5|||
147385872|NCT01345253|531574930|FG000|Double-blind (DB) Phase (52 Weeks)|Met Protocol Defined Stopping Criteria|6|||
147385873|NCT01345253|531574931|FG001|Double-blind (DB) Phase (52 Weeks)|Met Protocol Defined Stopping Criteria|1|||
147385874|NCT01345253|531574930|FG000|Double-blind (DB) Phase (52 Weeks)|Lost to Follow-up|3|||
147385875|NCT01345253|531574931|FG001|Double-blind (DB) Phase (52 Weeks)|Lost to Follow-up|8|||
147385876|NCT01345253|531574930|FG000|Double-blind (DB) Phase (52 Weeks)|Physician Decision|4|||
147385877|NCT01345253|531574931|FG001|Double-blind (DB) Phase (52 Weeks)|Physician Decision|12|||
147385878|NCT01345253|531574930|FG000|Double-blind (DB) Phase (52 Weeks)|Withdrawal by Subject|9|||
147385879|NCT01345253|531574931|FG001|Double-blind (DB) Phase (52 Weeks)|Withdrawal by Subject|19|||
147385880|NCT01345253|531574930|FG000|Open-label Phase (Up to Year 5 Week 44)|Adverse Event|7|||
147385881|NCT01345253|531574931|FG001|Open-label Phase (Up to Year 5 Week 44)|Adverse Event|18|||
147385882|NCT01345253|531574930|FG000|Open-label Phase (Up to Year 5 Week 44)|Death|0|||
147385883|NCT01345253|531574931|FG001|Open-label Phase (Up to Year 5 Week 44)|Death|1|||
147385884|NCT01345253|531574930|FG000|Open-label Phase (Up to Year 5 Week 44)|Lack of Efficacy|3|||
147456815|NCT03178487|531833436|FG001|Period 1|Adverse Event|2|||
147456816|NCT03178487|531833435|FG000|Period 1|Withdrawal by Subject|2|||
147456817|NCT03178487|531833436|FG001|Period 1|Withdrawal by Subject|1|||
147615034|NCT02586688|532406576|FG000|Overall Study|Withdrawal by Subject|1|||
147615035|NCT02586688|532406577|FG001|Overall Study|Withdrawal by Subject|1|||
147615036|NCT02586688|532406576|FG000|Overall Study|Adverse Event|3|||
147385885|NCT01345253|531574931|FG001|Open-label Phase (Up to Year 5 Week 44)|Lack of Efficacy|7|||
147385886|NCT01345253|531574930|FG000|Open-label Phase (Up to Year 5 Week 44)|Protocol Violation|2|||
147385887|NCT01345253|531574931|FG001|Open-label Phase (Up to Year 5 Week 44)|Protocol Violation|5|||
147385888|NCT01345253|531574930|FG000|Open-label Phase (Up to Year 5 Week 44)|Lost to Follow-up|4|||
147385889|NCT01345253|531574931|FG001|Open-label Phase (Up to Year 5 Week 44)|Lost to Follow-up|6|||
147385890|NCT01345253|531574930|FG000|Open-label Phase (Up to Year 5 Week 44)|Physician Decision|11|||
147385891|NCT01345253|531574931|FG001|Open-label Phase (Up to Year 5 Week 44)|Physician Decision|24|||
147385892|NCT01345253|531574930|FG000|Open-label Phase (Up to Year 5 Week 44)|Withdrawal by Subject|37|||
147385893|NCT01345253|531574931|FG001|Open-label Phase (Up to Year 5 Week 44)|Withdrawal by Subject|82|||
147385894|NCT01345253|531574930|FG000|Open-label Phase (Up to Year 5 Week 44)|Not Recorded|1|||
147385895|NCT01345253|531574931|FG001|Open-label Phase (Up to Year 5 Week 44)|Not Recorded|1|||
147385896|NCT05361304|531574934|FG000|Overall Study|Senofilcon A contact lenses made with a novel manufacturing technology Article Not Available.|1|||
147456818|NCT03178487|531833435|FG000|Period 1|Lost to Follow-up|1|||
147385897|NCT05361304|531574935|FG001|Overall Study|Senofilcon A contact lenses made with a novel manufacturing technology Article Not Available.|0|||
147385898|NCT05361304|531574934|FG000|Overall Study|COVID-19 Related|1|||
147385899|NCT05361304|531574935|FG001|Overall Study|COVID-19 Related|2|||
147385900|NCT05361304|531574934|FG000|Overall Study|Withdrawal by Subject|1|||
147385901|NCT05361304|531574935|FG001|Overall Study|Withdrawal by Subject|0|||
147385902|NCT00476151|531574936|FG000|Overall Study|Adverse Event|0|||
147385903|NCT00476151|531574937|FG001|Overall Study|Adverse Event|2|||
147385904|NCT00476151|531574936|FG000|Overall Study|Protocol Violation|1|||
147385905|NCT00476151|531574937|FG001|Overall Study|Protocol Violation|3|||
147385906|NCT00476151|531574936|FG000|Overall Study|Withdrawal by Subject|2|||
147385907|NCT00476151|531574937|FG001|Overall Study|Withdrawal by Subject|0|||
147385908|NCT00476151|531574936|FG000|Overall Study|Physician Decision|0|||
147385909|NCT00476151|531574937|FG001|Overall Study|Physician Decision|2|||
147385910|NCT03557307|531574941|FG000|Period 1: To End of OCS Reduction Phase|Withdrawal by Subject|10|||
147385911|NCT03557307|531574941|FG000|Period 1: To End of OCS Reduction Phase|Adverse Event|7|||
147385912|NCT03557307|531574941|FG000|Period 1: To End of OCS Reduction Phase|Protocol Violation|6|||
147385913|NCT03557307|531574941|FG000|Period 1: To End of OCS Reduction Phase|Lost to Follow-up|5|||
147385914|NCT03557307|531574941|FG000|Period 1: To End of OCS Reduction Phase|other|3|||
147385915|NCT03557307|531574941|FG000|Period 1: To End of OCS Reduction Phase|Death|2|||
147385916|NCT03557307|531574941|FG000|Period 1: To End of OCS Reduction Phase|Failure to meet inclusion/exclusion criteria|2|||
147385917|NCT03557307|531574941|FG000|Period 2: Maintenance Phase|Adverse Event|4|||
147385918|NCT03557307|531574941|FG000|Period 2: Maintenance Phase|Death|3|||
147385919|NCT03557307|531574941|FG000|Period 2: Maintenance Phase|Lost to Follow-up|2|||
147385920|NCT03557307|531574941|FG000|Period 2: Maintenance Phase|Pregnancy|2|||
147385921|NCT03557307|531574941|FG000|Period 2: Maintenance Phase|Protocol Violation|11|||
147385922|NCT03557307|531574941|FG000|Period 2: Maintenance Phase|Withdrawal by Subject|2|||
147385923|NCT03557307|531574941|FG000|Period 2: Maintenance Phase|other|3|||
147385924|NCT04239911|531574944|FG000|Overall Study|Lost to Follow-up|2|||
147385925|NCT04239911|531574945|FG001|Overall Study|Lost to Follow-up|1|||
147385926|NCT03456856|531574946|FG000|Overall Study|Lost to Follow-up|2|||
147385927|NCT03456856|531574946|FG000|Overall Study|Withdrawal by Subject|1|||
147385928|NCT03262389|531574949|FG000|Overall Study|Machine malfunction Day 1, no return Day 2|1|||
147385929|NCT03262389|531574949|FG000|Overall Study|opted out of the study once his clinical FDG PET CT was done.|1|||
147385930|NCT03262389|531574949|FG000|Overall Study|opted out of PET/MR|1|||
147385931|NCT01052272|531574950|FG000|Overall Study|Death|0|||
147385932|NCT01052272|531574951|FG001|Overall Study|Death|0|||
147385933|NCT01052272|531574952|FG002|Overall Study|Death|1|||
147385934|NCT01052272|531574953|FG003|Overall Study|Death|1|||
147385935|NCT01052272|531574950|FG000|Overall Study|Physician Decision|0|||
147385936|NCT01052272|531574951|FG001|Overall Study|Physician Decision|1|||
147385937|NCT01052272|531574952|FG002|Overall Study|Physician Decision|0|||
147385938|NCT01052272|531574953|FG003|Overall Study|Physician Decision|0|||
147385939|NCT01052272|531574950|FG000|Overall Study|patient refuses follow-up|5|||
147385940|NCT01052272|531574951|FG001|Overall Study|patient refuses follow-up|4|||
147385941|NCT01052272|531574952|FG002|Overall Study|patient refuses follow-up|2|||
147385942|NCT01052272|531574953|FG003|Overall Study|patient refuses follow-up|4|||
147385943|NCT01052272|531574950|FG000|Overall Study|Withdrawal by Subject|0|||
147385944|NCT01052272|531574951|FG001|Overall Study|Withdrawal by Subject|2|||
147385945|NCT01052272|531574952|FG002|Overall Study|Withdrawal by Subject|3|||
147385946|NCT01052272|531574953|FG003|Overall Study|Withdrawal by Subject|2|||
147385947|NCT01052272|531574950|FG000|Overall Study|placed in long-term care|0|||
147385948|NCT01052272|531574951|FG001|Overall Study|placed in long-term care|0|||
147385949|NCT01052272|531574952|FG002|Overall Study|placed in long-term care|1|||
147385950|NCT01052272|531574953|FG003|Overall Study|placed in long-term care|0|||
147385951|NCT01052272|531574950|FG000|Overall Study|decline in health|0|||
147456819|NCT03178487|531833436|FG001|Period 1|Lost to Follow-up|0|||
147385952|NCT01052272|531574951|FG001|Overall Study|decline in health|0|||
147385953|NCT01052272|531574952|FG002|Overall Study|decline in health|1|||
147385954|NCT01052272|531574953|FG003|Overall Study|decline in health|0|||
147385955|NCT00096278|531574958|FG000|Overall Study|No follow-up data|15|||
147385956|NCT00096278|531574959|FG001|Overall Study|No follow-up data|18|||
147385957|NCT00096278|531574958|FG000|Overall Study|Patient not at risk for primary endpoint|3|||
147385958|NCT00096278|531574959|FG001|Overall Study|Patient not at risk for primary endpoint|2|||
147385959|NCT02865083|531574960|FG000|Overall Study|Early Termination|3|||
147385960|NCT02865083|531574961|FG001|Overall Study|Early Termination|1|||
147385961|NCT02105688|531574962|FG000|Part A: Double-Blind|Adverse Event|1|||
147385962|NCT02105688|531574963|FG001|Part A: Double-Blind|Adverse Event|0|||
147385963|NCT02105688|531574962|FG000|Part A: Double-Blind|Death|0|||
147385964|NCT02105688|531574963|FG001|Part A: Double-Blind|Death|1|||
147385965|NCT02105688|531574962|FG000|Part A: Double-Blind|Lost to Follow-up|15|||
147385966|NCT02105688|531574963|FG001|Part A: Double-Blind|Lost to Follow-up|11|||
147385967|NCT02105688|531574962|FG000|Part A: Double-Blind|Physician Decision|0|||
147385968|NCT02105688|531574963|FG001|Part A: Double-Blind|Physician Decision|1|||
147385969|NCT02105688|531574962|FG000|Part A: Double-Blind|Status Unknown|0|||
147385970|NCT02105688|531574963|FG001|Part A: Double-Blind|Status Unknown|2|||
147456820|NCT03178487|531833435|FG000|Period 1|Other|0|||
147456821|NCT03178487|531833436|FG001|Period 1|Other|1|||
147456822|NCT03178487|531833435|FG000|Period 2|Adverse Event|4|||
147456823|NCT03178487|531833436|FG001|Period 2|Adverse Event|4|||
147385971|NCT02105688|531574962|FG000|Part A: Double-Blind|Withdrawal by Subject|4|||
147385972|NCT02105688|531574963|FG001|Part A: Double-Blind|Withdrawal by Subject|2|||
147385973|NCT02105688|531574962|FG000|Part B: Observational Follow-up|Death|2|||
147385974|NCT02105688|531574963|FG001|Part B: Observational Follow-up|Death|1|||
147385975|NCT02105688|531574962|FG000|Part B: Observational Follow-up|Lost to Follow-up|23|||
147385976|NCT02105688|531574963|FG001|Part B: Observational Follow-up|Lost to Follow-up|15|||
147385977|NCT02105688|531574962|FG000|Part B: Observational Follow-up|Withdrawal by Subject|9|||
147385978|NCT02105688|531574963|FG001|Part B: Observational Follow-up|Withdrawal by Subject|3|||
147385979|NCT02105688|531574962|FG000|Part B: Observational Follow-up|Physician Decision|3|||
147385980|NCT02105688|531574963|FG001|Part B: Observational Follow-up|Physician Decision|1|||
147385981|NCT01358175|531574964|FG000|Overall Study|Death|1|||
147385982|NCT01358175|531574965|FG001|Overall Study|Death|0|||
147385983|NCT01358175|531574966|FG002|Overall Study|Death|1|||
147385984|NCT01358175|531574964|FG000|Overall Study|Withdrawal by Subject|9|||
147385985|NCT01358175|531574965|FG001|Overall Study|Withdrawal by Subject|5|||
147385986|NCT01358175|531574966|FG002|Overall Study|Withdrawal by Subject|10|||
147385987|NCT01358175|531574964|FG000|Overall Study|Technical issues|0|||
147385988|NCT01358175|531574965|FG001|Overall Study|Technical issues|1|||
147385989|NCT01358175|531574966|FG002|Overall Study|Technical issues|0|||
147385990|NCT01358175|531574964|FG000|Overall Study|Pregnancy|0|||
147385991|NCT01358175|531574965|FG001|Overall Study|Pregnancy|1|||
147385992|NCT01358175|531574966|FG002|Overall Study|Pregnancy|0|||
147385993|NCT01358175|531574964|FG000|Overall Study|Physician Decision|1|||
147385994|NCT01358175|531574965|FG001|Overall Study|Physician Decision|0|||
147385995|NCT01358175|531574966|FG002|Overall Study|Physician Decision|0|||
147385996|NCT01358175|531574964|FG000|Overall Study|Non Compliance with Study Treatment|0|||
147385997|NCT01358175|531574965|FG001|Overall Study|Non Compliance with Study Treatment|1|||
147385998|NCT01358175|531574966|FG002|Overall Study|Non Compliance with Study Treatment|1|||
147385999|NCT01358175|531574964|FG000|Overall Study|Lost to Follow-up|1|||
147386000|NCT01358175|531574965|FG001|Overall Study|Lost to Follow-up|1|||
147386001|NCT01358175|531574966|FG002|Overall Study|Lost to Follow-up|3|||
147386002|NCT01358175|531574964|FG000|Overall Study|Lack of Efficacy|3|||
147386003|NCT01358175|531574965|FG001|Overall Study|Lack of Efficacy|8|||
147386004|NCT01358175|531574966|FG002|Overall Study|Lack of Efficacy|6|||
147386005|NCT01358175|531574964|FG000|Overall Study|Adverse Event|6|||
147386006|NCT01358175|531574965|FG001|Overall Study|Adverse Event|11|||
147386007|NCT01358175|531574966|FG002|Overall Study|Adverse Event|11|||
147386008|NCT04908488|531574969|FG000|First Wear Period (8 -0/+3 Days)|Adverse Event|1|||
147386009|NCT04908488|531574970|FG001|First Wear Period (8 -0/+3 Days)|Adverse Event|0|||
147386010|NCT04908488|531574969|FG000|Second Wear Period (8 -0/+3 Days)|Withdrawal by Subject|1|||
147386011|NCT04908488|531574970|FG001|Second Wear Period (8 -0/+3 Days)|Withdrawal by Subject|0|||
147386012|NCT01107912|531574972|FG000|Period 1|Adverse Event|0|||
147386013|NCT01107912|531574973|FG001|Period 1|Adverse Event|0|||
147386014|NCT01107912|531574974|FG002|Period 1|Adverse Event|0|||
147386015|NCT01107912|531574975|FG003|Period 1|Adverse Event|0|||
147386016|NCT01107912|531574976|FG004|Period 1|Adverse Event|2|||
147386017|NCT01107912|531574977|FG005|Period 1|Adverse Event|0|||
147386018|NCT01107912|531574972|FG000|Period 1|Physician Decision|0|||
147386019|NCT01107912|531574973|FG001|Period 1|Physician Decision|0|||
147456824|NCT03178487|531833435|FG000|Period 2|Withdrawal by Subject|6|||
147615037|NCT02586688|532406577|FG001|Overall Study|Adverse Event|1|||
147386020|NCT01107912|531574974|FG002|Period 1|Physician Decision|0|||
147386021|NCT01107912|531574975|FG003|Period 1|Physician Decision|0|||
147386022|NCT01107912|531574976|FG004|Period 1|Physician Decision|1|||
147386023|NCT01107912|531574977|FG005|Period 1|Physician Decision|0|||
147386024|NCT01107912|531574972|FG000|Period 1|Withdrawal by Subject|1|||
147386025|NCT01107912|531574973|FG001|Period 1|Withdrawal by Subject|0|||
147386026|NCT01107912|531574974|FG002|Period 1|Withdrawal by Subject|0|||
147615038|NCT04856917|532406578|FG000|Overall Study|Withdrawal by Subject|4|||
147386027|NCT01107912|531574975|FG003|Period 1|Withdrawal by Subject|0|||
147386028|NCT01107912|531574976|FG004|Period 1|Withdrawal by Subject|0|||
147386029|NCT01107912|531574977|FG005|Period 1|Withdrawal by Subject|0|||
147386030|NCT01107912|531574972|FG000|Period 2|Physician Decision|0|||
147386031|NCT01107912|531574973|FG001|Period 2|Physician Decision|0|||
147386032|NCT01107912|531574974|FG002|Period 2|Physician Decision|1|||
147386033|NCT01107912|531574975|FG003|Period 2|Physician Decision|0|||
147386034|NCT01107912|531574976|FG004|Period 2|Physician Decision|0|||
147386035|NCT01107912|531574977|FG005|Period 2|Physician Decision|0|||
147386036|NCT01107912|531574972|FG000|Period 3|Adverse Event|0|||
147386037|NCT01107912|531574973|FG001|Period 3|Adverse Event|1|||
147386038|NCT01107912|531574974|FG002|Period 3|Adverse Event|1|||
147386039|NCT01107912|531574975|FG003|Period 3|Adverse Event|0|||
147386040|NCT01107912|531574976|FG004|Period 3|Adverse Event|0|||
147386041|NCT01107912|531574977|FG005|Period 3|Adverse Event|0|||
147456825|NCT03178487|531833436|FG001|Period 2|Withdrawal by Subject|6|||
147456826|NCT03178487|531833435|FG000|Period 2|Lost to Follow-up|2|||
147456827|NCT03178487|531833436|FG001|Period 2|Lost to Follow-up|2|||
147456828|NCT03178487|531833435|FG000|Period 2|Coronavirus Disease 2019 (COVID-19) Logistical Restrictions|1|||
147456829|NCT03178487|531833436|FG001|Period 2|Coronavirus Disease 2019 (COVID-19) Logistical Restrictions|0|||
147456830|NCT03178487|531833435|FG000|Period 2|Other|8|||
147456831|NCT03178487|531833436|FG001|Period 2|Other|7|||
147456832|NCT04161495|531833437|FG000|Overall Study|Withdrawal by Subject|3|||
147456833|NCT04161495|531833438|FG001|Overall Study|Withdrawal by Subject|0|||
147456834|NCT04161495|531833437|FG000|Overall Study|Protocol Violation|1|||
147456835|NCT04161495|531833438|FG001|Overall Study|Protocol Violation|0|||
147456836|NCT04161495|531833437|FG000|Overall Study|Prohibited concomitant medication|3|||
147456837|NCT04161495|531833438|FG001|Overall Study|Prohibited concomitant medication|0|||
147456838|NCT04161495|531833437|FG000|Overall Study|Adverse Event|1|||
147456839|NCT04161495|531833438|FG001|Overall Study|Adverse Event|0|||
147456840|NCT04161495|531833437|FG000|Overall Study|Other - Unspecified|1|||
147456841|NCT04161495|531833438|FG001|Overall Study|Other - Unspecified|0|||
147456842|NCT04161495|531833437|FG000|Overall Study|Death|0|||
147456843|NCT04161495|531833438|FG001|Overall Study|Death|1|||
147456844|NCT00253630|531833439|FG000|Overall Study|ineligible|2|||
147456845|NCT00209339|531833442|FG000|At 12 Months Follow-up|Withdrawal by Subject|8|||
147456846|NCT00209339|531833442|FG000|At 12 Months Follow-up|Death|1|||
147456847|NCT00209339|531833442|FG000|At 12 Months Follow-up|No MitraClip Device Implanted|6|||
147456848|NCT00209339|531833442|FG000|At 24 Months Follow-up|Withdrawal by Subject|4|||
147456849|NCT00209339|531833442|FG000|At 24 Months Follow-up|Withdrawal because of other reasons|6|||
147456850|NCT00209339|531833442|FG000|At 24 Months Follow-up|Death|1|||
147456851|NCT00209339|531833442|FG000|At 3 Years Follow-up|Withdrawal by Subject|1|||
147456852|NCT00209339|531833442|FG000|At 4 Years Follow-up|Withdrawal by Subject|4|||
147456853|NCT00209339|531833442|FG000|At 4 Years Follow-up|Death|1|||
147456854|NCT00209339|531833442|FG000|At 5 Years Follow-up|Withdrawal by Subject|2|||
147456855|NCT00209339|531833442|FG000|At 5 Years Follow-up|Withdrawal because of other reasons|5|||
147456856|NCT00209339|531833442|FG000|At 5 Years Follow-up|Death|1|||
147456857|NCT00429858|531833443|FG000|Overall Study|Withdrawal by Subject|1|||
147456858|NCT00429858|531833443|FG000|Overall Study|Study Termination|1|||
147456859|NCT02268058|531833444|FG000|Overall Study|Protocol Violation|1|||
147456860|NCT02268058|531833445|FG001|Overall Study|Protocol Violation|0|||
147456861|NCT02268058|531833446|FG002|Overall Study|Protocol Violation|0|||
147456862|NCT02268058|531833447|FG003|Overall Study|Protocol Violation|0|||
147456863|NCT02475655|531833448|FG000|Overall Study|Lost to Follow-up|0|||
147456864|NCT02475655|531833449|FG001|Overall Study|Lost to Follow-up|1|||
147456865|NCT00257010|531833450|FG000|Overall Study|Lack of Efficacy|11|||
147456866|NCT00257010|531833450|FG000|Overall Study|Lost to Follow-up|53|||
147456867|NCT00257010|531833450|FG000|Overall Study|Withdrawal by Subject|34|||
147456868|NCT00257010|531833450|FG000|Overall Study|Adverse Event|10|||
147456869|NCT00257010|531833450|FG000|Overall Study|various|11|||
147456870|NCT00257010|531833450|FG000|Overall Study|no headache reported|9|||
147456871|NCT00441545|531833452|FG000|First Intervention|Adverse Event|6|||
147456872|NCT00441545|531833453|FG001|First Intervention|Adverse Event|5|||
147456873|NCT00441545|531833452|FG000|First Intervention|Protocol Violation|2|||
147456874|NCT00441545|531833453|FG001|First Intervention|Protocol Violation|2|||
147456875|NCT00441545|531833452|FG000|First Intervention|Withdrawal by Subject|3|||
147456876|NCT00441545|531833453|FG001|First Intervention|Withdrawal by Subject|3|||
147456877|NCT00441545|531833452|FG000|First Intervention|Kidney transplant|1|||
147456878|NCT00441545|531833453|FG001|First Intervention|Kidney transplant|1|||
147456879|NCT00441545|531833452|FG000|First Intervention|Lack of Efficacy|2|||
147456880|NCT00441545|531833453|FG001|First Intervention|Lack of Efficacy|0|||
147456881|NCT00441545|531833452|FG000|First Intervention|Subject exceeded safety criteria|0|||
147456882|NCT00441545|531833453|FG001|First Intervention|Subject exceeded safety criteria|1|||
147456883|NCT00441545|531833452|FG000|First Intervention|Subject met an exclusionary criteria|1|||
147456884|NCT00441545|531833453|FG001|First Intervention|Subject met an exclusionary criteria|0|||
147456885|NCT00441545|531833452|FG000|First Intervention|Extended hospitalization|1|||
147456886|NCT00441545|531833453|FG001|First Intervention|Extended hospitalization|0|||
147456887|NCT00441545|531833452|FG000|First Intervention|Site error|1|||
147456888|NCT00441545|531833453|FG001|First Intervention|Site error|0|||
147456889|NCT00441545|531833452|FG000|First Intervention|Sponsor's request|1|||
147456890|NCT00441545|531833453|FG001|First Intervention|Sponsor's request|0|||
147456891|NCT00441545|531833452|FG000|Second Intervention|Adverse Event|5|||
147664940|NCT04161391|532597965|FG001|Overall Study|Death|0|||
147456892|NCT00441545|531833453|FG001|Second Intervention|Adverse Event|2|||
147456893|NCT00441545|531833452|FG000|Second Intervention|Protocol Violation|4|||
147456894|NCT00441545|531833453|FG001|Second Intervention|Protocol Violation|1|||
147456895|NCT00441545|531833452|FG000|Second Intervention|Withdrawal by Subject|1|||
147456896|NCT00441545|531833453|FG001|Second Intervention|Withdrawal by Subject|1|||
147456897|NCT00441545|531833452|FG000|Second Intervention|Kidney Transplant|1|||
147456898|NCT00441545|531833453|FG001|Second Intervention|Kidney Transplant|1|||
147456899|NCT00441545|531833452|FG000|Second Intervention|Lack of Efficacy|0|||
147456900|NCT00441545|531833453|FG001|Second Intervention|Lack of Efficacy|1|||
147456901|NCT00441545|531833452|FG000|Second Intervention|Subject exceeded safety criteria|1|||
147386042|NCT01107912|531574972|FG000|Period 3|Withdrawal by Subject|0|||
147386043|NCT01107912|531574973|FG001|Period 3|Withdrawal by Subject|0|||
147386044|NCT01107912|531574974|FG002|Period 3|Withdrawal by Subject|0|||
147386045|NCT01107912|531574975|FG003|Period 3|Withdrawal by Subject|1|||
147386046|NCT01107912|531574976|FG004|Period 3|Withdrawal by Subject|0|||
147386047|NCT01107912|531574977|FG005|Period 3|Withdrawal by Subject|0|||
147386048|NCT01124916|531574982|FG000|Overall Study|Lost to Follow-up|3|||
147386049|NCT01124916|531574983|FG001|Overall Study|Lost to Follow-up|2|||
147386050|NCT02469155|531574990|FG000|Overall Study|Adverse Event|6|||
147386051|NCT02469155|531574991|FG001|Overall Study|Adverse Event|0|||
147386052|NCT02469155|531574992|FG002|Overall Study|Adverse Event|1|||
147386053|NCT02469155|531574993|FG003|Overall Study|Adverse Event|10|||
147386054|NCT02469155|531574990|FG000|Overall Study|Lack of Efficacy|13|||
147386055|NCT02469155|531574991|FG001|Overall Study|Lack of Efficacy|10|||
147386056|NCT02469155|531574992|FG002|Overall Study|Lack of Efficacy|10|||
147386057|NCT02469155|531574993|FG003|Overall Study|Lack of Efficacy|8|||
147386058|NCT02469155|531574990|FG000|Overall Study|Death|0|||
147386059|NCT02469155|531574991|FG001|Overall Study|Death|0|||
147386060|NCT02469155|531574992|FG002|Overall Study|Death|0|||
147386061|NCT02469155|531574993|FG003|Overall Study|Death|1|||
147386062|NCT02469155|531574990|FG000|Overall Study|Lost to Follow-up|5|||
147386063|NCT02469155|531574991|FG001|Overall Study|Lost to Follow-up|2|||
147386064|NCT02469155|531574992|FG002|Overall Study|Lost to Follow-up|7|||
147386065|NCT02469155|531574993|FG003|Overall Study|Lost to Follow-up|2|||
147386066|NCT02469155|531574990|FG000|Overall Study|Physician Decision|0|||
147386067|NCT02469155|531574991|FG001|Overall Study|Physician Decision|0|||
147386068|NCT02469155|531574992|FG002|Overall Study|Physician Decision|1|||
147386069|NCT02469155|531574993|FG003|Overall Study|Physician Decision|0|||
147386070|NCT02469155|531574990|FG000|Overall Study|Withdrawal by Subject|34|||
147386071|NCT02469155|531574991|FG001|Overall Study|Withdrawal by Subject|30|||
147386072|NCT02469155|531574992|FG002|Overall Study|Withdrawal by Subject|20|||
147386073|NCT02469155|531574993|FG003|Overall Study|Withdrawal by Subject|37|||
147386074|NCT02469155|531574990|FG000|Overall Study|Other|3|||
147386075|NCT02469155|531574991|FG001|Overall Study|Other|3|||
147386076|NCT02469155|531574992|FG002|Overall Study|Other|2|||
147386077|NCT02469155|531574993|FG003|Overall Study|Other|10|||
147386078|NCT02469155|531574990|FG000|Overall Study|Protocol Violation|0|||
147386079|NCT02469155|531574991|FG001|Overall Study|Protocol Violation|1|||
147386080|NCT02469155|531574992|FG002|Overall Study|Protocol Violation|0|||
147386081|NCT02469155|531574993|FG003|Overall Study|Protocol Violation|1|||
147386082|NCT00595959|531574994|FG000|Overall Study|Withdrawal by Subject|1|||
147386083|NCT00595959|531574994|FG000|Overall Study|Lost to Follow-up|1|||
147386084|NCT00901459|531574997|FG000|Overall Study|Withdrawal by Subject|6|||
147386085|NCT04765046|531574998|FG000|Overall Study|Screen Failure|2|||
147386086|NCT04765046|531574998|FG000|Overall Study|Withdrawal by Subject|4|||
147386087|NCT04765046|531574998|FG000|Overall Study|Physician Decision|4|||
147386088|NCT04765046|531574998|FG000|Overall Study|Surgery Cancelled|8|||
147386089|NCT03529942|531574999|FG000|Overall Study|Withdrawal by Subject|13|||
147386090|NCT03529942|531574999|FG000|Overall Study|Physician Decision|1|||
147386091|NCT03529942|531574999|FG000|Overall Study|Lost to Follow-up|7|||
147386092|NCT03529942|531574999|FG000|Overall Study|Needle inserted but no drug administered|1|||
147386093|NCT03529942|531574999|FG000|Overall Study|Personal reasons|1|||
147386094|NCT00636168|531575002|FG000|Randomized to Study Drug|Withdrawal by Subject|2|||
147386095|NCT00636168|531575003|FG001|Randomized to Study Drug|Withdrawal by Subject|2|||
147386096|NCT00636168|531575002|FG000|Randomized to Study Drug|Adverse Event|1|||
147386097|NCT00636168|531575003|FG001|Randomized to Study Drug|Adverse Event|0|||
147386098|NCT00636168|531575002|FG000|Randomized to Study Drug|No longer meets study criteria|1|||
147386099|NCT00636168|531575003|FG001|Randomized to Study Drug|No longer meets study criteria|0|||
147386100|NCT00636168|531575002|FG000|Treated With Study Drug|Recurrence of disease|135|||
147386101|NCT00636168|531575003|FG001|Treated With Study Drug|Recurrence of disease|282|||
147386102|NCT00636168|531575002|FG000|Treated With Study Drug|Adverse Event|250|||
147386103|NCT00636168|531575003|FG001|Treated With Study Drug|Adverse Event|22|||
147386104|NCT00636168|531575002|FG000|Treated With Study Drug|Participant withdrew consent|16|||
147386105|NCT00636168|531575003|FG001|Treated With Study Drug|Participant withdrew consent|21|||
147386106|NCT00636168|531575002|FG000|Treated With Study Drug|Poor/non-compliance|1|||
147386107|NCT00636168|531575003|FG001|Treated With Study Drug|Poor/non-compliance|3|||
147386108|NCT00636168|531575002|FG000|Treated With Study Drug|Death|3|||
147386109|NCT00636168|531575003|FG001|Treated With Study Drug|Death|0|||
147386110|NCT00636168|531575002|FG000|Treated With Study Drug|Pregnancy|1|||
147456902|NCT00441545|531833453|FG001|Second Intervention|Subject exceeded safety criteria|0|||
147456903|NCT00441545|531833452|FG000|Second Intervention|Subject moved|0|||
147386111|NCT00636168|531575003|FG001|Treated With Study Drug|Pregnancy|0|||
147386112|NCT00636168|531575002|FG000|Treated With Study Drug|No longer meets study criteria|1|||
147386113|NCT00636168|531575003|FG001|Treated With Study Drug|No longer meets study criteria|0|||
147386114|NCT00636168|531575002|FG000|Treated With Study Drug|Other reason|1|||
147386115|NCT00636168|531575003|FG001|Treated With Study Drug|Other reason|3|||
147386116|NCT00636168|531575002|FG000|Long Term Follow-Up|Lost to Follow-up|3|||
147386117|NCT00636168|531575003|FG001|Long Term Follow-Up|Lost to Follow-up|3|||
147386118|NCT00636168|531575002|FG000|Long Term Follow-Up|Participant withdrew consent|0|||
147386119|NCT00636168|531575003|FG001|Long Term Follow-Up|Participant withdrew consent|2|||
147386120|NCT00636168|531575002|FG000|Long Term Follow-Up|Death|8|||
147386121|NCT00636168|531575003|FG001|Long Term Follow-Up|Death|9|||
147386122|NCT03015220|531575004|FG000|Overall Study|Withdrawal by Subject|3|||
147386123|NCT03015220|531575005|FG001|Overall Study|Withdrawal by Subject|2|||
147386124|NCT03015220|531575006|FG002|Overall Study|Withdrawal by Subject|2|||
147386125|NCT03015220|531575007|FG003|Overall Study|Withdrawal by Subject|2|||
147386126|NCT03015220|531575004|FG000|Overall Study|Lost to Follow-up|0|||
147386127|NCT03015220|531575005|FG001|Overall Study|Lost to Follow-up|0|||
147386128|NCT03015220|531575006|FG002|Overall Study|Lost to Follow-up|1|||
147386129|NCT03015220|531575007|FG003|Overall Study|Lost to Follow-up|0|||
147386130|NCT02291549|531575008|FG000|Overall Study|Lost to Follow-up|1|||
147386131|NCT02291549|531575009|FG001|Overall Study|Lost to Follow-up|0|||
147386132|NCT02291549|531575008|FG000|Overall Study|Withdrawal by Subject|0|||
147386133|NCT02291549|531575009|FG001|Overall Study|Withdrawal by Subject|1|||
147386134|NCT01468597|531575011|FG000|Overall Study|Found ineligible|17|||
147386135|NCT01468597|531575011|FG000|Overall Study|concomitant valves|12|||
147386136|NCT01468597|531575011|FG000|Overall Study|off-pump CABG|1|||
147386137|NCT01468597|531575011|FG000|Overall Study|no platelet function data|5|||
147386138|NCT00912964|531575012|FG000|Overall Study|Eligibility criterion not met|1|||
147386139|NCT00912964|531575013|FG001|Overall Study|Eligibility criterion not met|1|||
147386140|NCT00912964|531575014|FG002|Overall Study|Eligibility criterion not met|0|||
147386141|NCT00912964|531575012|FG000|Overall Study|Adverse Event|15|||
147386142|NCT00912964|531575013|FG001|Overall Study|Adverse Event|18|||
147386143|NCT00912964|531575014|FG002|Overall Study|Adverse Event|12|||
147386144|NCT00912964|531575012|FG000|Overall Study|Lack of Efficacy|11|||
147386145|NCT00912964|531575013|FG001|Overall Study|Lack of Efficacy|4|||
147386146|NCT00912964|531575014|FG002|Overall Study|Lack of Efficacy|3|||
147386147|NCT00912964|531575012|FG000|Overall Study|Withdrawal by Subject|20|||
147386148|NCT00912964|531575013|FG001|Overall Study|Withdrawal by Subject|12|||
147386149|NCT00912964|531575014|FG002|Overall Study|Withdrawal by Subject|18|||
147386150|NCT00912964|531575012|FG000|Overall Study|Lost to Follow-up|4|||
147386151|NCT00912964|531575013|FG001|Overall Study|Lost to Follow-up|3|||
147386152|NCT00912964|531575014|FG002|Overall Study|Lost to Follow-up|3|||
147386153|NCT00912964|531575012|FG000|Overall Study|Protocol Violation|5|||
147386154|NCT00912964|531575013|FG001|Overall Study|Protocol Violation|3|||
147386155|NCT00912964|531575014|FG002|Overall Study|Protocol Violation|8|||
147386156|NCT00912964|531575012|FG000|Overall Study|Taking exclusionary medications|7|||
147386157|NCT00912964|531575013|FG001|Overall Study|Taking exclusionary medications|4|||
147386158|NCT00912964|531575014|FG002|Overall Study|Taking exclusionary medications|8|||
147386159|NCT00912964|531575012|FG000|Overall Study|Medical History|1|||
147386160|NCT00912964|531575013|FG001|Overall Study|Medical History|0|||
147386161|NCT00912964|531575014|FG002|Overall Study|Medical History|0|||
147386162|NCT00912964|531575012|FG000|Overall Study|Non-compliance with study procedures|2|||
147386163|NCT00912964|531575013|FG001|Overall Study|Non-compliance with study procedures|0|||
147386164|NCT00912964|531575014|FG002|Overall Study|Non-compliance with study procedures|0|||
147386165|NCT00912964|531575012|FG000|Overall Study|Violation of exclusion criterion|0|||
147386166|NCT00912964|531575013|FG001|Overall Study|Violation of exclusion criterion|0|||
147386167|NCT00912964|531575014|FG002|Overall Study|Violation of exclusion criterion|2|||
147386168|NCT00912964|531575012|FG000|Overall Study|Randomized but never received study drug|0|||
147386169|NCT00912964|531575013|FG001|Overall Study|Randomized but never received study drug|1|||
147386170|NCT00912964|531575014|FG002|Overall Study|Randomized but never received study drug|0|||
147386171|NCT04447287|531575015|FG000|Period 1: Run-in Period|Adverse Event|3|||
147386172|NCT04447287|531575016|FG001|Period 1: Run-in Period|Adverse Event|0|||
147386173|NCT04447287|531575017|FG002|Period 1: Run-in Period|Adverse Event|0|||
147386174|NCT04447287|531575015|FG000|Period 1: Run-in Period|Withdrawal by Subject|1|||
147386175|NCT04447287|531575016|FG001|Period 1: Run-in Period|Withdrawal by Subject|0|||
147386176|NCT04447287|531575017|FG002|Period 1: Run-in Period|Withdrawal by Subject|0|||
147386177|NCT04447287|531575015|FG000|Period 2: Investigational Period|Completed the run-in period but discontinued before randomization due to limited samples collected.|1|||
147386178|NCT04447287|531575016|FG001|Period 2: Investigational Period|Completed the run-in period but discontinued before randomization due to limited samples collected.|0|||
147386179|NCT04447287|531575017|FG002|Period 2: Investigational Period|Completed the run-in period but discontinued before randomization due to limited samples collected.|0|||
147386180|NCT00655824|531575020|FG000|Overall Study|Adverse Event|3|||
147386181|NCT00655824|531575020|FG000|Overall Study|Early Termination of Study by Sponsor|74|||
147386182|NCT00655824|531575020|FG000|Overall Study|Protocol Violation|1|||
147386183|NCT00655824|531575020|FG000|Overall Study|Withdrawal by Subject|4|||
147386184|NCT00655824|531575020|FG000|Overall Study|Deterioration of Trial Disease|2|||
147386185|NCT00960206|531575021|FG000|Overall Study|Death|7|||
147386186|NCT00960206|531575022|FG001|Overall Study|Death|4|||
147386187|NCT00960206|531575023|FG002|Overall Study|Death|1|||
147386188|NCT00960206|531575021|FG000|Overall Study|Unwilling/Unable to return|1|||
147386189|NCT00960206|531575022|FG001|Overall Study|Unwilling/Unable to return|2|||
147456904|NCT00441545|531833453|FG001|Second Intervention|Subject moved|1|||
147386190|NCT00960206|531575023|FG002|Overall Study|Unwilling/Unable to return|0|||
147386191|NCT00960206|531575021|FG000|Overall Study|Lost to Follow-up|8|||
147386192|NCT00960206|531575022|FG001|Overall Study|Lost to Follow-up|14|||
147386193|NCT00960206|531575023|FG002|Overall Study|Lost to Follow-up|8|||
147386194|NCT00960206|531575021|FG000|Overall Study|Withdrawal by Subject|2|||
147386195|NCT00960206|531575022|FG001|Overall Study|Withdrawal by Subject|4|||
147386196|NCT00960206|531575023|FG002|Overall Study|Withdrawal by Subject|0|||
147386197|NCT00960206|531575021|FG000|Overall Study|Revision of study component|2|||
147386198|NCT00960206|531575022|FG001|Overall Study|Revision of study component|2|||
147386199|NCT00960206|531575023|FG002|Overall Study|Revision of study component|2|||
147386200|NCT00960206|531575021|FG000|Overall Study|Missing 10 year data|20|||
147386201|NCT00960206|531575022|FG001|Overall Study|Missing 10 year data|1|||
147386202|NCT00960206|531575023|FG002|Overall Study|Missing 10 year data|1|||
147386203|NCT02470806|531575030|FG000|Overall Study|Lost to Follow-up|1|||
147386204|NCT02470806|531575031|FG001|Overall Study|Lost to Follow-up|1|||
147386205|NCT02470806|531575030|FG000|Overall Study|Adverse Event|5|||
147386206|NCT02470806|531575031|FG001|Overall Study|Adverse Event|2|||
147386207|NCT02470806|531575030|FG000|Overall Study|Protocol Violation|4|||
147386208|NCT02470806|531575031|FG001|Overall Study|Protocol Violation|11|||
147386209|NCT02470806|531575030|FG000|Overall Study|Physician Decision|0|||
147386210|NCT02470806|531575031|FG001|Overall Study|Physician Decision|3|||
147386211|NCT02470806|531575030|FG000|Overall Study|Withdrawal by Subject|3|||
147386212|NCT02470806|531575031|FG001|Overall Study|Withdrawal by Subject|10|||
147386213|NCT02470806|531575030|FG000|Overall Study|Lack of Efficacy|5|||
147386214|NCT02470806|531575031|FG001|Overall Study|Lack of Efficacy|15|||
147386215|NCT03032198|531575032|FG000|Overall Study|Screen Fail|1|||
147386216|NCT00866619|531575033|FG000|Overall Study|Adverse Event|112|||
147386217|NCT00866619|531575034|FG001|Overall Study|Adverse Event|106|||
147386218|NCT00866619|531575035|FG002|Overall Study|Adverse Event|47|||
147386219|NCT00866619|531575036|FG003|Overall Study|Adverse Event|44|||
147386220|NCT00866619|531575033|FG000|Overall Study|Protocol Violation|2|||
147386221|NCT00866619|531575034|FG001|Overall Study|Protocol Violation|39|||
147386222|NCT00866619|531575035|FG002|Overall Study|Protocol Violation|2|||
147386223|NCT00866619|531575036|FG003|Overall Study|Protocol Violation|17|||
147386224|NCT00866619|531575033|FG000|Overall Study|Withdrawal by Subject|587|||
147386225|NCT00866619|531575034|FG001|Overall Study|Withdrawal by Subject|295|||
147386226|NCT00866619|531575035|FG002|Overall Study|Withdrawal by Subject|272|||
147386227|NCT00866619|531575036|FG003|Overall Study|Withdrawal by Subject|144|||
147386228|NCT00866619|531575033|FG000|Overall Study|Lost to Follow-up|1145|||
147386229|NCT00866619|531575034|FG001|Overall Study|Lost to Follow-up|830|||
147386230|NCT00866619|531575035|FG002|Overall Study|Lost to Follow-up|568|||
147386231|NCT00866619|531575036|FG003|Overall Study|Lost to Follow-up|425|||
147386232|NCT02892019|531575038|FG000|Overall Study|randomized but not treated|0|||
147386233|NCT02892019|531575039|FG001|Overall Study|randomized but not treated|1|||
147386234|NCT02892019|531575038|FG000|Overall Study|Withdrawal by Subject|0|||
147386235|NCT02892019|531575039|FG001|Overall Study|Withdrawal by Subject|1|||
147386236|NCT02892019|531575038|FG000|Overall Study|Adverse Event|1|||
147386237|NCT02892019|531575039|FG001|Overall Study|Adverse Event|1|||
147386238|NCT01229176|531575040|FG000|Overall Study|Withdrawal by Subject|0|||
147386239|NCT01229176|531575041|FG001|Overall Study|Withdrawal by Subject|0|||
147386240|NCT01229176|531575042|FG002|Overall Study|Withdrawal by Subject|0|||
147386241|NCT01229176|531575043|FG003|Overall Study|Withdrawal by Subject|1|||
147386242|NCT01229176|531575044|FG004|Overall Study|Withdrawal by Subject|1|||
147386243|NCT01229176|531575045|FG005|Overall Study|Withdrawal by Subject|1|||
147386244|NCT01229176|531575046|FG006|Overall Study|Withdrawal by Subject|0|||
147386245|NCT01229176|531575047|FG007|Overall Study|Withdrawal by Subject|1|||
147386246|NCT01229176|531575040|FG000|Overall Study|Lost to Follow-up|0|||
147386247|NCT01229176|531575041|FG001|Overall Study|Lost to Follow-up|3|||
147386248|NCT01229176|531575042|FG002|Overall Study|Lost to Follow-up|0|||
147386249|NCT01229176|531575043|FG003|Overall Study|Lost to Follow-up|0|||
147386250|NCT01229176|531575044|FG004|Overall Study|Lost to Follow-up|1|||
147386251|NCT01229176|531575045|FG005|Overall Study|Lost to Follow-up|1|||
147386252|NCT01229176|531575046|FG006|Overall Study|Lost to Follow-up|0|||
147386253|NCT01229176|531575047|FG007|Overall Study|Lost to Follow-up|2|||
147386254|NCT00882050|531575048|FG000|Overall Study|Physician Decision|1|||
147386255|NCT00882050|531575049|FG001|Overall Study|Physician Decision|0|||
147386256|NCT00882050|531575050|FG002|Overall Study|Physician Decision|0|||
147386257|NCT01159600|531575051|FG000|Overall Study|Not treated|0|||
147386258|NCT01159600|531575052|FG001|Overall Study|Not treated|0|||
147386259|NCT01159600|531575053|FG002|Overall Study|Not treated|1|||
147386260|NCT01159600|531575054|FG003|Overall Study|Not treated|0|||
147386261|NCT01159600|531575055|FG004|Overall Study|Not treated|0|||
147386262|NCT01159600|531575056|FG005|Overall Study|Not treated|1|||
147386263|NCT01159600|531575057|FG006|Overall Study|Not treated|2|||
147386264|NCT01159600|531575058|FG007|Overall Study|Not treated|2|||
147386265|NCT01159600|531575051|FG000|Overall Study|Adverse Event|7|||
147386266|NCT01159600|531575052|FG001|Overall Study|Adverse Event|2|||
147386267|NCT01159600|531575053|FG002|Overall Study|Adverse Event|5|||
147386268|NCT01159600|531575054|FG003|Overall Study|Adverse Event|1|||
147386269|NCT01159600|531575055|FG004|Overall Study|Adverse Event|8|||
147386270|NCT01159600|531575056|FG005|Overall Study|Adverse Event|6|||
147386271|NCT01159600|531575057|FG006|Overall Study|Adverse Event|7|||
147386272|NCT01159600|531575058|FG007|Overall Study|Adverse Event|5|||
147386273|NCT01159600|531575051|FG000|Overall Study|Lack of Efficacy|0|||
147386274|NCT01159600|531575052|FG001|Overall Study|Lack of Efficacy|0|||
147386275|NCT01159600|531575053|FG002|Overall Study|Lack of Efficacy|0|||
147386276|NCT01159600|531575054|FG003|Overall Study|Lack of Efficacy|0|||
147386277|NCT01159600|531575055|FG004|Overall Study|Lack of Efficacy|2|||
147386278|NCT01159600|531575056|FG005|Overall Study|Lack of Efficacy|0|||
147386279|NCT01159600|531575057|FG006|Overall Study|Lack of Efficacy|0|||
147386280|NCT01159600|531575058|FG007|Overall Study|Lack of Efficacy|1|||
147386281|NCT01159600|531575051|FG000|Overall Study|Non compliant with protocol|2|||
147386282|NCT01159600|531575052|FG001|Overall Study|Non compliant with protocol|1|||
147386283|NCT01159600|531575053|FG002|Overall Study|Non compliant with protocol|0|||
147386284|NCT01159600|531575054|FG003|Overall Study|Non compliant with protocol|0|||
147386285|NCT01159600|531575055|FG004|Overall Study|Non compliant with protocol|2|||
147386286|NCT01159600|531575056|FG005|Overall Study|Non compliant with protocol|0|||
147386287|NCT01159600|531575057|FG006|Overall Study|Non compliant with protocol|2|||
147386288|NCT01159600|531575058|FG007|Overall Study|Non compliant with protocol|0|||
147386289|NCT01159600|531575051|FG000|Overall Study|Lost to Follow-up|2|||
147386290|NCT01159600|531575052|FG001|Overall Study|Lost to Follow-up|3|||
147386291|NCT01159600|531575053|FG002|Overall Study|Lost to Follow-up|4|||
147386292|NCT01159600|531575054|FG003|Overall Study|Lost to Follow-up|3|||
147386293|NCT01159600|531575055|FG004|Overall Study|Lost to Follow-up|3|||
147386294|NCT01159600|531575056|FG005|Overall Study|Lost to Follow-up|0|||
147386295|NCT01159600|531575057|FG006|Overall Study|Lost to Follow-up|3|||
147386296|NCT01159600|531575058|FG007|Overall Study|Lost to Follow-up|2|||
147386297|NCT01159600|531575051|FG000|Overall Study|Patient refusal to continue,not due toAE|7|||
147386298|NCT01159600|531575052|FG001|Overall Study|Patient refusal to continue,not due toAE|2|||
147386299|NCT01159600|531575053|FG002|Overall Study|Patient refusal to continue,not due toAE|4|||
147386300|NCT01159600|531575054|FG003|Overall Study|Patient refusal to continue,not due toAE|5|||
147386301|NCT01159600|531575055|FG004|Overall Study|Patient refusal to continue,not due toAE|4|||
147386302|NCT01159600|531575056|FG005|Overall Study|Patient refusal to continue,not due toAE|4|||
147386303|NCT01159600|531575057|FG006|Overall Study|Patient refusal to continue,not due toAE|2|||
147386304|NCT01159600|531575058|FG007|Overall Study|Patient refusal to continue,not due toAE|5|||
147386305|NCT01159600|531575051|FG000|Overall Study|Other reason not defined above|3|||
147386306|NCT01159600|531575052|FG001|Overall Study|Other reason not defined above|0|||
147386307|NCT01159600|531575053|FG002|Overall Study|Other reason not defined above|4|||
147386308|NCT01159600|531575054|FG003|Overall Study|Other reason not defined above|2|||
147386309|NCT01159600|531575055|FG004|Overall Study|Other reason not defined above|5|||
147386310|NCT01159600|531575056|FG005|Overall Study|Other reason not defined above|7|||
147386311|NCT01159600|531575057|FG006|Overall Study|Other reason not defined above|3|||
147386312|NCT01159600|531575058|FG007|Overall Study|Other reason not defined above|3|||
147386313|NCT00946998|531576407|FG000|Overall Study|Exited prior to first outcome assessment|5|||
147386314|NCT00946998|531576408|FG001|Overall Study|Exited prior to first outcome assessment|3|||
147386315|NCT01279447|531576417|FG000|Overall Study|Lost to Follow-up|3|||
147386316|NCT01279447|531576418|FG001|Overall Study|Lost to Follow-up|1|||
147386317|NCT00538629|531576424|FG000|Overall Study|At subject's request|1|||
147386318|NCT00538629|531576424|FG000|Overall Study|Adverse Event|2|||
147386319|NCT00538629|531576424|FG000|Overall Study|Lack of Efficacy|12|||
147386320|NCT00538629|531576424|FG000|Overall Study|Lost to Follow-up|6|||
147386321|NCT00538629|531576424|FG000|Overall Study|Subject's untimely distrust of medicine|1|||
147386322|NCT00555620|531576430|FG000|Overall Study|Death|0|||
147386323|NCT00555620|531576431|FG001|Overall Study|Death|1|||
147386324|NCT00555620|531576432|FG002|Overall Study|Death|0|||
147386325|NCT00555620|531576433|FG003|Overall Study|Death|0|||
147386326|NCT00555620|531576434|FG004|Overall Study|Death|0|||
147386327|NCT00555620|531576435|FG005|Overall Study|Death|1|||
147386328|NCT00555620|531576430|FG000|Overall Study|Study terminated by sponsor|0|||
147386329|NCT00555620|531576431|FG001|Overall Study|Study terminated by sponsor|0|||
147386330|NCT00555620|531576432|FG002|Overall Study|Study terminated by sponsor|1|||
147386331|NCT00555620|531576433|FG003|Overall Study|Study terminated by sponsor|0|||
147386332|NCT00555620|531576434|FG004|Overall Study|Study terminated by sponsor|0|||
147386333|NCT00555620|531576435|FG005|Overall Study|Study terminated by sponsor|0|||
147386334|NCT00555620|531576430|FG000|Overall Study|Adverse Event|0|||
147386335|NCT00555620|531576431|FG001|Overall Study|Adverse Event|0|||
147386336|NCT00555620|531576432|FG002|Overall Study|Adverse Event|1|||
147386337|NCT00555620|531576433|FG003|Overall Study|Adverse Event|5|||
147386338|NCT00555620|531576434|FG004|Overall Study|Adverse Event|0|||
147386339|NCT00555620|531576435|FG005|Overall Study|Adverse Event|1|||
147386340|NCT00555620|531576430|FG000|Overall Study|Objective progression or relapse|6|||
147386341|NCT00555620|531576431|FG001|Overall Study|Objective progression or relapse|5|||
147386342|NCT00555620|531576432|FG002|Overall Study|Objective progression or relapse|12|||
147386343|NCT00555620|531576433|FG003|Overall Study|Objective progression or relapse|17|||
147386344|NCT00555620|531576434|FG004|Overall Study|Objective progression or relapse|3|||
147386345|NCT00555620|531576435|FG005|Overall Study|Objective progression or relapse|16|||
147456905|NCT00411554|531833458|FG000|Overall Study|Adverse Event|2|||
147456906|NCT00411554|531833459|FG001|Overall Study|Adverse Event|4|||
147615039|NCT04856917|532406579|FG001|Overall Study|Withdrawal by Subject|3|||
147386346|NCT00555620|531576430|FG000|Overall Study|Participant refused treatment|0|||
147386347|NCT00555620|531576431|FG001|Overall Study|Participant refused treatment|1|||
147386348|NCT00555620|531576432|FG002|Overall Study|Participant refused treatment|1|||
147386349|NCT00555620|531576433|FG003|Overall Study|Participant refused treatment|0|||
147386350|NCT00555620|531576434|FG004|Overall Study|Participant refused treatment|0|||
147386351|NCT00555620|531576435|FG005|Overall Study|Participant refused treatment|1|||
147386352|NCT00555620|531576430|FG000|Overall Study|Other|0|||
147386353|NCT00555620|531576431|FG001|Overall Study|Other|0|||
147386354|NCT00555620|531576432|FG002|Overall Study|Other|0|||
147386355|NCT00555620|531576433|FG003|Overall Study|Other|1|||
147386356|NCT00555620|531576434|FG004|Overall Study|Other|0|||
147386357|NCT00555620|531576435|FG005|Overall Study|Other|3|||
147386358|NCT05203822|531576436|FG000|Overall Study|Adverse Event|1|||
147386359|NCT05203822|531576436|FG000|Overall Study|Withdrawal by Subject|1|||
147386360|NCT03320941|531576440|FG000|Overall Study|subject/guardian decision|0|||
147386361|NCT03320941|531576441|FG001|Overall Study|subject/guardian decision|0|||
147386362|NCT03320941|531576442|FG002|Overall Study|subject/guardian decision|0|||
147386363|NCT03320941|531576443|FG003|Overall Study|subject/guardian decision|1|||
147386364|NCT03320941|531576444|FG004|Overall Study|subject/guardian decision|0|||
147386365|NCT00447499|531576445|FG000|Overall Study|Adverse Event|1|||
147386366|NCT00447499|531576445|FG000|Overall Study|Patient Decision|4|||
147386367|NCT00447499|531576445|FG000|Overall Study|Sponsor Decision|1|||
147386368|NCT00447499|531576445|FG000|Overall Study|Physician Decision|1|||
147386369|NCT01767376|531576447|FG000|Overall Study|Lost to Follow-up|3|||
147386370|NCT01767376|531576448|FG001|Overall Study|Lost to Follow-up|2|||
147386371|NCT01767376|531576449|FG002|Overall Study|Lost to Follow-up|0|||
147386372|NCT01767376|531576447|FG000|Overall Study|Withdrawal by Subject|1|||
147386373|NCT01767376|531576448|FG001|Overall Study|Withdrawal by Subject|1|||
147386374|NCT01767376|531576449|FG002|Overall Study|Withdrawal by Subject|0|||
147386375|NCT03360071|531576450|FG000|Overall Study|Lost to Follow-up|1|||
147386376|NCT03360071|531576451|FG001|Overall Study|Lost to Follow-up|0|||
147386377|NCT00946088|531576452|FG000|Overall Study|Withdrawal by Subject|0|||
147386378|NCT00946088|531576453|FG001|Overall Study|Withdrawal by Subject|1|||
147386379|NCT03184519|531576455|FG000|Overall Study|Lost to Follow-up|6|||
147386380|NCT03184519|531576455|FG000|Overall Study|Physician Decision|21|||
147386381|NCT00584909|531576459|FG000|Overall Study|Adverse Event|4|||
147386382|NCT03345407|531576460|FG000|Overall Study|Withdrawal by Subject|11|||
147386383|NCT03345407|531576461|FG001|Overall Study|Withdrawal by Subject|1|||
147386384|NCT03345407|531576462|FG002|Overall Study|Withdrawal by Subject|5|||
147386385|NCT03345407|531576463|FG003|Overall Study|Withdrawal by Subject|6|||
147386386|NCT03345407|531576464|FG004|Overall Study|Withdrawal by Subject|3|||
147386387|NCT03345407|531576465|FG005|Overall Study|Withdrawal by Subject|6|||
147386388|NCT03345407|531576466|FG006|Overall Study|Withdrawal by Subject|16|||
147386389|NCT03345407|531576460|FG000|Overall Study|Physician Decision|3|||
147386390|NCT03345407|531576461|FG001|Overall Study|Physician Decision|1|||
147386391|NCT03345407|531576462|FG002|Overall Study|Physician Decision|0|||
147386392|NCT03345407|531576463|FG003|Overall Study|Physician Decision|0|||
147386393|NCT03345407|531576464|FG004|Overall Study|Physician Decision|1|||
147386394|NCT03345407|531576465|FG005|Overall Study|Physician Decision|2|||
147386395|NCT03345407|531576466|FG006|Overall Study|Physician Decision|3|||
147386396|NCT03345407|531576460|FG000|Overall Study|Lost to Follow-up|2|||
147386397|NCT03345407|531576461|FG001|Overall Study|Lost to Follow-up|0|||
147386398|NCT03345407|531576462|FG002|Overall Study|Lost to Follow-up|1|||
147386399|NCT03345407|531576463|FG003|Overall Study|Lost to Follow-up|0|||
147386400|NCT03345407|531576464|FG004|Overall Study|Lost to Follow-up|1|||
147386401|NCT03345407|531576465|FG005|Overall Study|Lost to Follow-up|2|||
147386402|NCT03345407|531576466|FG006|Overall Study|Lost to Follow-up|3|||
147386403|NCT03345407|531576460|FG000|Overall Study|Protocol-defined stopping criteria|9|||
147386404|NCT03345407|531576461|FG001|Overall Study|Protocol-defined stopping criteria|0|||
147386405|NCT03345407|531576462|FG002|Overall Study|Protocol-defined stopping criteria|0|||
147386406|NCT03345407|531576463|FG003|Overall Study|Protocol-defined stopping criteria|0|||
147386407|NCT03345407|531576464|FG004|Overall Study|Protocol-defined stopping criteria|2|||
147386408|NCT03345407|531576465|FG005|Overall Study|Protocol-defined stopping criteria|1|||
147386409|NCT03345407|531576466|FG006|Overall Study|Protocol-defined stopping criteria|1|||
147386410|NCT03345407|531576460|FG000|Overall Study|Protocol Violation|2|||
147386411|NCT03345407|531576461|FG001|Overall Study|Protocol Violation|0|||
147386412|NCT03345407|531576462|FG002|Overall Study|Protocol Violation|0|||
147386413|NCT03345407|531576463|FG003|Overall Study|Protocol Violation|0|||
147386414|NCT03345407|531576464|FG004|Overall Study|Protocol Violation|1|||
147386415|NCT03345407|531576465|FG005|Overall Study|Protocol Violation|0|||
147386416|NCT03345407|531576466|FG006|Overall Study|Protocol Violation|3|||
147386417|NCT03345407|531576460|FG000|Overall Study|Lack of Efficacy|1|||
147456907|NCT00411554|531833458|FG000|Overall Study|Lack of Efficacy|2|||
147386418|NCT03345407|531576461|FG001|Overall Study|Lack of Efficacy|1|||
147386419|NCT03345407|531576462|FG002|Overall Study|Lack of Efficacy|1|||
147386420|NCT03345407|531576463|FG003|Overall Study|Lack of Efficacy|1|||
147386421|NCT03345407|531576464|FG004|Overall Study|Lack of Efficacy|1|||
147386422|NCT03345407|531576465|FG005|Overall Study|Lack of Efficacy|0|||
147386423|NCT03345407|531576466|FG006|Overall Study|Lack of Efficacy|3|||
147386424|NCT03345407|531576460|FG000|Overall Study|Adverse Event|4|||
147386425|NCT03345407|531576461|FG001|Overall Study|Adverse Event|0|||
147386426|NCT03345407|531576462|FG002|Overall Study|Adverse Event|5|||
147386427|NCT03345407|531576463|FG003|Overall Study|Adverse Event|4|||
147386428|NCT03345407|531576464|FG004|Overall Study|Adverse Event|6|||
147386429|NCT03345407|531576465|FG005|Overall Study|Adverse Event|5|||
147386430|NCT03345407|531576466|FG006|Overall Study|Adverse Event|16|||
147386431|NCT02092909|531576469|FG000|Overall Study|Adverse Event|0|||
147386432|NCT02092909|531576470|FG001|Overall Study|Adverse Event|0|||
147386433|NCT02092909|531576471|FG002|Overall Study|Adverse Event|4|||
147386434|NCT02092909|531576472|FG003|Overall Study|Adverse Event|2|||
147386435|NCT02092909|531576469|FG000|Overall Study|Lack of Efficacy|0|||
147386436|NCT02092909|531576470|FG001|Overall Study|Lack of Efficacy|2|||
147386437|NCT02092909|531576471|FG002|Overall Study|Lack of Efficacy|1|||
147386438|NCT02092909|531576472|FG003|Overall Study|Lack of Efficacy|0|||
147386439|NCT02092909|531576469|FG000|Overall Study|Withdrawal by Subject|0|||
147386440|NCT02092909|531576470|FG001|Overall Study|Withdrawal by Subject|0|||
147386441|NCT02092909|531576471|FG002|Overall Study|Withdrawal by Subject|2|||
147386442|NCT02092909|531576472|FG003|Overall Study|Withdrawal by Subject|1|||
147386443|NCT02092909|531576469|FG000|Overall Study|Study terminated by Sponsor|0|||
147386444|NCT02092909|531576470|FG001|Overall Study|Study terminated by Sponsor|0|||
147386445|NCT02092909|531576471|FG002|Overall Study|Study terminated by Sponsor|0|||
147386446|NCT02092909|531576472|FG003|Overall Study|Study terminated by Sponsor|2|||
147386447|NCT02092909|531576469|FG000|Overall Study|Miscellaneous|1|||
147386448|NCT02092909|531576470|FG001|Overall Study|Miscellaneous|1|||
147386449|NCT02092909|531576471|FG002|Overall Study|Miscellaneous|2|||
147386450|NCT02092909|531576472|FG003|Overall Study|Miscellaneous|1|||
147386451|NCT03436797|531576473|FG000|Main Study|Withdrawal by Subject|2|||
147386452|NCT03436797|531576473|FG000|Main Study|Adverse Event|4|||
147386453|NCT03436797|531576473|FG000|Main Study|Lost to Follow-up|1|||
147386454|NCT03436797|531576473|FG000|Main Study|Death|1|||
147386455|NCT03436797|531576473|FG000|Main Study|Non-Specific|2|||
147386456|NCT03436797|531576473|FG000|Extended Dosing|Patient decision|1|||
147386457|NCT05104242|531576474|FG000|Overall Study|Withdrawal by Subject|1|||
147386458|NCT05104242|531576475|FG001|Overall Study|Withdrawal by Subject|5|||
147386459|NCT05104242|531576474|FG000|Overall Study|Control group: Acute kidney injury requiring dialysis Intervention group: transplant rejection|1|||
147386460|NCT05104242|531576475|FG001|Overall Study|Control group: Acute kidney injury requiring dialysis Intervention group: transplant rejection|1|||
147386461|NCT04930263|531576483|FG000|Overall Study|Withdrawal by Subject|3|||
147386462|NCT04930263|531576484|FG001|Overall Study|Withdrawal by Subject|5|||
147386463|NCT01989156|531576485|FG000|Confinement Period (Population at Day 5)|Withdrawal by Subject|0|||
147386464|NCT01989156|531576486|FG001|Confinement Period (Population at Day 5)|Withdrawal by Subject|1|||
147386465|NCT01989156|531576487|FG002|Confinement Period (Population at Day 5)|Withdrawal by Subject|3|||
147386466|NCT01989156|531576485|FG000|Confinement Period (Population at Day 5)|Patient Anxiety|0|||
147386467|NCT01989156|531576486|FG001|Confinement Period (Population at Day 5)|Patient Anxiety|0|||
147386468|NCT01989156|531576487|FG002|Confinement Period (Population at Day 5)|Patient Anxiety|1|||
147386469|NCT01989156|531576485|FG000|Confinement Period (Population at Day 5)|Adverse Event|0|||
147386470|NCT01989156|531576486|FG001|Confinement Period (Population at Day 5)|Adverse Event|0|||
147386471|NCT01989156|531576487|FG002|Confinement Period (Population at Day 5)|Adverse Event|1|||
147386472|NCT01989156|531576485|FG000|End of Study (Population at Day 90)|Withdrawal by Subject|2|||
147386473|NCT01989156|531576486|FG001|End of Study (Population at Day 90)|Withdrawal by Subject|2|||
147386474|NCT01989156|531576487|FG002|End of Study (Population at Day 90)|Withdrawal by Subject|2|||
147386475|NCT01989156|531576485|FG000|End of Study (Population at Day 90)|Lost to Follow-up|3|||
147386476|NCT01989156|531576486|FG001|End of Study (Population at Day 90)|Lost to Follow-up|2|||
147386477|NCT01989156|531576487|FG002|End of Study (Population at Day 90)|Lost to Follow-up|0|||
147386478|NCT01989156|531576485|FG000|End of Study (Population at Day 90)|Physician Decision|1|||
147386479|NCT01989156|531576486|FG001|End of Study (Population at Day 90)|Physician Decision|0|||
147386480|NCT01989156|531576487|FG002|End of Study (Population at Day 90)|Physician Decision|1|||
147386481|NCT01989156|531576485|FG000|End of Study (Population at Day 90)|Moved out of state|1|||
147386482|NCT01989156|531576486|FG001|End of Study (Population at Day 90)|Moved out of state|0|||
147386483|NCT01989156|531576487|FG002|End of Study (Population at Day 90)|Moved out of state|0|||
147386484|NCT01989156|531576485|FG000|End of Study (Population at Day 90)|Employment Conflict|0|||
147386485|NCT01989156|531576486|FG001|End of Study (Population at Day 90)|Employment Conflict|1|||
147386486|NCT01989156|531576487|FG002|End of Study (Population at Day 90)|Employment Conflict|0|||
147386487|NCT00850993|531576488|FG000|Overall Study|Parent/Guardian Voluntarily Withdrew|1|||
147386488|NCT00850993|531576489|FG001|Overall Study|Parent/Guardian Voluntarily Withdrew|0|||
147386489|NCT00850993|531576490|FG002|Overall Study|Parent/Guardian Voluntarily Withdrew|0|||
147386490|NCT00850993|531576491|FG003|Overall Study|Parent/Guardian Voluntarily Withdrew|1|||
147386491|NCT03839355|531576492|FG000|Overall Study|Withdrawal by Subject|1|||
147456908|NCT00411554|531833459|FG001|Overall Study|Lack of Efficacy|5|||
147456909|NCT00411554|531833458|FG000|Overall Study|Withdrawal by Subject|3|||
147456910|NCT00411554|531833459|FG001|Overall Study|Withdrawal by Subject|0|||
147456911|NCT00411554|531833458|FG000|Overall Study|Patient Moved|1|||
147456912|NCT00411554|531833459|FG001|Overall Study|Patient Moved|0|||
147456913|NCT00939692|531833466|FG000|Period 1 - First Intervention - 5 Days|Withdrawal by Subject|1|||
147456914|NCT00939692|531833467|FG001|Period 1 - First Intervention - 5 Days|Withdrawal by Subject|0|||
147456915|NCT00939692|531833466|FG000|Period 2 - Second Intervent - 5 Days|Protocol Violation|0|||
147456916|NCT00939692|531833467|FG001|Period 2 - Second Intervent - 5 Days|Protocol Violation|1|||
147456917|NCT04317274|531833468|FG000|Overall Study|participant did not provide enough information to calculate a shared decision making process score|2|||
147456918|NCT04317274|531833469|FG001|Overall Study|participant did not provide enough information to calculate a shared decision making process score|3|||
147456919|NCT04317274|531833470|FG002|Overall Study|participant did not provide enough information to calculate a shared decision making process score|4|||
147456920|NCT04317274|531833471|FG003|Overall Study|participant did not provide enough information to calculate a shared decision making process score|4|||
147456921|NCT02161211|531833474|FG000|Overall Study|Lost to Follow-up|21|||
147456922|NCT02161211|531833475|FG001|Overall Study|Lost to Follow-up|27|||
147456923|NCT02161211|531833476|FG002|Overall Study|Lost to Follow-up|21|||
147456924|NCT02161211|531833474|FG000|Overall Study|Dropped|12|||
147456925|NCT02161211|531833475|FG001|Overall Study|Dropped|5|||
147456926|NCT02161211|531833476|FG002|Overall Study|Dropped|9|||
147456927|NCT00797823|531833483|FG000|First Period (Initial Randomization)|Physician Decision|1|||
147456928|NCT00797823|531833484|FG001|First Period (Initial Randomization)|Physician Decision|0|||
147456929|NCT00797823|531833485|FG002|First Period (Initial Randomization)|Physician Decision|0|||
147456930|NCT00993031|531833492|FG000|Overall Study|Death|0|||
147456931|NCT00993031|531833493|FG001|Overall Study|Death|1|||
147456932|NCT00993031|531833492|FG000|Overall Study|Physician Decision|0|||
147456933|NCT00993031|531833493|FG001|Overall Study|Physician Decision|2|||
147456934|NCT00993031|531833492|FG000|Overall Study|Withdrawal by Subject|3|||
147456935|NCT00993031|531833493|FG001|Overall Study|Withdrawal by Subject|3|||
147456936|NCT00993031|531833492|FG000|Overall Study|Lost to Follow-up|19|||
147456937|NCT00993031|531833493|FG001|Overall Study|Lost to Follow-up|13|||
147456938|NCT01834729|531833496|FG000|Overall Study|Did not return bowel diaries|0|||
147456939|NCT01834729|531833497|FG001|Overall Study|Did not return bowel diaries|0|||
147456940|NCT01834729|531833498|FG002|Overall Study|Did not return bowel diaries|3|||
147456941|NCT01834729|531833499|FG003|Overall Study|Did not return bowel diaries|0|||
147456942|NCT01834729|531833496|FG000|Overall Study|Withdrawal by Subject|1|||
147456943|NCT01834729|531833497|FG001|Overall Study|Withdrawal by Subject|1|||
147456944|NCT01834729|531833498|FG002|Overall Study|Withdrawal by Subject|0|||
147456945|NCT01834729|531833499|FG003|Overall Study|Withdrawal by Subject|0|||
147456946|NCT01834729|531833496|FG000|Overall Study|Adverse Event|0|||
147456947|NCT01834729|531833497|FG001|Overall Study|Adverse Event|0|||
147456948|NCT01834729|531833498|FG002|Overall Study|Adverse Event|0|||
147456949|NCT01834729|531833499|FG003|Overall Study|Adverse Event|2|||
147456950|NCT00288080|531833500|FG000|Overall Study|Withdrawal by Subject|1|||
147456951|NCT00288080|531833501|FG001|Overall Study|Withdrawal by Subject|3|||
147456952|NCT00288080|531833500|FG000|Overall Study|Protocol Violation|25|||
147456953|NCT00288080|531833501|FG001|Overall Study|Protocol Violation|20|||
147456954|NCT03403192|531833502|FG000|Overall Study|Lost to Follow-up|1|||
147456955|NCT03403192|531833503|FG001|Overall Study|Lost to Follow-up|2|||
147456956|NCT03403192|531833504|FG002|Overall Study|Lost to Follow-up|0|||
147456957|NCT03403192|531833505|FG003|Overall Study|Lost to Follow-up|0|||
147456958|NCT03403192|531833502|FG000|Overall Study|Unable to respond|0|||
147456959|NCT03403192|531833503|FG001|Overall Study|Unable to respond|1|||
147456960|NCT03403192|531833504|FG002|Overall Study|Unable to respond|0|||
147456961|NCT03403192|531833505|FG003|Overall Study|Unable to respond|0|||
147456962|NCT03403192|531833502|FG000|Overall Study|Incomplete|3|||
147456963|NCT03403192|531833503|FG001|Overall Study|Incomplete|1|||
147456964|NCT03403192|531833504|FG002|Overall Study|Incomplete|3|||
147456965|NCT03403192|531833505|FG003|Overall Study|Incomplete|6|||
147456966|NCT02387580|531833507|FG000|Overall Study|Withdrawal by Subject|0|||
147456967|NCT02387580|531833508|FG001|Overall Study|Withdrawal by Subject|0|||
147456968|NCT02387580|531833509|FG002|Overall Study|Withdrawal by Subject|0|||
147456969|NCT02387580|531833510|FG003|Overall Study|Withdrawal by Subject|1|||
147456970|NCT02387580|531833511|FG004|Overall Study|Withdrawal by Subject|0|||
147456971|NCT02387580|531833512|FG005|Overall Study|Withdrawal by Subject|0|||
147456972|NCT00087646|531833513|FG000|Overall Study|Adverse Event|37|||
147456973|NCT00087646|531833514|FG001|Overall Study|Adverse Event|6|||
147456974|NCT00087646|531833515|FG002|Overall Study|Adverse Event|18|||
147456975|NCT00087646|531833516|FG003|Overall Study|Adverse Event|20|||
147456976|NCT00087646|531833513|FG000|Overall Study|Death|0|||
147456977|NCT00087646|531833514|FG001|Overall Study|Death|1|||
147456978|NCT00087646|531833515|FG002|Overall Study|Death|0|||
147456979|NCT00087646|531833516|FG003|Overall Study|Death|0|||
147456980|NCT00087646|531833513|FG000|Overall Study|Withdrawal by Subject|6|||
147456981|NCT00087646|531833514|FG001|Overall Study|Withdrawal by Subject|1|||
147456982|NCT00087646|531833515|FG002|Overall Study|Withdrawal by Subject|2|||
147456983|NCT00087646|531833516|FG003|Overall Study|Withdrawal by Subject|2|||
147456984|NCT00087646|531833513|FG000|Overall Study|Insufficient therapeutic response|64|||
147456985|NCT00087646|531833514|FG001|Overall Study|Insufficient therapeutic response|24|||
147456986|NCT00087646|531833515|FG002|Overall Study|Insufficient therapeutic response|38|||
147456987|NCT00087646|531833516|FG003|Overall Study|Insufficient therapeutic response|51|||
147456988|NCT00087646|531833513|FG000|Overall Study|Refused Treatment/Did Not Cooperate|13|||
147456989|NCT00087646|531833514|FG001|Overall Study|Refused Treatment/Did Not Cooperate|6|||
147456990|NCT00087646|531833515|FG002|Overall Study|Refused Treatment/Did Not Cooperate|4|||
147456991|NCT00087646|531833516|FG003|Overall Study|Refused Treatment/Did Not Cooperate|5|||
147456992|NCT00087646|531833513|FG000|Overall Study|Failure to Return|5|||
147456993|NCT00087646|531833514|FG001|Overall Study|Failure to Return|2|||
147456994|NCT00087646|531833515|FG002|Overall Study|Failure to Return|2|||
147456995|NCT00087646|531833516|FG003|Overall Study|Failure to Return|3|||
147456996|NCT00087646|531833513|FG000|Overall Study|Administrative/Other|6|||
147456997|NCT00087646|531833514|FG001|Overall Study|Administrative/Other|1|||
147456998|NCT00087646|531833515|FG002|Overall Study|Administrative/Other|1|||
147456999|NCT00087646|531833516|FG003|Overall Study|Administrative/Other|2|||
147457000|NCT00087646|531833513|FG000|Overall Study|Other Protocol Violation|3|||
147457001|NCT00087646|531833514|FG001|Overall Study|Other Protocol Violation|1|||
147457002|NCT00087646|531833515|FG002|Overall Study|Other Protocol Violation|0|||
147457003|NCT00087646|531833516|FG003|Overall Study|Other Protocol Violation|0|||
147457004|NCT00087646|531833513|FG000|Overall Study|Violation of Selection Criteria at Entry|1|||
147457005|NCT00087646|531833514|FG001|Overall Study|Violation of Selection Criteria at Entry|0|||
147457006|NCT00087646|531833515|FG002|Overall Study|Violation of Selection Criteria at Entry|0|||
147457007|NCT00087646|531833516|FG003|Overall Study|Violation of Selection Criteria at Entry|1|||
147457008|NCT04925752|531833533|FG000|Overall Study|Still on Study|1826|||
147457009|NCT04925752|531833534|FG001|Overall Study|Still on Study|926|||
147457010|NCT04925752|531833533|FG000|Overall Study|Withdrew Consent|128|||
147457011|NCT04925752|531833534|FG001|Overall Study|Withdrew Consent|59|||
147457012|NCT04925752|531833533|FG000|Overall Study|Lost to Follow-up|73|||
147457013|NCT04925752|531833534|FG001|Overall Study|Lost to Follow-up|47|||
147457014|NCT04925752|531833533|FG000|Overall Study|Randomized but Never Treated|12|||
147457015|NCT04925752|531833534|FG001|Overall Study|Randomized but Never Treated|9|||
147457016|NCT04925752|531833533|FG000|Overall Study|Hiv-1 Infection|6|||
147457017|NCT04925752|531833534|FG001|Overall Study|Hiv-1 Infection|7|||
147457018|NCT04925752|531833533|FG000|Overall Study|Investigator's discretion|8|||
147457019|NCT04925752|531833534|FG001|Overall Study|Investigator's discretion|5|||
147457020|NCT04925752|531833533|FG000|Overall Study|Non-compliance with Study Drug|8|||
147457021|NCT04925752|531833534|FG001|Overall Study|Non-compliance with Study Drug|5|||
147457022|NCT04925752|531833533|FG000|Overall Study|Adverse Event|5|||
147457023|NCT04925752|531833534|FG001|Overall Study|Adverse Event|2|||
147457024|NCT04925752|531833533|FG000|Overall Study|Death|4|||
147457025|NCT04925752|531833534|FG001|Overall Study|Death|2|||
147457026|NCT04925752|531833533|FG000|Overall Study|Protocol Violation|1|||
147457027|NCT04925752|531833534|FG001|Overall Study|Protocol Violation|3|||
147457028|NCT04925752|531833533|FG000|Overall Study|Withdrew Assent|1|||
147457029|NCT04925752|531833534|FG001|Overall Study|Withdrew Assent|0|||
147457030|NCT00516737|531833535|FG000|Overall Study|Lost to Follow-up|2|||
147457031|NCT00516737|531833536|FG001|Overall Study|Lost to Follow-up|0|||
147457032|NCT00516737|531833535|FG000|Overall Study|Physician Decision|0|||
147457033|NCT00516737|531833536|FG001|Overall Study|Physician Decision|1|||
147457034|NCT00516737|531833535|FG000|Overall Study|Withdrawal by Subject|0|||
147457035|NCT00516737|531833536|FG001|Overall Study|Withdrawal by Subject|1|||
147457036|NCT00516737|531833535|FG000|Overall Study|Lack of Qualifying Event|9|||
147457037|NCT00516737|531833536|FG001|Overall Study|Lack of Qualifying Event|6|||
147457038|NCT03920670|531833537|FG000|Overall Study|Protocol Violation|2|||
147457039|NCT03920670|531833538|FG001|Overall Study|Protocol Violation|2|||
147457040|NCT03920670|531833537|FG000|Overall Study|Adverse Event|1|||
147457041|NCT03920670|531833538|FG001|Overall Study|Adverse Event|0|||
147457042|NCT04820309|531833544|FG000|Overall Study|Adverse Event|96|||
147457043|NCT04820309|531833544|FG000|Overall Study|ineligible for further treatment according to inclusion/exclusion criteria|1|||
147457044|NCT04820309|531833544|FG000|Overall Study|Consent Withdrawn|93|||
147457045|NCT04820309|531833544|FG000|Overall Study|failure to adhere to protocol|32|||
147457046|NCT04820309|531833544|FG000|Overall Study|alcohol or drug use|6|||
147457047|NCT04820309|531833544|FG000|Overall Study|Lost to Follow-up|46|||
147457048|NCT04820309|531833544|FG000|Overall Study|Death|2|||
147615040|NCT04856917|532406580|FG002|Overall Study|Withdrawal by Subject|1|||
147615041|NCT04856917|532406578|FG000|Overall Study|Lost to Follow-up|3|||
147457049|NCT04820309|531833544|FG000|Overall Study|Pregnancy|1|||
147457050|NCT04820309|531833544|FG000|Overall Study|Other reasons|12|||
147457051|NCT03266016|531835492|FG000|Acute Phase (0 to 28 Days)|Withdrawal by Subject|1|||
147457052|NCT03266016|531835493|FG001|Acute Phase (0 to 28 Days)|Withdrawal by Subject|0|||
147457053|NCT03266016|531835494|FG002|Acute Phase (0 to 28 Days)|Withdrawal by Subject|0|||
147457054|NCT03266016|531835495|FG003|Acute Phase (0 to 28 Days)|Withdrawal by Subject|0|||
147457055|NCT03266016|531835492|FG000|Acute Phase (0 to 28 Days)|Completed study at acute phase.|75|||
147615042|NCT04856917|532406579|FG001|Overall Study|Lost to Follow-up|1|||
147386492|NCT03839355|531576493|FG001|Overall Study|Withdrawal by Subject|0|||
147386493|NCT04501614|531576500|FG000|Overall Study|Study Terminated by Sponsor|6|||
147386494|NCT04501614|531576501|FG001|Overall Study|Study Terminated by Sponsor|3|||
147386495|NCT04501614|531576500|FG000|Overall Study|Withdrawal by Participant (Parent/Legal Guardian)|1|||
147386496|NCT04501614|531576501|FG001|Overall Study|Withdrawal by Participant (Parent/Legal Guardian)|1|||
147386497|NCT02555397|531576502|FG000|Overall Study|Withdrawal by Subject|1|||
147386498|NCT02555397|531576503|FG001|Overall Study|Withdrawal by Subject|0|||
147386499|NCT02555397|531576504|FG002|Overall Study|Withdrawal by Subject|0|||
147386500|NCT02555397|531576505|FG003|Overall Study|Withdrawal by Subject|0|||
147386501|NCT02555397|531576506|FG004|Overall Study|Withdrawal by Subject|0|||
147386502|NCT04529941|531576507|FG000|Week 12/Month 3 Follow Up|Withdrawal by Subject|1|||
147386503|NCT04529941|531576508|FG001|Week 12/Month 3 Follow Up|Withdrawal by Subject|0|||
147386504|NCT01240785|531576509|FG000|Overall Study|Lost to Follow-up|1|||
147386505|NCT01240785|531576510|FG001|Overall Study|Lost to Follow-up|0|||
147386506|NCT01240785|531576509|FG000|Overall Study|Protocol Violation|0|||
147386507|NCT01240785|531576510|FG001|Overall Study|Protocol Violation|3|||
147386508|NCT00237809|531576511|FG000|Overall Study|Lost to Follow-up|11|||
147386509|NCT00237809|531576512|FG001|Overall Study|Lost to Follow-up|10|||
147386510|NCT00237809|531576513|FG002|Overall Study|Lost to Follow-up|9|||
147386511|NCT00237809|531576514|FG003|Overall Study|Lost to Follow-up|9|||
147386512|NCT02138838|531576523|FG000|Overall Study|Study Closure|7|||
147386513|NCT02138838|531576524|FG001|Overall Study|Study Closure|6|||
147386514|NCT02138838|531576523|FG000|Overall Study|Withdrawal by Subject|1|||
147386515|NCT02138838|531576524|FG001|Overall Study|Withdrawal by Subject|5|||
147386516|NCT02010684|531576527|FG000|Overall Study|Lost to Follow-up|8|||
147386517|NCT02010684|531576528|FG001|Overall Study|Lost to Follow-up|18|||
147386518|NCT02010684|531576527|FG000|Overall Study|Withdrawal by Subject|4|||
147386519|NCT02010684|531576528|FG001|Overall Study|Withdrawal by Subject|5|||
147386520|NCT01884571|531576533|FG000|Overall Study|Adverse Event|1|||
147386521|NCT01884571|531576533|FG000|Overall Study|Death|2|||
147386522|NCT01884571|531576533|FG000|Overall Study|Withdrawal by Subject|2|||
147386523|NCT01884571|531576533|FG000|Overall Study|Disease progression|3|||
147386524|NCT00091572|531576534|FG000|Overall Study|Lost to Follow-up|1|||
147386525|NCT00091572|531576535|FG001|Overall Study|Lost to Follow-up|1|||
147386526|NCT00091572|531576534|FG000|Overall Study|Subject's Refusal unrelated to toxicity|14|||
147386527|NCT00091572|531576535|FG001|Overall Study|Subject's Refusal unrelated to toxicity|22|||
147386528|NCT00091572|531576534|FG000|Overall Study|Death not due to malignancy/toxicity|1|||
147386529|NCT00091572|531576535|FG001|Overall Study|Death not due to malignancy/toxicity|3|||
147386530|NCT00091572|531576534|FG000|Overall Study|Medical Decision unrelated toxicity/PD|10|||
147386531|NCT00091572|531576535|FG001|Overall Study|Medical Decision unrelated toxicity/PD|22|||
147386532|NCT00091572|531576534|FG000|Overall Study|Other Reason|6|||
147386533|NCT00091572|531576535|FG001|Overall Study|Other Reason|13|||
147386534|NCT00091572|531576534|FG000|Overall Study|Ongoing (still on treatment)|8|||
147386535|NCT00091572|531576535|FG001|Overall Study|Ongoing (still on treatment)|12|||
147386536|NCT00091572|531576534|FG000|Overall Study|Major Protocol Violation|2|||
147386537|NCT00091572|531576535|FG001|Overall Study|Major Protocol Violation|0|||
147386538|NCT00091572|531576534|FG000|Overall Study|Toxicity (Related AE)|53|||
147386539|NCT00091572|531576535|FG001|Overall Study|Toxicity (Related AE)|9|||
147386540|NCT01199302|531576537|FG000|Overall Study|Adverse Event|1|||
147386541|NCT01199302|531576538|FG001|Overall Study|Adverse Event|1|||
147386542|NCT01199302|531576539|FG002|Overall Study|Adverse Event|2|||
147386543|NCT01199302|531576540|FG003|Overall Study|Adverse Event|0|||
147386544|NCT01199302|531576537|FG000|Overall Study|Withdrawal by Subject|2|||
147386545|NCT01199302|531576538|FG001|Overall Study|Withdrawal by Subject|2|||
147386546|NCT01199302|531576539|FG002|Overall Study|Withdrawal by Subject|3|||
147386547|NCT01199302|531576540|FG003|Overall Study|Withdrawal by Subject|0|||
147386548|NCT01199302|531576537|FG000|Overall Study|Disease Progression|3|||
147386549|NCT01199302|531576538|FG001|Overall Study|Disease Progression|4|||
147386550|NCT01199302|531576539|FG002|Overall Study|Disease Progression|4|||
147386551|NCT01199302|531576540|FG003|Overall Study|Disease Progression|2|||
147386552|NCT01199302|531576537|FG000|Overall Study|Study Termination|13|||
147386553|NCT01199302|531576538|FG001|Overall Study|Study Termination|8|||
147386554|NCT01199302|531576539|FG002|Overall Study|Study Termination|11|||
147386555|NCT01199302|531576540|FG003|Overall Study|Study Termination|9|||
147386556|NCT01199302|531576537|FG000|Overall Study|Lost to Follow-up|0|||
147386557|NCT01199302|531576538|FG001|Overall Study|Lost to Follow-up|1|||
147386558|NCT01199302|531576539|FG002|Overall Study|Lost to Follow-up|0|||
147386559|NCT01199302|531576540|FG003|Overall Study|Lost to Follow-up|0|||
147386560|NCT01199302|531576537|FG000|Overall Study|Other|1|||
147386561|NCT01199302|531576538|FG001|Overall Study|Other|0|||
147386562|NCT01199302|531576539|FG002|Overall Study|Other|0|||
147386563|NCT01199302|531576540|FG003|Overall Study|Other|0|||
147386564|NCT04433091|531576541|FG000|Overall Study|Lost to Follow-up|1|||
147386565|NCT04433091|531576542|FG001|Overall Study|Lost to Follow-up|0|||
147386566|NCT04433091|531576541|FG000|Overall Study|Withdrawn .|2|||
147386567|NCT04433091|531576542|FG001|Overall Study|Withdrawn .|4|||
147386568|NCT05356130|531577707|FG000|Overall Study|Withdrawal by Subject|0|||
147457056|NCT03266016|531835493|FG001|Acute Phase (0 to 28 Days)|Completed study at acute phase.|56|||
147457057|NCT03266016|531835494|FG002|Acute Phase (0 to 28 Days)|Completed study at acute phase.|0|||
147457058|NCT03266016|531835495|FG003|Acute Phase (0 to 28 Days)|Completed study at acute phase.|0|||
147457059|NCT03160560|531835504|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|2|||
147457060|NCT03160560|531835505|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
147386569|NCT05356130|531577708|FG001|Overall Study|Withdrawal by Subject|0|||
147386570|NCT05356130|531577709|FG002|Overall Study|Withdrawal by Subject|3|||
147386571|NCT04851587|531577710|FG000|Overall Study|Lost to Follow-up|18|||
147386572|NCT02880293|531577711|FG000|Overall Study|Inevaluable|5|||
147386573|NCT02109172|531577715|FG000|Overall Study|Withdrawal by Subject|1|||
147386574|NCT02109172|531577716|FG001|Overall Study|Withdrawal by Subject|0|||
147386575|NCT02109172|531577717|FG002|Overall Study|Withdrawal by Subject|0|||
147386576|NCT02109172|531577718|FG003|Overall Study|Withdrawal by Subject|1|||
147386577|NCT02109172|531577719|FG004|Overall Study|Withdrawal by Subject|0|||
147386578|NCT02109172|531577720|FG005|Overall Study|Withdrawal by Subject|0|||
147386579|NCT02109172|531577715|FG000|Overall Study|Adverse Event|0|||
147386580|NCT02109172|531577716|FG001|Overall Study|Adverse Event|0|||
147386581|NCT02109172|531577717|FG002|Overall Study|Adverse Event|1|||
147386582|NCT02109172|531577718|FG003|Overall Study|Adverse Event|0|||
147386583|NCT02109172|531577719|FG004|Overall Study|Adverse Event|0|||
147386584|NCT02109172|531577720|FG005|Overall Study|Adverse Event|1|||
147386585|NCT02109172|531577715|FG000|Overall Study|Death|0|||
147386586|NCT02109172|531577716|FG001|Overall Study|Death|0|||
147386587|NCT02109172|531577717|FG002|Overall Study|Death|0|||
147386588|NCT02109172|531577718|FG003|Overall Study|Death|0|||
147386589|NCT02109172|531577719|FG004|Overall Study|Death|1|||
147386590|NCT02109172|531577720|FG005|Overall Study|Death|0|||
147386591|NCT03409276|531577721|FG000|Overall Study|Withdrawal by Subject|0|||
147386592|NCT03409276|531577722|FG001|Overall Study|Withdrawal by Subject|0|||
147386593|NCT03409276|531577723|FG002|Overall Study|Withdrawal by Subject|0|||
147386594|NCT03409276|531577724|FG003|Overall Study|Withdrawal by Subject|0|||
147386595|NCT03409276|531577725|FG004|Overall Study|Withdrawal by Subject|1|||
147386596|NCT03409276|531577721|FG000|Overall Study|Lost to Follow-up|0|||
147386597|NCT03409276|531577722|FG001|Overall Study|Lost to Follow-up|0|||
147386598|NCT03409276|531577723|FG002|Overall Study|Lost to Follow-up|0|||
147386599|NCT03409276|531577724|FG003|Overall Study|Lost to Follow-up|2|||
147386600|NCT03409276|531577725|FG004|Overall Study|Lost to Follow-up|2|||
147386601|NCT03605745|531577726|FG000|Overall Study|Study was terminated for business reasons|47|||
147386602|NCT04454125|531577731|FG000|Overall Study|Lost to Follow-up|0|||
147386603|NCT04454125|531577732|FG001|Overall Study|Lost to Follow-up|1|||
147386604|NCT01193283|531577739|FG000|Overall Study|Death|1|||
147386605|NCT01183013|531577741|FG000|Overall Study|Adverse Event|6|||
147386606|NCT01183013|531577742|FG001|Overall Study|Adverse Event|8|||
147386607|NCT01183013|531577743|FG002|Overall Study|Adverse Event|5|||
147386608|NCT01183013|531577744|FG003|Overall Study|Adverse Event|5|||
147386609|NCT01183013|531577745|FG004|Overall Study|Adverse Event|10|||
147386610|NCT01183013|531577746|FG005|Overall Study|Adverse Event|10|||
147386611|NCT01183013|531577747|FG006|Overall Study|Adverse Event|6|||
147386612|NCT01183013|531577741|FG000|Overall Study|Lack of Efficacy|3|||
147386613|NCT01183013|531577742|FG001|Overall Study|Lack of Efficacy|2|||
147386614|NCT01183013|531577743|FG002|Overall Study|Lack of Efficacy|1|||
147386615|NCT01183013|531577744|FG003|Overall Study|Lack of Efficacy|2|||
147386616|NCT01183013|531577745|FG004|Overall Study|Lack of Efficacy|1|||
147386617|NCT01183013|531577746|FG005|Overall Study|Lack of Efficacy|2|||
147386618|NCT01183013|531577747|FG006|Overall Study|Lack of Efficacy|0|||
147386619|NCT01183013|531577741|FG000|Overall Study|Protocol Violation|5|||
147386620|NCT01183013|531577742|FG001|Overall Study|Protocol Violation|2|||
147386621|NCT01183013|531577743|FG002|Overall Study|Protocol Violation|4|||
147457061|NCT03160560|531835506|FG002|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
147457062|NCT03160560|531835507|FG003|First Intervention (3 Weeks)|Withdrawal by Subject|0|||
147457063|NCT03160560|531835504|FG000|Second Intervention (3 Weeks)|Withdrawal by Subject|1|||
147457064|NCT03160560|531835505|FG001|Second Intervention (3 Weeks)|Withdrawal by Subject|0|||
147615043|NCT04856917|532406580|FG002|Overall Study|Lost to Follow-up|1|||
147615044|NCT04856917|532406578|FG000|Overall Study|Used of Prohibited Medication or Treatment|0|||
147615045|NCT04856917|532406579|FG001|Overall Study|Used of Prohibited Medication or Treatment|1|||
147615046|NCT04856917|532406580|FG002|Overall Study|Used of Prohibited Medication or Treatment|2|||
147386622|NCT01183013|531577744|FG003|Overall Study|Protocol Violation|0|||
147386623|NCT01183013|531577745|FG004|Overall Study|Protocol Violation|4|||
147386624|NCT01183013|531577746|FG005|Overall Study|Protocol Violation|3|||
147386625|NCT01183013|531577747|FG006|Overall Study|Protocol Violation|3|||
147386626|NCT01183013|531577741|FG000|Overall Study|Lost to Follow-up|7|||
147386627|NCT01183013|531577742|FG001|Overall Study|Lost to Follow-up|3|||
147386628|NCT01183013|531577743|FG002|Overall Study|Lost to Follow-up|4|||
147386629|NCT01183013|531577744|FG003|Overall Study|Lost to Follow-up|3|||
147386630|NCT01183013|531577745|FG004|Overall Study|Lost to Follow-up|2|||
147386631|NCT01183013|531577746|FG005|Overall Study|Lost to Follow-up|6|||
147386632|NCT01183013|531577747|FG006|Overall Study|Lost to Follow-up|5|||
147457065|NCT03160560|531835506|FG002|Second Intervention (3 Weeks)|Withdrawal by Subject|0|||
147457066|NCT03160560|531835507|FG003|Second Intervention (3 Weeks)|Withdrawal by Subject|0|||
147457067|NCT01354028|531835520|FG000|Overall Study|Physician Decision|0|||
147457068|NCT01354028|531835521|FG001|Overall Study|Physician Decision|2|||
147457069|NCT01354028|531835520|FG000|Overall Study|Discharged before study start|2|||
147457070|NCT01354028|531835521|FG001|Overall Study|Discharged before study start|2|||
147386633|NCT01183013|531577741|FG000|Overall Study|Withdrawal by Subject|9|||
147386634|NCT01183013|531577742|FG001|Overall Study|Withdrawal by Subject|13|||
147386635|NCT01183013|531577743|FG002|Overall Study|Withdrawal by Subject|10|||
147386636|NCT01183013|531577744|FG003|Overall Study|Withdrawal by Subject|8|||
147386637|NCT01183013|531577745|FG004|Overall Study|Withdrawal by Subject|7|||
147386638|NCT01183013|531577746|FG005|Overall Study|Withdrawal by Subject|9|||
147386639|NCT01183013|531577747|FG006|Overall Study|Withdrawal by Subject|10|||
147386640|NCT01183013|531577741|FG000|Overall Study|Reasons other than stated above|15|||
147386641|NCT01183013|531577742|FG001|Overall Study|Reasons other than stated above|11|||
147386642|NCT01183013|531577743|FG002|Overall Study|Reasons other than stated above|17|||
147386643|NCT01183013|531577744|FG003|Overall Study|Reasons other than stated above|12|||
147386644|NCT01183013|531577745|FG004|Overall Study|Reasons other than stated above|12|||
147386645|NCT01183013|531577746|FG005|Overall Study|Reasons other than stated above|15|||
147386646|NCT01183013|531577747|FG006|Overall Study|Reasons other than stated above|13|||
147386647|NCT02256553|531577749|FG000|Period I|Adverse Event|5|||
147386648|NCT02256553|531577749|FG000|Period I|Protocol Violation|1|||
147386649|NCT02256553|531577749|FG000|Period II|Adverse Event|1|||
147386650|NCT02256553|531577749|FG000|Period II|Subject Moved|1|||
147386651|NCT02256553|531577749|FG000|Period III|Adverse Event|3|||
147386652|NCT04739306|531577750|FG000|Main Study Period|Adverse Event|6|||
147386653|NCT04739306|531577751|FG001|Main Study Period|Adverse Event|7|||
147386654|NCT04739306|531577750|FG000|Main Study Period|Lost to Follow-up|4|||
147386655|NCT04739306|531577751|FG001|Main Study Period|Lost to Follow-up|6|||
147386656|NCT04739306|531577750|FG000|Main Study Period|Physician Decision|1|||
147386657|NCT04739306|531577751|FG001|Main Study Period|Physician Decision|1|||
147386658|NCT04739306|531577750|FG000|Main Study Period|Withdrawal by Subject|8|||
147386659|NCT04739306|531577751|FG001|Main Study Period|Withdrawal by Subject|6|||
147386660|NCT04739306|531577750|FG000|Main Study Period|Protocol Violation|0|||
147386661|NCT04739306|531577751|FG001|Main Study Period|Protocol Violation|1|||
147386662|NCT04739306|531577750|FG000|Main Study Period|War in Ukraine|1|||
147386663|NCT04739306|531577751|FG001|Main Study Period|War in Ukraine|1|||
147386664|NCT01951105|531577752|FG000|Overall Study|Adverse Event|0|||
147386665|NCT01951105|531577753|FG001|Overall Study|Adverse Event|5|||
147457071|NCT01354028|531835520|FG000|Overall Study|No quiet alert state|0|||
147457072|NCT01354028|531835521|FG001|Overall Study|No quiet alert state|1|||
147457073|NCT01777763|531835522|FG000|Overall Study|Adverse Event|2|||
147457074|NCT01777763|531835523|FG001|Overall Study|Adverse Event|32|||
147457075|NCT01777763|531835522|FG000|Overall Study|Protocol Violation|1|||
147457076|NCT01777763|531835523|FG001|Overall Study|Protocol Violation|7|||
147457077|NCT01777763|531835522|FG000|Overall Study|Withdrawal by Subject|0|||
147457078|NCT01777763|531835523|FG001|Overall Study|Withdrawal by Subject|2|||
147457079|NCT01777763|531835522|FG000|Overall Study|Treatment Failure|1|||
147457080|NCT01777763|531835523|FG001|Overall Study|Treatment Failure|6|||
147457081|NCT00975156|531835526|FG000|Overall Study|Protocol Violation|0|||
147457082|NCT00975156|531835527|FG001|Overall Study|Protocol Violation|1|||
147457083|NCT05425563|531835528|FG000|Overall Study|Withdrawal by Subject|17|||
147457084|NCT00584233|531835530|FG000|Overall Study|Withdrawal by Subject|5|||
147457085|NCT00584233|531835530|FG000|Overall Study|Subjects did not complete both CT and MRI to be evaluated in results|13|||
147457086|NCT04537208|531835533|FG000|Overall Study|Adverse Event|0|||
147457087|NCT04537208|531835534|FG001|Overall Study|Adverse Event|0|||
147457088|NCT04537208|531835535|FG002|Overall Study|Adverse Event|0|||
147457089|NCT04537208|531835536|FG003|Overall Study|Adverse Event|0|||
147457090|NCT04537208|531835537|FG004|Overall Study|Adverse Event|0|||
147457091|NCT04537208|531835538|FG005|Overall Study|Adverse Event|0|||
147457092|NCT04537208|531835539|FG006|Overall Study|Adverse Event|0|||
147457093|NCT04537208|531835540|FG007|Overall Study|Adverse Event|0|||
147457094|NCT04537208|531835541|FG008|Overall Study|Adverse Event|1|||
147457095|NCT04537208|531835542|FG009|Overall Study|Adverse Event|0|||
147457096|NCT04537208|531835543|FG010|Overall Study|Adverse Event|0|||
147457097|NCT04537208|531835533|FG000|Overall Study|Protocol deviation|0|||
147457098|NCT04537208|531835534|FG001|Overall Study|Protocol deviation|0|||
147457099|NCT04537208|531835535|FG002|Overall Study|Protocol deviation|2|||
147457100|NCT04537208|531835536|FG003|Overall Study|Protocol deviation|0|||
147457101|NCT04537208|531835537|FG004|Overall Study|Protocol deviation|0|||
147457102|NCT04537208|531835538|FG005|Overall Study|Protocol deviation|2|||
147386666|NCT01951105|531577754|FG002|Overall Study|Adverse Event|0|||
147386667|NCT01951105|531577752|FG000|Overall Study|Lost to Follow-up|0|||
147386668|NCT01951105|531577753|FG001|Overall Study|Lost to Follow-up|1|||
147386669|NCT01951105|531577754|FG002|Overall Study|Lost to Follow-up|0|||
147386670|NCT01951105|531577752|FG000|Overall Study|Protocol Violation|1|||
147386671|NCT01951105|531577753|FG001|Overall Study|Protocol Violation|1|||
147457103|NCT04537208|531835539|FG006|Overall Study|Protocol deviation|4|||
147457104|NCT04537208|531835540|FG007|Overall Study|Protocol deviation|0|||
147457105|NCT04537208|531835541|FG008|Overall Study|Protocol deviation|1|||
147457106|NCT04537208|531835542|FG009|Overall Study|Protocol deviation|0|||
147457107|NCT04537208|531835543|FG010|Overall Study|Protocol deviation|2|||
147457108|NCT04537208|531835533|FG000|Overall Study|Withdrawal by Subject|4|||
147457109|NCT04537208|531835534|FG001|Overall Study|Withdrawal by Subject|2|||
147457110|NCT04537208|531835535|FG002|Overall Study|Withdrawal by Subject|1|||
147457111|NCT04537208|531835536|FG003|Overall Study|Withdrawal by Subject|3|||
147457112|NCT04537208|531835537|FG004|Overall Study|Withdrawal by Subject|5|||
147457113|NCT04537208|531835538|FG005|Overall Study|Withdrawal by Subject|1|||
147457114|NCT04537208|531835539|FG006|Overall Study|Withdrawal by Subject|6|||
147457115|NCT04537208|531835540|FG007|Overall Study|Withdrawal by Subject|1|||
147457116|NCT04537208|531835541|FG008|Overall Study|Withdrawal by Subject|7|||
147457117|NCT04537208|531835542|FG009|Overall Study|Withdrawal by Subject|2|||
147457118|NCT04537208|531835543|FG010|Overall Study|Withdrawal by Subject|4|||
147457119|NCT04537208|531835533|FG000|Overall Study|Lost to Follow-up|4|||
147457120|NCT04537208|531835534|FG001|Overall Study|Lost to Follow-up|1|||
147457121|NCT04537208|531835535|FG002|Overall Study|Lost to Follow-up|3|||
147457122|NCT04537208|531835536|FG003|Overall Study|Lost to Follow-up|4|||
147457123|NCT04537208|531835537|FG004|Overall Study|Lost to Follow-up|3|||
147457124|NCT04537208|531835538|FG005|Overall Study|Lost to Follow-up|2|||
147457125|NCT04537208|531835539|FG006|Overall Study|Lost to Follow-up|3|||
147457126|NCT04537208|531835540|FG007|Overall Study|Lost to Follow-up|2|||
147457127|NCT04537208|531835541|FG008|Overall Study|Lost to Follow-up|7|||
147457128|NCT04537208|531835542|FG009|Overall Study|Lost to Follow-up|2|||
147457129|NCT04537208|531835543|FG010|Overall Study|Lost to Follow-up|2|||
147457130|NCT03655756|531835544|FG000|Overall Study|Death|1|||
147457131|NCT01340209|531835545|FG000|Overall Study|Adverse Event|1|||
147457132|NCT01340209|531835546|FG001|Overall Study|Adverse Event|1|||
147457133|NCT01340209|531835547|FG002|Overall Study|Adverse Event|2|||
147457134|NCT01340209|531835545|FG000|Overall Study|Protocol Violation|1|||
147457135|NCT01340209|531835546|FG001|Overall Study|Protocol Violation|2|||
147457136|NCT01340209|531835547|FG002|Overall Study|Protocol Violation|1|||
147457137|NCT01340209|531835545|FG000|Overall Study|Withdrawal by Subject|0|||
147457138|NCT01340209|531835546|FG001|Overall Study|Withdrawal by Subject|0|||
147457139|NCT01340209|531835547|FG002|Overall Study|Withdrawal by Subject|1|||
147457140|NCT01340209|531835545|FG000|Overall Study|Other reason not defined above|3|||
147457141|NCT01340209|531835546|FG001|Overall Study|Other reason not defined above|5|||
147457142|NCT01340209|531835547|FG002|Overall Study|Other reason not defined above|4|||
147457143|NCT03237065|531835548|FG000|Overall Study|Adverse Event|0|||
147457144|NCT03237065|531835549|FG001|Overall Study|Adverse Event|2|||
147457145|NCT03237065|531835548|FG000|Overall Study|Protocol Violation|0|||
147386672|NCT01951105|531577754|FG002|Overall Study|Protocol Violation|1|||
147386673|NCT01951105|531577752|FG000|Overall Study|Withdrawal by Subject|0|||
147386674|NCT01951105|531577753|FG001|Overall Study|Withdrawal by Subject|3|||
147386675|NCT01951105|531577754|FG002|Overall Study|Withdrawal by Subject|1|||
147386676|NCT02727998|531577755|FG000|Overall Study|Lost to Follow-up|3|||
147386677|NCT02727998|531577756|FG001|Overall Study|Lost to Follow-up|3|||
147386678|NCT02727998|531577755|FG000|Overall Study|Withdrawal by Subject|0|||
147386679|NCT02727998|531577756|FG001|Overall Study|Withdrawal by Subject|1|||
147386680|NCT03651271|531577757|FG000|Overall Study|Death|4|||
147386681|NCT03651271|531577758|FG001|Overall Study|Death|37|||
147386682|NCT03651271|531577759|FG002|Overall Study|Death|0|||
147386683|NCT03651271|531577760|FG003|Overall Study|Death|2|||
147386684|NCT03651271|531577761|FG004|Overall Study|Death|6|||
147386685|NCT03651271|531577757|FG000|Overall Study|Lost to Follow-up|1|||
147386686|NCT03651271|531577758|FG001|Overall Study|Lost to Follow-up|5|||
147386687|NCT03651271|531577759|FG002|Overall Study|Lost to Follow-up|0|||
147386688|NCT03651271|531577760|FG003|Overall Study|Lost to Follow-up|1|||
147457146|NCT03237065|531835549|FG001|Overall Study|Protocol Violation|1|||
147457147|NCT03237065|531835548|FG000|Overall Study|Withdrawal by Subject|3|||
147457148|NCT03237065|531835549|FG001|Overall Study|Withdrawal by Subject|0|||
147457149|NCT03237065|531835548|FG000|Overall Study|Lost to Follow-up|1|||
147457150|NCT03237065|531835549|FG001|Overall Study|Lost to Follow-up|0|||
147457151|NCT03237065|531835548|FG000|Overall Study|Unable to obtain venous access|0|||
147457152|NCT03237065|531835549|FG001|Overall Study|Unable to obtain venous access|1|||
147457153|NCT00704964|531835551|FG000|Overall Study|Not completed on time|328|||
147457154|NCT02161562|531835552|FG000|Overall Study|Withdrawal by Subject|5|||
147615047|NCT04856917|532406578|FG000|Overall Study|Other|1|||
147615048|NCT04856917|532406579|FG001|Overall Study|Other|1|||
147386689|NCT03651271|531577761|FG004|Overall Study|Lost to Follow-up|0|||
147386690|NCT03651271|531577757|FG000|Overall Study|Physician Decision|0|||
147386691|NCT03651271|531577758|FG001|Overall Study|Physician Decision|2|||
147386692|NCT03651271|531577759|FG002|Overall Study|Physician Decision|0|||
147386693|NCT03651271|531577760|FG003|Overall Study|Physician Decision|0|||
147457155|NCT02161562|531835553|FG001|Overall Study|Withdrawal by Subject|8|||
147457156|NCT02161562|531835552|FG000|Overall Study|Protocol Violation|9|||
147457157|NCT02161562|531835553|FG001|Overall Study|Protocol Violation|4|||
147386694|NCT03651271|531577761|FG004|Overall Study|Physician Decision|0|||
147386695|NCT03651271|531577757|FG000|Overall Study|Withdrawal by Subject|1|||
147386696|NCT03651271|531577758|FG001|Overall Study|Withdrawal by Subject|15|||
147386697|NCT03651271|531577759|FG002|Overall Study|Withdrawal by Subject|0|||
147386698|NCT03651271|531577760|FG003|Overall Study|Withdrawal by Subject|0|||
147386699|NCT03651271|531577761|FG004|Overall Study|Withdrawal by Subject|1|||
147386700|NCT03651271|531577757|FG000|Overall Study|Patient medically unable to continue|0|||
147386701|NCT03651271|531577758|FG001|Overall Study|Patient medically unable to continue|0|||
147386702|NCT03651271|531577759|FG002|Overall Study|Patient medically unable to continue|0|||
147386703|NCT03651271|531577760|FG003|Overall Study|Patient medically unable to continue|1|||
147386704|NCT03651271|531577761|FG004|Overall Study|Patient medically unable to continue|0|||
147386705|NCT05072795|531577762|FG000|Overall Study|Lost to Follow-up|5|||
147386706|NCT00821093|531577765|FG000|Overall Study|Adverse Event|20|||
147386707|NCT00821093|531577766|FG001|Overall Study|Adverse Event|12|||
147386708|NCT00821093|531577765|FG000|Overall Study|Withdrawal by Subject|9|||
147386709|NCT00821093|531577766|FG001|Overall Study|Withdrawal by Subject|13|||
147386710|NCT00821093|531577765|FG000|Overall Study|Lost to Follow-up|9|||
147386711|NCT00821093|531577766|FG001|Overall Study|Lost to Follow-up|3|||
147386712|NCT00821093|531577765|FG000|Overall Study|Protocol deviation|3|||
147386713|NCT00821093|531577766|FG001|Overall Study|Protocol deviation|6|||
147386714|NCT00821093|531577765|FG000|Overall Study|Abnormal laboratory value(s)|2|||
147386715|NCT00821093|531577766|FG001|Overall Study|Abnormal laboratory value(s)|0|||
147386716|NCT00821093|531577765|FG000|Overall Study|Lack of Efficacy|2|||
147386717|NCT00821093|531577766|FG001|Overall Study|Lack of Efficacy|2|||
147386718|NCT00821093|531577765|FG000|Overall Study|Death|2|||
147386719|NCT00821093|531577766|FG001|Overall Study|Death|1|||
147386720|NCT00821093|531577765|FG000|Overall Study|Abnormal test procedure result(s)|1|||
147386721|NCT00821093|531577766|FG001|Overall Study|Abnormal test procedure result(s)|1|||
147386722|NCT00821093|531577765|FG000|Overall Study|Administrative problems|1|||
147386723|NCT00821093|531577766|FG001|Overall Study|Administrative problems|2|||
147386724|NCT01601821|531577767|FG000|Overall Study|Death|2|||
147386725|NCT01601821|531577768|FG001|Overall Study|Death|5|||
147386726|NCT01601821|531577767|FG000|Overall Study|Protocol Violation|2|||
147386727|NCT01601821|531577768|FG001|Overall Study|Protocol Violation|2|||
147386728|NCT01601821|531577767|FG000|Overall Study|Lost to Follow-up|6|||
147386729|NCT01601821|531577768|FG001|Overall Study|Lost to Follow-up|14|||
147386730|NCT01601821|531577767|FG000|Overall Study|Withdrawal by Subject|1|||
147386731|NCT01601821|531577768|FG001|Overall Study|Withdrawal by Subject|0|||
147386732|NCT01601821|531577767|FG000|Overall Study|Graft Loss|6|||
147386733|NCT01601821|531577768|FG001|Overall Study|Graft Loss|6|||
147386734|NCT01601821|531577767|FG000|Overall Study|Study Events|7|||
147386735|NCT01601821|531577768|FG001|Overall Study|Study Events|1|||
147386736|NCT01601821|531577767|FG000|Overall Study|Other|5|||
147386737|NCT01601821|531577768|FG001|Overall Study|Other|1|||
147386738|NCT01901302|531577772|FG000|Overall Study|Adverse Event|2|||
147386739|NCT01901302|531577773|FG001|Overall Study|Adverse Event|1|||
147386740|NCT01901302|531577772|FG000|Overall Study|Lack of Efficacy|0|||
147386741|NCT01901302|531577773|FG001|Overall Study|Lack of Efficacy|2|||
147386742|NCT01901302|531577772|FG000|Overall Study|Study Terminated by Sponsor|23|||
147386743|NCT01901302|531577773|FG001|Overall Study|Study Terminated by Sponsor|20|||
147386744|NCT01901302|531577772|FG000|Overall Study|Withdrawal by Subject|2|||
147386745|NCT01901302|531577773|FG001|Overall Study|Withdrawal by Subject|0|||
147386746|NCT02812706|531577778|FG000|Phase 1|Adverse Event|0|||
147386747|NCT02812706|531577779|FG001|Phase 1|Adverse Event|2|||
147386748|NCT02812706|531577780|FG002|Phase 1|Adverse Event|0|||
147386749|NCT02812706|531577778|FG000|Phase 1|Progressive disease|3|||
147386750|NCT02812706|531577779|FG001|Phase 1|Progressive disease|3|||
147386751|NCT02812706|531577780|FG002|Phase 1|Progressive disease|0|||
147386752|NCT02812706|531577778|FG000|Phase 2|Adverse Event|0|||
147386753|NCT02812706|531577779|FG001|Phase 2|Adverse Event|0|||
147386754|NCT02812706|531577780|FG002|Phase 2|Adverse Event|2|||
147386755|NCT02812706|531577778|FG000|Phase 2|Progressive disease|0|||
147386756|NCT02812706|531577779|FG001|Phase 2|Progressive disease|0|||
147386757|NCT02812706|531577780|FG002|Phase 2|Progressive disease|22|||
147386758|NCT02812706|531577778|FG000|Phase 2|Other-Unspecified|0|||
147386759|NCT02812706|531577779|FG001|Phase 2|Other-Unspecified|0|||
147386760|NCT02812706|531577780|FG002|Phase 2|Other-Unspecified|4|||
147386761|NCT00910871|531577786|FG000|Overall Study|Adverse Event|5|||
147386762|NCT00910871|531577786|FG000|Overall Study|Death|12|||
147386763|NCT00910871|531577786|FG000|Overall Study|Lost to Follow-up|8|||
147386764|NCT00910871|531577786|FG000|Overall Study|Protocol Violation|11|||
147386765|NCT00910871|531577786|FG000|Overall Study|Withdrawal by Subject|12|||
147386766|NCT00910871|531577786|FG000|Overall Study|Subject didn't meet eligibility criteria|5|||
147386767|NCT00910871|531577786|FG000|Overall Study|Undefined|1|||
147386768|NCT01005914|531577790|FG000|Overall Study|Adverse Event|4|||
147386769|NCT01005914|531577790|FG000|Overall Study|Death|4|||
147386770|NCT01005914|531577790|FG000|Overall Study|Lack of Efficacy|1|||
147386771|NCT01005914|531577790|FG000|Overall Study|Withdrawal by Subject|1|||
147386772|NCT01755598|531577791|FG000|Overall Study|Other|109|||
147386773|NCT01755598|531577792|FG001|Overall Study|Other|109|||
147386774|NCT01755598|531577791|FG000|Overall Study|Lost to Follow-up|32|||
147386775|NCT01755598|531577792|FG001|Overall Study|Lost to Follow-up|43|||
147386776|NCT01755598|531577791|FG000|Overall Study|Migrated/moved from study area|76|||
147386777|NCT01755598|531577792|FG001|Overall Study|Migrated/moved from study area|65|||
147386778|NCT01755598|531577791|FG000|Overall Study|Withdrawal by Subject|22|||
147386779|NCT01755598|531577792|FG001|Overall Study|Withdrawal by Subject|31|||
147386780|NCT01755598|531577791|FG000|Overall Study|Protocol Violation|7|||
147386781|NCT01755598|531577792|FG001|Overall Study|Protocol Violation|7|||
147386782|NCT01755598|531577791|FG000|Overall Study|Adverse Event|19|||
147386783|NCT01755598|531577792|FG001|Overall Study|Adverse Event|28|||
147386784|NCT04016415|531577793|FG000|Overall Study|Adverse Event|2|||
147386785|NCT04016415|531577794|FG001|Overall Study|Adverse Event|1|||
147386786|NCT04016415|531577793|FG000|Overall Study|Lost to Follow-up|6|||
147386787|NCT04016415|531577794|FG001|Overall Study|Lost to Follow-up|2|||
147386788|NCT04016415|531577793|FG000|Overall Study|Physician Decision|5|||
147386789|NCT04016415|531577794|FG001|Overall Study|Physician Decision|1|||
147386790|NCT04016415|531577793|FG000|Overall Study|Pregnancy|0|||
147386791|NCT04016415|531577794|FG001|Overall Study|Pregnancy|1|||
147386792|NCT04016415|531577793|FG000|Overall Study|Withdrawal by Subject|24|||
147386793|NCT04016415|531577794|FG001|Overall Study|Withdrawal by Subject|27|||
147386794|NCT04016415|531577793|FG000|Overall Study|Participant Non-Compliance: Orientation not completed prior to Class #2|2|||
147386795|NCT04016415|531577794|FG001|Overall Study|Participant Non-Compliance: Orientation not completed prior to Class #2|0|||
147386796|NCT02260154|531577803|FG000|Overall Study|Screening failure|2|||
147386797|NCT03547167|531577804|FG000|Overall Study|Withdrawal by Subject|34|||
147386798|NCT03547167|531577805|FG001|Overall Study|Withdrawal by Subject|12|||
147386799|NCT03547167|531577804|FG000|Overall Study|Screen Failure|0|||
147386800|NCT03547167|531577805|FG001|Overall Study|Screen Failure|1|||
147386801|NCT03547167|531577804|FG000|Overall Study|Lost to Follow-up|59|||
147386802|NCT03547167|531577805|FG001|Overall Study|Lost to Follow-up|15|||
147386803|NCT03547167|531577804|FG000|Overall Study|Death|4|||
147386804|NCT03547167|531577805|FG001|Overall Study|Death|2|||
147386805|NCT00736502|531577806|FG000|Overall Study|Adverse Event|22|||
147386806|NCT00736502|531577806|FG000|Overall Study|Lack of Efficacy|16|||
147386807|NCT00736502|531577806|FG000|Overall Study|Lost to Follow-up|27|||
147386808|NCT00645411|531577807|FG000|Overall Study|Adverse Event|0|||
147386809|NCT00645411|531577808|FG001|Overall Study|Adverse Event|0|||
147386810|NCT00645411|531577809|FG002|Overall Study|Adverse Event|0|||
147386811|NCT00645411|531577810|FG003|Overall Study|Adverse Event|2|||
147386812|NCT00645411|531577807|FG000|Overall Study|Withdrawal by Subject|2|||
147386813|NCT00645411|531577808|FG001|Overall Study|Withdrawal by Subject|1|||
147386814|NCT00645411|531577809|FG002|Overall Study|Withdrawal by Subject|19|||
147386815|NCT00645411|531577810|FG003|Overall Study|Withdrawal by Subject|21|||
147386816|NCT00645411|531577807|FG000|Overall Study|Lost to Follow-up|10|||
147457158|NCT02161562|531835552|FG000|Overall Study|Pregnancy|1|||
147457159|NCT02161562|531835553|FG001|Overall Study|Pregnancy|2|||
147457160|NCT02161562|531835552|FG000|Overall Study|Lost to Follow-up|3|||
147457161|NCT02161562|531835553|FG001|Overall Study|Lost to Follow-up|1|||
147457162|NCT02161562|531835552|FG000|Overall Study|Lack of Efficacy|4|||
147457163|NCT02161562|531835553|FG001|Overall Study|Lack of Efficacy|1|||
147457164|NCT02161562|531835552|FG000|Overall Study|Adverse Event|1|||
147457165|NCT02161562|531835553|FG001|Overall Study|Adverse Event|1|||
147457166|NCT02161562|531835552|FG000|Overall Study|Participant moved back to home country|1|||
147457167|NCT02161562|531835553|FG001|Overall Study|Participant moved back to home country|0|||
147457168|NCT02161562|531835552|FG000|Overall Study|Withdrew due to being out of the country|1|||
147457169|NCT02161562|531835553|FG001|Overall Study|Withdrew due to being out of the country|0|||
147457170|NCT02161562|531835552|FG000|Overall Study|Participant moved out of province|1|||
147457171|NCT02161562|531835553|FG001|Overall Study|Participant moved out of province|0|||
147457172|NCT01699087|531835566|FG000|Overall Study|Lost to Follow-up|7|||
147457173|NCT01699087|531835566|FG000|Overall Study|Screen failure (prior to treatment)|15|||
147457174|NCT01699087|531835566|FG000|Overall Study|Unable to make future visits|2|||
147457175|NCT00094757|531835567|FG000|Overall Study|Adverse Event|11|||
147457176|NCT00094757|531835568|FG001|Overall Study|Adverse Event|9|||
147457177|NCT00094757|531835569|FG002|Overall Study|Adverse Event|6|||
147615049|NCT04856917|532406580|FG002|Overall Study|Other|0|||
147615050|NCT06195930|532406586|FG000|Overall Study|Adverse Event|4|||
147386817|NCT00645411|531577808|FG001|Overall Study|Lost to Follow-up|5|||
147386818|NCT00645411|531577809|FG002|Overall Study|Lost to Follow-up|124|||
147386819|NCT00645411|531577810|FG003|Overall Study|Lost to Follow-up|75|||
147386820|NCT00645411|531577807|FG000|Overall Study|Protocol Violation|1|||
147457178|NCT00094757|531835567|FG000|Overall Study|Lack of Efficacy|11|||
147457179|NCT00094757|531835568|FG001|Overall Study|Lack of Efficacy|15|||
147457180|NCT00094757|531835569|FG002|Overall Study|Lack of Efficacy|8|||
147457181|NCT00094757|531835567|FG000|Overall Study|Lost to Follow-up|3|||
147457182|NCT00094757|531835568|FG001|Overall Study|Lost to Follow-up|5|||
147457183|NCT00094757|531835569|FG002|Overall Study|Lost to Follow-up|6|||
147615051|NCT03999996|532406587|FG000|Prior to Booster|Adverse Event|2|||
147386821|NCT00645411|531577808|FG001|Overall Study|Protocol Violation|0|||
147386822|NCT00645411|531577809|FG002|Overall Study|Protocol Violation|1|||
147386823|NCT00645411|531577810|FG003|Overall Study|Protocol Violation|0|||
147386824|NCT00645411|531577807|FG000|Overall Study|Inappropriate enrollment|0|||
147386825|NCT00645411|531577808|FG001|Overall Study|Inappropriate enrollment|0|||
147386826|NCT00645411|531577809|FG002|Overall Study|Inappropriate enrollment|4|||
147386827|NCT00645411|531577810|FG003|Overall Study|Inappropriate enrollment|1|||
147386828|NCT00645411|531577807|FG000|Overall Study|Unable to classify|0|||
147386829|NCT00645411|531577808|FG001|Overall Study|Unable to classify|0|||
147386830|NCT00645411|531577809|FG002|Overall Study|Unable to classify|3|||
147386831|NCT00645411|531577810|FG003|Overall Study|Unable to classify|4|||
147386832|NCT01307800|531577811|FG000|Overall Study|Adverse Event|9|||
147386833|NCT01307800|531577812|FG001|Overall Study|Adverse Event|8|||
147386834|NCT01307800|531577813|FG002|Overall Study|Adverse Event|10|||
147386835|NCT01307800|531577814|FG003|Overall Study|Adverse Event|14|||
147386836|NCT01307800|531577811|FG000|Overall Study|Entry Criteria Not Met|0|||
147386837|NCT01307800|531577812|FG001|Overall Study|Entry Criteria Not Met|0|||
147386838|NCT01307800|531577813|FG002|Overall Study|Entry Criteria Not Met|0|||
147386839|NCT01307800|531577814|FG003|Overall Study|Entry Criteria Not Met|2|||
147386840|NCT01307800|531577811|FG000|Overall Study|Lost to Follow-up|5|||
147386841|NCT01307800|531577812|FG001|Overall Study|Lost to Follow-up|6|||
147386842|NCT01307800|531577813|FG002|Overall Study|Lost to Follow-up|2|||
147386843|NCT01307800|531577814|FG003|Overall Study|Lost to Follow-up|8|||
147386844|NCT01307800|531577811|FG000|Overall Study|Perceived Lack of Efficacy|24|||
147386845|NCT01307800|531577812|FG001|Overall Study|Perceived Lack of Efficacy|23|||
147386846|NCT01307800|531577813|FG002|Overall Study|Perceived Lack of Efficacy|20|||
147386847|NCT01307800|531577814|FG003|Overall Study|Perceived Lack of Efficacy|33|||
147386848|NCT01307800|531577811|FG000|Overall Study|Protocol Violation|0|||
147386849|NCT01307800|531577812|FG001|Overall Study|Protocol Violation|3|||
147386850|NCT01307800|531577813|FG002|Overall Study|Protocol Violation|4|||
147386851|NCT01307800|531577814|FG003|Overall Study|Protocol Violation|5|||
147386852|NCT01307800|531577811|FG000|Overall Study|Schedule Conflict Prevented Continuation|0|||
147386853|NCT01307800|531577812|FG001|Overall Study|Schedule Conflict Prevented Continuation|3|||
147386854|NCT01307800|531577813|FG002|Overall Study|Schedule Conflict Prevented Continuation|1|||
147386855|NCT01307800|531577814|FG003|Overall Study|Schedule Conflict Prevented Continuation|2|||
147386856|NCT01307800|531577811|FG000|Overall Study|Sponsor Decision|6|||
147386857|NCT01307800|531577812|FG001|Overall Study|Sponsor Decision|9|||
147386858|NCT01307800|531577813|FG002|Overall Study|Sponsor Decision|12|||
147386859|NCT01307800|531577814|FG003|Overall Study|Sponsor Decision|28|||
147386860|NCT01307800|531577811|FG000|Overall Study|Withdrawal by Subject|10|||
147386861|NCT01307800|531577812|FG001|Overall Study|Withdrawal by Subject|11|||
147386862|NCT01307800|531577813|FG002|Overall Study|Withdrawal by Subject|8|||
147386863|NCT01307800|531577814|FG003|Overall Study|Withdrawal by Subject|15|||
147386864|NCT01307800|531577811|FG000|Overall Study|Participant Moved|0|||
147386865|NCT01307800|531577812|FG001|Overall Study|Participant Moved|2|||
147386866|NCT01307800|531577813|FG002|Overall Study|Participant Moved|1|||
147386867|NCT01307800|531577814|FG003|Overall Study|Participant Moved|3|||
147386868|NCT02674399|531577815|FG000|Overall Study|Lost to Follow-up|2|||
147386869|NCT02674399|531577816|FG001|Overall Study|Lost to Follow-up|0|||
147386870|NCT02255474|531577817|FG000|Overall Study|Lost to Follow-up|1|||
147386871|NCT02255474|531577818|FG001|Overall Study|Lost to Follow-up|1|||
147386872|NCT02255474|531577819|FG002|Overall Study|Lost to Follow-up|3|||
147386873|NCT02255474|531577817|FG000|Overall Study|Withdrawal by Subject|1|||
147386874|NCT02255474|531577818|FG001|Overall Study|Withdrawal by Subject|1|||
147386875|NCT02255474|531577819|FG002|Overall Study|Withdrawal by Subject|0|||
147386876|NCT04520256|531577827|FG000|Overall Study|Lost to Follow-up|6|||
147386877|NCT04520256|531577828|FG001|Overall Study|Lost to Follow-up|4|||
147386878|NCT04520256|531577829|FG002|Overall Study|Lost to Follow-up|2|||
147386879|NCT04520256|531577830|FG003|Overall Study|Lost to Follow-up|3|||
147386880|NCT04520256|531577831|FG004|Overall Study|Lost to Follow-up|6|||
147386881|NCT04520256|531577832|FG005|Overall Study|Lost to Follow-up|6|||
147386882|NCT04520256|531577833|FG006|Overall Study|Lost to Follow-up|4|||
147386883|NCT04520256|531577834|FG007|Overall Study|Lost to Follow-up|6|||
147386884|NCT04520256|531577835|FG008|Overall Study|Lost to Follow-up|1|||
147386885|NCT04520256|531577836|FG009|Overall Study|Lost to Follow-up|3|||
147386886|NCT04520256|531577837|FG010|Overall Study|Lost to Follow-up|3|||
147386887|NCT04520256|531577838|FG011|Overall Study|Lost to Follow-up|2|||
147386888|NCT04520256|531577839|FG012|Overall Study|Lost to Follow-up|5|||
147386889|NCT04520256|531577840|FG013|Overall Study|Lost to Follow-up|3|||
147386890|NCT04520256|531577841|FG014|Overall Study|Lost to Follow-up|3|||
147386891|NCT04520256|531577842|FG015|Overall Study|Lost to Follow-up|6|||
147386892|NCT04520256|531577843|FG016|Overall Study|Lost to Follow-up|6|||
147386893|NCT04520256|531577844|FG017|Overall Study|Lost to Follow-up|4|||
147386894|NCT04520256|531577845|FG018|Overall Study|Lost to Follow-up|3|||
147386895|NCT04520256|531577846|FG019|Overall Study|Lost to Follow-up|3|||
147386896|NCT04520256|531577847|FG020|Overall Study|Lost to Follow-up|7|||
147386897|NCT04520256|531577848|FG021|Overall Study|Lost to Follow-up|3|||
147386898|NCT04520256|531577849|FG022|Overall Study|Lost to Follow-up|3|||
147386899|NCT04520256|531577850|FG023|Overall Study|Lost to Follow-up|8|||
147386900|NCT04520256|531577851|FG024|Overall Study|Lost to Follow-up|5|||
147386901|NCT04520256|531577852|FG025|Overall Study|Lost to Follow-up|4|||
147386902|NCT04520256|531577853|FG026|Overall Study|Lost to Follow-up|3|||
147386903|NCT04520256|531577854|FG027|Overall Study|Lost to Follow-up|4|||
147386904|NCT04520256|531577855|FG028|Overall Study|Lost to Follow-up|3|||
147386905|NCT04520256|531577856|FG029|Overall Study|Lost to Follow-up|4|||
147386906|NCT04520256|531577857|FG030|Overall Study|Lost to Follow-up|4|||
147386907|NCT04520256|531577858|FG031|Overall Study|Lost to Follow-up|4|||
147386908|NCT01730118|531578914|FG000|Dose Escalation|Death on study|5|||
147386909|NCT01730118|531578915|FG001|Dose Escalation|Death on study|7|||
147386910|NCT01730118|531578916|FG002|Dose Escalation|Death on study|2|||
147386911|NCT01730118|531578917|FG003|Dose Escalation|Death on study|6|||
147386912|NCT01730118|531578918|FG004|Dose Escalation|Death on study|0|||
147386913|NCT01730118|531578919|FG005|Dose Escalation|Death on study|0|||
147386914|NCT01730118|531578920|FG006|Dose Escalation|Death on study|0|||
147386915|NCT01730118|531578914|FG000|Dose Escalation|Died before treatment|0|||
147386916|NCT01730118|531578915|FG001|Dose Escalation|Died before treatment|0|||
147386917|NCT01730118|531578916|FG002|Dose Escalation|Died before treatment|0|||
147386918|NCT01730118|531578917|FG003|Dose Escalation|Died before treatment|0|||
147386919|NCT01730118|531578918|FG004|Dose Escalation|Died before treatment|0|||
147386920|NCT01730118|531578919|FG005|Dose Escalation|Died before treatment|0|||
147386921|NCT01730118|531578920|FG006|Dose Escalation|Died before treatment|1|||
147386922|NCT01730118|531578914|FG000|Dose Escalation|Chose to start a different treatment|1|||
147386923|NCT01730118|531578915|FG001|Dose Escalation|Chose to start a different treatment|0|||
147386924|NCT01730118|531578916|FG002|Dose Escalation|Chose to start a different treatment|0|||
147386925|NCT01730118|531578917|FG003|Dose Escalation|Chose to start a different treatment|0|||
147386926|NCT01730118|531578918|FG004|Dose Escalation|Chose to start a different treatment|0|||
147386927|NCT01730118|531578919|FG005|Dose Escalation|Chose to start a different treatment|0|||
147386928|NCT01730118|531578920|FG006|Dose Escalation|Chose to start a different treatment|0|||
147386929|NCT01730118|531578914|FG000|Dose Escalation|Withdrawal by Subject|0|||
147386930|NCT01730118|531578915|FG001|Dose Escalation|Withdrawal by Subject|0|||
147386931|NCT01730118|531578916|FG002|Dose Escalation|Withdrawal by Subject|1|||
147386932|NCT01730118|531578917|FG003|Dose Escalation|Withdrawal by Subject|0|||
147386933|NCT01730118|531578918|FG004|Dose Escalation|Withdrawal by Subject|0|||
147386934|NCT01730118|531578919|FG005|Dose Escalation|Withdrawal by Subject|0|||
147386935|NCT01730118|531578920|FG006|Dose Escalation|Withdrawal by Subject|0|||
147386936|NCT01730118|531578914|FG000|Dose Escalation|Disease progression prior to treatment|0|||
147386937|NCT01730118|531578915|FG001|Dose Escalation|Disease progression prior to treatment|0|||
147386938|NCT01730118|531578916|FG002|Dose Escalation|Disease progression prior to treatment|0|||
147386939|NCT01730118|531578917|FG003|Dose Escalation|Disease progression prior to treatment|0|||
147386940|NCT01730118|531578918|FG004|Dose Escalation|Disease progression prior to treatment|0|||
147386941|NCT01730118|531578919|FG005|Dose Escalation|Disease progression prior to treatment|0|||
147386942|NCT01730118|531578920|FG006|Dose Escalation|Disease progression prior to treatment|1|||
147386943|NCT01730118|531578914|FG000|Dose Expansion|Death|0|||
147386944|NCT01730118|531578915|FG001|Dose Expansion|Death|0|||
147386945|NCT01730118|531578916|FG002|Dose Expansion|Death|0|||
147386946|NCT01730118|531578917|FG003|Dose Expansion|Death|0|||
147386947|NCT01730118|531578918|FG004|Dose Expansion|Death|1|||
147386948|NCT01730118|531578919|FG005|Dose Expansion|Death|0|||
147386949|NCT01730118|531578920|FG006|Dose Expansion|Death|0|||
147386950|NCT01730118|531578914|FG000|Dose Expansion|Other medical condition|0|||
147386951|NCT01730118|531578915|FG001|Dose Expansion|Other medical condition|0|||
147386952|NCT01730118|531578916|FG002|Dose Expansion|Other medical condition|0|||
147386953|NCT01730118|531578917|FG003|Dose Expansion|Other medical condition|0|||
147386954|NCT01730118|531578918|FG004|Dose Expansion|Other medical condition|1|||
147386955|NCT01730118|531578919|FG005|Dose Expansion|Other medical condition|0|||
147386956|NCT01730118|531578920|FG006|Dose Expansion|Other medical condition|0|||
147386957|NCT01730118|531578914|FG000|Dose Expansion|Withdrawal by Subject|0|||
147386958|NCT01730118|531578915|FG001|Dose Expansion|Withdrawal by Subject|0|||
147386959|NCT01730118|531578916|FG002|Dose Expansion|Withdrawal by Subject|0|||
147386960|NCT01730118|531578917|FG003|Dose Expansion|Withdrawal by Subject|0|||
147386961|NCT01730118|531578918|FG004|Dose Expansion|Withdrawal by Subject|1|||
147386962|NCT01730118|531578919|FG005|Dose Expansion|Withdrawal by Subject|0|||
147386963|NCT01730118|531578920|FG006|Dose Expansion|Withdrawal by Subject|0|||
147386964|NCT01730118|531578914|FG000|Dose Expansion|Disease progression|0|||
147386965|NCT01730118|531578915|FG001|Dose Expansion|Disease progression|0|||
147386966|NCT01730118|531578916|FG002|Dose Expansion|Disease progression|0|||
147386967|NCT01730118|531578917|FG003|Dose Expansion|Disease progression|0|||
147457184|NCT00094757|531835567|FG000|Overall Study|Patient Moved|2|||
147386968|NCT01730118|531578918|FG004|Dose Expansion|Disease progression|0|||
147386969|NCT01730118|531578919|FG005|Dose Expansion|Disease progression|1|||
147386970|NCT01730118|531578920|FG006|Dose Expansion|Disease progression|0|||
147386971|NCT01730118|531578914|FG000|Dose Expansion|Inability to return|0|||
147386972|NCT01730118|531578915|FG001|Dose Expansion|Inability to return|0|||
147386973|NCT01730118|531578916|FG002|Dose Expansion|Inability to return|0|||
147386974|NCT01730118|531578917|FG003|Dose Expansion|Inability to return|0|||
147457185|NCT00094757|531835568|FG001|Overall Study|Patient Moved|1|||
147386975|NCT01730118|531578918|FG004|Dose Expansion|Inability to return|0|||
147386976|NCT01730118|531578919|FG005|Dose Expansion|Inability to return|1|||
147386977|NCT01730118|531578920|FG006|Dose Expansion|Inability to return|0|||
147386978|NCT01730118|531578914|FG000|Dose Expansion|Physician Decision|0|||
147386979|NCT01730118|531578915|FG001|Dose Expansion|Physician Decision|0|||
147386980|NCT01730118|531578916|FG002|Dose Expansion|Physician Decision|0|||
147386981|NCT01730118|531578917|FG003|Dose Expansion|Physician Decision|0|||
147386982|NCT01730118|531578918|FG004|Dose Expansion|Physician Decision|0|||
147386983|NCT01730118|531578919|FG005|Dose Expansion|Physician Decision|1|||
147386984|NCT01730118|531578920|FG006|Dose Expansion|Physician Decision|0|||
147386985|NCT02101554|531578925|FG000|Overall Study|Protocol Violation|0|||
147386986|NCT02101554|531578926|FG001|Overall Study|Protocol Violation|1|||
147386987|NCT02101554|531578927|FG002|Overall Study|Protocol Violation|0|||
147386988|NCT02101554|531578925|FG000|Overall Study|Insufficient Clinical Response|0|||
147386989|NCT02101554|531578926|FG001|Overall Study|Insufficient Clinical Response|2|||
147386990|NCT02101554|531578927|FG002|Overall Study|Insufficient Clinical Response|0|||
147386991|NCT02101554|531578925|FG000|Overall Study|Adverse Event|2|||
147386992|NCT02101554|531578926|FG001|Overall Study|Adverse Event|1|||
147386993|NCT02101554|531578927|FG002|Overall Study|Adverse Event|1|||
147386994|NCT02101554|531578925|FG000|Overall Study|Lost to Follow-up|0|||
147386995|NCT02101554|531578926|FG001|Overall Study|Lost to Follow-up|1|||
147386996|NCT02101554|531578927|FG002|Overall Study|Lost to Follow-up|0|||
147386997|NCT02101554|531578925|FG000|Overall Study|Withdrawl by Parents/Guardians|1|||
147386998|NCT02101554|531578926|FG001|Overall Study|Withdrawl by Parents/Guardians|0|||
147386999|NCT02101554|531578927|FG002|Overall Study|Withdrawl by Parents/Guardians|0|||
147387000|NCT00668746|531578928|FG000|Overall Study|Lost to Follow-up|2|||
147387001|NCT00668746|531578929|FG001|Overall Study|Lost to Follow-up|1|||
147387002|NCT02409732|531578932|FG000|Overall Study|Withdrawal by Subject|4|||
147387003|NCT02409732|531578932|FG000|Overall Study|Lost to Follow-up|2|||
147387004|NCT00168805|531578933|FG000|Overall Study|Adverse Event|7|||
147387005|NCT00168805|531578934|FG001|Overall Study|Adverse Event|11|||
147387006|NCT00168805|531578935|FG002|Overall Study|Adverse Event|16|||
147387007|NCT00168805|531578933|FG000|Overall Study|Protocol Violation|12|||
147387008|NCT00168805|531578934|FG001|Overall Study|Protocol Violation|11|||
147387009|NCT00168805|531578935|FG002|Overall Study|Protocol Violation|8|||
147387010|NCT00168805|531578933|FG000|Overall Study|Lost to Follow-up|12|||
147387011|NCT00168805|531578934|FG001|Overall Study|Lost to Follow-up|17|||
147387012|NCT00168805|531578935|FG002|Overall Study|Lost to Follow-up|11|||
147387013|NCT00168805|531578933|FG000|Overall Study|Withdrawal by Subject|16|||
147387014|NCT00168805|531578934|FG001|Overall Study|Withdrawal by Subject|18|||
147387015|NCT00168805|531578935|FG002|Overall Study|Withdrawal by Subject|21|||
147387016|NCT00168805|531578933|FG000|Overall Study|Other|24|||
147387017|NCT00168805|531578934|FG001|Overall Study|Other|21|||
147387018|NCT00168805|531578935|FG002|Overall Study|Other|22|||
147387019|NCT00168805|531578933|FG000|Treatment|Adverse Event|25|||
147387020|NCT00168805|531578934|FG001|Treatment|Adverse Event|26|||
147387021|NCT00168805|531578935|FG002|Treatment|Adverse Event|32|||
147387022|NCT00168805|531578933|FG000|Treatment|Protocol Violation|3|||
147387023|NCT00168805|531578934|FG001|Treatment|Protocol Violation|5|||
147387024|NCT00168805|531578935|FG002|Treatment|Protocol Violation|5|||
147387025|NCT00168805|531578933|FG000|Treatment|Withdrawal by Subject|3|||
147387026|NCT00168805|531578934|FG001|Treatment|Withdrawal by Subject|7|||
147387027|NCT00168805|531578935|FG002|Treatment|Withdrawal by Subject|8|||
147387028|NCT00168805|531578933|FG000|Treatment|Other|18|||
147387029|NCT00168805|531578934|FG001|Treatment|Other|18|||
147387030|NCT00168805|531578935|FG002|Treatment|Other|17|||
147387031|NCT04175392|531578936|FG000|Overall Study|Withdrawal by Subject|3|||
147387032|NCT04175392|531578937|FG001|Overall Study|Withdrawal by Subject|2|||
147387033|NCT01613599|531578940|FG000|Overall Study|Death|9|||
147387034|NCT01613599|531578940|FG000|Overall Study|Lost to Follow-up|5|||
147387035|NCT01613599|531578940|FG000|Overall Study|Withdrawal by Subject|8|||
147387036|NCT01613599|531578940|FG000|Overall Study|Reason not specified|3|||
147387037|NCT02991456|531578941|FG000|Overall Study|Adverse Event|2|||
147387038|NCT02991456|531578942|FG001|Overall Study|Adverse Event|0|||
147387039|NCT02991456|531578941|FG000|Overall Study|Lost to Follow-up|0|||
147387040|NCT02991456|531578942|FG001|Overall Study|Lost to Follow-up|2|||
147457186|NCT00094757|531835569|FG002|Overall Study|Patient Moved|1|||
147387041|NCT02991456|531578941|FG000|Overall Study|Withdrawal by Subject|1|||
147387042|NCT02991456|531578942|FG001|Overall Study|Withdrawal by Subject|0|||
147387043|NCT03503188|531578943|FG000|Overall Study|Non eligible in the sub study|0|||
147387044|NCT03503188|531578944|FG001|Overall Study|Non eligible in the sub study|1|||
147387045|NCT01699178|531578945|FG000|Overall Study|Adverse Event|1|||
147387046|NCT01699178|531578946|FG001|Overall Study|Adverse Event|5|||
147387047|NCT01699178|531578945|FG000|Overall Study|Lost to Follow-up|1|||
147387048|NCT01699178|531578946|FG001|Overall Study|Lost to Follow-up|6|||
147387049|NCT01699178|531578945|FG000|Overall Study|Non-compliance with Study Drug|3|||
147387050|NCT01699178|531578946|FG001|Overall Study|Non-compliance with Study Drug|1|||
147387051|NCT01699178|531578945|FG000|Overall Study|Physician Decision|1|||
147387052|NCT01699178|531578946|FG001|Overall Study|Physician Decision|0|||
147457187|NCT00094757|531835567|FG000|Overall Study|Protocol Violation|8|||
147387053|NCT01699178|531578945|FG000|Overall Study|Withdrawal by Subject|4|||
147387054|NCT01699178|531578946|FG001|Overall Study|Withdrawal by Subject|12|||
147387055|NCT01699178|531578945|FG000|Overall Study|Hematocrit >54%|1|||
147387056|NCT01699178|531578946|FG001|Overall Study|Hematocrit >54%|1|||
147387057|NCT01699178|531578945|FG000|Overall Study|PSA increase of >1.4 ng/mL|4|||
147387058|NCT01699178|531578946|FG001|Overall Study|PSA increase of >1.4 ng/mL|3|||
147387059|NCT01699178|531578945|FG000|Overall Study|ineligible/noncompliant/ subject reason|4|||
147387060|NCT01699178|531578946|FG001|Overall Study|ineligible/noncompliant/ subject reason|4|||
147387061|NCT00321555|531578948|FG000|Overall Study|Developed antibodies|1|||
147387062|NCT00321555|531578948|FG000|Overall Study|Switched to alternative treatment|3|||
147387063|NCT00321555|531578948|FG000|Overall Study|Physician Decision|1|||
147387064|NCT00321555|531578948|FG000|Overall Study|Disease progression on study|1|||
147387065|NCT02066389|531578949|FG000|Overall Study|Adverse Event|1|||
147387066|NCT02066389|531578950|FG001|Overall Study|Adverse Event|1|||
147387067|NCT02066389|531578951|FG002|Overall Study|Adverse Event|1|||
147387068|NCT02066389|531578952|FG003|Overall Study|Adverse Event|1|||
147387069|NCT02066389|531578953|FG004|Overall Study|Adverse Event|5|||
147387070|NCT02066389|531578954|FG005|Overall Study|Adverse Event|1|||
147387071|NCT02066389|531578949|FG000|Overall Study|Withdrawal by Subject|4|||
147387072|NCT02066389|531578950|FG001|Overall Study|Withdrawal by Subject|0|||
147387073|NCT02066389|531578951|FG002|Overall Study|Withdrawal by Subject|5|||
147387074|NCT02066389|531578952|FG003|Overall Study|Withdrawal by Subject|1|||
147387075|NCT02066389|531578953|FG004|Overall Study|Withdrawal by Subject|1|||
147387076|NCT02066389|531578954|FG005|Overall Study|Withdrawal by Subject|2|||
147387077|NCT02066389|531578949|FG000|Overall Study|Lost to Follow-up|0|||
147387078|NCT02066389|531578950|FG001|Overall Study|Lost to Follow-up|0|||
147387079|NCT02066389|531578951|FG002|Overall Study|Lost to Follow-up|0|||
147387080|NCT02066389|531578952|FG003|Overall Study|Lost to Follow-up|1|||
147387081|NCT02066389|531578953|FG004|Overall Study|Lost to Follow-up|1|||
147387082|NCT02066389|531578954|FG005|Overall Study|Lost to Follow-up|1|||
147387083|NCT02066389|531578949|FG000|Overall Study|Randomized in Error|0|||
147387084|NCT02066389|531578950|FG001|Overall Study|Randomized in Error|0|||
147387085|NCT02066389|531578951|FG002|Overall Study|Randomized in Error|0|||
147387086|NCT02066389|531578952|FG003|Overall Study|Randomized in Error|0|||
147387087|NCT02066389|531578953|FG004|Overall Study|Randomized in Error|0|||
147387088|NCT02066389|531578954|FG005|Overall Study|Randomized in Error|1|||
147387089|NCT03905512|531578960|FG000|Overall Study|Withdrawal by Subject|9|||
147387090|NCT03905512|531578961|FG001|Overall Study|Withdrawal by Subject|8|||
147387091|NCT03905512|531578960|FG000|Overall Study|Adverse Event|1|||
147387092|NCT03905512|531578961|FG001|Overall Study|Adverse Event|2|||
147387093|NCT03905512|531578960|FG000|Overall Study|Lost to Follow-up|4|||
147387094|NCT03905512|531578961|FG001|Overall Study|Lost to Follow-up|3|||
147387095|NCT03905512|531578960|FG000|Overall Study|Other than Specified|7|||
147387096|NCT03905512|531578961|FG001|Overall Study|Other than Specified|4|||
147387097|NCT00070317|531578966|FG000|Overall Study|Inevaluable (Never Treated)|1|||
147387098|NCT00070317|531578966|FG000|Overall Study|Ineligible Wrong Cell type/primary/stage|3|||
147387099|NCT00070317|531578966|FG000|Overall Study|Ineligible required test not done|1|||
147387100|NCT00070317|531578966|FG000|Overall Study|Ineligible-Improper prior treatment|2|||
147387101|NCT00070317|531578966|FG000|Overall Study|Ineligible-Inadequate pathology|6|||
147387102|NCT03560206|531578968|FG000|Overall Study|Lost to Follow-up|19|||
147387103|NCT03560206|531578969|FG001|Overall Study|Lost to Follow-up|11|||
147387104|NCT03560206|531578968|FG000|Overall Study|Withdrawal by Subject|2|||
147387105|NCT03560206|531578969|FG001|Overall Study|Withdrawal by Subject|4|||
147387106|NCT03560206|531578968|FG000|Overall Study|caregivers' health condition and not becoming non-caregiver|5|||
147387107|NCT03560206|531578969|FG001|Overall Study|caregivers' health condition and not becoming non-caregiver|0|||
147387108|NCT03560206|531578968|FG000|Overall Study|Busy schedule|14|||
147387109|NCT03560206|531578969|FG001|Overall Study|Busy schedule|2|||
147387110|NCT03560206|531578968|FG000|Overall Study|patients' new health condition such as cancer|10|||
147387111|NCT03560206|531578969|FG001|Overall Study|patients' new health condition such as cancer|1|||
147387112|NCT03987074|531578970|FG000|Overall Study|Withdrew Consent|1|||
147387113|NCT03987074|531578971|FG001|Overall Study|Withdrew Consent|1|||
147387114|NCT03987074|531578972|FG002|Overall Study|Withdrew Consent|0|||
147387115|NCT03987074|531578973|FG003|Overall Study|Withdrew Consent|2|||
147387116|NCT03987074|531578974|FG004|Overall Study|Withdrew Consent|1|||
147387117|NCT03987074|531578970|FG000|Overall Study|Adverse Event|2|||
147387118|NCT03987074|531578971|FG001|Overall Study|Adverse Event|1|||
147387119|NCT03987074|531578972|FG002|Overall Study|Adverse Event|0|||
147387120|NCT03987074|531578973|FG003|Overall Study|Adverse Event|0|||
147387121|NCT03987074|531578974|FG004|Overall Study|Adverse Event|1|||
147387122|NCT03987074|531578970|FG000|Overall Study|Lost to Follow-up|0|||
147387123|NCT03987074|531578971|FG001|Overall Study|Lost to Follow-up|0|||
147387124|NCT03987074|531578972|FG002|Overall Study|Lost to Follow-up|1|||
147387125|NCT03987074|531578973|FG003|Overall Study|Lost to Follow-up|1|||
147387126|NCT03987074|531578974|FG004|Overall Study|Lost to Follow-up|0|||
147387127|NCT03987074|531578970|FG000|Overall Study|Investigator's Discretion|0|||
147387128|NCT03987074|531578971|FG001|Overall Study|Investigator's Discretion|0|||
147387129|NCT03987074|531578972|FG002|Overall Study|Investigator's Discretion|0|||
147387130|NCT03987074|531578973|FG003|Overall Study|Investigator's Discretion|1|||
147387131|NCT03987074|531578974|FG004|Overall Study|Investigator's Discretion|0|||
147387132|NCT03100370|531578975|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
147387133|NCT03100370|531578976|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
147387134|NCT03100370|531578977|FG002|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
147387135|NCT03100370|531578978|FG003|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
147387136|NCT03100370|531578979|FG004|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
147387137|NCT03100370|531578980|FG005|First Intervention (2 Weeks)|Withdrawal by Subject|0|||
147387138|NCT00508144|531578983|FG000|Overall Study|Not eligible|6|||
147387139|NCT00508144|531578983|FG000|Overall Study|Death|5|||
147387140|NCT01084772|531578985|FG000|Baseline|Withdrawal by Subject|7|||
147387141|NCT01084772|531578986|FG001|Baseline|Withdrawal by Subject|6|||
147387142|NCT01084772|531578985|FG000|3 Months|Death|1|||
147387143|NCT01084772|531578986|FG001|3 Months|Death|0|||
147387144|NCT01084772|531578985|FG000|3 Months|Study Termination|2|||
147387145|NCT01084772|531578986|FG001|3 Months|Study Termination|2|||
147387146|NCT01084772|531578985|FG000|1 Year|Withdrawal by Subject|0|||
147387147|NCT01084772|531578986|FG001|1 Year|Withdrawal by Subject|1|||
147387148|NCT01084772|531578985|FG000|1 Year|Lost to Follow-up|3|||
147387149|NCT01084772|531578986|FG001|1 Year|Lost to Follow-up|0|||
147387150|NCT01084772|531578985|FG000|1 Year|Study Termination|0|||
147387151|NCT01084772|531578986|FG001|1 Year|Study Termination|7|||
147387152|NCT01084772|531578985|FG000|2 Years|Withdrawal by Subject|1|||
147387153|NCT01084772|531578986|FG001|2 Years|Withdrawal by Subject|0|||
147387154|NCT01084772|531578985|FG000|2 Years|Lost to Follow-up|5|||
147387155|NCT01084772|531578986|FG001|2 Years|Lost to Follow-up|2|||
147387156|NCT01084772|531578985|FG000|2 Years|Study Termination|3|||
147387157|NCT01084772|531578986|FG001|2 Years|Study Termination|2|||
147387158|NCT02009865|531578991|FG000|Overall Study|Adverse Event|0|||
147387159|NCT02009865|531578992|FG001|Overall Study|Adverse Event|2|||
147387160|NCT02009865|531578991|FG000|Overall Study|Protocol Violation|0|||
147387161|NCT02009865|531578992|FG001|Overall Study|Protocol Violation|2|||
147387162|NCT02009865|531578991|FG000|Overall Study|Withdrawal by Subject|1|||
147387163|NCT02009865|531578992|FG001|Overall Study|Withdrawal by Subject|1|||
147387164|NCT01517282|531578993|FG000|Overall Study|Consent withdrawn|0|||
147387165|NCT01517282|531578994|FG001|Overall Study|Consent withdrawn|1|||
147387166|NCT01517282|531578995|FG002|Overall Study|Consent withdrawn|1|||
147387167|NCT01517282|531578996|FG003|Overall Study|Consent withdrawn|1|||
147387168|NCT01517282|531578993|FG000|Overall Study|Physician Decision|1|||
147387169|NCT01517282|531578994|FG001|Overall Study|Physician Decision|0|||
147387170|NCT01517282|531578995|FG002|Overall Study|Physician Decision|0|||
147387171|NCT01517282|531578996|FG003|Overall Study|Physician Decision|0|||
147387172|NCT00525915|531578997|FG000|Overall Study|Non-Compliance|0|||
147387173|NCT00525915|531578998|FG001|Overall Study|Non-Compliance|1|||
147387174|NCT00525915|531578997|FG000|Overall Study|Disease Progression|5|||
147387175|NCT00525915|531578998|FG001|Overall Study|Disease Progression|6|||
147387176|NCT00525915|531578997|FG000|Overall Study|Withdrawal by Subject|1|||
147387177|NCT00525915|531578998|FG001|Overall Study|Withdrawal by Subject|0|||
147387178|NCT00525915|531578997|FG000|Overall Study|Refused Surgery|1|||
147387179|NCT00525915|531578998|FG001|Overall Study|Refused Surgery|2|||
147387180|NCT00525915|531578997|FG000|Overall Study|Unrelated illness|1|||
147387181|NCT00525915|531578998|FG001|Overall Study|Unrelated illness|0|||
147387182|NCT02332889|531579006|FG000|Overall Study|Physician Decision|1|||
147387183|NCT01634165|531579010|FG000|Period 2|Adverse Event|0|||
147387184|NCT01634165|531579011|FG001|Period 2|Adverse Event|1|||
147387185|NCT01634165|531579012|FG002|Period 2|Adverse Event|0|||
147387186|NCT01634165|531579013|FG003|Period 2|Adverse Event|0|||
147387187|NCT02135445|531579014|FG000|Overall Study|Lost to Follow-up|1|||
147387188|NCT02135445|531579015|FG001|Overall Study|Lost to Follow-up|0|||
147457188|NCT00094757|531835568|FG001|Overall Study|Protocol Violation|5|||
147457189|NCT00094757|531835569|FG002|Overall Study|Protocol Violation|3|||
147457190|NCT00094757|531835567|FG000|Overall Study|Withdrawal by Subject|14|||
147457191|NCT00094757|531835568|FG001|Overall Study|Withdrawal by Subject|21|||
147615052|NCT03999996|532406588|FG001|Prior to Booster|Adverse Event|0|||
147615053|NCT03999996|532406589|FG002|Prior to Booster|Adverse Event|0|||
147615054|NCT03999996|532406590|FG003|Prior to Booster|Adverse Event|0|||
147387189|NCT02135445|531579014|FG000|Overall Study|Withdrawal by Subject|1|||
147387190|NCT02135445|531579015|FG001|Overall Study|Withdrawal by Subject|0|||
147387191|NCT04097535|531579018|FG000|Overall Study|[18F]FPIA/radiotracer production failure - Participant subsequently withdrew consent.|1|||
147387192|NCT03070301|531579019|FG000|Overall Study|Progression of disease|16|||
147387193|NCT03070301|531579019|FG000|Overall Study|Physician Decision|3|||
147387194|NCT03070301|531579019|FG000|Overall Study|Withdrawal by Subject|1|||
147387195|NCT03556891|531579020|FG000|Initial Pivotal Study|Adverse Event|4|||
147387196|NCT03556891|531579020|FG000|Initial Pivotal Study|MRI Need|3|||
147387197|NCT03556891|531579020|FG000|Initial Pivotal Study|Device Failure|1|||
147387198|NCT03556891|531579020|FG000|Initial Pivotal Study|Death|1|||
147387199|NCT03556891|531579020|FG000|Initial Pivotal Study|Lost to Follow-up|1|||
147387200|NCT03556891|531579020|FG000|Initial Pivotal Study|Missing at random|1|||
147387201|NCT03556891|531579020|FG000|Initial Pivotal Study|Missing due to COVID|1|||
147387202|NCT03556891|531579020|FG000|Initial Pivotal Study|Protocol Violation|1|||
147387203|NCT00489489|531580235|FG000|Overall Study|Not treated due to protocol violation|0|||
147387204|NCT00489489|531580236|FG001|Overall Study|Not treated due to protocol violation|1|||
147387205|NCT00489489|531580237|FG002|Overall Study|Not treated due to protocol violation|1|||
147387206|NCT00489489|531580235|FG000|Overall Study|Adverse Event|1|||
147387207|NCT00489489|531580236|FG001|Overall Study|Adverse Event|1|||
147387208|NCT00489489|531580237|FG002|Overall Study|Adverse Event|1|||
147387209|NCT00489489|531580235|FG000|Overall Study|Protocol Violation|1|||
147387210|NCT00489489|531580236|FG001|Overall Study|Protocol Violation|0|||
147387211|NCT00489489|531580237|FG002|Overall Study|Protocol Violation|1|||
147387212|NCT00489489|531580235|FG000|Overall Study|Progressive disease|0|||
147387213|NCT00489489|531580236|FG001|Overall Study|Progressive disease|1|||
147387214|NCT00489489|531580237|FG002|Overall Study|Progressive disease|0|||
147387215|NCT00489489|531580235|FG000|Overall Study|Participant did not wish to continue|1|||
147387216|NCT00489489|531580236|FG001|Overall Study|Participant did not wish to continue|1|||
147387217|NCT00489489|531580237|FG002|Overall Study|Participant did not wish to continue|0|||
147387218|NCT00489489|531580235|FG000|Overall Study|Other than above|0|||
147387219|NCT00489489|531580236|FG001|Overall Study|Other than above|1|||
147387220|NCT00489489|531580237|FG002|Overall Study|Other than above|0|||
147387221|NCT03978130|531580240|FG000|Overall Study|Lost to Follow-up|13|||
147387222|NCT03978130|531580241|FG001|Overall Study|Lost to Follow-up|14|||
147387223|NCT03978130|531580240|FG000|Overall Study|Withdrawal by Subject|12|||
147387224|NCT03978130|531580241|FG001|Overall Study|Withdrawal by Subject|2|||
147387225|NCT03978130|531580240|FG000|Overall Study|Adverse Event|2|||
147387226|NCT03978130|531580241|FG001|Overall Study|Adverse Event|1|||
147387227|NCT02136797|531580246|FG000|Overall Study|Not Treated|8|||
147387228|NCT04523571|531580247|FG000|Received 2 Doses|Withdrawal by Subject|0|||
147387229|NCT04523571|531580248|FG001|Received 2 Doses|Withdrawal by Subject|0|||
147387230|NCT04523571|531580249|FG002|Received 2 Doses|Withdrawal by Subject|0|||
147387231|NCT04523571|531580250|FG003|Received 2 Doses|Withdrawal by Subject|1|||
147387232|NCT04523571|531580251|FG004|Received 2 Doses|Withdrawal by Subject|1|||
147387233|NCT04523571|531580252|FG005|Received 2 Doses|Withdrawal by Subject|0|||
147387234|NCT04523571|531580247|FG000|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|1|||
147387235|NCT04523571|531580248|FG001|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|0|||
147387236|NCT04523571|531580249|FG002|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|1|||
147387237|NCT04523571|531580250|FG003|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|0|||
147387238|NCT04523571|531580251|FG004|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|0|||
147387239|NCT04523571|531580252|FG005|Received 2 Doses and Completed Follow-up|inoculated with other COVID-19 vaccine|0|||
147387240|NCT04523571|531580247|FG000|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|0|||
147387241|NCT04523571|531580248|FG001|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|0|||
147387242|NCT04523571|531580249|FG002|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|0|||
147387243|NCT04523571|531580250|FG003|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|0|||
147387244|NCT04523571|531580251|FG004|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|0|||
147387245|NCT04523571|531580252|FG005|Received 2 Doses and Completed Follow-up|Withdrawal by Subject|1|||
147387246|NCT04523571|531580247|FG000|Received 2 Doses and Completed Follow-up|Adverse Event|0|||
147387247|NCT04523571|531580248|FG001|Received 2 Doses and Completed Follow-up|Adverse Event|0|||
147387248|NCT04523571|531580249|FG002|Received 2 Doses and Completed Follow-up|Adverse Event|0|||
147387249|NCT04523571|531580250|FG003|Received 2 Doses and Completed Follow-up|Adverse Event|1|||
147387250|NCT04523571|531580251|FG004|Received 2 Doses and Completed Follow-up|Adverse Event|1|||
147387251|NCT04523571|531580252|FG005|Received 2 Doses and Completed Follow-up|Adverse Event|0|||
147387252|NCT04198428|531580253|FG000|Overall Study|Withdrawal by Subject|150|||
147387253|NCT04198428|531580254|FG001|Overall Study|Withdrawal by Subject|156|||
147387254|NCT03344458|531580257|FG000|Overall Study|Physician Decision|1|||
147387255|NCT03344458|531580257|FG000|Overall Study|Withdrawal by Subject|16|||
147387256|NCT03344458|531580257|FG000|Overall Study|Other reasons|10|||
147387257|NCT03344458|531580257|FG000|Overall Study|Lost to Follow-up|9|||
147387258|NCT03344458|531580257|FG000|Overall Study|Protocol Violation|3|||
147387259|NCT03696342|531580260|FG000|Overall Study|Lost to Follow-up|1|||
147387260|NCT03696342|531580261|FG001|Overall Study|Lost to Follow-up|0|||
147387261|NCT01816165|531580264|FG000|Overall Study|Adverse Event|1|||
147387262|NCT01816165|531580265|FG001|Overall Study|Adverse Event|0|||
147387263|NCT01816165|531580266|FG002|Overall Study|Adverse Event|0|||
147387264|NCT01816165|531580267|FG003|Overall Study|Adverse Event|0|||
147387265|NCT03960437|531580269|FG000|Overall Study|Removed by PI|4|||
147387266|NCT03960437|531580269|FG000|Overall Study|Lost to Follow-up|2|||
147387267|NCT03960437|531580269|FG000|Overall Study|Withdrawal by Subject|1|||
147387268|NCT03960437|531580269|FG000|Overall Study|Death|2|||
147387269|NCT01838499|531580270|FG000|Overall Study|Protocol Violation|0|||
147387270|NCT01838499|531580271|FG001|Overall Study|Protocol Violation|1|||
147387271|NCT01838499|531580270|FG000|Overall Study|Lost to Follow-up|2|||
147615055|NCT03999996|532406587|FG000|Prior to Booster|Lost to Follow-up|17|||
147615056|NCT03999996|532406588|FG001|Prior to Booster|Lost to Follow-up|22|||
147387272|NCT01838499|531580271|FG001|Overall Study|Lost to Follow-up|4|||
147387273|NCT01838499|531580270|FG000|Overall Study|Lack of Efficacy|1|||
147387274|NCT01838499|531580271|FG001|Overall Study|Lack of Efficacy|2|||
147387275|NCT01838499|531580270|FG000|Overall Study|Adverse Event|2|||
147387276|NCT01838499|531580271|FG001|Overall Study|Adverse Event|1|||
147387277|NCT01838499|531580270|FG000|Overall Study|Withdrawal by Subject|19|||
147387278|NCT01838499|531580271|FG001|Overall Study|Withdrawal by Subject|9|||
147387279|NCT03614923|531580272|FG000|Overall Study|Withdrawal by Subject|2|||
147387280|NCT03614923|531580273|FG001|Overall Study|Withdrawal by Subject|1|||
147387281|NCT03614923|531580274|FG002|Overall Study|Withdrawal by Subject|1|||
147387282|NCT03614923|531580272|FG000|Overall Study|Adverse Event|0|||
147387283|NCT03614923|531580273|FG001|Overall Study|Adverse Event|2|||
147387284|NCT03614923|531580274|FG002|Overall Study|Adverse Event|1|||
147387285|NCT03614923|531580272|FG000|Overall Study|Lost to Follow-up|1|||
147387286|NCT03614923|531580273|FG001|Overall Study|Lost to Follow-up|0|||
147387287|NCT03614923|531580274|FG002|Overall Study|Lost to Follow-up|1|||
147387288|NCT03614923|531580272|FG000|Overall Study|Lack of Efficacy|2|||
147387289|NCT03614923|531580273|FG001|Overall Study|Lack of Efficacy|0|||
147387290|NCT03614923|531580274|FG002|Overall Study|Lack of Efficacy|1|||
147387291|NCT03614923|531580272|FG000|Overall Study|Non-compliance|0|||
147387292|NCT03614923|531580273|FG001|Overall Study|Non-compliance|1|||
147387293|NCT03614923|531580274|FG002|Overall Study|Non-compliance|0|||
147387294|NCT03614923|531580272|FG000|Overall Study|Other|0|||
147387295|NCT03614923|531580273|FG001|Overall Study|Other|1|||
147387296|NCT03614923|531580274|FG002|Overall Study|Other|1|||
147387297|NCT01882088|531580275|FG000|Overall Study|Intolerance of esophageal manometry|1|||
147387298|NCT01882088|531580275|FG000|Overall Study|no possibility to place the catheter|1|||
147387299|NCT01882088|531580275|FG000|Overall Study|Protocol Violation|1|||
147387300|NCT01882088|531580275|FG000|Overall Study|inadequate pH-impedance tracings|2|||
147387301|NCT02030847|531580281|FG000|Overall Study|Death|10|||
147387302|NCT02030847|531580281|FG000|Overall Study|Disease Progression|15|||
147387303|NCT02030847|531580281|FG000|Overall Study|New Cancer Therapy|8|||
147387304|NCT02030847|531580281|FG000|Overall Study|Physician Decision|3|||
147387305|NCT02030847|531580281|FG000|Overall Study|Withdrawal by Subject|1|||
147387306|NCT01103141|531580289|FG000|Overall Study|Death|0|||
147387307|NCT01103141|531580290|FG001|Overall Study|Death|1|||
147387308|NCT01103141|531580289|FG000|Overall Study|Lost to Follow-up|2|||
147387309|NCT01103141|531580290|FG001|Overall Study|Lost to Follow-up|1|||
147387310|NCT00422162|531580293|FG000|Overall Study|Adverse Event|11|||
147387311|NCT00422162|531580294|FG001|Overall Study|Adverse Event|9|||
147387312|NCT00422162|531580293|FG000|Overall Study|Lack of Efficacy|4|||
147387313|NCT00422162|531580294|FG001|Overall Study|Lack of Efficacy|10|||
147387314|NCT00422162|531580293|FG000|Overall Study|Withdrawal by Subject|7|||
147387315|NCT00422162|531580294|FG001|Overall Study|Withdrawal by Subject|6|||
147387316|NCT00422162|531580293|FG000|Overall Study|Lost to Follow-up|1|||
147387317|NCT00422162|531580294|FG001|Overall Study|Lost to Follow-up|2|||
147387318|NCT00422162|531580293|FG000|Overall Study|Non-Compliant with Protocol|1|||
147387319|NCT00422162|531580294|FG001|Overall Study|Non-Compliant with Protocol|1|||
147387320|NCT00422162|531580293|FG000|Overall Study|Other|0|||
147387321|NCT00422162|531580294|FG001|Overall Study|Other|1|||
147387322|NCT00422162|531580293|FG000|Overall Study|Didn't Receive Treatment|0|||
147387323|NCT00422162|531580294|FG001|Overall Study|Didn't Receive Treatment|1|||
147387324|NCT05274906|531580296|FG000|Overall Study|Withdrawal by Subject|2|||
147387325|NCT05274906|531580297|FG001|Overall Study|Withdrawal by Subject|1|||
147387326|NCT00848198|531580298|FG000|Overall Study|Incomplete Case Report Forms|15|||
147387327|NCT02062827|531580299|FG000|Overall Study|Death|1|||
147387328|NCT02062827|531580300|FG001|Overall Study|Death|0|||
147387329|NCT02062827|531580301|FG002|Overall Study|Death|0|||
147387330|NCT02062827|531580302|FG003|Overall Study|Death|0|||
147387331|NCT02062827|531580303|FG004|Overall Study|Death|0|||
147387332|NCT02062827|531580304|FG005|Overall Study|Death|0|||
147387333|NCT02062827|531580305|FG006|Overall Study|Death|0|||
147387334|NCT02062827|531580306|FG007|Overall Study|Death|0|||
147387335|NCT02062827|531580299|FG000|Overall Study|Withdrawal by Subject|3|||
147387336|NCT02062827|531580300|FG001|Overall Study|Withdrawal by Subject|1|||
147387337|NCT02062827|531580301|FG002|Overall Study|Withdrawal by Subject|1|||
147387338|NCT02062827|531580302|FG003|Overall Study|Withdrawal by Subject|2|||
147387339|NCT02062827|531580303|FG004|Overall Study|Withdrawal by Subject|6|||
147387340|NCT02062827|531580304|FG005|Overall Study|Withdrawal by Subject|0|||
147387341|NCT02062827|531580305|FG006|Overall Study|Withdrawal by Subject|5|||
147387342|NCT02062827|531580306|FG007|Overall Study|Withdrawal by Subject|0|||
147387343|NCT02062827|531580299|FG000|Overall Study|Screen Fail|0|||
147387344|NCT02062827|531580300|FG001|Overall Study|Screen Fail|0|||
147387345|NCT02062827|531580301|FG002|Overall Study|Screen Fail|0|||
147387346|NCT02062827|531580302|FG003|Overall Study|Screen Fail|0|||
147387347|NCT02062827|531580303|FG004|Overall Study|Screen Fail|0|||
147387348|NCT02062827|531580304|FG005|Overall Study|Screen Fail|0|||
147387349|NCT02062827|531580305|FG006|Overall Study|Screen Fail|0|||
147387350|NCT02062827|531580306|FG007|Overall Study|Screen Fail|8|||
147387351|NCT02604199|531580309|FG000|Overall Study|Pregnancy|0|||
147387352|NCT02604199|531580310|FG001|Overall Study|Pregnancy|0|||
147387353|NCT02604199|531580311|FG002|Overall Study|Pregnancy|0|||
147387354|NCT02604199|531580312|FG003|Overall Study|Pregnancy|1|||
147387355|NCT02604199|531580309|FG000|Overall Study|Study terminated by sponsor|0|||
147387356|NCT02604199|531580310|FG001|Overall Study|Study terminated by sponsor|2|||
147387357|NCT02604199|531580311|FG002|Overall Study|Study terminated by sponsor|0|||
147387358|NCT02604199|531580312|FG003|Overall Study|Study terminated by sponsor|2|||
147387359|NCT02604199|531580309|FG000|Overall Study|Withdrawal by Subject|0|||
147387360|NCT02604199|531580310|FG001|Overall Study|Withdrawal by Subject|1|||
147387361|NCT02604199|531580311|FG002|Overall Study|Withdrawal by Subject|0|||
147387362|NCT02604199|531580312|FG003|Overall Study|Withdrawal by Subject|0|||
147387363|NCT02213458|531580317|FG000|Overall Study|No longer meets criteria: caregiver deceased|4|||
147387364|NCT02213458|531580318|FG001|Overall Study|No longer meets criteria: caregiver deceased|0|||
147387365|NCT02213458|531580317|FG000|Overall Study|No longer meets criteria: caregiver no longer caregiving|4|||
147387366|NCT02213458|531580318|FG001|Overall Study|No longer meets criteria: caregiver no longer caregiving|0|||
147387367|NCT02213458|531580317|FG000|Overall Study|No longer meets criteria: caregiver too sick to participate|2|||
147387368|NCT02213458|531580318|FG001|Overall Study|No longer meets criteria: caregiver too sick to participate|0|||
147387369|NCT02213458|531580317|FG000|Overall Study|No longer meets criteria: patient moved out of state|10|||
147387370|NCT02213458|531580318|FG001|Overall Study|No longer meets criteria: patient moved out of state|0|||
147387371|NCT02213458|531580317|FG000|Overall Study|Refused re-consent|6|||
147387372|NCT02213458|531580318|FG001|Overall Study|Refused re-consent|0|||
147387373|NCT02213458|531580317|FG000|Overall Study|Lost to Follow-up|2|||
147387374|NCT02213458|531580318|FG001|Overall Study|Lost to Follow-up|2|||
147387375|NCT02213458|531580317|FG000|Overall Study|Withdrawal by Subject|26|||
147387376|NCT02213458|531580318|FG001|Overall Study|Withdrawal by Subject|8|||
147387377|NCT01721109|531580320|FG000|Overall Study|Lack of Efficacy|1|||
147387378|NCT01721109|531580320|FG000|Overall Study|Non- Compliance with Study Drug|3|||
147387379|NCT01721109|531580320|FG000|Overall Study|Withdrew Consent|1|||
147387380|NCT01721109|531580320|FG000|Overall Study|Lost to Follow-up|2|||
147387381|NCT02632045|531580321|FG000|Overall Study|Withdrawal by Subject|1|||
147387382|NCT02632045|531580322|FG001|Overall Study|Withdrawal by Subject|2|||
147387383|NCT05878522|531580323|FG000|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
147387384|NCT05878522|531580324|FG001|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
147387385|NCT05878522|531580325|FG002|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
147387386|NCT05878522|531580326|FG003|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
147387387|NCT05878522|531580327|FG004|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
147387388|NCT05878522|531580328|FG005|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
147387389|NCT05878522|531580329|FG006|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
147387390|NCT05878522|531580330|FG007|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
147387391|NCT05878522|531580331|FG008|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|1|||
147387392|NCT05878522|531580332|FG009|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
147387393|NCT05878522|531580333|FG010|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
147387394|NCT05878522|531580334|FG011|Treatment Period- 1 (3 Days)|no longer meets eligibility criteria|0|||
147387395|NCT05878522|531580323|FG000|Treatment Period- 2 (3 Days)|Physician Decision|1|||
147387396|NCT05878522|531580324|FG001|Treatment Period- 2 (3 Days)|Physician Decision|0|||
147387397|NCT05878522|531580325|FG002|Treatment Period- 2 (3 Days)|Physician Decision|0|||
147387398|NCT05878522|531580326|FG003|Treatment Period- 2 (3 Days)|Physician Decision|0|||
147387399|NCT05878522|531580327|FG004|Treatment Period- 2 (3 Days)|Physician Decision|0|||
147387400|NCT05878522|531580328|FG005|Treatment Period- 2 (3 Days)|Physician Decision|0|||
147387401|NCT05878522|531580329|FG006|Treatment Period- 2 (3 Days)|Physician Decision|0|||
147387402|NCT05878522|531580330|FG007|Treatment Period- 2 (3 Days)|Physician Decision|0|||
147387403|NCT05878522|531580331|FG008|Treatment Period- 2 (3 Days)|Physician Decision|0|||
147387404|NCT05878522|531580332|FG009|Treatment Period- 2 (3 Days)|Physician Decision|1|||
147387405|NCT05878522|531580333|FG010|Treatment Period- 2 (3 Days)|Physician Decision|0|||
147387406|NCT05878522|531580334|FG011|Treatment Period- 2 (3 Days)|Physician Decision|0|||
147387407|NCT05878522|531580323|FG000|Treatment Period- 2 (3 Days)|Adverse Event|0|||
147387408|NCT05878522|531580324|FG001|Treatment Period- 2 (3 Days)|Adverse Event|1|||
147387409|NCT05878522|531580325|FG002|Treatment Period- 2 (3 Days)|Adverse Event|0|||
147387410|NCT05878522|531580326|FG003|Treatment Period- 2 (3 Days)|Adverse Event|1|||
147387411|NCT05878522|531580327|FG004|Treatment Period- 2 (3 Days)|Adverse Event|0|||
147387412|NCT05878522|531580328|FG005|Treatment Period- 2 (3 Days)|Adverse Event|0|||
147387413|NCT05878522|531580329|FG006|Treatment Period- 2 (3 Days)|Adverse Event|0|||
147387414|NCT05878522|531580330|FG007|Treatment Period- 2 (3 Days)|Adverse Event|0|||
147387415|NCT05878522|531580331|FG008|Treatment Period- 2 (3 Days)|Adverse Event|0|||
147387416|NCT05878522|531580332|FG009|Treatment Period- 2 (3 Days)|Adverse Event|0|||
147387417|NCT05878522|531580333|FG010|Treatment Period- 2 (3 Days)|Adverse Event|0|||
147615057|NCT03999996|532406589|FG002|Prior to Booster|Lost to Follow-up|0|||
147615058|NCT03999996|532406590|FG003|Prior to Booster|Lost to Follow-up|0|||
147615059|NCT03999996|532406587|FG000|Prior to Booster|Withdrawal of Consent|51|||
147615060|NCT03999996|532406588|FG001|Prior to Booster|Withdrawal of Consent|8|||
147387418|NCT05878522|531580334|FG011|Treatment Period- 2 (3 Days)|Adverse Event|0|||
147387419|NCT05878522|531580323|FG000|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
147387420|NCT05878522|531580324|FG001|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
147387421|NCT05878522|531580325|FG002|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
147387422|NCT05878522|531580326|FG003|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
147387423|NCT05878522|531580327|FG004|Treatment Period- 2 (3 Days)|Withdrawal by Subject|1|||
147387424|NCT05878522|531580328|FG005|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
147387425|NCT05878522|531580329|FG006|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
147387426|NCT05878522|531580330|FG007|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
147387427|NCT05878522|531580331|FG008|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
147387428|NCT05878522|531580332|FG009|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
147387429|NCT05878522|531580333|FG010|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
147387430|NCT05878522|531580334|FG011|Treatment Period- 2 (3 Days)|Withdrawal by Subject|0|||
147387431|NCT05740371|531580337|FG000|Overall Study|Death|1|||
147387432|NCT00617708|531580340|FG000|Overall Study|Adverse Event|0|||
147387433|NCT00617708|531580341|FG001|Overall Study|Adverse Event|6|||
147387434|NCT00617708|531580342|FG002|Overall Study|Adverse Event|9|||
147387435|NCT00617708|531580340|FG000|Overall Study|Withdrawal by Subject|1|||
147387436|NCT00617708|531580341|FG001|Overall Study|Withdrawal by Subject|1|||
147387437|NCT00617708|531580342|FG002|Overall Study|Withdrawal by Subject|7|||
147387438|NCT00617708|531580340|FG000|Overall Study|Death|0|||
147387439|NCT00617708|531580341|FG001|Overall Study|Death|6|||
147387440|NCT00617708|531580342|FG002|Overall Study|Death|5|||
147387441|NCT00617708|531580340|FG000|Overall Study|Progression/Relapse|7|||
147387442|NCT00617708|531580341|FG001|Overall Study|Progression/Relapse|40|||
147387443|NCT00617708|531580342|FG002|Overall Study|Progression/Relapse|36|||
147387444|NCT00617708|531580340|FG000|Overall Study|Not protocol specified|1|||
147387445|NCT00617708|531580341|FG001|Overall Study|Not protocol specified|4|||
147387446|NCT00617708|531580342|FG002|Overall Study|Not protocol specified|2|||
147387447|NCT00617708|531580340|FG000|Overall Study|Not eligible|1|||
147387448|NCT00617708|531580341|FG001|Overall Study|Not eligible|3|||
147387449|NCT00617708|531580342|FG002|Overall Study|Not eligible|5|||
147387450|NCT02561195|531580345|FG000|Vaccination 1 to 3|Adverse Event|4|||
147387451|NCT02561195|531580346|FG001|Vaccination 1 to 3|Adverse Event|5|||
147387452|NCT02561195|531580347|FG002|Vaccination 1 to 3|Adverse Event|0|||
147387453|NCT02561195|531580348|FG003|Vaccination 1 to 3|Adverse Event|3|||
147387454|NCT02561195|531580349|FG004|Vaccination 1 to 3|Adverse Event|4|||
147387455|NCT02561195|531580350|FG005|Vaccination 1 to 3|Adverse Event|0|||
147387456|NCT02561195|531580351|FG006|Vaccination 1 to 3|Adverse Event|0|||
147387457|NCT02561195|531580352|FG007|Vaccination 1 to 3|Adverse Event|0|||
147387458|NCT02561195|531580353|FG008|Vaccination 1 to 3|Adverse Event|0|||
147387459|NCT02561195|531580354|FG009|Vaccination 1 to 3|Adverse Event|0|||
147387460|NCT02561195|531580355|FG010|Vaccination 1 to 3|Adverse Event|0|||
147387461|NCT02561195|531580356|FG011|Vaccination 1 to 3|Adverse Event|0|||
147387462|NCT02561195|531580357|FG012|Vaccination 1 to 3|Adverse Event|0|||
147387463|NCT02561195|531580358|FG013|Vaccination 1 to 3|Adverse Event|0|||
147387464|NCT02561195|531580345|FG000|Vaccination 1 to 3|Lost to Follow-up|3|||
147387465|NCT02561195|531580346|FG001|Vaccination 1 to 3|Lost to Follow-up|4|||
147387466|NCT02561195|531580347|FG002|Vaccination 1 to 3|Lost to Follow-up|0|||
147387467|NCT02561195|531580348|FG003|Vaccination 1 to 3|Lost to Follow-up|2|||
147387468|NCT02561195|531580349|FG004|Vaccination 1 to 3|Lost to Follow-up|3|||
147387469|NCT02561195|531580350|FG005|Vaccination 1 to 3|Lost to Follow-up|3|||
147387470|NCT02561195|531580351|FG006|Vaccination 1 to 3|Lost to Follow-up|0|||
147387471|NCT02561195|531580352|FG007|Vaccination 1 to 3|Lost to Follow-up|0|||
147387472|NCT02561195|531580353|FG008|Vaccination 1 to 3|Lost to Follow-up|0|||
147387473|NCT02561195|531580354|FG009|Vaccination 1 to 3|Lost to Follow-up|0|||
147387474|NCT02561195|531580355|FG010|Vaccination 1 to 3|Lost to Follow-up|0|||
147387475|NCT02561195|531580356|FG011|Vaccination 1 to 3|Lost to Follow-up|0|||
147387476|NCT02561195|531580357|FG012|Vaccination 1 to 3|Lost to Follow-up|0|||
147387477|NCT02561195|531580358|FG013|Vaccination 1 to 3|Lost to Follow-up|0|||
147387478|NCT02561195|531580345|FG000|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
147387479|NCT02561195|531580346|FG001|Vaccination 1 to 3|No longer meets eligibility criteria|1|||
147457192|NCT00094757|531835569|FG002|Overall Study|Withdrawal by Subject|5|||
147457193|NCT00094757|531835567|FG000|Overall Study|Other|3|||
147457194|NCT00094757|531835568|FG001|Overall Study|Other|3|||
147387480|NCT02561195|531580347|FG002|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
147387481|NCT02561195|531580348|FG003|Vaccination 1 to 3|No longer meets eligibility criteria|4|||
147387482|NCT02561195|531580349|FG004|Vaccination 1 to 3|No longer meets eligibility criteria|4|||
147457195|NCT00094757|531835569|FG002|Overall Study|Other|1|||
147457196|NCT00094757|531835567|FG000|Overall Study|Protocol specified discontinuation|1|||
147387483|NCT02561195|531580350|FG005|Vaccination 1 to 3|No longer meets eligibility criteria|1|||
147387484|NCT02561195|531580351|FG006|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
147387485|NCT02561195|531580352|FG007|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
147387486|NCT02561195|531580353|FG008|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
147457197|NCT00094757|531835568|FG001|Overall Study|Protocol specified discontinuation|3|||
147387487|NCT02561195|531580354|FG009|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
147387488|NCT02561195|531580355|FG010|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
147387489|NCT02561195|531580356|FG011|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
147387490|NCT02561195|531580357|FG012|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
147387491|NCT02561195|531580358|FG013|Vaccination 1 to 3|No longer meets eligibility criteria|0|||
147387492|NCT02561195|531580345|FG000|Vaccination 1 to 3|No longer willing to participate|2|||
147387493|NCT02561195|531580346|FG001|Vaccination 1 to 3|No longer willing to participate|4|||
147387494|NCT02561195|531580347|FG002|Vaccination 1 to 3|No longer willing to participate|0|||
147387495|NCT02561195|531580348|FG003|Vaccination 1 to 3|No longer willing to participate|4|||
147387496|NCT02561195|531580349|FG004|Vaccination 1 to 3|No longer willing to participate|1|||
147387497|NCT02561195|531580350|FG005|Vaccination 1 to 3|No longer willing to participate|3|||
147387498|NCT02561195|531580351|FG006|Vaccination 1 to 3|No longer willing to participate|0|||
147387499|NCT02561195|531580352|FG007|Vaccination 1 to 3|No longer willing to participate|0|||
147387500|NCT02561195|531580353|FG008|Vaccination 1 to 3|No longer willing to participate|0|||
147387501|NCT02561195|531580354|FG009|Vaccination 1 to 3|No longer willing to participate|0|||
147387502|NCT02561195|531580355|FG010|Vaccination 1 to 3|No longer willing to participate|0|||
147387503|NCT02561195|531580356|FG011|Vaccination 1 to 3|No longer willing to participate|0|||
147387504|NCT02561195|531580357|FG012|Vaccination 1 to 3|No longer willing to participate|0|||
147387505|NCT02561195|531580358|FG013|Vaccination 1 to 3|No longer willing to participate|0|||
147387506|NCT02561195|531580345|FG000|Vaccination 1 to 3|Other|7|||
147387507|NCT02561195|531580346|FG001|Vaccination 1 to 3|Other|3|||
147387508|NCT02561195|531580347|FG002|Vaccination 1 to 3|Other|1|||
147387509|NCT02561195|531580348|FG003|Vaccination 1 to 3|Other|7|||
147387510|NCT02561195|531580349|FG004|Vaccination 1 to 3|Other|5|||
147387511|NCT02561195|531580350|FG005|Vaccination 1 to 3|Other|1|||
147387512|NCT02561195|531580351|FG006|Vaccination 1 to 3|Other|0|||
147387513|NCT02561195|531580352|FG007|Vaccination 1 to 3|Other|0|||
147387514|NCT02561195|531580353|FG008|Vaccination 1 to 3|Other|0|||
147387515|NCT02561195|531580354|FG009|Vaccination 1 to 3|Other|0|||
147387516|NCT02561195|531580355|FG010|Vaccination 1 to 3|Other|0|||
147387517|NCT02561195|531580356|FG011|Vaccination 1 to 3|Other|0|||
147387518|NCT02561195|531580357|FG012|Vaccination 1 to 3|Other|0|||
147387519|NCT02561195|531580358|FG013|Vaccination 1 to 3|Other|0|||
147387520|NCT02561195|531580345|FG000|Vaccination 1 to 3|Protocol Violation|1|||
147387521|NCT02561195|531580346|FG001|Vaccination 1 to 3|Protocol Violation|0|||
147387522|NCT02561195|531580347|FG002|Vaccination 1 to 3|Protocol Violation|1|||
147387523|NCT02561195|531580348|FG003|Vaccination 1 to 3|Protocol Violation|2|||
147387524|NCT02561195|531580349|FG004|Vaccination 1 to 3|Protocol Violation|5|||
147387525|NCT02561195|531580350|FG005|Vaccination 1 to 3|Protocol Violation|2|||
147387526|NCT02561195|531580351|FG006|Vaccination 1 to 3|Protocol Violation|0|||
147387527|NCT02561195|531580352|FG007|Vaccination 1 to 3|Protocol Violation|0|||
147387528|NCT02561195|531580353|FG008|Vaccination 1 to 3|Protocol Violation|0|||
147387529|NCT02561195|531580354|FG009|Vaccination 1 to 3|Protocol Violation|0|||
147387530|NCT02561195|531580355|FG010|Vaccination 1 to 3|Protocol Violation|0|||
147387531|NCT02561195|531580356|FG011|Vaccination 1 to 3|Protocol Violation|0|||
147387532|NCT02561195|531580357|FG012|Vaccination 1 to 3|Protocol Violation|0|||
147387533|NCT02561195|531580358|FG013|Vaccination 1 to 3|Protocol Violation|0|||
147387534|NCT02561195|531580345|FG000|Vaccination 1 to 3|Death|2|||
147387535|NCT02561195|531580346|FG001|Vaccination 1 to 3|Death|1|||
147387536|NCT02561195|531580347|FG002|Vaccination 1 to 3|Death|0|||
147387537|NCT02561195|531580348|FG003|Vaccination 1 to 3|Death|2|||
147387538|NCT02561195|531580349|FG004|Vaccination 1 to 3|Death|0|||
147387539|NCT02561195|531580350|FG005|Vaccination 1 to 3|Death|0|||
147387540|NCT02561195|531580351|FG006|Vaccination 1 to 3|Death|0|||
147387541|NCT02561195|531580352|FG007|Vaccination 1 to 3|Death|0|||
147387542|NCT02561195|531580353|FG008|Vaccination 1 to 3|Death|0|||
147387543|NCT02561195|531580354|FG009|Vaccination 1 to 3|Death|0|||
147387544|NCT02561195|531580355|FG010|Vaccination 1 to 3|Death|0|||
147387545|NCT02561195|531580356|FG011|Vaccination 1 to 3|Death|0|||
147387546|NCT02561195|531580357|FG012|Vaccination 1 to 3|Death|0|||
147387547|NCT02561195|531580358|FG013|Vaccination 1 to 3|Death|0|||
147387548|NCT02561195|531580345|FG000|Vaccination 1 to 3|Withdrawal by Subject|3|||
147387549|NCT02561195|531580346|FG001|Vaccination 1 to 3|Withdrawal by Subject|4|||
147387550|NCT02561195|531580347|FG002|Vaccination 1 to 3|Withdrawal by Subject|4|||
147387551|NCT02561195|531580348|FG003|Vaccination 1 to 3|Withdrawal by Subject|2|||
147387552|NCT02561195|531580349|FG004|Vaccination 1 to 3|Withdrawal by Subject|6|||
147387553|NCT02561195|531580350|FG005|Vaccination 1 to 3|Withdrawal by Subject|0|||
147387554|NCT02561195|531580351|FG006|Vaccination 1 to 3|Withdrawal by Subject|0|||
147387555|NCT02561195|531580352|FG007|Vaccination 1 to 3|Withdrawal by Subject|0|||
147387556|NCT02561195|531580353|FG008|Vaccination 1 to 3|Withdrawal by Subject|0|||
147387557|NCT02561195|531580354|FG009|Vaccination 1 to 3|Withdrawal by Subject|0|||
147387558|NCT02561195|531580355|FG010|Vaccination 1 to 3|Withdrawal by Subject|0|||
147387559|NCT02561195|531580356|FG011|Vaccination 1 to 3|Withdrawal by Subject|0|||
147387560|NCT02561195|531580357|FG012|Vaccination 1 to 3|Withdrawal by Subject|0|||
147387561|NCT02561195|531580358|FG013|Vaccination 1 to 3|Withdrawal by Subject|0|||
147387562|NCT02561195|531580345|FG000|Vaccination 1 to 3|Randomized but not treated|1|||
147615061|NCT03999996|532406589|FG002|Prior to Booster|Withdrawal of Consent|0|||
147615062|NCT03999996|532406590|FG003|Prior to Booster|Withdrawal of Consent|0|||
147615063|NCT03999996|532406587|FG000|Prior to Booster|Death|0|||
147615064|NCT03999996|532406588|FG001|Prior to Booster|Death|1|||
147615065|NCT03999996|532406589|FG002|Prior to Booster|Death|0|||
147387563|NCT02561195|531580346|FG001|Vaccination 1 to 3|Randomized but not treated|0|||
147387564|NCT02561195|531580347|FG002|Vaccination 1 to 3|Randomized but not treated|0|||
147387565|NCT02561195|531580348|FG003|Vaccination 1 to 3|Randomized but not treated|0|||
147387566|NCT02561195|531580349|FG004|Vaccination 1 to 3|Randomized but not treated|0|||
147387567|NCT02561195|531580350|FG005|Vaccination 1 to 3|Randomized but not treated|0|||
147387568|NCT02561195|531580351|FG006|Vaccination 1 to 3|Randomized but not treated|0|||
147387569|NCT02561195|531580352|FG007|Vaccination 1 to 3|Randomized but not treated|0|||
147387570|NCT02561195|531580353|FG008|Vaccination 1 to 3|Randomized but not treated|0|||
147387571|NCT02561195|531580354|FG009|Vaccination 1 to 3|Randomized but not treated|0|||
147387572|NCT02561195|531580355|FG010|Vaccination 1 to 3|Randomized but not treated|0|||
147457198|NCT00094757|531835569|FG002|Overall Study|Protocol specified discontinuation|0|||
147457199|NCT03433781|531835570|FG000|Overall Study|Progression of Disease|1|||
147457200|NCT03433781|531835571|FG001|Overall Study|Progression of Disease|0|||
147457201|NCT03433781|531835572|FG002|Overall Study|Progression of Disease|0|||
147457202|NCT03433781|531835570|FG000|Overall Study|Physician Decision|0|||
147457203|NCT03433781|531835571|FG001|Overall Study|Physician Decision|1|||
147457204|NCT03433781|531835572|FG002|Overall Study|Physician Decision|0|||
147457205|NCT03033875|531835573|FG000|Overall Study|Withdrawal by Subject|5|||
147457206|NCT03033875|531835574|FG001|Overall Study|Withdrawal by Subject|9|||
147457207|NCT03033875|531835575|FG002|Overall Study|Withdrawal by Subject|4|||
147457208|NCT03033875|531835573|FG000|Overall Study|Other|14|||
147457209|NCT03033875|531835574|FG001|Overall Study|Other|15|||
147457210|NCT03033875|531835575|FG002|Overall Study|Other|8|||
147457211|NCT02286947|531835578|FG000|Overall Study|Withdrawal by Subject|2|||
147457212|NCT03979274|531835579|FG000|Treatment Period 2|Withdrawal by Subject|0|||
147457213|NCT03979274|531835580|FG001|Treatment Period 2|Withdrawal by Subject|1|||
147457214|NCT01614093|531835585|FG000|Overall Study|Withdrawal by Subject|1|||
147457215|NCT00848354|531835586|FG000|Phase 1|Adverse Event|5|||
147457216|NCT00848354|531835587|FG001|Phase 1|Adverse Event|4|||
147457217|NCT00848354|531835586|FG000|Phase 1|Discontinuation of study by sponsor|2|||
147457218|NCT00848354|531835587|FG001|Phase 1|Discontinuation of study by sponsor|1|||
147457219|NCT00848354|531835586|FG000|Phase 1|Failed to return|0|||
147457220|NCT00848354|531835587|FG001|Phase 1|Failed to return|1|||
147457221|NCT00848354|531835586|FG000|Phase 1|Lost to Follow-up|1|||
147457222|NCT00848354|531835587|FG001|Phase 1|Lost to Follow-up|1|||
147457223|NCT00848354|531835586|FG000|Phase 1|Unspecified Reason|1|||
147457224|NCT00848354|531835587|FG001|Phase 1|Unspecified Reason|1|||
147457225|NCT00848354|531835586|FG000|Phase 1|Protocol Violation|1|||
147457226|NCT00848354|531835587|FG001|Phase 1|Protocol Violation|1|||
147457227|NCT00848354|531835586|FG000|Phase 1|Withdrawal by Subject|2|||
147457228|NCT00848354|531835587|FG001|Phase 1|Withdrawal by Subject|4|||
147457229|NCT00848354|531835586|FG000|Phase 1|Lack of Efficacy|0|||
147457230|NCT00848354|531835587|FG001|Phase 1|Lack of Efficacy|1|||
147457231|NCT00848354|531835586|FG000|Phase 2 Year 1|Adverse Event|7|||
147457232|NCT00848354|531835587|FG001|Phase 2 Year 1|Adverse Event|2|||
147457233|NCT00848354|531835586|FG000|Phase 2 Year 1|Death|1|||
147457234|NCT00848354|531835587|FG001|Phase 2 Year 1|Death|0|||
147457235|NCT00848354|531835586|FG000|Phase 2 Year 1|Failed to Return|1|||
147457236|NCT00848354|531835587|FG001|Phase 2 Year 1|Failed to Return|1|||
147457237|NCT00848354|531835586|FG000|Phase 2 Year 1|Lost to Follow-up|1|||
147457238|NCT00848354|531835587|FG001|Phase 2 Year 1|Lost to Follow-up|0|||
147457239|NCT00848354|531835586|FG000|Phase 2 Year 1|Unspecified Reason|3|||
147457240|NCT00848354|531835587|FG001|Phase 2 Year 1|Unspecified Reason|0|||
147457241|NCT00848354|531835586|FG000|Phase 2 Year 1|Protocol Violation|4|||
147457242|NCT00848354|531835587|FG001|Phase 2 Year 1|Protocol Violation|1|||
147457243|NCT00848354|531835586|FG000|Phase 2 Year 1|Subject Request|1|||
147457244|NCT00848354|531835587|FG001|Phase 2 Year 1|Subject Request|2|||
147457245|NCT00848354|531835586|FG000|Phase 2 Year 2|Adverse Event|12|||
147457246|NCT00848354|531835587|FG001|Phase 2 Year 2|Adverse Event|2|||
147615066|NCT03999996|532406590|FG003|Prior to Booster|Death|0|||
147387573|NCT02561195|531580356|FG011|Vaccination 1 to 3|Randomized but not treated|0|||
147457247|NCT00848354|531835586|FG000|Phase 2 Year 2|Death|2|||
147457248|NCT00848354|531835587|FG001|Phase 2 Year 2|Death|0|||
147457249|NCT00848354|531835586|FG000|Phase 2 Year 2|Failed to return|3|||
147457250|NCT00848354|531835587|FG001|Phase 2 Year 2|Failed to return|0|||
147457251|NCT00848354|531835586|FG000|Phase 2 Year 2|Lost to Follow-up|1|||
147457252|NCT00848354|531835587|FG001|Phase 2 Year 2|Lost to Follow-up|3|||
147615067|NCT03999996|532406587|FG000|Prior to Booster|Reason Not Specified|27|||
147615068|NCT03999996|532406588|FG001|Prior to Booster|Reason Not Specified|4|||
147457253|NCT00848354|531835586|FG000|Phase 2 Year 2|Unspecified Reason|1|||
147457254|NCT00848354|531835587|FG001|Phase 2 Year 2|Unspecified Reason|0|||
147457255|NCT00848354|531835586|FG000|Phase 2 Year 2|Protocol Violation|1|||
147457256|NCT00848354|531835587|FG001|Phase 2 Year 2|Protocol Violation|1|||
147457257|NCT00848354|531835586|FG000|Phase 2 Year 2|Subject Request|1|||
147457258|NCT00848354|531835587|FG001|Phase 2 Year 2|Subject Request|1|||
147457259|NCT00848354|531835586|FG000|Phase 2 Year 2|Unsatisfactory Response - Efficacy|2|||
147457260|NCT00848354|531835587|FG001|Phase 2 Year 2|Unsatisfactory Response - Efficacy|0|||
147457261|NCT00915343|531835590|FG000|Part B - Open Label Period|Treatment switch|0|||
147457262|NCT00915343|531835591|FG001|Part B - Open Label Period|Treatment switch|0|||
147457263|NCT00915343|531835592|FG002|Part B - Open Label Period|Treatment switch|1|||
147457264|NCT00915343|531835590|FG000|Part B - Open Label Period|Did not attend the last visit|0|||
147457265|NCT00915343|531835591|FG001|Part B - Open Label Period|Did not attend the last visit|0|||
147457266|NCT00915343|531835592|FG002|Part B - Open Label Period|Did not attend the last visit|1|||
147457267|NCT00626093|531835593|FG000|Overall Study|Lost to Follow-up|5|||
147457268|NCT00626093|531835593|FG000|Overall Study|Death|1|||
147457269|NCT00626093|531835593|FG000|Overall Study|Physician Decision|4|||
147457270|NCT00626093|531835593|FG000|Overall Study|Withdrawal by Subject|6|||
147457271|NCT00626093|531835593|FG000|Overall Study|Protocol Violation|1|||
147457272|NCT00626093|531835593|FG000|Overall Study|One of the required devices not implante|6|||
147457273|NCT00911989|531835594|FG000|Overall Study|Adverse Event|1|||
147457274|NCT03064841|531835595|FG000|Overall Study|Inclusion/exclusion criteria violation|4|||
147457275|NCT03064841|531835595|FG000|Overall Study|No glycated haemoglobinA1c measurement|11|||
147457276|NCT03064841|531835595|FG000|Overall Study|Screen failure|2|||
147457277|NCT03434977|531835596|FG000|Washout Period (at Least 6 Days)|Adverse Event|0|||
147457278|NCT03434977|531835597|FG001|Washout Period (at Least 6 Days)|Adverse Event|1|||
147457279|NCT01145066|531835598|FG000|Overall Study|To resume NSAIDs|2|||
147457280|NCT01145066|531835599|FG001|Overall Study|To resume NSAIDs|2|||
147457281|NCT01145066|531835600|FG002|Overall Study|To resume NSAIDs|1|||
147457282|NCT01145066|531835598|FG000|Overall Study|Non-related surgery|0|||
147457283|NCT01145066|531835599|FG001|Overall Study|Non-related surgery|0|||
147457284|NCT01145066|531835600|FG002|Overall Study|Non-related surgery|1|||
147457285|NCT01145066|531835598|FG000|Overall Study|Withdrawal by Subject|0|||
147457286|NCT01145066|531835599|FG001|Overall Study|Withdrawal by Subject|0|||
147457287|NCT01145066|531835600|FG002|Overall Study|Withdrawal by Subject|2|||
147457288|NCT01145066|531835598|FG000|Overall Study|To start new med|1|||
147457289|NCT01145066|531835599|FG001|Overall Study|To start new med|0|||
147457290|NCT01145066|531835600|FG002|Overall Study|To start new med|0|||
147457291|NCT01145066|531835598|FG000|Overall Study|problems swallowing capsule|1|||
147457292|NCT01145066|531835599|FG001|Overall Study|problems swallowing capsule|0|||
147457293|NCT01145066|531835600|FG002|Overall Study|problems swallowing capsule|0|||
147457294|NCT01145066|531835598|FG000|Overall Study|Abdominal discomfort|0|||
147457295|NCT01145066|531835599|FG001|Overall Study|Abdominal discomfort|1|||
147457296|NCT01145066|531835600|FG002|Overall Study|Abdominal discomfort|0|||
147457297|NCT01145066|531835598|FG000|Overall Study|Low platelet count|0|||
147457298|NCT01145066|531835599|FG001|Overall Study|Low platelet count|1|||
147457299|NCT01145066|531835600|FG002|Overall Study|Low platelet count|0|||
147457300|NCT00573794|531835601|FG000|Overall Study|Adverse Event|81|||
147457301|NCT00573794|531835601|FG000|Overall Study|Withdrew Consent|90|||
147457302|NCT00573794|531835601|FG000|Overall Study|Lost to Follow-up|13|||
147457303|NCT00573794|531835601|FG000|Overall Study|Protocol Violation|6|||
147457304|NCT00573794|531835601|FG000|Overall Study|Lack of Efficacy|94|||
147457305|NCT00573794|531835601|FG000|Overall Study|Other|46|||
147457306|NCT01724528|531835605|FG000|Overall Study|Death|3|||
147457307|NCT01724528|531835606|FG001|Overall Study|Death|0|||
147457308|NCT01724528|531835605|FG000|Overall Study|Withdrawal by Subject|0|||
147457309|NCT01724528|531835606|FG001|Overall Study|Withdrawal by Subject|2|||
147457310|NCT01724528|531835605|FG000|Overall Study|Protocol Violation|0|||
147457311|NCT01724528|531835606|FG001|Overall Study|Protocol Violation|1|||
147457312|NCT01724528|531835605|FG000|Overall Study|Patient refused to attend last visit|1|||
147457313|NCT01724528|531835606|FG001|Overall Study|Patient refused to attend last visit|0|||
147457314|NCT05574062|531835610|FG000|Pre Run-In|Screening failure|3|||
147457315|NCT05574062|531835611|FG001|Pre Run-In|Screening failure|0|||
147457316|NCT05574062|531835612|FG002|Pre Run-In|Screening failure|0|||
147457317|NCT05574062|531835613|FG003|Pre Run-In|Screening failure|0|||
147615069|NCT03999996|532406589|FG002|Prior to Booster|Reason Not Specified|0|||
147615070|NCT03999996|532406590|FG003|Prior to Booster|Reason Not Specified|0|||
147457318|NCT05574062|531835614|FG004|Pre Run-In|Screening failure|0|||
147457319|NCT05574062|531835610|FG000|Study Phase Period 1|Withdrawal by Subject|0|||
147457320|NCT05574062|531835611|FG001|Study Phase Period 1|Withdrawal by Subject|1|||
147457321|NCT05574062|531835612|FG002|Study Phase Period 1|Withdrawal by Subject|0|||
147457322|NCT05574062|531835613|FG003|Study Phase Period 1|Withdrawal by Subject|0|||
147615071|NCT03999996|532406587|FG000|Booster Phase|Lost to Follow-up|0|||
147457323|NCT05574062|531835614|FG004|Study Phase Period 1|Withdrawal by Subject|0|||
147457324|NCT05574062|531835610|FG000|Study Phase Period 2|Withdrawal by Subject|0|||
147457325|NCT05574062|531835611|FG001|Study Phase Period 2|Withdrawal by Subject|1|||
147457326|NCT05574062|531835612|FG002|Study Phase Period 2|Withdrawal by Subject|0|||
147457327|NCT05574062|531835613|FG003|Study Phase Period 2|Withdrawal by Subject|0|||
147615072|NCT03999996|532406588|FG001|Booster Phase|Lost to Follow-up|0|||
147615073|NCT03999996|532406589|FG002|Booster Phase|Lost to Follow-up|3|||
147615074|NCT03999996|532406590|FG003|Booster Phase|Lost to Follow-up|3|||
147457328|NCT05574062|531835614|FG004|Study Phase Period 2|Withdrawal by Subject|0|||
147457329|NCT05574062|531835610|FG000|Continuation Phase Period 1|Physician Decision|1|||
147457330|NCT05574062|531835611|FG001|Continuation Phase Period 1|Physician Decision|0|||
147457331|NCT05574062|531835612|FG002|Continuation Phase Period 1|Physician Decision|0|||
147457332|NCT05574062|531835613|FG003|Continuation Phase Period 1|Physician Decision|0|||
147457333|NCT05574062|531835614|FG004|Continuation Phase Period 1|Physician Decision|0|||
147457334|NCT05574062|531835610|FG000|Continuation Phase Period 1|Withdrawal by Subject|1|||
147457335|NCT05574062|531835611|FG001|Continuation Phase Period 1|Withdrawal by Subject|0|||
147457336|NCT05574062|531835612|FG002|Continuation Phase Period 1|Withdrawal by Subject|0|||
147457337|NCT05574062|531835613|FG003|Continuation Phase Period 1|Withdrawal by Subject|0|||
147457338|NCT05574062|531835614|FG004|Continuation Phase Period 1|Withdrawal by Subject|0|||
147457339|NCT05574062|531835610|FG000|Continuation Phase Period 1|Adverse Event|1|||
147457340|NCT05574062|531835611|FG001|Continuation Phase Period 1|Adverse Event|0|||
147457341|NCT05574062|531835612|FG002|Continuation Phase Period 1|Adverse Event|0|||
147457342|NCT05574062|531835613|FG003|Continuation Phase Period 1|Adverse Event|0|||
147457343|NCT05574062|531835614|FG004|Continuation Phase Period 1|Adverse Event|0|||
147457344|NCT05574062|531835610|FG000|Continuation Phase Period 1|Death|1|||
147457345|NCT05574062|531835611|FG001|Continuation Phase Period 1|Death|0|||
147457346|NCT05574062|531835612|FG002|Continuation Phase Period 1|Death|0|||
147387574|NCT02561195|531580357|FG012|Vaccination 1 to 3|Randomized but not treated|0|||
147387575|NCT02561195|531580358|FG013|Vaccination 1 to 3|Randomized but not treated|0|||
147387576|NCT02561195|531580345|FG000|Extension Stage (Vaccination 4)|Withdrew consent|0|||
147387577|NCT02561195|531580346|FG001|Extension Stage (Vaccination 4)|Withdrew consent|0|||
147387578|NCT02561195|531580347|FG002|Extension Stage (Vaccination 4)|Withdrew consent|0|||
147387579|NCT02561195|531580348|FG003|Extension Stage (Vaccination 4)|Withdrew consent|0|||
147387580|NCT02561195|531580349|FG004|Extension Stage (Vaccination 4)|Withdrew consent|0|||
147387581|NCT02561195|531580350|FG005|Extension Stage (Vaccination 4)|Withdrew consent|0|||
147387582|NCT02561195|531580351|FG006|Extension Stage (Vaccination 4)|Withdrew consent|0|||
147387583|NCT02561195|531580352|FG007|Extension Stage (Vaccination 4)|Withdrew consent|0|||
147387584|NCT02561195|531580353|FG008|Extension Stage (Vaccination 4)|Withdrew consent|3|||
147387585|NCT02561195|531580354|FG009|Extension Stage (Vaccination 4)|Withdrew consent|1|||
147387586|NCT02561195|531580355|FG010|Extension Stage (Vaccination 4)|Withdrew consent|2|||
147387587|NCT02561195|531580356|FG011|Extension Stage (Vaccination 4)|Withdrew consent|2|||
147387588|NCT02561195|531580357|FG012|Extension Stage (Vaccination 4)|Withdrew consent|3|||
147387589|NCT02561195|531580358|FG013|Extension Stage (Vaccination 4)|Withdrew consent|0|||
147387590|NCT02561195|531580345|FG000|Extension Stage (Vaccination 4)|Adverse Event|0|||
147387591|NCT02561195|531580346|FG001|Extension Stage (Vaccination 4)|Adverse Event|0|||
147387592|NCT02561195|531580347|FG002|Extension Stage (Vaccination 4)|Adverse Event|0|||
147387593|NCT02561195|531580348|FG003|Extension Stage (Vaccination 4)|Adverse Event|0|||
147387594|NCT02561195|531580349|FG004|Extension Stage (Vaccination 4)|Adverse Event|0|||
147387595|NCT02561195|531580350|FG005|Extension Stage (Vaccination 4)|Adverse Event|0|||
147387596|NCT02561195|531580351|FG006|Extension Stage (Vaccination 4)|Adverse Event|0|||
147387597|NCT02561195|531580352|FG007|Extension Stage (Vaccination 4)|Adverse Event|0|||
147387598|NCT02561195|531580353|FG008|Extension Stage (Vaccination 4)|Adverse Event|0|||
147387599|NCT02561195|531580354|FG009|Extension Stage (Vaccination 4)|Adverse Event|0|||
147387600|NCT02561195|531580355|FG010|Extension Stage (Vaccination 4)|Adverse Event|0|||
147387601|NCT02561195|531580356|FG011|Extension Stage (Vaccination 4)|Adverse Event|0|||
147387602|NCT02561195|531580357|FG012|Extension Stage (Vaccination 4)|Adverse Event|0|||
147387603|NCT02561195|531580358|FG013|Extension Stage (Vaccination 4)|Adverse Event|2|||
147387604|NCT02561195|531580345|FG000|Extension Stage (Vaccination 4)|Death|0|||
147387605|NCT02561195|531580346|FG001|Extension Stage (Vaccination 4)|Death|0|||
147387606|NCT02561195|531580347|FG002|Extension Stage (Vaccination 4)|Death|0|||
147387607|NCT02561195|531580348|FG003|Extension Stage (Vaccination 4)|Death|0|||
147387608|NCT02561195|531580349|FG004|Extension Stage (Vaccination 4)|Death|0|||
147387609|NCT02561195|531580350|FG005|Extension Stage (Vaccination 4)|Death|0|||
147387610|NCT02561195|531580351|FG006|Extension Stage (Vaccination 4)|Death|0|||
147387611|NCT02561195|531580352|FG007|Extension Stage (Vaccination 4)|Death|0|||
147387612|NCT02561195|531580353|FG008|Extension Stage (Vaccination 4)|Death|0|||
147387613|NCT02561195|531580354|FG009|Extension Stage (Vaccination 4)|Death|1|||
147387614|NCT02561195|531580355|FG010|Extension Stage (Vaccination 4)|Death|0|||
147387615|NCT02561195|531580356|FG011|Extension Stage (Vaccination 4)|Death|0|||
147387616|NCT02561195|531580357|FG012|Extension Stage (Vaccination 4)|Death|0|||
147387617|NCT02561195|531580358|FG013|Extension Stage (Vaccination 4)|Death|0|||
147387618|NCT02561195|531580345|FG000|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
147387619|NCT02561195|531580346|FG001|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
147387620|NCT02561195|531580347|FG002|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
147387621|NCT02561195|531580348|FG003|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
147387622|NCT02561195|531580349|FG004|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
147387623|NCT02561195|531580350|FG005|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
147387624|NCT02561195|531580351|FG006|Extension Stage (Vaccination 4)|Lost to Follow-up|1|||
147387625|NCT02561195|531580352|FG007|Extension Stage (Vaccination 4)|Lost to Follow-up|1|||
147387626|NCT02561195|531580353|FG008|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
147457347|NCT05574062|531835613|FG003|Continuation Phase Period 1|Death|0|||
147457348|NCT05574062|531835614|FG004|Continuation Phase Period 1|Death|0|||
147457349|NCT05574062|531835610|FG000|Continuation Phase Period 2|Withdrawal by Subject|0|||
147457350|NCT05574062|531835611|FG001|Continuation Phase Period 2|Withdrawal by Subject|0|||
147457351|NCT05574062|531835612|FG002|Continuation Phase Period 2|Withdrawal by Subject|0|||
147457352|NCT05574062|531835613|FG003|Continuation Phase Period 2|Withdrawal by Subject|1|||
147457353|NCT05574062|531835614|FG004|Continuation Phase Period 2|Withdrawal by Subject|0|||
147457354|NCT04811716|531835621|FG000|Overall Study|Withdrawal by Subject|2|||
147457355|NCT04811716|531835622|FG001|Overall Study|Withdrawal by Subject|0|||
147457356|NCT04202679|531835623|FG000|Overall Study|Adverse Event|2|||
147457357|NCT04202679|531835624|FG001|Overall Study|Adverse Event|0|||
147457358|NCT04202679|531835623|FG000|Overall Study|Poor compliance to protocol|1|||
147457359|NCT04202679|531835624|FG001|Overall Study|Poor compliance to protocol|0|||
147457360|NCT04202679|531835623|FG000|Overall Study|Withdrawal by Subject|23|||
147457361|NCT04202679|531835624|FG001|Overall Study|Withdrawal by Subject|6|||
147457362|NCT05902364|531835625|FG000|Overall Study|Adverse Event|1|||
147457363|NCT05902364|531835626|FG001|Overall Study|Adverse Event|0|||
147457364|NCT02270242|531835627|FG000|Overall Study|Withdrawal by Subject|18|||
147457365|NCT02270242|531835628|FG001|Overall Study|Withdrawal by Subject|25|||
147457366|NCT02270242|531835627|FG000|Overall Study|Lost to Follow-up|41|||
147457367|NCT02270242|531835628|FG001|Overall Study|Lost to Follow-up|27|||
147457368|NCT02270242|531835627|FG000|Overall Study|Physician Decision|0|||
147457369|NCT02270242|531835628|FG001|Overall Study|Physician Decision|1|||
147457370|NCT03864653|531835629|FG000|Overall Study|Withdrawal by Subject|1|||
147457371|NCT03048422|531835630|FG000|Overall Study|Death|1|||
147457372|NCT03048422|531835631|FG001|Overall Study|Death|0|||
147457373|NCT03048422|531835632|FG002|Overall Study|Death|0|||
147457374|NCT03048422|531835630|FG000|Overall Study|Lost to Follow-up|5|||
147457375|NCT03048422|531835631|FG001|Overall Study|Lost to Follow-up|0|||
147387627|NCT02561195|531580354|FG009|Extension Stage (Vaccination 4)|Lost to Follow-up|0|||
147387628|NCT02561195|531580355|FG010|Extension Stage (Vaccination 4)|Lost to Follow-up|2|||
147387629|NCT02561195|531580356|FG011|Extension Stage (Vaccination 4)|Lost to Follow-up|1|||
147387630|NCT02561195|531580357|FG012|Extension Stage (Vaccination 4)|Lost to Follow-up|2|||
147387631|NCT02561195|531580358|FG013|Extension Stage (Vaccination 4)|Lost to Follow-up|1|||
147387632|NCT02561195|531580345|FG000|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
147387633|NCT02561195|531580346|FG001|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
147387634|NCT02561195|531580347|FG002|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
147387635|NCT02561195|531580348|FG003|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
147457376|NCT03048422|531835632|FG002|Overall Study|Lost to Follow-up|1|||
147457377|NCT03048422|531835630|FG000|Overall Study|Withdrawal by Subject|5|||
147457378|NCT03048422|531835631|FG001|Overall Study|Withdrawal by Subject|7|||
147457379|NCT03048422|531835632|FG002|Overall Study|Withdrawal by Subject|4|||
147457380|NCT03048422|531835630|FG000|Overall Study|Moved|3|||
147457381|NCT03048422|531835631|FG001|Overall Study|Moved|2|||
147457382|NCT03048422|531835632|FG002|Overall Study|Moved|2|||
147457383|NCT03048422|531835630|FG000|Overall Study|Noncompliant with Study Requirements|2|||
147457384|NCT03048422|531835631|FG001|Overall Study|Noncompliant with Study Requirements|1|||
147457385|NCT03048422|531835632|FG002|Overall Study|Noncompliant with Study Requirements|2|||
147457386|NCT03048422|531835630|FG000|Overall Study|Not Able to Get to Clinic|1|||
147457387|NCT03048422|531835631|FG001|Overall Study|Not Able to Get to Clinic|0|||
147457388|NCT03048422|531835632|FG002|Overall Study|Not Able to Get to Clinic|0|||
147457389|NCT02482129|531835633|FG000|Overall Study|Adverse Event-prior to treatment|0|||
147457390|NCT02482129|531835634|FG001|Overall Study|Adverse Event-prior to treatment|1|||
147457391|NCT02482129|531835633|FG000|Overall Study|Withdrawal by subject-prior to treatment|0|||
147457392|NCT02482129|531835634|FG001|Overall Study|Withdrawal by subject-prior to treatment|1|||
147457393|NCT02482129|531835633|FG000|Overall Study|Unable to draw blood-prior to treatment|1|||
147457394|NCT02482129|531835634|FG001|Overall Study|Unable to draw blood-prior to treatment|0|||
147457395|NCT02482129|531835633|FG000|Overall Study|Criteria not met-prior to treatment|1|||
147457396|NCT02482129|531835634|FG001|Overall Study|Criteria not met-prior to treatment|0|||
147457397|NCT02482129|531835633|FG000|Overall Study|Adverse Event|1|||
147457398|NCT02482129|531835634|FG001|Overall Study|Adverse Event|0|||
147457399|NCT02482129|531835633|FG000|Overall Study|Withdrawal by Subject|2|||
147457400|NCT02482129|531835634|FG001|Overall Study|Withdrawal by Subject|0|||
147457401|NCT02482129|531835633|FG000|Overall Study|Criteria not met|1|||
147457402|NCT02482129|531835634|FG001|Overall Study|Criteria not met|0|||
147457403|NCT01928381|531835635|FG000|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|60|||
147664941|NCT04161391|532597966|FG002|Overall Study|Death|0|||
147457404|NCT01928381|531835636|FG001|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
147457405|NCT01928381|531835637|FG002|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
147457406|NCT01928381|531835638|FG003|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
147457407|NCT01928381|531835639|FG004|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
147457408|NCT01928381|531835640|FG005|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
147664942|NCT04161391|532597967|FG003|Overall Study|Death|0|||
147387636|NCT02561195|531580349|FG004|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
147387637|NCT02561195|531580350|FG005|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
147387638|NCT02561195|531580351|FG006|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
147387639|NCT02561195|531580352|FG007|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
147387640|NCT02561195|531580353|FG008|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
147387641|NCT02561195|531580354|FG009|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
147387642|NCT02561195|531580355|FG010|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|0|||
147387643|NCT02561195|531580356|FG011|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|1|||
147387644|NCT02561195|531580357|FG012|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|1|||
147387645|NCT02561195|531580358|FG013|Extension Stage (Vaccination 4)|No Longer Willing To Participate In Study|1|||
147387646|NCT02561195|531580345|FG000|Extension Stage (Vaccination 4)|Other|0|||
147457409|NCT01928381|531835641|FG006|Screening for Pain Training|Did not qualify (inclusion/Exclusion)|0|||
147457410|NCT01928381|531835635|FG000|Part 1 - Pain Training|Pain training criteria not met|29|||
147457411|NCT01928381|531835636|FG001|Part 1 - Pain Training|Pain training criteria not met|0|||
147457412|NCT01928381|531835637|FG002|Part 1 - Pain Training|Pain training criteria not met|0|||
147457413|NCT01928381|531835638|FG003|Part 1 - Pain Training|Pain training criteria not met|0|||
147457414|NCT01928381|531835639|FG004|Part 1 - Pain Training|Pain training criteria not met|0|||
147457415|NCT01928381|531835640|FG005|Part 1 - Pain Training|Pain training criteria not met|0|||
147457416|NCT01928381|531835641|FG006|Part 1 - Pain Training|Pain training criteria not met|0|||
147457417|NCT01928381|531835635|FG000|Part 1 - Pain Training|Withdrawal by Subject|1|||
147457418|NCT01928381|531835636|FG001|Part 1 - Pain Training|Withdrawal by Subject|0|||
147457419|NCT01928381|531835637|FG002|Part 1 - Pain Training|Withdrawal by Subject|0|||
147457420|NCT01928381|531835638|FG003|Part 1 - Pain Training|Withdrawal by Subject|0|||
147457421|NCT01928381|531835639|FG004|Part 1 - Pain Training|Withdrawal by Subject|0|||
147457422|NCT01928381|531835640|FG005|Part 1 - Pain Training|Withdrawal by Subject|0|||
147457423|NCT01928381|531835641|FG006|Part 1 - Pain Training|Withdrawal by Subject|0|||
147457424|NCT01928381|531835635|FG000|Part 1 - Pain Training|Lost to Follow-up|4|||
147457425|NCT01928381|531835636|FG001|Part 1 - Pain Training|Lost to Follow-up|0|||
147457426|NCT01928381|531835637|FG002|Part 1 - Pain Training|Lost to Follow-up|0|||
147457427|NCT01928381|531835638|FG003|Part 1 - Pain Training|Lost to Follow-up|0|||
147457428|NCT01928381|531835639|FG004|Part 1 - Pain Training|Lost to Follow-up|0|||
147457429|NCT01928381|531835640|FG005|Part 1 - Pain Training|Lost to Follow-up|0|||
147457430|NCT01928381|531835641|FG006|Part 1 - Pain Training|Lost to Follow-up|0|||
147457431|NCT01928381|531835635|FG000|Part 1 - Pain Training|Protocol Violation|1|||
147457432|NCT01928381|531835636|FG001|Part 1 - Pain Training|Protocol Violation|0|||
147457433|NCT01928381|531835637|FG002|Part 1 - Pain Training|Protocol Violation|0|||
147457434|NCT01928381|531835638|FG003|Part 1 - Pain Training|Protocol Violation|0|||
147457435|NCT01928381|531835639|FG004|Part 1 - Pain Training|Protocol Violation|0|||
147457436|NCT01928381|531835640|FG005|Part 1 - Pain Training|Protocol Violation|0|||
147457437|NCT01928381|531835641|FG006|Part 1 - Pain Training|Protocol Violation|0|||
147457438|NCT01928381|531835635|FG000|Placebo run-in & Part 2 Eligibility|Adverse Event|1|||
147457439|NCT01928381|531835636|FG001|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
147457440|NCT01928381|531835637|FG002|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
147457441|NCT01928381|531835638|FG003|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
147457442|NCT01928381|531835639|FG004|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
147457443|NCT01928381|531835640|FG005|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
147457444|NCT01928381|531835641|FG006|Placebo run-in & Part 2 Eligibility|Adverse Event|0|||
147457445|NCT01928381|531835635|FG000|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|2|||
147457446|NCT01928381|531835636|FG001|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
147457447|NCT01928381|531835637|FG002|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
147457448|NCT01928381|531835638|FG003|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
147457449|NCT01928381|531835639|FG004|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
147457450|NCT01928381|531835640|FG005|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
147457451|NCT01928381|531835641|FG006|Placebo run-in & Part 2 Eligibility|Withdrawal by Subject|0|||
147457452|NCT01928381|531835635|FG000|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|1|||
147457453|NCT01928381|531835636|FG001|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
147457454|NCT01928381|531835637|FG002|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
147457455|NCT01928381|531835638|FG003|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
147457456|NCT01928381|531835639|FG004|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
147457457|NCT01928381|531835640|FG005|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
147457458|NCT01928381|531835641|FG006|Placebo run-in & Part 2 Eligibility|Lost to Follow-up|0|||
147457459|NCT01928381|531835635|FG000|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|10|||
147457460|NCT01928381|531835636|FG001|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
147457461|NCT01928381|531835637|FG002|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
147457462|NCT01928381|531835638|FG003|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
147457463|NCT01928381|531835639|FG004|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
147387647|NCT02561195|531580346|FG001|Extension Stage (Vaccination 4)|Other|0|||
147387648|NCT02561195|531580347|FG002|Extension Stage (Vaccination 4)|Other|0|||
147387649|NCT02561195|531580348|FG003|Extension Stage (Vaccination 4)|Other|0|||
147387650|NCT02561195|531580349|FG004|Extension Stage (Vaccination 4)|Other|0|||
147387651|NCT02561195|531580350|FG005|Extension Stage (Vaccination 4)|Other|0|||
147387652|NCT02561195|531580351|FG006|Extension Stage (Vaccination 4)|Other|0|||
147387653|NCT02561195|531580352|FG007|Extension Stage (Vaccination 4)|Other|0|||
147387654|NCT02561195|531580353|FG008|Extension Stage (Vaccination 4)|Other|0|||
147387655|NCT02561195|531580354|FG009|Extension Stage (Vaccination 4)|Other|0|||
147387656|NCT02561195|531580355|FG010|Extension Stage (Vaccination 4)|Other|2|||
147387657|NCT02561195|531580356|FG011|Extension Stage (Vaccination 4)|Other|2|||
147387658|NCT02561195|531580357|FG012|Extension Stage (Vaccination 4)|Other|1|||
147387659|NCT02561195|531580358|FG013|Extension Stage (Vaccination 4)|Other|0|||
147387660|NCT02561195|531580345|FG000|Extension Stage (Vaccination 4)|Protocol Violation|0|||
147387661|NCT02561195|531580346|FG001|Extension Stage (Vaccination 4)|Protocol Violation|0|||
147387662|NCT02561195|531580347|FG002|Extension Stage (Vaccination 4)|Protocol Violation|0|||
147387663|NCT02561195|531580348|FG003|Extension Stage (Vaccination 4)|Protocol Violation|0|||
147387664|NCT02561195|531580349|FG004|Extension Stage (Vaccination 4)|Protocol Violation|0|||
147387665|NCT02561195|531580350|FG005|Extension Stage (Vaccination 4)|Protocol Violation|0|||
147387666|NCT02561195|531580351|FG006|Extension Stage (Vaccination 4)|Protocol Violation|1|||
147387667|NCT02561195|531580352|FG007|Extension Stage (Vaccination 4)|Protocol Violation|0|||
147387668|NCT02561195|531580353|FG008|Extension Stage (Vaccination 4)|Protocol Violation|0|||
147387669|NCT02561195|531580354|FG009|Extension Stage (Vaccination 4)|Protocol Violation|0|||
147387670|NCT02561195|531580355|FG010|Extension Stage (Vaccination 4)|Protocol Violation|2|||
147387671|NCT02561195|531580356|FG011|Extension Stage (Vaccination 4)|Protocol Violation|1|||
147387672|NCT02561195|531580357|FG012|Extension Stage (Vaccination 4)|Protocol Violation|0|||
147387673|NCT02561195|531580358|FG013|Extension Stage (Vaccination 4)|Protocol Violation|1|||
147387674|NCT01885559|531580361|FG000|Overall Study|Lost to Follow-up|15|||
147387675|NCT01885559|531580362|FG001|Overall Study|Lost to Follow-up|16|||
147387676|NCT01885559|531580361|FG000|Overall Study|Less than full participation|9|||
147387677|NCT01885559|531580362|FG001|Overall Study|Less than full participation|19|||
147387678|NCT01885559|531580361|FG000|Overall Study|Protocol Violation|0|||
147387679|NCT01885559|531580362|FG001|Overall Study|Protocol Violation|1|||
147387680|NCT01867307|531580365|FG000|Overall Study|Protocol Violation|2|||
147387681|NCT01867307|531580366|FG001|Overall Study|Protocol Violation|0|||
147387682|NCT01867307|531580365|FG000|Overall Study|Other Adverse Event|1|||
147387683|NCT01867307|531580366|FG001|Overall Study|Other Adverse Event|3|||
147387684|NCT03820024|531580367|FG000|Overall Study|Physician Decision|1|||
147387685|NCT03820024|531580368|FG001|Overall Study|Physician Decision|2|||
147387686|NCT00676195|531581416|FG000|Overall Study|Lost to Follow-up|1|||
147387687|NCT00676195|531581416|FG000|Overall Study|Adverse Event|1|||
147387688|NCT00676195|531581416|FG000|Overall Study|Physician Decision|1|||
147387689|NCT05927753|531581419|FG000|Overall Study|Withdrawal by Subject|0|||
147387690|NCT05927753|531581420|FG001|Overall Study|Withdrawal by Subject|2|||
147387691|NCT05927753|531581419|FG000|Overall Study|Physician Decision|0|||
147387692|NCT05927753|531581420|FG001|Overall Study|Physician Decision|1|||
147387693|NCT02011568|531581424|FG000|Overall Study|Withdrawal by Subject|8|||
147387694|NCT02011568|531581425|FG001|Overall Study|Withdrawal by Subject|10|||
147387695|NCT02011568|531581424|FG000|Overall Study|Physician Decision|1|||
147387696|NCT02011568|531581425|FG001|Overall Study|Physician Decision|3|||
147387697|NCT00396409|531581426|FG000|Period 1 - 2007|Adverse Event|0|||
147387698|NCT00396409|531581427|FG001|Period 1 - 2007|Adverse Event|1|||
147387699|NCT00396409|531581426|FG000|Period 1 - 2007|Lack of Efficacy|0|||
147387700|NCT00396409|531581427|FG001|Period 1 - 2007|Lack of Efficacy|1|||
147387701|NCT00396409|531581426|FG000|Period 1 - 2007|Withdrawal by Subject|1|||
147387702|NCT00396409|531581427|FG001|Period 1 - 2007|Withdrawal by Subject|1|||
147387703|NCT00396409|531581426|FG000|Period 1 - 2007|Lost to Follow-up|2|||
147387704|NCT00396409|531581427|FG001|Period 1 - 2007|Lost to Follow-up|3|||
147387705|NCT00396409|531581426|FG000|Between Period 1 and Period 2|Withdrawal by Subject|3|||
147387706|NCT00396409|531581427|FG001|Between Period 1 and Period 2|Withdrawal by Subject|2|||
147387707|NCT00396409|531581426|FG000|Period 2 - 2008|Protocol Violation|1|||
147387708|NCT00396409|531581427|FG001|Period 2 - 2008|Protocol Violation|0|||
147387709|NCT00396409|531581426|FG000|Period 2 - 2008|Withdrawal by Subject|3|||
147387710|NCT00396409|531581427|FG001|Period 2 - 2008|Withdrawal by Subject|1|||
147527360|NCT00682539|532084239|FG001|Ranibizumab vs Triamcinolone|Lost to Follow-up|3|||
147387711|NCT00396409|531581426|FG000|Period 2 - 2008|Lost to Follow-up|3|||
147387712|NCT00396409|531581427|FG001|Period 2 - 2008|Lost to Follow-up|1|||
147387713|NCT02069366|531581428|FG000|Overall Study|Lost to Follow-up|0|||
147387714|NCT02069366|531581429|FG001|Overall Study|Lost to Follow-up|0|||
147387715|NCT02069366|531581430|FG002|Overall Study|Lost to Follow-up|1|||
147387716|NCT02069366|531581431|FG003|Overall Study|Lost to Follow-up|0|||
147387717|NCT02069366|531581432|FG004|Overall Study|Lost to Follow-up|0|||
147387718|NCT02069366|531581433|FG005|Overall Study|Lost to Follow-up|2|||
147527361|NCT00682539|532084240|FG002|Ranibizumab vs Triamcinolone|Lost to Follow-up|8|||
147527362|NCT00508872|532084245|FG000|Overall Study|Lost to Follow-up|1|||
147615075|NCT03999996|532406587|FG000|Booster Phase|Withdrawal of Consent|0|||
147615076|NCT03999996|532406588|FG001|Booster Phase|Withdrawal of Consent|0|||
147615077|NCT03999996|532406589|FG002|Booster Phase|Withdrawal of Consent|0|||
147615078|NCT03999996|532406590|FG003|Booster Phase|Withdrawal of Consent|1|||
147615079|NCT03999996|532406587|FG000|Booster Phase|Reason Not Specified|0|||
147387719|NCT02069366|531581428|FG000|Overall Study|Protocol Violation|0|||
147387720|NCT02069366|531581429|FG001|Overall Study|Protocol Violation|0|||
147387721|NCT02069366|531581430|FG002|Overall Study|Protocol Violation|1|||
147387722|NCT02069366|531581431|FG003|Overall Study|Protocol Violation|0|||
147387723|NCT02069366|531581432|FG004|Overall Study|Protocol Violation|0|||
147387724|NCT02069366|531581433|FG005|Overall Study|Protocol Violation|0|||
147387725|NCT02069366|531581428|FG000|Overall Study|Withdrawal by Subject|1|||
147387726|NCT02069366|531581429|FG001|Overall Study|Withdrawal by Subject|0|||
147387727|NCT02069366|531581430|FG002|Overall Study|Withdrawal by Subject|1|||
147387728|NCT02069366|531581431|FG003|Overall Study|Withdrawal by Subject|2|||
147387729|NCT02069366|531581432|FG004|Overall Study|Withdrawal by Subject|0|||
147387730|NCT02069366|531581433|FG005|Overall Study|Withdrawal by Subject|0|||
147387731|NCT03314233|531581435|FG000|Overall Study|No longer eligible at time of delivery|1|||
147387732|NCT01797705|531581436|FG000|Overall Study|Equipment anomalies during sleep studies|4|||
147387733|NCT01797705|531581436|FG000|Overall Study|Withdrawal by Subject|1|||
147387734|NCT01838447|531581437|FG000|Overall Study|Change in surgical plan|1|||
147387735|NCT01838447|531581438|FG001|Overall Study|Change in surgical plan|2|||
147387736|NCT01838447|531581437|FG000|Overall Study|Withdrawal by Subject|1|||
147387737|NCT01838447|531581438|FG001|Overall Study|Withdrawal by Subject|1|||
147387738|NCT01114217|531581439|FG000|Overall Study|Adverse Event|5|||
147387739|NCT01114217|531581440|FG001|Overall Study|Adverse Event|3|||
147387740|NCT01114217|531581439|FG000|Overall Study|Lost to Follow-up|17|||
147387741|NCT01114217|531581440|FG001|Overall Study|Lost to Follow-up|33|||
147387742|NCT01114217|531581439|FG000|Overall Study|Withdrawal by Subject|21|||
147387743|NCT01114217|531581440|FG001|Overall Study|Withdrawal by Subject|28|||
147387744|NCT01114217|531581439|FG000|Overall Study|Other-Clerical Error|3|||
147387745|NCT01114217|531581440|FG001|Overall Study|Other-Clerical Error|0|||
147387746|NCT01114217|531581439|FG000|Overall Study|Other-Early termination|6|||
147387747|NCT01114217|531581440|FG001|Overall Study|Other-Early termination|10|||
147387748|NCT01114217|531581439|FG000|Overall Study|Other-Procedure|1|||
147387749|NCT01114217|531581440|FG001|Overall Study|Other-Procedure|1|||
147387750|NCT01114217|531581439|FG000|Overall Study|Other-Pregnancy|2|||
147387751|NCT01114217|531581440|FG001|Overall Study|Other-Pregnancy|4|||
147387752|NCT01114217|531581439|FG000|Overall Study|Other-Protocol Violation|1|||
147387753|NCT01114217|531581440|FG001|Overall Study|Other-Protocol Violation|3|||
147387754|NCT01114217|531581439|FG000|Overall Study|Other-Lack of Efficacy|1|||
147387755|NCT01114217|531581440|FG001|Overall Study|Other-Lack of Efficacy|0|||
147387756|NCT01114217|531581439|FG000|Overall Study|Other-Non Compliance|2|||
147387757|NCT01114217|531581440|FG001|Overall Study|Other-Non Compliance|0|||
147387758|NCT01114217|531581439|FG000|Overall Study|Other-Physician Decision|1|||
147387759|NCT01114217|531581440|FG001|Overall Study|Other-Physician Decision|1|||
147387760|NCT01114217|531581439|FG000|Overall Study|Other-Sponsor Decision|10|||
147387761|NCT01114217|531581440|FG001|Overall Study|Other-Sponsor Decision|12|||
147387762|NCT01114217|531581439|FG000|Overall Study|Other-Study Termination|0|||
147387763|NCT01114217|531581440|FG001|Overall Study|Other-Study Termination|1|||
147387764|NCT01114217|531581439|FG000|Overall Study|Other-Study Withdrawn|1|||
147387765|NCT01114217|531581440|FG001|Overall Study|Other-Study Withdrawn|1|||
147387766|NCT01114217|531581439|FG000|Overall Study|Other-Site Stopped Communicating|2|||
147387767|NCT01114217|531581440|FG001|Overall Study|Other-Site Stopped Communicating|0|||
147387768|NCT01114217|531581439|FG000|Overall Study|Other-Lost to Follow-up|1|||
147387769|NCT01114217|531581440|FG001|Overall Study|Other-Lost to Follow-up|0|||
147387770|NCT01114217|531581439|FG000|Overall Study|Other-Withdrawal by Subject|1|||
147387771|NCT01114217|531581440|FG001|Overall Study|Other-Withdrawal by Subject|1|||
147387772|NCT06247488|531581441|FG000|Washout From 2nd Dose (3 Days)|Withdrawal by Subject|1|||
147387773|NCT06247488|531581442|FG001|Washout From 2nd Dose (3 Days)|Withdrawal by Subject|0|||
147387774|NCT06247488|531581443|FG002|Washout From 2nd Dose (3 Days)|Withdrawal by Subject|0|||
147387775|NCT06247488|531581444|FG003|Washout From 2nd Dose (3 Days)|Withdrawal by Subject|0|||
147387776|NCT06247488|531581445|FG004|Washout From 2nd Dose (3 Days)|Withdrawal by Subject|0|||
147387777|NCT06247488|531581446|FG005|Washout From 2nd Dose (3 Days)|Withdrawal by Subject|0|||
147387778|NCT06247488|531581441|FG000|Washout From 2nd Dose (3 Days)|Physician Decision|0|||
147387779|NCT06247488|531581442|FG001|Washout From 2nd Dose (3 Days)|Physician Decision|0|||
147387780|NCT06247488|531581443|FG002|Washout From 2nd Dose (3 Days)|Physician Decision|0|||
147387781|NCT06247488|531581444|FG003|Washout From 2nd Dose (3 Days)|Physician Decision|1|||
147387782|NCT06247488|531581445|FG004|Washout From 2nd Dose (3 Days)|Physician Decision|0|||
147387783|NCT06247488|531581446|FG005|Washout From 2nd Dose (3 Days)|Physician Decision|0|||
147387784|NCT06247488|531581441|FG000|Washout of Third Dose (3 Days)|Withdrawal by Subject|1|||
147387785|NCT06247488|531581442|FG001|Washout of Third Dose (3 Days)|Withdrawal by Subject|0|||
147387786|NCT06247488|531581443|FG002|Washout of Third Dose (3 Days)|Withdrawal by Subject|0|||
147387787|NCT06247488|531581444|FG003|Washout of Third Dose (3 Days)|Withdrawal by Subject|0|||
147457464|NCT01928381|531835640|FG005|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
147457465|NCT01928381|531835641|FG006|Placebo run-in & Part 2 Eligibility|Eligibility for Part 2 not met|0|||
147457466|NCT01928381|531835635|FG000|Part 2 - First Intervention|Withdrawal by Subject|0|||
147457467|NCT01928381|531835636|FG001|Part 2 - First Intervention|Withdrawal by Subject|0|||
147457468|NCT01928381|531835637|FG002|Part 2 - First Intervention|Withdrawal by Subject|1|||
147457469|NCT01928381|531835638|FG003|Part 2 - First Intervention|Withdrawal by Subject|0|||
147457470|NCT01928381|531835639|FG004|Part 2 - First Intervention|Withdrawal by Subject|0|||
147457471|NCT01928381|531835640|FG005|Part 2 - First Intervention|Withdrawal by Subject|0|||
147457472|NCT01928381|531835641|FG006|Part 2 - First Intervention|Withdrawal by Subject|0|||
147457473|NCT01928381|531835635|FG000|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
147457474|NCT01928381|531835636|FG001|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
147457475|NCT01928381|531835637|FG002|Part 2 - First Intervention|Study specific withdrawal criteria|1|||
147457476|NCT01928381|531835638|FG003|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
147457477|NCT01928381|531835639|FG004|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
147457478|NCT01928381|531835640|FG005|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
147457479|NCT01928381|531835641|FG006|Part 2 - First Intervention|Study specific withdrawal criteria|0|||
147457480|NCT01928381|531835635|FG000|Part 2 - First Intervention|Eligibility criterion not met|0|||
147457481|NCT01928381|531835636|FG001|Part 2 - First Intervention|Eligibility criterion not met|0|||
147457482|NCT01928381|531835637|FG002|Part 2 - First Intervention|Eligibility criterion not met|0|||
147457483|NCT01928381|531835638|FG003|Part 2 - First Intervention|Eligibility criterion not met|0|||
147457484|NCT01928381|531835639|FG004|Part 2 - First Intervention|Eligibility criterion not met|0|||
147457485|NCT01928381|531835640|FG005|Part 2 - First Intervention|Eligibility criterion not met|1|||
147457486|NCT01928381|531835641|FG006|Part 2 - First Intervention|Eligibility criterion not met|1|||
147457487|NCT01928381|531835635|FG000|Part 2 - First Intervention|Lost to Follow-up|0|||
147457488|NCT01928381|531835636|FG001|Part 2 - First Intervention|Lost to Follow-up|0|||
147457489|NCT01928381|531835637|FG002|Part 2 - First Intervention|Lost to Follow-up|0|||
147457490|NCT01928381|531835638|FG003|Part 2 - First Intervention|Lost to Follow-up|1|||
147457491|NCT01928381|531835639|FG004|Part 2 - First Intervention|Lost to Follow-up|0|||
147457492|NCT01928381|531835640|FG005|Part 2 - First Intervention|Lost to Follow-up|0|||
147457493|NCT01928381|531835641|FG006|Part 2 - First Intervention|Lost to Follow-up|0|||
147457494|NCT01928381|531835635|FG000|Washout First Intervention|Protocol Violation|0|||
147457495|NCT01928381|531835636|FG001|Washout First Intervention|Protocol Violation|0|||
147457496|NCT01928381|531835637|FG002|Washout First Intervention|Protocol Violation|0|||
147457497|NCT01928381|531835638|FG003|Washout First Intervention|Protocol Violation|0|||
147457498|NCT01928381|531835639|FG004|Washout First Intervention|Protocol Violation|1|||
147457499|NCT01928381|531835640|FG005|Washout First Intervention|Protocol Violation|0|||
147457500|NCT01928381|531835641|FG006|Washout First Intervention|Protocol Violation|0|||
147457501|NCT01928381|531835635|FG000|Part 2 - Second Intervention|Lost to Follow-up|0|||
147457502|NCT01928381|531835636|FG001|Part 2 - Second Intervention|Lost to Follow-up|1|||
147457503|NCT01928381|531835637|FG002|Part 2 - Second Intervention|Lost to Follow-up|0|||
147457504|NCT01928381|531835638|FG003|Part 2 - Second Intervention|Lost to Follow-up|1|||
147457505|NCT01928381|531835639|FG004|Part 2 - Second Intervention|Lost to Follow-up|0|||
147457506|NCT01928381|531835640|FG005|Part 2 - Second Intervention|Lost to Follow-up|0|||
147457507|NCT01928381|531835641|FG006|Part 2 - Second Intervention|Lost to Follow-up|0|||
147457508|NCT01928381|531835635|FG000|Part 2 - Post Third Intervention|Protocol Violation|0|||
147457509|NCT01928381|531835636|FG001|Part 2 - Post Third Intervention|Protocol Violation|0|||
147457510|NCT01928381|531835637|FG002|Part 2 - Post Third Intervention|Protocol Violation|1|||
147457511|NCT01928381|531835638|FG003|Part 2 - Post Third Intervention|Protocol Violation|0|||
147457512|NCT01928381|531835639|FG004|Part 2 - Post Third Intervention|Protocol Violation|0|||
147457513|NCT01928381|531835640|FG005|Part 2 - Post Third Intervention|Protocol Violation|0|||
147457514|NCT01928381|531835641|FG006|Part 2 - Post Third Intervention|Protocol Violation|0|||
147457515|NCT01877083|531835642|FG000|Treatment Phase|Disease Progression|10|||
147457516|NCT01877083|531835642|FG000|Treatment Phase|Clinical Progression|1|||
147457517|NCT01877083|531835642|FG000|Treatment Phase|Adverse Event|6|||
147457518|NCT01877083|531835642|FG000|Treatment Phase|Withdrawal by Subject|2|||
147457519|NCT01877083|531835642|FG000|Treatment Phase|Lost to Follow-up|1|||
147457520|NCT01877083|531835642|FG000|Extension Phase|Disease Progression|3|||
147457521|NCT01877083|531835642|FG000|Extension Phase|Adverse Event|2|||
147457522|NCT00429585|531835645|FG000|Overall Study|Death|1|||
147457523|NCT00429585|531835646|FG001|Overall Study|Death|0|||
147457524|NCT00429585|531835645|FG000|Overall Study|Lost to Follow-up|27|||
147457525|NCT00429585|531835646|FG001|Overall Study|Lost to Follow-up|20|||
147457526|NCT00429585|531835645|FG000|Overall Study|Physician Decision|2|||
147457527|NCT00429585|531835646|FG001|Overall Study|Physician Decision|0|||
147457528|NCT01582308|531835647|FG000|Period 1|Withdrawal by Subject|0|||
147457529|NCT01582308|531835648|FG001|Period 1|Withdrawal by Subject|0|||
147457530|NCT01582308|531835649|FG002|Period 1|Withdrawal by Subject|0|||
147457531|NCT01582308|531835650|FG003|Period 1|Withdrawal by Subject|0|||
147457532|NCT01582308|531835651|FG004|Period 1|Withdrawal by Subject|0|||
147457533|NCT01582308|531835652|FG005|Period 1|Withdrawal by Subject|0|||
147615080|NCT03999996|532406588|FG001|Booster Phase|Reason Not Specified|0|||
147615081|NCT03999996|532406589|FG002|Booster Phase|Reason Not Specified|0|||
147387788|NCT06247488|531581445|FG004|Washout of Third Dose (3 Days)|Withdrawal by Subject|0|||
147387789|NCT06247488|531581446|FG005|Washout of Third Dose (3 Days)|Withdrawal by Subject|0|||
147387790|NCT06247488|531581441|FG000|Washout of Fourth Dose (3 Days)|Physician Decision|0|||
147387791|NCT06247488|531581442|FG001|Washout of Fourth Dose (3 Days)|Physician Decision|0|||
147387792|NCT06247488|531581443|FG002|Washout of Fourth Dose (3 Days)|Physician Decision|0|||
147387793|NCT06247488|531581444|FG003|Washout of Fourth Dose (3 Days)|Physician Decision|1|||
147387794|NCT06247488|531581445|FG004|Washout of Fourth Dose (3 Days)|Physician Decision|0|||
147387795|NCT06247488|531581446|FG005|Washout of Fourth Dose (3 Days)|Physician Decision|0|||
147387796|NCT06247488|531581441|FG000|Washout of 5th Dose (3 Days)|Pregnancy|0|||
147387797|NCT06247488|531581442|FG001|Washout of 5th Dose (3 Days)|Pregnancy|0|||
147387798|NCT06247488|531581443|FG002|Washout of 5th Dose (3 Days)|Pregnancy|0|||
147387799|NCT06247488|531581444|FG003|Washout of 5th Dose (3 Days)|Pregnancy|0|||
147387800|NCT06247488|531581445|FG004|Washout of 5th Dose (3 Days)|Pregnancy|0|||
147387801|NCT06247488|531581446|FG005|Washout of 5th Dose (3 Days)|Pregnancy|1|||
147387802|NCT06247488|531581441|FG000|Washout of 5th Dose (3 Days)|Withdrawal by Subject|0|||
147387803|NCT06247488|531581442|FG001|Washout of 5th Dose (3 Days)|Withdrawal by Subject|1|||
147387804|NCT06247488|531581443|FG002|Washout of 5th Dose (3 Days)|Withdrawal by Subject|1|||
147387805|NCT06247488|531581444|FG003|Washout of 5th Dose (3 Days)|Withdrawal by Subject|0|||
147387806|NCT06247488|531581445|FG004|Washout of 5th Dose (3 Days)|Withdrawal by Subject|0|||
147387807|NCT06247488|531581446|FG005|Washout of 5th Dose (3 Days)|Withdrawal by Subject|1|||
147387808|NCT06247488|531581441|FG000|Washout of 5th Dose (3 Days)|Adverse Event|0|||
147387809|NCT06247488|531581442|FG001|Washout of 5th Dose (3 Days)|Adverse Event|0|||
147387810|NCT06247488|531581443|FG002|Washout of 5th Dose (3 Days)|Adverse Event|0|||
147387811|NCT06247488|531581444|FG003|Washout of 5th Dose (3 Days)|Adverse Event|0|||
147387812|NCT06247488|531581445|FG004|Washout of 5th Dose (3 Days)|Adverse Event|0|||
147387813|NCT06247488|531581446|FG005|Washout of 5th Dose (3 Days)|Adverse Event|1|||
147387814|NCT03785210|531581449|FG000|Overall Study|Principal investigator decision - clinical progression|1|||
147387815|NCT03785210|531581450|FG001|Overall Study|Principal investigator decision - clinical progression|6|||
147387816|NCT00460434|531581451|FG000|Overall Study|Lost to Follow-up|3|||
147387817|NCT00460434|531581452|FG001|Overall Study|Lost to Follow-up|7|||
147387818|NCT02722278|531581453|FG000|Overall Study|Withdrawal by Subject|5|||
147387819|NCT02722278|531581454|FG001|Overall Study|Withdrawal by Subject|3|||
147387820|NCT02722278|531581453|FG000|Overall Study|Adverse Event|4|||
147387821|NCT02722278|531581454|FG001|Overall Study|Adverse Event|1|||
147387822|NCT02722278|531581453|FG000|Overall Study|Lost to Follow-up|2|||
147387823|NCT02722278|531581454|FG001|Overall Study|Lost to Follow-up|0|||
147387824|NCT02722278|531581453|FG000|Overall Study|Protocol Violation|1|||
147387825|NCT02722278|531581454|FG001|Overall Study|Protocol Violation|0|||
147387826|NCT02722278|531581453|FG000|Overall Study|High PSA pre-study/ not eligible|0|||
147387827|NCT02722278|531581454|FG001|Overall Study|High PSA pre-study/ not eligible|1|||
147387828|NCT02722278|531581453|FG000|Overall Study|Subject declined after tx assignment|0|||
147387829|NCT02722278|531581454|FG001|Overall Study|Subject declined after tx assignment|1|||
147387830|NCT02722278|531581453|FG000|Overall Study|Site closure not study related|0|||
147387831|NCT02722278|531581454|FG001|Overall Study|Site closure not study related|1|||
147387832|NCT00561678|531581455|FG000|Overall Study|Withdrawal by Subject|4|||
147387833|NCT00561678|531581456|FG001|Overall Study|Withdrawal by Subject|3|||
147387834|NCT00561678|531581455|FG000|Overall Study|surgery cancelled|1|||
147387835|NCT00561678|531581456|FG001|Overall Study|surgery cancelled|1|||
147387836|NCT00561678|531581455|FG000|Overall Study|surgery rescheduled to different site|2|||
147387837|NCT00561678|531581456|FG001|Overall Study|surgery rescheduled to different site|2|||
147387838|NCT00561678|531581455|FG000|Overall Study|anesthesia provider refusal|1|||
147387839|NCT00561678|531581456|FG001|Overall Study|anesthesia provider refusal|0|||
147387840|NCT03708744|531581457|FG000|Overall Study|Withdrawal by Subject|0|||
147387841|NCT03708744|531581458|FG001|Overall Study|Withdrawal by Subject|0|||
147387842|NCT03708744|531581459|FG002|Overall Study|Withdrawal by Subject|1|||
147387843|NCT03708744|531581460|FG003|Overall Study|Withdrawal by Subject|0|||
147387844|NCT00460577|531581461|FG000|Overall Study|Protocol Violation|2|||
147387845|NCT00460577|531581462|FG001|Overall Study|Protocol Violation|6|||
147387846|NCT04043806|531581463|FG000|Overall Study|Commercial drug is available for participants|13|||
147387847|NCT04043806|531581463|FG000|Overall Study|Physician Decision|2|||
147387848|NCT04043806|531581463|FG000|Overall Study|Other|12|||
147387849|NCT04043806|531581463|FG000|Overall Study|Adverse Event|2|||
147387850|NCT04043806|531581463|FG000|Overall Study|Lost to Follow-up|6|||
147387851|NCT04043806|531581463|FG000|Overall Study|Other non-compliance|2|||
147387852|NCT04043806|531581463|FG000|Overall Study|Withdrawal of Consent (not due to AE)|8|||
147387853|NCT04043806|531581463|FG000|Overall Study|Never Dosed|1|||
147387854|NCT01622088|531581466|FG000|Overall Study|Adverse Event|20|||
147387855|NCT01622088|531581466|FG000|Overall Study|Lost to Follow-up|1|||
147387856|NCT01622088|531581466|FG000|Overall Study|Withdrawal by Subject|20|||
147387857|NCT01622088|531581466|FG000|Overall Study|Investigator Decision|1|||
147387858|NCT01622088|531581466|FG000|Overall Study|Death|53|||
147387859|NCT01622088|531581466|FG000|Overall Study|STUDY TERMINATED EARLY BY SPONSOR|521|||
147387860|NCT03166215|531581471|FG000|Part 1 (Double-blind TP: Days 1 - 30)|Adverse Event|0|||
147387861|NCT03166215|531581472|FG001|Part 1 (Double-blind TP: Days 1 - 30)|Adverse Event|2|||
147387862|NCT03166215|531581473|FG002|Part 1 (Double-blind TP: Days 1 - 30)|Adverse Event|0|||
147387863|NCT03166215|531581471|FG000|Part 2 (Open-Label TP: Days 31 - 85)|Adverse Event|0|||
147387864|NCT03166215|531581472|FG001|Part 2 (Open-Label TP: Days 31 - 85)|Adverse Event|0|||
147387865|NCT03166215|531581473|FG002|Part 2 (Open-Label TP: Days 31 - 85)|Adverse Event|2|||
147387866|NCT04362176|531581476|FG000|Overall Study|Lost to Follow-up|5|||
147387867|NCT04362176|531581477|FG001|Overall Study|Lost to Follow-up|8|||
147387868|NCT04362176|531581476|FG000|Overall Study|Withdrawn (Participant/PI withdrew consent)|8|||
147387869|NCT04362176|531581477|FG001|Overall Study|Withdrawn (Participant/PI withdrew consent)|6|||
147387870|NCT00658632|531581479|FG000|Overall Study|Adverse Event|13|||
147387871|NCT00658632|531581480|FG001|Overall Study|Adverse Event|11|||
147387872|NCT00658632|531581479|FG000|Overall Study|Lost to Follow-up|25|||
147387873|NCT00658632|531581480|FG001|Overall Study|Lost to Follow-up|23|||
147387874|NCT00658632|531581479|FG000|Overall Study|Withdrawal by Subject|10|||
147387875|NCT00658632|531581480|FG001|Overall Study|Withdrawal by Subject|7|||
147387876|NCT00658632|531581479|FG000|Overall Study|Lack of Efficacy|0|||
147387877|NCT00658632|531581480|FG001|Overall Study|Lack of Efficacy|1|||
147387878|NCT00658632|531581479|FG000|Overall Study|Withdrawal of consent|8|||
147387879|NCT00658632|531581480|FG001|Overall Study|Withdrawal of consent|14|||
147387880|NCT00658632|531581479|FG000|Overall Study|Pregnancy|1|||
147387881|NCT00658632|531581480|FG001|Overall Study|Pregnancy|1|||
147387882|NCT00658632|531581479|FG000|Overall Study|Other|7|||
147387883|NCT00658632|531581480|FG001|Overall Study|Other|8|||
147387884|NCT04551053|531581484|FG000|Overall Study|Death|10|||
147387885|NCT04551053|531581485|FG001|Overall Study|Death|9|||
147387886|NCT04551053|531581484|FG000|Overall Study|Lost to Follow-up|0|||
147387887|NCT04551053|531581485|FG001|Overall Study|Lost to Follow-up|2|||
147387888|NCT04551053|531581484|FG000|Overall Study|Study Terminated by Sponsor|57|||
147387889|NCT04551053|531581485|FG001|Overall Study|Study Terminated by Sponsor|65|||
147387890|NCT04551053|531581484|FG000|Overall Study|Withdrawal by Subject|12|||
147387891|NCT04551053|531581485|FG001|Overall Study|Withdrawal by Subject|5|||
147387892|NCT04551053|531581484|FG000|Overall Study|Adverse Event|2|||
147387893|NCT04551053|531581485|FG001|Overall Study|Adverse Event|0|||
147387894|NCT04551053|531581484|FG000|Overall Study|Lack of Efficacy|2|||
147387895|NCT04551053|531581485|FG001|Overall Study|Lack of Efficacy|1|||
147387896|NCT04551053|531581484|FG000|Overall Study|Transitioned to Rollover per Protocol|5|||
147387897|NCT04551053|531581485|FG001|Overall Study|Transitioned to Rollover per Protocol|4|||
147387898|NCT04551053|531581484|FG000|Overall Study|Splenapendectomi|1|||
147387899|NCT04551053|531581485|FG001|Overall Study|Splenapendectomi|0|||
147387900|NCT04551053|531581484|FG000|Overall Study|Medical Decision|1|||
147387901|NCT04551053|531581485|FG001|Overall Study|Medical Decision|1|||
147387902|NCT02971683|531581486|FG000|Double-Blind (24 Weeks)|Other reasons|0|||
147387903|NCT02971683|531581487|FG001|Double-Blind (24 Weeks)|Other reasons|1|||
147387904|NCT02971683|531581486|FG000|Double-Blind (24 Weeks)|Poor/Non-Compliance|0|||
147387905|NCT02971683|531581487|FG001|Double-Blind (24 Weeks)|Poor/Non-Compliance|1|||
147387906|NCT02971683|531581486|FG000|Double-Blind (24 Weeks)|Lost to Follow-up|1|||
147387907|NCT02971683|531581487|FG001|Double-Blind (24 Weeks)|Lost to Follow-up|0|||
147387908|NCT02971683|531581486|FG000|Double-Blind (24 Weeks)|Participant withdrew consent|1|||
147387909|NCT02971683|531581487|FG001|Double-Blind (24 Weeks)|Participant withdrew consent|1|||
147387910|NCT02971683|531581486|FG000|Double-Blind (24 Weeks)|Participant request to discontinue study treatment|1|||
147457534|NCT01582308|531835653|FG006|Period 1|Withdrawal by Subject|1|||
147457535|NCT01582308|531835654|FG007|Period 1|Withdrawal by Subject|0|||
147457536|NCT01582308|531835655|FG008|Period 1|Withdrawal by Subject|0|||
147457537|NCT01582308|531835656|FG009|Period 1|Withdrawal by Subject|0|||
147457538|NCT01582308|531835647|FG000|10-day Washout Following Period 1|Physician Decision|0|||
147457539|NCT01582308|531835648|FG001|10-day Washout Following Period 1|Physician Decision|0|||
147387911|NCT02971683|531581487|FG001|Double-Blind (24 Weeks)|Participant request to discontinue study treatment|1|||
147387912|NCT02971683|531581486|FG000|Double-Blind (24 Weeks)|Adverse Event|0|||
147387913|NCT02971683|531581487|FG001|Double-Blind (24 Weeks)|Adverse Event|2|||
147387914|NCT02971683|531581486|FG000|Double-Blind (24 Weeks)|Lack of Efficacy|2|||
147387915|NCT02971683|531581487|FG001|Double-Blind (24 Weeks)|Lack of Efficacy|2|||
147387916|NCT02971683|531581486|FG000|Double-Blind (24 Weeks)|Participant no longer meets study criteria|1|||
147387917|NCT02971683|531581487|FG001|Double-Blind (24 Weeks)|Participant no longer meets study criteria|0|||
147387918|NCT02971683|531581486|FG000|Open-Label|Lost to Follow-up|1|||
147387919|NCT02971683|531581487|FG001|Open-Label|Lost to Follow-up|0|||
147387920|NCT02971683|531581486|FG000|Open-Label|Participants withdrew consent|0|||
147387921|NCT02971683|531581487|FG001|Open-Label|Participants withdrew consent|2|||
147387922|NCT02971683|531581486|FG000|Open-Label|Participant request to discontinue study treatment|1|||
147387923|NCT02971683|531581487|FG001|Open-Label|Participant request to discontinue study treatment|0|||
147457540|NCT01582308|531835649|FG002|10-day Washout Following Period 1|Physician Decision|0|||
147457541|NCT01582308|531835650|FG003|10-day Washout Following Period 1|Physician Decision|0|||
147457542|NCT01582308|531835651|FG004|10-day Washout Following Period 1|Physician Decision|1|||
147457543|NCT01582308|531835652|FG005|10-day Washout Following Period 1|Physician Decision|0|||
147457544|NCT01582308|531835653|FG006|10-day Washout Following Period 1|Physician Decision|0|||
147457545|NCT01582308|531835654|FG007|10-day Washout Following Period 1|Physician Decision|0|||
147457546|NCT01582308|531835655|FG008|10-day Washout Following Period 1|Physician Decision|0|||
147457547|NCT01582308|531835656|FG009|10-day Washout Following Period 1|Physician Decision|0|||
147457548|NCT01582308|531835647|FG000|Period 4|Physician Decision|1|||
147457549|NCT01582308|531835648|FG001|Period 4|Physician Decision|0|||
147457550|NCT01582308|531835649|FG002|Period 4|Physician Decision|0|||
147457551|NCT01582308|531835650|FG003|Period 4|Physician Decision|0|||
147457552|NCT01582308|531835651|FG004|Period 4|Physician Decision|0|||
147457553|NCT01582308|531835652|FG005|Period 4|Physician Decision|1|||
147457554|NCT01582308|531835653|FG006|Period 4|Physician Decision|0|||
147457555|NCT01582308|531835654|FG007|Period 4|Physician Decision|0|||
147457556|NCT01582308|531835655|FG008|Period 4|Physician Decision|0|||
147457557|NCT01582308|531835656|FG009|Period 4|Physician Decision|1|||
147457558|NCT00772668|531835664|FG000|Overall Study|Physician Decision|3|||
147457559|NCT03631706|531835665|FG000|Overall Study|Randomized, not treated|1|||
147457560|NCT03631706|531835666|FG001|Overall Study|Randomized, not treated|0|||
147457561|NCT01844986|531835667|FG000|Overall Study (Global Cohort)|Severe non-compliance to protocol|1|||
147457562|NCT01844986|531835668|FG001|Overall Study (Global Cohort)|Severe non-compliance to protocol|0|||
147457563|NCT01844986|531835667|FG000|Overall Study (Global Cohort)|Withdrawal by Subject|21|||
147457564|NCT01844986|531835668|FG001|Overall Study (Global Cohort)|Withdrawal by Subject|14|||
147457565|NCT01844986|531835667|FG000|Overall Study (Global Cohort)|Death|55|||
147457566|NCT01844986|531835668|FG001|Overall Study (Global Cohort)|Death|26|||
147457567|NCT01844986|531835667|FG000|Overall Study (China Cohort)|Withdrawal by Subject|1|||
147457568|NCT01844986|531835668|FG001|Overall Study (China Cohort)|Withdrawal by Subject|0|||
147457569|NCT01844986|531835667|FG000|Overall Study (China Cohort)|Death|10|||
147457570|NCT01844986|531835668|FG001|Overall Study (China Cohort)|Death|6|||
147457571|NCT03406897|531835670|FG000|Overall Study|Lost to Follow-up|1|||
147457572|NCT03406897|531835671|FG001|Overall Study|Lost to Follow-up|2|||
147457573|NCT03406897|531835670|FG000|Overall Study|Withdrawal by Subject|4|||
147457574|NCT03406897|531835671|FG001|Overall Study|Withdrawal by Subject|4|||
147457575|NCT03406897|531835670|FG000|Overall Study|Physician Decision|0|||
147457576|NCT03406897|531835671|FG001|Overall Study|Physician Decision|1|||
147457577|NCT01299766|531837643|FG000|Overall Study|Death|5|||
147457578|NCT01299766|531837644|FG001|Overall Study|Death|4|||
147457579|NCT01299766|531837643|FG000|Overall Study|Withdrawal by Subject|29|||
147457580|NCT01299766|531837644|FG001|Overall Study|Withdrawal by Subject|19|||
147457581|NCT03472560|531837652|FG000|Overall Study|Subject transfer to continuation protocol|0|||
147457582|NCT03472560|531837653|FG001|Overall Study|Subject transfer to continuation protocol|1|||
147457583|NCT03472560|531837652|FG000|Overall Study|Withdrawal by Subject|4|||
147457584|NCT03472560|531837653|FG001|Overall Study|Withdrawal by Subject|0|||
147457585|NCT03472560|531837652|FG000|Overall Study|Progressive disease|24|||
147457586|NCT03472560|531837653|FG001|Overall Study|Progressive disease|8|||
147457587|NCT03472560|531837652|FG000|Overall Study|Physician Decision|1|||
147457588|NCT03472560|531837653|FG001|Overall Study|Physician Decision|0|||
147457589|NCT03472560|531837652|FG000|Overall Study|Death|7|||
147457590|NCT03472560|531837653|FG001|Overall Study|Death|4|||
147457591|NCT03472560|531837652|FG000|Overall Study|Adverse Event|5|||
147457592|NCT03472560|531837653|FG001|Overall Study|Adverse Event|3|||
147457593|NCT03472560|531837652|FG000|Overall Study|Global deterioration of health status|0|||
147457594|NCT03472560|531837653|FG001|Overall Study|Global deterioration of health status|4|||
147457595|NCT01946178|531837654|FG000|Overall Study|Pregnancy|1|||
147457596|NCT01946178|531837654|FG000|Overall Study|Lost to Follow-up|1|||
147457597|NCT02494596|531837657|FG000|Overall Study|Insufficient Therapeutic Response|3|||
147457598|NCT02494596|531837658|FG001|Overall Study|Insufficient Therapeutic Response|3|||
147457599|NCT02494596|531837659|FG002|Overall Study|Insufficient Therapeutic Response|1|||
147457600|NCT02494596|531837657|FG000|Overall Study|Adverse Event|0|||
147457601|NCT02494596|531837658|FG001|Overall Study|Adverse Event|1|||
147457602|NCT02494596|531837659|FG002|Overall Study|Adverse Event|0|||
147457603|NCT02494596|531837657|FG000|Overall Study|Refused Treatment|0|||
147457604|NCT02494596|531837658|FG001|Overall Study|Refused Treatment|1|||
147457605|NCT02494596|531837659|FG002|Overall Study|Refused Treatment|0|||
147457606|NCT02222714|531837660|FG000|Overall Study|Death|0|||
147457607|NCT02222714|531837661|FG001|Overall Study|Death|2|||
147457608|NCT02222714|531837662|FG002|Overall Study|Death|3|||
147615082|NCT03999996|532406590|FG003|Booster Phase|Reason Not Specified|1|||
147457609|NCT02222714|531837663|FG003|Overall Study|Death|4|||
147457610|NCT02222714|531837664|FG004|Overall Study|Death|6|||
147457611|NCT02222714|531837660|FG000|Overall Study|Withdrawal by Subject|0|||
147457612|NCT02222714|531837661|FG001|Overall Study|Withdrawal by Subject|0|||
147457613|NCT02222714|531837662|FG002|Overall Study|Withdrawal by Subject|1|||
147457614|NCT02222714|531837663|FG003|Overall Study|Withdrawal by Subject|0|||
147457615|NCT02222714|531837664|FG004|Overall Study|Withdrawal by Subject|1|||
147457616|NCT01537211|531837667|FG000|Overall Study|Lost to Follow-up|0|||
147457617|NCT01537211|531837668|FG001|Overall Study|Lost to Follow-up|1|||
147457618|NCT00343512|531837676|FG000|Overall Study|Withdrawal by Subject|2|||
147457619|NCT00323557|531837677|FG000|Overall Study|Physician Decision|1|||
147457620|NCT00323557|531837678|FG001|Overall Study|Physician Decision|0|||
147457621|NCT00197054|531837679|FG000|Overall Study|Withdrawal by Subject|9|||
147457622|NCT00197054|531837680|FG001|Overall Study|Withdrawal by Subject|3|||
147457623|NCT00197054|531837681|FG002|Overall Study|Withdrawal by Subject|3|||
147457624|NCT00197054|531837679|FG000|Overall Study|Moved from area|7|||
147457625|NCT00197054|531837680|FG001|Overall Study|Moved from area|14|||
147457626|NCT00197054|531837681|FG002|Overall Study|Moved from area|9|||
147457627|NCT00197054|531837679|FG000|Overall Study|Lost to Follow-up|1|||
147457628|NCT00197054|531837680|FG001|Overall Study|Lost to Follow-up|4|||
147457629|NCT00197054|531837681|FG002|Overall Study|Lost to Follow-up|0|||
147457630|NCT00684515|531837682|FG000|Overall Study|Adverse Event|3|||
147457631|NCT00684515|531837683|FG001|Overall Study|Adverse Event|3|||
147457632|NCT00684515|531837684|FG002|Overall Study|Adverse Event|1|||
147457633|NCT00684515|531837682|FG000|Overall Study|Protocol-Defined Clinical Event|1|||
147457634|NCT00684515|531837683|FG001|Overall Study|Protocol-Defined Clinical Event|0|||
147457635|NCT00684515|531837684|FG002|Overall Study|Protocol-Defined Clinical Event|0|||
147457636|NCT02450578|531837685|FG000|Overall Study|ECG abnormality so not treated|1|||
147457637|NCT02450578|531837686|FG001|Overall Study|ECG abnormality so not treated|0|||
147457638|NCT02450578|531837687|FG002|Overall Study|ECG abnormality so not treated|0|||
147457639|NCT02450578|531837688|FG003|Overall Study|ECG abnormality so not treated|0|||
147457640|NCT04428411|531837689|FG000|Overall Study|Lost to Follow-up|114|||
147457641|NCT02918019|531837690|FG000|Overall Study|Death|0|||
147457642|NCT02918019|531837691|FG001|Overall Study|Death|0|||
147457643|NCT02918019|531837692|FG002|Overall Study|Death|1|||
147457644|NCT02918019|531837693|FG003|Overall Study|Death|0|||
147457645|NCT02918019|531837690|FG000|Overall Study|Lost to Follow-up|1|||
147457646|NCT02918019|531837691|FG001|Overall Study|Lost to Follow-up|1|||
147457647|NCT02918019|531837692|FG002|Overall Study|Lost to Follow-up|0|||
147457648|NCT02918019|531837693|FG003|Overall Study|Lost to Follow-up|1|||
147457649|NCT02918019|531837690|FG000|Overall Study|Principal investigator request|0|||
147457650|NCT02918019|531837691|FG001|Overall Study|Principal investigator request|0|||
147457651|NCT02918019|531837692|FG002|Overall Study|Principal investigator request|0|||
147457652|NCT02918019|531837693|FG003|Overall Study|Principal investigator request|1|||
147457653|NCT02918019|531837690|FG000|Overall Study|Physician Decision|1|||
147457654|NCT02918019|531837691|FG001|Overall Study|Physician Decision|3|||
147457655|NCT02918019|531837692|FG002|Overall Study|Physician Decision|2|||
147457656|NCT02918019|531837693|FG003|Overall Study|Physician Decision|0|||
147457657|NCT02918019|531837690|FG000|Overall Study|Protocol deviation|1|||
147457658|NCT02918019|531837691|FG001|Overall Study|Protocol deviation|1|||
147457659|NCT02918019|531837692|FG002|Overall Study|Protocol deviation|0|||
147457660|NCT02918019|531837693|FG003|Overall Study|Protocol deviation|2|||
147457661|NCT02918019|531837690|FG000|Overall Study|Withdrawal by Subject|3|||
147457662|NCT02918019|531837691|FG001|Overall Study|Withdrawal by Subject|4|||
147457663|NCT02918019|531837692|FG002|Overall Study|Withdrawal by Subject|6|||
147457664|NCT02918019|531837693|FG003|Overall Study|Withdrawal by Subject|4|||
147457665|NCT02918019|531837690|FG000|Overall Study|Adverse Event|0|||
147457666|NCT02918019|531837691|FG001|Overall Study|Adverse Event|1|||
147457667|NCT02918019|531837692|FG002|Overall Study|Adverse Event|0|||
147457668|NCT02918019|531837693|FG003|Overall Study|Adverse Event|1|||
147457669|NCT00662792|531837694|FG000|Period 1|Personal Reasons|0|||
147457670|NCT00662792|531837695|FG001|Period 1|Personal Reasons|0|||
147457671|NCT00662792|531837696|FG002|Period 1|Personal Reasons|1|||
147457672|NCT00662792|531837697|FG003|Period 1|Personal Reasons|0|||
147457673|NCT00662792|531837694|FG000|Period 1|Refused continuing medication|0|||
147457674|NCT00662792|531837695|FG001|Period 1|Refused continuing medication|1|||
147457675|NCT00662792|531837696|FG002|Period 1|Refused continuing medication|1|||
147615083|NCT03690388|532406591|FG000|Overall Study|Adverse Event|8|||
147615084|NCT03690388|532406592|FG001|Overall Study|Adverse Event|1|||
147615085|NCT03690388|532406591|FG000|Overall Study|Radiographic Progression|14|||
147615086|NCT03690388|532406592|FG001|Overall Study|Radiographic Progression|29|||
147615087|NCT03690388|532406591|FG000|Overall Study|Clinical deterioration|10|||
147615088|NCT03690388|532406592|FG001|Overall Study|Clinical deterioration|6|||
147615089|NCT03690388|532406591|FG000|Overall Study|Withdrawal by Subject|2|||
147457676|NCT00662792|531837697|FG003|Period 1|Refused continuing medication|0|||
147457677|NCT00662792|531837694|FG000|Period 1|Lost to Follow-up|1|||
147457678|NCT00662792|531837695|FG001|Period 1|Lost to Follow-up|0|||
147457679|NCT00662792|531837696|FG002|Period 1|Lost to Follow-up|0|||
147457680|NCT00662792|531837697|FG003|Period 1|Lost to Follow-up|0|||
147457681|NCT00662792|531837694|FG000|Period 1|Other adverse event (AE)|0|||
147457682|NCT00662792|531837695|FG001|Period 1|Other adverse event (AE)|2|||
147457683|NCT00662792|531837696|FG002|Period 1|Other adverse event (AE)|0|||
147457684|NCT00662792|531837697|FG003|Period 1|Other adverse event (AE)|0|||
147457685|NCT00662792|531837694|FG000|Period 1|Worsening of disease under study (AE)|1|||
147615090|NCT03690388|532406592|FG001|Overall Study|Withdrawal by Subject|0|||
147457686|NCT00662792|531837695|FG001|Period 1|Worsening of disease under study (AE)|3|||
147664943|NCT04161391|532597968|FG004|Overall Study|Death|0|||
147664944|NCT04161391|532597969|FG005|Overall Study|Death|0|||
147664945|NCT04161391|532597970|FG006|Overall Study|Death|0|||
147664946|NCT04161391|532597971|FG007|Overall Study|Death|1|||
147664947|NCT04161391|532597972|FG008|Overall Study|Death|0|||
147387924|NCT02971683|531581486|FG000|Open-Label|Lack of Efficacy|2|||
147387925|NCT02971683|531581487|FG001|Open-Label|Lack of Efficacy|0|||
147387926|NCT02971683|531581486|FG000|Long-Term Open Label|Administrative reason by sponsor|20|||
147387927|NCT02971683|531581487|FG001|Long-Term Open Label|Administrative reason by sponsor|17|||
147387928|NCT02971683|531581486|FG000|Long-Term Open Label|Participant withdrew consent|1|||
147387929|NCT02971683|531581487|FG001|Long-Term Open Label|Participant withdrew consent|0|||
147387930|NCT02971683|531581486|FG000|Long-Term Open Label|Participant request to discontinue study treatment|1|||
147387931|NCT02971683|531581487|FG001|Long-Term Open Label|Participant request to discontinue study treatment|1|||
147387932|NCT02971683|531581486|FG000|Long-Term Open Label|Adverse Event|1|||
147387933|NCT02971683|531581487|FG001|Long-Term Open Label|Adverse Event|2|||
147387934|NCT02971683|531581486|FG000|Long-Term Open Label|Lack of Efficacy|1|||
147387935|NCT02971683|531581487|FG001|Long-Term Open Label|Lack of Efficacy|1|||
147387936|NCT05615870|531581495|FG000|Overall Study|Lost to Follow-up|10|||
147387937|NCT05615870|531581496|FG001|Overall Study|Lost to Follow-up|13|||
147387938|NCT05615870|531581495|FG000|Overall Study|Physician Decision|2|||
147387939|NCT05615870|531581496|FG001|Overall Study|Physician Decision|0|||
147387940|NCT05615870|531581495|FG000|Overall Study|Withdrawal by Subject|0|||
147387941|NCT05615870|531581496|FG001|Overall Study|Withdrawal by Subject|2|||
147387942|NCT05615870|531581495|FG000|Overall Study|Protocol Violation|0|||
147387943|NCT05615870|531581496|FG001|Overall Study|Protocol Violation|3|||
147387944|NCT05615870|531581495|FG000|Overall Study|Unable to complete study activities after moving residences|0|||
147387945|NCT05615870|531581496|FG001|Overall Study|Unable to complete study activities after moving residences|2|||
147387946|NCT05615870|531581495|FG000|Overall Study|Terminated from the experimental or control intervention only and continued with the study|1|||
147387947|NCT05615870|531581496|FG001|Overall Study|Terminated from the experimental or control intervention only and continued with the study|0|||
147387948|NCT05615870|531581495|FG000|Overall Study|The participant thought the study was done and shipped the devices back.|0|||
147387949|NCT05615870|531581496|FG001|Overall Study|The participant thought the study was done and shipped the devices back.|1|||
147387950|NCT02993926|531581502|FG000|Enantone Treatment Phase|Adverse Event|1|||
147387951|NCT02993926|531581503|FG001|Enantone Treatment Phase|Adverse Event|0|||
147387952|NCT02993926|531581504|FG002|Enantone Treatment Phase|Adverse Event|0|||
147387953|NCT02993926|531581502|FG000|Enantone Treatment Phase|Changed CPP Therapy to Another GnRHa|26|||
147387954|NCT02993926|531581503|FG001|Enantone Treatment Phase|Changed CPP Therapy to Another GnRHa|0|||
147387955|NCT02993926|531581504|FG002|Enantone Treatment Phase|Changed CPP Therapy to Another GnRHa|0|||
147387956|NCT02993926|531581502|FG000|Enantone Treatment Phase|Investigator Judgment|1|||
147387957|NCT02993926|531581503|FG001|Enantone Treatment Phase|Investigator Judgment|0|||
147387958|NCT02993926|531581504|FG002|Enantone Treatment Phase|Investigator Judgment|0|||
147387959|NCT02993926|531581502|FG000|Enantone Treatment Phase|Reason Not Specified|4|||
147387960|NCT02993926|531581503|FG001|Enantone Treatment Phase|Reason Not Specified|0|||
147387961|NCT02993926|531581504|FG002|Enantone Treatment Phase|Reason Not Specified|0|||
147387962|NCT01760876|531581505|FG000|Overall Study|Non-cardiac death (head injury)|1|||
147387963|NCT01760876|531581505|FG000|Overall Study|Carcinoma of prostate|1|||
147387964|NCT01760876|531581505|FG000|Overall Study|Impaired renal function|1|||
147387965|NCT01760876|531581505|FG000|Overall Study|Major depression|1|||
147387966|NCT01760876|531581505|FG000|Overall Study|Very poor baseline OCT quality|2|||
147387967|NCT00732498|531581509|FG000|Overall Study|Ineligible|1|||
147387968|NCT00732498|531581509|FG000|Overall Study|Adverse Event|2|||
147387969|NCT00732498|531581509|FG000|Overall Study|Physician Decision|3|||
147387970|NCT03394508|531581513|FG000|Overall Study|Protocol Violation|0|||
147387971|NCT03394508|531581514|FG001|Overall Study|Protocol Violation|3|||
147387972|NCT03394508|531581513|FG000|Overall Study|Lost to Follow-up|1|||
147387973|NCT03394508|531581514|FG001|Overall Study|Lost to Follow-up|0|||
147387974|NCT00267865|531581515|FG000|Induction Treatment|Died before completing.|2|||
147387975|NCT00267865|531581515|FG000|Induction Treatment|Started induction w/MTX, RIX, & Temozol|1|||
147387976|NCT03122548|531581519|FG000|Overall Study|Death|2|||
147387977|NCT03122548|531581519|FG000|Overall Study|Progression - subject went into hospice|1|||
147387978|NCT03122548|531581519|FG000|Overall Study|Study Terminated by Sponsor|2|||
147387979|NCT02819141|531581520|FG000|Overall Study|Extubated or discontinued prior to day 7|6|||
147387980|NCT02819141|531581521|FG001|Overall Study|Extubated or discontinued prior to day 7|20|||
147387981|NCT00409006|531583070|FG000|Overall Study|Death|15|||
147387982|NCT00409006|531583071|FG001|Overall Study|Death|6|||
147387983|NCT00409006|531583070|FG000|Overall Study|Lost to Follow-up|1|||
147387984|NCT00409006|531583071|FG001|Overall Study|Lost to Follow-up|2|||
147387985|NCT00409006|531583070|FG000|Overall Study|Withdrawal by Subject|3|||
147387986|NCT00409006|531583071|FG001|Overall Study|Withdrawal by Subject|2|||
147387987|NCT00409006|531583070|FG000|Overall Study|Physician Decision|1|||
147387988|NCT00409006|531583071|FG001|Overall Study|Physician Decision|2|||
147387989|NCT03050372|531583074|FG000|Adaptation Night (Night #1 PSG)|Adverse Event|1|||
147664948|NCT04161391|532597964|FG000|Overall Study|Physician Decision|0|||
147387990|NCT03050372|531583075|FG001|Adaptation Night (Night #1 PSG)|Adverse Event|0|||
147387991|NCT03050372|531583074|FG000|Second Intervention (Nights #4 and #5)|Lost to Follow-up|0|||
147387992|NCT03050372|531583075|FG001|Second Intervention (Nights #4 and #5)|Lost to Follow-up|1|||
147387993|NCT02123797|531583076|FG000|Baseline Intervention|Death|9|||
147387994|NCT02123797|531583077|FG001|Baseline Intervention|Death|16|||
147387995|NCT02123797|531583078|FG002|Baseline Intervention|Death|0|||
147387996|NCT02123797|531583079|FG003|Baseline Intervention|Death|0|||
147387997|NCT02123797|531583080|FG004|Baseline Intervention|Death|0|||
147387998|NCT02123797|531583076|FG000|Baseline Intervention|Withdrawal by Subject|2|||
147387999|NCT02123797|531583077|FG001|Baseline Intervention|Withdrawal by Subject|8|||
147388000|NCT02123797|531583078|FG002|Baseline Intervention|Withdrawal by Subject|0|||
147388001|NCT02123797|531583079|FG003|Baseline Intervention|Withdrawal by Subject|0|||
147388002|NCT02123797|531583080|FG004|Baseline Intervention|Withdrawal by Subject|0|||
147388003|NCT02123797|531583076|FG000|Baseline Intervention|Relocation|2|||
147388004|NCT02123797|531583077|FG001|Baseline Intervention|Relocation|0|||
147388005|NCT02123797|531583078|FG002|Baseline Intervention|Relocation|0|||
147388006|NCT02123797|531583079|FG003|Baseline Intervention|Relocation|0|||
147388007|NCT02123797|531583080|FG004|Baseline Intervention|Relocation|0|||
147388008|NCT02123797|531583076|FG000|Baseline Intervention|Out of window for initial survey|6|||
147388009|NCT02123797|531583077|FG001|Baseline Intervention|Out of window for initial survey|13|||
147388010|NCT02123797|531583078|FG002|Baseline Intervention|Out of window for initial survey|0|||
147388011|NCT02123797|531583079|FG003|Baseline Intervention|Out of window for initial survey|0|||
147388012|NCT02123797|531583080|FG004|Baseline Intervention|Out of window for initial survey|0|||
147388013|NCT02123797|531583076|FG000|Baseline Intervention|Lost to Follow-up|0|||
147388014|NCT02123797|531583077|FG001|Baseline Intervention|Lost to Follow-up|5|||
147388015|NCT02123797|531583078|FG002|Baseline Intervention|Lost to Follow-up|0|||
147388016|NCT02123797|531583079|FG003|Baseline Intervention|Lost to Follow-up|0|||
147388017|NCT02123797|531583080|FG004|Baseline Intervention|Lost to Follow-up|0|||
147388018|NCT02123797|531583076|FG000|Baseline Intervention|Other Disease|3|||
147388019|NCT02123797|531583077|FG001|Baseline Intervention|Other Disease|0|||
147388020|NCT02123797|531583078|FG002|Baseline Intervention|Other Disease|0|||
147388021|NCT02123797|531583079|FG003|Baseline Intervention|Other Disease|0|||
147388022|NCT02123797|531583080|FG004|Baseline Intervention|Other Disease|0|||
147388023|NCT02123797|531583076|FG000|3-month Follow up (Cumulative Counts)|Death|33|||
147388024|NCT02123797|531583077|FG001|3-month Follow up (Cumulative Counts)|Death|57|||
147388025|NCT02123797|531583078|FG002|3-month Follow up (Cumulative Counts)|Death|0|||
147388026|NCT02123797|531583079|FG003|3-month Follow up (Cumulative Counts)|Death|0|||
147388027|NCT02123797|531583080|FG004|3-month Follow up (Cumulative Counts)|Death|0|||
147388028|NCT02123797|531583076|FG000|3-month Follow up (Cumulative Counts)|Lost to Follow-up|2|||
147388029|NCT02123797|531583077|FG001|3-month Follow up (Cumulative Counts)|Lost to Follow-up|7|||
147388030|NCT02123797|531583078|FG002|3-month Follow up (Cumulative Counts)|Lost to Follow-up|50|||
147388031|NCT02123797|531583079|FG003|3-month Follow up (Cumulative Counts)|Lost to Follow-up|82|||
147388032|NCT02123797|531583080|FG004|3-month Follow up (Cumulative Counts)|Lost to Follow-up|3|||
147388033|NCT02123797|531583076|FG000|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|6|||
147388034|NCT02123797|531583077|FG001|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|16|||
147388035|NCT02123797|531583078|FG002|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
147388036|NCT02123797|531583079|FG003|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
147388037|NCT02123797|531583080|FG004|3-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
147388038|NCT02123797|531583076|FG000|3-month Follow up (Cumulative Counts)|Relocation|0|||
147388039|NCT02123797|531583077|FG001|3-month Follow up (Cumulative Counts)|Relocation|1|||
147388040|NCT02123797|531583078|FG002|3-month Follow up (Cumulative Counts)|Relocation|0|||
147388041|NCT02123797|531583079|FG003|3-month Follow up (Cumulative Counts)|Relocation|0|||
147388042|NCT02123797|531583080|FG004|3-month Follow up (Cumulative Counts)|Relocation|0|||
147388043|NCT02123797|531583076|FG000|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|16|||
147388044|NCT02123797|531583077|FG001|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|36|||
147388045|NCT02123797|531583078|FG002|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|0|||
147388046|NCT02123797|531583079|FG003|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|0|||
147388047|NCT02123797|531583080|FG004|3-month Follow up (Cumulative Counts)|Out of window for follow-up survey|0|||
147388048|NCT02123797|531583076|FG000|6-month Follow up (Cumulative Counts)|Death|51|||
147388049|NCT02123797|531583077|FG001|6-month Follow up (Cumulative Counts)|Death|97|||
147388050|NCT02123797|531583078|FG002|6-month Follow up (Cumulative Counts)|Death|0|||
147388051|NCT02123797|531583079|FG003|6-month Follow up (Cumulative Counts)|Death|0|||
147388052|NCT02123797|531583080|FG004|6-month Follow up (Cumulative Counts)|Death|0|||
147388053|NCT02123797|531583076|FG000|6-month Follow up (Cumulative Counts)|Lost to Follow-up|3|||
147388054|NCT02123797|531583077|FG001|6-month Follow up (Cumulative Counts)|Lost to Follow-up|20|||
147388055|NCT02123797|531583078|FG002|6-month Follow up (Cumulative Counts)|Lost to Follow-up|66|||
147388056|NCT02123797|531583079|FG003|6-month Follow up (Cumulative Counts)|Lost to Follow-up|113|||
147388057|NCT02123797|531583080|FG004|6-month Follow up (Cumulative Counts)|Lost to Follow-up|3|||
147388058|NCT02123797|531583076|FG000|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|1|||
147388059|NCT02123797|531583077|FG001|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|9|||
147388060|NCT02123797|531583078|FG002|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
147388061|NCT02123797|531583079|FG003|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
147388062|NCT02123797|531583080|FG004|6-month Follow up (Cumulative Counts)|Withdrawal by Subject|0|||
147388063|NCT02123797|531583076|FG000|6-month Follow up (Cumulative Counts)|Relocation|0|||
147388064|NCT02123797|531583077|FG001|6-month Follow up (Cumulative Counts)|Relocation|2|||
147388065|NCT02123797|531583078|FG002|6-month Follow up (Cumulative Counts)|Relocation|0|||
147388066|NCT02123797|531583079|FG003|6-month Follow up (Cumulative Counts)|Relocation|0|||
147388067|NCT02123797|531583080|FG004|6-month Follow up (Cumulative Counts)|Relocation|0|||
147388068|NCT05878990|531583083|FG000|Overall Study|Lost to Follow-up|7|||
147388069|NCT05878990|531583083|FG000|Overall Study|Withdrawal by Subject|1|||
147388070|NCT00331799|531583091|FG000|Overall Study|Withdrawal by Subject|2|||
147388071|NCT00331799|531583091|FG000|Overall Study|Sedation|1|||
147388072|NCT02889809|531583092|FG000|Overall Study|Withdrawal by Subject|30|||
147388073|NCT02889809|531583093|FG001|Overall Study|Withdrawal by Subject|21|||
147388074|NCT02889809|531583092|FG000|Overall Study|Lost to Follow-up|1|||
147388075|NCT02889809|531583093|FG001|Overall Study|Lost to Follow-up|1|||
147388076|NCT02889809|531583092|FG000|Overall Study|Site Closed|12|||
147388077|NCT02889809|531583093|FG001|Overall Study|Site Closed|11|||
147388078|NCT04203199|531583096|FG000|First Intervention Period|Lost to Follow-up|0|||
147388079|NCT04203199|531583097|FG001|First Intervention Period|Lost to Follow-up|1|||
147388080|NCT04203199|531583096|FG000|Second Intervention Period|Medication change|1|||
147388081|NCT04203199|531583097|FG001|Second Intervention Period|Medication change|0|||
147388082|NCT01107353|531583106|FG000|Overall Study|Positive Drug Screen|1|||
147388083|NCT01107353|531583107|FG001|Overall Study|Positive Drug Screen|0|||
147388084|NCT03034772|531583108|FG000|Overall Study|Adverse Event|0|||
147388085|NCT03034772|531583109|FG001|Overall Study|Adverse Event|1|||
147388086|NCT03034772|531583108|FG000|Overall Study|Withdrawal by Subject|0|||
147388087|NCT03034772|531583109|FG001|Overall Study|Withdrawal by Subject|1|||
147388088|NCT01136733|531583110|FG000|Phase 1b|Adverse Event|0|||
147388089|NCT01136733|531583111|FG001|Phase 1b|Adverse Event|3|||
147388090|NCT01136733|531583112|FG002|Phase 1b|Adverse Event|1|||
147388091|NCT01136733|531583113|FG003|Phase 1b|Adverse Event|0|||
147388092|NCT01136733|531583114|FG004|Phase 1b|Adverse Event|0|||
147388093|NCT01136733|531583115|FG005|Phase 1b|Adverse Event|0|||
147388094|NCT01136733|531583116|FG006|Phase 1b|Adverse Event|0|||
147388095|NCT01136733|531583110|FG000|Phase 1b|Participant Choice|0|||
147388096|NCT01136733|531583111|FG001|Phase 1b|Participant Choice|0|||
147388097|NCT01136733|531583112|FG002|Phase 1b|Participant Choice|1|||
147388098|NCT01136733|531583113|FG003|Phase 1b|Participant Choice|0|||
147388099|NCT01136733|531583114|FG004|Phase 1b|Participant Choice|0|||
147388100|NCT01136733|531583115|FG005|Phase 1b|Participant Choice|0|||
147388101|NCT01136733|531583116|FG006|Phase 1b|Participant Choice|0|||
147388102|NCT01136733|531583110|FG000|Phase 1b|Administrative-Withdrew Consent|0|||
147388103|NCT01136733|531583111|FG001|Phase 1b|Administrative-Withdrew Consent|1|||
147388104|NCT01136733|531583112|FG002|Phase 1b|Administrative-Withdrew Consent|0|||
147388105|NCT01136733|531583113|FG003|Phase 1b|Administrative-Withdrew Consent|0|||
147388106|NCT01136733|531583114|FG004|Phase 1b|Administrative-Withdrew Consent|0|||
147388107|NCT01136733|531583115|FG005|Phase 1b|Administrative-Withdrew Consent|0|||
147388108|NCT01136733|531583116|FG006|Phase 1b|Administrative-Withdrew Consent|0|||
147388109|NCT01136733|531583110|FG000|Phase 1b|Clinical Progression|1|||
147388110|NCT01136733|531583111|FG001|Phase 1b|Clinical Progression|1|||
147388111|NCT01136733|531583112|FG002|Phase 1b|Clinical Progression|0|||
147388112|NCT01136733|531583113|FG003|Phase 1b|Clinical Progression|0|||
147664949|NCT04161391|532597965|FG001|Overall Study|Physician Decision|0|||
147388113|NCT01136733|531583114|FG004|Phase 1b|Clinical Progression|0|||
147388114|NCT01136733|531583115|FG005|Phase 1b|Clinical Progression|0|||
147388115|NCT01136733|531583116|FG006|Phase 1b|Clinical Progression|0|||
147388116|NCT01136733|531583110|FG000|Phase 2|Disease Progression|0|||
147388117|NCT01136733|531583111|FG001|Phase 2|Disease Progression|0|||
147388118|NCT01136733|531583112|FG002|Phase 2|Disease Progression|0|||
147388119|NCT01136733|531583113|FG003|Phase 2|Disease Progression|0|||
147388120|NCT01136733|531583114|FG004|Phase 2|Disease Progression|30|||
147388121|NCT01136733|531583115|FG005|Phase 2|Disease Progression|32|||
147388122|NCT01136733|531583116|FG006|Phase 2|Disease Progression|38|||
147388123|NCT01136733|531583110|FG000|Phase 2|Adverse Event|0|||
147388124|NCT01136733|531583111|FG001|Phase 2|Adverse Event|0|||
147388125|NCT01136733|531583112|FG002|Phase 2|Adverse Event|0|||
147388126|NCT01136733|531583113|FG003|Phase 2|Adverse Event|0|||
147388127|NCT01136733|531583114|FG004|Phase 2|Adverse Event|11|||
147388128|NCT01136733|531583115|FG005|Phase 2|Adverse Event|13|||
147388129|NCT01136733|531583116|FG006|Phase 2|Adverse Event|5|||
147388130|NCT01136733|531583110|FG000|Phase 2|Participant Choice|0|||
147388131|NCT01136733|531583111|FG001|Phase 2|Participant Choice|0|||
147388132|NCT01136733|531583112|FG002|Phase 2|Participant Choice|0|||
147388133|NCT01136733|531583113|FG003|Phase 2|Participant Choice|0|||
147388134|NCT01136733|531583114|FG004|Phase 2|Participant Choice|3|||
147388135|NCT01136733|531583115|FG005|Phase 2|Participant Choice|0|||
147388136|NCT01136733|531583116|FG006|Phase 2|Participant Choice|1|||
147457687|NCT00662792|531837696|FG002|Period 1|Worsening of disease under study (AE)|2|||
147457688|NCT00662792|531837697|FG003|Period 1|Worsening of disease under study (AE)|0|||
147388137|NCT01136733|531583110|FG000|Phase 2|Administrative-Withdrew Consent|0|||
147388138|NCT01136733|531583111|FG001|Phase 2|Administrative-Withdrew Consent|0|||
147388139|NCT01136733|531583112|FG002|Phase 2|Administrative-Withdrew Consent|0|||
147388140|NCT01136733|531583113|FG003|Phase 2|Administrative-Withdrew Consent|0|||
147388141|NCT01136733|531583114|FG004|Phase 2|Administrative-Withdrew Consent|1|||
147388142|NCT01136733|531583115|FG005|Phase 2|Administrative-Withdrew Consent|0|||
147388143|NCT01136733|531583116|FG006|Phase 2|Administrative-Withdrew Consent|0|||
147388144|NCT01136733|531583110|FG000|Phase 2|Other|0|||
147388145|NCT01136733|531583111|FG001|Phase 2|Other|0|||
147388146|NCT01136733|531583112|FG002|Phase 2|Other|0|||
147388147|NCT01136733|531583113|FG003|Phase 2|Other|0|||
147388148|NCT01136733|531583114|FG004|Phase 2|Other|6|||
147388149|NCT01136733|531583115|FG005|Phase 2|Other|7|||
147388150|NCT01136733|531583116|FG006|Phase 2|Other|6|||
147388151|NCT01745380|531583117|FG000|Overall Study|Lost to Follow-up|1|||
147388152|NCT01745380|531583118|FG001|Overall Study|Lost to Follow-up|0|||
147388153|NCT01745380|531583117|FG000|Overall Study|Lack of Efficacy|0|||
147388154|NCT01745380|531583118|FG001|Overall Study|Lack of Efficacy|1|||
147388155|NCT02368691|531583119|FG000|Overall Study|Death|13|||
147388156|NCT02368691|531583119|FG000|Overall Study|Lack of Efficacy|15|||
147388157|NCT02368691|531583119|FG000|Overall Study|Physician Decision|4|||
147388158|NCT02660034|531583120|FG000|Overall Study|Progressive Disease (Radiographic)|3|||
147388159|NCT02660034|531583121|FG001|Overall Study|Progressive Disease (Radiographic)|1|||
147388160|NCT02660034|531583122|FG002|Overall Study|Progressive Disease (Radiographic)|0|||
147388161|NCT02660034|531583123|FG003|Overall Study|Progressive Disease (Radiographic)|1|||
147388162|NCT02660034|531583124|FG004|Overall Study|Progressive Disease (Radiographic)|0|||
147388163|NCT02660034|531583125|FG005|Overall Study|Progressive Disease (Radiographic)|0|||
147388164|NCT02660034|531583126|FG006|Overall Study|Progressive Disease (Radiographic)|0|||
147388165|NCT02660034|531583127|FG007|Overall Study|Progressive Disease (Radiographic)|0|||
147388166|NCT02660034|531583128|FG008|Overall Study|Progressive Disease (Radiographic)|0|||
147388167|NCT02660034|531583129|FG009|Overall Study|Progressive Disease (Radiographic)|0|||
147388168|NCT02660034|531583130|FG010|Overall Study|Progressive Disease (Radiographic)|0|||
147388169|NCT02660034|531583131|FG011|Overall Study|Progressive Disease (Radiographic)|0|||
147388170|NCT02660034|531583132|FG012|Overall Study|Progressive Disease (Radiographic)|0|||
147388171|NCT02660034|531583133|FG013|Overall Study|Progressive Disease (Radiographic)|0|||
147388172|NCT02660034|531583120|FG000|Overall Study|Progressive Disease (Clinical)|7|||
147388173|NCT02660034|531583121|FG001|Overall Study|Progressive Disease (Clinical)|8|||
147388174|NCT02660034|531583122|FG002|Overall Study|Progressive Disease (Clinical)|3|||
147388175|NCT02660034|531583123|FG003|Overall Study|Progressive Disease (Clinical)|9|||
147388176|NCT02660034|531583124|FG004|Overall Study|Progressive Disease (Clinical)|3|||
147388177|NCT02660034|531583125|FG005|Overall Study|Progressive Disease (Clinical)|0|||
147388178|NCT02660034|531583126|FG006|Overall Study|Progressive Disease (Clinical)|0|||
147388179|NCT02660034|531583127|FG007|Overall Study|Progressive Disease (Clinical)|0|||
147457689|NCT00662792|531837694|FG000|Period 1|Not treated|0|||
147457690|NCT00662792|531837695|FG001|Period 1|Not treated|1|||
147457691|NCT00662792|531837696|FG002|Period 1|Not treated|0|||
147457692|NCT00662792|531837697|FG003|Period 1|Not treated|0|||
147457693|NCT00662792|531837694|FG000|Period 2|Worsening of disease under study|1|||
147457694|NCT00662792|531837695|FG001|Period 2|Worsening of disease under study|0|||
147457695|NCT00662792|531837696|FG002|Period 2|Worsening of disease under study|0|||
147457696|NCT00662792|531837697|FG003|Period 2|Worsening of disease under study|3|||
147457697|NCT00662792|531837694|FG000|Period 3|Refused continuing medication|1|||
147457698|NCT00662792|531837695|FG001|Period 3|Refused continuing medication|0|||
147457699|NCT00662792|531837696|FG002|Period 3|Refused continuing medication|1|||
147457700|NCT00662792|531837697|FG003|Period 3|Refused continuing medication|0|||
147615091|NCT03690388|532406591|FG000|Overall Study|Lack of Efficacy|1|||
147615092|NCT03690388|532406592|FG001|Overall Study|Lack of Efficacy|0|||
147615093|NCT03690388|532406591|FG000|Overall Study|Lost to Follow-up|1|||
147615094|NCT03690388|532406592|FG001|Overall Study|Lost to Follow-up|0|||
147615095|NCT00266630|532406597|FG000|Overall Study|Adverse Event|8|||
147388180|NCT02660034|531583128|FG008|Overall Study|Progressive Disease (Clinical)|0|||
147388181|NCT02660034|531583129|FG009|Overall Study|Progressive Disease (Clinical)|0|||
147388182|NCT02660034|531583130|FG010|Overall Study|Progressive Disease (Clinical)|0|||
147388183|NCT02660034|531583131|FG011|Overall Study|Progressive Disease (Clinical)|0|||
147388184|NCT02660034|531583132|FG012|Overall Study|Progressive Disease (Clinical)|0|||
147388185|NCT02660034|531583133|FG013|Overall Study|Progressive Disease (Clinical)|0|||
147388186|NCT02660034|531583120|FG000|Overall Study|Lost to Follow-up|0|||
147388187|NCT02660034|531583121|FG001|Overall Study|Lost to Follow-up|0|||
147388188|NCT02660034|531583122|FG002|Overall Study|Lost to Follow-up|1|||
147388189|NCT02660034|531583123|FG003|Overall Study|Lost to Follow-up|1|||
147457701|NCT00662792|531837694|FG000|Period 3|Other adverse event (AE)|0|||
147457702|NCT00662792|531837695|FG001|Period 3|Other adverse event (AE)|0|||
147615096|NCT00266630|532406598|FG001|Overall Study|Adverse Event|6|||
147615097|NCT00266630|532406597|FG000|Overall Study|Lack of Efficacy|1|||
147388190|NCT02660034|531583124|FG004|Overall Study|Lost to Follow-up|0|||
147388191|NCT02660034|531583125|FG005|Overall Study|Lost to Follow-up|0|||
147388192|NCT02660034|531583126|FG006|Overall Study|Lost to Follow-up|0|||
147388193|NCT02660034|531583127|FG007|Overall Study|Lost to Follow-up|0|||
147388194|NCT02660034|531583128|FG008|Overall Study|Lost to Follow-up|0|||
147388195|NCT02660034|531583129|FG009|Overall Study|Lost to Follow-up|1|||
147388196|NCT02660034|531583130|FG010|Overall Study|Lost to Follow-up|1|||
147388197|NCT02660034|531583131|FG011|Overall Study|Lost to Follow-up|1|||
147388198|NCT02660034|531583132|FG012|Overall Study|Lost to Follow-up|0|||
147388199|NCT02660034|531583133|FG013|Overall Study|Lost to Follow-up|0|||
147388200|NCT02660034|531583120|FG000|Overall Study|Participant moved into special access scheme|1|||
147388201|NCT02660034|531583121|FG001|Overall Study|Participant moved into special access scheme|2|||
147388202|NCT02660034|531583122|FG002|Overall Study|Participant moved into special access scheme|0|||
147388203|NCT02660034|531583123|FG003|Overall Study|Participant moved into special access scheme|0|||
147388204|NCT02660034|531583124|FG004|Overall Study|Participant moved into special access scheme|0|||
147388205|NCT02660034|531583125|FG005|Overall Study|Participant moved into special access scheme|0|||
147388206|NCT02660034|531583126|FG006|Overall Study|Participant moved into special access scheme|0|||
147388207|NCT02660034|531583127|FG007|Overall Study|Participant moved into special access scheme|0|||
147388208|NCT02660034|531583128|FG008|Overall Study|Participant moved into special access scheme|0|||
147388209|NCT02660034|531583129|FG009|Overall Study|Participant moved into special access scheme|0|||
147388210|NCT02660034|531583130|FG010|Overall Study|Participant moved into special access scheme|0|||
147388211|NCT02660034|531583131|FG011|Overall Study|Participant moved into special access scheme|0|||
147388212|NCT02660034|531583132|FG012|Overall Study|Participant moved into special access scheme|0|||
147388213|NCT02660034|531583133|FG013|Overall Study|Participant moved into special access scheme|0|||
147388214|NCT02660034|531583120|FG000|Overall Study|Adverse Event|1|||
147388215|NCT02660034|531583121|FG001|Overall Study|Adverse Event|0|||
147457703|NCT00662792|531837696|FG002|Period 3|Other adverse event (AE)|1|||
147457704|NCT00662792|531837697|FG003|Period 3|Other adverse event (AE)|1|||
147457705|NCT00662792|531837694|FG000|Period 4|Refused continuing medication|0|||
147457706|NCT00662792|531837695|FG001|Period 4|Refused continuing medication|1|||
147457707|NCT00662792|531837696|FG002|Period 4|Refused continuing medication|0|||
147457708|NCT00662792|531837697|FG003|Period 4|Refused continuing medication|0|||
147457709|NCT00662792|531837694|FG000|Period 4|Other adverse event (AE)|1|||
147457710|NCT00662792|531837695|FG001|Period 4|Other adverse event (AE)|0|||
147457711|NCT00662792|531837696|FG002|Period 4|Other adverse event (AE)|0|||
147457712|NCT00662792|531837697|FG003|Period 4|Other adverse event (AE)|0|||
147457713|NCT00662792|531837694|FG000|Period 4|Worsening of disease under study (AE)|0|||
147457714|NCT00662792|531837695|FG001|Period 4|Worsening of disease under study (AE)|0|||
147457715|NCT00662792|531837696|FG002|Period 4|Worsening of disease under study (AE)|0|||
147457716|NCT00662792|531837697|FG003|Period 4|Worsening of disease under study (AE)|1|||
147457717|NCT00090545|531837698|FG000|Overall Study|Disease progression on study|21|||
147457718|NCT00090545|531837699|FG001|Overall Study|Disease progression on study|17|||
147457719|NCT00090545|531837698|FG000|Overall Study|Refused further treatment|1|||
147457720|NCT00090545|531837699|FG001|Overall Study|Refused further treatment|4|||
147457721|NCT00090545|531837698|FG000|Overall Study|Death|0|||
147457722|NCT00090545|531837699|FG001|Overall Study|Death|1|||
147457723|NCT00090545|531837698|FG000|Overall Study|Adverse Event|0|||
147457724|NCT00090545|531837699|FG001|Overall Study|Adverse Event|2|||
147457725|NCT02474082|531837700|FG000|Overall Study|Adverse Event|2|||
147457726|NCT02474082|531837701|FG001|Overall Study|Adverse Event|32|||
147457727|NCT02474082|531837700|FG000|Overall Study|Withdrawal of informed consent|1|||
147457728|NCT02474082|531837701|FG001|Overall Study|Withdrawal of informed consent|11|||
147457729|NCT02474082|531837700|FG000|Overall Study|Lost to Follow-up|2|||
147457730|NCT02474082|531837701|FG001|Overall Study|Lost to Follow-up|2|||
147457731|NCT02474082|531837700|FG000|Overall Study|Dose tapering not achieved|0|||
147457732|NCT02474082|531837701|FG001|Overall Study|Dose tapering not achieved|4|||
147615098|NCT00266630|532406598|FG001|Overall Study|Lack of Efficacy|4|||
147615099|NCT00266630|532406597|FG000|Overall Study|Entry Criteria not met|1|||
147388216|NCT02660034|531583122|FG002|Overall Study|Adverse Event|0|||
147388217|NCT02660034|531583123|FG003|Overall Study|Adverse Event|0|||
147388218|NCT02660034|531583124|FG004|Overall Study|Adverse Event|0|||
147388219|NCT02660034|531583125|FG005|Overall Study|Adverse Event|0|||
147388220|NCT02660034|531583126|FG006|Overall Study|Adverse Event|0|||
147388221|NCT02660034|531583127|FG007|Overall Study|Adverse Event|0|||
147388222|NCT02660034|531583128|FG008|Overall Study|Adverse Event|0|||
147388223|NCT02660034|531583129|FG009|Overall Study|Adverse Event|0|||
147388224|NCT02660034|531583130|FG010|Overall Study|Adverse Event|0|||
147388225|NCT02660034|531583131|FG011|Overall Study|Adverse Event|0|||
147388226|NCT02660034|531583132|FG012|Overall Study|Adverse Event|0|||
147457733|NCT02474082|531837700|FG000|Overall Study|Participant/guardian decision|1|||
147457734|NCT02474082|531837701|FG001|Overall Study|Participant/guardian decision|2|||
147457735|NCT02474082|531837700|FG000|Overall Study|Non-compliance with study treatment|0|||
147457736|NCT02474082|531837701|FG001|Overall Study|Non-compliance with study treatment|2|||
147457737|NCT02474082|531837700|FG000|Overall Study|Protocol deviation|0|||
147615100|NCT00266630|532406598|FG001|Overall Study|Entry Criteria not met|0|||
147457738|NCT02474082|531837701|FG001|Overall Study|Protocol deviation|1|||
147457739|NCT01463098|531837702|FG000|Part A (11 Days)|Participant Choice|2|||
147457740|NCT01463098|531837703|FG001|Part A (11 Days)|Participant Choice|0|||
147457741|NCT01463098|531837704|FG002|Part A (11 Days)|Participant Choice|0|||
147457742|NCT01463098|531837705|FG003|Part A (11 Days)|Participant Choice|0|||
147457743|NCT01463098|531837706|FG004|Part A (11 Days)|Participant Choice|0|||
147457744|NCT01463098|531837707|FG005|Part A (11 Days)|Participant Choice|0|||
147615101|NCT00266630|532406597|FG000|Overall Study|Protocol Violation|1|||
147615102|NCT00266630|532406598|FG001|Overall Study|Protocol Violation|3|||
147615103|NCT00266630|532406597|FG000|Overall Study|Physician Decision|1|||
147388227|NCT02660034|531583133|FG013|Overall Study|Adverse Event|0|||
147388228|NCT02660034|531583120|FG000|Overall Study|Sponsor Decision|0|||
147388229|NCT02660034|531583121|FG001|Overall Study|Sponsor Decision|1|||
147388230|NCT02660034|531583122|FG002|Overall Study|Sponsor Decision|2|||
147388231|NCT02660034|531583123|FG003|Overall Study|Sponsor Decision|2|||
147388232|NCT02660034|531583124|FG004|Overall Study|Sponsor Decision|3|||
147388233|NCT02660034|531583125|FG005|Overall Study|Sponsor Decision|0|||
147388234|NCT02660034|531583126|FG006|Overall Study|Sponsor Decision|0|||
147388235|NCT02660034|531583127|FG007|Overall Study|Sponsor Decision|0|||
147388236|NCT02660034|531583128|FG008|Overall Study|Sponsor Decision|0|||
147388237|NCT02660034|531583129|FG009|Overall Study|Sponsor Decision|0|||
147388238|NCT02660034|531583130|FG010|Overall Study|Sponsor Decision|0|||
147388239|NCT02660034|531583131|FG011|Overall Study|Sponsor Decision|0|||
147388240|NCT02660034|531583132|FG012|Overall Study|Sponsor Decision|0|||
147388241|NCT02660034|531583133|FG013|Overall Study|Sponsor Decision|1|||
147388242|NCT02660034|531583120|FG000|Overall Study|Withdrawal by Subject|0|||
147388243|NCT02660034|531583121|FG001|Overall Study|Withdrawal by Subject|0|||
147388244|NCT02660034|531583122|FG002|Overall Study|Withdrawal by Subject|0|||
147388245|NCT02660034|531583123|FG003|Overall Study|Withdrawal by Subject|0|||
147388246|NCT02660034|531583124|FG004|Overall Study|Withdrawal by Subject|0|||
147388247|NCT02660034|531583125|FG005|Overall Study|Withdrawal by Subject|0|||
147388248|NCT02660034|531583126|FG006|Overall Study|Withdrawal by Subject|1|||
147388249|NCT02660034|531583127|FG007|Overall Study|Withdrawal by Subject|1|||
147388250|NCT02660034|531583128|FG008|Overall Study|Withdrawal by Subject|1|||
147388251|NCT02660034|531583129|FG009|Overall Study|Withdrawal by Subject|0|||
147388252|NCT02660034|531583130|FG010|Overall Study|Withdrawal by Subject|0|||
147388253|NCT02660034|531583131|FG011|Overall Study|Withdrawal by Subject|1|||
147388254|NCT02660034|531583132|FG012|Overall Study|Withdrawal by Subject|2|||
147388255|NCT02660034|531583133|FG013|Overall Study|Withdrawal by Subject|0|||
147388256|NCT02660034|531583120|FG000|Overall Study|Death|0|||
147388257|NCT02660034|531583121|FG001|Overall Study|Death|0|||
147388258|NCT02660034|531583122|FG002|Overall Study|Death|0|||
147388259|NCT02660034|531583123|FG003|Overall Study|Death|0|||
147388260|NCT02660034|531583124|FG004|Overall Study|Death|0|||
147388261|NCT02660034|531583125|FG005|Overall Study|Death|13|||
147388262|NCT02660034|531583126|FG006|Overall Study|Death|14|||
147388263|NCT02660034|531583127|FG007|Overall Study|Death|10|||
147388264|NCT02660034|531583128|FG008|Overall Study|Death|9|||
147388265|NCT02660034|531583129|FG009|Overall Study|Death|21|||
147388266|NCT02660034|531583130|FG010|Overall Study|Death|17|||
147388267|NCT02660034|531583131|FG011|Overall Study|Death|15|||
147388268|NCT02660034|531583132|FG012|Overall Study|Death|18|||
147388269|NCT02660034|531583133|FG013|Overall Study|Death|7|||
147388270|NCT02660034|531583120|FG000|Overall Study|Physician Decision|0|||
147388271|NCT02660034|531583121|FG001|Overall Study|Physician Decision|0|||
147388272|NCT02660034|531583122|FG002|Overall Study|Physician Decision|0|||
147388273|NCT02660034|531583123|FG003|Overall Study|Physician Decision|0|||
147388274|NCT02660034|531583124|FG004|Overall Study|Physician Decision|0|||
147388275|NCT02660034|531583125|FG005|Overall Study|Physician Decision|0|||
147388276|NCT02660034|531583126|FG006|Overall Study|Physician Decision|0|||
147388277|NCT02660034|531583127|FG007|Overall Study|Physician Decision|0|||
147388278|NCT02660034|531583128|FG008|Overall Study|Physician Decision|0|||
147388279|NCT02660034|531583129|FG009|Overall Study|Physician Decision|0|||
147388280|NCT02660034|531583130|FG010|Overall Study|Physician Decision|0|||
147388281|NCT02660034|531583131|FG011|Overall Study|Physician Decision|0|||
147388282|NCT02660034|531583132|FG012|Overall Study|Physician Decision|0|||
147388283|NCT02660034|531583133|FG013|Overall Study|Physician Decision|1|||
147388284|NCT02660034|531583120|FG000|Overall Study|Participants transferred to LTE|0|||
147388285|NCT02660034|531583121|FG001|Overall Study|Participants transferred to LTE|0|||
147388286|NCT02660034|531583122|FG002|Overall Study|Participants transferred to LTE|0|||
147388287|NCT02660034|531583123|FG003|Overall Study|Participants transferred to LTE|0|||
147388288|NCT02660034|531583124|FG004|Overall Study|Participants transferred to LTE|0|||
147388289|NCT02660034|531583125|FG005|Overall Study|Participants transferred to LTE|10|||
147388290|NCT02660034|531583126|FG006|Overall Study|Participants transferred to LTE|8|||
147457745|NCT01463098|531837708|FG006|Part A (11 Days)|Participant Choice|0|||
147457746|NCT01463098|531837709|FG007|Part A (11 Days)|Participant Choice|0|||
147388291|NCT02660034|531583127|FG007|Overall Study|Participants transferred to LTE|8|||
147388292|NCT02660034|531583128|FG008|Overall Study|Participants transferred to LTE|10|||
147615104|NCT00266630|532406598|FG001|Overall Study|Physician Decision|2|||
147457747|NCT01463098|531837710|FG008|Part A (11 Days)|Participant Choice|1|||
147457748|NCT01463098|531837711|FG009|Part A (11 Days)|Participant Choice|0|||
147457749|NCT01463098|531837712|FG010|Part A (11 Days)|Participant Choice|0|||
147457750|NCT01463098|531837713|FG011|Part A (11 Days)|Participant Choice|0|||
147457751|NCT01463098|531837714|FG012|Part A (11 Days)|Participant Choice|0|||
147457752|NCT01463098|531837715|FG013|Part A (11 Days)|Participant Choice|0|||
147457753|NCT01463098|531837702|FG000|Part A (11 Days)|Lost to Follow-up|0|||
147457754|NCT01463098|531837703|FG001|Part A (11 Days)|Lost to Follow-up|0|||
147457755|NCT01463098|531837704|FG002|Part A (11 Days)|Lost to Follow-up|0|||
147457756|NCT01463098|531837705|FG003|Part A (11 Days)|Lost to Follow-up|0|||
147457757|NCT01463098|531837706|FG004|Part A (11 Days)|Lost to Follow-up|1|||
147457758|NCT01463098|531837707|FG005|Part A (11 Days)|Lost to Follow-up|0|||
147457759|NCT01463098|531837708|FG006|Part A (11 Days)|Lost to Follow-up|0|||
147457760|NCT01463098|531837709|FG007|Part A (11 Days)|Lost to Follow-up|0|||
147457761|NCT01463098|531837710|FG008|Part A (11 Days)|Lost to Follow-up|0|||
147457762|NCT01463098|531837711|FG009|Part A (11 Days)|Lost to Follow-up|0|||
147457763|NCT01463098|531837712|FG010|Part A (11 Days)|Lost to Follow-up|0|||
147457764|NCT01463098|531837713|FG011|Part A (11 Days)|Lost to Follow-up|0|||
147457765|NCT01463098|531837714|FG012|Part A (11 Days)|Lost to Follow-up|0|||
147457766|NCT01463098|531837715|FG013|Part A (11 Days)|Lost to Follow-up|0|||
147457767|NCT01463098|531837702|FG000|Part B (11 Days)|Participant Choice|0|||
147457768|NCT01463098|531837703|FG001|Part B (11 Days)|Participant Choice|0|||
147457769|NCT01463098|531837704|FG002|Part B (11 Days)|Participant Choice|0|||
147457770|NCT01463098|531837705|FG003|Part B (11 Days)|Participant Choice|0|||
147457771|NCT01463098|531837706|FG004|Part B (11 Days)|Participant Choice|0|||
147457772|NCT01463098|531837707|FG005|Part B (11 Days)|Participant Choice|0|||
147457773|NCT01463098|531837708|FG006|Part B (11 Days)|Participant Choice|0|||
147457774|NCT01463098|531837709|FG007|Part B (11 Days)|Participant Choice|0|||
147457775|NCT01463098|531837710|FG008|Part B (11 Days)|Participant Choice|0|||
147457776|NCT01463098|531837711|FG009|Part B (11 Days)|Participant Choice|0|||
147457777|NCT01463098|531837712|FG010|Part B (11 Days)|Participant Choice|0|||
147457778|NCT01463098|531837713|FG011|Part B (11 Days)|Participant Choice|1|||
147457779|NCT01463098|531837714|FG012|Part B (11 Days)|Participant Choice|0|||
147457780|NCT01463098|531837715|FG013|Part B (11 Days)|Participant Choice|0|||
147457781|NCT01528787|531837718|FG000|Overall Study|Withdrawal by Subject|0|||
147457782|NCT01528787|531837719|FG001|Overall Study|Withdrawal by Subject|0|||
147457783|NCT01528787|531837720|FG002|Overall Study|Withdrawal by Subject|0|||
147457784|NCT01528787|531837721|FG003|Overall Study|Withdrawal by Subject|1|||
147457785|NCT01528787|531837718|FG000|Overall Study|Family Emergency|0|||
147615105|NCT00266630|532406597|FG000|Overall Study|Withdrawal by Subject|10|||
147388293|NCT02660034|531583129|FG009|Overall Study|Participants transferred to LTE|1|||
147388294|NCT02660034|531583130|FG010|Overall Study|Participants transferred to LTE|2|||
147388295|NCT02660034|531583131|FG011|Overall Study|Participants transferred to LTE|4|||
147388296|NCT02660034|531583132|FG012|Overall Study|Participants transferred to LTE|1|||
147388297|NCT02660034|531583133|FG013|Overall Study|Participants transferred to LTE|1|||
147388298|NCT01403805|531583136|FG000|Overall Study|Withdrawal by Subject|0|||
147388299|NCT01403805|531583137|FG001|Overall Study|Withdrawal by Subject|4|||
147388300|NCT01403805|531583136|FG000|Overall Study|Lost to Follow-up|0|||
147388301|NCT01403805|531583137|FG001|Overall Study|Lost to Follow-up|2|||
147388302|NCT01403805|531583136|FG000|Overall Study|Death|0|||
147388303|NCT01403805|531583137|FG001|Overall Study|Death|1|||
147388304|NCT00147745|531583138|FG000|Overall Study|Withdrawal by Subject|1|||
147388305|NCT00147745|531583139|FG001|Overall Study|Withdrawal by Subject|0|||
147388306|NCT00147745|531583140|FG002|Overall Study|Withdrawal by Subject|0|||
147388307|NCT00510783|531583145|FG000|Overall Study|Lost to Follow-up|29|||
147388308|NCT00510783|531583146|FG001|Overall Study|Lost to Follow-up|25|||
147388309|NCT00510783|531583145|FG000|Overall Study|Withdrawal by Subject|2|||
147388310|NCT00510783|531583146|FG001|Overall Study|Withdrawal by Subject|3|||
147388311|NCT00510783|531583145|FG000|Overall Study|Protocol Violation|0|||
147388312|NCT00510783|531583146|FG001|Overall Study|Protocol Violation|1|||
147388313|NCT00316121|531583147|FG000|Overall Study|Death|1|||
147388314|NCT00316121|531583148|FG001|Overall Study|Death|0|||
147388315|NCT00316121|531583147|FG000|Overall Study|Lost to Follow-up|14|||
147388316|NCT00316121|531583148|FG001|Overall Study|Lost to Follow-up|8|||
147388317|NCT00316121|531583147|FG000|Overall Study|Withdrawal by Subject|2|||
147388318|NCT00316121|531583148|FG001|Overall Study|Withdrawal by Subject|0|||
147388319|NCT00316121|531583147|FG000|Overall Study|Reason is missing|1|||
147388320|NCT00316121|531583148|FG001|Overall Study|Reason is missing|0|||
147388321|NCT00316121|531583147|FG000|Overall Study|Subject relocated|1|||
147457786|NCT01528787|531837719|FG001|Overall Study|Family Emergency|0|||
147457787|NCT01528787|531837720|FG002|Overall Study|Family Emergency|1|||
147457788|NCT01528787|531837721|FG003|Overall Study|Family Emergency|0|||
147457789|NCT02971670|531837724|FG000|Overall Study|Withdrawal by Subject|4|||
147457790|NCT02971670|531837725|FG001|Overall Study|Withdrawal by Subject|1|||
147457791|NCT02971670|531837726|FG002|Overall Study|Withdrawal by Subject|1|||
147664950|NCT04161391|532597966|FG002|Overall Study|Physician Decision|1|||
147388322|NCT00316121|531583148|FG001|Overall Study|Subject relocated|1|||
147388323|NCT00316121|531583147|FG000|Overall Study|Subject refused to return|1|||
147388324|NCT00316121|531583148|FG001|Overall Study|Subject refused to return|0|||
147388325|NCT00316121|531583147|FG000|Overall Study|Subject no show for visit x 3|1|||
147388326|NCT00316121|531583148|FG001|Overall Study|Subject no show for visit x 3|0|||
147388327|NCT00316121|531583147|FG000|Overall Study|Subject did not have 24 month visit|1|||
147388328|NCT00316121|531583148|FG001|Overall Study|Subject did not have 24 month visit|0|||
147388329|NCT03045302|531583153|FG000|Overall Study|Pre-treatment adverse event|1|||
147388330|NCT00134056|531583154|FG000|Randomization|Not eligible for assigned treatment|22|||
147388331|NCT00134056|531583155|FG001|Randomization|Not eligible for assigned treatment|20|||
147388332|NCT00134056|531583154|FG000|Eligible for Protocol Assigned Treatment|Lack of Efficacy|171|||
147388333|NCT00134056|531583155|FG001|Eligible for Protocol Assigned Treatment|Lack of Efficacy|171|||
147388334|NCT00134056|531583154|FG000|Eligible for Protocol Assigned Treatment|Adverse Event|81|||
147388335|NCT00134056|531583155|FG001|Eligible for Protocol Assigned Treatment|Adverse Event|67|||
147388336|NCT00134056|531583154|FG000|Eligible for Protocol Assigned Treatment|Withdrawal by Subject|20|||
147388337|NCT00134056|531583155|FG001|Eligible for Protocol Assigned Treatment|Withdrawal by Subject|21|||
147388338|NCT00134056|531583154|FG000|Eligible for Protocol Assigned Treatment|Other|55|||
147388339|NCT00134056|531583155|FG001|Eligible for Protocol Assigned Treatment|Other|56|||
147388340|NCT00742560|531583157|FG000|Overall Study|Adverse Event|0|||
147388341|NCT00742560|531583158|FG001|Overall Study|Adverse Event|0|||
147388342|NCT00742560|531583159|FG002|Overall Study|Adverse Event|1|||
147388343|NCT00742560|531583160|FG003|Overall Study|Adverse Event|1|||
147388344|NCT00742560|531583161|FG004|Overall Study|Adverse Event|1|||
147388345|NCT00742560|531583157|FG000|Overall Study|Death|0|||
147388346|NCT00742560|531583158|FG001|Overall Study|Death|2|||
147388347|NCT00742560|531583159|FG002|Overall Study|Death|0|||
147388348|NCT00742560|531583160|FG003|Overall Study|Death|2|||
147388349|NCT00742560|531583161|FG004|Overall Study|Death|3|||
147388350|NCT00742560|531583157|FG000|Overall Study|Subject's Decision|1|||
147388351|NCT00742560|531583158|FG001|Overall Study|Subject's Decision|0|||
147388352|NCT00742560|531583159|FG002|Overall Study|Subject's Decision|2|||
147388353|NCT00742560|531583160|FG003|Overall Study|Subject's Decision|3|||
147388354|NCT00742560|531583161|FG004|Overall Study|Subject's Decision|3|||
147388355|NCT00742560|531583157|FG000|Overall Study|Investigator's Decision|0|||
147388356|NCT00742560|531583158|FG001|Overall Study|Investigator's Decision|0|||
147388357|NCT00742560|531583159|FG002|Overall Study|Investigator's Decision|4|||
147388358|NCT00742560|531583160|FG003|Overall Study|Investigator's Decision|1|||
147388359|NCT00742560|531583161|FG004|Overall Study|Investigator's Decision|0|||
147388360|NCT00742560|531583157|FG000|Overall Study|Disease Progression|1|||
147388361|NCT00742560|531583158|FG001|Overall Study|Disease Progression|0|||
147388362|NCT00742560|531583159|FG002|Overall Study|Disease Progression|5|||
147388363|NCT00742560|531583160|FG003|Overall Study|Disease Progression|17|||
147388364|NCT00742560|531583161|FG004|Overall Study|Disease Progression|16|||
147388365|NCT00742560|531583157|FG000|Overall Study|New Multiple Myeloma Therapy|1|||
147388366|NCT00742560|531583158|FG001|Overall Study|New Multiple Myeloma Therapy|0|||
147388367|NCT00742560|531583159|FG002|Overall Study|New Multiple Myeloma Therapy|2|||
147388368|NCT00742560|531583160|FG003|Overall Study|New Multiple Myeloma Therapy|3|||
147388369|NCT00742560|531583161|FG004|Overall Study|New Multiple Myeloma Therapy|4|||
147388370|NCT00742560|531583157|FG000|Overall Study|Other|0|||
147388371|NCT00742560|531583158|FG001|Overall Study|Other|1|||
147388372|NCT00742560|531583159|FG002|Overall Study|Other|8|||
147388373|NCT00742560|531583160|FG003|Overall Study|Other|9|||
147388374|NCT00742560|531583161|FG004|Overall Study|Other|9|||
147388375|NCT00742560|531583157|FG000|Overall Study|MIssing|0|||
147388376|NCT00742560|531583158|FG001|Overall Study|MIssing|0|||
147388377|NCT00742560|531583159|FG002|Overall Study|MIssing|0|||
147388378|NCT00742560|531583160|FG003|Overall Study|MIssing|0|||
147388379|NCT00742560|531583161|FG004|Overall Study|MIssing|1|||
147388380|NCT01536795|531583162|FG000|Overall Study|Lost to Follow-up|0|||
147388381|NCT01536795|531583163|FG001|Overall Study|Lost to Follow-up|2|||
147388382|NCT01536795|531583162|FG000|Overall Study|Lack of Efficacy|1|||
147388383|NCT01536795|531583163|FG001|Overall Study|Lack of Efficacy|0|||
147388384|NCT04985604|531583164|FG000|Overall Study|Death|4|||
147388385|NCT04985604|531583165|FG001|Overall Study|Death|6|||
147388386|NCT04985604|531583164|FG000|Overall Study|Withdrawal by Subject|0|||
147388387|NCT04985604|531583165|FG001|Overall Study|Withdrawal by Subject|1|||
147388388|NCT04598776|531583166|FG000|Overall Study|Protocol Violation|5|||
147388389|NCT04598776|531583166|FG000|Overall Study|Physician Decision|4|||
147388390|NCT00348283|531583167|FG000|Induction|Adverse Event|0|||
147388391|NCT00348283|531583168|FG001|Induction|Adverse Event|2|||
147388392|NCT00348283|531583167|FG000|Induction|Protocol Violation|0|||
147388393|NCT00348283|531583168|FG001|Induction|Protocol Violation|4|||
147388394|NCT00348283|531583167|FG000|Double Blind|Adverse Event|2|||
147388395|NCT00348283|531583168|FG001|Double Blind|Adverse Event|5|||
147388396|NCT00348283|531583167|FG000|Double Blind|Withdrawal by Subject|1|||
147388397|NCT00348283|531583168|FG001|Double Blind|Withdrawal by Subject|1|||
147388398|NCT00348283|531583167|FG000|Double Blind|Protocol Violation|0|||
147388399|NCT00348283|531583168|FG001|Double Blind|Protocol Violation|1|||
147388400|NCT00348283|531583167|FG000|Double Blind|Lack of Efficacy|2|||
147615106|NCT00266630|532406598|FG001|Overall Study|Withdrawal by Subject|2|||
147615107|NCT00266630|532406597|FG000|Overall Study|Lost to Follow-up|1|||
147388401|NCT00348283|531583168|FG001|Double Blind|Lack of Efficacy|2|||
147388402|NCT00348283|531583167|FG000|Double Blind|Pregnancy|0|||
147388403|NCT00348283|531583168|FG001|Double Blind|Pregnancy|1|||
147388404|NCT00348283|531583167|FG000|Open Label|Adverse Event|0|||
147388405|NCT00348283|531583168|FG001|Open Label|Adverse Event|8|||
147388406|NCT00348283|531583167|FG000|Open Label|Withdrawal by Subject|0|||
147388407|NCT00348283|531583168|FG001|Open Label|Withdrawal by Subject|4|||
147388408|NCT00348283|531583167|FG000|Open Label|Lost to Follow-up|0|||
147388409|NCT00348283|531583168|FG001|Open Label|Lost to Follow-up|1|||
147388410|NCT00348283|531583167|FG000|Open Label|Lack of Efficacy|0|||
147388411|NCT00348283|531583168|FG001|Open Label|Lack of Efficacy|13|||
147388412|NCT00348283|531583167|FG000|Open Label|Administrative reasons|0|||
147388413|NCT00348283|531583168|FG001|Open Label|Administrative reasons|5|||
147388414|NCT00348283|531583167|FG000|Open Label|Subject moved to the United States|0|||
147388415|NCT00348283|531583168|FG001|Open Label|Subject moved to the United States|1|||
147388416|NCT00348283|531583167|FG000|Open Label|Pregnancy|0|||
147388417|NCT00348283|531583168|FG001|Open Label|Pregnancy|1|||
147388418|NCT00348283|531583167|FG000|Open Label|Sponsor decision|0|||
147388419|NCT00348283|531583168|FG001|Open Label|Sponsor decision|1|||
147388420|NCT02282761|531583171|FG000|Overall Study|Death|0|||
147388421|NCT02282761|531583172|FG001|Overall Study|Death|0|||
147388422|NCT02282761|531583173|FG002|Overall Study|Death|1|||
147388423|NCT02282761|531583171|FG000|Overall Study|Adverse Event|6|||
147388424|NCT02282761|531583172|FG001|Overall Study|Adverse Event|2|||
147388425|NCT02282761|531583173|FG002|Overall Study|Adverse Event|0|||
147388426|NCT02282761|531583171|FG000|Overall Study|Lack of Efficacy|11|||
147388427|NCT02282761|531583172|FG001|Overall Study|Lack of Efficacy|6|||
147388428|NCT02282761|531583173|FG002|Overall Study|Lack of Efficacy|17|||
147388429|NCT02282761|531583171|FG000|Overall Study|Lost to Follow-up|2|||
147388430|NCT02282761|531583172|FG001|Overall Study|Lost to Follow-up|2|||
147388431|NCT02282761|531583173|FG002|Overall Study|Lost to Follow-up|1|||
147388432|NCT02282761|531583171|FG000|Overall Study|Physician Decision|0|||
147388433|NCT02282761|531583172|FG001|Overall Study|Physician Decision|0|||
147388434|NCT02282761|531583173|FG002|Overall Study|Physician Decision|2|||
147388435|NCT02282761|531583171|FG000|Overall Study|Withdrawal by Subject|8|||
147388436|NCT02282761|531583172|FG001|Overall Study|Withdrawal by Subject|10|||
147388437|NCT02282761|531583173|FG002|Overall Study|Withdrawal by Subject|16|||
147388438|NCT02282761|531583171|FG000|Overall Study|Other|3|||
147388439|NCT02282761|531583172|FG001|Overall Study|Other|2|||
147388440|NCT02282761|531583173|FG002|Overall Study|Other|1|||
147388441|NCT06312566|531583177|FG000|Overall Study|Protocol Violation|0|||
147388442|NCT06312566|531583178|FG001|Overall Study|Protocol Violation|1|||
147388443|NCT03747575|531583179|FG000|Overall Study|Withdrawal by Subject|6|||
147388444|NCT03747575|531583180|FG001|Overall Study|Withdrawal by Subject|3|||
147388445|NCT03747575|531583179|FG000|Overall Study|Lost to Follow-up|3|||
147388446|NCT03747575|531583180|FG001|Overall Study|Lost to Follow-up|3|||
147388447|NCT03747575|531583179|FG000|Overall Study|Adverse Event|0|||
147388448|NCT03747575|531583180|FG001|Overall Study|Adverse Event|1|||
147388449|NCT02924051|531583183|FG000|Overall Study|Withdrawal by Subject|1|||
147388450|NCT02924051|531583184|FG001|Overall Study|Withdrawal by Subject|9|||
147388451|NCT00914732|531583188|FG000|Overall Study|Lost to Follow-up|6|||
147388452|NCT00914732|531583189|FG001|Overall Study|Lost to Follow-up|7|||
147388453|NCT00914732|531583190|FG002|Overall Study|Lost to Follow-up|9|||
147388454|NCT00914732|531583188|FG000|Overall Study|Withdrawal by Subject|3|||
147388455|NCT00914732|531583189|FG001|Overall Study|Withdrawal by Subject|0|||
147388456|NCT00914732|531583190|FG002|Overall Study|Withdrawal by Subject|2|||
147388457|NCT00914732|531583188|FG000|Overall Study|Adverse Event|1|||
147388458|NCT00914732|531583189|FG001|Overall Study|Adverse Event|0|||
147388459|NCT00914732|531583190|FG002|Overall Study|Adverse Event|0|||
147615108|NCT00266630|532406598|FG001|Overall Study|Lost to Follow-up|0|||
147615109|NCT00266630|532406597|FG000|Overall Study|Other|19|||
147615110|NCT00266630|532406598|FG001|Overall Study|Other|11|||
147388460|NCT02130401|531583191|FG000|Overall Study|Poor enrollment|6|||
147388461|NCT00321672|531583192|FG000|Overall Study|Withdrawal by Subject|5|||
147388462|NCT00321672|531583193|FG001|Overall Study|Withdrawal by Subject|1|||
147388463|NCT00321672|531583194|FG002|Overall Study|Withdrawal by Subject|2|||
147388464|NCT00321672|531583195|FG003|Overall Study|Withdrawal by Subject|0|||
147388465|NCT00321672|531583192|FG000|Overall Study|Noncompliance|1|||
147388466|NCT00321672|531583193|FG001|Overall Study|Noncompliance|2|||
147388467|NCT00321672|531583194|FG002|Overall Study|Noncompliance|1|||
147615111|NCT05377749|532406603|FG000|3 Weeks|Lost to Follow-up|2|||
147388468|NCT00321672|531583195|FG003|Overall Study|Noncompliance|0|||
147388469|NCT00321672|531583192|FG000|Overall Study|Adverse Event|1|||
147388470|NCT00321672|531583193|FG001|Overall Study|Adverse Event|1|||
147388471|NCT00321672|531583194|FG002|Overall Study|Adverse Event|0|||
147615112|NCT05377749|532406604|FG001|3 Weeks|Lost to Follow-up|4|||
147388472|NCT00321672|531583195|FG003|Overall Study|Adverse Event|0|||
147615113|NCT05377749|532406603|FG000|3 Weeks|Withdrawal by Subject|1|||
147615114|NCT05377749|532406604|FG001|3 Weeks|Withdrawal by Subject|1|||
147615115|NCT04909853|532406605|FG000|Part 1|Assigned but not treated|0|||
147388473|NCT00321672|531583192|FG000|Overall Study|Lack of Efficacy|1|||
147388474|NCT00321672|531583193|FG001|Overall Study|Lack of Efficacy|1|||
147388475|NCT00321672|531583194|FG002|Overall Study|Lack of Efficacy|0|||
147388476|NCT00321672|531583195|FG003|Overall Study|Lack of Efficacy|0|||
147388477|NCT00321672|531583192|FG000|Overall Study|Lost to Follow-up|2|||
147388478|NCT00321672|531583193|FG001|Overall Study|Lost to Follow-up|0|||
147388479|NCT00321672|531583194|FG002|Overall Study|Lost to Follow-up|4|||
147388480|NCT00321672|531583195|FG003|Overall Study|Lost to Follow-up|2|||
147388481|NCT00321672|531583192|FG000|Overall Study|Death|1|||
147388482|NCT00321672|531583193|FG001|Overall Study|Death|0|||
147388483|NCT00321672|531583194|FG002|Overall Study|Death|0|||
147388484|NCT00321672|531583195|FG003|Overall Study|Death|0|||
147388485|NCT00321672|531583192|FG000|Overall Study|Too far to travel for visits|1|||
147388486|NCT00321672|531583193|FG001|Overall Study|Too far to travel for visits|0|||
147388487|NCT00321672|531583194|FG002|Overall Study|Too far to travel for visits|0|||
147388488|NCT00321672|531583195|FG003|Overall Study|Too far to travel for visits|0|||
147388489|NCT00321672|531583192|FG000|Overall Study|Incarcerated|0|||
147388490|NCT00321672|531583193|FG001|Overall Study|Incarcerated|0|||
147388491|NCT00321672|531583194|FG002|Overall Study|Incarcerated|2|||
147388492|NCT00321672|531583195|FG003|Overall Study|Incarcerated|0|||
147388493|NCT00321672|531583192|FG000|Overall Study|Moved out of state|0|||
147388494|NCT00321672|531583193|FG001|Overall Study|Moved out of state|1|||
147388495|NCT00321672|531583194|FG002|Overall Study|Moved out of state|1|||
147388496|NCT00321672|531583195|FG003|Overall Study|Moved out of state|0|||
147388497|NCT00321672|531583192|FG000|Overall Study|Protocol Violation|0|||
147388498|NCT00321672|531583193|FG001|Overall Study|Protocol Violation|0|||
147388499|NCT00321672|531583194|FG002|Overall Study|Protocol Violation|1|||
147388500|NCT00321672|531583195|FG003|Overall Study|Protocol Violation|0|||
147388501|NCT00321672|531583192|FG000|Overall Study|Diagnosis of testicular cancer|0|||
147388502|NCT00321672|531583193|FG001|Overall Study|Diagnosis of testicular cancer|1|||
147388503|NCT00321672|531583194|FG002|Overall Study|Diagnosis of testicular cancer|0|||
147388504|NCT00321672|531583195|FG003|Overall Study|Diagnosis of testicular cancer|0|||
147388505|NCT00321672|531583192|FG000|Overall Study|Extensive travel required for new job|0|||
147388506|NCT00321672|531583193|FG001|Overall Study|Extensive travel required for new job|1|||
147388507|NCT00321672|531583194|FG002|Overall Study|Extensive travel required for new job|0|||
147388508|NCT00321672|531583195|FG003|Overall Study|Extensive travel required for new job|0|||
147388509|NCT00512902|531583198|FG000|Overall Study|Adverse Event|7|||
147388510|NCT00512902|531583198|FG000|Overall Study|Lost to Follow-up|1|||
147388511|NCT01549951|531583199|FG000|Overall Study|Adverse Event|15|||
147388512|NCT01549951|531583199|FG000|Overall Study|Withdrawal by Subject|2|||
147388513|NCT01549951|531583199|FG000|Overall Study|Unsatisfactory therapeutic response|1|||
147388514|NCT01549951|531583199|FG000|Overall Study|Progressive disease|29|||
147388515|NCT01549951|531583199|FG000|Overall Study|Symptomatic deterioration|1|||
147388516|NCT01549951|531583199|FG000|Overall Study|Other|2|||
147388517|NCT00738400|531583200|FG000|Overall Study|Adverse Event|3|||
147388518|NCT00738400|531583201|FG001|Overall Study|Adverse Event|1|||
147388519|NCT00738400|531583200|FG000|Overall Study|Withdrawal by Subject|0|||
147388520|NCT00738400|531583201|FG001|Overall Study|Withdrawal by Subject|1|||
147388521|NCT00738400|531583200|FG000|Overall Study|Lack of Efficacy|0|||
147388522|NCT00738400|531583201|FG001|Overall Study|Lack of Efficacy|1|||
147388523|NCT00738400|531583200|FG000|Overall Study|Lost to Follow-up|0|||
147388524|NCT00738400|531583201|FG001|Overall Study|Lost to Follow-up|3|||
147388525|NCT00738400|531583200|FG000|Overall Study|Protocol Violation|1|||
147388526|NCT00738400|531583201|FG001|Overall Study|Protocol Violation|0|||
147388527|NCT00738400|531583200|FG000|Overall Study|Non-compliant with study medication|0|||
147388528|NCT00738400|531583201|FG001|Overall Study|Non-compliant with study medication|1|||
147388529|NCT01052714|531583206|FG000|Overall Study|Adverse Event|6|||
147388530|NCT01052714|531583207|FG001|Overall Study|Adverse Event|3|||
147388531|NCT01052714|531583208|FG002|Overall Study|Adverse Event|0|||
147615116|NCT04909853|532406606|FG001|Part 1|Assigned but not treated|0|||
147615117|NCT04909853|532406607|FG002|Part 1|Assigned but not treated|1|||
147388532|NCT01052714|531583206|FG000|Overall Study|Death|1|||
147388533|NCT01052714|531583207|FG001|Overall Study|Death|2|||
147388534|NCT01052714|531583208|FG002|Overall Study|Death|0|||
147388535|NCT01052714|531583206|FG000|Overall Study|Lost to Follow-up|2|||
147457792|NCT02971670|531837727|FG003|Overall Study|Withdrawal by Subject|2|||
147457793|NCT02793232|531837728|FG000|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
147615118|NCT04909853|532406608|FG003|Part 1|Assigned but not treated|0|||
147388536|NCT01052714|531583207|FG001|Overall Study|Lost to Follow-up|3|||
147388537|NCT01052714|531583208|FG002|Overall Study|Lost to Follow-up|0|||
147388538|NCT01052714|531583206|FG000|Overall Study|Physician Decision|9|||
147388539|NCT01052714|531583207|FG001|Overall Study|Physician Decision|9|||
147388540|NCT01052714|531583208|FG002|Overall Study|Physician Decision|1|||
147388541|NCT01052714|531583206|FG000|Overall Study|Withdrawal by Subject|7|||
147388542|NCT01052714|531583207|FG001|Overall Study|Withdrawal by Subject|12|||
147388543|NCT01052714|531583208|FG002|Overall Study|Withdrawal by Subject|1|||
147388544|NCT00990314|531583209|FG000|Overall Study|Death|2|||
147457794|NCT02793232|531837729|FG001|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
147457795|NCT02793232|531837730|FG002|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
147457796|NCT02793232|531837731|FG003|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
147457797|NCT02793232|531837732|FG004|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|1|||
147457798|NCT02793232|531837733|FG005|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
147457799|NCT02793232|531837734|FG006|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|1|||
147457800|NCT02793232|531837735|FG007|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
147457801|NCT02793232|531837736|FG008|Period 1-Part A:5 Days; Part B,C:19 Days|Adverse Event|0|||
147457802|NCT04849780|531837737|FG000|Period 1|Covid-19 Related|1|||
147457803|NCT04849780|531837738|FG001|Period 1|Covid-19 Related|0|||
147457804|NCT04849780|531837737|FG000|Period 1|Subject no longer meet eligibility criteria|3|||
147457805|NCT04849780|531837738|FG001|Period 1|Subject no longer meet eligibility criteria|0|||
147457806|NCT04849780|531837737|FG000|Period 2|Subject no longer meet eligibility criteria|2|||
147457807|NCT04849780|531837738|FG001|Period 2|Subject no longer meet eligibility criteria|0|||
147457808|NCT01580397|531837739|FG000|Overall Study|Lack of Efficacy|14|||
147457809|NCT01405053|531837743|FG000|Overall Study|Adverse Event|3|||
147457810|NCT01405053|531837744|FG001|Overall Study|Adverse Event|0|||
147457811|NCT01405053|531837743|FG000|Overall Study|Lost to Follow-up|0|||
147457812|NCT01405053|531837744|FG001|Overall Study|Lost to Follow-up|1|||
147457813|NCT01405053|531837743|FG000|Overall Study|Participant choice|2|||
147457814|NCT01405053|531837744|FG001|Overall Study|Participant choice|1|||
147457815|NCT01405053|531837743|FG000|Overall Study|Inadequate therapeutic effect|2|||
147457816|NCT01405053|531837744|FG001|Overall Study|Inadequate therapeutic effect|1|||
147457817|NCT01405053|531837743|FG000|Overall Study|Withdrawal by Subject|3|||
147457818|NCT01405053|531837744|FG001|Overall Study|Withdrawal by Subject|4|||
147457819|NCT01405053|531837743|FG000|Overall Study|Other|0|||
147457820|NCT01405053|531837744|FG001|Overall Study|Other|1|||
147457821|NCT00357500|531837755|FG000|Overall Study|Adverse Event|3|||
147457822|NCT00357500|531837755|FG000|Overall Study|Withdrawal by Subject|5|||
147457823|NCT00357500|531837755|FG000|Overall Study|Progressive Disease|65|||
147457824|NCT00357500|531837755|FG000|Overall Study|Not Started Protocol Therapy|4|||
147457825|NCT02301403|531837756|FG000|Overall Study|Withdrawal by Subject|28|||
147457826|NCT02301403|531837757|FG001|Overall Study|Withdrawal by Subject|41|||
147457827|NCT01060059|531837760|FG000|Overall Study|Adverse Event|1|||
147457828|NCT01060059|531837761|FG001|Overall Study|Adverse Event|1|||
147457829|NCT01060059|531837760|FG000|Overall Study|Death|2|||
147457830|NCT01060059|531837761|FG001|Overall Study|Death|3|||
147457831|NCT01060059|531837760|FG000|Overall Study|Lost to Follow-up|18|||
147457832|NCT01060059|531837761|FG001|Overall Study|Lost to Follow-up|34|||
147457833|NCT01060059|531837760|FG000|Overall Study|entry criteria not met|4|||
147457834|NCT01060059|531837761|FG001|Overall Study|entry criteria not met|3|||
147457835|NCT01060059|531837760|FG000|Overall Study|Withdrawal by Subject|35|||
147457836|NCT01060059|531837761|FG001|Overall Study|Withdrawal by Subject|23|||
147457837|NCT01060059|531837760|FG000|Overall Study|lack of glycemic control|2|||
147457838|NCT01060059|531837761|FG001|Overall Study|lack of glycemic control|1|||
147457839|NCT01060059|531837760|FG000|Overall Study|lack of compliance|5|||
147664951|NCT04161391|532597967|FG003|Overall Study|Physician Decision|2|||
147664952|NCT04161391|532597968|FG004|Overall Study|Physician Decision|0|||
147457840|NCT01060059|531837761|FG001|Overall Study|lack of compliance|2|||
147457841|NCT02302963|531837762|FG000|Overall Study|Withdrawal by Subject|2|||
147457842|NCT02302963|531837763|FG001|Overall Study|Withdrawal by Subject|1|||
147457843|NCT02302963|531837762|FG000|Overall Study|Steroid injection|0|||
147457844|NCT02302963|531837763|FG001|Overall Study|Steroid injection|1|||
147457845|NCT02302963|531837762|FG000|Overall Study|Physician Decision|1|||
147457846|NCT02302963|531837763|FG001|Overall Study|Physician Decision|0|||
147457847|NCT01816243|531837768|FG000|Overall Study|Adverse Event|6|||
147457848|NCT01816243|531837768|FG000|Overall Study|Lost to Follow-up|1|||
147457849|NCT01816243|531837768|FG000|Overall Study|Lack of Efficacy|1|||
147457850|NCT01816243|531837768|FG000|Overall Study|Not eligible for the study|1|||
147457851|NCT01816243|531837768|FG000|Overall Study|Amputation|3|||
147457852|NCT02319044|531837775|FG000|Overall Study|Death, PI/sponsor decision, med history|0|||
147664953|NCT04161391|532597969|FG005|Overall Study|Physician Decision|0|||
147664954|NCT04161391|532597970|FG006|Overall Study|Physician Decision|2|||
147664955|NCT04161391|532597971|FG007|Overall Study|Physician Decision|0|||
147457853|NCT02319044|531837776|FG001|Overall Study|Death, PI/sponsor decision, med history|1|||
147457854|NCT02319044|531837777|FG002|Overall Study|Death, PI/sponsor decision, med history|4|||
147457855|NCT02319044|531837775|FG000|Overall Study|Withdrawal by Subject|3|||
147457856|NCT02319044|531837776|FG001|Overall Study|Withdrawal by Subject|3|||
147457857|NCT02319044|531837777|FG002|Overall Study|Withdrawal by Subject|6|||
147457858|NCT02319044|531837775|FG000|Overall Study|Condition under investigation worsened|100|||
147457859|NCT02319044|531837776|FG001|Overall Study|Condition under investigation worsened|50|||
147457860|NCT02319044|531837777|FG002|Overall Study|Condition under investigation worsened|46|||
147457861|NCT02319044|531837775|FG000|Overall Study|Adverse Event|17|||
147457862|NCT02319044|531837776|FG001|Overall Study|Adverse Event|2|||
147457863|NCT02319044|531837777|FG002|Overall Study|Adverse Event|8|||
147664956|NCT04161391|532597972|FG008|Overall Study|Physician Decision|0|||
147457864|NCT02319044|531837775|FG000|Overall Study|Study specific discontinuation criteria|2|||
147457865|NCT02319044|531837776|FG001|Overall Study|Study specific discontinuation criteria|2|||
147457866|NCT02319044|531837777|FG002|Overall Study|Study specific discontinuation criteria|1|||
147457867|NCT02319044|531837775|FG000|Overall Study|Not treated|0|||
147457868|NCT02319044|531837776|FG001|Overall Study|Not treated|2|||
147457869|NCT02319044|531837777|FG002|Overall Study|Not treated|2|||
147457870|NCT02317562|531837778|FG000|Overall Study|Physician Decision|1|||
147457871|NCT02317562|531837778|FG000|Overall Study|early termination of the study|8|||
147457872|NCT02317562|531837778|FG000|Overall Study|Lack of Efficacy|4|||
147457873|NCT02317562|531837778|FG000|Overall Study|Withdrawal by Subject|1|||
147457874|NCT00603915|531837779|FG000|Overall Study|Physician Decision|1|||
147457875|NCT03891901|531837780|FG000|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|1|||
147457876|NCT03891901|531837781|FG001|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
147457877|NCT03891901|531837782|FG002|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
147457878|NCT03891901|531837783|FG003|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
147457879|NCT03891901|531837784|FG004|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
147457880|NCT03891901|531837785|FG005|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
147457881|NCT03891901|531837786|FG006|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
147457882|NCT03891901|531837787|FG007|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
147457883|NCT03891901|531837788|FG008|Overall Study|Exposure to coronavirus disease 2019 (COVID-19)|0|||
147457884|NCT03891901|531837780|FG000|Overall Study|Adverse Event|2|||
147457885|NCT03891901|531837781|FG001|Overall Study|Adverse Event|2|||
147457886|NCT03891901|531837782|FG002|Overall Study|Adverse Event|0|||
147457887|NCT03891901|531837783|FG003|Overall Study|Adverse Event|0|||
147457888|NCT03891901|531837784|FG004|Overall Study|Adverse Event|0|||
147457889|NCT03891901|531837785|FG005|Overall Study|Adverse Event|0|||
147457890|NCT03891901|531837786|FG006|Overall Study|Adverse Event|0|||
147457891|NCT03891901|531837787|FG007|Overall Study|Adverse Event|0|||
147457892|NCT03891901|531837788|FG008|Overall Study|Adverse Event|0|||
147457893|NCT03891901|531837780|FG000|Overall Study|Poor venous access|1|||
147457894|NCT03891901|531837781|FG001|Overall Study|Poor venous access|0|||
147388545|NCT00990314|531583209|FG000|Overall Study|Adverse Event|2|||
147388546|NCT00990314|531583209|FG000|Overall Study|Withdrawal by Subject|3|||
147388547|NCT00990314|531583209|FG000|Overall Study|Non-Compliance|1|||
147388548|NCT00990314|531583209|FG000|Overall Study|Physician Decision|3|||
147388549|NCT00990314|531583209|FG000|Overall Study|Lack of Efficacy|1|||
147388550|NCT03689452|531583217|FG000|Overall Study|Lost to Follow-up|1|||
147388551|NCT03689452|531583218|FG001|Overall Study|Lost to Follow-up|1|||
147388552|NCT02676778|531583219|FG000|Overall Study|Disease Progression|7|||
147388553|NCT02676778|531583220|FG001|Overall Study|Disease Progression|3|||
147388554|NCT02676778|531583221|FG002|Overall Study|Disease Progression|1|||
147388555|NCT02676778|531583219|FG000|Overall Study|Couldn't Start Cycle After Planned Date|1|||
147388556|NCT02676778|531583220|FG001|Overall Study|Couldn't Start Cycle After Planned Date|1|||
147388557|NCT02676778|531583221|FG002|Overall Study|Couldn't Start Cycle After Planned Date|0|||
147388558|NCT02676778|531583219|FG000|Overall Study|Withdrawal by Subject|3|||
147388559|NCT02676778|531583220|FG001|Overall Study|Withdrawal by Subject|2|||
147388560|NCT02676778|531583221|FG002|Overall Study|Withdrawal by Subject|0|||
147388561|NCT02676778|531583219|FG000|Overall Study|Other|4|||
147388562|NCT02676778|531583220|FG001|Overall Study|Other|3|||
147388563|NCT02676778|531583221|FG002|Overall Study|Other|0|||
147388564|NCT02676778|531583219|FG000|Overall Study|Adverse Event|2|||
147388565|NCT02676778|531583220|FG001|Overall Study|Adverse Event|3|||
147388566|NCT02676778|531583221|FG002|Overall Study|Adverse Event|0|||
147388567|NCT03214198|531583228|FG000|Overall Study|Case Report Forms Uncollected|18|||
147388568|NCT03214198|531583228|FG000|Overall Study|Protocol Deviation|18|||
147388569|NCT03686176|531583229|FG000|Overall Study|Procedure cancelled|1|||
147388570|NCT03686176|531583230|FG001|Overall Study|Procedure cancelled|0|||
147388571|NCT03686176|531583231|FG002|Overall Study|Procedure cancelled|0|||
147388572|NCT03686176|531583229|FG000|Overall Study|VR Malfunction|1|||
147388573|NCT03686176|531583230|FG001|Overall Study|VR Malfunction|0|||
147388574|NCT03686176|531583231|FG002|Overall Study|VR Malfunction|0|||
147457895|NCT03891901|531837782|FG002|Overall Study|Poor venous access|0|||
147457896|NCT03891901|531837783|FG003|Overall Study|Poor venous access|0|||
147457897|NCT03891901|531837784|FG004|Overall Study|Poor venous access|0|||
147457898|NCT03891901|531837785|FG005|Overall Study|Poor venous access|0|||
147457899|NCT03891901|531837786|FG006|Overall Study|Poor venous access|0|||
147457900|NCT03891901|531837787|FG007|Overall Study|Poor venous access|0|||
147457901|NCT03891901|531837788|FG008|Overall Study|Poor venous access|0|||
147457902|NCT03891901|531837780|FG000|Overall Study|Withdrawal by Subject|0|||
147388575|NCT04295499|531583236|FG000|Overall Study|moving out of state|1|||
147388576|NCT04295499|531583237|FG001|Overall Study|moving out of state|0|||
147388577|NCT04295499|531583236|FG000|Overall Study|traveling overseas for business prior to the study completion|1|||
147388578|NCT04295499|531583237|FG001|Overall Study|traveling overseas for business prior to the study completion|0|||
147388579|NCT00308113|531583240|FG000|Overall Study|Protocol closure|0|||
147388580|NCT00308113|531583241|FG001|Overall Study|Protocol closure|0|||
147457903|NCT03891901|531837781|FG001|Overall Study|Withdrawal by Subject|2|||
147457904|NCT03891901|531837782|FG002|Overall Study|Withdrawal by Subject|0|||
147457905|NCT03891901|531837783|FG003|Overall Study|Withdrawal by Subject|0|||
147457906|NCT03891901|531837784|FG004|Overall Study|Withdrawal by Subject|0|||
147457907|NCT03891901|531837785|FG005|Overall Study|Withdrawal by Subject|0|||
147457908|NCT03891901|531837786|FG006|Overall Study|Withdrawal by Subject|0|||
147457909|NCT03891901|531837787|FG007|Overall Study|Withdrawal by Subject|0|||
147457910|NCT03891901|531837788|FG008|Overall Study|Withdrawal by Subject|0|||
147457911|NCT03687502|531837793|FG000|Overall Study|IV was removed prior to radiology visit for ultrasound|1|||
147457912|NCT03687502|531837793|FG000|Overall Study|Lumason not available|1|||
147457913|NCT01777581|531837794|FG000|Overall Study|Lost to Follow-up|1|||
147457914|NCT01777581|531837795|FG001|Overall Study|Lost to Follow-up|1|||
147457915|NCT01777581|531837794|FG000|Overall Study|Adverse Event|2|||
147457916|NCT01777581|531837795|FG001|Overall Study|Adverse Event|0|||
147457917|NCT01777581|531837794|FG000|Overall Study|Lack of Efficacy|0|||
147457918|NCT01777581|531837795|FG001|Overall Study|Lack of Efficacy|1|||
147457919|NCT05702736|531837796|FG000|Overall Study|2 patients didn't participate in the study voluntarily.|2|||
147457920|NCT05702736|531837797|FG001|Overall Study|2 patients didn't participate in the study voluntarily.|0|||
147457921|NCT05702736|531837796|FG000|Overall Study|2 patients didn't complete 6 interviews.|2|||
147457922|NCT05702736|531837797|FG001|Overall Study|2 patients didn't complete 6 interviews.|0|||
147457923|NCT02321436|531837800|FG000|Overall Study|Withdrawal by Subject|1|||
147457924|NCT02321436|531837801|FG001|Overall Study|Withdrawal by Subject|0|||
147457925|NCT02321436|531837800|FG000|Overall Study|Lost to Follow-up|0|||
147457926|NCT02321436|531837801|FG001|Overall Study|Lost to Follow-up|1|||
147457927|NCT00644787|531837802|FG000|Period 1: Titration Phase|Adverse Event|11|||
147457928|NCT00644787|531837803|FG001|Period 1: Titration Phase|Adverse Event|0|||
147457929|NCT00644787|531837804|FG002|Period 1: Titration Phase|Adverse Event|0|||
147457930|NCT00644787|531837802|FG000|Period 1: Titration Phase|Withdrawal by Subject|2|||
147457931|NCT00644787|531837803|FG001|Period 1: Titration Phase|Withdrawal by Subject|0|||
147457932|NCT00644787|531837804|FG002|Period 1: Titration Phase|Withdrawal by Subject|0|||
147457933|NCT00644787|531837802|FG000|Period 1: Titration Phase|Physician Decision|1|||
147457934|NCT00644787|531837803|FG001|Period 1: Titration Phase|Physician Decision|0|||
147457935|NCT00644787|531837804|FG002|Period 1: Titration Phase|Physician Decision|0|||
147457936|NCT00644787|531837802|FG000|Period 1: Titration Phase|Worsening of underlying disease|5|||
147457937|NCT00644787|531837803|FG001|Period 1: Titration Phase|Worsening of underlying disease|0|||
147457938|NCT00644787|531837804|FG002|Period 1: Titration Phase|Worsening of underlying disease|0|||
147457939|NCT00644787|531837802|FG000|Period 1: Titration Phase|Worsening of complications|1|||
147457940|NCT00644787|531837803|FG001|Period 1: Titration Phase|Worsening of complications|0|||
147457941|NCT00644787|531837804|FG002|Period 1: Titration Phase|Worsening of complications|0|||
147457942|NCT00644787|531837802|FG000|Period 1: Titration Phase|Worsening of symptoms|1|||
147457943|NCT00644787|531837803|FG001|Period 1: Titration Phase|Worsening of symptoms|0|||
147457944|NCT00644787|531837804|FG002|Period 1: Titration Phase|Worsening of symptoms|0|||
147457945|NCT00644787|531837802|FG000|Period 1: Titration Phase|Dose adjustment required on Day 12 or 13|3|||
147457946|NCT00644787|531837803|FG001|Period 1: Titration Phase|Dose adjustment required on Day 12 or 13|0|||
147457947|NCT00644787|531837804|FG002|Period 1: Titration Phase|Dose adjustment required on Day 12 or 13|0|||
147457948|NCT00644787|531837802|FG000|Period 1: Titration Phase|Participant was judged as ineligible|3|||
147457949|NCT00644787|531837803|FG001|Period 1: Titration Phase|Participant was judged as ineligible|0|||
147457950|NCT00644787|531837804|FG002|Period 1: Titration Phase|Participant was judged as ineligible|0|||
147457951|NCT00644787|531837802|FG000|Period 2: Double Blind Phase|Adverse Event|0|||
147457952|NCT00644787|531837803|FG001|Period 2: Double Blind Phase|Adverse Event|2|||
147457953|NCT00644787|531837804|FG002|Period 2: Double Blind Phase|Adverse Event|4|||
147388581|NCT00308113|531583242|FG002|Overall Study|Protocol closure|0|||
147388582|NCT00308113|531583243|FG003|Overall Study|Protocol closure|1|||
147388583|NCT04448561|531583244|FG000|Overall Study|Noncompliance|1|||
147388584|NCT04448561|531583245|FG001|Overall Study|Noncompliance|0|||
147388585|NCT04413149|531585153|FG000|Overall Study|Death|10|||
147388586|NCT04413149|531585154|FG001|Overall Study|Death|5|||
147388587|NCT04413149|531585153|FG000|Overall Study|Lung transplantation|1|||
147388588|NCT04413149|531585154|FG001|Overall Study|Lung transplantation|0|||
147388589|NCT02661490|531585157|FG000|Overall Study|Lost to Follow-up|0|||
147388590|NCT02661490|531585158|FG001|Overall Study|Lost to Follow-up|1|||
147388591|NCT02661490|531585159|FG002|Overall Study|Lost to Follow-up|0|||
147388592|NCT02661490|531585160|FG003|Overall Study|Lost to Follow-up|0|||
147388593|NCT02661490|531585161|FG004|Overall Study|Lost to Follow-up|2|||
147388594|NCT02661490|531585157|FG000|Overall Study|Withdrawal by Subject|2|||
147388595|NCT02661490|531585158|FG001|Overall Study|Withdrawal by Subject|0|||
147388596|NCT02661490|531585159|FG002|Overall Study|Withdrawal by Subject|2|||
147388597|NCT02661490|531585160|FG003|Overall Study|Withdrawal by Subject|0|||
147457954|NCT00644787|531837802|FG000|Period 2: Double Blind Phase|Withdrawal by Subject|0|||
147457955|NCT00644787|531837803|FG001|Period 2: Double Blind Phase|Withdrawal by Subject|1|||
147457956|NCT00644787|531837804|FG002|Period 2: Double Blind Phase|Withdrawal by Subject|0|||
147457957|NCT00644787|531837802|FG000|Period 2: Double Blind Phase|Worsening of underlying disease|0|||
147527363|NCT00508872|532084245|FG000|Overall Study|Physician Decision|1|||
147388598|NCT02661490|531585161|FG004|Overall Study|Withdrawal by Subject|0|||
147388599|NCT02661490|531585157|FG000|Overall Study|Death|1|||
147388600|NCT02661490|531585158|FG001|Overall Study|Death|1|||
147388601|NCT02661490|531585159|FG002|Overall Study|Death|0|||
147388602|NCT02661490|531585160|FG003|Overall Study|Death|1|||
147388603|NCT02661490|531585161|FG004|Overall Study|Death|0|||
147388604|NCT02661490|531585157|FG000|Overall Study|Reason not Specified|0|||
147388605|NCT02661490|531585158|FG001|Overall Study|Reason not Specified|0|||
147388606|NCT02661490|531585159|FG002|Overall Study|Reason not Specified|0|||
147388607|NCT02661490|531585160|FG003|Overall Study|Reason not Specified|0|||
147388608|NCT02661490|531585161|FG004|Overall Study|Reason not Specified|1|||
147388609|NCT02878590|531585162|FG000|Overall Study|Withdrawal by Subject|2|||
147388610|NCT03322514|531585163|FG000|Overall Study|Withdrawal by Subject|1|||
147388611|NCT03322514|531585164|FG001|Overall Study|Withdrawal by Subject|1|||
147388612|NCT01184859|531585165|FG000|Period 1: Single Dose|Insufficient urine production|0|||
147388613|NCT01184859|531585166|FG001|Period 1: Single Dose|Insufficient urine production|1|||
147388614|NCT01184859|531585167|FG002|Period 1: Single Dose|Insufficient urine production|0|||
147388615|NCT01184859|531585168|FG003|Period 1: Single Dose|Insufficient urine production|0|||
147388616|NCT01184859|531585169|FG004|Period 1: Single Dose|Insufficient urine production|0|||
147388617|NCT01184859|531585165|FG000|Period 1: Single Dose|Protocol Violation|0|||
147388618|NCT01184859|531585166|FG001|Period 1: Single Dose|Protocol Violation|1|||
147615119|NCT04909853|532406605|FG000|Part 2|Adverse Event|0|||
147615120|NCT04909853|532406606|FG001|Part 2|Adverse Event|0|||
147615121|NCT04909853|532406607|FG002|Part 2|Adverse Event|0|||
147615122|NCT04909853|532406608|FG003|Part 2|Adverse Event|1|||
147615123|NCT01720225|532406611|FG000|Overall Study|Withdrawal by Subject|0|||
147615124|NCT01720225|532406612|FG001|Overall Study|Withdrawal by Subject|1|||
147615125|NCT01720225|532406611|FG000|Overall Study|Did not complete 2 cycles of therapy|3|||
147615126|NCT01720225|532406612|FG001|Overall Study|Did not complete 2 cycles of therapy|0|||
147615127|NCT00661193|532406616|FG000|Overall Study|Adverse Event|2|||
147615128|NCT00661193|532406617|FG001|Overall Study|Adverse Event|1|||
147615129|NCT00661193|532406616|FG000|Overall Study|Withdrawal by Subject|3|||
147615130|NCT00661193|532406617|FG001|Overall Study|Withdrawal by Subject|1|||
147615131|NCT00661193|532406616|FG000|Overall Study|Progression|27|||
147615132|NCT00661193|532406617|FG001|Overall Study|Progression|24|||
147615133|NCT00661193|532406616|FG000|Overall Study|Not protocol specified|1|||
147664957|NCT04161391|532597964|FG000|Overall Study|Progressive Disease|4|||
147388619|NCT01184859|531585167|FG002|Period 1: Single Dose|Protocol Violation|0|||
147388620|NCT01184859|531585168|FG003|Period 1: Single Dose|Protocol Violation|0|||
147388621|NCT01184859|531585169|FG004|Period 1: Single Dose|Protocol Violation|0|||
147388622|NCT01184859|531585165|FG000|Period 1: Single Dose|Adverse Event|0|||
147388623|NCT01184859|531585166|FG001|Period 1: Single Dose|Adverse Event|0|||
147388624|NCT01184859|531585167|FG002|Period 1: Single Dose|Adverse Event|0|||
147388625|NCT01184859|531585168|FG003|Period 1: Single Dose|Adverse Event|0|||
147388626|NCT01184859|531585169|FG004|Period 1: Single Dose|Adverse Event|1|||
147388627|NCT01184859|531585165|FG000|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0|||
147388628|NCT01184859|531585166|FG001|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0|||
147388629|NCT01184859|531585167|FG002|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0|||
147388630|NCT01184859|531585168|FG003|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|0|||
147388631|NCT01184859|531585169|FG004|Period 2: Daily Dose for 28 Days|Withdrawal by Subject|1|||
147388632|NCT01184859|531585165|FG000|Period 2: Daily Dose for 28 Days|Adverse Event|1|||
147388633|NCT01184859|531585166|FG001|Period 2: Daily Dose for 28 Days|Adverse Event|0|||
147388634|NCT01184859|531585167|FG002|Period 2: Daily Dose for 28 Days|Adverse Event|0|||
147388635|NCT01184859|531585168|FG003|Period 2: Daily Dose for 28 Days|Adverse Event|0|||
147388636|NCT01184859|531585169|FG004|Period 2: Daily Dose for 28 Days|Adverse Event|0|||
147388637|NCT00961298|531585170|FG000|Two Week Placebo Run in|Withdrawal by Subject|1|||
147388638|NCT00961298|531585170|FG000|12 Weeks Duloxetine Treatment Phase|Withdrawal by Subject|2|||
147388639|NCT00961298|531585170|FG000|12 Weeks Duloxetine Treatment Phase|Protocol Violation|1|||
147388640|NCT00814632|531585171|FG000|Overall Study|Lack of Efficacy|2|||
147388641|NCT02514577|531585176|FG000|Overall Study|Lost to Follow-up|6|||
147388642|NCT02514577|531585177|FG001|Overall Study|Lost to Follow-up|6|||
147388643|NCT02514577|531585176|FG000|Overall Study|Protocol Violation|1|||
147388644|NCT02514577|531585177|FG001|Overall Study|Protocol Violation|0|||
147388645|NCT02514577|531585176|FG000|Overall Study|Withdrawal by Subject|6|||
147388646|NCT02514577|531585177|FG001|Overall Study|Withdrawal by Subject|6|||
147388647|NCT02514577|531585176|FG000|Overall Study|Adverse Event|1|||
147388648|NCT02514577|531585177|FG001|Overall Study|Adverse Event|1|||
147388649|NCT02388932|531585178|FG000|Overall Study|Death|1|||
147388650|NCT00627523|531585180|FG000|Overall Study|Lack of Efficacy|1|||
147388651|NCT00627523|531585181|FG001|Overall Study|Lack of Efficacy|0|||
147388652|NCT00627523|531585180|FG000|Overall Study|Withdrawal by Subject|0|||
147388653|NCT00627523|531585181|FG001|Overall Study|Withdrawal by Subject|2|||
147615134|NCT00661193|532406617|FG001|Overall Study|Not protocol specified|0|||
147615135|NCT01811472|532406618|FG000|Overall Study|Adverse Event|1|||
147615136|NCT01811472|532406619|FG001|Overall Study|Adverse Event|0|||
147664958|NCT04161391|532597965|FG001|Overall Study|Progressive Disease|3|||
147388654|NCT00627523|531585180|FG000|Overall Study|Other|1|||
147388655|NCT00627523|531585181|FG001|Overall Study|Other|0|||
147388656|NCT01038128|531585188|FG000|Overall Study|Lack of Efficacy|1|||
147388657|NCT01038128|531585188|FG000|Overall Study|Lost to Follow-up|1|||
147388658|NCT01038128|531585188|FG000|Overall Study|Withdrawal by Subject|2|||
147388659|NCT02186015|531585189|FG000|Overall Study|Physician Decision|1|||
147388660|NCT02186015|531585190|FG001|Overall Study|Physician Decision|0|||
147388661|NCT01533181|531585193|FG000|Overall Study|Disease progression pre-active treatment|0|||
147388662|NCT01533181|531585194|FG001|Overall Study|Disease progression pre-active treatment|1|||
147388663|NCT01533181|531585193|FG000|Overall Study|Patient withdrawal pre-active treatment|1|||
147388664|NCT01533181|531585194|FG001|Overall Study|Patient withdrawal pre-active treatment|0|||
147388665|NCT01837719|531585195|FG000|Period 2: Days 8-14 (Treatment B or A)|Withdrawal by Subject|1|||
147388666|NCT01837719|531585195|FG000|Period 5: Days 29-31 (Treatment E)|Poor compliance/noncompliance|1|||
147388667|NCT01703988|531585196|FG000|Overall Study|Investigator Judgment|0|||
147388668|NCT01703988|531585197|FG001|Overall Study|Investigator Judgment|0|||
147388669|NCT01703988|531585198|FG002|Overall Study|Investigator Judgment|0|||
147388670|NCT01703988|531585199|FG003|Overall Study|Investigator Judgment|1|||
147388671|NCT02995733|531585200|FG000|Overall Study|Study site closed|9|||
147388672|NCT02995733|531585201|FG001|Overall Study|Study site closed|10|||
147388673|NCT02995733|531585200|FG000|Overall Study|Death|3|||
147388674|NCT02995733|531585201|FG001|Overall Study|Death|4|||
147388675|NCT02995733|531585200|FG000|Overall Study|Withdrawal by Subject|6|||
147388676|NCT02995733|531585201|FG001|Overall Study|Withdrawal by Subject|2|||
147388677|NCT02995733|531585200|FG000|Overall Study|Removed by study team due to inappropriate behavior|1|||
147388678|NCT02995733|531585201|FG001|Overall Study|Removed by study team due to inappropriate behavior|0|||
147388679|NCT02995733|531585200|FG000|Overall Study|Lost to Follow-up|48|||
147388680|NCT02995733|531585201|FG001|Overall Study|Lost to Follow-up|37|||
147388681|NCT02995733|531585200|FG000|Overall Study|Other|0|||
147388682|NCT02995733|531585201|FG001|Overall Study|Other|1|||
147388683|NCT02720198|531585202|FG000|Overall Study|Withdrawal by Subject|0|||
147388684|NCT02720198|531585203|FG001|Overall Study|Withdrawal by Subject|1|||
147388685|NCT04879823|531585204|FG000|Overall Study|Physician Decision|3|||
147388686|NCT04879823|531585205|FG001|Overall Study|Physician Decision|1|||
147388687|NCT04879823|531585204|FG000|Overall Study|Protocol Violation|2|||
147388688|NCT04879823|531585205|FG001|Overall Study|Protocol Violation|3|||
147388689|NCT04879823|531585204|FG000|Overall Study|Lost to Follow-up|43|||
147388690|NCT04879823|531585205|FG001|Overall Study|Lost to Follow-up|35|||
147388691|NCT04468633|531585208|FG000|Overall Study|Withdrawal by Subject|4|||
147388692|NCT04468633|531585209|FG001|Overall Study|Withdrawal by Subject|0|||
147388693|NCT01498445|531585212|FG000|Overall Study|Lack of Efficacy|0|||
147388694|NCT01498445|531585213|FG001|Overall Study|Lack of Efficacy|0|||
147388695|NCT01498445|531585214|FG002|Overall Study|Lack of Efficacy|1|||
147388696|NCT01498445|531585215|FG003|Overall Study|Lack of Efficacy|2|||
147388697|NCT01498445|531585216|FG004|Overall Study|Lack of Efficacy|0|||
147388698|NCT01498445|531585217|FG005|Overall Study|Lack of Efficacy|0|||
147388699|NCT01498445|531585212|FG000|Overall Study|Screen Failure|0|||
147388700|NCT01498445|531585213|FG001|Overall Study|Screen Failure|0|||
147388701|NCT01498445|531585214|FG002|Overall Study|Screen Failure|0|||
147388702|NCT01498445|531585215|FG003|Overall Study|Screen Failure|0|||
147388703|NCT01498445|531585216|FG004|Overall Study|Screen Failure|1|||
147388704|NCT01498445|531585217|FG005|Overall Study|Screen Failure|1|||
147388705|NCT02592434|531585218|FG000|Open-Label Phase (18 Weeks)|Adverse Event|12|||
147388706|NCT02592434|531585219|FG001|Open-Label Phase (18 Weeks)|Adverse Event|0|||
147388707|NCT02592434|531585220|FG002|Open-Label Phase (18 Weeks)|Adverse Event|0|||
147388708|NCT02592434|531585218|FG000|Open-Label Phase (18 Weeks)|Insufficient Clinical Response|21|||
147388709|NCT02592434|531585219|FG001|Open-Label Phase (18 Weeks)|Insufficient Clinical Response|0|||
147388710|NCT02592434|531585220|FG002|Open-Label Phase (18 Weeks)|Insufficient Clinical Response|0|||
147388711|NCT02592434|531585218|FG000|Open-Label Phase (18 Weeks)|Other|3|||
147388712|NCT02592434|531585219|FG001|Open-Label Phase (18 Weeks)|Other|0|||
147388713|NCT02592434|531585220|FG002|Open-Label Phase (18 Weeks)|Other|0|||
147388714|NCT02592434|531585218|FG000|Open-Label Phase (18 Weeks)|Protocol Deviation|4|||
147388715|NCT02592434|531585219|FG001|Open-Label Phase (18 Weeks)|Protocol Deviation|0|||
147388716|NCT02592434|531585220|FG002|Open-Label Phase (18 Weeks)|Protocol Deviation|0|||
147388717|NCT02592434|531585218|FG000|Double Blind Phase (26 Weeks)|Adverse Event|0|||
147388718|NCT02592434|531585219|FG001|Double Blind Phase (26 Weeks)|Adverse Event|2|||
147388719|NCT02592434|531585220|FG002|Double Blind Phase (26 Weeks)|Adverse Event|2|||
147388720|NCT02592434|531585218|FG000|Double Blind Phase (26 Weeks)|Insufficient Clinical Response|0|||
147388721|NCT02592434|531585219|FG001|Double Blind Phase (26 Weeks)|Insufficient Clinical Response|22|||
147388722|NCT02592434|531585220|FG002|Double Blind Phase (26 Weeks)|Insufficient Clinical Response|44|||
147388723|NCT02592434|531585218|FG000|Double Blind Phase (26 Weeks)|Other|0|||
147388724|NCT02592434|531585219|FG001|Double Blind Phase (26 Weeks)|Other|1|||
147388725|NCT02592434|531585220|FG002|Double Blind Phase (26 Weeks)|Other|0|||
147388726|NCT02592434|531585218|FG000|Double Blind Phase (26 Weeks)|Protocol Deviation|0|||
147388727|NCT02592434|531585219|FG001|Double Blind Phase (26 Weeks)|Protocol Deviation|0|||
147388728|NCT02592434|531585220|FG002|Double Blind Phase (26 Weeks)|Protocol Deviation|1|||
147388729|NCT02592434|531585218|FG000|Double Blind Phase (26 Weeks)|Medication error without associated AEs|0|||
147388730|NCT02592434|531585219|FG001|Double Blind Phase (26 Weeks)|Medication error without associated AEs|1|||
147388731|NCT02592434|531585220|FG002|Double Blind Phase (26 Weeks)|Medication error without associated AEs|0|||
147388732|NCT02592434|531585218|FG000|Double Blind Phase (26 Weeks)|Withdrawal By Parent/Guardian|0|||
147388733|NCT02592434|531585219|FG001|Double Blind Phase (26 Weeks)|Withdrawal By Parent/Guardian|1|||
147388734|NCT02592434|531585220|FG002|Double Blind Phase (26 Weeks)|Withdrawal By Parent/Guardian|0|||
147388735|NCT00105521|531585223|FG000|Overall Study|Other|1|||
147388736|NCT00105521|531585224|FG001|Overall Study|Other|1|||
147388737|NCT00105521|531585225|FG002|Overall Study|Other|2|||
147388738|NCT00105521|531585226|FG003|Overall Study|Other|0|||
147388739|NCT00105521|531585223|FG000|Overall Study|Adverse Event|10|||
147388740|NCT00105521|531585224|FG001|Overall Study|Adverse Event|4|||
147388741|NCT00105521|531585225|FG002|Overall Study|Adverse Event|10|||
147388742|NCT00105521|531585226|FG003|Overall Study|Adverse Event|8|||
147388743|NCT00105521|531585223|FG000|Overall Study|Withdrawal by Subject|1|||
147388744|NCT00105521|531585224|FG001|Overall Study|Withdrawal by Subject|0|||
147388745|NCT00105521|531585225|FG002|Overall Study|Withdrawal by Subject|1|||
147388746|NCT00105521|531585226|FG003|Overall Study|Withdrawal by Subject|4|||
147388747|NCT00105521|531585223|FG000|Overall Study|Lack of Efficacy|0|||
147388748|NCT00105521|531585224|FG001|Overall Study|Lack of Efficacy|0|||
147388749|NCT00105521|531585225|FG002|Overall Study|Lack of Efficacy|0|||
147388750|NCT00105521|531585226|FG003|Overall Study|Lack of Efficacy|1|||
147388751|NCT00105521|531585223|FG000|Overall Study|Protocol Violation|3|||
147388752|NCT00105521|531585224|FG001|Overall Study|Protocol Violation|5|||
147388753|NCT00105521|531585225|FG002|Overall Study|Protocol Violation|4|||
147388754|NCT00105521|531585226|FG003|Overall Study|Protocol Violation|4|||
147388755|NCT00105521|531585223|FG000|Overall Study|Lost to Follow-up|0|||
147388756|NCT00105521|531585224|FG001|Overall Study|Lost to Follow-up|1|||
147388757|NCT00105521|531585225|FG002|Overall Study|Lost to Follow-up|0|||
147388758|NCT00105521|531585226|FG003|Overall Study|Lost to Follow-up|0|||
147388759|NCT00385697|531585228|FG000|Open-label Segment 1|Withdrawal by Subject|2|||
147388760|NCT00385697|531585229|FG001|Open-label Segment 1|Withdrawal by Subject|0|||
147388761|NCT00385697|531585230|FG002|Open-label Segment 1|Withdrawal by Subject|0|||
147388762|NCT00385697|531585231|FG003|Open-label Segment 1|Withdrawal by Subject|0|||
147388763|NCT00385697|531585232|FG004|Open-label Segment 1|Withdrawal by Subject|0|||
147388764|NCT00385697|531585228|FG000|Open-label Segment 1|Lost to Follow-up|1|||
147388765|NCT00385697|531585229|FG001|Open-label Segment 1|Lost to Follow-up|0|||
147388766|NCT00385697|531585230|FG002|Open-label Segment 1|Lost to Follow-up|0|||
147388767|NCT00385697|531585231|FG003|Open-label Segment 1|Lost to Follow-up|0|||
147388768|NCT00385697|531585232|FG004|Open-label Segment 1|Lost to Follow-up|0|||
147388769|NCT00385697|531585228|FG000|Double-blind Segment 2|Adverse Event|0|||
147388770|NCT00385697|531585229|FG001|Double-blind Segment 2|Adverse Event|3|||
147457958|NCT00644787|531837803|FG001|Period 2: Double Blind Phase|Worsening of underlying disease|6|||
147457959|NCT00644787|531837804|FG002|Period 2: Double Blind Phase|Worsening of underlying disease|2|||
147457960|NCT00644787|531837802|FG000|Period 2: Double Blind Phase|Worsening of symptoms|0|||
147457961|NCT00644787|531837803|FG001|Period 2: Double Blind Phase|Worsening of symptoms|0|||
147457962|NCT00644787|531837804|FG002|Period 2: Double Blind Phase|Worsening of symptoms|1|||
147457963|NCT00865020|531837816|FG000|Overall Study|Withdrawal by Subject|22|||
147457964|NCT00865020|531837817|FG001|Overall Study|Withdrawal by Subject|16|||
147457965|NCT00865020|531837816|FG000|Overall Study|Adverse Event|9|||
147457966|NCT00865020|531837817|FG001|Overall Study|Adverse Event|14|||
147457967|NCT00865020|531837816|FG000|Overall Study|Abnormal test procedure result(s)|6|||
147457968|NCT00865020|531837817|FG001|Overall Study|Abnormal test procedure result(s)|8|||
147457969|NCT00865020|531837816|FG000|Overall Study|Lost to Follow-up|6|||
147457970|NCT00865020|531837817|FG001|Overall Study|Lost to Follow-up|4|||
147457971|NCT00865020|531837816|FG000|Overall Study|Protocol deviation|4|||
147457972|NCT00865020|531837817|FG001|Overall Study|Protocol deviation|1|||
147457973|NCT00865020|531837816|FG000|Overall Study|Administrative problems|0|||
147457974|NCT00865020|531837817|FG001|Overall Study|Administrative problems|2|||
147457975|NCT00865020|531837816|FG000|Overall Study|Abnormal laboratory value(s)|0|||
147457976|NCT00865020|531837817|FG001|Overall Study|Abnormal laboratory value(s)|1|||
147457977|NCT00865020|531837816|FG000|Overall Study|Death|0|||
147457978|NCT00865020|531837817|FG001|Overall Study|Death|1|||
147457979|NCT00865020|531837816|FG000|Overall Study|Randomized but discontinued|2|||
147457980|NCT00865020|531837817|FG001|Overall Study|Randomized but discontinued|4|||
147457981|NCT01227902|531839628|FG000|Overall Study|Adverse Event|12|||
147388771|NCT00385697|531585230|FG002|Double-blind Segment 2|Adverse Event|1|||
147388772|NCT00385697|531585231|FG003|Double-blind Segment 2|Adverse Event|0|||
147388773|NCT00385697|531585232|FG004|Double-blind Segment 2|Adverse Event|0|||
147388774|NCT00385697|531585228|FG000|Double-blind Segment 2|Lost to Follow-up|0|||
147457982|NCT01227902|531839629|FG001|Overall Study|Adverse Event|8|||
147457983|NCT01227902|531839630|FG002|Overall Study|Adverse Event|11|||
147457984|NCT01227902|531839631|FG003|Overall Study|Adverse Event|4|||
147457985|NCT01227902|531839628|FG000|Overall Study|Lack of Efficacy|1|||
147457986|NCT01227902|531839629|FG001|Overall Study|Lack of Efficacy|2|||
147388775|NCT00385697|531585229|FG001|Double-blind Segment 2|Lost to Follow-up|11|||
147388776|NCT00385697|531585230|FG002|Double-blind Segment 2|Lost to Follow-up|5|||
147388777|NCT00385697|531585231|FG003|Double-blind Segment 2|Lost to Follow-up|2|||
147388778|NCT00385697|531585232|FG004|Double-blind Segment 2|Lost to Follow-up|5|||
147388779|NCT00385697|531585228|FG000|Double-blind Segment 2|Withdrawal by Subject|0|||
147388780|NCT00385697|531585229|FG001|Double-blind Segment 2|Withdrawal by Subject|10|||
147388781|NCT00385697|531585230|FG002|Double-blind Segment 2|Withdrawal by Subject|6|||
147388782|NCT00385697|531585231|FG003|Double-blind Segment 2|Withdrawal by Subject|7|||
147388783|NCT00385697|531585232|FG004|Double-blind Segment 2|Withdrawal by Subject|2|||
147388784|NCT00385697|531585228|FG000|Double-blind Segment 2|Other|0|||
147388785|NCT00385697|531585229|FG001|Double-blind Segment 2|Other|2|||
147388786|NCT00385697|531585230|FG002|Double-blind Segment 2|Other|0|||
147388787|NCT00385697|531585231|FG003|Double-blind Segment 2|Other|0|||
147388788|NCT00385697|531585232|FG004|Double-blind Segment 2|Other|0|||
147388789|NCT00442559|531585233|FG000|Overall Study|Lost to Follow-up|32|||
147388790|NCT00442559|531585234|FG001|Overall Study|Lost to Follow-up|34|||
147388791|NCT00442559|531585233|FG000|Overall Study|Protocol Violation|1|||
147388792|NCT00442559|531585234|FG001|Overall Study|Protocol Violation|1|||
147388793|NCT00442559|531585233|FG000|Overall Study|Withdrawal by Subject|1|||
147388794|NCT00442559|531585234|FG001|Overall Study|Withdrawal by Subject|0|||
147388795|NCT01426217|531585245|FG000|Overall Study|lost sample|8|||
147388796|NCT01426217|531585246|FG001|Overall Study|lost sample|14|||
147388797|NCT01648699|531585247|FG000|Overall Study|Death|1|||
147388798|NCT01648699|531585247|FG000|Overall Study|Lost to Follow-up|2|||
147388799|NCT01648699|531585247|FG000|Overall Study|Unspecified/unable to complete 4 visits|2|||
147388800|NCT02267746|531585248|FG000|Overall Study|Adverse Event|0|||
147388801|NCT02267746|531585249|FG001|Overall Study|Adverse Event|2|||
147388802|NCT02267746|531585250|FG002|Overall Study|Adverse Event|1|||
147388803|NCT02267746|531585248|FG000|Overall Study|Protocol Violation|8|||
147388804|NCT02267746|531585249|FG001|Overall Study|Protocol Violation|7|||
147388805|NCT02267746|531585250|FG002|Overall Study|Protocol Violation|3|||
147388806|NCT02267746|531585248|FG000|Overall Study|Lack of Efficacy|11|||
147388807|NCT02267746|531585249|FG001|Overall Study|Lack of Efficacy|11|||
147388808|NCT02267746|531585250|FG002|Overall Study|Lack of Efficacy|15|||
147388809|NCT02267746|531585248|FG000|Overall Study|Protocol Violation|1|||
147388810|NCT02267746|531585249|FG001|Overall Study|Protocol Violation|2|||
147388811|NCT02267746|531585250|FG002|Overall Study|Protocol Violation|1|||
147388812|NCT02267746|531585248|FG000|Overall Study|Miscellaneous|1|||
147388813|NCT02267746|531585249|FG001|Overall Study|Miscellaneous|0|||
147388814|NCT02267746|531585250|FG002|Overall Study|Miscellaneous|1|||
147388815|NCT01812837|531585251|FG000|Overall Study|Lost to Follow-up|1|||
147388816|NCT01812837|531585252|FG001|Overall Study|Lost to Follow-up|1|||
147388817|NCT01812837|531585253|FG002|Overall Study|Lost to Follow-up|0|||
147388818|NCT01812837|531585251|FG000|Overall Study|Protocol Violation|1|||
147388819|NCT01812837|531585252|FG001|Overall Study|Protocol Violation|0|||
147388820|NCT01812837|531585253|FG002|Overall Study|Protocol Violation|0|||
147388821|NCT05008224|531585258|FG000|Overall Study|Death|3|||
147388822|NCT05008224|531585258|FG000|Overall Study|Lost to Follow-up|2|||
147388823|NCT05008224|531585258|FG000|Overall Study|Did Not Continue on Extension Study|39|||
147388824|NCT05008224|531585258|FG000|Overall Study|Transferred to Extension Study|100|||
147388825|NCT05008224|531585258|FG000|Overall Study|Withdrawal by Subject|2|||
147388826|NCT05234632|531585259|FG000|Overall Study|Participant Withdrawn: Non-Compliance|1|||
147388827|NCT05234632|531585260|FG001|Overall Study|Participant Withdrawn: Non-Compliance|0|||
147388828|NCT05234632|531585259|FG000|Overall Study|Withdrawal by Subject|2|||
147388829|NCT05234632|531585260|FG001|Overall Study|Withdrawal by Subject|0|||
147388830|NCT05234632|531585259|FG000|Overall Study|Adverse Event|0|||
147388831|NCT05234632|531585260|FG001|Overall Study|Adverse Event|4|||
147388832|NCT05234632|531585259|FG000|Overall Study|Physician Decision|1|||
147388833|NCT05234632|531585260|FG001|Overall Study|Physician Decision|1|||
147388834|NCT05234632|531585259|FG000|Overall Study|Participant tested positive for COVID-19 and is in isolation|0|||
147388835|NCT05234632|531585260|FG001|Overall Study|Participant tested positive for COVID-19 and is in isolation|1|||
147388836|NCT05234632|531585259|FG000|Overall Study|Withdrawn by participant upon experiencing Adverse Event.|1|||
147388837|NCT05234632|531585260|FG001|Overall Study|Withdrawn by participant upon experiencing Adverse Event.|0|||
147388838|NCT04799587|531585261|FG000|Overall Study|Withdrawal by Subject|0|||
147388839|NCT04799587|531585262|FG001|Overall Study|Withdrawal by Subject|1|||
147388840|NCT00728884|531585263|FG000|Permanent Prosthesis Placement|Lost to Follow-up|13|||
147388841|NCT00728884|531585263|FG000|One Year Post Placement Follow-up|Lost to Follow-up|4|||
147388842|NCT05263492|531585264|FG000|Overall Study|Adverse Event|1|||
147388843|NCT05263492|531585264|FG000|Overall Study|Disease progression during active treatment|3|||
147388844|NCT03345420|531585267|FG000|Overall Study|Withdrawal by Subject|1|||
147388845|NCT05216835|531585268|FG000|Overall Study|Ongoing as of DCO (30 Aug 2024)|0|||
147388846|NCT05216835|531585269|FG001|Overall Study|Ongoing as of DCO (30 Aug 2024)|0|||
147388847|NCT05216835|531585270|FG002|Overall Study|Ongoing as of DCO (30 Aug 2024)|0|||
147388848|NCT05216835|531585271|FG003|Overall Study|Ongoing as of DCO (30 Aug 2024)|0|||
147388849|NCT05216835|531585272|FG004|Overall Study|Ongoing as of DCO (30 Aug 2024)|3|||
147457987|NCT01227902|531839630|FG002|Overall Study|Lack of Efficacy|2|||
147388850|NCT05216835|531585273|FG005|Overall Study|Ongoing as of DCO (30 Aug 2024)|10|||
147388851|NCT05216835|531585274|FG006|Overall Study|Ongoing as of DCO (30 Aug 2024)|10|||
147388852|NCT05216835|531585275|FG007|Overall Study|Ongoing as of DCO (30 Aug 2024)|9|||
147388853|NCT05216835|531585268|FG000|Overall Study|Death|0|||
147388854|NCT05216835|531585269|FG001|Overall Study|Death|0|||
147388855|NCT05216835|531585270|FG002|Overall Study|Death|0|||
147388856|NCT05216835|531585271|FG003|Overall Study|Death|1|||
147388857|NCT05216835|531585272|FG004|Overall Study|Death|1|||
147388858|NCT05216835|531585273|FG005|Overall Study|Death|1|||
147388859|NCT05216835|531585274|FG006|Overall Study|Death|1|||
147388860|NCT05216835|531585275|FG007|Overall Study|Death|1|||
147388861|NCT05216835|531585268|FG000|Overall Study|Physician Decision|0|||
147388862|NCT05216835|531585269|FG001|Overall Study|Physician Decision|0|||
147388863|NCT05216835|531585270|FG002|Overall Study|Physician Decision|0|||
147388864|NCT05216835|531585271|FG003|Overall Study|Physician Decision|0|||
147388865|NCT05216835|531585272|FG004|Overall Study|Physician Decision|0|||
147388866|NCT05216835|531585273|FG005|Overall Study|Physician Decision|1|||
147388867|NCT05216835|531585274|FG006|Overall Study|Physician Decision|1|||
147388868|NCT05216835|531585275|FG007|Overall Study|Physician Decision|0|||
147388869|NCT05216835|531585268|FG000|Overall Study|Study terminated by Sponsor|0|||
147388870|NCT05216835|531585269|FG001|Overall Study|Study terminated by Sponsor|0|||
147388871|NCT05216835|531585270|FG002|Overall Study|Study terminated by Sponsor|0|||
147388872|NCT05216835|531585271|FG003|Overall Study|Study terminated by Sponsor|0|||
147388873|NCT05216835|531585272|FG004|Overall Study|Study terminated by Sponsor|0|||
147388874|NCT05216835|531585273|FG005|Overall Study|Study terminated by Sponsor|0|||
147388875|NCT05216835|531585274|FG006|Overall Study|Study terminated by Sponsor|0|||
147388876|NCT05216835|531585275|FG007|Overall Study|Study terminated by Sponsor|1|||
147388877|NCT05216835|531585268|FG000|Overall Study|Withdrawal by Subject|1|||
147388878|NCT05216835|531585269|FG001|Overall Study|Withdrawal by Subject|0|||
147388879|NCT05216835|531585270|FG002|Overall Study|Withdrawal by Subject|1|||
147388880|NCT05216835|531585271|FG003|Overall Study|Withdrawal by Subject|0|||
147388881|NCT05216835|531585272|FG004|Overall Study|Withdrawal by Subject|1|||
147388882|NCT05216835|531585273|FG005|Overall Study|Withdrawal by Subject|0|||
147388883|NCT05216835|531585274|FG006|Overall Study|Withdrawal by Subject|0|||
147388884|NCT05216835|531585275|FG007|Overall Study|Withdrawal by Subject|1|||
147388885|NCT05216835|531585268|FG000|Overall Study|Other|0|||
147388886|NCT05216835|531585269|FG001|Overall Study|Other|1|||
147388887|NCT05216835|531585270|FG002|Overall Study|Other|0|||
147388888|NCT05216835|531585271|FG003|Overall Study|Other|0|||
147388889|NCT05216835|531585272|FG004|Overall Study|Other|0|||
147388890|NCT05216835|531585273|FG005|Overall Study|Other|0|||
147388891|NCT05216835|531585274|FG006|Overall Study|Other|0|||
147388892|NCT05216835|531585275|FG007|Overall Study|Other|0|||
147388893|NCT05179603|531585276|FG000|Overall Study|Unspecified: Not related to Coronavirus Disease 2019 (COVID-19)|3|||
147388894|NCT05179603|531585276|FG000|Overall Study|Withdrawal by Subject|1|||
147388895|NCT05179603|531585276|FG000|Overall Study|Progressive disease|4|||
147388896|NCT05179603|531585276|FG000|Overall Study|Adverse event: Not related to COVID-19|4|||
147388897|NCT03861078|531585277|FG000|Overall Study|COVID-19 shut down|4|||
147388898|NCT03861078|531585277|FG000|Overall Study|Lost to Follow-up|1|||
147388899|NCT03861078|531585277|FG000|Overall Study|Protocol Violation|2|||
147388900|NCT03861078|531585277|FG000|Overall Study|lack of venous access|1|||
147388901|NCT01075815|531585278|FG000|Overall Study|Withdrawal before r-hCG administration|6|||
147388902|NCT01075815|531585279|FG001|Overall Study|Withdrawal before r-hCG administration|1|||
147388903|NCT01075815|531585278|FG000|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|1|||
147388904|NCT01075815|531585279|FG001|Overall Study|Withdrawal between rhCG-ovum pickup(OPU)|1|||
147388905|NCT01075815|531585278|FG000|Overall Study|Withdrawal between OPU - embryo transfer|3|||
147388906|NCT01075815|531585279|FG001|Overall Study|Withdrawal between OPU - embryo transfer|2|||
147388907|NCT00596960|531585280|FG000|Overall Study|Death|1|||
147388908|NCT00596960|531585281|FG001|Overall Study|Death|2|||
147388909|NCT00596960|531585280|FG000|Overall Study|Lost to Follow-up|6|||
147388910|NCT00596960|531585281|FG001|Overall Study|Lost to Follow-up|5|||
147388911|NCT00596960|531585280|FG000|Overall Study|Withdrawal by Subject|1|||
147615137|NCT01811472|532406620|FG002|Overall Study|Adverse Event|4|||
147388912|NCT00596960|531585281|FG001|Overall Study|Withdrawal by Subject|0|||
147388913|NCT00596960|531585280|FG000|Overall Study|Incarcerated|2|||
147388914|NCT00596960|531585281|FG001|Overall Study|Incarcerated|0|||
147388915|NCT00596960|531585280|FG000|Overall Study|Physician Decision|1|||
147388916|NCT00596960|531585281|FG001|Overall Study|Physician Decision|0|||
147388917|NCT00596960|531585280|FG000|Overall Study|Protocol Violation|0|||
147388918|NCT00596960|531585281|FG001|Overall Study|Protocol Violation|1|||
147388919|NCT00596960|531585280|FG000|Overall Study|No alcohol use data|0|||
147615138|NCT01811472|532406618|FG000|Overall Study|Lost to Follow-up|0|||
147388920|NCT00596960|531585281|FG001|Overall Study|No alcohol use data|1|||
147388921|NCT02058992|531585282|FG000|Overall Study|Lost to Follow-up|4|||
147388922|NCT02058992|531585282|FG000|Overall Study|Protocol Violation|92|||
147388923|NCT02058992|531585282|FG000|Overall Study|CRF Uncollected|20|||
147388924|NCT03005106|531585286|FG000|Overall Study|Lost to Follow-up|16|||
147388925|NCT03005106|531585286|FG000|Overall Study|Adverse Event|1|||
147388926|NCT03005106|531585286|FG000|Overall Study|Physician Decision|1|||
147388927|NCT03005106|531585286|FG000|Overall Study|Death|2|||
147388928|NCT01855399|531585287|FG000|6 Month|Lost to Follow-up|12|||
147388929|NCT01855399|531585288|FG001|6 Month|Lost to Follow-up|9|||
147388930|NCT01855399|531585287|FG000|6 Month|Withdrawal by Subject|8|||
147388931|NCT01855399|531585288|FG001|6 Month|Withdrawal by Subject|6|||
147388932|NCT01855399|531585287|FG000|12 Month|Lost to Follow-up|7|||
147388933|NCT01855399|531585288|FG001|12 Month|Lost to Follow-up|11|||
147388934|NCT03019289|531585289|FG000|Overall Study|Adverse Event|1|||
147388935|NCT03019289|531585290|FG001|Overall Study|Adverse Event|0|||
147388936|NCT03019289|531585291|FG002|Overall Study|Adverse Event|0|||
147388937|NCT03019289|531585292|FG003|Overall Study|Adverse Event|0|||
147388938|NCT03019289|531585293|FG004|Overall Study|Adverse Event|0|||
147388939|NCT03019289|531585294|FG005|Overall Study|Adverse Event|0|||
147388940|NCT03019289|531585295|FG006|Overall Study|Adverse Event|0|||
147388941|NCT03019289|531585296|FG007|Overall Study|Adverse Event|0|||
147388942|NCT03019289|531585297|FG008|Overall Study|Adverse Event|1|||
147388943|NCT03019289|531585289|FG000|Overall Study|Other|1|||
147388944|NCT03019289|531585290|FG001|Overall Study|Other|0|||
147388945|NCT03019289|531585291|FG002|Overall Study|Other|0|||
147388946|NCT03019289|531585292|FG003|Overall Study|Other|0|||
147388947|NCT03019289|531585293|FG004|Overall Study|Other|0|||
147388948|NCT03019289|531585294|FG005|Overall Study|Other|0|||
147388949|NCT03019289|531585295|FG006|Overall Study|Other|0|||
147388950|NCT03019289|531585296|FG007|Overall Study|Other|0|||
147388951|NCT03019289|531585297|FG008|Overall Study|Other|0|||
147388952|NCT00936065|531585298|FG000|Overall Study|Adverse Event|1|||
147388953|NCT00936065|531585299|FG001|Overall Study|Adverse Event|0|||
147388954|NCT00936065|531585300|FG002|Overall Study|Adverse Event|1|||
147388955|NCT00936065|531585298|FG000|Overall Study|Lack of Efficacy|1|||
147388956|NCT00936065|531585299|FG001|Overall Study|Lack of Efficacy|0|||
147388957|NCT00936065|531585300|FG002|Overall Study|Lack of Efficacy|1|||
147388958|NCT00936065|531585298|FG000|Overall Study|Lost to Follow-up|1|||
147388959|NCT00936065|531585299|FG001|Overall Study|Lost to Follow-up|0|||
147388960|NCT00936065|531585300|FG002|Overall Study|Lost to Follow-up|0|||
147388961|NCT00936065|531585298|FG000|Overall Study|Protocol Violation|1|||
147388962|NCT00936065|531585299|FG001|Overall Study|Protocol Violation|2|||
147388963|NCT00936065|531585300|FG002|Overall Study|Protocol Violation|1|||
147388964|NCT00936065|531585298|FG000|Overall Study|Withdrawal by Subject|0|||
147388965|NCT00936065|531585299|FG001|Overall Study|Withdrawal by Subject|2|||
147388966|NCT00936065|531585300|FG002|Overall Study|Withdrawal by Subject|4|||
147388967|NCT02389894|531585301|FG000|Overall Study|Death|4|||
147388968|NCT02389894|531585302|FG001|Overall Study|Death|5|||
147388969|NCT02389894|531585303|FG002|Overall Study|Death|3|||
147388970|NCT02389894|531585301|FG000|Overall Study|Withdrawal by Subject|2|||
147388971|NCT02389894|531585302|FG001|Overall Study|Withdrawal by Subject|4|||
147388972|NCT02389894|531585303|FG002|Overall Study|Withdrawal by Subject|5|||
147388973|NCT02389894|531585301|FG000|Overall Study|Lost to Follow-up|2|||
147388974|NCT02389894|531585302|FG001|Overall Study|Lost to Follow-up|1|||
147388975|NCT02389894|531585303|FG002|Overall Study|Lost to Follow-up|1|||
147388976|NCT01429285|531585306|FG000|Overall Study|Protocol Violation|9|||
147388977|NCT01429285|531585307|FG001|Overall Study|Protocol Violation|4|||
147388978|NCT01429285|531585306|FG000|Overall Study|Missing Data|5|||
147388979|NCT01429285|531585307|FG001|Overall Study|Missing Data|3|||
147388980|NCT01429285|531585306|FG000|Overall Study|Erroneously Enrolled Twice|8|||
147388981|NCT01429285|531585307|FG001|Overall Study|Erroneously Enrolled Twice|2|||
147388982|NCT01288729|531585312|FG000|Overall Study|Withdrawal by Subject|1|||
147388983|NCT01288729|531585313|FG001|Overall Study|Withdrawal by Subject|0|||
147388984|NCT03602053|531586898|FG000|Overall Study|Withdrawal by Subject|7|||
147388985|NCT03602053|531586899|FG001|Overall Study|Withdrawal by Subject|9|||
147388986|NCT03602053|531586900|FG002|Overall Study|Withdrawal by Subject|7|||
147388987|NCT03602053|531586898|FG000|Overall Study|Lost to Follow-up|5|||
147388988|NCT03602053|531586899|FG001|Overall Study|Lost to Follow-up|6|||
147388989|NCT03602053|531586900|FG002|Overall Study|Lost to Follow-up|0|||
147388990|NCT03602053|531586898|FG000|Overall Study|Protocol Violation|3|||
147388991|NCT03602053|531586899|FG001|Overall Study|Protocol Violation|0|||
147388992|NCT03602053|531586900|FG002|Overall Study|Protocol Violation|4|||
147388993|NCT03602053|531586898|FG000|Overall Study|Physician Decision|1|||
147388994|NCT03602053|531586899|FG001|Overall Study|Physician Decision|0|||
147388995|NCT03602053|531586900|FG002|Overall Study|Physician Decision|0|||
147388996|NCT03602053|531586898|FG000|Overall Study|migration|2|||
147388997|NCT03602053|531586899|FG001|Overall Study|migration|3|||
147388998|NCT03602053|531586900|FG002|Overall Study|migration|0|||
147388999|NCT03602053|531586898|FG000|Overall Study|Other|1|||
147389000|NCT03602053|531586899|FG001|Overall Study|Other|0|||
147389001|NCT03602053|531586900|FG002|Overall Study|Other|0|||
147389002|NCT03672188|531586911|FG000|Overall Study|Withdrawal by Subject|0|||
147389003|NCT03672188|531586912|FG001|Overall Study|Withdrawal by Subject|0|||
147389004|NCT03672188|531586913|FG002|Overall Study|Withdrawal by Subject|0|||
147389005|NCT03672188|531586914|FG003|Overall Study|Withdrawal by Subject|3|||
147389006|NCT03672188|531586915|FG004|Overall Study|Withdrawal by Subject|0|||
147457988|NCT01227902|531839631|FG003|Overall Study|Lack of Efficacy|1|||
147389007|NCT03672188|531586916|FG005|Overall Study|Withdrawal by Subject|0|||
147389008|NCT03672188|531586917|FG006|Overall Study|Withdrawal by Subject|0|||
147389009|NCT03672188|531586918|FG007|Overall Study|Withdrawal by Subject|0|||
147389010|NCT03672188|531586919|FG008|Overall Study|Withdrawal by Subject|0|||
147389011|NCT03672188|531586920|FG009|Overall Study|Withdrawal by Subject|0|||
147389012|NCT03672188|531586921|FG010|Overall Study|Withdrawal by Subject|0|||
147389013|NCT03672188|531586922|FG011|Overall Study|Withdrawal by Subject|0|||
147389014|NCT03672188|531586923|FG012|Overall Study|Withdrawal by Subject|0|||
147389015|NCT03672188|531586924|FG013|Overall Study|Withdrawal by Subject|0|||
147389016|NCT03672188|531586925|FG014|Overall Study|Withdrawal by Subject|0|||
147389017|NCT03672188|531586911|FG000|Overall Study|Death|0|||
147389018|NCT03672188|531586912|FG001|Overall Study|Death|0|||
147389019|NCT03672188|531586913|FG002|Overall Study|Death|0|||
147389020|NCT03672188|531586914|FG003|Overall Study|Death|0|||
147389021|NCT03672188|531586915|FG004|Overall Study|Death|0|||
147389022|NCT03672188|531586916|FG005|Overall Study|Death|0|||
147389023|NCT03672188|531586917|FG006|Overall Study|Death|0|||
147389024|NCT03672188|531586918|FG007|Overall Study|Death|0|||
147389025|NCT03672188|531586919|FG008|Overall Study|Death|0|||
147389026|NCT03672188|531586920|FG009|Overall Study|Death|0|||
147389027|NCT03672188|531586921|FG010|Overall Study|Death|0|||
147389028|NCT03672188|531586922|FG011|Overall Study|Death|0|||
147389029|NCT03672188|531586923|FG012|Overall Study|Death|1|||
147389030|NCT03672188|531586924|FG013|Overall Study|Death|0|||
147389031|NCT03672188|531586925|FG014|Overall Study|Death|0|||
147389032|NCT03672188|531586911|FG000|Overall Study|Lost to Follow-up|0|||
147389033|NCT03672188|531586912|FG001|Overall Study|Lost to Follow-up|0|||
147389034|NCT03672188|531586913|FG002|Overall Study|Lost to Follow-up|1|||
147389035|NCT03672188|531586914|FG003|Overall Study|Lost to Follow-up|0|||
147389036|NCT03672188|531586915|FG004|Overall Study|Lost to Follow-up|0|||
147389037|NCT03672188|531586916|FG005|Overall Study|Lost to Follow-up|0|||
147389038|NCT03672188|531586917|FG006|Overall Study|Lost to Follow-up|0|||
147389039|NCT03672188|531586918|FG007|Overall Study|Lost to Follow-up|0|||
147389040|NCT03672188|531586919|FG008|Overall Study|Lost to Follow-up|0|||
147389041|NCT03672188|531586920|FG009|Overall Study|Lost to Follow-up|0|||
147389042|NCT03672188|531586921|FG010|Overall Study|Lost to Follow-up|0|||
147389043|NCT03672188|531586922|FG011|Overall Study|Lost to Follow-up|0|||
147389044|NCT03672188|531586923|FG012|Overall Study|Lost to Follow-up|0|||
147389045|NCT03672188|531586924|FG013|Overall Study|Lost to Follow-up|0|||
147389046|NCT03672188|531586925|FG014|Overall Study|Lost to Follow-up|0|||
147389047|NCT01234675|531586926|FG000|First Intervention (6 Weeks)|Adverse Event|0|||
147389048|NCT01234675|531586927|FG001|First Intervention (6 Weeks)|Adverse Event|1|||
147389049|NCT01234675|531586926|FG000|First Intervention (6 Weeks)|Withdrawal by Subject|1|||
147389050|NCT01234675|531586927|FG001|First Intervention (6 Weeks)|Withdrawal by Subject|0|||
147389051|NCT03997409|531586928|FG000|Overall Study|Protocol Violation|1|||
147389052|NCT03997409|531586929|FG001|Overall Study|Protocol Violation|1|||
147389053|NCT03997409|531586930|FG002|Overall Study|Protocol Violation|0|||
147389054|NCT03997409|531586928|FG000|Overall Study|Withdrawal by Subject|3|||
147389055|NCT03997409|531586929|FG001|Overall Study|Withdrawal by Subject|0|||
147389056|NCT03997409|531586930|FG002|Overall Study|Withdrawal by Subject|0|||
147389057|NCT03997409|531586928|FG000|Overall Study|Lost to Follow-up|0|||
147389058|NCT03997409|531586929|FG001|Overall Study|Lost to Follow-up|0|||
147389059|NCT03997409|531586930|FG002|Overall Study|Lost to Follow-up|1|||
147389060|NCT01753323|531586931|FG000|Overall Study|Lack of Efficacy|0|||
147389061|NCT01753323|531586932|FG001|Overall Study|Lack of Efficacy|0|||
147389062|NCT01753323|531586933|FG002|Overall Study|Lack of Efficacy|8|||
147457989|NCT01227902|531839628|FG000|Overall Study|Protocol Violation|1|||
147457990|NCT01227902|531839629|FG001|Overall Study|Protocol Violation|0|||
147457991|NCT01227902|531839630|FG002|Overall Study|Protocol Violation|0|||
147389063|NCT01753323|531586931|FG000|Overall Study|Protocol deviation|1|||
147389064|NCT01753323|531586932|FG001|Overall Study|Protocol deviation|0|||
147389065|NCT01753323|531586933|FG002|Overall Study|Protocol deviation|0|||
147389066|NCT01753323|531586931|FG000|Overall Study|Adverse Event|0|||
147457992|NCT01227902|531839631|FG003|Overall Study|Protocol Violation|0|||
147389067|NCT01753323|531586932|FG001|Overall Study|Adverse Event|0|||
147389068|NCT01753323|531586933|FG002|Overall Study|Adverse Event|1|||
147389069|NCT01870999|531586935|FG000|Overall Study|Adverse Event|0|||
147389070|NCT01870999|531586936|FG001|Overall Study|Adverse Event|4|||
147389071|NCT01870999|531586937|FG002|Overall Study|Adverse Event|1|||
147457993|NCT01227902|531839628|FG000|Overall Study|Lost to Follow-up|0|||
147389072|NCT01870999|531586935|FG000|Overall Study|Subject met withdrawal criteria|3|||
147389073|NCT01870999|531586936|FG001|Overall Study|Subject met withdrawal criteria|2|||
147389074|NCT01870999|531586937|FG002|Overall Study|Subject met withdrawal criteria|0|||
147389075|NCT01870999|531586935|FG000|Overall Study|Subject withdrawn by Investigator|1|||
147389076|NCT01870999|531586936|FG001|Overall Study|Subject withdrawn by Investigator|0|||
147389077|NCT01870999|531586937|FG002|Overall Study|Subject withdrawn by Investigator|0|||
147457994|NCT01227902|531839629|FG001|Overall Study|Lost to Follow-up|0|||
147457995|NCT01227902|531839630|FG002|Overall Study|Lost to Follow-up|1|||
147457996|NCT01227902|531839631|FG003|Overall Study|Lost to Follow-up|2|||
147664959|NCT04161391|532597966|FG002|Overall Study|Progressive Disease|3|||
147664960|NCT04161391|532597967|FG003|Overall Study|Progressive Disease|5|||
147664961|NCT04161391|532597968|FG004|Overall Study|Progressive Disease|3|||
147664962|NCT04161391|532597969|FG005|Overall Study|Progressive Disease|3|||
147389078|NCT01870999|531586935|FG000|Overall Study|Withdrawal by Subject|0|||
147389079|NCT01870999|531586936|FG001|Overall Study|Withdrawal by Subject|2|||
147389080|NCT01870999|531586937|FG002|Overall Study|Withdrawal by Subject|5|||
147389081|NCT01870999|531586935|FG000|Overall Study|Protocol Violation|0|||
147389082|NCT01870999|531586936|FG001|Overall Study|Protocol Violation|0|||
147389083|NCT01870999|531586937|FG002|Overall Study|Protocol Violation|1|||
147389084|NCT01636258|531586938|FG000|Overall Study|Lost to Follow-up|1|||
147389085|NCT01636258|531586939|FG001|Overall Study|Lost to Follow-up|0|||
147389086|NCT00116584|531586950|FG000|Overall Study|Withdrawal by Subject|1|||
147389087|NCT00116584|531586951|FG001|Overall Study|Withdrawal by Subject|0|||
147389088|NCT00116584|531586950|FG000|Overall Study|Protocol Violation|1|||
147389089|NCT00116584|531586951|FG001|Overall Study|Protocol Violation|1|||
147389090|NCT02798861|531586954|FG000|Overall Study|Lost to Follow-up|22|||
147389091|NCT02798861|531586954|FG000|Overall Study|Withdrawal by Subject|1|||
147389092|NCT00907517|531586955|FG000|Overall Study|Progressive Disease|3|||
147389093|NCT00907517|531586956|FG001|Overall Study|Progressive Disease|3|||
147389094|NCT00907517|531586957|FG002|Overall Study|Progressive Disease|4|||
147389095|NCT00907517|531586958|FG003|Overall Study|Progressive Disease|4|||
147389096|NCT00907517|531586959|FG004|Overall Study|Progressive Disease|4|||
147389097|NCT00907517|531586955|FG000|Overall Study|Symptomatic Deterioration|0|||
147389098|NCT00907517|531586956|FG001|Overall Study|Symptomatic Deterioration|0|||
147389099|NCT00907517|531586957|FG002|Overall Study|Symptomatic Deterioration|0|||
147389100|NCT00907517|531586958|FG003|Overall Study|Symptomatic Deterioration|0|||
147389101|NCT00907517|531586959|FG004|Overall Study|Symptomatic Deterioration|1|||
147389102|NCT02465866|531586967|FG000|Period 3|Withdrawal by Subject|0|||
147389103|NCT02465866|531586968|FG001|Period 3|Withdrawal by Subject|1|||
147389104|NCT02465866|531586969|FG002|Period 3|Withdrawal by Subject|0|||
147389105|NCT02465866|531586970|FG003|Period 3|Withdrawal by Subject|0|||
147389106|NCT02023099|531586971|FG000|Overall Study|Non-fatal Adverse Event (AE)|0|||
147389107|NCT02023099|531586972|FG001|Overall Study|Non-fatal Adverse Event (AE)|0|||
147389108|NCT02023099|531586973|FG002|Overall Study|Non-fatal Adverse Event (AE)|1|||
147389109|NCT02023099|531586971|FG000|Overall Study|Withdrawn Consent|3|||
147389110|NCT02023099|531586972|FG001|Overall Study|Withdrawn Consent|0|||
147389111|NCT02023099|531586973|FG002|Overall Study|Withdrawn Consent|1|||
147389112|NCT02023099|531586971|FG000|Overall Study|Non-treatment-emergent Fatal AE|0|||
147389113|NCT02023099|531586972|FG001|Overall Study|Non-treatment-emergent Fatal AE|0|||
147389114|NCT02023099|531586973|FG002|Overall Study|Non-treatment-emergent Fatal AE|1|||
147389115|NCT00203502|531586974|FG000|Overall Study|Death|1|||
147389116|NCT01469819|531586975|FG000|Overall Study|Withdrawal by Subject|1|||
147389117|NCT01469819|531586975|FG000|Overall Study|Did not meet inclusionary criteria|2|||
147389118|NCT01469819|531586975|FG000|Overall Study|Could not swallow SmartPill|2|||
147389119|NCT01469819|531586975|FG000|Overall Study|Technical malfunction of SmartPill data|3|||
147389120|NCT01695993|531586976|FG000|Overall Study|Lost to Follow-up|2|||
147389121|NCT01695993|531586977|FG001|Overall Study|Lost to Follow-up|1|||
147389122|NCT01695993|531586978|FG002|Overall Study|Lost to Follow-up|3|||
147389123|NCT01695993|531586976|FG000|Overall Study|Withdrawal by Subject|2|||
147389124|NCT01695993|531586977|FG001|Overall Study|Withdrawal by Subject|2|||
147389125|NCT01695993|531586978|FG002|Overall Study|Withdrawal by Subject|2|||
147389126|NCT01695993|531586976|FG000|Overall Study|To ill to continue|1|||
147389127|NCT01695993|531586977|FG001|Overall Study|To ill to continue|2|||
147389128|NCT01695993|531586978|FG002|Overall Study|To ill to continue|0|||
147664963|NCT04161391|532597970|FG006|Overall Study|Progressive Disease|5|||
147389129|NCT01695993|531586976|FG000|Overall Study|Changed Medical Facility|0|||
147389130|NCT01695993|531586977|FG001|Overall Study|Changed Medical Facility|0|||
147664964|NCT04161391|532597971|FG007|Overall Study|Progressive Disease|2|||
147664965|NCT04161391|532597972|FG008|Overall Study|Progressive Disease|2|||
147389131|NCT01695993|531586978|FG002|Overall Study|Changed Medical Facility|1|||
147389132|NCT04057937|531587001|FG000|Placebo-controlled Phase|Adverse Event|3|||
147389133|NCT04057937|531587002|FG001|Placebo-controlled Phase|Adverse Event|0|||
147389134|NCT04057937|531587001|FG000|Active-treatment Phase|Withdrawal by Subject|1|||
147389135|NCT04057937|531587002|FG001|Active-treatment Phase|Withdrawal by Subject|0|||
147389136|NCT04057937|531587001|FG000|Active-treatment Phase|Pregnancy|0|||
147389137|NCT04057937|531587002|FG001|Active-treatment Phase|Pregnancy|1|||
147389138|NCT04057937|531587001|FG000|Active-treatment Phase|Physician Decision|0|||
147389139|NCT04057937|531587002|FG001|Active-treatment Phase|Physician Decision|1|||
147389140|NCT02029521|531587003|FG000|Overall Study|Protocol Violation|1|||
147389141|NCT02029521|531587004|FG001|Overall Study|Protocol Violation|0|||
147389142|NCT02029521|531587003|FG000|Overall Study|Withdrawal by Subject|1|||
147389143|NCT02029521|531587004|FG001|Overall Study|Withdrawal by Subject|1|||
147389144|NCT01072396|531587005|FG000|Period One|Adverse Event|1|||
147389145|NCT01072396|531587006|FG001|Period One|Adverse Event|1|||
147389146|NCT01072396|531587005|FG000|Period One|Protocol Violation|2|||
147389147|NCT01072396|531587006|FG001|Period One|Protocol Violation|1|||
147664966|NCT01162343|532597975|FG000|Overall Study|Left ED prior to psychiatrist assessment|80|||
147615139|NCT01811472|532406619|FG001|Overall Study|Lost to Follow-up|0|||
147615140|NCT01811472|532406620|FG002|Overall Study|Lost to Follow-up|1|||
147615141|NCT01811472|532406618|FG000|Overall Study|Subject/guardian decision|1|||
147615142|NCT01811472|532406619|FG001|Overall Study|Subject/guardian decision|0|||
147615143|NCT01811472|532406620|FG002|Overall Study|Subject/guardian decision|0|||
147615144|NCT03288714|532406621|FG000|Overall Study|Lost to Follow-up|2|||
147615145|NCT03288714|532406622|FG001|Overall Study|Lost to Follow-up|1|||
147389148|NCT01072396|531587005|FG000|Period One|Withdrawal by Subject|2|||
147389149|NCT01072396|531587006|FG001|Period One|Withdrawal by Subject|0|||
147389150|NCT01072396|531587005|FG000|Washout Period|Missing termination information|0|||
147389151|NCT01072396|531587006|FG001|Washout Period|Missing termination information|1|||
147389152|NCT01072396|531587005|FG000|Period Two|Adverse Event|0|||
147389153|NCT01072396|531587006|FG001|Period Two|Adverse Event|3|||
147389154|NCT01072396|531587005|FG000|Period Two|Lost to Follow-up|1|||
147389155|NCT01072396|531587006|FG001|Period Two|Lost to Follow-up|0|||
147389156|NCT00472199|531587007|FG000|Overall Study|Adverse Event|19|||
147389157|NCT00472199|531587008|FG001|Overall Study|Adverse Event|23|||
147389158|NCT00472199|531587007|FG000|Overall Study|Lack of Efficacy|4|||
147389159|NCT00472199|531587008|FG001|Overall Study|Lack of Efficacy|25|||
147389160|NCT00472199|531587007|FG000|Overall Study|Lost to Follow-up|2|||
147389161|NCT00472199|531587008|FG001|Overall Study|Lost to Follow-up|4|||
147389162|NCT00472199|531587007|FG000|Overall Study|Protocol Violation|3|||
147389163|NCT00472199|531587008|FG001|Overall Study|Protocol Violation|2|||
147389164|NCT00472199|531587007|FG000|Overall Study|Withdrawal by Subject|6|||
147389165|NCT00472199|531587008|FG001|Overall Study|Withdrawal by Subject|5|||
147389166|NCT00472199|531587007|FG000|Overall Study|personal reason|0|||
147389167|NCT00472199|531587008|FG001|Overall Study|personal reason|1|||
147389168|NCT00472199|531587007|FG000|Overall Study|patient was asymptomatic|1|||
147389169|NCT00472199|531587008|FG001|Overall Study|patient was asymptomatic|0|||
147389170|NCT02446912|531587010|FG000|Overall Study|Adverse Event|3|||
147389171|NCT02446912|531587011|FG001|Overall Study|Adverse Event|13|||
147389172|NCT02446912|531587012|FG002|Overall Study|Adverse Event|5|||
147389173|NCT02446912|531587010|FG000|Overall Study|Condition under investigation worsened|0|||
147389174|NCT02446912|531587011|FG001|Overall Study|Condition under investigation worsened|1|||
147389175|NCT02446912|531587012|FG002|Overall Study|Condition under investigation worsened|1|||
147389176|NCT02446912|531587010|FG000|Overall Study|Study-specific withdrawal criteria|1|||
147389177|NCT02446912|531587011|FG001|Overall Study|Study-specific withdrawal criteria|0|||
147389178|NCT02446912|531587012|FG002|Overall Study|Study-specific withdrawal criteria|0|||
147389179|NCT02446912|531587010|FG000|Overall Study|Lack of Efficacy|1|||
147389180|NCT02446912|531587011|FG001|Overall Study|Lack of Efficacy|4|||
147389181|NCT02446912|531587012|FG002|Overall Study|Lack of Efficacy|7|||
147389182|NCT02446912|531587010|FG000|Overall Study|Lost to Follow-up|0|||
147389183|NCT02446912|531587011|FG001|Overall Study|Lost to Follow-up|0|||
147389184|NCT02446912|531587012|FG002|Overall Study|Lost to Follow-up|2|||
147389185|NCT02446912|531587010|FG000|Overall Study|Severe non-compliance to protocol|1|||
147389186|NCT02446912|531587011|FG001|Overall Study|Severe non-compliance to protocol|0|||
147389187|NCT02446912|531587012|FG002|Overall Study|Severe non-compliance to protocol|1|||
147389188|NCT02446912|531587010|FG000|Overall Study|Withdrawal by Subject|10|||
147389189|NCT02446912|531587011|FG001|Overall Study|Withdrawal by Subject|15|||
147389190|NCT02446912|531587012|FG002|Overall Study|Withdrawal by Subject|15|||
147389191|NCT02446912|531587010|FG000|Overall Study|Miscellaneous|2|||
147389192|NCT02446912|531587011|FG001|Overall Study|Miscellaneous|2|||
147389193|NCT02446912|531587012|FG002|Overall Study|Miscellaneous|4|||
147389194|NCT01268488|531587013|FG000|Overall Study|Adverse Event|3|||
147389195|NCT01268488|531587013|FG000|Overall Study|Physician Decision|2|||
147389196|NCT01106586|531587016|FG000|Overall Study|Adverse Event|9|||
147389197|NCT01106586|531587017|FG001|Overall Study|Adverse Event|15|||
147389198|NCT01106586|531587016|FG000|Overall Study|Death|1|||
147389199|NCT01106586|531587017|FG001|Overall Study|Death|3|||
147389200|NCT01106586|531587016|FG000|Overall Study|Pregnancy|2|||
147389201|NCT01106586|531587017|FG001|Overall Study|Pregnancy|2|||
147389202|NCT01106586|531587016|FG000|Overall Study|Lack of Efficacy|1|||
147389203|NCT01106586|531587017|FG001|Overall Study|Lack of Efficacy|0|||
147389204|NCT01106586|531587016|FG000|Overall Study|Investigator's Discretion|5|||
147389205|NCT01106586|531587017|FG001|Overall Study|Investigator's Discretion|8|||
147389206|NCT01106586|531587016|FG000|Overall Study|Withdrew Consent|18|||
147615146|NCT03288714|532406621|FG000|Overall Study|Non-compliance with study schedule|2|||
147389207|NCT01106586|531587017|FG001|Overall Study|Withdrew Consent|30|||
147389208|NCT01106586|531587016|FG000|Overall Study|Lost to Follow-up|24|||
147389209|NCT01106586|531587017|FG001|Overall Study|Lost to Follow-up|20|||
147389210|NCT01106586|531587016|FG000|Overall Study|Participant Noncompliance|12|||
147389211|NCT01106586|531587017|FG001|Overall Study|Participant Noncompliance|10|||
147389212|NCT01106586|531587016|FG000|Overall Study|Protocol Violation|1|||
147389213|NCT01106586|531587017|FG001|Overall Study|Protocol Violation|0|||
147389214|NCT01106586|531587016|FG000|Overall Study|Participant Transferred to Another Study|212|||
147389215|NCT01106586|531587017|FG001|Overall Study|Participant Transferred to Another Study|197|||
147615147|NCT03288714|532406622|FG001|Overall Study|Non-compliance with study schedule|0|||
147615148|NCT03288714|532406621|FG000|Overall Study|Withdrawal by Subject|3|||
147389216|NCT01757171|531587018|FG000|Overall Study|Adverse Event|5|||
147389217|NCT01757171|531587019|FG001|Overall Study|Adverse Event|1|||
147389218|NCT01757171|531587018|FG000|Overall Study|Disease Progression|1|||
147389219|NCT01757171|531587019|FG001|Overall Study|Disease Progression|0|||
147389220|NCT01757171|531587018|FG000|Overall Study|Hospitalization|1|||
147389221|NCT01757171|531587019|FG001|Overall Study|Hospitalization|0|||
147389222|NCT01757171|531587018|FG000|Overall Study|ECOG decline|1|||
147389223|NCT01757171|531587019|FG001|Overall Study|ECOG decline|0|||
147389224|NCT00428441|531587020|FG000|Overall Study|Lost to Follow-up|1|||
147389225|NCT01014013|531587024|FG000|Overall Study|Inclusion/Exclusion criteria not met|1|||
147389226|NCT01014013|531587025|FG001|Overall Study|Inclusion/Exclusion criteria not met|3|||
147389227|NCT01014013|531587024|FG000|Overall Study|Clinical adverse experience|4|||
147389228|NCT01014013|531587025|FG001|Overall Study|Clinical adverse experience|2|||
147389229|NCT01014013|531587024|FG000|Overall Study|Laboratory adverse experience|1|||
147389230|NCT01014013|531587025|FG001|Overall Study|Laboratory adverse experience|1|||
147389231|NCT01014013|531587024|FG000|Overall Study|Protocol Violation|1|||
147389232|NCT01014013|531587025|FG001|Overall Study|Protocol Violation|3|||
147389233|NCT01014013|531587024|FG000|Overall Study|Withdrawal by Subject|7|||
147389234|NCT01014013|531587025|FG001|Overall Study|Withdrawal by Subject|4|||
147389235|NCT01014013|531587024|FG000|Overall Study|Clinical/microbiologic failure|1|||
147389236|NCT01014013|531587025|FG001|Overall Study|Clinical/microbiologic failure|2|||
147389237|NCT01014013|531587024|FG000|Overall Study|Pathogen culture = no growth|26|||
147389238|NCT01014013|531587025|FG001|Overall Study|Pathogen culture = no growth|34|||
147389239|NCT01014013|531587024|FG000|Overall Study|Negative urine culture|2|||
147389240|NCT01014013|531587025|FG001|Overall Study|Negative urine culture|0|||
147389241|NCT01014013|531587024|FG000|Overall Study|Pathogen resistant|7|||
147389242|NCT01014013|531587025|FG001|Overall Study|Pathogen resistant|4|||
147389243|NCT01014013|531587024|FG000|Overall Study|Physician Decision|0|||
147389244|NCT01014013|531587025|FG001|Overall Study|Physician Decision|1|||
147389245|NCT01014013|531587024|FG000|Overall Study|Another antibiotic therapy required|0|||
147389246|NCT01014013|531587025|FG001|Overall Study|Another antibiotic therapy required|1|||
147389247|NCT01014013|531587024|FG000|Overall Study|Appendectomy|1|||
147389248|NCT01014013|531587025|FG001|Overall Study|Appendectomy|0|||
147389249|NCT01014013|531587024|FG000|Overall Study|Inappropriate therapy duration, < 7 Days|0|||
147389250|NCT01014013|531587025|FG001|Overall Study|Inappropriate therapy duration, < 7 Days|1|||
147389251|NCT02305797|531587026|FG000|Overall Study|Adverse Event|11|||
147389252|NCT02305797|531587027|FG001|Overall Study|Adverse Event|2|||
147389253|NCT02305797|531587026|FG000|Overall Study|Withdrawal by Subject|9|||
147389254|NCT02305797|531587027|FG001|Overall Study|Withdrawal by Subject|10|||
147389255|NCT02305797|531587026|FG000|Overall Study|Lack of Efficacy|6|||
147389256|NCT02305797|531587027|FG001|Overall Study|Lack of Efficacy|0|||
147389257|NCT02305797|531587026|FG000|Overall Study|Lost to Follow-up|5|||
147389258|NCT02305797|531587027|FG001|Overall Study|Lost to Follow-up|11|||
147389259|NCT02305797|531587026|FG000|Overall Study|Pregnancy|0|||
147389260|NCT02305797|531587027|FG001|Overall Study|Pregnancy|2|||
147389261|NCT02305797|531587026|FG000|Overall Study|Noncompliance|14|||
147389262|NCT02305797|531587027|FG001|Overall Study|Noncompliance|12|||
147389263|NCT02305797|531587026|FG000|Overall Study|Reason not collected|0|||
147389264|NCT02305797|531587027|FG001|Overall Study|Reason not collected|1|||
147389265|NCT03508830|531587028|FG000|Overall Study|Withdrawal by Subject|3|||
147389266|NCT03508830|531587029|FG001|Overall Study|Withdrawal by Subject|4|||
147389267|NCT03508830|531587028|FG000|Overall Study|Physician Decision|2|||
147389268|NCT03508830|531587029|FG001|Overall Study|Physician Decision|2|||
147389269|NCT02097056|531587032|FG000|Overall Study|Protocol Violation|2|||
147389270|NCT02097056|531587032|FG000|Overall Study|Withdrawal by Subject|15|||
147389271|NCT02097056|531587032|FG000|Overall Study|Lost to Follow-up|2|||
147389272|NCT02097056|531587032|FG000|Overall Study|Adverse Event|37|||
147389273|NCT02097056|531587032|FG000|Overall Study|Other|2|||
147389274|NCT01446042|531587033|FG000|Overall Study|Withdrawal by Subject|12|||
147389275|NCT01446042|531587034|FG001|Overall Study|Withdrawal by Subject|2|||
147389276|NCT01446042|531587035|FG002|Overall Study|Withdrawal by Subject|4|||
147389277|NCT01446042|531587033|FG000|Overall Study|Adverse Event|1|||
147389278|NCT01446042|531587034|FG001|Overall Study|Adverse Event|0|||
147389279|NCT01446042|531587035|FG002|Overall Study|Adverse Event|4|||
147389280|NCT01446042|531587033|FG000|Overall Study|Lost to Follow-up|5|||
147615149|NCT03288714|532406622|FG001|Overall Study|Withdrawal by Subject|1|||
147615150|NCT03288714|532406621|FG000|Overall Study|Clinical Worsening|2|||
147615151|NCT03288714|532406622|FG001|Overall Study|Clinical Worsening|1|||
147389281|NCT01446042|531587034|FG001|Overall Study|Lost to Follow-up|0|||
147389282|NCT01446042|531587035|FG002|Overall Study|Lost to Follow-up|0|||
147389283|NCT01446042|531587033|FG000|Overall Study|Other reasons|2|||
147389284|NCT01446042|531587034|FG001|Overall Study|Other reasons|1|||
147389285|NCT01446042|531587035|FG002|Overall Study|Other reasons|1|||
147389286|NCT03906240|531587036|FG000|Overall Study|Failed to complete Session 1 (essential orientation), thus excluded from future sessions.|4|||
147389287|NCT03906240|531587037|FG001|Overall Study|Failed to complete Session 1 (essential orientation), thus excluded from future sessions.|0|||
147615152|NCT03288714|532406621|FG000|Overall Study|Adverse Event|1|||
147389288|NCT03906240|531587036|FG000|Overall Study|Lost to Follow-up|1|||
147389289|NCT03906240|531587037|FG001|Overall Study|Lost to Follow-up|0|||
147389290|NCT03906240|531587036|FG000|Overall Study|Withdrawal by Subject|0|||
147389291|NCT03906240|531587037|FG001|Overall Study|Withdrawal by Subject|1|||
147389292|NCT05287178|531587048|FG000|Overall Study|Lost to Follow-up|2|||
147389293|NCT00288353|531587049|FG000|Overall Study|Lack of Efficacy|2|||
147389294|NCT00288353|531587050|FG001|Overall Study|Lack of Efficacy|2|||
147389295|NCT00288353|531587049|FG000|Overall Study|Withdrawal by Subject|5|||
147389296|NCT00288353|531587050|FG001|Overall Study|Withdrawal by Subject|5|||
147389297|NCT00145496|531587058|FG000|Overall Study|Adverse Event|42|||
147389298|NCT00145496|531587059|FG001|Overall Study|Adverse Event|30|||
147389299|NCT00145496|531587058|FG000|Overall Study|Lack of Efficacy|12|||
147389300|NCT00145496|531587059|FG001|Overall Study|Lack of Efficacy|7|||
147389301|NCT00145496|531587058|FG000|Overall Study|Withdrawal by Subject|32|||
147389302|NCT00145496|531587059|FG001|Overall Study|Withdrawal by Subject|26|||
147389303|NCT00145496|531587058|FG000|Overall Study|Lost to Follow-up|12|||
147389304|NCT00145496|531587059|FG001|Overall Study|Lost to Follow-up|5|||
147389305|NCT00145496|531587058|FG000|Overall Study|Other|25|||
147389306|NCT00145496|531587059|FG001|Overall Study|Other|13|||
147389307|NCT03138499|531587063|FG000|Overall Study|Lost to Follow-up|1|||
147389308|NCT03138499|531587064|FG001|Overall Study|Lost to Follow-up|0|||
147389309|NCT03138499|531587063|FG000|Overall Study|Participants withdrew consent|1|||
147389310|NCT03138499|531587064|FG001|Overall Study|Participants withdrew consent|0|||
147389311|NCT03138499|531587063|FG000|Overall Study|Participant discontinued study before treatment|0|||
147389312|NCT03138499|531587064|FG001|Overall Study|Participant discontinued study before treatment|1|||
147389313|NCT03138499|531587063|FG000|Overall Study|Disease Progression|2|||
147389314|NCT03138499|531587064|FG001|Overall Study|Disease Progression|6|||
147389315|NCT03138499|531587063|FG000|Overall Study|Study drug toxicity|2|||
147389316|NCT03138499|531587064|FG001|Overall Study|Study drug toxicity|2|||
147389317|NCT03138499|531587063|FG000|Overall Study|Participant request to discontinue study treatment|1|||
147389318|NCT03138499|531587064|FG001|Overall Study|Participant request to discontinue study treatment|1|||
147389319|NCT03138499|531587063|FG000|Overall Study|Other reasons|2|||
147389320|NCT03138499|531587064|FG001|Overall Study|Other reasons|0|||
147389321|NCT01334606|531587065|FG000|Overall Study|Study Terminated due to slow enrolment|18|||
147389322|NCT02312245|531587066|FG000|Overall Study|Death|0|||
147389323|NCT02312245|531587067|FG001|Overall Study|Death|0|||
147389324|NCT02312245|531587068|FG002|Overall Study|Death|0|||
147389325|NCT02312245|531587069|FG003|Overall Study|Death|1|||
147389326|NCT02312245|531587066|FG000|Overall Study|Withdrawal by Subject|1|||
147389327|NCT02312245|531587067|FG001|Overall Study|Withdrawal by Subject|1|||
147389328|NCT02312245|531587068|FG002|Overall Study|Withdrawal by Subject|0|||
147389329|NCT02312245|531587069|FG003|Overall Study|Withdrawal by Subject|2|||
147389330|NCT02312245|531587066|FG000|Overall Study|Alternative Therapy|1|||
147389331|NCT02312245|531587067|FG001|Overall Study|Alternative Therapy|0|||
147389332|NCT02312245|531587068|FG002|Overall Study|Alternative Therapy|0|||
147389333|NCT02312245|531587069|FG003|Overall Study|Alternative Therapy|0|||
147389334|NCT02312245|531587066|FG000|Overall Study|Progression|0|||
147389335|NCT02312245|531587067|FG001|Overall Study|Progression|0|||
147389336|NCT02312245|531587068|FG002|Overall Study|Progression|0|||
147389337|NCT02312245|531587069|FG003|Overall Study|Progression|5|||
147457997|NCT01227902|531839628|FG000|Overall Study|Physician Decision|0|||
147457998|NCT01227902|531839629|FG001|Overall Study|Physician Decision|1|||
147457999|NCT01227902|531839630|FG002|Overall Study|Physician Decision|1|||
147615153|NCT03288714|532406622|FG001|Overall Study|Adverse Event|0|||
147615154|NCT03280264|532406623|FG000|Overall Study|Adverse Event|1|||
147615155|NCT03280264|532406623|FG000|Overall Study|Physician Decision|1|||
147615156|NCT03280264|532406623|FG000|Overall Study|Withdrawal by Subject|1|||
147615157|NCT00524420|532406625|FG000|Overall Study|Lack of Efficacy|1|||
147615158|NCT00524420|532406626|FG001|Overall Study|Lack of Efficacy|0|||
147615159|NCT03934541|532406643|FG000|Overall Study|Study Terminated by Sponsor|0|||
147615160|NCT03934541|532406644|FG001|Overall Study|Study Terminated by Sponsor|1|||
147615161|NCT03934541|532406645|FG002|Overall Study|Study Terminated by Sponsor|0|||
147615162|NCT03934541|532406646|FG003|Overall Study|Study Terminated by Sponsor|0|||
147389338|NCT02312245|531587066|FG000|Overall Study|Patient went to hospice|0|||
147389339|NCT02312245|531587067|FG001|Overall Study|Patient went to hospice|0|||
147389340|NCT02312245|531587068|FG002|Overall Study|Patient went to hospice|0|||
147389341|NCT02312245|531587069|FG003|Overall Study|Patient went to hospice|1|||
147389342|NCT02312245|531587066|FG000|Overall Study|Ineligible|1|||
147389343|NCT02312245|531587067|FG001|Overall Study|Ineligible|0|||
147389344|NCT02312245|531587068|FG002|Overall Study|Ineligible|0|||
147389345|NCT02312245|531587069|FG003|Overall Study|Ineligible|0|||
147458000|NCT01227902|531839631|FG003|Overall Study|Physician Decision|0|||
147389346|NCT00448344|531587070|FG000|Overall Study|Lost to Follow-up|20|||
147389347|NCT00448344|531587071|FG001|Overall Study|Lost to Follow-up|22|||
147389348|NCT00448344|531587070|FG000|Overall Study|Withdrawal by Subject|6|||
147389349|NCT00448344|531587071|FG001|Overall Study|Withdrawal by Subject|8|||
147615163|NCT02673775|532406647|FG000|Washout (at Least 2 Weeks)|Lost to Follow-up|1|||
147615164|NCT02673775|532406648|FG001|Washout (at Least 2 Weeks)|Lost to Follow-up|0|||
147389350|NCT00448344|531587070|FG000|Overall Study|Death|3|||
147389351|NCT00448344|531587071|FG001|Overall Study|Death|4|||
147389352|NCT00448344|531587070|FG000|Overall Study|Physician Decision|1|||
147389353|NCT00448344|531587071|FG001|Overall Study|Physician Decision|2|||
147389354|NCT01123200|531587075|FG000|Overall Study|Withdrawal by Subject|1|||
147389355|NCT01232569|531588896|FG000|Double-blind Treatment Period|Withdrawal by Subject|9|||
147389356|NCT01232569|531588897|FG001|Double-blind Treatment Period|Withdrawal by Subject|2|||
147389357|NCT01232569|531588898|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
147389358|NCT01232569|531588899|FG003|Double-blind Treatment Period|Withdrawal by Subject|0|||
147389359|NCT01232569|531588896|FG000|Double-blind Treatment Period|Escape|2|||
147389360|NCT01232569|531588897|FG001|Double-blind Treatment Period|Escape|2|||
147389361|NCT01232569|531588898|FG002|Double-blind Treatment Period|Escape|0|||
147389362|NCT01232569|531588899|FG003|Double-blind Treatment Period|Escape|0|||
147389363|NCT01232569|531588896|FG000|Double-blind Treatment Period|Lost to Follow-up|4|||
147389364|NCT01232569|531588897|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
147389365|NCT01232569|531588898|FG002|Double-blind Treatment Period|Lost to Follow-up|0|||
147389366|NCT01232569|531588899|FG003|Double-blind Treatment Period|Lost to Follow-up|0|||
147389367|NCT01232569|531588896|FG000|Double-blind Treatment Period|Lack of Efficacy|1|||
147389368|NCT01232569|531588897|FG001|Double-blind Treatment Period|Lack of Efficacy|2|||
147389369|NCT01232569|531588898|FG002|Double-blind Treatment Period|Lack of Efficacy|0|||
147389370|NCT01232569|531588899|FG003|Double-blind Treatment Period|Lack of Efficacy|0|||
147389371|NCT01232569|531588896|FG000|Double-blind Treatment Period|Physician Decision|1|||
147389372|NCT01232569|531588897|FG001|Double-blind Treatment Period|Physician Decision|0|||
147389373|NCT01232569|531588898|FG002|Double-blind Treatment Period|Physician Decision|0|||
147389374|NCT01232569|531588899|FG003|Double-blind Treatment Period|Physician Decision|0|||
147389375|NCT01232569|531588896|FG000|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|9|||
147389376|NCT01232569|531588897|FG001|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|3|||
147389377|NCT01232569|531588898|FG002|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|0|||
147389378|NCT01232569|531588899|FG003|Double-blind Treatment Period|Adverse Event (Except Anaphylaxis)|0|||
147389379|NCT01232569|531588896|FG000|Double-blind Treatment Period|Death|2|||
147389380|NCT01232569|531588897|FG001|Double-blind Treatment Period|Death|0|||
147389381|NCT01232569|531588898|FG002|Double-blind Treatment Period|Death|0|||
147389382|NCT01232569|531588899|FG003|Double-blind Treatment Period|Death|0|||
147389383|NCT01537120|531588907|FG000|8 Weeks Washout|Inclusion/exclusion criteria not met|1|||
147389384|NCT01537120|531588907|FG000|3 Weeks Placebo|Withdrawal by Subject|1|||
147389385|NCT05335005|531588909|FG000|Overall Study|Lost to Follow-up|1|||
147389386|NCT00644332|531588911|FG000|Overall Study|Adverse Event|11|||
147389387|NCT00644332|531588911|FG000|Overall Study|Withdrawal by Subject|6|||
147389388|NCT00644332|531588911|FG000|Overall Study|Completion Status Unknown|2|||
147389389|NCT00644332|531588911|FG000|Overall Study|Did Not Meet Eligibility Requirements|1|||
147389390|NCT00644332|531588911|FG000|Overall Study|Could Not Attend Scheduled Visits|1|||
147389391|NCT03694210|531588912|FG000|Overall Study|Death|1|||
147389392|NCT03694210|531588912|FG000|Overall Study|Screen Failure|7|||
147389393|NCT00443755|531588913|FG000|Overall Study|Withdrawal by Subject|2|||
147389394|NCT00443755|531588914|FG001|Overall Study|Withdrawal by Subject|1|||
147389395|NCT02706834|531588917|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
147389396|NCT02706834|531588918|FG001|Overall Study|Pretreatment Event/Adverse Event|1|||
147389397|NCT02706834|531588919|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
147389398|NCT02706834|531588920|FG003|Overall Study|Pretreatment Event/Adverse Event|0|||
147389399|NCT02706834|531588921|FG004|Overall Study|Pretreatment Event/Adverse Event|0|||
147389400|NCT02706834|531588922|FG005|Overall Study|Pretreatment Event/Adverse Event|0|||
147389401|NCT02706834|531588923|FG006|Overall Study|Pretreatment Event/Adverse Event|0|||
147389402|NCT02706834|531588924|FG007|Overall Study|Pretreatment Event/Adverse Event|0|||
147389403|NCT02706834|531588925|FG008|Overall Study|Pretreatment Event/Adverse Event|0|||
147389404|NCT02706834|531588926|FG009|Overall Study|Pretreatment Event/Adverse Event|0|||
147389405|NCT02706834|531588927|FG010|Overall Study|Pretreatment Event/Adverse Event|1|||
147389406|NCT02706834|531588917|FG000|Overall Study|Lost to Follow-up|0|||
147389407|NCT02706834|531588918|FG001|Overall Study|Lost to Follow-up|0|||
147389408|NCT02706834|531588919|FG002|Overall Study|Lost to Follow-up|1|||
147389409|NCT02706834|531588920|FG003|Overall Study|Lost to Follow-up|0|||
147389410|NCT02706834|531588921|FG004|Overall Study|Lost to Follow-up|0|||
147389411|NCT02706834|531588922|FG005|Overall Study|Lost to Follow-up|0|||
147389412|NCT02706834|531588923|FG006|Overall Study|Lost to Follow-up|0|||
147389413|NCT02706834|531588924|FG007|Overall Study|Lost to Follow-up|0|||
147389414|NCT02706834|531588925|FG008|Overall Study|Lost to Follow-up|0|||
147389415|NCT02706834|531588926|FG009|Overall Study|Lost to Follow-up|0|||
147389416|NCT02706834|531588927|FG010|Overall Study|Lost to Follow-up|0|||
147389417|NCT02706834|531588917|FG000|Overall Study|Voluntary Withdrawal|1|||
147389418|NCT02706834|531588918|FG001|Overall Study|Voluntary Withdrawal|0|||
147389419|NCT02706834|531588919|FG002|Overall Study|Voluntary Withdrawal|0|||
147389420|NCT02706834|531588920|FG003|Overall Study|Voluntary Withdrawal|0|||
147389421|NCT02706834|531588921|FG004|Overall Study|Voluntary Withdrawal|0|||
147389422|NCT02706834|531588922|FG005|Overall Study|Voluntary Withdrawal|0|||
147389423|NCT02706834|531588923|FG006|Overall Study|Voluntary Withdrawal|0|||
147389424|NCT02706834|531588924|FG007|Overall Study|Voluntary Withdrawal|0|||
147389425|NCT02706834|531588925|FG008|Overall Study|Voluntary Withdrawal|0|||
147389426|NCT02706834|531588926|FG009|Overall Study|Voluntary Withdrawal|1|||
147389427|NCT02706834|531588927|FG010|Overall Study|Voluntary Withdrawal|0|||
147389428|NCT02706834|531588917|FG000|Overall Study|Other Reason Not Specified|1|||
147389429|NCT02706834|531588918|FG001|Overall Study|Other Reason Not Specified|0|||
147389430|NCT02706834|531588919|FG002|Overall Study|Other Reason Not Specified|0|||
147389431|NCT02706834|531588920|FG003|Overall Study|Other Reason Not Specified|0|||
147389432|NCT02706834|531588921|FG004|Overall Study|Other Reason Not Specified|1|||
147389433|NCT02706834|531588922|FG005|Overall Study|Other Reason Not Specified|0|||
147389434|NCT02706834|531588923|FG006|Overall Study|Other Reason Not Specified|0|||
147389435|NCT02706834|531588924|FG007|Overall Study|Other Reason Not Specified|0|||
147389436|NCT02706834|531588925|FG008|Overall Study|Other Reason Not Specified|0|||
147389437|NCT02706834|531588926|FG009|Overall Study|Other Reason Not Specified|0|||
147389438|NCT02706834|531588927|FG010|Overall Study|Other Reason Not Specified|0|||
147389439|NCT00678899|531588933|FG000|Overall Study|Adverse Event|1|||
147389440|NCT03451292|531588934|FG000|Overall Study|Death|44|||
147389441|NCT03451292|531588935|FG001|Overall Study|Death|59|||
147389442|NCT03451292|531588934|FG000|Overall Study|Withdrawal by Subject|18|||
147389443|NCT03451292|531588935|FG001|Overall Study|Withdrawal by Subject|13|||
147389444|NCT03451292|531588934|FG000|Overall Study|Transplantation|18|||
147389445|NCT03451292|531588935|FG001|Overall Study|Transplantation|12|||
147389446|NCT03451292|531588934|FG000|Overall Study|Lost to Follow-up|4|||
147389447|NCT03451292|531588935|FG001|Overall Study|Lost to Follow-up|12|||
147389448|NCT03451292|531588934|FG000|Overall Study|Physician Decision|4|||
147389449|NCT03451292|531588935|FG001|Overall Study|Physician Decision|3|||
147389450|NCT03451292|531588934|FG000|Overall Study|Adverse Event|3|||
147389451|NCT03451292|531588935|FG001|Overall Study|Adverse Event|3|||
147389452|NCT03451292|531588934|FG000|Overall Study|Non-compliance with Study Drug|2|||
147389453|NCT03451292|531588935|FG001|Overall Study|Non-compliance with Study Drug|0|||
147389454|NCT04385849|531588936|FG000|Overall Study|Lost to Follow-up|1|||
147389455|NCT04385849|531588937|FG001|Overall Study|Lost to Follow-up|0|||
147389456|NCT01375777|531588938|FG000|Overall Study|Withdrawal by Subject|0|||
147389457|NCT01375777|531588939|FG001|Overall Study|Withdrawal by Subject|2|||
147389458|NCT01375777|531588940|FG002|Overall Study|Withdrawal by Subject|1|||
147389459|NCT01375777|531588941|FG003|Overall Study|Withdrawal by Subject|0|||
147389460|NCT01375777|531588942|FG004|Overall Study|Withdrawal by Subject|1|||
147389461|NCT01375777|531588943|FG005|Overall Study|Withdrawal by Subject|1|||
147389462|NCT01375777|531588944|FG006|Overall Study|Withdrawal by Subject|1|||
147389463|NCT01375777|531588945|FG007|Overall Study|Withdrawal by Subject|2|||
147389464|NCT01375777|531588946|FG008|Overall Study|Withdrawal by Subject|1|||
147389465|NCT01375777|531588938|FG000|Overall Study|Lost to Follow-up|1|||
147389466|NCT01375777|531588939|FG001|Overall Study|Lost to Follow-up|0|||
147389467|NCT01375777|531588940|FG002|Overall Study|Lost to Follow-up|0|||
147389468|NCT01375777|531588941|FG003|Overall Study|Lost to Follow-up|0|||
147389469|NCT01375777|531588942|FG004|Overall Study|Lost to Follow-up|0|||
147389470|NCT01375777|531588943|FG005|Overall Study|Lost to Follow-up|0|||
147389471|NCT01375777|531588944|FG006|Overall Study|Lost to Follow-up|1|||
147389472|NCT01375777|531588945|FG007|Overall Study|Lost to Follow-up|0|||
147389473|NCT01375777|531588946|FG008|Overall Study|Lost to Follow-up|0|||
147389474|NCT01375777|531588938|FG000|Overall Study|Other|1|||
147389475|NCT01375777|531588939|FG001|Overall Study|Other|1|||
147389476|NCT01375777|531588940|FG002|Overall Study|Other|0|||
147389477|NCT01375777|531588941|FG003|Overall Study|Other|0|||
147615165|NCT02673775|532406647|FG000|Washout (at Least 2 Weeks)|Physician Decision|1|||
147389478|NCT01375777|531588942|FG004|Overall Study|Other|0|||
147389479|NCT01375777|531588943|FG005|Overall Study|Other|0|||
147389480|NCT01375777|531588944|FG006|Overall Study|Other|0|||
147389481|NCT01375777|531588945|FG007|Overall Study|Other|0|||
147389482|NCT01375777|531588946|FG008|Overall Study|Other|1|||
147389483|NCT00355784|531588947|FG000|Overall Study|Withdrawal by Subject|0|||
147389484|NCT00355784|531588948|FG001|Overall Study|Withdrawal by Subject|0|||
147389485|NCT00355784|531588949|FG002|Overall Study|Withdrawal by Subject|2|||
147389486|NCT02543294|531588950|FG000|Overall Study|Lost to Follow-up|3|||
147389487|NCT02543294|531588950|FG000|Overall Study|Physician Decision|2|||
147389488|NCT02543294|531588950|FG000|Overall Study|Withdrawal by Subject|7|||
147389489|NCT00730925|531588951|FG000|Overall Study|Progressive Disease|21|||
147389490|NCT00730925|531588951|FG000|Overall Study|Dose reducing Event|2|||
147389491|NCT00730925|531588951|FG000|Overall Study|Other Averse Event|7|||
147389492|NCT00730925|531588951|FG000|Overall Study|Protocol Violation|1|||
147389493|NCT00730925|531588951|FG000|Overall Study|Withdrawal by Subject|1|||
147389494|NCT00730925|531588951|FG000|Overall Study|Switch to combination therapy|8|||
147389495|NCT00730925|531588951|FG000|Overall Study|Other|1|||
147389496|NCT02504502|531588955|FG000|Routine Care vs. Enhanced Report|Lost to Follow-up|4|||
147389497|NCT02504502|531588956|FG001|Routine Care vs. Enhanced Report|Lost to Follow-up|7|||
147389498|NCT02504502|531588955|FG000|Crossover to Enhanced Report|Lost to Follow-up|5|||
147389499|NCT02504502|531588956|FG001|Crossover to Enhanced Report|Lost to Follow-up|0|||
147389500|NCT02475733|531588960|FG000|Overall Study|Withdrawal by Subject|1|||
147389501|NCT02475733|531588961|FG001|Overall Study|Withdrawal by Subject|0|||
147389502|NCT02475733|531588960|FG000|Overall Study|Physician Decision|1|||
147389503|NCT02475733|531588961|FG001|Overall Study|Physician Decision|0|||
147389504|NCT02131155|531588962|FG000|Overall Study|Adverse Event|1|||
147389505|NCT02131155|531588963|FG001|Overall Study|Adverse Event|0|||
147389506|NCT02131155|531588962|FG000|Overall Study|Treatment completed|1|||
147389507|NCT02131155|531588963|FG001|Overall Study|Treatment completed|0|||
147389508|NCT02131155|531588962|FG000|Overall Study|Primary tumour recurrence|2|||
147389509|NCT02131155|531588963|FG001|Overall Study|Primary tumour recurrence|1|||
147389510|NCT02131155|531588962|FG000|Overall Study|Refused to continue study medication|1|||
147389511|NCT02131155|531588963|FG001|Overall Study|Refused to continue study medication|0|||
147389512|NCT02131155|531588962|FG000|Overall Study|Study early termination|20|||
147389513|NCT02131155|531588963|FG001|Overall Study|Study early termination|10|||
147389514|NCT01887418|531588964|FG000|Overall Study|Travelling difficulties|0|||
147389515|NCT01887418|531588965|FG001|Overall Study|Travelling difficulties|0|||
147389516|NCT01887418|531588966|FG002|Overall Study|Travelling difficulties|1|||
147389517|NCT00475735|531588967|FG000|Treatment Period 1|Adverse Event|2|||
147389518|NCT00475735|531588968|FG001|Treatment Period 1|Adverse Event|0|||
147389519|NCT00475735|531588969|FG002|Treatment Period 1|Adverse Event|0|||
147389520|NCT00475735|531588970|FG003|Treatment Period 1|Adverse Event|0|||
147389521|NCT00475735|531588971|FG004|Treatment Period 1|Adverse Event|0|||
147389522|NCT00475735|531588972|FG005|Treatment Period 1|Adverse Event|0|||
147389523|NCT00475735|531588967|FG000|Treatment Period 1|Lack of Efficacy|1|||
147389524|NCT00475735|531588968|FG001|Treatment Period 1|Lack of Efficacy|0|||
147389525|NCT00475735|531588969|FG002|Treatment Period 1|Lack of Efficacy|0|||
147389526|NCT00475735|531588970|FG003|Treatment Period 1|Lack of Efficacy|0|||
147389527|NCT00475735|531588971|FG004|Treatment Period 1|Lack of Efficacy|0|||
147389528|NCT00475735|531588972|FG005|Treatment Period 1|Lack of Efficacy|0|||
147389529|NCT00475735|531588967|FG000|Treatment Period 1|Lost to Follow-up|0|||
147389530|NCT00475735|531588968|FG001|Treatment Period 1|Lost to Follow-up|0|||
147389531|NCT00475735|531588969|FG002|Treatment Period 1|Lost to Follow-up|0|||
147389532|NCT00475735|531588970|FG003|Treatment Period 1|Lost to Follow-up|0|||
147389533|NCT00475735|531588971|FG004|Treatment Period 1|Lost to Follow-up|0|||
147389534|NCT00475735|531588972|FG005|Treatment Period 1|Lost to Follow-up|1|||
147389535|NCT00475735|531588967|FG000|Treatment Period 1|Protocol Violation|0|||
147389536|NCT00475735|531588968|FG001|Treatment Period 1|Protocol Violation|0|||
147389537|NCT00475735|531588969|FG002|Treatment Period 1|Protocol Violation|0|||
147389538|NCT00475735|531588970|FG003|Treatment Period 1|Protocol Violation|1|||
147389539|NCT00475735|531588971|FG004|Treatment Period 1|Protocol Violation|0|||
147389540|NCT00475735|531588972|FG005|Treatment Period 1|Protocol Violation|0|||
147389541|NCT00475735|531588967|FG000|Treatment Period 1|Withdrawal by Subject|1|||
147389542|NCT00475735|531588968|FG001|Treatment Period 1|Withdrawal by Subject|1|||
147389543|NCT00475735|531588969|FG002|Treatment Period 1|Withdrawal by Subject|0|||
147389544|NCT00475735|531588970|FG003|Treatment Period 1|Withdrawal by Subject|0|||
147389545|NCT00475735|531588971|FG004|Treatment Period 1|Withdrawal by Subject|0|||
147389546|NCT00475735|531588972|FG005|Treatment Period 1|Withdrawal by Subject|0|||
147389547|NCT00475735|531588967|FG000|Treatment Period 1|DC due to AE but continuing|0|||
147389548|NCT00475735|531588968|FG001|Treatment Period 1|DC due to AE but continuing|0|||
147389549|NCT00475735|531588969|FG002|Treatment Period 1|DC due to AE but continuing|0|||
147389550|NCT00475735|531588970|FG003|Treatment Period 1|DC due to AE but continuing|1|||
147389551|NCT00475735|531588971|FG004|Treatment Period 1|DC due to AE but continuing|2|||
147389552|NCT00475735|531588972|FG005|Treatment Period 1|DC due to AE but continuing|2|||
147389553|NCT00475735|531588967|FG000|Treatment Period 1|DC due to no efficacy but Continuing|0|||
147389554|NCT00475735|531588968|FG001|Treatment Period 1|DC due to no efficacy but Continuing|1|||
147389555|NCT00475735|531588969|FG002|Treatment Period 1|DC due to no efficacy but Continuing|0|||
147389556|NCT00475735|531588970|FG003|Treatment Period 1|DC due to no efficacy but Continuing|0|||
147389557|NCT00475735|531588971|FG004|Treatment Period 1|DC due to no efficacy but Continuing|0|||
147389558|NCT00475735|531588972|FG005|Treatment Period 1|DC due to no efficacy but Continuing|0|||
147389559|NCT00475735|531588967|FG000|Treatment Washout|Lost to Follow-up|0|||
147389560|NCT00475735|531588968|FG001|Treatment Washout|Lost to Follow-up|1|||
147389561|NCT00475735|531588969|FG002|Treatment Washout|Lost to Follow-up|0|||
147389562|NCT00475735|531588970|FG003|Treatment Washout|Lost to Follow-up|0|||
147389563|NCT00475735|531588971|FG004|Treatment Washout|Lost to Follow-up|0|||
147389564|NCT00475735|531588972|FG005|Treatment Washout|Lost to Follow-up|0|||
147389565|NCT00475735|531588967|FG000|Treatment Washout|Protocol Violation|0|||
147389566|NCT00475735|531588968|FG001|Treatment Washout|Protocol Violation|1|||
147389567|NCT00475735|531588969|FG002|Treatment Washout|Protocol Violation|0|||
147389568|NCT00475735|531588970|FG003|Treatment Washout|Protocol Violation|0|||
147389569|NCT00475735|531588971|FG004|Treatment Washout|Protocol Violation|0|||
147389570|NCT00475735|531588972|FG005|Treatment Washout|Protocol Violation|0|||
147389571|NCT00475735|531588967|FG000|Treatment Period 2|Adverse Event|0|||
147389572|NCT00475735|531588968|FG001|Treatment Period 2|Adverse Event|1|||
147389573|NCT00475735|531588969|FG002|Treatment Period 2|Adverse Event|0|||
147389574|NCT00475735|531588970|FG003|Treatment Period 2|Adverse Event|2|||
147389575|NCT00475735|531588971|FG004|Treatment Period 2|Adverse Event|0|||
147389576|NCT00475735|531588972|FG005|Treatment Period 2|Adverse Event|0|||
147389577|NCT00475735|531588967|FG000|Treatment Period 2|Lack of Efficacy|0|||
147389578|NCT00475735|531588968|FG001|Treatment Period 2|Lack of Efficacy|0|||
147389579|NCT00475735|531588969|FG002|Treatment Period 2|Lack of Efficacy|0|||
147389580|NCT00475735|531588970|FG003|Treatment Period 2|Lack of Efficacy|0|||
147389581|NCT00475735|531588971|FG004|Treatment Period 2|Lack of Efficacy|0|||
147389582|NCT00475735|531588972|FG005|Treatment Period 2|Lack of Efficacy|1|||
147389583|NCT00475735|531588967|FG000|Treatment Period 2|Withdrawal by Subject|0|||
147389584|NCT00475735|531588968|FG001|Treatment Period 2|Withdrawal by Subject|0|||
147389585|NCT00475735|531588969|FG002|Treatment Period 2|Withdrawal by Subject|0|||
147389586|NCT00475735|531588970|FG003|Treatment Period 2|Withdrawal by Subject|0|||
147389587|NCT00475735|531588971|FG004|Treatment Period 2|Withdrawal by Subject|1|||
147389588|NCT00475735|531588972|FG005|Treatment Period 2|Withdrawal by Subject|0|||
147389589|NCT03132753|531588973|FG000|Baseline - 6 Month Follow-Up|Lost to Follow-up|27|||
147389590|NCT03132753|531588974|FG001|Baseline - 6 Month Follow-Up|Lost to Follow-up|32|||
147389591|NCT03132753|531588973|FG000|6 Month Follow-Up - 12 Month Follow-Up|Lost to Follow-up|6|||
147389592|NCT03132753|531588974|FG001|6 Month Follow-Up - 12 Month Follow-Up|Lost to Follow-up|2|||
147389593|NCT00084747|531588975|FG000|Overall Study|Relapsed|8|||
147389594|NCT00084747|531588975|FG000|Overall Study|Death|3|||
147389595|NCT00084747|531588975|FG000|Overall Study|Withdrawal by Subject|2|||
147389596|NCT00296504|531588984|FG000|Interim Analysis|Withdrawal by Subject|8|||
147389597|NCT00296504|531588985|FG001|Interim Analysis|Withdrawal by Subject|0|||
147389598|NCT00296504|531588986|FG002|Interim Analysis|Withdrawal by Subject|12|||
147389599|NCT00296504|531588987|FG003|Interim Analysis|Withdrawal by Subject|0|||
147389600|NCT00296504|531588988|FG004|Interim Analysis|Withdrawal by Subject|5|||
147389601|NCT00296504|531588989|FG005|Interim Analysis|Withdrawal by Subject|5|||
147389602|NCT00296504|531588990|FG006|Interim Analysis|Withdrawal by Subject|9|||
147389603|NCT00296504|531588991|FG007|Interim Analysis|Withdrawal by Subject|3|||
147389604|NCT00296504|531588992|FG008|Interim Analysis|Withdrawal by Subject|0|||
147389605|NCT00296504|531588984|FG000|Interim Analysis|Lost to Follow-up|13|||
147389606|NCT00296504|531588985|FG001|Interim Analysis|Lost to Follow-up|3|||
147389607|NCT00296504|531588986|FG002|Interim Analysis|Lost to Follow-up|26|||
147389608|NCT00296504|531588987|FG003|Interim Analysis|Lost to Follow-up|8|||
147389609|NCT00296504|531588988|FG004|Interim Analysis|Lost to Follow-up|14|||
147389610|NCT00296504|531588989|FG005|Interim Analysis|Lost to Follow-up|4|||
147389611|NCT00296504|531588990|FG006|Interim Analysis|Lost to Follow-up|11|||
147389612|NCT00296504|531588991|FG007|Interim Analysis|Lost to Follow-up|4|||
147389613|NCT00296504|531588992|FG008|Interim Analysis|Lost to Follow-up|0|||
147389614|NCT00296504|531588984|FG000|Interim Analysis|Clinical Progression|1|||
147389615|NCT00296504|531588985|FG001|Interim Analysis|Clinical Progression|0|||
147389616|NCT00296504|531588986|FG002|Interim Analysis|Clinical Progression|1|||
147389617|NCT00296504|531588987|FG003|Interim Analysis|Clinical Progression|1|||
147389618|NCT00296504|531588988|FG004|Interim Analysis|Clinical Progression|0|||
147389619|NCT00296504|531588989|FG005|Interim Analysis|Clinical Progression|2|||
147389620|NCT00296504|531588990|FG006|Interim Analysis|Clinical Progression|1|||
147389621|NCT00296504|531588991|FG007|Interim Analysis|Clinical Progression|2|||
147389622|NCT00296504|531588992|FG008|Interim Analysis|Clinical Progression|0|||
147389623|NCT00296504|531588984|FG000|Interim Analysis|Insufficient Viral Load Response|5|||
147389624|NCT00296504|531588985|FG001|Interim Analysis|Insufficient Viral Load Response|1|||
147389625|NCT00296504|531588986|FG002|Interim Analysis|Insufficient Viral Load Response|12|||
147389626|NCT00296504|531588987|FG003|Interim Analysis|Insufficient Viral Load Response|2|||
147389627|NCT00296504|531588988|FG004|Interim Analysis|Insufficient Viral Load Response|7|||
147389628|NCT00296504|531588989|FG005|Interim Analysis|Insufficient Viral Load Response|9|||
147389629|NCT00296504|531588990|FG006|Interim Analysis|Insufficient Viral Load Response|2|||
147389630|NCT00296504|531588991|FG007|Interim Analysis|Insufficient Viral Load Response|24|||
147389631|NCT00296504|531588992|FG008|Interim Analysis|Insufficient Viral Load Response|0|||
147389632|NCT00296504|531588984|FG000|Interim Analysis|Adverse Event|0|||
147389633|NCT00296504|531588985|FG001|Interim Analysis|Adverse Event|0|||
147389634|NCT00296504|531588986|FG002|Interim Analysis|Adverse Event|13|||
147389635|NCT00296504|531588987|FG003|Interim Analysis|Adverse Event|4|||
147389636|NCT00296504|531588988|FG004|Interim Analysis|Adverse Event|6|||
147389637|NCT00296504|531588989|FG005|Interim Analysis|Adverse Event|3|||
147389638|NCT00296504|531588990|FG006|Interim Analysis|Adverse Event|4|||
147389639|NCT00296504|531588991|FG007|Interim Analysis|Adverse Event|5|||
147389640|NCT00296504|531588992|FG008|Interim Analysis|Adverse Event|0|||
147389641|NCT00296504|531588984|FG000|Interim Analysis|Protocol Violation|0|||
147389642|NCT00296504|531588985|FG001|Interim Analysis|Protocol Violation|0|||
147389643|NCT00296504|531588986|FG002|Interim Analysis|Protocol Violation|2|||
147389644|NCT00296504|531588987|FG003|Interim Analysis|Protocol Violation|0|||
147389645|NCT00296504|531588988|FG004|Interim Analysis|Protocol Violation|1|||
147389646|NCT00296504|531588989|FG005|Interim Analysis|Protocol Violation|0|||
147389647|NCT00296504|531588990|FG006|Interim Analysis|Protocol Violation|0|||
147389648|NCT00296504|531588991|FG007|Interim Analysis|Protocol Violation|1|||
147389649|NCT00296504|531588992|FG008|Interim Analysis|Protocol Violation|0|||
147458001|NCT01227902|531839628|FG000|Overall Study|Withdrawal by Subject|4|||
147458002|NCT01227902|531839629|FG001|Overall Study|Withdrawal by Subject|2|||
147458003|NCT01227902|531839630|FG002|Overall Study|Withdrawal by Subject|4|||
147458004|NCT01227902|531839631|FG003|Overall Study|Withdrawal by Subject|3|||
147458005|NCT05280756|531839632|FG000|Overall Study|Lost to Follow-up|1|||
147458006|NCT05280756|531839633|FG001|Overall Study|Lost to Follow-up|1|||
147458007|NCT02363478|531839634|FG000|Overall Study|Lost to Follow-up|4|||
147458008|NCT02363478|531839634|FG000|Overall Study|Adverse Event|4|||
147458009|NCT00768898|531839635|FG000|Overall Study|Unrelated injury|1|||
147458010|NCT00768898|531839635|FG000|Overall Study|Headache|1|||
147458011|NCT02527707|531839636|FG000|Overall Study|Adverse Event|1|||
147458012|NCT02527707|531839636|FG000|Overall Study|Adverse Event|1|||
147458013|NCT00542997|531839637|FG000|Wash in / Wash Out Period|Withdrawal by Subject|2|||
147458014|NCT00542997|531839637|FG000|Wash in / Wash Out Period|Adverse Event|3|||
147458015|NCT00542997|531839637|FG000|Efficacy Period|Adverse Event|3|||
147458016|NCT00352534|531839638|FG000|Initial Staging|Ineligible|8|||
147458017|NCT00352534|531839639|FG001|Initial Staging|Ineligible|9|||
147458018|NCT00352534|531839640|FG002|Initial Staging|Ineligible|0|||
147458019|NCT00352534|531839641|FG003|Initial Staging|Ineligible|0|||
147458020|NCT00352534|531839642|FG004|Initial Staging|Ineligible|0|||
147458021|NCT00352534|531839643|FG005|Initial Staging|Ineligible|0|||
147458022|NCT00352534|531839644|FG006|Initial Staging|Ineligible|0|||
147458023|NCT00352534|531839638|FG000|Final Risk Group Assignment|Lack of Efficacy|0|||
147458024|NCT00352534|531839639|FG001|Final Risk Group Assignment|Lack of Efficacy|0|||
147458025|NCT00352534|531839640|FG002|Final Risk Group Assignment|Lack of Efficacy|0|||
147458026|NCT00352534|531839641|FG003|Final Risk Group Assignment|Lack of Efficacy|2|||
147458027|NCT00352534|531839642|FG004|Final Risk Group Assignment|Lack of Efficacy|1|||
147458028|NCT00352534|531839643|FG005|Final Risk Group Assignment|Lack of Efficacy|19|||
147458029|NCT00352534|531839644|FG006|Final Risk Group Assignment|Lack of Efficacy|0|||
147458030|NCT00352534|531839638|FG000|Final Risk Group Assignment|Physician Decision|0|||
147458031|NCT00352534|531839639|FG001|Final Risk Group Assignment|Physician Decision|0|||
147458032|NCT00352534|531839640|FG002|Final Risk Group Assignment|Physician Decision|0|||
147458033|NCT00352534|531839641|FG003|Final Risk Group Assignment|Physician Decision|0|||
147458034|NCT00352534|531839642|FG004|Final Risk Group Assignment|Physician Decision|0|||
147458035|NCT00352534|531839643|FG005|Final Risk Group Assignment|Physician Decision|8|||
147458036|NCT00352534|531839644|FG006|Final Risk Group Assignment|Physician Decision|0|||
147458037|NCT00352534|531839638|FG000|Final Risk Group Assignment|Withdrawal by Subject|0|||
147458038|NCT00352534|531839639|FG001|Final Risk Group Assignment|Withdrawal by Subject|0|||
147458039|NCT00352534|531839640|FG002|Final Risk Group Assignment|Withdrawal by Subject|0|||
147458040|NCT00352534|531839641|FG003|Final Risk Group Assignment|Withdrawal by Subject|0|||
147458041|NCT00352534|531839642|FG004|Final Risk Group Assignment|Withdrawal by Subject|0|||
147458042|NCT00352534|531839643|FG005|Final Risk Group Assignment|Withdrawal by Subject|3|||
147458043|NCT00352534|531839644|FG006|Final Risk Group Assignment|Withdrawal by Subject|0|||
147458044|NCT00352534|531839638|FG000|Final Risk Group Assignment|Ineligible|0|||
147458045|NCT00352534|531839639|FG001|Final Risk Group Assignment|Ineligible|0|||
147458046|NCT00352534|531839640|FG002|Final Risk Group Assignment|Ineligible|3|||
147458047|NCT00352534|531839641|FG003|Final Risk Group Assignment|Ineligible|1|||
147458048|NCT00352534|531839642|FG004|Final Risk Group Assignment|Ineligible|0|||
147458049|NCT00352534|531839643|FG005|Final Risk Group Assignment|Ineligible|13|||
147458050|NCT00352534|531839644|FG006|Final Risk Group Assignment|Ineligible|0|||
147458051|NCT00352534|531839638|FG000|Final Risk Group Assignment|Enrollment onto another COG study|0|||
147458052|NCT00352534|531839639|FG001|Final Risk Group Assignment|Enrollment onto another COG study|0|||
147458053|NCT00352534|531839640|FG002|Final Risk Group Assignment|Enrollment onto another COG study|0|||
147458054|NCT00352534|531839641|FG003|Final Risk Group Assignment|Enrollment onto another COG study|0|||
147458055|NCT00352534|531839642|FG004|Final Risk Group Assignment|Enrollment onto another COG study|0|||
147458056|NCT00352534|531839643|FG005|Final Risk Group Assignment|Enrollment onto another COG study|0|||
147458057|NCT00352534|531839644|FG006|Final Risk Group Assignment|Enrollment onto another COG study|28|||
147458058|NCT00352534|531839638|FG000|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
147458059|NCT00352534|531839639|FG001|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
147458060|NCT00352534|531839640|FG002|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
147458061|NCT00352534|531839641|FG003|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
147664967|NCT01162343|532597975|FG000|Overall Study|Refused psychiatrist assessment|12|||
147664968|NCT01130272|532597976|FG000|Overall Study|Adverse Event|2|||
147458062|NCT00352534|531839642|FG004|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
147458063|NCT00352534|531839643|FG005|Final Risk Group Assignment|Stage III Wilms tumor with LOH|0|||
147458064|NCT00352534|531839644|FG006|Final Risk Group Assignment|Stage III Wilms tumor with LOH|11|||
147458065|NCT00352534|531839638|FG000|Final Risk Group Assignment|Death|0|||
147458066|NCT00352534|531839639|FG001|Final Risk Group Assignment|Death|0|||
147458067|NCT00352534|531839640|FG002|Final Risk Group Assignment|Death|0|||
147458068|NCT00352534|531839641|FG003|Final Risk Group Assignment|Death|0|||
147458069|NCT00352534|531839642|FG004|Final Risk Group Assignment|Death|0|||
147458070|NCT00352534|531839643|FG005|Final Risk Group Assignment|Death|2|||
147458071|NCT00352534|531839644|FG006|Final Risk Group Assignment|Death|0|||
147458072|NCT00544869|531839647|FG000|Overall Study|Rsolution of congenitive symptoms|3|||
147389650|NCT00296504|531588984|FG000|Interim Analysis|Insufficient CD4 Response|0|||
147389651|NCT00296504|531588985|FG001|Interim Analysis|Insufficient CD4 Response|0|||
147389652|NCT00296504|531588986|FG002|Interim Analysis|Insufficient CD4 Response|0|||
147389653|NCT00296504|531588987|FG003|Interim Analysis|Insufficient CD4 Response|0|||
147389654|NCT00296504|531588988|FG004|Interim Analysis|Insufficient CD4 Response|1|||
147389655|NCT00296504|531588989|FG005|Interim Analysis|Insufficient CD4 Response|1|||
147389656|NCT00296504|531588990|FG006|Interim Analysis|Insufficient CD4 Response|0|||
147389657|NCT00296504|531588991|FG007|Interim Analysis|Insufficient CD4 Response|0|||
147389658|NCT00296504|531588992|FG008|Interim Analysis|Insufficient CD4 Response|0|||
147389659|NCT00296504|531588984|FG000|Interim Analysis|Switched to Commercially Available Drug|2|||
147389660|NCT00296504|531588985|FG001|Interim Analysis|Switched to Commercially Available Drug|0|||
147389661|NCT00296504|531588986|FG002|Interim Analysis|Switched to Commercially Available Drug|4|||
147389662|NCT00296504|531588987|FG003|Interim Analysis|Switched to Commercially Available Drug|1|||
147389663|NCT00296504|531588988|FG004|Interim Analysis|Switched to Commercially Available Drug|0|||
147389664|NCT00296504|531588989|FG005|Interim Analysis|Switched to Commercially Available Drug|5|||
147389665|NCT00296504|531588990|FG006|Interim Analysis|Switched to Commercially Available Drug|3|||
147389666|NCT00296504|531588991|FG007|Interim Analysis|Switched to Commercially Available Drug|4|||
147389667|NCT00296504|531588992|FG008|Interim Analysis|Switched to Commercially Available Drug|0|||
147389668|NCT00296504|531588984|FG000|Interim Analysis|Pregnancy|4|||
147389669|NCT00296504|531588985|FG001|Interim Analysis|Pregnancy|1|||
147389670|NCT00296504|531588986|FG002|Interim Analysis|Pregnancy|4|||
147389671|NCT00296504|531588987|FG003|Interim Analysis|Pregnancy|2|||
147389672|NCT00296504|531588988|FG004|Interim Analysis|Pregnancy|0|||
147389673|NCT00296504|531588989|FG005|Interim Analysis|Pregnancy|1|||
147389674|NCT00296504|531588990|FG006|Interim Analysis|Pregnancy|1|||
147389675|NCT00296504|531588991|FG007|Interim Analysis|Pregnancy|1|||
147389676|NCT00296504|531588992|FG008|Interim Analysis|Pregnancy|0|||
147389677|NCT00296504|531588984|FG000|Interim Analysis|Death|1|||
147389678|NCT00296504|531588985|FG001|Interim Analysis|Death|0|||
147389679|NCT00296504|531588986|FG002|Interim Analysis|Death|3|||
147389680|NCT00296504|531588987|FG003|Interim Analysis|Death|0|||
147389681|NCT00296504|531588988|FG004|Interim Analysis|Death|0|||
147389682|NCT00296504|531588989|FG005|Interim Analysis|Death|0|||
147389683|NCT00296504|531588990|FG006|Interim Analysis|Death|0|||
147389684|NCT00296504|531588991|FG007|Interim Analysis|Death|0|||
147389685|NCT00296504|531588992|FG008|Interim Analysis|Death|0|||
147389686|NCT00296504|531588984|FG000|Interim Analysis|Participant Non-compliant|0|||
147389687|NCT00296504|531588985|FG001|Interim Analysis|Participant Non-compliant|1|||
147389688|NCT00296504|531588986|FG002|Interim Analysis|Participant Non-compliant|2|||
147389689|NCT00296504|531588987|FG003|Interim Analysis|Participant Non-compliant|1|||
147389690|NCT00296504|531588988|FG004|Interim Analysis|Participant Non-compliant|1|||
147389691|NCT00296504|531588989|FG005|Interim Analysis|Participant Non-compliant|3|||
147389692|NCT00296504|531588990|FG006|Interim Analysis|Participant Non-compliant|6|||
147389693|NCT00296504|531588991|FG007|Interim Analysis|Participant Non-compliant|2|||
147389694|NCT00296504|531588992|FG008|Interim Analysis|Participant Non-compliant|0|||
147389695|NCT00296504|531588984|FG000|Interim Analysis|Participant Wanted to Become Pregnant|0|||
147389696|NCT00296504|531588985|FG001|Interim Analysis|Participant Wanted to Become Pregnant|0|||
147389697|NCT00296504|531588986|FG002|Interim Analysis|Participant Wanted to Become Pregnant|2|||
147389698|NCT00296504|531588987|FG003|Interim Analysis|Participant Wanted to Become Pregnant|0|||
147389699|NCT00296504|531588988|FG004|Interim Analysis|Participant Wanted to Become Pregnant|0|||
147389700|NCT00296504|531588989|FG005|Interim Analysis|Participant Wanted to Become Pregnant|1|||
147389701|NCT00296504|531588990|FG006|Interim Analysis|Participant Wanted to Become Pregnant|0|||
147389702|NCT00296504|531588991|FG007|Interim Analysis|Participant Wanted to Become Pregnant|0|||
147389703|NCT00296504|531588992|FG008|Interim Analysis|Participant Wanted to Become Pregnant|0|||
147389704|NCT00296504|531588984|FG000|Interim Analysis|To Simplify Treatment|0|||
147389705|NCT00296504|531588985|FG001|Interim Analysis|To Simplify Treatment|0|||
147389706|NCT00296504|531588986|FG002|Interim Analysis|To Simplify Treatment|1|||
147389707|NCT00296504|531588987|FG003|Interim Analysis|To Simplify Treatment|0|||
147389708|NCT00296504|531588988|FG004|Interim Analysis|To Simplify Treatment|0|||
147389709|NCT00296504|531588989|FG005|Interim Analysis|To Simplify Treatment|0|||
147389710|NCT00296504|531588990|FG006|Interim Analysis|To Simplify Treatment|2|||
147389711|NCT00296504|531588991|FG007|Interim Analysis|To Simplify Treatment|0|||
147389712|NCT00296504|531588992|FG008|Interim Analysis|To Simplify Treatment|0|||
147389713|NCT00296504|531588984|FG000|Interim Analysis|Participant Had Problems with Alcohol|0|||
147389714|NCT00296504|531588985|FG001|Interim Analysis|Participant Had Problems with Alcohol|0|||
147389715|NCT00296504|531588986|FG002|Interim Analysis|Participant Had Problems with Alcohol|1|||
147389716|NCT00296504|531588987|FG003|Interim Analysis|Participant Had Problems with Alcohol|0|||
147389717|NCT00296504|531588988|FG004|Interim Analysis|Participant Had Problems with Alcohol|0|||
147389718|NCT00296504|531588989|FG005|Interim Analysis|Participant Had Problems with Alcohol|0|||
147458073|NCT00544869|531839648|FG001|Overall Study|Rsolution of congenitive symptoms|0|||
147458074|NCT00544869|531839649|FG002|Overall Study|Rsolution of congenitive symptoms|0|||
147389719|NCT00296504|531588990|FG006|Interim Analysis|Participant Had Problems with Alcohol|0|||
147389720|NCT00296504|531588991|FG007|Interim Analysis|Participant Had Problems with Alcohol|0|||
147389721|NCT00296504|531588992|FG008|Interim Analysis|Participant Had Problems with Alcohol|0|||
147389722|NCT00296504|531588984|FG000|Interim Analysis|Participant Moved|1|||
147389723|NCT00296504|531588985|FG001|Interim Analysis|Participant Moved|0|||
147389724|NCT00296504|531588986|FG002|Interim Analysis|Participant Moved|1|||
147389725|NCT00296504|531588987|FG003|Interim Analysis|Participant Moved|0|||
147389726|NCT00296504|531588988|FG004|Interim Analysis|Participant Moved|0|||
147389727|NCT00296504|531588989|FG005|Interim Analysis|Participant Moved|1|||
147389728|NCT00296504|531588990|FG006|Interim Analysis|Participant Moved|1|||
147389729|NCT00296504|531588991|FG007|Interim Analysis|Participant Moved|0|||
147389730|NCT00296504|531588992|FG008|Interim Analysis|Participant Moved|0|||
147389731|NCT00296504|531588984|FG000|Interim Analysis|Participant Was Incarcerated|2|||
147389732|NCT00296504|531588985|FG001|Interim Analysis|Participant Was Incarcerated|0|||
147389733|NCT00296504|531588986|FG002|Interim Analysis|Participant Was Incarcerated|1|||
147389734|NCT00296504|531588987|FG003|Interim Analysis|Participant Was Incarcerated|0|||
147389735|NCT00296504|531588988|FG004|Interim Analysis|Participant Was Incarcerated|0|||
147389736|NCT00296504|531588989|FG005|Interim Analysis|Participant Was Incarcerated|0|||
147389737|NCT00296504|531588990|FG006|Interim Analysis|Participant Was Incarcerated|0|||
147389738|NCT00296504|531588991|FG007|Interim Analysis|Participant Was Incarcerated|0|||
147389739|NCT00296504|531588992|FG008|Interim Analysis|Participant Was Incarcerated|0|||
147389740|NCT00296504|531588984|FG000|Interim Analysis|Resistance to FPV|0|||
147389741|NCT00296504|531588985|FG001|Interim Analysis|Resistance to FPV|0|||
147389742|NCT00296504|531588986|FG002|Interim Analysis|Resistance to FPV|1|||
147389743|NCT00296504|531588987|FG003|Interim Analysis|Resistance to FPV|0|||
147389744|NCT00296504|531588988|FG004|Interim Analysis|Resistance to FPV|0|||
147389745|NCT00296504|531588989|FG005|Interim Analysis|Resistance to FPV|0|||
147389746|NCT00296504|531588990|FG006|Interim Analysis|Resistance to FPV|0|||
147389747|NCT00296504|531588991|FG007|Interim Analysis|Resistance to FPV|0|||
147389748|NCT00296504|531588992|FG008|Interim Analysis|Resistance to FPV|0|||
147389749|NCT00296504|531588984|FG000|Interim Analysis|Physician Decision|0|||
147389750|NCT00296504|531588985|FG001|Interim Analysis|Physician Decision|0|||
147389751|NCT00296504|531588986|FG002|Interim Analysis|Physician Decision|1|||
147389752|NCT00296504|531588987|FG003|Interim Analysis|Physician Decision|0|||
147389753|NCT00296504|531588988|FG004|Interim Analysis|Physician Decision|0|||
147389754|NCT00296504|531588989|FG005|Interim Analysis|Physician Decision|0|||
147389755|NCT00296504|531588990|FG006|Interim Analysis|Physician Decision|0|||
147389756|NCT00296504|531588991|FG007|Interim Analysis|Physician Decision|0|||
147389757|NCT00296504|531588992|FG008|Interim Analysis|Physician Decision|0|||
147389758|NCT00296504|531588984|FG000|Interim Analysis|Principle Investigator Discretion|2|||
147389759|NCT00296504|531588985|FG001|Interim Analysis|Principle Investigator Discretion|0|||
147389760|NCT00296504|531588986|FG002|Interim Analysis|Principle Investigator Discretion|1|||
147389761|NCT00296504|531588987|FG003|Interim Analysis|Principle Investigator Discretion|1|||
147389762|NCT00296504|531588988|FG004|Interim Analysis|Principle Investigator Discretion|0|||
147389763|NCT00296504|531588989|FG005|Interim Analysis|Principle Investigator Discretion|0|||
147389764|NCT00296504|531588990|FG006|Interim Analysis|Principle Investigator Discretion|0|||
147389765|NCT00296504|531588991|FG007|Interim Analysis|Principle Investigator Discretion|0|||
147389766|NCT00296504|531588992|FG008|Interim Analysis|Principle Investigator Discretion|0|||
147389767|NCT00296504|531588984|FG000|Interim Analysis|Principle Investigator Terminated Study|0|||
147389768|NCT00296504|531588985|FG001|Interim Analysis|Principle Investigator Terminated Study|0|||
147389769|NCT00296504|531588986|FG002|Interim Analysis|Principle Investigator Terminated Study|1|||
147389770|NCT00296504|531588987|FG003|Interim Analysis|Principle Investigator Terminated Study|0|||
147389771|NCT00296504|531588988|FG004|Interim Analysis|Principle Investigator Terminated Study|0|||
147389772|NCT00296504|531588989|FG005|Interim Analysis|Principle Investigator Terminated Study|0|||
147389773|NCT00296504|531588990|FG006|Interim Analysis|Principle Investigator Terminated Study|0|||
147389774|NCT00296504|531588991|FG007|Interim Analysis|Principle Investigator Terminated Study|0|||
147389775|NCT00296504|531588992|FG008|Interim Analysis|Principle Investigator Terminated Study|0|||
147389776|NCT00296504|531588984|FG000|Interim Analysis|Non-adherence|2|||
147389777|NCT00296504|531588985|FG001|Interim Analysis|Non-adherence|0|||
147389778|NCT00296504|531588986|FG002|Interim Analysis|Non-adherence|0|||
147389779|NCT00296504|531588987|FG003|Interim Analysis|Non-adherence|0|||
147389780|NCT00296504|531588988|FG004|Interim Analysis|Non-adherence|1|||
147389781|NCT00296504|531588989|FG005|Interim Analysis|Non-adherence|0|||
147389782|NCT00296504|531588990|FG006|Interim Analysis|Non-adherence|0|||
147389783|NCT00296504|531588991|FG007|Interim Analysis|Non-adherence|1|||
147389784|NCT00296504|531588992|FG008|Interim Analysis|Non-adherence|0|||
147389785|NCT00296504|531588984|FG000|Interim Analysis|Site Closing|1|||
147389786|NCT00296504|531588985|FG001|Interim Analysis|Site Closing|0|||
147389787|NCT00296504|531588986|FG002|Interim Analysis|Site Closing|0|||
147389788|NCT00296504|531588987|FG003|Interim Analysis|Site Closing|0|||
147389789|NCT00296504|531588988|FG004|Interim Analysis|Site Closing|0|||
147458075|NCT00544869|531839647|FG000|Overall Study|Adverse Event|6|||
147458076|NCT00544869|531839648|FG001|Overall Study|Adverse Event|1|||
147458077|NCT00544869|531839649|FG002|Overall Study|Adverse Event|0|||
147458078|NCT00544869|531839647|FG000|Overall Study|Lack of Efficacy|1|||
147458079|NCT00544869|531839648|FG001|Overall Study|Lack of Efficacy|1|||
147458080|NCT00544869|531839649|FG002|Overall Study|Lack of Efficacy|0|||
147458081|NCT00544869|531839647|FG000|Overall Study|Physician Decision|2|||
147458082|NCT00544869|531839648|FG001|Overall Study|Physician Decision|0|||
147458083|NCT00544869|531839649|FG002|Overall Study|Physician Decision|0|||
147458084|NCT00619502|531839650|FG000|Overall Study|Lost to Follow-up|8|||
147458085|NCT00619502|531839651|FG001|Overall Study|Lost to Follow-up|10|||
147458086|NCT03968419|531839652|FG000|Treatment Period|Adverse Event|0|||
147458087|NCT03968419|531839653|FG001|Treatment Period|Adverse Event|0|||
147458088|NCT03968419|531839654|FG002|Treatment Period|Adverse Event|1|||
147458089|NCT03968419|531839652|FG000|Safety Follow-up Period|Death|3|||
147458090|NCT03968419|531839653|FG001|Safety Follow-up Period|Death|2|||
147458091|NCT03968419|531839654|FG002|Safety Follow-up Period|Death|1|||
147458092|NCT03968419|531839652|FG000|Safety Follow-up Period|Subject Decision|2|||
147458093|NCT03968419|531839653|FG001|Safety Follow-up Period|Subject Decision|1|||
147458094|NCT03968419|531839654|FG002|Safety Follow-up Period|Subject Decision|0|||
147458095|NCT00935883|531839655|FG000|Treatment Period|Physician Decision|1|||
147458096|NCT00935883|531839656|FG001|Treatment Period|Physician Decision|0|||
147458097|NCT00935883|531839655|FG000|Treatment Period|Withdrawal by Subject|0|||
147458098|NCT00935883|531839656|FG001|Treatment Period|Withdrawal by Subject|2|||
147458099|NCT01641939|531839657|FG000|Overall Study|Death|90|||
147458100|NCT01641939|531839658|FG001|Overall Study|Death|187|||
147458101|NCT01641939|531839659|FG002|Overall Study|Death|61|||
147458102|NCT01641939|531839657|FG000|Overall Study|Lost to Follow-up|3|||
147458103|NCT01641939|531839658|FG001|Overall Study|Lost to Follow-up|2|||
147458104|NCT01641939|531839659|FG002|Overall Study|Lost to Follow-up|1|||
147458105|NCT01641939|531839657|FG000|Overall Study|Withdrawal by Subject|14|||
147458106|NCT01641939|531839658|FG001|Overall Study|Withdrawal by Subject|11|||
147458107|NCT01641939|531839659|FG002|Overall Study|Withdrawal by Subject|5|||
147458108|NCT01641939|531839657|FG000|Overall Study|Study Terminated by Sponsor|10|||
147458109|NCT01641939|531839658|FG001|Overall Study|Study Terminated by Sponsor|28|||
147389790|NCT00296504|531588989|FG005|Interim Analysis|Site Closing|1|||
147389791|NCT00296504|531588990|FG006|Interim Analysis|Site Closing|2|||
147389792|NCT00296504|531588991|FG007|Interim Analysis|Site Closing|0|||
147389793|NCT00296504|531588992|FG008|Interim Analysis|Site Closing|0|||
147389794|NCT00296504|531588984|FG000|Interim Analysis|Lack of Personnel at Site|1|||
147389795|NCT00296504|531588985|FG001|Interim Analysis|Lack of Personnel at Site|0|||
147389796|NCT00296504|531588986|FG002|Interim Analysis|Lack of Personnel at Site|0|||
147389797|NCT00296504|531588987|FG003|Interim Analysis|Lack of Personnel at Site|0|||
147389798|NCT00296504|531588988|FG004|Interim Analysis|Lack of Personnel at Site|0|||
147389799|NCT00296504|531588989|FG005|Interim Analysis|Lack of Personnel at Site|0|||
147389800|NCT00296504|531588990|FG006|Interim Analysis|Lack of Personnel at Site|0|||
147389801|NCT00296504|531588991|FG007|Interim Analysis|Lack of Personnel at Site|0|||
147389802|NCT00296504|531588992|FG008|Interim Analysis|Lack of Personnel at Site|0|||
147389803|NCT00296504|531588984|FG000|Interim Analysis|Missed Schedule Date|1|||
147389804|NCT00296504|531588985|FG001|Interim Analysis|Missed Schedule Date|0|||
147389805|NCT00296504|531588986|FG002|Interim Analysis|Missed Schedule Date|0|||
147389806|NCT00296504|531588987|FG003|Interim Analysis|Missed Schedule Date|0|||
147389807|NCT00296504|531588988|FG004|Interim Analysis|Missed Schedule Date|0|||
147458110|NCT01641939|531839659|FG002|Overall Study|Study Terminated by Sponsor|3|||
147458111|NCT02894840|531839660|FG000|Overall Study|Lost to Follow-up|1|||
147458112|NCT02894840|531839661|FG001|Overall Study|Lost to Follow-up|0|||
147458113|NCT02894840|531839662|FG002|Overall Study|Lost to Follow-up|3|||
147458114|NCT02894840|531839663|FG003|Overall Study|Lost to Follow-up|0|||
147615166|NCT02673775|532406648|FG001|Washout (at Least 2 Weeks)|Physician Decision|0|||
147615167|NCT02673775|532406647|FG000|Washout (at Least 2 Weeks)|Withdrawal by Subject|0|||
147615168|NCT02673775|532406648|FG001|Washout (at Least 2 Weeks)|Withdrawal by Subject|2|||
147389808|NCT00296504|531588989|FG005|Interim Analysis|Missed Schedule Date|0|||
147389809|NCT00296504|531588990|FG006|Interim Analysis|Missed Schedule Date|0|||
147389810|NCT00296504|531588991|FG007|Interim Analysis|Missed Schedule Date|0|||
147389811|NCT00296504|531588992|FG008|Interim Analysis|Missed Schedule Date|0|||
147389812|NCT00296504|531588984|FG000|Interim Analysis|Inclusion in Other Protocol|0|||
147615169|NCT02673775|532406647|FG000|Washout (at Least 2 Weeks)|Study paused during COVID pandemic (3/5/2020 to 9/15/2021)|2|||
147389813|NCT00296504|531588985|FG001|Interim Analysis|Inclusion in Other Protocol|0|||
147458115|NCT00804687|531839664|FG000|Period 3: Treatment Period|Positive Drug screen|0|||
147458116|NCT00804687|531839665|FG001|Period 3: Treatment Period|Positive Drug screen|0|||
147458117|NCT00804687|531839666|FG002|Period 3: Treatment Period|Positive Drug screen|0|||
147458118|NCT00804687|531839667|FG003|Period 3: Treatment Period|Positive Drug screen|1|||
147458119|NCT00804687|531839668|FG004|Period 3: Treatment Period|Positive Drug screen|0|||
147458120|NCT00804687|531839669|FG005|Period 3: Treatment Period|Positive Drug screen|0|||
147458121|NCT00804687|531839664|FG000|Period 5: Treatment Period|Withdrawal by Subject|0|||
147664969|NCT01130272|532597977|FG001|Overall Study|Adverse Event|5|||
147389814|NCT00296504|531588986|FG002|Interim Analysis|Inclusion in Other Protocol|0|||
147389815|NCT00296504|531588987|FG003|Interim Analysis|Inclusion in Other Protocol|1|||
147389816|NCT00296504|531588988|FG004|Interim Analysis|Inclusion in Other Protocol|0|||
147389817|NCT00296504|531588989|FG005|Interim Analysis|Inclusion in Other Protocol|0|||
147389818|NCT00296504|531588990|FG006|Interim Analysis|Inclusion in Other Protocol|0|||
147389819|NCT00296504|531588991|FG007|Interim Analysis|Inclusion in Other Protocol|0|||
147389820|NCT00296504|531588992|FG008|Interim Analysis|Inclusion in Other Protocol|0|||
147389821|NCT00296504|531588984|FG000|Interim Analysis|Participant Stopped|0|||
147389822|NCT00296504|531588985|FG001|Interim Analysis|Participant Stopped|0|||
147389823|NCT00296504|531588986|FG002|Interim Analysis|Participant Stopped|0|||
147389824|NCT00296504|531588987|FG003|Interim Analysis|Participant Stopped|0|||
147389825|NCT00296504|531588988|FG004|Interim Analysis|Participant Stopped|1|||
147389826|NCT00296504|531588989|FG005|Interim Analysis|Participant Stopped|0|||
147389827|NCT00296504|531588990|FG006|Interim Analysis|Participant Stopped|0|||
147389828|NCT00296504|531588991|FG007|Interim Analysis|Participant Stopped|0|||
147389829|NCT00296504|531588992|FG008|Interim Analysis|Participant Stopped|0|||
147389830|NCT00296504|531588984|FG000|Interim Analysis|Physician and Participant Decision|0|||
147389831|NCT00296504|531588985|FG001|Interim Analysis|Physician and Participant Decision|0|||
147389832|NCT00296504|531588986|FG002|Interim Analysis|Physician and Participant Decision|0|||
147389833|NCT00296504|531588987|FG003|Interim Analysis|Physician and Participant Decision|0|||
147389834|NCT00296504|531588988|FG004|Interim Analysis|Physician and Participant Decision|0|||
147389835|NCT00296504|531588989|FG005|Interim Analysis|Physician and Participant Decision|1|||
147389836|NCT00296504|531588990|FG006|Interim Analysis|Physician and Participant Decision|0|||
147389837|NCT00296504|531588991|FG007|Interim Analysis|Physician and Participant Decision|0|||
147389838|NCT00296504|531588992|FG008|Interim Analysis|Physician and Participant Decision|0|||
147389839|NCT00296504|531588984|FG000|Interim Analysis|Participant Stopped HIV Medications|0|||
147389840|NCT00296504|531588985|FG001|Interim Analysis|Participant Stopped HIV Medications|0|||
147389841|NCT00296504|531588986|FG002|Interim Analysis|Participant Stopped HIV Medications|0|||
147389842|NCT00296504|531588987|FG003|Interim Analysis|Participant Stopped HIV Medications|0|||
147389843|NCT00296504|531588988|FG004|Interim Analysis|Participant Stopped HIV Medications|0|||
147389844|NCT00296504|531588989|FG005|Interim Analysis|Participant Stopped HIV Medications|0|||
147389845|NCT00296504|531588990|FG006|Interim Analysis|Participant Stopped HIV Medications|1|||
147389846|NCT00296504|531588991|FG007|Interim Analysis|Participant Stopped HIV Medications|0|||
147389847|NCT00296504|531588992|FG008|Interim Analysis|Participant Stopped HIV Medications|0|||
147389848|NCT00296504|531588984|FG000|Interim Analysis|Study Ended|0|||
147389849|NCT00296504|531588985|FG001|Interim Analysis|Study Ended|0|||
147389850|NCT00296504|531588986|FG002|Interim Analysis|Study Ended|0|||
147389851|NCT00296504|531588987|FG003|Interim Analysis|Study Ended|0|||
147389852|NCT00296504|531588988|FG004|Interim Analysis|Study Ended|0|||
147389853|NCT00296504|531588989|FG005|Interim Analysis|Study Ended|0|||
147389854|NCT00296504|531588990|FG006|Interim Analysis|Study Ended|1|||
147389855|NCT00296504|531588991|FG007|Interim Analysis|Study Ended|0|||
147389856|NCT00296504|531588992|FG008|Interim Analysis|Study Ended|0|||
147389857|NCT00296504|531588984|FG000|Interim Analysis|Participant Needed Interferon|0|||
147389858|NCT00296504|531588985|FG001|Interim Analysis|Participant Needed Interferon|0|||
147389859|NCT00296504|531588986|FG002|Interim Analysis|Participant Needed Interferon|0|||
147389860|NCT00296504|531588987|FG003|Interim Analysis|Participant Needed Interferon|0|||
147389861|NCT00296504|531588988|FG004|Interim Analysis|Participant Needed Interferon|0|||
147389862|NCT00296504|531588989|FG005|Interim Analysis|Participant Needed Interferon|0|||
147389863|NCT00296504|531588990|FG006|Interim Analysis|Participant Needed Interferon|0|||
147389864|NCT00296504|531588991|FG007|Interim Analysis|Participant Needed Interferon|1|||
147389865|NCT00296504|531588992|FG008|Interim Analysis|Participant Needed Interferon|0|||
147389866|NCT00296504|531588984|FG000|Interim Analysis|Ongoing|32|||
147389867|NCT00296504|531588985|FG001|Interim Analysis|Ongoing|12|||
147389868|NCT00296504|531588986|FG002|Interim Analysis|Ongoing|16|||
147389869|NCT00296504|531588987|FG003|Interim Analysis|Ongoing|22|||
147389870|NCT00296504|531588988|FG004|Interim Analysis|Ongoing|0|||
147389871|NCT00296504|531588989|FG005|Interim Analysis|Ongoing|0|||
147389872|NCT00296504|531588990|FG006|Interim Analysis|Ongoing|30|||
147389873|NCT00296504|531588991|FG007|Interim Analysis|Ongoing|1|||
147389874|NCT00296504|531588992|FG008|Interim Analysis|Ongoing|0|||
147389875|NCT00296504|531588984|FG000|Final Analysis|Withdrawal by Subject|0|||
147389876|NCT00296504|531588985|FG001|Final Analysis|Withdrawal by Subject|0|||
147389877|NCT00296504|531588986|FG002|Final Analysis|Withdrawal by Subject|0|||
147389878|NCT00296504|531588987|FG003|Final Analysis|Withdrawal by Subject|0|||
147389879|NCT00296504|531588988|FG004|Final Analysis|Withdrawal by Subject|0|||
147389880|NCT00296504|531588989|FG005|Final Analysis|Withdrawal by Subject|0|||
147389881|NCT00296504|531588990|FG006|Final Analysis|Withdrawal by Subject|0|||
147389882|NCT00296504|531588991|FG007|Final Analysis|Withdrawal by Subject|0|||
147389883|NCT00296504|531588992|FG008|Final Analysis|Withdrawal by Subject|1|||
147389884|NCT00296504|531588984|FG000|Final Analysis|Lost to Follow-up|0|||
147389885|NCT00296504|531588985|FG001|Final Analysis|Lost to Follow-up|0|||
147389886|NCT00296504|531588986|FG002|Final Analysis|Lost to Follow-up|0|||
147389887|NCT00296504|531588987|FG003|Final Analysis|Lost to Follow-up|0|||
147389888|NCT00296504|531588988|FG004|Final Analysis|Lost to Follow-up|0|||
147389889|NCT00296504|531588989|FG005|Final Analysis|Lost to Follow-up|0|||
147389890|NCT00296504|531588990|FG006|Final Analysis|Lost to Follow-up|0|||
147389891|NCT00296504|531588991|FG007|Final Analysis|Lost to Follow-up|0|||
147389892|NCT00296504|531588992|FG008|Final Analysis|Lost to Follow-up|5|||
147389893|NCT00296504|531588984|FG000|Final Analysis|Insufficient Viral Load Response|0|||
147389894|NCT00296504|531588985|FG001|Final Analysis|Insufficient Viral Load Response|0|||
147389895|NCT00296504|531588986|FG002|Final Analysis|Insufficient Viral Load Response|0|||
147389896|NCT00296504|531588987|FG003|Final Analysis|Insufficient Viral Load Response|0|||
147389897|NCT00296504|531588988|FG004|Final Analysis|Insufficient Viral Load Response|0|||
147389898|NCT00296504|531588989|FG005|Final Analysis|Insufficient Viral Load Response|0|||
147389899|NCT00296504|531588990|FG006|Final Analysis|Insufficient Viral Load Response|0|||
147389900|NCT00296504|531588991|FG007|Final Analysis|Insufficient Viral Load Response|0|||
147389901|NCT00296504|531588992|FG008|Final Analysis|Insufficient Viral Load Response|6|||
147389902|NCT00296504|531588984|FG000|Final Analysis|Adverse Event|0|||
147389903|NCT00296504|531588985|FG001|Final Analysis|Adverse Event|0|||
147389904|NCT00296504|531588986|FG002|Final Analysis|Adverse Event|0|||
147389905|NCT00296504|531588987|FG003|Final Analysis|Adverse Event|0|||
147389906|NCT00296504|531588988|FG004|Final Analysis|Adverse Event|0|||
147389907|NCT00296504|531588989|FG005|Final Analysis|Adverse Event|0|||
147389908|NCT00296504|531588990|FG006|Final Analysis|Adverse Event|0|||
147389909|NCT00296504|531588991|FG007|Final Analysis|Adverse Event|0|||
147389910|NCT00296504|531588992|FG008|Final Analysis|Adverse Event|2|||
147389911|NCT00296504|531588984|FG000|Final Analysis|Pregnancy|0|||
147389912|NCT00296504|531588985|FG001|Final Analysis|Pregnancy|0|||
147389913|NCT00296504|531588986|FG002|Final Analysis|Pregnancy|0|||
147389914|NCT00296504|531588987|FG003|Final Analysis|Pregnancy|0|||
147389915|NCT00296504|531588988|FG004|Final Analysis|Pregnancy|0|||
147389916|NCT00296504|531588989|FG005|Final Analysis|Pregnancy|0|||
147389917|NCT00296504|531588990|FG006|Final Analysis|Pregnancy|0|||
147389918|NCT00296504|531588991|FG007|Final Analysis|Pregnancy|0|||
147389919|NCT00296504|531588992|FG008|Final Analysis|Pregnancy|4|||
147389920|NCT00296504|531588984|FG000|Final Analysis|Tuberculosis|0|||
147389921|NCT00296504|531588985|FG001|Final Analysis|Tuberculosis|0|||
147389922|NCT00296504|531588986|FG002|Final Analysis|Tuberculosis|0|||
147389923|NCT00296504|531588987|FG003|Final Analysis|Tuberculosis|0|||
147389924|NCT00296504|531588988|FG004|Final Analysis|Tuberculosis|0|||
147389925|NCT00296504|531588989|FG005|Final Analysis|Tuberculosis|0|||
147389926|NCT00296504|531588990|FG006|Final Analysis|Tuberculosis|0|||
147389927|NCT00296504|531588991|FG007|Final Analysis|Tuberculosis|0|||
147389928|NCT00296504|531588992|FG008|Final Analysis|Tuberculosis|1|||
147389929|NCT00296504|531588984|FG000|Final Analysis|Participant Moved to Another Country|0|||
147389930|NCT00296504|531588985|FG001|Final Analysis|Participant Moved to Another Country|0|||
147389931|NCT00296504|531588986|FG002|Final Analysis|Participant Moved to Another Country|0|||
147389932|NCT00296504|531588987|FG003|Final Analysis|Participant Moved to Another Country|0|||
147389933|NCT00296504|531588988|FG004|Final Analysis|Participant Moved to Another Country|0|||
147389934|NCT00296504|531588989|FG005|Final Analysis|Participant Moved to Another Country|0|||
147389935|NCT00296504|531588990|FG006|Final Analysis|Participant Moved to Another Country|0|||
147389936|NCT00296504|531588991|FG007|Final Analysis|Participant Moved to Another Country|0|||
147389937|NCT00296504|531588992|FG008|Final Analysis|Participant Moved to Another Country|1|||
147389938|NCT00296504|531588984|FG000|Final Analysis|Poor Adherence|0|||
147389939|NCT00296504|531588985|FG001|Final Analysis|Poor Adherence|0|||
147389940|NCT00296504|531588986|FG002|Final Analysis|Poor Adherence|0|||
147389941|NCT00296504|531588987|FG003|Final Analysis|Poor Adherence|0|||
147389942|NCT00296504|531588988|FG004|Final Analysis|Poor Adherence|0|||
147389943|NCT00296504|531588989|FG005|Final Analysis|Poor Adherence|0|||
147389944|NCT00296504|531588990|FG006|Final Analysis|Poor Adherence|0|||
147389945|NCT00296504|531588991|FG007|Final Analysis|Poor Adherence|0|||
147389946|NCT00296504|531588992|FG008|Final Analysis|Poor Adherence|1|||
147389947|NCT02162771|531588993|FG000|Core Study Period (Part 2)|Progressive Disease|2|||
147389948|NCT02162771|531588994|FG001|Core Study Period (Part 2)|Progressive Disease|3|||
147389949|NCT02162771|531588993|FG000|Core Study Period (Part 2)|Adverse Event|4|||
147389950|NCT02162771|531588994|FG001|Core Study Period (Part 2)|Adverse Event|1|||
147389951|NCT02162771|531588993|FG000|Core Study Period (Part 2)|Withdrawal by Subject|1|||
147389952|NCT02162771|531588994|FG001|Core Study Period (Part 2)|Withdrawal by Subject|2|||
147389953|NCT02162771|531588993|FG000|Core Study Period (Part 2)|Physician Decision|0|||
147389954|NCT02162771|531588994|FG001|Core Study Period (Part 2)|Physician Decision|2|||
147389955|NCT02162771|531588993|FG000|Core Study Period (Part 2)|Death|1|||
147389956|NCT02162771|531588994|FG001|Core Study Period (Part 2)|Death|0|||
147389957|NCT02162771|531588993|FG000|Maintenance Study Period (Part 2)|Progressive Disease|11|||
147389958|NCT02162771|531588994|FG001|Maintenance Study Period (Part 2)|Progressive Disease|13|||
147389959|NCT02162771|531588993|FG000|Maintenance Study Period (Part 2)|Adverse Event|3|||
147389960|NCT02162771|531588994|FG001|Maintenance Study Period (Part 2)|Adverse Event|3|||
147389961|NCT02162771|531588993|FG000|Maintenance Study Period (Part 2)|Death|2|||
147389962|NCT02162771|531588994|FG001|Maintenance Study Period (Part 2)|Death|1|||
147389963|NCT02162771|531588993|FG000|Maintenance Study Period (Part 2)|Withdrawal by Subject|0|||
147458122|NCT00804687|531839665|FG001|Period 5: Treatment Period|Withdrawal by Subject|0|||
147458123|NCT00804687|531839666|FG002|Period 5: Treatment Period|Withdrawal by Subject|0|||
147458124|NCT00804687|531839667|FG003|Period 5: Treatment Period|Withdrawal by Subject|0|||
147458125|NCT00804687|531839668|FG004|Period 5: Treatment Period|Withdrawal by Subject|1|||
147458126|NCT00804687|531839669|FG005|Period 5: Treatment Period|Withdrawal by Subject|0|||
147458127|NCT00804687|531839664|FG000|Period 5: Treatment Period|Positive drugs of abuse|0|||
147458128|NCT00804687|531839665|FG001|Period 5: Treatment Period|Positive drugs of abuse|0|||
147458129|NCT00804687|531839666|FG002|Period 5: Treatment Period|Positive drugs of abuse|1|||
147458130|NCT00804687|531839667|FG003|Period 5: Treatment Period|Positive drugs of abuse|0|||
147458131|NCT00804687|531839668|FG004|Period 5: Treatment Period|Positive drugs of abuse|0|||
147458132|NCT00804687|531839669|FG005|Period 5: Treatment Period|Positive drugs of abuse|0|||
147458133|NCT00804687|531839664|FG000|Period 5: Treatment Period|Positive drug test|1|||
147458134|NCT00804687|531839665|FG001|Period 5: Treatment Period|Positive drug test|0|||
147458135|NCT00804687|531839666|FG002|Period 5: Treatment Period|Positive drug test|0|||
147458136|NCT00804687|531839667|FG003|Period 5: Treatment Period|Positive drug test|0|||
147458137|NCT00804687|531839668|FG004|Period 5: Treatment Period|Positive drug test|0|||
147458138|NCT00804687|531839669|FG005|Period 5: Treatment Period|Positive drug test|0|||
147458139|NCT02397473|531839673|FG000|Treatment Phase|Adverse Event|1|||
147458140|NCT02397473|531839674|FG001|Treatment Phase|Adverse Event|2|||
147458141|NCT02397473|531839673|FG000|Treatment Phase|Lack of Efficacy|8|||
147458142|NCT02397473|531839674|FG001|Treatment Phase|Lack of Efficacy|1|||
147458143|NCT02397473|531839673|FG000|Treatment Phase|Lost to Follow-up|1|||
147458144|NCT02397473|531839674|FG001|Treatment Phase|Lost to Follow-up|0|||
147458145|NCT02397473|531839673|FG000|Treatment Phase|Withdrawal by Subject|2|||
147458146|NCT02397473|531839674|FG001|Treatment Phase|Withdrawal by Subject|1|||
147458147|NCT02397473|531839673|FG000|Treatment Phase|Protocol Violation(did not receive drug)|0|||
147458148|NCT02397473|531839674|FG001|Treatment Phase|Protocol Violation(did not receive drug)|3|||
147458149|NCT02397473|531839673|FG000|Post Treatment Follow-up Phase|Lack of Efficacy|1|||
147458150|NCT02397473|531839674|FG001|Post Treatment Follow-up Phase|Lack of Efficacy|1|||
147458151|NCT02397473|531839673|FG000|Post Treatment Follow-up Phase|Lost to Follow-up|1|||
147458152|NCT02397473|531839674|FG001|Post Treatment Follow-up Phase|Lost to Follow-up|0|||
147458153|NCT02397473|531839673|FG000|Post Treatment Follow-up Phase|Protocol Violation|1|||
147458154|NCT02397473|531839674|FG001|Post Treatment Follow-up Phase|Protocol Violation|0|||
147458155|NCT02397473|531839673|FG000|Post Treatment Follow-up Phase|Withdrawal by Subject|0|||
147458156|NCT02397473|531839674|FG001|Post Treatment Follow-up Phase|Withdrawal by Subject|1|||
147458157|NCT01001702|531839677|FG000|Overall Study|Lost to Follow-up|7|||
147458158|NCT01001702|531839677|FG000|Overall Study|Adverse Event|7|||
147458159|NCT01001702|531839677|FG000|Overall Study|Sponsor Discontinued Study|4|||
147458160|NCT01001702|531839677|FG000|Overall Study|Subject met Withdrawal Criteria|22|||
147458161|NCT01001702|531839677|FG000|Overall Study|Investigator withdrew Subject|10|||
147458162|NCT01001702|531839677|FG000|Overall Study|Withdrawal by Subject|19|||
147458163|NCT01001702|531839677|FG000|Overall Study|Lack of Efficacy per Investigator|3|||
147458164|NCT02624492|531839679|FG000|Overall Study|Adverse Event|2|||
147458165|NCT02624492|531839680|FG001|Overall Study|Adverse Event|2|||
147458166|NCT02624492|531839681|FG002|Overall Study|Adverse Event|2|||
147458167|NCT02624492|531839679|FG000|Overall Study|Progressive disease|0|||
147458168|NCT02624492|531839680|FG001|Overall Study|Progressive disease|2|||
147458169|NCT02624492|531839681|FG002|Overall Study|Progressive disease|3|||
147458170|NCT00634569|531839689|FG000|Overall Study|Withdrawal by Subject|0|||
147458171|NCT00634569|531839690|FG001|Overall Study|Withdrawal by Subject|4|||
147458172|NCT00634569|531839689|FG000|Overall Study|Physician Decision|0|||
147458173|NCT00634569|531839690|FG001|Overall Study|Physician Decision|1|||
147458174|NCT01163786|531839691|FG000|Treatment With Bortezomib|Withdrawal by Subject|1|||
147458175|NCT01163786|531839691|FG000|Treatment With Bortezomib|Adverse Event|2|||
147458176|NCT01163786|531839691|FG000|Completed Follow up (Visit 9 and 10)|Other|1|||
147458177|NCT01212185|531839692|FG000|Overall Study|Protocol Violation|2|||
147458178|NCT01212185|531839693|FG001|Overall Study|Protocol Violation|1|||
147458179|NCT03021642|531839696|FG000|Washout Period (21 Days)|Adverse Event|1|||
147458180|NCT03021642|531839697|FG001|Washout Period (21 Days)|Adverse Event|1|||
147458181|NCT02568046|531839701|FG000|Overall Study|Adverse Event|0|||
147458182|NCT02568046|531839702|FG001|Overall Study|Adverse Event|1|||
147458183|NCT02568046|531839701|FG000|Overall Study|Death|2|||
147458184|NCT02568046|531839702|FG001|Overall Study|Death|0|||
147458185|NCT02568046|531839701|FG000|Overall Study|Progressive Disease|1|||
147458186|NCT02568046|531839702|FG001|Overall Study|Progressive Disease|0|||
147458187|NCT02568046|531839701|FG000|Overall Study|Withdrawal by Subject|2|||
147458188|NCT02568046|531839702|FG001|Overall Study|Withdrawal by Subject|1|||
147458189|NCT02568046|531839701|FG000|Overall Study|Other Events|0|||
147458190|NCT02568046|531839702|FG001|Overall Study|Other Events|1|||
147458191|NCT02809833|531839703|FG000|Overall Study|Death|3|||
147458192|NCT02809833|531839703|FG000|Overall Study|Intolerance|54|||
147458193|NCT02809833|531839703|FG000|Overall Study|Lack of Efficacy|89|||
147458194|NCT02809833|531839703|FG000|Overall Study|Remission/Treatment No Longer Needed|3|||
147664970|NCT01130272|532597978|FG002|Overall Study|Adverse Event|6|||
147664971|NCT01130272|532597979|FG003|Overall Study|Adverse Event|22|||
147664972|NCT01130272|532597980|FG004|Overall Study|Adverse Event|7|||
147664973|NCT01130272|532597976|FG000|Overall Study|IVRS-confirmed constipation|0|||
147664974|NCT01130272|532597977|FG001|Overall Study|IVRS-confirmed constipation|1|||
147664975|NCT01130272|532597978|FG002|Overall Study|IVRS-confirmed constipation|1|||
147664976|NCT01130272|532597979|FG003|Overall Study|IVRS-confirmed constipation|2|||
147664977|NCT01130272|532597980|FG004|Overall Study|IVRS-confirmed constipation|0|||
147664978|NCT01130272|532597976|FG000|Overall Study|Rescue medications due to diarrhea|3|||
147664979|NCT01130272|532597977|FG001|Overall Study|Rescue medications due to diarrhea|5|||
147664980|NCT01130272|532597978|FG002|Overall Study|Rescue medications due to diarrhea|8|||
147389964|NCT02162771|531588994|FG001|Maintenance Study Period (Part 2)|Withdrawal by Subject|3|||
147389965|NCT02162771|531588993|FG000|Maintenance Study Period (Part 2)|Protocol Violation|0|||
147389966|NCT02162771|531588994|FG001|Maintenance Study Period (Part 2)|Protocol Violation|1|||
147389967|NCT02162771|531588993|FG000|Maintenance Study Period (Part 2)|Stable Disease|0|||
147389968|NCT02162771|531588994|FG001|Maintenance Study Period (Part 2)|Stable Disease|1|||
147389969|NCT01078571|531588995|FG000|Overall Study|Adverse Event|36|||
147389970|NCT01078571|531588995|FG000|Overall Study|Lack of effectiveness|36|||
147389971|NCT01078571|531588995|FG000|Overall Study|Reason not reported|21|||
147389972|NCT01078571|531588995|FG000|Overall Study|Withdrawal by Subject|12|||
147389973|NCT01078571|531588995|FG000|Overall Study|Lost to Follow-up|8|||
147389974|NCT01078571|531588995|FG000|Overall Study|Protocol Violation|2|||
147389975|NCT01047306|531589000|FG000|Overall Study|Withdrawal by Subject|2|||
147389976|NCT01047306|531589001|FG001|Overall Study|Withdrawal by Subject|0|||
147389977|NCT01047306|531589000|FG000|Overall Study|Lost to Follow-up|1|||
147389978|NCT01047306|531589001|FG001|Overall Study|Lost to Follow-up|0|||
147389979|NCT01878253|531589002|FG000|Overall Study|Death|1|||
147389980|NCT01878253|531589002|FG000|Overall Study|SIdus System Removal|3|||
147389981|NCT01878253|531589002|FG000|Overall Study|Withdrawal by Subject|1|||
147389982|NCT01878253|531589002|FG000|Overall Study|Lost to Follow-up|2|||
147389983|NCT01878253|531589002|FG000|Overall Study|Completed Study w/o Follow-up Data|2|||
147389984|NCT03647709|531589007|FG000|Overall Study|Lost to Follow-up|5|||
147389985|NCT03647709|531589007|FG000|Overall Study|Physician Decision|6|||
147389986|NCT03647709|531589007|FG000|Overall Study|Withdrawal by Subject|3|||
147389987|NCT04393779|531589010|FG000|Overall Study|Death|1|||
147389988|NCT04393779|531589010|FG000|Overall Study|Device reintervention or explant|4|||
147389989|NCT03802513|531589011|FG000|Overall Study|Lost to Follow-up|1|||
147389990|NCT00274846|531589016|FG000|Overall Study|Did not receive adequate NK cells|1|||
147389991|NCT01395914|531589019|FG000|Overall Study|Unrelated to study drug AE|6|||
147389992|NCT01395914|531589020|FG001|Overall Study|Unrelated to study drug AE|1|||
147389993|NCT01395914|531589019|FG000|Overall Study|Death|23|||
147389994|NCT01395914|531589020|FG001|Overall Study|Death|17|||
147389995|NCT01395914|531589019|FG000|Overall Study|Other|9|||
147389996|NCT01395914|531589020|FG001|Overall Study|Other|3|||
147389997|NCT01395914|531589019|FG000|Overall Study|Withdrawal by patient|27|||
147389998|NCT01395914|531589020|FG001|Overall Study|Withdrawal by patient|14|||
147389999|NCT01395914|531589019|FG000|Overall Study|Study drug-related AE|1|||
147390000|NCT01395914|531589020|FG001|Overall Study|Study drug-related AE|0|||
147390001|NCT01395914|531589019|FG000|Overall Study|Lost to Follow-up|6|||
147390002|NCT01395914|531589020|FG001|Overall Study|Lost to Follow-up|2|||
147390003|NCT01920178|531589021|FG000|Overall Study|Lost to Follow-up|2|||
147390004|NCT01920178|531589022|FG001|Overall Study|Lost to Follow-up|1|||
147390005|NCT03023878|531589023|FG000|Pre-Study Run-In Period|Protocol-specified criteria|11|||
147390006|NCT03023878|531589023|FG000|Pre-Study Run-In Period|Death|1|||
147390007|NCT03023878|531589023|FG000|Pre-Study Run-In Period|Withdrawal by Subject|5|||
147390008|NCT03023878|531589023|FG000|Between Run-In and Treatment Periods|Protocol-specified criteria|2|||
147390009|NCT03023878|531589023|FG000|Treatment Period|Disease Progression|1|||
147390010|NCT03023878|531589023|FG000|Treatment Period|Withdrawal by Subject|1|||
147390011|NCT03023878|531589023|FG000|Treatment Period|Adverse Event|1|||
147390012|NCT03023878|531589023|FG000|Long Term Follow-Up Period|Death|2|||
147390013|NCT02849509|531589024|FG000|Overall Study|Worsening of disease under study|1|||
147390014|NCT02849509|531589025|FG001|Overall Study|Worsening of disease under study|1|||
147390015|NCT02849509|531589026|FG002|Overall Study|Worsening of disease under study|1|||
147390016|NCT02849509|531589024|FG000|Overall Study|Worsening of other pre-existing disease|0|||
147664981|NCT01130272|532597979|FG003|Overall Study|Rescue medications due to diarrhea|8|||
147664982|NCT01130272|532597980|FG004|Overall Study|Rescue medications due to diarrhea|6|||
147390017|NCT02849509|531589025|FG001|Overall Study|Worsening of other pre-existing disease|1|||
147390018|NCT02849509|531589026|FG002|Overall Study|Worsening of other pre-existing disease|2|||
147390019|NCT02849509|531589024|FG000|Overall Study|Other adverse event|36|||
147390020|NCT02849509|531589025|FG001|Overall Study|Other adverse event|41|||
147390021|NCT02849509|531589026|FG002|Overall Study|Other adverse event|8|||
147390022|NCT02849509|531589024|FG000|Overall Study|Withdrawal by Subject|6|||
147390023|NCT02849509|531589025|FG001|Overall Study|Withdrawal by Subject|17|||
147390024|NCT02849509|531589026|FG002|Overall Study|Withdrawal by Subject|12|||
147390025|NCT02849509|531589024|FG000|Overall Study|Lost to Follow-up|27|||
147390026|NCT02849509|531589025|FG001|Overall Study|Lost to Follow-up|67|||
147458195|NCT02809833|531839703|FG000|Overall Study|Noncompliance|1|||
147458196|NCT02809833|531839703|FG000|Overall Study|Withdrawal by Subject|34|||
147458197|NCT02809833|531839703|FG000|Overall Study|Lost to Follow-up|35|||
147458198|NCT02809833|531839703|FG000|Overall Study|Adverse Event (AE)|24|||
147458199|NCT02809833|531839703|FG000|Overall Study|Other|5|||
147458200|NCT02809833|531839703|FG000|Overall Study|Missing Information|52|||
147458201|NCT00523991|531839704|FG000|Overall Study|Adverse Event|6|||
147458202|NCT00523991|531839705|FG001|Overall Study|Adverse Event|5|||
147458203|NCT00523991|531839704|FG000|Overall Study|Protocol Violation|1|||
147458204|NCT00523991|531839705|FG001|Overall Study|Protocol Violation|4|||
147458205|NCT00523991|531839704|FG000|Overall Study|Lost to Follow-up|4|||
147458206|NCT00523991|531839705|FG001|Overall Study|Lost to Follow-up|1|||
147458207|NCT00523991|531839704|FG000|Overall Study|Withdrawal by Subject|7|||
147458208|NCT00523991|531839705|FG001|Overall Study|Withdrawal by Subject|17|||
147458209|NCT00523991|531839704|FG000|Overall Study|Other reason (not specified)|3|||
147458210|NCT00523991|531839705|FG001|Overall Study|Other reason (not specified)|0|||
147458211|NCT01700192|531839706|FG000|Overall Study|Adverse Event|73|||
147458212|NCT01700192|531839707|FG001|Overall Study|Adverse Event|18|||
147458213|NCT01700192|531839706|FG000|Overall Study|Lack of Efficacy|1|||
147458214|NCT01700192|531839707|FG001|Overall Study|Lack of Efficacy|0|||
147458215|NCT01700192|531839706|FG000|Overall Study|Lost to Follow-up|42|||
147458216|NCT01700192|531839707|FG001|Overall Study|Lost to Follow-up|29|||
147458217|NCT01700192|531839706|FG000|Overall Study|Noncompliance with study drug|0|||
147458218|NCT01700192|531839707|FG001|Overall Study|Noncompliance with study drug|5|||
147458219|NCT01700192|531839706|FG000|Overall Study|Physician Decision|2|||
147458220|NCT01700192|531839707|FG001|Overall Study|Physician Decision|3|||
147458221|NCT01700192|531839706|FG000|Overall Study|Pregnancy|1|||
147458222|NCT01700192|531839707|FG001|Overall Study|Pregnancy|4|||
147458223|NCT01700192|531839706|FG000|Overall Study|Progressive disease|1|||
147458224|NCT01700192|531839707|FG001|Overall Study|Progressive disease|0|||
147458225|NCT01700192|531839706|FG000|Overall Study|Protocol Violation|3|||
147458226|NCT01700192|531839707|FG001|Overall Study|Protocol Violation|4|||
147458227|NCT01700192|531839706|FG000|Overall Study|Technical problems|0|||
147458228|NCT01700192|531839707|FG001|Overall Study|Technical problems|1|||
147458229|NCT01700192|531839706|FG000|Overall Study|Withdrawal by Subject|56|||
147458230|NCT01700192|531839707|FG001|Overall Study|Withdrawal by Subject|64|||
147458231|NCT01700192|531839706|FG000|Overall Study|Never received study drug|1|||
147458232|NCT01700192|531839707|FG001|Overall Study|Never received study drug|0|||
147390027|NCT02849509|531589026|FG002|Overall Study|Lost to Follow-up|36|||
147390028|NCT02849509|531589024|FG000|Overall Study|Other, reason not specified|14|||
147390029|NCT02849509|531589025|FG001|Overall Study|Other, reason not specified|29|||
147390030|NCT02849509|531589026|FG002|Overall Study|Other, reason not specified|25|||
147390031|NCT02849509|531589024|FG000|Overall Study|No inform. on termination of Pradaxa/VKA|6|||
147390032|NCT02849509|531589025|FG001|Overall Study|No inform. on termination of Pradaxa/VKA|10|||
147390033|NCT02849509|531589026|FG002|Overall Study|No inform. on termination of Pradaxa/VKA|1|||
147390034|NCT02374476|531589028|FG000|VT Induced Ablation|Screening Failures|36|||
147390035|NCT02374476|531589029|FG001|VT Induced Ablation|Screening Failures|0|||
147390036|NCT02374476|531589030|FG002|VT Induced Ablation|Screening Failures|0|||
147390037|NCT02374476|531589028|FG000|Arm Assignment|Withdrawal by Subject|0|||
147390038|NCT02374476|531589029|FG001|Arm Assignment|Withdrawal by Subject|0|||
147390039|NCT02374476|531589030|FG002|Arm Assignment|Withdrawal by Subject|1|||
147390040|NCT05431543|531589031|FG000|Overall Study|Medical History|1|||
147390041|NCT05431543|531589032|FG001|Overall Study|Medical History|0|||
147390042|NCT05431543|531589033|FG002|Overall Study|Medical History|0|||
147390043|NCT01945086|531589036|FG000|Overall Study|Withdrawal by Subject|1|||
147390044|NCT01945086|531589037|FG001|Overall Study|Withdrawal by Subject|0|||
147390045|NCT01945086|531589038|FG002|Overall Study|Withdrawal by Subject|1|||
147390046|NCT01945086|531589036|FG000|Overall Study|Adverse Event|0|||
147390047|NCT01945086|531589037|FG001|Overall Study|Adverse Event|0|||
147390048|NCT01945086|531589038|FG002|Overall Study|Adverse Event|1|||
147458233|NCT00744874|531839709|FG000|Overall Study|Lost to Follow-up|1|||
147458234|NCT00744874|531839709|FG000|Overall Study|Withdrawal by Subject|1|||
147390049|NCT04853394|531589040|FG000|Follow-up Interviews|Lost to Follow-up|22|||
147390050|NCT04853394|531589041|FG001|Follow-up Interviews|Lost to Follow-up|15|||
147390051|NCT00748098|531589044|FG000|First Treatment Intervention Period|Adverse Event|1|||
147458235|NCT00744874|531839709|FG000|Overall Study|Study Device not available at procedure|1|||
147458236|NCT00744874|531839709|FG000|Overall Study|Unable to accomodate schedule|1|||
147458237|NCT02486757|531839715|FG000|Overall Study|Lost to Follow-up|1|||
147458238|NCT00725075|531839716|FG000|Overall Study|Use of Excluded Medication|0|||
147458239|NCT00725075|531839717|FG001|Overall Study|Use of Excluded Medication|1|||
147390052|NCT00748098|531589045|FG001|First Treatment Intervention Period|Adverse Event|1|||
147458240|NCT00725075|531839718|FG002|Overall Study|Use of Excluded Medication|0|||
147458241|NCT00725075|531839716|FG000|Overall Study|Protocol Violation|0|||
147458242|NCT00725075|531839717|FG001|Overall Study|Protocol Violation|0|||
147458243|NCT00725075|531839718|FG002|Overall Study|Protocol Violation|1|||
147458244|NCT00725075|531839716|FG000|Overall Study|Lost to Follow-up|1|||
147458245|NCT00725075|531839717|FG001|Overall Study|Lost to Follow-up|0|||
147458246|NCT00725075|531839718|FG002|Overall Study|Lost to Follow-up|0|||
147458247|NCT00725075|531839716|FG000|Overall Study|Withdrawal by Subject|4|||
147458248|NCT00725075|531839717|FG001|Overall Study|Withdrawal by Subject|5|||
147458249|NCT00725075|531839718|FG002|Overall Study|Withdrawal by Subject|4|||
147458250|NCT00725075|531839716|FG000|Overall Study|Adverse Event|2|||
147458251|NCT00725075|531839717|FG001|Overall Study|Adverse Event|1|||
147458252|NCT00725075|531839718|FG002|Overall Study|Adverse Event|1|||
147458253|NCT00725075|531839716|FG000|Overall Study|Worsening of Disease|2|||
147458254|NCT00725075|531839717|FG001|Overall Study|Worsening of Disease|1|||
147458255|NCT00725075|531839718|FG002|Overall Study|Worsening of Disease|2|||
147458256|NCT00725075|531839716|FG000|Overall Study|Inclusion/Exclusion Criteria|1|||
147458257|NCT00725075|531839717|FG001|Overall Study|Inclusion/Exclusion Criteria|0|||
147458258|NCT00725075|531839718|FG002|Overall Study|Inclusion/Exclusion Criteria|1|||
147458259|NCT00725075|531839716|FG000|Overall Study|Other|1|||
147458260|NCT00725075|531839717|FG001|Overall Study|Other|0|||
147458261|NCT00725075|531839718|FG002|Overall Study|Other|0|||
147458262|NCT03984305|531839719|FG000|Overall Study|Sponsor Request due to Study Discontinuation|19|||
147458263|NCT03984305|531839720|FG001|Overall Study|Sponsor Request due to Study Discontinuation|15|||
147458264|NCT03984305|531839719|FG000|Overall Study|Withdrawal by Subject|3|||
147458265|NCT03984305|531839720|FG001|Overall Study|Withdrawal by Subject|3|||
147458266|NCT03984305|531839719|FG000|Overall Study|Lost to Follow-up|1|||
147458267|NCT03984305|531839720|FG001|Overall Study|Lost to Follow-up|0|||
147458268|NCT00352105|531839721|FG000|Overall Study|Death|5|||
147458269|NCT00352105|531839721|FG000|Overall Study|Withdrawal by Subject|5|||
147458270|NCT00352105|531839721|FG000|Overall Study|Lack of Efficacy|9|||
147458271|NCT00352105|531839721|FG000|Overall Study|Adverse Event|19|||
147458272|NCT00352105|531839721|FG000|Overall Study|Protocol Violation|2|||
147458273|NCT02979431|531839722|FG000|Overall Study|Parent/guardian withdrew consent|2|||
147458274|NCT02979431|531839723|FG001|Overall Study|Parent/guardian withdrew consent|1|||
147458275|NCT02979431|531839724|FG002|Overall Study|Parent/guardian withdrew consent|1|||
147458276|NCT02979431|531839725|FG003|Overall Study|Parent/guardian withdrew consent|1|||
147458277|NCT02979431|531839722|FG000|Overall Study|Randomized but received no study drug|1|||
147458278|NCT02979431|531839723|FG001|Overall Study|Randomized but received no study drug|1|||
147458279|NCT02979431|531839724|FG002|Overall Study|Randomized but received no study drug|0|||
147458280|NCT02979431|531839725|FG003|Overall Study|Randomized but received no study drug|0|||
147458281|NCT02979431|531839722|FG000|Overall Study|Adverse Event|0|||
147458282|NCT02979431|531839723|FG001|Overall Study|Adverse Event|0|||
147458283|NCT02979431|531839724|FG002|Overall Study|Adverse Event|1|||
147458284|NCT02979431|531839725|FG003|Overall Study|Adverse Event|0|||
147458285|NCT02979431|531839722|FG000|Overall Study|Subject left country after Day14|1|||
147458286|NCT02979431|531839723|FG001|Overall Study|Subject left country after Day14|0|||
147458287|NCT02979431|531839724|FG002|Overall Study|Subject left country after Day14|0|||
147458288|NCT02979431|531839725|FG003|Overall Study|Subject left country after Day14|0|||
147458289|NCT01235962|531839726|FG000|Overall Study|Withdrawal by Subject|20|||
147390053|NCT00748098|531589044|FG000|First Treatment Intervention Period|Protocol Violation|1|||
147390054|NCT00748098|531589045|FG001|First Treatment Intervention Period|Protocol Violation|0|||
147390055|NCT00748098|531589044|FG000|First Treatment Intervention Period|Lost to Follow-up|1|||
147390056|NCT00748098|531589045|FG001|First Treatment Intervention Period|Lost to Follow-up|0|||
147390057|NCT00748098|531589044|FG000|First Treatment Intervention Period|Withdrawal by Subject|2|||
147390058|NCT00748098|531589045|FG001|First Treatment Intervention Period|Withdrawal by Subject|0|||
147390059|NCT00748098|531589044|FG000|First Taper Period|Protocol Violation|1|||
147390060|NCT00748098|531589045|FG001|First Taper Period|Protocol Violation|0|||
147390061|NCT00748098|531589044|FG000|First Taper Period|Withdrawal by Subject|2|||
147390062|NCT00748098|531589045|FG001|First Taper Period|Withdrawal by Subject|0|||
147390063|NCT00748098|531589044|FG000|First Taper Period|Protocol Stopping Criteria Met|0|||
147390064|NCT00748098|531589045|FG001|First Taper Period|Protocol Stopping Criteria Met|1|||
147390065|NCT00748098|531589044|FG000|1-Week Washout Period|Adverse Event|0|||
147390066|NCT00748098|531589045|FG001|1-Week Washout Period|Adverse Event|1|||
147390067|NCT00748098|531589044|FG000|1-Week Washout Period|Withdrawal by Subject|2|||
147390068|NCT00748098|531589045|FG001|1-Week Washout Period|Withdrawal by Subject|0|||
147390069|NCT00748098|531589044|FG000|Second Treatment Intervention Period|Adverse Event|4|||
147390070|NCT00748098|531589045|FG001|Second Treatment Intervention Period|Adverse Event|1|||
147390071|NCT00748098|531589044|FG000|Second Treatment Intervention Period|Lost to Follow-up|1|||
147390072|NCT00748098|531589045|FG001|Second Treatment Intervention Period|Lost to Follow-up|1|||
147458290|NCT01235962|531839727|FG001|Overall Study|Withdrawal by Subject|19|||
147458291|NCT01235962|531839728|FG002|Overall Study|Withdrawal by Subject|62|||
147458292|NCT01235962|531839729|FG003|Overall Study|Withdrawal by Subject|49|||
147458293|NCT01235962|531839726|FG000|Overall Study|Lost to Follow-up|21|||
147458294|NCT01235962|531839727|FG001|Overall Study|Lost to Follow-up|16|||
147458295|NCT01235962|531839728|FG002|Overall Study|Lost to Follow-up|47|||
147458296|NCT01235962|531839729|FG003|Overall Study|Lost to Follow-up|32|||
147458297|NCT01235962|531839726|FG000|Overall Study|Physician Decision|5|||
147458298|NCT01235962|531839727|FG001|Overall Study|Physician Decision|0|||
147390073|NCT00748098|531589044|FG000|Second Treatment Intervention Period|Withdrawal by Subject|1|||
147390074|NCT00748098|531589045|FG001|Second Treatment Intervention Period|Withdrawal by Subject|1|||
147390075|NCT04212299|531589046|FG000|42-week Follow up in Sub-ischial Socket|Participant experienced a heart attack|1|||
147458299|NCT01235962|531839728|FG002|Overall Study|Physician Decision|9|||
147458300|NCT01235962|531839729|FG003|Overall Study|Physician Decision|5|||
147458301|NCT06098729|531839744|FG000|Overall Study|Withdrawal by Subject|1|||
147458302|NCT01665144|531839753|FG000|Core Part|Withdrawal by Subject|96|||
147458303|NCT01665144|531839754|FG001|Core Part|Withdrawal by Subject|77|||
147458304|NCT01665144|531839755|FG002|Core Part|Withdrawal by Subject|0|||
147458305|NCT01665144|531839753|FG000|Core Part|Adverse Event|45|||
147458306|NCT01665144|531839754|FG001|Core Part|Adverse Event|18|||
147458307|NCT01665144|531839755|FG002|Core Part|Adverse Event|0|||
147458308|NCT01665144|531839753|FG000|Core Part|Lack of Efficacy|16|||
147458309|NCT01665144|531839754|FG001|Core Part|Lack of Efficacy|11|||
147458310|NCT01665144|531839755|FG002|Core Part|Lack of Efficacy|0|||
147458311|NCT01665144|531839753|FG000|Core Part|Lost to Follow-up|9|||
147458312|NCT01665144|531839754|FG001|Core Part|Lost to Follow-up|8|||
147458313|NCT01665144|531839755|FG002|Core Part|Lost to Follow-up|0|||
147458314|NCT01665144|531839753|FG000|Core Part|Physician Decision|13|||
147458315|NCT01665144|531839754|FG001|Core Part|Physician Decision|1|||
147458316|NCT01665144|531839755|FG002|Core Part|Physician Decision|0|||
147458317|NCT01665144|531839753|FG000|Core Part|Progressive disease|8|||
147458318|NCT01665144|531839754|FG001|Core Part|Progressive disease|4|||
147458319|NCT01665144|531839755|FG002|Core Part|Progressive disease|0|||
147458320|NCT01665144|531839753|FG000|Core Part|Non-compliance with study treatment|5|||
147458321|NCT01665144|531839754|FG001|Core Part|Non-compliance with study treatment|0|||
147458322|NCT01665144|531839755|FG002|Core Part|Non-compliance with study treatment|0|||
147458323|NCT01665144|531839753|FG000|Core Part|Death|3|||
147458324|NCT01665144|531839754|FG001|Core Part|Death|1|||
147458325|NCT01665144|531839755|FG002|Core Part|Death|0|||
147458326|NCT01665144|531839753|FG000|Core Part|Protocol deviation|3|||
147458327|NCT01665144|531839754|FG001|Core Part|Protocol deviation|1|||
147458328|NCT01665144|531839755|FG002|Core Part|Protocol deviation|0|||
147458329|NCT01665144|531839753|FG000|Core Part|New therapy for study indication|2|||
147458330|NCT01665144|531839754|FG001|Core Part|New therapy for study indication|1|||
147458331|NCT01665144|531839755|FG002|Core Part|New therapy for study indication|0|||
147458332|NCT01665144|531839753|FG000|Core Part|Technical problems|2|||
147458333|NCT01665144|531839754|FG001|Core Part|Technical problems|0|||
147458334|NCT01665144|531839755|FG002|Core Part|Technical problems|0|||
147458335|NCT01665144|531839753|FG000|Extension Part|Patient/guardian decision|180|||
147458336|NCT01665144|531839754|FG001|Extension Part|Patient/guardian decision|0|||
147458337|NCT01665144|531839755|FG002|Extension Part|Patient/guardian decision|98|||
147458338|NCT01665144|531839753|FG000|Extension Part|Adverse Event|104|||
147458339|NCT01665144|531839754|FG001|Extension Part|Adverse Event|0|||
147458340|NCT01665144|531839755|FG002|Extension Part|Adverse Event|59|||
147458341|NCT01665144|531839753|FG000|Extension Part|Study closed early|42|||
147458342|NCT01665144|531839754|FG001|Extension Part|Study closed early|0|||
147458343|NCT01665144|531839755|FG002|Extension Part|Study closed early|19|||
147458344|NCT01665144|531839753|FG000|Extension Part|Progressive disease|36|||
147458345|NCT01665144|531839754|FG001|Extension Part|Progressive disease|0|||
147458346|NCT01665144|531839755|FG002|Extension Part|Progressive disease|14|||
147458347|NCT01665144|531839753|FG000|Extension Part|Lack of Efficacy|37|||
147458348|NCT01665144|531839754|FG001|Extension Part|Lack of Efficacy|0|||
147458349|NCT01665144|531839755|FG002|Extension Part|Lack of Efficacy|12|||
147458350|NCT01665144|531839753|FG000|Extension Part|Physician Decision|29|||
147458351|NCT01665144|531839754|FG001|Extension Part|Physician Decision|0|||
147458352|NCT01665144|531839755|FG002|Extension Part|Physician Decision|13|||
147458353|NCT01665144|531839753|FG000|Extension Part|Technical problems|20|||
147458354|NCT01665144|531839754|FG001|Extension Part|Technical problems|0|||
147458355|NCT01665144|531839755|FG002|Extension Part|Technical problems|8|||
147458356|NCT01665144|531839753|FG000|Extension Part|Death|20|||
147458357|NCT01665144|531839754|FG001|Extension Part|Death|0|||
147458358|NCT01665144|531839755|FG002|Extension Part|Death|4|||
147458359|NCT01665144|531839753|FG000|Extension Part|Missing|12|||
147458360|NCT01665144|531839754|FG001|Extension Part|Missing|0|||
147458361|NCT01665144|531839755|FG002|Extension Part|Missing|6|||
147458362|NCT01665144|531839753|FG000|Extension Part|Lost to Follow-up|9|||
147458363|NCT01665144|531839754|FG001|Extension Part|Lost to Follow-up|0|||
147458364|NCT01665144|531839755|FG002|Extension Part|Lost to Follow-up|5|||
147458365|NCT01665144|531839753|FG000|Extension Part|New therapy for study indication|3|||
147458366|NCT01665144|531839754|FG001|Extension Part|New therapy for study indication|0|||
147458367|NCT01665144|531839755|FG002|Extension Part|New therapy for study indication|2|||
147458368|NCT01665144|531839753|FG000|Extension Part|Protocol deviation|3|||
147458369|NCT01665144|531839754|FG001|Extension Part|Protocol deviation|0|||
147458370|NCT01665144|531839755|FG002|Extension Part|Protocol deviation|0|||
147458371|NCT01920711|531839756|FG000|Overall Study|Death|347|||
147458372|NCT01920711|531839757|FG001|Overall Study|Death|356|||
147458373|NCT01920711|531839756|FG000|Overall Study|Lost to Follow-up|13|||
147458374|NCT01920711|531839757|FG001|Overall Study|Lost to Follow-up|14|||
147458375|NCT01920711|531839756|FG000|Overall Study|Withdrawal by Subject|4|||
147458376|NCT01920711|531839757|FG001|Overall Study|Withdrawal by Subject|3|||
147458377|NCT01972074|531839758|FG000|Overall Study|Adverse Event|4|||
147458378|NCT01972074|531839759|FG001|Overall Study|Adverse Event|1|||
147458379|NCT01972074|531839760|FG002|Overall Study|Adverse Event|0|||
147458380|NCT01972074|531839758|FG000|Overall Study|Lack of Efficacy|1|||
147458381|NCT01972074|531839759|FG001|Overall Study|Lack of Efficacy|1|||
147458382|NCT01972074|531839760|FG002|Overall Study|Lack of Efficacy|0|||
147458383|NCT01972074|531839758|FG000|Overall Study|Lost to Follow-up|0|||
147458384|NCT01972074|531839759|FG001|Overall Study|Lost to Follow-up|1|||
147458385|NCT01972074|531839760|FG002|Overall Study|Lost to Follow-up|1|||
147458386|NCT01972074|531839758|FG000|Overall Study|Withdrawal by Subject|1|||
147458387|NCT01972074|531839759|FG001|Overall Study|Withdrawal by Subject|1|||
147458388|NCT01972074|531839760|FG002|Overall Study|Withdrawal by Subject|1|||
147458389|NCT01972074|531839758|FG000|Overall Study|Scanner Unavailable|0|||
147458390|NCT01972074|531839759|FG001|Overall Study|Scanner Unavailable|0|||
147458391|NCT01972074|531839760|FG002|Overall Study|Scanner Unavailable|1|||
147458392|NCT03551743|531839761|FG000|Overall Study|Adverse Event|1|||
147458393|NCT03551743|531839762|FG001|Overall Study|Adverse Event|0|||
147458394|NCT03551743|531839763|FG002|Overall Study|Adverse Event|0|||
147458395|NCT03551743|531839764|FG003|Overall Study|Adverse Event|0|||
147458396|NCT03551743|531839761|FG000|Overall Study|Withdrawal by Subject|1|||
147458397|NCT03551743|531839762|FG001|Overall Study|Withdrawal by Subject|0|||
147458398|NCT03551743|531839763|FG002|Overall Study|Withdrawal by Subject|0|||
147458399|NCT03551743|531839764|FG003|Overall Study|Withdrawal by Subject|0|||
147458400|NCT03110900|531839771|FG000|Overall Study|Sponsor withdrew|1|||
147458401|NCT03110900|531839772|FG001|Overall Study|Sponsor withdrew|1|||
147458402|NCT03355300|531839773|FG000|Overall Study|Physician Decision|0|||
147458403|NCT03355300|531839774|FG001|Overall Study|Physician Decision|1|||
147458404|NCT03355300|531839773|FG000|Overall Study|Lack of Efficacy|2|||
147458405|NCT03355300|531839774|FG001|Overall Study|Lack of Efficacy|1|||
147458406|NCT03355300|531839773|FG000|Overall Study|Other reason|1|||
147458407|NCT03355300|531839774|FG001|Overall Study|Other reason|0|||
147458408|NCT00546052|531839775|FG000|Overall Study|Adverse Event|47|||
147458409|NCT00546052|531839775|FG000|Overall Study|Lost to Follow-up|144|||
147458410|NCT00546052|531839775|FG000|Overall Study|Protocol Violation|9|||
147458411|NCT00546052|531839775|FG000|Overall Study|Withdrawal by Subject|20|||
147458412|NCT00546052|531839775|FG000|Overall Study|Non Compliance|7|||
147458413|NCT01031446|531839776|FG000|Overall Study|Disease Progression|38|||
147390076|NCT00088452|531590905|FG000|Overall Study|Did not receive intervention|1|||
147390077|NCT00088452|531590906|FG001|Overall Study|Did not receive intervention|0|||
147390078|NCT00088452|531590907|FG002|Overall Study|Did not receive intervention|1|||
147390079|NCT04044352|531590913|FG000|Overall Study|Lost to Follow-up|9|||
147390080|NCT04044352|531590913|FG000|Overall Study|Withdrawal by Subject|2|||
147390081|NCT02176356|531590915|FG000|Overall Study|Screen Failure|14|||
147390082|NCT02176356|531590915|FG000|Overall Study|Lost to Follow-up|4|||
147390083|NCT02176356|531590915|FG000|Overall Study|Personal Reasons|3|||
147390084|NCT02176356|531590915|FG000|Overall Study|Other Miscellaneous Reasons|2|||
147390085|NCT01654289|531590919|FG000|Overall Study|Withdrawal by Subject|10|||
147390086|NCT01654289|531590920|FG001|Overall Study|Withdrawal by Subject|8|||
147390087|NCT01654289|531590921|FG002|Overall Study|Withdrawal by Subject|5|||
147390088|NCT01654289|531590919|FG000|Overall Study|Withdrew from intervention only|17|||
147390089|NCT01654289|531590920|FG001|Overall Study|Withdrew from intervention only|20|||
147390090|NCT01654289|531590921|FG002|Overall Study|Withdrew from intervention only|0|||
147390091|NCT01732627|531590922|FG000|Overall Study|Withdrawal by Subject|1|||
147390092|NCT01732627|531590923|FG001|Overall Study|Withdrawal by Subject|0|||
147390093|NCT02137239|531590924|FG000|Overall Study|Discontinued Study Treatment|0|||
147390094|NCT02137239|531590925|FG001|Overall Study|Discontinued Study Treatment|3|||
147390095|NCT02137239|531590924|FG000|Overall Study|Withdrew Consent|1|||
147390096|NCT02137239|531590925|FG001|Overall Study|Withdrew Consent|1|||
147390097|NCT02137239|531590924|FG000|Overall Study|Adverse Event|2|||
147390098|NCT02137239|531590925|FG001|Overall Study|Adverse Event|2|||
147390099|NCT02744898|531590930|FG000|Overall Study|Progressive Disease|2|||
147390100|NCT02744898|531590930|FG000|Overall Study|Physician Decision|1|||
147390101|NCT02744898|531590930|FG000|Overall Study|Toxicity|1|||
147390102|NCT04908800|531590931|FG000|Overall Study|Adverse Event|0|||
147390103|NCT04908800|531590932|FG001|Overall Study|Adverse Event|0|||
147458414|NCT01031446|531839776|FG000|Overall Study|Adverse Event|9|||
147458415|NCT01031446|531839776|FG000|Overall Study|Physician Decision|4|||
147458416|NCT01031446|531839776|FG000|Overall Study|Withdrawal by Subject|3|||
147458417|NCT01031446|531839776|FG000|Overall Study|Still on treatment|1|||
147458418|NCT00500682|531839777|FG000|Overall Study|Adverse Event|37|||
147390104|NCT04908800|531590933|FG002|Overall Study|Adverse Event|0|||
147390105|NCT04908800|531590934|FG003|Overall Study|Adverse Event|0|||
147458419|NCT00500682|531839778|FG001|Overall Study|Adverse Event|29|||
147458420|NCT00500682|531839777|FG000|Overall Study|Death|25|||
147458421|NCT00500682|531839778|FG001|Overall Study|Death|16|||
147458422|NCT00500682|531839777|FG000|Overall Study|Lost to Follow-up|11|||
147458423|NCT00500682|531839778|FG001|Overall Study|Lost to Follow-up|11|||
147458424|NCT00500682|531839777|FG000|Overall Study|Physician Decision|6|||
147458425|NCT00500682|531839778|FG001|Overall Study|Physician Decision|10|||
147458426|NCT00500682|531839777|FG000|Overall Study|Pregnancy|2|||
147458427|NCT00500682|531839778|FG001|Overall Study|Pregnancy|0|||
147458428|NCT00500682|531839777|FG000|Overall Study|Protocol Violation|1|||
147458429|NCT00500682|531839778|FG001|Overall Study|Protocol Violation|3|||
147458430|NCT00500682|531839777|FG000|Overall Study|Withdrawal by Subject|80|||
147458431|NCT00500682|531839778|FG001|Overall Study|Withdrawal by Subject|74|||
147458432|NCT00500682|531839777|FG000|Overall Study|Reaching endpoints, Noncompliance, etc|144|||
147458433|NCT00500682|531839778|FG001|Overall Study|Reaching endpoints, Noncompliance, etc|144|||
147458434|NCT03344003|531839779|FG000|Overall Study|Switched to alternative treatment|1|||
147458435|NCT03344003|531839780|FG001|Overall Study|Switched to alternative treatment|0|||
147458436|NCT03344003|531839779|FG000|Overall Study|Experienced a better response with recombinant activated factor VII (rFVIIa)|1|||
147458437|NCT03344003|531839780|FG001|Overall Study|Experienced a better response with recombinant activated factor VII (rFVIIa)|0|||
147458438|NCT00684957|531839786|FG000|Overall Study|Withdrawal by Subject|1|||
147458439|NCT00684957|531839787|FG001|Overall Study|Withdrawal by Subject|1|||
147458440|NCT00684957|531839786|FG000|Overall Study|Lost to Follow-up|1|||
147458441|NCT00684957|531839787|FG001|Overall Study|Lost to Follow-up|0|||
147458442|NCT04484285|531841010|FG000|Overall Study|Unable to operate stimulator|3|||
147458443|NCT04484285|531841011|FG001|Overall Study|Unable to operate stimulator|0|||
147390106|NCT04908800|531590935|FG004|Overall Study|Adverse Event|0|||
147390107|NCT04908800|531590936|FG005|Overall Study|Adverse Event|0|||
147390108|NCT04908800|531590937|FG006|Overall Study|Adverse Event|0|||
147390109|NCT04908800|531590938|FG007|Overall Study|Adverse Event|0|||
147390110|NCT04908800|531590939|FG008|Overall Study|Adverse Event|0|||
147390111|NCT04908800|531590940|FG009|Overall Study|Adverse Event|0|||
147390112|NCT04908800|531590941|FG010|Overall Study|Adverse Event|1|||
147390113|NCT04908800|531590942|FG011|Overall Study|Adverse Event|0|||
147390114|NCT04908800|531590943|FG012|Overall Study|Adverse Event|0|||
147390115|NCT00157209|531590944|FG000|Overall Study|Ongoing at data cut-off|10|||
147390116|NCT00157209|531590945|FG001|Overall Study|Ongoing at data cut-off|0|||
147390117|NCT03751280|531590946|FG000|Overall Study|Adverse Event|0|||
147390118|NCT03751280|531590947|FG001|Overall Study|Adverse Event|1|||
147390119|NCT03751280|531590946|FG000|Overall Study|Lost to Follow-up|3|||
147390120|NCT03751280|531590947|FG001|Overall Study|Lost to Follow-up|5|||
147390121|NCT03751280|531590946|FG000|Overall Study|Physician Decision|0|||
147390122|NCT03751280|531590947|FG001|Overall Study|Physician Decision|2|||
147390123|NCT03751280|531590946|FG000|Overall Study|Protocol Violation|0|||
147390124|NCT03751280|531590947|FG001|Overall Study|Protocol Violation|2|||
147390125|NCT03751280|531590946|FG000|Overall Study|Withdrawal by Subject|5|||
147390126|NCT03751280|531590947|FG001|Overall Study|Withdrawal by Subject|2|||
147390127|NCT04474691|531590948|FG000|Overall Study|Withdrawal by Subject|9|||
147390128|NCT01323309|531590949|FG000|Overall Study|Death|9|||
147390129|NCT01323309|531590950|FG001|Overall Study|Death|15|||
147390130|NCT01323309|531590951|FG002|Overall Study|Death|5|||
147390131|NCT01323309|531590949|FG000|Overall Study|Lost to Follow-up|11|||
147390132|NCT01323309|531590950|FG001|Overall Study|Lost to Follow-up|14|||
147390133|NCT01323309|531590951|FG002|Overall Study|Lost to Follow-up|24|||
147390134|NCT01323309|531590949|FG000|Overall Study|Withdrawal by Subject|14|||
147390135|NCT01323309|531590950|FG001|Overall Study|Withdrawal by Subject|14|||
147390136|NCT01323309|531590951|FG002|Overall Study|Withdrawal by Subject|18|||
147390137|NCT01323309|531590949|FG000|Overall Study|Disease progression|5|||
147390138|NCT01323309|531590950|FG001|Overall Study|Disease progression|11|||
147390139|NCT01323309|531590951|FG002|Overall Study|Disease progression|4|||
147390140|NCT01348763|531590952|FG000|With Tenofovir/Emtricitabine (10 Days)|Withdrawal by Subject|1|||
147390141|NCT01348763|531590952|FG000|With Tenofovir/Emtricitabine (10 Days)|Physician Decision|1|||
147390142|NCT00449033|531590965|FG000|Treatment Period|Adverse Event|117|||
147390143|NCT00449033|531590966|FG001|Treatment Period|Adverse Event|83|||
147390144|NCT00449033|531590965|FG000|Treatment Period|Death|21|||
147390145|NCT00449033|531590966|FG001|Treatment Period|Death|12|||
147458444|NCT00930059|531841012|FG000|Overall Study|Death|1|||
147458445|NCT00930059|531841013|FG001|Overall Study|Death|0|||
147458446|NCT00930059|531841012|FG000|Overall Study|Did not meet entrance criteria|1|||
147458447|NCT00930059|531841013|FG001|Overall Study|Did not meet entrance criteria|1|||
147458448|NCT00930059|531841012|FG000|Overall Study|Withdrawal by Subject|3|||
147390146|NCT00449033|531590965|FG000|Treatment Period|Lost to Follow-up|0|||
147390147|NCT00449033|531590966|FG001|Treatment Period|Lost to Follow-up|2|||
147390148|NCT00449033|531590965|FG000|Treatment Period|Physician Decision|4|||
147458449|NCT00930059|531841013|FG001|Overall Study|Withdrawal by Subject|4|||
147458450|NCT00930059|531841012|FG000|Overall Study|Other|1|||
147390149|NCT00449033|531590966|FG001|Treatment Period|Physician Decision|5|||
147390150|NCT00449033|531590965|FG000|Treatment Period|Protocol Violation|8|||
147390151|NCT00449033|531590966|FG001|Treatment Period|Protocol Violation|7|||
147390152|NCT00449033|531590965|FG000|Treatment Period|Disease Progression|231|||
147390153|NCT00449033|531590966|FG001|Treatment Period|Disease Progression|288|||
147458451|NCT00930059|531841013|FG001|Overall Study|Other|0|||
147458452|NCT00930059|531841012|FG000|Overall Study|1 site terminated by sponsor|1|||
147615170|NCT02673775|532406648|FG001|Washout (at Least 2 Weeks)|Study paused during COVID pandemic (3/5/2020 to 9/15/2021)|2|||
147390154|NCT00449033|531590965|FG000|Treatment Period|Consent Withdrawn|36|||
147390155|NCT00449033|531590966|FG001|Treatment Period|Consent Withdrawn|20|||
147390156|NCT00449033|531590965|FG000|Treatment Period|Amended Protocol Criteria|22|||
147390157|NCT00449033|531590966|FG001|Treatment Period|Amended Protocol Criteria|18|||
147390158|NCT00449033|531590965|FG000|Treatment Period|Non-compliance|7|||
147390159|NCT00449033|531590966|FG001|Treatment Period|Non-compliance|8|||
147390160|NCT00449033|531590965|FG000|Treatment Period|Second Malignancy|0|||
147390161|NCT00449033|531590966|FG001|Treatment Period|Second Malignancy|1|||
147390162|NCT00449033|531590965|FG000|Treatment Period|Reason Missing|0|||
147615171|NCT00535405|532406649|FG000|Overall Study|Adverse Event|6|||
147390163|NCT00449033|531590966|FG001|Treatment Period|Reason Missing|4|||
147390164|NCT00449033|531590965|FG000|Treatment Period|Treatment Ongoing|6|||
147390165|NCT00449033|531590966|FG001|Treatment Period|Treatment Ongoing|4|||
147390166|NCT00449033|531590965|FG000|Follow-up Period|Death|299|||
147390167|NCT00449033|531590966|FG001|Follow-up Period|Death|311|||
147390168|NCT00449033|531590965|FG000|Follow-up Period|Lost to Follow-up|6|||
147390169|NCT00449033|531590966|FG001|Follow-up Period|Lost to Follow-up|10|||
147390170|NCT00449033|531590965|FG000|Follow-up Period|Reason Missing|120|||
147390171|NCT00449033|531590966|FG001|Follow-up Period|Reason Missing|113|||
147390172|NCT01190228|531590971|FG000|Overall Study|Protocol Violation|4|||
147390173|NCT01190228|531590972|FG001|Overall Study|Protocol Violation|0|||
147390174|NCT01190228|531590973|FG002|Overall Study|Protocol Violation|0|||
147390175|NCT01190228|531590971|FG000|Overall Study|Withdrawal by Subject|1|||
147390176|NCT01190228|531590972|FG001|Overall Study|Withdrawal by Subject|0|||
147390177|NCT01190228|531590973|FG002|Overall Study|Withdrawal by Subject|0|||
147390178|NCT00832650|531590979|FG000|Overall Study|Randomized but not treated|0|||
147390179|NCT00832650|531590980|FG001|Overall Study|Randomized but not treated|0|||
147390180|NCT00832650|531590981|FG002|Overall Study|Randomized but not treated|1|||
147390181|NCT03219216|531590982|FG000|Overall Study|Lost to Follow-up|0|||
147390182|NCT03219216|531590983|FG001|Overall Study|Lost to Follow-up|1|||
147390183|NCT02332824|531590984|FG000|Overall Study|Pretreatment Event/Adverse Event|4|||
147390184|NCT02332824|531590985|FG001|Overall Study|Pretreatment Event/Adverse Event|0|||
147390185|NCT02332824|531590986|FG002|Overall Study|Pretreatment Event/Adverse Event|1|||
147390186|NCT02332824|531590987|FG003|Overall Study|Pretreatment Event/Adverse Event|1|||
147390187|NCT02332824|531590988|FG004|Overall Study|Pretreatment Event/Adverse Event|4|||
147390188|NCT02332824|531590989|FG005|Overall Study|Pretreatment Event/Adverse Event|1|||
147390189|NCT02332824|531590984|FG000|Overall Study|Voluntary Withdrawal|1|||
147390190|NCT02332824|531590985|FG001|Overall Study|Voluntary Withdrawal|0|||
147390191|NCT02332824|531590986|FG002|Overall Study|Voluntary Withdrawal|0|||
147390192|NCT02332824|531590987|FG003|Overall Study|Voluntary Withdrawal|0|||
147390193|NCT02332824|531590988|FG004|Overall Study|Voluntary Withdrawal|0|||
147390194|NCT02332824|531590989|FG005|Overall Study|Voluntary Withdrawal|0|||
147390195|NCT02332824|531590984|FG000|Overall Study|Inconvenient schedule|1|||
147390196|NCT02332824|531590985|FG001|Overall Study|Inconvenient schedule|1|||
147390197|NCT02332824|531590986|FG002|Overall Study|Inconvenient schedule|0|||
147390198|NCT02332824|531590987|FG003|Overall Study|Inconvenient schedule|0|||
147390199|NCT02332824|531590988|FG004|Overall Study|Inconvenient schedule|0|||
147390200|NCT02332824|531590989|FG005|Overall Study|Inconvenient schedule|0|||
147390201|NCT02332824|531590984|FG000|Overall Study|Transfer|0|||
147390202|NCT02332824|531590985|FG001|Overall Study|Transfer|0|||
147390203|NCT02332824|531590986|FG002|Overall Study|Transfer|1|||
147390204|NCT02332824|531590987|FG003|Overall Study|Transfer|1|||
147390205|NCT02332824|531590988|FG004|Overall Study|Transfer|0|||
147390206|NCT02332824|531590989|FG005|Overall Study|Transfer|0|||
147390207|NCT00440037|531590990|FG000|Overall Study|Withdrawal by Subject|6|||
147390208|NCT00440037|531590990|FG000|Overall Study|Administrative decision|3|||
147390209|NCT00498797|531590991|FG000|Overall Study|Withdrawal by Subject|4|||
147390210|NCT00498797|531590992|FG001|Overall Study|Withdrawal by Subject|2|||
147390211|NCT00498797|531590991|FG000|Overall Study|Adverse Event|12|||
147390212|NCT00498797|531590992|FG001|Overall Study|Adverse Event|5|||
147390213|NCT00498797|531590991|FG000|Overall Study|Condition under investigation worsened|19|||
147390214|NCT00498797|531590992|FG001|Overall Study|Condition under investigation worsened|21|||
147390215|NCT00498797|531590991|FG000|Overall Study|Other|3|||
147390216|NCT00498797|531590992|FG001|Overall Study|Other|1|||
147390217|NCT03928821|531590993|FG000|Overall Study|Death|0|||
147390218|NCT03928821|531590994|FG001|Overall Study|Death|1|||
147390219|NCT03928821|531590995|FG002|Overall Study|Death|0|||
147390220|NCT03928821|531590996|FG003|Overall Study|Death|0|||
147390221|NCT03928821|531590993|FG000|Overall Study|Lost to Follow-up|0|||
147390222|NCT03928821|531590994|FG001|Overall Study|Lost to Follow-up|2|||
147615172|NCT00535405|532406650|FG001|Overall Study|Adverse Event|8|||
147615173|NCT00535405|532406651|FG002|Overall Study|Adverse Event|3|||
147390223|NCT03928821|531590995|FG002|Overall Study|Lost to Follow-up|3|||
147390224|NCT03928821|531590996|FG003|Overall Study|Lost to Follow-up|0|||
147390225|NCT03928821|531590993|FG000|Overall Study|Participant Unable to Adhere to Visit Schedule|0|||
147390226|NCT03928821|531590994|FG001|Overall Study|Participant Unable to Adhere to Visit Schedule|0|||
147390227|NCT03928821|531590995|FG002|Overall Study|Participant Unable to Adhere to Visit Schedule|0|||
147390228|NCT03928821|531590996|FG003|Overall Study|Participant Unable to Adhere to Visit Schedule|1|||
147390229|NCT02784535|531590997|FG000|Overall Study|Adverse Event|1|||
147390230|NCT02784535|531590998|FG001|Overall Study|Adverse Event|0|||
147390231|NCT02784535|531590997|FG000|Overall Study|Withdrawal by Subject|0|||
147390232|NCT02784535|531590998|FG001|Overall Study|Withdrawal by Subject|1|||
147390233|NCT02784535|531590997|FG000|Overall Study|Physician Decision|0|||
147390234|NCT02784535|531590998|FG001|Overall Study|Physician Decision|1|||
147390235|NCT03740919|531590999|FG000|Lead-in Period|Lost to Follow-up|1|||
147390236|NCT03740919|531591000|FG001|Lead-in Period|Lost to Follow-up|0|||
147390237|NCT03740919|531591001|FG002|Lead-in Period|Lost to Follow-up|0|||
147390238|NCT03740919|531591002|FG003|Lead-in Period|Lost to Follow-up|0|||
147390239|NCT03740919|531590999|FG000|Lead-in Period|Physician Decision|2|||
147390240|NCT03740919|531591000|FG001|Lead-in Period|Physician Decision|0|||
147390241|NCT03740919|531591001|FG002|Lead-in Period|Physician Decision|0|||
147390242|NCT03740919|531591002|FG003|Lead-in Period|Physician Decision|0|||
147390243|NCT03740919|531590999|FG000|Lead-in Period|Protocol Violation|1|||
147390244|NCT03740919|531591000|FG001|Lead-in Period|Protocol Violation|0|||
147390245|NCT03740919|531591001|FG002|Lead-in Period|Protocol Violation|0|||
147390246|NCT03740919|531591002|FG003|Lead-in Period|Protocol Violation|0|||
147390247|NCT03740919|531590999|FG000|Lead-in Period|Withdrawal by Subject|10|||
147390248|NCT03740919|531591000|FG001|Lead-in Period|Withdrawal by Subject|0|||
147390249|NCT03740919|531591001|FG002|Lead-in Period|Withdrawal by Subject|0|||
147390250|NCT03740919|531591002|FG003|Lead-in Period|Withdrawal by Subject|0|||
147390251|NCT03740919|531590999|FG000|Lead-in Period|Due to Coronavirus Disease 2019 (COVID-19)|18|||
147390252|NCT03740919|531591000|FG001|Lead-in Period|Due to Coronavirus Disease 2019 (COVID-19)|0|||
147390253|NCT03740919|531591001|FG002|Lead-in Period|Due to Coronavirus Disease 2019 (COVID-19)|0|||
147390254|NCT03740919|531591002|FG003|Lead-in Period|Due to Coronavirus Disease 2019 (COVID-19)|0|||
147390255|NCT03740919|531590999|FG000|Lead-in Period|Study Task Too Burdensome|1|||
147390256|NCT03740919|531591000|FG001|Lead-in Period|Study Task Too Burdensome|0|||
147390257|NCT03740919|531591001|FG002|Lead-in Period|Study Task Too Burdensome|0|||
147390258|NCT03740919|531591002|FG003|Lead-in Period|Study Task Too Burdensome|0|||
147390259|NCT03740919|531590999|FG000|Lead-in Period|Lab Results Did Not Match Inclusion Criteria|1|||
147390260|NCT03740919|531591000|FG001|Lead-in Period|Lab Results Did Not Match Inclusion Criteria|0|||
147390261|NCT03740919|531591001|FG002|Lead-in Period|Lab Results Did Not Match Inclusion Criteria|0|||
147390262|NCT03740919|531591002|FG003|Lead-in Period|Lab Results Did Not Match Inclusion Criteria|0|||
147390263|NCT03740919|531590999|FG000|Lead-in Period|Withdrew Consent Due to Required Procedures|1|||
147390264|NCT03740919|531591000|FG001|Lead-in Period|Withdrew Consent Due to Required Procedures|0|||
147390265|NCT03740919|531591001|FG002|Lead-in Period|Withdrew Consent Due to Required Procedures|0|||
147390266|NCT03740919|531591002|FG003|Lead-in Period|Withdrew Consent Due to Required Procedures|0|||
147390267|NCT03740919|531590999|FG000|Treatment Period|Adverse Event|0|||
147390268|NCT03740919|531591000|FG001|Treatment Period|Adverse Event|0|||
147390269|NCT03740919|531591001|FG002|Treatment Period|Adverse Event|2|||
147390270|NCT03740919|531591002|FG003|Treatment Period|Adverse Event|0|||
147390271|NCT03740919|531590999|FG000|Treatment Period|Protocol Violation|0|||
147390272|NCT03740919|531591000|FG001|Treatment Period|Protocol Violation|1|||
147390273|NCT03740919|531591001|FG002|Treatment Period|Protocol Violation|0|||
147390274|NCT03740919|531591002|FG003|Treatment Period|Protocol Violation|0|||
147390275|NCT03740919|531590999|FG000|Treatment Period|Withdrawal by Subject|0|||
147390276|NCT03740919|531591000|FG001|Treatment Period|Withdrawal by Subject|7|||
147390277|NCT03740919|531591001|FG002|Treatment Period|Withdrawal by Subject|6|||
147390278|NCT03740919|531591002|FG003|Treatment Period|Withdrawal by Subject|2|||
147390279|NCT03740919|531590999|FG000|Treatment Period|Terminated by Sponsor|0|||
147390280|NCT03740919|531591000|FG001|Treatment Period|Terminated by Sponsor|1|||
147390281|NCT03740919|531591001|FG002|Treatment Period|Terminated by Sponsor|0|||
147390282|NCT03740919|531591002|FG003|Treatment Period|Terminated by Sponsor|0|||
147390283|NCT03740919|531590999|FG000|Treatment Period|Issue with Insulin Pump|0|||
147390284|NCT03740919|531591000|FG001|Treatment Period|Issue with Insulin Pump|1|||
147390285|NCT03740919|531591001|FG002|Treatment Period|Issue with Insulin Pump|0|||
147390286|NCT03740919|531591002|FG003|Treatment Period|Issue with Insulin Pump|0|||
147390287|NCT03740919|531590999|FG000|Treatment Period|Due to COVID-19 Pandemic|0|||
147390288|NCT03740919|531591000|FG001|Treatment Period|Due to COVID-19 Pandemic|0|||
147390289|NCT03740919|531591001|FG002|Treatment Period|Due to COVID-19 Pandemic|3|||
147390290|NCT03740919|531591002|FG003|Treatment Period|Due to COVID-19 Pandemic|1|||
147390291|NCT03740919|531590999|FG000|Treatment Period|Failure of Inclusion Criteria|0|||
147390292|NCT03740919|531591000|FG001|Treatment Period|Failure of Inclusion Criteria|0|||
147390293|NCT03740919|531591001|FG002|Treatment Period|Failure of Inclusion Criteria|1|||
147390294|NCT03740919|531591002|FG003|Treatment Period|Failure of Inclusion Criteria|0|||
147390295|NCT03740919|531590999|FG000|Treatment Period|Not Completing Diary|0|||
147390296|NCT03740919|531591000|FG001|Treatment Period|Not Completing Diary|0|||
147390297|NCT03740919|531591001|FG002|Treatment Period|Not Completing Diary|1|||
147390298|NCT03740919|531591002|FG003|Treatment Period|Not Completing Diary|0|||
147390299|NCT03740919|531590999|FG000|Treatment Period|Insulin Painful to Participant|0|||
147615174|NCT00535405|532406652|FG003|Overall Study|Adverse Event|8|||
147458453|NCT00930059|531841013|FG001|Overall Study|1 site terminated by sponsor|1|||
147458454|NCT00930059|531841012|FG000|Overall Study|Adverse Event|1|||
147458455|NCT00930059|531841013|FG001|Overall Study|Adverse Event|6|||
147458456|NCT04002310|531841014|FG000|Overall Study|Sponsor put on hold on treatment plan.|0|||
147458457|NCT04002310|531841015|FG001|Overall Study|Sponsor put on hold on treatment plan.|0|||
147458458|NCT04002310|531841016|FG002|Overall Study|Sponsor put on hold on treatment plan.|0|||
147458459|NCT04002310|531841017|FG003|Overall Study|Sponsor put on hold on treatment plan.|0|||
147458460|NCT04002310|531841018|FG004|Overall Study|Sponsor put on hold on treatment plan.|1|||
147458461|NCT03064763|531841019|FG000|Overall Study|Lost to Follow-up|1|||
147458462|NCT03064763|531841019|FG000|Overall Study|Death|8|||
147458463|NCT00680836|531841020|FG000|Overall Study|Withdrawal by Subject|3|||
147458464|NCT00680836|531841021|FG001|Overall Study|Withdrawal by Subject|0|||
147458465|NCT00680836|531841020|FG000|Overall Study|Lost to Follow-up|3|||
147458466|NCT00680836|531841021|FG001|Overall Study|Lost to Follow-up|1|||
147458467|NCT00680836|531841020|FG000|Overall Study|Physician Decision|2|||
147458468|NCT00680836|531841021|FG001|Overall Study|Physician Decision|1|||
147458469|NCT03786432|531841022|FG000|Overall Study|Screen Failure after consent|1|||
147458470|NCT03786432|531841022|FG000|Overall Study|Lost to Follow-up|4|||
147458471|NCT03786432|531841022|FG000|Overall Study|did not complete 12 month CT scan|1|||
147458472|NCT03038308|531841023|FG000|Overall Study|Surgical resection|1|||
147458473|NCT03038308|531841023|FG000|Overall Study|Withdrawal by Subject|2|||
147458474|NCT03038308|531841023|FG000|Overall Study|Lost to Follow-up|1|||
147458475|NCT01773421|531841025|FG000|Treatment Phase|Other|0|||
147458476|NCT01773421|531841026|FG001|Treatment Phase|Other|0|||
147458477|NCT01773421|531841027|FG002|Treatment Phase|Other|2|||
147458478|NCT01773421|531841028|FG003|Treatment Phase|Other|0|||
147458479|NCT01773421|531841029|FG004|Treatment Phase|Other|0|||
147458480|NCT01773421|531841030|FG005|Treatment Phase|Other|0|||
147458481|NCT01773421|531841031|FG006|Treatment Phase|Other|0|||
147458482|NCT01773421|531841025|FG000|Treatment Phase|Adverse Event|0|||
147458483|NCT01773421|531841026|FG001|Treatment Phase|Adverse Event|0|||
147458484|NCT01773421|531841027|FG002|Treatment Phase|Adverse Event|3|||
147458485|NCT01773421|531841028|FG003|Treatment Phase|Adverse Event|1|||
147458486|NCT01773421|531841029|FG004|Treatment Phase|Adverse Event|0|||
147458487|NCT01773421|531841030|FG005|Treatment Phase|Adverse Event|0|||
147458488|NCT01773421|531841031|FG006|Treatment Phase|Adverse Event|0|||
147458489|NCT01773421|531841025|FG000|Treatment Phase|Withdrawal by Subject|0|||
147458490|NCT01773421|531841026|FG001|Treatment Phase|Withdrawal by Subject|0|||
147458491|NCT01773421|531841027|FG002|Treatment Phase|Withdrawal by Subject|1|||
147458492|NCT01773421|531841028|FG003|Treatment Phase|Withdrawal by Subject|1|||
147458493|NCT01773421|531841029|FG004|Treatment Phase|Withdrawal by Subject|0|||
147458494|NCT01773421|531841030|FG005|Treatment Phase|Withdrawal by Subject|0|||
147458495|NCT01773421|531841031|FG006|Treatment Phase|Withdrawal by Subject|0|||
147458496|NCT01773421|531841025|FG000|Extension Phase|Other|0|||
147458497|NCT01773421|531841026|FG001|Extension Phase|Other|0|||
147458498|NCT01773421|531841027|FG002|Extension Phase|Other|0|||
147458499|NCT01773421|531841028|FG003|Extension Phase|Other|0|||
147458500|NCT01773421|531841029|FG004|Extension Phase|Other|1|||
147458501|NCT01773421|531841030|FG005|Extension Phase|Other|2|||
147458502|NCT01773421|531841031|FG006|Extension Phase|Other|0|||
147458503|NCT01773421|531841025|FG000|Extension Phase|Adverse Event|0|||
147458504|NCT01773421|531841026|FG001|Extension Phase|Adverse Event|0|||
147458505|NCT01773421|531841027|FG002|Extension Phase|Adverse Event|0|||
147458506|NCT01773421|531841028|FG003|Extension Phase|Adverse Event|0|||
147458507|NCT01773421|531841029|FG004|Extension Phase|Adverse Event|2|||
147458508|NCT01773421|531841030|FG005|Extension Phase|Adverse Event|0|||
147458509|NCT01773421|531841031|FG006|Extension Phase|Adverse Event|0|||
147458510|NCT01220414|531841032|FG000|Overall Study|Withdrawal by Subject|1|||
147458511|NCT01220414|531841033|FG001|Overall Study|Withdrawal by Subject|0|||
147458512|NCT01220414|531841034|FG002|Overall Study|Withdrawal by Subject|0|||
147458513|NCT01220414|531841035|FG003|Overall Study|Withdrawal by Subject|1|||
147458514|NCT00669617|531841036|FG000|Period 1|Withdrawal by Subject|0|||
147458515|NCT00669617|531841037|FG001|Period 1|Withdrawal by Subject|0|||
147458516|NCT00669617|531841038|FG002|Period 1|Withdrawal by Subject|1|||
147458517|NCT00669617|531841039|FG003|Period 1|Withdrawal by Subject|0|||
147458518|NCT00669617|531841040|FG004|Period 1|Withdrawal by Subject|0|||
147458519|NCT00669617|531841036|FG000|Period 1|Protocol Deviation|0|||
147458520|NCT00669617|531841037|FG001|Period 1|Protocol Deviation|0|||
147458521|NCT00669617|531841038|FG002|Period 1|Protocol Deviation|0|||
147458522|NCT00669617|531841039|FG003|Period 1|Protocol Deviation|0|||
147458523|NCT00669617|531841040|FG004|Period 1|Protocol Deviation|1|||
147458524|NCT00669617|531841036|FG000|Period 3|Lost to Follow-up|1|||
147458525|NCT00669617|531841037|FG001|Period 3|Lost to Follow-up|0|||
147458526|NCT00669617|531841038|FG002|Period 3|Lost to Follow-up|0|||
147458527|NCT00669617|531841039|FG003|Period 3|Lost to Follow-up|0|||
147458528|NCT00669617|531841040|FG004|Period 3|Lost to Follow-up|0|||
147458529|NCT00623831|531841041|FG000|Overall Study|Withdrawal by Subject|1|||
147458530|NCT00623831|531841042|FG001|Overall Study|Withdrawal by Subject|0|||
147458531|NCT00623831|531841041|FG000|Overall Study|Progressive Disease|0|||
147390300|NCT03740919|531591000|FG001|Treatment Period|Insulin Painful to Participant|0|||
147390301|NCT03740919|531591001|FG002|Treatment Period|Insulin Painful to Participant|1|||
147390302|NCT03740919|531591002|FG003|Treatment Period|Insulin Painful to Participant|0|||
147390303|NCT00985621|531591005|FG000|Overall Study|Adverse Event|2|||
147390304|NCT00985621|531591006|FG001|Overall Study|Adverse Event|3|||
147390305|NCT00985621|531591007|FG002|Overall Study|Adverse Event|4|||
147390306|NCT00985621|531591008|FG003|Overall Study|Adverse Event|16|||
147390307|NCT00985621|531591005|FG000|Overall Study|Lack of Efficacy|10|||
147390308|NCT00985621|531591006|FG001|Overall Study|Lack of Efficacy|6|||
147390309|NCT00985621|531591007|FG002|Overall Study|Lack of Efficacy|5|||
147390310|NCT00985621|531591008|FG003|Overall Study|Lack of Efficacy|12|||
147390311|NCT00985621|531591005|FG000|Overall Study|Lost to Follow-up|2|||
147390312|NCT00985621|531591006|FG001|Overall Study|Lost to Follow-up|3|||
147390313|NCT00985621|531591007|FG002|Overall Study|Lost to Follow-up|4|||
147390314|NCT00985621|531591008|FG003|Overall Study|Lost to Follow-up|4|||
147390315|NCT00985621|531591005|FG000|Overall Study|Study Terminated by Sponsor|89|||
147390316|NCT00985621|531591006|FG001|Overall Study|Study Terminated by Sponsor|108|||
147390317|NCT00985621|531591007|FG002|Overall Study|Study Terminated by Sponsor|99|||
147390318|NCT00985621|531591008|FG003|Overall Study|Study Terminated by Sponsor|92|||
147390319|NCT00985621|531591005|FG000|Overall Study|Protocol Violation|1|||
147390320|NCT00985621|531591006|FG001|Overall Study|Protocol Violation|1|||
147390321|NCT00985621|531591007|FG002|Overall Study|Protocol Violation|1|||
147390322|NCT00985621|531591008|FG003|Overall Study|Protocol Violation|0|||
147390323|NCT00985621|531591005|FG000|Overall Study|Withdrawal by Subject|8|||
147390324|NCT00985621|531591006|FG001|Overall Study|Withdrawal by Subject|10|||
147390325|NCT00985621|531591007|FG002|Overall Study|Withdrawal by Subject|8|||
147390326|NCT00985621|531591008|FG003|Overall Study|Withdrawal by Subject|12|||
147390327|NCT00985621|531591005|FG000|Overall Study|Other|1|||
147390328|NCT00985621|531591006|FG001|Overall Study|Other|0|||
147390329|NCT00985621|531591007|FG002|Overall Study|Other|0|||
147390330|NCT00985621|531591008|FG003|Overall Study|Other|0|||
147390331|NCT00985621|531591005|FG000|Overall Study|Randomized but not Treated|1|||
147390332|NCT00985621|531591006|FG001|Overall Study|Randomized but not Treated|0|||
147390333|NCT00985621|531591007|FG002|Overall Study|Randomized but not Treated|2|||
147390334|NCT00985621|531591008|FG003|Overall Study|Randomized but not Treated|1|||
147390335|NCT01911819|531591009|FG000|Overall Study|Adverse Event|0|||
147390336|NCT01911819|531591010|FG001|Overall Study|Adverse Event|1|||
147390337|NCT01911819|531591011|FG002|Overall Study|Adverse Event|0|||
147390338|NCT01911819|531591009|FG000|Overall Study|Withdrawal by Subject|1|||
147390339|NCT01911819|531591010|FG001|Overall Study|Withdrawal by Subject|1|||
147390340|NCT01911819|531591011|FG002|Overall Study|Withdrawal by Subject|0|||
147390341|NCT03953079|531591012|FG000|Core Study|Withdrawal by Subject|1|||
147390342|NCT03953079|531591013|FG001|Core Study|Withdrawal by Subject|2|||
147390343|NCT03953079|531591014|FG002|Core Study|Withdrawal by Subject|1|||
147390344|NCT03953079|531591012|FG000|Core Study|COVID-19|0|||
147390345|NCT03953079|531591013|FG001|Core Study|COVID-19|1|||
147390346|NCT03953079|531591014|FG002|Core Study|COVID-19|0|||
147390347|NCT03953079|531591012|FG000|Core Study|Difficulties leaving the house|0|||
147390348|NCT03953079|531591013|FG001|Core Study|Difficulties leaving the house|1|||
147390349|NCT03953079|531591014|FG002|Core Study|Difficulties leaving the house|0|||
147390350|NCT03953079|531591012|FG000|Extension Study|Withdrawal by Subject|1|||
147390351|NCT03953079|531591013|FG001|Extension Study|Withdrawal by Subject|0|||
147390352|NCT03953079|531591014|FG002|Extension Study|Withdrawal by Subject|0|||
147390353|NCT03953079|531591012|FG000|Extension Study|Received Rescue Treatment|5|||
147390354|NCT03953079|531591013|FG001|Extension Study|Received Rescue Treatment|6|||
147390355|NCT03953079|531591014|FG002|Extension Study|Received Rescue Treatment|5|||
147390356|NCT04394624|531591018|FG000|Overall Study|Adverse Event|6|||
147390357|NCT04394624|531591019|FG001|Overall Study|Adverse Event|0|||
147390358|NCT04394624|531591018|FG000|Overall Study|Progressive disease|24|||
147390359|NCT04394624|531591019|FG001|Overall Study|Progressive disease|0|||
147390360|NCT04394624|531591018|FG000|Overall Study|Not related to COVID-19|1|||
147390361|NCT04394624|531591019|FG001|Overall Study|Not related to COVID-19|0|||
147390362|NCT00603278|531591021|FG000|Overall Study|Lack of Efficacy|35|||
147390363|NCT00603278|531591022|FG001|Overall Study|Lack of Efficacy|10|||
147458532|NCT00623831|531841042|FG001|Overall Study|Progressive Disease|1|||
147390364|NCT00603278|531591023|FG002|Overall Study|Lack of Efficacy|11|||
147390365|NCT00603278|531591024|FG003|Overall Study|Lack of Efficacy|8|||
147390366|NCT00603278|531591025|FG004|Overall Study|Lack of Efficacy|7|||
147390367|NCT00603278|531591026|FG005|Overall Study|Lack of Efficacy|14|||
147390368|NCT00603278|531591021|FG000|Overall Study|Adverse Event|0|||
147390369|NCT00603278|531591022|FG001|Overall Study|Adverse Event|3|||
147390370|NCT00603278|531591023|FG002|Overall Study|Adverse Event|1|||
147390371|NCT00603278|531591024|FG003|Overall Study|Adverse Event|0|||
147390372|NCT00603278|531591025|FG004|Overall Study|Adverse Event|2|||
147390373|NCT00603278|531591026|FG005|Overall Study|Adverse Event|1|||
147390374|NCT00603278|531591021|FG000|Overall Study|Withdrawal by Subject|2|||
147390375|NCT00603278|531591022|FG001|Overall Study|Withdrawal by Subject|3|||
147390376|NCT00603278|531591023|FG002|Overall Study|Withdrawal by Subject|1|||
147390377|NCT00603278|531591024|FG003|Overall Study|Withdrawal by Subject|2|||
147390378|NCT00603278|531591025|FG004|Overall Study|Withdrawal by Subject|1|||
147390379|NCT00603278|531591026|FG005|Overall Study|Withdrawal by Subject|2|||
147390380|NCT00603278|531591021|FG000|Overall Study|Protocol Violation|3|||
147390381|NCT00603278|531591022|FG001|Overall Study|Protocol Violation|0|||
147390382|NCT00603278|531591023|FG002|Overall Study|Protocol Violation|1|||
147390383|NCT00603278|531591024|FG003|Overall Study|Protocol Violation|1|||
147390384|NCT00603278|531591025|FG004|Overall Study|Protocol Violation|0|||
147390385|NCT00603278|531591026|FG005|Overall Study|Protocol Violation|1|||
147390386|NCT00603278|531591021|FG000|Overall Study|Physician Decision|0|||
147390387|NCT00603278|531591022|FG001|Overall Study|Physician Decision|1|||
147390388|NCT00603278|531591023|FG002|Overall Study|Physician Decision|0|||
147390389|NCT00603278|531591024|FG003|Overall Study|Physician Decision|0|||
147390390|NCT00603278|531591025|FG004|Overall Study|Physician Decision|2|||
147390391|NCT00603278|531591026|FG005|Overall Study|Physician Decision|1|||
147390392|NCT00603278|531591021|FG000|Overall Study|Lost to Follow-up|1|||
147390393|NCT00603278|531591022|FG001|Overall Study|Lost to Follow-up|0|||
147390394|NCT00603278|531591023|FG002|Overall Study|Lost to Follow-up|0|||
147390395|NCT00603278|531591024|FG003|Overall Study|Lost to Follow-up|0|||
147390396|NCT00603278|531591025|FG004|Overall Study|Lost to Follow-up|1|||
147390397|NCT00603278|531591026|FG005|Overall Study|Lost to Follow-up|0|||
147390398|NCT04743999|531591028|FG000|3-month Questionnaire|Death|1|||
147390399|NCT04743999|531591028|FG000|6-month Questionnaire|Study terminated due to low accrual|1|||
147390400|NCT04743999|531591028|FG000|12-month Questionnaire|Study terminated due to low accrual|1|||
147390401|NCT04743999|531591028|FG000|24-month Questionnaire|Study terminated due to low accrual|5|||
147390402|NCT01721759|531591029|FG000|Treatment Period|Disease Progression|85|||
147390403|NCT01721759|531591029|FG000|Treatment Period|Study drug toxicity|14|||
147390404|NCT01721759|531591029|FG000|Treatment Period|Death|1|||
147390405|NCT01721759|531591029|FG000|Treatment Period|Adverse event unrelated to study drug|11|||
147390406|NCT01721759|531591029|FG000|Treatment Period|Participant request to withdraw|3|||
147390407|NCT01721759|531591029|FG000|Treatment Period|Other Reasons|3|||
147390408|NCT01721759|531591029|FG000|End of Study Period|Participant Withdrew Consent|5|||
147390409|NCT01721759|531591029|FG000|End of Study Period|Death|101|||
147390410|NCT01721759|531591029|FG000|End of Study Period|Lost to Follow-up|1|||
147390411|NCT01721759|531591029|FG000|End of Study Period|Other Reasons|10|||
147390412|NCT02577315|531591036|FG000|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
147390413|NCT02577315|531591037|FG001|Treatment Period 1 (4 Days)|Withdrawal by Subject|1|||
147390414|NCT00417989|531591038|FG000|Overall Study|Withdrawal by Subject|13|||
147390415|NCT00417989|531591039|FG001|Overall Study|Withdrawal by Subject|13|||
147390416|NCT00417989|531591038|FG000|Overall Study|Lost to Follow-up|1|||
147390417|NCT00417989|531591039|FG001|Overall Study|Lost to Follow-up|6|||
147390418|NCT00417989|531591038|FG000|Overall Study|Protocol Violation|1|||
147390419|NCT00417989|531591039|FG001|Overall Study|Protocol Violation|0|||
147390420|NCT00417989|531591038|FG000|Overall Study|Death|0|||
147390421|NCT00417989|531591039|FG001|Overall Study|Death|1|||
147390422|NCT00417989|531591038|FG000|Overall Study|Physician Decision|5|||
147390423|NCT00417989|531591039|FG001|Overall Study|Physician Decision|2|||
147390424|NCT01636778|531591040|FG000|Pre-Antiviral Treatment Period (Part 1)|Protocol Violation|3|||
147390425|NCT01636778|531591041|FG001|Pre-Antiviral Treatment Period (Part 1)|Protocol Violation|0|||
147390426|NCT01636778|531591042|FG002|Pre-Antiviral Treatment Period (Part 1)|Protocol Violation|0|||
147390427|NCT01636778|531591040|FG000|Pre-Antiviral Treatment Period (Part 1)|Protocol-Defined Stopping Criteria|1|||
147390428|NCT01636778|531591041|FG001|Pre-Antiviral Treatment Period (Part 1)|Protocol-Defined Stopping Criteria|0|||
147390429|NCT01636778|531591042|FG002|Pre-Antiviral Treatment Period (Part 1)|Protocol-Defined Stopping Criteria|0|||
147390430|NCT01636778|531591040|FG000|Antiviral Treatment Period (Part 2)|Adverse Event|0|||
147390431|NCT01636778|531591041|FG001|Antiviral Treatment Period (Part 2)|Adverse Event|7|||
147390432|NCT01636778|531591042|FG002|Antiviral Treatment Period (Part 2)|Adverse Event|0|||
147390433|NCT01636778|531591040|FG000|Antiviral Treatment Period (Part 2)|Protocol Violation|0|||
147390434|NCT01636778|531591041|FG001|Antiviral Treatment Period (Part 2)|Protocol Violation|1|||
147390435|NCT01636778|531591042|FG002|Antiviral Treatment Period (Part 2)|Protocol Violation|0|||
147390436|NCT01636778|531591040|FG000|Antiviral Treatment Period (Part 2)|Physician Decision|0|||
147390437|NCT01636778|531591041|FG001|Antiviral Treatment Period (Part 2)|Physician Decision|2|||
147390438|NCT01636778|531591042|FG002|Antiviral Treatment Period (Part 2)|Physician Decision|0|||
147390439|NCT01636778|531591040|FG000|Follow-up Period After Part 2|Other|0|||
147390440|NCT01636778|531591041|FG001|Follow-up Period After Part 2|Other|0|||
147390441|NCT01636778|531591042|FG002|Follow-up Period After Part 2|Other|1|||
147390442|NCT01636778|531591040|FG000|Follow-up Period After Part 2|Not entered FU period after withdrawal|0|||
147390443|NCT01636778|531591041|FG001|Follow-up Period After Part 2|Not entered FU period after withdrawal|0|||
147390444|NCT01636778|531591042|FG002|Follow-up Period After Part 2|Not entered FU period after withdrawal|1|||
147390445|NCT01636778|531591040|FG000|Follow-up Period After Part 2|Withdrawal by Subject|0|||
147390446|NCT01636778|531591041|FG001|Follow-up Period After Part 2|Withdrawal by Subject|0|||
147390447|NCT01636778|531591042|FG002|Follow-up Period After Part 2|Withdrawal by Subject|2|||
147390448|NCT00990821|531591048|FG000|Overall Study|Withdrawal by Subject|0|||
147458533|NCT01337973|531841045|FG000|Overall Study|Lost to Follow-up|2|||
147458534|NCT01337973|531841046|FG001|Overall Study|Lost to Follow-up|4|||
147458535|NCT01337973|531841047|FG002|Overall Study|Lost to Follow-up|3|||
147458536|NCT01337973|531841045|FG000|Overall Study|Death|1|||
147458537|NCT01337973|531841046|FG001|Overall Study|Death|2|||
147458538|NCT01337973|531841047|FG002|Overall Study|Death|1|||
147458539|NCT01337973|531841045|FG000|Overall Study|Withdrawal by Subject|10|||
147458540|NCT01337973|531841046|FG001|Overall Study|Withdrawal by Subject|8|||
147458541|NCT01337973|531841047|FG002|Overall Study|Withdrawal by Subject|4|||
147458542|NCT01337973|531841045|FG000|Overall Study|missing data on primary outcome|3|||
147458543|NCT01337973|531841046|FG001|Overall Study|missing data on primary outcome|1|||
147458544|NCT01337973|531841047|FG002|Overall Study|missing data on primary outcome|3|||
147458545|NCT00191451|531841053|FG000|Overall Study|Withdrawal by Subject|2|||
147458546|NCT00191451|531841054|FG001|Overall Study|Withdrawal by Subject|3|||
147458547|NCT00191451|531841055|FG002|Overall Study|Withdrawal by Subject|5|||
147458548|NCT00191451|531841053|FG000|Overall Study|Physician Decision|2|||
147458549|NCT00191451|531841054|FG001|Overall Study|Physician Decision|9|||
147458550|NCT00191451|531841055|FG002|Overall Study|Physician Decision|6|||
147458551|NCT00191451|531841053|FG000|Overall Study|Sponsor Decision|1|||
147458552|NCT00191451|531841054|FG001|Overall Study|Sponsor Decision|0|||
147458553|NCT00191451|531841055|FG002|Overall Study|Sponsor Decision|0|||
147458554|NCT00191451|531841053|FG000|Overall Study|Ineligible|0|||
147458555|NCT00191451|531841054|FG001|Overall Study|Ineligible|1|||
147458556|NCT00191451|531841055|FG002|Overall Study|Ineligible|0|||
147458557|NCT00191451|531841053|FG000|Overall Study|Reason Not Specified|2|||
147458558|NCT00191451|531841054|FG001|Overall Study|Reason Not Specified|1|||
147458559|NCT00191451|531841055|FG002|Overall Study|Reason Not Specified|3|||
147458560|NCT01192347|531841056|FG000|Overall Study|Death|3|||
147390449|NCT00990821|531591049|FG001|Overall Study|Withdrawal by Subject|2|||
147390450|NCT00990821|531591050|FG002|Overall Study|Withdrawal by Subject|0|||
147390451|NCT00990821|531591051|FG003|Overall Study|Withdrawal by Subject|0|||
147390452|NCT00990821|531591052|FG004|Overall Study|Withdrawal by Subject|3|||
147390453|NCT00990821|531591053|FG005|Overall Study|Withdrawal by Subject|3|||
147390454|NCT00990821|531591054|FG006|Overall Study|Withdrawal by Subject|1|||
147390455|NCT00990821|531591055|FG007|Overall Study|Withdrawal by Subject|0|||
147390456|NCT00990821|531591056|FG008|Overall Study|Withdrawal by Subject|0|||
147390457|NCT00990821|531591057|FG009|Overall Study|Withdrawal by Subject|1|||
147390458|NCT00990821|531591058|FG010|Overall Study|Withdrawal by Subject|3|||
147390459|NCT00990821|531591059|FG011|Overall Study|Withdrawal by Subject|5|||
147390460|NCT00990821|531591060|FG012|Overall Study|Withdrawal by Subject|2|||
147390461|NCT00990821|531591061|FG013|Overall Study|Withdrawal by Subject|1|||
147390462|NCT03530345|531591062|FG000|Treatment Period A/Follow-up Period 1|Lost to Follow-up|1|||
147458561|NCT01192347|531841056|FG000|Overall Study|Lost to Follow-up|3|||
147458562|NCT01192347|531841056|FG000|Overall Study|Withdrawal by Subject|1|||
147458563|NCT01192347|531841056|FG000|Overall Study|Adverse Event|1|||
147458564|NCT01192347|531841056|FG000|Overall Study|Suspected serious adverse drug reaction|1|||
147458565|NCT01192347|531841056|FG000|Overall Study|Patient seen in different hospital|1|||
147458566|NCT01192347|531841056|FG000|Overall Study|Patient not visiting hospital regularly|1|||
147458567|NCT01192347|531841056|FG000|Overall Study|Patient did not show up for visits|1|||
147458568|NCT02623335|531841057|FG000|Overall Study|Death|8|||
147458569|NCT02623335|531841058|FG001|Overall Study|Death|7|||
147458570|NCT02623335|531841057|FG000|Overall Study|Lost to Follow-up|15|||
147458571|NCT02623335|531841058|FG001|Overall Study|Lost to Follow-up|23|||
147458572|NCT02623335|531841057|FG000|Overall Study|Withdrawal by Subject|2|||
147458573|NCT02623335|531841058|FG001|Overall Study|Withdrawal by Subject|5|||
147458574|NCT02623335|531841057|FG000|Overall Study|Protocol Violation|2|||
147458575|NCT02623335|531841058|FG001|Overall Study|Protocol Violation|1|||
147458576|NCT03739528|531841059|FG000|Overall Study|Not treated|8|||
147458577|NCT03739528|531841060|FG001|Overall Study|Not treated|12|||
147458578|NCT03739528|531841059|FG000|Overall Study|Treatment and study discontinued|6|||
147458579|NCT03739528|531841060|FG001|Overall Study|Treatment and study discontinued|2|||
147458580|NCT03739528|531841059|FG000|Overall Study|Treatment discontinued + study completed|1|||
147458581|NCT03739528|531841060|FG001|Overall Study|Treatment discontinued + study completed|3|||
147458582|NCT01262976|531841061|FG000|Up to Month 2|Serious Adverse Event|0|||
147458583|NCT01262976|531841062|FG001|Up to Month 2|Serious Adverse Event|0|||
147458584|NCT01262976|531841063|FG002|Up to Month 2|Serious Adverse Event|1|||
147390463|NCT03530345|531591063|FG001|Treatment Period A/Follow-up Period 1|Lost to Follow-up|0|||
147458585|NCT01262976|531841064|FG003|Up to Month 2|Serious Adverse Event|0|||
147458586|NCT01262976|531841065|FG004|Up to Month 2|Serious Adverse Event|0|||
147458587|NCT01262976|531841066|FG005|Up to Month 2|Serious Adverse Event|0|||
147615175|NCT00535405|532406653|FG004|Overall Study|Adverse Event|6|||
147615176|NCT00535405|532406649|FG000|Overall Study|Lost to Follow-up|1|||
147390464|NCT03530345|531591062|FG000|Treatment Period A/Follow-up Period 1|Withdrawal by Subject|3|||
147458588|NCT01262976|531841061|FG000|Up to Month 2|Withdrawal by Subject|1|||
147458589|NCT01262976|531841062|FG001|Up to Month 2|Withdrawal by Subject|0|||
147458590|NCT01262976|531841063|FG002|Up to Month 2|Withdrawal by Subject|0|||
147458591|NCT01262976|531841064|FG003|Up to Month 2|Withdrawal by Subject|0|||
147458592|NCT01262976|531841065|FG004|Up to Month 2|Withdrawal by Subject|0|||
147390465|NCT03530345|531591063|FG001|Treatment Period A/Follow-up Period 1|Withdrawal by Subject|1|||
147390466|NCT03530345|531591062|FG000|Treatment Period A/Follow-up Period 1|Other reasons for discontinuation|17|||
147390467|NCT03530345|531591063|FG001|Treatment Period A/Follow-up Period 1|Other reasons for discontinuation|21|||
147390468|NCT03530345|531591062|FG000|Treatment Period B/Follow-up Period 2|Other reasons for discontinuation|5|||
147390469|NCT03530345|531591063|FG001|Treatment Period B/Follow-up Period 2|Other reasons for discontinuation|7|||
147390470|NCT04150250|531591064|FG000|Overall Study|Lost to Follow-up|0|||
147390471|NCT04150250|531591065|FG001|Overall Study|Lost to Follow-up|2|||
147390472|NCT02442622|531591071|FG000|Overall Study|Withdrawal by Subject|3|||
147390473|NCT02442622|531591072|FG001|Overall Study|Withdrawal by Subject|1|||
147390474|NCT00383500|531591073|FG000|Overall Study|Withdrawal by Subject|8|||
147390475|NCT00383500|531591074|FG001|Overall Study|Withdrawal by Subject|3|||
147390476|NCT00383500|531591075|FG002|Overall Study|Withdrawal by Subject|0|||
147390477|NCT00383500|531591073|FG000|Overall Study|Lost to Follow-up|0|||
147390478|NCT00383500|531591074|FG001|Overall Study|Lost to Follow-up|0|||
147390479|NCT00383500|531591075|FG002|Overall Study|Lost to Follow-up|2|||
147390480|NCT01002547|531592815|FG000|Overall Study|Withdrawal by Subject|4|||
147390481|NCT01002547|531592816|FG001|Overall Study|Withdrawal by Subject|0|||
147390482|NCT01002547|531592817|FG002|Overall Study|Withdrawal by Subject|5|||
147390483|NCT01002547|531592815|FG000|Overall Study|Lost to Follow-up|2|||
147390484|NCT01002547|531592816|FG001|Overall Study|Lost to Follow-up|1|||
147390485|NCT01002547|531592817|FG002|Overall Study|Lost to Follow-up|1|||
147390486|NCT01002547|531592815|FG000|Overall Study|Physician Decision|1|||
147390487|NCT01002547|531592816|FG001|Overall Study|Physician Decision|0|||
147390488|NCT01002547|531592817|FG002|Overall Study|Physician Decision|0|||
147390489|NCT01002547|531592815|FG000|Overall Study|Death|0|||
147390490|NCT01002547|531592816|FG001|Overall Study|Death|2|||
147390491|NCT01002547|531592817|FG002|Overall Study|Death|2|||
147390492|NCT01002547|531592815|FG000|Overall Study|Adverse Event|1|||
147390493|NCT01002547|531592816|FG001|Overall Study|Adverse Event|0|||
147390494|NCT01002547|531592817|FG002|Overall Study|Adverse Event|0|||
147390495|NCT00705614|531592822|FG000|Initial Intervention|Adverse Event|40|||
147390496|NCT00705614|531592823|FG001|Initial Intervention|Adverse Event|21|||
147390497|NCT00705614|531592822|FG000|Initial Intervention|Lost to Follow-up|310|||
147390498|NCT00705614|531592823|FG001|Initial Intervention|Lost to Follow-up|191|||
147390499|NCT00705614|531592822|FG000|Initial Intervention|Withdrawal by Subject|114|||
147390500|NCT00705614|531592823|FG001|Initial Intervention|Withdrawal by Subject|71|||
147390501|NCT00705614|531592822|FG000|Initial Intervention|Administrative Reason|51|||
147390502|NCT00705614|531592823|FG001|Initial Intervention|Administrative Reason|38|||
147390503|NCT00705614|531592822|FG000|Initial Intervention|Status completion unknown|3|||
147390504|NCT00705614|531592823|FG001|Initial Intervention|Status completion unknown|0|||
147390505|NCT00705614|531592822|FG000|Switch to Remicade|Adverse Event|0|||
147390506|NCT00705614|531592823|FG001|Switch to Remicade|Adverse Event|5|||
147390507|NCT00705614|531592822|FG000|Switch to Remicade|Lost to Follow-up|0|||
147390508|NCT00705614|531592823|FG001|Switch to Remicade|Lost to Follow-up|23|||
147390509|NCT00705614|531592822|FG000|Switch to Remicade|Withdrawal by Subject|0|||
147390510|NCT00705614|531592823|FG001|Switch to Remicade|Withdrawal by Subject|12|||
147390511|NCT00705614|531592822|FG000|Switch to Remicade|Administrative Reason|0|||
147390512|NCT00705614|531592823|FG001|Switch to Remicade|Administrative Reason|9|||
147390513|NCT00925288|531592824|FG000|Overall Study|Lost to Follow-up|9|||
147390514|NCT00925288|531592825|FG001|Overall Study|Lost to Follow-up|7|||
147390515|NCT02081196|531592826|FG000|Overall Study|Lost to Follow-up|1|||
147390516|NCT00434577|531592827|FG000|Months 0-3|Serious Adverse Event|0|||
147390517|NCT00434577|531592828|FG001|Months 0-3|Serious Adverse Event|0|||
147390518|NCT00434577|531592829|FG002|Months 0-3|Serious Adverse Event|1|||
147390519|NCT00434577|531592830|FG003|Months 0-3|Serious Adverse Event|0|||
147390520|NCT00434577|531592831|FG004|Months 0-3|Serious Adverse Event|0|||
147390521|NCT00434577|531592827|FG000|Months 0-3|Adverse Event|0|||
147390522|NCT00434577|531592828|FG001|Months 0-3|Adverse Event|1|||
147390523|NCT00434577|531592829|FG002|Months 0-3|Adverse Event|1|||
147390524|NCT00434577|531592830|FG003|Months 0-3|Adverse Event|0|||
147390525|NCT00434577|531592831|FG004|Months 0-3|Adverse Event|0|||
147390526|NCT00434577|531592827|FG000|Months 0-3|Lost to Follow-up|0|||
147390527|NCT00434577|531592828|FG001|Months 0-3|Lost to Follow-up|0|||
147390528|NCT00434577|531592829|FG002|Months 0-3|Lost to Follow-up|0|||
147390529|NCT00434577|531592830|FG003|Months 0-3|Lost to Follow-up|0|||
147390530|NCT00434577|531592831|FG004|Months 0-3|Lost to Follow-up|2|||
147390531|NCT00434577|531592827|FG000|Months 0-3|Protocol Violation|1|||
147390532|NCT00434577|531592828|FG001|Months 0-3|Protocol Violation|0|||
147390533|NCT00434577|531592829|FG002|Months 0-3|Protocol Violation|1|||
147390534|NCT00434577|531592830|FG003|Months 0-3|Protocol Violation|0|||
147390535|NCT00434577|531592831|FG004|Months 0-3|Protocol Violation|0|||
147390536|NCT00434577|531592827|FG000|Months 0-3|Withdrawal by Subject|2|||
147390537|NCT00434577|531592828|FG001|Months 0-3|Withdrawal by Subject|1|||
147390538|NCT00434577|531592829|FG002|Months 0-3|Withdrawal by Subject|1|||
147390539|NCT00434577|531592830|FG003|Months 0-3|Withdrawal by Subject|1|||
147390540|NCT00434577|531592831|FG004|Months 0-3|Withdrawal by Subject|1|||
147390541|NCT01904019|531592837|FG000|1 Year Follow-up|Withdrawal by Subject|4|||
147390542|NCT01904019|531592837|FG000|1 Year Follow-up|Impossibility to contact patient|5|||
147390543|NCT01904019|531592837|FG000|3 Year Follow-up|Withdrawal by Subject|1|||
147390544|NCT01904019|531592837|FG000|3 Year Follow-up|Impossibility to contact patient|14|||
147390545|NCT01904019|531592837|FG000|5 Year Follow-up|Withdrawal by Subject|2|||
147390546|NCT01904019|531592837|FG000|5 Year Follow-up|Impossibility to contact patient|4|||
147390547|NCT00635570|531592838|FG000|Overall Study|Lost to Follow-up|8|||
147390548|NCT00635570|531592839|FG001|Overall Study|Lost to Follow-up|8|||
147390549|NCT00635570|531592838|FG000|Overall Study|Withdrawal by Subject|1|||
147390550|NCT00635570|531592839|FG001|Overall Study|Withdrawal by Subject|1|||
147390551|NCT00635570|531592838|FG000|Overall Study|Adverse Event|2|||
147390552|NCT00635570|531592839|FG001|Overall Study|Adverse Event|0|||
147390553|NCT00635570|531592838|FG000|Overall Study|Physician Decision|1|||
147390554|NCT00635570|531592839|FG001|Overall Study|Physician Decision|0|||
147390555|NCT00635570|531592838|FG000|Overall Study|Did not complete survey|2|||
147390556|NCT00635570|531592839|FG001|Overall Study|Did not complete survey|1|||
147390557|NCT00635570|531592838|FG000|Overall Study|Early termination(No sexual activity)|1|||
147390558|NCT00635570|531592839|FG001|Overall Study|Early termination(No sexual activity)|1|||
147390559|NCT00332488|531592843|FG000|Initial Treatment Phase (Weeks 0 - 12)|Adverse Event|8|||
147390560|NCT00332488|531592844|FG001|Initial Treatment Phase (Weeks 0 - 12)|Adverse Event|2|||
147390561|NCT00332488|531592845|FG002|Initial Treatment Phase (Weeks 0 - 12)|Adverse Event|6|||
147390562|NCT00332488|531592843|FG000|Initial Treatment Phase (Weeks 0 - 12)|Physician Decision|13|||
147390563|NCT00332488|531592844|FG001|Initial Treatment Phase (Weeks 0 - 12)|Physician Decision|2|||
147390564|NCT00332488|531592845|FG002|Initial Treatment Phase (Weeks 0 - 12)|Physician Decision|10|||
147390565|NCT00332488|531592843|FG000|Initial Treatment Phase (Weeks 0 - 12)|Withdrawal by Subject|21|||
147390566|NCT00332488|531592844|FG001|Initial Treatment Phase (Weeks 0 - 12)|Withdrawal by Subject|10|||
147390567|NCT00332488|531592845|FG002|Initial Treatment Phase (Weeks 0 - 12)|Withdrawal by Subject|20|||
147390568|NCT00332488|531592843|FG000|Initial Treatment Phase (Weeks 0 - 12)|Various|4|||
147390569|NCT00332488|531592844|FG001|Initial Treatment Phase (Weeks 0 - 12)|Various|0|||
147390570|NCT00332488|531592845|FG002|Initial Treatment Phase (Weeks 0 - 12)|Various|20|||
147390571|NCT00332488|531592843|FG000|Initial Treatment Phase (Weeks 0 - 12)|Lost to Follow-up|1|||
147390572|NCT00332488|531592844|FG001|Initial Treatment Phase (Weeks 0 - 12)|Lost to Follow-up|3|||
147390573|NCT00332488|531592845|FG002|Initial Treatment Phase (Weeks 0 - 12)|Lost to Follow-up|0|||
147390574|NCT00332488|531592843|FG000|Initial Treatment Phase (Weeks 0 - 12)|Protocol Violation|3|||
147390575|NCT00332488|531592844|FG001|Initial Treatment Phase (Weeks 0 - 12)|Protocol Violation|1|||
147390576|NCT00332488|531592845|FG002|Initial Treatment Phase (Weeks 0 - 12)|Protocol Violation|0|||
147390577|NCT00332488|531592843|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Adverse Event|0|||
147390578|NCT00332488|531592844|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Adverse Event|0|||
147390579|NCT00332488|531592845|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Adverse Event|3|||
147390580|NCT00332488|531592843|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Lost to Follow-up|0|||
147390581|NCT00332488|531592844|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Lost to Follow-up|0|||
147390582|NCT00332488|531592845|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Lost to Follow-up|1|||
147390583|NCT00332488|531592843|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Physician Decision|0|||
147390584|NCT00332488|531592844|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Physician Decision|0|||
147390585|NCT00332488|531592845|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Physician Decision|3|||
147390586|NCT00332488|531592843|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Protocol Violation|0|||
147390587|NCT00332488|531592844|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Protocol Violation|0|||
147390588|NCT00332488|531592845|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Protocol Violation|1|||
147390589|NCT00332488|531592843|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Withdrawal by Subject|2|||
147390590|NCT00332488|531592844|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Withdrawal by Subject|2|||
147390591|NCT00332488|531592845|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Withdrawal by Subject|8|||
147390592|NCT00332488|531592843|FG000|Transfer Treatment Phase (Weeks 12 - 24)|Various|0|||
147390593|NCT00332488|531592844|FG001|Transfer Treatment Phase (Weeks 12 - 24)|Various|0|||
147390594|NCT00332488|531592845|FG002|Transfer Treatment Phase (Weeks 12 - 24)|Various|5|||
147390595|NCT04816708|531592848|FG000|Overall Study|Lost to Follow-up|10|||
147390596|NCT04816708|531592849|FG001|Overall Study|Lost to Follow-up|4|||
147390597|NCT01503515|531592853|FG000|Overall Study|Adverse Event|4|||
147390598|NCT01503515|531592854|FG001|Overall Study|Adverse Event|5|||
147390599|NCT01503515|531592853|FG000|Overall Study|Death|0|||
147390600|NCT01503515|531592854|FG001|Overall Study|Death|1|||
147390601|NCT01503515|531592853|FG000|Overall Study|Physician Decision|14|||
147390602|NCT01503515|531592854|FG001|Overall Study|Physician Decision|23|||
147390603|NCT01503515|531592853|FG000|Overall Study|Withdrawal by Subject|0|||
147390604|NCT01503515|531592854|FG001|Overall Study|Withdrawal by Subject|1|||
147390605|NCT01503515|531592853|FG000|Overall Study|Institutional dx of proven/probable IFI|2|||
147390606|NCT01503515|531592854|FG001|Overall Study|Institutional dx of proven/probable IFI|4|||
147390607|NCT01503515|531592853|FG000|Overall Study|Ineligible|1|||
147390608|NCT01503515|531592854|FG001|Overall Study|Ineligible|1|||
147390609|NCT04050722|531592855|FG000|Overall Study|Withdrawal by Subject|1|||
147390610|NCT04050722|531592856|FG001|Overall Study|Withdrawal by Subject|0|||
147390611|NCT01350102|531592857|FG000|Overall Study|Adverse Event|0|||
147458593|NCT01262976|531841066|FG005|Up to Month 2|Withdrawal by Subject|0|||
147458594|NCT01262976|531841061|FG000|Up to Month 2|Migrated/moved from study area|0|||
147458595|NCT01262976|531841062|FG001|Up to Month 2|Migrated/moved from study area|1|||
147458596|NCT01262976|531841063|FG002|Up to Month 2|Migrated/moved from study area|0|||
147458597|NCT01262976|531841064|FG003|Up to Month 2|Migrated/moved from study area|0|||
147458598|NCT01262976|531841065|FG004|Up to Month 2|Migrated/moved from study area|1|||
147458599|NCT01262976|531841066|FG005|Up to Month 2|Migrated/moved from study area|1|||
147458600|NCT01262976|531841061|FG000|Up to Month 2|Lost to Follow-up|1|||
147458601|NCT01262976|531841062|FG001|Up to Month 2|Lost to Follow-up|0|||
147458602|NCT01262976|531841063|FG002|Up to Month 2|Lost to Follow-up|0|||
147458603|NCT01262976|531841064|FG003|Up to Month 2|Lost to Follow-up|1|||
147458604|NCT01262976|531841065|FG004|Up to Month 2|Lost to Follow-up|1|||
147458605|NCT01262976|531841066|FG005|Up to Month 2|Lost to Follow-up|1|||
147458606|NCT01262976|531841061|FG000|Up to Month 2|Other|1|||
147458607|NCT01262976|531841062|FG001|Up to Month 2|Other|0|||
147458608|NCT01262976|531841063|FG002|Up to Month 2|Other|0|||
147458609|NCT01262976|531841064|FG003|Up to Month 2|Other|1|||
147458610|NCT01262976|531841065|FG004|Up to Month 2|Other|0|||
147458611|NCT01262976|531841066|FG005|Up to Month 2|Other|2|||
147458612|NCT01262976|531841061|FG000|Up to Month 7|Serious Adverse Event|0|||
147458613|NCT01262976|531841062|FG001|Up to Month 7|Serious Adverse Event|0|||
147458614|NCT01262976|531841063|FG002|Up to Month 7|Serious Adverse Event|2|||
147458615|NCT01262976|531841064|FG003|Up to Month 7|Serious Adverse Event|0|||
147458616|NCT01262976|531841065|FG004|Up to Month 7|Serious Adverse Event|0|||
147458617|NCT01262976|531841066|FG005|Up to Month 7|Serious Adverse Event|0|||
147458618|NCT01262976|531841061|FG000|Up to Month 7|Withdrawal by Subject|1|||
147458619|NCT01262976|531841062|FG001|Up to Month 7|Withdrawal by Subject|0|||
147458620|NCT01262976|531841063|FG002|Up to Month 7|Withdrawal by Subject|0|||
147458621|NCT01262976|531841064|FG003|Up to Month 7|Withdrawal by Subject|0|||
147458622|NCT01262976|531841065|FG004|Up to Month 7|Withdrawal by Subject|0|||
147458623|NCT01262976|531841066|FG005|Up to Month 7|Withdrawal by Subject|0|||
147458624|NCT01262976|531841061|FG000|Up to Month 7|Migrated/moved from study area|0|||
147458625|NCT01262976|531841062|FG001|Up to Month 7|Migrated/moved from study area|0|||
147458626|NCT01262976|531841063|FG002|Up to Month 7|Migrated/moved from study area|1|||
147458627|NCT01262976|531841064|FG003|Up to Month 7|Migrated/moved from study area|3|||
147458628|NCT01262976|531841065|FG004|Up to Month 7|Migrated/moved from study area|1|||
147458629|NCT01262976|531841066|FG005|Up to Month 7|Migrated/moved from study area|1|||
147458630|NCT01262976|531841061|FG000|Up to Month 7|Lost to Follow-up|1|||
147458631|NCT01262976|531841062|FG001|Up to Month 7|Lost to Follow-up|0|||
147458632|NCT01262976|531841063|FG002|Up to Month 7|Lost to Follow-up|1|||
147458633|NCT01262976|531841064|FG003|Up to Month 7|Lost to Follow-up|3|||
147458634|NCT01262976|531841065|FG004|Up to Month 7|Lost to Follow-up|1|||
147458635|NCT01262976|531841066|FG005|Up to Month 7|Lost to Follow-up|3|||
147458636|NCT01262976|531841061|FG000|Up to Month 7|Other|3|||
147458637|NCT01262976|531841062|FG001|Up to Month 7|Other|0|||
147458638|NCT01262976|531841063|FG002|Up to Month 7|Other|2|||
147458639|NCT01262976|531841064|FG003|Up to Month 7|Other|0|||
147458640|NCT01262976|531841065|FG004|Up to Month 7|Other|0|||
147458641|NCT01262976|531841066|FG005|Up to Month 7|Other|0|||
147458642|NCT01262976|531841061|FG000|Up to Year 1|Serious Adverse Event|0|||
147458643|NCT01262976|531841062|FG001|Up to Year 1|Serious Adverse Event|0|||
147458644|NCT01262976|531841063|FG002|Up to Year 1|Serious Adverse Event|2|||
147458645|NCT01262976|531841064|FG003|Up to Year 1|Serious Adverse Event|0|||
147458646|NCT01262976|531841065|FG004|Up to Year 1|Serious Adverse Event|0|||
147458647|NCT01262976|531841066|FG005|Up to Year 1|Serious Adverse Event|0|||
147458648|NCT01262976|531841061|FG000|Up to Year 1|Withdrawal by Subject|1|||
147458649|NCT01262976|531841062|FG001|Up to Year 1|Withdrawal by Subject|0|||
147458650|NCT01262976|531841063|FG002|Up to Year 1|Withdrawal by Subject|0|||
147458651|NCT01262976|531841064|FG003|Up to Year 1|Withdrawal by Subject|0|||
147458652|NCT01262976|531841065|FG004|Up to Year 1|Withdrawal by Subject|0|||
147458653|NCT01262976|531841066|FG005|Up to Year 1|Withdrawal by Subject|0|||
147458654|NCT01262976|531841061|FG000|Up to Year 1|Migrated/moved from study area|1|||
147458655|NCT01262976|531841062|FG001|Up to Year 1|Migrated/moved from study area|0|||
147458656|NCT01262976|531841063|FG002|Up to Year 1|Migrated/moved from study area|0|||
147458657|NCT01262976|531841064|FG003|Up to Year 1|Migrated/moved from study area|3|||
147458658|NCT01262976|531841065|FG004|Up to Year 1|Migrated/moved from study area|3|||
147458659|NCT01262976|531841066|FG005|Up to Year 1|Migrated/moved from study area|2|||
147458660|NCT01262976|531841061|FG000|Up to Year 1|Lost to Follow-up|4|||
147458661|NCT01262976|531841062|FG001|Up to Year 1|Lost to Follow-up|0|||
147615177|NCT00535405|532406650|FG001|Overall Study|Lost to Follow-up|3|||
147615178|NCT00535405|532406651|FG002|Overall Study|Lost to Follow-up|3|||
147615179|NCT00535405|532406652|FG003|Overall Study|Lost to Follow-up|2|||
147458662|NCT01262976|531841063|FG002|Up to Year 1|Lost to Follow-up|0|||
147458663|NCT01262976|531841064|FG003|Up to Year 1|Lost to Follow-up|1|||
147458664|NCT01262976|531841065|FG004|Up to Year 1|Lost to Follow-up|6|||
147458665|NCT01262976|531841066|FG005|Up to Year 1|Lost to Follow-up|5|||
147458666|NCT01262976|531841061|FG000|Up to Year 1|Other|3|||
147458667|NCT01262976|531841062|FG001|Up to Year 1|Other|1|||
147458668|NCT01262976|531841063|FG002|Up to Year 1|Other|0|||
147458669|NCT01262976|531841064|FG003|Up to Year 1|Other|0|||
147458670|NCT01262976|531841065|FG004|Up to Year 1|Other|2|||
147458671|NCT01262976|531841066|FG005|Up to Year 1|Other|1|||
147458672|NCT01262976|531841061|FG000|Up to Year 1|Subjects with unknown completion status|0|||
147458673|NCT01262976|531841062|FG001|Up to Year 1|Subjects with unknown completion status|0|||
147458674|NCT01262976|531841063|FG002|Up to Year 1|Subjects with unknown completion status|1|||
147458675|NCT01262976|531841064|FG003|Up to Year 1|Subjects with unknown completion status|0|||
147458676|NCT01262976|531841065|FG004|Up to Year 1|Subjects with unknown completion status|0|||
147458677|NCT01262976|531841066|FG005|Up to Year 1|Subjects with unknown completion status|1|||
147390612|NCT01350102|531592858|FG001|Overall Study|Adverse Event|0|||
147390613|NCT01350102|531592859|FG002|Overall Study|Adverse Event|1|||
147390614|NCT01350102|531592860|FG003|Overall Study|Adverse Event|0|||
147390615|NCT03087851|531592864|FG000|Overall Study|Withdraw on medical grounds|0|||
147390616|NCT03087851|531592865|FG001|Overall Study|Withdraw on medical grounds|1|||
147390617|NCT03087851|531592866|FG002|Overall Study|Withdraw on medical grounds|2|||
147390618|NCT00377312|531592869|FG000|Overall Study|Adverse Event|1|||
147390619|NCT00377312|531592870|FG001|Overall Study|Adverse Event|1|||
147390620|NCT02775214|531592871|FG000|Overall Study|Withdrawal by Subject|2|||
147390621|NCT02775214|531592872|FG001|Overall Study|Withdrawal by Subject|0|||
147390622|NCT00762723|531592873|FG000|Overall Study|Study Terminated slow enrollement|5|||
147390623|NCT00762723|531592874|FG001|Overall Study|Study Terminated slow enrollement|5|||
147458678|NCT01262976|531841061|FG000|Up to Year 2|Serious Adverse Event|0|||
147458679|NCT01262976|531841062|FG001|Up to Year 2|Serious Adverse Event|0|||
147458680|NCT01262976|531841063|FG002|Up to Year 2|Serious Adverse Event|2|||
147458681|NCT01262976|531841064|FG003|Up to Year 2|Serious Adverse Event|0|||
147458682|NCT01262976|531841065|FG004|Up to Year 2|Serious Adverse Event|0|||
147458683|NCT01262976|531841066|FG005|Up to Year 2|Serious Adverse Event|0|||
147458684|NCT01262976|531841061|FG000|Up to Year 2|Withdrawal by Subject|1|||
147458685|NCT01262976|531841062|FG001|Up to Year 2|Withdrawal by Subject|0|||
147458686|NCT01262976|531841063|FG002|Up to Year 2|Withdrawal by Subject|0|||
147390624|NCT00762723|531592875|FG002|Overall Study|Study Terminated slow enrollement|3|||
147390625|NCT01572493|531592880|FG000|Overall Study|Physician Decision|1|||
147390626|NCT01572493|531592881|FG001|Overall Study|Physician Decision|0|||
147390627|NCT01572493|531592882|FG002|Overall Study|Physician Decision|0|||
147390628|NCT01572493|531592883|FG003|Overall Study|Physician Decision|0|||
147390629|NCT01572493|531592884|FG004|Overall Study|Physician Decision|0|||
147390630|NCT01572493|531592885|FG005|Overall Study|Physician Decision|0|||
147390631|NCT01572493|531592886|FG006|Overall Study|Physician Decision|0|||
147390632|NCT01572493|531592887|FG007|Overall Study|Physician Decision|0|||
147390633|NCT01572493|531592888|FG008|Overall Study|Physician Decision|0|||
147390634|NCT01572493|531592880|FG000|Overall Study|Switched to alternative treatment|0|||
147390635|NCT01572493|531592881|FG001|Overall Study|Switched to alternative treatment|1|||
147390636|NCT01572493|531592882|FG002|Overall Study|Switched to alternative treatment|2|||
147390637|NCT01572493|531592883|FG003|Overall Study|Switched to alternative treatment|1|||
147390638|NCT01572493|531592884|FG004|Overall Study|Switched to alternative treatment|2|||
147390639|NCT01572493|531592885|FG005|Overall Study|Switched to alternative treatment|0|||
147390640|NCT01572493|531592886|FG006|Overall Study|Switched to alternative treatment|2|||
147390641|NCT01572493|531592887|FG007|Overall Study|Switched to alternative treatment|0|||
147390642|NCT01572493|531592888|FG008|Overall Study|Switched to alternative treatment|2|||
147390643|NCT01572493|531592880|FG000|Overall Study|Death|0|||
147390644|NCT01572493|531592881|FG001|Overall Study|Death|0|||
147390645|NCT01572493|531592882|FG002|Overall Study|Death|0|||
147390646|NCT01572493|531592883|FG003|Overall Study|Death|1|||
147458687|NCT01262976|531841064|FG003|Up to Year 2|Withdrawal by Subject|0|||
147458688|NCT01262976|531841065|FG004|Up to Year 2|Withdrawal by Subject|0|||
147458689|NCT01262976|531841066|FG005|Up to Year 2|Withdrawal by Subject|0|||
147458690|NCT01262976|531841061|FG000|Up to Year 2|Migrated/moved from study area|0|||
147458691|NCT01262976|531841062|FG001|Up to Year 2|Migrated/moved from study area|0|||
147458692|NCT01262976|531841063|FG002|Up to Year 2|Migrated/moved from study area|0|||
147458693|NCT01262976|531841064|FG003|Up to Year 2|Migrated/moved from study area|2|||
147458694|NCT01262976|531841065|FG004|Up to Year 2|Migrated/moved from study area|1|||
147458695|NCT01262976|531841066|FG005|Up to Year 2|Migrated/moved from study area|2|||
147458696|NCT01262976|531841061|FG000|Up to Year 2|Lost to Follow-up|1|||
147458697|NCT01262976|531841062|FG001|Up to Year 2|Lost to Follow-up|1|||
147458698|NCT01262976|531841063|FG002|Up to Year 2|Lost to Follow-up|2|||
147458699|NCT01262976|531841064|FG003|Up to Year 2|Lost to Follow-up|2|||
147390647|NCT01572493|531592884|FG004|Overall Study|Death|0|||
147390648|NCT01572493|531592885|FG005|Overall Study|Death|1|||
147390649|NCT01572493|531592886|FG006|Overall Study|Death|0|||
147390650|NCT01572493|531592887|FG007|Overall Study|Death|0|||
147390651|NCT01572493|531592888|FG008|Overall Study|Death|0|||
147390652|NCT01572493|531592880|FG000|Overall Study|Adverse Event|0|||
147390653|NCT01572493|531592881|FG001|Overall Study|Adverse Event|0|||
147458700|NCT01262976|531841065|FG004|Up to Year 2|Lost to Follow-up|3|||
147390654|NCT01572493|531592882|FG002|Overall Study|Adverse Event|0|||
147458701|NCT01262976|531841066|FG005|Up to Year 2|Lost to Follow-up|3|||
147458702|NCT01262976|531841061|FG000|Up to Year 2|Subjects with unknown completion status|0|||
147458703|NCT01262976|531841062|FG001|Up to Year 2|Subjects with unknown completion status|0|||
147458704|NCT01262976|531841063|FG002|Up to Year 2|Subjects with unknown completion status|1|||
147458705|NCT01262976|531841064|FG003|Up to Year 2|Subjects with unknown completion status|0|||
147458706|NCT01262976|531841065|FG004|Up to Year 2|Subjects with unknown completion status|0|||
147458707|NCT01262976|531841066|FG005|Up to Year 2|Subjects with unknown completion status|0|||
147458708|NCT01262976|531841061|FG000|Up to Year 2|Other|3|||
147458709|NCT01262976|531841062|FG001|Up to Year 2|Other|0|||
147458710|NCT01262976|531841063|FG002|Up to Year 2|Other|0|||
147458711|NCT01262976|531841064|FG003|Up to Year 2|Other|0|||
147458712|NCT01262976|531841065|FG004|Up to Year 2|Other|0|||
147458713|NCT01262976|531841066|FG005|Up to Year 2|Other|0|||
147458714|NCT01262976|531841061|FG000|Up to Year 3|Serious Adverse Event|0|||
147458715|NCT01262976|531841062|FG001|Up to Year 3|Serious Adverse Event|0|||
147458716|NCT01262976|531841063|FG002|Up to Year 3|Serious Adverse Event|2|||
147458717|NCT01262976|531841064|FG003|Up to Year 3|Serious Adverse Event|0|||
147458718|NCT01262976|531841065|FG004|Up to Year 3|Serious Adverse Event|0|||
147458719|NCT01262976|531841066|FG005|Up to Year 3|Serious Adverse Event|0|||
147458720|NCT01262976|531841061|FG000|Up to Year 3|Withdrawal by Subject|1|||
147458721|NCT01262976|531841062|FG001|Up to Year 3|Withdrawal by Subject|0|||
147458722|NCT01262976|531841063|FG002|Up to Year 3|Withdrawal by Subject|0|||
147458723|NCT01262976|531841064|FG003|Up to Year 3|Withdrawal by Subject|0|||
147458724|NCT01262976|531841065|FG004|Up to Year 3|Withdrawal by Subject|0|||
147458725|NCT01262976|531841066|FG005|Up to Year 3|Withdrawal by Subject|0|||
147458726|NCT01262976|531841061|FG000|Up to Year 3|Migrated/moved from study area|0|||
147458727|NCT01262976|531841062|FG001|Up to Year 3|Migrated/moved from study area|0|||
147458728|NCT01262976|531841063|FG002|Up to Year 3|Migrated/moved from study area|0|||
147458729|NCT01262976|531841064|FG003|Up to Year 3|Migrated/moved from study area|2|||
147458730|NCT01262976|531841065|FG004|Up to Year 3|Migrated/moved from study area|1|||
147458731|NCT01262976|531841066|FG005|Up to Year 3|Migrated/moved from study area|1|||
147458732|NCT01262976|531841061|FG000|Up to Year 3|Lost to Follow-up|2|||
147458733|NCT01262976|531841062|FG001|Up to Year 3|Lost to Follow-up|2|||
147458734|NCT01262976|531841063|FG002|Up to Year 3|Lost to Follow-up|4|||
147458735|NCT01262976|531841064|FG003|Up to Year 3|Lost to Follow-up|3|||
147458736|NCT01262976|531841065|FG004|Up to Year 3|Lost to Follow-up|1|||
147458737|NCT01262976|531841066|FG005|Up to Year 3|Lost to Follow-up|3|||
147458738|NCT01262976|531841061|FG000|Up to Year 3|Subjects with unknown completion status|0|||
147458739|NCT01262976|531841062|FG001|Up to Year 3|Subjects with unknown completion status|0|||
147458740|NCT01262976|531841063|FG002|Up to Year 3|Subjects with unknown completion status|1|||
147458741|NCT01262976|531841064|FG003|Up to Year 3|Subjects with unknown completion status|0|||
147458742|NCT01262976|531841065|FG004|Up to Year 3|Subjects with unknown completion status|0|||
147458743|NCT01262976|531841066|FG005|Up to Year 3|Subjects with unknown completion status|0|||
147458744|NCT01262976|531841061|FG000|Up to Year 3|Other|3|||
147458745|NCT01262976|531841062|FG001|Up to Year 3|Other|0|||
147458746|NCT01262976|531841063|FG002|Up to Year 3|Other|0|||
147458747|NCT01262976|531841064|FG003|Up to Year 3|Other|0|||
147458748|NCT01262976|531841065|FG004|Up to Year 3|Other|0|||
147458749|NCT01262976|531841066|FG005|Up to Year 3|Other|0|||
147458750|NCT02400255|531841067|FG000|Overall Study|Relapse|4|||
147458751|NCT02400255|531841068|FG001|Overall Study|Relapse|1|||
147458752|NCT02400255|531841069|FG002|Overall Study|Relapse|1|||
147458753|NCT02400255|531841070|FG003|Overall Study|Relapse|2|||
147458754|NCT02400255|531841067|FG000|Overall Study|Adverse Event|6|||
147458755|NCT02400255|531841068|FG001|Overall Study|Adverse Event|3|||
147458756|NCT02400255|531841069|FG002|Overall Study|Adverse Event|0|||
147458757|NCT02400255|531841070|FG003|Overall Study|Adverse Event|0|||
147458758|NCT02400255|531841067|FG000|Overall Study|Physician Decision|6|||
147458759|NCT02400255|531841068|FG001|Overall Study|Physician Decision|0|||
147458760|NCT02400255|531841069|FG002|Overall Study|Physician Decision|0|||
147458761|NCT02400255|531841070|FG003|Overall Study|Physician Decision|0|||
147458762|NCT02400255|531841067|FG000|Overall Study|Loss of insurance|1|||
147458763|NCT02400255|531841068|FG001|Overall Study|Loss of insurance|0|||
147458764|NCT02400255|531841069|FG002|Overall Study|Loss of insurance|0|||
147458765|NCT02400255|531841070|FG003|Overall Study|Loss of insurance|0|||
147458766|NCT00193063|531841071|FG000|Overall Study|Lack of Efficacy|3|||
147458767|NCT00193063|531841071|FG000|Overall Study|Adverse Event|1|||
147458768|NCT03261531|531841072|FG000|Overall Study|Withdrawal by Subject|4|||
147458769|NCT01127165|531841073|FG000|Overall Study|Adverse Event|2|||
147458770|NCT01127165|531841074|FG001|Overall Study|Adverse Event|2|||
147458771|NCT01127165|531841073|FG000|Overall Study|Lack of Efficacy|10|||
147458772|NCT01127165|531841074|FG001|Overall Study|Lack of Efficacy|8|||
147458773|NCT01127165|531841073|FG000|Overall Study|Lost to Follow-up|3|||
147458774|NCT01127165|531841074|FG001|Overall Study|Lost to Follow-up|5|||
147458775|NCT01127165|531841073|FG000|Overall Study|Withdrawal by Subject|1|||
147458776|NCT01127165|531841074|FG001|Overall Study|Withdrawal by Subject|3|||
147458777|NCT01127165|531841073|FG000|Overall Study|Protocol Violation|0|||
147458778|NCT01127165|531841074|FG001|Overall Study|Protocol Violation|1|||
147458779|NCT00379795|531841075|FG000|Overall Study|Death|31|||
147458780|NCT00379795|531841076|FG001|Overall Study|Death|8|||
147458781|NCT00379795|531841077|FG002|Overall Study|Death|6|||
147458782|NCT00379795|531841078|FG003|Overall Study|Death|4|||
147458783|NCT00379795|531841079|FG004|Overall Study|Death|7|||
147458784|NCT00379795|531841075|FG000|Overall Study|Adverse Event|17|||
147458785|NCT00379795|531841076|FG001|Overall Study|Adverse Event|3|||
147458786|NCT00379795|531841077|FG002|Overall Study|Adverse Event|3|||
147458787|NCT00379795|531841078|FG003|Overall Study|Adverse Event|1|||
147458788|NCT00379795|531841079|FG004|Overall Study|Adverse Event|4|||
147458789|NCT00379795|531841075|FG000|Overall Study|Lost to Follow-up|8|||
147458790|NCT00379795|531841076|FG001|Overall Study|Lost to Follow-up|1|||
147458791|NCT00379795|531841077|FG002|Overall Study|Lost to Follow-up|2|||
147458792|NCT00379795|531841078|FG003|Overall Study|Lost to Follow-up|1|||
147458793|NCT00379795|531841079|FG004|Overall Study|Lost to Follow-up|4|||
147458794|NCT00379795|531841075|FG000|Overall Study|Physician Decision|25|||
147458795|NCT00379795|531841076|FG001|Overall Study|Physician Decision|0|||
147458796|NCT00379795|531841077|FG002|Overall Study|Physician Decision|2|||
147458797|NCT00379795|531841078|FG003|Overall Study|Physician Decision|2|||
147458798|NCT00379795|531841079|FG004|Overall Study|Physician Decision|2|||
147458799|NCT00379795|531841075|FG000|Overall Study|Withdrawal by Subject|94|||
147458800|NCT00379795|531841076|FG001|Overall Study|Withdrawal by Subject|11|||
147458801|NCT00379795|531841077|FG002|Overall Study|Withdrawal by Subject|19|||
147458802|NCT00379795|531841078|FG003|Overall Study|Withdrawal by Subject|7|||
147458803|NCT00379795|531841079|FG004|Overall Study|Withdrawal by Subject|14|||
147458804|NCT00379795|531841075|FG000|Overall Study|Subject non-compliance|7|||
147458805|NCT00379795|531841076|FG001|Overall Study|Subject non-compliance|2|||
147458806|NCT00379795|531841077|FG002|Overall Study|Subject non-compliance|0|||
147458807|NCT00379795|531841078|FG003|Overall Study|Subject non-compliance|0|||
147458808|NCT00379795|531841079|FG004|Overall Study|Subject non-compliance|1|||
147458809|NCT00379795|531841075|FG000|Overall Study|Verteporfin photodynamic therapy in eye|3|||
147458810|NCT00379795|531841076|FG001|Overall Study|Verteporfin photodynamic therapy in eye|0|||
147458811|NCT00379795|531841077|FG002|Overall Study|Verteporfin photodynamic therapy in eye|0|||
147458812|NCT00379795|531841078|FG003|Overall Study|Verteporfin photodynamic therapy in eye|1|||
147458813|NCT00379795|531841079|FG004|Overall Study|Verteporfin photodynamic therapy in eye|0|||
147458814|NCT00379795|531841075|FG000|Overall Study|Subjects condition mandated intervention|34|||
147458815|NCT00379795|531841076|FG001|Overall Study|Subjects condition mandated intervention|9|||
147458816|NCT00379795|531841077|FG002|Overall Study|Subjects condition mandated intervention|7|||
147458817|NCT00379795|531841078|FG003|Overall Study|Subjects condition mandated intervention|5|||
147458818|NCT00379795|531841079|FG004|Overall Study|Subjects condition mandated intervention|7|||
147458819|NCT00379795|531841075|FG000|Overall Study|Sponsor's decision|257|||
147458820|NCT00379795|531841076|FG001|Overall Study|Sponsor's decision|17|||
147458821|NCT00379795|531841077|FG002|Overall Study|Sponsor's decision|54|||
147458822|NCT00379795|531841078|FG003|Overall Study|Sponsor's decision|47|||
147458823|NCT00379795|531841079|FG004|Overall Study|Sponsor's decision|10|||
147458824|NCT00763321|531841080|FG000|Open-label Period|Adverse Event|24|||
147458825|NCT00763321|531841081|FG001|Open-label Period|Adverse Event|0|||
147458826|NCT00763321|531841082|FG002|Open-label Period|Adverse Event|0|||
147458827|NCT00763321|531841080|FG000|Open-label Period|Lost to Follow-up|14|||
147458828|NCT00763321|531841081|FG001|Open-label Period|Lost to Follow-up|0|||
147458829|NCT00763321|531841082|FG002|Open-label Period|Lost to Follow-up|0|||
147458830|NCT00763321|531841080|FG000|Open-label Period|Withdrawal by Subject|7|||
147458831|NCT00763321|531841081|FG001|Open-label Period|Withdrawal by Subject|0|||
147458832|NCT00763321|531841082|FG002|Open-label Period|Withdrawal by Subject|0|||
147458833|NCT00763321|531841080|FG000|Open-label Period|Subject noncompliant|7|||
147458834|NCT00763321|531841081|FG001|Open-label Period|Subject noncompliant|0|||
147458835|NCT00763321|531841082|FG002|Open-label Period|Subject noncompliant|0|||
147458836|NCT00763321|531841080|FG000|Open-label Period|Did not meet DB randomization criteria|5|||
147458837|NCT00763321|531841081|FG001|Open-label Period|Did not meet DB randomization criteria|0|||
147458838|NCT00763321|531841082|FG002|Open-label Period|Did not meet DB randomization criteria|0|||
147458839|NCT00763321|531841080|FG000|Open-label Period|Lack of Efficacy|2|||
147458840|NCT00763321|531841081|FG001|Open-label Period|Lack of Efficacy|0|||
147458841|NCT00763321|531841082|FG002|Open-label Period|Lack of Efficacy|0|||
147458842|NCT00763321|531841080|FG000|Open-label Period|Other|4|||
147458843|NCT00763321|531841081|FG001|Open-label Period|Other|0|||
147458844|NCT00763321|531841082|FG002|Open-label Period|Other|0|||
147458845|NCT00763321|531841080|FG000|Double-blind Period|Lack of Efficacy|0|||
147458846|NCT00763321|531841081|FG001|Double-blind Period|Lack of Efficacy|9|||
147458847|NCT00763321|531841082|FG002|Double-blind Period|Lack of Efficacy|17|||
147458848|NCT00763321|531841080|FG000|Double-blind Period|Adverse Event|0|||
147458849|NCT00763321|531841081|FG001|Double-blind Period|Adverse Event|4|||
147458850|NCT00763321|531841082|FG002|Double-blind Period|Adverse Event|4|||
147458851|NCT00763321|531841080|FG000|Double-blind Period|Lost to Follow-up|0|||
147458852|NCT00763321|531841081|FG001|Double-blind Period|Lost to Follow-up|4|||
147458853|NCT00763321|531841082|FG002|Double-blind Period|Lost to Follow-up|2|||
147458854|NCT00763321|531841080|FG000|Double-blind Period|Withdrawal by Subject|0|||
147458855|NCT00763321|531841081|FG001|Double-blind Period|Withdrawal by Subject|2|||
147458856|NCT00763321|531841082|FG002|Double-blind Period|Withdrawal by Subject|3|||
147458857|NCT00763321|531841080|FG000|Double-blind Period|Other|0|||
147458858|NCT00763321|531841081|FG001|Double-blind Period|Other|2|||
147458859|NCT00763321|531841082|FG002|Double-blind Period|Other|3|||
147458860|NCT02435849|531841083|FG000|Overall Study|Death|23|||
147458861|NCT02435849|531841084|FG001|Overall Study|Death|0|||
147458862|NCT02435849|531841083|FG000|Overall Study|Lack of Efficacy|10|||
147458863|NCT02435849|531841084|FG001|Overall Study|Lack of Efficacy|0|||
147458864|NCT02435849|531841083|FG000|Overall Study|New therapy for study indication|8|||
147390655|NCT01572493|531592883|FG003|Overall Study|Adverse Event|0|||
147390656|NCT01572493|531592884|FG004|Overall Study|Adverse Event|0|||
147390657|NCT01572493|531592885|FG005|Overall Study|Adverse Event|0|||
147390658|NCT01572493|531592886|FG006|Overall Study|Adverse Event|1|||
147390659|NCT01572493|531592887|FG007|Overall Study|Adverse Event|0|||
147390660|NCT01572493|531592888|FG008|Overall Study|Adverse Event|0|||
147390661|NCT00609245|531592889|FG000|Overall Study|Adverse Event|1|||
147390662|NCT01090076|531592890|FG000|Overall Study|Death|1|||
147390663|NCT01090076|531592891|FG001|Overall Study|Death|1|||
147390664|NCT01090076|531592890|FG000|Overall Study|Withdrawal by Subject|0|||
147390665|NCT01090076|531592891|FG001|Overall Study|Withdrawal by Subject|1|||
147390666|NCT01116440|531592892|FG000|Treatment|Withdrawal by Subject|2|||
147390667|NCT01116440|531592893|FG001|Treatment|Withdrawal by Subject|2|||
147390668|NCT01116440|531592892|FG000|Treatment|Lost to Follow-up|1|||
147390669|NCT01116440|531592893|FG001|Treatment|Lost to Follow-up|1|||
147390670|NCT01116440|531592892|FG000|Treatment|Protocol Violation|0|||
147390671|NCT01116440|531592893|FG001|Treatment|Protocol Violation|2|||
147390672|NCT01116440|531592892|FG000|Treatment|Lack of Efficacy|0|||
147390673|NCT01116440|531592893|FG001|Treatment|Lack of Efficacy|1|||
147390674|NCT01116440|531592892|FG000|Treatment|Adverse Event|0|||
147390675|NCT01116440|531592893|FG001|Treatment|Adverse Event|1|||
147390676|NCT01116440|531592892|FG000|Withdrawal|Withdrawal by Subject|0|||
147390677|NCT01116440|531592893|FG001|Withdrawal|Withdrawal by Subject|1|||
147390678|NCT01116440|531592892|FG000|Withdrawal|Lost to Follow-up|0|||
147390679|NCT01116440|531592893|FG001|Withdrawal|Lost to Follow-up|1|||
147390680|NCT01116440|531592892|FG000|Follow-up|Lost to Follow-up|0|||
147390681|NCT01116440|531592893|FG001|Follow-up|Lost to Follow-up|1|||
147390682|NCT01116440|531592892|FG000|Follow-up|Withdrawal by Subject|0|||
147390683|NCT01116440|531592893|FG001|Follow-up|Withdrawal by Subject|1|||
147390684|NCT02402465|531592904|FG000|Overall Study|Withdrawal by Subject|0|||
147390685|NCT02402465|531592905|FG001|Overall Study|Withdrawal by Subject|0|||
147390686|NCT02402465|531592906|FG002|Overall Study|Withdrawal by Subject|0|||
147390687|NCT02402465|531592907|FG003|Overall Study|Withdrawal by Subject|0|||
147390688|NCT02402465|531592908|FG004|Overall Study|Withdrawal by Subject|0|||
147390689|NCT02402465|531592909|FG005|Overall Study|Withdrawal by Subject|1|||
147390690|NCT02402465|531592904|FG000|Overall Study|Lost to Follow-up|0|||
147390691|NCT02402465|531592905|FG001|Overall Study|Lost to Follow-up|1|||
147390692|NCT02402465|531592906|FG002|Overall Study|Lost to Follow-up|0|||
147390693|NCT02402465|531592907|FG003|Overall Study|Lost to Follow-up|0|||
147390694|NCT02402465|531592908|FG004|Overall Study|Lost to Follow-up|1|||
147390695|NCT02402465|531592909|FG005|Overall Study|Lost to Follow-up|0|||
147390696|NCT01284634|531592910|FG000|Overall Study|Adverse Event|1|||
147390697|NCT01284634|531592911|FG001|Overall Study|Adverse Event|0|||
147390698|NCT01284634|531592912|FG002|Overall Study|Adverse Event|2|||
147390699|NCT01284634|531592913|FG003|Overall Study|Adverse Event|1|||
147390700|NCT02236598|531592914|FG000|Overall Study|Adverse Event|0|||
147390701|NCT02236598|531592915|FG001|Overall Study|Adverse Event|1|||
147390702|NCT02236598|531592914|FG000|Overall Study|Withdrawal by Subject|0|||
147458865|NCT02435849|531841084|FG001|Overall Study|New therapy for study indication|0|||
147458866|NCT02435849|531841083|FG000|Overall Study|Subject/guardian decision|5|||
147458867|NCT02435849|531841084|FG001|Overall Study|Subject/guardian decision|1|||
147458868|NCT02435849|531841083|FG000|Overall Study|Lost to Follow-up|1|||
147458869|NCT02435849|531841084|FG001|Overall Study|Lost to Follow-up|0|||
147458870|NCT02435849|531841083|FG000|Overall Study|Physician Decision|1|||
147458871|NCT02435849|531841084|FG001|Overall Study|Physician Decision|0|||
147390703|NCT02236598|531592915|FG001|Overall Study|Withdrawal by Subject|1|||
147390704|NCT03334747|531592925|FG000|Treatment Phase|Technical problems|0|||
147390705|NCT03334747|531592926|FG001|Treatment Phase|Technical problems|0|||
147390706|NCT03334747|531592927|FG002|Treatment Phase|Technical problems|0|||
147390707|NCT03334747|531592928|FG003|Treatment Phase|Technical problems|0|||
147390708|NCT03334747|531592929|FG004|Treatment Phase|Technical problems|1|||
147390709|NCT03334747|531592930|FG005|Treatment Phase|Technical problems|0|||
147390710|NCT03334747|531592931|FG006|Treatment Phase|Technical problems|0|||
147390711|NCT03334747|531592932|FG007|Treatment Phase|Technical problems|0|||
147390712|NCT03334747|531592933|FG008|Treatment Phase|Technical problems|0|||
147390713|NCT03334747|531592925|FG000|Treatment Phase|Subject/guardian decision|1|||
147458872|NCT03175549|531841085|FG000|Overall Study|Lost to Follow-up|2|||
147458873|NCT03175549|531841086|FG001|Overall Study|Lost to Follow-up|2|||
147458874|NCT03175549|531841085|FG000|Overall Study|Medication non-compliance|2|||
147390714|NCT03334747|531592926|FG001|Treatment Phase|Subject/guardian decision|0|||
147390715|NCT03334747|531592927|FG002|Treatment Phase|Subject/guardian decision|0|||
147390716|NCT03334747|531592928|FG003|Treatment Phase|Subject/guardian decision|0|||
147390717|NCT03334747|531592929|FG004|Treatment Phase|Subject/guardian decision|0|||
147390718|NCT03334747|531592930|FG005|Treatment Phase|Subject/guardian decision|1|||
147390719|NCT03334747|531592931|FG006|Treatment Phase|Subject/guardian decision|0|||
147390720|NCT03334747|531592932|FG007|Treatment Phase|Subject/guardian decision|0|||
147390721|NCT03334747|531592933|FG008|Treatment Phase|Subject/guardian decision|0|||
147390722|NCT03334747|531592925|FG000|Follow-Up Phase|Subject/guardian decision|0|||
147390723|NCT03334747|531592926|FG001|Follow-Up Phase|Subject/guardian decision|0|||
147390724|NCT03334747|531592927|FG002|Follow-Up Phase|Subject/guardian decision|0|||
147390725|NCT03334747|531592928|FG003|Follow-Up Phase|Subject/guardian decision|0|||
147390726|NCT03334747|531592929|FG004|Follow-Up Phase|Subject/guardian decision|0|||
147390727|NCT03334747|531592930|FG005|Follow-Up Phase|Subject/guardian decision|0|||
147390728|NCT03334747|531592931|FG006|Follow-Up Phase|Subject/guardian decision|1|||
147390729|NCT03334747|531592932|FG007|Follow-Up Phase|Subject/guardian decision|0|||
147390730|NCT03334747|531592933|FG008|Follow-Up Phase|Subject/guardian decision|1|||
147390731|NCT00191984|531592934|FG000|Overall Study|Disease Progression|21|||
147390732|NCT00191984|531592934|FG000|Overall Study|Adverse Event|4|||
147390733|NCT00191984|531592934|FG000|Overall Study|Death|2|||
147390734|NCT00191984|531592934|FG000|Overall Study|Entry Criteria Exclusion|1|||
147390735|NCT00191984|531592934|FG000|Overall Study|Withdrawal by Subject|7|||
147390736|NCT00191984|531592934|FG000|Overall Study|Physician Decision|4|||
147390737|NCT03303521|531592935|FG000|Overall Study|Withdrawal by Subject|2|||
147390738|NCT03303521|531592936|FG001|Overall Study|Withdrawal by Subject|0|||
147390739|NCT03303521|531592935|FG000|Overall Study|Death|1|||
147390740|NCT03303521|531592936|FG001|Overall Study|Death|0|||
147390741|NCT03303521|531592935|FG000|Overall Study|Kidney transplantation|0|||
147390742|NCT03303521|531592936|FG001|Overall Study|Kidney transplantation|1|||
147390743|NCT03303521|531592935|FG000|Overall Study|Investigational product discontinuation|0|||
147390744|NCT03303521|531592936|FG001|Overall Study|Investigational product discontinuation|1|||
147390745|NCT03303521|531592935|FG000|Overall Study|Transferred to non-study dialysis center|1|||
147390746|NCT03303521|531592936|FG001|Overall Study|Transferred to non-study dialysis center|0|||
147390747|NCT03303521|531592935|FG000|Overall Study|Non-comliance to study protocol|0|||
147390748|NCT03303521|531592936|FG001|Overall Study|Non-comliance to study protocol|1|||
147390749|NCT03303521|531592935|FG000|Overall Study|Adverse Event|1|||
147390750|NCT03303521|531592936|FG001|Overall Study|Adverse Event|0|||
147390751|NCT00005908|531592939|FG000|Overall Study|Withdrawal by Subject|1|||
147390752|NCT00005908|531592940|FG001|Overall Study|Withdrawal by Subject|0|||
147390753|NCT04736602|531592945|FG000|Main Study Phase|Withdrawal by Parent/Guardian|2|||
147390754|NCT04736602|531592945|FG000|Extension Phase|Withdrawal by Parent/Guardian|1|||
147390755|NCT01379521|531592946|FG000|Overall Study -Treatment Period|Adverse Event|3|||
147390756|NCT01379521|531592947|FG001|Overall Study -Treatment Period|Adverse Event|0|||
147390757|NCT01379521|531592946|FG000|Overall Study -Treatment Period|Abnormal test procedure results|0|||
147390758|NCT01379521|531592947|FG001|Overall Study -Treatment Period|Abnormal test procedure results|1|||
147390759|NCT01379521|531592946|FG000|Overall Study -Treatment Period|Disease Progression|23|||
147390760|NCT01379521|531592947|FG001|Overall Study -Treatment Period|Disease Progression|22|||
147390761|NCT01379521|531592946|FG000|Overall Study -Treatment Period|New Cancer Therapy|1|||
147390762|NCT01379521|531592947|FG001|Overall Study -Treatment Period|New Cancer Therapy|0|||
147390763|NCT01379521|531592946|FG000|Overall Study -Treatment Period|Protocol Deviation|0|||
147390764|NCT01379521|531592947|FG001|Overall Study -Treatment Period|Protocol Deviation|2|||
147390765|NCT01379521|531592946|FG000|Overall Study -Treatment Period|Withdrawal by Subject|3|||
147390766|NCT01379521|531592947|FG001|Overall Study -Treatment Period|Withdrawal by Subject|0|||
147390767|NCT01379521|531592946|FG000|Overall Study -Treatment Period|Administrative Problems|1|||
147390768|NCT01379521|531592947|FG001|Overall Study -Treatment Period|Administrative Problems|0|||
147390769|NCT01379521|531592946|FG000|Overall Study -Treatment Period|Death|2|||
147390770|NCT01379521|531592947|FG001|Overall Study -Treatment Period|Death|1|||
147390771|NCT01379521|531592946|FG000|Post-Treatment Evaluations|Disease Progression|22|||
147390772|NCT01379521|531592947|FG001|Post-Treatment Evaluations|Disease Progression|20|||
147390773|NCT01379521|531592946|FG000|Post-Treatment Evaluations|Withdrawal by Subject|2|||
147390774|NCT01379521|531592947|FG001|Post-Treatment Evaluations|Withdrawal by Subject|1|||
147390775|NCT01379521|531592946|FG000|Post-Treatment Evaluations|Death|1|||
147390776|NCT01379521|531592947|FG001|Post-Treatment Evaluations|Death|0|||
147390777|NCT00938041|531592948|FG000|Overall Study|Lost to Follow-up|6|||
147390778|NCT00938041|531592948|FG000|Overall Study|Received Alternative Therapy|1|||
147390779|NCT00938041|531592948|FG000|Overall Study|Progressive Disease|5|||
147458875|NCT03175549|531841086|FG001|Overall Study|Medication non-compliance|2|||
147615180|NCT00535405|532406653|FG004|Overall Study|Lost to Follow-up|1|||
147390780|NCT00938041|531592948|FG000|Overall Study|Death|12|||
147390781|NCT00938041|531592948|FG000|Overall Study|Adrenal Insufficiency|3|||
147390782|NCT03042559|531592949|FG000|Overall Study|drop out|1|||
147390783|NCT03042559|531592950|FG001|Overall Study|drop out|1|||
147390784|NCT01536535|531592952|FG000|Overall Study|Withdrawal by Subject|10|||
147615181|NCT00535405|532406649|FG000|Overall Study|Physician Decision|3|||
147458876|NCT01017952|531841087|FG000|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|356|||
147458877|NCT01017952|531841088|FG001|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
147458878|NCT01017952|531841089|FG002|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
147458879|NCT01017952|531841090|FG003|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
147458880|NCT01017952|531841091|FG004|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
147458881|NCT01017952|531841087|FG000|4-week, Open-label Run-In Period|Adverse Event|23|||
147458882|NCT01017952|531841088|FG001|4-week, Open-label Run-In Period|Adverse Event|0|||
147458883|NCT01017952|531841089|FG002|4-week, Open-label Run-In Period|Adverse Event|0|||
147458884|NCT01017952|531841090|FG003|4-week, Open-label Run-In Period|Adverse Event|0|||
147458885|NCT01017952|531841091|FG004|4-week, Open-label Run-In Period|Adverse Event|0|||
147458886|NCT01017952|531841087|FG000|4-week, Open-label Run-In Period|Study Closed/Tterminated|1|||
147458887|NCT01017952|531841088|FG001|4-week, Open-label Run-In Period|Study Closed/Tterminated|0|||
147458888|NCT01017952|531841089|FG002|4-week, Open-label Run-In Period|Study Closed/Tterminated|0|||
147458889|NCT01017952|531841090|FG003|4-week, Open-label Run-In Period|Study Closed/Tterminated|0|||
147458890|NCT01017952|531841091|FG004|4-week, Open-label Run-In Period|Study Closed/Tterminated|0|||
147458891|NCT01017952|531841087|FG000|4-week, Open-label Run-In Period|Lost to Follow-up|6|||
147458892|NCT01017952|531841088|FG001|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
147458893|NCT01017952|531841089|FG002|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
147458894|NCT01017952|531841090|FG003|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
147458895|NCT01017952|531841091|FG004|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
147458896|NCT01017952|531841087|FG000|4-week, Open-label Run-In Period|Physician Decision|10|||
147458897|NCT01017952|531841088|FG001|4-week, Open-label Run-In Period|Physician Decision|0|||
147458898|NCT01017952|531841089|FG002|4-week, Open-label Run-In Period|Physician Decision|0|||
147458899|NCT01017952|531841090|FG003|4-week, Open-label Run-In Period|Physician Decision|0|||
147458900|NCT01017952|531841091|FG004|4-week, Open-label Run-In Period|Physician Decision|0|||
147458901|NCT01017952|531841087|FG000|4-week, Open-label Run-In Period|Withdrawal by Subject|63|||
147458902|NCT01017952|531841088|FG001|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
147458903|NCT01017952|531841089|FG002|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
147458904|NCT01017952|531841090|FG003|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
147458905|NCT01017952|531841091|FG004|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
147458906|NCT01017952|531841087|FG000|52-week, Double-blind Treatment Period|Adverse Event|0|||
147458907|NCT01017952|531841088|FG001|52-week, Double-blind Treatment Period|Adverse Event|25|||
147458908|NCT01017952|531841089|FG002|52-week, Double-blind Treatment Period|Adverse Event|32|||
147458909|NCT01017952|531841090|FG003|52-week, Double-blind Treatment Period|Adverse Event|35|||
147458910|NCT01017952|531841091|FG004|52-week, Double-blind Treatment Period|Adverse Event|30|||
147458911|NCT01017952|531841087|FG000|52-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
147458912|NCT01017952|531841088|FG001|52-week, Double-blind Treatment Period|Withdrawal by Subject|30|||
147458913|NCT01017952|531841089|FG002|52-week, Double-blind Treatment Period|Withdrawal by Subject|22|||
147458914|NCT01017952|531841090|FG003|52-week, Double-blind Treatment Period|Withdrawal by Subject|25|||
147458915|NCT01017952|531841091|FG004|52-week, Double-blind Treatment Period|Withdrawal by Subject|25|||
147458916|NCT01017952|531841087|FG000|52-week, Double-blind Treatment Period|Lack of Efficacy|0|||
147458917|NCT01017952|531841088|FG001|52-week, Double-blind Treatment Period|Lack of Efficacy|35|||
147458918|NCT01017952|531841089|FG002|52-week, Double-blind Treatment Period|Lack of Efficacy|14|||
147458919|NCT01017952|531841090|FG003|52-week, Double-blind Treatment Period|Lack of Efficacy|16|||
147458920|NCT01017952|531841091|FG004|52-week, Double-blind Treatment Period|Lack of Efficacy|14|||
147458921|NCT01017952|531841087|FG000|52-week, Double-blind Treatment Period|Protocol Violation|0|||
147458922|NCT01017952|531841088|FG001|52-week, Double-blind Treatment Period|Protocol Violation|7|||
147458923|NCT01017952|531841089|FG002|52-week, Double-blind Treatment Period|Protocol Violation|11|||
147458924|NCT01017952|531841090|FG003|52-week, Double-blind Treatment Period|Protocol Violation|9|||
147458925|NCT01017952|531841091|FG004|52-week, Double-blind Treatment Period|Protocol Violation|8|||
147458926|NCT01017952|531841087|FG000|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0|||
147458927|NCT01017952|531841088|FG001|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|11|||
147458928|NCT01017952|531841089|FG002|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|13|||
147458929|NCT01017952|531841090|FG003|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|12|||
147458930|NCT01017952|531841091|FG004|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|9|||
147458931|NCT01017952|531841087|FG000|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
147458932|NCT01017952|531841088|FG001|52-week, Double-blind Treatment Period|Study Closed/Terminated|1|||
147458933|NCT01017952|531841089|FG002|52-week, Double-blind Treatment Period|Study Closed/Terminated|1|||
147458934|NCT01017952|531841090|FG003|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
147458935|NCT01017952|531841091|FG004|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
147458936|NCT01017952|531841087|FG000|52-week, Double-blind Treatment Period|Lost to Follow-up|0|||
147458937|NCT01017952|531841088|FG001|52-week, Double-blind Treatment Period|Lost to Follow-up|6|||
147458938|NCT01017952|531841089|FG002|52-week, Double-blind Treatment Period|Lost to Follow-up|8|||
147615182|NCT00535405|532406650|FG001|Overall Study|Physician Decision|2|||
147390785|NCT01536535|531592953|FG001|Overall Study|Withdrawal by Subject|5|||
147390786|NCT01536535|531592952|FG000|Overall Study|Lost to Follow-up|4|||
147390787|NCT01536535|531592953|FG001|Overall Study|Lost to Follow-up|6|||
147390788|NCT01536535|531592952|FG000|Overall Study|Physician Decision|1|||
147390789|NCT01536535|531592953|FG001|Overall Study|Physician Decision|1|||
147390790|NCT01536535|531592952|FG000|Overall Study|Participant moved|0|||
147390791|NCT01536535|531592953|FG001|Overall Study|Participant moved|1|||
147390792|NCT01485991|531592957|FG000|Overall Study|Adverse Event|0|||
147390793|NCT01485991|531592958|FG001|Overall Study|Adverse Event|4|||
147390794|NCT01485991|531592957|FG000|Overall Study|Lost to Follow-up|13|||
147390795|NCT01485991|531592958|FG001|Overall Study|Lost to Follow-up|10|||
147390796|NCT01485991|531592957|FG000|Overall Study|Withdrawal by Subject|13|||
147390797|NCT01485991|531592958|FG001|Overall Study|Withdrawal by Subject|20|||
147390798|NCT01485991|531592957|FG000|Overall Study|randomized but not treated|6|||
147390799|NCT01485991|531592958|FG001|Overall Study|randomized but not treated|2|||
147390800|NCT02538471|531592959|FG000|Overall Study|Progression of disease|2|||
147390801|NCT01475370|531592960|FG000|Overall Study|Exacerbation of primary disease|2|||
147390802|NCT01475370|531592961|FG001|Overall Study|Exacerbation of primary disease|2|||
147390803|NCT01475370|531592962|FG002|Overall Study|Exacerbation of primary disease|2|||
147390804|NCT01475370|531592960|FG000|Overall Study|Study drug administration difficult|0|||
147390805|NCT01475370|531592961|FG001|Overall Study|Study drug administration difficult|1|||
147390806|NCT01475370|531592962|FG002|Overall Study|Study drug administration difficult|1|||
147390807|NCT01475370|531592960|FG000|Overall Study|Other than specified|1|||
147390808|NCT01475370|531592961|FG001|Overall Study|Other than specified|0|||
147390809|NCT01475370|531592962|FG002|Overall Study|Other than specified|0|||
147390810|NCT00125853|531592963|FG000|Wash-out (4 Weeks)|Lost to Follow-up|3|||
147390811|NCT00125853|531592964|FG001|Wash-out (4 Weeks)|Lost to Follow-up|7|||
147390812|NCT02522299|531592965|FG000|Overall Study|Adverse Event|2|||
147390813|NCT02522299|531592966|FG001|Overall Study|Adverse Event|0|||
147390814|NCT02522299|531592965|FG000|Overall Study|Physician Decision|0|||
147390815|NCT02522299|531592966|FG001|Overall Study|Physician Decision|1|||
147390816|NCT02522299|531592965|FG000|Overall Study|Withdrawal by Subject|2|||
147390817|NCT02522299|531592966|FG001|Overall Study|Withdrawal by Subject|0|||
147390818|NCT01257698|531592967|FG000|Overall Study|Protocol Violation|4|||
147390819|NCT01257698|531592968|FG001|Overall Study|Protocol Violation|0|||
147390820|NCT00050167|531592970|FG000|Overall Study|not eligible not invasive|1|||
147390821|NCT00050167|531592971|FG001|Overall Study|not eligible not invasive|1|||
147390822|NCT02038803|531592975|FG000|Overall Study|poor adherence of subjects to protocol and withdrawal from study.|4|||
147390823|NCT02038803|531592975|FG000|Overall Study|Lost to Follow-up|1|||
147390824|NCT04754594|531592976|FG000|Blinded Period|Withdrawal by Subject|4|||
147390825|NCT04754594|531592977|FG001|Blinded Period|Withdrawal by Subject|9|||
147390826|NCT04754594|531592978|FG002|Blinded Period|Withdrawal by Subject|0|||
147390827|NCT04754594|531592979|FG003|Blinded Period|Withdrawal by Subject|0|||
147390828|NCT04754594|531592976|FG000|Blinded Period|Protocol Violation|2|||
147390829|NCT04754594|531592977|FG001|Blinded Period|Protocol Violation|2|||
147390830|NCT04754594|531592978|FG002|Blinded Period|Protocol Violation|0|||
147390831|NCT04754594|531592979|FG003|Blinded Period|Protocol Violation|0|||
147390832|NCT04754594|531592976|FG000|Blinded Period|Lost to Follow-up|1|||
147390833|NCT04754594|531592977|FG001|Blinded Period|Lost to Follow-up|1|||
147390834|NCT04754594|531592978|FG002|Blinded Period|Lost to Follow-up|0|||
147390835|NCT04754594|531592979|FG003|Blinded Period|Lost to Follow-up|0|||
147390836|NCT04754594|531592976|FG000|Blinded Period|Unblinded before 1-month postdelivery visit|6|||
147390837|NCT04754594|531592977|FG001|Blinded Period|Unblinded before 1-month postdelivery visit|3|||
147390838|NCT04754594|531592978|FG002|Blinded Period|Unblinded before 1-month postdelivery visit|0|||
147390839|NCT04754594|531592979|FG003|Blinded Period|Unblinded before 1-month postdelivery visit|0|||
147390840|NCT04754594|531592976|FG000|Unblinded Period|Withdrawal by Subject|6|||
147390841|NCT04754594|531592977|FG001|Unblinded Period|Withdrawal by Subject|8|||
147390842|NCT04754594|531592978|FG002|Unblinded Period|Withdrawal by Subject|0|||
147390843|NCT04754594|531592979|FG003|Unblinded Period|Withdrawal by Subject|0|||
147390844|NCT04754594|531592976|FG000|Unblinded Period|Lost to Follow-up|5|||
147615183|NCT00535405|532406651|FG002|Overall Study|Physician Decision|0|||
147615184|NCT00535405|532406652|FG003|Overall Study|Physician Decision|1|||
147615185|NCT00535405|532406653|FG004|Overall Study|Physician Decision|1|||
147390845|NCT04754594|531592977|FG001|Unblinded Period|Lost to Follow-up|3|||
147390846|NCT04754594|531592978|FG002|Unblinded Period|Lost to Follow-up|0|||
147390847|NCT04754594|531592979|FG003|Unblinded Period|Lost to Follow-up|0|||
147390848|NCT04754594|531592976|FG000|Unblinded Period|Protocol Violation|2|||
147390849|NCT04754594|531592977|FG001|Unblinded Period|Protocol Violation|4|||
147390850|NCT04754594|531592978|FG002|Unblinded Period|Protocol Violation|0|||
147390851|NCT04754594|531592979|FG003|Unblinded Period|Protocol Violation|0|||
147390852|NCT04754594|531592976|FG000|Unblinded Period|Other|3|||
147390853|NCT04754594|531592977|FG001|Unblinded Period|Other|0|||
147390854|NCT04754594|531592978|FG002|Unblinded Period|Other|0|||
147390855|NCT04754594|531592979|FG003|Unblinded Period|Other|0|||
147390856|NCT04754594|531592976|FG000|Infant Participants|Withdrawal by Subject|0|||
147615186|NCT00535405|532406649|FG000|Overall Study|Protocol Violation|2|||
147458939|NCT01017952|531841090|FG003|52-week, Double-blind Treatment Period|Lost to Follow-up|6|||
147458940|NCT01017952|531841091|FG004|52-week, Double-blind Treatment Period|Lost to Follow-up|10|||
147458941|NCT01017952|531841087|FG000|52-week, Double-blind Treatment Period|Physician Decision|0|||
147458942|NCT01017952|531841088|FG001|52-week, Double-blind Treatment Period|Physician Decision|10|||
147458943|NCT01017952|531841089|FG002|52-week, Double-blind Treatment Period|Physician Decision|8|||
147458944|NCT01017952|531841090|FG003|52-week, Double-blind Treatment Period|Physician Decision|9|||
147458945|NCT01017952|531841091|FG004|52-week, Double-blind Treatment Period|Physician Decision|7|||
147458946|NCT01064167|531841092|FG000|Overall Study|Protocol Violation|14|||
147458947|NCT01064167|531841093|FG001|Overall Study|Protocol Violation|15|||
147458948|NCT01656434|531841097|FG000|Overall Study|Adverse Event|199|||
147458949|NCT01656434|531841098|FG001|Overall Study|Adverse Event|63|||
147458950|NCT01656434|531841097|FG000|Overall Study|Enrollment terminated at trial site|2|||
147458951|NCT01656434|531841098|FG001|Overall Study|Enrollment terminated at trial site|0|||
147458952|NCT01656434|531841097|FG000|Overall Study|Lost to Follow-up|309|||
147458953|NCT01656434|531841098|FG001|Overall Study|Lost to Follow-up|76|||
147458954|NCT01656434|531841097|FG000|Overall Study|Site discontinued study participation|24|||
147458955|NCT01656434|531841098|FG001|Overall Study|Site discontinued study participation|9|||
147458956|NCT01656434|531841097|FG000|Overall Study|Screen failure|2|||
147458957|NCT01656434|531841098|FG001|Overall Study|Screen failure|0|||
147458958|NCT01656434|531841097|FG000|Overall Study|Protocol Violation|7|||
147458959|NCT01656434|531841098|FG001|Overall Study|Protocol Violation|0|||
147458960|NCT01656434|531841097|FG000|Overall Study|Pregnancy wish|18|||
147458961|NCT01656434|531841098|FG001|Overall Study|Pregnancy wish|6|||
147458962|NCT01656434|531841097|FG000|Overall Study|Pregnancy|45|||
147458963|NCT01656434|531841098|FG001|Overall Study|Pregnancy|10|||
147458964|NCT01656434|531841097|FG000|Overall Study|Physician Decision|7|||
147458965|NCT01656434|531841098|FG001|Overall Study|Physician Decision|2|||
147458966|NCT01656434|531841097|FG000|Overall Study|Non-compliance with study drug|48|||
147458967|NCT01656434|531841098|FG001|Overall Study|Non-compliance with study drug|9|||
147458968|NCT01656434|531841097|FG000|Overall Study|Study terminated by sponsor|1501|||
147458969|NCT01656434|531841098|FG001|Overall Study|Study terminated by sponsor|348|||
147458970|NCT01656434|531841097|FG000|Overall Study|Participant discontinued; drug related|13|||
147458971|NCT01656434|531841098|FG001|Overall Study|Participant discontinued; drug related|4|||
147458972|NCT01656434|531841097|FG000|Overall Study|Part. discontinued; unrelated to drug|55|||
147458973|NCT01656434|531841098|FG001|Overall Study|Part. discontinued; unrelated to drug|10|||
147458974|NCT01656434|531841097|FG000|Overall Study|Non-compliance with protocol|39|||
147458975|NCT01656434|531841098|FG001|Overall Study|Non-compliance with protocol|15|||
147458976|NCT01656434|531841097|FG000|Overall Study|Participant moved|40|||
147458977|NCT01656434|531841098|FG001|Overall Study|Participant moved|12|||
147458978|NCT01656434|531841097|FG000|Overall Study|Participant withdrew consent|28|||
147458979|NCT01656434|531841098|FG001|Overall Study|Participant withdrew consent|9|||
147458980|NCT01656434|531841097|FG000|Overall Study|Withdrawal by Subject|64|||
147458981|NCT01656434|531841098|FG001|Overall Study|Withdrawal by Subject|7|||
147458982|NCT00993928|531841099|FG000|Overall Study|Withdrawal by Subject|4|||
147458983|NCT00993928|531841100|FG001|Overall Study|Withdrawal by Subject|7|||
147458984|NCT00993928|531841099|FG000|Overall Study|ineligible|1|||
147458985|NCT00993928|531841100|FG001|Overall Study|ineligible|0|||
147458986|NCT01913483|531841101|FG000|Overall Study|Withdrawal by Subject|1|||
147458987|NCT01913483|531841102|FG001|Overall Study|Withdrawal by Subject|2|||
147458988|NCT01913483|531841101|FG000|Overall Study|Lost to Follow-up|6|||
147458989|NCT01913483|531841102|FG001|Overall Study|Lost to Follow-up|3|||
147458990|NCT01913483|531841101|FG000|Overall Study|Death|14|||
147458991|NCT01913483|531841102|FG001|Overall Study|Death|17|||
147458992|NCT00486278|531841113|FG000|Overall Study|Adverse Event|5|||
147458993|NCT00486278|531841113|FG000|Overall Study|Withdrawal by Subject|2|||
147458994|NCT00486278|531841113|FG000|Overall Study|Physician Decision|2|||
147458995|NCT05168267|531841114|FG000|Overall Study|Withdrawal by Subject|2|||
147458996|NCT05168267|531841115|FG001|Overall Study|Withdrawal by Subject|1|||
147458997|NCT05168267|531841114|FG000|Overall Study|Withdrawn by Therapist|1|||
147615187|NCT00535405|532406650|FG001|Overall Study|Protocol Violation|2|||
147615188|NCT00535405|532406651|FG002|Overall Study|Protocol Violation|2|||
147615189|NCT00535405|532406652|FG003|Overall Study|Protocol Violation|1|||
147615190|NCT00535405|532406653|FG004|Overall Study|Protocol Violation|0|||
147615191|NCT00535405|532406649|FG000|Overall Study|Withdrawal by Subject|5|||
147615192|NCT00535405|532406650|FG001|Overall Study|Withdrawal by Subject|11|||
147615193|NCT00535405|532406651|FG002|Overall Study|Withdrawal by Subject|10|||
147615194|NCT00535405|532406652|FG003|Overall Study|Withdrawal by Subject|10|||
147458998|NCT05168267|531841115|FG001|Overall Study|Withdrawn by Therapist|1|||
147458999|NCT05168267|531841114|FG000|Overall Study|Left Facility|1|||
147459000|NCT05168267|531841115|FG001|Overall Study|Left Facility|0|||
147459001|NCT02531646|531841127|FG000|Overall Study|equip. image processing issue|5|||
147459002|NCT02531646|531841128|FG001|Overall Study|equip. image processing issue|1|||
147459003|NCT02531646|531841129|FG002|Overall Study|equip. image processing issue|0|||
147459004|NCT04698629|531841132|FG000|Overall Study|Adverse Event|1|||
147459005|NCT02320487|531841133|FG000|Overall Study|Reason not Specified|1|||
147390857|NCT04754594|531592977|FG001|Infant Participants|Withdrawal by Subject|0|||
147390858|NCT04754594|531592978|FG002|Infant Participants|Withdrawal by Subject|9|||
147390859|NCT04754594|531592979|FG003|Infant Participants|Withdrawal by Subject|17|||
147390860|NCT04754594|531592976|FG000|Infant Participants|Lost to Follow-up|0|||
147390861|NCT04754594|531592977|FG001|Infant Participants|Lost to Follow-up|0|||
147390862|NCT04754594|531592978|FG002|Infant Participants|Lost to Follow-up|4|||
147390863|NCT04754594|531592979|FG003|Infant Participants|Lost to Follow-up|10|||
147390864|NCT04754594|531592976|FG000|Infant Participants|Death|0|||
147390865|NCT04754594|531592977|FG001|Infant Participants|Death|0|||
147390866|NCT04754594|531592978|FG002|Infant Participants|Death|1|||
147390867|NCT04754594|531592979|FG003|Infant Participants|Death|1|||
147390868|NCT04754594|531592976|FG000|Infant Participants|Other|0|||
147390869|NCT04754594|531592977|FG001|Infant Participants|Other|0|||
147390870|NCT04754594|531592978|FG002|Infant Participants|Other|1|||
147390871|NCT04754594|531592979|FG003|Infant Participants|Other|1|||
147390872|NCT01261793|531592980|FG000|Overall Study|Lack of Efficacy|44|||
147390873|NCT01261793|531592981|FG001|Overall Study|Lack of Efficacy|37|||
147390874|NCT01261793|531592982|FG002|Overall Study|Lack of Efficacy|32|||
147390875|NCT01261793|531592980|FG000|Overall Study|Protocol Violation|3|||
147390876|NCT01261793|531592981|FG001|Overall Study|Protocol Violation|5|||
147390877|NCT01261793|531592982|FG002|Overall Study|Protocol Violation|6|||
147390878|NCT01261793|531592980|FG000|Overall Study|Lost to Follow-up|10|||
147390879|NCT01261793|531592981|FG001|Overall Study|Lost to Follow-up|3|||
147390880|NCT01261793|531592982|FG002|Overall Study|Lost to Follow-up|7|||
147390881|NCT01261793|531592980|FG000|Overall Study|Withdrawal by Subject|12|||
147390882|NCT01261793|531592981|FG001|Overall Study|Withdrawal by Subject|14|||
147390883|NCT01261793|531592982|FG002|Overall Study|Withdrawal by Subject|14|||
147390884|NCT01261793|531592980|FG000|Overall Study|Death|3|||
147390885|NCT01261793|531592981|FG001|Overall Study|Death|1|||
147390886|NCT01261793|531592982|FG002|Overall Study|Death|0|||
147390887|NCT01261793|531592980|FG000|Overall Study|Adverse Event|9|||
147390888|NCT01261793|531592981|FG001|Overall Study|Adverse Event|24|||
147390889|NCT01261793|531592982|FG002|Overall Study|Adverse Event|19|||
147390890|NCT01261793|531592980|FG000|Overall Study|Patient non-availability|1|||
147390891|NCT01261793|531592981|FG001|Overall Study|Patient non-availability|1|||
147390892|NCT01261793|531592982|FG002|Overall Study|Patient non-availability|1|||
147390893|NCT01261793|531592980|FG000|Overall Study|Suspected pregnancy|1|||
147390894|NCT01261793|531592981|FG001|Overall Study|Suspected pregnancy|1|||
147390895|NCT01261793|531592982|FG002|Overall Study|Suspected pregnancy|0|||
147390896|NCT01261793|531592980|FG000|Overall Study|Patient non-compliance|1|||
147390897|NCT01261793|531592981|FG001|Overall Study|Patient non-compliance|0|||
147390898|NCT01261793|531592982|FG002|Overall Study|Patient non-compliance|1|||
147390899|NCT01261793|531592980|FG000|Overall Study|Patient pregnant|1|||
147390900|NCT01261793|531592981|FG001|Overall Study|Patient pregnant|0|||
147390901|NCT01261793|531592982|FG002|Overall Study|Patient pregnant|0|||
147390902|NCT01261793|531592980|FG000|Overall Study|Outside the study area|0|||
147390903|NCT01261793|531592981|FG001|Overall Study|Outside the study area|2|||
147390904|NCT01261793|531592982|FG002|Overall Study|Outside the study area|1|||
147390905|NCT01261793|531592980|FG000|Overall Study|Lack of efficacy & patient not available|0|||
147390906|NCT01261793|531592981|FG001|Overall Study|Lack of efficacy & patient not available|1|||
147390907|NCT01261793|531592982|FG002|Overall Study|Lack of efficacy & patient not available|0|||
147390908|NCT01261793|531592980|FG000|Overall Study|Patient withdrew after cardiology visit|0|||
147390909|NCT01261793|531592981|FG001|Overall Study|Patient withdrew after cardiology visit|1|||
147390910|NCT01261793|531592982|FG002|Overall Study|Patient withdrew after cardiology visit|0|||
147390911|NCT01261793|531592980|FG000|Overall Study|Randomization error|0|||
147390912|NCT01261793|531592981|FG001|Overall Study|Randomization error|1|||
147390913|NCT01261793|531592982|FG002|Overall Study|Randomization error|0|||
147390914|NCT01261793|531592980|FG000|Overall Study|Patient unable to start IV line|0|||
147390915|NCT01261793|531592981|FG001|Overall Study|Patient unable to start IV line|0|||
147390916|NCT01261793|531592982|FG002|Overall Study|Patient unable to start IV line|1|||
147390917|NCT03305458|531592983|FG000|Overall Study|Withdrawal by Subject|50|||
147390918|NCT03305458|531592984|FG001|Overall Study|Withdrawal by Subject|46|||
147390919|NCT03305458|531592985|FG002|Overall Study|Withdrawal by Subject|93|||
147390920|NCT03305458|531592983|FG000|Overall Study|Lost to Follow-up|85|||
147390921|NCT03305458|531592984|FG001|Overall Study|Lost to Follow-up|85|||
147390922|NCT03305458|531592985|FG002|Overall Study|Lost to Follow-up|35|||
147390923|NCT01786551|531592996|FG000|Overall Study|Participant withdrew consent|2|||
147390924|NCT04357964|531594738|FG000|Overall Study|Deemed not to have enough sufficient adipose tissue to undergo subcutaneous adipose biopsy|5|||
147390925|NCT04357964|531594739|FG001|Overall Study|Deemed not to have enough sufficient adipose tissue to undergo subcutaneous adipose biopsy|0|||
147390926|NCT04357964|531594738|FG000|Overall Study|Did not have usable primary endpoint data due to insufficient or low-quality adipose sample|13|||
147390927|NCT04357964|531594739|FG001|Overall Study|Did not have usable primary endpoint data due to insufficient or low-quality adipose sample|0|||
147390928|NCT04357964|531594738|FG000|Overall Study|Adipose sample was insufficient quality|0|||
147390929|NCT04357964|531594739|FG001|Overall Study|Adipose sample was insufficient quality|1|||
147390930|NCT00733226|531594740|FG000|Overall Study|Withdrawal by Subject|1|||
147390931|NCT00733226|531594741|FG001|Overall Study|Withdrawal by Subject|0|||
147390932|NCT00733226|531594740|FG000|Overall Study|Lost to Follow-up|2|||
147390933|NCT00733226|531594741|FG001|Overall Study|Lost to Follow-up|0|||
147390934|NCT00733226|531594740|FG000|Overall Study|moved to another place|2|||
147390935|NCT00733226|531594741|FG001|Overall Study|moved to another place|0|||
147390936|NCT02561078|531594742|FG000|Overall Study|Adverse Event|5|||
147390937|NCT02561078|531594743|FG001|Overall Study|Adverse Event|2|||
147390938|NCT02561078|531594742|FG000|Overall Study|Death|2|||
147390939|NCT02561078|531594743|FG001|Overall Study|Death|1|||
147390940|NCT02561078|531594742|FG000|Overall Study|Lost to Follow-up|2|||
147390941|NCT02561078|531594743|FG001|Overall Study|Lost to Follow-up|6|||
147390942|NCT02561078|531594742|FG000|Overall Study|Non-Compliance with Study Drug|6|||
147390943|NCT02561078|531594743|FG001|Overall Study|Non-Compliance with Study Drug|3|||
147390944|NCT02561078|531594742|FG000|Overall Study|Physician Decision|2|||
147390945|NCT02561078|531594743|FG001|Overall Study|Physician Decision|3|||
147390946|NCT02561078|531594742|FG000|Overall Study|Withdrawal by Subject|13|||
147390947|NCT02561078|531594743|FG001|Overall Study|Withdrawal by Subject|10|||
147390948|NCT00043186|531594744|FG000|Overall Study|Physician Decision|0|||
147390949|NCT00043186|531594745|FG001|Overall Study|Physician Decision|0|||
147390950|NCT00043186|531594746|FG002|Overall Study|Physician Decision|3|||
147390951|NCT00043186|531594747|FG003|Overall Study|Physician Decision|0|||
147390952|NCT00043186|531594748|FG004|Overall Study|Physician Decision|1|||
147390953|NCT00043186|531594749|FG005|Overall Study|Physician Decision|0|||
147390954|NCT00043186|531594750|FG006|Overall Study|Physician Decision|0|||
147390955|NCT00043186|531594751|FG007|Overall Study|Physician Decision|1|||
147390956|NCT00043186|531594752|FG008|Overall Study|Physician Decision|1|||
147390957|NCT00043186|531594744|FG000|Overall Study|Adverse Event|2|||
147390958|NCT00043186|531594745|FG001|Overall Study|Adverse Event|2|||
147390959|NCT00043186|531594746|FG002|Overall Study|Adverse Event|2|||
147390960|NCT00043186|531594747|FG003|Overall Study|Adverse Event|3|||
147390961|NCT00043186|531594748|FG004|Overall Study|Adverse Event|2|||
147390962|NCT00043186|531594749|FG005|Overall Study|Adverse Event|1|||
147390963|NCT00043186|531594750|FG006|Overall Study|Adverse Event|2|||
147390964|NCT00043186|531594751|FG007|Overall Study|Adverse Event|1|||
147390965|NCT00043186|531594752|FG008|Overall Study|Adverse Event|3|||
147390966|NCT00043186|531594744|FG000|Overall Study|Withdrawal by Subject|11|||
147390967|NCT00043186|531594745|FG001|Overall Study|Withdrawal by Subject|8|||
147390968|NCT00043186|531594746|FG002|Overall Study|Withdrawal by Subject|11|||
147390969|NCT00043186|531594747|FG003|Overall Study|Withdrawal by Subject|13|||
147390970|NCT00043186|531594748|FG004|Overall Study|Withdrawal by Subject|14|||
147390971|NCT00043186|531594749|FG005|Overall Study|Withdrawal by Subject|6|||
147390972|NCT00043186|531594750|FG006|Overall Study|Withdrawal by Subject|12|||
147390973|NCT00043186|531594751|FG007|Overall Study|Withdrawal by Subject|9|||
147390974|NCT00043186|531594752|FG008|Overall Study|Withdrawal by Subject|10|||
147390975|NCT00043186|531594744|FG000|Overall Study|Death|0|||
147390976|NCT00043186|531594745|FG001|Overall Study|Death|0|||
147390977|NCT00043186|531594746|FG002|Overall Study|Death|1|||
147390978|NCT00043186|531594747|FG003|Overall Study|Death|0|||
147390979|NCT00043186|531594748|FG004|Overall Study|Death|0|||
147390980|NCT00043186|531594749|FG005|Overall Study|Death|0|||
147390981|NCT00043186|531594750|FG006|Overall Study|Death|2|||
147390982|NCT00043186|531594751|FG007|Overall Study|Death|0|||
147390983|NCT00043186|531594752|FG008|Overall Study|Death|0|||
147390984|NCT00043186|531594744|FG000|Overall Study|Disease progression|1|||
147390985|NCT00043186|531594745|FG001|Overall Study|Disease progression|0|||
147390986|NCT00043186|531594746|FG002|Overall Study|Disease progression|0|||
147390987|NCT00043186|531594747|FG003|Overall Study|Disease progression|3|||
147390988|NCT00043186|531594748|FG004|Overall Study|Disease progression|0|||
147390989|NCT00043186|531594749|FG005|Overall Study|Disease progression|0|||
147390990|NCT00043186|531594750|FG006|Overall Study|Disease progression|0|||
147390991|NCT00043186|531594751|FG007|Overall Study|Disease progression|4|||
147390992|NCT00043186|531594752|FG008|Overall Study|Disease progression|0|||
147390993|NCT00043186|531594744|FG000|Overall Study|Ineligibility determined|0|||
147390994|NCT00043186|531594745|FG001|Overall Study|Ineligibility determined|0|||
147615195|NCT00535405|532406653|FG004|Overall Study|Withdrawal by Subject|8|||
147615196|NCT03519087|532406654|FG000|Clinic Evaluation|Physician Decision|15|||
147390995|NCT00043186|531594746|FG002|Overall Study|Ineligibility determined|0|||
147390996|NCT00043186|531594747|FG003|Overall Study|Ineligibility determined|0|||
147390997|NCT00043186|531594748|FG004|Overall Study|Ineligibility determined|0|||
147390998|NCT00043186|531594749|FG005|Overall Study|Ineligibility determined|0|||
147390999|NCT00043186|531594750|FG006|Overall Study|Ineligibility determined|0|||
147391000|NCT00043186|531594751|FG007|Overall Study|Ineligibility determined|0|||
147391001|NCT00043186|531594752|FG008|Overall Study|Ineligibility determined|1|||
147391002|NCT00043186|531594744|FG000|Overall Study|Lost to Follow-up|3|||
147391003|NCT00043186|531594745|FG001|Overall Study|Lost to Follow-up|5|||
147391004|NCT00043186|531594746|FG002|Overall Study|Lost to Follow-up|1|||
147391005|NCT00043186|531594747|FG003|Overall Study|Lost to Follow-up|1|||
147391006|NCT00043186|531594748|FG004|Overall Study|Lost to Follow-up|1|||
147391007|NCT00043186|531594749|FG005|Overall Study|Lost to Follow-up|1|||
147391008|NCT00043186|531594750|FG006|Overall Study|Lost to Follow-up|1|||
147391009|NCT00043186|531594751|FG007|Overall Study|Lost to Follow-up|1|||
147391010|NCT00043186|531594752|FG008|Overall Study|Lost to Follow-up|2|||
147391011|NCT00043186|531594744|FG000|Overall Study|Noncompliance|0|||
147391012|NCT00043186|531594745|FG001|Overall Study|Noncompliance|0|||
147391013|NCT00043186|531594746|FG002|Overall Study|Noncompliance|1|||
147391014|NCT00043186|531594747|FG003|Overall Study|Noncompliance|1|||
147391015|NCT00043186|531594748|FG004|Overall Study|Noncompliance|0|||
147391016|NCT00043186|531594749|FG005|Overall Study|Noncompliance|0|||
147391017|NCT00043186|531594750|FG006|Overall Study|Noncompliance|0|||
147391018|NCT00043186|531594751|FG007|Overall Study|Noncompliance|0|||
147391019|NCT00043186|531594752|FG008|Overall Study|Noncompliance|0|||
147391020|NCT00043186|531594744|FG000|Overall Study|Other|0|||
147391021|NCT00043186|531594745|FG001|Overall Study|Other|0|||
147391022|NCT00043186|531594746|FG002|Overall Study|Other|1|||
147391023|NCT00043186|531594747|FG003|Overall Study|Other|1|||
147391024|NCT00043186|531594748|FG004|Overall Study|Other|0|||
147391025|NCT00043186|531594749|FG005|Overall Study|Other|0|||
147391026|NCT00043186|531594750|FG006|Overall Study|Other|0|||
147391027|NCT00043186|531594751|FG007|Overall Study|Other|0|||
147391028|NCT00043186|531594752|FG008|Overall Study|Other|0|||
147391029|NCT00958711|531594753|FG000|Overall Study|Withdrawal by Subject|0|||
147391030|NCT00958711|531594754|FG001|Overall Study|Withdrawal by Subject|4|||
147391031|NCT00958711|531594753|FG000|Overall Study|Physician Decision|5|||
147391032|NCT00958711|531594754|FG001|Overall Study|Physician Decision|7|||
147391033|NCT00958711|531594753|FG000|Overall Study|Lost to Follow-up|4|||
147391034|NCT00958711|531594754|FG001|Overall Study|Lost to Follow-up|1|||
147391035|NCT00958711|531594753|FG000|Overall Study|Other|2|||
147391036|NCT00958711|531594754|FG001|Overall Study|Other|5|||
147391037|NCT00958711|531594753|FG000|Overall Study|Death|1|||
147391038|NCT00958711|531594754|FG001|Overall Study|Death|2|||
147391039|NCT00958711|531594753|FG000|Overall Study|Adverse Event|1|||
147391040|NCT00958711|531594754|FG001|Overall Study|Adverse Event|2|||
147391041|NCT03722485|531594755|FG000|Overall Study|Withdrawal by Subject|1|||
147391042|NCT03722485|531594756|FG001|Overall Study|Withdrawal by Subject|0|||
147391043|NCT03722485|531594755|FG000|Overall Study|Adverse Event|0|||
147391044|NCT03722485|531594756|FG001|Overall Study|Adverse Event|2|||
147391045|NCT03722485|531594755|FG000|Overall Study|subject discharged prior to study completion|1|||
147391046|NCT03722485|531594756|FG001|Overall Study|subject discharged prior to study completion|5|||
147391047|NCT03722485|531594755|FG000|Overall Study|eligibility criteria not met|2|||
147391048|NCT03722485|531594756|FG001|Overall Study|eligibility criteria not met|0|||
147391049|NCT02151643|531594757|FG000|Overall Study|Adverse Event|2|||
147391050|NCT02151643|531594758|FG001|Overall Study|Adverse Event|0|||
147391051|NCT02151643|531594759|FG002|Overall Study|Adverse Event|1|||
147391052|NCT02151643|531594760|FG003|Overall Study|Adverse Event|4|||
147391053|NCT02151643|531594761|FG004|Overall Study|Adverse Event|0|||
147391054|NCT02151643|531594757|FG000|Overall Study|Withdrawal by Subject|0|||
147391055|NCT02151643|531594758|FG001|Overall Study|Withdrawal by Subject|1|||
147391056|NCT02151643|531594759|FG002|Overall Study|Withdrawal by Subject|1|||
147391057|NCT02151643|531594760|FG003|Overall Study|Withdrawal by Subject|1|||
147391058|NCT02151643|531594761|FG004|Overall Study|Withdrawal by Subject|1|||
147391059|NCT02151643|531594757|FG000|Overall Study|Hyperphosphataemia|1|||
147391060|NCT02151643|531594758|FG001|Overall Study|Hyperphosphataemia|0|||
147391061|NCT02151643|531594759|FG002|Overall Study|Hyperphosphataemia|0|||
147391062|NCT02151643|531594760|FG003|Overall Study|Hyperphosphataemia|0|||
147391063|NCT02151643|531594761|FG004|Overall Study|Hyperphosphataemia|1|||
147391064|NCT02151643|531594757|FG000|Overall Study|High Ferritin levels|3|||
147391065|NCT02151643|531594758|FG001|Overall Study|High Ferritin levels|3|||
147391066|NCT02151643|531594759|FG002|Overall Study|High Ferritin levels|2|||
147391067|NCT02151643|531594760|FG003|Overall Study|High Ferritin levels|2|||
147391068|NCT02151643|531594761|FG004|Overall Study|High Ferritin levels|1|||
147391069|NCT00197106|531594762|FG000|4-Week Run-In Period|Did not meet entry criteria|99|||
147391070|NCT00197106|531594763|FG001|4-Week Run-In Period|Did not meet entry criteria|0|||
147391071|NCT00197106|531594764|FG002|4-Week Run-In Period|Did not meet entry criteria|0|||
147391072|NCT00197106|531594762|FG000|Overall Treatment Period|Lack of Efficacy|0|||
147664983|NCT01130272|532597976|FG000|Overall Study|Lack of efficacy- uncontrolled diarrhea|1|||
147664984|NCT01130272|532597977|FG001|Overall Study|Lack of efficacy- uncontrolled diarrhea|1|||
147391073|NCT00197106|531594763|FG001|Overall Treatment Period|Lack of Efficacy|1|||
147391074|NCT00197106|531594764|FG002|Overall Treatment Period|Lack of Efficacy|0|||
147391075|NCT00197106|531594762|FG000|Overall Treatment Period|Lost to Follow-up|0|||
147391076|NCT00197106|531594763|FG001|Overall Treatment Period|Lost to Follow-up|0|||
147391077|NCT00197106|531594764|FG002|Overall Treatment Period|Lost to Follow-up|2|||
147391078|NCT00197106|531594762|FG000|Overall Treatment Period|Protocol Violation|0|||
147391079|NCT00197106|531594763|FG001|Overall Treatment Period|Protocol Violation|0|||
147391080|NCT00197106|531594764|FG002|Overall Treatment Period|Protocol Violation|2|||
147391081|NCT00197106|531594762|FG000|Overall Treatment Period|Withdrawal by Subject|0|||
147391082|NCT00197106|531594763|FG001|Overall Treatment Period|Withdrawal by Subject|0|||
147391083|NCT00197106|531594764|FG002|Overall Treatment Period|Withdrawal by Subject|2|||
147459006|NCT02320487|531841133|FG000|Overall Study|Physician Decision|5|||
147391084|NCT00520403|531594770|FG000|Bevacizumab + IFN/Vinblastine|Radiological progression of cancer|6|||
147391085|NCT00520403|531594770|FG000|Bevacizumab + IFN/Vinblastine|Adverse Event|4|||
147391086|NCT00520403|531594770|FG000|Bevacizumab + IFN/Vinblastine|Withdrawal of consent|4|||
147391087|NCT00520403|531594770|FG000|Bevacizumab + IFN/Vinblastine|Death|2|||
147391088|NCT00520403|531594770|FG000|Bevacizumab + IFN/Vinblastine|Discontinuation of study/background drug|1|||
147391089|NCT00520403|531594770|FG000|Bevacizumab + IFN/Vinblastine|Protocol Deviation affecting safety|1|||
147391090|NCT00520403|531594770|FG000|Bevacizumab Monotherapy|Radiological progression of cancer|1|||
147391091|NCT00520403|531594770|FG000|Bevacizumab Monotherapy|Symptomatic progression of cancer|1|||
147391092|NCT01145417|531594771|FG000|Overall Study|Death|1|||
147391093|NCT01145417|531594772|FG001|Overall Study|Death|0|||
147391094|NCT01145417|531594771|FG000|Overall Study|Lost to Follow-up|2|||
147391095|NCT01145417|531594772|FG001|Overall Study|Lost to Follow-up|1|||
147391096|NCT01145417|531594771|FG000|Overall Study|Withdrawal by Subject|1|||
147391097|NCT01145417|531594772|FG001|Overall Study|Withdrawal by Subject|2|||
147391098|NCT01145417|531594771|FG000|Overall Study|Pregnancy|1|||
147391099|NCT01145417|531594772|FG001|Overall Study|Pregnancy|0|||
147391100|NCT01145417|531594771|FG000|Overall Study|Adverse Event|0|||
147391101|NCT01145417|531594772|FG001|Overall Study|Adverse Event|1|||
147391102|NCT01145417|531594771|FG000|Overall Study|Study terminated by sponsor|35|||
147391103|NCT01145417|531594772|FG001|Overall Study|Study terminated by sponsor|43|||
147391104|NCT01145417|531594771|FG000|Overall Study|Other|1|||
147391105|NCT01145417|531594772|FG001|Overall Study|Other|0|||
147391106|NCT01797562|531594773|FG000|Overall Study|Protocol Violation|5|||
147391107|NCT01370018|531594776|FG000|Overall Study|Did not meet criteria for analysis|1|||
147391108|NCT01525641|531594778|FG000|Overall Study|Case report form not collected|25|||
147391109|NCT01525641|531594778|FG000|Overall Study|No visit since the first visit|16|||
147391110|NCT01525641|531594778|FG000|Overall Study|Adverse Event|73|||
147391111|NCT01525641|531594778|FG000|Overall Study|Lack of Efficacy|24|||
147391112|NCT01525641|531594778|FG000|Overall Study|Improvement|5|||
147391113|NCT01525641|531594778|FG000|Overall Study|Lost to follow-up (relocation)|1|||
147391114|NCT01525641|531594778|FG000|Overall Study|Lost to follow-up (Unknown reason)|10|||
147391115|NCT01525641|531594778|FG000|Overall Study|Lost to follow-up (Changing hospital)|19|||
147391116|NCT01525641|531594778|FG000|Overall Study|Other than stated above|7|||
147391117|NCT03772041|531594779|FG000|Overall Study|Adverse Event|8|||
147391118|NCT03772041|531594780|FG001|Overall Study|Adverse Event|3|||
147391119|NCT03772041|531594779|FG000|Overall Study|Withdrawal by Subject|0|||
147391120|NCT03772041|531594780|FG001|Overall Study|Withdrawal by Subject|2|||
147391121|NCT03772041|531594779|FG000|Overall Study|Protocol Violation|4|||
147391122|NCT03772041|531594780|FG001|Overall Study|Protocol Violation|2|||
147391123|NCT03772041|531594779|FG000|Overall Study|Physician Decision|2|||
147391124|NCT03772041|531594780|FG001|Overall Study|Physician Decision|3|||
147391125|NCT02204319|531594781|FG000|Overall Study|Pregnancy|1|||
147391126|NCT02204319|531594781|FG000|Overall Study|Withdrawal by Subject|2|||
147391127|NCT03544229|531594786|FG000|Overall Study|Adverse Event|1|||
147391128|NCT03544229|531594787|FG001|Overall Study|Adverse Event|0|||
147391129|NCT03544229|531594788|FG002|Overall Study|Adverse Event|1|||
147391130|NCT03544229|531594789|FG003|Overall Study|Adverse Event|0|||
147391131|NCT03544229|531594786|FG000|Overall Study|Protocol Deviation|0|||
147391132|NCT03544229|531594787|FG001|Overall Study|Protocol Deviation|0|||
147391133|NCT03544229|531594788|FG002|Overall Study|Protocol Deviation|1|||
147391134|NCT03544229|531594789|FG003|Overall Study|Protocol Deviation|0|||
147391135|NCT03544229|531594786|FG000|Overall Study|Lost to Follow-up|3|||
147391136|NCT03544229|531594787|FG001|Overall Study|Lost to Follow-up|0|||
147391137|NCT03544229|531594788|FG002|Overall Study|Lost to Follow-up|0|||
147391138|NCT03544229|531594789|FG003|Overall Study|Lost to Follow-up|2|||
147391139|NCT03544229|531594786|FG000|Overall Study|Voluntary Withdrawal|2|||
147391140|NCT03544229|531594787|FG001|Overall Study|Voluntary Withdrawal|1|||
147391141|NCT03544229|531594788|FG002|Overall Study|Voluntary Withdrawal|3|||
147391142|NCT03544229|531594789|FG003|Overall Study|Voluntary Withdrawal|0|||
147391143|NCT03544229|531594786|FG000|Overall Study|Lack of Efficacy|0|||
147391144|NCT03544229|531594787|FG001|Overall Study|Lack of Efficacy|1|||
147391145|NCT03544229|531594788|FG002|Overall Study|Lack of Efficacy|0|||
147391146|NCT03544229|531594789|FG003|Overall Study|Lack of Efficacy|0|||
147391147|NCT05012397|531594791|FG000|Overall Study|Death|10|||
147459007|NCT02320487|531841133|FG000|Overall Study|Withdrawal by Subject|1|||
147459008|NCT02320487|531841133|FG000|Overall Study|Death|3|||
147391148|NCT05012397|531594791|FG000|Overall Study|Physician Decision|9|||
147391149|NCT05012397|531594791|FG000|Overall Study|Withdrawal by Subject|5|||
147391150|NCT05012397|531594791|FG000|Overall Study|Lost to Follow-up|2|||
147391151|NCT00404547|531594792|FG000|Overall Study|Adverse Event|39|||
147391152|NCT00404547|531594793|FG001|Overall Study|Adverse Event|6|||
147391153|NCT00404547|531594792|FG000|Overall Study|Withdrawal by Subject|19|||
147391154|NCT00404547|531594793|FG001|Overall Study|Withdrawal by Subject|2|||
147391155|NCT00404547|531594792|FG000|Overall Study|Protocol Violation|0|||
147391156|NCT00404547|531594793|FG001|Overall Study|Protocol Violation|1|||
147391157|NCT00404547|531594792|FG000|Overall Study|Lost to Follow-up|20|||
147391158|NCT00404547|531594793|FG001|Overall Study|Lost to Follow-up|9|||
147459009|NCT02320487|531841133|FG000|Overall Study|Adverse Event|11|||
147459010|NCT06228586|531841134|FG000|Overall Study|Withdrawal by Participant or Parent/Guardian|3|||
147459011|NCT06228586|531841135|FG001|Overall Study|Withdrawal by Participant or Parent/Guardian|1|||
147459012|NCT01182428|531841136|FG000|Overall Study|Physician Decision|1|||
147459013|NCT01182428|531841137|FG001|Overall Study|Physician Decision|0|||
147459014|NCT01182428|531841136|FG000|Overall Study|Lost to Follow-up|9|||
147459015|NCT01182428|531841137|FG001|Overall Study|Lost to Follow-up|1|||
147459016|NCT01182428|531841136|FG000|Overall Study|Withdrawal by Subject|1|||
147459017|NCT01182428|531841137|FG001|Overall Study|Withdrawal by Subject|0|||
147459018|NCT06272370|531842647|FG000|Overall Study|Lost to Follow-up|0|||
147459019|NCT06272370|531842648|FG001|Overall Study|Lost to Follow-up|3|||
147459020|NCT06272370|531842649|FG002|Overall Study|Lost to Follow-up|1|||
147459021|NCT06272370|531842650|FG003|Overall Study|Lost to Follow-up|1|||
147459022|NCT02949128|531842653|FG000|Initial Evaluation Period (26 Weeks)|Failed to Meet Eligibility Criteria|2|||
147459023|NCT02949128|531842653|FG000|Initial Evaluation Period (26 Weeks)|Adverse Event|3|||
147459024|NCT02949128|531842653|FG000|Initial Evaluation Period (26 Weeks)|Death|2|||
147459025|NCT02949128|531842653|FG000|Initial Evaluation Period (26 Weeks)|Physician Decision|1|||
147391159|NCT00404547|531594792|FG000|Overall Study|Lack of compliance|5|||
147391160|NCT00404547|531594793|FG001|Overall Study|Lack of compliance|1|||
147391161|NCT00404547|531594792|FG000|Overall Study|Other|4|||
147391162|NCT00404547|531594793|FG001|Overall Study|Other|0|||
147459026|NCT02949128|531842653|FG000|Initial Evaluation Period (26 Weeks)|Protocol Violation|1|||
147459027|NCT02949128|531842653|FG000|Extension Period (Up to 4.5 Years)|Death|1|||
147459028|NCT02949128|531842653|FG000|Extension Period (Up to 4.5 Years)|Physician Decision|5|||
147459029|NCT02949128|531842653|FG000|Extension Period (Up to 4.5 Years)|Protocol Violation|1|||
147459030|NCT02949128|531842653|FG000|Extension Period (Up to 4.5 Years)|Withdrawal by Subject|9|||
147459031|NCT02949128|531842653|FG000|Extension Period (Up to 4.5 Years)|Other than specified|5|||
147459032|NCT02324270|531842654|FG000|Overall Study|Withdrawal by Subject|0|||
147459033|NCT02324270|531842655|FG001|Overall Study|Withdrawal by Subject|1|||
147459034|NCT02324270|531842656|FG002|Overall Study|Withdrawal by Subject|0|||
147459035|NCT02324270|531842654|FG000|Overall Study|Lost to Follow-up|4|||
147459036|NCT02324270|531842655|FG001|Overall Study|Lost to Follow-up|3|||
147459037|NCT02324270|531842656|FG002|Overall Study|Lost to Follow-up|4|||
147459038|NCT02324270|531842654|FG000|Overall Study|Protocol Violation|0|||
147459039|NCT02324270|531842655|FG001|Overall Study|Protocol Violation|1|||
147459040|NCT02324270|531842656|FG002|Overall Study|Protocol Violation|1|||
147459041|NCT02324270|531842654|FG000|Overall Study|Non Compliance with Study Drug|1|||
147459042|NCT02324270|531842655|FG001|Overall Study|Non Compliance with Study Drug|2|||
147459043|NCT02324270|531842656|FG002|Overall Study|Non Compliance with Study Drug|0|||
147459044|NCT03521791|531842657|FG000|Overall Study|Protocol Violation|7|||
147459045|NCT03521791|531842658|FG001|Overall Study|Protocol Violation|17|||
147459046|NCT01475734|531842659|FG000|Overall Study|Withdrawal by Subject|1|||
147459047|NCT01475734|531842660|FG001|Overall Study|Withdrawal by Subject|0|||
147459048|NCT01475734|531842659|FG000|Overall Study|Protocol Violation|1|||
147459049|NCT01475734|531842660|FG001|Overall Study|Protocol Violation|0|||
147459050|NCT01475734|531842659|FG000|Overall Study|Physician Decision|0|||
147459051|NCT01475734|531842660|FG001|Overall Study|Physician Decision|1|||
147459052|NCT00771472|531842661|FG000|Overall Study|Physician Decision|2|||
147459053|NCT00771472|531842662|FG001|Overall Study|Physician Decision|3|||
147459054|NCT00771472|531842661|FG000|Overall Study|Progressive Disease|3|||
147459055|NCT00771472|531842662|FG001|Overall Study|Progressive Disease|1|||
147459056|NCT00771472|531842661|FG000|Overall Study|Protocol Violation|1|||
147459057|NCT00771472|531842662|FG001|Overall Study|Protocol Violation|0|||
147615197|NCT03519087|532406655|FG001|Clinic Evaluation|Physician Decision|18|||
147615198|NCT03519087|532406656|FG002|Clinic Evaluation|Physician Decision|0|||
147615199|NCT03519087|532406657|FG003|Clinic Evaluation|Physician Decision|0|||
147391163|NCT00404547|531594792|FG000|Overall Study|Reason not stated|3|||
147391164|NCT00404547|531594793|FG001|Overall Study|Reason not stated|6|||
147391165|NCT00679549|531594794|FG000|Overall Study|dropout|2|||
147391166|NCT00679549|531594795|FG001|Overall Study|dropout|4|||
147391167|NCT00679549|531594794|FG000|Overall Study|missing outcome echocardiograms|4|||
147391168|NCT00679549|531594795|FG001|Overall Study|missing outcome echocardiograms|5|||
147391169|NCT02350127|531594803|FG000|4-Month Assessment|Withdrawal by Subject|10|||
147391170|NCT02350127|531594804|FG001|4-Month Assessment|Withdrawal by Subject|9|||
147391171|NCT02350127|531594803|FG000|4-Month Assessment|Death|1|||
147391172|NCT02350127|531594804|FG001|4-Month Assessment|Death|0|||
147391173|NCT02350127|531594803|FG000|8-Month Assessment|Death|1|||
147391174|NCT02350127|531594804|FG001|8-Month Assessment|Death|1|||
147391175|NCT02350127|531594803|FG000|8-Month Assessment|Withdrawal by Subject|5|||
147391176|NCT02350127|531594804|FG001|8-Month Assessment|Withdrawal by Subject|8|||
147391177|NCT03575572|531594807|FG000|Overall Study|Withdrawal by Subject|2|||
147391178|NCT03575572|531594807|FG000|Overall Study|Physician Decision|2|||
147459058|NCT01390389|531842665|FG000|Overall Study|Withdrawal by Subject|2|||
147459059|NCT01390389|531842666|FG001|Overall Study|Withdrawal by Subject|0|||
147459060|NCT01390389|531842665|FG000|Overall Study|Screen Fail|2|||
147459061|NCT01390389|531842666|FG001|Overall Study|Screen Fail|1|||
147459062|NCT03593915|531842667|FG000|Overall Study|Adverse Event|0|||
147459063|NCT03593915|531842668|FG001|Overall Study|Adverse Event|0|||
147391179|NCT03048058|531594810|FG000|Overall Study|Lost to Follow-up|4|||
147391180|NCT03048058|531594811|FG001|Overall Study|Lost to Follow-up|0|||
147391181|NCT03048058|531594810|FG000|Overall Study|Withdrawal by Subject|0|||
147391182|NCT03048058|531594811|FG001|Overall Study|Withdrawal by Subject|4|||
147391183|NCT01247922|531594812|FG000|Overall Study|Disease progression|4|||
147391184|NCT02588027|531594813|FG000|Overall Study|Withdrawal by Subject|1|||
147391185|NCT02588027|531594814|FG001|Overall Study|Withdrawal by Subject|3|||
147391186|NCT02588027|531594813|FG000|Overall Study|Protocol Violation|4|||
147391187|NCT02588027|531594814|FG001|Overall Study|Protocol Violation|1|||
147391188|NCT04372186|531594815|FG000|Overall Study|Death|24|||
147391189|NCT04372186|531594816|FG001|Overall Study|Death|11|||
147391190|NCT04372186|531594815|FG000|Overall Study|Transferred to a different facility for care|0|||
147391191|NCT04372186|531594816|FG001|Overall Study|Transferred to a different facility for care|2|||
147391192|NCT04736472|531594817|FG000|Overall Study|Lost to Follow-up|1|||
147391193|NCT04736472|531594818|FG001|Overall Study|Lost to Follow-up|0|||
147391194|NCT04736472|531594819|FG002|Overall Study|Lost to Follow-up|0|||
147391195|NCT04736472|531594817|FG000|Overall Study|Withdrawal by Subject|2|||
147391196|NCT04736472|531594818|FG001|Overall Study|Withdrawal by Subject|0|||
147391197|NCT04736472|531594819|FG002|Overall Study|Withdrawal by Subject|0|||
147391198|NCT04736472|531594817|FG000|Overall Study|Protocol Violation|48|||
147391199|NCT04736472|531594818|FG001|Overall Study|Protocol Violation|0|||
147391200|NCT04736472|531594819|FG002|Overall Study|Protocol Violation|6|||
147391201|NCT02116582|531594820|FG000|Overall Study|Enrolled but Never Received Study Drug|1|||
147391202|NCT02116582|531594820|FG000|Overall Study|Adverse Event|22|||
147391203|NCT02116582|531594820|FG000|Overall Study|Death|9|||
147391204|NCT02116582|531594820|FG000|Overall Study|Progressive Disease|148|||
147391205|NCT02116582|531594820|FG000|Overall Study|Protocol Violation|3|||
147391206|NCT02116582|531594820|FG000|Overall Study|Withdrawal by Subject|8|||
147391207|NCT02116582|531594820|FG000|Overall Study|Other: Miscellaneous|11|||
147391208|NCT02116582|531594820|FG000|Overall Study|Lost to Follow-up|1|||
147391209|NCT02116582|531594820|FG000|Overall Study|Other: Transitioned to 9785-CL-0123|12|||
147391210|NCT01876823|531594821|FG000|Overall Study|Withdrawal by Subject|5|||
147391211|NCT01876823|531594821|FG000|Overall Study|Physician Decision|2|||
147391212|NCT01876823|531594821|FG000|Overall Study|Patients moved|2|||
147391213|NCT02256488|531594822|FG000|Overall Study|Lost to Follow-up|6|||
147391214|NCT02256488|531594823|FG001|Overall Study|Lost to Follow-up|6|||
147391215|NCT02256488|531594824|FG002|Overall Study|Lost to Follow-up|9|||
147391216|NCT02256488|531594825|FG003|Overall Study|Lost to Follow-up|3|||
147391217|NCT02256488|531594822|FG000|Overall Study|OTHER|1|||
147391218|NCT02256488|531594823|FG001|Overall Study|OTHER|0|||
147391219|NCT02256488|531594824|FG002|Overall Study|OTHER|1|||
147391220|NCT02256488|531594825|FG003|Overall Study|OTHER|1|||
147391221|NCT02256488|531594822|FG000|Overall Study|Withdrawal by Subject|1|||
147391222|NCT02256488|531594823|FG001|Overall Study|Withdrawal by Subject|0|||
147391223|NCT02256488|531594824|FG002|Overall Study|Withdrawal by Subject|0|||
147391224|NCT02256488|531594825|FG003|Overall Study|Withdrawal by Subject|2|||
147391225|NCT02268526|531594826|FG000|Overall Study|Adverse Event|0|||
147391226|NCT02268526|531594827|FG001|Overall Study|Adverse Event|2|||
147391227|NCT02268526|531594828|FG002|Overall Study|Adverse Event|1|||
147391228|NCT02268526|531594826|FG000|Overall Study|Death|1|||
147391229|NCT02268526|531594827|FG001|Overall Study|Death|11|||
147391230|NCT02268526|531594828|FG002|Overall Study|Death|0|||
147391231|NCT02268526|531594826|FG000|Overall Study|protocol deviation|0|||
147391232|NCT02268526|531594827|FG001|Overall Study|protocol deviation|1|||
147391233|NCT02268526|531594828|FG002|Overall Study|protocol deviation|0|||
147391234|NCT02268526|531594826|FG000|Overall Study|Physician Decision|0|||
147391235|NCT02268526|531594827|FG001|Overall Study|Physician Decision|0|||
147391236|NCT02268526|531594828|FG002|Overall Study|Physician Decision|1|||
147391237|NCT02268526|531594826|FG000|Overall Study|Subject/guardian decision|0|||
147391238|NCT02268526|531594827|FG001|Overall Study|Subject/guardian decision|7|||
147391239|NCT02268526|531594828|FG002|Overall Study|Subject/guardian decision|3|||
147391240|NCT00975130|531594829|FG000|Study Part 1|Adverse Event|150|||
147391241|NCT00975130|531594830|FG001|Study Part 1|Adverse Event|0|||
147391242|NCT00975130|531594831|FG002|Study Part 1|Adverse Event|0|||
147391243|NCT00975130|531594829|FG000|Study Part 1|Lost to Follow-up|19|||
147391244|NCT00975130|531594830|FG001|Study Part 1|Lost to Follow-up|0|||
147391245|NCT00975130|531594831|FG002|Study Part 1|Lost to Follow-up|0|||
147391246|NCT00975130|531594829|FG000|Study Part 1|Withdrawal by Subject|61|||
147391247|NCT00975130|531594830|FG001|Study Part 1|Withdrawal by Subject|0|||
147391248|NCT00975130|531594831|FG002|Study Part 1|Withdrawal by Subject|0|||
147391249|NCT00975130|531594829|FG000|Study Part 1|Protocol Violation|13|||
147391250|NCT00975130|531594830|FG001|Study Part 1|Protocol Violation|0|||
147391251|NCT00975130|531594831|FG002|Study Part 1|Protocol Violation|0|||
147391252|NCT00975130|531594829|FG000|Study Part 1|Did Not Meet Protocol Eligibility|9|||
147391253|NCT00975130|531594830|FG001|Study Part 1|Did Not Meet Protocol Eligibility|0|||
147391254|NCT00975130|531594831|FG002|Study Part 1|Did Not Meet Protocol Eligibility|0|||
147391255|NCT00975130|531594829|FG000|Study Part 1|Administrative|4|||
147391256|NCT00975130|531594830|FG001|Study Part 1|Administrative|0|||
147391257|NCT00975130|531594831|FG002|Study Part 1|Administrative|0|||
147391258|NCT00975130|531594829|FG000|Study Part 1|Withdrew Consent|24|||
147391259|NCT00975130|531594830|FG001|Study Part 1|Withdrew Consent|0|||
147391260|NCT00975130|531594831|FG002|Study Part 1|Withdrew Consent|0|||
147391261|NCT00975130|531594829|FG000|Study Part 2|Adverse Event|0|||
147391262|NCT00975130|531594830|FG001|Study Part 2|Adverse Event|14|||
147391263|NCT00975130|531594831|FG002|Study Part 2|Adverse Event|7|||
147391264|NCT00975130|531594829|FG000|Study Part 2|Lost to Follow-up|0|||
147391265|NCT00975130|531594830|FG001|Study Part 2|Lost to Follow-up|0|||
147391266|NCT00975130|531594831|FG002|Study Part 2|Lost to Follow-up|1|||
147391267|NCT00975130|531594829|FG000|Study Part 2|Withdrawal by Subject|0|||
147391268|NCT00975130|531594830|FG001|Study Part 2|Withdrawal by Subject|13|||
147391269|NCT00975130|531594831|FG002|Study Part 2|Withdrawal by Subject|5|||
147391270|NCT00975130|531594829|FG000|Study Part 2|Withdrew Consent|0|||
147391271|NCT00975130|531594830|FG001|Study Part 2|Withdrew Consent|6|||
147391272|NCT00975130|531594831|FG002|Study Part 2|Withdrew Consent|2|||
147391273|NCT00975130|531594829|FG000|Study Part 2|Did Not Meet Protocol Eligibility|0|||
147391274|NCT00975130|531594830|FG001|Study Part 2|Did Not Meet Protocol Eligibility|4|||
147391275|NCT00975130|531594831|FG002|Study Part 2|Did Not Meet Protocol Eligibility|1|||
147391276|NCT00975130|531594829|FG000|Study Part 2|Administrative|0|||
147391277|NCT00975130|531594830|FG001|Study Part 2|Administrative|1|||
147391278|NCT00975130|531594831|FG002|Study Part 2|Administrative|0|||
147391279|NCT00975130|531594829|FG000|Study Part 2|Protocol Violation|0|||
147391280|NCT00975130|531594830|FG001|Study Part 2|Protocol Violation|0|||
147391281|NCT00975130|531594831|FG002|Study Part 2|Protocol Violation|1|||
147391282|NCT00577096|531594832|FG000|Short Term Participation|withdrew from multiple myeloma treatment|3|||
147391283|NCT00577096|531594833|FG001|Short Term Participation|withdrew from multiple myeloma treatment|2|||
147391284|NCT00577096|531594832|FG000|Short Term Participation|Withdrawal by Subject|3|||
147391285|NCT00577096|531594833|FG001|Short Term Participation|Withdrawal by Subject|5|||
147391286|NCT00577096|531594832|FG000|Short Term Participation|Death|1|||
147391287|NCT00577096|531594833|FG001|Short Term Participation|Death|1|||
147391288|NCT03562117|531594834|FG000|Part 1, Up to 3 Days|Adverse Event|1|||
147391289|NCT03562117|531594835|FG001|Part 1, Up to 3 Days|Adverse Event|0|||
147391290|NCT03562117|531594836|FG002|Part 1, Up to 3 Days|Adverse Event|0|||
147391291|NCT02418819|531594839|FG000|Overall Study|Adverse Event|0|||
147391292|NCT02418819|531594840|FG001|Overall Study|Adverse Event|0|||
147391293|NCT02418819|531594841|FG002|Overall Study|Adverse Event|1|||
147391294|NCT02418819|531594842|FG003|Overall Study|Adverse Event|0|||
147391295|NCT02418819|531594839|FG000|Overall Study|Lost to Follow-up|1|||
147391296|NCT02418819|531594840|FG001|Overall Study|Lost to Follow-up|0|||
147391297|NCT02418819|531594841|FG002|Overall Study|Lost to Follow-up|0|||
147391298|NCT02418819|531594842|FG003|Overall Study|Lost to Follow-up|0|||
147391299|NCT02418819|531594839|FG000|Overall Study|No longer meets eligibility criteria|0|||
147391300|NCT02418819|531594840|FG001|Overall Study|No longer meets eligibility criteria|0|||
147391301|NCT02418819|531594841|FG002|Overall Study|No longer meets eligibility criteria|1|||
147391302|NCT02418819|531594842|FG003|Overall Study|No longer meets eligibility criteria|0|||
147391303|NCT02418819|531594839|FG000|Overall Study|No longer willing to participate|0|||
147391304|NCT02418819|531594840|FG001|Overall Study|No longer willing to participate|0|||
147391305|NCT02418819|531594841|FG002|Overall Study|No longer willing to participate|2|||
147391306|NCT02418819|531594842|FG003|Overall Study|No longer willing to participate|1|||
147391307|NCT04374253|531594843|FG000|Overall Study|Adverse Event|0|||
147391308|NCT04374253|531594844|FG001|Overall Study|Adverse Event|26|||
147391309|NCT04374253|531594845|FG002|Overall Study|Adverse Event|2|||
147391310|NCT04374253|531594846|FG003|Overall Study|Adverse Event|12|||
147391311|NCT04374253|531594843|FG000|Overall Study|Study terminated by sponsor|13|||
147391312|NCT04374253|531594844|FG001|Overall Study|Study terminated by sponsor|593|||
147391313|NCT04374253|531594845|FG002|Overall Study|Study terminated by sponsor|21|||
147391314|NCT04374253|531594846|FG003|Overall Study|Study terminated by sponsor|567|||
147391315|NCT04374253|531594843|FG000|Overall Study|Withdrawal by Subject|0|||
147391316|NCT04374253|531594844|FG001|Overall Study|Withdrawal by Subject|55|||
147391317|NCT04374253|531594845|FG002|Overall Study|Withdrawal by Subject|3|||
147391318|NCT04374253|531594846|FG003|Overall Study|Withdrawal by Subject|40|||
147391319|NCT04374253|531594843|FG000|Overall Study|Physician Decision|1|||
147391320|NCT04374253|531594844|FG001|Overall Study|Physician Decision|10|||
147391321|NCT04374253|531594845|FG002|Overall Study|Physician Decision|1|||
147391322|NCT04374253|531594846|FG003|Overall Study|Physician Decision|10|||
147391323|NCT04374253|531594843|FG000|Overall Study|Protocol Violation|0|||
147391324|NCT04374253|531594844|FG001|Overall Study|Protocol Violation|0|||
147391325|NCT04374253|531594845|FG002|Overall Study|Protocol Violation|0|||
147391326|NCT04374253|531594846|FG003|Overall Study|Protocol Violation|2|||
147391327|NCT04374253|531594843|FG000|Overall Study|Death|0|||
147391328|NCT04374253|531594844|FG001|Overall Study|Death|3|||
147391329|NCT04374253|531594845|FG002|Overall Study|Death|1|||
147391330|NCT04374253|531594846|FG003|Overall Study|Death|1|||
147391331|NCT04374253|531594843|FG000|Overall Study|Lack of Efficacy|0|||
147391332|NCT04374253|531594844|FG001|Overall Study|Lack of Efficacy|0|||
147391333|NCT04374253|531594845|FG002|Overall Study|Lack of Efficacy|0|||
147391334|NCT04374253|531594846|FG003|Overall Study|Lack of Efficacy|1|||
147459064|NCT03593915|531842669|FG002|Overall Study|Adverse Event|0|||
147459065|NCT03593915|531842670|FG003|Overall Study|Adverse Event|1|||
147459066|NCT03593915|531842671|FG004|Overall Study|Adverse Event|0|||
147459067|NCT03593915|531842672|FG005|Overall Study|Adverse Event|0|||
147459068|NCT03593915|531842667|FG000|Overall Study|Physician Decision|0|||
147459069|NCT03593915|531842668|FG001|Overall Study|Physician Decision|0|||
147459070|NCT03593915|531842669|FG002|Overall Study|Physician Decision|0|||
147459071|NCT03593915|531842670|FG003|Overall Study|Physician Decision|0|||
147459072|NCT03593915|531842671|FG004|Overall Study|Physician Decision|0|||
147459073|NCT03593915|531842672|FG005|Overall Study|Physician Decision|1|||
147459074|NCT01583179|531842673|FG000|Overall Study|Screen failure|1|||
147459075|NCT01583179|531842674|FG001|Overall Study|Screen failure|2|||
147459076|NCT01246206|531842675|FG000|Overall Study|Patient did not receive study regiments.|1|||
147459077|NCT02002975|531842676|FG000|Overall Study|Case Report Forms Uncollected|135|||
147459078|NCT02002975|531842676|FG000|Overall Study|Protocol Deviation|437|||
147459079|NCT04660643|531842677|FG000|Open-label Lead-in Period (Week 0 - 36)|Adverse Event|50|||
147459080|NCT04660643|531842678|FG001|Open-label Lead-in Period (Week 0 - 36)|Adverse Event|0|||
147459081|NCT04660643|531842679|FG002|Open-label Lead-in Period (Week 0 - 36)|Adverse Event|0|||
147459082|NCT04660643|531842677|FG000|Open-label Lead-in Period (Week 0 - 36)|Death|1|||
147459083|NCT04660643|531842678|FG001|Open-label Lead-in Period (Week 0 - 36)|Death|0|||
147459084|NCT04660643|531842679|FG002|Open-label Lead-in Period (Week 0 - 36)|Death|0|||
147459085|NCT04660643|531842677|FG000|Open-label Lead-in Period (Week 0 - 36)|Lost to Follow-up|14|||
147459086|NCT04660643|531842678|FG001|Open-label Lead-in Period (Week 0 - 36)|Lost to Follow-up|0|||
147459087|NCT04660643|531842679|FG002|Open-label Lead-in Period (Week 0 - 36)|Lost to Follow-up|0|||
147459088|NCT04660643|531842677|FG000|Open-label Lead-in Period (Week 0 - 36)|Pregnancy|1|||
147459089|NCT04660643|531842678|FG001|Open-label Lead-in Period (Week 0 - 36)|Pregnancy|0|||
147459090|NCT04660643|531842679|FG002|Open-label Lead-in Period (Week 0 - 36)|Pregnancy|0|||
147459091|NCT04660643|531842677|FG000|Open-label Lead-in Period (Week 0 - 36)|Physician Decision|1|||
147459092|NCT04660643|531842678|FG001|Open-label Lead-in Period (Week 0 - 36)|Physician Decision|0|||
147459093|NCT04660643|531842679|FG002|Open-label Lead-in Period (Week 0 - 36)|Physician Decision|0|||
147459094|NCT04660643|531842677|FG000|Open-label Lead-in Period (Week 0 - 36)|Protocol deviation|10|||
147459095|NCT04660643|531842678|FG001|Open-label Lead-in Period (Week 0 - 36)|Protocol deviation|0|||
147459096|NCT04660643|531842679|FG002|Open-label Lead-in Period (Week 0 - 36)|Protocol deviation|0|||
147459097|NCT04660643|531842677|FG000|Open-label Lead-in Period (Week 0 - 36)|Withdrawal by Subject|32|||
147459098|NCT04660643|531842678|FG001|Open-label Lead-in Period (Week 0 - 36)|Withdrawal by Subject|0|||
147459099|NCT04660643|531842679|FG002|Open-label Lead-in Period (Week 0 - 36)|Withdrawal by Subject|0|||
147459100|NCT04660643|531842677|FG000|Open-label Lead-in Period (Week 0 - 36)|Covid-19|1|||
147459101|NCT04660643|531842678|FG001|Open-label Lead-in Period (Week 0 - 36)|Covid-19|0|||
147459102|NCT04660643|531842679|FG002|Open-label Lead-in Period (Week 0 - 36)|Covid-19|0|||
147459103|NCT04660643|531842677|FG000|Open-label Lead-in Period (Week 0 - 36)|Other - as reported by the investigator|2|||
147459104|NCT04660643|531842678|FG001|Open-label Lead-in Period (Week 0 - 36)|Other - as reported by the investigator|0|||
147459105|NCT04660643|531842679|FG002|Open-label Lead-in Period (Week 0 - 36)|Other - as reported by the investigator|0|||
147459106|NCT04660643|531842677|FG000|Double-blind Study Period (Week 36 - 92)|Death|0|||
147459107|NCT04660643|531842678|FG001|Double-blind Study Period (Week 36 - 92)|Death|1|||
147459108|NCT04660643|531842679|FG002|Double-blind Study Period (Week 36 - 92)|Death|1|||
147459109|NCT04660643|531842677|FG000|Double-blind Study Period (Week 36 - 92)|Lost to Follow-up|0|||
147459110|NCT04660643|531842678|FG001|Double-blind Study Period (Week 36 - 92)|Lost to Follow-up|10|||
147459111|NCT04660643|531842679|FG002|Double-blind Study Period (Week 36 - 92)|Lost to Follow-up|8|||
147459112|NCT04660643|531842677|FG000|Double-blind Study Period (Week 36 - 92)|Pregnancy|0|||
147459113|NCT04660643|531842678|FG001|Double-blind Study Period (Week 36 - 92)|Pregnancy|2|||
147459114|NCT04660643|531842679|FG002|Double-blind Study Period (Week 36 - 92)|Pregnancy|1|||
147459115|NCT04660643|531842677|FG000|Double-blind Study Period (Week 36 - 92)|Withdrawal by Subject|0|||
147459116|NCT04660643|531842678|FG001|Double-blind Study Period (Week 36 - 92)|Withdrawal by Subject|22|||
147459117|NCT04660643|531842679|FG002|Double-blind Study Period (Week 36 - 92)|Withdrawal by Subject|13|||
147459118|NCT04660643|531842677|FG000|Double-blind Study Period (Week 36 - 92)|Protocol deviation|0|||
147459119|NCT04660643|531842678|FG001|Double-blind Study Period (Week 36 - 92)|Protocol deviation|1|||
147459120|NCT04660643|531842679|FG002|Double-blind Study Period (Week 36 - 92)|Protocol deviation|2|||
147459121|NCT04660643|531842677|FG000|Double-blind Study Period (Week 36 - 92)|Other - as reported by the investigator|0|||
147459122|NCT04660643|531842678|FG001|Double-blind Study Period (Week 36 - 92)|Other - as reported by the investigator|8|||
147459123|NCT04660643|531842679|FG002|Double-blind Study Period (Week 36 - 92)|Other - as reported by the investigator|0|||
147459124|NCT04660643|531842677|FG000|Double-blind Study Period (Week 36 - 92)|Perceived excessive weight loss|0|||
147459125|NCT04660643|531842678|FG001|Double-blind Study Period (Week 36 - 92)|Perceived excessive weight loss|1|||
147459126|NCT04660643|531842679|FG002|Double-blind Study Period (Week 36 - 92)|Perceived excessive weight loss|0|||
147459127|NCT03988907|531842680|FG000|Overall Study|Unable to complete visit|0|||
147459128|NCT03988907|531842681|FG001|Overall Study|Unable to complete visit|1|||
147664985|NCT01130272|532597978|FG002|Overall Study|Lack of efficacy- uncontrolled diarrhea|0|||
147459129|NCT03609619|531842687|FG000|Overall Study|Adverse Event|1|||
147459130|NCT03609619|531842688|FG001|Overall Study|Adverse Event|0|||
147459131|NCT03609619|531842687|FG000|Overall Study|Lack of Efficacy|1|||
147459132|NCT03609619|531842688|FG001|Overall Study|Lack of Efficacy|2|||
147459133|NCT03609619|531842687|FG000|Overall Study|Protocol Violation|5|||
147459134|NCT03609619|531842688|FG001|Overall Study|Protocol Violation|0|||
147459135|NCT03609619|531842687|FG000|Overall Study|Withdrawal by Subject|2|||
147459136|NCT03609619|531842688|FG001|Overall Study|Withdrawal by Subject|3|||
147459137|NCT03609619|531842687|FG000|Overall Study|Lost to Follow-up|1|||
147459138|NCT03609619|531842688|FG001|Overall Study|Lost to Follow-up|1|||
147459139|NCT00167245|531842689|FG000|Overall Study|Lost to Follow-up|20|||
147459140|NCT00167245|531842690|FG001|Overall Study|Lost to Follow-up|31|||
147459141|NCT00167245|531842689|FG000|Overall Study|Withdrawal by Subject|5|||
147459142|NCT00167245|531842690|FG001|Overall Study|Withdrawal by Subject|8|||
147459143|NCT00167245|531842689|FG000|Overall Study|Incarcerated|3|||
147459144|NCT00167245|531842690|FG001|Overall Study|Incarcerated|2|||
147459145|NCT00167245|531842689|FG000|Overall Study|Drowsy|1|||
147459146|NCT00167245|531842690|FG001|Overall Study|Drowsy|0|||
147459147|NCT00568555|531842693|FG000|Overall Study|Withdrawal by Subject|1|||
147459148|NCT00568555|531842694|FG001|Overall Study|Withdrawal by Subject|1|||
147459149|NCT01871090|531842695|FG000|Overall Study|Interrogation not done in Emergency Room|1|||
147459150|NCT01871090|531842696|FG001|Overall Study|Interrogation not done in Emergency Room|22|||
147459151|NCT01871090|531842695|FG000|Overall Study|Interrogation not completed correctly|1|||
147459152|NCT01871090|531842696|FG001|Overall Study|Interrogation not completed correctly|0|||
147459153|NCT01871090|531842695|FG000|Overall Study|Subject Non-Compliance|0|||
147459154|NCT01871090|531842696|FG001|Overall Study|Subject Non-Compliance|1|||
147459155|NCT01231555|531842697|FG000|Overall Study|Study terminated|8|||
147459156|NCT01231555|531842698|FG001|Overall Study|Study terminated|5|||
147459157|NCT01231555|531842699|FG002|Overall Study|Study terminated|8|||
147459158|NCT01231555|531842697|FG000|Overall Study|Withdrawal by Subject|0|||
147459159|NCT01231555|531842698|FG001|Overall Study|Withdrawal by Subject|2|||
147459160|NCT01231555|531842699|FG002|Overall Study|Withdrawal by Subject|0|||
147459161|NCT00688909|531842702|FG000|Overall Study|Adverse Event|28|||
147459162|NCT00688909|531842702|FG000|Overall Study|Patient withdrew consent|2|||
147459163|NCT00688909|531842702|FG000|Overall Study|Administrative problems|1|||
147459164|NCT00688909|531842702|FG000|Overall Study|Protocol Violation|2|||
147459165|NCT03502330|531842703|FG000|Overall Study|Adverse Event|2|||
147459166|NCT03502330|531842704|FG001|Overall Study|Adverse Event|1|||
147459167|NCT03502330|531842705|FG002|Overall Study|Adverse Event|0|||
147459168|NCT03502330|531842706|FG003|Overall Study|Adverse Event|0|||
147459169|NCT03502330|531842707|FG004|Overall Study|Adverse Event|1|||
147459170|NCT03502330|531842708|FG005|Overall Study|Adverse Event|0|||
147459171|NCT03502330|531842709|FG006|Overall Study|Adverse Event|1|||
147459172|NCT03502330|531842710|FG007|Overall Study|Adverse Event|1|||
147459173|NCT03502330|531842711|FG008|Overall Study|Adverse Event|0|||
147459174|NCT03502330|531842703|FG000|Overall Study|Lack of Efficacy|1|||
147459175|NCT03502330|531842704|FG001|Overall Study|Lack of Efficacy|5|||
147459176|NCT03502330|531842705|FG002|Overall Study|Lack of Efficacy|3|||
147459177|NCT03502330|531842706|FG003|Overall Study|Lack of Efficacy|5|||
147459178|NCT03502330|531842707|FG004|Overall Study|Lack of Efficacy|1|||
147459179|NCT03502330|531842708|FG005|Overall Study|Lack of Efficacy|5|||
147459180|NCT03502330|531842709|FG006|Overall Study|Lack of Efficacy|5|||
147459181|NCT03502330|531842710|FG007|Overall Study|Lack of Efficacy|6|||
147459182|NCT03502330|531842711|FG008|Overall Study|Lack of Efficacy|0|||
147459183|NCT03502330|531842703|FG000|Overall Study|Physician Decision|0|||
147459184|NCT03502330|531842704|FG001|Overall Study|Physician Decision|0|||
147459185|NCT03502330|531842705|FG002|Overall Study|Physician Decision|0|||
147459186|NCT03502330|531842706|FG003|Overall Study|Physician Decision|0|||
147459187|NCT03502330|531842707|FG004|Overall Study|Physician Decision|1|||
147459188|NCT03502330|531842708|FG005|Overall Study|Physician Decision|0|||
147459189|NCT03502330|531842709|FG006|Overall Study|Physician Decision|0|||
147459190|NCT03502330|531842710|FG007|Overall Study|Physician Decision|0|||
147459191|NCT03502330|531842711|FG008|Overall Study|Physician Decision|0|||
147664986|NCT01130272|532597979|FG003|Overall Study|Lack of efficacy- uncontrolled diarrhea|0|||
147459192|NCT03502330|531842703|FG000|Overall Study|Withdrawal by Subject|0|||
147664987|NCT01130272|532597980|FG004|Overall Study|Lack of efficacy- uncontrolled diarrhea|2|||
147459193|NCT03502330|531842704|FG001|Overall Study|Withdrawal by Subject|0|||
147459194|NCT03502330|531842705|FG002|Overall Study|Withdrawal by Subject|0|||
147459195|NCT03502330|531842706|FG003|Overall Study|Withdrawal by Subject|0|||
147459196|NCT03502330|531842707|FG004|Overall Study|Withdrawal by Subject|0|||
147459197|NCT03502330|531842708|FG005|Overall Study|Withdrawal by Subject|1|||
147459198|NCT03502330|531842709|FG006|Overall Study|Withdrawal by Subject|0|||
147459199|NCT03502330|531842710|FG007|Overall Study|Withdrawal by Subject|1|||
147459200|NCT03502330|531842711|FG008|Overall Study|Withdrawal by Subject|0|||
147459201|NCT03502330|531842703|FG000|Overall Study|Death|0|||
147459202|NCT03502330|531842704|FG001|Overall Study|Death|0|||
147459203|NCT03502330|531842705|FG002|Overall Study|Death|0|||
147459204|NCT03502330|531842706|FG003|Overall Study|Death|0|||
147459205|NCT03502330|531842707|FG004|Overall Study|Death|0|||
147615200|NCT03519087|532406658|FG004|Clinic Evaluation|Physician Decision|0|||
147615201|NCT03519087|532406654|FG000|Clinic Evaluation|Protocol Violation|1|||
147615202|NCT03519087|532406655|FG001|Clinic Evaluation|Protocol Violation|0|||
147391335|NCT04374253|531594843|FG000|Overall Study|Lost to Follow-up|1|||
147391336|NCT04374253|531594844|FG001|Overall Study|Lost to Follow-up|1|||
147391337|NCT04374253|531594845|FG002|Overall Study|Lost to Follow-up|0|||
147391338|NCT04374253|531594846|FG003|Overall Study|Lost to Follow-up|2|||
147391339|NCT04374253|531594843|FG000|Overall Study|Reason Not Specified|0|||
147391340|NCT04374253|531594844|FG001|Overall Study|Reason Not Specified|8|||
147391341|NCT04374253|531594845|FG002|Overall Study|Reason Not Specified|0|||
147391342|NCT04374253|531594846|FG003|Overall Study|Reason Not Specified|8|||
147391343|NCT01207453|531594849|FG000|First Intervention|Adverse Event|2|||
147391344|NCT01207453|531594850|FG001|First Intervention|Adverse Event|1|||
147391345|NCT01207453|531594849|FG000|Washout|Adverse Event|1|||
147391346|NCT01207453|531594850|FG001|Washout|Adverse Event|0|||
147391347|NCT01207453|531594849|FG000|Washout|Lost to Follow-up|1|||
147391348|NCT01207453|531594850|FG001|Washout|Lost to Follow-up|0|||
147391349|NCT01207453|531594849|FG000|2nd Intervention|Adverse Event|1|||
147391350|NCT01207453|531594850|FG001|2nd Intervention|Adverse Event|2|||
147391351|NCT01207453|531594849|FG000|2nd Intervention|Lost to Follow-up|1|||
147391352|NCT01207453|531594850|FG001|2nd Intervention|Lost to Follow-up|0|||
147391353|NCT00676663|531594851|FG000|Overall Study|Death|43|||
147391354|NCT00676663|531594852|FG001|Overall Study|Death|27|||
147391355|NCT00676663|531594851|FG000|Overall Study|Withdrew Consent|1|||
147391356|NCT00676663|531594852|FG001|Overall Study|Withdrew Consent|8|||
147391357|NCT00676663|531594851|FG000|Overall Study|Lost to Follow-up|1|||
147391358|NCT00676663|531594852|FG001|Overall Study|Lost to Follow-up|3|||
147391359|NCT04382053|531594858|FG000|Overall Study|Death|6|||
147391360|NCT04382053|531594859|FG001|Overall Study|Death|8|||
147391361|NCT04382053|531594858|FG000|Overall Study|Lost to Follow-up|0|||
147391362|NCT04382053|531594859|FG001|Overall Study|Lost to Follow-up|2|||
147391363|NCT04382053|531594858|FG000|Overall Study|Protocol Deviation|1|||
147391364|NCT04382053|531594859|FG001|Overall Study|Protocol Deviation|2|||
147391365|NCT04382053|531594858|FG000|Overall Study|Withdrawal by Subject|2|||
147391366|NCT04382053|531594859|FG001|Overall Study|Withdrawal by Subject|1|||
147391367|NCT01399905|531594862|FG000|Overall Study|Withdrawal by Subject|1|||
147391368|NCT01399905|531594863|FG001|Overall Study|Withdrawal by Subject|1|||
147391369|NCT00714688|531594871|FG000|Overall Study|Lack of Efficacy|14|||
147391370|NCT00714688|531594872|FG001|Overall Study|Lack of Efficacy|1|||
147391371|NCT00714688|531594873|FG002|Overall Study|Lack of Efficacy|4|||
147391372|NCT00714688|531594871|FG000|Overall Study|Withdrawal by Subject|4|||
147391373|NCT00714688|531594872|FG001|Overall Study|Withdrawal by Subject|3|||
147391374|NCT00714688|531594873|FG002|Overall Study|Withdrawal by Subject|3|||
147391375|NCT00714688|531594871|FG000|Overall Study|Lost to Follow-up|5|||
147391376|NCT00714688|531594872|FG001|Overall Study|Lost to Follow-up|2|||
147391377|NCT00714688|531594873|FG002|Overall Study|Lost to Follow-up|0|||
147391378|NCT00714688|531594871|FG000|Overall Study|Adverse Event|2|||
147391379|NCT00714688|531594872|FG001|Overall Study|Adverse Event|15|||
147391380|NCT00714688|531594873|FG002|Overall Study|Adverse Event|19|||
147391381|NCT00714688|531594871|FG000|Overall Study|Subject Non-compliant|3|||
147391382|NCT00714688|531594872|FG001|Overall Study|Subject Non-compliant|5|||
147391383|NCT00714688|531594873|FG002|Overall Study|Subject Non-compliant|5|||
147391384|NCT00714688|531594871|FG000|Overall Study|Ineligible to Continue the Study|0|||
147391385|NCT00714688|531594872|FG001|Overall Study|Ineligible to Continue the Study|1|||
147391386|NCT00714688|531594873|FG002|Overall Study|Ineligible to Continue the Study|1|||
147391387|NCT00714688|531594871|FG000|Overall Study|Sponsor's Decision|0|||
147391388|NCT00714688|531594872|FG001|Overall Study|Sponsor's Decision|2|||
147391389|NCT00714688|531594873|FG002|Overall Study|Sponsor's Decision|0|||
147391390|NCT00714688|531594871|FG000|Overall Study|Other|1|||
147391391|NCT00714688|531594872|FG001|Overall Study|Other|6|||
147391392|NCT00714688|531594873|FG002|Overall Study|Other|5|||
147391393|NCT01123642|531594874|FG000|Overall Study|Lost to Follow-up|23|||
147391394|NCT01123642|531594874|FG000|Overall Study|Withdrawal by Subject|9|||
147391395|NCT01123642|531594874|FG000|Overall Study|ineligible at baseline assessment|36|||
147391396|NCT00651937|531596486|FG000|Overall Study|Withdrawal by Subject|4|||
147391397|NCT00651937|531596487|FG001|Overall Study|Withdrawal by Subject|1|||
147391398|NCT00848393|531596494|FG000|Overall Study|Protocol Violation|0|||
147391399|NCT00848393|531596495|FG001|Overall Study|Protocol Violation|0|||
147391400|NCT00848393|531596496|FG002|Overall Study|Protocol Violation|1|||
147391401|NCT00848393|531596494|FG000|Overall Study|surgical complications unrelated to stud|0|||
147391402|NCT00848393|531596495|FG001|Overall Study|surgical complications unrelated to stud|0|||
147391403|NCT00848393|531596496|FG002|Overall Study|surgical complications unrelated to stud|2|||
147391404|NCT00443898|531596501|FG000|Overall Study|Adverse Event|0|||
147391405|NCT00443898|531596502|FG001|Overall Study|Adverse Event|0|||
147391406|NCT00443898|531596503|FG002|Overall Study|Adverse Event|1|||
147391407|NCT00443898|531596504|FG003|Overall Study|Adverse Event|1|||
147391408|NCT00443898|531596501|FG000|Overall Study|Lack of Efficacy|2|||
147391409|NCT00443898|531596502|FG001|Overall Study|Lack of Efficacy|3|||
147391410|NCT00443898|531596503|FG002|Overall Study|Lack of Efficacy|3|||
147391411|NCT00443898|531596504|FG003|Overall Study|Lack of Efficacy|1|||
147391412|NCT00443898|531596501|FG000|Overall Study|Protocol Violation|1|||
147391413|NCT00443898|531596502|FG001|Overall Study|Protocol Violation|1|||
147391414|NCT00443898|531596503|FG002|Overall Study|Protocol Violation|1|||
147391415|NCT00443898|531596504|FG003|Overall Study|Protocol Violation|0|||
147391416|NCT00443898|531596501|FG000|Overall Study|Withdrawal by Subject|11|||
147391417|NCT00443898|531596502|FG001|Overall Study|Withdrawal by Subject|10|||
147391418|NCT00443898|531596503|FG002|Overall Study|Withdrawal by Subject|10|||
147391419|NCT00443898|531596504|FG003|Overall Study|Withdrawal by Subject|6|||
147391420|NCT00443898|531596501|FG000|Overall Study|Lost to Follow-up|10|||
147391421|NCT00443898|531596502|FG001|Overall Study|Lost to Follow-up|10|||
147391422|NCT00443898|531596503|FG002|Overall Study|Lost to Follow-up|14|||
147459206|NCT03502330|531842708|FG005|Overall Study|Death|0|||
147459207|NCT03502330|531842709|FG006|Overall Study|Death|2|||
147459208|NCT03502330|531842710|FG007|Overall Study|Death|0|||
147459209|NCT03502330|531842711|FG008|Overall Study|Death|0|||
147459210|NCT02472847|531842720|FG000|Overall Study|Withdrawal by Subject|1|||
147459211|NCT02472847|531842721|FG001|Overall Study|Withdrawal by Subject|5|||
147459212|NCT01276821|531842725|FG000|Overall Study|Protocol Violation|0|||
147459213|NCT01276821|531842726|FG001|Overall Study|Protocol Violation|1|||
147459214|NCT01748071|531842729|FG000|Overall Study|Adverse Event|2|||
147459215|NCT01748071|531842730|FG001|Overall Study|Adverse Event|2|||
147459216|NCT01748071|531842731|FG002|Overall Study|Adverse Event|0|||
147459217|NCT03068325|531842732|FG000|Overall Study|Lost to Follow-up|5|||
147459218|NCT00066690|531842733|FG000|Overall Study|Adverse Event|145|||
147459219|NCT00066690|531842734|FG001|Overall Study|Adverse Event|58|||
147459220|NCT00066690|531842735|FG002|Overall Study|Adverse Event|126|||
147459221|NCT00066690|531842733|FG000|Overall Study|Death|3|||
147459222|NCT00066690|531842734|FG001|Overall Study|Death|0|||
147459223|NCT00066690|531842735|FG002|Overall Study|Death|2|||
147459224|NCT00066690|531842733|FG000|Overall Study|Lack of Efficacy|114|||
147459225|NCT00066690|531842734|FG001|Overall Study|Lack of Efficacy|110|||
147459226|NCT00066690|531842735|FG002|Overall Study|Lack of Efficacy|76|||
147459227|NCT00066690|531842733|FG000|Overall Study|Lost to Follow-up|40|||
147459228|NCT00066690|531842734|FG001|Overall Study|Lost to Follow-up|21|||
147459229|NCT00066690|531842735|FG002|Overall Study|Lost to Follow-up|29|||
147459230|NCT00066690|531842733|FG000|Overall Study|Withdrawal by Subject|50|||
147459231|NCT00066690|531842734|FG001|Overall Study|Withdrawal by Subject|55|||
147459232|NCT00066690|531842735|FG002|Overall Study|Withdrawal by Subject|49|||
147459233|NCT00066690|531842733|FG000|Overall Study|Treatment Ongoing|246|||
147459234|NCT00066690|531842734|FG001|Overall Study|Treatment Ongoing|278|||
147459235|NCT00066690|531842735|FG002|Overall Study|Treatment Ongoing|282|||
147459236|NCT00272987|531842738|FG000|Overall Study|Adverse Event|1|||
147459237|NCT00272987|531842739|FG001|Overall Study|Adverse Event|0|||
147459238|NCT00272987|531842740|FG002|Overall Study|Adverse Event|0|||
147459239|NCT00272987|531842738|FG000|Overall Study|Lost to Follow-up|3|||
147459240|NCT00272987|531842739|FG001|Overall Study|Lost to Follow-up|1|||
147459241|NCT00272987|531842740|FG002|Overall Study|Lost to Follow-up|1|||
147459242|NCT00272987|531842738|FG000|Overall Study|Withdrawal by Subject|1|||
147459243|NCT00272987|531842739|FG001|Overall Study|Withdrawal by Subject|0|||
147459244|NCT00272987|531842740|FG002|Overall Study|Withdrawal by Subject|3|||
147459245|NCT00272987|531842738|FG000|Overall Study|Sponsor Terminated study|0|||
147459246|NCT00272987|531842739|FG001|Overall Study|Sponsor Terminated study|1|||
147459247|NCT00272987|531842740|FG002|Overall Study|Sponsor Terminated study|1|||
147459248|NCT00272987|531842738|FG000|Overall Study|Disease progression|1|||
147459249|NCT00272987|531842739|FG001|Overall Study|Disease progression|1|||
147459250|NCT00272987|531842740|FG002|Overall Study|Disease progression|2|||
147459251|NCT00272987|531842738|FG000|Overall Study|Non-compliant- study visits, trtmnts, req. surgery|2|||
147459252|NCT00272987|531842739|FG001|Overall Study|Non-compliant- study visits, trtmnts, req. surgery|1|||
147664988|NCT01130272|532597976|FG000|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|0|||
147664989|NCT01130272|532597977|FG001|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|0|||
147391423|NCT00443898|531596504|FG003|Overall Study|Lost to Follow-up|10|||
147391424|NCT00443898|531596501|FG000|Overall Study|Death|0|||
147391425|NCT00443898|531596502|FG001|Overall Study|Death|1|||
147459253|NCT00272987|531842740|FG002|Overall Study|Non-compliant- study visits, trtmnts, req. surgery|4|||
147664990|NCT01130272|532597978|FG002|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|0|||
147459254|NCT00272987|531842738|FG000|Overall Study|Death|1|||
147459255|NCT00272987|531842739|FG001|Overall Study|Death|0|||
147391426|NCT00443898|531596503|FG002|Overall Study|Death|0|||
147391427|NCT00443898|531596504|FG003|Overall Study|Death|0|||
147391428|NCT00755716|531596507|FG000|Overall Study|Adverse Event|1|||
147391429|NCT00755716|531596508|FG001|Overall Study|Adverse Event|4|||
147391430|NCT00755716|531596509|FG002|Overall Study|Adverse Event|1|||
147459256|NCT00272987|531842740|FG002|Overall Study|Death|0|||
147459257|NCT03555266|531842745|FG000|Overall Study|Protocol Violation|6|||
147459258|NCT03555266|531842746|FG001|Overall Study|Protocol Violation|4|||
147459259|NCT03370770|531842750|FG000|Overall Study|Patient was followed in another hospital center|1|||
147459260|NCT03370770|531842750|FG000|Overall Study|Progressive Disease|98|||
147459261|NCT03370770|531842750|FG000|Overall Study|Adverse Event|2|||
147459262|NCT03370770|531842750|FG000|Overall Study|Death|5|||
147459263|NCT02167945|531842751|FG000|Overall Study|Adverse Event|16|||
147459264|NCT02167945|531842751|FG000|Overall Study|Withdrew Consent|42|||
147459265|NCT02167945|531842751|FG000|Overall Study|Lost to Follow-up|122|||
147459266|NCT02167945|531842751|FG000|Overall Study|COVID-19 logistical restrictions|6|||
147459267|NCT02167945|531842751|FG000|Overall Study|Other, not specified|63|||
147459268|NCT00132730|531842752|FG000|Period II - 12-week Treatment (Base)|Clinical adverse experience|11|||
147459269|NCT00132730|531842753|FG001|Period II - 12-week Treatment (Base)|Clinical adverse experience|4|||
147459270|NCT00132730|531842754|FG002|Period II - 12-week Treatment (Base)|Clinical adverse experience|9|||
147459271|NCT00132730|531842755|FG003|Period II - 12-week Treatment (Base)|Clinical adverse experience|9|||
147459272|NCT00132730|531842756|FG004|Period II - 12-week Treatment (Base)|Clinical adverse experience|0|||
147459273|NCT00132730|531842757|FG005|Period II - 12-week Treatment (Base)|Clinical adverse experience|0|||
147459274|NCT00132730|531842752|FG000|Period II - 12-week Treatment (Base)|Laboratory adverse experience|1|||
147459275|NCT00132730|531842753|FG001|Period II - 12-week Treatment (Base)|Laboratory adverse experience|1|||
147459276|NCT00132730|531842754|FG002|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0|||
147459277|NCT00132730|531842755|FG003|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0|||
147459278|NCT00132730|531842756|FG004|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0|||
147459279|NCT00132730|531842757|FG005|Period II - 12-week Treatment (Base)|Laboratory adverse experience|0|||
147459280|NCT00132730|531842752|FG000|Period II - 12-week Treatment (Base)|Other reasons|11|||
147459281|NCT00132730|531842753|FG001|Period II - 12-week Treatment (Base)|Other reasons|10|||
147459282|NCT00132730|531842754|FG002|Period II - 12-week Treatment (Base)|Other reasons|9|||
147459283|NCT00132730|531842755|FG003|Period II - 12-week Treatment (Base)|Other reasons|13|||
147459284|NCT00132730|531842756|FG004|Period II - 12-week Treatment (Base)|Other reasons|0|||
147459285|NCT00132730|531842757|FG005|Period II - 12-week Treatment (Base)|Other reasons|0|||
147459286|NCT00132730|531842752|FG000|Period III - Blinded Extension (EXT1)|Site terminated|0|||
147459287|NCT00132730|531842753|FG001|Period III - Blinded Extension (EXT1)|Site terminated|0|||
147459288|NCT00132730|531842754|FG002|Period III - Blinded Extension (EXT1)|Site terminated|57|||
147459289|NCT00132730|531842755|FG003|Period III - Blinded Extension (EXT1)|Site terminated|20|||
147459290|NCT00132730|531842756|FG004|Period III - Blinded Extension (EXT1)|Site terminated|0|||
147459291|NCT00132730|531842757|FG005|Period III - Blinded Extension (EXT1)|Site terminated|0|||
147459292|NCT00132730|531842752|FG000|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0|||
147459293|NCT00132730|531842753|FG001|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0|||
147459294|NCT00132730|531842754|FG002|Period III - Blinded Extension (EXT1)|Clinical adverse experience|11|||
147459295|NCT00132730|531842755|FG003|Period III - Blinded Extension (EXT1)|Clinical adverse experience|1|||
147459296|NCT00132730|531842756|FG004|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0|||
147459297|NCT00132730|531842757|FG005|Period III - Blinded Extension (EXT1)|Clinical adverse experience|0|||
147459298|NCT00132730|531842752|FG000|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0|||
147459299|NCT00132730|531842753|FG001|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0|||
147459300|NCT00132730|531842754|FG002|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0|||
147459301|NCT00132730|531842755|FG003|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|1|||
147459302|NCT00132730|531842756|FG004|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0|||
147459303|NCT00132730|531842757|FG005|Period III - Blinded Extension (EXT1)|Laboratory adverse experience|0|||
147459304|NCT00132730|531842752|FG000|Period III - Blinded Extension (EXT1)|Other reasons|0|||
147459305|NCT00132730|531842753|FG001|Period III - Blinded Extension (EXT1)|Other reasons|0|||
147459306|NCT00132730|531842754|FG002|Period III - Blinded Extension (EXT1)|Other reasons|14|||
147459307|NCT00132730|531842755|FG003|Period III - Blinded Extension (EXT1)|Other reasons|3|||
147664991|NCT01130272|532597979|FG003|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|1|||
147664992|NCT01130272|532597980|FG004|Overall Study|Lack of efficacy-uncontrolled IBS-d pain|0|||
147664993|NCT01130272|532597976|FG000|Overall Study|Protocol Violation|0|||
147664994|NCT01130272|532597977|FG001|Overall Study|Protocol Violation|0|||
147664995|NCT01130272|532597978|FG002|Overall Study|Protocol Violation|3|||
147664996|NCT01130272|532597979|FG003|Overall Study|Protocol Violation|5|||
147664997|NCT01130272|532597980|FG004|Overall Study|Protocol Violation|5|||
147664998|NCT01130272|532597976|FG000|Overall Study|Lost to Follow-up|4|||
147664999|NCT01130272|532597977|FG001|Overall Study|Lost to Follow-up|3|||
147665000|NCT01130272|532597978|FG002|Overall Study|Lost to Follow-up|4|||
147665001|NCT01130272|532597979|FG003|Overall Study|Lost to Follow-up|7|||
147665002|NCT01130272|532597980|FG004|Overall Study|Lost to Follow-up|6|||
147665003|NCT01130272|532597976|FG000|Overall Study|Withdrawal by Subject|4|||
147665004|NCT01130272|532597977|FG001|Overall Study|Withdrawal by Subject|11|||
147665005|NCT01130272|532597978|FG002|Overall Study|Withdrawal by Subject|10|||
147665006|NCT01130272|532597979|FG003|Overall Study|Withdrawal by Subject|9|||
147665007|NCT01130272|532597980|FG004|Overall Study|Withdrawal by Subject|8|||
147459308|NCT00132730|531842756|FG004|Period III - Blinded Extension (EXT1)|Other reasons|0|||
147459309|NCT00132730|531842757|FG005|Period III - Blinded Extension (EXT1)|Other reasons|0|||
147665008|NCT01130272|532597976|FG000|Overall Study|Physician Decision|1|||
147665009|NCT01130272|532597977|FG001|Overall Study|Physician Decision|1|||
147391431|NCT00755716|531596507|FG000|Overall Study|Lack of Efficacy|2|||
147391432|NCT00755716|531596508|FG001|Overall Study|Lack of Efficacy|0|||
147391433|NCT00755716|531596509|FG002|Overall Study|Lack of Efficacy|0|||
147391434|NCT00755716|531596507|FG000|Overall Study|Lost to Follow-up|5|||
147391435|NCT00755716|531596508|FG001|Overall Study|Lost to Follow-up|3|||
147391436|NCT00755716|531596509|FG002|Overall Study|Lost to Follow-up|1|||
147391437|NCT00755716|531596507|FG000|Overall Study|work schedule issues|0|||
147391438|NCT00755716|531596508|FG001|Overall Study|work schedule issues|1|||
147391439|NCT00755716|531596509|FG002|Overall Study|work schedule issues|1|||
147391440|NCT03681353|531596510|FG000|Overall Study|Lost to Follow-up|2|||
147391441|NCT03681353|531596510|FG000|Overall Study|Withdrawal by Subject|3|||
147391442|NCT03681353|531596510|FG000|Overall Study|withdrawn by PI|2|||
147391443|NCT00726388|531596511|FG000|Overall Study|Withdrawal by Subject|5|||
147391444|NCT00726388|531596511|FG000|Overall Study|Adverse Event|3|||
147391445|NCT00726388|531596511|FG000|Overall Study|Lost to Follow-up|10|||
147391446|NCT00726388|531596511|FG000|Overall Study|Participants Non-compliant With Study Procedures|5|||
147391447|NCT00726388|531596511|FG000|Overall Study|Other|5|||
147391448|NCT00726388|531596511|FG000|Overall Study|Enrolled, Not Treated|79|||
147391449|NCT00382408|531596515|FG000|Overall Study|Did not meet protocol requirement|3|||
147391450|NCT00382408|531596516|FG001|Overall Study|Did not meet protocol requirement|3|||
147391451|NCT00382408|531596515|FG000|Overall Study|Protocol Violation|2|||
147391452|NCT00382408|531596516|FG001|Overall Study|Protocol Violation|2|||
147391453|NCT00382408|531596515|FG000|Overall Study|Physician Decision|1|||
147391454|NCT00382408|531596516|FG001|Overall Study|Physician Decision|0|||
147391455|NCT00382408|531596515|FG000|Overall Study|Withdrawal by Subject|17|||
147391456|NCT00382408|531596516|FG001|Overall Study|Withdrawal by Subject|6|||
147391457|NCT00382408|531596515|FG000|Overall Study|Pregnancy|2|||
147391458|NCT00382408|531596516|FG001|Overall Study|Pregnancy|0|||
147391459|NCT00382408|531596515|FG000|Overall Study|Lost to Follow-up|19|||
147391460|NCT00382408|531596516|FG001|Overall Study|Lost to Follow-up|8|||
147391461|NCT00382408|531596515|FG000|Overall Study|Other|100|||
147391462|NCT00382408|531596516|FG001|Overall Study|Other|35|||
147391463|NCT00917462|531596517|FG000|Overall Study|Clinical Deterioration|1|||
147391464|NCT03341312|531596524|FG000|Period 1|Withdrawal by Subject|0|||
147391465|NCT03341312|531596525|FG001|Period 1|Withdrawal by Subject|1|||
147391466|NCT03341312|531596526|FG002|Period 1|Withdrawal by Subject|0|||
147391467|NCT03341312|531596527|FG003|Period 1|Withdrawal by Subject|0|||
147391468|NCT01812707|531596528|FG000|Overall Study|Adverse Event|0|||
147391469|NCT01812707|531596529|FG001|Overall Study|Adverse Event|0|||
147391470|NCT01812707|531596530|FG002|Overall Study|Adverse Event|0|||
147391471|NCT01812707|531596531|FG003|Overall Study|Adverse Event|2|||
147391472|NCT01812707|531596528|FG000|Overall Study|Poor compliance to protocol|1|||
147391473|NCT01812707|531596529|FG001|Overall Study|Poor compliance to protocol|0|||
147391474|NCT01812707|531596530|FG002|Overall Study|Poor compliance to protocol|0|||
147391475|NCT01812707|531596531|FG003|Overall Study|Poor compliance to protocol|0|||
147391476|NCT01812707|531596528|FG000|Overall Study|Consent withdrawn by participant|1|||
147391477|NCT01812707|531596529|FG001|Overall Study|Consent withdrawn by participant|0|||
147391478|NCT01812707|531596530|FG002|Overall Study|Consent withdrawn by participant|0|||
147391479|NCT01812707|531596531|FG003|Overall Study|Consent withdrawn by participant|0|||
147391480|NCT01631825|531596532|FG000|Overall Study|Adverse Event|42|||
147391481|NCT01631825|531596532|FG000|Overall Study|Lack of Efficacy|7|||
147391482|NCT01631825|531596532|FG000|Overall Study|Withdrawal by Subject|9|||
147391483|NCT01631825|531596532|FG000|Overall Study|Protocol Violation|4|||
147391484|NCT01631825|531596532|FG000|Overall Study|Discontinuation criteria|1|||
147391485|NCT01631825|531596532|FG000|Overall Study|Physician Decision|2|||
147391486|NCT03568708|531596534|FG000|Overall Study|Withdrawal by Subject|1|||
147391487|NCT03568708|531596535|FG001|Overall Study|Withdrawal by Subject|1|||
147391488|NCT03568708|531596534|FG000|Overall Study|Lost to Follow-up|0|||
147391489|NCT03568708|531596535|FG001|Overall Study|Lost to Follow-up|1|||
147391490|NCT00511147|531596538|FG000|Overall Study|Withdrawal by Subject|1|||
147391491|NCT00511147|531596538|FG000|Overall Study|Disease progression|5|||
147391492|NCT00511147|531596538|FG000|Overall Study|Required platelet transfusion|1|||
147391493|NCT00809783|531596539|FG000|Overall Study|Death|1|||
147391494|NCT00809783|531596540|FG001|Overall Study|Death|0|||
147459310|NCT00132730|531842752|FG000|Period IV - Open-label Extension (EXT2)|Site terminated|0|||
147391495|NCT00809783|531596541|FG002|Overall Study|Death|0|||
147391496|NCT00809783|531596539|FG000|Overall Study|Adverse Event|34|||
147391497|NCT00809783|531596540|FG001|Overall Study|Adverse Event|52|||
147391498|NCT00809783|531596541|FG002|Overall Study|Adverse Event|71|||
147391499|NCT00809783|531596539|FG000|Overall Study|Lack of Efficacy|39|||
147391500|NCT00809783|531596540|FG001|Overall Study|Lack of Efficacy|52|||
147391501|NCT00809783|531596541|FG002|Overall Study|Lack of Efficacy|63|||
147391502|NCT00809783|531596539|FG000|Overall Study|Lost to Follow-up|0|||
147391503|NCT00809783|531596540|FG001|Overall Study|Lost to Follow-up|3|||
147391504|NCT00809783|531596541|FG002|Overall Study|Lost to Follow-up|4|||
147391505|NCT00809783|531596539|FG000|Overall Study|Withdrawal by Subject|47|||
147391506|NCT00809783|531596540|FG001|Overall Study|Withdrawal by Subject|72|||
147391507|NCT00809783|531596541|FG002|Overall Study|Withdrawal by Subject|64|||
147391508|NCT00809783|531596539|FG000|Overall Study|Protocol Violation|2|||
147391509|NCT00809783|531596540|FG001|Overall Study|Protocol Violation|6|||
147391510|NCT00809783|531596541|FG002|Overall Study|Protocol Violation|5|||
147391511|NCT00809783|531596539|FG000|Overall Study|Randomized, but not treated|3|||
147391512|NCT00809783|531596540|FG001|Overall Study|Randomized, but not treated|0|||
147391513|NCT00809783|531596541|FG002|Overall Study|Randomized, but not treated|2|||
147391514|NCT00809783|531596539|FG000|Overall Study|Study Terminated by Sponsor|378|||
147391515|NCT00809783|531596540|FG001|Overall Study|Study Terminated by Sponsor|626|||
147391516|NCT00809783|531596541|FG002|Overall Study|Study Terminated by Sponsor|565|||
147391517|NCT00809783|531596539|FG000|Overall Study|Other|21|||
147391518|NCT00809783|531596540|FG001|Overall Study|Other|21|||
147391519|NCT00809783|531596541|FG002|Overall Study|Other|16|||
147391520|NCT05372913|531596551|FG000|Overall Study|Withdrawal by Subject|0|||
147391521|NCT05372913|531596552|FG001|Overall Study|Withdrawal by Subject|2|||
147391522|NCT05372913|531596551|FG000|Overall Study|Protocol Violation|2|||
147391523|NCT05372913|531596552|FG001|Overall Study|Protocol Violation|2|||
147391524|NCT05372913|531596551|FG000|Overall Study|Adverse Event|0|||
147391525|NCT05372913|531596552|FG001|Overall Study|Adverse Event|1|||
147391526|NCT03193216|531596553|FG000|Overall Study|Lost to Follow-up|1|||
147391527|NCT03193216|531596554|FG001|Overall Study|Lost to Follow-up|0|||
147391528|NCT03193216|531596553|FG000|Overall Study|Withdrawal by Subject|5|||
147391529|NCT03193216|531596554|FG001|Overall Study|Withdrawal by Subject|0|||
147391530|NCT03193216|531596553|FG000|Overall Study|Physician Decision|4|||
147391531|NCT03193216|531596554|FG001|Overall Study|Physician Decision|0|||
147391532|NCT03275402|531596555|FG000|Overall Study|Death|17|||
147391533|NCT03275402|531596555|FG000|Overall Study|Study terminated by sponsor|21|||
147391534|NCT03275402|531596555|FG000|Overall Study|Withdrawal by Subject|1|||
147391535|NCT01514864|531596556|FG000|Overall Study|Disease progression|7|||
147391536|NCT01514864|531596557|FG001|Overall Study|Disease progression|5|||
147391537|NCT01514864|531596556|FG000|Overall Study|Study drug toxicity|2|||
147391538|NCT01514864|531596557|FG001|Overall Study|Study drug toxicity|0|||
147391539|NCT05135156|531596558|FG000|Overall Study|Lost to Follow-up|0|||
147391540|NCT05135156|531596559|FG001|Overall Study|Lost to Follow-up|0|||
147391541|NCT05135156|531596560|FG002|Overall Study|Lost to Follow-up|2|||
147391542|NCT02986659|531596561|FG000|First Intervention Period|Adverse Event|3|||
147391543|NCT02986659|531596562|FG001|First Intervention Period|Adverse Event|1|||
147391544|NCT02986659|531596561|FG000|First Intervention Period|Lost to Follow-up|1|||
147391545|NCT02986659|531596562|FG001|First Intervention Period|Lost to Follow-up|0|||
147391546|NCT02986659|531596561|FG000|First Intervention Period|Withdrawal by Subject|0|||
147391547|NCT02986659|531596562|FG001|First Intervention Period|Withdrawal by Subject|1|||
147391548|NCT02986659|531596561|FG000|Second Intervention Period|Adverse Event|0|||
147391549|NCT02986659|531596562|FG001|Second Intervention Period|Adverse Event|6|||
147391550|NCT02254681|531596568|FG000|Overall Study|Lack of Efficacy|6|||
147391551|NCT02469077|531596569|FG000|Post Randomization/Intervention Period|Scheduling issues|3|||
147391552|NCT02469077|531596570|FG001|Post Randomization/Intervention Period|Scheduling issues|2|||
147391553|NCT02469077|531596569|FG000|Post Randomization/Intervention Period|Relocated|1|||
147391554|NCT02469077|531596570|FG001|Post Randomization/Intervention Period|Relocated|1|||
147391555|NCT02469077|531596569|FG000|Post Randomization/Intervention Period|Conflicting health issues|0|||
147391556|NCT02469077|531596570|FG001|Post Randomization/Intervention Period|Conflicting health issues|1|||
147391557|NCT02469077|531596569|FG000|Post Intervention /Followup|Withdrawal by Subject|2|||
147391558|NCT02469077|531596570|FG001|Post Intervention /Followup|Withdrawal by Subject|1|||
147391559|NCT01059526|531596571|FG000|Overall Study|Patient enrolled but not treated|20|||
147391560|NCT01059526|531596572|FG001|Overall Study|Patient enrolled but not treated|17|||
147391561|NCT01059526|531596571|FG000|Overall Study|Adverse Event|2|||
147391562|NCT01059526|531596572|FG001|Overall Study|Adverse Event|2|||
147391563|NCT01059526|531596571|FG000|Overall Study|Protocol Violation|0|||
147391564|NCT01059526|531596572|FG001|Overall Study|Protocol Violation|1|||
147391565|NCT01059526|531596571|FG000|Overall Study|Withdrawal by Subject|3|||
147391566|NCT01059526|531596572|FG001|Overall Study|Withdrawal by Subject|1|||
147391567|NCT01059526|531596571|FG000|Overall Study|Lost to Follow-up|4|||
147391568|NCT01059526|531596572|FG001|Overall Study|Lost to Follow-up|1|||
147391569|NCT01059526|531596571|FG000|Overall Study|Patient found to be dermatographic|1|||
147391570|NCT01059526|531596572|FG001|Overall Study|Patient found to be dermatographic|0|||
147391571|NCT01732588|531596573|FG000|First Intervention (7 Days)|Adverse Event|0|||
147665010|NCT01130272|532597978|FG002|Overall Study|Physician Decision|0|||
147391572|NCT01732588|531596574|FG001|First Intervention (7 Days)|Adverse Event|1|||
147391573|NCT01732588|531596575|FG002|First Intervention (7 Days)|Adverse Event|0|||
147391574|NCT02005029|531596576|FG000|First Intervention (1 Day)|participant withdrawn for noncompliance|1|||
147391575|NCT02005029|531596577|FG001|First Intervention (1 Day)|participant withdrawn for noncompliance|0|||
147391576|NCT02621047|531596578|FG000|Overall Study|Adverse Event|0|||
147391577|NCT02621047|531596579|FG001|Overall Study|Adverse Event|0|||
147391578|NCT02621047|531596580|FG002|Overall Study|Adverse Event|1|||
147391579|NCT04748445|531596587|FG000|Overall Study|No longer met eligibility criteria|12|||
147391580|NCT04748445|531596587|FG000|Overall Study|Other|36|||
147391581|NCT04748445|531596587|FG000|Overall Study|Withdrawal by Subject|553|||
147391582|NCT04748445|531596587|FG000|Overall Study|Lost to Follow-up|30|||
147391583|NCT00139659|531596590|FG000|Overall Study|Adverse Event|12|||
147391584|NCT00139659|531596591|FG001|Overall Study|Adverse Event|1|||
147391585|NCT00139659|531596590|FG000|Overall Study|Lack of Efficacy|1|||
147391586|NCT00139659|531596591|FG001|Overall Study|Lack of Efficacy|1|||
147391587|NCT00139659|531596590|FG000|Overall Study|Lost to Follow-up|7|||
147391588|NCT00139659|531596591|FG001|Overall Study|Lost to Follow-up|3|||
147391589|NCT00139659|531596590|FG000|Overall Study|Reason not Specified|6|||
147391590|NCT00139659|531596591|FG001|Overall Study|Reason not Specified|3|||
147391591|NCT00139659|531596590|FG000|Overall Study|Withdrawal by Subject|14|||
147391592|NCT00139659|531596591|FG001|Overall Study|Withdrawal by Subject|10|||
147391593|NCT04089332|531596621|FG000|Overall Study|COVID-19 Pandemic safety issues|6|||
147391594|NCT04089332|531596621|FG000|Overall Study|Moved in the MRI, no analysis possible|1|||
147391595|NCT04089332|531596621|FG000|Overall Study|Completed only OGTT, no analysis possible|1|||
147391596|NCT06016127|531596626|FG000|Overall Study|Withdrawal by Subject|4|||
147391597|NCT06016127|531596627|FG001|Overall Study|Withdrawal by Subject|3|||
147391598|NCT00734851|531596630|FG000|Overall Study|Withdrawal by Subject|2|||
147391599|NCT00734851|531596630|FG000|Overall Study|Lost to Follow-up|1|||
147391600|NCT00734851|531596630|FG000|Overall Study|Physician Decision|18|||
147391601|NCT01524887|531596631|FG000|Overall Study|Withdrawal by Subject|6|||
147391602|NCT01524887|531596632|FG001|Overall Study|Withdrawal by Subject|2|||
147391603|NCT01524887|531596633|FG002|Overall Study|Withdrawal by Subject|3|||
147391604|NCT01524887|531596631|FG000|Overall Study|Adverse Event|5|||
147391605|NCT01524887|531596632|FG001|Overall Study|Adverse Event|1|||
147391606|NCT01524887|531596633|FG002|Overall Study|Adverse Event|1|||
147391607|NCT01524887|531596631|FG000|Overall Study|Protocol Violation|0|||
147391608|NCT01524887|531596632|FG001|Overall Study|Protocol Violation|0|||
147391609|NCT01524887|531596633|FG002|Overall Study|Protocol Violation|1|||
147391610|NCT01524887|531596631|FG000|Overall Study|Study termination|73|||
147391611|NCT01524887|531596632|FG001|Overall Study|Study termination|87|||
147391612|NCT01524887|531596633|FG002|Overall Study|Study termination|79|||
147391613|NCT01524887|531596631|FG000|Overall Study|Withdrawal by Caregiver|0|||
147391614|NCT01524887|531596632|FG001|Overall Study|Withdrawal by Caregiver|0|||
147391615|NCT01524887|531596633|FG002|Overall Study|Withdrawal by Caregiver|2|||
147391616|NCT01524887|531596631|FG000|Overall Study|Use of prohibited medication|1|||
147391617|NCT01524887|531596632|FG001|Overall Study|Use of prohibited medication|0|||
147391618|NCT01524887|531596633|FG002|Overall Study|Use of prohibited medication|0|||
147391619|NCT00170950|531596634|FG000|Overall Study|Death|236|||
147391620|NCT00170950|531596635|FG001|Overall Study|Death|274|||
147391621|NCT00170950|531596634|FG000|Overall Study|Withdrawal by Subject|496|||
147391622|NCT00170950|531596635|FG001|Overall Study|Withdrawal by Subject|498|||
147391623|NCT00170950|531596634|FG000|Overall Study|Lost to Follow-up|134|||
147391624|NCT00170950|531596635|FG001|Overall Study|Lost to Follow-up|115|||
147391625|NCT00170950|531596634|FG000|Overall Study|Missing|2|||
147391626|NCT00170950|531596635|FG001|Overall Study|Missing|1|||
147391627|NCT00170950|531596634|FG000|Overall Study|Termination Data Not Recorded|17|||
147391628|NCT00170950|531596635|FG001|Overall Study|Termination Data Not Recorded|22|||
147391629|NCT00497198|531596640|FG000|Overall Study|Adverse Event|4|||
147391630|NCT00497198|531596641|FG001|Overall Study|Adverse Event|2|||
147391631|NCT00497198|531596640|FG000|Overall Study|Physician Decision|1|||
147391632|NCT00497198|531596641|FG001|Overall Study|Physician Decision|2|||
147391633|NCT00497198|531596640|FG000|Overall Study|Withdrawal by Subject|0|||
147391634|NCT00497198|531596641|FG001|Overall Study|Withdrawal by Subject|1|||
147391635|NCT01816685|531598571|FG000|Overall Study|Lost to Follow-up|7|||
147391636|NCT01816685|531598572|FG001|Overall Study|Lost to Follow-up|9|||
147391637|NCT01816685|531598571|FG000|Overall Study|Surgery Cancelled|3|||
147391638|NCT01816685|531598572|FG001|Overall Study|Surgery Cancelled|2|||
147391639|NCT02720185|531598573|FG000|Overall Study|Lost to Follow-up|1|||
147391640|NCT00381888|531598574|FG000|Overall Study|Death|1|||
147391641|NCT00381888|531598574|FG000|Overall Study|Withdrawal by Subject|1|||
147391642|NCT00381888|531598574|FG000|Overall Study|Physician Decision|1|||
147391643|NCT00381888|531598574|FG000|Overall Study|Protocol Violation|9|||
147391644|NCT00381888|531598574|FG000|Overall Study|Had laparoscopic surgery|2|||
147391645|NCT00381888|531598574|FG000|Overall Study|Surgery was cancelled|2|||
147391646|NCT00381888|531598574|FG000|Overall Study|Adverse Event|1|||
147391647|NCT01589523|531598577|FG000|Overall Study|Withdrawal by Subject|1|||
147391648|NCT00961896|531598578|FG000|Overall Study|Abnormal laboratory value|0|||
147391649|NCT00961896|531598579|FG001|Overall Study|Abnormal laboratory value|0|||
147391650|NCT00961896|531598580|FG002|Overall Study|Abnormal laboratory value|1|||
147391651|NCT00506922|531598581|FG000|Overall Study|Physician Decision|0|||
147391652|NCT00506922|531598582|FG001|Overall Study|Physician Decision|0|||
147391653|NCT00506922|531598583|FG002|Overall Study|Physician Decision|0|||
147391654|NCT00506922|531598584|FG003|Overall Study|Physician Decision|2|||
147391655|NCT00506922|531598585|FG004|Overall Study|Physician Decision|0|||
147391656|NCT00506922|531598581|FG000|Overall Study|Withdrawal by Subject|0|||
147391657|NCT00506922|531598582|FG001|Overall Study|Withdrawal by Subject|0|||
147391658|NCT00506922|531598583|FG002|Overall Study|Withdrawal by Subject|0|||
147391659|NCT00506922|531598584|FG003|Overall Study|Withdrawal by Subject|0|||
147391660|NCT00506922|531598585|FG004|Overall Study|Withdrawal by Subject|1|||
147459311|NCT00132730|531842753|FG001|Period IV - Open-label Extension (EXT2)|Site terminated|0|||
147459312|NCT00132730|531842754|FG002|Period IV - Open-label Extension (EXT2)|Site terminated|0|||
147459313|NCT00132730|531842755|FG003|Period IV - Open-label Extension (EXT2)|Site terminated|0|||
147459314|NCT00132730|531842756|FG004|Period IV - Open-label Extension (EXT2)|Site terminated|169|||
147459315|NCT00132730|531842757|FG005|Period IV - Open-label Extension (EXT2)|Site terminated|68|||
147459316|NCT00132730|531842752|FG000|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0|||
147459317|NCT00132730|531842753|FG001|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0|||
147459318|NCT00132730|531842754|FG002|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0|||
147459319|NCT00132730|531842755|FG003|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0|||
147459320|NCT00132730|531842756|FG004|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|3|||
147459321|NCT00132730|531842757|FG005|Period IV - Open-label Extension (EXT2)|Clinical adverse experience|0|||
147459322|NCT00132730|531842752|FG000|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0|||
147459323|NCT00132730|531842753|FG001|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0|||
147459324|NCT00132730|531842754|FG002|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0|||
147459325|NCT00132730|531842755|FG003|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0|||
147459326|NCT00132730|531842756|FG004|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|1|||
147459327|NCT00132730|531842757|FG005|Period IV - Open-label Extension (EXT2)|Laboratory adverse experience|0|||
147459328|NCT00132730|531842752|FG000|Period IV - Open-label Extension (EXT2)|Other reasons|0|||
147459329|NCT00132730|531842753|FG001|Period IV - Open-label Extension (EXT2)|Other reasons|0|||
147459330|NCT00132730|531842754|FG002|Period IV - Open-label Extension (EXT2)|Other reasons|0|||
147459331|NCT00132730|531842755|FG003|Period IV - Open-label Extension (EXT2)|Other reasons|0|||
147459332|NCT00132730|531842756|FG004|Period IV - Open-label Extension (EXT2)|Other reasons|6|||
147459333|NCT00132730|531842757|FG005|Period IV - Open-label Extension (EXT2)|Other reasons|0|||
147459334|NCT00132730|531842752|FG000|Period V - Open-label Extension (EXT2)|Site terminated|0|||
147459335|NCT00132730|531842753|FG001|Period V - Open-label Extension (EXT2)|Site terminated|0|||
147459336|NCT00132730|531842754|FG002|Period V - Open-label Extension (EXT2)|Site terminated|0|||
147459337|NCT00132730|531842755|FG003|Period V - Open-label Extension (EXT2)|Site terminated|0|||
147459338|NCT00132730|531842756|FG004|Period V - Open-label Extension (EXT2)|Site terminated|7|||
147459339|NCT00132730|531842757|FG005|Period V - Open-label Extension (EXT2)|Site terminated|2|||
147459340|NCT03072160|531842760|FG000|Overall Study|Adverse Event|3|||
147459341|NCT03072160|531842761|FG001|Overall Study|Adverse Event|1|||
147459342|NCT03072160|531842760|FG000|Overall Study|Refused further treatment|6|||
147459343|NCT03072160|531842761|FG001|Overall Study|Refused further treatment|1|||
147459344|NCT03072160|531842760|FG000|Overall Study|Physician Decision|1|||
147459345|NCT03072160|531842761|FG001|Overall Study|Physician Decision|0|||
147459346|NCT03072160|531842760|FG000|Overall Study|Disease progression on study|1|||
147459347|NCT03072160|531842761|FG001|Overall Study|Disease progression on study|1|||
147459348|NCT03072160|531842760|FG000|Overall Study|No contact|0|||
147459349|NCT03072160|531842761|FG001|Overall Study|No contact|1|||
147459350|NCT00395967|531842762|FG000|Treatment Period|Failed Mobilization|1|||
147459351|NCT00395967|531842762|FG000|Follow-up Period|Death|1|||
147459352|NCT00395967|531842762|FG000|Follow-up Period|Lost to Follow-up|1|||
147459353|NCT01109940|531842763|FG000|Overall Study|Administrative problems|2|||
147459354|NCT01109940|531842764|FG001|Overall Study|Administrative problems|0|||
147459355|NCT01109940|531842765|FG002|Overall Study|Administrative problems|0|||
147459356|NCT01109940|531842766|FG003|Overall Study|Administrative problems|0|||
147459357|NCT01109940|531842763|FG000|Overall Study|Serious Adverse Event|2|||
147459358|NCT01109940|531842764|FG001|Overall Study|Serious Adverse Event|1|||
147459359|NCT01109940|531842765|FG002|Overall Study|Serious Adverse Event|0|||
147459360|NCT01109940|531842766|FG003|Overall Study|Serious Adverse Event|0|||
147459361|NCT01109940|531842763|FG000|Overall Study|Lost to Follow-up|1|||
147459362|NCT01109940|531842764|FG001|Overall Study|Lost to Follow-up|0|||
147459363|NCT01109940|531842765|FG002|Overall Study|Lost to Follow-up|0|||
147459364|NCT01109940|531842766|FG003|Overall Study|Lost to Follow-up|0|||
147459365|NCT01109940|531842763|FG000|Overall Study|Patient withdrew consent|1|||
147459366|NCT01109940|531842764|FG001|Overall Study|Patient withdrew consent|1|||
147459367|NCT01109940|531842765|FG002|Overall Study|Patient withdrew consent|0|||
147459368|NCT01109940|531842766|FG003|Overall Study|Patient withdrew consent|0|||
147459369|NCT01109940|531842763|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
147459370|NCT01109940|531842764|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
147459371|NCT01109940|531842765|FG002|Overall Study|Unsatisfactory therapeutic effect|1|||
147459372|NCT01109940|531842766|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
147459373|NCT00179959|531842767|FG000|Overall Study|Lost to Follow-up|3|||
147459374|NCT00179959|531842768|FG001|Overall Study|Lost to Follow-up|1|||
147459375|NCT00179959|531842767|FG000|Overall Study|Withdrawal by Subject|3|||
147615203|NCT03519087|532406656|FG002|Clinic Evaluation|Protocol Violation|0|||
147615204|NCT03519087|532406657|FG003|Clinic Evaluation|Protocol Violation|0|||
147615205|NCT03519087|532406658|FG004|Clinic Evaluation|Protocol Violation|0|||
147615206|NCT03519087|532406654|FG000|Re-randomization for Treatment|Withdrawal by Subject|25|||
147615207|NCT03519087|532406655|FG001|Re-randomization for Treatment|Withdrawal by Subject|29|||
147391661|NCT00792259|531598586|FG000|Overall Study|Poor Quality Scans|1|||
147391662|NCT00792259|531598587|FG001|Overall Study|Poor Quality Scans|0|||
147391663|NCT00792259|531598588|FG002|Overall Study|Poor Quality Scans|0|||
147391664|NCT00371462|531598589|FG000|Overall Study|Withdrawal by Subject|1|||
147391665|NCT00371462|531598590|FG001|Overall Study|Withdrawal by Subject|0|||
147391666|NCT00371462|531598589|FG000|Overall Study|Other|7|||
147391667|NCT00371462|531598590|FG001|Overall Study|Other|8|||
147391668|NCT03721978|531598591|FG000|Overall Study|Withdrawal by Subject|6|||
147391669|NCT03721978|531598592|FG001|Overall Study|Withdrawal by Subject|1|||
147391670|NCT03721978|531598591|FG000|Overall Study|Adverse Event|1|||
147391671|NCT03721978|531598592|FG001|Overall Study|Adverse Event|1|||
147391672|NCT03721978|531598591|FG000|Overall Study|Progressive Disease|1|||
147391673|NCT03721978|531598592|FG001|Overall Study|Progressive Disease|0|||
147391674|NCT03721978|531598591|FG000|Overall Study|Lost to Follow-up|5|||
147391675|NCT03721978|531598592|FG001|Overall Study|Lost to Follow-up|1|||
147391676|NCT03721978|531598591|FG000|Overall Study|Reason not Specified|0|||
147391677|NCT03721978|531598592|FG001|Overall Study|Reason not Specified|2|||
147391678|NCT05244226|531598593|FG000|Overall Study|Adverse Event|1|||
147391679|NCT05244226|531598594|FG001|Overall Study|Adverse Event|0|||
147391680|NCT05244226|531598595|FG002|Overall Study|Adverse Event|0|||
147391681|NCT05244226|531598593|FG000|Overall Study|Lost to Follow-up|0|||
147391682|NCT05244226|531598594|FG001|Overall Study|Lost to Follow-up|0|||
147391683|NCT05244226|531598595|FG002|Overall Study|Lost to Follow-up|1|||
147391684|NCT05244226|531598593|FG000|Overall Study|Protocol Violation|0|||
147391685|NCT05244226|531598594|FG001|Overall Study|Protocol Violation|2|||
147391686|NCT05244226|531598595|FG002|Overall Study|Protocol Violation|2|||
147391687|NCT02507687|531598603|FG000|Overall Study|Adverse Event|3|||
147391688|NCT02507687|531598604|FG001|Overall Study|Adverse Event|2|||
147391689|NCT02507687|531598605|FG002|Overall Study|Adverse Event|2|||
147391690|NCT02507687|531598606|FG003|Overall Study|Adverse Event|2|||
147391691|NCT02507687|531598603|FG000|Overall Study|Withdrawal by Subject|1|||
147391692|NCT02507687|531598604|FG001|Overall Study|Withdrawal by Subject|4|||
147391693|NCT02507687|531598605|FG002|Overall Study|Withdrawal by Subject|6|||
147391694|NCT02507687|531598606|FG003|Overall Study|Withdrawal by Subject|6|||
147391695|NCT02507687|531598603|FG000|Overall Study|Protocol Violation|1|||
147391696|NCT02507687|531598604|FG001|Overall Study|Protocol Violation|0|||
147391697|NCT02507687|531598605|FG002|Overall Study|Protocol Violation|2|||
147391698|NCT02507687|531598606|FG003|Overall Study|Protocol Violation|0|||
147391699|NCT02507687|531598603|FG000|Overall Study|Lost to Follow-up|0|||
147391700|NCT02507687|531598604|FG001|Overall Study|Lost to Follow-up|0|||
147391701|NCT02507687|531598605|FG002|Overall Study|Lost to Follow-up|2|||
147391702|NCT02507687|531598606|FG003|Overall Study|Lost to Follow-up|1|||
147391703|NCT02507687|531598603|FG000|Overall Study|Screen Failure|0|||
147391704|NCT02507687|531598604|FG001|Overall Study|Screen Failure|0|||
147391705|NCT02507687|531598605|FG002|Overall Study|Screen Failure|1|||
147391706|NCT02507687|531598606|FG003|Overall Study|Screen Failure|0|||
147391707|NCT02507687|531598603|FG000|Overall Study|Other, Not Specified|0|||
147391708|NCT02507687|531598604|FG001|Overall Study|Other, Not Specified|0|||
147391709|NCT02507687|531598605|FG002|Overall Study|Other, Not Specified|2|||
147391710|NCT02507687|531598606|FG003|Overall Study|Other, Not Specified|4|||
147391711|NCT02675998|531598607|FG000|8-Week Treatment Period|Adverse Event|6|||
147391712|NCT02675998|531598608|FG001|8-Week Treatment Period|Adverse Event|5|||
147391713|NCT02675998|531598609|FG002|8-Week Treatment Period|Adverse Event|6|||
147391714|NCT02675998|531598610|FG003|8-Week Treatment Period|Adverse Event|0|||
147391715|NCT02675998|531598607|FG000|8-Week Treatment Period|Withdrawal by Subject|3|||
147391716|NCT02675998|531598608|FG001|8-Week Treatment Period|Withdrawal by Subject|3|||
147391717|NCT02675998|531598609|FG002|8-Week Treatment Period|Withdrawal by Subject|3|||
147391718|NCT02675998|531598610|FG003|8-Week Treatment Period|Withdrawal by Subject|0|||
147391719|NCT02675998|531598607|FG000|8-Week Treatment Period|Lack of Efficacy|2|||
147391720|NCT02675998|531598608|FG001|8-Week Treatment Period|Lack of Efficacy|5|||
147391721|NCT02675998|531598609|FG002|8-Week Treatment Period|Lack of Efficacy|3|||
147459376|NCT00179959|531842768|FG001|Overall Study|Withdrawal by Subject|2|||
147459377|NCT00236080|531842769|FG000|Overall Study|Adverse Event|0|||
147391722|NCT02675998|531598610|FG003|8-Week Treatment Period|Lack of Efficacy|0|||
147391723|NCT02675998|531598607|FG000|8-Week Treatment Period|Physician Decision|1|||
147391724|NCT02675998|531598608|FG001|8-Week Treatment Period|Physician Decision|0|||
147391725|NCT02675998|531598609|FG002|8-Week Treatment Period|Physician Decision|2|||
147391726|NCT02675998|531598610|FG003|8-Week Treatment Period|Physician Decision|0|||
147391727|NCT02675998|531598607|FG000|8-Week Treatment Period|GI side Effects|1|||
147391728|NCT02675998|531598608|FG001|8-Week Treatment Period|GI side Effects|4|||
147391729|NCT02675998|531598609|FG002|8-Week Treatment Period|GI side Effects|2|||
147391730|NCT02675998|531598610|FG003|8-Week Treatment Period|GI side Effects|0|||
147391731|NCT02675998|531598607|FG000|8-Week Treatment Period|Protocol Violation|1|||
147391732|NCT02675998|531598608|FG001|8-Week Treatment Period|Protocol Violation|1|||
147459378|NCT00236080|531842770|FG001|Overall Study|Adverse Event|0|||
147391733|NCT02675998|531598609|FG002|8-Week Treatment Period|Protocol Violation|1|||
147459379|NCT00236080|531842771|FG002|Overall Study|Adverse Event|3|||
147459380|NCT00236080|531842772|FG003|Overall Study|Adverse Event|1|||
147459381|NCT00236080|531842773|FG004|Overall Study|Adverse Event|0|||
147459382|NCT00236080|531842769|FG000|Overall Study|Lost to Follow-up|0|||
147459383|NCT00236080|531842770|FG001|Overall Study|Lost to Follow-up|1|||
147459384|NCT00236080|531842771|FG002|Overall Study|Lost to Follow-up|0|||
147459385|NCT00236080|531842772|FG003|Overall Study|Lost to Follow-up|0|||
147459386|NCT00236080|531842773|FG004|Overall Study|Lost to Follow-up|0|||
147459387|NCT00236080|531842769|FG000|Overall Study|Physician Decision|1|||
147459388|NCT00236080|531842770|FG001|Overall Study|Physician Decision|0|||
147459389|NCT00236080|531842771|FG002|Overall Study|Physician Decision|1|||
147459390|NCT00236080|531842772|FG003|Overall Study|Physician Decision|1|||
147459391|NCT00236080|531842773|FG004|Overall Study|Physician Decision|1|||
147459392|NCT00236080|531842769|FG000|Overall Study|Withdrawal by Subject|1|||
147459393|NCT00236080|531842770|FG001|Overall Study|Withdrawal by Subject|0|||
147459394|NCT00236080|531842771|FG002|Overall Study|Withdrawal by Subject|0|||
147459395|NCT00236080|531842772|FG003|Overall Study|Withdrawal by Subject|0|||
147459396|NCT00236080|531842773|FG004|Overall Study|Withdrawal by Subject|0|||
147459397|NCT00236080|531842769|FG000|Overall Study|Miscellaneous|0|||
147459398|NCT00236080|531842770|FG001|Overall Study|Miscellaneous|0|||
147459399|NCT00236080|531842771|FG002|Overall Study|Miscellaneous|1|||
147459400|NCT00236080|531842772|FG003|Overall Study|Miscellaneous|0|||
147459401|NCT00236080|531842773|FG004|Overall Study|Miscellaneous|0|||
147459402|NCT01214044|531842774|FG000|Visit 1: Screening and Consent, Washout|Withdrawal by Subject|5|||
147459403|NCT01214044|531842774|FG000|Visit 1: Screening and Consent, Washout|Ineligible|3|||
147459404|NCT01214044|531842774|FG000|Visit 1: Screening and Consent, Washout|Lost to Follow-up|4|||
147459405|NCT01214044|531842774|FG000|Visits 3-5: Escitalopram 10 mg Daily|Withdrawal by Subject|3|||
147459406|NCT01214044|531842774|FG000|Visits 6-11: Escitalopram 20 mg Daily|Withdrawal by Subject|3|||
147459407|NCT01214044|531842774|FG000|Visits 6-11: Escitalopram 20 mg Daily|Adverse Event|1|||
147459408|NCT00408694|531842775|FG000|Overall Study|Ineligible|1|||
147459409|NCT00408694|531842775|FG000|Overall Study|No protocol treatment|1|||
147459410|NCT01961544|531842776|FG000|Overall Study|Protocol Violation|1|||
147459411|NCT01961544|531842776|FG000|Overall Study|Withdrawal by Subject|7|||
147459412|NCT01961544|531842776|FG000|Overall Study|Adverse Event|1|||
147459413|NCT01961544|531842776|FG000|Overall Study|Physician Decision|2|||
147459414|NCT01961544|531842776|FG000|Overall Study|Poor Tolerance|1|||
147459415|NCT01961544|531842776|FG000|Overall Study|Aggravation of Steral Pain|1|||
147459416|NCT03543410|531842778|FG000|Overall Study|Adverse Event|10|||
147459417|NCT03543410|531842779|FG001|Overall Study|Adverse Event|8|||
147459418|NCT03543410|531842780|FG002|Overall Study|Adverse Event|2|||
147459419|NCT03543410|531842778|FG000|Overall Study|Lack of Efficacy|0|||
147459420|NCT03543410|531842779|FG001|Overall Study|Lack of Efficacy|1|||
147459421|NCT03543410|531842780|FG002|Overall Study|Lack of Efficacy|0|||
147459422|NCT03543410|531842778|FG000|Overall Study|Lost to Follow-up|0|||
147459423|NCT03543410|531842779|FG001|Overall Study|Lost to Follow-up|1|||
147459424|NCT03543410|531842780|FG002|Overall Study|Lost to Follow-up|0|||
147459425|NCT03543410|531842778|FG000|Overall Study|Withdrawal by Subject|5|||
147459426|NCT03543410|531842779|FG001|Overall Study|Withdrawal by Subject|2|||
147459427|NCT03543410|531842780|FG002|Overall Study|Withdrawal by Subject|8|||
147459428|NCT03543410|531842778|FG000|Overall Study|Protocol Violation|0|||
147459429|NCT03543410|531842779|FG001|Overall Study|Protocol Violation|1|||
147459430|NCT03543410|531842780|FG002|Overall Study|Protocol Violation|0|||
147459431|NCT03543410|531842778|FG000|Overall Study|Due to COVID-19|4|||
147459432|NCT03543410|531842779|FG001|Overall Study|Due to COVID-19|0|||
147459433|NCT03543410|531842780|FG002|Overall Study|Due to COVID-19|2|||
147459434|NCT03543410|531842778|FG000|Overall Study|NON-COMPLIANCE WITH STUDY DRUG|0|||
147459435|NCT03543410|531842779|FG001|Overall Study|NON-COMPLIANCE WITH STUDY DRUG|0|||
147459436|NCT03543410|531842780|FG002|Overall Study|NON-COMPLIANCE WITH STUDY DRUG|2|||
147459437|NCT03543410|531842778|FG000|Overall Study|Not Due to COVID-19|2|||
147459438|NCT03543410|531842779|FG001|Overall Study|Not Due to COVID-19|0|||
147459439|NCT03543410|531842780|FG002|Overall Study|Not Due to COVID-19|1|||
147459440|NCT02435914|531842781|FG000|Overall Study|Ocular Adverse Event|1|||
147459441|NCT02435914|531842782|FG001|Overall Study|Ocular Adverse Event|0|||
147459442|NCT02435914|531842783|FG002|Overall Study|Ocular Adverse Event|0|||
147459443|NCT02435914|531842784|FG003|Overall Study|Ocular Adverse Event|0|||
147459444|NCT02435914|531842781|FG000|Overall Study|Withdrawal by Subject|0|||
147459445|NCT02435914|531842782|FG001|Overall Study|Withdrawal by Subject|1|||
147459446|NCT02435914|531842783|FG002|Overall Study|Withdrawal by Subject|0|||
147459447|NCT02435914|531842784|FG003|Overall Study|Withdrawal by Subject|0|||
147459448|NCT02435914|531842781|FG000|Overall Study|Other Miscellaneous Reason|0|||
147459449|NCT02435914|531842782|FG001|Overall Study|Other Miscellaneous Reason|0|||
147459450|NCT02435914|531842783|FG002|Overall Study|Other Miscellaneous Reason|1|||
147459451|NCT02435914|531842784|FG003|Overall Study|Other Miscellaneous Reason|0|||
147459452|NCT02883244|531842785|FG000|Overall Study|Lost to Follow-up|0|||
147459453|NCT02883244|531842786|FG001|Overall Study|Lost to Follow-up|1|||
147459454|NCT01727258|531842787|FG000|Overall Study|Adverse Event|0|||
147459455|NCT01727258|531842788|FG001|Overall Study|Adverse Event|2|||
147459456|NCT01727258|531842789|FG002|Overall Study|Adverse Event|0|||
147391734|NCT02675998|531598610|FG003|8-Week Treatment Period|Protocol Violation|0|||
147615208|NCT03519087|532406656|FG002|Re-randomization for Treatment|Withdrawal by Subject|0|||
147615209|NCT03519087|532406657|FG003|Re-randomization for Treatment|Withdrawal by Subject|0|||
147391735|NCT02675998|531598607|FG000|8-Week Treatment Period|Other|3|||
147391736|NCT02675998|531598608|FG001|8-Week Treatment Period|Other|1|||
147391737|NCT02675998|531598609|FG002|8-Week Treatment Period|Other|2|||
147391738|NCT02675998|531598610|FG003|8-Week Treatment Period|Other|0|||
147391739|NCT02675998|531598607|FG000|4-Week Randomized Withdrawal Period|Lack of Efficacy|0|||
147391740|NCT02675998|531598608|FG001|4-Week Randomized Withdrawal Period|Lack of Efficacy|1|||
147391741|NCT02675998|531598609|FG002|4-Week Randomized Withdrawal Period|Lack of Efficacy|1|||
147391742|NCT02675998|531598610|FG003|4-Week Randomized Withdrawal Period|Lack of Efficacy|3|||
147391743|NCT02675998|531598607|FG000|4-Week Randomized Withdrawal Period|Adverse Event|0|||
147391744|NCT02675998|531598608|FG001|4-Week Randomized Withdrawal Period|Adverse Event|0|||
147391745|NCT02675998|531598609|FG002|4-Week Randomized Withdrawal Period|Adverse Event|1|||
147391746|NCT02675998|531598610|FG003|4-Week Randomized Withdrawal Period|Adverse Event|3|||
147391747|NCT02675998|531598607|FG000|4-Week Randomized Withdrawal Period|Protocol Violation|0|||
147391748|NCT02675998|531598608|FG001|4-Week Randomized Withdrawal Period|Protocol Violation|0|||
147391749|NCT02675998|531598609|FG002|4-Week Randomized Withdrawal Period|Protocol Violation|0|||
147391750|NCT02675998|531598610|FG003|4-Week Randomized Withdrawal Period|Protocol Violation|1|||
147391751|NCT02675998|531598607|FG000|4-Week Randomized Withdrawal Period|Physician Decision|1|||
147391752|NCT02675998|531598608|FG001|4-Week Randomized Withdrawal Period|Physician Decision|0|||
147391753|NCT02675998|531598609|FG002|4-Week Randomized Withdrawal Period|Physician Decision|0|||
147391754|NCT02675998|531598610|FG003|4-Week Randomized Withdrawal Period|Physician Decision|0|||
147391755|NCT02675998|531598607|FG000|4-Week Randomized Withdrawal Period|Withdrawal by Subject|0|||
147391756|NCT02675998|531598608|FG001|4-Week Randomized Withdrawal Period|Withdrawal by Subject|0|||
147391757|NCT02675998|531598609|FG002|4-Week Randomized Withdrawal Period|Withdrawal by Subject|0|||
147391758|NCT02675998|531598610|FG003|4-Week Randomized Withdrawal Period|Withdrawal by Subject|1|||
147391759|NCT00275301|531598611|FG000|Overall Study|Adverse Event|5|||
147391760|NCT00598871|531598616|FG000|Overall Study|Adverse Event|0|||
147391761|NCT00598871|531598617|FG001|Overall Study|Adverse Event|1|||
147391762|NCT01194271|531598618|FG000|Overall Study|Withdrawal by Subject|1|||
147391763|NCT01194271|531598618|FG000|Overall Study|Ineligible, Screen Failure|1|||
147391764|NCT01194271|531598618|FG000|Overall Study|Death|1|||
147391765|NCT01983462|531598621|FG000|Overall Study|Adverse Event|1|||
147391766|NCT01983462|531598622|FG001|Overall Study|Adverse Event|0|||
147391767|NCT01983462|531598623|FG002|Overall Study|Adverse Event|0|||
147391768|NCT00349622|531598624|FG000|Overall Study|Death|168|||
147391769|NCT00349622|531598625|FG001|Overall Study|Death|86|||
147391770|NCT00349622|531598624|FG000|Overall Study|Lost to Follow-up|5|||
147391771|NCT00349622|531598625|FG001|Overall Study|Lost to Follow-up|1|||
147391772|NCT00349622|531598624|FG000|Overall Study|Withdrawal by Subject|5|||
147391773|NCT00349622|531598625|FG001|Overall Study|Withdrawal by Subject|9|||
147391774|NCT00508274|531598626|FG000|Overall Study|Adverse Event|5|||
147391775|NCT00508274|531598626|FG000|Overall Study|Death|7|||
147391776|NCT00508274|531598626|FG000|Overall Study|Disease progression|32|||
147391777|NCT00508274|531598626|FG000|Overall Study|Withdrawal by Subject|1|||
147391778|NCT00508274|531598626|FG000|Overall Study|Subject received new anti-cancer chemotherapy/traditional Chinese medicine|2|||
147391779|NCT00508274|531598626|FG000|Overall Study|Missing|3|||
147391780|NCT03296566|531598627|FG000|Overall Study|Lost to Follow-up|19|||
147391781|NCT03296566|531598628|FG001|Overall Study|Lost to Follow-up|46|||
147391782|NCT03296566|531598627|FG000|Overall Study|Withdrawal by Subject|0|||
147391783|NCT03296566|531598628|FG001|Overall Study|Withdrawal by Subject|3|||
147391784|NCT00550771|531598632|FG000|Overall Study|Adverse Event|11|||
147391785|NCT00550771|531598633|FG001|Overall Study|Adverse Event|3|||
147391786|NCT00550771|531598632|FG000|Overall Study|Discontinued for study-related reasons|0|||
147391787|NCT00550771|531598633|FG001|Overall Study|Discontinued for study-related reasons|1|||
147391788|NCT00550771|531598632|FG000|Overall Study|Physician Decision|2|||
147391789|NCT00550771|531598633|FG001|Overall Study|Physician Decision|0|||
147391790|NCT00550771|531598632|FG000|Overall Study|Withdrawal by Subject|0|||
147391791|NCT00550771|531598633|FG001|Overall Study|Withdrawal by Subject|1|||
147391792|NCT00550771|531598632|FG000|Overall Study|Protocol Violation|4|||
147391793|NCT00550771|531598633|FG001|Overall Study|Protocol Violation|5|||
147391794|NCT01243411|531598634|FG000|Overall Study|Withdrawal by Subject|18|||
147615210|NCT03519087|532406658|FG004|Re-randomization for Treatment|Withdrawal by Subject|0|||
147391795|NCT01243411|531598634|FG000|Overall Study|Lost to Follow-up|10|||
147391796|NCT01243411|531598634|FG000|Overall Study|Adverse Event|5|||
147391797|NCT01243411|531598634|FG000|Overall Study|Other|8|||
147391798|NCT03022578|531598635|FG000|Overall Study|Adverse Event|1|||
147391799|NCT03022578|531598635|FG000|Overall Study|Lack of Efficacy|2|||
147391800|NCT03022578|531598635|FG000|Overall Study|Withdrawal by Subject|1|||
147391801|NCT00805285|531598636|FG000|Overall Study|Lack of Efficacy|1|||
147391802|NCT00839306|531598637|FG000|Overall Study|Adverse Event|3|||
147391803|NCT00839306|531598638|FG001|Overall Study|Adverse Event|5|||
147391804|NCT00839306|531598637|FG000|Overall Study|Lost to Follow-up|6|||
147459457|NCT01727258|531842787|FG000|Overall Study|Noncompliance with Study Drug|0|||
147459458|NCT01727258|531842788|FG001|Overall Study|Noncompliance with Study Drug|0|||
147459459|NCT01727258|531842789|FG002|Overall Study|Noncompliance with Study Drug|1|||
147459460|NCT01727258|531842787|FG000|Overall Study|Withdrawal by Subject|1|||
147459461|NCT01727258|531842788|FG001|Overall Study|Withdrawal by Subject|1|||
147459462|NCT01727258|531842789|FG002|Overall Study|Withdrawal by Subject|0|||
147459463|NCT01727258|531842787|FG000|Overall Study|Lost to Follow-up|1|||
147459464|NCT01727258|531842788|FG001|Overall Study|Lost to Follow-up|0|||
147459465|NCT01727258|531842789|FG002|Overall Study|Lost to Follow-up|0|||
147459466|NCT01818726|531842792|FG000|Overall Study|Administrative reasons|5|||
147459467|NCT01818726|531842793|FG001|Overall Study|Administrative reasons|1|||
147459468|NCT01818726|531842792|FG000|Overall Study|Withdrawal by Subject|0|||
147459469|NCT01818726|531842793|FG001|Overall Study|Withdrawal by Subject|1|||
147459470|NCT01818726|531842792|FG000|Overall Study|Decision to perform 2nd course of trtmnt|1|||
147459471|NCT01818726|531842793|FG001|Overall Study|Decision to perform 2nd course of trtmnt|0|||
147459472|NCT04871711|531842794|FG000|Overall Study|Withdrawal by Subject|11|||
147459473|NCT04871711|531842795|FG001|Overall Study|Withdrawal by Subject|5|||
147459474|NCT04871711|531842794|FG000|Overall Study|Lack of Efficacy|5|||
147459475|NCT04871711|531842795|FG001|Overall Study|Lack of Efficacy|7|||
147459476|NCT04871711|531842794|FG000|Overall Study|Adverse Event|2|||
147459477|NCT04871711|531842795|FG001|Overall Study|Adverse Event|6|||
147459478|NCT04871711|531842794|FG000|Overall Study|Various reasons|2|||
147459479|NCT04871711|531842795|FG001|Overall Study|Various reasons|1|||
147459480|NCT04871711|531842794|FG000|Overall Study|Lost to Follow-up|0|||
147459481|NCT04871711|531842795|FG001|Overall Study|Lost to Follow-up|2|||
147459482|NCT01469000|531842796|FG000|Overall Study|Withdrawal by Subject|16|||
147459483|NCT01469000|531842797|FG001|Overall Study|Withdrawal by Subject|3|||
147459484|NCT01469000|531842796|FG000|Overall Study|Sponsor Decision|4|||
147459485|NCT01469000|531842797|FG001|Overall Study|Sponsor Decision|1|||
147459486|NCT02026063|531842800|FG000|Overall Study|Physician Decision|0|||
147459487|NCT02026063|531842801|FG001|Overall Study|Physician Decision|10|||
147459488|NCT02026063|531842800|FG000|Overall Study|Noncompliance with Study Drug|1|||
147459489|NCT02026063|531842801|FG001|Overall Study|Noncompliance with Study Drug|1|||
147459490|NCT02026063|531842800|FG000|Overall Study|Withdrawal of Consent|1|||
147459491|NCT02026063|531842801|FG001|Overall Study|Withdrawal of Consent|6|||
147459492|NCT02026063|531842800|FG000|Overall Study|Adverse Event|5|||
147459493|NCT02026063|531842801|FG001|Overall Study|Adverse Event|20|||
147459494|NCT02026063|531842800|FG000|Overall Study|Lack of Efficacy|0|||
147459495|NCT02026063|531842801|FG001|Overall Study|Lack of Efficacy|4|||
147459496|NCT02026063|531842800|FG000|Overall Study|Lost to Follow-up|0|||
147459497|NCT02026063|531842801|FG001|Overall Study|Lost to Follow-up|1|||
147459498|NCT02026063|531842800|FG000|Overall Study|Reason not Specified|2|||
147459499|NCT02026063|531842801|FG001|Overall Study|Reason not Specified|7|||
147459500|NCT02154087|531842803|FG000|Overall Study|Study Termination|1|||
147459501|NCT02183519|531842809|FG000|Overall Study|computer error|3|||
147459502|NCT02183519|531842810|FG001|Overall Study|computer error|0|||
147459503|NCT02183519|531842809|FG000|Overall Study|Did not respond to cough inducter|0|||
147459504|NCT02183519|531842810|FG001|Overall Study|Did not respond to cough inducter|3|||
147459505|NCT04556617|531842811|FG000|Overall Study|progressive disease|0|||
147459506|NCT04556617|531842812|FG001|Overall Study|progressive disease|2|||
147459507|NCT04556617|531842813|FG002|Overall Study|progressive disease|2|||
147459508|NCT04556617|531842814|FG003|Overall Study|progressive disease|1|||
147459509|NCT04556617|531842815|FG004|Overall Study|progressive disease|1|||
147459510|NCT04556617|531842811|FG000|Overall Study|Physician Decision|0|||
147459511|NCT04556617|531842812|FG001|Overall Study|Physician Decision|0|||
147459512|NCT04556617|531842813|FG002|Overall Study|Physician Decision|2|||
147459513|NCT04556617|531842814|FG003|Overall Study|Physician Decision|0|||
147459514|NCT04556617|531842815|FG004|Overall Study|Physician Decision|0|||
147459515|NCT04556617|531842811|FG000|Overall Study|Adverse Event|0|||
147459516|NCT04556617|531842812|FG001|Overall Study|Adverse Event|0|||
147459517|NCT04556617|531842813|FG002|Overall Study|Adverse Event|2|||
147459518|NCT04556617|531842814|FG003|Overall Study|Adverse Event|3|||
147459519|NCT04556617|531842815|FG004|Overall Study|Adverse Event|0|||
147459520|NCT04556617|531842811|FG000|Overall Study|Withdrawal by Subject|0|||
147459521|NCT04556617|531842812|FG001|Overall Study|Withdrawal by Subject|2|||
147459522|NCT04556617|531842813|FG002|Overall Study|Withdrawal by Subject|1|||
147615211|NCT03519087|532406654|FG000|Re-randomization for Treatment|Not appropriate|2|||
147459523|NCT04556617|531842814|FG003|Overall Study|Withdrawal by Subject|1|||
147459524|NCT04556617|531842815|FG004|Overall Study|Withdrawal by Subject|0|||
147459525|NCT04556617|531842811|FG000|Overall Study|PSA increase|0|||
147459526|NCT04556617|531842812|FG001|Overall Study|PSA increase|1|||
147665011|NCT01130272|532597979|FG003|Overall Study|Physician Decision|1|||
147459527|NCT04556617|531842813|FG002|Overall Study|PSA increase|0|||
147459528|NCT04556617|531842814|FG003|Overall Study|PSA increase|0|||
147459529|NCT04556617|531842815|FG004|Overall Study|PSA increase|0|||
147459530|NCT04556617|531842811|FG000|Overall Study|Sponsor study termination|1|||
147459531|NCT04556617|531842812|FG001|Overall Study|Sponsor study termination|0|||
147459532|NCT04556617|531842813|FG002|Overall Study|Sponsor study termination|0|||
147391805|NCT00839306|531598638|FG001|Overall Study|Lost to Follow-up|9|||
147391806|NCT00839306|531598637|FG000|Overall Study|Withdrawal by Subject|5|||
147391807|NCT00839306|531598638|FG001|Overall Study|Withdrawal by Subject|7|||
147391808|NCT00839306|531598637|FG000|Overall Study|Lack of Efficacy|5|||
147391809|NCT00839306|531598638|FG001|Overall Study|Lack of Efficacy|4|||
147391810|NCT00839306|531598637|FG000|Overall Study|Other|6|||
147391811|NCT00839306|531598638|FG001|Overall Study|Other|18|||
147391812|NCT01066897|531598639|FG000|Overall Study|Withdrawal by Subject|1|||
147391813|NCT01066897|531598640|FG001|Overall Study|Withdrawal by Subject|0|||
147391814|NCT01066897|531598639|FG000|Overall Study|stopped study after developing the flu.|1|||
147391815|NCT01066897|531598640|FG001|Overall Study|stopped study after developing the flu.|0|||
147391816|NCT02396758|531598643|FG000|Overall Study|Withdrawal by Subject|2|||
147391817|NCT02396758|531598644|FG001|Overall Study|Withdrawal by Subject|0|||
147391818|NCT02396758|531598645|FG002|Overall Study|Withdrawal by Subject|0|||
147391819|NCT02396758|531598646|FG003|Overall Study|Withdrawal by Subject|1|||
147391820|NCT02396758|531598643|FG000|Overall Study|Lost to Follow-up|8|||
147391821|NCT02396758|531598644|FG001|Overall Study|Lost to Follow-up|5|||
147391822|NCT02396758|531598645|FG002|Overall Study|Lost to Follow-up|3|||
147391823|NCT02396758|531598646|FG003|Overall Study|Lost to Follow-up|3|||
147391824|NCT02396758|531598643|FG000|Overall Study|Death|1|||
147391825|NCT02396758|531598644|FG001|Overall Study|Death|1|||
147391826|NCT02396758|531598645|FG002|Overall Study|Death|0|||
147391827|NCT02396758|531598646|FG003|Overall Study|Death|1|||
147391828|NCT02396758|531598643|FG000|Overall Study|Randomized but not treated|1|||
147391829|NCT02396758|531598644|FG001|Overall Study|Randomized but not treated|0|||
147391830|NCT02396758|531598645|FG002|Overall Study|Randomized but not treated|1|||
147391831|NCT02396758|531598646|FG003|Overall Study|Randomized but not treated|0|||
147391832|NCT02110225|531598647|FG000|Overall Study|Lost to Follow-up|0|||
147391833|NCT02110225|531598648|FG001|Overall Study|Lost to Follow-up|1|||
147391834|NCT02110225|531598649|FG002|Overall Study|Lost to Follow-up|0|||
147391835|NCT02176018|531598650|FG000|Overall Study|Adverse Event|0|||
147391836|NCT02176018|531598651|FG001|Overall Study|Adverse Event|2|||
147391837|NCT02176018|531598650|FG000|Overall Study|Lost to Follow-up|3|||
147391838|NCT02176018|531598651|FG001|Overall Study|Lost to Follow-up|1|||
147391839|NCT02176018|531598650|FG000|Overall Study|Protocol Violation|1|||
147391840|NCT02176018|531598651|FG001|Overall Study|Protocol Violation|1|||
147391841|NCT02176018|531598650|FG000|Overall Study|Withdrawal by Subject|1|||
147391842|NCT02176018|531598651|FG001|Overall Study|Withdrawal by Subject|2|||
147391843|NCT00265096|531598652|FG000|Overall Study|Adverse Event|14|||
147391844|NCT00265096|531598653|FG001|Overall Study|Adverse Event|18|||
147391845|NCT00265096|531598654|FG002|Overall Study|Adverse Event|18|||
147391846|NCT00265096|531598652|FG000|Overall Study|Lost to Follow-up|2|||
147391847|NCT00265096|531598653|FG001|Overall Study|Lost to Follow-up|5|||
147391848|NCT00265096|531598654|FG002|Overall Study|Lost to Follow-up|3|||
147391849|NCT00265096|531598652|FG000|Overall Study|Death|0|||
147391850|NCT00265096|531598653|FG001|Overall Study|Death|1|||
147391851|NCT00265096|531598654|FG002|Overall Study|Death|2|||
147391852|NCT00265096|531598652|FG000|Overall Study|Unsatisfactory therapeutic effect|9|||
147391853|NCT00265096|531598653|FG001|Overall Study|Unsatisfactory therapeutic effect|8|||
147391854|NCT00265096|531598654|FG002|Overall Study|Unsatisfactory therapeutic effect|6|||
147391855|NCT00265096|531598652|FG000|Overall Study|Other|11|||
147391856|NCT00265096|531598653|FG001|Overall Study|Other|19|||
147391857|NCT00265096|531598654|FG002|Overall Study|Other|10|||
147391858|NCT00774306|531598655|FG000|Overall Study|Adverse Event|3|||
147391859|NCT00774306|531598656|FG001|Overall Study|Adverse Event|0|||
147391860|NCT00774306|531598657|FG002|Overall Study|Adverse Event|0|||
147391861|NCT00774306|531598658|FG003|Overall Study|Adverse Event|0|||
147391862|NCT00774306|531598655|FG000|Overall Study|Protocol Violation|2|||
147391863|NCT00774306|531598656|FG001|Overall Study|Protocol Violation|0|||
147391864|NCT00774306|531598657|FG002|Overall Study|Protocol Violation|3|||
147391865|NCT00774306|531598658|FG003|Overall Study|Protocol Violation|0|||
147391866|NCT00774306|531598655|FG000|Overall Study|Withdrawal by Subject|6|||
147391867|NCT00774306|531598656|FG001|Overall Study|Withdrawal by Subject|1|||
147391868|NCT00774306|531598657|FG002|Overall Study|Withdrawal by Subject|1|||
147391869|NCT00774306|531598658|FG003|Overall Study|Withdrawal by Subject|0|||
147391870|NCT00774306|531598655|FG000|Overall Study|Lost to Follow-up|6|||
147391871|NCT00774306|531598656|FG001|Overall Study|Lost to Follow-up|0|||
147391872|NCT00774306|531598657|FG002|Overall Study|Lost to Follow-up|4|||
147391873|NCT00774306|531598658|FG003|Overall Study|Lost to Follow-up|5|||
147391874|NCT00774306|531598655|FG000|Overall Study|Death|1|||
147391875|NCT00774306|531598656|FG001|Overall Study|Death|1|||
147391876|NCT00774306|531598657|FG002|Overall Study|Death|0|||
147391877|NCT00774306|531598658|FG003|Overall Study|Death|0|||
147391878|NCT03022045|531598659|FG000|Overall Study|Adverse Event|0|||
147391879|NCT03022045|531598660|FG001|Overall Study|Adverse Event|1|||
147391880|NCT03022045|531598659|FG000|Overall Study|Withdrawal by Subject|1|||
147391881|NCT03022045|531598660|FG001|Overall Study|Withdrawal by Subject|1|||
147391882|NCT01126879|531598664|FG000|Overall Study|Progressive Disease|3|||
147391883|NCT01126879|531598665|FG001|Overall Study|Progressive Disease|1|||
147391884|NCT01126879|531598664|FG000|Overall Study|Withdrawal by Subject|1|||
147459533|NCT04556617|531842814|FG003|Overall Study|Sponsor study termination|0|||
147459534|NCT04556617|531842815|FG004|Overall Study|Sponsor study termination|0|||
147459535|NCT04949841|531842816|FG000|Overall Study|Adverse Event|7|||
147391885|NCT01126879|531598665|FG001|Overall Study|Withdrawal by Subject|0|||
147391886|NCT01126879|531598664|FG000|Overall Study|Adverse Event|0|||
147459536|NCT04949841|531842816|FG000|Overall Study|Death|1|||
147459537|NCT04949841|531842816|FG000|Overall Study|Withdrawal by Subject|52|||
147459538|NCT04949841|531842816|FG000|Overall Study|Pregnancy|4|||
147459539|NCT04949841|531842816|FG000|Overall Study|Lost to Follow-up|9|||
147459540|NCT04949841|531842816|FG000|Overall Study|Lack of Efficacy|55|||
147459541|NCT04949841|531842816|FG000|Overall Study|Various reasons|9|||
147459542|NCT02937350|531842817|FG000|Overall Study|Withdrawal by Subject|0|||
147459543|NCT02937350|531842818|FG001|Overall Study|Withdrawal by Subject|1|||
147459544|NCT02937350|531842819|FG002|Overall Study|Withdrawal by Subject|0|||
147459545|NCT00695565|531842820|FG000|Overall Study|Lost to Follow-up|4|||
147459546|NCT00695565|531842821|FG001|Overall Study|Lost to Follow-up|4|||
147459547|NCT00695565|531842820|FG000|Overall Study|Adverse Event|3|||
147459548|NCT00695565|531842821|FG001|Overall Study|Adverse Event|1|||
147459549|NCT00695565|531842820|FG000|Overall Study|Protocol Violation|3|||
147459550|NCT00695565|531842821|FG001|Overall Study|Protocol Violation|1|||
147459551|NCT00695565|531842820|FG000|Overall Study|Withdrawal by Subject|1|||
147459552|NCT00695565|531842821|FG001|Overall Study|Withdrawal by Subject|1|||
147459553|NCT00695565|531842820|FG000|Overall Study|Lack of Efficacy|1|||
147459554|NCT00695565|531842821|FG001|Overall Study|Lack of Efficacy|1|||
147459555|NCT00695565|531842820|FG000|Overall Study|Subject did not follow instructions|1|||
147459556|NCT00695565|531842821|FG001|Overall Study|Subject did not follow instructions|1|||
147459557|NCT01462266|531842822|FG000|Overall Study|Adverse Event|7|||
147459558|NCT01462266|531842823|FG001|Overall Study|Adverse Event|6|||
147459559|NCT01462266|531842822|FG000|Overall Study|Death|2|||
147459560|NCT01462266|531842823|FG001|Overall Study|Death|1|||
147459561|NCT01462266|531842822|FG000|Overall Study|Lack of Efficacy|0|||
147459562|NCT01462266|531842823|FG001|Overall Study|Lack of Efficacy|2|||
147459563|NCT01462266|531842822|FG000|Overall Study|Lost to Follow-up|4|||
147459564|NCT01462266|531842823|FG001|Overall Study|Lost to Follow-up|3|||
147459565|NCT01462266|531842822|FG000|Overall Study|Non-compliance with study drug|3|||
147459566|NCT01462266|531842823|FG001|Overall Study|Non-compliance with study drug|0|||
147459567|NCT01462266|531842822|FG000|Overall Study|Creatinine and eGFR, excluded medication|8|||
147459568|NCT01462266|531842823|FG001|Overall Study|Creatinine and eGFR, excluded medication|4|||
147391887|NCT01126879|531598665|FG001|Overall Study|Adverse Event|1|||
147391888|NCT01126879|531598664|FG000|Overall Study|Physician Decision|1|||
147391889|NCT01126879|531598665|FG001|Overall Study|Physician Decision|0|||
147391890|NCT00126555|531598666|FG000|Overall Study|Withdrawal by Subject|1|||
147391891|NCT00126555|531598666|FG000|Overall Study|Adverse Event|2|||
147391892|NCT00126555|531598666|FG000|Overall Study|Progressive Disease|3|||
147391893|NCT01780545|531598667|FG000|Overall Study|Withdrawal by Subject|3|||
147391894|NCT01780545|531598668|FG001|Overall Study|Withdrawal by Subject|1|||
147391895|NCT01780545|531598667|FG000|Overall Study|Lost to Follow-up|1|||
147391896|NCT01780545|531598668|FG001|Overall Study|Lost to Follow-up|1|||
147391897|NCT00498433|531598672|FG000|Part 2: Placebo Run-in (2 Weeks)|Adverse Event|2|||
147391898|NCT00498433|531598673|FG001|Part 2: Placebo Run-in (2 Weeks)|Adverse Event|0|||
147391899|NCT00498433|531598674|FG002|Part 2: Placebo Run-in (2 Weeks)|Adverse Event|0|||
147391900|NCT00498433|531598672|FG000|Part 2: Placebo Run-in (2 Weeks)|Abnormal laboratory value|2|||
147391901|NCT00498433|531598673|FG001|Part 2: Placebo Run-in (2 Weeks)|Abnormal laboratory value|0|||
147391902|NCT00498433|531598674|FG002|Part 2: Placebo Run-in (2 Weeks)|Abnormal laboratory value|0|||
147459569|NCT01462266|531842822|FG000|Overall Study|Physician Decision|2|||
147459570|NCT01462266|531842823|FG001|Overall Study|Physician Decision|5|||
147459571|NCT01462266|531842822|FG000|Overall Study|Protocol Violation|1|||
147459572|NCT01462266|531842823|FG001|Overall Study|Protocol Violation|3|||
147459573|NCT01462266|531842822|FG000|Overall Study|Withdrawal by Subject|7|||
147459574|NCT01462266|531842823|FG001|Overall Study|Withdrawal by Subject|2|||
147459575|NCT01462266|531842822|FG000|Overall Study|Screen failure|1|||
147459576|NCT01462266|531842823|FG001|Overall Study|Screen failure|1|||
147459577|NCT01106846|531842824|FG000|Overall Study|Change in surgical procedure|0|||
147391903|NCT00498433|531598672|FG000|Part 2: Placebo Run-in (2 Weeks)|Abnormal test procedure|15|||
147459578|NCT01106846|531842825|FG001|Overall Study|Change in surgical procedure|1|||
147459579|NCT02419508|531842831|FG000|Overall Study|Adverse Event|9|||
147459580|NCT02419508|531842832|FG001|Overall Study|Adverse Event|3|||
147459581|NCT02419508|531842831|FG000|Overall Study|Withdrawal by Subject|1|||
147459582|NCT02419508|531842832|FG001|Overall Study|Withdrawal by Subject|0|||
147459583|NCT02419508|531842831|FG000|Overall Study|Other - Reason not specified|0|||
147459584|NCT02419508|531842832|FG001|Overall Study|Other - Reason not specified|1|||
147459585|NCT01602341|531845135|FG000|Overall Study|Adverse Event|0|||
147459586|NCT01602341|531845136|FG001|Overall Study|Adverse Event|1|||
147459587|NCT02554929|531845137|FG000|Overall Study|Lost to Follow-up|4|||
147391904|NCT00498433|531598673|FG001|Part 2: Placebo Run-in (2 Weeks)|Abnormal test procedure|0|||
147391905|NCT00498433|531598674|FG002|Part 2: Placebo Run-in (2 Weeks)|Abnormal test procedure|0|||
147459588|NCT02554929|531845138|FG001|Overall Study|Lost to Follow-up|4|||
147459589|NCT02554929|531845137|FG000|Overall Study|Withdrawal by Subject|2|||
147459590|NCT02554929|531845138|FG001|Overall Study|Withdrawal by Subject|8|||
147459591|NCT01916980|531845139|FG000|Overall Study|Adverse Event|4|||
147459592|NCT01916980|531845140|FG001|Overall Study|Adverse Event|2|||
147459593|NCT01916980|531845139|FG000|Overall Study|Lack of Efficacy|2|||
147459594|NCT01916980|531845140|FG001|Overall Study|Lack of Efficacy|2|||
147459595|NCT01916980|531845139|FG000|Overall Study|Withdrawal by Subject|1|||
147459596|NCT01916980|531845140|FG001|Overall Study|Withdrawal by Subject|0|||
147459597|NCT00700180|531845141|FG000|Overall Study|Death|99|||
147459598|NCT00700180|531845142|FG001|Overall Study|Death|114|||
147459599|NCT00700180|531845141|FG000|Overall Study|Alive on treatment|5|||
147459600|NCT00700180|531845142|FG001|Overall Study|Alive on treatment|3|||
147459601|NCT00700180|531845141|FG000|Overall Study|Alive in follow-up|46|||
147459602|NCT00700180|531845142|FG001|Overall Study|Alive in follow-up|27|||
147459603|NCT00700180|531845141|FG000|Overall Study|Lost to Follow-up|4|||
147459604|NCT00700180|531845142|FG001|Overall Study|Lost to Follow-up|5|||
147459605|NCT01613326|531845143|FG000|Overall Study|Adverse Event|7|||
147459606|NCT01613326|531845144|FG001|Overall Study|Adverse Event|5|||
147459607|NCT01613326|531845143|FG000|Overall Study|Withdrawal by Subject|3|||
147459608|NCT01613326|531845144|FG001|Overall Study|Withdrawal by Subject|4|||
147459609|NCT01613326|531845143|FG000|Overall Study|Abnormal test procedure result(s)|2|||
147459610|NCT01613326|531845144|FG001|Overall Study|Abnormal test procedure result(s)|0|||
147459611|NCT01613326|531845143|FG000|Overall Study|inability to use device|1|||
147459612|NCT01613326|531845144|FG001|Overall Study|inability to use device|0|||
147459613|NCT01613326|531845143|FG000|Overall Study|Lack of Efficacy|0|||
147459614|NCT01613326|531845144|FG001|Overall Study|Lack of Efficacy|1|||
147459615|NCT01613326|531845143|FG000|Overall Study|Lost to Follow-up|0|||
147459616|NCT01613326|531845144|FG001|Overall Study|Lost to Follow-up|1|||
147459617|NCT01613326|531845143|FG000|Overall Study|Administrative|0|||
147459618|NCT01613326|531845144|FG001|Overall Study|Administrative|2|||
147459619|NCT01613326|531845143|FG000|Overall Study|Protocol Violation|0|||
147459620|NCT01613326|531845144|FG001|Overall Study|Protocol Violation|1|||
147459621|NCT03980938|531845147|FG000|Treatment Period 1|Study Terminated|1|||
147459622|NCT03980938|531845148|FG001|Treatment Period 1|Study Terminated|1|||
147459623|NCT03980938|531845147|FG000|Treatment Period 2|Study Terminated|2|||
147459624|NCT03980938|531845148|FG001|Treatment Period 2|Study Terminated|2|||
147459625|NCT02939131|531845149|FG000|Overall Study|Unable to get to clinic|6|||
147459626|NCT02939131|531845150|FG001|Overall Study|Unable to get to clinic|4|||
147459627|NCT02939131|531845149|FG000|Overall Study|Lost to Follow-up|2|||
147459628|NCT02939131|531845150|FG001|Overall Study|Lost to Follow-up|4|||
147459629|NCT02939131|531845149|FG000|Overall Study|severe debilitation|1|||
147459630|NCT02939131|531845150|FG001|Overall Study|severe debilitation|0|||
147459631|NCT02939131|531845149|FG000|Overall Study|Other|0|||
147459632|NCT02939131|531845150|FG001|Overall Study|Other|1|||
147615212|NCT03519087|532406655|FG001|Re-randomization for Treatment|Not appropriate|3|||
147615213|NCT03519087|532406656|FG002|Re-randomization for Treatment|Not appropriate|0|||
147615214|NCT03519087|532406657|FG003|Re-randomization for Treatment|Not appropriate|0|||
147615215|NCT03519087|532406658|FG004|Re-randomization for Treatment|Not appropriate|0|||
147615216|NCT03519087|532406654|FG000|Laboratory Testing|Lost to Follow-up|0|||
147615217|NCT03519087|532406655|FG001|Laboratory Testing|Lost to Follow-up|0|||
147615218|NCT03519087|532406656|FG002|Laboratory Testing|Lost to Follow-up|2|||
147459633|NCT02939131|531845149|FG000|Overall Study|not willing to adhere to protocol|2|||
147459634|NCT02939131|531845150|FG001|Overall Study|not willing to adhere to protocol|0|||
147459635|NCT00605267|531845151|FG000|Overall Study|Adverse Event|0|||
147459636|NCT00605267|531845152|FG001|Overall Study|Adverse Event|1|||
147459637|NCT00605267|531845151|FG000|Overall Study|Lack of Efficacy|1|||
147459638|NCT00605267|531845152|FG001|Overall Study|Lack of Efficacy|5|||
147459639|NCT00605267|531845151|FG000|Overall Study|Withdrawal by Subject|2|||
147459640|NCT00605267|531845152|FG001|Overall Study|Withdrawal by Subject|3|||
147459641|NCT03569202|531845156|FG000|Part 3|Physician Decision|1|||
147459642|NCT03569202|531845157|FG001|Part 3|Physician Decision|0|||
147459643|NCT03569202|531845156|FG000|Part 3|Other|1|||
147615219|NCT03519087|532406657|FG003|Laboratory Testing|Lost to Follow-up|3|||
147615220|NCT03519087|532406658|FG004|Laboratory Testing|Lost to Follow-up|6|||
147459644|NCT03569202|531845157|FG001|Part 3|Other|1|||
147459645|NCT00420511|531845158|FG000|Overall Study|Adverse Event|1|||
147459646|NCT00420511|531845159|FG001|Overall Study|Adverse Event|1|||
147459647|NCT00420511|531845158|FG000|Overall Study|Lost to Follow-up|1|||
147615221|NCT03519087|532406654|FG000|Laboratory Testing|Protocol Violation|0|||
147459648|NCT00420511|531845159|FG001|Overall Study|Lost to Follow-up|0|||
147459649|NCT02415712|531845160|FG000|Overall Study|Protocol Violation|16|||
147459650|NCT01668654|531845161|FG000|Overall Study|Study Closed/Terminated|3|||
147459651|NCT01668654|531845161|FG000|Overall Study|Withdrawal by Subject|1|||
147459652|NCT04557384|531845162|FG000|Overall Study|Study Terminated by Sponsor|1|||
147459653|NCT04557384|531845162|FG000|Overall Study|Death|1|||
147459654|NCT00454779|531845164|FG000|First-line Treatment Phase|Lack of Efficacy|0|||
147459655|NCT00454779|531845165|FG001|First-line Treatment Phase|Lack of Efficacy|2|||
147391906|NCT00498433|531598672|FG000|Part 2: Placebo Run-in (2 Weeks)|Administrative problems|1|||
147391907|NCT00498433|531598673|FG001|Part 2: Placebo Run-in (2 Weeks)|Administrative problems|0|||
147391908|NCT00498433|531598674|FG002|Part 2: Placebo Run-in (2 Weeks)|Administrative problems|0|||
147391909|NCT01264887|531598678|FG000|Overall Study|Adverse Event|5|||
147391910|NCT01264887|531598678|FG000|Overall Study|Death|7|||
147391911|NCT01264887|531598678|FG000|Overall Study|Lack of Efficacy|5|||
147391912|NCT01264887|531598678|FG000|Overall Study|Physician Decision|4|||
147391913|NCT01264887|531598678|FG000|Overall Study|Withdrawal by Subject|6|||
147391914|NCT01264887|531598678|FG000|Overall Study|Sponsor Decision Administrative Reasons|2|||
147391915|NCT01264887|531598678|FG000|Overall Study|Other|2|||
147391916|NCT04531813|531598679|FG000|Overall Study|Protocol Violation|1|||
147391917|NCT04531813|531598679|FG000|Overall Study|Withdrawal by Subject|1|||
147391918|NCT02171130|531598680|FG000|Overall Study|Death|1|||
147391919|NCT02171130|531598680|FG000|Overall Study|Discontinued; Clinical Material Issue|16|||
147391920|NCT02171130|531598680|FG000|Overall Study|Discontinued; Site Termination|5|||
147391921|NCT02171130|531598680|FG000|Overall Study|Withdrawal by Subject|3|||
147391922|NCT02171130|531598680|FG000|Overall Study|Physician Decision|1|||
147391923|NCT02171130|531598680|FG000|Overall Study|Lost to Follow-up|1|||
147391924|NCT02171130|531598680|FG000|Overall Study|Met Exclusion Criteria|1|||
147391925|NCT00591409|531598681|FG000|Overall Study|Not Treated|0|||
147391926|NCT00591409|531598682|FG001|Overall Study|Not Treated|0|||
147391927|NCT00591409|531598683|FG002|Overall Study|Not Treated|0|||
147391928|NCT00591409|531598684|FG003|Overall Study|Not Treated|0|||
147391929|NCT00591409|531598685|FG004|Overall Study|Not Treated|1|||
147391930|NCT00591409|531598686|FG005|Overall Study|Not Treated|0|||
147391931|NCT00591409|531598687|FG006|Overall Study|Not Treated|0|||
147391932|NCT00591409|531598688|FG007|Overall Study|Not Treated|0|||
147391933|NCT00591409|531598689|FG008|Overall Study|Not Treated|0|||
147391934|NCT00591409|531598690|FG009|Overall Study|Not Treated|1|||
147391935|NCT02853305|531598693|FG000|Overall Study|Death|287|||
147391936|NCT02853305|531598694|FG001|Overall Study|Death|249|||
147391937|NCT02853305|531598695|FG002|Overall Study|Death|300|||
147391938|NCT02853305|531598693|FG000|Overall Study|Withdrawal by Subject|2|||
147391939|NCT02853305|531598694|FG001|Overall Study|Withdrawal by Subject|8|||
147391940|NCT02853305|531598695|FG002|Overall Study|Withdrawal by Subject|3|||
147391941|NCT02853305|531598693|FG000|Overall Study|Transferred to Extension Study|46|||
147391942|NCT02853305|531598694|FG001|Overall Study|Transferred to Extension Study|30|||
147391943|NCT02853305|531598695|FG002|Overall Study|Transferred to Extension Study|25|||
147391944|NCT02853305|531598693|FG000|Overall Study|Did Not Continue on Extension Study|16|||
147391945|NCT02853305|531598694|FG001|Overall Study|Did Not Continue on Extension Study|20|||
147391946|NCT02853305|531598695|FG002|Overall Study|Did Not Continue on Extension Study|24|||
147391947|NCT04772313|531598696|FG000|Pegloticase + MTX Treatment Period|Lost to Follow-up|3|||
147391948|NCT04772313|531598696|FG000|Pegloticase + MTX Treatment Period|Withdrawal by Subject|3|||
147391949|NCT01836198|531598697|FG000|Part A, Period 2|Protocol Violation|0|||
147391950|NCT01836198|531598698|FG001|Part A, Period 2|Protocol Violation|1|||
147391951|NCT01836198|531598699|FG002|Part A, Period 2|Protocol Violation|0|||
147391952|NCT03187353|531598700|FG000|First Intervention (6 Weeks)|Adverse Event|3|||
147391953|NCT03187353|531598701|FG001|First Intervention (6 Weeks)|Adverse Event|2|||
147391954|NCT03187353|531598700|FG000|First Intervention (6 Weeks)|Withdrawal by Subject|0|||
147391955|NCT03187353|531598701|FG001|First Intervention (6 Weeks)|Withdrawal by Subject|1|||
147391956|NCT03187353|531598700|FG000|Washout (2 Weeks)|Lost to Follow-up|1|||
147391957|NCT03187353|531598701|FG001|Washout (2 Weeks)|Lost to Follow-up|0|||
147391958|NCT03187353|531598700|FG000|Washout (2 Weeks)|Withdrawal by Subject|1|||
147391959|NCT03187353|531598701|FG001|Washout (2 Weeks)|Withdrawal by Subject|1|||
147391960|NCT03187353|531598700|FG000|Washout (2 Weeks)|Adverse Event|2|||
147391961|NCT03187353|531598701|FG001|Washout (2 Weeks)|Adverse Event|0|||
147391962|NCT03187353|531598700|FG000|Second Intervention (6 Weeks)|Adverse Event|1|||
147391963|NCT03187353|531598701|FG001|Second Intervention (6 Weeks)|Adverse Event|0|||
147391964|NCT03794609|531598705|FG000|Overall Study|Other|10|||
147459656|NCT00454779|531845164|FG000|First-line Treatment Phase|Withdrawal by Subject|2|||
147665012|NCT01130272|532597980|FG004|Overall Study|Physician Decision|2|||
147665013|NCT01130272|532597976|FG000|Overall Study|Sponsor decision|6|||
147665014|NCT01130272|532597977|FG001|Overall Study|Sponsor decision|15|||
147665015|NCT01130272|532597978|FG002|Overall Study|Sponsor decision|16|||
147391965|NCT03794609|531598705|FG000|Overall Study|Withdrawal by Subject|66|||
147391966|NCT03794609|531598705|FG000|Overall Study|The child is enrolled in an interventional study|70|||
147391967|NCT03794609|531598705|FG000|Overall Study|Inclusion/exclusion criteria|8|||
147391968|NCT03794609|531598705|FG000|Overall Study|At sponsor's request|151|||
147391969|NCT03794609|531598705|FG000|Overall Study|Physician Decision|1|||
147391970|NCT03794609|531598705|FG000|Overall Study|Lost to Follow-up|5|||
147391971|NCT02205476|531598706|FG000|Overall Study|Study termination by Sponsor|7|||
147391972|NCT02205476|531598707|FG001|Overall Study|Study termination by Sponsor|3|||
147391973|NCT02359552|531598712|FG000|Overall Study|Lost to Follow-up|3|||
147391974|NCT02359552|531598713|FG001|Overall Study|Lost to Follow-up|4|||
147391975|NCT02391116|531598714|FG000|Treatment|Withdrawal by Subject|1|||
147391976|NCT02391116|531598714|FG000|Treatment|Protocol Violation|1|||
147459657|NCT00454779|531845165|FG001|First-line Treatment Phase|Withdrawal by Subject|4|||
147459658|NCT00454779|531845164|FG000|First-line Treatment Phase|Lost to Follow-up|1|||
147459659|NCT00454779|531845165|FG001|First-line Treatment Phase|Lost to Follow-up|0|||
147459660|NCT00454779|531845164|FG000|First-line Treatment Phase|Protocol Violation|0|||
147459661|NCT00454779|531845165|FG001|First-line Treatment Phase|Protocol Violation|1|||
147459662|NCT00454779|531845164|FG000|First-line Treatment Phase|Ended follow-up prior to analysis|1|||
147459663|NCT00454779|531845165|FG001|First-line Treatment Phase|Ended follow-up prior to analysis|1|||
147459664|NCT00454779|531845164|FG000|First-line Treatment Phase|Ongoing|1|||
147459665|NCT00454779|531845165|FG001|First-line Treatment Phase|Ongoing|0|||
147459666|NCT00454779|531845164|FG000|Second-line Treatment Phase|Withdrawal by Subject|0|||
147459667|NCT00454779|531845165|FG001|Second-line Treatment Phase|Withdrawal by Subject|1|||
147459668|NCT00454779|531845164|FG000|Second-line Treatment Phase|Ended follow-up prior to analysis|0|||
147459669|NCT00454779|531845165|FG001|Second-line Treatment Phase|Ended follow-up prior to analysis|1|||
147459670|NCT00454779|531845164|FG000|Second-line Treatment Phase|Ongoing|0|||
147459671|NCT00454779|531845165|FG001|Second-line Treatment Phase|Ongoing|1|||
147459672|NCT00168831|531845167|FG000|Overall Study|Adverse Event|36|||
147391977|NCT02391116|531598714|FG000|Treatment|Adverse Event (AE) Without Clinical PD|9|||
147391978|NCT02391116|531598714|FG000|Treatment|AE with Clinical PD|3|||
147391979|NCT02391116|531598714|FG000|Safety Follow-up|Adverse Event|1|||
147391980|NCT02391116|531598714|FG000|Safety Follow-up|Withdrawal by Subject|4|||
147391981|NCT02391116|531598714|FG000|Safety Follow-up|Switching to Other Therapy|4|||
147391982|NCT02391116|531598714|FG000|Safety Follow-up|No Follow Up|1|||
147391983|NCT02391116|531598714|FG000|Safety Follow-up|Deterioration of General Conditions|3|||
147391984|NCT02391116|531598714|FG000|Active Follow-up|Withdrawal by Subject|1|||
147391985|NCT02391116|531598714|FG000|Active Follow-up|Switching to Other Therapy|2|||
147391986|NCT02391116|531598714|FG000|Survival Follow-up|Withdrawal by Subject|3|||
147391987|NCT02391116|531598714|FG000|Survival Follow-up|Switching to Other Therapy|1|||
147391988|NCT01747629|531598715|FG000|Overall Study|Adverse Event|1|||
147391989|NCT01747629|531598716|FG001|Overall Study|Adverse Event|2|||
147391990|NCT01747629|531598715|FG000|Overall Study|Withdrawal by Subject|2|||
147391991|NCT01747629|531598716|FG001|Overall Study|Withdrawal by Subject|2|||
147391992|NCT01747629|531598715|FG000|Overall Study|Noncompliance|1|||
147391993|NCT01747629|531598716|FG001|Overall Study|Noncompliance|1|||
147391994|NCT01747629|531598715|FG000|Overall Study|Inclusion criteria not met|1|||
147391995|NCT01747629|531598716|FG001|Overall Study|Inclusion criteria not met|0|||
147391996|NCT01747629|531598715|FG000|Overall Study|Not treated|1|||
147391997|NCT01747629|531598716|FG001|Overall Study|Not treated|0|||
147391998|NCT01747629|531598715|FG000|Overall Study|Other|2|||
147391999|NCT01747629|531598716|FG001|Overall Study|Other|1|||
147392000|NCT01770509|531598717|FG000|Overall Study|Injury|0|||
147392001|NCT01770509|531598718|FG001|Overall Study|Injury|1|||
147392002|NCT01770509|531598717|FG000|Overall Study|Lost to Follow-up|1|||
147392003|NCT01770509|531598718|FG001|Overall Study|Lost to Follow-up|2|||
147392004|NCT00794573|531598728|FG000|Overall Study|Death|3|||
147392005|NCT00794573|531598729|FG001|Overall Study|Death|0|||
147392006|NCT00794573|531598728|FG000|Overall Study|Withdrawal by Subject|9|||
147392007|NCT00794573|531598729|FG001|Overall Study|Withdrawal by Subject|12|||
147392008|NCT00794573|531598728|FG000|Overall Study|Lost to Follow-up|26|||
147392009|NCT00794573|531598729|FG001|Overall Study|Lost to Follow-up|33|||
147392010|NCT01294358|531598730|FG000|Cohort 2: 6/9/11-9/17/12|Disease progression|0|||
147392011|NCT01294358|531598731|FG001|Cohort 2: 6/9/11-9/17/12|Disease progression|2|||
147392012|NCT01294358|531598732|FG002|Cohort 2: 6/9/11-9/17/12|Disease progression|0|||
147392013|NCT01294358|531598733|FG003|Cohort 2: 6/9/11-9/17/12|Disease progression|0|||
147392014|NCT01294358|531598734|FG004|Cohort 2: 6/9/11-9/17/12|Disease progression|0|||
147392015|NCT01294358|531598730|FG000|Cohort 3: 12/1/11-10/6/12|Disease progression|0|||
147392016|NCT01294358|531598731|FG001|Cohort 3: 12/1/11-10/6/12|Disease progression|0|||
147392017|NCT01294358|531598732|FG002|Cohort 3: 12/1/11-10/6/12|Disease progression|2|||
147392018|NCT01294358|531598733|FG003|Cohort 3: 12/1/11-10/6/12|Disease progression|0|||
147392019|NCT01294358|531598734|FG004|Cohort 3: 12/1/11-10/6/12|Disease progression|0|||
147392020|NCT01294358|531598730|FG000|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|0|||
147459673|NCT00168831|531845168|FG001|Overall Study|Adverse Event|47|||
147459674|NCT00168831|531845169|FG002|Overall Study|Adverse Event|74|||
147459675|NCT00168831|531845167|FG000|Overall Study|Lost to Follow-up|5|||
147665016|NCT01130272|532597979|FG003|Overall Study|Sponsor decision|13|||
147665017|NCT01130272|532597980|FG004|Overall Study|Sponsor decision|16|||
147665018|NCT01130272|532597976|FG000|Overall Study|Study arm discontinued|38|||
147392021|NCT01294358|531598731|FG001|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|0|||
147392022|NCT01294358|531598732|FG002|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|0|||
147392023|NCT01294358|531598733|FG003|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|1|||
147392024|NCT01294358|531598734|FG004|Cohort 4: 12/30/11-2/17/17|pt rec'd surgical resection of pancreas|0|||
147392025|NCT01294358|531598730|FG000|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|0|||
147392026|NCT01294358|531598731|FG001|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|0|||
147665019|NCT01130272|532597977|FG001|Overall Study|Study arm discontinued|0|||
147615222|NCT03519087|532406655|FG001|Laboratory Testing|Protocol Violation|0|||
147615223|NCT03519087|532406656|FG002|Laboratory Testing|Protocol Violation|0|||
147392027|NCT01294358|531598732|FG002|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|0|||
147392028|NCT01294358|531598733|FG003|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|0|||
147392029|NCT01294358|531598734|FG004|Cohort 5: 3/8/12-3/9/12|dose limiting toxicity grade 4|1|||
147392030|NCT03356145|531598735|FG000|Overall Study|Withdrawal by Subject|2|||
147392031|NCT03356145|531598736|FG001|Overall Study|Withdrawal by Subject|1|||
147392032|NCT03356145|531598735|FG000|Overall Study|Did not meet inclusion criteria|1|||
147392033|NCT03356145|531598736|FG001|Overall Study|Did not meet inclusion criteria|0|||
147392034|NCT02963922|531598737|FG000|Overall Study|Adverse Event|15|||
147392035|NCT02963922|531598738|FG001|Overall Study|Adverse Event|6|||
147392036|NCT02963922|531598737|FG000|Overall Study|Protocol deviation|6|||
147392037|NCT02963922|531598738|FG001|Overall Study|Protocol deviation|6|||
147392038|NCT02963922|531598737|FG000|Overall Study|Lack of Efficacy|1|||
147392039|NCT02963922|531598738|FG001|Overall Study|Lack of Efficacy|1|||
147392040|NCT02963922|531598737|FG000|Overall Study|Lost to Follow-up|2|||
147392041|NCT02963922|531598738|FG001|Overall Study|Lost to Follow-up|3|||
147392042|NCT02963922|531598737|FG000|Overall Study|Other|8|||
147392043|NCT02963922|531598738|FG001|Overall Study|Other|14|||
147392044|NCT00905255|531598747|FG000|Overall Study|Adverse Event|7|||
147392045|NCT00905255|531598748|FG001|Overall Study|Adverse Event|5|||
147392046|NCT00905255|531598747|FG000|Overall Study|Withdrawal by Subject|5|||
147392047|NCT00905255|531598748|FG001|Overall Study|Withdrawal by Subject|4|||
147392048|NCT00905255|531598747|FG000|Overall Study|Familial and Personal Reasons|1|||
147392049|NCT00905255|531598748|FG001|Overall Study|Familial and Personal Reasons|0|||
147392050|NCT01332318|531598751|FG000|Overall Study|Adverse Event|0|||
147392051|NCT01332318|531598752|FG001|Overall Study|Adverse Event|3|||
147392052|NCT01332318|531598753|FG002|Overall Study|Adverse Event|0|||
147392053|NCT01332318|531598754|FG003|Overall Study|Adverse Event|0|||
147392054|NCT01332318|531598751|FG000|Overall Study|Withdrawal by Subject|1|||
147392055|NCT01332318|531598752|FG001|Overall Study|Withdrawal by Subject|1|||
147392056|NCT01332318|531598753|FG002|Overall Study|Withdrawal by Subject|0|||
147392057|NCT01332318|531598754|FG003|Overall Study|Withdrawal by Subject|1|||
147392058|NCT01332318|531598751|FG000|Overall Study|Protocol Violation|1|||
147392059|NCT01332318|531598752|FG001|Overall Study|Protocol Violation|0|||
147392060|NCT01332318|531598753|FG002|Overall Study|Protocol Violation|1|||
147392061|NCT01332318|531598754|FG003|Overall Study|Protocol Violation|1|||
147392062|NCT02040532|531598755|FG000|Overall Study|Lost to Follow-up|1|||
147392063|NCT02040532|531598755|FG000|Overall Study|Physician Decision|4|||
147392064|NCT02040532|531598755|FG000|Overall Study|Adverse Event|4|||
147392065|NCT02040532|531598755|FG000|Overall Study|Withdrawal by Subject|3|||
147392066|NCT00500539|531598757|FG000|Treatment Period (24 Weeks)|Adverse Event|4|||
147392067|NCT00500539|531598757|FG000|Treatment Period (24 Weeks)|Unsatisfactory therapeutic effect|1|||
147392068|NCT00500539|531598757|FG000|Treatment Period (24 Weeks)|Subject withdrew consent|1|||
147392069|NCT00500539|531598757|FG000|Treatment Period (24 Weeks)|Lost to Follow-up|2|||
147392070|NCT00500539|531598757|FG000|Treatment Period (24 Weeks)|Administrative problems|2|||
147392071|NCT00500539|531598757|FG000|Treatment Period (24 Weeks)|Protocol Deviation|5|||
147392072|NCT00500539|531598757|FG000|Follow-up Period (16 Weeks)|Adverse Event|1|||
147392073|NCT00500539|531598757|FG000|Follow-up Period (16 Weeks)|Subject withdrew consent|2|||
147392074|NCT00500539|531598757|FG000|Follow-up Period (16 Weeks)|Lost to Follow-up|3|||
147392075|NCT00500539|531598757|FG000|Follow-up Period (16 Weeks)|Administrative problems|1|||
147392076|NCT00500539|531598757|FG000|Follow-up Period (16 Weeks)|Death|1|||
147392077|NCT00500539|531598757|FG000|Follow-up Period (16 Weeks)|Protocol Deviation|1|||
147392078|NCT00500539|531598757|FG000|Follow-up Period (16 Weeks)|Missing|3|||
147392079|NCT01808144|531598758|FG000|Overall Study|Death|1|||
147392080|NCT01808144|531598759|FG001|Overall Study|Death|0|||
147392081|NCT01808144|531598758|FG000|Overall Study|Withdrawal by Subject|16|||
147392082|NCT01808144|531598759|FG001|Overall Study|Withdrawal by Subject|23|||
147392083|NCT01808144|531598758|FG000|Overall Study|Lost to Follow-up|6|||
147392084|NCT01808144|531598759|FG001|Overall Study|Lost to Follow-up|3|||
147392085|NCT01808144|531598758|FG000|Overall Study|Protocol Violation|6|||
147392086|NCT01808144|531598759|FG001|Overall Study|Protocol Violation|6|||
147392087|NCT01808144|531598758|FG000|Overall Study|Gout flare|0|||
147392088|NCT01808144|531598759|FG001|Overall Study|Gout flare|1|||
147392089|NCT01808144|531598758|FG000|Overall Study|Adverse Event|11|||
147392090|NCT01808144|531598759|FG001|Overall Study|Adverse Event|15|||
147392091|NCT03993054|531598760|FG000|Overall Study|PI Decision|1|||
147392092|NCT04341584|531598761|FG000|Overall Study|Withdrew consent|0|||
147392093|NCT04341584|531598762|FG001|Overall Study|Withdrew consent|2|||
147392094|NCT04341584|531598763|FG002|Overall Study|Withdrew consent|2|||
147392095|NCT04341584|531598764|FG003|Overall Study|Withdrew consent|1|||
147392096|NCT04853238|531598765|FG000|Overall Study|Death|4|||
147392097|NCT04853238|531598766|FG001|Overall Study|Death|0|||
147392098|NCT04853238|531598767|FG002|Overall Study|Death|2|||
147392099|NCT04853238|531598765|FG000|Overall Study|Lost to Follow-up|16|||
147392100|NCT04853238|531598766|FG001|Overall Study|Lost to Follow-up|2|||
147392101|NCT04853238|531598767|FG002|Overall Study|Lost to Follow-up|37|||
147392102|NCT04853238|531598765|FG000|Overall Study|Poor adherence, unable to cooperate with investigator to complete test|1|||
147392103|NCT04853238|531598766|FG001|Overall Study|Poor adherence, unable to cooperate with investigator to complete test|1|||
147392104|NCT04853238|531598767|FG002|Overall Study|Poor adherence, unable to cooperate with investigator to complete test|10|||
147392105|NCT04853238|531598765|FG000|Overall Study|Withdrawal by Subject|6|||
147392106|NCT04853238|531598766|FG001|Overall Study|Withdrawal by Subject|0|||
147392107|NCT04853238|531598767|FG002|Overall Study|Withdrawal by Subject|21|||
147392108|NCT04853238|531598765|FG000|Overall Study|Physician Decision|0|||
147392109|NCT04853238|531598766|FG001|Overall Study|Physician Decision|0|||
147392110|NCT04853238|531598767|FG002|Overall Study|Physician Decision|2|||
147392111|NCT04853238|531598765|FG000|Overall Study|Violation of inclusion/exclusion criteria|3|||
147392112|NCT04853238|531598766|FG001|Overall Study|Violation of inclusion/exclusion criteria|0|||
147392113|NCT04853238|531598767|FG002|Overall Study|Violation of inclusion/exclusion criteria|1|||
147392114|NCT02972242|531600449|FG000|Overall Study|Withdrawal by Subject|1|||
147392115|NCT02972242|531600450|FG001|Overall Study|Withdrawal by Subject|0|||
147392116|NCT03098797|531600451|FG000|Part 2 Open Label Extension|Adverse Event|2|||
147392117|NCT03098797|531600452|FG001|Part 2 Open Label Extension|Adverse Event|0|||
147392118|NCT00509821|531600453|FG000|Study Period 1 (Induction)|Death|0|||
147392119|NCT00509821|531600454|FG001|Study Period 1 (Induction)|Death|1|||
147392120|NCT00509821|531600453|FG000|Study Period 1 (Induction)|Adverse Event|0|||
147392121|NCT00509821|531600454|FG001|Study Period 1 (Induction)|Adverse Event|2|||
147392122|NCT00509821|531600453|FG000|Study Period 1 (Induction)|Progressive Disease|0|||
147392123|NCT00509821|531600454|FG001|Study Period 1 (Induction)|Progressive Disease|1|||
147392124|NCT00552513|531600459|FG000|Overall Study|Lost to Follow-up|5|||
147392125|NCT00552513|531600460|FG001|Overall Study|Lost to Follow-up|1|||
147392126|NCT02229396|531600465|FG000|Overall Study|Adverse Event|6|||
147392127|NCT02229396|531600466|FG001|Overall Study|Adverse Event|12|||
147392128|NCT02229396|531600467|FG002|Overall Study|Adverse Event|12|||
147392129|NCT02229396|531600465|FG000|Overall Study|Death|2|||
147392130|NCT02229396|531600466|FG001|Overall Study|Death|3|||
147392131|NCT02229396|531600467|FG002|Overall Study|Death|1|||
147392132|NCT02229396|531600465|FG000|Overall Study|Lost to Follow-up|14|||
147392133|NCT02229396|531600466|FG001|Overall Study|Lost to Follow-up|14|||
147392134|NCT02229396|531600467|FG002|Overall Study|Lost to Follow-up|21|||
147392135|NCT02229396|531600465|FG000|Overall Study|Protocol Violation|2|||
147392136|NCT02229396|531600466|FG001|Overall Study|Protocol Violation|1|||
147392137|NCT02229396|531600467|FG002|Overall Study|Protocol Violation|0|||
147392138|NCT02229396|531600465|FG000|Overall Study|Patient Incorrectly Randomized|0|||
147392139|NCT02229396|531600466|FG001|Overall Study|Patient Incorrectly Randomized|0|||
147392140|NCT02229396|531600467|FG002|Overall Study|Patient Incorrectly Randomized|1|||
147392141|NCT02229396|531600465|FG000|Overall Study|Other|10|||
147392142|NCT02229396|531600466|FG001|Overall Study|Other|18|||
147392143|NCT02229396|531600467|FG002|Overall Study|Other|15|||
147392144|NCT02229396|531600465|FG000|Overall Study|Withdrawal by Subject|42|||
147392145|NCT02229396|531600466|FG001|Overall Study|Withdrawal by Subject|28|||
147392146|NCT02229396|531600467|FG002|Overall Study|Withdrawal by Subject|41|||
147392147|NCT02229396|531600465|FG000|Overall Study|Study-Specific Withdrawal Criteria|0|||
147392148|NCT02229396|531600466|FG001|Overall Study|Study-Specific Withdrawal Criteria|1|||
147392149|NCT02229396|531600467|FG002|Overall Study|Study-Specific Withdrawal Criteria|3|||
147392150|NCT02229396|531600465|FG000|Overall Study|Withdrew; No Record on Termination Page|2|||
147392151|NCT02229396|531600466|FG001|Overall Study|Withdrew; No Record on Termination Page|0|||
147392152|NCT02229396|531600467|FG002|Overall Study|Withdrew; No Record on Termination Page|1|||
147392153|NCT02679079|531600474|FG000|Overall Study|Adverse Event|2|||
147392154|NCT02679079|531600475|FG001|Overall Study|Adverse Event|0|||
147392155|NCT02679079|531600476|FG002|Overall Study|Adverse Event|2|||
147392156|NCT02679079|531600474|FG000|Overall Study|Protocol Violation|0|||
147392157|NCT02679079|531600475|FG001|Overall Study|Protocol Violation|1|||
147392158|NCT02679079|531600476|FG002|Overall Study|Protocol Violation|0|||
147392159|NCT02679079|531600474|FG000|Overall Study|Withdrawal by Subject|2|||
147392160|NCT02679079|531600475|FG001|Overall Study|Withdrawal by Subject|1|||
147392161|NCT02679079|531600476|FG002|Overall Study|Withdrawal by Subject|0|||
147615224|NCT03519087|532406657|FG003|Laboratory Testing|Protocol Violation|1|||
147615225|NCT03519087|532406658|FG004|Laboratory Testing|Protocol Violation|0|||
147392162|NCT03924947|531600477|FG000|Part 1: Double Blind Period 1|Other, Not Specified|0|||
147392163|NCT03924947|531600478|FG001|Part 1: Double Blind Period 1|Other, Not Specified|0|||
147392164|NCT03924947|531600479|FG002|Part 1: Double Blind Period 1|Other, Not Specified|1|||
147392165|NCT03924947|531600480|FG003|Part 1: Double Blind Period 1|Other, Not Specified|0|||
147392166|NCT03924947|531600481|FG004|Part 1: Double Blind Period 1|Other, Not Specified|0|||
147392167|NCT03924947|531600482|FG005|Part 1: Double Blind Period 1|Other, Not Specified|0|||
147392168|NCT01441583|531600485|FG000|Overall Study|Withdrawal by Subject|1|||
147392169|NCT01441583|531600486|FG001|Overall Study|Withdrawal by Subject|1|||
147392170|NCT01441583|531600487|FG002|Overall Study|Withdrawal by Subject|1|||
147392171|NCT01441583|531600485|FG000|Overall Study|Death|1|||
147392172|NCT01441583|531600486|FG001|Overall Study|Death|0|||
147392173|NCT01441583|531600487|FG002|Overall Study|Death|4|||
147459676|NCT00168831|531845168|FG001|Overall Study|Lost to Follow-up|6|||
147459677|NCT00168831|531845169|FG002|Overall Study|Lost to Follow-up|4|||
147459678|NCT00168831|531845167|FG000|Overall Study|Withdrawal by Subject|7|||
147459679|NCT00168831|531845168|FG001|Overall Study|Withdrawal by Subject|14|||
147459680|NCT00168831|531845169|FG002|Overall Study|Withdrawal by Subject|19|||
147459681|NCT00168831|531845167|FG000|Overall Study|Protocol Violation|6|||
147459682|NCT00168831|531845168|FG001|Overall Study|Protocol Violation|11|||
147459683|NCT00168831|531845169|FG002|Overall Study|Protocol Violation|11|||
147459684|NCT00168831|531845167|FG000|Overall Study|Other|6|||
147459685|NCT00168831|531845168|FG001|Overall Study|Other|3|||
147459686|NCT00168831|531845169|FG002|Overall Study|Other|6|||
147459687|NCT01622569|531845170|FG000|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|4|||
147459688|NCT01622569|531845171|FG001|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|2|||
147459689|NCT01622569|531845172|FG002|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|3|||
147459690|NCT01622569|531845173|FG003|Double-Blind Treatment Phase (Wks 1-16)|Adverse Event|1|||
147459691|NCT01622569|531845170|FG000|Double-Blind Treatment Phase (Wks 1-16)|Lost to Follow-up|0|||
147459692|NCT01622569|531845171|FG001|Double-Blind Treatment Phase (Wks 1-16)|Lost to Follow-up|0|||
147459693|NCT01622569|531845172|FG002|Double-Blind Treatment Phase (Wks 1-16)|Lost to Follow-up|1|||
147459694|NCT01622569|531845173|FG003|Double-Blind Treatment Phase (Wks 1-16)|Lost to Follow-up|0|||
147459695|NCT01622569|531845170|FG000|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|6|||
147459696|NCT01622569|531845171|FG001|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|0|||
147459697|NCT01622569|531845172|FG002|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|3|||
147459698|NCT01622569|531845173|FG003|Double-Blind Treatment Phase (Wks 1-16)|Lack of Efficacy|2|||
147459699|NCT01622569|531845170|FG000|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0|||
147459700|NCT01622569|531845171|FG001|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|2|||
147459701|NCT01622569|531845172|FG002|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|0|||
147459702|NCT01622569|531845173|FG003|Double-Blind Treatment Phase (Wks 1-16)|Protocol Violation|1|||
147459703|NCT01622569|531845170|FG000|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|2|||
147459704|NCT01622569|531845171|FG001|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|2|||
147459705|NCT01622569|531845172|FG002|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|2|||
147459706|NCT01622569|531845173|FG003|Double-Blind Treatment Phase (Wks 1-16)|Withdrawal by Subject|0|||
147615226|NCT00104572|532406659|FG000|Overall Study|Withdrawal by Subject|3|||
147615227|NCT00104572|532406660|FG001|Overall Study|Withdrawal by Subject|3|||
147615228|NCT00104572|532406661|FG002|Overall Study|Withdrawal by Subject|0|||
147615229|NCT02290405|532406663|FG000|Overall Study|Withdrawal by Subject|1|||
147392174|NCT01441583|531600485|FG000|Overall Study|Underwent anaesthesia, but not finally implanted|0|||
147392175|NCT01441583|531600486|FG001|Overall Study|Underwent anaesthesia, but not finally implanted|0|||
147392176|NCT01441583|531600487|FG002|Overall Study|Underwent anaesthesia, but not finally implanted|4|||
147392177|NCT05060237|531600489|FG000|Overall Study|Withdrawal by Subject|4|||
147392178|NCT05060237|531600489|FG000|Overall Study|Screening failure|8|||
147392179|NCT01697592|531600493|FG000|Phase A (Up to 24 Weeks)|Lost to Follow-up|1|||
147392180|NCT01697592|531600494|FG001|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
147392181|NCT01697592|531600495|FG002|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
147392182|NCT01697592|531600496|FG003|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
147392183|NCT01697592|531600497|FG004|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
147392184|NCT01697592|531600498|FG005|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
147392185|NCT01697592|531600499|FG006|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
147392186|NCT01697592|531600500|FG007|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
147392187|NCT01697592|531600501|FG008|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
147392188|NCT01697592|531600502|FG009|Phase A (Up to 24 Weeks)|Lost to Follow-up|0|||
147392189|NCT01697592|531600493|FG000|Phase A (Up to 24 Weeks)|Physician Decision|0|||
147392190|NCT01697592|531600494|FG001|Phase A (Up to 24 Weeks)|Physician Decision|0|||
147392191|NCT01697592|531600495|FG002|Phase A (Up to 24 Weeks)|Physician Decision|0|||
147392192|NCT01697592|531600496|FG003|Phase A (Up to 24 Weeks)|Physician Decision|0|||
147392193|NCT01697592|531600497|FG004|Phase A (Up to 24 Weeks)|Physician Decision|0|||
147392194|NCT01697592|531600498|FG005|Phase A (Up to 24 Weeks)|Physician Decision|1|||
147392195|NCT01697592|531600499|FG006|Phase A (Up to 24 Weeks)|Physician Decision|0|||
147392196|NCT01697592|531600500|FG007|Phase A (Up to 24 Weeks)|Physician Decision|0|||
147459707|NCT01622569|531845170|FG000|Open-Label Extension Phase (Wks 17-24)|Adverse Event|0|||
147459708|NCT01622569|531845171|FG001|Open-Label Extension Phase (Wks 17-24)|Adverse Event|2|||
147459709|NCT01622569|531845172|FG002|Open-Label Extension Phase (Wks 17-24)|Adverse Event|1|||
147459710|NCT01622569|531845173|FG003|Open-Label Extension Phase (Wks 17-24)|Adverse Event|0|||
147459711|NCT01622569|531845170|FG000|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|1|||
147459712|NCT01622569|531845171|FG001|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|0|||
147459713|NCT01622569|531845172|FG002|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|2|||
147459714|NCT01622569|531845173|FG003|Open-Label Extension Phase (Wks 17-24)|Lack of Efficacy|1|||
147459715|NCT01622569|531845170|FG000|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
147392197|NCT01697592|531600501|FG008|Phase A (Up to 24 Weeks)|Physician Decision|0|||
147459716|NCT01622569|531845171|FG001|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
147459717|NCT01622569|531845172|FG002|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|0|||
147392198|NCT01697592|531600502|FG009|Phase A (Up to 24 Weeks)|Physician Decision|0|||
147392199|NCT01697592|531600493|FG000|Phase A (Up to 24 Weeks)|Protocol Violation|1|||
147392200|NCT01697592|531600494|FG001|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
147392201|NCT01697592|531600495|FG002|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
147392202|NCT01697592|531600496|FG003|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
147392203|NCT01697592|531600497|FG004|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
147392204|NCT01697592|531600498|FG005|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
147392205|NCT01697592|531600499|FG006|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
147392206|NCT01697592|531600500|FG007|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
147392207|NCT01697592|531600501|FG008|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
147392208|NCT01697592|531600502|FG009|Phase A (Up to 24 Weeks)|Protocol Violation|0|||
147392209|NCT01697592|531600493|FG000|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1|||
147392210|NCT01697592|531600494|FG001|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1|||
147392211|NCT01697592|531600495|FG002|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
147392212|NCT01697592|531600496|FG003|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
147392213|NCT01697592|531600497|FG004|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
147392214|NCT01697592|531600498|FG005|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
147392215|NCT01697592|531600499|FG006|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1|||
147392216|NCT01697592|531600500|FG007|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
147392217|NCT01697592|531600501|FG008|Phase A (Up to 24 Weeks)|Withdrawal by Subject|0|||
147392218|NCT01697592|531600502|FG009|Phase A (Up to 24 Weeks)|Withdrawal by Subject|1|||
147392219|NCT01697592|531600493|FG000|Phase A (Up to 24 Weeks)|Adverse Event|0|||
147392220|NCT01697592|531600494|FG001|Phase A (Up to 24 Weeks)|Adverse Event|2|||
147392221|NCT01697592|531600495|FG002|Phase A (Up to 24 Weeks)|Adverse Event|1|||
147392222|NCT01697592|531600496|FG003|Phase A (Up to 24 Weeks)|Adverse Event|2|||
147392223|NCT01697592|531600497|FG004|Phase A (Up to 24 Weeks)|Adverse Event|0|||
147392224|NCT01697592|531600498|FG005|Phase A (Up to 24 Weeks)|Adverse Event|0|||
147392225|NCT01697592|531600499|FG006|Phase A (Up to 24 Weeks)|Adverse Event|1|||
147392226|NCT01697592|531600500|FG007|Phase A (Up to 24 Weeks)|Adverse Event|0|||
147392227|NCT01697592|531600501|FG008|Phase A (Up to 24 Weeks)|Adverse Event|0|||
147392228|NCT01697592|531600502|FG009|Phase A (Up to 24 Weeks)|Adverse Event|1|||
147392229|NCT01697592|531600493|FG000|Phase B (Week 25 to Week 52)|Physician Decision|1|||
147392230|NCT01697592|531600494|FG001|Phase B (Week 25 to Week 52)|Physician Decision|0|||
147392231|NCT01697592|531600495|FG002|Phase B (Week 25 to Week 52)|Physician Decision|0|||
147392232|NCT01697592|531600496|FG003|Phase B (Week 25 to Week 52)|Physician Decision|1|||
147392233|NCT01697592|531600497|FG004|Phase B (Week 25 to Week 52)|Physician Decision|0|||
147392234|NCT01697592|531600498|FG005|Phase B (Week 25 to Week 52)|Physician Decision|0|||
147392235|NCT01697592|531600499|FG006|Phase B (Week 25 to Week 52)|Physician Decision|0|||
147392236|NCT01697592|531600500|FG007|Phase B (Week 25 to Week 52)|Physician Decision|0|||
147392237|NCT01697592|531600501|FG008|Phase B (Week 25 to Week 52)|Physician Decision|0|||
147392238|NCT01697592|531600502|FG009|Phase B (Week 25 to Week 52)|Physician Decision|0|||
147392239|NCT01697592|531600493|FG000|Phase B (Week 25 to Week 52)|Withdrawal by Subject|2|||
147392240|NCT01697592|531600494|FG001|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
147392241|NCT01697592|531600495|FG002|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
147392242|NCT01697592|531600496|FG003|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
147392243|NCT01697592|531600497|FG004|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
147392244|NCT01697592|531600498|FG005|Phase B (Week 25 to Week 52)|Withdrawal by Subject|1|||
147392245|NCT01697592|531600499|FG006|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
147392246|NCT01697592|531600500|FG007|Phase B (Week 25 to Week 52)|Withdrawal by Subject|1|||
147392247|NCT01697592|531600501|FG008|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
147392248|NCT01697592|531600502|FG009|Phase B (Week 25 to Week 52)|Withdrawal by Subject|0|||
147392249|NCT01697592|531600493|FG000|Phase B (Week 25 to Week 52)|Adverse Event|2|||
147392250|NCT01697592|531600494|FG001|Phase B (Week 25 to Week 52)|Adverse Event|1|||
147392251|NCT01697592|531600495|FG002|Phase B (Week 25 to Week 52)|Adverse Event|1|||
147392252|NCT01697592|531600496|FG003|Phase B (Week 25 to Week 52)|Adverse Event|2|||
147392253|NCT01697592|531600497|FG004|Phase B (Week 25 to Week 52)|Adverse Event|0|||
147392254|NCT01697592|531600498|FG005|Phase B (Week 25 to Week 52)|Adverse Event|1|||
147392255|NCT01697592|531600499|FG006|Phase B (Week 25 to Week 52)|Adverse Event|1|||
147459718|NCT01622569|531845173|FG003|Open-Label Extension Phase (Wks 17-24)|Withdrawal by Subject|1|||
147459719|NCT01505894|531845174|FG000|Overall Study|Adverse Event|1|||
147459720|NCT01505894|531845175|FG001|Overall Study|Adverse Event|0|||
147392256|NCT01697592|531600500|FG007|Phase B (Week 25 to Week 52)|Adverse Event|0|||
147392257|NCT01697592|531600501|FG008|Phase B (Week 25 to Week 52)|Adverse Event|2|||
147392258|NCT01697592|531600502|FG009|Phase B (Week 25 to Week 52)|Adverse Event|0|||
147392259|NCT00666835|531600503|FG000|Overall Study|Withdrawal by Subject|5|||
147392260|NCT00666835|531600504|FG001|Overall Study|Withdrawal by Subject|2|||
147459721|NCT01505894|531845176|FG002|Overall Study|Adverse Event|0|||
147459722|NCT01505894|531845177|FG003|Overall Study|Adverse Event|0|||
147459723|NCT01505894|531845178|FG004|Overall Study|Adverse Event|0|||
147459724|NCT01505894|531845179|FG005|Overall Study|Adverse Event|0|||
147665020|NCT01130272|532597978|FG002|Overall Study|Study arm discontinued|0|||
147392261|NCT00666835|531600503|FG000|Overall Study|Lack of Efficacy|0|||
147392262|NCT00666835|531600504|FG001|Overall Study|Lack of Efficacy|1|||
147392263|NCT00666835|531600503|FG000|Overall Study|Incl./excl. not fulfilled|7|||
147392264|NCT00666835|531600504|FG001|Overall Study|Incl./excl. not fulfilled|2|||
147392265|NCT00666835|531600503|FG000|Overall Study|Adverse Event|7|||
147392266|NCT00666835|531600504|FG001|Overall Study|Adverse Event|6|||
147392267|NCT00666835|531600503|FG000|Overall Study|Protocol Violation|2|||
147392268|NCT00666835|531600504|FG001|Overall Study|Protocol Violation|0|||
147392269|NCT00666835|531600503|FG000|Overall Study|Death|15|||
147392270|NCT00666835|531600504|FG001|Overall Study|Death|4|||
147392271|NCT00666835|531600503|FG000|Overall Study|Kidney Transplantation (NTX)|10|||
147392272|NCT00666835|531600504|FG001|Overall Study|Kidney Transplantation (NTX)|2|||
147392273|NCT00666835|531600503|FG000|Overall Study|Hemoglobulin concentration|4|||
147392274|NCT00666835|531600504|FG001|Overall Study|Hemoglobulin concentration|3|||
147392275|NCT00666835|531600503|FG000|Overall Study|Planned operation|2|||
147392276|NCT00666835|531600504|FG001|Overall Study|Planned operation|0|||
147392277|NCT00666835|531600503|FG000|Overall Study|Physician Decision|1|||
147392278|NCT00666835|531600504|FG001|Overall Study|Physician Decision|2|||
147392279|NCT00899379|531600505|FG000|Overall Study|Adverse Event|2|||
147392280|NCT00899379|531600506|FG001|Overall Study|Adverse Event|2|||
147392281|NCT00899379|531600507|FG002|Overall Study|Adverse Event|1|||
147392282|NCT00899379|531600508|FG003|Overall Study|Adverse Event|1|||
147392283|NCT00899379|531600509|FG004|Overall Study|Adverse Event|2|||
147392284|NCT00899379|531600505|FG000|Overall Study|Lack of Efficacy|0|||
147392285|NCT00899379|531600506|FG001|Overall Study|Lack of Efficacy|4|||
147392286|NCT00899379|531600507|FG002|Overall Study|Lack of Efficacy|3|||
147392287|NCT00899379|531600508|FG003|Overall Study|Lack of Efficacy|0|||
147392288|NCT00899379|531600509|FG004|Overall Study|Lack of Efficacy|1|||
147392289|NCT00899379|531600505|FG000|Overall Study|Lost to Follow-up|9|||
147392290|NCT00899379|531600506|FG001|Overall Study|Lost to Follow-up|3|||
147392291|NCT00899379|531600507|FG002|Overall Study|Lost to Follow-up|0|||
147392292|NCT00899379|531600508|FG003|Overall Study|Lost to Follow-up|6|||
147392293|NCT00899379|531600509|FG004|Overall Study|Lost to Follow-up|2|||
147392294|NCT00899379|531600505|FG000|Overall Study|Protocol Violation|0|||
147392295|NCT00899379|531600506|FG001|Overall Study|Protocol Violation|0|||
147392296|NCT00899379|531600507|FG002|Overall Study|Protocol Violation|1|||
147392297|NCT00899379|531600508|FG003|Overall Study|Protocol Violation|1|||
147392298|NCT00899379|531600509|FG004|Overall Study|Protocol Violation|0|||
147392299|NCT00899379|531600505|FG000|Overall Study|Withdrawal by Subject|2|||
147392300|NCT00899379|531600506|FG001|Overall Study|Withdrawal by Subject|4|||
147392301|NCT00899379|531600507|FG002|Overall Study|Withdrawal by Subject|2|||
147392302|NCT00899379|531600508|FG003|Overall Study|Withdrawal by Subject|3|||
147392303|NCT00899379|531600509|FG004|Overall Study|Withdrawal by Subject|6|||
147392304|NCT00899379|531600505|FG000|Overall Study|Pregnancy|0|||
147392305|NCT00899379|531600506|FG001|Overall Study|Pregnancy|0|||
147392306|NCT00899379|531600507|FG002|Overall Study|Pregnancy|1|||
147392307|NCT00899379|531600508|FG003|Overall Study|Pregnancy|0|||
147392308|NCT00899379|531600509|FG004|Overall Study|Pregnancy|1|||
147392309|NCT00899379|531600505|FG000|Overall Study|Patient Uncooperative|0|||
147392310|NCT00899379|531600506|FG001|Overall Study|Patient Uncooperative|1|||
147392311|NCT00899379|531600507|FG002|Overall Study|Patient Uncooperative|0|||
147665021|NCT01130272|532597979|FG003|Overall Study|Study arm discontinued|0|||
147665022|NCT01130272|532597980|FG004|Overall Study|Study arm discontinued|0|||
147665023|NCT01548404|532597981|FG000|Overall Study|Adverse Event|3|||
147665024|NCT01548404|532597982|FG001|Overall Study|Adverse Event|1|||
147665025|NCT01548404|532597981|FG000|Overall Study|Physician Decision|2|||
147665026|NCT01548404|532597982|FG001|Overall Study|Physician Decision|1|||
147665027|NCT01548404|532597981|FG000|Overall Study|Inadequate response to study treatment|23|||
147665028|NCT01548404|532597982|FG001|Overall Study|Inadequate response to study treatment|7|||
147665029|NCT01548404|532597981|FG000|Overall Study|Lost to Follow-up|2|||
147665030|NCT01548404|532597982|FG001|Overall Study|Lost to Follow-up|0|||
147665031|NCT01548404|532597981|FG000|Overall Study|Withdrawal by Subject|0|||
147665032|NCT01548404|532597982|FG001|Overall Study|Withdrawal by Subject|3|||
147392312|NCT00899379|531600508|FG003|Overall Study|Patient Uncooperative|1|||
147392313|NCT00899379|531600509|FG004|Overall Study|Patient Uncooperative|2|||
147665033|NCT01548404|532597981|FG000|Overall Study|Other than specified above|0|||
147665034|NCT01548404|532597982|FG001|Overall Study|Other than specified above|2|||
147665035|NCT00641056|532597983|FG000|Overall Study|Adverse Event|12|||
147392314|NCT00899379|531600505|FG000|Overall Study|Abnormal Baseline ECG|0|||
147665036|NCT00641056|532597984|FG001|Overall Study|Adverse Event|2|||
147392315|NCT00899379|531600506|FG001|Overall Study|Abnormal Baseline ECG|0|||
147392316|NCT00899379|531600507|FG002|Overall Study|Abnormal Baseline ECG|0|||
147665037|NCT00641056|532597983|FG000|Overall Study|Lost to Follow-up|2|||
147392317|NCT00899379|531600508|FG003|Overall Study|Abnormal Baseline ECG|1|||
147392318|NCT00899379|531600509|FG004|Overall Study|Abnormal Baseline ECG|0|||
147392319|NCT00899379|531600505|FG000|Overall Study|No Longer Met Inc/Exc Criteria|1|||
147665038|NCT00641056|532597984|FG001|Overall Study|Lost to Follow-up|1|||
147665039|NCT00641056|532597983|FG000|Overall Study|Physician Decision|3|||
147392320|NCT00899379|531600506|FG001|Overall Study|No Longer Met Inc/Exc Criteria|1|||
147392321|NCT00899379|531600507|FG002|Overall Study|No Longer Met Inc/Exc Criteria|1|||
147392322|NCT00899379|531600508|FG003|Overall Study|No Longer Met Inc/Exc Criteria|0|||
147392323|NCT00899379|531600509|FG004|Overall Study|No Longer Met Inc/Exc Criteria|0|||
147392324|NCT00899379|531600505|FG000|Overall Study|Not Completed/Entered Extn|5|||
147392325|NCT00899379|531600506|FG001|Overall Study|Not Completed/Entered Extn|1|||
147392326|NCT00899379|531600507|FG002|Overall Study|Not Completed/Entered Extn|6|||
147392327|NCT00899379|531600508|FG003|Overall Study|Not Completed/Entered Extn|4|||
147392328|NCT00899379|531600509|FG004|Overall Study|Not Completed/Entered Extn|3|||
147392329|NCT00899379|531600505|FG000|Overall Study|Study Terminated|3|||
147392330|NCT00899379|531600506|FG001|Overall Study|Study Terminated|0|||
147392331|NCT00899379|531600507|FG002|Overall Study|Study Terminated|3|||
147392332|NCT00899379|531600508|FG003|Overall Study|Study Terminated|3|||
147392333|NCT00899379|531600509|FG004|Overall Study|Study Terminated|1|||
147392334|NCT00899379|531600505|FG000|Overall Study|Lost to Follow-up|3|||
147392335|NCT00899379|531600506|FG001|Overall Study|Lost to Follow-up|1|||
147392336|NCT00899379|531600507|FG002|Overall Study|Lost to Follow-up|0|||
147392337|NCT00899379|531600508|FG003|Overall Study|Lost to Follow-up|2|||
147392338|NCT00899379|531600509|FG004|Overall Study|Lost to Follow-up|5|||
147392339|NCT00899379|531600505|FG000|Overall Study|Withdrawal by Subject|4|||
147392340|NCT00899379|531600506|FG001|Overall Study|Withdrawal by Subject|7|||
147392341|NCT00899379|531600507|FG002|Overall Study|Withdrawal by Subject|4|||
147392342|NCT00899379|531600508|FG003|Overall Study|Withdrawal by Subject|7|||
147392343|NCT00899379|531600509|FG004|Overall Study|Withdrawal by Subject|2|||
147392344|NCT00899379|531600505|FG000|Overall Study|Pregnancy|1|||
147392345|NCT00899379|531600506|FG001|Overall Study|Pregnancy|0|||
147392346|NCT00899379|531600507|FG002|Overall Study|Pregnancy|0|||
147392347|NCT00899379|531600508|FG003|Overall Study|Pregnancy|0|||
147392348|NCT00899379|531600509|FG004|Overall Study|Pregnancy|0|||
147392349|NCT00899379|531600505|FG000|Overall Study|Patient Uncooperative|0|||
147392350|NCT00899379|531600506|FG001|Overall Study|Patient Uncooperative|0|||
147392351|NCT00899379|531600507|FG002|Overall Study|Patient Uncooperative|0|||
147392352|NCT00899379|531600508|FG003|Overall Study|Patient Uncooperative|1|||
147392353|NCT00899379|531600509|FG004|Overall Study|Patient Uncooperative|0|||
147392354|NCT00899379|531600505|FG000|Overall Study|Abnormal Prestudy Labs|0|||
147392355|NCT00899379|531600506|FG001|Overall Study|Abnormal Prestudy Labs|0|||
147392356|NCT00899379|531600507|FG002|Overall Study|Abnormal Prestudy Labs|0|||
147392357|NCT00899379|531600508|FG003|Overall Study|Abnormal Prestudy Labs|0|||
147392358|NCT00899379|531600509|FG004|Overall Study|Abnormal Prestudy Labs|2|||
147392359|NCT00899379|531600505|FG000|Overall Study|Abnormal Baseline ECG|0|||
147392360|NCT00899379|531600506|FG001|Overall Study|Abnormal Baseline ECG|0|||
147392361|NCT00899379|531600507|FG002|Overall Study|Abnormal Baseline ECG|1|||
147392362|NCT00899379|531600508|FG003|Overall Study|Abnormal Baseline ECG|1|||
147392363|NCT00899379|531600509|FG004|Overall Study|Abnormal Baseline ECG|0|||
147392364|NCT00899379|531600505|FG000|Overall Study|No Attack Pretreatment|3|||
147392365|NCT00899379|531600506|FG001|Overall Study|No Attack Pretreatment|5|||
147392366|NCT00899379|531600507|FG002|Overall Study|No Attack Pretreatment|5|||
147392367|NCT00899379|531600508|FG003|Overall Study|No Attack Pretreatment|6|||
147392368|NCT00899379|531600509|FG004|Overall Study|No Attack Pretreatment|4|||
147392369|NCT00899379|531600505|FG000|Overall Study|No Longer Met Inc/Exc Criteria|1|||
147392370|NCT00899379|531600506|FG001|Overall Study|No Longer Met Inc/Exc Criteria|0|||
147392371|NCT00899379|531600507|FG002|Overall Study|No Longer Met Inc/Exc Criteria|0|||
147392372|NCT00899379|531600508|FG003|Overall Study|No Longer Met Inc/Exc Criteria|0|||
147392373|NCT00899379|531600509|FG004|Overall Study|No Longer Met Inc/Exc Criteria|0|||
147392374|NCT00899379|531600505|FG000|Overall Study|Inc/Exc Criteria Not Met|0|||
147392375|NCT00899379|531600506|FG001|Overall Study|Inc/Exc Criteria Not Met|0|||
147392376|NCT00899379|531600507|FG002|Overall Study|Inc/Exc Criteria Not Met|1|||
147392377|NCT00899379|531600508|FG003|Overall Study|Inc/Exc Criteria Not Met|0|||
147392378|NCT00899379|531600509|FG004|Overall Study|Inc/Exc Criteria Not Met|0|||
147392379|NCT03319719|531600515|FG000|Overall Study|Lost to Follow-up|1|||
147392380|NCT00744796|531600516|FG000|Post-Operative 6-9 Months|Lost to Follow-up|12|||
147392381|NCT02581189|531600517|FG000|Overall Study|Failure to return|36|||
147392382|NCT02581189|531600517|FG000|Overall Study|Withdrew consent|5|||
147392383|NCT02581189|531600517|FG000|Overall Study|Death|3|||
147392384|NCT02581189|531600517|FG000|Overall Study|Insufficient virological response|2|||
147392385|NCT02581189|531600517|FG000|Overall Study|Other, not specified|7|||
147392386|NCT02253147|531600518|FG000|Overall Study|Protocol Violation|30|||
147392387|NCT02253147|531600518|FG000|Overall Study|Did not consent to study extension|9|||
147459725|NCT01505894|531845180|FG006|Overall Study|Adverse Event|0|||
147392388|NCT02253147|531600518|FG000|Overall Study|Conditional re-treatment at W52|5|||
147392389|NCT02253147|531600518|FG000|Overall Study|Lost to Follow-up|2|||
147392390|NCT02253147|531600518|FG000|Overall Study|Withdrawal by Subject|1|||
147392391|NCT00396097|531600522|FG000|Overall Study|Withdrawal by Subject|17|||
147392392|NCT00396097|531600523|FG001|Overall Study|Withdrawal by Subject|17|||
147392393|NCT00396097|531600522|FG000|Overall Study|Lost to Follow-up|4|||
147392394|NCT00396097|531600523|FG001|Overall Study|Lost to Follow-up|9|||
147392395|NCT00396097|531600522|FG000|Overall Study|Other|3|||
147392396|NCT00396097|531600523|FG001|Overall Study|Other|5|||
147392397|NCT00396097|531600522|FG000|Overall Study|Protocol Violation|0|||
147392398|NCT00396097|531600523|FG001|Overall Study|Protocol Violation|6|||
147392399|NCT00396097|531600522|FG000|Overall Study|Adverse Event|1|||
147392400|NCT00396097|531600523|FG001|Overall Study|Adverse Event|5|||
147392401|NCT00396097|531600522|FG000|Overall Study|Insufficient Clinical Response|1|||
147392402|NCT00396097|531600523|FG001|Overall Study|Insufficient Clinical Response|4|||
147392403|NCT03461211|531600524|FG000|Overall Study|Adverse Event|1|||
147392404|NCT03461211|531600525|FG001|Overall Study|Adverse Event|1|||
147392405|NCT03461211|531600524|FG000|Overall Study|Lack of Efficacy|0|||
147392406|NCT03461211|531600525|FG001|Overall Study|Lack of Efficacy|1|||
147392407|NCT03807700|531600526|FG000|Overall Study|Withdrawal by Subject|2|||
147392408|NCT03807700|531600527|FG001|Overall Study|Withdrawal by Subject|1|||
147392409|NCT02720081|531600528|FG000|Overall Study|Adverse Event|0|||
147392410|NCT02720081|531600529|FG001|Overall Study|Adverse Event|3|||
147392411|NCT02720081|531600528|FG000|Overall Study|Protocol Violation|4|||
147392412|NCT02720081|531600529|FG001|Overall Study|Protocol Violation|1|||
147392413|NCT02316847|531600531|FG000|Overall Study|Adverse Event|0|||
147392414|NCT02316847|531600532|FG001|Overall Study|Adverse Event|3|||
147392415|NCT02316847|531600531|FG000|Overall Study|Lost to Follow-up|0|||
147392416|NCT02316847|531600532|FG001|Overall Study|Lost to Follow-up|2|||
147392417|NCT02316847|531600531|FG000|Overall Study|Physician Decision|0|||
147392418|NCT02316847|531600532|FG001|Overall Study|Physician Decision|1|||
147392419|NCT02316847|531600531|FG000|Overall Study|Pregnancy|0|||
147392420|NCT02316847|531600532|FG001|Overall Study|Pregnancy|1|||
147392421|NCT02316847|531600531|FG000|Overall Study|Withdrawal by Subject|2|||
147392422|NCT02316847|531600532|FG001|Overall Study|Withdrawal by Subject|9|||
147392423|NCT02316847|531600531|FG000|Overall Study|Noncompliance with study drug|0|||
147392424|NCT02316847|531600532|FG001|Overall Study|Noncompliance with study drug|3|||
147392425|NCT02316847|531600531|FG000|Overall Study|Withdrawn due to termination by Sponsor|7|||
147392426|NCT02316847|531600532|FG001|Overall Study|Withdrawn due to termination by Sponsor|67|||
147392427|NCT03371485|531600535|FG000|Main Trial (6 AST-VAC2 Vaccinations)|Participant died before receiving AST-VAC2.|1|||
147392428|NCT03371485|531600535|FG000|2-year Follow-up|Death|5|||
147392429|NCT01061775|531600538|FG000|Overall Study|Physician Decision|2|||
147392430|NCT01061775|531600538|FG000|Overall Study|Lost to Follow-up|1|||
147392431|NCT02567227|531600539|FG000|9 Weeks|Adverse Event|5|||
147392432|NCT02567227|531600540|FG001|9 Weeks|Adverse Event|5|||
147392433|NCT02567227|531600539|FG000|9 Weeks|Withdrawal by Subject|18|||
147392434|NCT02567227|531600540|FG001|9 Weeks|Withdrawal by Subject|8|||
147392435|NCT02567227|531600539|FG000|9 Weeks|Study suspended due to COVID-19 pandemic|11|||
147392436|NCT02567227|531600540|FG001|9 Weeks|Study suspended due to COVID-19 pandemic|11|||
147392437|NCT02567227|531600539|FG000|6 Month|Death|2|||
147392438|NCT02567227|531600540|FG001|6 Month|Death|0|||
147392439|NCT02567227|531600539|FG000|6 Month|Lost to Follow-up|43|||
147392440|NCT02567227|531600540|FG001|6 Month|Lost to Follow-up|40|||
147392441|NCT02567227|531600539|FG000|12 Months|Lost to Follow-up|31|||
147392442|NCT02567227|531600540|FG001|12 Months|Lost to Follow-up|32|||
147392443|NCT02567227|531600539|FG000|12 Months|Death|0|||
147392444|NCT02567227|531600540|FG001|12 Months|Death|2|||
147392445|NCT03746483|531600541|FG000|Overall Study|Adverse Event|0|||
147392446|NCT03746483|531600542|FG001|Overall Study|Adverse Event|1|||
147392447|NCT03746483|531600541|FG000|Overall Study|Lack of Efficacy|3|||
147392448|NCT03746483|531600542|FG001|Overall Study|Lack of Efficacy|2|||
147392449|NCT03746483|531600541|FG000|Overall Study|Lost to Follow-up|1|||
147392450|NCT03746483|531600542|FG001|Overall Study|Lost to Follow-up|0|||
147392451|NCT03746483|531600541|FG000|Overall Study|Protocol Violation|2|||
147392452|NCT03746483|531600542|FG001|Overall Study|Protocol Violation|0|||
147392453|NCT02498418|531600545|FG000|Overall Study|Lack of Efficacy|0|||
147392454|NCT02498418|531600546|FG001|Overall Study|Lack of Efficacy|0|||
147392455|NCT02498418|531600547|FG002|Overall Study|Lack of Efficacy|1|||
147392456|NCT02498418|531600545|FG000|Overall Study|Withdrawal by Subject|2|||
147392457|NCT02498418|531600546|FG001|Overall Study|Withdrawal by Subject|0|||
147392458|NCT02498418|531600547|FG002|Overall Study|Withdrawal by Subject|3|||
147392459|NCT02498418|531600545|FG000|Overall Study|Lost to Follow-up|0|||
147392460|NCT02498418|531600546|FG001|Overall Study|Lost to Follow-up|1|||
147392461|NCT02498418|531600547|FG002|Overall Study|Lost to Follow-up|1|||
147392462|NCT02498418|531600545|FG000|Overall Study|Participant taken prohibited medication|0|||
147392463|NCT02498418|531600546|FG001|Overall Study|Participant taken prohibited medication|1|||
147392464|NCT02498418|531600547|FG002|Overall Study|Participant taken prohibited medication|1|||
147392465|NCT01026103|531600549|FG000|Overall Study|Physician Decision|1|||
147392466|NCT01026103|531600549|FG000|Overall Study|did not receive study device bc of error|1|||
147392467|NCT00762502|531600550|FG000|Baseline to Month 3 (Period 1)|Adverse Event|4|||
147392468|NCT00762502|531600551|FG001|Baseline to Month 3 (Period 1)|Adverse Event|3|||
147392469|NCT00762502|531600552|FG002|Baseline to Month 3 (Period 1)|Adverse Event|6|||
147392470|NCT00762502|531600550|FG000|Baseline to Month 3 (Period 1)|Lost to Follow-up|6|||
147392471|NCT00762502|531600551|FG001|Baseline to Month 3 (Period 1)|Lost to Follow-up|3|||
147392472|NCT00762502|531600552|FG002|Baseline to Month 3 (Period 1)|Lost to Follow-up|13|||
147392473|NCT00762502|531600550|FG000|Month 3 to Month 6 (Period 2)|Pregnancy|0|||
147459726|NCT01505894|531845181|FG007|Overall Study|Adverse Event|0|||
147459727|NCT01505894|531845182|FG008|Overall Study|Adverse Event|0|||
147459728|NCT01505894|531845174|FG000|Overall Study|Other than specified|0|||
147459729|NCT01505894|531845175|FG001|Overall Study|Other than specified|0|||
147459730|NCT01505894|531845176|FG002|Overall Study|Other than specified|0|||
147459731|NCT01505894|531845177|FG003|Overall Study|Other than specified|0|||
147459732|NCT01505894|531845178|FG004|Overall Study|Other than specified|1|||
147459733|NCT01505894|531845179|FG005|Overall Study|Other than specified|0|||
147459734|NCT01505894|531845180|FG006|Overall Study|Other than specified|0|||
147459735|NCT01505894|531845181|FG007|Overall Study|Other than specified|0|||
147459736|NCT01505894|531845182|FG008|Overall Study|Other than specified|0|||
147459737|NCT04173741|531845184|FG000|Overall Study|IVC measurement cannot be done|1|||
147459738|NCT04173741|531845185|FG001|Overall Study|IVC measurement cannot be done|1|||
147459739|NCT02522767|531845186|FG000|Double-blind|Withdrawal by Subject|8|||
147459740|NCT02522767|531845187|FG001|Double-blind|Withdrawal by Subject|11|||
147459741|NCT02522767|531845186|FG000|Double-blind|Lost to Follow-up|1|||
147459742|NCT02522767|531845187|FG001|Double-blind|Lost to Follow-up|0|||
147459743|NCT02522767|531845186|FG000|Double-blind|Adverse Event|1|||
147459744|NCT02522767|531845187|FG001|Double-blind|Adverse Event|10|||
147459745|NCT02522767|531845186|FG000|Double-blind|Protocol Violation|0|||
147459746|NCT02522767|531845187|FG001|Double-blind|Protocol Violation|1|||
147459747|NCT02522767|531845186|FG000|Double-blind|Lack of Efficacy|0|||
147459748|NCT02522767|531845187|FG001|Double-blind|Lack of Efficacy|2|||
147459749|NCT02522767|531845186|FG000|Double-blind|Protocol Deviation|1|||
147459750|NCT02522767|531845187|FG001|Double-blind|Protocol Deviation|0|||
147459751|NCT02522767|531845186|FG000|Open-label|Withdrawal by Subject|2|||
147459752|NCT02522767|531845187|FG001|Open-label|Withdrawal by Subject|3|||
147459753|NCT02522767|531845186|FG000|Open-label|Lost to Follow-up|0|||
147459754|NCT02522767|531845187|FG001|Open-label|Lost to Follow-up|1|||
147459755|NCT02522767|531845186|FG000|Open-label|Adverse Event|2|||
147459756|NCT02522767|531845187|FG001|Open-label|Adverse Event|1|||
147459757|NCT02522767|531845186|FG000|Open-label|Lack of Efficacy|1|||
147459758|NCT02522767|531845187|FG001|Open-label|Lack of Efficacy|1|||
147459759|NCT02522767|531845186|FG000|Open-label|Protocol Violation|0|||
147459760|NCT02522767|531845187|FG001|Open-label|Protocol Violation|1|||
147459761|NCT00254566|531845189|FG000|Overall Study|Death|1|||
147459762|NCT00254566|531845190|FG001|Overall Study|Death|0|||
147459763|NCT00254566|531845189|FG000|Overall Study|Adverse Event|5|||
147459764|NCT00254566|531845190|FG001|Overall Study|Adverse Event|4|||
147459765|NCT00254566|531845189|FG000|Overall Study|Lack of Efficacy|12|||
147459766|NCT00254566|531845190|FG001|Overall Study|Lack of Efficacy|9|||
147459767|NCT00254566|531845189|FG000|Overall Study|Other|1|||
147459768|NCT00254566|531845190|FG001|Overall Study|Other|5|||
147459769|NCT00254566|531845189|FG000|Overall Study|Withdrawal by Subject|5|||
147459770|NCT00254566|531845190|FG001|Overall Study|Withdrawal by Subject|6|||
147459771|NCT00254566|531845189|FG000|Overall Study|Lost to Follow-up|7|||
147459772|NCT00254566|531845190|FG001|Overall Study|Lost to Follow-up|2|||
147459773|NCT00059202|531845191|FG000|Overall Study|Withdrawal by Subject|5|||
147459774|NCT00059202|531845192|FG001|Overall Study|Withdrawal by Subject|9|||
147459775|NCT00059202|531845191|FG000|Overall Study|Protocol Violation|1|||
147459776|NCT00059202|531845192|FG001|Overall Study|Protocol Violation|3|||
147459777|NCT00059202|531845191|FG000|Overall Study|drug toxicity|0|||
147459778|NCT00059202|531845192|FG001|Overall Study|drug toxicity|3|||
147459779|NCT00548548|531845195|FG000|Overall Study|Death|345|||
147459780|NCT00548548|531845196|FG001|Overall Study|Death|348|||
147459781|NCT00548548|531845195|FG000|Overall Study|Lost to Follow-up|17|||
147459782|NCT00548548|531845196|FG001|Overall Study|Lost to Follow-up|18|||
147459783|NCT01705691|531845198|FG000|Overall Study|Death|1|||
147459784|NCT01705691|531845199|FG001|Overall Study|Death|2|||
147459785|NCT01705691|531845198|FG000|Overall Study|Withdrawal by Subject|1|||
147392474|NCT00762502|531600551|FG001|Month 3 to Month 6 (Period 2)|Pregnancy|1|||
147392475|NCT00762502|531600552|FG002|Month 3 to Month 6 (Period 2)|Pregnancy|0|||
147392476|NCT02625922|531600554|FG000|Overall Study|Non-availability of IMP|1|||
147392477|NCT02625922|531600555|FG001|Overall Study|Non-availability of IMP|1|||
147392478|NCT02625922|531600554|FG000|Overall Study|Systolic blood pressure < 125 mmHg|1|||
147392479|NCT02625922|531600555|FG001|Overall Study|Systolic blood pressure < 125 mmHg|1|||
147392480|NCT03840148|531600560|FG000|Study Drug Disposition|Adverse Event|13|||
147392481|NCT03840148|531600561|FG001|Study Drug Disposition|Adverse Event|2|||
147392482|NCT03840148|531600560|FG000|Study Drug Disposition|Withdrawal by Subject|8|||
147392483|NCT03840148|531600561|FG001|Study Drug Disposition|Withdrawal by Subject|2|||
147392484|NCT03840148|531600560|FG000|Study Drug Disposition|Lack of Efficacy|3|||
147392485|NCT03840148|531600561|FG001|Study Drug Disposition|Lack of Efficacy|0|||
147392486|NCT03840148|531600560|FG000|Study Drug Disposition|Physician Decision|2|||
147392487|NCT03840148|531600561|FG001|Study Drug Disposition|Physician Decision|0|||
147392488|NCT03840148|531600560|FG000|Study Drug Disposition|Randomized but not treated, IWRS issue, lack of IMP supplies.|1|||
147459786|NCT01705691|531845199|FG001|Overall Study|Withdrawal by Subject|2|||
147459787|NCT01705691|531845198|FG000|Overall Study|Lost to Follow-up|1|||
147459788|NCT01705691|531845199|FG001|Overall Study|Lost to Follow-up|1|||
147392489|NCT03840148|531600561|FG001|Study Drug Disposition|Randomized but not treated, IWRS issue, lack of IMP supplies.|4|||
147392490|NCT03840148|531600560|FG000|Study Completion Disposition|Withdrawal by Subject|6|||
147392491|NCT03840148|531600561|FG001|Study Completion Disposition|Withdrawal by Subject|2|||
147392492|NCT03840148|531600560|FG000|Study Completion Disposition|Physician Decision|2|||
147392493|NCT03840148|531600561|FG001|Study Completion Disposition|Physician Decision|0|||
147392494|NCT03840148|531600560|FG000|Study Completion Disposition|Covid-19 related|2|||
147392495|NCT03840148|531600561|FG001|Study Completion Disposition|Covid-19 related|0|||
147392496|NCT03840148|531600560|FG000|Study Completion Disposition|Lost to Follow-up|1|||
147392497|NCT03840148|531600561|FG001|Study Completion Disposition|Lost to Follow-up|1|||
147392498|NCT03840148|531600560|FG000|Study Completion Disposition|Death|1|||
147392499|NCT03840148|531600561|FG001|Study Completion Disposition|Death|0|||
147392500|NCT03840148|531600560|FG000|Study Completion Disposition|IWRS issue, patient refused, SAE, randomized in error, patient did not take IMP or attend visits.|3|||
147392501|NCT03840148|531600561|FG001|Study Completion Disposition|IWRS issue, patient refused, SAE, randomized in error, patient did not take IMP or attend visits.|3|||
147392502|NCT03615404|531600562|FG000|Overall Study|Death|1|||
147392503|NCT03615404|531600562|FG000|Overall Study|vaccine did not pass quality assurance|1|||
147392504|NCT00257556|531600563|FG000|Overall Study|Adverse Event|1|||
147392505|NCT00257556|531600564|FG001|Overall Study|Adverse Event|4|||
147392506|NCT00257556|531600563|FG000|Overall Study|Physician Decision|6|||
147392507|NCT00257556|531600564|FG001|Overall Study|Physician Decision|0|||
147392508|NCT00257556|531600563|FG000|Overall Study|Did not meet hCG criterion|3|||
147392509|NCT00257556|531600564|FG001|Overall Study|Did not meet hCG criterion|0|||
147392510|NCT00257556|531600563|FG000|Overall Study|other reason|4|||
147392511|NCT00257556|531600564|FG001|Overall Study|other reason|6|||
147392512|NCT03849300|531600566|FG000|Overall Study|move out to different area|1|||
147392513|NCT03849300|531600567|FG001|Overall Study|move out to different area|3|||
147392514|NCT03849300|531600568|FG002|Overall Study|move out to different area|1|||
147392515|NCT03849300|531600569|FG003|Overall Study|move out to different area|4|||
147392516|NCT03849300|531600566|FG000|Overall Study|scheduling/transportation conflict|4|||
147392517|NCT03849300|531600567|FG001|Overall Study|scheduling/transportation conflict|4|||
147392518|NCT03849300|531600568|FG002|Overall Study|scheduling/transportation conflict|3|||
147392519|NCT03849300|531600569|FG003|Overall Study|scheduling/transportation conflict|2|||
147392520|NCT01774929|531600570|FG000|Overall Study|Adverse Event|3|||
147392521|NCT04839289|531600571|FG000|Overall Study|Withdrawal by Subject|1|||
147392522|NCT04839289|531600572|FG001|Overall Study|Withdrawal by Subject|0|||
147392523|NCT01544153|531600573|FG000|Overall Study|Under 18|0|||
147392524|NCT01544153|531600574|FG001|Overall Study|Under 18|1|||
147392525|NCT01544153|531600575|FG002|Overall Study|Under 18|0|||
147392526|NCT01544153|531600576|FG003|Overall Study|Under 18|0|||
147392527|NCT01544153|531600573|FG000|Overall Study|Non-smoker|0|||
147392528|NCT01544153|531600574|FG001|Overall Study|Non-smoker|0|||
147392529|NCT01544153|531600575|FG002|Overall Study|Non-smoker|1|||
147392530|NCT01544153|531600576|FG003|Overall Study|Non-smoker|0|||
147392531|NCT00390806|531600581|FG000|Overall Study|Lost to Follow-up|7|||
147392532|NCT00390806|531600582|FG001|Overall Study|Lost to Follow-up|6|||
147392533|NCT00390806|531600581|FG000|Overall Study|Protocol Violation|2|||
147392534|NCT00390806|531600582|FG001|Overall Study|Protocol Violation|2|||
147392535|NCT00390806|531600581|FG000|Overall Study|Withdrawal by Subject|12|||
147392536|NCT00390806|531600582|FG001|Overall Study|Withdrawal by Subject|15|||
147392537|NCT00390806|531600581|FG000|Overall Study|Investigator Decision|4|||
147392538|NCT00390806|531600582|FG001|Overall Study|Investigator Decision|6|||
147392539|NCT00390806|531600581|FG000|Overall Study|Death|1|||
147392540|NCT00390806|531600582|FG001|Overall Study|Death|0|||
147392541|NCT00390806|531600581|FG000|Overall Study|Physician Decision|0|||
147392542|NCT00390806|531600582|FG001|Overall Study|Physician Decision|1|||
147392543|NCT00390806|531600581|FG000|Overall Study|Ongoing|4|||
147392544|NCT00390806|531600582|FG001|Overall Study|Ongoing|2|||
147392545|NCT00884793|531600585|FG000|Overall Study|Withdrawal by Subject|1|||
147392546|NCT03169530|531600586|FG000|Overall Study|Study ended by NIH|15|||
147459789|NCT01705691|531845198|FG000|Overall Study|Other|0|||
147459790|NCT01705691|531845199|FG001|Overall Study|Other|1|||
147459791|NCT02658448|531845200|FG000|Overall Study|Lost to Follow-up|1|||
147459792|NCT03106779|531845201|FG000|Overall Study|Lack of Efficacy|33|||
147459793|NCT03106779|531845202|FG001|Overall Study|Lack of Efficacy|24|||
147459794|NCT03106779|531845201|FG000|Overall Study|Adverse Event|8|||
147392547|NCT03169530|531600587|FG001|Overall Study|Study ended by NIH|17|||
147392548|NCT01032200|531600588|FG000|Overall Study|Death|1|||
147392549|NCT01032200|531600589|FG001|Overall Study|Death|1|||
147392550|NCT01032200|531600588|FG000|Overall Study|Withdrawal by Subject|1|||
147392551|NCT01032200|531600589|FG001|Overall Study|Withdrawal by Subject|3|||
147392552|NCT01032200|531600588|FG000|Overall Study|Toxicity|0|||
147392553|NCT01032200|531600589|FG001|Overall Study|Toxicity|2|||
147392554|NCT01032200|531600588|FG000|Overall Study|Progression|1|||
147392555|NCT01032200|531600589|FG001|Overall Study|Progression|0|||
147392556|NCT01032200|531600588|FG000|Overall Study|Multiple|1|||
147392557|NCT01032200|531600589|FG001|Overall Study|Multiple|1|||
147665040|NCT00641056|532597984|FG001|Overall Study|Physician Decision|1|||
147459795|NCT03106779|531845202|FG001|Overall Study|Adverse Event|16|||
147392558|NCT00727259|531600593|FG000|Overall Study|Not all questionnaires completed|1055|||
147392559|NCT01021683|531600594|FG000|Overall Study|Lack of Efficacy|12|||
147392560|NCT01021683|531600594|FG000|Overall Study|Recovery of neutrophil count|51|||
147392561|NCT01021683|531600594|FG000|Overall Study|Other|8|||
147392562|NCT00663923|531600595|FG000|Overall Study|Lost to Follow-up|2|||
147392563|NCT01804140|531600597|FG000|Overall Study|No sampling or biopsy procedures done|114|||
147392564|NCT02785900|531600598|FG000|Overall Study|Study Termination by Sponsor|64|||
147392565|NCT02785900|531600599|FG001|Overall Study|Study Termination by Sponsor|81|||
147392566|NCT02785900|531600598|FG000|Overall Study|Death|46|||
147392567|NCT02785900|531600599|FG001|Overall Study|Death|32|||
147392568|NCT02785900|531600598|FG000|Overall Study|Withdrawal by Subject|4|||
147392569|NCT02785900|531600599|FG001|Overall Study|Withdrawal by Subject|8|||
147392570|NCT02785900|531600598|FG000|Overall Study|Physician Decision|3|||
147392571|NCT02785900|531600599|FG001|Overall Study|Physician Decision|2|||
147392572|NCT00547300|531600600|FG000|Overall Study|Study was Administratively Terminated|25|||
147392573|NCT00547300|531600601|FG001|Overall Study|Study was Administratively Terminated|24|||
147392574|NCT00547300|531600600|FG000|Overall Study|Did not Meet Entry Criteria|0|||
147392575|NCT00547300|531600601|FG001|Overall Study|Did not Meet Entry Criteria|2|||
147392576|NCT04130061|531600604|FG000|Overall Study|OR team forgot to request membrane|1|||
147392577|NCT04130061|531600605|FG001|Overall Study|OR team forgot to request membrane|0|||
147392578|NCT00111839|531602342|FG000|Overall Study|Disease Progression|30|||
147392579|NCT00111839|531602343|FG001|Overall Study|Disease Progression|33|||
147392580|NCT00111839|531602344|FG002|Overall Study|Disease Progression|33|||
147392581|NCT00111839|531602342|FG000|Overall Study|Adverse Event|5|||
147392582|NCT00111839|531602343|FG001|Overall Study|Adverse Event|3|||
147392583|NCT00111839|531602344|FG002|Overall Study|Adverse Event|1|||
147392584|NCT00111839|531602342|FG000|Overall Study|Protocol Violation|2|||
147615230|NCT02290405|532406664|FG001|Overall Study|Withdrawal by Subject|0|||
147615231|NCT02016183|532406665|FG000|Overall Study|Case Report Forms Uncollected|13|||
147615232|NCT02016183|532406665|FG000|Overall Study|Protocol Violation|52|||
147615233|NCT00129545|532406677|FG000|Overall Study|Death|5|||
147615234|NCT00129545|532406678|FG001|Overall Study|Death|60|||
147392585|NCT00111839|531602343|FG001|Overall Study|Protocol Violation|4|||
147392586|NCT00111839|531602344|FG002|Overall Study|Protocol Violation|2|||
147392587|NCT00111839|531602342|FG000|Overall Study|Death|1|||
147392588|NCT00111839|531602343|FG001|Overall Study|Death|1|||
147392589|NCT00111839|531602344|FG002|Overall Study|Death|6|||
147392590|NCT00111839|531602342|FG000|Overall Study|Withdrawal by Subject|2|||
147392591|NCT00111839|531602343|FG001|Overall Study|Withdrawal by Subject|2|||
147392592|NCT00111839|531602344|FG002|Overall Study|Withdrawal by Subject|2|||
147392593|NCT00111839|531602342|FG000|Overall Study|Lost to Follow-up|1|||
147392594|NCT00111839|531602343|FG001|Overall Study|Lost to Follow-up|0|||
147392595|NCT00111839|531602344|FG002|Overall Study|Lost to Follow-up|0|||
147392596|NCT00111839|531602342|FG000|Overall Study|Logistical Constraint|1|||
147392597|NCT00111839|531602343|FG001|Overall Study|Logistical Constraint|0|||
147392598|NCT00111839|531602344|FG002|Overall Study|Logistical Constraint|0|||
147392599|NCT00111839|531602342|FG000|Overall Study|Other|6|||
147392600|NCT00111839|531602343|FG001|Overall Study|Other|3|||
147615235|NCT00129545|532406679|FG002|Overall Study|Death|44|||
147615236|NCT00129545|532406677|FG000|Overall Study|Withdrawal by Subject|3|||
147615237|NCT00129545|532406678|FG001|Overall Study|Withdrawal by Subject|18|||
147615238|NCT00129545|532406679|FG002|Overall Study|Withdrawal by Subject|44|||
147615239|NCT00129545|532406677|FG000|Overall Study|Lost to Follow-up|2|||
147615240|NCT00129545|532406678|FG001|Overall Study|Lost to Follow-up|22|||
147615241|NCT00129545|532406679|FG002|Overall Study|Lost to Follow-up|13|||
147392601|NCT00111839|531602344|FG002|Overall Study|Other|3|||
147392602|NCT00111839|531602342|FG000|Overall Study|Randomized but Not Treated|0|||
147392603|NCT00111839|531602343|FG001|Overall Study|Randomized but Not Treated|0|||
147392604|NCT00111839|531602344|FG002|Overall Study|Randomized but Not Treated|2|||
147615242|NCT00129545|532406677|FG000|Overall Study|Physician Decision|0|||
147392605|NCT02499835|531602350|FG000|Overall Study|Withdrawal by Subject|1|||
147392606|NCT02499835|531602351|FG001|Overall Study|Withdrawal by Subject|0|||
147615243|NCT00129545|532406678|FG001|Overall Study|Physician Decision|3|||
147615244|NCT00129545|532406679|FG002|Overall Study|Physician Decision|10|||
147615245|NCT00129545|532406677|FG000|Overall Study|Device not implanted|16|||
147615246|NCT00129545|532406678|FG001|Overall Study|Device not implanted|61|||
147615247|NCT00129545|532406679|FG002|Overall Study|Device not implanted|0|||
147392607|NCT02499835|531602352|FG002|Overall Study|Withdrawal by Subject|0|||
147392608|NCT02499835|531602353|FG003|Overall Study|Withdrawal by Subject|1|||
147392609|NCT02499835|531602350|FG000|Overall Study|Physician Decision|0|||
147615248|NCT00770328|532406680|FG000|Overall Study|Adverse Event|11|||
147392610|NCT02499835|531602351|FG001|Overall Study|Physician Decision|3|||
147392611|NCT02499835|531602352|FG002|Overall Study|Physician Decision|18|||
147392612|NCT02499835|531602353|FG003|Overall Study|Physician Decision|7|||
147392613|NCT02499835|531602350|FG000|Overall Study|Adverse Event|0|||
147392614|NCT02499835|531602351|FG001|Overall Study|Adverse Event|0|||
147615249|NCT00770328|532406681|FG001|Overall Study|Adverse Event|2|||
147615250|NCT00770328|532406680|FG000|Overall Study|Lost to Follow-up|2|||
147459796|NCT03106779|531845201|FG000|Overall Study|Physician Decision|10|||
147459797|NCT03106779|531845202|FG001|Overall Study|Physician Decision|6|||
147459798|NCT03106779|531845201|FG000|Overall Study|Patient/guardian decision|4|||
147459799|NCT03106779|531845202|FG001|Overall Study|Patient/guardian decision|3|||
147459800|NCT03106779|531845201|FG000|Overall Study|Progressive disease|1|||
147459801|NCT03106779|531845202|FG001|Overall Study|Progressive disease|3|||
147459802|NCT03106779|531845201|FG000|Overall Study|Lost to Follow-up|1|||
147459803|NCT03106779|531845202|FG001|Overall Study|Lost to Follow-up|2|||
147459804|NCT03106779|531845201|FG000|Overall Study|Death|1|||
147459805|NCT03106779|531845202|FG001|Overall Study|Death|0|||
147459806|NCT03106779|531845201|FG000|Overall Study|Protocol Violation|1|||
147459807|NCT03106779|531845202|FG001|Overall Study|Protocol Violation|0|||
147459808|NCT03106779|531845201|FG000|Overall Study|Not treated|1|||
147459809|NCT03106779|531845202|FG001|Overall Study|Not treated|0|||
147459810|NCT04088409|531845203|FG000|Part A|Withdrawal by Subject|2|||
147459811|NCT04088409|531845204|FG001|Part A|Withdrawal by Subject|1|||
147459812|NCT04088409|531845203|FG000|Part A|Did Not Meet Randomization Criteria|2|||
147459813|NCT04088409|531845204|FG001|Part A|Did Not Meet Randomization Criteria|0|||
147459814|NCT04088409|531845203|FG000|Part A|Lack of Efficacy|9|||
147459815|NCT04088409|531845204|FG001|Part A|Lack of Efficacy|0|||
147459816|NCT04088409|531845203|FG000|Part A|Lost to Follow-up|1|||
147459817|NCT04088409|531845204|FG001|Part A|Lost to Follow-up|0|||
147459818|NCT04088409|531845203|FG000|Part A|Adverse Event|1|||
147459819|NCT04088409|531845204|FG001|Part A|Adverse Event|0|||
147459820|NCT04088409|531845203|FG000|Part A|Per Protocol, Participants in the Adalimumab Group Discontinued the Study|0|||
147459821|NCT04088409|531845204|FG001|Part A|Per Protocol, Participants in the Adalimumab Group Discontinued the Study|4|||
147459822|NCT04088409|531845203|FG000|Part B|Ongoing Treatment|10|||
147459823|NCT04088409|531845204|FG001|Part B|Ongoing Treatment|0|||
147459824|NCT04233229|531845205|FG000|Overall Study|Withdrawal by Subject|0|||
147459825|NCT04233229|531845206|FG001|Overall Study|Withdrawal by Subject|1|||
147459826|NCT04233229|531845205|FG000|Overall Study|Exclusion criterion found the day after initiation visit|1|||
147459827|NCT04233229|531845206|FG001|Overall Study|Exclusion criterion found the day after initiation visit|0|||
147459828|NCT04233229|531845205|FG000|Overall Study|Lack of complance to study procedures and less than 14 days on closed-loop|0|||
147459829|NCT04233229|531845206|FG001|Overall Study|Lack of complance to study procedures and less than 14 days on closed-loop|2|||
147459830|NCT02288247|531845207|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Adverse Event|52|||
147459831|NCT02288247|531845208|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Adverse Event|0|||
147459832|NCT02288247|531845207|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Death|35|||
147459833|NCT02288247|531845208|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Death|0|||
147459834|NCT02288247|531845207|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Lost to Follow-up|1|||
147459835|NCT02288247|531845208|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Lost to Follow-up|0|||
147459836|NCT02288247|531845207|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Progressive Disease|393|||
147459837|NCT02288247|531845208|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Progressive Disease|0|||
147459838|NCT02288247|531845207|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Protocol Violation|9|||
147459839|NCT02288247|531845208|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Protocol Violation|0|||
147459840|NCT02288247|531845207|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Withdrawal by Subject|54|||
147459841|NCT02288247|531845208|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Withdrawal by Subject|0|||
147459842|NCT02288247|531845207|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Other|142|||
147459843|NCT02288247|531845208|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Other|0|||
147459844|NCT02288247|531845207|FG000|Period 1: OL Treatment (Max: 462 Weeks)|Study Terminated By Sponsor|2|||
147459845|NCT02288247|531845208|FG001|Period 1: OL Treatment (Max: 462 Weeks)|Study Terminated By Sponsor|0|||
147459846|NCT02288247|531845207|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Adverse Event|10|||
147459847|NCT02288247|531845208|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Adverse Event|8|||
147459848|NCT02288247|531845207|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Death|8|||
147459849|NCT02288247|531845208|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Death|4|||
147459850|NCT02288247|531845207|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Lost to Follow-up|1|||
147459851|NCT02288247|531845208|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Lost to Follow-up|0|||
147459852|NCT02288247|531845207|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Progressive Disease|87|||
147459853|NCT02288247|531845208|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Progressive Disease|94|||
147459854|NCT02288247|531845207|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Protocol Violation|2|||
147459855|NCT02288247|531845208|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Protocol Violation|1|||
147615251|NCT00770328|532406681|FG001|Overall Study|Lost to Follow-up|2|||
147615252|NCT03541317|532406683|FG000|Stage 2 of the Implementation|Withdrawal by Subject|1|||
147615253|NCT03541317|532406684|FG001|Stage 2 of the Implementation|Withdrawal by Subject|0|||
147459856|NCT02288247|531845207|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Withdrawal by Subject|7|||
147459857|NCT02288247|531845208|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Withdrawal by Subject|7|||
147459858|NCT02288247|531845207|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Other|21|||
147459859|NCT02288247|531845208|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Other|21|||
147459860|NCT02288247|531845207|FG000|Period 2: DB Treatment (Max: 180 Weeks)|Randomized but not treated|1|||
147459861|NCT02288247|531845208|FG001|Period 2: DB Treatment (Max: 180 Weeks)|Randomized but not treated|0|||
147665041|NCT00641056|532597983|FG000|Overall Study|Protocol Violation|2|||
147665042|NCT00641056|532597984|FG001|Overall Study|Protocol Violation|0|||
147665043|NCT00641056|532597983|FG000|Overall Study|Entry Criteria Not Met|3|||
147392615|NCT02499835|531602352|FG002|Overall Study|Adverse Event|0|||
147392616|NCT02499835|531602353|FG003|Overall Study|Adverse Event|1|||
147392617|NCT02499835|531602350|FG000|Overall Study|Disease progression|2|||
147392618|NCT02499835|531602351|FG001|Overall Study|Disease progression|1|||
147392619|NCT02499835|531602352|FG002|Overall Study|Disease progression|0|||
147392620|NCT02499835|531602353|FG003|Overall Study|Disease progression|7|||
147392621|NCT05109117|531602354|FG000|Overall Study|Lost to Follow-up|1|||
147392622|NCT05109117|531602354|FG000|Overall Study|Discontinued for non-compliance|1|||
147392623|NCT03972137|531602358|FG000|Overall Study|Lost to Follow-up|2|||
147392624|NCT03972137|531602358|FG000|Overall Study|Withdrawal by Subject|4|||
147392625|NCT02973477|531602359|FG000|First Intervention|Lost to Follow-up|0|||
147392626|NCT02973477|531602360|FG001|First Intervention|Lost to Follow-up|2|||
147392627|NCT02973477|531602359|FG000|Washout|Withdrawal by Subject|1|||
147392628|NCT02973477|531602360|FG001|Washout|Withdrawal by Subject|0|||
147392629|NCT02973477|531602359|FG000|Second Intervention|Lost to Follow-up|1|||
147392630|NCT02973477|531602360|FG001|Second Intervention|Lost to Follow-up|0|||
147392631|NCT02381652|531602367|FG000|Overall Study|Withdrawal by Subject|0|||
147392632|NCT02381652|531602368|FG001|Overall Study|Withdrawal by Subject|0|||
147392633|NCT02381652|531602369|FG002|Overall Study|Withdrawal by Subject|1|||
147392634|NCT01340300|531602370|FG000|Overall Study|Lost to Follow-up|3|||
147392635|NCT01340300|531602371|FG001|Overall Study|Lost to Follow-up|0|||
147392636|NCT01340300|531602372|FG002|Overall Study|Lost to Follow-up|5|||
147392637|NCT01340300|531602373|FG003|Overall Study|Lost to Follow-up|10|||
147392638|NCT01340300|531602370|FG000|Overall Study|Withdrawal by Subject|5|||
147392639|NCT01340300|531602371|FG001|Overall Study|Withdrawal by Subject|6|||
147392640|NCT01340300|531602372|FG002|Overall Study|Withdrawal by Subject|6|||
147392641|NCT01340300|531602373|FG003|Overall Study|Withdrawal by Subject|3|||
147392642|NCT01340300|531602370|FG000|Overall Study|Adverse Event|1|||
147392643|NCT01340300|531602371|FG001|Overall Study|Adverse Event|0|||
147392644|NCT01340300|531602372|FG002|Overall Study|Adverse Event|4|||
147392645|NCT01340300|531602373|FG003|Overall Study|Adverse Event|0|||
147392646|NCT01340300|531602370|FG000|Overall Study|Physician Decision|0|||
147392647|NCT01340300|531602371|FG001|Overall Study|Physician Decision|1|||
147392648|NCT01340300|531602372|FG002|Overall Study|Physician Decision|0|||
147392649|NCT01340300|531602373|FG003|Overall Study|Physician Decision|0|||
147392650|NCT01340300|531602370|FG000|Overall Study|Unrelated sickness|0|||
147392651|NCT01340300|531602371|FG001|Overall Study|Unrelated sickness|2|||
147392652|NCT01340300|531602372|FG002|Overall Study|Unrelated sickness|0|||
147392653|NCT01340300|531602373|FG003|Overall Study|Unrelated sickness|1|||
147392654|NCT02642159|531602375|FG000|Overall Study|Randomized but not treated|1|||
147392655|NCT02642159|531602376|FG001|Overall Study|Randomized but not treated|0|||
147392656|NCT02642159|531602375|FG000|Overall Study|Adverse Event|10|||
147392657|NCT02642159|531602376|FG001|Overall Study|Adverse Event|4|||
147392658|NCT02642159|531602375|FG000|Overall Study|Withdrawal by Subject|9|||
147392659|NCT02642159|531602376|FG001|Overall Study|Withdrawal by Subject|1|||
147392660|NCT02642159|531602375|FG000|Overall Study|Poor compliance to study protocol|1|||
147392661|NCT02642159|531602376|FG001|Overall Study|Poor compliance to study protocol|0|||
147392662|NCT02642159|531602375|FG000|Overall Study|Other than specified above|10|||
147392663|NCT02642159|531602376|FG001|Overall Study|Other than specified above|3|||
147392664|NCT04194541|531602377|FG000|Day 1 Through 13|Lost to Follow-up|3|||
147392665|NCT04194541|531602377|FG000|Day 1 Through 13|Coronavirus Disease of 2019 (COVID-19) shut down|6|||
147392666|NCT04194541|531602377|FG000|Day 15 Through Week 6|Lost to Follow-up|5|||
147392667|NCT00588341|531602378|FG000|Overall Study|Withdrawal by Subject|3|||
147392668|NCT00588341|531602378|FG000|Overall Study|Not treated due to metastatic disease|1|||
147392669|NCT00588341|531602378|FG000|Overall Study|Patient ineligible|1|||
147392670|NCT01954771|531602379|FG000|Overall Study|Missing HbA1c of end-point|1|||
147392671|NCT01954771|531602380|FG001|Overall Study|Missing HbA1c of end-point|1|||
147392672|NCT01954771|531602381|FG002|Overall Study|Missing HbA1c of end-point|0|||
147392673|NCT01954771|531602379|FG000|Overall Study|Missing CGMS of end-point|1|||
147392674|NCT01954771|531602380|FG001|Overall Study|Missing CGMS of end-point|1|||
147392675|NCT01954771|531602381|FG002|Overall Study|Missing CGMS of end-point|0|||
147392676|NCT01954771|531602379|FG000|Overall Study|Missing HbA1c and CGMS of end-point|5|||
147392677|NCT01954771|531602380|FG001|Overall Study|Missing HbA1c and CGMS of end-point|1|||
147392678|NCT01954771|531602381|FG002|Overall Study|Missing HbA1c and CGMS of end-point|3|||
147392679|NCT03635775|531602384|FG000|Overall Study|Did not meet final inclusion criteria based on initial evaluation|0|||
147392680|NCT03635775|531602385|FG001|Overall Study|Did not meet final inclusion criteria based on initial evaluation|0|||
147392681|NCT03635775|531602386|FG002|Overall Study|Did not meet final inclusion criteria based on initial evaluation|0|||
147392682|NCT03635775|531602387|FG003|Overall Study|Did not meet final inclusion criteria based on initial evaluation|1|||
147392683|NCT01675050|531602389|FG000|Period One Treatment|Withdrawal by Subject|1|||
147392684|NCT01675050|531602390|FG001|Period One Treatment|Withdrawal by Subject|0|||
147392685|NCT01820637|531602392|FG000|Overall Study|Death|2|||
147392686|NCT01820637|531602392|FG000|Overall Study|Withdrawal by Subject|1|||
147392687|NCT00583115|531602393|FG000|Overall Study|Death|1|||
147615254|NCT03541317|532406685|FG002|Stage 2 of the Implementation|Withdrawal by Subject|0|||
147392688|NCT00264498|531602394|FG000|Randomized Treatment|Death|0|||
147392689|NCT00264498|531602395|FG001|Randomized Treatment|Death|3|||
147392690|NCT00264498|531602394|FG000|Randomized Treatment|Withdrawal by Subject|0|||
147392691|NCT00264498|531602395|FG001|Randomized Treatment|Withdrawal by Subject|1|||
147392692|NCT00264498|531602394|FG000|Randomized Treatment|Objective disease Progression|13|||
147392693|NCT00264498|531602395|FG001|Randomized Treatment|Objective disease Progression|14|||
147392694|NCT00264498|531602394|FG000|Randomized Treatment|Physician Decision|1|||
147392695|NCT00264498|531602395|FG001|Randomized Treatment|Physician Decision|0|||
147392696|NCT00264498|531602394|FG000|Randomized Treatment|Incorrectly randomized|1|||
147392697|NCT00264498|531602395|FG001|Randomized Treatment|Incorrectly randomized|0|||
147392698|NCT00264498|531602394|FG000|Randomized Treatment|Study Closure|1|||
147392699|NCT00264498|531602395|FG001|Randomized Treatment|Study Closure|0|||
147392700|NCT00264498|531602394|FG000|Randomized Treatment|Protocol Violation|1|||
147392701|NCT00264498|531602395|FG001|Randomized Treatment|Protocol Violation|0|||
147392702|NCT00264498|531602394|FG000|Crossover Treatment|Death|1|||
147392703|NCT00264498|531602395|FG001|Crossover Treatment|Death|3|||
147392704|NCT00264498|531602394|FG000|Crossover Treatment|Objective disease progression|4|||
147392705|NCT00264498|531602395|FG001|Crossover Treatment|Objective disease progression|5|||
147392706|NCT00264498|531602394|FG000|Crossover Treatment|Study closure|0|||
147392707|NCT00264498|531602395|FG001|Crossover Treatment|Study closure|1|||
147392708|NCT00264498|531602394|FG000|Crossover Treatment|Withdrawal by Subject|1|||
147392709|NCT00264498|531602395|FG001|Crossover Treatment|Withdrawal by Subject|0|||
147392710|NCT02382406|531602396|FG000|Study Treatment|Disease Progression|8|||
147392711|NCT02382406|531602397|FG001|Study Treatment|Disease Progression|0|||
147392712|NCT02382406|531602398|FG002|Study Treatment|Disease Progression|20|||
147392713|NCT02382406|531602396|FG000|Study Treatment|AE/ Side Effects/ Complications|4|||
147392714|NCT02382406|531602397|FG001|Study Treatment|AE/ Side Effects/ Complications|0|||
147392715|NCT02382406|531602398|FG002|Study Treatment|AE/ Side Effects/ Complications|6|||
147392716|NCT02382406|531602396|FG000|Study Treatment|Patient withdrawal after therapy start|1|||
147392717|NCT02382406|531602397|FG001|Study Treatment|Patient withdrawal after therapy start|0|||
147392718|NCT02382406|531602398|FG002|Study Treatment|Patient withdrawal after therapy start|1|||
147392719|NCT02382406|531602396|FG000|Study Treatment|symptomatic deterioration|1|||
147392720|NCT02382406|531602397|FG001|Study Treatment|symptomatic deterioration|0|||
147392721|NCT02382406|531602398|FG002|Study Treatment|symptomatic deterioration|1|||
147392722|NCT02382406|531602396|FG000|Study Treatment|Death|0|||
147392723|NCT02382406|531602397|FG001|Study Treatment|Death|0|||
147392724|NCT02382406|531602398|FG002|Study Treatment|Death|2|||
147392725|NCT02382406|531602396|FG000|Follow up|Death|11|||
147392726|NCT02382406|531602397|FG001|Follow up|Death|0|||
147392727|NCT02382406|531602398|FG002|Follow up|Death|19|||
147392728|NCT02382406|531602396|FG000|Follow up|Symptomatic deterioration|1|||
147392729|NCT02382406|531602397|FG001|Follow up|Symptomatic deterioration|0|||
147392730|NCT02382406|531602398|FG002|Follow up|Symptomatic deterioration|1|||
147392731|NCT02382406|531602396|FG000|Follow up|Patient Refused Follow-up|1|||
147392732|NCT02382406|531602397|FG001|Follow up|Patient Refused Follow-up|0|||
147392733|NCT02382406|531602398|FG002|Follow up|Patient Refused Follow-up|0|||
147392734|NCT02382406|531602396|FG000|Follow up|Study Terminated|1|||
147392735|NCT02382406|531602397|FG001|Follow up|Study Terminated|0|||
147392736|NCT02382406|531602398|FG002|Follow up|Study Terminated|8|||
147392737|NCT02382406|531602396|FG000|Follow up|Withdrawal by Subject|0|||
147392738|NCT02382406|531602397|FG001|Follow up|Withdrawal by Subject|0|||
147392739|NCT02382406|531602398|FG002|Follow up|Withdrawal by Subject|2|||
147392740|NCT04543942|531602399|FG000|First Intervention (2-3 Days)|Scheduling conflict|2|||
147392741|NCT04543942|531602400|FG001|First Intervention (2-3 Days)|Scheduling conflict|2|||
147392742|NCT04543942|531602399|FG000|Interval Period (2 Weeks)|scheduling conflict|1|||
147392743|NCT04543942|531602400|FG001|Interval Period (2 Weeks)|scheduling conflict|1|||
147392744|NCT02506881|531602406|FG000|First Intervention (Day 1)|Protocol Violation|0|||
147392745|NCT02506881|531602407|FG001|First Intervention (Day 1)|Protocol Violation|0|||
147392746|NCT02506881|531602408|FG002|First Intervention (Day 1)|Protocol Violation|1|||
147392747|NCT02506881|531602409|FG003|First Intervention (Day 1)|Protocol Violation|0|||
147392748|NCT02506881|531602406|FG000|First Intervention (Day 1)|Withdrawal by Subject|1|||
147392749|NCT02506881|531602407|FG001|First Intervention (Day 1)|Withdrawal by Subject|0|||
147392750|NCT02506881|531602408|FG002|First Intervention (Day 1)|Withdrawal by Subject|0|||
147392751|NCT02506881|531602409|FG003|First Intervention (Day 1)|Withdrawal by Subject|0|||
147392752|NCT02506881|531602406|FG000|First Intervention (Day 1)|Violation of blood storage conditions|0|||
147392753|NCT02506881|531602407|FG001|First Intervention (Day 1)|Violation of blood storage conditions|0|||
147392754|NCT02506881|531602408|FG002|First Intervention (Day 1)|Violation of blood storage conditions|12|||
147392755|NCT02506881|531602409|FG003|First Intervention (Day 1)|Violation of blood storage conditions|12|||
147392756|NCT02391545|531602412|FG000|Overall Study|Death|0|||
147392757|NCT02391545|531602413|FG001|Overall Study|Death|2|||
147392758|NCT02391545|531602412|FG000|Overall Study|Lost to Follow-up|0|||
147392759|NCT02391545|531602413|FG001|Overall Study|Lost to Follow-up|1|||
147392760|NCT02391545|531602412|FG000|Overall Study|Termination of study by sponsor|20|||
147392761|NCT02391545|531602413|FG001|Overall Study|Termination of study by sponsor|20|||
147392762|NCT02391545|531602412|FG000|Overall Study|Withdrawal by Subject|0|||
147392763|NCT02391545|531602413|FG001|Overall Study|Withdrawal by Subject|1|||
147392764|NCT02391545|531602412|FG000|Overall Study|Other Reasons|6|||
147392765|NCT02391545|531602413|FG001|Overall Study|Other Reasons|4|||
147392766|NCT02016690|531602414|FG000|Overall Study|Excluded from SAS: Enrollment violation|2|||
147392767|NCT02016690|531602414|FG000|Overall Study|Excluded from SAS: Duplication|2|||
147392768|NCT02016690|531602414|FG000|Overall Study|Excluded from SAS: Early treatment|2|||
147392769|NCT02016690|531602414|FG000|Overall Study|Excluded from SAS: Ineligible for study|2|||
147392770|NCT02016690|531602414|FG000|Overall Study|Did not meet inclusion criteria|13|||
147392771|NCT02016690|531602414|FG000|Overall Study|Hospitalized for RSV at study start|3|||
147392772|NCT01222078|531602415|FG000|Overall Study|Early termination of the study|1|||
147392773|NCT01363297|531602417|FG000|Overall Study|Other|0|||
147392774|NCT01363297|531602418|FG001|Overall Study|Other|0|||
147392775|NCT01363297|531602419|FG002|Overall Study|Other|0|||
147392776|NCT01363297|531602420|FG003|Overall Study|Other|0|||
147392777|NCT01363297|531602421|FG004|Overall Study|Other|1|||
147392778|NCT01363297|531602417|FG000|Overall Study|Death|3|||
147392779|NCT01363297|531602418|FG001|Overall Study|Death|6|||
147392780|NCT01363297|531602419|FG002|Overall Study|Death|6|||
147392781|NCT01363297|531602420|FG003|Overall Study|Death|10|||
147392782|NCT01363297|531602421|FG004|Overall Study|Death|30|||
147392783|NCT00495612|531602422|FG000|Overall Study|Lost to Follow-up|1|||
147392784|NCT00495612|531602423|FG001|Overall Study|Lost to Follow-up|0|||
147392785|NCT00495612|531602422|FG000|Overall Study|Subject's Decision to Withdraw|3|||
147392786|NCT00495612|531602423|FG001|Overall Study|Subject's Decision to Withdraw|0|||
147392787|NCT03340766|531602431|FG000|Overall Study|Withdrawal by Subject|2|||
147392788|NCT03340766|531602432|FG001|Overall Study|Withdrawal by Subject|1|||
147392789|NCT03340766|531602433|FG002|Overall Study|Withdrawal by Subject|3|||
147392790|NCT03340766|531602431|FG000|Overall Study|Lost to Follow-up|0|||
147392791|NCT03340766|531602432|FG001|Overall Study|Lost to Follow-up|0|||
147392792|NCT03340766|531602433|FG002|Overall Study|Lost to Follow-up|1|||
147392793|NCT03340766|531602431|FG000|Overall Study|Death|6|||
147392794|NCT03340766|531602432|FG001|Overall Study|Death|7|||
147392795|NCT03340766|531602433|FG002|Overall Study|Death|4|||
147392796|NCT02864147|531602437|FG000|Overall Study|Withdrawal by Subject|3|||
147392797|NCT02864147|531602438|FG001|Overall Study|Withdrawal by Subject|2|||
147392798|NCT02864147|531602439|FG002|Overall Study|Withdrawal by Subject|1|||
147392799|NCT02864147|531602437|FG000|Overall Study|Lost to Follow-up|0|||
147392800|NCT02864147|531602438|FG001|Overall Study|Lost to Follow-up|4|||
147392801|NCT02864147|531602439|FG002|Overall Study|Lost to Follow-up|0|||
147392802|NCT02864147|531602437|FG000|Overall Study|Adverse Event|0|||
147392803|NCT02864147|531602438|FG001|Overall Study|Adverse Event|1|||
147392804|NCT02864147|531602439|FG002|Overall Study|Adverse Event|0|||
147392805|NCT02864147|531602437|FG000|Overall Study|Pregnancy|4|||
147392806|NCT02864147|531602438|FG001|Overall Study|Pregnancy|0|||
147392807|NCT02864147|531602439|FG002|Overall Study|Pregnancy|0|||
147392808|NCT02864147|531602437|FG000|Overall Study|Physician Decision|0|||
147392809|NCT02864147|531602438|FG001|Overall Study|Physician Decision|0|||
147392810|NCT02864147|531602439|FG002|Overall Study|Physician Decision|1|||
147392811|NCT02864147|531602437|FG000|Overall Study|Opted for excisional procedures|0|||
147392812|NCT02864147|531602438|FG001|Overall Study|Opted for excisional procedures|0|||
147392813|NCT02864147|531602439|FG002|Overall Study|Opted for excisional procedures|3|||
147392814|NCT02269917|531602440|FG000|BL to EOE-Test and BL to Switch-Control|Lost to Follow-up|25|||
147392815|NCT02269917|531602441|FG001|BL to EOE-Test and BL to Switch-Control|Lost to Follow-up|7|||
147392816|NCT02269917|531602442|FG002|BL to EOE-Test and BL to Switch-Control|Lost to Follow-up|0|||
147392817|NCT02269917|531602440|FG000|BL to EOE-Test and BL to Switch-Control|Other|19|||
147392818|NCT02269917|531602441|FG001|BL to EOE-Test and BL to Switch-Control|Other|4|||
147392819|NCT02269917|531602442|FG002|BL to EOE-Test and BL to Switch-Control|Other|0|||
147392820|NCT02269917|531602440|FG000|BL to EOE-Test and BL to Switch-Control|Withdrawal by Subject|32|||
147392821|NCT02269917|531602441|FG001|BL to EOE-Test and BL to Switch-Control|Withdrawal by Subject|10|||
147392822|NCT02269917|531602442|FG002|BL to EOE-Test and BL to Switch-Control|Withdrawal by Subject|0|||
147392823|NCT02269917|531602440|FG000|BL to EOE-Test and BL to Switch-Control|Adverse Event|24|||
147392824|NCT02269917|531602441|FG001|BL to EOE-Test and BL to Switch-Control|Adverse Event|4|||
147392825|NCT02269917|531602442|FG002|BL to EOE-Test and BL to Switch-Control|Adverse Event|0|||
147392826|NCT02269917|531602440|FG000|BL to EOE-Test and BL to Switch-Control|Non-compliance with study drug|4|||
147392827|NCT02269917|531602441|FG001|BL to EOE-Test and BL to Switch-Control|Non-compliance with study drug|0|||
147392828|NCT02269917|531602442|FG002|BL to EOE-Test and BL to Switch-Control|Non-compliance with study drug|0|||
147392829|NCT02269917|531602440|FG000|BL to EOE-Test and BL to Switch-Control|Physician Decision|4|||
147392830|NCT02269917|531602441|FG001|BL to EOE-Test and BL to Switch-Control|Physician Decision|0|||
147392831|NCT02269917|531602442|FG002|BL to EOE-Test and BL to Switch-Control|Physician Decision|0|||
147392832|NCT02269917|531602440|FG000|BL to EOE-Test and BL to Switch-Control|Protocol Violation|2|||
147392833|NCT02269917|531602441|FG001|BL to EOE-Test and BL to Switch-Control|Protocol Violation|1|||
147392834|NCT02269917|531602442|FG002|BL to EOE-Test and BL to Switch-Control|Protocol Violation|0|||
147392835|NCT02269917|531602440|FG000|BL to EOE-Test and BL to Switch-Control|Death|4|||
147392836|NCT02269917|531602441|FG001|BL to EOE-Test and BL to Switch-Control|Death|0|||
147392837|NCT02269917|531602442|FG002|BL to EOE-Test and BL to Switch-Control|Death|0|||
147392838|NCT02269917|531602440|FG000|BL to EOE-Test and BL to Switch-Control|Randomized but not treated|3|||
147392839|NCT02269917|531602441|FG001|BL to EOE-Test and BL to Switch-Control|Randomized but not treated|5|||
147392840|NCT02269917|531602442|FG002|BL to EOE-Test and BL to Switch-Control|Randomized but not treated|0|||
147392841|NCT02269917|531602440|FG000|Switch to D/C/F/TAF (Until EOE)|Death|0|||
147392842|NCT02269917|531602441|FG001|Switch to D/C/F/TAF (Until EOE)|Death|0|||
147392843|NCT02269917|531602442|FG002|Switch to D/C/F/TAF (Until EOE)|Death|1|||
147392844|NCT02269917|531602440|FG000|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|0|||
147392845|NCT02269917|531602441|FG001|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|0|||
147392846|NCT02269917|531602442|FG002|Switch to D/C/F/TAF (Until EOE)|Lost to Follow-up|10|||
147392847|NCT02269917|531602440|FG000|Switch to D/C/F/TAF (Until EOE)|Adverse Event|0|||
147392848|NCT02269917|531602441|FG001|Switch to D/C/F/TAF (Until EOE)|Adverse Event|0|||
147392849|NCT02269917|531602442|FG002|Switch to D/C/F/TAF (Until EOE)|Adverse Event|11|||
147392850|NCT02269917|531602440|FG000|Switch to D/C/F/TAF (Until EOE)|Physician Decision|0|||
147392851|NCT02269917|531602441|FG001|Switch to D/C/F/TAF (Until EOE)|Physician Decision|0|||
147392852|NCT02269917|531602442|FG002|Switch to D/C/F/TAF (Until EOE)|Physician Decision|1|||
147392853|NCT02269917|531602440|FG000|Switch to D/C/F/TAF (Until EOE)|Pregnancy|0|||
147392854|NCT02269917|531602441|FG001|Switch to D/C/F/TAF (Until EOE)|Pregnancy|0|||
147392855|NCT02269917|531602442|FG002|Switch to D/C/F/TAF (Until EOE)|Pregnancy|2|||
147392856|NCT02269917|531602440|FG000|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|0|||
147392857|NCT02269917|531602441|FG001|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|0|||
147392858|NCT02269917|531602442|FG002|Switch to D/C/F/TAF (Until EOE)|Withdrawal by Subject|5|||
147392859|NCT02269917|531602440|FG000|Switch to D/C/F/TAF (Until EOE)|Other|0|||
147392860|NCT02269917|531602441|FG001|Switch to D/C/F/TAF (Until EOE)|Other|0|||
147392861|NCT02269917|531602442|FG002|Switch to D/C/F/TAF (Until EOE)|Other|8|||
147392862|NCT00240097|531602443|FG000|Part I|Adverse Event|1|||
147392863|NCT00240097|531602443|FG000|Part I|Death|1|||
147392864|NCT00240097|531602443|FG000|Part I|histology|1|||
147392865|NCT00240097|531602443|FG000|Part I|unevaluable|1|||
147392866|NCT00240097|531602443|FG000|Part II|did not continue from Part I|23|||
147392867|NCT02383927|531602444|FG000|Overall Study|Disease Progression|8|||
147392868|NCT02383927|531602445|FG001|Overall Study|Disease Progression|8|||
147392869|NCT02383927|531602446|FG002|Overall Study|Disease Progression|15|||
147392870|NCT02383927|531602447|FG003|Overall Study|Disease Progression|4|||
147392871|NCT02383927|531602444|FG000|Overall Study|Physician Decision|0|||
147392872|NCT02383927|531602445|FG001|Overall Study|Physician Decision|0|||
147392873|NCT02383927|531602446|FG002|Overall Study|Physician Decision|2|||
147392874|NCT02383927|531602447|FG003|Overall Study|Physician Decision|0|||
147392875|NCT02383927|531602444|FG000|Overall Study|Termination by Symptomatic Deterioration|0|||
147392876|NCT02383927|531602445|FG001|Overall Study|Termination by Symptomatic Deterioration|0|||
147392877|NCT02383927|531602446|FG002|Overall Study|Termination by Symptomatic Deterioration|6|||
147392878|NCT02383927|531602447|FG003|Overall Study|Termination by Symptomatic Deterioration|0|||
147392879|NCT02383927|531602444|FG000|Overall Study|Adverse Event|4|||
147392880|NCT02383927|531602445|FG001|Overall Study|Adverse Event|1|||
147392881|NCT02383927|531602446|FG002|Overall Study|Adverse Event|3|||
147392882|NCT02383927|531602447|FG003|Overall Study|Adverse Event|5|||
147392883|NCT02383927|531602444|FG000|Overall Study|Miscellaneous|1|||
147392884|NCT02383927|531602445|FG001|Overall Study|Miscellaneous|0|||
147392885|NCT02383927|531602446|FG002|Overall Study|Miscellaneous|0|||
147392886|NCT02383927|531602447|FG003|Overall Study|Miscellaneous|1|||
147392887|NCT02383927|531602444|FG000|Overall Study|Withdrawal by Subject|0|||
147392888|NCT02383927|531602445|FG001|Overall Study|Withdrawal by Subject|1|||
147392889|NCT02383927|531602446|FG002|Overall Study|Withdrawal by Subject|4|||
147392890|NCT02383927|531602447|FG003|Overall Study|Withdrawal by Subject|0|||
147392891|NCT00818519|531602448|FG000|Overall Study|Adverse Event|2|||
147392892|NCT00818519|531602449|FG001|Overall Study|Adverse Event|2|||
147392893|NCT00818519|531602448|FG000|Overall Study|Lost to Follow-up|4|||
147392894|NCT00818519|531602449|FG001|Overall Study|Lost to Follow-up|6|||
147392895|NCT00818519|531602448|FG000|Overall Study|Protocol Violation|2|||
147392896|NCT00818519|531602449|FG001|Overall Study|Protocol Violation|1|||
147392897|NCT00818519|531602448|FG000|Overall Study|Pregnancy|0|||
147392898|NCT00818519|531602449|FG001|Overall Study|Pregnancy|1|||
147392899|NCT00818519|531602448|FG000|Overall Study|Withdrawal by Subject|4|||
147392900|NCT00818519|531602449|FG001|Overall Study|Withdrawal by Subject|9|||
147392901|NCT00818519|531602448|FG000|Overall Study|participant recovered completely|1|||
147459862|NCT04652804|531845209|FG000|Overall Study|Ineligible post randomization|1|||
147459863|NCT04652804|531845210|FG001|Overall Study|Ineligible post randomization|0|||
147392902|NCT00818519|531602449|FG001|Overall Study|participant recovered completely|0|||
147392903|NCT00818519|531602448|FG000|Overall Study|participant will leave for long tme|1|||
147392904|NCT00818519|531602449|FG001|Overall Study|participant will leave for long tme|0|||
147392905|NCT00981578|531602450|FG000|Overall Study|Death|1|||
147392906|NCT00981578|531602450|FG000|Overall Study|Withdrawal by Subject|2|||
147615255|NCT03541317|532406686|FG003|Stage 2 of the Implementation|Withdrawal by Subject|0|||
147615256|NCT03541317|532406687|FG004|Stage 2 of the Implementation|Withdrawal by Subject|0|||
147615257|NCT03541317|532406688|FG005|Stage 2 of the Implementation|Withdrawal by Subject|0|||
147615258|NCT02536846|532406691|FG000|Overall Study|Withdrawal by Subject|1|||
147615259|NCT03164616|532406692|FG000|Overall Study|Death|250|||
147392907|NCT02865135|531602451|FG000|Overall Study|Death|0|||
147392908|NCT02865135|531602452|FG001|Overall Study|Death|1|||
147392909|NCT02865135|531602453|FG002|Overall Study|Death|0|||
147392910|NCT02865135|531602451|FG000|Overall Study|Progression|6|||
147392911|NCT02865135|531602452|FG001|Overall Study|Progression|2|||
147392912|NCT02865135|531602453|FG002|Overall Study|Progression|2|||
147392913|NCT01180790|531602460|FG000|Overall Study|Adverse Event|1|||
147392914|NCT01180790|531602461|FG001|Overall Study|Adverse Event|1|||
147392915|NCT01180790|531602462|FG002|Overall Study|Adverse Event|2|||
147392916|NCT01180790|531602463|FG003|Overall Study|Adverse Event|0|||
147392917|NCT01180790|531602464|FG004|Overall Study|Adverse Event|1|||
147392918|NCT01180790|531602465|FG005|Overall Study|Adverse Event|3|||
147392919|NCT01180790|531602466|FG006|Overall Study|Adverse Event|0|||
147392920|NCT01180790|531602460|FG000|Overall Study|Withdrawal by Subject|3|||
147392921|NCT01180790|531602461|FG001|Overall Study|Withdrawal by Subject|0|||
147392922|NCT01180790|531602462|FG002|Overall Study|Withdrawal by Subject|5|||
147392923|NCT01180790|531602463|FG003|Overall Study|Withdrawal by Subject|0|||
147392924|NCT01180790|531602464|FG004|Overall Study|Withdrawal by Subject|2|||
147392925|NCT01180790|531602465|FG005|Overall Study|Withdrawal by Subject|1|||
147392926|NCT01180790|531602466|FG006|Overall Study|Withdrawal by Subject|0|||
147392927|NCT01180790|531602460|FG000|Overall Study|Lost to Follow-up|3|||
147392928|NCT01180790|531602461|FG001|Overall Study|Lost to Follow-up|1|||
147392929|NCT01180790|531602462|FG002|Overall Study|Lost to Follow-up|0|||
147392930|NCT01180790|531602463|FG003|Overall Study|Lost to Follow-up|2|||
147392931|NCT01180790|531602464|FG004|Overall Study|Lost to Follow-up|1|||
147392932|NCT01180790|531602465|FG005|Overall Study|Lost to Follow-up|0|||
147392933|NCT01180790|531602466|FG006|Overall Study|Lost to Follow-up|1|||
147392934|NCT01180790|531602460|FG000|Overall Study|Physician Decision|1|||
147392935|NCT01180790|531602461|FG001|Overall Study|Physician Decision|0|||
147392936|NCT01180790|531602462|FG002|Overall Study|Physician Decision|0|||
147392937|NCT01180790|531602463|FG003|Overall Study|Physician Decision|1|||
147392938|NCT01180790|531602464|FG004|Overall Study|Physician Decision|0|||
147392939|NCT01180790|531602465|FG005|Overall Study|Physician Decision|0|||
147392940|NCT01180790|531602466|FG006|Overall Study|Physician Decision|0|||
147392941|NCT01180790|531602460|FG000|Overall Study|Lack of Efficacy|1|||
147392942|NCT01180790|531602461|FG001|Overall Study|Lack of Efficacy|2|||
147392943|NCT01180790|531602462|FG002|Overall Study|Lack of Efficacy|5|||
147392944|NCT01180790|531602463|FG003|Overall Study|Lack of Efficacy|6|||
147392945|NCT01180790|531602464|FG004|Overall Study|Lack of Efficacy|1|||
147392946|NCT01180790|531602465|FG005|Overall Study|Lack of Efficacy|3|||
147392947|NCT01180790|531602466|FG006|Overall Study|Lack of Efficacy|0|||
147392948|NCT01180790|531602460|FG000|Overall Study|compliance|0|||
147392949|NCT01180790|531602461|FG001|Overall Study|compliance|1|||
147392950|NCT01180790|531602462|FG002|Overall Study|compliance|0|||
147392951|NCT01180790|531602463|FG003|Overall Study|compliance|0|||
147392952|NCT01180790|531602464|FG004|Overall Study|compliance|0|||
147392953|NCT01180790|531602465|FG005|Overall Study|compliance|0|||
147392954|NCT01180790|531602466|FG006|Overall Study|compliance|0|||
147392955|NCT01180790|531602460|FG000|Overall Study|Severe coronary atherosclerosis (death)|0|||
147392956|NCT01180790|531602461|FG001|Overall Study|Severe coronary atherosclerosis (death)|0|||
147392957|NCT01180790|531602462|FG002|Overall Study|Severe coronary atherosclerosis (death)|1|||
147392958|NCT01180790|531602463|FG003|Overall Study|Severe coronary atherosclerosis (death)|0|||
147392959|NCT01180790|531602464|FG004|Overall Study|Severe coronary atherosclerosis (death)|0|||
147392960|NCT01180790|531602465|FG005|Overall Study|Severe coronary atherosclerosis (death)|0|||
147392961|NCT01180790|531602466|FG006|Overall Study|Severe coronary atherosclerosis (death)|0|||
147392962|NCT00655668|531602467|FG000|Overall Study|Adverse Event|6|||
147392963|NCT00655668|531602467|FG000|Overall Study|Death|5|||
147392964|NCT00655668|531602467|FG000|Overall Study|Disease Progression|27|||
147615260|NCT03164616|532406693|FG001|Overall Study|Death|264|||
147615261|NCT03164616|532406694|FG002|Overall Study|Death|279|||
147615262|NCT03164616|532406692|FG000|Overall Study|Lost to Follow-up|2|||
147392965|NCT00655668|531602467|FG000|Overall Study|Study Terminated|9|||
147392966|NCT00655668|531602467|FG000|Overall Study|Other|1|||
147392967|NCT00655668|531602467|FG000|Overall Study|New Lymphoma Treatment Started|4|||
147392968|NCT00655668|531602467|FG000|Overall Study|Withdrawal by Subject|2|||
147392969|NCT02335242|531602468|FG000|Randomized Phase (20 Weeks)|Withdrawal by Subject|1|||
147392970|NCT02335242|531602469|FG001|Randomized Phase (20 Weeks)|Withdrawal by Subject|0|||
147392971|NCT02335242|531602468|FG000|Follow-up Period (12 Weeks)|Lost to Follow-up|1|||
147392972|NCT02335242|531602469|FG001|Follow-up Period (12 Weeks)|Lost to Follow-up|0|||
147392973|NCT02335242|531602468|FG000|Follow-up Period (12 Weeks)|Discontinued intervention|1|||
147392974|NCT02335242|531602469|FG001|Follow-up Period (12 Weeks)|Discontinued intervention|1|||
147392975|NCT03873038|531602470|FG000|Part 2|Withdrawal by Subject|0|||
147615263|NCT03164616|532406693|FG001|Overall Study|Lost to Follow-up|2|||
147665044|NCT00641056|532597984|FG001|Overall Study|Entry Criteria Not Met|0|||
147665045|NCT00641056|532597983|FG000|Overall Study|Subject Decision|6|||
147665046|NCT00641056|532597984|FG001|Overall Study|Subject Decision|19|||
147392976|NCT03873038|531602471|FG001|Part 2|Withdrawal by Subject|0|||
147392977|NCT03873038|531602472|FG002|Part 2|Withdrawal by Subject|0|||
147392978|NCT03873038|531602473|FG003|Part 2|Withdrawal by Subject|0|||
147392979|NCT03873038|531602474|FG004|Part 2|Withdrawal by Subject|0|||
147392980|NCT03873038|531602475|FG005|Part 2|Withdrawal by Subject|1|||
147392981|NCT03873038|531602470|FG000|Part 2|Unknon|0|||
147392982|NCT03873038|531602471|FG001|Part 2|Unknon|0|||
147392983|NCT03873038|531602472|FG002|Part 2|Unknon|0|||
147392984|NCT03873038|531602473|FG003|Part 2|Unknon|0|||
147392985|NCT03873038|531602474|FG004|Part 2|Unknon|1|||
147392986|NCT03873038|531602475|FG005|Part 2|Unknon|0|||
147392987|NCT04222088|531602476|FG000|Overall Study|Lost to Follow-up|5|||
147392988|NCT04222088|531602477|FG001|Overall Study|Lost to Follow-up|1|||
147392989|NCT04222088|531602476|FG000|Overall Study|Withdrawal by Subject|4|||
147392990|NCT04222088|531602477|FG001|Overall Study|Withdrawal by Subject|0|||
147392991|NCT00595764|531602478|FG000|Overall Study|Protocol Violation|24|||
147392992|NCT00595764|531602479|FG001|Overall Study|Protocol Violation|19|||
147392993|NCT00595764|531602478|FG000|Overall Study|Missed Medication >1 week|10|||
147392994|NCT00595764|531602479|FG001|Overall Study|Missed Medication >1 week|17|||
147392995|NCT00595764|531602478|FG000|Overall Study|Missed 3 PM visits|1|||
147392996|NCT00595764|531602479|FG001|Overall Study|Missed 3 PM visits|7|||
147392997|NCT00595764|531602478|FG000|Overall Study|Withdrawal by Subject|4|||
147392998|NCT00595764|531602479|FG001|Overall Study|Withdrawal by Subject|0|||
147392999|NCT00464737|531602481|FG000|Overall Study|Adverse Event|12|||
147393000|NCT00464737|531602482|FG001|Overall Study|Adverse Event|17|||
147393001|NCT00464737|531602483|FG002|Overall Study|Adverse Event|33|||
147393002|NCT00464737|531602481|FG000|Overall Study|Lack of Efficacy|7|||
147393003|NCT00464737|531602482|FG001|Overall Study|Lack of Efficacy|7|||
147393004|NCT00464737|531602483|FG002|Overall Study|Lack of Efficacy|4|||
147393005|NCT00464737|531602481|FG000|Overall Study|Withdrawal by Subject|5|||
147393006|NCT00464737|531602482|FG001|Overall Study|Withdrawal by Subject|3|||
147393007|NCT00464737|531602483|FG002|Overall Study|Withdrawal by Subject|5|||
147393008|NCT00464737|531602481|FG000|Overall Study|Protocol Violation|1|||
147393009|NCT00464737|531602482|FG001|Overall Study|Protocol Violation|1|||
147393010|NCT00464737|531602483|FG002|Overall Study|Protocol Violation|5|||
147393011|NCT00464737|531602481|FG000|Overall Study|Non-compliance|0|||
147393012|NCT00464737|531602482|FG001|Overall Study|Non-compliance|1|||
147393013|NCT00464737|531602483|FG002|Overall Study|Non-compliance|1|||
147393014|NCT00464737|531602481|FG000|Overall Study|Lost to Follow-up|5|||
147393015|NCT00464737|531602482|FG001|Overall Study|Lost to Follow-up|2|||
147393016|NCT00464737|531602483|FG002|Overall Study|Lost to Follow-up|5|||
147393017|NCT00464737|531602481|FG000|Overall Study|Other: Subject's schedule doesn't permit|1|||
147393018|NCT00464737|531602482|FG001|Overall Study|Other: Subject's schedule doesn't permit|0|||
147393019|NCT00464737|531602483|FG002|Overall Study|Other: Subject's schedule doesn't permit|0|||
147393020|NCT00464737|531602481|FG000|Overall Study|Other: Subject left town; family illness|1|||
147393021|NCT00464737|531602482|FG001|Overall Study|Other: Subject left town; family illness|0|||
147393022|NCT00464737|531602483|FG002|Overall Study|Other: Subject left town; family illness|0|||
147393023|NCT00464737|531602481|FG000|Overall Study|Other: Study demands too great|0|||
147393024|NCT00464737|531602482|FG001|Overall Study|Other: Study demands too great|1|||
147393025|NCT00464737|531602483|FG002|Overall Study|Other: Study demands too great|0|||
147393026|NCT00464737|531602481|FG000|Overall Study|Other: Personal family reasons|0|||
147393027|NCT00464737|531602482|FG001|Overall Study|Other: Personal family reasons|0|||
147393028|NCT00464737|531602483|FG002|Overall Study|Other: Personal family reasons|1|||
147393029|NCT00464737|531602481|FG000|Overall Study|Other: Subject's disability per sponsor|0|||
147459864|NCT04652804|531845211|FG002|Overall Study|Ineligible post randomization|1|||
147459865|NCT04652804|531845212|FG003|Overall Study|Ineligible post randomization|0|||
147459866|NCT04652804|531845213|FG004|Overall Study|Ineligible post randomization|1|||
147459867|NCT04652804|531845214|FG005|Overall Study|Ineligible post randomization|1|||
147459868|NCT04652804|531845209|FG000|Overall Study|Missing SVR lab results|2|||
147459869|NCT04652804|531845210|FG001|Overall Study|Missing SVR lab results|0|||
147459870|NCT04652804|531845211|FG002|Overall Study|Missing SVR lab results|0|||
147459871|NCT04652804|531845212|FG003|Overall Study|Missing SVR lab results|0|||
147459872|NCT04652804|531845213|FG004|Overall Study|Missing SVR lab results|0|||
147459873|NCT04652804|531845214|FG005|Overall Study|Missing SVR lab results|0|||
147393030|NCT00464737|531602482|FG001|Overall Study|Other: Subject's disability per sponsor|0|||
147393031|NCT00464737|531602483|FG002|Overall Study|Other: Subject's disability per sponsor|1|||
147393032|NCT00580047|531602488|FG000|Overall Study|Lost to Follow-up|1|||
147393033|NCT00580047|531602489|FG001|Overall Study|Lost to Follow-up|1|||
147393034|NCT00580047|531602490|FG002|Overall Study|Lost to Follow-up|0|||
147393035|NCT00580047|531602488|FG000|Overall Study|Withdrawal by Subject|1|||
147393036|NCT00580047|531602489|FG001|Overall Study|Withdrawal by Subject|1|||
147393037|NCT00580047|531602490|FG002|Overall Study|Withdrawal by Subject|2|||
147393038|NCT00580047|531602488|FG000|Overall Study|Withdrawal by Subject|1|||
147393039|NCT00580047|531602489|FG001|Overall Study|Withdrawal by Subject|0|||
147393040|NCT00580047|531602490|FG002|Overall Study|Withdrawal by Subject|0|||
147393041|NCT02820298|531602491|FG000|Overall Study|Withdrawal by Subject|0|||
147393042|NCT02820298|531602492|FG001|Overall Study|Withdrawal by Subject|1|||
147393043|NCT02820298|531602491|FG000|Overall Study|Physician Decision|1|||
147393044|NCT02820298|531602492|FG001|Overall Study|Physician Decision|0|||
147393045|NCT02820298|531602491|FG000|Overall Study|Protocol Violation|0|||
147393046|NCT02820298|531602492|FG001|Overall Study|Protocol Violation|1|||
147393047|NCT01894256|531602495|FG000|Part A|Adverse Event|0|||
147393048|NCT01894256|531602496|FG001|Part A|Adverse Event|1|||
147393049|NCT01894256|531602497|FG002|Part A|Adverse Event|0|||
147393050|NCT01894256|531602495|FG000|Part B|Death|0|||
147393051|NCT01894256|531602496|FG001|Part B|Death|1|||
147393052|NCT01894256|531602497|FG002|Part B|Death|1|||
147393053|NCT01894256|531602495|FG000|Part B|Withdrawal by Subject|0|||
147393054|NCT01894256|531602496|FG001|Part B|Withdrawal by Subject|1|||
147393055|NCT01894256|531602497|FG002|Part B|Withdrawal by Subject|0|||
147393056|NCT01894256|531602495|FG000|Part B|Lack of Efficacy|15|||
147393057|NCT01894256|531602496|FG001|Part B|Lack of Efficacy|12|||
147393058|NCT01894256|531602497|FG002|Part B|Lack of Efficacy|13|||
147393059|NCT00141271|531602500|FG000|Overall Study|Adverse Event|31|||
147393060|NCT00141271|531602501|FG001|Overall Study|Adverse Event|19|||
147393061|NCT00141271|531602502|FG002|Overall Study|Adverse Event|17|||
147393062|NCT00141271|531602500|FG000|Overall Study|Laboratory Abnormality|2|||
147393063|NCT00141271|531602501|FG001|Overall Study|Laboratory Abnormality|1|||
147393064|NCT00141271|531602502|FG002|Overall Study|Laboratory Abnormality|1|||
147393065|NCT00141271|531602500|FG000|Overall Study|Lack of Efficacy|7|||
147393066|NCT00141271|531602501|FG001|Overall Study|Lack of Efficacy|7|||
147393067|NCT00141271|531602502|FG002|Overall Study|Lack of Efficacy|3|||
147393068|NCT00141271|531602500|FG000|Overall Study|Lost to Follow-up|15|||
147393069|NCT00141271|531602501|FG001|Overall Study|Lost to Follow-up|15|||
147393070|NCT00141271|531602502|FG002|Overall Study|Lost to Follow-up|21|||
147393071|NCT00141271|531602500|FG000|Overall Study|Withdrawal by Subject|14|||
147393072|NCT00141271|531602501|FG001|Overall Study|Withdrawal by Subject|9|||
147393073|NCT00141271|531602502|FG002|Overall Study|Withdrawal by Subject|10|||
147393074|NCT00141271|531602500|FG000|Overall Study|Other|11|||
147393075|NCT00141271|531602501|FG001|Overall Study|Other|12|||
147393076|NCT00141271|531602502|FG002|Overall Study|Other|5|||
147393077|NCT02133131|531602503|FG000|Overall Study|Adverse Event|0|||
147393078|NCT02133131|531602504|FG001|Overall Study|Adverse Event|0|||
147393079|NCT02133131|531602505|FG002|Overall Study|Adverse Event|0|||
147393080|NCT02133131|531602506|FG003|Overall Study|Adverse Event|1|||
147393081|NCT02133131|531602507|FG004|Overall Study|Adverse Event|0|||
147393082|NCT02133131|531602508|FG005|Overall Study|Adverse Event|0|||
147393083|NCT02133131|531602509|FG006|Overall Study|Adverse Event|0|||
147393084|NCT02133131|531602503|FG000|Overall Study|Lost to Follow-up|1|||
147393085|NCT02133131|531602504|FG001|Overall Study|Lost to Follow-up|0|||
147393086|NCT02133131|531602505|FG002|Overall Study|Lost to Follow-up|0|||
147393087|NCT02133131|531602506|FG003|Overall Study|Lost to Follow-up|1|||
147393088|NCT02133131|531602507|FG004|Overall Study|Lost to Follow-up|0|||
147393089|NCT02133131|531602508|FG005|Overall Study|Lost to Follow-up|0|||
147393090|NCT02133131|531602509|FG006|Overall Study|Lost to Follow-up|0|||
147393091|NCT02133131|531602503|FG000|Overall Study|Status not recorded|4|||
147393092|NCT02133131|531602504|FG001|Overall Study|Status not recorded|5|||
147393093|NCT02133131|531602505|FG002|Overall Study|Status not recorded|1|||
147393094|NCT02133131|531602506|FG003|Overall Study|Status not recorded|4|||
147393095|NCT02133131|531602507|FG004|Overall Study|Status not recorded|0|||
147393096|NCT02133131|531602508|FG005|Overall Study|Status not recorded|0|||
147393097|NCT02133131|531602509|FG006|Overall Study|Status not recorded|0|||
147393098|NCT02133131|531602503|FG000|Overall Study|Ongoing in study|0|||
147393099|NCT02133131|531602504|FG001|Overall Study|Ongoing in study|0|||
147393100|NCT02133131|531602505|FG002|Overall Study|Ongoing in study|0|||
147393101|NCT02133131|531602506|FG003|Overall Study|Ongoing in study|0|||
147393102|NCT02133131|531602507|FG004|Overall Study|Ongoing in study|15|||
147393103|NCT02133131|531602508|FG005|Overall Study|Ongoing in study|14|||
147665047|NCT00641056|532597983|FG000|Overall Study|Sponsor Decision|1|||
147393104|NCT02133131|531602509|FG006|Overall Study|Ongoing in study|11|||
147393105|NCT02133131|531602503|FG000|Overall Study|Protocol Violation|0|||
147393106|NCT02133131|531602504|FG001|Overall Study|Protocol Violation|0|||
147393107|NCT02133131|531602505|FG002|Overall Study|Protocol Violation|0|||
147393108|NCT02133131|531602506|FG003|Overall Study|Protocol Violation|0|||
147393109|NCT02133131|531602507|FG004|Overall Study|Protocol Violation|0|||
147393110|NCT02133131|531602508|FG005|Overall Study|Protocol Violation|0|||
147393111|NCT02133131|531602509|FG006|Overall Study|Protocol Violation|1|||
147393112|NCT02316171|531602510|FG000|Overall Study|difficulties with urinary catheter|1|||
147393113|NCT02316171|531602511|FG001|Overall Study|difficulties with urinary catheter|0|||
147393114|NCT02316171|531602512|FG002|Overall Study|difficulties with urinary catheter|0|||
147393115|NCT02316171|531602513|FG003|Overall Study|difficulties with urinary catheter|0|||
147393116|NCT01772147|531604160|FG000|Overall Study|Adverse Event|13|||
147393117|NCT01772147|531604161|FG001|Overall Study|Adverse Event|10|||
147393118|NCT01772147|531604162|FG002|Overall Study|Adverse Event|6|||
147393119|NCT01772147|531604160|FG000|Overall Study|Withdrew Consent|7|||
147459874|NCT00584194|531845215|FG000|Overall Study|Other|135|||
147459875|NCT04093531|531845216|FG000|Overall Study|failed screening|4|||
147459876|NCT00841763|531845217|FG000|Overall Study|Withdrawal by Subject|60|||
147459877|NCT00841763|531845218|FG001|Overall Study|Withdrawal by Subject|17|||
147459878|NCT00841763|531845219|FG002|Overall Study|Withdrawal by Subject|4|||
147459879|NCT00841763|531845220|FG003|Overall Study|Withdrawal by Subject|1|||
147459880|NCT00841763|531845217|FG000|Overall Study|Adverse Event|9|||
147459881|NCT00841763|531845218|FG001|Overall Study|Adverse Event|10|||
147459882|NCT00841763|531845219|FG002|Overall Study|Adverse Event|3|||
147459883|NCT00841763|531845220|FG003|Overall Study|Adverse Event|2|||
147459884|NCT00841763|531845217|FG000|Overall Study|Lost to Follow-up|63|||
147459885|NCT00841763|531845218|FG001|Overall Study|Lost to Follow-up|25|||
147459886|NCT00841763|531845219|FG002|Overall Study|Lost to Follow-up|0|||
147459887|NCT00841763|531845220|FG003|Overall Study|Lost to Follow-up|0|||
147459888|NCT00841763|531845217|FG000|Overall Study|Protocol Violation|20|||
147459889|NCT00841763|531845218|FG001|Overall Study|Protocol Violation|3|||
147459890|NCT00841763|531845219|FG002|Overall Study|Protocol Violation|1|||
147459891|NCT00841763|531845220|FG003|Overall Study|Protocol Violation|0|||
147459892|NCT00841763|531845217|FG000|Overall Study|Administrative Reasons|3|||
147459893|NCT00841763|531845218|FG001|Overall Study|Administrative Reasons|1|||
147459894|NCT00841763|531845219|FG002|Overall Study|Administrative Reasons|0|||
147459895|NCT00841763|531845220|FG003|Overall Study|Administrative Reasons|0|||
147459896|NCT00841763|531845217|FG000|Overall Study|Unable to Classify|7|||
147459897|NCT00841763|531845218|FG001|Overall Study|Unable to Classify|1|||
147459898|NCT00841763|531845219|FG002|Overall Study|Unable to Classify|0|||
147459899|NCT00841763|531845220|FG003|Overall Study|Unable to Classify|0|||
147459900|NCT03634800|531845221|FG000|Overall Study|Adverse Event|1|||
147459901|NCT03634800|531845221|FG000|Overall Study|Disease Progression|4|||
147615264|NCT03164616|532406694|FG002|Overall Study|Lost to Follow-up|2|||
147615265|NCT03164616|532406692|FG000|Overall Study|Withdrawal by Subject|6|||
147615266|NCT03164616|532406693|FG001|Overall Study|Withdrawal by Subject|7|||
147615267|NCT03164616|532406694|FG002|Overall Study|Withdrawal by Subject|16|||
147615268|NCT03449446|532406695|FG000|Overall Study|Randomized but Never Treated|0|||
147615269|NCT03449446|532406696|FG001|Overall Study|Randomized but Never Treated|0|||
147615270|NCT03449446|532406697|FG002|Overall Study|Randomized but Never Treated|1|||
147615271|NCT03449446|532406698|FG003|Overall Study|Randomized but Never Treated|1|||
147615272|NCT03449446|532406699|FG004|Overall Study|Randomized but Never Treated|1|||
147615273|NCT03449446|532406700|FG005|Overall Study|Randomized but Never Treated|0|||
147393120|NCT01772147|531604161|FG001|Overall Study|Withdrew Consent|8|||
147393121|NCT01772147|531604162|FG002|Overall Study|Withdrew Consent|4|||
147393122|NCT01772147|531604160|FG000|Overall Study|Lost to Follow-up|1|||
147393123|NCT01772147|531604161|FG001|Overall Study|Lost to Follow-up|0|||
147393124|NCT01772147|531604162|FG002|Overall Study|Lost to Follow-up|1|||
147393125|NCT01772147|531604160|FG000|Overall Study|Protocol Deviation|2|||
147393126|NCT01772147|531604161|FG001|Overall Study|Protocol Deviation|1|||
147393127|NCT01772147|531604162|FG002|Overall Study|Protocol Deviation|1|||
147393128|NCT01772147|531604160|FG000|Overall Study|Lack of Efficacy|8|||
147393129|NCT01772147|531604161|FG001|Overall Study|Lack of Efficacy|6|||
147393130|NCT01772147|531604162|FG002|Overall Study|Lack of Efficacy|6|||
147393131|NCT02093897|531604164|FG000|Overall Study|Physician Decision|1|||
147393132|NCT02093897|531604164|FG000|Overall Study|Planned age group closure - no's reached|17|||
147393133|NCT02093897|531604164|FG000|Overall Study|Adverse event, non-fatal|1|||
147393134|NCT04572997|531604168|FG000|Overall Study|Adverse Event|1|||
147393135|NCT02956278|531604169|FG000|Overall Study|Withdrawal by Subject|6|||
147393136|NCT02956278|531604170|FG001|Overall Study|Withdrawal by Subject|2|||
147393137|NCT02956278|531604171|FG002|Overall Study|Withdrawal by Subject|0|||
147393138|NCT01967719|531604172|FG000|First Intervention (Day 1)|Withdrawal by Subject|0|||
147393139|NCT01967719|531604173|FG001|First Intervention (Day 1)|Withdrawal by Subject|1|||
147393140|NCT01967719|531604174|FG002|First Intervention (Day 1)|Withdrawal by Subject|0|||
147393141|NCT01967719|531604175|FG003|First Intervention (Day 1)|Withdrawal by Subject|1|||
147393142|NCT01967719|531604172|FG000|Second Intervention (Day 3)|Withdrawal by Subject|0|||
147393143|NCT01967719|531604173|FG001|Second Intervention (Day 3)|Withdrawal by Subject|1|||
147459902|NCT03634800|531845221|FG000|Overall Study|Withdrawal by Subject|1|||
147459903|NCT00927368|531845224|FG000|Overall Study|enrollment in another study|1|||
147459904|NCT00927368|531845225|FG001|Overall Study|enrollment in another study|1|||
147459905|NCT00927368|531845226|FG002|Overall Study|enrollment in another study|2|||
147393144|NCT01967719|531604174|FG002|Second Intervention (Day 3)|Withdrawal by Subject|0|||
147459906|NCT00927368|531845224|FG000|Overall Study|Lost to Follow-up|4|||
147459907|NCT00927368|531845225|FG001|Overall Study|Lost to Follow-up|0|||
147459908|NCT00927368|531845226|FG002|Overall Study|Lost to Follow-up|0|||
147459909|NCT00927368|531845224|FG000|Overall Study|equipment failure|1|||
147459910|NCT00927368|531845225|FG001|Overall Study|equipment failure|0|||
147459911|NCT00927368|531845226|FG002|Overall Study|equipment failure|0|||
147459912|NCT00927368|531845224|FG000|Overall Study|ineligible post randomization|0|||
147615274|NCT03449446|532406701|FG006|Overall Study|Randomized but Never Treated|0|||
147459913|NCT00927368|531845225|FG001|Overall Study|ineligible post randomization|3|||
147459914|NCT00927368|531845226|FG002|Overall Study|ineligible post randomization|1|||
147393145|NCT01967719|531604175|FG003|Second Intervention (Day 3)|Withdrawal by Subject|0|||
147393146|NCT02329223|531604176|FG000|Overall Study|Withdrawal by Subject|1|||
147393147|NCT02329223|531604177|FG001|Overall Study|Withdrawal by Subject|2|||
147393148|NCT02329223|531604178|FG002|Overall Study|Withdrawal by Subject|5|||
147393149|NCT02329223|531604176|FG000|Overall Study|Physician Decision|0|||
147393150|NCT02329223|531604177|FG001|Overall Study|Physician Decision|0|||
147393151|NCT02329223|531604178|FG002|Overall Study|Physician Decision|1|||
147393152|NCT02329223|531604176|FG000|Overall Study|Adverse Event|0|||
147393153|NCT02329223|531604177|FG001|Overall Study|Adverse Event|1|||
147393154|NCT02329223|531604178|FG002|Overall Study|Adverse Event|0|||
147393155|NCT00796614|531604188|FG000|Overall Study|Adverse Event|1|||
147393156|NCT00796614|531604189|FG001|Overall Study|Adverse Event|2|||
147393157|NCT00796614|531604190|FG002|Overall Study|Adverse Event|0|||
147393158|NCT00796614|531604191|FG003|Overall Study|Adverse Event|0|||
147393159|NCT00796614|531604188|FG000|Overall Study|Protocol Violation|0|||
147393160|NCT00796614|531604189|FG001|Overall Study|Protocol Violation|0|||
147393161|NCT00796614|531604190|FG002|Overall Study|Protocol Violation|2|||
147393162|NCT00796614|531604191|FG003|Overall Study|Protocol Violation|0|||
147393163|NCT00796614|531604188|FG000|Overall Study|Lost to Follow-up|2|||
147393164|NCT00796614|531604189|FG001|Overall Study|Lost to Follow-up|2|||
147393165|NCT00796614|531604190|FG002|Overall Study|Lost to Follow-up|1|||
147393166|NCT00796614|531604191|FG003|Overall Study|Lost to Follow-up|0|||
147393167|NCT00796614|531604188|FG000|Overall Study|Withdrawal by Subject|1|||
147393168|NCT00796614|531604189|FG001|Overall Study|Withdrawal by Subject|0|||
147393169|NCT00796614|531604190|FG002|Overall Study|Withdrawal by Subject|0|||
147393170|NCT00796614|531604191|FG003|Overall Study|Withdrawal by Subject|1|||
147393171|NCT00796614|531604188|FG000|Overall Study|Other than stated|1|||
147393172|NCT00796614|531604189|FG001|Overall Study|Other than stated|0|||
147393173|NCT00796614|531604190|FG002|Overall Study|Other than stated|0|||
147393174|NCT00796614|531604191|FG003|Overall Study|Other than stated|0|||
147393175|NCT00740597|531604192|FG000|Overall Study|insurance would not cover treatment|1|||
147393176|NCT01157351|531604194|FG000|Overall Study|Adverse Event|5|||
147393177|NCT01157351|531604195|FG001|Overall Study|Adverse Event|4|||
147393178|NCT01157351|531604194|FG000|Overall Study|Death|1|||
147393179|NCT01157351|531604195|FG001|Overall Study|Death|0|||
147393180|NCT01157351|531604194|FG000|Overall Study|Lost to Follow-up|53|||
147393181|NCT01157351|531604195|FG001|Overall Study|Lost to Follow-up|55|||
147393182|NCT01157351|531604194|FG000|Overall Study|Withdrawal by Subject|37|||
147393183|NCT01157351|531604195|FG001|Overall Study|Withdrawal by Subject|27|||
147393184|NCT01157351|531604194|FG000|Overall Study|Physician Decision|5|||
147393185|NCT01157351|531604195|FG001|Overall Study|Physician Decision|4|||
147393186|NCT01157351|531604194|FG000|Overall Study|Protocol Violation|0|||
147393187|NCT01157351|531604195|FG001|Overall Study|Protocol Violation|1|||
147393188|NCT01157351|531604194|FG000|Overall Study|Other|32|||
147393189|NCT01157351|531604195|FG001|Overall Study|Other|36|||
147393190|NCT01157351|531604194|FG000|Overall Study|Noncompliance with Study Drug|0|||
147393191|NCT01157351|531604195|FG001|Overall Study|Noncompliance with Study Drug|3|||
147393192|NCT01157351|531604194|FG000|Overall Study|Randomized but not Treated|4|||
147393193|NCT01157351|531604195|FG001|Overall Study|Randomized but not Treated|2|||
147393194|NCT00746785|531604196|FG000|Overall Study|Lost to Follow-up|29|||
147393195|NCT00746785|531604197|FG001|Overall Study|Lost to Follow-up|25|||
147393196|NCT00746785|531604198|FG002|Overall Study|Lost to Follow-up|27|||
147393197|NCT01231464|531604199|FG000|Overall Study|Adverse Event|0|||
147393198|NCT01231464|531604200|FG001|Overall Study|Adverse Event|1|||
147393199|NCT01231464|531604199|FG000|Overall Study|Protocol Violation|1|||
147393200|NCT01231464|531604200|FG001|Overall Study|Protocol Violation|2|||
147393201|NCT01231464|531604199|FG000|Overall Study|Lost to Follow-up|1|||
147393202|NCT01231464|531604200|FG001|Overall Study|Lost to Follow-up|2|||
147393203|NCT01231464|531604199|FG000|Overall Study|Withdrawal by Subject|3|||
147393204|NCT01231464|531604200|FG001|Overall Study|Withdrawal by Subject|2|||
147393205|NCT03449134|531604201|FG000|52-Week Treatment Period|Death|2|||
147393206|NCT03449134|531604202|FG001|52-Week Treatment Period|Death|1|||
147393207|NCT03449134|531604203|FG002|52-Week Treatment Period|Death|0|||
147393208|NCT03449134|531604201|FG000|52-Week Treatment Period|Lost to Follow-up|2|||
147393209|NCT03449134|531604202|FG001|52-Week Treatment Period|Lost to Follow-up|1|||
147393210|NCT03449134|531604203|FG002|52-Week Treatment Period|Lost to Follow-up|1|||
147393211|NCT03449134|531604201|FG000|52-Week Treatment Period|Physician Decision|2|||
147393212|NCT03449134|531604202|FG001|52-Week Treatment Period|Physician Decision|3|||
147393213|NCT03449134|531604203|FG002|52-Week Treatment Period|Physician Decision|3|||
147393214|NCT03449134|531604201|FG000|52-Week Treatment Period|Screen Failure|1|||
147393215|NCT03449134|531604202|FG001|52-Week Treatment Period|Screen Failure|0|||
147393216|NCT03449134|531604203|FG002|52-Week Treatment Period|Screen Failure|1|||
147393217|NCT03449134|531604201|FG000|52-Week Treatment Period|Withdrawal by Subject|37|||
147393218|NCT03449134|531604202|FG001|52-Week Treatment Period|Withdrawal by Subject|39|||
147393219|NCT03449134|531604203|FG002|52-Week Treatment Period|Withdrawal by Subject|55|||
147393220|NCT03449134|531604201|FG000|52-Week Treatment Period|Site Closure|1|||
147393221|NCT03449134|531604202|FG001|52-Week Treatment Period|Site Closure|0|||
147393222|NCT03449134|531604203|FG002|52-Week Treatment Period|Site Closure|0|||
147393223|NCT00957996|531604209|FG000|Overall Study|Death|4|||
147393224|NCT00957996|531604210|FG001|Overall Study|Death|10|||
147393225|NCT00957996|531604209|FG000|Overall Study|Lost to Follow-up|4|||
147393226|NCT00957996|531604210|FG001|Overall Study|Lost to Follow-up|7|||
147393227|NCT00957996|531604209|FG000|Overall Study|Withdrawal by Subject|9|||
147393228|NCT00957996|531604210|FG001|Overall Study|Withdrawal by Subject|2|||
147393229|NCT00957996|531604209|FG000|Overall Study|Adverse Event|2|||
147393230|NCT00957996|531604210|FG001|Overall Study|Adverse Event|1|||
147393231|NCT00957996|531604209|FG000|Overall Study|Physician Decision|1|||
147393232|NCT00957996|531604210|FG001|Overall Study|Physician Decision|1|||
147393233|NCT00957996|531604209|FG000|Overall Study|Influenza-related complication|0|||
147393234|NCT00957996|531604210|FG001|Overall Study|Influenza-related complication|1|||
147393235|NCT00957996|531604209|FG000|Overall Study|Missing|1|||
147393236|NCT00957996|531604210|FG001|Overall Study|Missing|0|||
147393237|NCT00957996|531604209|FG000|Overall Study|Noncompliance; Protocol Deviations|5|||
147393238|NCT00957996|531604210|FG001|Overall Study|Noncompliance; Protocol Deviations|6|||
147393239|NCT01960348|531604216|FG000|Overall Study|Adverse event, not serious|2|||
147393240|NCT01960348|531604217|FG001|Overall Study|Adverse event, not serious|2|||
147393241|NCT01960348|531604216|FG000|Overall Study|Adverse event, serious fatal|6|||
147393242|NCT01960348|531604217|FG001|Overall Study|Adverse event, serious fatal|5|||
147393243|NCT01960348|531604216|FG000|Overall Study|Adverse event, serious non-fatal|0|||
147393244|NCT01960348|531604217|FG001|Overall Study|Adverse event, serious non-fatal|3|||
147393245|NCT01960348|531604216|FG000|Overall Study|Withdrawal by Subject|1|||
147393246|NCT01960348|531604217|FG001|Overall Study|Withdrawal by Subject|11|||
147393247|NCT01960348|531604216|FG000|Overall Study|Physician Decision|0|||
147393248|NCT01960348|531604217|FG001|Overall Study|Physician Decision|1|||
147393249|NCT01960348|531604216|FG000|Overall Study|Protocol Violation|1|||
147393250|NCT01960348|531604217|FG001|Overall Study|Protocol Violation|0|||
147393251|NCT01580995|531604218|FG000|Overall Study|Lost to Follow-up|2|||
147393252|NCT01580995|531604219|FG001|Overall Study|Lost to Follow-up|2|||
147393253|NCT01821729|531604220|FG000|Overall Study|Withdrawal by Subject|1|||
147393254|NCT02916706|531604221|FG000|Overall Study|Adverse Event|0|||
147393255|NCT02916706|531604222|FG001|Overall Study|Adverse Event|1|||
147393256|NCT02916706|531604221|FG000|Overall Study|Lost to Follow-up|0|||
147393257|NCT02916706|531604222|FG001|Overall Study|Lost to Follow-up|1|||
147393258|NCT02916706|531604221|FG000|Overall Study|Physician Decision|1|||
147393259|NCT02916706|531604222|FG001|Overall Study|Physician Decision|0|||
147393260|NCT02916706|531604221|FG000|Overall Study|Protocol Violation|3|||
147393261|NCT02916706|531604222|FG001|Overall Study|Protocol Violation|1|||
147393262|NCT02916706|531604221|FG000|Overall Study|Withdrawal by Subject|6|||
147393263|NCT02916706|531604222|FG001|Overall Study|Withdrawal by Subject|9|||
147393264|NCT02916706|531604221|FG000|Overall Study|Other|5|||
147393265|NCT02916706|531604222|FG001|Overall Study|Other|19|||
147393266|NCT01902381|531604230|FG000|Overall Study|Withdrawal by Subject|1|||
147393267|NCT04140266|531604231|FG000|Overall Study|Physician Decision|2|||
147393268|NCT04140266|531604232|FG001|Overall Study|Physician Decision|0|||
147393269|NCT04140266|531604231|FG000|Overall Study|Withdrawal by Subject|4|||
147393270|NCT04140266|531604232|FG001|Overall Study|Withdrawal by Subject|2|||
147393271|NCT03511378|531604235|FG000|Overall Study|Withdrawal by Subject|2|||
147393272|NCT03511378|531604236|FG001|Overall Study|Withdrawal by Subject|2|||
147393273|NCT03511378|531604235|FG000|Overall Study|Patient not coming or schedule visit|1|||
147393274|NCT03511378|531604236|FG001|Overall Study|Patient not coming or schedule visit|0|||
147393275|NCT02762500|531604237|FG000|Overall Study|Lack of Efficacy|1|||
147393276|NCT02762500|531604238|FG001|Overall Study|Lack of Efficacy|0|||
147393277|NCT02762500|531604237|FG000|Overall Study|Withdrawal by Subject|1|||
147393278|NCT02762500|531604238|FG001|Overall Study|Withdrawal by Subject|1|||
147393279|NCT02762500|531604237|FG000|Overall Study|Adverse Event|0|||
147393280|NCT02762500|531604238|FG001|Overall Study|Adverse Event|2|||
147393281|NCT00730847|531604240|FG000|Overall Study|Adverse Event|1|||
147393282|NCT00730847|531604240|FG000|Overall Study|Protocol Violation|2|||
147393283|NCT00730847|531604240|FG000|Overall Study|Withdrawal by Subject|16|||
147393284|NCT00730847|531604240|FG000|Overall Study|Lost to Follow-up|67|||
147393285|NCT00730847|531604240|FG000|Overall Study|Unknown completion status|21|||
147665048|NCT00641056|532597984|FG001|Overall Study|Sponsor Decision|2|||
147393286|NCT00730847|531604240|FG000|Overall Study|Other|24|||
147393287|NCT00280683|531604241|FG000|Overall Study|Withdrawal by Subject|1|||
147393288|NCT00280683|531604242|FG001|Overall Study|Withdrawal by Subject|2|||
147393289|NCT00280683|531604241|FG000|Overall Study|Adverse Event|1|||
147393290|NCT00280683|531604242|FG001|Overall Study|Adverse Event|1|||
147393291|NCT00329550|531604246|FG000|Overall Study|Adverse Event|3|||
147393292|NCT00329550|531604247|FG001|Overall Study|Adverse Event|4|||
147393293|NCT00329550|531604248|FG002|Overall Study|Adverse Event|2|||
147393294|NCT00329550|531604246|FG000|Overall Study|Withdrawal of Consent|1|||
147393295|NCT00329550|531604247|FG001|Overall Study|Withdrawal of Consent|0|||
147393296|NCT00329550|531604248|FG002|Overall Study|Withdrawal of Consent|1|||
147393297|NCT00329550|531604246|FG000|Overall Study|Due to Relocation|0|||
147393298|NCT00329550|531604247|FG001|Overall Study|Due to Relocation|0|||
147393299|NCT00329550|531604248|FG002|Overall Study|Due to Relocation|1|||
147393300|NCT00666198|531604250|FG000|Overall Study|Protocol Violation|10|||
147393301|NCT00666198|531604250|FG000|Overall Study|No Visit After First Day of Treatment|13|||
147393302|NCT00666198|531604250|FG000|Overall Study|Safety Not Assessable|6|||
147393303|NCT00666198|531604250|FG000|Overall Study|No Drug Administration|4|||
147393304|NCT05153499|531604251|FG000|Overall Study|Withdrawal by Subject|1|||
147393305|NCT05153499|531604252|FG001|Overall Study|Withdrawal by Subject|0|||
147393306|NCT05153499|531604251|FG000|Overall Study|Clinical Hold|1|||
147393307|NCT05153499|531604252|FG001|Overall Study|Clinical Hold|0|||
147393308|NCT05153499|531604251|FG000|Overall Study|Study Termination|6|||
147393309|NCT05153499|531604252|FG001|Overall Study|Study Termination|5|||
147393310|NCT03220776|531604256|FG000|Overall Study|Claustrophobia|0|||
147393311|NCT03220776|531604257|FG001|Overall Study|Claustrophobia|1|||
147393312|NCT03220776|531604258|FG002|Overall Study|Claustrophobia|1|||
147393313|NCT03220776|531604259|FG003|Overall Study|Claustrophobia|0|||
147393314|NCT03220776|531604260|FG004|Overall Study|Claustrophobia|1|||
147393315|NCT03220776|531604261|FG005|Overall Study|Claustrophobia|0|||
147393316|NCT03220776|531604256|FG000|Overall Study|MRI Equipment Failure|1|||
147393317|NCT03220776|531604257|FG001|Overall Study|MRI Equipment Failure|0|||
147393318|NCT03220776|531604258|FG002|Overall Study|MRI Equipment Failure|0|||
147393319|NCT03220776|531604259|FG003|Overall Study|MRI Equipment Failure|0|||
147393320|NCT03220776|531604260|FG004|Overall Study|MRI Equipment Failure|0|||
147393321|NCT03220776|531604261|FG005|Overall Study|MRI Equipment Failure|0|||
147393322|NCT03220776|531604256|FG000|Overall Study|Inclimate Weather|0|||
147393323|NCT03220776|531604257|FG001|Overall Study|Inclimate Weather|0|||
147393324|NCT03220776|531604258|FG002|Overall Study|Inclimate Weather|0|||
147393325|NCT03220776|531604259|FG003|Overall Study|Inclimate Weather|0|||
147393326|NCT03220776|531604260|FG004|Overall Study|Inclimate Weather|0|||
147393327|NCT03220776|531604261|FG005|Overall Study|Inclimate Weather|1|||
147393328|NCT03220776|531604256|FG000|Overall Study|Physician Decision|0|||
147393329|NCT03220776|531604257|FG001|Overall Study|Physician Decision|0|||
147393330|NCT03220776|531604258|FG002|Overall Study|Physician Decision|0|||
147393331|NCT03220776|531604259|FG003|Overall Study|Physician Decision|1|||
147393332|NCT03220776|531604260|FG004|Overall Study|Physician Decision|0|||
147393333|NCT03220776|531604261|FG005|Overall Study|Physician Decision|0|||
147393334|NCT03220776|531604256|FG000|Overall Study|Potential presence of non-MRI safe metal in body|0|||
147393335|NCT03220776|531604257|FG001|Overall Study|Potential presence of non-MRI safe metal in body|0|||
147393336|NCT03220776|531604258|FG002|Overall Study|Potential presence of non-MRI safe metal in body|0|||
147393337|NCT03220776|531604259|FG003|Overall Study|Potential presence of non-MRI safe metal in body|1|||
147393338|NCT03220776|531604260|FG004|Overall Study|Potential presence of non-MRI safe metal in body|0|||
147393339|NCT03220776|531604261|FG005|Overall Study|Potential presence of non-MRI safe metal in body|0|||
147393340|NCT03220776|531604256|FG000|Overall Study|Protocol Violation|0|||
147393341|NCT03220776|531604257|FG001|Overall Study|Protocol Violation|0|||
147393342|NCT03220776|531604258|FG002|Overall Study|Protocol Violation|0|||
147393343|NCT03220776|531604259|FG003|Overall Study|Protocol Violation|2|||
147393344|NCT03220776|531604260|FG004|Overall Study|Protocol Violation|0|||
147393345|NCT03220776|531604261|FG005|Overall Study|Protocol Violation|1|||
147393346|NCT03220776|531604256|FG000|Overall Study|Withdrawal by Subject|1|||
147393347|NCT03220776|531604257|FG001|Overall Study|Withdrawal by Subject|0|||
147393348|NCT03220776|531604258|FG002|Overall Study|Withdrawal by Subject|0|||
147393349|NCT03220776|531604259|FG003|Overall Study|Withdrawal by Subject|0|||
147393350|NCT03220776|531604260|FG004|Overall Study|Withdrawal by Subject|0|||
147393351|NCT03220776|531604261|FG005|Overall Study|Withdrawal by Subject|0|||
147393352|NCT03226353|531604262|FG000|Overall Study|Withdrawal by Subject|1|||
147393353|NCT03226353|531604262|FG000|Overall Study|Screen Failure|5|||
147393354|NCT02166047|531604265|FG000|Overall Study|Withdrawal by Participant|0|||
147393355|NCT02166047|531604266|FG001|Overall Study|Withdrawal by Participant|1|||
147393356|NCT02166047|531604267|FG002|Overall Study|Withdrawal by Participant|2|||
147393357|NCT02166047|531604268|FG003|Overall Study|Withdrawal by Participant|0|||
147393358|NCT02166047|531604269|FG004|Overall Study|Withdrawal by Participant|0|||
147393359|NCT02166047|531604270|FG005|Overall Study|Withdrawal by Participant|0|||
147393360|NCT02166047|531604271|FG006|Overall Study|Withdrawal by Participant|1|||
147393361|NCT02166047|531604272|FG007|Overall Study|Withdrawal by Participant|0|||
147393362|NCT02166047|531604273|FG008|Overall Study|Withdrawal by Participant|0|||
147393363|NCT02166047|531604274|FG009|Overall Study|Withdrawal by Participant|0|||
147393364|NCT02166047|531604275|FG010|Overall Study|Withdrawal by Participant|0|||
147615275|NCT03449446|532406695|FG000|Overall Study|Unknown Reason|33|||
147615276|NCT03449446|532406696|FG001|Overall Study|Unknown Reason|1|||
147393365|NCT02166047|531604276|FG011|Overall Study|Withdrawal by Participant|0|||
147393366|NCT02166047|531604265|FG000|Overall Study|Adverse Event|0|||
147393367|NCT02166047|531604266|FG001|Overall Study|Adverse Event|0|||
147393368|NCT02166047|531604267|FG002|Overall Study|Adverse Event|0|||
147393369|NCT02166047|531604268|FG003|Overall Study|Adverse Event|0|||
147393370|NCT02166047|531604269|FG004|Overall Study|Adverse Event|1|||
147393371|NCT02166047|531604270|FG005|Overall Study|Adverse Event|0|||
147393372|NCT02166047|531604271|FG006|Overall Study|Adverse Event|1|||
147615277|NCT03449446|532406697|FG002|Overall Study|Unknown Reason|1|||
147615278|NCT03449446|532406698|FG003|Overall Study|Unknown Reason|1|||
147459915|NCT00927368|531845224|FG000|Overall Study|cancellation of surgery|0|||
147459916|NCT00927368|531845225|FG001|Overall Study|cancellation of surgery|1|||
147459917|NCT00927368|531845226|FG002|Overall Study|cancellation of surgery|2|||
147459918|NCT00364689|531845227|FG000|Overall Study|Lost to Follow-up|1|||
147459919|NCT01114529|531845235|FG000|Completed Study Medication at Month 24|Adverse Event|87|||
147393373|NCT02166047|531604272|FG007|Overall Study|Adverse Event|0|||
147393374|NCT02166047|531604273|FG008|Overall Study|Adverse Event|0|||
147393375|NCT02166047|531604274|FG009|Overall Study|Adverse Event|0|||
147459920|NCT01114529|531845236|FG001|Completed Study Medication at Month 24|Adverse Event|18|||
147459921|NCT01114529|531845237|FG002|Completed Study Medication at Month 24|Adverse Event|17|||
147459922|NCT01114529|531845235|FG000|Completed Study Medication at Month 24|Abnormal laboratory value(s)|6|||
147459923|NCT01114529|531845236|FG001|Completed Study Medication at Month 24|Abnormal laboratory value(s)|0|||
147459924|NCT01114529|531845237|FG002|Completed Study Medication at Month 24|Abnormal laboratory value(s)|1|||
147459925|NCT01114529|531845235|FG000|Completed Study Medication at Month 24|Abnormal test procedure result(s)|3|||
147459926|NCT01114529|531845236|FG001|Completed Study Medication at Month 24|Abnormal test procedure result(s)|0|||
147459927|NCT01114529|531845237|FG002|Completed Study Medication at Month 24|Abnormal test procedure result(s)|1|||
147459928|NCT01114529|531845235|FG000|Completed Study Medication at Month 24|Lack of Efficacy|2|||
147459929|NCT01114529|531845236|FG001|Completed Study Medication at Month 24|Lack of Efficacy|1|||
147459930|NCT01114529|531845237|FG002|Completed Study Medication at Month 24|Lack of Efficacy|2|||
147459931|NCT01114529|531845235|FG000|Completed Study Medication at Month 24|Subject's no longer required drug|1|||
147459932|NCT01114529|531845236|FG001|Completed Study Medication at Month 24|Subject's no longer required drug|1|||
147459933|NCT01114529|531845237|FG002|Completed Study Medication at Month 24|Subject's no longer required drug|1|||
147459934|NCT01114529|531845235|FG000|Completed Study Medication at Month 24|Withdrawal by Subject|18|||
147459935|NCT01114529|531845236|FG001|Completed Study Medication at Month 24|Withdrawal by Subject|8|||
147459936|NCT01114529|531845237|FG002|Completed Study Medication at Month 24|Withdrawal by Subject|2|||
147459937|NCT01114529|531845235|FG000|Completed Study Medication at Month 24|Lost to Follow-up|1|||
147459938|NCT01114529|531845236|FG001|Completed Study Medication at Month 24|Lost to Follow-up|4|||
147459939|NCT01114529|531845237|FG002|Completed Study Medication at Month 24|Lost to Follow-up|2|||
147459940|NCT01114529|531845235|FG000|Completed Study Medication at Month 24|Administrative problems|2|||
147459941|NCT01114529|531845236|FG001|Completed Study Medication at Month 24|Administrative problems|1|||
147459942|NCT01114529|531845237|FG002|Completed Study Medication at Month 24|Administrative problems|2|||
147459943|NCT01114529|531845235|FG000|Completed Study Medication at Month 24|Death|2|||
147459944|NCT01114529|531845236|FG001|Completed Study Medication at Month 24|Death|1|||
147459945|NCT01114529|531845237|FG002|Completed Study Medication at Month 24|Death|2|||
147459946|NCT01114529|531845235|FG000|Completed Study Medication at Month 24|Graft loss|0|||
147459947|NCT01114529|531845236|FG001|Completed Study Medication at Month 24|Graft loss|2|||
147459948|NCT01114529|531845237|FG002|Completed Study Medication at Month 24|Graft loss|0|||
147459949|NCT01114529|531845235|FG000|Completed Study Medication at Month 24|Protocol Violation|0|||
147459950|NCT01114529|531845236|FG001|Completed Study Medication at Month 24|Protocol Violation|5|||
147459951|NCT01114529|531845237|FG002|Completed Study Medication at Month 24|Protocol Violation|2|||
147459952|NCT01114529|531845235|FG000|Completed Study Medication at Month 24|Missing|2|||
147393376|NCT02166047|531604275|FG010|Overall Study|Adverse Event|2|||
147393377|NCT02166047|531604276|FG011|Overall Study|Adverse Event|0|||
147393378|NCT02490878|531604278|FG000|Overall Study|deemed ineligible|0|||
147393379|NCT02490878|531604279|FG001|Overall Study|deemed ineligible|1|||
147393380|NCT02490878|531604278|FG000|Overall Study|progression prior to treatment|0|||
147393381|NCT02490878|531604279|FG001|Overall Study|progression prior to treatment|1|||
147393382|NCT02490878|531604278|FG000|Overall Study|only submitted baseline QOL|0|||
147393383|NCT02490878|531604279|FG001|Overall Study|only submitted baseline QOL|1|||
147393384|NCT03280108|531604280|FG000|Overall Study|Lost to Follow-up|2|||
147393385|NCT03280108|531604281|FG001|Overall Study|Lost to Follow-up|0|||
147393386|NCT01187407|531604282|FG000|Confirmation (CF) Phase, 3 Weeks|Adverse Event|29|||
147459953|NCT01114529|531845236|FG001|Completed Study Medication at Month 24|Missing|0|||
147459954|NCT01114529|531845237|FG002|Completed Study Medication at Month 24|Missing|0|||
147459955|NCT01114529|531845235|FG000|Completed Study Phase at Month 24|Withdrawal by Subject|18|||
147459956|NCT01114529|531845236|FG001|Completed Study Phase at Month 24|Withdrawal by Subject|6|||
147459957|NCT01114529|531845237|FG002|Completed Study Phase at Month 24|Withdrawal by Subject|3|||
147459958|NCT01114529|531845235|FG000|Completed Study Phase at Month 24|Lost to Follow-up|10|||
147459959|NCT01114529|531845236|FG001|Completed Study Phase at Month 24|Lost to Follow-up|5|||
147459960|NCT01114529|531845237|FG002|Completed Study Phase at Month 24|Lost to Follow-up|7|||
147459961|NCT01114529|531845235|FG000|Completed Study Phase at Month 24|Death|8|||
147459962|NCT01114529|531845236|FG001|Completed Study Phase at Month 24|Death|5|||
147459963|NCT01114529|531845237|FG002|Completed Study Phase at Month 24|Death|4|||
147459964|NCT01114529|531845235|FG000|Completed Study Phase at Month 24|Other|2|||
147459965|NCT01114529|531845236|FG001|Completed Study Phase at Month 24|Other|0|||
147459966|NCT01114529|531845237|FG002|Completed Study Phase at Month 24|Other|0|||
147459967|NCT01114529|531845235|FG000|Completed Study Phase at Month 24|Missing|2|||
147459968|NCT01114529|531845236|FG001|Completed Study Phase at Month 24|Missing|0|||
147393387|NCT01187407|531604283|FG001|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
147393388|NCT01187407|531604284|FG002|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
147393389|NCT01187407|531604285|FG003|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
147393390|NCT01187407|531604286|FG004|Confirmation (CF) Phase, 3 Weeks|Adverse Event|0|||
147393391|NCT01187407|531604282|FG000|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|4|||
147393392|NCT01187407|531604283|FG001|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
147393393|NCT01187407|531604284|FG002|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
147393394|NCT01187407|531604285|FG003|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
147393395|NCT01187407|531604286|FG004|Confirmation (CF) Phase, 3 Weeks|Lack of Efficacy|0|||
147393396|NCT01187407|531604282|FG000|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|9|||
147393397|NCT01187407|531604283|FG001|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
147393398|NCT01187407|531604284|FG002|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
147393399|NCT01187407|531604285|FG003|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
147393400|NCT01187407|531604286|FG004|Confirmation (CF) Phase, 3 Weeks|Lost to Follow-up|0|||
147393401|NCT01187407|531604282|FG000|Confirmation (CF) Phase, 3 Weeks|Physician Decision|2|||
147393402|NCT01187407|531604283|FG001|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
147393403|NCT01187407|531604284|FG002|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
147393404|NCT01187407|531604285|FG003|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
147393405|NCT01187407|531604286|FG004|Confirmation (CF) Phase, 3 Weeks|Physician Decision|0|||
147393406|NCT01187407|531604282|FG000|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|13|||
147393407|NCT01187407|531604283|FG001|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
147393408|NCT01187407|531604284|FG002|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
147393409|NCT01187407|531604285|FG003|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
147393410|NCT01187407|531604286|FG004|Confirmation (CF) Phase, 3 Weeks|Protocol Violation|0|||
147393411|NCT01187407|531604282|FG000|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|29|||
147393412|NCT01187407|531604283|FG001|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
147393413|NCT01187407|531604284|FG002|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
147393414|NCT01187407|531604285|FG003|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
147393415|NCT01187407|531604286|FG004|Confirmation (CF) Phase, 3 Weeks|Withdrawal by Subject|0|||
147393416|NCT01187407|531604282|FG000|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|4|||
147393417|NCT01187407|531604283|FG001|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
147393418|NCT01187407|531604284|FG002|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
147393419|NCT01187407|531604285|FG003|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
147393420|NCT01187407|531604286|FG004|Confirmation (CF) Phase, 3 Weeks|Sponsor Decision|0|||
147393421|NCT01187407|531604282|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|0|||
147393422|NCT01187407|531604283|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|13|||
147393423|NCT01187407|531604284|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|6|||
147393424|NCT01187407|531604285|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|5|||
147393425|NCT01187407|531604286|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Adverse Event|12|||
147393426|NCT01187407|531604282|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|0|||
147393427|NCT01187407|531604283|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|3|||
147393428|NCT01187407|531604284|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|8|||
147393429|NCT01187407|531604285|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|5|||
147393430|NCT01187407|531604286|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Lack of Efficacy|13|||
147393431|NCT01187407|531604282|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|0|||
147393432|NCT01187407|531604283|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|3|||
147393433|NCT01187407|531604284|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|5|||
147393434|NCT01187407|531604285|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|2|||
147393435|NCT01187407|531604286|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Lost to Follow-up|9|||
147393436|NCT01187407|531604282|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
147393437|NCT01187407|531604283|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
147393438|NCT01187407|531604284|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|0|||
147393439|NCT01187407|531604285|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|1|||
147393440|NCT01187407|531604286|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Physician Decision|2|||
147393441|NCT01187407|531604282|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|0|||
147393442|NCT01187407|531604283|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|6|||
147393443|NCT01187407|531604284|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|5|||
147665049|NCT00896493|532597987|FG000|Overall Study|Early disease relapse|3|||
147393444|NCT01187407|531604285|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|3|||
147393445|NCT01187407|531604286|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Protocol Violation|10|||
147393446|NCT01187407|531604282|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|0|||
147393447|NCT01187407|531604283|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|9|||
147393448|NCT01187407|531604284|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|9|||
147393449|NCT01187407|531604285|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|11|||
147393450|NCT01187407|531604286|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Withdrawal by Subject|22|||
147393451|NCT01187407|531604282|FG000|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|0|||
147393452|NCT01187407|531604283|FG001|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2|||
147393453|NCT01187407|531604284|FG002|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2|||
147393454|NCT01187407|531604285|FG003|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|2|||
147393455|NCT01187407|531604286|FG004|Adjunctive Treatment (AT) Phase, 8 Weeks|Sponsor Decision|7|||
147393456|NCT01713998|531604287|FG000|Overall Study|Lost to Follow-up|2|||
147393457|NCT01713998|531604288|FG001|Overall Study|Lost to Follow-up|0|||
147393458|NCT01713998|531604289|FG002|Overall Study|Lost to Follow-up|2|||
147393459|NCT01713998|531604287|FG000|Overall Study|Withdrawal by Subject|1|||
147393460|NCT01713998|531604288|FG001|Overall Study|Withdrawal by Subject|0|||
147393461|NCT01713998|531604289|FG002|Overall Study|Withdrawal by Subject|0|||
147393462|NCT03638258|531604290|FG000|Overall Study|Adverse Event|1|||
147393463|NCT03638258|531604291|FG001|Overall Study|Adverse Event|0|||
147393464|NCT03638258|531604292|FG002|Overall Study|Adverse Event|2|||
147393465|NCT03638258|531604290|FG000|Overall Study|Lost to Follow-up|2|||
147393466|NCT03638258|531604291|FG001|Overall Study|Lost to Follow-up|4|||
147393467|NCT03638258|531604292|FG002|Overall Study|Lost to Follow-up|5|||
147393468|NCT03638258|531604290|FG000|Overall Study|Pregnancy|0|||
147393469|NCT03638258|531604291|FG001|Overall Study|Pregnancy|0|||
147393470|NCT03638258|531604292|FG002|Overall Study|Pregnancy|1|||
147393471|NCT03638258|531604290|FG000|Overall Study|Protocol Violation|0|||
147393472|NCT03638258|531604291|FG001|Overall Study|Protocol Violation|0|||
147393473|NCT03638258|531604292|FG002|Overall Study|Protocol Violation|1|||
147393474|NCT03638258|531604290|FG000|Overall Study|Withdrawal by Subject|4|||
147393475|NCT03638258|531604291|FG001|Overall Study|Withdrawal by Subject|5|||
147393476|NCT03638258|531604292|FG002|Overall Study|Withdrawal by Subject|12|||
147393477|NCT03638258|531604290|FG000|Overall Study|Lack of Efficacy|0|||
147393478|NCT03638258|531604291|FG001|Overall Study|Lack of Efficacy|0|||
147393479|NCT03638258|531604292|FG002|Overall Study|Lack of Efficacy|2|||
147393480|NCT01287416|531604293|FG000|Pre-post Training|Withdrawal by Subject|17|||
147393481|NCT01287416|531604294|FG001|Pre-post Training|Withdrawal by Subject|24|||
147393482|NCT01287416|531604293|FG000|Pre-post Training|Lost to Follow-up|5|||
147393483|NCT01287416|531604294|FG001|Pre-post Training|Lost to Follow-up|1|||
147393484|NCT01287416|531604293|FG000|6 Month Follow-up|Lost to Follow-up|3|||
147393485|NCT01287416|531604294|FG001|6 Month Follow-up|Lost to Follow-up|2|||
147393486|NCT00607789|531604296|FG000|Overall Study|Adverse Event|3|||
147393487|NCT00607789|531604297|FG001|Overall Study|Adverse Event|0|||
147393488|NCT00607789|531604296|FG000|Overall Study|Lack of Efficacy|0|||
147393489|NCT00607789|531604297|FG001|Overall Study|Lack of Efficacy|1|||
147393490|NCT00607789|531604296|FG000|Overall Study|Inadequate adherence|3|||
147393491|NCT00607789|531604297|FG001|Overall Study|Inadequate adherence|0|||
147393492|NCT00607789|531604296|FG000|Overall Study|Lost to Follow-up|0|||
147393493|NCT00607789|531604297|FG001|Overall Study|Lost to Follow-up|5|||
147393494|NCT00607789|531604296|FG000|Overall Study|Withdrawal by Subject|1|||
147393495|NCT00607789|531604297|FG001|Overall Study|Withdrawal by Subject|0|||
147393496|NCT01313299|531604298|FG000|Overall Study|Adverse Event|3|||
147393497|NCT01313299|531604299|FG001|Overall Study|Adverse Event|1|||
147393498|NCT01313299|531604300|FG002|Overall Study|Adverse Event|1|||
147393499|NCT01313299|531604298|FG000|Overall Study|Lost to Follow-up|1|||
147393500|NCT01313299|531604299|FG001|Overall Study|Lost to Follow-up|0|||
147393501|NCT01313299|531604300|FG002|Overall Study|Lost to Follow-up|0|||
147393502|NCT01313299|531604298|FG000|Overall Study|Protocol Violation|2|||
147393503|NCT01313299|531604299|FG001|Overall Study|Protocol Violation|0|||
147393504|NCT01313299|531604300|FG002|Overall Study|Protocol Violation|0|||
147393505|NCT01313299|531604298|FG000|Overall Study|Withdrawal by Subject|1|||
147393506|NCT01313299|531604299|FG001|Overall Study|Withdrawal by Subject|0|||
147393507|NCT01313299|531604300|FG002|Overall Study|Withdrawal by Subject|2|||
147393508|NCT01313299|531604298|FG000|Overall Study|Family reason and moved out of state|0|||
147393509|NCT01313299|531604299|FG001|Overall Study|Family reason and moved out of state|2|||
147393510|NCT01313299|531604300|FG002|Overall Study|Family reason and moved out of state|0|||
147393511|NCT01313299|531604298|FG000|Overall Study|Lack of subject compliance|0|||
147393512|NCT01313299|531604299|FG001|Overall Study|Lack of subject compliance|0|||
147665050|NCT02026141|532597990|FG000|Overall Study|Protocol Violation|0|||
147665051|NCT02026141|532597991|FG001|Overall Study|Protocol Violation|1|||
147393513|NCT01313299|531604300|FG002|Overall Study|Lack of subject compliance|1|||
147393514|NCT01919398|531604301|FG000|Overall Study|Progressive Disease|0|||
147393515|NCT01919398|531604302|FG001|Overall Study|Progressive Disease|0|||
147393516|NCT01919398|531604303|FG002|Overall Study|Progressive Disease|4|||
147393517|NCT01064856|531604306|FG000|Double-blind (DB) Period|Adverse Event|1|||
147393518|NCT01064856|531604307|FG001|Double-blind (DB) Period|Adverse Event|0|||
147393519|NCT01064856|531604308|FG002|Double-blind (DB) Period|Adverse Event|0|||
147393520|NCT01064856|531604309|FG003|Double-blind (DB) Period|Adverse Event|0|||
147393521|NCT01064856|531604306|FG000|Double-blind (DB) Period|Consent withdrawn by participant|1|||
147393522|NCT01064856|531604307|FG001|Double-blind (DB) Period|Consent withdrawn by participant|0|||
147393523|NCT01064856|531604308|FG002|Double-blind (DB) Period|Consent withdrawn by participant|0|||
147393524|NCT01064856|531604309|FG003|Double-blind (DB) Period|Consent withdrawn by participant|0|||
147393525|NCT01064856|531604306|FG000|Open-label (OL) Period|Adverse Event|0|||
147393526|NCT01064856|531604307|FG001|Open-label (OL) Period|Adverse Event|0|||
147393527|NCT01064856|531604308|FG002|Open-label (OL) Period|Adverse Event|12|||
147393528|NCT01064856|531604309|FG003|Open-label (OL) Period|Adverse Event|6|||
147393529|NCT01064856|531604306|FG000|Open-label (OL) Period|Consent withdrawn by participant|0|||
147393530|NCT01064856|531604307|FG001|Open-label (OL) Period|Consent withdrawn by participant|0|||
147393531|NCT01064856|531604308|FG002|Open-label (OL) Period|Consent withdrawn by participant|5|||
147393532|NCT01064856|531604309|FG003|Open-label (OL) Period|Consent withdrawn by participant|6|||
147393533|NCT01064856|531604306|FG000|Open-label (OL) Period|Lost to Follow-up|0|||
147393534|NCT01064856|531604307|FG001|Open-label (OL) Period|Lost to Follow-up|0|||
147393535|NCT01064856|531604308|FG002|Open-label (OL) Period|Lost to Follow-up|2|||
147393536|NCT01064856|531604309|FG003|Open-label (OL) Period|Lost to Follow-up|1|||
147393537|NCT01064856|531604306|FG000|Open-label (OL) Period|Other|0|||
147393538|NCT01064856|531604307|FG001|Open-label (OL) Period|Other|0|||
147393539|NCT01064856|531604308|FG002|Open-label (OL) Period|Other|7|||
147393540|NCT01064856|531604309|FG003|Open-label (OL) Period|Other|7|||
147393541|NCT01780584|531604310|FG000|Overall Study|Death|1|||
147393542|NCT01780584|531604311|FG001|Overall Study|Death|0|||
147393543|NCT01780584|531604312|FG002|Overall Study|Death|1|||
147393544|NCT01780584|531604310|FG000|Overall Study|Adverse Event|0|||
147393545|NCT01780584|531604311|FG001|Overall Study|Adverse Event|1|||
147393546|NCT01780584|531604312|FG002|Overall Study|Adverse Event|0|||
147393547|NCT01780584|531604310|FG000|Overall Study|Protocol Violation|0|||
147393548|NCT01780584|531604311|FG001|Overall Study|Protocol Violation|0|||
147393549|NCT01780584|531604312|FG002|Overall Study|Protocol Violation|1|||
147393550|NCT04783519|531604313|FG000|Overall Study|Withdrawal by Subject|2|||
147393551|NCT04783519|531604314|FG001|Overall Study|Withdrawal by Subject|7|||
147393552|NCT04783519|531604315|FG002|Overall Study|Withdrawal by Subject|3|||
147393553|NCT04783519|531604313|FG000|Overall Study|Lost to Follow-up|9|||
147393554|NCT04783519|531604314|FG001|Overall Study|Lost to Follow-up|7|||
147393555|NCT04783519|531604315|FG002|Overall Study|Lost to Follow-up|6|||
147393556|NCT00645099|531604316|FG000|Overall Study|Lack of Efficacy|15|||
147393557|NCT00645099|531604317|FG001|Overall Study|Lack of Efficacy|6|||
147393558|NCT00645099|531604316|FG000|Overall Study|Withdrawal by Subject|30|||
147393559|NCT00645099|531604317|FG001|Overall Study|Withdrawal by Subject|22|||
147393560|NCT00645099|531604316|FG000|Overall Study|Lost to Follow-up|6|||
147393561|NCT00645099|531604317|FG001|Overall Study|Lost to Follow-up|4|||
147393562|NCT00645099|531604316|FG000|Overall Study|Adverse Event|11|||
147393563|NCT00645099|531604317|FG001|Overall Study|Adverse Event|5|||
147393564|NCT00645099|531604316|FG000|Overall Study|Other|9|||
147393565|NCT00645099|531604317|FG001|Overall Study|Other|5|||
147393566|NCT01201915|531604318|FG000|Overall Study|Adverse Event|2|||
147393567|NCT01201915|531604319|FG001|Overall Study|Adverse Event|1|||
147393568|NCT01201915|531604320|FG002|Overall Study|Adverse Event|1|||
147393569|NCT01201915|531604318|FG000|Overall Study|Lost to Follow-up|0|||
147393570|NCT01201915|531604319|FG001|Overall Study|Lost to Follow-up|4|||
147393571|NCT01201915|531604320|FG002|Overall Study|Lost to Follow-up|0|||
147393572|NCT01201915|531604318|FG000|Overall Study|Physician Decision|3|||
147393573|NCT01201915|531604319|FG001|Overall Study|Physician Decision|0|||
147393574|NCT01201915|531604320|FG002|Overall Study|Physician Decision|0|||
147393575|NCT01201915|531604318|FG000|Overall Study|Subject Decision|3|||
147393576|NCT01201915|531604319|FG001|Overall Study|Subject Decision|3|||
147393577|NCT01201915|531604320|FG002|Overall Study|Subject Decision|5|||
147393578|NCT01201915|531604318|FG000|Overall Study|Target Lesion Progression|0|||
147393579|NCT01201915|531604319|FG001|Overall Study|Target Lesion Progression|3|||
147393580|NCT01201915|531604320|FG002|Overall Study|Target Lesion Progression|0|||
147393581|NCT03406507|531604321|FG000|Extension Period|Lack of Efficacy|0|||
147393582|NCT03406507|531604322|FG001|Extension Period|Lack of Efficacy|1|||
147393583|NCT00381797|531606010|FG000|Overall Study|Withdrawal by Subject|1|||
147393584|NCT00381797|531606011|FG001|Overall Study|Withdrawal by Subject|1|||
147393585|NCT00381797|531606012|FG002|Overall Study|Withdrawal by Subject|0|||
147393586|NCT00381797|531606013|FG003|Overall Study|Withdrawal by Subject|0|||
147393587|NCT00381797|531606014|FG004|Overall Study|Withdrawal by Subject|2|||
147393588|NCT00381797|531606010|FG000|Overall Study|Ineligible|0|||
147393589|NCT00381797|531606011|FG001|Overall Study|Ineligible|0|||
147393590|NCT00381797|531606012|FG002|Overall Study|Ineligible|0|||
147393591|NCT00381797|531606013|FG003|Overall Study|Ineligible|1|||
147393592|NCT00381797|531606014|FG004|Overall Study|Ineligible|0|||
147393593|NCT00684203|531606015|FG000|Overall Study|Adverse Event|6|||
147393594|NCT00684203|531606016|FG001|Overall Study|Adverse Event|4|||
147393595|NCT00684203|531606017|FG002|Overall Study|Adverse Event|8|||
147393596|NCT00684203|531606018|FG003|Overall Study|Adverse Event|0|||
147393597|NCT00684203|531606019|FG004|Overall Study|Adverse Event|0|||
147393598|NCT00684203|531606020|FG005|Overall Study|Adverse Event|0|||
147393599|NCT00684203|531606015|FG000|Overall Study|Protocol-defined clinical event|3|||
147393600|NCT00684203|531606016|FG001|Overall Study|Protocol-defined clinical event|1|||
147393601|NCT00684203|531606017|FG002|Overall Study|Protocol-defined clinical event|0|||
147393602|NCT00684203|531606018|FG003|Overall Study|Protocol-defined clinical event|0|||
147393603|NCT00684203|531606019|FG004|Overall Study|Protocol-defined clinical event|0|||
147393604|NCT00684203|531606020|FG005|Overall Study|Protocol-defined clinical event|0|||
147393605|NCT00684203|531606015|FG000|Overall Study|Withdrawal by Subject|0|||
147393606|NCT00684203|531606016|FG001|Overall Study|Withdrawal by Subject|2|||
147393607|NCT00684203|531606017|FG002|Overall Study|Withdrawal by Subject|1|||
147393608|NCT00684203|531606018|FG003|Overall Study|Withdrawal by Subject|0|||
147393609|NCT00684203|531606019|FG004|Overall Study|Withdrawal by Subject|0|||
147393610|NCT00684203|531606020|FG005|Overall Study|Withdrawal by Subject|0|||
147393611|NCT00684203|531606015|FG000|Overall Study|Did not meet protocol eligibility|0|||
147393612|NCT00684203|531606016|FG001|Overall Study|Did not meet protocol eligibility|1|||
147393613|NCT00684203|531606017|FG002|Overall Study|Did not meet protocol eligibility|0|||
147393614|NCT00684203|531606018|FG003|Overall Study|Did not meet protocol eligibility|0|||
147393615|NCT00684203|531606019|FG004|Overall Study|Did not meet protocol eligibility|0|||
147393616|NCT00684203|531606020|FG005|Overall Study|Did not meet protocol eligibility|0|||
147393617|NCT00719212|531606023|FG000|Overall Study|Death|41|||
147393618|NCT00719212|531606023|FG000|Overall Study|Lost to Follow-up|2|||
147393619|NCT00719212|531606023|FG000|Overall Study|Withdrawal by Subject|1|||
147393620|NCT00837096|531606024|FG000|Overall Study|Physician Decision|1|||
147393621|NCT00837096|531606025|FG001|Overall Study|Physician Decision|1|||
147393622|NCT00837096|531606024|FG000|Overall Study|Not reported|9|||
147393623|NCT00837096|531606025|FG001|Overall Study|Not reported|8|||
147665052|NCT00960193|532597994|FG000|14 Day Washout Period|Withdrawal by Subject|1|||
147665053|NCT01324102|532597995|FG000|Overall Study|illness|1|||
147665054|NCT01324102|532597996|FG001|Overall Study|illness|6|||
147665055|NCT03238417|532597997|FG000|Overall|non-response|955|||
147665056|NCT03238417|532597998|FG001|Overall|non-response|1920|||
147665057|NCT03238417|532597997|FG000|Overall|partial completion|48|||
147665058|NCT03238417|532597998|FG001|Overall|partial completion|68|||
147665059|NCT03238417|532597997|FG000|Baseline|Partial completion|17|||
147665060|NCT03238417|532597998|FG001|Baseline|Partial completion|48|||
147665061|NCT03238417|532597997|FG000|Baseline|non-response|372|||
147665062|NCT03238417|532597998|FG001|Baseline|non-response|669|||
147665063|NCT03238417|532597997|FG000|12-month|non-response|296|||
147665064|NCT03238417|532597998|FG001|12-month|non-response|669|||
147393624|NCT00488319|531606026|FG000|Overall Study|Adverse Event|1|||
147393625|NCT00488319|531606027|FG001|Overall Study|Adverse Event|2|||
147393626|NCT00488319|531606028|FG002|Overall Study|Adverse Event|23|||
147393627|NCT00488319|531606026|FG000|Overall Study|Lack of Efficacy|6|||
147393628|NCT00488319|531606027|FG001|Overall Study|Lack of Efficacy|12|||
147393629|NCT00488319|531606028|FG002|Overall Study|Lack of Efficacy|27|||
147393630|NCT00488319|531606026|FG000|Overall Study|Lost to Follow-up|3|||
147393631|NCT00488319|531606027|FG001|Overall Study|Lost to Follow-up|5|||
147393632|NCT00488319|531606028|FG002|Overall Study|Lost to Follow-up|16|||
147393633|NCT00488319|531606026|FG000|Overall Study|Withdrawal by Subject|5|||
147393634|NCT00488319|531606027|FG001|Overall Study|Withdrawal by Subject|20|||
147393635|NCT00488319|531606028|FG002|Overall Study|Withdrawal by Subject|44|||
147393636|NCT00488319|531606026|FG000|Overall Study|Other reasons for withdrawal|0|||
147393637|NCT00488319|531606027|FG001|Overall Study|Other reasons for withdrawal|4|||
147393638|NCT00488319|531606028|FG002|Overall Study|Other reasons for withdrawal|12|||
147393639|NCT01011049|531606031|FG000|Overall Study|Protocol Violation|0|||
147393640|NCT01011049|531606032|FG001|Overall Study|Protocol Violation|0|||
147393641|NCT01011049|531606033|FG002|Overall Study|Protocol Violation|2|||
147393642|NCT01011049|531606034|FG003|Overall Study|Protocol Violation|0|||
147393643|NCT01011049|531606031|FG000|Overall Study|Lost to Follow-up|1|||
147393644|NCT01011049|531606032|FG001|Overall Study|Lost to Follow-up|2|||
147665065|NCT03238417|532597997|FG000|12-month|partial completion|23|||
147665066|NCT03238417|532597998|FG001|12-month|partial completion|37|||
147665067|NCT03238417|532597997|FG000|24-month|non-response|287|||
147665068|NCT03238417|532597998|FG001|24-month|non-response|594|||
147665069|NCT03238417|532597997|FG000|24-month|partial completion|8|||
147665070|NCT03238417|532597998|FG001|24-month|partial completion|31|||
147665071|NCT01249131|532597999|FG000|Washout Period of 10 Days|Adverse Event|0|||
147393645|NCT01011049|531606033|FG002|Overall Study|Lost to Follow-up|1|||
147393646|NCT01011049|531606034|FG003|Overall Study|Lost to Follow-up|0|||
147393647|NCT01011049|531606031|FG000|Overall Study|Withdrawal by Subject|0|||
147393648|NCT01011049|531606032|FG001|Overall Study|Withdrawal by Subject|0|||
147393649|NCT01011049|531606033|FG002|Overall Study|Withdrawal by Subject|1|||
147393650|NCT01011049|531606034|FG003|Overall Study|Withdrawal by Subject|0|||
147393651|NCT00352053|531606035|FG000|Double-Blind Phase (Through Week 48)|Virologic Failure|14|||
147393652|NCT00352053|531606036|FG001|Double-Blind Phase (Through Week 48)|Virologic Failure|10|||
147393653|NCT00352053|531606035|FG000|Double-Blind Phase (Through Week 48)|Physician Decision|2|||
147393654|NCT00352053|531606036|FG001|Double-Blind Phase (Through Week 48)|Physician Decision|2|||
147393655|NCT00352053|531606035|FG000|Double-Blind Phase (Through Week 48)|Adverse Event|1|||
147393656|NCT00352053|531606036|FG001|Double-Blind Phase (Through Week 48)|Adverse Event|0|||
147393657|NCT00352053|531606035|FG000|Double-Blind Phase (Through Week 48)|Withdrawal by Subject|0|||
147393658|NCT00352053|531606036|FG001|Double-Blind Phase (Through Week 48)|Withdrawal by Subject|1|||
147665072|NCT01249131|532598000|FG001|Washout Period of 10 Days|Adverse Event|0|||
147665073|NCT01249131|532598001|FG002|Washout Period of 10 Days|Adverse Event|0|||
147393659|NCT00352053|531606035|FG000|Double-Blind Phase (Through Week 48)|Intolerance to Antiretroviral Regimen|1|||
147393660|NCT00352053|531606036|FG001|Double-Blind Phase (Through Week 48)|Intolerance to Antiretroviral Regimen|0|||
147393661|NCT00352053|531606035|FG000|First Extension Phase (Weeks 48-144)|Physician Decision|9|||
147393662|NCT00352053|531606036|FG001|First Extension Phase (Weeks 48-144)|Physician Decision|13|||
147393663|NCT00352053|531606035|FG000|First Extension Phase (Weeks 48-144)|Lack of Efficacy|1|||
147393664|NCT00352053|531606036|FG001|First Extension Phase (Weeks 48-144)|Lack of Efficacy|4|||
147393665|NCT00352053|531606035|FG000|First Extension Phase (Weeks 48-144)|Pregnancy|1|||
147393666|NCT00352053|531606036|FG001|First Extension Phase (Weeks 48-144)|Pregnancy|0|||
147393667|NCT00352053|531606035|FG000|First Extension Phase (Weeks 48-144)|Lost to Follow-up|1|||
147393668|NCT00352053|531606036|FG001|First Extension Phase (Weeks 48-144)|Lost to Follow-up|0|||
147393669|NCT00352053|531606035|FG000|Second Extension Phase (Weeks 144-240)|Physician Decision|4|||
147393670|NCT00352053|531606036|FG001|Second Extension Phase (Weeks 144-240)|Physician Decision|4|||
147393671|NCT00352053|531606035|FG000|Second Extension Phase (Weeks 144-240)|Withdrawal by Subject|1|||
147393672|NCT00352053|531606036|FG001|Second Extension Phase (Weeks 144-240)|Withdrawal by Subject|1|||
147393673|NCT00352053|531606035|FG000|Third Extension Phase (Weeks 240-294)|Lack of Efficacy|1|||
147393674|NCT00352053|531606036|FG001|Third Extension Phase (Weeks 240-294)|Lack of Efficacy|1|||
147393675|NCT00352053|531606035|FG000|Third Extension Phase (Weeks 240-294)|Withdrawal by Subject|0|||
147393676|NCT00352053|531606036|FG001|Third Extension Phase (Weeks 240-294)|Withdrawal by Subject|1|||
147393677|NCT02435381|531606037|FG000|Overall Study|Lost to Follow-up|2|||
147393678|NCT02435381|531606038|FG001|Overall Study|Lost to Follow-up|1|||
147393679|NCT04150341|531606041|FG000|Overall Study|Physician Decision|0|||
147393680|NCT04150341|531606042|FG001|Overall Study|Physician Decision|0|||
147393681|NCT04150341|531606043|FG002|Overall Study|Physician Decision|1|||
147393682|NCT04150341|531606044|FG003|Overall Study|Physician Decision|0|||
147393683|NCT04150341|531606045|FG004|Overall Study|Physician Decision|0|||
147393684|NCT04150341|531606046|FG005|Overall Study|Physician Decision|0|||
147393685|NCT04150341|531606041|FG000|Overall Study|Adverse Event|0|||
147393686|NCT04150341|531606042|FG001|Overall Study|Adverse Event|0|||
147393687|NCT04150341|531606043|FG002|Overall Study|Adverse Event|0|||
147393688|NCT04150341|531606044|FG003|Overall Study|Adverse Event|0|||
147393689|NCT04150341|531606045|FG004|Overall Study|Adverse Event|1|||
147393690|NCT04150341|531606046|FG005|Overall Study|Adverse Event|0|||
147393691|NCT00875615|531606047|FG000|Overall Study|Withdrawal by Subject|1|||
147393692|NCT00833898|531606054|FG000|Overall Study|Withdrawal by Subject|33|||
147393693|NCT00833898|531606055|FG001|Overall Study|Withdrawal by Subject|27|||
147393694|NCT00833898|531606054|FG000|Overall Study|Lost to Follow-up|7|||
147393695|NCT00833898|531606055|FG001|Overall Study|Lost to Follow-up|7|||
147393696|NCT00833898|531606054|FG000|Overall Study|Patient did not receive transplant|0|||
147393697|NCT00833898|531606055|FG001|Overall Study|Patient did not receive transplant|2|||
147393698|NCT03441789|531606063|FG000|Overall Study|Withdrawal by Subject|1|||
147393699|NCT03441789|531606064|FG001|Overall Study|Withdrawal by Subject|1|||
147393700|NCT03441789|531606063|FG000|Overall Study|Adverse Event|0|||
147393701|NCT03441789|531606064|FG001|Overall Study|Adverse Event|1|||
147393702|NCT03441789|531606063|FG000|Overall Study|Protocol Violation|0|||
147393703|NCT03441789|531606064|FG001|Overall Study|Protocol Violation|1|||
147393704|NCT03441789|531606063|FG000|Overall Study|Lost to Follow-up|0|||
147393705|NCT03441789|531606064|FG001|Overall Study|Lost to Follow-up|1|||
147393706|NCT03168425|531606065|FG000|Overall Study|Lost to Follow-up|5|||
147393707|NCT03168425|531606066|FG001|Overall Study|Lost to Follow-up|8|||
147393708|NCT03168425|531606065|FG000|Overall Study|unable to confirm post op opioids|2|||
147393709|NCT03168425|531606066|FG001|Overall Study|unable to confirm post op opioids|3|||
147393710|NCT01960114|531606067|FG000|Overall Study|Adverse Event|1|||
147393711|NCT01960114|531606068|FG001|Overall Study|Adverse Event|0|||
147393712|NCT01960114|531606067|FG000|Overall Study|Could not swallow study medication|0|||
147459969|NCT01114529|531845237|FG002|Completed Study Phase at Month 24|Missing|0|||
147459970|NCT00331409|531845241|FG000|Overall Study|Lack of Efficacy|4|||
147459971|NCT01482910|531845242|FG000|Overall Study|Adverse Event|6|||
147393713|NCT01960114|531606068|FG001|Overall Study|Could not swallow study medication|1|||
147393714|NCT02845375|531606072|FG000|Overall Study|upper airway obstruction|1|||
147393715|NCT02845375|531606073|FG001|Overall Study|upper airway obstruction|2|||
147393716|NCT02845375|531606074|FG002|Overall Study|upper airway obstruction|1|||
147393717|NCT01177137|531606075|FG000|Overall Study|Withdrawal by Subject|10|||
147393718|NCT01177137|531606076|FG001|Overall Study|Withdrawal by Subject|10|||
147393719|NCT01177137|531606077|FG002|Overall Study|Withdrawal by Subject|2|||
147393720|NCT02959177|531606079|FG000|Double-Blind Treatment Phase|Adverse Event|5|||
147393721|NCT02959177|531606080|FG001|Double-Blind Treatment Phase|Adverse Event|2|||
147393722|NCT02959177|531606081|FG002|Double-Blind Treatment Phase|Adverse Event|0|||
147393723|NCT02959177|531606079|FG000|Double-Blind Treatment Phase|Physician Decision|1|||
147459972|NCT01482910|531845243|FG001|Overall Study|Adverse Event|5|||
147459973|NCT01482910|531845242|FG000|Overall Study|Lost to Follow-up|0|||
147615279|NCT03449446|532406699|FG004|Overall Study|Unknown Reason|2|||
147615280|NCT03449446|532406700|FG005|Overall Study|Unknown Reason|2|||
147615281|NCT03449446|532406701|FG006|Overall Study|Unknown Reason|0|||
147615282|NCT03449446|532406695|FG000|Overall Study|Withdrew Consent|1|||
147393724|NCT02959177|531606080|FG001|Double-Blind Treatment Phase|Physician Decision|0|||
147393725|NCT02959177|531606081|FG002|Double-Blind Treatment Phase|Physician Decision|0|||
147393726|NCT02959177|531606079|FG000|Double-Blind Treatment Phase|Protocol Violation|0|||
147393727|NCT02959177|531606080|FG001|Double-Blind Treatment Phase|Protocol Violation|1|||
147393728|NCT02959177|531606081|FG002|Double-Blind Treatment Phase|Protocol Violation|0|||
147393729|NCT02959177|531606079|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|5|||
147393730|NCT02959177|531606080|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
147393731|NCT02959177|531606081|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|5|||
147393732|NCT02959177|531606079|FG000|Follow-up Post Treatment Phase|Lost to Follow-up|1|||
147393733|NCT02959177|531606080|FG001|Follow-up Post Treatment Phase|Lost to Follow-up|0|||
147393734|NCT02959177|531606081|FG002|Follow-up Post Treatment Phase|Lost to Follow-up|0|||
147393735|NCT02959177|531606079|FG000|Follow-up Post Treatment Phase|Adverse Event|0|||
147393736|NCT02959177|531606080|FG001|Follow-up Post Treatment Phase|Adverse Event|1|||
147393737|NCT02959177|531606081|FG002|Follow-up Post Treatment Phase|Adverse Event|0|||
147393738|NCT02959177|531606079|FG000|Follow-up Post Treatment Phase|Withdrawal by Subject|0|||
147393739|NCT02959177|531606080|FG001|Follow-up Post Treatment Phase|Withdrawal by Subject|0|||
147393740|NCT02959177|531606081|FG002|Follow-up Post Treatment Phase|Withdrawal by Subject|2|||
147393741|NCT02215954|531606083|FG000|Overall Study|Adverse Event|0|||
147393742|NCT02215954|531606084|FG001|Overall Study|Adverse Event|0|||
147393743|NCT02215954|531606085|FG002|Overall Study|Adverse Event|1|||
147393744|NCT02215954|531606083|FG000|Overall Study|Withdrawal by Subject|0|||
147393745|NCT02215954|531606084|FG001|Overall Study|Withdrawal by Subject|0|||
147393746|NCT02215954|531606085|FG002|Overall Study|Withdrawal by Subject|2|||
147393747|NCT02215954|531606083|FG000|Overall Study|Not exposed|1|||
147393748|NCT02215954|531606084|FG001|Overall Study|Not exposed|1|||
147393749|NCT02215954|531606085|FG002|Overall Study|Not exposed|3|||
147393750|NCT02460562|531606086|FG000|Overall Study|Lost to Follow-up|15|||
147393751|NCT02460562|531606087|FG001|Overall Study|Lost to Follow-up|16|||
147393752|NCT01951261|531606088|FG000|Overall Study|Death|1|||
147393753|NCT01951261|531606089|FG001|Overall Study|Death|0|||
147393754|NCT01951261|531606088|FG000|Overall Study|Lost to Follow-up|4|||
147393755|NCT01951261|531606089|FG001|Overall Study|Lost to Follow-up|3|||
147393756|NCT01951261|531606088|FG000|Overall Study|Protocol Violation|4|||
147393757|NCT01951261|531606089|FG001|Overall Study|Protocol Violation|3|||
147393758|NCT01924806|531606090|FG000|Overall Study|Physician Decision|2|||
147393759|NCT01924806|531606091|FG001|Overall Study|Physician Decision|1|||
147393760|NCT00297778|531606099|FG000|Overall Study|Adverse Event|16|||
147393761|NCT00297778|531606100|FG001|Overall Study|Adverse Event|10|||
147393762|NCT00297778|531606099|FG000|Overall Study|Withdrawal by Subject|1|||
147393763|NCT00297778|531606100|FG001|Overall Study|Withdrawal by Subject|5|||
147393764|NCT00297778|531606099|FG000|Overall Study|Lack of Efficacy|2|||
147393765|NCT00297778|531606100|FG001|Overall Study|Lack of Efficacy|1|||
147393766|NCT00297778|531606099|FG000|Overall Study|Non-compliant with trial protocol|0|||
147393767|NCT00297778|531606100|FG001|Overall Study|Non-compliant with trial protocol|3|||
147393768|NCT00297778|531606099|FG000|Overall Study|Other|0|||
147393769|NCT00297778|531606100|FG001|Overall Study|Other|1|||
147393770|NCT02996097|531606101|FG000|Overall Study|Lost to Follow-up|11|||
147393771|NCT02996097|531606102|FG001|Overall Study|Lost to Follow-up|11|||
147393772|NCT02201771|531606103|FG000|Overall Study|Death|3|||
147393773|NCT02201771|531606104|FG001|Overall Study|Death|2|||
147393774|NCT02201771|531606105|FG002|Overall Study|Death|0|||
147393775|NCT02201771|531606103|FG000|Overall Study|Protocol Violation|10|||
147393776|NCT02201771|531606104|FG001|Overall Study|Protocol Violation|8|||
147393777|NCT02201771|531606105|FG002|Overall Study|Protocol Violation|10|||
147393778|NCT03569475|531606106|FG000|Double-blind Treatment Period (8 Weeks)|Adverse Event|1|||
147393779|NCT03569475|531606107|FG001|Double-blind Treatment Period (8 Weeks)|Adverse Event|2|||
147393780|NCT03569475|531606108|FG002|Double-blind Treatment Period (8 Weeks)|Adverse Event|5|||
147393781|NCT03569475|531606106|FG000|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|0|||
147393782|NCT03569475|531606107|FG001|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|1|||
147393783|NCT03569475|531606108|FG002|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|0|||
147393784|NCT03569475|531606106|FG000|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|7|||
147393785|NCT03569475|531606107|FG001|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|10|||
147393786|NCT03569475|531606108|FG002|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|9|||
147393787|NCT03569475|531606106|FG000|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|7|||
147393788|NCT03569475|531606107|FG001|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|7|||
147393789|NCT03569475|531606108|FG002|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|6|||
147393790|NCT03569475|531606106|FG000|Double-blind Treatment Period (8 Weeks)|Protocol Deviation|1|||
147393791|NCT03569475|531606107|FG001|Double-blind Treatment Period (8 Weeks)|Protocol Deviation|1|||
147393792|NCT03569475|531606108|FG002|Double-blind Treatment Period (8 Weeks)|Protocol Deviation|1|||
147393793|NCT03569475|531606106|FG000|Double-blind Treatment Period (8 Weeks)|Non-compliance with Study Drug|1|||
147393794|NCT03569475|531606107|FG001|Double-blind Treatment Period (8 Weeks)|Non-compliance with Study Drug|1|||
147393795|NCT03569475|531606108|FG002|Double-blind Treatment Period (8 Weeks)|Non-compliance with Study Drug|1|||
147459974|NCT01482910|531845243|FG001|Overall Study|Lost to Follow-up|1|||
147393796|NCT03569475|531606106|FG000|Double-blind Treatment Period (8 Weeks)|Reason not Specified|1|||
147393797|NCT03569475|531606107|FG001|Double-blind Treatment Period (8 Weeks)|Reason not Specified|1|||
147393798|NCT03569475|531606108|FG002|Double-blind Treatment Period (8 Weeks)|Reason not Specified|2|||
147393799|NCT03569475|531606106|FG000|Double-blind Down-taper Period (1 Week)|Lost to Follow-up|0|||
147393800|NCT03569475|531606107|FG001|Double-blind Down-taper Period (1 Week)|Lost to Follow-up|1|||
147393801|NCT03569475|531606108|FG002|Double-blind Down-taper Period (1 Week)|Lost to Follow-up|1|||
147393802|NCT03569475|531606106|FG000|Double-blind Down-taper Period (1 Week)|Withdrawal by Subject|0|||
147393803|NCT03569475|531606107|FG001|Double-blind Down-taper Period (1 Week)|Withdrawal by Subject|1|||
147393804|NCT03569475|531606108|FG002|Double-blind Down-taper Period (1 Week)|Withdrawal by Subject|1|||
147393805|NCT02109107|531606109|FG000|Overall Study|Lost to Follow-up|2|||
147393806|NCT03078751|531606114|FG000|Overall Study|Adverse Event|4|||
147393807|NCT03078751|531606115|FG001|Overall Study|Adverse Event|0|||
147393808|NCT03078751|531606114|FG000|Overall Study|Physician Decision|1|||
147393809|NCT03078751|531606115|FG001|Overall Study|Physician Decision|0|||
147393810|NCT03078751|531606114|FG000|Overall Study|Terminated by Sponsor = early terminated recruitment|0|||
147393811|NCT03078751|531606115|FG001|Overall Study|Terminated by Sponsor = early terminated recruitment|23|||
147393812|NCT03078751|531606114|FG000|Overall Study|Subject/guardian decision|8|||
147393813|NCT03078751|531606115|FG001|Overall Study|Subject/guardian decision|1|||
147393814|NCT03078751|531606114|FG000|Overall Study|Untreated|0|||
147393815|NCT03078751|531606115|FG001|Overall Study|Untreated|4|||
147393816|NCT02515097|531606116|FG000|Overall Study|Lost to Follow-up|4|||
147393817|NCT02515097|531606117|FG001|Overall Study|Lost to Follow-up|2|||
147393818|NCT02515097|531606116|FG000|Overall Study|Withdrawal by Subject|1|||
147393819|NCT02515097|531606117|FG001|Overall Study|Withdrawal by Subject|3|||
147393820|NCT02515097|531606116|FG000|Overall Study|Adverse Event|2|||
147393821|NCT02515097|531606117|FG001|Overall Study|Adverse Event|1|||
147393822|NCT00853021|531606118|FG000|Overall Study|Adverse Event|2|||
147393823|NCT00853021|531606118|FG000|Overall Study|Withdrawal by Subject|2|||
147393824|NCT00853021|531606118|FG000|Overall Study|Death|1|||
147393825|NCT03613454|531606119|FG000|Overall Study|Protocol Violation|1|||
147393826|NCT03613454|531606120|FG001|Overall Study|Protocol Violation|0|||
147393827|NCT03613454|531606119|FG000|Overall Study|Protocol Violation|0|||
147393828|NCT03613454|531606120|FG001|Overall Study|Protocol Violation|1|||
147393829|NCT04167085|531606121|FG000|Baseline|Withdrawal by Subject|2|||
147393830|NCT04167085|531606122|FG001|Baseline|Withdrawal by Subject|1|||
147393831|NCT04167085|531606121|FG000|Washout (1 Month)|Withdrawal by Subject|1|||
147393832|NCT04167085|531606122|FG001|Washout (1 Month)|Withdrawal by Subject|0|||
147393833|NCT02273180|531606126|FG000|Overall Study|Adverse Event|2|||
147393834|NCT02273180|531606127|FG001|Overall Study|Adverse Event|2|||
147393835|NCT02273180|531606126|FG000|Overall Study|Lack of Efficacy|1|||
147393836|NCT02273180|531606127|FG001|Overall Study|Lack of Efficacy|0|||
147393837|NCT02273180|531606126|FG000|Overall Study|Protocol Violation|1|||
147393838|NCT02273180|531606127|FG001|Overall Study|Protocol Violation|7|||
147393839|NCT02273180|531606126|FG000|Overall Study|Randomized but not treated|1|||
147393840|NCT02273180|531606127|FG001|Overall Study|Randomized but not treated|0|||
147393841|NCT02273180|531606126|FG000|Overall Study|Hypoglycemia(not reported as serious AE)|1|||
147393842|NCT02273180|531606127|FG001|Overall Study|Hypoglycemia(not reported as serious AE)|0|||
147393843|NCT02273180|531606126|FG000|Overall Study|Other than specified above|21|||
147393844|NCT02273180|531606127|FG001|Overall Study|Other than specified above|10|||
147393845|NCT02154516|531606128|FG000|Overall Study|Withdrawal by Subject|0|||
147393846|NCT02154516|531606129|FG001|Overall Study|Withdrawal by Subject|1|||
147393847|NCT02154516|531606128|FG000|Overall Study|Lost to Follow-up|1|||
147393848|NCT02154516|531606129|FG001|Overall Study|Lost to Follow-up|0|||
147393849|NCT02154516|531606128|FG000|Overall Study|Removal/revision of device|1|||
147393850|NCT02154516|531606129|FG001|Overall Study|Removal/revision of device|0|||
147393851|NCT02154516|531606128|FG000|Overall Study|Death|2|||
147393852|NCT02154516|531606129|FG001|Overall Study|Death|1|||
147393853|NCT02965599|531606133|FG000|Overall Study|Protocol-defined stop criteria reached|1|||
147393854|NCT02965599|531606134|FG001|Overall Study|Protocol-defined stop criteria reached|0|||
147393855|NCT04435522|531606138|FG000|Overall Study|Withdrawal by Subject|2|||
147393856|NCT02799745|531606141|FG000|Overall Study|Participant moved out of state|1|||
147393857|NCT02799745|531606142|FG001|Overall Study|Participant moved out of state|0|||
147459975|NCT01482910|531845242|FG000|Overall Study|Protocol Violation|1|||
147393858|NCT02799745|531606141|FG000|Overall Study|Discontinued due to planned surgery|1|||
147393859|NCT02799745|531606142|FG001|Overall Study|Discontinued due to planned surgery|0|||
147393860|NCT02799745|531606141|FG000|Overall Study|Withdrawal by Subject|16|||
147393861|NCT02799745|531606142|FG001|Overall Study|Withdrawal by Subject|25|||
147393862|NCT02799745|531606141|FG000|Overall Study|Protocol Deviation|4|||
147393863|NCT02799745|531606142|FG001|Overall Study|Protocol Deviation|5|||
147393864|NCT02799745|531606141|FG000|Overall Study|Progressive Disease|28|||
147393865|NCT02799745|531606142|FG001|Overall Study|Progressive Disease|38|||
147393866|NCT02799745|531606141|FG000|Overall Study|Lost to Follow-up|3|||
147393867|NCT02799745|531606142|FG001|Overall Study|Lost to Follow-up|2|||
147393868|NCT02799745|531606141|FG000|Overall Study|Death|3|||
147393869|NCT02799745|531606142|FG001|Overall Study|Death|0|||
147393870|NCT02799745|531606141|FG000|Overall Study|Adverse Event|0|||
147393871|NCT02799745|531606142|FG001|Overall Study|Adverse Event|1|||
147393872|NCT02517528|531607725|FG000|Overall Study|Withdrawal by Subject|1|||
147393873|NCT01268098|531607728|FG000|Overall Study|Adverse Event|1|||
147393874|NCT01268098|531607729|FG001|Overall Study|Adverse Event|0|||
147393875|NCT01093599|531607731|FG000|Overall Study|Lost to Follow-up|32|||
147393876|NCT01093599|531607732|FG001|Overall Study|Lost to Follow-up|46|||
147393877|NCT01703845|531607733|FG000|Overall Study|Adverse Event|1|||
147393878|NCT01703845|531607734|FG001|Overall Study|Adverse Event|0|||
147615283|NCT03449446|532406696|FG001|Overall Study|Withdrew Consent|3|||
147615284|NCT03449446|532406697|FG002|Overall Study|Withdrew Consent|1|||
147393879|NCT01703845|531607733|FG000|Overall Study|Protocol Violation|1|||
147393880|NCT01703845|531607734|FG001|Overall Study|Protocol Violation|0|||
147393881|NCT01703845|531607733|FG000|Overall Study|other than stated above|1|||
147393882|NCT01703845|531607734|FG001|Overall Study|other than stated above|0|||
147393883|NCT01845649|531607737|FG000|Overall Study|Adverse Event|7|||
147393884|NCT01845649|531607738|FG001|Overall Study|Adverse Event|10|||
147393885|NCT01845649|531607737|FG000|Overall Study|Lack of Efficacy|1|||
147393886|NCT01845649|531607738|FG001|Overall Study|Lack of Efficacy|1|||
147393887|NCT01845649|531607737|FG000|Overall Study|Lost to Follow-up|2|||
147393888|NCT01845649|531607738|FG001|Overall Study|Lost to Follow-up|2|||
147393889|NCT01845649|531607737|FG000|Overall Study|Withdrew Consent|12|||
147393890|NCT01845649|531607738|FG001|Overall Study|Withdrew Consent|4|||
147393891|NCT01845649|531607737|FG000|Overall Study|Protocol Deviation|7|||
147393892|NCT01845649|531607738|FG001|Overall Study|Protocol Deviation|4|||
147393893|NCT01845649|531607737|FG000|Overall Study|Reason not Specified|2|||
147393894|NCT01845649|531607738|FG001|Overall Study|Reason not Specified|1|||
147393895|NCT01222533|531607740|FG000|Overall Study|Adverse Event|5|||
147393896|NCT01222533|531607740|FG000|Overall Study|Withdrawal by Subject|5|||
147393897|NCT01222533|531607740|FG000|Overall Study|Other|4|||
147393898|NCT03418493|531607741|FG000|Overall Study|Adverse Event|1|||
147393899|NCT03418493|531607742|FG001|Overall Study|Adverse Event|0|||
147393900|NCT03418493|531607743|FG002|Overall Study|Adverse Event|0|||
147393901|NCT03418493|531607744|FG003|Overall Study|Adverse Event|0|||
147393902|NCT03418493|531607745|FG004|Overall Study|Adverse Event|0|||
147393903|NCT03418493|531607746|FG005|Overall Study|Adverse Event|0|||
147393904|NCT03418493|531607747|FG006|Overall Study|Adverse Event|0|||
147393905|NCT03418493|531607748|FG007|Overall Study|Adverse Event|0|||
147393906|NCT03418493|531607749|FG008|Overall Study|Adverse Event|0|||
147393907|NCT03418493|531607750|FG009|Overall Study|Adverse Event|0|||
147393908|NCT03418493|531607751|FG010|Overall Study|Adverse Event|0|||
147393909|NCT03418493|531607741|FG000|Overall Study|Protocol Violation|0|||
147393910|NCT03418493|531607742|FG001|Overall Study|Protocol Violation|0|||
147393911|NCT03418493|531607743|FG002|Overall Study|Protocol Violation|0|||
147393912|NCT03418493|531607744|FG003|Overall Study|Protocol Violation|0|||
147393913|NCT03418493|531607745|FG004|Overall Study|Protocol Violation|0|||
147393914|NCT03418493|531607746|FG005|Overall Study|Protocol Violation|0|||
147393915|NCT03418493|531607747|FG006|Overall Study|Protocol Violation|0|||
147393916|NCT03418493|531607748|FG007|Overall Study|Protocol Violation|0|||
147393917|NCT03418493|531607749|FG008|Overall Study|Protocol Violation|0|||
147393918|NCT03418493|531607750|FG009|Overall Study|Protocol Violation|1|||
147393919|NCT03418493|531607751|FG010|Overall Study|Protocol Violation|0|||
147393920|NCT00526097|531607755|FG000|Overall Study|Adverse Event|6|||
147615285|NCT03449446|532406698|FG003|Overall Study|Withdrew Consent|4|||
147615286|NCT03449446|532406699|FG004|Overall Study|Withdrew Consent|4|||
147615287|NCT03449446|532406700|FG005|Overall Study|Withdrew Consent|4|||
147615288|NCT03449446|532406701|FG006|Overall Study|Withdrew Consent|1|||
147393921|NCT00526097|531607756|FG001|Overall Study|Adverse Event|44|||
147393922|NCT00526097|531607755|FG000|Overall Study|Protocol Violation|4|||
147393923|NCT00526097|531607756|FG001|Overall Study|Protocol Violation|10|||
147393924|NCT00526097|531607755|FG000|Overall Study|Withdrawal by Subject|3|||
147393925|NCT00526097|531607756|FG001|Overall Study|Withdrawal by Subject|1|||
147615289|NCT03449446|532406695|FG000|Overall Study|Adverse Event|1|||
147393926|NCT00526097|531607755|FG000|Overall Study|Other|2|||
147393927|NCT00526097|531607756|FG001|Overall Study|Other|1|||
147393928|NCT00966979|531607757|FG000|Overall Study|Death|1|||
147393929|NCT00966979|531607757|FG000|Overall Study|Lost to Follow-up|6|||
147393930|NCT00966979|531607757|FG000|Overall Study|Withdrawal by Subject|14|||
147393931|NCT00966979|531607757|FG000|Overall Study|Adverse Event|5|||
147393932|NCT00966979|531607757|FG000|Overall Study|Sponsor terminated early|49|||
147393933|NCT00966979|531607757|FG000|Overall Study|Censored because surgery not done|2|||
147393934|NCT00966979|531607757|FG000|Overall Study|Censored because study device was not implanted|14|||
147393935|NCT00966979|531607757|FG000|Overall Study|Censored because of Inclusion/exclusion violation|7|||
147393936|NCT03713281|531607761|FG000|Overall Study|Lens handling difficuluties|2|||
147393937|NCT03713281|531607761|FG000|Overall Study|Subject was not dispensed enough lenses|1|||
147393938|NCT00630552|531607763|FG000|Overall Study|Adverse Event|0|||
147393939|NCT00630552|531607764|FG001|Overall Study|Adverse Event|1|||
147615290|NCT03449446|532406696|FG001|Overall Study|Adverse Event|2|||
147615291|NCT03449446|532406697|FG002|Overall Study|Adverse Event|1|||
147615292|NCT03449446|532406698|FG003|Overall Study|Adverse Event|0|||
147459976|NCT01482910|531845243|FG001|Overall Study|Protocol Violation|1|||
147459977|NCT01482910|531845242|FG000|Overall Study|Withdrawal by Subject|7|||
147459978|NCT01482910|531845243|FG001|Overall Study|Withdrawal by Subject|2|||
147459979|NCT01482910|531845242|FG000|Overall Study|Death|1|||
147459980|NCT01482910|531845243|FG001|Overall Study|Death|0|||
147459981|NCT03222349|531845245|FG000|Overall Study|Treatment B not done|5|||
147615293|NCT03449446|532406699|FG004|Overall Study|Adverse Event|0|||
147393940|NCT00630552|531607765|FG002|Overall Study|Adverse Event|5|||
147393941|NCT00630552|531607766|FG003|Overall Study|Adverse Event|4|||
147393942|NCT00630552|531607767|FG004|Overall Study|Adverse Event|2|||
147393943|NCT00630552|531607763|FG000|Overall Study|Disease progression|5|||
147393944|NCT00630552|531607764|FG001|Overall Study|Disease progression|6|||
147393945|NCT00630552|531607765|FG002|Overall Study|Disease progression|27|||
147393946|NCT00630552|531607766|FG003|Overall Study|Disease progression|22|||
147393947|NCT00630552|531607767|FG004|Overall Study|Disease progression|31|||
147393948|NCT00630552|531607763|FG000|Overall Study|Never received IP|0|||
147393949|NCT00630552|531607764|FG001|Overall Study|Never received IP|0|||
147393950|NCT00630552|531607765|FG002|Overall Study|Never received IP|0|||
147393951|NCT00630552|531607766|FG003|Overall Study|Never received IP|2|||
147393952|NCT00630552|531607767|FG004|Overall Study|Never received IP|2|||
147393953|NCT00630552|531607763|FG000|Overall Study|Ineligibility determined|0|||
147393954|NCT00630552|531607764|FG001|Overall Study|Ineligibility determined|0|||
147393955|NCT00630552|531607765|FG002|Overall Study|Ineligibility determined|0|||
147393956|NCT00630552|531607766|FG003|Overall Study|Ineligibility determined|0|||
147393957|NCT00630552|531607767|FG004|Overall Study|Ineligibility determined|1|||
147393958|NCT00630552|531607763|FG000|Overall Study|Protocol Violation|0|||
147393959|NCT00630552|531607764|FG001|Overall Study|Protocol Violation|0|||
147393960|NCT00630552|531607765|FG002|Overall Study|Protocol Violation|0|||
147393961|NCT00630552|531607766|FG003|Overall Study|Protocol Violation|1|||
147393962|NCT00630552|531607767|FG004|Overall Study|Protocol Violation|0|||
147393963|NCT00630552|531607763|FG000|Overall Study|Physician Decision|0|||
147393964|NCT00630552|531607764|FG001|Overall Study|Physician Decision|0|||
147393965|NCT00630552|531607765|FG002|Overall Study|Physician Decision|0|||
147393966|NCT00630552|531607766|FG003|Overall Study|Physician Decision|0|||
147393967|NCT00630552|531607767|FG004|Overall Study|Physician Decision|1|||
147393968|NCT00630552|531607763|FG000|Overall Study|Death|0|||
147393969|NCT00630552|531607764|FG001|Overall Study|Death|0|||
147393970|NCT00630552|531607765|FG002|Overall Study|Death|1|||
147393971|NCT00630552|531607766|FG003|Overall Study|Death|2|||
147393972|NCT00630552|531607767|FG004|Overall Study|Death|2|||
147393973|NCT00630552|531607763|FG000|Overall Study|Withdrawal by Subject|0|||
147393974|NCT00630552|531607764|FG001|Overall Study|Withdrawal by Subject|0|||
147393975|NCT00630552|531607765|FG002|Overall Study|Withdrawal by Subject|0|||
147393976|NCT00630552|531607766|FG003|Overall Study|Withdrawal by Subject|1|||
147393977|NCT00630552|531607767|FG004|Overall Study|Withdrawal by Subject|0|||
147393978|NCT00630552|531607763|FG000|Overall Study|Other|0|||
147393979|NCT00630552|531607764|FG001|Overall Study|Other|0|||
147393980|NCT00630552|531607765|FG002|Overall Study|Other|4|||
147393981|NCT00630552|531607766|FG003|Overall Study|Other|2|||
147393982|NCT00630552|531607767|FG004|Overall Study|Other|0|||
147393983|NCT03226106|531607768|FG000|Overall Study|Withdrawal by Subject|2|||
147393984|NCT03226106|531607769|FG001|Overall Study|Withdrawal by Subject|0|||
147393985|NCT03226106|531607768|FG000|Overall Study|Adverse Event|1|||
147393986|NCT03226106|531607769|FG001|Overall Study|Adverse Event|0|||
147393987|NCT03226106|531607768|FG000|Overall Study|Lost to Follow-up|2|||
147393988|NCT03226106|531607769|FG001|Overall Study|Lost to Follow-up|0|||
147393989|NCT01084239|531607770|FG000|28-Day Follow-up|Lost to Follow-up|4|||
147393990|NCT01084239|531607771|FG001|28-Day Follow-up|Lost to Follow-up|9|||
147393991|NCT00721214|531607772|FG000|Overall Study|Chose another center for transplant|1|||
147393992|NCT00721214|531607772|FG000|Overall Study|Death|3|||
147393993|NCT00983905|531607773|FG000|Theophylline Alone|Adverse Event|1|||
147393994|NCT00983905|531607773|FG000|Colchicine Alone|Adverse Event|2|||
147393995|NCT00494026|531607774|FG000|Overall Study|Sponsor Decision|4|||
147393996|NCT02466243|531607775|FG000|Part B Open-label Treatment Period|Adverse Event|1|||
147393997|NCT02466243|531607776|FG001|Part B Open-label Treatment Period|Adverse Event|0|||
147393998|NCT02466243|531607775|FG000|Part B Open-label Treatment Period|Withdrawal by Subject|0|||
147393999|NCT02466243|531607776|FG001|Part B Open-label Treatment Period|Withdrawal by Subject|2|||
147394000|NCT02466243|531607775|FG000|Part B Open-label Treatment Period|Sponsor Decision|8|||
147394001|NCT02466243|531607776|FG001|Part B Open-label Treatment Period|Sponsor Decision|6|||
147394002|NCT02466243|531607775|FG000|Part B Open-label Treatment Period|Missing|2|||
147394003|NCT02466243|531607776|FG001|Part B Open-label Treatment Period|Missing|2|||
147394004|NCT00405912|531607777|FG000|Overall Study|Withdrawal by Subject|12|||
147459982|NCT03222349|531845246|FG001|Overall Study|Treatment B not done|0|||
147459983|NCT03222349|531845245|FG000|Overall Study|Lost to Follow-up|1|||
147459984|NCT03222349|531845246|FG001|Overall Study|Lost to Follow-up|2|||
147459985|NCT03222349|531845245|FG000|Overall Study|Withdrawal by Subject|1|||
147394005|NCT00405912|531607778|FG001|Overall Study|Withdrawal by Subject|11|||
147459986|NCT03222349|531845246|FG001|Overall Study|Withdrawal by Subject|0|||
147459987|NCT03222349|531845245|FG000|Overall Study|Treatment A not done|0|||
147459988|NCT03222349|531845246|FG001|Overall Study|Treatment A not done|5|||
147459989|NCT03222349|531845245|FG000|Overall Study|Study terminated by sponsor|1|||
147459990|NCT03222349|531845246|FG001|Overall Study|Study terminated by sponsor|0|||
147459991|NCT02614079|531845247|FG000|Overall Study|Withdrawal by Subject|1|||
147459992|NCT00820755|531845248|FG000|Period 1: Combination Therapy Phase|Adverse Event|77|||
147459993|NCT00820755|531845249|FG001|Period 1: Combination Therapy Phase|Adverse Event|0|||
147459994|NCT00820755|531845250|FG002|Period 1: Combination Therapy Phase|Adverse Event|0|||
147459995|NCT00820755|531845248|FG000|Period 1: Combination Therapy Phase|Death|28|||
147459996|NCT00820755|531845249|FG001|Period 1: Combination Therapy Phase|Death|0|||
147459997|NCT00820755|531845250|FG002|Period 1: Combination Therapy Phase|Death|0|||
147459998|NCT00820755|531845248|FG000|Period 1: Combination Therapy Phase|Protocol Violation|4|||
147459999|NCT00820755|531845249|FG001|Period 1: Combination Therapy Phase|Protocol Violation|0|||
147460000|NCT00820755|531845250|FG002|Period 1: Combination Therapy Phase|Protocol Violation|0|||
147460001|NCT00820755|531845248|FG000|Period 1: Combination Therapy Phase|Lost to Follow-up|1|||
147460002|NCT00820755|531845249|FG001|Period 1: Combination Therapy Phase|Lost to Follow-up|0|||
147460003|NCT00820755|531845250|FG002|Period 1: Combination Therapy Phase|Lost to Follow-up|0|||
147460004|NCT00820755|531845248|FG000|Period 1: Combination Therapy Phase|Withdrawal by Subject|21|||
147460005|NCT00820755|531845249|FG001|Period 1: Combination Therapy Phase|Withdrawal by Subject|0|||
147460006|NCT00820755|531845250|FG002|Period 1: Combination Therapy Phase|Withdrawal by Subject|0|||
147460007|NCT00820755|531845248|FG000|Period 1: Combination Therapy Phase|Progressive disease|114|||
147460008|NCT00820755|531845249|FG001|Period 1: Combination Therapy Phase|Progressive disease|0|||
147460009|NCT00820755|531845250|FG002|Period 1: Combination Therapy Phase|Progressive disease|0|||
147460010|NCT00820755|531845248|FG000|Period 1: Combination Therapy Phase|Sympt. deterioration w/o PD by imaging|14|||
147460011|NCT00820755|531845249|FG001|Period 1: Combination Therapy Phase|Sympt. deterioration w/o PD by imaging|0|||
147460012|NCT00820755|531845250|FG002|Period 1: Combination Therapy Phase|Sympt. deterioration w/o PD by imaging|0|||
147460013|NCT00820755|531845248|FG000|Period 1: Combination Therapy Phase|Other|11|||
147460014|NCT00820755|531845249|FG001|Period 1: Combination Therapy Phase|Other|0|||
147460015|NCT00820755|531845250|FG002|Period 1: Combination Therapy Phase|Other|0|||
147460016|NCT00820755|531845248|FG000|Period 2: Maintenance Therapy Phase|Investigational study phase ongoing|0|||
147460017|NCT00820755|531845249|FG001|Period 2: Maintenance Therapy Phase|Investigational study phase ongoing|45|||
147460018|NCT00820755|531845250|FG002|Period 2: Maintenance Therapy Phase|Investigational study phase ongoing|45|||
147460019|NCT03604445|531845253|FG000|Overall Study|Death|0|||
147460020|NCT03604445|531845254|FG001|Overall Study|Death|0|||
147460021|NCT03604445|531845255|FG002|Overall Study|Death|0|||
147460022|NCT03604445|531845256|FG003|Overall Study|Death|0|||
147460023|NCT03604445|531845257|FG004|Overall Study|Death|0|||
147460024|NCT03604445|531845258|FG005|Overall Study|Death|0|||
147460025|NCT03604445|531845259|FG006|Overall Study|Death|0|||
147460026|NCT03604445|531845260|FG007|Overall Study|Death|0|||
147460027|NCT03604445|531845261|FG008|Overall Study|Death|1|||
147460028|NCT03604445|531845253|FG000|Overall Study|Withdrawal by Subject|0|||
147460029|NCT03604445|531845254|FG001|Overall Study|Withdrawal by Subject|0|||
147460030|NCT03604445|531845255|FG002|Overall Study|Withdrawal by Subject|0|||
147460031|NCT03604445|531845256|FG003|Overall Study|Withdrawal by Subject|0|||
147460032|NCT03604445|531845257|FG004|Overall Study|Withdrawal by Subject|0|||
147460033|NCT03604445|531845258|FG005|Overall Study|Withdrawal by Subject|0|||
147460034|NCT03604445|531845259|FG006|Overall Study|Withdrawal by Subject|1|||
147460035|NCT03604445|531845260|FG007|Overall Study|Withdrawal by Subject|0|||
147460036|NCT03604445|531845261|FG008|Overall Study|Withdrawal by Subject|0|||
147460037|NCT03604445|531845253|FG000|Overall Study|Missing visit|0|||
147460038|NCT03604445|531845254|FG001|Overall Study|Missing visit|0|||
147460039|NCT03604445|531845255|FG002|Overall Study|Missing visit|0|||
147460040|NCT03604445|531845256|FG003|Overall Study|Missing visit|0|||
147460041|NCT03604445|531845257|FG004|Overall Study|Missing visit|0|||
147460042|NCT03604445|531845258|FG005|Overall Study|Missing visit|1|||
147460043|NCT03604445|531845259|FG006|Overall Study|Missing visit|0|||
147460044|NCT03604445|531845260|FG007|Overall Study|Missing visit|1|||
147460045|NCT03604445|531845261|FG008|Overall Study|Missing visit|0|||
147460046|NCT03604445|531845253|FG000|Overall Study|Adverse Event|0|||
147460047|NCT03604445|531845254|FG001|Overall Study|Adverse Event|0|||
147460048|NCT03604445|531845255|FG002|Overall Study|Adverse Event|0|||
147460049|NCT03604445|531845256|FG003|Overall Study|Adverse Event|1|||
147460050|NCT03604445|531845257|FG004|Overall Study|Adverse Event|0|||
147460051|NCT03604445|531845258|FG005|Overall Study|Adverse Event|0|||
147460052|NCT03604445|531845259|FG006|Overall Study|Adverse Event|0|||
147460053|NCT03604445|531845260|FG007|Overall Study|Adverse Event|0|||
147460054|NCT03604445|531845261|FG008|Overall Study|Adverse Event|1|||
147460055|NCT00773279|531845262|FG000|Period 1|Adverse Event|2|||
147460056|NCT00773279|531845263|FG001|Period 1|Adverse Event|1|||
147460057|NCT00773279|531845262|FG000|Period 1|Lack of Efficacy|0|||
147460058|NCT00773279|531845263|FG001|Period 1|Lack of Efficacy|2|||
147460059|NCT00773279|531845262|FG000|Period 1|Unclassified|5|||
147460060|NCT00773279|531845263|FG001|Period 1|Unclassified|1|||
147460061|NCT00773279|531845262|FG000|Period 2|Adverse Event|0|||
147460062|NCT00773279|531845263|FG001|Period 2|Adverse Event|1|||
147460063|NCT00773279|531845262|FG000|Period 2|Lack of Efficacy|1|||
147460064|NCT00773279|531845263|FG001|Period 2|Lack of Efficacy|0|||
147460065|NCT00773279|531845262|FG000|Period 2|Protocol Violation|0|||
147460066|NCT00773279|531845263|FG001|Period 2|Protocol Violation|3|||
147460067|NCT00773279|531845262|FG000|Period 2|Unclassified|2|||
147460068|NCT00773279|531845263|FG001|Period 2|Unclassified|2|||
147460069|NCT02251912|531845265|FG000|Overall Study|Withdrawal by Subject|2|||
147460070|NCT02251912|531845266|FG001|Overall Study|Withdrawal by Subject|3|||
147460071|NCT02251912|531845265|FG000|Overall Study|Adverse Event|0|||
147460072|NCT02251912|531845266|FG001|Overall Study|Adverse Event|2|||
147460073|NCT00480857|531845267|FG000|Overall Study|Lack of Efficacy|2|||
147460074|NCT02551159|531845268|FG000|Overall Study|Death|352|||
147460075|NCT02551159|531845269|FG001|Overall Study|Death|174|||
147460076|NCT02551159|531845270|FG002|Overall Study|Death|161|||
147460077|NCT02551159|531845268|FG000|Overall Study|Withdrawal by Subject|8|||
147460078|NCT02551159|531845269|FG001|Overall Study|Withdrawal by Subject|5|||
147460079|NCT02551159|531845270|FG002|Overall Study|Withdrawal by Subject|16|||
147460080|NCT02551159|531845268|FG000|Overall Study|Patients alive or lost to follow-up at DCO|53|||
147460081|NCT02551159|531845269|FG001|Overall Study|Patients alive or lost to follow-up at DCO|25|||
147460082|NCT02551159|531845270|FG002|Overall Study|Patients alive or lost to follow-up at DCO|29|||
147460083|NCT00243659|531845271|FG000|Overall Study|Withdrawal by Subject|1|||
147460084|NCT00243659|531845272|FG001|Overall Study|Withdrawal by Subject|1|||
147460085|NCT00243659|531845271|FG000|Overall Study|Protocol Violation|1|||
147460086|NCT00243659|531845272|FG001|Overall Study|Protocol Violation|2|||
147460087|NCT00268242|531845273|FG000|Overall Study|Death|1|||
147460088|NCT02175680|531845274|FG000|Overall Study|non-compliance|1|||
147460089|NCT02175680|531845274|FG000|Overall Study|other non-medical reason|1|||
147460090|NCT03969888|531845275|FG000|Overall Study|Never Received Study Drug|0|||
147460091|NCT03969888|531845276|FG001|Overall Study|Never Received Study Drug|0|||
147460092|NCT03969888|531845277|FG002|Overall Study|Never Received Study Drug|1|||
147460093|NCT03969888|531845278|FG003|Overall Study|Never Received Study Drug|0|||
147460094|NCT03969888|531845279|FG004|Overall Study|Never Received Study Drug|0|||
147460095|NCT03969888|531845280|FG005|Overall Study|Never Received Study Drug|0|||
147460096|NCT03969888|531845281|FG006|Overall Study|Never Received Study Drug|1|||
147460097|NCT03969888|531845282|FG007|Overall Study|Never Received Study Drug|0|||
147460098|NCT03969888|531845275|FG000|Overall Study|Reason Not Specified|0|||
147460099|NCT03969888|531845276|FG001|Overall Study|Reason Not Specified|0|||
147460100|NCT03969888|531845277|FG002|Overall Study|Reason Not Specified|0|||
147460101|NCT03969888|531845278|FG003|Overall Study|Reason Not Specified|0|||
147460102|NCT03969888|531845279|FG004|Overall Study|Reason Not Specified|0|||
147460103|NCT03969888|531845280|FG005|Overall Study|Reason Not Specified|0|||
147460104|NCT03969888|531845281|FG006|Overall Study|Reason Not Specified|0|||
147460105|NCT03969888|531845282|FG007|Overall Study|Reason Not Specified|1|||
147460106|NCT00464178|531845285|FG000|Overall Study|Protocol Violation|1|||
147460107|NCT00464178|531845285|FG000|Overall Study|Withdrawal by Subject|1|||
147460108|NCT01557166|531845288|FG000|Overall Study|Adverse Event|20|||
147460109|NCT01557166|531845289|FG001|Overall Study|Adverse Event|6|||
147460110|NCT01557166|531845288|FG000|Overall Study|Lack of Efficacy|2|||
147460111|NCT01557166|531845289|FG001|Overall Study|Lack of Efficacy|1|||
147460112|NCT01557166|531845288|FG000|Overall Study|Protocol Violation|8|||
147460113|NCT01557166|531845289|FG001|Overall Study|Protocol Violation|5|||
147460114|NCT01557166|531845288|FG000|Overall Study|Withdrawn consent|12|||
147460115|NCT01557166|531845289|FG001|Overall Study|Withdrawn consent|20|||
147460116|NCT01557166|531845288|FG000|Overall Study|Target dose not tolerated|1|||
147460117|NCT01557166|531845289|FG001|Overall Study|Target dose not tolerated|0|||
147460118|NCT01557166|531845288|FG000|Overall Study|Psychiatric disorder|1|||
147460119|NCT01557166|531845289|FG001|Overall Study|Psychiatric disorder|0|||
147460120|NCT01557166|531845288|FG000|Overall Study|Unclassified|2|||
147460121|NCT01557166|531845289|FG001|Overall Study|Unclassified|5|||
147460122|NCT04506294|531845290|FG000|Overall Study|Lost to Follow-up|70|||
147460123|NCT04506294|531845291|FG001|Overall Study|Lost to Follow-up|20|||
147460124|NCT04506294|531845290|FG000|Overall Study|Withdrawal by Subject|16|||
147460125|NCT04506294|531845291|FG001|Overall Study|Withdrawal by Subject|2|||
147460126|NCT00946309|531845292|FG000|Overall Study|Protocol Violation|1|||
147460127|NCT00946309|531845293|FG001|Overall Study|Protocol Violation|0|||
147460128|NCT00946309|531845292|FG000|Overall Study|Lost to Follow-up|0|||
147460129|NCT00946309|531845293|FG001|Overall Study|Lost to Follow-up|1|||
147615294|NCT03449446|532406700|FG005|Overall Study|Adverse Event|2|||
147615295|NCT03449446|532406701|FG006|Overall Study|Adverse Event|0|||
147615296|NCT03449446|532406695|FG000|Overall Study|Lost to Follow-up|0|||
147460130|NCT00946309|531845292|FG000|Overall Study|Procedure cancelled/discontinued|0|||
147460131|NCT00946309|531845293|FG001|Overall Study|Procedure cancelled/discontinued|3|||
147460132|NCT03434379|531845297|FG000|Global Period|Lost to Follow-up|3|||
147460133|NCT03434379|531845298|FG001|Global Period|Lost to Follow-up|6|||
147460134|NCT03434379|531845299|FG002|Global Period|Lost to Follow-up|0|||
147460135|NCT03434379|531845300|FG003|Global Period|Lost to Follow-up|0|||
147460136|NCT03434379|531845297|FG000|Global Period|Death|115|||
147460137|NCT03434379|531845298|FG001|Global Period|Death|228|||
147394006|NCT00405912|531607779|FG002|Overall Study|Withdrawal by Subject|12|||
147394007|NCT00405912|531607777|FG000|Overall Study|Lost to Follow-up|4|||
147394008|NCT00405912|531607778|FG001|Overall Study|Lost to Follow-up|8|||
147394009|NCT00405912|531607779|FG002|Overall Study|Lost to Follow-up|4|||
147394010|NCT03730662|531607780|FG000|Treatment Period (52 Weeks)|Adverse Event|3|||
147394011|NCT03730662|531607781|FG001|Treatment Period (52 Weeks)|Adverse Event|2|||
147394012|NCT03730662|531607782|FG002|Treatment Period (52 Weeks)|Adverse Event|0|||
147394013|NCT03730662|531607783|FG003|Treatment Period (52 Weeks)|Adverse Event|3|||
147394014|NCT03730662|531607780|FG000|Treatment Period (52 Weeks)|Screen Failure|0|||
147394015|NCT03730662|531607781|FG001|Treatment Period (52 Weeks)|Screen Failure|1|||
147394016|NCT03730662|531607782|FG002|Treatment Period (52 Weeks)|Screen Failure|0|||
147394017|NCT03730662|531607783|FG003|Treatment Period (52 Weeks)|Screen Failure|0|||
147394018|NCT03730662|531607780|FG000|Treatment Period (52 Weeks)|Death|6|||
147394019|NCT03730662|531607781|FG001|Treatment Period (52 Weeks)|Death|2|||
147394020|NCT03730662|531607782|FG002|Treatment Period (52 Weeks)|Death|2|||
147394021|NCT03730662|531607783|FG003|Treatment Period (52 Weeks)|Death|9|||
147394022|NCT03730662|531607780|FG000|Treatment Period (52 Weeks)|Lost to Follow-up|4|||
147394023|NCT03730662|531607781|FG001|Treatment Period (52 Weeks)|Lost to Follow-up|2|||
147394024|NCT03730662|531607782|FG002|Treatment Period (52 Weeks)|Lost to Follow-up|2|||
147394025|NCT03730662|531607783|FG003|Treatment Period (52 Weeks)|Lost to Follow-up|11|||
147394026|NCT03730662|531607780|FG000|Treatment Period (52 Weeks)|Physician Decision|1|||
147394027|NCT03730662|531607781|FG001|Treatment Period (52 Weeks)|Physician Decision|1|||
147394028|NCT03730662|531607782|FG002|Treatment Period (52 Weeks)|Physician Decision|0|||
147394029|NCT03730662|531607783|FG003|Treatment Period (52 Weeks)|Physician Decision|3|||
147394030|NCT03730662|531607780|FG000|Treatment Period (52 Weeks)|Protocol Violation|0|||
147394031|NCT03730662|531607781|FG001|Treatment Period (52 Weeks)|Protocol Violation|1|||
147394032|NCT03730662|531607782|FG002|Treatment Period (52 Weeks)|Protocol Violation|0|||
147394033|NCT03730662|531607783|FG003|Treatment Period (52 Weeks)|Protocol Violation|1|||
147394034|NCT03730662|531607780|FG000|Treatment Period (52 Weeks)|Withdrawal by Subject|5|||
147394035|NCT03730662|531607781|FG001|Treatment Period (52 Weeks)|Withdrawal by Subject|0|||
147394036|NCT03730662|531607782|FG002|Treatment Period (52 Weeks)|Withdrawal by Subject|5|||
147394037|NCT03730662|531607783|FG003|Treatment Period (52 Weeks)|Withdrawal by Subject|23|||
147394038|NCT03730662|531607780|FG000|Treatment Period (52 Weeks)|Personal Reason|2|||
147394039|NCT03730662|531607781|FG001|Treatment Period (52 Weeks)|Personal Reason|2|||
147394040|NCT03730662|531607782|FG002|Treatment Period (52 Weeks)|Personal Reason|0|||
147394041|NCT03730662|531607783|FG003|Treatment Period (52 Weeks)|Personal Reason|2|||
147394042|NCT03730662|531607780|FG000|Variable Treatment Period|Adverse Event|1|||
147394043|NCT03730662|531607781|FG001|Variable Treatment Period|Adverse Event|2|||
147394044|NCT03730662|531607782|FG002|Variable Treatment Period|Adverse Event|0|||
147394045|NCT03730662|531607783|FG003|Variable Treatment Period|Adverse Event|7|||
147394046|NCT03730662|531607780|FG000|Variable Treatment Period|Death|9|||
147394047|NCT03730662|531607781|FG001|Variable Treatment Period|Death|0|||
147394048|NCT03730662|531607782|FG002|Variable Treatment Period|Death|6|||
147394049|NCT03730662|531607783|FG003|Variable Treatment Period|Death|26|||
147394050|NCT03730662|531607780|FG000|Variable Treatment Period|Lost to Follow-up|2|||
147394051|NCT03730662|531607781|FG001|Variable Treatment Period|Lost to Follow-up|1|||
147394052|NCT03730662|531607782|FG002|Variable Treatment Period|Lost to Follow-up|4|||
147394053|NCT03730662|531607783|FG003|Variable Treatment Period|Lost to Follow-up|11|||
147394054|NCT03730662|531607780|FG000|Variable Treatment Period|Personal Reason|0|||
147394055|NCT03730662|531607781|FG001|Variable Treatment Period|Personal Reason|2|||
147394056|NCT03730662|531607782|FG002|Variable Treatment Period|Personal Reason|1|||
147394057|NCT03730662|531607783|FG003|Variable Treatment Period|Personal Reason|6|||
147394058|NCT03730662|531607780|FG000|Variable Treatment Period|Physician Decision|0|||
147394059|NCT03730662|531607781|FG001|Variable Treatment Period|Physician Decision|0|||
147394060|NCT03730662|531607782|FG002|Variable Treatment Period|Physician Decision|0|||
147394061|NCT03730662|531607783|FG003|Variable Treatment Period|Physician Decision|3|||
147394062|NCT03730662|531607780|FG000|Variable Treatment Period|Protocol Violation|0|||
147394063|NCT03730662|531607781|FG001|Variable Treatment Period|Protocol Violation|1|||
147394064|NCT03730662|531607782|FG002|Variable Treatment Period|Protocol Violation|1|||
147394065|NCT03730662|531607783|FG003|Variable Treatment Period|Protocol Violation|1|||
147394066|NCT03730662|531607780|FG000|Variable Treatment Period|Withdrawal by Subject|2|||
147394067|NCT03730662|531607781|FG001|Variable Treatment Period|Withdrawal by Subject|1|||
147394068|NCT03730662|531607782|FG002|Variable Treatment Period|Withdrawal by Subject|4|||
147394069|NCT03730662|531607783|FG003|Variable Treatment Period|Withdrawal by Subject|17|||
147394070|NCT01309243|531607784|FG000|Randomized Phase Through Week 96|Randomized but not treated|6|||
147394071|NCT01309243|531607785|FG001|Randomized Phase Through Week 96|Randomized but not treated|7|||
147460138|NCT03434379|531845299|FG002|Global Period|Death|0|||
147460139|NCT03434379|531845300|FG003|Global Period|Death|0|||
147460140|NCT03434379|531845297|FG000|Global Period|Withdrawal by Subject|20|||
147394072|NCT01309243|531607784|FG000|Randomized Phase Through Week 96|Adverse Event|12|||
147394073|NCT01309243|531607785|FG001|Randomized Phase Through Week 96|Adverse Event|43|||
147394074|NCT01309243|531607784|FG000|Randomized Phase Through Week 96|Death|0|||
147460141|NCT03434379|531845298|FG001|Global Period|Withdrawal by Subject|21|||
147394075|NCT01309243|531607785|FG001|Randomized Phase Through Week 96|Death|1|||
147394076|NCT01309243|531607784|FG000|Randomized Phase Through Week 96|Pregnancy|2|||
147394077|NCT01309243|531607785|FG001|Randomized Phase Through Week 96|Pregnancy|0|||
147394078|NCT01309243|531607784|FG000|Randomized Phase Through Week 96|Lack of Efficacy|16|||
147394079|NCT01309243|531607785|FG001|Randomized Phase Through Week 96|Lack of Efficacy|4|||
147394080|NCT01309243|531607784|FG000|Randomized Phase Through Week 96|Investigators Discretion|3|||
147394081|NCT01309243|531607785|FG001|Randomized Phase Through Week 96|Investigators Discretion|6|||
147394082|NCT01309243|531607784|FG000|Randomized Phase Through Week 96|Withdrew Consent|12|||
147394083|NCT01309243|531607785|FG001|Randomized Phase Through Week 96|Withdrew Consent|18|||
147394084|NCT01309243|531607784|FG000|Randomized Phase Through Week 96|Lost to Follow-up|23|||
147394085|NCT01309243|531607785|FG001|Randomized Phase Through Week 96|Lost to Follow-up|22|||
147394086|NCT01309243|531607784|FG000|Randomized Phase Through Week 96|Subject Non-Compliance|9|||
147394087|NCT01309243|531607785|FG001|Randomized Phase Through Week 96|Subject Non-Compliance|7|||
147394088|NCT01309243|531607784|FG000|Randomized Phase Through Week 96|Protocol Violation|1|||
147394089|NCT01309243|531607785|FG001|Randomized Phase Through Week 96|Protocol Violation|1|||
147394090|NCT01309243|531607784|FG000|Extension Phase|Lost to Follow-up|6|||
147394091|NCT01309243|531607785|FG001|Extension Phase|Lost to Follow-up|0|||
147394092|NCT00632931|531607786|FG000|Part 1, Period 1|Protocol Violation|1|||
147394093|NCT00632931|531607787|FG001|Part 1, Period 1|Protocol Violation|0|||
147394094|NCT00632931|531607788|FG002|Part 1, Period 1|Protocol Violation|0|||
147394095|NCT00632931|531607786|FG000|Part 1, Period 1|Withdrawal by Subject|1|||
147394096|NCT00632931|531607787|FG001|Part 1, Period 1|Withdrawal by Subject|0|||
147394097|NCT00632931|531607788|FG002|Part 1, Period 1|Withdrawal by Subject|0|||
147394098|NCT00632931|531607786|FG000|Part 2|Adverse Event|0|||
147394099|NCT00632931|531607787|FG001|Part 2|Adverse Event|0|||
147394100|NCT00632931|531607788|FG002|Part 2|Adverse Event|3|||
147394101|NCT00632931|531607786|FG000|Part 2|Death|0|||
147394102|NCT00632931|531607787|FG001|Part 2|Death|0|||
147394103|NCT00632931|531607788|FG002|Part 2|Death|1|||
147394104|NCT00632931|531607786|FG000|Part 2|Lack of Efficacy|0|||
147394105|NCT00632931|531607787|FG001|Part 2|Lack of Efficacy|0|||
147394106|NCT00632931|531607788|FG002|Part 2|Lack of Efficacy|17|||
147394107|NCT00632931|531607786|FG000|Part 2|Withdrawal by Subject|0|||
147394108|NCT00632931|531607787|FG001|Part 2|Withdrawal by Subject|0|||
147394109|NCT00632931|531607788|FG002|Part 2|Withdrawal by Subject|3|||
147394110|NCT01402063|531607789|FG000|Overall Study|Withdrawal by Subject|3|||
147394111|NCT01402063|531607790|FG001|Overall Study|Withdrawal by Subject|3|||
147394112|NCT03712449|531607791|FG000|Overall Study|Withdraw Consent|0|||
147394113|NCT03712449|531607792|FG001|Overall Study|Withdraw Consent|1|||
147394114|NCT04491006|531607795|FG000|Overall Study|Adverse Event|0|||
147394115|NCT04491006|531607796|FG001|Overall Study|Adverse Event|3|||
147394116|NCT04491006|531607797|FG002|Overall Study|Adverse Event|5|||
147394117|NCT04491006|531607795|FG000|Overall Study|Withdrawal by Subject|1|||
147394118|NCT04491006|531607796|FG001|Overall Study|Withdrawal by Subject|0|||
147394119|NCT04491006|531607797|FG002|Overall Study|Withdrawal by Subject|2|||
147394120|NCT00451555|531607805|FG000|Overall Study|Protocol Violation|2|||
147394121|NCT00451555|531607806|FG001|Overall Study|Protocol Violation|2|||
147394122|NCT00451555|531607805|FG000|Overall Study|Adverse Event|3|||
147394123|NCT00451555|531607806|FG001|Overall Study|Adverse Event|1|||
147394124|NCT00451555|531607805|FG000|Overall Study|Withdrawal by Subject|6|||
147394125|NCT00451555|531607806|FG001|Overall Study|Withdrawal by Subject|0|||
147460142|NCT03434379|531845299|FG002|Global Period|Withdrawal by Subject|0|||
147460143|NCT03434379|531845300|FG003|Global Period|Withdrawal by Subject|0|||
147394126|NCT00451555|531607805|FG000|Overall Study|Physician Decision|2|||
147394127|NCT00451555|531607806|FG001|Overall Study|Physician Decision|1|||
147394128|NCT00922441|531607807|FG000|Overall Study|Protocol Violation|0|||
147394129|NCT00922441|531607808|FG001|Overall Study|Protocol Violation|0|||
147394130|NCT00922441|531607809|FG002|Overall Study|Protocol Violation|2|||
147394131|NCT00922441|531607807|FG000|Overall Study|Withdrawal by Subject|0|||
147394132|NCT00922441|531607808|FG001|Overall Study|Withdrawal by Subject|0|||
147394133|NCT00922441|531607809|FG002|Overall Study|Withdrawal by Subject|1|||
147394134|NCT00468858|531607815|FG000|Overall Study|Adverse Event|0|||
147394135|NCT00468858|531607816|FG001|Overall Study|Adverse Event|1|||
147394136|NCT00468858|531607817|FG002|Overall Study|Adverse Event|0|||
147394137|NCT00468858|531607815|FG000|Overall Study|Withdrawal by Subject|7|||
147394138|NCT00468858|531607816|FG001|Overall Study|Withdrawal by Subject|4|||
147394139|NCT00468858|531607817|FG002|Overall Study|Withdrawal by Subject|5|||
147394140|NCT00468858|531607815|FG000|Overall Study|Relocation|1|||
147394141|NCT00468858|531607816|FG001|Overall Study|Relocation|3|||
147394142|NCT00468858|531607817|FG002|Overall Study|Relocation|3|||
147394143|NCT00468858|531607815|FG000|Overall Study|Lost to Follow-up|1|||
147394144|NCT00468858|531607816|FG001|Overall Study|Lost to Follow-up|2|||
147394145|NCT00468858|531607817|FG002|Overall Study|Lost to Follow-up|5|||
147394146|NCT00468858|531607815|FG000|Overall Study|Other|0|||
147394147|NCT00468858|531607816|FG001|Overall Study|Other|0|||
147394148|NCT00468858|531607817|FG002|Overall Study|Other|1|||
147394149|NCT01885936|531607820|FG000|Overall Study|Withdrawal by Subject|1|||
147460144|NCT03434379|531845297|FG000|Global Period|Reason Unspecified|0|||
147665074|NCT01249131|532598002|FG003|Washout Period of 10 Days|Adverse Event|0|||
147665075|NCT01249131|532598003|FG004|Washout Period of 10 Days|Adverse Event|1|||
147665076|NCT01249131|532598004|FG005|Washout Period of 10 Days|Adverse Event|0|||
147665077|NCT00192114|532598005|FG000|Overall Study|Objective Tumor Progression|19|||
147665078|NCT00192114|532598005|FG000|Overall Study|Adverse Event|2|||
147394150|NCT01885936|531607821|FG001|Overall Study|Withdrawal by Subject|0|||
147394151|NCT00317603|531607824|FG000|Overall Study|Progressive Disease|3|||
147394152|NCT00523549|531607825|FG000|Overall Study|Adverse Event|6|||
147394153|NCT00523549|531607826|FG001|Overall Study|Adverse Event|3|||
147394154|NCT00523549|531607825|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
147394155|NCT00523549|531607826|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
147394156|NCT00523549|531607825|FG000|Overall Study|Protocol Deviation|3|||
147394157|NCT00523549|531607826|FG001|Overall Study|Protocol Deviation|1|||
147394158|NCT00523549|531607825|FG000|Overall Study|Patient withdrew consent|7|||
147394159|NCT00523549|531607826|FG001|Overall Study|Patient withdrew consent|6|||
147394160|NCT00523549|531607825|FG000|Overall Study|Lost to Follow-up|3|||
147394161|NCT00523549|531607826|FG001|Overall Study|Lost to Follow-up|5|||
147394162|NCT00427778|531607831|FG000|First Intervention (4 Weeks)|no longer interested|1|||
147394163|NCT00427778|531607832|FG001|First Intervention (4 Weeks)|no longer interested|0|||
147394164|NCT00427778|531607831|FG000|First Intervention (4 Weeks)|Not successfully fitted with ring|2|||
147394165|NCT00427778|531607832|FG001|First Intervention (4 Weeks)|Not successfully fitted with ring|0|||
147394166|NCT00427778|531607831|FG000|First Intervention (4 Weeks)|unable to manipulate ring due to OA|0|||
147394167|NCT00427778|531607832|FG001|First Intervention (4 Weeks)|unable to manipulate ring due to OA|1|||
147394168|NCT00427778|531607831|FG000|First Intervention (4 Weeks)|anxious about using ring|1|||
147394169|NCT00427778|531607832|FG001|First Intervention (4 Weeks)|anxious about using ring|0|||
147394170|NCT00439647|531607834|FG000|Overall Study|Withdrawal by Subject|25|||
147394171|NCT00439647|531607835|FG001|Overall Study|Withdrawal by Subject|22|||
147394172|NCT00439647|531607834|FG000|Overall Study|Death|15|||
147394173|NCT00439647|531607835|FG001|Overall Study|Death|18|||
147394174|NCT00439647|531607834|FG000|Overall Study|Adverse Event|11|||
147394175|NCT00439647|531607835|FG001|Overall Study|Adverse Event|11|||
147394176|NCT00439647|531607834|FG000|Overall Study|Lost to Follow-up|4|||
147394177|NCT00439647|531607835|FG001|Overall Study|Lost to Follow-up|12|||
147394178|NCT00439647|531607834|FG000|Overall Study|Protocol Violation|3|||
147394179|NCT00439647|531607835|FG001|Overall Study|Protocol Violation|4|||
147394180|NCT00439647|531607834|FG000|Overall Study|Lack of Efficacy|0|||
147394181|NCT00439647|531607835|FG001|Overall Study|Lack of Efficacy|4|||
147394182|NCT00843115|531607836|FG000|Overall Study|Death|4|||
147394183|NCT00843115|531607836|FG000|Overall Study|Adverse Event|30|||
147394184|NCT00843115|531607836|FG000|Overall Study|Lost to Follow-up|4|||
147394185|NCT00843115|531607836|FG000|Overall Study|Withdrawal by Subject|17|||
147394186|NCT00843115|531607836|FG000|Overall Study|Family wanted meds stopped|1|||
147394187|NCT00843115|531607836|FG000|Overall Study|Family does not want continuation|1|||
147394188|NCT00843115|531607836|FG000|Overall Study|Patient forgot to take meds|1|||
147394189|NCT00843115|531607836|FG000|Overall Study|Does not meet entrance criteria|1|||
147394190|NCT00843115|531607836|FG000|Overall Study|Physician Decision|1|||
147394191|NCT00843115|531607836|FG000|Overall Study|Family discontinued meds|1|||
147394192|NCT00843115|531607836|FG000|Overall Study|patient took for 2 days then stopped|1|||
147394193|NCT00843115|531607836|FG000|Overall Study|patient never took the medication|1|||
147394194|NCT00843115|531607836|FG000|Overall Study|hospitalized due to deterioration|1|||
147394195|NCT00843115|531607836|FG000|Overall Study|week 12 not done|1|||
147394196|NCT00843115|531607836|FG000|Overall Study|Syndrome De Glissement|1|||
147394197|NCT00225277|531607837|FG000|Overall Study|Adverse Event|30|||
147394198|NCT00225277|531607838|FG001|Overall Study|Adverse Event|34|||
147394199|NCT00225277|531607837|FG000|Overall Study|Lack of Efficacy|4|||
147394200|NCT00225277|531607838|FG001|Overall Study|Lack of Efficacy|1|||
147394201|NCT00225277|531607837|FG000|Overall Study|Lost to Follow-up|4|||
147394202|NCT00225277|531607838|FG001|Overall Study|Lost to Follow-up|6|||
147394203|NCT00225277|531607837|FG000|Overall Study|Physician Decision|6|||
147394204|NCT00225277|531607838|FG001|Overall Study|Physician Decision|8|||
147394205|NCT00225277|531607837|FG000|Overall Study|Protocol Violation|6|||
147394206|NCT00225277|531607838|FG001|Overall Study|Protocol Violation|3|||
147394207|NCT00225277|531607837|FG000|Overall Study|Withdrawal by Subject|40|||
147394208|NCT00225277|531607838|FG001|Overall Study|Withdrawal by Subject|34|||
147394209|NCT00225277|531607837|FG000|Overall Study|Other|7|||
147394210|NCT00225277|531607838|FG001|Overall Study|Other|9|||
147460145|NCT03434379|531845298|FG001|Global Period|Reason Unspecified|1|||
147394211|NCT00677092|531607841|FG000|Overall Study|Adverse Event|1|||
147394212|NCT00677092|531607841|FG000|Overall Study|Lost to Follow-up|1|||
147394213|NCT00677092|531607841|FG000|Overall Study|Withdrawal by Subject|3|||
147394214|NCT00677092|531607841|FG000|Overall Study|Death Prior to Receiving Treatment|1|||
147394215|NCT00784277|531607842|FG000|IR Treatment|Adverse Event|4|||
147394216|NCT00784277|531607843|FG001|IR Treatment|Adverse Event|8|||
147394217|NCT00784277|531607844|FG002|IR Treatment|Adverse Event|19|||
147394218|NCT00784277|531607845|FG003|IR Treatment|Adverse Event|35|||
147394219|NCT00784277|531607846|FG004|IR Treatment|Adverse Event|0|||
147394220|NCT00784277|531607847|FG005|IR Treatment|Adverse Event|0|||
147394221|NCT00784277|531607848|FG006|IR Treatment|Adverse Event|0|||
147394222|NCT00784277|531607842|FG000|IR Treatment|Lack of Efficacy|4|||
147394223|NCT00784277|531607843|FG001|IR Treatment|Lack of Efficacy|4|||
147394224|NCT00784277|531607844|FG002|IR Treatment|Lack of Efficacy|1|||
147394225|NCT00784277|531607845|FG003|IR Treatment|Lack of Efficacy|0|||
147394226|NCT00784277|531607846|FG004|IR Treatment|Lack of Efficacy|0|||
147394227|NCT00784277|531607847|FG005|IR Treatment|Lack of Efficacy|0|||
147394228|NCT00784277|531607848|FG006|IR Treatment|Lack of Efficacy|0|||
147394229|NCT00784277|531607842|FG000|IR Treatment|Lost to Follow-up|1|||
147394230|NCT00784277|531607843|FG001|IR Treatment|Lost to Follow-up|0|||
147394231|NCT00784277|531607844|FG002|IR Treatment|Lost to Follow-up|1|||
147394232|NCT00784277|531607845|FG003|IR Treatment|Lost to Follow-up|0|||
147394233|NCT00784277|531607846|FG004|IR Treatment|Lost to Follow-up|0|||
147394234|NCT00784277|531607847|FG005|IR Treatment|Lost to Follow-up|0|||
147394235|NCT00784277|531607848|FG006|IR Treatment|Lost to Follow-up|0|||
147394236|NCT00784277|531607842|FG000|IR Treatment|Withdrawal by Subject|5|||
147394237|NCT00784277|531607843|FG001|IR Treatment|Withdrawal by Subject|1|||
147394238|NCT00784277|531607844|FG002|IR Treatment|Withdrawal by Subject|4|||
147394239|NCT00784277|531607845|FG003|IR Treatment|Withdrawal by Subject|6|||
147394240|NCT00784277|531607846|FG004|IR Treatment|Withdrawal by Subject|0|||
147394241|NCT00784277|531607847|FG005|IR Treatment|Withdrawal by Subject|0|||
147394242|NCT00784277|531607848|FG006|IR Treatment|Withdrawal by Subject|0|||
147394243|NCT00784277|531607842|FG000|IR Treatment|Resolution Of Pain|0|||
147394244|NCT00784277|531607843|FG001|IR Treatment|Resolution Of Pain|1|||
147394245|NCT00784277|531607844|FG002|IR Treatment|Resolution Of Pain|0|||
147394246|NCT00784277|531607845|FG003|IR Treatment|Resolution Of Pain|0|||
147394247|NCT00784277|531607846|FG004|IR Treatment|Resolution Of Pain|0|||
147394248|NCT00784277|531607847|FG005|IR Treatment|Resolution Of Pain|0|||
147394249|NCT00784277|531607848|FG006|IR Treatment|Resolution Of Pain|0|||
147394250|NCT00784277|531607842|FG000|IR Treatment|Other|2|||
147394251|NCT00784277|531607843|FG001|IR Treatment|Other|3|||
147394252|NCT00784277|531607844|FG002|IR Treatment|Other|3|||
147394253|NCT00784277|531607845|FG003|IR Treatment|Other|2|||
147394254|NCT00784277|531607846|FG004|IR Treatment|Other|0|||
147394255|NCT00784277|531607847|FG005|IR Treatment|Other|0|||
147394256|NCT00784277|531607848|FG006|IR Treatment|Other|0|||
147394257|NCT00784277|531607842|FG000|ER Treatment|Adverse Event|0|||
147394258|NCT00784277|531607843|FG001|ER Treatment|Adverse Event|0|||
147394259|NCT00784277|531607844|FG002|ER Treatment|Adverse Event|0|||
147394260|NCT00784277|531607845|FG003|ER Treatment|Adverse Event|0|||
147394261|NCT00784277|531607846|FG004|ER Treatment|Adverse Event|1|||
147394262|NCT00784277|531607847|FG005|ER Treatment|Adverse Event|7|||
147394263|NCT00784277|531607848|FG006|ER Treatment|Adverse Event|7|||
147394264|NCT00784277|531607842|FG000|ER Treatment|Lack of Efficacy|0|||
147394265|NCT00784277|531607843|FG001|ER Treatment|Lack of Efficacy|0|||
147394266|NCT00784277|531607844|FG002|ER Treatment|Lack of Efficacy|0|||
147394267|NCT00784277|531607845|FG003|ER Treatment|Lack of Efficacy|0|||
147394268|NCT00784277|531607846|FG004|ER Treatment|Lack of Efficacy|3|||
147394269|NCT00784277|531607847|FG005|ER Treatment|Lack of Efficacy|4|||
147394270|NCT00784277|531607848|FG006|ER Treatment|Lack of Efficacy|0|||
147394271|NCT00784277|531607842|FG000|ER Treatment|Lost to Follow-up|0|||
147394272|NCT00784277|531607843|FG001|ER Treatment|Lost to Follow-up|0|||
147394273|NCT00784277|531607844|FG002|ER Treatment|Lost to Follow-up|0|||
147394274|NCT00784277|531607845|FG003|ER Treatment|Lost to Follow-up|0|||
147394275|NCT00784277|531607846|FG004|ER Treatment|Lost to Follow-up|0|||
147394276|NCT00784277|531607847|FG005|ER Treatment|Lost to Follow-up|2|||
147394277|NCT00784277|531607848|FG006|ER Treatment|Lost to Follow-up|0|||
147394278|NCT00784277|531607842|FG000|ER Treatment|Withdrawal by Subject|0|||
147460146|NCT03434379|531845299|FG002|Global Period|Reason Unspecified|0|||
147460147|NCT03434379|531845300|FG003|Global Period|Reason Unspecified|0|||
147460148|NCT03434379|531845297|FG000|Global Period|Study Ended by Sponsor|26|||
147460149|NCT03434379|531845298|FG001|Global Period|Study Ended by Sponsor|80|||
147460150|NCT03434379|531845299|FG002|Global Period|Study Ended by Sponsor|0|||
147460151|NCT03434379|531845300|FG003|Global Period|Study Ended by Sponsor|0|||
147460152|NCT03434379|531845297|FG000|Global Period|Physician Decision|1|||
147394279|NCT00784277|531607843|FG001|ER Treatment|Withdrawal by Subject|0|||
147394280|NCT00784277|531607844|FG002|ER Treatment|Withdrawal by Subject|0|||
147394281|NCT00784277|531607845|FG003|ER Treatment|Withdrawal by Subject|0|||
147394282|NCT00784277|531607846|FG004|ER Treatment|Withdrawal by Subject|2|||
147394283|NCT00784277|531607847|FG005|ER Treatment|Withdrawal by Subject|5|||
147394284|NCT00784277|531607848|FG006|ER Treatment|Withdrawal by Subject|3|||
147394285|NCT00784277|531607842|FG000|ER Treatment|Study Medication Non-Compliant|0|||
147394286|NCT00784277|531607843|FG001|ER Treatment|Study Medication Non-Compliant|0|||
147394287|NCT00784277|531607844|FG002|ER Treatment|Study Medication Non-Compliant|0|||
147394288|NCT00784277|531607845|FG003|ER Treatment|Study Medication Non-Compliant|0|||
147394289|NCT00784277|531607846|FG004|ER Treatment|Study Medication Non-Compliant|2|||
147394290|NCT00784277|531607847|FG005|ER Treatment|Study Medication Non-Compliant|3|||
147394291|NCT00784277|531607848|FG006|ER Treatment|Study Medication Non-Compliant|3|||
147394292|NCT00784277|531607842|FG000|ER Treatment|Other|0|||
147460153|NCT03434379|531845298|FG001|Global Period|Physician Decision|0|||
147460154|NCT03434379|531845299|FG002|Global Period|Physician Decision|0|||
147460155|NCT03434379|531845300|FG003|Global Period|Physician Decision|0|||
147460156|NCT03434379|531845297|FG000|China Extension Period|Lost to Follow-up|0|||
147460157|NCT03434379|531845298|FG001|China Extension Period|Lost to Follow-up|0|||
147460158|NCT03434379|531845299|FG002|China Extension Period|Lost to Follow-up|2|||
147460159|NCT03434379|531845300|FG003|China Extension Period|Lost to Follow-up|3|||
147460160|NCT03434379|531845297|FG000|China Extension Period|Death|0|||
147460161|NCT03434379|531845298|FG001|China Extension Period|Death|0|||
147460162|NCT03434379|531845299|FG002|China Extension Period|Death|46|||
147460163|NCT03434379|531845300|FG003|China Extension Period|Death|88|||
147460164|NCT03434379|531845297|FG000|China Extension Period|Withdrawal by Subject|0|||
147460165|NCT03434379|531845298|FG001|China Extension Period|Withdrawal by Subject|0|||
147460166|NCT03434379|531845299|FG002|China Extension Period|Withdrawal by Subject|8|||
147460167|NCT03434379|531845300|FG003|China Extension Period|Withdrawal by Subject|6|||
147460168|NCT03434379|531845297|FG000|China Extension Period|Study Ended by Sponsor|0|||
147460169|NCT03434379|531845298|FG001|China Extension Period|Study Ended by Sponsor|0|||
147460170|NCT03434379|531845299|FG002|China Extension Period|Study Ended by Sponsor|5|||
147460171|NCT03434379|531845300|FG003|China Extension Period|Study Ended by Sponsor|36|||
147460172|NCT00428597|531845301|FG000|Overall Study|Randomized but not treated|3|||
147460173|NCT00428597|531845302|FG001|Overall Study|Randomized but not treated|3|||
147460174|NCT00428597|531845301|FG000|Overall Study|Objective Progression or Relapse|19|||
147460175|NCT00428597|531845302|FG001|Overall Study|Objective Progression or Relapse|47|||
147460176|NCT00428597|531845301|FG000|Overall Study|Study Terminated by Sponsor|41|||
147460177|NCT00428597|531845302|FG001|Overall Study|Study Terminated by Sponsor|16|||
147460178|NCT00428597|531845301|FG000|Overall Study|Adverse Event|15|||
147460179|NCT00428597|531845302|FG001|Overall Study|Adverse Event|7|||
147460180|NCT00428597|531845301|FG000|Overall Study|Global Deterioration of Health Status|1|||
147460181|NCT00428597|531845302|FG001|Overall Study|Global Deterioration of Health Status|5|||
147460182|NCT00428597|531845301|FG000|Overall Study|Protocol Violation|2|||
147460183|NCT00428597|531845302|FG001|Overall Study|Protocol Violation|1|||
147460184|NCT00428597|531845301|FG000|Overall Study|Withdrawal by Subject|2|||
147460185|NCT00428597|531845302|FG001|Overall Study|Withdrawal by Subject|1|||
147460186|NCT00428597|531845301|FG000|Overall Study|Other|1|||
147460187|NCT00428597|531845302|FG001|Overall Study|Other|1|||
147460188|NCT00428597|531845301|FG000|Overall Study|Lost to Follow-up|0|||
147460189|NCT00428597|531845302|FG001|Overall Study|Lost to Follow-up|1|||
147460190|NCT00428597|531845301|FG000|Overall Study|Pregnancy|1|||
147460191|NCT00428597|531845302|FG001|Overall Study|Pregnancy|0|||
147460192|NCT00428597|531845301|FG000|Overall Study|Death|1|||
147460193|NCT00428597|531845302|FG001|Overall Study|Death|3|||
147460194|NCT00769119|531845308|FG000|Overall Study|Voluntary discontinuation|0|||
147394293|NCT00784277|531607843|FG001|ER Treatment|Other|0|||
147394294|NCT00784277|531607844|FG002|ER Treatment|Other|0|||
147394295|NCT00784277|531607845|FG003|ER Treatment|Other|0|||
147394296|NCT00784277|531607846|FG004|ER Treatment|Other|1|||
147394297|NCT00784277|531607847|FG005|ER Treatment|Other|3|||
147394298|NCT00784277|531607848|FG006|ER Treatment|Other|2|||
147394299|NCT01093222|531607849|FG000|Overall Study|Ineligible|6|||
147394300|NCT01093222|531607849|FG000|Overall Study|Adverse Event|7|||
147394301|NCT01093222|531607849|FG000|Overall Study|Progression/relapse|24|||
147394302|NCT01093222|531607849|FG000|Overall Study|Death|2|||
147394303|NCT01093222|531607849|FG000|Overall Study|Not protocol specified|1|||
147394304|NCT00187135|531607852|FG000|Visit One|Withdrawal by Subject|1|||
147394305|NCT00187135|531607853|FG001|Visit One|Withdrawal by Subject|0|||
147394306|NCT00187135|531607854|FG002|Visit One|Withdrawal by Subject|0|||
147394307|NCT00187135|531607855|FG003|Visit One|Withdrawal by Subject|0|||
147394308|NCT00187135|531607856|FG004|Visit One|Withdrawal by Subject|0|||
147394309|NCT00187135|531607857|FG005|Visit One|Withdrawal by Subject|1|||
147394310|NCT00187135|531607852|FG000|Visit One|Physician Decision|3|||
147394311|NCT00187135|531607853|FG001|Visit One|Physician Decision|1|||
147394312|NCT00187135|531607854|FG002|Visit One|Physician Decision|0|||
147394313|NCT00187135|531607855|FG003|Visit One|Physician Decision|0|||
147460195|NCT00769119|531845309|FG001|Overall Study|Voluntary discontinuation|2|||
147460196|NCT00769119|531845308|FG000|Overall Study|Adverse Event|1|||
147460197|NCT00769119|531845309|FG001|Overall Study|Adverse Event|1|||
147460198|NCT00769119|531845308|FG000|Overall Study|Disallowed medication|1|||
147615297|NCT03449446|532406696|FG001|Overall Study|Lost to Follow-up|0|||
147394314|NCT00187135|531607856|FG004|Visit One|Physician Decision|0|||
147394315|NCT00187135|531607857|FG005|Visit One|Physician Decision|1|||
147394316|NCT00187135|531607852|FG000|Visit Two|Death|0|||
147394317|NCT00187135|531607853|FG001|Visit Two|Death|0|||
147394318|NCT00187135|531607854|FG002|Visit Two|Death|0|||
147394319|NCT00187135|531607855|FG003|Visit Two|Death|1|||
147394320|NCT00187135|531607856|FG004|Visit Two|Death|0|||
147394321|NCT00187135|531607857|FG005|Visit Two|Death|1|||
147460199|NCT00769119|531845309|FG001|Overall Study|Disallowed medication|0|||
147460200|NCT00686647|531845310|FG000|Overall Study|Lost to Follow-up|1|||
147460201|NCT00686647|531845310|FG000|Overall Study|Death|1|||
147460202|NCT01116544|531845311|FG000|Overall Study|Protocol Violation|1|||
147394322|NCT00187135|531607852|FG000|Visit Two|Physician Decision|1|||
147394323|NCT00187135|531607853|FG001|Visit Two|Physician Decision|0|||
147394324|NCT00187135|531607854|FG002|Visit Two|Physician Decision|0|||
147394325|NCT00187135|531607855|FG003|Visit Two|Physician Decision|0|||
147394326|NCT00187135|531607856|FG004|Visit Two|Physician Decision|0|||
147394327|NCT00187135|531607857|FG005|Visit Two|Physician Decision|0|||
147394328|NCT00187135|531607852|FG000|Visit Two|Withdrawal by Subject|1|||
147394329|NCT00187135|531607853|FG001|Visit Two|Withdrawal by Subject|1|||
147394330|NCT00187135|531607854|FG002|Visit Two|Withdrawal by Subject|1|||
147394331|NCT00187135|531607855|FG003|Visit Two|Withdrawal by Subject|0|||
147394332|NCT00187135|531607856|FG004|Visit Two|Withdrawal by Subject|1|||
147394333|NCT00187135|531607857|FG005|Visit Two|Withdrawal by Subject|1|||
147394334|NCT00187135|531607852|FG000|Visit Two|Study Discontinued|3|||
147394335|NCT00187135|531607853|FG001|Visit Two|Study Discontinued|2|||
147394336|NCT00187135|531607854|FG002|Visit Two|Study Discontinued|1|||
147394337|NCT00187135|531607855|FG003|Visit Two|Study Discontinued|7|||
147394338|NCT00187135|531607856|FG004|Visit Two|Study Discontinued|5|||
147394339|NCT00187135|531607857|FG005|Visit Two|Study Discontinued|6|||
147394340|NCT00187135|531607852|FG000|Visit Three|Death|0|||
147394341|NCT00187135|531607853|FG001|Visit Three|Death|0|||
147394342|NCT00187135|531607854|FG002|Visit Three|Death|1|||
147394343|NCT00187135|531607855|FG003|Visit Three|Death|0|||
147394344|NCT00187135|531607856|FG004|Visit Three|Death|1|||
147394345|NCT00187135|531607857|FG005|Visit Three|Death|0|||
147394346|NCT00187135|531607852|FG000|Visit Three|Withdrawal by Subject|0|||
147394347|NCT00187135|531607853|FG001|Visit Three|Withdrawal by Subject|1|||
147394348|NCT00187135|531607854|FG002|Visit Three|Withdrawal by Subject|1|||
147394349|NCT00187135|531607855|FG003|Visit Three|Withdrawal by Subject|2|||
147394350|NCT00187135|531607856|FG004|Visit Three|Withdrawal by Subject|0|||
147394351|NCT00187135|531607857|FG005|Visit Three|Withdrawal by Subject|0|||
147394352|NCT00187135|531607852|FG000|Visit Three|Study Discontinued|7|||
147394353|NCT00187135|531607853|FG001|Visit Three|Study Discontinued|6|||
147394354|NCT00187135|531607854|FG002|Visit Three|Study Discontinued|7|||
147394355|NCT00187135|531607855|FG003|Visit Three|Study Discontinued|7|||
147394356|NCT00187135|531607856|FG004|Visit Three|Study Discontinued|7|||
147394357|NCT00187135|531607857|FG005|Visit Three|Study Discontinued|6|||
147394358|NCT03927222|531607858|FG000|Overall Study|Progression|3|||
147394359|NCT03927222|531607858|FG000|Overall Study|CMV testing results inconclusive|1|||
147394360|NCT03927222|531607858|FG000|Overall Study|Unable to generate enough vaccines|1|||
147394361|NCT03927222|531607858|FG000|Overall Study|Early study termination|1|||
147394362|NCT03723915|531607859|FG000|Screening|Failed to meet screening requirements.|2|||
147394363|NCT03723915|531607859|FG000|On Treatment|Failed to meet treatment requirements|2|||
147394364|NCT00640042|531607860|FG000|Enrollment|Did not receive study drug|83|||
147394365|NCT01592383|531607877|FG000|Overall Study|Adverse Event|1|||
147394366|NCT00560313|531609324|FG000|Overall Study|Adverse Events or Death|2|||
147394367|NCT00560313|531609324|FG000|Overall Study|Withdrawal by Subject|2|||
147394368|NCT00560313|531609324|FG000|Overall Study|Lost to Follow-up|1|||
147394369|NCT00560313|531609324|FG000|Overall Study|Protocol Violation|1|||
147394370|NCT00853372|531609329|FG000|Overall Study|Death|30|||
147394371|NCT00853372|531609330|FG001|Overall Study|Death|26|||
147394372|NCT00853372|531609329|FG000|Overall Study|Lost to Follow-up|1|||
147394373|NCT00853372|531609330|FG001|Overall Study|Lost to Follow-up|2|||
147394374|NCT00853372|531609329|FG000|Overall Study|Full Consent Withdrawn|1|||
147394375|NCT00853372|531609330|FG001|Overall Study|Full Consent Withdrawn|1|||
147394376|NCT01644188|531609333|FG000|Overall Study|Adverse Event|44|||
147394377|NCT01644188|531609334|FG001|Overall Study|Adverse Event|20|||
147394378|NCT01644188|531609333|FG000|Overall Study|Poor compliance to protocol|26|||
147394379|NCT01644188|531609334|FG001|Overall Study|Poor compliance to protocol|14|||
147394380|NCT01644188|531609333|FG000|Overall Study|Physician Decision|1|||
147394381|NCT01644188|531609334|FG001|Overall Study|Physician Decision|3|||
147394382|NCT01644188|531609333|FG000|Overall Study|Participant moved|7|||
147394383|NCT01644188|531609334|FG001|Overall Study|Participant moved|2|||
147394384|NCT01644188|531609333|FG000|Overall Study|Related to auto-injector administration|2|||
147394385|NCT01644188|531609334|FG001|Overall Study|Related to auto-injector administration|2|||
147394386|NCT01644188|531609333|FG000|Overall Study|Consent withdrawn by participant|14|||
147394387|NCT01644188|531609334|FG001|Overall Study|Consent withdrawn by participant|7|||
147394388|NCT01644188|531609333|FG000|Overall Study|Selection criteria finally not met|2|||
147394389|NCT01644188|531609334|FG001|Overall Study|Selection criteria finally not met|0|||
147394390|NCT01644188|531609333|FG000|Overall Study|Lost to Follow-up|1|||
147394391|NCT01644188|531609334|FG001|Overall Study|Lost to Follow-up|0|||
147394392|NCT01644188|531609333|FG000|Overall Study|Death|4|||
147394393|NCT01644188|531609334|FG001|Overall Study|Death|3|||
147394394|NCT01644188|531609333|FG000|Overall Study|Last visit outside protocol visit window|14|||
147394395|NCT01644188|531609334|FG001|Overall Study|Last visit outside protocol visit window|16|||
147394396|NCT01644188|531609333|FG000|Overall Study|Site closure|1|||
147394397|NCT01644188|531609334|FG001|Overall Study|Site closure|1|||
147394398|NCT01644188|531609333|FG000|Overall Study|Other than specified above|6|||
147394399|NCT01644188|531609334|FG001|Overall Study|Other than specified above|7|||
147394400|NCT01929876|531609336|FG000|Period 2|Non-Compliance|1|||
147394401|NCT03991988|531609339|FG000|Overall Study|Withdrawal by Subject|2|||
147394402|NCT03991988|531609340|FG001|Overall Study|Withdrawal by Subject|2|||
147394403|NCT04349644|531609342|FG000|Allocation/Pretest|Lost to pretest|0|||
147394404|NCT04349644|531609343|FG001|Allocation/Pretest|Lost to pretest|3|||
147394405|NCT04349644|531609342|FG000|Posttest|Lost to posttest|0|||
147394406|NCT04349644|531609343|FG001|Posttest|Lost to posttest|8|||
147394407|NCT04349644|531609342|FG000|Posttest|Discontinued intervention|6|||
147394408|NCT04349644|531609343|FG001|Posttest|Discontinued intervention|0|||
147394409|NCT04349644|531609342|FG000|Follow-up|Lost to Follow-up|0|||
147394410|NCT04349644|531609343|FG001|Follow-up|Lost to Follow-up|2|||
147394411|NCT05006417|531609344|FG000|Overall Study|PI terminated study for problems with strength testing equipment|1|||
147394412|NCT01169636|531609345|FG000|Overall Study|Adverse Event|0|||
147394413|NCT01169636|531609346|FG001|Overall Study|Adverse Event|0|||
147394414|NCT01169636|531609347|FG002|Overall Study|Adverse Event|1|||
147394415|NCT01169636|531609348|FG003|Overall Study|Adverse Event|1|||
147394416|NCT01169636|531609349|FG004|Overall Study|Adverse Event|0|||
147394417|NCT01169636|531609345|FG000|Overall Study|Screen failure|0|||
147394418|NCT01169636|531609346|FG001|Overall Study|Screen failure|0|||
147394419|NCT01169636|531609347|FG002|Overall Study|Screen failure|2|||
147394420|NCT01169636|531609348|FG003|Overall Study|Screen failure|0|||
147394421|NCT01169636|531609349|FG004|Overall Study|Screen failure|0|||
147394422|NCT01169636|531609345|FG000|Overall Study|Withdrawal by Subject|0|||
147394423|NCT01169636|531609346|FG001|Overall Study|Withdrawal by Subject|0|||
147394424|NCT01169636|531609347|FG002|Overall Study|Withdrawal by Subject|0|||
147394425|NCT01169636|531609348|FG003|Overall Study|Withdrawal by Subject|0|||
147394426|NCT01169636|531609349|FG004|Overall Study|Withdrawal by Subject|3|||
147394427|NCT02396953|531609350|FG000|Overall Study|Withdrawal by Subject|0|||
147394428|NCT02396953|531609351|FG001|Overall Study|Withdrawal by Subject|0|||
147394429|NCT02396953|531609352|FG002|Overall Study|Withdrawal by Subject|1|||
147394430|NCT02396953|531609350|FG000|Overall Study|Insulin like Growth Factor-1 increased|3|||
147394431|NCT02396953|531609351|FG001|Overall Study|Insulin like Growth Factor-1 increased|2|||
147394432|NCT02396953|531609352|FG002|Overall Study|Insulin like Growth Factor-1 increased|2|||
147394433|NCT02396953|531609350|FG000|Overall Study|Personal Reasons|1|||
147394434|NCT02396953|531609351|FG001|Overall Study|Personal Reasons|1|||
147394435|NCT02396953|531609352|FG002|Overall Study|Personal Reasons|0|||
147394436|NCT00510198|531609353|FG000|Overall Study|Withdrawal by Subject|5|||
147394437|NCT00510198|531609354|FG001|Overall Study|Withdrawal by Subject|4|||
147394438|NCT02994784|531609355|FG000|6 Months Follow-up|Lost to Follow-up|3|||
147394439|NCT01649557|531609359|FG000|Overall Study|Lost to Follow-up|5|||
147394440|NCT01649557|531609360|FG001|Overall Study|Lost to Follow-up|0|||
147394441|NCT01649557|531609361|FG002|Overall Study|Lost to Follow-up|3|||
147394442|NCT01649557|531609359|FG000|Overall Study|Adverse Event|7|||
147394443|NCT01649557|531609360|FG001|Overall Study|Adverse Event|5|||
147394444|NCT01649557|531609361|FG002|Overall Study|Adverse Event|1|||
147394445|NCT01649557|531609359|FG000|Overall Study|Met withdrawal criteria|4|||
147394446|NCT01649557|531609360|FG001|Overall Study|Met withdrawal criteria|0|||
147394447|NCT01649557|531609361|FG002|Overall Study|Met withdrawal criteria|0|||
147394448|NCT01649557|531609359|FG000|Overall Study|Physician Decision|8|||
147394449|NCT01649557|531609360|FG001|Overall Study|Physician Decision|2|||
147394450|NCT01649557|531609361|FG002|Overall Study|Physician Decision|1|||
147394451|NCT01649557|531609359|FG000|Overall Study|Withdrawal by Subject|15|||
147394452|NCT01649557|531609360|FG001|Overall Study|Withdrawal by Subject|5|||
147394453|NCT01649557|531609361|FG002|Overall Study|Withdrawal by Subject|4|||
147394454|NCT01649557|531609359|FG000|Overall Study|Protocol deviation|0|||
147394455|NCT01649557|531609360|FG001|Overall Study|Protocol deviation|2|||
147394456|NCT01649557|531609361|FG002|Overall Study|Protocol deviation|0|||
147394457|NCT01649557|531609359|FG000|Overall Study|Lack of Efficacy|5|||
147394458|NCT01649557|531609360|FG001|Overall Study|Lack of Efficacy|0|||
147394459|NCT01649557|531609361|FG002|Overall Study|Lack of Efficacy|0|||
147394460|NCT03029234|531609365|FG000|Overall Study|Sponsor Decision|1|||
147394461|NCT03029234|531609365|FG000|Overall Study|Withdrawal by Subject|5|||
147394462|NCT03029234|531609365|FG000|Overall Study|Death|91|||
147394463|NCT03029234|531609365|FG000|Overall Study|Lost to Follow-up|2|||
147394464|NCT02544113|531609367|FG000|Overall Study|Death|3|||
147394465|NCT02544113|531609368|FG001|Overall Study|Death|4|||
147394466|NCT02847637|531609370|FG000|Overall Study|Withdrawal by Subject|0|||
147394467|NCT02847637|531609371|FG001|Overall Study|Withdrawal by Subject|1|||
147394468|NCT02847637|531609372|FG002|Overall Study|Withdrawal by Subject|1|||
147394469|NCT02847637|531609373|FG003|Overall Study|Withdrawal by Subject|0|||
147394470|NCT02847637|531609370|FG000|Overall Study|Lost to Follow-up|1|||
147394471|NCT02847637|531609371|FG001|Overall Study|Lost to Follow-up|1|||
147394472|NCT02847637|531609372|FG002|Overall Study|Lost to Follow-up|0|||
147394473|NCT02847637|531609373|FG003|Overall Study|Lost to Follow-up|0|||
147394474|NCT01746108|531609376|FG000|Overall Study|Migrated /moved from study area|0|||
147394475|NCT01746108|531609377|FG001|Overall Study|Migrated /moved from study area|1|||
147394476|NCT01746108|531609378|FG002|Overall Study|Migrated /moved from study area|0|||
147394477|NCT01746108|531609376|FG000|Overall Study|Adverse event, non-fatal|0|||
147394478|NCT01746108|531609377|FG001|Overall Study|Adverse event, non-fatal|1|||
147394479|NCT01746108|531609378|FG002|Overall Study|Adverse event, non-fatal|0|||
147394480|NCT01746108|531609376|FG000|Overall Study|Withdrawal by Subject|0|||
147394481|NCT01746108|531609377|FG001|Overall Study|Withdrawal by Subject|1|||
147394482|NCT01746108|531609378|FG002|Overall Study|Withdrawal by Subject|0|||
147394483|NCT01746108|531609376|FG000|Overall Study|Lost to Follow-up|0|||
147394484|NCT01746108|531609377|FG001|Overall Study|Lost to Follow-up|1|||
147394485|NCT01746108|531609378|FG002|Overall Study|Lost to Follow-up|0|||
147394486|NCT00797511|531609381|FG000|Overall Study|Withdrawal by Subject|1|||
147394487|NCT03036150|531609382|FG000|Overall Study|Withdrawal by Subject|8|||
147394488|NCT03036150|531609383|FG001|Overall Study|Withdrawal by Subject|3|||
147394489|NCT03036150|531609382|FG000|Overall Study|Lost to Follow-up|2|||
147394490|NCT03036150|531609383|FG001|Overall Study|Lost to Follow-up|2|||
147394491|NCT01990664|531609386|FG000|Overall Study|Lost to Follow-up|2|||
147394492|NCT01990664|531609387|FG001|Overall Study|Lost to Follow-up|6|||
147394493|NCT01990664|531609386|FG000|Overall Study|Withdrawal by Subject|2|||
147394494|NCT01990664|531609387|FG001|Overall Study|Withdrawal by Subject|3|||
147394495|NCT01990664|531609386|FG000|Overall Study|Protocol Violation|1|||
147394496|NCT01990664|531609387|FG001|Overall Study|Protocol Violation|0|||
147394497|NCT01990664|531609386|FG000|Overall Study|Lens Discomfort|1|||
147394498|NCT01990664|531609387|FG001|Overall Study|Lens Discomfort|1|||
147394499|NCT01990664|531609386|FG000|Overall Study|Lens Handling Difficulties|1|||
147394500|NCT01990664|531609387|FG001|Overall Study|Lens Handling Difficulties|0|||
147394501|NCT01990664|531609386|FG000|Overall Study|Unsatisfactory Visual Response|0|||
147394502|NCT01990664|531609387|FG001|Overall Study|Unsatisfactory Visual Response|1|||
147394503|NCT00931918|531609388|FG000|Overall Study|Adverse Event|4|||
147394504|NCT00931918|531609389|FG001|Overall Study|Adverse Event|6|||
147394505|NCT00931918|531609388|FG000|Overall Study|Progressive Disease|2|||
147394506|NCT00931918|531609389|FG001|Overall Study|Progressive Disease|1|||
147394507|NCT00931918|531609388|FG000|Overall Study|Symptomatic Deterioration|1|||
147394508|NCT00931918|531609389|FG001|Overall Study|Symptomatic Deterioration|0|||
147394509|NCT00931918|531609388|FG000|Overall Study|Withdrawal by Patient|3|||
147394510|NCT00931918|531609389|FG001|Overall Study|Withdrawal by Patient|4|||
147394511|NCT00931918|531609388|FG000|Overall Study|Other Reason not Specified|4|||
147394512|NCT00931918|531609389|FG001|Overall Study|Other Reason not Specified|4|||
147394513|NCT00931918|531609388|FG000|Overall Study|Did not receive study drug|3|||
147394514|NCT00931918|531609389|FG001|Overall Study|Did not receive study drug|2|||
147394515|NCT00809341|531609390|FG000|Overall Study|Physician Decision|0|||
147394516|NCT00809341|531609391|FG001|Overall Study|Physician Decision|1|||
147394517|NCT00570921|531609395|FG000|Overall Study|Protocol Violation|1|||
147394518|NCT00570921|531609395|FG000|Overall Study|Physician Decision|1|||
147394519|NCT03891641|531609407|FG000|Overall Study|Study Stoppage Due to COVID-19|2|||
147394520|NCT03891641|531609408|FG001|Overall Study|Study Stoppage Due to COVID-19|2|||
147394521|NCT00745121|531609413|FG000|Overall Study|Death|3|||
147394522|NCT00745121|531609414|FG001|Overall Study|Death|0|||
147394523|NCT00745121|531609413|FG000|Overall Study|Adverse Event|1|||
147394524|NCT00745121|531609414|FG001|Overall Study|Adverse Event|0|||
147394525|NCT00745121|531609413|FG000|Overall Study|Lost to Follow-up|1|||
147394526|NCT00745121|531609414|FG001|Overall Study|Lost to Follow-up|0|||
147394527|NCT00745121|531609413|FG000|Overall Study|Withdrawal by Subject|4|||
147394528|NCT00745121|531609414|FG001|Overall Study|Withdrawal by Subject|2|||
147394529|NCT01281917|531609426|FG000|Overall Study|Withdrawal by Subject|1|||
147394530|NCT04016805|531609427|FG000|Overall Study|Sponsor's Discretion|30|||
147394531|NCT04016805|531609428|FG001|Overall Study|Sponsor's Discretion|6|||
147394532|NCT04016805|531609429|FG002|Overall Study|Sponsor's Discretion|5|||
147394533|NCT00740870|531609432|FG000|Overall Study|Not Catheterized|4|||
147394534|NCT00740870|531609432|FG000|Overall Study|Further testing contraindicated implant|17|||
147394535|NCT00607997|531609433|FG000|Overall Study|Lack of Efficacy|6|||
147394536|NCT00607997|531609434|FG001|Overall Study|Lack of Efficacy|20|||
147394537|NCT00607997|531609435|FG002|Overall Study|Lack of Efficacy|14|||
147394538|NCT00607997|531609436|FG003|Overall Study|Lack of Efficacy|10|||
147394539|NCT00607997|531609433|FG000|Overall Study|Death|8|||
147394540|NCT00607997|531609434|FG001|Overall Study|Death|5|||
147394541|NCT00607997|531609435|FG002|Overall Study|Death|2|||
147394542|NCT00607997|531609436|FG003|Overall Study|Death|5|||
147615298|NCT03449446|532406697|FG002|Overall Study|Lost to Follow-up|2|||
147394543|NCT00607997|531609433|FG000|Overall Study|Adverse Event|3|||
147394544|NCT00607997|531609434|FG001|Overall Study|Adverse Event|1|||
147394545|NCT00607997|531609435|FG002|Overall Study|Adverse Event|2|||
147615299|NCT03449446|532406698|FG003|Overall Study|Lost to Follow-up|1|||
147615300|NCT03449446|532406699|FG004|Overall Study|Lost to Follow-up|3|||
147615301|NCT03449446|532406700|FG005|Overall Study|Lost to Follow-up|0|||
147394546|NCT00607997|531609436|FG003|Overall Study|Adverse Event|0|||
147394547|NCT00607997|531609433|FG000|Overall Study|Physician Decision|4|||
147394548|NCT00607997|531609434|FG001|Overall Study|Physician Decision|1|||
147394549|NCT00607997|531609435|FG002|Overall Study|Physician Decision|0|||
147394550|NCT00607997|531609436|FG003|Overall Study|Physician Decision|0|||
147394551|NCT00607997|531609433|FG000|Overall Study|Relapse, recurrent illness|4|||
147615302|NCT03449446|532406701|FG006|Overall Study|Lost to Follow-up|0|||
147460203|NCT01116544|531845312|FG001|Overall Study|Protocol Violation|0|||
147460204|NCT01116544|531845311|FG000|Overall Study|Withdrawal by Subject|1|||
147460205|NCT01116544|531845312|FG001|Overall Study|Withdrawal by Subject|1|||
147460206|NCT00578643|531845313|FG000|Overall Study|Death|1|||
147460207|NCT00578643|531845313|FG000|Overall Study|Lost to Follow-up|1|||
147460208|NCT01725750|531845314|FG000|Overall Study|Adverse Event|1|||
147460209|NCT01725750|531845315|FG001|Overall Study|Adverse Event|0|||
147460210|NCT01725750|531845314|FG000|Overall Study|Lost to Follow-up|1|||
147460211|NCT01725750|531845315|FG001|Overall Study|Lost to Follow-up|1|||
147460212|NCT01725750|531845314|FG000|Overall Study|Withdrawal by Subject|0|||
147460213|NCT01725750|531845315|FG001|Overall Study|Withdrawal by Subject|9|||
147460214|NCT03179436|531845318|FG000|Overall Study|Withdrawal by Subject|1|||
147460215|NCT03179436|531845319|FG001|Overall Study|Withdrawal by Subject|0|||
147460216|NCT03179436|531845320|FG002|Overall Study|Withdrawal by Subject|0|||
147460217|NCT03179436|531845321|FG003|Overall Study|Withdrawal by Subject|4|||
147460218|NCT03179436|531845322|FG004|Overall Study|Withdrawal by Subject|2|||
147460219|NCT03179436|531845323|FG005|Overall Study|Withdrawal by Subject|2|||
147460220|NCT03179436|531845324|FG006|Overall Study|Withdrawal by Subject|5|||
147460221|NCT03179436|531845325|FG007|Overall Study|Withdrawal by Subject|0|||
147460222|NCT03179436|531845326|FG008|Overall Study|Withdrawal by Subject|3|||
147460223|NCT03179436|531845327|FG009|Overall Study|Withdrawal by Subject|0|||
147460224|NCT03179436|531845328|FG010|Overall Study|Withdrawal by Subject|0|||
147460225|NCT03179436|531845329|FG011|Overall Study|Withdrawal by Subject|0|||
147460226|NCT03179436|531845318|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
147460227|NCT03179436|531845319|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
147460228|NCT03179436|531845320|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
147460229|NCT03179436|531845321|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
147460230|NCT03179436|531845322|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
147460231|NCT03179436|531845323|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
147460232|NCT03179436|531845324|FG006|Overall Study|Withdrawal by Parent/Guardian|0|||
147460233|NCT03179436|531845325|FG007|Overall Study|Withdrawal by Parent/Guardian|1|||
147460234|NCT03179436|531845326|FG008|Overall Study|Withdrawal by Parent/Guardian|0|||
147460235|NCT03179436|531845327|FG009|Overall Study|Withdrawal by Parent/Guardian|0|||
147460236|NCT03179436|531845328|FG010|Overall Study|Withdrawal by Parent/Guardian|0|||
147460237|NCT03179436|531845329|FG011|Overall Study|Withdrawal by Parent/Guardian|0|||
147460238|NCT03179436|531845318|FG000|Overall Study|Sponsor Decision|0|||
147460239|NCT03179436|531845319|FG001|Overall Study|Sponsor Decision|0|||
147460240|NCT03179436|531845320|FG002|Overall Study|Sponsor Decision|1|||
147460241|NCT03179436|531845321|FG003|Overall Study|Sponsor Decision|3|||
147460242|NCT03179436|531845322|FG004|Overall Study|Sponsor Decision|9|||
147460243|NCT03179436|531845323|FG005|Overall Study|Sponsor Decision|7|||
147460244|NCT03179436|531845324|FG006|Overall Study|Sponsor Decision|2|||
147460245|NCT03179436|531845325|FG007|Overall Study|Sponsor Decision|4|||
147460246|NCT03179436|531845326|FG008|Overall Study|Sponsor Decision|23|||
147460247|NCT03179436|531845327|FG009|Overall Study|Sponsor Decision|6|||
147460248|NCT03179436|531845328|FG010|Overall Study|Sponsor Decision|7|||
147460249|NCT03179436|531845329|FG011|Overall Study|Sponsor Decision|5|||
147460250|NCT03179436|531845318|FG000|Overall Study|Randomized by Mistake without Study Treatment|0|||
147460251|NCT03179436|531845319|FG001|Overall Study|Randomized by Mistake without Study Treatment|1|||
147460252|NCT03179436|531845320|FG002|Overall Study|Randomized by Mistake without Study Treatment|0|||
147460253|NCT03179436|531845321|FG003|Overall Study|Randomized by Mistake without Study Treatment|0|||
147460254|NCT03179436|531845322|FG004|Overall Study|Randomized by Mistake without Study Treatment|0|||
147460255|NCT03179436|531845323|FG005|Overall Study|Randomized by Mistake without Study Treatment|1|||
147460256|NCT03179436|531845324|FG006|Overall Study|Randomized by Mistake without Study Treatment|0|||
147615303|NCT03449446|532406695|FG000|Overall Study|Investigator's Discretion|0|||
147615304|NCT03449446|532406696|FG001|Overall Study|Investigator's Discretion|1|||
147394552|NCT00607997|531609434|FG001|Overall Study|Relapse, recurrent illness|0|||
147394553|NCT00607997|531609435|FG002|Overall Study|Relapse, recurrent illness|2|||
147394554|NCT00607997|531609436|FG003|Overall Study|Relapse, recurrent illness|0|||
147394555|NCT00607997|531609433|FG000|Overall Study|Other without explanation|2|||
147394556|NCT00607997|531609434|FG001|Overall Study|Other without explanation|0|||
147394557|NCT00607997|531609435|FG002|Overall Study|Other without explanation|4|||
147394558|NCT00607997|531609436|FG003|Overall Study|Other without explanation|1|||
147394559|NCT04414397|531609440|FG000|Control Period|Withdrawal by Subject|2|||
147394560|NCT04414397|531609441|FG001|Control Period|Withdrawal by Subject|2|||
147460257|NCT03179436|531845325|FG007|Overall Study|Randomized by Mistake without Study Treatment|0|||
147460258|NCT03179436|531845326|FG008|Overall Study|Randomized by Mistake without Study Treatment|0|||
147460259|NCT03179436|531845327|FG009|Overall Study|Randomized by Mistake without Study Treatment|0|||
147460260|NCT03179436|531845328|FG010|Overall Study|Randomized by Mistake without Study Treatment|0|||
147460261|NCT03179436|531845329|FG011|Overall Study|Randomized by Mistake without Study Treatment|0|||
147615305|NCT03449446|532406697|FG002|Overall Study|Investigator's Discretion|1|||
147460262|NCT03179436|531845318|FG000|Overall Study|Lost to Follow-up|1|||
147460263|NCT03179436|531845319|FG001|Overall Study|Lost to Follow-up|0|||
147460264|NCT03179436|531845320|FG002|Overall Study|Lost to Follow-up|0|||
147460265|NCT03179436|531845321|FG003|Overall Study|Lost to Follow-up|1|||
147460266|NCT03179436|531845322|FG004|Overall Study|Lost to Follow-up|0|||
147460267|NCT03179436|531845323|FG005|Overall Study|Lost to Follow-up|1|||
147460268|NCT03179436|531845324|FG006|Overall Study|Lost to Follow-up|0|||
147460269|NCT03179436|531845325|FG007|Overall Study|Lost to Follow-up|0|||
147460270|NCT03179436|531845326|FG008|Overall Study|Lost to Follow-up|1|||
147460271|NCT03179436|531845327|FG009|Overall Study|Lost to Follow-up|1|||
147460272|NCT03179436|531845328|FG010|Overall Study|Lost to Follow-up|0|||
147460273|NCT03179436|531845329|FG011|Overall Study|Lost to Follow-up|0|||
147460274|NCT03179436|531845318|FG000|Overall Study|Death|12|||
147460275|NCT03179436|531845319|FG001|Overall Study|Death|17|||
147460276|NCT03179436|531845320|FG002|Overall Study|Death|7|||
147460277|NCT03179436|531845321|FG003|Overall Study|Death|32|||
147460278|NCT03179436|531845322|FG004|Overall Study|Death|29|||
147460279|NCT03179436|531845323|FG005|Overall Study|Death|30|||
147460280|NCT03179436|531845324|FG006|Overall Study|Death|33|||
147460281|NCT03179436|531845325|FG007|Overall Study|Death|9|||
147460282|NCT03179436|531845326|FG008|Overall Study|Death|84|||
147460283|NCT03179436|531845327|FG009|Overall Study|Death|33|||
147460284|NCT03179436|531845328|FG010|Overall Study|Death|22|||
147460285|NCT03179436|531845329|FG011|Overall Study|Death|15|||
147460286|NCT01634555|531845340|FG000|Overall Study|Adverse Event|3|||
147460287|NCT01634555|531845340|FG000|Overall Study|Physician Decision|1|||
147460288|NCT01738971|531845343|FG000|Overall Study|Lost to Follow-up|19|||
147460289|NCT01738971|531845344|FG001|Overall Study|Lost to Follow-up|30|||
147460290|NCT01738971|531845345|FG002|Overall Study|Lost to Follow-up|17|||
147460291|NCT05888103|531846969|FG000|Overall Study|Participant decision|3|||
147460292|NCT05888103|531846970|FG001|Overall Study|Participant decision|3|||
147460293|NCT05900115|531846971|FG000|Overall Study|Lost to Follow-up|129|||
147460294|NCT05900115|531846972|FG001|Overall Study|Lost to Follow-up|98|||
147460295|NCT02152345|531846973|FG000|Overall Study|Case Cancellations|2|||
147460296|NCT02152345|531846974|FG001|Overall Study|Case Cancellations|4|||
147460297|NCT02152345|531846973|FG000|Overall Study|Withdrawal by Subject|2|||
147460298|NCT02152345|531846974|FG001|Overall Study|Withdrawal by Subject|1|||
147460299|NCT00546364|531846976|FG000|Overall Study|Disease progression|5|||
147460300|NCT00546364|531846977|FG001|Overall Study|Disease progression|11|||
147460301|NCT00546364|531846978|FG002|Overall Study|Disease progression|8|||
147460302|NCT00546364|531846976|FG000|Overall Study|Completed and off treatment|1|||
147460303|NCT00546364|531846977|FG001|Overall Study|Completed and off treatment|0|||
147460304|NCT00546364|531846978|FG002|Overall Study|Completed and off treatment|2|||
147460305|NCT00546364|531846976|FG000|Overall Study|Administrative reason by sponsor|1|||
147460306|NCT00546364|531846977|FG001|Overall Study|Administrative reason by sponsor|0|||
147460307|NCT00546364|531846978|FG002|Overall Study|Administrative reason by sponsor|0|||
147460308|NCT00546364|531846976|FG000|Overall Study|Poor compliance/noncompliance|0|||
147460309|NCT00546364|531846977|FG001|Overall Study|Poor compliance/noncompliance|0|||
147460310|NCT00546364|531846978|FG002|Overall Study|Poor compliance/noncompliance|1|||
147460311|NCT00546364|531846976|FG000|Overall Study|No longer meets study criteria|1|||
147460312|NCT00546364|531846977|FG001|Overall Study|No longer meets study criteria|1|||
147460313|NCT00546364|531846978|FG002|Overall Study|No longer meets study criteria|0|||
147460314|NCT00546364|531846976|FG000|Overall Study|Withdrawal by Subject|5|||
147460315|NCT00546364|531846977|FG001|Overall Study|Withdrawal by Subject|6|||
147460316|NCT00546364|531846978|FG002|Overall Study|Withdrawal by Subject|3|||
147460317|NCT00546364|531846976|FG000|Overall Study|Prior taxotere|1|||
147460318|NCT00546364|531846977|FG001|Overall Study|Prior taxotere|0|||
147460319|NCT00546364|531846978|FG002|Overall Study|Prior taxotere|0|||
147460320|NCT00546364|531846976|FG000|Overall Study|Mixed response|1|||
147460321|NCT00546364|531846977|FG001|Overall Study|Mixed response|0|||
147460322|NCT00546364|531846978|FG002|Overall Study|Mixed response|0|||
147460323|NCT00546364|531846976|FG000|Overall Study|Palliative treatment|1|||
147460324|NCT00546364|531846977|FG001|Overall Study|Palliative treatment|0|||
147460325|NCT00546364|531846978|FG002|Overall Study|Palliative treatment|1|||
147460326|NCT00546364|531846976|FG000|Overall Study|Target lesions resected|1|||
147460327|NCT00546364|531846977|FG001|Overall Study|Target lesions resected|0|||
147460328|NCT00546364|531846978|FG002|Overall Study|Target lesions resected|0|||
147460329|NCT00546364|531846976|FG000|Overall Study|Physician Decision|0|||
147460330|NCT00546364|531846977|FG001|Overall Study|Physician Decision|0|||
147460331|NCT00546364|531846978|FG002|Overall Study|Physician Decision|1|||
147460332|NCT00546364|531846976|FG000|Overall Study|Sponsor decision|0|||
147460333|NCT00546364|531846977|FG001|Overall Study|Sponsor decision|0|||
147460334|NCT00546364|531846978|FG002|Overall Study|Sponsor decision|1|||
147460335|NCT02090855|531846979|FG000|Overall Study|no evaluable Standard of Truth results|2|||
147460336|NCT00388947|531846981|FG000|Overall Study|Protocol Violation|47|||
147460337|NCT04187092|531846982|FG000|Overall Study|Lost to Follow-up|1|||
147460338|NCT04187092|531846983|FG001|Overall Study|Lost to Follow-up|1|||
147665079|NCT00192114|532598005|FG000|Overall Study|Clinical Progression|2|||
147460339|NCT04187092|531846982|FG000|Overall Study|Withdrawal by Subject|1|||
147460340|NCT04187092|531846983|FG001|Overall Study|Withdrawal by Subject|1|||
147460341|NCT04187092|531846982|FG000|Overall Study|Adverse Event|0|||
147460342|NCT04187092|531846983|FG001|Overall Study|Adverse Event|1|||
147394561|NCT04414397|531609440|FG000|Control Period|Lost to Follow-up|0|||
147394562|NCT04414397|531609441|FG001|Control Period|Lost to Follow-up|4|||
147394563|NCT04414397|531609440|FG000|Control Period|Protocol deviation|0|||
147394564|NCT04414397|531609441|FG001|Control Period|Protocol deviation|1|||
147394565|NCT04414397|531609440|FG000|Post-Control Period|Withdrawal by Subject|3|||
147394566|NCT04414397|531609441|FG001|Post-Control Period|Withdrawal by Subject|6|||
147394567|NCT04414397|531609440|FG000|Post-Control Period|Lost to Follow-up|4|||
147394568|NCT04414397|531609441|FG001|Post-Control Period|Lost to Follow-up|9|||
147394569|NCT04414397|531609440|FG000|Maintenance Treatment Period|Withdrawal by Subject|0|||
147394570|NCT04414397|531609441|FG001|Maintenance Treatment Period|Withdrawal by Subject|2|||
147394571|NCT04414397|531609440|FG000|Maintenance Treatment Period|Lost to Follow-up|0|||
147394572|NCT04414397|531609441|FG001|Maintenance Treatment Period|Lost to Follow-up|3|||
147394573|NCT03640754|531609442|FG000|Overall Study|Withdrawal by Subject|1|||
147394574|NCT03640754|531609443|FG001|Overall Study|Withdrawal by Subject|0|||
147394575|NCT03640754|531609442|FG000|Overall Study|Lost to Follow-up|0|||
147394576|NCT03640754|531609443|FG001|Overall Study|Lost to Follow-up|1|||
147394577|NCT01204775|531609448|FG000|Overall Study|Poor/non-compliance|0|||
147394578|NCT01204775|531609449|FG001|Overall Study|Poor/non-compliance|1|||
147394579|NCT01204775|531609448|FG000|Overall Study|Withdrawal by Subject|1|||
147394580|NCT01204775|531609449|FG001|Overall Study|Withdrawal by Subject|0|||
147394581|NCT00276016|531609450|FG000|Intervention 1|Withdrawal by Subject|0|||
147394582|NCT00276016|531609451|FG001|Intervention 1|Withdrawal by Subject|1|||
147394583|NCT00276016|531609452|FG002|Intervention 1|Withdrawal by Subject|0|||
147394584|NCT00276016|531609453|FG003|Intervention 1|Withdrawal by Subject|0|||
147394585|NCT00276016|531609454|FG004|Intervention 1|Withdrawal by Subject|0|||
147394586|NCT00276016|531609455|FG005|Intervention 1|Withdrawal by Subject|0|||
147394587|NCT01679613|531609456|FG000|Overall Study|other than stated above|0|||
147394588|NCT01679613|531609457|FG001|Overall Study|other than stated above|1|||
147394589|NCT01679613|531609458|FG002|Overall Study|other than stated above|2|||
147394590|NCT01679613|531609459|FG003|Overall Study|other than stated above|2|||
147394591|NCT01374971|531609460|FG000|Overall Study|Withdrawal by Subject|1|||
147394592|NCT00509925|531609462|FG000|Overall Study|Personal reasons|0|||
147394593|NCT00509925|531609463|FG001|Overall Study|Personal reasons|1|||
147394594|NCT00951171|531609464|FG000|Overall Study|Adverse Event|2|||
147394595|NCT00951171|531609465|FG001|Overall Study|Adverse Event|0|||
147394596|NCT00919061|531609466|FG000|Overall Study|Adverse Event|1|||
147394597|NCT00919061|531609466|FG000|Overall Study|Withdrawal by Subject|1|||
147394598|NCT00092521|531611398|FG000|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|6|||
147394599|NCT00092521|531611399|FG001|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|0|||
147394600|NCT00092521|531611400|FG002|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|7|||
147394601|NCT00092521|531611401|FG003|Vaccination (Day 1 Through Month 7)|Randomized Not Vaccinated|0|||
147394602|NCT00092521|531611398|FG000|Vaccination (Day 1 Through Month 7)|Adverse Event|1|||
147394603|NCT00092521|531611399|FG001|Vaccination (Day 1 Through Month 7)|Adverse Event|0|||
147394604|NCT00092521|531611400|FG002|Vaccination (Day 1 Through Month 7)|Adverse Event|7|||
147394605|NCT00092521|531611401|FG003|Vaccination (Day 1 Through Month 7)|Adverse Event|0|||
147394606|NCT00092521|531611398|FG000|Vaccination (Day 1 Through Month 7)|Death|0|||
147394607|NCT00092521|531611399|FG001|Vaccination (Day 1 Through Month 7)|Death|0|||
147394608|NCT00092521|531611400|FG002|Vaccination (Day 1 Through Month 7)|Death|1|||
147394609|NCT00092521|531611401|FG003|Vaccination (Day 1 Through Month 7)|Death|0|||
147394610|NCT00092521|531611398|FG000|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|51|||
147394611|NCT00092521|531611399|FG001|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|6|||
147394612|NCT00092521|531611400|FG002|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|44|||
147394613|NCT00092521|531611401|FG003|Vaccination (Day 1 Through Month 7)|Lost to Follow-up|0|||
147394614|NCT00092521|531611398|FG000|Vaccination (Day 1 Through Month 7)|Pregnancy|5|||
147394615|NCT00092521|531611399|FG001|Vaccination (Day 1 Through Month 7)|Pregnancy|0|||
147394616|NCT00092521|531611400|FG002|Vaccination (Day 1 Through Month 7)|Pregnancy|7|||
147394617|NCT00092521|531611401|FG003|Vaccination (Day 1 Through Month 7)|Pregnancy|0|||
147394618|NCT00092521|531611398|FG000|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|59|||
147394619|NCT00092521|531611399|FG001|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|7|||
147394620|NCT00092521|531611400|FG002|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|62|||
147394621|NCT00092521|531611401|FG003|Vaccination (Day 1 Through Month 7)|Withdrawal by Subject|0|||
147394622|NCT00092521|531611398|FG000|Vaccination (Day 1 Through Month 7)|Moved|14|||
147394623|NCT00092521|531611399|FG001|Vaccination (Day 1 Through Month 7)|Moved|1|||
147394624|NCT00092521|531611400|FG002|Vaccination (Day 1 Through Month 7)|Moved|18|||
147394625|NCT00092521|531611401|FG003|Vaccination (Day 1 Through Month 7)|Moved|0|||
147394626|NCT00092521|531611398|FG000|Vaccination (Day 1 Through Month 7)|Unblinded|2|||
147394627|NCT00092521|531611399|FG001|Vaccination (Day 1 Through Month 7)|Unblinded|0|||
147394628|NCT00092521|531611400|FG002|Vaccination (Day 1 Through Month 7)|Unblinded|0|||
147394629|NCT00092521|531611401|FG003|Vaccination (Day 1 Through Month 7)|Unblinded|0|||
147394630|NCT00092521|531611398|FG000|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|2|||
147394631|NCT00092521|531611399|FG001|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|0|||
147394632|NCT00092521|531611400|FG002|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|0|||
147615306|NCT03449446|532406698|FG003|Overall Study|Investigator's Discretion|2|||
147615307|NCT03449446|532406699|FG004|Overall Study|Investigator's Discretion|0|||
147615308|NCT03449446|532406700|FG005|Overall Study|Investigator's Discretion|0|||
147615309|NCT03449446|532406701|FG006|Overall Study|Investigator's Discretion|0|||
147615310|NCT03449446|532406695|FG000|Overall Study|Non Compliance with Study Drug|1|||
147615311|NCT03449446|532406696|FG001|Overall Study|Non Compliance with Study Drug|0|||
147615312|NCT03449446|532406697|FG002|Overall Study|Non Compliance with Study Drug|0|||
147615313|NCT03449446|532406698|FG003|Overall Study|Non Compliance with Study Drug|0|||
147615314|NCT03449446|532406699|FG004|Overall Study|Non Compliance with Study Drug|0|||
147665080|NCT00192114|532598005|FG000|Overall Study|Death|1|||
147394633|NCT00092521|531611401|FG003|Vaccination (Day 1 Through Month 7)|New Medical History (Not AE)|0|||
147394634|NCT00092521|531611398|FG000|Follow-Up (After Month 7)|Subjects Continuing|34|||
147394635|NCT00092521|531611399|FG001|Follow-Up (After Month 7)|Subjects Continuing|4|||
147394636|NCT00092521|531611400|FG002|Follow-Up (After Month 7)|Subjects Continuing|35|||
147394637|NCT00092521|531611401|FG003|Follow-Up (After Month 7)|Subjects Continuing|0|||
147394638|NCT00092521|531611398|FG000|Follow-Up (After Month 7)|Subjects in Extension|13|||
147394639|NCT00092521|531611399|FG001|Follow-Up (After Month 7)|Subjects in Extension|109|||
147394640|NCT00092521|531611400|FG002|Follow-Up (After Month 7)|Subjects in Extension|412|||
147394641|NCT00092521|531611401|FG003|Follow-Up (After Month 7)|Subjects in Extension|0|||
147394642|NCT00092521|531611398|FG000|Follow-Up (After Month 7)|Adverse Event|1|||
147394643|NCT00092521|531611399|FG001|Follow-Up (After Month 7)|Adverse Event|0|||
147394644|NCT00092521|531611400|FG002|Follow-Up (After Month 7)|Adverse Event|0|||
147394645|NCT00092521|531611401|FG003|Follow-Up (After Month 7)|Adverse Event|0|||
147394646|NCT00092521|531611398|FG000|Follow-Up (After Month 7)|Death|2|||
147394647|NCT00092521|531611399|FG001|Follow-Up (After Month 7)|Death|0|||
147394648|NCT00092521|531611400|FG002|Follow-Up (After Month 7)|Death|1|||
147394649|NCT00092521|531611401|FG003|Follow-Up (After Month 7)|Death|0|||
147394650|NCT00092521|531611398|FG000|Follow-Up (After Month 7)|Lost to Follow-up|113|||
147394651|NCT00092521|531611399|FG001|Follow-Up (After Month 7)|Lost to Follow-up|14|||
147394652|NCT00092521|531611400|FG002|Follow-Up (After Month 7)|Lost to Follow-up|108|||
147394653|NCT00092521|531611401|FG003|Follow-Up (After Month 7)|Lost to Follow-up|0|||
147394654|NCT00092521|531611398|FG000|Follow-Up (After Month 7)|Protocol Violation|1|||
147394655|NCT00092521|531611399|FG001|Follow-Up (After Month 7)|Protocol Violation|1|||
147394656|NCT00092521|531611400|FG002|Follow-Up (After Month 7)|Protocol Violation|5|||
147394657|NCT00092521|531611401|FG003|Follow-Up (After Month 7)|Protocol Violation|0|||
147394658|NCT00092521|531611398|FG000|Follow-Up (After Month 7)|Withdrawal by Subject|40|||
147394659|NCT00092521|531611399|FG001|Follow-Up (After Month 7)|Withdrawal by Subject|6|||
147394660|NCT00092521|531611400|FG002|Follow-Up (After Month 7)|Withdrawal by Subject|51|||
147394661|NCT00092521|531611401|FG003|Follow-Up (After Month 7)|Withdrawal by Subject|0|||
147394662|NCT00092521|531611398|FG000|Follow-Up (After Month 7)|Moved|32|||
147394663|NCT00092521|531611399|FG001|Follow-Up (After Month 7)|Moved|2|||
147394664|NCT00092521|531611400|FG002|Follow-Up (After Month 7)|Moved|28|||
147394665|NCT00092521|531611401|FG003|Follow-Up (After Month 7)|Moved|0|||
147394666|NCT00092521|531611398|FG000|Follow-Up (After Month 7)|Site Terminated|3|||
147394667|NCT00092521|531611399|FG001|Follow-Up (After Month 7)|Site Terminated|0|||
147394668|NCT00092521|531611400|FG002|Follow-Up (After Month 7)|Site Terminated|3|||
147394669|NCT00092521|531611401|FG003|Follow-Up (After Month 7)|Site Terminated|0|||
147394670|NCT00092521|531611398|FG000|Follow-Up (After Month 7)|Travel|2|||
147394671|NCT00092521|531611399|FG001|Follow-Up (After Month 7)|Travel|0|||
147394672|NCT00092521|531611400|FG002|Follow-Up (After Month 7)|Travel|0|||
147394673|NCT00092521|531611401|FG003|Follow-Up (After Month 7)|Travel|0|||
147394674|NCT00092521|531611398|FG000|Follow-Up (After Month 7)|Visits Compressed|5|||
147394675|NCT00092521|531611399|FG001|Follow-Up (After Month 7)|Visits Compressed|0|||
147394676|NCT00092521|531611400|FG002|Follow-Up (After Month 7)|Visits Compressed|5|||
147394677|NCT00092521|531611401|FG003|Follow-Up (After Month 7)|Visits Compressed|0|||
147394678|NCT00092521|531611398|FG000|Extension Study (Group 4)|Excluded ineligible for extension|0|||
147394679|NCT00092521|531611399|FG001|Extension Study (Group 4)|Excluded ineligible for extension|0|||
147394680|NCT00092521|531611400|FG002|Extension Study (Group 4)|Excluded ineligible for extension|0|||
147394681|NCT00092521|531611401|FG003|Extension Study (Group 4)|Excluded ineligible for extension|23|||
147394682|NCT00092521|531611398|FG000|Extension Study (Group 4)|Adverse Event|0|||
147394683|NCT00092521|531611399|FG001|Extension Study (Group 4)|Adverse Event|0|||
147394684|NCT00092521|531611400|FG002|Extension Study (Group 4)|Adverse Event|0|||
147394685|NCT00092521|531611401|FG003|Extension Study (Group 4)|Adverse Event|2|||
147394686|NCT00092521|531611398|FG000|Extension Study (Group 4)|Lost to Follow-up|0|||
147394687|NCT00092521|531611399|FG001|Extension Study (Group 4)|Lost to Follow-up|0|||
147394688|NCT00092521|531611400|FG002|Extension Study (Group 4)|Lost to Follow-up|0|||
147394689|NCT00092521|531611401|FG003|Extension Study (Group 4)|Lost to Follow-up|87|||
147394690|NCT00092521|531611398|FG000|Extension Study (Group 4)|Pregnancy|0|||
147394691|NCT00092521|531611399|FG001|Extension Study (Group 4)|Pregnancy|0|||
147394692|NCT00092521|531611400|FG002|Extension Study (Group 4)|Pregnancy|0|||
147615315|NCT03449446|532406700|FG005|Overall Study|Non Compliance with Study Drug|0|||
147615316|NCT03449446|532406701|FG006|Overall Study|Non Compliance with Study Drug|0|||
147665081|NCT00113607|532598006|FG000|Overall Study|Adverse Event|40|||
147665082|NCT00113607|532598007|FG001|Overall Study|Adverse Event|71|||
147665083|NCT00113607|532598006|FG000|Overall Study|Death|8|||
147665084|NCT00113607|532598007|FG001|Overall Study|Death|8|||
147665085|NCT00113607|532598006|FG000|Overall Study|Withdrawal by Subject|50|||
147665086|NCT00113607|532598007|FG001|Overall Study|Withdrawal by Subject|58|||
147665087|NCT00113607|532598006|FG000|Overall Study|Lost to Follow-up|0|||
147394693|NCT00092521|531611401|FG003|Extension Study (Group 4)|Pregnancy|4|||
147394694|NCT00092521|531611398|FG000|Extension Study (Group 4)|Protocol Violation|0|||
147394695|NCT00092521|531611399|FG001|Extension Study (Group 4)|Protocol Violation|0|||
147394696|NCT00092521|531611400|FG002|Extension Study (Group 4)|Protocol Violation|0|||
147394697|NCT00092521|531611401|FG003|Extension Study (Group 4)|Protocol Violation|2|||
147394698|NCT00092521|531611398|FG000|Extension Study (Group 4)|Withdrawal by Subject|0|||
147394699|NCT00092521|531611399|FG001|Extension Study (Group 4)|Withdrawal by Subject|0|||
147394700|NCT00092521|531611400|FG002|Extension Study (Group 4)|Withdrawal by Subject|0|||
147394701|NCT00092521|531611401|FG003|Extension Study (Group 4)|Withdrawal by Subject|46|||
147394702|NCT00092521|531611398|FG000|Extension Study (Group 4)|Moved|0|||
147394703|NCT00092521|531611399|FG001|Extension Study (Group 4)|Moved|0|||
147394704|NCT00092521|531611400|FG002|Extension Study (Group 4)|Moved|0|||
147394705|NCT00092521|531611401|FG003|Extension Study (Group 4)|Moved|16|||
147394706|NCT00092521|531611398|FG000|Extension Study (Group 4)|Site Terminated|0|||
147394707|NCT00092521|531611399|FG001|Extension Study (Group 4)|Site Terminated|0|||
147394708|NCT00092521|531611400|FG002|Extension Study (Group 4)|Site Terminated|0|||
147394709|NCT00092521|531611401|FG003|Extension Study (Group 4)|Site Terminated|4|||
147394710|NCT00092521|531611398|FG000|Extension Study (Group 4)|Unable/unwilling to return|0|||
147394711|NCT00092521|531611399|FG001|Extension Study (Group 4)|Unable/unwilling to return|0|||
147394712|NCT00092521|531611400|FG002|Extension Study (Group 4)|Unable/unwilling to return|0|||
147394713|NCT00092521|531611401|FG003|Extension Study (Group 4)|Unable/unwilling to return|25|||
147394714|NCT01878383|531611402|FG000|Overall Study|Lost to Follow-up|0|||
147394715|NCT01878383|531611403|FG001|Overall Study|Lost to Follow-up|1499|||
147394716|NCT03464383|531611404|FG000|Overall Study|Lost to Follow-up|1|||
147394717|NCT03464383|531611405|FG001|Overall Study|Lost to Follow-up|0|||
147394718|NCT03464383|531611406|FG002|Overall Study|Lost to Follow-up|0|||
147394719|NCT03464383|531611404|FG000|Overall Study|Withdrawal by Subject|0|||
147394720|NCT03464383|531611405|FG001|Overall Study|Withdrawal by Subject|1|||
147394721|NCT03464383|531611406|FG002|Overall Study|Withdrawal by Subject|0|||
147394722|NCT03475056|531611407|FG000|Overall Study|Lost to Follow-up|0|||
147394723|NCT03475056|531611408|FG001|Overall Study|Lost to Follow-up|1|||
147394724|NCT03475056|531611407|FG000|Overall Study|Moved from Area|0|||
147394725|NCT03475056|531611408|FG001|Overall Study|Moved from Area|2|||
147394726|NCT00113269|531611409|FG000|Overall Study|Not transplanted, donor issues|4|||
147394727|NCT00113269|531611410|FG001|Overall Study|Not transplanted, donor issues|0|||
147394728|NCT00113269|531611411|FG002|Overall Study|Not transplanted, donor issues|2|||
147394729|NCT00113269|531611412|FG003|Overall Study|Not transplanted, donor issues|2|||
147394730|NCT00113269|531611409|FG000|Overall Study|Not transplanted, recipient issues|2|||
147394731|NCT00113269|531611410|FG001|Overall Study|Not transplanted, recipient issues|1|||
147394732|NCT00113269|531611411|FG002|Overall Study|Not transplanted, recipient issues|7|||
147394733|NCT00113269|531611412|FG003|Overall Study|Not transplanted, recipient issues|4|||
147394734|NCT00113269|531611409|FG000|Overall Study|Early graft loss, technical|0|||
147394735|NCT00113269|531611410|FG001|Overall Study|Early graft loss, technical|0|||
147394736|NCT00113269|531611411|FG002|Overall Study|Early graft loss, technical|2|||
147394737|NCT00113269|531611412|FG003|Overall Study|Early graft loss, technical|0|||
147394738|NCT00113269|531611409|FG000|Overall Study|Death in operating room|0|||
147394739|NCT00113269|531611410|FG001|Overall Study|Death in operating room|0|||
147394740|NCT00113269|531611411|FG002|Overall Study|Death in operating room|0|||
147394741|NCT00113269|531611412|FG003|Overall Study|Death in operating room|1|||
147394742|NCT00113269|531611409|FG000|Overall Study|Did not meet eligibility - pre-treatment|0|||
147394743|NCT00113269|531611410|FG001|Overall Study|Did not meet eligibility - pre-treatment|0|||
147394744|NCT00113269|531611411|FG002|Overall Study|Did not meet eligibility - pre-treatment|0|||
147394745|NCT00113269|531611412|FG003|Overall Study|Did not meet eligibility - pre-treatment|2|||
147394746|NCT00113269|531611409|FG000|Overall Study|Adverse Event|2|||
147394747|NCT00113269|531611410|FG001|Overall Study|Adverse Event|7|||
147394748|NCT00113269|531611411|FG002|Overall Study|Adverse Event|11|||
147394749|NCT00113269|531611412|FG003|Overall Study|Adverse Event|7|||
147394750|NCT00113269|531611409|FG000|Overall Study|Withdrawal by Subject|4|||
147394751|NCT00113269|531611410|FG001|Overall Study|Withdrawal by Subject|3|||
147394752|NCT00113269|531611411|FG002|Overall Study|Withdrawal by Subject|4|||
147394753|NCT00113269|531611412|FG003|Overall Study|Withdrawal by Subject|2|||
147394754|NCT00113269|531611409|FG000|Overall Study|Graft loss|6|||
147394755|NCT00113269|531611410|FG001|Overall Study|Graft loss|6|||
147394756|NCT00113269|531611411|FG002|Overall Study|Graft loss|4|||
147394757|NCT00113269|531611412|FG003|Overall Study|Graft loss|9|||
147394758|NCT00113269|531611409|FG000|Overall Study|Protocol Violation|1|||
147394759|NCT00113269|531611410|FG001|Overall Study|Protocol Violation|0|||
147460343|NCT00880750|531846990|FG000|First Intervention|Adverse Event|1|||
147665088|NCT00113607|532598007|FG001|Overall Study|Lost to Follow-up|2|||
147460344|NCT00880750|531846991|FG001|First Intervention|Adverse Event|0|||
147460345|NCT00880750|531846990|FG000|First Intervention|Unable to collect urine|4|||
147665089|NCT00113607|532598006|FG000|Overall Study|Disease Progression|180|||
147665090|NCT00113607|532598007|FG001|Overall Study|Disease Progression|142|||
147665091|NCT00113607|532598006|FG000|Overall Study|Complete Response (Confirmed)|14|||
147665092|NCT00113607|532598007|FG001|Overall Study|Complete Response (Confirmed)|24|||
147665093|NCT00113607|532598006|FG000|Overall Study|Other|43|||
147665094|NCT00113607|532598007|FG001|Overall Study|Other|32|||
147665095|NCT00749398|532598009|FG000|Overall Study|Lack of Efficacy|7|||
147665096|NCT00749398|532598009|FG000|Overall Study|Adverse Event|4|||
147665097|NCT00749398|532598009|FG000|Overall Study|Serious adverse event|11|||
147665098|NCT00749398|532598009|FG000|Overall Study|Withdrawal by Subject|17|||
147665099|NCT00749398|532598009|FG000|Overall Study|Lost to Follow-up|11|||
147665100|NCT00749398|532598009|FG000|Overall Study|Reason not specified|2|||
147665101|NCT00749398|532598009|FG000|Overall Study|Unknown reason|1|||
147665102|NCT02849080|532598018|FG000|Main Phase: 0 - 52 Weeks|Lost to Follow-up|7|||
147665103|NCT02849080|532598019|FG001|Main Phase: 0 - 52 Weeks|Lost to Follow-up|4|||
147665104|NCT02849080|532598020|FG002|Main Phase: 0 - 52 Weeks|Lost to Follow-up|0|||
147665105|NCT02849080|532598021|FG003|Main Phase: 0 - 52 Weeks|Lost to Follow-up|0|||
147665106|NCT02849080|532598018|FG000|Main Phase: 0 - 52 Weeks|Withdrawal by Subject|5|||
147394760|NCT00113269|531611411|FG002|Overall Study|Protocol Violation|4|||
147665107|NCT02849080|532598019|FG001|Main Phase: 0 - 52 Weeks|Withdrawal by Subject|1|||
147665108|NCT02849080|532598020|FG002|Main Phase: 0 - 52 Weeks|Withdrawal by Subject|0|||
147665109|NCT02849080|532598021|FG003|Main Phase: 0 - 52 Weeks|Withdrawal by Subject|0|||
147665110|NCT02849080|532598018|FG000|Main Phase: 0 - 52 Weeks|Death|0|||
147665111|NCT02849080|532598019|FG001|Main Phase: 0 - 52 Weeks|Death|2|||
147665112|NCT02849080|532598020|FG002|Main Phase: 0 - 52 Weeks|Death|0|||
147665113|NCT02849080|532598021|FG003|Main Phase: 0 - 52 Weeks|Death|0|||
147665114|NCT02849080|532598018|FG000|Extension Phase: 53 - 104 Weeks|Lost to Follow-up|2|||
147665115|NCT02849080|532598019|FG001|Extension Phase: 53 - 104 Weeks|Lost to Follow-up|0|||
147665116|NCT02849080|532598020|FG002|Extension Phase: 53 - 104 Weeks|Lost to Follow-up|0|||
147665117|NCT02849080|532598021|FG003|Extension Phase: 53 - 104 Weeks|Lost to Follow-up|0|||
147394761|NCT00113269|531611412|FG003|Overall Study|Protocol Violation|2|||
147394762|NCT00113269|531611409|FG000|Overall Study|Lost to Follow-up|2|||
147394763|NCT00113269|531611410|FG001|Overall Study|Lost to Follow-up|3|||
147394764|NCT00113269|531611411|FG002|Overall Study|Lost to Follow-up|6|||
147394765|NCT00113269|531611412|FG003|Overall Study|Lost to Follow-up|3|||
147394766|NCT00113269|531611409|FG000|Overall Study|Sponsor elected to discontinue patient|1|||
147394767|NCT00113269|531611410|FG001|Overall Study|Sponsor elected to discontinue patient|0|||
147394768|NCT00113269|531611411|FG002|Overall Study|Sponsor elected to discontinue patient|0|||
147394769|NCT00113269|531611412|FG003|Overall Study|Sponsor elected to discontinue patient|1|||
147394770|NCT00113269|531611409|FG000|Overall Study|Discontinued due to rejection|0|||
147394771|NCT00113269|531611410|FG001|Overall Study|Discontinued due to rejection|0|||
147394772|NCT00113269|531611411|FG002|Overall Study|Discontinued due to rejection|1|||
147394773|NCT00113269|531611412|FG003|Overall Study|Discontinued due to rejection|0|||
147394774|NCT00113269|531611409|FG000|Overall Study|Moved|0|||
147394775|NCT00113269|531611410|FG001|Overall Study|Moved|1|||
147394776|NCT00113269|531611411|FG002|Overall Study|Moved|0|||
147394777|NCT00113269|531611412|FG003|Overall Study|Moved|3|||
147394778|NCT00113269|531611409|FG000|Overall Study|Received pancreas transplant|0|||
147394779|NCT00113269|531611410|FG001|Overall Study|Received pancreas transplant|0|||
147394780|NCT00113269|531611411|FG002|Overall Study|Received pancreas transplant|0|||
147394781|NCT00113269|531611412|FG003|Overall Study|Received pancreas transplant|2|||
147394782|NCT00113269|531611409|FG000|Overall Study|Withdrew consent, Prednisone initiated|0|||
147394783|NCT00113269|531611410|FG001|Overall Study|Withdrew consent, Prednisone initiated|0|||
147394784|NCT00113269|531611411|FG002|Overall Study|Withdrew consent, Prednisone initiated|0|||
147394785|NCT00113269|531611412|FG003|Overall Study|Withdrew consent, Prednisone initiated|1|||
147394786|NCT00113269|531611409|FG000|Overall Study|Did not meet eligibility criteria|1|||
147394787|NCT00113269|531611410|FG001|Overall Study|Did not meet eligibility criteria|0|||
147394788|NCT00113269|531611411|FG002|Overall Study|Did not meet eligibility criteria|0|||
147394789|NCT00113269|531611412|FG003|Overall Study|Did not meet eligibility criteria|1|||
147394790|NCT00113269|531611409|FG000|Overall Study|Unable to return for follow up|2|||
147394791|NCT00113269|531611410|FG001|Overall Study|Unable to return for follow up|1|||
147394792|NCT00113269|531611411|FG002|Overall Study|Unable to return for follow up|0|||
147394793|NCT00113269|531611412|FG003|Overall Study|Unable to return for follow up|0|||
147394794|NCT01904136|531611416|FG000|Overall Study|Physician Decision|0|||
147394795|NCT01904136|531611417|FG001|Overall Study|Physician Decision|0|||
147460346|NCT00880750|531846991|FG001|First Intervention|Unable to collect urine|0|||
147665118|NCT02849080|532598018|FG000|Extension Phase: 53 - 104 Weeks|Other|0|||
147665119|NCT02849080|532598019|FG001|Extension Phase: 53 - 104 Weeks|Other|0|||
147665120|NCT02849080|532598020|FG002|Extension Phase: 53 - 104 Weeks|Other|1|||
147665121|NCT02849080|532598021|FG003|Extension Phase: 53 - 104 Weeks|Other|0|||
147665122|NCT02849080|532598018|FG000|Extension Phase: 53 - 104 Weeks|Withdrawal by Subject|1|||
147665123|NCT02849080|532598019|FG001|Extension Phase: 53 - 104 Weeks|Withdrawal by Subject|0|||
147394796|NCT01904136|531611418|FG002|Overall Study|Physician Decision|0|||
147394797|NCT01904136|531611419|FG003|Overall Study|Physician Decision|0|||
147394798|NCT01904136|531611420|FG004|Overall Study|Physician Decision|0|||
147394799|NCT01904136|531611421|FG005|Overall Study|Physician Decision|1|||
147394800|NCT01904136|531611422|FG006|Overall Study|Physician Decision|0|||
147394801|NCT01904136|531611423|FG007|Overall Study|Physician Decision|0|||
147394802|NCT01904136|531611424|FG008|Overall Study|Physician Decision|0|||
147394803|NCT01947517|531611425|FG000|Overall Study|Withdrawal by Subject|1|||
147394804|NCT01947517|531611426|FG001|Overall Study|Withdrawal by Subject|1|||
147394805|NCT05446714|531611427|FG000|Overall Study|Lost to Follow-up|1|||
147394806|NCT05446714|531611428|FG001|Overall Study|Lost to Follow-up|3|||
147394807|NCT05446714|531611429|FG002|Overall Study|Lost to Follow-up|2|||
147394808|NCT05446714|531611427|FG000|Overall Study|Protocol Violation|2|||
147394809|NCT05446714|531611428|FG001|Overall Study|Protocol Violation|0|||
147394810|NCT05446714|531611429|FG002|Overall Study|Protocol Violation|0|||
147394811|NCT02418845|531611435|FG000|Overall Study|Lost to Follow-up|7|||
147394812|NCT02418845|531611436|FG001|Overall Study|Lost to Follow-up|2|||
147394813|NCT02418845|531611435|FG000|Overall Study|Lack of Efficacy|0|||
147394814|NCT02418845|531611436|FG001|Overall Study|Lack of Efficacy|3|||
147394815|NCT02418845|531611435|FG000|Overall Study|Physician Decision|5|||
147394816|NCT02418845|531611436|FG001|Overall Study|Physician Decision|5|||
147394817|NCT02418845|531611435|FG000|Overall Study|Protocol Violation|1|||
147394818|NCT02418845|531611436|FG001|Overall Study|Protocol Violation|0|||
147394819|NCT02418845|531611435|FG000|Overall Study|Withdrawal by Subject|3|||
147394820|NCT02418845|531611436|FG001|Overall Study|Withdrawal by Subject|2|||
147394821|NCT00460564|531611437|FG000|Double-Blind Phase (12 Weeks)|Adverse Event|3|||
147394822|NCT00460564|531611438|FG001|Double-Blind Phase (12 Weeks)|Adverse Event|1|||
147394823|NCT00460564|531611439|FG002|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
147394824|NCT00460564|531611440|FG003|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
147394825|NCT00460564|531611441|FG004|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
147394826|NCT00460564|531611442|FG005|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
147394827|NCT00460564|531611443|FG006|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
147394828|NCT00460564|531611444|FG007|Double-Blind Phase (12 Weeks)|Adverse Event|0|||
147394829|NCT00460564|531611437|FG000|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|1|||
147394830|NCT00460564|531611438|FG001|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
147394831|NCT00460564|531611439|FG002|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
147394832|NCT00460564|531611440|FG003|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
147394833|NCT00460564|531611441|FG004|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
147394834|NCT00460564|531611442|FG005|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
147394835|NCT00460564|531611443|FG006|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
147394836|NCT00460564|531611444|FG007|Double-Blind Phase (12 Weeks)|Withdrawal by Subject|0|||
147394837|NCT00460564|531611437|FG000|Open-Label Phase (36 Weeks)|Adverse Event|0|||
147394838|NCT00460564|531611438|FG001|Open-Label Phase (36 Weeks)|Adverse Event|0|||
147394839|NCT00460564|531611439|FG002|Open-Label Phase (36 Weeks)|Adverse Event|0|||
147394840|NCT00460564|531611440|FG003|Open-Label Phase (36 Weeks)|Adverse Event|0|||
147394841|NCT00460564|531611441|FG004|Open-Label Phase (36 Weeks)|Adverse Event|3|||
147394842|NCT00460564|531611442|FG005|Open-Label Phase (36 Weeks)|Adverse Event|5|||
147394843|NCT00460564|531611443|FG006|Open-Label Phase (36 Weeks)|Adverse Event|2|||
147394844|NCT00460564|531611444|FG007|Open-Label Phase (36 Weeks)|Adverse Event|0|||
147394845|NCT00460564|531611437|FG000|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
147394846|NCT00460564|531611438|FG001|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
147394847|NCT00460564|531611439|FG002|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
147394848|NCT00460564|531611440|FG003|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
147394849|NCT00460564|531611441|FG004|Open-Label Phase (36 Weeks)|Withdrawal by Subject|5|||
147394850|NCT00460564|531611442|FG005|Open-Label Phase (36 Weeks)|Withdrawal by Subject|1|||
147394851|NCT00460564|531611443|FG006|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
147394852|NCT00460564|531611444|FG007|Open-Label Phase (36 Weeks)|Withdrawal by Subject|0|||
147394853|NCT00460564|531611437|FG000|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
147394854|NCT00460564|531611438|FG001|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
147394855|NCT00460564|531611439|FG002|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
147394856|NCT00460564|531611440|FG003|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
147394857|NCT00460564|531611441|FG004|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|1|||
147394858|NCT00460564|531611442|FG005|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
147394859|NCT00460564|531611443|FG006|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
147394860|NCT00460564|531611444|FG007|Open-Label Phase (36 Weeks)|Concentrate on Treatment of Diabetes|0|||
147394861|NCT00943618|531611447|FG000|Overall Study|Lost to Follow-up|38|||
147394862|NCT00943618|531611448|FG001|Overall Study|Lost to Follow-up|48|||
147394863|NCT00943618|531611449|FG002|Overall Study|Lost to Follow-up|20|||
147394864|NCT00943618|531611447|FG000|Overall Study|Discontinued Medication|17|||
147394865|NCT00943618|531611448|FG001|Overall Study|Discontinued Medication|29|||
147394866|NCT00943618|531611449|FG002|Overall Study|Discontinued Medication|11|||
147394867|NCT01990313|531611454|FG000|Overall Study|Lost to Follow-up|1|||
147394868|NCT02412111|531611455|FG000|Ivacaftor Run-in Period (4 Weeks)|Did not meet eligibility criteria|1|||
147394869|NCT02412111|531611456|FG001|Ivacaftor Run-in Period (4 Weeks)|Did not meet eligibility criteria|0|||
147394870|NCT02412111|531611457|FG002|Ivacaftor Run-in Period (4 Weeks)|Did not meet eligibility criteria|0|||
147394871|NCT02412111|531611455|FG000|Ivacaftor Run-in Period (4 Weeks)|Participants refused further dosing|2|||
147394872|NCT02412111|531611456|FG001|Ivacaftor Run-in Period (4 Weeks)|Participants refused further dosing|0|||
147394873|NCT02412111|531611457|FG002|Ivacaftor Run-in Period (4 Weeks)|Participants refused further dosing|0|||
147394874|NCT02412111|531611455|FG000|Active Comparator Period (8 Weeks)|Adverse Event|0|||
147394875|NCT02412111|531611456|FG001|Active Comparator Period (8 Weeks)|Adverse Event|0|||
147394876|NCT02412111|531611457|FG002|Active Comparator Period (8 Weeks)|Adverse Event|2|||
147394877|NCT02412111|531611455|FG000|Active Comparator Period (8 Weeks)|Participants refused further dosing|0|||
147394878|NCT02412111|531611456|FG001|Active Comparator Period (8 Weeks)|Participants refused further dosing|0|||
147394879|NCT02412111|531611457|FG002|Active Comparator Period (8 Weeks)|Participants refused further dosing|1|||
147394880|NCT02412111|531611455|FG000|Active Comparator Period (8 Weeks)|Lost to Follow-up|0|||
147394881|NCT02412111|531611456|FG001|Active Comparator Period (8 Weeks)|Lost to Follow-up|0|||
147394882|NCT02412111|531611457|FG002|Active Comparator Period (8 Weeks)|Lost to Follow-up|1|||
147394883|NCT02412111|531611455|FG000|Active Comparator Period (8 Weeks)|Other non-compliance|0|||
147394884|NCT02412111|531611456|FG001|Active Comparator Period (8 Weeks)|Other non-compliance|1|||
147394885|NCT02412111|531611457|FG002|Active Comparator Period (8 Weeks)|Other non-compliance|0|||
147394886|NCT02412111|531611455|FG000|Active Comparator Period (8 Weeks)|Other|0|||
147394887|NCT02412111|531611456|FG001|Active Comparator Period (8 Weeks)|Other|0|||
147394888|NCT02412111|531611457|FG002|Active Comparator Period (8 Weeks)|Other|2|||
147394889|NCT00487552|531611458|FG000|Overall Study|Unsuccessful magnet placements|3|||
147394890|NCT00487552|531611458|FG000|Overall Study|Death due to progressive malignancy|2|||
147394891|NCT00487552|531611458|FG000|Overall Study|Stent not placed|1|||
147394892|NCT02624869|531611459|FG000|Overall Study|Lost to Follow-up|0|||
147394893|NCT02624869|531611460|FG001|Overall Study|Lost to Follow-up|0|||
147394894|NCT02624869|531611461|FG002|Overall Study|Lost to Follow-up|1|||
147394895|NCT02624869|531611459|FG000|Overall Study|Withdrawal by Subject|1|||
147394896|NCT02624869|531611460|FG001|Overall Study|Withdrawal by Subject|3|||
147394897|NCT02624869|531611461|FG002|Overall Study|Withdrawal by Subject|1|||
147394898|NCT01917006|531611462|FG000|Randomized-treatment Period|Lost to Follow-up|1|||
147394899|NCT01917006|531611463|FG001|Randomized-treatment Period|Lost to Follow-up|0|||
147394900|NCT01917006|531611464|FG002|Randomized-treatment Period|Lost to Follow-up|0|||
147394901|NCT01917006|531611465|FG003|Randomized-treatment Period|Lost to Follow-up|1|||
147394902|NCT01917006|531611466|FG004|Randomized-treatment Period|Lost to Follow-up|0|||
147394903|NCT01917006|531611467|FG005|Randomized-treatment Period|Lost to Follow-up|0|||
147394904|NCT01917006|531611468|FG006|Randomized-treatment Period|Lost to Follow-up|0|||
147394905|NCT01917006|531611469|FG007|Randomized-treatment Period|Lost to Follow-up|0|||
147394906|NCT01917006|531611462|FG000|Randomized-treatment Period|Personal Reasons|0|||
147394907|NCT01917006|531611463|FG001|Randomized-treatment Period|Personal Reasons|0|||
147394908|NCT01917006|531611464|FG002|Randomized-treatment Period|Personal Reasons|0|||
147394909|NCT01917006|531611465|FG003|Randomized-treatment Period|Personal Reasons|0|||
147394910|NCT01917006|531611466|FG004|Randomized-treatment Period|Personal Reasons|0|||
147394911|NCT01917006|531611467|FG005|Randomized-treatment Period|Personal Reasons|1|||
147394912|NCT01917006|531611468|FG006|Randomized-treatment Period|Personal Reasons|0|||
147394913|NCT01917006|531611469|FG007|Randomized-treatment Period|Personal Reasons|0|||
147394914|NCT01917006|531611462|FG000|Randomized-treatment Period|Protocol Violation|1|||
147394915|NCT01917006|531611463|FG001|Randomized-treatment Period|Protocol Violation|0|||
147394916|NCT01917006|531611464|FG002|Randomized-treatment Period|Protocol Violation|0|||
147394917|NCT01917006|531611465|FG003|Randomized-treatment Period|Protocol Violation|0|||
147394918|NCT01917006|531611466|FG004|Randomized-treatment Period|Protocol Violation|0|||
147394919|NCT01917006|531611467|FG005|Randomized-treatment Period|Protocol Violation|0|||
147394920|NCT01917006|531611468|FG006|Randomized-treatment Period|Protocol Violation|0|||
147394921|NCT01917006|531611469|FG007|Randomized-treatment Period|Protocol Violation|0|||
147394922|NCT01917006|531611462|FG000|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
147394923|NCT01917006|531611463|FG001|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
147394924|NCT01917006|531611464|FG002|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
147394925|NCT01917006|531611465|FG003|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
147394926|NCT01917006|531611466|FG004|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
147394927|NCT01917006|531611467|FG005|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
147394928|NCT01917006|531611468|FG006|Randomized-treatment Period|Other Miscellaneous Reasons|1|||
147394929|NCT01917006|531611469|FG007|Randomized-treatment Period|Other Miscellaneous Reasons|0|||
147394930|NCT01917006|531611462|FG000|Open-label Period|Adverse Event|0|||
147394931|NCT01917006|531611463|FG001|Open-label Period|Adverse Event|0|||
147394932|NCT01917006|531611464|FG002|Open-label Period|Adverse Event|0|||
147394933|NCT01917006|531611465|FG003|Open-label Period|Adverse Event|0|||
147394934|NCT01917006|531611466|FG004|Open-label Period|Adverse Event|0|||
147394935|NCT01917006|531611467|FG005|Open-label Period|Adverse Event|0|||
147394936|NCT01917006|531611468|FG006|Open-label Period|Adverse Event|0|||
147394937|NCT01917006|531611469|FG007|Open-label Period|Adverse Event|1|||
147615317|NCT03449446|532406695|FG000|Overall Study|Protocol Violation|0|||
147665124|NCT02849080|532598020|FG002|Extension Phase: 53 - 104 Weeks|Withdrawal by Subject|0|||
147665125|NCT02849080|532598021|FG003|Extension Phase: 53 - 104 Weeks|Withdrawal by Subject|0|||
147665126|NCT02283658|532598031|FG000|Overall Study|Withdrawal by Subject|1|||
147665127|NCT03528551|532598033|FG000|Overall Study|Lost to Follow-up|0|||
147665128|NCT03528551|532598034|FG001|Overall Study|Lost to Follow-up|1|||
147665129|NCT03528551|532598035|FG002|Overall Study|Lost to Follow-up|0|||
147665130|NCT03528551|532598033|FG000|Overall Study|Transferred to other arm/group|2|||
147665131|NCT03528551|532598034|FG001|Overall Study|Transferred to other arm/group|3|||
147665132|NCT03528551|532598035|FG002|Overall Study|Transferred to other arm/group|0|||
147665133|NCT03528551|532598033|FG000|Overall Study|Withdrawal by parent/guardian|0|||
147665134|NCT03528551|532598034|FG001|Overall Study|Withdrawal by parent/guardian|5|||
147665135|NCT03528551|532598035|FG002|Overall Study|Withdrawal by parent/guardian|0|||
147665136|NCT03528551|532598033|FG000|Overall Study|Protocol Violation|0|||
147665137|NCT03528551|532598034|FG001|Overall Study|Protocol Violation|3|||
147665138|NCT03528551|532598035|FG002|Overall Study|Protocol Violation|0|||
147665139|NCT03528551|532598033|FG000|Overall Study|Withdrawal by Subject|0|||
147665140|NCT03528551|532598034|FG001|Overall Study|Withdrawal by Subject|7|||
147665141|NCT03528551|532598035|FG002|Overall Study|Withdrawal by Subject|0|||
147665142|NCT01789047|532598038|FG000|Overall Study|Adverse Event|3|||
147665143|NCT01789047|532598039|FG001|Overall Study|Adverse Event|2|||
147665144|NCT01789047|532598038|FG000|Overall Study|Withdrawal by Subject|1|||
147665145|NCT01789047|532598039|FG001|Overall Study|Withdrawal by Subject|2|||
147665146|NCT03644017|532598040|FG000|Overall Study|Access Abandonment|5|||
147665147|NCT03644017|532598040|FG000|Overall Study|Kidney Transplant|2|||
147665148|NCT02700048|532598041|FG000|Overall Study|The device failed so the study wasn't completed and participants were dropped|0|||
147665149|NCT02700048|532598042|FG001|Overall Study|The device failed so the study wasn't completed and participants were dropped|3|||
147394938|NCT01917006|531611462|FG000|Open-label Period|Lost to Follow-up|0|||
147394939|NCT01917006|531611463|FG001|Open-label Period|Lost to Follow-up|0|||
147394940|NCT01917006|531611464|FG002|Open-label Period|Lost to Follow-up|0|||
147394941|NCT01917006|531611465|FG003|Open-label Period|Lost to Follow-up|0|||
147394942|NCT01917006|531611466|FG004|Open-label Period|Lost to Follow-up|0|||
147394943|NCT01917006|531611467|FG005|Open-label Period|Lost to Follow-up|0|||
147394944|NCT01917006|531611468|FG006|Open-label Period|Lost to Follow-up|0|||
147394945|NCT01917006|531611469|FG007|Open-label Period|Lost to Follow-up|1|||
147394946|NCT02158247|531611470|FG000|Overall Study|Invisible vocal cords|5|||
147394947|NCT00053352|531611474|FG000|Overall Study|Lost to Follow-up|0|||
147394948|NCT00053352|531611475|FG001|Overall Study|Lost to Follow-up|1|||
147394949|NCT00053352|531611474|FG000|Overall Study|Physician Decision|11|||
147394950|NCT00053352|531611475|FG001|Overall Study|Physician Decision|1|||
147394951|NCT00053352|531611474|FG000|Overall Study|Withdrawal by Subject|1|||
147394952|NCT00053352|531611475|FG001|Overall Study|Withdrawal by Subject|0|||
147394953|NCT00053352|531611474|FG000|Overall Study|Ineligible|8|||
147394954|NCT00053352|531611475|FG001|Overall Study|Ineligible|8|||
147394955|NCT00053352|531611474|FG000|Overall Study|Disease at new site|1|||
147394956|NCT00053352|531611475|FG001|Overall Study|Disease at new site|0|||
147394957|NCT02741713|531611478|FG000|Overall Study|Surgery type changed intra-operatively|2|||
147394958|NCT02741713|531611479|FG001|Overall Study|Surgery type changed intra-operatively|1|||
147394959|NCT01388478|531611480|FG000|Overall Study|Adverse Event|4|||
147394960|NCT01388478|531611480|FG000|Overall Study|Withdrawal by Subject|1|||
147394961|NCT01037413|531611481|FG000|Part A: Skin Testing|Adverse Event|1|||
147394962|NCT01037413|531611482|FG001|Part A: Skin Testing|Adverse Event|0|||
147394963|NCT01037413|531611481|FG000|Part A: Skin Testing|Protocol Violation|1|||
147394964|NCT01037413|531611482|FG001|Part A: Skin Testing|Protocol Violation|0|||
147394965|NCT01037413|531611481|FG000|Part B: Scar Revision|Withdrawal by Subject|0|||
147665150|NCT02175225|532598043|FG000|Overall Study|Withdrawal by Subject|1|||
147665151|NCT02175225|532598044|FG001|Overall Study|Withdrawal by Subject|2|||
147665152|NCT02175225|532598043|FG000|Overall Study|Lost to Follow-up|6|||
147665153|NCT02175225|532598044|FG001|Overall Study|Lost to Follow-up|7|||
147665154|NCT02175225|532598043|FG000|Overall Study|Study drug not administered|1|||
147665155|NCT02175225|532598044|FG001|Overall Study|Study drug not administered|2|||
147665156|NCT02340000|532598045|FG000|Time Period 1|Withdrawal by Subject|6|||
147665157|NCT02340000|532598046|FG001|Time Period 1|Withdrawal by Subject|8|||
147665158|NCT02340000|532598045|FG000|Time Period 1|Lost to Follow-up|6|||
147665159|NCT02340000|532598046|FG001|Time Period 1|Lost to Follow-up|7|||
147665160|NCT02340000|532598045|FG000|Time Period 2|Withdrawal by Subject|9|||
147665161|NCT02340000|532598046|FG001|Time Period 2|Withdrawal by Subject|7|||
147665162|NCT02340000|532598045|FG000|Time Period 2|Lost to Follow-up|10|||
147665163|NCT02340000|532598046|FG001|Time Period 2|Lost to Follow-up|8|||
147394966|NCT01037413|531611482|FG001|Part B: Scar Revision|Withdrawal by Subject|1|||
147394967|NCT01037413|531611481|FG000|Part B: Scar Revision|Assigned But Not Treated|0|||
147394968|NCT01037413|531611482|FG001|Part B: Scar Revision|Assigned But Not Treated|1|||
147394969|NCT00619983|531611486|FG000|Test Drug Alone|Withdrawal by Subject|1|||
147394970|NCT00619983|531611487|FG001|Test Drug Alone|Withdrawal by Subject|0|||
147665164|NCT02668640|532598047|FG000|Overall Study|Lost to Follow-up|13|||
147665165|NCT02668640|532598047|FG000|Overall Study|Other, not specified|1|||
147394971|NCT00619983|531611488|FG002|Test Drug Alone|Withdrawal by Subject|0|||
147394972|NCT00619983|531611489|FG003|Test Drug Alone|Withdrawal by Subject|1|||
147394973|NCT00619983|531611486|FG000|Test Drug Alone|Failure of daily diary device|1|||
147394974|NCT00619983|531611487|FG001|Test Drug Alone|Failure of daily diary device|1|||
147394975|NCT00619983|531611488|FG002|Test Drug Alone|Failure of daily diary device|2|||
147394976|NCT00619983|531611489|FG003|Test Drug Alone|Failure of daily diary device|2|||
147394977|NCT03201900|531611490|FG000|Treatment Phase (Up to 62 Weeks)|Adverse Event|9|||
147394978|NCT03201900|531611490|FG000|Treatment Phase (Up to 62 Weeks)|Subject Choice|1|||
147394979|NCT03201900|531611490|FG000|Treatment Phase (Up to 62 Weeks)|Inadequate therapeutic effect|6|||
147394980|NCT03201900|531611490|FG000|Treatment Phase (Up to 62 Weeks)|Lost to Follow-up|2|||
147394981|NCT03201900|531611490|FG000|Treatment Phase (Up to 62 Weeks)|Withdrawal of consent|6|||
147394982|NCT03201900|531611490|FG000|Treatment Phase (Up to 62 Weeks)|Other than specified|11|||
147394983|NCT03201900|531611490|FG000|Treatment Phase (Up to 62 Weeks)|Not treated|2|||
147394984|NCT03201900|531611490|FG000|Extension Phase (From Week 63 to 156)|Subject choice|1|||
147394985|NCT03201900|531611490|FG000|Extension Phase (From Week 63 to 156)|Pregnancy|1|||
147394986|NCT03201900|531611490|FG000|Extension Phase (From Week 63 to 156)|Inadequate therapeutic effect|1|||
147394987|NCT03201900|531611490|FG000|Extension Phase (From Week 63 to 156)|Lost to Follow-up|1|||
147394988|NCT03201900|531611490|FG000|Extension Phase (From Week 63 to 156)|Withdrawal of consent|3|||
147394989|NCT03201900|531611490|FG000|Extension Phase (From Week 63 to 156)|Other|1|||
147394990|NCT02971228|531611491|FG000|Overall Study|Withdrawal by Subject|1|||
147394991|NCT02971228|531611492|FG001|Overall Study|Withdrawal by Subject|1|||
147394992|NCT02971228|531611493|FG002|Overall Study|Withdrawal by Subject|0|||
147394993|NCT02971228|531611494|FG003|Overall Study|Withdrawal by Subject|0|||
147394994|NCT02971228|531611495|FG004|Overall Study|Withdrawal by Subject|0|||
147394995|NCT02971228|531611491|FG000|Overall Study|Logistical challenges|0|||
147394996|NCT02971228|531611492|FG001|Overall Study|Logistical challenges|1|||
147394997|NCT02971228|531611493|FG002|Overall Study|Logistical challenges|0|||
147394998|NCT02971228|531611494|FG003|Overall Study|Logistical challenges|0|||
147394999|NCT02971228|531611495|FG004|Overall Study|Logistical challenges|0|||
147395000|NCT01233999|531611498|FG000|Overall Study|Withdrawal by Subject|1|||
147395001|NCT01233999|531611498|FG000|Overall Study|Lost to Follow-up|1|||
147395002|NCT02560389|531611499|FG000|Overall Study|Lost to Follow-up|1|||
147395003|NCT02560389|531611500|FG001|Overall Study|Lost to Follow-up|2|||
147395004|NCT02560389|531611501|FG002|Overall Study|Lost to Follow-up|2|||
147395005|NCT02560389|531611499|FG000|Overall Study|Tested positive for illicit substance|0|||
147395006|NCT02560389|531611500|FG001|Overall Study|Tested positive for illicit substance|1|||
147395007|NCT02560389|531611501|FG002|Overall Study|Tested positive for illicit substance|0|||
147395008|NCT00550446|531611502|FG000|Up To Week 12|Adverse Event|2|||
147395009|NCT00550446|531611503|FG001|Up To Week 12|Adverse Event|2|||
147395010|NCT00550446|531611504|FG002|Up To Week 12|Adverse Event|0|||
147395011|NCT00550446|531611505|FG003|Up To Week 12|Adverse Event|0|||
147395012|NCT00550446|531611506|FG004|Up To Week 12|Adverse Event|2|||
147395013|NCT00550446|531611507|FG005|Up To Week 12|Adverse Event|2|||
147395014|NCT00550446|531611508|FG006|Up To Week 12|Adverse Event|1|||
147395015|NCT00550446|531611509|FG007|Up To Week 12|Adverse Event|0|||
147395016|NCT00550446|531611510|FG008|Up To Week 12|Adverse Event|0|||
147395017|NCT00550446|531611511|FG009|Up To Week 12|Adverse Event|0|||
147395018|NCT00550446|531611512|FG010|Up To Week 12|Adverse Event|0|||
147395019|NCT00550446|531611502|FG000|Up To Week 12|Lack of Efficacy|3|||
147395020|NCT00550446|531611503|FG001|Up To Week 12|Lack of Efficacy|1|||
147395021|NCT00550446|531611504|FG002|Up To Week 12|Lack of Efficacy|0|||
147395022|NCT00550446|531611505|FG003|Up To Week 12|Lack of Efficacy|1|||
147395023|NCT00550446|531611506|FG004|Up To Week 12|Lack of Efficacy|0|||
147395024|NCT00550446|531611507|FG005|Up To Week 12|Lack of Efficacy|3|||
147395025|NCT00550446|531611508|FG006|Up To Week 12|Lack of Efficacy|3|||
147395026|NCT00550446|531611509|FG007|Up To Week 12|Lack of Efficacy|0|||
147395027|NCT00550446|531611510|FG008|Up To Week 12|Lack of Efficacy|0|||
147395028|NCT00550446|531611511|FG009|Up To Week 12|Lack of Efficacy|0|||
147395029|NCT00550446|531611512|FG010|Up To Week 12|Lack of Efficacy|0|||
147395030|NCT00550446|531611502|FG000|Up To Week 12|Lost to Follow-up|0|||
147395031|NCT00550446|531611503|FG001|Up To Week 12|Lost to Follow-up|1|||
147395032|NCT00550446|531611504|FG002|Up To Week 12|Lost to Follow-up|0|||
147460347|NCT00880750|531846990|FG000|First Intervention|Non-compliance with meals|0|||
147615318|NCT03449446|532406696|FG001|Overall Study|Protocol Violation|0|||
147615319|NCT03449446|532406697|FG002|Overall Study|Protocol Violation|0|||
147395033|NCT00550446|531611505|FG003|Up To Week 12|Lost to Follow-up|0|||
147395034|NCT00550446|531611506|FG004|Up To Week 12|Lost to Follow-up|1|||
147395035|NCT00550446|531611507|FG005|Up To Week 12|Lost to Follow-up|1|||
147395036|NCT00550446|531611508|FG006|Up To Week 12|Lost to Follow-up|2|||
147395037|NCT00550446|531611509|FG007|Up To Week 12|Lost to Follow-up|0|||
147395038|NCT00550446|531611510|FG008|Up To Week 12|Lost to Follow-up|0|||
147395039|NCT00550446|531611511|FG009|Up To Week 12|Lost to Follow-up|0|||
147395040|NCT00550446|531611512|FG010|Up To Week 12|Lost to Follow-up|0|||
147395041|NCT00550446|531611502|FG000|Up To Week 12|Withdrawal by Subject|2|||
147395042|NCT00550446|531611503|FG001|Up To Week 12|Withdrawal by Subject|0|||
147395043|NCT00550446|531611504|FG002|Up To Week 12|Withdrawal by Subject|3|||
147395044|NCT00550446|531611505|FG003|Up To Week 12|Withdrawal by Subject|2|||
147395045|NCT00550446|531611506|FG004|Up To Week 12|Withdrawal by Subject|0|||
147395046|NCT00550446|531611507|FG005|Up To Week 12|Withdrawal by Subject|1|||
147395047|NCT00550446|531611508|FG006|Up To Week 12|Withdrawal by Subject|3|||
147395048|NCT00550446|531611509|FG007|Up To Week 12|Withdrawal by Subject|0|||
147395049|NCT00550446|531611510|FG008|Up To Week 12|Withdrawal by Subject|0|||
147395050|NCT00550446|531611511|FG009|Up To Week 12|Withdrawal by Subject|0|||
147395051|NCT00550446|531611512|FG010|Up To Week 12|Withdrawal by Subject|0|||
147395052|NCT00550446|531611502|FG000|Up To Week 12|Other|3|||
147395053|NCT00550446|531611503|FG001|Up To Week 12|Other|0|||
147395054|NCT00550446|531611504|FG002|Up To Week 12|Other|0|||
147395055|NCT00550446|531611505|FG003|Up To Week 12|Other|0|||
147395056|NCT00550446|531611506|FG004|Up To Week 12|Other|0|||
147395057|NCT00550446|531611507|FG005|Up To Week 12|Other|1|||
147395058|NCT00550446|531611508|FG006|Up To Week 12|Other|4|||
147395059|NCT00550446|531611509|FG007|Up To Week 12|Other|0|||
147395060|NCT00550446|531611510|FG008|Up To Week 12|Other|0|||
147395061|NCT00550446|531611511|FG009|Up To Week 12|Other|0|||
147395062|NCT00550446|531611512|FG010|Up To Week 12|Other|0|||
147395063|NCT00550446|531611502|FG000|Up To Week 12|Randomized not treated|0|||
147395064|NCT00550446|531611503|FG001|Up To Week 12|Randomized not treated|1|||
147395065|NCT00550446|531611504|FG002|Up To Week 12|Randomized not treated|1|||
147395066|NCT00550446|531611505|FG003|Up To Week 12|Randomized not treated|0|||
147395067|NCT00550446|531611506|FG004|Up To Week 12|Randomized not treated|0|||
147395068|NCT00550446|531611507|FG005|Up To Week 12|Randomized not treated|0|||
147395069|NCT00550446|531611508|FG006|Up To Week 12|Randomized not treated|0|||
147395070|NCT00550446|531611509|FG007|Up To Week 12|Randomized not treated|0|||
147395071|NCT00550446|531611510|FG008|Up To Week 12|Randomized not treated|0|||
147395072|NCT00550446|531611511|FG009|Up To Week 12|Randomized not treated|0|||
147395073|NCT00550446|531611512|FG010|Up To Week 12|Randomized not treated|0|||
147395074|NCT00550446|531611502|FG000|Post Week 12|Adverse Event|2|||
147395075|NCT00550446|531611503|FG001|Post Week 12|Adverse Event|1|||
147395076|NCT00550446|531611504|FG002|Post Week 12|Adverse Event|1|||
147395077|NCT00550446|531611505|FG003|Post Week 12|Adverse Event|1|||
147395078|NCT00550446|531611506|FG004|Post Week 12|Adverse Event|1|||
147395079|NCT00550446|531611507|FG005|Post Week 12|Adverse Event|1|||
147395080|NCT00550446|531611508|FG006|Post Week 12|Adverse Event|0|||
147395081|NCT00550446|531611509|FG007|Post Week 12|Adverse Event|0|||
147395082|NCT00550446|531611510|FG008|Post Week 12|Adverse Event|0|||
147395083|NCT00550446|531611511|FG009|Post Week 12|Adverse Event|4|||
147395084|NCT00550446|531611512|FG010|Post Week 12|Adverse Event|0|||
147395085|NCT00550446|531611502|FG000|Post Week 12|Lack of Efficacy|0|||
147395086|NCT00550446|531611503|FG001|Post Week 12|Lack of Efficacy|0|||
147395087|NCT00550446|531611504|FG002|Post Week 12|Lack of Efficacy|1|||
147395088|NCT00550446|531611505|FG003|Post Week 12|Lack of Efficacy|0|||
147395089|NCT00550446|531611506|FG004|Post Week 12|Lack of Efficacy|0|||
147395090|NCT00550446|531611507|FG005|Post Week 12|Lack of Efficacy|0|||
147395091|NCT00550446|531611508|FG006|Post Week 12|Lack of Efficacy|0|||
147395092|NCT00550446|531611509|FG007|Post Week 12|Lack of Efficacy|1|||
147395093|NCT00550446|531611510|FG008|Post Week 12|Lack of Efficacy|1|||
147395094|NCT00550446|531611511|FG009|Post Week 12|Lack of Efficacy|2|||
147395095|NCT00550446|531611512|FG010|Post Week 12|Lack of Efficacy|1|||
147395096|NCT00550446|531611502|FG000|Post Week 12|Lost to Follow-up|0|||
147395097|NCT00550446|531611503|FG001|Post Week 12|Lost to Follow-up|0|||
147395098|NCT00550446|531611504|FG002|Post Week 12|Lost to Follow-up|1|||
147395099|NCT00550446|531611505|FG003|Post Week 12|Lost to Follow-up|1|||
147395100|NCT00550446|531611506|FG004|Post Week 12|Lost to Follow-up|0|||
147395101|NCT00550446|531611507|FG005|Post Week 12|Lost to Follow-up|0|||
147395102|NCT00550446|531611508|FG006|Post Week 12|Lost to Follow-up|1|||
147395103|NCT00550446|531611509|FG007|Post Week 12|Lost to Follow-up|0|||
147395104|NCT00550446|531611510|FG008|Post Week 12|Lost to Follow-up|0|||
147395105|NCT00550446|531611511|FG009|Post Week 12|Lost to Follow-up|0|||
147395106|NCT00550446|531611512|FG010|Post Week 12|Lost to Follow-up|0|||
147395107|NCT00550446|531611502|FG000|Post Week 12|Withdrawal by Subject|0|||
147395108|NCT00550446|531611503|FG001|Post Week 12|Withdrawal by Subject|0|||
147395109|NCT00550446|531611504|FG002|Post Week 12|Withdrawal by Subject|0|||
147395110|NCT00550446|531611505|FG003|Post Week 12|Withdrawal by Subject|0|||
147395111|NCT00550446|531611506|FG004|Post Week 12|Withdrawal by Subject|1|||
147395112|NCT00550446|531611507|FG005|Post Week 12|Withdrawal by Subject|0|||
147395113|NCT00550446|531611508|FG006|Post Week 12|Withdrawal by Subject|0|||
147395114|NCT00550446|531611509|FG007|Post Week 12|Withdrawal by Subject|0|||
147395115|NCT00550446|531611510|FG008|Post Week 12|Withdrawal by Subject|0|||
147395116|NCT00550446|531611511|FG009|Post Week 12|Withdrawal by Subject|0|||
147395117|NCT00550446|531611512|FG010|Post Week 12|Withdrawal by Subject|0|||
147395118|NCT00550446|531611502|FG000|Post Week 12|Other|1|||
147395119|NCT00550446|531611503|FG001|Post Week 12|Other|1|||
147395120|NCT00550446|531611504|FG002|Post Week 12|Other|0|||
147395121|NCT00550446|531611505|FG003|Post Week 12|Other|1|||
147395122|NCT00550446|531611506|FG004|Post Week 12|Other|0|||
147395123|NCT00550446|531611507|FG005|Post Week 12|Other|0|||
147395124|NCT00550446|531611508|FG006|Post Week 12|Other|1|||
147395125|NCT00550446|531611509|FG007|Post Week 12|Other|0|||
147395126|NCT00550446|531611510|FG008|Post Week 12|Other|1|||
147395127|NCT00550446|531611511|FG009|Post Week 12|Other|1|||
147395128|NCT00550446|531611512|FG010|Post Week 12|Other|0|||
147395129|NCT02716298|531611513|FG000|First Intervention (1 Month)|Lens discomfort|1|||
147395130|NCT02716298|531611514|FG001|First Intervention (1 Month)|Lens discomfort|1|||
147395131|NCT01321723|531611515|FG000|Overall Study|Adverse Event|3|||
147395132|NCT01321723|531611516|FG001|Overall Study|Adverse Event|5|||
147395133|NCT01321723|531611517|FG002|Overall Study|Adverse Event|2|||
147395134|NCT01321723|531611515|FG000|Overall Study|Withdrawal by Subject|2|||
147395135|NCT01321723|531611516|FG001|Overall Study|Withdrawal by Subject|0|||
147395136|NCT01321723|531611517|FG002|Overall Study|Withdrawal by Subject|2|||
147395137|NCT02246218|531611518|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
147395138|NCT02246218|531611519|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
147395139|NCT02246218|531611518|FG000|Overall Study|Stopping Rule: Liver Transplant|2|||
147395140|NCT02246218|531611519|FG001|Overall Study|Stopping Rule: Liver Transplant|4|||
147395141|NCT02246218|531611518|FG000|Overall Study|Adverse Event|1|||
147395142|NCT02246218|531611519|FG001|Overall Study|Adverse Event|1|||
147395143|NCT02246218|531611518|FG000|Overall Study|Lost to Follow-up|1|||
147395144|NCT02246218|531611519|FG001|Overall Study|Lost to Follow-up|0|||
147395145|NCT04081389|531611521|FG000|Overall Study|Withdrawal by Subject|0|||
147395146|NCT04081389|531611522|FG001|Overall Study|Withdrawal by Subject|0|||
147395147|NCT04081389|531611523|FG002|Overall Study|Withdrawal by Subject|1|||
147395148|NCT04081389|531611524|FG003|Overall Study|Withdrawal by Subject|0|||
147395149|NCT00827775|531611530|FG000|Overall Study|Withdrawal by Subject|0|||
147395150|NCT00827775|531611531|FG001|Overall Study|Withdrawal by Subject|5|||
147395151|NCT01670188|531611535|FG000|Overall Study|Death|0|||
147395152|NCT01670188|531611536|FG001|Overall Study|Death|1|||
147395153|NCT00866918|531611537|FG000|Overall Study|Death|1|||
147395154|NCT00866918|531611538|FG001|Overall Study|Death|5|||
147395155|NCT00866918|531611537|FG000|Overall Study|Lack of Efficacy|1|||
147395156|NCT00866918|531611538|FG001|Overall Study|Lack of Efficacy|1|||
147395157|NCT00866918|531611537|FG000|Overall Study|Physician Decision|10|||
147395158|NCT00866918|531611538|FG001|Overall Study|Physician Decision|2|||
147395159|NCT00866918|531611537|FG000|Overall Study|Ineligible|2|||
147395160|NCT00866918|531611538|FG001|Overall Study|Ineligible|4|||
147395161|NCT00866918|531611537|FG000|Overall Study|Inevaluable- RQPCR negative at diagnosi|1|||
147395162|NCT00866918|531611538|FG001|Overall Study|Inevaluable- RQPCR negative at diagnosi|0|||
147395163|NCT00866918|531611537|FG000|Overall Study|Secondary malignancy|1|||
147395164|NCT00866918|531611538|FG001|Overall Study|Secondary malignancy|0|||
147395165|NCT00802438|531611539|FG000|Overall Study|Screen Failure|20|||
147395166|NCT00802438|531611539|FG000|Overall Study|Withdrawal by Subject|7|||
147395167|NCT00802438|531611539|FG000|Overall Study|Physician Decision|1|||
147395168|NCT02101268|531611542|FG000|Randomized Treatment Phase|Subject Decision|8|||
147395169|NCT02101268|531611543|FG001|Randomized Treatment Phase|Subject Decision|4|||
147395170|NCT02101268|531611544|FG002|Randomized Treatment Phase|Subject Decision|0|||
147395171|NCT02101268|531611545|FG003|Randomized Treatment Phase|Subject Decision|0|||
147395172|NCT02101268|531611542|FG000|Randomized Treatment Phase|Physician Decision|4|||
147395173|NCT02101268|531611543|FG001|Randomized Treatment Phase|Physician Decision|1|||
147395174|NCT02101268|531611544|FG002|Randomized Treatment Phase|Physician Decision|0|||
147395175|NCT02101268|531611545|FG003|Randomized Treatment Phase|Physician Decision|0|||
147395176|NCT02101268|531611542|FG000|Randomized Treatment Phase|Symptomatic Spleen Growth|0|||
147395177|NCT02101268|531611543|FG001|Randomized Treatment Phase|Symptomatic Spleen Growth|1|||
147395178|NCT02101268|531611544|FG002|Randomized Treatment Phase|Symptomatic Spleen Growth|0|||
147395179|NCT02101268|531611545|FG003|Randomized Treatment Phase|Symptomatic Spleen Growth|0|||
147395180|NCT02101268|531611542|FG000|Randomized Treatment Phase|Adverse Event|6|||
147395181|NCT02101268|531611543|FG001|Randomized Treatment Phase|Adverse Event|0|||
147395182|NCT02101268|531611544|FG002|Randomized Treatment Phase|Adverse Event|0|||
147395183|NCT02101268|531611545|FG003|Randomized Treatment Phase|Adverse Event|0|||
147395184|NCT02101268|531611542|FG000|Randomized Treatment Phase|Death|5|||
147395185|NCT02101268|531611543|FG001|Randomized Treatment Phase|Death|4|||
147395186|NCT02101268|531611544|FG002|Randomized Treatment Phase|Death|0|||
147395187|NCT02101268|531611545|FG003|Randomized Treatment Phase|Death|0|||
147395188|NCT02101268|531611542|FG000|Randomized Treatment Phase|Disease Progression|4|||
147395189|NCT02101268|531611543|FG001|Randomized Treatment Phase|Disease Progression|1|||
147395190|NCT02101268|531611544|FG002|Randomized Treatment Phase|Disease Progression|0|||
147395191|NCT02101268|531611545|FG003|Randomized Treatment Phase|Disease Progression|0|||
147395192|NCT02101268|531611542|FG000|Extended Treatment Phase|Subject Decision|0|||
147395193|NCT02101268|531611543|FG001|Extended Treatment Phase|Subject Decision|0|||
147395194|NCT02101268|531611544|FG002|Extended Treatment Phase|Subject Decision|3|||
147395195|NCT02101268|531611545|FG003|Extended Treatment Phase|Subject Decision|2|||
147395196|NCT02101268|531611542|FG000|Extended Treatment Phase|Physician Decision|0|||
147395197|NCT02101268|531611543|FG001|Extended Treatment Phase|Physician Decision|0|||
147395198|NCT02101268|531611544|FG002|Extended Treatment Phase|Physician Decision|5|||
147395199|NCT02101268|531611545|FG003|Extended Treatment Phase|Physician Decision|2|||
147395200|NCT02101268|531611542|FG000|Extended Treatment Phase|Adverse Event|0|||
147395201|NCT02101268|531611543|FG001|Extended Treatment Phase|Adverse Event|0|||
147395202|NCT02101268|531611544|FG002|Extended Treatment Phase|Adverse Event|14|||
147395203|NCT02101268|531611545|FG003|Extended Treatment Phase|Adverse Event|18|||
147395204|NCT02101268|531611542|FG000|Extended Treatment Phase|Death|0|||
147395205|NCT02101268|531611543|FG001|Extended Treatment Phase|Death|0|||
147395206|NCT02101268|531611544|FG002|Extended Treatment Phase|Death|5|||
147395207|NCT02101268|531611545|FG003|Extended Treatment Phase|Death|1|||
147395208|NCT02101268|531611542|FG000|Extended Treatment Phase|Transferred to Study SRA-MMB-4365|0|||
147395209|NCT02101268|531611543|FG001|Extended Treatment Phase|Transferred to Study SRA-MMB-4365|0|||
147395210|NCT02101268|531611544|FG002|Extended Treatment Phase|Transferred to Study SRA-MMB-4365|15|||
147395211|NCT02101268|531611545|FG003|Extended Treatment Phase|Transferred to Study SRA-MMB-4365|7|||
147395212|NCT02101268|531611542|FG000|Extended Treatment Phase|Disease Progression|0|||
147395213|NCT02101268|531611543|FG001|Extended Treatment Phase|Disease Progression|0|||
147395214|NCT02101268|531611544|FG002|Extended Treatment Phase|Disease Progression|13|||
147395215|NCT02101268|531611545|FG003|Extended Treatment Phase|Disease Progression|6|||
147395216|NCT02101268|531611542|FG000|Extended Treatment Phase|Lack of Efficacy|0|||
147395217|NCT02101268|531611543|FG001|Extended Treatment Phase|Lack of Efficacy|0|||
147395218|NCT02101268|531611544|FG002|Extended Treatment Phase|Lack of Efficacy|9|||
147395219|NCT02101268|531611545|FG003|Extended Treatment Phase|Lack of Efficacy|4|||
147395220|NCT00819013|531611547|FG000|Overall Study|Not meeting continuing study eligibility|2|||
147395221|NCT00819013|531611548|FG001|Overall Study|Not meeting continuing study eligibility|1|||
147395222|NCT00819013|531611549|FG002|Overall Study|Not meeting continuing study eligibility|2|||
147395223|NCT00819013|531611550|FG003|Overall Study|Not meeting continuing study eligibility|1|||
147395224|NCT00819013|531611547|FG000|Overall Study|Adverse Event|0|||
147395225|NCT00819013|531611548|FG001|Overall Study|Adverse Event|0|||
147395226|NCT00819013|531611549|FG002|Overall Study|Adverse Event|1|||
147395227|NCT00819013|531611550|FG003|Overall Study|Adverse Event|0|||
147395228|NCT00819013|531611547|FG000|Overall Study|Withdrawal by Subject|1|||
147395229|NCT00819013|531611548|FG001|Overall Study|Withdrawal by Subject|0|||
147395230|NCT00819013|531611549|FG002|Overall Study|Withdrawal by Subject|1|||
147395231|NCT00819013|531611550|FG003|Overall Study|Withdrawal by Subject|0|||
147395232|NCT00819013|531611547|FG000|Overall Study|Lost to Follow-up|0|||
147395233|NCT00819013|531611548|FG001|Overall Study|Lost to Follow-up|0|||
147395234|NCT00819013|531611549|FG002|Overall Study|Lost to Follow-up|1|||
147395235|NCT00819013|531611550|FG003|Overall Study|Lost to Follow-up|2|||
147395236|NCT00819013|531611547|FG000|Overall Study|Death|0|||
147395237|NCT00819013|531611548|FG001|Overall Study|Death|0|||
147395238|NCT00819013|531611549|FG002|Overall Study|Death|0|||
147395239|NCT00819013|531611550|FG003|Overall Study|Death|1|||
147395240|NCT00839332|531611554|FG000|Phase 1|Disease Progression|38|||
147395241|NCT00839332|531611555|FG001|Phase 1|Disease Progression|0|||
147395242|NCT00839332|531611556|FG002|Phase 1|Disease Progression|0|||
147395243|NCT00839332|531611554|FG000|Phase 1|Adverse Event|6|||
147395244|NCT00839332|531611555|FG001|Phase 1|Adverse Event|0|||
147395245|NCT00839332|531611556|FG002|Phase 1|Adverse Event|0|||
147395246|NCT00839332|531611554|FG000|Phase 1|Withdrawal by Subject|4|||
147395247|NCT00839332|531611555|FG001|Phase 1|Withdrawal by Subject|0|||
147395248|NCT00839332|531611556|FG002|Phase 1|Withdrawal by Subject|0|||
147395249|NCT00839332|531611554|FG000|Phase 1|Physician Decision|2|||
147395250|NCT00839332|531611555|FG001|Phase 1|Physician Decision|0|||
147395251|NCT00839332|531611556|FG002|Phase 1|Physician Decision|0|||
147395252|NCT00839332|531611554|FG000|Phase 2|Protocol Violation|0|||
147395253|NCT00839332|531611555|FG001|Phase 2|Protocol Violation|1|||
147395254|NCT00839332|531611556|FG002|Phase 2|Protocol Violation|0|||
147395255|NCT00839332|531611554|FG000|Phase 2|Disease Progression|0|||
147395256|NCT00839332|531611555|FG001|Phase 2|Disease Progression|46|||
147395257|NCT00839332|531611556|FG002|Phase 2|Disease Progression|21|||
147395258|NCT00839332|531611554|FG000|Phase 2|Adverse Event|0|||
147395259|NCT00839332|531611555|FG001|Phase 2|Adverse Event|8|||
147395260|NCT00839332|531611556|FG002|Phase 2|Adverse Event|6|||
147395261|NCT00839332|531611554|FG000|Phase 2|Death|0|||
147395262|NCT00839332|531611555|FG001|Phase 2|Death|4|||
147395263|NCT00839332|531611556|FG002|Phase 2|Death|2|||
147395264|NCT00839332|531611554|FG000|Phase 2|Withdrawal by Subject|0|||
147665166|NCT03311945|532598048|FG000|Overall Study|Adverse Event|2|||
147395265|NCT00839332|531611555|FG001|Phase 2|Withdrawal by Subject|5|||
147665167|NCT03311945|532598048|FG000|Overall Study|Lack of Efficacy|1|||
147395266|NCT00839332|531611556|FG002|Phase 2|Withdrawal by Subject|8|||
147395267|NCT00839332|531611554|FG000|Phase 2|Physician Decision|0|||
147395268|NCT00839332|531611555|FG001|Phase 2|Physician Decision|4|||
147395269|NCT00839332|531611556|FG002|Phase 2|Physician Decision|1|||
147395270|NCT00839332|531611554|FG000|Phase 2|Lost to Follow-up|0|||
147395271|NCT00839332|531611555|FG001|Phase 2|Lost to Follow-up|0|||
147395272|NCT00839332|531611556|FG002|Phase 2|Lost to Follow-up|1|||
147395273|NCT01200485|531611557|FG000|Cycle 1: Rasburicase Alone Delivery|Withdrawal by Subject|1|||
147395274|NCT01200485|531611558|FG001|Cycle 1: Rasburicase Alone Delivery|Withdrawal by Subject|0|||
147395275|NCT01200485|531611559|FG002|Cycle 1: Rasburicase Alone Delivery|Withdrawal by Subject|0|||
147395276|NCT01200485|531611557|FG000|Cycle 1: Rasburicase Alone Delivery|Insurance Coverage Denied|2|||
147395277|NCT01200485|531611558|FG001|Cycle 1: Rasburicase Alone Delivery|Insurance Coverage Denied|0|||
147395278|NCT01200485|531611559|FG002|Cycle 1: Rasburicase Alone Delivery|Insurance Coverage Denied|0|||
147395279|NCT06080438|531611560|FG000|Overall Study|Lost to Follow-up|2|||
147395280|NCT03589300|531611562|FG000|Overall Study|Adverse Event|2|||
147395281|NCT03589300|531611562|FG000|Overall Study|Death|4|||
147395282|NCT03589300|531611562|FG000|Overall Study|Lost to Follow-up|12|||
147395283|NCT03589300|531611562|FG000|Overall Study|Withdrawal by Subject|5|||
147395284|NCT01678898|531611565|FG000|PB-102-F01|Adverse Event|0|||
147395285|NCT01678898|531611566|FG001|PB-102-F01|Adverse Event|1|||
147395286|NCT01678898|531611567|FG002|PB-102-F01|Adverse Event|0|||
147395287|NCT01678898|531611565|FG000|PB-102-F01|Physician Decision|0|||
147395288|NCT01678898|531611566|FG001|PB-102-F01|Physician Decision|1|||
147395289|NCT01678898|531611567|FG002|PB-102-F01|Physician Decision|0|||
147395290|NCT00776984|531611568|FG000|Overall Study|Adverse Event|8|||
147395291|NCT00776984|531611569|FG001|Overall Study|Adverse Event|2|||
147395292|NCT00776984|531611568|FG000|Overall Study|Protocol Violation|4|||
147395293|NCT00776984|531611569|FG001|Overall Study|Protocol Violation|2|||
147395294|NCT00776984|531611568|FG000|Overall Study|Lost to Follow-up|2|||
147395295|NCT00776984|531611569|FG001|Overall Study|Lost to Follow-up|0|||
147395296|NCT00776984|531611568|FG000|Overall Study|Withdrawal by Subject|12|||
147395297|NCT00776984|531611569|FG001|Overall Study|Withdrawal by Subject|7|||
147395298|NCT00776984|531611568|FG000|Overall Study|Lack of Efficacy|0|||
147395299|NCT00776984|531611569|FG001|Overall Study|Lack of Efficacy|1|||
147395300|NCT00776984|531611568|FG000|Overall Study|Other|5|||
147395301|NCT00776984|531611569|FG001|Overall Study|Other|9|||
147395302|NCT03030599|531611570|FG000|Open Label Treatment and Titration|Protocol deviation|8|||
147395303|NCT03030599|531611571|FG001|Open Label Treatment and Titration|Protocol deviation|0|||
147395304|NCT03030599|531611572|FG002|Open Label Treatment and Titration|Protocol deviation|0|||
147395305|NCT03030599|531611570|FG000|Open Label Treatment and Titration|Other|1|||
147395306|NCT03030599|531611571|FG001|Open Label Treatment and Titration|Other|0|||
147395307|NCT03030599|531611572|FG002|Open Label Treatment and Titration|Other|0|||
147395308|NCT03030599|531611570|FG000|Open Label Treatment and Titration|Physician Decision|3|||
147395309|NCT03030599|531611571|FG001|Open Label Treatment and Titration|Physician Decision|0|||
147395310|NCT03030599|531611572|FG002|Open Label Treatment and Titration|Physician Decision|0|||
147395311|NCT03030599|531611570|FG000|Open Label Treatment and Titration|Lack of Efficacy|1|||
147395312|NCT03030599|531611571|FG001|Open Label Treatment and Titration|Lack of Efficacy|0|||
147395313|NCT03030599|531611572|FG002|Open Label Treatment and Titration|Lack of Efficacy|0|||
147615320|NCT03449446|532406698|FG003|Overall Study|Protocol Violation|0|||
147615321|NCT03449446|532406699|FG004|Overall Study|Protocol Violation|1|||
147615322|NCT03449446|532406700|FG005|Overall Study|Protocol Violation|1|||
147615323|NCT03449446|532406701|FG006|Overall Study|Protocol Violation|0|||
147615324|NCT03449446|532406695|FG000|Overall Study|Death|0|||
147615325|NCT03449446|532406696|FG001|Overall Study|Death|0|||
147615326|NCT03449446|532406697|FG002|Overall Study|Death|0|||
147615327|NCT03449446|532406698|FG003|Overall Study|Death|0|||
147615328|NCT03449446|532406699|FG004|Overall Study|Death|1|||
147615329|NCT03449446|532406700|FG005|Overall Study|Death|0|||
147615330|NCT03449446|532406701|FG006|Overall Study|Death|0|||
147615331|NCT00625872|532406704|FG000|Overall Study|Withdrawal by Subject|1|||
147615332|NCT00625872|532406705|FG001|Overall Study|Withdrawal by Subject|0|||
147615333|NCT00625872|532406704|FG000|Overall Study|Does not meet inclusion criteria|1|||
147615334|NCT00625872|532406705|FG001|Overall Study|Does not meet inclusion criteria|0|||
147615335|NCT00625872|532406704|FG000|Overall Study|Terminated by sponsor|2|||
147615336|NCT00625872|532406705|FG001|Overall Study|Terminated by sponsor|5|||
147615337|NCT00625872|532406704|FG000|Overall Study|Randomized but not treated|0|||
147615338|NCT00625872|532406705|FG001|Overall Study|Randomized but not treated|1|||
147615339|NCT02201277|532406706|FG000|Overall Study|Death|3|||
147615340|NCT02201277|532406707|FG001|Overall Study|Death|4|||
147615341|NCT02201277|532406706|FG000|Overall Study|Lost to Follow-up|2|||
147615342|NCT02201277|532406707|FG001|Overall Study|Lost to Follow-up|1|||
147615343|NCT02201277|532406706|FG000|Overall Study|Failed retrieval|1|||
147615344|NCT02201277|532406707|FG001|Overall Study|Failed retrieval|0|||
147615345|NCT02201277|532406706|FG000|Overall Study|Physician Decision|1|||
147615346|NCT02201277|532406707|FG001|Overall Study|Physician Decision|0|||
147615347|NCT01512160|532406708|FG000|Overall Study|Lost to Follow-up|1|||
147615348|NCT01512160|532406709|FG001|Overall Study|Lost to Follow-up|0|||
147615349|NCT01512160|532406710|FG002|Overall Study|Lost to Follow-up|0|||
147615350|NCT01512160|532406711|FG003|Overall Study|Lost to Follow-up|0|||
147615351|NCT01512160|532406708|FG000|Overall Study|Withdrawal by Subject|1|||
147615352|NCT01512160|532406709|FG001|Overall Study|Withdrawal by Subject|0|||
147615353|NCT01512160|532406710|FG002|Overall Study|Withdrawal by Subject|0|||
147615354|NCT01512160|532406711|FG003|Overall Study|Withdrawal by Subject|1|||
147615355|NCT00866359|532406714|FG000|Treatment Phase (Days 1 to 85)|Adverse Event|5|||
147615356|NCT00866359|532406715|FG001|Treatment Phase (Days 1 to 85)|Adverse Event|4|||
147615357|NCT00866359|532406716|FG002|Treatment Phase (Days 1 to 85)|Adverse Event|0|||
147615358|NCT00866359|532406717|FG003|Treatment Phase (Days 1 to 85)|Adverse Event|0|||
147395314|NCT03030599|531611570|FG000|Open Label Treatment and Titration|Non-Compliance with Study Drug|4|||
147395315|NCT03030599|531611571|FG001|Open Label Treatment and Titration|Non-Compliance with Study Drug|0|||
147395316|NCT03030599|531611572|FG002|Open Label Treatment and Titration|Non-Compliance with Study Drug|0|||
147395317|NCT03030599|531611570|FG000|Open Label Treatment and Titration|Adverse Event|18|||
147395318|NCT03030599|531611571|FG001|Open Label Treatment and Titration|Adverse Event|0|||
147395319|NCT03030599|531611572|FG002|Open Label Treatment and Titration|Adverse Event|0|||
147395320|NCT03030599|531611570|FG000|Open Label Treatment and Titration|Withdrawal by Subject|6|||
147395321|NCT03030599|531611571|FG001|Open Label Treatment and Titration|Withdrawal by Subject|0|||
147395322|NCT03030599|531611572|FG002|Open Label Treatment and Titration|Withdrawal by Subject|0|||
147395323|NCT03030599|531611570|FG000|Open Label Treatment and Titration|Sponsor decision|2|||
147395324|NCT03030599|531611571|FG001|Open Label Treatment and Titration|Sponsor decision|0|||
147395325|NCT03030599|531611572|FG002|Open Label Treatment and Titration|Sponsor decision|0|||
147395326|NCT03030599|531611570|FG000|Open Label Treatment and Titration|Lost to Follow-up|3|||
147395327|NCT03030599|531611571|FG001|Open Label Treatment and Titration|Lost to Follow-up|0|||
147395328|NCT03030599|531611572|FG002|Open Label Treatment and Titration|Lost to Follow-up|0|||
147395329|NCT03030599|531611570|FG000|Stable Dose|Protocol deviation|3|||
147395330|NCT03030599|531611571|FG001|Stable Dose|Protocol deviation|0|||
147395331|NCT03030599|531611572|FG002|Stable Dose|Protocol deviation|0|||
147395332|NCT03030599|531611570|FG000|Stable Dose|Adverse Event|1|||
147395333|NCT03030599|531611571|FG001|Stable Dose|Adverse Event|0|||
147395334|NCT03030599|531611572|FG002|Stable Dose|Adverse Event|0|||
147395335|NCT03030599|531611570|FG000|Stable Dose|Lost to Follow-up|1|||
147395336|NCT03030599|531611571|FG001|Stable Dose|Lost to Follow-up|0|||
147395337|NCT03030599|531611572|FG002|Stable Dose|Lost to Follow-up|0|||
147395338|NCT03030599|531611570|FG000|Double Blind Randomized Withdrawal|Lack of Efficacy|0|||
147395339|NCT03030599|531611571|FG001|Double Blind Randomized Withdrawal|Lack of Efficacy|0|||
147395340|NCT03030599|531611572|FG002|Double Blind Randomized Withdrawal|Lack of Efficacy|2|||
147395341|NCT03030599|531611570|FG000|Double Blind Randomized Withdrawal|Adverse Event|0|||
147395342|NCT03030599|531611571|FG001|Double Blind Randomized Withdrawal|Adverse Event|0|||
147395343|NCT03030599|531611572|FG002|Double Blind Randomized Withdrawal|Adverse Event|3|||
147395344|NCT03030599|531611570|FG000|Double Blind Randomized Withdrawal|Randomized in error|0|||
147395345|NCT03030599|531611571|FG001|Double Blind Randomized Withdrawal|Randomized in error|0|||
147395346|NCT03030599|531611572|FG002|Double Blind Randomized Withdrawal|Randomized in error|2|||
147395347|NCT03030599|531611570|FG000|Double Blind Randomized Withdrawal|Withdrawal by Subject|0|||
147395348|NCT03030599|531611571|FG001|Double Blind Randomized Withdrawal|Withdrawal by Subject|0|||
147395349|NCT03030599|531611572|FG002|Double Blind Randomized Withdrawal|Withdrawal by Subject|1|||
147395350|NCT03030599|531611570|FG000|Open-label Extension|Adverse Event|3|||
147395351|NCT03030599|531611571|FG001|Open-label Extension|Adverse Event|0|||
147395352|NCT03030599|531611572|FG002|Open-label Extension|Adverse Event|0|||
147395353|NCT03030599|531611570|FG000|Open-label Extension|Lost to Follow-up|2|||
147395354|NCT03030599|531611571|FG001|Open-label Extension|Lost to Follow-up|0|||
147395355|NCT03030599|531611572|FG002|Open-label Extension|Lost to Follow-up|0|||
147395356|NCT03030599|531611570|FG000|Open-label Extension|Lack of Efficacy|1|||
147395357|NCT03030599|531611571|FG001|Open-label Extension|Lack of Efficacy|0|||
147395358|NCT03030599|531611572|FG002|Open-label Extension|Lack of Efficacy|0|||
147395359|NCT03030599|531611570|FG000|Open-label Extension|Other Reason|1|||
147395360|NCT03030599|531611571|FG001|Open-label Extension|Other Reason|0|||
147395361|NCT03030599|531611572|FG002|Open-label Extension|Other Reason|0|||
147395362|NCT00230971|531611574|FG000|Randomization|No study drug administered|3|||
147395363|NCT00230971|531611575|FG001|Randomization|No study drug administered|3|||
147395364|NCT00230971|531611574|FG000|Baseline Participants|Lost to Follow-up|5|||
147395365|NCT00230971|531611575|FG001|Baseline Participants|Lost to Follow-up|12|||
147395366|NCT00230971|531611574|FG000|Baseline Participants|Death|6|||
147395367|NCT00230971|531611575|FG001|Baseline Participants|Death|5|||
147395368|NCT00230971|531611574|FG000|Baseline Participants|Withdrawal by Subject|7|||
147395369|NCT00230971|531611575|FG001|Baseline Participants|Withdrawal by Subject|1|||
147395370|NCT00230971|531611574|FG000|Baseline Participants|Adverse Event|1|||
147395371|NCT00230971|531611575|FG001|Baseline Participants|Adverse Event|0|||
147395372|NCT00230971|531611574|FG000|Baseline Participants|No bacteria observed|1|||
147395373|NCT00230971|531611575|FG001|Baseline Participants|No bacteria observed|0|||
147395374|NCT00230971|531611574|FG000|Baseline Participants|Failure to return|1|||
147395375|NCT00230971|531611575|FG001|Baseline Participants|Failure to return|1|||
147395376|NCT00230971|531611574|FG000|Baseline Participants|Reintervention|1|||
147395377|NCT00230971|531611575|FG001|Baseline Participants|Reintervention|0|||
147395378|NCT04380688|531611576|FG000|Overall Study|Death|2|||
147395379|NCT04380688|531611577|FG001|Overall Study|Death|2|||
147615359|NCT00866359|532406714|FG000|Treatment Phase (Days 1 to 85)|Lack of Efficacy|3|||
147395380|NCT04380688|531611576|FG000|Overall Study|Lost to Follow-up|2|||
147395381|NCT04380688|531611577|FG001|Overall Study|Lost to Follow-up|4|||
147395382|NCT04380688|531611576|FG000|Overall Study|Withdrawal by Subject|3|||
147395383|NCT04380688|531611577|FG001|Overall Study|Withdrawal by Subject|3|||
147395384|NCT05294328|531611583|FG000|Overall Study|Adverse Event|1|||
147665168|NCT01619878|532598049|FG000|6 Week Follow-up Phase|Adverse Event|1|||
147665169|NCT01619878|532598049|FG000|Follow-up at 12 Months of Age|Lost to Follow-up|1|||
147665170|NCT01619878|532598049|FG000|Follow-up at 12 Months of Age|Death|2|||
147665171|NCT01305564|532598052|FG000|Overall Study|Death|21|||
147665172|NCT01305564|532598052|FG000|Overall Study|Lost to Follow-up|12|||
147665173|NCT01305564|532598052|FG000|Overall Study|Withdrawal by Subject|1|||
147665174|NCT01305564|532598052|FG000|Overall Study|Physician Decision|3|||
147665175|NCT00073918|532598057|FG000|Overall Study|Eligibility requirement not met - HAMA+|1|||
147665176|NCT00073918|532598057|FG000|Overall Study|Rapid disease progression|2|||
147665177|NCT00073918|532598057|FG000|Overall Study|Eligibility requirement not met-low CD20|1|||
147665178|NCT01190813|532598060|FG000|Overall Study|Lost to Follow-up|1|||
147665179|NCT01190813|532598061|FG001|Overall Study|Lost to Follow-up|2|||
147395385|NCT05294328|531611584|FG001|Overall Study|Adverse Event|0|||
147395386|NCT05294328|531611585|FG002|Overall Study|Adverse Event|0|||
147395387|NCT05294328|531611583|FG000|Overall Study|Physician Decision|1|||
147395388|NCT05294328|531611584|FG001|Overall Study|Physician Decision|1|||
147395389|NCT05294328|531611585|FG002|Overall Study|Physician Decision|0|||
147395390|NCT05294328|531611583|FG000|Overall Study|Withdrawal by Subject|0|||
147395391|NCT05294328|531611584|FG001|Overall Study|Withdrawal by Subject|2|||
147395392|NCT05294328|531611585|FG002|Overall Study|Withdrawal by Subject|1|||
147395393|NCT05294328|531611583|FG000|Overall Study|Other (Corneal Surface Disease and Distance VA)|0|||
147395394|NCT05294328|531611584|FG001|Overall Study|Other (Corneal Surface Disease and Distance VA)|1|||
147395395|NCT05294328|531611585|FG002|Overall Study|Other (Corneal Surface Disease and Distance VA)|0|||
147395396|NCT04267393|531611586|FG000|Randomization|Adverse Event|1|||
147395397|NCT04267393|531611587|FG001|Randomization|Adverse Event|0|||
147395398|NCT04267393|531611588|FG002|Randomization|Adverse Event|0|||
147395399|NCT04267393|531611586|FG000|Randomization|Administrative Reasons by Sponsor|0|||
147395400|NCT04267393|531611587|FG001|Randomization|Administrative Reasons by Sponsor|1|||
147395401|NCT04267393|531611588|FG002|Randomization|Administrative Reasons by Sponsor|0|||
147395402|NCT04267393|531611586|FG000|Treatment Period|Adverse Event|0|||
147395403|NCT04267393|531611587|FG001|Treatment Period|Adverse Event|2|||
147395404|NCT04267393|531611588|FG002|Treatment Period|Adverse Event|3|||
147395405|NCT04267393|531611586|FG000|Treatment Period|Participant Withdrew Consent|0|||
147395406|NCT04267393|531611587|FG001|Treatment Period|Participant Withdrew Consent|0|||
147395407|NCT04267393|531611588|FG002|Treatment Period|Participant Withdrew Consent|1|||
147395408|NCT04267393|531611586|FG000|Treatment Period|Administrative Reasons by Sponsor|3|||
147395409|NCT04267393|531611587|FG001|Treatment Period|Administrative Reasons by Sponsor|4|||
147395410|NCT04267393|531611588|FG002|Treatment Period|Administrative Reasons by Sponsor|3|||
147395411|NCT02056873|531611589|FG000|Responsive DBS|CDBS parameters of 3 subjects|3|||
147395412|NCT03119688|531613110|FG000|Overall Study|Adverse Event|4|||
147395413|NCT02705625|531613111|FG000|Overall Study|Protocol Violation|1|||
147395414|NCT02705625|531613112|FG001|Overall Study|Protocol Violation|0|||
147395415|NCT02705625|531613113|FG002|Overall Study|Protocol Violation|0|||
147395416|NCT02705625|531613111|FG000|Overall Study|Adverse Event|6|||
147395417|NCT02705625|531613112|FG001|Overall Study|Adverse Event|5|||
147395418|NCT02705625|531613113|FG002|Overall Study|Adverse Event|2|||
147395419|NCT02705625|531613111|FG000|Overall Study|Death|0|||
147395420|NCT02705625|531613112|FG001|Overall Study|Death|0|||
147395421|NCT02705625|531613113|FG002|Overall Study|Death|1|||
147395422|NCT02705625|531613111|FG000|Overall Study|Withdrawal by Subject|1|||
147395423|NCT02705625|531613112|FG001|Overall Study|Withdrawal by Subject|4|||
147395424|NCT02705625|531613113|FG002|Overall Study|Withdrawal by Subject|5|||
147395425|NCT02705625|531613111|FG000|Overall Study|Lost to Follow-up|0|||
147395426|NCT02705625|531613112|FG001|Overall Study|Lost to Follow-up|0|||
147395427|NCT02705625|531613113|FG002|Overall Study|Lost to Follow-up|1|||
147395428|NCT02705625|531613111|FG000|Overall Study|Non-compliance|0|||
147395429|NCT02705625|531613112|FG001|Overall Study|Non-compliance|1|||
147665180|NCT01190813|532598060|FG000|Overall Study|Withdrawal by Subject|2|||
147665181|NCT01190813|532598061|FG001|Overall Study|Withdrawal by Subject|1|||
147665182|NCT01190813|532598060|FG000|Overall Study|Refused study treatment after randomized|1|||
147665183|NCT01190813|532598061|FG001|Overall Study|Refused study treatment after randomized|0|||
147665184|NCT01190813|532598060|FG000|Overall Study|Adverse Event|0|||
147395430|NCT02705625|531613113|FG002|Overall Study|Non-compliance|1|||
147395431|NCT02705625|531613111|FG000|Overall Study|Overdosing|0|||
147395432|NCT02705625|531613112|FG001|Overall Study|Overdosing|0|||
147395433|NCT02705625|531613113|FG002|Overall Study|Overdosing|1|||
147395434|NCT00863798|531613114|FG000|Overall Study|Adverse Event|5|||
147395435|NCT00863798|531613115|FG001|Overall Study|Adverse Event|2|||
147395436|NCT00863798|531613116|FG002|Overall Study|Adverse Event|4|||
147395437|NCT00863798|531613114|FG000|Overall Study|Participant failed to return|2|||
147395438|NCT00863798|531613115|FG001|Overall Study|Participant failed to return|1|||
147395439|NCT00863798|531613116|FG002|Overall Study|Participant failed to return|0|||
147395440|NCT00863798|531613114|FG000|Overall Study|Investigator request|1|||
147395441|NCT00863798|531613115|FG001|Overall Study|Investigator request|2|||
147395442|NCT00863798|531613116|FG002|Overall Study|Investigator request|1|||
147395443|NCT00863798|531613114|FG000|Overall Study|Lack of Efficacy|4|||
147460348|NCT00880750|531846991|FG001|First Intervention|Non-compliance with meals|1|||
147460349|NCT00880750|531846990|FG000|First Intervention|Withdrawal by Subject|2|||
147460350|NCT00880750|531846991|FG001|First Intervention|Withdrawal by Subject|0|||
147460351|NCT00880750|531846990|FG000|First Intervention|Lost to Follow-up|2|||
147460352|NCT00880750|531846991|FG001|First Intervention|Lost to Follow-up|0|||
147460353|NCT00880750|531846990|FG000|Second Intervention|Withdrawal by Subject|2|||
147460354|NCT00880750|531846991|FG001|Second Intervention|Withdrawal by Subject|2|||
147460355|NCT00880750|531846990|FG000|Second Intervention|Protocol Violation|1|||
147460356|NCT00880750|531846991|FG001|Second Intervention|Protocol Violation|0|||
147460357|NCT00880750|531846990|FG000|Second Intervention|Unable to collect urine|1|||
147460358|NCT00880750|531846991|FG001|Second Intervention|Unable to collect urine|0|||
147460359|NCT00667576|531846998|FG000|Overall Study|Withdrawal by Subject|1|||
147460360|NCT00667576|531846999|FG001|Overall Study|Withdrawal by Subject|0|||
147460361|NCT00667576|531847000|FG002|Overall Study|Withdrawal by Subject|1|||
147460362|NCT00667576|531847001|FG003|Overall Study|Withdrawal by Subject|1|||
147460363|NCT00667576|531847002|FG004|Overall Study|Withdrawal by Subject|1|||
147460364|NCT00667576|531846998|FG000|Overall Study|Adverse Event|1|||
147460365|NCT00667576|531846999|FG001|Overall Study|Adverse Event|1|||
147460366|NCT00667576|531847000|FG002|Overall Study|Adverse Event|0|||
147460367|NCT00667576|531847001|FG003|Overall Study|Adverse Event|0|||
147460368|NCT00667576|531847002|FG004|Overall Study|Adverse Event|0|||
147460369|NCT00667576|531846998|FG000|Overall Study|Lost to Follow-up|0|||
147460370|NCT00667576|531846999|FG001|Overall Study|Lost to Follow-up|0|||
147460371|NCT00667576|531847000|FG002|Overall Study|Lost to Follow-up|1|||
147460372|NCT00667576|531847001|FG003|Overall Study|Lost to Follow-up|0|||
147460373|NCT00667576|531847002|FG004|Overall Study|Lost to Follow-up|0|||
147460374|NCT00667576|531846998|FG000|Overall Study|Protocol Violation|0|||
147460375|NCT00667576|531846999|FG001|Overall Study|Protocol Violation|0|||
147460376|NCT00667576|531847000|FG002|Overall Study|Protocol Violation|0|||
147460377|NCT00667576|531847001|FG003|Overall Study|Protocol Violation|1|||
147460378|NCT00667576|531847002|FG004|Overall Study|Protocol Violation|0|||
147460379|NCT00667576|531846998|FG000|Overall Study|Physician Decision|0|||
147460380|NCT00667576|531846999|FG001|Overall Study|Physician Decision|0|||
147460381|NCT00667576|531847000|FG002|Overall Study|Physician Decision|0|||
147460382|NCT00667576|531847001|FG003|Overall Study|Physician Decision|1|||
147460383|NCT00667576|531847002|FG004|Overall Study|Physician Decision|0|||
147460384|NCT00667576|531846998|FG000|Overall Study|Missed Visit|0|||
147460385|NCT00667576|531846999|FG001|Overall Study|Missed Visit|0|||
147460386|NCT00667576|531847000|FG002|Overall Study|Missed Visit|0|||
147460387|NCT00667576|531847001|FG003|Overall Study|Missed Visit|1|||
147460388|NCT00667576|531847002|FG004|Overall Study|Missed Visit|0|||
147460389|NCT00483327|531847006|FG000|Overall Study|Adverse Event|1|||
147460390|NCT00483327|531847006|FG000|Overall Study|Withdrawal by Subject|3|||
147460391|NCT00483327|531847006|FG000|Overall Study|Lost to Follow-up|4|||
147460392|NCT00483327|531847006|FG000|Overall Study|Patient Non Compliance|2|||
147615360|NCT00866359|532406715|FG001|Treatment Phase (Days 1 to 85)|Lack of Efficacy|0|||
147615361|NCT00866359|532406716|FG002|Treatment Phase (Days 1 to 85)|Lack of Efficacy|0|||
147615362|NCT00866359|532406717|FG003|Treatment Phase (Days 1 to 85)|Lack of Efficacy|0|||
147615363|NCT00866359|532406714|FG000|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|1|||
147615364|NCT00866359|532406715|FG001|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|0|||
147615365|NCT00866359|532406716|FG002|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|0|||
147615366|NCT00866359|532406717|FG003|Treatment Phase (Days 1 to 85)|Withdrawal by Subject|0|||
147615367|NCT00866359|532406714|FG000|Treatment Phase (Days 1 to 85)|Protocol Violation|1|||
147615368|NCT00866359|532406715|FG001|Treatment Phase (Days 1 to 85)|Protocol Violation|1|||
147615369|NCT00866359|532406716|FG002|Treatment Phase (Days 1 to 85)|Protocol Violation|0|||
147615370|NCT00866359|532406717|FG003|Treatment Phase (Days 1 to 85)|Protocol Violation|0|||
147615371|NCT00866359|532406714|FG000|Treatment Phase (Days 1 to 85)|Other|1|||
147615372|NCT00866359|532406715|FG001|Treatment Phase (Days 1 to 85)|Other|0|||
147615373|NCT00866359|532406716|FG002|Treatment Phase (Days 1 to 85)|Other|0|||
147615374|NCT00866359|532406717|FG003|Treatment Phase (Days 1 to 85)|Other|0|||
147665185|NCT01190813|532598061|FG001|Overall Study|Adverse Event|1|||
147460393|NCT00618722|531847007|FG000|Overall Study|Refusal of Treatment|0|||
147460394|NCT00618722|531847008|FG001|Overall Study|Refusal of Treatment|0|||
147460395|NCT00618722|531847009|FG002|Overall Study|Refusal of Treatment|1|||
147460396|NCT00618722|531847010|FG003|Overall Study|Refusal of Treatment|0|||
147460397|NCT00618722|531847007|FG000|Overall Study|Patient Request|1|||
147460398|NCT00618722|531847008|FG001|Overall Study|Patient Request|1|||
147460399|NCT00618722|531847009|FG002|Overall Study|Patient Request|1|||
147460400|NCT00618722|531847010|FG003|Overall Study|Patient Request|1|||
147460401|NCT00618722|531847007|FG000|Overall Study|Inability to Complete Study Procedure|0|||
147460402|NCT00618722|531847008|FG001|Overall Study|Inability to Complete Study Procedure|1|||
147460403|NCT00618722|531847009|FG002|Overall Study|Inability to Complete Study Procedure|0|||
147460404|NCT00618722|531847010|FG003|Overall Study|Inability to Complete Study Procedure|0|||
147460405|NCT00618722|531847007|FG000|Overall Study|Lost to Follow-up|2|||
147460406|NCT00618722|531847008|FG001|Overall Study|Lost to Follow-up|0|||
147460407|NCT00618722|531847009|FG002|Overall Study|Lost to Follow-up|0|||
147460408|NCT00618722|531847010|FG003|Overall Study|Lost to Follow-up|2|||
147460409|NCT00618722|531847007|FG000|Overall Study|Miscellaneous Reasons|0|||
147460410|NCT00618722|531847008|FG001|Overall Study|Miscellaneous Reasons|0|||
147460411|NCT00618722|531847009|FG002|Overall Study|Miscellaneous Reasons|1|||
147460412|NCT00618722|531847010|FG003|Overall Study|Miscellaneous Reasons|1|||
147460413|NCT00200057|531847011|FG000|Overall Study|Lack of Efficacy|3|||
147460414|NCT00200057|531847011|FG000|Overall Study|Exited due to terminal illness of PI|2|||
147460415|NCT00200057|531847011|FG000|Overall Study|Withdrawal by Subject|1|||
147460416|NCT00200057|531847011|FG000|Overall Study|Change in medical condition|1|||
147460417|NCT00200057|531847011|FG000|Overall Study|Infection|1|||
147460418|NCT00200057|531847011|FG000|Overall Study|Death|1|||
147460419|NCT05512949|531847012|FG000|Overall Study|Lost to Follow-up|4|||
147460420|NCT05512949|531847013|FG001|Overall Study|Lost to Follow-up|6|||
147460421|NCT05512949|531847014|FG002|Overall Study|Lost to Follow-up|2|||
147460422|NCT05512949|531847012|FG000|Overall Study|Protocol Violation|0|||
147460423|NCT05512949|531847013|FG001|Overall Study|Protocol Violation|0|||
147460424|NCT05512949|531847014|FG002|Overall Study|Protocol Violation|1|||
147460425|NCT05512949|531847012|FG000|Overall Study|Withdrawal by Subject|1|||
147460426|NCT05512949|531847013|FG001|Overall Study|Withdrawal by Subject|1|||
147460427|NCT05512949|531847014|FG002|Overall Study|Withdrawal by Subject|2|||
147460428|NCT05512949|531847012|FG000|Overall Study|Completion status unknown|1|||
147460429|NCT05512949|531847013|FG001|Overall Study|Completion status unknown|3|||
147460430|NCT05512949|531847014|FG002|Overall Study|Completion status unknown|0|||
147460431|NCT02810964|531847015|FG000|Double-Blind Treatment Phase (16 Weeks)|Withdrawal by Subject|1|||
147460432|NCT02810964|531847016|FG001|Double-Blind Treatment Phase (16 Weeks)|Withdrawal by Subject|2|||
147460433|NCT02810964|531847015|FG000|Double-Blind Treatment Phase (16 Weeks)|Lost to Follow-up|1|||
147460434|NCT02810964|531847016|FG001|Double-Blind Treatment Phase (16 Weeks)|Lost to Follow-up|0|||
147395444|NCT00863798|531613115|FG001|Overall Study|Lack of Efficacy|3|||
147395445|NCT00863798|531613116|FG002|Overall Study|Lack of Efficacy|6|||
147395446|NCT00863798|531613114|FG000|Overall Study|Lost to Follow-up|6|||
147395447|NCT00863798|531613115|FG001|Overall Study|Lost to Follow-up|9|||
147395448|NCT00863798|531613116|FG002|Overall Study|Lost to Follow-up|5|||
147395449|NCT00863798|531613114|FG000|Overall Study|Other|2|||
147395450|NCT00863798|531613115|FG001|Overall Study|Other|3|||
147395451|NCT00863798|531613116|FG002|Overall Study|Other|1|||
147395452|NCT00863798|531613114|FG000|Overall Study|Protocol Violation|0|||
147395453|NCT00863798|531613115|FG001|Overall Study|Protocol Violation|1|||
147395454|NCT00863798|531613116|FG002|Overall Study|Protocol Violation|1|||
147395455|NCT00863798|531613114|FG000|Overall Study|Withdrawal by Subject|8|||
147395456|NCT00863798|531613115|FG001|Overall Study|Withdrawal by Subject|7|||
147395457|NCT00863798|531613116|FG002|Overall Study|Withdrawal by Subject|4|||
147395458|NCT00863798|531613114|FG000|Overall Study|Randomized not treated|4|||
147395459|NCT00863798|531613115|FG001|Overall Study|Randomized not treated|2|||
147395460|NCT00863798|531613116|FG002|Overall Study|Randomized not treated|3|||
147395461|NCT04238520|531613118|FG000|Overall Study|Withdrawal by Subject|1|||
147395462|NCT04238520|531613119|FG001|Overall Study|Withdrawal by Subject|1|||
147395463|NCT04238520|531613118|FG000|Overall Study|Lost to Follow-up|1|||
147395464|NCT04238520|531613119|FG001|Overall Study|Lost to Follow-up|2|||
147395465|NCT04238520|531613118|FG000|Overall Study|Death|0|||
147395466|NCT04238520|531613119|FG001|Overall Study|Death|2|||
147395467|NCT04238520|531613118|FG000|Overall Study|Unsafe home environment for research staff|0|||
147395468|NCT04238520|531613119|FG001|Overall Study|Unsafe home environment for research staff|1|||
147395469|NCT01470599|531613120|FG000|Overall Study|Did not meet entrance criteria|1|||
147395470|NCT01470599|531613121|FG001|Overall Study|Did not meet entrance criteria|0|||
147395471|NCT01470599|531613120|FG000|Overall Study|Lost to Follow-up|2|||
147395472|NCT01470599|531613121|FG001|Overall Study|Lost to Follow-up|1|||
147395473|NCT01470599|531613120|FG000|Overall Study|Withdrawal by Subject|3|||
147395474|NCT01470599|531613121|FG001|Overall Study|Withdrawal by Subject|4|||
147395475|NCT01470599|531613120|FG000|Overall Study|Other|1|||
147395476|NCT01470599|531613121|FG001|Overall Study|Other|0|||
147395477|NCT01470599|531613120|FG000|Overall Study|Protocol Violation|3|||
147460435|NCT02810964|531847015|FG000|Double-Blind Treatment Phase (16 Weeks)|Protocol Violation|0|||
147460436|NCT02810964|531847016|FG001|Double-Blind Treatment Phase (16 Weeks)|Protocol Violation|1|||
147460437|NCT02810964|531847015|FG000|Double-Blind Treatment Phase (16 Weeks)|Relocation|1|||
147460438|NCT02810964|531847016|FG001|Double-Blind Treatment Phase (16 Weeks)|Relocation|0|||
147460439|NCT03523351|531847017|FG000|Overall Study|Death|13|||
147460440|NCT03523351|531847018|FG001|Overall Study|Death|11|||
147460441|NCT03523351|531847017|FG000|Overall Study|Lost to Follow-up|2|||
147460442|NCT03523351|531847018|FG001|Overall Study|Lost to Follow-up|3|||
147395478|NCT01470599|531613121|FG001|Overall Study|Protocol Violation|1|||
147395479|NCT01470599|531613120|FG000|Overall Study|Adverse event related to study drug|2|||
147395480|NCT01470599|531613121|FG001|Overall Study|Adverse event related to study drug|5|||
147395481|NCT01470599|531613120|FG000|Overall Study|Insufficient clinical response|6|||
147395482|NCT01470599|531613121|FG001|Overall Study|Insufficient clinical response|27|||
147395483|NCT01470599|531613120|FG000|Overall Study|Adverse event not related to study drug|1|||
147395484|NCT01470599|531613121|FG001|Overall Study|Adverse event not related to study drug|5|||
147395485|NCT00195442|531613122|FG000|Overall Study|Less than expected therapeutic effect|38|||
147395486|NCT00195442|531613122|FG000|Overall Study|Lost to Follow-up|27|||
147395487|NCT00195442|531613122|FG000|Overall Study|Switch to other Factor VIII preparation|23|||
147395488|NCT00195442|531613122|FG000|Overall Study|Intermittent product shortage|21|||
147395489|NCT00195442|531613122|FG000|Overall Study|Death|7|||
147395490|NCT00195442|531613122|FG000|Overall Study|No reason specified|4|||
147395491|NCT00195442|531613122|FG000|Overall Study|Poor cooperation|2|||
147395492|NCT00195442|531613122|FG000|Overall Study|Other|14|||
147395493|NCT02637856|531613130|FG000|Main Study (Baseline to Week 100)|Adverse Event|9|||
147395494|NCT02637856|531613131|FG001|Main Study (Baseline to Week 100)|Adverse Event|0|||
147395495|NCT02637856|531613130|FG000|Main Study (Baseline to Week 100)|Lost to Follow-up|5|||
147395496|NCT02637856|531613131|FG001|Main Study (Baseline to Week 100)|Lost to Follow-up|0|||
147395497|NCT02637856|531613130|FG000|Main Study (Baseline to Week 100)|Physician Decision|2|||
147395498|NCT02637856|531613131|FG001|Main Study (Baseline to Week 100)|Physician Decision|0|||
147395499|NCT02637856|531613130|FG000|Main Study (Baseline to Week 100)|Pregnancy|7|||
147395500|NCT02637856|531613131|FG001|Main Study (Baseline to Week 100)|Pregnancy|0|||
147395501|NCT02637856|531613130|FG000|Main Study (Baseline to Week 100)|Withdrawal by Subject|20|||
147395502|NCT02637856|531613131|FG001|Main Study (Baseline to Week 100)|Withdrawal by Subject|0|||
147395503|NCT02637856|531613130|FG000|Main Study (Baseline to Week 100)|Protocol Deviation|2|||
147395504|NCT02637856|531613131|FG001|Main Study (Baseline to Week 100)|Protocol Deviation|0|||
147395505|NCT02637856|531613130|FG000|Main Study (Baseline to Week 100)|Continued on Commercial Ocrevus|164|||
147395506|NCT02637856|531613131|FG001|Main Study (Baseline to Week 100)|Continued on Commercial Ocrevus|0|||
147395507|NCT02637856|531613130|FG000|Main Study (Baseline to Week 100)|Failed Drug Test|1|||
147395508|NCT02637856|531613131|FG001|Main Study (Baseline to Week 100)|Failed Drug Test|0|||
147395509|NCT02637856|531613130|FG000|Main Study (Baseline to Week 100)|Incarceration|1|||
147395510|NCT02637856|531613131|FG001|Main Study (Baseline to Week 100)|Incarceration|0|||
147395511|NCT02637856|531613130|FG000|Main Study (Baseline to Week 100)|Pregnancy Attempts|2|||
147395512|NCT02637856|531613131|FG001|Main Study (Baseline to Week 100)|Pregnancy Attempts|0|||
147395513|NCT02637856|531613130|FG000|Main Study (Baseline to Week 100)|Site Closing|6|||
147395514|NCT02637856|531613131|FG001|Main Study (Baseline to Week 100)|Site Closing|0|||
147395515|NCT02637856|531613130|FG000|Sub-Study (Week 72 to Week 100)|Non-safety reason (moved out of state)|0|||
147395516|NCT02637856|531613131|FG001|Sub-Study (Week 72 to Week 100)|Non-safety reason (moved out of state)|1|||
147395517|NCT02637856|531613130|FG000|Sub-Study (Week 72 to Week 100)|Lost to Follow-up|0|||
147395518|NCT02637856|531613131|FG001|Sub-Study (Week 72 to Week 100)|Lost to Follow-up|3|||
147395519|NCT02509312|531613132|FG000|Overall Study|Cesarean after 4pm / Unable to complete enrollment due to floor acuity|5|||
147395520|NCT02509312|531613133|FG001|Overall Study|Cesarean after 4pm / Unable to complete enrollment due to floor acuity|3|||
147395521|NCT02509312|531613132|FG000|Overall Study|Obstetrician refusal|0|||
147395522|NCT02509312|531613133|FG001|Overall Study|Obstetrician refusal|1|||
147395523|NCT02509312|531613132|FG000|Overall Study|Patient elected for TOLAC|1|||
147395524|NCT02509312|531613133|FG001|Overall Study|Patient elected for TOLAC|0|||
147395525|NCT02509312|531613132|FG000|Overall Study|Cesarean deemed stat|1|||
147395526|NCT02509312|531613133|FG001|Overall Study|Cesarean deemed stat|0|||
147395527|NCT02509312|531613132|FG000|Overall Study|Anaphylaxis prior to cord clamp to non-study drug|0|||
147395528|NCT02509312|531613133|FG001|Overall Study|Anaphylaxis prior to cord clamp to non-study drug|1|||
147395529|NCT02815735|531613134|FG000|First Intervention (4 Weeks)|Discomfort|1|||
147395530|NCT02815735|531613135|FG001|First Intervention (4 Weeks)|Discomfort|0|||
147395531|NCT02815735|531613134|FG000|First Intervention (4 Weeks)|Lost to Follow-up|1|||
147395532|NCT02815735|531613135|FG001|First Intervention (4 Weeks)|Lost to Follow-up|0|||
147395533|NCT02815735|531613134|FG000|First Intervention (4 Weeks)|Poor fitting characteristics|0|||
147395534|NCT02815735|531613135|FG001|First Intervention (4 Weeks)|Poor fitting characteristics|1|||
147395535|NCT02815735|531613134|FG000|Second Intervention (4 Weeks)|Protocol Violation|1|||
147395536|NCT02815735|531613135|FG001|Second Intervention (4 Weeks)|Protocol Violation|0|||
147395537|NCT00702650|531613139|FG000|Overall Study|Withdrawal by Subject|9|||
147395538|NCT00702650|531613139|FG000|Overall Study|Non-Compliance of Study Drug|3|||
147395539|NCT00702650|531613139|FG000|Overall Study|Lost to Follow-up|2|||
147395540|NCT00702650|531613139|FG000|Overall Study|Non-Compliance with Site Directives|1|||
147395541|NCT00702650|531613139|FG000|Overall Study|Sponsor Request|1|||
147395542|NCT00702650|531613139|FG000|Overall Study|Screening Testosterone Levels >300 ng/dL|1|||
147395543|NCT00702650|531613139|FG000|Overall Study|Adverse Event|3|||
147395544|NCT00988533|531613140|FG000|Overall Study|Lost to Follow-up|3|||
147395545|NCT00943722|531613142|FG000|Base Study|Adverse Event|0|||
147615375|NCT00866359|532406714|FG000|Extension Phase (Day 86 to 169)|Adverse Event|0|||
147395546|NCT00943722|531613143|FG001|Base Study|Adverse Event|0|||
147395547|NCT00943722|531613144|FG002|Base Study|Adverse Event|0|||
147395548|NCT00943722|531613145|FG003|Base Study|Adverse Event|1|||
147395549|NCT00943722|531613146|FG004|Base Study|Adverse Event|0|||
147395550|NCT00943722|531613147|FG005|Base Study|Adverse Event|0|||
147395551|NCT00943722|531613148|FG006|Base Study|Adverse Event|0|||
147395552|NCT00943722|531613142|FG000|Base Study|Lost to Follow-up|12|||
147395553|NCT00943722|531613143|FG001|Base Study|Lost to Follow-up|8|||
147395554|NCT00943722|531613144|FG002|Base Study|Lost to Follow-up|10|||
147460443|NCT03523351|531847017|FG000|Overall Study|Withdrawal by Subject|4|||
147460444|NCT03523351|531847018|FG001|Overall Study|Withdrawal by Subject|0|||
147460445|NCT03523351|531847017|FG000|Overall Study|Patient was not treated on study but enrolled due to progressive disease during active treatment|0|||
147460446|NCT03523351|531847018|FG001|Overall Study|Patient was not treated on study but enrolled due to progressive disease during active treatment|2|||
147460447|NCT01430442|531847019|FG000|Overall Study|Subject Withdrew Consent|3|||
147460448|NCT01430442|531847020|FG001|Overall Study|Subject Withdrew Consent|0|||
147460449|NCT01430442|531847021|FG002|Overall Study|Subject Withdrew Consent|1|||
147460450|NCT01430442|531847022|FG003|Overall Study|Subject Withdrew Consent|0|||
147460451|NCT01430442|531847023|FG004|Overall Study|Subject Withdrew Consent|2|||
147460452|NCT01430442|531847024|FG005|Overall Study|Subject Withdrew Consent|1|||
147460453|NCT01430442|531847025|FG006|Overall Study|Subject Withdrew Consent|5|||
147460454|NCT01430442|531847026|FG007|Overall Study|Subject Withdrew Consent|2|||
147460455|NCT01430442|531847019|FG000|Overall Study|Lost to Follow-up|2|||
147460456|NCT01430442|531847020|FG001|Overall Study|Lost to Follow-up|0|||
147460457|NCT01430442|531847021|FG002|Overall Study|Lost to Follow-up|1|||
147460458|NCT01430442|531847022|FG003|Overall Study|Lost to Follow-up|2|||
147460459|NCT01430442|531847023|FG004|Overall Study|Lost to Follow-up|2|||
147460460|NCT01430442|531847024|FG005|Overall Study|Lost to Follow-up|1|||
147460461|NCT01430442|531847025|FG006|Overall Study|Lost to Follow-up|5|||
147460462|NCT01430442|531847026|FG007|Overall Study|Lost to Follow-up|1|||
147460463|NCT01430442|531847019|FG000|Overall Study|Pregnancy|1|||
147460464|NCT01430442|531847020|FG001|Overall Study|Pregnancy|0|||
147460465|NCT01430442|531847021|FG002|Overall Study|Pregnancy|0|||
147460466|NCT01430442|531847022|FG003|Overall Study|Pregnancy|0|||
147460467|NCT01430442|531847023|FG004|Overall Study|Pregnancy|0|||
147460468|NCT01430442|531847024|FG005|Overall Study|Pregnancy|1|||
147460469|NCT01430442|531847025|FG006|Overall Study|Pregnancy|0|||
147460470|NCT01430442|531847026|FG007|Overall Study|Pregnancy|0|||
147460471|NCT01430442|531847019|FG000|Overall Study|Patient No Longer Meets Study Criteria|7|||
147615376|NCT00866359|532406715|FG001|Extension Phase (Day 86 to 169)|Adverse Event|0|||
147615377|NCT00866359|532406716|FG002|Extension Phase (Day 86 to 169)|Adverse Event|1|||
147615378|NCT00866359|532406717|FG003|Extension Phase (Day 86 to 169)|Adverse Event|3|||
147615379|NCT01625091|532406718|FG000|Intervention|Death|1|||
147395555|NCT00943722|531613145|FG003|Base Study|Lost to Follow-up|8|||
147395556|NCT00943722|531613146|FG004|Base Study|Lost to Follow-up|11|||
147395557|NCT00943722|531613147|FG005|Base Study|Lost to Follow-up|0|||
147395558|NCT00943722|531613148|FG006|Base Study|Lost to Follow-up|0|||
147395559|NCT00943722|531613142|FG000|Base Study|Physician Decision|1|||
147395560|NCT00943722|531613143|FG001|Base Study|Physician Decision|0|||
147395561|NCT00943722|531613144|FG002|Base Study|Physician Decision|0|||
147395562|NCT00943722|531613145|FG003|Base Study|Physician Decision|0|||
147395563|NCT00943722|531613146|FG004|Base Study|Physician Decision|1|||
147395564|NCT00943722|531613147|FG005|Base Study|Physician Decision|0|||
147395565|NCT00943722|531613148|FG006|Base Study|Physician Decision|0|||
147395566|NCT00943722|531613142|FG000|Base Study|Pregnancy|0|||
147395567|NCT00943722|531613143|FG001|Base Study|Pregnancy|0|||
147395568|NCT00943722|531613144|FG002|Base Study|Pregnancy|1|||
147395569|NCT00943722|531613145|FG003|Base Study|Pregnancy|0|||
147395570|NCT00943722|531613146|FG004|Base Study|Pregnancy|2|||
147395571|NCT00943722|531613147|FG005|Base Study|Pregnancy|0|||
147395572|NCT00943722|531613148|FG006|Base Study|Pregnancy|0|||
147395573|NCT00943722|531613142|FG000|Base Study|Protocol Violation|0|||
147395574|NCT00943722|531613143|FG001|Base Study|Protocol Violation|1|||
147395575|NCT00943722|531613144|FG002|Base Study|Protocol Violation|0|||
147395576|NCT00943722|531613145|FG003|Base Study|Protocol Violation|0|||
147395577|NCT00943722|531613146|FG004|Base Study|Protocol Violation|2|||
147395578|NCT00943722|531613147|FG005|Base Study|Protocol Violation|0|||
147395579|NCT00943722|531613148|FG006|Base Study|Protocol Violation|0|||
147395580|NCT00943722|531613142|FG000|Base Study|Withdrawal by Subject|12|||
147395581|NCT00943722|531613143|FG001|Base Study|Withdrawal by Subject|13|||
147395582|NCT00943722|531613144|FG002|Base Study|Withdrawal by Subject|2|||
147395583|NCT00943722|531613145|FG003|Base Study|Withdrawal by Subject|13|||
147395584|NCT00943722|531613146|FG004|Base Study|Withdrawal by Subject|8|||
147395585|NCT00943722|531613147|FG005|Base Study|Withdrawal by Subject|0|||
147395586|NCT00943722|531613148|FG006|Base Study|Withdrawal by Subject|0|||
147395587|NCT00943722|531613142|FG000|Base Study|Month 12 visit not completed|0|||
147395588|NCT00943722|531613143|FG001|Base Study|Month 12 visit not completed|0|||
147395589|NCT00943722|531613144|FG002|Base Study|Month 12 visit not completed|0|||
147395590|NCT00943722|531613145|FG003|Base Study|Month 12 visit not completed|0|||
147395591|NCT00943722|531613146|FG004|Base Study|Month 12 visit not completed|2|||
147395592|NCT00943722|531613147|FG005|Base Study|Month 12 visit not completed|0|||
147395593|NCT00943722|531613148|FG006|Base Study|Month 12 visit not completed|0|||
147395594|NCT00943722|531613142|FG000|First Extension Study: EXT 1|Adverse Event|0|||
147395595|NCT00943722|531613143|FG001|First Extension Study: EXT 1|Adverse Event|0|||
147395596|NCT00943722|531613144|FG002|First Extension Study: EXT 1|Adverse Event|0|||
147395597|NCT00943722|531613145|FG003|First Extension Study: EXT 1|Adverse Event|0|||
147395598|NCT00943722|531613146|FG004|First Extension Study: EXT 1|Adverse Event|0|||
147395599|NCT00943722|531613147|FG005|First Extension Study: EXT 1|Adverse Event|1|||
147395600|NCT00943722|531613148|FG006|First Extension Study: EXT 1|Adverse Event|0|||
147395601|NCT00943722|531613142|FG000|First Extension Study: EXT 1|Lost to Follow-up|0|||
147395602|NCT00943722|531613143|FG001|First Extension Study: EXT 1|Lost to Follow-up|0|||
147395603|NCT00943722|531613144|FG002|First Extension Study: EXT 1|Lost to Follow-up|0|||
147395604|NCT00943722|531613145|FG003|First Extension Study: EXT 1|Lost to Follow-up|0|||
147395605|NCT00943722|531613146|FG004|First Extension Study: EXT 1|Lost to Follow-up|0|||
147395606|NCT00943722|531613147|FG005|First Extension Study: EXT 1|Lost to Follow-up|38|||
147395607|NCT00943722|531613148|FG006|First Extension Study: EXT 1|Lost to Follow-up|10|||
147395608|NCT00943722|531613142|FG000|First Extension Study: EXT 1|Withdrawal by Subject|0|||
147395609|NCT00943722|531613143|FG001|First Extension Study: EXT 1|Withdrawal by Subject|0|||
147395610|NCT00943722|531613144|FG002|First Extension Study: EXT 1|Withdrawal by Subject|0|||
147395611|NCT00943722|531613145|FG003|First Extension Study: EXT 1|Withdrawal by Subject|0|||
147395612|NCT00943722|531613146|FG004|First Extension Study: EXT 1|Withdrawal by Subject|0|||
147395613|NCT00943722|531613147|FG005|First Extension Study: EXT 1|Withdrawal by Subject|32|||
147395614|NCT00943722|531613148|FG006|First Extension Study: EXT 1|Withdrawal by Subject|10|||
147395615|NCT00943722|531613142|FG000|First Extension Study: EXT 1|Disposition Unknown|0|||
147395616|NCT00943722|531613143|FG001|First Extension Study: EXT 1|Disposition Unknown|0|||
147395617|NCT00943722|531613144|FG002|First Extension Study: EXT 1|Disposition Unknown|0|||
147395618|NCT00943722|531613145|FG003|First Extension Study: EXT 1|Disposition Unknown|0|||
147395619|NCT00943722|531613146|FG004|First Extension Study: EXT 1|Disposition Unknown|0|||
147395620|NCT00943722|531613147|FG005|First Extension Study: EXT 1|Disposition Unknown|44|||
147395621|NCT00943722|531613148|FG006|First Extension Study: EXT 1|Disposition Unknown|21|||
147395622|NCT00943722|531613142|FG000|Second Extension Study: EXT 2|Adverse Event|0|||
147395623|NCT00943722|531613143|FG001|Second Extension Study: EXT 2|Adverse Event|0|||
147395624|NCT00943722|531613144|FG002|Second Extension Study: EXT 2|Adverse Event|0|||
147395625|NCT00943722|531613145|FG003|Second Extension Study: EXT 2|Adverse Event|0|||
147395626|NCT00943722|531613146|FG004|Second Extension Study: EXT 2|Adverse Event|0|||
147395627|NCT00943722|531613147|FG005|Second Extension Study: EXT 2|Adverse Event|1|||
147395628|NCT00943722|531613148|FG006|Second Extension Study: EXT 2|Adverse Event|0|||
147395629|NCT00943722|531613142|FG000|Second Extension Study: EXT 2|Lost to Follow-up|0|||
147395630|NCT00943722|531613143|FG001|Second Extension Study: EXT 2|Lost to Follow-up|0|||
147395631|NCT00943722|531613144|FG002|Second Extension Study: EXT 2|Lost to Follow-up|0|||
147395632|NCT00943722|531613145|FG003|Second Extension Study: EXT 2|Lost to Follow-up|0|||
147395633|NCT00943722|531613146|FG004|Second Extension Study: EXT 2|Lost to Follow-up|0|||
147395634|NCT00943722|531613147|FG005|Second Extension Study: EXT 2|Lost to Follow-up|111|||
147395635|NCT00943722|531613148|FG006|Second Extension Study: EXT 2|Lost to Follow-up|46|||
147395636|NCT00943722|531613142|FG000|Second Extension Study: EXT 2|Physician Decision|0|||
147395637|NCT00943722|531613143|FG001|Second Extension Study: EXT 2|Physician Decision|0|||
147395638|NCT00943722|531613144|FG002|Second Extension Study: EXT 2|Physician Decision|0|||
147395639|NCT00943722|531613145|FG003|Second Extension Study: EXT 2|Physician Decision|0|||
147395640|NCT00943722|531613146|FG004|Second Extension Study: EXT 2|Physician Decision|0|||
147395641|NCT00943722|531613147|FG005|Second Extension Study: EXT 2|Physician Decision|1|||
147395642|NCT00943722|531613148|FG006|Second Extension Study: EXT 2|Physician Decision|3|||
147395643|NCT00943722|531613142|FG000|Second Extension Study: EXT 2|Pregnancy|0|||
147395644|NCT00943722|531613143|FG001|Second Extension Study: EXT 2|Pregnancy|0|||
147395645|NCT00943722|531613144|FG002|Second Extension Study: EXT 2|Pregnancy|0|||
147395646|NCT00943722|531613145|FG003|Second Extension Study: EXT 2|Pregnancy|0|||
147395647|NCT00943722|531613146|FG004|Second Extension Study: EXT 2|Pregnancy|0|||
147395648|NCT00943722|531613147|FG005|Second Extension Study: EXT 2|Pregnancy|1|||
147395649|NCT00943722|531613148|FG006|Second Extension Study: EXT 2|Pregnancy|0|||
147395650|NCT00943722|531613142|FG000|Second Extension Study: EXT 2|Withdrawal by Subject|0|||
147395651|NCT00943722|531613143|FG001|Second Extension Study: EXT 2|Withdrawal by Subject|0|||
147395652|NCT00943722|531613144|FG002|Second Extension Study: EXT 2|Withdrawal by Subject|0|||
147395653|NCT00943722|531613145|FG003|Second Extension Study: EXT 2|Withdrawal by Subject|0|||
147395654|NCT00943722|531613146|FG004|Second Extension Study: EXT 2|Withdrawal by Subject|0|||
147395655|NCT00943722|531613147|FG005|Second Extension Study: EXT 2|Withdrawal by Subject|137|||
147395656|NCT00943722|531613148|FG006|Second Extension Study: EXT 2|Withdrawal by Subject|50|||
147460472|NCT01430442|531847020|FG001|Overall Study|Patient No Longer Meets Study Criteria|6|||
147460473|NCT01430442|531847021|FG002|Overall Study|Patient No Longer Meets Study Criteria|3|||
147460474|NCT01430442|531847022|FG003|Overall Study|Patient No Longer Meets Study Criteria|2|||
147395657|NCT01036165|531613149|FG000|Overall Study|Adverse Event|6|||
147395658|NCT01036165|531613149|FG000|Overall Study|Lost to Follow-up|2|||
147395659|NCT01036165|531613149|FG000|Overall Study|Withdrawal by Subject|3|||
147395660|NCT01036165|531613149|FG000|Overall Study|Device Related Issues|3|||
147395661|NCT01036165|531613149|FG000|Overall Study|Problems finding proper area to inject|1|||
147395662|NCT00307164|531613152|FG000|Overall Study|Death|1|||
147395663|NCT00307164|531613153|FG001|Overall Study|Death|0|||
147395664|NCT00307164|531613152|FG000|Overall Study|Severe debilitation, unable to continue|1|||
147395665|NCT00307164|531613153|FG001|Overall Study|Severe debilitation, unable to continue|0|||
147395666|NCT00307164|531613152|FG000|Overall Study|Subject/parent not able to get to clinic|2|||
147395667|NCT00307164|531613153|FG001|Overall Study|Subject/parent not able to get to clinic|1|||
147395668|NCT00307164|531613152|FG000|Overall Study|Withdrawal by Subject|1|||
147395669|NCT00307164|531613153|FG001|Overall Study|Withdrawal by Subject|8|||
147395670|NCT00307164|531613152|FG000|Overall Study|Not compliant with requirements|4|||
147395671|NCT00307164|531613153|FG001|Overall Study|Not compliant with requirements|4|||
147395672|NCT00307164|531613152|FG000|Overall Study|Lost to Follow-up|6|||
147395673|NCT00307164|531613153|FG001|Overall Study|Lost to Follow-up|1|||
147395674|NCT01649297|531613155|FG000|Overall Study|Adverse Event|5|||
147395675|NCT01649297|531613156|FG001|Overall Study|Adverse Event|5|||
147395676|NCT01649297|531613157|FG002|Overall Study|Adverse Event|4|||
147395677|NCT01649297|531613158|FG003|Overall Study|Adverse Event|13|||
147395678|NCT01649297|531613159|FG004|Overall Study|Adverse Event|1|||
147395679|NCT01649297|531613155|FG000|Overall Study|Lack of Efficacy|0|||
147395680|NCT01649297|531613156|FG001|Overall Study|Lack of Efficacy|0|||
147395681|NCT01649297|531613157|FG002|Overall Study|Lack of Efficacy|0|||
147395682|NCT01649297|531613158|FG003|Overall Study|Lack of Efficacy|0|||
147395683|NCT01649297|531613159|FG004|Overall Study|Lack of Efficacy|1|||
147395684|NCT01649297|531613155|FG000|Overall Study|Non compliant with Protocol|1|||
147395685|NCT01649297|531613156|FG001|Overall Study|Non compliant with Protocol|0|||
147395686|NCT01649297|531613157|FG002|Overall Study|Non compliant with Protocol|3|||
147395687|NCT01649297|531613158|FG003|Overall Study|Non compliant with Protocol|2|||
147395688|NCT01649297|531613159|FG004|Overall Study|Non compliant with Protocol|1|||
147395689|NCT01649297|531613155|FG000|Overall Study|Lost to Follow-up|1|||
147395690|NCT01649297|531613156|FG001|Overall Study|Lost to Follow-up|1|||
147395691|NCT01649297|531613157|FG002|Overall Study|Lost to Follow-up|4|||
147395692|NCT01649297|531613158|FG003|Overall Study|Lost to Follow-up|3|||
147395693|NCT01649297|531613159|FG004|Overall Study|Lost to Follow-up|0|||
147395694|NCT01649297|531613155|FG000|Overall Study|Patient withdrawal (not due to AE)|3|||
147395695|NCT01649297|531613156|FG001|Overall Study|Patient withdrawal (not due to AE)|6|||
147395696|NCT01649297|531613157|FG002|Overall Study|Patient withdrawal (not due to AE)|4|||
147395697|NCT01649297|531613158|FG003|Overall Study|Patient withdrawal (not due to AE)|1|||
147395698|NCT01649297|531613159|FG004|Overall Study|Patient withdrawal (not due to AE)|1|||
147395699|NCT01649297|531613155|FG000|Overall Study|For other reason|4|||
147395700|NCT01649297|531613156|FG001|Overall Study|For other reason|1|||
147395701|NCT01649297|531613157|FG002|Overall Study|For other reason|2|||
147395702|NCT01649297|531613158|FG003|Overall Study|For other reason|0|||
147395703|NCT01649297|531613159|FG004|Overall Study|For other reason|0|||
147395704|NCT01685047|531613160|FG000|Overall Study|Withdrawal by Subject|20|||
147395705|NCT01685047|531613160|FG000|Overall Study|Death|26|||
147395706|NCT01685047|531613160|FG000|Overall Study|Lost to Follow-up|8|||
147395707|NCT01685047|531613160|FG000|Overall Study|Physician Decision|25|||
147395708|NCT01685047|531613160|FG000|Overall Study|Adverse Event|5|||
147395709|NCT01685047|531613160|FG000|Overall Study|patient withdrawn by sponsor|1|||
147395710|NCT01732926|531613162|FG000|Overall Study|Study Terminated by Sponsor|168|||
147395711|NCT01732926|531613163|FG001|Overall Study|Study Terminated by Sponsor|80|||
147395712|NCT01732926|531613162|FG000|Overall Study|Withdrawal by Subject|46|||
147395713|NCT01732926|531613163|FG001|Overall Study|Withdrawal by Subject|8|||
147395714|NCT01732926|531613162|FG000|Overall Study|Physician Decision|24|||
147395715|NCT01732926|531613163|FG001|Overall Study|Physician Decision|11|||
147395716|NCT01732926|531613162|FG000|Overall Study|Other Reason|21|||
147395717|NCT01732926|531613163|FG001|Overall Study|Other Reason|4|||
147395718|NCT01732926|531613162|FG000|Overall Study|Initiation of Other Anti-Cancer Therapy|7|||
147395719|NCT01732926|531613163|FG001|Overall Study|Initiation of Other Anti-Cancer Therapy|6|||
147395720|NCT01732926|531613162|FG000|Overall Study|Blind Broken by Subject or Study Site|1|||
147395721|NCT01732926|531613163|FG001|Overall Study|Blind Broken by Subject or Study Site|1|||
147395722|NCT01049984|531613168|FG000|Overall Study|Withdrawal by Subject|1|||
147395723|NCT01049984|531613169|FG001|Overall Study|Withdrawal by Subject|5|||
147395724|NCT01049984|531613168|FG000|Overall Study|Protocol Violation|3|||
147395725|NCT01049984|531613169|FG001|Overall Study|Protocol Violation|4|||
147395726|NCT01049984|531613168|FG000|Overall Study|Lost to Follow-up|2|||
147395727|NCT01049984|531613169|FG001|Overall Study|Lost to Follow-up|1|||
147395728|NCT01049984|531613168|FG000|Overall Study|Adverse Event|13|||
147395729|NCT01049984|531613169|FG001|Overall Study|Adverse Event|7|||
147395730|NCT01049984|531613168|FG000|Overall Study|Treatment failure|0|||
147395731|NCT01049984|531613169|FG001|Overall Study|Treatment failure|2|||
147395732|NCT01040403|531613170|FG000|Overall Study|Adverse Event|10|||
147395733|NCT01040403|531613170|FG000|Overall Study|Protocol Violation|2|||
147395734|NCT01040403|531613170|FG000|Overall Study|Lost to Follow-up|1|||
147395735|NCT01040403|531613170|FG000|Overall Study|Not treated|1|||
147395736|NCT01040403|531613170|FG000|Overall Study|Other reason not defined above|6|||
147395737|NCT00292981|531613171|FG000|Overall Study|Adverse Event|1|||
147395738|NCT00292981|531613171|FG000|Overall Study|Lost to Follow-up|13|||
147395739|NCT00292981|531613171|FG000|Overall Study|Withdrawal by Subject|22|||
147395740|NCT00292981|531613171|FG000|Overall Study|Other|3|||
147395741|NCT00594178|531613174|FG000|Overall Study|Physician Decision|5|||
147615380|NCT01625091|532406719|FG001|Intervention|Death|1|||
147395742|NCT04191148|531613180|FG000|Overall Study|Withdrawal by Subject|1|||
147395743|NCT04191148|531613181|FG001|Overall Study|Withdrawal by Subject|0|||
147395744|NCT04191148|531613180|FG000|Overall Study|Adverse Event|1|||
147395745|NCT04191148|531613181|FG001|Overall Study|Adverse Event|0|||
147395746|NCT00129649|531613192|FG000|Overall Study|Withdrawal by Subject|76|||
147395747|NCT00129649|531613193|FG001|Overall Study|Withdrawal by Subject|65|||
147395748|NCT02482935|531613194|FG000|Period 1|Withdrawal by Subject|1|||
147395749|NCT02482935|531613195|FG001|Period 1|Withdrawal by Subject|0|||
147395750|NCT04952701|531613196|FG000|Control Lens|Physician Decision|4|||
147395751|NCT04952701|531613196|FG000|Test Lens|Physician Decision|1|||
147395752|NCT02212301|531613197|FG000|Period 1|Lost to Follow-up|0|||
147395753|NCT02212301|531613198|FG001|Period 1|Lost to Follow-up|1|||
147395754|NCT00578318|531613203|FG000|Overall Study|Lost to Follow-up|2|||
147395755|NCT00578318|531613204|FG001|Overall Study|Lost to Follow-up|0|||
147395756|NCT00578318|531613203|FG000|Overall Study|Physician Decision|1|||
147395757|NCT00578318|531613204|FG001|Overall Study|Physician Decision|0|||
147395758|NCT02025985|531613205|FG000|Overall Study|Consent withdrawn|0|||
147395759|NCT02025985|531613206|FG001|Overall Study|Consent withdrawn|0|||
147395760|NCT02025985|531613207|FG002|Overall Study|Consent withdrawn|1|||
147395761|NCT02025985|531613208|FG003|Overall Study|Consent withdrawn|0|||
147395762|NCT02025985|531613209|FG004|Overall Study|Consent withdrawn|0|||
147395763|NCT02025985|531613205|FG000|Overall Study|Termination of study by Sponsor|4|||
147395764|NCT02025985|531613206|FG001|Overall Study|Termination of study by Sponsor|3|||
147395765|NCT02025985|531613207|FG002|Overall Study|Termination of study by Sponsor|1|||
147395766|NCT02025985|531613208|FG003|Overall Study|Termination of study by Sponsor|1|||
147395767|NCT02025985|531613209|FG004|Overall Study|Termination of study by Sponsor|3|||
147395768|NCT02025985|531613205|FG000|Overall Study|Death|21|||
147395769|NCT02025985|531613206|FG001|Overall Study|Death|20|||
147395770|NCT02025985|531613207|FG002|Overall Study|Death|23|||
147395771|NCT02025985|531613208|FG003|Overall Study|Death|20|||
147395772|NCT02025985|531613209|FG004|Overall Study|Death|17|||
147395773|NCT00527514|531613210|FG000|Weeks 1-3: Amlodipine (Aml) 5mg|Adverse Event|1|||
147395774|NCT00527514|531613210|FG000|Weeks 4-6: Aml 5mg+Olmesartan 20 mg|Withdrawal by Subject|2|||
147395775|NCT00527514|531613210|FG000|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg|Adverse Event|1|||
147395776|NCT00527514|531613210|FG000|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg|Lost to Follow-up|1|||
147395777|NCT00527514|531613210|FG000|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg|Withdrawal by Subject|1|||
147395778|NCT00527514|531613210|FG000|Weeks 10-12:Aml 10 mg +Olmesartan 40 mg|Adverse Event|1|||
147395779|NCT00527514|531613210|FG000|Weeks 10-12:Aml 10 mg +Olmesartan 40 mg|Withdrawal by Subject|1|||
147395780|NCT03041701|531613211|FG000|Ph I: Dose Level 1 and 2 Dose Escalation|Not evaluable for toxicity|1|||
147395781|NCT03041701|531613212|FG001|Ph I: Dose Level 1 and 2 Dose Escalation|Not evaluable for toxicity|1|||
147395782|NCT03041701|531613213|FG002|Ph I: Dose Level 1 and 2 Dose Escalation|Not evaluable for toxicity|0|||
147395783|NCT03041701|531613211|FG000|Ph 2:Dose Level 1 Maximum Tolerated Dose|Unacceptable further treatment|0|||
147395784|NCT03041701|531613212|FG001|Ph 2:Dose Level 1 Maximum Tolerated Dose|Unacceptable further treatment|0|||
147395785|NCT03041701|531613213|FG002|Ph 2:Dose Level 1 Maximum Tolerated Dose|Unacceptable further treatment|1|||
147395786|NCT00920699|531613214|FG000|Overall Study|Withdrawal by Subject|2|||
147395787|NCT00920699|531613215|FG001|Overall Study|Withdrawal by Subject|0|||
147395788|NCT00920699|531613216|FG002|Overall Study|Withdrawal by Subject|2|||
147395789|NCT00920699|531613214|FG000|Overall Study|no longer met eligibility|0|||
147395790|NCT00920699|531613215|FG001|Overall Study|no longer met eligibility|1|||
147395791|NCT00920699|531613216|FG002|Overall Study|no longer met eligibility|0|||
147395792|NCT00920699|531613214|FG000|Overall Study|Lost to Follow-up|0|||
147395793|NCT00920699|531613215|FG001|Overall Study|Lost to Follow-up|0|||
147395794|NCT00920699|531613216|FG002|Overall Study|Lost to Follow-up|2|||
147395795|NCT00001941|531613217|FG000|Overall Study|not treated- rapidly progressing disease|0|||
147395796|NCT00001941|531613218|FG001|Overall Study|not treated- rapidly progressing disease|0|||
147395797|NCT00001941|531613219|FG002|Overall Study|not treated- rapidly progressing disease|0|||
147395798|NCT00001941|531613220|FG003|Overall Study|not treated- rapidly progressing disease|0|||
147395799|NCT00001941|531613221|FG004|Overall Study|not treated- rapidly progressing disease|1|||
147395800|NCT03175198|531613222|FG000|Overall Study|Adverse Event|480|||
147395801|NCT03175198|531613222|FG000|Overall Study|No actual visit|120|||
147395802|NCT03175198|531613222|FG000|Overall Study|Registration rule not followed|4|||
147395803|NCT03175198|531613222|FG000|Overall Study|Patients received Prazaxa treatment before|5|||
147395804|NCT03175198|531613222|FG000|Overall Study|Other personal reason|509|||
147395805|NCT03175198|531613222|FG000|Overall Study|To take a contraindication/careful administration drug|8|||
147395806|NCT03175198|531613222|FG000|Overall Study|Lost to follow-up (changing hospital)|373|||
147395807|NCT03175198|531613222|FG000|Overall Study|Lost to follow-up (unknown reason)|146|||
147395808|NCT03175198|531613222|FG000|Overall Study|To conduct invasive treatment of operation|53|||
147395809|NCT03175198|531613222|FG000|Overall Study|Improvement of nonvalvular atrial fibrillation|629|||
147395810|NCT02630706|531613223|FG000|Overall Study|Adverse Event|2|||
147615381|NCT01625091|532406718|FG000|Intervention|Withdrawal by Subject|4|||
147615382|NCT01625091|532406719|FG001|Intervention|Withdrawal by Subject|1|||
147615383|NCT01625091|532406718|FG000|Intervention|Adverse Event|0|||
147395811|NCT02630706|531613224|FG001|Overall Study|Adverse Event|1|||
147395812|NCT02630706|531613225|FG002|Overall Study|Adverse Event|1|||
147395813|NCT02630706|531613223|FG000|Overall Study|Lost to Follow-up|0|||
147395814|NCT02630706|531613224|FG001|Overall Study|Lost to Follow-up|1|||
147395815|NCT02630706|531613225|FG002|Overall Study|Lost to Follow-up|2|||
147395816|NCT02630706|531613223|FG000|Overall Study|Physician Decision|1|||
147395817|NCT02630706|531613224|FG001|Overall Study|Physician Decision|1|||
147395818|NCT02630706|531613225|FG002|Overall Study|Physician Decision|0|||
147395819|NCT02630706|531613223|FG000|Overall Study|Pregnancy|0|||
147395820|NCT02630706|531613224|FG001|Overall Study|Pregnancy|1|||
147395821|NCT02630706|531613225|FG002|Overall Study|Pregnancy|0|||
147395822|NCT02630706|531613223|FG000|Overall Study|Withdrawal by Subject|4|||
147395823|NCT02630706|531613224|FG001|Overall Study|Withdrawal by Subject|5|||
147395824|NCT02630706|531613225|FG002|Overall Study|Withdrawal by Subject|7|||
147395825|NCT01544309|531613230|FG000|Overall Study|Withdrawal by Subject|12|||
147395826|NCT01544309|531613231|FG001|Overall Study|Withdrawal by Subject|7|||
147395827|NCT01544309|531613230|FG000|Overall Study|Protocol Violation|2|||
147395828|NCT01544309|531613231|FG001|Overall Study|Protocol Violation|1|||
147395829|NCT01544309|531613230|FG000|Overall Study|Physician Decision|4|||
147395830|NCT01544309|531613231|FG001|Overall Study|Physician Decision|1|||
147395831|NCT01544309|531613230|FG000|Overall Study|Not performed pre-dose examination|1|||
147395832|NCT01544309|531613231|FG001|Overall Study|Not performed pre-dose examination|2|||
147395833|NCT01544309|531613230|FG000|Overall Study|Administered prohibit prior medication|1|||
147395834|NCT01544309|531613231|FG001|Overall Study|Administered prohibit prior medication|0|||
147395835|NCT02551692|531613236|FG000|Overall Study|Lost to Follow-up|0|||
147395836|NCT02551692|531613237|FG001|Overall Study|Lost to Follow-up|1|||
147395837|NCT02551692|531613238|FG002|Overall Study|Lost to Follow-up|4|||
147395838|NCT02551692|531613236|FG000|Overall Study|Withdrawal by Subject|1|||
147395839|NCT02551692|531613237|FG001|Overall Study|Withdrawal by Subject|0|||
147395840|NCT02551692|531613238|FG002|Overall Study|Withdrawal by Subject|1|||
147395841|NCT01091519|531613239|FG000|Overall Study|Adverse Event|12|||
147395842|NCT01091519|531613240|FG001|Overall Study|Adverse Event|16|||
147395843|NCT01091519|531613239|FG000|Overall Study|Death|1|||
147395844|NCT01091519|531613240|FG001|Overall Study|Death|0|||
147395845|NCT01091519|531613239|FG000|Overall Study|Lack of Efficacy|16|||
147395846|NCT01091519|531613240|FG001|Overall Study|Lack of Efficacy|19|||
147395847|NCT01091519|531613239|FG000|Overall Study|Lost to Follow-up|14|||
147395848|NCT01091519|531613240|FG001|Overall Study|Lost to Follow-up|24|||
147395849|NCT01091519|531613239|FG000|Overall Study|Withdrawal by Subject|2|||
147395850|NCT01091519|531613240|FG001|Overall Study|Withdrawal by Subject|2|||
147395851|NCT01091519|531613239|FG000|Overall Study|Other|6|||
147395852|NCT01091519|531613240|FG001|Overall Study|Other|8|||
147395853|NCT01091519|531613239|FG000|Overall Study|Randomized not treated|4|||
147395854|NCT01091519|531613240|FG001|Overall Study|Randomized not treated|4|||
147395855|NCT01196741|531613243|FG000|Overall Study|Disease progression|34|||
147395856|NCT01196741|531613244|FG001|Overall Study|Disease progression|14|||
147395857|NCT01196741|531613243|FG000|Overall Study|Adverse Event|10|||
147395858|NCT01196741|531613244|FG001|Overall Study|Adverse Event|6|||
147395859|NCT01196741|531613243|FG000|Overall Study|Serious Adverse Event|3|||
147395860|NCT01196741|531613244|FG001|Overall Study|Serious Adverse Event|1|||
147395861|NCT01196741|531613243|FG000|Overall Study|Dose limiting Adverse Event|2|||
147395862|NCT01196741|531613244|FG001|Overall Study|Dose limiting Adverse Event|1|||
147395863|NCT01196741|531613243|FG000|Overall Study|Withdrawal by Subject|3|||
147395864|NCT01196741|531613244|FG001|Overall Study|Withdrawal by Subject|0|||
147395865|NCT01196741|531613243|FG000|Overall Study|Other reason|3|||
147395866|NCT01196741|531613244|FG001|Overall Study|Other reason|3|||
147395867|NCT01196741|531613243|FG000|Overall Study|Other|3|||
147395868|NCT01196741|531613244|FG001|Overall Study|Other|2|||
147395869|NCT01196741|531613243|FG000|Overall Study|Protocol Violation|2|||
147460475|NCT01430442|531847023|FG004|Overall Study|Patient No Longer Meets Study Criteria|5|||
147615384|NCT01625091|532406719|FG001|Intervention|Adverse Event|2|||
147395870|NCT01196741|531613244|FG001|Overall Study|Protocol Violation|1|||
147395871|NCT01227928|531613245|FG000|Overall Study|Lost to Follow-up|4|||
147395872|NCT01227928|531613246|FG001|Overall Study|Lost to Follow-up|2|||
147395873|NCT01227928|531613245|FG000|Overall Study|Withdrawal by Subject|4|||
147395874|NCT01227928|531613246|FG001|Overall Study|Withdrawal by Subject|3|||
147395875|NCT01227928|531613245|FG000|Overall Study|Death|14|||
147395876|NCT01227928|531613246|FG001|Overall Study|Death|12|||
147395877|NCT04582864|531613247|FG000|Overall Study|Did not complete cycle 1 due to disease progression|2|||
147395878|NCT04582864|531613247|FG000|Overall Study|Death|1|||
147395879|NCT00605566|531614958|FG000|Overall Study|Adverse Event|1|||
147395880|NCT00605566|531614958|FG000|Overall Study|Clinical deterioration|1|||
147395881|NCT00605566|531614958|FG000|Overall Study|Poor compliance in run-in period|1|||
147395882|NCT03864341|531614961|FG000|Overall Study|Withdrawal by Subject|1|||
147395883|NCT01066936|531614962|FG000|Overall Study|Death|2|||
147395884|NCT01066936|531614962|FG000|Overall Study|Device revised/removed|1|||
147395885|NCT01066936|531614962|FG000|Overall Study|Lost to Follow-up|3|||
147395886|NCT01066936|531614962|FG000|Overall Study|Withdrawal by Subject|4|||
147395887|NCT04156399|531614969|FG000|Overall Study|hospitalization unrelated to acupuncture|1|||
147395888|NCT04156399|531614969|FG000|Overall Study|study suspension due to COVID pandemic|3|||
147395889|NCT01333111|531614972|FG000|Overall Study|patient undergoing major surgery|0|||
147395890|NCT01333111|531614973|FG001|Overall Study|patient undergoing major surgery|2|||
147395891|NCT01333111|531614974|FG002|Overall Study|patient undergoing major surgery|0|||
147395892|NCT01333111|531614972|FG000|Overall Study|personal reasons|0|||
147395893|NCT01333111|531614973|FG001|Overall Study|personal reasons|0|||
147395894|NCT01333111|531614974|FG002|Overall Study|personal reasons|1|||
147395895|NCT01333111|531614972|FG000|Overall Study|unclassified|1|||
147395896|NCT01333111|531614973|FG001|Overall Study|unclassified|0|||
147395897|NCT01333111|531614974|FG002|Overall Study|unclassified|0|||
147395898|NCT01333111|531614972|FG000|Overall Study|withdrawal criteria|0|||
147395899|NCT01333111|531614973|FG001|Overall Study|withdrawal criteria|1|||
147395900|NCT01333111|531614974|FG002|Overall Study|withdrawal criteria|0|||
147395901|NCT01333111|531614972|FG000|Overall Study|Non-compliance|1|||
147395902|NCT01333111|531614973|FG001|Overall Study|Non-compliance|0|||
147395903|NCT01333111|531614974|FG002|Overall Study|Non-compliance|0|||
147395904|NCT01333111|531614972|FG000|Overall Study|Ineffective therapy|0|||
147395905|NCT01333111|531614973|FG001|Overall Study|Ineffective therapy|0|||
147395906|NCT01333111|531614974|FG002|Overall Study|Ineffective therapy|1|||
147395907|NCT00847132|531614977|FG000|Overall Study|Death|1|||
147395908|NCT00847132|531614978|FG001|Overall Study|Death|1|||
147395909|NCT01772823|531614983|FG000|Behavioral Intervention (BL -3MV or PCC)|Lost to Follow-up|1|||
147395910|NCT01772823|531614984|FG001|Behavioral Intervention (BL -3MV or PCC)|Lost to Follow-up|0|||
147395911|NCT01772823|531614983|FG000|Behavioral Intervention (BL -3MV or PCC)|Withdrawal by Subject|1|||
147395912|NCT01772823|531614984|FG001|Behavioral Intervention (BL -3MV or PCC)|Withdrawal by Subject|1|||
147395913|NCT01772823|531614983|FG000|Behavioral Intervention (BL -3MV or PCC)|Inadvertent enrollment|1|||
147395914|NCT01772823|531614984|FG001|Behavioral Intervention (BL -3MV or PCC)|Inadvertent enrollment|0|||
147395915|NCT01772823|531614983|FG000|Behavioral Intervention (BL -3MV or PCC)|Inelligible at rescreen|2|||
147395916|NCT01772823|531614984|FG001|Behavioral Intervention (BL -3MV or PCC)|Inelligible at rescreen|1|||
147395917|NCT01772823|531614983|FG000|Behavioral Intervention (BL -3MV or PCC)|Wk 0 not completed, 30 days of baseline|6|||
147395918|NCT01772823|531614984|FG001|Behavioral Intervention (BL -3MV or PCC)|Wk 0 not completed, 30 days of baseline|0|||
147395919|NCT01772823|531614983|FG000|Behavioral Intervention (BL -3MV or PCC)|Moved out of area|1|||
147395920|NCT01772823|531614984|FG001|Behavioral Intervention (BL -3MV or PCC)|Moved out of area|0|||
147395921|NCT01772823|531614983|FG000|Treatment Phase (Week 0- Week 48)|Lost to Follow-up|15|||
147395922|NCT01772823|531614984|FG001|Treatment Phase (Week 0- Week 48)|Lost to Follow-up|13|||
147395923|NCT01772823|531614983|FG000|Treatment Phase (Week 0- Week 48)|Withdrawal by Subject|6|||
147395924|NCT01772823|531614984|FG001|Treatment Phase (Week 0- Week 48)|Withdrawal by Subject|1|||
147395925|NCT01772823|531614983|FG000|Treatment Phase (Week 0- Week 48)|Moved out of area|4|||
147395926|NCT01772823|531614984|FG001|Treatment Phase (Week 0- Week 48)|Moved out of area|3|||
147395927|NCT01772823|531614983|FG000|Treatment Phase (Week 0- Week 48)|Incarcerated|1|||
147395928|NCT01772823|531614984|FG001|Treatment Phase (Week 0- Week 48)|Incarcerated|0|||
147395929|NCT01772823|531614983|FG000|Treatment Phase (Week 0- Week 48)|Suicide gesture/disruptive behavior|1|||
147395930|NCT01772823|531614984|FG001|Treatment Phase (Week 0- Week 48)|Suicide gesture/disruptive behavior|0|||
147395931|NCT01772823|531614983|FG000|Treatment Phase (Week 0- Week 48)|Wk 0 not completed, 30 days of baseline|1|||
147395932|NCT01772823|531614984|FG001|Treatment Phase (Week 0- Week 48)|Wk 0 not completed, 30 days of baseline|1|||
147395933|NCT01772823|531614983|FG000|Extension Phase (Visits 24,48wks Post tx|Lost to Follow-up|6|||
147395934|NCT01772823|531614984|FG001|Extension Phase (Visits 24,48wks Post tx|Lost to Follow-up|5|||
147395935|NCT01772823|531614983|FG000|Extension Phase (Visits 24,48wks Post tx|Withdrawal by Subject|1|||
147395936|NCT01772823|531614984|FG001|Extension Phase (Visits 24,48wks Post tx|Withdrawal by Subject|2|||
147395937|NCT01772823|531614983|FG000|Extension Phase (Visits 24,48wks Post tx|Moved out of area|2|||
147395938|NCT01772823|531614984|FG001|Extension Phase (Visits 24,48wks Post tx|Moved out of area|2|||
147395939|NCT01772823|531614983|FG000|Extension Phase (Visits 24,48wks Post tx|Became unavailable for study visits|1|||
147395940|NCT01772823|531614984|FG001|Extension Phase (Visits 24,48wks Post tx|Became unavailable for study visits|0|||
147395941|NCT02895360|531614985|FG000|Phase 1 - 30 mg/m² Cohort|Progressive disease|4|||
147395942|NCT02895360|531614986|FG001|Phase 1 - 30 mg/m² Cohort|Progressive disease|0|||
147395943|NCT02895360|531614987|FG002|Phase 1 - 30 mg/m² Cohort|Progressive disease|0|||
147395944|NCT02895360|531614988|FG003|Phase 1 - 30 mg/m² Cohort|Progressive disease|0|||
147395945|NCT02895360|531614989|FG004|Phase 1 - 30 mg/m² Cohort|Progressive disease|0|||
147395946|NCT02895360|531614990|FG005|Phase 1 - 30 mg/m² Cohort|Progressive disease|0|||
147395947|NCT02895360|531614985|FG000|Phase 1 - 45 mg/m² Cohort|Progressive disease|0|||
147395948|NCT02895360|531614986|FG001|Phase 1 - 45 mg/m² Cohort|Progressive disease|3|||
147395949|NCT02895360|531614987|FG002|Phase 1 - 45 mg/m² Cohort|Progressive disease|0|||
147395950|NCT02895360|531614988|FG003|Phase 1 - 45 mg/m² Cohort|Progressive disease|0|||
147395951|NCT02895360|531614989|FG004|Phase 1 - 45 mg/m² Cohort|Progressive disease|0|||
147395952|NCT02895360|531614990|FG005|Phase 1 - 45 mg/m² Cohort|Progressive disease|0|||
147395953|NCT02895360|531614985|FG000|Phase 1 - 70 mg/m² Cohort|Adverse Event|0|||
147395954|NCT02895360|531614986|FG001|Phase 1 - 70 mg/m² Cohort|Adverse Event|0|||
147395955|NCT02895360|531614987|FG002|Phase 1 - 70 mg/m² Cohort|Adverse Event|2|||
147460476|NCT01430442|531847024|FG005|Overall Study|Patient No Longer Meets Study Criteria|5|||
147460477|NCT01430442|531847025|FG006|Overall Study|Patient No Longer Meets Study Criteria|9|||
147460478|NCT01430442|531847026|FG007|Overall Study|Patient No Longer Meets Study Criteria|6|||
147460479|NCT00772629|531847031|FG000|Overall Study|Subject was not vaccinated|1|||
147460480|NCT00772629|531847032|FG001|Overall Study|Subject was not vaccinated|0|||
147460481|NCT01097629|531847036|FG000|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|10|||
147460482|NCT01097629|531847037|FG001|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|19|||
147460483|NCT01097629|531847038|FG002|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|17|||
147460484|NCT01097629|531847039|FG003|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
147460485|NCT01097629|531847040|FG004|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
147460486|NCT01097629|531847041|FG005|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
147460487|NCT01097629|531847042|FG006|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
147460488|NCT01097629|531847043|FG007|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
147460489|NCT01097629|531847036|FG000|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|8|||
147460490|NCT01097629|531847037|FG001|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|9|||
147460491|NCT01097629|531847038|FG002|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|19|||
147460492|NCT01097629|531847039|FG003|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
147460493|NCT01097629|531847040|FG004|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
147460494|NCT01097629|531847041|FG005|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
147460495|NCT01097629|531847042|FG006|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
147460496|NCT01097629|531847043|FG007|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
147460497|NCT01097629|531847036|FG000|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|5|||
147460498|NCT01097629|531847037|FG001|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|4|||
147460499|NCT01097629|531847038|FG002|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|8|||
147460500|NCT01097629|531847039|FG003|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
147460501|NCT01097629|531847040|FG004|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
147460502|NCT01097629|531847041|FG005|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
147460503|NCT01097629|531847042|FG006|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
147460504|NCT01097629|531847043|FG007|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
147460505|NCT01097629|531847036|FG000|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|2|||
147460506|NCT01097629|531847037|FG001|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|4|||
147460507|NCT01097629|531847038|FG002|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|1|||
147460508|NCT01097629|531847039|FG003|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
147460509|NCT01097629|531847040|FG004|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
147460510|NCT01097629|531847041|FG005|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
147460511|NCT01097629|531847042|FG006|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
147460512|NCT01097629|531847043|FG007|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
147460513|NCT01097629|531847036|FG000|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|7|||
147460514|NCT01097629|531847037|FG001|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|4|||
147460515|NCT01097629|531847038|FG002|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|8|||
147460516|NCT01097629|531847039|FG003|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
147460517|NCT01097629|531847040|FG004|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
147460518|NCT01097629|531847041|FG005|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
147460519|NCT01097629|531847042|FG006|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
147460520|NCT01097629|531847043|FG007|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
147460521|NCT01097629|531847036|FG000|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|2|||
147460522|NCT01097629|531847037|FG001|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|1|||
147460523|NCT01097629|531847038|FG002|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
147615385|NCT01625091|532406718|FG000|Intervention|Lost to Follow-up|4|||
147615386|NCT01625091|532406719|FG001|Intervention|Lost to Follow-up|4|||
147615387|NCT01625091|532406718|FG000|Intervention|Study termination|2|||
147615388|NCT01625091|532406719|FG001|Intervention|Study termination|3|||
147615389|NCT01625091|532406718|FG000|Post-intervention|Death|0|||
147615390|NCT01625091|532406719|FG001|Post-intervention|Death|1|||
147615391|NCT01625091|532406718|FG000|Post-intervention|Lost to Follow-up|2|||
147615392|NCT01625091|532406719|FG001|Post-intervention|Lost to Follow-up|0|||
147615393|NCT01625091|532406718|FG000|Post-intervention|Study termination|2|||
147615394|NCT01625091|532406719|FG001|Post-intervention|Study termination|1|||
147615395|NCT00768248|532406723|FG000|Overall Study|Research coordinator didn't collect data|1|||
147460524|NCT01097629|531847039|FG003|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
147460525|NCT01097629|531847040|FG004|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
147460526|NCT01097629|531847041|FG005|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
147460527|NCT01097629|531847042|FG006|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
147460528|NCT01097629|531847043|FG007|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
147460529|NCT01097629|531847036|FG000|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|1|||
147460530|NCT01097629|531847037|FG001|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|5|||
147395956|NCT02895360|531614988|FG003|Phase 1 - 70 mg/m² Cohort|Adverse Event|0|||
147395957|NCT02895360|531614989|FG004|Phase 1 - 70 mg/m² Cohort|Adverse Event|0|||
147395958|NCT02895360|531614990|FG005|Phase 1 - 70 mg/m² Cohort|Adverse Event|0|||
147395959|NCT02895360|531614985|FG000|Phase 1 - 70 mg/m² Cohort|Progressive disease|0|||
147395960|NCT02895360|531614986|FG001|Phase 1 - 70 mg/m² Cohort|Progressive disease|0|||
147395961|NCT02895360|531614987|FG002|Phase 1 - 70 mg/m² Cohort|Progressive disease|7|||
147395962|NCT02895360|531614988|FG003|Phase 1 - 70 mg/m² Cohort|Progressive disease|0|||
147395963|NCT02895360|531614989|FG004|Phase 1 - 70 mg/m² Cohort|Progressive disease|0|||
147395964|NCT02895360|531614990|FG005|Phase 1 - 70 mg/m² Cohort|Progressive disease|0|||
147395965|NCT02895360|531614985|FG000|Phase 1 - 90 mg/m² Cohort|Progressive disease|0|||
147395966|NCT02895360|531614986|FG001|Phase 1 - 90 mg/m² Cohort|Progressive disease|0|||
147395967|NCT02895360|531614987|FG002|Phase 1 - 90 mg/m² Cohort|Progressive disease|0|||
147395968|NCT02895360|531614988|FG003|Phase 1 - 90 mg/m² Cohort|Progressive disease|4|||
147395969|NCT02895360|531614989|FG004|Phase 1 - 90 mg/m² Cohort|Progressive disease|0|||
147395970|NCT02895360|531614990|FG005|Phase 1 - 90 mg/m² Cohort|Progressive disease|0|||
147395971|NCT02895360|531614985|FG000|Phase 2a|Adverse Event|0|||
147395972|NCT02895360|531614986|FG001|Phase 2a|Adverse Event|0|||
147395973|NCT02895360|531614987|FG002|Phase 2a|Adverse Event|0|||
147395974|NCT02895360|531614988|FG003|Phase 2a|Adverse Event|0|||
147395975|NCT02895360|531614989|FG004|Phase 2a|Adverse Event|0|||
147395976|NCT02895360|531614990|FG005|Phase 2a|Adverse Event|1|||
147395977|NCT02895360|531614985|FG000|Phase 2a|Progressive disease|0|||
147395978|NCT02895360|531614986|FG001|Phase 2a|Progressive disease|0|||
147395979|NCT02895360|531614987|FG002|Phase 2a|Progressive disease|0|||
147395980|NCT02895360|531614988|FG003|Phase 2a|Progressive disease|0|||
147395981|NCT02895360|531614989|FG004|Phase 2a|Progressive disease|11|||
147395982|NCT02895360|531614990|FG005|Phase 2a|Progressive disease|11|||
147395983|NCT02262364|531614991|FG000|Blood Draw for Device Processing|Insufficient blood could be drawn|1|||
147395984|NCT00337285|531614994|FG000|Overall Study|Withdrawal by Subject|42|||
147395985|NCT00337285|531614994|FG000|Overall Study|Lost to Follow-up|41|||
147395986|NCT00337285|531614994|FG000|Overall Study|Adverse Event|28|||
147395987|NCT00337285|531614994|FG000|Overall Study|Protocol Violation|27|||
147395988|NCT00337285|531614994|FG000|Overall Study|Lack of Efficacy|11|||
147395989|NCT00337285|531614994|FG000|Overall Study|Death|1|||
147395990|NCT00337285|531614994|FG000|Overall Study|Physician Decision|1|||
147395991|NCT00337285|531614994|FG000|Overall Study|Lack of protocol compliance|7|||
147395992|NCT01004185|531614996|FG000|Overall Study|Adverse Event|1|||
147395993|NCT01004185|531614997|FG001|Overall Study|Adverse Event|1|||
147395994|NCT01004185|531614996|FG000|Overall Study|Lost to Follow-up|0|||
147395995|NCT01004185|531614997|FG001|Overall Study|Lost to Follow-up|1|||
147395996|NCT01004185|531614996|FG000|Overall Study|Lack of Efficacy|2|||
147395997|NCT01004185|531614997|FG001|Overall Study|Lack of Efficacy|1|||
147395998|NCT01004185|531614996|FG000|Overall Study|Sponsor Terminated Study|4|||
147395999|NCT01004185|531614997|FG001|Overall Study|Sponsor Terminated Study|5|||
147396000|NCT01004185|531614996|FG000|Overall Study|Withdrawal by Subject|2|||
147396001|NCT01004185|531614997|FG001|Overall Study|Withdrawal by Subject|1|||
147396002|NCT03214250|531614998|FG000|Overall Study|Death|5|||
147396003|NCT03214250|531614999|FG001|Overall Study|Death|5|||
147396004|NCT03214250|531615000|FG002|Overall Study|Death|7|||
147396005|NCT03214250|531615001|FG003|Overall Study|Death|4|||
147396006|NCT03214250|531615002|FG004|Overall Study|Death|23|||
147396007|NCT03214250|531615003|FG005|Overall Study|Death|23|||
147396008|NCT03214250|531615004|FG006|Overall Study|Death|24|||
147396009|NCT03214250|531614998|FG000|Overall Study|Lost to Follow-up|0|||
147396010|NCT03214250|531614999|FG001|Overall Study|Lost to Follow-up|0|||
147396011|NCT03214250|531615000|FG002|Overall Study|Lost to Follow-up|0|||
147396012|NCT03214250|531615001|FG003|Overall Study|Lost to Follow-up|1|||
147396013|NCT03214250|531615002|FG004|Overall Study|Lost to Follow-up|1|||
147396014|NCT03214250|531615003|FG005|Overall Study|Lost to Follow-up|2|||
147396015|NCT03214250|531615004|FG006|Overall Study|Lost to Follow-up|0|||
147396016|NCT03214250|531614998|FG000|Overall Study|Other|0|||
147396017|NCT03214250|531614999|FG001|Overall Study|Other|0|||
147396018|NCT03214250|531615000|FG002|Overall Study|Other|0|||
147396019|NCT03214250|531615001|FG003|Overall Study|Other|0|||
147396020|NCT03214250|531615002|FG004|Overall Study|Other|1|||
147396021|NCT03214250|531615003|FG005|Overall Study|Other|1|||
147396022|NCT03214250|531615004|FG006|Overall Study|Other|2|||
147396023|NCT03214250|531614998|FG000|Overall Study|Remains on Study|2|||
147396024|NCT03214250|531614999|FG001|Overall Study|Remains on Study|2|||
147396025|NCT03214250|531615000|FG002|Overall Study|Remains on Study|0|||
147396026|NCT03214250|531615001|FG003|Overall Study|Remains on Study|1|||
147396027|NCT03214250|531615002|FG004|Overall Study|Remains on Study|7|||
147396028|NCT03214250|531615003|FG005|Overall Study|Remains on Study|5|||
147396029|NCT03214250|531615004|FG006|Overall Study|Remains on Study|3|||
147396030|NCT03214250|531614998|FG000|Overall Study|Withdrawal by Subject|0|||
147396031|NCT03214250|531614999|FG001|Overall Study|Withdrawal by Subject|0|||
147396032|NCT03214250|531615000|FG002|Overall Study|Withdrawal by Subject|1|||
147396033|NCT03214250|531615001|FG003|Overall Study|Withdrawal by Subject|2|||
147396034|NCT03214250|531615002|FG004|Overall Study|Withdrawal by Subject|5|||
147460531|NCT01097629|531847038|FG002|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|4|||
147460532|NCT01097629|531847039|FG003|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
147460533|NCT01097629|531847040|FG004|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
147460534|NCT01097629|531847041|FG005|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
147460535|NCT01097629|531847042|FG006|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
147460536|NCT01097629|531847043|FG007|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
147460537|NCT01097629|531847036|FG000|DB RO Phase|Withdrawal by Subject|0|||
147460538|NCT01097629|531847037|FG001|DB RO Phase|Withdrawal by Subject|0|||
147460539|NCT01097629|531847038|FG002|DB RO Phase|Withdrawal by Subject|0|||
147460540|NCT01097629|531847039|FG003|DB RO Phase|Withdrawal by Subject|0|||
147460541|NCT01097629|531847040|FG004|DB RO Phase|Withdrawal by Subject|0|||
147460542|NCT01097629|531847041|FG005|DB RO Phase|Withdrawal by Subject|0|||
147460543|NCT01097629|531847042|FG006|DB RO Phase|Withdrawal by Subject|0|||
147460544|NCT01097629|531847043|FG007|DB RO Phase|Withdrawal by Subject|1|||
147460545|NCT01097629|531847036|FG000|DB RO Phase|Protocol Violation|0|||
147460546|NCT01097629|531847037|FG001|DB RO Phase|Protocol Violation|0|||
147460547|NCT01097629|531847038|FG002|DB RO Phase|Protocol Violation|0|||
147460548|NCT01097629|531847039|FG003|DB RO Phase|Protocol Violation|1|||
147460549|NCT01097629|531847040|FG004|DB RO Phase|Protocol Violation|0|||
147460550|NCT01097629|531847041|FG005|DB RO Phase|Protocol Violation|1|||
147460551|NCT01097629|531847042|FG006|DB RO Phase|Protocol Violation|1|||
147460552|NCT01097629|531847043|FG007|DB RO Phase|Protocol Violation|0|||
147460553|NCT01097629|531847036|FG000|DB RO Phase|Lost to Follow-up|0|||
147460554|NCT01097629|531847037|FG001|DB RO Phase|Lost to Follow-up|0|||
147460555|NCT01097629|531847038|FG002|DB RO Phase|Lost to Follow-up|0|||
147460556|NCT01097629|531847039|FG003|DB RO Phase|Lost to Follow-up|0|||
147460557|NCT01097629|531847040|FG004|DB RO Phase|Lost to Follow-up|0|||
147460558|NCT01097629|531847041|FG005|DB RO Phase|Lost to Follow-up|0|||
147460559|NCT01097629|531847042|FG006|DB RO Phase|Lost to Follow-up|2|||
147460560|NCT01097629|531847043|FG007|DB RO Phase|Lost to Follow-up|0|||
147460561|NCT00132041|531847046|FG000|Baseline|Ineligible|6|||
147460562|NCT00132041|531847046|FG000|3 Months Post Ablation|Transplant|1|||
147460563|NCT00132041|531847046|FG000|3 Months Post Ablation|Non-Protocol Treatment|2|||
147460564|NCT00132041|531847046|FG000|6 Months Post Ablation|Withdrawal by Subject|2|||
147460565|NCT00132041|531847046|FG000|6 Months Post Ablation|Death|2|||
147460566|NCT00132041|531847046|FG000|6 Months Post Ablation|Transplant|6|||
147460567|NCT00132041|531847046|FG000|9 Months Post Ablation|Death|1|||
147460568|NCT00132041|531847046|FG000|9 Months Post Ablation|Transplant|1|||
147460569|NCT00132041|531847046|FG000|12 Months Post Ablation|Withdrawal by Subject|1|||
147460570|NCT00132041|531847046|FG000|12 Months Post Ablation|Death|1|||
147460571|NCT00132041|531847046|FG000|12 Months Post Ablation|Transplant|1|||
147460572|NCT00132041|531847046|FG000|12 Months Post Ablation|non-protocol Treatment|1|||
147460573|NCT00132041|531847046|FG000|15 Months Post Ablation|Withdrawal by Subject|1|||
147460574|NCT00132041|531847046|FG000|15 Months Post Ablation|Death|1|||
147460575|NCT00132041|531847046|FG000|15 Months Post Ablation|Transplant|5|||
147460576|NCT00132041|531847046|FG000|15 Months Post Ablation|Non-Protocol Treatment|1|||
147460577|NCT00132041|531847046|FG000|18 Months Post Ablation|Withdrawal by Subject|1|||
147460578|NCT00132041|531847046|FG000|18 Months Post Ablation|Transplant|1|||
147460579|NCT00132041|531847046|FG000|18 Months Post Ablation|Non-Protocol Treatment|3|||
147460580|NCT00132041|531847046|FG000|18 Months Post Ablation|ExtraHepatic tumor|1|||
147460581|NCT05162066|531847047|FG000|Overall Study|Adverse Event|1|||
147460582|NCT05162066|531847048|FG001|Overall Study|Adverse Event|0|||
147396035|NCT03214250|531615003|FG005|Overall Study|Withdrawal by Subject|0|||
147396036|NCT03214250|531615004|FG006|Overall Study|Withdrawal by Subject|2|||
147396037|NCT00496626|531615013|FG000|Overall Study|Lost to Follow-up|0|||
147396038|NCT00496626|531615014|FG001|Overall Study|Lost to Follow-up|1|||
147396039|NCT00496626|531615013|FG000|Overall Study|Protocol Violation|1|||
147396040|NCT00496626|531615014|FG001|Overall Study|Protocol Violation|0|||
147396041|NCT00496626|531615013|FG000|Overall Study|Withdrawal by Subject|5|||
147396042|NCT00496626|531615014|FG001|Overall Study|Withdrawal by Subject|4|||
147396043|NCT00496626|531615013|FG000|Overall Study|Relocated|0|||
147460583|NCT05162066|531847049|FG002|Overall Study|Adverse Event|0|||
147460584|NCT05162066|531847047|FG000|Overall Study|Perceived lack of efficacy|1|||
147460585|NCT05162066|531847048|FG001|Overall Study|Perceived lack of efficacy|0|||
147460586|NCT05162066|531847049|FG002|Overall Study|Perceived lack of efficacy|0|||
147460587|NCT01171820|531847050|FG000|Overall Study|Death|3|||
147460588|NCT01171820|531847051|FG001|Overall Study|Death|3|||
147460589|NCT01171820|531847050|FG000|Overall Study|Lost to Follow-up|0|||
147460590|NCT01171820|531847051|FG001|Overall Study|Lost to Follow-up|1|||
147460591|NCT01171820|531847050|FG000|Overall Study|Withdrawal by Subject|2|||
147460592|NCT01171820|531847051|FG001|Overall Study|Withdrawal by Subject|0|||
147460593|NCT01171820|531847050|FG000|Overall Study|Physician Decision|0|||
147460594|NCT01171820|531847051|FG001|Overall Study|Physician Decision|1|||
147460595|NCT01171820|531847050|FG000|Overall Study|1-Year Missed Visit|1|||
147460596|NCT01171820|531847051|FG001|Overall Study|1-Year Missed Visit|1|||
147460597|NCT03969875|531847052|FG000|Overall Study|did not receive allocated intervention|3|||
147396044|NCT00496626|531615014|FG001|Overall Study|Relocated|1|||
147396045|NCT04582669|531615015|FG000|Overall Study|Subject missed appointment(s).|1|||
147396046|NCT04582669|531615016|FG001|Overall Study|Subject missed appointment(s).|0|||
147396047|NCT04582669|531615017|FG002|Overall Study|Subject missed appointment(s).|1|||
147396048|NCT04582669|531615018|FG003|Overall Study|Subject missed appointment(s).|2|||
147396049|NCT04582669|531615015|FG000|Overall Study|Protocol Violation|0|||
147396050|NCT04582669|531615016|FG001|Overall Study|Protocol Violation|1|||
147396051|NCT04582669|531615017|FG002|Overall Study|Protocol Violation|1|||
147396052|NCT04582669|531615018|FG003|Overall Study|Protocol Violation|0|||
147396053|NCT01874665|531615019|FG000|Overall Study|Adverse Event|6|||
147396054|NCT01874665|531615020|FG001|Overall Study|Adverse Event|2|||
147396055|NCT01874665|531615019|FG000|Overall Study|Withdrawal by Subject|4|||
147396056|NCT01874665|531615020|FG001|Overall Study|Withdrawal by Subject|1|||
147396057|NCT01874665|531615019|FG000|Overall Study|Physician Decision|3|||
147396058|NCT01874665|531615020|FG001|Overall Study|Physician Decision|0|||
147396059|NCT01874665|531615019|FG000|Overall Study|Clinical Progressive Disease|4|||
147396060|NCT01874665|531615020|FG001|Overall Study|Clinical Progressive Disease|3|||
147396061|NCT01874665|531615019|FG000|Overall Study|Study Terminated by Sponsor|0|||
147396062|NCT01874665|531615020|FG001|Overall Study|Study Terminated by Sponsor|2|||
147396063|NCT01874665|531615019|FG000|Overall Study|Documented Progressive Disease|11|||
147396064|NCT01874665|531615020|FG001|Overall Study|Documented Progressive Disease|7|||
147396065|NCT01874665|531615019|FG000|Overall Study|Other|2|||
147396066|NCT01874665|531615020|FG001|Overall Study|Other|0|||
147396067|NCT02647788|531615023|FG000|Overall Study|Lost to Follow-up|13|||
147396068|NCT02647788|531615024|FG001|Overall Study|Lost to Follow-up|11|||
147396069|NCT02647788|531615023|FG000|Overall Study|Did not want opiate|0|||
147396070|NCT02647788|531615024|FG001|Overall Study|Did not want opiate|1|||
147396071|NCT02647788|531615023|FG000|Overall Study|Withdrawal by Subject|1|||
147396072|NCT02647788|531615024|FG001|Overall Study|Withdrawal by Subject|0|||
147396073|NCT02647788|531615023|FG000|Overall Study|Felt itchy with assigned medication|1|||
147396074|NCT02647788|531615024|FG001|Overall Study|Felt itchy with assigned medication|0|||
147396075|NCT02647788|531615023|FG000|Overall Study|Felt nauseous with assigned medication|1|||
147396076|NCT02647788|531615024|FG001|Overall Study|Felt nauseous with assigned medication|1|||
147396077|NCT01274559|531615025|FG000|Overall Study|Adverse Event|57|||
147396078|NCT01274559|531615026|FG001|Overall Study|Adverse Event|13|||
147396079|NCT01274559|531615025|FG000|Overall Study|Death|1|||
147396080|NCT01274559|531615026|FG001|Overall Study|Death|1|||
147396081|NCT01274559|531615025|FG000|Overall Study|Lost to Follow-up|3|||
147396082|NCT01274559|531615026|FG001|Overall Study|Lost to Follow-up|3|||
147396083|NCT01274559|531615025|FG000|Overall Study|Non-compliance with Study Drug|2|||
147396084|NCT01274559|531615026|FG001|Overall Study|Non-compliance with Study Drug|4|||
147396085|NCT01274559|531615025|FG000|Overall Study|Physician Decision|2|||
147396086|NCT01274559|531615026|FG001|Overall Study|Physician Decision|1|||
147396087|NCT01274559|531615025|FG000|Overall Study|Protocol Violation|28|||
147396088|NCT01274559|531615026|FG001|Overall Study|Protocol Violation|23|||
147396089|NCT01274559|531615025|FG000|Overall Study|Study Terminated by Sponsor|79|||
147396090|NCT01274559|531615026|FG001|Overall Study|Study Terminated by Sponsor|87|||
147396091|NCT01274559|531615025|FG000|Overall Study|Withdrawal by Subject|25|||
147396092|NCT01274559|531615026|FG001|Overall Study|Withdrawal by Subject|13|||
147396093|NCT03245619|531615027|FG000|Part A (Up to Day 22)|Physician Decision|4|||
147396094|NCT03245619|531615028|FG001|Part A (Up to Day 22)|Physician Decision|6|||
147396095|NCT03245619|531615029|FG002|Part A (Up to Day 22)|Physician Decision|6|||
147396096|NCT03245619|531615030|FG003|Part A (Up to Day 22)|Physician Decision|0|||
147396097|NCT03245619|531615031|FG004|Part A (Up to Day 22)|Physician Decision|0|||
147396098|NCT03245619|531615032|FG005|Part A (Up to Day 22)|Physician Decision|0|||
147396099|NCT03245619|531615033|FG006|Part A (Up to Day 22)|Physician Decision|0|||
147396100|NCT03245619|531615034|FG007|Part A (Up to Day 22)|Physician Decision|0|||
147396101|NCT03245619|531615035|FG008|Part A (Up to Day 22)|Physician Decision|0|||
147396102|NCT03245619|531615036|FG009|Part A (Up to Day 22)|Physician Decision|0|||
147396103|NCT03245619|531615037|FG010|Part A (Up to Day 22)|Physician Decision|0|||
147396104|NCT03245619|531615038|FG011|Part A (Up to Day 22)|Physician Decision|0|||
147396105|NCT03245619|531615039|FG012|Part A (Up to Day 22)|Physician Decision|0|||
147396106|NCT03245619|531615040|FG013|Part A (Up to Day 22)|Physician Decision|0|||
147615396|NCT00768248|532406724|FG001|Overall Study|Research coordinator didn't collect data|1|||
147615397|NCT01547390|532406728|FG000|Overall Study|Withdrawal by Subject|10|||
147615398|NCT01547390|532406729|FG001|Overall Study|Withdrawal by Subject|7|||
147615399|NCT01547390|532406728|FG000|Overall Study|termination of pregnancy|0|||
147396107|NCT03245619|531615041|FG014|Part A (Up to Day 22)|Physician Decision|0|||
147396108|NCT03245619|531615042|FG015|Part A (Up to Day 22)|Physician Decision|0|||
147396109|NCT03245619|531615043|FG016|Part A (Up to Day 22)|Physician Decision|0|||
147396110|NCT00776659|531615060|FG000|Overall Study|Lost to Follow-up|15|||
147396111|NCT00776659|531615060|FG000|Overall Study|Withdrawal by Subject|10|||
147396112|NCT00776659|531615060|FG000|Overall Study|Study Terminated by Sponsor|1|||
147396113|NCT01167192|531615061|FG000|Overall Study|Adverse Event|1|||
147396114|NCT01167192|531615061|FG000|Overall Study|Death|1|||
147396115|NCT01167192|531615061|FG000|Overall Study|Withdrawal by Subject|1|||
147396116|NCT01167192|531615061|FG000|Overall Study|Insurance denial|1|||
147396117|NCT01336205|531615066|FG000|Overall Study|Other|22|||
147396118|NCT01336205|531615067|FG001|Overall Study|Other|9|||
147396119|NCT01336205|531615066|FG000|Overall Study|Lost to Follow-up|40|||
147396120|NCT01336205|531615067|FG001|Overall Study|Lost to Follow-up|20|||
147396121|NCT01336205|531615066|FG000|Overall Study|Study-Specific Withdrawal Criteria|16|||
147396122|NCT01336205|531615067|FG001|Overall Study|Study-Specific Withdrawal Criteria|7|||
147396123|NCT01336205|531615066|FG000|Overall Study|Lack of Efficacy|4|||
147396124|NCT01336205|531615067|FG001|Overall Study|Lack of Efficacy|0|||
147396125|NCT01336205|531615066|FG000|Overall Study|Severe noncompliance with protocol|9|||
147396126|NCT01336205|531615067|FG001|Overall Study|Severe noncompliance with protocol|2|||
147396127|NCT01336205|531615066|FG000|Overall Study|Adverse Event|56|||
147396128|NCT01336205|531615067|FG001|Overall Study|Adverse Event|6|||
147396129|NCT01336205|531615066|FG000|Overall Study|Death|1|||
147396130|NCT01336205|531615067|FG001|Overall Study|Death|1|||
147396131|NCT01336205|531615066|FG000|Overall Study|Eligibility Criteria Not Fulfilled|9|||
147396132|NCT01336205|531615067|FG001|Overall Study|Eligibility Criteria Not Fulfilled|6|||
147396133|NCT01336205|531615066|FG000|Overall Study|Withdrawal by Subject|72|||
147396134|NCT01336205|531615067|FG001|Overall Study|Withdrawal by Subject|38|||
147396135|NCT01336205|531615066|FG000|Overall Study|Did not receive treatment|4|||
147396136|NCT01336205|531615067|FG001|Overall Study|Did not receive treatment|0|||
147396137|NCT03503162|531615071|FG000|Overall Study|did not meet eligibility|1|||
147396138|NCT02835092|531615072|FG000|Overall Study|Withdrawal by Subject|3|||
147396139|NCT02835092|531615073|FG001|Overall Study|Withdrawal by Subject|6|||
147396140|NCT02835092|531615074|FG002|Overall Study|Withdrawal by Subject|3|||
147396141|NCT02835092|531615072|FG000|Overall Study|Lost to Follow-up|0|||
147396142|NCT02835092|531615073|FG001|Overall Study|Lost to Follow-up|2|||
147396143|NCT02835092|531615074|FG002|Overall Study|Lost to Follow-up|0|||
147396144|NCT00025506|531615075|FG000|Overall Study|Ineligible: clerical error|1|||
147396145|NCT00025506|531615075|FG000|Overall Study|Ineligible: wrong cell type|5|||
147396146|NCT00025506|531615075|FG000|Overall Study|Ineligible: inadequate pathology|2|||
147396147|NCT00025506|531615075|FG000|Overall Study|Never Treated|2|||
147396148|NCT00713206|531615076|FG000|Overall Study|Lost to Follow-up|4|||
147396149|NCT00713206|531615077|FG001|Overall Study|Lost to Follow-up|4|||
147396150|NCT00713206|531615076|FG000|Overall Study|Death|1|||
147396151|NCT00713206|531615077|FG001|Overall Study|Death|0|||
147396152|NCT02547441|531615078|FG000|Double-Blind Study Period|Adverse Event|4|||
147396153|NCT02547441|531615079|FG001|Double-Blind Study Period|Adverse Event|9|||
147396154|NCT02547441|531615078|FG000|Double-Blind Study Period|Lost to Follow-up|2|||
147396155|NCT02547441|531615079|FG001|Double-Blind Study Period|Lost to Follow-up|4|||
147396156|NCT02547441|531615078|FG000|Double-Blind Study Period|Physician Decision|1|||
147396157|NCT02547441|531615079|FG001|Double-Blind Study Period|Physician Decision|0|||
147396158|NCT02547441|531615078|FG000|Double-Blind Study Period|Protocol Violation|1|||
147396159|NCT02547441|531615079|FG001|Double-Blind Study Period|Protocol Violation|2|||
147396160|NCT02547441|531615078|FG000|Double-Blind Study Period|Withdrawal by Subject|15|||
147396161|NCT02547441|531615079|FG001|Double-Blind Study Period|Withdrawal by Subject|17|||
147396162|NCT02547441|531615078|FG000|Double-Blind Study Period|Sponsor Decision|1|||
147396163|NCT02547441|531615079|FG001|Double-Blind Study Period|Sponsor Decision|0|||
147396164|NCT02547441|531615078|FG000|Open-Label Study Period|Adverse Event|10|||
147396165|NCT02547441|531615079|FG001|Open-Label Study Period|Adverse Event|11|||
147396166|NCT02547441|531615078|FG000|Open-Label Study Period|Lack of Efficacy|3|||
147396167|NCT02547441|531615079|FG001|Open-Label Study Period|Lack of Efficacy|2|||
147396168|NCT02547441|531615078|FG000|Open-Label Study Period|Lost to Follow-up|7|||
147396169|NCT02547441|531615079|FG001|Open-Label Study Period|Lost to Follow-up|8|||
147396170|NCT02547441|531615078|FG000|Open-Label Study Period|Physician Decision|1|||
147396171|NCT02547441|531615079|FG001|Open-Label Study Period|Physician Decision|0|||
147396172|NCT02547441|531615078|FG000|Open-Label Study Period|Protocol Violation|2|||
147396173|NCT02547441|531615079|FG001|Open-Label Study Period|Protocol Violation|0|||
147396174|NCT02547441|531615078|FG000|Open-Label Study Period|Withdrawal by Subject|33|||
147396175|NCT02547441|531615079|FG001|Open-Label Study Period|Withdrawal by Subject|37|||
147396176|NCT02547441|531615078|FG000|Open-Label Study Period|Terminated by Sponsor|66|||
147396177|NCT02547441|531615079|FG001|Open-Label Study Period|Terminated by Sponsor|69|||
147396178|NCT01657877|531615080|FG000|Overall Study|Withdrawal by Subject|4|||
147396179|NCT01657877|531615080|FG000|Overall Study|Protocol Violation|6|||
147396180|NCT01657877|531615080|FG000|Overall Study|Adverse Event|2|||
147396181|NCT01657877|531615080|FG000|Overall Study|Other Reason|2|||
147396182|NCT00905034|531615082|FG000|Overall Study|Withdrawal by Subject|1|||
147396183|NCT01978236|531615085|FG000|Overall Study|Discontinued due to study close|2|||
147396184|NCT00634920|531615086|FG000|Period 1 - Pre-Randomization|Adverse Event|0|||
147396185|NCT00634920|531615087|FG001|Period 1 - Pre-Randomization|Adverse Event|0|||
147396186|NCT00634920|531615088|FG002|Period 1 - Pre-Randomization|Adverse Event|36|||
147396187|NCT00634920|531615086|FG000|Period 1 - Pre-Randomization|Wound healing problems|0|||
147396188|NCT00634920|531615087|FG001|Period 1 - Pre-Randomization|Wound healing problems|0|||
147396189|NCT00634920|531615088|FG002|Period 1 - Pre-Randomization|Wound healing problems|16|||
147396190|NCT00634920|531615086|FG000|Period 1 - Pre-Randomization|Rejections|0|||
147396191|NCT00634920|531615087|FG001|Period 1 - Pre-Randomization|Rejections|0|||
147615400|NCT01547390|532406729|FG001|Overall Study|termination of pregnancy|1|||
147615401|NCT01547390|532406728|FG000|Overall Study|Lost to Follow-up|0|||
147396192|NCT00634920|531615088|FG002|Period 1 - Pre-Randomization|Rejections|55|||
147396193|NCT00634920|531615086|FG000|Period 1 - Pre-Randomization|Withdrawal by Subject|0|||
147396194|NCT00634920|531615087|FG001|Period 1 - Pre-Randomization|Withdrawal by Subject|0|||
147396195|NCT00634920|531615088|FG002|Period 1 - Pre-Randomization|Withdrawal by Subject|21|||
147396196|NCT00634920|531615086|FG000|Period 1 - Pre-Randomization|Non-Compliance|0|||
147396197|NCT00634920|531615087|FG001|Period 1 - Pre-Randomization|Non-Compliance|0|||
147396198|NCT00634920|531615088|FG002|Period 1 - Pre-Randomization|Non-Compliance|3|||
147396199|NCT00634920|531615086|FG000|Period 1 - Pre-Randomization|Other issues|0|||
147396200|NCT00634920|531615087|FG001|Period 1 - Pre-Randomization|Other issues|0|||
147396201|NCT00634920|531615088|FG002|Period 1 - Pre-Randomization|Other issues|6|||
147396202|NCT00634920|531615086|FG000|Period 2 - Post-Randomization|Adverse Event|37|||
147396203|NCT00634920|531615087|FG001|Period 2 - Post-Randomization|Adverse Event|9|||
147396204|NCT00634920|531615088|FG002|Period 2 - Post-Randomization|Adverse Event|0|||
147396205|NCT00634920|531615086|FG000|Period 2 - Post-Randomization|Rejection|11|||
147396206|NCT00634920|531615087|FG001|Period 2 - Post-Randomization|Rejection|5|||
147396207|NCT00634920|531615088|FG002|Period 2 - Post-Randomization|Rejection|0|||
147396208|NCT00634920|531615086|FG000|Period 2 - Post-Randomization|Death|2|||
147396209|NCT00634920|531615087|FG001|Period 2 - Post-Randomization|Death|5|||
147396210|NCT00634920|531615088|FG002|Period 2 - Post-Randomization|Death|0|||
147396211|NCT00634920|531615086|FG000|Period 2 - Post-Randomization|consent withdrawal, non compliance|9|||
147396212|NCT00634920|531615087|FG001|Period 2 - Post-Randomization|consent withdrawal, non compliance|13|||
147396213|NCT00634920|531615088|FG002|Period 2 - Post-Randomization|consent withdrawal, non compliance|0|||
147396214|NCT00634920|531615086|FG000|Period 2 - Post-Randomization|Patients did not receive study drug|2|||
147396215|NCT00634920|531615087|FG001|Period 2 - Post-Randomization|Patients did not receive study drug|0|||
147396216|NCT00634920|531615088|FG002|Period 2 - Post-Randomization|Patients did not receive study drug|0|||
147396217|NCT01527500|531615090|FG000|Part A|Administrative|11|||
147396218|NCT01527500|531615091|FG001|Part A|Administrative|7|||
147396219|NCT01527500|531615090|FG000|Part A|Adverse Event|4|||
147396220|NCT01527500|531615091|FG001|Part A|Adverse Event|2|||
147396221|NCT01527500|531615090|FG000|Part A|Death|4|||
147396222|NCT01527500|531615091|FG001|Part A|Death|1|||
147396223|NCT01527500|531615090|FG000|Part A|Lost to Follow-up|0|||
147396224|NCT01527500|531615091|FG001|Part A|Lost to Follow-up|1|||
147396225|NCT01527500|531615090|FG000|Part A|Protocol Deviation|9|||
147396226|NCT01527500|531615091|FG001|Part A|Protocol Deviation|2|||
147396227|NCT01527500|531615090|FG000|Part A|Withdrawal by Subject|2|||
147396228|NCT01527500|531615091|FG001|Part A|Withdrawal by Subject|0|||
147396229|NCT01527500|531615090|FG000|Part B|Adverse Event|1|||
147396230|NCT01527500|531615091|FG001|Part B|Adverse Event|0|||
147396231|NCT00372255|531615092|FG000|Overall Study|Withdrawn for other reasons|2|||
147396232|NCT00372255|531615093|FG001|Overall Study|Withdrawn for other reasons|1|||
147396233|NCT02864342|531615094|FG000|Overall Study|Eligibility Criteria Deviation|2|||
147396234|NCT02864342|531615095|FG001|Overall Study|Eligibility Criteria Deviation|3|||
147396235|NCT02864342|531615094|FG000|Overall Study|Withdrawal by Subject|4|||
147396236|NCT02864342|531615095|FG001|Overall Study|Withdrawal by Subject|2|||
147396237|NCT02864342|531615094|FG000|Overall Study|Device Technology Issue|6|||
147396238|NCT02864342|531615095|FG001|Overall Study|Device Technology Issue|7|||
147396239|NCT02864342|531615094|FG000|Overall Study|Death|0|||
147396240|NCT02864342|531615095|FG001|Overall Study|Death|1|||
147396241|NCT02864342|531615094|FG000|Overall Study|Did Not Start Treatment with Symbicort|0|||
147396242|NCT02864342|531615095|FG001|Overall Study|Did Not Start Treatment with Symbicort|1|||
147396243|NCT02864342|531615094|FG000|Overall Study|Lost to Follow-up|1|||
147396244|NCT02864342|531615095|FG001|Overall Study|Lost to Follow-up|5|||
147396245|NCT02864342|531615094|FG000|Overall Study|Lost Device|1|||
147396246|NCT02864342|531615095|FG001|Overall Study|Lost Device|0|||
147396247|NCT02864342|531615094|FG000|Overall Study|Adverse Event|1|||
147396248|NCT02864342|531615095|FG001|Overall Study|Adverse Event|0|||
147396249|NCT02573883|531615096|FG000|Six Month Follow Up|Lost to Follow-up|1|||
147396250|NCT02573883|531615097|FG001|Six Month Follow Up|Lost to Follow-up|0|||
147615402|NCT01547390|532406729|FG001|Overall Study|Lost to Follow-up|2|||
147396251|NCT02573883|531615098|FG002|Six Month Follow Up|Lost to Follow-up|0|||
147615403|NCT01547390|532406728|FG000|Overall Study|Adverse Event|3|||
147615404|NCT01547390|532406729|FG001|Overall Study|Adverse Event|0|||
147396252|NCT02573883|531615099|FG003|Six Month Follow Up|Lost to Follow-up|0|||
147396253|NCT02573883|531615096|FG000|One Year Follow Up|Lost to Follow-up|2|||
147396254|NCT02573883|531615097|FG001|One Year Follow Up|Lost to Follow-up|1|||
147396255|NCT02573883|531615098|FG002|One Year Follow Up|Lost to Follow-up|0|||
147396256|NCT02573883|531615099|FG003|One Year Follow Up|Lost to Follow-up|0|||
147396257|NCT01125566|531615105|FG000|Patients Before the Switch (26Apr2013)|Progressive disease according to RECIST|182|||
147396258|NCT01125566|531615106|FG001|Patients Before the Switch (26Apr2013)|Progressive disease according to RECIST|119|||
147396259|NCT01125566|531615107|FG002|Patients Before the Switch (26Apr2013)|Progressive disease according to RECIST|0|||
147615405|NCT01959295|532406732|FG000|Overall Study|Adverse Event|2|||
147615406|NCT01959295|532406733|FG001|Overall Study|Adverse Event|0|||
147396260|NCT01125566|531615105|FG000|Patients Before the Switch (26Apr2013)|Worsening of underlying cancer disease|6|||
147396261|NCT01125566|531615106|FG001|Patients Before the Switch (26Apr2013)|Worsening of underlying cancer disease|6|||
147396262|NCT01125566|531615107|FG002|Patients Before the Switch (26Apr2013)|Worsening of underlying cancer disease|0|||
147396263|NCT01125566|531615105|FG000|Patients Before the Switch (26Apr2013)|Adverse Event|25|||
147396264|NCT01125566|531615106|FG001|Patients Before the Switch (26Apr2013)|Adverse Event|5|||
147396265|NCT01125566|531615107|FG002|Patients Before the Switch (26Apr2013)|Adverse Event|0|||
147396266|NCT01125566|531615105|FG000|Patients Before the Switch (26Apr2013)|Protocol Violation|0|||
147396267|NCT01125566|531615106|FG001|Patients Before the Switch (26Apr2013)|Protocol Violation|2|||
147396268|NCT01125566|531615107|FG002|Patients Before the Switch (26Apr2013)|Protocol Violation|0|||
147396269|NCT01125566|531615105|FG000|Patients Before the Switch (26Apr2013)|Refused to continue taking medication|24|||
147396270|NCT01125566|531615106|FG001|Patients Before the Switch (26Apr2013)|Refused to continue taking medication|23|||
147396271|NCT01125566|531615107|FG002|Patients Before the Switch (26Apr2013)|Refused to continue taking medication|0|||
147396272|NCT01125566|531615105|FG000|Patients Before the Switch (26Apr2013)|Not treated|2|||
147396273|NCT01125566|531615106|FG001|Patients Before the Switch (26Apr2013)|Not treated|0|||
147396274|NCT01125566|531615107|FG002|Patients Before the Switch (26Apr2013)|Not treated|0|||
147396275|NCT01125566|531615105|FG000|Patients Before the Switch (26Apr2013)|Other than listed above|25|||
147396276|NCT01125566|531615106|FG001|Patients Before the Switch (26Apr2013)|Other than listed above|13|||
147396277|NCT01125566|531615107|FG002|Patients Before the Switch (26Apr2013)|Other than listed above|0|||
147396278|NCT01125566|531615105|FG000|Patients Before the Switch (26Apr2013)|Lost to Follow-up|1|||
147396279|NCT01125566|531615106|FG001|Patients Before the Switch (26Apr2013)|Lost to Follow-up|1|||
147396280|NCT01125566|531615107|FG002|Patients Before the Switch (26Apr2013)|Lost to Follow-up|0|||
147396281|NCT01125566|531615105|FG000|Patients Who Switched From AV to TV|Progressive disease according to RECIST|0|||
147396282|NCT01125566|531615106|FG001|Patients Who Switched From AV to TV|Progressive disease according to RECIST|0|||
147396283|NCT01125566|531615107|FG002|Patients Who Switched From AV to TV|Progressive disease according to RECIST|59|||
147396284|NCT01125566|531615105|FG000|Patients Who Switched From AV to TV|Refused to continue taking medication|0|||
147396285|NCT01125566|531615106|FG001|Patients Who Switched From AV to TV|Refused to continue taking medication|0|||
147396286|NCT01125566|531615107|FG002|Patients Who Switched From AV to TV|Refused to continue taking medication|7|||
147396287|NCT01125566|531615105|FG000|Patients Who Switched From AV to TV|Worsening of underlying cancer disease|0|||
147396288|NCT01125566|531615106|FG001|Patients Who Switched From AV to TV|Worsening of underlying cancer disease|0|||
147396289|NCT01125566|531615107|FG002|Patients Who Switched From AV to TV|Worsening of underlying cancer disease|3|||
147396290|NCT01125566|531615105|FG000|Patients Who Switched From AV to TV|Other than listed above|0|||
147396291|NCT01125566|531615106|FG001|Patients Who Switched From AV to TV|Other than listed above|0|||
147396292|NCT01125566|531615107|FG002|Patients Who Switched From AV to TV|Other than listed above|4|||
147396293|NCT01560585|531615108|FG000|Overall Study|Physician Decision|3|||
147396294|NCT00519285|531615109|FG000|Overall Study|Adverse Event|127|||
147396295|NCT00519285|531615110|FG001|Overall Study|Adverse Event|266|||
147396296|NCT00519285|531615109|FG000|Overall Study|Disease progression|334|||
147396297|NCT00519285|531615110|FG001|Overall Study|Disease progression|186|||
147396298|NCT00519285|531615109|FG000|Overall Study|Physician Decision|75|||
147460598|NCT03969875|531847053|FG001|Overall Study|did not receive allocated intervention|3|||
147460599|NCT03969875|531847054|FG002|Overall Study|did not receive allocated intervention|4|||
147460600|NCT03969875|531847052|FG000|Overall Study|Protocol Violation|4|||
147460601|NCT03969875|531847053|FG001|Overall Study|Protocol Violation|2|||
147460602|NCT03969875|531847054|FG002|Overall Study|Protocol Violation|2|||
147460603|NCT01307033|531847055|FG000|8-week Double-blind Period|Adverse Event|2|||
147460604|NCT01307033|531847056|FG001|8-week Double-blind Period|Adverse Event|0|||
147460605|NCT01307033|531847057|FG002|8-week Double-blind Period|Adverse Event|0|||
147460606|NCT01307033|531847058|FG003|8-week Double-blind Period|Adverse Event|0|||
147460607|NCT01307033|531847055|FG000|8-week Double-blind Period|Withdrawal by Subject|4|||
147460608|NCT01307033|531847056|FG001|8-week Double-blind Period|Withdrawal by Subject|1|||
147460609|NCT01307033|531847057|FG002|8-week Double-blind Period|Withdrawal by Subject|0|||
147460610|NCT01307033|531847058|FG003|8-week Double-blind Period|Withdrawal by Subject|0|||
147460611|NCT01307033|531847055|FG000|8-week Double-blind Period|Lack of Efficacy|1|||
147460612|NCT01307033|531847056|FG001|8-week Double-blind Period|Lack of Efficacy|0|||
147460613|NCT01307033|531847057|FG002|8-week Double-blind Period|Lack of Efficacy|0|||
147460614|NCT01307033|531847058|FG003|8-week Double-blind Period|Lack of Efficacy|0|||
147460615|NCT01307033|531847055|FG000|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|0|||
147460616|NCT01307033|531847056|FG001|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|3|||
147460617|NCT01307033|531847057|FG002|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|0|||
147460618|NCT01307033|531847058|FG003|8-week Double-blind Period|Blood Pressure Withdrawal Criteria Met|0|||
147460619|NCT01307033|531847055|FG000|8-week Double-blind Period|Potassium Withdrawal Criteria Met|6|||
147460620|NCT01307033|531847056|FG001|8-week Double-blind Period|Potassium Withdrawal Criteria Met|3|||
147460621|NCT01307033|531847057|FG002|8-week Double-blind Period|Potassium Withdrawal Criteria Met|0|||
147460622|NCT01307033|531847058|FG003|8-week Double-blind Period|Potassium Withdrawal Criteria Met|0|||
147460623|NCT01307033|531847055|FG000|44-week Open-label Extension|Adverse Event|0|||
147396299|NCT00519285|531615110|FG001|Overall Study|Physician Decision|47|||
147396300|NCT00519285|531615109|FG000|Overall Study|Participant's request|53|||
147396301|NCT00519285|531615110|FG001|Overall Study|Participant's request|84|||
147396302|NCT00519285|531615109|FG000|Overall Study|Consent withdrawn|4|||
147396303|NCT00519285|531615110|FG001|Overall Study|Consent withdrawn|5|||
147396304|NCT00519285|531615109|FG000|Overall Study|Poor compliance to protocol|5|||
147396305|NCT00519285|531615110|FG001|Overall Study|Poor compliance to protocol|7|||
147396306|NCT00519285|531615109|FG000|Overall Study|Reason unspecified|5|||
147396307|NCT00519285|531615110|FG001|Overall Study|Reason unspecified|8|||
147396308|NCT00519285|531615109|FG000|Overall Study|Not treated|8|||
147396309|NCT00519285|531615110|FG001|Overall Study|Not treated|7|||
147396310|NCT00519285|531615109|FG000|Overall Study|Treatment ongoing|1|||
147396311|NCT00519285|531615110|FG001|Overall Study|Treatment ongoing|2|||
147396312|NCT02970305|531615111|FG000|Overall Study|Adverse Event|10|||
147396313|NCT02970305|531615112|FG001|Overall Study|Adverse Event|6|||
147396314|NCT02970305|531615111|FG000|Overall Study|Lack of Efficacy|1|||
147396315|NCT02970305|531615112|FG001|Overall Study|Lack of Efficacy|1|||
147396316|NCT02970305|531615111|FG000|Overall Study|Noncompliance with study drug|2|||
147396317|NCT02970305|531615112|FG001|Overall Study|Noncompliance with study drug|4|||
147396318|NCT02970305|531615111|FG000|Overall Study|Protocol Violation|2|||
147396319|NCT02970305|531615112|FG001|Overall Study|Protocol Violation|2|||
147396320|NCT02970305|531615111|FG000|Overall Study|Withdrawal by Subject|12|||
147396321|NCT02970305|531615112|FG001|Overall Study|Withdrawal by Subject|11|||
147396322|NCT02970305|531615111|FG000|Overall Study|Not further specified|1|||
147396323|NCT02970305|531615112|FG001|Overall Study|Not further specified|2|||
147396324|NCT02970305|531615111|FG000|Overall Study|Lost to Follow-up|1|||
147396325|NCT02970305|531615112|FG001|Overall Study|Lost to Follow-up|2|||
147396326|NCT01813305|531615114|FG000|Overall Study|Withdrawal by Subject|12|||
147396327|NCT01813305|531615115|FG001|Overall Study|Withdrawal by Subject|5|||
147396328|NCT01813305|531615114|FG000|Overall Study|Safety Concern|4|||
147396329|NCT01813305|531615115|FG001|Overall Study|Safety Concern|0|||
147396330|NCT01813305|531615114|FG000|Overall Study|Ulcer became worse|4|||
147396331|NCT01813305|531615115|FG001|Overall Study|Ulcer became worse|0|||
147396332|NCT01813305|531615114|FG000|Overall Study|Physician Decision|4|||
147396333|NCT01813305|531615115|FG001|Overall Study|Physician Decision|0|||
147396334|NCT01813305|531615114|FG000|Overall Study|Lost to Follow-up|3|||
147396335|NCT01813305|531615115|FG001|Overall Study|Lost to Follow-up|1|||
147396336|NCT01813305|531615114|FG000|Overall Study|Protocol Violation|1|||
147396337|NCT01813305|531615115|FG001|Overall Study|Protocol Violation|0|||
147396338|NCT01813305|531615114|FG000|Overall Study|Prohibited Medication Administration or Condition Worsening|7|||
147396339|NCT01813305|531615115|FG001|Overall Study|Prohibited Medication Administration or Condition Worsening|2|||
147396340|NCT00988117|531615116|FG000|4.6 mg/24 Hours From Baseline to Week 4|Adverse Event|1|||
147396341|NCT00988117|531615116|FG000|9.5 mg/24 Hours From Week 4 to 12|Adverse Event|2|||
147396342|NCT04088500|531615117|FG000|Overall Study|Reason unknown|1|||
147396343|NCT04088500|531615117|FG000|Overall Study|Participant withdrew consent|1|||
147396344|NCT04088500|531615117|FG000|Overall Study|Disease progression|3|||
147396345|NCT02930837|531615121|FG000|Overall Study|Adverse Event|6|||
147396346|NCT02930837|531615121|FG000|Overall Study|Lost to Follow-up|5|||
147396347|NCT02930837|531615121|FG000|Overall Study|Withdrawal by Subject|1|||
147396348|NCT00006436|531615122|FG000|Overall Study|Refused further treatment|2|||
147396349|NCT00006436|531615122|FG000|Overall Study|Declined to participate (before treatment started)|1|||
147396350|NCT01071317|531615123|FG000|Overall Study|Lost to Follow-up|2|||
147396351|NCT01071317|531615124|FG001|Overall Study|Lost to Follow-up|2|||
147396352|NCT01502371|531615131|FG000|Overall Study|Withdrawal by Subject|1|||
147396353|NCT01502371|531615132|FG001|Overall Study|Withdrawal by Subject|2|||
147396354|NCT01502371|531615133|FG002|Overall Study|Withdrawal by Subject|1|||
147396355|NCT01502371|531615134|FG003|Overall Study|Withdrawal by Subject|1|||
147396356|NCT01502371|531615135|FG004|Overall Study|Withdrawal by Subject|1|||
147396357|NCT01502371|531615131|FG000|Overall Study|Adverse Event|2|||
147396358|NCT01502371|531615132|FG001|Overall Study|Adverse Event|1|||
147396359|NCT01502371|531615133|FG002|Overall Study|Adverse Event|0|||
147396360|NCT01502371|531615134|FG003|Overall Study|Adverse Event|4|||
147396361|NCT01502371|531615135|FG004|Overall Study|Adverse Event|3|||
147396362|NCT01502371|531615131|FG000|Overall Study|Treatment Failure|22|||
147396363|NCT01502371|531615132|FG001|Overall Study|Treatment Failure|20|||
147396364|NCT01502371|531615133|FG002|Overall Study|Treatment Failure|12|||
147396365|NCT01502371|531615134|FG003|Overall Study|Treatment Failure|19|||
147460624|NCT01307033|531847056|FG001|44-week Open-label Extension|Adverse Event|0|||
147396366|NCT01502371|531615135|FG004|Overall Study|Treatment Failure|30|||
147396367|NCT01502371|531615131|FG000|Overall Study|Lack of Efficacy|3|||
147396368|NCT01502371|531615132|FG001|Overall Study|Lack of Efficacy|3|||
147396369|NCT01502371|531615133|FG002|Overall Study|Lack of Efficacy|2|||
147396370|NCT01502371|531615134|FG003|Overall Study|Lack of Efficacy|2|||
147396371|NCT01502371|531615135|FG004|Overall Study|Lack of Efficacy|4|||
147396372|NCT01502371|531615131|FG000|Overall Study|Physician Decision|3|||
147396373|NCT01502371|531615132|FG001|Overall Study|Physician Decision|0|||
147396374|NCT01502371|531615133|FG002|Overall Study|Physician Decision|0|||
147396375|NCT01502371|531615134|FG003|Overall Study|Physician Decision|0|||
147460625|NCT01307033|531847057|FG002|44-week Open-label Extension|Adverse Event|2|||
147460626|NCT01307033|531847058|FG003|44-week Open-label Extension|Adverse Event|1|||
147460627|NCT01307033|531847055|FG000|44-week Open-label Extension|Withdrawal by Subject|0|||
147460628|NCT01307033|531847056|FG001|44-week Open-label Extension|Withdrawal by Subject|0|||
147460629|NCT01307033|531847057|FG002|44-week Open-label Extension|Withdrawal by Subject|2|||
147460630|NCT01307033|531847058|FG003|44-week Open-label Extension|Withdrawal by Subject|1|||
147460631|NCT01307033|531847055|FG000|44-week Open-label Extension|Physician Decision|0|||
147460632|NCT01307033|531847056|FG001|44-week Open-label Extension|Physician Decision|0|||
147460633|NCT01307033|531847057|FG002|44-week Open-label Extension|Physician Decision|1|||
147460634|NCT01307033|531847058|FG003|44-week Open-label Extension|Physician Decision|0|||
147460635|NCT01307033|531847055|FG000|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|0|||
147460636|NCT01307033|531847056|FG001|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|0|||
147460637|NCT01307033|531847057|FG002|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|0|||
147460638|NCT01307033|531847058|FG003|44-week Open-label Extension|Blood Pressure Withdrawal Criteria Met|2|||
147460639|NCT01307033|531847055|FG000|44-week Open-label Extension|Potassium Withdrawal Criteria Met|0|||
147460640|NCT01307033|531847056|FG001|44-week Open-label Extension|Potassium Withdrawal Criteria Met|0|||
147460641|NCT01307033|531847057|FG002|44-week Open-label Extension|Potassium Withdrawal Criteria Met|6|||
147460642|NCT01307033|531847058|FG003|44-week Open-label Extension|Potassium Withdrawal Criteria Met|7|||
147460643|NCT01307033|531847055|FG000|44-week Open-label Extension|Death|0|||
147460644|NCT01307033|531847056|FG001|44-week Open-label Extension|Death|0|||
147460645|NCT01307033|531847057|FG002|44-week Open-label Extension|Death|0|||
147460646|NCT01307033|531847058|FG003|44-week Open-label Extension|Death|1|||
147460647|NCT02327260|531847060|FG000|Overall Study|Lost to Follow-up|2|||
147460648|NCT02327260|531847061|FG001|Overall Study|Lost to Follow-up|3|||
147460649|NCT02327260|531847062|FG002|Overall Study|Lost to Follow-up|2|||
147460650|NCT02327260|531847060|FG000|Overall Study|invalid phone number|1|||
147460651|NCT02327260|531847061|FG001|Overall Study|invalid phone number|1|||
147460652|NCT02327260|531847062|FG002|Overall Study|invalid phone number|0|||
147460653|NCT02327260|531847060|FG000|Overall Study|non-adherence to protocol|2|||
147460654|NCT02327260|531847061|FG001|Overall Study|non-adherence to protocol|0|||
147460655|NCT02327260|531847062|FG002|Overall Study|non-adherence to protocol|0|||
147460656|NCT02327260|531847060|FG000|Overall Study|cognitive concerns|1|||
147460657|NCT02327260|531847061|FG001|Overall Study|cognitive concerns|0|||
147460658|NCT02327260|531847062|FG002|Overall Study|cognitive concerns|0|||
147460659|NCT02804763|531847065|FG000|Double-Blind Period (Week 1 to Week 24)|Adverse Event|1|||
147460660|NCT02804763|531847066|FG001|Double-Blind Period (Week 1 to Week 24)|Adverse Event|0|||
147460661|NCT02804763|531847067|FG002|Double-Blind Period (Week 1 to Week 24)|Adverse Event|0|||
147460662|NCT02804763|531847068|FG003|Double-Blind Period (Week 1 to Week 24)|Adverse Event|0|||
147460663|NCT02804763|531847065|FG000|Double-Blind Period (Week 1 to Week 24)|Withdrawal by Subject|0|||
147460664|NCT02804763|531847066|FG001|Double-Blind Period (Week 1 to Week 24)|Withdrawal by Subject|0|||
147460665|NCT02804763|531847067|FG002|Double-Blind Period (Week 1 to Week 24)|Withdrawal by Subject|1|||
147460666|NCT02804763|531847068|FG003|Double-Blind Period (Week 1 to Week 24)|Withdrawal by Subject|2|||
147460667|NCT02804763|531847065|FG000|Double-Blind Period (Week 1 to Week 24)|Consent withdrawal after Week 24|0|||
147460668|NCT02804763|531847066|FG001|Double-Blind Period (Week 1 to Week 24)|Consent withdrawal after Week 24|1|||
147460669|NCT02804763|531847067|FG002|Double-Blind Period (Week 1 to Week 24)|Consent withdrawal after Week 24|0|||
147460670|NCT02804763|531847068|FG003|Double-Blind Period (Week 1 to Week 24)|Consent withdrawal after Week 24|0|||
147460671|NCT02804763|531847065|FG000|Observational Period (Wk 24 to Wk 48)|Lost to Follow-up|2|||
147460672|NCT02804763|531847066|FG001|Observational Period (Wk 24 to Wk 48)|Lost to Follow-up|0|||
147460673|NCT02804763|531847067|FG002|Observational Period (Wk 24 to Wk 48)|Lost to Follow-up|1|||
147460674|NCT02804763|531847068|FG003|Observational Period (Wk 24 to Wk 48)|Lost to Follow-up|1|||
147460675|NCT02804763|531847065|FG000|Observational Period (Wk 24 to Wk 48)|Withdrawal by Subject|4|||
147460676|NCT02804763|531847066|FG001|Observational Period (Wk 24 to Wk 48)|Withdrawal by Subject|0|||
147460677|NCT02804763|531847067|FG002|Observational Period (Wk 24 to Wk 48)|Withdrawal by Subject|2|||
147460678|NCT02804763|531847068|FG003|Observational Period (Wk 24 to Wk 48)|Withdrawal by Subject|2|||
147460679|NCT02804763|531847065|FG000|Observational Period (Wk 24 to Wk 48)|Patient moved out of state|0|||
147460680|NCT02804763|531847066|FG001|Observational Period (Wk 24 to Wk 48)|Patient moved out of state|1|||
147460681|NCT02804763|531847067|FG002|Observational Period (Wk 24 to Wk 48)|Patient moved out of state|0|||
147460682|NCT02804763|531847068|FG003|Observational Period (Wk 24 to Wk 48)|Patient moved out of state|0|||
147460683|NCT00860158|531847069|FG000|Overall Study|Study Terminated|1|||
147460684|NCT03588741|531847070|FG000|Overall Study|Withdrawal by Subject|1|||
147460685|NCT00840827|531847072|FG000|Overall Study|Adverse Event|1|||
147460686|NCT00840827|531847072|FG000|Overall Study|Lack of Efficacy|4|||
147460687|NCT00840827|531847072|FG000|Overall Study|Physician Decision|1|||
147460688|NCT01445535|531847073|FG000|Overall Study|Enrolled/taken off study, no drug avail.|0|||
147460689|NCT01445535|531847074|FG001|Overall Study|Enrolled/taken off study, no drug avail.|0|||
147460690|NCT01445535|531847075|FG002|Overall Study|Enrolled/taken off study, no drug avail.|0|||
147460691|NCT01445535|531847076|FG003|Overall Study|Enrolled/taken off study, no drug avail.|1|||
147396376|NCT01502371|531615135|FG004|Overall Study|Physician Decision|1|||
147396377|NCT01502371|531615131|FG000|Overall Study|Noncompliance with Study Drug|0|||
147396378|NCT01502371|531615132|FG001|Overall Study|Noncompliance with Study Drug|0|||
147396379|NCT01502371|531615133|FG002|Overall Study|Noncompliance with Study Drug|1|||
147396380|NCT01502371|531615134|FG003|Overall Study|Noncompliance with Study Drug|2|||
147396381|NCT01502371|531615135|FG004|Overall Study|Noncompliance with Study Drug|1|||
147396382|NCT01502371|531615131|FG000|Overall Study|Technical Problems|1|||
147396383|NCT01502371|531615132|FG001|Overall Study|Technical Problems|0|||
147396384|NCT01502371|531615133|FG002|Overall Study|Technical Problems|2|||
147396385|NCT01502371|531615134|FG003|Overall Study|Technical Problems|4|||
147396386|NCT01502371|531615135|FG004|Overall Study|Technical Problems|1|||
147396387|NCT01502371|531615131|FG000|Overall Study|Protocol Violation|9|||
147396388|NCT01502371|531615132|FG001|Overall Study|Protocol Violation|5|||
147396389|NCT01502371|531615133|FG002|Overall Study|Protocol Violation|6|||
147396390|NCT01502371|531615134|FG003|Overall Study|Protocol Violation|5|||
147396391|NCT01502371|531615135|FG004|Overall Study|Protocol Violation|10|||
147396392|NCT01502371|531615131|FG000|Overall Study|Excluded Medication|0|||
147396393|NCT01502371|531615132|FG001|Overall Study|Excluded Medication|1|||
147396394|NCT01502371|531615133|FG002|Overall Study|Excluded Medication|1|||
147396395|NCT01502371|531615134|FG003|Overall Study|Excluded Medication|0|||
147396396|NCT01502371|531615135|FG004|Overall Study|Excluded Medication|1|||
147396397|NCT02598934|531615141|FG000|Overall Study|Adverse Event|11|||
147396398|NCT02598934|531615142|FG001|Overall Study|Adverse Event|13|||
147396399|NCT02598934|531615141|FG000|Overall Study|Failure to Return|3|||
147396400|NCT02598934|531615142|FG001|Overall Study|Failure to Return|3|||
147396401|NCT02598934|531615141|FG000|Overall Study|Withdrawal by Subject|2|||
147396402|NCT02598934|531615142|FG001|Overall Study|Withdrawal by Subject|3|||
147396403|NCT02598934|531615141|FG000|Overall Study|Administrative|2|||
147396404|NCT02598934|531615142|FG001|Overall Study|Administrative|1|||
147396405|NCT02598934|531615141|FG000|Overall Study|Protocol Violation|1|||
147396406|NCT02598934|531615142|FG001|Overall Study|Protocol Violation|2|||
147396407|NCT02481934|531615143|FG000|Overall Study|Death|2|||
147396408|NCT03749616|531615147|FG000|Overall Study|Lost to Follow-up|4|||
147396409|NCT03749616|531615148|FG001|Overall Study|Lost to Follow-up|7|||
147396410|NCT03749616|531615147|FG000|Overall Study|Screen Failure|1|||
147396411|NCT03749616|531615148|FG001|Overall Study|Screen Failure|1|||
147396412|NCT03749616|531615147|FG000|Overall Study|Withdrawal by Subject|2|||
147396413|NCT03749616|531615148|FG001|Overall Study|Withdrawal by Subject|0|||
147396414|NCT03302559|531615149|FG000|Overall Study|Adverse Event|2|||
147396415|NCT03302559|531615149|FG000|Overall Study|Lost to Follow-up|1|||
147396416|NCT03302559|531615149|FG000|Overall Study|Withdrew Consent|3|||
147396417|NCT01932762|531617052|FG000|Overall Study|Withdrawal by Subject|1|||
147396418|NCT01932762|531617053|FG001|Overall Study|Withdrawal by Subject|2|||
147396419|NCT01932762|531617054|FG002|Overall Study|Withdrawal by Subject|0|||
147396420|NCT01932762|531617055|FG003|Overall Study|Withdrawal by Subject|0|||
147396421|NCT01932762|531617052|FG000|Overall Study|Lost to Follow-up|4|||
147396422|NCT01932762|531617053|FG001|Overall Study|Lost to Follow-up|0|||
147396423|NCT01932762|531617054|FG002|Overall Study|Lost to Follow-up|0|||
147396424|NCT01932762|531617055|FG003|Overall Study|Lost to Follow-up|1|||
147396425|NCT01932762|531617052|FG000|Overall Study|Physician Decision|1|||
147396426|NCT01932762|531617053|FG001|Overall Study|Physician Decision|0|||
147396427|NCT01932762|531617054|FG002|Overall Study|Physician Decision|0|||
147396428|NCT01932762|531617055|FG003|Overall Study|Physician Decision|0|||
147396429|NCT00695136|531617056|FG000|Overall Study|Withdrawal by Subject|1|||
147396430|NCT00695136|531617056|FG000|Overall Study|unrelated adverse event|1|||
147396431|NCT01726049|531617058|FG000|Overall Study|Death|1|||
147396432|NCT01726049|531617059|FG001|Overall Study|Death|1|||
147396433|NCT01726049|531617058|FG000|Overall Study|Adverse Event|4|||
147396434|NCT01726049|531617059|FG001|Overall Study|Adverse Event|1|||
147396435|NCT01726049|531617058|FG000|Overall Study|refused second HC|0|||
147396436|NCT01726049|531617059|FG001|Overall Study|refused second HC|2|||
147396437|NCT02202109|531617062|FG000|Overall Study|Lost to Follow-up|88|||
147615407|NCT01959295|532406732|FG000|Overall Study|Lost to Follow-up|0|||
147615408|NCT01959295|532406733|FG001|Overall Study|Lost to Follow-up|2|||
147396438|NCT02202109|531617063|FG001|Overall Study|Lost to Follow-up|87|||
147396439|NCT02202109|531617062|FG000|Overall Study|Withdrawal by Subject|2|||
147396440|NCT02202109|531617063|FG001|Overall Study|Withdrawal by Subject|0|||
147396441|NCT00320398|531617073|FG000|Overall Study|Adverse Event|1|||
147396442|NCT00320398|531617074|FG001|Overall Study|Adverse Event|4|||
147396443|NCT00320398|531617073|FG000|Overall Study|Other|1|||
147396444|NCT00320398|531617074|FG001|Overall Study|Other|0|||
147396445|NCT04190225|531617075|FG000|Overall Study|Lost to Follow-up|2|||
147396446|NCT04190225|531617076|FG001|Overall Study|Lost to Follow-up|3|||
147396447|NCT04190225|531617075|FG000|Overall Study|Withdrawal by Subject|3|||
147396448|NCT04190225|531617076|FG001|Overall Study|Withdrawal by Subject|2|||
147396449|NCT04190225|531617075|FG000|Overall Study|Unrelated health condition|2|||
147396450|NCT04190225|531617076|FG001|Overall Study|Unrelated health condition|0|||
147396451|NCT01057251|531617077|FG000|Overall Study|Did not meet InclusionExclusion criteria|4|||
147615409|NCT01959295|532406732|FG000|Overall Study|Physician Decision|2|||
147396452|NCT01057251|531617078|FG001|Overall Study|Did not meet InclusionExclusion criteria|2|||
147396453|NCT01057251|531617077|FG000|Overall Study|Adverse Event|4|||
147396454|NCT01057251|531617078|FG001|Overall Study|Adverse Event|2|||
147396455|NCT01057251|531617077|FG000|Overall Study|Lack of Efficacy|2|||
147396456|NCT01057251|531617078|FG001|Overall Study|Lack of Efficacy|11|||
147396457|NCT01057251|531617077|FG000|Overall Study|Protocol Violation|6|||
147396458|NCT01057251|531617078|FG001|Overall Study|Protocol Violation|2|||
147396459|NCT01057251|531617077|FG000|Overall Study|Withdrawal by Subject|4|||
147396460|NCT01057251|531617078|FG001|Overall Study|Withdrawal by Subject|5|||
147396461|NCT01057251|531617077|FG000|Overall Study|Lost to Follow-up|7|||
147396462|NCT01057251|531617078|FG001|Overall Study|Lost to Follow-up|6|||
147396463|NCT01057251|531617077|FG000|Overall Study|Other Reason|1|||
147396464|NCT01057251|531617078|FG001|Overall Study|Other Reason|1|||
147396465|NCT04544865|531617079|FG000|Overall Study|Death|0|||
147396466|NCT04544865|531617080|FG001|Overall Study|Death|2|||
147396467|NCT04544865|531617079|FG000|Overall Study|Lost to Follow-up|11|||
147396468|NCT04544865|531617080|FG001|Overall Study|Lost to Follow-up|7|||
147396469|NCT04544865|531617079|FG000|Overall Study|Withdrawal by Subject|0|||
147396470|NCT04544865|531617080|FG001|Overall Study|Withdrawal by Subject|1|||
147396471|NCT04544865|531617079|FG000|Overall Study|Other|0|||
147396472|NCT04544865|531617080|FG001|Overall Study|Other|1|||
147396473|NCT02973802|531617081|FG000|Overall Study|Lost to Follow-up|1|||
147396474|NCT02973802|531617081|FG000|Overall Study|Withdrawal by Subject|1|||
147396475|NCT01850823|531617082|FG000|Overall Study|Early Visit Window|0|||
147396476|NCT01850823|531617083|FG001|Overall Study|Early Visit Window|1|||
147396477|NCT01850823|531617084|FG002|Overall Study|Early Visit Window|4|||
147396478|NCT01850823|531617082|FG000|Overall Study|Enrolled in Error|0|||
147396479|NCT01850823|531617083|FG001|Overall Study|Enrolled in Error|1|||
147396480|NCT01850823|531617084|FG002|Overall Study|Enrolled in Error|2|||
147396481|NCT01850823|531617082|FG000|Overall Study|Lack of Efficacy|1|||
147396482|NCT01850823|531617083|FG001|Overall Study|Lack of Efficacy|0|||
147396483|NCT01850823|531617084|FG002|Overall Study|Lack of Efficacy|0|||
147396484|NCT01850823|531617082|FG000|Overall Study|Lost to Follow-up|0|||
147396485|NCT01850823|531617083|FG001|Overall Study|Lost to Follow-up|0|||
147396486|NCT01850823|531617084|FG002|Overall Study|Lost to Follow-up|1|||
147396487|NCT01850823|531617082|FG000|Overall Study|Restricted Medication|0|||
147396488|NCT01850823|531617083|FG001|Overall Study|Restricted Medication|0|||
147396489|NCT01850823|531617084|FG002|Overall Study|Restricted Medication|2|||
147396490|NCT01850823|531617082|FG000|Overall Study|Significant worstening of SAR|0|||
147396491|NCT01850823|531617083|FG001|Overall Study|Significant worstening of SAR|1|||
147396492|NCT01850823|531617084|FG002|Overall Study|Significant worstening of SAR|0|||
147396493|NCT01850823|531617082|FG000|Overall Study|Withdrawal by Subject|2|||
147396494|NCT01850823|531617083|FG001|Overall Study|Withdrawal by Subject|0|||
147396495|NCT01850823|531617084|FG002|Overall Study|Withdrawal by Subject|1|||
147396496|NCT01751165|531617085|FG000|Overall Study|Adverse event, serious fatal|1|||
147396497|NCT01751165|531617086|FG001|Overall Study|Adverse event, serious fatal|0|||
147396498|NCT01751165|531617087|FG002|Overall Study|Adverse event, serious fatal|1|||
147396499|NCT01751165|531617085|FG000|Overall Study|Withdrawal by Subject|0|||
147396500|NCT01751165|531617086|FG001|Overall Study|Withdrawal by Subject|0|||
147396501|NCT01751165|531617087|FG002|Overall Study|Withdrawal by Subject|1|||
147396502|NCT01751165|531617085|FG000|Overall Study|Serious adverse event|0|||
147396503|NCT01751165|531617086|FG001|Overall Study|Serious adverse event|2|||
147396504|NCT01751165|531617087|FG002|Overall Study|Serious adverse event|0|||
147396505|NCT01751165|531617085|FG000|Overall Study|Lost to Follow-up|1|||
147396506|NCT01751165|531617086|FG001|Overall Study|Lost to Follow-up|1|||
147396507|NCT01751165|531617087|FG002|Overall Study|Lost to Follow-up|1|||
147396508|NCT00913523|531617091|FG000|Overall Study|Withdrawal by Subject|3|||
147396509|NCT00913523|531617092|FG001|Overall Study|Withdrawal by Subject|2|||
147396510|NCT00913523|531617093|FG002|Overall Study|Withdrawal by Subject|2|||
147396511|NCT00913523|531617091|FG000|Overall Study|Lost to Follow-up|1|||
147396512|NCT00913523|531617092|FG001|Overall Study|Lost to Follow-up|1|||
147396513|NCT00913523|531617093|FG002|Overall Study|Lost to Follow-up|1|||
147396514|NCT00913523|531617091|FG000|Overall Study|Adverse Event|1|||
147396515|NCT00913523|531617092|FG001|Overall Study|Adverse Event|0|||
147396516|NCT00913523|531617093|FG002|Overall Study|Adverse Event|0|||
147460692|NCT01445535|531847073|FG000|Overall Study|Disease progression|1|||
147460693|NCT01445535|531847074|FG001|Overall Study|Disease progression|0|||
147460694|NCT01445535|531847075|FG002|Overall Study|Disease progression|1|||
147396517|NCT00913523|531617091|FG000|Overall Study|Protocol Violation|5|||
147396518|NCT00913523|531617092|FG001|Overall Study|Protocol Violation|8|||
147396519|NCT00913523|531617093|FG002|Overall Study|Protocol Violation|8|||
147396520|NCT00913523|531617091|FG000|Overall Study|Pregnancy|1|||
147396521|NCT00913523|531617092|FG001|Overall Study|Pregnancy|3|||
147396522|NCT00913523|531617093|FG002|Overall Study|Pregnancy|0|||
147396523|NCT00913523|531617091|FG000|Overall Study|Inadequate Number of Tampons Used|7|||
147396524|NCT00913523|531617092|FG001|Overall Study|Inadequate Number of Tampons Used|2|||
147396525|NCT00913523|531617093|FG002|Overall Study|Inadequate Number of Tampons Used|3|||
147460695|NCT01445535|531847076|FG003|Overall Study|Disease progression|0|||
147396526|NCT01202409|531617094|FG000|Overall Study|Adverse Event|1|||
147396527|NCT01202409|531617094|FG000|Overall Study|Ineligible - KRAS mutants|7|||
147396528|NCT01774019|531617095|FG000|Overall Study|No longer meets protocol criteria|2|||
147396529|NCT01774019|531617096|FG001|Overall Study|No longer meets protocol criteria|0|||
147396530|NCT01774019|531617095|FG000|Overall Study|Withdrawal by Subject|1|||
147396531|NCT01774019|531617096|FG001|Overall Study|Withdrawal by Subject|0|||
147396532|NCT01774019|531617095|FG000|Overall Study|Surgery delayed > 120 days|1|||
147396533|NCT01774019|531617096|FG001|Overall Study|Surgery delayed > 120 days|0|||
147396534|NCT01774019|531617095|FG000|Overall Study|Patient refused surgery|1|||
147396535|NCT01774019|531617096|FG001|Overall Study|Patient refused surgery|1|||
147396536|NCT01774019|531617095|FG000|Overall Study|Unable to implant study device|1|||
147396537|NCT01774019|531617096|FG001|Overall Study|Unable to implant study device|0|||
147396538|NCT01774019|531617095|FG000|Overall Study|Lost to Follow-up|0|||
147396539|NCT01774019|531617096|FG001|Overall Study|Lost to Follow-up|3|||
147396540|NCT00553605|531617097|FG000|Overall Study|Did not meet entrance criteria|1|||
147396541|NCT00553605|531617098|FG001|Overall Study|Did not meet entrance criteria|3|||
147396542|NCT00553605|531617097|FG000|Overall Study|Did not receive full dose|1|||
147396543|NCT00553605|531617098|FG001|Overall Study|Did not receive full dose|0|||
147396544|NCT00553605|531617097|FG000|Overall Study|Randomized but not treated|2|||
147396545|NCT00553605|531617098|FG001|Overall Study|Randomized but not treated|0|||
147396546|NCT01085812|531617101|FG000|Open-Label Period|Adverse Event|0|||
147396547|NCT01085812|531617102|FG001|Open-Label Period|Adverse Event|80|||
147396548|NCT01085812|531617101|FG000|Open-Label Period|Lack of Efficacy|0|||
147396549|NCT01085812|531617102|FG001|Open-Label Period|Lack of Efficacy|26|||
147396550|NCT01085812|531617101|FG000|Open-Label Period|Protocol Violation|0|||
147396551|NCT01085812|531617102|FG001|Open-Label Period|Protocol Violation|39|||
147396552|NCT01085812|531617101|FG000|Open-Label Period|Withdrawal by Subject|0|||
147396553|NCT01085812|531617102|FG001|Open-Label Period|Withdrawal by Subject|53|||
147396554|NCT01085812|531617101|FG000|Open-Label Period|Lost to Follow-up|0|||
147396555|NCT01085812|531617102|FG001|Open-Label Period|Lost to Follow-up|42|||
147396556|NCT01085812|531617101|FG000|Double-Blind Period|Adverse Event|3|||
147396557|NCT01085812|531617102|FG001|Double-Blind Period|Adverse Event|8|||
147396558|NCT01085812|531617101|FG000|Double-Blind Period|Protocol Violation|2|||
147396559|NCT01085812|531617102|FG001|Double-Blind Period|Protocol Violation|7|||
147396560|NCT01085812|531617101|FG000|Double-Blind Period|Withdrawal by Subject|11|||
147396561|NCT01085812|531617102|FG001|Double-Blind Period|Withdrawal by Subject|24|||
147396562|NCT01085812|531617101|FG000|Double-Blind Period|Lost to Follow-up|5|||
147396563|NCT01085812|531617102|FG001|Double-Blind Period|Lost to Follow-up|17|||
147396564|NCT01085812|531617101|FG000|Double-Blind Period|Other Reasons|0|||
147396565|NCT01085812|531617102|FG001|Double-Blind Period|Other Reasons|2|||
147396566|NCT01085812|531617101|FG000|Double-blind Intent-to-treat Population|Adverse Event|3|||
147396567|NCT01085812|531617102|FG001|Double-blind Intent-to-treat Population|Adverse Event|8|||
147396568|NCT01085812|531617101|FG000|Double-blind Intent-to-treat Population|Protocol Violation|2|||
147396569|NCT01085812|531617102|FG001|Double-blind Intent-to-treat Population|Protocol Violation|7|||
147396570|NCT01085812|531617101|FG000|Double-blind Intent-to-treat Population|Withdrawal by Subject|11|||
147396571|NCT01085812|531617102|FG001|Double-blind Intent-to-treat Population|Withdrawal by Subject|22|||
147396572|NCT01085812|531617101|FG000|Double-blind Intent-to-treat Population|Lost to Follow-up|4|||
147396573|NCT01085812|531617102|FG001|Double-blind Intent-to-treat Population|Lost to Follow-up|17|||
147396574|NCT01085812|531617101|FG000|Double-blind Intent-to-treat Population|Positive serum pregnancy test result|0|||
147396575|NCT01085812|531617102|FG001|Double-blind Intent-to-treat Population|Positive serum pregnancy test result|2|||
147396576|NCT02561806|531617103|FG000|Induction Period|Adverse Event|0|||
147396577|NCT02561806|531617104|FG001|Induction Period|Adverse Event|2|||
147396578|NCT02561806|531617103|FG000|Induction Period|Lack of Efficacy|1|||
147396579|NCT02561806|531617104|FG001|Induction Period|Lack of Efficacy|0|||
147396580|NCT02561806|531617103|FG000|Induction Period|Withdrawal by Subject|0|||
147396581|NCT02561806|531617104|FG001|Induction Period|Withdrawal by Subject|2|||
147396582|NCT02561806|531617103|FG000|Induction Period|Site staff became unblinded|1|||
147396583|NCT02561806|531617104|FG001|Induction Period|Site staff became unblinded|0|||
147396584|NCT02561806|531617103|FG000|Induction Period|Randomized but not treated|0|||
147396585|NCT02561806|531617104|FG001|Induction Period|Randomized but not treated|1|||
147396586|NCT02561806|531617103|FG000|Maintenance Period|Adverse Event|2|||
147396587|NCT02561806|531617104|FG001|Maintenance Period|Adverse Event|1|||
147396588|NCT02561806|531617103|FG000|Maintenance Period|Lack of Efficacy|3|||
147396589|NCT02561806|531617104|FG001|Maintenance Period|Lack of Efficacy|1|||
147396590|NCT02561806|531617103|FG000|Maintenance Period|Lost to Follow-up|2|||
147396591|NCT02561806|531617104|FG001|Maintenance Period|Lost to Follow-up|2|||
147396592|NCT02561806|531617103|FG000|Maintenance Period|Protocol Violation|1|||
147396593|NCT02561806|531617104|FG001|Maintenance Period|Protocol Violation|0|||
147396594|NCT02561806|531617103|FG000|Maintenance Period|Withdrawal by Subject|5|||
147396595|NCT02561806|531617104|FG001|Maintenance Period|Withdrawal by Subject|3|||
147396596|NCT02561806|531617103|FG000|Maintenance Period|Site staff became unblinded|0|||
147396597|NCT02561806|531617104|FG001|Maintenance Period|Site staff became unblinded|1|||
147396598|NCT02561806|531617103|FG000|Post-Treatment Follow-up|Lost to Follow-up|1|||
147460696|NCT01445535|531847073|FG000|Overall Study|PI discretion|0|||
147460697|NCT01445535|531847074|FG001|Overall Study|PI discretion|0|||
147460698|NCT01445535|531847075|FG002|Overall Study|PI discretion|0|||
147460699|NCT01445535|531847076|FG003|Overall Study|PI discretion|1|||
147460700|NCT01940484|531847082|FG000|Overall Study|Withdrawal by Subject|3|||
147460701|NCT01940484|531847082|FG000|Overall Study|Underwent transplantation|4|||
147460702|NCT01940484|531847082|FG000|Overall Study|Death|2|||
147460703|NCT01940484|531847082|FG000|Overall Study|Adverse Event|1|||
147460704|NCT02769624|531847086|FG000|Overall Study|Lost to Follow-up|0|||
147460705|NCT02769624|531847087|FG001|Overall Study|Lost to Follow-up|1|||
147460706|NCT01552681|531847089|FG000|Overall Study|Withdrawal by Subject|4|||
147460707|NCT01552681|531847090|FG001|Overall Study|Withdrawal by Subject|0|||
147460708|NCT01552681|531847089|FG000|Overall Study|Physician Decision|1|||
147396599|NCT02561806|531617104|FG001|Post-Treatment Follow-up|Lost to Follow-up|1|||
147396600|NCT02561806|531617103|FG000|Post-Treatment Follow-up|Withdrawal by Subject|1|||
147396601|NCT02561806|531617104|FG001|Post-Treatment Follow-up|Withdrawal by Subject|0|||
147396602|NCT01322009|531617105|FG000|Overall Study|Death|0|||
147396603|NCT01322009|531617106|FG001|Overall Study|Death|1|||
147396604|NCT01322009|531617105|FG000|Overall Study|Adverse Event|0|||
147396605|NCT01322009|531617106|FG001|Overall Study|Adverse Event|1|||
147396606|NCT01322009|531617105|FG000|Overall Study|ng tube discontinued|0|||
147396607|NCT01322009|531617106|FG001|Overall Study|ng tube discontinued|1|||
147396608|NCT00394589|531617107|FG000|Overall Study|Adverse Event|2|||
147396609|NCT00394589|531617108|FG001|Overall Study|Adverse Event|1|||
147396610|NCT00394589|531617109|FG002|Overall Study|Adverse Event|2|||
147396611|NCT00394589|531617107|FG000|Overall Study|Lack of Efficacy|2|||
147396612|NCT00394589|531617108|FG001|Overall Study|Lack of Efficacy|2|||
147396613|NCT00394589|531617109|FG002|Overall Study|Lack of Efficacy|3|||
147396614|NCT00394589|531617107|FG000|Overall Study|Protocol Violation|4|||
147396615|NCT00394589|531617108|FG001|Overall Study|Protocol Violation|0|||
147396616|NCT00394589|531617109|FG002|Overall Study|Protocol Violation|2|||
147396617|NCT03409731|531617111|FG000|Overall Study|Withdrawal by Subject|17|||
147396618|NCT03409731|531617111|FG000|Overall Study|Death|4|||
147396619|NCT01114672|531617112|FG000|Overall Study|Death|0|||
147396620|NCT01114672|531617113|FG001|Overall Study|Death|1|||
147396621|NCT01114672|531617112|FG000|Overall Study|Withdrawal by Subject|2|||
147396622|NCT01114672|531617113|FG001|Overall Study|Withdrawal by Subject|1|||
147396623|NCT01114672|531617112|FG000|Overall Study|Lost to Follow-up|1|||
147396624|NCT01114672|531617113|FG001|Overall Study|Lost to Follow-up|0|||
147396625|NCT01114672|531617112|FG000|Overall Study|transplanted|1|||
147396626|NCT01114672|531617113|FG001|Overall Study|transplanted|0|||
147396627|NCT01710800|531617116|FG000|Overall Study|Withdrawal by Subject|21|||
147396628|NCT01710800|531617116|FG000|Overall Study|Protocol Violation|1|||
147396629|NCT02427958|531617117|FG000|Overall Study|Pretreatment Event (PTE) or AE|3|||
147396630|NCT02427958|531617117|FG000|Overall Study|Lost to Follow-up|6|||
147396631|NCT02427958|531617117|FG000|Overall Study|Withdrawal by Subject|14|||
147396632|NCT02427958|531617117|FG000|Overall Study|Lack of Efficacy|1|||
147396633|NCT02287883|531617123|FG000|Overall Study|Death|8|||
147396634|NCT02287883|531617124|FG001|Overall Study|Death|7|||
147396635|NCT02287883|531617123|FG000|Overall Study|No longer eligible|222|||
147396636|NCT02287883|531617124|FG001|Overall Study|No longer eligible|182|||
147396637|NCT02287883|531617123|FG000|Overall Study|Non-response to survey|229|||
147396638|NCT02287883|531617124|FG001|Overall Study|Non-response to survey|237|||
147396639|NCT00545571|531617128|FG000|Overall Study|Administrative Reasons|1|||
147396640|NCT00545571|531617128|FG000|Overall Study|Adverse Event|2|||
147460709|NCT01552681|531847090|FG001|Overall Study|Physician Decision|0|||
147615410|NCT01959295|532406733|FG001|Overall Study|Physician Decision|3|||
147396641|NCT00545571|531617128|FG000|Overall Study|Death|5|||
147396642|NCT00545571|531617128|FG000|Overall Study|Lack of Efficacy|1|||
147396643|NCT00545571|531617128|FG000|Overall Study|Protocol Violation|2|||
147460710|NCT01552681|531847089|FG000|Overall Study|Subject moved away|0|||
147460711|NCT01552681|531847090|FG001|Overall Study|Subject moved away|1|||
147460712|NCT00448708|531847091|FG000|Overall Study|Death|21|||
147460713|NCT00448708|531847092|FG001|Overall Study|Death|17|||
147615411|NCT01959295|532406732|FG000|Overall Study|Protocol Violation|16|||
147396644|NCT00545571|531617128|FG000|Overall Study|Refused Treatment|1|||
147396645|NCT00545571|531617128|FG000|Overall Study|Screen Failure|16|||
147396646|NCT00545571|531617128|FG000|Overall Study|Transfusion|12|||
147460714|NCT00448708|531847091|FG000|Overall Study|Withdrawal by Subject|8|||
147460715|NCT00448708|531847092|FG001|Overall Study|Withdrawal by Subject|4|||
147460716|NCT00448708|531847091|FG000|Overall Study|Lost to Follow-up|6|||
147396647|NCT00545571|531617128|FG000|Overall Study|Early Termination of Study|24|||
147396648|NCT00545571|531617128|FG000|Overall Study|Kidney Transplantation|3|||
147460717|NCT00448708|531847092|FG001|Overall Study|Lost to Follow-up|8|||
147460718|NCT00448708|531847091|FG000|Overall Study|not listed|0|||
147615412|NCT01959295|532406733|FG001|Overall Study|Protocol Violation|5|||
147396649|NCT01193218|531617130|FG000|0-12 Weeks|Adverse Event|6|||
147396650|NCT01193218|531617131|FG001|0-12 Weeks|Adverse Event|0|||
147396651|NCT01193218|531617132|FG002|0-12 Weeks|Adverse Event|1|||
147396652|NCT01193218|531617133|FG003|0-12 Weeks|Adverse Event|0|||
147396653|NCT01193218|531617134|FG004|0-12 Weeks|Adverse Event|0|||
147460719|NCT00448708|531847092|FG001|Overall Study|not listed|2|||
147460720|NCT04698525|531847093|FG000|Overall Study|Lost to Follow-up|1|||
147460721|NCT04698525|531847094|FG001|Overall Study|Lost to Follow-up|2|||
147460722|NCT04698525|531847093|FG000|Overall Study|Three suffered of Covid-19|2|||
147460723|NCT04698525|531847094|FG001|Overall Study|Three suffered of Covid-19|1|||
147460724|NCT00354601|531847095|FG000|Overall Study|Protocol Violation|1|||
147460725|NCT00354601|531847095|FG000|Overall Study|progression|1|||
147460726|NCT00130286|531847097|FG000|Overall Study|Withdrawal by Subject|0|||
147460727|NCT00130286|531847098|FG001|Overall Study|Withdrawal by Subject|1|||
147460728|NCT00130286|531847099|FG002|Overall Study|Withdrawal by Subject|2|||
147460729|NCT00130286|531847100|FG003|Overall Study|Withdrawal by Subject|2|||
147460730|NCT00130286|531847097|FG000|Overall Study|Adverse Event|0|||
147460731|NCT00130286|531847098|FG001|Overall Study|Adverse Event|0|||
147460732|NCT00130286|531847099|FG002|Overall Study|Adverse Event|2|||
147460733|NCT00130286|531847100|FG003|Overall Study|Adverse Event|0|||
147460734|NCT00130286|531847097|FG000|Overall Study|Missing lab specimens|0|||
147460735|NCT00130286|531847098|FG001|Overall Study|Missing lab specimens|2|||
147460736|NCT00130286|531847099|FG002|Overall Study|Missing lab specimens|0|||
147460737|NCT00130286|531847100|FG003|Overall Study|Missing lab specimens|0|||
147460738|NCT01360645|531847101|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|16|||
147460739|NCT01360645|531847102|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|0|||
147460740|NCT01360645|531847103|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|0|||
147460741|NCT01360645|531847104|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Lost to Follow-up|0|||
147460742|NCT01360645|531847101|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|19|||
147460743|NCT01360645|531847102|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|0|||
147460744|NCT01360645|531847103|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|0|||
147460745|NCT01360645|531847104|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Adverse Event|0|||
147460746|NCT01360645|531847101|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|16|||
147460747|NCT01360645|531847102|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|0|||
147460748|NCT01360645|531847103|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|0|||
147460749|NCT01360645|531847104|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Met Withdrawal Criteria|0|||
147460750|NCT01360645|531847101|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|34|||
147460751|NCT01360645|531847102|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|0|||
147460752|NCT01360645|531847103|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|0|||
147460753|NCT01360645|531847104|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Withdrawal by Subject|0|||
147460754|NCT01360645|531847101|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|24|||
147460755|NCT01360645|531847102|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|0|||
147460756|NCT01360645|531847103|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|0|||
147460757|NCT01360645|531847104|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Protocol Deviation|0|||
147460758|NCT01360645|531847101|FG000|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|5|||
147460759|NCT01360645|531847102|FG001|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|0|||
147460760|NCT01360645|531847103|FG002|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|0|||
147460761|NCT01360645|531847104|FG003|Placebo+ADT Prospective Phase-A(8 Weeks)|Physician Decision|0|||
147396654|NCT01193218|531617135|FG005|0-12 Weeks|Adverse Event|2|||
147396655|NCT01193218|531617136|FG006|0-12 Weeks|Adverse Event|2|||
147396656|NCT01193218|531617137|FG007|0-12 Weeks|Adverse Event|0|||
147396657|NCT01193218|531617130|FG000|0-12 Weeks|Protocol Violation|0|||
147396658|NCT01193218|531617131|FG001|0-12 Weeks|Protocol Violation|0|||
147396659|NCT01193218|531617132|FG002|0-12 Weeks|Protocol Violation|0|||
147396660|NCT01193218|531617133|FG003|0-12 Weeks|Protocol Violation|0|||
147396661|NCT01193218|531617134|FG004|0-12 Weeks|Protocol Violation|1|||
147396662|NCT01193218|531617135|FG005|0-12 Weeks|Protocol Violation|1|||
147396663|NCT01193218|531617136|FG006|0-12 Weeks|Protocol Violation|0|||
147396664|NCT01193218|531617137|FG007|0-12 Weeks|Protocol Violation|0|||
147396665|NCT01193218|531617130|FG000|0-12 Weeks|Withdrawal by Subject|3|||
147396666|NCT01193218|531617131|FG001|0-12 Weeks|Withdrawal by Subject|0|||
147460762|NCT01360645|531847101|FG000|Phase B (6 Weeks)|Lost to Follow-up|0|||
147460763|NCT01360645|531847102|FG001|Phase B (6 Weeks)|Lost to Follow-up|1|||
147460764|NCT01360645|531847103|FG002|Phase B (6 Weeks)|Lost to Follow-up|0|||
147460765|NCT01360645|531847104|FG003|Phase B (6 Weeks)|Lost to Follow-up|0|||
147396667|NCT01193218|531617132|FG002|0-12 Weeks|Withdrawal by Subject|2|||
147396668|NCT01193218|531617133|FG003|0-12 Weeks|Withdrawal by Subject|0|||
147460766|NCT01360645|531847101|FG000|Phase B (6 Weeks)|Adverse Event|0|||
147460767|NCT01360645|531847102|FG001|Phase B (6 Weeks)|Adverse Event|6|||
147460768|NCT01360645|531847103|FG002|Phase B (6 Weeks)|Adverse Event|0|||
147460769|NCT01360645|531847104|FG003|Phase B (6 Weeks)|Adverse Event|0|||
147460770|NCT01360645|531847101|FG000|Phase B (6 Weeks)|Met Withdrawal Criteria|0|||
147460771|NCT01360645|531847102|FG001|Phase B (6 Weeks)|Met Withdrawal Criteria|3|||
147460772|NCT01360645|531847103|FG002|Phase B (6 Weeks)|Met Withdrawal Criteria|2|||
147396669|NCT01193218|531617134|FG004|0-12 Weeks|Withdrawal by Subject|0|||
147396670|NCT01193218|531617135|FG005|0-12 Weeks|Withdrawal by Subject|0|||
147396671|NCT01193218|531617136|FG006|0-12 Weeks|Withdrawal by Subject|1|||
147396672|NCT01193218|531617137|FG007|0-12 Weeks|Withdrawal by Subject|0|||
147396673|NCT01193218|531617130|FG000|12-52 Weeks|Adverse Event|1|||
147396674|NCT01193218|531617131|FG001|12-52 Weeks|Adverse Event|0|||
147396675|NCT01193218|531617132|FG002|12-52 Weeks|Adverse Event|1|||
147396676|NCT01193218|531617133|FG003|12-52 Weeks|Adverse Event|2|||
147396677|NCT01193218|531617134|FG004|12-52 Weeks|Adverse Event|3|||
147396678|NCT01193218|531617135|FG005|12-52 Weeks|Adverse Event|3|||
147396679|NCT01193218|531617136|FG006|12-52 Weeks|Adverse Event|1|||
147396680|NCT01193218|531617137|FG007|12-52 Weeks|Adverse Event|2|||
147396681|NCT01193218|531617130|FG000|12-52 Weeks|Lack of Efficacy|0|||
147396682|NCT01193218|531617131|FG001|12-52 Weeks|Lack of Efficacy|0|||
147396683|NCT01193218|531617132|FG002|12-52 Weeks|Lack of Efficacy|0|||
147396684|NCT01193218|531617133|FG003|12-52 Weeks|Lack of Efficacy|0|||
147396685|NCT01193218|531617134|FG004|12-52 Weeks|Lack of Efficacy|0|||
147396686|NCT01193218|531617135|FG005|12-52 Weeks|Lack of Efficacy|0|||
147396687|NCT01193218|531617136|FG006|12-52 Weeks|Lack of Efficacy|1|||
147396688|NCT01193218|531617137|FG007|12-52 Weeks|Lack of Efficacy|0|||
147396689|NCT01193218|531617130|FG000|12-52 Weeks|Withdrawal by Subject|3|||
147396690|NCT01193218|531617131|FG001|12-52 Weeks|Withdrawal by Subject|0|||
147396691|NCT01193218|531617132|FG002|12-52 Weeks|Withdrawal by Subject|3|||
147396692|NCT01193218|531617133|FG003|12-52 Weeks|Withdrawal by Subject|0|||
147396693|NCT01193218|531617134|FG004|12-52 Weeks|Withdrawal by Subject|0|||
147396694|NCT01193218|531617135|FG005|12-52 Weeks|Withdrawal by Subject|2|||
147396695|NCT01193218|531617136|FG006|12-52 Weeks|Withdrawal by Subject|1|||
147396696|NCT01193218|531617137|FG007|12-52 Weeks|Withdrawal by Subject|2|||
147396697|NCT01193218|531617130|FG000|12-52 Weeks|Other reason than above|1|||
147396698|NCT01193218|531617131|FG001|12-52 Weeks|Other reason than above|0|||
147396699|NCT01193218|531617132|FG002|12-52 Weeks|Other reason than above|0|||
147396700|NCT01193218|531617133|FG003|12-52 Weeks|Other reason than above|1|||
147396701|NCT01193218|531617134|FG004|12-52 Weeks|Other reason than above|1|||
147396702|NCT01193218|531617135|FG005|12-52 Weeks|Other reason than above|0|||
147396703|NCT01193218|531617136|FG006|12-52 Weeks|Other reason than above|0|||
147396704|NCT01193218|531617137|FG007|12-52 Weeks|Other reason than above|0|||
147396705|NCT00363649|531617138|FG000|Overall Study|Withdrawal by Subject|1|||
147396706|NCT00363649|531617139|FG001|Overall Study|Withdrawal by Subject|1|||
147396707|NCT00363649|531617138|FG000|Overall Study|Adverse Event|6|||
147396708|NCT00363649|531617139|FG001|Overall Study|Adverse Event|0|||
147396709|NCT01013740|531617140|FG000|Overall Study|Lost to Follow-up|3|||
147396710|NCT01013740|531617141|FG001|Overall Study|Lost to Follow-up|5|||
147396711|NCT01013740|531617140|FG000|Overall Study|Physician Decision|2|||
147396712|NCT01013740|531617141|FG001|Overall Study|Physician Decision|0|||
147396713|NCT01013740|531617140|FG000|Overall Study|Withdrawal by Subject|2|||
147396714|NCT01013740|531617141|FG001|Overall Study|Withdrawal by Subject|10|||
147396715|NCT01013740|531617140|FG000|Overall Study|study close / terminated : done in error|2|||
147396716|NCT01013740|531617141|FG001|Overall Study|study close / terminated : done in error|1|||
147396717|NCT01013740|531617140|FG000|Overall Study|Missing|2|||
147396718|NCT01013740|531617141|FG001|Overall Study|Missing|1|||
147396719|NCT01013740|531617140|FG000|Overall Study|Ongoing: Study records not completed|0|||
147396720|NCT01013740|531617141|FG001|Overall Study|Ongoing: Study records not completed|2|||
147396721|NCT03811834|531617144|FG000|Period 1 ( 7 Days)|Adverse Event|1|||
147396722|NCT00576823|531617145|FG000|12-week Efficacy Phase|Parent's schedule issue|1|||
147396723|NCT00576823|531617146|FG001|12-week Efficacy Phase|Parent's schedule issue|0|||
147396724|NCT00576823|531617147|FG002|12-week Efficacy Phase|Parent's schedule issue|0|||
147396725|NCT00576823|531617145|FG000|40-week Safety Extension Phase|Lack of Efficacy|1|||
147396726|NCT00576823|531617146|FG001|40-week Safety Extension Phase|Lack of Efficacy|0|||
147396727|NCT00576823|531617147|FG002|40-week Safety Extension Phase|Lack of Efficacy|0|||
147396728|NCT01242371|531617148|FG000|Overall Study|Withdrawal by Subject|2|||
147396729|NCT01242371|531617149|FG001|Overall Study|Withdrawal by Subject|2|||
147396730|NCT01242371|531617148|FG000|Overall Study|Protocol Violation|0|||
147396731|NCT01242371|531617149|FG001|Overall Study|Protocol Violation|3|||
147396732|NCT00510146|531617152|FG000|Double-Blind Treatment|Adverse Event|30|||
147396733|NCT00510146|531617153|FG001|Double-Blind Treatment|Adverse Event|13|||
147396734|NCT00510146|531617152|FG000|Double-Blind Treatment|Lack of Efficacy|6|||
147396735|NCT00510146|531617153|FG001|Double-Blind Treatment|Lack of Efficacy|13|||
147396736|NCT00510146|531617152|FG000|Double-Blind Treatment|Lost to Follow-up|3|||
147396737|NCT00510146|531617153|FG001|Double-Blind Treatment|Lost to Follow-up|7|||
147396738|NCT00510146|531617152|FG000|Double-Blind Treatment|Physician Decision|6|||
147396739|NCT00510146|531617153|FG001|Double-Blind Treatment|Physician Decision|0|||
147396740|NCT00510146|531617152|FG000|Double-Blind Treatment|Protocol Violation|1|||
147396741|NCT00510146|531617153|FG001|Double-Blind Treatment|Protocol Violation|2|||
147396742|NCT00510146|531617152|FG000|Double-Blind Treatment|Withdrawal by Subject|27|||
147396743|NCT00510146|531617153|FG001|Double-Blind Treatment|Withdrawal by Subject|13|||
147396744|NCT00510146|531617152|FG000|Double-Blind Treatment|Clinical Relapse|0|||
147396745|NCT00510146|531617153|FG001|Double-Blind Treatment|Clinical Relapse|1|||
147396746|NCT00510146|531617152|FG000|Double-Blind Treatment|Entry Criteria Not Met|3|||
147396747|NCT00510146|531617153|FG001|Double-Blind Treatment|Entry Criteria Not Met|0|||
147396748|NCT00510146|531617152|FG000|Open-Label Treatment|Adverse Event|22|||
147396749|NCT00510146|531617153|FG001|Open-Label Treatment|Adverse Event|8|||
147396750|NCT00510146|531617152|FG000|Open-Label Treatment|Death|1|||
147396751|NCT00510146|531617153|FG001|Open-Label Treatment|Death|1|||
147396752|NCT00510146|531617152|FG000|Open-Label Treatment|Lack of Efficacy|4|||
147396753|NCT00510146|531617153|FG001|Open-Label Treatment|Lack of Efficacy|0|||
147396754|NCT00510146|531617152|FG000|Open-Label Treatment|Lost to Follow-up|10|||
147396755|NCT00510146|531617153|FG001|Open-Label Treatment|Lost to Follow-up|1|||
147396756|NCT00510146|531617152|FG000|Open-Label Treatment|Physician Decision|3|||
147396757|NCT00510146|531617153|FG001|Open-Label Treatment|Physician Decision|1|||
147396758|NCT00510146|531617152|FG000|Open-Label Treatment|Protocol Violation|4|||
147396759|NCT00510146|531617153|FG001|Open-Label Treatment|Protocol Violation|2|||
147396760|NCT00510146|531617152|FG000|Open-Label Treatment|Withdrawal by Subject|24|||
147396761|NCT00510146|531617153|FG001|Open-Label Treatment|Withdrawal by Subject|12|||
147396762|NCT00510146|531617152|FG000|Open-Label Treatment|Clinical Relapse|1|||
147396763|NCT00510146|531617153|FG001|Open-Label Treatment|Clinical Relapse|1|||
147396764|NCT00510146|531617152|FG000|Open-Label Treatment|Sponsor Decision|2|||
147396765|NCT00510146|531617153|FG001|Open-Label Treatment|Sponsor Decision|0|||
147396766|NCT03188536|531617154|FG000|Overall Study|No relapse/refractoriness(last 6 months)|5|||
147396767|NCT03188536|531617154|FG000|Overall Study|Not participated/met inclusion criteria|1|||
147396768|NCT01930214|531617155|FG000|Overall Study|Death|4|||
147396769|NCT01930214|531617156|FG001|Overall Study|Death|4|||
147396770|NCT01930214|531617157|FG002|Overall Study|Death|11|||
147396771|NCT01930214|531617155|FG000|Overall Study|Lost to Follow-up|12|||
147396772|NCT01930214|531617156|FG001|Overall Study|Lost to Follow-up|13|||
147396773|NCT01930214|531617157|FG002|Overall Study|Lost to Follow-up|12|||
147396774|NCT01930214|531617155|FG000|Overall Study|Voluntary withdrawal of infomed consent|2|||
147396775|NCT01930214|531617156|FG001|Overall Study|Voluntary withdrawal of infomed consent|4|||
147396776|NCT01930214|531617157|FG002|Overall Study|Voluntary withdrawal of infomed consent|2|||
147396777|NCT01930214|531617155|FG000|Overall Study|Physician Decision|2|||
147396778|NCT01930214|531617156|FG001|Overall Study|Physician Decision|0|||
147396779|NCT01930214|531617157|FG002|Overall Study|Physician Decision|0|||
147396780|NCT00025662|531617158|FG000|Overall Study|Withdrawal by Subject|2|||
147396781|NCT00025662|531617158|FG000|Overall Study|Technical failure of manipulation|1|||
147396782|NCT02132117|531617161|FG000|Overall Study|Adverse Event|6|||
147396783|NCT02132117|531617162|FG001|Overall Study|Adverse Event|1|||
147396784|NCT02132117|531617161|FG000|Overall Study|Lost to Follow-up|2|||
147396785|NCT02132117|531617162|FG001|Overall Study|Lost to Follow-up|2|||
147396786|NCT02132117|531617161|FG000|Overall Study|Personal Reasons|1|||
147396787|NCT02132117|531617162|FG001|Overall Study|Personal Reasons|2|||
147460773|NCT01360645|531847104|FG003|Phase B (6 Weeks)|Met Withdrawal Criteria|0|||
147460774|NCT01360645|531847101|FG000|Phase B (6 Weeks)|Withdrawal by Subject|0|||
147460775|NCT01360645|531847102|FG001|Phase B (6 Weeks)|Withdrawal by Subject|3|||
147460776|NCT01360645|531847103|FG002|Phase B (6 Weeks)|Withdrawal by Subject|8|||
147460777|NCT01360645|531847104|FG003|Phase B (6 Weeks)|Withdrawal by Subject|0|||
147460778|NCT01360645|531847101|FG000|Phase B (6 Weeks)|Protocol Deviation|0|||
147460779|NCT01360645|531847102|FG001|Phase B (6 Weeks)|Protocol Deviation|1|||
147460780|NCT01360645|531847103|FG002|Phase B (6 Weeks)|Protocol Deviation|3|||
147460781|NCT01360645|531847104|FG003|Phase B (6 Weeks)|Protocol Deviation|0|||
147460782|NCT01360645|531847101|FG000|Phase A+|Lost to Follow-up|0|||
147460783|NCT01360645|531847102|FG001|Phase A+|Lost to Follow-up|0|||
147460784|NCT01360645|531847103|FG002|Phase A+|Lost to Follow-up|0|||
147460785|NCT01360645|531847104|FG003|Phase A+|Lost to Follow-up|7|||
147460786|NCT01360645|531847101|FG000|Phase A+|Adverse Event|0|||
147460787|NCT01360645|531847102|FG001|Phase A+|Adverse Event|0|||
147460788|NCT01360645|531847103|FG002|Phase A+|Adverse Event|0|||
147460789|NCT01360645|531847104|FG003|Phase A+|Adverse Event|2|||
147460790|NCT01360645|531847101|FG000|Phase A+|Met Withdrawal Criteria|0|||
147460791|NCT01360645|531847102|FG001|Phase A+|Met Withdrawal Criteria|0|||
147460792|NCT01360645|531847103|FG002|Phase A+|Met Withdrawal Criteria|0|||
147460793|NCT01360645|531847104|FG003|Phase A+|Met Withdrawal Criteria|4|||
147460794|NCT01360645|531847101|FG000|Phase A+|Physician Decision|0|||
147460795|NCT01360645|531847102|FG001|Phase A+|Physician Decision|0|||
147396788|NCT02132117|531617161|FG000|Overall Study|Other Miscellaneous Reasons|2|||
147396789|NCT02132117|531617162|FG001|Overall Study|Other Miscellaneous Reasons|0|||
147396790|NCT04947436|531617163|FG000|Overall Study|Lost to Follow-up|3|||
147396791|NCT04947436|531617164|FG001|Overall Study|Lost to Follow-up|7|||
147396792|NCT04947436|531617165|FG002|Overall Study|Lost to Follow-up|5|||
147396793|NCT04947436|531617163|FG000|Overall Study|Death|1|||
147460796|NCT01360645|531847103|FG002|Phase A+|Physician Decision|0|||
147396794|NCT04947436|531617164|FG001|Overall Study|Death|1|||
147396795|NCT04947436|531617165|FG002|Overall Study|Death|1|||
147396796|NCT02161185|531617169|FG000|Treatment Phase|Administrative/Other|7|||
147396797|NCT00582114|531617173|FG000|Overall Study|Death|4|||
147396798|NCT00582114|531617174|FG001|Overall Study|Death|4|||
147396799|NCT00582114|531617173|FG000|Overall Study|Kidney Transplant|3|||
147396800|NCT00582114|531617174|FG001|Overall Study|Kidney Transplant|1|||
147396801|NCT00582114|531617173|FG000|Overall Study|Lost to Follow-up|7|||
147460797|NCT01360645|531847104|FG003|Phase A+|Physician Decision|2|||
147460798|NCT01360645|531847101|FG000|Phase A+|Withdrawal by Subject|0|||
147460799|NCT01360645|531847102|FG001|Phase A+|Withdrawal by Subject|0|||
147460800|NCT01360645|531847103|FG002|Phase A+|Withdrawal by Subject|0|||
147460801|NCT01360645|531847104|FG003|Phase A+|Withdrawal by Subject|5|||
147460802|NCT01360645|531847101|FG000|Phase A+|Protocol Deviation|0|||
147460803|NCT01360645|531847102|FG001|Phase A+|Protocol Deviation|0|||
147460804|NCT01360645|531847103|FG002|Phase A+|Protocol Deviation|0|||
147460805|NCT01360645|531847104|FG003|Phase A+|Protocol Deviation|4|||
147460806|NCT01465659|531847106|FG000|Completed 1 Cycle of Treatment|Death|0|||
147460807|NCT01465659|531847107|FG001|Completed 1 Cycle of Treatment|Death|1|||
147460808|NCT01465659|531847108|FG002|Completed 1 Cycle of Treatment|Death|0|||
147460809|NCT01465659|531847109|FG003|Completed 1 Cycle of Treatment|Death|0|||
147460810|NCT01465659|531847106|FG000|Completed 1 Cycle of Treatment|Adverse Event|0|||
147460811|NCT01465659|531847107|FG001|Completed 1 Cycle of Treatment|Adverse Event|0|||
147460812|NCT01465659|531847108|FG002|Completed 1 Cycle of Treatment|Adverse Event|0|||
147460813|NCT01465659|531847109|FG003|Completed 1 Cycle of Treatment|Adverse Event|1|||
147460814|NCT01465659|531847106|FG000|Completed 2 Cycles/Reached 1st Response|Progressive Disease|1|||
147460815|NCT01465659|531847107|FG001|Completed 2 Cycles/Reached 1st Response|Progressive Disease|0|||
147460816|NCT01465659|531847108|FG002|Completed 2 Cycles/Reached 1st Response|Progressive Disease|1|||
147460817|NCT01465659|531847109|FG003|Completed 2 Cycles/Reached 1st Response|Progressive Disease|1|||
147460818|NCT01465659|531847106|FG000|Completed 2 Cycles/Reached 1st Response|Adverse Event|1|||
147460819|NCT01465659|531847107|FG001|Completed 2 Cycles/Reached 1st Response|Adverse Event|0|||
147460820|NCT01465659|531847108|FG002|Completed 2 Cycles/Reached 1st Response|Adverse Event|1|||
147460821|NCT01465659|531847109|FG003|Completed 2 Cycles/Reached 1st Response|Adverse Event|0|||
147460822|NCT01465659|531847106|FG000|Completed Follow for 1 Year|Death|6|||
147460823|NCT01465659|531847107|FG001|Completed Follow for 1 Year|Death|3|||
147460824|NCT01465659|531847108|FG002|Completed Follow for 1 Year|Death|2|||
147460825|NCT01465659|531847109|FG003|Completed Follow for 1 Year|Death|4|||
147460826|NCT03828487|531847110|FG000|Overall Study|Physician Decision|1|||
147460827|NCT02887521|531847113|FG000|Overall Study|Withdrawal by Subject|0|||
147460828|NCT02887521|531847114|FG001|Overall Study|Withdrawal by Subject|3|||
147460829|NCT05499520|531849352|FG000|Overall Study|Lost to Follow-up|0|||
147460830|NCT05499520|531849353|FG001|Overall Study|Lost to Follow-up|0|||
147460831|NCT05499520|531849354|FG002|Overall Study|Lost to Follow-up|38|||
147460832|NCT05499520|531849355|FG003|Overall Study|Lost to Follow-up|41|||
147460833|NCT05499520|531849356|FG004|Overall Study|Lost to Follow-up|46|||
147460834|NCT05499520|531849357|FG005|Overall Study|Lost to Follow-up|0|||
147460835|NCT05499520|531849358|FG006|Overall Study|Lost to Follow-up|31|||
147460836|NCT05499520|531849359|FG007|Overall Study|Lost to Follow-up|45|||
147460837|NCT05499520|531849360|FG008|Overall Study|Lost to Follow-up|42|||
147460838|NCT05499520|531849361|FG009|Overall Study|Lost to Follow-up|0|||
147460839|NCT05499520|531849362|FG010|Overall Study|Lost to Follow-up|0|||
147460840|NCT05499520|531849363|FG011|Overall Study|Lost to Follow-up|37|||
147460841|NCT05499520|531849364|FG012|Overall Study|Lost to Follow-up|53|||
147460842|NCT05499520|531849365|FG013|Overall Study|Lost to Follow-up|49|||
147460843|NCT05499520|531849366|FG014|Overall Study|Lost to Follow-up|0|||
147460844|NCT05499520|531849367|FG015|Overall Study|Lost to Follow-up|36|||
147460845|NCT05499520|531849368|FG016|Overall Study|Lost to Follow-up|58|||
147460846|NCT05499520|531849369|FG017|Overall Study|Lost to Follow-up|53|||
147460847|NCT00793793|531849371|FG000|Overall Study|Adverse Event|0|||
147460848|NCT00793793|531849372|FG001|Overall Study|Adverse Event|0|||
147460849|NCT00793793|531849373|FG002|Overall Study|Adverse Event|1|||
147460850|NCT00793793|531849374|FG003|Overall Study|Adverse Event|1|||
147460851|NCT00793793|531849375|FG004|Overall Study|Adverse Event|0|||
147460852|NCT00793793|531849376|FG005|Overall Study|Adverse Event|1|||
147460853|NCT00793793|531849377|FG006|Overall Study|Adverse Event|2|||
147460854|NCT00793793|531849378|FG007|Overall Study|Adverse Event|0|||
147460855|NCT00793793|531849379|FG008|Overall Study|Adverse Event|0|||
147460856|NCT00793793|531849380|FG009|Overall Study|Adverse Event|0|||
147460857|NCT00793793|531849381|FG010|Overall Study|Adverse Event|0|||
147460858|NCT00793793|531849382|FG011|Overall Study|Adverse Event|2|||
147460859|NCT00793793|531849371|FG000|Overall Study|Protocol Violation|0|||
147460860|NCT00793793|531849372|FG001|Overall Study|Protocol Violation|0|||
147460861|NCT00793793|531849373|FG002|Overall Study|Protocol Violation|0|||
147460862|NCT00793793|531849374|FG003|Overall Study|Protocol Violation|1|||
147460863|NCT00793793|531849375|FG004|Overall Study|Protocol Violation|0|||
147460864|NCT00793793|531849376|FG005|Overall Study|Protocol Violation|0|||
147460865|NCT00793793|531849377|FG006|Overall Study|Protocol Violation|0|||
147460866|NCT00793793|531849378|FG007|Overall Study|Protocol Violation|0|||
147460867|NCT00793793|531849379|FG008|Overall Study|Protocol Violation|0|||
147460868|NCT00793793|531849380|FG009|Overall Study|Protocol Violation|0|||
147460869|NCT00793793|531849381|FG010|Overall Study|Protocol Violation|0|||
147460870|NCT00793793|531849382|FG011|Overall Study|Protocol Violation|0|||
147460871|NCT00793793|531849371|FG000|Overall Study|Lost to Follow-up|0|||
147460872|NCT00793793|531849372|FG001|Overall Study|Lost to Follow-up|0|||
147460873|NCT00793793|531849373|FG002|Overall Study|Lost to Follow-up|1|||
147460874|NCT00793793|531849374|FG003|Overall Study|Lost to Follow-up|0|||
147460875|NCT00793793|531849375|FG004|Overall Study|Lost to Follow-up|0|||
147460876|NCT00793793|531849376|FG005|Overall Study|Lost to Follow-up|0|||
147460877|NCT00793793|531849377|FG006|Overall Study|Lost to Follow-up|0|||
147460878|NCT00793793|531849378|FG007|Overall Study|Lost to Follow-up|0|||
147460879|NCT00793793|531849379|FG008|Overall Study|Lost to Follow-up|1|||
147460880|NCT00793793|531849380|FG009|Overall Study|Lost to Follow-up|3|||
147460881|NCT00793793|531849381|FG010|Overall Study|Lost to Follow-up|1|||
147460882|NCT00793793|531849382|FG011|Overall Study|Lost to Follow-up|0|||
147460883|NCT00793793|531849371|FG000|Overall Study|Withdrawal by Subject|0|||
147460884|NCT00793793|531849372|FG001|Overall Study|Withdrawal by Subject|0|||
147460885|NCT00793793|531849373|FG002|Overall Study|Withdrawal by Subject|0|||
147460886|NCT00793793|531849374|FG003|Overall Study|Withdrawal by Subject|0|||
147460887|NCT00793793|531849375|FG004|Overall Study|Withdrawal by Subject|1|||
147460888|NCT00793793|531849376|FG005|Overall Study|Withdrawal by Subject|0|||
147460889|NCT00793793|531849377|FG006|Overall Study|Withdrawal by Subject|0|||
147460890|NCT00793793|531849378|FG007|Overall Study|Withdrawal by Subject|0|||
147460891|NCT00793793|531849379|FG008|Overall Study|Withdrawal by Subject|1|||
147460892|NCT00793793|531849380|FG009|Overall Study|Withdrawal by Subject|0|||
147460893|NCT00793793|531849381|FG010|Overall Study|Withdrawal by Subject|0|||
147460894|NCT00793793|531849382|FG011|Overall Study|Withdrawal by Subject|0|||
147460895|NCT00793793|531849371|FG000|Overall Study|reason not specified|0|||
147460896|NCT00793793|531849372|FG001|Overall Study|reason not specified|1|||
147460897|NCT00793793|531849373|FG002|Overall Study|reason not specified|0|||
147460898|NCT00793793|531849374|FG003|Overall Study|reason not specified|1|||
147460899|NCT00793793|531849375|FG004|Overall Study|reason not specified|1|||
147460900|NCT00793793|531849376|FG005|Overall Study|reason not specified|1|||
147460901|NCT00793793|531849377|FG006|Overall Study|reason not specified|2|||
147460902|NCT00793793|531849378|FG007|Overall Study|reason not specified|0|||
147460903|NCT00793793|531849379|FG008|Overall Study|reason not specified|7|||
147460904|NCT00793793|531849380|FG009|Overall Study|reason not specified|6|||
147460905|NCT00793793|531849381|FG010|Overall Study|reason not specified|2|||
147396802|NCT00582114|531617174|FG001|Overall Study|Lost to Follow-up|6|||
147396803|NCT00582114|531617173|FG000|Overall Study|Withdrawal by Subject|8|||
147396804|NCT00582114|531617174|FG001|Overall Study|Withdrawal by Subject|16|||
147396805|NCT00582114|531617173|FG000|Overall Study|Adverse Event|1|||
147396806|NCT00582114|531617174|FG001|Overall Study|Adverse Event|1|||
147396807|NCT00582114|531617173|FG000|Overall Study|Physician Decision|0|||
147396808|NCT00582114|531617174|FG001|Overall Study|Physician Decision|6|||
147396809|NCT00582114|531617173|FG000|Overall Study|Stopped by data safety monitoring board|19|||
147396810|NCT00582114|531617174|FG001|Overall Study|Stopped by data safety monitoring board|20|||
147396811|NCT00118703|531617175|FG000|Overall Study|Protocol Violation|1|||
147396812|NCT00118703|531617176|FG001|Overall Study|Protocol Violation|0|||
147460906|NCT00793793|531849382|FG011|Overall Study|reason not specified|4|||
147460907|NCT02487108|531849383|FG000|Overall Study|Adverse Event|1|||
147460908|NCT02487108|531849384|FG001|Overall Study|Adverse Event|6|||
147460909|NCT02487108|531849385|FG002|Overall Study|Adverse Event|12|||
147460910|NCT02487108|531849386|FG003|Overall Study|Adverse Event|6|||
147460911|NCT02487108|531849383|FG000|Overall Study|Withdrawal by Subject|8|||
147460912|NCT02487108|531849384|FG001|Overall Study|Withdrawal by Subject|5|||
147460913|NCT02487108|531849385|FG002|Overall Study|Withdrawal by Subject|5|||
147460914|NCT02487108|531849386|FG003|Overall Study|Withdrawal by Subject|0|||
147460915|NCT02487108|531849383|FG000|Overall Study|Non-compliance to study medication|3|||
147460916|NCT02487108|531849384|FG001|Overall Study|Non-compliance to study medication|2|||
147460917|NCT02487108|531849385|FG002|Overall Study|Non-compliance to study medication|5|||
147460918|NCT02487108|531849386|FG003|Overall Study|Non-compliance to study medication|4|||
147460919|NCT02487108|531849383|FG000|Overall Study|Protocol Violation|1|||
147460920|NCT02487108|531849384|FG001|Overall Study|Protocol Violation|1|||
147460921|NCT02487108|531849385|FG002|Overall Study|Protocol Violation|2|||
147460922|NCT02487108|531849386|FG003|Overall Study|Protocol Violation|0|||
147460923|NCT02487108|531849383|FG000|Overall Study|Non-compliance to study procedures|0|||
147460924|NCT02487108|531849384|FG001|Overall Study|Non-compliance to study procedures|0|||
147396813|NCT00118703|531617175|FG000|Overall Study|Adverse Event|1|||
147396814|NCT00118703|531617176|FG001|Overall Study|Adverse Event|1|||
147396815|NCT00118703|531617175|FG000|Overall Study|Participant took two different treatment|0|||
147396816|NCT00118703|531617176|FG001|Overall Study|Participant took two different treatment|1|||
147460925|NCT02487108|531849385|FG002|Overall Study|Non-compliance to study procedures|0|||
147460926|NCT02487108|531849386|FG003|Overall Study|Non-compliance to study procedures|1|||
147460927|NCT02487108|531849383|FG000|Overall Study|Other than specified|3|||
147460928|NCT02487108|531849384|FG001|Overall Study|Other than specified|2|||
147460929|NCT02487108|531849385|FG002|Overall Study|Other than specified|2|||
147396817|NCT00118703|531617175|FG000|Overall Study|Withdrawal by Subject|2|||
147460930|NCT02487108|531849386|FG003|Overall Study|Other than specified|0|||
147396818|NCT00118703|531617176|FG001|Overall Study|Withdrawal by Subject|5|||
147396819|NCT00118703|531617175|FG000|Overall Study|Lost to Follow-up|1|||
147396820|NCT00118703|531617176|FG001|Overall Study|Lost to Follow-up|2|||
147396821|NCT01209286|531617181|FG000|Overall Study|Adverse Event|4|||
147396822|NCT01209286|531617182|FG001|Overall Study|Adverse Event|3|||
147396823|NCT01209286|531617183|FG002|Overall Study|Adverse Event|1|||
147460931|NCT00883493|531849387|FG000|Overall Study|Adverse Event|11|||
147460932|NCT00883493|531849388|FG001|Overall Study|Adverse Event|12|||
147460933|NCT00883493|531849387|FG000|Overall Study|Lack of Efficacy|4|||
147460934|NCT00883493|531849388|FG001|Overall Study|Lack of Efficacy|3|||
147665186|NCT04821830|532598064|FG000|Overall Study|Withdrawal by Subject|1|||
147665187|NCT04821830|532598065|FG001|Overall Study|Withdrawal by Subject|0|||
147665188|NCT00919633|532598066|FG000|Overall Study|Adverse Event|1|||
147665189|NCT00919633|532598067|FG001|Overall Study|Adverse Event|9|||
147396824|NCT01209286|531617181|FG000|Overall Study|Hematological Relapse After Remission|0|||
147396825|NCT01209286|531617182|FG001|Overall Study|Hematological Relapse After Remission|1|||
147460935|NCT00883493|531849387|FG000|Overall Study|Lost to Follow-up|7|||
147460936|NCT00883493|531849388|FG001|Overall Study|Lost to Follow-up|6|||
147460937|NCT00883493|531849387|FG000|Overall Study|Withdrawal by Subject|11|||
147396826|NCT01209286|531617183|FG002|Overall Study|Hematological Relapse After Remission|1|||
147396827|NCT01209286|531617181|FG000|Overall Study|Remission Not Achieved in 2 Cycles|1|||
147396828|NCT01209286|531617182|FG001|Overall Study|Remission Not Achieved in 2 Cycles|3|||
147396829|NCT01209286|531617183|FG002|Overall Study|Remission Not Achieved in 2 Cycles|1|||
147396830|NCT01209286|531617181|FG000|Overall Study|Physician Decision|0|||
147396831|NCT01209286|531617182|FG001|Overall Study|Physician Decision|2|||
147396832|NCT01209286|531617183|FG002|Overall Study|Physician Decision|0|||
147396833|NCT01209286|531617181|FG000|Overall Study|Other|0|||
147396834|NCT01209286|531617182|FG001|Overall Study|Other|1|||
147396835|NCT01209286|531617183|FG002|Overall Study|Other|0|||
147396836|NCT01349036|531617184|FG000|Overall Study|Disease progression|13|||
147396837|NCT01349036|531617185|FG001|Overall Study|Disease progression|22|||
147396838|NCT01349036|531617184|FG000|Overall Study|Other|1|||
147396839|NCT01349036|531617185|FG001|Overall Study|Other|0|||
147396840|NCT01349036|531617184|FG000|Overall Study|Withdrawal by Subject|0|||
147396841|NCT01349036|531617185|FG001|Overall Study|Withdrawal by Subject|2|||
147396842|NCT03796208|531617186|FG000|Overall Study|Withdrawal by Subject|3|||
147396843|NCT03796208|531617187|FG001|Overall Study|Withdrawal by Subject|0|||
147396844|NCT03796208|531617186|FG000|Overall Study|Loss of pregnancy|1|||
147396845|NCT03796208|531617187|FG001|Overall Study|Loss of pregnancy|1|||
147396846|NCT03796208|531617186|FG000|Overall Study|Changed prenatal clinics|0|||
147396847|NCT03796208|531617187|FG001|Overall Study|Changed prenatal clinics|5|||
147396848|NCT03796208|531617186|FG000|Overall Study|Lost to Follow-up|20|||
147396849|NCT03796208|531617187|FG001|Overall Study|Lost to Follow-up|16|||
147396850|NCT01215032|531617189|FG000|Overall Study|Adverse Event|3|||
147396851|NCT01215032|531617189|FG000|Overall Study|Lack of Efficacy|17|||
147396852|NCT03120949|531617190|FG000|Overall Study|randomized in error|1|||
147396853|NCT03120949|531617191|FG001|Overall Study|randomized in error|0|||
147396854|NCT03120949|531617190|FG000|Overall Study|Death|13|||
147396855|NCT03120949|531617191|FG001|Overall Study|Death|13|||
147396856|NCT03120949|531617190|FG000|Overall Study|Lost to Follow-up|23|||
147396857|NCT03120949|531617191|FG001|Overall Study|Lost to Follow-up|13|||
147396858|NCT03120949|531617190|FG000|Overall Study|Withdrawal by Subject|139|||
147396859|NCT03120949|531617191|FG001|Overall Study|Withdrawal by Subject|124|||
147396860|NCT03120949|531617190|FG000|Overall Study|Covid-19|43|||
147396861|NCT03120949|531617191|FG001|Overall Study|Covid-19|34|||
147396862|NCT03120949|531617190|FG000|Overall Study|Patient Moved Out Of Residence And was Not Able To Come To The Site|1|||
147396863|NCT03120949|531617191|FG001|Overall Study|Patient Moved Out Of Residence And was Not Able To Come To The Site|3|||
147396864|NCT03120949|531617190|FG000|Overall Study|Lack Of Discipline In Adhering To The Schedule Of Visits, Difficult Cooperation With The Patient|1|||
147396865|NCT03120949|531617191|FG001|Overall Study|Lack Of Discipline In Adhering To The Schedule Of Visits, Difficult Cooperation With The Patient|0|||
147396866|NCT03120949|531617190|FG000|Overall Study|Safety Follow-Up Visit (SFU)-3 Was Performed By Phone Due To Family Reasons|1|||
147396867|NCT03120949|531617191|FG001|Overall Study|Safety Follow-Up Visit (SFU)-3 Was Performed By Phone Due To Family Reasons|0|||
147396868|NCT03120949|531617190|FG000|Overall Study|Patient Completed The Treatment, But Could Not Come For Follow-Up Visits Due To Another City Moving|1|||
147396869|NCT03120949|531617191|FG001|Overall Study|Patient Completed The Treatment, But Could Not Come For Follow-Up Visits Due To Another City Moving|0|||
147396870|NCT03120949|531617190|FG000|Overall Study|Site was closed|2|||
147396871|NCT03120949|531617191|FG001|Overall Study|Site was closed|3|||
147396872|NCT03120949|531617190|FG000|Overall Study|Study Coordinator Error, Patient Started A Biologic And Study Coordinator Forgot To Complete SFU|1|||
147396873|NCT03120949|531617191|FG001|Overall Study|Study Coordinator Error, Patient Started A Biologic And Study Coordinator Forgot To Complete SFU|0|||
147460938|NCT00883493|531849388|FG001|Overall Study|Withdrawal by Subject|20|||
147460939|NCT00883493|531849387|FG000|Overall Study|Eligibility Criteria not fullfilled|6|||
147460940|NCT00883493|531849388|FG001|Overall Study|Eligibility Criteria not fullfilled|6|||
147396874|NCT03120949|531617190|FG000|Overall Study|Principal Investigator (PI) Decision, The PI Starting Subject On Another Biologic Medication|0|||
147396875|NCT03120949|531617191|FG001|Overall Study|Principal Investigator (PI) Decision, The PI Starting Subject On Another Biologic Medication|1|||
147460941|NCT00883493|531849387|FG000|Overall Study|Study specific disc. criteria|2|||
147460942|NCT00883493|531849388|FG001|Overall Study|Study specific disc. criteria|0|||
147460943|NCT00883493|531849387|FG000|Overall Study|Other|5|||
147460944|NCT00883493|531849388|FG001|Overall Study|Other|3|||
147665190|NCT00919633|532598068|FG002|Overall Study|Adverse Event|12|||
147460945|NCT05099640|531849394|FG000|Part 1: Open-label (14 Days)|Non-responsive for sepiapterin|39|||
147460946|NCT05099640|531849395|FG001|Part 1: Open-label (14 Days)|Non-responsive for sepiapterin|0|||
147460947|NCT05099640|531849396|FG002|Part 1: Open-label (14 Days)|Non-responsive for sepiapterin|0|||
147460948|NCT05099640|531849394|FG000|Part 1: Open-label (14 Days)|Participant decision|3|||
147460949|NCT05099640|531849395|FG001|Part 1: Open-label (14 Days)|Participant decision|0|||
147460950|NCT05099640|531849396|FG002|Part 1: Open-label (14 Days)|Participant decision|0|||
147460951|NCT05099640|531849394|FG000|Part 1: Open-label (14 Days)|Adverse Event|1|||
147460952|NCT05099640|531849395|FG001|Part 1: Open-label (14 Days)|Adverse Event|0|||
147460953|NCT05099640|531849396|FG002|Part 1: Open-label (14 Days)|Adverse Event|0|||
147460954|NCT05099640|531849394|FG000|Part 1: Open-label (14 Days)|Withdrawal by Subject|1|||
147460955|NCT05099640|531849395|FG001|Part 1: Open-label (14 Days)|Withdrawal by Subject|0|||
147460956|NCT05099640|531849396|FG002|Part 1: Open-label (14 Days)|Withdrawal by Subject|0|||
147460957|NCT05099640|531849394|FG000|Part 1: Open-label (14 Days)|Other than specified|2|||
147460958|NCT05099640|531849395|FG001|Part 1: Open-label (14 Days)|Other than specified|0|||
147460959|NCT05099640|531849396|FG002|Part 1: Open-label (14 Days)|Other than specified|0|||
147460960|NCT05099640|531849394|FG000|Part 2: Randomized Treatment (6 Weeks)|Participant decision|0|||
147460961|NCT05099640|531849395|FG001|Part 2: Randomized Treatment (6 Weeks)|Participant decision|1|||
147460962|NCT05099640|531849396|FG002|Part 2: Randomized Treatment (6 Weeks)|Participant decision|0|||
147460963|NCT01987908|531849405|FG000|Placebo Lead-in Period|Adverse Event|2|||
147460964|NCT01987908|531849406|FG001|Placebo Lead-in Period|Adverse Event|0|||
147460965|NCT01987908|531849407|FG002|Placebo Lead-in Period|Adverse Event|0|||
147460966|NCT01987908|531849405|FG000|Placebo Lead-in Period|Physician Decision|2|||
147460967|NCT01987908|531849406|FG001|Placebo Lead-in Period|Physician Decision|0|||
147460968|NCT01987908|531849407|FG002|Placebo Lead-in Period|Physician Decision|0|||
147460969|NCT01987908|531849405|FG000|Placebo Lead-in Period|Withdrawal by Subject|1|||
147460970|NCT01987908|531849406|FG001|Placebo Lead-in Period|Withdrawal by Subject|0|||
147460971|NCT01987908|531849407|FG002|Placebo Lead-in Period|Withdrawal by Subject|0|||
147460972|NCT01987908|531849405|FG000|Placebo Lead-in Period|Other: Study Termination by Sponsor|4|||
147460973|NCT01987908|531849406|FG001|Placebo Lead-in Period|Other: Study Termination by Sponsor|0|||
147460974|NCT01987908|531849407|FG002|Placebo Lead-in Period|Other: Study Termination by Sponsor|0|||
147460975|NCT01987908|531849405|FG000|Treatment Period|Adverse Event|0|||
147460976|NCT01987908|531849406|FG001|Treatment Period|Adverse Event|1|||
147460977|NCT01987908|531849407|FG002|Treatment Period|Adverse Event|1|||
147460978|NCT01987908|531849405|FG000|Post-Treatment Observation Period|Other: Study Termination by Sponsor|0|||
147460979|NCT01987908|531849406|FG001|Post-Treatment Observation Period|Other: Study Termination by Sponsor|2|||
147460980|NCT01987908|531849407|FG002|Post-Treatment Observation Period|Other: Study Termination by Sponsor|0|||
147460981|NCT01987908|531849405|FG000|Post-Treatment Observation Period|Other: Bad Veins|0|||
147460982|NCT01987908|531849406|FG001|Post-Treatment Observation Period|Other: Bad Veins|1|||
147460983|NCT01987908|531849407|FG002|Post-Treatment Observation Period|Other: Bad Veins|0|||
147460984|NCT01500057|531849411|FG000|Overall Study|Lost to Follow-up|6|||
147460985|NCT01500057|531849412|FG001|Overall Study|Lost to Follow-up|4|||
147460986|NCT00441792|531849413|FG000|Overall Study|Lost to Follow-up|0|||
147460987|NCT00441792|531849414|FG001|Overall Study|Lost to Follow-up|2|||
147460988|NCT01731678|531849415|FG000|Overall Study|Withdrawal by Subject|3|||
147460989|NCT01731678|531849415|FG000|Overall Study|Did not meet inclusion criteria|1|||
147460990|NCT01731678|531849415|FG000|Overall Study|RMT too high, making TMS difficult|3|||
147460991|NCT02471716|531849416|FG000|Overall Study|Withdrawal by Subject|0|||
147460992|NCT02471716|531849417|FG001|Overall Study|Withdrawal by Subject|1|||
147460993|NCT02471716|531849418|FG002|Overall Study|Withdrawal by Subject|0|||
147460994|NCT02471716|531849419|FG003|Overall Study|Withdrawal by Subject|2|||
147460995|NCT02471716|531849420|FG004|Overall Study|Withdrawal by Subject|5|||
147460996|NCT02471716|531849416|FG000|Overall Study|Study Terminiated by sponsor|0|||
147460997|NCT02471716|531849417|FG001|Overall Study|Study Terminiated by sponsor|0|||
147460998|NCT02471716|531849418|FG002|Overall Study|Study Terminiated by sponsor|0|||
147460999|NCT02471716|531849419|FG003|Overall Study|Study Terminiated by sponsor|1|||
147461000|NCT02471716|531849420|FG004|Overall Study|Study Terminiated by sponsor|0|||
147461001|NCT02471716|531849416|FG000|Overall Study|Lost to Follow-up|0|||
147461002|NCT02471716|531849417|FG001|Overall Study|Lost to Follow-up|0|||
147461003|NCT02471716|531849418|FG002|Overall Study|Lost to Follow-up|0|||
147461004|NCT02471716|531849419|FG003|Overall Study|Lost to Follow-up|3|||
147461005|NCT02471716|531849420|FG004|Overall Study|Lost to Follow-up|2|||
147461006|NCT02471716|531849416|FG000|Overall Study|Death|0|||
147461007|NCT02471716|531849417|FG001|Overall Study|Death|0|||
147461008|NCT02471716|531849418|FG002|Overall Study|Death|0|||
147461009|NCT02471716|531849419|FG003|Overall Study|Death|1|||
147461010|NCT02471716|531849420|FG004|Overall Study|Death|0|||
147461011|NCT02471716|531849416|FG000|Overall Study|Other|0|||
147461012|NCT02471716|531849417|FG001|Overall Study|Other|0|||
147461013|NCT02471716|531849418|FG002|Overall Study|Other|0|||
147461014|NCT02471716|531849419|FG003|Overall Study|Other|8|||
147461015|NCT02471716|531849420|FG004|Overall Study|Other|9|||
147461016|NCT01014585|531849424|FG000|Overall Study|Adverse Event|0|||
147396876|NCT03120949|531617190|FG000|Overall Study|PI Terminated Subject From IP (Ae's Abnormal Wbc, Abnormal Absolute Neutrophils Lab)|1|||
147396877|NCT03120949|531617191|FG001|Overall Study|PI Terminated Subject From IP (Ae's Abnormal Wbc, Abnormal Absolute Neutrophils Lab)|0|||
147396878|NCT03120949|531617190|FG000|Overall Study|Patient Was Hospitalized Due To The SAE And Couldn't Visit The Site For Sfu-3|1|||
147396879|NCT03120949|531617191|FG001|Overall Study|Patient Was Hospitalized Due To The SAE And Couldn't Visit The Site For Sfu-3|0|||
147396880|NCT03120949|531617190|FG000|Overall Study|Other: Adverse Event|0|||
147396881|NCT03120949|531617191|FG001|Overall Study|Other: Adverse Event|1|||
147396882|NCT03120949|531617190|FG000|Overall Study|Due To The Death Of His Wife, He Refused To Participate In Follow Up 3|0|||
147396883|NCT03120949|531617191|FG001|Overall Study|Due To The Death Of His Wife, He Refused To Participate In Follow Up 3|1|||
147396884|NCT03120949|531617190|FG000|Overall Study|Follow Up Visit Not Performed (Patient Outside Residence)|0|||
147396885|NCT03120949|531617191|FG001|Overall Study|Follow Up Visit Not Performed (Patient Outside Residence)|2|||
147396886|NCT03120949|531617190|FG000|Overall Study|Subject Refusal To Attend Visit|0|||
147396887|NCT03120949|531617191|FG001|Overall Study|Subject Refusal To Attend Visit|1|||
147396888|NCT03120949|531617190|FG000|Overall Study|Personal Reasons|0|||
147396889|NCT03120949|531617191|FG001|Overall Study|Personal Reasons|1|||
147396890|NCT03120949|531617190|FG000|Overall Study|PI Did Not Feel It Was Best For Subject To Be Without Treatment For 12 Weeks.|0|||
147396891|NCT03120949|531617191|FG001|Overall Study|PI Did Not Feel It Was Best For Subject To Be Without Treatment For 12 Weeks.|1|||
147396892|NCT03120949|531617190|FG000|Overall Study|Lack Of Efficacy (PI Perspective) End Of Study Visit|0|||
147396893|NCT03120949|531617191|FG001|Overall Study|Lack Of Efficacy (PI Perspective) End Of Study Visit|1|||
147396894|NCT03120949|531617190|FG000|Overall Study|Compliance With Medication|0|||
147396895|NCT03120949|531617191|FG001|Overall Study|Compliance With Medication|1|||
147396896|NCT03120949|531617190|FG000|Overall Study|Subject Has A Severe Or Life Threatening Infection That Requires Hospitalization Per Medical Monitor|0|||
147396897|NCT03120949|531617191|FG001|Overall Study|Subject Has A Severe Or Life Threatening Infection That Requires Hospitalization Per Medical Monitor|1|||
147396898|NCT03120949|531617190|FG000|Overall Study|Other: Protocol Violation (Refused From SFU Visits)|0|||
147396899|NCT03120949|531617191|FG001|Overall Study|Other: Protocol Violation (Refused From SFU Visits)|1|||
147396900|NCT03120949|531617190|FG000|Overall Study|Study Terminated By Principal Investigator|0|||
147396901|NCT03120949|531617191|FG001|Overall Study|Study Terminated By Principal Investigator|1|||
147396902|NCT01705145|531617192|FG000|Part B|Adverse Event|1|||
147396903|NCT00312845|531617193|FG000|Overall Study|Adverse Event|19|||
147396904|NCT00312845|531617194|FG001|Overall Study|Adverse Event|5|||
147396905|NCT00312845|531617193|FG000|Overall Study|Death|2|||
147396906|NCT00312845|531617194|FG001|Overall Study|Death|2|||
147396907|NCT00312845|531617193|FG000|Overall Study|Withdrawal by Subject|14|||
147396908|NCT00312845|531617194|FG001|Overall Study|Withdrawal by Subject|6|||
147396909|NCT00312845|531617193|FG000|Overall Study|Disease Progression|56|||
147396910|NCT00312845|531617194|FG001|Overall Study|Disease Progression|77|||
147396911|NCT00312845|531617193|FG000|Overall Study|Lost to Follow-up|2|||
147396912|NCT00312845|531617194|FG001|Overall Study|Lost to Follow-up|0|||
147396913|NCT00312845|531617193|FG000|Overall Study|Other|6|||
147396914|NCT00312845|531617194|FG001|Overall Study|Other|5|||
147396915|NCT00316589|531617195|FG000|Overall Study|Withdrawal by Subject|0|||
147396916|NCT00316589|531617196|FG001|Overall Study|Withdrawal by Subject|5|||
147396917|NCT00316589|531617197|FG002|Overall Study|Withdrawal by Subject|0|||
147396918|NCT00316589|531617198|FG003|Overall Study|Withdrawal by Subject|1|||
147396919|NCT00316589|531617195|FG000|Overall Study|Subject unwilling/unable to comply|0|||
147396920|NCT00316589|531617196|FG001|Overall Study|Subject unwilling/unable to comply|6|||
147396921|NCT00316589|531617197|FG002|Overall Study|Subject unwilling/unable to comply|0|||
147396922|NCT00316589|531617198|FG003|Overall Study|Subject unwilling/unable to comply|2|||
147396923|NCT00316589|531617195|FG000|Overall Study|Adverse Event|1|||
147396924|NCT00316589|531617196|FG001|Overall Study|Adverse Event|0|||
147396925|NCT00316589|531617197|FG002|Overall Study|Adverse Event|0|||
147396926|NCT00316589|531617198|FG003|Overall Study|Adverse Event|1|||
147396927|NCT00316589|531617195|FG000|Overall Study|Physician Decision|0|||
147396928|NCT00316589|531617196|FG001|Overall Study|Physician Decision|1|||
147396929|NCT00316589|531617197|FG002|Overall Study|Physician Decision|0|||
147396930|NCT00316589|531617198|FG003|Overall Study|Physician Decision|0|||
147396931|NCT00316589|531617195|FG000|Overall Study|Other reason|0|||
147396932|NCT00316589|531617196|FG001|Overall Study|Other reason|12|||
147396933|NCT00316589|531617197|FG002|Overall Study|Other reason|1|||
147396934|NCT00316589|531617198|FG003|Overall Study|Other reason|1|||
147396935|NCT01283971|531617201|FG000|Overall Study|Adverse Event|3|||
147396936|NCT01283971|531617202|FG001|Overall Study|Adverse Event|5|||
147396937|NCT01283971|531617201|FG000|Overall Study|Insufficient therapeutic responses|3|||
147396938|NCT01283971|531617202|FG001|Overall Study|Insufficient therapeutic responses|3|||
147396939|NCT01283971|531617201|FG000|Overall Study|Protocol Violation|5|||
147396940|NCT01283971|531617202|FG001|Overall Study|Protocol Violation|1|||
147396941|NCT01283971|531617201|FG000|Overall Study|Refused treatment|3|||
147615413|NCT01959295|532406732|FG000|Overall Study|Withdrawal by Subject|3|||
147615414|NCT01959295|532406733|FG001|Overall Study|Withdrawal by Subject|1|||
147615415|NCT01959295|532406732|FG000|Overall Study|Clinical laboratory value is ineligible on day 1|10|||
147396942|NCT01283971|531617202|FG001|Overall Study|Refused treatment|1|||
147396943|NCT01283971|531617201|FG000|Overall Study|Failure to return|0|||
147396944|NCT01283971|531617202|FG001|Overall Study|Failure to return|1|||
147396945|NCT01283971|531617201|FG000|Overall Study|Administrative reasons|1|||
147396946|NCT01283971|531617202|FG001|Overall Study|Administrative reasons|1|||
147396947|NCT03325608|531617203|FG000|Overall Study|Lost to Follow-up|23|||
147396948|NCT03325608|531617204|FG001|Overall Study|Lost to Follow-up|23|||
147396949|NCT03325608|531617205|FG002|Overall Study|Lost to Follow-up|30|||
147396950|NCT03325608|531617206|FG003|Overall Study|Lost to Follow-up|30|||
147396951|NCT03325608|531617203|FG000|Overall Study|Death of Caregiver|0|||
147396952|NCT03325608|531617204|FG001|Overall Study|Death of Caregiver|0|||
147396953|NCT03325608|531617205|FG002|Overall Study|Death of Caregiver|2|||
147396954|NCT03325608|531617206|FG003|Overall Study|Death of Caregiver|2|||
147396955|NCT03325608|531617203|FG000|Overall Study|Death of Care Recipient|34|||
147396956|NCT03325608|531617204|FG001|Overall Study|Death of Care Recipient|34|||
147396957|NCT03325608|531617205|FG002|Overall Study|Death of Care Recipient|28|||
147396958|NCT03325608|531617206|FG003|Overall Study|Death of Care Recipient|28|||
147396959|NCT03325608|531617203|FG000|Overall Study|Withdrawal by Subject|49|||
147396960|NCT03325608|531617204|FG001|Overall Study|Withdrawal by Subject|49|||
147396961|NCT03325608|531617205|FG002|Overall Study|Withdrawal by Subject|35|||
147396962|NCT03325608|531617206|FG003|Overall Study|Withdrawal by Subject|35|||
147396963|NCT03325608|531617203|FG000|Overall Study|Ineligible|7|||
147396964|NCT03325608|531617204|FG001|Overall Study|Ineligible|7|||
147396965|NCT03325608|531617205|FG002|Overall Study|Ineligible|5|||
147396966|NCT03325608|531617206|FG003|Overall Study|Ineligible|5|||
147396967|NCT02154347|531617207|FG000|Double-blind Period|Adverse Event|1|||
147396968|NCT02154347|531617208|FG001|Double-blind Period|Adverse Event|2|||
147396969|NCT02154347|531617207|FG000|Double-blind Period|Lack of Efficacy|1|||
147396970|NCT02154347|531617208|FG001|Double-blind Period|Lack of Efficacy|0|||
147396971|NCT02154347|531617207|FG000|Double-blind Period|Physician Decision|0|||
147396972|NCT02154347|531617208|FG001|Double-blind Period|Physician Decision|1|||
147396973|NCT02154347|531617207|FG000|Double-blind Period|Withdrawal by Subject|1|||
147396974|NCT02154347|531617208|FG001|Double-blind Period|Withdrawal by Subject|1|||
147396975|NCT02154347|531617207|FG000|Open-label Period|Adverse Event|3|||
147396976|NCT02154347|531617208|FG001|Open-label Period|Adverse Event|4|||
147396977|NCT02154347|531617207|FG000|Open-label Period|Lack of Efficacy|4|||
147396978|NCT02154347|531617208|FG001|Open-label Period|Lack of Efficacy|19|||
147396979|NCT02154347|531617207|FG000|Open-label Period|Protocol Violation|0|||
147396980|NCT02154347|531617208|FG001|Open-label Period|Protocol Violation|1|||
147396981|NCT02154347|531617207|FG000|Open-label Period|Withdrawal by Subject|0|||
147396982|NCT02154347|531617208|FG001|Open-label Period|Withdrawal by Subject|1|||
147396983|NCT02188784|531617209|FG000|Overall Study|Death|3|||
147396984|NCT02188784|531617210|FG001|Overall Study|Death|1|||
147396985|NCT02188784|531617209|FG000|Overall Study|Lost to Follow-up|1|||
147396986|NCT02188784|531617210|FG001|Overall Study|Lost to Follow-up|0|||
147396987|NCT02188784|531617209|FG000|Overall Study|Withdrawal by Subject|3|||
147396988|NCT02188784|531617210|FG001|Overall Study|Withdrawal by Subject|9|||
147396989|NCT02188784|531617209|FG000|Overall Study|Physician Decision|2|||
147396990|NCT02188784|531617210|FG001|Overall Study|Physician Decision|3|||
147396991|NCT05041439|531617211|FG000|Overall Study|Withdrawal by Subject|1|||
147396992|NCT05041439|531617212|FG001|Overall Study|Withdrawal by Subject|1|||
147396993|NCT05041439|531617211|FG000|Overall Study|Death|1|||
147396994|NCT05041439|531617212|FG001|Overall Study|Death|0|||
147396995|NCT00664105|531618578|FG000|Overall Study|Death|3|||
147396996|NCT00664105|531618578|FG000|Overall Study|Withdrawal by Subject|5|||
147396997|NCT00664105|531618578|FG000|Overall Study|Adverse Event|9|||
147396998|NCT00664105|531618578|FG000|Overall Study|Disease progression|7|||
147396999|NCT01468077|531618585|FG000|Overall Study|Adverse Event|2|||
147397000|NCT01468077|531618586|FG001|Overall Study|Adverse Event|2|||
147397001|NCT01468077|531618585|FG000|Overall Study|Lack of Efficacy|1|||
147397002|NCT01468077|531618586|FG001|Overall Study|Lack of Efficacy|1|||
147397003|NCT01468077|531618585|FG000|Overall Study|Physician Decision|1|||
147397004|NCT01468077|531618586|FG001|Overall Study|Physician Decision|0|||
147397005|NCT04843579|531618587|FG000|Overall Study|Adverse Event|1|||
147397006|NCT04843579|531618587|FG000|Overall Study|Disease Progression|1|||
147397007|NCT03834623|531618588|FG000|Overall Study|Progression|0|||
147397008|NCT03834623|531618589|FG001|Overall Study|Progression|1|||
147397009|NCT03024996|531618591|FG000|Overall Study|Death|57|||
147397010|NCT03024996|531618592|FG001|Overall Study|Death|55|||
147397011|NCT03024996|531618591|FG000|Overall Study|Disease relapse|1|||
147397012|NCT03024996|531618592|FG001|Overall Study|Disease relapse|0|||
147397013|NCT03024996|531618591|FG000|Overall Study|Lost to Follow-up|5|||
147397014|NCT03024996|531618592|FG001|Overall Study|Lost to Follow-up|10|||
147397015|NCT03024996|531618591|FG000|Overall Study|Other|3|||
147397016|NCT03024996|531618592|FG001|Overall Study|Other|3|||
147397017|NCT03024996|531618591|FG000|Overall Study|Physician Decision|0|||
147397018|NCT03024996|531618592|FG001|Overall Study|Physician Decision|1|||
147397019|NCT03024996|531618591|FG000|Overall Study|Study terminated by sponsor|303|||
147397020|NCT03024996|531618592|FG001|Overall Study|Study terminated by sponsor|283|||
147397021|NCT03024996|531618591|FG000|Overall Study|Withdrawal by Subject|21|||
147397022|NCT03024996|531618592|FG001|Overall Study|Withdrawal by Subject|36|||
147397023|NCT00478647|531618593|FG000|Overall Study|Adverse Event|1|||
147397024|NCT00478647|531618593|FG000|Overall Study|Withdrawal by Subject|1|||
147397025|NCT00477464|531618597|FG000|Overall Study|Lost to Follow-up|1|||
147397026|NCT00477464|531618597|FG000|Overall Study|Death|36|||
147397027|NCT00477464|531618597|FG000|Overall Study|Completion of protocol-defined follow-up|14|||
147397028|NCT00639769|531618598|FG000|Overall Study|Death|2|||
147397029|NCT00639769|531618598|FG000|Overall Study|Adverse Event|7|||
147397030|NCT00639769|531618598|FG000|Overall Study|Lack of Efficacy|1|||
147397031|NCT00639769|531618598|FG000|Overall Study|Disease progression|26|||
147397032|NCT00639769|531618598|FG000|Overall Study|Withdrawal by Subject|4|||
147397033|NCT00784147|531618599|FG000|Overall Study|Lost to Follow-up|2|||
147397034|NCT00784147|531618600|FG001|Overall Study|Lost to Follow-up|4|||
147397035|NCT00784147|531618599|FG000|Overall Study|Withdrawal by Subject|1|||
147397036|NCT00784147|531618600|FG001|Overall Study|Withdrawal by Subject|3|||
147397037|NCT00784147|531618599|FG000|Overall Study|Physician Decision|2|||
147397038|NCT00784147|531618600|FG001|Overall Study|Physician Decision|1|||
147397039|NCT00784147|531618599|FG000|Overall Study|Protocol Violation|1|||
147397040|NCT00784147|531618600|FG001|Overall Study|Protocol Violation|1|||
147397041|NCT00784147|531618599|FG000|Overall Study|Death|2|||
147397042|NCT00784147|531618600|FG001|Overall Study|Death|0|||
147397043|NCT03357471|531618605|FG000|Overall Study|Adverse Event|1|||
147397044|NCT03357471|531618606|FG001|Overall Study|Adverse Event|0|||
147397045|NCT03357471|531618605|FG000|Overall Study|Lost to Follow-up|1|||
147397046|NCT03357471|531618606|FG001|Overall Study|Lost to Follow-up|0|||
147397047|NCT03294941|531618607|FG000|Overall Study|Withdrawal by Subject|0|||
147397048|NCT03294941|531618608|FG001|Overall Study|Withdrawal by Subject|2|||
147397049|NCT04051242|531618609|FG000|Overall Study|Withdrawal by Subject|1|||
147397050|NCT04051242|531618609|FG000|Overall Study|Physician Decision|1|||
147397051|NCT04545476|531618612|FG000|Overall Study|Lost to Follow-up|1|||
147397052|NCT04545476|531618613|FG001|Overall Study|Lost to Follow-up|1|||
147397053|NCT04545476|531618614|FG002|Overall Study|Lost to Follow-up|0|||
147397054|NCT04545476|531618615|FG003|Overall Study|Lost to Follow-up|0|||
147397055|NCT00130728|531618618|FG000|Overall Study|Death|258|||
147397056|NCT00130728|531618619|FG001|Overall Study|Death|258|||
147397057|NCT00130728|531618618|FG000|Overall Study|Lost to Follow-up|4|||
147397058|NCT00130728|531618619|FG001|Overall Study|Lost to Follow-up|0|||
147397059|NCT00130728|531618618|FG000|Overall Study|Withdrawal by Subject|0|||
147397060|NCT00130728|531618619|FG001|Overall Study|Withdrawal by Subject|2|||
147397061|NCT03029819|531618621|FG000|Overall Study|Lost to Follow-up|3|||
147397062|NCT03029819|531618622|FG001|Overall Study|Lost to Follow-up|5|||
147397063|NCT03029819|531618621|FG000|Overall Study|Removed due to disruptive behavior|0|||
147397064|NCT03029819|531618622|FG001|Overall Study|Removed due to disruptive behavior|1|||
147397065|NCT02725008|531618627|FG000|Overall Study|Lost to Follow-up|7|||
147397066|NCT02725008|531618628|FG001|Overall Study|Lost to Follow-up|9|||
147397067|NCT02725008|531618627|FG000|Overall Study|Withdrawal by Subject|2|||
147397068|NCT02725008|531618628|FG001|Overall Study|Withdrawal by Subject|2|||
147397069|NCT02725008|531618627|FG000|Overall Study|Admitted to hospital|0|||
147397070|NCT02725008|531618628|FG001|Overall Study|Admitted to hospital|1|||
147397071|NCT01020747|531618629|FG000|Overall Study|Withdrawal by Subject|1|||
147397072|NCT02175745|531618634|FG000|Overall Study|Not Eligible|1|||
147397073|NCT00983892|531618635|FG000|Overall Study|Withdrawal by Subject|10|||
147397074|NCT00983892|531618636|FG001|Overall Study|Withdrawal by Subject|12|||
147397075|NCT00808899|531618637|FG000|Overall Study|Death|1|||
147397076|NCT00808899|531618637|FG000|Overall Study|Physician Decision|3|||
147397077|NCT03028012|531618638|FG000|Overall Study|Lost to Follow-up|2|||
147397078|NCT03028012|531618639|FG001|Overall Study|Lost to Follow-up|3|||
147397079|NCT03028012|531618640|FG002|Overall Study|Lost to Follow-up|3|||
147397080|NCT03448536|531618649|FG000|Overall Study|Protocol Violation|2|||
147397081|NCT03448536|531618650|FG001|Overall Study|Protocol Violation|0|||
147397082|NCT03448536|531618649|FG000|Overall Study|Pregnancy|1|||
147397083|NCT03448536|531618650|FG001|Overall Study|Pregnancy|0|||
147397084|NCT03448536|531618649|FG000|Overall Study|Withdrawal by Subject|1|||
147397085|NCT03448536|531618650|FG001|Overall Study|Withdrawal by Subject|2|||
147397086|NCT03448536|531618649|FG000|Overall Study|Lost to Follow-up|3|||
147397087|NCT03448536|531618650|FG001|Overall Study|Lost to Follow-up|2|||
147397088|NCT03448536|531618649|FG000|Overall Study|Inadequate pain reporter|1|||
147397089|NCT03448536|531618650|FG001|Overall Study|Inadequate pain reporter|0|||
147397090|NCT03448536|531618649|FG000|Overall Study|Other|3|||
147397091|NCT03448536|531618650|FG001|Overall Study|Other|0|||
147397092|NCT03448536|531618649|FG000|Overall Study|Physician Decision|1|||
147397093|NCT03448536|531618650|FG001|Overall Study|Physician Decision|0|||
147397094|NCT01424189|531618654|FG000|Overall Study|Adverse Event|1|||
147397095|NCT01424189|531618655|FG001|Overall Study|Adverse Event|0|||
147397096|NCT01424189|531618654|FG000|Overall Study|Lost to Follow-up|4|||
147397097|NCT01424189|531618655|FG001|Overall Study|Lost to Follow-up|1|||
147397098|NCT01424189|531618654|FG000|Overall Study|Withdrawal by Subject|4|||
147397099|NCT01424189|531618655|FG001|Overall Study|Withdrawal by Subject|4|||
147397100|NCT01424189|531618654|FG000|Overall Study|Subject moved|1|||
147397101|NCT01424189|531618655|FG001|Overall Study|Subject moved|0|||
147397102|NCT01424189|531618654|FG000|Overall Study|Death|3|||
147397103|NCT01424189|531618655|FG001|Overall Study|Death|1|||
147397104|NCT04688086|531618656|FG000|Overall Study|Lost to Follow-up|164|||
147397105|NCT04688086|531618656|FG000|Overall Study|Imaging error;|64|||
147397106|NCT01203956|531618657|FG000|Second Two-week Period|Non-compliant: no evaluable results|5|||
147397107|NCT01203956|531618658|FG001|Second Two-week Period|Non-compliant: no evaluable results|6|||
147397108|NCT01329419|531618661|FG000|Overall Study|Protocol Violation|235|||
147397109|NCT04522778|531618664|FG000|Overall Study|Patient did not want to wear the device|1|||
147397110|NCT04522778|531618665|FG001|Overall Study|Patient did not want to wear the device|0|||
147397111|NCT04522778|531618664|FG000|Overall Study|Lost to Follow-up|0|||
147397112|NCT04522778|531618665|FG001|Overall Study|Lost to Follow-up|1|||
147397113|NCT00069277|531618666|FG000|Overall Study|Adverse Event|3|||
147397114|NCT00069277|531618666|FG000|Overall Study|Withdrawal by Subject|1|||
147397115|NCT00069277|531618666|FG000|Overall Study|Progressive Disease|15|||
147397116|NCT00069277|531618666|FG000|Overall Study|Physician Decision|2|||
147397117|NCT01225159|531618667|FG000|Overall Study|Change operation|1|||
147397118|NCT01225159|531618668|FG001|Overall Study|Change operation|0|||
147397119|NCT02230306|531618669|FG000|Overall Study|Did not receive study treatment|1|||
147397120|NCT03512288|531618675|FG000|Overall Study|Adverse Event|1|||
147397121|NCT03512288|531618676|FG001|Overall Study|Adverse Event|0|||
147397122|NCT03512288|531618675|FG000|Overall Study|Lost to Follow-up|12|||
147397123|NCT03512288|531618676|FG001|Overall Study|Lost to Follow-up|15|||
147397124|NCT03512288|531618675|FG000|Overall Study|Physician Decision|0|||
147397125|NCT03512288|531618676|FG001|Overall Study|Physician Decision|2|||
147397126|NCT03512288|531618675|FG000|Overall Study|Protocol Violation|6|||
147397127|NCT03512288|531618676|FG001|Overall Study|Protocol Violation|4|||
147397128|NCT03512288|531618675|FG000|Overall Study|Medication error without associated adverse event|1|||
147397129|NCT03512288|531618676|FG001|Overall Study|Medication error without associated adverse event|0|||
147397130|NCT03512288|531618675|FG000|Overall Study|No longer met eligibility criteria|5|||
147397131|NCT03512288|531618676|FG001|Overall Study|No longer met eligibility criteria|2|||
147397132|NCT03512288|531618675|FG000|Overall Study|Withdrawal by parent/guardian|14|||
147397133|NCT03512288|531618676|FG001|Overall Study|Withdrawal by parent/guardian|18|||
147397134|NCT03512288|531618675|FG000|Overall Study|Other|1|||
147397135|NCT03512288|531618676|FG001|Overall Study|Other|1|||
147397136|NCT03512288|531618675|FG000|Overall Study|Randomized but not treated|1|||
147397137|NCT03512288|531618676|FG001|Overall Study|Randomized but not treated|1|||
147397138|NCT01078584|531618677|FG000|Overall Study|Final Status Unknown|1073|||
147397139|NCT01078584|531618677|FG000|Overall Study|Lost to Follow-up|670|||
147397140|NCT01078584|531618677|FG000|Overall Study|Non-serious Adverse Event|577|||
147397141|NCT01078584|531618677|FG000|Overall Study|Withdrawal of Consent|244|||
147397142|NCT01078584|531618677|FG000|Overall Study|Physician Withdrew from Study|90|||
147397143|NCT01078584|531618677|FG000|Overall Study|Non-compliance|67|||
147397144|NCT01078584|531618677|FG000|Overall Study|Blood Pressure Controlled|49|||
147397145|NCT01078584|531618677|FG000|Overall Study|Physician Switched Medication|26|||
147397146|NCT01078584|531618677|FG000|Overall Study|Physician Discontinued Patient|12|||
147397147|NCT01078584|531618677|FG000|Overall Study|Lack of Efficacy|98|||
147397148|NCT01078584|531618677|FG000|Overall Study|Protocol Violation|75|||
147397149|NCT01078584|531618677|FG000|Overall Study|Serious Adverse Event|27|||
147397150|NCT01078584|531618677|FG000|Overall Study|Multiple Reasons|2|||
147397151|NCT01208870|531618678|FG000|Overall Study|Lost to Follow-up|2|||
147397152|NCT01208870|531618679|FG001|Overall Study|Lost to Follow-up|8|||
147397153|NCT01121185|531618680|FG000|Overall Study|Not infused|0|||
147397154|NCT01121185|531618681|FG001|Overall Study|Not infused|1|||
147397155|NCT01121185|531618680|FG000|Overall Study|Not transplanted|1|||
147397156|NCT01121185|531618681|FG001|Overall Study|Not transplanted|0|||
147397157|NCT00424177|531618682|FG000|Cycle 1: Eltrombopag 50 mg Starting Dose|Lack of Efficacy|8|||
147397158|NCT00424177|531618682|FG000|Cycle 1: Eltrombopag 50 mg Starting Dose|Adverse Event|1|||
147397159|NCT00424177|531618682|FG000|Cycle 1: Eltrombopag 50 mg Starting Dose|Prolonged Response|1|||
147397160|NCT00424177|531618682|FG000|Cycle 1: Eltrombopag 50 mg Starting Dose|Relocation|1|||
147397161|NCT00424177|531618682|FG000|Cycle 2: Eltrombopag 50 or 75 mg|Lack of Efficacy|2|||
147397162|NCT00424177|531618682|FG000|Cycle 2: Eltrombopag 50 or 75 mg|Prolonged Response|1|||
147461017|NCT01014585|531849425|FG001|Overall Study|Adverse Event|2|||
147397163|NCT00424177|531618682|FG000|Cycle 2: Eltrombopag 50 or 75 mg|Withdrawal by Subject|1|||
147461018|NCT01014585|531849426|FG002|Overall Study|Adverse Event|0|||
147461019|NCT01014585|531849427|FG003|Overall Study|Adverse Event|3|||
147397164|NCT00424177|531618682|FG000|Cycle 3: Eltrombopag 50 or 75 mg|Lack of Efficacy|1|||
147397165|NCT00424177|531618682|FG000|Cycle 3: Eltrombopag 50 or 75 mg|Withdrawal by Subject|1|||
147397166|NCT00424177|531618682|FG000|Cycle 3: Eltrombopag 50 or 75 mg|Physician Decision|1|||
147397167|NCT01393613|531618683|FG000|Overall Study|Adverse Event|11|||
147397168|NCT01393613|531618684|FG001|Overall Study|Adverse Event|11|||
147397169|NCT01393613|531618685|FG002|Overall Study|Adverse Event|13|||
147397170|NCT01393613|531618686|FG003|Overall Study|Adverse Event|22|||
147397171|NCT01393613|531618683|FG000|Overall Study|Participant Met Withdrawal Criteria|0|||
147397172|NCT01393613|531618684|FG001|Overall Study|Participant Met Withdrawal Criteria|0|||
147397173|NCT01393613|531618685|FG002|Overall Study|Participant Met Withdrawal Criteria|2|||
147397174|NCT01393613|531618686|FG003|Overall Study|Participant Met Withdrawal Criteria|1|||
147397175|NCT01393613|531618683|FG000|Overall Study|Physician Decision|2|||
147397176|NCT01393613|531618684|FG001|Overall Study|Physician Decision|0|||
147397177|NCT01393613|531618685|FG002|Overall Study|Physician Decision|0|||
147397178|NCT01393613|531618686|FG003|Overall Study|Physician Decision|1|||
147397179|NCT01393613|531618683|FG000|Overall Study|Withdrawal by Subject|15|||
147397180|NCT01393613|531618684|FG001|Overall Study|Withdrawal by Subject|25|||
147397181|NCT01393613|531618685|FG002|Overall Study|Withdrawal by Subject|23|||
147397182|NCT01393613|531618686|FG003|Overall Study|Withdrawal by Subject|21|||
147397183|NCT01393613|531618683|FG000|Overall Study|Protocol Deviation|2|||
147397184|NCT01393613|531618684|FG001|Overall Study|Protocol Deviation|1|||
147397185|NCT01393613|531618685|FG002|Overall Study|Protocol Deviation|0|||
147397186|NCT01393613|531618686|FG003|Overall Study|Protocol Deviation|0|||
147397187|NCT01393613|531618683|FG000|Overall Study|Lack of Efficacy|9|||
147397188|NCT01393613|531618684|FG001|Overall Study|Lack of Efficacy|20|||
147397189|NCT01393613|531618685|FG002|Overall Study|Lack of Efficacy|16|||
147397190|NCT01393613|531618686|FG003|Overall Study|Lack of Efficacy|21|||
147397191|NCT00474383|531618692|FG000|Main Study|Adverse Event|11|||
147397192|NCT00474383|531618693|FG001|Main Study|Adverse Event|0|||
147397193|NCT00474383|531618692|FG000|Main Study|Symptomatic Deterioration|1|||
147397194|NCT00474383|531618693|FG001|Main Study|Symptomatic Deterioration|0|||
147397195|NCT00474383|531618692|FG000|Main Study|Progressive Disease|23|||
147397196|NCT00474383|531618693|FG001|Main Study|Progressive Disease|0|||
147397197|NCT00474383|531618692|FG000|Main Study|Other|1|||
147397198|NCT00474383|531618693|FG001|Main Study|Other|0|||
147397199|NCT00474383|531618692|FG000|Between Main Study and Extension|Did Not Enter Extension Phase|6|||
147397200|NCT00474383|531618693|FG001|Between Main Study and Extension|Did Not Enter Extension Phase|0|||
147397201|NCT00474383|531618692|FG000|Extension|Progressive Disease|0|||
147397202|NCT00474383|531618693|FG001|Extension|Progressive Disease|5|||
147397203|NCT01482819|531618694|FG000|Overall Study|Lost to Follow-up|2|||
147397204|NCT00562484|531618697|FG000|Overall Study|Adverse Event|6|||
147397205|NCT00562484|531618698|FG001|Overall Study|Adverse Event|1|||
147397206|NCT00562484|531618697|FG000|Overall Study|Protocol Violation|11|||
147397207|NCT00562484|531618698|FG001|Overall Study|Protocol Violation|2|||
147397208|NCT00562484|531618697|FG000|Overall Study|Withdrawal by Subject|12|||
147397209|NCT00562484|531618698|FG001|Overall Study|Withdrawal by Subject|9|||
147397210|NCT00562484|531618697|FG000|Overall Study|Moved away from the study area|20|||
147397211|NCT00562484|531618698|FG001|Overall Study|Moved away from the study area|9|||
147397212|NCT00562484|531618697|FG000|Overall Study|Lost to Follow-up|132|||
147397213|NCT00562484|531618698|FG001|Overall Study|Lost to Follow-up|71|||
147397214|NCT00562484|531618697|FG000|Overall Study|Reason not provided or not specified|25|||
147397215|NCT00562484|531618698|FG001|Overall Study|Reason not provided or not specified|12|||
147397216|NCT00702520|531618701|FG000|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|0|||
147397217|NCT00702520|531618702|FG001|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|1|||
147397218|NCT00702520|531618703|FG002|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|0|||
147397219|NCT00702520|531618704|FG003|Base Study P05788 - Assigned Treatment|Spontaneous pregnancy|0|||
147397220|NCT00702520|531618701|FG000|Base Study P05788 - Embryo Transfer|No embryo transfer|3|||
147397221|NCT00702520|531618702|FG001|Base Study P05788 - Embryo Transfer|No embryo transfer|6|||
147397222|NCT00702520|531618703|FG002|Base Study P05788 - Embryo Transfer|No embryo transfer|0|||
147397223|NCT00702520|531618704|FG003|Base Study P05788 - Embryo Transfer|No embryo transfer|0|||
147397224|NCT00702520|531618701|FG000|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|15|||
147397225|NCT00702520|531618702|FG001|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|10|||
147397226|NCT00702520|531618703|FG002|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|0|||
147397227|NCT00702520|531618704|FG003|Base Study P05788 - Follow-Up|No ongoing pregnancy at 10 weeks|0|||
147397228|NCT00942188|531618705|FG000|Overall Study|Adverse Event|0|||
147397229|NCT00942188|531618706|FG001|Overall Study|Adverse Event|3|||
147397230|NCT00942188|531618707|FG002|Overall Study|Adverse Event|2|||
147397231|NCT00942188|531618708|FG003|Overall Study|Adverse Event|0|||
147397232|NCT00942188|531618705|FG000|Overall Study|Lack of Efficacy|0|||
147397233|NCT00942188|531618706|FG001|Overall Study|Lack of Efficacy|0|||
147397234|NCT00942188|531618707|FG002|Overall Study|Lack of Efficacy|0|||
147397235|NCT00942188|531618708|FG003|Overall Study|Lack of Efficacy|1|||
147397236|NCT00942188|531618705|FG000|Overall Study|Protocol Violation|1|||
147397237|NCT00942188|531618706|FG001|Overall Study|Protocol Violation|1|||
147665191|NCT00919633|532598069|FG003|Overall Study|Adverse Event|10|||
147397238|NCT00942188|531618707|FG002|Overall Study|Protocol Violation|0|||
147397239|NCT00942188|531618708|FG003|Overall Study|Protocol Violation|0|||
147397240|NCT00942188|531618705|FG000|Overall Study|Lost to Follow-up|2|||
147397241|NCT00942188|531618706|FG001|Overall Study|Lost to Follow-up|1|||
147397242|NCT00942188|531618707|FG002|Overall Study|Lost to Follow-up|2|||
147397243|NCT00942188|531618708|FG003|Overall Study|Lost to Follow-up|0|||
147397244|NCT00942188|531618705|FG000|Overall Study|Withdrawal by Subject|1|||
147397245|NCT00942188|531618706|FG001|Overall Study|Withdrawal by Subject|3|||
147397246|NCT00942188|531618707|FG002|Overall Study|Withdrawal by Subject|4|||
147397247|NCT00942188|531618708|FG003|Overall Study|Withdrawal by Subject|2|||
147397248|NCT00942188|531618705|FG000|Overall Study|Physician Decision|0|||
147397249|NCT00942188|531618706|FG001|Overall Study|Physician Decision|0|||
147397250|NCT00942188|531618707|FG002|Overall Study|Physician Decision|1|||
147615416|NCT01959295|532406733|FG001|Overall Study|Clinical laboratory value is ineligible on day 1|6|||
147615417|NCT04917861|532406735|FG000|Main Study (196 Days)|Adverse Event|0|||
147615418|NCT04917861|532406736|FG001|Main Study (196 Days)|Adverse Event|1|||
147615419|NCT04917861|532406737|FG002|Main Study (196 Days)|Adverse Event|0|||
147397251|NCT00942188|531618708|FG003|Overall Study|Physician Decision|0|||
147397252|NCT00942188|531618705|FG000|Overall Study|Sponsor Decision|0|||
147397253|NCT00942188|531618706|FG001|Overall Study|Sponsor Decision|2|||
147397254|NCT00942188|531618707|FG002|Overall Study|Sponsor Decision|0|||
147397255|NCT00942188|531618708|FG003|Overall Study|Sponsor Decision|1|||
147397256|NCT02250183|531618709|FG000|Overall Study|Withdrawal by Subject|2|||
147397257|NCT02250183|531618709|FG000|Overall Study|Adverse Event|5|||
147397258|NCT02250183|531618709|FG000|Overall Study|Lost to Follow-up|1|||
147397259|NCT03282799|531618710|FG000|Overall Study|Pregnancy|1|||
147397260|NCT03282799|531618711|FG001|Overall Study|Pregnancy|0|||
147397261|NCT03282799|531618710|FG000|Overall Study|Physician Decision|1|||
147397262|NCT03282799|531618711|FG001|Overall Study|Physician Decision|0|||
147397263|NCT03614676|531620739|FG000|Overall Study|Delivery before planned visit|2|||
147397264|NCT03614676|531620740|FG001|Overall Study|Delivery before planned visit|0|||
147397265|NCT03614676|531620739|FG000|Overall Study|Consent withdrawal, not due to SAE related to study or a pregnancy related event of special interest|34|||
147397266|NCT03614676|531620740|FG001|Overall Study|Consent withdrawal, not due to SAE related to study or a pregnancy related event of special interest|0|||
147397267|NCT03614676|531620739|FG000|Overall Study|Migrated / moved from the study area|30|||
147397268|NCT03614676|531620740|FG001|Overall Study|Migrated / moved from the study area|22|||
147397269|NCT03614676|531620739|FG000|Overall Study|Lost to Follow-up|17|||
147397270|NCT03614676|531620740|FG001|Overall Study|Lost to Follow-up|42|||
147397271|NCT03614676|531620739|FG000|Overall Study|Not willing/ not able to participate in this visit|17|||
147397272|NCT03614676|531620740|FG001|Overall Study|Not willing/ not able to participate in this visit|16|||
147397273|NCT03614676|531620739|FG000|Overall Study|Other|16|||
147397274|NCT03614676|531620740|FG001|Overall Study|Other|47|||
147397275|NCT03614676|531620739|FG000|Overall Study|Protocol Violation|0|||
147397276|NCT03614676|531620740|FG001|Overall Study|Protocol Violation|2|||
147397277|NCT03614676|531620739|FG000|Overall Study|Neonatal event of interest|0|||
147397278|NCT03614676|531620740|FG001|Overall Study|Neonatal event of interest|6|||
147397279|NCT03614676|531620739|FG000|Overall Study|Death in infant greater than 28 days old|0|||
147397280|NCT03614676|531620740|FG001|Overall Study|Death in infant greater than 28 days old|12|||
147397281|NCT03614676|531620739|FG000|Overall Study|Consent withdrawal not due to SAE related to study or neonatal event of special interest|0|||
147397282|NCT03614676|531620740|FG001|Overall Study|Consent withdrawal not due to SAE related to study or neonatal event of special interest|17|||
147397283|NCT02080403|531620741|FG000|Overall Study|Adverse Event|5|||
147397284|NCT02080403|531620742|FG001|Overall Study|Adverse Event|1|||
147397285|NCT02080403|531620741|FG000|Overall Study|Death|0|||
147397286|NCT02080403|531620742|FG001|Overall Study|Death|2|||
147397287|NCT02080403|531620741|FG000|Overall Study|Lost to Follow-up|2|||
147397288|NCT02080403|531620742|FG001|Overall Study|Lost to Follow-up|0|||
147397289|NCT02080403|531620741|FG000|Overall Study|Pregnancy|0|||
147397290|NCT02080403|531620742|FG001|Overall Study|Pregnancy|1|||
147397291|NCT02080403|531620741|FG000|Overall Study|Protocol Violation|3|||
147397292|NCT02080403|531620742|FG001|Overall Study|Protocol Violation|7|||
147397293|NCT02080403|531620741|FG000|Overall Study|Withdrawal by Subject|5|||
147397294|NCT02080403|531620742|FG001|Overall Study|Withdrawal by Subject|1|||
147397295|NCT01999972|531620743|FG000|Dose Escalation Part|Participant refused further follow-up|1|||
147397296|NCT01999972|531620744|FG001|Dose Escalation Part|Participant refused further follow-up|0|||
147397297|NCT01999972|531620745|FG002|Dose Escalation Part|Participant refused further follow-up|1|||
147397298|NCT01999972|531620746|FG003|Dose Escalation Part|Participant refused further follow-up|1|||
147397299|NCT01999972|531620747|FG004|Dose Escalation Part|Participant refused further follow-up|0|||
147397300|NCT01999972|531620748|FG005|Dose Escalation Part|Participant refused further follow-up|0|||
147397301|NCT01999972|531620743|FG000|Dose Escalation Part|Death|0|||
147397302|NCT01999972|531620744|FG001|Dose Escalation Part|Death|1|||
147397303|NCT01999972|531620745|FG002|Dose Escalation Part|Death|0|||
147461020|NCT01014585|531849424|FG000|Overall Study|Withdrawal by Subject|2|||
147615420|NCT04917861|532406738|FG003|Main Study (196 Days)|Adverse Event|0|||
147615421|NCT04917861|532406735|FG000|Main Study (196 Days)|Death|0|||
147397304|NCT01999972|531620746|FG003|Dose Escalation Part|Death|0|||
147615422|NCT04917861|532406736|FG001|Main Study (196 Days)|Death|0|||
147397305|NCT01999972|531620747|FG004|Dose Escalation Part|Death|0|||
147397306|NCT01999972|531620748|FG005|Dose Escalation Part|Death|0|||
147397307|NCT01999972|531620743|FG000|Dose Escalation Part|Enrolled but not treated|0|||
147397308|NCT01999972|531620744|FG001|Dose Escalation Part|Enrolled but not treated|0|||
147397309|NCT01999972|531620745|FG002|Dose Escalation Part|Enrolled but not treated|1|||
147397310|NCT01999972|531620746|FG003|Dose Escalation Part|Enrolled but not treated|1|||
147397311|NCT01999972|531620747|FG004|Dose Escalation Part|Enrolled but not treated|0|||
147615423|NCT04917861|532406737|FG002|Main Study (196 Days)|Death|0|||
147615424|NCT04917861|532406738|FG003|Main Study (196 Days)|Death|1|||
147397312|NCT01999972|531620748|FG005|Dose Escalation Part|Enrolled but not treated|0|||
147397313|NCT01999972|531620743|FG000|Dose Escalation Part|Disease progression|3|||
147397314|NCT01999972|531620744|FG001|Dose Escalation Part|Disease progression|2|||
147397315|NCT01999972|531620745|FG002|Dose Escalation Part|Disease progression|3|||
147397316|NCT01999972|531620746|FG003|Dose Escalation Part|Disease progression|6|||
147397317|NCT01999972|531620747|FG004|Dose Escalation Part|Disease progression|0|||
147397318|NCT01999972|531620748|FG005|Dose Escalation Part|Disease progression|0|||
147397319|NCT01999972|531620743|FG000|Dose Escalation Part|Adverse Event|0|||
147397320|NCT01999972|531620744|FG001|Dose Escalation Part|Adverse Event|0|||
147397321|NCT01999972|531620745|FG002|Dose Escalation Part|Adverse Event|0|||
147397322|NCT01999972|531620746|FG003|Dose Escalation Part|Adverse Event|2|||
147397323|NCT01999972|531620747|FG004|Dose Escalation Part|Adverse Event|0|||
147397324|NCT01999972|531620748|FG005|Dose Escalation Part|Adverse Event|0|||
147397325|NCT01999972|531620743|FG000|Dose Escalation Part|Global deterioration of health status|1|||
147397326|NCT01999972|531620744|FG001|Dose Escalation Part|Global deterioration of health status|0|||
147397327|NCT01999972|531620745|FG002|Dose Escalation Part|Global deterioration of health status|0|||
147397328|NCT01999972|531620746|FG003|Dose Escalation Part|Global deterioration of health status|1|||
147397329|NCT01999972|531620747|FG004|Dose Escalation Part|Global deterioration of health status|0|||
147397330|NCT01999972|531620748|FG005|Dose Escalation Part|Global deterioration of health status|0|||
147397331|NCT01999972|531620743|FG000|Dose Expansion Part|Death|0|||
147397332|NCT01999972|531620744|FG001|Dose Expansion Part|Death|0|||
147397333|NCT01999972|531620745|FG002|Dose Expansion Part|Death|0|||
147397334|NCT01999972|531620746|FG003|Dose Expansion Part|Death|0|||
147397335|NCT01999972|531620747|FG004|Dose Expansion Part|Death|2|||
147397336|NCT01999972|531620748|FG005|Dose Expansion Part|Death|1|||
147397337|NCT01999972|531620743|FG000|Dose Expansion Part|Disease progression|0|||
147397338|NCT01999972|531620744|FG001|Dose Expansion Part|Disease progression|0|||
147397339|NCT01999972|531620745|FG002|Dose Expansion Part|Disease progression|0|||
147397340|NCT01999972|531620746|FG003|Dose Expansion Part|Disease progression|0|||
147397341|NCT01999972|531620747|FG004|Dose Expansion Part|Disease progression|9|||
147397342|NCT01999972|531620748|FG005|Dose Expansion Part|Disease progression|3|||
147397343|NCT01999972|531620743|FG000|Dose Expansion Part|Sponsor decision|0|||
147397344|NCT01999972|531620744|FG001|Dose Expansion Part|Sponsor decision|0|||
147397345|NCT01999972|531620745|FG002|Dose Expansion Part|Sponsor decision|0|||
147397346|NCT01999972|531620746|FG003|Dose Expansion Part|Sponsor decision|0|||
147397347|NCT01999972|531620747|FG004|Dose Expansion Part|Sponsor decision|1|||
147397348|NCT01999972|531620748|FG005|Dose Expansion Part|Sponsor decision|0|||
147397349|NCT01999972|531620743|FG000|Dose Expansion Part|Adverse Event|0|||
147397350|NCT01999972|531620744|FG001|Dose Expansion Part|Adverse Event|0|||
147397351|NCT01999972|531620745|FG002|Dose Expansion Part|Adverse Event|0|||
147397352|NCT01999972|531620746|FG003|Dose Expansion Part|Adverse Event|0|||
147397353|NCT01999972|531620747|FG004|Dose Expansion Part|Adverse Event|4|||
147397354|NCT01999972|531620748|FG005|Dose Expansion Part|Adverse Event|2|||
147397355|NCT01999972|531620743|FG000|Dose Expansion Part|Participant's non-compliance|0|||
147397356|NCT01999972|531620744|FG001|Dose Expansion Part|Participant's non-compliance|0|||
147397357|NCT01999972|531620745|FG002|Dose Expansion Part|Participant's non-compliance|0|||
147397358|NCT01999972|531620746|FG003|Dose Expansion Part|Participant's non-compliance|0|||
147397359|NCT01999972|531620747|FG004|Dose Expansion Part|Participant's non-compliance|0|||
147397360|NCT01999972|531620748|FG005|Dose Expansion Part|Participant's non-compliance|1|||
147397361|NCT01999972|531620743|FG000|Dose Expansion Part|Participant refused further follow-up|0|||
147397362|NCT01999972|531620744|FG001|Dose Expansion Part|Participant refused further follow-up|0|||
147397363|NCT01999972|531620745|FG002|Dose Expansion Part|Participant refused further follow-up|0|||
147397364|NCT01999972|531620746|FG003|Dose Expansion Part|Participant refused further follow-up|0|||
147397365|NCT01999972|531620747|FG004|Dose Expansion Part|Participant refused further follow-up|4|||
147397366|NCT01999972|531620748|FG005|Dose Expansion Part|Participant refused further follow-up|0|||
147397367|NCT01999972|531620743|FG000|Dose Expansion Part|Changed to standard of care|0|||
147397368|NCT01999972|531620744|FG001|Dose Expansion Part|Changed to standard of care|0|||
147397369|NCT01999972|531620745|FG002|Dose Expansion Part|Changed to standard of care|0|||
147397370|NCT01999972|531620746|FG003|Dose Expansion Part|Changed to standard of care|0|||
147397371|NCT01999972|531620747|FG004|Dose Expansion Part|Changed to standard of care|1|||
147397372|NCT01999972|531620748|FG005|Dose Expansion Part|Changed to standard of care|0|||
147397373|NCT02210208|531620749|FG000|Period A (Graft Site)|Withdrawal by Subject|1|||
147461021|NCT01014585|531849425|FG001|Overall Study|Withdrawal by Subject|0|||
147461022|NCT01014585|531849426|FG002|Overall Study|Withdrawal by Subject|1|||
147461023|NCT01014585|531849427|FG003|Overall Study|Withdrawal by Subject|3|||
147461024|NCT01014585|531849424|FG000|Overall Study|Lost to Follow-up|0|||
147461025|NCT01014585|531849425|FG001|Overall Study|Lost to Follow-up|0|||
147397374|NCT02210208|531620749|FG000|Period A (Graft Site)|Physician decided not to graft at OR|1|||
147397375|NCT02210208|531620749|FG000|Period B (Donor Site)|7 subjects healed at or before Day 14|7|||
147397376|NCT01171183|531620750|FG000|Residential Facility (Weeks 1-2)|Withdrawal by Subject|2|||
147397377|NCT01171183|531620751|FG001|Residential Facility (Weeks 1-2)|Withdrawal by Subject|2|||
147397378|NCT01171183|531620750|FG000|Residential Facility (Weeks 1-2)|Protocol Violation|0|||
147461026|NCT01014585|531849426|FG002|Overall Study|Lost to Follow-up|0|||
147397379|NCT01171183|531620751|FG001|Residential Facility (Weeks 1-2)|Protocol Violation|1|||
147397380|NCT01171183|531620750|FG000|Residential Facility (Weeks 1-2)|BP outside of study parameters|0|||
147397381|NCT01171183|531620751|FG001|Residential Facility (Weeks 1-2)|BP outside of study parameters|3|||
147397382|NCT01171183|531620750|FG000|Outpatient Participation (Weeks 3-10)|Withdrawal by Subject|2|||
147397383|NCT01171183|531620751|FG001|Outpatient Participation (Weeks 3-10)|Withdrawal by Subject|2|||
147397384|NCT01171183|531620750|FG000|Outpatient Participation (Weeks 3-10)|Lost to Follow-up|7|||
147397385|NCT01171183|531620751|FG001|Outpatient Participation (Weeks 3-10)|Lost to Follow-up|3|||
147397386|NCT01171183|531620750|FG000|Outpatient Participation (Weeks 3-10)|Use of contraindicated med: PI term|1|||
147397387|NCT01171183|531620751|FG001|Outpatient Participation (Weeks 3-10)|Use of contraindicated med: PI term|0|||
147397388|NCT01101334|531620752|FG000|Overall Study|Adverse Event|9|||
147397389|NCT01101334|531620753|FG001|Overall Study|Adverse Event|4|||
147397390|NCT01101334|531620752|FG000|Overall Study|Death|7|||
147397391|NCT01101334|531620753|FG001|Overall Study|Death|1|||
147397392|NCT01101334|531620752|FG000|Overall Study|Withdrawal by Subject|4|||
147397393|NCT01101334|531620753|FG001|Overall Study|Withdrawal by Subject|3|||
147397394|NCT01101334|531620752|FG000|Overall Study|Withdrawal by Sponsor|1|||
147397395|NCT01101334|531620753|FG001|Overall Study|Withdrawal by Sponsor|1|||
147397396|NCT01101334|531620752|FG000|Overall Study|Progressive Disease|22|||
147397397|NCT01101334|531620753|FG001|Overall Study|Progressive Disease|35|||
147397398|NCT01101334|531620752|FG000|Overall Study|Other|2|||
147397399|NCT01101334|531620753|FG001|Overall Study|Other|1|||
147397400|NCT03440047|531620754|FG000|Overall Study|Withdrawal by Subject|2|||
147397401|NCT01181609|531620755|FG000|Overall Study|Adverse Event|1|||
147397402|NCT01181609|531620755|FG000|Overall Study|Withdrawal by Subject|1|||
147397403|NCT01181609|531620755|FG000|Overall Study|Lost to Follow-up|1|||
147397404|NCT01181609|531620755|FG000|Overall Study|Death|50|||
147397405|NCT01722045|531620756|FG000|Overall Study|Adverse Event|8|||
147397406|NCT01722045|531620756|FG000|Overall Study|Death|3|||
147397407|NCT01722045|531620756|FG000|Overall Study|Withdrawal by Subject|8|||
147397408|NCT01722045|531620756|FG000|Overall Study|Lost to Follow-up|4|||
147397409|NCT01722045|531620756|FG000|Overall Study|Protocol Deviation|1|||
147397410|NCT01722045|531620756|FG000|Overall Study|Physician Decision|3|||
147397411|NCT01722045|531620756|FG000|Overall Study|Relocation (did not wish to transfer)|1|||
147397412|NCT00612352|531620757|FG000|Overall Study|Adverse Event|1|||
147397413|NCT00612352|531620758|FG001|Overall Study|Adverse Event|0|||
147397414|NCT00612352|531620757|FG000|Overall Study|Withdrawal by Subject|3|||
147397415|NCT00612352|531620758|FG001|Overall Study|Withdrawal by Subject|5|||
147397416|NCT00612352|531620757|FG000|Overall Study|moved out of state|1|||
147397417|NCT00612352|531620758|FG001|Overall Study|moved out of state|0|||
147397418|NCT00612352|531620757|FG000|Overall Study|didn't return calls/show up on test date|4|||
147397419|NCT00612352|531620758|FG001|Overall Study|didn't return calls/show up on test date|1|||
147397420|NCT02161406|531620759|FG000|Overall Study|Death|2|||
147397421|NCT02161406|531620760|FG001|Overall Study|Death|1|||
147397422|NCT02161406|531620759|FG000|Overall Study|Lost to Follow-up|2|||
147397423|NCT02161406|531620760|FG001|Overall Study|Lost to Follow-up|1|||
147397424|NCT02161406|531620759|FG000|Overall Study|Withdrawal by Subject|2|||
147397425|NCT02161406|531620760|FG001|Overall Study|Withdrawal by Subject|4|||
147397426|NCT02161406|531620759|FG000|Overall Study|investigator withdrew subject|3|||
147397427|NCT02161406|531620760|FG001|Overall Study|investigator withdrew subject|1|||
147397428|NCT02161406|531620759|FG000|Overall Study|Lack of Efficacy|1|||
147397429|NCT02161406|531620760|FG001|Overall Study|Lack of Efficacy|1|||
147397430|NCT02161406|531620759|FG000|Overall Study|relocation|0|||
147397431|NCT02161406|531620760|FG001|Overall Study|relocation|1|||
147397432|NCT00263211|531620763|FG000|Overall Study|Death|1|||
147397433|NCT00263211|531620764|FG001|Overall Study|Death|0|||
147397434|NCT00263211|531620763|FG000|Overall Study|Withdrawal by Subject|3|||
147397435|NCT00263211|531620764|FG001|Overall Study|Withdrawal by Subject|0|||
147397436|NCT00263211|531620763|FG000|Overall Study|Protocol Violation|1|||
147397437|NCT00263211|531620764|FG001|Overall Study|Protocol Violation|0|||
147397438|NCT00263211|531620763|FG000|Overall Study|Disease Progression|0|||
147397439|NCT00263211|531620764|FG001|Overall Study|Disease Progression|1|||
147397440|NCT02034162|531620765|FG000|Double-blind|Lost to Follow-up|3|||
147397441|NCT02034162|531620766|FG001|Double-blind|Lost to Follow-up|0|||
147397442|NCT02034162|531620767|FG002|Double-blind|Lost to Follow-up|0|||
147397443|NCT02034162|531620765|FG000|Double-blind|Physician Decision|1|||
147397444|NCT02034162|531620766|FG001|Double-blind|Physician Decision|0|||
147397445|NCT02034162|531620767|FG002|Double-blind|Physician Decision|0|||
147397446|NCT02034162|531620765|FG000|Double-blind|Protocol Violation|0|||
147397447|NCT02034162|531620766|FG001|Double-blind|Protocol Violation|1|||
147397448|NCT02034162|531620767|FG002|Double-blind|Protocol Violation|0|||
147397449|NCT02034162|531620765|FG000|Double-blind|Withdrawal by Subject|5|||
147397450|NCT02034162|531620766|FG001|Double-blind|Withdrawal by Subject|7|||
147397451|NCT02034162|531620767|FG002|Double-blind|Withdrawal by Subject|0|||
147397452|NCT00760513|531620768|FG000|Overall Study|Withdrawal by Subject|5|||
147397453|NCT00760513|531620769|FG001|Overall Study|Withdrawal by Subject|7|||
147397454|NCT04333147|531620775|FG000|Overall Study|Adverse Event|43|||
147397455|NCT04333147|531620776|FG001|Overall Study|Adverse Event|40|||
147397456|NCT04333147|531620775|FG000|Overall Study|Lack of Efficacy|49|||
147397457|NCT04333147|531620776|FG001|Overall Study|Lack of Efficacy|48|||
147397458|NCT04333147|531620775|FG000|Overall Study|Lost to Follow-up|19|||
147397459|NCT04333147|531620776|FG001|Overall Study|Lost to Follow-up|16|||
147397460|NCT04333147|531620775|FG000|Overall Study|Physician Decision|17|||
147397461|NCT04333147|531620776|FG001|Overall Study|Physician Decision|20|||
147397462|NCT04333147|531620775|FG000|Overall Study|Withdrawal by Subject|65|||
147397463|NCT04333147|531620776|FG001|Overall Study|Withdrawal by Subject|68|||
147397464|NCT04333147|531620775|FG000|Overall Study|INVESTIGATOR SITE CLOSED|6|||
147397465|NCT04333147|531620776|FG001|Overall Study|INVESTIGATOR SITE CLOSED|2|||
147397466|NCT04333147|531620775|FG000|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|6|||
147397467|NCT04333147|531620776|FG001|Overall Study|PROTOCOL-SPECIFIED WITHDRAWAL CRITERION MET|9|||
147397468|NCT04333147|531620775|FG000|Overall Study|STUDY TERMINATED BY SPONSOR|1251|||
147397469|NCT04333147|531620776|FG001|Overall Study|STUDY TERMINATED BY SPONSOR|1256|||
147397470|NCT04606199|531620777|FG000|Overall Study|Withdrawal by Subject|2|||
147397471|NCT03596242|531620778|FG000|Overall Study|Lost to Follow-up|2|||
147397472|NCT03596242|531620779|FG001|Overall Study|Lost to Follow-up|2|||
147397473|NCT00706914|531620780|FG000|Overall Study|Lack of Efficacy|0|||
147397474|NCT00706914|531620781|FG001|Overall Study|Lack of Efficacy|1|||
147397475|NCT00706914|531620782|FG002|Overall Study|Lack of Efficacy|0|||
147397476|NCT00706914|531620780|FG000|Overall Study|Lost to Follow-up|1|||
147397477|NCT00706914|531620781|FG001|Overall Study|Lost to Follow-up|0|||
147397478|NCT00706914|531620782|FG002|Overall Study|Lost to Follow-up|0|||
147397479|NCT00706914|531620780|FG000|Overall Study|Adverse Event|2|||
147397480|NCT00706914|531620781|FG001|Overall Study|Adverse Event|2|||
147397481|NCT00706914|531620782|FG002|Overall Study|Adverse Event|0|||
147397482|NCT00706914|531620780|FG000|Overall Study|Protocol Violation|3|||
147397483|NCT00706914|531620781|FG001|Overall Study|Protocol Violation|1|||
147397484|NCT00706914|531620782|FG002|Overall Study|Protocol Violation|1|||
147397485|NCT00916305|531620783|FG000|Overall Study|Lost to Follow-up|21|||
147397486|NCT00916305|531620784|FG001|Overall Study|Lost to Follow-up|27|||
147397487|NCT00916305|531620783|FG000|Overall Study|Withdrawal by Subject|0|||
147397488|NCT00916305|531620784|FG001|Overall Study|Withdrawal by Subject|1|||
147397489|NCT01475461|531620787|FG000|Run-in Period|Not meet eligibility criteria|16|||
147397490|NCT01475461|531620788|FG001|Run-in Period|Not meet eligibility criteria|0|||
147397491|NCT01475461|531620789|FG002|Run-in Period|Not meet eligibility criteria|0|||
147397492|NCT01475461|531620790|FG003|Run-in Period|Not meet eligibility criteria|0|||
147397493|NCT01475461|531620791|FG004|Run-in Period|Not meet eligibility criteria|0|||
147397494|NCT01475461|531620792|FG005|Run-in Period|Not meet eligibility criteria|0|||
147397495|NCT01475461|531620793|FG006|Run-in Period|Not meet eligibility criteria|0|||
147397496|NCT01475461|531620787|FG000|Run-in Period|Lost to Follow-up|7|||
147397497|NCT01475461|531620788|FG001|Run-in Period|Lost to Follow-up|0|||
147397498|NCT01475461|531620789|FG002|Run-in Period|Lost to Follow-up|0|||
147397499|NCT01475461|531620790|FG003|Run-in Period|Lost to Follow-up|0|||
147397500|NCT01475461|531620791|FG004|Run-in Period|Lost to Follow-up|0|||
147397501|NCT01475461|531620792|FG005|Run-in Period|Lost to Follow-up|0|||
147397502|NCT01475461|531620793|FG006|Run-in Period|Lost to Follow-up|0|||
147397503|NCT01475461|531620787|FG000|Run-in Period|Withdrawal by Subject|11|||
147397504|NCT01475461|531620788|FG001|Run-in Period|Withdrawal by Subject|0|||
147397505|NCT01475461|531620789|FG002|Run-in Period|Withdrawal by Subject|0|||
147397506|NCT01475461|531620790|FG003|Run-in Period|Withdrawal by Subject|0|||
147397507|NCT01475461|531620791|FG004|Run-in Period|Withdrawal by Subject|0|||
147397508|NCT01475461|531620792|FG005|Run-in Period|Withdrawal by Subject|0|||
147397509|NCT01475461|531620793|FG006|Run-in Period|Withdrawal by Subject|0|||
147397510|NCT01475461|531620787|FG000|Run-in Period|Other|3|||
147397511|NCT01475461|531620788|FG001|Run-in Period|Other|0|||
147397512|NCT01475461|531620789|FG002|Run-in Period|Other|0|||
147397513|NCT01475461|531620790|FG003|Run-in Period|Other|0|||
147397514|NCT01475461|531620791|FG004|Run-in Period|Other|0|||
147397515|NCT01475461|531620792|FG005|Run-in Period|Other|0|||
147397516|NCT01475461|531620793|FG006|Run-in Period|Other|0|||
147397517|NCT01475461|531620787|FG000|Run-in Period|Protocol Violation|4|||
147397518|NCT01475461|531620788|FG001|Run-in Period|Protocol Violation|0|||
147397519|NCT01475461|531620789|FG002|Run-in Period|Protocol Violation|0|||
147461027|NCT01014585|531849427|FG003|Overall Study|Lost to Follow-up|2|||
147461028|NCT01014585|531849424|FG000|Overall Study|Withdrawn Due to Worsening Fibromyalgia|18|||
147397520|NCT01475461|531620790|FG003|Run-in Period|Protocol Violation|0|||
147397521|NCT01475461|531620791|FG004|Run-in Period|Protocol Violation|0|||
147397522|NCT01475461|531620792|FG005|Run-in Period|Protocol Violation|0|||
147397523|NCT01475461|531620793|FG006|Run-in Period|Protocol Violation|0|||
147397524|NCT01475461|531620787|FG000|Treatment Period|Death|0|||
147397525|NCT01475461|531620788|FG001|Treatment Period|Death|0|||
147397526|NCT01475461|531620789|FG002|Treatment Period|Death|0|||
147397527|NCT01475461|531620790|FG003|Treatment Period|Death|1|||
147397528|NCT01475461|531620791|FG004|Treatment Period|Death|0|||
147397529|NCT01475461|531620792|FG005|Treatment Period|Death|0|||
147397530|NCT01475461|531620793|FG006|Treatment Period|Death|0|||
147397531|NCT01475461|531620787|FG000|Treatment Period|Lost to Follow-up|0|||
147397532|NCT01475461|531620788|FG001|Treatment Period|Lost to Follow-up|3|||
147397533|NCT01475461|531620789|FG002|Treatment Period|Lost to Follow-up|2|||
147397534|NCT01475461|531620790|FG003|Treatment Period|Lost to Follow-up|3|||
147397535|NCT01475461|531620791|FG004|Treatment Period|Lost to Follow-up|1|||
147397536|NCT01475461|531620792|FG005|Treatment Period|Lost to Follow-up|2|||
147397537|NCT01475461|531620793|FG006|Treatment Period|Lost to Follow-up|1|||
147397538|NCT01475461|531620787|FG000|Treatment Period|Withdrawal by Subject|0|||
147397539|NCT01475461|531620788|FG001|Treatment Period|Withdrawal by Subject|2|||
147397540|NCT01475461|531620789|FG002|Treatment Period|Withdrawal by Subject|2|||
147397541|NCT01475461|531620790|FG003|Treatment Period|Withdrawal by Subject|0|||
147397542|NCT01475461|531620791|FG004|Treatment Period|Withdrawal by Subject|2|||
147397543|NCT01475461|531620792|FG005|Treatment Period|Withdrawal by Subject|2|||
147397544|NCT01475461|531620793|FG006|Treatment Period|Withdrawal by Subject|0|||
147397545|NCT01475461|531620787|FG000|Treatment Period|Other|0|||
147397546|NCT01475461|531620788|FG001|Treatment Period|Other|1|||
147397547|NCT01475461|531620789|FG002|Treatment Period|Other|0|||
147397548|NCT01475461|531620790|FG003|Treatment Period|Other|0|||
147397549|NCT01475461|531620791|FG004|Treatment Period|Other|0|||
147397550|NCT01475461|531620792|FG005|Treatment Period|Other|0|||
147397551|NCT01475461|531620793|FG006|Treatment Period|Other|0|||
147397552|NCT01475461|531620787|FG000|Treatment Period|Protocol Violation|0|||
147397553|NCT01475461|531620788|FG001|Treatment Period|Protocol Violation|1|||
147397554|NCT01475461|531620789|FG002|Treatment Period|Protocol Violation|0|||
147397555|NCT01475461|531620790|FG003|Treatment Period|Protocol Violation|0|||
147397556|NCT01475461|531620791|FG004|Treatment Period|Protocol Violation|0|||
147397557|NCT01475461|531620792|FG005|Treatment Period|Protocol Violation|0|||
147397558|NCT01475461|531620793|FG006|Treatment Period|Protocol Violation|1|||
147397559|NCT01475461|531620787|FG000|Treatment Period|Lack of Efficacy|0|||
147397560|NCT01475461|531620788|FG001|Treatment Period|Lack of Efficacy|2|||
147397561|NCT01475461|531620789|FG002|Treatment Period|Lack of Efficacy|0|||
147397562|NCT01475461|531620790|FG003|Treatment Period|Lack of Efficacy|2|||
147397563|NCT01475461|531620791|FG004|Treatment Period|Lack of Efficacy|1|||
147397564|NCT01475461|531620792|FG005|Treatment Period|Lack of Efficacy|1|||
147397565|NCT01475461|531620793|FG006|Treatment Period|Lack of Efficacy|0|||
147397566|NCT01475461|531620787|FG000|Treatment Period|Medication Error|0|||
147397567|NCT01475461|531620788|FG001|Treatment Period|Medication Error|0|||
147397568|NCT01475461|531620789|FG002|Treatment Period|Medication Error|0|||
147397569|NCT01475461|531620790|FG003|Treatment Period|Medication Error|1|||
147397570|NCT01475461|531620791|FG004|Treatment Period|Medication Error|0|||
147397571|NCT01475461|531620792|FG005|Treatment Period|Medication Error|0|||
147397572|NCT01475461|531620793|FG006|Treatment Period|Medication Error|0|||
147397573|NCT01475461|531620787|FG000|Treatment Period|Adverse Event|0|||
147397574|NCT01475461|531620788|FG001|Treatment Period|Adverse Event|0|||
147397575|NCT01475461|531620789|FG002|Treatment Period|Adverse Event|0|||
147397576|NCT01475461|531620790|FG003|Treatment Period|Adverse Event|1|||
147397577|NCT01475461|531620791|FG004|Treatment Period|Adverse Event|0|||
147397578|NCT01475461|531620792|FG005|Treatment Period|Adverse Event|0|||
147397579|NCT01475461|531620793|FG006|Treatment Period|Adverse Event|0|||
147397580|NCT04035577|531620800|FG000|Overall Study|Lost to Follow-up|1|||
147397581|NCT04035577|531620800|FG000|Overall Study|Withdrawal by Subject|1|||
147397582|NCT00505414|531620802|FG000|Titration Phase|Adverse Event|0|||
147397583|NCT00505414|531620803|FG001|Titration Phase|Adverse Event|0|||
147397584|NCT00505414|531620804|FG002|Titration Phase|Adverse Event|0|||
147397585|NCT00505414|531620805|FG003|Titration Phase|Adverse Event|8|||
147397586|NCT00505414|531620806|FG004|Titration Phase|Adverse Event|3|||
147397587|NCT00505414|531620802|FG000|Titration Phase|Death|0|||
147397588|NCT00505414|531620803|FG001|Titration Phase|Death|0|||
147397589|NCT00505414|531620804|FG002|Titration Phase|Death|0|||
147397590|NCT00505414|531620805|FG003|Titration Phase|Death|2|||
147397591|NCT00505414|531620806|FG004|Titration Phase|Death|0|||
147397592|NCT00505414|531620802|FG000|Titration Phase|Lack of Efficacy|0|||
147397593|NCT00505414|531620803|FG001|Titration Phase|Lack of Efficacy|0|||
147397594|NCT00505414|531620804|FG002|Titration Phase|Lack of Efficacy|0|||
147397595|NCT00505414|531620805|FG003|Titration Phase|Lack of Efficacy|10|||
147397596|NCT00505414|531620806|FG004|Titration Phase|Lack of Efficacy|1|||
147397597|NCT00505414|531620802|FG000|Titration Phase|Protocol Violation|0|||
147397598|NCT00505414|531620803|FG001|Titration Phase|Protocol Violation|0|||
147397599|NCT00505414|531620804|FG002|Titration Phase|Protocol Violation|0|||
147397600|NCT00505414|531620805|FG003|Titration Phase|Protocol Violation|0|||
147397601|NCT00505414|531620806|FG004|Titration Phase|Protocol Violation|1|||
147397602|NCT00505414|531620802|FG000|Titration Phase|Withdrawal by Subject|0|||
147397603|NCT00505414|531620803|FG001|Titration Phase|Withdrawal by Subject|0|||
147397604|NCT00505414|531620804|FG002|Titration Phase|Withdrawal by Subject|0|||
147397605|NCT00505414|531620805|FG003|Titration Phase|Withdrawal by Subject|3|||
147397606|NCT00505414|531620806|FG004|Titration Phase|Withdrawal by Subject|4|||
147397607|NCT00505414|531620802|FG000|Titration Phase|Underlying disease and therapy required|0|||
147397608|NCT00505414|531620803|FG001|Titration Phase|Underlying disease and therapy required|0|||
147397609|NCT00505414|531620804|FG002|Titration Phase|Underlying disease and therapy required|0|||
147397610|NCT00505414|531620805|FG003|Titration Phase|Underlying disease and therapy required|7|||
147397611|NCT00505414|531620806|FG004|Titration Phase|Underlying disease and therapy required|3|||
147397612|NCT00505414|531620802|FG000|Maintenance Phase|Adverse Event|2|||
147397613|NCT00505414|531620803|FG001|Maintenance Phase|Adverse Event|2|||
147397614|NCT00505414|531620804|FG002|Maintenance Phase|Adverse Event|3|||
147397615|NCT00505414|531620805|FG003|Maintenance Phase|Adverse Event|0|||
147397616|NCT00505414|531620806|FG004|Maintenance Phase|Adverse Event|0|||
147397617|NCT00505414|531620802|FG000|Maintenance Phase|Death|2|||
147397618|NCT00505414|531620803|FG001|Maintenance Phase|Death|0|||
147397619|NCT00505414|531620804|FG002|Maintenance Phase|Death|1|||
147397620|NCT00505414|531620805|FG003|Maintenance Phase|Death|0|||
147397621|NCT00505414|531620806|FG004|Maintenance Phase|Death|0|||
147397622|NCT00505414|531620802|FG000|Maintenance Phase|Lack of Efficacy|2|||
147397623|NCT00505414|531620803|FG001|Maintenance Phase|Lack of Efficacy|1|||
147397624|NCT00505414|531620804|FG002|Maintenance Phase|Lack of Efficacy|1|||
147397625|NCT00505414|531620805|FG003|Maintenance Phase|Lack of Efficacy|0|||
147397626|NCT00505414|531620806|FG004|Maintenance Phase|Lack of Efficacy|0|||
147397627|NCT00505414|531620802|FG000|Maintenance Phase|Withdrawal by Subject|0|||
147397628|NCT00505414|531620803|FG001|Maintenance Phase|Withdrawal by Subject|0|||
147397629|NCT00505414|531620804|FG002|Maintenance Phase|Withdrawal by Subject|1|||
147397630|NCT00505414|531620805|FG003|Maintenance Phase|Withdrawal by Subject|0|||
147397631|NCT00505414|531620806|FG004|Maintenance Phase|Withdrawal by Subject|0|||
147397632|NCT00505414|531620802|FG000|Maintenance Phase|underlying disease and therapy required|0|||
147397633|NCT00505414|531620803|FG001|Maintenance Phase|underlying disease and therapy required|2|||
147397634|NCT00505414|531620804|FG002|Maintenance Phase|underlying disease and therapy required|2|||
147397635|NCT00505414|531620805|FG003|Maintenance Phase|underlying disease and therapy required|0|||
147397636|NCT00505414|531620806|FG004|Maintenance Phase|underlying disease and therapy required|0|||
147397637|NCT00846768|531620807|FG000|Overall Study|Adverse Event|0|||
147397638|NCT00846768|531620808|FG001|Overall Study|Adverse Event|1|||
147397639|NCT00846768|531620809|FG002|Overall Study|Adverse Event|0|||
147397640|NCT00846768|531620810|FG003|Overall Study|Adverse Event|0|||
147397641|NCT04353817|531620811|FG000|Overall Study|Adverse Event|0|||
147397642|NCT04353817|531620812|FG001|Overall Study|Adverse Event|1|||
147397643|NCT04358068|531620813|FG000|Overall Study|Did not initiate study treatment|2|||
147397644|NCT04358068|531620814|FG001|Overall Study|Did not initiate study treatment|2|||
147397645|NCT00338949|531620815|FG000|Subject Screening|Screen failures|11|||
147397646|NCT00338949|531620816|FG001|Subject Screening|Screen failures|11|||
147397647|NCT00338949|531620815|FG000|Randomization|Withdrawal by Subject|1|||
147397648|NCT00338949|531620816|FG001|Randomization|Withdrawal by Subject|0|||
147397649|NCT00338949|531620815|FG000|Randomization|Adverse Event|0|||
147397650|NCT00338949|531620816|FG001|Randomization|Adverse Event|5|||
147397651|NCT01841112|531620818|FG000|Single Dose Segment (Day 1)|Not Treated|1|||
147397652|NCT01841112|531620819|FG001|Single Dose Segment (Day 1)|Not Treated|1|||
147397653|NCT01841112|531620820|FG002|Single Dose Segment (Day 1)|Not Treated|1|||
147397654|NCT01841112|531620821|FG003|Single Dose Segment (Day 1)|Not Treated|0|||
147397655|NCT01841112|531620822|FG004|Single Dose Segment (Day 1)|Not Treated|0|||
147397656|NCT00878553|531620823|FG000|Sleep Study|Withdrawal by Subject|2|||
147397657|NCT00878553|531620824|FG001|Sleep Study|Withdrawal by Subject|0|||
147397658|NCT00878553|531620825|FG002|Sleep Study|Withdrawal by Subject|0|||
147397659|NCT00878553|531620826|FG003|Sleep Study|Withdrawal by Subject|0|||
147397660|NCT00878553|531620827|FG004|Sleep Study|Withdrawal by Subject|0|||
147397661|NCT00878553|531620823|FG000|Sleep Study|Lost to Follow-up|1|||
147397662|NCT00878553|531620824|FG001|Sleep Study|Lost to Follow-up|0|||
147397663|NCT00878553|531620825|FG002|Sleep Study|Lost to Follow-up|0|||
147397664|NCT00878553|531620826|FG003|Sleep Study|Lost to Follow-up|0|||
147397665|NCT00878553|531620827|FG004|Sleep Study|Lost to Follow-up|0|||
147397666|NCT00878553|531620823|FG000|Sleep Study|car accident|1|||
147397667|NCT00878553|531620824|FG001|Sleep Study|car accident|0|||
147397668|NCT00878553|531620825|FG002|Sleep Study|car accident|0|||
147397669|NCT00878553|531620826|FG003|Sleep Study|car accident|0|||
147397670|NCT00878553|531620827|FG004|Sleep Study|car accident|0|||
147461029|NCT01014585|531849425|FG001|Overall Study|Withdrawn Due to Worsening Fibromyalgia|23|||
147461030|NCT01014585|531849426|FG002|Overall Study|Withdrawn Due to Worsening Fibromyalgia|22|||
147397671|NCT00878553|531620823|FG000|Sleep Study|family emergency|1|||
147397672|NCT00878553|531620824|FG001|Sleep Study|family emergency|0|||
147397673|NCT00878553|531620825|FG002|Sleep Study|family emergency|0|||
147397674|NCT00878553|531620826|FG003|Sleep Study|family emergency|0|||
147397675|NCT00878553|531620827|FG004|Sleep Study|family emergency|0|||
147397676|NCT00878553|531620823|FG000|PK Study|Withdrawal by Subject|0|||
147461031|NCT01014585|531849427|FG003|Overall Study|Withdrawn Due to Worsening Fibromyalgia|22|||
147461032|NCT02154425|531849428|FG000|Screening Period|Adverse Event|1|||
147461033|NCT02211261|531849429|FG000|Overall Study|Withdrawal by Subject|0|||
147397677|NCT00878553|531620824|FG001|PK Study|Withdrawal by Subject|0|||
147397678|NCT00878553|531620825|FG002|PK Study|Withdrawal by Subject|0|||
147397679|NCT00878553|531620826|FG003|PK Study|Withdrawal by Subject|1|||
147397680|NCT00878553|531620827|FG004|PK Study|Withdrawal by Subject|0|||
147397681|NCT02143063|531620828|FG000|Overall Study|Lost to Follow-up|16|||
147397682|NCT02143063|531620829|FG001|Overall Study|Lost to Follow-up|28|||
147397683|NCT02143063|531620830|FG002|Overall Study|Lost to Follow-up|29|||
147397684|NCT02143063|531620828|FG000|Overall Study|Withdrawal by Subject|0|||
147397685|NCT02143063|531620829|FG001|Overall Study|Withdrawal by Subject|1|||
147397686|NCT02143063|531620830|FG002|Overall Study|Withdrawal by Subject|0|||
147397687|NCT02143063|531620828|FG000|Overall Study|Death|0|||
147397688|NCT02143063|531620829|FG001|Overall Study|Death|1|||
147397689|NCT02143063|531620830|FG002|Overall Study|Death|1|||
147397690|NCT02062645|531620833|FG000|Overall Study|Adverse Event|2|||
147397691|NCT02062645|531620833|FG000|Overall Study|Protocol Violation|8|||
147397692|NCT02062645|531620833|FG000|Overall Study|Lost to Follow-up|5|||
147397693|NCT00461123|531620834|FG000|Overall Study|Adverse Event|1|||
147397694|NCT00461123|531620835|FG001|Overall Study|Adverse Event|0|||
147397695|NCT00461123|531620834|FG000|Overall Study|Lost to Follow-up|1|||
147397696|NCT00461123|531620835|FG001|Overall Study|Lost to Follow-up|1|||
147397697|NCT00461123|531620834|FG000|Overall Study|Protocol Violation|3|||
147397698|NCT00461123|531620835|FG001|Overall Study|Protocol Violation|2|||
147397699|NCT00461123|531620834|FG000|Overall Study|Withdrawal by Subject|1|||
147397700|NCT00461123|531620835|FG001|Overall Study|Withdrawal by Subject|3|||
147397701|NCT02604342|531620836|FG000|Overall Study|Death|32|||
147397702|NCT02604342|531620837|FG001|Overall Study|Death|16|||
147397703|NCT02604342|531620836|FG000|Overall Study|Progression of disease|1|||
147397704|NCT02604342|531620837|FG001|Overall Study|Progression of disease|0|||
147397705|NCT02604342|531620836|FG000|Overall Study|Withdrawal by Subject|5|||
147397706|NCT02604342|531620837|FG001|Overall Study|Withdrawal by Subject|6|||
147397707|NCT02604342|531620836|FG000|Overall Study|Other|1|||
147397708|NCT02604342|531620837|FG001|Overall Study|Other|0|||
147397709|NCT02604342|531620836|FG000|Overall Study|Study Termination by Sponsor|1|||
147397710|NCT02604342|531620837|FG001|Overall Study|Study Termination by Sponsor|0|||
147397711|NCT02604342|531620836|FG000|Overall Study|Lost to Follow-up|1|||
147397712|NCT02604342|531620837|FG001|Overall Study|Lost to Follow-up|1|||
147397713|NCT02604342|531620836|FG000|Overall Study|Physician Decision|2|||
147397714|NCT02604342|531620837|FG001|Overall Study|Physician Decision|0|||
147397715|NCT02024750|531620838|FG000|Overall Study|Withdrawal by Subject|2|||
147397716|NCT02024750|531620839|FG001|Overall Study|Withdrawal by Subject|1|||
147397717|NCT01891890|531620841|FG000|Overall Study|Lost to Follow-up|0|||
147397718|NCT01891890|531620842|FG001|Overall Study|Lost to Follow-up|0|||
147397719|NCT01891890|531620843|FG002|Overall Study|Lost to Follow-up|1|||
147397720|NCT01891890|531620841|FG000|Overall Study|Study ended before endpoint reached|7|||
147397721|NCT01891890|531620842|FG001|Overall Study|Study ended before endpoint reached|3|||
147397722|NCT01891890|531620843|FG002|Overall Study|Study ended before endpoint reached|6|||
147397723|NCT01161628|531620844|FG000|Overall Study|Death|6|||
147397724|NCT01161628|531620844|FG000|Overall Study|Lack of Efficacy|2|||
147397725|NCT00770588|531620852|FG000|Overall Study|Adverse Event|9|||
147397726|NCT00770588|531620853|FG001|Overall Study|Adverse Event|2|||
147397727|NCT00770588|531620852|FG000|Overall Study|Death caused by progression of disease|70|||
147397728|NCT00770588|531620853|FG001|Overall Study|Death caused by progression of disease|91|||
147397729|NCT00770588|531620852|FG000|Overall Study|Lost to Follow-up|1|||
147397730|NCT00770588|531620853|FG001|Overall Study|Lost to Follow-up|1|||
147397731|NCT00770588|531620852|FG000|Overall Study|Withdrawal by Subject|1|||
147397732|NCT00770588|531620853|FG001|Overall Study|Withdrawal by Subject|1|||
147397733|NCT01220856|531620856|FG000|Overall Study|graft loss|3|||
147397734|NCT01220856|531620857|FG001|Overall Study|graft loss|3|||
147397735|NCT01220856|531620856|FG000|Overall Study|Lost to Follow-up|1|||
147397736|NCT01220856|531620857|FG001|Overall Study|Lost to Follow-up|0|||
147397737|NCT00361842|531620858|FG000|Overall Study|Withdrawal by Subject|2|||
147397738|NCT00361842|531620859|FG001|Overall Study|Withdrawal by Subject|3|||
147397739|NCT00361842|531620858|FG000|Overall Study|Death|2|||
147397740|NCT00361842|531620859|FG001|Overall Study|Death|1|||
147397741|NCT00361842|531620858|FG000|Overall Study|Disease progression|19|||
147397742|NCT00361842|531620859|FG001|Overall Study|Disease progression|20|||
147397743|NCT00361842|531620858|FG000|Overall Study|Adverse Event|2|||
147397744|NCT00361842|531620859|FG001|Overall Study|Adverse Event|3|||
147397745|NCT00361842|531620858|FG000|Overall Study|Occurrence of unacceptable toxicity|1|||
147397746|NCT00361842|531620859|FG001|Overall Study|Occurrence of unacceptable toxicity|5|||
147397747|NCT00361842|531620858|FG000|Overall Study|Other|1|||
147397748|NCT00361842|531620859|FG001|Overall Study|Other|0|||
147397749|NCT00361842|531620858|FG000|Overall Study|Other|0|||
147461034|NCT02211261|531849430|FG001|Overall Study|Withdrawal by Subject|0|||
147461035|NCT02211261|531849431|FG002|Overall Study|Withdrawal by Subject|1|||
147665192|NCT00919633|532598066|FG000|Overall Study|Death|0|||
147397750|NCT00361842|531620859|FG001|Overall Study|Other|2|||
147397751|NCT04206384|531620860|FG000|Overall Study|Withdrawal by Subject|8|||
147397752|NCT04206384|531620860|FG000|Overall Study|Adverse Event|2|||
147397753|NCT02212197|531620861|FG000|Overall Study|Need for radiotherapy|1|||
147665193|NCT00919633|532598067|FG001|Overall Study|Death|0|||
147461036|NCT02211261|531849432|FG003|Overall Study|Withdrawal by Subject|0|||
147397754|NCT02212197|531620862|FG001|Overall Study|Need for radiotherapy|0|||
147397755|NCT02212197|531620863|FG002|Overall Study|Need for radiotherapy|0|||
147397756|NCT03015181|531620864|FG000|Overall Study|Enrolled, but product never administered|1|||
147397757|NCT03015181|531620865|FG001|Overall Study|Enrolled, but product never administered|0|||
147665194|NCT00919633|532598068|FG002|Overall Study|Death|2|||
147397758|NCT03015181|531620866|FG002|Overall Study|Enrolled, but product never administered|0|||
147397759|NCT03015181|531620867|FG003|Overall Study|Enrolled, but product never administered|0|||
147397760|NCT03015181|531620868|FG004|Overall Study|Enrolled, but product never administered|0|||
147397761|NCT03015181|531620869|FG005|Overall Study|Enrolled, but product never administered|0|||
147397762|NCT03015181|531620870|FG006|Overall Study|Enrolled, but product never administered|0|||
147397763|NCT03015181|531620864|FG000|Overall Study|Withdrawal by Subject|0|||
147397764|NCT03015181|531620865|FG001|Overall Study|Withdrawal by Subject|0|||
147397765|NCT03015181|531620866|FG002|Overall Study|Withdrawal by Subject|0|||
147397766|NCT03015181|531620867|FG003|Overall Study|Withdrawal by Subject|0|||
147397767|NCT03015181|531620868|FG004|Overall Study|Withdrawal by Subject|0|||
147397768|NCT03015181|531620869|FG005|Overall Study|Withdrawal by Subject|1|||
147397769|NCT03015181|531620870|FG006|Overall Study|Withdrawal by Subject|0|||
147397770|NCT03015181|531620864|FG000|Overall Study|Physician Decision|0|||
147397771|NCT03015181|531620865|FG001|Overall Study|Physician Decision|0|||
147397772|NCT03015181|531620866|FG002|Overall Study|Physician Decision|0|||
147397773|NCT03015181|531620867|FG003|Overall Study|Physician Decision|0|||
147397774|NCT03015181|531620868|FG004|Overall Study|Physician Decision|0|||
147397775|NCT03015181|531620869|FG005|Overall Study|Physician Decision|0|||
147397776|NCT03015181|531620870|FG006|Overall Study|Physician Decision|1|||
147397777|NCT01077622|531620872|FG000|Overall Study|Physician Decision|2|||
147397778|NCT01077622|531620872|FG000|Overall Study|Withdrawal by Subject|1|||
147397779|NCT01260142|531620873|FG000|Treatment Period 1|Study on hold|1|||
147397780|NCT01260142|531620874|FG001|Treatment Period 1|Study on hold|1|||
147397781|NCT01260142|531620875|FG002|Treatment Period 1|Study on hold|0|||
147397782|NCT01260142|531620876|FG003|Treatment Period 1|Study on hold|0|||
147397783|NCT01260142|531620877|FG004|Treatment Period 1|Study on hold|1|||
147397784|NCT01260142|531620878|FG005|Treatment Period 1|Study on hold|2|||
147397785|NCT01260142|531620873|FG000|Treatment Period 1|Unexplained elevated sys. BP|0|||
147397786|NCT01260142|531620874|FG001|Treatment Period 1|Unexplained elevated sys. BP|0|||
147397787|NCT01260142|531620875|FG002|Treatment Period 1|Unexplained elevated sys. BP|0|||
147397788|NCT01260142|531620876|FG003|Treatment Period 1|Unexplained elevated sys. BP|0|||
147397789|NCT01260142|531620877|FG004|Treatment Period 1|Unexplained elevated sys. BP|1|||
147397790|NCT01260142|531620878|FG005|Treatment Period 1|Unexplained elevated sys. BP|0|||
147397791|NCT01260142|531620873|FG000|Treatment Period 1|Withdrawal by Subject|0|||
147397792|NCT01260142|531620874|FG001|Treatment Period 1|Withdrawal by Subject|0|||
147397793|NCT01260142|531620875|FG002|Treatment Period 1|Withdrawal by Subject|0|||
147397794|NCT01260142|531620876|FG003|Treatment Period 1|Withdrawal by Subject|0|||
147397795|NCT01260142|531620877|FG004|Treatment Period 1|Withdrawal by Subject|0|||
147397796|NCT01260142|531620878|FG005|Treatment Period 1|Withdrawal by Subject|1|||
147397797|NCT00496834|531620887|FG000|Overall Study|Withdrawal by Subject|4|||
147397798|NCT00496834|531620888|FG001|Overall Study|Withdrawal by Subject|6|||
147397799|NCT00496834|531620887|FG000|Overall Study|Contraindicated medication administered|0|||
147397800|NCT00496834|531620888|FG001|Overall Study|Contraindicated medication administered|1|||
147397801|NCT00496834|531620887|FG000|Overall Study|Inclusion/exclusion criteria not met|3|||
147397802|NCT00496834|531620888|FG001|Overall Study|Inclusion/exclusion criteria not met|2|||
147397803|NCT00496834|531620887|FG000|Overall Study|Adverse Event|5|||
147397804|NCT00496834|531620888|FG001|Overall Study|Adverse Event|3|||
147397805|NCT00496834|531620887|FG000|Overall Study|IP administration violation|2|||
147397806|NCT00496834|531620888|FG001|Overall Study|IP administration violation|0|||
147397807|NCT00496834|531620887|FG000|Overall Study|Lost to Follow-up|2|||
147397808|NCT00496834|531620888|FG001|Overall Study|Lost to Follow-up|0|||
147397809|NCT00496834|531620887|FG000|Overall Study|Blood Pressure control failure|2|||
147397810|NCT00496834|531620888|FG001|Overall Study|Blood Pressure control failure|1|||
147397811|NCT01503164|531620889|FG000|Overall Study|Withdrawal by Subject|2|||
147397812|NCT01503164|531620890|FG001|Overall Study|Withdrawal by Subject|1|||
147397813|NCT04088136|531620893|FG000|Overall Study|Withdrawal by Subject|5|||
147397814|NCT04088136|531620894|FG001|Overall Study|Withdrawal by Subject|0|||
147397815|NCT04088136|531620893|FG000|Overall Study|Lack of Efficacy|0|||
147397816|NCT04088136|531620894|FG001|Overall Study|Lack of Efficacy|1|||
147397817|NCT01177228|531620895|FG000|Overall Study|Positive tuberculosis test|0|||
147397818|NCT01177228|531620896|FG001|Overall Study|Positive tuberculosis test|1|||
147397819|NCT01177228|531620897|FG002|Overall Study|Positive tuberculosis test|0|||
147397820|NCT01177228|531620898|FG003|Overall Study|Positive tuberculosis test|0|||
147461037|NCT02211261|531849433|FG004|Overall Study|Withdrawal by Subject|2|||
147397821|NCT01177228|531620895|FG000|Overall Study|Worsening disease activity|1|||
147397822|NCT01177228|531620896|FG001|Overall Study|Worsening disease activity|0|||
147397823|NCT01177228|531620897|FG002|Overall Study|Worsening disease activity|0|||
147397824|NCT01177228|531620898|FG003|Overall Study|Worsening disease activity|0|||
147397825|NCT01177228|531620895|FG000|Overall Study|Withdrawal by Subject|0|||
147461038|NCT02211261|531849434|FG005|Overall Study|Withdrawal by Subject|0|||
147397826|NCT01177228|531620896|FG001|Overall Study|Withdrawal by Subject|1|||
147397827|NCT01177228|531620897|FG002|Overall Study|Withdrawal by Subject|0|||
147397828|NCT01177228|531620898|FG003|Overall Study|Withdrawal by Subject|0|||
147461039|NCT02211261|531849435|FG006|Overall Study|Withdrawal by Subject|0|||
147461040|NCT02211261|531849436|FG007|Overall Study|Withdrawal by Subject|0|||
147397829|NCT00356759|531620899|FG000|Overall Study|Death|5|||
147397830|NCT00356759|531620900|FG001|Overall Study|Death|2|||
147397831|NCT00356759|531620899|FG000|Overall Study|Withdrawal by Subject|2|||
147397832|NCT00356759|531620900|FG001|Overall Study|Withdrawal by Subject|2|||
147397833|NCT00356759|531620899|FG000|Overall Study|Adverse Event|1|||
147397834|NCT00356759|531620900|FG001|Overall Study|Adverse Event|3|||
147397835|NCT00356759|531620899|FG000|Overall Study|Lost to Follow-up|1|||
147397836|NCT00356759|531620900|FG001|Overall Study|Lost to Follow-up|1|||
147397837|NCT00356759|531620899|FG000|Overall Study|Intercurrent disease or persistent extre|5|||
147397838|NCT00356759|531620900|FG001|Overall Study|Intercurrent disease or persistent extre|2|||
147397839|NCT04159805|531620901|FG000|Overall Study|Withdrawal by Subject|0|||
147397840|NCT04159805|531620902|FG001|Overall Study|Withdrawal by Subject|2|||
147397841|NCT04159805|531620903|FG002|Overall Study|Withdrawal by Subject|2|||
147397842|NCT03821064|531620904|FG000|Overall Study|did not meet study eligibility criteria of needing adjuvant radiation per NCCN guidelines on path|1|||
147397843|NCT02998918|531620906|FG000|Overall Study|Withdrawal by Subject|1|||
147397844|NCT02998918|531620907|FG001|Overall Study|Withdrawal by Subject|0|||
147397845|NCT02473913|531620908|FG000|Overall Study|Lost to Follow-up|3|||
147397846|NCT02473913|531620909|FG001|Overall Study|Lost to Follow-up|3|||
147397847|NCT00497874|531622739|FG000|Overall Study|Withdrawal by Subject|48|||
147397848|NCT00497874|531622740|FG001|Overall Study|Withdrawal by Subject|17|||
147397849|NCT00497874|531622739|FG000|Overall Study|Illness|8|||
147397850|NCT00497874|531622740|FG001|Overall Study|Illness|4|||
147397851|NCT00497874|531622739|FG000|Overall Study|Death|2|||
147397852|NCT00497874|531622740|FG001|Overall Study|Death|4|||
147397853|NCT00497874|531622739|FG000|Overall Study|Unable to contact|52|||
147397854|NCT00497874|531622740|FG001|Overall Study|Unable to contact|67|||
147397855|NCT00497874|531622739|FG000|Overall Study|Unable to schedule|37|||
147397856|NCT00497874|531622740|FG001|Overall Study|Unable to schedule|24|||
147397857|NCT02826798|531622747|FG000|Overall Study|Withdrawal by Subject|0|||
147397858|NCT02826798|531622748|FG001|Overall Study|Withdrawal by Subject|1|||
147397859|NCT02826798|531622749|FG002|Overall Study|Withdrawal by Subject|0|||
147397860|NCT02826798|531622750|FG003|Overall Study|Withdrawal by Subject|1|||
147397861|NCT02826798|531622751|FG004|Overall Study|Withdrawal by Subject|0|||
147397862|NCT02806505|531622752|FG000|Overall Study|Adverse event/intercurrent illness|1|||
147397863|NCT02806505|531622753|FG001|Overall Study|Adverse event/intercurrent illness|3|||
147397864|NCT02806505|531622752|FG000|Overall Study|Death|4|||
147397865|NCT02806505|531622753|FG001|Overall Study|Death|0|||
147397866|NCT02806505|531622752|FG000|Overall Study|Did not cooperate/refused treatment|3|||
147397867|NCT02806505|531622753|FG001|Overall Study|Did not cooperate/refused treatment|3|||
147397868|NCT02806505|531622752|FG000|Overall Study|Failure to return|0|||
147397869|NCT02806505|531622753|FG001|Overall Study|Failure to return|1|||
147397870|NCT02806505|531622752|FG000|Overall Study|Insufficient therapeutic response|2|||
147397871|NCT02806505|531622753|FG001|Overall Study|Insufficient therapeutic response|4|||
147397872|NCT02820597|531622759|FG000|Overall Study|Lost to Follow-up|12|||
147397873|NCT01053247|531622760|FG000|Overall Study|Withdrawal by Subject|9|||
147397874|NCT01053247|531622761|FG001|Overall Study|Withdrawal by Subject|4|||
147397875|NCT01053247|531622762|FG002|Overall Study|Withdrawal by Subject|15|||
147397876|NCT01053247|531622760|FG000|Overall Study|Lack of Efficacy|1|||
147397877|NCT01053247|531622761|FG001|Overall Study|Lack of Efficacy|0|||
147397878|NCT01053247|531622762|FG002|Overall Study|Lack of Efficacy|1|||
147397879|NCT01053247|531622760|FG000|Overall Study|Protocol Violation|2|||
147397880|NCT01053247|531622761|FG001|Overall Study|Protocol Violation|1|||
147397881|NCT01053247|531622762|FG002|Overall Study|Protocol Violation|2|||
147397882|NCT01053247|531622760|FG000|Overall Study|Lost to Follow-up|8|||
147397883|NCT01053247|531622761|FG001|Overall Study|Lost to Follow-up|5|||
147397884|NCT01053247|531622762|FG002|Overall Study|Lost to Follow-up|7|||
147397885|NCT01053247|531622760|FG000|Overall Study|Adverse Event|0|||
147397886|NCT01053247|531622761|FG001|Overall Study|Adverse Event|9|||
147397887|NCT01053247|531622762|FG002|Overall Study|Adverse Event|3|||
147397888|NCT03458728|531622763|FG000|Overall Study|Adverse Event|1|||
147397889|NCT03458728|531622764|FG001|Overall Study|Adverse Event|0|||
147397890|NCT03458728|531622763|FG000|Overall Study|Physician Decision|1|||
147397891|NCT03458728|531622764|FG001|Overall Study|Physician Decision|0|||
147397892|NCT03458728|531622763|FG000|Overall Study|Progressive disease - clinical assessment|1|||
147397893|NCT03458728|531622764|FG001|Overall Study|Progressive disease - clinical assessment|0|||
147397894|NCT03458728|531622763|FG000|Overall Study|Progressive disease - radiological progression|21|||
147397895|NCT03458728|531622764|FG001|Overall Study|Progressive disease - radiological progression|6|||
147397896|NCT03458728|531622763|FG000|Overall Study|Withdrawal by Subject|0|||
147397897|NCT03458728|531622764|FG001|Overall Study|Withdrawal by Subject|1|||
147397898|NCT00908349|531622770|FG000|Overall Study|Adverse Event|10|||
147397899|NCT00908349|531622770|FG000|Overall Study|Withdrawal by Subject|9|||
147397900|NCT00908349|531622770|FG000|Overall Study|Physician Decision|5|||
147397901|NCT00908349|531622770|FG000|Overall Study|Lost to Follow-up|5|||
147397902|NCT00908349|531622770|FG000|Overall Study|Various|6|||
147397903|NCT00511836|531622776|FG000|Double-blind Period|Lost to Follow-up|1|||
147397904|NCT00511836|531622777|FG001|Double-blind Period|Lost to Follow-up|0|||
147397905|NCT00030823|531622778|FG000|Overall Study|Withdrawal by Subject|1|||
147397906|NCT01755546|531622779|FG000|Screened and Taper (Rollover and DeNovo)|Protocol Violation|1|||
147397907|NCT01755546|531622779|FG000|Screened and Taper (Rollover and DeNovo)|Withdrawal by Subject|3|||
147397908|NCT01755546|531622779|FG000|Screened and Taper (Rollover and DeNovo)|Lost to Follow-up|1|||
147397909|NCT01755546|531622779|FG000|Screened and Taper (Rollover and DeNovo)|Any other reason and screen failures|5|||
147397910|NCT01755546|531622779|FG000|Titration Phase|Adverse Event|11|||
147397911|NCT01755546|531622779|FG000|Titration Phase|Lack of Efficacy|18|||
147397912|NCT01755546|531622779|FG000|Titration Phase|Protocol Violation|9|||
147397913|NCT01755546|531622779|FG000|Titration Phase|Lost to Follow-up|2|||
147397914|NCT01755546|531622779|FG000|Titration Phase|Other and Continuing|22|||
147397915|NCT01755546|531622779|FG000|Titration Phase|Withdrawal by Subject|8|||
147397916|NCT01755546|531622779|FG000|Long Term Treatment|Adverse Event|12|||
147397917|NCT01755546|531622779|FG000|Long Term Treatment|Lack of Efficacy|6|||
147397918|NCT01755546|531622779|FG000|Long Term Treatment|Protocol Violation|10|||
147397919|NCT01755546|531622779|FG000|Long Term Treatment|Withdrawal by Subject|35|||
147397920|NCT01755546|531622779|FG000|Long Term Treatment|Lost to Follow-up|17|||
147397921|NCT01755546|531622779|FG000|Long Term Treatment|other and ongoing|41|||
147397922|NCT01114139|531622780|FG000|Overall Study|Adverse Event|3|||
147397923|NCT01114139|531622781|FG001|Overall Study|Adverse Event|2|||
147397924|NCT01114139|531622780|FG000|Overall Study|Lost to Follow-up|15|||
147397925|NCT01114139|531622781|FG001|Overall Study|Lost to Follow-up|3|||
147397926|NCT01114139|531622780|FG000|Overall Study|Withdrawal by Subject|17|||
147397927|NCT01114139|531622781|FG001|Overall Study|Withdrawal by Subject|6|||
147397928|NCT01114139|531622780|FG000|Overall Study|Other-Missed 1 visit|1|||
147397929|NCT01114139|531622781|FG001|Overall Study|Other-Missed 1 visit|0|||
147397930|NCT01114139|531622780|FG000|Overall Study|Other-Protocol Violation|1|||
147397931|NCT01114139|531622781|FG001|Overall Study|Other-Protocol Violation|0|||
147397932|NCT01114139|531622780|FG000|Overall Study|Other-Out of window for study drug dose|1|||
147397933|NCT01114139|531622781|FG001|Overall Study|Other-Out of window for study drug dose|0|||
147397934|NCT01114139|531622780|FG000|Overall Study|Other-Participant falsified records|0|||
147397935|NCT01114139|531622781|FG001|Overall Study|Other-Participant falsified records|1|||
147397936|NCT01114139|531622780|FG000|Overall Study|Other-Participant went on hospice|0|||
147397937|NCT01114139|531622781|FG001|Overall Study|Other-Participant went on hospice|1|||
147397938|NCT01114139|531622780|FG000|Overall Study|Other-Physician changed treatment|1|||
147397939|NCT01114139|531622781|FG001|Overall Study|Other-Physician changed treatment|0|||
147397940|NCT01114139|531622780|FG000|Overall Study|Other-Withdrew prior to receiving dose|1|||
147397941|NCT01114139|531622781|FG001|Overall Study|Other-Withdrew prior to receiving dose|3|||
147397942|NCT02536742|531622783|FG000|Overall Study|Did not start protocol therapy|1|||
147397943|NCT02536742|531622783|FG000|Overall Study|Patient determined to have triple-negative breast cancer, thus not having the target disease|1|||
147397944|NCT04629443|531622784|FG000|Overall Study|Adverse Event|2|||
147397945|NCT04629443|531622785|FG001|Overall Study|Adverse Event|1|||
147397946|NCT04629443|531622786|FG002|Overall Study|Adverse Event|2|||
147397947|NCT04629443|531622784|FG000|Overall Study|Progressive Disease|2|||
147397948|NCT04629443|531622785|FG001|Overall Study|Progressive Disease|3|||
147397949|NCT04629443|531622786|FG002|Overall Study|Progressive Disease|3|||
147397950|NCT04629443|531622784|FG000|Overall Study|Physician Decision|1|||
147397951|NCT04629443|531622785|FG001|Overall Study|Physician Decision|3|||
147397952|NCT04629443|531622786|FG002|Overall Study|Physician Decision|0|||
147397953|NCT00858247|531622793|FG000|Baseline Assessment|Withdrawal by Subject|1|||
147397954|NCT00858247|531622794|FG001|Baseline Assessment|Withdrawal by Subject|1|||
147397955|NCT00858247|531622793|FG000|Baseline Assessment|Poor IV access|1|||
147397956|NCT00858247|531622794|FG001|Baseline Assessment|Poor IV access|0|||
147397957|NCT00858247|531622793|FG000|Baseline Assessment|Protocol Violation|0|||
147397958|NCT00858247|531622794|FG001|Baseline Assessment|Protocol Violation|1|||
147397959|NCT00858247|531622793|FG000|Week 12 Follow-up|Withdrawal by Subject|0|||
147397960|NCT00858247|531622794|FG001|Week 12 Follow-up|Withdrawal by Subject|1|||
147397961|NCT02512861|531622795|FG000|Overall Study|Protocol Violation|3|||
147397962|NCT02512861|531622796|FG001|Overall Study|Protocol Violation|7|||
147397963|NCT02512861|531622795|FG000|Overall Study|Physician Decision|3|||
147397964|NCT02512861|531622796|FG001|Overall Study|Physician Decision|1|||
147397965|NCT02512861|531622795|FG000|Overall Study|Withdrawal by Subject|0|||
147397966|NCT02512861|531622796|FG001|Overall Study|Withdrawal by Subject|1|||
147397967|NCT01172639|531622797|FG000|Overall Study|Death|1|||
147397968|NCT01172639|531622798|FG001|Overall Study|Death|1|||
147397969|NCT01172639|531622799|FG002|Overall Study|Death|0|||
147397970|NCT01172639|531622800|FG003|Overall Study|Death|0|||
147397971|NCT01172639|531622801|FG004|Overall Study|Death|0|||
147397972|NCT01172639|531622797|FG000|Overall Study|Lost to Follow-up|9|||
147397973|NCT01172639|531622798|FG001|Overall Study|Lost to Follow-up|7|||
147397974|NCT01172639|531622799|FG002|Overall Study|Lost to Follow-up|11|||
147397975|NCT01172639|531622800|FG003|Overall Study|Lost to Follow-up|6|||
147397976|NCT01172639|531622801|FG004|Overall Study|Lost to Follow-up|6|||
147397977|NCT01172639|531622797|FG000|Overall Study|Withdrawal by Subject|3|||
147397978|NCT01172639|531622798|FG001|Overall Study|Withdrawal by Subject|3|||
147397979|NCT01172639|531622799|FG002|Overall Study|Withdrawal by Subject|5|||
147397980|NCT01172639|531622800|FG003|Overall Study|Withdrawal by Subject|5|||
147615425|NCT04917861|532406735|FG000|Main Study (196 Days)|Lost to Follow-up|14|||
147615426|NCT04917861|532406736|FG001|Main Study (196 Days)|Lost to Follow-up|26|||
147615427|NCT04917861|532406737|FG002|Main Study (196 Days)|Lost to Follow-up|20|||
147615428|NCT04917861|532406738|FG003|Main Study (196 Days)|Lost to Follow-up|11|||
147615429|NCT04917861|532406735|FG000|Main Study (196 Days)|Physician Decision|0|||
147615430|NCT04917861|532406736|FG001|Main Study (196 Days)|Physician Decision|0|||
147665195|NCT00919633|532598069|FG003|Overall Study|Death|0|||
147665196|NCT00919633|532598066|FG000|Overall Study|Lack of Efficacy|17|||
147397981|NCT01172639|531622801|FG004|Overall Study|Withdrawal by Subject|0|||
147397982|NCT02447432|531622802|FG000|Epoch 001|Adverse Event|1|||
147397983|NCT02447432|531622803|FG001|Epoch 001|Adverse Event|1|||
147397984|NCT02447432|531622802|FG000|Epoch 001|Withdrawal by Subject|0|||
147397985|NCT02447432|531622803|FG001|Epoch 001|Withdrawal by Subject|4|||
147397986|NCT02447432|531622802|FG000|Epoch 001|Migrated/moved from study area|3|||
147397987|NCT02447432|531622803|FG001|Epoch 001|Migrated/moved from study area|5|||
147397988|NCT02447432|531622802|FG000|Epoch 001|Lost to Follow-up|1|||
147397989|NCT02447432|531622803|FG001|Epoch 001|Lost to Follow-up|3|||
147397990|NCT01585298|531622806|FG000|Overall Study|Study completion was not documented.|1|||
147397991|NCT01585298|531622806|FG000|Overall Study|Protocol deviation|1|||
147397992|NCT01585298|531622806|FG000|Overall Study|Administrative problems|4|||
147397993|NCT01585298|531622806|FG000|Overall Study|Lost to Follow-up|2|||
147397994|NCT01585298|531622806|FG000|Overall Study|Withdrawal by Subject|4|||
147397995|NCT01585298|531622806|FG000|Overall Study|Abnormal test procedure results|1|||
147397996|NCT01585298|531622806|FG000|Overall Study|Adverse Event|24|||
147397997|NCT00874497|531622814|FG000|Overall Study|Lost to Follow-up|2|||
147397998|NCT00874497|531622815|FG001|Overall Study|Lost to Follow-up|4|||
147397999|NCT00874497|531622814|FG000|Overall Study|Adverse Event|9|||
147398000|NCT00874497|531622815|FG001|Overall Study|Adverse Event|4|||
147398001|NCT00874497|531622814|FG000|Overall Study|Sponsor Discontinued Trial|7|||
147398002|NCT00874497|531622815|FG001|Overall Study|Sponsor Discontinued Trial|3|||
147398003|NCT00874497|531622814|FG000|Overall Study|Met Withdrawal Criteria|4|||
147398004|NCT00874497|531622815|FG001|Overall Study|Met Withdrawal Criteria|2|||
147398005|NCT00874497|531622814|FG000|Overall Study|Physician Decision|1|||
147398006|NCT00874497|531622815|FG001|Overall Study|Physician Decision|1|||
147398007|NCT00874497|531622814|FG000|Overall Study|Withdrawal by Subject|5|||
147398008|NCT00874497|531622815|FG001|Overall Study|Withdrawal by Subject|4|||
147398009|NCT00644878|531622816|FG000|Overall Study|Adverse Event|2|||
147398010|NCT00644878|531622816|FG000|Overall Study|Abnormal laboratory value|3|||
147398011|NCT00644878|531622816|FG000|Overall Study|Protocol deviation|2|||
147398012|NCT00644878|531622816|FG000|Overall Study|Treatment duration completed as per protocol|11|||
147398013|NCT00665223|531622819|FG000|Randomized Phase (26 Weeks)|Adverse Event|13|||
147398014|NCT00665223|531622820|FG001|Randomized Phase (26 Weeks)|Adverse Event|9|||
147398015|NCT00665223|531622821|FG002|Randomized Phase (26 Weeks)|Adverse Event|15|||
147398016|NCT00665223|531622819|FG000|Randomized Phase (26 Weeks)|Death|0|||
147398017|NCT00665223|531622820|FG001|Randomized Phase (26 Weeks)|Death|0|||
147398018|NCT00665223|531622821|FG002|Randomized Phase (26 Weeks)|Death|1|||
147398019|NCT00665223|531622819|FG000|Randomized Phase (26 Weeks)|Withdrawal by Subject|5|||
147398020|NCT00665223|531622820|FG001|Randomized Phase (26 Weeks)|Withdrawal by Subject|2|||
147398021|NCT00665223|531622821|FG002|Randomized Phase (26 Weeks)|Withdrawal by Subject|3|||
147398022|NCT00665223|531622819|FG000|Randomized Phase (26 Weeks)|Protocol Violation|0|||
147398023|NCT00665223|531622820|FG001|Randomized Phase (26 Weeks)|Protocol Violation|1|||
147398024|NCT00665223|531622821|FG002|Randomized Phase (26 Weeks)|Protocol Violation|1|||
147398025|NCT00665223|531622819|FG000|Randomized Phase (26 Weeks)|Other than specified|0|||
147398026|NCT00665223|531622820|FG001|Randomized Phase (26 Weeks)|Other than specified|0|||
147398027|NCT00665223|531622821|FG002|Randomized Phase (26 Weeks)|Other than specified|1|||
147398028|NCT00665223|531622819|FG000|Open-Label Period (26 Weeks)|Adverse Event|8|||
147398029|NCT00665223|531622820|FG001|Open-Label Period (26 Weeks)|Adverse Event|11|||
147398030|NCT00665223|531622821|FG002|Open-Label Period (26 Weeks)|Adverse Event|7|||
147398031|NCT00665223|531622819|FG000|Open-Label Period (26 Weeks)|Death|0|||
147398032|NCT00665223|531622820|FG001|Open-Label Period (26 Weeks)|Death|1|||
147398033|NCT00665223|531622821|FG002|Open-Label Period (26 Weeks)|Death|0|||
147398034|NCT00665223|531622819|FG000|Open-Label Period (26 Weeks)|Lost to Follow-up|3|||
147398035|NCT00665223|531622820|FG001|Open-Label Period (26 Weeks)|Lost to Follow-up|1|||
147398036|NCT00665223|531622821|FG002|Open-Label Period (26 Weeks)|Lost to Follow-up|2|||
147665197|NCT00919633|532598067|FG001|Overall Study|Lack of Efficacy|3|||
147398037|NCT00665223|531622819|FG000|Open-Label Period (26 Weeks)|Withdrawal by Subject|5|||
147398038|NCT00665223|531622820|FG001|Open-Label Period (26 Weeks)|Withdrawal by Subject|3|||
147398039|NCT00665223|531622821|FG002|Open-Label Period (26 Weeks)|Withdrawal by Subject|4|||
147398040|NCT00665223|531622819|FG000|Open-Label Period (26 Weeks)|Protocol Violation|0|||
147398041|NCT00665223|531622820|FG001|Open-Label Period (26 Weeks)|Protocol Violation|1|||
147398042|NCT00665223|531622821|FG002|Open-Label Period (26 Weeks)|Protocol Violation|0|||
147398043|NCT00665223|531622819|FG000|Open-Label Period (26 Weeks)|Other than specified|0|||
147398044|NCT00665223|531622820|FG001|Open-Label Period (26 Weeks)|Other than specified|0|||
147615431|NCT04917861|532406737|FG002|Main Study (196 Days)|Physician Decision|0|||
147665198|NCT00919633|532598068|FG002|Overall Study|Lack of Efficacy|2|||
147398045|NCT00665223|531622821|FG002|Open-Label Period (26 Weeks)|Other than specified|2|||
147398046|NCT00591591|531622822|FG000|Overall Study|Withdrawal by Subject|1|||
147398047|NCT00591591|531622823|FG001|Overall Study|Withdrawal by Subject|37|||
147398048|NCT00591591|531622822|FG000|Overall Study|Lack of Efficacy|10|||
147398049|NCT00591591|531622823|FG001|Overall Study|Lack of Efficacy|2|||
147398050|NCT00002597|531622824|FG000|Overall Study|Protocol Violation|19|||
147398051|NCT00002597|531622825|FG001|Overall Study|Protocol Violation|17|||
147398052|NCT00002597|531622824|FG000|Overall Study|Withdrawal by Subject|7|||
147398053|NCT00002597|531622825|FG001|Overall Study|Withdrawal by Subject|6|||
147398054|NCT01426113|531622828|FG000|Overall Study|Study Discontinued|1|||
147398055|NCT01426113|531622829|FG001|Overall Study|Study Discontinued|1|||
147398056|NCT01426113|531622828|FG000|Overall Study|Adverse Event|0|||
147398057|NCT01426113|531622829|FG001|Overall Study|Adverse Event|1|||
147398058|NCT00468130|531622832|FG000|Overall Study|Adverse Event|2|||
147398059|NCT00468130|531622833|FG001|Overall Study|Adverse Event|1|||
147398060|NCT00468130|531622832|FG000|Overall Study|Withdrawal by Subject|0|||
147398061|NCT00468130|531622833|FG001|Overall Study|Withdrawal by Subject|1|||
147398062|NCT00436956|531622834|FG000|Overall Study|Not evaluable|1|||
147398063|NCT00436956|531622835|FG001|Overall Study|Not evaluable|0|||
147398064|NCT02485899|531622836|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|2|||
147398065|NCT02485899|531622837|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
147398066|NCT02485899|531622836|FG000|Overall Study|Withdrawal by Subject|1|||
147398067|NCT02485899|531622837|FG001|Overall Study|Withdrawal by Subject|0|||
147398068|NCT02485899|531622836|FG000|Overall Study|Withdrawal by Parent/ Guardian|4|||
147398069|NCT02485899|531622837|FG001|Overall Study|Withdrawal by Parent/ Guardian|0|||
147398070|NCT03517111|531622840|FG000|Enrolled|Withdrawal by Subject|0|||
147398071|NCT03517111|531622841|FG001|Enrolled|Withdrawal by Subject|1|||
147398072|NCT03517111|531622842|FG002|Enrolled|Withdrawal by Subject|0|||
147398073|NCT03517111|531622840|FG000|T2 Survey (Week 10-12)|Intervention workshops cancelled|83|||
147398074|NCT03517111|531622841|FG001|T2 Survey (Week 10-12)|Intervention workshops cancelled|78|||
147398075|NCT03517111|531622842|FG002|T2 Survey (Week 10-12)|Intervention workshops cancelled|60|||
147398076|NCT03517111|531622840|FG000|T2 Survey (Week 10-12)|Lost to Follow-up|36|||
147398077|NCT03517111|531622841|FG001|T2 Survey (Week 10-12)|Lost to Follow-up|12|||
147398078|NCT03517111|531622842|FG002|T2 Survey (Week 10-12)|Lost to Follow-up|23|||
147398079|NCT03517111|531622840|FG000|T2 Survey (Week 10-12)|Did not complete T2 survey, but continued with data collection|9|||
147398080|NCT03517111|531622841|FG001|T2 Survey (Week 10-12)|Did not complete T2 survey, but continued with data collection|3|||
147398081|NCT03517111|531622842|FG002|T2 Survey (Week 10-12)|Did not complete T2 survey, but continued with data collection|4|||
147398082|NCT03517111|531622840|FG000|T3 Survey (Weeks 24-26)|Lost to Follow-up|27|||
147398083|NCT03517111|531622841|FG001|T3 Survey (Weeks 24-26)|Lost to Follow-up|6|||
147398084|NCT03517111|531622842|FG002|T3 Survey (Weeks 24-26)|Lost to Follow-up|15|||
147398085|NCT00912223|531622843|FG000|Overall Study|Withdrawal by Subject|1|||
147398086|NCT00912223|531622843|FG000|Overall Study|Not transplanted|1|||
147398087|NCT00912223|531622843|FG000|Overall Study|Transformed disease|1|||
147398088|NCT02719743|531622844|FG000|Overall Study|Consent withdrawal|0|||
147398089|NCT02719743|531622845|FG001|Overall Study|Consent withdrawal|2|||
147398090|NCT02719743|531622846|FG002|Overall Study|Consent withdrawal|0|||
147398091|NCT02719743|531622847|FG003|Overall Study|Consent withdrawal|1|||
147398092|NCT02719743|531622848|FG004|Overall Study|Consent withdrawal|0|||
147398093|NCT02719743|531622844|FG000|Overall Study|Migrated/moved from study area|0|||
147398094|NCT02719743|531622845|FG001|Overall Study|Migrated/moved from study area|0|||
147398095|NCT02719743|531622846|FG002|Overall Study|Migrated/moved from study area|0|||
147398096|NCT02719743|531622847|FG003|Overall Study|Migrated/moved from study area|0|||
147398097|NCT02719743|531622848|FG004|Overall Study|Migrated/moved from study area|2|||
147398098|NCT02719743|531622844|FG000|Overall Study|Lost to Follow-up|1|||
147398099|NCT02719743|531622845|FG001|Overall Study|Lost to Follow-up|1|||
147398100|NCT02719743|531622846|FG002|Overall Study|Lost to Follow-up|0|||
147398101|NCT02719743|531622847|FG003|Overall Study|Lost to Follow-up|0|||
147398102|NCT02719743|531622848|FG004|Overall Study|Lost to Follow-up|0|||
147398103|NCT01438840|531622849|FG000|Core Study|Adverse Event|0|||
147398104|NCT01438840|531622850|FG001|Core Study|Adverse Event|3|||
147398105|NCT01438840|531622851|FG002|Core Study|Adverse Event|0|||
147398106|NCT01438840|531622849|FG000|Core Study|Lack of Efficacy|15|||
147398107|NCT01438840|531622850|FG001|Core Study|Lack of Efficacy|7|||
147665199|NCT00919633|532598069|FG003|Overall Study|Lack of Efficacy|3|||
147398108|NCT01438840|531622851|FG002|Core Study|Lack of Efficacy|0|||
147398109|NCT01438840|531622849|FG000|Core Study|Withdrawal of consent|1|||
147398110|NCT01438840|531622850|FG001|Core Study|Withdrawal of consent|0|||
147398111|NCT01438840|531622851|FG002|Core Study|Withdrawal of consent|0|||
147398112|NCT01438840|531622849|FG000|Extension Phase|Adverse Event|0|||
147398113|NCT01438840|531622850|FG001|Extension Phase|Adverse Event|0|||
147398114|NCT01438840|531622851|FG002|Extension Phase|Adverse Event|3|||
147398115|NCT01438840|531622849|FG000|Extension Phase|Lost to Follow-up|0|||
147398116|NCT01438840|531622850|FG001|Extension Phase|Lost to Follow-up|0|||
147398117|NCT01438840|531622851|FG002|Extension Phase|Lost to Follow-up|1|||
147398118|NCT01438840|531622849|FG000|Extension Phase|Withdrawal by Subject|0|||
147398119|NCT01438840|531622850|FG001|Extension Phase|Withdrawal by Subject|0|||
147398120|NCT01438840|531622851|FG002|Extension Phase|Withdrawal by Subject|3|||
147398121|NCT01438840|531622849|FG000|Extension Phase|Lack of Efficacy|0|||
147398122|NCT01438840|531622850|FG001|Extension Phase|Lack of Efficacy|0|||
147398123|NCT01438840|531622851|FG002|Extension Phase|Lack of Efficacy|2|||
147398124|NCT01438840|531622849|FG000|Extension Phase|Other|0|||
147398125|NCT01438840|531622850|FG001|Extension Phase|Other|0|||
147398126|NCT01438840|531622851|FG002|Extension Phase|Other|1|||
147398127|NCT02601209|531622852|FG000|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|1|||
147398128|NCT02601209|531622853|FG001|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|1|||
147398129|NCT02601209|531622854|FG002|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|1|||
147398130|NCT02601209|531622855|FG003|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
147398131|NCT02601209|531622856|FG004|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
147398132|NCT02601209|531622857|FG005|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
147398133|NCT02601209|531622858|FG006|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
147398134|NCT02601209|531622859|FG007|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
147398135|NCT02601209|531622860|FG008|Initial Treatment (Up to 4 Months)|Did not meet eligibility criteria|0|||
147398136|NCT02601209|531622852|FG000|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
147398137|NCT02601209|531622853|FG001|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
147398138|NCT02601209|531622854|FG002|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
147398139|NCT02601209|531622855|FG003|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
147398140|NCT02601209|531622856|FG004|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|1|||
147398141|NCT02601209|531622857|FG005|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|2|||
147398142|NCT02601209|531622858|FG006|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|1|||
147398143|NCT02601209|531622859|FG007|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
147398144|NCT02601209|531622860|FG008|Initial Treatment (Up to 4 Months)|Withdrew before initiation of regimen|0|||
147398145|NCT02261285|531622863|FG000|Overall Study|Disease progression|0|||
147398146|NCT02261285|531622864|FG001|Overall Study|Disease progression|0|||
147398147|NCT02261285|531622865|FG002|Overall Study|Disease progression|1|||
147398148|NCT01702519|531622866|FG000|Washout Period|Lost to Follow-up|1|||
147398149|NCT01702519|531622867|FG001|Washout Period|Lost to Follow-up|0|||
147398150|NCT01702519|531622866|FG000|Washout Period|Withdrawal by Subject|0|||
147398151|NCT01702519|531622867|FG001|Washout Period|Withdrawal by Subject|2|||
147398152|NCT00746356|531622870|FG000|Overall Study|Withdrawal by Subject|2|||
147398153|NCT00746356|531622871|FG001|Overall Study|Withdrawal by Subject|3|||
147398154|NCT00746356|531622870|FG000|Overall Study|Death|7|||
147398155|NCT00746356|531622871|FG001|Overall Study|Death|3|||
147398156|NCT00746356|531622870|FG000|Overall Study|Lost to Follow-up|1|||
147398157|NCT00746356|531622871|FG001|Overall Study|Lost to Follow-up|0|||
147398158|NCT00746356|531622870|FG000|Overall Study|Removal of Device|0|||
147398159|NCT00746356|531622871|FG001|Overall Study|Removal of Device|1|||
147398160|NCT00746356|531622870|FG000|Overall Study|Patient relocated|1|||
147398161|NCT00746356|531622871|FG001|Overall Study|Patient relocated|0|||
147398162|NCT01263925|531622872|FG000|Overall Study|Protocol Violation|1|||
147398163|NCT01263925|531622873|FG001|Overall Study|Protocol Violation|0|||
147398164|NCT01263925|531622872|FG000|Overall Study|Lack of Efficacy|0|||
147398165|NCT01263925|531622873|FG001|Overall Study|Lack of Efficacy|1|||
147398166|NCT01263925|531622872|FG000|Overall Study|Adverse Event|23|||
147398167|NCT01263925|531622873|FG001|Overall Study|Adverse Event|22|||
147398168|NCT01263925|531622872|FG000|Overall Study|Unsatisfactory Compliance of Subject|8|||
147398169|NCT01263925|531622873|FG001|Overall Study|Unsatisfactory Compliance of Subject|5|||
147398170|NCT01263925|531622872|FG000|Overall Study|Withdrawal by Subject|6|||
147398171|NCT01263925|531622873|FG001|Overall Study|Withdrawal by Subject|8|||
147398172|NCT01263925|531622872|FG000|Overall Study|Other|4|||
147398173|NCT01263925|531622873|FG001|Overall Study|Other|4|||
147398174|NCT01263925|531622872|FG000|Overall Study|Lost to Follow-up|3|||
147398175|NCT01263925|531622873|FG001|Overall Study|Lost to Follow-up|1|||
147398176|NCT01263925|531622872|FG000|Overall Study|Lack of Efficacy/ Adverse Event (AE)|1|||
147398177|NCT01263925|531622873|FG001|Overall Study|Lack of Efficacy/ Adverse Event (AE)|1|||
147398178|NCT01263925|531622872|FG000|Overall Study|AE/ Unsatisfactory Compliance|2|||
147398179|NCT01263925|531622873|FG001|Overall Study|AE/ Unsatisfactory Compliance|2|||
147398180|NCT01263925|531622872|FG000|Overall Study|AE/ Withdrawal|1|||
147398181|NCT01263925|531622873|FG001|Overall Study|AE/ Withdrawal|4|||
147398182|NCT01263925|531622872|FG000|Overall Study|Unsatisfactory Compliance/ Withdrawal|1|||
147398183|NCT01263925|531622873|FG001|Overall Study|Unsatisfactory Compliance/ Withdrawal|1|||
147398184|NCT01263925|531622872|FG000|Overall Study|Unsatisfactory Compl./ Lost to Follow up|1|||
147665200|NCT00919633|532598066|FG000|Overall Study|Withdrawal by Subject|1|||
147398185|NCT01263925|531622873|FG001|Overall Study|Unsatisfactory Compl./ Lost to Follow up|2|||
147398186|NCT01263925|531622872|FG000|Overall Study|Withdrawal/ Not specified|0|||
147398187|NCT01263925|531622873|FG001|Overall Study|Withdrawal/ Not specified|1|||
147398188|NCT03605368|531622876|FG000|Overall Study|Lost to Follow-up|2|||
147398189|NCT03605368|531622877|FG001|Overall Study|Lost to Follow-up|1|||
147398190|NCT03605368|531622878|FG002|Overall Study|Lost to Follow-up|3|||
147398191|NCT03605368|531622879|FG003|Overall Study|Lost to Follow-up|2|||
147398192|NCT03605368|531622876|FG000|Overall Study|Withdrawal by Subject|0|||
147398193|NCT03605368|531622877|FG001|Overall Study|Withdrawal by Subject|0|||
147398194|NCT03605368|531622878|FG002|Overall Study|Withdrawal by Subject|4|||
147398195|NCT03605368|531622879|FG003|Overall Study|Withdrawal by Subject|3|||
147398196|NCT01726517|531622880|FG000|Overall Study|Withdrawal by Subject|0|||
147398197|NCT01726517|531622881|FG001|Overall Study|Withdrawal by Subject|0|||
147398198|NCT01726517|531622882|FG002|Overall Study|Withdrawal by Subject|1|||
147398199|NCT01726517|531622883|FG003|Overall Study|Withdrawal by Subject|0|||
147398200|NCT01726517|531622884|FG004|Overall Study|Withdrawal by Subject|0|||
147398201|NCT03765164|531622885|FG000|Pre-intervention|Withdrawal by Subject|5|||
147398202|NCT03765164|531622886|FG001|Pre-intervention|Withdrawal by Subject|6|||
147398203|NCT02484547|531622887|FG000|Placebo-Controlled Period|Adverse Event|10|||
147398204|NCT02484547|531622888|FG001|Placebo-Controlled Period|Adverse Event|13|||
147398205|NCT02484547|531622889|FG002|Placebo-Controlled Period|Adverse Event|20|||
147398206|NCT02484547|531622890|FG003|Placebo-Controlled Period|Adverse Event|0|||
147398207|NCT02484547|531622891|FG004|Placebo-Controlled Period|Adverse Event|0|||
147398208|NCT02484547|531622892|FG005|Placebo-Controlled Period|Adverse Event|0|||
147398209|NCT02484547|531622893|FG006|Placebo-Controlled Period|Adverse Event|0|||
147398210|NCT02484547|531622887|FG000|Placebo-Controlled Period|Change of Treatment|0|||
147398211|NCT02484547|531622888|FG001|Placebo-Controlled Period|Change of Treatment|0|||
147398212|NCT02484547|531622889|FG002|Placebo-Controlled Period|Change of Treatment|1|||
147398213|NCT02484547|531622890|FG003|Placebo-Controlled Period|Change of Treatment|0|||
147398214|NCT02484547|531622891|FG004|Placebo-Controlled Period|Change of Treatment|0|||
147398215|NCT02484547|531622892|FG005|Placebo-Controlled Period|Change of Treatment|0|||
147398216|NCT02484547|531622893|FG006|Placebo-Controlled Period|Change of Treatment|0|||
147398217|NCT02484547|531622887|FG000|Placebo-Controlled Period|Consent Withdrawn|15|||
147398218|NCT02484547|531622888|FG001|Placebo-Controlled Period|Consent Withdrawn|32|||
147398219|NCT02484547|531622889|FG002|Placebo-Controlled Period|Consent Withdrawn|26|||
147398220|NCT02484547|531622890|FG003|Placebo-Controlled Period|Consent Withdrawn|0|||
147398221|NCT02484547|531622891|FG004|Placebo-Controlled Period|Consent Withdrawn|0|||
147398222|NCT02484547|531622892|FG005|Placebo-Controlled Period|Consent Withdrawn|0|||
147398223|NCT02484547|531622893|FG006|Placebo-Controlled Period|Consent Withdrawn|0|||
147398224|NCT02484547|531622887|FG000|Placebo-Controlled Period|Death|5|||
147398225|NCT02484547|531622888|FG001|Placebo-Controlled Period|Death|0|||
147398226|NCT02484547|531622889|FG002|Placebo-Controlled Period|Death|6|||
147398227|NCT02484547|531622890|FG003|Placebo-Controlled Period|Death|0|||
147398228|NCT02484547|531622891|FG004|Placebo-Controlled Period|Death|0|||
147398229|NCT02484547|531622892|FG005|Placebo-Controlled Period|Death|0|||
147398230|NCT02484547|531622893|FG006|Placebo-Controlled Period|Death|0|||
147398231|NCT02484547|531622887|FG000|Placebo-Controlled Period|Disease Progression|2|||
147398232|NCT02484547|531622888|FG001|Placebo-Controlled Period|Disease Progression|0|||
147398233|NCT02484547|531622889|FG002|Placebo-Controlled Period|Disease Progression|1|||
147398234|NCT02484547|531622890|FG003|Placebo-Controlled Period|Disease Progression|0|||
147398235|NCT02484547|531622891|FG004|Placebo-Controlled Period|Disease Progression|0|||
147398236|NCT02484547|531622892|FG005|Placebo-Controlled Period|Disease Progression|0|||
147398237|NCT02484547|531622893|FG006|Placebo-Controlled Period|Disease Progression|0|||
147398238|NCT02484547|531622887|FG000|Placebo-Controlled Period|Investigator Decision|2|||
147398239|NCT02484547|531622888|FG001|Placebo-Controlled Period|Investigator Decision|2|||
147398240|NCT02484547|531622889|FG002|Placebo-Controlled Period|Investigator Decision|5|||
147398241|NCT02484547|531622890|FG003|Placebo-Controlled Period|Investigator Decision|0|||
147398242|NCT02484547|531622891|FG004|Placebo-Controlled Period|Investigator Decision|0|||
147398243|NCT02484547|531622892|FG005|Placebo-Controlled Period|Investigator Decision|0|||
147398244|NCT02484547|531622893|FG006|Placebo-Controlled Period|Investigator Decision|0|||
147398245|NCT02484547|531622887|FG000|Placebo-Controlled Period|Lost to Follow-up|3|||
147398246|NCT02484547|531622888|FG001|Placebo-Controlled Period|Lost to Follow-up|1|||
147398247|NCT02484547|531622889|FG002|Placebo-Controlled Period|Lost to Follow-up|3|||
147398248|NCT02484547|531622890|FG003|Placebo-Controlled Period|Lost to Follow-up|0|||
147398249|NCT02484547|531622891|FG004|Placebo-Controlled Period|Lost to Follow-up|0|||
147398250|NCT02484547|531622892|FG005|Placebo-Controlled Period|Lost to Follow-up|0|||
147398251|NCT02484547|531622893|FG006|Placebo-Controlled Period|Lost to Follow-up|0|||
147398252|NCT02484547|531622887|FG000|Placebo-Controlled Period|Relocation|1|||
147398253|NCT02484547|531622888|FG001|Placebo-Controlled Period|Relocation|1|||
147398254|NCT02484547|531622889|FG002|Placebo-Controlled Period|Relocation|1|||
147398255|NCT02484547|531622890|FG003|Placebo-Controlled Period|Relocation|0|||
147398256|NCT02484547|531622891|FG004|Placebo-Controlled Period|Relocation|0|||
147398257|NCT02484547|531622892|FG005|Placebo-Controlled Period|Relocation|0|||
147398258|NCT02484547|531622893|FG006|Placebo-Controlled Period|Relocation|0|||
147398259|NCT02484547|531622887|FG000|Placebo-Controlled Period|Study Visit Burden|2|||
147398260|NCT02484547|531622888|FG001|Placebo-Controlled Period|Study Visit Burden|8|||
147398261|NCT02484547|531622889|FG002|Placebo-Controlled Period|Study Visit Burden|5|||
147398262|NCT02484547|531622890|FG003|Placebo-Controlled Period|Study Visit Burden|0|||
147398263|NCT02484547|531622891|FG004|Placebo-Controlled Period|Study Visit Burden|0|||
147398264|NCT02484547|531622892|FG005|Placebo-Controlled Period|Study Visit Burden|0|||
147398265|NCT02484547|531622893|FG006|Placebo-Controlled Period|Study Visit Burden|0|||
147398266|NCT02484547|531622887|FG000|Placebo-Controlled Period|Withdrawal by Parent/Guardian|4|||
147398267|NCT02484547|531622888|FG001|Placebo-Controlled Period|Withdrawal by Parent/Guardian|1|||
147398268|NCT02484547|531622889|FG002|Placebo-Controlled Period|Withdrawal by Parent/Guardian|1|||
147398269|NCT02484547|531622890|FG003|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
147398270|NCT02484547|531622891|FG004|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
147398271|NCT02484547|531622892|FG005|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
147398272|NCT02484547|531622893|FG006|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
147398273|NCT02484547|531622887|FG000|Placebo-Controlled Period|Reason not Specified|216|||
147398274|NCT02484547|531622888|FG001|Placebo-Controlled Period|Reason not Specified|194|||
147398275|NCT02484547|531622889|FG002|Placebo-Controlled Period|Reason not Specified|183|||
147398276|NCT02484547|531622890|FG003|Placebo-Controlled Period|Reason not Specified|0|||
147398277|NCT02484547|531622891|FG004|Placebo-Controlled Period|Reason not Specified|0|||
147398278|NCT02484547|531622892|FG005|Placebo-Controlled Period|Reason not Specified|0|||
147398279|NCT02484547|531622893|FG006|Placebo-Controlled Period|Reason not Specified|0|||
147398280|NCT02484547|531622887|FG000|Long-Term Extension Period|Adverse Event|0|||
147398281|NCT02484547|531622888|FG001|Long-Term Extension Period|Adverse Event|0|||
147398282|NCT02484547|531622889|FG002|Long-Term Extension Period|Adverse Event|0|||
147398283|NCT02484547|531622890|FG003|Long-Term Extension Period|Adverse Event|0|||
147398284|NCT02484547|531622891|FG004|Long-Term Extension Period|Adverse Event|1|||
147398285|NCT02484547|531622892|FG005|Long-Term Extension Period|Adverse Event|3|||
147398286|NCT02484547|531622893|FG006|Long-Term Extension Period|Adverse Event|2|||
147398287|NCT02484547|531622887|FG000|Long-Term Extension Period|Death|0|||
147398288|NCT02484547|531622888|FG001|Long-Term Extension Period|Death|0|||
147398289|NCT02484547|531622889|FG002|Long-Term Extension Period|Death|0|||
147398290|NCT02484547|531622890|FG003|Long-Term Extension Period|Death|0|||
147398291|NCT02484547|531622891|FG004|Long-Term Extension Period|Death|0|||
147398292|NCT02484547|531622892|FG005|Long-Term Extension Period|Death|3|||
147398293|NCT02484547|531622893|FG006|Long-Term Extension Period|Death|0|||
147398294|NCT02484547|531622887|FG000|Long-Term Extension Period|Disease Progression|0|||
147398295|NCT02484547|531622888|FG001|Long-Term Extension Period|Disease Progression|0|||
147398296|NCT02484547|531622889|FG002|Long-Term Extension Period|Disease Progression|0|||
147398297|NCT02484547|531622890|FG003|Long-Term Extension Period|Disease Progression|0|||
147398298|NCT02484547|531622891|FG004|Long-Term Extension Period|Disease Progression|2|||
147398299|NCT02484547|531622892|FG005|Long-Term Extension Period|Disease Progression|4|||
147398300|NCT02484547|531622893|FG006|Long-Term Extension Period|Disease Progression|0|||
147398301|NCT02484547|531622887|FG000|Long-Term Extension Period|Lost to Follow-up|0|||
147398302|NCT02484547|531622888|FG001|Long-Term Extension Period|Lost to Follow-up|0|||
147398303|NCT02484547|531622889|FG002|Long-Term Extension Period|Lost to Follow-up|0|||
147398304|NCT02484547|531622890|FG003|Long-Term Extension Period|Lost to Follow-up|1|||
147398305|NCT02484547|531622891|FG004|Long-Term Extension Period|Lost to Follow-up|1|||
147398306|NCT02484547|531622892|FG005|Long-Term Extension Period|Lost to Follow-up|2|||
147398307|NCT02484547|531622893|FG006|Long-Term Extension Period|Lost to Follow-up|0|||
147398308|NCT02484547|531622887|FG000|Long-Term Extension Period|Loss of Capacity|0|||
147398309|NCT02484547|531622888|FG001|Long-Term Extension Period|Loss of Capacity|0|||
147398310|NCT02484547|531622889|FG002|Long-Term Extension Period|Loss of Capacity|0|||
147398311|NCT02484547|531622890|FG003|Long-Term Extension Period|Loss of Capacity|0|||
147398312|NCT02484547|531622891|FG004|Long-Term Extension Period|Loss of Capacity|1|||
147398313|NCT02484547|531622892|FG005|Long-Term Extension Period|Loss of Capacity|0|||
147398314|NCT02484547|531622893|FG006|Long-Term Extension Period|Loss of Capacity|0|||
147398315|NCT02484547|531622887|FG000|Long-Term Extension Period|Change of Treatment|0|||
147398316|NCT02484547|531622888|FG001|Long-Term Extension Period|Change of Treatment|0|||
147398317|NCT02484547|531622889|FG002|Long-Term Extension Period|Change of Treatment|0|||
147398318|NCT02484547|531622890|FG003|Long-Term Extension Period|Change of Treatment|0|||
147398319|NCT02484547|531622891|FG004|Long-Term Extension Period|Change of Treatment|0|||
147398320|NCT02484547|531622892|FG005|Long-Term Extension Period|Change of Treatment|0|||
147398321|NCT02484547|531622893|FG006|Long-Term Extension Period|Change of Treatment|1|||
147398322|NCT02484547|531622887|FG000|Long-Term Extension Period|Consent Withdrawn|0|||
147398323|NCT02484547|531622888|FG001|Long-Term Extension Period|Consent Withdrawn|0|||
147398324|NCT02484547|531622889|FG002|Long-Term Extension Period|Consent Withdrawn|0|||
147398325|NCT02484547|531622890|FG003|Long-Term Extension Period|Consent Withdrawn|6|||
147398326|NCT02484547|531622891|FG004|Long-Term Extension Period|Consent Withdrawn|7|||
147398327|NCT02484547|531622892|FG005|Long-Term Extension Period|Consent Withdrawn|13|||
147398328|NCT02484547|531622893|FG006|Long-Term Extension Period|Consent Withdrawn|17|||
147461041|NCT02211261|531849437|FG008|Overall Study|Withdrawal by Subject|0|||
147398329|NCT02484547|531622887|FG000|Long-Term Extension Period|Investigator Decision|0|||
147398330|NCT02484547|531622888|FG001|Long-Term Extension Period|Investigator Decision|0|||
147398331|NCT02484547|531622889|FG002|Long-Term Extension Period|Investigator Decision|0|||
147461042|NCT02211261|531849438|FG009|Overall Study|Withdrawal by Subject|0|||
147398332|NCT02484547|531622890|FG003|Long-Term Extension Period|Investigator Decision|2|||
147398333|NCT02484547|531622891|FG004|Long-Term Extension Period|Investigator Decision|1|||
147398334|NCT02484547|531622892|FG005|Long-Term Extension Period|Investigator Decision|0|||
147398335|NCT02484547|531622893|FG006|Long-Term Extension Period|Investigator Decision|1|||
147398336|NCT02484547|531622887|FG000|Long-Term Extension Period|Relocation|0|||
147398337|NCT02484547|531622888|FG001|Long-Term Extension Period|Relocation|0|||
147398338|NCT02484547|531622889|FG002|Long-Term Extension Period|Relocation|0|||
147398339|NCT02484547|531622890|FG003|Long-Term Extension Period|Relocation|1|||
147398340|NCT02484547|531622891|FG004|Long-Term Extension Period|Relocation|1|||
147398341|NCT02484547|531622892|FG005|Long-Term Extension Period|Relocation|0|||
147398342|NCT02484547|531622893|FG006|Long-Term Extension Period|Relocation|0|||
147398343|NCT02484547|531622887|FG000|Long-Term Extension Period|Study Visit Burden|0|||
147398344|NCT02484547|531622888|FG001|Long-Term Extension Period|Study Visit Burden|0|||
147398345|NCT02484547|531622889|FG002|Long-Term Extension Period|Study Visit Burden|0|||
147398346|NCT02484547|531622890|FG003|Long-Term Extension Period|Study Visit Burden|2|||
147398347|NCT02484547|531622891|FG004|Long-Term Extension Period|Study Visit Burden|0|||
147398348|NCT02484547|531622892|FG005|Long-Term Extension Period|Study Visit Burden|0|||
147398349|NCT02484547|531622893|FG006|Long-Term Extension Period|Study Visit Burden|3|||
147398350|NCT02484547|531622887|FG000|Long-Term Extension Period|Withdrawal by Parent/Guardian|0|||
147398351|NCT02484547|531622888|FG001|Long-Term Extension Period|Withdrawal by Parent/Guardian|0|||
147398352|NCT02484547|531622889|FG002|Long-Term Extension Period|Withdrawal by Parent/Guardian|0|||
147398353|NCT02484547|531622890|FG003|Long-Term Extension Period|Withdrawal by Parent/Guardian|0|||
147398354|NCT02484547|531622891|FG004|Long-Term Extension Period|Withdrawal by Parent/Guardian|1|||
147398355|NCT02484547|531622892|FG005|Long-Term Extension Period|Withdrawal by Parent/Guardian|3|||
147398356|NCT02484547|531622893|FG006|Long-Term Extension Period|Withdrawal by Parent/Guardian|2|||
147398357|NCT02484547|531622887|FG000|Long-Term Extension Period|Reason not Specified|0|||
147398358|NCT02484547|531622888|FG001|Long-Term Extension Period|Reason not Specified|0|||
147398359|NCT02484547|531622889|FG002|Long-Term Extension Period|Reason not Specified|0|||
147398360|NCT02484547|531622890|FG003|Long-Term Extension Period|Reason not Specified|119|||
147398361|NCT02484547|531622891|FG004|Long-Term Extension Period|Reason not Specified|117|||
147398362|NCT02484547|531622892|FG005|Long-Term Extension Period|Reason not Specified|223|||
147398363|NCT02484547|531622893|FG006|Long-Term Extension Period|Reason not Specified|231|||
147398364|NCT01665599|531622894|FG000|Overall Study|Adverse Event|1|||
147398365|NCT01665599|531622894|FG000|Overall Study|Consent Withdrawn|1|||
147398366|NCT01665599|531622894|FG000|Overall Study|Investigator/Sponsor decision|1|||
147398367|NCT01665599|531622894|FG000|Overall Study|Death|1|||
147398368|NCT01665599|531622894|FG000|Overall Study|Lost to Follow-up|2|||
147398369|NCT01665599|531622894|FG000|Overall Study|Participant Left for More Than 3 Months|1|||
147398370|NCT01665599|531622894|FG000|Overall Study|Could Not Continue Due to Time Constrain|1|||
147398371|NCT01494298|531622895|FG000|Overall Study|Protocol Violation|2|||
147398372|NCT01494298|531622896|FG001|Overall Study|Protocol Violation|8|||
147398373|NCT00514813|531622897|FG000|Overall Study|Study terminated|14|||
147398374|NCT00514813|531622898|FG001|Overall Study|Study terminated|74|||
147398375|NCT00514813|531622899|FG002|Overall Study|Study terminated|40|||
147398376|NCT00514813|531622900|FG003|Overall Study|Study terminated|2|||
147398377|NCT00514813|531622897|FG000|Overall Study|Adverse Event|0|||
147398378|NCT00514813|531622898|FG001|Overall Study|Adverse Event|2|||
147398379|NCT00514813|531622899|FG002|Overall Study|Adverse Event|2|||
147398380|NCT00514813|531622900|FG003|Overall Study|Adverse Event|0|||
147398381|NCT00514813|531622897|FG000|Overall Study|Protocol Violation|1|||
147398382|NCT00514813|531622898|FG001|Overall Study|Protocol Violation|0|||
147398383|NCT00514813|531622899|FG002|Overall Study|Protocol Violation|0|||
147398384|NCT00514813|531622900|FG003|Overall Study|Protocol Violation|0|||
147398385|NCT00514813|531622897|FG000|Overall Study|Withdrawal by Subject|0|||
147398386|NCT00514813|531622898|FG001|Overall Study|Withdrawal by Subject|1|||
147398387|NCT00514813|531622899|FG002|Overall Study|Withdrawal by Subject|0|||
147398388|NCT00514813|531622900|FG003|Overall Study|Withdrawal by Subject|0|||
147398389|NCT00514813|531622897|FG000|Overall Study|Lack of Efficacy|0|||
147398390|NCT00514813|531622898|FG001|Overall Study|Lack of Efficacy|1|||
147615432|NCT04917861|532406738|FG003|Main Study (196 Days)|Physician Decision|1|||
147615433|NCT04917861|532406735|FG000|Main Study (196 Days)|Pregnancy|1|||
147615434|NCT04917861|532406736|FG001|Main Study (196 Days)|Pregnancy|1|||
147615435|NCT04917861|532406737|FG002|Main Study (196 Days)|Pregnancy|0|||
147398391|NCT00514813|531622899|FG002|Overall Study|Lack of Efficacy|0|||
147398392|NCT00514813|531622900|FG003|Overall Study|Lack of Efficacy|0|||
147398393|NCT00514813|531622897|FG000|Overall Study|Kidney transplant|0|||
147398394|NCT00514813|531622898|FG001|Overall Study|Kidney transplant|6|||
147398395|NCT00514813|531622899|FG002|Overall Study|Kidney transplant|2|||
147398396|NCT00514813|531622900|FG003|Overall Study|Kidney transplant|0|||
147398397|NCT00514813|531622897|FG000|Overall Study|Death|0|||
147398398|NCT00514813|531622898|FG001|Overall Study|Death|2|||
147398399|NCT00514813|531622899|FG002|Overall Study|Death|3|||
147398400|NCT00514813|531622900|FG003|Overall Study|Death|2|||
147615436|NCT04917861|532406738|FG003|Main Study (196 Days)|Pregnancy|0|||
147615437|NCT04917861|532406735|FG000|Main Study (196 Days)|Withdrawal by Subject|14|||
147398401|NCT02979613|531622901|FG000|Double-Blind Phase|Withdrew Consent|2|||
147398402|NCT02979613|531622902|FG001|Double-Blind Phase|Withdrew Consent|4|||
147398403|NCT02979613|531622901|FG000|Double-Blind Phase|Pregnancy|2|||
147398404|NCT02979613|531622902|FG001|Double-Blind Phase|Pregnancy|2|||
147398405|NCT02979613|531622901|FG000|Double-Blind Phase|Adverse Event|2|||
147398406|NCT02979613|531622902|FG001|Double-Blind Phase|Adverse Event|0|||
147398407|NCT02979613|531622901|FG000|Double-Blind Phase|Lost to Follow-up|1|||
147398408|NCT02979613|531622902|FG001|Double-Blind Phase|Lost to Follow-up|1|||
147398409|NCT02979613|531622901|FG000|Double-Blind Phase|Protocol Violation|1|||
147398410|NCT02979613|531622902|FG001|Double-Blind Phase|Protocol Violation|1|||
147398411|NCT02979613|531622901|FG000|Double-Blind Phase|Randomized but Never Treated|2|||
147398412|NCT02979613|531622902|FG001|Double-Blind Phase|Randomized but Never Treated|0|||
147398413|NCT02979613|531622901|FG000|Open-Label Extension (OLE) Phase|Withdrew Consent|2|||
147398414|NCT02979613|531622902|FG001|Open-Label Extension (OLE) Phase|Withdrew Consent|4|||
147398415|NCT02979613|531622901|FG000|Open-Label Extension (OLE) Phase|Adverse Event|1|||
147398416|NCT02979613|531622902|FG001|Open-Label Extension (OLE) Phase|Adverse Event|0|||
147398417|NCT02979613|531622901|FG000|Open-Label Extension (OLE) Phase|Death|0|||
147398418|NCT02979613|531622902|FG001|Open-Label Extension (OLE) Phase|Death|1|||
147398419|NCT02979613|531622901|FG000|Open-Label Extension (OLE) Phase|Investigator's Discretion|0|||
147398420|NCT02979613|531622902|FG001|Open-Label Extension (OLE) Phase|Investigator's Discretion|1|||
147398421|NCT04944784|531622907|FG000|Double-blind Period|Study Terminated by Sponsor|96|||
147398422|NCT04944784|531622908|FG001|Double-blind Period|Study Terminated by Sponsor|46|||
147398423|NCT04944784|531622909|FG002|Double-blind Period|Study Terminated by Sponsor|0|||
147398424|NCT04944784|531622910|FG003|Double-blind Period|Study Terminated by Sponsor|0|||
147398425|NCT04944784|531622907|FG000|Double-blind Period|Adverse Event|20|||
147398426|NCT04944784|531622908|FG001|Double-blind Period|Adverse Event|4|||
147398427|NCT04944784|531622909|FG002|Double-blind Period|Adverse Event|0|||
147398428|NCT04944784|531622910|FG003|Double-blind Period|Adverse Event|0|||
147398429|NCT04944784|531622907|FG000|Double-blind Period|Withdrawal by Subject|15|||
147398430|NCT04944784|531622908|FG001|Double-blind Period|Withdrawal by Subject|4|||
147398431|NCT04944784|531622909|FG002|Double-blind Period|Withdrawal by Subject|0|||
147398432|NCT04944784|531622910|FG003|Double-blind Period|Withdrawal by Subject|0|||
147398433|NCT04944784|531622907|FG000|Double-blind Period|Death|7|||
147398434|NCT04944784|531622908|FG001|Double-blind Period|Death|2|||
147398435|NCT04944784|531622909|FG002|Double-blind Period|Death|0|||
147398436|NCT04944784|531622910|FG003|Double-blind Period|Death|0|||
147398437|NCT04944784|531622907|FG000|Double-blind Period|Physician Decision|2|||
147398438|NCT04944784|531622908|FG001|Double-blind Period|Physician Decision|1|||
147398439|NCT04944784|531622909|FG002|Double-blind Period|Physician Decision|0|||
147398440|NCT04944784|531622910|FG003|Double-blind Period|Physician Decision|0|||
147398441|NCT04944784|531622907|FG000|Double-blind Period|Lack of Efficacy|0|||
147398442|NCT04944784|531622908|FG001|Double-blind Period|Lack of Efficacy|1|||
147398443|NCT04944784|531622909|FG002|Double-blind Period|Lack of Efficacy|0|||
147398444|NCT04944784|531622910|FG003|Double-blind Period|Lack of Efficacy|0|||
147398445|NCT04944784|531622907|FG000|Double-blind Period|Sponsor Request|2|||
147398446|NCT04944784|531622908|FG001|Double-blind Period|Sponsor Request|1|||
147398447|NCT04944784|531622909|FG002|Double-blind Period|Sponsor Request|0|||
147398448|NCT04944784|531622910|FG003|Double-blind Period|Sponsor Request|0|||
147398449|NCT04944784|531622907|FG000|Double-blind Period|Planned Medical Assistance in Dying|0|||
147398450|NCT04944784|531622908|FG001|Double-blind Period|Planned Medical Assistance in Dying|3|||
147398451|NCT04944784|531622909|FG002|Double-blind Period|Planned Medical Assistance in Dying|0|||
147398452|NCT04944784|531622910|FG003|Double-blind Period|Planned Medical Assistance in Dying|0|||
147398453|NCT04944784|531622907|FG000|Double-blind Period|Participant Choice|1|||
147398454|NCT04944784|531622908|FG001|Double-blind Period|Participant Choice|1|||
147398455|NCT04944784|531622909|FG002|Double-blind Period|Participant Choice|0|||
147398456|NCT04944784|531622910|FG003|Double-blind Period|Participant Choice|0|||
147398457|NCT04944784|531622907|FG000|Double-blind Period|Progressive Disease|2|||
147398458|NCT04944784|531622908|FG001|Double-blind Period|Progressive Disease|2|||
147398459|NCT04944784|531622909|FG002|Double-blind Period|Progressive Disease|0|||
147398460|NCT04944784|531622910|FG003|Double-blind Period|Progressive Disease|0|||
147398461|NCT04944784|531622907|FG000|Active Drug Period|Study Terminated by Sponsor|0|||
147665201|NCT00919633|532598067|FG001|Overall Study|Withdrawal by Subject|2|||
147665202|NCT00919633|532598068|FG002|Overall Study|Withdrawal by Subject|4|||
147398462|NCT04944784|531622908|FG001|Active Drug Period|Study Terminated by Sponsor|0|||
147398463|NCT04944784|531622909|FG002|Active Drug Period|Study Terminated by Sponsor|49|||
147398464|NCT04944784|531622910|FG003|Active Drug Period|Study Terminated by Sponsor|92|||
147398465|NCT04944784|531622907|FG000|Active Drug Period|Adverse Event|0|||
147398466|NCT04944784|531622908|FG001|Active Drug Period|Adverse Event|0|||
147398467|NCT04944784|531622909|FG002|Active Drug Period|Adverse Event|3|||
147398468|NCT04944784|531622910|FG003|Active Drug Period|Adverse Event|6|||
147398469|NCT04944784|531622907|FG000|Active Drug Period|Withdrawal by Subject|0|||
147398470|NCT04944784|531622908|FG001|Active Drug Period|Withdrawal by Subject|0|||
147398471|NCT04944784|531622909|FG002|Active Drug Period|Withdrawal by Subject|4|||
147398472|NCT04944784|531622910|FG003|Active Drug Period|Withdrawal by Subject|7|||
147398473|NCT04944784|531622907|FG000|Active Drug Period|Death|0|||
147398474|NCT04944784|531622908|FG001|Active Drug Period|Death|0|||
147398475|NCT04944784|531622909|FG002|Active Drug Period|Death|3|||
147398476|NCT04944784|531622910|FG003|Active Drug Period|Death|4|||
147398477|NCT04944784|531622907|FG000|Active Drug Period|Lack of Efficacy|0|||
147398478|NCT04944784|531622908|FG001|Active Drug Period|Lack of Efficacy|0|||
147398479|NCT04944784|531622909|FG002|Active Drug Period|Lack of Efficacy|2|||
147398480|NCT04944784|531622910|FG003|Active Drug Period|Lack of Efficacy|2|||
147398481|NCT04944784|531622907|FG000|Active Drug Period|Planned Medical Assistance in Dying|0|||
147398482|NCT04944784|531622908|FG001|Active Drug Period|Planned Medical Assistance in Dying|0|||
147398483|NCT04944784|531622909|FG002|Active Drug Period|Planned Medical Assistance in Dying|0|||
147398484|NCT04944784|531622910|FG003|Active Drug Period|Planned Medical Assistance in Dying|1|||
147398485|NCT04944784|531622907|FG000|Active Drug Period|Participant Choice|0|||
147398486|NCT04944784|531622908|FG001|Active Drug Period|Participant Choice|0|||
147398487|NCT04944784|531622909|FG002|Active Drug Period|Participant Choice|0|||
147398488|NCT04944784|531622910|FG003|Active Drug Period|Participant Choice|1|||
147398489|NCT04944784|531622907|FG000|Active Drug Period|Progressive Disease|0|||
147398490|NCT04944784|531622908|FG001|Active Drug Period|Progressive Disease|0|||
147398491|NCT04944784|531622909|FG002|Active Drug Period|Progressive Disease|4|||
147398492|NCT04944784|531622910|FG003|Active Drug Period|Progressive Disease|4|||
147398493|NCT04944784|531622907|FG000|Active Drug Period|Lost to Follow-up|0|||
147398494|NCT04944784|531622908|FG001|Active Drug Period|Lost to Follow-up|0|||
147398495|NCT04944784|531622909|FG002|Active Drug Period|Lost to Follow-up|0|||
147398496|NCT04944784|531622910|FG003|Active Drug Period|Lost to Follow-up|1|||
147398497|NCT01568112|531622911|FG000|Overall Study|Randomized But Not Treated|0|||
147398498|NCT01568112|531622912|FG001|Overall Study|Randomized But Not Treated|1|||
147398499|NCT01568112|531622913|FG002|Overall Study|Randomized But Not Treated|0|||
147398500|NCT01568112|531622914|FG003|Overall Study|Randomized But Not Treated|0|||
147398501|NCT01568112|531622911|FG000|Overall Study|Withdrew due to Adverse Event|2|||
147398502|NCT01568112|531622912|FG001|Overall Study|Withdrew due to Adverse Event|4|||
147398503|NCT01568112|531622913|FG002|Overall Study|Withdrew due to Adverse Event|6|||
147398504|NCT01568112|531622914|FG003|Overall Study|Withdrew due to Adverse Event|3|||
147398505|NCT01568112|531622911|FG000|Overall Study|Lost to Follow-up|0|||
147398506|NCT01568112|531622912|FG001|Overall Study|Lost to Follow-up|0|||
147398507|NCT01568112|531622913|FG002|Overall Study|Lost to Follow-up|0|||
147398508|NCT01568112|531622914|FG003|Overall Study|Lost to Follow-up|1|||
147398509|NCT01568112|531622911|FG000|Overall Study|Withdrawal by Subject|2|||
147398510|NCT01568112|531622912|FG001|Overall Study|Withdrawal by Subject|3|||
147398511|NCT01568112|531622913|FG002|Overall Study|Withdrawal by Subject|0|||
147398512|NCT01568112|531622914|FG003|Overall Study|Withdrawal by Subject|7|||
147398513|NCT01568112|531622911|FG000|Overall Study|Withdrawal by Physician|1|||
147398514|NCT01568112|531622912|FG001|Overall Study|Withdrawal by Physician|0|||
147398515|NCT01568112|531622913|FG002|Overall Study|Withdrawal by Physician|1|||
147398516|NCT01568112|531622914|FG003|Overall Study|Withdrawal by Physician|1|||
147398517|NCT00891046|531624100|FG000|Overall Study|Protocol Violation|1|||
147398518|NCT00891046|531624101|FG001|Overall Study|Protocol Violation|1|||
147398519|NCT00891046|531624102|FG002|Overall Study|Protocol Violation|0|||
147398520|NCT00891046|531624103|FG003|Overall Study|Protocol Violation|0|||
147398521|NCT00891046|531624104|FG004|Overall Study|Protocol Violation|1|||
147398522|NCT00891046|531624100|FG000|Overall Study|Unsatisfactory therapeutic effect|5|||
147398523|NCT00891046|531624101|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
147398524|NCT00891046|531624102|FG002|Overall Study|Unsatisfactory therapeutic effect|19|||
147398525|NCT00891046|531624103|FG003|Overall Study|Unsatisfactory therapeutic effect|2|||
147398526|NCT00891046|531624104|FG004|Overall Study|Unsatisfactory therapeutic effect|20|||
147398527|NCT00891046|531624100|FG000|Overall Study|Administrative problems|0|||
147398528|NCT00891046|531624101|FG001|Overall Study|Administrative problems|0|||
147398529|NCT00891046|531624102|FG002|Overall Study|Administrative problems|0|||
147398530|NCT00891046|531624103|FG003|Overall Study|Administrative problems|0|||
147398531|NCT00891046|531624104|FG004|Overall Study|Administrative problems|1|||
147398532|NCT00891046|531624100|FG000|Overall Study|Participant no longer required drug|0|||
147398533|NCT00891046|531624101|FG001|Overall Study|Participant no longer required drug|2|||
147398534|NCT00891046|531624102|FG002|Overall Study|Participant no longer required drug|0|||
147398535|NCT00891046|531624103|FG003|Overall Study|Participant no longer required drug|0|||
147398536|NCT00891046|531624104|FG004|Overall Study|Participant no longer required drug|1|||
147398537|NCT00891046|531624100|FG000|Overall Study|Adverse Event|4|||
147398538|NCT00891046|531624101|FG001|Overall Study|Adverse Event|3|||
147398539|NCT00891046|531624102|FG002|Overall Study|Adverse Event|2|||
147398540|NCT00891046|531624103|FG003|Overall Study|Adverse Event|0|||
147398541|NCT00891046|531624104|FG004|Overall Study|Adverse Event|14|||
147398542|NCT00891046|531624100|FG000|Overall Study|Withdrawal by Subject|2|||
147398543|NCT00891046|531624101|FG001|Overall Study|Withdrawal by Subject|1|||
147398544|NCT00891046|531624102|FG002|Overall Study|Withdrawal by Subject|2|||
147398545|NCT00891046|531624103|FG003|Overall Study|Withdrawal by Subject|1|||
147398546|NCT00891046|531624104|FG004|Overall Study|Withdrawal by Subject|1|||
147398547|NCT00891046|531624100|FG000|Overall Study|Lost to Follow-up|0|||
147461043|NCT02211261|531849439|FG010|Overall Study|Withdrawal by Subject|0|||
147398548|NCT00891046|531624101|FG001|Overall Study|Lost to Follow-up|0|||
147398549|NCT00891046|531624102|FG002|Overall Study|Lost to Follow-up|0|||
147398550|NCT00891046|531624103|FG003|Overall Study|Lost to Follow-up|0|||
147398551|NCT00891046|531624104|FG004|Overall Study|Lost to Follow-up|1|||
147398552|NCT00362375|531624105|FG000|Overall Study|Lost to Follow-up|40|||
147398553|NCT00362375|531624106|FG001|Overall Study|Lost to Follow-up|35|||
147398554|NCT04984239|531624107|FG000|Overall Study|Lost to Follow-up|1|||
147398555|NCT04523207|531624110|FG000|Overall Study|Adverse Event|5|||
147398556|NCT04523207|531624111|FG001|Overall Study|Adverse Event|1|||
147398557|NCT04523207|531624110|FG000|Overall Study|Lost to Follow-up|2|||
147398558|NCT04523207|531624111|FG001|Overall Study|Lost to Follow-up|0|||
147398559|NCT04523207|531624110|FG000|Overall Study|Withdrawal by Subject|2|||
147398560|NCT04523207|531624111|FG001|Overall Study|Withdrawal by Subject|0|||
147398561|NCT04523207|531624110|FG000|Overall Study|Progressive Disease|2|||
147398562|NCT04523207|531624111|FG001|Overall Study|Progressive Disease|1|||
147398563|NCT04523207|531624110|FG000|Overall Study|Other|7|||
147398564|NCT04523207|531624111|FG001|Overall Study|Other|1|||
147398565|NCT03113383|531624112|FG000|Overall Study|Death|4|||
147398566|NCT03113383|531624113|FG001|Overall Study|Death|0|||
147398567|NCT03062449|531624115|FG000|Overall Study|Withdrawal by Subject|7|||
147398568|NCT03062449|531624116|FG001|Overall Study|Withdrawal by Subject|1|||
147398569|NCT04702893|531624118|FG000|Overall Study|Other reasons than listed|11|||
147398570|NCT04702893|531624118|FG000|Overall Study|Withdrawal by Subject|3|||
147398571|NCT04702893|531624118|FG000|Overall Study|Lost to Follow-up|7|||
147398572|NCT04702893|531624118|FG000|Overall Study|Death|10|||
147398573|NCT04702893|531624118|FG000|Overall Study|Not treated|6|||
147398574|NCT00408928|531624119|FG000|Overall Study|Withdrawal by Subject|1|||
147398575|NCT00408928|531624119|FG000|Overall Study|Death|1|||
147398576|NCT00408928|531624119|FG000|Overall Study|Infection indistinguishable from GVHD|1|||
147398577|NCT01951378|531624122|FG000|Overall Study|Study Terminated-Not completed|23|||
147398578|NCT01951378|531624123|FG001|Overall Study|Study Terminated-Not completed|17|||
147398579|NCT00543062|531624124|FG000|Overall Study|Withdrawal by Subject|1|||
147398580|NCT00543062|531624125|FG001|Overall Study|Withdrawal by Subject|0|||
147398581|NCT00543062|531624126|FG002|Overall Study|Withdrawal by Subject|2|||
147398582|NCT00543062|531624127|FG003|Overall Study|Withdrawal by Subject|0|||
147398583|NCT00543062|531624124|FG000|Overall Study|Adverse Event|0|||
147398584|NCT00543062|531624125|FG001|Overall Study|Adverse Event|1|||
147398585|NCT00543062|531624126|FG002|Overall Study|Adverse Event|1|||
147398586|NCT00543062|531624127|FG003|Overall Study|Adverse Event|1|||
147398587|NCT00543062|531624124|FG000|Overall Study|Protocol Violation|1|||
147398588|NCT00543062|531624125|FG001|Overall Study|Protocol Violation|0|||
147398589|NCT00543062|531624126|FG002|Overall Study|Protocol Violation|0|||
147398590|NCT00543062|531624127|FG003|Overall Study|Protocol Violation|0|||
147398591|NCT03927690|531624130|FG000|Overall Study|Withdrawal by Subject|3|||
147398592|NCT03927690|531624131|FG001|Overall Study|Withdrawal by Subject|1|||
147398593|NCT03927690|531624132|FG002|Overall Study|Withdrawal by Subject|1|||
147398594|NCT03927690|531624130|FG000|Overall Study|Adverse Event|1|||
147398595|NCT03927690|531624131|FG001|Overall Study|Adverse Event|0|||
147398596|NCT03927690|531624132|FG002|Overall Study|Adverse Event|0|||
147398597|NCT03927690|531624130|FG000|Overall Study|Death|1|||
147398598|NCT03927690|531624131|FG001|Overall Study|Death|0|||
147398599|NCT03927690|531624132|FG002|Overall Study|Death|0|||
147398600|NCT03927690|531624130|FG000|Overall Study|Lost to Follow-up|2|||
147398601|NCT03927690|531624131|FG001|Overall Study|Lost to Follow-up|2|||
147398602|NCT03927690|531624132|FG002|Overall Study|Lost to Follow-up|1|||
147398603|NCT01844726|531624139|FG000|Overall Study|Withdrawal by Subject|0|||
147398604|NCT01844726|531624140|FG001|Overall Study|Withdrawal by Subject|1|||
147398605|NCT01844726|531624139|FG000|Overall Study|Excessive motion in MRI resulted in discontinuation.|1|||
147398606|NCT01844726|531624140|FG001|Overall Study|Excessive motion in MRI resulted in discontinuation.|0|||
147398607|NCT03898960|531624143|FG000|Overall Study|Death|10|||
147398608|NCT00548847|531624144|FG000|Overall Study|Disease progression|7|||
147398609|NCT03463577|531624145|FG000|Overall Study|Lost to Follow-up|238|||
147398610|NCT03463577|531624146|FG001|Overall Study|Lost to Follow-up|435|||
147398611|NCT03463577|531624147|FG002|Overall Study|Lost to Follow-up|0|||
147398612|NCT03463577|531624148|FG003|Overall Study|Lost to Follow-up|0|||
147665203|NCT00919633|532598069|FG003|Overall Study|Withdrawal by Subject|3|||
147398613|NCT03463577|531624149|FG004|Overall Study|Lost to Follow-up|0|||
147398614|NCT03463577|531624150|FG005|Overall Study|Lost to Follow-up|0|||
147398615|NCT03463577|531624145|FG000|Overall Study|With unknown pregnancy outcome|0|||
147398616|NCT03463577|531624146|FG001|Overall Study|With unknown pregnancy outcome|5|||
147398617|NCT03463577|531624147|FG002|Overall Study|With unknown pregnancy outcome|0|||
147398618|NCT03463577|531624148|FG003|Overall Study|With unknown pregnancy outcome|0|||
147398619|NCT03463577|531624149|FG004|Overall Study|With unknown pregnancy outcome|0|||
147398620|NCT03463577|531624150|FG005|Overall Study|With unknown pregnancy outcome|0|||
147398621|NCT03463577|531624145|FG000|Overall Study|Maternal death|2|||
147398622|NCT03463577|531624146|FG001|Overall Study|Maternal death|0|||
147398623|NCT03463577|531624147|FG002|Overall Study|Maternal death|0|||
147398624|NCT03463577|531624148|FG003|Overall Study|Maternal death|0|||
147398625|NCT03463577|531624149|FG004|Overall Study|Maternal death|0|||
147398626|NCT03463577|531624150|FG005|Overall Study|Maternal death|0|||
147398627|NCT03463577|531624145|FG000|Overall Study|Neonatal death|0|||
147398628|NCT03463577|531624146|FG001|Overall Study|Neonatal death|0|||
147398629|NCT03463577|531624147|FG002|Overall Study|Neonatal death|0|||
147398630|NCT03463577|531624148|FG003|Overall Study|Neonatal death|15|||
147398631|NCT03463577|531624149|FG004|Overall Study|Neonatal death|17|||
147398632|NCT03463577|531624150|FG005|Overall Study|Neonatal death|0|||
147398633|NCT00236184|531624151|FG000|Overall Study|Adverse Event|5|||
147398634|NCT00236184|531624152|FG001|Overall Study|Adverse Event|2|||
147398635|NCT00236184|531624151|FG000|Overall Study|Lack of Efficacy|0|||
147398636|NCT00236184|531624152|FG001|Overall Study|Lack of Efficacy|1|||
147398637|NCT00236184|531624151|FG000|Overall Study|Lost to Follow-up|3|||
147398638|NCT00236184|531624152|FG001|Overall Study|Lost to Follow-up|4|||
147398639|NCT00236184|531624151|FG000|Overall Study|Physician Decision|1|||
147398640|NCT00236184|531624152|FG001|Overall Study|Physician Decision|1|||
147398641|NCT00236184|531624151|FG000|Overall Study|Withdrawal by Subject|3|||
147398642|NCT00236184|531624152|FG001|Overall Study|Withdrawal by Subject|0|||
147398643|NCT00236184|531624151|FG000|Overall Study|Protocol Violation|3|||
147398644|NCT00236184|531624152|FG001|Overall Study|Protocol Violation|0|||
147398645|NCT00236184|531624151|FG000|Overall Study|non-compliance with study drug|2|||
147398646|NCT00236184|531624152|FG001|Overall Study|non-compliance with study drug|1|||
147398647|NCT00236184|531624151|FG000|Overall Study|other|1|||
147398648|NCT00236184|531624152|FG001|Overall Study|other|2|||
147398649|NCT01101997|531624153|FG000|Overall Study|Withdrawal by Subject|2|||
147398650|NCT00469456|531624154|FG000|Overall Study|Adverse Event|4|||
147398651|NCT00469456|531624155|FG001|Overall Study|Adverse Event|3|||
147398652|NCT00469456|531624154|FG000|Overall Study|Protocol Violation|1|||
147398653|NCT00469456|531624155|FG001|Overall Study|Protocol Violation|0|||
147398654|NCT00469456|531624154|FG000|Overall Study|Withdrawal by Subject|4|||
147398655|NCT00469456|531624155|FG001|Overall Study|Withdrawal by Subject|1|||
147398656|NCT01772563|531624165|FG000|Cycle 1|Dose limiting toxicity|2|||
147398657|NCT01772563|531624165|FG000|Cycle 1|Progressive disease|2|||
147398658|NCT01772563|531624165|FG000|Cycle 2 and Beyond|Progressive disease|17|||
147398659|NCT01772563|531624165|FG000|Cycle 2 and Beyond|Refused continuing medication|4|||
147398660|NCT01772563|531624165|FG000|Cycle 2 and Beyond|Withdrawal by Subject|2|||
147398661|NCT00832000|531624166|FG000|Overall Study|Adverse Event|2|||
147398662|NCT00832000|531624167|FG001|Overall Study|Adverse Event|0|||
147398663|NCT00832000|531624166|FG000|Overall Study|Withdrawal by Subject|1|||
147398664|NCT00832000|531624167|FG001|Overall Study|Withdrawal by Subject|0|||
147398665|NCT00832000|531624166|FG000|Overall Study|No calls to IVR in either period|1|||
147398666|NCT00832000|531624167|FG001|Overall Study|No calls to IVR in either period|1|||
147398667|NCT00832000|531624166|FG000|Overall Study|No calls to IVR in period 2|2|||
147398668|NCT00832000|531624167|FG001|Overall Study|No calls to IVR in period 2|0|||
147398669|NCT01898442|531624168|FG000|Overall Study|Hemolysis/technical problems|1|||
147398670|NCT01898442|531624169|FG001|Overall Study|Hemolysis/technical problems|2|||
147398671|NCT01898442|531624170|FG002|Overall Study|Hemolysis/technical problems|2|||
147398672|NCT01898442|531624168|FG000|Overall Study|Patient vomited pills|0|||
147398673|NCT01898442|531624169|FG001|Overall Study|Patient vomited pills|0|||
147398674|NCT01898442|531624170|FG002|Overall Study|Patient vomited pills|1|||
147398675|NCT01435798|531624171|FG000|Overall Study|Withdrawal by Subject|1|||
147398676|NCT03974100|531624172|FG000|TP1 - Day 1 to Week 52|Adverse Event|1|||
147398677|NCT03974100|531624173|FG001|TP1 - Day 1 to Week 52|Adverse Event|3|||
147398678|NCT03974100|531624174|FG002|TP1 - Day 1 to Week 52|Adverse Event|0|||
147398679|NCT03974100|531624175|FG003|TP1 - Day 1 to Week 52|Adverse Event|0|||
147398680|NCT03974100|531624176|FG004|TP1 - Day 1 to Week 52|Adverse Event|0|||
147398681|NCT03974100|531624172|FG000|TP1 - Day 1 to Week 52|Death|1|||
147398682|NCT03974100|531624173|FG001|TP1 - Day 1 to Week 52|Death|0|||
147398683|NCT03974100|531624174|FG002|TP1 - Day 1 to Week 52|Death|0|||
147398684|NCT03974100|531624175|FG003|TP1 - Day 1 to Week 52|Death|0|||
147398685|NCT03974100|531624176|FG004|TP1 - Day 1 to Week 52|Death|0|||
147461044|NCT02211261|531849429|FG000|Overall Study|Other|0|||
147461045|NCT02211261|531849430|FG001|Overall Study|Other|0|||
147461046|NCT02211261|531849431|FG002|Overall Study|Other|0|||
147398686|NCT03974100|531624172|FG000|TP1 - Day 1 to Week 52|Lost to Follow-up|0|||
147398687|NCT03974100|531624173|FG001|TP1 - Day 1 to Week 52|Lost to Follow-up|1|||
147461047|NCT02211261|531849432|FG003|Overall Study|Other|0|||
147461048|NCT02211261|531849433|FG004|Overall Study|Other|0|||
147398688|NCT03974100|531624174|FG002|TP1 - Day 1 to Week 52|Lost to Follow-up|0|||
147461049|NCT02211261|531849434|FG005|Overall Study|Other|1|||
147615438|NCT04917861|532406736|FG001|Main Study (196 Days)|Withdrawal by Subject|7|||
147398689|NCT03974100|531624175|FG003|TP1 - Day 1 to Week 52|Lost to Follow-up|0|||
147398690|NCT03974100|531624176|FG004|TP1 - Day 1 to Week 52|Lost to Follow-up|0|||
147398691|NCT03974100|531624172|FG000|TP1 - Day 1 to Week 52|Physician Decision|0|||
147398692|NCT03974100|531624173|FG001|TP1 - Day 1 to Week 52|Physician Decision|2|||
147398693|NCT03974100|531624174|FG002|TP1 - Day 1 to Week 52|Physician Decision|0|||
147398694|NCT03974100|531624175|FG003|TP1 - Day 1 to Week 52|Physician Decision|0|||
147461050|NCT02211261|531849435|FG006|Overall Study|Other|0|||
147398695|NCT03974100|531624176|FG004|TP1 - Day 1 to Week 52|Physician Decision|0|||
147398696|NCT03974100|531624172|FG000|TP1 - Day 1 to Week 52|Subject decision|8|||
147398697|NCT03974100|531624173|FG001|TP1 - Day 1 to Week 52|Subject decision|9|||
147398698|NCT03974100|531624174|FG002|TP1 - Day 1 to Week 52|Subject decision|0|||
147398699|NCT03974100|531624175|FG003|TP1 - Day 1 to Week 52|Subject decision|0|||
147398700|NCT03974100|531624176|FG004|TP1 - Day 1 to Week 52|Subject decision|0|||
147398701|NCT03974100|531624172|FG000|TP2- Week 52 to Week 78|Lost to Follow-up|0|||
147398702|NCT03974100|531624173|FG001|TP2- Week 52 to Week 78|Lost to Follow-up|0|||
147398703|NCT03974100|531624174|FG002|TP2- Week 52 to Week 78|Lost to Follow-up|0|||
147398704|NCT03974100|531624175|FG003|TP2- Week 52 to Week 78|Lost to Follow-up|1|||
147398705|NCT03974100|531624176|FG004|TP2- Week 52 to Week 78|Lost to Follow-up|0|||
147398706|NCT03974100|531624172|FG000|TP2- Week 52 to Week 78|Subject decision|0|||
147398707|NCT03974100|531624173|FG001|TP2- Week 52 to Week 78|Subject decision|0|||
147398708|NCT03974100|531624174|FG002|TP2- Week 52 to Week 78|Subject decision|0|||
147398709|NCT03974100|531624175|FG003|TP2- Week 52 to Week 78|Subject decision|1|||
147398710|NCT03974100|531624176|FG004|TP2- Week 52 to Week 78|Subject decision|0|||
147398711|NCT00690378|531624177|FG000|Overall Study|Adverse Event|1|||
147398712|NCT00690378|531624178|FG001|Overall Study|Adverse Event|0|||
147398713|NCT00690378|531624177|FG000|Overall Study|Withdrawal by Subject|2|||
147398714|NCT00690378|531624178|FG001|Overall Study|Withdrawal by Subject|0|||
147398715|NCT00690378|531624177|FG000|Overall Study|Protocol Violation|1|||
147398716|NCT00690378|531624178|FG001|Overall Study|Protocol Violation|0|||
147398717|NCT00690378|531624177|FG000|Overall Study|Lost to Follow-up|2|||
147398718|NCT00690378|531624178|FG001|Overall Study|Lost to Follow-up|3|||
147398719|NCT00690378|531624177|FG000|Overall Study|Did not meet inc/exc criteria|13|||
147398720|NCT00690378|531624178|FG001|Overall Study|Did not meet inc/exc criteria|11|||
147398721|NCT00690378|531624177|FG000|Overall Study|Social problem|1|||
147398722|NCT00690378|531624178|FG001|Overall Study|Social problem|0|||
147398723|NCT00935259|531624179|FG000|Period 1|Administrative (scheduling conflict)|1|||
147398724|NCT00935259|531624180|FG001|Period 1|Administrative (scheduling conflict)|1|||
147398725|NCT03318783|531624181|FG000|Overall Study|Withdrawal by Subject|0|||
147398726|NCT03318783|531624182|FG001|Overall Study|Withdrawal by Subject|1|||
147398727|NCT03318783|531624181|FG000|Overall Study|Death|0|||
147398728|NCT03318783|531624182|FG001|Overall Study|Death|1|||
147398729|NCT01721746|531624186|FG000|Pre-Treatment|Participant request to discontinue Study treatment|0|||
147398730|NCT01721746|531624187|FG001|Pre-Treatment|Participant request to discontinue Study treatment|13|||
147398731|NCT01721746|531624186|FG000|Pre-Treatment|Withdrawal by Subject|1|||
147398732|NCT01721746|531624187|FG001|Pre-Treatment|Withdrawal by Subject|16|||
147398733|NCT01721746|531624186|FG000|Pre-Treatment|Poor/Non-compliance|1|||
147398734|NCT01721746|531624187|FG001|Pre-Treatment|Poor/Non-compliance|0|||
147398735|NCT01721746|531624186|FG000|Pre-Treatment|Participant no longer met study criteria|2|||
147398736|NCT01721746|531624187|FG001|Pre-Treatment|Participant no longer met study criteria|2|||
147398737|NCT01721746|531624186|FG000|Treatment|Disease Progression|192|||
147398738|NCT01721746|531624187|FG001|Treatment|Disease Progression|74|||
147398739|NCT01721746|531624186|FG000|Treatment|Study Drug Toxicity|19|||
147398740|NCT01721746|531624187|FG001|Treatment|Study Drug Toxicity|11|||
147398741|NCT01721746|531624186|FG000|Treatment|Adverse Event unrelated to Study Drug|6|||
147398742|NCT01721746|531624187|FG001|Treatment|Adverse Event unrelated to Study Drug|3|||
147398743|NCT01721746|531624186|FG000|Treatment|Participant request to discontinue Study treatment|26|||
147398744|NCT01721746|531624187|FG001|Treatment|Participant request to discontinue Study treatment|7|||
147398745|NCT01721746|531624186|FG000|Treatment|Participant withdrew consent|4|||
147398746|NCT01721746|531624187|FG001|Treatment|Participant withdrew consent|2|||
147398747|NCT01721746|531624186|FG000|Treatment|Maximum Clinical Benefit|9|||
147398748|NCT01721746|531624187|FG001|Treatment|Maximum Clinical Benefit|3|||
147398749|NCT01721746|531624186|FG000|Treatment|Poor/Non-compliance|2|||
147398750|NCT01721746|531624187|FG001|Treatment|Poor/Non-compliance|0|||
147398751|NCT01721746|531624186|FG000|Treatment|Participant no longer met Study criteria|4|||
147398752|NCT01721746|531624187|FG001|Treatment|Participant no longer met Study criteria|0|||
147398753|NCT01721746|531624186|FG000|Treatment|Other reasons|6|||
147398754|NCT01721746|531624187|FG001|Treatment|Other reasons|2|||
147398755|NCT00623363|531624190|FG000|Overall Study|Adverse Event|2|||
147398756|NCT00623363|531624191|FG001|Overall Study|Adverse Event|2|||
147398757|NCT00927901|531624195|FG000|Treatment Period 1|Subject withdrew consent|0|||
147398758|NCT00927901|531624196|FG001|Treatment Period 1|Subject withdrew consent|0|||
147398759|NCT00927901|531624197|FG002|Treatment Period 1|Subject withdrew consent|1|||
147398760|NCT00927901|531624198|FG003|Treatment Period 1|Subject withdrew consent|0|||
147398761|NCT00927901|531624195|FG000|Treatment Period 4|Adverse Event|0|||
147398762|NCT00927901|531624196|FG001|Treatment Period 4|Adverse Event|0|||
147398763|NCT00927901|531624197|FG002|Treatment Period 4|Adverse Event|0|||
147398764|NCT00927901|531624198|FG003|Treatment Period 4|Adverse Event|1|||
147398765|NCT00927901|531624195|FG000|Treatment Period 4|Subject withdrew consent|0|||
147398766|NCT00927901|531624196|FG001|Treatment Period 4|Subject withdrew consent|0|||
147398767|NCT00927901|531624197|FG002|Treatment Period 4|Subject withdrew consent|1|||
147398768|NCT00927901|531624198|FG003|Treatment Period 4|Subject withdrew consent|0|||
147398769|NCT02344173|531624199|FG000|Procedure|Ablation Procedure Not Performed|7|||
147398770|NCT02344173|531624199|FG000|12-month Visit|Death|8|||
147398771|NCT02344173|531624199|FG000|12-month Visit|Withdrawal by Subject|30|||
147398772|NCT02344173|531624199|FG000|12-month Visit|Lost to Follow-up|58|||
147398773|NCT03738397|531624200|FG000|Overall Study|Adverse Event|3|||
147398774|NCT03738397|531624201|FG001|Overall Study|Adverse Event|7|||
147398775|NCT03738397|531624200|FG000|Overall Study|Withdrawal by Subject|8|||
147398776|NCT03738397|531624201|FG001|Overall Study|Withdrawal by Subject|11|||
147398777|NCT03738397|531624200|FG000|Overall Study|Lost to Follow-up|7|||
147398778|NCT03738397|531624201|FG001|Overall Study|Lost to Follow-up|5|||
147398779|NCT03738397|531624200|FG000|Overall Study|COVID-19 Logistical Restrictions|1|||
147398780|NCT03738397|531624201|FG001|Overall Study|COVID-19 Logistical Restrictions|1|||
147398781|NCT03738397|531624200|FG000|Overall Study|Other|4|||
147398782|NCT03738397|531624201|FG001|Overall Study|Other|6|||
147398783|NCT02881047|531624202|FG000|Overall Study|Adverse Event|1|||
147398784|NCT02881047|531624202|FG000|Overall Study|Withdrawal by Subject|1|||
147398785|NCT04814992|531624212|FG000|Overall Study|Withdrawal by Subject|6|||
147398786|NCT04814992|531624213|FG001|Overall Study|Withdrawal by Subject|3|||
147398787|NCT04814992|531624212|FG000|Overall Study|Lost to Follow-up|1|||
147398788|NCT04814992|531624213|FG001|Overall Study|Lost to Follow-up|4|||
147398789|NCT01831726|531624218|FG000|Overall Study|Adverse Event|16|||
147398790|NCT01831726|531624218|FG000|Overall Study|Death|7|||
147398791|NCT01831726|531624218|FG000|Overall Study|Disease Progression|49|||
147398792|NCT01831726|531624218|FG000|Overall Study|Physician Decision|1|||
147398793|NCT01831726|531624218|FG000|Overall Study|Subject/guardian decision|7|||
147398794|NCT01075100|531624221|FG000|Overall Study|Adverse Event|15|||
147398795|NCT01075100|531624222|FG001|Overall Study|Adverse Event|18|||
147398796|NCT01075100|531624221|FG000|Overall Study|Patient Request|4|||
147398797|NCT01075100|531624222|FG001|Overall Study|Patient Request|4|||
147398798|NCT01075100|531624221|FG000|Overall Study|Investigator Request|2|||
147398799|NCT01075100|531624222|FG001|Overall Study|Investigator Request|1|||
147398800|NCT01075100|531624221|FG000|Overall Study|Disease Progression|25|||
147398801|NCT01075100|531624222|FG001|Overall Study|Disease Progression|29|||
147398802|NCT01075100|531624221|FG000|Overall Study|Other|3|||
147398803|NCT01075100|531624222|FG001|Overall Study|Other|1|||
147398804|NCT02388347|531626324|FG000|Overall Study|Withdrawal by Subject|0|||
147398805|NCT02388347|531626325|FG001|Overall Study|Withdrawal by Subject|0|||
147398806|NCT02388347|531626326|FG002|Overall Study|Withdrawal by Subject|1|||
147398807|NCT02388347|531626327|FG003|Overall Study|Withdrawal by Subject|0|||
147398808|NCT02388347|531626328|FG004|Overall Study|Withdrawal by Subject|0|||
147398809|NCT03898700|531626329|FG000|Overall Study|Withdrawal by Subject|2|||
147398810|NCT00701909|531626330|FG000|Overall Study|Withdrawal by Subject|0|||
147398811|NCT00701909|531626331|FG001|Overall Study|Withdrawal by Subject|1|||
147398812|NCT00971997|531626332|FG000|Overall Study|Adverse Event|2|||
147398813|NCT00971997|531626332|FG000|Overall Study|Death|1|||
147398814|NCT00971997|531626332|FG000|Overall Study|Protocol Violation|4|||
147398815|NCT00971997|531626332|FG000|Overall Study|Withdrawal by Subject|5|||
147398816|NCT00971997|531626332|FG000|Overall Study|Physician Decision|7|||
147398817|NCT04009629|531626333|FG000|Overall Study|Withdrawal by Subject|2|||
147398818|NCT04009629|531626334|FG001|Overall Study|Withdrawal by Subject|0|||
147398819|NCT00761956|531626335|FG000|Overall Study|Lost to Follow-up|6|||
147398820|NCT00761956|531626336|FG001|Overall Study|Lost to Follow-up|11|||
147398821|NCT00761956|531626335|FG000|Overall Study|Withdrawal by Subject|3|||
147615439|NCT04917861|532406737|FG002|Main Study (196 Days)|Withdrawal by Subject|6|||
147615440|NCT04917861|532406738|FG003|Main Study (196 Days)|Withdrawal by Subject|8|||
147615441|NCT04917861|532406735|FG000|Main Study (196 Days)|Other Than Specified|1|||
147615442|NCT04917861|532406736|FG001|Main Study (196 Days)|Other Than Specified|0|||
147398822|NCT00761956|531626336|FG001|Overall Study|Withdrawal by Subject|8|||
147398823|NCT00761956|531626335|FG000|Overall Study|Death|0|||
147615443|NCT04917861|532406737|FG002|Main Study (196 Days)|Other Than Specified|1|||
147398824|NCT00761956|531626336|FG001|Overall Study|Death|1|||
147398825|NCT00761956|531626335|FG000|Overall Study|Adverse Event|26|||
147398826|NCT00761956|531626336|FG001|Overall Study|Adverse Event|34|||
147615444|NCT04917861|532406738|FG003|Main Study (196 Days)|Other Than Specified|2|||
147665204|NCT00919633|532598066|FG000|Overall Study|Lost to Follow-up|3|||
147398827|NCT04398368|531626342|FG000|Overall Study|Withdrawal by Subject|2|||
147398828|NCT02808975|531626343|FG000|Overall Study|Adverse Event|3|||
147398829|NCT02808975|531626344|FG001|Overall Study|Adverse Event|4|||
147398830|NCT02808975|531626343|FG000|Overall Study|Withdrew consent|9|||
147398831|NCT02808975|531626344|FG001|Overall Study|Withdrew consent|8|||
147398832|NCT02808975|531626343|FG000|Overall Study|Lost to Follow-up|4|||
147398833|NCT02808975|531626344|FG001|Overall Study|Lost to Follow-up|6|||
147398834|NCT02808975|531626343|FG000|Overall Study|Planned HS surgery performed prior Wk 13|1|||
147615445|NCT04917861|532406735|FG000|Extension Period (Day 197 to Day 700)|Lost to Follow-up|8|||
147398835|NCT02808975|531626344|FG001|Overall Study|Planned HS surgery performed prior Wk 13|0|||
147398836|NCT02808975|531626343|FG000|Overall Study|Other, not specified|5|||
147665205|NCT00919633|532598067|FG001|Overall Study|Lost to Follow-up|1|||
147398837|NCT02808975|531626344|FG001|Overall Study|Other, not specified|1|||
147398838|NCT03602586|531626345|FG000|Overall Study|Withdrawal by Subject|3|||
147398839|NCT02106195|531626347|FG000|Overall Study|Adverse Event|2|||
147398840|NCT02106195|531626347|FG000|Overall Study|Protocol Violation|1|||
147398841|NCT03568812|531626348|FG000|Overall Study|Physician Decision|0|||
147398842|NCT03568812|531626349|FG001|Overall Study|Physician Decision|1|||
147398843|NCT00634842|531626356|FG000|Overall Study|Adverse Event|2|||
147398844|NCT00634842|531626357|FG001|Overall Study|Adverse Event|3|||
147398845|NCT00634842|531626356|FG000|Overall Study|Protocol Violation|8|||
147398846|NCT00634842|531626357|FG001|Overall Study|Protocol Violation|4|||
147398847|NCT00634842|531626356|FG000|Overall Study|Move to another state|1|||
147398848|NCT00634842|531626357|FG001|Overall Study|Move to another state|0|||
147398849|NCT00634842|531626356|FG000|Overall Study|Inclusion criteria were not met|1|||
147398850|NCT00634842|531626357|FG001|Overall Study|Inclusion criteria were not met|0|||
147398851|NCT00634842|531626356|FG000|Overall Study|Lost to Follow-up|1|||
147398852|NCT00634842|531626357|FG001|Overall Study|Lost to Follow-up|2|||
147398853|NCT00634842|531626356|FG000|Overall Study|Physician Decision|1|||
147398854|NCT00634842|531626357|FG001|Overall Study|Physician Decision|0|||
147398855|NCT00634842|531626356|FG000|Overall Study|Withdrawal by Subject|1|||
147398856|NCT00634842|531626357|FG001|Overall Study|Withdrawal by Subject|3|||
147398857|NCT00634842|531626356|FG000|Overall Study|Lack of time and intolerance to drug|0|||
147398858|NCT00634842|531626357|FG001|Overall Study|Lack of time and intolerance to drug|1|||
147398859|NCT00634842|531626356|FG000|Overall Study|Discontinued due to injection|0|||
147398860|NCT00634842|531626357|FG001|Overall Study|Discontinued due to injection|2|||
147398861|NCT00634842|531626356|FG000|Overall Study|No need of study drug to treat diabetes|0|||
147398862|NCT00634842|531626357|FG001|Overall Study|No need of study drug to treat diabetes|1|||
147398863|NCT00634842|531626356|FG000|Overall Study|No wish to keep taking Avandia|0|||
147398864|NCT00634842|531626357|FG001|Overall Study|No wish to keep taking Avandia|1|||
147398865|NCT00634842|531626356|FG000|Overall Study|Subject off study drug for too long|0|||
147398866|NCT00634842|531626357|FG001|Overall Study|Subject off study drug for too long|1|||
147398867|NCT03194867|531626358|FG000|Overall Study|Incorrect completion of end of study form|0|||
147398868|NCT03194867|531626359|FG001|Overall Study|Incorrect completion of end of study form|0|||
147398869|NCT03194867|531626360|FG002|Overall Study|Incorrect completion of end of study form|1|||
147398870|NCT03194867|531626361|FG003|Overall Study|Incorrect completion of end of study form|0|||
147398871|NCT00464945|531626362|FG000|Infant Series|Withdrawal by parent/guardian request|2|||
147398872|NCT00464945|531626363|FG001|Infant Series|Withdrawal by parent/guardian request|1|||
147398873|NCT00464945|531626362|FG000|Infant Series|Protocol Violation|1|||
147398874|NCT00464945|531626363|FG001|Infant Series|Protocol Violation|0|||
147398875|NCT00464945|531626362|FG000|Infant Series|Lost to Follow-up|1|||
147398876|NCT00464945|531626363|FG001|Infant Series|Lost to Follow-up|0|||
147398877|NCT00464945|531626362|FG000|After Infant Series|Withdrawal by Subject|0|||
147398878|NCT00464945|531626363|FG001|After Infant Series|Withdrawal by Subject|2|||
147398879|NCT00464945|531626362|FG000|Toddler Dose|Lost to Follow-up|0|||
147398880|NCT00464945|531626363|FG001|Toddler Dose|Lost to Follow-up|1|||
147398881|NCT01010204|531626364|FG000|Overall Study|Lost to Follow-up|2|||
147398882|NCT01010204|531626365|FG001|Overall Study|Lost to Follow-up|2|||
147398883|NCT01010204|531626364|FG000|Overall Study|Adverse Event|1|||
147398884|NCT01010204|531626365|FG001|Overall Study|Adverse Event|3|||
147398885|NCT01010204|531626364|FG000|Overall Study|Withdrawal by Subject|2|||
147398886|NCT01010204|531626365|FG001|Overall Study|Withdrawal by Subject|3|||
147398887|NCT01010204|531626364|FG000|Overall Study|psychiatric hospitalization|2|||
147398888|NCT01010204|531626365|FG001|Overall Study|psychiatric hospitalization|1|||
147398889|NCT01513330|531626366|FG000|SenSura Mio First,|Adverse Event|2|||
147398890|NCT01513330|531626367|FG001|SenSura Mio First,|Adverse Event|0|||
147398891|NCT01513330|531626366|FG000|SenSura Mio First,|Lack of Efficacy|0|||
147398892|NCT01513330|531626367|FG001|SenSura Mio First,|Lack of Efficacy|1|||
147398893|NCT01513330|531626366|FG000|SenSura Mio First,|Withdrawal by Subject|1|||
147398894|NCT01513330|531626367|FG001|SenSura Mio First,|Withdrawal by Subject|1|||
147398895|NCT01513330|531626366|FG000|SenSura Mio First,|Other|1|||
147398896|NCT01513330|531626367|FG001|SenSura Mio First,|Other|0|||
147398897|NCT01513330|531626366|FG000|Standard Care First,|Lack of Efficacy|2|||
147398898|NCT01513330|531626367|FG001|Standard Care First,|Lack of Efficacy|2|||
147398899|NCT01513330|531626366|FG000|Standard Care First,|Withdrawal by Subject|1|||
147398900|NCT01513330|531626367|FG001|Standard Care First,|Withdrawal by Subject|2|||
147398901|NCT01513330|531626366|FG000|Standard Care First,|Other|1|||
147398902|NCT01513330|531626367|FG001|Standard Care First,|Other|0|||
147398903|NCT01519778|531626368|FG000|Overall Study|Withdrawal by Subject|3|||
147398904|NCT01519778|531626368|FG000|Overall Study|Lost to Follow-up|10|||
147398905|NCT01519778|531626368|FG000|Overall Study|Physician Decision|1|||
147398906|NCT03021551|531626374|FG000|Overall Study|Equipment Issues|2|||
147398907|NCT03021551|531626374|FG000|Overall Study|Protocol Violation|1|||
147398908|NCT00551135|531626381|FG000|Overall Study|Adverse Event|1|||
147398909|NCT00551135|531626382|FG001|Overall Study|Adverse Event|0|||
147398910|NCT00551135|531626383|FG002|Overall Study|Adverse Event|1|||
147398911|NCT00551135|531626384|FG003|Overall Study|Adverse Event|1|||
147398912|NCT00551135|531626381|FG000|Overall Study|Lost to Follow-up|0|||
147398913|NCT00551135|531626382|FG001|Overall Study|Lost to Follow-up|0|||
147398914|NCT00551135|531626383|FG002|Overall Study|Lost to Follow-up|0|||
147398915|NCT00551135|531626384|FG003|Overall Study|Lost to Follow-up|1|||
147398916|NCT00551135|531626381|FG000|Overall Study|Other|3|||
147398917|NCT00551135|531626382|FG001|Overall Study|Other|2|||
147398918|NCT00551135|531626383|FG002|Overall Study|Other|1|||
147398919|NCT00551135|531626384|FG003|Overall Study|Other|2|||
147398920|NCT00551135|531626381|FG000|Overall Study|Withdrawal by Subject|1|||
147398921|NCT00551135|531626382|FG001|Overall Study|Withdrawal by Subject|0|||
147398922|NCT00551135|531626383|FG002|Overall Study|Withdrawal by Subject|3|||
147398923|NCT00551135|531626384|FG003|Overall Study|Withdrawal by Subject|1|||
147398924|NCT04799418|531626385|FG000|Overall Study|Death|1|||
147398925|NCT04799418|531626386|FG001|Overall Study|Death|1|||
147398926|NCT04799418|531626385|FG000|Overall Study|Lack of Efficacy|14|||
147398927|NCT04799418|531626386|FG001|Overall Study|Lack of Efficacy|14|||
147398928|NCT04799418|531626385|FG000|Overall Study|Withdrawal by Subject|10|||
147398929|NCT04799418|531626386|FG001|Overall Study|Withdrawal by Subject|7|||
147398930|NCT04799418|531626385|FG000|Overall Study|Adverse Event|3|||
147398931|NCT04799418|531626386|FG001|Overall Study|Adverse Event|2|||
147398932|NCT01379703|531626387|FG000|Study Start Through 9 Months|Lost to Follow-up|2|||
147398933|NCT01379703|531626388|FG001|Study Start Through 9 Months|Lost to Follow-up|61|||
147398934|NCT01379703|531626389|FG002|Study Start Through 9 Months|Lost to Follow-up|104|||
147398935|NCT01379703|531626387|FG000|Study Start Through 9 Months|Adverse Event|0|||
147398936|NCT01379703|531626388|FG001|Study Start Through 9 Months|Adverse Event|14|||
147398937|NCT01379703|531626389|FG002|Study Start Through 9 Months|Adverse Event|10|||
147398938|NCT01379703|531626387|FG000|Study Start Through 9 Months|Withdrawal by Subject|0|||
147398939|NCT01379703|531626388|FG001|Study Start Through 9 Months|Withdrawal by Subject|6|||
147398940|NCT01379703|531626389|FG002|Study Start Through 9 Months|Withdrawal by Subject|1|||
147398941|NCT01379703|531626387|FG000|Study Start Through 9 Months|Treatment Failure|0|||
147398942|NCT01379703|531626388|FG001|Study Start Through 9 Months|Treatment Failure|2|||
147398943|NCT01379703|531626389|FG002|Study Start Through 9 Months|Treatment Failure|2|||
147398944|NCT01379703|531626387|FG000|Study Start Through 9 Months|Patient Noncompliance|0|||
147398945|NCT01379703|531626388|FG001|Study Start Through 9 Months|Patient Noncompliance|0|||
147398946|NCT01379703|531626389|FG002|Study Start Through 9 Months|Patient Noncompliance|1|||
147398947|NCT01379703|531626387|FG000|Study Start Through 9 Months|Tuberculosis/TB treatment|0|||
147398948|NCT01379703|531626388|FG001|Study Start Through 9 Months|Tuberculosis/TB treatment|4|||
147398949|NCT01379703|531626389|FG002|Study Start Through 9 Months|Tuberculosis/TB treatment|0|||
147398950|NCT01379703|531626387|FG000|Study Start Through 9 Months|Medication not available|0|||
147398951|NCT01379703|531626388|FG001|Study Start Through 9 Months|Medication not available|2|||
147398952|NCT01379703|531626389|FG002|Study Start Through 9 Months|Medication not available|1|||
147398953|NCT01379703|531626387|FG000|Study Start Through 9 Months|Poor general condition|0|||
147398954|NCT01379703|531626388|FG001|Study Start Through 9 Months|Poor general condition|1|||
147398955|NCT01379703|531626389|FG002|Study Start Through 9 Months|Poor general condition|0|||
147398956|NCT01379703|531626387|FG000|Study Start Through 9 Months|Increased triglycerides|0|||
147398957|NCT01379703|531626388|FG001|Study Start Through 9 Months|Increased triglycerides|1|||
147398958|NCT01379703|531626389|FG002|Study Start Through 9 Months|Increased triglycerides|0|||
147398959|NCT01379703|531626387|FG000|Study Start Through 9 Months|Reason unknown|2|||
147398960|NCT01379703|531626388|FG001|Study Start Through 9 Months|Reason unknown|31|||
147398961|NCT01379703|531626389|FG002|Study Start Through 9 Months|Reason unknown|24|||
147398962|NCT01379703|531626387|FG000|9 Months Through 18 Months|Lost to Follow-up|0|||
147398963|NCT01379703|531626388|FG001|9 Months Through 18 Months|Lost to Follow-up|178|||
147398964|NCT01379703|531626389|FG002|9 Months Through 18 Months|Lost to Follow-up|0|||
147398965|NCT01379703|531626387|FG000|9 Months Through 18 Months|Withdrawal by Subject|0|||
147398966|NCT01379703|531626388|FG001|9 Months Through 18 Months|Withdrawal by Subject|11|||
147398967|NCT01379703|531626389|FG002|9 Months Through 18 Months|Withdrawal by Subject|0|||
147398968|NCT01379703|531626387|FG000|9 Months Through 18 Months|Adverse Event|0|||
147398969|NCT01379703|531626388|FG001|9 Months Through 18 Months|Adverse Event|6|||
147398970|NCT01379703|531626389|FG002|9 Months Through 18 Months|Adverse Event|0|||
147398971|NCT01379703|531626387|FG000|9 Months Through 18 Months|Treatment failure|0|||
147398972|NCT01379703|531626388|FG001|9 Months Through 18 Months|Treatment failure|5|||
147398973|NCT01379703|531626389|FG002|9 Months Through 18 Months|Treatment failure|0|||
147398974|NCT01379703|531626387|FG000|9 Months Through 18 Months|Patient Noncompliance|0|||
147398975|NCT01379703|531626388|FG001|9 Months Through 18 Months|Patient Noncompliance|4|||
147398976|NCT01379703|531626389|FG002|9 Months Through 18 Months|Patient Noncompliance|0|||
147398977|NCT01379703|531626387|FG000|9 Months Through 18 Months|Tuberculosis/TB treatment|0|||
147398978|NCT01379703|531626388|FG001|9 Months Through 18 Months|Tuberculosis/TB treatment|2|||
147398979|NCT01379703|531626389|FG002|9 Months Through 18 Months|Tuberculosis/TB treatment|0|||
147398980|NCT01379703|531626387|FG000|9 Months Through 18 Months|Fatigue|0|||
147398981|NCT01379703|531626388|FG001|9 Months Through 18 Months|Fatigue|1|||
147398982|NCT01379703|531626389|FG002|9 Months Through 18 Months|Fatigue|0|||
147398983|NCT01379703|531626387|FG000|9 Months Through 18 Months|Reason Unknown|0|||
147398984|NCT01379703|531626388|FG001|9 Months Through 18 Months|Reason Unknown|23|||
147398985|NCT01379703|531626389|FG002|9 Months Through 18 Months|Reason Unknown|0|||
147398986|NCT02669407|531626392|FG000|Overall Study|Physician Decision|3|||
147398987|NCT00704171|531626393|FG000|Overall Study|Withdrawal by Subject|1|||
147398988|NCT00704171|531626394|FG001|Overall Study|Withdrawal by Subject|0|||
147398989|NCT03634839|531626397|FG000|First Intervention (2 Hours)|Adverse Event|0|||
147398990|NCT03634839|531626398|FG001|First Intervention (2 Hours)|Adverse Event|2|||
147398991|NCT01588366|531626404|FG000|Overall Study|Adverse Event|0|||
147398992|NCT01588366|531626405|FG001|Overall Study|Adverse Event|1|||
147398993|NCT01588366|531626406|FG002|Overall Study|Adverse Event|0|||
147398994|NCT01588366|531626407|FG003|Overall Study|Adverse Event|1|||
147398995|NCT01588366|531626408|FG004|Overall Study|Adverse Event|0|||
147398996|NCT01588366|531626409|FG005|Overall Study|Adverse Event|2|||
147398997|NCT00719043|531626410|FG000|Overall Study|Adverse Event|5|||
147398998|NCT00719043|531626411|FG001|Overall Study|Adverse Event|1|||
147398999|NCT00719043|531626412|FG002|Overall Study|Adverse Event|2|||
147399000|NCT00719043|531626413|FG003|Overall Study|Adverse Event|2|||
147399001|NCT00719043|531626414|FG004|Overall Study|Adverse Event|1|||
147399002|NCT00719043|531626415|FG005|Overall Study|Adverse Event|4|||
147399003|NCT00719043|531626416|FG006|Overall Study|Adverse Event|4|||
147399004|NCT00719043|531626410|FG000|Overall Study|Lost to Follow-up|14|||
147399005|NCT00719043|531626411|FG001|Overall Study|Lost to Follow-up|10|||
147399006|NCT00719043|531626412|FG002|Overall Study|Lost to Follow-up|8|||
147399007|NCT00719043|531626413|FG003|Overall Study|Lost to Follow-up|9|||
147399008|NCT00719043|531626414|FG004|Overall Study|Lost to Follow-up|10|||
147399009|NCT00719043|531626415|FG005|Overall Study|Lost to Follow-up|9|||
147399010|NCT00719043|531626416|FG006|Overall Study|Lost to Follow-up|9|||
147399011|NCT00719043|531626410|FG000|Overall Study|Protocol Violation|0|||
147399012|NCT00719043|531626411|FG001|Overall Study|Protocol Violation|0|||
147399013|NCT00719043|531626412|FG002|Overall Study|Protocol Violation|0|||
147399014|NCT00719043|531626413|FG003|Overall Study|Protocol Violation|0|||
147399015|NCT00719043|531626414|FG004|Overall Study|Protocol Violation|0|||
147399016|NCT00719043|531626415|FG005|Overall Study|Protocol Violation|1|||
147399017|NCT00719043|531626416|FG006|Overall Study|Protocol Violation|0|||
147399018|NCT00719043|531626410|FG000|Overall Study|Other|1|||
147399019|NCT00719043|531626411|FG001|Overall Study|Other|0|||
147399020|NCT00719043|531626412|FG002|Overall Study|Other|1|||
147399021|NCT00719043|531626413|FG003|Overall Study|Other|2|||
147399022|NCT00719043|531626414|FG004|Overall Study|Other|0|||
147399023|NCT00719043|531626415|FG005|Overall Study|Other|2|||
147399024|NCT00719043|531626416|FG006|Overall Study|Other|1|||
147399025|NCT00719043|531626410|FG000|Overall Study|Withdrawal by Subject|12|||
147399026|NCT00719043|531626411|FG001|Overall Study|Withdrawal by Subject|14|||
147399027|NCT00719043|531626412|FG002|Overall Study|Withdrawal by Subject|9|||
147399028|NCT00719043|531626413|FG003|Overall Study|Withdrawal by Subject|10|||
147399029|NCT00719043|531626414|FG004|Overall Study|Withdrawal by Subject|16|||
147399030|NCT00719043|531626415|FG005|Overall Study|Withdrawal by Subject|18|||
147399031|NCT00719043|531626416|FG006|Overall Study|Withdrawal by Subject|14|||
147399032|NCT00302159|531626417|FG000|Overall Study|pt declined before treatment started|1|||
147399033|NCT00302159|531626417|FG000|Overall Study|pt started Avastin|1|||
147399034|NCT00813098|531626418|FG000|Overall Study|Adverse Event|2|||
147399035|NCT00813098|531626419|FG001|Overall Study|Adverse Event|4|||
147399036|NCT00813098|531626420|FG002|Overall Study|Adverse Event|1|||
147399037|NCT00813098|531626418|FG000|Overall Study|Withdrawal by Subject|0|||
147399038|NCT00813098|531626419|FG001|Overall Study|Withdrawal by Subject|1|||
147399039|NCT00813098|531626420|FG002|Overall Study|Withdrawal by Subject|0|||
147461051|NCT02211261|531849436|FG007|Overall Study|Other|0|||
147461052|NCT02211261|531849437|FG008|Overall Study|Other|0|||
147461053|NCT02211261|531849438|FG009|Overall Study|Other|2|||
147461054|NCT02211261|531849439|FG010|Overall Study|Other|0|||
147461055|NCT02211261|531849429|FG000|Overall Study|Lost to Follow-up|0|||
147461056|NCT02211261|531849430|FG001|Overall Study|Lost to Follow-up|0|||
147461057|NCT02211261|531849431|FG002|Overall Study|Lost to Follow-up|0|||
147461058|NCT02211261|531849432|FG003|Overall Study|Lost to Follow-up|0|||
147461059|NCT02211261|531849433|FG004|Overall Study|Lost to Follow-up|0|||
147461060|NCT02211261|531849434|FG005|Overall Study|Lost to Follow-up|0|||
147665206|NCT00919633|532598068|FG002|Overall Study|Lost to Follow-up|0|||
147399040|NCT00813098|531626418|FG000|Overall Study|Inability to complete study procedures|1|||
147399041|NCT00813098|531626419|FG001|Overall Study|Inability to complete study procedures|0|||
147399042|NCT00813098|531626420|FG002|Overall Study|Inability to complete study procedures|0|||
147399043|NCT00813098|531626418|FG000|Overall Study|Lost to Follow-up|0|||
147399044|NCT00813098|531626419|FG001|Overall Study|Lost to Follow-up|1|||
147399045|NCT00813098|531626420|FG002|Overall Study|Lost to Follow-up|0|||
147399046|NCT00813098|531626418|FG000|Overall Study|Protocol Violation|0|||
147399047|NCT00813098|531626419|FG001|Overall Study|Protocol Violation|0|||
147399048|NCT00813098|531626420|FG002|Overall Study|Protocol Violation|1|||
147399049|NCT00813098|531626418|FG000|Overall Study|Principal Investigator decision|0|||
147399050|NCT00813098|531626419|FG001|Overall Study|Principal Investigator decision|1|||
147399051|NCT00813098|531626420|FG002|Overall Study|Principal Investigator decision|0|||
147399052|NCT00813098|531626418|FG000|Overall Study|Withdrew Consent|0|||
147461061|NCT02211261|531849435|FG006|Overall Study|Lost to Follow-up|0|||
147461062|NCT02211261|531849436|FG007|Overall Study|Lost to Follow-up|1|||
147399053|NCT00813098|531626419|FG001|Overall Study|Withdrew Consent|1|||
147399054|NCT00813098|531626420|FG002|Overall Study|Withdrew Consent|0|||
147399055|NCT03470545|531626421|FG000|Overall Study|Death|0|||
147399056|NCT03470545|531626422|FG001|Overall Study|Death|1|||
147399057|NCT03470545|531626421|FG000|Overall Study|Did not complete Week 30 assessments due to scheduling conflict|1|||
147399058|NCT03470545|531626422|FG001|Overall Study|Did not complete Week 30 assessments due to scheduling conflict|0|||
147399059|NCT03470545|531626421|FG000|Overall Study|Adverse Event|2|||
147399060|NCT03470545|531626422|FG001|Overall Study|Adverse Event|0|||
147399061|NCT03470545|531626421|FG000|Overall Study|Withdrawal by Subject|1|||
147399062|NCT03470545|531626422|FG001|Overall Study|Withdrawal by Subject|1|||
147399063|NCT03470545|531626421|FG000|Overall Study|Week 30 not completed due to circumstances surrounding the COVID-19 pandemic|0|||
147399064|NCT03470545|531626422|FG001|Overall Study|Week 30 not completed due to circumstances surrounding the COVID-19 pandemic|1|||
147399065|NCT01664923|531626423|FG000|Period1:Double Blind Phase-29 Months|Death|8|||
147399066|NCT01664923|531626424|FG001|Period1:Double Blind Phase-29 Months|Death|6|||
147399067|NCT01664923|531626423|FG000|Period1:Double Blind Phase-29 Months|Lost to Follow-up|0|||
147399068|NCT01664923|531626424|FG001|Period1:Double Blind Phase-29 Months|Lost to Follow-up|1|||
147399069|NCT01664923|531626423|FG000|Period1:Double Blind Phase-29 Months|Protocol Violation|2|||
147399070|NCT01664923|531626424|FG001|Period1:Double Blind Phase-29 Months|Protocol Violation|0|||
147399071|NCT01664923|531626423|FG000|Period1:Double Blind Phase-29 Months|Withdrawal by Subject|12|||
147399072|NCT01664923|531626424|FG001|Period1:Double Blind Phase-29 Months|Withdrawal by Subject|8|||
147399073|NCT01664923|531626423|FG000|Period1:Double Blind Phase-29 Months|Disease Progression|65|||
147399074|NCT01664923|531626424|FG001|Period1:Double Blind Phase-29 Months|Disease Progression|132|||
147399075|NCT01664923|531626423|FG000|Period1:Double Blind Phase-29 Months|Adverse Event|14|||
147399076|NCT01664923|531626424|FG001|Period1:Double Blind Phase-29 Months|Adverse Event|9|||
147399077|NCT01664923|531626423|FG000|Period1:Double Blind Phase-29 Months|Other|3|||
147399078|NCT01664923|531626424|FG001|Period1:Double Blind Phase-29 Months|Other|4|||
147399079|NCT01664923|531626423|FG000|Period1:Double Blind Phase-29 Months|Randomized, But Not treated|1|||
147399080|NCT01664923|531626424|FG001|Period1:Double Blind Phase-29 Months|Randomized, But Not treated|0|||
147399081|NCT01664923|531626423|FG000|Period 2: Open-label Phase-36 Months|Death|3|||
147399082|NCT01664923|531626424|FG001|Period 2: Open-label Phase-36 Months|Death|1|||
147399083|NCT01664923|531626423|FG000|Period 2: Open-label Phase-36 Months|On Treatment|1|||
147399084|NCT01664923|531626424|FG001|Period 2: Open-label Phase-36 Months|On Treatment|1|||
147399085|NCT01664923|531626423|FG000|Period 2: Open-label Phase-36 Months|Disease progression|28|||
147399086|NCT01664923|531626424|FG001|Period 2: Open-label Phase-36 Months|Disease progression|9|||
147399087|NCT01664923|531626423|FG000|Period 2: Open-label Phase-36 Months|Other|3|||
147399088|NCT01664923|531626424|FG001|Period 2: Open-label Phase-36 Months|Other|1|||
147399089|NCT01664923|531626423|FG000|Period 2: Open-label Phase-36 Months|Adverse Event|4|||
147399090|NCT01664923|531626424|FG001|Period 2: Open-label Phase-36 Months|Adverse Event|7|||
147399091|NCT01664923|531626423|FG000|Period 2: Open-label Phase-36 Months|Withdrawal by Subject|2|||
147399092|NCT01664923|531626424|FG001|Period 2: Open-label Phase-36 Months|Withdrawal by Subject|4|||
147399093|NCT03672175|531626427|FG000|Treatment Period (Days 1 to 14)|Withdrawal by Subject|6|||
147399094|NCT03672175|531626428|FG001|Treatment Period (Days 1 to 14)|Withdrawal by Subject|6|||
147399095|NCT03672175|531626429|FG002|Treatment Period (Days 1 to 14)|Withdrawal by Subject|4|||
147399096|NCT03672175|531626427|FG000|Treatment Period (Days 1 to 14)|Lost to Follow-up|2|||
147399097|NCT03672175|531626428|FG001|Treatment Period (Days 1 to 14)|Lost to Follow-up|2|||
147399098|NCT03672175|531626429|FG002|Treatment Period (Days 1 to 14)|Lost to Follow-up|3|||
147399099|NCT03672175|531626427|FG000|Treatment Period (Days 1 to 14)|Randomized but not Treated|3|||
147399100|NCT03672175|531626428|FG001|Treatment Period (Days 1 to 14)|Randomized but not Treated|6|||
147399101|NCT03672175|531626429|FG002|Treatment Period (Days 1 to 14)|Randomized but not Treated|2|||
147399102|NCT03672175|531626427|FG000|FU Period (Days 15 to 42)|Adverse Event|0|||
147399103|NCT03672175|531626428|FG001|FU Period (Days 15 to 42)|Adverse Event|0|||
147399104|NCT03672175|531626429|FG002|FU Period (Days 15 to 42)|Adverse Event|1|||
147399105|NCT03672175|531626427|FG000|FU Period (Days 15 to 42)|Lost to Follow-up|3|||
147615446|NCT04917861|532406736|FG001|Extension Period (Day 197 to Day 700)|Lost to Follow-up|3|||
147615447|NCT04917861|532406737|FG002|Extension Period (Day 197 to Day 700)|Lost to Follow-up|5|||
147399106|NCT03672175|531626428|FG001|FU Period (Days 15 to 42)|Lost to Follow-up|6|||
147399107|NCT03672175|531626429|FG002|FU Period (Days 15 to 42)|Lost to Follow-up|2|||
147399108|NCT03672175|531626427|FG000|FU Period (Days 15 to 42)|Withdrawal by Subject|1|||
147399109|NCT03672175|531626428|FG001|FU Period (Days 15 to 42)|Withdrawal by Subject|4|||
147399110|NCT03672175|531626429|FG002|FU Period (Days 15 to 42)|Withdrawal by Subject|4|||
147399111|NCT03672175|531626427|FG000|Extended FU Period (Days 43 to 182)|Adverse Event|5|||
147399112|NCT03672175|531626428|FG001|Extended FU Period (Days 43 to 182)|Adverse Event|3|||
147615448|NCT04917861|532406738|FG003|Extension Period (Day 197 to Day 700)|Lost to Follow-up|11|||
147461063|NCT02211261|531849437|FG008|Overall Study|Lost to Follow-up|0|||
147461064|NCT02211261|531849438|FG009|Overall Study|Lost to Follow-up|0|||
147615449|NCT04917861|532406735|FG000|Extension Period (Day 197 to Day 700)|Pregnancy|1|||
147615450|NCT04917861|532406736|FG001|Extension Period (Day 197 to Day 700)|Pregnancy|0|||
147615451|NCT04917861|532406737|FG002|Extension Period (Day 197 to Day 700)|Pregnancy|1|||
147399113|NCT03672175|531626429|FG002|Extended FU Period (Days 43 to 182)|Adverse Event|3|||
147399114|NCT03672175|531626427|FG000|Extended FU Period (Days 43 to 182)|Lost to Follow-up|6|||
147399115|NCT03672175|531626428|FG001|Extended FU Period (Days 43 to 182)|Lost to Follow-up|8|||
147399116|NCT03672175|531626429|FG002|Extended FU Period (Days 43 to 182)|Lost to Follow-up|7|||
147399117|NCT03672175|531626427|FG000|Extended FU Period (Days 43 to 182)|Non-compliance with Study Drug|1|||
147399118|NCT03672175|531626428|FG001|Extended FU Period (Days 43 to 182)|Non-compliance with Study Drug|0|||
147399119|NCT03672175|531626429|FG002|Extended FU Period (Days 43 to 182)|Non-compliance with Study Drug|1|||
147399120|NCT03672175|531626427|FG000|Extended FU Period (Days 43 to 182)|Reason not Specified|3|||
147399121|NCT03672175|531626428|FG001|Extended FU Period (Days 43 to 182)|Reason not Specified|4|||
147399122|NCT03672175|531626429|FG002|Extended FU Period (Days 43 to 182)|Reason not Specified|3|||
147399123|NCT03672175|531626427|FG000|Extended FU Period (Days 43 to 182)|Physician Decision|4|||
147399124|NCT03672175|531626428|FG001|Extended FU Period (Days 43 to 182)|Physician Decision|0|||
147399125|NCT03672175|531626429|FG002|Extended FU Period (Days 43 to 182)|Physician Decision|2|||
147399126|NCT03672175|531626427|FG000|Extended FU Period (Days 43 to 182)|Withdrawal by Subject|18|||
147399127|NCT03672175|531626428|FG001|Extended FU Period (Days 43 to 182)|Withdrawal by Subject|24|||
147399128|NCT03672175|531626429|FG002|Extended FU Period (Days 43 to 182)|Withdrawal by Subject|21|||
147399129|NCT01086384|531626433|FG000|2-week Run-in Period|Adverse Event|1|||
147399130|NCT01086384|531626434|FG001|2-week Run-in Period|Adverse Event|0|||
147399131|NCT01086384|531626435|FG002|2-week Run-in Period|Adverse Event|0|||
147399132|NCT01086384|531626433|FG000|2-week Run-in Period|Protocol Violation|1|||
147399133|NCT01086384|531626434|FG001|2-week Run-in Period|Protocol Violation|0|||
147399134|NCT01086384|531626435|FG002|2-week Run-in Period|Protocol Violation|0|||
147399135|NCT01086384|531626433|FG000|2-week Run-in Period|Lost to Follow-up|1|||
147399136|NCT01086384|531626434|FG001|2-week Run-in Period|Lost to Follow-up|0|||
147399137|NCT01086384|531626435|FG002|2-week Run-in Period|Lost to Follow-up|0|||
147399138|NCT01086384|531626433|FG000|2-week Run-in Period|Physician Decision|6|||
147399139|NCT01086384|531626434|FG001|2-week Run-in Period|Physician Decision|0|||
147399140|NCT01086384|531626435|FG002|2-week Run-in Period|Physician Decision|0|||
147399141|NCT01086384|531626433|FG000|2-week Run-in Period|Withdrawal by Subject|19|||
147399142|NCT01086384|531626434|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
147399143|NCT01086384|531626435|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
147399144|NCT01086384|531626433|FG000|2-week Run-in Period|Study Closed/Terminated|42|||
147399145|NCT01086384|531626434|FG001|2-week Run-in Period|Study Closed/Terminated|0|||
147399146|NCT01086384|531626435|FG002|2-week Run-in Period|Study Closed/Terminated|0|||
147399147|NCT01086384|531626433|FG000|2-week Run-in Period|Continuation Criteria Not Met|92|||
147399148|NCT01086384|531626434|FG001|2-week Run-in Period|Continuation Criteria Not Met|0|||
147399149|NCT01086384|531626435|FG002|2-week Run-in Period|Continuation Criteria Not Met|0|||
147399150|NCT01086384|531626433|FG000|2-week Run-in Period|Randomized in Error|1|||
147399151|NCT01086384|531626434|FG001|2-week Run-in Period|Randomized in Error|0|||
147399152|NCT01086384|531626435|FG002|2-week Run-in Period|Randomized in Error|0|||
147399153|NCT01086384|531626433|FG000|Treatment Period|Withdrawal by Subject|0|||
147399154|NCT01086384|531626434|FG001|Treatment Period|Withdrawal by Subject|53|||
147399155|NCT01086384|531626435|FG002|Treatment Period|Withdrawal by Subject|55|||
147399156|NCT01086384|531626433|FG000|Treatment Period|Protocol Violation|0|||
147399157|NCT01086384|531626434|FG001|Treatment Period|Protocol Violation|26|||
147399158|NCT01086384|531626435|FG002|Treatment Period|Protocol Violation|17|||
147399159|NCT01086384|531626433|FG000|Treatment Period|Lack of Efficacy|0|||
147399160|NCT01086384|531626434|FG001|Treatment Period|Lack of Efficacy|22|||
147399161|NCT01086384|531626435|FG002|Treatment Period|Lack of Efficacy|13|||
147399162|NCT01086384|531626433|FG000|Treatment Period|Adverse Event|0|||
147399163|NCT01086384|531626434|FG001|Treatment Period|Adverse Event|19|||
147399164|NCT01086384|531626435|FG002|Treatment Period|Adverse Event|15|||
147399165|NCT01086384|531626433|FG000|Treatment Period|Lost to Follow-up|0|||
147399166|NCT01086384|531626434|FG001|Treatment Period|Lost to Follow-up|11|||
147399167|NCT01086384|531626435|FG002|Treatment Period|Lost to Follow-up|9|||
147399168|NCT01086384|531626433|FG000|Treatment Period|Physician Decision|0|||
147399169|NCT01086384|531626434|FG001|Treatment Period|Physician Decision|9|||
147399170|NCT01086384|531626435|FG002|Treatment Period|Physician Decision|6|||
147615452|NCT04917861|532406738|FG003|Extension Period (Day 197 to Day 700)|Pregnancy|1|||
147615453|NCT04917861|532406735|FG000|Extension Period (Day 197 to Day 700)|Protocol Violation|0|||
147615454|NCT04917861|532406736|FG001|Extension Period (Day 197 to Day 700)|Protocol Violation|1|||
147615455|NCT04917861|532406737|FG002|Extension Period (Day 197 to Day 700)|Protocol Violation|0|||
147461065|NCT02211261|531849439|FG010|Overall Study|Lost to Follow-up|0|||
147399171|NCT01086384|531626433|FG000|Treatment Period|Study Closed/Terminated|0|||
147399172|NCT01086384|531626434|FG001|Treatment Period|Study Closed/Terminated|7|||
147615456|NCT04917861|532406738|FG003|Extension Period (Day 197 to Day 700)|Protocol Violation|0|||
147615457|NCT04917861|532406735|FG000|Extension Period (Day 197 to Day 700)|Withdrawal by Subject|6|||
147399173|NCT01086384|531626435|FG002|Treatment Period|Study Closed/Terminated|8|||
147399174|NCT01086384|531626433|FG000|Treatment Period|Protocol-Defined Stopping Criteria|0|||
147399175|NCT01086384|531626434|FG001|Treatment Period|Protocol-Defined Stopping Criteria|0|||
147399176|NCT01086384|531626435|FG002|Treatment Period|Protocol-Defined Stopping Criteria|1|||
147399177|NCT01086384|531626433|FG000|Treatment Period|Received Treatment in Error|0|||
147399178|NCT01086384|531626434|FG001|Treatment Period|Received Treatment in Error|1|||
147399179|NCT01086384|531626435|FG002|Treatment Period|Received Treatment in Error|0|||
147399180|NCT02872311|531626442|FG000|Overall Study|Death|2|||
147399181|NCT02872311|531626443|FG001|Overall Study|Death|0|||
147399182|NCT02872311|531626444|FG002|Overall Study|Death|0|||
147399183|NCT02872311|531626445|FG003|Overall Study|Death|0|||
147399184|NCT02872311|531626446|FG004|Overall Study|Death|0|||
147399185|NCT02872311|531626442|FG000|Overall Study|Lost to Follow-up|2|||
147399186|NCT02872311|531626443|FG001|Overall Study|Lost to Follow-up|0|||
147399187|NCT02872311|531626444|FG002|Overall Study|Lost to Follow-up|0|||
147399188|NCT02872311|531626445|FG003|Overall Study|Lost to Follow-up|0|||
147399189|NCT02872311|531626446|FG004|Overall Study|Lost to Follow-up|0|||
147399190|NCT02872311|531626442|FG000|Overall Study|Protocol Violation|0|||
147399191|NCT02872311|531626443|FG001|Overall Study|Protocol Violation|2|||
147399192|NCT02872311|531626444|FG002|Overall Study|Protocol Violation|1|||
147399193|NCT02872311|531626445|FG003|Overall Study|Protocol Violation|0|||
147399194|NCT02872311|531626446|FG004|Overall Study|Protocol Violation|0|||
147399195|NCT02725567|531626448|FG000|Part B + A/B ( Up to 24 Weeks)|Lost to Follow-up|0|||
147399196|NCT02725567|531626449|FG001|Part B + A/B ( Up to 24 Weeks)|Lost to Follow-up|1|||
147399197|NCT02725567|531626448|FG000|Part B + A/B ( Up to 24 Weeks)|Physician Decision|0|||
147399198|NCT02725567|531626449|FG001|Part B + A/B ( Up to 24 Weeks)|Physician Decision|1|||
147399199|NCT02725567|531626448|FG000|Part B + A/B ( Up to 24 Weeks)|Withdrawal of Consent (not due to adverse event)|0|||
147399200|NCT02725567|531626449|FG001|Part B + A/B ( Up to 24 Weeks)|Withdrawal of Consent (not due to adverse event)|1|||
147399201|NCT01129115|531626450|FG000|Overall Study|Adverse Event|1|||
147399202|NCT01129115|531626451|FG001|Overall Study|Adverse Event|2|||
147399203|NCT01129115|531626452|FG002|Overall Study|Adverse Event|3|||
147399204|NCT01129115|531626453|FG003|Overall Study|Adverse Event|3|||
147399205|NCT01129115|531626450|FG000|Overall Study|Withdrawal by Subject|1|||
147399206|NCT01129115|531626451|FG001|Overall Study|Withdrawal by Subject|3|||
147399207|NCT01129115|531626452|FG002|Overall Study|Withdrawal by Subject|1|||
147399208|NCT01129115|531626453|FG003|Overall Study|Withdrawal by Subject|4|||
147399209|NCT01129115|531626450|FG000|Overall Study|Protocol Violation|0|||
147399210|NCT01129115|531626451|FG001|Overall Study|Protocol Violation|2|||
147399211|NCT01129115|531626452|FG002|Overall Study|Protocol Violation|2|||
147399212|NCT01129115|531626453|FG003|Overall Study|Protocol Violation|2|||
147399213|NCT01747837|531626455|FG000|Overall Study|Lost to Follow-up|5|||
147399214|NCT01747837|531626456|FG001|Overall Study|Lost to Follow-up|2|||
147399215|NCT01747837|531626455|FG000|Overall Study|Death|4|||
147399216|NCT01747837|531626456|FG001|Overall Study|Death|4|||
147399217|NCT00817336|531626458|FG000|Overall Study|Withdrawal by Subject|1|||
147399218|NCT00817336|531626459|FG001|Overall Study|Withdrawal by Subject|1|||
147399219|NCT02019641|531626466|FG000|10-Week Follow up|Withdrawal by investigator|2|||
147399220|NCT02019641|531626467|FG001|10-Week Follow up|Withdrawal by investigator|0|||
147399221|NCT02019641|531626468|FG002|10-Week Follow up|Withdrawal by investigator|0|||
147399222|NCT02019641|531626466|FG000|10-Week Follow up|Withdrawal by Subject|1|||
147399223|NCT02019641|531626467|FG001|10-Week Follow up|Withdrawal by Subject|1|||
147399224|NCT02019641|531626468|FG002|10-Week Follow up|Withdrawal by Subject|0|||
147399225|NCT02019641|531626466|FG000|20-Week Follow up|Withdrawal by investigator|0|||
147399226|NCT02019641|531626467|FG001|20-Week Follow up|Withdrawal by investigator|0|||
147399227|NCT02019641|531626468|FG002|20-Week Follow up|Withdrawal by investigator|1|||
147399228|NCT03856047|531626471|FG000|Overall Study|Withdrawal by Subject|0|||
147399229|NCT03856047|531626472|FG001|Overall Study|Withdrawal by Subject|1|||
147399230|NCT03856047|531626473|FG002|Overall Study|Withdrawal by Subject|1|||
147399231|NCT03856047|531626474|FG003|Overall Study|Withdrawal by Subject|0|||
147399232|NCT03856047|531626475|FG004|Overall Study|Withdrawal by Subject|3|||
147399233|NCT03856047|531626476|FG005|Overall Study|Withdrawal by Subject|0|||
147399234|NCT03856047|531626477|FG006|Overall Study|Withdrawal by Subject|2|||
147399235|NCT03856047|531626471|FG000|Overall Study|Lost to Follow-up|4|||
147399236|NCT03856047|531626472|FG001|Overall Study|Lost to Follow-up|2|||
147399237|NCT03856047|531626473|FG002|Overall Study|Lost to Follow-up|3|||
147399238|NCT03856047|531626474|FG003|Overall Study|Lost to Follow-up|1|||
147399239|NCT03856047|531626475|FG004|Overall Study|Lost to Follow-up|4|||
147399240|NCT03856047|531626476|FG005|Overall Study|Lost to Follow-up|4|||
147665207|NCT00919633|532598069|FG003|Overall Study|Lost to Follow-up|2|||
147665208|NCT00919633|532598066|FG000|Overall Study|Withdraw consent post transition to SOC|0|||
147399241|NCT03856047|531626477|FG006|Overall Study|Lost to Follow-up|4|||
147399242|NCT03410108|531626478|FG000|Overall Study|Ongoing|41|||
147399243|NCT03410108|531626478|FG000|Overall Study|Adverse Event|4|||
147399244|NCT03410108|531626478|FG000|Overall Study|Progressive Disease|58|||
147399245|NCT03410108|531626478|FG000|Overall Study|Withdrawal by Subject|1|||
147399246|NCT00937521|531626479|FG000|Overall Study - Prior to Booster Dose|Adverse Event|0|||
147399247|NCT00937521|531626480|FG001|Overall Study - Prior to Booster Dose|Adverse Event|0|||
147399248|NCT00937521|531626481|FG002|Overall Study - Prior to Booster Dose|Adverse Event|2|||
147399249|NCT00937521|531626482|FG003|Overall Study - Prior to Booster Dose|Adverse Event|0|||
147665209|NCT00919633|532598067|FG001|Overall Study|Withdraw consent post transition to SOC|0|||
147399250|NCT00937521|531626483|FG004|Overall Study - Prior to Booster Dose|Adverse Event|0|||
147399251|NCT00937521|531626484|FG005|Overall Study - Prior to Booster Dose|Adverse Event|0|||
147399252|NCT00937521|531626485|FG006|Overall Study - Prior to Booster Dose|Adverse Event|1|||
147399253|NCT00937521|531626486|FG007|Overall Study - Prior to Booster Dose|Adverse Event|0|||
147399254|NCT00937521|531626479|FG000|Overall Study - Prior to Booster Dose|Withdrawal by Subject|2|||
147399255|NCT00937521|531626480|FG001|Overall Study - Prior to Booster Dose|Withdrawal by Subject|1|||
147399256|NCT00937521|531626481|FG002|Overall Study - Prior to Booster Dose|Withdrawal by Subject|3|||
147399257|NCT00937521|531626482|FG003|Overall Study - Prior to Booster Dose|Withdrawal by Subject|0|||
147399258|NCT00937521|531626483|FG004|Overall Study - Prior to Booster Dose|Withdrawal by Subject|1|||
147399259|NCT00937521|531626484|FG005|Overall Study - Prior to Booster Dose|Withdrawal by Subject|0|||
147399260|NCT00937521|531626485|FG006|Overall Study - Prior to Booster Dose|Withdrawal by Subject|2|||
147399261|NCT00937521|531626486|FG007|Overall Study - Prior to Booster Dose|Withdrawal by Subject|1|||
147399262|NCT00937521|531626479|FG000|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
147399263|NCT00937521|531626480|FG001|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
147399264|NCT00937521|531626481|FG002|Overall Study - Prior to Booster Dose|Lost to Follow-up|1|||
147399265|NCT00937521|531626482|FG003|Overall Study - Prior to Booster Dose|Lost to Follow-up|1|||
147399266|NCT00937521|531626483|FG004|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
147399267|NCT00937521|531626484|FG005|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
147399268|NCT00937521|531626485|FG006|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
147399269|NCT00937521|531626486|FG007|Overall Study - Prior to Booster Dose|Lost to Follow-up|0|||
147399270|NCT00937521|531626479|FG000|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0|||
147399271|NCT00937521|531626480|FG001|Overall Study - Prior to Booster Dose|Inappropriate enrollment|4|||
147399272|NCT00937521|531626481|FG002|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0|||
147399273|NCT00937521|531626482|FG003|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0|||
147399274|NCT00937521|531626483|FG004|Overall Study - Prior to Booster Dose|Inappropriate enrollment|2|||
147399275|NCT00937521|531626484|FG005|Overall Study - Prior to Booster Dose|Inappropriate enrollment|1|||
147399276|NCT00937521|531626485|FG006|Overall Study - Prior to Booster Dose|Inappropriate enrollment|1|||
147399277|NCT00937521|531626486|FG007|Overall Study - Prior to Booster Dose|Inappropriate enrollment|0|||
147399278|NCT00937521|531626479|FG000|Overall Study - Prior to Booster Dose|Protocol Deviation|1|||
147399279|NCT00937521|531626480|FG001|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
147399280|NCT00937521|531626481|FG002|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
147399281|NCT00937521|531626482|FG003|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
147399282|NCT00937521|531626483|FG004|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
147399283|NCT00937521|531626484|FG005|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
147399284|NCT00937521|531626485|FG006|Overall Study - Prior to Booster Dose|Protocol Deviation|1|||
147399285|NCT00937521|531626486|FG007|Overall Study - Prior to Booster Dose|Protocol Deviation|0|||
147399286|NCT00937521|531626479|FG000|Booster Phase|Adverse Event|0|||
147399287|NCT00937521|531626480|FG001|Booster Phase|Adverse Event|0|||
147399288|NCT00937521|531626481|FG002|Booster Phase|Adverse Event|0|||
147399289|NCT00937521|531626482|FG003|Booster Phase|Adverse Event|0|||
147399290|NCT00937521|531626483|FG004|Booster Phase|Adverse Event|0|||
147399291|NCT00937521|531626484|FG005|Booster Phase|Adverse Event|0|||
147399292|NCT00937521|531626485|FG006|Booster Phase|Adverse Event|1|||
147399293|NCT00937521|531626486|FG007|Booster Phase|Adverse Event|0|||
147399294|NCT00937521|531626479|FG000|Booster Phase|Withdrawal by Subject|1|||
147399295|NCT00937521|531626480|FG001|Booster Phase|Withdrawal by Subject|0|||
147399296|NCT00937521|531626481|FG002|Booster Phase|Withdrawal by Subject|0|||
147399297|NCT00937521|531626482|FG003|Booster Phase|Withdrawal by Subject|1|||
147461066|NCT02817087|531849440|FG000|Overall Study|Withdrawal by Subject|2|||
147399298|NCT00937521|531626483|FG004|Booster Phase|Withdrawal by Subject|0|||
147399299|NCT00937521|531626484|FG005|Booster Phase|Withdrawal by Subject|0|||
147399300|NCT00937521|531626485|FG006|Booster Phase|Withdrawal by Subject|0|||
147399301|NCT00937521|531626486|FG007|Booster Phase|Withdrawal by Subject|2|||
147399302|NCT00937521|531626479|FG000|Booster Phase|Lost to Follow-up|2|||
147399303|NCT00937521|531626480|FG001|Booster Phase|Lost to Follow-up|2|||
147461067|NCT02817087|531849441|FG001|Overall Study|Withdrawal by Subject|0|||
147461068|NCT00508391|531849442|FG000|First Treatment|Withdrawal by Subject|6|||
147461069|NCT00508391|531849443|FG001|First Treatment|Withdrawal by Subject|3|||
147461070|NCT00508391|531849442|FG000|Second Treatment|Withdrawal by Subject|2|||
147461071|NCT00508391|531849443|FG001|Second Treatment|Withdrawal by Subject|0|||
147399304|NCT00937521|531626481|FG002|Booster Phase|Lost to Follow-up|4|||
147399305|NCT00937521|531626482|FG003|Booster Phase|Lost to Follow-up|2|||
147399306|NCT00937521|531626483|FG004|Booster Phase|Lost to Follow-up|4|||
147461072|NCT00880256|531849444|FG000|Overall Study|Lost to Follow-up|28|||
147615458|NCT04917861|532406736|FG001|Extension Period (Day 197 to Day 700)|Withdrawal by Subject|8|||
147615459|NCT04917861|532406737|FG002|Extension Period (Day 197 to Day 700)|Withdrawal by Subject|8|||
147615460|NCT04917861|532406738|FG003|Extension Period (Day 197 to Day 700)|Withdrawal by Subject|10|||
147615461|NCT04917861|532406735|FG000|Extension Period (Day 197 to Day 700)|Other Than Specified|1|||
147615462|NCT04917861|532406736|FG001|Extension Period (Day 197 to Day 700)|Other Than Specified|0|||
147461073|NCT00802360|531849445|FG000|Overall Study|Stimulation failure|4|||
147461074|NCT00802360|531849446|FG001|Overall Study|Stimulation failure|0|||
147461075|NCT00802360|531849447|FG002|Overall Study|Stimulation failure|3|||
147461076|NCT00802360|531849448|FG003|Overall Study|Stimulation failure|3|||
147461077|NCT00802360|531849445|FG000|Overall Study|Inadequate number of oocytes retrieved|0|||
147461078|NCT00802360|531849446|FG001|Overall Study|Inadequate number of oocytes retrieved|0|||
147461079|NCT00802360|531849447|FG002|Overall Study|Inadequate number of oocytes retrieved|0|||
147461080|NCT00802360|531849448|FG003|Overall Study|Inadequate number of oocytes retrieved|1|||
147461081|NCT00802360|531849445|FG000|Overall Study|Cycle cancelled|0|||
147461082|NCT00802360|531849446|FG001|Overall Study|Cycle cancelled|1|||
147461083|NCT00802360|531849447|FG002|Overall Study|Cycle cancelled|1|||
147461084|NCT00802360|531849448|FG003|Overall Study|Cycle cancelled|1|||
147461085|NCT00802360|531849445|FG000|Overall Study|Risk of ovarian hyperstimulation syndrom|0|||
147461086|NCT00802360|531849446|FG001|Overall Study|Risk of ovarian hyperstimulation syndrom|0|||
147461087|NCT00802360|531849447|FG002|Overall Study|Risk of ovarian hyperstimulation syndrom|0|||
147461088|NCT00802360|531849448|FG003|Overall Study|Risk of ovarian hyperstimulation syndrom|1|||
147461089|NCT00802360|531849445|FG000|Overall Study|No positive serum pregnancy|17|||
147461090|NCT00802360|531849446|FG001|Overall Study|No positive serum pregnancy|20|||
147461091|NCT00802360|531849447|FG002|Overall Study|No positive serum pregnancy|14|||
147461092|NCT00802360|531849448|FG003|Overall Study|No positive serum pregnancy|10|||
147461093|NCT00802360|531849445|FG000|Overall Study|Pregnancy not confirmed by ultrasound|1|||
147399307|NCT00937521|531626484|FG005|Booster Phase|Lost to Follow-up|4|||
147399308|NCT00937521|531626485|FG006|Booster Phase|Lost to Follow-up|3|||
147399309|NCT00937521|531626486|FG007|Booster Phase|Lost to Follow-up|0|||
147399310|NCT00937521|531626479|FG000|Booster Phase|Administrative Reason|0|||
147399311|NCT00937521|531626480|FG001|Booster Phase|Administrative Reason|0|||
147399312|NCT00937521|531626481|FG002|Booster Phase|Administrative Reason|1|||
147399313|NCT00937521|531626482|FG003|Booster Phase|Administrative Reason|0|||
147399314|NCT00937521|531626483|FG004|Booster Phase|Administrative Reason|1|||
147399315|NCT00937521|531626484|FG005|Booster Phase|Administrative Reason|1|||
147399316|NCT00937521|531626485|FG006|Booster Phase|Administrative Reason|0|||
147399317|NCT00937521|531626486|FG007|Booster Phase|Administrative Reason|0|||
147399318|NCT00937521|531626479|FG000|Booster Phase|Protocol Deviation|0|||
147399319|NCT00937521|531626480|FG001|Booster Phase|Protocol Deviation|0|||
147399320|NCT00937521|531626481|FG002|Booster Phase|Protocol Deviation|0|||
147399321|NCT00937521|531626482|FG003|Booster Phase|Protocol Deviation|0|||
147399322|NCT00937521|531626483|FG004|Booster Phase|Protocol Deviation|0|||
147399323|NCT00937521|531626484|FG005|Booster Phase|Protocol Deviation|0|||
147399324|NCT00937521|531626485|FG006|Booster Phase|Protocol Deviation|1|||
147399325|NCT00937521|531626486|FG007|Booster Phase|Protocol Deviation|0|||
147399326|NCT01185171|531626490|FG000|Induction Chemotherapy|Withdrawal by Subject|1|||
147399327|NCT01185171|531626490|FG000|Induction Chemotherapy|Duodenal Ulcer|1|||
147399328|NCT01185171|531626490|FG000|Concurrent Chemo and Radiation Treatment|Death|3|||
147399329|NCT01185171|531626490|FG000|Maintenance|Elevated liver transaminases|3|||
147399330|NCT01185171|531626490|FG000|Maintenance|Rush|2|||
147399331|NCT01185171|531626490|FG000|Maintenance|Diarrhea|1|||
147399332|NCT01185171|531626490|FG000|Maintenance|Xerostomia|1|||
147399333|NCT01185171|531626490|FG000|Maintenance|Nausea|1|||
147399334|NCT01185171|531626490|FG000|Maintenance|Comorbid Illness|2|||
147399335|NCT01185171|531626490|FG000|Maintenance|Withdrawal by Subject|1|||
147399336|NCT01185171|531626490|FG000|Maintenance|Disease Recurrence|1|||
147399337|NCT00573651|531626495|FG000|Overall Study|Lost to Follow-up|3|||
147399338|NCT00573651|531626495|FG000|Overall Study|Withdrawal by Subject|1|||
147399339|NCT01837797|531626496|FG000|Period 1|Adverse Event|9|||
147399340|NCT01837797|531626497|FG001|Period 1|Adverse Event|0|||
147399341|NCT01837797|531626498|FG002|Period 1|Adverse Event|0|||
147399342|NCT01837797|531626499|FG003|Period 1|Adverse Event|0|||
147399343|NCT01837797|531626500|FG004|Period 1|Adverse Event|0|||
147399344|NCT01837797|531626496|FG000|Period 1|Withdrawal by Subject|6|||
147399345|NCT01837797|531626497|FG001|Period 1|Withdrawal by Subject|0|||
147399346|NCT01837797|531626498|FG002|Period 1|Withdrawal by Subject|0|||
147399347|NCT01837797|531626499|FG003|Period 1|Withdrawal by Subject|0|||
147399348|NCT01837797|531626500|FG004|Period 1|Withdrawal by Subject|0|||
147399349|NCT01837797|531626496|FG000|Period 1|Administrative reasons|76|||
147399350|NCT01837797|531626497|FG001|Period 1|Administrative reasons|0|||
147399351|NCT01837797|531626498|FG002|Period 1|Administrative reasons|0|||
147399352|NCT01837797|531626499|FG003|Period 1|Administrative reasons|0|||
147461094|NCT00802360|531849446|FG001|Overall Study|Pregnancy not confirmed by ultrasound|0|||
147461095|NCT00802360|531849447|FG002|Overall Study|Pregnancy not confirmed by ultrasound|1|||
147461096|NCT00802360|531849448|FG003|Overall Study|Pregnancy not confirmed by ultrasound|0|||
147615463|NCT04917861|532406737|FG002|Extension Period (Day 197 to Day 700)|Other Than Specified|1|||
147615464|NCT04917861|532406738|FG003|Extension Period (Day 197 to Day 700)|Other Than Specified|1|||
147399353|NCT01837797|531626500|FG004|Period 1|Administrative reasons|0|||
147399354|NCT01837797|531626496|FG000|Period 1|Withdrawal of consent before treatment|1|||
147399355|NCT01837797|531626497|FG001|Period 1|Withdrawal of consent before treatment|0|||
147399356|NCT01837797|531626498|FG002|Period 1|Withdrawal of consent before treatment|0|||
147399357|NCT01837797|531626499|FG003|Period 1|Withdrawal of consent before treatment|0|||
147399358|NCT01837797|531626500|FG004|Period 1|Withdrawal of consent before treatment|0|||
147399359|NCT01837797|531626496|FG000|Period 1|Other|10|||
147399360|NCT01837797|531626497|FG001|Period 1|Other|0|||
147399361|NCT01837797|531626498|FG002|Period 1|Other|0|||
147399362|NCT01837797|531626499|FG003|Period 1|Other|0|||
147399363|NCT01837797|531626500|FG004|Period 1|Other|0|||
147399364|NCT01837797|531626496|FG000|Period 2|Administrative or other reasons|0|||
147399365|NCT01837797|531626497|FG001|Period 2|Administrative or other reasons|5|||
147399366|NCT01837797|531626498|FG002|Period 2|Administrative or other reasons|2|||
147399367|NCT01837797|531626499|FG003|Period 2|Administrative or other reasons|4|||
147399368|NCT01837797|531626500|FG004|Period 2|Administrative or other reasons|0|||
147399369|NCT01837797|531626496|FG000|Period 2|Adverse Event|0|||
147399370|NCT01837797|531626497|FG001|Period 2|Adverse Event|0|||
147399371|NCT01837797|531626498|FG002|Period 2|Adverse Event|0|||
147399372|NCT01837797|531626499|FG003|Period 2|Adverse Event|1|||
147399373|NCT01837797|531626500|FG004|Period 2|Adverse Event|0|||
147399374|NCT01837797|531626496|FG000|Period 3|Adverse Event|0|||
147399375|NCT01837797|531626497|FG001|Period 3|Adverse Event|0|||
147399376|NCT01837797|531626498|FG002|Period 3|Adverse Event|0|||
147399377|NCT01837797|531626499|FG003|Period 3|Adverse Event|0|||
147399378|NCT01837797|531626500|FG004|Period 3|Adverse Event|1|||
147399379|NCT01837797|531626496|FG000|Period 3|Administrative reasons|0|||
147399380|NCT01837797|531626497|FG001|Period 3|Administrative reasons|0|||
147399381|NCT01837797|531626498|FG002|Period 3|Administrative reasons|0|||
147399382|NCT01837797|531626499|FG003|Period 3|Administrative reasons|0|||
147399383|NCT01837797|531626500|FG004|Period 3|Administrative reasons|20|||
147399384|NCT01837797|531626496|FG000|Period 3|Other|0|||
147399385|NCT01837797|531626497|FG001|Period 3|Other|0|||
147399386|NCT01837797|531626498|FG002|Period 3|Other|0|||
147399387|NCT01837797|531626499|FG003|Period 3|Other|0|||
147399388|NCT01837797|531626500|FG004|Period 3|Other|2|||
147399389|NCT03797989|531626501|FG000|VAC069A|Withdrawal by Subject|0|||
147399390|NCT03797989|531626502|FG001|VAC069A|Withdrawal by Subject|0|||
147399391|NCT03797989|531626503|FG002|VAC069A|Withdrawal by Subject|1|||
147399392|NCT03797989|531626504|FG003|VAC069A|Withdrawal by Subject|0|||
147399393|NCT03797989|531626505|FG004|VAC069A|Withdrawal by Subject|0|||
147399394|NCT03797989|531626506|FG005|VAC069A|Withdrawal by Subject|0|||
147399395|NCT03797989|531626507|FG006|VAC069A|Withdrawal by Subject|0|||
147399396|NCT03797989|531626508|FG007|VAC069A|Withdrawal by Subject|0|||
147399397|NCT03797989|531626509|FG008|VAC069A|Withdrawal by Subject|0|||
147399398|NCT03797989|531626510|FG009|VAC069A|Withdrawal by Subject|0|||
147399399|NCT03797989|531626511|FG010|VAC069A|Withdrawal by Subject|0|||
147399400|NCT03797989|531626512|FG011|VAC069A|Withdrawal by Subject|0|||
147399401|NCT04052997|531626513|FG000|Overall Study|Withdrawal by Subject|17|||
147399402|NCT04052997|531626513|FG000|Overall Study|Physician Decision|50|||
147399403|NCT04052997|531626513|FG000|Overall Study|Death|43|||
147399404|NCT04052997|531626513|FG000|Overall Study|Lost to Follow-up|5|||
147399405|NCT04052997|531626513|FG000|Overall Study|Progression of Disease|1|||
147399406|NCT00934700|531626520|FG000|Overall Study|missing scan|5|||
147399407|NCT00934700|531626521|FG001|Overall Study|missing scan|9|||
147399408|NCT00934700|531626520|FG000|Overall Study|Death|8|||
147399409|NCT00934700|531626521|FG001|Overall Study|Death|3|||
147399410|NCT03049306|531626524|FG000|First Intervention (1 Night)|Lost to Follow-up|1|||
147399411|NCT03049306|531626525|FG001|First Intervention (1 Night)|Lost to Follow-up|1|||
147399412|NCT03151551|531626526|FG000|Open-Label Treatment Period|Adverse Event|0|||
147399413|NCT03151551|531626527|FG001|Open-Label Treatment Period|Adverse Event|2|||
147399414|NCT03151551|531626526|FG000|Open-Label Treatment Period|Lost to Follow-up|1|||
147399415|NCT03151551|531626527|FG001|Open-Label Treatment Period|Lost to Follow-up|1|||
147399416|NCT03151551|531626526|FG000|Open-Label Treatment Period|Withdrawal by Subject|12|||
147399417|NCT03151551|531626527|FG001|Open-Label Treatment Period|Withdrawal by Subject|18|||
147399418|NCT03151551|531626526|FG000|Open-Label Treatment Period|Lack of Efficacy|1|||
147399419|NCT03151551|531626527|FG001|Open-Label Treatment Period|Lack of Efficacy|1|||
147399420|NCT03151551|531626526|FG000|Open-Label Treatment Period|Physician Decision|3|||
147399421|NCT03151551|531626527|FG001|Open-Label Treatment Period|Physician Decision|0|||
147399422|NCT03151551|531626526|FG000|Open-Label Treatment Period|Protocol Deviation|1|||
147399423|NCT03151551|531626527|FG001|Open-Label Treatment Period|Protocol Deviation|2|||
147399424|NCT03151551|531626526|FG000|Post-Treatment Follow-Up Period|Adverse Event|1|||
147399425|NCT03151551|531626527|FG001|Post-Treatment Follow-Up Period|Adverse Event|3|||
147399426|NCT03151551|531626526|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|4|||
147399427|NCT03151551|531626527|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|2|||
147399428|NCT03151551|531626526|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|20|||
147399429|NCT03151551|531626527|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|22|||
147399430|NCT03151551|531626526|FG000|Post-Treatment Follow-Up Period|Physician Decision|0|||
147399431|NCT03151551|531626527|FG001|Post-Treatment Follow-Up Period|Physician Decision|1|||
147399432|NCT05896696|531626528|FG000|Overall Study|Screening Failure|7|||
147399433|NCT05896696|531626528|FG000|Overall Study|Withdrawal by Subject|2|||
147399434|NCT00143598|531626529|FG000|Overall Study|Lost to Follow-up|23|||
147399435|NCT00143598|531626530|FG001|Overall Study|Lost to Follow-up|21|||
147461097|NCT00802360|531849445|FG000|Overall Study|Pregnancy loss/miscarriage|0|||
147461098|NCT00802360|531849446|FG001|Overall Study|Pregnancy loss/miscarriage|2|||
147461099|NCT00802360|531849447|FG002|Overall Study|Pregnancy loss/miscarriage|0|||
147461100|NCT00802360|531849448|FG003|Overall Study|Pregnancy loss/miscarriage|3|||
147461101|NCT00802360|531849445|FG000|Overall Study|Other|2|||
147461102|NCT00802360|531849446|FG001|Overall Study|Other|3|||
147461103|NCT00802360|531849447|FG002|Overall Study|Other|6|||
147461104|NCT00802360|531849448|FG003|Overall Study|Other|3|||
147461105|NCT02041962|531849449|FG000|Overall Study|Lost Aetna Coverage|43|||
147461106|NCT02041962|531849450|FG001|Overall Study|Lost Aetna Coverage|40|||
147461107|NCT02041962|531849449|FG000|Overall Study|Death|1|||
147461108|NCT02041962|531849450|FG001|Overall Study|Death|1|||
147461109|NCT02041962|531849449|FG000|Overall Study|Lost to Follow-up|37|||
147461110|NCT02041962|531849450|FG001|Overall Study|Lost to Follow-up|32|||
147461111|NCT02041962|531849449|FG000|Overall Study|Withdrawal by Subject|0|||
147461112|NCT02041962|531849450|FG001|Overall Study|Withdrawal by Subject|11|||
147461113|NCT01481896|531849451|FG000|Overall Study|Lost to Follow-up|12|||
147461114|NCT01162421|531849458|FG000|Overall Study|Did not receive study drug|2|||
147461115|NCT01162421|531849459|FG001|Overall Study|Did not receive study drug|1|||
147461116|NCT01162421|531849458|FG000|Overall Study|Adverse Event|2|||
147461117|NCT01162421|531849459|FG001|Overall Study|Adverse Event|5|||
147461118|NCT01162421|531849458|FG000|Overall Study|Lost to Follow-up|0|||
147461119|NCT01162421|531849459|FG001|Overall Study|Lost to Follow-up|2|||
147461120|NCT01162421|531849458|FG000|Overall Study|Lack of Efficacy|2|||
147461121|NCT01162421|531849459|FG001|Overall Study|Lack of Efficacy|2|||
147461122|NCT01162421|531849458|FG000|Overall Study|Other|2|||
147461123|NCT01162421|531849459|FG001|Overall Study|Other|3|||
147461124|NCT03336502|531849460|FG000|Overall Study|Physician Decision|0|||
147461125|NCT03336502|531849461|FG001|Overall Study|Physician Decision|1|||
147461126|NCT03336502|531849460|FG000|Overall Study|Prohibited Drugs|1|||
147461127|NCT03336502|531849461|FG001|Overall Study|Prohibited Drugs|1|||
147461128|NCT03336502|531849460|FG000|Overall Study|Death|1|||
147461129|NCT03336502|531849461|FG001|Overall Study|Death|2|||
147461130|NCT03336502|531849460|FG000|Overall Study|Adverse Event|2|||
147461131|NCT03336502|531849461|FG001|Overall Study|Adverse Event|5|||
147461132|NCT00611247|531849463|FG000|Overall Study|Death|1|||
147461133|NCT00611247|531849464|FG001|Overall Study|Death|5|||
147461134|NCT00611247|531849463|FG000|Overall Study|Lack of Efficacy|1|||
147461135|NCT00611247|531849464|FG001|Overall Study|Lack of Efficacy|16|||
147461136|NCT01107444|531849465|FG000|Overall Study|Withdrawal by Subject|8|||
147461137|NCT01107444|531849466|FG001|Overall Study|Withdrawal by Subject|12|||
147461138|NCT01107444|531849465|FG000|Overall Study|Protocol Entry Criteria Not Met|0|||
147461139|NCT01107444|531849466|FG001|Overall Study|Protocol Entry Criteria Not Met|1|||
147461140|NCT01948830|531849469|FG000|Overall Study|Physician Decision|1|||
147461141|NCT01948830|531849470|FG001|Overall Study|Physician Decision|3|||
147461142|NCT01948830|531849469|FG000|Overall Study|Protocol deviation|1|||
147461143|NCT01948830|531849470|FG001|Overall Study|Protocol deviation|2|||
147461144|NCT01948830|531849469|FG000|Overall Study|Lost to Follow-up|5|||
147461145|NCT01948830|531849470|FG001|Overall Study|Lost to Follow-up|4|||
147461146|NCT01948830|531849469|FG000|Overall Study|Withdrawal by Subject|14|||
147461147|NCT01948830|531849470|FG001|Overall Study|Withdrawal by Subject|17|||
147461148|NCT01948830|531849469|FG000|Overall Study|Adverse Event|9|||
147461149|NCT01948830|531849470|FG001|Overall Study|Adverse Event|2|||
147461150|NCT01948830|531849469|FG000|Overall Study|Death|3|||
147461151|NCT01948830|531849470|FG001|Overall Study|Death|4|||
147461152|NCT01890421|531849471|FG000|Overall Study|Adverse Event|1|||
147615465|NCT04917861|532406735|FG000|Extension Period (Day 197 to Day 700)|Death|0|||
147615466|NCT04917861|532406736|FG001|Extension Period (Day 197 to Day 700)|Death|1|||
147615467|NCT04917861|532406737|FG002|Extension Period (Day 197 to Day 700)|Death|0|||
147615468|NCT04917861|532406738|FG003|Extension Period (Day 197 to Day 700)|Death|0|||
147615469|NCT01128179|532406739|FG000|Overall Study|Death|1|||
147615470|NCT01128179|532406740|FG001|Overall Study|Death|0|||
147615471|NCT01128179|532406739|FG000|Overall Study|Protocol Violation|1|||
147615472|NCT01128179|532406740|FG001|Overall Study|Protocol Violation|0|||
147665210|NCT00919633|532598068|FG002|Overall Study|Withdraw consent post transition to SOC|1|||
147665211|NCT00919633|532598069|FG003|Overall Study|Withdraw consent post transition to SOC|1|||
147461153|NCT01890421|531849471|FG000|Overall Study|Other reason|10|||
147615473|NCT02694328|532406741|FG000|Overall Study|Adverse Event|27|||
147615474|NCT02694328|532406742|FG001|Overall Study|Adverse Event|33|||
147615475|NCT02694328|532406741|FG000|Overall Study|Withdrawal by Subject|27|||
147665212|NCT00919633|532598066|FG000|Overall Study|Protocol Violation|0|||
147461154|NCT03310970|531849472|FG000|Overall Study|Withdrawal by Subject|0|||
147461155|NCT03310970|531849473|FG001|Overall Study|Withdrawal by Subject|1|||
147461156|NCT01133171|531849474|FG000|Overall Study|Withdrawal by Subject|1|||
147461157|NCT01133171|531849475|FG001|Overall Study|Withdrawal by Subject|2|||
147461158|NCT01133171|531849476|FG002|Overall Study|Withdrawal by Subject|0|||
147461159|NCT02526550|531849477|FG000|Overall Study|Lost to Follow-up|1|||
147461160|NCT00091832|531849481|FG000|Overall Study|Physician Decision|1|||
147461161|NCT00091832|531849482|FG001|Overall Study|Physician Decision|0|||
147461162|NCT00091832|531849483|FG002|Overall Study|Physician Decision|0|||
147399436|NCT00143598|531626529|FG000|Overall Study|Withdrawal by Subject|33|||
147399437|NCT00143598|531626530|FG001|Overall Study|Withdrawal by Subject|37|||
147399438|NCT00143598|531626529|FG000|Overall Study|Death|36|||
147399439|NCT00143598|531626530|FG001|Overall Study|Death|36|||
147399440|NCT03900715|531626531|FG000|Overall Study|Protocol Deviation|1|||
147399441|NCT03900715|531626531|FG000|Overall Study|Lack of Efficacy|1|||
147399442|NCT03900715|531626531|FG000|Overall Study|Progressive Disease|6|||
147399443|NCT03900715|531626531|FG000|Overall Study|Adverse Event|2|||
147399444|NCT03900715|531626531|FG000|Overall Study|Other reasons|11|||
147399445|NCT01639742|531628683|FG000|Overall Study|Study Ongoing|17|||
147399446|NCT01639742|531628683|FG000|Overall Study|Lost to Follow-up|1|||
147399447|NCT02370251|531628684|FG000|Overall Study|Received less than 8 days of Omegaven|7|||
147399448|NCT02370251|531628684|FG000|Overall Study|Death|4|||
147399449|NCT04469465|531628685|FG000|Treatment Period 1 (TP1)|Adverse Event|2|||
147399450|NCT04469465|531628686|FG001|Treatment Period 1 (TP1)|Adverse Event|1|||
147399451|NCT04469465|531628685|FG000|Treatment Period 1 (TP1)|Withdrawal by Subject|0|||
147399452|NCT04469465|531628686|FG001|Treatment Period 1 (TP1)|Withdrawal by Subject|1|||
147399453|NCT04469465|531628685|FG000|Treatment Period 2 (TP2)|Adverse Event|1|||
147399454|NCT04469465|531628686|FG001|Treatment Period 2 (TP2)|Adverse Event|1|||
147399455|NCT04469465|531628685|FG000|Long-Term Extension (LTE)|Withdrawal by Subject|3|||
147399456|NCT04469465|531628686|FG001|Long-Term Extension (LTE)|Withdrawal by Subject|0|||
147399457|NCT04469465|531628685|FG000|Long-Term Extension (LTE)|Physician Decision|3|||
147399458|NCT04469465|531628686|FG001|Long-Term Extension (LTE)|Physician Decision|0|||
147399459|NCT04469465|531628685|FG000|Long-Term Extension (LTE)|Noncompliance with study intervention|1|||
147399460|NCT04469465|531628686|FG001|Long-Term Extension (LTE)|Noncompliance with study intervention|0|||
147399461|NCT04469465|531628685|FG000|Long-Term Extension (LTE)|Death|0|||
147399462|NCT04469465|531628686|FG001|Long-Term Extension (LTE)|Death|1|||
147399463|NCT04469465|531628685|FG000|Long-Term Extension (LTE)|Adverse Event|1|||
147399464|NCT04469465|531628686|FG001|Long-Term Extension (LTE)|Adverse Event|1|||
147399465|NCT04120376|531628687|FG000|Overall Study|Determined to be ineligible or there was no APP to perform the counseling.|9|||
147399466|NCT04120376|531628688|FG001|Overall Study|Determined to be ineligible or there was no APP to perform the counseling.|0|||
147399467|NCT02053610|531628689|FG000|Overall Study|Adverse Event/Intercurrent Illness|25|||
147399468|NCT02053610|531628690|FG001|Overall Study|Adverse Event/Intercurrent Illness|43|||
147399469|NCT02053610|531628689|FG000|Overall Study|Withdrew Consent|2|||
147399470|NCT02053610|531628690|FG001|Overall Study|Withdrew Consent|9|||
147399471|NCT02053610|531628689|FG000|Overall Study|Death|5|||
147399472|NCT02053610|531628690|FG001|Overall Study|Death|5|||
147399473|NCT02053610|531628689|FG000|Overall Study|Administrative/Other|1|||
147399474|NCT02053610|531628690|FG001|Overall Study|Administrative/Other|1|||
147399475|NCT02053610|531628689|FG000|Overall Study|Disease Progression|2|||
147399476|NCT02053610|531628690|FG001|Overall Study|Disease Progression|3|||
147399477|NCT02053610|531628689|FG000|Overall Study|Refused treatment/Did not cooperate|1|||
147399478|NCT02053610|531628690|FG001|Overall Study|Refused treatment/Did not cooperate|3|||
147399479|NCT02053610|531628689|FG000|Overall Study|Did not Receive Treatment|4|||
147399480|NCT02053610|531628690|FG001|Overall Study|Did not Receive Treatment|2|||
147399481|NCT02053610|531628689|FG000|Overall Study|Insufficient Therapeutic Response|1|||
147399482|NCT02053610|531628690|FG001|Overall Study|Insufficient Therapeutic Response|1|||
147399483|NCT02053610|531628689|FG000|Overall Study|Violation of Selection Criteria|1|||
147399484|NCT02053610|531628690|FG001|Overall Study|Violation of Selection Criteria|0|||
147399485|NCT00781937|531628693|FG000|Main Trial Period Through Week 56|Adverse Event|18|||
147399486|NCT00781937|531628694|FG001|Main Trial Period Through Week 56|Adverse Event|18|||
147399487|NCT00781937|531628693|FG000|Main Trial Period Through Week 56|Lack of Efficacy|0|||
147399488|NCT00781937|531628694|FG001|Main Trial Period Through Week 56|Lack of Efficacy|2|||
147399489|NCT00781937|531628693|FG000|Main Trial Period Through Week 56|Protocol Violation|8|||
147399490|NCT00781937|531628694|FG001|Main Trial Period Through Week 56|Protocol Violation|5|||
147399491|NCT00781937|531628693|FG000|Main Trial Period Through Week 56|Withdrawal by Subject|17|||
147399492|NCT00781937|531628694|FG001|Main Trial Period Through Week 56|Withdrawal by Subject|24|||
147399493|NCT00781937|531628693|FG000|Main Trial Period Through Week 56|Unclassified|10|||
147399494|NCT00781937|531628694|FG001|Main Trial Period Through Week 56|Unclassified|15|||
147399495|NCT00781937|531628693|FG000|Follow up Period (Week 56-68)|Protocol Violation|1|||
147399496|NCT00781937|531628694|FG001|Follow up Period (Week 56-68)|Protocol Violation|1|||
147399497|NCT00781937|531628693|FG000|Follow up Period (Week 56-68)|Unclassified|5|||
147399498|NCT00781937|531628694|FG001|Follow up Period (Week 56-68)|Unclassified|4|||
147399499|NCT01150045|531628695|FG000|Overall Study|Protocol Violation|0|||
147399500|NCT01150045|531628696|FG001|Overall Study|Protocol Violation|1|||
147399501|NCT01150045|531628697|FG002|Overall Study|Protocol Violation|0|||
147399502|NCT01150045|531628698|FG003|Overall Study|Protocol Violation|1|||
147399503|NCT01663506|531628700|FG000|Overall Study|Lack of Efficacy|3|||
147399504|NCT01663506|531628700|FG000|Overall Study|Consent Withdrawal by Subject|1|||
147399505|NCT01663506|531628700|FG000|Overall Study|Lost to Follow-up|1|||
147399506|NCT01663506|531628700|FG000|Overall Study|Adverse Event|1|||
147399507|NCT01663506|531628700|FG000|Overall Study|Switched to Subcutaneous Tocilizumab|2|||
147399508|NCT02094898|531628706|FG000|Overall Study|Clinical Worsening|2|||
147399509|NCT02094898|531628706|FG000|Overall Study|Adverse Event|2|||
147399510|NCT02094898|531628706|FG000|Overall Study|Lack of Efficacy|1|||
147399511|NCT03520075|531628707|FG000|Phase 1 (Dose Escalation)|Death|2|||
147399512|NCT03520075|531628708|FG001|Phase 1 (Dose Escalation)|Death|2|||
147399513|NCT03520075|531628709|FG002|Phase 1 (Dose Escalation)|Death|3|||
147399514|NCT03520075|531628710|FG003|Phase 1 (Dose Escalation)|Death|2|||
147399515|NCT03520075|531628711|FG004|Phase 1 (Dose Escalation)|Death|6|||
147399516|NCT03520075|531628712|FG005|Phase 1 (Dose Escalation)|Death|5|||
147399517|NCT03520075|531628713|FG006|Phase 1 (Dose Escalation)|Death|3|||
147399518|NCT03520075|531628714|FG007|Phase 1 (Dose Escalation)|Death|2|||
147399519|NCT03520075|531628715|FG008|Phase 1 (Dose Escalation)|Death|3|||
147399520|NCT03520075|531628716|FG009|Phase 1 (Dose Escalation)|Death|1|||
147399521|NCT03520075|531628717|FG010|Phase 1 (Dose Escalation)|Death|5|||
147399522|NCT03520075|531628718|FG011|Phase 1 (Dose Escalation)|Death|7|||
147399523|NCT03520075|531628719|FG012|Phase 1 (Dose Escalation)|Death|11|||
147399524|NCT03520075|531628720|FG013|Phase 1 (Dose Escalation)|Death|0|||
147399525|NCT03520075|531628721|FG014|Phase 1 (Dose Escalation)|Death|0|||
147399526|NCT03520075|531628722|FG015|Phase 1 (Dose Escalation)|Death|0|||
147399527|NCT03520075|531628723|FG016|Phase 1 (Dose Escalation)|Death|0|||
147399528|NCT03520075|531628724|FG017|Phase 1 (Dose Escalation)|Death|0|||
147399529|NCT03520075|531628725|FG018|Phase 1 (Dose Escalation)|Death|0|||
147399530|NCT03520075|531628707|FG000|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|1|||
147399531|NCT03520075|531628708|FG001|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
147399532|NCT03520075|531628709|FG002|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
147399533|NCT03520075|531628710|FG003|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|2|||
147399534|NCT03520075|531628711|FG004|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|3|||
147399535|NCT03520075|531628712|FG005|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|2|||
147399536|NCT03520075|531628713|FG006|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
147399537|NCT03520075|531628714|FG007|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|1|||
147399538|NCT03520075|531628715|FG008|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
147399539|NCT03520075|531628716|FG009|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|1|||
147399540|NCT03520075|531628717|FG010|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
147399541|NCT03520075|531628718|FG011|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
147399542|NCT03520075|531628719|FG012|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|4|||
147399543|NCT03520075|531628720|FG013|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
147399544|NCT03520075|531628721|FG014|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
147399545|NCT03520075|531628722|FG015|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
147399546|NCT03520075|531628723|FG016|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
147399547|NCT03520075|531628724|FG017|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
147399548|NCT03520075|531628725|FG018|Phase 1 (Dose Escalation)|Complete Consent Withdrawal|0|||
147399549|NCT03520075|531628707|FG000|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
147399550|NCT03520075|531628708|FG001|Phase 1 (Dose Escalation)|Lost to Follow-up|1|||
147399551|NCT03520075|531628709|FG002|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
147399552|NCT03520075|531628710|FG003|Phase 1 (Dose Escalation)|Lost to Follow-up|1|||
147399553|NCT03520075|531628711|FG004|Phase 1 (Dose Escalation)|Lost to Follow-up|1|||
147399554|NCT03520075|531628712|FG005|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
147399555|NCT03520075|531628713|FG006|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
147399556|NCT03520075|531628714|FG007|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
147399557|NCT03520075|531628715|FG008|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
147399558|NCT03520075|531628716|FG009|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
147399559|NCT03520075|531628717|FG010|Phase 1 (Dose Escalation)|Lost to Follow-up|1|||
147399560|NCT03520075|531628718|FG011|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
147399561|NCT03520075|531628719|FG012|Phase 1 (Dose Escalation)|Lost to Follow-up|1|||
147399562|NCT03520075|531628720|FG013|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
147399563|NCT03520075|531628721|FG014|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
147399564|NCT03520075|531628722|FG015|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
147399565|NCT03520075|531628723|FG016|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
147399566|NCT03520075|531628724|FG017|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
147399567|NCT03520075|531628725|FG018|Phase 1 (Dose Escalation)|Lost to Follow-up|0|||
147399568|NCT03520075|531628707|FG000|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
147399569|NCT03520075|531628708|FG001|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
147399570|NCT03520075|531628709|FG002|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
147399571|NCT03520075|531628710|FG003|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
147399572|NCT03520075|531628711|FG004|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
147615476|NCT02694328|532406742|FG001|Overall Study|Withdrawal by Subject|23|||
147615477|NCT02694328|532406741|FG000|Overall Study|Lost to Follow-up|26|||
147615478|NCT02694328|532406742|FG001|Overall Study|Lost to Follow-up|22|||
147665213|NCT00919633|532598067|FG001|Overall Study|Protocol Violation|0|||
147399573|NCT03520075|531628712|FG005|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
147399574|NCT03520075|531628713|FG006|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
147399575|NCT03520075|531628714|FG007|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
147461163|NCT00091832|531849484|FG003|Overall Study|Physician Decision|0|||
147461164|NCT00091832|531849485|FG004|Overall Study|Physician Decision|0|||
147461165|NCT00091832|531849486|FG005|Overall Study|Physician Decision|0|||
147461166|NCT00091832|531849481|FG000|Overall Study|Adverse Event|0|||
147461167|NCT00091832|531849482|FG001|Overall Study|Adverse Event|0|||
147461168|NCT00091832|531849483|FG002|Overall Study|Adverse Event|0|||
147461169|NCT00091832|531849484|FG003|Overall Study|Adverse Event|1|||
147399576|NCT03520075|531628715|FG008|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
147399577|NCT03520075|531628716|FG009|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|1|||
147399578|NCT03520075|531628717|FG010|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
147399579|NCT03520075|531628718|FG011|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
147399580|NCT03520075|531628719|FG012|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|3|||
147399581|NCT03520075|531628720|FG013|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
147399582|NCT03520075|531628721|FG014|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
147399583|NCT03520075|531628722|FG015|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
147399584|NCT03520075|531628723|FG016|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
147399585|NCT03520075|531628724|FG017|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
147399586|NCT03520075|531628725|FG018|Phase 1 (Dose Escalation)|Study Terminated by Sponsor|0|||
147399587|NCT03520075|531628707|FG000|Phase 2 (Dose Expansion)|Death|0|||
147399588|NCT03520075|531628708|FG001|Phase 2 (Dose Expansion)|Death|0|||
147399589|NCT03520075|531628709|FG002|Phase 2 (Dose Expansion)|Death|0|||
147399590|NCT03520075|531628710|FG003|Phase 2 (Dose Expansion)|Death|0|||
147399591|NCT03520075|531628711|FG004|Phase 2 (Dose Expansion)|Death|0|||
147399592|NCT03520075|531628712|FG005|Phase 2 (Dose Expansion)|Death|0|||
147399593|NCT03520075|531628713|FG006|Phase 2 (Dose Expansion)|Death|0|||
147399594|NCT03520075|531628714|FG007|Phase 2 (Dose Expansion)|Death|0|||
147399595|NCT03520075|531628715|FG008|Phase 2 (Dose Expansion)|Death|0|||
147399596|NCT03520075|531628716|FG009|Phase 2 (Dose Expansion)|Death|0|||
147399597|NCT03520075|531628717|FG010|Phase 2 (Dose Expansion)|Death|0|||
147399598|NCT03520075|531628718|FG011|Phase 2 (Dose Expansion)|Death|0|||
147399599|NCT03520075|531628719|FG012|Phase 2 (Dose Expansion)|Death|0|||
147399600|NCT03520075|531628720|FG013|Phase 2 (Dose Expansion)|Death|20|||
147399601|NCT03520075|531628721|FG014|Phase 2 (Dose Expansion)|Death|13|||
147399602|NCT03520075|531628722|FG015|Phase 2 (Dose Expansion)|Death|9|||
147399603|NCT03520075|531628723|FG016|Phase 2 (Dose Expansion)|Death|5|||
147399604|NCT03520075|531628724|FG017|Phase 2 (Dose Expansion)|Death|14|||
147399605|NCT03520075|531628725|FG018|Phase 2 (Dose Expansion)|Death|12|||
147399606|NCT03520075|531628707|FG000|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
147399607|NCT03520075|531628708|FG001|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
147399608|NCT03520075|531628709|FG002|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
147399609|NCT03520075|531628710|FG003|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
147399610|NCT03520075|531628711|FG004|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
147399611|NCT03520075|531628712|FG005|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
147399612|NCT03520075|531628713|FG006|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
147399613|NCT03520075|531628714|FG007|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
147399614|NCT03520075|531628715|FG008|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
147399615|NCT03520075|531628716|FG009|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
147399616|NCT03520075|531628717|FG010|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
147399617|NCT03520075|531628718|FG011|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
147399618|NCT03520075|531628719|FG012|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
147399619|NCT03520075|531628720|FG013|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|0|||
147399620|NCT03520075|531628721|FG014|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|1|||
147399621|NCT03520075|531628722|FG015|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|2|||
147399622|NCT03520075|531628723|FG016|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|1|||
147399623|NCT03520075|531628724|FG017|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|3|||
147399624|NCT03520075|531628725|FG018|Phase 2 (Dose Expansion)|Complete Consent Withdrawal|2|||
147399625|NCT03520075|531628707|FG000|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
147399626|NCT03520075|531628708|FG001|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
147399627|NCT03520075|531628709|FG002|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
147399628|NCT03520075|531628710|FG003|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
147461170|NCT00091832|531849485|FG004|Overall Study|Adverse Event|3|||
147461171|NCT00091832|531849486|FG005|Overall Study|Adverse Event|0|||
147461172|NCT00091832|531849481|FG000|Overall Study|Withdrawal by Subject|4|||
147461173|NCT00091832|531849482|FG001|Overall Study|Withdrawal by Subject|5|||
147461174|NCT00091832|531849483|FG002|Overall Study|Withdrawal by Subject|0|||
147399629|NCT03520075|531628711|FG004|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
147399630|NCT03520075|531628712|FG005|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
147399631|NCT03520075|531628713|FG006|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
147399632|NCT03520075|531628714|FG007|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
147399633|NCT03520075|531628715|FG008|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
147461175|NCT00091832|531849484|FG003|Overall Study|Withdrawal by Subject|1|||
147461176|NCT00091832|531849485|FG004|Overall Study|Withdrawal by Subject|3|||
147461177|NCT00091832|531849486|FG005|Overall Study|Withdrawal by Subject|1|||
147399634|NCT03520075|531628716|FG009|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
147399635|NCT03520075|531628717|FG010|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
147399636|NCT03520075|531628718|FG011|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
147399637|NCT03520075|531628719|FG012|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
147615479|NCT02694328|532406741|FG000|Overall Study|Noncompliant with study drug|11|||
147615480|NCT02694328|532406742|FG001|Overall Study|Noncompliant with study drug|8|||
147615481|NCT02694328|532406741|FG000|Overall Study|Incarceration|1|||
147615482|NCT02694328|532406742|FG001|Overall Study|Incarceration|1|||
147399638|NCT03520075|531628720|FG013|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
147399639|NCT03520075|531628721|FG014|Phase 2 (Dose Expansion)|Lost to Follow-up|1|||
147399640|NCT03520075|531628722|FG015|Phase 2 (Dose Expansion)|Lost to Follow-up|1|||
147399641|NCT03520075|531628723|FG016|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
147399642|NCT03520075|531628724|FG017|Phase 2 (Dose Expansion)|Lost to Follow-up|0|||
147399643|NCT03520075|531628725|FG018|Phase 2 (Dose Expansion)|Lost to Follow-up|1|||
147399644|NCT03520075|531628707|FG000|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
147399645|NCT03520075|531628708|FG001|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
147399646|NCT03520075|531628709|FG002|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
147399647|NCT03520075|531628710|FG003|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
147399648|NCT03520075|531628711|FG004|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
147399649|NCT03520075|531628712|FG005|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
147399650|NCT03520075|531628713|FG006|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
147399651|NCT03520075|531628714|FG007|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
147399652|NCT03520075|531628715|FG008|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
147399653|NCT03520075|531628716|FG009|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
147399654|NCT03520075|531628717|FG010|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
147399655|NCT03520075|531628718|FG011|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
147399656|NCT03520075|531628719|FG012|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
147399657|NCT03520075|531628720|FG013|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|6|||
147399658|NCT03520075|531628721|FG014|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
147399659|NCT03520075|531628722|FG015|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
147399660|NCT03520075|531628723|FG016|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|3|||
147399661|NCT03520075|531628724|FG017|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|10|||
147399662|NCT03520075|531628725|FG018|Phase 2 (Dose Expansion)|Study Terminated by Sponsor|0|||
147399663|NCT00328562|531628728|FG000|Overall Study|Disease progression|1|||
147399664|NCT03305809|531628729|FG000|Overall Study|Adverse Event|2|||
147399665|NCT03305809|531628730|FG001|Overall Study|Adverse Event|2|||
147461178|NCT00091832|531849481|FG000|Overall Study|Death|6|||
147461179|NCT00091832|531849482|FG001|Overall Study|Death|4|||
147461180|NCT00091832|531849483|FG002|Overall Study|Death|5|||
147461181|NCT00091832|531849484|FG003|Overall Study|Death|8|||
147461182|NCT00091832|531849485|FG004|Overall Study|Death|5|||
147461183|NCT00091832|531849486|FG005|Overall Study|Death|6|||
147461184|NCT00091832|531849481|FG000|Overall Study|Disease Progression|2|||
147461185|NCT00091832|531849482|FG001|Overall Study|Disease Progression|0|||
147461186|NCT00091832|531849483|FG002|Overall Study|Disease Progression|0|||
147461187|NCT00091832|531849484|FG003|Overall Study|Disease Progression|1|||
147461188|NCT00091832|531849485|FG004|Overall Study|Disease Progression|1|||
147461189|NCT00091832|531849486|FG005|Overall Study|Disease Progression|2|||
147461190|NCT00091832|531849481|FG000|Overall Study|Ineligibility Determined|0|||
147461191|NCT00091832|531849482|FG001|Overall Study|Ineligibility Determined|0|||
147461192|NCT00091832|531849483|FG002|Overall Study|Ineligibility Determined|1|||
147461193|NCT00091832|531849484|FG003|Overall Study|Ineligibility Determined|0|||
147461194|NCT00091832|531849485|FG004|Overall Study|Ineligibility Determined|1|||
147461195|NCT00091832|531849486|FG005|Overall Study|Ineligibility Determined|0|||
147461196|NCT00091832|531849481|FG000|Overall Study|Lost to Follow-up|1|||
147615483|NCT02694328|532406741|FG000|Overall Study|Lack of Efficacy|1|||
147615484|NCT02694328|532406742|FG001|Overall Study|Lack of Efficacy|2|||
147615485|NCT02694328|532406741|FG000|Overall Study|Pregnancy|1|||
147615486|NCT02694328|532406742|FG001|Overall Study|Pregnancy|1|||
147615487|NCT02694328|532406741|FG000|Overall Study|Protocol Violation|6|||
147615488|NCT02694328|532406742|FG001|Overall Study|Protocol Violation|5|||
147399666|NCT03305809|531628731|FG002|Overall Study|Adverse Event|6|||
147399667|NCT03305809|531628732|FG003|Overall Study|Adverse Event|6|||
147399668|NCT03305809|531628729|FG000|Overall Study|Death|0|||
147399669|NCT03305809|531628730|FG001|Overall Study|Death|0|||
147461197|NCT00091832|531849482|FG001|Overall Study|Lost to Follow-up|0|||
147461198|NCT00091832|531849483|FG002|Overall Study|Lost to Follow-up|3|||
147461199|NCT00091832|531849484|FG003|Overall Study|Lost to Follow-up|3|||
147461200|NCT00091832|531849485|FG004|Overall Study|Lost to Follow-up|2|||
147461201|NCT00091832|531849486|FG005|Overall Study|Lost to Follow-up|1|||
147461202|NCT00091832|531849481|FG000|Overall Study|Noncompliance|0|||
147461203|NCT00091832|531849482|FG001|Overall Study|Noncompliance|1|||
147461204|NCT00091832|531849483|FG002|Overall Study|Noncompliance|0|||
147461205|NCT00091832|531849484|FG003|Overall Study|Noncompliance|0|||
147461206|NCT00091832|531849485|FG004|Overall Study|Noncompliance|0|||
147615489|NCT02694328|532406741|FG000|Overall Study|Abnormal Laboratory Value|0|||
147615490|NCT02694328|532406742|FG001|Overall Study|Abnormal Laboratory Value|3|||
147615491|NCT00720382|532406746|FG000|Overall Study|Adverse Event|54|||
147615492|NCT00720382|532406747|FG001|Overall Study|Adverse Event|17|||
147399670|NCT03305809|531628731|FG002|Overall Study|Death|1|||
147399671|NCT03305809|531628732|FG003|Overall Study|Death|1|||
147399672|NCT03305809|531628729|FG000|Overall Study|Lost to Follow-up|1|||
147399673|NCT03305809|531628730|FG001|Overall Study|Lost to Follow-up|2|||
147399674|NCT03305809|531628731|FG002|Overall Study|Lost to Follow-up|0|||
147399675|NCT03305809|531628732|FG003|Overall Study|Lost to Follow-up|0|||
147399676|NCT03305809|531628729|FG000|Overall Study|Sponsor Decision|1|||
147399677|NCT03305809|531628730|FG001|Overall Study|Sponsor Decision|0|||
147399678|NCT03305809|531628731|FG002|Overall Study|Sponsor Decision|1|||
147399679|NCT03305809|531628732|FG003|Overall Study|Sponsor Decision|8|||
147399680|NCT03305809|531628729|FG000|Overall Study|Physician Decision|0|||
147399681|NCT03305809|531628730|FG001|Overall Study|Physician Decision|0|||
147399682|NCT03305809|531628731|FG002|Overall Study|Physician Decision|2|||
147399683|NCT03305809|531628732|FG003|Overall Study|Physician Decision|4|||
147399684|NCT03305809|531628729|FG000|Overall Study|Progressive Disease|0|||
147399685|NCT03305809|531628730|FG001|Overall Study|Progressive Disease|0|||
147399686|NCT03305809|531628731|FG002|Overall Study|Progressive Disease|1|||
147399687|NCT03305809|531628732|FG003|Overall Study|Progressive Disease|0|||
147399688|NCT03305809|531628729|FG000|Overall Study|Protocol Violation|1|||
147399689|NCT03305809|531628730|FG001|Overall Study|Protocol Violation|0|||
147399690|NCT03305809|531628731|FG002|Overall Study|Protocol Violation|2|||
147399691|NCT03305809|531628732|FG003|Overall Study|Protocol Violation|3|||
147399692|NCT03305809|531628729|FG000|Overall Study|Withdrawal due to Assessment Committee Decision|0|||
147399693|NCT03305809|531628730|FG001|Overall Study|Withdrawal due to Assessment Committee Decision|0|||
147399694|NCT03305809|531628731|FG002|Overall Study|Withdrawal due to Assessment Committee Decision|0|||
147399695|NCT03305809|531628732|FG003|Overall Study|Withdrawal due to Assessment Committee Decision|2|||
147399696|NCT03305809|531628729|FG000|Overall Study|Withdrawal by Subject|2|||
147399697|NCT03305809|531628730|FG001|Overall Study|Withdrawal by Subject|4|||
147399698|NCT03305809|531628731|FG002|Overall Study|Withdrawal by Subject|5|||
147399699|NCT03305809|531628732|FG003|Overall Study|Withdrawal by Subject|2|||
147399700|NCT03305809|531628729|FG000|Overall Study|Withdrawal due to Caregiver Circumstances|0|||
147399701|NCT03305809|531628730|FG001|Overall Study|Withdrawal due to Caregiver Circumstances|0|||
147399702|NCT03305809|531628731|FG002|Overall Study|Withdrawal due to Caregiver Circumstances|1|||
147399703|NCT03305809|531628732|FG003|Overall Study|Withdrawal due to Caregiver Circumstances|1|||
147399704|NCT00816556|531628733|FG000|Overall Study|Adverse Event|1|||
147399705|NCT00816556|531628734|FG001|Overall Study|Adverse Event|1|||
147399706|NCT00816556|531628735|FG002|Overall Study|Adverse Event|1|||
147399707|NCT00816556|531628733|FG000|Overall Study|Withdrawal by Subject|1|||
147399708|NCT00816556|531628734|FG001|Overall Study|Withdrawal by Subject|1|||
147399709|NCT00816556|531628735|FG002|Overall Study|Withdrawal by Subject|1|||
147399710|NCT00816556|531628733|FG000|Overall Study|Lost to Follow-up|0|||
147399711|NCT00816556|531628734|FG001|Overall Study|Lost to Follow-up|0|||
147399712|NCT00816556|531628735|FG002|Overall Study|Lost to Follow-up|1|||
147399713|NCT04014790|531628736|FG000|Overall Study|Death|4|||
147399714|NCT04014790|531628736|FG000|Overall Study|Adverse Event|1|||
147399715|NCT04014790|531628736|FG000|Overall Study|Withdrawal by Subject|1|||
147399716|NCT03546816|531628737|FG000|Overall Study|Adverse Event|5|||
147399717|NCT03546816|531628738|FG001|Overall Study|Adverse Event|3|||
147399718|NCT03546816|531628737|FG000|Overall Study|Lack of Efficacy|2|||
147399719|NCT03546816|531628738|FG001|Overall Study|Lack of Efficacy|4|||
147399720|NCT03546816|531628737|FG000|Overall Study|Pregnancy|1|||
147399721|NCT03546816|531628738|FG001|Overall Study|Pregnancy|0|||
147399722|NCT03546816|531628737|FG000|Overall Study|Physician Decision|2|||
147399723|NCT03546816|531628738|FG001|Overall Study|Physician Decision|0|||
147399724|NCT03546816|531628737|FG000|Overall Study|Withdrawal by Subject|8|||
147399725|NCT03546816|531628738|FG001|Overall Study|Withdrawal by Subject|10|||
147399726|NCT03546816|531628737|FG000|Overall Study|Lost to Follow-up|3|||
147399727|NCT03546816|531628738|FG001|Overall Study|Lost to Follow-up|2|||
147615493|NCT00720382|532406746|FG000|Overall Study|Lack of Efficacy|18|||
147615494|NCT00720382|532406747|FG001|Overall Study|Lack of Efficacy|7|||
147615495|NCT00720382|532406746|FG000|Overall Study|Non-Compliance|15|||
147615496|NCT00720382|532406747|FG001|Overall Study|Non-Compliance|5|||
147615497|NCT00720382|532406746|FG000|Overall Study|Withdrawal by Subject|47|||
147399728|NCT02438371|531628739|FG000|Overall Study|Lost to Follow-up|3|||
147399729|NCT02438371|531628740|FG001|Overall Study|Lost to Follow-up|2|||
147399730|NCT02438371|531628739|FG000|Overall Study|Withdrawal by Subject|1|||
147399731|NCT02438371|531628740|FG001|Overall Study|Withdrawal by Subject|1|||
147399732|NCT01161446|531628741|FG000|Overall Study|Lost to Follow-up|18|||
147399733|NCT01161446|531628742|FG001|Overall Study|Lost to Follow-up|14|||
147399734|NCT01161446|531628741|FG000|Overall Study|Withdrawal by Subject|0|||
147399735|NCT01161446|531628742|FG001|Overall Study|Withdrawal by Subject|1|||
147399736|NCT00810342|531628743|FG000|Month 1 Follow-up|Lost to Follow-up|4|||
147399737|NCT00810342|531628744|FG001|Month 1 Follow-up|Lost to Follow-up|2|||
147399738|NCT00810342|531628743|FG000|Month 1 Follow-up|Pregnancy|1|||
147461207|NCT00091832|531849486|FG005|Overall Study|Noncompliance|0|||
147461208|NCT00091832|531849481|FG000|Overall Study|Other|0|||
147461209|NCT00091832|531849482|FG001|Overall Study|Other|1|||
147399739|NCT00810342|531628744|FG001|Month 1 Follow-up|Pregnancy|0|||
147399740|NCT00810342|531628743|FG000|6-month Follow-up|Lost to Follow-up|18|||
147399741|NCT00810342|531628744|FG001|6-month Follow-up|Lost to Follow-up|6|||
147399742|NCT00810342|531628743|FG000|6-month Follow-up|Pregnancy|6|||
147399743|NCT00810342|531628744|FG001|6-month Follow-up|Pregnancy|2|||
147399744|NCT00810342|531628743|FG000|12-month Followup|Pregnancy|9|||
147399745|NCT00810342|531628744|FG001|12-month Followup|Pregnancy|10|||
147399746|NCT00810342|531628743|FG000|12-month Followup|Lost to Follow-up|3|||
147399747|NCT00810342|531628744|FG001|12-month Followup|Lost to Follow-up|1|||
147399748|NCT03065933|531628746|FG000|Overall Study|study terminated|5|||
147399749|NCT04504630|531628747|FG000|Assigned to Treatment|Withdrawal by Subject|2|||
147399750|NCT04504630|531628748|FG001|Assigned to Treatment|Withdrawal by Subject|0|||
147399751|NCT04504630|531628747|FG000|Follow-Up at 3 Months|Lost to Follow-up|3|||
147399752|NCT04504630|531628748|FG001|Follow-Up at 3 Months|Lost to Follow-up|1|||
147399753|NCT02330562|531628749|FG000|Overall Study|Adverse Event|0|||
147399754|NCT02330562|531628750|FG001|Overall Study|Adverse Event|0|||
147399755|NCT02330562|531628751|FG002|Overall Study|Adverse Event|3|||
147399756|NCT02330562|531628752|FG003|Overall Study|Adverse Event|0|||
147399757|NCT02330562|531628753|FG004|Overall Study|Adverse Event|3|||
147399758|NCT02330562|531628754|FG005|Overall Study|Adverse Event|1|||
147399759|NCT02330562|531628755|FG006|Overall Study|Adverse Event|0|||
147399760|NCT02330562|531628756|FG007|Overall Study|Adverse Event|0|||
147399761|NCT02330562|531628757|FG008|Overall Study|Adverse Event|0|||
147399762|NCT02330562|531628758|FG009|Overall Study|Adverse Event|1|||
147399763|NCT02330562|531628759|FG010|Overall Study|Adverse Event|1|||
147399764|NCT02330562|531628749|FG000|Overall Study|Participant decision|1|||
147399765|NCT02330562|531628750|FG001|Overall Study|Participant decision|0|||
147399766|NCT02330562|531628751|FG002|Overall Study|Participant decision|4|||
147399767|NCT02330562|531628752|FG003|Overall Study|Participant decision|1|||
147399768|NCT02330562|531628753|FG004|Overall Study|Participant decision|5|||
147399769|NCT02330562|531628754|FG005|Overall Study|Participant decision|2|||
147399770|NCT02330562|531628755|FG006|Overall Study|Participant decision|0|||
147399771|NCT02330562|531628756|FG007|Overall Study|Participant decision|0|||
147399772|NCT02330562|531628757|FG008|Overall Study|Participant decision|0|||
147399773|NCT02330562|531628758|FG009|Overall Study|Participant decision|3|||
147399774|NCT02330562|531628759|FG010|Overall Study|Participant decision|0|||
147399775|NCT02330562|531628749|FG000|Overall Study|Disease progression|5|||
147399776|NCT02330562|531628750|FG001|Overall Study|Disease progression|3|||
147399777|NCT02330562|531628751|FG002|Overall Study|Disease progression|20|||
147399778|NCT02330562|531628752|FG003|Overall Study|Disease progression|28|||
147399779|NCT02330562|531628753|FG004|Overall Study|Disease progression|23|||
147399780|NCT02330562|531628754|FG005|Overall Study|Disease progression|7|||
147399781|NCT02330562|531628755|FG006|Overall Study|Disease progression|1|||
147399782|NCT02330562|531628756|FG007|Overall Study|Disease progression|1|||
147399783|NCT02330562|531628757|FG008|Overall Study|Disease progression|1|||
147399784|NCT02330562|531628758|FG009|Overall Study|Disease progression|0|||
147399785|NCT02330562|531628759|FG010|Overall Study|Disease progression|5|||
147399786|NCT02330562|531628749|FG000|Overall Study|Other reasons|0|||
147399787|NCT02330562|531628750|FG001|Overall Study|Other reasons|0|||
147399788|NCT02330562|531628751|FG002|Overall Study|Other reasons|0|||
147399789|NCT02330562|531628752|FG003|Overall Study|Other reasons|1|||
147399790|NCT02330562|531628753|FG004|Overall Study|Other reasons|0|||
147399791|NCT02330562|531628754|FG005|Overall Study|Other reasons|0|||
147399792|NCT02330562|531628755|FG006|Overall Study|Other reasons|0|||
147399793|NCT02330562|531628756|FG007|Overall Study|Other reasons|0|||
147399794|NCT02330562|531628757|FG008|Overall Study|Other reasons|0|||
147399795|NCT02330562|531628758|FG009|Overall Study|Other reasons|0|||
147399796|NCT02330562|531628759|FG010|Overall Study|Other reasons|0|||
147399797|NCT02330562|531628749|FG000|Overall Study|Withdrawal by Subject|0|||
147461210|NCT00091832|531849483|FG002|Overall Study|Other|2|||
147461211|NCT00091832|531849484|FG003|Overall Study|Other|0|||
147399798|NCT02330562|531628750|FG001|Overall Study|Withdrawal by Subject|0|||
147399799|NCT02330562|531628751|FG002|Overall Study|Withdrawal by Subject|0|||
147399800|NCT02330562|531628752|FG003|Overall Study|Withdrawal by Subject|0|||
147399801|NCT02330562|531628753|FG004|Overall Study|Withdrawal by Subject|0|||
147461212|NCT00091832|531849485|FG004|Overall Study|Other|0|||
147399802|NCT02330562|531628754|FG005|Overall Study|Withdrawal by Subject|0|||
147399803|NCT02330562|531628755|FG006|Overall Study|Withdrawal by Subject|0|||
147399804|NCT02330562|531628756|FG007|Overall Study|Withdrawal by Subject|0|||
147399805|NCT02330562|531628757|FG008|Overall Study|Withdrawal by Subject|0|||
147399806|NCT02330562|531628758|FG009|Overall Study|Withdrawal by Subject|1|||
147399807|NCT02330562|531628759|FG010|Overall Study|Withdrawal by Subject|0|||
147399808|NCT01547117|531628760|FG000|Overall Study|Physician Decision|0|||
147461213|NCT00091832|531849486|FG005|Overall Study|Other|0|||
147461214|NCT00091832|531849481|FG000|Overall Study|Protocol Violation|0|||
147461215|NCT00091832|531849482|FG001|Overall Study|Protocol Violation|0|||
147461216|NCT00091832|531849483|FG002|Overall Study|Protocol Violation|1|||
147461217|NCT00091832|531849484|FG003|Overall Study|Protocol Violation|0|||
147461218|NCT00091832|531849485|FG004|Overall Study|Protocol Violation|0|||
147461219|NCT00091832|531849486|FG005|Overall Study|Protocol Violation|1|||
147461220|NCT01446419|531849490|FG000|Overall Study|Death|1|||
147461221|NCT01446419|531849491|FG001|Overall Study|Death|0|||
147461222|NCT01446419|531849490|FG000|Overall Study|Withdrawal by Subject|1|||
147461223|NCT01446419|531849491|FG001|Overall Study|Withdrawal by Subject|1|||
147461224|NCT01446419|531849490|FG000|Overall Study|Terminated per protocol|3|||
147461225|NCT01446419|531849491|FG001|Overall Study|Terminated per protocol|0|||
147461226|NCT02445586|531849496|FG000|Overall Study|Death|14|||
147461227|NCT02445586|531849496|FG000|Overall Study|Withdrawal by Subject|13|||
147461228|NCT02445586|531849496|FG000|Overall Study|Disease Progression|10|||
147461229|NCT02445586|531849496|FG000|Overall Study|Protocol Violation|1|||
147461230|NCT02445586|531849496|FG000|Overall Study|Medical Condition|1|||
147461231|NCT02542072|531849502|FG000|First Intervention (1 Month)|Adverse Event|1|||
147461232|NCT02542072|531849503|FG001|First Intervention (1 Month)|Adverse Event|1|||
147461233|NCT02542072|531849502|FG000|First Intervention (1 Month)|Lost to Follow-up|2|||
147461234|NCT02542072|531849503|FG001|First Intervention (1 Month)|Lost to Follow-up|0|||
147461235|NCT02542072|531849502|FG000|First Intervention (1 Month)|Lens discomfort|1|||
147461236|NCT02542072|531849503|FG001|First Intervention (1 Month)|Lens discomfort|2|||
147461237|NCT02542072|531849502|FG000|First Intervention (1 Month)|Protocol Violation|1|||
147461238|NCT02542072|531849503|FG001|First Intervention (1 Month)|Protocol Violation|0|||
147461239|NCT02542072|531849502|FG000|Second Intervention (1 Month)|Lost to Follow-up|1|||
147461240|NCT02542072|531849503|FG001|Second Intervention (1 Month)|Lost to Follow-up|0|||
147461241|NCT02542072|531849502|FG000|Second Intervention (1 Month)|Lens discomfort|1|||
147461242|NCT02542072|531849503|FG001|Second Intervention (1 Month)|Lens discomfort|0|||
147461243|NCT00654498|531849506|FG000|Overall Study|Not Treated|1|||
147461244|NCT00654498|531849507|FG001|Overall Study|Not Treated|0|||
147461245|NCT00654498|531849506|FG000|Overall Study|Adverse Event|6|||
147461246|NCT00654498|531849507|FG001|Overall Study|Adverse Event|1|||
147461247|NCT00654498|531849506|FG000|Overall Study|Protocol Violation|1|||
147461248|NCT00654498|531849507|FG001|Overall Study|Protocol Violation|1|||
147461249|NCT00654498|531849506|FG000|Overall Study|Lost to Follow-up|1|||
147461250|NCT00654498|531849507|FG001|Overall Study|Lost to Follow-up|5|||
147399809|NCT01547117|531628761|FG001|Overall Study|Physician Decision|1|||
147399810|NCT01547117|531628762|FG002|Overall Study|Physician Decision|1|||
147399811|NCT01547117|531628763|FG003|Overall Study|Physician Decision|3|||
147399812|NCT01547117|531628760|FG000|Overall Study|Withdrawal by Subject|1|||
147399813|NCT01547117|531628761|FG001|Overall Study|Withdrawal by Subject|2|||
147399814|NCT01547117|531628762|FG002|Overall Study|Withdrawal by Subject|1|||
147399815|NCT01547117|531628763|FG003|Overall Study|Withdrawal by Subject|2|||
147399816|NCT00412880|531628768|FG000|Overall Study|Withdrew, overdose of study treatment|1|||
147399817|NCT00412880|531628768|FG000|Overall Study|Consent withdrawn|1|||
147399818|NCT00412880|531628768|FG000|Overall Study|Adverse Event|1|||
147399819|NCT00412880|531628768|FG000|Overall Study|Progressive disease|20|||
147399820|NCT01288209|531628769|FG000|Overall Study|Withdrawal by Subject|1|||
147399821|NCT01288209|531628770|FG001|Overall Study|Withdrawal by Subject|3|||
147399822|NCT01288209|531628769|FG000|Overall Study|Other|1|||
147399823|NCT01288209|531628770|FG001|Overall Study|Other|0|||
147399824|NCT01496365|531628771|FG000|Overall Study|Adverse Event|2|||
147399825|NCT01496365|531628772|FG001|Overall Study|Adverse Event|3|||
147399826|NCT01496365|531628773|FG002|Overall Study|Adverse Event|3|||
147399827|NCT01496365|531628774|FG003|Overall Study|Adverse Event|2|||
147399828|NCT01496365|531628775|FG004|Overall Study|Adverse Event|5|||
147399829|NCT01496365|531628776|FG005|Overall Study|Adverse Event|6|||
147399830|NCT01496365|531628777|FG006|Overall Study|Adverse Event|4|||
147461251|NCT00654498|531849506|FG000|Overall Study|Withdrawal by Subject|1|||
147461252|NCT00654498|531849507|FG001|Overall Study|Withdrawal by Subject|0|||
147461253|NCT00654498|531849506|FG000|Overall Study|Other reason not defined above|4|||
147461254|NCT00654498|531849507|FG001|Overall Study|Other reason not defined above|5|||
147461255|NCT01990261|531849508|FG000|Overall Study|Death Before Treatment Start|2|||
147461256|NCT01990261|531849508|FG000|Overall Study|Death due to Disease Progression (PD)|10|||
147461257|NCT01990261|531849508|FG000|Overall Study|Death From other Causes|1|||
147461258|NCT01990261|531849508|FG000|Overall Study|Disease Progression (PD)|8|||
147461259|NCT01990261|531849508|FG000|Overall Study|PD Before Treatment Start|1|||
147461260|NCT01990261|531849508|FG000|Overall Study|Dossier not Approved|1|||
147461261|NCT01990261|531849508|FG000|Overall Study|Lost to Follow-up|2|||
147461262|NCT01609842|531849509|FG000|Concurrent Intervention Control|pharmacy data not available|2|||
147461263|NCT01609842|531849510|FG001|Concurrent Intervention Control|pharmacy data not available|0|||
147461264|NCT02474329|531849512|FG000|Overall Study|Withdraw or did not contribute data.|13|||
147461265|NCT01583374|531849513|FG000|Placebo-controlled Phase (Week 0-24)|Adverse Event|6|||
147461266|NCT01583374|531849514|FG001|Placebo-controlled Phase (Week 0-24)|Adverse Event|7|||
147461267|NCT01583374|531849515|FG002|Placebo-controlled Phase (Week 0-24)|Adverse Event|12|||
147461268|NCT01583374|531849516|FG003|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
147665214|NCT00919633|532598068|FG002|Overall Study|Protocol Violation|0|||
147399831|NCT01496365|531628771|FG000|Overall Study|Withdrawal by Subject|6|||
147399832|NCT01496365|531628772|FG001|Overall Study|Withdrawal by Subject|6|||
147399833|NCT01496365|531628773|FG002|Overall Study|Withdrawal by Subject|0|||
147399834|NCT01496365|531628774|FG003|Overall Study|Withdrawal by Subject|1|||
147399835|NCT01496365|531628775|FG004|Overall Study|Withdrawal by Subject|3|||
147399836|NCT01496365|531628776|FG005|Overall Study|Withdrawal by Subject|2|||
147399837|NCT01496365|531628777|FG006|Overall Study|Withdrawal by Subject|1|||
147399838|NCT01496365|531628771|FG000|Overall Study|Protocol Violation|2|||
147399839|NCT01496365|531628772|FG001|Overall Study|Protocol Violation|1|||
147399840|NCT01496365|531628773|FG002|Overall Study|Protocol Violation|1|||
147399841|NCT01496365|531628774|FG003|Overall Study|Protocol Violation|0|||
147399842|NCT01496365|531628775|FG004|Overall Study|Protocol Violation|0|||
147399843|NCT01496365|531628776|FG005|Overall Study|Protocol Violation|1|||
147399844|NCT01496365|531628777|FG006|Overall Study|Protocol Violation|0|||
147399845|NCT01496365|531628771|FG000|Overall Study|Lack of Efficacy|1|||
147399846|NCT01496365|531628772|FG001|Overall Study|Lack of Efficacy|0|||
147399847|NCT01496365|531628773|FG002|Overall Study|Lack of Efficacy|0|||
147399848|NCT01496365|531628774|FG003|Overall Study|Lack of Efficacy|0|||
147399849|NCT01496365|531628775|FG004|Overall Study|Lack of Efficacy|0|||
147399850|NCT01496365|531628776|FG005|Overall Study|Lack of Efficacy|1|||
147399851|NCT01496365|531628777|FG006|Overall Study|Lack of Efficacy|0|||
147399852|NCT01496365|531628771|FG000|Overall Study|Lost to Follow-up|0|||
147399853|NCT01496365|531628772|FG001|Overall Study|Lost to Follow-up|1|||
147399854|NCT01496365|531628773|FG002|Overall Study|Lost to Follow-up|0|||
147399855|NCT01496365|531628774|FG003|Overall Study|Lost to Follow-up|0|||
147399856|NCT01496365|531628775|FG004|Overall Study|Lost to Follow-up|2|||
147399857|NCT01496365|531628776|FG005|Overall Study|Lost to Follow-up|0|||
147399858|NCT01496365|531628777|FG006|Overall Study|Lost to Follow-up|0|||
147399859|NCT01496365|531628771|FG000|Overall Study|Other|4|||
147399860|NCT01496365|531628772|FG001|Overall Study|Other|4|||
147399861|NCT01496365|531628773|FG002|Overall Study|Other|2|||
147399862|NCT01496365|531628774|FG003|Overall Study|Other|1|||
147399863|NCT01496365|531628775|FG004|Overall Study|Other|3|||
147399864|NCT01496365|531628776|FG005|Overall Study|Other|0|||
147399865|NCT01496365|531628777|FG006|Overall Study|Other|1|||
147399866|NCT01015677|531628779|FG000|Overall Study|Adverse Event|0|||
147399867|NCT01015677|531628780|FG001|Overall Study|Adverse Event|1|||
147399868|NCT01015677|531628781|FG002|Overall Study|Adverse Event|0|||
147399869|NCT01015677|531628779|FG000|Overall Study|Lack of Efficacy|0|||
147399870|NCT01015677|531628780|FG001|Overall Study|Lack of Efficacy|1|||
147399871|NCT01015677|531628781|FG002|Overall Study|Lack of Efficacy|0|||
147399872|NCT01015677|531628779|FG000|Overall Study|Protocol Violation|0|||
147399873|NCT01015677|531628780|FG001|Overall Study|Protocol Violation|1|||
147399874|NCT01015677|531628781|FG002|Overall Study|Protocol Violation|0|||
147399875|NCT01015677|531628779|FG000|Overall Study|Withdrawal by Subject|1|||
147399876|NCT01015677|531628780|FG001|Overall Study|Withdrawal by Subject|1|||
147399877|NCT01015677|531628781|FG002|Overall Study|Withdrawal by Subject|0|||
147399878|NCT02706951|531628782|FG000|Period 1|Adverse Event|1|||
147399879|NCT02706951|531628783|FG001|Period 1|Adverse Event|5|||
147399880|NCT02706951|531628784|FG002|Period 1|Adverse Event|3|||
147399881|NCT02706951|531628785|FG003|Period 1|Adverse Event|0|||
147399882|NCT02706951|531628786|FG004|Period 1|Adverse Event|0|||
147399883|NCT02706951|531628782|FG000|Period 1|Withdrawal by Subject|10|||
147399884|NCT02706951|531628783|FG001|Period 1|Withdrawal by Subject|6|||
147399885|NCT02706951|531628784|FG002|Period 1|Withdrawal by Subject|6|||
147399886|NCT02706951|531628785|FG003|Period 1|Withdrawal by Subject|0|||
147399887|NCT02706951|531628786|FG004|Period 1|Withdrawal by Subject|0|||
147399888|NCT02706951|531628782|FG000|Period 1|Lost to Follow-up|0|||
147399889|NCT02706951|531628783|FG001|Period 1|Lost to Follow-up|4|||
147399890|NCT02706951|531628784|FG002|Period 1|Lost to Follow-up|1|||
147399891|NCT02706951|531628785|FG003|Period 1|Lost to Follow-up|0|||
147399892|NCT02706951|531628786|FG004|Period 1|Lost to Follow-up|0|||
147399893|NCT02706951|531628782|FG000|Period 1|Other|2|||
147399894|NCT02706951|531628783|FG001|Period 1|Other|1|||
147399895|NCT02706951|531628784|FG002|Period 1|Other|0|||
147399896|NCT02706951|531628785|FG003|Period 1|Other|0|||
147399897|NCT02706951|531628786|FG004|Period 1|Other|0|||
147399898|NCT02706951|531628782|FG000|Period 2|Adverse Event|0|||
147399899|NCT02706951|531628783|FG001|Period 2|Adverse Event|0|||
147399900|NCT02706951|531628784|FG002|Period 2|Adverse Event|0|||
147399901|NCT02706951|531628785|FG003|Period 2|Adverse Event|25|||
147399902|NCT02706951|531628786|FG004|Period 2|Adverse Event|34|||
147399903|NCT02706951|531628782|FG000|Period 2|Withdrawal by Subject|0|||
147399904|NCT02706951|531628783|FG001|Period 2|Withdrawal by Subject|0|||
147399905|NCT02706951|531628784|FG002|Period 2|Withdrawal by Subject|0|||
147399906|NCT02706951|531628785|FG003|Period 2|Withdrawal by Subject|38|||
147399907|NCT02706951|531628786|FG004|Period 2|Withdrawal by Subject|44|||
147399908|NCT02706951|531628782|FG000|Period 2|Lost to Follow-up|0|||
147399909|NCT02706951|531628783|FG001|Period 2|Lost to Follow-up|0|||
147399910|NCT02706951|531628784|FG002|Period 2|Lost to Follow-up|0|||
147399911|NCT02706951|531628785|FG003|Period 2|Lost to Follow-up|17|||
147399912|NCT02706951|531628786|FG004|Period 2|Lost to Follow-up|9|||
147399913|NCT02706951|531628782|FG000|Period 2|COVID-19 Related|0|||
147399914|NCT02706951|531628783|FG001|Period 2|COVID-19 Related|0|||
147399915|NCT02706951|531628784|FG002|Period 2|COVID-19 Related|0|||
147399916|NCT02706951|531628785|FG003|Period 2|COVID-19 Related|1|||
147399917|NCT02706951|531628786|FG004|Period 2|COVID-19 Related|2|||
147399918|NCT02706951|531628782|FG000|Period 2|Other|0|||
147399919|NCT02706951|531628783|FG001|Period 2|Other|0|||
147399920|NCT02706951|531628784|FG002|Period 2|Other|0|||
147399921|NCT02706951|531628785|FG003|Period 2|Other|37|||
147399922|NCT02706951|531628786|FG004|Period 2|Other|31|||
147399923|NCT03491215|531628787|FG000|Overall Study|Death|6|||
147399924|NCT03491215|531628788|FG001|Overall Study|Death|2|||
147399925|NCT03491215|531628789|FG002|Overall Study|Death|1|||
147399926|NCT03491215|531628790|FG003|Overall Study|Death|0|||
147399927|NCT03491215|531628787|FG000|Overall Study|Physician Decision|1|||
147399928|NCT03491215|531628788|FG001|Overall Study|Physician Decision|0|||
147399929|NCT03491215|531628789|FG002|Overall Study|Physician Decision|0|||
147399930|NCT03491215|531628790|FG003|Overall Study|Physician Decision|0|||
147399931|NCT02172950|531628797|FG000|Overall Study|Physician Decision|3|||
147399932|NCT02172950|531628798|FG001|Overall Study|Physician Decision|3|||
147399933|NCT02172950|531628797|FG000|Overall Study|Lack of Efficacy|1|||
147399934|NCT02172950|531628798|FG001|Overall Study|Lack of Efficacy|0|||
147399935|NCT02172950|531628797|FG000|Overall Study|Adverse Event|4|||
147399936|NCT02172950|531628798|FG001|Overall Study|Adverse Event|1|||
147399937|NCT02172950|531628797|FG000|Overall Study|Withdrawal by Subject|10|||
147399938|NCT02172950|531628798|FG001|Overall Study|Withdrawal by Subject|0|||
147399939|NCT02172950|531628797|FG000|Overall Study|Protocol Violation|1|||
147399940|NCT02172950|531628798|FG001|Overall Study|Protocol Violation|0|||
147399941|NCT02172950|531628797|FG000|Overall Study|Lost to Follow-up|1|||
147399942|NCT02172950|531628798|FG001|Overall Study|Lost to Follow-up|0|||
147399943|NCT02172950|531628797|FG000|Overall Study|Death|1|||
147399944|NCT02172950|531628798|FG001|Overall Study|Death|0|||
147399945|NCT02172950|531628797|FG000|Overall Study|Patient traveling|1|||
147399946|NCT02172950|531628798|FG001|Overall Study|Patient traveling|0|||
147399947|NCT02172950|531628797|FG000|Overall Study|Patient went to other country|1|||
147399948|NCT02172950|531628798|FG001|Overall Study|Patient went to other country|0|||
147399949|NCT02172950|531628797|FG000|Overall Study|Patient relocated overseas|1|||
147399950|NCT02172950|531628798|FG001|Overall Study|Patient relocated overseas|1|||
147399951|NCT02172950|531628797|FG000|Overall Study|Patient moving|1|||
147399952|NCT02172950|531628798|FG001|Overall Study|Patient moving|0|||
147399953|NCT04962698|531628799|FG000|Motor Imagery|Technical difficulty|1|||
147399954|NCT04962698|531628800|FG001|Motor Imagery|Technical difficulty|0|||
147399955|NCT04962698|531628799|FG000|Motor Imagery|Exclusion criteria met after enrollment|0|||
147399956|NCT04962698|531628800|FG001|Motor Imagery|Exclusion criteria met after enrollment|2|||
147399957|NCT04962698|531628799|FG000|Kinesthetic MI|Technical difficulty|1|||
147399958|NCT04962698|531628800|FG001|Kinesthetic MI|Technical difficulty|0|||
147399959|NCT04962698|531628799|FG000|Robotic-hand Interaction With MI|Technical difficulty|1|||
147399960|NCT04962698|531628800|FG001|Robotic-hand Interaction With MI|Technical difficulty|0|||
147399961|NCT04962698|531628799|FG000|Robotic-hand Interaction With MI|Exclusion criteria met after enrollment|0|||
147399962|NCT04962698|531628800|FG001|Robotic-hand Interaction With MI|Exclusion criteria met after enrollment|2|||
147399963|NCT04962698|531628799|FG000|Robotic-hand Interaction Without MI|Technical difficulty|1|||
147399964|NCT04962698|531628800|FG001|Robotic-hand Interaction Without MI|Technical difficulty|0|||
147399965|NCT04962698|531628799|FG000|Virtual-hand Interaction|Technical difficulty|1|||
147399966|NCT04962698|531628800|FG001|Virtual-hand Interaction|Technical difficulty|0|||
147399967|NCT04962698|531628799|FG000|Robotic Action Observation|Technical difficulty|1|||
147399968|NCT04962698|531628800|FG001|Robotic Action Observation|Technical difficulty|0|||
147399969|NCT04962698|531628799|FG000|Rest|Technical difficulty|1|||
147399970|NCT04962698|531628800|FG001|Rest|Technical difficulty|0|||
147399971|NCT04962698|531628799|FG000|Rest|Exclusion criteria met after enrollment|0|||
147399972|NCT04962698|531628800|FG001|Rest|Exclusion criteria met after enrollment|2|||
147399973|NCT00853229|531628801|FG000|Phase 1: Initial Intervention|Early study termination, poor enrollment|8|||
147399974|NCT00853229|531628802|FG001|Phase 1: Initial Intervention|Early study termination, poor enrollment|8|||
147399975|NCT02586415|531628803|FG000|Overall Study|Death|13|||
147399976|NCT02586415|531628804|FG001|Overall Study|Death|23|||
147399977|NCT02586415|531628803|FG000|Overall Study|Lost to Follow-up|1|||
147399978|NCT02586415|531628804|FG001|Overall Study|Lost to Follow-up|2|||
147399979|NCT02777242|531628805|FG000|Overall Study|Other|2|||
147399980|NCT02777242|531628805|FG000|Overall Study|Lost to Follow-up|1|||
147399981|NCT02777242|531628805|FG000|Overall Study|Multiple|1|||
147399982|NCT02777242|531628805|FG000|Overall Study|Sponsor's request|1|||
147399983|NCT02777242|531628805|FG000|Overall Study|Withdrawal by Subject|1|||
147399984|NCT00255944|531628806|FG000|Overall Study|Lost to Follow-up|797|||
147399985|NCT00255944|531628807|FG001|Overall Study|Lost to Follow-up|834|||
147399986|NCT05178979|531628808|FG000|Overall Study|Death|0|||
147399987|NCT05178979|531628809|FG001|Overall Study|Death|5|||
147399988|NCT05178979|531628810|FG002|Overall Study|Death|0|||
147665215|NCT00919633|532598069|FG003|Overall Study|Protocol Violation|1|||
147399989|NCT05178979|531628811|FG003|Overall Study|Death|3|||
147399990|NCT05178979|531628808|FG000|Overall Study|Adverse Event|0|||
147399991|NCT05178979|531628809|FG001|Overall Study|Adverse Event|1|||
147461269|NCT01583374|531849517|FG004|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
147461270|NCT01583374|531849518|FG005|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
147461271|NCT01583374|531849519|FG006|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
147461272|NCT01583374|531849520|FG007|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
147461273|NCT01583374|531849521|FG008|Placebo-controlled Phase (Week 0-24)|Adverse Event|0|||
147461274|NCT01583374|531849513|FG000|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|3|||
147461275|NCT01583374|531849514|FG001|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|2|||
147461276|NCT01583374|531849515|FG002|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|5|||
147461277|NCT01583374|531849516|FG003|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
147461278|NCT01583374|531849517|FG004|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
147461279|NCT01583374|531849518|FG005|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
147461280|NCT01583374|531849519|FG006|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
147461281|NCT01583374|531849520|FG007|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
147461282|NCT01583374|531849521|FG008|Placebo-controlled Phase (Week 0-24)|Lack of Efficacy|0|||
147461283|NCT01583374|531849513|FG000|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|1|||
147461284|NCT01583374|531849514|FG001|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|1|||
147461285|NCT01583374|531849515|FG002|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
147461286|NCT01583374|531849516|FG003|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
147461287|NCT01583374|531849517|FG004|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
147461288|NCT01583374|531849518|FG005|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
147615498|NCT00720382|532406747|FG001|Overall Study|Withdrawal by Subject|11|||
147615499|NCT00720382|532406746|FG000|Overall Study|Lost to Follow-up|28|||
147615500|NCT00720382|532406747|FG001|Overall Study|Lost to Follow-up|14|||
147615501|NCT00720382|532406746|FG000|Overall Study|administrative|14|||
147615502|NCT00720382|532406747|FG001|Overall Study|administrative|5|||
147615503|NCT05192889|532406748|FG000|Block 1: All Eligible Patients|Death|2|||
147615504|NCT05192889|532406749|FG001|Block 1: All Eligible Patients|Death|0|||
147615505|NCT05192889|532406750|FG002|Block 1: All Eligible Patients|Death|0|||
147615506|NCT05192889|532406748|FG000|Block 2b - Dose Level 1|Adverse Event|0|||
147399992|NCT05178979|531628810|FG002|Overall Study|Adverse Event|0|||
147399993|NCT05178979|531628811|FG003|Overall Study|Adverse Event|0|||
147399994|NCT05178979|531628808|FG000|Overall Study|Lost to Follow-up|1|||
147399995|NCT05178979|531628809|FG001|Overall Study|Lost to Follow-up|8|||
147399996|NCT05178979|531628810|FG002|Overall Study|Lost to Follow-up|3|||
147399997|NCT05178979|531628811|FG003|Overall Study|Lost to Follow-up|8|||
147399998|NCT02299427|531628813|FG000|Overall Study|Withdrawal by Subject|1|||
147399999|NCT02299427|531628814|FG001|Overall Study|Withdrawal by Subject|0|||
147400000|NCT02299427|531628813|FG000|Overall Study|Lost to Follow-up|1|||
147400001|NCT02299427|531628814|FG001|Overall Study|Lost to Follow-up|3|||
147400002|NCT02299427|531628813|FG000|Overall Study|not adherent to dog website use|21|||
147400003|NCT02299427|531628814|FG001|Overall Study|not adherent to dog website use|0|||
147400004|NCT00511797|531628815|FG000|Overall Study|Adverse Event|1|||
147400005|NCT00511797|531628816|FG001|Overall Study|Adverse Event|2|||
147400006|NCT00511797|531628817|FG002|Overall Study|Adverse Event|2|||
147400007|NCT00511797|531628818|FG003|Overall Study|Adverse Event|2|||
147400008|NCT00511797|531628815|FG000|Overall Study|Lost to Follow-up|1|||
147400009|NCT00511797|531628816|FG001|Overall Study|Lost to Follow-up|0|||
147400010|NCT00511797|531628817|FG002|Overall Study|Lost to Follow-up|0|||
147400011|NCT00511797|531628818|FG003|Overall Study|Lost to Follow-up|1|||
147400012|NCT00511797|531628815|FG000|Overall Study|Pregnancy|0|||
147400013|NCT00511797|531628816|FG001|Overall Study|Pregnancy|0|||
147400014|NCT00511797|531628817|FG002|Overall Study|Pregnancy|0|||
147400015|NCT00511797|531628818|FG003|Overall Study|Pregnancy|1|||
147400016|NCT00511797|531628815|FG000|Overall Study|Protocol Violation|0|||
147400017|NCT00511797|531628816|FG001|Overall Study|Protocol Violation|2|||
147400018|NCT00511797|531628817|FG002|Overall Study|Protocol Violation|2|||
147400019|NCT00511797|531628818|FG003|Overall Study|Protocol Violation|3|||
147400020|NCT00511797|531628815|FG000|Overall Study|Withdrawal by Subject|3|||
147400021|NCT00511797|531628816|FG001|Overall Study|Withdrawal by Subject|3|||
147400022|NCT00511797|531628817|FG002|Overall Study|Withdrawal by Subject|4|||
147400023|NCT00511797|531628818|FG003|Overall Study|Withdrawal by Subject|2|||
147400024|NCT00511797|531628815|FG000|Overall Study|Never dispensed|1|||
147400025|NCT00511797|531628816|FG001|Overall Study|Never dispensed|0|||
147400026|NCT00511797|531628817|FG002|Overall Study|Never dispensed|1|||
147400027|NCT00511797|531628818|FG003|Overall Study|Never dispensed|3|||
147400028|NCT00511797|531628815|FG000|Overall Study|Study drug not taken|0|||
147400029|NCT00511797|531628816|FG001|Overall Study|Study drug not taken|1|||
147400030|NCT00511797|531628817|FG002|Overall Study|Study drug not taken|0|||
147400031|NCT00511797|531628818|FG003|Overall Study|Study drug not taken|1|||
147400032|NCT00511797|531628815|FG000|Overall Study|Partially missing diary|0|||
147400033|NCT00511797|531628816|FG001|Overall Study|Partially missing diary|0|||
147400034|NCT00511797|531628817|FG002|Overall Study|Partially missing diary|1|||
147461289|NCT01583374|531849519|FG006|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
147615507|NCT05192889|532406749|FG001|Block 2b - Dose Level 1|Adverse Event|0|||
147461290|NCT01583374|531849520|FG007|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
147461291|NCT01583374|531849521|FG008|Placebo-controlled Phase (Week 0-24)|Non-compliance with Study Drug|0|||
147461292|NCT01583374|531849513|FG000|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|8|||
147461293|NCT01583374|531849514|FG001|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|3|||
147461294|NCT01583374|531849515|FG002|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|5|||
147461295|NCT01583374|531849516|FG003|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
147461296|NCT01583374|531849517|FG004|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
147461297|NCT01583374|531849518|FG005|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
147461298|NCT01583374|531849519|FG006|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
147461299|NCT01583374|531849520|FG007|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
147461300|NCT01583374|531849521|FG008|Placebo-controlled Phase (Week 0-24)|Withdrawal by Subject|0|||
147461301|NCT01583374|531849513|FG000|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|1|||
147461302|NCT01583374|531849514|FG001|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|2|||
147461303|NCT01583374|531849515|FG002|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
147461304|NCT01583374|531849516|FG003|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
147461305|NCT01583374|531849517|FG004|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
147461306|NCT01583374|531849518|FG005|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
147461307|NCT01583374|531849519|FG006|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
147461308|NCT01583374|531849520|FG007|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
147461309|NCT01583374|531849521|FG008|Placebo-controlled Phase (Week 0-24)|Lost to Follow-up|0|||
147461310|NCT01583374|531849513|FG000|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
147461311|NCT01583374|531849514|FG001|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
147461312|NCT01583374|531849515|FG002|Placebo-controlled Phase (Week 0-24)|Protocol Violation|3|||
147461313|NCT01583374|531849516|FG003|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
147461314|NCT01583374|531849517|FG004|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
147461315|NCT01583374|531849518|FG005|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
147461316|NCT01583374|531849519|FG006|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
147461317|NCT01583374|531849520|FG007|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
147461318|NCT01583374|531849521|FG008|Placebo-controlled Phase (Week 0-24)|Protocol Violation|0|||
147461319|NCT01583374|531849513|FG000|Placebo-controlled Phase (Week 0-24)|Other|0|||
147461320|NCT01583374|531849514|FG001|Placebo-controlled Phase (Week 0-24)|Other|1|||
147461321|NCT01583374|531849515|FG002|Placebo-controlled Phase (Week 0-24)|Other|0|||
147461322|NCT01583374|531849516|FG003|Placebo-controlled Phase (Week 0-24)|Other|0|||
147461323|NCT01583374|531849517|FG004|Placebo-controlled Phase (Week 0-24)|Other|0|||
147461324|NCT01583374|531849518|FG005|Placebo-controlled Phase (Week 0-24)|Other|0|||
147461325|NCT01583374|531849519|FG006|Placebo-controlled Phase (Week 0-24)|Other|0|||
147461326|NCT01583374|531849520|FG007|Placebo-controlled Phase (Week 0-24)|Other|0|||
147461327|NCT01583374|531849521|FG008|Placebo-controlled Phase (Week 0-24)|Other|0|||
147461328|NCT01583374|531849513|FG000|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
147461329|NCT01583374|531849514|FG001|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
147461330|NCT01583374|531849515|FG002|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
147461331|NCT01583374|531849516|FG003|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
147461332|NCT01583374|531849517|FG004|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
147461333|NCT01583374|531849518|FG005|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
147461334|NCT01583374|531849519|FG006|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
147461335|NCT01583374|531849520|FG007|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|1|||
147461336|NCT01583374|531849521|FG008|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
147461337|NCT01583374|531849513|FG000|Extension Phase (Weeks 24 to 52)|Adverse Event|0|||
147461338|NCT01583374|531849514|FG001|Extension Phase (Weeks 24 to 52)|Adverse Event|1|||
147461339|NCT01583374|531849515|FG002|Extension Phase (Weeks 24 to 52)|Adverse Event|2|||
147461340|NCT01583374|531849516|FG003|Extension Phase (Weeks 24 to 52)|Adverse Event|0|||
147461341|NCT01583374|531849517|FG004|Extension Phase (Weeks 24 to 52)|Adverse Event|1|||
147461342|NCT01583374|531849518|FG005|Extension Phase (Weeks 24 to 52)|Adverse Event|1|||
147461343|NCT01583374|531849519|FG006|Extension Phase (Weeks 24 to 52)|Adverse Event|0|||
147461344|NCT01583374|531849520|FG007|Extension Phase (Weeks 24 to 52)|Adverse Event|1|||
147461345|NCT01583374|531849521|FG008|Extension Phase (Weeks 24 to 52)|Adverse Event|0|||
147461346|NCT01583374|531849513|FG000|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|0|||
147461347|NCT01583374|531849514|FG001|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|2|||
147461348|NCT01583374|531849515|FG002|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|0|||
147461349|NCT01583374|531849516|FG003|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|6|||
147461350|NCT01583374|531849517|FG004|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|3|||
147461351|NCT01583374|531849518|FG005|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|2|||
147461352|NCT01583374|531849519|FG006|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|5|||
147461353|NCT01583374|531849520|FG007|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|1|||
147615508|NCT05192889|532406750|FG002|Block 2b - Dose Level 1|Adverse Event|1|||
147615509|NCT05192889|532406748|FG000|Block 2b - Dose Level 1|Refused Therapy|0|||
147615510|NCT05192889|532406749|FG001|Block 2b - Dose Level 1|Refused Therapy|0|||
147461354|NCT01583374|531849521|FG008|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|2|||
147461355|NCT01583374|531849513|FG000|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
147400035|NCT00511797|531628818|FG003|Overall Study|Partially missing diary|0|||
147400036|NCT00511797|531628815|FG000|Overall Study|Other (moving etc)|1|||
147400037|NCT00511797|531628816|FG001|Overall Study|Other (moving etc)|0|||
147400038|NCT00511797|531628817|FG002|Overall Study|Other (moving etc)|1|||
147400039|NCT00511797|531628818|FG003|Overall Study|Other (moving etc)|2|||
147461356|NCT01583374|531849514|FG001|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|2|||
147461357|NCT01583374|531849515|FG002|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|1|||
147400040|NCT01121913|531628819|FG000|First Intervention Period|Adverse Event|0|||
147400041|NCT01121913|531628820|FG001|First Intervention Period|Adverse Event|0|||
147400042|NCT01121913|531628821|FG002|First Intervention Period|Adverse Event|1|||
147400043|NCT01121913|531628822|FG003|First Intervention Period|Adverse Event|0|||
147400044|NCT01121913|531628819|FG000|First Washout Period|Withdrawal by Subject|1|||
147400045|NCT01121913|531628820|FG001|First Washout Period|Withdrawal by Subject|0|||
147400046|NCT01121913|531628821|FG002|First Washout Period|Withdrawal by Subject|0|||
147400047|NCT01121913|531628822|FG003|First Washout Period|Withdrawal by Subject|0|||
147400048|NCT01121913|531628819|FG000|Second Intervention Period|Adverse Event|0|||
147400049|NCT01121913|531628820|FG001|Second Intervention Period|Adverse Event|0|||
147400050|NCT01121913|531628821|FG002|Second Intervention Period|Adverse Event|1|||
147400051|NCT01121913|531628822|FG003|Second Intervention Period|Adverse Event|0|||
147400052|NCT01121913|531628819|FG000|Second Washout Period|Withdrawal by Subject|0|||
147461358|NCT01583374|531849516|FG003|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
147461359|NCT01583374|531849517|FG004|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|1|||
147461360|NCT01583374|531849518|FG005|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
147461361|NCT01583374|531849519|FG006|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
147461362|NCT01583374|531849520|FG007|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
147461363|NCT01583374|531849521|FG008|Extension Phase (Weeks 24 to 52)|Non-compliance study drug|0|||
147461364|NCT01583374|531849513|FG000|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
147461365|NCT01583374|531849514|FG001|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
147461366|NCT01583374|531849515|FG002|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|1|||
147461367|NCT01583374|531849516|FG003|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
147461368|NCT01583374|531849517|FG004|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|1|||
147461369|NCT01583374|531849518|FG005|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|2|||
147461370|NCT01583374|531849519|FG006|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
147461371|NCT01583374|531849520|FG007|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
147461372|NCT01583374|531849521|FG008|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
147461373|NCT01583374|531849513|FG000|Long-Term Extension Phase Weeks 52-260|Adverse Event|0|||
147461374|NCT01583374|531849514|FG001|Long-Term Extension Phase Weeks 52-260|Adverse Event|5|||
147400053|NCT01121913|531628820|FG001|Second Washout Period|Withdrawal by Subject|0|||
147400054|NCT01121913|531628821|FG002|Second Washout Period|Withdrawal by Subject|1|||
147400055|NCT01121913|531628822|FG003|Second Washout Period|Withdrawal by Subject|0|||
147400056|NCT01121913|531628819|FG000|Third Washout Period|Adverse Event|1|||
147400057|NCT01121913|531628820|FG001|Third Washout Period|Adverse Event|0|||
147400058|NCT01121913|531628821|FG002|Third Washout Period|Adverse Event|0|||
147400059|NCT01121913|531628822|FG003|Third Washout Period|Adverse Event|0|||
147400060|NCT03269695|531628823|FG000|Overall Study|Adverse Event|2|||
147400061|NCT03269695|531628824|FG001|Overall Study|Adverse Event|1|||
147400062|NCT03269695|531628823|FG000|Overall Study|Lack of Efficacy|0|||
147400063|NCT03269695|531628824|FG001|Overall Study|Lack of Efficacy|1|||
147400064|NCT03269695|531628823|FG000|Overall Study|Withdrawal by Subject|0|||
147400065|NCT03269695|531628824|FG001|Overall Study|Withdrawal by Subject|1|||
147400066|NCT00104637|531628825|FG000|Period 1: ( TREATMENT: 4 Weeks)|Adverse Event|1|||
147400067|NCT00104637|531628826|FG001|Period 1: ( TREATMENT: 4 Weeks)|Adverse Event|0|||
147400068|NCT01313624|531628827|FG000|Double-Blind Phase|Adverse Event|27|||
147400069|NCT01313624|531628828|FG001|Double-Blind Phase|Adverse Event|4|||
147400070|NCT01313624|531628827|FG000|Double-Blind Phase|Withdrawal by Subject|9|||
147400071|NCT01313624|531628828|FG001|Double-Blind Phase|Withdrawal by Subject|4|||
147400072|NCT01313624|531628827|FG000|Double-Blind Phase|Lost to Follow-up|0|||
147400073|NCT01313624|531628828|FG001|Double-Blind Phase|Lost to Follow-up|2|||
147400074|NCT01313624|531628827|FG000|Double-Blind Phase|Physician Decision|1|||
147461375|NCT01583374|531849515|FG002|Long-Term Extension Phase Weeks 52-260|Adverse Event|2|||
147461376|NCT01583374|531849516|FG003|Long-Term Extension Phase Weeks 52-260|Adverse Event|2|||
147461377|NCT01583374|531849517|FG004|Long-Term Extension Phase Weeks 52-260|Adverse Event|6|||
147461378|NCT01583374|531849518|FG005|Long-Term Extension Phase Weeks 52-260|Adverse Event|2|||
147461379|NCT01583374|531849519|FG006|Long-Term Extension Phase Weeks 52-260|Adverse Event|2|||
147461380|NCT01583374|531849520|FG007|Long-Term Extension Phase Weeks 52-260|Adverse Event|3|||
147461381|NCT01583374|531849521|FG008|Long-Term Extension Phase Weeks 52-260|Adverse Event|1|||
147461382|NCT01583374|531849513|FG000|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|0|||
147461383|NCT01583374|531849514|FG001|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|4|||
147400075|NCT01313624|531628828|FG001|Double-Blind Phase|Physician Decision|0|||
147400076|NCT01313624|531628827|FG000|Double-Blind Phase|Lack of Efficacy|1|||
147400077|NCT01313624|531628828|FG001|Double-Blind Phase|Lack of Efficacy|0|||
147400078|NCT01313624|531628827|FG000|Open-Label Phase|Adverse Event|1|||
147400079|NCT01313624|531628828|FG001|Open-Label Phase|Adverse Event|10|||
147400080|NCT01313624|531628827|FG000|Open-Label Phase|Withdrawal by Subject|2|||
147400081|NCT01313624|531628828|FG001|Open-Label Phase|Withdrawal by Subject|2|||
147400082|NCT01313624|531628827|FG000|Open-Label Phase|Lost to Follow-up|1|||
147400083|NCT01313624|531628828|FG001|Open-Label Phase|Lost to Follow-up|1|||
147400084|NCT01017263|531628829|FG000|Overall Study|not eligible|12|||
147400085|NCT02447718|531628832|FG000|Overall Study|Lost to Follow-up|8|||
147400086|NCT02447718|531628833|FG001|Overall Study|Lost to Follow-up|0|||
147400087|NCT02447718|531628832|FG000|Overall Study|Withdrawal by Subject|3|||
147400088|NCT02447718|531628833|FG001|Overall Study|Withdrawal by Subject|0|||
147400089|NCT02447718|531628832|FG000|Overall Study|Screen Failure|1|||
147400090|NCT02447718|531628833|FG001|Overall Study|Screen Failure|0|||
147400091|NCT00239681|531628834|FG000|Overall Study|Adverse Event|100|||
147400092|NCT00239681|531628835|FG001|Overall Study|Adverse Event|99|||
147400093|NCT00239681|531628834|FG000|Overall Study|Withdrawal by Subject|458|||
147400094|NCT00239681|531628835|FG001|Overall Study|Withdrawal by Subject|489|||
147400095|NCT00239681|531628834|FG000|Overall Study|Lost to Follow-up|28|||
147400096|NCT00239681|531628835|FG001|Overall Study|Lost to Follow-up|22|||
147400097|NCT00239681|531628834|FG000|Overall Study|Protocol Violation|4|||
147400098|NCT00239681|531628835|FG001|Overall Study|Protocol Violation|4|||
147400099|NCT00239681|531628834|FG000|Overall Study|Physician Decision|13|||
147400100|NCT00239681|531628835|FG001|Overall Study|Physician Decision|17|||
147400101|NCT00239681|531628834|FG000|Overall Study|No information chacked on CaseReportForm|90|||
147400102|NCT00239681|531628835|FG001|Overall Study|No information chacked on CaseReportForm|84|||
147400103|NCT02654132|531628838|FG000|Pre-Treatment Period|Participant Withdrew Consent|0|||
147400104|NCT02654132|531628839|FG001|Pre-Treatment Period|Participant Withdrew Consent|2|||
147400105|NCT02654132|531628838|FG000|Treatment Period|Disease progression|43|||
147400106|NCT02654132|531628839|FG001|Treatment Period|Disease progression|38|||
147400107|NCT02654132|531628838|FG000|Treatment Period|Adverse Event unrelated to study drug|6|||
147400108|NCT02654132|531628839|FG001|Treatment Period|Adverse Event unrelated to study drug|9|||
147400109|NCT02654132|531628838|FG000|Treatment Period|Other reasons|4|||
147400110|NCT02654132|531628839|FG001|Treatment Period|Other reasons|2|||
147400111|NCT02654132|531628838|FG000|Treatment Period|Study drug toxicity|2|||
147400112|NCT02654132|531628839|FG001|Treatment Period|Study drug toxicity|2|||
147400113|NCT02654132|531628838|FG000|Treatment Period|Withdrawal by Subject|2|||
147400114|NCT02654132|531628839|FG001|Treatment Period|Withdrawal by Subject|1|||
147400115|NCT02654132|531628838|FG000|Treatment Period|Maximum Clinical Benefit|0|||
147400116|NCT02654132|531628839|FG001|Treatment Period|Maximum Clinical Benefit|2|||
147400117|NCT02654132|531628838|FG000|Treatment Period|Participant request to discontinue|2|||
147400118|NCT02654132|531628839|FG001|Treatment Period|Participant request to discontinue|0|||
147400119|NCT02654132|531628838|FG000|Treatment Period|Administrative reasons by sponsor|0|||
147400120|NCT02654132|531628839|FG001|Treatment Period|Administrative reasons by sponsor|1|||
147400121|NCT02654132|531628838|FG000|Treatment Period|Death|1|||
147400122|NCT02654132|531628839|FG001|Treatment Period|Death|0|||
147400123|NCT01880437|531628840|FG000|Overall Study|Death|12|||
147400124|NCT01880437|531628841|FG001|Overall Study|Death|4|||
147400125|NCT01880437|531628842|FG002|Overall Study|Death|17|||
147400126|NCT01880437|531628840|FG000|Overall Study|Study terminated by Sponsor|3|||
147400127|NCT01880437|531628841|FG001|Overall Study|Study terminated by Sponsor|0|||
147400128|NCT01880437|531628842|FG002|Overall Study|Study terminated by Sponsor|2|||
147400129|NCT03713320|531628843|FG000|Randomized Period|Adverse Event|1|||
147400130|NCT03713320|531628844|FG001|Randomized Period|Adverse Event|5|||
147400131|NCT03713320|531628845|FG002|Randomized Period|Adverse Event|0|||
147400132|NCT03713320|531628843|FG000|Randomized Period|Physician Decision|1|||
147461384|NCT01583374|531849515|FG002|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|6|||
147461385|NCT01583374|531849516|FG003|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|7|||
147461386|NCT01583374|531849517|FG004|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|10|||
147400133|NCT03713320|531628844|FG001|Randomized Period|Physician Decision|1|||
147400134|NCT03713320|531628845|FG002|Randomized Period|Physician Decision|0|||
147461387|NCT01583374|531849518|FG005|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|7|||
147461388|NCT01583374|531849519|FG006|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|4|||
147615511|NCT05192889|532406750|FG002|Block 2b - Dose Level 1|Refused Therapy|2|||
147615512|NCT05221320|532408991|FG000|Overall Study|Lack of Efficacy|3|||
147400135|NCT03713320|531628843|FG000|Randomized Period|Withdrawal by Subject|4|||
147400136|NCT03713320|531628844|FG001|Randomized Period|Withdrawal by Subject|0|||
147400137|NCT03713320|531628845|FG002|Randomized Period|Withdrawal by Subject|0|||
147400138|NCT03713320|531628843|FG000|Randomized Period|Participant decision|3|||
147400139|NCT03713320|531628844|FG001|Randomized Period|Participant decision|1|||
147400140|NCT03713320|531628845|FG002|Randomized Period|Participant decision|0|||
147400141|NCT03713320|531628843|FG000|Randomized Period|Study terminated by sponsor|6|||
147400142|NCT03713320|531628844|FG001|Randomized Period|Study terminated by sponsor|3|||
147461389|NCT01583374|531849520|FG007|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|2|||
147461390|NCT01583374|531849521|FG008|Long-Term Extension Phase Weeks 52-260|Lack of Efficacy|4|||
147461391|NCT01583374|531849513|FG000|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
147461392|NCT01583374|531849514|FG001|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
147461393|NCT01583374|531849515|FG002|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
147461394|NCT01583374|531849516|FG003|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
147461395|NCT01583374|531849517|FG004|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|1|||
147461396|NCT01583374|531849518|FG005|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
147461397|NCT01583374|531849519|FG006|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|0|||
147461398|NCT01583374|531849520|FG007|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|1|||
147461399|NCT01583374|531849521|FG008|Long-Term Extension Phase Weeks 52-260|Noncomplinace with Study Drug|1|||
147461400|NCT01583374|531849513|FG000|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|0|||
147461401|NCT01583374|531849514|FG001|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|11|||
147461402|NCT01583374|531849515|FG002|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|11|||
147461403|NCT01583374|531849516|FG003|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|1|||
147461404|NCT01583374|531849517|FG004|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|12|||
147461405|NCT01583374|531849518|FG005|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|7|||
147461406|NCT01583374|531849519|FG006|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|5|||
147461407|NCT01583374|531849520|FG007|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|3|||
147461408|NCT01583374|531849521|FG008|Long-Term Extension Phase Weeks 52-260|Withdrawal by Subject|3|||
147461409|NCT01583374|531849513|FG000|Long-Term Extension Phase Weeks 52-260|Death|0|||
147461410|NCT01583374|531849514|FG001|Long-Term Extension Phase Weeks 52-260|Death|0|||
147461411|NCT01583374|531849515|FG002|Long-Term Extension Phase Weeks 52-260|Death|0|||
147461412|NCT01583374|531849516|FG003|Long-Term Extension Phase Weeks 52-260|Death|0|||
147461413|NCT01583374|531849517|FG004|Long-Term Extension Phase Weeks 52-260|Death|1|||
147461414|NCT01583374|531849518|FG005|Long-Term Extension Phase Weeks 52-260|Death|0|||
147461415|NCT01583374|531849519|FG006|Long-Term Extension Phase Weeks 52-260|Death|1|||
147461416|NCT01583374|531849520|FG007|Long-Term Extension Phase Weeks 52-260|Death|0|||
147461417|NCT01583374|531849521|FG008|Long-Term Extension Phase Weeks 52-260|Death|0|||
147461418|NCT01583374|531849513|FG000|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0|||
147461419|NCT01583374|531849514|FG001|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|1|||
147461420|NCT01583374|531849515|FG002|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0|||
147461421|NCT01583374|531849516|FG003|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|1|||
147461422|NCT01583374|531849517|FG004|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|1|||
147461423|NCT01583374|531849518|FG005|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0|||
147461424|NCT01583374|531849519|FG006|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|1|||
147461425|NCT01583374|531849520|FG007|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0|||
147461426|NCT01583374|531849521|FG008|Long-Term Extension Phase Weeks 52-260|Lost to Follow-up|0|||
147461427|NCT01583374|531849513|FG000|Long-Term Extension Phase Weeks 52-260|Miscellaneous|0|||
147461428|NCT01583374|531849514|FG001|Long-Term Extension Phase Weeks 52-260|Miscellaneous|5|||
147461429|NCT01583374|531849515|FG002|Long-Term Extension Phase Weeks 52-260|Miscellaneous|1|||
147461430|NCT01583374|531849516|FG003|Long-Term Extension Phase Weeks 52-260|Miscellaneous|2|||
147461431|NCT01583374|531849517|FG004|Long-Term Extension Phase Weeks 52-260|Miscellaneous|0|||
147461432|NCT01583374|531849518|FG005|Long-Term Extension Phase Weeks 52-260|Miscellaneous|1|||
147461433|NCT01583374|531849519|FG006|Long-Term Extension Phase Weeks 52-260|Miscellaneous|5|||
147461434|NCT01583374|531849520|FG007|Long-Term Extension Phase Weeks 52-260|Miscellaneous|0|||
147461435|NCT01583374|531849521|FG008|Long-Term Extension Phase Weeks 52-260|Miscellaneous|1|||
147461436|NCT02447848|531849522|FG000|Overall Study|Patient discharged|3|||
147461437|NCT02447848|531849522|FG000|Overall Study|Lack of Efficacy|4|||
147461438|NCT02447848|531849522|FG000|Overall Study|Withdrawal by Subject|4|||
147461439|NCT02307370|531849523|FG000|Overall Study|Death|5|||
147461440|NCT02307370|531849523|FG000|Overall Study|Lost to Follow-up|1|||
147461441|NCT02307370|531849523|FG000|Overall Study|Withdrawal by Subject|1|||
147461442|NCT02307370|531849523|FG000|Overall Study|Declined Addendum ICF|6|||
147461443|NCT02307370|531849523|FG000|Overall Study|No response during telephone contact|5|||
147461444|NCT02307370|531849523|FG000|Overall Study|Protocol Violation|1|||
147461445|NCT01506882|531849524|FG000|Overall Study|Lack of Efficacy|4|||
147461446|NCT01506882|531849525|FG001|Overall Study|Lack of Efficacy|3|||
147461447|NCT01506882|531849524|FG000|Overall Study|Lost to Follow-up|1|||
147461448|NCT01506882|531849525|FG001|Overall Study|Lost to Follow-up|0|||
147461449|NCT01506882|531849524|FG000|Overall Study|Withdrawal by Subject|9|||
147461450|NCT01506882|531849525|FG001|Overall Study|Withdrawal by Subject|3|||
147461451|NCT01506882|531849524|FG000|Overall Study|SAE, non-fatal|2|||
147461452|NCT01506882|531849525|FG001|Overall Study|SAE, non-fatal|0|||
147461453|NCT01506882|531849524|FG000|Overall Study|AE, non-serious non-fatal|3|||
147461454|NCT01506882|531849525|FG001|Overall Study|AE, non-serious non-fatal|1|||
147461455|NCT01506882|531849524|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|1|||
147615513|NCT05221320|532408992|FG001|Overall Study|Lack of Efficacy|7|||
147400143|NCT03713320|531628845|FG002|Randomized Period|Study terminated by sponsor|0|||
147400144|NCT03713320|531628843|FG000|Cobomarsen Crossover Period|Physician Decision|0|||
147400145|NCT03713320|531628844|FG001|Cobomarsen Crossover Period|Physician Decision|0|||
147400146|NCT03713320|531628845|FG002|Cobomarsen Crossover Period|Physician Decision|2|||
147400147|NCT03713320|531628843|FG000|Cobomarsen Crossover Period|Sponsor Decision to terminate trial|0|||
147400148|NCT03713320|531628844|FG001|Cobomarsen Crossover Period|Sponsor Decision to terminate trial|0|||
147400149|NCT03713320|531628845|FG002|Cobomarsen Crossover Period|Sponsor Decision to terminate trial|5|||
147400150|NCT00909532|531628846|FG000|Overall Study|Adverse Event|4|||
147400151|NCT00909532|531628847|FG001|Overall Study|Adverse Event|1|||
147400152|NCT00909532|531628846|FG000|Overall Study|Pregnancy|0|||
147400153|NCT00909532|531628847|FG001|Overall Study|Pregnancy|1|||
147400154|NCT00909532|531628846|FG000|Overall Study|Prohibited Medication|2|||
147400155|NCT00909532|531628847|FG001|Overall Study|Prohibited Medication|1|||
147400156|NCT00909532|531628846|FG000|Overall Study|Withdrawal of Consent|1|||
147400157|NCT00909532|531628847|FG001|Overall Study|Withdrawal of Consent|1|||
147400158|NCT00909532|531628846|FG000|Overall Study|Noncompliance with Study Requirements|0|||
147400159|NCT00909532|531628847|FG001|Overall Study|Noncompliance with Study Requirements|2|||
147400160|NCT00909532|531628846|FG000|Overall Study|Physician Decision|1|||
147400161|NCT00909532|531628847|FG001|Overall Study|Physician Decision|0|||
147400162|NCT00909532|531628846|FG000|Overall Study|Wrong Genotype|1|||
147400163|NCT00909532|531628847|FG001|Overall Study|Wrong Genotype|0|||
147400164|NCT00909532|531628846|FG000|Overall Study|Increased Lab Draws, Difficult Lab Stick|1|||
147400165|NCT00909532|531628847|FG001|Overall Study|Increased Lab Draws, Difficult Lab Stick|0|||
147400166|NCT01209598|531628848|FG000|Overall Study|Withdrawal by Subject|1|||
147400167|NCT01209598|531628849|FG001|Overall Study|Withdrawal by Subject|0|||
147400168|NCT00085566|531628850|FG000|Overall Study|Adverse Event|0|||
147400169|NCT00085566|531628851|FG001|Overall Study|Adverse Event|0|||
147400170|NCT00085566|531628852|FG002|Overall Study|Adverse Event|10|||
147400171|NCT00085566|531628850|FG000|Overall Study|Patient Not treated|0|||
147400172|NCT00085566|531628851|FG001|Overall Study|Patient Not treated|0|||
147400173|NCT00085566|531628852|FG002|Overall Study|Patient Not treated|3|||
147400174|NCT00085566|531628850|FG000|Overall Study|Clinical progression|0|||
147400175|NCT00085566|531628851|FG001|Overall Study|Clinical progression|0|||
147400176|NCT00085566|531628852|FG002|Overall Study|Clinical progression|1|||
147400177|NCT01174264|531628853|FG000|Single Dose Pharmacokinetics|Early progressive disease|1|||
147400178|NCT01174264|531628854|FG001|Single Dose Pharmacokinetics|Early progressive disease|0|||
147400179|NCT01174264|531628855|FG002|Single Dose Pharmacokinetics|Early progressive disease|1|||
147400180|NCT01174264|531628853|FG000|Single Dose Pharmacokinetics|Patient entered hospice care|0|||
147400181|NCT01174264|531628854|FG001|Single Dose Pharmacokinetics|Patient entered hospice care|0|||
147400182|NCT01174264|531628855|FG002|Single Dose Pharmacokinetics|Patient entered hospice care|1|||
147400183|NCT01174264|531628853|FG000|Steady-state Pharmacokinetics|Not evaluable|6|||
147400184|NCT01174264|531628854|FG001|Steady-state Pharmacokinetics|Not evaluable|0|||
147400185|NCT01174264|531628855|FG002|Steady-state Pharmacokinetics|Not evaluable|2|||
147400186|NCT00087555|531628858|FG000|Overall Study|Adverse Event|3|||
147400187|NCT00087555|531628859|FG001|Overall Study|Adverse Event|6|||
147400188|NCT00087555|531628860|FG002|Overall Study|Adverse Event|14|||
147400189|NCT00087555|531628858|FG000|Overall Study|Lost to Follow-up|0|||
147400190|NCT00087555|531628859|FG001|Overall Study|Lost to Follow-up|1|||
147400191|NCT00087555|531628860|FG002|Overall Study|Lost to Follow-up|1|||
147400192|NCT00087555|531628858|FG000|Overall Study|Non - Compliance|1|||
147400193|NCT00087555|531628859|FG001|Overall Study|Non - Compliance|0|||
147400194|NCT00087555|531628860|FG002|Overall Study|Non - Compliance|0|||
147400195|NCT00087555|531628858|FG000|Overall Study|Protocol Violation|0|||
147400196|NCT00087555|531628859|FG001|Overall Study|Protocol Violation|0|||
147400197|NCT00087555|531628860|FG002|Overall Study|Protocol Violation|2|||
147400198|NCT00087555|531628858|FG000|Overall Study|Screen Failure|1|||
147400199|NCT00087555|531628859|FG001|Overall Study|Screen Failure|1|||
147400200|NCT00087555|531628860|FG002|Overall Study|Screen Failure|0|||
147400201|NCT00087555|531628858|FG000|Overall Study|Pregnancy|0|||
147400202|NCT00087555|531628859|FG001|Overall Study|Pregnancy|1|||
147400203|NCT00087555|531628860|FG002|Overall Study|Pregnancy|1|||
147400204|NCT00087555|531628858|FG000|Overall Study|Withdrawal by Subject|3|||
147400205|NCT00087555|531628859|FG001|Overall Study|Withdrawal by Subject|2|||
147400206|NCT00087555|531628860|FG002|Overall Study|Withdrawal by Subject|1|||
147400207|NCT00087555|531628858|FG000|Overall Study|Lack of Efficacy|2|||
147400208|NCT00087555|531628859|FG001|Overall Study|Lack of Efficacy|0|||
147400209|NCT00087555|531628860|FG002|Overall Study|Lack of Efficacy|1|||
147400210|NCT00087555|531628858|FG000|Overall Study|Non Compliance|0|||
147400211|NCT00087555|531628859|FG001|Overall Study|Non Compliance|0|||
147400212|NCT00087555|531628860|FG002|Overall Study|Non Compliance|1|||
147400213|NCT00087555|531628858|FG000|Overall Study|Chronic Migraine Headaches (Med History)|1|||
147400214|NCT00087555|531628859|FG001|Overall Study|Chronic Migraine Headaches (Med History)|0|||
147400215|NCT00087555|531628860|FG002|Overall Study|Chronic Migraine Headaches (Med History)|0|||
147400216|NCT00087555|531628858|FG000|Overall Study|Patient wanted to go back on Med|1|||
147400217|NCT00087555|531628859|FG001|Overall Study|Patient wanted to go back on Med|0|||
147400218|NCT00087555|531628860|FG002|Overall Study|Patient wanted to go back on Med|0|||
147400219|NCT05523219|531628861|FG000|Overall Study|Wrong inclusion|1|||
147400220|NCT05523219|531628861|FG000|Overall Study|Lost to Follow-up|7|||
147400221|NCT03772613|531628862|FG000|Overall Study|Lost to Follow-up|0|||
147400222|NCT03772613|531628863|FG001|Overall Study|Lost to Follow-up|1|||
147400223|NCT03772613|531628864|FG002|Overall Study|Lost to Follow-up|1|||
147400224|NCT00661713|531628865|FG000|Overall Study|Death|1|||
147400225|NCT00661713|531628866|FG001|Overall Study|Death|0|||
147400226|NCT00661713|531628867|FG002|Overall Study|Death|0|||
147400227|NCT00661713|531628868|FG003|Overall Study|Death|0|||
147400228|NCT00661713|531628869|FG004|Overall Study|Death|1|||
147400229|NCT00661713|531628870|FG005|Overall Study|Death|0|||
147400230|NCT00661713|531628871|FG006|Overall Study|Death|0|||
147400231|NCT00661713|531628872|FG007|Overall Study|Death|0|||
147400232|NCT00661713|531628865|FG000|Overall Study|Unable to Classify|1|||
147400233|NCT00661713|531628866|FG001|Overall Study|Unable to Classify|0|||
147400234|NCT00661713|531628867|FG002|Overall Study|Unable to Classify|0|||
147400235|NCT00661713|531628868|FG003|Overall Study|Unable to Classify|0|||
147400236|NCT00661713|531628869|FG004|Overall Study|Unable to Classify|0|||
147400237|NCT00661713|531628870|FG005|Overall Study|Unable to Classify|0|||
147400238|NCT00661713|531628871|FG006|Overall Study|Unable to Classify|0|||
147400239|NCT00661713|531628872|FG007|Overall Study|Unable to Classify|0|||
147400240|NCT00661713|531628865|FG000|Overall Study|Protocol Violation|1|||
147400241|NCT00661713|531628866|FG001|Overall Study|Protocol Violation|6|||
147400242|NCT00661713|531628867|FG002|Overall Study|Protocol Violation|3|||
147400243|NCT00661713|531628868|FG003|Overall Study|Protocol Violation|3|||
147400244|NCT00661713|531628869|FG004|Overall Study|Protocol Violation|0|||
147400245|NCT00661713|531628870|FG005|Overall Study|Protocol Violation|2|||
147400246|NCT00661713|531628871|FG006|Overall Study|Protocol Violation|2|||
147400247|NCT00661713|531628872|FG007|Overall Study|Protocol Violation|1|||
147400248|NCT00661713|531628865|FG000|Overall Study|Withdrawal by Subject|11|||
147400249|NCT00661713|531628866|FG001|Overall Study|Withdrawal by Subject|25|||
147400250|NCT00661713|531628867|FG002|Overall Study|Withdrawal by Subject|12|||
147400251|NCT00661713|531628868|FG003|Overall Study|Withdrawal by Subject|21|||
147400252|NCT00661713|531628869|FG004|Overall Study|Withdrawal by Subject|12|||
147400253|NCT00661713|531628870|FG005|Overall Study|Withdrawal by Subject|26|||
147400254|NCT00661713|531628871|FG006|Overall Study|Withdrawal by Subject|45|||
147400255|NCT00661713|531628872|FG007|Overall Study|Withdrawal by Subject|9|||
147400256|NCT00661713|531628865|FG000|Overall Study|Lost to Follow-up|2|||
147400257|NCT00661713|531628866|FG001|Overall Study|Lost to Follow-up|7|||
147400258|NCT00661713|531628867|FG002|Overall Study|Lost to Follow-up|2|||
147400259|NCT00661713|531628868|FG003|Overall Study|Lost to Follow-up|2|||
147400260|NCT00661713|531628869|FG004|Overall Study|Lost to Follow-up|5|||
147400261|NCT00661713|531628870|FG005|Overall Study|Lost to Follow-up|7|||
147400262|NCT00661713|531628871|FG006|Overall Study|Lost to Follow-up|14|||
147400263|NCT00661713|531628872|FG007|Overall Study|Lost to Follow-up|1|||
147400264|NCT00661713|531628865|FG000|Overall Study|Administrative Reason|0|||
147400265|NCT00661713|531628866|FG001|Overall Study|Administrative Reason|1|||
147400266|NCT00661713|531628867|FG002|Overall Study|Administrative Reason|0|||
147400267|NCT00661713|531628868|FG003|Overall Study|Administrative Reason|2|||
147400268|NCT00661713|531628869|FG004|Overall Study|Administrative Reason|2|||
147400269|NCT00661713|531628870|FG005|Overall Study|Administrative Reason|2|||
147400270|NCT00661713|531628871|FG006|Overall Study|Administrative Reason|1|||
147400271|NCT00661713|531628872|FG007|Overall Study|Administrative Reason|0|||
147400272|NCT00661713|531628865|FG000|Overall Study|Adverse Event|0|||
147400273|NCT00661713|531628866|FG001|Overall Study|Adverse Event|0|||
147400274|NCT00661713|531628867|FG002|Overall Study|Adverse Event|0|||
147400275|NCT00661713|531628868|FG003|Overall Study|Adverse Event|0|||
147400276|NCT00661713|531628869|FG004|Overall Study|Adverse Event|0|||
147400277|NCT00661713|531628870|FG005|Overall Study|Adverse Event|0|||
147400278|NCT00661713|531628871|FG006|Overall Study|Adverse Event|1|||
147400279|NCT00661713|531628872|FG007|Overall Study|Adverse Event|0|||
147400280|NCT00661713|531628865|FG000|Overall Study|Inappropriate Enrollment|0|||
147400281|NCT00661713|531628866|FG001|Overall Study|Inappropriate Enrollment|0|||
147400282|NCT00661713|531628867|FG002|Overall Study|Inappropriate Enrollment|0|||
147400283|NCT00661713|531628868|FG003|Overall Study|Inappropriate Enrollment|0|||
147400284|NCT00661713|531628869|FG004|Overall Study|Inappropriate Enrollment|0|||
147400285|NCT00661713|531628870|FG005|Overall Study|Inappropriate Enrollment|0|||
147400286|NCT00661713|531628871|FG006|Overall Study|Inappropriate Enrollment|1|||
147400287|NCT00661713|531628872|FG007|Overall Study|Inappropriate Enrollment|0|||
147400288|NCT01660256|531630959|FG000|Overall Study|Adverse Event|4|||
147400289|NCT01660256|531630960|FG001|Overall Study|Adverse Event|0|||
147400290|NCT01660256|531630961|FG002|Overall Study|Adverse Event|2|||
147400291|NCT01660256|531630959|FG000|Overall Study|Withdrawal by Subject|1|||
147400292|NCT01660256|531630960|FG001|Overall Study|Withdrawal by Subject|0|||
147400293|NCT01660256|531630961|FG002|Overall Study|Withdrawal by Subject|2|||
147400294|NCT02232399|531630962|FG000|Overall Study|Adverse Event|1|||
147400295|NCT02232399|531630963|FG001|Overall Study|Adverse Event|0|||
147400296|NCT02232399|531630962|FG000|Overall Study|Withdrawal by Subject|0|||
147400297|NCT02232399|531630963|FG001|Overall Study|Withdrawal by Subject|1|||
147400298|NCT04599855|531630967|FG000|Double Blind Period (Day 1 to Day 28)|Withdrawal by Subject|5|||
147400299|NCT04599855|531630968|FG001|Double Blind Period (Day 1 to Day 28)|Withdrawal by Subject|2|||
147400300|NCT04599855|531630969|FG002|Double Blind Period (Day 1 to Day 28)|Withdrawal by Subject|5|||
147400301|NCT04599855|531630967|FG000|Double Blind Period (Day 1 to Day 28)|Adverse Event|2|||
147400302|NCT04599855|531630968|FG001|Double Blind Period (Day 1 to Day 28)|Adverse Event|1|||
147400303|NCT04599855|531630969|FG002|Double Blind Period (Day 1 to Day 28)|Adverse Event|5|||
147400304|NCT04599855|531630967|FG000|Double Blind Period (Day 1 to Day 28)|Lack of Efficacy|2|||
147400305|NCT04599855|531630968|FG001|Double Blind Period (Day 1 to Day 28)|Lack of Efficacy|0|||
147400306|NCT04599855|531630969|FG002|Double Blind Period (Day 1 to Day 28)|Lack of Efficacy|2|||
147400307|NCT04599855|531630967|FG000|Double Blind Period (Day 1 to Day 28)|Protocol Violation|1|||
147400308|NCT04599855|531630968|FG001|Double Blind Period (Day 1 to Day 28)|Protocol Violation|0|||
147400309|NCT04599855|531630969|FG002|Double Blind Period (Day 1 to Day 28)|Protocol Violation|1|||
147400310|NCT04599855|531630967|FG000|Double Blind Period (Day 1 to Day 28)|Lost to Follow-up|0|||
147400311|NCT04599855|531630968|FG001|Double Blind Period (Day 1 to Day 28)|Lost to Follow-up|1|||
147400312|NCT04599855|531630969|FG002|Double Blind Period (Day 1 to Day 28)|Lost to Follow-up|0|||
147400313|NCT04599855|531630967|FG000|Double Blind Period (Day 1 to Day 28)|Pregnancy|1|||
147400314|NCT04599855|531630968|FG001|Double Blind Period (Day 1 to Day 28)|Pregnancy|0|||
147400315|NCT04599855|531630969|FG002|Double Blind Period (Day 1 to Day 28)|Pregnancy|0|||
147400316|NCT04599855|531630967|FG000|Double Blind Period (Day 1 to Day 28)|Other|1|||
147400317|NCT04599855|531630968|FG001|Double Blind Period (Day 1 to Day 28)|Other|0|||
147400318|NCT04599855|531630969|FG002|Double Blind Period (Day 1 to Day 28)|Other|1|||
147400319|NCT04599855|531630967|FG000|Double Blind Period (Day 1 to Day 28)|Randomized but not treated|0|||
147400320|NCT04599855|531630968|FG001|Double Blind Period (Day 1 to Day 28)|Randomized but not treated|1|||
147400321|NCT04599855|531630969|FG002|Double Blind Period (Day 1 to Day 28)|Randomized but not treated|0|||
147400322|NCT04599855|531630967|FG000|Period Title: OL Period (Week 5 to 16)|Withdrawal by Subject|8|||
147400323|NCT04599855|531630968|FG001|Period Title: OL Period (Week 5 to 16)|Withdrawal by Subject|5|||
147400324|NCT04599855|531630969|FG002|Period Title: OL Period (Week 5 to 16)|Withdrawal by Subject|6|||
147400325|NCT04599855|531630967|FG000|Period Title: OL Period (Week 5 to 16)|Lack of Efficacy|10|||
147400326|NCT04599855|531630968|FG001|Period Title: OL Period (Week 5 to 16)|Lack of Efficacy|3|||
147400327|NCT04599855|531630969|FG002|Period Title: OL Period (Week 5 to 16)|Lack of Efficacy|2|||
147400328|NCT04599855|531630967|FG000|Period Title: OL Period (Week 5 to 16)|Adverse Event|4|||
147400329|NCT04599855|531630968|FG001|Period Title: OL Period (Week 5 to 16)|Adverse Event|2|||
147400330|NCT04599855|531630969|FG002|Period Title: OL Period (Week 5 to 16)|Adverse Event|1|||
147400331|NCT04599855|531630967|FG000|Period Title: OL Period (Week 5 to 16)|Lost to Follow-up|4|||
147400332|NCT04599855|531630968|FG001|Period Title: OL Period (Week 5 to 16)|Lost to Follow-up|1|||
147400333|NCT04599855|531630969|FG002|Period Title: OL Period (Week 5 to 16)|Lost to Follow-up|2|||
147400334|NCT04599855|531630967|FG000|Period Title: OL Period (Week 5 to 16)|Protocol Violation|2|||
147400335|NCT04599855|531630968|FG001|Period Title: OL Period (Week 5 to 16)|Protocol Violation|0|||
147400336|NCT04599855|531630969|FG002|Period Title: OL Period (Week 5 to 16)|Protocol Violation|0|||
147400337|NCT04599855|531630967|FG000|Period Title: OL Period (Week 5 to 16)|Other|5|||
147400338|NCT04599855|531630968|FG001|Period Title: OL Period (Week 5 to 16)|Other|1|||
147400339|NCT04599855|531630969|FG002|Period Title: OL Period (Week 5 to 16)|Other|0|||
147400340|NCT04294667|531630970|FG000|Overall Study|Lack of Efficacy|4|||
147400341|NCT04294667|531630971|FG001|Overall Study|Lack of Efficacy|4|||
147400342|NCT04294667|531630970|FG000|Overall Study|Consent Withdrawal by Study Participant|9|||
147400343|NCT04294667|531630971|FG001|Overall Study|Consent Withdrawal by Study Participant|7|||
147400344|NCT04294667|531630970|FG000|Overall Study|Patient has a Renal Flare|1|||
147400345|NCT04294667|531630971|FG001|Overall Study|Patient has a Renal Flare|0|||
147400346|NCT04294667|531630970|FG000|Overall Study|SLE Worsening|0|||
147400347|NCT04294667|531630971|FG001|Overall Study|SLE Worsening|1|||
147400348|NCT04294667|531630970|FG000|Overall Study|Subject Decision due to Personal Reason|0|||
147400349|NCT04294667|531630971|FG001|Overall Study|Subject Decision due to Personal Reason|1|||
147400350|NCT04294667|531630970|FG000|Overall Study|PI closed Site - Subject Early Withdrawal|0|||
147400351|NCT04294667|531630971|FG001|Overall Study|PI closed Site - Subject Early Withdrawal|1|||
147400352|NCT04294667|531630970|FG000|Overall Study|Subject Withdrew due to Personal Reason|0|||
147400353|NCT04294667|531630971|FG001|Overall Study|Subject Withdrew due to Personal Reason|1|||
147400354|NCT04294667|531630970|FG000|Overall Study|Subject Moved to Another State|0|||
147461456|NCT01506882|531849525|FG001|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|0|||
147665216|NCT00919633|532598066|FG000|Overall Study|Physician Decision|0|||
147665217|NCT00919633|532598067|FG001|Overall Study|Physician Decision|0|||
147665218|NCT00919633|532598068|FG002|Overall Study|Physician Decision|0|||
147665219|NCT00919633|532598069|FG003|Overall Study|Physician Decision|1|||
147665220|NCT00919633|532598066|FG000|Overall Study|Request of withdrawal w/o future contact|0|||
147665221|NCT00919633|532598067|FG001|Overall Study|Request of withdrawal w/o future contact|0|||
147665222|NCT00919633|532598068|FG002|Overall Study|Request of withdrawal w/o future contact|1|||
147665223|NCT00919633|532598069|FG003|Overall Study|Request of withdrawal w/o future contact|0|||
147665224|NCT00919633|532598066|FG000|Overall Study|Viral rebound outside protocol timepoint|0|||
147665225|NCT00919633|532598067|FG001|Overall Study|Viral rebound outside protocol timepoint|0|||
147665226|NCT00919633|532598068|FG002|Overall Study|Viral rebound outside protocol timepoint|1|||
147665227|NCT00919633|532598069|FG003|Overall Study|Viral rebound outside protocol timepoint|0|||
147665228|NCT00960804|532598070|FG000|Overall Study|Adverse Event|1|||
147665229|NCT00960804|532598071|FG001|Overall Study|Adverse Event|0|||
147665230|NCT00960804|532598072|FG002|Overall Study|Adverse Event|0|||
147665231|NCT00960804|532598070|FG000|Overall Study|Withdrawal by Subject|1|||
147665232|NCT00960804|532598071|FG001|Overall Study|Withdrawal by Subject|0|||
147665233|NCT00960804|532598072|FG002|Overall Study|Withdrawal by Subject|0|||
147665234|NCT00960804|532598070|FG000|Overall Study|Study terminated by the sponsor|5|||
147665235|NCT00960804|532598071|FG001|Overall Study|Study terminated by the sponsor|4|||
147665236|NCT00960804|532598072|FG002|Overall Study|Study terminated by the sponsor|10|||
147665237|NCT00922636|532599515|FG000|Overall Study|Adverse Event|3|||
147665238|NCT00922636|532599516|FG001|Overall Study|Adverse Event|3|||
147665239|NCT00922636|532599517|FG002|Overall Study|Adverse Event|2|||
147665240|NCT00922636|532599518|FG003|Overall Study|Adverse Event|3|||
147665241|NCT00922636|532599519|FG004|Overall Study|Adverse Event|2|||
147400355|NCT04294667|531630971|FG001|Overall Study|Subject Moved to Another State|1|||
147400356|NCT04294667|531630970|FG000|Overall Study|Adverse event, serious fatal|0|||
147400357|NCT04294667|531630971|FG001|Overall Study|Adverse event, serious fatal|1|||
147400358|NCT04294667|531630970|FG000|Overall Study|Adverse event, non-fatal|3|||
147400359|NCT04294667|531630971|FG001|Overall Study|Adverse event, non-fatal|4|||
147400360|NCT02165397|531630972|FG000|Overall Study|Death|7|||
147400361|NCT02165397|531630973|FG001|Overall Study|Death|10|||
147400362|NCT02165397|531630974|FG002|Overall Study|Death|8|||
147400363|NCT02165397|531630972|FG000|Overall Study|Lost to Follow-up|1|||
147400364|NCT02165397|531630973|FG001|Overall Study|Lost to Follow-up|3|||
147400365|NCT02165397|531630974|FG002|Overall Study|Lost to Follow-up|0|||
147400366|NCT02165397|531630972|FG000|Overall Study|Withdrawal by Subject|6|||
147400367|NCT02165397|531630973|FG001|Overall Study|Withdrawal by Subject|6|||
147400368|NCT02165397|531630974|FG002|Overall Study|Withdrawal by Subject|1|||
147400369|NCT02165397|531630972|FG000|Overall Study|Other, Not Specified|0|||
147400370|NCT02165397|531630973|FG001|Overall Study|Other, Not Specified|0|||
147400371|NCT02165397|531630974|FG002|Overall Study|Other, Not Specified|1|||
147400372|NCT03297398|531630975|FG000|Overall Study|Sponsor's decision|6|||
147400373|NCT03297398|531630976|FG001|Overall Study|Sponsor's decision|9|||
147400374|NCT03297398|531630977|FG002|Overall Study|Sponsor's decision|7|||
147400375|NCT03297398|531630975|FG000|Overall Study|Adverse Event|1|||
147400376|NCT03297398|531630976|FG001|Overall Study|Adverse Event|4|||
147400377|NCT03297398|531630977|FG002|Overall Study|Adverse Event|4|||
147400378|NCT03297398|531630975|FG000|Overall Study|Withdrawal by Subject|1|||
147400379|NCT03297398|531630976|FG001|Overall Study|Withdrawal by Subject|2|||
147400380|NCT03297398|531630977|FG002|Overall Study|Withdrawal by Subject|2|||
147400381|NCT03297398|531630975|FG000|Overall Study|Protocol Violation|0|||
147400382|NCT03297398|531630976|FG001|Overall Study|Protocol Violation|2|||
147400383|NCT03297398|531630977|FG002|Overall Study|Protocol Violation|0|||
147400384|NCT03297398|531630975|FG000|Overall Study|Physician Decision|0|||
147400385|NCT03297398|531630976|FG001|Overall Study|Physician Decision|0|||
147400386|NCT03297398|531630977|FG002|Overall Study|Physician Decision|1|||
147400387|NCT03297398|531630975|FG000|Overall Study|Lost to Follow-up|0|||
147400388|NCT03297398|531630976|FG001|Overall Study|Lost to Follow-up|0|||
147400389|NCT03297398|531630977|FG002|Overall Study|Lost to Follow-up|1|||
147400390|NCT03481556|531630978|FG000|Overall Study|Adverse Event|1|||
147400391|NCT03481556|531630979|FG001|Overall Study|Adverse Event|0|||
147400392|NCT03481556|531630980|FG002|Overall Study|Adverse Event|0|||
147400393|NCT03481556|531630981|FG003|Overall Study|Adverse Event|0|||
147400394|NCT03481556|531630978|FG000|Overall Study|Death|4|||
147400395|NCT03481556|531630979|FG001|Overall Study|Death|2|||
147400396|NCT03481556|531630980|FG002|Overall Study|Death|3|||
147400397|NCT03481556|531630981|FG003|Overall Study|Death|16|||
147400398|NCT03481556|531630978|FG000|Overall Study|Study Terminated by Sponsor|10|||
147400399|NCT03481556|531630979|FG001|Overall Study|Study Terminated by Sponsor|5|||
147400400|NCT03481556|531630980|FG002|Overall Study|Study Terminated by Sponsor|2|||
147400401|NCT03481556|531630981|FG003|Overall Study|Study Terminated by Sponsor|9|||
147400402|NCT01316887|531630982|FG000|Overall Study|Adverse Event|13|||
147400403|NCT01316887|531630983|FG001|Overall Study|Adverse Event|21|||
147400404|NCT01316887|531630984|FG002|Overall Study|Adverse Event|17|||
147400405|NCT01316887|531630982|FG000|Overall Study|Lack of Efficacy|9|||
147400406|NCT01316887|531630983|FG001|Overall Study|Lack of Efficacy|3|||
147400407|NCT01316887|531630984|FG002|Overall Study|Lack of Efficacy|1|||
147400408|NCT01316887|531630982|FG000|Overall Study|Protocol Violation|2|||
147461457|NCT01506882|531849524|FG000|Overall Study|Other Reason|2|||
147461458|NCT01506882|531849525|FG001|Overall Study|Other Reason|0|||
147400409|NCT01316887|531630983|FG001|Overall Study|Protocol Violation|6|||
147400410|NCT01316887|531630984|FG002|Overall Study|Protocol Violation|6|||
147400411|NCT01316887|531630982|FG000|Overall Study|Protocol-defined Stopping Criteria|8|||
147461459|NCT01400932|531851663|FG000|Overall Study|Adverse Event|10|||
147400412|NCT01316887|531630983|FG001|Overall Study|Protocol-defined Stopping Criteria|37|||
147400413|NCT01316887|531630984|FG002|Overall Study|Protocol-defined Stopping Criteria|36|||
147400414|NCT01316887|531630982|FG000|Overall Study|Study Closed/Terminated|2|||
147400415|NCT01316887|531630983|FG001|Overall Study|Study Closed/Terminated|4|||
147400416|NCT01316887|531630984|FG002|Overall Study|Study Closed/Terminated|3|||
147400417|NCT01316887|531630982|FG000|Overall Study|Lost to Follow-up|1|||
147400418|NCT01316887|531630983|FG001|Overall Study|Lost to Follow-up|7|||
147400419|NCT01316887|531630984|FG002|Overall Study|Lost to Follow-up|5|||
147400420|NCT01316887|531630982|FG000|Overall Study|Withdrawal by Subject|8|||
147400421|NCT01316887|531630983|FG001|Overall Study|Withdrawal by Subject|16|||
147400422|NCT01316887|531630984|FG002|Overall Study|Withdrawal by Subject|15|||
147400423|NCT00611715|531630985|FG000|Overall Study|Disease Progression|24|||
147400424|NCT00611715|531630986|FG001|Overall Study|Disease Progression|4|||
147400425|NCT00611715|531630985|FG000|Overall Study|Withdrawal by Subject|5|||
147400426|NCT00611715|531630986|FG001|Overall Study|Withdrawal by Subject|1|||
147400427|NCT00611715|531630985|FG000|Overall Study|Adverse Event|9|||
147400428|NCT00611715|531630986|FG001|Overall Study|Adverse Event|1|||
147400429|NCT00611715|531630985|FG000|Overall Study|Death|1|||
147400430|NCT00611715|531630986|FG001|Overall Study|Death|0|||
147400431|NCT00611715|531630985|FG000|Overall Study|two patients are still on treatment|2|||
147400432|NCT00611715|531630986|FG001|Overall Study|two patients are still on treatment|0|||
147400433|NCT00107978|531630987|FG000|Overall Study|Adverse Event|1|||
147400434|NCT00107978|531630988|FG001|Overall Study|Adverse Event|5|||
147400435|NCT00107978|531630987|FG000|Overall Study|Death|3|||
147400436|NCT00107978|531630988|FG001|Overall Study|Death|3|||
147400437|NCT00107978|531630987|FG000|Overall Study|Lost to Follow-up|20|||
147400438|NCT00107978|531630988|FG001|Overall Study|Lost to Follow-up|28|||
147400439|NCT00107978|531630987|FG000|Overall Study|Withdrawal by Subject|4|||
147400440|NCT00107978|531630988|FG001|Overall Study|Withdrawal by Subject|9|||
147400441|NCT00107978|531630987|FG000|Overall Study|Protocol Violation|0|||
147400442|NCT00107978|531630988|FG001|Overall Study|Protocol Violation|1|||
147400443|NCT00107978|531630987|FG000|Overall Study|Other|5|||
147400444|NCT00107978|531630988|FG001|Overall Study|Other|4|||
147400445|NCT01841697|531630989|FG000|Overall Study|Death|0|||
147400446|NCT01841697|531630990|FG001|Overall Study|Death|1|||
147400447|NCT01841697|531630989|FG000|Overall Study|Lost to Follow-up|4|||
147400448|NCT01841697|531630990|FG001|Overall Study|Lost to Follow-up|1|||
147400449|NCT01841697|531630989|FG000|Overall Study|Withdrawal by Subject|16|||
147400450|NCT01841697|531630990|FG001|Overall Study|Withdrawal by Subject|16|||
147400451|NCT00350298|531630993|FG000|Overall Study|Death|7|||
147400452|NCT00350298|531630994|FG001|Overall Study|Death|8|||
147400453|NCT00350298|531630993|FG000|Overall Study|Lost to Follow-up|1|||
147400454|NCT00350298|531630994|FG001|Overall Study|Lost to Follow-up|2|||
147400455|NCT00350298|531630993|FG000|Overall Study|Withdrawal by Subject|1|||
147400456|NCT00350298|531630994|FG001|Overall Study|Withdrawal by Subject|3|||
147400457|NCT00233389|531630997|FG000|Overall Study|Adverse Event|5|||
147400458|NCT00233389|531630998|FG001|Overall Study|Adverse Event|5|||
147400459|NCT00233389|531630997|FG000|Overall Study|Lack of Efficacy|11|||
147400460|NCT00233389|531630998|FG001|Overall Study|Lack of Efficacy|8|||
147400461|NCT00233389|531630997|FG000|Overall Study|Lost to Follow-up|1|||
147400462|NCT00233389|531630998|FG001|Overall Study|Lost to Follow-up|1|||
147400463|NCT00233389|531630997|FG000|Overall Study|Physician Decision|1|||
147400464|NCT00233389|531630998|FG001|Overall Study|Physician Decision|0|||
147400465|NCT00233389|531630997|FG000|Overall Study|Protocol Violation|0|||
147400466|NCT00233389|531630998|FG001|Overall Study|Protocol Violation|1|||
147400467|NCT00233389|531630997|FG000|Overall Study|Withdrawal by Subject|0|||
147400468|NCT00233389|531630998|FG001|Overall Study|Withdrawal by Subject|1|||
147400469|NCT01777490|531631004|FG000|Overall Study|Dyad withdrew with data use prohibition|0|||
147400470|NCT01777490|531631005|FG001|Overall Study|Dyad withdrew with data use prohibition|0|||
147400471|NCT01777490|531631006|FG002|Overall Study|Dyad withdrew with data use prohibition|1|||
147400472|NCT01777490|531631007|FG003|Overall Study|Dyad withdrew with data use prohibition|1|||
147400473|NCT02312206|531631011|FG000|Overall Study|Adverse Event|3|||
147400474|NCT02312206|531631012|FG001|Overall Study|Adverse Event|6|||
147400475|NCT02312206|531631011|FG000|Overall Study|Withdrawal by Subject|6|||
147400476|NCT02312206|531631012|FG001|Overall Study|Withdrawal by Subject|6|||
147400477|NCT02312206|531631011|FG000|Overall Study|Physician Decision|7|||
147400478|NCT02312206|531631012|FG001|Overall Study|Physician Decision|6|||
147400479|NCT02312206|531631011|FG000|Overall Study|Death|31|||
147400480|NCT02312206|531631012|FG001|Overall Study|Death|36|||
147400481|NCT02312206|531631011|FG000|Overall Study|Study Terminated by Sponsor|81|||
147400482|NCT02312206|531631012|FG001|Overall Study|Study Terminated by Sponsor|74|||
147461460|NCT01400932|531851664|FG001|Overall Study|Adverse Event|5|||
147400483|NCT02312206|531631011|FG000|Overall Study|Patient transferred to hospice|0|||
147400484|NCT02312206|531631012|FG001|Overall Study|Patient transferred to hospice|1|||
147400485|NCT02312206|531631011|FG000|Overall Study|Subject missed three consecutive treatment visits|0|||
147400486|NCT02312206|531631012|FG001|Overall Study|Subject missed three consecutive treatment visits|1|||
147400487|NCT02312206|531631011|FG000|Overall Study|Patient progression and institution of a new therapy|1|||
147461461|NCT01400932|531851663|FG000|Overall Study|Lack of Efficacy|0|||
147461462|NCT01400932|531851664|FG001|Overall Study|Lack of Efficacy|3|||
147461463|NCT01400932|531851663|FG000|Overall Study|Withdrawal by Subject|2|||
147461464|NCT01400932|531851664|FG001|Overall Study|Withdrawal by Subject|6|||
147461465|NCT01400932|531851663|FG000|Overall Study|Lost to Follow-up|1|||
147461466|NCT01400932|531851664|FG001|Overall Study|Lost to Follow-up|0|||
147461467|NCT01400932|531851663|FG000|Overall Study|Protocol Deviation|0|||
147461468|NCT01400932|531851664|FG001|Overall Study|Protocol Deviation|1|||
147461469|NCT01400932|531851663|FG000|Overall Study|Met Protocol-defined Stopping Criteria|1|||
147461470|NCT01400932|531851664|FG001|Overall Study|Met Protocol-defined Stopping Criteria|0|||
147461471|NCT04656990|531851665|FG000|Baseline|pandemic|20|||
147461472|NCT04656990|531851666|FG001|Baseline|pandemic|24|||
147461473|NCT04656990|531851665|FG000|Follow Up Period|Lost to Follow-up|61|||
147461474|NCT04656990|531851666|FG001|Follow Up Period|Lost to Follow-up|73|||
147461475|NCT03244059|531851667|FG000|Specific Aim 1|Physician Decision|1|||
147461476|NCT03244059|531851668|FG001|Specific Aim 1|Physician Decision|0|||
147461477|NCT03244059|531851667|FG000|Specific Aim 2|Physician Decision|1|||
147461478|NCT03244059|531851668|FG001|Specific Aim 2|Physician Decision|0|||
147461479|NCT00282243|531851670|FG000|Pharmacokinetic Treatment Period|Adverse Event|3|||
147461480|NCT00282243|531851670|FG000|Pharmacokinetic Treatment Period|Withdrawal by Subject|2|||
147461481|NCT00282243|531851670|FG000|Extension Treatment Period|Adverse Event|15|||
147461482|NCT00282243|531851670|FG000|Extension Treatment Period|Withdrawal by Subject|4|||
147461483|NCT00282243|531851670|FG000|Extension Treatment Period|Non-compliance|2|||
147461484|NCT00282243|531851670|FG000|Extension Treatment Period|Physician Decision|1|||
147461485|NCT00686127|531851671|FG000|Overall Study|Withdrawal by Subject|14|||
147461486|NCT00686127|531851672|FG001|Overall Study|Withdrawal by Subject|6|||
147461487|NCT06441877|531851673|FG000|Overall Study|Withdrawal by Subject|0|||
147461488|NCT06441877|531851674|FG001|Overall Study|Withdrawal by Subject|2|||
147461489|NCT06441877|531851675|FG002|Overall Study|Withdrawal by Subject|0|||
147461490|NCT06441877|531851676|FG003|Overall Study|Withdrawal by Subject|0|||
147461491|NCT03706365|531851683|FG000|Overall Study|Lost to Follow-up|7|||
147461492|NCT03706365|531851684|FG001|Overall Study|Lost to Follow-up|0|||
147461493|NCT03706365|531851683|FG000|Overall Study|Withdrawal by Subject|17|||
147461494|NCT03706365|531851684|FG001|Overall Study|Withdrawal by Subject|15|||
147461495|NCT03706365|531851683|FG000|Overall Study|On Study Treatment|51|||
147461496|NCT03706365|531851684|FG001|Overall Study|On Study Treatment|51|||
147461497|NCT05195528|531851685|FG000|Placebo-controlled Treatment Period|Protocol Violation|1|||
147461498|NCT05195528|531851686|FG001|Placebo-controlled Treatment Period|Protocol Violation|1|||
147461499|NCT05195528|531851687|FG002|Placebo-controlled Treatment Period|Protocol Violation|0|||
147461500|NCT05195528|531851688|FG003|Placebo-controlled Treatment Period|Protocol Violation|0|||
147461501|NCT05195528|531851689|FG004|Placebo-controlled Treatment Period|Protocol Violation|0|||
147461502|NCT05195528|531851685|FG000|Placebo-controlled Treatment Period|Pre-Treatment Event (PTE) or Adverse Event (AE) or Serious Adverse Event (SAE)|2|||
147461503|NCT05195528|531851686|FG001|Placebo-controlled Treatment Period|Pre-Treatment Event (PTE) or Adverse Event (AE) or Serious Adverse Event (SAE)|1|||
147461504|NCT05195528|531851687|FG002|Placebo-controlled Treatment Period|Pre-Treatment Event (PTE) or Adverse Event (AE) or Serious Adverse Event (SAE)|6|||
147461505|NCT05195528|531851688|FG003|Placebo-controlled Treatment Period|Pre-Treatment Event (PTE) or Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
147461506|NCT05195528|531851689|FG004|Placebo-controlled Treatment Period|Pre-Treatment Event (PTE) or Adverse Event (AE) or Serious Adverse Event (SAE)|0|||
147461507|NCT05195528|531851685|FG000|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
147461508|NCT05195528|531851686|FG001|Placebo-controlled Treatment Period|Lost to Follow-up|3|||
147461509|NCT05195528|531851687|FG002|Placebo-controlled Treatment Period|Lost to Follow-up|4|||
147461510|NCT05195528|531851688|FG003|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
147461511|NCT05195528|531851689|FG004|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
147461512|NCT05195528|531851685|FG000|Placebo-controlled Treatment Period|Withdrawal by Subject|6|||
147461513|NCT05195528|531851686|FG001|Placebo-controlled Treatment Period|Withdrawal by Subject|2|||
147461514|NCT05195528|531851687|FG002|Placebo-controlled Treatment Period|Withdrawal by Subject|4|||
147461515|NCT05195528|531851688|FG003|Placebo-controlled Treatment Period|Withdrawal by Subject|0|||
147461516|NCT05195528|531851689|FG004|Placebo-controlled Treatment Period|Withdrawal by Subject|0|||
147461517|NCT05195528|531851685|FG000|Placebo-controlled Treatment Period|Lack of Efficacy|2|||
147461518|NCT05195528|531851686|FG001|Placebo-controlled Treatment Period|Lack of Efficacy|0|||
147461519|NCT05195528|531851687|FG002|Placebo-controlled Treatment Period|Lack of Efficacy|0|||
147461520|NCT05195528|531851688|FG003|Placebo-controlled Treatment Period|Lack of Efficacy|0|||
147461521|NCT05195528|531851689|FG004|Placebo-controlled Treatment Period|Lack of Efficacy|0|||
147461522|NCT05195528|531851685|FG000|Placebo-controlled Treatment Period|Not Treated|1|||
147461523|NCT05195528|531851686|FG001|Placebo-controlled Treatment Period|Not Treated|1|||
147461524|NCT05195528|531851687|FG002|Placebo-controlled Treatment Period|Not Treated|2|||
147461525|NCT05195528|531851688|FG003|Placebo-controlled Treatment Period|Not Treated|0|||
147461526|NCT05195528|531851689|FG004|Placebo-controlled Treatment Period|Not Treated|0|||
147461527|NCT05195528|531851685|FG000|Placebo-controlled Treatment Period|Other|0|||
147461528|NCT05195528|531851686|FG001|Placebo-controlled Treatment Period|Other|0|||
147461529|NCT05195528|531851687|FG002|Placebo-controlled Treatment Period|Other|1|||
147461530|NCT05195528|531851688|FG003|Placebo-controlled Treatment Period|Other|0|||
147461531|NCT05195528|531851689|FG004|Placebo-controlled Treatment Period|Other|0|||
147461532|NCT05195528|531851685|FG000|Extension Period|PTE or AE or SAE|0|||
147461533|NCT05195528|531851686|FG001|Extension Period|PTE or AE or SAE|4|||
147461534|NCT05195528|531851687|FG002|Extension Period|PTE or AE or SAE|5|||
147461535|NCT05195528|531851688|FG003|Extension Period|PTE or AE or SAE|4|||
147461536|NCT05195528|531851689|FG004|Extension Period|PTE or AE or SAE|4|||
147461537|NCT05195528|531851685|FG000|Extension Period|Protocol Violation|0|||
147461538|NCT05195528|531851686|FG001|Extension Period|Protocol Violation|2|||
147461539|NCT05195528|531851687|FG002|Extension Period|Protocol Violation|1|||
147461540|NCT05195528|531851688|FG003|Extension Period|Protocol Violation|0|||
147461541|NCT05195528|531851689|FG004|Extension Period|Protocol Violation|1|||
147461542|NCT05195528|531851685|FG000|Extension Period|Lost to Follow-up|0|||
147461543|NCT05195528|531851686|FG001|Extension Period|Lost to Follow-up|6|||
147461544|NCT05195528|531851687|FG002|Extension Period|Lost to Follow-up|13|||
147461545|NCT05195528|531851688|FG003|Extension Period|Lost to Follow-up|3|||
147461546|NCT05195528|531851689|FG004|Extension Period|Lost to Follow-up|7|||
147461547|NCT05195528|531851685|FG000|Extension Period|Withdrawal by Subject|0|||
147461548|NCT05195528|531851686|FG001|Extension Period|Withdrawal by Subject|12|||
147461549|NCT05195528|531851687|FG002|Extension Period|Withdrawal by Subject|9|||
147461550|NCT05195528|531851688|FG003|Extension Period|Withdrawal by Subject|6|||
147461551|NCT05195528|531851689|FG004|Extension Period|Withdrawal by Subject|5|||
147461552|NCT05195528|531851685|FG000|Extension Period|Lack of Efficacy|0|||
147461553|NCT05195528|531851686|FG001|Extension Period|Lack of Efficacy|3|||
147461554|NCT05195528|531851687|FG002|Extension Period|Lack of Efficacy|0|||
147461555|NCT05195528|531851688|FG003|Extension Period|Lack of Efficacy|0|||
147461556|NCT05195528|531851689|FG004|Extension Period|Lack of Efficacy|2|||
147461557|NCT05195528|531851685|FG000|Extension Period|Not Treated|0|||
147461558|NCT05195528|531851686|FG001|Extension Period|Not Treated|0|||
147461559|NCT05195528|531851687|FG002|Extension Period|Not Treated|2|||
147461560|NCT05195528|531851688|FG003|Extension Period|Not Treated|3|||
147461561|NCT05195528|531851689|FG004|Extension Period|Not Treated|0|||
147461562|NCT05195528|531851685|FG000|Extension Period|Other|0|||
147461563|NCT05195528|531851686|FG001|Extension Period|Other|1|||
147461564|NCT05195528|531851687|FG002|Extension Period|Other|1|||
147461565|NCT05195528|531851688|FG003|Extension Period|Other|0|||
147461566|NCT05195528|531851689|FG004|Extension Period|Other|0|||
147461567|NCT01552902|531851690|FG000|Overall Study|Adverse Event|1|||
147461568|NCT01552902|531851691|FG001|Overall Study|Adverse Event|15|||
147461569|NCT01552902|531851692|FG002|Overall Study|Adverse Event|14|||
147461570|NCT01552902|531851690|FG000|Overall Study|Protocol Violation|3|||
147461571|NCT01552902|531851691|FG001|Overall Study|Protocol Violation|3|||
147461572|NCT01552902|531851692|FG002|Overall Study|Protocol Violation|3|||
147461573|NCT01552902|531851690|FG000|Overall Study|Lack of Efficacy|4|||
147461574|NCT01552902|531851691|FG001|Overall Study|Lack of Efficacy|3|||
147461575|NCT01552902|531851692|FG002|Overall Study|Lack of Efficacy|1|||
147461576|NCT01552902|531851690|FG000|Overall Study|Withdrawal by Subject|1|||
147461577|NCT01552902|531851691|FG001|Overall Study|Withdrawal by Subject|9|||
147461578|NCT01552902|531851692|FG002|Overall Study|Withdrawal by Subject|6|||
147461579|NCT01552902|531851690|FG000|Overall Study|Lost to Follow-up|1|||
147461580|NCT01552902|531851691|FG001|Overall Study|Lost to Follow-up|3|||
147461581|NCT01552902|531851692|FG002|Overall Study|Lost to Follow-up|6|||
147461582|NCT01552902|531851690|FG000|Overall Study|Other|3|||
147461583|NCT01552902|531851691|FG001|Overall Study|Other|4|||
147461584|NCT01552902|531851692|FG002|Overall Study|Other|3|||
147461585|NCT02720757|531851693|FG000|Overall Study|Other reason|5|||
147461586|NCT02720757|531851693|FG000|Overall Study|Loss of contact|4|||
147461587|NCT02720757|531851693|FG000|Overall Study|Informed consent withdrawal|1|||
147461588|NCT02720757|531851693|FG000|Overall Study|Patients wish to withdraw|2|||
147461589|NCT02720757|531851693|FG000|Overall Study|Missing|3|||
147461590|NCT02720757|531851693|FG000|Overall Study|General exclusion|3|||
147461591|NCT02631538|531851694|FG000|Treatment Period (Up to Week 52)|Adverse Event|1|||
147461592|NCT02631538|531851695|FG001|Treatment Period (Up to Week 52)|Adverse Event|5|||
147461593|NCT02631538|531851696|FG002|Treatment Period (Up to Week 52)|Adverse Event|2|||
147461594|NCT02631538|531851697|FG003|Treatment Period (Up to Week 52)|Adverse Event|2|||
147461595|NCT02631538|531851694|FG000|Treatment Period (Up to Week 52)|Withdrawal by Subject|1|||
147461596|NCT02631538|531851695|FG001|Treatment Period (Up to Week 52)|Withdrawal by Subject|1|||
147461597|NCT02631538|531851696|FG002|Treatment Period (Up to Week 52)|Withdrawal by Subject|2|||
147461598|NCT02631538|531851697|FG003|Treatment Period (Up to Week 52)|Withdrawal by Subject|5|||
147461599|NCT02631538|531851694|FG000|Treatment Period (Up to Week 52)|Lack of Efficacy|1|||
147461600|NCT02631538|531851695|FG001|Treatment Period (Up to Week 52)|Lack of Efficacy|1|||
147461601|NCT02631538|531851696|FG002|Treatment Period (Up to Week 52)|Lack of Efficacy|0|||
147461602|NCT02631538|531851697|FG003|Treatment Period (Up to Week 52)|Lack of Efficacy|0|||
147461603|NCT02631538|531851694|FG000|Treatment Period (Up to Week 52)|Physician Decision|1|||
147461604|NCT02631538|531851695|FG001|Treatment Period (Up to Week 52)|Physician Decision|0|||
147461605|NCT02631538|531851696|FG002|Treatment Period (Up to Week 52)|Physician Decision|0|||
147461606|NCT02631538|531851697|FG003|Treatment Period (Up to Week 52)|Physician Decision|1|||
147461607|NCT02631538|531851694|FG000|Treatment Period (Up to Week 52)|Reached stopping criteria|0|||
147400488|NCT02312206|531631012|FG001|Overall Study|Patient progression and institution of a new therapy|0|||
147400489|NCT02312206|531631011|FG000|Overall Study|Disease Progression|1|||
147400490|NCT02312206|531631012|FG001|Overall Study|Disease Progression|0|||
147400491|NCT00585975|531631013|FG000|Overall Study|Withdrawal by Subject|3|||
147400492|NCT00585975|531631014|FG001|Overall Study|Withdrawal by Subject|3|||
147400493|NCT00585975|531631013|FG000|Overall Study|Lost to Follow-up|2|||
147400494|NCT00585975|531631014|FG001|Overall Study|Lost to Follow-up|1|||
147400495|NCT00585975|531631013|FG000|Overall Study|Enrollment met/over-enrolled|10|||
147400496|NCT00585975|531631014|FG001|Overall Study|Enrollment met/over-enrolled|9|||
147400497|NCT03082612|531631017|FG000|Overall Study|Lost to Follow-up|2|||
147400498|NCT03082612|531631018|FG001|Overall Study|Lost to Follow-up|0|||
147400499|NCT01006616|531631019|FG000|Period 1 (6 Months)|Adverse Event|10|||
147400500|NCT01006616|531631020|FG001|Period 1 (6 Months)|Adverse Event|31|||
147400501|NCT01006616|531631021|FG002|Period 1 (6 Months)|Adverse Event|37|||
147400502|NCT01006616|531631022|FG003|Period 1 (6 Months)|Adverse Event|9|||
147400503|NCT01006616|531631019|FG000|Period 1 (6 Months)|Lack of Efficacy|3|||
147400504|NCT01006616|531631020|FG001|Period 1 (6 Months)|Lack of Efficacy|4|||
147400505|NCT01006616|531631021|FG002|Period 1 (6 Months)|Lack of Efficacy|0|||
147400506|NCT01006616|531631022|FG003|Period 1 (6 Months)|Lack of Efficacy|4|||
147400507|NCT01006616|531631019|FG000|Period 1 (6 Months)|Lost to Follow-up|0|||
147400508|NCT01006616|531631020|FG001|Period 1 (6 Months)|Lost to Follow-up|0|||
147400509|NCT01006616|531631021|FG002|Period 1 (6 Months)|Lost to Follow-up|1|||
147400510|NCT01006616|531631022|FG003|Period 1 (6 Months)|Lost to Follow-up|0|||
147400511|NCT01006616|531631019|FG000|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|6|||
147400512|NCT01006616|531631020|FG001|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|5|||
147400513|NCT01006616|531631021|FG002|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|2|||
147400514|NCT01006616|531631022|FG003|Period 1 (6 Months)|Withdrew, Reason Unrelated to Treatment|3|||
147400515|NCT01006616|531631019|FG000|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|0|||
147400516|NCT01006616|531631020|FG001|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|3|||
147400517|NCT01006616|531631021|FG002|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|1|||
147400518|NCT01006616|531631022|FG003|Period 1 (6 Months)|Withdrew, Reason Related to Treatment|2|||
147400519|NCT01006616|531631019|FG000|Period 1 (6 Months)|Withdrawal by Subject|2|||
147400520|NCT01006616|531631020|FG001|Period 1 (6 Months)|Withdrawal by Subject|2|||
147400521|NCT01006616|531631021|FG002|Period 1 (6 Months)|Withdrawal by Subject|2|||
147400522|NCT01006616|531631022|FG003|Period 1 (6 Months)|Withdrawal by Subject|0|||
147400523|NCT01006616|531631019|FG000|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|5|||
147400524|NCT01006616|531631020|FG001|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|7|||
147400525|NCT01006616|531631021|FG002|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|5|||
147400526|NCT01006616|531631022|FG003|Period 1 (6 Months)|Did Not Meet Protocol Eligibility|5|||
147400527|NCT01006616|531631019|FG000|Period 1 (6 Months)|Noncompliance With Protocol|0|||
147400528|NCT01006616|531631020|FG001|Period 1 (6 Months)|Noncompliance With Protocol|2|||
147400529|NCT01006616|531631021|FG002|Period 1 (6 Months)|Noncompliance With Protocol|2|||
147400530|NCT01006616|531631022|FG003|Period 1 (6 Months)|Noncompliance With Protocol|3|||
147400531|NCT01006616|531631019|FG000|Period 1 (6 Months)|Not Treated|0|||
147400532|NCT01006616|531631020|FG001|Period 1 (6 Months)|Not Treated|0|||
147400533|NCT01006616|531631021|FG002|Period 1 (6 Months)|Not Treated|1|||
147400534|NCT01006616|531631022|FG003|Period 1 (6 Months)|Not Treated|1|||
147400535|NCT01006616|531631019|FG000|Period 2 (18 Months)|Adverse Event|6|||
147400536|NCT01006616|531631020|FG001|Period 2 (18 Months)|Adverse Event|6|||
147400537|NCT01006616|531631021|FG002|Period 2 (18 Months)|Adverse Event|6|||
147400538|NCT01006616|531631022|FG003|Period 2 (18 Months)|Adverse Event|4|||
147400539|NCT01006616|531631019|FG000|Period 2 (18 Months)|Lack of Efficacy|0|||
147400540|NCT01006616|531631020|FG001|Period 2 (18 Months)|Lack of Efficacy|0|||
147400541|NCT01006616|531631021|FG002|Period 2 (18 Months)|Lack of Efficacy|1|||
147400542|NCT01006616|531631022|FG003|Period 2 (18 Months)|Lack of Efficacy|2|||
147400543|NCT01006616|531631019|FG000|Period 2 (18 Months)|Lost to Follow-up|2|||
147400544|NCT01006616|531631020|FG001|Period 2 (18 Months)|Lost to Follow-up|0|||
147400545|NCT01006616|531631021|FG002|Period 2 (18 Months)|Lost to Follow-up|0|||
147400546|NCT01006616|531631022|FG003|Period 2 (18 Months)|Lost to Follow-up|0|||
147400547|NCT01006616|531631019|FG000|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|3|||
147400548|NCT01006616|531631020|FG001|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|0|||
147400549|NCT01006616|531631021|FG002|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|3|||
147400550|NCT01006616|531631022|FG003|Period 2 (18 Months)|Withdrew, Reason Unrelated to Treatment|2|||
147400551|NCT01006616|531631019|FG000|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|0|||
147400552|NCT01006616|531631020|FG001|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|6|||
147400553|NCT01006616|531631021|FG002|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|1|||
147400554|NCT01006616|531631022|FG003|Period 2 (18 Months)|Withdrew, Reason Related to Treatment|2|||
147400555|NCT01006616|531631019|FG000|Period 2 (18 Months)|Withdrawal by Subject|1|||
147400556|NCT01006616|531631020|FG001|Period 2 (18 Months)|Withdrawal by Subject|4|||
147461608|NCT02631538|531851695|FG001|Treatment Period (Up to Week 52)|Reached stopping criteria|0|||
147461609|NCT02631538|531851696|FG002|Treatment Period (Up to Week 52)|Reached stopping criteria|1|||
147400557|NCT01006616|531631021|FG002|Period 2 (18 Months)|Withdrawal by Subject|0|||
147400558|NCT01006616|531631022|FG003|Period 2 (18 Months)|Withdrawal by Subject|1|||
147400559|NCT01006616|531631019|FG000|Period 2 (18 Months)|Noncompliance With Protocol|0|||
147400560|NCT01006616|531631020|FG001|Period 2 (18 Months)|Noncompliance With Protocol|1|||
147400561|NCT01006616|531631021|FG002|Period 2 (18 Months)|Noncompliance With Protocol|0|||
147400562|NCT01006616|531631022|FG003|Period 2 (18 Months)|Noncompliance With Protocol|1|||
147400563|NCT01006616|531631019|FG000|Period 2 (18 Months)|Study Terminated|63|||
147400564|NCT01006616|531631020|FG001|Period 2 (18 Months)|Study Terminated|46|||
147400565|NCT01006616|531631021|FG002|Period 2 (18 Months)|Study Terminated|44|||
147400566|NCT01006616|531631022|FG003|Period 2 (18 Months)|Study Terminated|70|||
147400567|NCT00992992|531631029|FG000|Overall Study|Lost to Follow-up|3|||
147400568|NCT00992992|531631029|FG000|Overall Study|Death|16|||
147400569|NCT00992992|531631029|FG000|Overall Study|GlaxoSmithKline Closed the Study|2|||
147400570|NCT00992992|531631029|FG000|Overall Study|Sponsor Closed the Study|4|||
147400571|NCT00952848|531631030|FG000|Overall Study|Withdrawal by Subject|4|||
147400572|NCT02250534|531631031|FG000|Overall Study|Lost to Follow-up|18|||
147400573|NCT02250534|531631032|FG001|Overall Study|Lost to Follow-up|28|||
147400574|NCT02250534|531631033|FG002|Overall Study|Lost to Follow-up|33|||
147400575|NCT02250534|531631031|FG000|Overall Study|Personal reasons|7|||
147400576|NCT02250534|531631032|FG001|Overall Study|Personal reasons|8|||
147400577|NCT02250534|531631033|FG002|Overall Study|Personal reasons|14|||
147400578|NCT02250534|531631031|FG000|Overall Study|Adverse Event|6|||
147400579|NCT02250534|531631032|FG001|Overall Study|Adverse Event|3|||
147400580|NCT02250534|531631033|FG002|Overall Study|Adverse Event|8|||
147400581|NCT02250534|531631031|FG000|Overall Study|incarcerated|2|||
147400582|NCT02250534|531631032|FG001|Overall Study|incarcerated|1|||
147400583|NCT02250534|531631033|FG002|Overall Study|incarcerated|2|||
147400584|NCT02250534|531631031|FG000|Overall Study|Withdrawal by Subject|0|||
147400585|NCT02250534|531631032|FG001|Overall Study|Withdrawal by Subject|1|||
147400586|NCT02250534|531631033|FG002|Overall Study|Withdrawal by Subject|2|||
147400587|NCT02250534|531631031|FG000|Overall Study|Death|0|||
147400588|NCT02250534|531631032|FG001|Overall Study|Death|1|||
147400589|NCT02250534|531631033|FG002|Overall Study|Death|1|||
147400590|NCT02250534|531631031|FG000|Overall Study|Physician Decision|1|||
147400591|NCT02250534|531631032|FG001|Overall Study|Physician Decision|3|||
147400592|NCT02250534|531631033|FG002|Overall Study|Physician Decision|1|||
147400593|NCT02250534|531631031|FG000|Overall Study|Protocol Violation|1|||
147400594|NCT02250534|531631032|FG001|Overall Study|Protocol Violation|0|||
147400595|NCT02250534|531631033|FG002|Overall Study|Protocol Violation|1|||
147400596|NCT02250534|531631031|FG000|Overall Study|Reason unknown|1|||
147400597|NCT02250534|531631032|FG001|Overall Study|Reason unknown|0|||
147400598|NCT02250534|531631033|FG002|Overall Study|Reason unknown|0|||
147400599|NCT00217022|531631035|FG000|Overall Study|Withdrawal by Subject|1|||
147400600|NCT00217022|531631036|FG001|Overall Study|Withdrawal by Subject|1|||
147400601|NCT00458393|531631037|FG000|Overall Study|Withdrawal by Subject|67|||
147400602|NCT00458393|531631038|FG001|Overall Study|Withdrawal by Subject|80|||
147400603|NCT00458393|531631037|FG000|Overall Study|Physician Decision|31|||
147400604|NCT00458393|531631038|FG001|Overall Study|Physician Decision|22|||
147400605|NCT00458393|531631037|FG000|Overall Study|Relocated|77|||
147400606|NCT00458393|531631038|FG001|Overall Study|Relocated|81|||
147400607|NCT00458393|531631037|FG000|Overall Study|Lost to Follow-up|115|||
147400608|NCT00458393|531631038|FG001|Overall Study|Lost to Follow-up|92|||
147400609|NCT00458393|531631037|FG000|Overall Study|Sites marked other on the form.|19|||
147400610|NCT00458393|531631038|FG001|Overall Study|Sites marked other on the form.|20|||
147400611|NCT01253447|531631040|FG000|Overall Study|Adverse Event|2|||
147400612|NCT02108652|531631041|FG000|Overall Study|Death|253|||
147400613|NCT02108652|531631041|FG000|Overall Study|Lost to Follow-up|2|||
147400614|NCT02108652|531631041|FG000|Overall Study|Withdrawal by Subject|16|||
147400615|NCT02108652|531631041|FG000|Overall Study|Study Terminated By Sponsor|31|||
147400616|NCT02108652|531631041|FG000|Overall Study|Non-Compliance|1|||
147400617|NCT02108652|531631041|FG000|Overall Study|Physician Decision|6|||
147400618|NCT02108652|531631041|FG000|Overall Study|Progression Of Disease|1|||
147400619|NCT02564718|531631049|FG000|Overall Study|Withdrew from treatment|0|||
147400620|NCT02564718|531631050|FG001|Overall Study|Withdrew from treatment|1|||
147400621|NCT03845075|531631051|FG000|Part 1 - DB|Withdrawal by Subject|1|||
147400622|NCT03845075|531631052|FG001|Part 1 - DB|Withdrawal by Subject|1|||
147400623|NCT03845075|531631053|FG002|Part 1 - DB|Withdrawal by Subject|0|||
147400624|NCT03845075|531631054|FG003|Part 1 - DB|Withdrawal by Subject|0|||
147400625|NCT03845075|531631051|FG000|Part 1 - DB|Adverse Event|0|||
147400626|NCT03845075|531631052|FG001|Part 1 - DB|Adverse Event|1|||
147400627|NCT03845075|531631053|FG002|Part 1 - DB|Adverse Event|0|||
147400628|NCT03845075|531631054|FG003|Part 1 - DB|Adverse Event|0|||
147400629|NCT03845075|531631051|FG000|Part 1 - DB|Screen failure, but received 1 dose of study drug in error|1|||
147400630|NCT03845075|531631052|FG001|Part 1 - DB|Screen failure, but received 1 dose of study drug in error|0|||
147400631|NCT03845075|531631053|FG002|Part 1 - DB|Screen failure, but received 1 dose of study drug in error|0|||
147400632|NCT03845075|531631054|FG003|Part 1 - DB|Screen failure, but received 1 dose of study drug in error|0|||
147400633|NCT01560871|531631055|FG000|Overall Study|transportation issues|2|||
147615514|NCT05221320|532408993|FG002|Overall Study|Lack of Efficacy|10|||
147400634|NCT01560871|531631056|FG001|Overall Study|transportation issues|1|||
147400635|NCT01560871|531631055|FG000|Overall Study|relocation|1|||
147400636|NCT01560871|531631056|FG001|Overall Study|relocation|0|||
147400637|NCT01560871|531631055|FG000|Overall Study|readmission to a hospital|2|||
147400638|NCT01560871|531631056|FG001|Overall Study|readmission to a hospital|1|||
147400639|NCT01560871|531631055|FG000|Overall Study|Lost to Follow-up|1|||
147400640|NCT01560871|531631056|FG001|Overall Study|Lost to Follow-up|0|||
147400641|NCT01130168|531631062|FG000|Period 1|Withdrawal by Subject|0|||
147400642|NCT01130168|531631063|FG001|Period 1|Withdrawal by Subject|1|||
147400643|NCT01130168|531631064|FG002|Period 1|Withdrawal by Subject|0|||
147400644|NCT01130168|531631065|FG003|Period 1|Withdrawal by Subject|1|||
147400645|NCT01130168|531631066|FG004|Period 1|Withdrawal by Subject|0|||
147400646|NCT01130168|531631067|FG005|Period 1|Withdrawal by Subject|0|||
147400647|NCT01130168|531631062|FG000|Period 1|Discontinued For Other Reason|0|||
147400648|NCT01130168|531631063|FG001|Period 1|Discontinued For Other Reason|0|||
147400649|NCT01130168|531631064|FG002|Period 1|Discontinued For Other Reason|1|||
147400650|NCT01130168|531631065|FG003|Period 1|Discontinued For Other Reason|1|||
147400651|NCT01130168|531631066|FG004|Period 1|Discontinued For Other Reason|0|||
147400652|NCT01130168|531631067|FG005|Period 1|Discontinued For Other Reason|0|||
147400653|NCT01130168|531631062|FG000|Period 1|Adverse Event|0|||
147400654|NCT01130168|531631063|FG001|Period 1|Adverse Event|0|||
147400655|NCT01130168|531631064|FG002|Period 1|Adverse Event|0|||
147400656|NCT01130168|531631065|FG003|Period 1|Adverse Event|1|||
147400657|NCT01130168|531631066|FG004|Period 1|Adverse Event|0|||
147400658|NCT01130168|531631067|FG005|Period 1|Adverse Event|0|||
147400659|NCT04354168|531631070|FG000|Overall Study|Lost to Follow-up|22|||
147400660|NCT01781832|531631071|FG000|Overall Study|Withdrawal by Subject|1|||
147400661|NCT02287233|531631072|FG000|Overall Study|Adverse Event Not Related to Progression|1|||
147400662|NCT02287233|531631073|FG001|Overall Study|Adverse Event Not Related to Progression|2|||
147400663|NCT02287233|531631074|FG002|Overall Study|Adverse Event Not Related to Progression|10|||
147400664|NCT02287233|531631072|FG000|Overall Study|Adverse Event Related to Progression|0|||
147400665|NCT02287233|531631073|FG001|Overall Study|Adverse Event Related to Progression|2|||
147400666|NCT02287233|531631074|FG002|Overall Study|Adverse Event Related to Progression|8|||
147400667|NCT02287233|531631072|FG000|Overall Study|Physician Decision|1|||
147400668|NCT02287233|531631073|FG001|Overall Study|Physician Decision|2|||
147400669|NCT02287233|531631074|FG002|Overall Study|Physician Decision|4|||
147400670|NCT02287233|531631072|FG000|Overall Study|Progressive Disease with Death|0|||
147400671|NCT02287233|531631073|FG001|Overall Study|Progressive Disease with Death|0|||
147400672|NCT02287233|531631074|FG002|Overall Study|Progressive Disease with Death|10|||
147400673|NCT02287233|531631072|FG000|Overall Study|Progressive Disease Without Death|2|||
147400674|NCT02287233|531631073|FG001|Overall Study|Progressive Disease Without Death|3|||
147400675|NCT02287233|531631074|FG002|Overall Study|Progressive Disease Without Death|20|||
147400676|NCT02287233|531631072|FG000|Overall Study|Withdrawal by Subject|1|||
147400677|NCT02287233|531631073|FG001|Overall Study|Withdrawal by Subject|1|||
147400678|NCT02287233|531631074|FG002|Overall Study|Withdrawal by Subject|7|||
147400679|NCT02287233|531631072|FG000|Overall Study|Other|3|||
147400680|NCT02287233|531631073|FG001|Overall Study|Other|0|||
147400681|NCT02287233|531631074|FG002|Overall Study|Other|15|||
147400682|NCT02287233|531631072|FG000|Overall Study|Did Not Receive Treatment|0|||
147400683|NCT02287233|531631073|FG001|Overall Study|Did Not Receive Treatment|0|||
147400684|NCT02287233|531631074|FG002|Overall Study|Did Not Receive Treatment|2|||
147400685|NCT02804399|531631075|FG000|Period 2|Adverse Event|0|||
147400686|NCT02804399|531631076|FG001|Period 2|Adverse Event|1|||
147400687|NCT01774305|531631077|FG000|Overall Study|Physician Decision|1|||
147400688|NCT01774305|531631078|FG001|Overall Study|Physician Decision|0|||
147400689|NCT01157377|531631079|FG000|Overall Study|Lost to Follow-up|0|||
147400690|NCT01157377|531631080|FG001|Overall Study|Lost to Follow-up|0|||
147400691|NCT01157377|531631081|FG002|Overall Study|Lost to Follow-up|1|||
147400692|NCT01157377|531631082|FG003|Overall Study|Lost to Follow-up|0|||
147400693|NCT01157377|531631083|FG004|Overall Study|Lost to Follow-up|1|||
147400694|NCT01157377|531631084|FG005|Overall Study|Lost to Follow-up|1|||
147400695|NCT01157377|531631085|FG006|Overall Study|Lost to Follow-up|0|||
147400696|NCT01157377|531631079|FG000|Overall Study|Personal Reasons|2|||
147400697|NCT01157377|531631080|FG001|Overall Study|Personal Reasons|1|||
147400698|NCT01157377|531631081|FG002|Overall Study|Personal Reasons|0|||
147400699|NCT01157377|531631082|FG003|Overall Study|Personal Reasons|1|||
147400700|NCT01157377|531631083|FG004|Overall Study|Personal Reasons|0|||
147400701|NCT01157377|531631084|FG005|Overall Study|Personal Reasons|0|||
147615515|NCT05221320|532408994|FG003|Overall Study|Lack of Efficacy|1|||
147400702|NCT01157377|531631085|FG006|Overall Study|Personal Reasons|0|||
147400703|NCT01157377|531631079|FG000|Overall Study|Protocol Violation|0|||
147400704|NCT01157377|531631080|FG001|Overall Study|Protocol Violation|0|||
147400705|NCT01157377|531631081|FG002|Overall Study|Protocol Violation|0|||
147400706|NCT01157377|531631082|FG003|Overall Study|Protocol Violation|0|||
147400707|NCT01157377|531631083|FG004|Overall Study|Protocol Violation|0|||
147400708|NCT01157377|531631084|FG005|Overall Study|Protocol Violation|1|||
147400709|NCT01157377|531631085|FG006|Overall Study|Protocol Violation|0|||
147400710|NCT01157377|531631079|FG000|Overall Study|Lack of Efficacy|0|||
147615516|NCT05221320|532408995|FG004|Overall Study|Lack of Efficacy|0|||
147400711|NCT01157377|531631080|FG001|Overall Study|Lack of Efficacy|0|||
147400712|NCT01157377|531631081|FG002|Overall Study|Lack of Efficacy|0|||
147400713|NCT01157377|531631082|FG003|Overall Study|Lack of Efficacy|0|||
147400714|NCT01157377|531631083|FG004|Overall Study|Lack of Efficacy|0|||
147400715|NCT01157377|531631084|FG005|Overall Study|Lack of Efficacy|0|||
147400716|NCT01157377|531631085|FG006|Overall Study|Lack of Efficacy|1|||
147400717|NCT01157377|531631079|FG000|Overall Study|Other Miscellaneous Reasons|0|||
147400718|NCT01157377|531631080|FG001|Overall Study|Other Miscellaneous Reasons|2|||
147400719|NCT01157377|531631081|FG002|Overall Study|Other Miscellaneous Reasons|0|||
147400720|NCT01157377|531631082|FG003|Overall Study|Other Miscellaneous Reasons|0|||
147400721|NCT01157377|531631083|FG004|Overall Study|Other Miscellaneous Reasons|1|||
147400722|NCT01157377|531631084|FG005|Overall Study|Other Miscellaneous Reasons|1|||
147400723|NCT01157377|531631085|FG006|Overall Study|Other Miscellaneous Reasons|1|||
147400724|NCT00904722|531631088|FG000|Overall Study|Physician Decision|1|||
147400725|NCT01801982|531631092|FG000|Overall Study|Lost to Follow-up|1|||
147400726|NCT00727506|531631093|FG000|Overall Study|Adverse Event|0|||
147400727|NCT00727506|531631094|FG001|Overall Study|Adverse Event|0|||
147400728|NCT00727506|531631095|FG002|Overall Study|Adverse Event|4|||
147400729|NCT00727506|531631096|FG003|Overall Study|Adverse Event|4|||
147400730|NCT00727506|531631097|FG004|Overall Study|Adverse Event|1|||
147400731|NCT00727506|531631098|FG005|Overall Study|Adverse Event|8|||
147400732|NCT00727506|531631093|FG000|Overall Study|Dose Limiting Toxicity (DLT)|2|||
147400733|NCT00727506|531631094|FG001|Overall Study|Dose Limiting Toxicity (DLT)|0|||
147400734|NCT00727506|531631095|FG002|Overall Study|Dose Limiting Toxicity (DLT)|2|||
147400735|NCT00727506|531631096|FG003|Overall Study|Dose Limiting Toxicity (DLT)|0|||
147400736|NCT00727506|531631097|FG004|Overall Study|Dose Limiting Toxicity (DLT)|0|||
147400737|NCT00727506|531631098|FG005|Overall Study|Dose Limiting Toxicity (DLT)|0|||
147400738|NCT00727506|531631093|FG000|Overall Study|Progressive disease|4|||
147400739|NCT00727506|531631094|FG001|Overall Study|Progressive disease|7|||
147400740|NCT00727506|531631095|FG002|Overall Study|Progressive disease|9|||
147400741|NCT00727506|531631096|FG003|Overall Study|Progressive disease|28|||
147400742|NCT00727506|531631097|FG004|Overall Study|Progressive disease|38|||
147400743|NCT00727506|531631098|FG005|Overall Study|Progressive disease|28|||
147400744|NCT00727506|531631093|FG000|Overall Study|Refused to continue medication|0|||
147400745|NCT00727506|531631094|FG001|Overall Study|Refused to continue medication|1|||
147400746|NCT00727506|531631095|FG002|Overall Study|Refused to continue medication|2|||
147400747|NCT00727506|531631096|FG003|Overall Study|Refused to continue medication|3|||
147400748|NCT00727506|531631097|FG004|Overall Study|Refused to continue medication|1|||
147400749|NCT00727506|531631098|FG005|Overall Study|Refused to continue medication|2|||
147400750|NCT00727506|531631093|FG000|Overall Study|Other reason not described above|0|||
147400751|NCT00727506|531631094|FG001|Overall Study|Other reason not described above|0|||
147400752|NCT00727506|531631095|FG002|Overall Study|Other reason not described above|1|||
147400753|NCT00727506|531631096|FG003|Overall Study|Other reason not described above|4|||
147400754|NCT00727506|531631097|FG004|Overall Study|Other reason not described above|1|||
147400755|NCT00727506|531631098|FG005|Overall Study|Other reason not described above|1|||
147400756|NCT01482429|531631099|FG000|Care Usual|Protocol Violation|0|||
147400757|NCT01482429|531631100|FG001|Care Usual|Protocol Violation|172|||
147400758|NCT01482429|531631099|FG000|Care Usual|Lost to Follow-up|0|||
147400759|NCT01482429|531631100|FG001|Care Usual|Lost to Follow-up|1|||
147400760|NCT01482429|531631099|FG000|Protocol|Protocol Violation|275|||
147400761|NCT01482429|531631100|FG001|Protocol|Protocol Violation|0|||
147400762|NCT03561597|531631101|FG000|Overall Study|Lost to Follow-up|20|||
147400763|NCT04887506|531631102|FG000|Overall Study|Death|1|||
147400764|NCT04887506|531631103|FG001|Overall Study|Death|1|||
147400765|NCT04887506|531631102|FG000|Overall Study|Withdrawal by Subject|0|||
147400766|NCT04887506|531631103|FG001|Overall Study|Withdrawal by Subject|3|||
147400767|NCT04887506|531631102|FG000|Overall Study|Adverse Event|4|||
147400768|NCT04887506|531631103|FG001|Overall Study|Adverse Event|3|||
147400769|NCT04887506|531631102|FG000|Overall Study|Other - Not Reported|1|||
147400770|NCT04887506|531631103|FG001|Overall Study|Other - Not Reported|1|||
147400771|NCT02636608|531631104|FG000|Overall Study|Failure to Return|4|||
147400772|NCT02636608|531631104|FG000|Overall Study|Insufficient Virological Response|1|||
147400773|NCT02636608|531631104|FG000|Overall Study|Death|3|||
147400774|NCT02636608|531631104|FG000|Overall Study|Other|2|||
147400775|NCT02636608|531631104|FG000|Overall Study|Did Not Receive Treatment|1|||
147400776|NCT04594733|531631128|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|0|||
147400777|NCT04594733|531631129|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|1|||
147400778|NCT04594733|531631128|FG000|First Intervention (8 Weeks)|Lost to Follow-up|0|||
147400779|NCT04594733|531631129|FG001|First Intervention (8 Weeks)|Lost to Follow-up|3|||
147400780|NCT04594733|531631128|FG000|Second Intervention (8 Weeks)|Lost to Follow-up|2|||
147400781|NCT04594733|531631129|FG001|Second Intervention (8 Weeks)|Lost to Follow-up|0|||
147400782|NCT01024036|531631130|FG000|Blinded Treatment|Adverse Event|1|||
147400783|NCT01024036|531631131|FG001|Blinded Treatment|Adverse Event|1|||
147400784|NCT01024036|531631130|FG000|Blinded Treatment|Lack of Efficacy|16|||
147400785|NCT01024036|531631131|FG001|Blinded Treatment|Lack of Efficacy|14|||
147400786|NCT01024036|531631130|FG000|Blinded Treatment|Physician Decision|1|||
147461610|NCT02631538|531851697|FG003|Treatment Period (Up to Week 52)|Reached stopping criteria|0|||
147461611|NCT02631538|531851694|FG000|General Follow-up (GFU) (Up to Week 68)|Lost to Follow-up|1|||
147461612|NCT02631538|531851695|FG001|General Follow-up (GFU) (Up to Week 68)|Lost to Follow-up|0|||
147461613|NCT02631538|531851696|FG002|General Follow-up (GFU) (Up to Week 68)|Lost to Follow-up|0|||
147461614|NCT02631538|531851697|FG003|General Follow-up (GFU) (Up to Week 68)|Lost to Follow-up|1|||
147461615|NCT00400400|531851698|FG000|Overall Study|Adverse Event|9|||
147461616|NCT00400400|531851699|FG001|Overall Study|Adverse Event|8|||
147461617|NCT00400400|531851698|FG000|Overall Study|Protocol Violation|2|||
147461618|NCT00400400|531851699|FG001|Overall Study|Protocol Violation|0|||
147461619|NCT00400400|531851698|FG000|Overall Study|Withdrawal by Subject|1|||
147461620|NCT00400400|531851699|FG001|Overall Study|Withdrawal by Subject|3|||
147461621|NCT00400400|531851698|FG000|Overall Study|Administrative Problem|1|||
147461622|NCT00400400|531851699|FG001|Overall Study|Administrative Problem|0|||
147461623|NCT00400400|531851698|FG000|Overall Study|Lost to Follow-up|0|||
147461624|NCT00400400|531851699|FG001|Overall Study|Lost to Follow-up|1|||
147461625|NCT00400400|531851698|FG000|Overall Study|Did not receive study drug|1|||
147461626|NCT00400400|531851699|FG001|Overall Study|Did not receive study drug|3|||
147461627|NCT00648167|531851700|FG000|Overall Study|Adverse Event|6|||
147461628|NCT00648167|531851700|FG000|Overall Study|unable to swallow tablets|1|||
147461629|NCT01688050|531851701|FG000|Overall Study|Death|7|||
147461630|NCT01688050|531851701|FG000|Overall Study|Conversion to open repair|1|||
147461631|NCT01688050|531851701|FG000|Overall Study|Lost to Follow-up|13|||
147461632|NCT01688050|531851701|FG000|Overall Study|Withdrawal by Subject|10|||
147461633|NCT01554579|531851702|FG000|Overall Study|Adverse Event|6|||
147461634|NCT01554579|531851703|FG001|Overall Study|Adverse Event|25|||
147461635|NCT01554579|531851702|FG000|Overall Study|Lack of Efficacy|2|||
147461636|NCT01554579|531851703|FG001|Overall Study|Lack of Efficacy|1|||
147461637|NCT01554579|531851702|FG000|Overall Study|Withdrawal by Subject|2|||
147461638|NCT01554579|531851703|FG001|Overall Study|Withdrawal by Subject|1|||
147461639|NCT00234039|531851704|FG000|Overall Study|Adverse Event|2|||
147461640|NCT00234039|531851704|FG000|Overall Study|Progression/relapse|34|||
147461641|NCT00234039|531851704|FG000|Overall Study|Other - Not Protocol Specified|3|||
147461642|NCT00234039|531851704|FG000|Overall Study|Ineligible|9|||
147400787|NCT01024036|531631131|FG001|Blinded Treatment|Physician Decision|0|||
147400788|NCT01024036|531631130|FG000|Blinded Treatment|Death|0|||
147400789|NCT01024036|531631131|FG001|Blinded Treatment|Death|2|||
147400790|NCT01024036|531631130|FG000|Blinded Treatment|Withdrawal by Subject|4|||
147400791|NCT01024036|531631131|FG001|Blinded Treatment|Withdrawal by Subject|3|||
147400792|NCT01024036|531631130|FG000|Unblinded Treatment|Adverse Event|0|||
147400793|NCT01024036|531631131|FG001|Unblinded Treatment|Adverse Event|1|||
147400794|NCT01024036|531631130|FG000|Unblinded Treatment|Lack of Efficacy|0|||
147400795|NCT01024036|531631131|FG001|Unblinded Treatment|Lack of Efficacy|2|||
147400796|NCT01024036|531631130|FG000|Follow-Up Period|Lost to Follow-up|1|||
147400797|NCT01024036|531631131|FG001|Follow-Up Period|Lost to Follow-up|1|||
147400798|NCT01024036|531631130|FG000|Follow-Up Period|Withdrawal by Subject|0|||
147400799|NCT01024036|531631131|FG001|Follow-Up Period|Withdrawal by Subject|1|||
147400800|NCT01024036|531631130|FG000|Follow-Up Period|Adverse Event|4|||
147400801|NCT01024036|531631131|FG001|Follow-Up Period|Adverse Event|1|||
147400802|NCT00691678|531631137|FG000|Overall Study|Adverse Event|5|||
147400803|NCT00691678|531631137|FG000|Overall Study|life events, pain|11|||
147400804|NCT01251887|531631138|FG000|Overall Study|Scheduling conflict|1|||
147400805|NCT01251887|531631139|FG001|Overall Study|Scheduling conflict|2|||
147400806|NCT01251887|531631140|FG002|Overall Study|Scheduling conflict|2|||
147400807|NCT01251887|531631138|FG000|Overall Study|Physician Decision|0|||
147400808|NCT01251887|531631139|FG001|Overall Study|Physician Decision|1|||
147400809|NCT01251887|531631140|FG002|Overall Study|Physician Decision|0|||
147400810|NCT01190449|531631143|FG000|Overall Study|Ineligible|0|||
147400811|NCT01190449|531631144|FG001|Overall Study|Ineligible|4|||
147400812|NCT04811339|531631145|FG000|Overall Study|lack of transportation not wanting to return|4|||
147400813|NCT04811339|531631146|FG001|Overall Study|lack of transportation not wanting to return|8|||
147461643|NCT00234039|531851704|FG000|Overall Study|No Protocol Treatment Received|2|||
147461644|NCT00110019|531851705|FG000|Overall Study|Lack of Efficacy|253|||
147461645|NCT00110019|531851706|FG001|Overall Study|Lack of Efficacy|285|||
147400814|NCT04811339|531631147|FG002|Overall Study|lack of transportation not wanting to return|0|||
147400815|NCT04811339|531631145|FG000|Overall Study|Adverse Event|3|||
147400816|NCT04811339|531631146|FG001|Overall Study|Adverse Event|0|||
147400817|NCT04811339|531631147|FG002|Overall Study|Adverse Event|0|||
147400818|NCT04811339|531631145|FG000|Overall Study|Lost to Follow-up|1|||
147400819|NCT04811339|531631146|FG001|Overall Study|Lost to Follow-up|0|||
147400820|NCT04811339|531631147|FG002|Overall Study|Lost to Follow-up|0|||
147461646|NCT00110019|531851705|FG000|Overall Study|Adverse Event|61|||
147461647|NCT00110019|531851706|FG001|Overall Study|Adverse Event|40|||
147461648|NCT00110019|531851705|FG000|Overall Study|Death|13|||
147461649|NCT00110019|531851706|FG001|Overall Study|Death|15|||
147461650|NCT00110019|531851705|FG000|Overall Study|Withdrawal by Subject|21|||
147461651|NCT00110019|531851706|FG001|Overall Study|Withdrawal by Subject|9|||
147461652|NCT00110019|531851705|FG000|Overall Study|alternative therapy|5|||
147461653|NCT00110019|531851706|FG001|Overall Study|alternative therapy|1|||
147461654|NCT00110019|531851705|FG000|Overall Study|complicating disease|1|||
147461655|NCT00110019|531851706|FG001|Overall Study|complicating disease|1|||
147400821|NCT04811339|531631145|FG000|Overall Study|Inconclusive saliva SARS CoV2 test (3X)|1|||
147400822|NCT04811339|531631146|FG001|Overall Study|Inconclusive saliva SARS CoV2 test (3X)|0|||
147400823|NCT04811339|531631147|FG002|Overall Study|Inconclusive saliva SARS CoV2 test (3X)|0|||
147400824|NCT04811339|531631145|FG000|Overall Study|Negative primary or secondary salivary SARS-CoV2 test|0|||
147400825|NCT04811339|531631146|FG001|Overall Study|Negative primary or secondary salivary SARS-CoV2 test|6|||
147400826|NCT04811339|531631147|FG002|Overall Study|Negative primary or secondary salivary SARS-CoV2 test|0|||
147400827|NCT04811339|531631145|FG000|Overall Study|Medications. Standard of Care medications were changing rapidly Protocol needed constant amending|0|||
147400828|NCT04811339|531631146|FG001|Overall Study|Medications. Standard of Care medications were changing rapidly Protocol needed constant amending|4|||
147400829|NCT04811339|531631147|FG002|Overall Study|Medications. Standard of Care medications were changing rapidly Protocol needed constant amending|0|||
147400830|NCT04811339|531631145|FG000|Overall Study|Withdrawal by Subject|0|||
147400831|NCT04811339|531631146|FG001|Overall Study|Withdrawal by Subject|3|||
147400832|NCT04811339|531631147|FG002|Overall Study|Withdrawal by Subject|0|||
147400833|NCT04811339|531631145|FG000|Overall Study|Transferred to ICU for non-COVID-19 related problem|0|||
147400834|NCT04811339|531631146|FG001|Overall Study|Transferred to ICU for non-COVID-19 related problem|1|||
147400835|NCT04811339|531631147|FG002|Overall Study|Transferred to ICU for non-COVID-19 related problem|0|||
147400836|NCT04811339|531631145|FG000|Overall Study|Early on Nurse/Physician communication issue|0|||
147400837|NCT04811339|531631146|FG001|Overall Study|Early on Nurse/Physician communication issue|3|||
147400838|NCT04811339|531631147|FG002|Overall Study|Early on Nurse/Physician communication issue|0|||
147400839|NCT00903760|531632755|FG000|Overall Study|Disease Progression/Death|8|||
147400840|NCT00903760|531632756|FG001|Overall Study|Disease Progression/Death|6|||
147400841|NCT00903760|531632755|FG000|Overall Study|Stem Cell Transplant|8|||
147400842|NCT00903760|531632756|FG001|Overall Study|Stem Cell Transplant|4|||
147400843|NCT00903760|531632755|FG000|Overall Study|Physician Decision|1|||
147400844|NCT00903760|531632756|FG001|Overall Study|Physician Decision|2|||
147400845|NCT00903760|531632755|FG000|Overall Study|Death|0|||
147400846|NCT00903760|531632756|FG001|Overall Study|Death|1|||
147400847|NCT00903760|531632755|FG000|Overall Study|Lost to Follow-up|1|||
147400848|NCT00903760|531632756|FG001|Overall Study|Lost to Follow-up|0|||
147400849|NCT00903760|531632755|FG000|Overall Study|Withdrawal by Subject|1|||
147400850|NCT00903760|531632756|FG001|Overall Study|Withdrawal by Subject|2|||
147400851|NCT00903760|531632755|FG000|Overall Study|Off treatment for long period|0|||
147400852|NCT00903760|531632756|FG001|Overall Study|Off treatment for long period|1|||
147400853|NCT01256671|531632762|FG000|Overall Study|Adverse Event|29|||
147400854|NCT01256671|531632762|FG000|Overall Study|Lost to Follow-up|16|||
147400855|NCT01256671|531632762|FG000|Overall Study|Withdrawal by Subject|31|||
147400856|NCT01256671|531632762|FG000|Overall Study|Physician Decision|3|||
147400857|NCT01256671|531632762|FG000|Overall Study|Lack of Efficacy|4|||
147400858|NCT01256671|531632762|FG000|Overall Study|Non-compliance/Sponsor Decision/Other|12|||
147400859|NCT04411186|531632763|FG000|Overall Study|Withdrawn due to protocol violation|0|||
147400860|NCT04411186|531632764|FG001|Overall Study|Withdrawn due to protocol violation|1|||
147400861|NCT01266018|531632765|FG000|Overall Study|Physician Decision|1|||
147400862|NCT01266018|531632766|FG001|Overall Study|Physician Decision|0|||
147400863|NCT01266018|531632765|FG000|Overall Study|Progressive disease|0|||
147400864|NCT01266018|531632766|FG001|Overall Study|Progressive disease|1|||
147400865|NCT02641587|531632768|FG000|Confinement Period|Adverse Event|1|||
147400866|NCT02641587|531632769|FG001|Confinement Period|Adverse Event|0|||
147400867|NCT02641587|531632768|FG000|Confinement Period|Withdrawal by Subject|2|||
147400868|NCT02641587|531632769|FG001|Confinement Period|Withdrawal by Subject|1|||
147400869|NCT02641587|531632768|FG000|Ambulatory Period|Withdrawal by Subject|1|||
147400870|NCT02641587|531632769|FG001|Ambulatory Period|Withdrawal by Subject|0|||
147400871|NCT01165177|531632770|FG000|Overall Study|Serious Adverse Event|227|||
147400872|NCT01165177|531632771|FG001|Overall Study|Serious Adverse Event|235|||
147400873|NCT01165177|531632770|FG000|Overall Study|Withdrawal by Subject|368|||
147400874|NCT01165177|531632771|FG001|Overall Study|Withdrawal by Subject|354|||
147400875|NCT01165177|531632770|FG000|Overall Study|Protocol Violation|19|||
147400876|NCT01165177|531632771|FG001|Overall Study|Protocol Violation|21|||
147400877|NCT01165177|531632770|FG000|Overall Study|Non-serious adverse event|30|||
147400878|NCT01165177|531632771|FG001|Overall Study|Non-serious adverse event|18|||
147400879|NCT01165177|531632770|FG000|Overall Study|Other unspecified reasons|47|||
147400880|NCT01165177|531632771|FG001|Overall Study|Other unspecified reasons|35|||
147400881|NCT01165177|531632770|FG000|Overall Study|Suspected HZ episode|0|||
147400882|NCT01165177|531632771|FG001|Overall Study|Suspected HZ episode|2|||
147400883|NCT01165177|531632770|FG000|Overall Study|Lost to Follow-up|183|||
147400884|NCT01165177|531632771|FG001|Overall Study|Lost to Follow-up|194|||
147400885|NCT01165177|531632770|FG000|Overall Study|Migrated/ moved from study area|48|||
147400886|NCT01165177|531632771|FG001|Overall Study|Migrated/ moved from study area|43|||
147461656|NCT00110019|531851705|FG000|Overall Study|symptom deterioration|13|||
147665242|NCT00922636|532599515|FG000|Overall Study|Lack of Efficacy|1|||
147461657|NCT00110019|531851706|FG001|Overall Study|symptom deterioration|16|||
147461658|NCT00110019|531851705|FG000|Overall Study|Not start protocol therapy|17|||
147400887|NCT01657799|531632775|FG000|Overall Study|Adverse Event Related to progression|6|||
147400888|NCT01657799|531632776|FG001|Overall Study|Adverse Event Related to progression|8|||
147400889|NCT01657799|531632777|FG002|Overall Study|Adverse Event Related to progression|12|||
147400890|NCT01657799|531632775|FG000|Overall Study|Adverse Event Not Related to Progression|5|||
147400891|NCT01657799|531632776|FG001|Overall Study|Adverse Event Not Related to Progression|4|||
147400892|NCT01657799|531632777|FG002|Overall Study|Adverse Event Not Related to Progression|4|||
147400893|NCT01657799|531632775|FG000|Overall Study|Withdrawal by Subject|13|||
147400894|NCT01657799|531632776|FG001|Overall Study|Withdrawal by Subject|10|||
147400895|NCT01657799|531632777|FG002|Overall Study|Withdrawal by Subject|10|||
147400896|NCT01657799|531632775|FG000|Overall Study|Lost to Follow-up|1|||
147400897|NCT01657799|531632776|FG001|Overall Study|Lost to Follow-up|0|||
147400898|NCT01657799|531632777|FG002|Overall Study|Lost to Follow-up|1|||
147400899|NCT01657799|531632775|FG000|Overall Study|Disease Progression|2|||
147400900|NCT01657799|531632776|FG001|Overall Study|Disease Progression|4|||
147400901|NCT01657799|531632777|FG002|Overall Study|Disease Progression|4|||
147400902|NCT01657799|531632775|FG000|Overall Study|Progressive Disease Clinical|7|||
147400903|NCT01657799|531632776|FG001|Overall Study|Progressive Disease Clinical|4|||
147400904|NCT01657799|531632777|FG002|Overall Study|Progressive Disease Clinical|7|||
147400905|NCT01657799|531632775|FG000|Overall Study|Radiographic & Clinical Progression|16|||
147400906|NCT01657799|531632776|FG001|Overall Study|Radiographic & Clinical Progression|11|||
147400907|NCT01657799|531632777|FG002|Overall Study|Radiographic & Clinical Progression|15|||
147400908|NCT01657799|531632775|FG000|Overall Study|Other|52|||
147400909|NCT01657799|531632776|FG001|Overall Study|Other|62|||
147400910|NCT01657799|531632777|FG002|Overall Study|Other|49|||
147400911|NCT01646385|531632784|FG000|Overall Study|Death|202|||
147400912|NCT01646385|531632785|FG001|Overall Study|Death|222|||
147400913|NCT01646385|531632784|FG000|Overall Study|Switched to alternate biologic|636|||
147400914|NCT01646385|531632785|FG001|Overall Study|Switched to alternate biologic|649|||
147400915|NCT01777334|531632786|FG000|Overall Study|Adverse Event|18|||
147400916|NCT01777334|531632787|FG001|Overall Study|Adverse Event|14|||
147400917|NCT01777334|531632786|FG000|Overall Study|Lack of Efficacy|15|||
147400918|NCT01777334|531632787|FG001|Overall Study|Lack of Efficacy|29|||
147400919|NCT01777334|531632786|FG000|Overall Study|Protocol Violation|3|||
147400920|NCT01777334|531632787|FG001|Overall Study|Protocol Violation|7|||
147400921|NCT01777334|531632786|FG000|Overall Study|Lost to Follow-up|3|||
147400922|NCT01777334|531632787|FG001|Overall Study|Lost to Follow-up|2|||
147400923|NCT01777334|531632786|FG000|Overall Study|Withdrawal by Subject|14|||
147400924|NCT01777334|531632787|FG001|Overall Study|Withdrawal by Subject|11|||
147400925|NCT00727415|531632791|FG000|Phase I|Dose Limiting Toxicity|2|||
147400926|NCT00756457|531632793|FG000|Overall Study|Lost to Follow-up|1|||
147400927|NCT00756457|531632794|FG001|Overall Study|Lost to Follow-up|2|||
147400928|NCT04593823|531632798|FG000|Overall Study|Withdrawal by Subject|1|||
147400929|NCT04593823|531632799|FG001|Overall Study|Withdrawal by Subject|1|||
147400930|NCT04593823|531632798|FG000|Overall Study|Lost to Follow-up|0|||
147400931|NCT04593823|531632799|FG001|Overall Study|Lost to Follow-up|1|||
147400932|NCT05043883|531632800|FG000|Overall Study|Minimum required measurements could not be taken|4|||
147400933|NCT02980705|531632801|FG000|Overall Study|Adverse Event|0|||
147400934|NCT02980705|531632802|FG001|Overall Study|Adverse Event|1|||
147400935|NCT02980705|531632801|FG000|Overall Study|Withdrawal by Subject|6|||
147400936|NCT02980705|531632802|FG001|Overall Study|Withdrawal by Subject|9|||
147400937|NCT02980705|531632801|FG000|Overall Study|withdrew participation|0|||
147400938|NCT02980705|531632802|FG001|Overall Study|withdrew participation|1|||
147400939|NCT02980705|531632801|FG000|Overall Study|Lost to Follow-up|2|||
147400940|NCT02980705|531632802|FG001|Overall Study|Lost to Follow-up|0|||
147400941|NCT00263575|531632803|FG000|Titration Period|Adverse Event|14|||
147400942|NCT00263575|531632803|FG000|Titration Period|Withdrawal by Subject|10|||
147400943|NCT00263575|531632803|FG000|Titration Period|Protocol Violation|9|||
147400944|NCT00263575|531632803|FG000|Titration Period|Sponsor Decision|2|||
147400945|NCT00263575|531632803|FG000|Titration Period|Other|2|||
147400946|NCT00263575|531632803|FG000|Titration Period|Lack of Efficacy|6|||
147400947|NCT00263575|531632803|FG000|Maintence Period|Adverse Event|23|||
147400948|NCT00263575|531632803|FG000|Maintence Period|Withdrawal by Subject|8|||
147400949|NCT00263575|531632803|FG000|Maintence Period|Protocol Violation|4|||
147400950|NCT00263575|531632803|FG000|Maintence Period|Lack of Efficacy|4|||
147400951|NCT00263575|531632803|FG000|Maintence Period|Physician Decision|6|||
147665243|NCT00922636|532599516|FG001|Overall Study|Lack of Efficacy|7|||
147665244|NCT00922636|532599517|FG002|Overall Study|Lack of Efficacy|3|||
147400952|NCT00263575|531632803|FG000|Maintence Period|Lost to Follow-up|1|||
147400953|NCT00263575|531632803|FG000|Maintence Period|Sponsor Decision|24|||
147400954|NCT00263575|531632803|FG000|Maintence Period|Other|7|||
147400955|NCT00537329|531632804|FG000|Overall Study|Death|10|||
147400956|NCT00537329|531632804|FG000|Overall Study|Adverse Event|3|||
147400957|NCT00537329|531632804|FG000|Overall Study|Lack of Efficacy|2|||
147400958|NCT00537329|531632804|FG000|Overall Study|Lost to Follow-up|6|||
147400959|NCT00537329|531632804|FG000|Overall Study|Withdrawal by Subject|4|||
147665245|NCT00922636|532599518|FG003|Overall Study|Lack of Efficacy|2|||
147400960|NCT00537329|531632804|FG000|Overall Study|Other|1|||
147461659|NCT00110019|531851706|FG001|Overall Study|Not start protocol therapy|16|||
147461660|NCT00110019|531851705|FG000|Overall Study|other reasons|22|||
147461661|NCT00110019|531851706|FG001|Overall Study|other reasons|30|||
147461662|NCT01046695|531851709|FG000|Overall Study|Subject had a pacemaker|0|||
147461663|NCT01046695|531851710|FG001|Overall Study|Subject had a pacemaker|1|||
147461664|NCT01046695|531851709|FG000|Overall Study|TENS interfered with the cardiac monitor|0|||
147461665|NCT01046695|531851710|FG001|Overall Study|TENS interfered with the cardiac monitor|1|||
147461666|NCT02239263|531851711|FG000|Overall Study|Protocol Violation|6|||
147461667|NCT04426695|531851712|FG000|Overall Study|Death|2|||
147461668|NCT04426695|531851713|FG001|Overall Study|Death|0|||
147461669|NCT04426695|531851714|FG002|Overall Study|Death|1|||
147461670|NCT04426695|531851715|FG003|Overall Study|Death|27|||
147461671|NCT04426695|531851716|FG004|Overall Study|Death|25|||
147461672|NCT04426695|531851717|FG005|Overall Study|Death|21|||
147461673|NCT04426695|531851718|FG006|Overall Study|Death|42|||
147461674|NCT04426695|531851719|FG007|Overall Study|Death|23|||
147461675|NCT04426695|531851720|FG008|Overall Study|Death|37|||
147461676|NCT04426695|531851721|FG009|Overall Study|Death|14|||
147461677|NCT04426695|531851722|FG010|Overall Study|Death|8|||
147461678|NCT04426695|531851723|FG011|Overall Study|Death|7|||
147461679|NCT04426695|531851724|FG012|Overall Study|Death|13|||
147461680|NCT04426695|531851725|FG013|Overall Study|Death|25|||
147461681|NCT04426695|531851726|FG014|Overall Study|Death|19|||
147461682|NCT04426695|531851727|FG015|Overall Study|Death|7|||
147461683|NCT04426695|531851728|FG016|Overall Study|Death|8|||
147461684|NCT04426695|531851729|FG017|Overall Study|Death|4|||
147461685|NCT04426695|531851712|FG000|Overall Study|Lost to Follow-up|2|||
147461686|NCT04426695|531851713|FG001|Overall Study|Lost to Follow-up|4|||
147461687|NCT04426695|531851714|FG002|Overall Study|Lost to Follow-up|1|||
147461688|NCT04426695|531851715|FG003|Overall Study|Lost to Follow-up|19|||
147461689|NCT04426695|531851716|FG004|Overall Study|Lost to Follow-up|10|||
147461690|NCT04426695|531851717|FG005|Overall Study|Lost to Follow-up|14|||
147461691|NCT04426695|531851718|FG006|Overall Study|Lost to Follow-up|5|||
147461692|NCT04426695|531851719|FG007|Overall Study|Lost to Follow-up|14|||
147461693|NCT04426695|531851720|FG008|Overall Study|Lost to Follow-up|10|||
147461694|NCT04426695|531851721|FG009|Overall Study|Lost to Follow-up|11|||
147461695|NCT04426695|531851722|FG010|Overall Study|Lost to Follow-up|12|||
147461696|NCT04426695|531851723|FG011|Overall Study|Lost to Follow-up|6|||
147461697|NCT04426695|531851724|FG012|Overall Study|Lost to Follow-up|2|||
147461698|NCT04426695|531851725|FG013|Overall Study|Lost to Follow-up|2|||
147461699|NCT04426695|531851726|FG014|Overall Study|Lost to Follow-up|2|||
147461700|NCT04426695|531851727|FG015|Overall Study|Lost to Follow-up|0|||
147461701|NCT04426695|531851728|FG016|Overall Study|Lost to Follow-up|0|||
147461702|NCT04426695|531851729|FG017|Overall Study|Lost to Follow-up|0|||
147461703|NCT04426695|531851712|FG000|Overall Study|Participant Decision|1|||
147461704|NCT04426695|531851713|FG001|Overall Study|Participant Decision|2|||
147461705|NCT04426695|531851714|FG002|Overall Study|Participant Decision|2|||
147400961|NCT03599622|531632807|FG000|Pre-Treatment Period|Withdrawal by Subject|0|||
147400962|NCT03599622|531632808|FG001|Pre-Treatment Period|Withdrawal by Subject|1|||
147400963|NCT03599622|531632809|FG002|Pre-Treatment Period|Withdrawal by Subject|0|||
147400964|NCT03599622|531632810|FG003|Pre-Treatment Period|Withdrawal by Subject|0|||
147400965|NCT03599622|531632807|FG000|Pre-Treatment Period|Other reasons|1|||
147400966|NCT03599622|531632808|FG001|Pre-Treatment Period|Other reasons|1|||
147400967|NCT03599622|531632809|FG002|Pre-Treatment Period|Other reasons|1|||
147400968|NCT03599622|531632810|FG003|Pre-Treatment Period|Other reasons|0|||
147400969|NCT03599622|531632807|FG000|Treatment Period|Adverse Event|11|||
147400970|NCT03599622|531632808|FG001|Treatment Period|Adverse Event|20|||
147400971|NCT03599622|531632809|FG002|Treatment Period|Adverse Event|18|||
147400972|NCT03599622|531632810|FG003|Treatment Period|Adverse Event|2|||
147400973|NCT03599622|531632807|FG000|Treatment Period|Lack of Efficacy|18|||
147400974|NCT03599622|531632808|FG001|Treatment Period|Lack of Efficacy|12|||
147400975|NCT03599622|531632809|FG002|Treatment Period|Lack of Efficacy|13|||
147400976|NCT03599622|531632810|FG003|Treatment Period|Lack of Efficacy|2|||
147461706|NCT04426695|531851715|FG003|Overall Study|Participant Decision|12|||
147461707|NCT04426695|531851716|FG004|Overall Study|Participant Decision|18|||
147461708|NCT04426695|531851717|FG005|Overall Study|Participant Decision|22|||
147461709|NCT04426695|531851718|FG006|Overall Study|Participant Decision|13|||
147461710|NCT04426695|531851719|FG007|Overall Study|Participant Decision|13|||
147461711|NCT04426695|531851720|FG008|Overall Study|Participant Decision|10|||
147461712|NCT04426695|531851721|FG009|Overall Study|Participant Decision|15|||
147461713|NCT04426695|531851722|FG010|Overall Study|Participant Decision|16|||
147461714|NCT04426695|531851723|FG011|Overall Study|Participant Decision|17|||
147461715|NCT04426695|531851724|FG012|Overall Study|Participant Decision|2|||
147461716|NCT04426695|531851725|FG013|Overall Study|Participant Decision|1|||
147461717|NCT04426695|531851726|FG014|Overall Study|Participant Decision|2|||
147461718|NCT04426695|531851727|FG015|Overall Study|Participant Decision|0|||
147461719|NCT04426695|531851728|FG016|Overall Study|Participant Decision|0|||
147461720|NCT04426695|531851729|FG017|Overall Study|Participant Decision|0|||
147461721|NCT04426695|531851712|FG000|Overall Study|Adverse Event|0|||
147461722|NCT04426695|531851713|FG001|Overall Study|Adverse Event|0|||
147461723|NCT04426695|531851714|FG002|Overall Study|Adverse Event|0|||
147461724|NCT04426695|531851715|FG003|Overall Study|Adverse Event|0|||
147461725|NCT04426695|531851716|FG004|Overall Study|Adverse Event|0|||
147461726|NCT04426695|531851717|FG005|Overall Study|Adverse Event|0|||
147461727|NCT04426695|531851718|FG006|Overall Study|Adverse Event|0|||
147461728|NCT04426695|531851719|FG007|Overall Study|Adverse Event|1|||
147461729|NCT04426695|531851720|FG008|Overall Study|Adverse Event|0|||
147461730|NCT04426695|531851721|FG009|Overall Study|Adverse Event|0|||
147461731|NCT04426695|531851722|FG010|Overall Study|Adverse Event|1|||
147461732|NCT04426695|531851723|FG011|Overall Study|Adverse Event|1|||
147461733|NCT04426695|531851724|FG012|Overall Study|Adverse Event|0|||
147461734|NCT04426695|531851725|FG013|Overall Study|Adverse Event|0|||
147461735|NCT04426695|531851726|FG014|Overall Study|Adverse Event|0|||
147461736|NCT04426695|531851727|FG015|Overall Study|Adverse Event|0|||
147461737|NCT04426695|531851728|FG016|Overall Study|Adverse Event|0|||
147461738|NCT04426695|531851729|FG017|Overall Study|Adverse Event|0|||
147461739|NCT04426695|531851712|FG000|Overall Study|Sponsor Request|0|||
147461740|NCT04426695|531851713|FG001|Overall Study|Sponsor Request|0|||
147461741|NCT04426695|531851714|FG002|Overall Study|Sponsor Request|0|||
147461742|NCT04426695|531851715|FG003|Overall Study|Sponsor Request|0|||
147461743|NCT04426695|531851716|FG004|Overall Study|Sponsor Request|0|||
147461744|NCT04426695|531851717|FG005|Overall Study|Sponsor Request|0|||
147461745|NCT04426695|531851718|FG006|Overall Study|Sponsor Request|1|||
147461746|NCT04426695|531851719|FG007|Overall Study|Sponsor Request|0|||
147461747|NCT04426695|531851720|FG008|Overall Study|Sponsor Request|0|||
147461748|NCT04426695|531851721|FG009|Overall Study|Sponsor Request|0|||
147461749|NCT04426695|531851722|FG010|Overall Study|Sponsor Request|0|||
147461750|NCT04426695|531851723|FG011|Overall Study|Sponsor Request|0|||
147461751|NCT04426695|531851724|FG012|Overall Study|Sponsor Request|0|||
147461752|NCT04426695|531851725|FG013|Overall Study|Sponsor Request|0|||
147461753|NCT04426695|531851726|FG014|Overall Study|Sponsor Request|0|||
147400977|NCT03599622|531632807|FG000|Treatment Period|Withdrawal by Subject|5|||
147400978|NCT03599622|531632808|FG001|Treatment Period|Withdrawal by Subject|11|||
147400979|NCT03599622|531632809|FG002|Treatment Period|Withdrawal by Subject|16|||
147400980|NCT03599622|531632810|FG003|Treatment Period|Withdrawal by Subject|1|||
147400981|NCT03599622|531632807|FG000|Treatment Period|Other reasons|4|||
147400982|NCT03599622|531632808|FG001|Treatment Period|Other reasons|6|||
147400983|NCT03599622|531632809|FG002|Treatment Period|Other reasons|7|||
147400984|NCT03599622|531632810|FG003|Treatment Period|Other reasons|0|||
147400985|NCT03599622|531632807|FG000|Treatment Period|Lost to Follow-up|1|||
147400986|NCT03599622|531632808|FG001|Treatment Period|Lost to Follow-up|0|||
147400987|NCT03599622|531632809|FG002|Treatment Period|Lost to Follow-up|0|||
147400988|NCT03599622|531632810|FG003|Treatment Period|Lost to Follow-up|0|||
147400989|NCT03599622|531632807|FG000|Treatment Period|Study terminated by sponsor|7|||
147400990|NCT03599622|531632808|FG001|Treatment Period|Study terminated by sponsor|20|||
147400991|NCT03599622|531632809|FG002|Treatment Period|Study terminated by sponsor|15|||
147400992|NCT03599622|531632810|FG003|Treatment Period|Study terminated by sponsor|0|||
147400993|NCT03599622|531632807|FG000|Treatment Period|Site terminated by sponsor|0|||
147400994|NCT03599622|531632808|FG001|Treatment Period|Site terminated by sponsor|1|||
147400995|NCT03599622|531632809|FG002|Treatment Period|Site terminated by sponsor|0|||
147400996|NCT03599622|531632810|FG003|Treatment Period|Site terminated by sponsor|0|||
147400997|NCT01278615|531632813|FG000|Overall Study|Withdrawal by Subject|2|||
147400998|NCT00905359|531632814|FG000|Overall Study|Lost to Follow-up|17|||
147400999|NCT00905359|531632815|FG001|Overall Study|Lost to Follow-up|10|||
147401000|NCT00905359|531632814|FG000|Overall Study|Death|2|||
147461754|NCT04426695|531851727|FG015|Overall Study|Sponsor Request|0|||
147461755|NCT04426695|531851728|FG016|Overall Study|Sponsor Request|0|||
147461756|NCT04426695|531851729|FG017|Overall Study|Sponsor Request|0|||
147461757|NCT04426695|531851712|FG000|Overall Study|Physician Decision|0|||
147461758|NCT04426695|531851713|FG001|Overall Study|Physician Decision|0|||
147461759|NCT04426695|531851714|FG002|Overall Study|Physician Decision|0|||
147461760|NCT04426695|531851715|FG003|Overall Study|Physician Decision|0|||
147461761|NCT04426695|531851716|FG004|Overall Study|Physician Decision|0|||
147665246|NCT00922636|532599519|FG004|Overall Study|Lack of Efficacy|4|||
147401001|NCT00905359|531632815|FG001|Overall Study|Death|0|||
147401002|NCT00905359|531632814|FG000|Overall Study|Withdrawal consent|5|||
147401003|NCT00905359|531632815|FG001|Overall Study|Withdrawal consent|6|||
147401004|NCT02138253|531632816|FG000|Overall Study|Adverse Event|3|||
147401005|NCT02138253|531632817|FG001|Overall Study|Adverse Event|3|||
147461762|NCT04426695|531851717|FG005|Overall Study|Physician Decision|0|||
147461763|NCT04426695|531851718|FG006|Overall Study|Physician Decision|0|||
147461764|NCT04426695|531851719|FG007|Overall Study|Physician Decision|0|||
147461765|NCT04426695|531851720|FG008|Overall Study|Physician Decision|0|||
147461766|NCT04426695|531851721|FG009|Overall Study|Physician Decision|1|||
147461767|NCT04426695|531851722|FG010|Overall Study|Physician Decision|0|||
147461768|NCT04426695|531851723|FG011|Overall Study|Physician Decision|0|||
147461769|NCT04426695|531851724|FG012|Overall Study|Physician Decision|1|||
147461770|NCT04426695|531851725|FG013|Overall Study|Physician Decision|0|||
147461771|NCT04426695|531851726|FG014|Overall Study|Physician Decision|0|||
147401006|NCT02138253|531632816|FG000|Overall Study|Lost to Follow-up|2|||
147401007|NCT02138253|531632817|FG001|Overall Study|Lost to Follow-up|1|||
147401008|NCT02138253|531632816|FG000|Overall Study|Physician Decision|2|||
147401009|NCT02138253|531632817|FG001|Overall Study|Physician Decision|0|||
147401010|NCT02138253|531632816|FG000|Overall Study|Non compliance|1|||
147401011|NCT02138253|531632817|FG001|Overall Study|Non compliance|0|||
147401012|NCT02138253|531632816|FG000|Overall Study|Withdrawal by Subject|1|||
147401013|NCT02138253|531632817|FG001|Overall Study|Withdrawal by Subject|0|||
147401014|NCT01918371|531632818|FG000|Overall Study|Missing Data|1|||
147401015|NCT01918371|531632819|FG001|Overall Study|Missing Data|1|||
147401016|NCT01006889|531632820|FG000|Overall Study|Withdrawal by Subject|3|||
147401017|NCT00243022|531632821|FG000|Overall Study|Withdrawal by Subject|1|||
147401018|NCT00243022|531632822|FG001|Overall Study|Withdrawal by Subject|0|||
147401019|NCT00243022|531632821|FG000|Overall Study|Death|1|||
147401020|NCT00243022|531632822|FG001|Overall Study|Death|0|||
147401021|NCT00243022|531632821|FG000|Overall Study|Difficult Travel Distance|0|||
147401022|NCT00243022|531632822|FG001|Overall Study|Difficult Travel Distance|1|||
147401023|NCT01390441|531632827|FG000|Treatment Period|Protocol Violation|0|||
147401024|NCT01390441|531632828|FG001|Treatment Period|Protocol Violation|1|||
147401025|NCT01390441|531632829|FG002|Treatment Period|Protocol Violation|0|||
147401026|NCT01390441|531632830|FG003|Treatment Period|Protocol Violation|0|||
147401027|NCT01390441|531632831|FG004|Treatment Period|Protocol Violation|0|||
147401028|NCT01390441|531632827|FG000|Treatment Period|Physician Decision|0|||
147401029|NCT01390441|531632828|FG001|Treatment Period|Physician Decision|0|||
147401030|NCT01390441|531632829|FG002|Treatment Period|Physician Decision|0|||
147401031|NCT01390441|531632830|FG003|Treatment Period|Physician Decision|1|||
147401032|NCT01390441|531632831|FG004|Treatment Period|Physician Decision|0|||
147401033|NCT01390441|531632827|FG000|Treatment Period|Lack of Efficacy|0|||
147401034|NCT01390441|531632828|FG001|Treatment Period|Lack of Efficacy|0|||
147401035|NCT01390441|531632829|FG002|Treatment Period|Lack of Efficacy|0|||
147401036|NCT01390441|531632830|FG003|Treatment Period|Lack of Efficacy|0|||
147401037|NCT01390441|531632831|FG004|Treatment Period|Lack of Efficacy|1|||
147401038|NCT01390441|531632827|FG000|Treatment Period|Unknown due to early stopping of study|0|||
147401039|NCT01390441|531632828|FG001|Treatment Period|Unknown due to early stopping of study|0|||
147401040|NCT01390441|531632829|FG002|Treatment Period|Unknown due to early stopping of study|8|||
147401041|NCT01390441|531632830|FG003|Treatment Period|Unknown due to early stopping of study|11|||
147401042|NCT01390441|531632831|FG004|Treatment Period|Unknown due to early stopping of study|7|||
147401043|NCT01390441|531632827|FG000|Treatment Period|Adverse Event|0|||
147401044|NCT01390441|531632828|FG001|Treatment Period|Adverse Event|0|||
147401045|NCT01390441|531632829|FG002|Treatment Period|Adverse Event|1|||
147401046|NCT01390441|531632830|FG003|Treatment Period|Adverse Event|1|||
147401047|NCT01390441|531632831|FG004|Treatment Period|Adverse Event|2|||
147401048|NCT01390441|531632827|FG000|Treatment Period|Withdrawal by Subject|0|||
147401049|NCT01390441|531632828|FG001|Treatment Period|Withdrawal by Subject|0|||
147401050|NCT01390441|531632829|FG002|Treatment Period|Withdrawal by Subject|1|||
147401051|NCT01390441|531632830|FG003|Treatment Period|Withdrawal by Subject|0|||
147401052|NCT01390441|531632831|FG004|Treatment Period|Withdrawal by Subject|1|||
147401053|NCT01390441|531632827|FG000|Treatment Period|Lost to Follow-up|1|||
147401054|NCT01390441|531632828|FG001|Treatment Period|Lost to Follow-up|0|||
147401055|NCT01390441|531632829|FG002|Treatment Period|Lost to Follow-up|0|||
147401056|NCT01390441|531632830|FG003|Treatment Period|Lost to Follow-up|0|||
147401057|NCT01390441|531632831|FG004|Treatment Period|Lost to Follow-up|0|||
147401058|NCT01390441|531632827|FG000|Extension Period|Protocol Violation|3|||
147401059|NCT01390441|531632828|FG001|Extension Period|Protocol Violation|1|||
147401060|NCT01390441|531632829|FG002|Extension Period|Protocol Violation|0|||
147401061|NCT01390441|531632830|FG003|Extension Period|Protocol Violation|1|||
147401062|NCT01390441|531632831|FG004|Extension Period|Protocol Violation|0|||
147401063|NCT00621192|531632832|FG000|Overall Study|Withdrawal by Subject|0|||
147401064|NCT00621192|531632833|FG001|Overall Study|Withdrawal by Subject|0|||
147401065|NCT00621192|531632834|FG002|Overall Study|Withdrawal by Subject|2|||
147401066|NCT00621192|531632835|FG003|Overall Study|Withdrawal by Subject|0|||
147401067|NCT00621192|531632832|FG000|Overall Study|Physician Decision|1|||
147401068|NCT00621192|531632833|FG001|Overall Study|Physician Decision|3|||
147401069|NCT00621192|531632834|FG002|Overall Study|Physician Decision|0|||
147401070|NCT00621192|531632835|FG003|Overall Study|Physician Decision|0|||
147401071|NCT00621192|531632832|FG000|Overall Study|Protocol Violation|1|||
147401072|NCT00621192|531632833|FG001|Overall Study|Protocol Violation|0|||
147401073|NCT00621192|531632834|FG002|Overall Study|Protocol Violation|0|||
147401074|NCT00621192|531632835|FG003|Overall Study|Protocol Violation|1|||
147401075|NCT00621192|531632832|FG000|Overall Study|Adverse Event|0|||
147401076|NCT00621192|531632833|FG001|Overall Study|Adverse Event|1|||
147401077|NCT00621192|531632834|FG002|Overall Study|Adverse Event|0|||
147401078|NCT00621192|531632835|FG003|Overall Study|Adverse Event|1|||
147401079|NCT00621192|531632832|FG000|Overall Study|Death|2|||
147401080|NCT00621192|531632833|FG001|Overall Study|Death|5|||
147401081|NCT00621192|531632834|FG002|Overall Study|Death|0|||
147401082|NCT00621192|531632835|FG003|Overall Study|Death|0|||
147461772|NCT04426695|531851727|FG015|Overall Study|Physician Decision|0|||
147461773|NCT04426695|531851728|FG016|Overall Study|Physician Decision|0|||
147461774|NCT04426695|531851729|FG017|Overall Study|Physician Decision|0|||
147461775|NCT04426695|531851712|FG000|Overall Study|Randomized but Never Treated|3|||
147461776|NCT04426695|531851713|FG001|Overall Study|Randomized but Never Treated|1|||
147461777|NCT04426695|531851714|FG002|Overall Study|Randomized but Never Treated|0|||
147461778|NCT04426695|531851715|FG003|Overall Study|Randomized but Never Treated|4|||
147461779|NCT04426695|531851716|FG004|Overall Study|Randomized but Never Treated|5|||
147461780|NCT04426695|531851717|FG005|Overall Study|Randomized but Never Treated|5|||
147461781|NCT04426695|531851718|FG006|Overall Study|Randomized but Never Treated|4|||
147461782|NCT04426695|531851719|FG007|Overall Study|Randomized but Never Treated|6|||
147461783|NCT04426695|531851720|FG008|Overall Study|Randomized but Never Treated|6|||
147461784|NCT04426695|531851721|FG009|Overall Study|Randomized but Never Treated|3|||
147461785|NCT04426695|531851722|FG010|Overall Study|Randomized but Never Treated|3|||
147461786|NCT04426695|531851723|FG011|Overall Study|Randomized but Never Treated|6|||
147461787|NCT04426695|531851724|FG012|Overall Study|Randomized but Never Treated|1|||
147461788|NCT04426695|531851725|FG013|Overall Study|Randomized but Never Treated|2|||
147461789|NCT04426695|531851726|FG014|Overall Study|Randomized but Never Treated|0|||
147461790|NCT04426695|531851727|FG015|Overall Study|Randomized but Never Treated|0|||
147461791|NCT04426695|531851728|FG016|Overall Study|Randomized but Never Treated|0|||
147461792|NCT04426695|531851729|FG017|Overall Study|Randomized but Never Treated|0|||
147461793|NCT04303000|531851730|FG000|Opioid Use Questionnaire|Withdrawal by Subject|15|||
147461794|NCT04303000|531851731|FG001|Opioid Use Questionnaire|Withdrawal by Subject|0|||
147461795|NCT04303000|531851732|FG002|Opioid Use Questionnaire|Withdrawal by Subject|0|||
147461796|NCT04276207|531851734|FG000|Period 1|Withdrawal by Subject|0|||
147461797|NCT04276207|531851735|FG001|Period 1|Withdrawal by Subject|1|||
147461798|NCT05655377|531851736|FG000|Overall Study|Withdrawal by Subject|2|||
147461799|NCT01256177|531851737|FG000|Overall Study|Withdrawal by Subject|23|||
147461800|NCT01256177|531851738|FG001|Overall Study|Withdrawal by Subject|22|||
147461801|NCT01256177|531851737|FG000|Overall Study|Lost to Follow-up|2|||
147461802|NCT01256177|531851738|FG001|Overall Study|Lost to Follow-up|2|||
147461803|NCT01256177|531851737|FG000|Overall Study|Adverse Event|8|||
147461804|NCT01256177|531851738|FG001|Overall Study|Adverse Event|9|||
147461805|NCT01256177|531851737|FG000|Overall Study|Severe Non-Compliance to Protocol|4|||
147461806|NCT01256177|531851738|FG001|Overall Study|Severe Non-Compliance to Protocol|2|||
147461807|NCT01256177|531851737|FG000|Overall Study|Condition under Investigation Worsened|1|||
147461808|NCT01256177|531851738|FG001|Overall Study|Condition under Investigation Worsened|0|||
147461809|NCT01256177|531851737|FG000|Overall Study|Lack of Efficacy|11|||
147461810|NCT01256177|531851738|FG001|Overall Study|Lack of Efficacy|2|||
147461811|NCT01256177|531851737|FG000|Overall Study|TG=593mg/dL, not fit to participate.|1|||
147461812|NCT01256177|531851738|FG001|Overall Study|TG=593mg/dL, not fit to participate.|0|||
147461813|NCT03118947|531851739|FG000|Overall Study|Adverse Event|7|||
147461814|NCT03118947|531851739|FG000|Overall Study|Death|3|||
147461815|NCT03118947|531851739|FG000|Overall Study|Lack of Efficacy|4|||
147461816|NCT03118947|531851739|FG000|Overall Study|Non-compliance with study drug|1|||
147461817|NCT03118947|531851739|FG000|Overall Study|Protocol Violation|2|||
147461818|NCT03118947|531851739|FG000|Overall Study|Withdrawal by Subject|3|||
147461819|NCT03118947|531851739|FG000|Overall Study|Withdrawal by caregiver|3|||
147461820|NCT03118947|531851739|FG000|Overall Study|Change in patient's living situation|4|||
147461821|NCT03118947|531851739|FG000|Overall Study|Lost to Follow-up|2|||
147461822|NCT03653390|531851740|FG000|Overall Study|Lost to Follow-up|12|||
147615517|NCT05221320|532408996|FG005|Overall Study|Lack of Efficacy|0|||
147615518|NCT05221320|532408991|FG000|Overall Study|Physician Decision|1|||
147615519|NCT05221320|532408992|FG001|Overall Study|Physician Decision|0|||
147615520|NCT05221320|532408993|FG002|Overall Study|Physician Decision|3|||
147615521|NCT05221320|532408994|FG003|Overall Study|Physician Decision|1|||
147401083|NCT00621192|531632832|FG000|Overall Study|Final Assessments not Completed|0|||
147401084|NCT00621192|531632833|FG001|Overall Study|Final Assessments not Completed|0|||
147401085|NCT00621192|531632834|FG002|Overall Study|Final Assessments not Completed|3|||
147401086|NCT00621192|531632835|FG003|Overall Study|Final Assessments not Completed|1|||
147401087|NCT04706793|531632836|FG000|Treatment|Disease worsening|10|||
147401088|NCT04706793|531632837|FG001|Treatment|Disease worsening|10|||
147401089|NCT04706793|531632836|FG000|Follow-up|Lack of Efficacy|1|||
147401090|NCT04706793|531632837|FG001|Follow-up|Lack of Efficacy|0|||
147401091|NCT04706793|531632836|FG000|Follow-up|Disease worsening|8|||
147401092|NCT04706793|531632837|FG001|Follow-up|Disease worsening|10|||
147401093|NCT04706793|531632836|FG000|Follow-up|Adverse Event|1|||
147401094|NCT04706793|531632837|FG001|Follow-up|Adverse Event|0|||
147401095|NCT00823836|531632840|FG000|NV and PR/XR Switching Phases|Adverse Event|22|||
147401096|NCT00823836|531632841|FG001|NV and PR/XR Switching Phases|Adverse Event|21|||
147401097|NCT00823836|531632840|FG000|NV and PR/XR Switching Phases|Protocol Violation|1|||
147401098|NCT00823836|531632841|FG001|NV and PR/XR Switching Phases|Protocol Violation|1|||
147401099|NCT00823836|531632840|FG000|NV and PR/XR Switching Phases|Physician Decision|5|||
147401100|NCT00823836|531632841|FG001|NV and PR/XR Switching Phases|Physician Decision|2|||
147401101|NCT00823836|531632840|FG000|NV and PR/XR Switching Phases|Withdrawal by Subject|4|||
147461823|NCT03653390|531851741|FG001|Overall Study|Lost to Follow-up|8|||
147461824|NCT03653390|531851742|FG002|Overall Study|Lost to Follow-up|7|||
147461825|NCT03653390|531851740|FG000|Overall Study|Withdrawal by Subject|6|||
147461826|NCT03653390|531851741|FG001|Overall Study|Withdrawal by Subject|1|||
147461827|NCT03653390|531851742|FG002|Overall Study|Withdrawal by Subject|1|||
147461828|NCT03653390|531851740|FG000|Overall Study|Death|1|||
147461829|NCT03653390|531851741|FG001|Overall Study|Death|0|||
147461830|NCT03653390|531851742|FG002|Overall Study|Death|0|||
147461831|NCT03653390|531851740|FG000|Overall Study|Paper Survey Lost|1|||
147461832|NCT03653390|531851741|FG001|Overall Study|Paper Survey Lost|0|||
147461833|NCT03653390|531851742|FG002|Overall Study|Paper Survey Lost|0|||
147461834|NCT04451330|531851745|FG000|Overall Study|Adverse Event|1|||
147461835|NCT04451330|531851746|FG001|Overall Study|Adverse Event|2|||
147461836|NCT04451330|531851745|FG000|Overall Study|Lost to Follow-up|5|||
147461837|NCT04451330|531851746|FG001|Overall Study|Lost to Follow-up|0|||
147461838|NCT04451330|531851745|FG000|Overall Study|Withdrawal by Subject|3|||
147461839|NCT04451330|531851746|FG001|Overall Study|Withdrawal by Subject|1|||
147461840|NCT04451330|531851745|FG000|Overall Study|Withdrawal by parent/guardian|1|||
147461841|NCT04451330|531851746|FG001|Overall Study|Withdrawal by parent/guardian|0|||
147461842|NCT04451330|531851745|FG000|Overall Study|Other than specified|0|||
147461843|NCT04451330|531851746|FG001|Overall Study|Other than specified|1|||
147461844|NCT00849667|531851747|FG000|Overall Study|Withdrawal by Subject|16|||
147461845|NCT00849667|531851748|FG001|Overall Study|Withdrawal by Subject|33|||
147461846|NCT00849667|531851749|FG002|Overall Study|Withdrawal by Subject|35|||
147461847|NCT00849667|531851747|FG000|Overall Study|Lost to Follow-up|8|||
147461848|NCT00849667|531851748|FG001|Overall Study|Lost to Follow-up|8|||
147461849|NCT00849667|531851749|FG002|Overall Study|Lost to Follow-up|8|||
147461850|NCT00849667|531851747|FG000|Overall Study|Adverse Event|1|||
147461851|NCT00849667|531851748|FG001|Overall Study|Adverse Event|2|||
147461852|NCT00849667|531851749|FG002|Overall Study|Adverse Event|0|||
147461853|NCT00849667|531851747|FG000|Overall Study|Other|18|||
147461854|NCT00849667|531851748|FG001|Overall Study|Other|19|||
147461855|NCT00849667|531851749|FG002|Overall Study|Other|18|||
147461856|NCT00849667|531851747|FG000|Overall Study|Progressive disease|119|||
147461857|NCT00849667|531851748|FG001|Overall Study|Progressive disease|100|||
147461858|NCT00849667|531851749|FG002|Overall Study|Progressive disease|112|||
147461859|NCT00849667|531851747|FG000|Overall Study|Sponsor decision|208|||
147461860|NCT00849667|531851748|FG001|Overall Study|Sponsor decision|204|||
147461861|NCT00849667|531851749|FG002|Overall Study|Sponsor decision|190|||
147461862|NCT00849667|531851747|FG000|Overall Study|Investigator discretion|0|||
147461863|NCT00849667|531851748|FG001|Overall Study|Investigator discretion|0|||
147461864|NCT00849667|531851749|FG002|Overall Study|Investigator discretion|1|||
147461865|NCT00189462|531851753|FG000|Overall Study|Lack of Efficacy|5|||
147461866|NCT00189462|531851754|FG001|Overall Study|Lack of Efficacy|1|||
147461867|NCT00189462|531851753|FG000|Overall Study|Lost to Follow-up|18|||
147401102|NCT00823836|531632841|FG001|NV and PR/XR Switching Phases|Withdrawal by Subject|5|||
147401103|NCT00823836|531632840|FG000|Long-term Phase|Adverse Event|3|||
147401104|NCT00823836|531632841|FG001|Long-term Phase|Adverse Event|2|||
147401105|NCT00823836|531632840|FG000|Long-term Phase|Physician Decision|1|||
147401106|NCT00823836|531632841|FG001|Long-term Phase|Physician Decision|2|||
147401107|NCT00823836|531632840|FG000|Long-term Phase|Withdrawal by Subject|1|||
147401108|NCT00823836|531632841|FG001|Long-term Phase|Withdrawal by Subject|1|||
147401109|NCT01099579|531632842|FG000|Stage 1 (ATV Powder Formulation)|Adverse Event|4|||
147401110|NCT01099579|531632843|FG001|Stage 1 (ATV Powder Formulation)|Adverse Event|1|||
147401111|NCT01099579|531632844|FG002|Stage 1 (ATV Powder Formulation)|Adverse Event|0|||
147401112|NCT01099579|531632842|FG000|Stage 1 (ATV Powder Formulation)|Withdrawal by Subject|0|||
147401113|NCT01099579|531632843|FG001|Stage 1 (ATV Powder Formulation)|Withdrawal by Subject|0|||
147401114|NCT01099579|531632844|FG002|Stage 1 (ATV Powder Formulation)|Withdrawal by Subject|1|||
147401115|NCT01099579|531632842|FG000|Stage 1 (ATV Powder Formulation)|Lack of Efficacy|0|||
147401116|NCT01099579|531632843|FG001|Stage 1 (ATV Powder Formulation)|Lack of Efficacy|2|||
147401117|NCT01099579|531632844|FG002|Stage 1 (ATV Powder Formulation)|Lack of Efficacy|0|||
147401118|NCT01099579|531632842|FG000|Stage 1 (ATV Powder Formulation)|Poor compliance/noncompliance|0|||
147401119|NCT01099579|531632843|FG001|Stage 1 (ATV Powder Formulation)|Poor compliance/noncompliance|2|||
147401120|NCT01099579|531632844|FG002|Stage 1 (ATV Powder Formulation)|Poor compliance/noncompliance|0|||
147401121|NCT01099579|531632842|FG000|Stage 2 (ATV Capsule)|No longer met study criteria|2|||
147401122|NCT01099579|531632843|FG001|Stage 2 (ATV Capsule)|No longer met study criteria|2|||
147401123|NCT01099579|531632844|FG002|Stage 2 (ATV Capsule)|No longer met study criteria|1|||
147401124|NCT01099579|531632842|FG000|Stage 2 (ATV Capsule)|Lost to Follow-up|1|||
147461868|NCT00189462|531851754|FG001|Overall Study|Lost to Follow-up|20|||
147461869|NCT00553462|531851757|FG000|Overall Study|Adverse Event|4|||
147461870|NCT00553462|531851757|FG000|Overall Study|Progression|4|||
147461871|NCT00553462|531851757|FG000|Overall Study|Withdrawal by Subject|5|||
147461872|NCT00553462|531851757|FG000|Overall Study|Physician Decision|1|||
147461873|NCT01262625|531851758|FG000|Overall Study|Administrative Error|1|||
147461874|NCT01262625|531851759|FG001|Overall Study|Administrative Error|1|||
147461875|NCT01262625|531851758|FG000|Overall Study|Site Closed|1|||
147401125|NCT01099579|531632843|FG001|Stage 2 (ATV Capsule)|Lost to Follow-up|1|||
147401126|NCT01099579|531632844|FG002|Stage 2 (ATV Capsule)|Lost to Follow-up|1|||
147401127|NCT01099579|531632842|FG000|Stage 2 (ATV Capsule)|Lack of Efficacy|0|||
147401128|NCT01099579|531632843|FG001|Stage 2 (ATV Capsule)|Lack of Efficacy|0|||
147401129|NCT01099579|531632844|FG002|Stage 2 (ATV Capsule)|Lack of Efficacy|2|||
147401130|NCT01099579|531632842|FG000|Stage 2 (ATV Capsule)|Withdrawal by Subject|1|||
147401131|NCT01099579|531632843|FG001|Stage 2 (ATV Capsule)|Withdrawal by Subject|1|||
147401132|NCT01099579|531632844|FG002|Stage 2 (ATV Capsule)|Withdrawal by Subject|1|||
147401133|NCT01099579|531632842|FG000|Stage 2 (ATV Capsule)|Poor/Non-Compliance|2|||
147401134|NCT01099579|531632843|FG001|Stage 2 (ATV Capsule)|Poor/Non-Compliance|0|||
147401135|NCT01099579|531632844|FG002|Stage 2 (ATV Capsule)|Poor/Non-Compliance|1|||
147401136|NCT01099579|531632842|FG000|Stage 2 (ATV Capsule)|Adverse Event|0|||
147401137|NCT01099579|531632843|FG001|Stage 2 (ATV Capsule)|Adverse Event|1|||
147401138|NCT01099579|531632844|FG002|Stage 2 (ATV Capsule)|Adverse Event|0|||
147401139|NCT02725528|531632845|FG000|Overall Study|Lost to Follow-up|1|||
147401140|NCT02725528|531632846|FG001|Overall Study|Lost to Follow-up|4|||
147401141|NCT02725528|531632845|FG000|Overall Study|Withdrawal by Subject|0|||
147401142|NCT02725528|531632846|FG001|Overall Study|Withdrawal by Subject|1|||
147401143|NCT03432390|531632849|FG000|Apnea Period|Protocol Violation|2|||
147401144|NCT03432390|531632850|FG001|Apnea Period|Protocol Violation|2|||
147401145|NCT01214421|531632851|FG000|Overall Study|Lost to Follow-up|7|||
147401146|NCT01214421|531632852|FG001|Overall Study|Lost to Follow-up|3|||
147401147|NCT01214421|531632853|FG002|Overall Study|Lost to Follow-up|7|||
147401148|NCT01214421|531632854|FG003|Overall Study|Lost to Follow-up|3|||
147401149|NCT01214421|531632851|FG000|Overall Study|Adverse Event|16|||
147401150|NCT01214421|531632852|FG001|Overall Study|Adverse Event|35|||
147401151|NCT01214421|531632853|FG002|Overall Study|Adverse Event|14|||
147401152|NCT01214421|531632854|FG003|Overall Study|Adverse Event|3|||
147401153|NCT01214421|531632851|FG000|Overall Study|Sponsor Discontinued Site|1|||
147401154|NCT01214421|531632852|FG001|Overall Study|Sponsor Discontinued Site|2|||
147401155|NCT01214421|531632853|FG002|Overall Study|Sponsor Discontinued Site|0|||
147401156|NCT01214421|531632854|FG003|Overall Study|Sponsor Discontinued Site|0|||
147401157|NCT01214421|531632851|FG000|Overall Study|Withdrawal Criteria Met|3|||
147401158|NCT01214421|531632852|FG001|Overall Study|Withdrawal Criteria Met|0|||
147401159|NCT01214421|531632853|FG002|Overall Study|Withdrawal Criteria Met|2|||
147401160|NCT01214421|531632854|FG003|Overall Study|Withdrawal Criteria Met|1|||
147401161|NCT01214421|531632851|FG000|Overall Study|Physician Decision|2|||
147401162|NCT01214421|531632852|FG001|Overall Study|Physician Decision|0|||
147401163|NCT01214421|531632853|FG002|Overall Study|Physician Decision|4|||
147401164|NCT01214421|531632854|FG003|Overall Study|Physician Decision|0|||
147401165|NCT01214421|531632851|FG000|Overall Study|Withdrawal by Subject|21|||
147401166|NCT01214421|531632852|FG001|Overall Study|Withdrawal by Subject|18|||
147401167|NCT01214421|531632853|FG002|Overall Study|Withdrawal by Subject|11|||
147401168|NCT01214421|531632854|FG003|Overall Study|Withdrawal by Subject|2|||
147401169|NCT03783689|531632856|FG000|Overall Study|Adverse Event|2|||
147401170|NCT03783689|531632857|FG001|Overall Study|Adverse Event|0|||
147401171|NCT03783689|531632856|FG000|Overall Study|Lost to Follow-up|2|||
147401172|NCT03783689|531632857|FG001|Overall Study|Lost to Follow-up|1|||
147401173|NCT03783689|531632856|FG000|Overall Study|Physician Decision|2|||
147401174|NCT03783689|531632857|FG001|Overall Study|Physician Decision|1|||
147401175|NCT03783689|531632856|FG000|Overall Study|Withdrawal by Subject|3|||
147401176|NCT03783689|531632857|FG001|Overall Study|Withdrawal by Subject|3|||
147401177|NCT02392104|531632861|FG000|Overall Study|discontinuation of warfarin|3|||
147401178|NCT02392104|531632861|FG000|Overall Study|bleeding event|1|||
147401179|NCT02392104|531632861|FG000|Overall Study|transferred care to another doctor|2|||
147401180|NCT02392104|531632861|FG000|Overall Study|INR goal range changed|1|||
147401181|NCT02392104|531632861|FG000|Overall Study|admitted to skilled nursing facility|3|||
147401182|NCT02392104|531632861|FG000|Overall Study|INRs drawn by visiting nurse services|1|||
147401183|NCT03912532|531632865|FG000|Overall Study|Adverse Event|3|||
147401184|NCT03912532|531632866|FG001|Overall Study|Adverse Event|3|||
147401185|NCT03912532|531632867|FG002|Overall Study|Adverse Event|2|||
147401186|NCT03912532|531632868|FG003|Overall Study|Adverse Event|2|||
147401187|NCT03912532|531632865|FG000|Overall Study|Lost to Follow-up|3|||
147401188|NCT03912532|531632866|FG001|Overall Study|Lost to Follow-up|2|||
147401189|NCT03912532|531632867|FG002|Overall Study|Lost to Follow-up|1|||
147401190|NCT03912532|531632868|FG003|Overall Study|Lost to Follow-up|2|||
147401191|NCT03912532|531632865|FG000|Overall Study|Withdrawal by Subject|1|||
147401192|NCT03912532|531632866|FG001|Overall Study|Withdrawal by Subject|1|||
147401193|NCT03912532|531632867|FG002|Overall Study|Withdrawal by Subject|2|||
147401194|NCT03912532|531632868|FG003|Overall Study|Withdrawal by Subject|0|||
147401195|NCT03912532|531632865|FG000|Overall Study|Physician Decision|1|||
147401196|NCT03912532|531632866|FG001|Overall Study|Physician Decision|0|||
147401197|NCT03912532|531632867|FG002|Overall Study|Physician Decision|0|||
147401198|NCT03912532|531632868|FG003|Overall Study|Physician Decision|3|||
147401199|NCT03912532|531632865|FG000|Overall Study|Other|0|||
147401200|NCT03912532|531632866|FG001|Overall Study|Other|1|||
147401201|NCT03912532|531632867|FG002|Overall Study|Other|1|||
147461876|NCT01262625|531851759|FG001|Overall Study|Site Closed|0|||
147401202|NCT03912532|531632868|FG003|Overall Study|Other|0|||
147401203|NCT04913948|531632869|FG000|Overall Study|Withdrawal by Subject|2|||
147401204|NCT04913948|531632869|FG000|Overall Study|Sample processing issues|1|||
147401205|NCT04913948|531632869|FG000|Overall Study|Suspected to have COVID-19 at the time of delivery but was found to be negative upon RT-PCR testing|1|||
147401206|NCT03783871|531632872|FG000|Overall Study|Withdrawal by Subject|15|||
147401207|NCT03783871|531632872|FG000|Overall Study|Death|13|||
147401208|NCT03783871|531632872|FG000|Overall Study|Lost to Follow-up|2|||
147401209|NCT05990387|531632873|FG000|Informed Consent/Screening Visit|Withdrawal by Subject|3|||
147401210|NCT05990387|531632874|FG001|Informed Consent/Screening Visit|Withdrawal by Subject|2|||
147401211|NCT00815919|531632875|FG000|Overall Study|Unrelated Fungal Infection|1|||
147401212|NCT00815919|531632875|FG000|Overall Study|AML Relapse|1|||
147401213|NCT00815919|531632875|FG000|Overall Study|Lack of Efficacy|2|||
147401214|NCT03522389|531632876|FG000|Overall Study|Lost to Follow-up|1|||
147401215|NCT03522389|531632877|FG001|Overall Study|Lost to Follow-up|1|||
147401216|NCT03522389|531632878|FG002|Overall Study|Lost to Follow-up|2|||
147401217|NCT03522389|531632876|FG000|Overall Study|had herniated nucleus pulposus|0|||
147401218|NCT03522389|531632877|FG001|Overall Study|had herniated nucleus pulposus|1|||
147401219|NCT03522389|531632878|FG002|Overall Study|had herniated nucleus pulposus|0|||
147401220|NCT03522389|531632876|FG000|Overall Study|go to work in other province|1|||
147401221|NCT03522389|531632877|FG001|Overall Study|go to work in other province|0|||
147401222|NCT03522389|531632878|FG002|Overall Study|go to work in other province|0|||
147401223|NCT04680637|531632879|FG000|Overall Study|Lost to Follow-up|0|||
147401224|NCT04680637|531632880|FG001|Overall Study|Lost to Follow-up|1|||
147401225|NCT04680637|531632881|FG002|Overall Study|Lost to Follow-up|0|||
147401226|NCT04680637|531632882|FG003|Overall Study|Lost to Follow-up|1|||
147401227|NCT04680637|531632879|FG000|Overall Study|Death|1|||
147401228|NCT04680637|531632880|FG001|Overall Study|Death|0|||
147401229|NCT04680637|531632881|FG002|Overall Study|Death|0|||
147401230|NCT04680637|531632882|FG003|Overall Study|Death|0|||
147401231|NCT04680637|531632879|FG000|Overall Study|Withdrawal by Subject|7|||
147401232|NCT04680637|531632880|FG001|Overall Study|Withdrawal by Subject|10|||
147401233|NCT04680637|531632881|FG002|Overall Study|Withdrawal by Subject|17|||
147401234|NCT04680637|531632882|FG003|Overall Study|Withdrawal by Subject|15|||
147401235|NCT04680637|531632879|FG000|Overall Study|Decision by Sponsor|21|||
147401236|NCT04680637|531632880|FG001|Overall Study|Decision by Sponsor|15|||
147401237|NCT04680637|531632881|FG002|Overall Study|Decision by Sponsor|7|||
147401238|NCT04680637|531632882|FG003|Overall Study|Decision by Sponsor|32|||
147401239|NCT03167151|531634459|FG000|Overall Study|Withdrawal by Subject|1|||
147401240|NCT03167151|531634460|FG001|Overall Study|Withdrawal by Subject|0|||
147401241|NCT03167151|531634461|FG002|Overall Study|Withdrawal by Subject|0|||
147401242|NCT03167151|531634459|FG000|Overall Study|No evidence of tumour at surgery|0|||
147401243|NCT03167151|531634460|FG001|Overall Study|No evidence of tumour at surgery|1|||
147401244|NCT03167151|531634461|FG002|Overall Study|No evidence of tumour at surgery|1|||
147401245|NCT01458522|531634462|FG000|Overall Study|Withdrawal by Subject|2|||
147401246|NCT01458522|531634463|FG001|Overall Study|Withdrawal by Subject|2|||
147401247|NCT01458522|531634462|FG000|Overall Study|Physician Decision|1|||
147401248|NCT01458522|531634463|FG001|Overall Study|Physician Decision|9|||
147401249|NCT00516139|531634464|FG000|Overall Study|Adverse Event|27|||
147401250|NCT00516139|531634464|FG000|Overall Study|Lost to Follow-up|1|||
147401251|NCT00516139|531634464|FG000|Overall Study|Protocol Violation|1|||
147401252|NCT00516139|531634464|FG000|Overall Study|Withdrawal by Subject|8|||
147401253|NCT00516139|531634464|FG000|Overall Study|Lack of Efficacy|1|||
147401254|NCT00416598|531634465|FG000|Induction & Intensification|Adverse Event|38|||
147401255|NCT00416598|531634465|FG000|Induction & Intensification|Death|32|||
147401256|NCT00416598|531634465|FG000|Induction & Intensification|Withdrawal by Subject|46|||
147401257|NCT00416598|531634465|FG000|Induction & Intensification|Alternative Treatment|135|||
147401258|NCT00416598|531634465|FG000|Induction & Intensification|Physician discretion/other medical issue|45|||
147401259|NCT00416598|531634465|FG000|Induction & Intensification|Relapse/progression|29|||
147461877|NCT01869348|531851760|FG000|Overall Study|Withdrawal by Subject|1|||
147461878|NCT01869348|531851761|FG001|Overall Study|Withdrawal by Subject|1|||
147461879|NCT02789657|531851762|FG000|Overall Study|Withdrawal by Subject|2|||
147461880|NCT02789657|531851763|FG001|Overall Study|Withdrawal by Subject|0|||
147461881|NCT02789657|531851764|FG002|Overall Study|Withdrawal by Subject|0|||
147461882|NCT02789657|531851765|FG003|Overall Study|Withdrawal by Subject|0|||
147461883|NCT03075163|531851766|FG000|Overall Study|not eligible for treatment limb|138|||
147461884|NCT03075163|531851767|FG001|Overall Study|not eligible for treatment limb|138|||
147461885|NCT04398732|531851768|FG000|Overall Study|Participants Who Did Not Meet Entrance Criteria|50|||
147461886|NCT03882424|531851771|FG000|Overall Study|Lost to Follow-up|3|||
147461887|NCT03882424|531851772|FG001|Overall Study|Lost to Follow-up|0|||
147461888|NCT03882424|531851773|FG002|Overall Study|Lost to Follow-up|0|||
147615522|NCT05221320|532408995|FG004|Overall Study|Physician Decision|0|||
147401260|NCT00416598|531634465|FG000|Induction & Intensification|Failed induction|87|||
147401261|NCT00416598|531634465|FG000|Decitabine Maintenance|Adverse Event|5|||
147401262|NCT00416598|531634465|FG000|Decitabine Maintenance|Withdrawal by Subject|18|||
147401263|NCT00416598|531634465|FG000|Decitabine Maintenance|Progression/relapse|38|||
147401264|NCT00416598|531634465|FG000|Decitabine Maintenance|Alternative treatment|2|||
147401265|NCT00416598|531634465|FG000|Decitabine Maintenance|Physician discretion/other medical issue|9|||
147401266|NCT02166476|531634472|FG000|Overall Study|Withdrawal by Subject|5|||
147401267|NCT02166476|531634473|FG001|Overall Study|Withdrawal by Subject|7|||
147401268|NCT02166476|531634472|FG000|Overall Study|Adverse Event|3|||
147401269|NCT02166476|531634473|FG001|Overall Study|Adverse Event|3|||
147401270|NCT02166476|531634472|FG000|Overall Study|Lost to Follow-up|5|||
147401271|NCT02166476|531634473|FG001|Overall Study|Lost to Follow-up|10|||
147401272|NCT02166476|531634472|FG000|Overall Study|Physician Decision|1|||
147401273|NCT02166476|531634473|FG001|Overall Study|Physician Decision|0|||
147401274|NCT02166476|531634472|FG000|Overall Study|Unable to Come for Visit|0|||
147401275|NCT02166476|531634473|FG001|Overall Study|Unable to Come for Visit|3|||
147401276|NCT04367480|531634480|FG000|Overall Study|Adverse Event|1|||
147401277|NCT04367480|531634481|FG001|Overall Study|Adverse Event|1|||
147401278|NCT04367480|531634480|FG000|Overall Study|Death|1|||
147401279|NCT04367480|531634481|FG001|Overall Study|Death|0|||
147401280|NCT04367480|531634480|FG000|Overall Study|Lost to Follow-up|1|||
147401281|NCT04367480|531634481|FG001|Overall Study|Lost to Follow-up|1|||
147401282|NCT04367480|531634480|FG000|Overall Study|Withdrawal by Subject|0|||
147401283|NCT04367480|531634481|FG001|Overall Study|Withdrawal by Subject|3|||
147401284|NCT04367480|531634480|FG000|Overall Study|App glitch during the study|1|||
147401285|NCT04367480|531634481|FG001|Overall Study|App glitch during the study|0|||
147401286|NCT04367480|531634480|FG000|Overall Study|Device Distribution Error|0|||
147401287|NCT04367480|531634481|FG001|Overall Study|Device Distribution Error|2|||
147401288|NCT04367480|531634480|FG000|Overall Study|Ineligible after Randomization|0|||
147401289|NCT04367480|531634481|FG001|Overall Study|Ineligible after Randomization|1|||
147401290|NCT04367480|531634480|FG000|Overall Study|Other Medical Reasons|0|||
147401291|NCT04367480|531634481|FG001|Overall Study|Other Medical Reasons|2|||
147401292|NCT03382561|531634482|FG000|Overall Study|Disease progression|47|||
147401293|NCT03382561|531634483|FG001|Overall Study|Disease progression|6|||
147401294|NCT03382561|531634482|FG000|Overall Study|Adverse Event|10|||
147401295|NCT03382561|531634483|FG001|Overall Study|Adverse Event|2|||
147401296|NCT03382561|531634482|FG000|Overall Study|Death|8|||
147401297|NCT03382561|531634483|FG001|Overall Study|Death|3|||
147401298|NCT03382561|531634482|FG000|Overall Study|Withdrawal by Subject|6|||
147401299|NCT03382561|531634483|FG001|Overall Study|Withdrawal by Subject|5|||
147401300|NCT03382561|531634482|FG000|Overall Study|Alternative therapy|2|||
147401301|NCT03382561|531634483|FG001|Overall Study|Alternative therapy|8|||
147401302|NCT03382561|531634482|FG000|Overall Study|Never started treatment|3|||
147401303|NCT03382561|531634483|FG001|Overall Study|Never started treatment|6|||
147401304|NCT03382561|531634482|FG000|Overall Study|Lack of Efficacy|0|||
147401305|NCT03382561|531634483|FG001|Overall Study|Lack of Efficacy|1|||
147401306|NCT03382561|531634482|FG000|Overall Study|Physician Decision|0|||
147401307|NCT03382561|531634483|FG001|Overall Study|Physician Decision|1|||
147401308|NCT03382561|531634482|FG000|Overall Study|Other complicating disease|0|||
147401309|NCT03382561|531634483|FG001|Overall Study|Other complicating disease|1|||
147401310|NCT01131104|531634484|FG000|Overall Study|Withdrawal by Subject|3|||
147401311|NCT01131104|531634484|FG000|Overall Study|Physician Decision|4|||
147401312|NCT01131104|531634484|FG000|Overall Study|Information Not Available|5|||
147401313|NCT01131104|531634484|FG000|Overall Study|No Information on Index Date of Onset|1|||
147401314|NCT04836559|531634486|FG000|Double Blind Period (Day 1 to Day 85)|Adverse Event|0|||
147401315|NCT04836559|531634487|FG001|Double Blind Period (Day 1 to Day 85)|Adverse Event|4|||
147401316|NCT04836559|531634488|FG002|Double Blind Period (Day 1 to Day 85)|Adverse Event|1|||
147401317|NCT04836559|531634489|FG003|Double Blind Period (Day 1 to Day 85)|Adverse Event|1|||
147401318|NCT04836559|531634490|FG004|Double Blind Period (Day 1 to Day 85)|Adverse Event|0|||
147401319|NCT04836559|531634491|FG005|Double Blind Period (Day 1 to Day 85)|Adverse Event|0|||
147401320|NCT04836559|531634492|FG006|Double Blind Period (Day 1 to Day 85)|Adverse Event|0|||
147401321|NCT04836559|531634493|FG007|Double Blind Period (Day 1 to Day 85)|Adverse Event|0|||
147401322|NCT04836559|531634486|FG000|Double Blind Period (Day 1 to Day 85)|Withdrawal by Subject|0|||
147401323|NCT04836559|531634487|FG001|Double Blind Period (Day 1 to Day 85)|Withdrawal by Subject|1|||
147401324|NCT04836559|531634488|FG002|Double Blind Period (Day 1 to Day 85)|Withdrawal by Subject|1|||
147401325|NCT04836559|531634489|FG003|Double Blind Period (Day 1 to Day 85)|Withdrawal by Subject|3|||
147401326|NCT04836559|531634490|FG004|Double Blind Period (Day 1 to Day 85)|Withdrawal by Subject|0|||
147401327|NCT04836559|531634491|FG005|Double Blind Period (Day 1 to Day 85)|Withdrawal by Subject|0|||
147401328|NCT04836559|531634492|FG006|Double Blind Period (Day 1 to Day 85)|Withdrawal by Subject|0|||
147401329|NCT04836559|531634493|FG007|Double Blind Period (Day 1 to Day 85)|Withdrawal by Subject|0|||
147401330|NCT04836559|531634486|FG000|Double Blind Period (Day 1 to Day 85)|Protocol Violation|1|||
147401331|NCT04836559|531634487|FG001|Double Blind Period (Day 1 to Day 85)|Protocol Violation|0|||
147401332|NCT04836559|531634488|FG002|Double Blind Period (Day 1 to Day 85)|Protocol Violation|0|||
147401333|NCT04836559|531634489|FG003|Double Blind Period (Day 1 to Day 85)|Protocol Violation|0|||
147401334|NCT04836559|531634490|FG004|Double Blind Period (Day 1 to Day 85)|Protocol Violation|0|||
147401335|NCT04836559|531634491|FG005|Double Blind Period (Day 1 to Day 85)|Protocol Violation|0|||
147401336|NCT04836559|531634492|FG006|Double Blind Period (Day 1 to Day 85)|Protocol Violation|0|||
147461889|NCT03882424|531851771|FG000|Overall Study|schedule conflict|1|||
147461890|NCT03882424|531851772|FG001|Overall Study|schedule conflict|0|||
147461891|NCT03882424|531851773|FG002|Overall Study|schedule conflict|0|||
147461892|NCT02772757|531851779|FG000|Overall Study|Withdrawal by Subject|1|||
147461893|NCT02772757|531851780|FG001|Overall Study|Withdrawal by Subject|0|||
147461894|NCT02772757|531851781|FG002|Overall Study|Withdrawal by Subject|1|||
147461895|NCT02772757|531851779|FG000|Overall Study|Protocol Violation|0|||
147461896|NCT02772757|531851780|FG001|Overall Study|Protocol Violation|0|||
147461897|NCT02772757|531851781|FG002|Overall Study|Protocol Violation|1|||
147461898|NCT02772757|531851779|FG000|Overall Study|Physician Decision|0|||
147461899|NCT02772757|531851780|FG001|Overall Study|Physician Decision|3|||
147461900|NCT02772757|531851781|FG002|Overall Study|Physician Decision|3|||
147461901|NCT00510276|531851785|FG000|Acute Double-Blind Phase|Adverse Event|21|||
147461902|NCT00510276|531851786|FG001|Acute Double-Blind Phase|Adverse Event|6|||
147461903|NCT00510276|531851785|FG000|Acute Double-Blind Phase|Entry Criteria Not Met|1|||
147461904|NCT00510276|531851786|FG001|Acute Double-Blind Phase|Entry Criteria Not Met|1|||
147461905|NCT00510276|531851785|FG000|Acute Double-Blind Phase|Lack of Efficacy|3|||
147461906|NCT00510276|531851786|FG001|Acute Double-Blind Phase|Lack of Efficacy|4|||
147461907|NCT00510276|531851785|FG000|Acute Double-Blind Phase|Lost to Follow-up|48|||
147461908|NCT00510276|531851786|FG001|Acute Double-Blind Phase|Lost to Follow-up|49|||
147461909|NCT00510276|531851785|FG000|Acute Double-Blind Phase|Physician Decision|0|||
147461910|NCT00510276|531851786|FG001|Acute Double-Blind Phase|Physician Decision|3|||
147401337|NCT04836559|531634493|FG007|Double Blind Period (Day 1 to Day 85)|Protocol Violation|0|||
147461911|NCT00510276|531851785|FG000|Acute Double-Blind Phase|Protocol Violation|4|||
147461912|NCT00510276|531851786|FG001|Acute Double-Blind Phase|Protocol Violation|3|||
147401338|NCT04836559|531634486|FG000|Double Blind Period (Day 1 to Day 85)|Other|1|||
147401339|NCT04836559|531634487|FG001|Double Blind Period (Day 1 to Day 85)|Other|0|||
147401340|NCT04836559|531634488|FG002|Double Blind Period (Day 1 to Day 85)|Other|0|||
147401341|NCT04836559|531634489|FG003|Double Blind Period (Day 1 to Day 85)|Other|0|||
147401342|NCT04836559|531634490|FG004|Double Blind Period (Day 1 to Day 85)|Other|0|||
147401343|NCT04836559|531634491|FG005|Double Blind Period (Day 1 to Day 85)|Other|0|||
147401344|NCT04836559|531634492|FG006|Double Blind Period (Day 1 to Day 85)|Other|0|||
147401345|NCT04836559|531634493|FG007|Double Blind Period (Day 1 to Day 85)|Other|0|||
147401346|NCT04836559|531634486|FG000|Double Blind Period (Day 1 to Day 85)|Randomized by Mistake With Study Treatment|0|||
147401347|NCT04836559|531634487|FG001|Double Blind Period (Day 1 to Day 85)|Randomized by Mistake With Study Treatment|0|||
147401348|NCT04836559|531634488|FG002|Double Blind Period (Day 1 to Day 85)|Randomized by Mistake With Study Treatment|0|||
147401349|NCT04836559|531634489|FG003|Double Blind Period (Day 1 to Day 85)|Randomized by Mistake With Study Treatment|1|||
147401350|NCT04836559|531634490|FG004|Double Blind Period (Day 1 to Day 85)|Randomized by Mistake With Study Treatment|0|||
147401351|NCT04836559|531634491|FG005|Double Blind Period (Day 1 to Day 85)|Randomized by Mistake With Study Treatment|0|||
147401352|NCT04836559|531634492|FG006|Double Blind Period (Day 1 to Day 85)|Randomized by Mistake With Study Treatment|0|||
147401353|NCT04836559|531634493|FG007|Double Blind Period (Day 1 to Day 85)|Randomized by Mistake With Study Treatment|0|||
147401354|NCT04836559|531634486|FG000|OLE Period (Day 1 of OLE up to 2 Years)|Sponsor's Decision|0|||
147401355|NCT04836559|531634487|FG001|OLE Period (Day 1 of OLE up to 2 Years)|Sponsor's Decision|0|||
147401356|NCT04836559|531634488|FG002|OLE Period (Day 1 of OLE up to 2 Years)|Sponsor's Decision|0|||
147401357|NCT04836559|531634489|FG003|OLE Period (Day 1 of OLE up to 2 Years)|Sponsor's Decision|0|||
147401358|NCT04836559|531634490|FG004|OLE Period (Day 1 of OLE up to 2 Years)|Sponsor's Decision|7|||
147401359|NCT04836559|531634491|FG005|OLE Period (Day 1 of OLE up to 2 Years)|Sponsor's Decision|14|||
147401360|NCT04836559|531634492|FG006|OLE Period (Day 1 of OLE up to 2 Years)|Sponsor's Decision|4|||
147401361|NCT04836559|531634493|FG007|OLE Period (Day 1 of OLE up to 2 Years)|Sponsor's Decision|24|||
147401362|NCT04836559|531634486|FG000|OLE Period (Day 1 of OLE up to 2 Years)|Lack of Efficacy|0|||
147401363|NCT04836559|531634487|FG001|OLE Period (Day 1 of OLE up to 2 Years)|Lack of Efficacy|0|||
147401364|NCT04836559|531634488|FG002|OLE Period (Day 1 of OLE up to 2 Years)|Lack of Efficacy|0|||
147401365|NCT04836559|531634489|FG003|OLE Period (Day 1 of OLE up to 2 Years)|Lack of Efficacy|0|||
147401366|NCT04836559|531634490|FG004|OLE Period (Day 1 of OLE up to 2 Years)|Lack of Efficacy|1|||
147401367|NCT04836559|531634491|FG005|OLE Period (Day 1 of OLE up to 2 Years)|Lack of Efficacy|7|||
147401368|NCT04836559|531634492|FG006|OLE Period (Day 1 of OLE up to 2 Years)|Lack of Efficacy|3|||
147401369|NCT04836559|531634493|FG007|OLE Period (Day 1 of OLE up to 2 Years)|Lack of Efficacy|4|||
147401370|NCT04836559|531634486|FG000|OLE Period (Day 1 of OLE up to 2 Years)|Withdrawal by Subject|0|||
147401371|NCT04836559|531634487|FG001|OLE Period (Day 1 of OLE up to 2 Years)|Withdrawal by Subject|0|||
147401372|NCT04836559|531634488|FG002|OLE Period (Day 1 of OLE up to 2 Years)|Withdrawal by Subject|0|||
147401373|NCT04836559|531634489|FG003|OLE Period (Day 1 of OLE up to 2 Years)|Withdrawal by Subject|0|||
147461913|NCT00510276|531851785|FG000|Acute Double-Blind Phase|Sponsor Decision|2|||
147461914|NCT00510276|531851786|FG001|Acute Double-Blind Phase|Sponsor Decision|1|||
147461915|NCT00510276|531851785|FG000|Acute Double-Blind Phase|Subject Decision|26|||
147461916|NCT00510276|531851786|FG001|Acute Double-Blind Phase|Subject Decision|28|||
147461917|NCT00510276|531851785|FG000|Extension Open-Label Phase|Adverse Event|9|||
147461918|NCT00510276|531851786|FG001|Extension Open-Label Phase|Adverse Event|18|||
147461919|NCT00510276|531851785|FG000|Extension Open-Label Phase|Lack of Efficacy|2|||
147401374|NCT04836559|531634490|FG004|OLE Period (Day 1 of OLE up to 2 Years)|Withdrawal by Subject|4|||
147401375|NCT04836559|531634491|FG005|OLE Period (Day 1 of OLE up to 2 Years)|Withdrawal by Subject|2|||
147401376|NCT04836559|531634492|FG006|OLE Period (Day 1 of OLE up to 2 Years)|Withdrawal by Subject|0|||
147401377|NCT04836559|531634493|FG007|OLE Period (Day 1 of OLE up to 2 Years)|Withdrawal by Subject|2|||
147401378|NCT04836559|531634486|FG000|OLE Period (Day 1 of OLE up to 2 Years)|No Longer Clinically Benefitting|0|||
147401379|NCT04836559|531634487|FG001|OLE Period (Day 1 of OLE up to 2 Years)|No Longer Clinically Benefitting|0|||
147401380|NCT04836559|531634488|FG002|OLE Period (Day 1 of OLE up to 2 Years)|No Longer Clinically Benefitting|0|||
147401381|NCT04836559|531634489|FG003|OLE Period (Day 1 of OLE up to 2 Years)|No Longer Clinically Benefitting|0|||
147401382|NCT04836559|531634490|FG004|OLE Period (Day 1 of OLE up to 2 Years)|No Longer Clinically Benefitting|0|||
147401383|NCT04836559|531634491|FG005|OLE Period (Day 1 of OLE up to 2 Years)|No Longer Clinically Benefitting|0|||
147401384|NCT04836559|531634492|FG006|OLE Period (Day 1 of OLE up to 2 Years)|No Longer Clinically Benefitting|0|||
147401385|NCT04836559|531634493|FG007|OLE Period (Day 1 of OLE up to 2 Years)|No Longer Clinically Benefitting|1|||
147401386|NCT00730015|531634494|FG000|Overall Study|Adverse Event|11|||
147401387|NCT00730015|531634495|FG001|Overall Study|Adverse Event|10|||
147401388|NCT00730015|531634496|FG002|Overall Study|Adverse Event|8|||
147401389|NCT00730015|531634494|FG000|Overall Study|Protocol Violation|2|||
147401390|NCT00730015|531634495|FG001|Overall Study|Protocol Violation|6|||
147401391|NCT00730015|531634496|FG002|Overall Study|Protocol Violation|4|||
147401392|NCT00730015|531634494|FG000|Overall Study|Withdrawal by Subject|12|||
147401393|NCT00730015|531634495|FG001|Overall Study|Withdrawal by Subject|12|||
147401394|NCT00730015|531634496|FG002|Overall Study|Withdrawal by Subject|8|||
147401395|NCT00730015|531634494|FG000|Overall Study|Lost to Follow-up|4|||
147401396|NCT00730015|531634495|FG001|Overall Study|Lost to Follow-up|10|||
147401397|NCT00730015|531634496|FG002|Overall Study|Lost to Follow-up|3|||
147401398|NCT00730015|531634494|FG000|Overall Study|Lack of Efficacy|1|||
147401399|NCT00730015|531634495|FG001|Overall Study|Lack of Efficacy|2|||
147401400|NCT00730015|531634496|FG002|Overall Study|Lack of Efficacy|8|||
147401401|NCT00730015|531634494|FG000|Overall Study|Other Reason|1|||
147401402|NCT00730015|531634495|FG001|Overall Study|Other Reason|0|||
147401403|NCT00730015|531634496|FG002|Overall Study|Other Reason|1|||
147401404|NCT01432626|531634497|FG000|Overall Study|LV function recovered|2|||
147401405|NCT01432626|531634497|FG000|Overall Study|Withdrawal by Subject|2|||
147401406|NCT01432626|531634497|FG000|Overall Study|Only 1 image competed|2|||
147401407|NCT01432626|531634497|FG000|Overall Study|Imaging agent not available|1|||
147401408|NCT05382039|531634498|FG000|Overall Study|Score on pain scale was not zero. Subjects randomized to this arm had to have zero pain.|5|||
147401409|NCT05382039|531634499|FG001|Overall Study|Score on pain scale was not zero. Subjects randomized to this arm had to have zero pain.|0|||
147401410|NCT05382039|531634500|FG002|Overall Study|Score on pain scale was not zero. Subjects randomized to this arm had to have zero pain.|0|||
147401411|NCT05382039|531634498|FG000|Overall Study|One subject unable to return for reassessment as required by protocol timeline.|0|||
147401412|NCT05382039|531634499|FG001|Overall Study|One subject unable to return for reassessment as required by protocol timeline.|0|||
147401413|NCT05382039|531634500|FG002|Overall Study|One subject unable to return for reassessment as required by protocol timeline.|1|||
147401414|NCT05382039|531634498|FG000|Overall Study|waiting for confirmation|0|||
147401415|NCT05382039|531634499|FG001|Overall Study|waiting for confirmation|0|||
147401416|NCT05382039|531634500|FG002|Overall Study|waiting for confirmation|1|||
147401417|NCT03210519|531634503|FG000|Overall Study|Adverse Event|2|||
147401418|NCT03210519|531634504|FG001|Overall Study|Adverse Event|0|||
147401419|NCT02270671|531634505|FG000|Overall Study|Withdrawal by Subject|1|||
147401420|NCT02270671|531634506|FG001|Overall Study|Withdrawal by Subject|1|||
147401421|NCT02270671|531634505|FG000|Overall Study|Protocol Violation|0|||
147401422|NCT02270671|531634506|FG001|Overall Study|Protocol Violation|1|||
147401423|NCT02270671|531634505|FG000|Overall Study|Missed Post-intervention Data Collection|2|||
147401424|NCT02270671|531634506|FG001|Overall Study|Missed Post-intervention Data Collection|2|||
147401425|NCT02270671|531634505|FG000|Overall Study|Lost to Follow-up|2|||
147401426|NCT02270671|531634506|FG001|Overall Study|Lost to Follow-up|1|||
147401427|NCT04486313|531634507|FG000|Overall Study|Lost to Follow-up|7|||
147401428|NCT04486313|531634508|FG001|Overall Study|Lost to Follow-up|9|||
147401429|NCT04486313|531634507|FG000|Overall Study|Withdrawal by Subject|8|||
147401430|NCT04486313|531634508|FG001|Overall Study|Withdrawal by Subject|6|||
147401431|NCT04486313|531634507|FG000|Overall Study|Physician Decision|1|||
147401432|NCT04486313|531634508|FG001|Overall Study|Physician Decision|1|||
147401433|NCT04486313|531634507|FG000|Overall Study|Death|2|||
147461920|NCT00510276|531851786|FG001|Extension Open-Label Phase|Lack of Efficacy|7|||
147401434|NCT04486313|531634508|FG001|Overall Study|Death|0|||
147401435|NCT04486313|531634507|FG000|Overall Study|Protocol Violation|1|||
147401436|NCT04486313|531634508|FG001|Overall Study|Protocol Violation|1|||
147401437|NCT00126659|531634509|FG000|Overall Study|Adverse Event|0|||
147461921|NCT00510276|531851785|FG000|Extension Open-Label Phase|Lost to Follow-up|12|||
147615523|NCT05221320|532408996|FG005|Overall Study|Physician Decision|0|||
147401438|NCT00126659|531634510|FG001|Overall Study|Adverse Event|0|||
147401439|NCT00126659|531634511|FG002|Overall Study|Adverse Event|2|||
147401440|NCT00174447|531634512|FG000|Overall Study|Adverse Event|19|||
147401441|NCT00174447|531634512|FG000|Overall Study|Withdrawal by Subject|15|||
147401442|NCT00174447|531634512|FG000|Overall Study|Protocol Violation|1|||
147401443|NCT00174447|531634512|FG000|Overall Study|Lack of Efficacy|1|||
147401444|NCT00174447|531634512|FG000|Overall Study|Administrative reason/Other|2|||
147401445|NCT00940875|531634515|FG000|Treatment Phase|Adverse Event|9|||
147401446|NCT00940875|531634516|FG001|Treatment Phase|Adverse Event|3|||
147401447|NCT00940875|531634515|FG000|Treatment Phase|Death|3|||
147401448|NCT00940875|531634516|FG001|Treatment Phase|Death|5|||
147401449|NCT00940875|531634515|FG000|Treatment Phase|Lack of Efficacy|1|||
147401450|NCT00940875|531634516|FG001|Treatment Phase|Lack of Efficacy|0|||
147401451|NCT00940875|531634515|FG000|Treatment Phase|Withdrawal by Subject|3|||
147401452|NCT00940875|531634516|FG001|Treatment Phase|Withdrawal by Subject|0|||
147401453|NCT00940875|531634515|FG000|Treatment Phase|Disease progression|9|||
147401454|NCT00940875|531634516|FG001|Treatment Phase|Disease progression|11|||
147401455|NCT00940875|531634515|FG000|Treatment Phase|Physician Decision|1|||
147401456|NCT00940875|531634516|FG001|Treatment Phase|Physician Decision|0|||
147401457|NCT00940875|531634515|FG000|Post-Study Treatment|Death|0|||
147401458|NCT00940875|531634516|FG001|Post-Study Treatment|Death|1|||
147401459|NCT00940875|531634515|FG000|Post-Study Treatment|Disease Progression|0|||
147401460|NCT00940875|531634516|FG001|Post-Study Treatment|Disease Progression|2|||
147401461|NCT03603639|531634521|FG000|Washout Period (at Least 3 Weeks)|Adverse Event|0|||
147401462|NCT03603639|531634522|FG001|Washout Period (at Least 3 Weeks)|Adverse Event|0|||
147401463|NCT03603639|531634523|FG002|Washout Period (at Least 3 Weeks)|Adverse Event|0|||
147401464|NCT03603639|531634524|FG003|Washout Period (at Least 3 Weeks)|Adverse Event|1|||
147401465|NCT03603639|531634525|FG004|Washout Period (at Least 3 Weeks)|Adverse Event|0|||
147401466|NCT03603639|531634526|FG005|Washout Period (at Least 3 Weeks)|Adverse Event|0|||
147401467|NCT03603639|531634521|FG000|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|0|||
147401468|NCT03603639|531634522|FG001|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|0|||
147401469|NCT03603639|531634523|FG002|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|1|||
147401470|NCT03603639|531634524|FG003|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|0|||
147401471|NCT03603639|531634525|FG004|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|1|||
147401472|NCT03603639|531634526|FG005|Washout Period (at Least 3 Weeks)|Study terminated by sponsor|1|||
147401473|NCT02402322|531634532|FG000|Pretreatment|Withdrawal by Subject|3|||
147401474|NCT02402322|531634533|FG001|Pretreatment|Withdrawal by Subject|1|||
147401475|NCT02402322|531634534|FG002|Pretreatment|Withdrawal by Subject|1|||
147401476|NCT02402322|531634532|FG000|Follow-up|Withdrawal by Subject|6|||
147401477|NCT02402322|531634533|FG001|Follow-up|Withdrawal by Subject|3|||
147401478|NCT02402322|531634534|FG002|Follow-up|Withdrawal by Subject|24|||
147401479|NCT02818998|531634535|FG000|Overall Study|Adverse Event|3|||
147401480|NCT02818998|531634536|FG001|Overall Study|Adverse Event|2|||
147401481|NCT02818998|531634537|FG002|Overall Study|Adverse Event|1|||
147401482|NCT02818998|531634535|FG000|Overall Study|Lost to Follow-up|4|||
147401483|NCT02818998|531634536|FG001|Overall Study|Lost to Follow-up|1|||
147401484|NCT02818998|531634537|FG002|Overall Study|Lost to Follow-up|2|||
147401485|NCT02818998|531634535|FG000|Overall Study|Withdrawal by sponsor|0|||
147401486|NCT02818998|531634536|FG001|Overall Study|Withdrawal by sponsor|1|||
147401487|NCT02818998|531634537|FG002|Overall Study|Withdrawal by sponsor|1|||
147401488|NCT02818998|531634535|FG000|Overall Study|Death|3|||
147401489|NCT02818998|531634536|FG001|Overall Study|Death|6|||
147401490|NCT02818998|531634537|FG002|Overall Study|Death|8|||
147401491|NCT02818998|531634535|FG000|Overall Study|Withdrawal by Subject|7|||
147401492|NCT02818998|531634536|FG001|Overall Study|Withdrawal by Subject|6|||
147401493|NCT02818998|531634537|FG002|Overall Study|Withdrawal by Subject|6|||
147401494|NCT02818998|531634535|FG000|Overall Study|Physician Decision|1|||
147401495|NCT02818998|531634536|FG001|Overall Study|Physician Decision|0|||
147401496|NCT02818998|531634537|FG002|Overall Study|Physician Decision|0|||
147401497|NCT03414047|531634538|FG000|Overall Study|Adverse Event|0|||
147401498|NCT03414047|531634539|FG001|Overall Study|Adverse Event|0|||
147401499|NCT03414047|531634540|FG002|Overall Study|Adverse Event|1|||
147401500|NCT03414047|531634541|FG003|Overall Study|Adverse Event|1|||
147401501|NCT03414047|531634538|FG000|Overall Study|Physician Decision|1|||
147401502|NCT03414047|531634539|FG001|Overall Study|Physician Decision|0|||
147401503|NCT03414047|531634540|FG002|Overall Study|Physician Decision|0|||
147401504|NCT03414047|531634541|FG003|Overall Study|Physician Decision|1|||
147401505|NCT03414047|531634538|FG000|Overall Study|Withdrawal by Subject|1|||
147401506|NCT03414047|531634539|FG001|Overall Study|Withdrawal by Subject|0|||
147401507|NCT03414047|531634540|FG002|Overall Study|Withdrawal by Subject|2|||
147401508|NCT03414047|531634541|FG003|Overall Study|Withdrawal by Subject|0|||
147401509|NCT01704547|531634543|FG000|Overall Study|Physician Decision|4|||
147401510|NCT01704547|531634543|FG000|Overall Study|Withdrawal by Subject|1|||
147401511|NCT02413593|531634546|FG000|Overall Study|Lost to Follow-up|3|||
147401512|NCT02413593|531634546|FG000|Overall Study|Adverse Event|1|||
147401513|NCT01101061|531634547|FG000|Overall Study|Adverse Event|0|||
147401514|NCT01101061|531634548|FG001|Overall Study|Adverse Event|0|||
147401515|NCT01101061|531634549|FG002|Overall Study|Adverse Event|1|||
147401516|NCT01101061|531634550|FG003|Overall Study|Adverse Event|0|||
147401517|NCT01101061|531634551|FG004|Overall Study|Adverse Event|0|||
147401518|NCT01101061|531634552|FG005|Overall Study|Adverse Event|0|||
147461922|NCT00510276|531851786|FG001|Extension Open-Label Phase|Lost to Follow-up|10|||
147461923|NCT00510276|531851785|FG000|Extension Open-Label Phase|Physician Decision|2|||
147461924|NCT00510276|531851786|FG001|Extension Open-Label Phase|Physician Decision|3|||
147461925|NCT00510276|531851785|FG000|Extension Open-Label Phase|Protocol Violation|0|||
147461926|NCT00510276|531851786|FG001|Extension Open-Label Phase|Protocol Violation|1|||
147461927|NCT00510276|531851785|FG000|Extension Open-Label Phase|Sponsor Decision|1|||
147461928|NCT00510276|531851786|FG001|Extension Open-Label Phase|Sponsor Decision|0|||
147461929|NCT00510276|531851785|FG000|Extension Open-Label Phase|Subject Decision|7|||
147461930|NCT00510276|531851786|FG001|Extension Open-Label Phase|Subject Decision|9|||
147461931|NCT03486392|531851787|FG000|Overall Study|Lost to Follow-up|0|||
147461932|NCT03486392|531851788|FG001|Overall Study|Lost to Follow-up|0|||
147461933|NCT03486392|531851789|FG002|Overall Study|Lost to Follow-up|8|||
147461934|NCT03486392|531851790|FG003|Overall Study|Lost to Follow-up|5|||
147461935|NCT03486392|531851791|FG004|Overall Study|Lost to Follow-up|2|||
147461936|NCT03486392|531851787|FG000|Overall Study|Withdrawal by Subject|3|||
147461937|NCT03486392|531851788|FG001|Overall Study|Withdrawal by Subject|0|||
147461938|NCT03486392|531851789|FG002|Overall Study|Withdrawal by Subject|6|||
147461939|NCT03486392|531851790|FG003|Overall Study|Withdrawal by Subject|4|||
147461940|NCT03486392|531851791|FG004|Overall Study|Withdrawal by Subject|1|||
147461941|NCT03486392|531851787|FG000|Overall Study|Death|0|||
147461942|NCT03486392|531851788|FG001|Overall Study|Death|0|||
147461943|NCT03486392|531851789|FG002|Overall Study|Death|0|||
147461944|NCT03486392|531851790|FG003|Overall Study|Death|0|||
147461945|NCT03486392|531851791|FG004|Overall Study|Death|1|||
147461946|NCT03665285|531851796|FG000|Overall Study|Started New Anticancer Treatment|1|||
147461947|NCT03665285|531851797|FG001|Overall Study|Started New Anticancer Treatment|1|||
147461948|NCT03665285|531851798|FG002|Overall Study|Started New Anticancer Treatment|2|||
147461949|NCT03665285|531851799|FG003|Overall Study|Started New Anticancer Treatment|4|||
147461950|NCT03665285|531851800|FG004|Overall Study|Started New Anticancer Treatment|1|||
147461951|NCT03665285|531851801|FG005|Overall Study|Started New Anticancer Treatment|1|||
147461952|NCT03665285|531851802|FG006|Overall Study|Started New Anticancer Treatment|2|||
147461953|NCT03665285|531851803|FG007|Overall Study|Started New Anticancer Treatment|15|||
147461954|NCT03665285|531851804|FG008|Overall Study|Started New Anticancer Treatment|1|||
147461955|NCT03665285|531851796|FG000|Overall Study|Disease Progression|0|||
147461956|NCT03665285|531851797|FG001|Overall Study|Disease Progression|0|||
147461957|NCT03665285|531851798|FG002|Overall Study|Disease Progression|3|||
147461958|NCT03665285|531851799|FG003|Overall Study|Disease Progression|1|||
147461959|NCT03665285|531851800|FG004|Overall Study|Disease Progression|0|||
147461960|NCT03665285|531851801|FG005|Overall Study|Disease Progression|0|||
147461961|NCT03665285|531851802|FG006|Overall Study|Disease Progression|0|||
147461962|NCT03665285|531851803|FG007|Overall Study|Disease Progression|7|||
147461963|NCT03665285|531851804|FG008|Overall Study|Disease Progression|1|||
147461964|NCT03665285|531851796|FG000|Overall Study|Hospice|0|||
147461965|NCT03665285|531851797|FG001|Overall Study|Hospice|0|||
147461966|NCT03665285|531851798|FG002|Overall Study|Hospice|0|||
147461967|NCT03665285|531851799|FG003|Overall Study|Hospice|0|||
147461968|NCT03665285|531851800|FG004|Overall Study|Hospice|0|||
147461969|NCT03665285|531851801|FG005|Overall Study|Hospice|0|||
147461970|NCT03665285|531851802|FG006|Overall Study|Hospice|0|||
147461971|NCT03665285|531851803|FG007|Overall Study|Hospice|2|||
147461972|NCT03665285|531851804|FG008|Overall Study|Hospice|0|||
147461973|NCT03665285|531851796|FG000|Overall Study|Withdrawal by Subject|0|||
147615524|NCT05221320|532408991|FG000|Overall Study|Withdrawal by Subject|0|||
147615525|NCT05221320|532408992|FG001|Overall Study|Withdrawal by Subject|3|||
147615526|NCT05221320|532408993|FG002|Overall Study|Withdrawal by Subject|1|||
147615527|NCT05221320|532408994|FG003|Overall Study|Withdrawal by Subject|0|||
147615528|NCT05221320|532408995|FG004|Overall Study|Withdrawal by Subject|0|||
147401519|NCT00857233|531634553|FG000|Overall Study|Adverse Event|24|||
147401520|NCT00857233|531634553|FG000|Overall Study|Lack of Efficacy|1|||
147401521|NCT00857233|531634553|FG000|Overall Study|Non-compliance|1|||
147401522|NCT00857233|531634553|FG000|Overall Study|Withdrawal of Consent|9|||
147401523|NCT00857233|531634553|FG000|Overall Study|Lost to Follow-up|4|||
147401524|NCT00857233|531634553|FG000|Overall Study|Nursing Home Placement|14|||
147401525|NCT00857233|531634553|FG000|Overall Study|Other Reasons|2|||
147401526|NCT00409409|531634554|FG000|Overall Study|Adverse Event|7|||
147401527|NCT00409409|531634555|FG001|Overall Study|Adverse Event|2|||
147401528|NCT00409409|531634554|FG000|Overall Study|Withdrawal by Subject|1|||
147401529|NCT00409409|531634555|FG001|Overall Study|Withdrawal by Subject|1|||
147401530|NCT00409409|531634554|FG000|Overall Study|Any other reason not above-mentioned|0|||
147461974|NCT03665285|531851797|FG001|Overall Study|Withdrawal by Subject|0|||
147461975|NCT03665285|531851798|FG002|Overall Study|Withdrawal by Subject|0|||
147461976|NCT03665285|531851799|FG003|Overall Study|Withdrawal by Subject|0|||
147461977|NCT03665285|531851800|FG004|Overall Study|Withdrawal by Subject|1|||
147461978|NCT03665285|531851801|FG005|Overall Study|Withdrawal by Subject|0|||
147461979|NCT03665285|531851802|FG006|Overall Study|Withdrawal by Subject|0|||
147461980|NCT03665285|531851803|FG007|Overall Study|Withdrawal by Subject|2|||
147461981|NCT03665285|531851804|FG008|Overall Study|Withdrawal by Subject|0|||
147461982|NCT03665285|531851796|FG000|Overall Study|Physician Decision|0|||
147461983|NCT03665285|531851797|FG001|Overall Study|Physician Decision|0|||
147461984|NCT03665285|531851798|FG002|Overall Study|Physician Decision|0|||
147461985|NCT03665285|531851799|FG003|Overall Study|Physician Decision|0|||
147461986|NCT03665285|531851800|FG004|Overall Study|Physician Decision|0|||
147461987|NCT03665285|531851801|FG005|Overall Study|Physician Decision|0|||
147461988|NCT03665285|531851802|FG006|Overall Study|Physician Decision|0|||
147461989|NCT03665285|531851803|FG007|Overall Study|Physician Decision|2|||
147461990|NCT03665285|531851804|FG008|Overall Study|Physician Decision|0|||
147461991|NCT00888355|531851805|FG000|Overall Study|Adverse Event|10|||
147461992|NCT00888355|531851806|FG001|Overall Study|Adverse Event|0|||
147461993|NCT00888355|531851807|FG002|Overall Study|Adverse Event|3|||
147461994|NCT00888355|531851808|FG003|Overall Study|Adverse Event|3|||
147461995|NCT00888355|531851805|FG000|Overall Study|Lack of Efficacy|9|||
147461996|NCT00888355|531851806|FG001|Overall Study|Lack of Efficacy|2|||
147615529|NCT05221320|532408996|FG005|Overall Study|Withdrawal by Subject|0|||
147615530|NCT05221320|532408991|FG000|Overall Study|Death|0|||
147615531|NCT05221320|532408992|FG001|Overall Study|Death|5|||
147615532|NCT05221320|532408993|FG002|Overall Study|Death|6|||
147615533|NCT05221320|532408994|FG003|Overall Study|Death|0|||
147401531|NCT00409409|531634555|FG001|Overall Study|Any other reason not above-mentioned|1|||
147401532|NCT02569957|531634556|FG000|Overall Study|Withdrawal by Subject|0|||
147401533|NCT02569957|531634557|FG001|Overall Study|Withdrawal by Subject|1|||
147401534|NCT02635386|531634558|FG000|Overall Study|Pregnancy|2|||
147401535|NCT02635386|531634559|FG001|Overall Study|Pregnancy|0|||
147401536|NCT02635386|531634560|FG002|Overall Study|Pregnancy|0|||
147401537|NCT02635386|531634561|FG003|Overall Study|Pregnancy|0|||
147401538|NCT02635386|531634562|FG004|Overall Study|Pregnancy|2|||
147401539|NCT02635386|531634558|FG000|Overall Study|Withdrawal by Subject|1|||
147401540|NCT02635386|531634559|FG001|Overall Study|Withdrawal by Subject|1|||
147401541|NCT02635386|531634560|FG002|Overall Study|Withdrawal by Subject|0|||
147401542|NCT02635386|531634561|FG003|Overall Study|Withdrawal by Subject|1|||
147401543|NCT02635386|531634562|FG004|Overall Study|Withdrawal by Subject|0|||
147401544|NCT02635386|531634558|FG000|Overall Study|Physician Decision|0|||
147401545|NCT02635386|531634559|FG001|Overall Study|Physician Decision|1|||
147401546|NCT02635386|531634560|FG002|Overall Study|Physician Decision|0|||
147401547|NCT02635386|531634561|FG003|Overall Study|Physician Decision|0|||
147401548|NCT02635386|531634562|FG004|Overall Study|Physician Decision|0|||
147401549|NCT02635386|531634558|FG000|Overall Study|Moved Out of State|0|||
147401550|NCT02635386|531634559|FG001|Overall Study|Moved Out of State|1|||
147401551|NCT02635386|531634560|FG002|Overall Study|Moved Out of State|0|||
147401552|NCT02635386|531634561|FG003|Overall Study|Moved Out of State|0|||
147401553|NCT02635386|531634562|FG004|Overall Study|Moved Out of State|0|||
147401554|NCT02635386|531634558|FG000|Overall Study|Noncompliant|0|||
147401555|NCT02635386|531634559|FG001|Overall Study|Noncompliant|2|||
147401556|NCT02635386|531634560|FG002|Overall Study|Noncompliant|1|||
147401557|NCT02635386|531634561|FG003|Overall Study|Noncompliant|1|||
147401558|NCT02635386|531634562|FG004|Overall Study|Noncompliant|1|||
147401559|NCT02635386|531634558|FG000|Overall Study|side effects|0|||
147401560|NCT02635386|531634559|FG001|Overall Study|side effects|0|||
147401561|NCT02635386|531634560|FG002|Overall Study|side effects|1|||
147401562|NCT02635386|531634561|FG003|Overall Study|side effects|4|||
147401563|NCT02635386|531634562|FG004|Overall Study|side effects|6|||
147401564|NCT02635386|531634558|FG000|Overall Study|needed other major surgery|0|||
147401565|NCT02635386|531634559|FG001|Overall Study|needed other major surgery|1|||
147401566|NCT02635386|531634560|FG002|Overall Study|needed other major surgery|0|||
147401567|NCT02635386|531634561|FG003|Overall Study|needed other major surgery|0|||
147401568|NCT02635386|531634562|FG004|Overall Study|needed other major surgery|0|||
147401569|NCT02635386|531634558|FG000|Overall Study|Other medical problems not drug related|0|||
147401570|NCT02635386|531634559|FG001|Overall Study|Other medical problems not drug related|0|||
147401571|NCT02635386|531634560|FG002|Overall Study|Other medical problems not drug related|0|||
147401572|NCT02635386|531634561|FG003|Overall Study|Other medical problems not drug related|1|||
147461997|NCT00888355|531851807|FG002|Overall Study|Lack of Efficacy|5|||
147461998|NCT00888355|531851808|FG003|Overall Study|Lack of Efficacy|2|||
147461999|NCT00888355|531851805|FG000|Overall Study|Lost to Follow-up|0|||
147462000|NCT00888355|531851806|FG001|Overall Study|Lost to Follow-up|2|||
147462001|NCT00888355|531851807|FG002|Overall Study|Lost to Follow-up|2|||
147462002|NCT00888355|531851808|FG003|Overall Study|Lost to Follow-up|0|||
147462003|NCT00888355|531851805|FG000|Overall Study|Protocol Violation|3|||
147615534|NCT05221320|532408995|FG004|Overall Study|Death|1|||
147401573|NCT02635386|531634562|FG004|Overall Study|Other medical problems not drug related|0|||
147401574|NCT02706847|531634565|FG000|Period 1: Day 1 to Week 12|Adverse Event|2|||
147401575|NCT02706847|531634566|FG001|Period 1: Day 1 to Week 12|Adverse Event|2|||
147401576|NCT02706847|531634567|FG002|Period 1: Day 1 to Week 12|Adverse Event|1|||
147401577|NCT02706847|531634568|FG003|Period 1: Day 1 to Week 12|Adverse Event|12|||
147401578|NCT02706847|531634565|FG000|Period 1: Day 1 to Week 12|Withdrawal by Subject|2|||
147401579|NCT02706847|531634566|FG001|Period 1: Day 1 to Week 12|Withdrawal by Subject|1|||
147615535|NCT05221320|532408996|FG005|Overall Study|Death|0|||
147462004|NCT00888355|531851806|FG001|Overall Study|Protocol Violation|2|||
147615536|NCT06473519|532408997|FG000|Overall Study|Lost to Follow-up|2|||
147615537|NCT06473519|532408998|FG001|Overall Study|Lost to Follow-up|5|||
147615538|NCT06473519|532408997|FG000|Overall Study|Withdrawal by Subject|1|||
147615539|NCT06473519|532408998|FG001|Overall Study|Withdrawal by Subject|4|||
147615540|NCT06473519|532408997|FG000|Overall Study|Randomized but not vaccinated|1|||
147615541|NCT06473519|532408998|FG001|Overall Study|Randomized but not vaccinated|2|||
147401580|NCT02706847|531634567|FG002|Period 1: Day 1 to Week 12|Withdrawal by Subject|4|||
147401581|NCT02706847|531634568|FG003|Period 1: Day 1 to Week 12|Withdrawal by Subject|2|||
147401582|NCT02706847|531634565|FG000|Period 1: Day 1 to Week 12|Lost to Follow-up|2|||
147401583|NCT02706847|531634566|FG001|Period 1: Day 1 to Week 12|Lost to Follow-up|1|||
147401584|NCT02706847|531634567|FG002|Period 1: Day 1 to Week 12|Lost to Follow-up|0|||
147401585|NCT02706847|531634568|FG003|Period 1: Day 1 to Week 12|Lost to Follow-up|0|||
147401586|NCT02706847|531634565|FG000|Period 1: Day 1 to Week 12|Other|4|||
147401587|NCT02706847|531634566|FG001|Period 1: Day 1 to Week 12|Other|4|||
147401588|NCT02706847|531634567|FG002|Period 1: Day 1 to Week 12|Other|2|||
147401589|NCT02706847|531634568|FG003|Period 1: Day 1 to Week 12|Other|2|||
147401590|NCT02706847|531634565|FG000|Period 1: Day 1 to Week 12|Randomized in Error|0|||
147401591|NCT02706847|531634566|FG001|Period 1: Day 1 to Week 12|Randomized in Error|0|||
147401592|NCT02706847|531634567|FG002|Period 1: Day 1 to Week 12|Randomized in Error|1|||
147401593|NCT02706847|531634568|FG003|Period 1: Day 1 to Week 12|Randomized in Error|0|||
147401594|NCT02706847|531634565|FG000|Period 1: Week 12 to Week 24|Adverse Event|1|||
147401595|NCT02706847|531634566|FG001|Period 1: Week 12 to Week 24|Adverse Event|2|||
147401596|NCT02706847|531634567|FG002|Period 1: Week 12 to Week 24|Adverse Event|2|||
147401597|NCT02706847|531634568|FG003|Period 1: Week 12 to Week 24|Adverse Event|5|||
147401598|NCT02706847|531634565|FG000|Period 1: Week 12 to Week 24|Withdrawal by Subject|1|||
147401599|NCT02706847|531634566|FG001|Period 1: Week 12 to Week 24|Withdrawal by Subject|0|||
147401600|NCT02706847|531634567|FG002|Period 1: Week 12 to Week 24|Withdrawal by Subject|1|||
147401601|NCT02706847|531634568|FG003|Period 1: Week 12 to Week 24|Withdrawal by Subject|4|||
147401602|NCT02706847|531634565|FG000|Period 1: Week 12 to Week 24|Lost to Follow-up|0|||
147401603|NCT02706847|531634566|FG001|Period 1: Week 12 to Week 24|Lost to Follow-up|0|||
147401604|NCT02706847|531634567|FG002|Period 1: Week 12 to Week 24|Lost to Follow-up|0|||
147401605|NCT02706847|531634568|FG003|Period 1: Week 12 to Week 24|Lost to Follow-up|1|||
147401606|NCT02706847|531634565|FG000|Period 1: Week 12 to Week 24|Other|1|||
147401607|NCT02706847|531634566|FG001|Period 1: Week 12 to Week 24|Other|0|||
147401608|NCT02706847|531634567|FG002|Period 1: Week 12 to Week 24|Other|1|||
147401609|NCT02706847|531634568|FG003|Period 1: Week 12 to Week 24|Other|4|||
147401610|NCT02706847|531634565|FG000|Period 2: Week 24 to Week 260|Adverse Event|11|||
147401611|NCT02706847|531634566|FG001|Period 2: Week 24 to Week 260|Adverse Event|9|||
147401612|NCT02706847|531634567|FG002|Period 2: Week 24 to Week 260|Adverse Event|21|||
147401613|NCT02706847|531634568|FG003|Period 2: Week 24 to Week 260|Adverse Event|11|||
147401614|NCT02706847|531634565|FG000|Period 2: Week 24 to Week 260|Withdrawal by Subject|11|||
147401615|NCT02706847|531634566|FG001|Period 2: Week 24 to Week 260|Withdrawal by Subject|10|||
147401616|NCT02706847|531634567|FG002|Period 2: Week 24 to Week 260|Withdrawal by Subject|17|||
147401617|NCT02706847|531634568|FG003|Period 2: Week 24 to Week 260|Withdrawal by Subject|10|||
147401618|NCT02706847|531634565|FG000|Period 2: Week 24 to Week 260|Lost to Follow-up|1|||
147401619|NCT02706847|531634566|FG001|Period 2: Week 24 to Week 260|Lost to Follow-up|5|||
147401620|NCT02706847|531634567|FG002|Period 2: Week 24 to Week 260|Lost to Follow-up|9|||
147401621|NCT02706847|531634568|FG003|Period 2: Week 24 to Week 260|Lost to Follow-up|6|||
147401622|NCT02706847|531634565|FG000|Period 2: Week 24 to Week 260|Lack of Efficacy|5|||
147401623|NCT02706847|531634566|FG001|Period 2: Week 24 to Week 260|Lack of Efficacy|3|||
147401624|NCT02706847|531634567|FG002|Period 2: Week 24 to Week 260|Lack of Efficacy|9|||
147401625|NCT02706847|531634568|FG003|Period 2: Week 24 to Week 260|Lack of Efficacy|8|||
147401626|NCT02706847|531634565|FG000|Period 2: Week 24 to Week 260|Other|8|||
147401627|NCT02706847|531634566|FG001|Period 2: Week 24 to Week 260|Other|5|||
147401628|NCT02706847|531634567|FG002|Period 2: Week 24 to Week 260|Other|15|||
147401629|NCT02706847|531634568|FG003|Period 2: Week 24 to Week 260|Other|15|||
147401630|NCT02058836|531634569|FG000|Overall Study|Withdrawal by Subject|1|||
147401631|NCT02058836|531634570|FG001|Overall Study|Withdrawal by Subject|1|||
147401632|NCT00798304|531634574|FG000|Overall Study|Adverse Event|0|||
147401633|NCT00798304|531634575|FG001|Overall Study|Adverse Event|1|||
147401634|NCT00798304|531634576|FG002|Overall Study|Adverse Event|1|||
147401635|NCT00798304|531634574|FG000|Overall Study|Discontinuation by Sponsor|14|||
147401636|NCT00798304|531634575|FG001|Overall Study|Discontinuation by Sponsor|21|||
147401637|NCT00798304|531634576|FG002|Overall Study|Discontinuation by Sponsor|9|||
147401638|NCT04211389|531634577|FG000|Overall Study|Adverse Event|1|||
147401639|NCT04211389|531634578|FG001|Overall Study|Adverse Event|2|||
147401640|NCT04211389|531634577|FG000|Overall Study|Lost to Follow-up|15|||
147401641|NCT04211389|531634578|FG001|Overall Study|Lost to Follow-up|7|||
147615542|NCT02514447|532409002|FG000|Overall Study|Withdrawal by Subject|3|||
147615543|NCT02514447|532409003|FG001|Overall Study|Withdrawal by Subject|1|||
147615544|NCT02514447|532409004|FG002|Overall Study|Withdrawal by Subject|1|||
147615545|NCT02514447|532409005|FG003|Overall Study|Withdrawal by Subject|0|||
147615546|NCT02514447|532409006|FG004|Overall Study|Withdrawal by Subject|0|||
147462005|NCT00888355|531851807|FG002|Overall Study|Protocol Violation|1|||
147462006|NCT00888355|531851808|FG003|Overall Study|Protocol Violation|2|||
147462007|NCT00888355|531851805|FG000|Overall Study|Withdrawal by Subject|0|||
147462008|NCT00888355|531851806|FG001|Overall Study|Withdrawal by Subject|3|||
147462009|NCT00888355|531851807|FG002|Overall Study|Withdrawal by Subject|1|||
147462010|NCT00888355|531851808|FG003|Overall Study|Withdrawal by Subject|3|||
147462011|NCT03603652|531851810|FG000|Overall Study|Death|2|||
147462012|NCT00666926|531851811|FG000|Overall Study|Adverse Event|0|||
147462013|NCT00666926|531851812|FG001|Overall Study|Adverse Event|0|||
147462014|NCT00666926|531851813|FG002|Overall Study|Adverse Event|0|||
147462015|NCT00666926|531851814|FG003|Overall Study|Adverse Event|0|||
147462016|NCT00666926|531851815|FG004|Overall Study|Adverse Event|0|||
147462017|NCT00666926|531851816|FG005|Overall Study|Adverse Event|0|||
147462018|NCT00666926|531851817|FG006|Overall Study|Adverse Event|0|||
147462019|NCT00666926|531851818|FG007|Overall Study|Adverse Event|0|||
147462020|NCT00666926|531851819|FG008|Overall Study|Adverse Event|0|||
147462021|NCT00666926|531851820|FG009|Overall Study|Adverse Event|2|||
147462022|NCT00666926|531851821|FG010|Overall Study|Adverse Event|2|||
147462023|NCT00666926|531851822|FG011|Overall Study|Adverse Event|2|||
147462024|NCT00666926|531851823|FG012|Overall Study|Adverse Event|0|||
147462025|NCT00666926|531851824|FG013|Overall Study|Adverse Event|1|||
147462026|NCT00666926|531851825|FG014|Overall Study|Adverse Event|0|||
147462027|NCT00666926|531851826|FG015|Overall Study|Adverse Event|0|||
147462028|NCT00666926|531851811|FG000|Overall Study|Laboratory abnormality|0|||
147462029|NCT00666926|531851812|FG001|Overall Study|Laboratory abnormality|0|||
147462030|NCT00666926|531851813|FG002|Overall Study|Laboratory abnormality|0|||
147462031|NCT00666926|531851814|FG003|Overall Study|Laboratory abnormality|0|||
147462032|NCT00666926|531851815|FG004|Overall Study|Laboratory abnormality|0|||
147462033|NCT00666926|531851816|FG005|Overall Study|Laboratory abnormality|0|||
147462034|NCT00666926|531851817|FG006|Overall Study|Laboratory abnormality|0|||
147462035|NCT00666926|531851818|FG007|Overall Study|Laboratory abnormality|0|||
147462036|NCT00666926|531851819|FG008|Overall Study|Laboratory abnormality|0|||
147462037|NCT00666926|531851820|FG009|Overall Study|Laboratory abnormality|0|||
147462038|NCT00666926|531851821|FG010|Overall Study|Laboratory abnormality|1|||
147462039|NCT00666926|531851822|FG011|Overall Study|Laboratory abnormality|0|||
147462040|NCT00666926|531851823|FG012|Overall Study|Laboratory abnormality|0|||
147462041|NCT00666926|531851824|FG013|Overall Study|Laboratory abnormality|0|||
147462042|NCT00666926|531851825|FG014|Overall Study|Laboratory abnormality|0|||
147462043|NCT00666926|531851826|FG015|Overall Study|Laboratory abnormality|1|||
147462044|NCT00666926|531851811|FG000|Overall Study|Lack of Efficacy|0|||
147462045|NCT00666926|531851812|FG001|Overall Study|Lack of Efficacy|0|||
147462046|NCT00666926|531851813|FG002|Overall Study|Lack of Efficacy|0|||
147462047|NCT00666926|531851814|FG003|Overall Study|Lack of Efficacy|0|||
147462048|NCT00666926|531851815|FG004|Overall Study|Lack of Efficacy|0|||
147462049|NCT00666926|531851816|FG005|Overall Study|Lack of Efficacy|1|||
147462050|NCT00666926|531851817|FG006|Overall Study|Lack of Efficacy|0|||
147615547|NCT02514447|532409007|FG005|Overall Study|Withdrawal by Subject|0|||
147615548|NCT02514447|532409008|FG006|Overall Study|Withdrawal by Subject|0|||
147615549|NCT02514447|532409009|FG007|Overall Study|Withdrawal by Subject|1|||
147615550|NCT02514447|532409010|FG008|Overall Study|Withdrawal by Subject|1|||
147462051|NCT00666926|531851818|FG007|Overall Study|Lack of Efficacy|0|||
147462052|NCT00666926|531851819|FG008|Overall Study|Lack of Efficacy|0|||
147462053|NCT00666926|531851820|FG009|Overall Study|Lack of Efficacy|0|||
147462054|NCT00666926|531851821|FG010|Overall Study|Lack of Efficacy|0|||
147462055|NCT00666926|531851822|FG011|Overall Study|Lack of Efficacy|1|||
147462056|NCT00666926|531851823|FG012|Overall Study|Lack of Efficacy|0|||
147462057|NCT00666926|531851824|FG013|Overall Study|Lack of Efficacy|0|||
147462058|NCT00666926|531851825|FG014|Overall Study|Lack of Efficacy|0|||
147462059|NCT00666926|531851826|FG015|Overall Study|Lack of Efficacy|0|||
147462060|NCT00666926|531851811|FG000|Overall Study|Lost to Follow-up|0|||
147615551|NCT02514447|532409002|FG000|Overall Study|Death|24|||
147615552|NCT02514447|532409003|FG001|Overall Study|Death|28|||
147615553|NCT02514447|532409004|FG002|Overall Study|Death|29|||
147615554|NCT02514447|532409005|FG003|Overall Study|Death|0|||
147462061|NCT00666926|531851812|FG001|Overall Study|Lost to Follow-up|0|||
147462062|NCT00666926|531851813|FG002|Overall Study|Lost to Follow-up|0|||
147462063|NCT00666926|531851814|FG003|Overall Study|Lost to Follow-up|1|||
147462064|NCT00666926|531851815|FG004|Overall Study|Lost to Follow-up|0|||
147462065|NCT00666926|531851816|FG005|Overall Study|Lost to Follow-up|0|||
147462066|NCT00666926|531851817|FG006|Overall Study|Lost to Follow-up|0|||
147462067|NCT00666926|531851818|FG007|Overall Study|Lost to Follow-up|0|||
147462068|NCT00666926|531851819|FG008|Overall Study|Lost to Follow-up|0|||
147462069|NCT00666926|531851820|FG009|Overall Study|Lost to Follow-up|0|||
147462070|NCT00666926|531851821|FG010|Overall Study|Lost to Follow-up|0|||
147462071|NCT00666926|531851822|FG011|Overall Study|Lost to Follow-up|0|||
147462072|NCT00666926|531851823|FG012|Overall Study|Lost to Follow-up|0|||
147462073|NCT00666926|531851824|FG013|Overall Study|Lost to Follow-up|0|||
147615555|NCT02514447|532409006|FG004|Overall Study|Death|3|||
147462074|NCT00666926|531851825|FG014|Overall Study|Lost to Follow-up|0|||
147615556|NCT02514447|532409007|FG005|Overall Study|Death|4|||
147462075|NCT00666926|531851826|FG015|Overall Study|Lost to Follow-up|0|||
147462076|NCT00666926|531851811|FG000|Overall Study|Other|2|||
147462077|NCT00666926|531851812|FG001|Overall Study|Other|4|||
147462078|NCT00666926|531851813|FG002|Overall Study|Other|3|||
147462079|NCT00666926|531851814|FG003|Overall Study|Other|3|||
147462080|NCT00666926|531851815|FG004|Overall Study|Other|3|||
147462081|NCT00666926|531851816|FG005|Overall Study|Other|3|||
147462082|NCT00666926|531851817|FG006|Overall Study|Other|4|||
147462083|NCT00666926|531851818|FG007|Overall Study|Other|0|||
147462084|NCT00666926|531851819|FG008|Overall Study|Other|3|||
147462085|NCT00666926|531851820|FG009|Overall Study|Other|5|||
147462086|NCT00666926|531851821|FG010|Overall Study|Other|3|||
147462087|NCT00666926|531851822|FG011|Overall Study|Other|26|||
147462088|NCT00666926|531851823|FG012|Overall Study|Other|3|||
147462089|NCT00666926|531851824|FG013|Overall Study|Other|2|||
147462090|NCT00666926|531851825|FG014|Overall Study|Other|4|||
147462091|NCT00666926|531851826|FG015|Overall Study|Other|4|||
147462092|NCT00666926|531851811|FG000|Overall Study|Withdrawal by Subject|0|||
147462093|NCT00666926|531851812|FG001|Overall Study|Withdrawal by Subject|0|||
147462094|NCT00666926|531851813|FG002|Overall Study|Withdrawal by Subject|0|||
147462095|NCT00666926|531851814|FG003|Overall Study|Withdrawal by Subject|0|||
147462096|NCT00666926|531851815|FG004|Overall Study|Withdrawal by Subject|0|||
147462097|NCT00666926|531851816|FG005|Overall Study|Withdrawal by Subject|0|||
147462098|NCT00666926|531851817|FG006|Overall Study|Withdrawal by Subject|0|||
147462099|NCT00666926|531851818|FG007|Overall Study|Withdrawal by Subject|1|||
147462100|NCT00666926|531851819|FG008|Overall Study|Withdrawal by Subject|0|||
147462101|NCT00666926|531851820|FG009|Overall Study|Withdrawal by Subject|3|||
147462102|NCT00666926|531851821|FG010|Overall Study|Withdrawal by Subject|0|||
147462103|NCT00666926|531851822|FG011|Overall Study|Withdrawal by Subject|3|||
147462104|NCT00666926|531851823|FG012|Overall Study|Withdrawal by Subject|0|||
147462105|NCT00666926|531851824|FG013|Overall Study|Withdrawal by Subject|1|||
147462106|NCT00666926|531851825|FG014|Overall Study|Withdrawal by Subject|3|||
147462107|NCT00666926|531851826|FG015|Overall Study|Withdrawal by Subject|3|||
147462108|NCT00666926|531851811|FG000|Overall Study|Death|0|||
147462109|NCT00666926|531851812|FG001|Overall Study|Death|0|||
147462110|NCT00666926|531851813|FG002|Overall Study|Death|0|||
147462111|NCT00666926|531851814|FG003|Overall Study|Death|0|||
147462112|NCT00666926|531851815|FG004|Overall Study|Death|0|||
147462113|NCT00666926|531851816|FG005|Overall Study|Death|0|||
147462114|NCT00666926|531851817|FG006|Overall Study|Death|0|||
147462115|NCT00666926|531851818|FG007|Overall Study|Death|0|||
147462116|NCT00666926|531851819|FG008|Overall Study|Death|0|||
147462117|NCT00666926|531851820|FG009|Overall Study|Death|0|||
147462118|NCT00666926|531851821|FG010|Overall Study|Death|0|||
147462119|NCT00666926|531851822|FG011|Overall Study|Death|1|||
147462120|NCT00666926|531851823|FG012|Overall Study|Death|0|||
147462121|NCT00666926|531851824|FG013|Overall Study|Death|0|||
147462122|NCT00666926|531851825|FG014|Overall Study|Death|0|||
147462123|NCT00666926|531851826|FG015|Overall Study|Death|0|||
147462124|NCT01960855|531851827|FG000|Overall Study|Subject noncompliant|1|||
147462125|NCT01960855|531851828|FG001|Overall Study|Subject noncompliant|0|||
147462126|NCT01960855|531851829|FG002|Overall Study|Subject noncompliant|0|||
147615557|NCT02514447|532409008|FG006|Overall Study|Death|8|||
147462127|NCT01960855|531851830|FG003|Overall Study|Subject noncompliant|0|||
147462128|NCT01960855|531851831|FG004|Overall Study|Subject noncompliant|0|||
147462129|NCT01960855|531851827|FG000|Overall Study|Adverse Event|2|||
147462130|NCT01960855|531851828|FG001|Overall Study|Adverse Event|0|||
147462131|NCT01960855|531851829|FG002|Overall Study|Adverse Event|6|||
147462132|NCT01960855|531851830|FG003|Overall Study|Adverse Event|2|||
147462133|NCT01960855|531851831|FG004|Overall Study|Adverse Event|2|||
147462134|NCT01960855|531851827|FG000|Overall Study|Lack of Efficacy|1|||
147462135|NCT01960855|531851828|FG001|Overall Study|Lack of Efficacy|1|||
147615558|NCT02514447|532409009|FG007|Overall Study|Death|6|||
147462136|NCT01960855|531851829|FG002|Overall Study|Lack of Efficacy|0|||
147462137|NCT01960855|531851830|FG003|Overall Study|Lack of Efficacy|0|||
147615559|NCT02514447|532409010|FG008|Overall Study|Death|5|||
147462138|NCT01960855|531851831|FG004|Overall Study|Lack of Efficacy|0|||
147462139|NCT01960855|531851827|FG000|Overall Study|Other|2|||
147462140|NCT01960855|531851828|FG001|Overall Study|Other|1|||
147462141|NCT01960855|531851829|FG002|Overall Study|Other|1|||
147462142|NCT01960855|531851830|FG003|Overall Study|Other|1|||
147462143|NCT01960855|531851831|FG004|Overall Study|Other|0|||
147462144|NCT01960855|531851827|FG000|Overall Study|Consent withdrawn by subject|3|||
147462145|NCT01960855|531851828|FG001|Overall Study|Consent withdrawn by subject|1|||
147462146|NCT01960855|531851829|FG002|Overall Study|Consent withdrawn by subject|2|||
147462147|NCT01960855|531851830|FG003|Overall Study|Consent withdrawn by subject|1|||
147462148|NCT01960855|531851831|FG004|Overall Study|Consent withdrawn by subject|1|||
147462149|NCT01960855|531851827|FG000|Overall Study|Lost to Follow-up|2|||
147462150|NCT01960855|531851828|FG001|Overall Study|Lost to Follow-up|1|||
147462151|NCT01960855|531851829|FG002|Overall Study|Lost to Follow-up|0|||
147462152|NCT01960855|531851830|FG003|Overall Study|Lost to Follow-up|0|||
147462153|NCT01960855|531851831|FG004|Overall Study|Lost to Follow-up|2|||
147401642|NCT04211389|531634577|FG000|Overall Study|Protocol Violation|0|||
147401643|NCT04211389|531634578|FG001|Overall Study|Protocol Violation|1|||
147401644|NCT04211389|531634577|FG000|Overall Study|Withdrawal by Subject|10|||
147401645|NCT04211389|531634578|FG001|Overall Study|Withdrawal by Subject|11|||
147401646|NCT02168478|531634587|FG000|Overall Study|Withdrawal by Subject|1|||
147401647|NCT02168478|531634587|FG000|Overall Study|Did Not Consent to Participation|2|||
147401648|NCT02168478|531634587|FG000|Overall Study|Did Not Meet Exclusionary Criteria|1|||
147401649|NCT01530087|531634588|FG000|Overall Study|Physician Decision|2|||
147401650|NCT01087814|531634597|FG000|First Intervention (5 Days)|Withdrawal by Subject|3|||
147401651|NCT01087814|531634598|FG001|First Intervention (5 Days)|Withdrawal by Subject|1|||
147401652|NCT01087814|531634597|FG000|Second Intervention (5 Days)|Physician Decision|1|||
147401653|NCT01087814|531634598|FG001|Second Intervention (5 Days)|Physician Decision|0|||
147401654|NCT01427738|531634599|FG000|Overall Study|Death|12|||
147401655|NCT01427738|531634600|FG001|Overall Study|Death|9|||
147401656|NCT01427738|531634599|FG000|Overall Study|Severe debilitation, unable to continue|0|||
147401657|NCT01427738|531634600|FG001|Overall Study|Severe debilitation, unable to continue|1|||
147401658|NCT01427738|531634599|FG000|Overall Study|Subject unable to get to clinic|5|||
147401659|NCT01427738|531634600|FG001|Overall Study|Subject unable to get to clinic|2|||
147401660|NCT01427738|531634599|FG000|Overall Study|Withdrawal by Subject|0|||
147401661|NCT01427738|531634600|FG001|Overall Study|Withdrawal by Subject|2|||
147401662|NCT01427738|531634599|FG000|Overall Study|Subject not willing to adhere to reqs|1|||
147401663|NCT01427738|531634600|FG001|Overall Study|Subject not willing to adhere to reqs|2|||
147401664|NCT01427738|531634599|FG000|Overall Study|Lost to Follow-up|1|||
147401665|NCT01427738|531634600|FG001|Overall Study|Lost to Follow-up|5|||
147401666|NCT05314374|531634601|FG000|Overall Study|Adverse Event|2|||
147401667|NCT05314374|531634602|FG001|Overall Study|Adverse Event|2|||
147401668|NCT02658175|531634603|FG000|Treatment Period: Weeks 1 to 52|Investigator Judgment|1|||
147401669|NCT02658175|531634604|FG001|Treatment Period: Weeks 1 to 52|Investigator Judgment|0|||
147401670|NCT02658175|531634605|FG002|Treatment Period: Weeks 1 to 52|Investigator Judgment|0|||
147401671|NCT02658175|531634603|FG000|Treatment Period: Weeks 1 to 52|Voluntary Withdrawal|6|||
147401672|NCT02658175|531634604|FG001|Treatment Period: Weeks 1 to 52|Voluntary Withdrawal|2|||
147401673|NCT02658175|531634605|FG002|Treatment Period: Weeks 1 to 52|Voluntary Withdrawal|0|||
147401674|NCT02658175|531634603|FG000|Treatment Period: Weeks 1 to 52|Adverse Event or Serious Adverse Event (SAE)|8|||
147401675|NCT02658175|531634604|FG001|Treatment Period: Weeks 1 to 52|Adverse Event or Serious Adverse Event (SAE)|5|||
147401676|NCT02658175|531634605|FG002|Treatment Period: Weeks 1 to 52|Adverse Event or Serious Adverse Event (SAE)|0|||
147401677|NCT02658175|531634603|FG000|1st Extended Treatment: Weeks 53 to 104|Investigator Judgment|1|||
147401678|NCT02658175|531634604|FG001|1st Extended Treatment: Weeks 53 to 104|Investigator Judgment|0|||
147401679|NCT02658175|531634605|FG002|1st Extended Treatment: Weeks 53 to 104|Investigator Judgment|0|||
147401680|NCT02658175|531634603|FG000|1st Extended Treatment: Weeks 53 to 104|Voluntary Withdrawal|4|||
147401681|NCT02658175|531634604|FG001|1st Extended Treatment: Weeks 53 to 104|Voluntary Withdrawal|0|||
147401682|NCT02658175|531634605|FG002|1st Extended Treatment: Weeks 53 to 104|Voluntary Withdrawal|1|||
147401683|NCT02658175|531634603|FG000|1st Extended Treatment: Weeks 53 to 104|Adverse Event or SAE|7|||
147401684|NCT02658175|531634604|FG001|1st Extended Treatment: Weeks 53 to 104|Adverse Event or SAE|0|||
147401685|NCT02658175|531634605|FG002|1st Extended Treatment: Weeks 53 to 104|Adverse Event or SAE|0|||
147401686|NCT02658175|531634603|FG000|1st Extended Treatment: Weeks 53 to 104|Other|1|||
147401687|NCT02658175|531634604|FG001|1st Extended Treatment: Weeks 53 to 104|Other|0|||
147401688|NCT02658175|531634605|FG002|1st Extended Treatment: Weeks 53 to 104|Other|1|||
147401689|NCT02658175|531634603|FG000|1st Extended Treatment: Weeks 53 to 104|Transferred to Early Access Programs|8|||
147401690|NCT02658175|531634604|FG001|1st Extended Treatment: Weeks 53 to 104|Transferred to Early Access Programs|2|||
147401691|NCT02658175|531634605|FG002|1st Extended Treatment: Weeks 53 to 104|Transferred to Early Access Programs|0|||
147401692|NCT02658175|531634603|FG000|2nd Extended Treatment: Weeks 105 to156|Adverse Event or SAE|0|||
147401693|NCT02658175|531634604|FG001|2nd Extended Treatment: Weeks 105 to156|Adverse Event or SAE|0|||
147401694|NCT02658175|531634605|FG002|2nd Extended Treatment: Weeks 105 to156|Adverse Event or SAE|1|||
147401695|NCT02658175|531634603|FG000|2nd Extended Treatment: Weeks 105 to156|Transferred to Commercial Treatment|1|||
147401696|NCT02658175|531634604|FG001|2nd Extended Treatment: Weeks 105 to156|Transferred to Commercial Treatment|0|||
147401697|NCT02658175|531634605|FG002|2nd Extended Treatment: Weeks 105 to156|Transferred to Commercial Treatment|0|||
147401698|NCT02918292|531634608|FG000|Study Enrollment Prior to Transplant|Death|1|||
147401699|NCT02918292|531634608|FG000|Study Follow up After Transplant|Death|6|||
147401700|NCT02650466|531634611|FG000|Overall Study|Physician Decision|1|||
147401701|NCT02650466|531634611|FG000|Overall Study|Withdrawal by Subject|5|||
147401702|NCT02650466|531634611|FG000|Overall Study|Lost to Follow-up|1|||
147401703|NCT00604188|531634612|FG000|Overall Study|Adverse Event|1|||
147401704|NCT00604188|531634613|FG001|Overall Study|Adverse Event|4|||
147401705|NCT00604188|531634612|FG000|Overall Study|Lost to Follow-up|17|||
147401706|NCT00604188|531634613|FG001|Overall Study|Lost to Follow-up|15|||
147401707|NCT00604188|531634612|FG000|Overall Study|Withdrawal by Subject|5|||
147401708|NCT00604188|531634613|FG001|Overall Study|Withdrawal by Subject|1|||
147462154|NCT02058147|531851832|FG000|Overall Study|Randomized but not treated|0|||
147615560|NCT02514447|532409002|FG000|Overall Study|Lost to Follow-up|1|||
147615561|NCT02514447|532409003|FG001|Overall Study|Lost to Follow-up|0|||
147615562|NCT02514447|532409004|FG002|Overall Study|Lost to Follow-up|0|||
147615563|NCT02514447|532409005|FG003|Overall Study|Lost to Follow-up|0|||
147615564|NCT02514447|532409006|FG004|Overall Study|Lost to Follow-up|0|||
147615565|NCT02514447|532409007|FG005|Overall Study|Lost to Follow-up|0|||
147401709|NCT00604188|531634612|FG000|Overall Study|Non-compliance with protocol|4|||
147401710|NCT00604188|531634613|FG001|Overall Study|Non-compliance with protocol|4|||
147401711|NCT00604188|531634612|FG000|Overall Study|Did not receive study drug|0|||
147401712|NCT00604188|531634613|FG001|Overall Study|Did not receive study drug|1|||
147401713|NCT04599907|531634615|FG000|Overall Study|Withdrawal by Subject|1|||
147401714|NCT04599907|531634616|FG001|Overall Study|Withdrawal by Subject|7|||
147401715|NCT04599907|531634617|FG002|Overall Study|Withdrawal by Subject|6|||
147401716|NCT04599907|531634615|FG000|Overall Study|Lost to Follow-up|0|||
147401717|NCT04599907|531634616|FG001|Overall Study|Lost to Follow-up|1|||
147401718|NCT04599907|531634617|FG002|Overall Study|Lost to Follow-up|0|||
147401719|NCT00443599|531634623|FG000|Overall Study|Physician Decision|2|||
147401720|NCT00443599|531634624|FG001|Overall Study|Physician Decision|1|||
147401721|NCT00443599|531634623|FG000|Overall Study|Death|1|||
147401722|NCT00443599|531634624|FG001|Overall Study|Death|1|||
147401723|NCT00443599|531634623|FG000|Overall Study|Cardiopulmonary bypass canceled|3|||
147401724|NCT00443599|531634624|FG001|Overall Study|Cardiopulmonary bypass canceled|1|||
147401725|NCT00966264|531636628|FG000|Overall Study|Lost to Follow-up|4|||
147401726|NCT00966264|531636629|FG001|Overall Study|Lost to Follow-up|3|||
147401727|NCT00487825|531636630|FG000|Overall Study|Adverse Event|2|||
147401728|NCT00487825|531636631|FG001|Overall Study|Adverse Event|2|||
147401729|NCT00487825|531636630|FG000|Overall Study|Lack of Efficacy|1|||
147401730|NCT00487825|531636631|FG001|Overall Study|Lack of Efficacy|1|||
147401731|NCT00487825|531636630|FG000|Overall Study|Other|3|||
147401732|NCT00487825|531636631|FG001|Overall Study|Other|2|||
147401733|NCT01986114|531636634|FG000|Overall Study|Adverse Event|59|||
147401734|NCT01986114|531636634|FG000|Overall Study|Lack of Efficacy|23|||
147401735|NCT01986114|531636634|FG000|Overall Study|Withdrawal by Subject|58|||
147401736|NCT01986114|531636634|FG000|Overall Study|Noncompliance|3|||
147401737|NCT01986114|531636634|FG000|Overall Study|Protocol Violation|1|||
147401738|NCT01986114|531636634|FG000|Overall Study|Lost to Follow-up|5|||
147401739|NCT01986114|531636634|FG000|Overall Study|Other reason|7|||
147401740|NCT01190644|531636635|FG000|Overall Study|Death|2|||
147401741|NCT01190644|531636635|FG000|Overall Study|Disease progression|1|||
147401742|NCT02366143|531636636|FG000|Overall Study|Death|307|||
147401743|NCT02366143|531636637|FG001|Overall Study|Death|278|||
147401744|NCT02366143|531636638|FG002|Overall Study|Death|280|||
147401745|NCT02366143|531636636|FG000|Overall Study|Lost to Follow-up|2|||
147401746|NCT02366143|531636637|FG001|Overall Study|Lost to Follow-up|4|||
147401747|NCT02366143|531636638|FG002|Overall Study|Lost to Follow-up|2|||
147401748|NCT02366143|531636636|FG000|Overall Study|Physician Decision|1|||
147401749|NCT02366143|531636637|FG001|Overall Study|Physician Decision|2|||
147401750|NCT02366143|531636638|FG002|Overall Study|Physician Decision|1|||
147401751|NCT02366143|531636636|FG000|Overall Study|Protocol Violation|0|||
147401752|NCT02366143|531636637|FG001|Overall Study|Protocol Violation|0|||
147401753|NCT02366143|531636638|FG002|Overall Study|Protocol Violation|2|||
147401754|NCT02366143|531636636|FG000|Overall Study|Withdrawal by Subject|16|||
147401755|NCT02366143|531636637|FG001|Overall Study|Withdrawal by Subject|17|||
147401756|NCT02366143|531636638|FG002|Overall Study|Withdrawal by Subject|22|||
147401757|NCT02366143|531636636|FG000|Overall Study|Sponsor request to withdraw/discontinue patient|0|||
147401758|NCT02366143|531636637|FG001|Overall Study|Sponsor request to withdraw/discontinue patient|6|||
147401759|NCT02366143|531636638|FG002|Overall Study|Sponsor request to withdraw/discontinue patient|0|||
147401760|NCT02366143|531636636|FG000|Overall Study|Increased Microscopic RBCS on Urinalysis|0|||
147401761|NCT02366143|531636637|FG001|Overall Study|Increased Microscopic RBCS on Urinalysis|1|||
147401762|NCT02366143|531636638|FG002|Overall Study|Increased Microscopic RBCS on Urinalysis|0|||
147401763|NCT02366143|531636636|FG000|Overall Study|Randomization Error|1|||
147401764|NCT02366143|531636637|FG001|Overall Study|Randomization Error|0|||
147401765|NCT02366143|531636638|FG002|Overall Study|Randomization Error|0|||
147401766|NCT02366143|531636636|FG000|Overall Study|PI Move and Site Closure|1|||
147401767|NCT02366143|531636637|FG001|Overall Study|PI Move and Site Closure|0|||
147401768|NCT02366143|531636638|FG002|Overall Study|PI Move and Site Closure|1|||
147401769|NCT02366143|531636636|FG000|Overall Study|Study Terminated By Sponsor|0|||
147401770|NCT02366143|531636637|FG001|Overall Study|Study Terminated By Sponsor|0|||
147615566|NCT02514447|532409008|FG006|Overall Study|Lost to Follow-up|0|||
147401771|NCT02366143|531636638|FG002|Overall Study|Study Terminated By Sponsor|2|||
147401772|NCT02366143|531636636|FG000|Overall Study|Sponsor request to withdraw/discontinue patient in survival follow up|70|||
147401773|NCT02366143|531636637|FG001|Overall Study|Sponsor request to withdraw/discontinue patient in survival follow up|57|||
147401774|NCT02366143|531636638|FG002|Overall Study|Sponsor request to withdraw/discontinue patient in survival follow up|52|||
147462155|NCT02058147|531851833|FG001|Overall Study|Randomized but not treated|0|||
147615567|NCT02514447|532409009|FG007|Overall Study|Lost to Follow-up|0|||
147401775|NCT02366143|531636636|FG000|Overall Study|Patient moved to roll-over study|1|||
147401776|NCT02366143|531636637|FG001|Overall Study|Patient moved to roll-over study|19|||
147401777|NCT02366143|531636638|FG002|Overall Study|Patient moved to roll-over study|28|||
147401778|NCT02366143|531636636|FG000|Overall Study|Patient moved to commercial stock|0|||
147401779|NCT02366143|531636637|FG001|Overall Study|Patient moved to commercial stock|0|||
147401780|NCT02366143|531636638|FG002|Overall Study|Patient moved to commercial stock|1|||
147401781|NCT02366143|531636636|FG000|Overall Study|Patient stopped treatment due to disease progression;didn't enter follow up due to study termination|0|||
147401782|NCT02366143|531636637|FG001|Overall Study|Patient stopped treatment due to disease progression;didn't enter follow up due to study termination|0|||
147401783|NCT02366143|531636638|FG002|Overall Study|Patient stopped treatment due to disease progression;didn't enter follow up due to study termination|1|||
147401784|NCT02366143|531636636|FG000|Overall Study|Patient rolling over to patient assistance program|0|||
147401785|NCT02366143|531636637|FG001|Overall Study|Patient rolling over to patient assistance program|0|||
147401786|NCT02366143|531636638|FG002|Overall Study|Patient rolling over to patient assistance program|1|||
147401787|NCT02366143|531636636|FG000|Overall Study|Patient continue same treatment via Post Trial Access Progarm (PTAP)|0|||
147401788|NCT02366143|531636637|FG001|Overall Study|Patient continue same treatment via Post Trial Access Progarm (PTAP)|0|||
147401789|NCT02366143|531636638|FG002|Overall Study|Patient continue same treatment via Post Trial Access Progarm (PTAP)|1|||
147401790|NCT02366143|531636636|FG000|Overall Study|Requester's instructions|1|||
147401791|NCT02366143|531636637|FG001|Overall Study|Requester's instructions|1|||
147401792|NCT02366143|531636638|FG002|Overall Study|Requester's instructions|1|||
147401793|NCT02366143|531636636|FG000|Overall Study|Uneligible|0|||
147401794|NCT02366143|531636637|FG001|Overall Study|Uneligible|1|||
147401795|NCT02366143|531636638|FG002|Overall Study|Uneligible|0|||
147401796|NCT02366143|531636636|FG000|Overall Study|Post Trial Migration|0|||
147401797|NCT02366143|531636637|FG001|Overall Study|Post Trial Migration|1|||
147401798|NCT02366143|531636638|FG002|Overall Study|Post Trial Migration|0|||
147401799|NCT02366143|531636636|FG000|Overall Study|Patient moving onto PTAP commercial stock|0|||
147401800|NCT02366143|531636637|FG001|Overall Study|Patient moving onto PTAP commercial stock|1|||
147401801|NCT02366143|531636638|FG002|Overall Study|Patient moving onto PTAP commercial stock|0|||
147401802|NCT02366143|531636636|FG000|Overall Study|Patient switched to PTAP|0|||
147401803|NCT02366143|531636637|FG001|Overall Study|Patient switched to PTAP|1|||
147401804|NCT02366143|531636638|FG002|Overall Study|Patient switched to PTAP|0|||
147401805|NCT02366143|531636636|FG000|Overall Study|Patient moved to commercial atezolizumab use|0|||
147401806|NCT02366143|531636637|FG001|Overall Study|Patient moved to commercial atezolizumab use|11|||
147401807|NCT02366143|531636638|FG002|Overall Study|Patient moved to commercial atezolizumab use|7|||
147401808|NCT02172911|531636639|FG000|Overall Study|Serious Adverse Event|0|||
147401809|NCT02172911|531636640|FG001|Overall Study|Serious Adverse Event|1|||
147401810|NCT02172911|531636639|FG000|Overall Study|Progression of Disease|0|||
147401811|NCT02172911|531636640|FG001|Overall Study|Progression of Disease|1|||
147401812|NCT02172911|531636639|FG000|Overall Study|Loss of insurance coverage|1|||
147401813|NCT02172911|531636640|FG001|Overall Study|Loss of insurance coverage|0|||
147401814|NCT00575042|531636643|FG000|Overall Study|Adverse Event|2|||
147401815|NCT00575042|531636643|FG000|Overall Study|Lost to Follow-up|1|||
147401816|NCT04795336|531636646|FG000|Overall Study|Withdrawal by Subject|3|||
147401817|NCT04795336|531636647|FG001|Overall Study|Withdrawal by Subject|4|||
147401818|NCT04795336|531636648|FG002|Overall Study|Withdrawal by Subject|3|||
147401819|NCT04795336|531636649|FG003|Overall Study|Withdrawal by Subject|12|||
147401820|NCT04795336|531636646|FG000|Overall Study|Lost study logs|0|||
147401821|NCT04795336|531636647|FG001|Overall Study|Lost study logs|1|||
147401822|NCT04795336|531636648|FG002|Overall Study|Lost study logs|0|||
147401823|NCT04795336|531636649|FG003|Overall Study|Lost study logs|2|||
147401824|NCT04795336|531636646|FG000|Overall Study|Did not take study medication|2|||
147401825|NCT04795336|531636647|FG001|Overall Study|Did not take study medication|0|||
147401826|NCT04795336|531636648|FG002|Overall Study|Did not take study medication|0|||
147401827|NCT04795336|531636649|FG003|Overall Study|Did not take study medication|0|||
147401828|NCT01638390|531636650|FG000|Overall Study|screening failures|21|||
147401829|NCT01536587|531636657|FG000|Overall Study|Adverse Event|2|||
147401830|NCT02666664|531636658|FG000|Overall Study|Physician Decision|0|||
147401831|NCT02666664|531636659|FG001|Overall Study|Physician Decision|1|||
147401832|NCT02666664|531636658|FG000|Overall Study|Protocol Violation|0|||
147401833|NCT02666664|531636659|FG001|Overall Study|Protocol Violation|2|||
147401834|NCT02666664|531636658|FG000|Overall Study|Other|0|||
147401835|NCT02666664|531636659|FG001|Overall Study|Other|1|||
147401836|NCT02666664|531636658|FG000|Overall Study|Adverse Event|12|||
147401837|NCT02666664|531636659|FG001|Overall Study|Adverse Event|37|||
147401838|NCT02666664|531636658|FG000|Overall Study|Withdrawal by participant|23|||
147401839|NCT02666664|531636659|FG001|Overall Study|Withdrawal by participant|40|||
147401840|NCT02666664|531636658|FG000|Overall Study|Sponsor decision|0|||
147401841|NCT02666664|531636659|FG001|Overall Study|Sponsor decision|1|||
147401842|NCT02666664|531636658|FG000|Overall Study|Lost to Follow-up|1|||
147401843|NCT02666664|531636659|FG001|Overall Study|Lost to Follow-up|2|||
147401844|NCT04596995|531636660|FG000|Overall Study|Lack of Efficacy|8|||
147401845|NCT04596995|531636660|FG000|Overall Study|Lost to Follow-up|3|||
147401846|NCT04596995|531636660|FG000|Overall Study|Withdrawal by Subject|12|||
147615568|NCT02514447|532409010|FG008|Overall Study|Lost to Follow-up|1|||
147615569|NCT02514447|532409002|FG000|Overall Study|Sponsor Termination of Study|0|||
147615570|NCT02514447|532409003|FG001|Overall Study|Sponsor Termination of Study|1|||
147615571|NCT02514447|532409004|FG002|Overall Study|Sponsor Termination of Study|1|||
147615572|NCT02514447|532409005|FG003|Overall Study|Sponsor Termination of Study|0|||
147615573|NCT02514447|532409006|FG004|Overall Study|Sponsor Termination of Study|0|||
147615574|NCT02514447|532409007|FG005|Overall Study|Sponsor Termination of Study|0|||
147401847|NCT04596995|531636660|FG000|Overall Study|Sponsor decision|3|||
147401848|NCT04596995|531636660|FG000|Overall Study|Enrolled in managed access program|3|||
147462156|NCT02058147|531851834|FG002|Overall Study|Randomized but not treated|1|||
147462157|NCT02058147|531851832|FG000|Overall Study|Adverse Event|12|||
147462158|NCT02058147|531851833|FG001|Overall Study|Adverse Event|9|||
147462159|NCT02058147|531851834|FG002|Overall Study|Adverse Event|21|||
147462160|NCT02058147|531851832|FG000|Overall Study|Lack of Efficacy|1|||
147462161|NCT02058147|531851833|FG001|Overall Study|Lack of Efficacy|0|||
147462162|NCT02058147|531851834|FG002|Overall Study|Lack of Efficacy|3|||
147462163|NCT02058147|531851832|FG000|Overall Study|Poor compliance to protocol|8|||
147462164|NCT02058147|531851833|FG001|Overall Study|Poor compliance to protocol|9|||
147462165|NCT02058147|531851834|FG002|Overall Study|Poor compliance to protocol|4|||
147462166|NCT02058147|531851832|FG000|Overall Study|Other than specified|8|||
147462167|NCT02058147|531851833|FG001|Overall Study|Other than specified|9|||
147462168|NCT02058147|531851834|FG002|Overall Study|Other than specified|0|||
147462169|NCT01318122|531851837|FG000|Enrolled - Long-Term Extension Study|Adverse Event|0|||
147462170|NCT01318122|531851838|FG001|Enrolled - Long-Term Extension Study|Adverse Event|0|||
147462171|NCT01318122|531851839|FG002|Enrolled - Long-Term Extension Study|Adverse Event|2|||
147401849|NCT00129935|531636661|FG000|Overall Study|Adverse Event|18|||
147401850|NCT00129935|531636662|FG001|Overall Study|Adverse Event|56|||
147401851|NCT00129935|531636661|FG000|Overall Study|Death|1|||
147401852|NCT00129935|531636662|FG001|Overall Study|Death|1|||
147401853|NCT00129935|531636661|FG000|Overall Study|Withdrawal by Subject|7|||
147401854|NCT00129935|531636662|FG001|Overall Study|Withdrawal by Subject|20|||
147401855|NCT00129935|531636661|FG000|Overall Study|Protocol Violation|0|||
147401856|NCT00129935|531636662|FG001|Overall Study|Protocol Violation|4|||
147401857|NCT00129935|531636661|FG000|Overall Study|Physician Decision|3|||
147401858|NCT00129935|531636662|FG001|Overall Study|Physician Decision|4|||
147401859|NCT00129935|531636661|FG000|Overall Study|Recurrence|1|||
147401860|NCT00129935|531636662|FG001|Overall Study|Recurrence|3|||
147401861|NCT00129935|531636661|FG000|Overall Study|Second primary|0|||
147401862|NCT00129935|531636662|FG001|Overall Study|Second primary|1|||
147401863|NCT00129935|531636661|FG000|Overall Study|Other|3|||
147401864|NCT00129935|531636662|FG001|Overall Study|Other|2|||
147401865|NCT00129935|531636661|FG000|Overall Study|Crossed to the other arm|2|||
147401866|NCT00129935|531636662|FG001|Overall Study|Crossed to the other arm|1|||
147401867|NCT00129935|531636661|FG000|Overall Study|Incorrect study treatment|1|||
147401868|NCT00129935|531636662|FG001|Overall Study|Incorrect study treatment|0|||
147401869|NCT02783573|531636664|FG000|Placebo-Controlled Treatment Period|Adverse Event|13|||
147401870|NCT02783573|531636665|FG001|Placebo-Controlled Treatment Period|Adverse Event|17|||
147401871|NCT02783573|531636666|FG002|Placebo-Controlled Treatment Period|Adverse Event|13|||
147401872|NCT02783573|531636664|FG000|Placebo-Controlled Treatment Period|Death|4|||
147401873|NCT02783573|531636665|FG001|Placebo-Controlled Treatment Period|Death|2|||
147401874|NCT02783573|531636666|FG002|Placebo-Controlled Treatment Period|Death|3|||
147401875|NCT02783573|531636664|FG000|Placebo-Controlled Treatment Period|Lack of Efficacy|0|||
147401876|NCT02783573|531636665|FG001|Placebo-Controlled Treatment Period|Lack of Efficacy|0|||
147401877|NCT02783573|531636666|FG002|Placebo-Controlled Treatment Period|Lack of Efficacy|2|||
147401878|NCT02783573|531636664|FG000|Placebo-Controlled Treatment Period|Lost to Follow-up|3|||
147401879|NCT02783573|531636665|FG001|Placebo-Controlled Treatment Period|Lost to Follow-up|3|||
147401880|NCT02783573|531636666|FG002|Placebo-Controlled Treatment Period|Lost to Follow-up|1|||
147401881|NCT02783573|531636664|FG000|Placebo-Controlled Treatment Period|Non-Compliance|0|||
147401882|NCT02783573|531636665|FG001|Placebo-Controlled Treatment Period|Non-Compliance|1|||
147401883|NCT02783573|531636666|FG002|Placebo-Controlled Treatment Period|Non-Compliance|0|||
147401884|NCT02783573|531636664|FG000|Placebo-Controlled Treatment Period|Other-determined by Investigator|0|||
147401885|NCT02783573|531636665|FG001|Placebo-Controlled Treatment Period|Other-determined by Investigator|1|||
147462172|NCT01318122|531851840|FG003|Enrolled - Long-Term Extension Study|Adverse Event|1|||
147462173|NCT01318122|531851837|FG000|Enrolled - Long-Term Extension Study|Other|1|||
147462174|NCT01318122|531851838|FG001|Enrolled - Long-Term Extension Study|Other|0|||
147462175|NCT01318122|531851839|FG002|Enrolled - Long-Term Extension Study|Other|0|||
147615575|NCT02514447|532409008|FG006|Overall Study|Sponsor Termination of Study|0|||
147615576|NCT02514447|532409009|FG007|Overall Study|Sponsor Termination of Study|0|||
147401886|NCT02783573|531636666|FG002|Placebo-Controlled Treatment Period|Other-determined by Investigator|2|||
147401887|NCT02783573|531636664|FG000|Placebo-Controlled Treatment Period|Physician Decision|3|||
147401888|NCT02783573|531636665|FG001|Placebo-Controlled Treatment Period|Physician Decision|1|||
147401889|NCT02783573|531636666|FG002|Placebo-Controlled Treatment Period|Physician Decision|3|||
147401890|NCT02783573|531636664|FG000|Placebo-Controlled Treatment Period|Protocol Violation|1|||
147462176|NCT01318122|531851840|FG003|Enrolled - Long-Term Extension Study|Other|0|||
147462177|NCT01318122|531851837|FG000|Entered - Long-Term Extension Study|Adverse Event|6|||
147462178|NCT01318122|531851838|FG001|Entered - Long-Term Extension Study|Adverse Event|6|||
147462179|NCT01318122|531851839|FG002|Entered - Long-Term Extension Study|Adverse Event|2|||
147462180|NCT01318122|531851840|FG003|Entered - Long-Term Extension Study|Adverse Event|4|||
147462181|NCT01318122|531851837|FG000|Entered - Long-Term Extension Study|Lost to Follow-up|1|||
147462182|NCT01318122|531851838|FG001|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
147462183|NCT01318122|531851839|FG002|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
147462184|NCT01318122|531851840|FG003|Entered - Long-Term Extension Study|Lost to Follow-up|0|||
147462185|NCT01318122|531851837|FG000|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
147462186|NCT01318122|531851838|FG001|Entered - Long-Term Extension Study|Withdrawal by Subject|3|||
147462187|NCT01318122|531851839|FG002|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
147462188|NCT01318122|531851840|FG003|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
147462189|NCT01318122|531851837|FG000|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
147462190|NCT01318122|531851838|FG001|Entered - Long-Term Extension Study|Lack of Efficacy|2|||
147462191|NCT01318122|531851839|FG002|Entered - Long-Term Extension Study|Lack of Efficacy|3|||
147462192|NCT01318122|531851840|FG003|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
147462193|NCT01486199|531851841|FG000|Two Year Period Between Study Days|Physician Decision|1|||
147462194|NCT01486199|531851842|FG001|Two Year Period Between Study Days|Physician Decision|0|||
147462195|NCT04178772|531851849|FG000|Overall Study|Unsatisfacotry VIsual Response|1|||
147462196|NCT04178772|531851849|FG000|Overall Study|study terminated early due to COVID-19|7|||
147462197|NCT04897867|531851859|FG000|Overall Study|Withdrawal of Consent|1|||
147462198|NCT04897867|531851859|FG000|Overall Study|Pregnancy|1|||
147462199|NCT04897867|531851859|FG000|Overall Study|Lost to Follow-up|7|||
147462200|NCT04897867|531851859|FG000|Overall Study|Reason not Specified|2|||
147462201|NCT00330187|531851862|FG000|Overall Study|Lost to Follow-up|12|||
147462202|NCT00330187|531851863|FG001|Overall Study|Lost to Follow-up|13|||
147462203|NCT00330187|531851864|FG002|Overall Study|Lost to Follow-up|14|||
147462204|NCT00330187|531851865|FG003|Overall Study|Lost to Follow-up|10|||
147462205|NCT00330187|531851862|FG000|Overall Study|Withdrawal by Subject|8|||
147462206|NCT00330187|531851863|FG001|Overall Study|Withdrawal by Subject|5|||
147462207|NCT00330187|531851864|FG002|Overall Study|Withdrawal by Subject|4|||
147462208|NCT00330187|531851865|FG003|Overall Study|Withdrawal by Subject|4|||
147462209|NCT02908516|531851866|FG000|Overall Study|Study Terminated|3|||
147462210|NCT02908516|531851867|FG001|Overall Study|Study Terminated|3|||
147462211|NCT01225562|531851868|FG000|Overall Study|Withdrawal by Subject|52|||
147462212|NCT01225562|531851869|FG001|Overall Study|Withdrawal by Subject|50|||
147462213|NCT01225562|531851870|FG002|Overall Study|Withdrawal by Subject|52|||
147462214|NCT01225562|531851868|FG000|Overall Study|Lost to Follow-up|3|||
147462215|NCT01225562|531851869|FG001|Overall Study|Lost to Follow-up|6|||
147462216|NCT01225562|531851870|FG002|Overall Study|Lost to Follow-up|1|||
147462217|NCT02601573|531851873|FG000|Overall Study|Lost to Follow-up|0|||
147462218|NCT02601573|531851874|FG001|Overall Study|Lost to Follow-up|3|||
147462219|NCT02601573|531851875|FG002|Overall Study|Lost to Follow-up|1|||
147462220|NCT02601573|531851876|FG003|Overall Study|Lost to Follow-up|0|||
147462221|NCT02601573|531851877|FG004|Overall Study|Lost to Follow-up|2|||
147462222|NCT02601573|531851873|FG000|Overall Study|Withdrawal by Subject|0|||
147462223|NCT02601573|531851874|FG001|Overall Study|Withdrawal by Subject|1|||
147401891|NCT02783573|531636665|FG001|Placebo-Controlled Treatment Period|Protocol Violation|2|||
147401892|NCT02783573|531636666|FG002|Placebo-Controlled Treatment Period|Protocol Violation|0|||
147401893|NCT02783573|531636664|FG000|Placebo-Controlled Treatment Period|Withdrawal by Subject|15|||
147401894|NCT02783573|531636665|FG001|Placebo-Controlled Treatment Period|Withdrawal by Subject|20|||
147401895|NCT02783573|531636666|FG002|Placebo-Controlled Treatment Period|Withdrawal by Subject|23|||
147401896|NCT02783573|531636664|FG000|Placebo-Controlled Treatment Period|Withdrawal due to Caregiver Circumstance|3|||
147401897|NCT02783573|531636665|FG001|Placebo-Controlled Treatment Period|Withdrawal due to Caregiver Circumstance|3|||
147401898|NCT02783573|531636666|FG002|Placebo-Controlled Treatment Period|Withdrawal due to Caregiver Circumstance|9|||
147401899|NCT02783573|531636664|FG000|Placebo-Controlled Treatment Period|Sponsor Decision|494|||
147401900|NCT02783573|531636665|FG001|Placebo-Controlled Treatment Period|Sponsor Decision|512|||
147401901|NCT02783573|531636666|FG002|Placebo-Controlled Treatment Period|Sponsor Decision|492|||
147462224|NCT02601573|531851875|FG002|Overall Study|Withdrawal by Subject|0|||
147401902|NCT02783573|531636664|FG000|Delayed-Start Period|Sponsor Decision|0|||
147401903|NCT02783573|531636665|FG001|Delayed-Start Period|Sponsor Decision|17|||
147401904|NCT02783573|531636666|FG002|Delayed-Start Period|Sponsor Decision|12|||
147462225|NCT02601573|531851876|FG003|Overall Study|Withdrawal by Subject|1|||
147462226|NCT02601573|531851877|FG004|Overall Study|Withdrawal by Subject|0|||
147462227|NCT00670007|531853744|FG000|Overall Study|Drug abuse|1|||
147462228|NCT00670007|531853744|FG000|Overall Study|Lung transplant|1|||
147462229|NCT00670007|531853744|FG000|Overall Study|Travel/Vacation|1|||
147401905|NCT03020069|531636667|FG000|Overall Study|Lost to Follow-up|0|||
147462230|NCT00670007|531853744|FG000|Overall Study|Adverse event, serious fatal|1|||
147462231|NCT00670007|531853744|FG000|Overall Study|Adverse Event|1|||
147615577|NCT02514447|532409010|FG008|Overall Study|Sponsor Termination of Study|0|||
147462232|NCT00670007|531853744|FG000|Overall Study|Withdrawal by Subject|4|||
147462233|NCT00925600|531853745|FG000|Overall Study|Withdrawal by Subject|16|||
147462234|NCT00925600|531853746|FG001|Overall Study|Withdrawal by Subject|14|||
147462235|NCT00925600|531853745|FG000|Overall Study|Death|4|||
147462236|NCT00925600|531853746|FG001|Overall Study|Death|3|||
147462237|NCT00925600|531853745|FG000|Overall Study|Lost to Follow-up|2|||
147462238|NCT00925600|531853746|FG001|Overall Study|Lost to Follow-up|2|||
147462239|NCT00925600|531853745|FG000|Overall Study|Disease Progression|1|||
147462240|NCT00925600|531853746|FG001|Overall Study|Disease Progression|3|||
147462241|NCT00925600|531853745|FG000|Overall Study|Administrative Decision|1|||
147462242|NCT00925600|531853746|FG001|Overall Study|Administrative Decision|1|||
147615578|NCT02514447|532409002|FG000|Overall Study|Study completion per Investigator|1|||
147615579|NCT02514447|532409003|FG001|Overall Study|Study completion per Investigator|0|||
147615580|NCT02514447|532409004|FG002|Overall Study|Study completion per Investigator|1|||
147615581|NCT02514447|532409005|FG003|Overall Study|Study completion per Investigator|2|||
147615582|NCT02514447|532409006|FG004|Overall Study|Study completion per Investigator|0|||
147615583|NCT02514447|532409007|FG005|Overall Study|Study completion per Investigator|0|||
147615584|NCT02514447|532409008|FG006|Overall Study|Study completion per Investigator|0|||
147615585|NCT02514447|532409009|FG007|Overall Study|Study completion per Investigator|0|||
147615586|NCT02514447|532409010|FG008|Overall Study|Study completion per Investigator|1|||
147615587|NCT03300817|532409012|FG000|Overall Study|Withdrawal by Subject|1|||
147615588|NCT03300817|532409012|FG000|Overall Study|Adverse Event|1|||
147615589|NCT03300817|532409012|FG000|Overall Study|Subject Found to be Ineligible|2|||
147615590|NCT00265759|532409013|FG000|Overall Study|Withdrawal by Subject|0|||
147462243|NCT00925600|531853745|FG000|Overall Study|Noncompliance|2|||
147462244|NCT00925600|531853746|FG001|Overall Study|Noncompliance|0|||
147462245|NCT00925600|531853745|FG000|Overall Study|Ineligibility Determined|2|||
147462246|NCT00925600|531853746|FG001|Overall Study|Ineligibility Determined|0|||
147462247|NCT00925600|531853745|FG000|Overall Study|Protocol Deviation|0|||
147462248|NCT00925600|531853746|FG001|Overall Study|Protocol Deviation|1|||
147462249|NCT00925600|531853745|FG000|Overall Study|Requirement for Alternative Therapy|0|||
147462250|NCT00925600|531853746|FG001|Overall Study|Requirement for Alternative Therapy|1|||
147462251|NCT00925600|531853745|FG000|Overall Study|Other|3|||
147462252|NCT00925600|531853746|FG001|Overall Study|Other|1|||
147462253|NCT00925600|531853745|FG000|Overall Study|Adverse Event|1|||
147462254|NCT00925600|531853746|FG001|Overall Study|Adverse Event|2|||
147462255|NCT00127127|531853751|FG000|Overall Study|Adverse Event|0|||
147462256|NCT00127127|531853752|FG001|Overall Study|Adverse Event|2|||
147462257|NCT00127127|531853753|FG002|Overall Study|Adverse Event|0|||
147462258|NCT00127127|531853754|FG003|Overall Study|Adverse Event|1|||
147462259|NCT00127127|531853751|FG000|Overall Study|Lack of Efficacy|1|||
147462260|NCT00127127|531853752|FG001|Overall Study|Lack of Efficacy|3|||
147462261|NCT00127127|531853753|FG002|Overall Study|Lack of Efficacy|0|||
147462262|NCT00127127|531853754|FG003|Overall Study|Lack of Efficacy|2|||
147462263|NCT01059448|531853756|FG000|Overall Study|Adverse Event|1|||
147462264|NCT01059448|531853757|FG001|Overall Study|Adverse Event|3|||
147462265|NCT01059448|531853758|FG002|Overall Study|Adverse Event|0|||
147462266|NCT01059448|531853759|FG003|Overall Study|Adverse Event|1|||
147462267|NCT01059448|531853756|FG000|Overall Study|Withdrawal by Subject|2|||
147462268|NCT01059448|531853757|FG001|Overall Study|Withdrawal by Subject|0|||
147462269|NCT01059448|531853758|FG002|Overall Study|Withdrawal by Subject|2|||
147462270|NCT01059448|531853759|FG003|Overall Study|Withdrawal by Subject|4|||
147462271|NCT01059448|531853756|FG000|Overall Study|Disease Progression|2|||
147462272|NCT01059448|531853757|FG001|Overall Study|Disease Progression|1|||
147462273|NCT01059448|531853758|FG002|Overall Study|Disease Progression|4|||
147462274|NCT01059448|531853759|FG003|Overall Study|Disease Progression|2|||
147462275|NCT01059448|531853756|FG000|Overall Study|Administrative Decision|43|||
147462276|NCT01059448|531853757|FG001|Overall Study|Administrative Decision|49|||
147615591|NCT00265759|532409014|FG001|Overall Study|Withdrawal by Subject|1|||
147615592|NCT00265759|532409015|FG002|Overall Study|Withdrawal by Subject|2|||
147615593|NCT00265759|532409016|FG003|Overall Study|Withdrawal by Subject|2|||
147615594|NCT00265759|532409013|FG000|Overall Study|Cancel|0|||
147615595|NCT00265759|532409014|FG001|Overall Study|Cancel|0|||
147615596|NCT00265759|532409015|FG002|Overall Study|Cancel|0|||
147615597|NCT00265759|532409016|FG003|Overall Study|Cancel|3|||
147462277|NCT01059448|531853758|FG002|Overall Study|Administrative Decision|45|||
147615598|NCT00265759|532409013|FG000|Overall Study|Ineligible|0|||
147615599|NCT00265759|532409014|FG001|Overall Study|Ineligible|0|||
147615600|NCT00265759|532409015|FG002|Overall Study|Ineligible|0|||
147462278|NCT01059448|531853759|FG003|Overall Study|Administrative Decision|46|||
147462279|NCT01059448|531853756|FG000|Overall Study|Lost to Follow-up|0|||
147462280|NCT01059448|531853757|FG001|Overall Study|Lost to Follow-up|0|||
147462281|NCT01059448|531853758|FG002|Overall Study|Lost to Follow-up|2|||
147462282|NCT01059448|531853759|FG003|Overall Study|Lost to Follow-up|0|||
147462283|NCT01059448|531853756|FG000|Overall Study|Death|0|||
147462284|NCT01059448|531853757|FG001|Overall Study|Death|1|||
147462285|NCT01059448|531853758|FG002|Overall Study|Death|0|||
147462286|NCT01059448|531853759|FG003|Overall Study|Death|0|||
147615601|NCT00265759|532409016|FG003|Overall Study|Ineligible|1|||
147462287|NCT01059448|531853756|FG000|Overall Study|Other|1|||
147462288|NCT01059448|531853757|FG001|Overall Study|Other|1|||
147462289|NCT01059448|531853758|FG002|Overall Study|Other|0|||
147462290|NCT01059448|531853759|FG003|Overall Study|Other|1|||
147462291|NCT00778830|531853760|FG000|Overall Study|Ongoing at data cut-off|0|||
147462292|NCT00778830|531853761|FG001|Overall Study|Ongoing at data cut-off|1|||
147462293|NCT01891643|531853762|FG000|Overall Study|Adverse event unrelated to study drug|2|||
147462294|NCT01891643|531853763|FG001|Overall Study|Adverse event unrelated to study drug|5|||
147462295|NCT01891643|531853762|FG000|Overall Study|Disease Progression|4|||
147462296|NCT01891643|531853763|FG001|Overall Study|Disease Progression|3|||
147462297|NCT01891643|531853762|FG000|Overall Study|Study Drug Toxicity|3|||
147462298|NCT01891643|531853763|FG001|Overall Study|Study Drug Toxicity|0|||
147462299|NCT01891643|531853762|FG000|Overall Study|Maximum Clinical Benefit|0|||
147462300|NCT01891643|531853763|FG001|Overall Study|Maximum Clinical Benefit|1|||
147462301|NCT01891643|531853762|FG000|Overall Study|Poor/Non-compliance|0|||
147462302|NCT01891643|531853763|FG001|Overall Study|Poor/Non-compliance|1|||
147462303|NCT01891643|531853762|FG000|Overall Study|Participant request to discontinue|1|||
147462304|NCT01891643|531853763|FG001|Overall Study|Participant request to discontinue|0|||
147462305|NCT02591615|531853766|FG000|Arm B Pembro Lead in Phase|Withdrawal by Subject|0|||
147462306|NCT02591615|531853767|FG001|Arm B Pembro Lead in Phase|Withdrawal by Subject|0|||
147462307|NCT02591615|531853768|FG002|Arm B Pembro Lead in Phase|Withdrawal by Subject|1|||
147462308|NCT02591615|531853769|FG003|Arm B Pembro Lead in Phase|Withdrawal by Subject|0|||
147462309|NCT02591615|531853766|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Withdrawal by Subject|0|||
147462310|NCT02591615|531853767|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Withdrawal by Subject|1|||
147462311|NCT02591615|531853768|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Withdrawal by Subject|0|||
147462312|NCT02591615|531853769|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Withdrawal by Subject|0|||
147462313|NCT02591615|531853766|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Adverse Event|1|||
147462314|NCT02591615|531853767|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Adverse Event|2|||
147462315|NCT02591615|531853768|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Adverse Event|0|||
147462316|NCT02591615|531853769|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Adverse Event|2|||
147462317|NCT02591615|531853766|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Lack of Efficacy|1|||
147462318|NCT02591615|531853767|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Lack of Efficacy|3|||
147462319|NCT02591615|531853768|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Lack of Efficacy|4|||
147462320|NCT02591615|531853769|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Lack of Efficacy|12|||
147462321|NCT02591615|531853766|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Death|1|||
147462322|NCT02591615|531853767|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Death|2|||
147462323|NCT02591615|531853768|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Death|0|||
147462324|NCT02591615|531853769|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Death|2|||
147462325|NCT02591615|531853766|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Deemed ineligible|0|||
147462326|NCT02591615|531853767|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Deemed ineligible|1|||
147462327|NCT02591615|531853768|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Deemed ineligible|0|||
147462328|NCT02591615|531853769|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Deemed ineligible|0|||
147462329|NCT02591615|531853766|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Withdrew to hospice|1|||
147462330|NCT02591615|531853767|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Withdrew to hospice|0|||
147462331|NCT02591615|531853768|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Withdrew to hospice|0|||
147462332|NCT02591615|531853769|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Withdrew to hospice|1|||
147462333|NCT02591615|531853766|FG000|Platinum Doublet Arm A, MK-3475 Arm B|Non compliance|1|||
147401906|NCT03020069|531636668|FG001|Overall Study|Lost to Follow-up|1|||
147401907|NCT00589303|531636669|FG000|Overall Study|Withdrawal by Subject|2|||
147401908|NCT00589303|531636670|FG001|Overall Study|Withdrawal by Subject|1|||
147401909|NCT02056626|531636671|FG000|Overall Study|patient did not follow directions|3|||
147401910|NCT02056626|531636672|FG001|Overall Study|patient did not follow directions|1|||
147401911|NCT02056626|531636673|FG002|Overall Study|patient did not follow directions|0|||
147401912|NCT02056626|531636674|FG003|Overall Study|patient did not follow directions|0|||
147401913|NCT04978350|531636677|FG000|Overall Study|Lost to Follow-up|6|||
147401914|NCT00013611|531636678|FG000|Overall Study|Lost to Follow-up|91|||
147401915|NCT00013611|531636679|FG001|Overall Study|Lost to Follow-up|100|||
147401916|NCT02577003|531636680|FG000|Overall Study|Adverse Event|2|||
147401917|NCT02577003|531636681|FG001|Overall Study|Adverse Event|4|||
147401918|NCT02577003|531636680|FG000|Overall Study|Withdrawal by Subject|0|||
147462334|NCT02591615|531853767|FG001|Platinum Doublet Arm A, MK-3475 Arm B|Non compliance|0|||
147462335|NCT02591615|531853768|FG002|Platinum Doublet Arm A, MK-3475 Arm B|Non compliance|0|||
147462336|NCT02591615|531853769|FG003|Platinum Doublet Arm A, MK-3475 Arm B|Non compliance|0|||
147462337|NCT02591615|531853766|FG000|MK-3475 Arm A, Platinum Doublet Arm B|Adverse Event|0|||
147462338|NCT02591615|531853767|FG001|MK-3475 Arm A, Platinum Doublet Arm B|Adverse Event|2|||
147462339|NCT02591615|531853768|FG002|MK-3475 Arm A, Platinum Doublet Arm B|Adverse Event|0|||
147462340|NCT02591615|531853769|FG003|MK-3475 Arm A, Platinum Doublet Arm B|Adverse Event|1|||
147462341|NCT02591615|531853766|FG000|MK-3475 Arm A, Platinum Doublet Arm B|Lack of Efficacy|2|||
147462342|NCT02591615|531853767|FG001|MK-3475 Arm A, Platinum Doublet Arm B|Lack of Efficacy|6|||
147462343|NCT02591615|531853768|FG002|MK-3475 Arm A, Platinum Doublet Arm B|Lack of Efficacy|0|||
147401919|NCT02577003|531636681|FG001|Overall Study|Withdrawal by Subject|1|||
147401920|NCT02786004|531636682|FG000|Overall Study|Withdrawal by Subject|0|||
147401921|NCT02786004|531636683|FG001|Overall Study|Withdrawal by Subject|1|||
147401922|NCT01234883|531636684|FG000|Overall Study|Early treatment release|8|||
147401923|NCT01234883|531636685|FG001|Overall Study|Early treatment release|10|||
147401924|NCT01234883|531636684|FG000|Overall Study|Parent/guardian withdrew consent|1|||
147401925|NCT01234883|531636685|FG001|Overall Study|Parent/guardian withdrew consent|2|||
147401926|NCT01234883|531636684|FG000|Overall Study|Technical difficulties with IV infusion|0|||
147401927|NCT01234883|531636685|FG001|Overall Study|Technical difficulties with IV infusion|1|||
147401928|NCT01234883|531636684|FG000|Overall Study|Inclusion/exclusion failure|1|||
147401929|NCT01234883|531636685|FG001|Overall Study|Inclusion/exclusion failure|0|||
147401930|NCT04351269|531636686|FG000|Overall Study|Subjects did not meet Inclusion criteria after protocol revision B|70|||
147401931|NCT04351269|531636687|FG001|Overall Study|Subjects did not meet Inclusion criteria after protocol revision B|32|||
147401932|NCT04351269|531636688|FG002|Overall Study|Subjects did not meet Inclusion criteria after protocol revision B|29|||
147401933|NCT04351269|531636686|FG000|Overall Study|CanGaroo Envelope used during a previous procedure|0|||
147401934|NCT04351269|531636687|FG001|Overall Study|CanGaroo Envelope used during a previous procedure|1|||
147401935|NCT04351269|531636688|FG002|Overall Study|CanGaroo Envelope used during a previous procedure|0|||
147401936|NCT04351269|531636686|FG000|Overall Study|Subjects had both CanGaroo Envelope and TYRX Envelope used during procedure|1|||
147401937|NCT04351269|531636687|FG001|Overall Study|Subjects had both CanGaroo Envelope and TYRX Envelope used during procedure|1|||
147401938|NCT04351269|531636688|FG002|Overall Study|Subjects had both CanGaroo Envelope and TYRX Envelope used during procedure|0|||
147401939|NCT04351269|531636686|FG000|Overall Study|Subjects followed long-term at different health care system|0|||
147401940|NCT04351269|531636687|FG001|Overall Study|Subjects followed long-term at different health care system|4|||
147401941|NCT04351269|531636688|FG002|Overall Study|Subjects followed long-term at different health care system|0|||
147401942|NCT04351269|531636686|FG000|Overall Study|Lost to Follow-up|1|||
147401943|NCT04351269|531636687|FG001|Overall Study|Lost to Follow-up|3|||
147401944|NCT04351269|531636688|FG002|Overall Study|Lost to Follow-up|0|||
147401945|NCT01013961|531636691|FG000|Overall Study|Adverse Event|2|||
147401946|NCT01013961|531636692|FG001|Overall Study|Adverse Event|2|||
147401947|NCT01013961|531636691|FG000|Overall Study|Withdrawal by Subject|1|||
147401948|NCT01013961|531636692|FG001|Overall Study|Withdrawal by Subject|0|||
147401949|NCT01013961|531636691|FG000|Overall Study|Physician Decision|0|||
147401950|NCT01013961|531636692|FG001|Overall Study|Physician Decision|1|||
147401951|NCT00882115|531636693|FG000|Overall Study|Withdrawal by Subject|3|||
147401952|NCT00882115|531636693|FG000|Overall Study|did not respond to DEP challe|6|||
147401953|NCT01271504|531636694|FG000|Overall Study|Death|7|||
147401954|NCT01271504|531636695|FG001|Overall Study|Death|6|||
147401955|NCT01271504|531636696|FG002|Overall Study|Death|32|||
147401956|NCT01271504|531636697|FG003|Overall Study|Death|32|||
147401957|NCT01271504|531636694|FG000|Overall Study|Lost to Follow-up|0|||
147401958|NCT01271504|531636695|FG001|Overall Study|Lost to Follow-up|1|||
147401959|NCT01271504|531636696|FG002|Overall Study|Lost to Follow-up|3|||
147401960|NCT01271504|531636697|FG003|Overall Study|Lost to Follow-up|1|||
147401961|NCT01271504|531636694|FG000|Overall Study|Protocol Violation|0|||
147401962|NCT01271504|531636695|FG001|Overall Study|Protocol Violation|0|||
147401963|NCT01271504|531636696|FG002|Overall Study|Protocol Violation|0|||
147401964|NCT01271504|531636697|FG003|Overall Study|Protocol Violation|2|||
147401965|NCT01271504|531636694|FG000|Overall Study|Administrative Reasons|0|||
147401966|NCT01271504|531636695|FG001|Overall Study|Administrative Reasons|0|||
147401967|NCT01271504|531636696|FG002|Overall Study|Administrative Reasons|6|||
147401968|NCT01271504|531636697|FG003|Overall Study|Administrative Reasons|5|||
147401969|NCT01271504|531636694|FG000|Overall Study|Withdrawal by Subject|0|||
147401970|NCT01271504|531636695|FG001|Overall Study|Withdrawal by Subject|0|||
147401971|NCT01271504|531636696|FG002|Overall Study|Withdrawal by Subject|1|||
147401972|NCT01271504|531636697|FG003|Overall Study|Withdrawal by Subject|3|||
147401973|NCT01271504|531636694|FG000|Overall Study|Other|0|||
147401974|NCT01271504|531636695|FG001|Overall Study|Other|1|||
147401975|NCT01271504|531636696|FG002|Overall Study|Other|2|||
147401976|NCT01271504|531636697|FG003|Overall Study|Other|0|||
147401977|NCT03865953|531636698|FG000|First Intervention (4 Weeks)|Lost to Follow-up|2|||
147401978|NCT03865953|531636699|FG001|First Intervention (4 Weeks)|Lost to Follow-up|0|||
147401979|NCT03865953|531636698|FG000|First Intervention (4 Weeks)|Protocol Violation|0|||
147401980|NCT03865953|531636699|FG001|First Intervention (4 Weeks)|Protocol Violation|1|||
147401981|NCT03865953|531636698|FG000|Second Intervention (4 Weeks)|Lost to Follow-up|0|||
147401982|NCT03865953|531636699|FG001|Second Intervention (4 Weeks)|Lost to Follow-up|2|||
147401983|NCT02229578|531636714|FG000|Overall Study|Withdrawal by Subject|1|||
147401984|NCT02229578|531636715|FG001|Overall Study|Withdrawal by Subject|3|||
147401985|NCT02229578|531636714|FG000|Overall Study|Protocol Violation|2|||
147665247|NCT00922636|532599515|FG000|Overall Study|Sponsor Decision|0|||
147401986|NCT02229578|531636715|FG001|Overall Study|Protocol Violation|0|||
147401987|NCT00943787|531636716|FG000|Overall Study|Physician Decision|4|||
147401988|NCT00943787|531636716|FG000|Overall Study|Withdrawal by Subject|3|||
147401989|NCT00490945|531636717|FG000|Overall Study|Adverse Event|0|||
147401990|NCT00490945|531636718|FG001|Overall Study|Adverse Event|1|||
147462344|NCT02591615|531853769|FG003|MK-3475 Arm A, Platinum Doublet Arm B|Lack of Efficacy|0|||
147462345|NCT02591615|531853766|FG000|MK-3475 Arm A, Platinum Doublet Arm B|Death|0|||
147462346|NCT02591615|531853767|FG001|MK-3475 Arm A, Platinum Doublet Arm B|Death|0|||
147462347|NCT02591615|531853768|FG002|MK-3475 Arm A, Platinum Doublet Arm B|Death|1|||
147462348|NCT02591615|531853769|FG003|MK-3475 Arm A, Platinum Doublet Arm B|Death|1|||
147462349|NCT02591615|531853766|FG000|MK-3475 Arm A, Platinum Doublet Arm B|Alternative Therapy|0|||
147462350|NCT02591615|531853767|FG001|MK-3475 Arm A, Platinum Doublet Arm B|Alternative Therapy|0|||
147462351|NCT02591615|531853768|FG002|MK-3475 Arm A, Platinum Doublet Arm B|Alternative Therapy|1|||
147462352|NCT02591615|531853769|FG003|MK-3475 Arm A, Platinum Doublet Arm B|Alternative Therapy|0|||
147462353|NCT02591615|531853766|FG000|Maintenance MK-3475|Adverse Event|0|||
147462354|NCT02591615|531853767|FG001|Maintenance MK-3475|Adverse Event|3|||
147462355|NCT02591615|531853768|FG002|Maintenance MK-3475|Adverse Event|1|||
147462356|NCT02591615|531853769|FG003|Maintenance MK-3475|Adverse Event|2|||
147462357|NCT02591615|531853766|FG000|Maintenance MK-3475|Lack of Efficacy|0|||
147462358|NCT02591615|531853767|FG001|Maintenance MK-3475|Lack of Efficacy|9|||
147462359|NCT02591615|531853768|FG002|Maintenance MK-3475|Lack of Efficacy|0|||
147462360|NCT02591615|531853769|FG003|Maintenance MK-3475|Lack of Efficacy|8|||
147462361|NCT02591615|531853766|FG000|Maintenance MK-3475|Death|0|||
147462362|NCT02591615|531853767|FG001|Maintenance MK-3475|Death|1|||
147462363|NCT02591615|531853768|FG002|Maintenance MK-3475|Death|1|||
147462364|NCT02591615|531853769|FG003|Maintenance MK-3475|Death|0|||
147462365|NCT02591615|531853766|FG000|Maintenance MK-3475|Physician discretion|0|||
147462366|NCT02591615|531853767|FG001|Maintenance MK-3475|Physician discretion|0|||
147462367|NCT02591615|531853768|FG002|Maintenance MK-3475|Physician discretion|1|||
147462368|NCT02591615|531853769|FG003|Maintenance MK-3475|Physician discretion|0|||
147462369|NCT02591615|531853766|FG000|Maintenance MK-3475|Withdrew to hospice|0|||
147462370|NCT02591615|531853767|FG001|Maintenance MK-3475|Withdrew to hospice|1|||
147462371|NCT02591615|531853768|FG002|Maintenance MK-3475|Withdrew to hospice|0|||
147462372|NCT02591615|531853769|FG003|Maintenance MK-3475|Withdrew to hospice|0|||
147462373|NCT02591615|531853766|FG000|Maintenance MK-3475|In active treatment|2|||
147462374|NCT02591615|531853767|FG001|Maintenance MK-3475|In active treatment|0|||
147462375|NCT02591615|531853768|FG002|Maintenance MK-3475|In active treatment|0|||
147462376|NCT02591615|531853769|FG003|Maintenance MK-3475|In active treatment|1|||
147462377|NCT04188197|531853770|FG000|Overall Study|Lost to Follow-up|4|||
147462378|NCT04188197|531853771|FG001|Overall Study|Lost to Follow-up|1|||
147462379|NCT04188197|531853770|FG000|Overall Study|Withdrawal by Subject|1|||
147462380|NCT04188197|531853771|FG001|Overall Study|Withdrawal by Subject|1|||
147462381|NCT04188197|531853770|FG000|Overall Study|Pregnancy|0|||
147462382|NCT04188197|531853771|FG001|Overall Study|Pregnancy|1|||
147462383|NCT00956943|531853779|FG000|Overall Study|Lost to Follow-up|9|||
147462384|NCT00956943|531853780|FG001|Overall Study|Lost to Follow-up|10|||
147462385|NCT02613208|531853781|FG000|Overall Study|Withdrawal by Subject|1|||
147462386|NCT02613208|531853781|FG000|Overall Study|Change of address|2|||
147462387|NCT02613208|531853781|FG000|Overall Study|Physician Decision|2|||
147462388|NCT02613208|531853781|FG000|Overall Study|Lost to Follow-up|5|||
147462389|NCT02613208|531853781|FG000|Overall Study|Death|37|||
147462390|NCT02663895|531853782|FG000|Overall Study|Adverse Event|3|||
147462391|NCT02663895|531853782|FG000|Overall Study|Physician Decision|2|||
147462392|NCT02663895|531853782|FG000|Overall Study|Progressive Systemic Sclerosis (SSc)|1|||
147462393|NCT02663895|531853782|FG000|Overall Study|Withdrawal by Subject|1|||
147462394|NCT02911688|531853786|FG000|Washout|Lost to Follow-up|1|||
147462395|NCT02911688|531853787|FG001|Washout|Lost to Follow-up|1|||
147462396|NCT02911688|531853786|FG000|Washout|Withdrawal by Subject|0|||
147462397|NCT02911688|531853787|FG001|Washout|Withdrawal by Subject|1|||
147615602|NCT00265759|532409013|FG000|Overall Study|Bilateral disease|0|||
147615603|NCT00265759|532409014|FG001|Overall Study|Bilateral disease|0|||
147615604|NCT00265759|532409015|FG002|Overall Study|Bilateral disease|0|||
147615605|NCT00265759|532409016|FG003|Overall Study|Bilateral disease|2|||
147615606|NCT00265759|532409013|FG000|Overall Study|Discontinued due to intolerability|0|||
147615607|NCT00265759|532409014|FG001|Overall Study|Discontinued due to intolerability|0|||
147615608|NCT00265759|532409015|FG002|Overall Study|Discontinued due to intolerability|0|||
147615609|NCT00265759|532409016|FG003|Overall Study|Discontinued due to intolerability|1|||
147462398|NCT00809328|531853788|FG000|Overall Study|Lack of Efficacy|18|||
147615610|NCT03729596|532409019|FG000|Overall Study|Death|3|||
147615611|NCT03729596|532409020|FG001|Overall Study|Death|5|||
147462399|NCT00809328|531853788|FG000|Overall Study|Adverse Event|6|||
147462400|NCT00809328|531853788|FG000|Overall Study|Protocol Violation|3|||
147462401|NCT00809328|531853788|FG000|Overall Study|Withdrawal by Subject|2|||
147462402|NCT00947531|531853793|FG000|Overall Study|Withdrawal by Subject|10|||
147462403|NCT00947531|531853794|FG001|Overall Study|Withdrawal by Subject|7|||
147462404|NCT00947531|531853793|FG000|Overall Study|Administrative Reason|0|||
147462405|NCT00947531|531853794|FG001|Overall Study|Administrative Reason|1|||
147462406|NCT00947531|531853793|FG000|Overall Study|Adverse Event|2|||
147462407|NCT00947531|531853794|FG001|Overall Study|Adverse Event|2|||
147462408|NCT00947531|531853793|FG000|Overall Study|Lack of Efficacy|1|||
147462409|NCT00947531|531853794|FG001|Overall Study|Lack of Efficacy|0|||
147615612|NCT03729596|532409021|FG002|Overall Study|Death|4|||
147615613|NCT03729596|532409022|FG003|Overall Study|Death|1|||
147462410|NCT00947531|531853793|FG000|Overall Study|Other|1|||
147462411|NCT00947531|531853794|FG001|Overall Study|Other|1|||
147462412|NCT00851903|531853795|FG000|Overall Study|Withdrawal by Subject|2|||
147462413|NCT00270894|531853796|FG000|Overall Study|Adverse Event|1|||
147462414|NCT00270894|531853796|FG000|Overall Study|Withdrawal by Subject|1|||
147462415|NCT01070329|531853797|FG000|Overall Study|Adverse Event|13|||
147462416|NCT01070329|531853798|FG001|Overall Study|Adverse Event|10|||
147462417|NCT01070329|531853797|FG000|Overall Study|Lost to Follow-up|22|||
147462418|NCT01070329|531853798|FG001|Overall Study|Lost to Follow-up|12|||
147462419|NCT01070329|531853797|FG000|Overall Study|Withdrawal by Subject|9|||
147462420|NCT01070329|531853798|FG001|Overall Study|Withdrawal by Subject|11|||
147462421|NCT01070329|531853797|FG000|Overall Study|Protocol Violation|3|||
147462422|NCT01070329|531853798|FG001|Overall Study|Protocol Violation|8|||
147462423|NCT01070329|531853797|FG000|Overall Study|Lack of Efficacy|2|||
147462424|NCT01070329|531853798|FG001|Overall Study|Lack of Efficacy|6|||
147462425|NCT01070329|531853797|FG000|Overall Study|Physician Decision|2|||
147462426|NCT01070329|531853798|FG001|Overall Study|Physician Decision|1|||
147462427|NCT01070329|531853797|FG000|Overall Study|Entry Criteria Not Met|1|||
147462428|NCT01070329|531853798|FG001|Overall Study|Entry Criteria Not Met|0|||
147462429|NCT01070329|531853797|FG000|Overall Study|Sponsor Decision|0|||
147462430|NCT01070329|531853798|FG001|Overall Study|Sponsor Decision|1|||
147462431|NCT02863848|531853799|FG000|Overall Study|Lost to Follow-up|1|||
147462432|NCT02863848|531853800|FG001|Overall Study|Lost to Follow-up|1|||
147462433|NCT02863848|531853799|FG000|Overall Study|Protocol Violation|1|||
147462434|NCT02863848|531853800|FG001|Overall Study|Protocol Violation|2|||
147462435|NCT03116113|531853803|FG000|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
147462436|NCT03116113|531853804|FG001|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
147462437|NCT03116113|531853805|FG002|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
147462438|NCT03116113|531853806|FG003|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
147462439|NCT03116113|531853807|FG004|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
147462440|NCT03116113|531853808|FG005|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
147462441|NCT03116113|531853809|FG006|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|0|||
147462442|NCT03116113|531853810|FG007|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|1|||
147462443|NCT03116113|531853811|FG008|Part 2 (Month 25 up to Month 36)|Withdrew due to Coronavirus 2019COVID-19|2|||
147462444|NCT02159807|531853812|FG000|Overall Study|Adverse Event|0|||
147462445|NCT02159807|531853813|FG001|Overall Study|Adverse Event|0|||
147462446|NCT02159807|531853814|FG002|Overall Study|Adverse Event|1|||
147462447|NCT02159807|531853812|FG000|Overall Study|No CSF|1|||
147462448|NCT02159807|531853813|FG001|Overall Study|No CSF|1|||
147462449|NCT02159807|531853814|FG002|Overall Study|No CSF|1|||
147462450|NCT02159807|531853812|FG000|Overall Study|elevated blood pressure|0|||
147462451|NCT02159807|531853813|FG001|Overall Study|elevated blood pressure|0|||
147462452|NCT02159807|531853814|FG002|Overall Study|elevated blood pressure|1|||
147462453|NCT00950170|531853815|FG000|Overall Study|Parent/Legal Guardian Request|1|||
147462454|NCT00950170|531853815|FG000|Overall Study|Adverse Event|2|||
147462455|NCT00950170|531853815|FG000|Overall Study|Discontinuation of Study by Sponsor|1|||
147462456|NCT01254669|531853816|FG000|Overall Study|Withdrawal by Subject|0|||
147462457|NCT01254669|531853817|FG001|Overall Study|Withdrawal by Subject|1|||
147462458|NCT01254669|531853816|FG000|Overall Study|time constraint|2|||
147462459|NCT01254669|531853817|FG001|Overall Study|time constraint|2|||
147462460|NCT01254669|531853816|FG000|Overall Study|called to clinic during intervention|1|||
147665248|NCT00922636|532599516|FG001|Overall Study|Sponsor Decision|0|||
147665249|NCT00922636|532599517|FG002|Overall Study|Sponsor Decision|2|||
147462461|NCT01254669|531853817|FG001|Overall Study|called to clinic during intervention|1|||
147462462|NCT02367521|531853818|FG000|Overall Study|severe headache after intervention|2|||
147462463|NCT02367521|531853819|FG001|Overall Study|severe headache after intervention|0|||
147462464|NCT02367521|531853818|FG000|Overall Study|unable to find transportation|2|||
147462465|NCT02367521|531853819|FG001|Overall Study|unable to find transportation|0|||
147462466|NCT00600171|531853820|FG000|Overall Study|Adverse Event|0|||
147462467|NCT00600171|531853821|FG001|Overall Study|Adverse Event|1|||
147462468|NCT00600171|531853822|FG002|Overall Study|Adverse Event|0|||
147462469|NCT00600171|531853823|FG003|Overall Study|Adverse Event|0|||
147462470|NCT00600171|531853824|FG004|Overall Study|Adverse Event|1|||
147665250|NCT00922636|532599518|FG003|Overall Study|Sponsor Decision|0|||
147462471|NCT00600171|531853825|FG005|Overall Study|Adverse Event|0|||
147462472|NCT00600171|531853820|FG000|Overall Study|Lack of Efficacy|9|||
147462473|NCT00600171|531853821|FG001|Overall Study|Lack of Efficacy|12|||
147462474|NCT00600171|531853822|FG002|Overall Study|Lack of Efficacy|3|||
147462475|NCT00600171|531853823|FG003|Overall Study|Lack of Efficacy|5|||
147462476|NCT00600171|531853824|FG004|Overall Study|Lack of Efficacy|4|||
147462477|NCT00600171|531853825|FG005|Overall Study|Lack of Efficacy|0|||
147462478|NCT00600171|531853820|FG000|Overall Study|Protocol Violation|1|||
147462479|NCT00600171|531853821|FG001|Overall Study|Protocol Violation|2|||
147462480|NCT00600171|531853822|FG002|Overall Study|Protocol Violation|0|||
147462481|NCT00600171|531853823|FG003|Overall Study|Protocol Violation|1|||
147462482|NCT00600171|531853824|FG004|Overall Study|Protocol Violation|0|||
147462483|NCT00600171|531853825|FG005|Overall Study|Protocol Violation|0|||
147462484|NCT00600171|531853820|FG000|Overall Study|Met Protocol-defined Stopping Criteria|3|||
147462485|NCT00600171|531853821|FG001|Overall Study|Met Protocol-defined Stopping Criteria|1|||
147462486|NCT00600171|531853822|FG002|Overall Study|Met Protocol-defined Stopping Criteria|7|||
147462487|NCT00600171|531853823|FG003|Overall Study|Met Protocol-defined Stopping Criteria|3|||
147462488|NCT00600171|531853824|FG004|Overall Study|Met Protocol-defined Stopping Criteria|2|||
147462489|NCT00600171|531853825|FG005|Overall Study|Met Protocol-defined Stopping Criteria|2|||
147462490|NCT00600171|531853820|FG000|Overall Study|Withdrawal by Subject|3|||
147462491|NCT00600171|531853821|FG001|Overall Study|Withdrawal by Subject|0|||
147462492|NCT00600171|531853822|FG002|Overall Study|Withdrawal by Subject|0|||
147462493|NCT00600171|531853823|FG003|Overall Study|Withdrawal by Subject|1|||
147462494|NCT00600171|531853824|FG004|Overall Study|Withdrawal by Subject|1|||
147462495|NCT00600171|531853825|FG005|Overall Study|Withdrawal by Subject|1|||
147462496|NCT00600171|531853820|FG000|Overall Study|Physician Decision|0|||
147462497|NCT00600171|531853821|FG001|Overall Study|Physician Decision|1|||
147462498|NCT00600171|531853822|FG002|Overall Study|Physician Decision|0|||
147462499|NCT00600171|531853823|FG003|Overall Study|Physician Decision|1|||
147462500|NCT00600171|531853824|FG004|Overall Study|Physician Decision|0|||
147462501|NCT00600171|531853825|FG005|Overall Study|Physician Decision|2|||
147462502|NCT00600171|531853820|FG000|Overall Study|Lost to Follow-up|0|||
147462503|NCT00600171|531853821|FG001|Overall Study|Lost to Follow-up|0|||
147462504|NCT00600171|531853822|FG002|Overall Study|Lost to Follow-up|0|||
147462505|NCT00600171|531853823|FG003|Overall Study|Lost to Follow-up|1|||
147462506|NCT00600171|531853824|FG004|Overall Study|Lost to Follow-up|0|||
147462507|NCT00600171|531853825|FG005|Overall Study|Lost to Follow-up|0|||
147462508|NCT00469612|531853829|FG000|Overall Study|Study terminated before data collected|2|||
147462509|NCT00469612|531853830|FG001|Overall Study|Study terminated before data collected|0|||
147462510|NCT00542191|531853831|FG000|Overall Study|Death|3|||
147462511|NCT00289913|531853834|FG000|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
147462512|NCT00289913|531853835|FG001|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|1|||
147462513|NCT00289913|531853836|FG002|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
147462514|NCT00289913|531853837|FG003|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
147462515|NCT00289913|531853838|FG004|Visit 1 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
147462516|NCT00289913|531853834|FG000|Visit 1 (Stage I and Stage II)|Lost during safety F/U|3|||
147462517|NCT00289913|531853835|FG001|Visit 1 (Stage I and Stage II)|Lost during safety F/U|2|||
147462518|NCT00289913|531853836|FG002|Visit 1 (Stage I and Stage II)|Lost during safety F/U|2|||
147462519|NCT00289913|531853837|FG003|Visit 1 (Stage I and Stage II)|Lost during safety F/U|2|||
147462520|NCT00289913|531853838|FG004|Visit 1 (Stage I and Stage II)|Lost during safety F/U|1|||
147462521|NCT00289913|531853834|FG000|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2|||
147462522|NCT00289913|531853835|FG001|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2|||
147462523|NCT00289913|531853836|FG002|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
147462524|NCT00289913|531853837|FG003|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2|||
147462525|NCT00289913|531853838|FG004|Visit 1 (Stage I and Stage II)|Withdrew consent during safety F/U|2|||
147462526|NCT00289913|531853834|FG000|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0|||
147462527|NCT00289913|531853835|FG001|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0|||
147462528|NCT00289913|531853836|FG002|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0|||
147462529|NCT00289913|531853837|FG003|Visit 1 (Stage I and Stage II)|Moved during safety F/U|0|||
147462530|NCT00289913|531853838|FG004|Visit 1 (Stage I and Stage II)|Moved during safety F/U|1|||
147462531|NCT00289913|531853834|FG000|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0|||
147462532|NCT00289913|531853835|FG001|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0|||
147462533|NCT00289913|531853836|FG002|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0|||
147462534|NCT00289913|531853837|FG003|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|1|||
147462535|NCT00289913|531853838|FG004|Visit 1 (Stage I and Stage II)|Other reasons during safety F/U|0|||
147462536|NCT00289913|531853834|FG000|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|1|||
147462537|NCT00289913|531853835|FG001|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|2|||
147462538|NCT00289913|531853836|FG002|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|0|||
147462539|NCT00289913|531853837|FG003|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|0|||
147462540|NCT00289913|531853838|FG004|Visit 1 (Stage I and Stage II)|Protocol deviation after safety F/U|0|||
147462541|NCT00289913|531853834|FG000|Visit 1 (Stage I and Stage II)|Lost after safety F/U|2|||
147462542|NCT00289913|531853835|FG001|Visit 1 (Stage I and Stage II)|Lost after safety F/U|1|||
147462543|NCT00289913|531853836|FG002|Visit 1 (Stage I and Stage II)|Lost after safety F/U|0|||
147462544|NCT00289913|531853837|FG003|Visit 1 (Stage I and Stage II)|Lost after safety F/U|0|||
147462545|NCT00289913|531853838|FG004|Visit 1 (Stage I and Stage II)|Lost after safety F/U|5|||
147462546|NCT00289913|531853834|FG000|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|0|||
147462547|NCT00289913|531853835|FG001|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|8|||
147615614|NCT03729596|532409023|FG004|Overall Study|Death|0|||
147615615|NCT03729596|532409024|FG005|Overall Study|Death|34|||
147615616|NCT03729596|532409025|FG006|Overall Study|Death|18|||
147401991|NCT00490945|531636719|FG002|Overall Study|Adverse Event|0|||
147401992|NCT00490945|531636720|FG003|Overall Study|Adverse Event|0|||
147401993|NCT00490945|531636721|FG004|Overall Study|Adverse Event|0|||
147401994|NCT03721172|531636728|FG000|Placebo-controlled Phase|Adverse Event|7|||
147401995|NCT03721172|531636729|FG001|Placebo-controlled Phase|Adverse Event|7|||
147401996|NCT03721172|531636730|FG002|Placebo-controlled Phase|Adverse Event|0|||
147401997|NCT03721172|531636728|FG000|Placebo-controlled Phase|Lack of Efficacy|4|||
147401998|NCT03721172|531636729|FG001|Placebo-controlled Phase|Lack of Efficacy|0|||
147401999|NCT03721172|531636730|FG002|Placebo-controlled Phase|Lack of Efficacy|0|||
147402000|NCT03721172|531636728|FG000|Placebo-controlled Phase|Non-compliance with study drug|0|||
147402001|NCT03721172|531636729|FG001|Placebo-controlled Phase|Non-compliance with study drug|1|||
147402002|NCT03721172|531636730|FG002|Placebo-controlled Phase|Non-compliance with study drug|0|||
147402003|NCT03721172|531636728|FG000|Placebo-controlled Phase|Lost to Follow-up|15|||
147402004|NCT03721172|531636729|FG001|Placebo-controlled Phase|Lost to Follow-up|13|||
147402005|NCT03721172|531636730|FG002|Placebo-controlled Phase|Lost to Follow-up|0|||
147402006|NCT03721172|531636728|FG000|Placebo-controlled Phase|Withdrawal by Subject|23|||
147402007|NCT03721172|531636729|FG001|Placebo-controlled Phase|Withdrawal by Subject|18|||
147402008|NCT03721172|531636730|FG002|Placebo-controlled Phase|Withdrawal by Subject|0|||
147402009|NCT03721172|531636728|FG000|Placebo-controlled Phase|Other|3|||
147402010|NCT03721172|531636729|FG001|Placebo-controlled Phase|Other|0|||
147402011|NCT03721172|531636730|FG002|Placebo-controlled Phase|Other|0|||
147402012|NCT03721172|531636728|FG000|Apremilast Extension Phase|Adverse Event|0|||
147402013|NCT03721172|531636729|FG001|Apremilast Extension Phase|Adverse Event|0|||
147402014|NCT03721172|531636730|FG002|Apremilast Extension Phase|Adverse Event|10|||
147402015|NCT03721172|531636728|FG000|Apremilast Extension Phase|Lack of Efficacy|0|||
147402016|NCT03721172|531636729|FG001|Apremilast Extension Phase|Lack of Efficacy|0|||
147402017|NCT03721172|531636730|FG002|Apremilast Extension Phase|Lack of Efficacy|2|||
147402018|NCT03721172|531636728|FG000|Apremilast Extension Phase|Non-compliance with study drug|0|||
147402019|NCT03721172|531636729|FG001|Apremilast Extension Phase|Non-compliance with study drug|0|||
147402020|NCT03721172|531636730|FG002|Apremilast Extension Phase|Non-compliance with study drug|1|||
147402021|NCT03721172|531636728|FG000|Apremilast Extension Phase|Lost to Follow-up|0|||
147402022|NCT03721172|531636729|FG001|Apremilast Extension Phase|Lost to Follow-up|0|||
147402023|NCT03721172|531636730|FG002|Apremilast Extension Phase|Lost to Follow-up|20|||
147402024|NCT03721172|531636728|FG000|Apremilast Extension Phase|Protocol Violation|0|||
147402025|NCT03721172|531636729|FG001|Apremilast Extension Phase|Protocol Violation|0|||
147402026|NCT03721172|531636730|FG002|Apremilast Extension Phase|Protocol Violation|1|||
147402027|NCT03721172|531636728|FG000|Apremilast Extension Phase|Physician Decision|0|||
147402028|NCT03721172|531636729|FG001|Apremilast Extension Phase|Physician Decision|0|||
147402029|NCT03721172|531636730|FG002|Apremilast Extension Phase|Physician Decision|1|||
147402030|NCT03721172|531636728|FG000|Apremilast Extension Phase|Withdrawal by Subject|0|||
147402031|NCT03721172|531636729|FG001|Apremilast Extension Phase|Withdrawal by Subject|0|||
147402032|NCT03721172|531636730|FG002|Apremilast Extension Phase|Withdrawal by Subject|21|||
147402033|NCT03721172|531636728|FG000|Apremilast Extension Phase|Other|0|||
147402034|NCT03721172|531636729|FG001|Apremilast Extension Phase|Other|0|||
147402035|NCT03721172|531636730|FG002|Apremilast Extension Phase|Other|3|||
147402036|NCT03721172|531636728|FG000|Apremilast Extension Phase|Other (Related to COVID-19)|0|||
147402037|NCT03721172|531636729|FG001|Apremilast Extension Phase|Other (Related to COVID-19)|0|||
147402038|NCT03721172|531636730|FG002|Apremilast Extension Phase|Other (Related to COVID-19)|7|||
147402039|NCT01162135|531636732|FG000|Overall Study|Withdrawal by Subject|1|||
147402040|NCT01162135|531636732|FG000|Overall Study|Severe back pain|1|||
147402041|NCT01162135|531636732|FG000|Overall Study|Ineligible|1|||
147402042|NCT01216072|531636735|FG000|Open-Label Core Period ( 6 Months)|Adverse Event|40|||
147402043|NCT01216072|531636736|FG001|Open-Label Core Period ( 6 Months)|Adverse Event|4|||
147402044|NCT01216072|531636735|FG000|Open-Label Core Period ( 6 Months)|Abnormal laboratory value(s)|2|||
147402045|NCT01216072|531636736|FG001|Open-Label Core Period ( 6 Months)|Abnormal laboratory value(s)|0|||
147402046|NCT01216072|531636735|FG000|Open-Label Core Period ( 6 Months)|Abnormal test procedure result(s)|3|||
147402047|NCT01216072|531636736|FG001|Open-Label Core Period ( 6 Months)|Abnormal test procedure result(s)|0|||
147402048|NCT01216072|531636735|FG000|Open-Label Core Period ( 6 Months)|Lack of Efficacy|3|||
147402049|NCT01216072|531636736|FG001|Open-Label Core Period ( 6 Months)|Lack of Efficacy|4|||
147402050|NCT01216072|531636735|FG000|Open-Label Core Period ( 6 Months)|Withdrawal by Subject|12|||
147402051|NCT01216072|531636736|FG001|Open-Label Core Period ( 6 Months)|Withdrawal by Subject|22|||
147402052|NCT01216072|531636735|FG000|Open-Label Core Period ( 6 Months)|Lost to Follow-up|5|||
147402053|NCT01216072|531636736|FG001|Open-Label Core Period ( 6 Months)|Lost to Follow-up|0|||
147402054|NCT01216072|531636735|FG000|Open-Label Core Period ( 6 Months)|Protocol Deviation|11|||
147402055|NCT01216072|531636736|FG001|Open-Label Core Period ( 6 Months)|Protocol Deviation|4|||
147402056|NCT01216072|531636735|FG000|Open-Label Extension Period (3 Months)|Adverse Event|0|||
147402057|NCT01216072|531636736|FG001|Open-Label Extension Period (3 Months)|Adverse Event|10|||
147402058|NCT01216072|531636735|FG000|Open-Label Extension Period (3 Months)|Abnormal test procedure results|0|||
147615617|NCT03729596|532409026|FG007|Overall Study|Death|14|||
147615618|NCT03729596|532409027|FG008|Overall Study|Death|19|||
147615619|NCT03729596|532409028|FG009|Overall Study|Death|9|||
147462548|NCT00289913|531853836|FG002|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|5|||
147462549|NCT00289913|531853837|FG003|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|6|||
147462550|NCT00289913|531853838|FG004|Visit 1 (Stage I and Stage II)|Withdrew consent after safety F/U]|0|||
147402059|NCT01216072|531636736|FG001|Open-Label Extension Period (3 Months)|Abnormal test procedure results|1|||
147402060|NCT01216072|531636735|FG000|Open-Label Extension Period (3 Months)|Withdrawal by Subject|0|||
147402061|NCT01216072|531636736|FG001|Open-Label Extension Period (3 Months)|Withdrawal by Subject|3|||
147402062|NCT02947100|531636740|FG000|Overall Study|study terminated early|3|||
147402063|NCT02947100|531636740|FG000|Overall Study|did not meet inclusion criteria|1|||
147402064|NCT00822770|531636741|FG000|Overall Study|Not treated|1|||
147402065|NCT00822770|531636742|FG001|Overall Study|Not treated|0|||
147402066|NCT00822770|531636741|FG000|Overall Study|Complication/Incomplete treatment|1|||
147402067|NCT00822770|531636742|FG001|Overall Study|Complication/Incomplete treatment|0|||
147402068|NCT00822770|531636741|FG000|Overall Study|Death|1|||
147402069|NCT00822770|531636742|FG001|Overall Study|Death|1|||
147402070|NCT02472145|531636746|FG000|Overall Study|Death|10|||
147402071|NCT02472145|531636747|FG001|Overall Study|Death|101|||
147402072|NCT02472145|531636748|FG002|Overall Study|Death|99|||
147402073|NCT02472145|531636746|FG000|Overall Study|Lost to Follow-up|0|||
147402074|NCT02472145|531636747|FG001|Overall Study|Lost to Follow-up|1|||
147402075|NCT02472145|531636748|FG002|Overall Study|Lost to Follow-up|0|||
147402076|NCT02472145|531636746|FG000|Overall Study|Withdrawal by Subject|0|||
147402077|NCT02472145|531636747|FG001|Overall Study|Withdrawal by Subject|9|||
147402078|NCT02472145|531636748|FG002|Overall Study|Withdrawal by Subject|13|||
147402079|NCT02472145|531636746|FG000|Overall Study|Sponsor decision|0|||
147402080|NCT02472145|531636747|FG001|Overall Study|Sponsor decision|3|||
147402081|NCT02472145|531636748|FG002|Overall Study|Sponsor decision|2|||
147402082|NCT02472145|531636746|FG000|Overall Study|Other|0|||
147402083|NCT02472145|531636747|FG001|Overall Study|Other|45|||
147402084|NCT02472145|531636748|FG002|Overall Study|Other|43|||
147402085|NCT01080326|531636749|FG000|Overall Study|Patient deterioration prior to procedure|3|||
147402086|NCT01080326|531636749|FG000|Overall Study|Surgeon decision|1|||
147402087|NCT01296555|531636750|FG000|Overall Study|Adverse Event|0|||
147402088|NCT01296555|531636751|FG001|Overall Study|Adverse Event|0|||
147402089|NCT01296555|531636752|FG002|Overall Study|Adverse Event|1|||
147402090|NCT01296555|531636753|FG003|Overall Study|Adverse Event|1|||
147402091|NCT01296555|531636754|FG004|Overall Study|Adverse Event|2|||
147402092|NCT01296555|531636755|FG005|Overall Study|Adverse Event|4|||
147402093|NCT01296555|531636756|FG006|Overall Study|Adverse Event|1|||
147402094|NCT01296555|531636757|FG007|Overall Study|Adverse Event|4|||
147402095|NCT01296555|531636758|FG008|Overall Study|Adverse Event|3|||
147402096|NCT01296555|531636759|FG009|Overall Study|Adverse Event|1|||
147402097|NCT01296555|531636760|FG010|Overall Study|Adverse Event|0|||
147402098|NCT01296555|531636761|FG011|Overall Study|Adverse Event|4|||
147402099|NCT01296555|531636762|FG012|Overall Study|Adverse Event|1|||
147402100|NCT01296555|531636763|FG013|Overall Study|Adverse Event|4|||
147402101|NCT01296555|531636764|FG014|Overall Study|Adverse Event|0|||
147402102|NCT01296555|531636765|FG015|Overall Study|Adverse Event|0|||
147402103|NCT01296555|531636766|FG016|Overall Study|Adverse Event|0|||
147402104|NCT01296555|531636767|FG017|Overall Study|Adverse Event|0|||
147402105|NCT01296555|531636768|FG018|Overall Study|Adverse Event|0|||
147402106|NCT01296555|531636769|FG019|Overall Study|Adverse Event|1|||
147402107|NCT01296555|531636770|FG020|Overall Study|Adverse Event|0|||
147402108|NCT01296555|531636771|FG021|Overall Study|Adverse Event|0|||
147402109|NCT01296555|531636772|FG022|Overall Study|Adverse Event|0|||
147402110|NCT01296555|531636773|FG023|Overall Study|Adverse Event|0|||
147402111|NCT01296555|531636774|FG024|Overall Study|Adverse Event|0|||
147402112|NCT01296555|531636775|FG025|Overall Study|Adverse Event|0|||
147402113|NCT01296555|531636776|FG026|Overall Study|Adverse Event|0|||
147402114|NCT01296555|531636777|FG027|Overall Study|Adverse Event|0|||
147402115|NCT01296555|531636778|FG028|Overall Study|Adverse Event|0|||
147402116|NCT01296555|531636750|FG000|Overall Study|Reason Not Specified|0|||
147402117|NCT01296555|531636751|FG001|Overall Study|Reason Not Specified|0|||
147402118|NCT01296555|531636752|FG002|Overall Study|Reason Not Specified|0|||
147402119|NCT01296555|531636753|FG003|Overall Study|Reason Not Specified|0|||
147402120|NCT01296555|531636754|FG004|Overall Study|Reason Not Specified|0|||
147402121|NCT01296555|531636755|FG005|Overall Study|Reason Not Specified|0|||
147402122|NCT01296555|531636756|FG006|Overall Study|Reason Not Specified|0|||
147402123|NCT01296555|531636757|FG007|Overall Study|Reason Not Specified|0|||
147402124|NCT01296555|531636758|FG008|Overall Study|Reason Not Specified|0|||
147402125|NCT01296555|531636759|FG009|Overall Study|Reason Not Specified|0|||
147615620|NCT03729596|532409019|FG000|Overall Study|Lost to Follow-up|0|||
147402126|NCT01296555|531636760|FG010|Overall Study|Reason Not Specified|0|||
147402127|NCT01296555|531636761|FG011|Overall Study|Reason Not Specified|0|||
147402128|NCT01296555|531636762|FG012|Overall Study|Reason Not Specified|0|||
147402129|NCT01296555|531636763|FG013|Overall Study|Reason Not Specified|1|||
147402130|NCT01296555|531636764|FG014|Overall Study|Reason Not Specified|2|||
147615621|NCT03729596|532409020|FG001|Overall Study|Lost to Follow-up|0|||
147615622|NCT03729596|532409021|FG002|Overall Study|Lost to Follow-up|0|||
147462551|NCT00289913|531853834|FG000|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|1|||
147462552|NCT00289913|531853835|FG001|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|0|||
147462553|NCT00289913|531853836|FG002|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|2|||
147462554|NCT00289913|531853837|FG003|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|0|||
147615623|NCT03729596|532409022|FG003|Overall Study|Lost to Follow-up|0|||
147615624|NCT03729596|532409023|FG004|Overall Study|Lost to Follow-up|0|||
147402131|NCT01296555|531636765|FG015|Overall Study|Reason Not Specified|3|||
147402132|NCT01296555|531636766|FG016|Overall Study|Reason Not Specified|7|||
147402133|NCT01296555|531636767|FG017|Overall Study|Reason Not Specified|4|||
147402134|NCT01296555|531636768|FG018|Overall Study|Reason Not Specified|3|||
147402135|NCT01296555|531636769|FG019|Overall Study|Reason Not Specified|7|||
147402136|NCT01296555|531636770|FG020|Overall Study|Reason Not Specified|11|||
147402137|NCT01296555|531636771|FG021|Overall Study|Reason Not Specified|5|||
147402138|NCT01296555|531636772|FG022|Overall Study|Reason Not Specified|5|||
147402139|NCT01296555|531636773|FG023|Overall Study|Reason Not Specified|7|||
147402140|NCT01296555|531636774|FG024|Overall Study|Reason Not Specified|2|||
147402141|NCT01296555|531636775|FG025|Overall Study|Reason Not Specified|2|||
147402142|NCT01296555|531636776|FG026|Overall Study|Reason Not Specified|19|||
147402143|NCT01296555|531636777|FG027|Overall Study|Reason Not Specified|11|||
147402144|NCT01296555|531636778|FG028|Overall Study|Reason Not Specified|9|||
147402145|NCT01296555|531636750|FG000|Overall Study|Physician Decision|0|||
147402146|NCT01296555|531636751|FG001|Overall Study|Physician Decision|0|||
147402147|NCT01296555|531636752|FG002|Overall Study|Physician Decision|0|||
147402148|NCT01296555|531636753|FG003|Overall Study|Physician Decision|0|||
147402149|NCT01296555|531636754|FG004|Overall Study|Physician Decision|1|||
147402150|NCT01296555|531636755|FG005|Overall Study|Physician Decision|0|||
147402151|NCT01296555|531636756|FG006|Overall Study|Physician Decision|0|||
147402152|NCT01296555|531636757|FG007|Overall Study|Physician Decision|0|||
147402153|NCT01296555|531636758|FG008|Overall Study|Physician Decision|0|||
147402154|NCT01296555|531636759|FG009|Overall Study|Physician Decision|0|||
147402155|NCT01296555|531636760|FG010|Overall Study|Physician Decision|0|||
147402156|NCT01296555|531636761|FG011|Overall Study|Physician Decision|0|||
147402157|NCT01296555|531636762|FG012|Overall Study|Physician Decision|0|||
147402158|NCT01296555|531636763|FG013|Overall Study|Physician Decision|1|||
147402159|NCT01296555|531636764|FG014|Overall Study|Physician Decision|0|||
147402160|NCT01296555|531636765|FG015|Overall Study|Physician Decision|0|||
147402161|NCT01296555|531636766|FG016|Overall Study|Physician Decision|0|||
147402162|NCT01296555|531636767|FG017|Overall Study|Physician Decision|0|||
147402163|NCT01296555|531636768|FG018|Overall Study|Physician Decision|0|||
147402164|NCT01296555|531636769|FG019|Overall Study|Physician Decision|1|||
147402165|NCT01296555|531636770|FG020|Overall Study|Physician Decision|0|||
147402166|NCT01296555|531636771|FG021|Overall Study|Physician Decision|0|||
147402167|NCT01296555|531636772|FG022|Overall Study|Physician Decision|0|||
147402168|NCT01296555|531636773|FG023|Overall Study|Physician Decision|0|||
147402169|NCT01296555|531636774|FG024|Overall Study|Physician Decision|0|||
147402170|NCT01296555|531636775|FG025|Overall Study|Physician Decision|0|||
147402171|NCT01296555|531636776|FG026|Overall Study|Physician Decision|0|||
147402172|NCT01296555|531636777|FG027|Overall Study|Physician Decision|0|||
147402173|NCT01296555|531636778|FG028|Overall Study|Physician Decision|0|||
147402174|NCT01296555|531636750|FG000|Overall Study|Progressive Disease|6|||
147402175|NCT01296555|531636751|FG001|Overall Study|Progressive Disease|3|||
147402176|NCT01296555|531636752|FG002|Overall Study|Progressive Disease|3|||
147402177|NCT01296555|531636753|FG003|Overall Study|Progressive Disease|7|||
147402178|NCT01296555|531636754|FG004|Overall Study|Progressive Disease|6|||
147402179|NCT01296555|531636755|FG005|Overall Study|Progressive Disease|16|||
147402180|NCT01296555|531636756|FG006|Overall Study|Progressive Disease|16|||
147402181|NCT01296555|531636757|FG007|Overall Study|Progressive Disease|8|||
147402182|NCT01296555|531636758|FG008|Overall Study|Progressive Disease|7|||
147402183|NCT01296555|531636759|FG009|Overall Study|Progressive Disease|18|||
147402184|NCT01296555|531636760|FG010|Overall Study|Progressive Disease|7|||
147615625|NCT03729596|532409024|FG005|Overall Study|Lost to Follow-up|0|||
147402185|NCT01296555|531636761|FG011|Overall Study|Progressive Disease|14|||
147402186|NCT01296555|531636762|FG012|Overall Study|Progressive Disease|5|||
147615626|NCT03729596|532409025|FG006|Overall Study|Lost to Follow-up|1|||
147402187|NCT01296555|531636763|FG013|Overall Study|Progressive Disease|12|||
147402188|NCT01296555|531636764|FG014|Overall Study|Progressive Disease|1|||
147402189|NCT01296555|531636765|FG015|Overall Study|Progressive Disease|1|||
147402190|NCT01296555|531636766|FG016|Overall Study|Progressive Disease|0|||
147615627|NCT03729596|532409026|FG007|Overall Study|Lost to Follow-up|0|||
147615628|NCT03729596|532409027|FG008|Overall Study|Lost to Follow-up|0|||
147402191|NCT01296555|531636767|FG017|Overall Study|Progressive Disease|0|||
147402192|NCT01296555|531636768|FG018|Overall Study|Progressive Disease|0|||
147402193|NCT01296555|531636769|FG019|Overall Study|Progressive Disease|1|||
147402194|NCT01296555|531636770|FG020|Overall Study|Progressive Disease|0|||
147402195|NCT01296555|531636771|FG021|Overall Study|Progressive Disease|0|||
147402196|NCT01296555|531636772|FG022|Overall Study|Progressive Disease|0|||
147402197|NCT01296555|531636773|FG023|Overall Study|Progressive Disease|0|||
147402198|NCT01296555|531636774|FG024|Overall Study|Progressive Disease|1|||
147402199|NCT01296555|531636775|FG025|Overall Study|Progressive Disease|0|||
147615629|NCT03729596|532409028|FG009|Overall Study|Lost to Follow-up|1|||
147615630|NCT03729596|532409019|FG000|Overall Study|protocol amendment|0|||
147615631|NCT03729596|532409020|FG001|Overall Study|protocol amendment|1|||
147615632|NCT03729596|532409021|FG002|Overall Study|protocol amendment|3|||
147615633|NCT03729596|532409022|FG003|Overall Study|protocol amendment|6|||
147615634|NCT03729596|532409023|FG004|Overall Study|protocol amendment|5|||
147615635|NCT03729596|532409024|FG005|Overall Study|protocol amendment|0|||
147615636|NCT03729596|532409025|FG006|Overall Study|protocol amendment|0|||
147615637|NCT03729596|532409026|FG007|Overall Study|protocol amendment|0|||
147615638|NCT03729596|532409027|FG008|Overall Study|protocol amendment|0|||
147615639|NCT03729596|532409028|FG009|Overall Study|protocol amendment|0|||
147615640|NCT03729596|532409019|FG000|Overall Study|Withdrawal by Subject|0|||
147402200|NCT01296555|531636776|FG026|Overall Study|Progressive Disease|5|||
147402201|NCT01296555|531636777|FG027|Overall Study|Progressive Disease|1|||
147402202|NCT01296555|531636778|FG028|Overall Study|Progressive Disease|0|||
147402203|NCT01296555|531636750|FG000|Overall Study|Protocol Violation|0|||
147402204|NCT01296555|531636751|FG001|Overall Study|Protocol Violation|0|||
147402205|NCT01296555|531636752|FG002|Overall Study|Protocol Violation|0|||
147402206|NCT01296555|531636753|FG003|Overall Study|Protocol Violation|0|||
147402207|NCT01296555|531636754|FG004|Overall Study|Protocol Violation|0|||
147402208|NCT01296555|531636755|FG005|Overall Study|Protocol Violation|0|||
147402209|NCT01296555|531636756|FG006|Overall Study|Protocol Violation|0|||
147402210|NCT01296555|531636757|FG007|Overall Study|Protocol Violation|0|||
147402211|NCT01296555|531636758|FG008|Overall Study|Protocol Violation|0|||
147402212|NCT01296555|531636759|FG009|Overall Study|Protocol Violation|0|||
147402213|NCT01296555|531636760|FG010|Overall Study|Protocol Violation|0|||
147402214|NCT01296555|531636761|FG011|Overall Study|Protocol Violation|0|||
147402215|NCT01296555|531636762|FG012|Overall Study|Protocol Violation|0|||
147402216|NCT01296555|531636763|FG013|Overall Study|Protocol Violation|1|||
147402217|NCT01296555|531636764|FG014|Overall Study|Protocol Violation|0|||
147402218|NCT01296555|531636765|FG015|Overall Study|Protocol Violation|0|||
147402219|NCT01296555|531636766|FG016|Overall Study|Protocol Violation|0|||
147402220|NCT01296555|531636767|FG017|Overall Study|Protocol Violation|0|||
147402221|NCT01296555|531636768|FG018|Overall Study|Protocol Violation|0|||
147402222|NCT01296555|531636769|FG019|Overall Study|Protocol Violation|0|||
147402223|NCT01296555|531636770|FG020|Overall Study|Protocol Violation|0|||
147402224|NCT01296555|531636771|FG021|Overall Study|Protocol Violation|0|||
147402225|NCT01296555|531636772|FG022|Overall Study|Protocol Violation|0|||
147402226|NCT01296555|531636773|FG023|Overall Study|Protocol Violation|0|||
147402227|NCT01296555|531636774|FG024|Overall Study|Protocol Violation|0|||
147402228|NCT01296555|531636775|FG025|Overall Study|Protocol Violation|0|||
147402229|NCT01296555|531636776|FG026|Overall Study|Protocol Violation|0|||
147402230|NCT01296555|531636777|FG027|Overall Study|Protocol Violation|0|||
147402231|NCT01296555|531636778|FG028|Overall Study|Protocol Violation|0|||
147402232|NCT01296555|531636750|FG000|Overall Study|Study Terminated By Sponsor|0|||
147402233|NCT01296555|531636751|FG001|Overall Study|Study Terminated By Sponsor|0|||
147402234|NCT01296555|531636752|FG002|Overall Study|Study Terminated By Sponsor|0|||
147402235|NCT01296555|531636753|FG003|Overall Study|Study Terminated By Sponsor|0|||
147402236|NCT01296555|531636754|FG004|Overall Study|Study Terminated By Sponsor|0|||
147402237|NCT01296555|531636755|FG005|Overall Study|Study Terminated By Sponsor|0|||
147402238|NCT01296555|531636756|FG006|Overall Study|Study Terminated By Sponsor|0|||
147402239|NCT01296555|531636757|FG007|Overall Study|Study Terminated By Sponsor|0|||
147402240|NCT01296555|531636758|FG008|Overall Study|Study Terminated By Sponsor|0|||
147402241|NCT01296555|531636759|FG009|Overall Study|Study Terminated By Sponsor|0|||
147402242|NCT01296555|531636760|FG010|Overall Study|Study Terminated By Sponsor|0|||
147402243|NCT01296555|531636761|FG011|Overall Study|Study Terminated By Sponsor|0|||
147402244|NCT01296555|531636762|FG012|Overall Study|Study Terminated By Sponsor|0|||
147402245|NCT01296555|531636763|FG013|Overall Study|Study Terminated By Sponsor|0|||
147462555|NCT00289913|531853838|FG004|Visit 1 (Stage I and Stage II)|Other reasons after safety F/U|0|||
147615641|NCT03729596|532409020|FG001|Overall Study|Withdrawal by Subject|0|||
147615642|NCT03729596|532409021|FG002|Overall Study|Withdrawal by Subject|0|||
147402246|NCT01296555|531636764|FG014|Overall Study|Study Terminated By Sponsor|0|||
147402247|NCT01296555|531636765|FG015|Overall Study|Study Terminated By Sponsor|0|||
147462556|NCT00289913|531853834|FG000|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
147615643|NCT03729596|532409022|FG003|Overall Study|Withdrawal by Subject|0|||
147615644|NCT03729596|532409023|FG004|Overall Study|Withdrawal by Subject|0|||
147615645|NCT03729596|532409024|FG005|Overall Study|Withdrawal by Subject|4|||
147402248|NCT01296555|531636766|FG016|Overall Study|Study Terminated By Sponsor|0|||
147402249|NCT01296555|531636767|FG017|Overall Study|Study Terminated By Sponsor|0|||
147402250|NCT01296555|531636768|FG018|Overall Study|Study Terminated By Sponsor|0|||
147402251|NCT01296555|531636769|FG019|Overall Study|Study Terminated By Sponsor|0|||
147402252|NCT01296555|531636770|FG020|Overall Study|Study Terminated By Sponsor|0|||
147402253|NCT01296555|531636771|FG021|Overall Study|Study Terminated By Sponsor|0|||
147402254|NCT01296555|531636772|FG022|Overall Study|Study Terminated By Sponsor|0|||
147615646|NCT03729596|532409025|FG006|Overall Study|Withdrawal by Subject|2|||
147615647|NCT03729596|532409026|FG007|Overall Study|Withdrawal by Subject|3|||
147615648|NCT03729596|532409027|FG008|Overall Study|Withdrawal by Subject|2|||
147615649|NCT03729596|532409028|FG009|Overall Study|Withdrawal by Subject|3|||
147462557|NCT00289913|531853835|FG001|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
147462558|NCT00289913|531853836|FG002|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|1|||
147462559|NCT00289913|531853837|FG003|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
147462560|NCT00289913|531853838|FG004|Visit 2 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
147462561|NCT00289913|531853834|FG000|Visit 2 (Stage I and Stage II)|Lost during safety F/U|8|||
147462562|NCT00289913|531853835|FG001|Visit 2 (Stage I and Stage II)|Lost during safety F/U|11|||
147462563|NCT00289913|531853836|FG002|Visit 2 (Stage I and Stage II)|Lost during safety F/U|2|||
147462564|NCT00289913|531853837|FG003|Visit 2 (Stage I and Stage II)|Lost during safety F/U|2|||
147462565|NCT00289913|531853838|FG004|Visit 2 (Stage I and Stage II)|Lost during safety F/U|0|||
147462566|NCT00289913|531853834|FG000|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0|||
147462567|NCT00289913|531853835|FG001|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|1|||
147462568|NCT00289913|531853836|FG002|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0|||
147462569|NCT00289913|531853837|FG003|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0|||
147462570|NCT00289913|531853838|FG004|Visit 2 (Stage I and Stage II)|Subject moved during safety F/U|0|||
147462571|NCT00289913|531853834|FG000|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|3|||
147462572|NCT00289913|531853835|FG001|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|2|||
147462573|NCT00289913|531853836|FG002|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|1|||
147462574|NCT00289913|531853837|FG003|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
147462575|NCT00289913|531853838|FG004|Visit 2 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
147462576|NCT00289913|531853834|FG000|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|1|||
147462577|NCT00289913|531853835|FG001|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|0|||
147462578|NCT00289913|531853836|FG002|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|1|||
147462579|NCT00289913|531853837|FG003|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|0|||
147462580|NCT00289913|531853838|FG004|Visit 2 (Stage I and Stage II)|Other reasons during safety F/U|0|||
147462581|NCT00289913|531853834|FG000|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|0|||
147462582|NCT00289913|531853835|FG001|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|1|||
147462583|NCT00289913|531853836|FG002|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|3|||
147462584|NCT00289913|531853837|FG003|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|1|||
147462585|NCT00289913|531853838|FG004|Visit 2 (Stage I and Stage II)|Protocol deviation after safety F/U|0|||
147462586|NCT00289913|531853834|FG000|Visit 2 (Stage I and Stage II)|Lost after safety F/U|2|||
147462587|NCT00289913|531853835|FG001|Visit 2 (Stage I and Stage II)|Lost after safety F/U|5|||
147615650|NCT03729596|532409019|FG000|Overall Study|study terminated by sponsor|0|||
147615651|NCT03729596|532409020|FG001|Overall Study|study terminated by sponsor|0|||
147462588|NCT00289913|531853836|FG002|Visit 2 (Stage I and Stage II)|Lost after safety F/U|0|||
147462589|NCT00289913|531853837|FG003|Visit 2 (Stage I and Stage II)|Lost after safety F/U|3|||
147462590|NCT00289913|531853838|FG004|Visit 2 (Stage I and Stage II)|Lost after safety F/U|0|||
147462591|NCT00289913|531853834|FG000|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|0|||
147462592|NCT00289913|531853835|FG001|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|1|||
147462593|NCT00289913|531853836|FG002|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|2|||
147462594|NCT00289913|531853837|FG003|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|0|||
147462595|NCT00289913|531853838|FG004|Visit 2 (Stage I and Stage II)|Withdrew consent after safety F/U|0|||
147462596|NCT00289913|531853834|FG000|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|1|||
147462597|NCT00289913|531853835|FG001|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0|||
147462598|NCT00289913|531853836|FG002|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0|||
147462599|NCT00289913|531853837|FG003|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0|||
147462600|NCT00289913|531853838|FG004|Visit 2 (Stage I and Stage II)|Other reasons after safety F/U]|0|||
147462601|NCT00289913|531853834|FG000|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0|||
147462602|NCT00289913|531853835|FG001|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0|||
147462603|NCT00289913|531853836|FG002|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0|||
147462604|NCT00289913|531853837|FG003|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|0|||
147462605|NCT00289913|531853838|FG004|Visit 2 (Stage I and Stage II)|Protocol deviation (Stage II)|7|||
147462606|NCT00289913|531853834|FG000|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0|||
147462607|NCT00289913|531853835|FG001|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0|||
147462608|NCT00289913|531853836|FG002|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0|||
147462609|NCT00289913|531853837|FG003|Visit 2 (Stage I and Stage II)|Lost (Stage II)|0|||
147462610|NCT00289913|531853838|FG004|Visit 2 (Stage I and Stage II)|Lost (Stage II)|11|||
147462611|NCT00289913|531853834|FG000|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0|||
147462612|NCT00289913|531853835|FG001|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0|||
147462613|NCT00289913|531853836|FG002|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0|||
147615652|NCT03729596|532409021|FG002|Overall Study|study terminated by sponsor|0|||
147615653|NCT03729596|532409022|FG003|Overall Study|study terminated by sponsor|0|||
147615654|NCT03729596|532409023|FG004|Overall Study|study terminated by sponsor|1|||
147615655|NCT03729596|532409024|FG005|Overall Study|study terminated by sponsor|3|||
147615656|NCT03729596|532409025|FG006|Overall Study|study terminated by sponsor|0|||
147462614|NCT00289913|531853837|FG003|Visit 2 (Stage I and Stage II)|Moved (Stage II)|0|||
147462615|NCT00289913|531853838|FG004|Visit 2 (Stage I and Stage II)|Moved (Stage II)|6|||
147462616|NCT00289913|531853834|FG000|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0|||
147462617|NCT00289913|531853835|FG001|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0|||
147462618|NCT00289913|531853836|FG002|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0|||
147462619|NCT00289913|531853837|FG003|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|0|||
147462620|NCT00289913|531853838|FG004|Visit 2 (Stage I and Stage II)|Withdrew consent (Stage II)|7|||
147462621|NCT00289913|531853834|FG000|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0|||
147462622|NCT00289913|531853835|FG001|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0|||
147462623|NCT00289913|531853836|FG002|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0|||
147462624|NCT00289913|531853837|FG003|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|0|||
147462625|NCT00289913|531853838|FG004|Visit 2 (Stage I and Stage II)|Other reasons (Stage II)|9|||
147462626|NCT00289913|531853834|FG000|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
147462627|NCT00289913|531853835|FG001|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|1|||
147462628|NCT00289913|531853836|FG002|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
147462629|NCT00289913|531853837|FG003|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
147462630|NCT00289913|531853838|FG004|Visit 3 (Stage I and Stage II)|Protocol deviation during safety F/U|0|||
147462631|NCT00289913|531853834|FG000|Visit 3 (Stage I and Stage II)|Lost during safety F/U|8|||
147462632|NCT00289913|531853835|FG001|Visit 3 (Stage I and Stage II)|Lost during safety F/U|3|||
147462633|NCT00289913|531853836|FG002|Visit 3 (Stage I and Stage II)|Lost during safety F/U|1|||
147462634|NCT00289913|531853837|FG003|Visit 3 (Stage I and Stage II)|Lost during safety F/U|2|||
147462635|NCT00289913|531853838|FG004|Visit 3 (Stage I and Stage II)|Lost during safety F/U|2|||
147462636|NCT00289913|531853834|FG000|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
147462637|NCT00289913|531853835|FG001|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
147462638|NCT00289913|531853836|FG002|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
147462639|NCT00289913|531853837|FG003|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|1|||
147462640|NCT00289913|531853838|FG004|Visit 3 (Stage I and Stage II)|Withdrew consent during safety F/U|0|||
147462641|NCT00289913|531853834|FG000|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0|||
147462642|NCT00289913|531853835|FG001|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0|||
147462643|NCT00289913|531853836|FG002|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0|||
147462644|NCT00289913|531853837|FG003|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|0|||
147462645|NCT00289913|531853838|FG004|Visit 3 (Stage I and Stage II)|Other reasons during safety F/U|1|||
147462646|NCT00289913|531853834|FG000|Visit 3 (Stage I and Stage II)|Lost after safety F/U|1|||
147462647|NCT00289913|531853835|FG001|Visit 3 (Stage I and Stage II)|Lost after safety F/U|2|||
147462648|NCT00289913|531853836|FG002|Visit 3 (Stage I and Stage II)|Lost after safety F/U|0|||
147462649|NCT00289913|531853837|FG003|Visit 3 (Stage I and Stage II)|Lost after safety F/U|1|||
147462650|NCT00289913|531853838|FG004|Visit 3 (Stage I and Stage II)|Lost after safety F/U|4|||
147462651|NCT00289913|531853834|FG000|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|0|||
147462652|NCT00289913|531853835|FG001|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|1|||
147462653|NCT00289913|531853836|FG002|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|1|||
147462654|NCT00289913|531853837|FG003|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|0|||
147462655|NCT00289913|531853838|FG004|Visit 3 (Stage I and Stage II)|Withdrew consent after safety F/U]|0|||
147462656|NCT00289913|531853834|FG000|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0|||
147462657|NCT00289913|531853835|FG001|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0|||
147462658|NCT00289913|531853836|FG002|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0|||
147462659|NCT00289913|531853837|FG003|Visit 3 (Stage I and Stage II)|Moved after safety F/U|0|||
147462660|NCT00289913|531853838|FG004|Visit 3 (Stage I and Stage II)|Moved after safety F/U|1|||
147462661|NCT00289913|531853834|FG000|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0|||
147462662|NCT00289913|531853835|FG001|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|1|||
147462663|NCT00289913|531853836|FG002|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0|||
147462664|NCT00289913|531853837|FG003|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0|||
147462665|NCT00289913|531853838|FG004|Visit 3 (Stage I and Stage II)|Other reasons after safety F/U|0|||
147462666|NCT02357420|531853841|FG000|Overall Study|Adverse Event|3|||
147462667|NCT02357420|531853842|FG001|Overall Study|Adverse Event|3|||
147462668|NCT02357420|531853843|FG002|Overall Study|Adverse Event|8|||
147462669|NCT02357420|531853844|FG003|Overall Study|Adverse Event|9|||
147462670|NCT02357420|531853841|FG000|Overall Study|Investigator Decision|1|||
147462671|NCT02357420|531853842|FG001|Overall Study|Investigator Decision|0|||
147462672|NCT02357420|531853843|FG002|Overall Study|Investigator Decision|0|||
147462673|NCT02357420|531853844|FG003|Overall Study|Investigator Decision|0|||
147665251|NCT00922636|532599519|FG004|Overall Study|Sponsor Decision|0|||
147665252|NCT00922636|532599515|FG000|Overall Study|Withdrawal by Subject|0|||
147665253|NCT00922636|532599516|FG001|Overall Study|Withdrawal by Subject|0|||
147462674|NCT02357420|531853841|FG000|Overall Study|Prohibited Medication|1|||
147665254|NCT00922636|532599517|FG002|Overall Study|Withdrawal by Subject|5|||
147462675|NCT02357420|531853842|FG001|Overall Study|Prohibited Medication|1|||
147462676|NCT02357420|531853843|FG002|Overall Study|Prohibited Medication|0|||
147462677|NCT02357420|531853844|FG003|Overall Study|Prohibited Medication|0|||
147462678|NCT02357420|531853841|FG000|Overall Study|Protocol Non-compliance|0|||
147462679|NCT02357420|531853842|FG001|Overall Study|Protocol Non-compliance|0|||
147462680|NCT02357420|531853843|FG002|Overall Study|Protocol Non-compliance|0|||
147462681|NCT02357420|531853844|FG003|Overall Study|Protocol Non-compliance|1|||
147462682|NCT02357420|531853841|FG000|Overall Study|Withdrawn Consent|4|||
147462683|NCT02357420|531853842|FG001|Overall Study|Withdrawn Consent|8|||
147462684|NCT02357420|531853843|FG002|Overall Study|Withdrawn Consent|6|||
147462685|NCT02357420|531853844|FG003|Overall Study|Withdrawn Consent|6|||
147462686|NCT02357420|531853841|FG000|Overall Study|Lost to Follow-up|3|||
147462687|NCT02357420|531853842|FG001|Overall Study|Lost to Follow-up|0|||
147462688|NCT02357420|531853843|FG002|Overall Study|Lost to Follow-up|2|||
147462689|NCT02357420|531853844|FG003|Overall Study|Lost to Follow-up|3|||
147462690|NCT01061008|531853845|FG000|Overall Study|Badiocephalic fistula failed|3|||
147462691|NCT01061008|531853846|FG001|Overall Study|Badiocephalic fistula failed|2|||
147462692|NCT01061008|531853845|FG000|Overall Study|Death|1|||
147462693|NCT01061008|531853846|FG001|Overall Study|Death|0|||
147462694|NCT01061008|531853845|FG000|Overall Study|Withdrawal by Subject|1|||
147462695|NCT01061008|531853846|FG001|Overall Study|Withdrawal by Subject|3|||
147462696|NCT01061008|531853845|FG000|Overall Study|Unable to exercise following surgery|1|||
147462697|NCT01061008|531853846|FG001|Overall Study|Unable to exercise following surgery|0|||
147462698|NCT01061008|531853845|FG000|Overall Study|Adverse Event|0|||
147462699|NCT01061008|531853846|FG001|Overall Study|Adverse Event|1|||
147462700|NCT02024971|531853848|FG000|Overall Study|Data Not Available|30|||
147462701|NCT02024971|531853848|FG000|Overall Study|Lost to Follow-up|6|||
147462702|NCT02908100|531853849|FG000|Overall Study|Adverse Event|7|||
147462703|NCT02908100|531853850|FG001|Overall Study|Adverse Event|6|||
147462704|NCT02908100|531853851|FG002|Overall Study|Adverse Event|9|||
147462705|NCT02908100|531853849|FG000|Overall Study|Death|2|||
147462706|NCT02908100|531853850|FG001|Overall Study|Death|0|||
147462707|NCT02908100|531853851|FG002|Overall Study|Death|0|||
147462708|NCT02908100|531853849|FG000|Overall Study|Lack of Efficacy|2|||
147462709|NCT02908100|531853850|FG001|Overall Study|Lack of Efficacy|3|||
147462710|NCT02908100|531853851|FG002|Overall Study|Lack of Efficacy|3|||
147462711|NCT02908100|531853849|FG000|Overall Study|Lost to Follow-up|0|||
147462712|NCT02908100|531853850|FG001|Overall Study|Lost to Follow-up|1|||
147462713|NCT02908100|531853851|FG002|Overall Study|Lost to Follow-up|2|||
147462714|NCT02908100|531853849|FG000|Overall Study|Non-Compliance With Study Drug|1|||
147462715|NCT02908100|531853850|FG001|Overall Study|Non-Compliance With Study Drug|1|||
147462716|NCT02908100|531853851|FG002|Overall Study|Non-Compliance With Study Drug|2|||
147462717|NCT02908100|531853849|FG000|Overall Study|Non-Compliance With Contraceptive Method|1|||
147462718|NCT02908100|531853850|FG001|Overall Study|Non-Compliance With Contraceptive Method|0|||
147462719|NCT02908100|531853851|FG002|Overall Study|Non-Compliance With Contraceptive Method|0|||
147462720|NCT02908100|531853849|FG000|Overall Study|Physician Decision|0|||
147462721|NCT02908100|531853850|FG001|Overall Study|Physician Decision|1|||
147462722|NCT02908100|531853851|FG002|Overall Study|Physician Decision|0|||
147462723|NCT02908100|531853849|FG000|Overall Study|Pregnancy|1|||
147462724|NCT02908100|531853850|FG001|Overall Study|Pregnancy|2|||
147462725|NCT02908100|531853851|FG002|Overall Study|Pregnancy|0|||
147462726|NCT02908100|531853849|FG000|Overall Study|Withdrawal by Subject|8|||
147462727|NCT02908100|531853850|FG001|Overall Study|Withdrawal by Subject|7|||
147462728|NCT02908100|531853851|FG002|Overall Study|Withdrawal by Subject|5|||
147462729|NCT02908100|531853849|FG000|Overall Study|Randomised in Error|1|||
147462730|NCT02908100|531853850|FG001|Overall Study|Randomised in Error|0|||
147462731|NCT02908100|531853851|FG002|Overall Study|Randomised in Error|0|||
147462732|NCT05254418|531853853|FG000|Overall Study|Adverse Event|2|||
147462733|NCT00440726|531853854|FG000|Phase 1|Dose-Limiting Toxicity|0|||
147462734|NCT00440726|531853855|FG001|Phase 1|Dose-Limiting Toxicity|1|||
147462735|NCT00440726|531853856|FG002|Phase 1|Dose-Limiting Toxicity|0|||
147462736|NCT00440726|531853854|FG000|Phase 1|Physician Decision|1|||
147462737|NCT00440726|531853855|FG001|Phase 1|Physician Decision|0|||
147462738|NCT00440726|531853856|FG002|Phase 1|Physician Decision|0|||
147462739|NCT00440726|531853854|FG000|Phase 2|Death|0|||
147462740|NCT00440726|531853855|FG001|Phase 2|Death|0|||
147462741|NCT00440726|531853856|FG002|Phase 2|Death|1|||
147462742|NCT00440726|531853854|FG000|Phase 2|Adverse Event|0|||
147615657|NCT03729596|532409026|FG007|Overall Study|study terminated by sponsor|1|||
147615658|NCT03729596|532409027|FG008|Overall Study|study terminated by sponsor|0|||
147462743|NCT00440726|531853855|FG001|Phase 2|Adverse Event|0|||
147462744|NCT00440726|531853856|FG002|Phase 2|Adverse Event|1|||
147462745|NCT01808612|531853857|FG000|Treatment Period|Adverse Event|8|||
147462746|NCT01808612|531853858|FG001|Treatment Period|Adverse Event|4|||
147462747|NCT01808612|531853859|FG002|Treatment Period|Adverse Event|3|||
147462748|NCT01808612|531853857|FG000|Treatment Period|Lost to Follow-up|2|||
147462749|NCT01808612|531853858|FG001|Treatment Period|Lost to Follow-up|2|||
147462750|NCT01808612|531853859|FG002|Treatment Period|Lost to Follow-up|1|||
147462751|NCT01808612|531853857|FG000|Treatment Period|Protocol Violation|1|||
147462752|NCT01808612|531853858|FG001|Treatment Period|Protocol Violation|0|||
147462753|NCT01808612|531853859|FG002|Treatment Period|Protocol Violation|0|||
147462754|NCT01808612|531853857|FG000|Treatment Period|Withdrawal by Subject|1|||
147462755|NCT01808612|531853858|FG001|Treatment Period|Withdrawal by Subject|0|||
147462756|NCT01808612|531853859|FG002|Treatment Period|Withdrawal by Subject|4|||
147462757|NCT01808612|531853857|FG000|Treatment Period|Physician Decision|1|||
147462758|NCT01808612|531853858|FG001|Treatment Period|Physician Decision|0|||
147462759|NCT01808612|531853859|FG002|Treatment Period|Physician Decision|4|||
147462760|NCT01808612|531853857|FG000|Treatment Period|Sponsor Decision|1|||
147462761|NCT01808612|531853858|FG001|Treatment Period|Sponsor Decision|0|||
147462762|NCT01808612|531853859|FG002|Treatment Period|Sponsor Decision|0|||
147462763|NCT01808612|531853857|FG000|Treatment Period|Lack of Efficacy|1|||
147462764|NCT01808612|531853858|FG001|Treatment Period|Lack of Efficacy|1|||
147462765|NCT01808612|531853859|FG002|Treatment Period|Lack of Efficacy|2|||
147462766|NCT01808612|531853857|FG000|Discontinuation Period|Adverse Event|1|||
147462767|NCT01808612|531853858|FG001|Discontinuation Period|Adverse Event|0|||
147462768|NCT01808612|531853859|FG002|Discontinuation Period|Adverse Event|0|||
147462769|NCT01808612|531853857|FG000|Discontinuation Period|Physician Decision|1|||
147462770|NCT01808612|531853858|FG001|Discontinuation Period|Physician Decision|0|||
147462771|NCT01808612|531853859|FG002|Discontinuation Period|Physician Decision|0|||
147462772|NCT01808612|531853857|FG000|Discontinuation Period|Lost to Follow-up|0|||
147462773|NCT01808612|531853858|FG001|Discontinuation Period|Lost to Follow-up|1|||
147462774|NCT01808612|531853859|FG002|Discontinuation Period|Lost to Follow-up|0|||
147462775|NCT03683394|531853860|FG000|Overall Study|Withdrawal by Subject|4|||
147462776|NCT03683394|531853861|FG001|Overall Study|Withdrawal by Subject|8|||
147462777|NCT03683394|531853860|FG000|Overall Study|Lost to Follow-up|7|||
147462778|NCT03683394|531853861|FG001|Overall Study|Lost to Follow-up|0|||
147462779|NCT03683394|531853860|FG000|Overall Study|Death|3|||
147462780|NCT03683394|531853861|FG001|Overall Study|Death|1|||
147462781|NCT02690194|531853862|FG000|Overall Study|Withdrawal by Subject|1|||
147462782|NCT02690194|531853863|FG001|Overall Study|Withdrawal by Subject|4|||
147462783|NCT02690194|531853864|FG002|Overall Study|Withdrawal by Subject|0|||
147462784|NCT03157531|531853872|FG000|Overall Study|Death|2|||
147462785|NCT03157531|531853872|FG000|Overall Study|Lost to Follow-up|4|||
147462786|NCT00331006|531853873|FG000|Screening Phase|Withdrawal by Subject|1|||
147462787|NCT00331006|531853873|FG000|Screening Phase|enrollment halted|1|||
147462788|NCT00331006|531853873|FG000|Screening Phase|Lost to Follow-up|1|||
147462789|NCT00331006|531853873|FG000|Screening Phase|Ineligible for treatment phase|4|||
147462790|NCT00331006|531853873|FG000|Treatment Phase|Withdrawal by Subject|1|||
147462791|NCT00331006|531853873|FG000|Follow-Up Phase I|Lost to Follow-up|1|||
147462792|NCT00331006|531853873|FG000|Follow-Up Phase II|Lost to Follow-up|3|||
147462793|NCT03213366|531853880|FG000|Overall Study|Lost to Follow-up|9|||
147462794|NCT03213366|531853881|FG001|Overall Study|Lost to Follow-up|4|||
147462795|NCT02532855|531853885|FG000|Overall Study|Lost to Follow-up|4|||
147462796|NCT02532855|531853886|FG001|Overall Study|Lost to Follow-up|3|||
147462797|NCT02532855|531853885|FG000|Overall Study|Withdrawal by Subject|4|||
147462798|NCT02532855|531853886|FG001|Overall Study|Withdrawal by Subject|8|||
147462799|NCT01879410|531853889|FG000|Overall Study|Adverse Event|9|||
147462800|NCT01879410|531853890|FG001|Overall Study|Adverse Event|14|||
147462801|NCT01879410|531853889|FG000|Overall Study|Lack of Efficacy|4|||
147462802|NCT01879410|531853890|FG001|Overall Study|Lack of Efficacy|6|||
147462803|NCT01879410|531853889|FG000|Overall Study|Protocol Violation|1|||
147462804|NCT01879410|531853890|FG001|Overall Study|Protocol Violation|7|||
147462805|NCT01879410|531853889|FG000|Overall Study|Lost to Follow-up|2|||
147462806|NCT01879410|531853890|FG001|Overall Study|Lost to Follow-up|1|||
147462807|NCT01879410|531853889|FG000|Overall Study|Withdrawal by Subject|7|||
147462808|NCT01879410|531853890|FG001|Overall Study|Withdrawal by Subject|8|||
147462809|NCT01879410|531853889|FG000|Overall Study|Randomised in Error|1|||
147462810|NCT01879410|531853890|FG001|Overall Study|Randomised in Error|2|||
147462811|NCT01737931|531853901|FG000|Overall Study|Withdrawal by Subject|0|||
147462812|NCT01737931|531853902|FG001|Overall Study|Withdrawal by Subject|1|||
147462813|NCT01737931|531853903|FG002|Overall Study|Withdrawal by Subject|1|||
147462814|NCT01737931|531853901|FG000|Overall Study|Physician Decision|0|||
147462815|NCT01737931|531853902|FG001|Overall Study|Physician Decision|1|||
147615659|NCT03729596|532409028|FG009|Overall Study|study terminated by sponsor|0|||
147462816|NCT01737931|531853903|FG002|Overall Study|Physician Decision|0|||
147462817|NCT01573910|531853904|FG000|Overall Study|Adverse Event|4|||
147462818|NCT01573910|531853905|FG001|Overall Study|Adverse Event|4|||
147615660|NCT03713593|532409029|FG000|Overall Study|Sponsor Decision|73|||
147462819|NCT01573910|531853904|FG000|Overall Study|Lost to Follow-up|2|||
147462820|NCT01573910|531853905|FG001|Overall Study|Lost to Follow-up|1|||
147462821|NCT01573910|531853904|FG000|Overall Study|Withdrawal by Subject|0|||
147462822|NCT01573910|531853905|FG001|Overall Study|Withdrawal by Subject|1|||
147462823|NCT01573910|531853904|FG000|Overall Study|Protocol Violation|3|||
147462824|NCT01573910|531853905|FG001|Overall Study|Protocol Violation|0|||
147462825|NCT01573910|531853904|FG000|Overall Study|Patient decision unrelated to Advs Event|11|||
147462826|NCT01573910|531853905|FG001|Overall Study|Patient decision unrelated to Advs Event|11|||
147615661|NCT03713593|532409030|FG001|Overall Study|Sponsor Decision|41|||
147615662|NCT03713593|532409029|FG000|Overall Study|Lost to Follow-up|2|||
147615663|NCT03713593|532409030|FG001|Overall Study|Lost to Follow-up|1|||
147615664|NCT03713593|532409029|FG000|Overall Study|Death|314|||
147615665|NCT03713593|532409030|FG001|Overall Study|Death|349|||
147615666|NCT03713593|532409029|FG000|Overall Study|Withdrawal by Subject|6|||
147615667|NCT03713593|532409030|FG001|Overall Study|Withdrawal by Subject|8|||
147615668|NCT03560037|532409032|FG000|Overall Study|Protocol Violation|1|||
147615669|NCT03560037|532409033|FG001|Overall Study|Protocol Violation|0|||
147615670|NCT03560037|532409032|FG000|Overall Study|Physician Decision|0|||
147665255|NCT00922636|532599518|FG003|Overall Study|Withdrawal by Subject|2|||
147665256|NCT00922636|532599519|FG004|Overall Study|Withdrawal by Subject|4|||
147402255|NCT01296555|531636773|FG023|Overall Study|Study Terminated By Sponsor|0|||
147402256|NCT01296555|531636774|FG024|Overall Study|Study Terminated By Sponsor|0|||
147402257|NCT01296555|531636775|FG025|Overall Study|Study Terminated By Sponsor|1|||
147402258|NCT01296555|531636776|FG026|Overall Study|Study Terminated By Sponsor|0|||
147402259|NCT01296555|531636777|FG027|Overall Study|Study Terminated By Sponsor|0|||
147402260|NCT01296555|531636778|FG028|Overall Study|Study Terminated By Sponsor|0|||
147402261|NCT01296555|531636750|FG000|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
147402262|NCT01296555|531636751|FG001|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
147402263|NCT01296555|531636752|FG002|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
147402264|NCT01296555|531636753|FG003|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
147402265|NCT01296555|531636754|FG004|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
147402266|NCT01296555|531636755|FG005|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
147402267|NCT01296555|531636756|FG006|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
147402268|NCT01296555|531636757|FG007|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
147402269|NCT01296555|531636758|FG008|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
147402270|NCT01296555|531636759|FG009|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
147402271|NCT01296555|531636760|FG010|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
147402272|NCT01296555|531636761|FG011|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
147402273|NCT01296555|531636762|FG012|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
147402274|NCT01296555|531636763|FG013|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
147402275|NCT01296555|531636764|FG014|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
147402276|NCT01296555|531636765|FG015|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
147402277|NCT01296555|531636766|FG016|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
147402278|NCT01296555|531636767|FG017|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
147402279|NCT01296555|531636768|FG018|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
147402280|NCT01296555|531636769|FG019|Overall Study|Use Of Another Anti-Cancer Therapy|2|||
147402281|NCT01296555|531636770|FG020|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
147402282|NCT01296555|531636771|FG021|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
147402283|NCT01296555|531636772|FG022|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
147402284|NCT01296555|531636773|FG023|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
147402285|NCT01296555|531636774|FG024|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
147402286|NCT01296555|531636775|FG025|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
147402287|NCT01296555|531636776|FG026|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
147402288|NCT01296555|531636777|FG027|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
147402289|NCT01296555|531636778|FG028|Overall Study|Use Of Another Anti-Cancer Therapy|0|||
147402290|NCT01296555|531636750|FG000|Overall Study|Death|0|||
147402291|NCT01296555|531636751|FG001|Overall Study|Death|0|||
147402292|NCT01296555|531636752|FG002|Overall Study|Death|0|||
147402293|NCT01296555|531636753|FG003|Overall Study|Death|2|||
147402294|NCT01296555|531636754|FG004|Overall Study|Death|1|||
147402295|NCT01296555|531636755|FG005|Overall Study|Death|0|||
147402296|NCT01296555|531636756|FG006|Overall Study|Death|2|||
147402297|NCT01296555|531636757|FG007|Overall Study|Death|0|||
147402298|NCT01296555|531636758|FG008|Overall Study|Death|0|||
147402299|NCT01296555|531636759|FG009|Overall Study|Death|1|||
147402300|NCT01296555|531636760|FG010|Overall Study|Death|0|||
147402301|NCT01296555|531636761|FG011|Overall Study|Death|1|||
147402302|NCT01296555|531636762|FG012|Overall Study|Death|0|||
147402303|NCT01296555|531636763|FG013|Overall Study|Death|2|||
147402304|NCT01296555|531636764|FG014|Overall Study|Death|27|||
147402305|NCT01296555|531636765|FG015|Overall Study|Death|15|||
147402306|NCT01296555|531636766|FG016|Overall Study|Death|11|||
147402307|NCT01296555|531636767|FG017|Overall Study|Death|11|||
147402308|NCT01296555|531636768|FG018|Overall Study|Death|17|||
147402309|NCT01296555|531636769|FG019|Overall Study|Death|12|||
147402310|NCT01296555|531636770|FG020|Overall Study|Death|13|||
147402311|NCT01296555|531636771|FG021|Overall Study|Death|12|||
147402312|NCT01296555|531636772|FG022|Overall Study|Death|12|||
147402313|NCT01296555|531636773|FG023|Overall Study|Death|13|||
147402314|NCT01296555|531636774|FG024|Overall Study|Death|7|||
147402315|NCT01296555|531636775|FG025|Overall Study|Death|7|||
147615671|NCT03560037|532409033|FG001|Overall Study|Physician Decision|1|||
147615672|NCT03620708|532409034|FG000|Overall Study|Lost to Follow-up|1|||
147402316|NCT01296555|531636776|FG026|Overall Study|Death|35|||
147402317|NCT01296555|531636777|FG027|Overall Study|Death|92|||
147402318|NCT01296555|531636778|FG028|Overall Study|Death|44|||
147402319|NCT01296555|531636750|FG000|Overall Study|Lost to Follow-up|0|||
147615673|NCT03620708|532409035|FG001|Overall Study|Lost to Follow-up|1|||
147615674|NCT03620708|532409036|FG002|Overall Study|Lost to Follow-up|2|||
147615675|NCT03620708|532409034|FG000|Overall Study|Withdrawal by Subject|0|||
147615676|NCT03620708|532409035|FG001|Overall Study|Withdrawal by Subject|0|||
147615677|NCT03620708|532409036|FG002|Overall Study|Withdrawal by Subject|1|||
147615678|NCT05168202|532409037|FG000|Overall Study|Progressive Disease|4|||
147462827|NCT00364182|531853906|FG000|First Intervention|Secondary prophylaxis|1|||
147462828|NCT00364182|531853907|FG001|First Intervention|Secondary prophylaxis|0|||
147462829|NCT00364182|531853908|FG002|First Intervention|Secondary prophylaxis|0|||
147462830|NCT00364182|531853906|FG000|First Intervention|Withdrawal by Subject|2|||
147462831|NCT00364182|531853907|FG001|First Intervention|Withdrawal by Subject|0|||
147462832|NCT00364182|531853908|FG002|First Intervention|Withdrawal by Subject|0|||
147462833|NCT00364182|531853906|FG000|Second Intervention|non-compliance|0|||
147462834|NCT00364182|531853907|FG001|Second Intervention|non-compliance|1|||
147462835|NCT00364182|531853908|FG002|Second Intervention|non-compliance|1|||
147462836|NCT00364182|531853906|FG000|Second Intervention|Protocol Violation|0|||
147462837|NCT00364182|531853907|FG001|Second Intervention|Protocol Violation|1|||
147462838|NCT00364182|531853908|FG002|Second Intervention|Protocol Violation|0|||
147462839|NCT00364182|531853906|FG000|Second Intervention|Adverse Event|0|||
147462840|NCT00364182|531853907|FG001|Second Intervention|Adverse Event|0|||
147462841|NCT00364182|531853908|FG002|Second Intervention|Adverse Event|1|||
147462842|NCT00364182|531853906|FG000|Third Intervention|non-compliance|0|||
147462843|NCT00364182|531853907|FG001|Third Intervention|non-compliance|1|||
147462844|NCT00364182|531853908|FG002|Third Intervention|non-compliance|0|||
147462845|NCT00364182|531853906|FG000|Third Intervention|Lost to Follow-up|0|||
147615679|NCT05168202|532409038|FG001|Overall Study|Progressive Disease|4|||
147615680|NCT05168202|532409039|FG002|Overall Study|Progressive Disease|2|||
147615681|NCT05168202|532409040|FG003|Overall Study|Progressive Disease|3|||
147615682|NCT05168202|532409041|FG004|Overall Study|Progressive Disease|2|||
147615683|NCT05168202|532409042|FG005|Overall Study|Progressive Disease|3|||
147402320|NCT01296555|531636751|FG001|Overall Study|Lost to Follow-up|0|||
147402321|NCT01296555|531636752|FG002|Overall Study|Lost to Follow-up|0|||
147402322|NCT01296555|531636753|FG003|Overall Study|Lost to Follow-up|0|||
147402323|NCT01296555|531636754|FG004|Overall Study|Lost to Follow-up|0|||
147402324|NCT01296555|531636755|FG005|Overall Study|Lost to Follow-up|0|||
147402325|NCT01296555|531636756|FG006|Overall Study|Lost to Follow-up|0|||
147402326|NCT01296555|531636757|FG007|Overall Study|Lost to Follow-up|0|||
147402327|NCT01296555|531636758|FG008|Overall Study|Lost to Follow-up|0|||
147402328|NCT01296555|531636759|FG009|Overall Study|Lost to Follow-up|0|||
147402329|NCT01296555|531636760|FG010|Overall Study|Lost to Follow-up|0|||
147402330|NCT01296555|531636761|FG011|Overall Study|Lost to Follow-up|0|||
147402331|NCT01296555|531636762|FG012|Overall Study|Lost to Follow-up|0|||
147402332|NCT01296555|531636763|FG013|Overall Study|Lost to Follow-up|0|||
147402333|NCT01296555|531636764|FG014|Overall Study|Lost to Follow-up|2|||
147402334|NCT01296555|531636765|FG015|Overall Study|Lost to Follow-up|1|||
147402335|NCT01296555|531636766|FG016|Overall Study|Lost to Follow-up|0|||
147402336|NCT01296555|531636767|FG017|Overall Study|Lost to Follow-up|2|||
147402337|NCT01296555|531636768|FG018|Overall Study|Lost to Follow-up|0|||
147402338|NCT01296555|531636769|FG019|Overall Study|Lost to Follow-up|2|||
147402339|NCT01296555|531636770|FG020|Overall Study|Lost to Follow-up|3|||
147402340|NCT01296555|531636771|FG021|Overall Study|Lost to Follow-up|2|||
147402341|NCT01296555|531636772|FG022|Overall Study|Lost to Follow-up|0|||
147402342|NCT01296555|531636773|FG023|Overall Study|Lost to Follow-up|0|||
147402343|NCT01296555|531636774|FG024|Overall Study|Lost to Follow-up|0|||
147402344|NCT01296555|531636775|FG025|Overall Study|Lost to Follow-up|0|||
147402345|NCT01296555|531636776|FG026|Overall Study|Lost to Follow-up|3|||
147402346|NCT01296555|531636777|FG027|Overall Study|Lost to Follow-up|13|||
147402347|NCT01296555|531636778|FG028|Overall Study|Lost to Follow-up|5|||
147402348|NCT01296555|531636750|FG000|Overall Study|Non-Compliance With Study Drug|0|||
147402349|NCT01296555|531636751|FG001|Overall Study|Non-Compliance With Study Drug|0|||
147402350|NCT01296555|531636752|FG002|Overall Study|Non-Compliance With Study Drug|0|||
147402351|NCT01296555|531636753|FG003|Overall Study|Non-Compliance With Study Drug|0|||
147462846|NCT00364182|531853907|FG001|Third Intervention|Lost to Follow-up|0|||
147462847|NCT00364182|531853908|FG002|Third Intervention|Lost to Follow-up|1|||
147462848|NCT04062214|531853910|FG000|Week 12|Death|1|||
147615684|NCT05168202|532409043|FG006|Overall Study|Progressive Disease|2|||
147615685|NCT05168202|532409037|FG000|Overall Study|Adverse Event|2|||
147615686|NCT05168202|532409038|FG001|Overall Study|Adverse Event|1|||
147402352|NCT01296555|531636754|FG004|Overall Study|Non-Compliance With Study Drug|0|||
147402353|NCT01296555|531636755|FG005|Overall Study|Non-Compliance With Study Drug|0|||
147402354|NCT01296555|531636756|FG006|Overall Study|Non-Compliance With Study Drug|0|||
147402355|NCT01296555|531636757|FG007|Overall Study|Non-Compliance With Study Drug|1|||
147402356|NCT01296555|531636758|FG008|Overall Study|Non-Compliance With Study Drug|0|||
147402357|NCT01296555|531636759|FG009|Overall Study|Non-Compliance With Study Drug|0|||
147402358|NCT01296555|531636760|FG010|Overall Study|Non-Compliance With Study Drug|0|||
147402359|NCT01296555|531636761|FG011|Overall Study|Non-Compliance With Study Drug|0|||
147462849|NCT04062214|531853911|FG001|Week 12|Death|1|||
147462850|NCT04062214|531853910|FG000|Week 12|Withdrawal by Subject|14|||
147615687|NCT05168202|532409039|FG002|Overall Study|Adverse Event|4|||
147615688|NCT05168202|532409040|FG003|Overall Study|Adverse Event|4|||
147615689|NCT05168202|532409041|FG004|Overall Study|Adverse Event|3|||
147615690|NCT05168202|532409042|FG005|Overall Study|Adverse Event|2|||
147615691|NCT05168202|532409043|FG006|Overall Study|Adverse Event|0|||
147615692|NCT05168202|532409037|FG000|Overall Study|Lack of Efficacy|0|||
147615693|NCT05168202|532409038|FG001|Overall Study|Lack of Efficacy|1|||
147615694|NCT05168202|532409039|FG002|Overall Study|Lack of Efficacy|1|||
147615695|NCT05168202|532409040|FG003|Overall Study|Lack of Efficacy|0|||
147615696|NCT05168202|532409041|FG004|Overall Study|Lack of Efficacy|1|||
147615697|NCT05168202|532409042|FG005|Overall Study|Lack of Efficacy|2|||
147615698|NCT05168202|532409043|FG006|Overall Study|Lack of Efficacy|2|||
147615699|NCT05168202|532409037|FG000|Overall Study|Withdrawal by Subject|0|||
147615700|NCT05168202|532409038|FG001|Overall Study|Withdrawal by Subject|0|||
147615701|NCT05168202|532409039|FG002|Overall Study|Withdrawal by Subject|1|||
147615702|NCT05168202|532409040|FG003|Overall Study|Withdrawal by Subject|1|||
147615703|NCT05168202|532409041|FG004|Overall Study|Withdrawal by Subject|1|||
147615704|NCT05168202|532409042|FG005|Overall Study|Withdrawal by Subject|1|||
147615705|NCT05168202|532409043|FG006|Overall Study|Withdrawal by Subject|0|||
147615706|NCT05168202|532409037|FG000|Overall Study|Disease Relapse|0|||
147615707|NCT05168202|532409038|FG001|Overall Study|Disease Relapse|1|||
147615708|NCT05168202|532409039|FG002|Overall Study|Disease Relapse|0|||
147615709|NCT05168202|532409040|FG003|Overall Study|Disease Relapse|1|||
147615710|NCT05168202|532409041|FG004|Overall Study|Disease Relapse|1|||
147615711|NCT05168202|532409042|FG005|Overall Study|Disease Relapse|0|||
147615712|NCT05168202|532409043|FG006|Overall Study|Disease Relapse|0|||
147615713|NCT05168202|532409037|FG000|Overall Study|Other Reasons|0|||
147615714|NCT05168202|532409038|FG001|Overall Study|Other Reasons|0|||
147615715|NCT05168202|532409039|FG002|Overall Study|Other Reasons|0|||
147615716|NCT05168202|532409040|FG003|Overall Study|Other Reasons|0|||
147615717|NCT05168202|532409041|FG004|Overall Study|Other Reasons|0|||
147615718|NCT05168202|532409042|FG005|Overall Study|Other Reasons|2|||
147615719|NCT05168202|532409043|FG006|Overall Study|Other Reasons|1|||
147615720|NCT05168202|532409037|FG000|Overall Study|Physician Decision|0|||
147615721|NCT05168202|532409038|FG001|Overall Study|Physician Decision|1|||
147615722|NCT05168202|532409039|FG002|Overall Study|Physician Decision|1|||
147615723|NCT05168202|532409040|FG003|Overall Study|Physician Decision|0|||
147615724|NCT05168202|532409041|FG004|Overall Study|Physician Decision|0|||
147615725|NCT05168202|532409042|FG005|Overall Study|Physician Decision|0|||
147615726|NCT05168202|532409043|FG006|Overall Study|Physician Decision|0|||
147615727|NCT05168202|532409037|FG000|Overall Study|Study Terminated by Sponsor|0|||
147615728|NCT05168202|532409038|FG001|Overall Study|Study Terminated by Sponsor|0|||
147615729|NCT05168202|532409039|FG002|Overall Study|Study Terminated by Sponsor|0|||
147615730|NCT05168202|532409040|FG003|Overall Study|Study Terminated by Sponsor|1|||
147615731|NCT05168202|532409041|FG004|Overall Study|Study Terminated by Sponsor|0|||
147615732|NCT05168202|532409042|FG005|Overall Study|Study Terminated by Sponsor|0|||
147615733|NCT05168202|532409043|FG006|Overall Study|Study Terminated by Sponsor|0|||
147615734|NCT04011722|532409047|FG000|30 Days|Death|5|||
147615735|NCT04011722|532409048|FG001|30 Days|Death|1|||
147615736|NCT04011722|532409047|FG000|1 Year|Death|13|||
147615737|NCT04011722|532409048|FG001|1 Year|Death|5|||
147615738|NCT04011722|532409047|FG000|1 Year|Withdrawal by Subject|8|||
147615739|NCT04011722|532409048|FG001|1 Year|Withdrawal by Subject|2|||
147615740|NCT04011722|532409047|FG000|1 Year|Missed Visit|6|||
147615741|NCT04011722|532409048|FG001|1 Year|Missed Visit|1|||
147615742|NCT04011722|532409047|FG000|1 Year|Pending Visit|0|||
147402360|NCT01296555|531636762|FG012|Overall Study|Non-Compliance With Study Drug|0|||
147402361|NCT01296555|531636763|FG013|Overall Study|Non-Compliance With Study Drug|0|||
147402362|NCT01296555|531636764|FG014|Overall Study|Non-Compliance With Study Drug|0|||
147402363|NCT01296555|531636765|FG015|Overall Study|Non-Compliance With Study Drug|0|||
147402364|NCT01296555|531636766|FG016|Overall Study|Non-Compliance With Study Drug|0|||
147402365|NCT01296555|531636767|FG017|Overall Study|Non-Compliance With Study Drug|0|||
147402366|NCT01296555|531636768|FG018|Overall Study|Non-Compliance With Study Drug|0|||
147402367|NCT01296555|531636769|FG019|Overall Study|Non-Compliance With Study Drug|0|||
147402368|NCT01296555|531636770|FG020|Overall Study|Non-Compliance With Study Drug|0|||
147402369|NCT01296555|531636771|FG021|Overall Study|Non-Compliance With Study Drug|0|||
147402370|NCT01296555|531636772|FG022|Overall Study|Non-Compliance With Study Drug|0|||
147615743|NCT04011722|532409048|FG001|1 Year|Pending Visit|11|||
147665257|NCT00922636|532599515|FG000|Overall Study|Protocol Violation|0|||
147402371|NCT01296555|531636773|FG023|Overall Study|Non-Compliance With Study Drug|0|||
147402372|NCT01296555|531636774|FG024|Overall Study|Non-Compliance With Study Drug|0|||
147615744|NCT04011722|532409047|FG000|1 Year|Not Yet Due|0|||
147615745|NCT04011722|532409048|FG001|1 Year|Not Yet Due|9|||
147615746|NCT04011722|532409047|FG000|2 Year|Death|16|||
147615747|NCT04011722|532409048|FG001|2 Year|Death|1|||
147615748|NCT04011722|532409047|FG000|2 Year|Withdrawal by Subject|10|||
147615749|NCT04011722|532409048|FG001|2 Year|Withdrawal by Subject|1|||
147615750|NCT04011722|532409047|FG000|2 Year|Missed Visit|9|||
147615751|NCT04011722|532409048|FG001|2 Year|Missed Visit|0|||
147615752|NCT04011722|532409047|FG000|2 Year|Visit Pending|1|||
147462851|NCT04062214|531853911|FG001|Week 12|Withdrawal by Subject|13|||
147462852|NCT04062214|531853910|FG000|Week 12|Lost to Follow-up|55|||
147462853|NCT04062214|531853911|FG001|Week 12|Lost to Follow-up|68|||
147462854|NCT04062214|531853910|FG000|Week 12|Intermittent missing|31|||
147462855|NCT04062214|531853911|FG001|Week 12|Intermittent missing|29|||
147462856|NCT04062214|531853910|FG000|Week 36|Withdrawal by Subject|4|||
147462857|NCT04062214|531853911|FG001|Week 36|Withdrawal by Subject|5|||
147462858|NCT04062214|531853910|FG000|Week 36|Lost to Follow-up|50|||
147462859|NCT04062214|531853911|FG001|Week 36|Lost to Follow-up|46|||
147462860|NCT04062214|531853910|FG000|Week 36|Death|0|||
147462861|NCT04062214|531853911|FG001|Week 36|Death|1|||
147462862|NCT01356589|531853915|FG000|Overall Study|Enrolled, but not treated|3|||
147462863|NCT01356589|531853915|FG000|Overall Study|Dose data not recorded|2|||
147462864|NCT04343651|531853916|FG000|Overall Study|Physician Decision|2|||
147462865|NCT04343651|531853917|FG001|Overall Study|Physician Decision|1|||
147462866|NCT04343651|531853916|FG000|Overall Study|Lost to Follow-up|2|||
147462867|NCT04343651|531853917|FG001|Overall Study|Lost to Follow-up|1|||
147462868|NCT04343651|531853916|FG000|Overall Study|Protocol Violation|4|||
147462869|NCT04343651|531853917|FG001|Overall Study|Protocol Violation|6|||
147462870|NCT04343651|531853916|FG000|Overall Study|Missing|3|||
147462871|NCT04343651|531853917|FG001|Overall Study|Missing|9|||
147462872|NCT04343651|531853916|FG000|Overall Study|Withdrawal by Subject|0|||
147462873|NCT04343651|531853917|FG001|Overall Study|Withdrawal by Subject|4|||
147462874|NCT04343651|531853916|FG000|Overall Study|Death|0|||
147462875|NCT04343651|531853917|FG001|Overall Study|Death|1|||
147462876|NCT04343651|531853916|FG000|Overall Study|Did not start treatment|1|||
147462877|NCT04343651|531853917|FG001|Overall Study|Did not start treatment|1|||
147462878|NCT04343651|531853916|FG000|Overall Study|Patient did not complete visits 3-6|0|||
147462879|NCT04343651|531853917|FG001|Overall Study|Patient did not complete visits 3-6|1|||
147462880|NCT04025632|531855500|FG000|Overall Study|Adverse Event|1|||
147462881|NCT04025632|531855501|FG001|Overall Study|Adverse Event|1|||
147462882|NCT04025632|531855500|FG000|Overall Study|Withdrawal by Subject|1|||
147462883|NCT04025632|531855501|FG001|Overall Study|Withdrawal by Subject|1|||
147462884|NCT04025632|531855500|FG000|Overall Study|Study Terminated by Sponsor|10|||
147462885|NCT04025632|531855501|FG001|Overall Study|Study Terminated by Sponsor|9|||
147462886|NCT04025632|531855500|FG000|Overall Study|Physician Decision|3|||
147462887|NCT04025632|531855501|FG001|Overall Study|Physician Decision|1|||
147462888|NCT00376961|531855502|FG000|Initial Registration|Adverse Event|1|||
147462889|NCT00376961|531855503|FG001|Initial Registration|Adverse Event|0|||
147462890|NCT00376961|531855502|FG000|Initial Registration|Refusal Unrelated to Adverse Event|2|||
147462891|NCT00376961|531855503|FG001|Initial Registration|Refusal Unrelated to Adverse Event|0|||
147462892|NCT00376961|531855502|FG000|Initial Registration|Progression/relapse|1|||
147462893|NCT00376961|531855503|FG001|Initial Registration|Progression/relapse|0|||
147462894|NCT00376961|531855502|FG000|Initial Registration|Ineligible|3|||
147462895|NCT00376961|531855503|FG001|Initial Registration|Ineligible|0|||
147462896|NCT00376961|531855502|FG000|Maintenance|Adverse Event|0|||
147462897|NCT00376961|531855503|FG001|Maintenance|Adverse Event|1|||
147462898|NCT00376961|531855502|FG000|Maintenance|Refusal Unrelated to Adverse Event|0|||
147462899|NCT00376961|531855503|FG001|Maintenance|Refusal Unrelated to Adverse Event|1|||
147462900|NCT00376961|531855502|FG000|Maintenance|Progression/relapse|0|||
147462901|NCT00376961|531855503|FG001|Maintenance|Progression/relapse|18|||
147462902|NCT00376961|531855502|FG000|Maintenance|Ineligible|0|||
147462903|NCT00376961|531855503|FG001|Maintenance|Ineligible|3|||
147462904|NCT04047797|531855504|FG000|Overall Study|Progressive Disease|1|||
147615753|NCT04011722|532409048|FG001|2 Year|Visit Pending|3|||
147615754|NCT04011722|532409047|FG000|2 Year|Not Yet Due|43|||
147615755|NCT04011722|532409048|FG001|2 Year|Not Yet Due|54|||
147615756|NCT04011722|532409047|FG000|3 Year|Death|10|||
147615757|NCT04011722|532409048|FG001|3 Year|Death|0|||
147462905|NCT01793792|531855505|FG000|Overall Study|Death|5|||
147462906|NCT01793792|531855505|FG000|Overall Study|Lost to Follow-up|5|||
147462907|NCT01793792|531855505|FG000|Overall Study|Withdrawal by Subject|1|||
147462908|NCT01793792|531855505|FG000|Overall Study|Device Not Implanted|1|||
147462909|NCT03822884|531855510|FG000|Overall Study|Withdrawal by Subject|0|||
147462910|NCT03822884|531855511|FG001|Overall Study|Withdrawal by Subject|0|||
147462911|NCT03822884|531855512|FG002|Overall Study|Withdrawal by Subject|0|||
147462912|NCT03822884|531855513|FG003|Overall Study|Withdrawal by Subject|0|||
147615758|NCT04011722|532409047|FG000|3 Year|Withdrawal by Subject|2|||
147615759|NCT04011722|532409048|FG001|3 Year|Withdrawal by Subject|0|||
147615760|NCT04011722|532409047|FG000|3 Year|Missed Visit|2|||
147462913|NCT03822884|531855514|FG004|Overall Study|Withdrawal by Subject|1|||
147462914|NCT03822884|531855515|FG005|Overall Study|Withdrawal by Subject|0|||
147462915|NCT03617705|531855519|FG000|Overall Study|Withdrawal by Subject|2|||
147462916|NCT03617705|531855519|FG000|Overall Study|lost contact after screening due to covid pandemic|6|||
147462917|NCT03617705|531855519|FG000|Overall Study|withdrawal by study team due to non-compliance|1|||
147462918|NCT00214461|531855520|FG000|Overall Study|Adverse Event|0|||
147462919|NCT00214461|531855521|FG001|Overall Study|Adverse Event|0|||
147615761|NCT04011722|532409048|FG001|3 Year|Missed Visit|0|||
147615762|NCT04011722|532409047|FG000|3 Year|Pending Visit|34|||
147615763|NCT04011722|532409048|FG001|3 Year|Pending Visit|0|||
147402373|NCT01296555|531636775|FG025|Overall Study|Non-Compliance With Study Drug|0|||
147402374|NCT01296555|531636776|FG026|Overall Study|Non-Compliance With Study Drug|0|||
147402375|NCT01296555|531636777|FG027|Overall Study|Non-Compliance With Study Drug|0|||
147402376|NCT01296555|531636778|FG028|Overall Study|Non-Compliance With Study Drug|0|||
147402377|NCT01296555|531636750|FG000|Overall Study|Withdrawal by Subject|0|||
147402378|NCT01296555|531636751|FG001|Overall Study|Withdrawal by Subject|0|||
147402379|NCT01296555|531636752|FG002|Overall Study|Withdrawal by Subject|0|||
147402380|NCT01296555|531636753|FG003|Overall Study|Withdrawal by Subject|0|||
147402381|NCT01296555|531636754|FG004|Overall Study|Withdrawal by Subject|1|||
147402382|NCT01296555|531636755|FG005|Overall Study|Withdrawal by Subject|0|||
147402383|NCT01296555|531636756|FG006|Overall Study|Withdrawal by Subject|1|||
147402384|NCT01296555|531636757|FG007|Overall Study|Withdrawal by Subject|0|||
147402385|NCT01296555|531636758|FG008|Overall Study|Withdrawal by Subject|0|||
147402386|NCT01296555|531636759|FG009|Overall Study|Withdrawal by Subject|0|||
147402387|NCT01296555|531636760|FG010|Overall Study|Withdrawal by Subject|1|||
147402388|NCT01296555|531636761|FG011|Overall Study|Withdrawal by Subject|1|||
147402389|NCT01296555|531636762|FG012|Overall Study|Withdrawal by Subject|0|||
147402390|NCT01296555|531636763|FG013|Overall Study|Withdrawal by Subject|0|||
147402391|NCT01296555|531636764|FG014|Overall Study|Withdrawal by Subject|3|||
147402392|NCT01296555|531636765|FG015|Overall Study|Withdrawal by Subject|0|||
147402393|NCT01296555|531636766|FG016|Overall Study|Withdrawal by Subject|2|||
147402394|NCT01296555|531636767|FG017|Overall Study|Withdrawal by Subject|1|||
147402395|NCT01296555|531636768|FG018|Overall Study|Withdrawal by Subject|0|||
147402396|NCT01296555|531636769|FG019|Overall Study|Withdrawal by Subject|1|||
147402397|NCT01296555|531636770|FG020|Overall Study|Withdrawal by Subject|1|||
147402398|NCT01296555|531636771|FG021|Overall Study|Withdrawal by Subject|1|||
147402399|NCT01296555|531636772|FG022|Overall Study|Withdrawal by Subject|3|||
147402400|NCT01296555|531636773|FG023|Overall Study|Withdrawal by Subject|0|||
147402401|NCT01296555|531636774|FG024|Overall Study|Withdrawal by Subject|0|||
147402402|NCT01296555|531636775|FG025|Overall Study|Withdrawal by Subject|0|||
147402403|NCT01296555|531636776|FG026|Overall Study|Withdrawal by Subject|8|||
147402404|NCT01296555|531636777|FG027|Overall Study|Withdrawal by Subject|4|||
147402405|NCT01296555|531636778|FG028|Overall Study|Withdrawal by Subject|2|||
147402406|NCT01628692|531636781|FG000|Overall Study|Lack of Efficacy|4|||
147402407|NCT01628692|531636782|FG001|Overall Study|Lack of Efficacy|4|||
147402408|NCT01628692|531636783|FG002|Overall Study|Lack of Efficacy|5|||
147402409|NCT01628692|531636784|FG003|Overall Study|Lack of Efficacy|1|||
147402410|NCT01628692|531636785|FG004|Overall Study|Lack of Efficacy|4|||
147402411|NCT01628692|531636786|FG005|Overall Study|Lack of Efficacy|7|||
147402412|NCT01628692|531636781|FG000|Overall Study|Adverse Event|2|||
147402413|NCT01628692|531636782|FG001|Overall Study|Adverse Event|0|||
147402414|NCT01628692|531636783|FG002|Overall Study|Adverse Event|2|||
147402415|NCT01628692|531636784|FG003|Overall Study|Adverse Event|0|||
147402416|NCT01628692|531636785|FG004|Overall Study|Adverse Event|0|||
147402417|NCT01628692|531636786|FG005|Overall Study|Adverse Event|0|||
147402418|NCT01628692|531636781|FG000|Overall Study|Withdrawal by Subject|0|||
147402419|NCT01628692|531636782|FG001|Overall Study|Withdrawal by Subject|1|||
147402420|NCT01628692|531636783|FG002|Overall Study|Withdrawal by Subject|1|||
147402421|NCT01628692|531636784|FG003|Overall Study|Withdrawal by Subject|0|||
147402422|NCT01628692|531636785|FG004|Overall Study|Withdrawal by Subject|0|||
147402423|NCT01628692|531636786|FG005|Overall Study|Withdrawal by Subject|0|||
147402424|NCT01628692|531636781|FG000|Overall Study|Death|0|||
147402425|NCT01628692|531636782|FG001|Overall Study|Death|1|||
147402426|NCT01628692|531636783|FG002|Overall Study|Death|0|||
147402427|NCT01628692|531636784|FG003|Overall Study|Death|0|||
147402428|NCT01628692|531636785|FG004|Overall Study|Death|0|||
147402429|NCT01628692|531636786|FG005|Overall Study|Death|0|||
147402430|NCT01628692|531636781|FG000|Overall Study|Poor compliance/noncompliance|1|||
147402431|NCT01628692|531636782|FG001|Overall Study|Poor compliance/noncompliance|0|||
147402432|NCT01628692|531636783|FG002|Overall Study|Poor compliance/noncompliance|0|||
147402433|NCT01628692|531636784|FG003|Overall Study|Poor compliance/noncompliance|0|||
147402434|NCT01628692|531636785|FG004|Overall Study|Poor compliance/noncompliance|0|||
147402435|NCT01628692|531636786|FG005|Overall Study|Poor compliance/noncompliance|0|||
147402436|NCT01628692|531636781|FG000|Overall Study|Administrative reason by sponsor|0|||
147402437|NCT01628692|531636782|FG001|Overall Study|Administrative reason by sponsor|0|||
147402438|NCT01628692|531636783|FG002|Overall Study|Administrative reason by sponsor|0|||
147402439|NCT01628692|531636784|FG003|Overall Study|Administrative reason by sponsor|0|||
147402440|NCT01628692|531636785|FG004|Overall Study|Administrative reason by sponsor|0|||
147402441|NCT01628692|531636786|FG005|Overall Study|Administrative reason by sponsor|1|||
147402442|NCT01628692|531636781|FG000|Overall Study|Completed 12 Week only|0|||
147402443|NCT01628692|531636782|FG001|Overall Study|Completed 12 Week only|0|||
147462920|NCT00214461|531855522|FG002|Overall Study|Adverse Event|1|||
147402444|NCT01628692|531636783|FG002|Overall Study|Completed 12 Week only|0|||
147402445|NCT01628692|531636784|FG003|Overall Study|Completed 12 Week only|0|||
147402446|NCT01628692|531636785|FG004|Overall Study|Completed 12 Week only|0|||
147402447|NCT01628692|531636786|FG005|Overall Study|Completed 12 Week only|1|||
147462921|NCT00214461|531855523|FG003|Overall Study|Adverse Event|1|||
147462922|NCT00214461|531855520|FG000|Overall Study|Withdrawal by Subject|0|||
147462923|NCT00214461|531855521|FG001|Overall Study|Withdrawal by Subject|0|||
147462924|NCT00214461|531855522|FG002|Overall Study|Withdrawal by Subject|1|||
147462925|NCT00214461|531855523|FG003|Overall Study|Withdrawal by Subject|0|||
147462926|NCT01058096|531855524|FG000|Double-blind Treatment Phase|Adverse Event|11|||
147462927|NCT01058096|531855525|FG001|Double-blind Treatment Phase|Adverse Event|15|||
147462928|NCT01058096|531855524|FG000|Double-blind Treatment Phase|Insufficient Therapeutic Response|16|||
147462929|NCT01058096|531855525|FG001|Double-blind Treatment Phase|Insufficient Therapeutic Response|7|||
147462930|NCT01058096|531855524|FG000|Double-blind Treatment Phase|Protocol Violation|2|||
147462931|NCT01058096|531855525|FG001|Double-blind Treatment Phase|Protocol Violation|1|||
147462932|NCT01058096|531855524|FG000|Double-blind Treatment Phase|Withdrawal of Consent|17|||
147462933|NCT01058096|531855525|FG001|Double-blind Treatment Phase|Withdrawal of Consent|26|||
147462934|NCT01058096|531855524|FG000|Double-blind Treatment Phase|Lost to Follow-up|0|||
147462935|NCT01058096|531855525|FG001|Double-blind Treatment Phase|Lost to Follow-up|1|||
147462936|NCT01058096|531855524|FG000|Double-blind Treatment Phase|Other Unspecified|2|||
147462937|NCT01058096|531855525|FG001|Double-blind Treatment Phase|Other Unspecified|0|||
147462938|NCT00559273|531855526|FG000|Correction Period (20 Weeks)|Death|3|||
147462939|NCT00559273|531855527|FG001|Correction Period (20 Weeks)|Death|4|||
147462940|NCT00559273|531855526|FG000|Correction Period (20 Weeks)|Adverse Event|2|||
147462941|NCT00559273|531855527|FG001|Correction Period (20 Weeks)|Adverse Event|1|||
147462942|NCT00559273|531855526|FG000|Correction Period (20 Weeks)|Withdrawal by Subject|2|||
147462943|NCT00559273|531855527|FG001|Correction Period (20 Weeks)|Withdrawal by Subject|6|||
147462944|NCT00559273|531855526|FG000|Correction Period (20 Weeks)|Participant treated by another center|0|||
147462945|NCT00559273|531855527|FG001|Correction Period (20 Weeks)|Participant treated by another center|1|||
147402448|NCT01182181|531636787|FG000|First Intervention|Adverse Event|1|||
147402449|NCT01182181|531636788|FG001|First Intervention|Adverse Event|0|||
147402450|NCT01182181|531636787|FG000|Washout of 21 Days|Withdrawal by Subject|0|||
147402451|NCT01182181|531636788|FG001|Washout of 21 Days|Withdrawal by Subject|1|||
147402452|NCT01587118|531636789|FG000|Overall Study|Adverse Event|3|||
147402453|NCT01587118|531636789|FG000|Overall Study|Lost to Follow-up|2|||
147402454|NCT01587118|531636789|FG000|Overall Study|Relocation|1|||
147402455|NCT01587118|531636789|FG000|Overall Study|nonresponse|1|||
147402456|NCT00267098|531636790|FG000|Overall Study|Death|0|||
147402457|NCT00267098|531636791|FG001|Overall Study|Death|0|||
147402458|NCT00267098|531636792|FG002|Overall Study|Death|57|||
147402459|NCT00267098|531636793|FG003|Overall Study|Death|66|||
147402460|NCT00267098|531636794|FG004|Overall Study|Death|14|||
147402461|NCT00267098|531636795|FG005|Overall Study|Death|23|||
147402462|NCT00267098|531636796|FG006|Overall Study|Death|28|||
147402463|NCT00267098|531636797|FG007|Overall Study|Death|9|||
147402464|NCT00267098|531636790|FG000|Overall Study|Lost to Follow-up|0|||
147402465|NCT00267098|531636791|FG001|Overall Study|Lost to Follow-up|0|||
147402466|NCT00267098|531636792|FG002|Overall Study|Lost to Follow-up|6|||
147402467|NCT00267098|531636793|FG003|Overall Study|Lost to Follow-up|5|||
147402468|NCT00267098|531636794|FG004|Overall Study|Lost to Follow-up|2|||
147402469|NCT00267098|531636795|FG005|Overall Study|Lost to Follow-up|3|||
147402470|NCT00267098|531636796|FG006|Overall Study|Lost to Follow-up|1|||
147402471|NCT00267098|531636797|FG007|Overall Study|Lost to Follow-up|1|||
147402472|NCT00267098|531636790|FG000|Overall Study|Withdrawal by Subject|8|||
147402473|NCT00267098|531636791|FG001|Overall Study|Withdrawal by Subject|0|||
147402474|NCT00267098|531636792|FG002|Overall Study|Withdrawal by Subject|24|||
147402475|NCT00267098|531636793|FG003|Overall Study|Withdrawal by Subject|21|||
147402476|NCT00267098|531636794|FG004|Overall Study|Withdrawal by Subject|12|||
147402477|NCT00267098|531636795|FG005|Overall Study|Withdrawal by Subject|9|||
147402478|NCT00267098|531636796|FG006|Overall Study|Withdrawal by Subject|12|||
147402479|NCT00267098|531636797|FG007|Overall Study|Withdrawal by Subject|5|||
147402480|NCT00267098|531636790|FG000|Overall Study|Physician Decision|5|||
147402481|NCT00267098|531636791|FG001|Overall Study|Physician Decision|0|||
147462946|NCT00559273|531855526|FG000|Correction Period (20 Weeks)|Did not received study treatment|2|||
147462947|NCT00559273|531855527|FG001|Correction Period (20 Weeks)|Did not received study treatment|0|||
147462948|NCT00559273|531855526|FG000|Evaluation Period (8 Weeks)|Death|1|||
147462949|NCT00559273|531855527|FG001|Evaluation Period (8 Weeks)|Death|3|||
147462950|NCT00559273|531855526|FG000|Evaluation Period (8 Weeks)|Adverse Event|0|||
147462951|NCT00559273|531855527|FG001|Evaluation Period (8 Weeks)|Adverse Event|1|||
147462952|NCT00559273|531855526|FG000|Evaluation Period (8 Weeks)|Withdrawal by Subject|2|||
147462953|NCT00559273|531855527|FG001|Evaluation Period (8 Weeks)|Withdrawal by Subject|0|||
147462954|NCT00559273|531855526|FG000|Evaluation Period (8 Weeks)|Physician Decision|0|||
147462955|NCT00559273|531855527|FG001|Evaluation Period (8 Weeks)|Physician Decision|1|||
147462956|NCT01925209|531855532|FG000|Treatment Epoch|Physician Decision|1|||
147462957|NCT01925209|531855533|FG001|Treatment Epoch|Physician Decision|0|||
147462958|NCT01925209|531855534|FG002|Treatment Epoch|Physician Decision|0|||
147402482|NCT00267098|531636792|FG002|Overall Study|Physician Decision|7|||
147402483|NCT00267098|531636793|FG003|Overall Study|Physician Decision|11|||
147402484|NCT00267098|531636794|FG004|Overall Study|Physician Decision|5|||
147462959|NCT01925209|531855535|FG003|Treatment Epoch|Physician Decision|0|||
147462960|NCT01925209|531855532|FG000|Treatment Epoch|Non-compliance with study treatment|0|||
147462961|NCT01925209|531855533|FG001|Treatment Epoch|Non-compliance with study treatment|0|||
147462962|NCT01925209|531855534|FG002|Treatment Epoch|Non-compliance with study treatment|0|||
147462963|NCT01925209|531855535|FG003|Treatment Epoch|Non-compliance with study treatment|1|||
147462964|NCT01925209|531855532|FG000|Treatment Epoch|Death|1|||
147462965|NCT01925209|531855533|FG001|Treatment Epoch|Death|0|||
147462966|NCT01925209|531855534|FG002|Treatment Epoch|Death|0|||
147462967|NCT01925209|531855535|FG003|Treatment Epoch|Death|0|||
147462968|NCT01925209|531855532|FG000|Treatment Epoch|Protocol deviation|0|||
147462969|NCT01925209|531855533|FG001|Treatment Epoch|Protocol deviation|0|||
147462970|NCT01925209|531855534|FG002|Treatment Epoch|Protocol deviation|1|||
147462971|NCT01925209|531855535|FG003|Treatment Epoch|Protocol deviation|1|||
147462972|NCT01925209|531855532|FG000|Treatment Epoch|Withdrawal by Subject|4|||
147462973|NCT01925209|531855533|FG001|Treatment Epoch|Withdrawal by Subject|3|||
147462974|NCT01925209|531855534|FG002|Treatment Epoch|Withdrawal by Subject|3|||
147462975|NCT01925209|531855535|FG003|Treatment Epoch|Withdrawal by Subject|2|||
147462976|NCT01925209|531855532|FG000|Treatment Epoch|Adverse Event|3|||
147462977|NCT01925209|531855533|FG001|Treatment Epoch|Adverse Event|5|||
147462978|NCT01925209|531855534|FG002|Treatment Epoch|Adverse Event|3|||
147462979|NCT01925209|531855535|FG003|Treatment Epoch|Adverse Event|1|||
147462980|NCT01925209|531855532|FG000|Maintenance Treatment Epoch|Withdrawal by Subject|0|||
147462981|NCT01925209|531855533|FG001|Maintenance Treatment Epoch|Withdrawal by Subject|1|||
147462982|NCT01925209|531855534|FG002|Maintenance Treatment Epoch|Withdrawal by Subject|1|||
147462983|NCT01925209|531855535|FG003|Maintenance Treatment Epoch|Withdrawal by Subject|2|||
147462984|NCT01925209|531855532|FG000|Maintenance Treatment Epoch|Adverse Event|0|||
147462985|NCT01925209|531855533|FG001|Maintenance Treatment Epoch|Adverse Event|0|||
147462986|NCT01925209|531855534|FG002|Maintenance Treatment Epoch|Adverse Event|1|||
147462987|NCT01925209|531855535|FG003|Maintenance Treatment Epoch|Adverse Event|0|||
147462988|NCT01925209|531855532|FG000|Follow-up|Adverse Event|1|||
147462989|NCT01925209|531855533|FG001|Follow-up|Adverse Event|4|||
147402485|NCT00267098|531636795|FG005|Overall Study|Physician Decision|4|||
147402486|NCT00267098|531636796|FG006|Overall Study|Physician Decision|3|||
147402487|NCT00267098|531636797|FG007|Overall Study|Physician Decision|0|||
147402488|NCT00267098|531636790|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|96|||
147402489|NCT00267098|531636791|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
147402490|NCT00267098|531636792|FG002|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
147402491|NCT00267098|531636793|FG003|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
147402492|NCT00267098|531636794|FG004|Overall Study|Inclusion/Exclusion Criteria Not Met|2|||
147402493|NCT00267098|531636795|FG005|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
147402494|NCT00267098|531636796|FG006|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
147402495|NCT00267098|531636797|FG007|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
147402496|NCT00267098|531636790|FG000|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
147402497|NCT00267098|531636791|FG001|Overall Study|Unsuccessful Implant Exit Per Protocol|51|||
147402498|NCT00267098|531636792|FG002|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
147402499|NCT00267098|531636793|FG003|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
147402500|NCT00267098|531636794|FG004|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
147402501|NCT00267098|531636795|FG005|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
147402502|NCT00267098|531636796|FG006|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
147402503|NCT00267098|531636797|FG007|Overall Study|Unsuccessful Implant Exit Per Protocol|0|||
147402504|NCT00267098|531636790|FG000|Overall Study|Site closure|0|||
147402505|NCT00267098|531636791|FG001|Overall Study|Site closure|0|||
147402506|NCT00267098|531636792|FG002|Overall Study|Site closure|0|||
147402507|NCT00267098|531636793|FG003|Overall Study|Site closure|1|||
147462990|NCT01925209|531855534|FG002|Follow-up|Adverse Event|0|||
147462991|NCT01925209|531855535|FG003|Follow-up|Adverse Event|1|||
147462992|NCT01925209|531855532|FG000|Follow-up|Physician Decision|0|||
147462993|NCT01925209|531855533|FG001|Follow-up|Physician Decision|0|||
147462994|NCT01925209|531855534|FG002|Follow-up|Physician Decision|1|||
147462995|NCT01925209|531855535|FG003|Follow-up|Physician Decision|0|||
147462996|NCT01925209|531855532|FG000|Follow-up|Non-compliance with study treatment|0|||
147462997|NCT01925209|531855533|FG001|Follow-up|Non-compliance with study treatment|0|||
147462998|NCT01925209|531855534|FG002|Follow-up|Non-compliance with study treatment|0|||
147462999|NCT01925209|531855535|FG003|Follow-up|Non-compliance with study treatment|1|||
147463000|NCT01925209|531855532|FG000|Follow-up|Withdrawal by Subject|0|||
147402508|NCT00267098|531636794|FG004|Overall Study|Site closure|0|||
147463001|NCT01925209|531855533|FG001|Follow-up|Withdrawal by Subject|2|||
147463002|NCT01925209|531855534|FG002|Follow-up|Withdrawal by Subject|0|||
147402509|NCT00267098|531636795|FG005|Overall Study|Site closure|1|||
147402510|NCT00267098|531636796|FG006|Overall Study|Site closure|1|||
147463003|NCT01925209|531855535|FG003|Follow-up|Withdrawal by Subject|2|||
147463004|NCT00675025|531855536|FG000|Overall Study|Study Terminated by Sponsor|38|||
147463005|NCT00675025|531855537|FG001|Overall Study|Study Terminated by Sponsor|42|||
147463006|NCT00675025|531855536|FG000|Overall Study|Adverse Event|6|||
147463007|NCT00675025|531855537|FG001|Overall Study|Adverse Event|11|||
147463008|NCT00675025|531855536|FG000|Overall Study|Lost to Follow-up|6|||
147463009|NCT00675025|531855537|FG001|Overall Study|Lost to Follow-up|4|||
147463010|NCT00675025|531855536|FG000|Overall Study|Withdrawal by Subject|4|||
147463011|NCT00675025|531855537|FG001|Overall Study|Withdrawal by Subject|6|||
147463012|NCT00110994|531855538|FG000|Double-blind (DB) Treatment|Adverse Event|3|||
147463013|NCT00110994|531855539|FG001|Double-blind (DB) Treatment|Adverse Event|0|||
147463014|NCT00110994|531855538|FG000|Double-blind (DB) Treatment|Death|1|||
147463015|NCT00110994|531855539|FG001|Double-blind (DB) Treatment|Death|0|||
147463016|NCT00110994|531855538|FG000|Double-blind (DB) Treatment|Withdrawal by Subject|0|||
147463017|NCT00110994|531855539|FG001|Double-blind (DB) Treatment|Withdrawal by Subject|2|||
147463018|NCT00110994|531855538|FG000|Double-blind (DB) Treatment|Progression by clinical judgement|2|||
147463019|NCT00110994|531855539|FG001|Double-blind (DB) Treatment|Progression by clinical judgement|1|||
147463020|NCT00110994|531855538|FG000|Double-blind (DB) Treatment|Radiological and symptomatic progression|34|||
147463021|NCT00110994|531855539|FG001|Double-blind (DB) Treatment|Radiological and symptomatic progression|41|||
147463022|NCT00110994|531855538|FG000|Double-blind (DB) Treatment|other reasons|2|||
147463023|NCT00110994|531855539|FG001|Double-blind (DB) Treatment|other reasons|3|||
147463024|NCT00110994|531855538|FG000|Active Follow-up|Disease progression/recurrence/replace|1|||
147463025|NCT00110994|531855539|FG001|Active Follow-up|Disease progression/recurrence/replace|0|||
147463026|NCT00110994|531855538|FG000|Active Follow-up|Other reasons|0|||
147463027|NCT00110994|531855539|FG001|Active Follow-up|Other reasons|2|||
147463028|NCT00110994|531855538|FG000|Long Term Follow-up|Death|19|||
147463029|NCT00110994|531855539|FG001|Long Term Follow-up|Death|17|||
147463030|NCT01299727|531855540|FG000|Overall Study|Withdrawal by Subject|1|||
147463031|NCT01299727|531855541|FG001|Overall Study|Withdrawal by Subject|0|||
147463032|NCT01299727|531855542|FG002|Overall Study|Withdrawal by Subject|0|||
147463033|NCT01299727|531855540|FG000|Overall Study|Adverse Event|0|||
147463034|NCT01299727|531855541|FG001|Overall Study|Adverse Event|0|||
147463035|NCT01299727|531855542|FG002|Overall Study|Adverse Event|1|||
147463036|NCT01299727|531855540|FG000|Overall Study|Completed the Treatment Period|3|||
147463037|NCT01299727|531855541|FG001|Overall Study|Completed the Treatment Period|4|||
147463038|NCT01299727|531855542|FG002|Overall Study|Completed the Treatment Period|3|||
147463039|NCT00944034|531855547|FG000|Overall Study|Inappropriate enrollment|0|||
147463040|NCT00944034|531855548|FG001|Overall Study|Inappropriate enrollment|1|||
147463041|NCT00944034|531855549|FG002|Overall Study|Inappropriate enrollment|0|||
147463042|NCT00944034|531855550|FG003|Overall Study|Inappropriate enrollment|1|||
147463043|NCT00944034|531855551|FG004|Overall Study|Inappropriate enrollment|2|||
147463044|NCT00944034|531855552|FG005|Overall Study|Inappropriate enrollment|1|||
147463045|NCT00944034|531855553|FG006|Overall Study|Inappropriate enrollment|0|||
147463046|NCT00944034|531855554|FG007|Overall Study|Inappropriate enrollment|0|||
147463047|NCT00944034|531855555|FG008|Overall Study|Inappropriate enrollment|1|||
147463048|NCT00944034|531855556|FG009|Overall Study|Inappropriate enrollment|1|||
147463049|NCT00944034|531855557|FG010|Overall Study|Inappropriate enrollment|0|||
147463050|NCT00944034|531855558|FG011|Overall Study|Inappropriate enrollment|0|||
147463051|NCT00944034|531855547|FG000|Overall Study|Withdrawal by Subject|3|||
147463052|NCT00944034|531855548|FG001|Overall Study|Withdrawal by Subject|2|||
147402511|NCT00267098|531636797|FG007|Overall Study|Site closure|0|||
147402512|NCT00267098|531636790|FG000|Overall Study|Explanted Medtronic device|0|||
147402513|NCT00267098|531636791|FG001|Overall Study|Explanted Medtronic device|0|||
147402514|NCT00267098|531636792|FG002|Overall Study|Explanted Medtronic device|0|||
147402515|NCT00267098|531636793|FG003|Overall Study|Explanted Medtronic device|1|||
147402516|NCT00267098|531636794|FG004|Overall Study|Explanted Medtronic device|0|||
147402517|NCT00267098|531636795|FG005|Overall Study|Explanted Medtronic device|0|||
147402518|NCT00267098|531636796|FG006|Overall Study|Explanted Medtronic device|0|||
147402519|NCT00267098|531636797|FG007|Overall Study|Explanted Medtronic device|0|||
147402520|NCT00267098|531636790|FG000|Overall Study|Non-Medtronic LV Lead Implanted|0|||
147402521|NCT00267098|531636791|FG001|Overall Study|Non-Medtronic LV Lead Implanted|0|||
147402522|NCT00267098|531636792|FG002|Overall Study|Non-Medtronic LV Lead Implanted|0|||
147402523|NCT00267098|531636793|FG003|Overall Study|Non-Medtronic LV Lead Implanted|0|||
147402524|NCT00267098|531636794|FG004|Overall Study|Non-Medtronic LV Lead Implanted|2|||
147402525|NCT00267098|531636795|FG005|Overall Study|Non-Medtronic LV Lead Implanted|0|||
147402526|NCT00267098|531636796|FG006|Overall Study|Non-Medtronic LV Lead Implanted|0|||
147402527|NCT00267098|531636797|FG007|Overall Study|Non-Medtronic LV Lead Implanted|0|||
147402528|NCT00267098|531636790|FG000|Overall Study|Subject listed for heart transplant|0|||
147402529|NCT00267098|531636791|FG001|Overall Study|Subject listed for heart transplant|0|||
147402530|NCT00267098|531636792|FG002|Overall Study|Subject listed for heart transplant|0|||
147402531|NCT00267098|531636793|FG003|Overall Study|Subject listed for heart transplant|0|||
147402532|NCT00267098|531636794|FG004|Overall Study|Subject listed for heart transplant|0|||
147463053|NCT00944034|531855549|FG002|Overall Study|Withdrawal by Subject|6|||
147463054|NCT00944034|531855550|FG003|Overall Study|Withdrawal by Subject|2|||
147463055|NCT00944034|531855551|FG004|Overall Study|Withdrawal by Subject|5|||
147463056|NCT00944034|531855552|FG005|Overall Study|Withdrawal by Subject|8|||
147463057|NCT00944034|531855553|FG006|Overall Study|Withdrawal by Subject|2|||
147463058|NCT00944034|531855554|FG007|Overall Study|Withdrawal by Subject|2|||
147463059|NCT00944034|531855555|FG008|Overall Study|Withdrawal by Subject|3|||
147665258|NCT00922636|532599516|FG001|Overall Study|Protocol Violation|0|||
147665259|NCT00922636|532599517|FG002|Overall Study|Protocol Violation|2|||
147665260|NCT00922636|532599518|FG003|Overall Study|Protocol Violation|2|||
147665261|NCT00922636|532599519|FG004|Overall Study|Protocol Violation|0|||
147402533|NCT00267098|531636795|FG005|Overall Study|Subject listed for heart transplant|0|||
147402534|NCT00267098|531636796|FG006|Overall Study|Subject listed for heart transplant|1|||
147402535|NCT00267098|531636797|FG007|Overall Study|Subject listed for heart transplant|0|||
147402536|NCT00267098|531636790|FG000|Overall Study|Sponsor withdrew subject|0|||
147402537|NCT00267098|531636791|FG001|Overall Study|Sponsor withdrew subject|0|||
147402538|NCT00267098|531636792|FG002|Overall Study|Sponsor withdrew subject|0|||
147402539|NCT00267098|531636793|FG003|Overall Study|Sponsor withdrew subject|1|||
147402540|NCT00267098|531636794|FG004|Overall Study|Sponsor withdrew subject|0|||
147402541|NCT00267098|531636795|FG005|Overall Study|Sponsor withdrew subject|0|||
147402542|NCT00267098|531636796|FG006|Overall Study|Sponsor withdrew subject|0|||
147402543|NCT00267098|531636797|FG007|Overall Study|Sponsor withdrew subject|0|||
147402544|NCT00547534|531636798|FG000|Overall Study|Adverse Event|7|||
147402545|NCT00547534|531636798|FG000|Overall Study|Disease Progression|4|||
147402546|NCT02688530|531636801|FG000|Overall Study|Withdrawal by Subject|0|||
147402547|NCT02688530|531636802|FG001|Overall Study|Withdrawal by Subject|1|||
147402548|NCT02688530|531636803|FG002|Overall Study|Withdrawal by Subject|0|||
147402549|NCT02688530|531636804|FG003|Overall Study|Withdrawal by Subject|0|||
147402550|NCT02688530|531636801|FG000|Overall Study|Lost to Follow-up|0|||
147402551|NCT02688530|531636802|FG001|Overall Study|Lost to Follow-up|0|||
147402552|NCT02688530|531636803|FG002|Overall Study|Lost to Follow-up|2|||
147402553|NCT02688530|531636804|FG003|Overall Study|Lost to Follow-up|0|||
147402554|NCT01658020|531636805|FG000|Overall Study|Adverse Event|3|||
147402555|NCT01658020|531636806|FG001|Overall Study|Adverse Event|3|||
147402556|NCT01658020|531636805|FG000|Overall Study|Lost to Follow-up|1|||
147402557|NCT01658020|531636806|FG001|Overall Study|Lost to Follow-up|0|||
147402558|NCT01658020|531636805|FG000|Overall Study|Withdrawal by Subject|4|||
147402559|NCT01658020|531636806|FG001|Overall Study|Withdrawal by Subject|5|||
147402560|NCT01658020|531636805|FG000|Overall Study|Protocol Violation|0|||
147402561|NCT01658020|531636806|FG001|Overall Study|Protocol Violation|1|||
147402562|NCT04206085|531636807|FG000|Overall Study|Lost to Follow-up|0|||
147402563|NCT04206085|531636808|FG001|Overall Study|Lost to Follow-up|1|||
147402564|NCT04206085|531636809|FG002|Overall Study|Lost to Follow-up|0|||
147402565|NCT04206085|531636807|FG000|Overall Study|Lost to Follow-up|0|||
147402566|NCT04206085|531636808|FG001|Overall Study|Lost to Follow-up|0|||
147402567|NCT04206085|531636809|FG002|Overall Study|Lost to Follow-up|1|||
147402568|NCT00763451|531636810|FG000|Overall Study|Adverse Event|4|||
147402569|NCT00763451|531636811|FG001|Overall Study|Adverse Event|6|||
147402570|NCT00763451|531636812|FG002|Overall Study|Adverse Event|19|||
147402571|NCT00763451|531636813|FG003|Overall Study|Adverse Event|14|||
147402572|NCT00763451|531636810|FG000|Overall Study|Lack of Efficacy|1|||
147402573|NCT00763451|531636811|FG001|Overall Study|Lack of Efficacy|4|||
147402574|NCT00763451|531636812|FG002|Overall Study|Lack of Efficacy|3|||
147402575|NCT00763451|531636813|FG003|Overall Study|Lack of Efficacy|2|||
147402576|NCT00763451|531636810|FG000|Overall Study|Withdrawal by Subject|1|||
147402577|NCT00763451|531636811|FG001|Overall Study|Withdrawal by Subject|6|||
147402578|NCT00763451|531636812|FG002|Overall Study|Withdrawal by Subject|9|||
147402579|NCT00763451|531636813|FG003|Overall Study|Withdrawal by Subject|7|||
147402580|NCT00763451|531636810|FG000|Overall Study|Protocol Violation|0|||
147402581|NCT00763451|531636811|FG001|Overall Study|Protocol Violation|0|||
147402582|NCT00763451|531636812|FG002|Overall Study|Protocol Violation|1|||
147402583|NCT00763451|531636813|FG003|Overall Study|Protocol Violation|0|||
147402584|NCT00763451|531636810|FG000|Overall Study|Poor Compliance to Protocol|1|||
147402585|NCT00763451|531636811|FG001|Overall Study|Poor Compliance to Protocol|1|||
147402586|NCT00763451|531636812|FG002|Overall Study|Poor Compliance to Protocol|2|||
147402587|NCT00763451|531636813|FG003|Overall Study|Poor Compliance to Protocol|2|||
147402588|NCT00763451|531636810|FG000|Overall Study|Familial and Personal Reasons|5|||
147402589|NCT00763451|531636811|FG001|Overall Study|Familial and Personal Reasons|3|||
147402590|NCT00763451|531636812|FG002|Overall Study|Familial and Personal Reasons|5|||
147402591|NCT00763451|531636813|FG003|Overall Study|Familial and Personal Reasons|4|||
147402592|NCT00763451|531636810|FG000|Overall Study|Randomized but not Treated|1|||
147402593|NCT00763451|531636811|FG001|Overall Study|Randomized but not Treated|1|||
147402594|NCT00763451|531636812|FG002|Overall Study|Randomized but not Treated|0|||
147402595|NCT00763451|531636813|FG003|Overall Study|Randomized but not Treated|0|||
147402596|NCT00763451|531636810|FG000|Overall Study|Study Site Reason|0|||
147402597|NCT00763451|531636811|FG001|Overall Study|Study Site Reason|1|||
147402598|NCT00763451|531636812|FG002|Overall Study|Study Site Reason|1|||
147402599|NCT00763451|531636813|FG003|Overall Study|Study Site Reason|1|||
147402600|NCT00725543|531636817|FG000|Overall Study|Adverse Event|10|||
147402601|NCT00725543|531636817|FG000|Overall Study|Lack of Efficacy|3|||
147402602|NCT00725543|531636817|FG000|Overall Study|Withdrawal by Subject|10|||
147402603|NCT00725543|531636817|FG000|Overall Study|Physician Decision|5|||
147402604|NCT00725543|531636817|FG000|Overall Study|Lost to Follow-up|4|||
147402605|NCT00725543|531636817|FG000|Overall Study|Non-compliance|2|||
147665262|NCT00922636|532599515|FG000|Overall Study|Entry Criteria Not Met|0|||
147402606|NCT00725543|531636817|FG000|Overall Study|Other|119|||
147402607|NCT05594589|531636820|FG000|Overall Study|Other|0|||
147402608|NCT05594589|531636821|FG001|Overall Study|Other|1|||
147402609|NCT05594589|531636822|FG002|Overall Study|Other|0|||
147402610|NCT01062971|531636830|FG000|Overall Study|Protocol Violation|1|||
147402611|NCT01062971|531636831|FG001|Overall Study|Protocol Violation|3|||
147402612|NCT01062971|531636830|FG000|Overall Study|Lost to Follow-up|3|||
147402613|NCT01062971|531636831|FG001|Overall Study|Lost to Follow-up|4|||
147402614|NCT02760485|531636832|FG000|Phase 1|Death|3|||
147402615|NCT02760485|531636833|FG001|Phase 1|Death|6|||
147402616|NCT02760485|531636834|FG002|Phase 1|Death|0|||
147402617|NCT02760485|531636832|FG000|Phase 1|Withdrawal by Subject|2|||
147402618|NCT02760485|531636833|FG001|Phase 1|Withdrawal by Subject|0|||
147402619|NCT02760485|531636834|FG002|Phase 1|Withdrawal by Subject|0|||
147402620|NCT02760485|531636832|FG000|Phase 1|Progressive Disease|1|||
147402621|NCT02760485|531636833|FG001|Phase 1|Progressive Disease|0|||
147402622|NCT02760485|531636834|FG002|Phase 1|Progressive Disease|0|||
147402623|NCT02760485|531636832|FG000|Phase 1|Amendment Removed Survival Follow-up|0|||
147402624|NCT02760485|531636833|FG001|Phase 1|Amendment Removed Survival Follow-up|1|||
147402625|NCT02760485|531636834|FG002|Phase 1|Amendment Removed Survival Follow-up|0|||
147402626|NCT02760485|531636832|FG000|Phase 1|Unknown; Did Not Complete End-of-Study Visit|1|||
147402627|NCT02760485|531636833|FG001|Phase 1|Unknown; Did Not Complete End-of-Study Visit|0|||
147402628|NCT02760485|531636834|FG002|Phase 1|Unknown; Did Not Complete End-of-Study Visit|0|||
147402629|NCT02760485|531636832|FG000|Phase 2|Death|0|||
147463060|NCT00944034|531855556|FG009|Overall Study|Withdrawal by Subject|4|||
147463061|NCT00944034|531855557|FG010|Overall Study|Withdrawal by Subject|0|||
147463062|NCT00944034|531855558|FG011|Overall Study|Withdrawal by Subject|4|||
147463063|NCT00944034|531855547|FG000|Overall Study|Lost to Follow-up|0|||
147463064|NCT00944034|531855548|FG001|Overall Study|Lost to Follow-up|4|||
147463065|NCT00944034|531855549|FG002|Overall Study|Lost to Follow-up|2|||
147463066|NCT00944034|531855550|FG003|Overall Study|Lost to Follow-up|0|||
147463067|NCT00944034|531855551|FG004|Overall Study|Lost to Follow-up|5|||
147463068|NCT00944034|531855552|FG005|Overall Study|Lost to Follow-up|7|||
147463069|NCT00944034|531855553|FG006|Overall Study|Lost to Follow-up|0|||
147463070|NCT00944034|531855554|FG007|Overall Study|Lost to Follow-up|1|||
147463071|NCT00944034|531855555|FG008|Overall Study|Lost to Follow-up|5|||
147463072|NCT00944034|531855556|FG009|Overall Study|Lost to Follow-up|1|||
147463073|NCT00944034|531855557|FG010|Overall Study|Lost to Follow-up|1|||
147463074|NCT00944034|531855558|FG011|Overall Study|Lost to Follow-up|0|||
147463075|NCT00944034|531855547|FG000|Overall Study|Death|0|||
147463076|NCT00944034|531855548|FG001|Overall Study|Death|0|||
147463077|NCT00944034|531855549|FG002|Overall Study|Death|1|||
147463078|NCT00944034|531855550|FG003|Overall Study|Death|0|||
147463079|NCT00944034|531855551|FG004|Overall Study|Death|0|||
147463080|NCT00944034|531855552|FG005|Overall Study|Death|0|||
147463081|NCT00944034|531855553|FG006|Overall Study|Death|0|||
147463082|NCT00944034|531855554|FG007|Overall Study|Death|0|||
147463083|NCT00944034|531855555|FG008|Overall Study|Death|0|||
147463084|NCT00944034|531855556|FG009|Overall Study|Death|0|||
147463085|NCT00944034|531855557|FG010|Overall Study|Death|0|||
147463086|NCT00944034|531855558|FG011|Overall Study|Death|0|||
147463087|NCT00944034|531855547|FG000|Overall Study|Protocol Violation|2|||
147463088|NCT00944034|531855548|FG001|Overall Study|Protocol Violation|0|||
147463089|NCT00944034|531855549|FG002|Overall Study|Protocol Violation|0|||
147463090|NCT00944034|531855550|FG003|Overall Study|Protocol Violation|1|||
147463091|NCT00944034|531855551|FG004|Overall Study|Protocol Violation|2|||
147463092|NCT00944034|531855552|FG005|Overall Study|Protocol Violation|3|||
147463093|NCT00944034|531855553|FG006|Overall Study|Protocol Violation|0|||
147463094|NCT00944034|531855554|FG007|Overall Study|Protocol Violation|1|||
147463095|NCT00944034|531855555|FG008|Overall Study|Protocol Violation|1|||
147463096|NCT00944034|531855556|FG009|Overall Study|Protocol Violation|4|||
147463097|NCT00944034|531855557|FG010|Overall Study|Protocol Violation|0|||
147463098|NCT00944034|531855558|FG011|Overall Study|Protocol Violation|0|||
147463099|NCT00944034|531855547|FG000|Overall Study|Unable to classify|0|||
147402630|NCT02760485|531636833|FG001|Phase 2|Death|0|||
147402631|NCT02760485|531636834|FG002|Phase 2|Death|12|||
147402632|NCT02760485|531636832|FG000|Phase 2|Withdrawal by Subject|0|||
147463100|NCT00944034|531855548|FG001|Overall Study|Unable to classify|0|||
147463101|NCT00944034|531855549|FG002|Overall Study|Unable to classify|0|||
147463102|NCT00944034|531855550|FG003|Overall Study|Unable to classify|0|||
147402633|NCT02760485|531636833|FG001|Phase 2|Withdrawal by Subject|0|||
147402634|NCT02760485|531636834|FG002|Phase 2|Withdrawal by Subject|3|||
147402635|NCT02760485|531636832|FG000|Phase 2|Progressive Disease|0|||
147463103|NCT00944034|531855551|FG004|Overall Study|Unable to classify|0|||
147463104|NCT00944034|531855552|FG005|Overall Study|Unable to classify|1|||
147463105|NCT00944034|531855553|FG006|Overall Study|Unable to classify|1|||
147463106|NCT00944034|531855554|FG007|Overall Study|Unable to classify|1|||
147463107|NCT00944034|531855555|FG008|Overall Study|Unable to classify|0|||
147463108|NCT00944034|531855556|FG009|Overall Study|Unable to classify|0|||
147463109|NCT00944034|531855557|FG010|Overall Study|Unable to classify|0|||
147463110|NCT00944034|531855558|FG011|Overall Study|Unable to classify|0|||
147463111|NCT00944034|531855547|FG000|Overall Study|Administrative reason|0|||
147615764|NCT04011722|532409047|FG000|3 Year|Not Yet Due|99|||
147615765|NCT04011722|532409048|FG001|3 Year|Not Yet Due|0|||
147615766|NCT05061134|532409049|FG000|Overall Study|Patients ongoing in the study at data cut-off (DCO) of 12-April-2024|19|||
147615767|NCT05061134|532409050|FG001|Overall Study|Patients ongoing in the study at data cut-off (DCO) of 12-April-2024|3|||
147615768|NCT05061134|532409051|FG002|Overall Study|Patients ongoing in the study at data cut-off (DCO) of 12-April-2024|6|||
147615769|NCT05061134|532409049|FG000|Overall Study|Subject not treated|0|||
147615770|NCT05061134|532409050|FG001|Overall Study|Subject not treated|0|||
147615771|NCT05061134|532409051|FG002|Overall Study|Subject not treated|2|||
147615772|NCT05061134|532409049|FG000|Overall Study|Other|0|||
147615773|NCT05061134|532409050|FG001|Overall Study|Other|0|||
147615774|NCT05061134|532409051|FG002|Overall Study|Other|9|||
147615775|NCT05061134|532409049|FG000|Overall Study|Withdrawal by Subject|9|||
147615776|NCT05061134|532409050|FG001|Overall Study|Withdrawal by Subject|8|||
147615777|NCT05061134|532409051|FG002|Overall Study|Withdrawal by Subject|5|||
147615778|NCT05061134|532409049|FG000|Overall Study|Study Terminated by Sponsor|22|||
147615779|NCT05061134|532409050|FG001|Overall Study|Study Terminated by Sponsor|14|||
147615780|NCT05061134|532409051|FG002|Overall Study|Study Terminated by Sponsor|7|||
147615781|NCT05061134|532409049|FG000|Overall Study|Progressive Disease|1|||
147615782|NCT05061134|532409050|FG001|Overall Study|Progressive Disease|2|||
147615783|NCT05061134|532409051|FG002|Overall Study|Progressive Disease|0|||
147615784|NCT05061134|532409049|FG000|Overall Study|Patient Is on Survival Follow Up Beyond DCO|1|||
147615785|NCT05061134|532409050|FG001|Overall Study|Patient Is on Survival Follow Up Beyond DCO|0|||
147615786|NCT05061134|532409051|FG002|Overall Study|Patient Is on Survival Follow Up Beyond DCO|0|||
147615787|NCT05061134|532409049|FG000|Overall Study|Lost to Follow-up|1|||
147615788|NCT05061134|532409050|FG001|Overall Study|Lost to Follow-up|0|||
147615789|NCT05061134|532409051|FG002|Overall Study|Lost to Follow-up|0|||
147615790|NCT05061134|532409049|FG000|Overall Study|Physician Decision|1|||
147615791|NCT05061134|532409050|FG001|Overall Study|Physician Decision|1|||
147615792|NCT05061134|532409051|FG002|Overall Study|Physician Decision|0|||
147615793|NCT05061134|532409049|FG000|Overall Study|Disease progression|1|||
147615794|NCT05061134|532409050|FG001|Overall Study|Disease progression|0|||
147615795|NCT05061134|532409051|FG002|Overall Study|Disease progression|0|||
147615796|NCT05061134|532409049|FG000|Overall Study|Death|43|||
147615797|NCT05061134|532409050|FG001|Overall Study|Death|23|||
147615798|NCT05061134|532409051|FG002|Overall Study|Death|14|||
147615799|NCT05061134|532409049|FG000|Overall Study|Database lock|2|||
147615800|NCT05061134|532409050|FG001|Overall Study|Database lock|0|||
147615801|NCT05061134|532409051|FG002|Overall Study|Database lock|0|||
147615802|NCT00001521|532409052|FG000|Overall Study|Withdrawal by Subject|3|||
147615803|NCT00001521|532409053|FG001|Overall Study|Withdrawal by Subject|3|||
147615804|NCT00001521|532409052|FG000|Overall Study|Physician Decision|1|||
147615805|NCT00001521|532409053|FG001|Overall Study|Physician Decision|1|||
147615806|NCT00001521|532409052|FG000|Overall Study|Noncompliant|6|||
147402636|NCT02760485|531636833|FG001|Phase 2|Progressive Disease|0|||
147402637|NCT02760485|531636834|FG002|Phase 2|Progressive Disease|1|||
147402638|NCT02760485|531636832|FG000|Phase 2|Unknown; Did Not Complete End-of-Study Visit|0|||
147402639|NCT02760485|531636833|FG001|Phase 2|Unknown; Did Not Complete End-of-Study Visit|0|||
147402640|NCT02760485|531636834|FG002|Phase 2|Unknown; Did Not Complete End-of-Study Visit|3|||
147402641|NCT01182207|531636835|FG000|First Intervention|Positive Hepatitis Results|0|||
147402642|NCT01182207|531636836|FG001|First Intervention|Positive Hepatitis Results|1|||
147402643|NCT01182207|531636835|FG000|Second Intervention|Emeses within 1 hour of dosing|1|||
147615807|NCT00001521|532409053|FG001|Overall Study|Noncompliant|3|||
147615808|NCT03176134|532409054|FG000|Overall Study|Lost to Follow-up|0|||
147615809|NCT03176134|532409055|FG001|Overall Study|Lost to Follow-up|2|||
147615810|NCT03176134|532409056|FG002|Overall Study|Lost to Follow-up|0|||
147615811|NCT03176134|532409057|FG003|Overall Study|Lost to Follow-up|0|||
147615812|NCT03176134|532409058|FG004|Overall Study|Lost to Follow-up|0|||
147402644|NCT01182207|531636836|FG001|Second Intervention|Emeses within 1 hour of dosing|0|||
147615813|NCT03176134|532409059|FG005|Overall Study|Lost to Follow-up|0|||
147615814|NCT03176134|532409060|FG006|Overall Study|Lost to Follow-up|0|||
147615815|NCT03176134|532409061|FG007|Overall Study|Lost to Follow-up|0|||
147615816|NCT03176134|532409054|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
147615817|NCT03176134|532409055|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
147615818|NCT03176134|532409056|FG002|Overall Study|Withdrawal by Parent/Guardian|2|||
147615819|NCT03176134|532409057|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
147615820|NCT03176134|532409058|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
147615821|NCT03176134|532409059|FG005|Overall Study|Withdrawal by Parent/Guardian|0|||
147615822|NCT03176134|532409060|FG006|Overall Study|Withdrawal by Parent/Guardian|0|||
147615823|NCT03176134|532409061|FG007|Overall Study|Withdrawal by Parent/Guardian|0|||
147615824|NCT03410056|532409066|FG000|Overall Study|Decision by Sponsor|0|||
147615825|NCT03410056|532409067|FG001|Overall Study|Decision by Sponsor|0|||
147615826|NCT03410056|532409068|FG002|Overall Study|Decision by Sponsor|3|||
147615827|NCT03410056|532409069|FG003|Overall Study|Decision by Sponsor|0|||
147615828|NCT03410056|532409070|FG004|Overall Study|Decision by Sponsor|0|||
147615829|NCT03410056|532409071|FG005|Overall Study|Decision by Sponsor|0|||
147615830|NCT03410056|532409072|FG006|Overall Study|Decision by Sponsor|0|||
147402645|NCT02581059|531636841|FG000|Study Treatment|Disease Progression|1|||
147402646|NCT02581059|531636842|FG001|Study Treatment|Disease Progression|1|||
147402647|NCT02581059|531636841|FG000|Study Treatment|Adverse Event|2|||
147402648|NCT02581059|531636842|FG001|Study Treatment|Adverse Event|1|||
147402649|NCT02581059|531636841|FG000|Study Treatment|Death|1|||
147402650|NCT02581059|531636842|FG001|Study Treatment|Death|1|||
147402651|NCT02581059|531636841|FG000|Study Treatment|Patient Withdrawal After Therapy Start|0|||
147402652|NCT02581059|531636842|FG001|Study Treatment|Patient Withdrawal After Therapy Start|1|||
147402653|NCT02581059|531636841|FG000|Study Treatment|Screen Failure Before Therapy Start|0|||
147402654|NCT02581059|531636842|FG001|Study Treatment|Screen Failure Before Therapy Start|1|||
147402655|NCT02581059|531636841|FG000|Follow up|Death|1|||
147402656|NCT02581059|531636842|FG001|Follow up|Death|3|||
147402657|NCT02581059|531636841|FG000|Follow up|study terminated|1|||
147402658|NCT02581059|531636842|FG001|Follow up|study terminated|1|||
147402659|NCT02581059|531636841|FG000|Follow up|screen failure|0|||
147402660|NCT02581059|531636842|FG001|Follow up|screen failure|1|||
147402661|NCT02581059|531636841|FG000|Follow up|Patient started new clinical trial|1|||
147402662|NCT02581059|531636842|FG001|Follow up|Patient started new clinical trial|0|||
147402663|NCT03569891|531636844|FG000|Lead-in|Ineligible during lead-in|8|||
147402664|NCT03569891|531636844|FG000|Lead-in|Withdrawal by Subject|3|||
147402665|NCT03569891|531636844|FG000|Lead-in|Risks related to COVID-19|2|||
147402666|NCT03569891|531636844|FG000|AMT-061|Adverse Event|1|||
147402667|NCT04750577|531636845|FG000|Overall Study|Adverse Event|2|||
147402668|NCT04750577|531636846|FG001|Overall Study|Adverse Event|10|||
147402669|NCT04750577|531636847|FG002|Overall Study|Adverse Event|8|||
147402670|NCT04750577|531636848|FG003|Overall Study|Adverse Event|1|||
147402671|NCT04750577|531636845|FG000|Overall Study|Change of residence|0|||
147402672|NCT04750577|531636846|FG001|Overall Study|Change of residence|0|||
147402673|NCT04750577|531636847|FG002|Overall Study|Change of residence|1|||
147402674|NCT04750577|531636848|FG003|Overall Study|Change of residence|0|||
147402675|NCT04750577|531636845|FG000|Overall Study|Burden of study procedures|0|||
147402676|NCT04750577|531636846|FG001|Overall Study|Burden of study procedures|2|||
147402677|NCT04750577|531636847|FG002|Overall Study|Burden of study procedures|2|||
147402678|NCT04750577|531636848|FG003|Overall Study|Burden of study procedures|0|||
147402679|NCT04750577|531636845|FG000|Overall Study|Prematurely discontinued|0|||
147402680|NCT04750577|531636846|FG001|Overall Study|Prematurely discontinued|0|||
147402681|NCT04750577|531636847|FG002|Overall Study|Prematurely discontinued|0|||
147402682|NCT04750577|531636848|FG003|Overall Study|Prematurely discontinued|2|||
147402683|NCT04750577|531636845|FG000|Overall Study|Protocol deviation|1|||
147402684|NCT04750577|531636846|FG001|Overall Study|Protocol deviation|1|||
147402685|NCT04750577|531636847|FG002|Overall Study|Protocol deviation|1|||
147402686|NCT04750577|531636848|FG003|Overall Study|Protocol deviation|1|||
147402687|NCT04750577|531636845|FG000|Overall Study|Other than listed|3|||
147402688|NCT04750577|531636846|FG001|Overall Study|Other than listed|2|||
147402689|NCT04750577|531636847|FG002|Overall Study|Other than listed|2|||
147402690|NCT04750577|531636848|FG003|Overall Study|Other than listed|1|||
147402691|NCT04750577|531636845|FG000|Overall Study|Not treated|0|||
147402692|NCT04750577|531636846|FG001|Overall Study|Not treated|0|||
147402693|NCT04750577|531636847|FG002|Overall Study|Not treated|0|||
147402694|NCT04750577|531636848|FG003|Overall Study|Not treated|2|||
147402695|NCT02647645|531636853|FG000|Overall Study|Lost to Follow-up|2|||
147402696|NCT02647645|531636854|FG001|Overall Study|Lost to Follow-up|1|||
147402697|NCT02037256|531636855|FG000|Overall Study|Protocol Violation|0|||
147402698|NCT02037256|531636856|FG001|Overall Study|Protocol Violation|1|||
147402699|NCT02037256|531636855|FG000|Overall Study|Withdrawn prior to Velcade|0|||
147402700|NCT02037256|531636856|FG001|Overall Study|Withdrawn prior to Velcade|2|||
147402701|NCT01466790|531636860|FG000|Overall Study|Adverse Event|1|||
147402702|NCT01466790|531636861|FG001|Overall Study|Adverse Event|0|||
147402703|NCT01466790|531636862|FG002|Overall Study|Adverse Event|0|||
147402704|NCT01466790|531636863|FG003|Overall Study|Adverse Event|0|||
147402705|NCT01466790|531636864|FG004|Overall Study|Adverse Event|2|||
147402706|NCT01466790|531636865|FG005|Overall Study|Adverse Event|0|||
147402707|NCT01466790|531636866|FG006|Overall Study|Adverse Event|0|||
147402708|NCT01466790|531636867|FG007|Overall Study|Adverse Event|0|||
147402709|NCT01466790|531636860|FG000|Overall Study|Lost to Follow-up|2|||
147402710|NCT01466790|531636861|FG001|Overall Study|Lost to Follow-up|0|||
147402711|NCT01466790|531636862|FG002|Overall Study|Lost to Follow-up|0|||
147402712|NCT01466790|531636863|FG003|Overall Study|Lost to Follow-up|0|||
147402713|NCT01466790|531636864|FG004|Overall Study|Lost to Follow-up|0|||
147402714|NCT01466790|531636865|FG005|Overall Study|Lost to Follow-up|0|||
147402715|NCT01466790|531636866|FG006|Overall Study|Lost to Follow-up|0|||
147402716|NCT01466790|531636867|FG007|Overall Study|Lost to Follow-up|0|||
147402717|NCT01466790|531636860|FG000|Overall Study|Withdrawal by Subject|1|||
147402718|NCT01466790|531636861|FG001|Overall Study|Withdrawal by Subject|1|||
147402719|NCT01466790|531636862|FG002|Overall Study|Withdrawal by Subject|0|||
147402720|NCT01466790|531636863|FG003|Overall Study|Withdrawal by Subject|0|||
147402721|NCT01466790|531636864|FG004|Overall Study|Withdrawal by Subject|1|||
147402722|NCT01466790|531636865|FG005|Overall Study|Withdrawal by Subject|0|||
147402723|NCT01466790|531636866|FG006|Overall Study|Withdrawal by Subject|1|||
147402724|NCT01466790|531636867|FG007|Overall Study|Withdrawal by Subject|1|||
147402725|NCT00826228|531639025|FG000|Overall Study|Withdrawal by Subject|1|||
147402726|NCT01090011|531639026|FG000|Overall Study|Progressive disease|128|||
147402727|NCT01090011|531639026|FG000|Overall Study|Adverse Event|32|||
147402728|NCT01090011|531639026|FG000|Overall Study|Protocol Violation|1|||
147402729|NCT01090011|531639026|FG000|Overall Study|Refusal to start/continue medication|5|||
147402730|NCT01090011|531639026|FG000|Overall Study|Other reason not defined above|5|||
147402731|NCT00307047|531639027|FG000|Overall Study|Lost to Follow-up|35|||
147402732|NCT00307047|531639028|FG001|Overall Study|Lost to Follow-up|24|||
147402733|NCT00307047|531639027|FG000|Overall Study|Withdrawal by Subject|6|||
147402734|NCT00307047|531639028|FG001|Overall Study|Withdrawal by Subject|6|||
147402735|NCT00307047|531639027|FG000|Overall Study|Physician Decision|1|||
147402736|NCT00307047|531639028|FG001|Overall Study|Physician Decision|2|||
147402737|NCT00307047|531639027|FG000|Overall Study|Lost to follow-up for other reasons|0|||
147402738|NCT00307047|531639028|FG001|Overall Study|Lost to follow-up for other reasons|1|||
147402739|NCT00307047|531639027|FG000|Overall Study|All death, all MI, all Revascularization|27|||
147402740|NCT00307047|531639028|FG001|Overall Study|All death, all MI, all Revascularization|16|||
147402741|NCT00379769|531639029|FG000|Main Study|Death|57|||
147402742|NCT00379769|531639030|FG001|Main Study|Death|67|||
147402743|NCT00379769|531639031|FG002|Main Study|Death|54|||
147402744|NCT00379769|531639032|FG003|Main Study|Death|72|||
147402745|NCT00379769|531639033|FG004|Main Study|Death|0|||
147402746|NCT00379769|531639034|FG005|Main Study|Death|0|||
147402747|NCT00379769|531639029|FG000|Main Study|Adverse Event|5|||
147402748|NCT00379769|531639030|FG001|Main Study|Adverse Event|8|||
147402749|NCT00379769|531639031|FG002|Main Study|Adverse Event|10|||
147402750|NCT00379769|531639032|FG003|Main Study|Adverse Event|11|||
147402751|NCT00379769|531639033|FG004|Main Study|Adverse Event|0|||
147402752|NCT00379769|531639034|FG005|Main Study|Adverse Event|0|||
147402753|NCT00379769|531639029|FG000|Main Study|Lost to Follow-up|29|||
147402754|NCT00379769|531639030|FG001|Main Study|Lost to Follow-up|29|||
147402755|NCT00379769|531639031|FG002|Main Study|Lost to Follow-up|25|||
147402756|NCT00379769|531639032|FG003|Main Study|Lost to Follow-up|26|||
147402757|NCT00379769|531639033|FG004|Main Study|Lost to Follow-up|0|||
147402758|NCT00379769|531639034|FG005|Main Study|Lost to Follow-up|0|||
147402759|NCT00379769|531639029|FG000|Main Study|Withdrawal by Subject|46|||
147402760|NCT00379769|531639030|FG001|Main Study|Withdrawal by Subject|56|||
147402761|NCT00379769|531639031|FG002|Main Study|Withdrawal by Subject|72|||
147402762|NCT00379769|531639032|FG003|Main Study|Withdrawal by Subject|70|||
147402763|NCT00379769|531639033|FG004|Main Study|Withdrawal by Subject|0|||
147402764|NCT00379769|531639034|FG005|Main Study|Withdrawal by Subject|0|||
147402765|NCT00379769|531639029|FG000|Main Study|Moved to survival status follow-up only|27|||
147402766|NCT00379769|531639030|FG001|Main Study|Moved to survival status follow-up only|25|||
147402767|NCT00379769|531639031|FG002|Main Study|Moved to survival status follow-up only|32|||
147402768|NCT00379769|531639032|FG003|Main Study|Moved to survival status follow-up only|36|||
147402769|NCT00379769|531639033|FG004|Main Study|Moved to survival status follow-up only|0|||
147402770|NCT00379769|531639034|FG005|Main Study|Moved to survival status follow-up only|0|||
147402771|NCT00379769|531639029|FG000|Main Study|Participant moved|3|||
147402772|NCT00379769|531639030|FG001|Main Study|Participant moved|2|||
147402773|NCT00379769|531639031|FG002|Main Study|Participant moved|3|||
147402774|NCT00379769|531639032|FG003|Main Study|Participant moved|3|||
147402775|NCT00379769|531639033|FG004|Main Study|Participant moved|0|||
147402776|NCT00379769|531639034|FG005|Main Study|Participant moved|0|||
147402777|NCT00379769|531639029|FG000|Main Study|Poor compliance|3|||
147402778|NCT00379769|531639030|FG001|Main Study|Poor compliance|2|||
147402779|NCT00379769|531639031|FG002|Main Study|Poor compliance|2|||
147402780|NCT00379769|531639032|FG003|Main Study|Poor compliance|1|||
147402781|NCT00379769|531639033|FG004|Main Study|Poor compliance|0|||
147402782|NCT00379769|531639034|FG005|Main Study|Poor compliance|0|||
147402783|NCT00379769|531639029|FG000|Main Study|Prohibited glucose lowering medication|0|||
147402784|NCT00379769|531639030|FG001|Main Study|Prohibited glucose lowering medication|3|||
147402785|NCT00379769|531639031|FG002|Main Study|Prohibited glucose lowering medication|0|||
147615831|NCT03410056|532409066|FG000|Overall Study|Withdrawal by Subject|0|||
147615832|NCT03410056|532409067|FG001|Overall Study|Withdrawal by Subject|2|||
147402786|NCT00379769|531639032|FG003|Main Study|Prohibited glucose lowering medication|1|||
147402787|NCT00379769|531639033|FG004|Main Study|Prohibited glucose lowering medication|0|||
147402788|NCT00379769|531639034|FG005|Main Study|Prohibited glucose lowering medication|0|||
147402789|NCT00379769|531639029|FG000|Main Study|Site closed|4|||
147402790|NCT00379769|531639030|FG001|Main Study|Site closed|4|||
147402791|NCT00379769|531639031|FG002|Main Study|Site closed|4|||
147402792|NCT00379769|531639032|FG003|Main Study|Site closed|8|||
147402793|NCT00379769|531639033|FG004|Main Study|Site closed|0|||
147402794|NCT00379769|531639034|FG005|Main Study|Site closed|0|||
147402795|NCT00379769|531639029|FG000|Main Study|Entry criteria violation|0|||
147402796|NCT00379769|531639030|FG001|Main Study|Entry criteria violation|0|||
147402797|NCT00379769|531639031|FG002|Main Study|Entry criteria violation|1|||
147402798|NCT00379769|531639032|FG003|Main Study|Entry criteria violation|1|||
147402799|NCT00379769|531639033|FG004|Main Study|Entry criteria violation|0|||
147615833|NCT03410056|532409068|FG002|Overall Study|Withdrawal by Subject|5|||
147402800|NCT00379769|531639034|FG005|Main Study|Entry criteria violation|0|||
147402801|NCT00379769|531639029|FG000|Main Study|Participant did not take study drug|0|||
147402802|NCT00379769|531639030|FG001|Main Study|Participant did not take study drug|0|||
147402803|NCT00379769|531639031|FG002|Main Study|Participant did not take study drug|1|||
147402804|NCT00379769|531639032|FG003|Main Study|Participant did not take study drug|0|||
147402805|NCT00379769|531639033|FG004|Main Study|Participant did not take study drug|0|||
147402806|NCT00379769|531639034|FG005|Main Study|Participant did not take study drug|0|||
147402807|NCT00379769|531639029|FG000|Main Study|Physician Decision|2|||
147402808|NCT00379769|531639030|FG001|Main Study|Physician Decision|2|||
147402809|NCT00379769|531639031|FG002|Main Study|Physician Decision|1|||
147402810|NCT00379769|531639032|FG003|Main Study|Physician Decision|1|||
147402811|NCT00379769|531639033|FG004|Main Study|Physician Decision|0|||
147402812|NCT00379769|531639034|FG005|Main Study|Physician Decision|0|||
147402813|NCT00379769|531639029|FG000|Main Study|Participant completed study at visit 27|1|||
147402814|NCT00379769|531639030|FG001|Main Study|Participant completed study at visit 27|0|||
147402815|NCT00379769|531639031|FG002|Main Study|Participant completed study at visit 27|0|||
147402816|NCT00379769|531639032|FG003|Main Study|Participant completed study at visit 27|0|||
147402817|NCT00379769|531639033|FG004|Main Study|Participant completed study at visit 27|0|||
147402818|NCT00379769|531639034|FG005|Main Study|Participant completed study at visit 27|0|||
147402819|NCT00379769|531639029|FG000|Main Study|Personal reasons|1|||
147402820|NCT00379769|531639030|FG001|Main Study|Personal reasons|0|||
147402821|NCT00379769|531639031|FG002|Main Study|Personal reasons|0|||
147402822|NCT00379769|531639032|FG003|Main Study|Personal reasons|0|||
147402823|NCT00379769|531639033|FG004|Main Study|Personal reasons|0|||
147402824|NCT00379769|531639034|FG005|Main Study|Personal reasons|0|||
147402825|NCT00379769|531639029|FG000|Main Study|Risk of heart failure|0|||
147402826|NCT00379769|531639030|FG001|Main Study|Risk of heart failure|1|||
147402827|NCT00379769|531639031|FG002|Main Study|Risk of heart failure|0|||
147402828|NCT00379769|531639032|FG003|Main Study|Risk of heart failure|0|||
147402829|NCT00379769|531639033|FG004|Main Study|Risk of heart failure|0|||
147402830|NCT00379769|531639034|FG005|Main Study|Risk of heart failure|0|||
147402831|NCT00379769|531639029|FG000|Main Study|Investigator refused to log temperature|0|||
147402832|NCT00379769|531639030|FG001|Main Study|Investigator refused to log temperature|0|||
147402833|NCT00379769|531639031|FG002|Main Study|Investigator refused to log temperature|1|||
147402834|NCT00379769|531639032|FG003|Main Study|Investigator refused to log temperature|0|||
147402835|NCT00379769|531639033|FG004|Main Study|Investigator refused to log temperature|0|||
147402836|NCT00379769|531639034|FG005|Main Study|Investigator refused to log temperature|0|||
147402837|NCT00379769|531639029|FG000|Main Study|Reason unspecified|0|||
147402838|NCT00379769|531639030|FG001|Main Study|Reason unspecified|0|||
147402839|NCT00379769|531639031|FG002|Main Study|Reason unspecified|1|||
147402840|NCT00379769|531639032|FG003|Main Study|Reason unspecified|0|||
147402841|NCT00379769|531639033|FG004|Main Study|Reason unspecified|0|||
147402842|NCT00379769|531639034|FG005|Main Study|Reason unspecified|0|||
147402843|NCT00379769|531639029|FG000|Observational Follow-up|Death|0|||
147402844|NCT00379769|531639030|FG001|Observational Follow-up|Death|0|||
147402845|NCT00379769|531639031|FG002|Observational Follow-up|Death|0|||
147402846|NCT00379769|531639032|FG003|Observational Follow-up|Death|0|||
147402847|NCT00379769|531639033|FG004|Observational Follow-up|Death|78|||
147402848|NCT00379769|531639034|FG005|Observational Follow-up|Death|70|||
147402849|NCT00379769|531639029|FG000|Observational Follow-up|Adverse Event|0|||
147402850|NCT00379769|531639030|FG001|Observational Follow-up|Adverse Event|0|||
147402851|NCT00379769|531639031|FG002|Observational Follow-up|Adverse Event|0|||
147402852|NCT00379769|531639032|FG003|Observational Follow-up|Adverse Event|0|||
147402853|NCT00379769|531639033|FG004|Observational Follow-up|Adverse Event|1|||
147402854|NCT00379769|531639034|FG005|Observational Follow-up|Adverse Event|0|||
147402855|NCT00379769|531639029|FG000|Observational Follow-up|Lost to Follow-up|0|||
147402856|NCT00379769|531639030|FG001|Observational Follow-up|Lost to Follow-up|0|||
147402857|NCT00379769|531639031|FG002|Observational Follow-up|Lost to Follow-up|0|||
147402858|NCT00379769|531639032|FG003|Observational Follow-up|Lost to Follow-up|0|||
147402859|NCT00379769|531639033|FG004|Observational Follow-up|Lost to Follow-up|25|||
147402860|NCT00379769|531639034|FG005|Observational Follow-up|Lost to Follow-up|27|||
147402861|NCT00379769|531639029|FG000|Observational Follow-up|Withdrawal by Subject|0|||
147402862|NCT00379769|531639030|FG001|Observational Follow-up|Withdrawal by Subject|0|||
147402863|NCT00379769|531639031|FG002|Observational Follow-up|Withdrawal by Subject|0|||
147402864|NCT00379769|531639032|FG003|Observational Follow-up|Withdrawal by Subject|0|||
147402865|NCT00379769|531639033|FG004|Observational Follow-up|Withdrawal by Subject|12|||
147402866|NCT00379769|531639034|FG005|Observational Follow-up|Withdrawal by Subject|12|||
147402867|NCT00379769|531639029|FG000|Observational Follow-up|Entered into Another Clinical Trial|0|||
147402868|NCT00379769|531639030|FG001|Observational Follow-up|Entered into Another Clinical Trial|0|||
147402869|NCT00379769|531639031|FG002|Observational Follow-up|Entered into Another Clinical Trial|0|||
147402870|NCT00379769|531639032|FG003|Observational Follow-up|Entered into Another Clinical Trial|0|||
147402871|NCT00379769|531639033|FG004|Observational Follow-up|Entered into Another Clinical Trial|18|||
147402872|NCT00379769|531639034|FG005|Observational Follow-up|Entered into Another Clinical Trial|22|||
147402873|NCT00379769|531639029|FG000|Observational Follow-up|Physician Decision|0|||
147402874|NCT00379769|531639030|FG001|Observational Follow-up|Physician Decision|0|||
147402875|NCT00379769|531639031|FG002|Observational Follow-up|Physician Decision|0|||
147402876|NCT00379769|531639032|FG003|Observational Follow-up|Physician Decision|0|||
147402877|NCT00379769|531639033|FG004|Observational Follow-up|Physician Decision|8|||
147402878|NCT00379769|531639034|FG005|Observational Follow-up|Physician Decision|8|||
147402879|NCT00379769|531639029|FG000|Observational Follow-up|Site Closed Early|0|||
147402880|NCT00379769|531639030|FG001|Observational Follow-up|Site Closed Early|0|||
147402881|NCT00379769|531639031|FG002|Observational Follow-up|Site Closed Early|0|||
147402882|NCT00379769|531639032|FG003|Observational Follow-up|Site Closed Early|0|||
147402883|NCT00379769|531639033|FG004|Observational Follow-up|Site Closed Early|6|||
147402884|NCT00379769|531639034|FG005|Observational Follow-up|Site Closed Early|7|||
147402885|NCT00379769|531639029|FG000|Observational Follow-up|Participant Moved|0|||
147402886|NCT00379769|531639030|FG001|Observational Follow-up|Participant Moved|0|||
147402887|NCT00379769|531639031|FG002|Observational Follow-up|Participant Moved|0|||
147402888|NCT00379769|531639032|FG003|Observational Follow-up|Participant Moved|0|||
147402889|NCT00379769|531639033|FG004|Observational Follow-up|Participant Moved|0|||
147402890|NCT00379769|531639034|FG005|Observational Follow-up|Participant Moved|1|||
147402891|NCT00379769|531639029|FG000|Observational Follow-up|Unknown; Reason Not Provided|0|||
147402892|NCT00379769|531639030|FG001|Observational Follow-up|Unknown; Reason Not Provided|0|||
147402893|NCT00379769|531639031|FG002|Observational Follow-up|Unknown; Reason Not Provided|0|||
147402894|NCT00379769|531639032|FG003|Observational Follow-up|Unknown; Reason Not Provided|0|||
147402895|NCT00379769|531639033|FG004|Observational Follow-up|Unknown; Reason Not Provided|1|||
147402896|NCT00379769|531639034|FG005|Observational Follow-up|Unknown; Reason Not Provided|1|||
147402897|NCT03778294|531639035|FG000|Overall Study|Death|1|||
147402898|NCT03778294|531639035|FG000|Overall Study|Issues with insurance|1|||
147402899|NCT03778294|531639035|FG000|Overall Study|disease progression before treatment|2|||
147402900|NCT02825251|531639038|FG000|Overall Study|Adverse Event|0|||
147402901|NCT02825251|531639039|FG001|Overall Study|Adverse Event|1|||
147402902|NCT02825251|531639038|FG000|Overall Study|Lost to Follow-up|0|||
147402903|NCT02825251|531639039|FG001|Overall Study|Lost to Follow-up|1|||
147402904|NCT02825251|531639038|FG000|Overall Study|Withdrawal by Subject|1|||
147402905|NCT02825251|531639039|FG001|Overall Study|Withdrawal by Subject|4|||
147402906|NCT02825251|531639038|FG000|Overall Study|Unclassified|2|||
147402907|NCT02825251|531639039|FG001|Overall Study|Unclassified|0|||
147402908|NCT01689363|531639047|FG000|Overall Study|Protocol Violation|0|||
147402909|NCT01689363|531639048|FG001|Overall Study|Protocol Violation|1|||
147402910|NCT01689363|531639049|FG002|Overall Study|Protocol Violation|0|||
147402911|NCT01689363|531639050|FG003|Overall Study|Protocol Violation|0|||
147402912|NCT01689363|531639051|FG004|Overall Study|Protocol Violation|0|||
147402913|NCT01689363|531639052|FG005|Overall Study|Protocol Violation|0|||
147402914|NCT01689363|531639053|FG006|Overall Study|Protocol Violation|0|||
147402915|NCT01689363|531639054|FG007|Overall Study|Protocol Violation|0|||
147402916|NCT02104505|531639055|FG000|First Intervention (14 Days)|Adverse Event|2|||
147402917|NCT02104505|531639056|FG001|First Intervention (14 Days)|Adverse Event|0|||
147402918|NCT02104505|531639055|FG000|First Intervention (14 Days)|Withdrawal by Subject|0|||
147402919|NCT02104505|531639056|FG001|First Intervention (14 Days)|Withdrawal by Subject|1|||
147402920|NCT02104505|531639055|FG000|First Intervention (14 Days)|Lost to Follow-up|0|||
147402921|NCT02104505|531639056|FG001|First Intervention (14 Days)|Lost to Follow-up|1|||
147402922|NCT02104505|531639055|FG000|First Intervention (14 Days)|exclusionary condition|0|||
147402923|NCT02104505|531639056|FG001|First Intervention (14 Days)|exclusionary condition|1|||
147402924|NCT02104505|531639055|FG000|Second Intervention (14 Days)|Withdrawal by Subject|0|||
147402925|NCT02104505|531639056|FG001|Second Intervention (14 Days)|Withdrawal by Subject|1|||
147402926|NCT02104505|531639055|FG000|Second Intervention (14 Days)|Adverse Event|2|||
147402927|NCT02104505|531639056|FG001|Second Intervention (14 Days)|Adverse Event|0|||
147402928|NCT01845805|531639057|FG000|Overall Study|Withdrawal by Subject|1|||
147402929|NCT01845805|531639058|FG001|Overall Study|Withdrawal by Subject|2|||
147402930|NCT01845805|531639057|FG000|Overall Study|Disease Progression|13|||
147402931|NCT01845805|531639058|FG001|Overall Study|Disease Progression|14|||
147402932|NCT01845805|531639057|FG000|Overall Study|Drug-related Toxicity|4|||
147402933|NCT01845805|531639058|FG001|Overall Study|Drug-related Toxicity|0|||
147402934|NCT02859064|531639059|FG000|Overall Study|Progressive Disease|3|||
147402935|NCT02859064|531639059|FG000|Overall Study|Physician Decision|1|||
147402936|NCT02859064|531639059|FG000|Overall Study|Withdrawal by Subject|1|||
147402937|NCT02859064|531639059|FG000|Overall Study|Death|1|||
147402938|NCT00321685|531639060|FG000|Overall Study|Adverse Event|18|||
147402939|NCT00321685|531639060|FG000|Overall Study|Death|2|||
147402940|NCT00321685|531639060|FG000|Overall Study|Withdrawal by Subject|8|||
147402941|NCT00321685|531639060|FG000|Overall Study|Alternative therapy|1|||
147402942|NCT00321685|531639060|FG000|Overall Study|Complicating disese|1|||
147463112|NCT00944034|531855548|FG001|Overall Study|Administrative reason|0|||
147463113|NCT00944034|531855549|FG002|Overall Study|Administrative reason|0|||
147463114|NCT00944034|531855550|FG003|Overall Study|Administrative reason|0|||
147402943|NCT00321685|531639060|FG000|Overall Study|Other|5|||
147463115|NCT00944034|531855551|FG004|Overall Study|Administrative reason|0|||
147463116|NCT00944034|531855552|FG005|Overall Study|Administrative reason|0|||
147665263|NCT00922636|532599516|FG001|Overall Study|Entry Criteria Not Met|0|||
147665264|NCT00922636|532599517|FG002|Overall Study|Entry Criteria Not Met|1|||
147665265|NCT00922636|532599518|FG003|Overall Study|Entry Criteria Not Met|1|||
147402944|NCT00321685|531639060|FG000|Overall Study|Not start protocol therapy|2|||
147402945|NCT00321685|531639060|FG000|Overall Study|Ineligible|2|||
147402946|NCT00127842|531639064|FG000|Overall Study|Adverse Event|15|||
147402947|NCT00127842|531639064|FG000|Overall Study|Withdrawal by Subject|3|||
147402948|NCT00127842|531639064|FG000|Overall Study|Lost to Follow-up|1|||
147402949|NCT00127842|531639064|FG000|Overall Study|Lack of Efficacy|12|||
147402950|NCT00127842|531639064|FG000|Overall Study|Noncompliance|2|||
147402951|NCT00127842|531639064|FG000|Overall Study|Protocol Violation|1|||
147402952|NCT00127842|531639064|FG000|Overall Study|Other|5|||
147402953|NCT01730950|531639065|FG000|Overall Study|Protocol Violation|6|||
147402954|NCT01730950|531639066|FG001|Overall Study|Protocol Violation|6|||
147402955|NCT03023722|531639067|FG000|Overall Study|No follow-up assessment|4|||
147402956|NCT00667459|531639068|FG000|Overall Study|Death|0|||
147402957|NCT00667459|531639069|FG001|Overall Study|Death|2|||
147402958|NCT00667459|531639068|FG000|Overall Study|Lost to Follow-up|8|||
147402959|NCT00667459|531639069|FG001|Overall Study|Lost to Follow-up|43|||
147402960|NCT03616964|531639070|FG000|Overall Study|Adverse Event|15|||
147402961|NCT03616964|531639071|FG001|Overall Study|Adverse Event|10|||
147402962|NCT03616964|531639072|FG002|Overall Study|Adverse Event|16|||
147402963|NCT03616964|531639070|FG000|Overall Study|Death|3|||
147402964|NCT03616964|531639071|FG001|Overall Study|Death|0|||
147402965|NCT03616964|531639072|FG002|Overall Study|Death|4|||
147402966|NCT03616964|531639070|FG000|Overall Study|Lack of Efficacy|4|||
147402967|NCT03616964|531639071|FG001|Overall Study|Lack of Efficacy|8|||
147402968|NCT03616964|531639072|FG002|Overall Study|Lack of Efficacy|8|||
147402969|NCT03616964|531639070|FG000|Overall Study|Lost to Follow-up|2|||
147402970|NCT03616964|531639071|FG001|Overall Study|Lost to Follow-up|1|||
147402971|NCT03616964|531639072|FG002|Overall Study|Lost to Follow-up|3|||
147402972|NCT03616964|531639070|FG000|Overall Study|Withdrawal by Subject|18|||
147402973|NCT03616964|531639071|FG001|Overall Study|Withdrawal by Subject|14|||
147402974|NCT03616964|531639072|FG002|Overall Study|Withdrawal by Subject|21|||
147402975|NCT03616964|531639070|FG000|Overall Study|Withdrawal by Principal Investigator (PI)|1|||
147402976|NCT03616964|531639071|FG001|Overall Study|Withdrawal by Principal Investigator (PI)|1|||
147402977|NCT03616964|531639072|FG002|Overall Study|Withdrawal by Principal Investigator (PI)|1|||
147402978|NCT03616964|531639070|FG000|Overall Study|Sponsor's Decision|1|||
147402979|NCT03616964|531639071|FG001|Overall Study|Sponsor's Decision|0|||
147402980|NCT03616964|531639072|FG002|Overall Study|Sponsor's Decision|0|||
147402981|NCT03616964|531639070|FG000|Overall Study|Physician Decision|0|||
147402982|NCT03616964|531639071|FG001|Overall Study|Physician Decision|2|||
147402983|NCT03616964|531639072|FG002|Overall Study|Physician Decision|0|||
147402984|NCT03616964|531639070|FG000|Overall Study|Decreased Neutrophils due to Systemic Lupus Erythematosus (SLE)|0|||
147402985|NCT03616964|531639071|FG001|Overall Study|Decreased Neutrophils due to Systemic Lupus Erythematosus (SLE)|1|||
147402986|NCT03616964|531639072|FG002|Overall Study|Decreased Neutrophils due to Systemic Lupus Erythematosus (SLE)|0|||
147402987|NCT03616964|531639070|FG000|Overall Study|Protocol Violation|0|||
147402988|NCT03616964|531639071|FG001|Overall Study|Protocol Violation|1|||
147402989|NCT03616964|531639072|FG002|Overall Study|Protocol Violation|0|||
147402990|NCT03616964|531639070|FG000|Overall Study|Due to Epidemic/Pandemic|0|||
147402991|NCT03616964|531639071|FG001|Overall Study|Due to Epidemic/Pandemic|1|||
147402992|NCT03616964|531639072|FG002|Overall Study|Due to Epidemic/Pandemic|0|||
147402993|NCT03616964|531639070|FG000|Overall Study|Randomized but Never Treated|1|||
147402994|NCT03616964|531639071|FG001|Overall Study|Randomized but Never Treated|1|||
147402995|NCT03616964|531639072|FG002|Overall Study|Randomized but Never Treated|1|||
147402996|NCT04071301|531639078|FG000|Overall Study|Withdrawal by Subject|6|||
147402997|NCT04071301|531639078|FG000|Overall Study|Death|1|||
147463117|NCT00944034|531855553|FG006|Overall Study|Administrative reason|1|||
147463118|NCT00944034|531855554|FG007|Overall Study|Administrative reason|0|||
147463119|NCT00944034|531855555|FG008|Overall Study|Administrative reason|0|||
147463120|NCT00944034|531855556|FG009|Overall Study|Administrative reason|0|||
147463121|NCT00944034|531855557|FG010|Overall Study|Administrative reason|0|||
147463122|NCT00944034|531855558|FG011|Overall Study|Administrative reason|0|||
147463123|NCT01596257|531855559|FG000|Overall Study|Inadequate Collection|23|||
147463124|NCT01596257|531855560|FG001|Overall Study|Inadequate Collection|19|||
147402998|NCT01850589|531639079|FG000|Overall Study|Withdrawal by Subject|8|||
147402999|NCT01850589|531639080|FG001|Overall Study|Withdrawal by Subject|0|||
147403000|NCT03721705|531639083|FG000|Overall Study|Adverse Event|2|||
147403001|NCT03721705|531639084|FG001|Overall Study|Adverse Event|0|||
147403002|NCT03721705|531639083|FG000|Overall Study|Withdrawal by Subject|4|||
147403003|NCT03721705|531639084|FG001|Overall Study|Withdrawal by Subject|10|||
147463125|NCT01570244|531855561|FG000|Microgynon+Faldaprevir|Adverse Event|1|||
147403004|NCT03721705|531639083|FG000|Overall Study|No Suitable Study Partner|1|||
147403005|NCT03721705|531639084|FG001|Overall Study|No Suitable Study Partner|0|||
147463126|NCT00531960|531855572|FG000|Overall Study|Adverse Event|5|||
147403006|NCT03721705|531639083|FG000|Overall Study|Early Termination Due to Coronavirus Disease 2019 (COVID-19)|3|||
147403007|NCT03721705|531639084|FG001|Overall Study|Early Termination Due to Coronavirus Disease 2019 (COVID-19)|7|||
147403008|NCT03721705|531639083|FG000|Overall Study|Death|0|||
147403009|NCT03721705|531639084|FG001|Overall Study|Death|1|||
147403010|NCT01843777|531639085|FG000|Overall Study|Withdrawal by Subject|1|||
147403011|NCT01843777|531639086|FG001|Overall Study|Withdrawal by Subject|0|||
147403012|NCT00632021|531639088|FG000|Overall Study|Withdrawal/death|4|||
147403013|NCT00632021|531639089|FG001|Overall Study|Withdrawal/death|7|||
147403014|NCT02049515|531639090|FG000|Overall Study|Adverse Event|46|||
147403015|NCT02049515|531639091|FG001|Overall Study|Adverse Event|2|||
147403016|NCT02049515|531639090|FG000|Overall Study|Protocol-specified Disease Progression|23|||
147403017|NCT02049515|531639091|FG001|Overall Study|Protocol-specified Disease Progression|2|||
147403018|NCT02049515|531639090|FG000|Overall Study|Death|6|||
147403019|NCT02049515|531639091|FG001|Overall Study|Death|0|||
147403020|NCT02049515|531639090|FG000|Overall Study|Physician Decision|5|||
147403021|NCT02049515|531639091|FG001|Overall Study|Physician Decision|1|||
147403022|NCT02049515|531639090|FG000|Overall Study|Withdrawal by Subject|3|||
147403023|NCT02049515|531639091|FG001|Overall Study|Withdrawal by Subject|0|||
147403024|NCT02049515|531639090|FG000|Overall Study|Termination of the Study by Sponsor|2|||
147403025|NCT02049515|531639091|FG001|Overall Study|Termination of the Study by Sponsor|0|||
147403026|NCT02049515|531639090|FG000|Overall Study|Protocol Violation|1|||
147403027|NCT02049515|531639091|FG001|Overall Study|Protocol Violation|1|||
147403028|NCT02049515|531639090|FG000|Overall Study|Clinical Deterioration|1|||
147403029|NCT02049515|531639091|FG001|Overall Study|Clinical Deterioration|0|||
147403030|NCT02049515|531639090|FG000|Overall Study|Need Treatment for Metastatic Melanoma|1|||
147403031|NCT02049515|531639091|FG001|Overall Study|Need Treatment for Metastatic Melanoma|0|||
147403032|NCT02049515|531639090|FG000|Overall Study|Treatment Interruption >42 Days|1|||
147403033|NCT02049515|531639091|FG001|Overall Study|Treatment Interruption >42 Days|0|||
147403034|NCT02049515|531639090|FG000|Overall Study|Suspected and Unconfirmed Disease Progression|1|||
147403035|NCT02049515|531639091|FG001|Overall Study|Suspected and Unconfirmed Disease Progression|0|||
147403036|NCT00224029|531639098|FG000|Overall Study|Lost to Follow-up|1|||
147403037|NCT00224029|531639098|FG000|Overall Study|Withdrawal by Subject|4|||
147403038|NCT00224029|531639098|FG000|Overall Study|Other|1|||
147403039|NCT02872012|531639099|FG000|Overall Study|Withdrawal by Subject|1|||
147403040|NCT02872012|531639100|FG001|Overall Study|Withdrawal by Subject|0|||
147403041|NCT02872012|531639101|FG002|Overall Study|Withdrawal by Subject|0|||
147403042|NCT02872012|531639102|FG003|Overall Study|Withdrawal by Subject|0|||
147403043|NCT02872012|531639103|FG004|Overall Study|Withdrawal by Subject|0|||
147403044|NCT01728623|531639104|FG000|Overall Study|Disease progression|26|||
147403045|NCT01728623|531639104|FG000|Overall Study|Adverse Event|1|||
147403046|NCT01728623|531639104|FG000|Overall Study|Withdrawal by Subject|1|||
147403047|NCT03000348|531639105|FG000|Overall Study|Adverse Event|1|||
147403048|NCT03000348|531639106|FG001|Overall Study|Adverse Event|1|||
147403049|NCT03000348|531639107|FG002|Overall Study|Adverse Event|1|||
147403050|NCT03000348|531639108|FG003|Overall Study|Adverse Event|1|||
147403051|NCT03000348|531639109|FG004|Overall Study|Adverse Event|1|||
147403052|NCT03000348|531639110|FG005|Overall Study|Adverse Event|1|||
147403053|NCT03000348|531639105|FG000|Overall Study|Lost to Follow-up|0|||
147403054|NCT03000348|531639106|FG001|Overall Study|Lost to Follow-up|0|||
147403055|NCT03000348|531639107|FG002|Overall Study|Lost to Follow-up|1|||
147403056|NCT03000348|531639108|FG003|Overall Study|Lost to Follow-up|0|||
147403057|NCT03000348|531639109|FG004|Overall Study|Lost to Follow-up|0|||
147403058|NCT03000348|531639110|FG005|Overall Study|Lost to Follow-up|0|||
147403059|NCT03000348|531639105|FG000|Overall Study|Withdrawal by Subject|0|||
147403060|NCT03000348|531639106|FG001|Overall Study|Withdrawal by Subject|1|||
147403061|NCT03000348|531639107|FG002|Overall Study|Withdrawal by Subject|0|||
147403062|NCT03000348|531639108|FG003|Overall Study|Withdrawal by Subject|0|||
147403063|NCT03000348|531639109|FG004|Overall Study|Withdrawal by Subject|0|||
147403064|NCT03000348|531639110|FG005|Overall Study|Withdrawal by Subject|0|||
147403065|NCT03000348|531639105|FG000|Overall Study|Consent|0|||
147615834|NCT03410056|532409069|FG003|Overall Study|Withdrawal by Subject|5|||
147615835|NCT03410056|532409070|FG004|Overall Study|Withdrawal by Subject|0|||
147615836|NCT03410056|532409071|FG005|Overall Study|Withdrawal by Subject|0|||
147403066|NCT03000348|531639106|FG001|Overall Study|Consent|0|||
147403067|NCT03000348|531639107|FG002|Overall Study|Consent|0|||
147403068|NCT03000348|531639108|FG003|Overall Study|Consent|0|||
147403069|NCT03000348|531639109|FG004|Overall Study|Consent|1|||
147403070|NCT03000348|531639110|FG005|Overall Study|Consent|0|||
147403071|NCT03000348|531639105|FG000|Overall Study|Failure to expectorate sputum|1|||
147403072|NCT03000348|531639106|FG001|Overall Study|Failure to expectorate sputum|0|||
147403073|NCT03000348|531639107|FG002|Overall Study|Failure to expectorate sputum|1|||
147403074|NCT03000348|531639108|FG003|Overall Study|Failure to expectorate sputum|0|||
147403075|NCT03000348|531639109|FG004|Overall Study|Failure to expectorate sputum|1|||
147403076|NCT03000348|531639110|FG005|Overall Study|Failure to expectorate sputum|0|||
147403077|NCT03000348|531639105|FG000|Overall Study|No gram negative|1|||
147403078|NCT03000348|531639106|FG001|Overall Study|No gram negative|2|||
147403079|NCT03000348|531639107|FG002|Overall Study|No gram negative|1|||
147403080|NCT03000348|531639108|FG003|Overall Study|No gram negative|1|||
147403081|NCT03000348|531639109|FG004|Overall Study|No gram negative|1|||
147403082|NCT03000348|531639110|FG005|Overall Study|No gram negative|1|||
147403083|NCT03000348|531639105|FG000|Overall Study|Patient had no transport|0|||
147403084|NCT03000348|531639106|FG001|Overall Study|Patient had no transport|0|||
147403085|NCT03000348|531639107|FG002|Overall Study|Patient had no transport|0|||
147403086|NCT03000348|531639108|FG003|Overall Study|Patient had no transport|1|||
147403087|NCT03000348|531639109|FG004|Overall Study|Patient had no transport|0|||
147403088|NCT03000348|531639110|FG005|Overall Study|Patient had no transport|0|||
147403089|NCT03000348|531639105|FG000|Overall Study|Dosing|0|||
147403090|NCT03000348|531639106|FG001|Overall Study|Dosing|0|||
147403091|NCT03000348|531639107|FG002|Overall Study|Dosing|0|||
147403092|NCT03000348|531639108|FG003|Overall Study|Dosing|0|||
147403093|NCT03000348|531639109|FG004|Overall Study|Dosing|1|||
147403094|NCT03000348|531639110|FG005|Overall Study|Dosing|0|||
147403095|NCT01807182|531639112|FG000|Overall Study|Death|1|||
147403096|NCT01807182|531639112|FG000|Overall Study|New therapy|1|||
147403097|NCT01807182|531639112|FG000|Overall Study|Moved to hospice care|1|||
147403098|NCT03513068|531639113|FG000|Overall Study|Death|1|||
147403099|NCT03513068|531639114|FG001|Overall Study|Death|0|||
147403100|NCT03513068|531639113|FG000|Overall Study|Withdrawal by Subject|4|||
147403101|NCT03513068|531639114|FG001|Overall Study|Withdrawal by Subject|6|||
147403102|NCT00745498|531639115|FG000|Overall Study|Lost to Follow-up|1|||
147403103|NCT00745498|531639116|FG001|Overall Study|Lost to Follow-up|1|||
147403104|NCT00745498|531639117|FG002|Overall Study|Lost to Follow-up|3|||
147403105|NCT00745498|531639115|FG000|Overall Study|Injection of intravitreal silicone oil o|3|||
147403106|NCT00745498|531639116|FG001|Overall Study|Injection of intravitreal silicone oil o|4|||
147403107|NCT00745498|531639117|FG002|Overall Study|Injection of intravitreal silicone oil o|4|||
147403108|NCT00745498|531639115|FG000|Overall Study|Non-PDR related VH|0|||
147403109|NCT00745498|531639116|FG001|Overall Study|Non-PDR related VH|1|||
147403110|NCT00745498|531639117|FG002|Overall Study|Non-PDR related VH|1|||
147403111|NCT00745498|531639115|FG000|Overall Study|Edophthalmitis after preoperative IVB|1|||
147403112|NCT00745498|531639116|FG001|Overall Study|Edophthalmitis after preoperative IVB|0|||
147403113|NCT00745498|531639117|FG002|Overall Study|Edophthalmitis after preoperative IVB|0|||
147403114|NCT03174782|531639118|FG000|Overall Study|Protocol Violation|1|||
147403115|NCT03174782|531639119|FG001|Overall Study|Protocol Violation|0|||
147403116|NCT03174782|531639118|FG000|Overall Study|Unable to perform procedure by medical staff|0|||
147403117|NCT03174782|531639119|FG001|Overall Study|Unable to perform procedure by medical staff|1|||
147403118|NCT00778921|531639120|FG000|Overall Study|Adverse Event|9|||
147403119|NCT00778921|531639121|FG001|Overall Study|Adverse Event|10|||
147403120|NCT00778921|531639122|FG002|Overall Study|Adverse Event|14|||
147403121|NCT00778921|531639120|FG000|Overall Study|Abnormal Laboratory Value(s)|1|||
147403122|NCT00778921|531639121|FG001|Overall Study|Abnormal Laboratory Value(s)|0|||
147403123|NCT00778921|531639122|FG002|Overall Study|Abnormal Laboratory Value(s)|0|||
147403124|NCT00778921|531639120|FG000|Overall Study|Abnormal Test Procedure Result(s)|0|||
147403125|NCT00778921|531639121|FG001|Overall Study|Abnormal Test Procedure Result(s)|0|||
147403126|NCT00778921|531639122|FG002|Overall Study|Abnormal Test Procedure Result(s)|2|||
147403127|NCT00778921|531639120|FG000|Overall Study|Unsatisfactory therapeutic response|1|||
147403128|NCT00778921|531639121|FG001|Overall Study|Unsatisfactory therapeutic response|1|||
147403129|NCT00778921|531639122|FG002|Overall Study|Unsatisfactory therapeutic response|1|||
147403130|NCT00778921|531639120|FG000|Overall Study|Patient No Longer Requires Study Drug|0|||
147403131|NCT00778921|531639121|FG001|Overall Study|Patient No Longer Requires Study Drug|1|||
147403132|NCT00778921|531639122|FG002|Overall Study|Patient No Longer Requires Study Drug|0|||
147403133|NCT00778921|531639120|FG000|Overall Study|Patient withdrew request|3|||
147403134|NCT00778921|531639121|FG001|Overall Study|Patient withdrew request|1|||
147403135|NCT00778921|531639122|FG002|Overall Study|Patient withdrew request|6|||
147403136|NCT00778921|531639120|FG000|Overall Study|Lost to Follow-up|0|||
147403137|NCT00778921|531639121|FG001|Overall Study|Lost to Follow-up|2|||
147403138|NCT00778921|531639122|FG002|Overall Study|Lost to Follow-up|1|||
147403139|NCT00778921|531639120|FG000|Overall Study|Administrative Problems|1|||
147403140|NCT00778921|531639121|FG001|Overall Study|Administrative Problems|2|||
147403141|NCT00778921|531639122|FG002|Overall Study|Administrative Problems|0|||
147403142|NCT00778921|531639120|FG000|Overall Study|Protocol Violation|3|||
147403143|NCT00778921|531639121|FG001|Overall Study|Protocol Violation|0|||
147403144|NCT00778921|531639122|FG002|Overall Study|Protocol Violation|2|||
147403145|NCT00778921|531639120|FG000|Overall Study|Not treated|0|||
147403146|NCT00778921|531639121|FG001|Overall Study|Not treated|2|||
147403147|NCT00778921|531639122|FG002|Overall Study|Not treated|2|||
147403148|NCT01791413|531639123|FG000|Overall Study|Lost to Follow-up|5|||
147403149|NCT01791413|531639124|FG001|Overall Study|Lost to Follow-up|1|||
147403150|NCT03178045|531639125|FG000|Overall Study|Withdrawal by Subject|5|||
147403151|NCT03178045|531639126|FG001|Overall Study|Withdrawal by Subject|7|||
147403152|NCT03178045|531639125|FG000|Overall Study|Surgery Cancelled/Relocated|34|||
147403153|NCT03178045|531639126|FG001|Overall Study|Surgery Cancelled/Relocated|30|||
147403154|NCT03178045|531639125|FG000|Overall Study|Procedure Ineligible Post-Operatively/Pr|47|||
147463127|NCT00531960|531855573|FG001|Overall Study|Adverse Event|4|||
147463128|NCT00531960|531855572|FG000|Overall Study|Death|3|||
147463129|NCT00531960|531855573|FG001|Overall Study|Death|2|||
147463130|NCT00531960|531855572|FG000|Overall Study|Lack of Efficacy|42|||
147463131|NCT00531960|531855573|FG001|Overall Study|Lack of Efficacy|41|||
147463132|NCT00531960|531855572|FG000|Overall Study|Violation of Selection Criteria|2|||
147463133|NCT00531960|531855573|FG001|Overall Study|Violation of Selection Criteria|0|||
147463134|NCT00531960|531855572|FG000|Overall Study|Refused Treatment|5|||
147463135|NCT00531960|531855573|FG001|Overall Study|Refused Treatment|6|||
147463136|NCT00531960|531855572|FG000|Overall Study|Other|4|||
147463137|NCT00531960|531855573|FG001|Overall Study|Other|10|||
147463138|NCT00713219|531855576|FG000|Overall Study|Death|1|||
147463139|NCT00713219|531855576|FG000|Overall Study|Protocol Violation|1|||
147463140|NCT03183128|531855582|FG000|Overall Study|Adverse Event|1|||
147463141|NCT03183128|531855583|FG001|Overall Study|Adverse Event|2|||
147463142|NCT03183128|531855582|FG000|Overall Study|Withdrawal by Subject|1|||
147463143|NCT03183128|531855583|FG001|Overall Study|Withdrawal by Subject|8|||
147463144|NCT03183128|531855582|FG000|Overall Study|Protocol Violation|2|||
147463145|NCT03183128|531855583|FG001|Overall Study|Protocol Violation|0|||
147463146|NCT03183128|531855582|FG000|Overall Study|Lack of Efficacy|4|||
147463147|NCT03183128|531855583|FG001|Overall Study|Lack of Efficacy|27|||
147463148|NCT03183128|531855582|FG000|Overall Study|Lost to Follow-up|1|||
147463149|NCT03183128|531855583|FG001|Overall Study|Lost to Follow-up|0|||
147463150|NCT03183128|531855582|FG000|Overall Study|Death|2|||
147463151|NCT03183128|531855583|FG001|Overall Study|Death|0|||
147463152|NCT03183128|531855582|FG000|Overall Study|Physician Decision|1|||
147463153|NCT03183128|531855583|FG001|Overall Study|Physician Decision|0|||
147463154|NCT01686568|531855586|FG000|Main Study|Withdrawal by Subject|1|||
147463155|NCT01686568|531855587|FG001|Main Study|Withdrawal by Subject|3|||
147463156|NCT01686568|531855586|FG000|Main Study|Noncompliance with protocol|0|||
147463157|NCT01686568|531855587|FG001|Main Study|Noncompliance with protocol|1|||
147463158|NCT01686568|531855586|FG000|Main Study|Liver enzymes above range of exclusion|1|||
147463159|NCT01686568|531855587|FG001|Main Study|Liver enzymes above range of exclusion|0|||
147463160|NCT01686568|531855586|FG000|Sub-Study|Not consented for sub-study|2|||
147463161|NCT01686568|531855587|FG001|Sub-Study|Not consented for sub-study|2|||
147463162|NCT02978222|531855588|FG000|Overall Study|Withdrawal by Subject|2|||
147463163|NCT02978222|531855589|FG001|Overall Study|Withdrawal by Subject|2|||
147463164|NCT02978222|531855588|FG000|Overall Study|Physician Decision|2|||
147463165|NCT02978222|531855589|FG001|Overall Study|Physician Decision|0|||
147463166|NCT02978222|531855588|FG000|Overall Study|Adverse Event|0|||
147463167|NCT02978222|531855589|FG001|Overall Study|Adverse Event|1|||
147463168|NCT02978222|531855588|FG000|Overall Study|Death|1|||
147463169|NCT02978222|531855589|FG001|Overall Study|Death|0|||
147463170|NCT02978222|531855588|FG000|Overall Study|Disease Progression|32|||
147463171|NCT02978222|531855589|FG001|Overall Study|Disease Progression|32|||
147463172|NCT02978222|531855588|FG000|Overall Study|Early Study Termination|24|||
147463173|NCT02978222|531855589|FG001|Overall Study|Early Study Termination|21|||
147463174|NCT03258814|531855590|FG000|Overall Study|Early Termination|4|||
147463175|NCT03258814|531855591|FG001|Overall Study|Early Termination|3|||
147463176|NCT03258814|531855592|FG002|Overall Study|Early Termination|10|||
147463177|NCT01413958|531855593|FG000|Overall Study|Lost to Follow-up|0|||
147463178|NCT01413958|531855594|FG001|Overall Study|Lost to Follow-up|1|||
147463179|NCT01900002|531855595|FG000|Overall Study|Withdrawal by Subject|2|||
147463180|NCT01900002|531855595|FG000|Overall Study|ineligible for Y-90|4|||
147463181|NCT02921425|531855602|FG000|Overall Study|Protocol Violation|9|||
147463182|NCT01227967|531855603|FG000|Overall Study|Protocol Violation|3|||
147463183|NCT01227967|531855604|FG001|Overall Study|Protocol Violation|1|||
147463184|NCT01227967|531855603|FG000|Overall Study|Death|0|||
147463185|NCT01227967|531855604|FG001|Overall Study|Death|1|||
147463186|NCT01227967|531855603|FG000|Overall Study|Lost to Follow-up|8|||
147463187|NCT01227967|531855604|FG001|Overall Study|Lost to Follow-up|3|||
147463188|NCT01227967|531855603|FG000|Overall Study|Withdrawal by Subject|4|||
147463189|NCT01227967|531855604|FG001|Overall Study|Withdrawal by Subject|3|||
147463190|NCT01227967|531855603|FG000|Overall Study|Physician Decision|0|||
147463191|NCT01227967|531855604|FG001|Overall Study|Physician Decision|1|||
147463192|NCT01227967|531855603|FG000|Overall Study|Never Started Treatment|0|||
147463193|NCT01227967|531855604|FG001|Overall Study|Never Started Treatment|4|||
147463194|NCT01227967|531855603|FG000|Overall Study|Taking Additional Antiviral Drug|1|||
147463195|NCT01227967|531855604|FG001|Overall Study|Taking Additional Antiviral Drug|0|||
147463196|NCT01145560|531855605|FG000|Overall Study|Withdrawal by Subject|2|||
147463197|NCT01145560|531855606|FG001|Overall Study|Withdrawal by Subject|1|||
147463198|NCT01145560|531855607|FG002|Overall Study|Withdrawal by Subject|0|||
147463199|NCT01145560|531855605|FG000|Overall Study|Lost to Follow-up|1|||
147463200|NCT01145560|531855606|FG001|Overall Study|Lost to Follow-up|1|||
147463201|NCT01145560|531855607|FG002|Overall Study|Lost to Follow-up|1|||
147463202|NCT01145560|531855605|FG000|Overall Study|No study drug by 24h after organ failure|1|||
147463203|NCT01145560|531855606|FG001|Overall Study|No study drug by 24h after organ failure|0|||
147463204|NCT01145560|531855607|FG002|Overall Study|No study drug by 24h after organ failure|0|||
147463205|NCT01145560|531855605|FG000|Overall Study|Accidental unblinding of study treatment|0|||
147403155|NCT03178045|531639126|FG001|Overall Study|Procedure Ineligible Post-Operatively/Pr|46|||
147403156|NCT03636373|531639128|FG000|Overall Study|Study closure due to Covid-19|1|||
147403157|NCT03636373|531639129|FG001|Overall Study|Study closure due to Covid-19|0|||
147615837|NCT03410056|532409072|FG006|Overall Study|Withdrawal by Subject|0|||
147615838|NCT00077207|532409077|FG000|Overall Study|Adverse Event|5|||
147615839|NCT00077207|532409077|FG000|Overall Study|Lack of Efficacy|12|||
147615840|NCT00077207|532409077|FG000|Overall Study|Physician Decision|6|||
147615841|NCT00077207|532409077|FG000|Overall Study|Withdrawal by Subject|6|||
147615842|NCT00077207|532409077|FG000|Overall Study|Ineligible|1|||
147615843|NCT03052751|532409079|FG000|Dosing Period 1|Adverse Event|0|||
147615844|NCT03052751|532409080|FG001|Dosing Period 1|Adverse Event|1|||
147615845|NCT03052751|532409081|FG002|Dosing Period 1|Adverse Event|0|||
147615846|NCT03052751|532409082|FG003|Dosing Period 1|Adverse Event|0|||
147615847|NCT03052751|532409083|FG004|Dosing Period 1|Adverse Event|0|||
147615848|NCT03052751|532409084|FG005|Dosing Period 1|Adverse Event|0|||
147615849|NCT03052751|532409079|FG000|Dosing Period 2|Adverse Event|0|||
147615850|NCT03052751|532409080|FG001|Dosing Period 2|Adverse Event|0|||
147615851|NCT03052751|532409081|FG002|Dosing Period 2|Adverse Event|3|||
147615852|NCT03052751|532409082|FG003|Dosing Period 2|Adverse Event|0|||
147615853|NCT03052751|532409083|FG004|Dosing Period 2|Adverse Event|0|||
147615854|NCT03052751|532409084|FG005|Dosing Period 2|Adverse Event|0|||
147615855|NCT03052751|532409079|FG000|Observation Period|Adverse Event|0|||
147615856|NCT03052751|532409080|FG001|Observation Period|Adverse Event|0|||
147615857|NCT03052751|532409081|FG002|Observation Period|Adverse Event|0|||
147615858|NCT03052751|532409082|FG003|Observation Period|Adverse Event|0|||
147615859|NCT03052751|532409083|FG004|Observation Period|Adverse Event|1|||
147615860|NCT03052751|532409084|FG005|Observation Period|Adverse Event|0|||
147615861|NCT04882241|532409085|FG000|Overall Study|Ongoing in study|46|||
147615862|NCT04882241|532409086|FG001|Overall Study|Ongoing in study|48|||
147615863|NCT04882241|532409087|FG002|Overall Study|Ongoing in study|0|||
147615864|NCT04882241|532409088|FG003|Overall Study|Ongoing in study|0|||
147615865|NCT04882241|532409085|FG000|Overall Study|Death|13|||
147615866|NCT04882241|532409086|FG001|Overall Study|Death|13|||
147615867|NCT04882241|532409087|FG002|Overall Study|Death|0|||
147615868|NCT04882241|532409088|FG003|Overall Study|Death|0|||
147615869|NCT01349192|532409094|FG000|Overall Study|Protocol Violation|0|||
147615870|NCT01349192|532409095|FG001|Overall Study|Protocol Violation|1|||
147615871|NCT01349192|532409094|FG000|Overall Study|Withdrawal by Subject|0|||
147615872|NCT01349192|532409095|FG001|Overall Study|Withdrawal by Subject|2|||
147615873|NCT01349192|532409094|FG000|Overall Study|Lost to Follow-up|1|||
147615874|NCT01349192|532409095|FG001|Overall Study|Lost to Follow-up|3|||
147615875|NCT01349192|532409094|FG000|Overall Study|Failure to adhere to Protocol|2|||
147615876|NCT01349192|532409095|FG001|Overall Study|Failure to adhere to Protocol|0|||
147615877|NCT01973439|532409096|FG000|Overall Study|Lost samples from one PK Day|2|||
147615878|NCT01973439|532409096|FG000|Overall Study|Vomiting after commencing once daily|1|||
147615879|NCT01973439|532409096|FG000|Overall Study|PK curve incomplete|2|||
147615880|NCT02038010|532409100|FG000|Completed 1st Cycle and Started Cycle 2|Progressive Disease|0|||
147615881|NCT02038010|532409101|FG001|Completed 1st Cycle and Started Cycle 2|Progressive Disease|1|||
147615882|NCT02038010|532409102|FG002|Completed 1st Cycle and Started Cycle 2|Progressive Disease|0|||
147615883|NCT02038010|532409103|FG003|Completed 1st Cycle and Started Cycle 2|Progressive Disease|0|||
147615884|NCT02038010|532409100|FG000|Completed 1st Cycle and Started Cycle 2|Patient Non Compliance|1|||
147615885|NCT02038010|532409101|FG001|Completed 1st Cycle and Started Cycle 2|Patient Non Compliance|0|||
147615886|NCT02038010|532409102|FG002|Completed 1st Cycle and Started Cycle 2|Patient Non Compliance|0|||
147615887|NCT02038010|532409103|FG003|Completed 1st Cycle and Started Cycle 2|Patient Non Compliance|0|||
147615888|NCT02038010|532409100|FG000|Completed 1st Cycle and Started Cycle 2|Withdrawal by Subject|0|||
147615889|NCT02038010|532409101|FG001|Completed 1st Cycle and Started Cycle 2|Withdrawal by Subject|1|||
147615890|NCT02038010|532409102|FG002|Completed 1st Cycle and Started Cycle 2|Withdrawal by Subject|0|||
147615891|NCT02038010|532409103|FG003|Completed 1st Cycle and Started Cycle 2|Withdrawal by Subject|0|||
147615892|NCT02038010|532409100|FG000|Completed 3 Cycles/Reached 1st Response|Progressive Disease|1|||
147403158|NCT00572533|531639139|FG000|Overall Study|Death|4|||
147615893|NCT02038010|532409101|FG001|Completed 3 Cycles/Reached 1st Response|Progressive Disease|1|||
147615894|NCT02038010|532409102|FG002|Completed 3 Cycles/Reached 1st Response|Progressive Disease|0|||
147615895|NCT02038010|532409103|FG003|Completed 3 Cycles/Reached 1st Response|Progressive Disease|0|||
147615896|NCT02038010|532409100|FG000|Follow Up|Death|4|||
147615897|NCT02038010|532409101|FG001|Follow Up|Death|3|||
147615898|NCT02038010|532409102|FG002|Follow Up|Death|0|||
147615899|NCT02038010|532409103|FG003|Follow Up|Death|0|||
147615900|NCT02038010|532409100|FG000|Follow Up|Other|3|||
147615901|NCT02038010|532409101|FG001|Follow Up|Other|0|||
147615902|NCT02038010|532409102|FG002|Follow Up|Other|0|||
147615903|NCT02038010|532409103|FG003|Follow Up|Other|0|||
147615904|NCT02262325|532409104|FG000|Overall Study|Death|16|||
147615905|NCT02262325|532409104|FG000|Overall Study|Lost to Follow-up|1|||
147615906|NCT02815995|532409105|FG000|Overall Study|Disease Progression|3|||
147615907|NCT02815995|532409106|FG001|Overall Study|Disease Progression|7|||
147665266|NCT00922636|532599519|FG004|Overall Study|Entry Criteria Not Met|0|||
147463206|NCT01145560|531855606|FG001|Overall Study|Accidental unblinding of study treatment|1|||
147463207|NCT01145560|531855607|FG002|Overall Study|Accidental unblinding of study treatment|0|||
147463208|NCT01145560|531855605|FG000|Overall Study|False insurance information|0|||
147463209|NCT01145560|531855606|FG001|Overall Study|False insurance information|1|||
147463210|NCT01145560|531855607|FG002|Overall Study|False insurance information|0|||
147463211|NCT01145560|531855605|FG000|Overall Study|Withdrawal of therapy|0|||
147463212|NCT01145560|531855606|FG001|Overall Study|Withdrawal of therapy|0|||
147463213|NCT01145560|531855607|FG002|Overall Study|Withdrawal of therapy|1|||
147463214|NCT00712348|531855608|FG000|Overall Study|Withdrawal by Subject|1|||
147463215|NCT01273064|531855609|FG000|Overall Study|Adverse Event|5|||
147463216|NCT01273064|531855610|FG001|Overall Study|Adverse Event|1|||
147463217|NCT01273064|531855611|FG002|Overall Study|Adverse Event|3|||
147463218|NCT01273064|531855612|FG003|Overall Study|Adverse Event|2|||
147463219|NCT01273064|531855613|FG004|Overall Study|Adverse Event|1|||
147463220|NCT01273064|531855609|FG000|Overall Study|Withdrawal by Subject|4|||
147463221|NCT01273064|531855610|FG001|Overall Study|Withdrawal by Subject|2|||
147463222|NCT01273064|531855611|FG002|Overall Study|Withdrawal by Subject|2|||
147463223|NCT01273064|531855612|FG003|Overall Study|Withdrawal by Subject|2|||
147463224|NCT01273064|531855613|FG004|Overall Study|Withdrawal by Subject|0|||
147463225|NCT01273064|531855609|FG000|Overall Study|Study Termination|13|||
147463226|NCT01273064|531855610|FG001|Overall Study|Study Termination|27|||
147463227|NCT01273064|531855611|FG002|Overall Study|Study Termination|26|||
147463228|NCT01273064|531855612|FG003|Overall Study|Study Termination|16|||
147463229|NCT01273064|531855613|FG004|Overall Study|Study Termination|8|||
147463230|NCT01273064|531855609|FG000|Overall Study|Lost to Follow-up|1|||
147463231|NCT01273064|531855610|FG001|Overall Study|Lost to Follow-up|0|||
147463232|NCT01273064|531855611|FG002|Overall Study|Lost to Follow-up|0|||
147463233|NCT01273064|531855612|FG003|Overall Study|Lost to Follow-up|0|||
147463234|NCT01273064|531855613|FG004|Overall Study|Lost to Follow-up|0|||
147463235|NCT01273064|531855609|FG000|Overall Study|Physician Decision|0|||
147463236|NCT01273064|531855610|FG001|Overall Study|Physician Decision|0|||
147463237|NCT01273064|531855611|FG002|Overall Study|Physician Decision|0|||
147463238|NCT01273064|531855612|FG003|Overall Study|Physician Decision|0|||
147463239|NCT01273064|531855613|FG004|Overall Study|Physician Decision|1|||
147463240|NCT01375764|531855617|FG000|Overall Study|Lost to Follow-up|0|||
147463241|NCT01375764|531855618|FG001|Overall Study|Lost to Follow-up|1|||
147463242|NCT01375764|531855619|FG002|Overall Study|Lost to Follow-up|0|||
147463243|NCT01375764|531855620|FG003|Overall Study|Lost to Follow-up|0|||
147463244|NCT01375764|531855621|FG004|Overall Study|Lost to Follow-up|0|||
147463245|NCT01375764|531855617|FG000|Overall Study|Withdrawal by Subject|2|||
147463246|NCT01375764|531855618|FG001|Overall Study|Withdrawal by Subject|0|||
147463247|NCT01375764|531855619|FG002|Overall Study|Withdrawal by Subject|0|||
147463248|NCT01375764|531855620|FG003|Overall Study|Withdrawal by Subject|0|||
147463249|NCT01375764|531855621|FG004|Overall Study|Withdrawal by Subject|1|||
147463250|NCT01375764|531855617|FG000|Overall Study|Other|0|||
147463251|NCT01375764|531855618|FG001|Overall Study|Other|0|||
147463252|NCT01375764|531855619|FG002|Overall Study|Other|0|||
147463253|NCT01375764|531855620|FG003|Overall Study|Other|1|||
147463254|NCT01375764|531855621|FG004|Overall Study|Other|0|||
147463255|NCT02867761|531855622|FG000|Overall Study|Participant withdrawn by investigator|0|||
147463256|NCT02867761|531855623|FG001|Overall Study|Participant withdrawn by investigator|1|||
147463257|NCT02867761|531855622|FG000|Overall Study|Lost to Follow-up|25|||
147463258|NCT02867761|531855623|FG001|Overall Study|Lost to Follow-up|18|||
147463259|NCT02867761|531855622|FG000|Overall Study|Unable to complete protocol|3|||
147463260|NCT02867761|531855623|FG001|Overall Study|Unable to complete protocol|7|||
147463261|NCT03595280|531855624|FG000|Overall Study|Lost to Follow-up|6|||
147463262|NCT03595280|531855625|FG001|Overall Study|Lost to Follow-up|9|||
147463263|NCT03595280|531855626|FG002|Overall Study|Lost to Follow-up|15|||
147463264|NCT03158220|531855627|FG000|Overall Study|Screen Failure|0|||
147463265|NCT03158220|531855628|FG001|Overall Study|Screen Failure|1|||
147463266|NCT03158220|531855627|FG000|Overall Study|Withdrawal by Subject|8|||
147463267|NCT03158220|531855628|FG001|Overall Study|Withdrawal by Subject|9|||
147463268|NCT03158220|531855627|FG000|Overall Study|Status unknown|0|||
147463269|NCT03158220|531855628|FG001|Overall Study|Status unknown|1|||
147463270|NCT03158220|531855627|FG000|Overall Study|Lost to Follow-up|8|||
147463271|NCT03158220|531855628|FG001|Overall Study|Lost to Follow-up|5|||
147463272|NCT03158220|531855627|FG000|Overall Study|Physician Decision|1|||
147463273|NCT03158220|531855628|FG001|Overall Study|Physician Decision|0|||
147463274|NCT00848120|531855631|FG000|Overall Study|Adverse Event|1|||
147463275|NCT00560755|531855632|FG000|Overall Study|Protocol Violation|15|||
147463276|NCT00560755|531855632|FG000|Overall Study|Withdrawal by Subject|26|||
147463277|NCT00560755|531855632|FG000|Overall Study|Lost to Follow-up|9|||
147463278|NCT00560755|531855632|FG000|Overall Study|Adverse Event|8|||
147463279|NCT00560755|531855632|FG000|Overall Study|Physician Decision|2|||
147463280|NCT01961115|531855643|FG000|Overall Study|Disease Progression|1|||
147463281|NCT01961115|531855644|FG001|Overall Study|Disease Progression|0|||
147463282|NCT01961115|531855645|FG002|Overall Study|Disease Progression|3|||
147463283|NCT01961115|531855643|FG000|Overall Study|Adverse Event|1|||
147463284|NCT01961115|531855644|FG001|Overall Study|Adverse Event|0|||
147615908|NCT02815995|532409107|FG002|Overall Study|Disease Progression|2|||
147615909|NCT02815995|532409108|FG003|Overall Study|Disease Progression|4|||
147615910|NCT02815995|532409109|FG004|Overall Study|Disease Progression|3|||
147615911|NCT02815995|532409110|FG005|Overall Study|Disease Progression|9|||
147615912|NCT02815995|532409111|FG006|Overall Study|Disease Progression|3|||
147615913|NCT02815995|532409112|FG007|Overall Study|Disease Progression|1|||
147615914|NCT02815995|532409105|FG000|Overall Study|Adverse Event|1|||
147615915|NCT02815995|532409106|FG001|Overall Study|Adverse Event|2|||
147615916|NCT02815995|532409107|FG002|Overall Study|Adverse Event|2|||
147615917|NCT02815995|532409108|FG003|Overall Study|Adverse Event|0|||
147615918|NCT02815995|532409109|FG004|Overall Study|Adverse Event|0|||
147403159|NCT00572533|531639140|FG001|Overall Study|Death|1|||
147403160|NCT00572533|531639139|FG000|Overall Study|Received Kidney Transplant|2|||
147403161|NCT00572533|531639140|FG001|Overall Study|Received Kidney Transplant|1|||
147403162|NCT00572533|531639139|FG000|Overall Study|Social Issues|1|||
147403163|NCT00572533|531639140|FG001|Overall Study|Social Issues|0|||
147403164|NCT00572533|531639139|FG000|Overall Study|Transfer out of Facility|0|||
147403165|NCT00572533|531639140|FG001|Overall Study|Transfer out of Facility|1|||
147403166|NCT01078922|531639141|FG000|Overall Study|Adverse Event|1|||
147403167|NCT02353468|531639142|FG000|Overall Study|Study terminated|3|||
147403168|NCT00003477|531639145|FG000|Overall Study|Not evalauable|4|||
147403169|NCT01236352|531639146|FG000|Overall Study|Death|0|||
147403170|NCT01236352|531639147|FG001|Overall Study|Death|0|||
147403171|NCT01236352|531639148|FG002|Overall Study|Death|0|||
147403172|NCT01236352|531639149|FG003|Overall Study|Death|0|||
147403173|NCT01236352|531639150|FG004|Overall Study|Death|0|||
147403174|NCT01236352|531639151|FG005|Overall Study|Death|0|||
147403175|NCT01236352|531639152|FG006|Overall Study|Death|0|||
147403176|NCT01236352|531639153|FG007|Overall Study|Death|1|||
147403177|NCT01236352|531639154|FG008|Overall Study|Death|0|||
147403178|NCT01236352|531639155|FG009|Overall Study|Death|0|||
147403179|NCT01236352|531639156|FG010|Overall Study|Death|0|||
147403180|NCT01236352|531639146|FG000|Overall Study|Withdrawal by Subject|0|||
147403181|NCT01236352|531639147|FG001|Overall Study|Withdrawal by Subject|0|||
147403182|NCT01236352|531639148|FG002|Overall Study|Withdrawal by Subject|0|||
147403183|NCT01236352|531639149|FG003|Overall Study|Withdrawal by Subject|0|||
147403184|NCT01236352|531639150|FG004|Overall Study|Withdrawal by Subject|0|||
147403185|NCT01236352|531639151|FG005|Overall Study|Withdrawal by Subject|0|||
147403186|NCT01236352|531639152|FG006|Overall Study|Withdrawal by Subject|0|||
147403187|NCT01236352|531639153|FG007|Overall Study|Withdrawal by Subject|0|||
147403188|NCT01236352|531639154|FG008|Overall Study|Withdrawal by Subject|0|||
147403189|NCT01236352|531639155|FG009|Overall Study|Withdrawal by Subject|2|||
147403190|NCT01236352|531639156|FG010|Overall Study|Withdrawal by Subject|1|||
147403191|NCT01236352|531639146|FG000|Overall Study|Adverse Event|0|||
147403192|NCT01236352|531639147|FG001|Overall Study|Adverse Event|0|||
147403193|NCT01236352|531639148|FG002|Overall Study|Adverse Event|0|||
147403194|NCT01236352|531639149|FG003|Overall Study|Adverse Event|0|||
147403195|NCT01236352|531639150|FG004|Overall Study|Adverse Event|0|||
147403196|NCT01236352|531639151|FG005|Overall Study|Adverse Event|0|||
147403197|NCT01236352|531639152|FG006|Overall Study|Adverse Event|2|||
147403198|NCT01236352|531639153|FG007|Overall Study|Adverse Event|0|||
147403199|NCT01236352|531639154|FG008|Overall Study|Adverse Event|0|||
147403200|NCT01236352|531639155|FG009|Overall Study|Adverse Event|4|||
147403201|NCT01236352|531639156|FG010|Overall Study|Adverse Event|1|||
147403202|NCT01236352|531639146|FG000|Overall Study|Study drug toxicity|0|||
147403203|NCT01236352|531639147|FG001|Overall Study|Study drug toxicity|0|||
147403204|NCT01236352|531639148|FG002|Overall Study|Study drug toxicity|0|||
147403205|NCT01236352|531639149|FG003|Overall Study|Study drug toxicity|0|||
147403206|NCT01236352|531639150|FG004|Overall Study|Study drug toxicity|0|||
147615919|NCT02815995|532409110|FG005|Overall Study|Adverse Event|1|||
147615920|NCT02815995|532409111|FG006|Overall Study|Adverse Event|0|||
147615921|NCT02815995|532409112|FG007|Overall Study|Adverse Event|0|||
147665267|NCT00922636|532599515|FG000|Overall Study|Parent/Caregiver Decision|2|||
147403207|NCT01236352|531639151|FG005|Overall Study|Study drug toxicity|1|||
147403208|NCT01236352|531639152|FG006|Overall Study|Study drug toxicity|1|||
147403209|NCT01236352|531639153|FG007|Overall Study|Study drug toxicity|0|||
147403210|NCT01236352|531639154|FG008|Overall Study|Study drug toxicity|0|||
147403211|NCT01236352|531639155|FG009|Overall Study|Study drug toxicity|2|||
147403212|NCT01236352|531639156|FG010|Overall Study|Study drug toxicity|2|||
147403213|NCT01236352|531639146|FG000|Overall Study|Disease progression|1|||
147403214|NCT01236352|531639147|FG001|Overall Study|Disease progression|2|||
147403215|NCT01236352|531639148|FG002|Overall Study|Disease progression|1|||
147403216|NCT01236352|531639149|FG003|Overall Study|Disease progression|2|||
147403217|NCT01236352|531639150|FG004|Overall Study|Disease progression|2|||
147403218|NCT01236352|531639151|FG005|Overall Study|Disease progression|2|||
147403219|NCT01236352|531639152|FG006|Overall Study|Disease progression|1|||
147403220|NCT01236352|531639153|FG007|Overall Study|Disease progression|3|||
147403221|NCT01236352|531639154|FG008|Overall Study|Disease progression|2|||
147615922|NCT02815995|532409105|FG000|Overall Study|Pregnancy|0|||
147615923|NCT02815995|532409106|FG001|Overall Study|Pregnancy|0|||
147615924|NCT02815995|532409107|FG002|Overall Study|Pregnancy|0|||
147463285|NCT01961115|531855645|FG002|Overall Study|Adverse Event|1|||
147463286|NCT01439945|531855658|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|3|||
147463287|NCT01439945|531855659|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|3|||
147463288|NCT01439945|531855660|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|3|||
147463289|NCT01439945|531855661|FG003|Double-Blind Treatment Phase|Withdrawal by Subject|1|||
147463290|NCT01439945|531855658|FG000|Double-Blind Treatment Phase|Ineligible|1|||
147463291|NCT01439945|531855659|FG001|Double-Blind Treatment Phase|Ineligible|2|||
147463292|NCT01439945|531855660|FG002|Double-Blind Treatment Phase|Ineligible|0|||
147463293|NCT01439945|531855661|FG003|Double-Blind Treatment Phase|Ineligible|1|||
147463294|NCT04082663|531855662|FG000|Overall Study|Adverse Event|6|||
147463295|NCT04082663|531855662|FG000|Overall Study|Lost to Follow-up|1|||
147463296|NCT05501119|531855665|FG000|Overall Study|Withdrawal by Subject|2|||
147463297|NCT05501119|531855665|FG000|Overall Study|Lost to Follow-up|5|||
147463298|NCT01752023|531855666|FG000|Overall Study|Physician Decision|2|||
147463299|NCT01752023|531855667|FG001|Overall Study|Physician Decision|1|||
147463300|NCT01445678|531855668|FG000|Overall Study|Adverse Event|12|||
147463301|NCT01445678|531855669|FG001|Overall Study|Adverse Event|8|||
147463302|NCT01445678|531855668|FG000|Overall Study|Lack of Efficacy|0|||
147463303|NCT01445678|531855669|FG001|Overall Study|Lack of Efficacy|2|||
147463304|NCT01445678|531855668|FG000|Overall Study|Lost to Follow-up|8|||
147463305|NCT01445678|531855669|FG001|Overall Study|Lost to Follow-up|5|||
147463306|NCT01445678|531855668|FG000|Overall Study|Protocol Violation|1|||
147463307|NCT01445678|531855669|FG001|Overall Study|Protocol Violation|1|||
147463308|NCT01445678|531855668|FG000|Overall Study|Withdrawal by Subject|9|||
147463309|NCT01445678|531855669|FG001|Overall Study|Withdrawal by Subject|5|||
147463310|NCT00821678|531855675|FG000|Overall Study|Withdrawal by Subject|8|||
147463311|NCT00821678|531855676|FG001|Overall Study|Withdrawal by Subject|0|||
147463312|NCT00821678|531855675|FG000|Overall Study|Lost to Follow-up|13|||
147463313|NCT00821678|531855676|FG001|Overall Study|Lost to Follow-up|12|||
147463314|NCT00821678|531855675|FG000|Overall Study|Death|0|||
147463315|NCT00821678|531855676|FG001|Overall Study|Death|2|||
147463316|NCT01974817|531857642|FG000|Overall Study|Death|4|||
147463317|NCT01974817|531857642|FG000|Overall Study|Lost to Follow-up|2|||
147463318|NCT01974817|531857642|FG000|Overall Study|Protocol Violation|2|||
147463319|NCT05742984|531857650|FG000|Overall Study|Adverse Event|0|||
147463320|NCT05742984|531857651|FG001|Overall Study|Adverse Event|0|||
147463321|NCT05742984|531857652|FG002|Overall Study|Adverse Event|1|||
147463322|NCT05742984|531857653|FG003|Overall Study|Adverse Event|0|||
147463323|NCT05742984|531857654|FG004|Overall Study|Adverse Event|1|||
147463324|NCT05742984|531857655|FG005|Overall Study|Adverse Event|1|||
147463325|NCT05742984|531857650|FG000|Overall Study|Withdrawal by Subject|0|||
147463326|NCT05742984|531857651|FG001|Overall Study|Withdrawal by Subject|1|||
147463327|NCT05742984|531857652|FG002|Overall Study|Withdrawal by Subject|0|||
147463328|NCT05742984|531857653|FG003|Overall Study|Withdrawal by Subject|0|||
147463329|NCT05742984|531857654|FG004|Overall Study|Withdrawal by Subject|0|||
147463330|NCT05742984|531857655|FG005|Overall Study|Withdrawal by Subject|2|||
147463331|NCT02162862|531857656|FG000|Overall Study|Lost to Follow-up|0|||
147463332|NCT02162862|531857657|FG001|Overall Study|Lost to Follow-up|11|||
147463333|NCT02162862|531857658|FG002|Overall Study|Lost to Follow-up|0|||
147463334|NCT02162862|531857656|FG000|Overall Study|Subject did not feel the med was needed|0|||
147463335|NCT02162862|531857657|FG001|Overall Study|Subject did not feel the med was needed|0|||
147463336|NCT02162862|531857658|FG002|Overall Study|Subject did not feel the med was needed|4|||
147463337|NCT01409928|531857661|FG000|Overall Study|Physician Decision|12|||
147463338|NCT00988247|531857662|FG000|Overall Study|Adverse Event|17|||
147463339|NCT00988247|531857663|FG001|Overall Study|Adverse Event|3|||
147463340|NCT00988247|531857662|FG000|Overall Study|Withdrawal by Subject|44|||
147463341|NCT00988247|531857663|FG001|Overall Study|Withdrawal by Subject|13|||
147463342|NCT00988247|531857662|FG000|Overall Study|Pregnancy|1|||
147615925|NCT02815995|532409108|FG003|Overall Study|Pregnancy|0|||
147615926|NCT02815995|532409109|FG004|Overall Study|Pregnancy|0|||
147615927|NCT02815995|532409110|FG005|Overall Study|Pregnancy|0|||
147615928|NCT02815995|532409111|FG006|Overall Study|Pregnancy|1|||
147615929|NCT02815995|532409112|FG007|Overall Study|Pregnancy|0|||
147615930|NCT01071915|532409113|FG000|Overall Study|Adverse Event|3|||
147463343|NCT00988247|531857663|FG001|Overall Study|Pregnancy|2|||
147463344|NCT00988247|531857662|FG000|Overall Study|Lost to Follow-up|11|||
147463345|NCT00988247|531857663|FG001|Overall Study|Lost to Follow-up|2|||
147463346|NCT00988247|531857662|FG000|Overall Study|Protocol Violation|4|||
147463347|NCT00988247|531857663|FG001|Overall Study|Protocol Violation|5|||
147463348|NCT00988247|531857662|FG000|Overall Study|Sponsor requested withdrawal|3|||
147463349|NCT00988247|531857663|FG001|Overall Study|Sponsor requested withdrawal|1|||
147463350|NCT00988247|531857662|FG000|Overall Study|Other|3|||
147463351|NCT00988247|531857663|FG001|Overall Study|Other|0|||
147463352|NCT01703000|531857664|FG000|Overall Study|Death|1|||
147463353|NCT01279057|531857668|FG000|Overall Study|Adverse Event|1|||
147463354|NCT01279057|531857669|FG001|Overall Study|Adverse Event|0|||
147463355|NCT01279057|531857670|FG002|Overall Study|Adverse Event|1|||
147615931|NCT01071915|532409113|FG000|Overall Study|Physician Decision|2|||
147615932|NCT01071915|532409113|FG000|Overall Study|Withdrawal by Subject|2|||
147615933|NCT01071915|532409113|FG000|Overall Study|Miscellaneous Reasons|2|||
147615934|NCT01125189|532409114|FG000|Treatment Period|Lack of Efficacy|15|||
147615935|NCT01125189|532409115|FG001|Treatment Period|Lack of Efficacy|18|||
147615936|NCT01125189|532409116|FG002|Treatment Period|Lack of Efficacy|25|||
147615937|NCT01125189|532409114|FG000|Treatment Period|Adverse Event|7|||
147615938|NCT01125189|532409115|FG001|Treatment Period|Adverse Event|8|||
147615939|NCT01125189|532409116|FG002|Treatment Period|Adverse Event|8|||
147615940|NCT01125189|532409114|FG000|Treatment Period|Withdrawal by Subject|3|||
147615941|NCT01125189|532409115|FG001|Treatment Period|Withdrawal by Subject|1|||
147615942|NCT01125189|532409116|FG002|Treatment Period|Withdrawal by Subject|1|||
147615943|NCT01125189|532409114|FG000|Treatment Period|Death|1|||
147615944|NCT01125189|532409115|FG001|Treatment Period|Death|0|||
147615945|NCT01125189|532409116|FG002|Treatment Period|Death|0|||
147615946|NCT01125189|532409114|FG000|Treatment Period|Lost to Follow-up|1|||
147615947|NCT01125189|532409115|FG001|Treatment Period|Lost to Follow-up|2|||
147615948|NCT01125189|532409116|FG002|Treatment Period|Lost to Follow-up|1|||
147615949|NCT01125189|532409114|FG000|Treatment Period|Poor compliance/noncompliance|0|||
147615950|NCT01125189|532409115|FG001|Treatment Period|Poor compliance/noncompliance|1|||
147615951|NCT01125189|532409116|FG002|Treatment Period|Poor compliance/noncompliance|0|||
147615952|NCT01125189|532409114|FG000|Treatment Period|Participants requested to discontinue|1|||
147615953|NCT01125189|532409115|FG001|Treatment Period|Participants requested to discontinue|3|||
147615954|NCT01125189|532409116|FG002|Treatment Period|Participants requested to discontinue|4|||
147615955|NCT01125189|532409114|FG000|Treatment Period|Other reasons|1|||
147615956|NCT01125189|532409115|FG001|Treatment Period|Other reasons|1|||
147615957|NCT01125189|532409116|FG002|Treatment Period|Other reasons|0|||
147615958|NCT01125189|532409114|FG000|Treatment Period|Completed 24 week treatment period only|2|||
147615959|NCT01125189|532409115|FG001|Treatment Period|Completed 24 week treatment period only|1|||
147615960|NCT01125189|532409116|FG002|Treatment Period|Completed 24 week treatment period only|2|||
147615961|NCT01125189|532409114|FG000|Follow up Period|Withdrawal by Subject|3|||
147615962|NCT01125189|532409115|FG001|Follow up Period|Withdrawal by Subject|2|||
147615963|NCT01125189|532409116|FG002|Follow up Period|Withdrawal by Subject|5|||
147615964|NCT01125189|532409114|FG000|Follow up Period|Death|1|||
147615965|NCT01125189|532409115|FG001|Follow up Period|Death|0|||
147615966|NCT01125189|532409116|FG002|Follow up Period|Death|0|||
147615967|NCT01125189|532409114|FG000|Follow up Period|Lost to Follow-up|12|||
147615968|NCT01125189|532409115|FG001|Follow up Period|Lost to Follow-up|9|||
147615969|NCT01125189|532409116|FG002|Follow up Period|Lost to Follow-up|6|||
147615970|NCT01125189|532409114|FG000|Follow up Period|Other reasons|4|||
147615971|NCT01125189|532409115|FG001|Follow up Period|Other reasons|4|||
147615972|NCT01125189|532409116|FG002|Follow up Period|Other reasons|5|||
147615973|NCT00114140|532409117|FG000|Overall Study|Protocol Violation|7|||
147615974|NCT00110396|532409118|FG000|Overall Study|Adverse Event|15|||
147615975|NCT00110396|532409118|FG000|Overall Study|Lost to Follow-up|1|||
147615976|NCT00110396|532409118|FG000|Overall Study|Administration of plasmapheresis|1|||
147615977|NCT00110396|532409118|FG000|Overall Study|Initiated mitoxantrone therapy|1|||
147615978|NCT00110396|532409118|FG000|Overall Study|Lack of Efficacy|1|||
147615979|NCT00110396|532409118|FG000|Overall Study|Decided not to continue treatment|1|||
147615980|NCT00110396|532409118|FG000|Overall Study|Patient non-compliance|1|||
147615981|NCT00110396|532409118|FG000|Overall Study|Patient refused to continue|1|||
147615982|NCT00110396|532409118|FG000|Overall Study|Patient refused to participate|1|||
147615983|NCT00110396|532409118|FG000|Overall Study|Patient will|1|||
147615984|NCT00110396|532409118|FG000|Overall Study|Patient's decision|1|||
147403222|NCT01236352|531639155|FG009|Overall Study|Disease progression|2|||
147403223|NCT01236352|531639156|FG010|Overall Study|Disease progression|2|||
147615985|NCT00110396|532409118|FG000|Overall Study|Participation in MS vaccine study|1|||
147615986|NCT00110396|532409118|FG000|Overall Study|Pregnancy|1|||
147615987|NCT00110396|532409118|FG000|Overall Study|Pregnancy (Protocol violation)|2|||
147615988|NCT00110396|532409118|FG000|Overall Study|Protocol Violation|2|||
147615989|NCT00110396|532409118|FG000|Overall Study|Patient refused to come back|1|||
147615990|NCT00110396|532409118|FG000|Overall Study|The patient has refused|2|||
147615991|NCT00110396|532409118|FG000|Overall Study|The patient has refused to visit site|1|||
147615992|NCT00110396|532409118|FG000|Overall Study|Patient is to be administered copaxone|1|||
147615993|NCT02414958|532409121|FG000|Overall Study|Adverse Event|6|||
147615994|NCT02414958|532409122|FG001|Overall Study|Adverse Event|6|||
147615995|NCT02414958|532409123|FG002|Overall Study|Adverse Event|3|||
147615996|NCT02414958|532409121|FG000|Overall Study|Protocol Violation|10|||
147615997|NCT02414958|532409122|FG001|Overall Study|Protocol Violation|3|||
147615998|NCT02414958|532409123|FG002|Overall Study|Protocol Violation|1|||
147615999|NCT02414958|532409121|FG000|Overall Study|Lost to Follow-up|7|||
147616000|NCT02414958|532409122|FG001|Overall Study|Lost to Follow-up|4|||
147616001|NCT02414958|532409123|FG002|Overall Study|Lost to Follow-up|0|||
147616002|NCT02414958|532409121|FG000|Overall Study|Withdrawal by Subject|5|||
147616003|NCT02414958|532409122|FG001|Overall Study|Withdrawal by Subject|3|||
147616004|NCT02414958|532409123|FG002|Overall Study|Withdrawal by Subject|5|||
147403224|NCT01236352|531639146|FG000|Overall Study|Poor/Non-compliance|1|||
147616005|NCT02414958|532409121|FG000|Overall Study|Other than specified|4|||
147616006|NCT02414958|532409122|FG001|Overall Study|Other than specified|4|||
147463356|NCT01279057|531857668|FG000|Overall Study|Insufficient therapeutic response|0|||
147463357|NCT01279057|531857669|FG001|Overall Study|Insufficient therapeutic response|0|||
147463358|NCT01279057|531857670|FG002|Overall Study|Insufficient therapeutic response|1|||
147463359|NCT01279057|531857668|FG000|Overall Study|Restricted medication for seasonal allergic rhinitis|0|||
147463360|NCT01279057|531857669|FG001|Overall Study|Restricted medication for seasonal allergic rhinitis|1|||
147463361|NCT01279057|531857670|FG002|Overall Study|Restricted medication for seasonal allergic rhinitis|0|||
147463362|NCT01279057|531857668|FG000|Overall Study|Withdrew consent|2|||
147463363|NCT01279057|531857669|FG001|Overall Study|Withdrew consent|0|||
147463364|NCT01279057|531857670|FG002|Overall Study|Withdrew consent|1|||
147463365|NCT01279057|531857668|FG000|Overall Study|Pregnancy|0|||
147463366|NCT01279057|531857669|FG001|Overall Study|Pregnancy|1|||
147463367|NCT01279057|531857670|FG002|Overall Study|Pregnancy|0|||
147463368|NCT01279057|531857668|FG000|Overall Study|Other|3|||
147463369|NCT01279057|531857669|FG001|Overall Study|Other|3|||
147463370|NCT01279057|531857670|FG002|Overall Study|Other|0|||
147463371|NCT01427309|531857672|FG000|Overall Study|Lost to Follow-up|130|||
147463372|NCT01427309|531857673|FG001|Overall Study|Lost to Follow-up|145|||
147463373|NCT01427309|531857674|FG002|Overall Study|Lost to Follow-up|122|||
147463374|NCT01427309|531857675|FG003|Overall Study|Lost to Follow-up|135|||
147463375|NCT01427309|531857672|FG000|Overall Study|Protocol Violation|42|||
147463376|NCT01427309|531857673|FG001|Overall Study|Protocol Violation|69|||
147463377|NCT01427309|531857674|FG002|Overall Study|Protocol Violation|125|||
147463378|NCT01427309|531857675|FG003|Overall Study|Protocol Violation|124|||
147463379|NCT01427309|531857672|FG000|Overall Study|Adverse Event|0|||
147463380|NCT01427309|531857673|FG001|Overall Study|Adverse Event|0|||
147463381|NCT01427309|531857674|FG002|Overall Study|Adverse Event|3|||
147463382|NCT01427309|531857675|FG003|Overall Study|Adverse Event|1|||
147463383|NCT01427309|531857672|FG000|Overall Study|Serious adverse event|52|||
147463384|NCT01427309|531857673|FG001|Overall Study|Serious adverse event|45|||
147463385|NCT01427309|531857674|FG002|Overall Study|Serious adverse event|50|||
147463386|NCT01427309|531857675|FG003|Overall Study|Serious adverse event|61|||
147463387|NCT01427309|531857672|FG000|Overall Study|Withdrawal by Subject|148|||
147463388|NCT01427309|531857673|FG001|Overall Study|Withdrawal by Subject|148|||
147463389|NCT01427309|531857674|FG002|Overall Study|Withdrawal by Subject|61|||
147463390|NCT01427309|531857675|FG003|Overall Study|Withdrawal by Subject|55|||
147463391|NCT00849017|531857678|FG000|Treatment Period (156 Weeks)|Adverse Event|5|||
147463392|NCT00849017|531857679|FG001|Treatment Period (156 Weeks)|Adverse Event|6|||
147463393|NCT00849017|531857680|FG002|Treatment Period (156 Weeks)|Adverse Event|15|||
147463394|NCT00849017|531857678|FG000|Treatment Period (156 Weeks)|Noncompliance|3|||
147463395|NCT00849017|531857679|FG001|Treatment Period (156 Weeks)|Noncompliance|3|||
147463396|NCT00849017|531857680|FG002|Treatment Period (156 Weeks)|Noncompliance|4|||
147463397|NCT00849017|531857678|FG000|Treatment Period (156 Weeks)|Lost to Follow-up|10|||
147463398|NCT00849017|531857679|FG001|Treatment Period (156 Weeks)|Lost to Follow-up|7|||
147463399|NCT00849017|531857680|FG002|Treatment Period (156 Weeks)|Lost to Follow-up|8|||
147463400|NCT00849017|531857678|FG000|Treatment Period (156 Weeks)|Withdrawal by Subject|18|||
147463401|NCT00849017|531857679|FG001|Treatment Period (156 Weeks)|Withdrawal by Subject|14|||
147463402|NCT00849017|531857680|FG002|Treatment Period (156 Weeks)|Withdrawal by Subject|11|||
147463403|NCT00849017|531857678|FG000|Treatment Period (156 Weeks)|Physician Decision|0|||
147463404|NCT00849017|531857679|FG001|Treatment Period (156 Weeks)|Physician Decision|2|||
147463405|NCT00849017|531857680|FG002|Treatment Period (156 Weeks)|Physician Decision|1|||
147463406|NCT00849017|531857678|FG000|Treatment Period (156 Weeks)|Termination of Study/ Site by GSK|3|||
147463407|NCT00849017|531857679|FG001|Treatment Period (156 Weeks)|Termination of Study/ Site by GSK|1|||
147463408|NCT00849017|531857680|FG002|Treatment Period (156 Weeks)|Termination of Study/ Site by GSK|1|||
147463409|NCT00849017|531857678|FG000|Treatment Period (156 Weeks)|Increased Calcitonin|1|||
147463410|NCT00849017|531857679|FG001|Treatment Period (156 Weeks)|Increased Calcitonin|0|||
147463411|NCT00849017|531857680|FG002|Treatment Period (156 Weeks)|Increased Calcitonin|0|||
147463412|NCT00849017|531857678|FG000|Treatment Period (156 Weeks)|Physician Discontinued-Thrombocytopenia|1|||
147463413|NCT00849017|531857679|FG001|Treatment Period (156 Weeks)|Physician Discontinued-Thrombocytopenia|0|||
147463414|NCT00849017|531857680|FG002|Treatment Period (156 Weeks)|Physician Discontinued-Thrombocytopenia|0|||
147463415|NCT00849017|531857678|FG000|Treatment Period (156 Weeks)|Participant Moved to Africa|1|||
147463416|NCT00849017|531857679|FG001|Treatment Period (156 Weeks)|Participant Moved to Africa|0|||
147463417|NCT00849017|531857680|FG002|Treatment Period (156 Weeks)|Participant Moved to Africa|0|||
147463418|NCT00849017|531857678|FG000|Treatment Period (156 Weeks)|Pregnancy|1|||
147463419|NCT00849017|531857679|FG001|Treatment Period (156 Weeks)|Pregnancy|0|||
147463420|NCT00849017|531857680|FG002|Treatment Period (156 Weeks)|Pregnancy|1|||
147463421|NCT00849017|531857678|FG000|Treatment Period (156 Weeks)|Participant Decided to Move Out of State|0|||
147463422|NCT00849017|531857679|FG001|Treatment Period (156 Weeks)|Participant Decided to Move Out of State|0|||
147463423|NCT00849017|531857680|FG002|Treatment Period (156 Weeks)|Participant Decided to Move Out of State|1|||
147463424|NCT00849017|531857678|FG000|Follow-up Period (8 Weeks)|Adverse Event|1|||
147463425|NCT00849017|531857679|FG001|Follow-up Period (8 Weeks)|Adverse Event|0|||
147463426|NCT00849017|531857680|FG002|Follow-up Period (8 Weeks)|Adverse Event|0|||
147463427|NCT00849017|531857678|FG000|Follow-up Period (8 Weeks)|Noncompliance|2|||
147463428|NCT00849017|531857679|FG001|Follow-up Period (8 Weeks)|Noncompliance|1|||
147463429|NCT00849017|531857680|FG002|Follow-up Period (8 Weeks)|Noncompliance|0|||
147463430|NCT00849017|531857678|FG000|Follow-up Period (8 Weeks)|Lost to Follow-up|13|||
147463431|NCT00849017|531857679|FG001|Follow-up Period (8 Weeks)|Lost to Follow-up|12|||
147463432|NCT00849017|531857680|FG002|Follow-up Period (8 Weeks)|Lost to Follow-up|16|||
147463433|NCT00849017|531857678|FG000|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|1|||
147463434|NCT00849017|531857679|FG001|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|1|||
147463435|NCT00849017|531857680|FG002|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|4|||
147463436|NCT00849017|531857678|FG000|Follow-up Period (8 Weeks)|Withdrawal by Subject|4|||
147463437|NCT00849017|531857679|FG001|Follow-up Period (8 Weeks)|Withdrawal by Subject|2|||
147463438|NCT00849017|531857680|FG002|Follow-up Period (8 Weeks)|Withdrawal by Subject|3|||
147463439|NCT00849017|531857678|FG000|Follow-up Period (8 Weeks)|Physician Decision|0|||
147463440|NCT00849017|531857679|FG001|Follow-up Period (8 Weeks)|Physician Decision|1|||
147463441|NCT00849017|531857680|FG002|Follow-up Period (8 Weeks)|Physician Decision|1|||
147463442|NCT00849017|531857678|FG000|Follow-up Period (8 Weeks)|Termination of Study/ Site by GSK|3|||
147463443|NCT00849017|531857679|FG001|Follow-up Period (8 Weeks)|Termination of Study/ Site by GSK|1|||
147463444|NCT00849017|531857680|FG002|Follow-up Period (8 Weeks)|Termination of Study/ Site by GSK|1|||
147463445|NCT00849017|531857678|FG000|Follow-up Period (8 Weeks)|Participant Relocating to Africa|1|||
147463446|NCT00849017|531857679|FG001|Follow-up Period (8 Weeks)|Participant Relocating to Africa|0|||
147463447|NCT00849017|531857680|FG002|Follow-up Period (8 Weeks)|Participant Relocating to Africa|0|||
147463448|NCT03502187|531857681|FG000|Overall Study|Withdrawal by Subject|4|||
147463449|NCT03502187|531857682|FG001|Overall Study|Withdrawal by Subject|3|||
147463450|NCT03502187|531857683|FG002|Overall Study|Withdrawal by Subject|3|||
147463451|NCT03502187|531857681|FG000|Overall Study|Lost to Follow-up|5|||
147463452|NCT03502187|531857682|FG001|Overall Study|Lost to Follow-up|4|||
147463453|NCT03502187|531857683|FG002|Overall Study|Lost to Follow-up|5|||
147463454|NCT02913313|531857684|FG000|Overall Study|DISEASE PROGRESSION|1|||
147463455|NCT02913313|531857685|FG001|Overall Study|DISEASE PROGRESSION|2|||
147463456|NCT02913313|531857686|FG002|Overall Study|DISEASE PROGRESSION|2|||
147463457|NCT02913313|531857687|FG003|Overall Study|DISEASE PROGRESSION|4|||
147463458|NCT02913313|531857688|FG004|Overall Study|DISEASE PROGRESSION|6|||
147463459|NCT02913313|531857689|FG005|Overall Study|DISEASE PROGRESSION|4|||
147463460|NCT02913313|531857690|FG006|Overall Study|DISEASE PROGRESSION|19|||
147463461|NCT02913313|531857691|FG007|Overall Study|DISEASE PROGRESSION|3|||
147463462|NCT02913313|531857692|FG008|Overall Study|DISEASE PROGRESSION|4|||
147463463|NCT02913313|531857693|FG009|Overall Study|DISEASE PROGRESSION|4|||
147463464|NCT02913313|531857694|FG010|Overall Study|DISEASE PROGRESSION|11|||
147463465|NCT02913313|531857695|FG011|Overall Study|DISEASE PROGRESSION|5|||
147463466|NCT02913313|531857696|FG012|Overall Study|DISEASE PROGRESSION|14|||
147463467|NCT02913313|531857697|FG013|Overall Study|DISEASE PROGRESSION|3|||
147463468|NCT02913313|531857684|FG000|Overall Study|Not Reported|0|||
147463469|NCT02913313|531857685|FG001|Overall Study|Not Reported|0|||
147463470|NCT02913313|531857686|FG002|Overall Study|Not Reported|0|||
147463471|NCT02913313|531857687|FG003|Overall Study|Not Reported|0|||
147463472|NCT02913313|531857688|FG004|Overall Study|Not Reported|1|||
147463473|NCT02913313|531857689|FG005|Overall Study|Not Reported|0|||
147463474|NCT02913313|531857690|FG006|Overall Study|Not Reported|0|||
147463475|NCT02913313|531857691|FG007|Overall Study|Not Reported|0|||
147463476|NCT02913313|531857692|FG008|Overall Study|Not Reported|0|||
147463477|NCT02913313|531857693|FG009|Overall Study|Not Reported|0|||
147463478|NCT02913313|531857694|FG010|Overall Study|Not Reported|4|||
147463479|NCT02913313|531857695|FG011|Overall Study|Not Reported|0|||
147463480|NCT02913313|531857696|FG012|Overall Study|Not Reported|0|||
147463481|NCT02913313|531857697|FG013|Overall Study|Not Reported|0|||
147463482|NCT02913313|531857684|FG000|Overall Study|Other reasons|0|||
147463483|NCT02913313|531857685|FG001|Overall Study|Other reasons|0|||
147463484|NCT02913313|531857686|FG002|Overall Study|Other reasons|0|||
147463485|NCT02913313|531857687|FG003|Overall Study|Other reasons|0|||
147463486|NCT02913313|531857688|FG004|Overall Study|Other reasons|1|||
147463487|NCT02913313|531857689|FG005|Overall Study|Other reasons|0|||
147463488|NCT02913313|531857690|FG006|Overall Study|Other reasons|0|||
147463489|NCT02913313|531857691|FG007|Overall Study|Other reasons|0|||
147463490|NCT02913313|531857692|FG008|Overall Study|Other reasons|0|||
147463491|NCT02913313|531857693|FG009|Overall Study|Other reasons|0|||
147463492|NCT02913313|531857694|FG010|Overall Study|Other reasons|1|||
147463493|NCT02913313|531857695|FG011|Overall Study|Other reasons|0|||
147463494|NCT02913313|531857696|FG012|Overall Study|Other reasons|0|||
147463495|NCT02913313|531857697|FG013|Overall Study|Other reasons|0|||
147665268|NCT00922636|532599516|FG001|Overall Study|Parent/Caregiver Decision|4|||
147463496|NCT02913313|531857684|FG000|Overall Study|Withdrawal by Subject|0|||
147463497|NCT02913313|531857685|FG001|Overall Study|Withdrawal by Subject|0|||
147463498|NCT02913313|531857686|FG002|Overall Study|Withdrawal by Subject|1|||
147463499|NCT02913313|531857687|FG003|Overall Study|Withdrawal by Subject|0|||
147463500|NCT02913313|531857688|FG004|Overall Study|Withdrawal by Subject|0|||
147463501|NCT02913313|531857689|FG005|Overall Study|Withdrawal by Subject|0|||
147463502|NCT02913313|531857690|FG006|Overall Study|Withdrawal by Subject|1|||
147463503|NCT02913313|531857691|FG007|Overall Study|Withdrawal by Subject|1|||
147463504|NCT02913313|531857692|FG008|Overall Study|Withdrawal by Subject|0|||
147463505|NCT02913313|531857693|FG009|Overall Study|Withdrawal by Subject|0|||
147463506|NCT02913313|531857694|FG010|Overall Study|Withdrawal by Subject|1|||
147463507|NCT02913313|531857695|FG011|Overall Study|Withdrawal by Subject|0|||
147463508|NCT02913313|531857696|FG012|Overall Study|Withdrawal by Subject|0|||
147463509|NCT02913313|531857697|FG013|Overall Study|Withdrawal by Subject|0|||
147463510|NCT02913313|531857684|FG000|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
147463511|NCT02913313|531857685|FG001|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
147463512|NCT02913313|531857686|FG002|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
147463513|NCT02913313|531857687|FG003|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
147463514|NCT02913313|531857688|FG004|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
147463515|NCT02913313|531857689|FG005|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
147463516|NCT02913313|531857690|FG006|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
147463517|NCT02913313|531857691|FG007|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
147463518|NCT02913313|531857692|FG008|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
147463519|NCT02913313|531857693|FG009|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
147463520|NCT02913313|531857694|FG010|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|1|||
147463521|NCT02913313|531857695|FG011|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|0|||
147463522|NCT02913313|531857696|FG012|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|1|||
147463523|NCT02913313|531857697|FG013|Overall Study|ADVERSE EVENT UNRELATED TO STUDY DRUG|1|||
147463524|NCT02913313|531857684|FG000|Overall Study|STUDY DRUG TOXICITY|0|||
147463525|NCT02913313|531857685|FG001|Overall Study|STUDY DRUG TOXICITY|0|||
147463526|NCT02913313|531857686|FG002|Overall Study|STUDY DRUG TOXICITY|0|||
147463527|NCT02913313|531857687|FG003|Overall Study|STUDY DRUG TOXICITY|0|||
147463528|NCT02913313|531857688|FG004|Overall Study|STUDY DRUG TOXICITY|0|||
147463529|NCT02913313|531857689|FG005|Overall Study|STUDY DRUG TOXICITY|0|||
147463530|NCT02913313|531857690|FG006|Overall Study|STUDY DRUG TOXICITY|0|||
147463531|NCT02913313|531857691|FG007|Overall Study|STUDY DRUG TOXICITY|0|||
147463532|NCT02913313|531857692|FG008|Overall Study|STUDY DRUG TOXICITY|0|||
147463533|NCT02913313|531857693|FG009|Overall Study|STUDY DRUG TOXICITY|0|||
147463534|NCT02913313|531857694|FG010|Overall Study|STUDY DRUG TOXICITY|0|||
147463535|NCT02913313|531857695|FG011|Overall Study|STUDY DRUG TOXICITY|1|||
147463536|NCT02913313|531857696|FG012|Overall Study|STUDY DRUG TOXICITY|2|||
147463537|NCT02913313|531857697|FG013|Overall Study|STUDY DRUG TOXICITY|1|||
147463538|NCT06118385|531857700|FG000|Overall Study|Protocol Violation|0|||
147463539|NCT06118385|531857701|FG001|Overall Study|Protocol Violation|0|||
147463540|NCT06118385|531857702|FG002|Overall Study|Protocol Violation|0|||
147463541|NCT06118385|531857703|FG003|Overall Study|Protocol Violation|0|||
147463542|NCT06118385|531857704|FG004|Overall Study|Protocol Violation|0|||
147463543|NCT06118385|531857705|FG005|Overall Study|Protocol Violation|0|||
147403225|NCT01236352|531639147|FG001|Overall Study|Poor/Non-compliance|0|||
147403226|NCT01236352|531639148|FG002|Overall Study|Poor/Non-compliance|0|||
147403227|NCT01236352|531639149|FG003|Overall Study|Poor/Non-compliance|0|||
147403228|NCT01236352|531639150|FG004|Overall Study|Poor/Non-compliance|0|||
147403229|NCT01236352|531639151|FG005|Overall Study|Poor/Non-compliance|0|||
147403230|NCT01236352|531639152|FG006|Overall Study|Poor/Non-compliance|0|||
147403231|NCT01236352|531639153|FG007|Overall Study|Poor/Non-compliance|0|||
147403232|NCT01236352|531639154|FG008|Overall Study|Poor/Non-compliance|0|||
147403233|NCT01236352|531639155|FG009|Overall Study|Poor/Non-compliance|0|||
147403234|NCT01236352|531639156|FG010|Overall Study|Poor/Non-compliance|0|||
147403235|NCT01236352|531639146|FG000|Overall Study|Maximum clinical benefit|1|||
147403236|NCT01236352|531639147|FG001|Overall Study|Maximum clinical benefit|1|||
147403237|NCT01236352|531639148|FG002|Overall Study|Maximum clinical benefit|1|||
147403238|NCT01236352|531639149|FG003|Overall Study|Maximum clinical benefit|0|||
147403239|NCT01236352|531639150|FG004|Overall Study|Maximum clinical benefit|2|||
147403240|NCT01236352|531639151|FG005|Overall Study|Maximum clinical benefit|0|||
147403241|NCT01236352|531639152|FG006|Overall Study|Maximum clinical benefit|3|||
147403242|NCT01236352|531639153|FG007|Overall Study|Maximum clinical benefit|1|||
147403243|NCT01236352|531639154|FG008|Overall Study|Maximum clinical benefit|1|||
147403244|NCT01236352|531639155|FG009|Overall Study|Maximum clinical benefit|4|||
147403245|NCT01236352|531639156|FG010|Overall Study|Maximum clinical benefit|2|||
147463544|NCT06118385|531857706|FG006|Overall Study|Protocol Violation|0|||
147463545|NCT06118385|531857707|FG007|Overall Study|Protocol Violation|0|||
147463546|NCT06118385|531857708|FG008|Overall Study|Protocol Violation|1|||
147463547|NCT06118385|531857709|FG009|Overall Study|Protocol Violation|0|||
147463548|NCT06118385|531857710|FG010|Overall Study|Protocol Violation|0|||
147463549|NCT06118385|531857711|FG011|Overall Study|Protocol Violation|0|||
147403246|NCT01236352|531639146|FG000|Overall Study|Subject request to discontinue treatment|0|||
147403247|NCT01236352|531639147|FG001|Overall Study|Subject request to discontinue treatment|0|||
147403248|NCT01236352|531639148|FG002|Overall Study|Subject request to discontinue treatment|1|||
147403249|NCT01236352|531639149|FG003|Overall Study|Subject request to discontinue treatment|1|||
147463550|NCT06118385|531857700|FG000|Overall Study|Out-of-range blood tests|0|||
147463551|NCT06118385|531857701|FG001|Overall Study|Out-of-range blood tests|0|||
147463552|NCT06118385|531857702|FG002|Overall Study|Out-of-range blood tests|0|||
147403250|NCT01236352|531639150|FG004|Overall Study|Subject request to discontinue treatment|0|||
147403251|NCT01236352|531639151|FG005|Overall Study|Subject request to discontinue treatment|1|||
147403252|NCT01236352|531639152|FG006|Overall Study|Subject request to discontinue treatment|0|||
147403253|NCT01236352|531639153|FG007|Overall Study|Subject request to discontinue treatment|0|||
147403254|NCT01236352|531639154|FG008|Overall Study|Subject request to discontinue treatment|0|||
147403255|NCT01236352|531639155|FG009|Overall Study|Subject request to discontinue treatment|1|||
147403256|NCT01236352|531639156|FG010|Overall Study|Subject request to discontinue treatment|4|||
147403257|NCT01236352|531639146|FG000|Overall Study|Subject to receive drug via EAP|1|||
147403258|NCT01236352|531639147|FG001|Overall Study|Subject to receive drug via EAP|1|||
147403259|NCT01236352|531639148|FG002|Overall Study|Subject to receive drug via EAP|1|||
147403260|NCT01236352|531639149|FG003|Overall Study|Subject to receive drug via EAP|0|||
147403261|NCT01236352|531639150|FG004|Overall Study|Subject to receive drug via EAP|0|||
147403262|NCT01236352|531639151|FG005|Overall Study|Subject to receive drug via EAP|0|||
147403263|NCT01236352|531639152|FG006|Overall Study|Subject to receive drug via EAP|0|||
147403264|NCT01236352|531639153|FG007|Overall Study|Subject to receive drug via EAP|2|||
147403265|NCT01236352|531639154|FG008|Overall Study|Subject to receive drug via EAP|0|||
147403266|NCT01236352|531639155|FG009|Overall Study|Subject to receive drug via EAP|4|||
147403267|NCT01236352|531639156|FG010|Overall Study|Subject to receive drug via EAP|0|||
147403268|NCT01236352|531639146|FG000|Overall Study|Patient moving to allogeneic transplant|0|||
147403269|NCT01236352|531639147|FG001|Overall Study|Patient moving to allogeneic transplant|0|||
147403270|NCT01236352|531639148|FG002|Overall Study|Patient moving to allogeneic transplant|0|||
147403271|NCT01236352|531639149|FG003|Overall Study|Patient moving to allogeneic transplant|0|||
147403272|NCT01236352|531639150|FG004|Overall Study|Patient moving to allogeneic transplant|0|||
147403273|NCT01236352|531639151|FG005|Overall Study|Patient moving to allogeneic transplant|0|||
147403274|NCT01236352|531639152|FG006|Overall Study|Patient moving to allogeneic transplant|1|||
147403275|NCT01236352|531639153|FG007|Overall Study|Patient moving to allogeneic transplant|0|||
147403276|NCT01236352|531639154|FG008|Overall Study|Patient moving to allogeneic transplant|0|||
147403277|NCT01236352|531639155|FG009|Overall Study|Patient moving to allogeneic transplant|0|||
147403278|NCT01236352|531639156|FG010|Overall Study|Patient moving to allogeneic transplant|0|||
147403279|NCT01236352|531639146|FG000|Overall Study|Relapse of Splenomegaly and symptoms|0|||
147403280|NCT01236352|531639147|FG001|Overall Study|Relapse of Splenomegaly and symptoms|0|||
147403281|NCT01236352|531639148|FG002|Overall Study|Relapse of Splenomegaly and symptoms|0|||
147403282|NCT01236352|531639149|FG003|Overall Study|Relapse of Splenomegaly and symptoms|0|||
147403283|NCT01236352|531639150|FG004|Overall Study|Relapse of Splenomegaly and symptoms|0|||
147403284|NCT01236352|531639151|FG005|Overall Study|Relapse of Splenomegaly and symptoms|0|||
147403285|NCT01236352|531639152|FG006|Overall Study|Relapse of Splenomegaly and symptoms|0|||
147403286|NCT01236352|531639153|FG007|Overall Study|Relapse of Splenomegaly and symptoms|0|||
147403287|NCT01236352|531639154|FG008|Overall Study|Relapse of Splenomegaly and symptoms|0|||
147403288|NCT01236352|531639155|FG009|Overall Study|Relapse of Splenomegaly and symptoms|0|||
147403289|NCT01236352|531639156|FG010|Overall Study|Relapse of Splenomegaly and symptoms|1|||
147403290|NCT01236352|531639146|FG000|Overall Study|Lack of response to drug|0|||
147403291|NCT01236352|531639147|FG001|Overall Study|Lack of response to drug|0|||
147403292|NCT01236352|531639148|FG002|Overall Study|Lack of response to drug|0|||
147403293|NCT01236352|531639149|FG003|Overall Study|Lack of response to drug|0|||
147403294|NCT01236352|531639150|FG004|Overall Study|Lack of response to drug|0|||
147403295|NCT01236352|531639151|FG005|Overall Study|Lack of response to drug|0|||
147403296|NCT01236352|531639152|FG006|Overall Study|Lack of response to drug|0|||
147403297|NCT01236352|531639153|FG007|Overall Study|Lack of response to drug|0|||
147403298|NCT01236352|531639154|FG008|Overall Study|Lack of response to drug|0|||
147403299|NCT01236352|531639155|FG009|Overall Study|Lack of response to drug|1|||
147403300|NCT01236352|531639156|FG010|Overall Study|Lack of response to drug|1|||
147403301|NCT01236352|531639146|FG000|Overall Study|Patient transferred to IST|0|||
147403302|NCT01236352|531639147|FG001|Overall Study|Patient transferred to IST|0|||
147403303|NCT01236352|531639148|FG002|Overall Study|Patient transferred to IST|0|||
147403304|NCT01236352|531639149|FG003|Overall Study|Patient transferred to IST|0|||
147403305|NCT01236352|531639150|FG004|Overall Study|Patient transferred to IST|0|||
147403306|NCT01236352|531639151|FG005|Overall Study|Patient transferred to IST|0|||
147403307|NCT01236352|531639152|FG006|Overall Study|Patient transferred to IST|0|||
147403308|NCT01236352|531639153|FG007|Overall Study|Patient transferred to IST|0|||
147403309|NCT01236352|531639154|FG008|Overall Study|Patient transferred to IST|0|||
147403310|NCT01236352|531639155|FG009|Overall Study|Patient transferred to IST|2|||
147403311|NCT01236352|531639156|FG010|Overall Study|Patient transferred to IST|6|||
147403312|NCT01575873|531639157|FG000|Overall Study|Withdrawal by Subject|15|||
147403313|NCT01575873|531639158|FG001|Overall Study|Withdrawal by Subject|20|||
147403314|NCT01575873|531639159|FG002|Overall Study|Withdrawal by Subject|34|||
147463553|NCT06118385|531857703|FG003|Overall Study|Out-of-range blood tests|0|||
147403315|NCT01575873|531639160|FG003|Overall Study|Withdrawal by Subject|34|||
147403316|NCT01575873|531639157|FG000|Overall Study|Adverse Event|7|||
147403317|NCT01575873|531639158|FG001|Overall Study|Adverse Event|7|||
147403318|NCT01575873|531639159|FG002|Overall Study|Adverse Event|9|||
147463554|NCT06118385|531857704|FG004|Overall Study|Out-of-range blood tests|0|||
147463555|NCT06118385|531857705|FG005|Overall Study|Out-of-range blood tests|0|||
147463556|NCT06118385|531857706|FG006|Overall Study|Out-of-range blood tests|0|||
147463557|NCT06118385|531857707|FG007|Overall Study|Out-of-range blood tests|0|||
147463558|NCT06118385|531857708|FG008|Overall Study|Out-of-range blood tests|1|||
147463559|NCT06118385|531857709|FG009|Overall Study|Out-of-range blood tests|0|||
147463560|NCT06118385|531857710|FG010|Overall Study|Out-of-range blood tests|0|||
147463561|NCT06118385|531857711|FG011|Overall Study|Out-of-range blood tests|0|||
147463562|NCT02411448|531857712|FG000|Overall Study|Withdrawal by Subject|1|||
147463563|NCT02411448|531857713|FG001|Overall Study|Withdrawal by Subject|14|||
147463564|NCT02411448|531857714|FG002|Overall Study|Withdrawal by Subject|9|||
147463565|NCT02411448|531857712|FG000|Overall Study|Other|0|||
147463566|NCT02411448|531857713|FG001|Overall Study|Other|2|||
147463567|NCT02411448|531857714|FG002|Overall Study|Other|0|||
147463568|NCT02411448|531857712|FG000|Overall Study|Did not receive study treatment|0|||
147463569|NCT02411448|531857713|FG001|Overall Study|Did not receive study treatment|3|||
147463570|NCT02411448|531857714|FG002|Overall Study|Did not receive study treatment|0|||
147463571|NCT02411448|531857712|FG000|Overall Study|Alive on study treatment|3|||
147463572|NCT02411448|531857713|FG001|Overall Study|Alive on study treatment|64|||
147463573|NCT02411448|531857714|FG002|Overall Study|Alive on study treatment|43|||
147463574|NCT01848145|531857715|FG000|Infusion 1: Week 1, Day 1 - 226 Minutes|Adverse Event|1|||
147463575|NCT01848145|531857715|FG000|Infusion 2: Week 1, Day 3 - 167 Minutes|Adverse Event|1|||
147463576|NCT01848145|531857715|FG000|Infusion 2: Week 1, Day 3 - 167 Minutes|Disease Progression|1|||
147463577|NCT01848145|531857715|FG000|Infusion 3: Week 2, Day 1 - 120 Minutes|Adverse Event|1|||
147463578|NCT01848145|531857715|FG000|Subsequent Infusions: Weeks 3-8|Disease Progression|6|||
147463579|NCT01848145|531857715|FG000|Subsequent Infusions: Weeks 3-8|Withdrawal by Subject|3|||
147463580|NCT01848145|531857715|FG000|Subsequent Infusions: Weeks 3-8|Death|1|||
147463581|NCT03624946|531857718|FG000|Overall Study|Lost to Follow-up|0|||
147463582|NCT03624946|531857719|FG001|Overall Study|Lost to Follow-up|1|||
147463583|NCT01728779|531857720|FG000|Overall Study|Withdrawal by Subject|1|||
147463584|NCT00624520|531857721|FG000|Overall Study|Withdrawal by Subject|12|||
147463585|NCT00624520|531857722|FG001|Overall Study|Withdrawal by Subject|7|||
147463586|NCT00624520|531857721|FG000|Overall Study|Death|0|||
147463587|NCT00624520|531857722|FG001|Overall Study|Death|1|||
147463588|NCT01950819|531857728|FG000|Overall Study|Graft Loss|35|||
147463589|NCT01950819|531857729|FG001|Overall Study|Graft Loss|30|||
147463590|NCT01950819|531857728|FG000|Overall Study|Death|29|||
147463591|NCT01950819|531857729|FG001|Overall Study|Death|34|||
147463592|NCT01950819|531857728|FG000|Overall Study|Subject / Gardian decision|54|||
147463593|NCT01950819|531857729|FG001|Overall Study|Subject / Gardian decision|51|||
147463594|NCT01950819|531857728|FG000|Overall Study|technical problems|2|||
147463595|NCT01950819|531857729|FG001|Overall Study|technical problems|0|||
147463596|NCT01950819|531857728|FG000|Overall Study|Pregnancy|0|||
147463597|NCT01950819|531857729|FG001|Overall Study|Pregnancy|2|||
147463598|NCT01950819|531857728|FG000|Overall Study|Lost to Follow-up|9|||
147463599|NCT01950819|531857729|FG001|Overall Study|Lost to Follow-up|17|||
147463600|NCT00781365|531857730|FG000|Overall Study|Withdrawal by Subject|13|||
147463601|NCT00781365|531857731|FG001|Overall Study|Withdrawal by Subject|8|||
147616007|NCT02414958|532409123|FG002|Overall Study|Other than specified|5|||
147616008|NCT00245466|532409125|FG000|Overall Study|Adverse Event|2|||
147616009|NCT00245466|532409126|FG001|Overall Study|Adverse Event|8|||
147616010|NCT00245466|532409127|FG002|Overall Study|Adverse Event|4|||
147616011|NCT00245466|532409125|FG000|Overall Study|Low prostate specific antigen suppr|16|||
147616012|NCT00245466|532409126|FG001|Overall Study|Low prostate specific antigen suppr|14|||
147616013|NCT00245466|532409127|FG002|Overall Study|Low prostate specific antigen suppr|5|||
147616014|NCT00245466|532409125|FG000|Overall Study|Insufficient testosterone suppr|12|||
147616015|NCT00245466|532409126|FG001|Overall Study|Insufficient testosterone suppr|12|||
147616016|NCT00245466|532409127|FG002|Overall Study|Insufficient testosterone suppr|21|||
147616017|NCT00245466|532409125|FG000|Overall Study|Insufficient PSA and testosterone suppr|0|||
147616018|NCT00245466|532409126|FG001|Overall Study|Insufficient PSA and testosterone suppr|0|||
147616019|NCT00245466|532409127|FG002|Overall Study|Insufficient PSA and testosterone suppr|3|||
147616020|NCT00245466|532409125|FG000|Overall Study|Withdrawal by Subject|2|||
147616021|NCT00245466|532409126|FG001|Overall Study|Withdrawal by Subject|2|||
147616022|NCT00245466|532409127|FG002|Overall Study|Withdrawal by Subject|1|||
147616023|NCT00245466|532409125|FG000|Overall Study|Lost to Follow-up|3|||
147616024|NCT00245466|532409126|FG001|Overall Study|Lost to Follow-up|0|||
147616025|NCT00245466|532409127|FG002|Overall Study|Lost to Follow-up|0|||
147616026|NCT00245466|532409125|FG000|Overall Study|Disease progression|0|||
147463602|NCT00781365|531857730|FG000|Overall Study|Did Not Attend Visit|20|||
147463603|NCT00781365|531857731|FG001|Overall Study|Did Not Attend Visit|28|||
147616027|NCT00245466|532409126|FG001|Overall Study|Disease progression|3|||
147616028|NCT00245466|532409127|FG002|Overall Study|Disease progression|1|||
147463604|NCT00781365|531857730|FG000|Overall Study|Language barrier|1|||
147463605|NCT00781365|531857731|FG001|Overall Study|Language barrier|0|||
147463606|NCT02649634|531857732|FG000|Overall Study|Withdrawal by Subject|3|||
147463607|NCT02649634|531857733|FG001|Overall Study|Withdrawal by Subject|5|||
147403319|NCT01575873|531639160|FG003|Overall Study|Adverse Event|12|||
147403320|NCT01575873|531639157|FG000|Overall Study|Lost to Follow-up|1|||
147403321|NCT01575873|531639158|FG001|Overall Study|Lost to Follow-up|3|||
147403322|NCT01575873|531639159|FG002|Overall Study|Lost to Follow-up|13|||
147403323|NCT01575873|531639160|FG003|Overall Study|Lost to Follow-up|5|||
147403324|NCT01575873|531639157|FG000|Overall Study|Death|3|||
147403325|NCT01575873|531639158|FG001|Overall Study|Death|2|||
147403326|NCT01575873|531639159|FG002|Overall Study|Death|8|||
147403327|NCT01575873|531639160|FG003|Overall Study|Death|9|||
147403328|NCT01575873|531639157|FG000|Overall Study|Noncompliance|1|||
147403329|NCT01575873|531639158|FG001|Overall Study|Noncompliance|2|||
147403330|NCT01575873|531639159|FG002|Overall Study|Noncompliance|4|||
147403331|NCT01575873|531639160|FG003|Overall Study|Noncompliance|3|||
147403332|NCT01575873|531639157|FG000|Overall Study|Administrative decision|1|||
147403333|NCT01575873|531639158|FG001|Overall Study|Administrative decision|1|||
147403334|NCT01575873|531639159|FG002|Overall Study|Administrative decision|1|||
147403335|NCT01575873|531639160|FG003|Overall Study|Administrative decision|0|||
147403336|NCT01575873|531639157|FG000|Overall Study|Protocol deviation|0|||
147403337|NCT01575873|531639158|FG001|Overall Study|Protocol deviation|1|||
147403338|NCT01575873|531639159|FG002|Overall Study|Protocol deviation|0|||
147403339|NCT01575873|531639160|FG003|Overall Study|Protocol deviation|1|||
147403340|NCT01575873|531639157|FG000|Overall Study|Requirement for Alternative Therapy|0|||
147403341|NCT01575873|531639158|FG001|Overall Study|Requirement for Alternative Therapy|0|||
147403342|NCT01575873|531639159|FG002|Overall Study|Requirement for Alternative Therapy|1|||
147403343|NCT01575873|531639160|FG003|Overall Study|Requirement for Alternative Therapy|1|||
147403344|NCT01575873|531639157|FG000|Overall Study|Other|0|||
147403345|NCT01575873|531639158|FG001|Overall Study|Other|0|||
147403346|NCT01575873|531639159|FG002|Overall Study|Other|4|||
147403347|NCT01575873|531639160|FG003|Overall Study|Other|2|||
147403348|NCT02031536|531639161|FG000|Overall Study|ineligible|1|||
147403349|NCT02031536|531639162|FG001|Overall Study|ineligible|0|||
147403350|NCT01850030|531639163|FG000|Overall Study|Adverse Event|64|||
147403351|NCT01850030|531639164|FG001|Overall Study|Adverse Event|82|||
147403352|NCT01850030|531639163|FG000|Overall Study|Lack of Efficacy|3|||
147403353|NCT01850030|531639164|FG001|Overall Study|Lack of Efficacy|1|||
147403354|NCT01850030|531639163|FG000|Overall Study|Lost to Follow-up|5|||
147403355|NCT01850030|531639164|FG001|Overall Study|Lost to Follow-up|5|||
147403356|NCT01850030|531639163|FG000|Overall Study|Withdrawal by Subject|3|||
147403357|NCT01850030|531639164|FG001|Overall Study|Withdrawal by Subject|4|||
147403358|NCT01850030|531639163|FG000|Overall Study|Protocol Violation|24|||
147403359|NCT01850030|531639164|FG001|Overall Study|Protocol Violation|28|||
147403360|NCT01850030|531639163|FG000|Overall Study|pregnancy not confirmed at visit 4|248|||
147403361|NCT01850030|531639164|FG001|Overall Study|pregnancy not confirmed at visit 4|249|||
147403362|NCT03845023|531639172|FG000|Follow-Up (14 Days)|Lost to Follow-up|1|||
147403363|NCT03845023|531639173|FG001|Follow-Up (14 Days)|Lost to Follow-up|0|||
147403364|NCT03845023|531639174|FG002|Follow-Up (14 Days)|Lost to Follow-up|0|||
147403365|NCT03845023|531639175|FG003|Follow-Up (14 Days)|Lost to Follow-up|0|||
147403366|NCT03845023|531639172|FG000|Follow-Up (14 Days)|Adverse Event|0|||
147403367|NCT03845023|531639173|FG001|Follow-Up (14 Days)|Adverse Event|0|||
147403368|NCT03845023|531639174|FG002|Follow-Up (14 Days)|Adverse Event|1|||
147403369|NCT03845023|531639175|FG003|Follow-Up (14 Days)|Adverse Event|1|||
147403370|NCT02353871|531639176|FG000|Overall Study|Protocol deviation|0|||
147403371|NCT02353871|531639177|FG001|Overall Study|Protocol deviation|1|||
147403372|NCT02353871|531639176|FG000|Overall Study|Consent withdrawn|1|||
147403373|NCT02353871|531639177|FG001|Overall Study|Consent withdrawn|8|||
147403374|NCT02353871|531639176|FG000|Overall Study|Lost to Follow-up|2|||
147403375|NCT02353871|531639177|FG001|Overall Study|Lost to Follow-up|0|||
147403376|NCT00115336|531639178|FG000|Overall Study|Hospital discharge before study drug|0|||
147403377|NCT00115336|531639179|FG001|Overall Study|Hospital discharge before study drug|1|||
147403378|NCT03371823|531639180|FG000|Overall Study|Screen fail (did not meet inclusion criteria)|1|||
147403379|NCT03371823|531639181|FG001|Overall Study|Screen fail (did not meet inclusion criteria)|0|||
147403380|NCT00356811|531639182|FG000|Overall Study|Death|35|||
147403381|NCT00356811|531639182|FG000|Overall Study|Lost to Follow-up|2|||
147403382|NCT00356811|531639182|FG000|Overall Study|Withdrawal by Subject|6|||
147463608|NCT02649634|531857732|FG000|Overall Study|Lost to Follow-up|0|||
147463609|NCT02649634|531857733|FG001|Overall Study|Lost to Follow-up|1|||
147403383|NCT00356811|531639182|FG000|Overall Study|Participant Could Not Make a Checkup|1|||
147403384|NCT00356811|531639182|FG000|Overall Study|Study Is Terminating|3|||
147463610|NCT00238264|531857734|FG000|Overall Study|Death|7|||
147463611|NCT00238264|531857734|FG000|Overall Study|Lost to Follow-up|18|||
147403385|NCT00356811|531639182|FG000|Overall Study|Site Closed during Follow-up|2|||
147403386|NCT02386839|531639183|FG000|Overall Study|Death|1|||
147403387|NCT02386839|531639184|FG001|Overall Study|Death|0|||
147403388|NCT02386839|531639183|FG000|Overall Study|Withdrawal by Subject|9|||
147403389|NCT02386839|531639184|FG001|Overall Study|Withdrawal by Subject|10|||
147403390|NCT02386839|531639183|FG000|Overall Study|Lost to Follow-up|4|||
147403391|NCT02386839|531639184|FG001|Overall Study|Lost to Follow-up|4|||
147403392|NCT02386839|531639183|FG000|Overall Study|Other (Site Terminated by Sponsor)|1|||
147616029|NCT00245466|532409125|FG000|Overall Study|Protocol Violation|1|||
147616030|NCT00245466|532409126|FG001|Overall Study|Protocol Violation|2|||
147616031|NCT00245466|532409127|FG002|Overall Study|Protocol Violation|2|||
147616032|NCT00245466|532409125|FG000|Overall Study|Death|0|||
147616033|NCT00245466|532409126|FG001|Overall Study|Death|2|||
147616034|NCT00245466|532409127|FG002|Overall Study|Death|0|||
147616035|NCT00245466|532409125|FG000|Overall Study|Administrative reasons|0|||
147616036|NCT00245466|532409126|FG001|Overall Study|Administrative reasons|1|||
147616037|NCT00245466|532409127|FG002|Overall Study|Administrative reasons|0|||
147616038|NCT03885661|532409128|FG000|Overall Study|Withdrawal by Subject|0|||
147616039|NCT03885661|532409129|FG001|Overall Study|Withdrawal by Subject|1|||
147616040|NCT03885661|532409128|FG000|Overall Study|Unwilling to undergo required study procedure|1|||
147616041|NCT03885661|532409129|FG001|Overall Study|Unwilling to undergo required study procedure|0|||
147616042|NCT05064397|532409130|FG000|Overall Study|Adverse Event|4|||
147616043|NCT05064397|532409130|FG000|Overall Study|Lack of Efficacy|12|||
147616044|NCT05064397|532409130|FG000|Overall Study|Withdrawal by Subject|3|||
147616045|NCT05064397|532409130|FG000|Overall Study|Lost to Follow-up|1|||
147616046|NCT05064397|532409130|FG000|Overall Study|Other reasons|3|||
147616047|NCT02232984|532409131|FG000|Overall Study|Withdrawal by Subject|5|||
147616048|NCT02232984|532409131|FG000|Overall Study|Death|1|||
147616049|NCT02232984|532409131|FG000|Overall Study|Investigator withdrawal|10|||
147616050|NCT02232984|532409131|FG000|Overall Study|Device implant unsuccessful|53|||
147403393|NCT02386839|531639184|FG001|Overall Study|Other (Site Terminated by Sponsor)|0|||
147403394|NCT02386839|531639183|FG000|Overall Study|Other (Covid 19 Pandemic)|0|||
147403395|NCT02386839|531639184|FG001|Overall Study|Other (Covid 19 Pandemic)|1|||
147403396|NCT02386839|531639183|FG000|Overall Study|Other (unspecified)|1|||
147403397|NCT02386839|531639184|FG001|Overall Study|Other (unspecified)|0|||
147403398|NCT02242643|531639187|FG000|Overall Study|Protocol Violation|1|||
147403399|NCT02242643|531639188|FG001|Overall Study|Protocol Violation|2|||
147403400|NCT02242643|531639187|FG000|Overall Study|Withdrawal by Subject|15|||
147403401|NCT02242643|531639188|FG001|Overall Study|Withdrawal by Subject|10|||
147403402|NCT02242643|531639187|FG000|Overall Study|Migrated/moved from study area|1|||
147403403|NCT02242643|531639188|FG001|Overall Study|Migrated/moved from study area|3|||
147403404|NCT02242643|531639187|FG000|Overall Study|Lost to Follow-up|54|||
147403405|NCT02242643|531639188|FG001|Overall Study|Lost to Follow-up|61|||
147403406|NCT02242643|531639187|FG000|Overall Study|Child placed in foster care by family|0|||
147403407|NCT02242643|531639188|FG001|Overall Study|Child placed in foster care by family|1|||
147403408|NCT02242643|531639187|FG000|Overall Study|Non-compliance|1|||
147403409|NCT02242643|531639188|FG001|Overall Study|Non-compliance|0|||
147403410|NCT02242643|531639187|FG000|Overall Study|Consent withdrawal by parent|1|||
147403411|NCT02242643|531639188|FG001|Overall Study|Consent withdrawal by parent|0|||
147403412|NCT02242643|531639187|FG000|Overall Study|Protocol requirements not followed|1|||
147403413|NCT02242643|531639188|FG001|Overall Study|Protocol requirements not followed|0|||
147403414|NCT02242643|531639187|FG000|Overall Study|Language barrier|1|||
147403415|NCT02242643|531639188|FG001|Overall Study|Language barrier|0|||
147403416|NCT02242643|531639187|FG000|Overall Study|Withdrawal by subject at Visit 2|0|||
147403417|NCT02242643|531639188|FG001|Overall Study|Withdrawal by subject at Visit 2|1|||
147403418|NCT02101983|531639192|FG000|Overall Study|Physician Decision|1|||
147403419|NCT02101983|531639193|FG001|Overall Study|Physician Decision|0|||
147403420|NCT01103232|531639195|FG000|Overall Study|Withdrawal by Subject|1|||
147403421|NCT01103232|531639196|FG001|Overall Study|Withdrawal by Subject|1|||
147403422|NCT01103232|531639195|FG000|Overall Study|Protocol Violation|0|||
147403423|NCT01103232|531639196|FG001|Overall Study|Protocol Violation|1|||
147403424|NCT05093504|531639197|FG000|Overall Study|Death|0|||
147403425|NCT05093504|531639198|FG001|Overall Study|Death|1|||
147403426|NCT05347485|531639203|FG000|Overall Study|Death|14|||
147403427|NCT05347485|531639203|FG000|Overall Study|Lost to Follow-up|2|||
147403428|NCT05347485|531639203|FG000|Overall Study|Withdrawal by Subject|13|||
147403429|NCT05347485|531639203|FG000|Overall Study|Progressive Disease|1|||
147403430|NCT05347485|531639203|FG000|Overall Study|Study Terminated by Sponsor|49|||
147403431|NCT05347485|531639203|FG000|Overall Study|Other|1|||
147403432|NCT05347485|531639203|FG000|Overall Study|Enrolled (consented) but not treated|4|||
147403433|NCT05347485|531639203|FG000|Overall Study|Disease Relapse|2|||
147403434|NCT04886518|531639204|FG000|Overall Study|Noncompliance with study drug|1|||
147403435|NCT04886518|531639205|FG001|Overall Study|Noncompliance with study drug|0|||
147403436|NCT04886518|531639206|FG002|Overall Study|Noncompliance with study drug|0|||
147403437|NCT04886518|531639204|FG000|Overall Study|Adverse Event|0|||
147403438|NCT04886518|531639205|FG001|Overall Study|Adverse Event|1|||
147403439|NCT04886518|531639206|FG002|Overall Study|Adverse Event|0|||
147403440|NCT04886518|531639204|FG000|Overall Study|Withdrawal by Subject|1|||
147403441|NCT04886518|531639205|FG001|Overall Study|Withdrawal by Subject|0|||
147403442|NCT04886518|531639206|FG002|Overall Study|Withdrawal by Subject|0|||
147403443|NCT03733899|531639207|FG000|Period 1|Protocol Violation|0|||
147616051|NCT02232984|532409131|FG000|Overall Study|not disclosed by site|7|||
147616052|NCT02232984|532409131|FG000|Overall Study|Protocol Violation|1|||
147616053|NCT00769379|532409134|FG000|Overall Study|No follow up data mapped to Other.|3|||
147616054|NCT00769379|532409135|FG001|Overall Study|No follow up data mapped to Other.|13|||
147616055|NCT04194645|532409140|FG000|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
147616056|NCT04194645|532409141|FG001|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
147616057|NCT04194645|532409142|FG002|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
147616058|NCT04194645|532409143|FG003|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
147616059|NCT04194645|532409144|FG004|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
147616060|NCT04194645|532409145|FG005|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
147616061|NCT04194645|532409146|FG006|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
147616062|NCT04194645|532409147|FG007|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
147616063|NCT04194645|532409148|FG008|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
147616064|NCT04194645|532409149|FG009|Wash-out Period 2 (BA Part Only)|Adverse Event|1|||
147616065|NCT04194645|532409150|FG010|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
147616066|NCT04194645|532409151|FG011|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
147616067|NCT04194645|532409152|FG012|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
147616068|NCT04194645|532409153|FG013|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
147616069|NCT04194645|532409154|FG014|Wash-out Period 2 (BA Part Only)|Adverse Event|0|||
147616070|NCT03076775|532409155|FG000|Overall Study|Lost to Follow-up|1|||
147616071|NCT03076775|532409156|FG001|Overall Study|Lost to Follow-up|0|||
147616072|NCT04604795|532409159|FG000|Part A: Washout Period 1(Up to Day 20)|Physician Decision|1|||
147616073|NCT04604795|532409160|FG001|Part A: Washout Period 1(Up to Day 20)|Physician Decision|1|||
147616074|NCT04604795|532409161|FG002|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
147616075|NCT04604795|532409162|FG003|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
147616076|NCT04604795|532409163|FG004|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
147616077|NCT04604795|532409164|FG005|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
147616078|NCT04604795|532409165|FG006|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
147616079|NCT04604795|532409166|FG007|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
147616080|NCT04604795|532409167|FG008|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
147616081|NCT04604795|532409168|FG009|Part A: Washout Period 1(Up to Day 20)|Physician Decision|0|||
147616082|NCT04604795|532409159|FG000|Part B: Up to Day 14|Adverse Event|0|||
147616083|NCT04604795|532409160|FG001|Part B: Up to Day 14|Adverse Event|0|||
147616084|NCT04604795|532409161|FG002|Part B: Up to Day 14|Adverse Event|0|||
147616085|NCT04604795|532409162|FG003|Part B: Up to Day 14|Adverse Event|0|||
147616086|NCT04604795|532409163|FG004|Part B: Up to Day 14|Adverse Event|2|||
147616087|NCT04604795|532409164|FG005|Part B: Up to Day 14|Adverse Event|1|||
147616088|NCT04604795|532409165|FG006|Part B: Up to Day 14|Adverse Event|0|||
147616089|NCT04604795|532409166|FG007|Part B: Up to Day 14|Adverse Event|0|||
147616090|NCT04604795|532409167|FG008|Part B: Up to Day 14|Adverse Event|0|||
147616091|NCT04604795|532409168|FG009|Part B: Up to Day 14|Adverse Event|0|||
147616092|NCT04604795|532409159|FG000|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
147616093|NCT04604795|532409160|FG001|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
147616094|NCT04604795|532409161|FG002|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
147616095|NCT04604795|532409162|FG003|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
147616096|NCT04604795|532409163|FG004|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
147616097|NCT04604795|532409164|FG005|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
147616098|NCT04604795|532409165|FG006|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
147616099|NCT04604795|532409166|FG007|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
147616100|NCT04604795|532409167|FG008|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|0|||
147616101|NCT04604795|532409168|FG009|Part C: Washout Period 1 (Up to Day 6)|Adverse Event|1|||
147616102|NCT04604795|532409159|FG000|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
147403444|NCT03733899|531639208|FG001|Period 1|Protocol Violation|0|||
147403445|NCT03733899|531639209|FG002|Period 1|Protocol Violation|0|||
147403446|NCT03733899|531639210|FG003|Period 1|Protocol Violation|0|||
147403447|NCT03733899|531639211|FG004|Period 1|Protocol Violation|0|||
147403448|NCT03733899|531639212|FG005|Period 1|Protocol Violation|1|||
147403449|NCT03733899|531639207|FG000|Period 2|Unscuccessful Treatment|0|||
147403450|NCT03733899|531639208|FG001|Period 2|Unscuccessful Treatment|1|||
147403451|NCT03733899|531639209|FG002|Period 2|Unscuccessful Treatment|0|||
147403452|NCT03733899|531639210|FG003|Period 2|Unscuccessful Treatment|0|||
147403453|NCT03733899|531639211|FG004|Period 2|Unscuccessful Treatment|0|||
147403454|NCT03733899|531639212|FG005|Period 2|Unscuccessful Treatment|0|||
147403455|NCT03733899|531639207|FG000|Period 3|Withdrawal by Subject|1|||
147616103|NCT04604795|532409160|FG001|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
147616104|NCT04604795|532409161|FG002|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
147616105|NCT04604795|532409162|FG003|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
147616106|NCT04604795|532409163|FG004|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
147616107|NCT04604795|532409164|FG005|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
147403456|NCT03733899|531639208|FG001|Period 3|Withdrawal by Subject|0|||
147616108|NCT04604795|532409165|FG006|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
147665269|NCT00922636|532599517|FG002|Overall Study|Parent/Caregiver Decision|3|||
147403457|NCT03733899|531639209|FG002|Period 3|Withdrawal by Subject|0|||
147403458|NCT03733899|531639210|FG003|Period 3|Withdrawal by Subject|0|||
147403459|NCT03733899|531639211|FG004|Period 3|Withdrawal by Subject|0|||
147616109|NCT04604795|532409166|FG007|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
147616110|NCT04604795|532409167|FG008|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|1|||
147616111|NCT04604795|532409168|FG009|Part C: Washout Period 3 (Up to Day10)|Withdrawal by Subject|0|||
147616112|NCT04604795|532409159|FG000|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
147616113|NCT04604795|532409160|FG001|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
147616114|NCT04604795|532409161|FG002|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
147616115|NCT04604795|532409162|FG003|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
147403460|NCT03733899|531639212|FG005|Period 3|Withdrawal by Subject|0|||
147403461|NCT02035696|531640552|FG000|Overall Study|Lost to Follow-up|0|||
147403462|NCT02035696|531640553|FG001|Overall Study|Lost to Follow-up|3|||
147403463|NCT02035696|531640554|FG002|Overall Study|Lost to Follow-up|1|||
147403464|NCT02035696|531640555|FG003|Overall Study|Lost to Follow-up|2|||
147403465|NCT02035696|531640552|FG000|Overall Study|Withdrawal by Subject|3|||
147403466|NCT02035696|531640553|FG001|Overall Study|Withdrawal by Subject|0|||
147403467|NCT02035696|531640554|FG002|Overall Study|Withdrawal by Subject|2|||
147403468|NCT02035696|531640555|FG003|Overall Study|Withdrawal by Subject|1|||
147403469|NCT01246999|531640557|FG000|Overall Study|Lost to Follow-up|0|||
147403470|NCT01246999|531640558|FG001|Overall Study|Lost to Follow-up|1|||
147403471|NCT01246999|531640559|FG002|Overall Study|Lost to Follow-up|0|||
147403472|NCT01246999|531640560|FG003|Overall Study|Lost to Follow-up|0|||
147403473|NCT01246999|531640557|FG000|Overall Study|Withdrawal by Subject|0|||
147403474|NCT01246999|531640558|FG001|Overall Study|Withdrawal by Subject|0|||
147403475|NCT01246999|531640559|FG002|Overall Study|Withdrawal by Subject|0|||
147403476|NCT01246999|531640560|FG003|Overall Study|Withdrawal by Subject|2|||
147403477|NCT01867047|531640561|FG000|Overall Study|Lost to Follow-up|3|||
147403478|NCT01867047|531640562|FG001|Overall Study|Lost to Follow-up|3|||
147403479|NCT01867047|531640561|FG000|Overall Study|Withdrawal by Subject|2|||
147403480|NCT01867047|531640562|FG001|Overall Study|Withdrawal by Subject|0|||
147403481|NCT01867047|531640561|FG000|Overall Study|Physician Decision|2|||
147403482|NCT01867047|531640562|FG001|Overall Study|Physician Decision|0|||
147403483|NCT01867047|531640561|FG000|Overall Study|surgery not indicated in protocol|1|||
147403484|NCT01867047|531640562|FG001|Overall Study|surgery not indicated in protocol|2|||
147403485|NCT04650698|531640563|FG000|Overall Study|Protocol Violation|2|||
147403486|NCT04650698|531640564|FG001|Overall Study|Protocol Violation|1|||
147403487|NCT04650698|531640563|FG000|Overall Study|Withdrawal by Subject|0|||
147403488|NCT04650698|531640564|FG001|Overall Study|Withdrawal by Subject|1|||
147403489|NCT02568397|531640565|FG000|Period 2|Withdrawal by Subject|0|||
147403490|NCT02568397|531640566|FG001|Period 2|Withdrawal by Subject|1|||
147403491|NCT02568397|531640565|FG000|Period 2|Physician Decision|0|||
147403492|NCT02568397|531640566|FG001|Period 2|Physician Decision|1|||
147403493|NCT01385748|531640567|FG000|Overall Study|Withdrawal by Subject|7|||
147403494|NCT01385748|531640568|FG001|Overall Study|Withdrawal by Subject|4|||
147403495|NCT01385748|531640569|FG002|Overall Study|Withdrawal by Subject|5|||
147403496|NCT01385748|531640567|FG000|Overall Study|Noncompliance|3|||
147403497|NCT01385748|531640568|FG001|Overall Study|Noncompliance|1|||
147403498|NCT01385748|531640569|FG002|Overall Study|Noncompliance|6|||
147403499|NCT01385748|531640567|FG000|Overall Study|Other|1|||
147403500|NCT01385748|531640568|FG001|Overall Study|Other|7|||
147403501|NCT01385748|531640569|FG002|Overall Study|Other|1|||
147403502|NCT01385748|531640567|FG000|Overall Study|Adverse Event|4|||
147403503|NCT01385748|531640568|FG001|Overall Study|Adverse Event|2|||
147403504|NCT01385748|531640569|FG002|Overall Study|Adverse Event|1|||
147403505|NCT02354651|531640570|FG000|Overall Study|Withdrawal by Subject|2|||
147403506|NCT02354651|531640570|FG000|Overall Study|Physician Decision|1|||
147403507|NCT00581893|531640571|FG000|Second Intervention (1 Month)|Lost to Follow-up|3|||
147403508|NCT00581893|531640572|FG001|Second Intervention (1 Month)|Lost to Follow-up|2|||
147403509|NCT00590564|531640573|FG000|Overall Study|Withdrawal by Subject|4|||
147403510|NCT00590564|531640573|FG000|Overall Study|Lost to Follow-up|6|||
147403511|NCT00590564|531640573|FG000|Overall Study|Protocol Violation|1|||
147403512|NCT00590564|531640573|FG000|Overall Study|Patient Found to be Ineligible|1|||
147403513|NCT00590564|531640573|FG000|Overall Study|Patient Non-compliance|6|||
147403514|NCT01377389|531640576|FG000|Overall Study|Withdrawal by Subject|1|||
147403515|NCT01377389|531640576|FG000|Overall Study|Screen failure|2|||
147403516|NCT01434680|531640583|FG000|Overall Study|Withdrawal by Subject|1|||
147403517|NCT01434680|531640584|FG001|Overall Study|Withdrawal by Subject|0|||
147403518|NCT01434680|531640585|FG002|Overall Study|Withdrawal by Subject|2|||
147403519|NCT01434680|531640586|FG003|Overall Study|Withdrawal by Subject|0|||
147403520|NCT01434680|531640583|FG000|Overall Study|Lost to Follow-up|1|||
147403521|NCT01434680|531640584|FG001|Overall Study|Lost to Follow-up|1|||
147616116|NCT04604795|532409163|FG004|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
147403522|NCT01434680|531640585|FG002|Overall Study|Lost to Follow-up|0|||
147403523|NCT01434680|531640586|FG003|Overall Study|Lost to Follow-up|0|||
147403524|NCT01434680|531640583|FG000|Overall Study|Protocol Violation|1|||
147403525|NCT01434680|531640584|FG001|Overall Study|Protocol Violation|1|||
147403526|NCT01434680|531640585|FG002|Overall Study|Protocol Violation|0|||
147403527|NCT01434680|531640586|FG003|Overall Study|Protocol Violation|0|||
147403528|NCT00725712|531640588|FG000|Overall Study|Withdrawal by Subject|2|||
147463612|NCT00238264|531857734|FG000|Overall Study|Withdrawal by Subject|4|||
147463613|NCT00238264|531857734|FG000|Overall Study|Ineligible|7|||
147463614|NCT01662648|531857735|FG000|Overall Study|Death|1|||
147463615|NCT01662648|531857736|FG001|Overall Study|Death|3|||
147463616|NCT01662648|531857735|FG000|Overall Study|Adverse Event|40|||
147463617|NCT01662648|531857736|FG001|Overall Study|Adverse Event|37|||
147463618|NCT01662648|531857735|FG000|Overall Study|Lack of Efficacy|17|||
147463619|NCT01662648|531857736|FG001|Overall Study|Lack of Efficacy|16|||
147463620|NCT01662648|531857735|FG000|Overall Study|Participant ineligible to continue trial|1|||
147463621|NCT01662648|531857736|FG001|Overall Study|Participant ineligible to continue trial|1|||
147463622|NCT01662648|531857735|FG000|Overall Study|Lost to Follow-up|24|||
147463623|NCT01662648|531857736|FG001|Overall Study|Lost to Follow-up|36|||
147403529|NCT00725712|531640589|FG001|Overall Study|Withdrawal by Subject|1|||
147403530|NCT00725712|531640588|FG000|Overall Study|Protocol Violation|1|||
147403531|NCT00725712|531640589|FG001|Overall Study|Protocol Violation|0|||
147403532|NCT00725712|531640588|FG000|Overall Study|Progressive disease|37|||
147403533|NCT00725712|531640589|FG001|Overall Study|Progressive disease|16|||
147403534|NCT00725712|531640588|FG000|Overall Study|Clinical progression not based on RECIST|0|||
147403535|NCT00725712|531640589|FG001|Overall Study|Clinical progression not based on RECIST|3|||
147403536|NCT00725712|531640588|FG000|Overall Study|Adverse Event|5|||
147403537|NCT00725712|531640589|FG001|Overall Study|Adverse Event|5|||
147403538|NCT00725712|531640588|FG000|Overall Study|Death|2|||
147403539|NCT00725712|531640589|FG001|Overall Study|Death|0|||
147403540|NCT00725712|531640588|FG000|Overall Study|Other: Death|1|||
147403541|NCT00725712|531640589|FG001|Overall Study|Other: Death|0|||
147403542|NCT00725712|531640588|FG000|Overall Study|Hospitalized, unable to continue|0|||
147403543|NCT00725712|531640589|FG001|Overall Study|Hospitalized, unable to continue|1|||
147403544|NCT02684123|531640593|FG000|Phase 1|Lack of Efficacy|5|||
147403545|NCT02684123|531640594|FG001|Phase 1|Lack of Efficacy|0|||
147403546|NCT02684123|531640593|FG000|Phase 1|Adverse Event|3|||
147403547|NCT02684123|531640594|FG001|Phase 1|Adverse Event|0|||
147403548|NCT02684123|531640593|FG000|Phase 1|Lost to Follow-up|0|||
147403549|NCT02684123|531640594|FG001|Phase 1|Lost to Follow-up|1|||
147403550|NCT02684123|531640593|FG000|Phase 2|Lack of Efficacy|1|||
147403551|NCT02684123|531640594|FG001|Phase 2|Lack of Efficacy|8|||
147403552|NCT01245140|531640600|FG000|Overall Study|Adverse Event|1|||
147403553|NCT01245140|531640601|FG001|Overall Study|Adverse Event|3|||
147403554|NCT01245140|531640600|FG000|Overall Study|Lack of Efficacy|2|||
147403555|NCT01245140|531640601|FG001|Overall Study|Lack of Efficacy|4|||
147403556|NCT01245140|531640600|FG000|Overall Study|Protocol Violation|0|||
147403557|NCT01245140|531640601|FG001|Overall Study|Protocol Violation|1|||
147403558|NCT01245140|531640600|FG000|Overall Study|Withdrawal by Subject|0|||
147403559|NCT01245140|531640601|FG001|Overall Study|Withdrawal by Subject|1|||
147403560|NCT01245140|531640600|FG000|Overall Study|Refused Treatment/Did Not Coopera|0|||
147403561|NCT01245140|531640601|FG001|Overall Study|Refused Treatment/Did Not Coopera|1|||
147403562|NCT02037477|531640602|FG000|Treatment Period 1|Pre-treatment Event/Adverse Event|0|||
147403563|NCT02037477|531640603|FG001|Treatment Period 1|Pre-treatment Event/Adverse Event|0|||
147403564|NCT02037477|531640604|FG002|Treatment Period 1|Pre-treatment Event/Adverse Event|1|||
147403565|NCT02037477|531640605|FG003|Treatment Period 1|Pre-treatment Event/Adverse Event|0|||
147403566|NCT02635360|531640606|FG000|Overall Study|Adverse Event|0|||
147403567|NCT02635360|531640607|FG001|Overall Study|Adverse Event|3|||
147403568|NCT02635360|531640606|FG000|Overall Study|Withdrawal by Subject|2|||
147403569|NCT02635360|531640607|FG001|Overall Study|Withdrawal by Subject|0|||
147403570|NCT02635360|531640606|FG000|Overall Study|Non-Compliance|3|||
147403571|NCT02635360|531640607|FG001|Overall Study|Non-Compliance|1|||
147403572|NCT02635360|531640606|FG000|Overall Study|Disease Progression|0|||
147403573|NCT02635360|531640607|FG001|Overall Study|Disease Progression|2|||
147403574|NCT02635360|531640606|FG000|Overall Study|Lost to Follow-up|1|||
147403575|NCT02635360|531640607|FG001|Overall Study|Lost to Follow-up|1|||
147463624|NCT01662648|531857735|FG000|Overall Study|Withdrawal by Subject|36|||
147463625|NCT01662648|531857736|FG001|Overall Study|Withdrawal by Subject|53|||
147403576|NCT00983749|531640608|FG000|Follow-up Phase (Hospital DC to 30 Days)|Lost to Follow-up|1|||
147403577|NCT00983749|531640609|FG001|Follow-up Phase (Hospital DC to 30 Days)|Lost to Follow-up|3|||
147403578|NCT05765435|531640610|FG000|Overall Study|Lost to Follow-up|0|||
147403579|NCT05765435|531640611|FG001|Overall Study|Lost to Follow-up|1|||
147403580|NCT05765435|531640612|FG002|Overall Study|Lost to Follow-up|0|||
147403581|NCT05765435|531640610|FG000|Overall Study|Withdrawal by Subject|0|||
147403582|NCT05765435|531640611|FG001|Overall Study|Withdrawal by Subject|0|||
147403583|NCT05765435|531640612|FG002|Overall Study|Withdrawal by Subject|1|||
147403584|NCT01952847|531640613|FG000|Overall Study|Ineligible|1|||
147403585|NCT01952847|531640614|FG001|Overall Study|Ineligible|0|||
147403586|NCT01952847|531640615|FG002|Overall Study|Ineligible|0|||
147403587|NCT01952847|531640616|FG003|Overall Study|Ineligible|0|||
147403588|NCT01952847|531640613|FG000|Overall Study|Lack of Insurance Coverage|0|||
147403589|NCT01952847|531640614|FG001|Overall Study|Lack of Insurance Coverage|1|||
147403590|NCT01952847|531640615|FG002|Overall Study|Lack of Insurance Coverage|0|||
147463626|NCT01662648|531857735|FG000|Overall Study|Participant non-compliant|16|||
147463627|NCT01662648|531857736|FG001|Overall Study|Participant non-compliant|20|||
147463628|NCT01662648|531857735|FG000|Overall Study|Other|8|||
147463629|NCT01662648|531857736|FG001|Overall Study|Other|11|||
147463630|NCT01662648|531857735|FG000|Overall Study|Adverse event and lack of efficacy (LOE)|3|||
147463631|NCT01662648|531857736|FG001|Overall Study|Adverse event and lack of efficacy (LOE)|0|||
147463632|NCT01662648|531857735|FG000|Overall Study|LOE and other reason unspecified|1|||
147463633|NCT01662648|531857736|FG001|Overall Study|LOE and other reason unspecified|0|||
147463634|NCT01662648|531857735|FG000|Overall Study|LOE and Participant non-compliant|0|||
147463635|NCT01662648|531857736|FG001|Overall Study|LOE and Participant non-compliant|1|||
147463636|NCT02928952|531857739|FG000|Overall Study|Lost to Follow-up|5|||
147463637|NCT02928952|531857740|FG001|Overall Study|Lost to Follow-up|5|||
147463638|NCT02928952|531857739|FG000|Overall Study|Withdrawal by Subject|5|||
147463639|NCT02928952|531857740|FG001|Overall Study|Withdrawal by Subject|1|||
147463640|NCT02928952|531857739|FG000|Overall Study|Physician Decision|0|||
147463641|NCT02928952|531857740|FG001|Overall Study|Physician Decision|1|||
147463642|NCT01850615|531857741|FG000|Overall Study|Protocol Violation|4|||
147463643|NCT01850615|531857742|FG001|Overall Study|Protocol Violation|1|||
147463644|NCT01850615|531857741|FG000|Overall Study|Adverse Event|2|||
147463645|NCT01850615|531857742|FG001|Overall Study|Adverse Event|1|||
147463646|NCT01850615|531857741|FG000|Overall Study|Withdrawal by Subject|3|||
147463647|NCT01850615|531857742|FG001|Overall Study|Withdrawal by Subject|1|||
147463648|NCT01850615|531857741|FG000|Overall Study|Lost to Follow-up|0|||
147463649|NCT01850615|531857742|FG001|Overall Study|Lost to Follow-up|1|||
147463650|NCT01850615|531857741|FG000|Overall Study|Unclassified|0|||
147463651|NCT01850615|531857742|FG001|Overall Study|Unclassified|1|||
147463652|NCT00974220|531857743|FG000|Treatment Period 1|Adverse Event|2|||
147463653|NCT00974220|531857744|FG001|Treatment Period 1|Adverse Event|1|||
147463654|NCT00974220|531857743|FG000|Treatment Period 1|noncompliant subjects|0|||
147463655|NCT00974220|531857744|FG001|Treatment Period 1|noncompliant subjects|1|||
147463656|NCT00706628|531857745|FG000|Overall Study|Other Adverse Event|16|||
147463657|NCT00706628|531857746|FG001|Overall Study|Other Adverse Event|5|||
147463658|NCT00706628|531857747|FG002|Overall Study|Other Adverse Event|5|||
147463659|NCT00706628|531857748|FG003|Overall Study|Other Adverse Event|2|||
147463660|NCT00706628|531857745|FG000|Overall Study|Non compliant with protocol|0|||
147463661|NCT00706628|531857746|FG001|Overall Study|Non compliant with protocol|1|||
147463662|NCT00706628|531857747|FG002|Overall Study|Non compliant with protocol|0|||
147463663|NCT00706628|531857748|FG003|Overall Study|Non compliant with protocol|0|||
147463664|NCT00706628|531857745|FG000|Overall Study|Consent withdrawn|6|||
147463665|NCT00706628|531857746|FG001|Overall Study|Consent withdrawn|1|||
147463666|NCT00706628|531857747|FG002|Overall Study|Consent withdrawn|3|||
147463667|NCT00706628|531857748|FG003|Overall Study|Consent withdrawn|0|||
147463668|NCT00706628|531857745|FG000|Overall Study|Progressive disease|20|||
147463669|NCT00706628|531857746|FG001|Overall Study|Progressive disease|13|||
147463670|NCT00706628|531857747|FG002|Overall Study|Progressive disease|8|||
147463671|NCT00706628|531857748|FG003|Overall Study|Progressive disease|1|||
147463672|NCT00706628|531857745|FG000|Overall Study|Other than those stated above|4|||
147463673|NCT00706628|531857746|FG001|Overall Study|Other than those stated above|0|||
147463674|NCT00706628|531857747|FG002|Overall Study|Other than those stated above|0|||
147463675|NCT00706628|531857748|FG003|Overall Study|Other than those stated above|0|||
147463676|NCT00706628|531857745|FG000|Overall Study|Not treated|1|||
147463677|NCT00706628|531857746|FG001|Overall Study|Not treated|1|||
147463678|NCT00706628|531857747|FG002|Overall Study|Not treated|0|||
147463679|NCT00706628|531857748|FG003|Overall Study|Not treated|0|||
147463680|NCT03403400|531857749|FG000|Overall Study|Lost to Follow-up|1|||
147463681|NCT03403400|531857750|FG001|Overall Study|Lost to Follow-up|0|||
147463682|NCT03403400|531857751|FG002|Overall Study|Lost to Follow-up|1|||
147463683|NCT03403400|531857749|FG000|Overall Study|Hospitalization|1|||
147463684|NCT03403400|531857750|FG001|Overall Study|Hospitalization|0|||
147463685|NCT03403400|531857751|FG002|Overall Study|Hospitalization|0|||
147463686|NCT03403400|531857749|FG000|Overall Study|Benign Paroxysmal Positional Vertigo|0|||
147463687|NCT03403400|531857750|FG001|Overall Study|Benign Paroxysmal Positional Vertigo|0|||
147463688|NCT03403400|531857751|FG002|Overall Study|Benign Paroxysmal Positional Vertigo|1|||
147463689|NCT02266433|531857758|FG000|Overall Study|Lost to Follow-up|54|||
147463690|NCT02266433|531857759|FG001|Overall Study|Lost to Follow-up|46|||
147463691|NCT02266433|531857758|FG000|Overall Study|Withdrawal by Subject|5|||
147463692|NCT02266433|531857759|FG001|Overall Study|Withdrawal by Subject|7|||
147463693|NCT00565617|531857760|FG000|Overall Study|Withdrawal by Subject|1|||
147463694|NCT01512264|531857765|FG000|Overall Study|Lost to Follow-up|0|||
147463695|NCT01512264|531857766|FG001|Overall Study|Lost to Follow-up|0|||
147463696|NCT01512264|531857767|FG002|Overall Study|Lost to Follow-up|0|||
147463697|NCT01512264|531857768|FG003|Overall Study|Lost to Follow-up|1|||
147463698|NCT01194440|531857769|FG000|Baseline (First Dose)|Reason not specified|4|||
147463699|NCT01194440|531857769|FG000|Baseline (First Dose)|Lack of Efficacy|1|||
147463700|NCT01194440|531857769|FG000|Baseline (First Dose)|Change in therapy|1|||
147463701|NCT01194440|531857769|FG000|Baseline (First Dose)|Adverse Event|1|||
147463702|NCT01194440|531857769|FG000|6-months (2nd Dose)|Change in therapy|4|||
147463703|NCT00854828|531857770|FG000|Overall Study|Death|1|||
147463704|NCT00854828|531857771|FG001|Overall Study|Death|0|||
147463705|NCT00854828|531857772|FG002|Overall Study|Death|0|||
147463706|NCT00854828|531857773|FG003|Overall Study|Death|0|||
147463707|NCT00854828|531857770|FG000|Overall Study|Withdrawal by Subject|1|||
147463708|NCT00854828|531857771|FG001|Overall Study|Withdrawal by Subject|1|||
147463709|NCT00854828|531857772|FG002|Overall Study|Withdrawal by Subject|0|||
147463710|NCT00854828|531857773|FG003|Overall Study|Withdrawal by Subject|9|||
147463711|NCT00854828|531857770|FG000|Overall Study|Missed 24mo visit|1|||
147463712|NCT00854828|531857771|FG001|Overall Study|Missed 24mo visit|1|||
147463713|NCT00854828|531857772|FG002|Overall Study|Missed 24mo visit|8|||
147463714|NCT00854828|531857773|FG003|Overall Study|Missed 24mo visit|8|||
147463715|NCT01931059|531857774|FG000|Day 1|Pregnancy|0|||
147463716|NCT01931059|531857775|FG001|Day 1|Pregnancy|1|||
147463717|NCT01931059|531857774|FG000|Day3|Lost to Follow-up|1|||
147463718|NCT01931059|531857775|FG001|Day3|Lost to Follow-up|0|||
147463719|NCT02675075|531857776|FG000|Overall Study|Lost to Follow-up|3|||
147463720|NCT02675075|531857777|FG001|Overall Study|Lost to Follow-up|0|||
147463721|NCT02292212|531857778|FG000|ViE Phase|Withdrawal by Subject|1|||
147463722|NCT02292212|531857778|FG000|ViE Phase|Protocol Violation|2|||
147463723|NCT02411747|531857779|FG000|Overall Study|Withdrawal by Subject|1|||
147463724|NCT02411747|531857780|FG001|Overall Study|Withdrawal by Subject|0|||
147463725|NCT02411747|531857779|FG000|Overall Study|Protocol Violation|2|||
147463726|NCT02411747|531857780|FG001|Overall Study|Protocol Violation|4|||
147463727|NCT02149810|531857781|FG000|Overall Study|Physician Decision|1|||
147463728|NCT02149810|531857782|FG001|Overall Study|Physician Decision|2|||
147463729|NCT02149810|531857781|FG000|Overall Study|Lost to Follow-up|2|||
147463730|NCT02149810|531857782|FG001|Overall Study|Lost to Follow-up|1|||
147463731|NCT02149810|531857781|FG000|Overall Study|Withdrawal by Subject|5|||
147463732|NCT02149810|531857782|FG001|Overall Study|Withdrawal by Subject|1|||
147463733|NCT01176916|531857783|FG000|Overall Study|Adverse Event|61|||
147463734|NCT01176916|531857783|FG000|Overall Study|Death|1|||
147463735|NCT01176916|531857783|FG000|Overall Study|Lost to Follow-up|15|||
147463736|NCT01176916|531857783|FG000|Overall Study|Objective progression or relapse|17|||
147463737|NCT01176916|531857783|FG000|Overall Study|Protocol Violation|24|||
147463738|NCT01176916|531857783|FG000|Overall Study|Withdrawal by Subject|37|||
147463739|NCT01176916|531857783|FG000|Overall Study|Other|6|||
147463740|NCT01176916|531857783|FG000|Overall Study|Withdrawal prior to Treatment|6|||
147463741|NCT00675597|531857784|FG000|Overall Study|Withdrawal by Subject|3|||
147463742|NCT00705263|531857787|FG000|Overall Study|Withdrawal by Subject|2|||
147463743|NCT02440581|531857790|FG000|Overall Study|Death|0|||
147463744|NCT02440581|531857791|FG001|Overall Study|Death|0|||
147463745|NCT02440581|531857792|FG002|Overall Study|Death|7|||
147463746|NCT02440581|531857793|FG003|Overall Study|Death|5|||
147463747|NCT02440581|531857790|FG000|Overall Study|Transplanted|1|||
147463748|NCT02440581|531857791|FG001|Overall Study|Transplanted|0|||
147463749|NCT02440581|531857792|FG002|Overall Study|Transplanted|3|||
147463750|NCT02440581|531857793|FG003|Overall Study|Transplanted|2|||
147463751|NCT02440581|531857790|FG000|Overall Study|Withdrawal by Subject|4|||
147463752|NCT02440581|531857791|FG001|Overall Study|Withdrawal by Subject|11|||
147403591|NCT01952847|531640616|FG003|Overall Study|Lack of Insurance Coverage|0|||
147403592|NCT01952847|531640613|FG000|Overall Study|Withdrawal by Subject|1|||
147403593|NCT01952847|531640614|FG001|Overall Study|Withdrawal by Subject|1|||
147403594|NCT01952847|531640615|FG002|Overall Study|Withdrawal by Subject|0|||
147403595|NCT01952847|531640616|FG003|Overall Study|Withdrawal by Subject|1|||
147403596|NCT02367352|531640624|FG000|Overall Study|Progressive disease|7|||
147403597|NCT02367352|531640625|FG001|Overall Study|Progressive disease|0|||
147403598|NCT02367352|531640626|FG002|Overall Study|Progressive disease|0|||
147403599|NCT02367352|531640624|FG000|Overall Study|Participant Received Alternative Therapy|1|||
147403600|NCT02367352|531640625|FG001|Overall Study|Participant Received Alternative Therapy|0|||
147403601|NCT02367352|531640626|FG002|Overall Study|Participant Received Alternative Therapy|0|||
147403602|NCT02367352|531640624|FG000|Overall Study|Adverse Event|1|||
147403603|NCT02367352|531640625|FG001|Overall Study|Adverse Event|0|||
147403604|NCT02367352|531640626|FG002|Overall Study|Adverse Event|0|||
147403605|NCT01437423|531640627|FG000|Overall Study|Lost to Follow-up|12|||
147403606|NCT01437423|531640627|FG000|Overall Study|Off label usage|3|||
147403607|NCT05878873|531640628|FG000|Overall Study|Lost to Follow-up|2|||
147403608|NCT05878873|531640629|FG001|Overall Study|Lost to Follow-up|0|||
147463753|NCT02440581|531857792|FG002|Overall Study|Withdrawal by Subject|3|||
147463754|NCT02440581|531857793|FG003|Overall Study|Withdrawal by Subject|7|||
147463755|NCT05032950|531857795|FG000|Overall Study|Adverse Event|0|||
147463756|NCT05032950|531857796|FG001|Overall Study|Adverse Event|0|||
147463757|NCT05032950|531857797|FG002|Overall Study|Adverse Event|1|||
147463758|NCT05032950|531857798|FG003|Overall Study|Adverse Event|1|||
147463759|NCT05032950|531857799|FG004|Overall Study|Adverse Event|0|||
147463760|NCT05032950|531857800|FG005|Overall Study|Adverse Event|0|||
147463761|NCT02959814|531857801|FG000|Overall Study|Excluded based on diagnostic angiography|16|||
147463762|NCT02959814|531857801|FG000|Overall Study|Excluded based on anatomical criteria|2|||
147463763|NCT02959814|531857801|FG000|Overall Study|Protocol Violation|7|||
147463764|NCT02959814|531857801|FG000|Overall Study|FFR not measured|2|||
147463765|NCT02959814|531857801|FG000|Overall Study|In-procedure QFR not computed|6|||
147463766|NCT02959814|531857801|FG000|Overall Study|Excluded by FFR core-lab|24|||
147463767|NCT01245673|531857802|FG000|MAGE-A3, Hiltonol®, PVC After T Cells|Off Study due to Disease Progression|1|||
147463768|NCT01078805|531857812|FG000|Overall Study|Clinically significant abnormal lab|5|||
147463769|NCT01078805|531857812|FG000|Overall Study|Death|134|||
147463770|NCT01078805|531857812|FG000|Overall Study|Lost to Follow-up|676|||
147463771|NCT01078805|531857812|FG000|Overall Study|Physician Decision|169|||
147463772|NCT01078805|531857812|FG000|Overall Study|Serious adverse event|26|||
147463773|NCT01078805|531857812|FG000|Overall Study|Sponsor decision|46|||
147463774|NCT01078805|531857812|FG000|Overall Study|Withdrawal by Subject|739|||
147463775|NCT01078805|531857812|FG000|Overall Study|Other|173|||
147463776|NCT01078805|531857812|FG000|Overall Study|Didn't take study drug|82|||
147463777|NCT03641560|531857813|FG000|Overall Study|Withdrawal by Subject|6|||
147463778|NCT03641560|531857813|FG000|Overall Study|Progressive disease|40|||
147616117|NCT04604795|532409164|FG005|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
147616118|NCT04604795|532409165|FG006|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
147616119|NCT04604795|532409166|FG007|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
147403609|NCT02980523|531640630|FG000|Overall Study|Lost to Follow-up|1|||
147403610|NCT02980523|531640631|FG001|Overall Study|Lost to Follow-up|4|||
147403611|NCT02980523|531640632|FG002|Overall Study|Lost to Follow-up|1|||
147403612|NCT02980523|531640633|FG003|Overall Study|Lost to Follow-up|2|||
147403613|NCT02980523|531640634|FG004|Overall Study|Lost to Follow-up|1|||
147403614|NCT02980523|531640630|FG000|Overall Study|Excluded from analysis|1|||
147403615|NCT02980523|531640631|FG001|Overall Study|Excluded from analysis|3|||
147403616|NCT02980523|531640632|FG002|Overall Study|Excluded from analysis|1|||
147403617|NCT02980523|531640633|FG003|Overall Study|Excluded from analysis|1|||
147403618|NCT02980523|531640634|FG004|Overall Study|Excluded from analysis|1|||
147403619|NCT02980523|531640630|FG000|Overall Study|Lack of Efficacy|1|||
147403620|NCT02980523|531640631|FG001|Overall Study|Lack of Efficacy|4|||
147403621|NCT02980523|531640632|FG002|Overall Study|Lack of Efficacy|4|||
147403622|NCT02980523|531640633|FG003|Overall Study|Lack of Efficacy|5|||
147403623|NCT02980523|531640634|FG004|Overall Study|Lack of Efficacy|8|||
147403624|NCT02980523|531640630|FG000|Overall Study|Did not receive intervention|0|||
147403625|NCT02980523|531640631|FG001|Overall Study|Did not receive intervention|0|||
147403626|NCT02980523|531640632|FG002|Overall Study|Did not receive intervention|0|||
147403627|NCT02980523|531640633|FG003|Overall Study|Did not receive intervention|1|||
147403628|NCT02980523|531640634|FG004|Overall Study|Did not receive intervention|0|||
147403629|NCT00633945|531640635|FG000|Overall Study|Physician Decision|2|||
147403630|NCT02552147|531640636|FG000|First Intervention (7 Days)|Protocol Violation|1|||
147403631|NCT02552147|531640637|FG001|First Intervention (7 Days)|Protocol Violation|0|||
147403632|NCT02552147|531640636|FG000|Second Intervention (7 Days)|Protocol Violation|2|||
147403633|NCT02552147|531640637|FG001|Second Intervention (7 Days)|Protocol Violation|0|||
147403634|NCT01790295|531640638|FG000|Overall Study|Adverse Event|1|||
147403635|NCT01790295|531640638|FG000|Overall Study|Death|4|||
147403636|NCT01790295|531640638|FG000|Overall Study|Lack of Efficacy|2|||
147403637|NCT01790295|531640638|FG000|Overall Study|Study closure|4|||
147403638|NCT00443209|531640642|FG000|Months 1 to 12 Treatment Period|Adverse Event|22|||
147403639|NCT00443209|531640643|FG001|Months 1 to 12 Treatment Period|Adverse Event|11|||
147403640|NCT00443209|531640642|FG000|Months 1 to 12 Treatment Period|Protocol Violation|14|||
147403641|NCT00443209|531640643|FG001|Months 1 to 12 Treatment Period|Protocol Violation|7|||
147403642|NCT00443209|531640642|FG000|Months 1 to 12 Treatment Period|Lack of Efficacy|50|||
147403643|NCT00443209|531640643|FG001|Months 1 to 12 Treatment Period|Lack of Efficacy|11|||
147403644|NCT00443209|531640642|FG000|Months 1 to 12 Treatment Period|Lack of Qualifying Event|1|||
147403645|NCT00443209|531640643|FG001|Months 1 to 12 Treatment Period|Lack of Qualifying Event|1|||
147403646|NCT00443209|531640642|FG000|Months 1 to 12 Treatment Period|Lost to Follow-up|36|||
147403647|NCT00443209|531640643|FG001|Months 1 to 12 Treatment Period|Lost to Follow-up|15|||
147403648|NCT00443209|531640642|FG000|Months 1 to 12 Treatment Period|Physician Decision|8|||
147403649|NCT00443209|531640643|FG001|Months 1 to 12 Treatment Period|Physician Decision|4|||
147403650|NCT00443209|531640642|FG000|Months 1 to 12 Treatment Period|Pregnancy|3|||
147403651|NCT00443209|531640643|FG001|Months 1 to 12 Treatment Period|Pregnancy|4|||
147403652|NCT00443209|531640642|FG000|Months 1 to 12 Treatment Period|Trial Terminated|43|||
147403653|NCT00443209|531640643|FG001|Months 1 to 12 Treatment Period|Trial Terminated|23|||
147403654|NCT00443209|531640642|FG000|Months 1 to 12 Treatment Period|Withdrawal by Subject|95|||
147463779|NCT03641560|531857813|FG000|Overall Study|Death|6|||
147463780|NCT03219164|531860165|FG000|Overall Study|Study Terminated by Sponsor|16|||
147403655|NCT00443209|531640643|FG001|Months 1 to 12 Treatment Period|Withdrawal by Subject|34|||
147403656|NCT00443209|531640642|FG000|Months 1 to 12 Treatment Period|Missing|2|||
147403657|NCT00443209|531640643|FG001|Months 1 to 12 Treatment Period|Missing|1|||
147403658|NCT00443209|531640642|FG000|Months 1 to 12 Treatment Period|Not Treated|71|||
147403659|NCT00443209|531640643|FG001|Months 1 to 12 Treatment Period|Not Treated|43|||
147403660|NCT00443209|531640642|FG000|Months 13 to 18 Treatment Period|Adverse Event|1|||
147463781|NCT03219164|531860166|FG001|Overall Study|Study Terminated by Sponsor|12|||
147463782|NCT03219164|531860165|FG000|Overall Study|Withdrew Consent by Parent/Guardian|5|||
147463783|NCT03219164|531860166|FG001|Overall Study|Withdrew Consent by Parent/Guardian|4|||
147403661|NCT00443209|531640643|FG001|Months 13 to 18 Treatment Period|Adverse Event|0|||
147403662|NCT00443209|531640642|FG000|Months 13 to 18 Treatment Period|Protocol Violation|1|||
147403663|NCT00443209|531640643|FG001|Months 13 to 18 Treatment Period|Protocol Violation|0|||
147403664|NCT00443209|531640642|FG000|Months 13 to 18 Treatment Period|Lack of Efficacy|1|||
147403665|NCT00443209|531640643|FG001|Months 13 to 18 Treatment Period|Lack of Efficacy|0|||
147403666|NCT00443209|531640642|FG000|Months 13 to 18 Treatment Period|Lost to Follow-up|2|||
147403667|NCT00443209|531640643|FG001|Months 13 to 18 Treatment Period|Lost to Follow-up|2|||
147403668|NCT00443209|531640642|FG000|Months 13 to 18 Treatment Period|Trial Terminated|87|||
147403669|NCT00443209|531640643|FG001|Months 13 to 18 Treatment Period|Trial Terminated|43|||
147403670|NCT00443209|531640642|FG000|Months 13 to 18 Treatment Period|Withdrawal by Subject|7|||
147403671|NCT00443209|531640643|FG001|Months 13 to 18 Treatment Period|Withdrawal by Subject|2|||
147403672|NCT01318876|531640644|FG000|Day 8 Survey|email address invalid|96|||
147403673|NCT01318876|531640644|FG000|Day 8 Survey|survey not completed-don't know why|1724|||
147403674|NCT01318876|531640644|FG000|Day 29 Survey|survey not completed-don't know why|1825|||
147403675|NCT00825305|531640651|FG000|Overall Study|Adverse Event|1|||
147403676|NCT00825305|531640652|FG001|Overall Study|Adverse Event|1|||
147403677|NCT00825305|531640651|FG000|Overall Study|Withdrawal by Subject|6|||
147403678|NCT00825305|531640652|FG001|Overall Study|Withdrawal by Subject|12|||
147403679|NCT00825305|531640651|FG000|Overall Study|Inappropriate inclusion|1|||
147403680|NCT00825305|531640652|FG001|Overall Study|Inappropriate inclusion|0|||
147403681|NCT00825305|531640651|FG000|Overall Study|Protocol Violation|9|||
147403682|NCT00825305|531640652|FG001|Overall Study|Protocol Violation|9|||
147403683|NCT00825305|531640651|FG000|Overall Study|Can not be classified|0|||
147403684|NCT00825305|531640652|FG001|Overall Study|Can not be classified|1|||
147403685|NCT04016272|531640653|FG000|Overall Study|Withdrawal by Subject|1|||
147403686|NCT04016272|531640654|FG001|Overall Study|Withdrawal by Subject|2|||
147403687|NCT00246090|531640659|FG000|Overall Study|Adverse Event|25|||
147403688|NCT00246090|531640659|FG000|Overall Study|Withdrawal by Subject|7|||
147403689|NCT00246090|531640659|FG000|Overall Study|Progressive Disease|212|||
147403690|NCT00246090|531640659|FG000|Overall Study|Clinical Progression|30|||
147403691|NCT00246090|531640659|FG000|Overall Study|Physician Decision|11|||
147403692|NCT00246090|531640659|FG000|Overall Study|Not Otherwise Specified|10|||
147403693|NCT01827046|531640660|FG000|Overall Study|Lost to Follow-up|1|||
147403694|NCT01827046|531640661|FG001|Overall Study|Lost to Follow-up|5|||
147403695|NCT01827046|531640660|FG000|Overall Study|Withdrawal by Subject|0|||
147403696|NCT01827046|531640661|FG001|Overall Study|Withdrawal by Subject|4|||
147403697|NCT02554383|531640662|FG000|Overall Study|Ineligible|3|||
147403698|NCT02554383|531640663|FG001|Overall Study|Ineligible|2|||
147403699|NCT02554383|531640662|FG000|Overall Study|Parent completed 0 diaries by Day 4 and 0 diaries Days 5-11|8|||
147403700|NCT02554383|531640663|FG001|Overall Study|Parent completed 0 diaries by Day 4 and 0 diaries Days 5-11|6|||
147403701|NCT02554383|531640662|FG000|Overall Study|Parent completed 0 diaries by Day 4 and >=1 diary Days 5-11|0|||
147403702|NCT02554383|531640663|FG001|Overall Study|Parent completed 0 diaries by Day 4 and >=1 diary Days 5-11|2|||
147403703|NCT02554383|531640662|FG000|Overall Study|Parent completed >=1 diary by Day 4, but <2 diaries Days 2-4 or <3 diaries Days 5-11|12|||
147403704|NCT02554383|531640663|FG001|Overall Study|Parent completed >=1 diary by Day 4, but <2 diaries Days 2-4 or <3 diaries Days 5-11|9|||
147403705|NCT00715117|531640672|FG000|Overall Study|Crohn's flare and rescue with steroids|0|||
147403706|NCT00715117|531640673|FG001|Overall Study|Crohn's flare and rescue with steroids|1|||
147403707|NCT01191008|531640677|FG000|Overall Study|Protocol Violation|7|||
147403708|NCT01191008|531640677|FG000|Overall Study|Lost to Follow-up|8|||
147403709|NCT00978562|531640678|FG000|Overall Study|Withdrawal by participant before receiving study drug/imaging|2|||
147403710|NCT02394665|531640681|FG000|Overall Study|Physician Decision|1|||
147403711|NCT02394665|531640682|FG001|Overall Study|Physician Decision|0|||
147403712|NCT02394665|531640683|FG002|Overall Study|Physician Decision|0|||
147403713|NCT01310699|531640686|FG000|Overall Study|Patients did not complete tandem.|4|||
147403714|NCT01310699|531640687|FG001|Overall Study|Patients did not complete tandem.|6|||
147403715|NCT00926575|531640688|FG000|Overall Study|Adverse Event|1|||
147403716|NCT00926575|531640689|FG001|Overall Study|Adverse Event|1|||
147403717|NCT00926575|531640688|FG000|Overall Study|Death|4|||
147616120|NCT04604795|532409167|FG008|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|1|||
147616121|NCT04604795|532409168|FG009|Part C: Washout Period 4 (Up to Day 13)|Withdrawal by Subject|0|||
147403718|NCT00926575|531640689|FG001|Overall Study|Death|4|||
147403719|NCT00926575|531640688|FG000|Overall Study|Lost to Follow-up|1|||
147403720|NCT00926575|531640689|FG001|Overall Study|Lost to Follow-up|1|||
147403721|NCT00926575|531640688|FG000|Overall Study|Physician Decision|1|||
147403722|NCT00926575|531640689|FG001|Overall Study|Physician Decision|2|||
147403723|NCT00926575|531640688|FG000|Overall Study|Protocol Violation|1|||
147403724|NCT00926575|531640689|FG001|Overall Study|Protocol Violation|0|||
147403725|NCT00926575|531640688|FG000|Overall Study|Withdrawal by Subject|8|||
147403726|NCT00926575|531640689|FG001|Overall Study|Withdrawal by Subject|9|||
147403727|NCT00490698|531640690|FG000|Overall Study|Withdrawal by Subject|1|||
147403728|NCT00490698|531640690|FG000|Overall Study|Disease Progression|7|||
147403729|NCT00490698|531640690|FG000|Overall Study|Physician Decision|2|||
147403730|NCT00738283|531640696|FG000|Overall Study|Death|1|||
147616122|NCT04604795|532409159|FG000|Part C: Period 5 (Day 1)|Adverse Event|0|||
147403731|NCT00738283|531640696|FG000|Overall Study|Transfer to another facility|2|||
147403732|NCT00738283|531640696|FG000|Overall Study|Discharge home prior to end of study|1|||
147403733|NCT02282059|531640697|FG000|Overall Study|Other|15|||
147403734|NCT02282059|531640698|FG001|Overall Study|Other|3|||
147403735|NCT02282059|531640697|FG000|Overall Study|Participant refused further follow-up|8|||
147403736|NCT02282059|531640698|FG001|Overall Study|Participant refused further follow-up|4|||
147403737|NCT02282059|531640697|FG000|Overall Study|Lost to Follow-up|19|||
147403738|NCT02282059|531640698|FG001|Overall Study|Lost to Follow-up|3|||
147403739|NCT02282059|531640697|FG000|Overall Study|Death|40|||
147403740|NCT02282059|531640698|FG001|Overall Study|Death|8|||
147403741|NCT00334542|531642887|FG000|Overall Study|Adverse Event|3|||
147403742|NCT00334542|531642887|FG000|Overall Study|Withdrawal by Subject|1|||
147403743|NCT00334542|531642887|FG000|Overall Study|New cancer diagnosis|1|||
147403744|NCT01454739|531642892|FG000|Overall Study|Protocol Violation|2|||
147403745|NCT01454739|531642893|FG001|Overall Study|Protocol Violation|3|||
147403746|NCT01454739|531642892|FG000|Overall Study|Withdrawal by Subject|2|||
147403747|NCT01454739|531642893|FG001|Overall Study|Withdrawal by Subject|6|||
147403748|NCT01454739|531642892|FG000|Overall Study|Other|3|||
147403749|NCT01454739|531642893|FG001|Overall Study|Other|5|||
147403750|NCT01454739|531642892|FG000|Overall Study|Physician Decision|0|||
147403751|NCT01454739|531642893|FG001|Overall Study|Physician Decision|5|||
147403752|NCT01454739|531642892|FG000|Overall Study|Lost to Follow-up|0|||
147403753|NCT01454739|531642893|FG001|Overall Study|Lost to Follow-up|1|||
147403754|NCT01454739|531642892|FG000|Overall Study|Adverse Event|0|||
147403755|NCT01454739|531642893|FG001|Overall Study|Adverse Event|1|||
147403756|NCT01375751|531642894|FG000|Overall Study|Other|0|||
147403757|NCT01375751|531642895|FG001|Overall Study|Other|1|||
147403758|NCT01375751|531642896|FG002|Overall Study|Other|0|||
147403759|NCT02375347|531642898|FG000|Overall Study|Protocol Violation|1|||
147403760|NCT00193479|531642899|FG000|Induction Chemotherapy|Adverse Event|2|||
147403761|NCT00193479|531642899|FG000|Induction Chemotherapy|Disease Progression|1|||
147403762|NCT00193479|531642899|FG000|Maintenance Rituximab|Opted for full course rituximab/chemotherapy|2|||
147403763|NCT00193479|531642899|FG000|Maintenance Rituximab|Withdrawal by Subject|2|||
147403764|NCT00559377|531642901|FG000|Overall Study|Withdrawal by Subject|9|||
147403765|NCT02229227|531642907|FG000|Overall Study|Adverse Event|14|||
147403766|NCT02229227|531642908|FG001|Overall Study|Adverse Event|9|||
147403767|NCT02229227|531642907|FG000|Overall Study|Lack of Efficacy|3|||
147403768|NCT02229227|531642908|FG001|Overall Study|Lack of Efficacy|3|||
147403769|NCT02229227|531642907|FG000|Overall Study|Protocol Violation|6|||
147403770|NCT02229227|531642908|FG001|Overall Study|Protocol Violation|8|||
147403771|NCT02229227|531642907|FG000|Overall Study|Protocol defined stopping criteria|1|||
147403772|NCT02229227|531642908|FG001|Overall Study|Protocol defined stopping criteria|3|||
147403773|NCT02229227|531642907|FG000|Overall Study|Lost to Follow-up|3|||
147403774|NCT02229227|531642908|FG001|Overall Study|Lost to Follow-up|3|||
147403775|NCT02229227|531642907|FG000|Overall Study|Study terminated by sponsor|11|||
147403776|NCT02229227|531642908|FG001|Overall Study|Study terminated by sponsor|11|||
147403777|NCT02229227|531642907|FG000|Overall Study|Withdrawal by Subject|8|||
147403778|NCT02229227|531642908|FG001|Overall Study|Withdrawal by Subject|12|||
147403779|NCT02229227|531642907|FG000|Overall Study|Other|0|||
147403780|NCT02229227|531642908|FG001|Overall Study|Other|1|||
147403781|NCT02229227|531642907|FG000|Overall Study|Physician Decision|5|||
147403782|NCT02229227|531642908|FG001|Overall Study|Physician Decision|12|||
147403783|NCT00872001|531642909|FG000|Overall Study|Adverse Event|34|||
147403784|NCT00872001|531642910|FG001|Overall Study|Adverse Event|23|||
147403785|NCT00872001|531642909|FG000|Overall Study|Protocol Defined Clinical Event|5|||
147403786|NCT00872001|531642910|FG001|Overall Study|Protocol Defined Clinical Event|7|||
147403787|NCT00872001|531642909|FG000|Overall Study|Lost to Follow-up|13|||
147403788|NCT00872001|531642910|FG001|Overall Study|Lost to Follow-up|12|||
147403789|NCT00872001|531642909|FG000|Overall Study|Withdrawal by Subject|18|||
147403790|NCT00872001|531642910|FG001|Overall Study|Withdrawal by Subject|30|||
147403791|NCT00872001|531642909|FG000|Overall Study|Protocol Violation|5|||
147403792|NCT00872001|531642910|FG001|Overall Study|Protocol Violation|8|||
147403793|NCT00872001|531642909|FG000|Overall Study|Did Not Meet Protocol Eligibility|38|||
147403794|NCT00872001|531642910|FG001|Overall Study|Did Not Meet Protocol Eligibility|36|||
147403795|NCT00872001|531642909|FG000|Overall Study|Administrative|23|||
147403796|NCT00872001|531642910|FG001|Overall Study|Administrative|15|||
147403797|NCT01453023|531642913|FG000|Treatment Period (TP) 1|Protocol Violation|1|||
147403798|NCT01453023|531642914|FG001|Treatment Period (TP) 1|Protocol Violation|0|||
147463784|NCT03219164|531860165|FG000|Overall Study|Lost to Follow-up|1|||
147665270|NCT00922636|532599518|FG003|Overall Study|Parent/Caregiver Decision|5|||
147403799|NCT01453023|531642913|FG000|Treatment Period (TP) 1|Met Protocol-defined Stopping Criteria|0|||
147403800|NCT01453023|531642914|FG001|Treatment Period (TP) 1|Met Protocol-defined Stopping Criteria|1|||
147403801|NCT01453023|531642913|FG000|Treatment Period 2|Protocol Violation|0|||
147403802|NCT01453023|531642914|FG001|Treatment Period 2|Protocol Violation|1|||
147403803|NCT04468230|531642917|FG000|Overall Study|Adverse Event|2|||
147403804|NCT00420784|531642921|FG000|Overall Study|Adverse Event|11|||
147403805|NCT00420784|531642922|FG001|Overall Study|Adverse Event|29|||
147616123|NCT04604795|532409160|FG001|Part C: Period 5 (Day 1)|Adverse Event|0|||
147616124|NCT04604795|532409161|FG002|Part C: Period 5 (Day 1)|Adverse Event|0|||
147616125|NCT04604795|532409162|FG003|Part C: Period 5 (Day 1)|Adverse Event|0|||
147616126|NCT04604795|532409163|FG004|Part C: Period 5 (Day 1)|Adverse Event|0|||
147616127|NCT04604795|532409164|FG005|Part C: Period 5 (Day 1)|Adverse Event|0|||
147616128|NCT04604795|532409165|FG006|Part C: Period 5 (Day 1)|Adverse Event|0|||
147616129|NCT04604795|532409166|FG007|Part C: Period 5 (Day 1)|Adverse Event|0|||
147616130|NCT04604795|532409167|FG008|Part C: Period 5 (Day 1)|Adverse Event|1|||
147403806|NCT00420784|531642923|FG002|Overall Study|Adverse Event|10|||
147403807|NCT00420784|531642924|FG003|Overall Study|Adverse Event|5|||
147403808|NCT00420784|531642921|FG000|Overall Study|Withdrawal by Subject|0|||
147403809|NCT00420784|531642922|FG001|Overall Study|Withdrawal by Subject|1|||
147403810|NCT00420784|531642923|FG002|Overall Study|Withdrawal by Subject|0|||
147403811|NCT00420784|531642924|FG003|Overall Study|Withdrawal by Subject|0|||
147403812|NCT00420784|531642921|FG000|Overall Study|Lost to Follow-up|0|||
147403813|NCT00420784|531642922|FG001|Overall Study|Lost to Follow-up|0|||
147403814|NCT00420784|531642923|FG002|Overall Study|Lost to Follow-up|2|||
147403815|NCT00420784|531642924|FG003|Overall Study|Lost to Follow-up|1|||
147403816|NCT00420784|531642921|FG000|Overall Study|Virologic Stopping Rule|17|||
147403817|NCT00420784|531642922|FG001|Overall Study|Virologic Stopping Rule|26|||
147403818|NCT00420784|531642923|FG002|Overall Study|Virologic Stopping Rule|41|||
147403819|NCT00420784|531642924|FG003|Overall Study|Virologic Stopping Rule|67|||
147403820|NCT00420784|531642921|FG000|Overall Study|Other|1|||
147403821|NCT00420784|531642922|FG001|Overall Study|Other|2|||
147403822|NCT00420784|531642923|FG002|Overall Study|Other|0|||
147403823|NCT00420784|531642924|FG003|Overall Study|Other|5|||
147403824|NCT02417441|531642927|FG000|Overall Study|Inconclusive due to missing data|52|||
147403825|NCT02417441|531642928|FG001|Overall Study|Inconclusive due to missing data|19|||
147403826|NCT00983853|531642931|FG000|Overall Study|Lost to Follow-up|1|||
147403827|NCT00983853|531642932|FG001|Overall Study|Lost to Follow-up|1|||
147403828|NCT00983853|531642933|FG002|Overall Study|Lost to Follow-up|2|||
147403829|NCT00983853|531642934|FG003|Overall Study|Lost to Follow-up|2|||
147403830|NCT00983853|531642935|FG004|Overall Study|Lost to Follow-up|2|||
147403831|NCT00983853|531642936|FG005|Overall Study|Lost to Follow-up|1|||
147403832|NCT00983853|531642931|FG000|Overall Study|Withdrawal by Subject|0|||
147403833|NCT00983853|531642932|FG001|Overall Study|Withdrawal by Subject|0|||
147403834|NCT00983853|531642933|FG002|Overall Study|Withdrawal by Subject|1|||
147403835|NCT00983853|531642934|FG003|Overall Study|Withdrawal by Subject|0|||
147403836|NCT00983853|531642935|FG004|Overall Study|Withdrawal by Subject|1|||
147403837|NCT00983853|531642936|FG005|Overall Study|Withdrawal by Subject|0|||
147403838|NCT00983853|531642931|FG000|Overall Study|Unable to come to study follow-up visits|0|||
147403839|NCT00983853|531642932|FG001|Overall Study|Unable to come to study follow-up visits|1|||
147403840|NCT00983853|531642933|FG002|Overall Study|Unable to come to study follow-up visits|0|||
147403841|NCT00983853|531642934|FG003|Overall Study|Unable to come to study follow-up visits|0|||
147403842|NCT00983853|531642935|FG004|Overall Study|Unable to come to study follow-up visits|0|||
147403843|NCT00983853|531642936|FG005|Overall Study|Unable to come to study follow-up visits|0|||
147403844|NCT02599688|531642947|FG000|Overall Study|Lack of Efficacy|1|||
147403845|NCT02599688|531642947|FG000|Overall Study|Withdrawal by Subject|1|||
147403846|NCT02599688|531642947|FG000|Overall Study|Termination by Sponsor|2|||
147403847|NCT03016598|531642948|FG000|Overall Study|Lost to Follow-up|0|||
147403848|NCT03016598|531642949|FG001|Overall Study|Lost to Follow-up|2|||
147403849|NCT01667549|531642951|FG000|Overall Study|Withdrawal by Subject|3|||
147403850|NCT01667549|531642952|FG001|Overall Study|Withdrawal by Subject|5|||
147403851|NCT01667549|531642953|FG002|Overall Study|Withdrawal by Subject|7|||
147403852|NCT01667549|531642954|FG003|Overall Study|Withdrawal by Subject|6|||
147403853|NCT01667549|531642955|FG004|Overall Study|Withdrawal by Subject|1|||
147403854|NCT01407276|531642956|FG000|Overall Study|Withdrawal by Subject|0|||
147403855|NCT01407276|531642957|FG001|Overall Study|Withdrawal by Subject|0|||
147403856|NCT01407276|531642958|FG002|Overall Study|Withdrawal by Subject|0|||
147403857|NCT01407276|531642959|FG003|Overall Study|Withdrawal by Subject|0|||
147403858|NCT01407276|531642960|FG004|Overall Study|Withdrawal by Subject|0|||
147403859|NCT01407276|531642961|FG005|Overall Study|Withdrawal by Subject|0|||
147403860|NCT01407276|531642962|FG006|Overall Study|Withdrawal by Subject|0|||
147403861|NCT01407276|531642963|FG007|Overall Study|Withdrawal by Subject|1|||
147403862|NCT00478205|531642966|FG000|Overall Study|Adverse Event|182|||
147403863|NCT00478205|531642967|FG001|Overall Study|Adverse Event|39|||
147403864|NCT00478205|531642966|FG000|Overall Study|Medication Non-compliance|9|||
147403865|NCT00478205|531642967|FG001|Overall Study|Medication Non-compliance|4|||
147403866|NCT00478205|531642966|FG000|Overall Study|Protocol Violation|15|||
147403867|NCT00478205|531642967|FG001|Overall Study|Protocol Violation|5|||
147403868|NCT00478205|531642966|FG000|Overall Study|Request of Investigator or Sponsor|4|||
147403869|NCT00478205|531642967|FG001|Overall Study|Request of Investigator or Sponsor|5|||
147616131|NCT04604795|532409168|FG009|Part C: Period 5 (Day 1)|Adverse Event|0|||
147643999|NCT01447446|532516691|FG005|Overall Study|Administrative/Other|4|||
147403870|NCT00478205|531642966|FG000|Overall Study|Withdrawal by Subject|61|||
147403871|NCT00478205|531642967|FG001|Overall Study|Withdrawal by Subject|22|||
147644000|NCT01447446|532516686|FG000|Overall Study|SVR12 Assessment|13|||
147403872|NCT00478205|531642966|FG000|Overall Study|Lack of Efficacy|1|||
147403873|NCT00478205|531642967|FG001|Overall Study|Lack of Efficacy|0|||
147403874|NCT00478205|531642966|FG000|Overall Study|Other|24|||
147403875|NCT00478205|531642967|FG001|Overall Study|Other|12|||
147403876|NCT04092452|531642968|FG000|Overall Study|Adverse Event|1|||
147403877|NCT04092452|531642969|FG001|Overall Study|Adverse Event|3|||
147403878|NCT04092452|531642970|FG002|Overall Study|Adverse Event|3|||
147403879|NCT04092452|531642971|FG003|Overall Study|Adverse Event|7|||
147403880|NCT04092452|531642968|FG000|Overall Study|Lack of Efficacy|1|||
147403881|NCT04092452|531642969|FG001|Overall Study|Lack of Efficacy|1|||
147403882|NCT04092452|531642970|FG002|Overall Study|Lack of Efficacy|1|||
147403883|NCT04092452|531642971|FG003|Overall Study|Lack of Efficacy|0|||
147403884|NCT04092452|531642968|FG000|Overall Study|Lost to Follow-up|4|||
147403885|NCT04092452|531642969|FG001|Overall Study|Lost to Follow-up|3|||
147403886|NCT04092452|531642970|FG002|Overall Study|Lost to Follow-up|5|||
147403887|NCT04092452|531642971|FG003|Overall Study|Lost to Follow-up|1|||
147403888|NCT04092452|531642968|FG000|Overall Study|Non-Compliance With Study Drug|0|||
147403889|NCT04092452|531642969|FG001|Overall Study|Non-Compliance With Study Drug|0|||
147403890|NCT04092452|531642970|FG002|Overall Study|Non-Compliance With Study Drug|1|||
147403891|NCT04092452|531642971|FG003|Overall Study|Non-Compliance With Study Drug|1|||
147403892|NCT04092452|531642968|FG000|Overall Study|Physician Decision|1|||
147403893|NCT04092452|531642969|FG001|Overall Study|Physician Decision|0|||
147403894|NCT04092452|531642970|FG002|Overall Study|Physician Decision|1|||
147403895|NCT04092452|531642971|FG003|Overall Study|Physician Decision|0|||
147403896|NCT04092452|531642968|FG000|Overall Study|Pregnancy|2|||
147403897|NCT04092452|531642969|FG001|Overall Study|Pregnancy|0|||
147403898|NCT04092452|531642970|FG002|Overall Study|Pregnancy|0|||
147403899|NCT04092452|531642971|FG003|Overall Study|Pregnancy|0|||
147403900|NCT04092452|531642968|FG000|Overall Study|Protocol Deviation|1|||
147403901|NCT04092452|531642969|FG001|Overall Study|Protocol Deviation|0|||
147403902|NCT04092452|531642970|FG002|Overall Study|Protocol Deviation|0|||
147403903|NCT04092452|531642971|FG003|Overall Study|Protocol Deviation|0|||
147403904|NCT04092452|531642968|FG000|Overall Study|Withdrawal by Subject|3|||
147403905|NCT04092452|531642969|FG001|Overall Study|Withdrawal by Subject|10|||
147403906|NCT04092452|531642970|FG002|Overall Study|Withdrawal by Subject|3|||
147403907|NCT04092452|531642971|FG003|Overall Study|Withdrawal by Subject|5|||
147403908|NCT04092452|531642968|FG000|Overall Study|Other|0|||
147403909|NCT04092452|531642969|FG001|Overall Study|Other|0|||
147403910|NCT04092452|531642970|FG002|Overall Study|Other|1|||
147403911|NCT04092452|531642971|FG003|Overall Study|Other|2|||
147403912|NCT01012947|531642980|FG000|Overall Study|Lost to Follow-up|131|||
147403913|NCT01012947|531642981|FG001|Overall Study|Lost to Follow-up|135|||
147403914|NCT01012947|531642982|FG002|Overall Study|Lost to Follow-up|130|||
147403915|NCT01012947|531642983|FG003|Overall Study|Lost to Follow-up|118|||
147403916|NCT01012947|531642984|FG004|Overall Study|Lost to Follow-up|142|||
147403917|NCT02127125|531642985|FG000|Overall Study|Lost to Follow-up|0|||
147403918|NCT02127125|531642986|FG001|Overall Study|Lost to Follow-up|0|||
147403919|NCT02127125|531642987|FG002|Overall Study|Lost to Follow-up|0|||
147403920|NCT02127125|531642988|FG003|Overall Study|Lost to Follow-up|0|||
147403921|NCT02127125|531642989|FG004|Overall Study|Lost to Follow-up|2|||
147403922|NCT02127125|531642990|FG005|Overall Study|Lost to Follow-up|1|||
147403923|NCT02127125|531642991|FG006|Overall Study|Lost to Follow-up|0|||
147403924|NCT02127125|531642992|FG007|Overall Study|Lost to Follow-up|0|||
147403925|NCT02127125|531642993|FG008|Overall Study|Lost to Follow-up|0|||
147403926|NCT02127125|531642985|FG000|Overall Study|Withdrawal by Subject|0|||
147403927|NCT02127125|531642986|FG001|Overall Study|Withdrawal by Subject|0|||
147403928|NCT02127125|531642987|FG002|Overall Study|Withdrawal by Subject|0|||
147403929|NCT02127125|531642988|FG003|Overall Study|Withdrawal by Subject|1|||
147403930|NCT02127125|531642989|FG004|Overall Study|Withdrawal by Subject|0|||
147403931|NCT02127125|531642990|FG005|Overall Study|Withdrawal by Subject|0|||
147403932|NCT02127125|531642991|FG006|Overall Study|Withdrawal by Subject|0|||
147403933|NCT02127125|531642992|FG007|Overall Study|Withdrawal by Subject|0|||
147403934|NCT02127125|531642993|FG008|Overall Study|Withdrawal by Subject|0|||
147403935|NCT02127125|531642985|FG000|Overall Study|Physician Decision|0|||
147403936|NCT02127125|531642986|FG001|Overall Study|Physician Decision|0|||
147403937|NCT02127125|531642987|FG002|Overall Study|Physician Decision|1|||
147403938|NCT02127125|531642988|FG003|Overall Study|Physician Decision|0|||
147403939|NCT02127125|531642989|FG004|Overall Study|Physician Decision|1|||
147403940|NCT02127125|531642990|FG005|Overall Study|Physician Decision|2|||
147403941|NCT02127125|531642991|FG006|Overall Study|Physician Decision|0|||
147403942|NCT02127125|531642992|FG007|Overall Study|Physician Decision|0|||
147403943|NCT02127125|531642993|FG008|Overall Study|Physician Decision|0|||
147403944|NCT02493946|531642997|FG000|DB Period|Withdrawal by Subject|8|||
147403945|NCT02493946|531642998|FG001|DB Period|Withdrawal by Subject|5|||
147403946|NCT02493946|531642999|FG002|DB Period|Withdrawal by Subject|0|||
147403947|NCT02493946|531642997|FG000|Open Label Period|Withdrawal by Subject|0|||
147403948|NCT02493946|531642998|FG001|Open Label Period|Withdrawal by Subject|0|||
147403949|NCT02493946|531642999|FG002|Open Label Period|Withdrawal by Subject|74|||
147403950|NCT02493946|531642997|FG000|Open Label Period|Adverse Event|0|||
147403951|NCT02493946|531642998|FG001|Open Label Period|Adverse Event|0|||
147403952|NCT02493946|531642999|FG002|Open Label Period|Adverse Event|4|||
147403953|NCT02493946|531642997|FG000|Open Label Period|Lost to Follow-up|0|||
147403954|NCT02493946|531642998|FG001|Open Label Period|Lost to Follow-up|0|||
147403955|NCT02493946|531642999|FG002|Open Label Period|Lost to Follow-up|1|||
147403956|NCT02493946|531642997|FG000|Open Label Period|Investigator decision, non-compliance|0|||
147403957|NCT02493946|531642998|FG001|Open Label Period|Investigator decision, non-compliance|0|||
147403958|NCT02493946|531642999|FG002|Open Label Period|Investigator decision, non-compliance|2|||
147403959|NCT02493946|531642997|FG000|Open Label Period|Investigator decision, non-availability|0|||
147403960|NCT02493946|531642998|FG001|Open Label Period|Investigator decision, non-availability|0|||
147403961|NCT02493946|531642999|FG002|Open Label Period|Investigator decision, non-availability|1|||
147403962|NCT02493946|531642997|FG000|Open Label Period|Pregnancy|0|||
147403963|NCT02493946|531642998|FG001|Open Label Period|Pregnancy|0|||
147403964|NCT02493946|531642999|FG002|Open Label Period|Pregnancy|3|||
147403965|NCT02493946|531642997|FG000|Open Label Period|Site error|0|||
147403966|NCT02493946|531642998|FG001|Open Label Period|Site error|0|||
147403967|NCT02493946|531642999|FG002|Open Label Period|Site error|1|||
147403968|NCT03332784|531643002|FG000|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
147403969|NCT03332784|531643003|FG001|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|1|||
147403970|NCT03332784|531643004|FG002|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
147403971|NCT03332784|531643005|FG003|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
147403972|NCT03332784|531643006|FG004|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
147403973|NCT03332784|531643007|FG005|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
147403974|NCT03332784|531643008|FG006|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
147403975|NCT03332784|531643009|FG007|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
147403976|NCT03332784|531643010|FG008|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
147403977|NCT03332784|531643011|FG009|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
147403978|NCT03332784|531643012|FG010|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
147403979|NCT03332784|531643013|FG011|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
147403980|NCT03332784|531643014|FG012|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
147403981|NCT03332784|531643015|FG013|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
147403982|NCT03332784|531643016|FG014|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|1|||
147403983|NCT03332784|531643017|FG015|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
147403984|NCT03332784|531643018|FG016|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
147403985|NCT03332784|531643019|FG017|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
147403986|NCT03332784|531643020|FG018|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
147403987|NCT03332784|531643021|FG019|Parts 1 and 2 - Period 1 (1 Day)|Adverse Event|0|||
147403988|NCT01018732|531643035|FG000|Overall Study|Lost to Follow-up|0|||
147403989|NCT01018732|531643036|FG001|Overall Study|Lost to Follow-up|0|||
147403990|NCT01018732|531643037|FG002|Overall Study|Lost to Follow-up|3|||
147403991|NCT01018732|531643035|FG000|Overall Study|Protocol Violation|1|||
147403992|NCT01018732|531643036|FG001|Overall Study|Protocol Violation|1|||
147403993|NCT01018732|531643037|FG002|Overall Study|Protocol Violation|0|||
147403994|NCT01018732|531643035|FG000|Overall Study|Inappropriate Enrollment|0|||
147403995|NCT01018732|531643036|FG001|Overall Study|Inappropriate Enrollment|1|||
147403996|NCT01018732|531643037|FG002|Overall Study|Inappropriate Enrollment|0|||
147403997|NCT01018732|531643035|FG000|Overall Study|Unable to Classify|0|||
147403998|NCT01018732|531643036|FG001|Overall Study|Unable to Classify|0|||
147403999|NCT01018732|531643037|FG002|Overall Study|Unable to Classify|1|||
147404000|NCT01536171|531643038|FG000|Overall Study|Withdrawal by Subject|1|||
147404001|NCT02781311|531643041|FG000|Overall Study|Adverse Event|2|||
147404002|NCT02781311|531643042|FG001|Overall Study|Adverse Event|6|||
147404003|NCT02781311|531643043|FG002|Overall Study|Adverse Event|1|||
147404004|NCT02781311|531643041|FG000|Overall Study|Withdrawal of Consent|11|||
147404005|NCT02781311|531643042|FG001|Overall Study|Withdrawal of Consent|12|||
147404006|NCT02781311|531643043|FG002|Overall Study|Withdrawal of Consent|2|||
147404007|NCT02781311|531643041|FG000|Overall Study|Lost to Follow-up|11|||
147404008|NCT02781311|531643042|FG001|Overall Study|Lost to Follow-up|8|||
147404009|NCT02781311|531643043|FG002|Overall Study|Lost to Follow-up|1|||
147404010|NCT02781311|531643041|FG000|Overall Study|Non-Compliance with Study Drug|2|||
147404011|NCT02781311|531643042|FG001|Overall Study|Non-Compliance with Study Drug|0|||
147404012|NCT02781311|531643043|FG002|Overall Study|Non-Compliance with Study Drug|0|||
147404013|NCT02165826|531643044|FG000|Main Treatment Period|Pre-treatment Event/Adverse Event|44|||
147404014|NCT02165826|531643045|FG001|Main Treatment Period|Pre-treatment Event/Adverse Event|57|||
147404015|NCT02165826|531643046|FG002|Main Treatment Period|Pre-treatment Event/Adverse Event|68|||
147404016|NCT02165826|531643044|FG000|Main Treatment Period|Major/Significant Protocol Deviation|0|||
147404017|NCT02165826|531643045|FG001|Main Treatment Period|Major/Significant Protocol Deviation|1|||
147404018|NCT02165826|531643046|FG002|Main Treatment Period|Major/Significant Protocol Deviation|3|||
147404019|NCT02165826|531643044|FG000|Main Treatment Period|Lost to Follow-up|4|||
147404020|NCT02165826|531643045|FG001|Main Treatment Period|Lost to Follow-up|2|||
147404021|NCT02165826|531643046|FG002|Main Treatment Period|Lost to Follow-up|1|||
147463785|NCT03219164|531860166|FG001|Overall Study|Lost to Follow-up|1|||
147463786|NCT03219164|531860165|FG000|Overall Study|Adverse Event|1|||
147404022|NCT02165826|531643044|FG000|Main Treatment Period|Voluntary Withdrawal|23|||
147404023|NCT02165826|531643045|FG001|Main Treatment Period|Voluntary Withdrawal|23|||
147404024|NCT02165826|531643046|FG002|Main Treatment Period|Voluntary Withdrawal|21|||
147404025|NCT02165826|531643044|FG000|Main Treatment Period|Lack of Efficacy|2|||
147404026|NCT02165826|531643045|FG001|Main Treatment Period|Lack of Efficacy|0|||
147404027|NCT02165826|531643046|FG002|Main Treatment Period|Lack of Efficacy|0|||
147404028|NCT02165826|531643044|FG000|Main Treatment Period|Reason Not Specified|8|||
147404029|NCT02165826|531643045|FG001|Main Treatment Period|Reason Not Specified|5|||
147404030|NCT02165826|531643046|FG002|Main Treatment Period|Reason Not Specified|16|||
147404031|NCT02165826|531643044|FG000|Main Treatment Period|Did Not Receive Study Drug|0|||
147404032|NCT02165826|531643045|FG001|Main Treatment Period|Did Not Receive Study Drug|2|||
147404033|NCT02165826|531643046|FG002|Main Treatment Period|Did Not Receive Study Drug|0|||
147404034|NCT02165826|531643044|FG000|Down-Titration Period|Pre-treatment Event/Adverse Event|4|||
147404035|NCT02165826|531643045|FG001|Down-Titration Period|Pre-treatment Event/Adverse Event|10|||
147404036|NCT02165826|531643046|FG002|Down-Titration Period|Pre-treatment Event/Adverse Event|3|||
147404037|NCT02165826|531643044|FG000|Down-Titration Period|Voluntary Withdrawal|2|||
147404038|NCT02165826|531643045|FG001|Down-Titration Period|Voluntary Withdrawal|1|||
147404039|NCT02165826|531643046|FG002|Down-Titration Period|Voluntary Withdrawal|2|||
147404040|NCT02165826|531643044|FG000|Down-Titration Period|Reason Not Specified|1|||
147404041|NCT02165826|531643045|FG001|Down-Titration Period|Reason Not Specified|0|||
147404042|NCT02165826|531643046|FG002|Down-Titration Period|Reason Not Specified|2|||
147404043|NCT00250432|531643049|FG000|Overall Study|Adverse Event|25|||
147404044|NCT00250432|531643050|FG001|Overall Study|Adverse Event|29|||
147404045|NCT00250432|531643049|FG000|Overall Study|Lack of Efficacy|2|||
147404046|NCT00250432|531643050|FG001|Overall Study|Lack of Efficacy|1|||
147404047|NCT00250432|531643049|FG000|Overall Study|Lost to Follow-up|6|||
147404048|NCT00250432|531643050|FG001|Overall Study|Lost to Follow-up|5|||
147404049|NCT00250432|531643049|FG000|Overall Study|Patient Moved|0|||
147404050|NCT00250432|531643050|FG001|Overall Study|Patient Moved|1|||
147404051|NCT00250432|531643049|FG000|Overall Study|Protocol Violation|0|||
147404052|NCT00250432|531643050|FG001|Overall Study|Protocol Violation|3|||
147404053|NCT00250432|531643049|FG000|Overall Study|Withdrawal by Subject|6|||
147404054|NCT00250432|531643050|FG001|Overall Study|Withdrawal by Subject|2|||
147404055|NCT00250432|531643049|FG000|Overall Study|Pt died out of posttherapy report period|6|||
147404056|NCT00250432|531643050|FG001|Overall Study|Pt died out of posttherapy report period|5|||
147404057|NCT00250432|531643049|FG000|Overall Study|Pt was considered untreatable|0|||
147404058|NCT00250432|531643050|FG001|Overall Study|Pt was considered untreatable|1|||
147404059|NCT01255761|531643051|FG000|Overall Study|Adverse Event|29|||
147404060|NCT01255761|531643052|FG001|Overall Study|Adverse Event|43|||
147404061|NCT01255761|531643051|FG000|Overall Study|Lack of Efficacy|86|||
147404062|NCT01255761|531643052|FG001|Overall Study|Lack of Efficacy|74|||
147404063|NCT01255761|531643051|FG000|Overall Study|Protocol Violation|9|||
147404064|NCT01255761|531643052|FG001|Overall Study|Protocol Violation|5|||
147404065|NCT01255761|531643051|FG000|Overall Study|Lost to Follow-up|10|||
147404066|NCT01255761|531643052|FG001|Overall Study|Lost to Follow-up|8|||
147404067|NCT01255761|531643051|FG000|Overall Study|Withdrawal by Subject|11|||
147404068|NCT01255761|531643052|FG001|Overall Study|Withdrawal by Subject|27|||
147404069|NCT01255761|531643051|FG000|Overall Study|Other Reasons|37|||
147404070|NCT01255761|531643052|FG001|Overall Study|Other Reasons|18|||
147404071|NCT04147858|531643054|FG000|Overall Study|Adverse Event|6|||
147404072|NCT04147858|531643055|FG001|Overall Study|Adverse Event|6|||
147404073|NCT04147858|531643056|FG002|Overall Study|Adverse Event|6|||
147404074|NCT04147858|531643054|FG000|Overall Study|Lack of Efficacy|3|||
147404075|NCT04147858|531643055|FG001|Overall Study|Lack of Efficacy|3|||
147404076|NCT04147858|531643056|FG002|Overall Study|Lack of Efficacy|1|||
147404077|NCT04147858|531643054|FG000|Overall Study|Lost to Follow-up|1|||
147404078|NCT04147858|531643055|FG001|Overall Study|Lost to Follow-up|6|||
147404079|NCT04147858|531643056|FG002|Overall Study|Lost to Follow-up|2|||
147404080|NCT04147858|531643054|FG000|Overall Study|Withdrawal by Subject|3|||
147404081|NCT04147858|531643055|FG001|Overall Study|Withdrawal by Subject|4|||
147404082|NCT04147858|531643056|FG002|Overall Study|Withdrawal by Subject|10|||
147404083|NCT04147858|531643054|FG000|Overall Study|Subject Noncompliance, Other|4|||
147404084|NCT04147858|531643055|FG001|Overall Study|Subject Noncompliance, Other|3|||
147404085|NCT04147858|531643056|FG002|Overall Study|Subject Noncompliance, Other|1|||
147404086|NCT02336425|531643057|FG000|Overall Study|Study terminated.|2|||
147404087|NCT02336425|531643058|FG001|Overall Study|Study terminated.|2|||
147404088|NCT02336425|531643059|FG002|Overall Study|Study terminated.|3|||
147404089|NCT02336425|531643060|FG003|Overall Study|Study terminated.|3|||
147404090|NCT00658606|531643063|FG000|Overall Study|Adverse Event|2|||
147404091|NCT00658606|531643064|FG001|Overall Study|Adverse Event|1|||
147404092|NCT00658606|531643063|FG000|Overall Study|Lack of Efficacy|6|||
147404093|NCT00658606|531643064|FG001|Overall Study|Lack of Efficacy|3|||
147404094|NCT00658606|531643063|FG000|Overall Study|Lost to Follow-up|1|||
147404095|NCT00658606|531643064|FG001|Overall Study|Lost to Follow-up|0|||
147404096|NCT00658606|531643063|FG000|Overall Study|Withdrawal by Subject|7|||
147404097|NCT00658606|531643064|FG001|Overall Study|Withdrawal by Subject|16|||
147463787|NCT03219164|531860166|FG001|Overall Study|Adverse Event|0|||
147463788|NCT03219164|531860165|FG000|Overall Study|Non-Compliance with Study Drug|1|||
147463789|NCT03219164|531860166|FG001|Overall Study|Non-Compliance with Study Drug|0|||
147463790|NCT03219164|531860165|FG000|Overall Study|Protocol Violation|0|||
147463791|NCT03219164|531860166|FG001|Overall Study|Protocol Violation|1|||
147463792|NCT03219164|531860165|FG000|Overall Study|Withdrew Assent|1|||
147463793|NCT03219164|531860166|FG001|Overall Study|Withdrew Assent|0|||
147463794|NCT02689492|531860167|FG000|Overall Study|Lost to Follow-up|61|||
147463795|NCT02689492|531860167|FG000|Overall Study|Withdrawal by Subject|11|||
147463796|NCT02689492|531860167|FG000|Overall Study|Death|9|||
147463797|NCT02689492|531860167|FG000|Overall Study|Physician Decision|2|||
147463798|NCT02689492|531860167|FG000|Overall Study|Withdrawal/Loss To Follow-Up|1|||
147463799|NCT02689492|531860167|FG000|Overall Study|Withdrawal/ Physician's Decision|1|||
147463800|NCT02689492|531860167|FG000|Overall Study|Other than listed|1|||
147463801|NCT02732951|531860168|FG000|Overall Study|Other than listed|1|||
147463802|NCT02732951|531860169|FG001|Overall Study|Other than listed|0|||
147463803|NCT02732951|531860168|FG000|Overall Study|Lost to Follow-up|0|||
147463804|NCT02732951|531860169|FG001|Overall Study|Lost to Follow-up|1|||
147463805|NCT02732951|531860168|FG000|Overall Study|Adverse Event|4|||
147463806|NCT02732951|531860169|FG001|Overall Study|Adverse Event|4|||
147463807|NCT02732951|531860168|FG000|Overall Study|Protocol Violation|0|||
147463808|NCT02732951|531860169|FG001|Overall Study|Protocol Violation|1|||
147463809|NCT01750918|531860170|FG000|Overall Study|Last patient transitioned to a rollover protocol|0|||
147463810|NCT01750918|531860171|FG001|Overall Study|Last patient transitioned to a rollover protocol|0|||
147463811|NCT01750918|531860172|FG002|Overall Study|Last patient transitioned to a rollover protocol|5|||
147463812|NCT01750918|531860173|FG003|Overall Study|Last patient transitioned to a rollover protocol|2|||
147463813|NCT01750918|531860174|FG004|Overall Study|Last patient transitioned to a rollover protocol|0|||
147463814|NCT01750918|531860175|FG005|Overall Study|Last patient transitioned to a rollover protocol|2|||
147463815|NCT01750918|531860176|FG006|Overall Study|Last patient transitioned to a rollover protocol|1|||
147463816|NCT01750918|531860177|FG007|Overall Study|Last patient transitioned to a rollover protocol|1|||
147463817|NCT01750918|531860170|FG000|Overall Study|Lost to Follow-up|0|||
147463818|NCT01750918|531860171|FG001|Overall Study|Lost to Follow-up|0|||
147463819|NCT01750918|531860172|FG002|Overall Study|Lost to Follow-up|2|||
147463820|NCT01750918|531860173|FG003|Overall Study|Lost to Follow-up|2|||
147463821|NCT01750918|531860174|FG004|Overall Study|Lost to Follow-up|0|||
147463822|NCT01750918|531860175|FG005|Overall Study|Lost to Follow-up|0|||
147463823|NCT01750918|531860176|FG006|Overall Study|Lost to Follow-up|0|||
147463824|NCT01750918|531860177|FG007|Overall Study|Lost to Follow-up|1|||
147463825|NCT01750918|531860170|FG000|Overall Study|Withdrawal by Subject|0|||
147463826|NCT01750918|531860171|FG001|Overall Study|Withdrawal by Subject|0|||
147463827|NCT01750918|531860172|FG002|Overall Study|Withdrawal by Subject|1|||
147463828|NCT01750918|531860173|FG003|Overall Study|Withdrawal by Subject|2|||
147463829|NCT01750918|531860174|FG004|Overall Study|Withdrawal by Subject|1|||
147463830|NCT01750918|531860175|FG005|Overall Study|Withdrawal by Subject|1|||
147463831|NCT01750918|531860176|FG006|Overall Study|Withdrawal by Subject|2|||
147463832|NCT01750918|531860177|FG007|Overall Study|Withdrawal by Subject|2|||
147463833|NCT05047523|531860189|FG000|Primary Evaluation Period (48 Weeks)|Physician Decision|0|||
147463834|NCT05047523|531860190|FG001|Primary Evaluation Period (48 Weeks)|Physician Decision|0|||
147463835|NCT05047523|531860191|FG002|Primary Evaluation Period (48 Weeks)|Physician Decision|1|||
147463836|NCT05047523|531860192|FG003|Primary Evaluation Period (48 Weeks)|Physician Decision|0|||
147463837|NCT05047523|531860193|FG004|Primary Evaluation Period (48 Weeks)|Physician Decision|0|||
147463838|NCT05047523|531860194|FG005|Primary Evaluation Period (48 Weeks)|Physician Decision|0|||
147463839|NCT05047523|531860189|FG000|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
147463840|NCT05047523|531860190|FG001|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|1|||
147463841|NCT05047523|531860191|FG002|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
147463842|NCT05047523|531860192|FG003|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
147463843|NCT05047523|531860193|FG004|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
147463844|NCT05047523|531860194|FG005|Primary Evaluation Period (48 Weeks)|Withdrawal by Subject|0|||
147463845|NCT05047523|531860189|FG000|Primary Evaluation Period (48 Weeks)|Study Terminated by Sponsor|2|||
147463846|NCT05047523|531860190|FG001|Primary Evaluation Period (48 Weeks)|Study Terminated by Sponsor|4|||
147463847|NCT05047523|531860191|FG002|Primary Evaluation Period (48 Weeks)|Study Terminated by Sponsor|3|||
147463848|NCT05047523|531860192|FG003|Primary Evaluation Period (48 Weeks)|Study Terminated by Sponsor|4|||
147463849|NCT05047523|531860193|FG004|Primary Evaluation Period (48 Weeks)|Study Terminated by Sponsor|0|||
147463850|NCT05047523|531860194|FG005|Primary Evaluation Period (48 Weeks)|Study Terminated by Sponsor|0|||
147463851|NCT05047523|531860189|FG000|Primary Evaluation Period (48 Weeks)|Adverse Event|1|||
147463852|NCT05047523|531860190|FG001|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
147463853|NCT05047523|531860191|FG002|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
147463854|NCT05047523|531860192|FG003|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
147463855|NCT05047523|531860193|FG004|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
147665271|NCT00922636|532599519|FG004|Overall Study|Parent/Caregiver Decision|2|||
147665272|NCT00922636|532599515|FG000|Overall Study|Lost to Follow-up|1|||
147463856|NCT05047523|531860194|FG005|Primary Evaluation Period (48 Weeks)|Adverse Event|0|||
147463857|NCT05047523|531860189|FG000|Extension Period (24 Weeks)|Study Terminated by Sponsor|0|||
147463858|NCT05047523|531860190|FG001|Extension Period (24 Weeks)|Study Terminated by Sponsor|0|||
147463859|NCT05047523|531860191|FG002|Extension Period (24 Weeks)|Study Terminated by Sponsor|0|||
147463860|NCT05047523|531860192|FG003|Extension Period (24 Weeks)|Study Terminated by Sponsor|0|||
147463861|NCT05047523|531860193|FG004|Extension Period (24 Weeks)|Study Terminated by Sponsor|8|||
147463862|NCT05047523|531860194|FG005|Extension Period (24 Weeks)|Study Terminated by Sponsor|8|||
147463863|NCT05047523|531860189|FG000|Extension Period (24 Weeks)|Adverse Event|0|||
147463864|NCT05047523|531860190|FG001|Extension Period (24 Weeks)|Adverse Event|0|||
147463865|NCT05047523|531860191|FG002|Extension Period (24 Weeks)|Adverse Event|0|||
147665273|NCT00922636|532599516|FG001|Overall Study|Lost to Follow-up|2|||
147665274|NCT00922636|532599517|FG002|Overall Study|Lost to Follow-up|2|||
147665275|NCT00922636|532599518|FG003|Overall Study|Lost to Follow-up|2|||
147665276|NCT00922636|532599519|FG004|Overall Study|Lost to Follow-up|4|||
147665277|NCT00557466|532599520|FG000|Overall Study|Adverse Event|3|||
147404098|NCT00658606|531643063|FG000|Overall Study|Lack of Compliance|0|||
147404099|NCT00658606|531643064|FG001|Overall Study|Lack of Compliance|3|||
147463866|NCT05047523|531860192|FG003|Extension Period (24 Weeks)|Adverse Event|0|||
147463867|NCT05047523|531860193|FG004|Extension Period (24 Weeks)|Adverse Event|1|||
147463868|NCT05047523|531860194|FG005|Extension Period (24 Weeks)|Adverse Event|1|||
147463869|NCT00008385|531860195|FG000|Overall Study|Off treatment reasons not reported|79|||
147463870|NCT00008385|531860196|FG001|Overall Study|Off treatment reasons not reported|70|||
147463871|NCT00008385|531860195|FG000|Overall Study|Progressive disease|52|||
147463872|NCT00008385|531860196|FG001|Overall Study|Progressive disease|117|||
147463873|NCT00008385|531860195|FG000|Overall Study|Adverse Event|8|||
147463874|NCT00008385|531860196|FG001|Overall Study|Adverse Event|20|||
147404100|NCT01056263|531643068|FG000|Overall Study|Adverse Event|12|||
147404101|NCT01056263|531643068|FG000|Overall Study|Death|1|||
147404102|NCT01056263|531643068|FG000|Overall Study|Withdrawal by Subject|1|||
147404103|NCT01056263|531643068|FG000|Overall Study|Lack of Efficacy|29|||
147404104|NCT01056263|531643068|FG000|Overall Study|Progressive disease|2|||
147404105|NCT01056263|531643068|FG000|Overall Study|Neoplasm progression|1|||
147404106|NCT01056263|531643068|FG000|Overall Study|Objective progression or relapse|1|||
147404107|NCT01056263|531643068|FG000|Overall Study|Ongoing in study A4061008 (NCT00828919)|5|||
147404108|NCT01068210|531643073|FG000|Overall Study|Lost to Follow-up|1|||
147404109|NCT01068210|531643074|FG001|Overall Study|Lost to Follow-up|2|||
147404110|NCT01068210|531643075|FG002|Overall Study|Lost to Follow-up|2|||
147404111|NCT01068210|531643076|FG003|Overall Study|Lost to Follow-up|1|||
147404112|NCT01068210|531643073|FG000|Overall Study|Second cancer|0|||
147404113|NCT01068210|531643074|FG001|Overall Study|Second cancer|1|||
147404114|NCT01068210|531643075|FG002|Overall Study|Second cancer|0|||
147404115|NCT01068210|531643076|FG003|Overall Study|Second cancer|0|||
147404116|NCT01068210|531643073|FG000|Overall Study|Disease progression|0|||
147404117|NCT01068210|531643074|FG001|Overall Study|Disease progression|0|||
147404118|NCT01068210|531643075|FG002|Overall Study|Disease progression|0|||
147404119|NCT01068210|531643076|FG003|Overall Study|Disease progression|2|||
147404120|NCT00699842|531643077|FG000|Overall Study|Death|0|||
147404121|NCT00699842|531643078|FG001|Overall Study|Death|1|||
147404122|NCT00699842|531643079|FG002|Overall Study|Death|0|||
147404123|NCT01806389|531643082|FG000|Overall Study|Withdrawal by Subject|4|||
147404124|NCT02201901|531643083|FG000|Overall Study|Randomized but never treated|0|||
147404125|NCT02201901|531643084|FG001|Overall Study|Randomized but never treated|1|||
147404126|NCT02201901|531643085|FG002|Overall Study|Randomized but never treated|0|||
147404127|NCT02201901|531643083|FG000|Overall Study|Lack of Efficacy|7|||
147404128|NCT02201901|531643084|FG001|Overall Study|Lack of Efficacy|1|||
147404129|NCT02201901|531643085|FG002|Overall Study|Lack of Efficacy|6|||
147404130|NCT02201901|531643083|FG000|Overall Study|Death|3|||
147404131|NCT02201901|531643084|FG001|Overall Study|Death|3|||
147404132|NCT02201901|531643085|FG002|Overall Study|Death|3|||
147404133|NCT02201901|531643083|FG000|Overall Study|Lost to Follow-up|2|||
147404134|NCT02201901|531643084|FG001|Overall Study|Lost to Follow-up|3|||
147404135|NCT02201901|531643085|FG002|Overall Study|Lost to Follow-up|2|||
147404136|NCT02201901|531643083|FG000|Overall Study|Withdrew Consent|2|||
147404137|NCT02201901|531643084|FG001|Overall Study|Withdrew Consent|0|||
147463875|NCT00008385|531860195|FG000|Overall Study|Death|12|||
147463876|NCT00008385|531860196|FG001|Overall Study|Death|18|||
147463877|NCT00008385|531860195|FG000|Overall Study|Withdrawal by Subject|67|||
147463878|NCT00008385|531860196|FG001|Overall Study|Withdrawal by Subject|157|||
147463879|NCT00008385|531860195|FG000|Overall Study|Start non-protocol therapy|3|||
147463880|NCT00008385|531860196|FG001|Overall Study|Start non-protocol therapy|1|||
147463881|NCT00008385|531860195|FG000|Overall Study|Other complicating disease|17|||
147463882|NCT00008385|531860196|FG001|Overall Study|Other complicating disease|30|||
147665278|NCT00557466|532599521|FG001|Overall Study|Adverse Event|1|||
147404138|NCT02201901|531643085|FG002|Overall Study|Withdrew Consent|2|||
147404139|NCT02201901|531643083|FG000|Overall Study|Adverse Event|1|||
147463883|NCT00008385|531860195|FG000|Overall Study|Maximum dose reached|0|||
147463884|NCT00008385|531860196|FG001|Overall Study|Maximum dose reached|2|||
147463885|NCT00008385|531860195|FG000|Overall Study|Other|105|||
147463886|NCT00008385|531860196|FG001|Overall Study|Other|212|||
147463887|NCT00008385|531860195|FG000|Overall Study|Not start protocol therapy|44|||
147463888|NCT00008385|531860196|FG001|Overall Study|Not start protocol therapy|175|||
147404140|NCT02201901|531643084|FG001|Overall Study|Adverse Event|1|||
147463889|NCT00582556|531860197|FG000|Overall Study|Withdrawal by Subject|0|||
147463890|NCT00582556|531860198|FG001|Overall Study|Withdrawal by Subject|1|||
147463891|NCT00582556|531860199|FG002|Overall Study|Withdrawal by Subject|1|||
147463892|NCT00582556|531860197|FG000|Overall Study|Physician Decision|0|||
147463893|NCT00582556|531860198|FG001|Overall Study|Physician Decision|0|||
147463894|NCT00582556|531860199|FG002|Overall Study|Physician Decision|1|||
147463895|NCT01993888|531860200|FG000|Overall Study|Death|1|||
147463896|NCT01993888|531860201|FG001|Overall Study|Death|1|||
147463897|NCT01993888|531860200|FG000|Overall Study|Lost to Follow-up|1|||
147463898|NCT01993888|531860201|FG001|Overall Study|Lost to Follow-up|1|||
147463899|NCT01993888|531860200|FG000|Overall Study|Withdrawal by Subject|0|||
147463900|NCT01993888|531860201|FG001|Overall Study|Withdrawal by Subject|1|||
147463901|NCT01341457|531860202|FG000|Overall Study|Adverse Event|2|||
147463902|NCT01341457|531860203|FG001|Overall Study|Adverse Event|0|||
147463903|NCT01719757|531860209|FG000|Overall Study|Adverse Event|38|||
147463904|NCT01719757|531860209|FG000|Overall Study|Withdrawal by Subject|15|||
147404141|NCT02201901|531643085|FG002|Overall Study|Adverse Event|0|||
147404142|NCT02559310|531643088|FG000|Overall Study|Death|4|||
147404143|NCT02559310|531643089|FG001|Overall Study|Death|3|||
147404144|NCT02559310|531643088|FG000|Overall Study|Lost to Follow-up|5|||
147404145|NCT02559310|531643089|FG001|Overall Study|Lost to Follow-up|3|||
147404146|NCT02559310|531643088|FG000|Overall Study|Physician Decision|2|||
147404147|NCT02559310|531643089|FG001|Overall Study|Physician Decision|1|||
147404148|NCT02559310|531643088|FG000|Overall Study|Withdrawal by Subject|13|||
147404149|NCT02559310|531643089|FG001|Overall Study|Withdrawal by Subject|9|||
147404150|NCT02559310|531643088|FG000|Overall Study|Sponsor Decision|0|||
147404151|NCT02559310|531643089|FG001|Overall Study|Sponsor Decision|1|||
147404152|NCT02559310|531643088|FG000|Overall Study|Randomized but not treated|3|||
147404153|NCT02559310|531643089|FG001|Overall Study|Randomized but not treated|2|||
147404154|NCT02633397|531643090|FG000|Overall Study|Adverse Event|8|||
147404155|NCT02633397|531643091|FG001|Overall Study|Adverse Event|8|||
147404156|NCT02633397|531643090|FG000|Overall Study|Study Burden|4|||
147404157|NCT02633397|531643091|FG001|Overall Study|Study Burden|1|||
147404158|NCT02633397|531643090|FG000|Overall Study|Treatment interruption|2|||
147404159|NCT02633397|531643091|FG001|Overall Study|Treatment interruption|5|||
147404160|NCT02633397|531643090|FG000|Overall Study|Death|2|||
147404161|NCT02633397|531643091|FG001|Overall Study|Death|2|||
147404162|NCT02633397|531643090|FG000|Overall Study|Physician Decision|0|||
147404163|NCT02633397|531643091|FG001|Overall Study|Physician Decision|1|||
147404164|NCT03595878|531643092|FG000|Overall Study|Death|2|||
147404165|NCT03595878|531643093|FG001|Overall Study|Death|1|||
147404166|NCT03595878|531643094|FG002|Overall Study|Death|0|||
147404167|NCT03595878|531643092|FG000|Overall Study|Disease progression|2|||
147404168|NCT03595878|531643093|FG001|Overall Study|Disease progression|1|||
147404169|NCT03595878|531643094|FG002|Overall Study|Disease progression|2|||
147404170|NCT00469859|531643095|FG000|Overall Study|Inevaluable|0|||
147404171|NCT00469859|531643096|FG001|Overall Study|Inevaluable|2|||
147404172|NCT03494985|531643097|FG000|Overall Study|Adverse Event|3|||
147404173|NCT03494985|531643098|FG001|Overall Study|Adverse Event|2|||
147404174|NCT03494985|531643099|FG002|Overall Study|Adverse Event|3|||
147404175|NCT03494985|531643100|FG003|Overall Study|Adverse Event|0|||
147404176|NCT03494985|531643097|FG000|Overall Study|Other (Withdrawal of consent)|2|||
147404177|NCT03494985|531643098|FG001|Overall Study|Other (Withdrawal of consent)|3|||
147404178|NCT03494985|531643099|FG002|Overall Study|Other (Withdrawal of consent)|2|||
147404179|NCT03494985|531643100|FG003|Overall Study|Other (Withdrawal of consent)|5|||
147404180|NCT03494985|531643097|FG000|Overall Study|Other (Not specified)|0|||
147404181|NCT03494985|531643098|FG001|Overall Study|Other (Not specified)|1|||
147404182|NCT03494985|531643099|FG002|Overall Study|Other (Not specified)|1|||
147404183|NCT03494985|531643100|FG003|Overall Study|Other (Not specified)|0|||
147463905|NCT01719757|531860209|FG000|Overall Study|Lost to Follow-up|20|||
147463906|NCT01719757|531860209|FG000|Overall Study|Protocol Violation|1|||
147463907|NCT01719757|531860209|FG000|Overall Study|well controlled pain|27|||
147463908|NCT02626338|531860210|FG000|Overall Study|Lack of Efficacy|3|||
147463909|NCT02626338|531860211|FG001|Overall Study|Lack of Efficacy|2|||
147463910|NCT02626338|531860212|FG002|Overall Study|Lack of Efficacy|0|||
147463911|NCT00103012|531860216|FG000|Overall Study|Withdrawal by Subject|2|||
147463912|NCT00103012|531860217|FG001|Overall Study|Withdrawal by Subject|1|||
147404184|NCT04124471|531643101|FG000|Overall Study|screen failure|1|||
147404185|NCT03036124|531643102|FG000|Overall Study|Lost to Follow-up|0|||
147463913|NCT00103012|531860218|FG002|Overall Study|Withdrawal by Subject|2|||
147463914|NCT00103012|531860216|FG000|Overall Study|Pregnancy|1|||
147463915|NCT00103012|531860217|FG001|Overall Study|Pregnancy|0|||
147463916|NCT00103012|531860218|FG002|Overall Study|Pregnancy|0|||
147463917|NCT00103012|531860216|FG000|Overall Study|Adverse Event|0|||
147463918|NCT00103012|531860217|FG001|Overall Study|Adverse Event|0|||
147463919|NCT00103012|531860218|FG002|Overall Study|Adverse Event|1|||
147404186|NCT03036124|531643103|FG001|Overall Study|Lost to Follow-up|2|||
147404187|NCT03036124|531643102|FG000|Overall Study|Withdrawal by Subject|5|||
147404188|NCT03036124|531643103|FG001|Overall Study|Withdrawal by Subject|4|||
147404189|NCT02394925|531643104|FG000|Overall Study|Adverse Event|1|||
147404190|NCT02394925|531643104|FG000|Overall Study|Lens Discomfort|3|||
147404191|NCT02394925|531643104|FG000|Overall Study|Lens handling difficulities|5|||
147404192|NCT02394925|531643104|FG000|Overall Study|Lost to Follow-up|9|||
147404193|NCT02394925|531643104|FG000|Overall Study|Protocol Violation|5|||
147404194|NCT02394925|531643104|FG000|Overall Study|No longer meet eligibility criteria|1|||
147616132|NCT04502212|532409174|FG000|Overall Study|Unevaluable data; excluded from Ultrasound Insonification Effect Pop; included in Safety Pop|1|||
147616133|NCT04502212|532409174|FG000|Overall Study|Clamp protocol deviation; excluded from Ultrasound Insonification Effect Pop; included in Safety Pop|1|||
147404195|NCT02394925|531643104|FG000|Overall Study|Unsatisfactory Visual Response|5|||
147404196|NCT02737826|531645366|FG000|Phase II - Randomization + Taper|Withdrawal by Subject|0|||
147404197|NCT02737826|531645367|FG001|Phase II - Randomization + Taper|Withdrawal by Subject|12|||
147404198|NCT02737826|531645368|FG002|Phase II - Randomization + Taper|Withdrawal by Subject|14|||
147404199|NCT00078377|531645369|FG000|Overall Study|Adverse Event|2|||
147404200|NCT00078377|531645370|FG001|Overall Study|Adverse Event|5|||
147404201|NCT00078377|531645371|FG002|Overall Study|Adverse Event|1|||
147404202|NCT00078377|531645369|FG000|Overall Study|Lack of Efficacy|2|||
147404203|NCT00078377|531645370|FG001|Overall Study|Lack of Efficacy|0|||
147404204|NCT00078377|531645371|FG002|Overall Study|Lack of Efficacy|2|||
147404205|NCT00078377|531645369|FG000|Overall Study|Lost to Follow-up|0|||
147404206|NCT00078377|531645370|FG001|Overall Study|Lost to Follow-up|1|||
147404207|NCT00078377|531645371|FG002|Overall Study|Lost to Follow-up|1|||
147404208|NCT00078377|531645369|FG000|Overall Study|Physician Decision|2|||
147404209|NCT00078377|531645370|FG001|Overall Study|Physician Decision|0|||
147404210|NCT00078377|531645371|FG002|Overall Study|Physician Decision|0|||
147404211|NCT00078377|531645369|FG000|Overall Study|Withdrawal by Subject|3|||
147404212|NCT00078377|531645370|FG001|Overall Study|Withdrawal by Subject|4|||
147404213|NCT00078377|531645371|FG002|Overall Study|Withdrawal by Subject|4|||
147404214|NCT00078377|531645369|FG000|Overall Study|Miscellaneous|2|||
147404215|NCT00078377|531645370|FG001|Overall Study|Miscellaneous|6|||
147404216|NCT00078377|531645371|FG002|Overall Study|Miscellaneous|1|||
147404217|NCT04546217|531645372|FG000|Overall Study|Withdrawal by Subject|2|||
147404218|NCT04546217|531645373|FG001|Overall Study|Withdrawal by Subject|0|||
147404219|NCT04546217|531645372|FG000|Overall Study|Uncontrolled hypertension|1|||
147404220|NCT04546217|531645373|FG001|Overall Study|Uncontrolled hypertension|0|||
147404221|NCT00863512|531645374|FG000|Overall Study|Adverse Event|2|||
147404222|NCT00863512|531645375|FG001|Overall Study|Adverse Event|0|||
147404223|NCT00863512|531645374|FG000|Overall Study|Withdrawal by Subject|11|||
147404224|NCT00863512|531645375|FG001|Overall Study|Withdrawal by Subject|0|||
147404225|NCT00863512|531645374|FG000|Overall Study|Physician Decision|1|||
147404226|NCT00863512|531645375|FG001|Overall Study|Physician Decision|0|||
147404227|NCT04292470|531645380|FG000|Overall Study|Withdrawal by Subject|0|||
147404228|NCT04292470|531645381|FG001|Overall Study|Withdrawal by Subject|1|||
147404229|NCT02906020|531645395|FG000|Part 1: Dose Escalation Period|Adverse Event|0|||
147404230|NCT02906020|531645396|FG001|Part 1: Dose Escalation Period|Adverse Event|1|||
147404231|NCT02906020|531645397|FG002|Part 1: Dose Escalation Period|Adverse Event|0|||
147404232|NCT02906020|531645398|FG003|Part 1: Dose Escalation Period|Adverse Event|1|||
147404233|NCT02906020|531645399|FG004|Part 1: Dose Escalation Period|Adverse Event|0|||
147404234|NCT02906020|531645400|FG005|Part 1: Dose Escalation Period|Adverse Event|0|||
147404235|NCT02906020|531645401|FG006|Part 1: Dose Escalation Period|Adverse Event|0|||
147404236|NCT02906020|531645402|FG007|Part 1: Dose Escalation Period|Adverse Event|0|||
147404237|NCT02906020|531645403|FG008|Part 1: Dose Escalation Period|Adverse Event|0|||
147404238|NCT02906020|531645404|FG009|Part 1: Dose Escalation Period|Adverse Event|0|||
147404239|NCT02906020|531645405|FG010|Part 1: Dose Escalation Period|Adverse Event|0|||
147404240|NCT02906020|531645406|FG011|Part 1: Dose Escalation Period|Adverse Event|0|||
147404241|NCT02906020|531645407|FG012|Part 1: Dose Escalation Period|Adverse Event|0|||
147404242|NCT02906020|531645408|FG013|Part 1: Dose Escalation Period|Adverse Event|0|||
147404243|NCT02906020|531645409|FG014|Part 1: Dose Escalation Period|Adverse Event|0|||
147404244|NCT02906020|531645410|FG015|Part 1: Dose Escalation Period|Adverse Event|0|||
147404245|NCT02906020|531645395|FG000|Part 2: Double-blind Treatment Period|Adverse Event|0|||
147404246|NCT02906020|531645396|FG001|Part 2: Double-blind Treatment Period|Adverse Event|0|||
147404247|NCT02906020|531645397|FG002|Part 2: Double-blind Treatment Period|Adverse Event|0|||
147404248|NCT02906020|531645398|FG003|Part 2: Double-blind Treatment Period|Adverse Event|0|||
147404249|NCT02906020|531645399|FG004|Part 2: Double-blind Treatment Period|Adverse Event|0|||
147404250|NCT02906020|531645400|FG005|Part 2: Double-blind Treatment Period|Adverse Event|0|||
147404251|NCT02906020|531645401|FG006|Part 2: Double-blind Treatment Period|Adverse Event|0|||
147404252|NCT02906020|531645402|FG007|Part 2: Double-blind Treatment Period|Adverse Event|0|||
147404253|NCT02906020|531645403|FG008|Part 2: Double-blind Treatment Period|Adverse Event|6|||
147404254|NCT02906020|531645404|FG009|Part 2: Double-blind Treatment Period|Adverse Event|15|||
147404255|NCT02906020|531645405|FG010|Part 2: Double-blind Treatment Period|Adverse Event|0|||
147616134|NCT00111241|532409175|FG000|Overall Study|Lost to Follow-up|1|||
147616135|NCT00111241|532409176|FG001|Overall Study|Lost to Follow-up|0|||
147616136|NCT00111241|532409175|FG000|Overall Study|Withdrawal by Subject|4|||
147616137|NCT00111241|532409176|FG001|Overall Study|Withdrawal by Subject|0|||
147616138|NCT00111241|532409175|FG000|Overall Study|Protocol Violation|9|||
147404256|NCT02906020|531645406|FG011|Part 2: Double-blind Treatment Period|Adverse Event|0|||
147404257|NCT02906020|531645407|FG012|Part 2: Double-blind Treatment Period|Adverse Event|0|||
147616139|NCT00111241|532409176|FG001|Overall Study|Protocol Violation|8|||
147616140|NCT00111241|532409175|FG000|Overall Study|Adverse Event|1|||
147404258|NCT02906020|531645408|FG013|Part 2: Double-blind Treatment Period|Adverse Event|0|||
147404259|NCT02906020|531645409|FG014|Part 2: Double-blind Treatment Period|Adverse Event|0|||
147404260|NCT02906020|531645410|FG015|Part 2: Double-blind Treatment Period|Adverse Event|0|||
147404261|NCT02906020|531645395|FG000|Part 2: Double-blind Treatment Period|Other|0|||
147404262|NCT02906020|531645396|FG001|Part 2: Double-blind Treatment Period|Other|0|||
147404263|NCT02906020|531645397|FG002|Part 2: Double-blind Treatment Period|Other|0|||
147404264|NCT02906020|531645398|FG003|Part 2: Double-blind Treatment Period|Other|0|||
147404265|NCT02906020|531645399|FG004|Part 2: Double-blind Treatment Period|Other|0|||
147404266|NCT02906020|531645400|FG005|Part 2: Double-blind Treatment Period|Other|0|||
147404267|NCT02906020|531645401|FG006|Part 2: Double-blind Treatment Period|Other|0|||
147404268|NCT02906020|531645402|FG007|Part 2: Double-blind Treatment Period|Other|0|||
147404269|NCT02906020|531645403|FG008|Part 2: Double-blind Treatment Period|Other|6|||
147404270|NCT02906020|531645404|FG009|Part 2: Double-blind Treatment Period|Other|10|||
147404271|NCT02906020|531645405|FG010|Part 2: Double-blind Treatment Period|Other|0|||
147404272|NCT02906020|531645406|FG011|Part 2: Double-blind Treatment Period|Other|0|||
147404273|NCT02906020|531645407|FG012|Part 2: Double-blind Treatment Period|Other|0|||
147404274|NCT02906020|531645408|FG013|Part 2: Double-blind Treatment Period|Other|0|||
147404275|NCT02906020|531645409|FG014|Part 2: Double-blind Treatment Period|Other|0|||
147404276|NCT02906020|531645410|FG015|Part 2: Double-blind Treatment Period|Other|0|||
147404277|NCT02906020|531645395|FG000|Part 2: Long-term Follow-up Period|Adverse Event|0|||
147404278|NCT02906020|531645396|FG001|Part 2: Long-term Follow-up Period|Adverse Event|0|||
147404279|NCT02906020|531645397|FG002|Part 2: Long-term Follow-up Period|Adverse Event|0|||
147404280|NCT02906020|531645398|FG003|Part 2: Long-term Follow-up Period|Adverse Event|0|||
147404281|NCT02906020|531645399|FG004|Part 2: Long-term Follow-up Period|Adverse Event|0|||
147404282|NCT02906020|531645400|FG005|Part 2: Long-term Follow-up Period|Adverse Event|0|||
147404283|NCT02906020|531645401|FG006|Part 2: Long-term Follow-up Period|Adverse Event|0|||
147404284|NCT02906020|531645402|FG007|Part 2: Long-term Follow-up Period|Adverse Event|0|||
147404285|NCT02906020|531645403|FG008|Part 2: Long-term Follow-up Period|Adverse Event|0|||
147404286|NCT02906020|531645404|FG009|Part 2: Long-term Follow-up Period|Adverse Event|0|||
147404287|NCT02906020|531645405|FG010|Part 2: Long-term Follow-up Period|Adverse Event|0|||
147404288|NCT02906020|531645406|FG011|Part 2: Long-term Follow-up Period|Adverse Event|0|||
147404289|NCT02906020|531645407|FG012|Part 2: Long-term Follow-up Period|Adverse Event|10|||
147404290|NCT02906020|531645408|FG013|Part 2: Long-term Follow-up Period|Adverse Event|4|||
147404291|NCT02906020|531645409|FG014|Part 2: Long-term Follow-up Period|Adverse Event|0|||
147404292|NCT02906020|531645410|FG015|Part 2: Long-term Follow-up Period|Adverse Event|0|||
147404293|NCT02906020|531645395|FG000|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
147404294|NCT02906020|531645396|FG001|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
147404295|NCT02906020|531645397|FG002|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
147404296|NCT02906020|531645398|FG003|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
147404297|NCT02906020|531645399|FG004|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
147404298|NCT02906020|531645400|FG005|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
147404299|NCT02906020|531645401|FG006|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
147404300|NCT02906020|531645402|FG007|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
147404301|NCT02906020|531645403|FG008|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
147404302|NCT02906020|531645404|FG009|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
147404303|NCT02906020|531645405|FG010|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
147404304|NCT02906020|531645406|FG011|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
147404305|NCT02906020|531645407|FG012|Part 2: Long-term Follow-up Period|Progressive Disease|7|||
147404306|NCT02906020|531645408|FG013|Part 2: Long-term Follow-up Period|Progressive Disease|4|||
147404307|NCT02906020|531645409|FG014|Part 2: Long-term Follow-up Period|Progressive Disease|0|||
147404308|NCT02906020|531645410|FG015|Part 2: Long-term Follow-up Period|Progressive Disease|1|||
147404309|NCT02906020|531645395|FG000|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
147404310|NCT02906020|531645396|FG001|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
147616141|NCT00111241|532409176|FG001|Overall Study|Adverse Event|0|||
147616142|NCT02096744|532409187|FG000|Treatment Period 1(7 Days)|Accidental early removal of the patch|0|||
147404311|NCT02906020|531645397|FG002|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
147616143|NCT02096744|532409188|FG001|Treatment Period 1(7 Days)|Accidental early removal of the patch|1|||
147616144|NCT02096744|532409187|FG000|Treatment Period 1(7 Days)|Non compliance with the site rule|1|||
147616145|NCT02096744|532409188|FG001|Treatment Period 1(7 Days)|Non compliance with the site rule|0|||
147616146|NCT02096744|532409187|FG000|Treatment Period 3 (7 Days)|Withdrawal by Subject|0|||
147463920|NCT00103012|531860216|FG000|Overall Study|Subject non-compliant with medications|0|||
147463921|NCT00103012|531860217|FG001|Overall Study|Subject non-compliant with medications|0|||
147463922|NCT00103012|531860218|FG002|Overall Study|Subject non-compliant with medications|1|||
147463923|NCT05211336|531860221|FG000|Overall Study|Unacceptable adverse event - autoimmune hepatitis|1|||
147463924|NCT05211336|531860222|FG001|Overall Study|Unacceptable adverse event - autoimmune hepatitis|0|||
147463925|NCT05211336|531860221|FG000|Overall Study|Progressive disease|0|||
147463926|NCT05211336|531860222|FG001|Overall Study|Progressive disease|4|||
147463927|NCT05211336|531860221|FG000|Overall Study|Death due to myocardial infarction|0|||
147463928|NCT05211336|531860222|FG001|Overall Study|Death due to myocardial infarction|1|||
147463929|NCT05211336|531860221|FG000|Overall Study|Death due to unknown cause|0|||
147463930|NCT05211336|531860222|FG001|Overall Study|Death due to unknown cause|1|||
147463931|NCT05211336|531860221|FG000|Overall Study|Worsening kidney function and quality of response|0|||
147463932|NCT05211336|531860222|FG001|Overall Study|Worsening kidney function and quality of response|1|||
147463933|NCT00393718|531860226|FG000|Overall Study|Adverse Event|20|||
147463934|NCT00393718|531860227|FG001|Overall Study|Adverse Event|8|||
147463935|NCT00393718|531860226|FG000|Overall Study|Protocol Violation|1|||
147463936|NCT00393718|531860227|FG001|Overall Study|Protocol Violation|2|||
147463937|NCT00393718|531860226|FG000|Overall Study|Lack of Efficacy|10|||
147463938|NCT00393718|531860227|FG001|Overall Study|Lack of Efficacy|9|||
147463939|NCT00393718|531860226|FG000|Overall Study|Hypoglycaemia|3|||
147463940|NCT00393718|531860227|FG001|Overall Study|Hypoglycaemia|2|||
147463941|NCT00393718|531860226|FG000|Overall Study|Subject decision|5|||
147463942|NCT00393718|531860227|FG001|Overall Study|Subject decision|0|||
147463943|NCT00393718|531860226|FG000|Overall Study|Withdrawal of consent|2|||
147463944|NCT00393718|531860227|FG001|Overall Study|Withdrawal of consent|1|||
147463945|NCT00393718|531860226|FG000|Overall Study|Missed measurement|1|||
147463946|NCT00393718|531860227|FG001|Overall Study|Missed measurement|0|||
147463947|NCT00393718|531860226|FG000|Overall Study|Move|1|||
147463948|NCT00393718|531860227|FG001|Overall Study|Move|0|||
147463949|NCT01084551|531860229|FG000|Overall Study|Adverse Event|2|||
147463950|NCT01084551|531860230|FG001|Overall Study|Adverse Event|9|||
147463951|NCT01084551|531860231|FG002|Overall Study|Adverse Event|4|||
147463952|NCT01084551|531860229|FG000|Overall Study|Lack of Efficacy|2|||
147463953|NCT01084551|531860230|FG001|Overall Study|Lack of Efficacy|0|||
147463954|NCT01084551|531860231|FG002|Overall Study|Lack of Efficacy|1|||
147463955|NCT01084551|531860229|FG000|Overall Study|Withdrawal by Subject|2|||
147463956|NCT01084551|531860230|FG001|Overall Study|Withdrawal by Subject|1|||
147463957|NCT01084551|531860231|FG002|Overall Study|Withdrawal by Subject|0|||
147463958|NCT01084551|531860229|FG000|Overall Study|Protocol Violation|2|||
147463959|NCT01084551|531860230|FG001|Overall Study|Protocol Violation|4|||
147463960|NCT01084551|531860231|FG002|Overall Study|Protocol Violation|0|||
147463961|NCT01084551|531860229|FG000|Overall Study|Lost to Follow-up|0|||
147463962|NCT01084551|531860230|FG001|Overall Study|Lost to Follow-up|0|||
147463963|NCT01084551|531860231|FG002|Overall Study|Lost to Follow-up|3|||
147463964|NCT01084551|531860229|FG000|Overall Study|Physician Decision|1|||
147463965|NCT01084551|531860230|FG001|Overall Study|Physician Decision|0|||
147463966|NCT01084551|531860231|FG002|Overall Study|Physician Decision|0|||
147463967|NCT03902080|531860232|FG000|Overall Study|Adverse Event|17|||
147463968|NCT03902080|531860233|FG001|Overall Study|Adverse Event|15|||
147463969|NCT03902080|531860232|FG000|Overall Study|Withdrawal by Subject|28|||
147463970|NCT03902080|531860233|FG001|Overall Study|Withdrawal by Subject|35|||
147463971|NCT03902080|531860232|FG000|Overall Study|Lost to Follow-up|6|||
147463972|NCT03902080|531860233|FG001|Overall Study|Lost to Follow-up|7|||
147463973|NCT03902080|531860232|FG000|Overall Study|Other|3|||
147463974|NCT03902080|531860233|FG001|Overall Study|Other|5|||
147463975|NCT03902080|531860232|FG000|Overall Study|Non compliance|4|||
147463976|NCT03902080|531860233|FG001|Overall Study|Non compliance|3|||
147463977|NCT03902080|531860232|FG000|Overall Study|Physician Decision|5|||
147463978|NCT03902080|531860233|FG001|Overall Study|Physician Decision|1|||
147665279|NCT00557466|532599522|FG002|Overall Study|Adverse Event|4|||
147665280|NCT00557466|532599523|FG003|Overall Study|Adverse Event|1|||
147463979|NCT03902080|531860232|FG000|Overall Study|Protocol Violation|3|||
147463980|NCT03902080|531860233|FG001|Overall Study|Protocol Violation|3|||
147463981|NCT03902080|531860232|FG000|Overall Study|Lack of Efficacy|1|||
147463982|NCT03902080|531860233|FG001|Overall Study|Lack of Efficacy|3|||
147463983|NCT03902080|531860232|FG000|Overall Study|Withdrawn prior to dosing|0|||
147463984|NCT03902080|531860233|FG001|Overall Study|Withdrawn prior to dosing|1|||
147463985|NCT03575104|531860234|FG000|Overall Study|Adverse Event|4|||
147463986|NCT03575104|531860235|FG001|Overall Study|Adverse Event|3|||
147463987|NCT03575104|531860236|FG002|Overall Study|Adverse Event|4|||
147463988|NCT03575104|531860234|FG000|Overall Study|Withdrawal by Subject|13|||
147463989|NCT03575104|531860235|FG001|Overall Study|Withdrawal by Subject|16|||
147463990|NCT03575104|531860236|FG002|Overall Study|Withdrawal by Subject|11|||
147463991|NCT03575104|531860234|FG000|Overall Study|Other reasons|6|||
147463992|NCT03575104|531860235|FG001|Overall Study|Other reasons|8|||
147463993|NCT03575104|531860236|FG002|Overall Study|Other reasons|6|||
147463994|NCT03575104|531860234|FG000|Overall Study|Lost to Follow-up|1|||
147463995|NCT03575104|531860235|FG001|Overall Study|Lost to Follow-up|2|||
147616147|NCT02096744|532409188|FG001|Treatment Period 3 (7 Days)|Withdrawal by Subject|1|||
147616148|NCT02445963|532409191|FG000|Overall Study|Lost to Follow-up|1|||
147616149|NCT02445963|532409192|FG001|Overall Study|Lost to Follow-up|0|||
147616150|NCT02445963|532409193|FG002|Overall Study|Lost to Follow-up|0|||
147616151|NCT02445963|532409194|FG003|Overall Study|Lost to Follow-up|0|||
147616152|NCT02445963|532409191|FG000|Overall Study|Change in employment|1|||
147616153|NCT02445963|532409192|FG001|Overall Study|Change in employment|0|||
147616154|NCT02445963|532409193|FG002|Overall Study|Change in employment|0|||
147616155|NCT02445963|532409194|FG003|Overall Study|Change in employment|0|||
147616156|NCT02445963|532409191|FG000|Overall Study|Symptoms post-vaccination|0|||
147616157|NCT02445963|532409192|FG001|Overall Study|Symptoms post-vaccination|0|||
147616158|NCT02445963|532409193|FG002|Overall Study|Symptoms post-vaccination|1|||
147616159|NCT02445963|532409194|FG003|Overall Study|Symptoms post-vaccination|0|||
147616160|NCT01449812|532409198|FG000|Overall Study|Migrated/moved from study area|1|||
147616161|NCT01449812|532409199|FG001|Overall Study|Migrated/moved from study area|0|||
147616162|NCT01449812|532409200|FG002|Overall Study|Migrated/moved from study area|0|||
147616163|NCT01449812|532409198|FG000|Overall Study|Withdrawal by Subject|0|||
147616164|NCT01449812|532409199|FG001|Overall Study|Withdrawal by Subject|0|||
147616165|NCT01449812|532409200|FG002|Overall Study|Withdrawal by Subject|1|||
147616166|NCT01449812|532409198|FG000|Overall Study|Lost to Follow-up|1|||
147616167|NCT01449812|532409199|FG001|Overall Study|Lost to Follow-up|0|||
147616168|NCT01449812|532409200|FG002|Overall Study|Lost to Follow-up|0|||
147616169|NCT02517463|532409201|FG000|Overall Study|Lost to Follow-up|5|||
147616170|NCT02517463|532409202|FG001|Overall Study|Lost to Follow-up|2|||
147616171|NCT03180645|532409207|FG000|Overall Study|Adverse Event|0|||
147616172|NCT03180645|532409208|FG001|Overall Study|Adverse Event|1|||
147616173|NCT03180645|532409209|FG002|Overall Study|Adverse Event|2|||
147616174|NCT04208750|532409210|FG000|Overall Study|Lost to Follow-up|16|||
147616175|NCT04208750|532409211|FG001|Overall Study|Lost to Follow-up|15|||
147616176|NCT02163057|532409212|FG000|Overall Study|Participant Refusal to Continue|2|||
147616177|NCT02163057|532409213|FG001|Overall Study|Participant Refusal to Continue|2|||
147616178|NCT02163057|532409212|FG000|Overall Study|Participant Significant Noncompliance|0|||
147616179|NCT02163057|532409213|FG001|Overall Study|Participant Significant Noncompliance|1|||
147616180|NCT02163057|532409212|FG000|Overall Study|Progression of Disease|1|||
147616181|NCT02163057|532409213|FG001|Overall Study|Progression of Disease|2|||
147616182|NCT01499095|532410955|FG000|Overall Study|Randomized But Not Treated|1|||
147616183|NCT01499095|532410956|FG001|Overall Study|Randomized But Not Treated|1|||
147616184|NCT01499095|532410955|FG000|Overall Study|Adverse Event|12|||
147616185|NCT01499095|532410956|FG001|Overall Study|Adverse Event|7|||
147616186|NCT01499095|532410955|FG000|Overall Study|Lack of Efficacy|2|||
147616187|NCT01499095|532410956|FG001|Overall Study|Lack of Efficacy|1|||
147616188|NCT01499095|532410955|FG000|Overall Study|Protocol Violation|6|||
147404312|NCT02906020|531645398|FG003|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
147404313|NCT02906020|531645399|FG004|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
147404314|NCT02906020|531645400|FG005|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
147404315|NCT02906020|531645401|FG006|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
147404316|NCT02906020|531645402|FG007|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
147404317|NCT02906020|531645403|FG008|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
147404318|NCT02906020|531645404|FG009|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
147404319|NCT02906020|531645405|FG010|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
147404320|NCT02906020|531645406|FG011|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
147404321|NCT02906020|531645407|FG012|Part 2: Long-term Follow-up Period|Lack of Efficacy|1|||
147404322|NCT02906020|531645408|FG013|Part 2: Long-term Follow-up Period|Lack of Efficacy|1|||
147404323|NCT02906020|531645409|FG014|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
147404324|NCT02906020|531645410|FG015|Part 2: Long-term Follow-up Period|Lack of Efficacy|0|||
147463996|NCT03575104|531860236|FG002|Overall Study|Lost to Follow-up|1|||
147616189|NCT01499095|532410956|FG001|Overall Study|Protocol Violation|7|||
147616190|NCT01499095|532410955|FG000|Overall Study|Received Rescue Therapy|32|||
147616191|NCT01499095|532410956|FG001|Overall Study|Received Rescue Therapy|40|||
147616192|NCT01499095|532410955|FG000|Overall Study|Diverse Reasons|22|||
147616193|NCT01499095|532410956|FG001|Overall Study|Diverse Reasons|25|||
147616194|NCT01499095|532410955|FG000|Overall Study|Lost to Follow-up|6|||
147616195|NCT01499095|532410956|FG001|Overall Study|Lost to Follow-up|4|||
147616196|NCT01499095|532410955|FG000|Overall Study|Insulin Dropped Below Authorized Dose|0|||
147616197|NCT01499095|532410956|FG001|Overall Study|Insulin Dropped Below Authorized Dose|5|||
147463997|NCT04684420|531860237|FG000|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
147616198|NCT01499095|532410955|FG000|Overall Study|Hypoglycemia|3|||
147616199|NCT01499095|532410956|FG001|Overall Study|Hypoglycemia|1|||
147616200|NCT01499095|532410955|FG000|Overall Study|Diagnosed With Type 1 Diabetes Mellitus|2|||
147616201|NCT01499095|532410956|FG001|Overall Study|Diagnosed With Type 1 Diabetes Mellitus|1|||
147616202|NCT01499095|532410955|FG000|Overall Study|Change in Injection Schedule|2|||
147616203|NCT01499095|532410956|FG001|Overall Study|Change in Injection Schedule|0|||
147616204|NCT01499095|532410955|FG000|Overall Study|Perceived Lack of Efficacy|1|||
147616205|NCT01499095|532410956|FG001|Overall Study|Perceived Lack of Efficacy|1|||
147463998|NCT04684420|531860238|FG001|Treatment Period 1 (Day 1)|Withdrawal by Subject|0|||
147463999|NCT04684420|531860239|FG002|Treatment Period 1 (Day 1)|Withdrawal by Subject|2|||
147464000|NCT04684420|531860240|FG003|Treatment Period 1 (Day 1)|Withdrawal by Subject|1|||
147464001|NCT04684420|531860237|FG000|Treatment Period 1 (Day 1)|Adverse Event|0|||
147464002|NCT04684420|531860238|FG001|Treatment Period 1 (Day 1)|Adverse Event|1|||
147464003|NCT04684420|531860239|FG002|Treatment Period 1 (Day 1)|Adverse Event|0|||
147464004|NCT04684420|531860240|FG003|Treatment Period 1 (Day 1)|Adverse Event|0|||
147464005|NCT00463476|531860241|FG000|Overall Study|Withdrawal by Subject|1|||
147464006|NCT00463476|531860242|FG001|Overall Study|Withdrawal by Subject|2|||
147464007|NCT00463476|531860241|FG000|Overall Study|Lost to Follow-up|1|||
147464008|NCT00463476|531860242|FG001|Overall Study|Lost to Follow-up|1|||
147464009|NCT00434967|531860245|FG000|Overall Study|Adverse Event|2|||
147464010|NCT00434967|531860246|FG001|Overall Study|Adverse Event|4|||
147464011|NCT00434967|531860247|FG002|Overall Study|Adverse Event|3|||
147464012|NCT00434967|531860248|FG003|Overall Study|Adverse Event|3|||
147464013|NCT00434967|531860245|FG000|Overall Study|Lost to Follow-up|0|||
147464014|NCT00434967|531860246|FG001|Overall Study|Lost to Follow-up|0|||
147464015|NCT00434967|531860247|FG002|Overall Study|Lost to Follow-up|1|||
147464016|NCT00434967|531860248|FG003|Overall Study|Lost to Follow-up|0|||
147464017|NCT00434967|531860245|FG000|Overall Study|Withdrawal by Subject|2|||
147464018|NCT00434967|531860246|FG001|Overall Study|Withdrawal by Subject|2|||
147464019|NCT00434967|531860247|FG002|Overall Study|Withdrawal by Subject|4|||
147464020|NCT00434967|531860248|FG003|Overall Study|Withdrawal by Subject|6|||
147464021|NCT00434967|531860245|FG000|Overall Study|Randomized in error|0|||
147464022|NCT00434967|531860246|FG001|Overall Study|Randomized in error|0|||
147464023|NCT00434967|531860247|FG002|Overall Study|Randomized in error|0|||
147464024|NCT00434967|531860248|FG003|Overall Study|Randomized in error|1|||
147464025|NCT00434967|531860245|FG000|Overall Study|Protocol Violation|0|||
147464026|NCT00434967|531860246|FG001|Overall Study|Protocol Violation|1|||
147464027|NCT00434967|531860247|FG002|Overall Study|Protocol Violation|0|||
147464028|NCT00434967|531860248|FG003|Overall Study|Protocol Violation|1|||
147464029|NCT00434967|531860245|FG000|Overall Study|Physician Decision|1|||
147464030|NCT00434967|531860246|FG001|Overall Study|Physician Decision|1|||
147464031|NCT00434967|531860247|FG002|Overall Study|Physician Decision|1|||
147464032|NCT00434967|531860248|FG003|Overall Study|Physician Decision|0|||
147464033|NCT00434967|531860245|FG000|Overall Study|Patient Disposition Challenges|2|||
147464034|NCT00434967|531860246|FG001|Overall Study|Patient Disposition Challenges|0|||
147616206|NCT04358081|532410957|FG000|Treatment Phase of Study|Withdrawal by Subject|0|||
147616207|NCT04358081|532410958|FG001|Treatment Phase of Study|Withdrawal by Subject|1|||
147616208|NCT04358081|532410959|FG002|Treatment Phase of Study|Withdrawal by Subject|1|||
147616209|NCT04358081|532410957|FG000|Treatment Phase of Study|Adverse Event|1|||
147616210|NCT04358081|532410958|FG001|Treatment Phase of Study|Adverse Event|0|||
147616211|NCT04358081|532410959|FG002|Treatment Phase of Study|Adverse Event|1|||
147616212|NCT04358081|532410957|FG000|Treatment Phase of Study|Physician Decision|2|||
147616213|NCT04358081|532410958|FG001|Treatment Phase of Study|Physician Decision|0|||
147616214|NCT04358081|532410959|FG002|Treatment Phase of Study|Physician Decision|1|||
147616215|NCT04358081|532410957|FG000|Treatment Phase of Study|Protocol Violation|1|||
147616216|NCT04358081|532410958|FG001|Treatment Phase of Study|Protocol Violation|0|||
147616217|NCT04358081|532410959|FG002|Treatment Phase of Study|Protocol Violation|0|||
147616218|NCT04358081|532410957|FG000|Study Completion Phase|Death|0|||
147616219|NCT04358081|532410958|FG001|Study Completion Phase|Death|0|||
147665281|NCT00557466|532599524|FG004|Overall Study|Adverse Event|2|||
147665282|NCT00557466|532599525|FG005|Overall Study|Adverse Event|4|||
147665283|NCT00557466|532599520|FG000|Overall Study|Abnormal laboratory value(s)|1|||
147464035|NCT00434967|531860247|FG002|Overall Study|Patient Disposition Challenges|0|||
147464036|NCT00434967|531860248|FG003|Overall Study|Patient Disposition Challenges|3|||
147464037|NCT00928070|531860249|FG000|Overall Study|Lost to Follow-up|1|||
147665284|NCT00557466|532599521|FG001|Overall Study|Abnormal laboratory value(s)|2|||
147464038|NCT00928070|531860250|FG001|Overall Study|Lost to Follow-up|2|||
147464039|NCT00928070|531860249|FG000|Overall Study|Withdrawal by Subject|10|||
147464040|NCT00928070|531860250|FG001|Overall Study|Withdrawal by Subject|3|||
147665285|NCT00557466|532599522|FG002|Overall Study|Abnormal laboratory value(s)|0|||
147464041|NCT00928070|531860249|FG000|Overall Study|Adverse Event|14|||
147464042|NCT00928070|531860250|FG001|Overall Study|Adverse Event|26|||
147665286|NCT00557466|532599523|FG003|Overall Study|Abnormal laboratory value(s)|0|||
147464043|NCT00928070|531860249|FG000|Overall Study|Lack of Efficacy|9|||
147464044|NCT00928070|531860250|FG001|Overall Study|Lack of Efficacy|5|||
147464045|NCT00928070|531860249|FG000|Overall Study|Did not meet entrance criteria|16|||
147665287|NCT00557466|532599524|FG004|Overall Study|Abnormal laboratory value(s)|0|||
147665288|NCT00557466|532599525|FG005|Overall Study|Abnormal laboratory value(s)|0|||
147464046|NCT00928070|531860250|FG001|Overall Study|Did not meet entrance criteria|9|||
147464047|NCT00928070|531860249|FG000|Overall Study|Protocol Violation|6|||
147464048|NCT00928070|531860250|FG001|Overall Study|Protocol Violation|5|||
147464049|NCT00928070|531860249|FG000|Overall Study|Randomized but not treated|2|||
147464050|NCT00928070|531860250|FG001|Overall Study|Randomized but not treated|2|||
147464051|NCT00928070|531860249|FG000|Overall Study|Other|5|||
147464052|NCT00928070|531860250|FG001|Overall Study|Other|5|||
147464053|NCT01551693|531860253|FG000|Overall Study|Disease Progression|1|||
147464054|NCT01551693|531860254|FG001|Overall Study|Disease Progression|0|||
147464055|NCT01551693|531860253|FG000|Overall Study|Adverse Event|0|||
147464056|NCT01551693|531860254|FG001|Overall Study|Adverse Event|1|||
147464057|NCT01551693|531860253|FG000|Overall Study|Withdrawal by Subject|0|||
147464058|NCT01551693|531860254|FG001|Overall Study|Withdrawal by Subject|1|||
147464059|NCT04134494|531860255|FG000|Overall Study|Lost to Follow-up|2|||
147464060|NCT01756456|531860258|FG000|Treatment Period: Phase I/II|decision unrelated to adverse event|0|||
147464061|NCT01756456|531860259|FG001|Treatment Period: Phase I/II|decision unrelated to adverse event|0|||
147464062|NCT01756456|531860260|FG002|Treatment Period: Phase I/II|decision unrelated to adverse event|0|||
147464063|NCT01756456|531860261|FG003|Treatment Period: Phase I/II|decision unrelated to adverse event|1|||
147464064|NCT01756456|531860262|FG004|Treatment Period: Phase I/II|decision unrelated to adverse event|1|||
147464065|NCT01756456|531860263|FG005|Treatment Period: Phase I/II|decision unrelated to adverse event|1|||
147464066|NCT01756456|531860258|FG000|Treatment Period: Phase I/II|Lack of Efficacy|0|||
147464067|NCT01756456|531860259|FG001|Treatment Period: Phase I/II|Lack of Efficacy|0|||
147464068|NCT01756456|531860260|FG002|Treatment Period: Phase I/II|Lack of Efficacy|0|||
147464069|NCT01756456|531860261|FG003|Treatment Period: Phase I/II|Lack of Efficacy|2|||
147464070|NCT01756456|531860262|FG004|Treatment Period: Phase I/II|Lack of Efficacy|1|||
147464071|NCT01756456|531860263|FG005|Treatment Period: Phase I/II|Lack of Efficacy|0|||
147464072|NCT01756456|531860258|FG000|Treatment Period: Phase I/II|Withdrawal by Subject|0|||
147464073|NCT01756456|531860259|FG001|Treatment Period: Phase I/II|Withdrawal by Subject|1|||
147464074|NCT01756456|531860260|FG002|Treatment Period: Phase I/II|Withdrawal by Subject|0|||
147464075|NCT01756456|531860261|FG003|Treatment Period: Phase I/II|Withdrawal by Subject|0|||
147464076|NCT01756456|531860262|FG004|Treatment Period: Phase I/II|Withdrawal by Subject|0|||
147464077|NCT01756456|531860263|FG005|Treatment Period: Phase I/II|Withdrawal by Subject|0|||
147464078|NCT01756456|531860258|FG000|Treatment Period: Phase I/II|Adverse Event|1|||
147464079|NCT01756456|531860259|FG001|Treatment Period: Phase I/II|Adverse Event|0|||
147464080|NCT01756456|531860260|FG002|Treatment Period: Phase I/II|Adverse Event|2|||
147464081|NCT01756456|531860261|FG003|Treatment Period: Phase I/II|Adverse Event|3|||
147464082|NCT01756456|531860262|FG004|Treatment Period: Phase I/II|Adverse Event|9|||
147464083|NCT01756456|531860263|FG005|Treatment Period: Phase I/II|Adverse Event|1|||
147464084|NCT01756456|531860258|FG000|Treatment Period: Phase I/II|Other causes|0|||
147464085|NCT01756456|531860259|FG001|Treatment Period: Phase I/II|Other causes|0|||
147464086|NCT01756456|531860260|FG002|Treatment Period: Phase I/II|Other causes|0|||
147464087|NCT01756456|531860261|FG003|Treatment Period: Phase I/II|Other causes|1|||
147464088|NCT01756456|531860262|FG004|Treatment Period: Phase I/II|Other causes|2|||
147464089|NCT01756456|531860263|FG005|Treatment Period: Phase I/II|Other causes|2|||
147464090|NCT01756456|531860258|FG000|Follow Up Period Phase I/II|still in study after week 20|0|||
147616220|NCT04358081|532410959|FG002|Study Completion Phase|Death|1|||
147616221|NCT04358081|532410957|FG000|Study Completion Phase|Lost to Follow-up|1|||
147616222|NCT04358081|532410958|FG001|Study Completion Phase|Lost to Follow-up|0|||
147616223|NCT04358081|532410959|FG002|Study Completion Phase|Lost to Follow-up|1|||
147616224|NCT00443729|532410960|FG000|Overall Study|Never Treated|0|||
147616225|NCT00443729|532410961|FG001|Overall Study|Never Treated|1|||
147616226|NCT00443729|532410960|FG000|Overall Study|Lack of Efficacy|4|||
147616227|NCT00443729|532410961|FG001|Overall Study|Lack of Efficacy|2|||
147616228|NCT00443729|532410960|FG000|Overall Study|Lost to Follow-up|0|||
147616229|NCT00443729|532410961|FG001|Overall Study|Lost to Follow-up|1|||
147616230|NCT00443729|532410960|FG000|Overall Study|Physician Decision|2|||
147616231|NCT00443729|532410961|FG001|Overall Study|Physician Decision|1|||
147616232|NCT00443729|532410960|FG000|Overall Study|Protocol Violation|1|||
147616233|NCT00443729|532410961|FG001|Overall Study|Protocol Violation|1|||
147616234|NCT00443729|532410960|FG000|Overall Study|Withdrawal by Subject|3|||
147616235|NCT00443729|532410961|FG001|Overall Study|Withdrawal by Subject|1|||
147616236|NCT01842438|532410962|FG000|T1: Immediately After the Intervention|Withdrawal by Subject|6|||
147616237|NCT01842438|532410963|FG001|T1: Immediately After the Intervention|Withdrawal by Subject|8|||
147616238|NCT01842438|532410962|FG000|T2: 6month Follow-up|Withdrawal by Subject|4|||
147616239|NCT01842438|532410963|FG001|T2: 6month Follow-up|Withdrawal by Subject|3|||
147616240|NCT01842438|532410962|FG000|T2: 6month Follow-up|Death|0|||
147616241|NCT01842438|532410963|FG001|T2: 6month Follow-up|Death|1|||
147616242|NCT00782626|532410967|FG000|Overall Study|Adverse Event|1|||
147616243|NCT00782626|532410967|FG000|Overall Study|Progressive Disease|5|||
147616244|NCT00782626|532410967|FG000|Overall Study|Other Complicating Disease|1|||
147616245|NCT04054765|532410968|FG000|Baseline|Withdrawal by Subject|5|||
147616246|NCT04054765|532410969|FG001|Baseline|Withdrawal by Subject|3|||
147616247|NCT04054765|532410968|FG000|Post-Gameplay / 1-week Follow up|Withdrawal by Subject|8|||
147616248|NCT04054765|532410969|FG001|Post-Gameplay / 1-week Follow up|Withdrawal by Subject|3|||
147616249|NCT04054765|532410968|FG000|3-month Follow up|Withdrawal by Subject|0|||
147616250|NCT04054765|532410969|FG001|3-month Follow up|Withdrawal by Subject|3|||
147616251|NCT04054765|532410968|FG000|6-month Follow up|Lost to Follow-up|32|||
147616252|NCT04054765|532410969|FG001|6-month Follow up|Lost to Follow-up|32|||
147464091|NCT01756456|531860259|FG001|Follow Up Period Phase I/II|still in study after week 20|0|||
147464092|NCT01756456|531860260|FG002|Follow Up Period Phase I/II|still in study after week 20|0|||
147464093|NCT01756456|531860261|FG003|Follow Up Period Phase I/II|still in study after week 20|25|||
147464094|NCT01756456|531860262|FG004|Follow Up Period Phase I/II|still in study after week 20|23|||
147464095|NCT01756456|531860263|FG005|Follow Up Period Phase I/II|still in study after week 20|25|||
147464096|NCT01756456|531860258|FG000|Follow Up Period Phase I/II|parent withdrew the consent to continue|0|||
147464097|NCT01756456|531860259|FG001|Follow Up Period Phase I/II|parent withdrew the consent to continue|1|||
147464098|NCT01756456|531860260|FG002|Follow Up Period Phase I/II|parent withdrew the consent to continue|0|||
147464099|NCT01756456|531860261|FG003|Follow Up Period Phase I/II|parent withdrew the consent to continue|0|||
147464100|NCT01756456|531860262|FG004|Follow Up Period Phase I/II|parent withdrew the consent to continue|0|||
147464101|NCT01756456|531860263|FG005|Follow Up Period Phase I/II|parent withdrew the consent to continue|0|||
147464102|NCT01756456|531860258|FG000|Follow Up Period Phase I/II|Lack of Efficacy|0|||
147464103|NCT01756456|531860259|FG001|Follow Up Period Phase I/II|Lack of Efficacy|0|||
147464104|NCT01756456|531860260|FG002|Follow Up Period Phase I/II|Lack of Efficacy|0|||
147464105|NCT01756456|531860261|FG003|Follow Up Period Phase I/II|Lack of Efficacy|0|||
147464106|NCT01756456|531860262|FG004|Follow Up Period Phase I/II|Lack of Efficacy|0|||
147464107|NCT01756456|531860263|FG005|Follow Up Period Phase I/II|Lack of Efficacy|1|||
147464108|NCT01756456|531860258|FG000|Follow Up Period Phase I/II|Adverse Event|1|||
147464109|NCT01756456|531860259|FG001|Follow Up Period Phase I/II|Adverse Event|0|||
147464110|NCT01756456|531860260|FG002|Follow Up Period Phase I/II|Adverse Event|0|||
147464111|NCT01756456|531860261|FG003|Follow Up Period Phase I/II|Adverse Event|5|||
147464112|NCT01756456|531860262|FG004|Follow Up Period Phase I/II|Adverse Event|0|||
147464113|NCT01756456|531860263|FG005|Follow Up Period Phase I/II|Adverse Event|1|||
147464114|NCT01756456|531860258|FG000|Follow Up Period Phase I/II|Lost to Follow-up|0|||
147464115|NCT01756456|531860259|FG001|Follow Up Period Phase I/II|Lost to Follow-up|0|||
147464116|NCT01756456|531860260|FG002|Follow Up Period Phase I/II|Lost to Follow-up|1|||
147464117|NCT01756456|531860261|FG003|Follow Up Period Phase I/II|Lost to Follow-up|2|||
147464118|NCT01756456|531860262|FG004|Follow Up Period Phase I/II|Lost to Follow-up|0|||
147464119|NCT01756456|531860263|FG005|Follow Up Period Phase I/II|Lost to Follow-up|1|||
147464120|NCT01756456|531860258|FG000|Follow Up Period Phase I/II|Other causes|0|||
147464121|NCT01756456|531860259|FG001|Follow Up Period Phase I/II|Other causes|0|||
147464122|NCT01756456|531860260|FG002|Follow Up Period Phase I/II|Other causes|0|||
147464123|NCT01756456|531860261|FG003|Follow Up Period Phase I/II|Other causes|1|||
147464124|NCT01756456|531860262|FG004|Follow Up Period Phase I/II|Other causes|3|||
147464125|NCT01756456|531860263|FG005|Follow Up Period Phase I/II|Other causes|5|||
147464126|NCT01838044|531860264|FG000|Overall Study|Adverse Event|4|||
147464127|NCT01838044|531860265|FG001|Overall Study|Adverse Event|6|||
147464128|NCT01838044|531860264|FG000|Overall Study|Protocol Violation|3|||
147464129|NCT01838044|531860265|FG001|Overall Study|Protocol Violation|3|||
147464130|NCT01838044|531860264|FG000|Overall Study|Withdrawal by Subject|0|||
147464131|NCT01838044|531860265|FG001|Overall Study|Withdrawal by Subject|2|||
147464132|NCT01838044|531860264|FG000|Overall Study|Insufficient clinical response|1|||
147464133|NCT01838044|531860265|FG001|Overall Study|Insufficient clinical response|2|||
147464134|NCT01838044|531860264|FG000|Overall Study|Medication error without associated AE|0|||
147464135|NCT01838044|531860265|FG001|Overall Study|Medication error without associated AE|1|||
147464136|NCT01838044|531860264|FG000|Overall Study|Lost to Follow-up|0|||
147464137|NCT01838044|531860265|FG001|Overall Study|Lost to Follow-up|2|||
147464138|NCT02658812|531860269|FG000|Overall Study|Disease Progression|7|||
147464139|NCT02658812|531860269|FG000|Overall Study|Unrelated to study treatment|1|||
147464140|NCT02658812|531860269|FG000|Overall Study|Adverse Event|1|||
147464141|NCT01282229|531860280|FG000|Overall Study|Protocol Violation|2|||
147464142|NCT00896532|531860281|FG000|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
147464143|NCT00896532|531860282|FG001|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
147464144|NCT00896532|531860283|FG002|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
147464145|NCT00896532|531860284|FG003|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|1|||
147464146|NCT00896532|531860285|FG004|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
147464147|NCT00896532|531860286|FG005|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|1|||
147464148|NCT00896532|531860287|FG006|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
147464149|NCT00896532|531860288|FG007|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
147464150|NCT00896532|531860289|FG008|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
147464151|NCT00896532|531860290|FG009|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
147464152|NCT00896532|531860291|FG010|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
147464153|NCT00896532|531860292|FG011|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
147464154|NCT00896532|531860293|FG012|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
147464155|NCT00896532|531860294|FG013|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
147464156|NCT00896532|531860295|FG014|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
147464157|NCT00896532|531860296|FG015|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
147464158|NCT00896532|531860297|FG016|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
147464159|NCT00896532|531860298|FG017|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
147404325|NCT02906020|531645395|FG000|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
147404326|NCT02906020|531645396|FG001|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
147404327|NCT02906020|531645397|FG002|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
147404328|NCT02906020|531645398|FG003|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
147404329|NCT02906020|531645399|FG004|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
147404330|NCT02906020|531645400|FG005|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
147404331|NCT02906020|531645401|FG006|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
147404332|NCT02906020|531645402|FG007|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
147404333|NCT02906020|531645403|FG008|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
147404334|NCT02906020|531645404|FG009|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
147404335|NCT02906020|531645405|FG010|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
147404336|NCT02906020|531645406|FG011|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
147404337|NCT02906020|531645407|FG012|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|1|||
147404338|NCT02906020|531645408|FG013|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|4|||
147404339|NCT02906020|531645409|FG014|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
147404340|NCT02906020|531645410|FG015|Part 2: Long-term Follow-up Period|Poor Compliance to Protocol|0|||
147404341|NCT02906020|531645395|FG000|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
147404342|NCT02906020|531645396|FG001|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
147404343|NCT02906020|531645397|FG002|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
147404344|NCT02906020|531645398|FG003|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
147404345|NCT02906020|531645399|FG004|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
147404346|NCT02906020|531645400|FG005|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
147404347|NCT02906020|531645401|FG006|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
147404348|NCT02906020|531645402|FG007|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
147404349|NCT02906020|531645403|FG008|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
147404350|NCT02906020|531645404|FG009|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
147404351|NCT02906020|531645405|FG010|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
147404352|NCT02906020|531645406|FG011|Part 2: Long-term Follow-up Period|Study terminated by sponsor|0|||
147404353|NCT02906020|531645407|FG012|Part 2: Long-term Follow-up Period|Study terminated by sponsor|67|||
147404354|NCT02906020|531645408|FG013|Part 2: Long-term Follow-up Period|Study terminated by sponsor|64|||
147404355|NCT02906020|531645409|FG014|Part 2: Long-term Follow-up Period|Study terminated by sponsor|7|||
147404356|NCT02906020|531645410|FG015|Part 2: Long-term Follow-up Period|Study terminated by sponsor|8|||
147404357|NCT02906020|531645395|FG000|Part 2: Long-term Follow-up Period|Other|0|||
147404358|NCT02906020|531645396|FG001|Part 2: Long-term Follow-up Period|Other|0|||
147404359|NCT02906020|531645397|FG002|Part 2: Long-term Follow-up Period|Other|0|||
147404360|NCT02906020|531645398|FG003|Part 2: Long-term Follow-up Period|Other|0|||
147404361|NCT02906020|531645399|FG004|Part 2: Long-term Follow-up Period|Other|0|||
147404362|NCT02906020|531645400|FG005|Part 2: Long-term Follow-up Period|Other|0|||
147404363|NCT02906020|531645401|FG006|Part 2: Long-term Follow-up Period|Other|0|||
147404364|NCT02906020|531645402|FG007|Part 2: Long-term Follow-up Period|Other|0|||
147404365|NCT02906020|531645403|FG008|Part 2: Long-term Follow-up Period|Other|0|||
147404366|NCT02906020|531645404|FG009|Part 2: Long-term Follow-up Period|Other|0|||
147404367|NCT02906020|531645405|FG010|Part 2: Long-term Follow-up Period|Other|0|||
147404368|NCT02906020|531645406|FG011|Part 2: Long-term Follow-up Period|Other|0|||
147404369|NCT02906020|531645407|FG012|Part 2: Long-term Follow-up Period|Other|13|||
147404370|NCT02906020|531645408|FG013|Part 2: Long-term Follow-up Period|Other|8|||
147404371|NCT02906020|531645409|FG014|Part 2: Long-term Follow-up Period|Other|3|||
147404372|NCT02906020|531645410|FG015|Part 2: Long-term Follow-up Period|Other|2|||
147404373|NCT04698915|531645411|FG000|Overall Study|Adverse Event|2|||
147404374|NCT04698915|531645412|FG001|Overall Study|Adverse Event|0|||
147404375|NCT04698915|531645411|FG000|Overall Study|Death|23|||
147404376|NCT04698915|531645412|FG001|Overall Study|Death|20|||
147404377|NCT04698915|531645411|FG000|Overall Study|Physician Decision|1|||
147404378|NCT04698915|531645412|FG001|Overall Study|Physician Decision|1|||
147404379|NCT04698915|531645411|FG000|Overall Study|Lost to Follow-up|1|||
147404380|NCT04698915|531645412|FG001|Overall Study|Lost to Follow-up|0|||
147404381|NCT04698915|531645411|FG000|Overall Study|Study Terminated by Sponsor|55|||
147404382|NCT04698915|531645412|FG001|Overall Study|Study Terminated by Sponsor|60|||
147404383|NCT04698915|531645411|FG000|Overall Study|Withdrawal by Subject|2|||
147404384|NCT04698915|531645412|FG001|Overall Study|Withdrawal by Subject|3|||
147404385|NCT01124097|531645413|FG000|Overall Study|Withdrawal by Subject|4|||
147404386|NCT01124097|531645414|FG001|Overall Study|Withdrawal by Subject|3|||
147404387|NCT01124097|531645415|FG002|Overall Study|Withdrawal by Subject|2|||
147404388|NCT01124097|531645416|FG003|Overall Study|Withdrawal by Subject|3|||
147404389|NCT01124097|531645413|FG000|Overall Study|Lack of Efficacy|2|||
147404390|NCT01124097|531645414|FG001|Overall Study|Lack of Efficacy|3|||
147404391|NCT01124097|531645415|FG002|Overall Study|Lack of Efficacy|1|||
147404392|NCT01124097|531645416|FG003|Overall Study|Lack of Efficacy|3|||
147404393|NCT01124097|531645413|FG000|Overall Study|Adverse Event|24|||
147616253|NCT03718832|532410974|FG000|Analysis Sample|Withdrawal by Subject|18|||
147616254|NCT03718832|532410975|FG001|Analysis Sample|Withdrawal by Subject|15|||
147616255|NCT03718832|532410974|FG000|Analysis Sample|Legal hold on data|1|||
147616256|NCT03718832|532410975|FG001|Analysis Sample|Legal hold on data|0|||
147616257|NCT03718832|532410974|FG000|Analysis Sample|Participant from treated household|0|||
147616258|NCT03718832|532410975|FG001|Analysis Sample|Participant from treated household|1|||
147616259|NCT03718832|532410974|FG000|6-month HbA1c Sample|Lost to Follow-up|60|||
147616260|NCT03718832|532410975|FG001|6-month HbA1c Sample|Lost to Follow-up|56|||
147616261|NCT01996241|532410976|FG000|Overall Study|Lost to Follow-up|252|||
147616262|NCT01996241|532410977|FG001|Overall Study|Lost to Follow-up|235|||
147616263|NCT01068262|532410980|FG000|Overall Study|Adverse Event|2|||
147404394|NCT01124097|531645414|FG001|Overall Study|Adverse Event|15|||
147404395|NCT01124097|531645415|FG002|Overall Study|Adverse Event|15|||
147404396|NCT01124097|531645416|FG003|Overall Study|Adverse Event|7|||
147404397|NCT01124097|531645413|FG000|Overall Study|Protocol Violation|2|||
147404398|NCT01124097|531645414|FG001|Overall Study|Protocol Violation|0|||
147404399|NCT01124097|531645415|FG002|Overall Study|Protocol Violation|2|||
147404400|NCT01124097|531645416|FG003|Overall Study|Protocol Violation|1|||
147404401|NCT01124097|531645413|FG000|Overall Study|Physician Decision|2|||
147404402|NCT01124097|531645414|FG001|Overall Study|Physician Decision|1|||
147616264|NCT01068262|532410981|FG001|Overall Study|Adverse Event|0|||
147616265|NCT01068262|532410982|FG002|Overall Study|Adverse Event|1|||
147665289|NCT00557466|532599520|FG000|Overall Study|Protocol deviation|0|||
147404403|NCT01124097|531645415|FG002|Overall Study|Physician Decision|0|||
147404404|NCT01124097|531645416|FG003|Overall Study|Physician Decision|0|||
147404405|NCT04829747|531645422|FG000|Overall Study|Protocol Violation|1|||
147404406|NCT00079339|531645428|FG000|Overall Study|Adverse Event|1|||
147404407|NCT00079339|531645429|FG001|Overall Study|Adverse Event|7|||
147404408|NCT00079339|531645430|FG002|Overall Study|Adverse Event|2|||
147404409|NCT00079339|531645428|FG000|Overall Study|Death|1|||
147404410|NCT00079339|531645429|FG001|Overall Study|Death|0|||
147404411|NCT00079339|531645430|FG002|Overall Study|Death|0|||
147404412|NCT00079339|531645428|FG000|Overall Study|Non-compliance|0|||
147404413|NCT00079339|531645429|FG001|Overall Study|Non-compliance|0|||
147404414|NCT00079339|531645430|FG002|Overall Study|Non-compliance|1|||
147404415|NCT00079339|531645428|FG000|Overall Study|Withdrawal by Subject|0|||
147404416|NCT00079339|531645429|FG001|Overall Study|Withdrawal by Subject|4|||
147404417|NCT00079339|531645430|FG002|Overall Study|Withdrawal by Subject|1|||
147404418|NCT00079339|531645428|FG000|Overall Study|Disease progression|3|||
147404419|NCT00079339|531645429|FG001|Overall Study|Disease progression|28|||
147404420|NCT00079339|531645430|FG002|Overall Study|Disease progression|2|||
147404421|NCT02563548|531645431|FG000|Dose Escalation (Up to 46 Weeks)|Adverse Event|2|||
147404422|NCT02563548|531645432|FG001|Dose Escalation (Up to 46 Weeks)|Adverse Event|0|||
147404423|NCT02563548|531645433|FG002|Dose Escalation (Up to 46 Weeks)|Adverse Event|0|||
147404424|NCT02563548|531645434|FG003|Dose Escalation (Up to 46 Weeks)|Adverse Event|1|||
147404425|NCT02563548|531645435|FG004|Dose Escalation (Up to 46 Weeks)|Adverse Event|0|||
147404426|NCT02563548|531645436|FG005|Dose Escalation (Up to 46 Weeks)|Adverse Event|0|||
147404427|NCT02563548|531645431|FG000|Dose Escalation (Up to 46 Weeks)|Radiological Progression|1|||
147404428|NCT02563548|531645432|FG001|Dose Escalation (Up to 46 Weeks)|Radiological Progression|2|||
147404429|NCT02563548|531645433|FG002|Dose Escalation (Up to 46 Weeks)|Radiological Progression|2|||
147404430|NCT02563548|531645434|FG003|Dose Escalation (Up to 46 Weeks)|Radiological Progression|0|||
147404431|NCT02563548|531645435|FG004|Dose Escalation (Up to 46 Weeks)|Radiological Progression|0|||
147404432|NCT02563548|531645436|FG005|Dose Escalation (Up to 46 Weeks)|Radiological Progression|0|||
147404433|NCT02563548|531645431|FG000|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0|||
147404434|NCT02563548|531645432|FG001|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0|||
147404435|NCT02563548|531645433|FG002|Dose Escalation (Up to 46 Weeks)|Clinical Progression|3|||
147404436|NCT02563548|531645434|FG003|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0|||
147404437|NCT02563548|531645435|FG004|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0|||
147404438|NCT02563548|531645436|FG005|Dose Escalation (Up to 46 Weeks)|Clinical Progression|0|||
147404439|NCT02563548|531645431|FG000|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|0|||
147404440|NCT02563548|531645432|FG001|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|0|||
147404441|NCT02563548|531645433|FG002|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|2|||
147616266|NCT01068262|532410983|FG003|Overall Study|Adverse Event|0|||
147616267|NCT01068262|532410980|FG000|Overall Study|Protocol Violation|1|||
147404442|NCT02563548|531645434|FG003|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|1|||
147404443|NCT02563548|531645435|FG004|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|0|||
147404444|NCT02563548|531645436|FG005|Dose Escalation (Up to 46 Weeks)|Withdrawal by Subject|0|||
147404445|NCT02563548|531645431|FG000|Dose Expansion (Up to 60 Weeks)|Adverse Event|0|||
147404446|NCT02563548|531645432|FG001|Dose Expansion (Up to 60 Weeks)|Adverse Event|0|||
147404447|NCT02563548|531645433|FG002|Dose Expansion (Up to 60 Weeks)|Adverse Event|0|||
147404448|NCT02563548|531645434|FG003|Dose Expansion (Up to 60 Weeks)|Adverse Event|0|||
147404449|NCT02563548|531645435|FG004|Dose Expansion (Up to 60 Weeks)|Adverse Event|1|||
147616268|NCT01068262|532410981|FG001|Overall Study|Protocol Violation|0|||
147616269|NCT01068262|532410982|FG002|Overall Study|Protocol Violation|0|||
147464160|NCT00896532|531860299|FG018|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
147464161|NCT00896532|531860300|FG019|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
147464162|NCT00896532|531860301|FG020|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
147464163|NCT00896532|531860302|FG021|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
147464164|NCT00896532|531860303|FG022|Months 1-24: Romosozumab Treatment Phase|Protocol Deviation|0|||
147464165|NCT00896532|531860281|FG000|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1|||
147464166|NCT00896532|531860282|FG001|Months 1-24: Romosozumab Treatment Phase|Adverse Event|2|||
147464167|NCT00896532|531860283|FG002|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1|||
147464168|NCT00896532|531860284|FG003|Months 1-24: Romosozumab Treatment Phase|Adverse Event|2|||
147665290|NCT00557466|532599521|FG001|Overall Study|Protocol deviation|1|||
147665291|NCT00557466|532599522|FG002|Overall Study|Protocol deviation|0|||
147665292|NCT00557466|532599523|FG003|Overall Study|Protocol deviation|2|||
147665293|NCT00557466|532599524|FG004|Overall Study|Protocol deviation|0|||
147665294|NCT00557466|532599525|FG005|Overall Study|Protocol deviation|0|||
147665295|NCT00557466|532599520|FG000|Overall Study|Subject withdrew consent|0|||
147665296|NCT00557466|532599521|FG001|Overall Study|Subject withdrew consent|0|||
147665297|NCT00557466|532599522|FG002|Overall Study|Subject withdrew consent|0|||
147665298|NCT00557466|532599523|FG003|Overall Study|Subject withdrew consent|0|||
147665299|NCT00557466|532599524|FG004|Overall Study|Subject withdrew consent|1|||
147665300|NCT00557466|532599525|FG005|Overall Study|Subject withdrew consent|2|||
147665301|NCT00557466|532599520|FG000|Overall Study|Administrative problems|0|||
147665302|NCT00557466|532599521|FG001|Overall Study|Administrative problems|1|||
147665303|NCT00557466|532599522|FG002|Overall Study|Administrative problems|1|||
147665304|NCT00557466|532599523|FG003|Overall Study|Administrative problems|0|||
147665305|NCT00557466|532599524|FG004|Overall Study|Administrative problems|0|||
147665306|NCT00557466|532599525|FG005|Overall Study|Administrative problems|0|||
147665307|NCT00557466|532599520|FG000|Overall Study|Abnormal test procedure results|0|||
147665308|NCT00557466|532599521|FG001|Overall Study|Abnormal test procedure results|0|||
147665309|NCT00557466|532599522|FG002|Overall Study|Abnormal test procedure results|1|||
147665310|NCT00557466|532599523|FG003|Overall Study|Abnormal test procedure results|0|||
147665311|NCT00557466|532599524|FG004|Overall Study|Abnormal test procedure results|0|||
147665312|NCT00557466|532599525|FG005|Overall Study|Abnormal test procedure results|0|||
147665313|NCT00557466|532599520|FG000|Overall Study|Lost to Follow-up|0|||
147665314|NCT00557466|532599521|FG001|Overall Study|Lost to Follow-up|0|||
147665315|NCT00557466|532599522|FG002|Overall Study|Lost to Follow-up|0|||
147665316|NCT00557466|532599523|FG003|Overall Study|Lost to Follow-up|1|||
147665317|NCT00557466|532599524|FG004|Overall Study|Lost to Follow-up|0|||
147665318|NCT00557466|532599525|FG005|Overall Study|Lost to Follow-up|0|||
147665319|NCT02308046|532599526|FG000|Overall Study|Negative yeast culture at Baseline|32|||
147404450|NCT02563548|531645436|FG005|Dose Expansion (Up to 60 Weeks)|Adverse Event|8|||
147404451|NCT02563548|531645431|FG000|Dose Expansion (Up to 60 Weeks)|Radiological Progression|0|||
147404452|NCT02563548|531645432|FG001|Dose Expansion (Up to 60 Weeks)|Radiological Progression|0|||
147404453|NCT02563548|531645433|FG002|Dose Expansion (Up to 60 Weeks)|Radiological Progression|0|||
147404454|NCT02563548|531645434|FG003|Dose Expansion (Up to 60 Weeks)|Radiological Progression|0|||
147404455|NCT02563548|531645435|FG004|Dose Expansion (Up to 60 Weeks)|Radiological Progression|15|||
147404456|NCT02563548|531645436|FG005|Dose Expansion (Up to 60 Weeks)|Radiological Progression|3|||
147404457|NCT02563548|531645431|FG000|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0|||
147404458|NCT02563548|531645432|FG001|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0|||
147404459|NCT02563548|531645433|FG002|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0|||
147404460|NCT02563548|531645434|FG003|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0|||
147404461|NCT02563548|531645435|FG004|Dose Expansion (Up to 60 Weeks)|Clinical Progression|6|||
147404462|NCT02563548|531645436|FG005|Dose Expansion (Up to 60 Weeks)|Clinical Progression|0|||
147404463|NCT02563548|531645431|FG000|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|0|||
147404464|NCT02563548|531645432|FG001|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|0|||
147404465|NCT02563548|531645433|FG002|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|0|||
147404466|NCT02563548|531645434|FG003|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|0|||
147404467|NCT02563548|531645435|FG004|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|2|||
147404468|NCT02563548|531645436|FG005|Dose Expansion (Up to 60 Weeks)|Withdrawal by Subject|1|||
147404469|NCT02563548|531645431|FG000|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0|||
147404470|NCT02563548|531645432|FG001|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0|||
147404471|NCT02563548|531645433|FG002|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0|||
147404472|NCT02563548|531645434|FG003|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0|||
147464169|NCT00896532|531860285|FG004|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1|||
147665320|NCT02308046|532599527|FG001|Overall Study|Negative yeast culture at Baseline|33|||
147464170|NCT00896532|531860286|FG005|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1|||
147665321|NCT02308046|532599526|FG000|Overall Study|Positive for STD at Baseline|1|||
147665322|NCT02308046|532599527|FG001|Overall Study|Positive for STD at Baseline|2|||
147404473|NCT02563548|531645435|FG004|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|0|||
147404474|NCT02563548|531645436|FG005|Dose Expansion (Up to 60 Weeks)|Investigator or Sponsor Decision|2|||
147616270|NCT01068262|532410983|FG003|Overall Study|Protocol Violation|0|||
147616271|NCT01068262|532410980|FG000|Overall Study|Withdrawal by Subject|0|||
147616272|NCT01068262|532410981|FG001|Overall Study|Withdrawal by Subject|1|||
147616273|NCT01068262|532410982|FG002|Overall Study|Withdrawal by Subject|0|||
147616274|NCT01068262|532410983|FG003|Overall Study|Withdrawal by Subject|0|||
147616275|NCT04182490|532410984|FG000|Overall Study|Withdrawal by Subject|3|||
147616276|NCT04182490|532410985|FG001|Overall Study|Withdrawal by Subject|3|||
147616277|NCT04182490|532410984|FG000|Overall Study|Lost to Follow-up|0|||
147616278|NCT04182490|532410985|FG001|Overall Study|Lost to Follow-up|1|||
147616279|NCT04182490|532410984|FG000|Overall Study|Physician Decision|0|||
147616280|NCT04182490|532410985|FG001|Overall Study|Physician Decision|1|||
147616281|NCT05024747|532410986|FG000|Period 1 (Day 1 to 2)|Protocol Violation|1|||
147616282|NCT05024747|532410987|FG001|Period 1 (Day 1 to 2)|Protocol Violation|3|||
147616283|NCT05024747|532410986|FG000|Period 1 (Day 1 to 2)|Adverse Event|0|||
147616284|NCT05024747|532410987|FG001|Period 1 (Day 1 to 2)|Adverse Event|1|||
147616285|NCT05024747|532410986|FG000|Period 1 (Day 1 to 2)|Patch fall off or patch is inadvertently removed by the participant|0|||
147616286|NCT05024747|532410987|FG001|Period 1 (Day 1 to 2)|Patch fall off or patch is inadvertently removed by the participant|1|||
147616287|NCT04428034|532410988|FG000|Enrollment to Intervention Completion|Protocol Violation|6|||
147665323|NCT02308046|532599526|FG000|Overall Study|Lost to Follow-up|1|||
147404475|NCT02563548|531645431|FG000|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0|||
147404476|NCT02563548|531645432|FG001|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0|||
147404477|NCT02563548|531645433|FG002|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0|||
147404478|NCT02563548|531645434|FG003|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0|||
147404479|NCT02563548|531645435|FG004|Dose Expansion (Up to 60 Weeks)|Protocol Violation|0|||
147404480|NCT02563548|531645436|FG005|Dose Expansion (Up to 60 Weeks)|Protocol Violation|2|||
147404481|NCT02563548|531645431|FG000|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0|||
147404482|NCT02563548|531645432|FG001|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0|||
147404483|NCT02563548|531645433|FG002|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0|||
147404484|NCT02563548|531645434|FG003|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0|||
147404485|NCT02563548|531645435|FG004|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|0|||
147404486|NCT02563548|531645436|FG005|Dose Expansion (Up to 60 Weeks)|Increased brain lesions|1|||
147404487|NCT02563548|531645431|FG000|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0|||
147404488|NCT02563548|531645432|FG001|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0|||
147404489|NCT02563548|531645433|FG002|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0|||
147404490|NCT02563548|531645434|FG003|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0|||
147404491|NCT02563548|531645435|FG004|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|1|||
147404492|NCT02563548|531645436|FG005|Dose Expansion (Up to 60 Weeks)|Enrolled but not treated|0|||
147404493|NCT01547598|531645437|FG000|Overall Study|Withdrew consent|1|||
147404494|NCT01547598|531645438|FG001|Overall Study|Withdrew consent|1|||
147404495|NCT01547598|531645437|FG000|Overall Study|Lost to Follow-up|1|||
147404496|NCT01547598|531645438|FG001|Overall Study|Lost to Follow-up|1|||
147404497|NCT01547598|531645437|FG000|Overall Study|Adverse Event|1|||
147404498|NCT01547598|531645438|FG001|Overall Study|Adverse Event|1|||
147404499|NCT01547598|531645437|FG000|Overall Study|Protocol Violation|1|||
147404500|NCT01547598|531645438|FG001|Overall Study|Protocol Violation|1|||
147404501|NCT01547598|531645437|FG000|Overall Study|Other Miscellaneous Reasons|2|||
147404502|NCT01547598|531645438|FG001|Overall Study|Other Miscellaneous Reasons|1|||
147404503|NCT00203047|531645442|FG000|Overall Study|Ongoing: in database - January 29, 2009|131|||
147404504|NCT00203047|531645443|FG001|Overall Study|Ongoing: in database - January 29, 2009|109|||
147404505|NCT00203047|531645442|FG000|Overall Study|Ongoing: not in database - Jan 29, 2009|5|||
147404506|NCT00203047|531645443|FG001|Overall Study|Ongoing: not in database - Jan 29, 2009|1|||
147404507|NCT00203047|531645442|FG000|Overall Study|Withdrawal by Subject|13|||
147404508|NCT00203047|531645443|FG001|Overall Study|Withdrawal by Subject|47|||
147404509|NCT00203047|531645442|FG000|Overall Study|Teva requested participant withdrawal|1|||
147404510|NCT00203047|531645443|FG001|Overall Study|Teva requested participant withdrawal|1|||
147404511|NCT00203047|531645442|FG000|Overall Study|Physician Decision|8|||
147404512|NCT00203047|531645443|FG001|Overall Study|Physician Decision|7|||
147404513|NCT00203047|531645442|FG000|Overall Study|Non-compliance|4|||
147404514|NCT00203047|531645443|FG001|Overall Study|Non-compliance|8|||
147404515|NCT00203047|531645442|FG000|Overall Study|Protocol Violation|1|||
147404516|NCT00203047|531645443|FG001|Overall Study|Protocol Violation|0|||
147404517|NCT00203047|531645442|FG000|Overall Study|Lost to Follow-up|11|||
147404518|NCT00203047|531645443|FG001|Overall Study|Lost to Follow-up|5|||
147404519|NCT00203047|531645442|FG000|Overall Study|Adverse Event|8|||
147404520|NCT00203047|531645443|FG001|Overall Study|Adverse Event|18|||
147404521|NCT00203047|531645442|FG000|Overall Study|Death|1|||
147404522|NCT00203047|531645443|FG001|Overall Study|Death|2|||
147404523|NCT00203047|531645442|FG000|Overall Study|Pregnancy|3|||
147616288|NCT02556801|532410995|FG000|Overall Study|Lost to Follow-up|1|||
147616289|NCT02556801|532410996|FG001|Overall Study|Lost to Follow-up|0|||
147616290|NCT02556801|532410997|FG002|Overall Study|Lost to Follow-up|2|||
147404524|NCT00203047|531645443|FG001|Overall Study|Pregnancy|0|||
147404525|NCT00203047|531645442|FG000|Overall Study|Other|5|||
147404526|NCT00203047|531645443|FG001|Overall Study|Other|5|||
147404527|NCT00340704|531645444|FG000|PK Study|Adverse Event|0|||
147404528|NCT00340704|531645445|FG001|PK Study|Adverse Event|1|||
147404529|NCT00340704|531645446|FG002|PK Study|Adverse Event|0|||
147404530|NCT00340704|531645447|FG003|PK Study|Adverse Event|0|||
147404531|NCT00340704|531645448|FG004|PK Study|Adverse Event|0|||
147404532|NCT00340704|531645449|FG005|PK Study|Adverse Event|0|||
147404533|NCT00340704|531645450|FG006|PK Study|Adverse Event|0|||
147404534|NCT00340704|531645451|FG007|PK Study|Adverse Event|0|||
147404535|NCT00340704|531645452|FG008|PK Study|Adverse Event|0|||
147404536|NCT00340704|531645444|FG000|PK Study|Not treated|0|||
147404537|NCT00340704|531645445|FG001|PK Study|Not treated|0|||
147404538|NCT00340704|531645446|FG002|PK Study|Not treated|1|||
147404539|NCT00340704|531645447|FG003|PK Study|Not treated|0|||
147404540|NCT00340704|531645448|FG004|PK Study|Not treated|0|||
147404541|NCT00340704|531645449|FG005|PK Study|Not treated|0|||
147404542|NCT00340704|531645450|FG006|PK Study|Not treated|0|||
147404543|NCT00340704|531645451|FG007|PK Study|Not treated|0|||
147404544|NCT00340704|531645452|FG008|PK Study|Not treated|0|||
147404545|NCT00340704|531645444|FG000|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0|||
147404546|NCT00340704|531645445|FG001|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0|||
147404547|NCT00340704|531645446|FG002|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0|||
147404548|NCT00340704|531645447|FG003|Group D- Denovo & 527.51 Rollover Study|Adverse Event|2|||
147404549|NCT00340704|531645448|FG004|Group D- Denovo & 527.51 Rollover Study|Adverse Event|4|||
147404550|NCT00340704|531645449|FG005|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0|||
147404551|NCT00340704|531645450|FG006|Group D- Denovo & 527.51 Rollover Study|Adverse Event|0|||
147404552|NCT00340704|531645451|FG007|Group D- Denovo & 527.51 Rollover Study|Adverse Event|1|||
147404553|NCT00340704|531645452|FG008|Group D- Denovo & 527.51 Rollover Study|Adverse Event|1|||
147404554|NCT00340704|531645444|FG000|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
147404555|NCT00340704|531645445|FG001|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
147404556|NCT00340704|531645446|FG002|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
147404557|NCT00340704|531645447|FG003|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
147404558|NCT00340704|531645448|FG004|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
147404559|NCT00340704|531645449|FG005|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|1|||
147404560|NCT00340704|531645450|FG006|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
147404561|NCT00340704|531645451|FG007|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
147404562|NCT00340704|531645452|FG008|Group D- Denovo & 527.51 Rollover Study|Protocol Violation|0|||
147404563|NCT00340704|531645444|FG000|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
147404564|NCT00340704|531645445|FG001|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
147404565|NCT00340704|531645446|FG002|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
147404566|NCT00340704|531645447|FG003|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
147404567|NCT00340704|531645448|FG004|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|1|||
147404568|NCT00340704|531645449|FG005|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|3|||
147404569|NCT00340704|531645450|FG006|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
147404570|NCT00340704|531645451|FG007|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
147404571|NCT00340704|531645452|FG008|Group D- Denovo & 527.51 Rollover Study|Withdrawal by Subject|0|||
147404572|NCT00340704|531645444|FG000|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0|||
147404573|NCT00340704|531645445|FG001|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0|||
147404574|NCT00340704|531645446|FG002|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0|||
147404575|NCT00340704|531645447|FG003|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0|||
147404576|NCT00340704|531645448|FG004|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|0|||
147404577|NCT00340704|531645449|FG005|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|3|||
147404578|NCT00340704|531645450|FG006|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|53|||
147404579|NCT00340704|531645451|FG007|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|11|||
147404580|NCT00340704|531645452|FG008|Group D- Denovo & 527.51 Rollover Study|Other reason not defined above|28|||
147404581|NCT00121667|531645453|FG000|Short Term (ST) Period|Lack of Efficacy|25|||
147404582|NCT00121667|531645454|FG001|Short Term (ST) Period|Lack of Efficacy|22|||
147404583|NCT00121667|531645455|FG002|Short Term (ST) Period|Lack of Efficacy|27|||
147404584|NCT00121667|531645456|FG003|Short Term (ST) Period|Lack of Efficacy|44|||
147404585|NCT00121667|531645453|FG000|Short Term (ST) Period|Subject Withdrew Consent|8|||
147404586|NCT00121667|531645454|FG001|Short Term (ST) Period|Subject Withdrew Consent|13|||
147404587|NCT00121667|531645455|FG002|Short Term (ST) Period|Subject Withdrew Consent|4|||
147464171|NCT00896532|531860287|FG006|Months 1-24: Romosozumab Treatment Phase|Adverse Event|1|||
147464172|NCT00896532|531860288|FG007|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
147464173|NCT00896532|531860289|FG008|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
147464174|NCT00896532|531860290|FG009|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
147464175|NCT00896532|531860291|FG010|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
147616291|NCT02556801|532410998|FG003|Overall Study|Lost to Follow-up|0|||
147404588|NCT00121667|531645456|FG003|Short Term (ST) Period|Subject Withdrew Consent|11|||
147404589|NCT00121667|531645453|FG000|Short Term (ST) Period|Adverse Event|5|||
147404590|NCT00121667|531645454|FG001|Short Term (ST) Period|Adverse Event|6|||
147404591|NCT00121667|531645455|FG002|Short Term (ST) Period|Adverse Event|5|||
147404592|NCT00121667|531645456|FG003|Short Term (ST) Period|Adverse Event|3|||
147404593|NCT00121667|531645453|FG000|Short Term (ST) Period|Lost to Follow-up|3|||
147404594|NCT00121667|531645454|FG001|Short Term (ST) Period|Lost to Follow-up|4|||
147404595|NCT00121667|531645455|FG002|Short Term (ST) Period|Lost to Follow-up|4|||
147404596|NCT00121667|531645456|FG003|Short Term (ST) Period|Lost to Follow-up|3|||
147404597|NCT00121667|531645453|FG000|Short Term (ST) Period|Poor / Non-compliance|0|||
147404598|NCT00121667|531645454|FG001|Short Term (ST) Period|Poor / Non-compliance|1|||
147404599|NCT00121667|531645455|FG002|Short Term (ST) Period|Poor / Non-compliance|1|||
147404600|NCT00121667|531645456|FG003|Short Term (ST) Period|Poor / Non-compliance|2|||
147404601|NCT00121667|531645453|FG000|Short Term (ST) Period|Subject No Longer Meets Study Criteria|0|||
147404602|NCT00121667|531645454|FG001|Short Term (ST) Period|Subject No Longer Meets Study Criteria|2|||
147404603|NCT00121667|531645455|FG002|Short Term (ST) Period|Subject No Longer Meets Study Criteria|0|||
147404604|NCT00121667|531645456|FG003|Short Term (ST) Period|Subject No Longer Meets Study Criteria|2|||
147404605|NCT00121667|531645453|FG000|Short Term (ST) Period|Other Reason|3|||
147404606|NCT00121667|531645454|FG001|Short Term (ST) Period|Other Reason|0|||
147404607|NCT00121667|531645455|FG002|Short Term (ST) Period|Other Reason|0|||
147404608|NCT00121667|531645456|FG003|Short Term (ST) Period|Other Reason|0|||
147404609|NCT00121667|531645453|FG000|Short Term (ST) Period|Death|0|||
147404610|NCT00121667|531645454|FG001|Short Term (ST) Period|Death|0|||
147404611|NCT00121667|531645455|FG002|Short Term (ST) Period|Death|0|||
147404612|NCT00121667|531645456|FG003|Short Term (ST) Period|Death|1|||
147404613|NCT00121667|531645453|FG000|Short Term (ST) Period|Pregnancy|0|||
147404614|NCT00121667|531645454|FG001|Short Term (ST) Period|Pregnancy|0|||
147404615|NCT00121667|531645455|FG002|Short Term (ST) Period|Pregnancy|0|||
147404616|NCT00121667|531645456|FG003|Short Term (ST) Period|Pregnancy|1|||
147404617|NCT00121667|531645453|FG000|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|54|||
147404618|NCT00121667|531645454|FG001|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|51|||
147404619|NCT00121667|531645455|FG002|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|42|||
147404620|NCT00121667|531645456|FG003|Short Term (ST) + Long Term (LT) Period|Lack of Efficacy|65|||
147404621|NCT00121667|531645453|FG000|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|38|||
147404622|NCT00121667|531645454|FG001|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|34|||
147404623|NCT00121667|531645455|FG002|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|26|||
147404624|NCT00121667|531645456|FG003|Short Term (ST) + Long Term (LT) Period|Subject Withdrew Consent|30|||
147404625|NCT00121667|531645453|FG000|Short Term (ST) + Long Term (LT) Period|Adverse Event|12|||
147404626|NCT00121667|531645454|FG001|Short Term (ST) + Long Term (LT) Period|Adverse Event|18|||
147404627|NCT00121667|531645455|FG002|Short Term (ST) + Long Term (LT) Period|Adverse Event|13|||
147404628|NCT00121667|531645456|FG003|Short Term (ST) + Long Term (LT) Period|Adverse Event|10|||
147404629|NCT00121667|531645453|FG000|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|11|||
147404630|NCT00121667|531645454|FG001|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|11|||
147404631|NCT00121667|531645455|FG002|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|13|||
147404632|NCT00121667|531645456|FG003|Short Term (ST) + Long Term (LT) Period|Lost to Follow-up|16|||
147404633|NCT00121667|531645453|FG000|Short Term (ST) + Long Term (LT) Period|Other Reason|5|||
147404634|NCT00121667|531645454|FG001|Short Term (ST) + Long Term (LT) Period|Other Reason|7|||
147404635|NCT00121667|531645455|FG002|Short Term (ST) + Long Term (LT) Period|Other Reason|6|||
147404636|NCT00121667|531645456|FG003|Short Term (ST) + Long Term (LT) Period|Other Reason|3|||
147404637|NCT00121667|531645453|FG000|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|3|||
147404638|NCT00121667|531645454|FG001|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|6|||
147404639|NCT00121667|531645455|FG002|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|5|||
147404640|NCT00121667|531645456|FG003|Short Term (ST) + Long Term (LT) Period|Subject No Longer Meets Study Criteria|9|||
147404641|NCT00121667|531645453|FG000|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|3|||
147404642|NCT00121667|531645454|FG001|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|5|||
147404643|NCT00121667|531645455|FG002|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|8|||
147404644|NCT00121667|531645456|FG003|Short Term (ST) + Long Term (LT) Period|Poor / Non-compliance|4|||
147404645|NCT00121667|531645453|FG000|Short Term (ST) + Long Term (LT) Period|Pregnancy|1|||
147404646|NCT00121667|531645454|FG001|Short Term (ST) + Long Term (LT) Period|Pregnancy|1|||
147404647|NCT00121667|531645455|FG002|Short Term (ST) + Long Term (LT) Period|Pregnancy|0|||
147404648|NCT00121667|531645456|FG003|Short Term (ST) + Long Term (LT) Period|Pregnancy|1|||
147404649|NCT00121667|531645453|FG000|Short Term (ST) + Long Term (LT) Period|Death|1|||
147404650|NCT00121667|531645454|FG001|Short Term (ST) + Long Term (LT) Period|Death|0|||
147404651|NCT00121667|531645455|FG002|Short Term (ST) + Long Term (LT) Period|Death|0|||
147404652|NCT00121667|531645456|FG003|Short Term (ST) + Long Term (LT) Period|Death|2|||
147404653|NCT02879383|531645457|FG000|First 24 Weeks|Physician Decision|0|||
147404654|NCT02879383|531645458|FG001|First 24 Weeks|Physician Decision|1|||
147404655|NCT02879383|531645459|FG002|First 24 Weeks|Physician Decision|0|||
147464176|NCT00896532|531860292|FG011|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
147404656|NCT02879383|531645460|FG003|First 24 Weeks|Physician Decision|0|||
147404657|NCT05186311|531645461|FG000|Part A: Serum|Withdrawal by Subject|1|||
147404658|NCT02125279|531645462|FG000|Overall Study|Lack of Efficacy|2|||
147404659|NCT02125279|531645462|FG000|Overall Study|Withdrawal by Subject|6|||
147404660|NCT02125279|531645462|FG000|Overall Study|Protocol Violation|1|||
147404661|NCT02125279|531645462|FG000|Overall Study|Lost to Follow-up|4|||
147404662|NCT01607879|531645467|FG000|Overall Study|Death|1|||
147404663|NCT01607879|531645468|FG001|Overall Study|Death|0|||
147404664|NCT03845140|531645472|FG000|Overall Study|Participant travelled outside study area|0|||
147404665|NCT03845140|531645473|FG001|Overall Study|Participant travelled outside study area|1|||
147404666|NCT03845140|531645474|FG002|Overall Study|Participant travelled outside study area|0|||
147404667|NCT03845140|531645475|FG003|Overall Study|Participant travelled outside study area|0|||
147404668|NCT03845140|531645476|FG004|Overall Study|Participant travelled outside study area|0|||
147404669|NCT03845140|531645477|FG005|Overall Study|Participant travelled outside study area|0|||
147404670|NCT01592045|531645485|FG000|Overall Study|Disease Progression|1|||
147404671|NCT01592045|531645486|FG001|Overall Study|Disease Progression|1|||
147404672|NCT01592045|531645485|FG000|Overall Study|Adverse Event|1|||
147404673|NCT01592045|531645486|FG001|Overall Study|Adverse Event|1|||
147404674|NCT01592045|531645485|FG000|Overall Study|Withdrawal by Subject|1|||
147404675|NCT01592045|531645486|FG001|Overall Study|Withdrawal by Subject|0|||
147404676|NCT01592045|531645485|FG000|Overall Study|Moved out of country|2|||
147404677|NCT01592045|531645486|FG001|Overall Study|Moved out of country|0|||
147404678|NCT00742326|531645493|FG000|Overall Study|Physician Decision|0|||
147404679|NCT00742326|531645494|FG001|Overall Study|Physician Decision|1|||
147404680|NCT03635086|531645503|FG000|Overall Study|Withdrawal of consent|0|||
147404681|NCT03635086|531645504|FG001|Overall Study|Withdrawal of consent|0|||
147464177|NCT00896532|531860293|FG012|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
147464178|NCT00896532|531860294|FG013|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
147464179|NCT00896532|531860295|FG014|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
147616292|NCT02556801|532410995|FG000|Overall Study|Withdrawal by Subject|1|||
147616293|NCT02556801|532410996|FG001|Overall Study|Withdrawal by Subject|1|||
147616294|NCT02556801|532410997|FG002|Overall Study|Withdrawal by Subject|1|||
147616295|NCT02556801|532410998|FG003|Overall Study|Withdrawal by Subject|0|||
147616296|NCT02556801|532410995|FG000|Overall Study|Protocol Violation|0|||
147616297|NCT02556801|532410996|FG001|Overall Study|Protocol Violation|3|||
147616298|NCT02556801|532410997|FG002|Overall Study|Protocol Violation|1|||
147616299|NCT02556801|532410998|FG003|Overall Study|Protocol Violation|1|||
147616300|NCT02556801|532410995|FG000|Overall Study|Adverse Event|0|||
147616301|NCT02556801|532410996|FG001|Overall Study|Adverse Event|2|||
147616302|NCT02556801|532410997|FG002|Overall Study|Adverse Event|0|||
147616303|NCT02556801|532410998|FG003|Overall Study|Adverse Event|3|||
147616304|NCT02556801|532410995|FG000|Overall Study|Pregnancy|0|||
147616305|NCT02556801|532410996|FG001|Overall Study|Pregnancy|1|||
147616306|NCT02556801|532410997|FG002|Overall Study|Pregnancy|0|||
147616307|NCT02556801|532410998|FG003|Overall Study|Pregnancy|0|||
147616308|NCT02556801|532410995|FG000|Overall Study|Personal reasons patient|0|||
147616309|NCT02556801|532410996|FG001|Overall Study|Personal reasons patient|0|||
147616310|NCT02556801|532410997|FG002|Overall Study|Personal reasons patient|0|||
147616311|NCT02556801|532410998|FG003|Overall Study|Personal reasons patient|1|||
147616312|NCT04747470|532410999|FG000|Overall Study|Death|0|||
147616313|NCT04747470|532411000|FG001|Overall Study|Death|3|||
147616314|NCT04747470|532411001|FG002|Overall Study|Death|2|||
147616315|NCT04747470|532411002|FG003|Overall Study|Death|2|||
147616316|NCT04747470|532411003|FG004|Overall Study|Death|2|||
147616317|NCT04747470|532411004|FG005|Overall Study|Death|0|||
147616318|NCT04747470|532411005|FG006|Overall Study|Death|0|||
147616319|NCT04747470|532411006|FG007|Overall Study|Death|0|||
147616320|NCT04747470|532411007|FG008|Overall Study|Death|0|||
147404682|NCT03635086|531645505|FG002|Overall Study|Withdrawal of consent|1|||
147464180|NCT00896532|531860296|FG015|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
147616321|NCT04747470|532411008|FG009|Overall Study|Death|0|||
147616322|NCT04747470|532411009|FG010|Overall Study|Death|0|||
147616323|NCT04747470|532410999|FG000|Overall Study|Withdrew Consent|0|||
147616324|NCT04747470|532411000|FG001|Overall Study|Withdrew Consent|0|||
147616325|NCT04747470|532411001|FG002|Overall Study|Withdrew Consent|0|||
147665324|NCT02308046|532599527|FG001|Overall Study|Lost to Follow-up|3|||
147404683|NCT03635086|531645506|FG003|Overall Study|Withdrawal of consent|0|||
147404684|NCT03635086|531645507|FG004|Overall Study|Withdrawal of consent|0|||
147404685|NCT03635086|531645503|FG000|Overall Study|Adverse Event|0|||
147616326|NCT04747470|532411002|FG003|Overall Study|Withdrew Consent|1|||
147616327|NCT04747470|532411003|FG004|Overall Study|Withdrew Consent|0|||
147616328|NCT04747470|532411004|FG005|Overall Study|Withdrew Consent|0|||
147616329|NCT04747470|532411005|FG006|Overall Study|Withdrew Consent|0|||
147616330|NCT04747470|532411006|FG007|Overall Study|Withdrew Consent|0|||
147665325|NCT01181167|532599530|FG000|Overall Study|Adverse Event|11|||
147616331|NCT04747470|532411007|FG008|Overall Study|Withdrew Consent|0|||
147616332|NCT04747470|532411008|FG009|Overall Study|Withdrew Consent|0|||
147616333|NCT04747470|532411009|FG010|Overall Study|Withdrew Consent|0|||
147665326|NCT01181167|532599531|FG001|Overall Study|Adverse Event|21|||
147616334|NCT04747470|532410999|FG000|Overall Study|Study Terminated by Sponsor|0|||
147616335|NCT04747470|532411000|FG001|Overall Study|Study Terminated by Sponsor|0|||
147616336|NCT04747470|532411001|FG002|Overall Study|Study Terminated by Sponsor|1|||
147616337|NCT04747470|532411002|FG003|Overall Study|Study Terminated by Sponsor|0|||
147616338|NCT04747470|532411003|FG004|Overall Study|Study Terminated by Sponsor|2|||
147616339|NCT04747470|532411004|FG005|Overall Study|Study Terminated by Sponsor|0|||
147616340|NCT04747470|532411005|FG006|Overall Study|Study Terminated by Sponsor|0|||
147665327|NCT01181167|532599530|FG000|Overall Study|Lost to Follow-up|1|||
147665328|NCT01181167|532599531|FG001|Overall Study|Lost to Follow-up|0|||
147404686|NCT03635086|531645504|FG001|Overall Study|Adverse Event|1|||
147404687|NCT03635086|531645505|FG002|Overall Study|Adverse Event|0|||
147404688|NCT03635086|531645506|FG003|Overall Study|Adverse Event|0|||
147404689|NCT03635086|531645507|FG004|Overall Study|Adverse Event|0|||
147404690|NCT03635086|531645503|FG000|Overall Study|Lost to Follow-up|1|||
147404691|NCT03635086|531645504|FG001|Overall Study|Lost to Follow-up|0|||
147404692|NCT03635086|531645505|FG002|Overall Study|Lost to Follow-up|0|||
147404693|NCT03635086|531645506|FG003|Overall Study|Lost to Follow-up|0|||
147404694|NCT03635086|531645507|FG004|Overall Study|Lost to Follow-up|0|||
147404695|NCT00723125|531645508|FG000|Overall Study|Met Dx|1|||
147404696|NCT00723125|531645509|FG001|Overall Study|Met Dx|0|||
147404697|NCT00723125|531645508|FG000|Overall Study|Withdrawal by Subject|15|||
147404698|NCT00723125|531645509|FG001|Overall Study|Withdrawal by Subject|6|||
147404699|NCT00723125|531645508|FG000|Overall Study|Adverse Event|2|||
147404700|NCT00723125|531645509|FG001|Overall Study|Adverse Event|0|||
147404701|NCT02196077|531645510|FG000|Overall Study|Adverse Event|4|||
147404702|NCT02196077|531645510|FG000|Overall Study|Lack of Efficacy|1|||
147404703|NCT02196077|531645510|FG000|Overall Study|Withdrawal by Subject|14|||
147404704|NCT02196077|531645510|FG000|Overall Study|Physician Decision|1|||
147404705|NCT02196077|531645510|FG000|Overall Study|Lost to Follow-up|3|||
147404706|NCT02196077|531645510|FG000|Overall Study|Protocol Violation|24|||
147404707|NCT04042077|531645513|FG000|Overall Study|Adverse Event|0|||
147404708|NCT04042077|531645514|FG001|Overall Study|Adverse Event|1|||
147404709|NCT04042077|531645513|FG000|Overall Study|Death|2|||
147404710|NCT04042077|531645514|FG001|Overall Study|Death|1|||
147404711|NCT04042077|531645513|FG000|Overall Study|Physician Decision|2|||
147404712|NCT04042077|531645514|FG001|Overall Study|Physician Decision|0|||
147404713|NCT04042077|531645513|FG000|Overall Study|Withdrawal by Subject|3|||
147404714|NCT04042077|531645514|FG001|Overall Study|Withdrawal by Subject|2|||
147404715|NCT04042077|531645513|FG000|Overall Study|Lack of Efficacy|0|||
147404716|NCT04042077|531645514|FG001|Overall Study|Lack of Efficacy|1|||
147404717|NCT03482752|531645517|FG000|Overall Study|Withdrawal by Subject|2|||
147404718|NCT03482752|531645517|FG000|Overall Study|Lost to Follow-up|1|||
147404719|NCT03482752|531645517|FG000|Overall Study|1 participant died 24 days after last dose ie outside the definition of treatment-emergent|1|||
147404720|NCT01080300|531645518|FG000|Overall Study|Adverse Event|49|||
147404721|NCT01080300|531645519|FG001|Overall Study|Adverse Event|35|||
147404722|NCT01080300|531645518|FG000|Overall Study|Lack of Efficacy|12|||
147404723|NCT01080300|531645519|FG001|Overall Study|Lack of Efficacy|15|||
147404724|NCT01080300|531645518|FG000|Overall Study|Protocol Violation|7|||
147404725|NCT01080300|531645519|FG001|Overall Study|Protocol Violation|13|||
147404726|NCT01080300|531645518|FG000|Overall Study|Lost to Follow-up|10|||
147404727|NCT01080300|531645519|FG001|Overall Study|Lost to Follow-up|6|||
147404728|NCT01080300|531645518|FG000|Overall Study|Death|0|||
147404729|NCT01080300|531645519|FG001|Overall Study|Death|1|||
147404730|NCT01080300|531645518|FG000|Overall Study|Withdrawal by Subject|12|||
147404731|NCT01080300|531645519|FG001|Overall Study|Withdrawal by Subject|28|||
147404732|NCT01080300|531645518|FG000|Overall Study|Reasons not specified|4|||
147404733|NCT01080300|531645519|FG001|Overall Study|Reasons not specified|6|||
147404734|NCT02844777|531645520|FG000|Overall Study|Withdrawal by Subject|2|||
147404735|NCT02844777|531645521|FG001|Overall Study|Withdrawal by Subject|0|||
147404736|NCT02844777|531645522|FG002|Overall Study|Withdrawal by Subject|0|||
147404737|NCT01776008|531645523|FG000|Overall Study|ineligible|2|||
147404738|NCT00150618|531645524|FG000|Overall Study|Adverse Event|2|||
147404739|NCT00150618|531645525|FG001|Overall Study|Adverse Event|2|||
147404740|NCT00150618|531645526|FG002|Overall Study|Adverse Event|6|||
147404741|NCT00150618|531645527|FG003|Overall Study|Adverse Event|9|||
147616341|NCT04747470|532411006|FG007|Overall Study|Study Terminated by Sponsor|0|||
147665329|NCT01181167|532599530|FG000|Overall Study|Physician Decision|2|||
147665330|NCT01181167|532599531|FG001|Overall Study|Physician Decision|3|||
147665331|NCT01181167|532599530|FG000|Overall Study|Protocol Violation|3|||
147665332|NCT01181167|532599531|FG001|Overall Study|Protocol Violation|0|||
147404742|NCT00150618|531645528|FG004|Overall Study|Adverse Event|5|||
147404743|NCT00150618|531645524|FG000|Overall Study|Withdrawal by Subject|6|||
147404744|NCT00150618|531645525|FG001|Overall Study|Withdrawal by Subject|8|||
147404745|NCT00150618|531645526|FG002|Overall Study|Withdrawal by Subject|8|||
147616342|NCT04747470|532411007|FG008|Overall Study|Study Terminated by Sponsor|0|||
147616343|NCT04747470|532411008|FG009|Overall Study|Study Terminated by Sponsor|0|||
147665333|NCT01181167|532599530|FG000|Overall Study|Withdrawal by Subject|6|||
147404746|NCT00150618|531645527|FG003|Overall Study|Withdrawal by Subject|4|||
147665334|NCT01181167|532599531|FG001|Overall Study|Withdrawal by Subject|8|||
147464181|NCT00896532|531860297|FG016|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
147464182|NCT00896532|531860298|FG017|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
147464183|NCT00896532|531860299|FG018|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
147464184|NCT00896532|531860300|FG019|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
147464185|NCT00896532|531860301|FG020|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
147464186|NCT00896532|531860302|FG021|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
147464187|NCT00896532|531860303|FG022|Months 1-24: Romosozumab Treatment Phase|Adverse Event|0|||
147464188|NCT00896532|531860281|FG000|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|4|||
147464189|NCT00896532|531860282|FG001|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|3|||
147464190|NCT00896532|531860283|FG002|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|4|||
147464191|NCT00896532|531860284|FG003|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|6|||
147464192|NCT00896532|531860285|FG004|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|5|||
147464193|NCT00896532|531860286|FG005|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|6|||
147464194|NCT00896532|531860287|FG006|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|4|||
147464195|NCT00896532|531860288|FG007|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|4|||
147464196|NCT00896532|531860289|FG008|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
147464197|NCT00896532|531860290|FG009|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
147464198|NCT00896532|531860291|FG010|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
147464199|NCT00896532|531860292|FG011|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
147464200|NCT00896532|531860293|FG012|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
147464201|NCT00896532|531860294|FG013|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
147464202|NCT00896532|531860295|FG014|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
147464203|NCT00896532|531860296|FG015|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
147464204|NCT00896532|531860297|FG016|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
147464205|NCT00896532|531860298|FG017|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
147464206|NCT00896532|531860299|FG018|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
147464207|NCT00896532|531860300|FG019|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
147464208|NCT00896532|531860301|FG020|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
147464209|NCT00896532|531860302|FG021|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
147464210|NCT00896532|531860303|FG022|Months 1-24: Romosozumab Treatment Phase|Withdrawal by Subject|0|||
147464211|NCT00896532|531860281|FG000|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
147464212|NCT00896532|531860282|FG001|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
147464213|NCT00896532|531860283|FG002|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|2|||
147464214|NCT00896532|531860284|FG003|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
147464215|NCT00896532|531860285|FG004|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|1|||
147464216|NCT00896532|531860286|FG005|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
147464217|NCT00896532|531860287|FG006|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
147464218|NCT00896532|531860288|FG007|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
147464219|NCT00896532|531860289|FG008|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
147464220|NCT00896532|531860290|FG009|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
147464221|NCT00896532|531860291|FG010|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
147464222|NCT00896532|531860292|FG011|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
147464223|NCT00896532|531860293|FG012|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
147464224|NCT00896532|531860294|FG013|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
147464225|NCT00896532|531860295|FG014|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
147464226|NCT00896532|531860296|FG015|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
147464227|NCT00896532|531860297|FG016|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
147464228|NCT00896532|531860298|FG017|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
147464229|NCT00896532|531860299|FG018|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
147464230|NCT00896532|531860300|FG019|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
147464231|NCT00896532|531860301|FG020|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
147464232|NCT00896532|531860302|FG021|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
147464233|NCT00896532|531860303|FG022|Months 1-24: Romosozumab Treatment Phase|Lost to Follow-up|0|||
147464234|NCT00896532|531860281|FG000|Months 1-24: Romosozumab Treatment Phase|Death|1|||
147464235|NCT00896532|531860282|FG001|Months 1-24: Romosozumab Treatment Phase|Death|0|||
147464236|NCT00896532|531860283|FG002|Months 1-24: Romosozumab Treatment Phase|Death|0|||
147464237|NCT00896532|531860284|FG003|Months 1-24: Romosozumab Treatment Phase|Death|1|||
147464238|NCT00896532|531860285|FG004|Months 1-24: Romosozumab Treatment Phase|Death|0|||
147464239|NCT00896532|531860286|FG005|Months 1-24: Romosozumab Treatment Phase|Death|0|||
147464240|NCT00896532|531860287|FG006|Months 1-24: Romosozumab Treatment Phase|Death|0|||
147464241|NCT00896532|531860288|FG007|Months 1-24: Romosozumab Treatment Phase|Death|0|||
147464242|NCT00896532|531860289|FG008|Months 1-24: Romosozumab Treatment Phase|Death|0|||
147616344|NCT04747470|532411009|FG010|Overall Study|Study Terminated by Sponsor|0|||
147404747|NCT00150618|531645528|FG004|Overall Study|Withdrawal by Subject|5|||
147404748|NCT00150618|531645524|FG000|Overall Study|Lost to Follow-up|4|||
147404749|NCT00150618|531645525|FG001|Overall Study|Lost to Follow-up|1|||
147404750|NCT00150618|531645526|FG002|Overall Study|Lost to Follow-up|5|||
147404751|NCT00150618|531645527|FG003|Overall Study|Lost to Follow-up|8|||
147404752|NCT00150618|531645528|FG004|Overall Study|Lost to Follow-up|4|||
147404753|NCT00150618|531645524|FG000|Overall Study|Protocol Violation|1|||
147404754|NCT00150618|531645525|FG001|Overall Study|Protocol Violation|0|||
147404755|NCT00150618|531645526|FG002|Overall Study|Protocol Violation|0|||
147404756|NCT00150618|531645527|FG003|Overall Study|Protocol Violation|0|||
147404757|NCT00150618|531645528|FG004|Overall Study|Protocol Violation|1|||
147404758|NCT00150618|531645524|FG000|Overall Study|Lack of Efficacy|1|||
147404759|NCT00150618|531645525|FG001|Overall Study|Lack of Efficacy|4|||
147404760|NCT00150618|531645526|FG002|Overall Study|Lack of Efficacy|7|||
147404761|NCT00150618|531645527|FG003|Overall Study|Lack of Efficacy|4|||
147404762|NCT00150618|531645528|FG004|Overall Study|Lack of Efficacy|6|||
147404763|NCT00150618|531645524|FG000|Overall Study|No study meds|0|||
147404764|NCT00150618|531645525|FG001|Overall Study|No study meds|0|||
147404765|NCT00150618|531645526|FG002|Overall Study|No study meds|0|||
147404766|NCT00150618|531645527|FG003|Overall Study|No study meds|0|||
147404767|NCT00150618|531645528|FG004|Overall Study|No study meds|2|||
147404768|NCT00150618|531645524|FG000|Overall Study|Physician Decision|0|||
147404769|NCT00150618|531645525|FG001|Overall Study|Physician Decision|2|||
147404770|NCT00150618|531645526|FG002|Overall Study|Physician Decision|0|||
147404771|NCT00150618|531645527|FG003|Overall Study|Physician Decision|0|||
147404772|NCT00150618|531645528|FG004|Overall Study|Physician Decision|1|||
147404773|NCT00150618|531645524|FG000|Overall Study|Lack of compliance|2|||
147404774|NCT00150618|531645525|FG001|Overall Study|Lack of compliance|1|||
147404775|NCT00150618|531645526|FG002|Overall Study|Lack of compliance|1|||
147404776|NCT00150618|531645527|FG003|Overall Study|Lack of compliance|0|||
147404777|NCT00150618|531645528|FG004|Overall Study|Lack of compliance|1|||
147404778|NCT00150618|531645524|FG000|Overall Study|Abnormal ECG|1|||
147404779|NCT00150618|531645525|FG001|Overall Study|Abnormal ECG|0|||
147404780|NCT00150618|531645526|FG002|Overall Study|Abnormal ECG|0|||
147404781|NCT00150618|531645527|FG003|Overall Study|Abnormal ECG|0|||
147404782|NCT00150618|531645528|FG004|Overall Study|Abnormal ECG|0|||
147404783|NCT00150618|531645524|FG000|Overall Study|Sponsor's decision|0|||
147404784|NCT00150618|531645525|FG001|Overall Study|Sponsor's decision|0|||
147404785|NCT00150618|531645526|FG002|Overall Study|Sponsor's decision|0|||
147404786|NCT00150618|531645527|FG003|Overall Study|Sponsor's decision|1|||
147404787|NCT00150618|531645528|FG004|Overall Study|Sponsor's decision|0|||
147404788|NCT01162486|531645530|FG000|Overall Study|low ANC|1|||
147404789|NCT01162486|531645531|FG001|Overall Study|low ANC|0|||
147404790|NCT01162486|531645532|FG002|Overall Study|low ANC|0|||
147404791|NCT01162486|531645533|FG003|Overall Study|low ANC|0|||
147404792|NCT01162486|531645534|FG004|Overall Study|low ANC|0|||
147404793|NCT01162486|531645530|FG000|Overall Study|vomited Rifampin/ gagged with midazolam|1|||
147404794|NCT01162486|531645531|FG001|Overall Study|vomited Rifampin/ gagged with midazolam|0|||
147404795|NCT01162486|531645532|FG002|Overall Study|vomited Rifampin/ gagged with midazolam|0|||
147404796|NCT01162486|531645533|FG003|Overall Study|vomited Rifampin/ gagged with midazolam|0|||
147404797|NCT01162486|531645534|FG004|Overall Study|vomited Rifampin/ gagged with midazolam|0|||
147404798|NCT01162486|531645530|FG000|Overall Study|elevated LFTs|0|||
147404799|NCT01162486|531645531|FG001|Overall Study|elevated LFTs|0|||
147404800|NCT01162486|531645532|FG002|Overall Study|elevated LFTs|1|||
147404801|NCT01162486|531645533|FG003|Overall Study|elevated LFTs|0|||
147404802|NCT01162486|531645534|FG004|Overall Study|elevated LFTs|0|||
147404803|NCT01162486|531645530|FG000|Overall Study|Pregnancy|0|||
147404804|NCT01162486|531645531|FG001|Overall Study|Pregnancy|0|||
147404805|NCT01162486|531645532|FG002|Overall Study|Pregnancy|0|||
147404806|NCT01162486|531645533|FG003|Overall Study|Pregnancy|1|||
147404807|NCT01162486|531645534|FG004|Overall Study|Pregnancy|0|||
147404808|NCT00953615|531645535|FG000|Overall Study|Adverse Event|1|||
147404809|NCT02498236|531645538|FG000|Overall Study|Did not show for testing|1|||
147404810|NCT02498236|531645539|FG001|Overall Study|Did not show for testing|0|||
147404811|NCT02498236|531645540|FG002|Overall Study|Did not show for testing|0|||
147404812|NCT02498236|531645541|FG003|Overall Study|Did not show for testing|0|||
147404813|NCT02498236|531645542|FG004|Overall Study|Did not show for testing|0|||
147404814|NCT02498236|531645543|FG005|Overall Study|Did not show for testing|0|||
147404815|NCT02498236|531645544|FG006|Overall Study|Did not show for testing|0|||
147404816|NCT02498236|531645545|FG007|Overall Study|Did not show for testing|1|||
147404817|NCT02498236|531645538|FG000|Overall Study|Equipment failure|0|||
147404818|NCT02498236|531645539|FG001|Overall Study|Equipment failure|0|||
147404819|NCT02498236|531645540|FG002|Overall Study|Equipment failure|0|||
147404820|NCT02498236|531645541|FG003|Overall Study|Equipment failure|0|||
147404821|NCT02498236|531645542|FG004|Overall Study|Equipment failure|0|||
147404822|NCT02498236|531645543|FG005|Overall Study|Equipment failure|0|||
147404823|NCT02498236|531645544|FG006|Overall Study|Equipment failure|1|||
147404824|NCT02498236|531645545|FG007|Overall Study|Equipment failure|0|||
147404825|NCT02498236|531645538|FG000|Overall Study|Withdrawal by Subject|0|||
147404826|NCT02498236|531645539|FG001|Overall Study|Withdrawal by Subject|0|||
147404827|NCT02498236|531645540|FG002|Overall Study|Withdrawal by Subject|0|||
147404828|NCT02498236|531645541|FG003|Overall Study|Withdrawal by Subject|0|||
147404829|NCT02498236|531645542|FG004|Overall Study|Withdrawal by Subject|1|||
147404830|NCT02498236|531645543|FG005|Overall Study|Withdrawal by Subject|0|||
147404831|NCT02498236|531645544|FG006|Overall Study|Withdrawal by Subject|0|||
147404832|NCT02498236|531645545|FG007|Overall Study|Withdrawal by Subject|0|||
147404833|NCT02296892|531645546|FG000|Overall Study|Exclusion Criteria at Day of Procedure|7|||
147404834|NCT02296892|531645547|FG001|Overall Study|Exclusion Criteria at Day of Procedure|4|||
147404835|NCT02296892|531645548|FG002|Overall Study|Exclusion Criteria at Day of Procedure|4|||
147404836|NCT02296892|531645546|FG000|Overall Study|Lost to Follow-up|5|||
147404837|NCT02296892|531645547|FG001|Overall Study|Lost to Follow-up|0|||
147404838|NCT02296892|531645548|FG002|Overall Study|Lost to Follow-up|1|||
147404839|NCT00585078|531645549|FG000|Overall Study|Withdrawal by Subject|4|||
147404840|NCT00585078|531645549|FG000|Overall Study|Poor performance status|1|||
147404841|NCT00585078|531645549|FG000|Overall Study|Disease Progression|24|||
147404842|NCT00585078|531645549|FG000|Overall Study|Adverse Event|10|||
147404843|NCT00585078|531645549|FG000|Overall Study|Death|1|||
147404844|NCT01814072|531645552|FG000|Overall Study|Lost to Follow-up|2|||
147404845|NCT01814072|531645553|FG001|Overall Study|Lost to Follow-up|2|||
147404846|NCT01814072|531645554|FG002|Overall Study|Lost to Follow-up|2|||
147404847|NCT01814072|531645555|FG003|Overall Study|Lost to Follow-up|0|||
147404848|NCT01814072|531645556|FG004|Overall Study|Lost to Follow-up|2|||
147404849|NCT01814072|531645557|FG005|Overall Study|Lost to Follow-up|3|||
147404850|NCT01814072|531645558|FG006|Overall Study|Lost to Follow-up|3|||
147404851|NCT01814072|531645559|FG007|Overall Study|Lost to Follow-up|1|||
147404852|NCT01814072|531645560|FG008|Overall Study|Lost to Follow-up|2|||
147404853|NCT01814072|531645561|FG009|Overall Study|Lost to Follow-up|3|||
147404854|NCT01814072|531645562|FG010|Overall Study|Lost to Follow-up|1|||
147404855|NCT01814072|531645563|FG011|Overall Study|Lost to Follow-up|2|||
147404856|NCT01814072|531645564|FG012|Overall Study|Lost to Follow-up|2|||
147404857|NCT01814072|531645565|FG013|Overall Study|Lost to Follow-up|1|||
147404858|NCT01814072|531645566|FG014|Overall Study|Lost to Follow-up|2|||
147404859|NCT01814072|531645567|FG015|Overall Study|Lost to Follow-up|1|||
147404860|NCT01814072|531645568|FG016|Overall Study|Lost to Follow-up|3|||
147404861|NCT01814072|531645569|FG017|Overall Study|Lost to Follow-up|1|||
147404862|NCT01814072|531645570|FG018|Overall Study|Lost to Follow-up|3|||
147404863|NCT01814072|531645571|FG019|Overall Study|Lost to Follow-up|3|||
147404864|NCT01814072|531645572|FG020|Overall Study|Lost to Follow-up|2|||
147404865|NCT01814072|531645573|FG021|Overall Study|Lost to Follow-up|1|||
147404866|NCT01814072|531645574|FG022|Overall Study|Lost to Follow-up|3|||
147404867|NCT01814072|531645575|FG023|Overall Study|Lost to Follow-up|1|||
147404868|NCT01814072|531645576|FG024|Overall Study|Lost to Follow-up|4|||
147404869|NCT01814072|531645577|FG025|Overall Study|Lost to Follow-up|1|||
147404870|NCT01814072|531645578|FG026|Overall Study|Lost to Follow-up|1|||
147404871|NCT01814072|531645579|FG027|Overall Study|Lost to Follow-up|2|||
147404872|NCT01814072|531645580|FG028|Overall Study|Lost to Follow-up|3|||
147404873|NCT01814072|531645581|FG029|Overall Study|Lost to Follow-up|3|||
147404874|NCT01814072|531645582|FG030|Overall Study|Lost to Follow-up|2|||
147404875|NCT01814072|531645583|FG031|Overall Study|Lost to Follow-up|0|||
147404876|NCT01814072|531645552|FG000|Overall Study|Withdrawal by Subject|2|||
147404877|NCT01814072|531645553|FG001|Overall Study|Withdrawal by Subject|0|||
147404878|NCT01814072|531645554|FG002|Overall Study|Withdrawal by Subject|1|||
147404879|NCT01814072|531645555|FG003|Overall Study|Withdrawal by Subject|0|||
147404880|NCT01814072|531645556|FG004|Overall Study|Withdrawal by Subject|2|||
147404881|NCT01814072|531645557|FG005|Overall Study|Withdrawal by Subject|3|||
147404882|NCT01814072|531645558|FG006|Overall Study|Withdrawal by Subject|1|||
147404883|NCT01814072|531645559|FG007|Overall Study|Withdrawal by Subject|0|||
147404884|NCT01814072|531645560|FG008|Overall Study|Withdrawal by Subject|1|||
147404885|NCT01814072|531645561|FG009|Overall Study|Withdrawal by Subject|2|||
147404886|NCT01814072|531645562|FG010|Overall Study|Withdrawal by Subject|0|||
147404887|NCT01814072|531645563|FG011|Overall Study|Withdrawal by Subject|0|||
147404888|NCT01814072|531645564|FG012|Overall Study|Withdrawal by Subject|1|||
147404889|NCT01814072|531645565|FG013|Overall Study|Withdrawal by Subject|1|||
147404890|NCT01814072|531645566|FG014|Overall Study|Withdrawal by Subject|1|||
147616345|NCT01942993|532411010|FG000|Overall Study|Lost to Follow-up|1|||
147404891|NCT01814072|531645567|FG015|Overall Study|Withdrawal by Subject|1|||
147404892|NCT01814072|531645568|FG016|Overall Study|Withdrawal by Subject|0|||
147404893|NCT01814072|531645569|FG017|Overall Study|Withdrawal by Subject|0|||
147404894|NCT01814072|531645570|FG018|Overall Study|Withdrawal by Subject|0|||
147404895|NCT01814072|531645571|FG019|Overall Study|Withdrawal by Subject|2|||
147404896|NCT01814072|531645572|FG020|Overall Study|Withdrawal by Subject|0|||
147404897|NCT01814072|531645573|FG021|Overall Study|Withdrawal by Subject|0|||
147404898|NCT01814072|531645574|FG022|Overall Study|Withdrawal by Subject|1|||
147404899|NCT01814072|531645575|FG023|Overall Study|Withdrawal by Subject|0|||
147404900|NCT01814072|531645576|FG024|Overall Study|Withdrawal by Subject|2|||
147404901|NCT01814072|531645577|FG025|Overall Study|Withdrawal by Subject|1|||
147404902|NCT01814072|531645578|FG026|Overall Study|Withdrawal by Subject|1|||
147404903|NCT01814072|531645579|FG027|Overall Study|Withdrawal by Subject|2|||
147404904|NCT01814072|531645580|FG028|Overall Study|Withdrawal by Subject|1|||
147404905|NCT01814072|531645581|FG029|Overall Study|Withdrawal by Subject|0|||
147404906|NCT01814072|531645582|FG030|Overall Study|Withdrawal by Subject|0|||
147404907|NCT01814072|531645583|FG031|Overall Study|Withdrawal by Subject|0|||
147404908|NCT00383123|531645584|FG000|Overall Study|Adverse Event|1|||
147404909|NCT00383123|531645585|FG001|Overall Study|Adverse Event|0|||
147404910|NCT00383123|531645584|FG000|Overall Study|Lost to Follow-up|68|||
147404911|NCT00383123|531645585|FG001|Overall Study|Lost to Follow-up|61|||
147404912|NCT00383123|531645584|FG000|Overall Study|Protocol Violation|5|||
147404913|NCT00383123|531645585|FG001|Overall Study|Protocol Violation|1|||
147404914|NCT00383123|531645584|FG000|Overall Study|Withdrawal by Subject|27|||
147404915|NCT00383123|531645585|FG001|Overall Study|Withdrawal by Subject|18|||
147404916|NCT00383123|531645584|FG000|Overall Study|Other reason|10|||
147404917|NCT00383123|531645585|FG001|Overall Study|Other reason|6|||
147404918|NCT03566979|531645587|FG000|Overall Study|Withdrawal by Subject|2|||
147404919|NCT03566979|531645588|FG001|Overall Study|Withdrawal by Subject|0|||
147404920|NCT03566979|531645589|FG002|Overall Study|Withdrawal by Subject|1|||
147404921|NCT03566979|531645590|FG003|Overall Study|Withdrawal by Subject|1|||
147404922|NCT03566979|531645587|FG000|Overall Study|Lost to Follow-up|2|||
147404923|NCT03566979|531645588|FG001|Overall Study|Lost to Follow-up|7|||
147404924|NCT03566979|531645589|FG002|Overall Study|Lost to Follow-up|9|||
147404925|NCT03566979|531645590|FG003|Overall Study|Lost to Follow-up|5|||
147404926|NCT03566979|531645587|FG000|Overall Study|Adverse Event|1|||
147404927|NCT03566979|531645588|FG001|Overall Study|Adverse Event|0|||
147404928|NCT03566979|531645589|FG002|Overall Study|Adverse Event|0|||
147404929|NCT03566979|531645590|FG003|Overall Study|Adverse Event|0|||
147404930|NCT04547023|531645597|FG000|Overall Study|Did Not Receive Intervention|3|||
147404931|NCT04547023|531645598|FG001|Overall Study|Did Not Receive Intervention|2|||
147404932|NCT04547023|531645597|FG000|Overall Study|Lost to Follow-up|1|||
147404933|NCT04547023|531645598|FG001|Overall Study|Lost to Follow-up|1|||
147404934|NCT01011868|531645599|FG000|After Week 18 Follow-up|Adverse Event|8|||
147404935|NCT01011868|531645600|FG001|After Week 18 Follow-up|Adverse Event|6|||
147404936|NCT01011868|531645601|FG002|After Week 18 Follow-up|Adverse Event|13|||
147404937|NCT01011868|531645599|FG000|After Week 18 Follow-up|Lack of Efficacy|1|||
147404938|NCT01011868|531645600|FG001|After Week 18 Follow-up|Lack of Efficacy|0|||
147404939|NCT01011868|531645601|FG002|After Week 18 Follow-up|Lack of Efficacy|0|||
147404940|NCT01011868|531645599|FG000|After Week 18 Follow-up|Protocol Violation|1|||
147404941|NCT01011868|531645600|FG001|After Week 18 Follow-up|Protocol Violation|1|||
147404942|NCT01011868|531645601|FG002|After Week 18 Follow-up|Protocol Violation|1|||
147404943|NCT01011868|531645599|FG000|After Week 18 Follow-up|Lost to Follow-up|5|||
147404944|NCT01011868|531645600|FG001|After Week 18 Follow-up|Lost to Follow-up|3|||
147404945|NCT01011868|531645601|FG002|After Week 18 Follow-up|Lost to Follow-up|0|||
147404946|NCT01011868|531645599|FG000|After Week 18 Follow-up|Withdrawal by Subject|6|||
147404947|NCT01011868|531645600|FG001|After Week 18 Follow-up|Withdrawal by Subject|3|||
147404948|NCT01011868|531645601|FG002|After Week 18 Follow-up|Withdrawal by Subject|0|||
147404949|NCT01011868|531645599|FG000|After Week 18 Follow-up|Other reason not defined above|2|||
147404950|NCT01011868|531645600|FG001|After Week 18 Follow-up|Other reason not defined above|3|||
147404951|NCT01011868|531645601|FG002|After Week 18 Follow-up|Other reason not defined above|12|||
147404952|NCT01011868|531645599|FG000|After Week 78 Follow-up|Adverse Event|14|||
147404953|NCT01011868|531645600|FG001|After Week 78 Follow-up|Adverse Event|18|||
147404954|NCT01011868|531645601|FG002|After Week 78 Follow-up|Adverse Event|21|||
147404955|NCT01011868|531645599|FG000|After Week 78 Follow-up|Lack of Efficacy|4|||
147404956|NCT01011868|531645600|FG001|After Week 78 Follow-up|Lack of Efficacy|0|||
147404957|NCT01011868|531645601|FG002|After Week 78 Follow-up|Lack of Efficacy|0|||
147404958|NCT01011868|531645599|FG000|After Week 78 Follow-up|Protocol Violation|9|||
147404959|NCT01011868|531645600|FG001|After Week 78 Follow-up|Protocol Violation|1|||
147404960|NCT01011868|531645601|FG002|After Week 78 Follow-up|Protocol Violation|2|||
147404961|NCT01011868|531645599|FG000|After Week 78 Follow-up|Lost to Follow-up|11|||
147404962|NCT01011868|531645600|FG001|After Week 78 Follow-up|Lost to Follow-up|6|||
147404963|NCT01011868|531645601|FG002|After Week 78 Follow-up|Lost to Follow-up|4|||
147404964|NCT01011868|531645599|FG000|After Week 78 Follow-up|Withdrawal by Subject|9|||
147404965|NCT01011868|531645600|FG001|After Week 78 Follow-up|Withdrawal by Subject|8|||
147404966|NCT01011868|531645601|FG002|After Week 78 Follow-up|Withdrawal by Subject|1|||
147404967|NCT01011868|531645599|FG000|After Week 78 Follow-up|Other reason not defined above|5|||
147404968|NCT01011868|531645600|FG001|After Week 78 Follow-up|Other reason not defined above|5|||
147404969|NCT01011868|531645601|FG002|After Week 78 Follow-up|Other reason not defined above|16|||
147404970|NCT01262092|531645602|FG000|Buprenorphine+Gabapentin/Plac Induction|Lost to Follow-up|2|||
147404971|NCT01262092|531645603|FG001|Buprenorphine+Gabapentin/Plac Induction|Lost to Follow-up|1|||
147404972|NCT01262092|531645602|FG000|Buprenorphine+Gabapentin/Plac Induction|Physician Decision|1|||
147616346|NCT01942993|532411010|FG000|Overall Study|Physician Decision|1|||
147404973|NCT01262092|531645603|FG001|Buprenorphine+Gabapentin/Plac Induction|Physician Decision|0|||
147404974|NCT01262092|531645602|FG000|Buprenorphine Taper|noncompliance - missed medication|1|||
147404975|NCT01262092|531645603|FG001|Buprenorphine Taper|noncompliance - missed medication|1|||
147616347|NCT01350271|532411014|FG000|Overall Study|Lost to Follow-up|21|||
147464243|NCT00896532|531860290|FG009|Months 1-24: Romosozumab Treatment Phase|Death|0|||
147464244|NCT00896532|531860291|FG010|Months 1-24: Romosozumab Treatment Phase|Death|0|||
147464245|NCT00896532|531860292|FG011|Months 1-24: Romosozumab Treatment Phase|Death|0|||
147464246|NCT00896532|531860293|FG012|Months 1-24: Romosozumab Treatment Phase|Death|0|||
147464247|NCT00896532|531860294|FG013|Months 1-24: Romosozumab Treatment Phase|Death|0|||
147464248|NCT00896532|531860295|FG014|Months 1-24: Romosozumab Treatment Phase|Death|0|||
147464249|NCT00896532|531860296|FG015|Months 1-24: Romosozumab Treatment Phase|Death|0|||
147464250|NCT00896532|531860297|FG016|Months 1-24: Romosozumab Treatment Phase|Death|0|||
147464251|NCT00896532|531860298|FG017|Months 1-24: Romosozumab Treatment Phase|Death|0|||
147464252|NCT00896532|531860299|FG018|Months 1-24: Romosozumab Treatment Phase|Death|0|||
147464253|NCT00896532|531860300|FG019|Months 1-24: Romosozumab Treatment Phase|Death|0|||
147464254|NCT00896532|531860301|FG020|Months 1-24: Romosozumab Treatment Phase|Death|0|||
147464255|NCT00896532|531860302|FG021|Months 1-24: Romosozumab Treatment Phase|Death|0|||
147464256|NCT00896532|531860303|FG022|Months 1-24: Romosozumab Treatment Phase|Death|0|||
147464257|NCT00896532|531860281|FG000|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
147464258|NCT00896532|531860282|FG001|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
147464259|NCT00896532|531860283|FG002|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|1|||
147464260|NCT00896532|531860284|FG003|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
147464261|NCT00896532|531860285|FG004|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
147464262|NCT00896532|531860286|FG005|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
147464263|NCT00896532|531860287|FG006|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
147464264|NCT00896532|531860288|FG007|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
147464265|NCT00896532|531860289|FG008|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
147464266|NCT00896532|531860290|FG009|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
147464267|NCT00896532|531860291|FG010|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
147464268|NCT00896532|531860292|FG011|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
147464269|NCT00896532|531860293|FG012|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
147464270|NCT00896532|531860294|FG013|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
147665335|NCT03342001|532599532|FG000|Overall Study|Adverse Event|1|||
147665336|NCT03342001|532599532|FG000|Overall Study|Lost to Follow-up|1|||
147665337|NCT01433159|532599533|FG000|Overall Study|Adverse Event|1|||
147665338|NCT01433159|532599534|FG001|Overall Study|Adverse Event|0|||
147404976|NCT01262092|531645602|FG000|Gabapentin Taper|noncompliance - missed medications|1|||
147404977|NCT01262092|531645603|FG001|Gabapentin Taper|noncompliance - missed medications|0|||
147404978|NCT03784820|531645604|FG000|Overall Study|Lost to Follow-up|5|||
147404979|NCT03784820|531645605|FG001|Overall Study|Lost to Follow-up|5|||
147404980|NCT03784820|531645606|FG002|Overall Study|Lost to Follow-up|3|||
147404981|NCT03784820|531645607|FG003|Overall Study|Lost to Follow-up|3|||
147404982|NCT04905849|531645608|FG000|Overall Study|The COVID pandemic devastated this study, as Brookdale efforts focused on resident health and safety|6|||
147404983|NCT04905849|531645609|FG001|Overall Study|The COVID pandemic devastated this study, as Brookdale efforts focused on resident health and safety|0|||
147404984|NCT00838929|531645616|FG000|Overall Study|Protocol Violation|0|||
147404985|NCT00838929|531645617|FG001|Overall Study|Protocol Violation|1|||
147404986|NCT00838929|531645618|FG002|Overall Study|Protocol Violation|0|||
147404987|NCT00838929|531645616|FG000|Overall Study|Disease progression|0|||
147404988|NCT00838929|531645617|FG001|Overall Study|Disease progression|2|||
147404989|NCT00838929|531645618|FG002|Overall Study|Disease progression|1|||
147404990|NCT02358668|531647597|FG000|Overall Study|Adverse Event|2|||
147404991|NCT02358668|531647598|FG001|Overall Study|Adverse Event|0|||
147404992|NCT02358668|531647599|FG002|Overall Study|Adverse Event|0|||
147404993|NCT02358668|531647597|FG000|Overall Study|Withdrawal by Subject|0|||
147404994|NCT02358668|531647598|FG001|Overall Study|Withdrawal by Subject|1|||
147404995|NCT02358668|531647599|FG002|Overall Study|Withdrawal by Subject|0|||
147404996|NCT02419417|531647600|FG000|Overall Study|Disease progression|5|||
147404997|NCT02419417|531647601|FG001|Overall Study|Disease progression|4|||
147404998|NCT02419417|531647602|FG002|Overall Study|Disease progression|13|||
147404999|NCT02419417|531647603|FG003|Overall Study|Disease progression|10|||
147405000|NCT02419417|531647604|FG004|Overall Study|Disease progression|10|||
147405001|NCT02419417|531647605|FG005|Overall Study|Disease progression|3|||
147405002|NCT02419417|531647606|FG006|Overall Study|Disease progression|4|||
147405003|NCT02419417|531647607|FG007|Overall Study|Disease progression|5|||
147405004|NCT02419417|531647608|FG008|Overall Study|Disease progression|13|||
147405005|NCT02419417|531647609|FG009|Overall Study|Disease progression|9|||
147405006|NCT02419417|531647610|FG010|Overall Study|Disease progression|0|||
147405007|NCT02419417|531647600|FG000|Overall Study|Study drug toxicity|0|||
147405008|NCT02419417|531647601|FG001|Overall Study|Study drug toxicity|0|||
147405009|NCT02419417|531647602|FG002|Overall Study|Study drug toxicity|0|||
147405010|NCT02419417|531647603|FG003|Overall Study|Study drug toxicity|0|||
147405011|NCT02419417|531647604|FG004|Overall Study|Study drug toxicity|1|||
147405012|NCT02419417|531647605|FG005|Overall Study|Study drug toxicity|0|||
147405013|NCT02419417|531647606|FG006|Overall Study|Study drug toxicity|0|||
147405014|NCT02419417|531647607|FG007|Overall Study|Study drug toxicity|0|||
147405015|NCT02419417|531647608|FG008|Overall Study|Study drug toxicity|0|||
147405016|NCT02419417|531647609|FG009|Overall Study|Study drug toxicity|0|||
147405017|NCT02419417|531647610|FG010|Overall Study|Study drug toxicity|0|||
147405018|NCT02419417|531647600|FG000|Overall Study|Adverse event unrelated to study drug|0|||
147405019|NCT02419417|531647601|FG001|Overall Study|Adverse event unrelated to study drug|0|||
147405020|NCT02419417|531647602|FG002|Overall Study|Adverse event unrelated to study drug|0|||
147405021|NCT02419417|531647603|FG003|Overall Study|Adverse event unrelated to study drug|0|||
147405022|NCT02419417|531647604|FG004|Overall Study|Adverse event unrelated to study drug|2|||
147405023|NCT02419417|531647605|FG005|Overall Study|Adverse event unrelated to study drug|1|||
147405024|NCT02419417|531647606|FG006|Overall Study|Adverse event unrelated to study drug|0|||
147405025|NCT02419417|531647607|FG007|Overall Study|Adverse event unrelated to study drug|1|||
147405026|NCT02419417|531647608|FG008|Overall Study|Adverse event unrelated to study drug|0|||
147405027|NCT02419417|531647609|FG009|Overall Study|Adverse event unrelated to study drug|0|||
147405028|NCT02419417|531647610|FG010|Overall Study|Adverse event unrelated to study drug|0|||
147405029|NCT02419417|531647600|FG000|Overall Study|Participant request to discontinue|0|||
147405030|NCT02419417|531647601|FG001|Overall Study|Participant request to discontinue|0|||
147405031|NCT02419417|531647602|FG002|Overall Study|Participant request to discontinue|0|||
147405032|NCT02419417|531647603|FG003|Overall Study|Participant request to discontinue|0|||
147405033|NCT02419417|531647604|FG004|Overall Study|Participant request to discontinue|0|||
147405034|NCT02419417|531647605|FG005|Overall Study|Participant request to discontinue|0|||
147405035|NCT02419417|531647606|FG006|Overall Study|Participant request to discontinue|0|||
147405036|NCT02419417|531647607|FG007|Overall Study|Participant request to discontinue|0|||
147405037|NCT02419417|531647608|FG008|Overall Study|Participant request to discontinue|0|||
147405038|NCT02419417|531647609|FG009|Overall Study|Participant request to discontinue|1|||
147405039|NCT02419417|531647610|FG010|Overall Study|Participant request to discontinue|0|||
147405040|NCT02419417|531647600|FG000|Overall Study|Withdrawal by Subject|0|||
147405041|NCT02419417|531647601|FG001|Overall Study|Withdrawal by Subject|0|||
147405042|NCT02419417|531647602|FG002|Overall Study|Withdrawal by Subject|0|||
147405043|NCT02419417|531647603|FG003|Overall Study|Withdrawal by Subject|0|||
147405044|NCT02419417|531647604|FG004|Overall Study|Withdrawal by Subject|0|||
147405045|NCT02419417|531647605|FG005|Overall Study|Withdrawal by Subject|0|||
147405046|NCT02419417|531647606|FG006|Overall Study|Withdrawal by Subject|0|||
147405047|NCT02419417|531647607|FG007|Overall Study|Withdrawal by Subject|0|||
147405048|NCT02419417|531647608|FG008|Overall Study|Withdrawal by Subject|0|||
147405049|NCT02419417|531647609|FG009|Overall Study|Withdrawal by Subject|0|||
147405050|NCT02419417|531647610|FG010|Overall Study|Withdrawal by Subject|1|||
147405051|NCT01240551|531647611|FG000|Overall Study|Refused further treatment|3|||
147405052|NCT01240551|531647612|FG001|Overall Study|Refused further treatment|2|||
147405053|NCT01240551|531647611|FG000|Overall Study|Lost to Follow-up|1|||
147405054|NCT01240551|531647612|FG001|Overall Study|Lost to Follow-up|1|||
147405055|NCT01317875|531647616|FG000|Overall Study|Other|0|||
147405056|NCT01317875|531647617|FG001|Overall Study|Other|0|||
147405057|NCT01317875|531647618|FG002|Overall Study|Other|1|||
147405058|NCT01317875|531647619|FG003|Overall Study|Other|0|||
147405059|NCT01317875|531647620|FG004|Overall Study|Other|0|||
147405060|NCT01317875|531647621|FG005|Overall Study|Other|0|||
147405061|NCT01317875|531647622|FG006|Overall Study|Other|0|||
147405062|NCT01317875|531647623|FG007|Overall Study|Other|0|||
147405063|NCT01317875|531647624|FG008|Overall Study|Other|0|||
147405064|NCT01317875|531647625|FG009|Overall Study|Other|0|||
147405065|NCT01317875|531647616|FG000|Overall Study|Noncompliance with study drug|0|||
147405066|NCT01317875|531647617|FG001|Overall Study|Noncompliance with study drug|0|||
147405067|NCT01317875|531647618|FG002|Overall Study|Noncompliance with study drug|1|||
147405068|NCT01317875|531647619|FG003|Overall Study|Noncompliance with study drug|0|||
147405069|NCT01317875|531647620|FG004|Overall Study|Noncompliance with study drug|0|||
147405070|NCT01317875|531647621|FG005|Overall Study|Noncompliance with study drug|0|||
147405071|NCT01317875|531647622|FG006|Overall Study|Noncompliance with study drug|0|||
147405072|NCT01317875|531647623|FG007|Overall Study|Noncompliance with study drug|0|||
147405073|NCT01317875|531647624|FG008|Overall Study|Noncompliance with study drug|0|||
147405074|NCT01317875|531647625|FG009|Overall Study|Noncompliance with study drug|0|||
147405075|NCT01317875|531647616|FG000|Overall Study|Progressive Disease|1|||
147405076|NCT01317875|531647617|FG001|Overall Study|Progressive Disease|0|||
147405077|NCT01317875|531647618|FG002|Overall Study|Progressive Disease|2|||
147405078|NCT01317875|531647619|FG003|Overall Study|Progressive Disease|0|||
147405079|NCT01317875|531647620|FG004|Overall Study|Progressive Disease|1|||
147405080|NCT01317875|531647621|FG005|Overall Study|Progressive Disease|0|||
147405081|NCT01317875|531647622|FG006|Overall Study|Progressive Disease|0|||
147405082|NCT01317875|531647623|FG007|Overall Study|Progressive Disease|1|||
147405083|NCT01317875|531647624|FG008|Overall Study|Progressive Disease|0|||
147405084|NCT01317875|531647625|FG009|Overall Study|Progressive Disease|0|||
147405085|NCT01317875|531647616|FG000|Overall Study|Withdrawal by Subject|0|||
147405086|NCT01317875|531647617|FG001|Overall Study|Withdrawal by Subject|0|||
147405087|NCT01317875|531647618|FG002|Overall Study|Withdrawal by Subject|0|||
147405088|NCT01317875|531647619|FG003|Overall Study|Withdrawal by Subject|0|||
147405089|NCT01317875|531647620|FG004|Overall Study|Withdrawal by Subject|1|||
147616348|NCT01350271|532411015|FG001|Overall Study|Lost to Follow-up|17|||
147405090|NCT01317875|531647621|FG005|Overall Study|Withdrawal by Subject|0|||
147405091|NCT01317875|531647622|FG006|Overall Study|Withdrawal by Subject|0|||
147405092|NCT01317875|531647623|FG007|Overall Study|Withdrawal by Subject|3|||
147405093|NCT01317875|531647624|FG008|Overall Study|Withdrawal by Subject|0|||
147405094|NCT01317875|531647625|FG009|Overall Study|Withdrawal by Subject|0|||
147405095|NCT01317875|531647616|FG000|Overall Study|Physician Decision|0|||
147405096|NCT01317875|531647617|FG001|Overall Study|Physician Decision|1|||
147405097|NCT01317875|531647618|FG002|Overall Study|Physician Decision|1|||
147405098|NCT01317875|531647619|FG003|Overall Study|Physician Decision|0|||
147405099|NCT01317875|531647620|FG004|Overall Study|Physician Decision|2|||
147405100|NCT01317875|531647621|FG005|Overall Study|Physician Decision|0|||
147405101|NCT01317875|531647622|FG006|Overall Study|Physician Decision|0|||
147464271|NCT00896532|531860295|FG014|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
147464272|NCT00896532|531860296|FG015|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
147464273|NCT00896532|531860297|FG016|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
147464274|NCT00896532|531860298|FG017|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
147464275|NCT00896532|531860299|FG018|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
147464276|NCT00896532|531860300|FG019|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
147464277|NCT00896532|531860301|FG020|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
147464278|NCT00896532|531860302|FG021|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
147464279|NCT00896532|531860303|FG022|Months 1-24: Romosozumab Treatment Phase|Administrative Decision|0|||
147464280|NCT00896532|531860281|FG000|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
147464281|NCT00896532|531860282|FG001|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
147464282|NCT00896532|531860283|FG002|Months 1-24: Romosozumab Treatment Phase|Noncompliance|1|||
147464283|NCT00896532|531860284|FG003|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
147464284|NCT00896532|531860285|FG004|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
147464285|NCT00896532|531860286|FG005|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
147464286|NCT00896532|531860287|FG006|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
147464287|NCT00896532|531860288|FG007|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
147464288|NCT00896532|531860289|FG008|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
147464289|NCT00896532|531860290|FG009|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
147464290|NCT00896532|531860291|FG010|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
147464291|NCT00896532|531860292|FG011|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
147464292|NCT00896532|531860293|FG012|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
147464293|NCT00896532|531860294|FG013|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
147464294|NCT00896532|531860295|FG014|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
147464295|NCT00896532|531860296|FG015|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
147464296|NCT00896532|531860297|FG016|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
147464297|NCT00896532|531860298|FG017|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
147464298|NCT00896532|531860299|FG018|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
147464299|NCT00896532|531860300|FG019|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
147464300|NCT00896532|531860301|FG020|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
147464301|NCT00896532|531860302|FG021|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
147464302|NCT00896532|531860303|FG022|Months 1-24: Romosozumab Treatment Phase|Noncompliance|0|||
147464303|NCT00896532|531860281|FG000|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
147464304|NCT00896532|531860282|FG001|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
147464305|NCT00896532|531860283|FG002|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
147464306|NCT00896532|531860284|FG003|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|1|||
147464307|NCT00896532|531860285|FG004|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
147464308|NCT00896532|531860286|FG005|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
147464309|NCT00896532|531860287|FG006|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
147464310|NCT00896532|531860288|FG007|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
147464311|NCT00896532|531860289|FG008|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
147464312|NCT00896532|531860290|FG009|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
147464313|NCT00896532|531860291|FG010|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
147464314|NCT00896532|531860292|FG011|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
147464315|NCT00896532|531860293|FG012|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
147464316|NCT00896532|531860294|FG013|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
147464317|NCT00896532|531860295|FG014|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
147464318|NCT00896532|531860296|FG015|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
147464319|NCT00896532|531860297|FG016|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
147464320|NCT00896532|531860298|FG017|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
147616349|NCT01350271|532411016|FG002|Overall Study|Lost to Follow-up|26|||
147405102|NCT01317875|531647623|FG007|Overall Study|Physician Decision|2|||
147405103|NCT01317875|531647624|FG008|Overall Study|Physician Decision|0|||
147405104|NCT01317875|531647625|FG009|Overall Study|Physician Decision|0|||
147405105|NCT01317875|531647616|FG000|Overall Study|Death|0|||
147405106|NCT01317875|531647617|FG001|Overall Study|Death|0|||
147405107|NCT01317875|531647618|FG002|Overall Study|Death|2|||
147405108|NCT01317875|531647619|FG003|Overall Study|Death|1|||
147405109|NCT01317875|531647620|FG004|Overall Study|Death|0|||
147405110|NCT01317875|531647621|FG005|Overall Study|Death|1|||
147405111|NCT01317875|531647622|FG006|Overall Study|Death|0|||
147405112|NCT01317875|531647623|FG007|Overall Study|Death|4|||
147405113|NCT01317875|531647624|FG008|Overall Study|Death|0|||
147405114|NCT01317875|531647625|FG009|Overall Study|Death|0|||
147405115|NCT01317875|531647616|FG000|Overall Study|Adverse Event|2|||
147405116|NCT01317875|531647617|FG001|Overall Study|Adverse Event|1|||
147405117|NCT01317875|531647618|FG002|Overall Study|Adverse Event|2|||
147405118|NCT01317875|531647619|FG003|Overall Study|Adverse Event|1|||
147405119|NCT01317875|531647620|FG004|Overall Study|Adverse Event|5|||
147405120|NCT01317875|531647621|FG005|Overall Study|Adverse Event|1|||
147405121|NCT01317875|531647622|FG006|Overall Study|Adverse Event|2|||
147405122|NCT01317875|531647623|FG007|Overall Study|Adverse Event|5|||
147405123|NCT01317875|531647624|FG008|Overall Study|Adverse Event|0|||
147405124|NCT01317875|531647625|FG009|Overall Study|Adverse Event|0|||
147405125|NCT01381575|531647626|FG000|Overall Study|Serious Adverse Event|1|||
147405126|NCT01381575|531647627|FG001|Overall Study|Serious Adverse Event|0|||
147405127|NCT01381575|531647628|FG002|Overall Study|Serious Adverse Event|0|||
147405128|NCT01381575|531647626|FG000|Overall Study|Non-Serious Adverse Event|0|||
147405129|NCT01381575|531647627|FG001|Overall Study|Non-Serious Adverse Event|0|||
147405130|NCT01381575|531647628|FG002|Overall Study|Non-Serious Adverse Event|1|||
147405131|NCT01381575|531647626|FG000|Overall Study|Protocol Violation|0|||
147405132|NCT01381575|531647627|FG001|Overall Study|Protocol Violation|1|||
147405133|NCT01381575|531647628|FG002|Overall Study|Protocol Violation|1|||
147405134|NCT01381575|531647626|FG000|Overall Study|Withdrawal by Subject|15|||
147405135|NCT01381575|531647627|FG001|Overall Study|Withdrawal by Subject|9|||
147405136|NCT01381575|531647628|FG002|Overall Study|Withdrawal by Subject|7|||
147405137|NCT01381575|531647626|FG000|Overall Study|Migrated/moved from study area|2|||
147405138|NCT01381575|531647627|FG001|Overall Study|Migrated/moved from study area|12|||
147405139|NCT01381575|531647628|FG002|Overall Study|Migrated/moved from study area|2|||
147405140|NCT01381575|531647626|FG000|Overall Study|Lost to Follow-up|8|||
147405141|NCT01381575|531647627|FG001|Overall Study|Lost to Follow-up|17|||
147405142|NCT01381575|531647628|FG002|Overall Study|Lost to Follow-up|9|||
147405143|NCT01200342|531647629|FG000|Overall Study|Disease Progression|1|||
147405144|NCT02550938|531647632|FG000|Overall Study|Lost to Follow-up|8|||
147405145|NCT02550938|531647633|FG001|Overall Study|Lost to Follow-up|7|||
147405146|NCT02550938|531647634|FG002|Overall Study|Lost to Follow-up|12|||
147405147|NCT02550938|531647635|FG003|Overall Study|Lost to Follow-up|11|||
147405148|NCT01367847|531647636|FG000|Overall Study|Withdrawal by Subject|2|||
147405149|NCT01367847|531647637|FG001|Overall Study|Withdrawal by Subject|2|||
147405150|NCT01439867|531647638|FG000|Overall Study|Non-compliance|0|||
147405151|NCT01439867|531647639|FG001|Overall Study|Non-compliance|1|||
147405152|NCT01439867|531647638|FG000|Overall Study|Withdrawal by Subject|1|||
147405153|NCT01439867|531647639|FG001|Overall Study|Withdrawal by Subject|2|||
147405154|NCT01439867|531647638|FG000|Overall Study|Administrative Decision|4|||
147405155|NCT01439867|531647639|FG001|Overall Study|Administrative Decision|5|||
147405156|NCT01439867|531647638|FG000|Overall Study|Protocol-specified Criteria|1|||
147405157|NCT01439867|531647639|FG001|Overall Study|Protocol-specified Criteria|0|||
147405158|NCT01375673|531647651|FG000|Overall Study|Withdrawal by Subject|0|||
147405159|NCT01375673|531647652|FG001|Overall Study|Withdrawal by Subject|1|||
147405160|NCT00979953|531647653|FG000|Overall Study|Adverse Event|5|||
147405161|NCT00979953|531647654|FG001|Overall Study|Adverse Event|2|||
147405162|NCT00979953|531647655|FG002|Overall Study|Adverse Event|17|||
147405163|NCT00979953|531647656|FG003|Overall Study|Adverse Event|4|||
147405164|NCT00979953|531647653|FG000|Overall Study|Lack of Efficacy|1|||
147405165|NCT00979953|531647654|FG001|Overall Study|Lack of Efficacy|2|||
147405166|NCT00979953|531647655|FG002|Overall Study|Lack of Efficacy|0|||
147665339|NCT01433159|532599533|FG000|Overall Study|Physician Decision|1|||
147665340|NCT01433159|532599534|FG001|Overall Study|Physician Decision|0|||
147405167|NCT00979953|531647656|FG003|Overall Study|Lack of Efficacy|0|||
147405168|NCT00979953|531647653|FG000|Overall Study|Lost to Follow-up|1|||
147405169|NCT00979953|531647654|FG001|Overall Study|Lost to Follow-up|1|||
147405170|NCT00979953|531647655|FG002|Overall Study|Lost to Follow-up|1|||
147405171|NCT00979953|531647656|FG003|Overall Study|Lost to Follow-up|0|||
147405172|NCT00979953|531647653|FG000|Overall Study|Withdrawal by Subject|0|||
147405173|NCT00979953|531647654|FG001|Overall Study|Withdrawal by Subject|0|||
147405174|NCT00979953|531647655|FG002|Overall Study|Withdrawal by Subject|2|||
147405175|NCT00979953|531647656|FG003|Overall Study|Withdrawal by Subject|1|||
147405176|NCT00979953|531647653|FG000|Overall Study|Protocol Violation|1|||
147405177|NCT00979953|531647654|FG001|Overall Study|Protocol Violation|0|||
147405178|NCT00979953|531647655|FG002|Overall Study|Protocol Violation|2|||
147405179|NCT00979953|531647656|FG003|Overall Study|Protocol Violation|2|||
147405180|NCT00425607|531647661|FG000|Overall Study|Death|1|||
147405181|NCT00425607|531647661|FG000|Overall Study|Withdrawal by Subject|1|||
147405182|NCT01163474|531647665|FG000|Overall Study|Withdrawal by Subject|1|||
147405183|NCT01163474|531647665|FG000|Overall Study|Tech barriers to videoteleconference vis|12|||
147405184|NCT01163474|531647665|FG000|Overall Study|Lost to Follow-up|3|||
147405185|NCT00762476|531647667|FG000|Overall Study|Adverse Event|7|||
147405186|NCT00762476|531647668|FG001|Overall Study|Adverse Event|1|||
147405187|NCT00762476|531647667|FG000|Overall Study|Lost to Follow-up|2|||
147405188|NCT00762476|531647668|FG001|Overall Study|Lost to Follow-up|0|||
147405189|NCT00762476|531647667|FG000|Overall Study|Protocol Violation|5|||
147405190|NCT00762476|531647668|FG001|Overall Study|Protocol Violation|6|||
147405191|NCT00762476|531647667|FG000|Overall Study|Physician Decision|2|||
147405192|NCT00762476|531647668|FG001|Overall Study|Physician Decision|14|||
147405193|NCT00762476|531647667|FG000|Overall Study|Withdrawal by Subject|6|||
147405194|NCT00762476|531647668|FG001|Overall Study|Withdrawal by Subject|12|||
147405195|NCT00762476|531647667|FG000|Overall Study|antibiotic use|0|||
147405196|NCT00762476|531647668|FG001|Overall Study|antibiotic use|1|||
147405197|NCT00762476|531647667|FG000|Overall Study|non-compliance with study visits|0|||
147405198|NCT00762476|531647668|FG001|Overall Study|non-compliance with study visits|2|||
147405199|NCT00762476|531647667|FG000|Overall Study|Seasonal allergies|1|||
147405200|NCT00762476|531647668|FG001|Overall Study|Seasonal allergies|0|||
147405201|NCT00965497|531647669|FG000|Overall Study|Physician Decision|1|||
147405202|NCT02878603|531647670|FG000|Overall Study|Lost to Follow-up|4|||
147405203|NCT02878603|531647671|FG001|Overall Study|Lost to Follow-up|1|||
147405204|NCT02878603|531647670|FG000|Overall Study|Withdrawal by Subject|1|||
147405205|NCT02878603|531647671|FG001|Overall Study|Withdrawal by Subject|1|||
147405206|NCT02878603|531647670|FG000|Overall Study|Death|1|||
147405207|NCT02878603|531647671|FG001|Overall Study|Death|0|||
147405208|NCT02878603|531647670|FG000|Overall Study|Physician Decision|0|||
147405209|NCT02878603|531647671|FG001|Overall Study|Physician Decision|3|||
147405210|NCT02689453|531647672|FG000|Overall Study|Progressive disease|0|||
147405211|NCT02689453|531647673|FG001|Overall Study|Progressive disease|1|||
147405212|NCT02689453|531647674|FG002|Overall Study|Progressive disease|1|||
147405213|NCT02838134|531647675|FG000|Overall Study|Lost to Follow-up|1|||
147405214|NCT02838134|531647676|FG001|Overall Study|Lost to Follow-up|2|||
147405215|NCT02838134|531647675|FG000|Overall Study|logistic problems|1|||
147405216|NCT02838134|531647676|FG001|Overall Study|logistic problems|1|||
147405217|NCT00794924|531647677|FG000|Overall Study|Lost to Follow-up|6|||
147405218|NCT00794924|531647678|FG001|Overall Study|Lost to Follow-up|8|||
147405219|NCT00794924|531647677|FG000|Overall Study|Withdrawal by Subject|48|||
147405220|NCT00794924|531647678|FG001|Overall Study|Withdrawal by Subject|60|||
147405221|NCT00794924|531647677|FG000|Overall Study|Adverse Event|6|||
147405222|NCT00794924|531647678|FG001|Overall Study|Adverse Event|2|||
147405223|NCT03274895|531647679|FG000|Overall Study|Lack of Efficacy|1|||
147405224|NCT03274895|531647680|FG001|Overall Study|Lack of Efficacy|0|||
147405225|NCT03274895|531647679|FG000|Overall Study|Adverse Event|8|||
147405226|NCT03274895|531647680|FG001|Overall Study|Adverse Event|7|||
147405227|NCT03274895|531647679|FG000|Overall Study|Lost to Follow-up|1|||
147405228|NCT03274895|531647680|FG001|Overall Study|Lost to Follow-up|0|||
147405229|NCT03274895|531647679|FG000|Overall Study|Diagnosis not confirmed|3|||
147405230|NCT03274895|531647680|FG001|Overall Study|Diagnosis not confirmed|4|||
147405231|NCT01294436|531647681|FG000|Overall Study|Adverse Event|10|||
147405232|NCT01294436|531647682|FG001|Overall Study|Adverse Event|17|||
147405233|NCT01294436|531647681|FG000|Overall Study|Withdrawal by Subject|11|||
147405234|NCT01294436|531647682|FG001|Overall Study|Withdrawal by Subject|28|||
147405235|NCT01294436|531647681|FG000|Overall Study|subject no longer meets study criteria|5|||
147405236|NCT01294436|531647682|FG001|Overall Study|subject no longer meets study criteria|20|||
147405237|NCT01294436|531647681|FG000|Overall Study|poor/non-compliance|2|||
147405238|NCT01294436|531647682|FG001|Overall Study|poor/non-compliance|5|||
147405239|NCT02389764|531647683|FG000|Overall Study|Lack of Efficacy|9|||
147405240|NCT04674189|531647688|FG000|Overall Study|Adverse Event|0|||
147405241|NCT04674189|531647689|FG001|Overall Study|Adverse Event|0|||
147665341|NCT01433159|532599533|FG000|Overall Study|Protocol Violation|0|||
147405242|NCT04674189|531647690|FG002|Overall Study|Adverse Event|1|||
147405243|NCT04674189|531647688|FG000|Overall Study|Received Alternative Authorized Vaccine|0|||
147405244|NCT04674189|531647689|FG001|Overall Study|Received Alternative Authorized Vaccine|1|||
147405245|NCT04674189|531647690|FG002|Overall Study|Received Alternative Authorized Vaccine|17|||
147405246|NCT04674189|531647688|FG000|Overall Study|Physician Decision|1|||
147405247|NCT04674189|531647689|FG001|Overall Study|Physician Decision|0|||
147405248|NCT04674189|531647690|FG002|Overall Study|Physician Decision|0|||
147405249|NCT04674189|531647688|FG000|Overall Study|Withdrawal by Participant|83|||
147405250|NCT04674189|531647689|FG001|Overall Study|Withdrawal by Participant|71|||
147405251|NCT04674189|531647690|FG002|Overall Study|Withdrawal by Participant|142|||
147405252|NCT04674189|531647688|FG000|Overall Study|Lost to Follow-up|55|||
147405253|NCT04674189|531647689|FG001|Overall Study|Lost to Follow-up|53|||
147405254|NCT04674189|531647690|FG002|Overall Study|Lost to Follow-up|44|||
147405255|NCT04674189|531647688|FG000|Overall Study|Miscellaneous|27|||
147405256|NCT04674189|531647689|FG001|Overall Study|Miscellaneous|23|||
147405257|NCT04674189|531647690|FG002|Overall Study|Miscellaneous|207|||
147405258|NCT04674189|531647688|FG000|Overall Study|Did Not Receive Treatment|3|||
147405259|NCT04674189|531647689|FG001|Overall Study|Did Not Receive Treatment|1|||
147405260|NCT04674189|531647690|FG002|Overall Study|Did Not Receive Treatment|2|||
147405261|NCT01637077|531647691|FG000|Overall Study|Cancel|1|||
147405262|NCT01637077|531647692|FG001|Overall Study|Cancel|1|||
147405263|NCT01637077|531647691|FG000|Overall Study|Withdrawal by Subject|1|||
147405264|NCT01637077|531647692|FG001|Overall Study|Withdrawal by Subject|0|||
147405265|NCT01637077|531647691|FG000|Overall Study|No cycle 1 questionnaire data|2|||
147405266|NCT01637077|531647692|FG001|Overall Study|No cycle 1 questionnaire data|0|||
147405267|NCT02638103|531647694|FG000|Overall Study|Adverse Event|13|||
147405268|NCT02638103|531647695|FG001|Overall Study|Adverse Event|12|||
147405269|NCT02638103|531647696|FG002|Overall Study|Adverse Event|19|||
147405270|NCT02638103|531647697|FG003|Overall Study|Adverse Event|12|||
147405271|NCT02638103|531647694|FG000|Overall Study|Withdrawal by Subject|43|||
147405272|NCT02638103|531647695|FG001|Overall Study|Withdrawal by Subject|53|||
147405273|NCT02638103|531647696|FG002|Overall Study|Withdrawal by Subject|30|||
147464321|NCT00896532|531860299|FG018|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
147464322|NCT00896532|531860300|FG019|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
147464323|NCT00896532|531860301|FG020|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
147464324|NCT00896532|531860302|FG021|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
147464325|NCT00896532|531860303|FG022|Months 1-24: Romosozumab Treatment Phase|On-study But No Month 24 Visit|0|||
147464326|NCT00896532|531860281|FG000|Months 1-24: Romosozumab Treatment Phase|Other|0|||
147464327|NCT00896532|531860282|FG001|Months 1-24: Romosozumab Treatment Phase|Other|1|||
147464328|NCT00896532|531860283|FG002|Months 1-24: Romosozumab Treatment Phase|Other|0|||
147464329|NCT00896532|531860284|FG003|Months 1-24: Romosozumab Treatment Phase|Other|1|||
147464330|NCT00896532|531860285|FG004|Months 1-24: Romosozumab Treatment Phase|Other|1|||
147405274|NCT02638103|531647697|FG003|Overall Study|Withdrawal by Subject|61|||
147405275|NCT02638103|531647694|FG000|Overall Study|Protocol Violation|1|||
147405276|NCT02638103|531647695|FG001|Overall Study|Protocol Violation|2|||
147405277|NCT02638103|531647696|FG002|Overall Study|Protocol Violation|1|||
147405278|NCT02638103|531647697|FG003|Overall Study|Protocol Violation|4|||
147405279|NCT02638103|531647694|FG000|Overall Study|Pregnancy|2|||
147405280|NCT02638103|531647695|FG001|Overall Study|Pregnancy|3|||
147405281|NCT02638103|531647696|FG002|Overall Study|Pregnancy|0|||
147405282|NCT02638103|531647697|FG003|Overall Study|Pregnancy|1|||
147405283|NCT02638103|531647694|FG000|Overall Study|Non-compliance to Study Procedures|2|||
147405284|NCT02638103|531647695|FG001|Overall Study|Non-compliance to Study Procedures|1|||
147405285|NCT02638103|531647696|FG002|Overall Study|Non-compliance to Study Procedures|1|||
147405286|NCT02638103|531647697|FG003|Overall Study|Non-compliance to Study Procedures|1|||
147405287|NCT02638103|531647694|FG000|Overall Study|Lost to Follow-up|26|||
147405288|NCT02638103|531647695|FG001|Overall Study|Lost to Follow-up|33|||
147405289|NCT02638103|531647696|FG002|Overall Study|Lost to Follow-up|20|||
147405290|NCT02638103|531647697|FG003|Overall Study|Lost to Follow-up|37|||
147405291|NCT02638103|531647694|FG000|Overall Study|Lack of Efficacy|14|||
147405292|NCT02638103|531647695|FG001|Overall Study|Lack of Efficacy|10|||
147405293|NCT02638103|531647696|FG002|Overall Study|Lack of Efficacy|12|||
147405294|NCT02638103|531647697|FG003|Overall Study|Lack of Efficacy|22|||
147405295|NCT02638103|531647694|FG000|Overall Study|Other than specified|5|||
147405296|NCT02638103|531647695|FG001|Overall Study|Other than specified|4|||
147405297|NCT02638103|531647696|FG002|Overall Study|Other than specified|2|||
147405298|NCT02638103|531647697|FG003|Overall Study|Other than specified|4|||
147405299|NCT01358331|531647698|FG000|Overall Study|Lost to Follow-up|0|||
147405300|NCT01358331|531647699|FG001|Overall Study|Lost to Follow-up|0|||
147405301|NCT01358331|531647700|FG002|Overall Study|Lost to Follow-up|0|||
147405302|NCT01358331|531647701|FG003|Overall Study|Lost to Follow-up|1|||
147405303|NCT01358331|531647702|FG004|Overall Study|Lost to Follow-up|0|||
147405304|NCT01358331|531647703|FG005|Overall Study|Lost to Follow-up|0|||
147405305|NCT01358331|531647698|FG000|Overall Study|Withdrawal by Subject|0|||
147405306|NCT01358331|531647699|FG001|Overall Study|Withdrawal by Subject|0|||
147464331|NCT00896532|531860286|FG005|Months 1-24: Romosozumab Treatment Phase|Other|0|||
147464332|NCT00896532|531860287|FG006|Months 1-24: Romosozumab Treatment Phase|Other|0|||
147464333|NCT00896532|531860288|FG007|Months 1-24: Romosozumab Treatment Phase|Other|0|||
147464334|NCT00896532|531860289|FG008|Months 1-24: Romosozumab Treatment Phase|Other|0|||
147464335|NCT00896532|531860290|FG009|Months 1-24: Romosozumab Treatment Phase|Other|0|||
147464336|NCT00896532|531860291|FG010|Months 1-24: Romosozumab Treatment Phase|Other|0|||
147405307|NCT01358331|531647700|FG002|Overall Study|Withdrawal by Subject|0|||
147405308|NCT01358331|531647701|FG003|Overall Study|Withdrawal by Subject|1|||
147405309|NCT01358331|531647702|FG004|Overall Study|Withdrawal by Subject|1|||
147405310|NCT01358331|531647703|FG005|Overall Study|Withdrawal by Subject|1|||
147405311|NCT01358331|531647698|FG000|Overall Study|Adverse Events|1|||
147464337|NCT00896532|531860292|FG011|Months 1-24: Romosozumab Treatment Phase|Other|0|||
147405312|NCT01358331|531647699|FG001|Overall Study|Adverse Events|1|||
147405313|NCT01358331|531647700|FG002|Overall Study|Adverse Events|1|||
147405314|NCT01358331|531647701|FG003|Overall Study|Adverse Events|0|||
147405315|NCT01358331|531647702|FG004|Overall Study|Adverse Events|1|||
147405316|NCT01358331|531647703|FG005|Overall Study|Adverse Events|5|||
147405317|NCT01358331|531647698|FG000|Overall Study|Symptomatic Deterioration|0|||
147405318|NCT01358331|531647699|FG001|Overall Study|Symptomatic Deterioration|0|||
147405319|NCT01358331|531647700|FG002|Overall Study|Symptomatic Deterioration|0|||
147405320|NCT01358331|531647701|FG003|Overall Study|Symptomatic Deterioration|0|||
147405321|NCT01358331|531647702|FG004|Overall Study|Symptomatic Deterioration|1|||
147405322|NCT01358331|531647703|FG005|Overall Study|Symptomatic Deterioration|0|||
147405323|NCT01358331|531647698|FG000|Overall Study|Participants did not wish to continue|0|||
147405324|NCT01358331|531647699|FG001|Overall Study|Participants did not wish to continue|0|||
147405325|NCT01358331|531647700|FG002|Overall Study|Participants did not wish to continue|0|||
147405326|NCT01358331|531647701|FG003|Overall Study|Participants did not wish to continue|0|||
147405327|NCT01358331|531647702|FG004|Overall Study|Participants did not wish to continue|1|||
147405328|NCT01358331|531647703|FG005|Overall Study|Participants did not wish to continue|0|||
147405329|NCT01358331|531647698|FG000|Overall Study|Progress of disease under investigation|1|||
147405330|NCT01358331|531647699|FG001|Overall Study|Progress of disease under investigation|2|||
147405331|NCT01358331|531647700|FG002|Overall Study|Progress of disease under investigation|3|||
147405332|NCT01358331|531647701|FG003|Overall Study|Progress of disease under investigation|1|||
147405333|NCT01358331|531647702|FG004|Overall Study|Progress of disease under investigation|3|||
147405334|NCT01358331|531647703|FG005|Overall Study|Progress of disease under investigation|0|||
147405335|NCT04946942|531647704|FG000|Overall Study|Lost to Follow-up|6|||
147405336|NCT04946942|531647705|FG001|Overall Study|Lost to Follow-up|2|||
147405337|NCT04946942|531647706|FG002|Overall Study|Lost to Follow-up|0|||
147405338|NCT04907357|531647707|FG000|Overall Study|Death|0|||
147405339|NCT04907357|531647708|FG001|Overall Study|Death|1|||
147405340|NCT04907357|531647707|FG000|Overall Study|Lost to Follow-up|9|||
147405341|NCT04907357|531647708|FG001|Overall Study|Lost to Follow-up|18|||
147405342|NCT04907357|531647707|FG000|Overall Study|Physician Decision|1|||
147405343|NCT04907357|531647708|FG001|Overall Study|Physician Decision|0|||
147405344|NCT04907357|531647707|FG000|Overall Study|Withdrawal by Subject|0|||
147405345|NCT04907357|531647708|FG001|Overall Study|Withdrawal by Subject|1|||
147405346|NCT04907357|531647707|FG000|Overall Study|Unable to attend visits|1|||
147405347|NCT04907357|531647708|FG001|Overall Study|Unable to attend visits|0|||
147405348|NCT04907357|531647707|FG000|Overall Study|Incarcerated|1|||
147405349|NCT04907357|531647708|FG001|Overall Study|Incarcerated|1|||
147405350|NCT00365547|531647709|FG000|Overall Study|Insurance did not cover Avastin|1|||
147405351|NCT00365547|531647709|FG000|Overall Study|Screen failure|1|||
147405352|NCT00365547|531647709|FG000|Overall Study|Withdrawal by Subject|1|||
147405353|NCT03170518|531647710|FG000|Overall Study|Lost to Follow-up|4|||
147405354|NCT03170518|531647711|FG001|Overall Study|Lost to Follow-up|1|||
147405355|NCT03170518|531647712|FG002|Overall Study|Lost to Follow-up|0|||
147405356|NCT03170518|531647710|FG000|Overall Study|Physician Decision|1|||
147405357|NCT03170518|531647711|FG001|Overall Study|Physician Decision|0|||
147405358|NCT03170518|531647712|FG002|Overall Study|Physician Decision|0|||
147405359|NCT03170518|531647710|FG000|Overall Study|Withdrawal by Subject|4|||
147405360|NCT03170518|531647711|FG001|Overall Study|Withdrawal by Subject|5|||
147405361|NCT03170518|531647712|FG002|Overall Study|Withdrawal by Subject|2|||
147405362|NCT03170518|531647710|FG000|Overall Study|Site terminated by sponsor|0|||
147405363|NCT03170518|531647711|FG001|Overall Study|Site terminated by sponsor|1|||
147405364|NCT03170518|531647712|FG002|Overall Study|Site terminated by sponsor|0|||
147405365|NCT03170518|531647710|FG000|Overall Study|Non-compliance with study drug|1|||
147405366|NCT03170518|531647711|FG001|Overall Study|Non-compliance with study drug|0|||
147405367|NCT03170518|531647712|FG002|Overall Study|Non-compliance with study drug|1|||
147405368|NCT03170518|531647710|FG000|Overall Study|Withdrawal by parent/guardian|2|||
147405369|NCT03170518|531647711|FG001|Overall Study|Withdrawal by parent/guardian|0|||
147405370|NCT03170518|531647712|FG002|Overall Study|Withdrawal by parent/guardian|0|||
147405371|NCT00546078|531647713|FG000|Overall Study|Lost to Follow-up|1|||
147405372|NCT00546078|531647714|FG001|Overall Study|Lost to Follow-up|3|||
147405373|NCT00546078|531647713|FG000|Overall Study|Withdrawal by Subject|2|||
147405374|NCT00546078|531647714|FG001|Overall Study|Withdrawal by Subject|3|||
147405375|NCT00546078|531647713|FG000|Overall Study|Other reason|1|||
147405376|NCT00546078|531647714|FG001|Overall Study|Other reason|1|||
147405377|NCT02257918|531647715|FG000|Overall Study|Lost to Follow-up|4|||
147405378|NCT02257918|531647716|FG001|Overall Study|Lost to Follow-up|1|||
147405379|NCT02257918|531647717|FG002|Overall Study|Lost to Follow-up|0|||
147405380|NCT02257918|531647715|FG000|Overall Study|Withdrawal by Subject|0|||
147405381|NCT02257918|531647716|FG001|Overall Study|Withdrawal by Subject|0|||
147405382|NCT02257918|531647717|FG002|Overall Study|Withdrawal by Subject|1|||
147405383|NCT02257918|531647715|FG000|Overall Study|Pregnancy|0|||
147665342|NCT01433159|532599534|FG001|Overall Study|Protocol Violation|1|||
147665343|NCT00301834|532599537|FG000|Overall Study|Death|1|||
147405384|NCT02257918|531647716|FG001|Overall Study|Pregnancy|0|||
147405385|NCT02257918|531647717|FG002|Overall Study|Pregnancy|1|||
147405386|NCT03023423|531647718|FG000|Overall Study|Death|5|||
147405387|NCT03023423|531647719|FG001|Overall Study|Death|12|||
147405388|NCT03023423|531647720|FG002|Overall Study|Death|20|||
147405389|NCT03023423|531647718|FG000|Overall Study|Other|0|||
147405390|NCT03023423|531647719|FG001|Overall Study|Other|2|||
147405391|NCT03023423|531647720|FG002|Overall Study|Other|2|||
147405392|NCT03023423|531647718|FG000|Overall Study|Ongoing|2|||
147405393|NCT03023423|531647719|FG001|Overall Study|Ongoing|32|||
147405394|NCT03023423|531647720|FG002|Overall Study|Ongoing|24|||
147405395|NCT03512197|531647721|FG000|Overall Study|Guardian decision|1|||
147405396|NCT03512197|531647722|FG001|Overall Study|Guardian decision|1|||
147405397|NCT03512197|531647721|FG000|Overall Study|Lack of Efficacy|19|||
147405398|NCT03512197|531647722|FG001|Overall Study|Lack of Efficacy|11|||
147405399|NCT03512197|531647721|FG000|Overall Study|New Therapy for Study Indication|16|||
147405400|NCT03512197|531647722|FG001|Overall Study|New Therapy for Study Indication|16|||
147405401|NCT03512197|531647721|FG000|Overall Study|Physician Decision|60|||
147405402|NCT03512197|531647722|FG001|Overall Study|Physician Decision|60|||
147405403|NCT03512197|531647721|FG000|Overall Study|Protocol Violation|0|||
147405404|NCT03512197|531647722|FG001|Overall Study|Protocol Violation|2|||
147405405|NCT03512197|531647721|FG000|Overall Study|Terminated by Sponsored|46|||
147405406|NCT03512197|531647722|FG001|Overall Study|Terminated by Sponsored|50|||
147405407|NCT03512197|531647721|FG000|Overall Study|Subject Decision|15|||
147405408|NCT03512197|531647722|FG001|Overall Study|Subject Decision|12|||
147405409|NCT03512197|531647721|FG000|Overall Study|Withdrawal of informed consent|20|||
147405410|NCT03512197|531647722|FG001|Overall Study|Withdrawal of informed consent|14|||
147405411|NCT03512197|531647721|FG000|Overall Study|Adverse Event|30|||
147405412|NCT03512197|531647722|FG001|Overall Study|Adverse Event|34|||
147405413|NCT03512197|531647721|FG000|Overall Study|Death|14|||
147405414|NCT03512197|531647722|FG001|Overall Study|Death|9|||
147405415|NCT03512197|531647721|FG000|Overall Study|Failure to meet Continuation Criteria|24|||
147405416|NCT03512197|531647722|FG001|Overall Study|Failure to meet Continuation Criteria|28|||
147405417|NCT03512197|531647721|FG000|Overall Study|Missing|3|||
147405418|NCT03512197|531647722|FG001|Overall Study|Missing|13|||
147405419|NCT03842436|531647723|FG000|Overall Study|Lost to Follow-up|1|||
147405420|NCT01263054|531647727|FG000|Overall Study|Death|1|||
147405421|NCT01263054|531647728|FG001|Overall Study|Death|0|||
147405422|NCT01263054|531647727|FG000|Overall Study|Lost to Follow-up|2|||
147405423|NCT01263054|531647728|FG001|Overall Study|Lost to Follow-up|2|||
147405424|NCT01263054|531647727|FG000|Overall Study|Withdrawal by Subject|1|||
147405425|NCT01263054|531647728|FG001|Overall Study|Withdrawal by Subject|3|||
147405426|NCT01263054|531647727|FG000|Overall Study|Qualification Violation|1|||
147405427|NCT01263054|531647728|FG001|Overall Study|Qualification Violation|0|||
147405428|NCT01263054|531647727|FG000|Overall Study|Other|0|||
147405429|NCT01263054|531647728|FG001|Overall Study|Other|1|||
147405430|NCT00936598|531647729|FG000|Overall Study|Withdrawal by Subject|1|||
147405431|NCT00936598|531647730|FG001|Overall Study|Withdrawal by Subject|0|||
147405432|NCT00936598|531647729|FG000|Overall Study|Ineligible after consent|1|||
147405433|NCT00936598|531647730|FG001|Overall Study|Ineligible after consent|0|||
147405434|NCT03358238|531647732|FG000|Overall Study|Withdrawal by Subject|0|||
147405435|NCT03358238|531647733|FG001|Overall Study|Withdrawal by Subject|1|||
147405436|NCT04277507|531647736|FG000|Overall Study|Lost to Follow-up|17|||
147405437|NCT04277507|531647736|FG000|Overall Study|Completed through 24M but not interested in extension to 36M|3|||
147405438|NCT04277507|531647736|FG000|Overall Study|Received Treatment Outside of Study that could affect study results|2|||
147405439|NCT04277507|531647736|FG000|Overall Study|Withdrawal by Subject|3|||
147405440|NCT04277507|531647736|FG000|Overall Study|Death due to COVID-19|1|||
147405441|NCT04277507|531647736|FG000|Overall Study|Data missing for full evaluation|5|||
147405442|NCT01431950|531647737|FG000|Overall Study|Study Site Closed/Terminated|7|||
147405443|NCT01431950|531647738|FG001|Overall Study|Study Site Closed/Terminated|3|||
147405444|NCT01431950|531647737|FG000|Overall Study|Withdrawal by Subject|4|||
147405445|NCT01431950|531647738|FG001|Overall Study|Withdrawal by Subject|3|||
147405446|NCT01431950|531647737|FG000|Overall Study|Protocol Violation|2|||
147405447|NCT01431950|531647738|FG001|Overall Study|Protocol Violation|3|||
147405448|NCT01431950|531647737|FG000|Overall Study|Adverse Event|2|||
147405449|NCT01431950|531647738|FG001|Overall Study|Adverse Event|2|||
147405450|NCT01431950|531647737|FG000|Overall Study|Physician Decision|2|||
147405451|NCT01431950|531647738|FG001|Overall Study|Physician Decision|1|||
147405452|NCT01431950|531647737|FG000|Overall Study|Lack of Efficacy|2|||
147405453|NCT01431950|531647738|FG001|Overall Study|Lack of Efficacy|1|||
147405454|NCT01431950|531647737|FG000|Overall Study|Lost to Follow-up|0|||
147405455|NCT01431950|531647738|FG001|Overall Study|Lost to Follow-up|1|||
147405456|NCT01431950|531647737|FG000|Overall Study|Met Protocol-defined Stopping Criteria|0|||
147405457|NCT01431950|531647738|FG001|Overall Study|Met Protocol-defined Stopping Criteria|1|||
147405458|NCT00583947|531647739|FG000|Cross-over Period|Adverse Event|2|||
147405459|NCT00583947|531647740|FG001|Cross-over Period|Adverse Event|0|||
147405460|NCT00583947|531647739|FG000|Cross-over Period|Withdrawal by Subject|2|||
147405461|NCT00583947|531647740|FG001|Cross-over Period|Withdrawal by Subject|0|||
147405462|NCT00583947|531647739|FG000|Cross-over Period|Did not meet-no longer met entry criteri|0|||
147405463|NCT00583947|531647740|FG001|Cross-over Period|Did not meet-no longer met entry criteri|1|||
147405464|NCT00583947|531647739|FG000|Cross-over Period|Other|1|||
147405465|NCT00583947|531647740|FG001|Cross-over Period|Other|1|||
147405466|NCT00486252|531647742|FG000|Overall Study|Adverse Event|7|||
147405467|NCT00486252|531647742|FG000|Overall Study|Lack of Efficacy|9|||
147616350|NCT02906670|532411017|FG000|Cohort 1, QW|Radiological Progression|1|||
147616351|NCT02906670|532411018|FG001|Cohort 1, QW|Radiological Progression|0|||
147616352|NCT02906670|532411019|FG002|Cohort 1, QW|Radiological Progression|0|||
147616353|NCT02906670|532411020|FG003|Cohort 1, QW|Radiological Progression|0|||
147616354|NCT02906670|532411021|FG004|Cohort 1, QW|Radiological Progression|0|||
147405468|NCT00486252|531647742|FG000|Overall Study|Lost to Follow-up|24|||
147405469|NCT00486252|531647742|FG000|Overall Study|Other|18|||
147405470|NCT01261247|531647743|FG000|Overall Study|Ineligible|2|||
147405471|NCT01210651|531647744|FG000|Overall Study|Lost to Follow-up|1|||
147405472|NCT01210651|531647745|FG001|Overall Study|Lost to Follow-up|1|||
147405473|NCT01210651|531647744|FG000|Overall Study|schedule conflicts|1|||
147405474|NCT01210651|531647745|FG001|Overall Study|schedule conflicts|5|||
147405475|NCT01210651|531647744|FG000|Overall Study|Withdrawn by PI for disruptive behavior|0|||
147405476|NCT01210651|531647745|FG001|Overall Study|Withdrawn by PI for disruptive behavior|1|||
147405477|NCT01210651|531647744|FG000|Overall Study|Withdrawal by Subject|1|||
147405478|NCT01210651|531647745|FG001|Overall Study|Withdrawal by Subject|1|||
147405479|NCT01210651|531647744|FG000|Overall Study|Injury outside study|2|||
147405480|NCT01210651|531647745|FG001|Overall Study|Injury outside study|0|||
147405481|NCT01740154|531647746|FG000|Overall Study|Adverse Event|1|||
147405482|NCT04013971|531647747|FG000|Overall Study|Treadmill speed less than 0.50 miles per hour|2|||
147405483|NCT04013971|531647748|FG001|Overall Study|Treadmill speed less than 0.50 miles per hour|0|||
147405484|NCT04013971|531647747|FG000|Overall Study|Missing biomechanical data|0|||
147405485|NCT04013971|531647748|FG001|Overall Study|Missing biomechanical data|1|||
147405486|NCT01340014|531647751|FG000|Period 1, First 7 Days|Adverse Event|1|||
147405487|NCT01340014|531647752|FG001|Period 1, First 7 Days|Adverse Event|0|||
147405488|NCT01340014|531647751|FG000|Period 1, First 7 Days|Personal Reasons|1|||
147405489|NCT01340014|531647752|FG001|Period 1, First 7 Days|Personal Reasons|0|||
147405490|NCT01340014|531647751|FG000|Period 2, Second 7 Days|Adverse Event|0|||
147405491|NCT01340014|531647752|FG001|Period 2, Second 7 Days|Adverse Event|1|||
147405492|NCT04577573|531647753|FG000|Overall Study|Technical - invalid protocol|0|||
147405493|NCT04577573|531647754|FG001|Overall Study|Technical - invalid protocol|2|||
147405494|NCT04577573|531647755|FG002|Overall Study|Technical - invalid protocol|0|||
147405495|NCT04297618|531647756|FG000|Overall Study|Adverse Event|1|||
147405496|NCT04297618|531647756|FG000|Overall Study|Withdrawal by Subject|1|||
147405497|NCT04949802|531649425|FG000|Overall Study|Lost to Follow-up|3|||
147405498|NCT00233480|531649433|FG000|Overall Study|Underwent status II heart transplant|0|||
147405499|NCT00233480|531649434|FG001|Overall Study|Underwent status II heart transplant|1|||
147405500|NCT01443403|531649435|FG000|Overall Study|Adverse Event|1|||
147405501|NCT01443403|531649436|FG001|Overall Study|Adverse Event|1|||
147405502|NCT01443403|531649437|FG002|Overall Study|Adverse Event|4|||
147405503|NCT01443403|531649438|FG003|Overall Study|Adverse Event|5|||
147405504|NCT01443403|531649435|FG000|Overall Study|Withdrawal by Subject|0|||
147405505|NCT01443403|531649436|FG001|Overall Study|Withdrawal by Subject|1|||
147405506|NCT01443403|531649437|FG002|Overall Study|Withdrawal by Subject|2|||
147405507|NCT01443403|531649438|FG003|Overall Study|Withdrawal by Subject|1|||
147405508|NCT01443403|531649435|FG000|Overall Study|Lost to Follow-up|0|||
147405509|NCT01443403|531649436|FG001|Overall Study|Lost to Follow-up|0|||
147405510|NCT01443403|531649437|FG002|Overall Study|Lost to Follow-up|0|||
147405511|NCT01443403|531649438|FG003|Overall Study|Lost to Follow-up|1|||
147405512|NCT01443403|531649435|FG000|Overall Study|Protocol Violation|2|||
147405513|NCT01443403|531649436|FG001|Overall Study|Protocol Violation|1|||
147405514|NCT01443403|531649437|FG002|Overall Study|Protocol Violation|1|||
147405515|NCT01443403|531649438|FG003|Overall Study|Protocol Violation|1|||
147405516|NCT01443403|531649435|FG000|Overall Study|Use of Prohibited Treatment|2|||
147405517|NCT01443403|531649436|FG001|Overall Study|Use of Prohibited Treatment|3|||
147405518|NCT01443403|531649437|FG002|Overall Study|Use of Prohibited Treatment|0|||
147405519|NCT01443403|531649438|FG003|Overall Study|Use of Prohibited Treatment|0|||
147405520|NCT01443403|531649435|FG000|Overall Study|Other - Miscellaneous|1|||
147405521|NCT01443403|531649436|FG001|Overall Study|Other - Miscellaneous|0|||
147405522|NCT01443403|531649437|FG002|Overall Study|Other - Miscellaneous|0|||
147405523|NCT01443403|531649438|FG003|Overall Study|Other - Miscellaneous|1|||
147405524|NCT00474526|531649439|FG000|Overall Study|ADMINISTRATIVE REASON|11|||
147405525|NCT00474526|531649440|FG001|Overall Study|ADMINISTRATIVE REASON|9|||
147405526|NCT00474526|531649441|FG002|Overall Study|ADMINISTRATIVE REASON|9|||
147405527|NCT00474526|531649442|FG003|Overall Study|ADMINISTRATIVE REASON|20|||
147405528|NCT00474526|531649443|FG004|Overall Study|ADMINISTRATIVE REASON|9|||
147405529|NCT00474526|531649444|FG005|Overall Study|ADMINISTRATIVE REASON|1|||
147405530|NCT00474526|531649445|FG006|Overall Study|ADMINISTRATIVE REASON|1|||
147405531|NCT00474526|531649446|FG007|Overall Study|ADMINISTRATIVE REASON|0|||
147405532|NCT00474526|531649447|FG008|Overall Study|ADMINISTRATIVE REASON|2|||
147405533|NCT00474526|531649448|FG009|Overall Study|ADMINISTRATIVE REASON|1|||
147405534|NCT00474526|531649449|FG010|Overall Study|ADMINISTRATIVE REASON|1|||
147405535|NCT00474526|531649450|FG011|Overall Study|ADMINISTRATIVE REASON|1|||
147405536|NCT00474526|531649451|FG012|Overall Study|ADMINISTRATIVE REASON|1|||
147405537|NCT00474526|531649452|FG013|Overall Study|ADMINISTRATIVE REASON|1|||
147405538|NCT00474526|531649453|FG014|Overall Study|ADMINISTRATIVE REASON|2|||
147616355|NCT02906670|532411022|FG005|Cohort 1, QW|Radiological Progression|0|||
147405539|NCT00474526|531649454|FG015|Overall Study|ADMINISTRATIVE REASON|0|||
147405540|NCT00474526|531649455|FG016|Overall Study|ADMINISTRATIVE REASON|0|||
147405541|NCT00474526|531649439|FG000|Overall Study|Adverse Event|2|||
147405542|NCT00474526|531649440|FG001|Overall Study|Adverse Event|0|||
147405543|NCT00474526|531649441|FG002|Overall Study|Adverse Event|2|||
147405544|NCT00474526|531649442|FG003|Overall Study|Adverse Event|4|||
147405545|NCT00474526|531649443|FG004|Overall Study|Adverse Event|2|||
147405546|NCT00474526|531649444|FG005|Overall Study|Adverse Event|1|||
147405547|NCT00474526|531649445|FG006|Overall Study|Adverse Event|1|||
147405548|NCT00474526|531649446|FG007|Overall Study|Adverse Event|0|||
147405549|NCT00474526|531649447|FG008|Overall Study|Adverse Event|0|||
147405550|NCT00474526|531649448|FG009|Overall Study|Adverse Event|0|||
147405551|NCT00474526|531649449|FG010|Overall Study|Adverse Event|0|||
147405552|NCT00474526|531649450|FG011|Overall Study|Adverse Event|0|||
147405553|NCT00474526|531649451|FG012|Overall Study|Adverse Event|0|||
147405554|NCT00474526|531649452|FG013|Overall Study|Adverse Event|0|||
147405555|NCT00474526|531649453|FG014|Overall Study|Adverse Event|1|||
147405556|NCT00474526|531649454|FG015|Overall Study|Adverse Event|1|||
147405557|NCT00474526|531649455|FG016|Overall Study|Adverse Event|0|||
147405558|NCT00474526|531649439|FG000|Overall Study|Death|0|||
147405559|NCT00474526|531649440|FG001|Overall Study|Death|0|||
147405560|NCT00474526|531649441|FG002|Overall Study|Death|0|||
147405561|NCT00474526|531649442|FG003|Overall Study|Death|0|||
147405562|NCT00474526|531649443|FG004|Overall Study|Death|0|||
147405563|NCT00474526|531649444|FG005|Overall Study|Death|0|||
147405564|NCT00474526|531649445|FG006|Overall Study|Death|0|||
147405565|NCT00474526|531649446|FG007|Overall Study|Death|0|||
147405566|NCT00474526|531649447|FG008|Overall Study|Death|0|||
147405567|NCT00474526|531649448|FG009|Overall Study|Death|0|||
147405568|NCT00474526|531649449|FG010|Overall Study|Death|0|||
147405569|NCT00474526|531649450|FG011|Overall Study|Death|0|||
147405570|NCT00474526|531649451|FG012|Overall Study|Death|0|||
147405571|NCT00474526|531649452|FG013|Overall Study|Death|3|||
147405572|NCT00474526|531649453|FG014|Overall Study|Death|0|||
147405573|NCT00474526|531649454|FG015|Overall Study|Death|0|||
147405574|NCT00474526|531649455|FG016|Overall Study|Death|0|||
147405575|NCT00474526|531649439|FG000|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
147405576|NCT00474526|531649440|FG001|Overall Study|INAPPROPRIATE ENROLLMENT|1|||
147405577|NCT00474526|531649441|FG002|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
147405578|NCT00474526|531649442|FG003|Overall Study|INAPPROPRIATE ENROLLMENT|1|||
147405579|NCT00474526|531649443|FG004|Overall Study|INAPPROPRIATE ENROLLMENT|2|||
147405580|NCT00474526|531649444|FG005|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
147405581|NCT00474526|531649445|FG006|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
147405582|NCT00474526|531649446|FG007|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
147405583|NCT00474526|531649447|FG008|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
147405584|NCT00474526|531649448|FG009|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
147405585|NCT00474526|531649449|FG010|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
147405586|NCT00474526|531649450|FG011|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
147405587|NCT00474526|531649451|FG012|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
147405588|NCT00474526|531649452|FG013|Overall Study|INAPPROPRIATE ENROLLMENT|2|||
147405589|NCT00474526|531649453|FG014|Overall Study|INAPPROPRIATE ENROLLMENT|2|||
147405590|NCT00474526|531649454|FG015|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
147405591|NCT00474526|531649455|FG016|Overall Study|INAPPROPRIATE ENROLLMENT|0|||
147405592|NCT00474526|531649439|FG000|Overall Study|Lost to Follow-up|8|||
147405593|NCT00474526|531649440|FG001|Overall Study|Lost to Follow-up|6|||
147405594|NCT00474526|531649441|FG002|Overall Study|Lost to Follow-up|13|||
147405595|NCT00474526|531649442|FG003|Overall Study|Lost to Follow-up|29|||
147405596|NCT00474526|531649443|FG004|Overall Study|Lost to Follow-up|11|||
147405597|NCT00474526|531649444|FG005|Overall Study|Lost to Follow-up|5|||
147405598|NCT00474526|531649445|FG006|Overall Study|Lost to Follow-up|8|||
147405599|NCT00474526|531649446|FG007|Overall Study|Lost to Follow-up|1|||
147405600|NCT00474526|531649447|FG008|Overall Study|Lost to Follow-up|0|||
147405601|NCT00474526|531649448|FG009|Overall Study|Lost to Follow-up|6|||
147405602|NCT00474526|531649449|FG010|Overall Study|Lost to Follow-up|2|||
147616356|NCT02906670|532411023|FG006|Cohort 1, QW|Radiological Progression|0|||
147616357|NCT02906670|532411024|FG007|Cohort 1, QW|Radiological Progression|0|||
147616358|NCT02906670|532411025|FG008|Cohort 1, QW|Radiological Progression|0|||
147616359|NCT02906670|532411026|FG009|Cohort 1, QW|Radiological Progression|0|||
147405603|NCT00474526|531649450|FG011|Overall Study|Lost to Follow-up|4|||
147405604|NCT00474526|531649451|FG012|Overall Study|Lost to Follow-up|6|||
147405605|NCT00474526|531649452|FG013|Overall Study|Lost to Follow-up|74|||
147405606|NCT00474526|531649453|FG014|Overall Study|Lost to Follow-up|29|||
147405607|NCT00474526|531649454|FG015|Overall Study|Lost to Follow-up|4|||
147405608|NCT00474526|531649455|FG016|Overall Study|Lost to Follow-up|5|||
147616360|NCT02906670|532411017|FG000|Cohort 2, QW|Radiological Progression|0|||
147616361|NCT02906670|532411018|FG001|Cohort 2, QW|Radiological Progression|1|||
147405609|NCT00474526|531649439|FG000|Overall Study|Protocol Violation|2|||
147405610|NCT00474526|531649440|FG001|Overall Study|Protocol Violation|6|||
147405611|NCT00474526|531649441|FG002|Overall Study|Protocol Violation|4|||
147616362|NCT02906670|532411019|FG002|Cohort 2, QW|Radiological Progression|0|||
147616363|NCT02906670|532411020|FG003|Cohort 2, QW|Radiological Progression|0|||
147405612|NCT00474526|531649442|FG003|Overall Study|Protocol Violation|12|||
147405613|NCT00474526|531649443|FG004|Overall Study|Protocol Violation|3|||
147405614|NCT00474526|531649444|FG005|Overall Study|Protocol Violation|1|||
147405615|NCT00474526|531649445|FG006|Overall Study|Protocol Violation|3|||
147405616|NCT00474526|531649446|FG007|Overall Study|Protocol Violation|0|||
147405617|NCT00474526|531649447|FG008|Overall Study|Protocol Violation|0|||
147405618|NCT00474526|531649448|FG009|Overall Study|Protocol Violation|4|||
147405619|NCT00474526|531649449|FG010|Overall Study|Protocol Violation|2|||
147405620|NCT00474526|531649450|FG011|Overall Study|Protocol Violation|2|||
147405621|NCT00474526|531649451|FG012|Overall Study|Protocol Violation|4|||
147405622|NCT00474526|531649452|FG013|Overall Study|Protocol Violation|19|||
147405623|NCT00474526|531649453|FG014|Overall Study|Protocol Violation|9|||
147405624|NCT00474526|531649454|FG015|Overall Study|Protocol Violation|6|||
147405625|NCT00474526|531649455|FG016|Overall Study|Protocol Violation|2|||
147405626|NCT00474526|531649439|FG000|Overall Study|UNABLE TO CLASSIFY|1|||
147405627|NCT00474526|531649440|FG001|Overall Study|UNABLE TO CLASSIFY|0|||
147405628|NCT00474526|531649441|FG002|Overall Study|UNABLE TO CLASSIFY|0|||
147405629|NCT00474526|531649442|FG003|Overall Study|UNABLE TO CLASSIFY|1|||
147405630|NCT00474526|531649443|FG004|Overall Study|UNABLE TO CLASSIFY|3|||
147405631|NCT00474526|531649444|FG005|Overall Study|UNABLE TO CLASSIFY|2|||
147405632|NCT00474526|531649445|FG006|Overall Study|UNABLE TO CLASSIFY|0|||
147405633|NCT00474526|531649446|FG007|Overall Study|UNABLE TO CLASSIFY|1|||
147405634|NCT00474526|531649447|FG008|Overall Study|UNABLE TO CLASSIFY|0|||
147405635|NCT00474526|531649448|FG009|Overall Study|UNABLE TO CLASSIFY|3|||
147405636|NCT00474526|531649449|FG010|Overall Study|UNABLE TO CLASSIFY|0|||
147405637|NCT00474526|531649450|FG011|Overall Study|UNABLE TO CLASSIFY|0|||
147405638|NCT00474526|531649451|FG012|Overall Study|UNABLE TO CLASSIFY|0|||
147405639|NCT00474526|531649452|FG013|Overall Study|UNABLE TO CLASSIFY|20|||
147405640|NCT00474526|531649453|FG014|Overall Study|UNABLE TO CLASSIFY|12|||
147405641|NCT00474526|531649454|FG015|Overall Study|UNABLE TO CLASSIFY|6|||
147405642|NCT00474526|531649455|FG016|Overall Study|UNABLE TO CLASSIFY|1|||
147405643|NCT00474526|531649439|FG000|Overall Study|Withdrawal by Subject|9|||
147405644|NCT00474526|531649440|FG001|Overall Study|Withdrawal by Subject|24|||
147405645|NCT00474526|531649441|FG002|Overall Study|Withdrawal by Subject|21|||
147405646|NCT00474526|531649442|FG003|Overall Study|Withdrawal by Subject|52|||
147405647|NCT00474526|531649443|FG004|Overall Study|Withdrawal by Subject|38|||
147405648|NCT00474526|531649444|FG005|Overall Study|Withdrawal by Subject|6|||
147405649|NCT00474526|531649445|FG006|Overall Study|Withdrawal by Subject|12|||
147405650|NCT00474526|531649446|FG007|Overall Study|Withdrawal by Subject|4|||
147405651|NCT00474526|531649447|FG008|Overall Study|Withdrawal by Subject|4|||
147405652|NCT00474526|531649448|FG009|Overall Study|Withdrawal by Subject|13|||
147405653|NCT00474526|531649449|FG010|Overall Study|Withdrawal by Subject|5|||
147405654|NCT00474526|531649450|FG011|Overall Study|Withdrawal by Subject|4|||
147405655|NCT00474526|531649451|FG012|Overall Study|Withdrawal by Subject|4|||
147405656|NCT00474526|531649452|FG013|Overall Study|Withdrawal by Subject|37|||
147405657|NCT00474526|531649453|FG014|Overall Study|Withdrawal by Subject|22|||
147405658|NCT00474526|531649454|FG015|Overall Study|Withdrawal by Subject|1|||
147405659|NCT00474526|531649455|FG016|Overall Study|Withdrawal by Subject|1|||
147405660|NCT02763215|531649456|FG000|Overall Study|Participants withdrew from study|3|||
147405661|NCT02763215|531649456|FG000|Overall Study|Missed visit|1|||
147405662|NCT02763215|531649456|FG000|Overall Study|Visit outside visit-window|1|||
147405663|NCT02763215|531649456|FG000|Overall Study|Death|1|||
147405664|NCT02763215|531649456|FG000|Overall Study|Lost to Follow-up|1|||
147405665|NCT03258723|531649457|FG000|Overall Study|COVID Interruption of study|54|||
147405666|NCT03258723|531649457|FG000|Overall Study|Lost to Follow-up|8|||
147405667|NCT01107899|531649458|FG000|Overall Study|Physician Decision|5|||
147405668|NCT01107899|531649459|FG001|Overall Study|Physician Decision|0|||
147464338|NCT00896532|531860293|FG012|Months 1-24: Romosozumab Treatment Phase|Other|0|||
147464339|NCT00896532|531860294|FG013|Months 1-24: Romosozumab Treatment Phase|Other|0|||
147464340|NCT00896532|531860295|FG014|Months 1-24: Romosozumab Treatment Phase|Other|0|||
147616364|NCT02906670|532411021|FG004|Cohort 2, QW|Radiological Progression|0|||
147616365|NCT02906670|532411022|FG005|Cohort 2, QW|Radiological Progression|0|||
147405669|NCT01107899|531649460|FG002|Overall Study|Physician Decision|3|||
147405670|NCT01107899|531649458|FG000|Overall Study|Withdrawal by Subject|0|||
147405671|NCT01107899|531649459|FG001|Overall Study|Withdrawal by Subject|0|||
147405672|NCT01107899|531649460|FG002|Overall Study|Withdrawal by Subject|1|||
147616366|NCT02906670|532411023|FG006|Cohort 2, QW|Radiological Progression|0|||
147405673|NCT00953771|531649461|FG000|Overall Study|Death|1|||
147405674|NCT00953771|531649462|FG001|Overall Study|Death|0|||
147405675|NCT00974259|531649463|FG000|Overall Study|Technically inadequate PbtO2 recordings|2|||
147405676|NCT00974259|531649464|FG001|Overall Study|Technically inadequate PbtO2 recordings|1|||
147405677|NCT00592293|531649466|FG000|Overall Study|Withdrawal by Subject|1|||
147405678|NCT01606319|531649467|FG000|Overall Study|Lost to Follow-up|17|||
147405679|NCT01606319|531649468|FG001|Overall Study|Lost to Follow-up|14|||
147405680|NCT01606319|531649467|FG000|Overall Study|Withdrawal by Subject|9|||
147405681|NCT01606319|531649468|FG001|Overall Study|Withdrawal by Subject|12|||
147405682|NCT01606319|531649467|FG000|Overall Study|Physician Decision|1|||
147405683|NCT01606319|531649468|FG001|Overall Study|Physician Decision|2|||
147405684|NCT01606319|531649467|FG000|Overall Study|Lack of Efficacy|6|||
147405685|NCT01606319|531649468|FG001|Overall Study|Lack of Efficacy|8|||
147405686|NCT01606319|531649467|FG000|Overall Study|Adverse Event|1|||
147616367|NCT02906670|532411024|FG007|Cohort 2, QW|Radiological Progression|0|||
147616368|NCT02906670|532411025|FG008|Cohort 2, QW|Radiological Progression|0|||
147616369|NCT02906670|532411026|FG009|Cohort 2, QW|Radiological Progression|0|||
147616370|NCT02906670|532411017|FG000|Cohort 3, QW|Radiological Progression|0|||
147616371|NCT02906670|532411018|FG001|Cohort 3, QW|Radiological Progression|0|||
147616372|NCT02906670|532411019|FG002|Cohort 3, QW|Radiological Progression|2|||
147616373|NCT02906670|532411020|FG003|Cohort 3, QW|Radiological Progression|0|||
147616374|NCT02906670|532411021|FG004|Cohort 3, QW|Radiological Progression|0|||
147616375|NCT02906670|532411022|FG005|Cohort 3, QW|Radiological Progression|0|||
147616376|NCT02906670|532411023|FG006|Cohort 3, QW|Radiological Progression|0|||
147616377|NCT02906670|532411024|FG007|Cohort 3, QW|Radiological Progression|0|||
147616378|NCT02906670|532411025|FG008|Cohort 3, QW|Radiological Progression|0|||
147616379|NCT02906670|532411026|FG009|Cohort 3, QW|Radiological Progression|0|||
147616380|NCT02906670|532411017|FG000|Cohort 3, QW|Lack of Clinical Benefit|0|||
147616381|NCT02906670|532411018|FG001|Cohort 3, QW|Lack of Clinical Benefit|0|||
147616382|NCT02906670|532411019|FG002|Cohort 3, QW|Lack of Clinical Benefit|2|||
147616383|NCT02906670|532411020|FG003|Cohort 3, QW|Lack of Clinical Benefit|0|||
147616384|NCT02906670|532411021|FG004|Cohort 3, QW|Lack of Clinical Benefit|0|||
147616385|NCT02906670|532411022|FG005|Cohort 3, QW|Lack of Clinical Benefit|0|||
147616386|NCT02906670|532411023|FG006|Cohort 3, QW|Lack of Clinical Benefit|0|||
147616387|NCT02906670|532411024|FG007|Cohort 3, QW|Lack of Clinical Benefit|0|||
147616388|NCT02906670|532411025|FG008|Cohort 3, QW|Lack of Clinical Benefit|0|||
147616389|NCT02906670|532411026|FG009|Cohort 3, QW|Lack of Clinical Benefit|0|||
147616390|NCT02906670|532411017|FG000|Cohort 4, Q2W|Radiological Progression|0|||
147616391|NCT02906670|532411018|FG001|Cohort 4, Q2W|Radiological Progression|0|||
147616392|NCT02906670|532411019|FG002|Cohort 4, Q2W|Radiological Progression|0|||
147616393|NCT02906670|532411020|FG003|Cohort 4, Q2W|Radiological Progression|0|||
147616394|NCT02906670|532411021|FG004|Cohort 4, Q2W|Radiological Progression|0|||
147616395|NCT02906670|532411022|FG005|Cohort 4, Q2W|Radiological Progression|1|||
147616396|NCT02906670|532411023|FG006|Cohort 4, Q2W|Radiological Progression|0|||
147616397|NCT02906670|532411024|FG007|Cohort 4, Q2W|Radiological Progression|0|||
147616398|NCT02906670|532411025|FG008|Cohort 4, Q2W|Radiological Progression|0|||
147616399|NCT02906670|532411026|FG009|Cohort 4, Q2W|Radiological Progression|0|||
147616400|NCT02906670|532411017|FG000|Cohort 4, Q2W|Clinical Progression|0|||
147616401|NCT02906670|532411018|FG001|Cohort 4, Q2W|Clinical Progression|0|||
147616402|NCT02906670|532411019|FG002|Cohort 4, Q2W|Clinical Progression|0|||
147616403|NCT02906670|532411020|FG003|Cohort 4, Q2W|Clinical Progression|0|||
147616404|NCT02906670|532411021|FG004|Cohort 4, Q2W|Clinical Progression|0|||
147616405|NCT02906670|532411022|FG005|Cohort 4, Q2W|Clinical Progression|2|||
147616406|NCT02906670|532411023|FG006|Cohort 4, Q2W|Clinical Progression|0|||
147616407|NCT02906670|532411024|FG007|Cohort 4, Q2W|Clinical Progression|0|||
147616408|NCT02906670|532411025|FG008|Cohort 4, Q2W|Clinical Progression|0|||
147616409|NCT02906670|532411026|FG009|Cohort 4, Q2W|Clinical Progression|0|||
147616410|NCT02906670|532411017|FG000|Cohort 5, Q2W|Radiological Progression|0|||
147616411|NCT02906670|532411018|FG001|Cohort 5, Q2W|Radiological Progression|0|||
147616412|NCT02906670|532411019|FG002|Cohort 5, Q2W|Radiological Progression|0|||
147616413|NCT02906670|532411020|FG003|Cohort 5, Q2W|Radiological Progression|0|||
147616414|NCT02906670|532411021|FG004|Cohort 5, Q2W|Radiological Progression|0|||
147616415|NCT02906670|532411022|FG005|Cohort 5, Q2W|Radiological Progression|0|||
147616416|NCT02906670|532411023|FG006|Cohort 5, Q2W|Radiological Progression|4|||
147616417|NCT02906670|532411024|FG007|Cohort 5, Q2W|Radiological Progression|0|||
147616418|NCT02906670|532411025|FG008|Cohort 5, Q2W|Radiological Progression|0|||
147616419|NCT02906670|532411026|FG009|Cohort 5, Q2W|Radiological Progression|0|||
147616420|NCT02906670|532411017|FG000|Cohort 5, Q2W|Clinical Progression|0|||
147616421|NCT02906670|532411018|FG001|Cohort 5, Q2W|Clinical Progression|0|||
147616422|NCT02906670|532411019|FG002|Cohort 5, Q2W|Clinical Progression|0|||
147616423|NCT02906670|532411020|FG003|Cohort 5, Q2W|Clinical Progression|0|||
147616424|NCT02906670|532411021|FG004|Cohort 5, Q2W|Clinical Progression|0|||
147616425|NCT02906670|532411022|FG005|Cohort 5, Q2W|Clinical Progression|0|||
147616426|NCT02906670|532411023|FG006|Cohort 5, Q2W|Clinical Progression|1|||
147616427|NCT02906670|532411024|FG007|Cohort 5, Q2W|Clinical Progression|0|||
147616428|NCT02906670|532411025|FG008|Cohort 5, Q2W|Clinical Progression|0|||
147616429|NCT02906670|532411026|FG009|Cohort 5, Q2W|Clinical Progression|0|||
147616430|NCT02906670|532411017|FG000|Cohort 5, Q2W|Adverse Event|0|||
147616431|NCT02906670|532411018|FG001|Cohort 5, Q2W|Adverse Event|0|||
147616432|NCT02906670|532411019|FG002|Cohort 5, Q2W|Adverse Event|0|||
147405687|NCT01606319|531649468|FG001|Overall Study|Adverse Event|4|||
147405688|NCT01784523|531649471|FG000|Overall Study|Study closed early|7|||
147616433|NCT02906670|532411020|FG003|Cohort 5, Q2W|Adverse Event|0|||
147616434|NCT02906670|532411021|FG004|Cohort 5, Q2W|Adverse Event|0|||
147616435|NCT02906670|532411022|FG005|Cohort 5, Q2W|Adverse Event|0|||
147616436|NCT02906670|532411023|FG006|Cohort 5, Q2W|Adverse Event|1|||
147665344|NCT02870868|532599538|FG000|Overall Study|Withdrawal by Subject|2|||
147665345|NCT02870868|532599539|FG001|Overall Study|Withdrawal by Subject|1|||
147665346|NCT04040439|532599540|FG000|Overall Study|Invalid registration|11|||
147665347|NCT04040439|532599540|FG000|Overall Study|No IC* on publication of study results|2|||
147665348|NCT01248455|532599545|FG000|Overall Study|switched to alternate treatment|1|||
147665349|NCT01117870|532599546|FG000|Overall Study|Inability to place needle|1|||
147665350|NCT01117870|532599547|FG001|Overall Study|Inability to place needle|0|||
147665351|NCT01309386|532599548|FG000|Overall Study|Other|2|||
147665352|NCT01309386|532599549|FG001|Overall Study|Other|0|||
147665353|NCT01309386|532599548|FG000|Overall Study|Withdrawal by Subject|2|||
147665354|NCT01309386|532599549|FG001|Overall Study|Withdrawal by Subject|0|||
147665355|NCT01309386|532599548|FG000|Overall Study|Progressive disease|9|||
147665356|NCT01309386|532599549|FG001|Overall Study|Progressive disease|11|||
147665357|NCT01309386|532599548|FG000|Overall Study|Physician Decision|1|||
147665358|NCT01309386|532599549|FG001|Overall Study|Physician Decision|1|||
147665359|NCT01309386|532599548|FG000|Overall Study|Lack of Efficacy|3|||
147665360|NCT01309386|532599549|FG001|Overall Study|Lack of Efficacy|1|||
147665361|NCT01309386|532599548|FG000|Overall Study|Adverse Event|5|||
147665362|NCT01309386|532599549|FG001|Overall Study|Adverse Event|8|||
147665363|NCT00723229|532599550|FG000|First Intervention|Lost to Follow-up|7|||
147665364|NCT00723229|532599551|FG001|First Intervention|Lost to Follow-up|3|||
147665365|NCT01674725|532599552|FG000|Overall Study|Adverse Event|1|||
147665366|NCT01674725|532599553|FG001|Overall Study|Adverse Event|0|||
147665367|NCT01674725|532599552|FG000|Overall Study|Did not receive study drug|1|||
147665368|NCT01674725|532599553|FG001|Overall Study|Did not receive study drug|0|||
147665369|NCT01674725|532599552|FG000|Overall Study|Withdrawal by Subject|1|||
147665370|NCT01674725|532599553|FG001|Overall Study|Withdrawal by Subject|0|||
147665371|NCT01674725|532599552|FG000|Overall Study|Lost to Follow-up|0|||
147665372|NCT01674725|532599553|FG001|Overall Study|Lost to Follow-up|1|||
147665373|NCT02089347|532599554|FG000|Overall Study|Protocol Violation|1|||
147665374|NCT02089347|532599555|FG001|Overall Study|Protocol Violation|0|||
147665375|NCT00001566|532599556|FG000|Overall Study|patients' choice to discontinue protocol|3|||
147665376|NCT00001566|532599556|FG000|Overall Study|stopped after C3 due to symptomatic PD|1|||
147665377|NCT00001566|532599556|FG000|Overall Study|Death|13|||
147665378|NCT00001566|532599556|FG000|Overall Study|Lost to Follow-up|1|||
147665379|NCT00001566|532599556|FG000|Overall Study|unable to complete initial apheresis|1|||
147665380|NCT03439137|532599561|FG000|Overall Study|Adverse Event|16|||
147665381|NCT03439137|532599562|FG001|Overall Study|Adverse Event|12|||
147665382|NCT03439137|532599561|FG000|Overall Study|Physician Decision|0|||
147665383|NCT03439137|532599562|FG001|Overall Study|Physician Decision|5|||
147665384|NCT03439137|532599561|FG000|Overall Study|Withdrawal by Subject|14|||
147665385|NCT03439137|532599562|FG001|Overall Study|Withdrawal by Subject|4|||
147665386|NCT03439137|532599561|FG000|Overall Study|Conducting rescue therapy|2|||
147665387|NCT03439137|532599562|FG001|Overall Study|Conducting rescue therapy|1|||
147665388|NCT03439137|532599561|FG000|Overall Study|Difficult to control Hb|10|||
147665389|NCT03439137|532599562|FG001|Overall Study|Difficult to control Hb|2|||
147665390|NCT03439137|532599561|FG000|Overall Study|Initiation of a renal transplant|0|||
147665391|NCT03439137|532599562|FG001|Overall Study|Initiation of a renal transplant|2|||
147665392|NCT01225549|532599567|FG000|Period 4 - Washout|Disallowed medication|0|||
147665393|NCT01225549|532599568|FG001|Period 4 - Washout|Disallowed medication|1|||
147665394|NCT01225549|532599569|FG002|Period 4 - Washout|Disallowed medication|0|||
147665395|NCT01225549|532599570|FG003|Period 4 - Washout|Disallowed medication|0|||
147665396|NCT01225549|532599571|FG004|Period 4 - Washout|Disallowed medication|0|||
147665397|NCT01225549|532599572|FG005|Period 4 - Washout|Disallowed medication|0|||
147616437|NCT02906670|532411024|FG007|Cohort 5, Q2W|Adverse Event|0|||
147616438|NCT02906670|532411025|FG008|Cohort 5, Q2W|Adverse Event|0|||
147616439|NCT02906670|532411026|FG009|Cohort 5, Q2W|Adverse Event|0|||
147616440|NCT02906670|532411017|FG000|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
147616441|NCT02906670|532411018|FG001|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
147616442|NCT02906670|532411019|FG002|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
147616443|NCT02906670|532411020|FG003|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
147665398|NCT01225549|532599573|FG006|Period 4 - Washout|Disallowed medication|0|||
147665399|NCT01225549|532599574|FG007|Period 4 - Washout|Disallowed medication|0|||
147665400|NCT01225549|532599575|FG008|Period 4 - Washout|Disallowed medication|0|||
147665401|NCT01225549|532599576|FG009|Period 4 - Washout|Disallowed medication|0|||
147665402|NCT01225549|532599567|FG000|Period 6 - Washout|Disallowed medication|0|||
147665403|NCT01225549|532599568|FG001|Period 6 - Washout|Disallowed medication|0|||
147616444|NCT02906670|532411021|FG004|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
147665404|NCT01225549|532599569|FG002|Period 6 - Washout|Disallowed medication|0|||
147665405|NCT01225549|532599570|FG003|Period 6 - Washout|Disallowed medication|1|||
147665406|NCT01225549|532599571|FG004|Period 6 - Washout|Disallowed medication|0|||
147616445|NCT02906670|532411022|FG005|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
147665407|NCT01225549|532599572|FG005|Period 6 - Washout|Disallowed medication|0|||
147665408|NCT01225549|532599573|FG006|Period 6 - Washout|Disallowed medication|0|||
147665409|NCT01225549|532599574|FG007|Period 6 - Washout|Disallowed medication|0|||
147616446|NCT02906670|532411023|FG006|Cohort 5, Q2W|Lack of Clinical Benefit|1|||
147616447|NCT02906670|532411024|FG007|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
147616448|NCT02906670|532411025|FG008|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
147616449|NCT02906670|532411026|FG009|Cohort 5, Q2W|Lack of Clinical Benefit|0|||
147464341|NCT00896532|531860296|FG015|Months 1-24: Romosozumab Treatment Phase|Other|0|||
147616450|NCT02906670|532411017|FG000|Cohort 5P, Q2W|Radiological Progression|0|||
147616451|NCT02906670|532411018|FG001|Cohort 5P, Q2W|Radiological Progression|0|||
147616452|NCT02906670|532411019|FG002|Cohort 5P, Q2W|Radiological Progression|0|||
147616453|NCT02906670|532411020|FG003|Cohort 5P, Q2W|Radiological Progression|0|||
147616454|NCT02906670|532411021|FG004|Cohort 5P, Q2W|Radiological Progression|0|||
147616455|NCT02906670|532411022|FG005|Cohort 5P, Q2W|Radiological Progression|0|||
147616456|NCT02906670|532411023|FG006|Cohort 5P, Q2W|Radiological Progression|0|||
147616457|NCT02906670|532411024|FG007|Cohort 5P, Q2W|Radiological Progression|2|||
147616458|NCT02906670|532411025|FG008|Cohort 5P, Q2W|Radiological Progression|0|||
147616459|NCT02906670|532411026|FG009|Cohort 5P, Q2W|Radiological Progression|0|||
147616460|NCT02906670|532411017|FG000|Cohort 5P, Q2W|Adverse Event|0|||
147616461|NCT02906670|532411018|FG001|Cohort 5P, Q2W|Adverse Event|0|||
147616462|NCT02906670|532411019|FG002|Cohort 5P, Q2W|Adverse Event|0|||
147616463|NCT02906670|532411020|FG003|Cohort 5P, Q2W|Adverse Event|0|||
147616464|NCT02906670|532411021|FG004|Cohort 5P, Q2W|Adverse Event|0|||
147616465|NCT02906670|532411022|FG005|Cohort 5P, Q2W|Adverse Event|0|||
147616466|NCT02906670|532411023|FG006|Cohort 5P, Q2W|Adverse Event|0|||
147616467|NCT02906670|532411024|FG007|Cohort 5P, Q2W|Adverse Event|1|||
147616468|NCT02906670|532411025|FG008|Cohort 5P, Q2W|Adverse Event|0|||
147616469|NCT02906670|532411026|FG009|Cohort 5P, Q2W|Adverse Event|0|||
147616470|NCT02906670|532411017|FG000|Cohort 6P, Q2W|Radiological Progression|0|||
147616471|NCT02906670|532411018|FG001|Cohort 6P, Q2W|Radiological Progression|0|||
147616472|NCT02906670|532411019|FG002|Cohort 6P, Q2W|Radiological Progression|0|||
147616473|NCT02906670|532411020|FG003|Cohort 6P, Q2W|Radiological Progression|0|||
147616474|NCT02906670|532411021|FG004|Cohort 6P, Q2W|Radiological Progression|0|||
147616475|NCT02906670|532411022|FG005|Cohort 6P, Q2W|Radiological Progression|0|||
147616476|NCT02906670|532411023|FG006|Cohort 6P, Q2W|Radiological Progression|0|||
147616477|NCT02906670|532411024|FG007|Cohort 6P, Q2W|Radiological Progression|0|||
147616478|NCT02906670|532411025|FG008|Cohort 6P, Q2W|Radiological Progression|1|||
147616479|NCT02906670|532411026|FG009|Cohort 6P, Q2W|Radiological Progression|0|||
147616480|NCT02906670|532411017|FG000|Cohort 6P, Q2W|Clinical Progression|0|||
147616481|NCT02906670|532411018|FG001|Cohort 6P, Q2W|Clinical Progression|0|||
147616482|NCT02906670|532411019|FG002|Cohort 6P, Q2W|Clinical Progression|0|||
147616483|NCT02906670|532411020|FG003|Cohort 6P, Q2W|Clinical Progression|0|||
147616484|NCT02906670|532411021|FG004|Cohort 6P, Q2W|Clinical Progression|0|||
147616485|NCT02906670|532411022|FG005|Cohort 6P, Q2W|Clinical Progression|0|||
147616486|NCT02906670|532411023|FG006|Cohort 6P, Q2W|Clinical Progression|0|||
147616487|NCT02906670|532411024|FG007|Cohort 6P, Q2W|Clinical Progression|0|||
147616488|NCT02906670|532411025|FG008|Cohort 6P, Q2W|Clinical Progression|3|||
147616489|NCT02906670|532411026|FG009|Cohort 6P, Q2W|Clinical Progression|0|||
147616490|NCT02906670|532411017|FG000|Cohort 4P, QW|Radiological Progression|0|||
147616491|NCT02906670|532411018|FG001|Cohort 4P, QW|Radiological Progression|0|||
147616492|NCT02906670|532411019|FG002|Cohort 4P, QW|Radiological Progression|0|||
147616493|NCT02906670|532411020|FG003|Cohort 4P, QW|Radiological Progression|3|||
147616494|NCT02906670|532411021|FG004|Cohort 4P, QW|Radiological Progression|0|||
147616495|NCT02906670|532411022|FG005|Cohort 4P, QW|Radiological Progression|0|||
147616496|NCT02906670|532411023|FG006|Cohort 4P, QW|Radiological Progression|0|||
147616497|NCT02906670|532411024|FG007|Cohort 4P, QW|Radiological Progression|0|||
147616498|NCT02906670|532411025|FG008|Cohort 4P, QW|Radiological Progression|0|||
147616499|NCT02906670|532411026|FG009|Cohort 4P, QW|Radiological Progression|0|||
147616500|NCT02906670|532411017|FG000|Cohort 7P, Q2W|Adverse Event|0|||
147616501|NCT02906670|532411018|FG001|Cohort 7P, Q2W|Adverse Event|0|||
147616502|NCT02906670|532411019|FG002|Cohort 7P, Q2W|Adverse Event|0|||
147616503|NCT02906670|532411020|FG003|Cohort 7P, Q2W|Adverse Event|0|||
147616504|NCT02906670|532411021|FG004|Cohort 7P, Q2W|Adverse Event|0|||
147616505|NCT02906670|532411022|FG005|Cohort 7P, Q2W|Adverse Event|0|||
147616506|NCT02906670|532411023|FG006|Cohort 7P, Q2W|Adverse Event|0|||
147616507|NCT02906670|532411024|FG007|Cohort 7P, Q2W|Adverse Event|0|||
147616508|NCT02906670|532411025|FG008|Cohort 7P, Q2W|Adverse Event|0|||
147616509|NCT02906670|532411026|FG009|Cohort 7P, Q2W|Adverse Event|1|||
147616510|NCT02906670|532411017|FG000|Cohort 7P, Q2W|Physician Decision|0|||
147616511|NCT02906670|532411018|FG001|Cohort 7P, Q2W|Physician Decision|0|||
147616512|NCT02906670|532411019|FG002|Cohort 7P, Q2W|Physician Decision|0|||
147616513|NCT02906670|532411020|FG003|Cohort 7P, Q2W|Physician Decision|0|||
147616514|NCT02906670|532411021|FG004|Cohort 7P, Q2W|Physician Decision|0|||
147616515|NCT02906670|532411022|FG005|Cohort 7P, Q2W|Physician Decision|0|||
147616516|NCT02906670|532411023|FG006|Cohort 7P, Q2W|Physician Decision|0|||
147616517|NCT02906670|532411024|FG007|Cohort 7P, Q2W|Physician Decision|0|||
147464342|NCT00896532|531860297|FG016|Months 1-24: Romosozumab Treatment Phase|Other|0|||
147616518|NCT02906670|532411025|FG008|Cohort 7P, Q2W|Physician Decision|0|||
147616519|NCT02906670|532411026|FG009|Cohort 7P, Q2W|Physician Decision|1|||
147616520|NCT02906670|532411017|FG000|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
147616521|NCT02906670|532411018|FG001|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
147616522|NCT02906670|532411019|FG002|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
147616523|NCT02906670|532411020|FG003|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
147616524|NCT02906670|532411021|FG004|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
147616525|NCT02906670|532411022|FG005|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
147616526|NCT02906670|532411023|FG006|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
147616527|NCT02906670|532411024|FG007|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
147616528|NCT02906670|532411025|FG008|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|0|||
147616529|NCT02906670|532411026|FG009|Cohort 7P, Q2W|More than 3 Dose-reduction of Pan-Her|1|||
147616530|NCT02906670|532411017|FG000|Cohort 5P, QW|Radiological Progression|0|||
147616531|NCT02906670|532411018|FG001|Cohort 5P, QW|Radiological Progression|0|||
147616532|NCT02906670|532411019|FG002|Cohort 5P, QW|Radiological Progression|0|||
147616533|NCT02906670|532411020|FG003|Cohort 5P, QW|Radiological Progression|0|||
147616534|NCT02906670|532411021|FG004|Cohort 5P, QW|Radiological Progression|3|||
147616535|NCT02906670|532411022|FG005|Cohort 5P, QW|Radiological Progression|0|||
147616536|NCT02906670|532411023|FG006|Cohort 5P, QW|Radiological Progression|0|||
147616537|NCT02906670|532411024|FG007|Cohort 5P, QW|Radiological Progression|0|||
147616538|NCT02906670|532411025|FG008|Cohort 5P, QW|Radiological Progression|0|||
147616539|NCT02906670|532411026|FG009|Cohort 5P, QW|Radiological Progression|0|||
147616540|NCT00344448|532411027|FG000|Screening|Withdrawal by Subject|0|||
147616541|NCT00344448|532411028|FG001|Screening|Withdrawal by Subject|1|||
147616542|NCT00344448|532411027|FG000|Double Blind, Placebo Controlled|Withdrawal by Subject|1|||
147616543|NCT00344448|532411028|FG001|Double Blind, Placebo Controlled|Withdrawal by Subject|0|||
147616544|NCT00344448|532411027|FG000|Double Blind, Placebo Controlled|Study terminated|1|||
147665410|NCT01225549|532599575|FG008|Period 6 - Washout|Disallowed medication|0|||
147665411|NCT01225549|532599576|FG009|Period 6 - Washout|Disallowed medication|0|||
147665412|NCT00473083|532599579|FG000|Overall Study|Adverse Event|1|||
147665413|NCT00473083|532599580|FG001|Overall Study|Adverse Event|0|||
147665414|NCT00473083|532599581|FG002|Overall Study|Adverse Event|0|||
147665415|NCT02915835|532599582|FG000|Overall Study|Physician Decision|1|||
147665416|NCT02915835|532599583|FG001|Overall Study|Physician Decision|0|||
147665417|NCT02915835|532599582|FG000|Overall Study|Withdrawal by Subject|0|||
147665418|NCT02915835|532599583|FG001|Overall Study|Withdrawal by Subject|1|||
147665419|NCT01184872|532599584|FG000|Overall Study|Adverse Event|3|||
147665420|NCT01184872|532599585|FG001|Overall Study|Adverse Event|4|||
147665421|NCT01184872|532599584|FG000|Overall Study|Unsatisfactory therapeutic effect|3|||
147665422|NCT01184872|532599585|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
147665423|NCT01184872|532599584|FG000|Overall Study|Withdrawal by Subject|2|||
147665424|NCT01184872|532599585|FG001|Overall Study|Withdrawal by Subject|0|||
147665425|NCT01184872|532599584|FG000|Overall Study|Lost to Follow-up|0|||
147665426|NCT01184872|532599585|FG001|Overall Study|Lost to Follow-up|1|||
147665427|NCT01184872|532599584|FG000|Overall Study|Administrative problems|1|||
147665428|NCT01184872|532599585|FG001|Overall Study|Administrative problems|1|||
147665429|NCT01184872|532599584|FG000|Overall Study|Protocol deviation|1|||
147665430|NCT01184872|532599585|FG001|Overall Study|Protocol deviation|0|||
147665431|NCT03426345|532599586|FG000|Overall Study|Adverse Event|4|||
147665432|NCT03426345|532599587|FG001|Overall Study|Adverse Event|4|||
147665433|NCT03426345|532599586|FG000|Overall Study|Lack of Efficacy|1|||
147665434|NCT03426345|532599587|FG001|Overall Study|Lack of Efficacy|0|||
147665435|NCT03426345|532599586|FG000|Overall Study|Withdrawal by Subject|5|||
147665436|NCT03426345|532599587|FG001|Overall Study|Withdrawal by Subject|6|||
147665437|NCT03426345|532599586|FG000|Overall Study|Lost to Follow-up|3|||
147665438|NCT03426345|532599587|FG001|Overall Study|Lost to Follow-up|1|||
147665439|NCT03426345|532599586|FG000|Overall Study|Protocol Deviation|3|||
147665440|NCT03426345|532599587|FG001|Overall Study|Protocol Deviation|4|||
147665441|NCT03426345|532599586|FG000|Overall Study|Reason Not Specified|1|||
147665442|NCT03426345|532599587|FG001|Overall Study|Reason Not Specified|2|||
147665443|NCT03426345|532599586|FG000|Overall Study|Missing Completion Status|1|||
147665444|NCT03426345|532599587|FG001|Overall Study|Missing Completion Status|0|||
147665445|NCT00433836|532599588|FG000|Overall Study|Adverse Event|7|||
147665446|NCT00433836|532599589|FG001|Overall Study|Adverse Event|0|||
147616545|NCT00344448|532411028|FG001|Double Blind, Placebo Controlled|Study terminated|0|||
147665447|NCT00433836|532599588|FG000|Overall Study|Lost to Follow-up|3|||
147665448|NCT00433836|532599589|FG001|Overall Study|Lost to Follow-up|0|||
147665449|NCT00433836|532599588|FG000|Overall Study|Withdrawal by Subject|2|||
147665450|NCT00433836|532599589|FG001|Overall Study|Withdrawal by Subject|1|||
147665451|NCT00433836|532599588|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
147665452|NCT00433836|532599589|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
147665453|NCT00433836|532599588|FG000|Overall Study|Protocol Violation|0|||
147665454|NCT00433836|532599589|FG001|Overall Study|Protocol Violation|2|||
147665455|NCT00433836|532599588|FG000|Overall Study|Condition no longer requires study drug|0|||
147665456|NCT00433836|532599589|FG001|Overall Study|Condition no longer requires study drug|1|||
147665457|NCT00433836|532599588|FG000|Overall Study|Abnormal laboratory values|0|||
147665458|NCT00433836|532599589|FG001|Overall Study|Abnormal laboratory values|1|||
147665459|NCT01474486|532599590|FG000|Overall Study|Death|2|||
147464343|NCT00896532|531860298|FG017|Months 1-24: Romosozumab Treatment Phase|Other|0|||
147464344|NCT00896532|531860299|FG018|Months 1-24: Romosozumab Treatment Phase|Other|0|||
147464345|NCT00896532|531860300|FG019|Months 1-24: Romosozumab Treatment Phase|Other|0|||
147464346|NCT00896532|531860301|FG020|Months 1-24: Romosozumab Treatment Phase|Other|0|||
147464347|NCT00896532|531860302|FG021|Months 1-24: Romosozumab Treatment Phase|Other|0|||
147464348|NCT00896532|531860303|FG022|Months 1-24: Romosozumab Treatment Phase|Other|0|||
147464349|NCT00896532|531860281|FG000|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
147464350|NCT00896532|531860282|FG001|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
147616546|NCT00344448|532411027|FG000|Open Label|Withdrawal by Subject|1|||
147616547|NCT00344448|532411028|FG001|Open Label|Withdrawal by Subject|1|||
147616548|NCT00344448|532411027|FG000|Open Label|Study terminated|1|||
147464351|NCT00896532|531860283|FG002|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
147464352|NCT00896532|531860284|FG003|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
147616549|NCT00344448|532411028|FG001|Open Label|Study terminated|0|||
147616550|NCT01783886|532411031|FG000|Overall Study|Lost to Follow-up|0|||
147616551|NCT01783886|532411032|FG001|Overall Study|Lost to Follow-up|3|||
147616552|NCT01783886|532411033|FG002|Overall Study|Lost to Follow-up|0|||
147616553|NCT01783886|532411031|FG000|Overall Study|Protocol deviation|0|||
147616554|NCT01783886|532411032|FG001|Overall Study|Protocol deviation|0|||
147616555|NCT01783886|532411033|FG002|Overall Study|Protocol deviation|2|||
147616556|NCT01783886|532411031|FG000|Overall Study|Withdrawal of consent by participant|1|||
147616557|NCT01783886|532411032|FG001|Overall Study|Withdrawal of consent by participant|3|||
147616558|NCT01783886|532411033|FG002|Overall Study|Withdrawal of consent by participant|4|||
147616559|NCT01783886|532411031|FG000|Overall Study|Adverse Event|4|||
147616560|NCT01783886|532411032|FG001|Overall Study|Adverse Event|5|||
147616561|NCT01783886|532411033|FG002|Overall Study|Adverse Event|4|||
147616562|NCT00940316|532411036|FG000|Reached First Response at 8 Weeks|Adverse Event|2|||
147616563|NCT00940316|532411037|FG001|Reached First Response at 8 Weeks|Adverse Event|1|||
147616564|NCT00940316|532411038|FG002|Reached First Response at 8 Weeks|Adverse Event|0|||
147616565|NCT00940316|532411036|FG000|Reached First Response at 8 Weeks|Progressive disease|1|||
147616566|NCT00940316|532411037|FG001|Reached First Response at 8 Weeks|Progressive disease|3|||
147616567|NCT00940316|532411038|FG002|Reached First Response at 8 Weeks|Progressive disease|0|||
147616568|NCT00940316|532411036|FG000|Moved on to be Treated Cycle 5|Adverse Event|2|||
147616569|NCT00940316|532411037|FG001|Moved on to be Treated Cycle 5|Adverse Event|0|||
147616570|NCT00940316|532411038|FG002|Moved on to be Treated Cycle 5|Adverse Event|0|||
147616571|NCT00940316|532411036|FG000|Treated After Cycle 5|Adverse Event|0|||
147616572|NCT00940316|532411037|FG001|Treated After Cycle 5|Adverse Event|0|||
147616573|NCT00940316|532411038|FG002|Treated After Cycle 5|Adverse Event|1|||
147616574|NCT00940316|532411036|FG000|Treated After Cycle 5|Progressive disease|0|||
147616575|NCT00940316|532411037|FG001|Treated After Cycle 5|Progressive disease|1|||
147616576|NCT00940316|532411038|FG002|Treated After Cycle 5|Progressive disease|0|||
147616577|NCT02324582|532411039|FG000|Overall Study|Screen Failures|0|||
147616578|NCT02324582|532411040|FG001|Overall Study|Screen Failures|5|||
147616579|NCT00996489|532411042|FG000|Overall Study|Device failure|45|||
147616580|NCT00996489|532411042|FG000|Overall Study|Discontinued|116|||
147616581|NCT02286843|532411051|FG000|Overall Study|Not Treated|4|||
147616582|NCT02286843|532411051|FG000|Overall Study|Protocol Violation|1|||
147616583|NCT02286843|532411051|FG000|Overall Study|Withdrawal by Subject|1|||
147616584|NCT01855828|532411054|FG000|Overall Study|Adverse Event|1|||
147616585|NCT01855828|532411054|FG000|Overall Study|Withdrawal by Subject|1|||
147616586|NCT01866098|532411055|FG000|Overall Study|Lost to Follow-up|11|||
147616587|NCT01866098|532411056|FG001|Overall Study|Lost to Follow-up|18|||
147616588|NCT01866098|532411057|FG002|Overall Study|Lost to Follow-up|13|||
147616589|NCT01866098|532411055|FG000|Overall Study|Physician Decision|0|||
147616590|NCT01866098|532411056|FG001|Overall Study|Physician Decision|1|||
147616591|NCT01866098|532411057|FG002|Overall Study|Physician Decision|2|||
147616592|NCT01866098|532411055|FG000|Overall Study|Adverse Event|1|||
147616593|NCT01866098|532411056|FG001|Overall Study|Adverse Event|5|||
147616594|NCT01866098|532411057|FG002|Overall Study|Adverse Event|4|||
147616595|NCT01866098|532411055|FG000|Overall Study|Protocol Violation|1|||
147616596|NCT01866098|532411056|FG001|Overall Study|Protocol Violation|0|||
147616597|NCT01866098|532411057|FG002|Overall Study|Protocol Violation|0|||
147616598|NCT01866098|532411055|FG000|Overall Study|Withdrawal by Subject|1|||
147616599|NCT01866098|532411056|FG001|Overall Study|Withdrawal by Subject|2|||
147616600|NCT01866098|532411057|FG002|Overall Study|Withdrawal by Subject|0|||
147616601|NCT01866098|532411055|FG000|Overall Study|Unrelated Hospitalization|2|||
147464353|NCT00896532|531860285|FG004|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
147616602|NCT01866098|532411056|FG001|Overall Study|Unrelated Hospitalization|0|||
147616603|NCT01866098|532411057|FG002|Overall Study|Unrelated Hospitalization|1|||
147616604|NCT01866098|532411055|FG000|Overall Study|Non-compliance|1|||
147616605|NCT01866098|532411056|FG001|Overall Study|Non-compliance|0|||
147616606|NCT01866098|532411057|FG002|Overall Study|Non-compliance|1|||
147616607|NCT01866098|532411055|FG000|Overall Study|Pregnancy|2|||
147616608|NCT01866098|532411056|FG001|Overall Study|Pregnancy|0|||
147616609|NCT01866098|532411057|FG002|Overall Study|Pregnancy|0|||
147616610|NCT01866098|532411055|FG000|Overall Study|Death|0|||
147464354|NCT00896532|531860286|FG005|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
147464355|NCT00896532|531860287|FG006|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
147464356|NCT00896532|531860288|FG007|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
147464357|NCT00896532|531860289|FG008|Months 24-36: Denosumab Extension Phase|Protocol Deviation|1|||
147464358|NCT00896532|531860290|FG009|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
147464359|NCT00896532|531860291|FG010|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
147464360|NCT00896532|531860292|FG011|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
147464361|NCT00896532|531860293|FG012|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
147464362|NCT00896532|531860294|FG013|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
147464363|NCT00896532|531860295|FG014|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
147464364|NCT00896532|531860296|FG015|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
147464365|NCT00896532|531860297|FG016|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
147464366|NCT00896532|531860298|FG017|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
147464367|NCT00896532|531860299|FG018|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
147464368|NCT00896532|531860300|FG019|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
147464369|NCT00896532|531860301|FG020|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
147464370|NCT00896532|531860302|FG021|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
147464371|NCT00896532|531860303|FG022|Months 24-36: Denosumab Extension Phase|Protocol Deviation|0|||
147464372|NCT00896532|531860281|FG000|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
147464373|NCT00896532|531860282|FG001|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
147464374|NCT00896532|531860283|FG002|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
147464375|NCT00896532|531860284|FG003|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
147464376|NCT00896532|531860285|FG004|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
147464377|NCT00896532|531860286|FG005|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
147464378|NCT00896532|531860287|FG006|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
147464379|NCT00896532|531860288|FG007|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
147464380|NCT00896532|531860289|FG008|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
147464381|NCT00896532|531860290|FG009|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
147464382|NCT00896532|531860291|FG010|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
147464383|NCT00896532|531860292|FG011|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
147464384|NCT00896532|531860293|FG012|Months 24-36: Denosumab Extension Phase|Noncompliance|1|||
147464385|NCT00896532|531860294|FG013|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
147464386|NCT00896532|531860295|FG014|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
147464387|NCT00896532|531860296|FG015|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
147464388|NCT00896532|531860297|FG016|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
147464389|NCT00896532|531860298|FG017|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
147464390|NCT00896532|531860299|FG018|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
147464391|NCT00896532|531860300|FG019|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
147464392|NCT00896532|531860301|FG020|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
147464393|NCT00896532|531860302|FG021|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
147464394|NCT00896532|531860303|FG022|Months 24-36: Denosumab Extension Phase|Noncompliance|0|||
147464395|NCT00896532|531860281|FG000|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
147464396|NCT00896532|531860282|FG001|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
147464397|NCT00896532|531860283|FG002|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
147616611|NCT01866098|532411056|FG001|Overall Study|Death|1|||
147616612|NCT01866098|532411057|FG002|Overall Study|Death|0|||
147616613|NCT04239027|532411062|FG000|Overall Study|Adverse Event|4|||
147616614|NCT04239027|532411062|FG000|Overall Study|Withdrawal by Subject|9|||
147616615|NCT04239027|532411062|FG000|Overall Study|Death|1|||
147616616|NCT04239027|532411062|FG000|Overall Study|Physician Decision|9|||
147616617|NCT04239027|532411062|FG000|Overall Study|Lost to Follow-up|2|||
147616618|NCT04239027|532411062|FG000|Overall Study|Lack of Efficacy|1|||
147616619|NCT03172494|532411069|FG000|Overall Study|Adverse Event|5|||
147616620|NCT03172494|532411070|FG001|Overall Study|Adverse Event|1|||
147616621|NCT03172494|532411071|FG002|Overall Study|Adverse Event|15|||
147616622|NCT03172494|532411069|FG000|Overall Study|Protocol Violation|3|||
147616623|NCT03172494|532411070|FG001|Overall Study|Protocol Violation|2|||
147616624|NCT03172494|532411071|FG002|Overall Study|Protocol Violation|1|||
147616625|NCT03172494|532411069|FG000|Overall Study|Lack of Efficacy|0|||
147616626|NCT03172494|532411070|FG001|Overall Study|Lack of Efficacy|0|||
147616627|NCT03172494|532411071|FG002|Overall Study|Lack of Efficacy|4|||
147616628|NCT03172494|532411069|FG000|Overall Study|Pregnancy|0|||
147616629|NCT03172494|532411070|FG001|Overall Study|Pregnancy|1|||
147616630|NCT03172494|532411071|FG002|Overall Study|Pregnancy|0|||
147665460|NCT01474486|532599590|FG000|Overall Study|Withdrawal by Subject|4|||
147616631|NCT03172494|532411069|FG000|Overall Study|Withdrawal by Subject|10|||
147616632|NCT03172494|532411070|FG001|Overall Study|Withdrawal by Subject|8|||
147616633|NCT03172494|532411071|FG002|Overall Study|Withdrawal by Subject|8|||
147616634|NCT03172494|532411069|FG000|Overall Study|Severe hypoglycaemic episode|0|||
147665461|NCT01474486|532599590|FG000|Overall Study|Withdrawn by the PI: One didn't understand what he consented for and one required surgery.|2|||
147665462|NCT04613518|532599591|FG000|Double-Blind Treatment Period|Lack of Efficacy|1|||
147665463|NCT04613518|532599592|FG001|Double-Blind Treatment Period|Lack of Efficacy|0|||
147665464|NCT04613518|532599593|FG002|Double-Blind Treatment Period|Lack of Efficacy|0|||
147665465|NCT04613518|532599591|FG000|Double-Blind Treatment Period|Adverse Event|2|||
147665466|NCT04613518|532599592|FG001|Double-Blind Treatment Period|Adverse Event|0|||
147665467|NCT04613518|532599593|FG002|Double-Blind Treatment Period|Adverse Event|1|||
147665468|NCT04613518|532599591|FG000|Double-Blind Treatment Period|Participant request to discontinue treatment|1|||
147665469|NCT04613518|532599592|FG001|Double-Blind Treatment Period|Participant request to discontinue treatment|0|||
147665470|NCT04613518|532599593|FG002|Double-Blind Treatment Period|Participant request to discontinue treatment|0|||
147665471|NCT04613518|532599591|FG000|Double-Blind Treatment Period|Participant withdrew consent|1|||
147665472|NCT04613518|532599592|FG001|Double-Blind Treatment Period|Participant withdrew consent|1|||
147665473|NCT04613518|532599593|FG002|Double-Blind Treatment Period|Participant withdrew consent|0|||
147665474|NCT04613518|532599591|FG000|Double-Blind Treatment Period|Other Reasons|2|||
147665475|NCT04613518|532599592|FG001|Double-Blind Treatment Period|Other Reasons|0|||
147665476|NCT04613518|532599593|FG002|Double-Blind Treatment Period|Other Reasons|0|||
147665477|NCT04613518|532599591|FG000|Open-Label Treatment Period|Lack of Efficacy|0|||
147665478|NCT04613518|532599592|FG001|Open-Label Treatment Period|Lack of Efficacy|3|||
147665479|NCT04613518|532599593|FG002|Open-Label Treatment Period|Lack of Efficacy|0|||
147665480|NCT04613518|532599591|FG000|Open-Label Treatment Period|Adverse Event|1|||
147665481|NCT04613518|532599592|FG001|Open-Label Treatment Period|Adverse Event|0|||
147665482|NCT04613518|532599593|FG002|Open-Label Treatment Period|Adverse Event|3|||
147665483|NCT04613518|532599591|FG000|Open-Label Treatment Period|Participant request to discontinue treatment|1|||
147405689|NCT01784523|531649472|FG001|Overall Study|Study closed early|4|||
147405690|NCT02179177|531649475|FG000|Overall Study|Lost to Follow-up|1|||
147405691|NCT02179177|531649476|FG001|Overall Study|Lost to Follow-up|1|||
147405692|NCT02179177|531649475|FG000|Overall Study|Withdrawal by Subject|1|||
147405693|NCT02179177|531649476|FG001|Overall Study|Withdrawal by Subject|1|||
147405694|NCT00022659|531649477|FG000|Overall Study|Ineligible: wrong primary|1|||
147405695|NCT00022659|531649477|FG000|Overall Study|Never treated|1|||
147405696|NCT04340947|531649478|FG000|7-day Washout Period|Lost to Follow-up|5|||
147405697|NCT04340947|531649479|FG001|7-day Washout Period|Lost to Follow-up|4|||
147405698|NCT01907906|531649482|FG000|Overall Study|Withdrawal by Subject|1|||
147405699|NCT01907906|531649483|FG001|Overall Study|Withdrawal by Subject|0|||
147405700|NCT01907906|531649482|FG000|Overall Study|Physician Decision|3|||
147405701|NCT01907906|531649483|FG001|Overall Study|Physician Decision|1|||
147405702|NCT00884650|531649484|FG000|Overall Study|Did not return complete pain diaries|7|||
147405703|NCT00884650|531649485|FG001|Overall Study|Did not return complete pain diaries|7|||
147405704|NCT00884650|531649484|FG000|Overall Study|Admitted Post-Op|1|||
147405705|NCT00884650|531649485|FG001|Overall Study|Admitted Post-Op|0|||
147405706|NCT00884650|531649484|FG000|Overall Study|Femoral Stress Fracture|1|||
147405707|NCT00884650|531649485|FG001|Overall Study|Femoral Stress Fracture|0|||
147405708|NCT00884650|531649484|FG000|Overall Study|Pain Pump Complication|0|||
147405709|NCT00884650|531649485|FG001|Overall Study|Pain Pump Complication|1|||
147405710|NCT04052425|531649494|FG000|24-Week Double-blind Period|Adverse Event|0|||
147405711|NCT04052425|531649495|FG001|24-Week Double-blind Period|Adverse Event|1|||
147405712|NCT04052425|531649496|FG002|24-Week Double-blind Period|Adverse Event|0|||
147405713|NCT04052425|531649497|FG003|24-Week Double-blind Period|Adverse Event|0|||
147405714|NCT04052425|531649494|FG000|24-Week Double-blind Period|Lack of Efficacy|0|||
147405715|NCT04052425|531649495|FG001|24-Week Double-blind Period|Lack of Efficacy|1|||
147405716|NCT04052425|531649496|FG002|24-Week Double-blind Period|Lack of Efficacy|0|||
147405717|NCT04052425|531649497|FG003|24-Week Double-blind Period|Lack of Efficacy|0|||
147405718|NCT04052425|531649494|FG000|24-Week Double-blind Period|Lost to Follow-up|14|||
147405719|NCT04052425|531649495|FG001|24-Week Double-blind Period|Lost to Follow-up|7|||
147405720|NCT04052425|531649496|FG002|24-Week Double-blind Period|Lost to Follow-up|0|||
147405721|NCT04052425|531649497|FG003|24-Week Double-blind Period|Lost to Follow-up|0|||
147405722|NCT04052425|531649494|FG000|24-Week Double-blind Period|Physician Decision|1|||
147405723|NCT04052425|531649495|FG001|24-Week Double-blind Period|Physician Decision|0|||
147405724|NCT04052425|531649496|FG002|24-Week Double-blind Period|Physician Decision|0|||
147405725|NCT04052425|531649497|FG003|24-Week Double-blind Period|Physician Decision|0|||
147405726|NCT04052425|531649494|FG000|24-Week Double-blind Period|Protocol Violation|1|||
147405727|NCT04052425|531649495|FG001|24-Week Double-blind Period|Protocol Violation|0|||
147405728|NCT04052425|531649496|FG002|24-Week Double-blind Period|Protocol Violation|0|||
147405729|NCT04052425|531649497|FG003|24-Week Double-blind Period|Protocol Violation|0|||
147405730|NCT04052425|531649494|FG000|24-Week Double-blind Period|Withdrawal by Subject|9|||
147405731|NCT04052425|531649495|FG001|24-Week Double-blind Period|Withdrawal by Subject|10|||
147405732|NCT04052425|531649496|FG002|24-Week Double-blind Period|Withdrawal by Subject|0|||
147405733|NCT04052425|531649497|FG003|24-Week Double-blind Period|Withdrawal by Subject|0|||
147464398|NCT00896532|531860284|FG003|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
147464399|NCT00896532|531860285|FG004|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
147464400|NCT00896532|531860286|FG005|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
147464401|NCT00896532|531860287|FG006|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
147464402|NCT00896532|531860288|FG007|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
147464403|NCT00896532|531860289|FG008|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
147464404|NCT00896532|531860290|FG009|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
147464405|NCT00896532|531860291|FG010|Months 24-36: Denosumab Extension Phase|Adverse Event|1|||
147464406|NCT00896532|531860292|FG011|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
147464407|NCT00896532|531860293|FG012|Months 24-36: Denosumab Extension Phase|Adverse Event|1|||
147464408|NCT00896532|531860294|FG013|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
147464409|NCT00896532|531860295|FG014|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
147464410|NCT00896532|531860296|FG015|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
147464411|NCT00896532|531860297|FG016|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
147464412|NCT00896532|531860298|FG017|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
147464413|NCT00896532|531860299|FG018|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
147464414|NCT00896532|531860300|FG019|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
147464415|NCT00896532|531860301|FG020|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
147616635|NCT03172494|532411070|FG001|Overall Study|Severe hypoglycaemic episode|0|||
147616636|NCT03172494|532411071|FG002|Overall Study|Severe hypoglycaemic episode|1|||
147405734|NCT04052425|531649494|FG000|24-Week Double-blind Period|Discontinued Treatment Due to COVID-19 Pandemic|3|||
147405735|NCT04052425|531649495|FG001|24-Week Double-blind Period|Discontinued Treatment Due to COVID-19 Pandemic|0|||
147405736|NCT04052425|531649496|FG002|24-Week Double-blind Period|Discontinued Treatment Due to COVID-19 Pandemic|0|||
147405737|NCT04052425|531649497|FG003|24-Week Double-blind Period|Discontinued Treatment Due to COVID-19 Pandemic|0|||
147405738|NCT04052425|531649494|FG000|28-Week Treatment-Extension Period|Adverse Event|0|||
147405739|NCT04052425|531649495|FG001|28-Week Treatment-Extension Period|Adverse Event|0|||
147405740|NCT04052425|531649496|FG002|28-Week Treatment-Extension Period|Adverse Event|1|||
147405741|NCT04052425|531649497|FG003|28-Week Treatment-Extension Period|Adverse Event|0|||
147405742|NCT04052425|531649494|FG000|28-Week Treatment-Extension Period|Lack of Efficacy|0|||
147405743|NCT04052425|531649495|FG001|28-Week Treatment-Extension Period|Lack of Efficacy|0|||
147405744|NCT04052425|531649496|FG002|28-Week Treatment-Extension Period|Lack of Efficacy|1|||
147405745|NCT04052425|531649497|FG003|28-Week Treatment-Extension Period|Lack of Efficacy|0|||
147405746|NCT04052425|531649494|FG000|28-Week Treatment-Extension Period|Lost to Follow-up|0|||
147405747|NCT04052425|531649495|FG001|28-Week Treatment-Extension Period|Lost to Follow-up|0|||
147405748|NCT04052425|531649496|FG002|28-Week Treatment-Extension Period|Lost to Follow-up|5|||
147405749|NCT04052425|531649497|FG003|28-Week Treatment-Extension Period|Lost to Follow-up|1|||
147405750|NCT04052425|531649494|FG000|28-Week Treatment-Extension Period|Physician Decision|0|||
147405751|NCT04052425|531649495|FG001|28-Week Treatment-Extension Period|Physician Decision|0|||
147405752|NCT04052425|531649496|FG002|28-Week Treatment-Extension Period|Physician Decision|0|||
147405753|NCT04052425|531649497|FG003|28-Week Treatment-Extension Period|Physician Decision|1|||
147405754|NCT04052425|531649494|FG000|28-Week Treatment-Extension Period|Withdrawal by Subject|0|||
147405755|NCT04052425|531649495|FG001|28-Week Treatment-Extension Period|Withdrawal by Subject|0|||
147405756|NCT04052425|531649496|FG002|28-Week Treatment-Extension Period|Withdrawal by Subject|10|||
147405757|NCT04052425|531649497|FG003|28-Week Treatment-Extension Period|Withdrawal by Subject|7|||
147405758|NCT04052425|531649494|FG000|28-Week Treatment-Extension Period|Sponsor Opinion Due to Safety Reason|0|||
147405759|NCT04052425|531649495|FG001|28-Week Treatment-Extension Period|Sponsor Opinion Due to Safety Reason|0|||
147405760|NCT04052425|531649496|FG002|28-Week Treatment-Extension Period|Sponsor Opinion Due to Safety Reason|1|||
147405761|NCT04052425|531649497|FG003|28-Week Treatment-Extension Period|Sponsor Opinion Due to Safety Reason|0|||
147405762|NCT04052425|531649494|FG000|28-Week Treatment-Extension Period|Participant Moved|0|||
147405763|NCT04052425|531649495|FG001|28-Week Treatment-Extension Period|Participant Moved|0|||
147405764|NCT04052425|531649496|FG002|28-Week Treatment-Extension Period|Participant Moved|1|||
147405765|NCT04052425|531649497|FG003|28-Week Treatment-Extension Period|Participant Moved|1|||
147405766|NCT04334278|531649498|FG000|Overall Study|Lost to Follow-up|0|||
147405767|NCT04334278|531649499|FG001|Overall Study|Lost to Follow-up|3|||
147405768|NCT04334278|531649498|FG000|Overall Study|Withdrawal by Subject|4|||
147405769|NCT04334278|531649499|FG001|Overall Study|Withdrawal by Subject|2|||
147405770|NCT01821937|531649500|FG000|Overall Study|Adverse Event|0|||
147405771|NCT01821937|531649501|FG001|Overall Study|Adverse Event|3|||
147405772|NCT01677299|531649502|FG000|Overall Study|Adverse Event|0|||
147464416|NCT00896532|531860302|FG021|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
147464417|NCT00896532|531860303|FG022|Months 24-36: Denosumab Extension Phase|Adverse Event|0|||
147464418|NCT00896532|531860281|FG000|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
147464419|NCT00896532|531860282|FG001|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
147464420|NCT00896532|531860283|FG002|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
147464421|NCT00896532|531860284|FG003|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
147464422|NCT00896532|531860285|FG004|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
147616637|NCT03172494|532411069|FG000|Overall Study|Non-compliance towards treatment|2|||
147616638|NCT03172494|532411070|FG001|Overall Study|Non-compliance towards treatment|0|||
147405773|NCT01677299|531649503|FG001|Overall Study|Adverse Event|2|||
147405774|NCT01677299|531649504|FG002|Overall Study|Adverse Event|1|||
147405775|NCT01677299|531649505|FG003|Overall Study|Adverse Event|0|||
147405776|NCT01677299|531649502|FG000|Overall Study|Withdrawal by Subject|0|||
147405777|NCT01677299|531649503|FG001|Overall Study|Withdrawal by Subject|1|||
147405778|NCT01677299|531649504|FG002|Overall Study|Withdrawal by Subject|0|||
147405779|NCT01677299|531649505|FG003|Overall Study|Withdrawal by Subject|1|||
147405780|NCT02153905|531649506|FG000|Overall Study|Death|1|||
147405781|NCT02153905|531649507|FG001|Overall Study|Death|0|||
147405782|NCT00520845|531649508|FG000|Overall Study|Death|3|||
147405783|NCT00520845|531649508|FG000|Overall Study|Adverse Event|4|||
147405784|NCT00520845|531649508|FG000|Overall Study|Disease Progression, relapse|13|||
147405785|NCT00520845|531649508|FG000|Overall Study|Withdrawal by Subject|1|||
147405786|NCT00520845|531649508|FG000|Overall Study|Alternative Therapy|1|||
147405787|NCT00351377|531649511|FG000|Overall Study|Adverse Event|5|||
147405788|NCT00351377|531649511|FG000|Overall Study|Death|1|||
147405789|NCT00351377|531649511|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
147405790|NCT01516749|531649512|FG000|Active Therapy|Lost to Follow-up|1|||
147405791|NCT01516749|531649512|FG000|Follow-up Off Therapy|Lost to Follow-up|1|||
147405792|NCT01732549|531649513|FG000|Overall Study|Adverse Event|13|||
147405793|NCT01732549|531649514|FG001|Overall Study|Adverse Event|3|||
147405794|NCT01732549|531649513|FG000|Overall Study|Consent withdrawn|13|||
147405795|NCT01732549|531649514|FG001|Overall Study|Consent withdrawn|6|||
147405796|NCT01732549|531649513|FG000|Overall Study|Disease progression|37|||
147405797|NCT01732549|531649514|FG001|Overall Study|Disease progression|50|||
147405798|NCT01732549|531649513|FG000|Overall Study|Other|8|||
147405799|NCT01732549|531649514|FG001|Overall Study|Other|14|||
147405800|NCT02030002|531649515|FG000|Enrollment|Participant had change in treatment plan and no longer met the inclusion criteria|1|||
147405801|NCT02030002|531649515|FG000|Enrollment|Participants signed consent, but enrollment was completed before their treatment began.|4|||
147405802|NCT02030002|531649515|FG000|Follow-up|Lost to Follow-up|2|||
147405803|NCT03994731|531649517|FG000|Pegloticase + IMM Period|Death|2|||
147405804|NCT03994731|531649518|FG001|Pegloticase + IMM Period|Death|0|||
147405805|NCT03994731|531649517|FG000|Pegloticase + IMM Period|Lost to Follow-up|3|||
147405806|NCT03994731|531649518|FG001|Pegloticase + IMM Period|Lost to Follow-up|6|||
147405807|NCT03994731|531649517|FG000|Pegloticase + IMM Period|Withdrawal by Subject|15|||
147405808|NCT03994731|531649518|FG001|Pegloticase + IMM Period|Withdrawal by Subject|9|||
147405809|NCT01681992|531649521|FG000|Overall Study|Adverse Event|3|||
147405810|NCT01681992|531649522|FG001|Overall Study|Adverse Event|2|||
147405811|NCT01681992|531649523|FG002|Overall Study|Adverse Event|3|||
147405812|NCT01681992|531649521|FG000|Overall Study|Lost to Follow-up|36|||
147405813|NCT01681992|531649522|FG001|Overall Study|Lost to Follow-up|38|||
147405814|NCT01681992|531649523|FG002|Overall Study|Lost to Follow-up|53|||
147405815|NCT01681992|531649521|FG000|Overall Study|As Per Sponsor Decision|0|||
147405816|NCT01681992|531649522|FG001|Overall Study|As Per Sponsor Decision|0|||
147405817|NCT01681992|531649523|FG002|Overall Study|As Per Sponsor Decision|1|||
147405818|NCT01681992|531649521|FG000|Overall Study|Protocol Violation|0|||
147405819|NCT01681992|531649522|FG001|Overall Study|Protocol Violation|0|||
147405820|NCT01681992|531649523|FG002|Overall Study|Protocol Violation|1|||
147405821|NCT01681992|531649521|FG000|Overall Study|Withdrawal by Subject|27|||
147405822|NCT01681992|531649522|FG001|Overall Study|Withdrawal by Subject|30|||
147405823|NCT01681992|531649523|FG002|Overall Study|Withdrawal by Subject|25|||
147405824|NCT02406248|531649528|FG000|Overall Study|Death|7|||
147405825|NCT02406248|531649528|FG000|Overall Study|Withdrawal by Subject|2|||
147405826|NCT00732992|531649533|FG000|Overall Study|Adverse Event|1|||
147405827|NCT00732992|531649534|FG001|Overall Study|Adverse Event|1|||
147405828|NCT00732992|531649533|FG000|Overall Study|Objective Progression or Relapse|3|||
147405829|NCT00732992|531649534|FG001|Overall Study|Objective Progression or Relapse|5|||
147405830|NCT00732992|531649533|FG000|Overall Study|Global Deterioration of Health Status|1|||
147405831|NCT00732992|531649534|FG001|Overall Study|Global Deterioration of Health Status|0|||
147405832|NCT00732992|531649533|FG000|Overall Study|Withdrawal by Subject|1|||
147405833|NCT00732992|531649534|FG001|Overall Study|Withdrawal by Subject|0|||
147405834|NCT01969851|531649535|FG000|Overall Study|Adverse Event|0|||
147405835|NCT01969851|531649536|FG001|Overall Study|Adverse Event|0|||
147405836|NCT01969851|531649537|FG002|Overall Study|Adverse Event|3|||
147405837|NCT01969851|531649535|FG000|Overall Study|Lack of Efficacy|0|||
147405838|NCT01969851|531649536|FG001|Overall Study|Lack of Efficacy|3|||
147405839|NCT01969851|531649537|FG002|Overall Study|Lack of Efficacy|1|||
147405840|NCT01969851|531649535|FG000|Overall Study|Withdrawal by Subject|1|||
147405841|NCT01969851|531649536|FG001|Overall Study|Withdrawal by Subject|0|||
147405842|NCT01969851|531649537|FG002|Overall Study|Withdrawal by Subject|1|||
147405843|NCT01969851|531649535|FG000|Overall Study|No effective dose in Titration period|0|||
147405844|NCT01969851|531649536|FG001|Overall Study|No effective dose in Titration period|0|||
147405845|NCT01969851|531649537|FG002|Overall Study|No effective dose in Titration period|1|||
147405846|NCT01969851|531649535|FG000|Overall Study|Sponsor decision|0|||
147405847|NCT01969851|531649536|FG001|Overall Study|Sponsor decision|0|||
147405848|NCT01969851|531649537|FG002|Overall Study|Sponsor decision|1|||
147464423|NCT00896532|531860286|FG005|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
147464424|NCT00896532|531860287|FG006|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
147464425|NCT00896532|531860288|FG007|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
147464426|NCT00896532|531860289|FG008|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
147464427|NCT00896532|531860290|FG009|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
147464428|NCT00896532|531860291|FG010|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
147405849|NCT05226130|531649538|FG000|Overall Study|Lost to Follow-up|0|||
147405850|NCT05226130|531649539|FG001|Overall Study|Lost to Follow-up|1|||
147405851|NCT05226130|531649538|FG000|Overall Study|Not treatment adherent|0|||
147405852|NCT05226130|531649539|FG001|Overall Study|Not treatment adherent|2|||
147405853|NCT02520310|531649540|FG000|At 6 Months Clinical Follow-up|Death|1|||
147405854|NCT02520310|531649540|FG000|At 1 Year Clinical Follow-up|Withdrawal by Subject|1|||
147405855|NCT02520310|531649540|FG000|AT 3 Year Clinical Follow-up|Death|2|||
147405856|NCT02520310|531649540|FG000|AT 3 Year Clinical Follow-up|Withdrawal by Subject|2|||
147405857|NCT02520310|531649540|FG000|AT 4 Year Clinical Follow-up|Death|1|||
147405858|NCT02520310|531649540|FG000|AT 4 Year Clinical Follow-up|missed visit|1|||
147405859|NCT05101993|531649543|FG000|Overall Study|Withdrawal by Subject|1|||
147405860|NCT01124838|531649544|FG000|Overall Study|Miscellaneous|4|||
147405861|NCT01124838|531649545|FG001|Overall Study|Miscellaneous|2|||
147405862|NCT01124838|531649544|FG000|Overall Study|Adverse Event|7|||
147405863|NCT01124838|531649545|FG001|Overall Study|Adverse Event|11|||
147405864|NCT01124838|531649544|FG000|Overall Study|Lack of Efficacy|2|||
147405865|NCT01124838|531649545|FG001|Overall Study|Lack of Efficacy|0|||
147405866|NCT01124838|531649544|FG000|Overall Study|Withdrawal by Subject|3|||
147405867|NCT01124838|531649545|FG001|Overall Study|Withdrawal by Subject|2|||
147405868|NCT01124838|531649544|FG000|Overall Study|Lost to Follow-up|2|||
147405869|NCT01124838|531649545|FG001|Overall Study|Lost to Follow-up|0|||
147405870|NCT02065882|531649546|FG000|Part I: PK/PD|Screening failure|5|||
147405871|NCT02065882|531649546|FG000|Part I: PK/PD|Withdrawal by Subject|2|||
147405872|NCT02065882|531649546|FG000|Part I: PK/PD|Adverse Event|1|||
147405873|NCT02065882|531649546|FG000|Part II: Clinical Efficacy|Screening failure|7|||
147405874|NCT02065882|531649546|FG000|Part II: Clinical Efficacy|Withdrawal by Subject|2|||
147405875|NCT02065882|531649546|FG000|Part II: Clinical Efficacy|Adverse Event|5|||
147405876|NCT02065882|531649546|FG000|Part II: Clinical Efficacy|Regulatory Authority Decision|3|||
147405877|NCT02065882|531649546|FG000|Part II: Clinical Efficacy|No Bleeding Event|11|||
147405878|NCT02065882|531649546|FG000|Part II: Clinical Efficacy|Protocol Violation|3|||
147405879|NCT03816761|531651056|FG000|First Treatment Period (7 Days)|Withdrawal by Subject|0|||
147405880|NCT03816761|531651057|FG001|First Treatment Period (7 Days)|Withdrawal by Subject|0|||
147405881|NCT03816761|531651058|FG002|First Treatment Period (7 Days)|Withdrawal by Subject|0|||
147405882|NCT03816761|531651059|FG003|First Treatment Period (7 Days)|Withdrawal by Subject|0|||
147405883|NCT03816761|531651060|FG004|First Treatment Period (7 Days)|Withdrawal by Subject|0|||
147405884|NCT03816761|531651061|FG005|First Treatment Period (7 Days)|Withdrawal by Subject|1|||
147405885|NCT03816761|531651056|FG000|Second Treatment Period (7 Days)|Unclassified|0|||
147405886|NCT03816761|531651057|FG001|Second Treatment Period (7 Days)|Unclassified|0|||
147405887|NCT03816761|531651058|FG002|Second Treatment Period (7 Days)|Unclassified|0|||
147405888|NCT03816761|531651059|FG003|Second Treatment Period (7 Days)|Unclassified|1|||
147405889|NCT03816761|531651060|FG004|Second Treatment Period (7 Days)|Unclassified|0|||
147405890|NCT03816761|531651061|FG005|Second Treatment Period (7 Days)|Unclassified|0|||
147405891|NCT04991753|531651062|FG000|Overall Study|Withdrawal by Subject|0|||
147405892|NCT04991753|531651063|FG001|Overall Study|Withdrawal by Subject|1|||
147405893|NCT02797522|531651066|FG000|Overall Study|Study Terminated by Sponsor|0|||
147405894|NCT02797522|531651067|FG001|Overall Study|Study Terminated by Sponsor|0|||
147405895|NCT02797522|531651068|FG002|Overall Study|Study Terminated by Sponsor|0|||
147405896|NCT02797522|531651069|FG003|Overall Study|Study Terminated by Sponsor|0|||
147405897|NCT02797522|531651070|FG004|Overall Study|Study Terminated by Sponsor|0|||
147405898|NCT02797522|531651071|FG005|Overall Study|Study Terminated by Sponsor|0|||
147405899|NCT02797522|531651072|FG006|Overall Study|Study Terminated by Sponsor|0|||
147405900|NCT02797522|531651073|FG007|Overall Study|Study Terminated by Sponsor|4|||
147405901|NCT02797522|531651074|FG008|Overall Study|Study Terminated by Sponsor|2|||
147405902|NCT02797522|531651075|FG009|Overall Study|Study Terminated by Sponsor|4|||
147405903|NCT02797522|531651076|FG010|Overall Study|Study Terminated by Sponsor|1|||
147405904|NCT00132678|531651079|FG000|Period II (Open-Label Oral Risperidone)|Death|0|||
147405905|NCT00132678|531651080|FG001|Period II (Open-Label Oral Risperidone)|Death|0|||
147405906|NCT00132678|531651081|FG002|Period II (Open-Label Oral Risperidone)|Death|1|||
147405907|NCT00132678|531651079|FG000|Period II (Open-Label Oral Risperidone)|Adverse Event|0|||
147464429|NCT00896532|531860292|FG011|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
147405908|NCT00132678|531651080|FG001|Period II (Open-Label Oral Risperidone)|Adverse Event|0|||
147405909|NCT00132678|531651081|FG002|Period II (Open-Label Oral Risperidone)|Adverse Event|13|||
147405910|NCT00132678|531651079|FG000|Period II (Open-Label Oral Risperidone)|Non responder|0|||
147405911|NCT00132678|531651080|FG001|Period II (Open-Label Oral Risperidone)|Non responder|0|||
147405912|NCT00132678|531651081|FG002|Period II (Open-Label Oral Risperidone)|Non responder|6|||
147405913|NCT00132678|531651079|FG000|Period II (Open-Label Oral Risperidone)|Ineligible to continue trial|0|||
147405914|NCT00132678|531651080|FG001|Period II (Open-Label Oral Risperidone)|Ineligible to continue trial|0|||
147405915|NCT00132678|531651081|FG002|Period II (Open-Label Oral Risperidone)|Ineligible to continue trial|7|||
147405916|NCT00132678|531651079|FG000|Period II (Open-Label Oral Risperidone)|Lost to Follow-up|0|||
147405917|NCT00132678|531651080|FG001|Period II (Open-Label Oral Risperidone)|Lost to Follow-up|0|||
147405918|NCT00132678|531651081|FG002|Period II (Open-Label Oral Risperidone)|Lost to Follow-up|14|||
147405919|NCT00132678|531651079|FG000|Period II (Open-Label Oral Risperidone)|Withdrawal by Subject|0|||
147405920|NCT00132678|531651080|FG001|Period II (Open-Label Oral Risperidone)|Withdrawal by Subject|0|||
147405921|NCT00132678|531651081|FG002|Period II (Open-Label Oral Risperidone)|Withdrawal by Subject|16|||
147405922|NCT00132678|531651079|FG000|Period II (Open-Label Oral Risperidone)|Physician Decision|0|||
147405923|NCT00132678|531651080|FG001|Period II (Open-Label Oral Risperidone)|Physician Decision|0|||
147405924|NCT00132678|531651081|FG002|Period II (Open-Label Oral Risperidone)|Physician Decision|1|||
147405925|NCT00132678|531651079|FG000|Period III (Open-Label Stabilization)|Death|2|||
147405926|NCT00132678|531651080|FG001|Period III (Open-Label Stabilization)|Death|0|||
147405927|NCT00132678|531651081|FG002|Period III (Open-Label Stabilization)|Death|0|||
147405928|NCT00132678|531651079|FG000|Period III (Open-Label Stabilization)|Adverse Event|12|||
147405929|NCT00132678|531651080|FG001|Period III (Open-Label Stabilization)|Adverse Event|0|||
147405930|NCT00132678|531651081|FG002|Period III (Open-Label Stabilization)|Adverse Event|0|||
147405931|NCT00132678|531651079|FG000|Period III (Open-Label Stabilization)|Non responder|107|||
147405932|NCT00132678|531651080|FG001|Period III (Open-Label Stabilization)|Non responder|0|||
147405933|NCT00132678|531651081|FG002|Period III (Open-Label Stabilization)|Non responder|0|||
147405934|NCT00132678|531651079|FG000|Period III (Open-Label Stabilization)|Ineligible to continue trial|5|||
147405935|NCT00132678|531651080|FG001|Period III (Open-Label Stabilization)|Ineligible to continue trial|0|||
147405936|NCT00132678|531651081|FG002|Period III (Open-Label Stabilization)|Ineligible to continue trial|0|||
147405937|NCT00132678|531651079|FG000|Period III (Open-Label Stabilization)|Lost to Follow-up|19|||
147405938|NCT00132678|531651080|FG001|Period III (Open-Label Stabilization)|Lost to Follow-up|0|||
147405939|NCT00132678|531651081|FG002|Period III (Open-Label Stabilization)|Lost to Follow-up|0|||
147405940|NCT00132678|531651079|FG000|Period III (Open-Label Stabilization)|Withdrawal by Subject|49|||
147405941|NCT00132678|531651080|FG001|Period III (Open-Label Stabilization)|Withdrawal by Subject|0|||
147405942|NCT00132678|531651081|FG002|Period III (Open-Label Stabilization)|Withdrawal by Subject|0|||
147405943|NCT00132678|531651079|FG000|Period III (Open-Label Stabilization)|Subject non-compliant|1|||
147405944|NCT00132678|531651080|FG001|Period III (Open-Label Stabilization)|Subject non-compliant|0|||
147405945|NCT00132678|531651081|FG002|Period III (Open-Label Stabilization)|Subject non-compliant|0|||
147405946|NCT00132678|531651079|FG000|Period III (Open-Label Stabilization)|Physician Decision|1|||
147405947|NCT00132678|531651080|FG001|Period III (Open-Label Stabilization)|Physician Decision|0|||
147405948|NCT00132678|531651081|FG002|Period III (Open-Label Stabilization)|Physician Decision|0|||
147405949|NCT00132678|531651079|FG000|Period III (Open-Label Stabilization)|Pregnancy|2|||
147405950|NCT00132678|531651080|FG001|Period III (Open-Label Stabilization)|Pregnancy|0|||
147405951|NCT00132678|531651081|FG002|Period III (Open-Label Stabilization)|Pregnancy|0|||
147405952|NCT00132678|531651079|FG000|Period IV (Double-Blind Treatment)|Adverse Event|1|||
147405953|NCT00132678|531651080|FG001|Period IV (Double-Blind Treatment)|Adverse Event|1|||
147405954|NCT00132678|531651081|FG002|Period IV (Double-Blind Treatment)|Adverse Event|0|||
147405955|NCT00132678|531651079|FG000|Period IV (Double-Blind Treatment)|Ineligible to continue the trial|4|||
147405956|NCT00132678|531651080|FG001|Period IV (Double-Blind Treatment)|Ineligible to continue the trial|4|||
147405957|NCT00132678|531651081|FG002|Period IV (Double-Blind Treatment)|Ineligible to continue the trial|0|||
147405958|NCT00132678|531651079|FG000|Period IV (Double-Blind Treatment)|Lost to Follow-up|6|||
147405959|NCT00132678|531651080|FG001|Period IV (Double-Blind Treatment)|Lost to Follow-up|3|||
147405960|NCT00132678|531651081|FG002|Period IV (Double-Blind Treatment)|Lost to Follow-up|0|||
147405961|NCT00132678|531651079|FG000|Period IV (Double-Blind Treatment)|Withdrawal by Subject|14|||
147405962|NCT00132678|531651080|FG001|Period IV (Double-Blind Treatment)|Withdrawal by Subject|15|||
147405963|NCT00132678|531651081|FG002|Period IV (Double-Blind Treatment)|Withdrawal by Subject|0|||
147405964|NCT00132678|531651079|FG000|Period IV (Double-Blind Treatment)|Physician Decision|10|||
147405965|NCT00132678|531651080|FG001|Period IV (Double-Blind Treatment)|Physician Decision|14|||
147405966|NCT00132678|531651081|FG002|Period IV (Double-Blind Treatment)|Physician Decision|0|||
147405967|NCT00132678|531651079|FG000|Period IV (Double-Blind Treatment)|Subject Non-compliant|2|||
147405968|NCT00132678|531651080|FG001|Period IV (Double-Blind Treatment)|Subject Non-compliant|1|||
147405969|NCT00132678|531651081|FG002|Period IV (Double-Blind Treatment)|Subject Non-compliant|0|||
147405970|NCT00132678|531651079|FG000|Period IV (Double-Blind Treatment)|Pregnancy|0|||
147405971|NCT00132678|531651080|FG001|Period IV (Double-Blind Treatment)|Pregnancy|2|||
147405972|NCT00132678|531651081|FG002|Period IV (Double-Blind Treatment)|Pregnancy|0|||
147405973|NCT00953147|531651084|FG000|Overall Study|Adverse Event|8|||
147405974|NCT00953147|531651085|FG001|Overall Study|Adverse Event|16|||
147405975|NCT00953147|531651086|FG002|Overall Study|Adverse Event|6|||
147405976|NCT00953147|531651084|FG000|Overall Study|Protocol Violation|2|||
147464430|NCT00896532|531860293|FG012|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|1|||
147464431|NCT00896532|531860294|FG013|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|1|||
147405977|NCT00953147|531651085|FG001|Overall Study|Protocol Violation|8|||
147405978|NCT00953147|531651086|FG002|Overall Study|Protocol Violation|4|||
147405979|NCT00953147|531651084|FG000|Overall Study|Withdrawal by Subject|13|||
147405980|NCT00953147|531651085|FG001|Overall Study|Withdrawal by Subject|15|||
147405981|NCT00953147|531651086|FG002|Overall Study|Withdrawal by Subject|12|||
147405982|NCT00953147|531651084|FG000|Overall Study|Lost to Follow-up|8|||
147405983|NCT00953147|531651085|FG001|Overall Study|Lost to Follow-up|9|||
147464432|NCT00896532|531860295|FG014|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
147464433|NCT00896532|531860296|FG015|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
147464434|NCT00896532|531860297|FG016|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
147464435|NCT00896532|531860298|FG017|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
147405984|NCT00953147|531651086|FG002|Overall Study|Lost to Follow-up|4|||
147405985|NCT00953147|531651084|FG000|Overall Study|Physician Decision|2|||
147405986|NCT00953147|531651085|FG001|Overall Study|Physician Decision|7|||
147405987|NCT00953147|531651086|FG002|Overall Study|Physician Decision|3|||
147405988|NCT00953147|531651084|FG000|Overall Study|Other|4|||
147405989|NCT00953147|531651085|FG001|Overall Study|Other|11|||
147405990|NCT00953147|531651086|FG002|Overall Study|Other|13|||
147405991|NCT01484431|531651088|FG000|Period 1: High Dose|Physician Decision|0|||
147405992|NCT01484431|531651089|FG001|Period 1: High Dose|Physician Decision|1|||
147405993|NCT01484431|531651090|FG002|Period 1: High Dose|Physician Decision|0|||
147405994|NCT01484431|531651088|FG000|Period 2|Death|0|||
147405995|NCT01484431|531651089|FG001|Period 2|Death|1|||
147405996|NCT01484431|531651090|FG002|Period 2|Death|1|||
147405997|NCT01484431|531651088|FG000|Period 2|Physician Decision|0|||
147405998|NCT01484431|531651089|FG001|Period 2|Physician Decision|0|||
147405999|NCT01484431|531651090|FG002|Period 2|Physician Decision|1|||
147406000|NCT01484431|531651088|FG000|Period 2|Non-Compliance with Study Drug|1|||
147406001|NCT01484431|531651089|FG001|Period 2|Non-Compliance with Study Drug|0|||
147406002|NCT01484431|531651090|FG002|Period 2|Non-Compliance with Study Drug|0|||
147406003|NCT01251770|531651091|FG000|Overall Study|Protocol Violation|13|||
147406004|NCT01251770|531651092|FG001|Overall Study|Protocol Violation|7|||
147406005|NCT02514239|531651093|FG000|Overall Study|Refused to continue trial medication|0|||
147406006|NCT02514239|531651094|FG001|Overall Study|Refused to continue trial medication|0|||
147406007|NCT02514239|531651095|FG002|Overall Study|Refused to continue trial medication|0|||
147406008|NCT02514239|531651096|FG003|Overall Study|Refused to continue trial medication|0|||
147406009|NCT02514239|531651097|FG004|Overall Study|Refused to continue trial medication|0|||
147406010|NCT02514239|531651098|FG005|Overall Study|Refused to continue trial medication|0|||
147406011|NCT02514239|531651099|FG006|Overall Study|Refused to continue trial medication|0|||
147406012|NCT02514239|531651100|FG007|Overall Study|Refused to continue trial medication|0|||
147406013|NCT02514239|531651101|FG008|Overall Study|Refused to continue trial medication|0|||
147406014|NCT02514239|531651102|FG009|Overall Study|Refused to continue trial medication|1|||
147406015|NCT02514239|531651093|FG000|Overall Study|Dose-limiting toxicity (DLT)|0|||
147406016|NCT02514239|531651094|FG001|Overall Study|Dose-limiting toxicity (DLT)|0|||
147406017|NCT02514239|531651095|FG002|Overall Study|Dose-limiting toxicity (DLT)|0|||
147406018|NCT02514239|531651096|FG003|Overall Study|Dose-limiting toxicity (DLT)|0|||
147406019|NCT02514239|531651097|FG004|Overall Study|Dose-limiting toxicity (DLT)|0|||
147406020|NCT02514239|531651098|FG005|Overall Study|Dose-limiting toxicity (DLT)|0|||
147406021|NCT02514239|531651099|FG006|Overall Study|Dose-limiting toxicity (DLT)|0|||
147406022|NCT02514239|531651100|FG007|Overall Study|Dose-limiting toxicity (DLT)|0|||
147406023|NCT02514239|531651101|FG008|Overall Study|Dose-limiting toxicity (DLT)|1|||
147406024|NCT02514239|531651102|FG009|Overall Study|Dose-limiting toxicity (DLT)|2|||
147406025|NCT02514239|531651093|FG000|Overall Study|Not treated|0|||
147464436|NCT00896532|531860299|FG018|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
147464437|NCT00896532|531860300|FG019|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
147464438|NCT00896532|531860301|FG020|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
147464439|NCT00896532|531860302|FG021|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
147464440|NCT00896532|531860303|FG022|Months 24-36: Denosumab Extension Phase|Withdrawal by Subject|0|||
147464441|NCT00896532|531860281|FG000|Months 24-36: Denosumab Extension Phase|Other|0|||
147406026|NCT02514239|531651094|FG001|Overall Study|Not treated|1|||
147406027|NCT02514239|531651095|FG002|Overall Study|Not treated|0|||
147406028|NCT02514239|531651096|FG003|Overall Study|Not treated|0|||
147406029|NCT02514239|531651097|FG004|Overall Study|Not treated|0|||
147406030|NCT02514239|531651098|FG005|Overall Study|Not treated|0|||
147464442|NCT00896532|531860282|FG001|Months 24-36: Denosumab Extension Phase|Other|0|||
147464443|NCT00896532|531860283|FG002|Months 24-36: Denosumab Extension Phase|Other|0|||
147406031|NCT02514239|531651099|FG006|Overall Study|Not treated|0|||
147464444|NCT00896532|531860284|FG003|Months 24-36: Denosumab Extension Phase|Other|0|||
147406032|NCT02514239|531651100|FG007|Overall Study|Not treated|0|||
147406033|NCT02514239|531651101|FG008|Overall Study|Not treated|0|||
147406034|NCT02514239|531651102|FG009|Overall Study|Not treated|0|||
147406035|NCT02514239|531651093|FG000|Overall Study|Other Adverse Events|2|||
147406036|NCT02514239|531651094|FG001|Overall Study|Other Adverse Events|0|||
147616639|NCT03172494|532411071|FG002|Overall Study|Non-compliance towards treatment|0|||
147616640|NCT00143390|532411072|FG000|Overall Study|Death|2|||
147616641|NCT00143390|532411073|FG001|Overall Study|Death|0|||
147406037|NCT02514239|531651095|FG002|Overall Study|Other Adverse Events|0|||
147616642|NCT00143390|532411072|FG000|Overall Study|Not meeting entry criteria|2|||
147616643|NCT00143390|532411073|FG001|Overall Study|Not meeting entry criteria|5|||
147616644|NCT00143390|532411072|FG000|Overall Study|Withdrawal by Subject|4|||
147616645|NCT00143390|532411073|FG001|Overall Study|Withdrawal by Subject|4|||
147616646|NCT00143390|532411072|FG000|Overall Study|Progressive disease|119|||
147616647|NCT00143390|532411073|FG001|Overall Study|Progressive disease|115|||
147616648|NCT00143390|532411072|FG000|Overall Study|Protocol Violation|2|||
147616649|NCT00143390|532411073|FG001|Overall Study|Protocol Violation|0|||
147616650|NCT00143390|532411072|FG000|Overall Study|Study termination|10|||
147616651|NCT00143390|532411073|FG001|Overall Study|Study termination|15|||
147616652|NCT00143390|532411072|FG000|Overall Study|Adverse Event|9|||
147616653|NCT00143390|532411073|FG001|Overall Study|Adverse Event|8|||
147616654|NCT00143390|532411072|FG000|Overall Study|Other|1|||
147616655|NCT00143390|532411073|FG001|Overall Study|Other|2|||
147616656|NCT02764151|532411076|FG000|Overall Study|Subject refused further follow-up|0|||
147616657|NCT02764151|532411077|FG001|Overall Study|Subject refused further follow-up|0|||
147616658|NCT02764151|532411078|FG002|Overall Study|Subject refused further follow-up|0|||
147616659|NCT02764151|532411079|FG003|Overall Study|Subject refused further follow-up|1|||
147616660|NCT02764151|532411076|FG000|Overall Study|Other|0|||
147616661|NCT02764151|532411077|FG001|Overall Study|Other|0|||
147616662|NCT02764151|532411078|FG002|Overall Study|Other|0|||
147616663|NCT02764151|532411079|FG003|Overall Study|Other|2|||
147616664|NCT01450683|532411080|FG000|Overall Study|Adverse Event|2|||
147616665|NCT02108912|532411082|FG000|Overall Study|Lost to Follow-up|1|||
147616666|NCT02108912|532411083|FG001|Overall Study|Lost to Follow-up|1|||
147616667|NCT02108912|532411082|FG000|Overall Study|lack of transportation|1|||
147616668|NCT02108912|532411083|FG001|Overall Study|lack of transportation|0|||
147616669|NCT02108912|532411082|FG000|Overall Study|high blood pressure|1|||
147616670|NCT02108912|532411083|FG001|Overall Study|high blood pressure|0|||
147616671|NCT00852202|532411088|FG000|Overall Study|Adverse Event|2|||
147616672|NCT00852202|532411089|FG001|Overall Study|Adverse Event|3|||
147616673|NCT00852202|532411090|FG002|Overall Study|Adverse Event|7|||
147616674|NCT00852202|532411088|FG000|Overall Study|Lack of Efficacy|4|||
147616675|NCT00852202|532411089|FG001|Overall Study|Lack of Efficacy|1|||
147616676|NCT00852202|532411090|FG002|Overall Study|Lack of Efficacy|2|||
147406038|NCT02514239|531651096|FG003|Overall Study|Other Adverse Events|1|||
147406039|NCT02514239|531651097|FG004|Overall Study|Other Adverse Events|0|||
147406040|NCT02514239|531651098|FG005|Overall Study|Other Adverse Events|1|||
147406041|NCT02514239|531651099|FG006|Overall Study|Other Adverse Events|0|||
147406042|NCT02514239|531651100|FG007|Overall Study|Other Adverse Events|1|||
147406043|NCT02514239|531651101|FG008|Overall Study|Other Adverse Events|2|||
147406044|NCT02514239|531651102|FG009|Overall Study|Other Adverse Events|0|||
147406045|NCT02514239|531651093|FG000|Overall Study|Progressive disease|3|||
147406046|NCT02514239|531651094|FG001|Overall Study|Progressive disease|3|||
147406047|NCT02514239|531651095|FG002|Overall Study|Progressive disease|2|||
147406048|NCT02514239|531651096|FG003|Overall Study|Progressive disease|2|||
147406049|NCT02514239|531651097|FG004|Overall Study|Progressive disease|3|||
147406050|NCT02514239|531651098|FG005|Overall Study|Progressive disease|3|||
147406051|NCT02514239|531651099|FG006|Overall Study|Progressive disease|4|||
147406052|NCT02514239|531651100|FG007|Overall Study|Progressive disease|2|||
147406053|NCT02514239|531651101|FG008|Overall Study|Progressive disease|5|||
147406054|NCT02514239|531651102|FG009|Overall Study|Progressive disease|0|||
147406055|NCT01888874|531651103|FG000|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|2|||
147406056|NCT01888874|531651104|FG001|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|2|||
147616677|NCT00852202|532411088|FG000|Overall Study|Protocol Violation|2|||
147616678|NCT00852202|532411089|FG001|Overall Study|Protocol Violation|2|||
147616679|NCT00852202|532411090|FG002|Overall Study|Protocol Violation|7|||
147616680|NCT00852202|532411088|FG000|Overall Study|Withdrawal by Subject|3|||
147616681|NCT00852202|532411089|FG001|Overall Study|Withdrawal by Subject|1|||
147616682|NCT00852202|532411090|FG002|Overall Study|Withdrawal by Subject|2|||
147616683|NCT00852202|532411088|FG000|Overall Study|Lost to Follow-up|5|||
147616684|NCT00852202|532411089|FG001|Overall Study|Lost to Follow-up|5|||
147616685|NCT00852202|532411090|FG002|Overall Study|Lost to Follow-up|6|||
147616686|NCT00852202|532411088|FG000|Overall Study|pregnancy,moving away and surgery|1|||
147616687|NCT00852202|532411089|FG001|Overall Study|pregnancy,moving away and surgery|0|||
147616688|NCT00852202|532411090|FG002|Overall Study|pregnancy,moving away and surgery|2|||
147616689|NCT02905032|532411093|FG000|Overall Study|Withdrawal by Subject|2|||
147616690|NCT02905032|532411094|FG001|Overall Study|Withdrawal by Subject|0|||
147616691|NCT02905032|532411095|FG002|Overall Study|Withdrawal by Subject|0|||
147406057|NCT01888874|531651105|FG002|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|3|||
147406058|NCT01888874|531651106|FG003|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|4|||
147616692|NCT02905032|532411093|FG000|Overall Study|Protocol Violation|6|||
147616693|NCT02905032|532411094|FG001|Overall Study|Protocol Violation|12|||
147616694|NCT02905032|532411095|FG002|Overall Study|Protocol Violation|0|||
147464445|NCT00896532|531860285|FG004|Months 24-36: Denosumab Extension Phase|Other|0|||
147464446|NCT00896532|531860286|FG005|Months 24-36: Denosumab Extension Phase|Other|0|||
147464447|NCT00896532|531860287|FG006|Months 24-36: Denosumab Extension Phase|Other|0|||
147464448|NCT00896532|531860288|FG007|Months 24-36: Denosumab Extension Phase|Other|0|||
147406059|NCT01888874|531651107|FG004|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|3|||
147406060|NCT01888874|531651108|FG005|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|0|||
147464449|NCT00896532|531860289|FG008|Months 24-36: Denosumab Extension Phase|Other|0|||
147464450|NCT00896532|531860290|FG009|Months 24-36: Denosumab Extension Phase|Other|0|||
147464451|NCT00896532|531860291|FG010|Months 24-36: Denosumab Extension Phase|Other|1|||
147464452|NCT00896532|531860292|FG011|Months 24-36: Denosumab Extension Phase|Other|2|||
147464453|NCT00896532|531860293|FG012|Months 24-36: Denosumab Extension Phase|Other|2|||
147464454|NCT00896532|531860294|FG013|Months 24-36: Denosumab Extension Phase|Other|1|||
147464455|NCT00896532|531860295|FG014|Months 24-36: Denosumab Extension Phase|Other|0|||
147464456|NCT00896532|531860296|FG015|Months 24-36: Denosumab Extension Phase|Other|0|||
147464457|NCT00896532|531860297|FG016|Months 24-36: Denosumab Extension Phase|Other|0|||
147464458|NCT00896532|531860298|FG017|Months 24-36: Denosumab Extension Phase|Other|0|||
147464459|NCT00896532|531860299|FG018|Months 24-36: Denosumab Extension Phase|Other|0|||
147464460|NCT00896532|531860300|FG019|Months 24-36: Denosumab Extension Phase|Other|0|||
147464461|NCT00896532|531860301|FG020|Months 24-36: Denosumab Extension Phase|Other|0|||
147464462|NCT00896532|531860302|FG021|Months 24-36: Denosumab Extension Phase|Other|0|||
147464463|NCT00896532|531860303|FG022|Months 24-36: Denosumab Extension Phase|Other|0|||
147464464|NCT00896532|531860281|FG000|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
147464465|NCT00896532|531860282|FG001|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
147464466|NCT00896532|531860283|FG002|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
147464467|NCT00896532|531860284|FG003|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
147464468|NCT00896532|531860285|FG004|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
147464469|NCT00896532|531860286|FG005|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
147406061|NCT01888874|531651109|FG006|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|0|||
147406062|NCT01888874|531651103|FG000|Period 1 (Baseline up to Week 12)|Other|1|||
147406063|NCT01888874|531651104|FG001|Period 1 (Baseline up to Week 12)|Other|0|||
147406064|NCT01888874|531651105|FG002|Period 1 (Baseline up to Week 12)|Other|1|||
147406065|NCT01888874|531651106|FG003|Period 1 (Baseline up to Week 12)|Other|1|||
147406066|NCT01888874|531651107|FG004|Period 1 (Baseline up to Week 12)|Other|3|||
147406067|NCT01888874|531651108|FG005|Period 1 (Baseline up to Week 12)|Other|3|||
147406068|NCT01888874|531651109|FG006|Period 1 (Baseline up to Week 12)|Other|0|||
147406069|NCT01888874|531651103|FG000|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
147406070|NCT01888874|531651104|FG001|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
147406071|NCT01888874|531651105|FG002|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
147406072|NCT01888874|531651106|FG003|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
147406073|NCT01888874|531651107|FG004|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
147406074|NCT01888874|531651108|FG005|Period 1 (Baseline up to Week 12)|Physician Decision|0|||
147406075|NCT01888874|531651109|FG006|Period 1 (Baseline up to Week 12)|Physician Decision|1|||
147406076|NCT01888874|531651103|FG000|Period 1 (Baseline up to Week 12)|Adverse Event|0|||
147406077|NCT01888874|531651104|FG001|Period 1 (Baseline up to Week 12)|Adverse Event|2|||
147406078|NCT01888874|531651105|FG002|Period 1 (Baseline up to Week 12)|Adverse Event|3|||
147406079|NCT01888874|531651106|FG003|Period 1 (Baseline up to Week 12)|Adverse Event|1|||
147406080|NCT01888874|531651107|FG004|Period 1 (Baseline up to Week 12)|Adverse Event|2|||
147406081|NCT01888874|531651108|FG005|Period 1 (Baseline up to Week 12)|Adverse Event|1|||
147406082|NCT01888874|531651109|FG006|Period 1 (Baseline up to Week 12)|Adverse Event|0|||
147406083|NCT01888874|531651103|FG000|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
147406084|NCT01888874|531651104|FG001|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
147406085|NCT01888874|531651105|FG002|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
147406086|NCT01888874|531651106|FG003|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
147406087|NCT01888874|531651107|FG004|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|1|||
147406088|NCT01888874|531651108|FG005|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
147406089|NCT01888874|531651109|FG006|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
147406090|NCT01888874|531651103|FG000|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
147406091|NCT01888874|531651104|FG001|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|1|||
147406092|NCT01888874|531651105|FG002|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
147406093|NCT01888874|531651106|FG003|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
147406094|NCT01888874|531651107|FG004|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
147406095|NCT01888874|531651108|FG005|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
147464470|NCT00896532|531860287|FG006|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
147464471|NCT00896532|531860288|FG007|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
147464472|NCT00896532|531860289|FG008|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
147464473|NCT00896532|531860290|FG009|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
147406096|NCT01888874|531651109|FG006|Period 1 (Baseline up to Week 12)|Non-compliance with the study procedures|0|||
147406097|NCT01888874|531651103|FG000|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0|||
147406098|NCT01888874|531651104|FG001|Period 1 (Baseline up to Week 12)|Lost to Follow-up|1|||
147406099|NCT01888874|531651105|FG002|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0|||
147406100|NCT01888874|531651106|FG003|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0|||
147406101|NCT01888874|531651107|FG004|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0|||
147406102|NCT01888874|531651108|FG005|Period 1 (Baseline up to Week 12)|Lost to Follow-up|1|||
147406103|NCT01888874|531651109|FG006|Period 1 (Baseline up to Week 12)|Lost to Follow-up|0|||
147406104|NCT01888874|531651103|FG000|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|1|||
147406105|NCT01888874|531651104|FG001|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|1|||
147406106|NCT01888874|531651105|FG002|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|2|||
147406107|NCT01888874|531651106|FG003|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
147406108|NCT01888874|531651107|FG004|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|1|||
147406109|NCT01888874|531651108|FG005|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
147406110|NCT01888874|531651109|FG006|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
147406111|NCT01888874|531651103|FG000|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
147406112|NCT01888874|531651104|FG001|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
147406113|NCT01888874|531651105|FG002|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
147406114|NCT01888874|531651106|FG003|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
147406115|NCT01888874|531651107|FG004|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|1|||
147406116|NCT01888874|531651108|FG005|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
147406117|NCT01888874|531651109|FG006|Period 2 (Week 13 to Week 24)|Adverse event and treatment failure|0|||
147406118|NCT01888874|531651103|FG000|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0|||
147406119|NCT01888874|531651104|FG001|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0|||
147406120|NCT01888874|531651105|FG002|Period 2 (Week 13 to Week 24)|Non compliance with study medication|2|||
147406121|NCT01888874|531651106|FG003|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0|||
147406122|NCT01888874|531651107|FG004|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0|||
147406123|NCT01888874|531651108|FG005|Period 2 (Week 13 to Week 24)|Non compliance with study medication|1|||
147406124|NCT01888874|531651109|FG006|Period 2 (Week 13 to Week 24)|Non compliance with study medication|0|||
147406125|NCT01888874|531651103|FG000|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
147406126|NCT01888874|531651104|FG001|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
147406127|NCT01888874|531651105|FG002|Period 2 (Week 13 to Week 24)|Treatment failure|1|||
147406128|NCT01888874|531651106|FG003|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
147406129|NCT01888874|531651107|FG004|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
147406130|NCT01888874|531651108|FG005|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
147406131|NCT01888874|531651109|FG006|Period 2 (Week 13 to Week 24)|Treatment failure|0|||
147406132|NCT01888874|531651103|FG000|Period 2 (Week 13 to Week 24)|Adverse Event|2|||
147406133|NCT01888874|531651104|FG001|Period 2 (Week 13 to Week 24)|Adverse Event|0|||
147406134|NCT01888874|531651105|FG002|Period 2 (Week 13 to Week 24)|Adverse Event|3|||
147406135|NCT01888874|531651106|FG003|Period 2 (Week 13 to Week 24)|Adverse Event|2|||
147406136|NCT01888874|531651107|FG004|Period 2 (Week 13 to Week 24)|Adverse Event|1|||
147406137|NCT01888874|531651108|FG005|Period 2 (Week 13 to Week 24)|Adverse Event|1|||
147406138|NCT01888874|531651109|FG006|Period 2 (Week 13 to Week 24)|Adverse Event|3|||
147406139|NCT01888874|531651103|FG000|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0|||
147406140|NCT01888874|531651104|FG001|Period 2 (Week 13 to Week 24)|Lost to Follow-up|1|||
147406141|NCT01888874|531651105|FG002|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0|||
147406142|NCT01888874|531651106|FG003|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0|||
147406143|NCT01888874|531651107|FG004|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0|||
147406144|NCT01888874|531651108|FG005|Period 2 (Week 13 to Week 24)|Lost to Follow-up|1|||
147406145|NCT01888874|531651109|FG006|Period 2 (Week 13 to Week 24)|Lost to Follow-up|0|||
147406146|NCT00475644|531651110|FG000|Overall Study|Protocol Violation|13|||
147406147|NCT01411241|531651111|FG000|Overall Study|Protocol Violation|0|||
147406148|NCT01411241|531651112|FG001|Overall Study|Protocol Violation|5|||
147406149|NCT01411241|531651111|FG000|Overall Study|Withdrawal by Subject|9|||
147406150|NCT01411241|531651112|FG001|Overall Study|Withdrawal by Subject|10|||
147406151|NCT01411241|531651111|FG000|Overall Study|Serious Adverse Event|0|||
147406152|NCT01411241|531651112|FG001|Overall Study|Serious Adverse Event|3|||
147406153|NCT01411241|531651111|FG000|Overall Study|Lost to Follow-up|2|||
147406154|NCT01411241|531651112|FG001|Overall Study|Lost to Follow-up|4|||
147406155|NCT02980042|531651115|FG000|Overall Study|Lost to Follow-up|5|||
147406156|NCT02980042|531651116|FG001|Overall Study|Lost to Follow-up|0|||
147406157|NCT02980042|531651115|FG000|Overall Study|Insurance issues/treatment plan changes|2|||
147406158|NCT02980042|531651116|FG001|Overall Study|Insurance issues/treatment plan changes|0|||
147406159|NCT03104075|531651123|FG000|Overall Study|Participant did not complete the last study visit due to hospitalization unrelated to the vaccine|1|||
147616695|NCT00739063|532411096|FG000|Overall Study|Screen failures|8|||
147616696|NCT01682811|532411100|FG000|Part 2 Dose Level 1|Withdrawal by Subject|0|||
147616697|NCT01682811|532411101|FG001|Part 2 Dose Level 1|Withdrawal by Subject|0|||
147406160|NCT03104075|531651124|FG001|Overall Study|Participant did not complete the last study visit due to hospitalization unrelated to the vaccine|0|||
147406161|NCT00944229|531651125|FG000|Overall Study|Withdrawal by Subject|11|||
147406162|NCT00944229|531651125|FG000|Overall Study|Physician Decision|14|||
147406163|NCT01810939|531651126|FG000|Part A Treatment Period|Non-compliance with Study Drug|1|||
147406164|NCT01810939|531651127|FG001|Part A Treatment Period|Non-compliance with Study Drug|0|||
147406165|NCT01810939|531651128|FG002|Part A Treatment Period|Non-compliance with Study Drug|0|||
147406166|NCT01810939|531651126|FG000|Part A Treatment Period|Protocol Violation|2|||
147406167|NCT01810939|531651127|FG001|Part A Treatment Period|Protocol Violation|0|||
147406168|NCT01810939|531651128|FG002|Part A Treatment Period|Protocol Violation|0|||
147406169|NCT01810939|531651126|FG000|Part A Treatment Period|Adverse Event|10|||
147406170|NCT01810939|531651127|FG001|Part A Treatment Period|Adverse Event|0|||
147406171|NCT01810939|531651128|FG002|Part A Treatment Period|Adverse Event|0|||
147406172|NCT01810939|531651126|FG000|Part A Treatment Period|Withdrawal by Subject|5|||
147406173|NCT01810939|531651127|FG001|Part A Treatment Period|Withdrawal by Subject|0|||
147406174|NCT01810939|531651128|FG002|Part A Treatment Period|Withdrawal by Subject|0|||
147406175|NCT01810939|531651126|FG000|Part A Treatment Period|Protocol-specified (eGFR)|2|||
147406176|NCT01810939|531651127|FG001|Part A Treatment Period|Protocol-specified (eGFR)|0|||
147406177|NCT01810939|531651128|FG002|Part A Treatment Period|Protocol-specified (eGFR)|0|||
147406178|NCT01810939|531651126|FG000|Part A Treatment Period|Protocol-specified (High K+)|3|||
147406179|NCT01810939|531651127|FG001|Part A Treatment Period|Protocol-specified (High K+)|0|||
147406180|NCT01810939|531651128|FG002|Part A Treatment Period|Protocol-specified (High K+)|0|||
147406181|NCT01810939|531651126|FG000|Part A Treatment Period|Protocol-specified (Low K+)|1|||
147406182|NCT01810939|531651127|FG001|Part A Treatment Period|Protocol-specified (Low K+)|0|||
147406183|NCT01810939|531651128|FG002|Part A Treatment Period|Protocol-specified (Low K+)|0|||
147406184|NCT01810939|531651126|FG000|Part B Placebo-Controlled Withdrawal|Physician Decision|0|||
147406185|NCT01810939|531651127|FG001|Part B Placebo-Controlled Withdrawal|Physician Decision|1|||
147406186|NCT01810939|531651128|FG002|Part B Placebo-Controlled Withdrawal|Physician Decision|1|||
147406187|NCT01810939|531651126|FG000|Part B Placebo-Controlled Withdrawal|Non-compliance with Study Drug|0|||
147406188|NCT01810939|531651127|FG001|Part B Placebo-Controlled Withdrawal|Non-compliance with Study Drug|1|||
147406189|NCT01810939|531651128|FG002|Part B Placebo-Controlled Withdrawal|Non-compliance with Study Drug|0|||
147406190|NCT01810939|531651126|FG000|Part B Placebo-Controlled Withdrawal|Adverse Event|0|||
147406191|NCT01810939|531651127|FG001|Part B Placebo-Controlled Withdrawal|Adverse Event|1|||
147406192|NCT01810939|531651128|FG002|Part B Placebo-Controlled Withdrawal|Adverse Event|1|||
147406193|NCT01810939|531651126|FG000|Part B Placebo-Controlled Withdrawal|Death|0|||
147406194|NCT01810939|531651127|FG001|Part B Placebo-Controlled Withdrawal|Death|0|||
147406195|NCT01810939|531651128|FG002|Part B Placebo-Controlled Withdrawal|Death|1|||
147406196|NCT01810939|531651126|FG000|Part B Placebo-Controlled Withdrawal|Withdrawal by Subject|0|||
147406197|NCT01810939|531651127|FG001|Part B Placebo-Controlled Withdrawal|Withdrawal by Subject|0|||
147406198|NCT01810939|531651128|FG002|Part B Placebo-Controlled Withdrawal|Withdrawal by Subject|1|||
147406199|NCT01810939|531651126|FG000|Part B Placebo-Controlled Withdrawal|Protocol-specified (eGFR)|0|||
147406200|NCT01810939|531651127|FG001|Part B Placebo-Controlled Withdrawal|Protocol-specified (eGFR)|1|||
147406201|NCT01810939|531651128|FG002|Part B Placebo-Controlled Withdrawal|Protocol-specified (eGFR)|1|||
147406202|NCT01810939|531651126|FG000|Part B Placebo-Controlled Withdrawal|Protocol-specified (K+ result)|0|||
147406203|NCT01810939|531651127|FG001|Part B Placebo-Controlled Withdrawal|Protocol-specified (K+ result)|1|||
147406204|NCT01810939|531651128|FG002|Part B Placebo-Controlled Withdrawal|Protocol-specified (K+ result)|2|||
147406205|NCT01810939|531651126|FG000|Part B Placebo-Controlled Withdrawal|Protocol-specified (High K+)|0|||
147406206|NCT01810939|531651127|FG001|Part B Placebo-Controlled Withdrawal|Protocol-specified (High K+)|2|||
147406207|NCT01810939|531651128|FG002|Part B Placebo-Controlled Withdrawal|Protocol-specified (High K+)|14|||
147406208|NCT01810939|531651126|FG000|Part B Placebo-Controlled Withdrawal|Protocol-specified (Low K+)|0|||
147406209|NCT01810939|531651127|FG001|Part B Placebo-Controlled Withdrawal|Protocol-specified (Low K+)|2|||
147406210|NCT01810939|531651128|FG002|Part B Placebo-Controlled Withdrawal|Protocol-specified (Low K+)|1|||
147406211|NCT01810939|531651126|FG000|Part B Placebo-Controlled Withdrawal|Lost to Follow-up|0|||
147406212|NCT01810939|531651127|FG001|Part B Placebo-Controlled Withdrawal|Lost to Follow-up|1|||
147406213|NCT01810939|531651128|FG002|Part B Placebo-Controlled Withdrawal|Lost to Follow-up|0|||
147406214|NCT02963090|531651129|FG000|Non-cross Over Phase|Patient deterioration before starting protocol treatment|1|||
147406215|NCT02963090|531651130|FG001|Non-cross Over Phase|Patient deterioration before starting protocol treatment|0|||
147406216|NCT00709228|531651131|FG000|Overall Study|Not treated|14|||
147406217|NCT00709228|531651131|FG000|Overall Study|Eligibility criteria not met|281|||
147406218|NCT00709228|531651131|FG000|Overall Study|Adverse events|2|||
147406219|NCT00709228|531651131|FG000|Overall Study|Discontinued treatment|14|||
147406220|NCT00709228|531651131|FG000|Overall Study|Did not enter follow-up|4|||
147406221|NCT00709228|531651131|FG000|Overall Study|Discontinued follow-up|5|||
147406222|NCT00709228|531651131|FG000|Overall Study|Disease progression|1|||
147406223|NCT00709228|531651131|FG000|Overall Study|Lost to Follow-up|6|||
147464474|NCT00896532|531860291|FG010|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
147406224|NCT00709228|531651131|FG000|Overall Study|Non-compliance|5|||
147616698|NCT01682811|532411102|FG002|Part 2 Dose Level 1|Withdrawal by Subject|0|||
147616699|NCT01682811|532411103|FG003|Part 2 Dose Level 1|Withdrawal by Subject|0|||
147616700|NCT01682811|532411104|FG004|Part 2 Dose Level 1|Withdrawal by Subject|1|||
147616701|NCT01682811|532411105|FG005|Part 2 Dose Level 1|Withdrawal by Subject|0|||
147406225|NCT04805073|531651138|FG000|Overall Study|study personnel not available|2|||
147406226|NCT04805073|531651139|FG001|Overall Study|study personnel not available|0|||
147406227|NCT04805073|531651138|FG000|Overall Study|spinal anesthesia failure|0|||
147406228|NCT04805073|531651139|FG001|Overall Study|spinal anesthesia failure|1|||
147406229|NCT04805073|531651138|FG000|Overall Study|Lost to Follow-up|0|||
147406230|NCT04805073|531651139|FG001|Overall Study|Lost to Follow-up|2|||
147406231|NCT03017742|531651145|FG000|Overall Study|Protocol Violation|36|||
147406232|NCT03017742|531651145|FG000|Overall Study|Withdrawal by Subject|37|||
147406233|NCT02975102|531651146|FG000|Overall Study|Adverse Event|2|||
147406234|NCT02975102|531651147|FG001|Overall Study|Adverse Event|1|||
147406235|NCT01825577|531651151|FG000|Overall Study|Physician Decision|2|||
147406236|NCT01825577|531651151|FG000|Overall Study|Withdrawal by Subject|1|||
147406237|NCT01825577|531651151|FG000|Overall Study|Withdrawn by family members|2|||
147406238|NCT01825577|531651151|FG000|Overall Study|Lack of Efficacy|3|||
147406239|NCT01245374|531651158|FG000|Overall Study|Protocol Violation|1|||
147406240|NCT01245374|531651158|FG000|Overall Study|Withdrawal by Subject|3|||
147406241|NCT01782690|531651160|FG000|Overall Study|Not reported|7|||
147406242|NCT01782690|531651160|FG000|Overall Study|Toxicity of gemcitabine|1|||
147406243|NCT01782690|531651160|FG000|Overall Study|Toxicity of erlotinib|1|||
147406244|NCT01782690|531651160|FG000|Overall Study|Lost to Follow-up|31|||
147406245|NCT01782690|531651160|FG000|Overall Study|Withdrawal of informed consent|2|||
147406246|NCT01782690|531651160|FG000|Overall Study|Absent rash|9|||
147406247|NCT01782690|531651160|FG000|Overall Study|Physician Decision|13|||
147406248|NCT01782690|531651160|FG000|Overall Study|Patient's wish|21|||
147406249|NCT01782690|531651160|FG000|Overall Study|Tumor progression|74|||
147406250|NCT01782690|531651160|FG000|Overall Study|Death|133|||
147406251|NCT01782690|531651160|FG000|Overall Study|Study completion unknown|7|||
147406252|NCT04199052|531651163|FG000|Overall Study|Lost to Follow-up|11|||
147406253|NCT04199052|531651164|FG001|Overall Study|Lost to Follow-up|18|||
147406254|NCT01948076|531651165|FG000|Overall Study|Withdrawal by Subject|0|||
147406255|NCT01948076|531651166|FG001|Overall Study|Withdrawal by Subject|1|||
147406256|NCT01151423|531651167|FG000|Overall Study|Study terminated by Sponsor|9|||
147406257|NCT01151423|531651168|FG001|Overall Study|Study terminated by Sponsor|10|||
147406258|NCT01151423|531651167|FG000|Overall Study|Protocol Violation|0|||
147406259|NCT01151423|531651168|FG001|Overall Study|Protocol Violation|1|||
147406260|NCT01151423|531651167|FG000|Overall Study|Physician Decision|1|||
147406261|NCT01151423|531651168|FG001|Overall Study|Physician Decision|1|||
147406262|NCT01151423|531651167|FG000|Overall Study|Pregnancy|0|||
147406263|NCT01151423|531651168|FG001|Overall Study|Pregnancy|1|||
147406264|NCT01151423|531651167|FG000|Overall Study|Death|0|||
147406265|NCT01151423|531651168|FG001|Overall Study|Death|1|||
147406266|NCT01151423|531651167|FG000|Overall Study|Adverse Event|3|||
147406267|NCT01151423|531651168|FG001|Overall Study|Adverse Event|0|||
147406268|NCT01151423|531651167|FG000|Overall Study|Withdrawal by Subject|1|||
147406269|NCT01151423|531651168|FG001|Overall Study|Withdrawal by Subject|3|||
147406270|NCT01151423|531651167|FG000|Overall Study|Lost to Follow-up|1|||
147406271|NCT01151423|531651168|FG001|Overall Study|Lost to Follow-up|0|||
147616702|NCT01682811|532411106|FG006|Part 2 Dose Level 1|Withdrawal by Subject|0|||
147616703|NCT01682811|532411100|FG000|Part 2 Dose Level 1|Protocol Violation|0|||
147616704|NCT01682811|532411101|FG001|Part 2 Dose Level 1|Protocol Violation|0|||
147616705|NCT01682811|532411102|FG002|Part 2 Dose Level 1|Protocol Violation|0|||
147616706|NCT01682811|532411103|FG003|Part 2 Dose Level 1|Protocol Violation|0|||
147616707|NCT01682811|532411104|FG004|Part 2 Dose Level 1|Protocol Violation|4|||
147616708|NCT01682811|532411105|FG005|Part 2 Dose Level 1|Protocol Violation|0|||
147616709|NCT01682811|532411106|FG006|Part 2 Dose Level 1|Protocol Violation|0|||
147616710|NCT01682811|532411100|FG000|Part 2 Dose Level 1|Lost to Follow-up|0|||
147616711|NCT01682811|532411101|FG001|Part 2 Dose Level 1|Lost to Follow-up|0|||
147616712|NCT01682811|532411102|FG002|Part 2 Dose Level 1|Lost to Follow-up|0|||
147616713|NCT01682811|532411103|FG003|Part 2 Dose Level 1|Lost to Follow-up|0|||
147616714|NCT01682811|532411104|FG004|Part 2 Dose Level 1|Lost to Follow-up|6|||
147616715|NCT01682811|532411105|FG005|Part 2 Dose Level 1|Lost to Follow-up|0|||
147616716|NCT01682811|532411106|FG006|Part 2 Dose Level 1|Lost to Follow-up|0|||
147616717|NCT01682811|532411100|FG000|Part 2 Dose Level 2|Lost to Follow-up|0|||
147406272|NCT01151423|531651167|FG000|Overall Study|Diagnosed as non-TTP patient|0|||
147406273|NCT01151423|531651168|FG001|Overall Study|Diagnosed as non-TTP patient|1|||
147406274|NCT01151423|531651167|FG000|Overall Study|Participated in other clinical trial|1|||
147406275|NCT01151423|531651168|FG001|Overall Study|Participated in other clinical trial|0|||
147406276|NCT00681668|531651169|FG000|Overall Study|Protocol Violation|1|||
147406277|NCT00681668|531651169|FG000|Overall Study|Withdrawal by Subject|1|||
147406278|NCT06719986|531651181|FG000|Washout (up to 72 Hours)|Adverse Event|0|||
147406279|NCT06719986|531651182|FG001|Washout (up to 72 Hours)|Adverse Event|0|||
147406280|NCT06719986|531651183|FG002|Washout (up to 72 Hours)|Adverse Event|1|||
147616718|NCT01682811|532411101|FG001|Part 2 Dose Level 2|Lost to Follow-up|0|||
147616719|NCT01682811|532411102|FG002|Part 2 Dose Level 2|Lost to Follow-up|0|||
147616720|NCT01682811|532411103|FG003|Part 2 Dose Level 2|Lost to Follow-up|0|||
147616721|NCT01682811|532411104|FG004|Part 2 Dose Level 2|Lost to Follow-up|0|||
147616722|NCT01682811|532411105|FG005|Part 2 Dose Level 2|Lost to Follow-up|3|||
147616723|NCT01682811|532411106|FG006|Part 2 Dose Level 2|Lost to Follow-up|0|||
147616724|NCT02603146|532413650|FG000|Overall Study|Lost to Follow-up|5|||
147616725|NCT02603146|532413651|FG001|Overall Study|Lost to Follow-up|6|||
147616726|NCT02603146|532413650|FG000|Overall Study|Withdrawal by Subject|8|||
147406281|NCT06719986|531651181|FG000|Washout (up to 72 Hours)|Withdrawal by Subject|0|||
147406282|NCT06719986|531651182|FG001|Washout (up to 72 Hours)|Withdrawal by Subject|1|||
147406283|NCT06719986|531651183|FG002|Washout (up to 72 Hours)|Withdrawal by Subject|0|||
147406284|NCT02600897|531651184|FG000|Overall Study|Death|1|||
147406285|NCT02600897|531651185|FG001|Overall Study|Death|2|||
147406286|NCT02600897|531651186|FG002|Overall Study|Death|1|||
147406287|NCT02600897|531651187|FG003|Overall Study|Death|2|||
147406288|NCT02600897|531651188|FG004|Overall Study|Death|3|||
147406289|NCT02600897|531651189|FG005|Overall Study|Death|2|||
147406290|NCT02600897|531651190|FG006|Overall Study|Death|10|||
147406291|NCT02600897|531651191|FG007|Overall Study|Death|7|||
147406292|NCT02600897|531651192|FG008|Overall Study|Death|20|||
147406293|NCT02600897|531651184|FG000|Overall Study|Lost to Follow-up|1|||
147406294|NCT02600897|531651185|FG001|Overall Study|Lost to Follow-up|0|||
147406295|NCT02600897|531651186|FG002|Overall Study|Lost to Follow-up|0|||
147406296|NCT02600897|531651187|FG003|Overall Study|Lost to Follow-up|0|||
147406297|NCT02600897|531651188|FG004|Overall Study|Lost to Follow-up|0|||
147406298|NCT02600897|531651189|FG005|Overall Study|Lost to Follow-up|0|||
147406299|NCT02600897|531651190|FG006|Overall Study|Lost to Follow-up|0|||
147406300|NCT02600897|531651191|FG007|Overall Study|Lost to Follow-up|1|||
147406301|NCT02600897|531651192|FG008|Overall Study|Lost to Follow-up|0|||
147406302|NCT02600897|531651184|FG000|Overall Study|Withdrawal by Subject|0|||
147406303|NCT02600897|531651185|FG001|Overall Study|Withdrawal by Subject|0|||
147406304|NCT02600897|531651186|FG002|Overall Study|Withdrawal by Subject|0|||
147406305|NCT02600897|531651187|FG003|Overall Study|Withdrawal by Subject|0|||
147406306|NCT02600897|531651188|FG004|Overall Study|Withdrawal by Subject|0|||
147406307|NCT02600897|531651189|FG005|Overall Study|Withdrawal by Subject|0|||
147406308|NCT02600897|531651190|FG006|Overall Study|Withdrawal by Subject|0|||
147406309|NCT02600897|531651191|FG007|Overall Study|Withdrawal by Subject|4|||
147406310|NCT02600897|531651192|FG008|Overall Study|Withdrawal by Subject|2|||
147406311|NCT02600897|531651184|FG000|Overall Study|Reason Not Specified|0|||
147406312|NCT02600897|531651185|FG001|Overall Study|Reason Not Specified|0|||
147406313|NCT02600897|531651186|FG002|Overall Study|Reason Not Specified|0|||
147406314|NCT02600897|531651187|FG003|Overall Study|Reason Not Specified|0|||
147406315|NCT02600897|531651188|FG004|Overall Study|Reason Not Specified|0|||
147406316|NCT02600897|531651189|FG005|Overall Study|Reason Not Specified|0|||
147406317|NCT02600897|531651190|FG006|Overall Study|Reason Not Specified|0|||
147406318|NCT02600897|531651191|FG007|Overall Study|Reason Not Specified|0|||
147406319|NCT02600897|531651192|FG008|Overall Study|Reason Not Specified|1|||
147406320|NCT02614183|531651195|FG000|Double Blind Treatment Phase|Adverse Event|10|||
147406321|NCT02614183|531651196|FG001|Double Blind Treatment Phase|Adverse Event|9|||
147406322|NCT02614183|531651197|FG002|Double Blind Treatment Phase|Adverse Event|7|||
147406323|NCT02614183|531651195|FG000|Double Blind Treatment Phase|Lack of Efficacy|10|||
147406324|NCT02614183|531651196|FG001|Double Blind Treatment Phase|Lack of Efficacy|1|||
147406325|NCT02614183|531651197|FG002|Double Blind Treatment Phase|Lack of Efficacy|2|||
147406326|NCT02614183|531651195|FG000|Double Blind Treatment Phase|Lost to Follow-up|18|||
147406327|NCT02614183|531651196|FG001|Double Blind Treatment Phase|Lost to Follow-up|9|||
147406328|NCT02614183|531651197|FG002|Double Blind Treatment Phase|Lost to Follow-up|5|||
147406329|NCT02614183|531651195|FG000|Double Blind Treatment Phase|Physician Decision|7|||
147406330|NCT02614183|531651196|FG001|Double Blind Treatment Phase|Physician Decision|3|||
147406331|NCT02614183|531651197|FG002|Double Blind Treatment Phase|Physician Decision|2|||
147406332|NCT02614183|531651195|FG000|Double Blind Treatment Phase|Pregnancy|2|||
147406333|NCT02614183|531651196|FG001|Double Blind Treatment Phase|Pregnancy|1|||
147406334|NCT02614183|531651197|FG002|Double Blind Treatment Phase|Pregnancy|3|||
147406335|NCT02614183|531651195|FG000|Double Blind Treatment Phase|Protocol Violation|2|||
147406336|NCT02614183|531651196|FG001|Double Blind Treatment Phase|Protocol Violation|2|||
147406337|NCT02614183|531651197|FG002|Double Blind Treatment Phase|Protocol Violation|2|||
147406338|NCT02614183|531651195|FG000|Double Blind Treatment Phase|Withdrawal by Subject|33|||
147406339|NCT02614183|531651196|FG001|Double Blind Treatment Phase|Withdrawal by Subject|11|||
147406340|NCT02614183|531651197|FG002|Double Blind Treatment Phase|Withdrawal by Subject|16|||
147406341|NCT02614183|531651195|FG000|Double Blind Treatment Phase|Did not receive study drug|1|||
147406342|NCT02614183|531651196|FG001|Double Blind Treatment Phase|Did not receive study drug|1|||
147616727|NCT02603146|532413651|FG001|Overall Study|Withdrawal by Subject|10|||
147616728|NCT02603146|532413650|FG000|Overall Study|Withdrawn by Investigator or NIAID|15|||
147616729|NCT02603146|532413651|FG001|Overall Study|Withdrawn by Investigator or NIAID|18|||
147616730|NCT02603146|532413650|FG000|Overall Study|Participant moved|2|||
147616731|NCT02603146|532413651|FG001|Overall Study|Participant moved|0|||
147464475|NCT00896532|531860292|FG011|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
147406343|NCT02614183|531651197|FG002|Double Blind Treatment Phase|Did not receive study drug|2|||
147406344|NCT02614183|531651195|FG000|Post Treatment Follow-up Phase|Lost to Follow-up|5|||
147406345|NCT02614183|531651196|FG001|Post Treatment Follow-up Phase|Lost to Follow-up|3|||
147406346|NCT02614183|531651197|FG002|Post Treatment Follow-up Phase|Lost to Follow-up|5|||
147406347|NCT02614183|531651195|FG000|Post Treatment Follow-up Phase|Physician Decision|5|||
147406348|NCT02614183|531651196|FG001|Post Treatment Follow-up Phase|Physician Decision|1|||
147406349|NCT02614183|531651197|FG002|Post Treatment Follow-up Phase|Physician Decision|2|||
147406350|NCT02614183|531651195|FG000|Post Treatment Follow-up Phase|Protocol Violation|1|||
147406351|NCT02614183|531651196|FG001|Post Treatment Follow-up Phase|Protocol Violation|0|||
147406352|NCT02614183|531651197|FG002|Post Treatment Follow-up Phase|Protocol Violation|0|||
147406353|NCT02614183|531651195|FG000|Post Treatment Follow-up Phase|Withdrawal by Subject|7|||
147406354|NCT02614183|531651196|FG001|Post Treatment Follow-up Phase|Withdrawal by Subject|2|||
147406355|NCT02614183|531651197|FG002|Post Treatment Follow-up Phase|Withdrawal by Subject|5|||
147406356|NCT05992922|531651198|FG000|Overall Study|Adverse Event|6|||
147406357|NCT05992922|531651199|FG001|Overall Study|Adverse Event|0|||
147406358|NCT05992922|531651198|FG000|Overall Study|Sponsor Termination of Study|14|||
147406359|NCT05992922|531651199|FG001|Overall Study|Sponsor Termination of Study|20|||
147406360|NCT02473965|531652970|FG000|Overall Study|Adverse Event|6|||
147406361|NCT02473965|531652971|FG001|Overall Study|Adverse Event|4|||
147406362|NCT02473965|531652970|FG000|Overall Study|MG worsening|4|||
147406363|NCT02473965|531652971|FG001|Overall Study|MG worsening|1|||
147406364|NCT02473965|531652970|FG000|Overall Study|Withdrawal by Subject|2|||
147406365|NCT02473965|531652971|FG001|Overall Study|Withdrawal by Subject|3|||
147406366|NCT02473965|531652970|FG000|Overall Study|Physician Decision|0|||
147406367|NCT02473965|531652971|FG001|Overall Study|Physician Decision|2|||
147406368|NCT01183390|531652972|FG000|First Intervention|Adverse Event|0|||
147406369|NCT01183390|531652973|FG001|First Intervention|Adverse Event|1|||
147406370|NCT04057573|531652974|FG000|24-Week Double-Blind Period|Adverse Event|2|||
147406371|NCT04057573|531652975|FG001|24-Week Double-Blind Period|Adverse Event|0|||
147406372|NCT04057573|531652976|FG002|24-Week Double-Blind Period|Adverse Event|0|||
147406373|NCT04057573|531652977|FG003|24-Week Double-Blind Period|Adverse Event|0|||
147406374|NCT04057573|531652974|FG000|24-Week Double-Blind Period|Lack of Efficacy|0|||
147406375|NCT04057573|531652975|FG001|24-Week Double-Blind Period|Lack of Efficacy|1|||
147406376|NCT04057573|531652976|FG002|24-Week Double-Blind Period|Lack of Efficacy|0|||
147406377|NCT04057573|531652977|FG003|24-Week Double-Blind Period|Lack of Efficacy|0|||
147406378|NCT04057573|531652974|FG000|24-Week Double-Blind Period|Lost to Follow-up|11|||
147406379|NCT04057573|531652975|FG001|24-Week Double-Blind Period|Lost to Follow-up|6|||
147406380|NCT04057573|531652976|FG002|24-Week Double-Blind Period|Lost to Follow-up|0|||
147406381|NCT04057573|531652977|FG003|24-Week Double-Blind Period|Lost to Follow-up|0|||
147406382|NCT04057573|531652974|FG000|24-Week Double-Blind Period|Physician Decision|1|||
147406383|NCT04057573|531652975|FG001|24-Week Double-Blind Period|Physician Decision|0|||
147406384|NCT04057573|531652976|FG002|24-Week Double-Blind Period|Physician Decision|0|||
147406385|NCT04057573|531652977|FG003|24-Week Double-Blind Period|Physician Decision|0|||
147406386|NCT04057573|531652974|FG000|24-Week Double-Blind Period|Pregnancy|1|||
147406387|NCT04057573|531652975|FG001|24-Week Double-Blind Period|Pregnancy|0|||
147406388|NCT04057573|531652976|FG002|24-Week Double-Blind Period|Pregnancy|0|||
147406389|NCT04057573|531652977|FG003|24-Week Double-Blind Period|Pregnancy|0|||
147406390|NCT04057573|531652974|FG000|24-Week Double-Blind Period|Withdrawal by Subject|10|||
147406391|NCT04057573|531652975|FG001|24-Week Double-Blind Period|Withdrawal by Subject|8|||
147406392|NCT04057573|531652976|FG002|24-Week Double-Blind Period|Withdrawal by Subject|0|||
147406393|NCT04057573|531652977|FG003|24-Week Double-Blind Period|Withdrawal by Subject|0|||
147406394|NCT04057573|531652974|FG000|24-Week Double-Blind Period|Discontinued Treatment due to COVID-19 Pandemic|3|||
147406395|NCT04057573|531652975|FG001|24-Week Double-Blind Period|Discontinued Treatment due to COVID-19 Pandemic|1|||
147406396|NCT04057573|531652976|FG002|24-Week Double-Blind Period|Discontinued Treatment due to COVID-19 Pandemic|0|||
147406397|NCT04057573|531652977|FG003|24-Week Double-Blind Period|Discontinued Treatment due to COVID-19 Pandemic|0|||
147406398|NCT04057573|531652974|FG000|24-Week Double-Blind Period|Non-compliance with Attending Study Visits|1|||
147406399|NCT04057573|531652975|FG001|24-Week Double-Blind Period|Non-compliance with Attending Study Visits|0|||
147406400|NCT04057573|531652976|FG002|24-Week Double-Blind Period|Non-compliance with Attending Study Visits|0|||
147406401|NCT04057573|531652977|FG003|24-Week Double-Blind Period|Non-compliance with Attending Study Visits|0|||
147616732|NCT02603146|532413650|FG000|Overall Study|Participant could not complete the Month 36 visit due to COVID-19|1|||
147616733|NCT02603146|532413651|FG001|Overall Study|Participant could not complete the Month 36 visit due to COVID-19|0|||
147616734|NCT06082843|532413652|FG000|Overall Study|Withdrawal by Subject|0|||
147406402|NCT04057573|531652974|FG000|24-Week Double-Blind Period|Unable to Attend Study Visits Due to Travel|0|||
147406403|NCT04057573|531652975|FG001|24-Week Double-Blind Period|Unable to Attend Study Visits Due to Travel|1|||
147406404|NCT04057573|531652976|FG002|24-Week Double-Blind Period|Unable to Attend Study Visits Due to Travel|0|||
147616735|NCT06082843|532413653|FG001|Overall Study|Withdrawal by Subject|2|||
147616736|NCT06082843|532413652|FG000|Overall Study|Study terminated by sponsor|12|||
147616737|NCT06082843|532413653|FG001|Overall Study|Study terminated by sponsor|8|||
147406405|NCT04057573|531652977|FG003|24-Week Double-Blind Period|Unable to Attend Study Visits Due to Travel|0|||
147406406|NCT04057573|531652974|FG000|24-Week Double-Blind Period|Not Treated|1|||
147406407|NCT04057573|531652975|FG001|24-Week Double-Blind Period|Not Treated|0|||
147406408|NCT04057573|531652976|FG002|24-Week Double-Blind Period|Not Treated|0|||
147406409|NCT04057573|531652977|FG003|24-Week Double-Blind Period|Not Treated|0|||
147406410|NCT04057573|531652974|FG000|28-Week Treatment Extension Period|Adverse Event|0|||
147406411|NCT04057573|531652975|FG001|28-Week Treatment Extension Period|Adverse Event|0|||
147406412|NCT04057573|531652976|FG002|28-Week Treatment Extension Period|Adverse Event|1|||
147406413|NCT04057573|531652977|FG003|28-Week Treatment Extension Period|Adverse Event|0|||
147406414|NCT04057573|531652974|FG000|28-Week Treatment Extension Period|Lack of Efficacy|0|||
147406415|NCT04057573|531652975|FG001|28-Week Treatment Extension Period|Lack of Efficacy|0|||
147406416|NCT04057573|531652976|FG002|28-Week Treatment Extension Period|Lack of Efficacy|1|||
147406417|NCT04057573|531652977|FG003|28-Week Treatment Extension Period|Lack of Efficacy|0|||
147406418|NCT04057573|531652974|FG000|28-Week Treatment Extension Period|Lost to Follow-up|0|||
147406419|NCT04057573|531652975|FG001|28-Week Treatment Extension Period|Lost to Follow-up|0|||
147406420|NCT04057573|531652976|FG002|28-Week Treatment Extension Period|Lost to Follow-up|9|||
147406421|NCT04057573|531652977|FG003|28-Week Treatment Extension Period|Lost to Follow-up|10|||
147406422|NCT04057573|531652974|FG000|28-Week Treatment Extension Period|Withdrawal by Subject|0|||
147406423|NCT04057573|531652975|FG001|28-Week Treatment Extension Period|Withdrawal by Subject|0|||
147406424|NCT04057573|531652976|FG002|28-Week Treatment Extension Period|Withdrawal by Subject|9|||
147406425|NCT04057573|531652977|FG003|28-Week Treatment Extension Period|Withdrawal by Subject|9|||
147406426|NCT04057573|531652974|FG000|28-Week Treatment Extension Period|Unable to Perform Safety Follow-up Visit|0|||
147406427|NCT04057573|531652975|FG001|28-Week Treatment Extension Period|Unable to Perform Safety Follow-up Visit|0|||
147406428|NCT04057573|531652976|FG002|28-Week Treatment Extension Period|Unable to Perform Safety Follow-up Visit|1|||
147406429|NCT04057573|531652977|FG003|28-Week Treatment Extension Period|Unable to Perform Safety Follow-up Visit|0|||
147406430|NCT02113124|531652978|FG000|Overall Study|Unable to retrieve blood sample|1|||
147406431|NCT02113124|531652979|FG001|Overall Study|Unable to retrieve blood sample|1|||
147406432|NCT03299049|531652980|FG000|Overall Study|On-going|486|||
147406433|NCT03299049|531652981|FG001|Overall Study|On-going|481|||
147406434|NCT03299049|531652980|FG000|Overall Study|Withdrawal by Subject|6|||
147406435|NCT03299049|531652981|FG001|Overall Study|Withdrawal by Subject|21|||
147406436|NCT03299049|531652980|FG000|Overall Study|Physician Decision|5|||
147406437|NCT03299049|531652981|FG001|Overall Study|Physician Decision|1|||
147406438|NCT03299049|531652980|FG000|Overall Study|Lost to Follow-up|2|||
147406439|NCT03299049|531652981|FG001|Overall Study|Lost to Follow-up|0|||
147406440|NCT03299049|531652980|FG000|Overall Study|Pregnancy|1|||
147406441|NCT03299049|531652981|FG001|Overall Study|Pregnancy|3|||
147406442|NCT03299049|531652980|FG000|Overall Study|Protocol Violation|1|||
147406443|NCT03299049|531652981|FG001|Overall Study|Protocol Violation|1|||
147406444|NCT03299049|531652980|FG000|Overall Study|Lack of Efficacy|9|||
147406445|NCT03299049|531652981|FG001|Overall Study|Lack of Efficacy|3|||
147406446|NCT03299049|531652980|FG000|Overall Study|Adverse Event|12|||
147464476|NCT00896532|531860293|FG012|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
147464477|NCT00896532|531860294|FG013|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
147464478|NCT00896532|531860295|FG014|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
147464479|NCT00896532|531860296|FG015|Months 36-48: Romosozumab Retreatment|Adverse Event|1|||
147464480|NCT00896532|531860297|FG016|Months 36-48: Romosozumab Retreatment|Adverse Event|3|||
147464481|NCT00896532|531860298|FG017|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
147464482|NCT00896532|531860299|FG018|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
147464483|NCT00896532|531860300|FG019|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
147464484|NCT00896532|531860301|FG020|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
147464485|NCT00896532|531860302|FG021|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
147464486|NCT00896532|531860303|FG022|Months 36-48: Romosozumab Retreatment|Adverse Event|0|||
147464487|NCT00896532|531860281|FG000|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
147464488|NCT00896532|531860282|FG001|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
147464489|NCT00896532|531860283|FG002|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
147464490|NCT00896532|531860284|FG003|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
147406447|NCT03299049|531652981|FG001|Overall Study|Adverse Event|13|||
147464491|NCT00896532|531860285|FG004|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
147464492|NCT00896532|531860286|FG005|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
147464493|NCT00896532|531860287|FG006|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
147464494|NCT00896532|531860288|FG007|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
147406448|NCT01901419|531652982|FG000|Overall Study|Protocol Violation|2|||
147406449|NCT01901419|531652983|FG001|Overall Study|Protocol Violation|6|||
147406450|NCT01901419|531652982|FG000|Overall Study|unavailable researchers|6|||
147406451|NCT01901419|531652983|FG001|Overall Study|unavailable researchers|3|||
147406452|NCT01020877|531652992|FG000|Second Intervention|Withdrawal by Subject|1|||
147406453|NCT01020877|531652993|FG001|Second Intervention|Withdrawal by Subject|0|||
147406454|NCT00790400|531652994|FG000|Double-blind Period (Core Phase)|Protocol Violation|1|||
147464495|NCT00896532|531860289|FG008|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
147464496|NCT00896532|531860290|FG009|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
147464497|NCT00896532|531860291|FG010|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
147464498|NCT00896532|531860292|FG011|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
147464499|NCT00896532|531860293|FG012|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
147464500|NCT00896532|531860294|FG013|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
147464501|NCT00896532|531860295|FG014|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
147464502|NCT00896532|531860296|FG015|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|1|||
147464503|NCT00896532|531860297|FG016|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|2|||
147464504|NCT00896532|531860298|FG017|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|2|||
147464505|NCT00896532|531860299|FG018|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
147464506|NCT00896532|531860300|FG019|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
147464507|NCT00896532|531860301|FG020|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
147464508|NCT00896532|531860302|FG021|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
147464509|NCT00896532|531860303|FG022|Months 36-48: Romosozumab Retreatment|Withdrawal by Subject|0|||
147464510|NCT00896532|531860281|FG000|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
147464511|NCT00896532|531860282|FG001|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
147464512|NCT00896532|531860283|FG002|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
147464513|NCT00896532|531860284|FG003|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
147464514|NCT00896532|531860285|FG004|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
147464515|NCT00896532|531860286|FG005|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
147464516|NCT00896532|531860287|FG006|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
147464517|NCT00896532|531860288|FG007|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
147464518|NCT00896532|531860289|FG008|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
147464519|NCT00896532|531860290|FG009|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
147464520|NCT00896532|531860291|FG010|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
147464521|NCT00896532|531860292|FG011|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
147464522|NCT00896532|531860293|FG012|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
147464523|NCT00896532|531860294|FG013|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
147464524|NCT00896532|531860295|FG014|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
147464525|NCT00896532|531860296|FG015|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
147464526|NCT00896532|531860297|FG016|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|1|||
147464527|NCT00896532|531860298|FG017|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
147464528|NCT00896532|531860299|FG018|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
147464529|NCT00896532|531860300|FG019|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
147464530|NCT00896532|531860301|FG020|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
147464531|NCT00896532|531860302|FG021|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
147464532|NCT00896532|531860303|FG022|Months 36-48: Romosozumab Retreatment|Lost to Follow-up|0|||
147464533|NCT00896532|531860281|FG000|Months 36-48: Romosozumab Retreatment|Other|0|||
147464534|NCT00896532|531860282|FG001|Months 36-48: Romosozumab Retreatment|Other|0|||
147464535|NCT00896532|531860283|FG002|Months 36-48: Romosozumab Retreatment|Other|0|||
147464536|NCT00896532|531860284|FG003|Months 36-48: Romosozumab Retreatment|Other|0|||
147464537|NCT00896532|531860285|FG004|Months 36-48: Romosozumab Retreatment|Other|0|||
147464538|NCT00896532|531860286|FG005|Months 36-48: Romosozumab Retreatment|Other|0|||
147464539|NCT00896532|531860287|FG006|Months 36-48: Romosozumab Retreatment|Other|0|||
147464540|NCT00896532|531860288|FG007|Months 36-48: Romosozumab Retreatment|Other|0|||
147464541|NCT00896532|531860289|FG008|Months 36-48: Romosozumab Retreatment|Other|0|||
147464542|NCT00896532|531860290|FG009|Months 36-48: Romosozumab Retreatment|Other|0|||
147464543|NCT00896532|531860291|FG010|Months 36-48: Romosozumab Retreatment|Other|0|||
147464544|NCT00896532|531860292|FG011|Months 36-48: Romosozumab Retreatment|Other|0|||
147464545|NCT00896532|531860293|FG012|Months 36-48: Romosozumab Retreatment|Other|0|||
147464546|NCT00896532|531860294|FG013|Months 36-48: Romosozumab Retreatment|Other|0|||
147406455|NCT00790400|531652995|FG001|Double-blind Period (Core Phase)|Protocol Violation|0|||
147406456|NCT00790400|531652994|FG000|Double-blind Period (Core Phase)|Progressive disease|0|||
147406457|NCT00790400|531652995|FG001|Double-blind Period (Core Phase)|Progressive disease|9|||
147406458|NCT00790400|531652994|FG000|Double-blind Period (Core Phase)|Adverse Event|2|||
147406459|NCT00790400|531652995|FG001|Double-blind Period (Core Phase)|Adverse Event|4|||
147406460|NCT00790400|531652994|FG000|Double-blind Period (Core Phase)|Abnormal lab value (s)|1|||
147406461|NCT00790400|531652995|FG001|Double-blind Period (Core Phase)|Abnormal lab value (s)|0|||
147406462|NCT00790400|531652994|FG000|Double-blind Period (Core Phase)|Withdrawal by Subject|1|||
147406463|NCT00790400|531652995|FG001|Double-blind Period (Core Phase)|Withdrawal by Subject|0|||
147406464|NCT00790400|531652994|FG000|Double-blind Period (Core Phase)|Administrative problems|1|||
147406465|NCT00790400|531652995|FG001|Double-blind Period (Core Phase)|Administrative problems|0|||
147406466|NCT00790400|531652994|FG000|Double-blind Period (Core Phase)|Death|1|||
147406467|NCT00790400|531652995|FG001|Double-blind Period (Core Phase)|Death|0|||
147406468|NCT00790400|531652994|FG000|Everolimus Period (Core or Extension)|Adverse Event|9|||
147464547|NCT00896532|531860295|FG014|Months 36-48: Romosozumab Retreatment|Other|0|||
147464548|NCT00896532|531860296|FG015|Months 36-48: Romosozumab Retreatment|Other|0|||
147464549|NCT00896532|531860297|FG016|Months 36-48: Romosozumab Retreatment|Other|0|||
147464550|NCT00896532|531860298|FG017|Months 36-48: Romosozumab Retreatment|Other|1|||
147616738|NCT01368497|532413654|FG000|Overall Study|Lost to Follow-up|2|||
147616739|NCT01130532|532413655|FG000|Period III (Weeks 0-12)|Adverse Event|3|||
147406469|NCT00790400|531652995|FG001|Everolimus Period (Core or Extension)|Adverse Event|0|||
147406470|NCT00790400|531652994|FG000|Everolimus Period (Core or Extension)|Abnormal lab value (s)|1|||
147406471|NCT00790400|531652995|FG001|Everolimus Period (Core or Extension)|Abnormal lab value (s)|0|||
147406472|NCT00790400|531652994|FG000|Everolimus Period (Core or Extension)|Withdrawal by Subject|7|||
147406473|NCT00790400|531652995|FG001|Everolimus Period (Core or Extension)|Withdrawal by Subject|0|||
147406474|NCT00790400|531652994|FG000|Everolimus Period (Core or Extension)|Lost to Follow-up|1|||
147406475|NCT00790400|531652995|FG001|Everolimus Period (Core or Extension)|Lost to Follow-up|0|||
147406476|NCT00790400|531652994|FG000|Everolimus Period (Core or Extension)|Administrative problems|2|||
147406477|NCT00790400|531652995|FG001|Everolimus Period (Core or Extension)|Administrative problems|0|||
147406478|NCT00790400|531652994|FG000|Everolimus Period (Core or Extension)|Death|1|||
147406479|NCT00790400|531652995|FG001|Everolimus Period (Core or Extension)|Death|0|||
147406480|NCT00790400|531652994|FG000|Everolimus Period (Core or Extension)|Disease progression|5|||
147406481|NCT00790400|531652995|FG001|Everolimus Period (Core or Extension)|Disease progression|0|||
147406482|NCT00790400|531652994|FG000|Everolimus Period (Core or Extension)|Protocol Violation|1|||
147406483|NCT00790400|531652995|FG001|Everolimus Period (Core or Extension)|Protocol Violation|0|||
147406484|NCT00790400|531652994|FG000|Everolimus Period (Core or Extension)|New treatment|2|||
147406485|NCT00790400|531652995|FG001|Everolimus Period (Core or Extension)|New treatment|0|||
147406486|NCT01006980|531652996|FG000|Vemurafenib and Dacarbazine|Randomized but Not Treated|1|||
147406487|NCT01006980|531652997|FG001|Vemurafenib and Dacarbazine|Randomized but Not Treated|45|||
147406488|NCT01006980|531652996|FG000|Vemurafenib and Dacarbazine|Adverse Event|25|||
147406489|NCT01006980|531652997|FG001|Vemurafenib and Dacarbazine|Adverse Event|5|||
147406490|NCT01006980|531652996|FG000|Vemurafenib and Dacarbazine|Death|13|||
147406491|NCT01006980|531652997|FG001|Vemurafenib and Dacarbazine|Death|12|||
147406492|NCT01006980|531652996|FG000|Vemurafenib and Dacarbazine|Progression|257|||
147406493|NCT01006980|531652997|FG001|Vemurafenib and Dacarbazine|Progression|218|||
147406494|NCT01006980|531652996|FG000|Vemurafenib and Dacarbazine|Withdrawal of Consent|4|||
147406495|NCT01006980|531652997|FG001|Vemurafenib and Dacarbazine|Withdrawal of Consent|6|||
147406496|NCT01006980|531652996|FG000|Vemurafenib and Dacarbazine|Refuse Treatment|9|||
147406497|NCT01006980|531652997|FG001|Vemurafenib and Dacarbazine|Refuse Treatment|6|||
147406498|NCT01006980|531652996|FG000|Vemurafenib and Dacarbazine|Protocol Violation|2|||
147406499|NCT01006980|531652997|FG001|Vemurafenib and Dacarbazine|Protocol Violation|3|||
147406500|NCT01006980|531652996|FG000|Vemurafenib and Dacarbazine|Reason Not Specified|26|||
147406501|NCT01006980|531652997|FG001|Vemurafenib and Dacarbazine|Reason Not Specified|43|||
147406502|NCT01006980|531652996|FG000|Crossover: Dacarbazine to Vemurafenib|Adverse Event|0|||
147406503|NCT01006980|531652997|FG001|Crossover: Dacarbazine to Vemurafenib|Adverse Event|4|||
147406504|NCT01006980|531652996|FG000|Crossover: Dacarbazine to Vemurafenib|Death|0|||
147406505|NCT01006980|531652997|FG001|Crossover: Dacarbazine to Vemurafenib|Death|4|||
147406506|NCT01006980|531652996|FG000|Crossover: Dacarbazine to Vemurafenib|Progression|0|||
147406507|NCT01006980|531652997|FG001|Crossover: Dacarbazine to Vemurafenib|Progression|65|||
147406508|NCT01006980|531652996|FG000|Crossover: Dacarbazine to Vemurafenib|Withdrawal of Consent|0|||
147406509|NCT01006980|531652997|FG001|Crossover: Dacarbazine to Vemurafenib|Withdrawal of Consent|1|||
147406510|NCT01006980|531652996|FG000|Crossover: Dacarbazine to Vemurafenib|Reason Not Specified|0|||
147406511|NCT01006980|531652997|FG001|Crossover: Dacarbazine to Vemurafenib|Reason Not Specified|10|||
147406512|NCT00078338|531652998|FG000|Overall Study|Adverse Event|31|||
147406513|NCT00078338|531652999|FG001|Overall Study|Adverse Event|24|||
147406514|NCT00078338|531652998|FG000|Overall Study|Lost to Follow-up|17|||
147406515|NCT00078338|531652999|FG001|Overall Study|Lost to Follow-up|2|||
147406516|NCT00078338|531652998|FG000|Overall Study|Protocol Violation|2|||
147406517|NCT00078338|531652999|FG001|Overall Study|Protocol Violation|2|||
147406518|NCT00078338|531652998|FG000|Overall Study|Disease Progression|4|||
147406519|NCT00078338|531652999|FG001|Overall Study|Disease Progression|7|||
147406520|NCT00078338|531652998|FG000|Overall Study|Other|28|||
147406521|NCT00078338|531652999|FG001|Overall Study|Other|16|||
147406522|NCT00078338|531652998|FG000|Overall Study|Subjects randomized, but not treated|3|||
147406523|NCT00078338|531652999|FG001|Overall Study|Subjects randomized, but not treated|3|||
147406524|NCT01483144|531653000|FG000|Overall Study|Adverse Event|9|||
147406525|NCT01483144|531653001|FG001|Overall Study|Adverse Event|4|||
147406526|NCT01483144|531653002|FG002|Overall Study|Adverse Event|6|||
147406527|NCT01483144|531653000|FG000|Overall Study|Withdrawal by Subject|0|||
147406528|NCT01483144|531653001|FG001|Overall Study|Withdrawal by Subject|2|||
147464551|NCT00896532|531860299|FG018|Months 36-48: Romosozumab Retreatment|Other|0|||
147616740|NCT01130532|532413656|FG001|Period III (Weeks 0-12)|Adverse Event|3|||
147616741|NCT01130532|532413657|FG002|Period III (Weeks 0-12)|Adverse Event|2|||
147406529|NCT01483144|531653002|FG002|Overall Study|Withdrawal by Subject|5|||
147616742|NCT01130532|532413658|FG003|Period III (Weeks 0-12)|Adverse Event|0|||
147406530|NCT01483144|531653000|FG000|Overall Study|Physician Decision|1|||
147406531|NCT01483144|531653001|FG001|Overall Study|Physician Decision|0|||
147406532|NCT01483144|531653002|FG002|Overall Study|Physician Decision|0|||
147406533|NCT01483144|531653000|FG000|Overall Study|Lost to Follow-up|2|||
147406534|NCT01483144|531653001|FG001|Overall Study|Lost to Follow-up|4|||
147406535|NCT01483144|531653002|FG002|Overall Study|Lost to Follow-up|1|||
147406536|NCT01483144|531653000|FG000|Overall Study|Protocol Violation|3|||
147406537|NCT01483144|531653001|FG001|Overall Study|Protocol Violation|3|||
147406538|NCT01483144|531653002|FG002|Overall Study|Protocol Violation|3|||
147406539|NCT02460575|531653003|FG000|Overall Study|Lost to Follow-up|1|||
147406540|NCT02460575|531653004|FG001|Overall Study|Lost to Follow-up|0|||
147406541|NCT04307940|531653005|FG000|Overall Study|Adverse Event|1|||
147406542|NCT04307940|531653006|FG001|Overall Study|Adverse Event|0|||
147406543|NCT04307940|531653007|FG002|Overall Study|Adverse Event|0|||
147406544|NCT04307940|531653005|FG000|Overall Study|Withdrawal by Subject|2|||
147406545|NCT04307940|531653006|FG001|Overall Study|Withdrawal by Subject|3|||
147406546|NCT04307940|531653007|FG002|Overall Study|Withdrawal by Subject|1|||
147406547|NCT04307940|531653005|FG000|Overall Study|Lost to Follow-up|2|||
147406548|NCT04307940|531653006|FG001|Overall Study|Lost to Follow-up|0|||
147406549|NCT04307940|531653007|FG002|Overall Study|Lost to Follow-up|1|||
147406550|NCT02521363|531653008|FG000|Overall Study|Withdrawal by Subject|1|||
147406551|NCT02521363|531653009|FG001|Overall Study|Withdrawal by Subject|2|||
147406552|NCT05543174|531653010|FG000|Overall Study|Ongoing|7|||
147406553|NCT04896008|531653013|FG000|Overall Study|Ongoing|70|||
147406554|NCT04896008|531653014|FG001|Overall Study|Ongoing|38|||
147406555|NCT04896008|531653013|FG000|Overall Study|Adverse Event|0|||
147406556|NCT04896008|531653014|FG001|Overall Study|Adverse Event|2|||
147406557|NCT04896008|531653013|FG000|Overall Study|Death|5|||
147406558|NCT04896008|531653014|FG001|Overall Study|Death|10|||
147406559|NCT04896008|531653013|FG000|Overall Study|More Than 3 Dose Delays Required Per Dose Adjustment Guidelines|1|||
147406560|NCT04896008|531653014|FG001|Overall Study|More Than 3 Dose Delays Required Per Dose Adjustment Guidelines|0|||
147406561|NCT04896008|531653013|FG000|Overall Study|Fridericia's Corrected QT Interval Above 500 ms|0|||
147406562|NCT04896008|531653014|FG001|Overall Study|Fridericia's Corrected QT Interval Above 500 ms|1|||
147406563|NCT04896008|531653013|FG000|Overall Study|Unwillingness Or Inability To Comply With Protocol|1|||
147406564|NCT04896008|531653014|FG001|Overall Study|Unwillingness Or Inability To Comply With Protocol|0|||
147406565|NCT04896008|531653013|FG000|Overall Study|Withdrawal by Subject|1|||
147406566|NCT04896008|531653014|FG001|Overall Study|Withdrawal by Subject|4|||
147406567|NCT04896008|531653013|FG000|Overall Study|Investigator Decision|2|||
147406568|NCT04896008|531653014|FG001|Overall Study|Investigator Decision|0|||
147406569|NCT04896008|531653013|FG000|Overall Study|Transitioned to Commercial Sotatercept|2|||
147406570|NCT04896008|531653014|FG001|Overall Study|Transitioned to Commercial Sotatercept|1|||
147406571|NCT04201288|531653017|FG000|Overall Study|Death|1|||
147406572|NCT04201288|531653018|FG001|Overall Study|Death|1|||
147406573|NCT04201288|531653017|FG000|Overall Study|Lost to Follow-up|5|||
147406574|NCT04201288|531653018|FG001|Overall Study|Lost to Follow-up|3|||
147406575|NCT04201288|531653017|FG000|Overall Study|Withdrawal by Subject|1|||
147406576|NCT04201288|531653018|FG001|Overall Study|Withdrawal by Subject|0|||
147406577|NCT01270828|531653021|FG000|Pregabalin CR SB|Reason Unspecified|0|||
147406578|NCT01270828|531653022|FG001|Pregabalin CR SB|Reason Unspecified|0|||
147406579|NCT01270828|531653023|FG002|Pregabalin CR SB|Reason Unspecified|8|||
147406580|NCT01270828|531653021|FG000|Pregabalin CR SB|Enrolled but not treated|0|||
147406581|NCT01270828|531653022|FG001|Pregabalin CR SB|Enrolled but not treated|0|||
147406582|NCT01270828|531653023|FG002|Pregabalin CR SB|Enrolled but not treated|5|||
147406583|NCT01270828|531653021|FG000|Pregabalin CR SB|Related adverse event|0|||
147406584|NCT01270828|531653022|FG001|Pregabalin CR SB|Related adverse event|0|||
147406585|NCT01270828|531653023|FG002|Pregabalin CR SB|Related adverse event|46|||
147406586|NCT01270828|531653021|FG000|Pregabalin CR SB|Lack of Efficacy|0|||
147406587|NCT01270828|531653022|FG001|Pregabalin CR SB|Lack of Efficacy|0|||
147406588|NCT01270828|531653023|FG002|Pregabalin CR SB|Lack of Efficacy|32|||
147406589|NCT01270828|531653021|FG000|Pregabalin CR SB|Withdrawal by Subject|0|||
147406590|NCT01270828|531653022|FG001|Pregabalin CR SB|Withdrawal by Subject|0|||
147406591|NCT01270828|531653023|FG002|Pregabalin CR SB|Withdrawal by Subject|29|||
147406592|NCT01270828|531653021|FG000|Pregabalin CR SB|Lost to Follow-up|0|||
147406593|NCT01270828|531653022|FG001|Pregabalin CR SB|Lost to Follow-up|0|||
147406594|NCT01270828|531653023|FG002|Pregabalin CR SB|Lost to Follow-up|10|||
147406595|NCT01270828|531653021|FG000|Pregabalin CR SB|Unrelated AE|0|||
147406596|NCT01270828|531653022|FG001|Pregabalin CR SB|Unrelated AE|0|||
147406597|NCT01270828|531653023|FG002|Pregabalin CR SB|Unrelated AE|8|||
147406598|NCT01270828|531653021|FG000|Pregabalin CR SB|Protocol Violation|0|||
147406599|NCT01270828|531653022|FG001|Pregabalin CR SB|Protocol Violation|0|||
147406600|NCT01270828|531653023|FG002|Pregabalin CR SB|Protocol Violation|8|||
147406601|NCT01270828|531653021|FG000|Double Blind Phase|Death|0|||
147406602|NCT01270828|531653022|FG001|Double Blind Phase|Death|1|||
147406603|NCT01270828|531653023|FG002|Double Blind Phase|Death|0|||
147406604|NCT01270828|531653021|FG000|Double Blind Phase|Protocol Violation|0|||
147406605|NCT01270828|531653022|FG001|Double Blind Phase|Protocol Violation|1|||
147406606|NCT01270828|531653023|FG002|Double Blind Phase|Protocol Violation|0|||
147406607|NCT01270828|531653021|FG000|Double Blind Phase|Protocol and GCP non-compliance|4|||
147406608|NCT01270828|531653022|FG001|Double Blind Phase|Protocol and GCP non-compliance|3|||
147406609|NCT01270828|531653023|FG002|Double Blind Phase|Protocol and GCP non-compliance|0|||
147406610|NCT01270828|531653021|FG000|Double Blind Phase|Reason Unspecified|7|||
147406611|NCT01270828|531653022|FG001|Double Blind Phase|Reason Unspecified|4|||
147406612|NCT01270828|531653023|FG002|Double Blind Phase|Reason Unspecified|0|||
147406613|NCT01270828|531653021|FG000|Double Blind Phase|Withdrawal by Subject|6|||
147406614|NCT01270828|531653022|FG001|Double Blind Phase|Withdrawal by Subject|15|||
147406615|NCT01270828|531653023|FG002|Double Blind Phase|Withdrawal by Subject|0|||
147406616|NCT01270828|531653021|FG000|Double Blind Phase|Lost to Follow-up|1|||
147406617|NCT01270828|531653022|FG001|Double Blind Phase|Lost to Follow-up|2|||
147406618|NCT01270828|531653023|FG002|Double Blind Phase|Lost to Follow-up|0|||
147406619|NCT01270828|531653021|FG000|Double Blind Phase|Lack of Efficacy|2|||
147406620|NCT01270828|531653022|FG001|Double Blind Phase|Lack of Efficacy|11|||
147406621|NCT01270828|531653023|FG002|Double Blind Phase|Lack of Efficacy|0|||
147406622|NCT01270828|531653021|FG000|Double Blind Phase|Adverse event not related to study drug|1|||
147406623|NCT01270828|531653022|FG001|Double Blind Phase|Adverse event not related to study drug|1|||
147406624|NCT01270828|531653023|FG002|Double Blind Phase|Adverse event not related to study drug|0|||
147406625|NCT01270828|531653021|FG000|Double Blind Phase|Adverse event related to study drug|5|||
147406626|NCT01270828|531653022|FG001|Double Blind Phase|Adverse event related to study drug|7|||
147406627|NCT01270828|531653023|FG002|Double Blind Phase|Adverse event related to study drug|0|||
147406628|NCT04400487|531653027|FG000|Treatment Period (24 Weeks)|Withdrawal by Subject|1|||
147406629|NCT04400487|531653027|FG000|Treatment Period (24 Weeks)|Non-compliance|1|||
147406630|NCT04400487|531653027|FG000|Follow-up Period (28 Days)|Started commercial product|2|||
147406631|NCT01594827|531653029|FG000|Overall Study|Adverse Event|1|||
147406632|NCT01594827|531653030|FG001|Overall Study|Adverse Event|0|||
147406633|NCT01594827|531653029|FG000|Overall Study|Physician Decision|3|||
147406634|NCT01594827|531653030|FG001|Overall Study|Physician Decision|0|||
147406635|NCT03334253|531653032|FG000|Overall Study|Withdrawal by Subject|1|||
147406636|NCT03334253|531653033|FG001|Overall Study|Withdrawal by Subject|0|||
147406637|NCT03334253|531653032|FG000|Overall Study|Lost to Follow-up|4|||
147406638|NCT03334253|531653033|FG001|Overall Study|Lost to Follow-up|3|||
147406639|NCT03334253|531653032|FG000|Overall Study|Moved residence|2|||
147406640|NCT03334253|531653033|FG001|Overall Study|Moved residence|2|||
147406641|NCT00945672|531653035|FG000|Overall Study|Withdrawal by Subject|0|||
147406642|NCT00945672|531653036|FG001|Overall Study|Withdrawal by Subject|0|||
147406643|NCT00945672|531653037|FG002|Overall Study|Withdrawal by Subject|0|||
147406644|NCT00945672|531653038|FG003|Overall Study|Withdrawal by Subject|1|||
147406645|NCT03054337|531653040|FG000|Dose Adjustment and Maintenance Period|Investigator discretion|1|||
147406646|NCT03054337|531653041|FG001|Dose Adjustment and Maintenance Period|Investigator discretion|2|||
147406647|NCT03054337|531653042|FG002|Dose Adjustment and Maintenance Period|Investigator discretion|1|||
147406648|NCT03054337|531653043|FG003|Dose Adjustment and Maintenance Period|Investigator discretion|0|||
147406649|NCT03054337|531653044|FG004|Dose Adjustment and Maintenance Period|Investigator discretion|0|||
147406650|NCT03054337|531653045|FG005|Dose Adjustment and Maintenance Period|Investigator discretion|1|||
147406651|NCT00447590|531653048|FG000|Overall Study|Withdrawal by Subject|26|||
147406652|NCT00447590|531653048|FG000|Overall Study|Lost to Follow-up|24|||
147406653|NCT00447590|531653048|FG000|Overall Study|Band Removed/Eroded/Other Follow-Up Loss|10|||
147406654|NCT00609947|531653052|FG000|Overall Study|Death|1|||
147406655|NCT05569421|531653053|FG000|Overall Study|Withdrawal by Subject|1|||
147406656|NCT05569421|531653054|FG001|Overall Study|Withdrawal by Subject|0|||
147406657|NCT05569421|531653055|FG002|Overall Study|Withdrawal by Subject|0|||
147406658|NCT00504075|531653056|FG000|Overall Study|Adverse Event|1|||
147406659|NCT00504075|531653056|FG000|Overall Study|Lost to Follow-up|5|||
147406660|NCT00504075|531653056|FG000|Overall Study|Withdrawal by Subject|1|||
147406661|NCT00504075|531653056|FG000|Overall Study|Required other therapeutic intervention|1|||
147406662|NCT03812029|531653059|FG000|Overall Study|Protocol Violation|1|||
147406663|NCT03812029|531653060|FG001|Overall Study|Protocol Violation|0|||
147406664|NCT03812029|531653061|FG002|Overall Study|Protocol Violation|0|||
147406665|NCT03812029|531653062|FG003|Overall Study|Protocol Violation|1|||
147406666|NCT03812029|531653063|FG004|Overall Study|Protocol Violation|0|||
147406667|NCT03812029|531653059|FG000|Overall Study|Withdrawal by Subject|1|||
147406668|NCT03812029|531653060|FG001|Overall Study|Withdrawal by Subject|0|||
147406669|NCT03812029|531653061|FG002|Overall Study|Withdrawal by Subject|0|||
147406670|NCT03812029|531653062|FG003|Overall Study|Withdrawal by Subject|2|||
147406671|NCT03812029|531653063|FG004|Overall Study|Withdrawal by Subject|2|||
147406672|NCT03812029|531653059|FG000|Overall Study|Stopping rules|0|||
147406673|NCT03812029|531653060|FG001|Overall Study|Stopping rules|1|||
147406674|NCT03812029|531653061|FG002|Overall Study|Stopping rules|0|||
147406675|NCT03812029|531653062|FG003|Overall Study|Stopping rules|0|||
147406676|NCT03812029|531653063|FG004|Overall Study|Stopping rules|0|||
147406677|NCT03812029|531653059|FG000|Overall Study|Adverse Event|0|||
147406678|NCT03812029|531653060|FG001|Overall Study|Adverse Event|9|||
147406679|NCT03812029|531653061|FG002|Overall Study|Adverse Event|0|||
147406680|NCT03812029|531653062|FG003|Overall Study|Adverse Event|3|||
147406681|NCT03812029|531653063|FG004|Overall Study|Adverse Event|5|||
147406682|NCT03812029|531653059|FG000|Overall Study|Lost to Follow-up|0|||
147406683|NCT03812029|531653060|FG001|Overall Study|Lost to Follow-up|0|||
147406684|NCT03812029|531653061|FG002|Overall Study|Lost to Follow-up|0|||
147406685|NCT03812029|531653062|FG003|Overall Study|Lost to Follow-up|0|||
147406686|NCT03812029|531653063|FG004|Overall Study|Lost to Follow-up|3|||
147406687|NCT00581477|531653064|FG000|Overall Study|Physician Decision|2|||
147406688|NCT03106753|531653065|FG000|Overall Study|Withdrawal by Subject|0|||
147406689|NCT03106753|531653066|FG001|Overall Study|Withdrawal by Subject|1|||
147406690|NCT01643044|531653067|FG000|Overall Study|Lost to Follow-up|1|||
147406691|NCT01643044|531653068|FG001|Overall Study|Lost to Follow-up|1|||
147406692|NCT01643044|531653067|FG000|Overall Study|Miscarried baby|2|||
147406693|NCT01643044|531653068|FG001|Overall Study|Miscarried baby|2|||
147406694|NCT01643044|531653067|FG000|Overall Study|Delivered outside of hospital|1|||
147406695|NCT01643044|531653068|FG001|Overall Study|Delivered outside of hospital|2|||
147406696|NCT03149042|531653069|FG000|Overall Study|Invasive FFR not performed|21|||
147406697|NCT03149042|531653069|FG000|Overall Study|Poor CT Image Quality|1|||
147406698|NCT03149042|531653069|FG000|Overall Study|Invasive FFR Measurement cancelled|1|||
147406699|NCT00790205|531653070|FG000|Overall Study|Lost to Follow-up|61|||
147406700|NCT00790205|531653071|FG001|Overall Study|Lost to Follow-up|71|||
147406701|NCT00790205|531653070|FG000|Overall Study|Withdrawal by Subject|299|||
147406702|NCT00790205|531653071|FG001|Overall Study|Withdrawal by Subject|363|||
147406703|NCT02643628|531653072|FG000|Overall Study|Lost to Follow-up|1|||
147406704|NCT02643628|531653073|FG001|Overall Study|Lost to Follow-up|4|||
147406705|NCT02643628|531653072|FG000|Overall Study|Withdrawal by Subject|0|||
147406706|NCT02643628|531653073|FG001|Overall Study|Withdrawal by Subject|1|||
147406707|NCT02643628|531653072|FG000|Overall Study|Relocated out of state|0|||
147406708|NCT02643628|531653073|FG001|Overall Study|Relocated out of state|1|||
147406709|NCT03933462|531653074|FG000|Overall Study|Adverse Event|2|||
147406710|NCT03933462|531653075|FG001|Overall Study|Adverse Event|0|||
147406711|NCT04148651|531653076|FG000|Overall Study|Lost to Follow-up|2|||
147406712|NCT02597712|531653079|FG000|Overall Study|Baseline biopsies showed indefinite for dysplasia|2|||
147406713|NCT02597712|531653080|FG001|Overall Study|Baseline biopsies showed indefinite for dysplasia|0|||
147406714|NCT02597712|531653079|FG000|Overall Study|Baseline biopsies showed low grade dysplasia|1|||
147406715|NCT02597712|531653080|FG001|Overall Study|Baseline biopsies showed low grade dysplasia|0|||
147406716|NCT02597712|531653079|FG000|Overall Study|Recurrent metastatic prostate cancer|0|||
147406717|NCT02597712|531653080|FG001|Overall Study|Recurrent metastatic prostate cancer|1|||
147406718|NCT01441635|531653081|FG000|Overall Study|Adverse Event|4|||
147406719|NCT01441635|531653082|FG001|Overall Study|Adverse Event|3|||
147406720|NCT01441635|531653083|FG002|Overall Study|Adverse Event|1|||
147406721|NCT01441635|531653084|FG003|Overall Study|Adverse Event|5|||
147406722|NCT01441635|531653085|FG004|Overall Study|Adverse Event|1|||
147406723|NCT01441635|531653086|FG005|Overall Study|Adverse Event|2|||
147406724|NCT01441635|531653087|FG006|Overall Study|Adverse Event|2|||
147406725|NCT01441635|531653088|FG007|Overall Study|Adverse Event|2|||
147406726|NCT01441635|531653089|FG008|Overall Study|Adverse Event|1|||
147406727|NCT01441635|531653090|FG009|Overall Study|Adverse Event|0|||
147406728|NCT01441635|531653081|FG000|Overall Study|Withdrawal by Subject|1|||
147406729|NCT01441635|531653082|FG001|Overall Study|Withdrawal by Subject|1|||
147406730|NCT01441635|531653083|FG002|Overall Study|Withdrawal by Subject|0|||
147406731|NCT01441635|531653084|FG003|Overall Study|Withdrawal by Subject|1|||
147406732|NCT01441635|531653085|FG004|Overall Study|Withdrawal by Subject|0|||
147406733|NCT01441635|531653086|FG005|Overall Study|Withdrawal by Subject|0|||
147406734|NCT01441635|531653087|FG006|Overall Study|Withdrawal by Subject|2|||
147406735|NCT01441635|531653088|FG007|Overall Study|Withdrawal by Subject|0|||
147406736|NCT01441635|531653089|FG008|Overall Study|Withdrawal by Subject|1|||
147406737|NCT01441635|531653090|FG009|Overall Study|Withdrawal by Subject|1|||
147406738|NCT01441635|531653081|FG000|Overall Study|Lost to Follow-up|0|||
147406739|NCT01441635|531653082|FG001|Overall Study|Lost to Follow-up|1|||
147406740|NCT01441635|531653083|FG002|Overall Study|Lost to Follow-up|1|||
147406741|NCT01441635|531653084|FG003|Overall Study|Lost to Follow-up|1|||
147406742|NCT01441635|531653085|FG004|Overall Study|Lost to Follow-up|1|||
147406743|NCT01441635|531653086|FG005|Overall Study|Lost to Follow-up|3|||
147406744|NCT01441635|531653087|FG006|Overall Study|Lost to Follow-up|1|||
147406745|NCT01441635|531653088|FG007|Overall Study|Lost to Follow-up|1|||
147406746|NCT01441635|531653089|FG008|Overall Study|Lost to Follow-up|0|||
147406747|NCT01441635|531653090|FG009|Overall Study|Lost to Follow-up|1|||
147406748|NCT01441635|531653081|FG000|Overall Study|Noncompliance|0|||
147406749|NCT01441635|531653082|FG001|Overall Study|Noncompliance|1|||
147406750|NCT01441635|531653083|FG002|Overall Study|Noncompliance|0|||
147406751|NCT01441635|531653084|FG003|Overall Study|Noncompliance|0|||
147406752|NCT01441635|531653085|FG004|Overall Study|Noncompliance|0|||
147406753|NCT01441635|531653086|FG005|Overall Study|Noncompliance|0|||
147406754|NCT01441635|531653087|FG006|Overall Study|Noncompliance|1|||
147406755|NCT01441635|531653088|FG007|Overall Study|Noncompliance|0|||
147406756|NCT01441635|531653089|FG008|Overall Study|Noncompliance|0|||
147406757|NCT01441635|531653090|FG009|Overall Study|Noncompliance|0|||
147406758|NCT01441635|531653081|FG000|Overall Study|Surgery or Invasive Intervention|0|||
147406759|NCT01441635|531653082|FG001|Overall Study|Surgery or Invasive Intervention|0|||
147406760|NCT01441635|531653083|FG002|Overall Study|Surgery or Invasive Intervention|1|||
147406761|NCT01441635|531653084|FG003|Overall Study|Surgery or Invasive Intervention|0|||
147406762|NCT01441635|531653085|FG004|Overall Study|Surgery or Invasive Intervention|0|||
147406763|NCT01441635|531653086|FG005|Overall Study|Surgery or Invasive Intervention|0|||
147406764|NCT01441635|531653087|FG006|Overall Study|Surgery or Invasive Intervention|0|||
147406765|NCT01441635|531653088|FG007|Overall Study|Surgery or Invasive Intervention|0|||
147406766|NCT01441635|531653089|FG008|Overall Study|Surgery or Invasive Intervention|0|||
147406767|NCT01441635|531653090|FG009|Overall Study|Surgery or Invasive Intervention|0|||
147406768|NCT01441635|531653081|FG000|Overall Study|Received Exclusionary Medication|1|||
147406769|NCT01441635|531653082|FG001|Overall Study|Received Exclusionary Medication|0|||
147406770|NCT01441635|531653083|FG002|Overall Study|Received Exclusionary Medication|0|||
147406771|NCT01441635|531653084|FG003|Overall Study|Received Exclusionary Medication|0|||
147406772|NCT01441635|531653085|FG004|Overall Study|Received Exclusionary Medication|0|||
147406773|NCT01441635|531653086|FG005|Overall Study|Received Exclusionary Medication|0|||
147406774|NCT01441635|531653087|FG006|Overall Study|Received Exclusionary Medication|0|||
147406775|NCT01441635|531653088|FG007|Overall Study|Received Exclusionary Medication|0|||
147406776|NCT01441635|531653089|FG008|Overall Study|Received Exclusionary Medication|0|||
147406777|NCT01441635|531653090|FG009|Overall Study|Received Exclusionary Medication|0|||
147406778|NCT01441635|531653081|FG000|Overall Study|Other|0|||
147406779|NCT01441635|531653082|FG001|Overall Study|Other|0|||
147406780|NCT01441635|531653083|FG002|Overall Study|Other|0|||
147406781|NCT01441635|531653084|FG003|Overall Study|Other|0|||
147406782|NCT01441635|531653085|FG004|Overall Study|Other|0|||
147406783|NCT01441635|531653086|FG005|Overall Study|Other|0|||
147406784|NCT01441635|531653087|FG006|Overall Study|Other|0|||
147406785|NCT01441635|531653088|FG007|Overall Study|Other|1|||
147406786|NCT01441635|531653089|FG008|Overall Study|Other|0|||
147406787|NCT01441635|531653090|FG009|Overall Study|Other|0|||
147406788|NCT02637323|531653091|FG000|Overall Study|Lost to Follow-up|2|||
147406789|NCT02637323|531653092|FG001|Overall Study|Lost to Follow-up|0|||
147406790|NCT02637323|531653091|FG000|Overall Study|Protocol Violation|0|||
147406791|NCT02637323|531653092|FG001|Overall Study|Protocol Violation|1|||
147406792|NCT00358644|531653093|FG000|Overall Study|Progressive Disease|21|||
147406793|NCT00358644|531653093|FG000|Overall Study|Adverse Event|7|||
147406794|NCT00358644|531653093|FG000|Overall Study|Death|11|||
147406795|NCT00358644|531653093|FG000|Overall Study|Withdrawal by Subject|4|||
147406796|NCT00358644|531653093|FG000|Overall Study|Physician Decision|6|||
147406797|NCT00358644|531653093|FG000|Overall Study|Patient not eligible for study|1|||
147406798|NCT00513708|531653094|FG000|Overall Study|Lost to Follow-up|4|||
147406799|NCT00513708|531653095|FG001|Overall Study|Lost to Follow-up|4|||
147406800|NCT00513708|531653096|FG002|Overall Study|Lost to Follow-up|4|||
147406801|NCT00368875|531653097|FG000|Overall Study|Adverse Event|0|||
147406802|NCT00368875|531653098|FG001|Overall Study|Adverse Event|12|||
147406803|NCT00368875|531653097|FG000|Overall Study|Progressive disease|3|||
147406804|NCT00368875|531653098|FG001|Overall Study|Progressive disease|27|||
147406805|NCT00368875|531653097|FG000|Overall Study|Withdrawal by Subject|2|||
147406806|NCT00368875|531653098|FG001|Overall Study|Withdrawal by Subject|6|||
147406807|NCT00368875|531653097|FG000|Overall Study|Other Reason|0|||
147406808|NCT00368875|531653098|FG001|Overall Study|Other Reason|2|||
147406809|NCT00368875|531653097|FG000|Overall Study|Alternative Therapy|1|||
147406810|NCT00368875|531653098|FG001|Overall Study|Alternative Therapy|1|||
147406811|NCT03327831|531653099|FG000|Overall Study|Lost to Follow-up|2|||
147406812|NCT01564277|531653100|FG000|Overall Study|Protocol Violation|0|||
147406813|NCT01564277|531653101|FG001|Overall Study|Protocol Violation|1|||
147406814|NCT01564277|531653100|FG000|Overall Study|Physician Decision|1|||
147406815|NCT01564277|531653101|FG001|Overall Study|Physician Decision|0|||
147406816|NCT02595372|531653102|FG000|Overall Study|Adverse Event|6|||
147406817|NCT02595372|531653102|FG000|Overall Study|Physician Decision|2|||
147406818|NCT02595372|531653102|FG000|Overall Study|Disease Progression|1|||
147406819|NCT00401258|531653105|FG000|Overall Study|Adverse Event|7|||
147406820|NCT01305239|531653107|FG000|Overall Study|Adverse Event|22|||
147406821|NCT01305239|531653107|FG000|Overall Study|Exemestane taken prior to inclusion only|1|||
147406822|NCT02726945|531653111|FG000|Overall Study|Withdrawal by Subject|0|||
147406823|NCT02726945|531653112|FG001|Overall Study|Withdrawal by Subject|0|||
147406824|NCT02726945|531653113|FG002|Overall Study|Withdrawal by Subject|1|||
147406825|NCT02726945|531653111|FG000|Overall Study|Elected to have total knee replacement|0|||
147616743|NCT01130532|532413655|FG000|Period III (Weeks 0-12)|Entry Criteria Not Met|4|||
147406826|NCT02726945|531653112|FG001|Overall Study|Elected to have total knee replacement|1|||
147616744|NCT01130532|532413656|FG001|Period III (Weeks 0-12)|Entry Criteria Not Met|2|||
147616745|NCT01130532|532413657|FG002|Period III (Weeks 0-12)|Entry Criteria Not Met|4|||
147406827|NCT02726945|531653113|FG002|Overall Study|Elected to have total knee replacement|0|||
147406828|NCT00699153|531655615|FG000|Overall Study|Lost to Follow-up|1|||
147406829|NCT00699153|531655616|FG001|Overall Study|Lost to Follow-up|0|||
147406830|NCT00699153|531655615|FG000|Overall Study|Adverse Event|0|||
147406831|NCT00699153|531655616|FG001|Overall Study|Adverse Event|2|||
147406832|NCT00699153|531655615|FG000|Overall Study|Protocol Violation|1|||
147406833|NCT00699153|531655616|FG001|Overall Study|Protocol Violation|0|||
147406834|NCT00699153|531655615|FG000|Overall Study|Travel Problem|1|||
147406835|NCT00699153|531655616|FG001|Overall Study|Travel Problem|0|||
147406836|NCT02870972|531655628|FG000|Overall Study|Adverse Event|1|||
147406837|NCT02870972|531655629|FG001|Overall Study|Adverse Event|0|||
147406838|NCT02870972|531655630|FG002|Overall Study|Adverse Event|0|||
147406839|NCT02870972|531655631|FG003|Overall Study|Adverse Event|0|||
147406840|NCT02870972|531655632|FG004|Overall Study|Adverse Event|0|||
147406841|NCT04497389|531655633|FG000|Overall Study|Withdrawal by Subject|1|||
147406842|NCT04497389|531655634|FG001|Overall Study|Withdrawal by Subject|0|||
147406843|NCT00789360|531655635|FG000|Overall Study|Protocol Violation|3|||
147406844|NCT00789360|531655636|FG001|Overall Study|Protocol Violation|1|||
147406845|NCT03559062|531655637|FG000|Overall Study|Other|0|||
147406846|NCT03559062|531655638|FG001|Overall Study|Other|1|||
147406847|NCT03559062|531655639|FG002|Overall Study|Other|0|||
147406848|NCT03445533|531655644|FG000|Overall Study|Progressive Disease|48|||
147406849|NCT03445533|531655645|FG001|Overall Study|Progressive Disease|81|||
147406850|NCT03445533|531655644|FG000|Overall Study|Adverse Event|60|||
147406851|NCT03445533|531655645|FG001|Overall Study|Adverse Event|64|||
147406852|NCT03445533|531655644|FG000|Overall Study|Death|9|||
147406853|NCT03445533|531655645|FG001|Overall Study|Death|19|||
147406854|NCT03445533|531655644|FG000|Overall Study|Miscellaneous|0|||
147406855|NCT03445533|531655645|FG001|Overall Study|Miscellaneous|16|||
147406856|NCT03445533|531655644|FG000|Overall Study|Withdrawal by Subject|3|||
147406857|NCT03445533|531655645|FG001|Overall Study|Withdrawal by Subject|4|||
147406858|NCT03445533|531655644|FG000|Overall Study|Physician Decision|1|||
147406859|NCT03445533|531655645|FG001|Overall Study|Physician Decision|3|||
147406860|NCT03445533|531655644|FG000|Overall Study|Sponsor Decision|0|||
147406861|NCT03445533|531655645|FG001|Overall Study|Sponsor Decision|1|||
147406862|NCT03445533|531655644|FG000|Overall Study|Lost to Follow-up|0|||
147406863|NCT03445533|531655645|FG001|Overall Study|Lost to Follow-up|1|||
147406864|NCT03445533|531655644|FG000|Overall Study|Never Received any Study Treatment|7|||
147406865|NCT03445533|531655645|FG001|Overall Study|Never Received any Study Treatment|4|||
147406866|NCT02615509|531655646|FG000|Overall Study|Lost to Follow-up|134|||
147406867|NCT02615509|531655646|FG000|Overall Study|Death|4|||
147406868|NCT02615509|531655646|FG000|Overall Study|Withdrawal by Subject|8|||
147406869|NCT03274453|531655647|FG000|Overall Study|Lost to Follow-up|2|||
147406870|NCT03274453|531655648|FG001|Overall Study|Lost to Follow-up|5|||
147406871|NCT03274453|531655649|FG002|Overall Study|Lost to Follow-up|4|||
147406872|NCT03274453|531655650|FG003|Overall Study|Lost to Follow-up|1|||
147406873|NCT03274453|531655647|FG000|Overall Study|Physician Decision|2|||
147406874|NCT03274453|531655648|FG001|Overall Study|Physician Decision|0|||
147406875|NCT03274453|531655649|FG002|Overall Study|Physician Decision|0|||
147406876|NCT03274453|531655650|FG003|Overall Study|Physician Decision|3|||
147406877|NCT03274453|531655647|FG000|Overall Study|Surgery Cancelled|0|||
147406878|NCT03274453|531655648|FG001|Overall Study|Surgery Cancelled|1|||
147406879|NCT03274453|531655649|FG002|Overall Study|Surgery Cancelled|0|||
147406880|NCT03274453|531655650|FG003|Overall Study|Surgery Cancelled|0|||
147406881|NCT00968526|531655651|FG000|Overall Study|Adverse Event|2|||
147406882|NCT00968526|531655652|FG001|Overall Study|Adverse Event|0|||
147406883|NCT00968526|531655651|FG000|Overall Study|Migrated/moved from study area|1|||
147406884|NCT00968526|531655652|FG001|Overall Study|Migrated/moved from study area|0|||
147406885|NCT03926195|531655655|FG000|DB Treatment Phase (Through Week 13)|Withdrawal by Subject|0|||
147406886|NCT03926195|531655656|FG001|DB Treatment Phase (Through Week 13)|Withdrawal by Subject|2|||
147406887|NCT03926195|531655655|FG000|EXT Phase (Through Week 156)|Adverse Event|5|||
147406888|NCT03926195|531655656|FG001|EXT Phase (Through Week 156)|Adverse Event|1|||
147406889|NCT03926195|531655655|FG000|EXT Phase (Through Week 156)|Pre-Specified Decrease In Sperm Parameters|16|||
147406890|NCT03926195|531655656|FG001|EXT Phase (Through Week 156)|Pre-Specified Decrease In Sperm Parameters|17|||
147406891|NCT03926195|531655655|FG000|EXT Phase (Through Week 156)|Withdrawal by Subject|1|||
147406892|NCT03926195|531655656|FG001|EXT Phase (Through Week 156)|Withdrawal by Subject|3|||
147406893|NCT03926195|531655655|FG000|EXT Phase (Through Week 156)|Physician Decision|0|||
147406894|NCT03926195|531655656|FG001|EXT Phase (Through Week 156)|Physician Decision|2|||
147406895|NCT03926195|531655655|FG000|Monitoring Phase (52 Weeks)|Withdrawal by Subject|0|||
147406896|NCT03926195|531655656|FG001|Monitoring Phase (52 Weeks)|Withdrawal by Subject|1|||
147406897|NCT01967069|531655658|FG000|Overall Study|Adverse Event|2|||
147406898|NCT01967069|531655659|FG001|Overall Study|Adverse Event|2|||
147406899|NCT01967069|531655658|FG000|Overall Study|Lost to Follow-up|5|||
147406900|NCT01967069|531655659|FG001|Overall Study|Lost to Follow-up|2|||
147406901|NCT01967069|531655658|FG000|Overall Study|Withdrawal by Subject|1|||
147406902|NCT01967069|531655659|FG001|Overall Study|Withdrawal by Subject|3|||
147406903|NCT01967069|531655658|FG000|Overall Study|Lack of Efficacy|0|||
147406904|NCT01967069|531655659|FG001|Overall Study|Lack of Efficacy|1|||
147406905|NCT01689857|531655661|FG000|Overall Study|Lost to Follow-up|5|||
147406906|NCT01689857|531655662|FG001|Overall Study|Lost to Follow-up|2|||
147406907|NCT00874731|531655663|FG000|Part 1, Day 1: Placebo|Disease Progression|1|||
147406908|NCT00874731|531655664|FG001|Part 1, Day 1: Placebo|Disease Progression|0|||
147406909|NCT00874731|531655665|FG002|Part 1, Day 1: Placebo|Disease Progression|0|||
147406910|NCT00874731|531655663|FG000|Part 2: Ridaforolimus 40 mg|Adverse Event|0|||
147406911|NCT00874731|531655664|FG001|Part 2: Ridaforolimus 40 mg|Adverse Event|0|||
147406912|NCT00874731|531655665|FG002|Part 2: Ridaforolimus 40 mg|Adverse Event|3|||
147406913|NCT00874731|531655663|FG000|Part 2: Ridaforolimus 40 mg|Disease Progression|0|||
147406914|NCT00874731|531655664|FG001|Part 2: Ridaforolimus 40 mg|Disease Progression|0|||
147406915|NCT00874731|531655665|FG002|Part 2: Ridaforolimus 40 mg|Disease Progression|19|||
147406916|NCT01736540|531655669|FG000|Overall Study|Did not complete scan within 45 days|2|||
147406917|NCT01736540|531655669|FG000|Overall Study|Death|1|||
147406918|NCT01736540|531655669|FG000|Overall Study|Abnormal test procedure|1|||
147406919|NCT01736540|531655669|FG000|Overall Study|Withdrawal by Subject|5|||
147406920|NCT01736540|531655669|FG000|Overall Study|Protocol Violation|1|||
147406921|NCT01736540|531655669|FG000|Overall Study|Unable to tolerate MRI; claustrophobic|1|||
147406922|NCT01736540|531655669|FG000|Overall Study|No show for MRI appointment|1|||
147406923|NCT01736540|531655669|FG000|Overall Study|Unable to make MRI appointment|3|||
147406924|NCT00479882|531655670|FG000|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|96|||
147406925|NCT00479882|531655671|FG001|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|99|||
147406926|NCT00479882|531655672|FG002|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|98|||
147406927|NCT00479882|531655673|FG003|Precrossover: Periods I/II (Weeks 1-12)|Clinical Adverse Event|87|||
147406928|NCT00479882|531655670|FG000|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|0|||
147406929|NCT00479882|531655671|FG001|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|4|||
147406930|NCT00479882|531655672|FG002|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|4|||
147406931|NCT00479882|531655673|FG003|Precrossover: Periods I/II (Weeks 1-12)|Laboratory Adverse Event|4|||
147406932|NCT00479882|531655670|FG000|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|12|||
147406933|NCT00479882|531655671|FG001|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|9|||
147406934|NCT00479882|531655672|FG002|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|9|||
147406935|NCT00479882|531655673|FG003|Precrossover: Periods I/II (Weeks 1-12)|Lost to Follow-up|11|||
147406936|NCT00479882|531655670|FG000|Precrossover: Periods I/II (Weeks 1-12)|Other|4|||
147406937|NCT00479882|531655671|FG001|Precrossover: Periods I/II (Weeks 1-12)|Other|6|||
147406938|NCT00479882|531655672|FG002|Precrossover: Periods I/II (Weeks 1-12)|Other|9|||
147406939|NCT00479882|531655673|FG003|Precrossover: Periods I/II (Weeks 1-12)|Other|5|||
147406940|NCT00479882|531655670|FG000|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|0|||
147406941|NCT00479882|531655671|FG001|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|4|||
147406942|NCT00479882|531655672|FG002|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|2|||
147406943|NCT00479882|531655673|FG003|Precrossover: Periods I/II (Weeks 1-12)|Participant moved|1|||
147406944|NCT00479882|531655670|FG000|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|24|||
147406945|NCT00479882|531655671|FG001|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|33|||
147406946|NCT00479882|531655672|FG002|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|30|||
147406947|NCT00479882|531655673|FG003|Precrossover: Periods I/II (Weeks 1-12)|Withdrawal by Subject|25|||
147406948|NCT00479882|531655670|FG000|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|2|||
147406949|NCT00479882|531655671|FG001|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|7|||
147406950|NCT00479882|531655672|FG002|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|5|||
147406951|NCT00479882|531655673|FG003|Precrossover: Periods I/II (Weeks 1-12)|Protocol Violation|7|||
147406952|NCT00479882|531655670|FG000|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|12|||
147406953|NCT00479882|531655671|FG001|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|13|||
147406954|NCT00479882|531655672|FG002|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|12|||
147406955|NCT00479882|531655673|FG003|Crossover: Period III (Weeks 13-20)|Clinical Adverse Event|10|||
147406956|NCT00479882|531655670|FG000|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|3|||
147406957|NCT00479882|531655671|FG001|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|1|||
147406958|NCT00479882|531655672|FG002|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|2|||
147406959|NCT00479882|531655673|FG003|Crossover: Period III (Weeks 13-20)|Laboratory Adverse Event|2|||
147406960|NCT00479882|531655670|FG000|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|1|||
147406961|NCT00479882|531655671|FG001|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|2|||
147406962|NCT00479882|531655672|FG002|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|1|||
147406963|NCT00479882|531655673|FG003|Crossover: Period III (Weeks 13-20)|Lost to Follow-up|1|||
147406964|NCT00479882|531655670|FG000|Crossover: Period III (Weeks 13-20)|Other|5|||
147406965|NCT00479882|531655671|FG001|Crossover: Period III (Weeks 13-20)|Other|0|||
147406966|NCT00479882|531655672|FG002|Crossover: Period III (Weeks 13-20)|Other|2|||
147406967|NCT00479882|531655673|FG003|Crossover: Period III (Weeks 13-20)|Other|2|||
147406968|NCT00479882|531655670|FG000|Crossover: Period III (Weeks 13-20)|Participant moved|1|||
147406969|NCT00479882|531655671|FG001|Crossover: Period III (Weeks 13-20)|Participant moved|2|||
147406970|NCT00479882|531655672|FG002|Crossover: Period III (Weeks 13-20)|Participant moved|1|||
147464552|NCT00896532|531860300|FG019|Months 36-48: Romosozumab Retreatment|Other|0|||
147464553|NCT00896532|531860301|FG020|Months 36-48: Romosozumab Retreatment|Other|0|||
147464554|NCT00896532|531860302|FG021|Months 36-48: Romosozumab Retreatment|Other|0|||
147464555|NCT00896532|531860303|FG022|Months 36-48: Romosozumab Retreatment|Other|0|||
147644001|NCT01447446|532516687|FG001|Overall Study|SVR12 Assessment|1|||
147406971|NCT00479882|531655673|FG003|Crossover: Period III (Weeks 13-20)|Participant moved|0|||
147406972|NCT00479882|531655670|FG000|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|3|||
147406973|NCT00479882|531655671|FG001|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|3|||
147406974|NCT00479882|531655672|FG002|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|1|||
147406975|NCT00479882|531655673|FG003|Crossover: Period III (Weeks 13-20)|Withdrawal by Subject|3|||
147406976|NCT00479882|531655670|FG000|Crossover: Period III (Weeks 13-20)|Protocol Violation|0|||
147406977|NCT00479882|531655671|FG001|Crossover: Period III (Weeks 13-20)|Protocol Violation|0|||
147406978|NCT00479882|531655672|FG002|Crossover: Period III (Weeks 13-20)|Protocol Violation|1|||
147406979|NCT00479882|531655673|FG003|Crossover: Period III (Weeks 13-20)|Protocol Violation|0|||
147406980|NCT03004404|531655690|FG000|Period 2|Adverse Event|0|||
147406981|NCT03004404|531655691|FG001|Period 2|Adverse Event|0|||
147406982|NCT03004404|531655692|FG002|Period 2|Adverse Event|0|||
147406983|NCT03004404|531655693|FG003|Period 2|Adverse Event|0|||
147406984|NCT03004404|531655694|FG004|Period 2|Adverse Event|0|||
147406985|NCT03004404|531655695|FG005|Period 2|Adverse Event|0|||
147406986|NCT03004404|531655696|FG006|Period 2|Adverse Event|0|||
147406987|NCT03004404|531655697|FG007|Period 2|Adverse Event|0|||
147406988|NCT03004404|531655698|FG008|Period 2|Adverse Event|1|||
147406989|NCT03004404|531655699|FG009|Period 2|Adverse Event|0|||
147406990|NCT03004404|531655700|FG010|Period 2|Adverse Event|0|||
147406991|NCT03004404|531655701|FG011|Period 2|Adverse Event|0|||
147406992|NCT03004404|531655702|FG012|Period 2|Adverse Event|0|||
147406993|NCT03004404|531655703|FG013|Period 2|Adverse Event|0|||
147406994|NCT03004404|531655704|FG014|Period 2|Adverse Event|0|||
147406995|NCT03004404|531655705|FG015|Period 2|Adverse Event|1|||
147406996|NCT02522728|531655709|FG000|Overall Study|Withdrawal by Subject|6|||
147406997|NCT02522728|531655710|FG001|Overall Study|Withdrawal by Subject|6|||
147406998|NCT02522728|531655709|FG000|Overall Study|Death|4|||
147406999|NCT02522728|531655710|FG001|Overall Study|Death|3|||
147407000|NCT02522728|531655709|FG000|Overall Study|Adverse Event|2|||
147407001|NCT02522728|531655710|FG001|Overall Study|Adverse Event|1|||
147407002|NCT02522728|531655709|FG000|Overall Study|Did not receive randomized study device|0|||
147407003|NCT02522728|531655710|FG001|Overall Study|Did not receive randomized study device|1|||
147407004|NCT01266161|531655718|FG000|Overall Study|Ineligible|1|||
147407005|NCT01266161|531655719|FG001|Overall Study|Ineligible|0|||
147407006|NCT01266161|531655718|FG000|Overall Study|Lack of Efficacy|0|||
147407007|NCT01266161|531655719|FG001|Overall Study|Lack of Efficacy|1|||
147407008|NCT01266161|531655718|FG000|Overall Study|Vomited within 4 hours of dosing|3|||
147407009|NCT01266161|531655719|FG001|Overall Study|Vomited within 4 hours of dosing|0|||
147407010|NCT02990468|531655720|FG000|Phase 2: MTD|Change in treatment|0|||
147407011|NCT02990468|531655721|FG001|Phase 2: MTD|Change in treatment|0|||
147407012|NCT02990468|531655722|FG002|Phase 2: MTD|Change in treatment|1|||
147407013|NCT01436305|531655724|FG000|Overall Study|Death|1|||
147407014|NCT01436305|531655725|FG001|Overall Study|Death|0|||
147407015|NCT01436305|531655726|FG002|Overall Study|Death|0|||
147407016|NCT01436305|531655724|FG000|Overall Study|Lost to Follow-up|0|||
147407017|NCT01436305|531655725|FG001|Overall Study|Lost to Follow-up|1|||
147407018|NCT01436305|531655726|FG002|Overall Study|Lost to Follow-up|0|||
147407019|NCT01436305|531655724|FG000|Overall Study|Withdrawal by Subject|1|||
147407020|NCT01436305|531655725|FG001|Overall Study|Withdrawal by Subject|3|||
147407021|NCT01436305|531655726|FG002|Overall Study|Withdrawal by Subject|0|||
147407022|NCT03690427|531655734|FG000|Overall Study|Requested by subject not to complete traditional hookah|0|||
147407023|NCT03690427|531655735|FG001|Overall Study|Requested by subject not to complete traditional hookah|2|||
147407024|NCT03519204|531655739|FG000|Overall Study|Lost to Follow-up|3|||
147407025|NCT03519204|531655740|FG001|Overall Study|Lost to Follow-up|8|||
147407026|NCT03519204|531655739|FG000|Overall Study|Withdrawal by Subject|9|||
147407027|NCT03519204|531655740|FG001|Overall Study|Withdrawal by Subject|7|||
147407028|NCT03519204|531655739|FG000|Overall Study|Other Miscellaneous Reasons|1|||
147407029|NCT03519204|531655740|FG001|Overall Study|Other Miscellaneous Reasons|0|||
147407030|NCT02609672|531655741|FG000|Overall Study|Lost to Follow-up|3|||
147407031|NCT02609672|531655742|FG001|Overall Study|Lost to Follow-up|1|||
147407032|NCT03392168|531655743|FG000|Period 2: Cohort 2|Lost to Follow-up|0|||
147407033|NCT03392168|531655744|FG001|Period 2: Cohort 2|Lost to Follow-up|1|||
147407034|NCT03392168|531655745|FG002|Period 2: Cohort 2|Lost to Follow-up|1|||
147407035|NCT03392168|531655746|FG003|Period 2: Cohort 2|Lost to Follow-up|1|||
147407036|NCT03392168|531655743|FG000|Period 2: Cohort 2|Other|0|||
147407037|NCT03392168|531655744|FG001|Period 2: Cohort 2|Other|1|||
147407038|NCT03392168|531655745|FG002|Period 2: Cohort 2|Other|0|||
147407039|NCT03392168|531655746|FG003|Period 2: Cohort 2|Other|0|||
147407040|NCT01721954|531655748|FG000|Overall Study|Death|58|||
147464556|NCT00896532|531860281|FG000|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
147407041|NCT01721954|531655749|FG001|Overall Study|Death|64|||
147407042|NCT01721954|531655748|FG000|Overall Study|Withdrawal by Subject|8|||
147407043|NCT01721954|531655749|FG001|Overall Study|Withdrawal by Subject|4|||
147407044|NCT01721954|531655748|FG000|Overall Study|Adverse Event|2|||
147407045|NCT01721954|531655749|FG001|Overall Study|Adverse Event|0|||
147407046|NCT01721954|531655748|FG000|Overall Study|Lost to Follow-up|2|||
147407047|NCT01721954|531655749|FG001|Overall Study|Lost to Follow-up|1|||
147407048|NCT02956837|531655752|FG000|Overall Study|Serious Adverse Events|0|||
147407049|NCT02956837|531655753|FG001|Overall Study|Serious Adverse Events|1|||
147407050|NCT02956837|531655754|FG002|Overall Study|Serious Adverse Events|0|||
147407051|NCT02956837|531655755|FG003|Overall Study|Serious Adverse Events|0|||
147407052|NCT02956837|531655752|FG000|Overall Study|Withdrawal by Subject|0|||
147407053|NCT02956837|531655753|FG001|Overall Study|Withdrawal by Subject|1|||
147407054|NCT02956837|531655754|FG002|Overall Study|Withdrawal by Subject|0|||
147407055|NCT02956837|531655755|FG003|Overall Study|Withdrawal by Subject|3|||
147407056|NCT02956837|531655752|FG000|Overall Study|Lost to Follow-up|0|||
147407057|NCT02956837|531655753|FG001|Overall Study|Lost to Follow-up|1|||
147407058|NCT02956837|531655754|FG002|Overall Study|Lost to Follow-up|2|||
147407059|NCT02956837|531655755|FG003|Overall Study|Lost to Follow-up|0|||
147407060|NCT01727505|531655760|FG000|First 24 Hours|Adverse Event|0|||
147407061|NCT01727505|531655761|FG001|First 24 Hours|Adverse Event|1|||
147407062|NCT01727505|531655760|FG000|Second 24 Hours|Missing data|0|||
147407063|NCT01727505|531655761|FG001|Second 24 Hours|Missing data|1|||
147407064|NCT01594970|531655762|FG000|Overall Study|Non-Adverse Event Related|4|||
147407065|NCT01594970|531655763|FG001|Overall Study|Non-Adverse Event Related|5|||
147407066|NCT01594970|531655764|FG002|Overall Study|Non-Adverse Event Related|6|||
147407067|NCT01594970|531655762|FG000|Overall Study|Adverse Event|17|||
147407068|NCT01594970|531655763|FG001|Overall Study|Adverse Event|23|||
147407069|NCT01594970|531655764|FG002|Overall Study|Adverse Event|23|||
147407070|NCT01594970|531655762|FG000|Overall Study|Lost to Follow-up|54|||
147407071|NCT01594970|531655763|FG001|Overall Study|Lost to Follow-up|54|||
147407072|NCT01594970|531655764|FG002|Overall Study|Lost to Follow-up|37|||
147407073|NCT01427725|531655765|FG000|Overall Study|Lost to Follow-up|17|||
147407074|NCT01427725|531655765|FG000|Overall Study|Protocol Violation|1|||
147407075|NCT01427725|531655765|FG000|Overall Study|Drug not administered|1|||
147407076|NCT01427725|531655765|FG000|Overall Study|Failure to visit|7|||
147407077|NCT01427725|531655765|FG000|Overall Study|Adverse Event|46|||
147407078|NCT01427725|531655765|FG000|Overall Study|Failure to visit after administration|40|||
147407079|NCT01427725|531655765|FG000|Overall Study|Patient's rejection|27|||
147407080|NCT01427725|531655765|FG000|Overall Study|Transfer to a different hospital|17|||
147407081|NCT01427725|531655765|FG000|Overall Study|Lack of Efficacy|8|||
147407082|NCT01427725|531655765|FG000|Overall Study|Death|7|||
147407083|NCT01427725|531655765|FG000|Overall Study|Symptom improvement|6|||
147407084|NCT01427725|531655765|FG000|Overall Study|AE and Patient's rejection|5|||
147407085|NCT01427725|531655765|FG000|Overall Study|Physician Decision|5|||
147407086|NCT01427725|531655765|FG000|Overall Study|Exacerbation of underlying disease|5|||
147407087|NCT01427725|531655765|FG000|Overall Study|Oral feeding difficulty|5|||
147407088|NCT01427725|531655765|FG000|Overall Study|Lack of Efficacy and Patient's rejection|1|||
147407089|NCT01427725|531655765|FG000|Overall Study|Forgetting prescription|1|||
147407090|NCT01427725|531655765|FG000|Overall Study|Other|2|||
147407091|NCT01299480|531655766|FG000|Overall Study|No longer willing to participate|19|||
147407092|NCT01299480|531655767|FG001|Overall Study|No longer willing to participate|17|||
147407093|NCT01299480|531655768|FG002|Overall Study|No longer willing to participate|14|||
147407094|NCT01299480|531655769|FG003|Overall Study|No longer willing to participate|13|||
147407095|NCT01299480|531655770|FG004|Overall Study|No longer willing to participate|10|||
147407096|NCT01299480|531655766|FG000|Overall Study|Protocol Violation|7|||
147407097|NCT01299480|531655767|FG001|Overall Study|Protocol Violation|5|||
147407098|NCT01299480|531655768|FG002|Overall Study|Protocol Violation|8|||
147407099|NCT01299480|531655769|FG003|Overall Study|Protocol Violation|1|||
147407100|NCT01299480|531655770|FG004|Overall Study|Protocol Violation|1|||
147407101|NCT01299480|531655766|FG000|Overall Study|Withdrawal by Subject|3|||
147407102|NCT01299480|531655767|FG001|Overall Study|Withdrawal by Subject|4|||
147407103|NCT01299480|531655768|FG002|Overall Study|Withdrawal by Subject|7|||
147407104|NCT01299480|531655769|FG003|Overall Study|Withdrawal by Subject|3|||
147407105|NCT01299480|531655770|FG004|Overall Study|Withdrawal by Subject|4|||
147407106|NCT01299480|531655766|FG000|Overall Study|Adverse Event|6|||
147407107|NCT01299480|531655767|FG001|Overall Study|Adverse Event|4|||
147407108|NCT01299480|531655768|FG002|Overall Study|Adverse Event|5|||
147407109|NCT01299480|531655769|FG003|Overall Study|Adverse Event|4|||
147407110|NCT01299480|531655770|FG004|Overall Study|Adverse Event|0|||
147407111|NCT01299480|531655766|FG000|Overall Study|Withdrawal due to pregnancy|0|||
147407112|NCT01299480|531655767|FG001|Overall Study|Withdrawal due to pregnancy|1|||
147407113|NCT01299480|531655768|FG002|Overall Study|Withdrawal due to pregnancy|1|||
147407114|NCT01299480|531655769|FG003|Overall Study|Withdrawal due to pregnancy|0|||
147407115|NCT01299480|531655770|FG004|Overall Study|Withdrawal due to pregnancy|0|||
147407116|NCT01299480|531655766|FG000|Overall Study|Physician Decision|1|||
147407117|NCT01299480|531655767|FG001|Overall Study|Physician Decision|1|||
147407118|NCT01299480|531655768|FG002|Overall Study|Physician Decision|0|||
147407119|NCT01299480|531655769|FG003|Overall Study|Physician Decision|2|||
147407120|NCT01299480|531655770|FG004|Overall Study|Physician Decision|0|||
147407121|NCT01299480|531655766|FG000|Overall Study|Lost to Follow-up|3|||
147407122|NCT01299480|531655767|FG001|Overall Study|Lost to Follow-up|1|||
147407123|NCT01299480|531655768|FG002|Overall Study|Lost to Follow-up|2|||
147407124|NCT01299480|531655769|FG003|Overall Study|Lost to Follow-up|1|||
147407125|NCT01299480|531655770|FG004|Overall Study|Lost to Follow-up|2|||
147407126|NCT01299480|531655766|FG000|Overall Study|Other|3|||
147407127|NCT01299480|531655767|FG001|Overall Study|Other|2|||
147407128|NCT01299480|531655768|FG002|Overall Study|Other|3|||
147407129|NCT01299480|531655769|FG003|Overall Study|Other|0|||
147407130|NCT01299480|531655770|FG004|Overall Study|Other|3|||
147407131|NCT01299480|531655766|FG000|Overall Study|Started, but not vaccinated|0|||
147407132|NCT01299480|531655767|FG001|Overall Study|Started, but not vaccinated|0|||
147407133|NCT01299480|531655768|FG002|Overall Study|Started, but not vaccinated|1|||
147407134|NCT01299480|531655769|FG003|Overall Study|Started, but not vaccinated|1|||
147407135|NCT01299480|531655770|FG004|Overall Study|Started, but not vaccinated|0|||
147407136|NCT01430468|531655777|FG000|Overall Study|Physician Decision|2|||
147407137|NCT01430468|531655778|FG001|Overall Study|Physician Decision|1|||
147407138|NCT01430468|531655777|FG000|Overall Study|Withdrawal by Subject|5|||
147407139|NCT01430468|531655778|FG001|Overall Study|Withdrawal by Subject|5|||
147407140|NCT01281839|531655779|FG000|Overall Study|Lost to Follow-up|6|||
147407141|NCT01281839|531655780|FG001|Overall Study|Lost to Follow-up|3|||
147407142|NCT01281839|531655779|FG000|Overall Study|Withdrawal by Subject|4|||
147407143|NCT01281839|531655780|FG001|Overall Study|Withdrawal by Subject|10|||
147407144|NCT01281839|531655779|FG000|Overall Study|Reason not specified|0|||
147407145|NCT01281839|531655780|FG001|Overall Study|Reason not specified|1|||
147407146|NCT00617929|531655782|FG000|Overall Study|Physician Decision|1|||
147407147|NCT03229486|531655783|FG000|Overall Study|Protocol Violation|0|||
147407148|NCT03229486|531655784|FG001|Overall Study|Protocol Violation|1|||
147407149|NCT04855734|531655792|FG000|Overall Study|Lost to Follow-up|2|||
147407150|NCT04855734|531655793|FG001|Overall Study|Lost to Follow-up|2|||
147407151|NCT04535544|531655794|FG000|Double-blind (Day 1 up to Week 52)|Lost to Follow-up|0|||
147407152|NCT04535544|531655795|FG001|Double-blind (Day 1 up to Week 52)|Lost to Follow-up|0|||
147407153|NCT04535544|531655796|FG002|Double-blind (Day 1 up to Week 52)|Lost to Follow-up|1|||
147407154|NCT04535544|531655797|FG003|Double-blind (Day 1 up to Week 52)|Lost to Follow-up|0|||
147407155|NCT04535544|531655794|FG000|Double-blind (Day 1 up to Week 52)|Withdrawal by Subject|1|||
147407156|NCT04535544|531655795|FG001|Double-blind (Day 1 up to Week 52)|Withdrawal by Subject|0|||
147407157|NCT04535544|531655796|FG002|Double-blind (Day 1 up to Week 52)|Withdrawal by Subject|2|||
147407158|NCT04535544|531655797|FG003|Double-blind (Day 1 up to Week 52)|Withdrawal by Subject|0|||
147407159|NCT04535544|531655794|FG000|Double-blind (Day 1 up to Week 52)|Ongoing after Week 48|0|||
147407160|NCT04535544|531655795|FG001|Double-blind (Day 1 up to Week 52)|Ongoing after Week 48|0|||
147407161|NCT04535544|531655796|FG002|Double-blind (Day 1 up to Week 52)|Ongoing after Week 48|1|||
147407162|NCT04535544|531655797|FG003|Double-blind (Day 1 up to Week 52)|Ongoing after Week 48|1|||
147407163|NCT04535544|531655794|FG000|Open-label (Week 52 up to Week 148)|Withdrawal by Subject|0|||
147407164|NCT04535544|531655795|FG001|Open-label (Week 52 up to Week 148)|Withdrawal by Subject|1|||
147407165|NCT04535544|531655796|FG002|Open-label (Week 52 up to Week 148)|Withdrawal by Subject|0|||
147407166|NCT04535544|531655797|FG003|Open-label (Week 52 up to Week 148)|Withdrawal by Subject|1|||
147407167|NCT04535544|531655794|FG000|Open-label (Week 52 up to Week 148)|Ongoing|0|||
147407168|NCT04535544|531655795|FG001|Open-label (Week 52 up to Week 148)|Ongoing|1|||
147407169|NCT04535544|531655796|FG002|Open-label (Week 52 up to Week 148)|Ongoing|14|||
147407170|NCT04535544|531655797|FG003|Open-label (Week 52 up to Week 148)|Ongoing|4|||
147407171|NCT04535544|531655794|FG000|Follow-up (Week 148 up to Week 161)|Withdrawal by Subject|5|||
147407172|NCT04535544|531655795|FG001|Follow-up (Week 148 up to Week 161)|Withdrawal by Subject|0|||
147407173|NCT04535544|531655796|FG002|Follow-up (Week 148 up to Week 161)|Withdrawal by Subject|4|||
147407174|NCT04535544|531655797|FG003|Follow-up (Week 148 up to Week 161)|Withdrawal by Subject|0|||
147407175|NCT04535544|531655794|FG000|Follow-up (Week 148 up to Week 161)|Ongoing|4|||
147407176|NCT04535544|531655795|FG001|Follow-up (Week 148 up to Week 161)|Ongoing|0|||
147407177|NCT04535544|531655796|FG002|Follow-up (Week 148 up to Week 161)|Ongoing|0|||
147407178|NCT04535544|531655797|FG003|Follow-up (Week 148 up to Week 161)|Ongoing|0|||
147407179|NCT04535544|531655794|FG000|Follow-up (Week 148 up to Week 161)|Other|0|||
147407180|NCT04535544|531655795|FG001|Follow-up (Week 148 up to Week 161)|Other|0|||
147407181|NCT04535544|531655796|FG002|Follow-up (Week 148 up to Week 161)|Other|1|||
147407182|NCT04535544|531655797|FG003|Follow-up (Week 148 up to Week 161)|Other|0|||
147407183|NCT00344032|531655798|FG000|Overall Study|Adverse Event|0|||
147407184|NCT00344032|531655799|FG001|Overall Study|Adverse Event|1|||
147407185|NCT00344032|531655798|FG000|Overall Study|Withdrawal by Subject|6|||
147407186|NCT00344032|531655799|FG001|Overall Study|Withdrawal by Subject|2|||
147407187|NCT00344032|531655798|FG000|Overall Study|Lost to Follow-up|4|||
147407188|NCT00344032|531655799|FG001|Overall Study|Lost to Follow-up|6|||
147407189|NCT00344032|531655798|FG000|Overall Study|Physician Decision|4|||
147407190|NCT00344032|531655799|FG001|Overall Study|Physician Decision|1|||
147407191|NCT05131477|531655806|FG000|PART 1|Withdrawal by Subject|2|||
147407192|NCT05131477|531655807|FG001|PART 1|Withdrawal by Subject|9|||
147407193|NCT05131477|531655808|FG002|PART 1|Withdrawal by Subject|6|||
147407194|NCT05131477|531655809|FG003|PART 1|Withdrawal by Subject|2|||
147407195|NCT05131477|531655810|FG004|PART 1|Withdrawal by Subject|8|||
147407196|NCT05131477|531655811|FG005|PART 1|Withdrawal by Subject|0|||
147407197|NCT05131477|531655812|FG006|PART 1|Withdrawal by Subject|0|||
147407198|NCT05131477|531655813|FG007|PART 1|Withdrawal by Subject|0|||
147407199|NCT05131477|531655814|FG008|PART 1|Withdrawal by Subject|0|||
147407200|NCT05131477|531655815|FG009|PART 1|Withdrawal by Subject|0|||
147407201|NCT05131477|531655816|FG010|PART 1|Withdrawal by Subject|0|||
147407202|NCT05131477|531655817|FG011|PART 1|Withdrawal by Subject|0|||
147407203|NCT05131477|531655818|FG012|PART 1|Withdrawal by Subject|0|||
147407204|NCT05131477|531655819|FG013|PART 1|Withdrawal by Subject|0|||
147407205|NCT05131477|531655806|FG000|PART 1|Physician Decision|1|||
147407206|NCT05131477|531655807|FG001|PART 1|Physician Decision|0|||
147407207|NCT05131477|531655808|FG002|PART 1|Physician Decision|0|||
147407208|NCT05131477|531655809|FG003|PART 1|Physician Decision|0|||
147407209|NCT05131477|531655810|FG004|PART 1|Physician Decision|0|||
147407210|NCT05131477|531655811|FG005|PART 1|Physician Decision|0|||
147407211|NCT05131477|531655812|FG006|PART 1|Physician Decision|0|||
147407212|NCT05131477|531655813|FG007|PART 1|Physician Decision|0|||
147407213|NCT05131477|531655814|FG008|PART 1|Physician Decision|0|||
147407214|NCT05131477|531655815|FG009|PART 1|Physician Decision|0|||
147407215|NCT05131477|531655816|FG010|PART 1|Physician Decision|0|||
147407216|NCT05131477|531655817|FG011|PART 1|Physician Decision|0|||
147407217|NCT05131477|531655818|FG012|PART 1|Physician Decision|0|||
147407218|NCT05131477|531655819|FG013|PART 1|Physician Decision|0|||
147407219|NCT05131477|531655806|FG000|PART 1|Adverse Event|3|||
147407220|NCT05131477|531655807|FG001|PART 1|Adverse Event|5|||
147407221|NCT05131477|531655808|FG002|PART 1|Adverse Event|1|||
147407222|NCT05131477|531655809|FG003|PART 1|Adverse Event|6|||
147407223|NCT05131477|531655810|FG004|PART 1|Adverse Event|4|||
147407224|NCT05131477|531655811|FG005|PART 1|Adverse Event|0|||
147407225|NCT05131477|531655812|FG006|PART 1|Adverse Event|0|||
147407226|NCT05131477|531655813|FG007|PART 1|Adverse Event|0|||
147407227|NCT05131477|531655814|FG008|PART 1|Adverse Event|0|||
147407228|NCT05131477|531655815|FG009|PART 1|Adverse Event|0|||
147407229|NCT05131477|531655816|FG010|PART 1|Adverse Event|0|||
147407230|NCT05131477|531655817|FG011|PART 1|Adverse Event|0|||
147407231|NCT05131477|531655818|FG012|PART 1|Adverse Event|0|||
147407232|NCT05131477|531655819|FG013|PART 1|Adverse Event|0|||
147407233|NCT05131477|531655806|FG000|PART 1|unclassified|1|||
147407234|NCT05131477|531655807|FG001|PART 1|unclassified|1|||
147407235|NCT05131477|531655808|FG002|PART 1|unclassified|0|||
147407236|NCT05131477|531655809|FG003|PART 1|unclassified|0|||
147407237|NCT05131477|531655810|FG004|PART 1|unclassified|4|||
147407238|NCT05131477|531655811|FG005|PART 1|unclassified|0|||
147407239|NCT05131477|531655812|FG006|PART 1|unclassified|0|||
147407240|NCT05131477|531655813|FG007|PART 1|unclassified|0|||
147407241|NCT05131477|531655814|FG008|PART 1|unclassified|0|||
147407242|NCT05131477|531655815|FG009|PART 1|unclassified|0|||
147407243|NCT05131477|531655816|FG010|PART 1|unclassified|0|||
147407244|NCT05131477|531655817|FG011|PART 1|unclassified|0|||
147407245|NCT05131477|531655818|FG012|PART 1|unclassified|0|||
147407246|NCT05131477|531655819|FG013|PART 1|unclassified|0|||
147407247|NCT05131477|531655806|FG000|PART 1|Randomized and not treated|0|||
147407248|NCT05131477|531655807|FG001|PART 1|Randomized and not treated|0|||
147407249|NCT05131477|531655808|FG002|PART 1|Randomized and not treated|0|||
147407250|NCT05131477|531655809|FG003|PART 1|Randomized and not treated|1|||
147407251|NCT05131477|531655810|FG004|PART 1|Randomized and not treated|1|||
147407252|NCT05131477|531655811|FG005|PART 1|Randomized and not treated|0|||
147407253|NCT05131477|531655812|FG006|PART 1|Randomized and not treated|0|||
147407254|NCT05131477|531655813|FG007|PART 1|Randomized and not treated|0|||
147407255|NCT05131477|531655814|FG008|PART 1|Randomized and not treated|0|||
147407256|NCT05131477|531655815|FG009|PART 1|Randomized and not treated|0|||
147407257|NCT05131477|531655816|FG010|PART 1|Randomized and not treated|0|||
147407258|NCT05131477|531655817|FG011|PART 1|Randomized and not treated|0|||
147407259|NCT05131477|531655818|FG012|PART 1|Randomized and not treated|0|||
147407260|NCT05131477|531655819|FG013|PART 1|Randomized and not treated|0|||
147407261|NCT05131477|531655806|FG000|PART 1|Protocol Violation|2|||
147407262|NCT05131477|531655807|FG001|PART 1|Protocol Violation|0|||
147407263|NCT05131477|531655808|FG002|PART 1|Protocol Violation|0|||
147644002|NCT01447446|532516688|FG002|Overall Study|SVR12 Assessment|2|||
147407264|NCT05131477|531655809|FG003|PART 1|Protocol Violation|1|||
147407265|NCT05131477|531655810|FG004|PART 1|Protocol Violation|0|||
147407266|NCT05131477|531655811|FG005|PART 1|Protocol Violation|0|||
147407267|NCT05131477|531655812|FG006|PART 1|Protocol Violation|0|||
147407268|NCT05131477|531655813|FG007|PART 1|Protocol Violation|0|||
147407269|NCT05131477|531655814|FG008|PART 1|Protocol Violation|0|||
147407270|NCT05131477|531655815|FG009|PART 1|Protocol Violation|0|||
147407271|NCT05131477|531655816|FG010|PART 1|Protocol Violation|0|||
147407272|NCT05131477|531655817|FG011|PART 1|Protocol Violation|0|||
147407273|NCT05131477|531655818|FG012|PART 1|Protocol Violation|0|||
147407274|NCT05131477|531655819|FG013|PART 1|Protocol Violation|0|||
147407275|NCT05131477|531655806|FG000|PART 1|Lack of Efficacy|0|||
147407276|NCT05131477|531655807|FG001|PART 1|Lack of Efficacy|1|||
147407277|NCT05131477|531655808|FG002|PART 1|Lack of Efficacy|1|||
147407278|NCT05131477|531655809|FG003|PART 1|Lack of Efficacy|2|||
147407279|NCT05131477|531655810|FG004|PART 1|Lack of Efficacy|5|||
147407280|NCT05131477|531655811|FG005|PART 1|Lack of Efficacy|0|||
147407281|NCT05131477|531655812|FG006|PART 1|Lack of Efficacy|0|||
147407282|NCT05131477|531655813|FG007|PART 1|Lack of Efficacy|0|||
147407283|NCT05131477|531655814|FG008|PART 1|Lack of Efficacy|0|||
147407284|NCT05131477|531655815|FG009|PART 1|Lack of Efficacy|0|||
147407285|NCT05131477|531655816|FG010|PART 1|Lack of Efficacy|0|||
147464557|NCT00896532|531860282|FG001|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
147464558|NCT00896532|531860283|FG002|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
147464559|NCT00896532|531860284|FG003|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
147464560|NCT00896532|531860285|FG004|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
147464561|NCT00896532|531860286|FG005|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
147464562|NCT00896532|531860287|FG006|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
147464563|NCT00896532|531860288|FG007|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
147464564|NCT00896532|531860289|FG008|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
147464565|NCT00896532|531860290|FG009|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
147464566|NCT00896532|531860291|FG010|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
147464567|NCT00896532|531860292|FG011|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
147464568|NCT00896532|531860293|FG012|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
147464569|NCT00896532|531860294|FG013|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
147464570|NCT00896532|531860295|FG014|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
147464571|NCT00896532|531860296|FG015|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
147464572|NCT00896532|531860297|FG016|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|1|||
147464573|NCT00896532|531860298|FG017|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
147464574|NCT00896532|531860299|FG018|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
147464575|NCT00896532|531860300|FG019|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
147616746|NCT01130532|532413658|FG003|Period III (Weeks 0-12)|Entry Criteria Not Met|0|||
147616747|NCT01130532|532413655|FG000|Period III (Weeks 0-12)|Lack of Efficacy|2|||
147616748|NCT01130532|532413656|FG001|Period III (Weeks 0-12)|Lack of Efficacy|0|||
147616749|NCT01130532|532413657|FG002|Period III (Weeks 0-12)|Lack of Efficacy|1|||
147616750|NCT01130532|532413658|FG003|Period III (Weeks 0-12)|Lack of Efficacy|0|||
147616751|NCT01130532|532413655|FG000|Period III (Weeks 0-12)|Lost to Follow-up|2|||
147616752|NCT01130532|532413656|FG001|Period III (Weeks 0-12)|Lost to Follow-up|2|||
147616753|NCT01130532|532413657|FG002|Period III (Weeks 0-12)|Lost to Follow-up|3|||
147616754|NCT01130532|532413658|FG003|Period III (Weeks 0-12)|Lost to Follow-up|0|||
147616755|NCT01130532|532413655|FG000|Period III (Weeks 0-12)|Protocol Violation|0|||
147616756|NCT01130532|532413656|FG001|Period III (Weeks 0-12)|Protocol Violation|0|||
147616757|NCT01130532|532413657|FG002|Period III (Weeks 0-12)|Protocol Violation|1|||
147616758|NCT01130532|532413658|FG003|Period III (Weeks 0-12)|Protocol Violation|0|||
147616759|NCT01130532|532413655|FG000|Period III (Weeks 0-12)|Sponsor Decision|3|||
147616760|NCT01130532|532413656|FG001|Period III (Weeks 0-12)|Sponsor Decision|4|||
147616761|NCT01130532|532413657|FG002|Period III (Weeks 0-12)|Sponsor Decision|2|||
147616762|NCT01130532|532413658|FG003|Period III (Weeks 0-12)|Sponsor Decision|0|||
147616763|NCT01130532|532413655|FG000|Period III (Weeks 0-12)|Withdrawal by Subject|7|||
147616764|NCT01130532|532413656|FG001|Period III (Weeks 0-12)|Withdrawal by Subject|7|||
147616765|NCT01130532|532413657|FG002|Period III (Weeks 0-12)|Withdrawal by Subject|6|||
147616766|NCT01130532|532413658|FG003|Period III (Weeks 0-12)|Withdrawal by Subject|0|||
147616767|NCT01130532|532413655|FG000|Period IV (Weeks 13-16)|Adverse Event|0|||
147616768|NCT01130532|532413656|FG001|Period IV (Weeks 13-16)|Adverse Event|0|||
147616769|NCT01130532|532413657|FG002|Period IV (Weeks 13-16)|Adverse Event|0|||
147616770|NCT01130532|532413658|FG003|Period IV (Weeks 13-16)|Adverse Event|1|||
147616771|NCT01130532|532413655|FG000|Period IV (Weeks 13-16)|Entry Criteria Not Met|0|||
147616772|NCT01130532|532413656|FG001|Period IV (Weeks 13-16)|Entry Criteria Not Met|0|||
147616773|NCT01130532|532413657|FG002|Period IV (Weeks 13-16)|Entry Criteria Not Met|0|||
147616774|NCT01130532|532413658|FG003|Period IV (Weeks 13-16)|Entry Criteria Not Met|1|||
147616775|NCT01130532|532413655|FG000|Period IV (Weeks 13-16)|Lost to Follow-up|0|||
147616776|NCT01130532|532413656|FG001|Period IV (Weeks 13-16)|Lost to Follow-up|0|||
147616777|NCT01130532|532413657|FG002|Period IV (Weeks 13-16)|Lost to Follow-up|0|||
147616778|NCT01130532|532413658|FG003|Period IV (Weeks 13-16)|Lost to Follow-up|5|||
147616779|NCT01130532|532413655|FG000|Period IV (Weeks 13-16)|Withdrawal by Subject|0|||
147616780|NCT01130532|532413656|FG001|Period IV (Weeks 13-16)|Withdrawal by Subject|0|||
147616781|NCT01130532|532413657|FG002|Period IV (Weeks 13-16)|Withdrawal by Subject|0|||
147616782|NCT01130532|532413658|FG003|Period IV (Weeks 13-16)|Withdrawal by Subject|3|||
147616783|NCT02762929|532413659|FG000|Overall Study|Adverse Event|0|||
147616784|NCT02762929|532413660|FG001|Overall Study|Adverse Event|0|||
147616785|NCT02762929|532413661|FG002|Overall Study|Adverse Event|0|||
147616786|NCT02762929|532413662|FG003|Overall Study|Adverse Event|1|||
147616787|NCT02762929|532413663|FG004|Overall Study|Adverse Event|0|||
147616788|NCT02762929|532413664|FG005|Overall Study|Adverse Event|0|||
147616789|NCT02762929|532413659|FG000|Overall Study|Lost to Follow-up|1|||
147616790|NCT02762929|532413660|FG001|Overall Study|Lost to Follow-up|2|||
147616791|NCT02762929|532413661|FG002|Overall Study|Lost to Follow-up|0|||
147616792|NCT02762929|532413662|FG003|Overall Study|Lost to Follow-up|1|||
147616793|NCT02762929|532413663|FG004|Overall Study|Lost to Follow-up|0|||
147616794|NCT02762929|532413664|FG005|Overall Study|Lost to Follow-up|0|||
147616795|NCT02762929|532413659|FG000|Overall Study|Withdrawal by Subject|0|||
147407286|NCT05131477|531655817|FG011|PART 1|Lack of Efficacy|0|||
147407287|NCT05131477|531655818|FG012|PART 1|Lack of Efficacy|0|||
147407288|NCT05131477|531655819|FG013|PART 1|Lack of Efficacy|0|||
147407289|NCT05131477|531655806|FG000|PART 2|Withdrawal by Subject|0|||
147407290|NCT05131477|531655807|FG001|PART 2|Withdrawal by Subject|0|||
147407291|NCT05131477|531655808|FG002|PART 2|Withdrawal by Subject|0|||
147407292|NCT05131477|531655809|FG003|PART 2|Withdrawal by Subject|0|||
147407293|NCT05131477|531655810|FG004|PART 2|Withdrawal by Subject|0|||
147407294|NCT05131477|531655811|FG005|PART 2|Withdrawal by Subject|0|||
147407295|NCT05131477|531655812|FG006|PART 2|Withdrawal by Subject|2|||
147407296|NCT05131477|531655813|FG007|PART 2|Withdrawal by Subject|0|||
147407297|NCT05131477|531655814|FG008|PART 2|Withdrawal by Subject|0|||
147407298|NCT05131477|531655815|FG009|PART 2|Withdrawal by Subject|0|||
147407299|NCT05131477|531655816|FG010|PART 2|Withdrawal by Subject|2|||
147407300|NCT05131477|531655817|FG011|PART 2|Withdrawal by Subject|0|||
147407301|NCT05131477|531655818|FG012|PART 2|Withdrawal by Subject|2|||
147407302|NCT05131477|531655819|FG013|PART 2|Withdrawal by Subject|2|||
147407303|NCT05131477|531655806|FG000|PART 2|Other|0|||
147407304|NCT05131477|531655807|FG001|PART 2|Other|0|||
147407305|NCT05131477|531655808|FG002|PART 2|Other|0|||
147407306|NCT05131477|531655809|FG003|PART 2|Other|0|||
147407307|NCT05131477|531655810|FG004|PART 2|Other|0|||
147407308|NCT05131477|531655811|FG005|PART 2|Other|0|||
147407309|NCT05131477|531655812|FG006|PART 2|Other|0|||
147407310|NCT05131477|531655813|FG007|PART 2|Other|0|||
147407311|NCT05131477|531655814|FG008|PART 2|Other|1|||
147407312|NCT05131477|531655815|FG009|PART 2|Other|1|||
147407313|NCT05131477|531655816|FG010|PART 2|Other|0|||
147407314|NCT05131477|531655817|FG011|PART 2|Other|0|||
147407315|NCT05131477|531655818|FG012|PART 2|Other|1|||
147407316|NCT05131477|531655819|FG013|PART 2|Other|0|||
147407317|NCT05131477|531655806|FG000|PART 2|Lack of Efficacy|0|||
147407318|NCT05131477|531655807|FG001|PART 2|Lack of Efficacy|0|||
147407319|NCT05131477|531655808|FG002|PART 2|Lack of Efficacy|0|||
147407320|NCT05131477|531655809|FG003|PART 2|Lack of Efficacy|0|||
147407321|NCT05131477|531655810|FG004|PART 2|Lack of Efficacy|0|||
147407322|NCT05131477|531655811|FG005|PART 2|Lack of Efficacy|1|||
147407323|NCT05131477|531655812|FG006|PART 2|Lack of Efficacy|1|||
147407324|NCT05131477|531655813|FG007|PART 2|Lack of Efficacy|0|||
147407325|NCT05131477|531655814|FG008|PART 2|Lack of Efficacy|3|||
147407326|NCT05131477|531655815|FG009|PART 2|Lack of Efficacy|0|||
147407327|NCT05131477|531655816|FG010|PART 2|Lack of Efficacy|1|||
147407328|NCT05131477|531655817|FG011|PART 2|Lack of Efficacy|0|||
147407329|NCT05131477|531655818|FG012|PART 2|Lack of Efficacy|2|||
147407330|NCT05131477|531655819|FG013|PART 2|Lack of Efficacy|0|||
147407331|NCT05131477|531655806|FG000|PART 2|Unclassified|0|||
147407332|NCT05131477|531655807|FG001|PART 2|Unclassified|0|||
147407333|NCT05131477|531655808|FG002|PART 2|Unclassified|0|||
147407334|NCT05131477|531655809|FG003|PART 2|Unclassified|0|||
147407335|NCT05131477|531655810|FG004|PART 2|Unclassified|0|||
147407336|NCT05131477|531655811|FG005|PART 2|Unclassified|0|||
147407337|NCT05131477|531655812|FG006|PART 2|Unclassified|0|||
147407338|NCT05131477|531655813|FG007|PART 2|Unclassified|0|||
147407339|NCT05131477|531655814|FG008|PART 2|Unclassified|0|||
147616796|NCT02762929|532413660|FG001|Overall Study|Withdrawal by Subject|1|||
147407340|NCT05131477|531655815|FG009|PART 2|Unclassified|0|||
147407341|NCT05131477|531655816|FG010|PART 2|Unclassified|1|||
147407342|NCT05131477|531655817|FG011|PART 2|Unclassified|0|||
147407343|NCT05131477|531655818|FG012|PART 2|Unclassified|0|||
147407344|NCT05131477|531655819|FG013|PART 2|Unclassified|0|||
147407345|NCT05131477|531655806|FG000|PART 2|Re-randomized and not treated|0|||
147407346|NCT05131477|531655807|FG001|PART 2|Re-randomized and not treated|0|||
147407347|NCT05131477|531655808|FG002|PART 2|Re-randomized and not treated|0|||
147407348|NCT05131477|531655809|FG003|PART 2|Re-randomized and not treated|0|||
147407349|NCT05131477|531655810|FG004|PART 2|Re-randomized and not treated|0|||
147616797|NCT02762929|532413661|FG002|Overall Study|Withdrawal by Subject|0|||
147616798|NCT02762929|532413662|FG003|Overall Study|Withdrawal by Subject|0|||
147407350|NCT05131477|531655811|FG005|PART 2|Re-randomized and not treated|0|||
147407351|NCT05131477|531655812|FG006|PART 2|Re-randomized and not treated|0|||
147407352|NCT05131477|531655813|FG007|PART 2|Re-randomized and not treated|1|||
147407353|NCT05131477|531655814|FG008|PART 2|Re-randomized and not treated|0|||
147407354|NCT05131477|531655815|FG009|PART 2|Re-randomized and not treated|0|||
147407355|NCT05131477|531655816|FG010|PART 2|Re-randomized and not treated|1|||
147407356|NCT05131477|531655817|FG011|PART 2|Re-randomized and not treated|0|||
147407357|NCT05131477|531655818|FG012|PART 2|Re-randomized and not treated|1|||
147407358|NCT05131477|531655819|FG013|PART 2|Re-randomized and not treated|1|||
147407359|NCT02194829|531655820|FG000|Overall Study|Adverse Event|2|||
147407360|NCT02194829|531655821|FG001|Overall Study|Adverse Event|2|||
147407361|NCT02194829|531655820|FG000|Overall Study|Death|0|||
147407362|NCT02194829|531655821|FG001|Overall Study|Death|1|||
147407363|NCT02194829|531655820|FG000|Overall Study|Disease progression|0|||
147407364|NCT02194829|531655821|FG001|Overall Study|Disease progression|1|||
147407365|NCT02194829|531655820|FG000|Overall Study|Withdrawal by Subject|0|||
147407366|NCT02194829|531655821|FG001|Overall Study|Withdrawal by Subject|1|||
147644003|NCT01447446|532516689|FG003|Overall Study|SVR12 Assessment|1|||
147464576|NCT00896532|531860301|FG020|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
147464577|NCT00896532|531860302|FG021|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
147464578|NCT00896532|531860303|FG022|Months 36-48: Romosozumab Retreatment|Continuing the re-treatment phase|0|||
147464579|NCT00896532|531860281|FG000|Months 48-72: Follow-on Phase|Death|0|||
147464580|NCT00896532|531860282|FG001|Months 48-72: Follow-on Phase|Death|0|||
147464581|NCT00896532|531860283|FG002|Months 48-72: Follow-on Phase|Death|0|||
147464582|NCT00896532|531860284|FG003|Months 48-72: Follow-on Phase|Death|0|||
147464583|NCT00896532|531860285|FG004|Months 48-72: Follow-on Phase|Death|0|||
147464584|NCT00896532|531860286|FG005|Months 48-72: Follow-on Phase|Death|0|||
147464585|NCT00896532|531860287|FG006|Months 48-72: Follow-on Phase|Death|0|||
147464586|NCT00896532|531860288|FG007|Months 48-72: Follow-on Phase|Death|0|||
147464587|NCT00896532|531860289|FG008|Months 48-72: Follow-on Phase|Death|0|||
147464588|NCT00896532|531860290|FG009|Months 48-72: Follow-on Phase|Death|0|||
147464589|NCT00896532|531860291|FG010|Months 48-72: Follow-on Phase|Death|0|||
147464590|NCT00896532|531860292|FG011|Months 48-72: Follow-on Phase|Death|0|||
147464591|NCT00896532|531860293|FG012|Months 48-72: Follow-on Phase|Death|0|||
147464592|NCT00896532|531860294|FG013|Months 48-72: Follow-on Phase|Death|0|||
147464593|NCT00896532|531860295|FG014|Months 48-72: Follow-on Phase|Death|0|||
147464594|NCT00896532|531860296|FG015|Months 48-72: Follow-on Phase|Death|0|||
147464595|NCT00896532|531860297|FG016|Months 48-72: Follow-on Phase|Death|0|||
147464596|NCT00896532|531860298|FG017|Months 48-72: Follow-on Phase|Death|0|||
147464597|NCT00896532|531860299|FG018|Months 48-72: Follow-on Phase|Death|1|||
147464598|NCT00896532|531860300|FG019|Months 48-72: Follow-on Phase|Death|0|||
147464599|NCT00896532|531860301|FG020|Months 48-72: Follow-on Phase|Death|0|||
147464600|NCT00896532|531860302|FG021|Months 48-72: Follow-on Phase|Death|0|||
147464601|NCT00896532|531860303|FG022|Months 48-72: Follow-on Phase|Death|0|||
147464602|NCT00896532|531860281|FG000|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
147464603|NCT00896532|531860282|FG001|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
147464604|NCT00896532|531860283|FG002|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
147464605|NCT00896532|531860284|FG003|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
147464606|NCT00896532|531860285|FG004|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
147464607|NCT00896532|531860286|FG005|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
147464608|NCT00896532|531860287|FG006|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
147464609|NCT00896532|531860288|FG007|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
147464610|NCT00896532|531860289|FG008|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
147464611|NCT00896532|531860290|FG009|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
147464612|NCT00896532|531860291|FG010|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
147464613|NCT00896532|531860292|FG011|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
147464614|NCT00896532|531860293|FG012|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
147464615|NCT00896532|531860294|FG013|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
147464616|NCT00896532|531860295|FG014|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
147464617|NCT00896532|531860296|FG015|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
147464618|NCT00896532|531860297|FG016|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
147464619|NCT00896532|531860298|FG017|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
147464620|NCT00896532|531860299|FG018|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
147464621|NCT00896532|531860300|FG019|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
147464622|NCT00896532|531860301|FG020|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
147464623|NCT00896532|531860302|FG021|Months 48-72: Follow-on Phase|Ineligibility Determined|1|||
147464624|NCT00896532|531860303|FG022|Months 48-72: Follow-on Phase|Ineligibility Determined|0|||
147464625|NCT00896532|531860281|FG000|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
147464626|NCT00896532|531860282|FG001|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
147464627|NCT00896532|531860283|FG002|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
147464628|NCT00896532|531860284|FG003|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
147464629|NCT00896532|531860285|FG004|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
147464630|NCT00896532|531860286|FG005|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
147464631|NCT00896532|531860287|FG006|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
147464632|NCT00896532|531860288|FG007|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
147464633|NCT00896532|531860289|FG008|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
147464634|NCT00896532|531860290|FG009|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
147464635|NCT00896532|531860291|FG010|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
147464636|NCT00896532|531860292|FG011|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
147464637|NCT00896532|531860293|FG012|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
147464638|NCT00896532|531860294|FG013|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
147464639|NCT00896532|531860295|FG014|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
147464640|NCT00896532|531860296|FG015|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
147464641|NCT00896532|531860297|FG016|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
147464642|NCT00896532|531860298|FG017|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
147464643|NCT00896532|531860299|FG018|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
147407367|NCT02194829|531655820|FG000|Overall Study|Never started protocol therapy|0|||
147407368|NCT02194829|531655821|FG001|Overall Study|Never started protocol therapy|1|||
147407369|NCT06840769|531655823|FG000|Overall Study|Withdrawal by Subject|1|||
147407370|NCT06840769|531655824|FG001|Overall Study|Withdrawal by Subject|0|||
147407371|NCT06840769|531655825|FG002|Overall Study|Withdrawal by Subject|0|||
147407372|NCT06840769|531655826|FG003|Overall Study|Withdrawal by Subject|0|||
147407373|NCT06840769|531655827|FG004|Overall Study|Withdrawal by Subject|0|||
147407374|NCT02412735|531658137|FG000|Overall Study|Adverse Event|0|||
147407375|NCT02412735|531658138|FG001|Overall Study|Adverse Event|1|||
147407376|NCT02412735|531658139|FG002|Overall Study|Adverse Event|2|||
147407377|NCT02412735|531658137|FG000|Overall Study|Withdrawal by Subject|23|||
147407378|NCT02412735|531658138|FG001|Overall Study|Withdrawal by Subject|27|||
147407379|NCT02412735|531658139|FG002|Overall Study|Withdrawal by Subject|22|||
147407380|NCT02412735|531658137|FG000|Overall Study|Investigator Decision|3|||
147407381|NCT02412735|531658138|FG001|Overall Study|Investigator Decision|3|||
147407382|NCT02412735|531658139|FG002|Overall Study|Investigator Decision|2|||
147407383|NCT02412735|531658137|FG000|Overall Study|Lost to Follow-up|17|||
147407384|NCT02412735|531658138|FG001|Overall Study|Lost to Follow-up|11|||
147407385|NCT02412735|531658139|FG002|Overall Study|Lost to Follow-up|18|||
147407386|NCT02412735|531658137|FG000|Overall Study|Reason not Specified|3|||
147407387|NCT02412735|531658138|FG001|Overall Study|Reason not Specified|2|||
147407388|NCT02412735|531658139|FG002|Overall Study|Reason not Specified|2|||
147407389|NCT01228318|531658140|FG000|Overall Study|Clinic no show to receive intervention|1|||
147407390|NCT01228318|531658141|FG001|Overall Study|Clinic no show to receive intervention|0|||
147407391|NCT01228318|531658140|FG000|Overall Study|Unable to contact|2|||
147407392|NCT01228318|531658141|FG001|Overall Study|Unable to contact|5|||
147407393|NCT01228318|531658140|FG000|Overall Study|Moved|0|||
147407394|NCT01228318|531658141|FG001|Overall Study|Moved|2|||
147407395|NCT01228318|531658140|FG000|Overall Study|Incarcerated|1|||
147407396|NCT01228318|531658141|FG001|Overall Study|Incarcerated|0|||
147407397|NCT00603525|531658146|FG000|DB Treatment Period (24 Weeks)|Adverse Event|3|||
147407398|NCT00603525|531658147|FG001|DB Treatment Period (24 Weeks)|Adverse Event|9|||
147407399|NCT00603525|531658148|FG002|DB Treatment Period (24 Weeks)|Adverse Event|0|||
147407400|NCT00603525|531658146|FG000|DB Treatment Period (24 Weeks)|Lack of Efficacy|7|||
147407401|NCT00603525|531658147|FG001|DB Treatment Period (24 Weeks)|Lack of Efficacy|0|||
147407402|NCT00603525|531658148|FG002|DB Treatment Period (24 Weeks)|Lack of Efficacy|0|||
147407403|NCT00603525|531658146|FG000|DB Treatment Period (24 Weeks)|Protocol Violation|1|||
147407404|NCT00603525|531658147|FG001|DB Treatment Period (24 Weeks)|Protocol Violation|2|||
147407405|NCT00603525|531658148|FG002|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
147407406|NCT00603525|531658146|FG000|DB Treatment Period (24 Weeks)|Lost to Follow-up|1|||
147407407|NCT00603525|531658147|FG001|DB Treatment Period (24 Weeks)|Lost to Follow-up|3|||
147407408|NCT00603525|531658148|FG002|DB Treatment Period (24 Weeks)|Lost to Follow-up|0|||
147407409|NCT00603525|531658146|FG000|DB Treatment Period (24 Weeks)|Withdrawal by Subject|5|||
147407410|NCT00603525|531658147|FG001|DB Treatment Period (24 Weeks)|Withdrawal by Subject|6|||
147407411|NCT00603525|531658148|FG002|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
147407412|NCT00603525|531658146|FG000|DB Treatment Period (24 Weeks)|Physician Decision|0|||
147407413|NCT00603525|531658147|FG001|DB Treatment Period (24 Weeks)|Physician Decision|1|||
147407414|NCT00603525|531658148|FG002|DB Treatment Period (24 Weeks)|Physician Decision|0|||
147407415|NCT00603525|531658146|FG000|DB Treatment Period (24 Weeks)|Participant Met Stopping Criteria|0|||
147407416|NCT00603525|531658147|FG001|DB Treatment Period (24 Weeks)|Participant Met Stopping Criteria|1|||
147407417|NCT00603525|531658148|FG002|DB Treatment Period (24 Weeks)|Participant Met Stopping Criteria|0|||
147407418|NCT00603525|531658146|FG000|OL Treatment Period (120 Weeks)|Adverse Event|0|||
147407419|NCT00603525|531658147|FG001|OL Treatment Period (120 Weeks)|Adverse Event|12|||
147407420|NCT00603525|531658148|FG002|OL Treatment Period (120 Weeks)|Adverse Event|0|||
147407421|NCT00603525|531658146|FG000|OL Treatment Period (120 Weeks)|Lack of Efficacy|0|||
147407422|NCT00603525|531658147|FG001|OL Treatment Period (120 Weeks)|Lack of Efficacy|13|||
147407423|NCT00603525|531658148|FG002|OL Treatment Period (120 Weeks)|Lack of Efficacy|0|||
147407424|NCT00603525|531658146|FG000|OL Treatment Period (120 Weeks)|Protocol Violation|0|||
147407425|NCT00603525|531658147|FG001|OL Treatment Period (120 Weeks)|Protocol Violation|1|||
147407426|NCT00603525|531658148|FG002|OL Treatment Period (120 Weeks)|Protocol Violation|0|||
147407427|NCT00603525|531658146|FG000|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0|||
147407428|NCT00603525|531658147|FG001|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|5|||
147464644|NCT00896532|531860300|FG019|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
147616799|NCT02762929|532413663|FG004|Overall Study|Withdrawal by Subject|0|||
147616800|NCT02762929|532413664|FG005|Overall Study|Withdrawal by Subject|0|||
147407429|NCT00603525|531658148|FG002|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0|||
147407430|NCT00603525|531658146|FG000|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0|||
147407431|NCT00603525|531658147|FG001|OL Treatment Period (120 Weeks)|Study Closed/Terminated|71|||
147464645|NCT00896532|531860301|FG020|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
147407432|NCT00603525|531658148|FG002|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0|||
147407433|NCT00603525|531658146|FG000|OL Treatment Period (120 Weeks)|Physician Decision|0|||
147407434|NCT00603525|531658147|FG001|OL Treatment Period (120 Weeks)|Physician Decision|2|||
147407435|NCT00603525|531658148|FG002|OL Treatment Period (120 Weeks)|Physician Decision|0|||
147407436|NCT00603525|531658146|FG000|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0|||
147407437|NCT00603525|531658147|FG001|OL Treatment Period (120 Weeks)|Withdrawal by Subject|8|||
147407438|NCT00603525|531658148|FG002|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0|||
147407439|NCT00603525|531658146|FG000|Follow-up Period (Approximately 2 Years)|Unknown Reason for Withdrawal|0|||
147407440|NCT00603525|531658147|FG001|Follow-up Period (Approximately 2 Years)|Unknown Reason for Withdrawal|0|||
147407441|NCT00603525|531658148|FG002|Follow-up Period (Approximately 2 Years)|Unknown Reason for Withdrawal|111|||
147407442|NCT00770029|531658149|FG000|Overall Study|Lost to Follow-up|2|||
147407443|NCT00770029|531658150|FG001|Overall Study|Lost to Follow-up|0|||
147407444|NCT00770029|531658149|FG000|Overall Study|Withdrawal by Subject|3|||
147407445|NCT00770029|531658150|FG001|Overall Study|Withdrawal by Subject|3|||
147407446|NCT00770029|531658149|FG000|Overall Study|Adverse Event|1|||
147407447|NCT00770029|531658150|FG001|Overall Study|Adverse Event|0|||
147407448|NCT02124811|531658151|FG000|Overall Study|Early termination|2|||
147407449|NCT02124811|531658152|FG001|Overall Study|Early termination|2|||
147407450|NCT02124811|531658151|FG000|Overall Study|Withdrawal by Subject|1|||
147407451|NCT02124811|531658152|FG001|Overall Study|Withdrawal by Subject|0|||
147407452|NCT04043143|531658153|FG000|Overall Study|Lost to Follow-up|5|||
147407453|NCT04043143|531658154|FG001|Overall Study|Lost to Follow-up|5|||
147407454|NCT04043143|531658153|FG000|Overall Study|screen failure|1|||
147407455|NCT04043143|531658154|FG001|Overall Study|screen failure|0|||
147407456|NCT03480932|531658155|FG000|Overall Study|Death|1|||
147407457|NCT03480932|531658156|FG001|Overall Study|Death|1|||
147407458|NCT03480932|531658157|FG002|Overall Study|Death|0|||
147407459|NCT03480932|531658155|FG000|Overall Study|Lost to Follow-up|0|||
147407460|NCT03480932|531658156|FG001|Overall Study|Lost to Follow-up|2|||
147407461|NCT03480932|531658157|FG002|Overall Study|Lost to Follow-up|3|||
147407462|NCT03480932|531658155|FG000|Overall Study|Incarcerated|2|||
147407463|NCT03480932|531658156|FG001|Overall Study|Incarcerated|2|||
147407464|NCT03480932|531658157|FG002|Overall Study|Incarcerated|2|||
147407465|NCT04624243|531658161|FG000|Overall Study|Death|0|||
147407466|NCT04624243|531658162|FG001|Overall Study|Death|1|||
147407467|NCT04624243|531658163|FG002|Overall Study|Death|0|||
147407468|NCT04624243|531658164|FG003|Overall Study|Death|0|||
147407469|NCT04624243|531658165|FG004|Overall Study|Death|0|||
147407470|NCT04624243|531658161|FG000|Overall Study|Lost to Follow-up|2|||
147407471|NCT04624243|531658162|FG001|Overall Study|Lost to Follow-up|3|||
147407472|NCT04624243|531658163|FG002|Overall Study|Lost to Follow-up|7|||
147407473|NCT04624243|531658164|FG003|Overall Study|Lost to Follow-up|1|||
147407474|NCT04624243|531658165|FG004|Overall Study|Lost to Follow-up|3|||
147407475|NCT04624243|531658161|FG000|Overall Study|Physician Decision|3|||
147407476|NCT04624243|531658162|FG001|Overall Study|Physician Decision|8|||
147407477|NCT04624243|531658163|FG002|Overall Study|Physician Decision|15|||
147407478|NCT04624243|531658164|FG003|Overall Study|Physician Decision|2|||
147407479|NCT04624243|531658165|FG004|Overall Study|Physician Decision|11|||
147407480|NCT04624243|531658161|FG000|Overall Study|Withdrawal by Subject|19|||
147407481|NCT04624243|531658162|FG001|Overall Study|Withdrawal by Subject|44|||
147407482|NCT04624243|531658163|FG002|Overall Study|Withdrawal by Subject|40|||
147407483|NCT04624243|531658164|FG003|Overall Study|Withdrawal by Subject|21|||
147407484|NCT04624243|531658165|FG004|Overall Study|Withdrawal by Subject|39|||
147407485|NCT04624243|531658161|FG000|Overall Study|Miscellaneous|3|||
147407486|NCT04624243|531658162|FG001|Overall Study|Miscellaneous|12|||
147407487|NCT04624243|531658163|FG002|Overall Study|Miscellaneous|9|||
147407488|NCT04624243|531658164|FG003|Overall Study|Miscellaneous|4|||
147407489|NCT04624243|531658165|FG004|Overall Study|Miscellaneous|6|||
147407490|NCT04996004|531658166|FG000|Phase I|Death|1|||
147407491|NCT04996004|531658167|FG001|Phase I|Death|2|||
147407492|NCT04996004|531658168|FG002|Phase I|Death|1|||
147407493|NCT04996004|531658169|FG003|Phase I|Death|0|||
147407494|NCT04996004|531658170|FG004|Phase I|Death|0|||
147407495|NCT04996004|531658171|FG005|Phase I|Death|0|||
147407496|NCT04996004|531658166|FG000|Phase I|Study terminated by sponsor|2|||
147407497|NCT04996004|531658167|FG001|Phase I|Study terminated by sponsor|1|||
147407498|NCT04996004|531658168|FG002|Phase I|Study terminated by sponsor|2|||
147407499|NCT04996004|531658169|FG003|Phase I|Study terminated by sponsor|0|||
147407500|NCT04996004|531658170|FG004|Phase I|Study terminated by sponsor|0|||
147407501|NCT04996004|531658171|FG005|Phase I|Study terminated by sponsor|0|||
147407502|NCT04996004|531658166|FG000|Phase II|Study terminated by sponsor|0|||
147407503|NCT04996004|531658167|FG001|Phase II|Study terminated by sponsor|0|||
147407504|NCT04996004|531658168|FG002|Phase II|Study terminated by sponsor|0|||
147407505|NCT04996004|531658169|FG003|Phase II|Study terminated by sponsor|20|||
147407506|NCT04996004|531658170|FG004|Phase II|Study terminated by sponsor|10|||
147407507|NCT04996004|531658171|FG005|Phase II|Study terminated by sponsor|10|||
147407508|NCT04996004|531658166|FG000|Phase II|Withdrawal by Subject|0|||
147407509|NCT04996004|531658167|FG001|Phase II|Withdrawal by Subject|0|||
147407510|NCT04996004|531658168|FG002|Phase II|Withdrawal by Subject|0|||
147407511|NCT04996004|531658169|FG003|Phase II|Withdrawal by Subject|0|||
147407512|NCT04996004|531658170|FG004|Phase II|Withdrawal by Subject|1|||
147407513|NCT04996004|531658171|FG005|Phase II|Withdrawal by Subject|2|||
147407514|NCT04996004|531658166|FG000|Phase II|Death|0|||
147407515|NCT04996004|531658167|FG001|Phase II|Death|0|||
147407516|NCT04996004|531658168|FG002|Phase II|Death|0|||
147407517|NCT04996004|531658169|FG003|Phase II|Death|12|||
147407518|NCT04996004|531658170|FG004|Phase II|Death|2|||
147407519|NCT04996004|531658171|FG005|Phase II|Death|9|||
147407520|NCT04996004|531658166|FG000|Phase II|Other|0|||
147407521|NCT04996004|531658167|FG001|Phase II|Other|0|||
147407522|NCT04996004|531658168|FG002|Phase II|Other|0|||
147407523|NCT04996004|531658169|FG003|Phase II|Other|0|||
147407524|NCT04996004|531658170|FG004|Phase II|Other|0|||
147407525|NCT04996004|531658171|FG005|Phase II|Other|1|||
147407526|NCT03374488|531658174|FG000|Overall Study|Death|13|||
147407527|NCT03374488|531658175|FG001|Overall Study|Death|13|||
147407528|NCT03374488|531658174|FG000|Overall Study|Withdrawal by Subject|3|||
147407529|NCT03374488|531658175|FG001|Overall Study|Withdrawal by Subject|1|||
147407530|NCT03374488|531658174|FG000|Overall Study|Physician Decision|3|||
147407531|NCT03374488|531658175|FG001|Overall Study|Physician Decision|0|||
147407532|NCT03322540|531658180|FG000|Overall Study|Death|21|||
147407533|NCT03322540|531658181|FG001|Overall Study|Death|28|||
147407534|NCT03322540|531658180|FG000|Overall Study|Lost to Follow-up|0|||
147407535|NCT03322540|531658181|FG001|Overall Study|Lost to Follow-up|1|||
147407536|NCT03322540|531658180|FG000|Overall Study|Physician Decision|7|||
147407537|NCT03322540|531658181|FG001|Overall Study|Physician Decision|6|||
147407538|NCT03322540|531658180|FG000|Overall Study|Withdrawal by Subject|3|||
147407539|NCT03322540|531658181|FG001|Overall Study|Withdrawal by Subject|1|||
147407540|NCT03322540|531658180|FG000|Overall Study|Study terminated by sponsor|0|||
147407541|NCT03322540|531658181|FG001|Overall Study|Study terminated by sponsor|1|||
147407542|NCT04703192|531658186|FG000|Overall Study|Withdrawal by Subject|2|||
147407543|NCT04703192|531658187|FG001|Overall Study|Withdrawal by Subject|0|||
147407544|NCT04703192|531658186|FG000|Overall Study|Death|3|||
147407545|NCT04703192|531658187|FG001|Overall Study|Death|1|||
147407546|NCT04703192|531658186|FG000|Overall Study|Adverse Event|13|||
147407547|NCT04703192|531658187|FG001|Overall Study|Adverse Event|2|||
147407548|NCT04703192|531658186|FG000|Overall Study|Progressive or Relapsed Disease|46|||
147407549|NCT04703192|531658187|FG001|Overall Study|Progressive or Relapsed Disease|7|||
147407550|NCT04703192|531658186|FG000|Overall Study|Clinical Progression|19|||
147407551|NCT04703192|531658187|FG001|Overall Study|Clinical Progression|8|||
147407552|NCT04703192|531658186|FG000|Overall Study|Lost to Follow-up|1|||
147407553|NCT04703192|531658187|FG001|Overall Study|Lost to Follow-up|0|||
147407554|NCT04703192|531658186|FG000|Overall Study|Hematopoietic Cell Transplantation|12|||
147407555|NCT04703192|531658187|FG001|Overall Study|Hematopoietic Cell Transplantation|1|||
147407556|NCT04703192|531658186|FG000|Overall Study|Other|5|||
147407557|NCT04703192|531658187|FG001|Overall Study|Other|1|||
147407558|NCT02493062|531658188|FG000|Overall Study|Physician Decision|12|||
147407559|NCT01327612|531658189|FG000|Overall Study|Withdrawal by Subject|0|||
147407560|NCT01327612|531658190|FG001|Overall Study|Withdrawal by Subject|0|||
147407561|NCT01327612|531658191|FG002|Overall Study|Withdrawal by Subject|0|||
147407562|NCT01327612|531658192|FG003|Overall Study|Withdrawal by Subject|0|||
147407563|NCT01327612|531658193|FG004|Overall Study|Withdrawal by Subject|0|||
147407564|NCT01327612|531658194|FG005|Overall Study|Withdrawal by Subject|1|||
147407565|NCT01327612|531658195|FG006|Overall Study|Withdrawal by Subject|0|||
147407566|NCT01327612|531658189|FG000|Overall Study|Disease Progression|1|||
147407567|NCT01327612|531658190|FG001|Overall Study|Disease Progression|1|||
147407568|NCT01327612|531658191|FG002|Overall Study|Disease Progression|1|||
147407569|NCT01327612|531658192|FG003|Overall Study|Disease Progression|0|||
147407570|NCT01327612|531658193|FG004|Overall Study|Disease Progression|1|||
147407571|NCT01327612|531658194|FG005|Overall Study|Disease Progression|2|||
147407572|NCT01327612|531658195|FG006|Overall Study|Disease Progression|2|||
147407573|NCT01327612|531658189|FG000|Overall Study|Administrative Decision|0|||
147407574|NCT01327612|531658190|FG001|Overall Study|Administrative Decision|0|||
147407575|NCT01327612|531658191|FG002|Overall Study|Administrative Decision|0|||
147407576|NCT01327612|531658192|FG003|Overall Study|Administrative Decision|1|||
147407577|NCT01327612|531658193|FG004|Overall Study|Administrative Decision|0|||
147407578|NCT01327612|531658194|FG005|Overall Study|Administrative Decision|0|||
147407579|NCT01327612|531658195|FG006|Overall Study|Administrative Decision|0|||
147407580|NCT01327612|531658189|FG000|Overall Study|Death|0|||
147407581|NCT01327612|531658190|FG001|Overall Study|Death|0|||
147407582|NCT01327612|531658191|FG002|Overall Study|Death|0|||
147407583|NCT01327612|531658192|FG003|Overall Study|Death|0|||
147407584|NCT01327612|531658193|FG004|Overall Study|Death|1|||
147407585|NCT01327612|531658194|FG005|Overall Study|Death|0|||
147407586|NCT01327612|531658195|FG006|Overall Study|Death|0|||
147407587|NCT05105087|531658197|FG000|Overall Study|Withdrawal by Subject|2|||
147407588|NCT05105087|531658197|FG000|Overall Study|Ineligible for surgery due to advanced disease|2|||
147407589|NCT01016262|531658198|FG000|Double-blind Phase|Adverse Event|0|||
147407590|NCT01016262|531658199|FG001|Double-blind Phase|Adverse Event|0|||
147407591|NCT01016262|531658200|FG002|Double-blind Phase|Adverse Event|1|||
147407592|NCT01016262|531658201|FG003|Double-blind Phase|Adverse Event|0|||
147407593|NCT01016262|531658202|FG004|Double-blind Phase|Adverse Event|0|||
147407594|NCT01016262|531658203|FG005|Double-blind Phase|Adverse Event|0|||
147407595|NCT01016262|531658198|FG000|Double-blind Phase|Lack of Efficacy|1|||
147407596|NCT01016262|531658199|FG001|Double-blind Phase|Lack of Efficacy|0|||
147407597|NCT01016262|531658200|FG002|Double-blind Phase|Lack of Efficacy|5|||
147407598|NCT01016262|531658201|FG003|Double-blind Phase|Lack of Efficacy|0|||
147407599|NCT01016262|531658202|FG004|Double-blind Phase|Lack of Efficacy|0|||
147407600|NCT01016262|531658203|FG005|Double-blind Phase|Lack of Efficacy|0|||
147407601|NCT01016262|531658198|FG000|Double-blind Phase|Disease Progression|0|||
147407602|NCT01016262|531658199|FG001|Double-blind Phase|Disease Progression|1|||
147407603|NCT01016262|531658200|FG002|Double-blind Phase|Disease Progression|2|||
147407604|NCT01016262|531658201|FG003|Double-blind Phase|Disease Progression|0|||
147407605|NCT01016262|531658202|FG004|Double-blind Phase|Disease Progression|0|||
147407606|NCT01016262|531658203|FG005|Double-blind Phase|Disease Progression|0|||
147407607|NCT01016262|531658198|FG000|Double-blind Phase|Withdrawal of Informed Consent|0|||
147407608|NCT01016262|531658199|FG001|Double-blind Phase|Withdrawal of Informed Consent|0|||
147407609|NCT01016262|531658200|FG002|Double-blind Phase|Withdrawal of Informed Consent|1|||
147407610|NCT01016262|531658201|FG003|Double-blind Phase|Withdrawal of Informed Consent|0|||
147407611|NCT01016262|531658202|FG004|Double-blind Phase|Withdrawal of Informed Consent|0|||
147407612|NCT01016262|531658203|FG005|Double-blind Phase|Withdrawal of Informed Consent|0|||
147407613|NCT01016262|531658198|FG000|Open-Label Phase|Adverse Event|0|||
147407614|NCT01016262|531658199|FG001|Open-Label Phase|Adverse Event|0|||
147407615|NCT01016262|531658200|FG002|Open-Label Phase|Adverse Event|0|||
147407616|NCT01016262|531658201|FG003|Open-Label Phase|Adverse Event|1|||
147407617|NCT01016262|531658202|FG004|Open-Label Phase|Adverse Event|0|||
147407618|NCT01016262|531658203|FG005|Open-Label Phase|Adverse Event|0|||
147407619|NCT01016262|531658198|FG000|Open-Label Phase|Lost to Follow-up|0|||
147407620|NCT01016262|531658199|FG001|Open-Label Phase|Lost to Follow-up|0|||
147407621|NCT01016262|531658200|FG002|Open-Label Phase|Lost to Follow-up|0|||
147407622|NCT01016262|531658201|FG003|Open-Label Phase|Lost to Follow-up|0|||
147407623|NCT01016262|531658202|FG004|Open-Label Phase|Lost to Follow-up|1|||
147407624|NCT01016262|531658203|FG005|Open-Label Phase|Lost to Follow-up|0|||
147407625|NCT01016262|531658198|FG000|Open-Label Phase|Lack of Efficacy|0|||
147407626|NCT01016262|531658199|FG001|Open-Label Phase|Lack of Efficacy|0|||
147407627|NCT01016262|531658200|FG002|Open-Label Phase|Lack of Efficacy|0|||
147407628|NCT01016262|531658201|FG003|Open-Label Phase|Lack of Efficacy|1|||
147407629|NCT01016262|531658202|FG004|Open-Label Phase|Lack of Efficacy|0|||
147407630|NCT01016262|531658203|FG005|Open-Label Phase|Lack of Efficacy|0|||
147407631|NCT01016262|531658198|FG000|Open-Label Phase|Withdrawal of Informed Consent|0|||
147407632|NCT01016262|531658199|FG001|Open-Label Phase|Withdrawal of Informed Consent|0|||
147407633|NCT01016262|531658200|FG002|Open-Label Phase|Withdrawal of Informed Consent|0|||
147407634|NCT01016262|531658201|FG003|Open-Label Phase|Withdrawal of Informed Consent|0|||
147407635|NCT01016262|531658202|FG004|Open-Label Phase|Withdrawal of Informed Consent|1|||
147407636|NCT01016262|531658203|FG005|Open-Label Phase|Withdrawal of Informed Consent|0|||
147407637|NCT01730378|531658204|FG000|Overall Study|Lost to Follow-up|1|||
147407638|NCT01730378|531658205|FG001|Overall Study|Lost to Follow-up|0|||
147407639|NCT03199469|531658206|FG000|Overall Study|Randomized, not treated|0|||
147407640|NCT03199469|531658207|FG001|Overall Study|Randomized, not treated|3|||
147407641|NCT03199469|531658206|FG000|Overall Study|Withdrawal by Subject|1|||
147407642|NCT03199469|531658207|FG001|Overall Study|Withdrawal by Subject|0|||
147407643|NCT03199469|531658206|FG000|Overall Study|Death|1|||
147407644|NCT03199469|531658207|FG001|Overall Study|Death|3|||
147407645|NCT03199469|531658206|FG000|Overall Study|Ongoing|5|||
147407646|NCT03199469|531658207|FG001|Overall Study|Ongoing|14|||
147407647|NCT01023958|531658212|FG000|Overall Study|Progressive disease|48|||
147407648|NCT01023958|531658212|FG000|Overall Study|Other adverse event|1|||
147407649|NCT01023958|531658212|FG000|Overall Study|Refused to continue medication|1|||
147407650|NCT01031628|531658213|FG000|Overall Study|Study terminated early|0|||
147407651|NCT01031628|531658214|FG001|Overall Study|Study terminated early|1|||
147407652|NCT01031628|531658215|FG002|Overall Study|Study terminated early|3|||
147407653|NCT01031628|531658216|FG003|Overall Study|Study terminated early|0|||
147407654|NCT03080493|531658217|FG000|Overall Study|Did not provide NRS pain results|1|||
147407655|NCT03080493|531658218|FG001|Overall Study|Did not provide NRS pain results|0|||
147407656|NCT03080493|531658217|FG000|Overall Study|Adverse Event|0|||
147407657|NCT03080493|531658218|FG001|Overall Study|Adverse Event|1|||
147407658|NCT03080493|531658217|FG000|Overall Study|Randomization error (parity group)|0|||
147407659|NCT03080493|531658218|FG001|Overall Study|Randomization error (parity group)|1|||
147407660|NCT00755417|531658220|FG000|Overall Study|Adverse Event|28|||
147407661|NCT00755417|531658221|FG001|Overall Study|Adverse Event|20|||
147407662|NCT00755417|531658222|FG002|Overall Study|Adverse Event|7|||
147407663|NCT00755417|531658220|FG000|Overall Study|Lack of Efficacy|8|||
147407664|NCT00755417|531658221|FG001|Overall Study|Lack of Efficacy|4|||
147407665|NCT00755417|531658222|FG002|Overall Study|Lack of Efficacy|9|||
147407666|NCT00755417|531658220|FG000|Overall Study|Protocol Violation|2|||
147407667|NCT00755417|531658221|FG001|Overall Study|Protocol Violation|1|||
147407668|NCT00755417|531658222|FG002|Overall Study|Protocol Violation|1|||
147407669|NCT00755417|531658220|FG000|Overall Study|Lost to Follow-up|3|||
147407670|NCT00755417|531658221|FG001|Overall Study|Lost to Follow-up|0|||
147616801|NCT02762929|532413659|FG000|Overall Study|exclusionary medication disclosed late|0|||
147616802|NCT02762929|532413660|FG001|Overall Study|exclusionary medication disclosed late|0|||
147616803|NCT02762929|532413661|FG002|Overall Study|exclusionary medication disclosed late|0|||
147616804|NCT02762929|532413662|FG003|Overall Study|exclusionary medication disclosed late|1|||
147616805|NCT02762929|532413663|FG004|Overall Study|exclusionary medication disclosed late|0|||
147616806|NCT02762929|532413664|FG005|Overall Study|exclusionary medication disclosed late|0|||
147616807|NCT02656303|532413666|FG000|Overall Study|Adverse Event|3|||
147616808|NCT02656303|532413667|FG001|Overall Study|Adverse Event|2|||
147616809|NCT02656303|532413668|FG002|Overall Study|Adverse Event|0|||
147616810|NCT02656303|532413666|FG000|Overall Study|Death|12|||
147616811|NCT02656303|532413667|FG001|Overall Study|Death|4|||
147616812|NCT02656303|532413668|FG002|Overall Study|Death|1|||
147616813|NCT02656303|532413666|FG000|Overall Study|Lack of Efficacy|1|||
147616814|NCT02656303|532413667|FG001|Overall Study|Lack of Efficacy|0|||
147616815|NCT02656303|532413668|FG002|Overall Study|Lack of Efficacy|0|||
147616816|NCT02656303|532413666|FG000|Overall Study|Non-Compliance with Study|1|||
147616817|NCT02656303|532413667|FG001|Overall Study|Non-Compliance with Study|1|||
147616818|NCT02656303|532413668|FG002|Overall Study|Non-Compliance with Study|0|||
147616819|NCT02656303|532413666|FG000|Overall Study|Investigator Decision|2|||
147407671|NCT00755417|531658222|FG002|Overall Study|Lost to Follow-up|1|||
147407672|NCT00755417|531658220|FG000|Overall Study|Withdrawal by Subject|12|||
147407673|NCT00755417|531658221|FG001|Overall Study|Withdrawal by Subject|12|||
147407674|NCT00755417|531658222|FG002|Overall Study|Withdrawal by Subject|12|||
147407675|NCT00755417|531658220|FG000|Overall Study|Not specified or missing data|9|||
147407676|NCT00755417|531658221|FG001|Overall Study|Not specified or missing data|18|||
147407677|NCT00755417|531658222|FG002|Overall Study|Not specified or missing data|12|||
147407678|NCT02362503|531658224|FG000|Double-blind Period-Up to 8 Days|Adverse Event|0|||
147407679|NCT02362503|531658225|FG001|Double-blind Period-Up to 8 Days|Adverse Event|2|||
147407680|NCT02362503|531658226|FG002|Double-blind Period-Up to 8 Days|Adverse Event|0|||
147407681|NCT02362503|531658224|FG000|Double-blind Period-Up to 8 Days|Death|1|||
147407682|NCT02362503|531658225|FG001|Double-blind Period-Up to 8 Days|Death|0|||
147407683|NCT02362503|531658226|FG002|Double-blind Period-Up to 8 Days|Death|0|||
147407684|NCT02362503|531658224|FG000|Double-blind Period-Up to 8 Days|Lost to Follow-up|0|||
147407685|NCT02362503|531658225|FG001|Double-blind Period-Up to 8 Days|Lost to Follow-up|1|||
147407686|NCT02362503|531658226|FG002|Double-blind Period-Up to 8 Days|Lost to Follow-up|0|||
147407687|NCT02362503|531658224|FG000|Double-blind Period-Up to 8 Days|No longer meets study criteria|0|||
147407688|NCT02362503|531658225|FG001|Double-blind Period-Up to 8 Days|No longer meets study criteria|1|||
147407689|NCT02362503|531658226|FG002|Double-blind Period-Up to 8 Days|No longer meets study criteria|0|||
147407690|NCT02362503|531658224|FG000|Open Label Period-Up to 96 Weeks|Other|0|||
147407691|NCT02362503|531658225|FG001|Open Label Period-Up to 96 Weeks|Other|1|||
147407692|NCT02362503|531658226|FG002|Open Label Period-Up to 96 Weeks|Other|1|||
147407693|NCT02362503|531658224|FG000|Open Label Period-Up to 96 Weeks|No longer meets criteria|0|||
147407694|NCT02362503|531658225|FG001|Open Label Period-Up to 96 Weeks|No longer meets criteria|4|||
147407695|NCT02362503|531658226|FG002|Open Label Period-Up to 96 Weeks|No longer meets criteria|4|||
147407696|NCT02362503|531658224|FG000|Open Label Period-Up to 96 Weeks|Pregnancy|0|||
147407697|NCT02362503|531658225|FG001|Open Label Period-Up to 96 Weeks|Pregnancy|1|||
147407698|NCT02362503|531658226|FG002|Open Label Period-Up to 96 Weeks|Pregnancy|0|||
147407699|NCT02362503|531658224|FG000|Open Label Period-Up to 96 Weeks|Non-compliance with study drug|3|||
147407700|NCT02362503|531658225|FG001|Open Label Period-Up to 96 Weeks|Non-compliance with study drug|8|||
147407701|NCT02362503|531658226|FG002|Open Label Period-Up to 96 Weeks|Non-compliance with study drug|6|||
147407702|NCT02362503|531658224|FG000|Open Label Period-Up to 96 Weeks|Lost to Follow-up|4|||
147407703|NCT02362503|531658225|FG001|Open Label Period-Up to 96 Weeks|Lost to Follow-up|3|||
147407704|NCT02362503|531658226|FG002|Open Label Period-Up to 96 Weeks|Lost to Follow-up|1|||
147407705|NCT02362503|531658224|FG000|Open Label Period-Up to 96 Weeks|Death|1|||
147407706|NCT02362503|531658225|FG001|Open Label Period-Up to 96 Weeks|Death|7|||
147407707|NCT02362503|531658226|FG002|Open Label Period-Up to 96 Weeks|Death|15|||
147407708|NCT02362503|531658224|FG000|Open Label Period-Up to 96 Weeks|Withdrawal by Subject|0|||
147407709|NCT02362503|531658225|FG001|Open Label Period-Up to 96 Weeks|Withdrawal by Subject|5|||
147407710|NCT02362503|531658226|FG002|Open Label Period-Up to 96 Weeks|Withdrawal by Subject|1|||
147407711|NCT02362503|531658224|FG000|Open Label Period-Up to 96 Weeks|Adverse Event|3|||
147407712|NCT02362503|531658225|FG001|Open Label Period-Up to 96 Weeks|Adverse Event|2|||
147407713|NCT02362503|531658226|FG002|Open Label Period-Up to 96 Weeks|Adverse Event|4|||
147407714|NCT02362503|531658224|FG000|Open Label Period-Up to 96 Weeks|Lack of Efficacy|3|||
147407715|NCT02362503|531658225|FG001|Open Label Period-Up to 96 Weeks|Lack of Efficacy|9|||
147407716|NCT02362503|531658226|FG002|Open Label Period-Up to 96 Weeks|Lack of Efficacy|6|||
147407717|NCT02362503|531658224|FG000|Open Label Period-Up to 96 Weeks|Ongoing at the time of analysis|54|||
147407718|NCT02362503|531658225|FG001|Open Label Period-Up to 96 Weeks|Ongoing at the time of analysis|159|||
147407719|NCT02362503|531658226|FG002|Open Label Period-Up to 96 Weeks|Ongoing at the time of analysis|61|||
147407720|NCT02803593|531658227|FG000|Overall Study|Lost to Follow-up|17|||
147616820|NCT02656303|532413667|FG001|Overall Study|Investigator Decision|1|||
147407721|NCT02803593|531658228|FG001|Overall Study|Lost to Follow-up|35|||
147407722|NCT05143138|531658229|FG000|Overall Study|Death|5|||
147407723|NCT05143138|531658230|FG001|Overall Study|Death|35|||
147407724|NCT05143138|531658231|FG002|Overall Study|Death|1|||
147407725|NCT05143138|531658229|FG000|Overall Study|Lost to Follow-up|2|||
147407726|NCT05143138|531658230|FG001|Overall Study|Lost to Follow-up|4|||
147407727|NCT05143138|531658231|FG002|Overall Study|Lost to Follow-up|0|||
147407728|NCT05143138|531658229|FG000|Overall Study|withdrawal|1|||
147407729|NCT05143138|531658230|FG001|Overall Study|withdrawal|1|||
147407730|NCT05143138|531658231|FG002|Overall Study|withdrawal|0|||
147407731|NCT04245345|531658242|FG000|Overall Study|Death|1|||
147407732|NCT04245345|531658242|FG000|Overall Study|Exited prior to implant|5|||
147407733|NCT04245345|531658242|FG000|Overall Study|Exited prior to 1-month|9|||
147407734|NCT04245345|531658242|FG000|Overall Study|Missed 1-month visit|3|||
147407735|NCT04245345|531658242|FG000|Overall Study|Predominant rhythm exclusion at 1-month|83|||
147407736|NCT04245345|531658242|FG000|Overall Study|Fewer than 500 evaluable beats|2|||
147407737|NCT01834586|531658243|FG000|Overall Study|Adverse Event|1|||
147407738|NCT03443414|531658244|FG000|Overall Study|Adverse Event|6|||
147407739|NCT03443414|531658245|FG001|Overall Study|Adverse Event|0|||
147407740|NCT03443414|531658246|FG002|Overall Study|Adverse Event|4|||
147407741|NCT03443414|531658247|FG003|Overall Study|Adverse Event|2|||
147407742|NCT03443414|531658248|FG004|Overall Study|Adverse Event|3|||
147407743|NCT03443414|531658244|FG000|Overall Study|Withdrawal by Subject|3|||
147616821|NCT02656303|532413668|FG002|Overall Study|Investigator Decision|0|||
147616822|NCT02656303|532413666|FG000|Overall Study|Progressive Disease|25|||
147616823|NCT02656303|532413667|FG001|Overall Study|Progressive Disease|14|||
147616824|NCT02656303|532413668|FG002|Overall Study|Progressive Disease|10|||
147616825|NCT02656303|532413666|FG000|Overall Study|Study Terminated by Sponsor|20|||
147616826|NCT02656303|532413667|FG001|Overall Study|Study Terminated by Sponsor|7|||
147616827|NCT02656303|532413668|FG002|Overall Study|Study Terminated by Sponsor|5|||
147616828|NCT02656303|532413666|FG000|Overall Study|Withdrawal of Consent by Participants|1|||
147616829|NCT02656303|532413667|FG001|Overall Study|Withdrawal of Consent by Participants|1|||
147616830|NCT02656303|532413668|FG002|Overall Study|Withdrawal of Consent by Participants|0|||
147616831|NCT02656303|532413666|FG000|Overall Study|Initiation of Non-protocol Intervention|1|||
147616832|NCT02656303|532413667|FG001|Overall Study|Initiation of Non-protocol Intervention|0|||
147616833|NCT02656303|532413668|FG002|Overall Study|Initiation of Non-protocol Intervention|0|||
147616834|NCT02656303|532413666|FG000|Overall Study|Reason not Specified|1|||
147616835|NCT02656303|532413667|FG001|Overall Study|Reason not Specified|1|||
147616836|NCT02656303|532413668|FG002|Overall Study|Reason not Specified|2|||
147616837|NCT03041311|532413671|FG000|Overall Study|Death|39|||
147616838|NCT03041311|532413672|FG001|Overall Study|Death|42|||
147616839|NCT03041311|532413671|FG000|Overall Study|Lost to Follow-up|0|||
147616840|NCT03041311|532413672|FG001|Overall Study|Lost to Follow-up|1|||
147616841|NCT03041311|532413671|FG000|Overall Study|Withdrawal by Subject|8|||
147407744|NCT03443414|531658245|FG001|Overall Study|Withdrawal by Subject|2|||
147407745|NCT03443414|531658246|FG002|Overall Study|Withdrawal by Subject|2|||
147407746|NCT03443414|531658247|FG003|Overall Study|Withdrawal by Subject|2|||
147407747|NCT03443414|531658248|FG004|Overall Study|Withdrawal by Subject|1|||
147407748|NCT03443414|531658244|FG000|Overall Study|Death|0|||
147407749|NCT03443414|531658245|FG001|Overall Study|Death|1|||
147407750|NCT03443414|531658246|FG002|Overall Study|Death|0|||
147407751|NCT03443414|531658247|FG003|Overall Study|Death|1|||
147407752|NCT03443414|531658248|FG004|Overall Study|Death|0|||
147407753|NCT03443414|531658244|FG000|Overall Study|Reason not specified|2|||
147407754|NCT03443414|531658245|FG001|Overall Study|Reason not specified|0|||
147407755|NCT03443414|531658246|FG002|Overall Study|Reason not specified|0|||
147616842|NCT03041311|532413672|FG001|Overall Study|Withdrawal by Subject|5|||
147616843|NCT03041311|532413671|FG000|Overall Study|Sponsor Terminated Study|2|||
147616844|NCT03041311|532413672|FG001|Overall Study|Sponsor Terminated Study|4|||
147616845|NCT03041311|532413671|FG000|Overall Study|Disease Progression|3|||
147665484|NCT04613518|532599592|FG001|Open-Label Treatment Period|Participant request to discontinue treatment|0|||
147665485|NCT04613518|532599593|FG002|Open-Label Treatment Period|Participant request to discontinue treatment|0|||
147665486|NCT04613518|532599591|FG000|Open-Label Treatment Period|Participant withdrew consent|1|||
147665487|NCT04613518|532599592|FG001|Open-Label Treatment Period|Participant withdrew consent|0|||
147665488|NCT04613518|532599593|FG002|Open-Label Treatment Period|Participant withdrew consent|3|||
147407756|NCT03443414|531658247|FG003|Overall Study|Reason not specified|0|||
147407757|NCT03443414|531658248|FG004|Overall Study|Reason not specified|1|||
147407758|NCT03325777|531658249|FG000|Overall Study|Lost to Follow-up|9|||
147407759|NCT03325777|531658250|FG001|Overall Study|Lost to Follow-up|12|||
147407760|NCT04210843|531658252|FG000|First Half Treatment Period (52 Weeks)|Study terminated by sponsor|134|||
147407761|NCT04210843|531658253|FG001|First Half Treatment Period (52 Weeks)|Study terminated by sponsor|322|||
147464646|NCT00896532|531860302|FG021|Months 48-72: Follow-on Phase|Withdrawal by Subject|1|||
147616846|NCT03041311|532413672|FG001|Overall Study|Disease Progression|1|||
147616847|NCT03041311|532413671|FG000|Overall Study|Randomized in error, did not receive drug|2|||
147616848|NCT03041311|532413672|FG001|Overall Study|Randomized in error, did not receive drug|0|||
147616849|NCT02366689|532413673|FG000|Overall Study|Withdrawal by Subject|1|||
147616850|NCT02366689|532413674|FG001|Overall Study|Withdrawal by Subject|0|||
147665489|NCT04613518|532599591|FG000|Open-Label Treatment Period|Administrative reason by sponsor|4|||
147665490|NCT04613518|532599592|FG001|Open-Label Treatment Period|Administrative reason by sponsor|0|||
147665491|NCT04613518|532599593|FG002|Open-Label Treatment Period|Administrative reason by sponsor|0|||
147665492|NCT04613518|532599591|FG000|Open-Label Treatment Period|Other reasons|1|||
147665493|NCT04613518|532599592|FG001|Open-Label Treatment Period|Other reasons|0|||
147665494|NCT04613518|532599593|FG002|Open-Label Treatment Period|Other reasons|0|||
147665495|NCT01077323|532599595|FG000|Overall Study|<9 months enroll before drug dispensed|11226|||
147665496|NCT01077323|532599596|FG001|Overall Study|<9 months enroll before drug dispensed|263954|||
147665497|NCT01077323|532599597|FG002|Overall Study|<9 months enroll before drug dispensed|11655523|||
147665498|NCT01077323|532599595|FG000|Overall Study|Dispensing of drug in baseline period|0|||
147665499|NCT01077323|532599596|FG001|Overall Study|Dispensing of drug in baseline period|120229|||
147665500|NCT01077323|532599597|FG002|Overall Study|Dispensing of drug in baseline period|256446|||
147665501|NCT01077323|532599595|FG000|Overall Study|Baseline diagnosis of pancreatic disease|152|||
147665502|NCT01077323|532599596|FG001|Overall Study|Baseline diagnosis of pancreatic disease|2080|||
147665503|NCT01077323|532599597|FG002|Overall Study|Baseline diagnosis of pancreatic disease|120|||
147665504|NCT02984982|532599598|FG000|Overall Study|Adverse Event|2|||
147665505|NCT02984982|532599599|FG001|Overall Study|Adverse Event|5|||
147665506|NCT02984982|532599598|FG000|Overall Study|Poor Compliance to Protocol|4|||
147665507|NCT02984982|532599599|FG001|Overall Study|Poor Compliance to Protocol|4|||
147665508|NCT02984982|532599598|FG000|Overall Study|Withdrawal by Subject|2|||
147665509|NCT02984982|532599599|FG001|Overall Study|Withdrawal by Subject|0|||
147665510|NCT02984982|532599598|FG000|Overall Study|Randomized but not treated|0|||
147665511|NCT02984982|532599599|FG001|Overall Study|Randomized but not treated|1|||
147665512|NCT02153918|532599602|FG000|Overall Study|Refused further treatment|1|||
147665513|NCT02144701|532599603|FG000|Overall Study|development of relapse, GVHD or death|9|||
147665514|NCT02144701|532599604|FG001|Overall Study|development of relapse, GVHD or death|3|||
147665515|NCT02616783|532599605|FG000|Overall Study|Randomized but Not Treated|1|||
147665516|NCT02616783|532599606|FG001|Overall Study|Randomized but Not Treated|0|||
147665517|NCT02616783|532599605|FG000|Overall Study|Adverse Event|1|||
147665518|NCT02616783|532599606|FG001|Overall Study|Adverse Event|0|||
147665519|NCT02616783|532599605|FG000|Overall Study|Death|1|||
147665520|NCT02616783|532599606|FG001|Overall Study|Death|0|||
147665521|NCT02616783|532599605|FG000|Overall Study|Non-Compliance with Study Drug|1|||
147665522|NCT02616783|532599606|FG001|Overall Study|Non-Compliance with Study Drug|0|||
147665523|NCT02616783|532599605|FG000|Overall Study|Protocol Violation|1|||
147407762|NCT04210843|531658252|FG000|First Half Treatment Period (52 Weeks)|Subject decision|11|||
147407763|NCT04210843|531658253|FG001|First Half Treatment Period (52 Weeks)|Subject decision|28|||
147407764|NCT04210843|531658252|FG000|First Half Treatment Period (52 Weeks)|Lost to Follow-up|4|||
147407765|NCT04210843|531658253|FG001|First Half Treatment Period (52 Weeks)|Lost to Follow-up|2|||
147407766|NCT04210843|531658252|FG000|First Half Treatment Period (52 Weeks)|Adverse Event|1|||
147407767|NCT04210843|531658253|FG001|First Half Treatment Period (52 Weeks)|Adverse Event|11|||
147407768|NCT04210843|531658252|FG000|First Half Treatment Period (52 Weeks)|Physician Decision|0|||
147407769|NCT04210843|531658253|FG001|First Half Treatment Period (52 Weeks)|Physician Decision|3|||
147407770|NCT04210843|531658252|FG000|First Half Treatment Period (52 Weeks)|Protocol deviation|0|||
147407771|NCT04210843|531658253|FG001|First Half Treatment Period (52 Weeks)|Protocol deviation|3|||
147407772|NCT04210843|531658252|FG000|First Half Treatment Period (52 Weeks)|Death|0|||
147407773|NCT04210843|531658253|FG001|First Half Treatment Period (52 Weeks)|Death|2|||
147407774|NCT04210843|531658252|FG000|First Half Treatment Period (52 Weeks)|Lack of Efficacy|0|||
147407775|NCT04210843|531658253|FG001|First Half Treatment Period (52 Weeks)|Lack of Efficacy|2|||
147407776|NCT04210843|531658252|FG000|First Half Treatment Period (52 Weeks)|Pregnancy|0|||
147407777|NCT04210843|531658253|FG001|First Half Treatment Period (52 Weeks)|Pregnancy|1|||
147407778|NCT04210843|531658252|FG000|Second Half Treatment Period (52 Weeks)|Study terminated by sponsor|71|||
147407779|NCT04210843|531658253|FG001|Second Half Treatment Period (52 Weeks)|Study terminated by sponsor|195|||
147407780|NCT04210843|531658252|FG000|Second Half Treatment Period (52 Weeks)|Subject decision|5|||
147407781|NCT04210843|531658253|FG001|Second Half Treatment Period (52 Weeks)|Subject decision|8|||
147407782|NCT04210843|531658252|FG000|Second Half Treatment Period (52 Weeks)|Lost to Follow-up|0|||
147407783|NCT04210843|531658253|FG001|Second Half Treatment Period (52 Weeks)|Lost to Follow-up|1|||
147407784|NCT04210843|531658252|FG000|Observation Period 2 (up to 52 Weeks)|Study terminated by sponsor|45|||
147616851|NCT02366689|532413675|FG002|Overall Study|Withdrawal by Subject|1|||
147616852|NCT02366689|532413673|FG000|Overall Study|Lost to Follow-up|3|||
147616853|NCT02366689|532413674|FG001|Overall Study|Lost to Follow-up|2|||
147616854|NCT02366689|532413675|FG002|Overall Study|Lost to Follow-up|0|||
147616855|NCT02366689|532413673|FG000|Overall Study|Pregnancy|0|||
147616856|NCT02366689|532413674|FG001|Overall Study|Pregnancy|1|||
147616857|NCT02366689|532413675|FG002|Overall Study|Pregnancy|1|||
147665524|NCT02616783|532599606|FG001|Overall Study|Protocol Violation|1|||
147665525|NCT02616783|532599605|FG000|Overall Study|Withdrew Consent|1|||
147665526|NCT02616783|532599606|FG001|Overall Study|Withdrew Consent|1|||
147665527|NCT01103323|532599607|FG000|Without/Before Drug Switch|Adverse Event|50|||
147407785|NCT04210843|531658253|FG001|Observation Period 2 (up to 52 Weeks)|Study terminated by sponsor|107|||
147407786|NCT04210843|531658252|FG000|Observation Period 2 (up to 52 Weeks)|Adverse Event|0|||
147407787|NCT04210843|531658253|FG001|Observation Period 2 (up to 52 Weeks)|Adverse Event|1|||
147407788|NCT04210843|531658252|FG000|Observation Period 2 (up to 52 Weeks)|Lost to Follow-up|0|||
147407789|NCT04210843|531658253|FG001|Observation Period 2 (up to 52 Weeks)|Lost to Follow-up|1|||
147407790|NCT04210843|531658252|FG000|Observation Period 2 (up to 52 Weeks)|Subject decision|0|||
147407791|NCT04210843|531658253|FG001|Observation Period 2 (up to 52 Weeks)|Subject decision|1|||
147407792|NCT04210843|531658252|FG000|Follow-up Period (up to 12 or 52 Weeks)|Subject decision|16|||
147407793|NCT04210843|531658253|FG001|Follow-up Period (up to 12 or 52 Weeks)|Subject decision|32|||
147407794|NCT04210843|531658252|FG000|Follow-up Period (up to 12 or 52 Weeks)|Physician Decision|4|||
147407795|NCT04210843|531658253|FG001|Follow-up Period (up to 12 or 52 Weeks)|Physician Decision|16|||
147407796|NCT04210843|531658252|FG000|Follow-up Period (up to 12 or 52 Weeks)|Adverse Event|1|||
147407797|NCT04210843|531658253|FG001|Follow-up Period (up to 12 or 52 Weeks)|Adverse Event|6|||
147407798|NCT04210843|531658252|FG000|Follow-up Period (up to 12 or 52 Weeks)|Lost to Follow-up|0|||
147407799|NCT04210843|531658253|FG001|Follow-up Period (up to 12 or 52 Weeks)|Lost to Follow-up|5|||
147407800|NCT04210843|531658252|FG000|Follow-up Period (up to 12 or 52 Weeks)|New therapy for study indication|2|||
147407801|NCT04210843|531658253|FG001|Follow-up Period (up to 12 or 52 Weeks)|New therapy for study indication|1|||
147407802|NCT04210843|531658252|FG000|Follow-up Period (up to 12 or 52 Weeks)|Lack of Efficacy|0|||
147407803|NCT04210843|531658253|FG001|Follow-up Period (up to 12 or 52 Weeks)|Lack of Efficacy|2|||
147407804|NCT04210843|531658252|FG000|Follow-up Period (up to 12 or 52 Weeks)|Pregnancy|0|||
147407805|NCT04210843|531658253|FG001|Follow-up Period (up to 12 or 52 Weeks)|Pregnancy|1|||
147407806|NCT04210843|531658252|FG000|Follow-up Period (up to 12 or 52 Weeks)|Protocol deviation|0|||
147407807|NCT04210843|531658253|FG001|Follow-up Period (up to 12 or 52 Weeks)|Protocol deviation|1|||
147407808|NCT01099917|531658254|FG000|Overall Study|Adverse Event|3|||
147407809|NCT01099917|531658254|FG000|Overall Study|Not Treated|24|||
147407810|NCT01485120|531658257|FG000|Overall Study|Withdrawal by Subject|2|||
147407811|NCT00422734|531658258|FG000|Overall Study|Physician Decision|1|||
147407812|NCT00422734|531658259|FG001|Overall Study|Physician Decision|1|||
147407813|NCT00422734|531658258|FG000|Overall Study|Protocol Violation|1|||
147407814|NCT00422734|531658259|FG001|Overall Study|Protocol Violation|6|||
147407815|NCT00422734|531658258|FG000|Overall Study|Withdrawal by Subject|12|||
147407816|NCT00422734|531658259|FG001|Overall Study|Withdrawal by Subject|8|||
147407817|NCT00422734|531658258|FG000|Overall Study|Adverse Event|0|||
147407818|NCT00422734|531658259|FG001|Overall Study|Adverse Event|3|||
147407819|NCT00422734|531658258|FG000|Overall Study|Partner Decision|0|||
147407820|NCT00422734|531658259|FG001|Overall Study|Partner Decision|3|||
147407821|NCT02344342|531658260|FG000|Overall Study|Industry partner dropped out|11|||
147407822|NCT02344342|531658261|FG001|Overall Study|Industry partner dropped out|9|||
147407823|NCT02344342|531658262|FG002|Overall Study|Industry partner dropped out|14|||
147407824|NCT02344342|531658263|FG003|Overall Study|Industry partner dropped out|10|||
147407825|NCT00848484|531658264|FG000|First Intervention (Treatment Period 1)|Adverse Event|2|||
147407826|NCT00848484|531658265|FG001|First Intervention (Treatment Period 1)|Adverse Event|1|||
147407827|NCT00848484|531658264|FG000|First Intervention (Treatment Period 1)|Physician Decision|0|||
147407828|NCT00848484|531658265|FG001|First Intervention (Treatment Period 1)|Physician Decision|1|||
147407829|NCT00848484|531658264|FG000|First Intervention (Treatment Period 1)|Withdrawal by Subject|0|||
147407830|NCT00848484|531658265|FG001|First Intervention (Treatment Period 1)|Withdrawal by Subject|1|||
147407831|NCT00848484|531658264|FG000|Washout Period of Two Weeks|Withdrawal by Subject|0|||
147407832|NCT00848484|531658265|FG001|Washout Period of Two Weeks|Withdrawal by Subject|3|||
147407833|NCT00848484|531658264|FG000|Second Intervention (Treatment Period 2)|Lost to Follow-up|0|||
147407834|NCT00848484|531658265|FG001|Second Intervention (Treatment Period 2)|Lost to Follow-up|1|||
147407835|NCT03355209|531658269|FG000|Part 1: Double-Blind Period|Adverse Event|0|||
147407836|NCT03355209|531658270|FG001|Part 1: Double-Blind Period|Adverse Event|4|||
147407837|NCT03355209|531658271|FG002|Part 1: Double-Blind Period|Adverse Event|4|||
147407838|NCT03355209|531658272|FG003|Part 1: Double-Blind Period|Adverse Event|0|||
147407839|NCT03355209|531658273|FG004|Part 1: Double-Blind Period|Adverse Event|1|||
147407840|NCT03355209|531658274|FG005|Part 1: Double-Blind Period|Adverse Event|0|||
147407841|NCT03355209|531658269|FG000|Part 1: Double-Blind Period|Death|0|||
147407842|NCT03355209|531658270|FG001|Part 1: Double-Blind Period|Death|0|||
147407843|NCT03355209|531658271|FG002|Part 1: Double-Blind Period|Death|1|||
147407844|NCT03355209|531658272|FG003|Part 1: Double-Blind Period|Death|0|||
147407845|NCT03355209|531658273|FG004|Part 1: Double-Blind Period|Death|0|||
147407846|NCT03355209|531658274|FG005|Part 1: Double-Blind Period|Death|0|||
147407847|NCT03355209|531658269|FG000|Part 1: Double-Blind Period|Physician Decision|0|||
147407848|NCT03355209|531658270|FG001|Part 1: Double-Blind Period|Physician Decision|1|||
147407849|NCT03355209|531658271|FG002|Part 1: Double-Blind Period|Physician Decision|0|||
147407850|NCT03355209|531658272|FG003|Part 1: Double-Blind Period|Physician Decision|0|||
147407851|NCT03355209|531658273|FG004|Part 1: Double-Blind Period|Physician Decision|0|||
147407852|NCT03355209|531658274|FG005|Part 1: Double-Blind Period|Physician Decision|0|||
147407853|NCT03355209|531658269|FG000|Part 1: Double-Blind Period|Withdrawal by Subject|1|||
147464647|NCT00896532|531860303|FG022|Months 48-72: Follow-on Phase|Withdrawal by Subject|0|||
147616858|NCT01290068|532413676|FG000|Overall Study|Adverse Event|1|||
147616859|NCT01290068|532413677|FG001|Overall Study|Adverse Event|3|||
147616860|NCT01290068|532413676|FG000|Overall Study|Lost to Follow-up|3|||
147616861|NCT01290068|532413677|FG001|Overall Study|Lost to Follow-up|0|||
147616862|NCT01290068|532413676|FG000|Overall Study|Withdrawal by subject prior to implant|0|||
147407854|NCT03355209|531658270|FG001|Part 1: Double-Blind Period|Withdrawal by Subject|1|||
147407855|NCT03355209|531658271|FG002|Part 1: Double-Blind Period|Withdrawal by Subject|1|||
147407856|NCT03355209|531658272|FG003|Part 1: Double-Blind Period|Withdrawal by Subject|0|||
147407857|NCT03355209|531658273|FG004|Part 1: Double-Blind Period|Withdrawal by Subject|0|||
147407858|NCT03355209|531658274|FG005|Part 1: Double-Blind Period|Withdrawal by Subject|0|||
147407859|NCT03355209|531658269|FG000|Part 2:Open-Label Extension (OLE) Period|Adverse Event|5|||
147407860|NCT03355209|531658270|FG001|Part 2:Open-Label Extension (OLE) Period|Adverse Event|5|||
147407861|NCT03355209|531658271|FG002|Part 2:Open-Label Extension (OLE) Period|Adverse Event|3|||
147407862|NCT03355209|531658272|FG003|Part 2:Open-Label Extension (OLE) Period|Adverse Event|0|||
147407863|NCT03355209|531658273|FG004|Part 2:Open-Label Extension (OLE) Period|Adverse Event|1|||
147407864|NCT03355209|531658274|FG005|Part 2:Open-Label Extension (OLE) Period|Adverse Event|1|||
147407865|NCT03355209|531658269|FG000|Part 2:Open-Label Extension (OLE) Period|Death|0|||
147407866|NCT03355209|531658270|FG001|Part 2:Open-Label Extension (OLE) Period|Death|1|||
147407867|NCT03355209|531658271|FG002|Part 2:Open-Label Extension (OLE) Period|Death|0|||
147407868|NCT03355209|531658272|FG003|Part 2:Open-Label Extension (OLE) Period|Death|0|||
147407869|NCT03355209|531658273|FG004|Part 2:Open-Label Extension (OLE) Period|Death|0|||
147407870|NCT03355209|531658274|FG005|Part 2:Open-Label Extension (OLE) Period|Death|0|||
147407871|NCT03355209|531658269|FG000|Part 2:Open-Label Extension (OLE) Period|Lack of Efficacy|13|||
147407872|NCT03355209|531658270|FG001|Part 2:Open-Label Extension (OLE) Period|Lack of Efficacy|21|||
147407873|NCT03355209|531658271|FG002|Part 2:Open-Label Extension (OLE) Period|Lack of Efficacy|23|||
147407874|NCT03355209|531658272|FG003|Part 2:Open-Label Extension (OLE) Period|Lack of Efficacy|0|||
147407875|NCT03355209|531658273|FG004|Part 2:Open-Label Extension (OLE) Period|Lack of Efficacy|0|||
147407876|NCT03355209|531658274|FG005|Part 2:Open-Label Extension (OLE) Period|Lack of Efficacy|1|||
147407877|NCT03355209|531658269|FG000|Part 2:Open-Label Extension (OLE) Period|Switching to commercial ZX008|0|||
147407878|NCT03355209|531658270|FG001|Part 2:Open-Label Extension (OLE) Period|Switching to commercial ZX008|0|||
147407879|NCT03355209|531658271|FG002|Part 2:Open-Label Extension (OLE) Period|Switching to commercial ZX008|0|||
147407880|NCT03355209|531658272|FG003|Part 2:Open-Label Extension (OLE) Period|Switching to commercial ZX008|5|||
147407881|NCT03355209|531658273|FG004|Part 2:Open-Label Extension (OLE) Period|Switching to commercial ZX008|6|||
147407882|NCT03355209|531658274|FG005|Part 2:Open-Label Extension (OLE) Period|Switching to commercial ZX008|3|||
147407883|NCT03355209|531658269|FG000|Part 2:Open-Label Extension (OLE) Period|Withdrawal by Subject|6|||
147407884|NCT03355209|531658270|FG001|Part 2:Open-Label Extension (OLE) Period|Withdrawal by Subject|5|||
147407885|NCT03355209|531658271|FG002|Part 2:Open-Label Extension (OLE) Period|Withdrawal by Subject|4|||
147407886|NCT03355209|531658272|FG003|Part 2:Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
147407887|NCT03355209|531658273|FG004|Part 2:Open-Label Extension (OLE) Period|Withdrawal by Subject|2|||
147407888|NCT03355209|531658274|FG005|Part 2:Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
147407889|NCT03355209|531658269|FG000|Part 2:Open-Label Extension (OLE) Period|Physician Decision|0|||
147407890|NCT03355209|531658270|FG001|Part 2:Open-Label Extension (OLE) Period|Physician Decision|0|||
147407891|NCT03355209|531658271|FG002|Part 2:Open-Label Extension (OLE) Period|Physician Decision|0|||
147407892|NCT03355209|531658272|FG003|Part 2:Open-Label Extension (OLE) Period|Physician Decision|1|||
147407893|NCT03355209|531658273|FG004|Part 2:Open-Label Extension (OLE) Period|Physician Decision|0|||
147407894|NCT03355209|531658274|FG005|Part 2:Open-Label Extension (OLE) Period|Physician Decision|1|||
147407895|NCT03355209|531658269|FG000|Part 2:Open-Label Extension (OLE) Period|Rollover into ZX008-1900|1|||
147407896|NCT03355209|531658270|FG001|Part 2:Open-Label Extension (OLE) Period|Rollover into ZX008-1900|0|||
147407897|NCT03355209|531658271|FG002|Part 2:Open-Label Extension (OLE) Period|Rollover into ZX008-1900|2|||
147407898|NCT03355209|531658272|FG003|Part 2:Open-Label Extension (OLE) Period|Rollover into ZX008-1900|0|||
147407899|NCT03355209|531658273|FG004|Part 2:Open-Label Extension (OLE) Period|Rollover into ZX008-1900|0|||
147407900|NCT03355209|531658274|FG005|Part 2:Open-Label Extension (OLE) Period|Rollover into ZX008-1900|0|||
147407901|NCT01081886|531658275|FG000|Overall Study|Study termination|11|||
147407902|NCT01081886|531658276|FG001|Overall Study|Study termination|13|||
147407903|NCT02567708|531658277|FG000|Treatment Period 1 (Up to 4 Weeks)|Adverse Event|0|||
147407904|NCT02567708|531658278|FG001|Treatment Period 1 (Up to 4 Weeks)|Adverse Event|2|||
147407905|NCT02567708|531658277|FG000|Treatment Period 1 (Up to 4 Weeks)|Protocol Violation|0|||
147407906|NCT02567708|531658278|FG001|Treatment Period 1 (Up to 4 Weeks)|Protocol Violation|1|||
147407907|NCT02567708|531658277|FG000|Treatment Period 1 (Up to 4 Weeks)|Other: Reached stopping criteria|2|||
147407908|NCT02567708|531658278|FG001|Treatment Period 1 (Up to 4 Weeks)|Other: Reached stopping criteria|0|||
147407909|NCT02567708|531658277|FG000|Treatment Period 2 (Up to 4 Weeks)|Other: Reached stopping criteria|0|||
147407910|NCT02567708|531658278|FG001|Treatment Period 2 (Up to 4 Weeks)|Other: Reached stopping criteria|3|||
147616863|NCT01290068|532413677|FG001|Overall Study|Withdrawal by subject prior to implant|2|||
147616864|NCT01290068|532413676|FG000|Overall Study|Other|3|||
147616865|NCT01290068|532413677|FG001|Overall Study|Other|1|||
147616866|NCT03283566|532413678|FG000|Overall Study|Lost to Follow-up|1|||
147407911|NCT00706654|531658279|FG000|Conversion Phase|Lost to Follow-up|4|||
147407912|NCT00706654|531658280|FG001|Conversion Phase|Lost to Follow-up|0|||
147407913|NCT00706654|531658281|FG002|Conversion Phase|Lost to Follow-up|0|||
147407914|NCT00706654|531658282|FG003|Conversion Phase|Lost to Follow-up|0|||
147407915|NCT00706654|531658279|FG000|Conversion Phase|Sponsor Discontinued Trial|8|||
147407916|NCT00706654|531658280|FG001|Conversion Phase|Sponsor Discontinued Trial|0|||
147407917|NCT00706654|531658281|FG002|Conversion Phase|Sponsor Discontinued Trial|0|||
147407918|NCT00706654|531658282|FG003|Conversion Phase|Sponsor Discontinued Trial|0|||
147407919|NCT00706654|531658279|FG000|Conversion Phase|Met Withdrawal Criteria|2|||
147407920|NCT00706654|531658280|FG001|Conversion Phase|Met Withdrawal Criteria|0|||
147407921|NCT00706654|531658281|FG002|Conversion Phase|Met Withdrawal Criteria|0|||
147407922|NCT00706654|531658282|FG003|Conversion Phase|Met Withdrawal Criteria|0|||
147407923|NCT00706654|531658279|FG000|Conversion Phase|Withdrawn by Investigator|14|||
147407924|NCT00706654|531658280|FG001|Conversion Phase|Withdrawn by Investigator|0|||
147407925|NCT00706654|531658281|FG002|Conversion Phase|Withdrawn by Investigator|0|||
147407926|NCT00706654|531658282|FG003|Conversion Phase|Withdrawn by Investigator|0|||
147407927|NCT00706654|531658279|FG000|Conversion Phase|Withdrew Consent|38|||
147407928|NCT00706654|531658280|FG001|Conversion Phase|Withdrew Consent|0|||
147407929|NCT00706654|531658281|FG002|Conversion Phase|Withdrew Consent|0|||
147407930|NCT00706654|531658282|FG003|Conversion Phase|Withdrew Consent|0|||
147407931|NCT00706654|531658279|FG000|Conversion Phase|Adverse Event|18|||
147407932|NCT00706654|531658280|FG001|Conversion Phase|Adverse Event|0|||
147407933|NCT00706654|531658281|FG002|Conversion Phase|Adverse Event|0|||
147407934|NCT00706654|531658282|FG003|Conversion Phase|Adverse Event|0|||
147407935|NCT00706654|531658279|FG000|Conversion Phase|Lack of Efficacy with Adverse Event|9|||
147407936|NCT00706654|531658280|FG001|Conversion Phase|Lack of Efficacy with Adverse Event|0|||
147407937|NCT00706654|531658281|FG002|Conversion Phase|Lack of Efficacy with Adverse Event|0|||
147407938|NCT00706654|531658282|FG003|Conversion Phase|Lack of Efficacy with Adverse Event|0|||
147407939|NCT00706654|531658279|FG000|Conversion Phase|Lack of Efficacy without Adverse Event|2|||
147407940|NCT00706654|531658280|FG001|Conversion Phase|Lack of Efficacy without Adverse Event|0|||
147407941|NCT00706654|531658281|FG002|Conversion Phase|Lack of Efficacy without Adverse Event|0|||
147407942|NCT00706654|531658282|FG003|Conversion Phase|Lack of Efficacy without Adverse Event|0|||
147407943|NCT00706654|531658279|FG000|Oral Stabilization Phase|Lost to Follow-up|17|||
147407944|NCT00706654|531658280|FG001|Oral Stabilization Phase|Lost to Follow-up|0|||
147407945|NCT00706654|531658281|FG002|Oral Stabilization Phase|Lost to Follow-up|0|||
147407946|NCT00706654|531658282|FG003|Oral Stabilization Phase|Lost to Follow-up|0|||
147407947|NCT00706654|531658279|FG000|Oral Stabilization Phase|Sponsor Discontinue Trial|19|||
147407948|NCT00706654|531658280|FG001|Oral Stabilization Phase|Sponsor Discontinue Trial|0|||
147407949|NCT00706654|531658281|FG002|Oral Stabilization Phase|Sponsor Discontinue Trial|0|||
147407950|NCT00706654|531658282|FG003|Oral Stabilization Phase|Sponsor Discontinue Trial|0|||
147407951|NCT00706654|531658279|FG000|Oral Stabilization Phase|Met Withdrawal Criteria|15|||
147407952|NCT00706654|531658280|FG001|Oral Stabilization Phase|Met Withdrawal Criteria|0|||
147407953|NCT00706654|531658281|FG002|Oral Stabilization Phase|Met Withdrawal Criteria|0|||
147407954|NCT00706654|531658282|FG003|Oral Stabilization Phase|Met Withdrawal Criteria|0|||
147407955|NCT00706654|531658279|FG000|Oral Stabilization Phase|Withdrawn by Investigator|21|||
147407956|NCT00706654|531658280|FG001|Oral Stabilization Phase|Withdrawn by Investigator|0|||
147407957|NCT00706654|531658281|FG002|Oral Stabilization Phase|Withdrawn by Investigator|0|||
147407958|NCT00706654|531658282|FG003|Oral Stabilization Phase|Withdrawn by Investigator|0|||
147407959|NCT00706654|531658279|FG000|Oral Stabilization Phase|Withdrew consent|55|||
147407960|NCT00706654|531658280|FG001|Oral Stabilization Phase|Withdrew consent|0|||
147407961|NCT00706654|531658281|FG002|Oral Stabilization Phase|Withdrew consent|0|||
147407962|NCT00706654|531658282|FG003|Oral Stabilization Phase|Withdrew consent|0|||
147407963|NCT00706654|531658279|FG000|Oral Stabilization Phase|Protocol Deviation|2|||
147407964|NCT00706654|531658280|FG001|Oral Stabilization Phase|Protocol Deviation|0|||
147407965|NCT00706654|531658281|FG002|Oral Stabilization Phase|Protocol Deviation|0|||
147407966|NCT00706654|531658282|FG003|Oral Stabilization Phase|Protocol Deviation|0|||
147407967|NCT00706654|531658279|FG000|Oral Stabilization Phase|Adverse Event|21|||
147407968|NCT00706654|531658280|FG001|Oral Stabilization Phase|Adverse Event|0|||
147407969|NCT00706654|531658281|FG002|Oral Stabilization Phase|Adverse Event|0|||
147407970|NCT00706654|531658282|FG003|Oral Stabilization Phase|Adverse Event|0|||
147407971|NCT00706654|531658279|FG000|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|20|||
147407972|NCT00706654|531658280|FG001|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
147407973|NCT00706654|531658281|FG002|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
147407974|NCT00706654|531658282|FG003|Oral Stabilization Phase|Lack of Efficacy with Adverse Event|0|||
147616867|NCT03283566|532413679|FG001|Overall Study|Lost to Follow-up|2|||
147616868|NCT00853099|532413680|FG000|Double-blind Period|Adverse Event|7|||
147616869|NCT00853099|532413681|FG001|Double-blind Period|Adverse Event|9|||
147407975|NCT00706654|531658279|FG000|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|10|||
147407976|NCT00706654|531658280|FG001|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
147407977|NCT00706654|531658281|FG002|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
147616870|NCT00853099|532413682|FG002|Double-blind Period|Adverse Event|13|||
147407978|NCT00706654|531658282|FG003|Oral Stabilization Phase|Lack of Efficacy without Adverse Event|0|||
147407979|NCT00706654|531658279|FG000|Depot Maintenance Phase|Lost to Follow-up|0|||
147407980|NCT00706654|531658280|FG001|Depot Maintenance Phase|Lost to Follow-up|4|||
147407981|NCT00706654|531658281|FG002|Depot Maintenance Phase|Lost to Follow-up|10|||
147407982|NCT00706654|531658282|FG003|Depot Maintenance Phase|Lost to Follow-up|6|||
147407983|NCT00706654|531658279|FG000|Depot Maintenance Phase|Met Withdrawal Criteria|0|||
147407984|NCT00706654|531658280|FG001|Depot Maintenance Phase|Met Withdrawal Criteria|4|||
147407985|NCT00706654|531658281|FG002|Depot Maintenance Phase|Met Withdrawal Criteria|6|||
147407986|NCT00706654|531658282|FG003|Depot Maintenance Phase|Met Withdrawal Criteria|5|||
147407987|NCT00706654|531658279|FG000|Depot Maintenance Phase|Withdrawn by Investigator|0|||
147407988|NCT00706654|531658280|FG001|Depot Maintenance Phase|Withdrawn by Investigator|8|||
147407989|NCT00706654|531658281|FG002|Depot Maintenance Phase|Withdrawn by Investigator|12|||
147407990|NCT00706654|531658282|FG003|Depot Maintenance Phase|Withdrawn by Investigator|8|||
147407991|NCT00706654|531658279|FG000|Depot Maintenance Phase|Withdrew Consent|0|||
147407992|NCT00706654|531658280|FG001|Depot Maintenance Phase|Withdrew Consent|21|||
147407993|NCT00706654|531658281|FG002|Depot Maintenance Phase|Withdrew Consent|29|||
147407994|NCT00706654|531658282|FG003|Depot Maintenance Phase|Withdrew Consent|14|||
147407995|NCT00706654|531658279|FG000|Depot Maintenance Phase|Protocol Deviation|0|||
147407996|NCT00706654|531658280|FG001|Depot Maintenance Phase|Protocol Deviation|2|||
147407997|NCT00706654|531658281|FG002|Depot Maintenance Phase|Protocol Deviation|3|||
147407998|NCT00706654|531658282|FG003|Depot Maintenance Phase|Protocol Deviation|1|||
147407999|NCT00706654|531658279|FG000|Depot Maintenance Phase|Adverse Event without Impending Relapse|0|||
147408000|NCT00706654|531658280|FG001|Depot Maintenance Phase|Adverse Event without Impending Relapse|8|||
147408001|NCT00706654|531658281|FG002|Depot Maintenance Phase|Adverse Event without Impending Relapse|7|||
147408002|NCT00706654|531658282|FG003|Depot Maintenance Phase|Adverse Event without Impending Relapse|7|||
147408003|NCT00706654|531658279|FG000|Depot Maintenance Phase|Impending Relapse with Adverse Event|0|||
147408004|NCT00706654|531658280|FG001|Depot Maintenance Phase|Impending Relapse with Adverse Event|13|||
147408005|NCT00706654|531658281|FG002|Depot Maintenance Phase|Impending Relapse with Adverse Event|12|||
147408006|NCT00706654|531658282|FG003|Depot Maintenance Phase|Impending Relapse with Adverse Event|17|||
147408007|NCT00706654|531658279|FG000|Depot Maintenance Phase|Impending Relapse without Adverse Event|0|||
147408008|NCT00706654|531658280|FG001|Depot Maintenance Phase|Impending Relapse without Adverse Event|9|||
147408009|NCT00706654|531658281|FG002|Depot Maintenance Phase|Impending Relapse without Adverse Event|9|||
147408010|NCT00706654|531658282|FG003|Depot Maintenance Phase|Impending Relapse without Adverse Event|12|||
147408011|NCT05262751|531658284|FG000|Washout Period 2|Adverse Event|1|||
147408012|NCT05262751|531658285|FG001|Washout Period 2|Adverse Event|0|||
147408013|NCT05262751|531658286|FG002|Washout Period 2|Adverse Event|0|||
147408014|NCT05262751|531658287|FG003|Washout Period 2|Adverse Event|0|||
147408015|NCT05262751|531658288|FG004|Washout Period 2|Adverse Event|0|||
147408016|NCT05262751|531658289|FG005|Washout Period 2|Adverse Event|0|||
147408017|NCT05262751|531658284|FG000|Treatment Period 3|Not treated because of an adverse event|0|||
147408018|NCT05262751|531658285|FG001|Treatment Period 3|Not treated because of an adverse event|1|||
147408019|NCT05262751|531658286|FG002|Treatment Period 3|Not treated because of an adverse event|0|||
147408020|NCT05262751|531658287|FG003|Treatment Period 3|Not treated because of an adverse event|0|||
147408021|NCT05262751|531658288|FG004|Treatment Period 3|Not treated because of an adverse event|0|||
147408022|NCT05262751|531658289|FG005|Treatment Period 3|Not treated because of an adverse event|0|||
147408023|NCT01154140|531658291|FG000|Overall Study|Death|71|||
147408024|NCT01154140|531658292|FG001|Overall Study|Death|81|||
147408025|NCT01154140|531658291|FG000|Overall Study|Lost to Follow-up|4|||
147408026|NCT01154140|531658292|FG001|Overall Study|Lost to Follow-up|5|||
147408027|NCT01154140|531658291|FG000|Overall Study|Withdrawal by Subject|12|||
147408028|NCT01154140|531658292|FG001|Overall Study|Withdrawal by Subject|13|||
147408029|NCT01154140|531658291|FG000|Overall Study|Other|3|||
147408030|NCT01154140|531658292|FG001|Overall Study|Other|1|||
147408031|NCT01154140|531658291|FG000|Overall Study|Randomized but not treated|1|||
147408032|NCT01154140|531658292|FG001|Overall Study|Randomized but not treated|2|||
147408033|NCT04276051|531658295|FG000|Overall Study|Lost to Follow-up|0|||
147408034|NCT04276051|531658296|FG001|Overall Study|Lost to Follow-up|1|||
147408035|NCT04276051|531658295|FG000|Overall Study|Physician Decision|0|||
147408036|NCT04276051|531658296|FG001|Overall Study|Physician Decision|1|||
147408037|NCT04276051|531658295|FG000|Overall Study|Withdrawal by Subject|1|||
147408038|NCT04276051|531658296|FG001|Overall Study|Withdrawal by Subject|1|||
147408039|NCT01912404|531658297|FG000|Overall Study|Due to personal reasons|1|||
147408040|NCT01912404|531658298|FG001|Overall Study|Due to personal reasons|0|||
147408041|NCT01754753|531658299|FG000|Overall Study|Study close|43|||
147408042|NCT01754753|531658300|FG001|Overall Study|Study close|44|||
147408043|NCT01754753|531658299|FG000|Overall Study|Lost to Follow-up|9|||
147408044|NCT01754753|531658300|FG001|Overall Study|Lost to Follow-up|5|||
147408045|NCT00760747|531658308|FG000|Study Period II|Adverse Event|3|||
147408046|NCT00760747|531658309|FG001|Study Period II|Adverse Event|4|||
147408047|NCT00760747|531658308|FG000|Study Period II|Lack of Efficacy|0|||
147408048|NCT00760747|531658309|FG001|Study Period II|Lack of Efficacy|6|||
147408049|NCT00760747|531658308|FG000|Study Period II|Parent/Caregiver Decision|3|||
147616871|NCT00853099|532413683|FG003|Double-blind Period|Adverse Event|0|||
147616872|NCT00853099|532413680|FG000|Double-blind Period|Withdrawal by Subject|2|||
147616873|NCT00853099|532413681|FG001|Double-blind Period|Withdrawal by Subject|3|||
147616874|NCT00853099|532413682|FG002|Double-blind Period|Withdrawal by Subject|0|||
147616875|NCT00853099|532413683|FG003|Double-blind Period|Withdrawal by Subject|0|||
147616876|NCT00853099|532413680|FG000|Double-blind Period|Lack of Efficacy|14|||
147616877|NCT00853099|532413681|FG001|Double-blind Period|Lack of Efficacy|17|||
147616878|NCT00853099|532413682|FG002|Double-blind Period|Lack of Efficacy|16|||
147616879|NCT00853099|532413683|FG003|Double-blind Period|Lack of Efficacy|0|||
147616880|NCT00853099|532413680|FG000|Double-blind Period|Other|0|||
147616881|NCT00853099|532413681|FG001|Double-blind Period|Other|0|||
147616882|NCT00853099|532413682|FG002|Double-blind Period|Other|1|||
147616883|NCT00853099|532413683|FG003|Double-blind Period|Other|0|||
147616884|NCT00853099|532413680|FG000|Double-blind Period|Mistreated with rescue study drug|0|||
147616885|NCT00853099|532413681|FG001|Double-blind Period|Mistreated with rescue study drug|0|||
147616886|NCT00853099|532413682|FG002|Double-blind Period|Mistreated with rescue study drug|1|||
147616887|NCT00853099|532413683|FG003|Double-blind Period|Mistreated with rescue study drug|0|||
147616888|NCT00853099|532413680|FG000|Double-blind + Open-label Periods|Lack of Efficacy|0|||
147616889|NCT00853099|532413681|FG001|Double-blind + Open-label Periods|Lack of Efficacy|0|||
147616890|NCT00853099|532413682|FG002|Double-blind + Open-label Periods|Lack of Efficacy|0|||
147616891|NCT00853099|532413683|FG003|Double-blind + Open-label Periods|Lack of Efficacy|74|||
147616892|NCT00853099|532413680|FG000|Double-blind + Open-label Periods|Adverse Event|0|||
147616893|NCT00853099|532413681|FG001|Double-blind + Open-label Periods|Adverse Event|0|||
147616894|NCT00853099|532413682|FG002|Double-blind + Open-label Periods|Adverse Event|0|||
147616895|NCT00853099|532413683|FG003|Double-blind + Open-label Periods|Adverse Event|47|||
147616896|NCT00853099|532413680|FG000|Double-blind + Open-label Periods|Withdrawal by Subject|0|||
147408050|NCT00760747|531658309|FG001|Study Period II|Parent/Caregiver Decision|0|||
147408051|NCT00760747|531658308|FG000|Study Period II|Protocol Violation|6|||
147408052|NCT00760747|531658309|FG001|Study Period II|Protocol Violation|3|||
147408053|NCT00760747|531658308|FG000|Study Period II|Withdrawal by Subject|1|||
147408054|NCT00760747|531658309|FG001|Study Period II|Withdrawal by Subject|0|||
147408055|NCT00760747|531658308|FG000|Study Period II|No drug administered|0|||
147408056|NCT00760747|531658309|FG001|Study Period II|No drug administered|1|||
147408057|NCT00760747|531658308|FG000|Study Period III|Adverse Event|1|||
147408058|NCT00760747|531658309|FG001|Study Period III|Adverse Event|0|||
147408059|NCT00760747|531658308|FG000|Study Period III|Lack of Efficacy|1|||
147408060|NCT00760747|531658309|FG001|Study Period III|Lack of Efficacy|0|||
147408061|NCT00760747|531658308|FG000|Study Period III|Parent/Caregiver Decision|0|||
147408062|NCT00760747|531658309|FG001|Study Period III|Parent/Caregiver Decision|1|||
147408063|NCT00760747|531658308|FG000|Study Period III|Protocol Violation|1|||
147408064|NCT00760747|531658309|FG001|Study Period III|Protocol Violation|1|||
147408065|NCT00760747|531658308|FG000|Study Period III|Physician Decision|0|||
147408066|NCT00760747|531658309|FG001|Study Period III|Physician Decision|1|||
147408067|NCT00844597|531658310|FG000|Overall Study|Adverse Event|0|||
147408068|NCT00844597|531658311|FG001|Overall Study|Adverse Event|0|||
147408069|NCT00844597|531658312|FG002|Overall Study|Adverse Event|0|||
147408070|NCT00844597|531658313|FG003|Overall Study|Adverse Event|1|||
147408071|NCT00844597|531658314|FG004|Overall Study|Adverse Event|0|||
147408072|NCT00844597|531658315|FG005|Overall Study|Adverse Event|0|||
147408073|NCT00455741|531658318|FG000|Overall Study|Physician Decision|0|||
147408074|NCT00455741|531658319|FG001|Overall Study|Physician Decision|1|||
147408075|NCT00243074|531658321|FG000|Overall Study|Ineligible|6|||
147408076|NCT00243074|531658321|FG000|Overall Study|Adverse Event|6|||
147408077|NCT00243074|531658321|FG000|Overall Study|Withdrawal by Subject|2|||
147616897|NCT00853099|532413681|FG001|Double-blind + Open-label Periods|Withdrawal by Subject|0|||
147616898|NCT00853099|532413682|FG002|Double-blind + Open-label Periods|Withdrawal by Subject|0|||
147616899|NCT00853099|532413683|FG003|Double-blind + Open-label Periods|Withdrawal by Subject|20|||
147616900|NCT00853099|532413680|FG000|Double-blind + Open-label Periods|Other|0|||
147408078|NCT00243074|531658321|FG000|Overall Study|Lack of Efficacy|36|||
147408079|NCT00243074|531658321|FG000|Overall Study|Death|2|||
147408080|NCT00243074|531658321|FG000|Overall Study|not protocol specified|1|||
147408081|NCT00243074|531658321|FG000|Overall Study|Did not receive any treatment|1|||
147408082|NCT00475228|531658322|FG000|Overall Study|Lost to Follow-up|17|||
147408083|NCT00475228|531658323|FG001|Overall Study|Lost to Follow-up|17|||
147408084|NCT02209181|531658324|FG000|Overall Study|Adverse Event|1|||
147408085|NCT02209181|531658325|FG001|Overall Study|Adverse Event|0|||
147408086|NCT02209181|531658326|FG002|Overall Study|Adverse Event|1|||
147408087|NCT02209181|531658327|FG003|Overall Study|Adverse Event|0|||
147616901|NCT00853099|532413681|FG001|Double-blind + Open-label Periods|Other|0|||
147616902|NCT00853099|532413682|FG002|Double-blind + Open-label Periods|Other|0|||
147616903|NCT00853099|532413683|FG003|Double-blind + Open-label Periods|Other|6|||
147408088|NCT02209181|531658324|FG000|Overall Study|Withdrawal by Subject|0|||
147408089|NCT02209181|531658325|FG001|Overall Study|Withdrawal by Subject|1|||
147408090|NCT02209181|531658326|FG002|Overall Study|Withdrawal by Subject|0|||
147408091|NCT02209181|531658327|FG003|Overall Study|Withdrawal by Subject|0|||
147464648|NCT01671280|531860304|FG000|Overall Study|Withdrawal by Subject|2|||
147464649|NCT03686969|531860305|FG000|Overall Study|Study terminated|1|||
147464650|NCT03686969|531860306|FG001|Overall Study|Study terminated|0|||
147464651|NCT01988090|531860311|FG000|Start Treament After Randomization|Withdrawal by Subject|2|||
147464652|NCT01988090|531860312|FG001|Start Treament After Randomization|Withdrawal by Subject|3|||
147464653|NCT01988090|531860311|FG000|Start Treament After Randomization|Protocol Violation|0|||
147464654|NCT01988090|531860312|FG001|Start Treament After Randomization|Protocol Violation|1|||
147464655|NCT01988090|531860311|FG000|Complete Study After Start|Withdrawal by Subject|2|||
147464656|NCT01988090|531860312|FG001|Complete Study After Start|Withdrawal by Subject|0|||
147464657|NCT01988090|531860311|FG000|Complete Study After Start|Protocol Violation|1|||
147464658|NCT01988090|531860312|FG001|Complete Study After Start|Protocol Violation|1|||
147464659|NCT03887130|531860317|FG000|Overall Study|Progressive disease|23|||
147464660|NCT03887130|531860318|FG001|Overall Study|Progressive disease|14|||
147464661|NCT03887130|531860319|FG002|Overall Study|Progressive disease|7|||
147464662|NCT03887130|531860317|FG000|Overall Study|Protocol Violation|3|||
147464663|NCT03887130|531860318|FG001|Overall Study|Protocol Violation|1|||
147464664|NCT03887130|531860319|FG002|Overall Study|Protocol Violation|2|||
147464665|NCT03887130|531860317|FG000|Overall Study|Drug related toxicity|7|||
147464666|NCT03887130|531860318|FG001|Overall Study|Drug related toxicity|7|||
147464667|NCT03887130|531860319|FG002|Overall Study|Drug related toxicity|13|||
147464668|NCT03887130|531860317|FG000|Overall Study|Non drug related toxicity|3|||
147464669|NCT03887130|531860318|FG001|Overall Study|Non drug related toxicity|0|||
147464670|NCT03887130|531860319|FG002|Overall Study|Non drug related toxicity|0|||
147464671|NCT03887130|531860317|FG000|Overall Study|Death|2|||
147464672|NCT03887130|531860318|FG001|Overall Study|Death|2|||
147464673|NCT03887130|531860319|FG002|Overall Study|Death|1|||
147464674|NCT03887130|531860317|FG000|Overall Study|Withdrawal by Subject|7|||
147464675|NCT03887130|531860318|FG001|Overall Study|Withdrawal by Subject|6|||
147464676|NCT03887130|531860319|FG002|Overall Study|Withdrawal by Subject|11|||
147464677|NCT03887130|531860317|FG000|Overall Study|other reason|6|||
147464678|NCT03887130|531860318|FG001|Overall Study|other reason|20|||
147464679|NCT03887130|531860319|FG002|Overall Study|other reason|17|||
147464680|NCT01468987|531860320|FG000|Overall Study|Adverse Event|12|||
147464681|NCT01468987|531860321|FG001|Overall Study|Adverse Event|9|||
147464682|NCT01468987|531860320|FG000|Overall Study|Death|4|||
147464683|NCT01468987|531860321|FG001|Overall Study|Death|1|||
147464684|NCT01468987|531860320|FG000|Overall Study|Lost to Follow-up|10|||
147464685|NCT01468987|531860321|FG001|Overall Study|Lost to Follow-up|5|||
147464686|NCT01468987|531860320|FG000|Overall Study|Protocol Violation|8|||
147464687|NCT01468987|531860321|FG001|Overall Study|Protocol Violation|2|||
147464688|NCT01468987|531860320|FG000|Overall Study|Withdrawal by Subject|28|||
147464689|NCT01468987|531860321|FG001|Overall Study|Withdrawal by Subject|28|||
147464690|NCT01468987|531860320|FG000|Overall Study|Physician Decision|8|||
147464691|NCT01468987|531860321|FG001|Overall Study|Physician Decision|15|||
147464692|NCT01468987|531860320|FG000|Overall Study|Sponsor Decision|1|||
147464693|NCT01468987|531860321|FG001|Overall Study|Sponsor Decision|0|||
147464694|NCT03430986|531860322|FG000|24-week Control Period|Adverse Event|1|||
147464695|NCT03430986|531860323|FG001|24-week Control Period|Adverse Event|0|||
147464696|NCT03430986|531860322|FG000|24-week Control Period|Lost to Follow-up|2|||
147464697|NCT03430986|531860323|FG001|24-week Control Period|Lost to Follow-up|2|||
147464698|NCT03430986|531860322|FG000|24-week Control Period|Withdrawal by Participant|5|||
147464699|NCT03430986|531860323|FG001|24-week Control Period|Withdrawal by Participant|0|||
147464700|NCT03430986|531860322|FG000|24-week Control Period|Protocol Deviation|0|||
147464701|NCT03430986|531860323|FG001|24-week Control Period|Protocol Deviation|2|||
147464702|NCT03430986|531860322|FG000|24-week Post-Control Period|Lost to Follow-up|1|||
147464703|NCT03430986|531860323|FG001|24-week Post-Control Period|Lost to Follow-up|1|||
147464704|NCT03430986|531860322|FG000|24-week Post-Control Period|Withdrawal by Participant|0|||
147464705|NCT03430986|531860323|FG001|24-week Post-Control Period|Withdrawal by Participant|1|||
147464706|NCT00961961|531860327|FG000|Phase I|Withdrawal by Subject|7|||
147464707|NCT00961961|531860328|FG001|Phase I|Withdrawal by Subject|0|||
147464708|NCT00961961|531860329|FG002|Phase I|Withdrawal by Subject|0|||
147464709|NCT00961961|531860330|FG003|Phase I|Withdrawal by Subject|0|||
147464710|NCT00961961|531860327|FG000|Phase I|Lost to Follow-up|10|||
147464711|NCT00961961|531860328|FG001|Phase I|Lost to Follow-up|0|||
147464712|NCT00961961|531860329|FG002|Phase I|Lost to Follow-up|0|||
147464713|NCT00961961|531860330|FG003|Phase I|Lost to Follow-up|0|||
147464714|NCT00961961|531860327|FG000|Phase I|Lack of Efficacy|94|||
147464715|NCT00961961|531860328|FG001|Phase I|Lack of Efficacy|0|||
147464716|NCT00961961|531860329|FG002|Phase I|Lack of Efficacy|0|||
147464717|NCT00961961|531860330|FG003|Phase I|Lack of Efficacy|0|||
147464718|NCT00961961|531860327|FG000|Phase I|Adverse Event|7|||
147464719|NCT00961961|531860328|FG001|Phase I|Adverse Event|0|||
147464720|NCT00961961|531860329|FG002|Phase I|Adverse Event|0|||
147464721|NCT00961961|531860330|FG003|Phase I|Adverse Event|0|||
147464722|NCT00961961|531860327|FG000|Phase I|Physician Decision|8|||
147616904|NCT02719184|532413689|FG000|Overall Study|Other than listed|1|||
147616905|NCT02719184|532413690|FG001|Overall Study|Other than listed|12|||
147616906|NCT02719184|532413691|FG002|Overall Study|Other than listed|13|||
147616907|NCT02719184|532413692|FG003|Overall Study|Other than listed|22|||
147408092|NCT02579772|531658328|FG000|Overall Study|Withdrawal by Subject|0|||
147408093|NCT02579772|531658329|FG001|Overall Study|Withdrawal by Subject|1|||
147408094|NCT02579772|531658328|FG000|Overall Study|Usage of additional antioxidants|1|||
147408095|NCT02579772|531658329|FG001|Overall Study|Usage of additional antioxidants|0|||
147408096|NCT02579772|531658328|FG000|Overall Study|flu-like illness, orthopedic trauma|1|||
147408097|NCT02579772|531658329|FG001|Overall Study|flu-like illness, orthopedic trauma|1|||
147408098|NCT00862836|531658331|FG000|Overall Study|Withdrawal by Subject|1|||
147408099|NCT04463680|531658334|FG000|Overall Study|Not eligible due to laboratory criteria|5|||
147408100|NCT04463680|531658334|FG000|Overall Study|Not eligible due to implant duration of use|1|||
147408101|NCT04463680|531658334|FG000|Overall Study|Withdrawal by Subject|3|||
147408102|NCT02592707|531658335|FG000|Overall Study|Consent Withdrawn|0|||
147408103|NCT02592707|531658336|FG001|Overall Study|Consent Withdrawn|1|||
147408104|NCT02592707|531658337|FG002|Overall Study|Consent Withdrawn|2|||
147408105|NCT02592707|531658338|FG003|Overall Study|Consent Withdrawn|0|||
147408106|NCT02592707|531658335|FG000|Overall Study|Death|1|||
147408107|NCT02592707|531658336|FG001|Overall Study|Death|0|||
147408108|NCT02592707|531658337|FG002|Overall Study|Death|0|||
147408109|NCT02592707|531658338|FG003|Overall Study|Death|0|||
147408110|NCT02592707|531658335|FG000|Overall Study|Progressive Disease|4|||
147408111|NCT02592707|531658336|FG001|Overall Study|Progressive Disease|4|||
147408112|NCT02592707|531658337|FG002|Overall Study|Progressive Disease|3|||
147408113|NCT02592707|531658338|FG003|Overall Study|Progressive Disease|3|||
147408114|NCT02592707|531658335|FG000|Overall Study|Other|0|||
147408115|NCT02592707|531658336|FG001|Overall Study|Other|0|||
147408116|NCT02592707|531658337|FG002|Overall Study|Other|1|||
147408117|NCT02592707|531658338|FG003|Overall Study|Other|2|||
147408118|NCT02592707|531658335|FG000|Overall Study|Never entered LTFU period|1|||
147408119|NCT02592707|531658336|FG001|Overall Study|Never entered LTFU period|0|||
147408120|NCT02592707|531658337|FG002|Overall Study|Never entered LTFU period|0|||
147408121|NCT02592707|531658338|FG003|Overall Study|Never entered LTFU period|2|||
147408122|NCT01294397|531659975|FG000|Overall Study|Withdrawal by Subject|1|||
147408123|NCT01294397|531659975|FG000|Overall Study|Administrative Decision|1|||
147408124|NCT01661205|531659976|FG000|Overall Study|Physician Decision|2|||
147408125|NCT00426127|531659977|FG000|Overall Study|Adverse Event|1|||
147408126|NCT00426127|531659977|FG000|Overall Study|Removed due to disease progression|1|||
147408127|NCT03111095|531659981|FG000|Aim 1: Feasibility and Satisfaction|Withdrawal by Subject|3|||
147408128|NCT03111095|531659982|FG001|Aim 1: Feasibility and Satisfaction|Withdrawal by Subject|0|||
147408129|NCT03111095|531659981|FG000|Aims 2-5: Intervention|Withdrawal by Subject|19|||
147408130|NCT03111095|531659982|FG001|Aims 2-5: Intervention|Withdrawal by Subject|0|||
147408131|NCT00955708|531659983|FG000|Overall Study|Death|269|||
147408132|NCT00955708|531659983|FG000|Overall Study|Lost to Follow-up|72|||
147408133|NCT00955708|531659983|FG000|Overall Study|Physician Decision|36|||
147408134|NCT00955708|531659983|FG000|Overall Study|Protocol Violation|134|||
147408135|NCT00955708|531659983|FG000|Overall Study|Registry Conclusion|186|||
147408136|NCT00955708|531659983|FG000|Overall Study|Product removed from service|94|||
147408137|NCT00955708|531659983|FG000|Overall Study|Patient Refused to participate further|116|||
147408138|NCT00955708|531659983|FG000|Overall Study|Closure of study location|60|||
147408139|NCT00955708|531659983|FG000|Overall Study|Patient changed care provider/moved|91|||
147408140|NCT03738475|531659984|FG000|Overall Study|Participant Non-Compliance|1|||
147408141|NCT03738475|531659985|FG001|Overall Study|Participant Non-Compliance|0|||
147408142|NCT00737477|531659986|FG000|Overall Study|Adverse Event|9|||
147408143|NCT00737477|531659986|FG000|Overall Study|Death|9|||
147408144|NCT00737477|531659986|FG000|Overall Study|Treatment Refusal|1|||
147408145|NCT00737477|531659986|FG000|Overall Study|Withdrawal by Subject|1|||
147408146|NCT00737477|531659986|FG000|Overall Study|Renal Transplantation|10|||
147408147|NCT00737477|531659986|FG000|Overall Study|Other|4|||
147408148|NCT01132820|531659987|FG000|Overall Study|Ineligible: wrong cell type|1|||
147408149|NCT01132820|531659987|FG000|Overall Study|Ineligible:Improper pre-protocol therapy|1|||
147408150|NCT01132820|531659987|FG000|Overall Study|Ineligible:Inadequate pathology|1|||
147408151|NCT01132820|531659987|FG000|Overall Study|Never treated|1|||
147408152|NCT01132820|531659987|FG000|Overall Study|Inadequate data|1|||
147616908|NCT02719184|532413693|FG004|Overall Study|Other than listed|9|||
147408153|NCT01370655|531659988|FG000|Period 1|Adverse Event|2|||
147408154|NCT01370655|531659989|FG001|Period 1|Adverse Event|0|||
147408155|NCT01370655|531659990|FG002|Period 1|Adverse Event|0|||
147408156|NCT01370655|531659991|FG003|Period 1|Adverse Event|0|||
147408157|NCT01370655|531659992|FG004|Period 1|Adverse Event|0|||
147408158|NCT01370655|531659993|FG005|Period 1|Adverse Event|0|||
147408159|NCT01370655|531659994|FG006|Period 1|Adverse Event|1|||
147408160|NCT01370655|531659995|FG007|Period 1|Adverse Event|0|||
147408161|NCT01370655|531659996|FG008|Period 1|Adverse Event|0|||
147408162|NCT01370655|531659997|FG009|Period 1|Adverse Event|0|||
147616909|NCT02719184|532413689|FG000|Overall Study|Withdrawal by Subject|5|||
147408163|NCT01370655|531659998|FG010|Period 1|Adverse Event|0|||
147408164|NCT01370655|531659999|FG011|Period 1|Adverse Event|0|||
147616910|NCT02719184|532413690|FG001|Overall Study|Withdrawal by Subject|3|||
147408165|NCT01370655|531659988|FG000|Period 2|Adverse Event|0|||
147408166|NCT01370655|531659989|FG001|Period 2|Adverse Event|0|||
147408167|NCT01370655|531659990|FG002|Period 2|Adverse Event|1|||
147408168|NCT01370655|531659991|FG003|Period 2|Adverse Event|0|||
147408169|NCT01370655|531659992|FG004|Period 2|Adverse Event|1|||
147408170|NCT01370655|531659993|FG005|Period 2|Adverse Event|0|||
147408171|NCT01370655|531659994|FG006|Period 2|Adverse Event|0|||
147408172|NCT01370655|531659995|FG007|Period 2|Adverse Event|1|||
147408173|NCT01370655|531659996|FG008|Period 2|Adverse Event|0|||
147408174|NCT01370655|531659997|FG009|Period 2|Adverse Event|0|||
147408175|NCT01370655|531659998|FG010|Period 2|Adverse Event|0|||
147408176|NCT01370655|531659999|FG011|Period 2|Adverse Event|0|||
147408177|NCT01370655|531659988|FG000|Period 2|met protocol specified stopping criteria|0|||
147408178|NCT01370655|531659989|FG001|Period 2|met protocol specified stopping criteria|0|||
147408179|NCT01370655|531659990|FG002|Period 2|met protocol specified stopping criteria|1|||
147408180|NCT01370655|531659991|FG003|Period 2|met protocol specified stopping criteria|0|||
147408181|NCT01370655|531659992|FG004|Period 2|met protocol specified stopping criteria|0|||
147408182|NCT01370655|531659993|FG005|Period 2|met protocol specified stopping criteria|0|||
147408183|NCT01370655|531659994|FG006|Period 2|met protocol specified stopping criteria|1|||
147408184|NCT01370655|531659995|FG007|Period 2|met protocol specified stopping criteria|0|||
147408185|NCT01370655|531659996|FG008|Period 2|met protocol specified stopping criteria|1|||
147408186|NCT01370655|531659997|FG009|Period 2|met protocol specified stopping criteria|0|||
147408187|NCT01370655|531659998|FG010|Period 2|met protocol specified stopping criteria|1|||
147408188|NCT01370655|531659999|FG011|Period 2|met protocol specified stopping criteria|0|||
147408189|NCT01370655|531659988|FG000|Period 2|Withdrawal by Subject|0|||
147408190|NCT01370655|531659989|FG001|Period 2|Withdrawal by Subject|0|||
147408191|NCT01370655|531659990|FG002|Period 2|Withdrawal by Subject|0|||
147408192|NCT01370655|531659991|FG003|Period 2|Withdrawal by Subject|0|||
147408193|NCT01370655|531659992|FG004|Period 2|Withdrawal by Subject|0|||
147408194|NCT01370655|531659993|FG005|Period 2|Withdrawal by Subject|0|||
147408195|NCT01370655|531659994|FG006|Period 2|Withdrawal by Subject|0|||
147408196|NCT01370655|531659995|FG007|Period 2|Withdrawal by Subject|0|||
147408197|NCT01370655|531659996|FG008|Period 2|Withdrawal by Subject|1|||
147408198|NCT01370655|531659997|FG009|Period 2|Withdrawal by Subject|0|||
147408199|NCT01370655|531659998|FG010|Period 2|Withdrawal by Subject|0|||
147408200|NCT01370655|531659999|FG011|Period 2|Withdrawal by Subject|0|||
147408201|NCT01735175|531660002|FG000|Overall Study|Withdrawal by Subject|9|||
147408202|NCT01735175|531660003|FG001|Overall Study|Withdrawal by Subject|2|||
147408203|NCT01735175|531660002|FG000|Overall Study|Lost to Follow-up|4|||
147408204|NCT01735175|531660003|FG001|Overall Study|Lost to Follow-up|2|||
147408205|NCT01735175|531660002|FG000|Overall Study|Death|3|||
147408206|NCT01735175|531660003|FG001|Overall Study|Death|2|||
147408207|NCT01735175|531660002|FG000|Overall Study|Other (mostly EOS/EOT visit missing)|13|||
147408208|NCT01735175|531660003|FG001|Overall Study|Other (mostly EOS/EOT visit missing)|7|||
147408209|NCT00659880|531660004|FG000|Overall Study|Lost to Follow-up|5|||
147408210|NCT01853475|531660005|FG000|Overall Study|Withdrawal by Subject|0|||
147408211|NCT01853475|531660006|FG001|Overall Study|Withdrawal by Subject|1|||
147408212|NCT01853475|531660007|FG002|Overall Study|Withdrawal by Subject|0|||
147408213|NCT02159040|531660008|FG000|Overall Study|Death|1|||
147408214|NCT01304498|531660009|FG000|Overall Study|Adverse Event|1|||
147408215|NCT01304498|531660010|FG001|Overall Study|Adverse Event|1|||
147616911|NCT02719184|532413691|FG002|Overall Study|Withdrawal by Subject|6|||
147408216|NCT01304498|531660009|FG000|Overall Study|Withdrawal by Subject|2|||
147408217|NCT01304498|531660010|FG001|Overall Study|Withdrawal by Subject|3|||
147408218|NCT01304498|531660009|FG000|Overall Study|Protocol Violation|1|||
147408219|NCT01304498|531660010|FG001|Overall Study|Protocol Violation|0|||
147408220|NCT01304498|531660009|FG000|Overall Study|Lost to Follow-up|2|||
147408221|NCT01304498|531660010|FG001|Overall Study|Lost to Follow-up|1|||
147408222|NCT01151215|531660011|FG000|Overall Study|Worsening of condition under study|1|||
147408223|NCT01151215|531660012|FG001|Overall Study|Worsening of condition under study|1|||
147464723|NCT00961961|531860328|FG001|Phase I|Physician Decision|0|||
147464724|NCT00961961|531860329|FG002|Phase I|Physician Decision|0|||
147464725|NCT00961961|531860330|FG003|Phase I|Physician Decision|0|||
147464726|NCT00961961|531860327|FG000|Phase II|Lost to Follow-up|0|||
147464727|NCT00961961|531860328|FG001|Phase II|Lost to Follow-up|0|||
147464728|NCT00961961|531860329|FG002|Phase II|Lost to Follow-up|10|||
147464729|NCT00961961|531860330|FG003|Phase II|Lost to Follow-up|7|||
147464730|NCT00961961|531860327|FG000|Phase II|Adverse Event|0|||
147464731|NCT00961961|531860328|FG001|Phase II|Adverse Event|0|||
147464732|NCT00961961|531860329|FG002|Phase II|Adverse Event|0|||
147464733|NCT00961961|531860330|FG003|Phase II|Adverse Event|1|||
147464734|NCT00961961|531860327|FG000|Phase II|Physician Decision|0|||
147464735|NCT00961961|531860328|FG001|Phase II|Physician Decision|0|||
147464736|NCT00961961|531860329|FG002|Phase II|Physician Decision|1|||
147464737|NCT00961961|531860330|FG003|Phase II|Physician Decision|0|||
147464738|NCT00961961|531860327|FG000|Phase II|Withdrawal by Subject|0|||
147464739|NCT00961961|531860328|FG001|Phase II|Withdrawal by Subject|0|||
147408224|NCT01151215|531660013|FG002|Overall Study|Worsening of condition under study|1|||
147464740|NCT00961961|531860329|FG002|Phase II|Withdrawal by Subject|1|||
147408225|NCT01151215|531660011|FG000|Overall Study|Death|16|||
147408226|NCT01151215|531660012|FG001|Overall Study|Death|20|||
147616912|NCT02719184|532413692|FG003|Overall Study|Withdrawal by Subject|6|||
147616913|NCT02719184|532413693|FG004|Overall Study|Withdrawal by Subject|0|||
147616914|NCT02719184|532413689|FG000|Overall Study|Lost to Follow-up|0|||
147616915|NCT02719184|532413690|FG001|Overall Study|Lost to Follow-up|4|||
147616916|NCT02719184|532413691|FG002|Overall Study|Lost to Follow-up|1|||
147616917|NCT02719184|532413692|FG003|Overall Study|Lost to Follow-up|3|||
147616918|NCT02719184|532413693|FG004|Overall Study|Lost to Follow-up|0|||
147616919|NCT02719184|532413689|FG000|Overall Study|Protocol Violation|0|||
147616920|NCT02719184|532413690|FG001|Overall Study|Protocol Violation|3|||
147616921|NCT02719184|532413691|FG002|Overall Study|Protocol Violation|0|||
147616922|NCT02719184|532413692|FG003|Overall Study|Protocol Violation|2|||
147616923|NCT02719184|532413693|FG004|Overall Study|Protocol Violation|0|||
147616924|NCT02719184|532413689|FG000|Overall Study|Adverse Event|0|||
147616925|NCT02719184|532413690|FG001|Overall Study|Adverse Event|0|||
147616926|NCT02719184|532413691|FG002|Overall Study|Adverse Event|0|||
147616927|NCT02719184|532413692|FG003|Overall Study|Adverse Event|3|||
147616928|NCT02719184|532413693|FG004|Overall Study|Adverse Event|0|||
147616929|NCT00470535|532413697|FG000|Overall Study|Disease Progression|13|||
147616930|NCT00470535|532413697|FG000|Overall Study|Withdrawal by Subject|1|||
147616931|NCT00470535|532413697|FG000|Overall Study|Adverse Event|1|||
147616932|NCT00470535|532413697|FG000|Overall Study|Death|1|||
147616933|NCT00470535|532413697|FG000|Overall Study|Other|2|||
147616934|NCT04108299|532413699|FG000|Overall Study|Not interested in participating|2|||
147616935|NCT04108299|532413700|FG001|Overall Study|Not interested in participating|1|||
147616936|NCT04108299|532413701|FG002|Overall Study|Not interested in participating|2|||
147616937|NCT04108299|532413702|FG003|Overall Study|Not interested in participating|1|||
147616938|NCT04123405|532413706|FG000|Overall Study|Adverse Event|1|||
147616939|NCT04123405|532413707|FG001|Overall Study|Adverse Event|2|||
147616940|NCT04123405|532413708|FG002|Overall Study|Adverse Event|3|||
147616941|NCT04123405|532413709|FG003|Overall Study|Adverse Event|3|||
147616942|NCT04123405|532413706|FG000|Overall Study|Exclusion criteria met|1|||
147616943|NCT04123405|532413707|FG001|Overall Study|Exclusion criteria met|2|||
147616944|NCT04123405|532413708|FG002|Overall Study|Exclusion criteria met|0|||
147616945|NCT04123405|532413709|FG003|Overall Study|Exclusion criteria met|2|||
147616946|NCT04123405|532413706|FG000|Overall Study|Withdrawal by Subject|1|||
147616947|NCT04123405|532413707|FG001|Overall Study|Withdrawal by Subject|3|||
147616948|NCT04123405|532413708|FG002|Overall Study|Withdrawal by Subject|0|||
147616949|NCT04123405|532413709|FG003|Overall Study|Withdrawal by Subject|2|||
147616950|NCT04123405|532413706|FG000|Overall Study|Contact to subject lost|0|||
147616951|NCT04123405|532413707|FG001|Overall Study|Contact to subject lost|0|||
147616952|NCT04123405|532413708|FG002|Overall Study|Contact to subject lost|0|||
147616953|NCT04123405|532413709|FG003|Overall Study|Contact to subject lost|1|||
147616954|NCT04123405|532413706|FG000|Overall Study|screening failure|1|||
147616955|NCT04123405|532413707|FG001|Overall Study|screening failure|0|||
147616956|NCT04123405|532413708|FG002|Overall Study|screening failure|0|||
147408227|NCT01151215|531660013|FG002|Overall Study|Death|11|||
147408228|NCT01151215|531660011|FG000|Overall Study|Lost to Follow-up|0|||
147408229|NCT01151215|531660012|FG001|Overall Study|Lost to Follow-up|0|||
147408230|NCT01151215|531660013|FG002|Overall Study|Lost to Follow-up|3|||
147408231|NCT01151215|531660011|FG000|Overall Study|Withdrawal by Subject|3|||
147408232|NCT01151215|531660012|FG001|Overall Study|Withdrawal by Subject|1|||
147408233|NCT01151215|531660013|FG002|Overall Study|Withdrawal by Subject|2|||
147408234|NCT01151215|531660011|FG000|Overall Study|Disease progression|0|||
147408235|NCT01151215|531660012|FG001|Overall Study|Disease progression|1|||
147408236|NCT01151215|531660013|FG002|Overall Study|Disease progression|1|||
147408237|NCT01151215|531660011|FG000|Overall Study|Safety as judged by the investigator|0|||
147408238|NCT01151215|531660012|FG001|Overall Study|Safety as judged by the investigator|0|||
147408239|NCT01151215|531660013|FG002|Overall Study|Safety as judged by the investigator|1|||
147408240|NCT01374568|531660016|FG000|Overall Study|Lab unable to analyze BTM|0|||
147408241|NCT01374568|531660017|FG001|Overall Study|Lab unable to analyze BTM|2|||
147408242|NCT02269423|531660018|FG000|Overall Study|Discontinued due to change in residence|0|||
147616957|NCT04123405|532413709|FG003|Overall Study|screening failure|0|||
147616958|NCT00662649|532413711|FG000|Core Study (24 Months)|Withdrawal by Subject|31|||
147616959|NCT00662649|532413712|FG001|Core Study (24 Months)|Withdrawal by Subject|17|||
147616960|NCT00662649|532413713|FG002|Core Study (24 Months)|Withdrawal by Subject|28|||
147408243|NCT02269423|531660019|FG001|Overall Study|Discontinued due to change in residence|1|||
147616961|NCT00662649|532413714|FG003|Core Study (24 Months)|Withdrawal by Subject|0|||
147616962|NCT00662649|532413715|FG004|Core Study (24 Months)|Withdrawal by Subject|0|||
147616963|NCT00662649|532413711|FG000|Core Study (24 Months)|Adverse Event|22|||
147616964|NCT00662649|532413712|FG001|Core Study (24 Months)|Adverse Event|13|||
147616965|NCT00662649|532413713|FG002|Core Study (24 Months)|Adverse Event|18|||
147616966|NCT00662649|532413714|FG003|Core Study (24 Months)|Adverse Event|0|||
147408244|NCT02269423|531660020|FG002|Overall Study|Discontinued due to change in residence|0|||
147408245|NCT02269423|531660021|FG003|Overall Study|Discontinued due to change in residence|1|||
147464741|NCT00961961|531860330|FG003|Phase II|Withdrawal by Subject|0|||
147464742|NCT04722991|531860338|FG000|Overall Study|Adverse Event|12|||
147408246|NCT00856245|531660022|FG000|Overall Study|Was not transplanted|5|||
147616967|NCT00662649|532413715|FG004|Core Study (24 Months)|Adverse Event|0|||
147616968|NCT00662649|532413711|FG000|Core Study (24 Months)|Unsatisfactory therapeutic effect|13|||
147616969|NCT00662649|532413712|FG001|Core Study (24 Months)|Unsatisfactory therapeutic effect|6|||
147616970|NCT00662649|532413713|FG002|Core Study (24 Months)|Unsatisfactory therapeutic effect|25|||
147408247|NCT01443923|531660023|FG000|Overall Study|Adverse Event|1|||
147408248|NCT01443923|531660024|FG001|Overall Study|Adverse Event|0|||
147408249|NCT04160988|531660027|FG000|Overall Study|poor image quality|28|||
147408250|NCT01250509|531660028|FG000|Overall Study|Lost to Follow-up|5|||
147408251|NCT01250509|531660029|FG001|Overall Study|Lost to Follow-up|2|||
147408252|NCT02670122|531660030|FG000|Overall Study|Lost to Follow-up|4|||
147408253|NCT02762903|531660035|FG000|Overall Study|Lost to Follow-up|0|||
147408254|NCT02762903|531660036|FG001|Overall Study|Lost to Follow-up|1|||
147408255|NCT01889069|531660037|FG000|Overall Study|Death|18|||
147408256|NCT01889069|531660037|FG000|Overall Study|Progression of Disease|14|||
147408257|NCT01889069|531660037|FG000|Overall Study|Lost to Follow-up|6|||
147408258|NCT01889069|531660037|FG000|Overall Study|Other|4|||
147408259|NCT01889069|531660037|FG000|Overall Study|Consent Withdrawal|3|||
147408260|NCT00108745|531660038|FG000|Overall Study|Withdrawal by Subject|19|||
147408261|NCT00108745|531660039|FG001|Overall Study|Withdrawal by Subject|12|||
147408262|NCT00108745|531660040|FG002|Overall Study|Withdrawal by Subject|12|||
147408263|NCT00108745|531660038|FG000|Overall Study|Never Treated|8|||
147408264|NCT00108745|531660039|FG001|Overall Study|Never Treated|10|||
147408265|NCT00108745|531660040|FG002|Overall Study|Never Treated|12|||
147408266|NCT00108745|531660038|FG000|Overall Study|Ineligible|7|||
147408267|NCT00108745|531660039|FG001|Overall Study|Ineligible|13|||
147408268|NCT00108745|531660040|FG002|Overall Study|Ineligible|13|||
147408269|NCT01228175|531660041|FG000|Overall Study|Lost to Follow-up|64|||
147408270|NCT01228175|531660042|FG001|Overall Study|Lost to Follow-up|50|||
147408271|NCT01228175|531660041|FG000|Overall Study|Withdrawal by Subject|1|||
147408272|NCT01228175|531660042|FG001|Overall Study|Withdrawal by Subject|2|||
147408273|NCT01228175|531660041|FG000|Overall Study|Physician Decision|1|||
147408274|NCT01228175|531660042|FG001|Overall Study|Physician Decision|1|||
147408275|NCT01426347|531660046|FG000|Overall Study|Lost to Follow-up|0|||
147408276|NCT01426347|531660047|FG001|Overall Study|Lost to Follow-up|3|||
147408277|NCT01426347|531660046|FG000|Overall Study|Protocol Violation|2|||
147408278|NCT01426347|531660047|FG001|Overall Study|Protocol Violation|0|||
147408279|NCT01426347|531660046|FG000|Overall Study|Withdrawal by Subject|5|||
147408280|NCT01426347|531660047|FG001|Overall Study|Withdrawal by Subject|0|||
147408281|NCT00664534|531660048|FG000|Overall Study|Adverse Event|2|||
147408282|NCT00664534|531660049|FG001|Overall Study|Adverse Event|3|||
147408283|NCT00664534|531660048|FG000|Overall Study|Lost to Follow-up|6|||
147408284|NCT00664534|531660049|FG001|Overall Study|Lost to Follow-up|10|||
147408285|NCT00664534|531660048|FG000|Overall Study|Protocol Violation|10|||
147408286|NCT00664534|531660049|FG001|Overall Study|Protocol Violation|8|||
147408287|NCT00664534|531660048|FG000|Overall Study|Withdrawal by Subject|7|||
147408288|NCT00664534|531660049|FG001|Overall Study|Withdrawal by Subject|6|||
147408289|NCT00664534|531660048|FG000|Overall Study|Physician Decision|8|||
147408290|NCT00664534|531660049|FG001|Overall Study|Physician Decision|0|||
147408291|NCT00664534|531660048|FG000|Overall Study|Sponsor decision|8|||
147408292|NCT00664534|531660049|FG001|Overall Study|Sponsor decision|6|||
147408293|NCT03041792|531660052|FG000|Overall Study|Adverse Event|4|||
147408294|NCT03041792|531660053|FG001|Overall Study|Adverse Event|0|||
147408295|NCT03041792|531660052|FG000|Overall Study|Death in the family|0|||
147408296|NCT03041792|531660053|FG001|Overall Study|Death in the family|2|||
147408297|NCT03041792|531660052|FG000|Overall Study|Randomized but not treated|0|||
147408298|NCT03041792|531660053|FG001|Overall Study|Randomized but not treated|1|||
147408299|NCT04978090|531660054|FG000|Overall Study|unable to adequately fit device|2|||
147408300|NCT02227992|531660057|FG000|Overall Study|Lost to Follow-up|1|||
147408301|NCT02227992|531660058|FG001|Overall Study|Lost to Follow-up|1|||
147408302|NCT00935532|531660061|FG000|Overall Study|Adverse Event|11|||
147408303|NCT00935532|531660062|FG001|Overall Study|Adverse Event|6|||
147408304|NCT00935532|531660061|FG000|Overall Study|Death|1|||
147408305|NCT00935532|531660062|FG001|Overall Study|Death|0|||
147408306|NCT00935532|531660061|FG000|Overall Study|Lost to Follow-up|1|||
147408307|NCT00935532|531660062|FG001|Overall Study|Lost to Follow-up|0|||
147408308|NCT00935532|531660061|FG000|Overall Study|Physician Decision|1|||
147408309|NCT00935532|531660062|FG001|Overall Study|Physician Decision|2|||
147408310|NCT00935532|531660061|FG000|Overall Study|Protocol Violation|2|||
147408311|NCT00935532|531660062|FG001|Overall Study|Protocol Violation|1|||
147616971|NCT00662649|532413714|FG003|Core Study (24 Months)|Unsatisfactory therapeutic effect|0|||
147408312|NCT00935532|531660061|FG000|Overall Study|Subject Decision|2|||
147408313|NCT00935532|531660062|FG001|Overall Study|Subject Decision|1|||
147408314|NCT00935532|531660061|FG000|Overall Study|Sponsor Decision|0|||
147408315|NCT00935532|531660062|FG001|Overall Study|Sponsor Decision|1|||
147408316|NCT00935532|531660061|FG000|Overall Study|Loss Glucose Control|4|||
147408317|NCT00935532|531660062|FG001|Overall Study|Loss Glucose Control|0|||
147408318|NCT01371708|531660067|FG000|Overall Study|Insufficient clinical response|3|||
147408319|NCT01371708|531660068|FG001|Overall Study|Insufficient clinical response|2|||
147408320|NCT01371708|531660069|FG002|Overall Study|Insufficient clinical response|0|||
147408321|NCT01371708|531660067|FG000|Overall Study|Lost to Follow-up|5|||
147408322|NCT01371708|531660068|FG001|Overall Study|Lost to Follow-up|9|||
147408323|NCT01371708|531660069|FG002|Overall Study|Lost to Follow-up|7|||
147408324|NCT01371708|531660067|FG000|Overall Study|Protocol Violation|2|||
147408325|NCT01371708|531660068|FG001|Overall Study|Protocol Violation|1|||
147408326|NCT01371708|531660069|FG002|Overall Study|Protocol Violation|2|||
147408327|NCT01371708|531660067|FG000|Overall Study|No longer willing to participate|7|||
147408328|NCT01371708|531660068|FG001|Overall Study|No longer willing to participate|7|||
147408329|NCT01371708|531660069|FG002|Overall Study|No longer willing to participate|13|||
147408330|NCT01371708|531660067|FG000|Overall Study|Medication error/not related to AE|0|||
147408331|NCT01371708|531660068|FG001|Overall Study|Medication error/not related to AE|1|||
147408332|NCT01371708|531660069|FG002|Overall Study|Medication error/not related to AE|0|||
147408333|NCT01371708|531660067|FG000|Overall Study|Other|3|||
147408334|NCT01371708|531660068|FG001|Overall Study|Other|2|||
147408335|NCT01371708|531660069|FG002|Overall Study|Other|4|||
147408336|NCT01371708|531660067|FG000|Overall Study|Adverse Event|5|||
147408337|NCT01371708|531660068|FG001|Overall Study|Adverse Event|8|||
147408338|NCT01371708|531660069|FG002|Overall Study|Adverse Event|12|||
147408339|NCT01371708|531660067|FG000|Overall Study|Started but did not receive treatment|1|||
147408340|NCT01371708|531660068|FG001|Overall Study|Started but did not receive treatment|0|||
147408341|NCT01371708|531660069|FG002|Overall Study|Started but did not receive treatment|1|||
147408342|NCT00402051|531660070|FG000|Overall Study|Progressive Disease|13|||
147408343|NCT00402051|531660071|FG001|Overall Study|Progressive Disease|20|||
147408344|NCT00402051|531660070|FG000|Overall Study|Adverse Event|11|||
147408345|NCT00402051|531660071|FG001|Overall Study|Adverse Event|4|||
147408346|NCT00402051|531660070|FG000|Overall Study|Physician Decision|7|||
147408347|NCT00402051|531660071|FG001|Overall Study|Physician Decision|3|||
147408348|NCT00402051|531660070|FG000|Overall Study|Withdrawal by Subject|3|||
147408349|NCT00402051|531660071|FG001|Overall Study|Withdrawal by Subject|3|||
147408350|NCT00402051|531660070|FG000|Overall Study|Death - Related to Study Drug|1|||
147408351|NCT00402051|531660071|FG001|Overall Study|Death - Related to Study Drug|2|||
147408352|NCT00402051|531660070|FG000|Overall Study|Death Due to Study Disease|2|||
147408353|NCT00402051|531660071|FG001|Overall Study|Death Due to Study Disease|1|||
147408354|NCT00402051|531660070|FG000|Overall Study|Death Due to Adverse Event|0|||
147408355|NCT00402051|531660071|FG001|Overall Study|Death Due to Adverse Event|2|||
147408356|NCT00402051|531660070|FG000|Overall Study|Lost to Follow-up|1|||
147408357|NCT00402051|531660071|FG001|Overall Study|Lost to Follow-up|0|||
147408358|NCT00632502|531660084|FG000|Overall Study|Adverse Event|0|||
147408359|NCT00632502|531660085|FG001|Overall Study|Adverse Event|1|||
147408360|NCT00632502|531660084|FG000|Overall Study|Randomized not treated|3|||
147408361|NCT00632502|531660085|FG001|Overall Study|Randomized not treated|0|||
147408362|NCT04954326|531660086|FG000|Overall Study|Protocol Violation|0|||
147408363|NCT04954326|531660087|FG001|Overall Study|Protocol Violation|1|||
147408364|NCT04954326|531660086|FG000|Overall Study|Death|0|||
147408365|NCT04954326|531660087|FG001|Overall Study|Death|2|||
147408366|NCT04954326|531660086|FG000|Overall Study|Physician Decision|0|||
147408367|NCT04954326|531660087|FG001|Overall Study|Physician Decision|1|||
147408368|NCT00277095|531660088|FG000|Overall Study|Death|2|||
147408369|NCT00277095|531660088|FG000|Overall Study|Explanted|7|||
147408370|NCT00277095|531660088|FG000|Overall Study|Lost to Follow-up|2|||
147408371|NCT00277095|531660088|FG000|Overall Study|Missed Follow-up|9|||
147408372|NCT00277095|531660088|FG000|Overall Study|Physician Decision|1|||
147408373|NCT00281320|531660093|FG000|Overall Study|Adverse Event|12|||
147408374|NCT00281320|531660094|FG001|Overall Study|Adverse Event|9|||
147408375|NCT00281320|531660093|FG000|Overall Study|Lack of Efficacy|4|||
147408376|NCT00281320|531660094|FG001|Overall Study|Lack of Efficacy|3|||
147408377|NCT00281320|531660093|FG000|Overall Study|Withdrawal by Subject|5|||
147408378|NCT00281320|531660094|FG001|Overall Study|Withdrawal by Subject|6|||
147408379|NCT00281320|531660093|FG000|Overall Study|Lost to Follow-up|1|||
147408380|NCT00281320|531660094|FG001|Overall Study|Lost to Follow-up|2|||
147408381|NCT00281320|531660093|FG000|Overall Study|Other|3|||
147408382|NCT00281320|531660094|FG001|Overall Study|Other|1|||
147408383|NCT00975676|531660096|FG000|Overall Study|Baseline samples only, no sample analyzed or only single sample available|6|||
147408384|NCT00975676|531660097|FG001|Overall Study|Baseline samples only, no sample analyzed or only single sample available|8|||
147408385|NCT02548078|531660098|FG000|Overall Study|Serious adverse event/Adverse event|1|||
147408386|NCT02548078|531660099|FG001|Overall Study|Serious adverse event/Adverse event|0|||
147408387|NCT02548078|531660098|FG000|Overall Study|Moved from study area|3|||
147408388|NCT02548078|531660099|FG001|Overall Study|Moved from study area|3|||
147408389|NCT02548078|531660098|FG000|Overall Study|Lost to Follow-up|1|||
147408390|NCT02548078|531660099|FG001|Overall Study|Lost to Follow-up|3|||
147408391|NCT03128671|531660100|FG000|Allocation|ICU discharge prior to intervention initiation|4|||
147408392|NCT03128671|531660101|FG001|Allocation|ICU discharge prior to intervention initiation|0|||
147408393|NCT03128671|531660100|FG000|Allocation|Death|1|||
147408394|NCT03128671|531660101|FG001|Allocation|Death|0|||
147408395|NCT03128671|531660100|FG000|Allocation|Withdrawal by Subject|4|||
147408396|NCT03128671|531660101|FG001|Allocation|Withdrawal by Subject|0|||
147616972|NCT00662649|532413715|FG004|Core Study (24 Months)|Unsatisfactory therapeutic effect|0|||
147408397|NCT03128671|531660100|FG000|Intervention|Withdrawal by Subject|11|||
147408398|NCT03128671|531660101|FG001|Intervention|Withdrawal by Subject|10|||
147408399|NCT03128671|531660100|FG000|Intervention|Palliative/hospice care initiated|9|||
147408400|NCT03128671|531660101|FG001|Intervention|Palliative/hospice care initiated|10|||
147408401|NCT03128671|531660100|FG000|Intervention|Death|13|||
147408402|NCT03128671|531660101|FG001|Intervention|Death|11|||
147408403|NCT03128671|531660100|FG000|Intervention|Interrupted by hurricane|1|||
147408404|NCT03128671|531660101|FG001|Intervention|Interrupted by hurricane|0|||
147408405|NCT03128671|531660100|FG000|Intervention|Physician Decision|2|||
147408406|NCT03128671|531660101|FG001|Intervention|Physician Decision|3|||
147408407|NCT04641962|531660103|FG000|DBT Period: Up to 52 Weeks|Miscellaneous|5|||
147408408|NCT04641962|531660104|FG001|DBT Period: Up to 52 Weeks|Miscellaneous|3|||
147408409|NCT04641962|531660105|FG002|DBT Period: Up to 52 Weeks|Miscellaneous|0|||
147408410|NCT04641962|531660106|FG003|DBT Period: Up to 52 Weeks|Miscellaneous|3|||
147408411|NCT04641962|531660107|FG004|DBT Period: Up to 52 Weeks|Miscellaneous|0|||
147408412|NCT04641962|531660103|FG000|DBT Period: Up to 52 Weeks|Withdrawal by Subject|0|||
147408413|NCT04641962|531660104|FG001|DBT Period: Up to 52 Weeks|Withdrawal by Subject|0|||
147408414|NCT04641962|531660105|FG002|DBT Period: Up to 52 Weeks|Withdrawal by Subject|0|||
147408415|NCT04641962|531660106|FG003|DBT Period: Up to 52 Weeks|Withdrawal by Subject|1|||
147408416|NCT04641962|531660107|FG004|DBT Period: Up to 52 Weeks|Withdrawal by Subject|0|||
147408417|NCT04641962|531660103|FG000|DBT Period: Up to 52 Weeks|Protocol deviation|1|||
147408418|NCT04641962|531660104|FG001|DBT Period: Up to 52 Weeks|Protocol deviation|0|||
147408419|NCT04641962|531660105|FG002|DBT Period: Up to 52 Weeks|Protocol deviation|0|||
147408420|NCT04641962|531660106|FG003|DBT Period: Up to 52 Weeks|Protocol deviation|2|||
147408421|NCT04641962|531660107|FG004|DBT Period: Up to 52 Weeks|Protocol deviation|0|||
147408422|NCT04641962|531660103|FG000|DBT Period: Up to 52 Weeks|Death|1|||
147408423|NCT04641962|531660104|FG001|DBT Period: Up to 52 Weeks|Death|0|||
147408424|NCT04641962|531660105|FG002|DBT Period: Up to 52 Weeks|Death|0|||
147408425|NCT04641962|531660106|FG003|DBT Period: Up to 52 Weeks|Death|0|||
147408426|NCT04641962|531660107|FG004|DBT Period: Up to 52 Weeks|Death|0|||
147408427|NCT04641962|531660103|FG000|DBT Period: Up to 52 Weeks|Adverse Event|0|||
147408428|NCT04641962|531660104|FG001|DBT Period: Up to 52 Weeks|Adverse Event|3|||
147408429|NCT04641962|531660105|FG002|DBT Period: Up to 52 Weeks|Adverse Event|0|||
147408430|NCT04641962|531660106|FG003|DBT Period: Up to 52 Weeks|Adverse Event|2|||
147408431|NCT04641962|531660107|FG004|DBT Period: Up to 52 Weeks|Adverse Event|0|||
147408432|NCT04641962|531660103|FG000|OLE Treatment Period: Up to 76 Weeks|Miscellaneous|0|||
147408433|NCT04641962|531660104|FG001|OLE Treatment Period: Up to 76 Weeks|Miscellaneous|0|||
147408434|NCT04641962|531660105|FG002|OLE Treatment Period: Up to 76 Weeks|Miscellaneous|4|||
147408435|NCT04641962|531660106|FG003|OLE Treatment Period: Up to 76 Weeks|Miscellaneous|0|||
147408436|NCT04641962|531660107|FG004|OLE Treatment Period: Up to 76 Weeks|Miscellaneous|1|||
147408437|NCT04641962|531660103|FG000|OLE Treatment Period: Up to 76 Weeks|Death|0|||
147408438|NCT04641962|531660104|FG001|OLE Treatment Period: Up to 76 Weeks|Death|0|||
147408439|NCT04641962|531660105|FG002|OLE Treatment Period: Up to 76 Weeks|Death|1|||
147408440|NCT04641962|531660106|FG003|OLE Treatment Period: Up to 76 Weeks|Death|0|||
147408441|NCT04641962|531660107|FG004|OLE Treatment Period: Up to 76 Weeks|Death|0|||
147408442|NCT03832595|531660112|FG000|Overall Study|Death|142|||
147408443|NCT03832595|531660113|FG001|Overall Study|Death|130|||
147408444|NCT03832595|531660112|FG000|Overall Study|Medical management without dialysis|37|||
147408445|NCT03832595|531660113|FG001|Overall Study|Medical management without dialysis|1|||
147408446|NCT03277352|531660114|FG000|Overall Study|Study Terminated By Sponsor|2|||
147408447|NCT03277352|531660114|FG000|Overall Study|Withdrawal by Subject|4|||
147408448|NCT03277352|531660114|FG000|Overall Study|Death|4|||
147408449|NCT04147195|531660115|FG000|Overall Study|Adverse Event|0|||
147408450|NCT04147195|531660116|FG001|Overall Study|Adverse Event|3|||
147408451|NCT04147195|531660115|FG000|Overall Study|Study Terminated by Sponsor|4|||
147408452|NCT04147195|531660116|FG001|Overall Study|Study Terminated by Sponsor|2|||
147408453|NCT04147195|531660115|FG000|Overall Study|Withdrawal by Subject|0|||
147408454|NCT04147195|531660116|FG001|Overall Study|Withdrawal by Subject|1|||
147408455|NCT06926673|531660117|FG000|Overall Study|Lost to Follow-up|0|||
147408456|NCT06926673|531660118|FG001|Overall Study|Lost to Follow-up|0|||
147616973|NCT00662649|532413711|FG000|Core Study (24 Months)|Abnormal laboratory value(s)|20|||
147616974|NCT00662649|532413712|FG001|Core Study (24 Months)|Abnormal laboratory value(s)|9|||
147408457|NCT06926673|531660119|FG002|Overall Study|Lost to Follow-up|0|||
147408458|NCT06926673|531660120|FG003|Overall Study|Lost to Follow-up|1|||
147408459|NCT06926673|531660121|FG004|Overall Study|Lost to Follow-up|0|||
147408460|NCT06926673|531660122|FG005|Overall Study|Lost to Follow-up|0|||
147408461|NCT06926673|531660123|FG006|Overall Study|Lost to Follow-up|0|||
147408462|NCT06926673|531660117|FG000|Overall Study|Physician Decision|0|||
147408463|NCT06926673|531660118|FG001|Overall Study|Physician Decision|0|||
147408464|NCT06926673|531660119|FG002|Overall Study|Physician Decision|0|||
147408465|NCT06926673|531660120|FG003|Overall Study|Physician Decision|0|||
147408466|NCT06926673|531660121|FG004|Overall Study|Physician Decision|0|||
147408467|NCT06926673|531660122|FG005|Overall Study|Physician Decision|0|||
147408468|NCT06926673|531660123|FG006|Overall Study|Physician Decision|1|||
147464743|NCT04722991|531860339|FG001|Overall Study|Adverse Event|4|||
147464744|NCT04722991|531860338|FG000|Overall Study|Death|2|||
147464745|NCT04722991|531860339|FG001|Overall Study|Death|0|||
147464746|NCT04722991|531860338|FG000|Overall Study|Lost to Follow-up|1|||
147464747|NCT04722991|531860339|FG001|Overall Study|Lost to Follow-up|1|||
147464748|NCT04722991|531860338|FG000|Overall Study|Withdrawal cirterion met|2|||
147464749|NCT04722991|531860339|FG001|Overall Study|Withdrawal cirterion met|2|||
147464750|NCT04722991|531860338|FG000|Overall Study|Other|1|||
147464751|NCT04722991|531860339|FG001|Overall Study|Other|0|||
147464752|NCT04722991|531860338|FG000|Overall Study|Non-compliance|0|||
147464753|NCT04722991|531860339|FG001|Overall Study|Non-compliance|1|||
147464754|NCT04722991|531860338|FG000|Overall Study|Withdrawal by Subject|0|||
147464755|NCT04722991|531860339|FG001|Overall Study|Withdrawal by Subject|1|||
147464756|NCT03186989|531860340|FG000|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
147464757|NCT03186989|531860341|FG001|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
147464758|NCT03186989|531860342|FG002|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|1|||
147464759|NCT03186989|531860343|FG003|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|1|||
147464760|NCT03186989|531860344|FG004|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|1|||
147464761|NCT03186989|531860345|FG005|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
147464762|NCT03186989|531860346|FG006|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
147464763|NCT03186989|531860347|FG007|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
147464764|NCT03186989|531860348|FG008|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
147464765|NCT03186989|531860349|FG009|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
147464766|NCT03186989|531860350|FG010|Part 1: MAD (Day 1 up to Week 36)|Voluntary Withdrawal|0|||
147464767|NCT03186989|531860340|FG000|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
147464768|NCT03186989|531860341|FG001|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
147464769|NCT03186989|531860342|FG002|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
147464770|NCT03186989|531860343|FG003|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
147464771|NCT03186989|531860344|FG004|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
147464772|NCT03186989|531860345|FG005|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|1|||
147464773|NCT03186989|531860346|FG006|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
147464774|NCT03186989|531860347|FG007|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
147464775|NCT03186989|531860348|FG008|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
147464776|NCT03186989|531860349|FG009|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
147408469|NCT06926673|531660117|FG000|Overall Study|Withdrawal by Subject|0|||
147408470|NCT06926673|531660118|FG001|Overall Study|Withdrawal by Subject|3|||
147408471|NCT06926673|531660119|FG002|Overall Study|Withdrawal by Subject|2|||
147408472|NCT06926673|531660120|FG003|Overall Study|Withdrawal by Subject|1|||
147408473|NCT06926673|531660121|FG004|Overall Study|Withdrawal by Subject|0|||
147408474|NCT06926673|531660122|FG005|Overall Study|Withdrawal by Subject|2|||
147408475|NCT06926673|531660123|FG006|Overall Study|Withdrawal by Subject|0|||
147408476|NCT01424813|531660124|FG000|Overall Study|Withdrawal by Subject|3|||
147408477|NCT01424813|531660125|FG001|Overall Study|Withdrawal by Subject|0|||
147616975|NCT00662649|532413713|FG002|Core Study (24 Months)|Abnormal laboratory value(s)|1|||
147616976|NCT00662649|532413714|FG003|Core Study (24 Months)|Abnormal laboratory value(s)|0|||
147408478|NCT01424813|531660124|FG000|Overall Study|Protocol Violation|1|||
147408479|NCT01424813|531660125|FG001|Overall Study|Protocol Violation|0|||
147408480|NCT01424813|531660124|FG000|Overall Study|Other|1|||
147408481|NCT01424813|531660125|FG001|Overall Study|Other|2|||
147408482|NCT03939689|531662345|FG000|Overall Study|Radiographic progression|14|||
147408483|NCT03939689|531662346|FG001|Overall Study|Radiographic progression|17|||
147408484|NCT03939689|531662345|FG000|Overall Study|Treatment is no longer benefiting participant|5|||
147408485|NCT03939689|531662346|FG001|Overall Study|Treatment is no longer benefiting participant|6|||
147408486|NCT03939689|531662345|FG000|Overall Study|Adverse Event|1|||
147408487|NCT03939689|531662346|FG001|Overall Study|Adverse Event|8|||
147464777|NCT03186989|531860350|FG010|Part 2: LTE (Week 37 to Week 101)|Voluntary Withdrawal|0|||
147464778|NCT03186989|531860340|FG000|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
147464779|NCT03186989|531860341|FG001|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
147464780|NCT03186989|531860342|FG002|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
147464781|NCT03186989|531860343|FG003|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
147616977|NCT00662649|532413715|FG004|Core Study (24 Months)|Abnormal laboratory value(s)|0|||
147616978|NCT00662649|532413711|FG000|Core Study (24 Months)|Lost to Follow-up|3|||
147408488|NCT03939689|531662345|FG000|Overall Study|Unequivocal clinical progression|2|||
147408489|NCT03939689|531662346|FG001|Overall Study|Unequivocal clinical progression|5|||
147408490|NCT03939689|531662345|FG000|Overall Study|Other|1|||
147408491|NCT03939689|531662346|FG001|Overall Study|Other|4|||
147464782|NCT03186989|531860344|FG004|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
147408492|NCT03939689|531662345|FG000|Overall Study|Death|0|||
147408493|NCT03939689|531662346|FG001|Overall Study|Death|3|||
147408494|NCT03939689|531662345|FG000|Overall Study|Participant decision|0|||
147408495|NCT03939689|531662346|FG001|Overall Study|Participant decision|3|||
147408496|NCT03939689|531662345|FG000|Overall Study|Withdrawal of consent|2|||
147408497|NCT03939689|531662346|FG001|Overall Study|Withdrawal of consent|1|||
147408498|NCT03939689|531662345|FG000|Overall Study|Investigator decision|1|||
147408499|NCT03939689|531662346|FG001|Overall Study|Investigator decision|0|||
147408500|NCT04427280|531662347|FG000|Overall Study|Withdrawal by Subject|0|||
147408501|NCT04427280|531662348|FG001|Overall Study|Withdrawal by Subject|2|||
147408502|NCT01667926|531662359|FG000|Overall Study|Withdrawal by Subject|1|||
147408503|NCT01667926|531662360|FG001|Overall Study|Withdrawal by Subject|2|||
147408504|NCT01667926|531662361|FG002|Overall Study|Withdrawal by Subject|2|||
147408505|NCT01667926|531662359|FG000|Overall Study|Physician Decision|0|||
147408506|NCT01667926|531662360|FG001|Overall Study|Physician Decision|0|||
147408507|NCT01667926|531662361|FG002|Overall Study|Physician Decision|1|||
147408508|NCT01667926|531662359|FG000|Overall Study|Time committment|0|||
147408509|NCT01667926|531662360|FG001|Overall Study|Time committment|0|||
147408510|NCT01667926|531662361|FG002|Overall Study|Time committment|2|||
147408511|NCT01667926|531662359|FG000|Overall Study|Inclusion/Exclusion Criteria|0|||
147408512|NCT01667926|531662360|FG001|Overall Study|Inclusion/Exclusion Criteria|0|||
147408513|NCT01667926|531662361|FG002|Overall Study|Inclusion/Exclusion Criteria|5|||
147408514|NCT01667926|531662359|FG000|Overall Study|Lost to Follow-up|1|||
147408515|NCT01667926|531662360|FG001|Overall Study|Lost to Follow-up|2|||
147408516|NCT01667926|531662361|FG002|Overall Study|Lost to Follow-up|1|||
147408517|NCT01667926|531662359|FG000|Overall Study|Side effects|3|||
147408518|NCT01667926|531662360|FG001|Overall Study|Side effects|0|||
147408519|NCT01667926|531662361|FG002|Overall Study|Side effects|0|||
147408520|NCT02271984|531662364|FG000|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
147408521|NCT02271984|531662365|FG001|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
147408522|NCT02271984|531662366|FG002|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
147408523|NCT02271984|531662367|FG003|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
147408524|NCT02271984|531662368|FG004|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
147408525|NCT02271984|531662369|FG005|Washout Period 4 (7 Days)|Withdrawal by Subject|1|||
147408526|NCT02271984|531662370|FG006|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
147408527|NCT02271984|531662371|FG007|Washout Period 4 (7 Days)|Withdrawal by Subject|1|||
147408528|NCT02271984|531662372|FG008|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
147408529|NCT02271984|531662373|FG009|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
147408530|NCT02271984|531662374|FG010|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
147408531|NCT02271984|531662375|FG011|Washout Period 4 (7 Days)|Withdrawal by Subject|0|||
147408532|NCT01088984|531662376|FG000|Phase 1|Death|2|||
147408533|NCT01088984|531662377|FG001|Phase 1|Death|1|||
147408534|NCT01088984|531662376|FG000|Phase 1|Disease Progression|2|||
147408535|NCT01088984|531662377|FG001|Phase 1|Disease Progression|4|||
147408536|NCT01088984|531662376|FG000|Phase 1|Other|1|||
147408537|NCT01088984|531662377|FG001|Phase 1|Other|1|||
147408538|NCT01088984|531662376|FG000|Phase 2|Death|0|||
147408539|NCT01088984|531662377|FG001|Phase 2|Death|5|||
147408540|NCT01088984|531662376|FG000|Phase 2|Withdrawal by Subject|0|||
147408541|NCT01088984|531662377|FG001|Phase 2|Withdrawal by Subject|1|||
147408542|NCT01088984|531662376|FG000|Phase 2|DIsease Progression|0|||
147408543|NCT01088984|531662377|FG001|Phase 2|DIsease Progression|25|||
147408544|NCT01088984|531662376|FG000|Phase 2|Other|0|||
147408545|NCT01088984|531662377|FG001|Phase 2|Other|1|||
147408546|NCT04079868|531662382|FG000|Overall Study|Lost to Follow-up|100|||
147408547|NCT04079868|531662383|FG001|Overall Study|Lost to Follow-up|200|||
147408548|NCT04079868|531662382|FG000|Overall Study|Physician Decision|100|||
147408549|NCT04079868|531662383|FG001|Overall Study|Physician Decision|0|||
147408550|NCT01757197|531662384|FG000|Overall Study|Death|2|||
147408551|NCT05332912|531662385|FG000|Overall Study|Withdrawal by Subject|0|||
147408552|NCT05332912|531662386|FG001|Overall Study|Withdrawal by Subject|1|||
147408553|NCT05332912|531662387|FG002|Overall Study|Withdrawal by Subject|2|||
147408554|NCT05332912|531662388|FG003|Overall Study|Withdrawal by Subject|0|||
147408555|NCT05332912|531662385|FG000|Overall Study|Lost to Follow-up|0|||
147408556|NCT05332912|531662386|FG001|Overall Study|Lost to Follow-up|0|||
147408557|NCT05332912|531662387|FG002|Overall Study|Lost to Follow-up|1|||
147408558|NCT05332912|531662388|FG003|Overall Study|Lost to Follow-up|0|||
147408559|NCT01174446|531662389|FG000|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|0|||
147408560|NCT01174446|531662390|FG001|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|0|||
147408561|NCT01174446|531662391|FG002|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|1|||
147408562|NCT01174446|531662392|FG003|Part 2 -BAX326 Prophylaxis and On-demand|Withdrawal by Subject|0|||
147408563|NCT01174446|531662389|FG000|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|0|||
147408564|NCT01174446|531662390|FG001|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|0|||
147408565|NCT01174446|531662391|FG002|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|1|||
147408566|NCT01174446|531662392|FG003|Part 2 -BAX326 Prophylaxis and On-demand|Physician Decision|0|||
147408567|NCT01174446|531662389|FG000|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|1|||
147408568|NCT01174446|531662390|FG001|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|0|||
147408569|NCT01174446|531662391|FG002|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|0|||
147464783|NCT03186989|531860345|FG005|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
147408570|NCT01174446|531662392|FG003|Part 3 -Pharmacokinetic BAX326 Only|Protocol Violation|0|||
147616979|NCT00662649|532413712|FG001|Core Study (24 Months)|Lost to Follow-up|5|||
147616980|NCT00662649|532413713|FG002|Core Study (24 Months)|Lost to Follow-up|7|||
147616981|NCT00662649|532413714|FG003|Core Study (24 Months)|Lost to Follow-up|0|||
147616982|NCT00662649|532413715|FG004|Core Study (24 Months)|Lost to Follow-up|0|||
147616983|NCT00662649|532413711|FG000|Core Study (24 Months)|Protocol Violation|5|||
147616984|NCT00662649|532413712|FG001|Core Study (24 Months)|Protocol Violation|5|||
147616985|NCT00662649|532413713|FG002|Core Study (24 Months)|Protocol Violation|4|||
147616986|NCT00662649|532413714|FG003|Core Study (24 Months)|Protocol Violation|0|||
147616987|NCT00662649|532413715|FG004|Core Study (24 Months)|Protocol Violation|0|||
147408571|NCT01174446|531662389|FG000|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|0|||
147408572|NCT01174446|531662390|FG001|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|1|||
147408573|NCT01174446|531662391|FG002|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|0|||
147408574|NCT01174446|531662392|FG003|Part 3 -Pharmacokinetic BAX326 Only|Required Emergency Surgery|0|||
147408575|NCT05000216|531662398|FG000|Stage 1|Lost to Follow-up|0|||
147408576|NCT05000216|531662399|FG001|Stage 1|Lost to Follow-up|0|||
147408577|NCT05000216|531662400|FG002|Stage 1|Lost to Follow-up|0|||
147408578|NCT05000216|531662401|FG003|Stage 1|Lost to Follow-up|0|||
147408579|NCT05000216|531662402|FG004|Stage 1|Lost to Follow-up|0|||
147408580|NCT05000216|531662403|FG005|Stage 1|Lost to Follow-up|0|||
147408581|NCT05000216|531662404|FG006|Stage 1|Lost to Follow-up|1|||
147408582|NCT05000216|531662405|FG007|Stage 1|Lost to Follow-up|1|||
147408583|NCT05000216|531662406|FG008|Stage 1|Lost to Follow-up|0|||
147408584|NCT05000216|531662407|FG009|Stage 1|Lost to Follow-up|2|||
147408585|NCT05000216|531662408|FG010|Stage 1|Lost to Follow-up|3|||
147408586|NCT05000216|531662409|FG011|Stage 1|Lost to Follow-up|0|||
147408587|NCT05000216|531662410|FG012|Stage 1|Lost to Follow-up|0|||
147408588|NCT05000216|531662411|FG013|Stage 1|Lost to Follow-up|0|||
147408589|NCT05000216|531662412|FG014|Stage 1|Lost to Follow-up|0|||
147408590|NCT05000216|531662413|FG015|Stage 1|Lost to Follow-up|0|||
147408591|NCT05000216|531662414|FG016|Stage 1|Lost to Follow-up|0|||
147408592|NCT05000216|531662415|FG017|Stage 1|Lost to Follow-up|0|||
147408593|NCT05000216|531662416|FG018|Stage 1|Lost to Follow-up|0|||
147408594|NCT05000216|531662417|FG019|Stage 1|Lost to Follow-up|0|||
147408595|NCT05000216|531662418|FG020|Stage 1|Lost to Follow-up|0|||
147408596|NCT05000216|531662419|FG021|Stage 1|Lost to Follow-up|0|||
147408597|NCT05000216|531662398|FG000|Stage 1|Physician Decision|0|||
147408598|NCT05000216|531662399|FG001|Stage 1|Physician Decision|0|||
147408599|NCT05000216|531662400|FG002|Stage 1|Physician Decision|0|||
147408600|NCT05000216|531662401|FG003|Stage 1|Physician Decision|0|||
147408601|NCT05000216|531662402|FG004|Stage 1|Physician Decision|0|||
147408602|NCT05000216|531662403|FG005|Stage 1|Physician Decision|0|||
147408603|NCT05000216|531662404|FG006|Stage 1|Physician Decision|0|||
147408604|NCT05000216|531662405|FG007|Stage 1|Physician Decision|1|||
147408605|NCT05000216|531662406|FG008|Stage 1|Physician Decision|1|||
147408606|NCT05000216|531662407|FG009|Stage 1|Physician Decision|0|||
147408607|NCT05000216|531662408|FG010|Stage 1|Physician Decision|0|||
147408608|NCT05000216|531662409|FG011|Stage 1|Physician Decision|0|||
147408609|NCT05000216|531662410|FG012|Stage 1|Physician Decision|0|||
147408610|NCT05000216|531662411|FG013|Stage 1|Physician Decision|0|||
147408611|NCT05000216|531662412|FG014|Stage 1|Physician Decision|0|||
147408612|NCT05000216|531662413|FG015|Stage 1|Physician Decision|0|||
147408613|NCT05000216|531662414|FG016|Stage 1|Physician Decision|0|||
147408614|NCT05000216|531662415|FG017|Stage 1|Physician Decision|0|||
147408615|NCT05000216|531662416|FG018|Stage 1|Physician Decision|0|||
147408616|NCT05000216|531662417|FG019|Stage 1|Physician Decision|0|||
147408617|NCT05000216|531662418|FG020|Stage 1|Physician Decision|0|||
147408618|NCT05000216|531662419|FG021|Stage 1|Physician Decision|0|||
147408619|NCT05000216|531662398|FG000|Stage 1|Withdrawal by Subject|0|||
147408620|NCT05000216|531662399|FG001|Stage 1|Withdrawal by Subject|1|||
147408621|NCT05000216|531662400|FG002|Stage 1|Withdrawal by Subject|0|||
147408622|NCT05000216|531662401|FG003|Stage 1|Withdrawal by Subject|0|||
147408623|NCT05000216|531662402|FG004|Stage 1|Withdrawal by Subject|0|||
147408624|NCT05000216|531662403|FG005|Stage 1|Withdrawal by Subject|0|||
147408625|NCT05000216|531662404|FG006|Stage 1|Withdrawal by Subject|0|||
147408626|NCT05000216|531662405|FG007|Stage 1|Withdrawal by Subject|0|||
147408627|NCT05000216|531662406|FG008|Stage 1|Withdrawal by Subject|0|||
147408628|NCT05000216|531662407|FG009|Stage 1|Withdrawal by Subject|3|||
147408629|NCT05000216|531662408|FG010|Stage 1|Withdrawal by Subject|10|||
147408630|NCT05000216|531662409|FG011|Stage 1|Withdrawal by Subject|0|||
147408631|NCT05000216|531662410|FG012|Stage 1|Withdrawal by Subject|0|||
147408632|NCT05000216|531662411|FG013|Stage 1|Withdrawal by Subject|0|||
147408633|NCT05000216|531662412|FG014|Stage 1|Withdrawal by Subject|0|||
147408634|NCT05000216|531662413|FG015|Stage 1|Withdrawal by Subject|0|||
147616988|NCT00662649|532413711|FG000|Core Study (24 Months)|Abnormal test procedure result(s)|2|||
147408635|NCT05000216|531662414|FG016|Stage 1|Withdrawal by Subject|0|||
147408636|NCT05000216|531662415|FG017|Stage 1|Withdrawal by Subject|0|||
147408637|NCT05000216|531662416|FG018|Stage 1|Withdrawal by Subject|0|||
147408638|NCT05000216|531662417|FG019|Stage 1|Withdrawal by Subject|0|||
147408639|NCT05000216|531662418|FG020|Stage 1|Withdrawal by Subject|0|||
147408640|NCT05000216|531662419|FG021|Stage 1|Withdrawal by Subject|0|||
147644004|NCT01447446|532516690|FG004|Overall Study|SVR12 Assessment|5|||
147408641|NCT05000216|531662398|FG000|Stage 1|Did not receive vaccine at Week 0|0|||
147408642|NCT05000216|531662399|FG001|Stage 1|Did not receive vaccine at Week 0|0|||
147408643|NCT05000216|531662400|FG002|Stage 1|Did not receive vaccine at Week 0|1|||
147408644|NCT05000216|531662401|FG003|Stage 1|Did not receive vaccine at Week 0|1|||
147408645|NCT05000216|531662402|FG004|Stage 1|Did not receive vaccine at Week 0|0|||
147408646|NCT05000216|531662403|FG005|Stage 1|Did not receive vaccine at Week 0|0|||
147408647|NCT05000216|531662404|FG006|Stage 1|Did not receive vaccine at Week 0|0|||
147408648|NCT05000216|531662405|FG007|Stage 1|Did not receive vaccine at Week 0|0|||
147408649|NCT05000216|531662406|FG008|Stage 1|Did not receive vaccine at Week 0|0|||
147408650|NCT05000216|531662407|FG009|Stage 1|Did not receive vaccine at Week 0|1|||
147408651|NCT05000216|531662408|FG010|Stage 1|Did not receive vaccine at Week 0|0|||
147408652|NCT05000216|531662409|FG011|Stage 1|Did not receive vaccine at Week 0|0|||
147408653|NCT05000216|531662410|FG012|Stage 1|Did not receive vaccine at Week 0|0|||
147408654|NCT05000216|531662411|FG013|Stage 1|Did not receive vaccine at Week 0|0|||
147408655|NCT05000216|531662412|FG014|Stage 1|Did not receive vaccine at Week 0|0|||
147408656|NCT05000216|531662413|FG015|Stage 1|Did not receive vaccine at Week 0|0|||
147408657|NCT05000216|531662414|FG016|Stage 1|Did not receive vaccine at Week 0|0|||
147408658|NCT05000216|531662415|FG017|Stage 1|Did not receive vaccine at Week 0|0|||
147408659|NCT05000216|531662416|FG018|Stage 1|Did not receive vaccine at Week 0|0|||
147408660|NCT05000216|531662417|FG019|Stage 1|Did not receive vaccine at Week 0|0|||
147408661|NCT05000216|531662418|FG020|Stage 1|Did not receive vaccine at Week 0|0|||
147408662|NCT05000216|531662419|FG021|Stage 1|Did not receive vaccine at Week 0|0|||
147408663|NCT05000216|531662398|FG000|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
147408664|NCT05000216|531662399|FG001|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
147408665|NCT05000216|531662400|FG002|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
147408666|NCT05000216|531662401|FG003|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
147408667|NCT05000216|531662402|FG004|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
147408668|NCT05000216|531662403|FG005|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
147408669|NCT05000216|531662404|FG006|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
147408670|NCT05000216|531662405|FG007|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
147408671|NCT05000216|531662406|FG008|Stage 1|Received a SARS-CoV-2 vaccine off study|1|||
147408672|NCT05000216|531662407|FG009|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
147408673|NCT05000216|531662408|FG010|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
147408674|NCT05000216|531662409|FG011|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
147408675|NCT05000216|531662410|FG012|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
147408676|NCT05000216|531662411|FG013|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
147408677|NCT05000216|531662412|FG014|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
147408678|NCT05000216|531662413|FG015|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
147408679|NCT05000216|531662414|FG016|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
147408680|NCT05000216|531662415|FG017|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
147408681|NCT05000216|531662416|FG018|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
147408682|NCT05000216|531662417|FG019|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
147408683|NCT05000216|531662418|FG020|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
147408684|NCT05000216|531662419|FG021|Stage 1|Received a SARS-CoV-2 vaccine off study|0|||
147408685|NCT05000216|531662398|FG000|Stage 1|Other|0|||
147408686|NCT05000216|531662399|FG001|Stage 1|Other|0|||
147408687|NCT05000216|531662400|FG002|Stage 1|Other|0|||
147408688|NCT05000216|531662401|FG003|Stage 1|Other|0|||
147408689|NCT05000216|531662402|FG004|Stage 1|Other|1|||
147408690|NCT05000216|531662403|FG005|Stage 1|Other|0|||
147408691|NCT05000216|531662404|FG006|Stage 1|Other|0|||
147408692|NCT05000216|531662405|FG007|Stage 1|Other|2|||
147408693|NCT05000216|531662406|FG008|Stage 1|Other|0|||
147408694|NCT05000216|531662407|FG009|Stage 1|Other|0|||
147408695|NCT05000216|531662408|FG010|Stage 1|Other|1|||
147408696|NCT05000216|531662409|FG011|Stage 1|Other|1|||
147408697|NCT05000216|531662410|FG012|Stage 1|Other|0|||
147408698|NCT05000216|531662411|FG013|Stage 1|Other|0|||
147408699|NCT05000216|531662412|FG014|Stage 1|Other|0|||
147408700|NCT05000216|531662413|FG015|Stage 1|Other|0|||
147408701|NCT05000216|531662414|FG016|Stage 1|Other|0|||
147408702|NCT05000216|531662415|FG017|Stage 1|Other|0|||
147408703|NCT05000216|531662416|FG018|Stage 1|Other|0|||
147408704|NCT05000216|531662417|FG019|Stage 1|Other|0|||
147408705|NCT05000216|531662418|FG020|Stage 1|Other|0|||
147408706|NCT05000216|531662419|FG021|Stage 1|Other|0|||
147408707|NCT05000216|531662398|FG000|Stage 1|Rolled over to Stage 2 of the study|1|||
147408708|NCT05000216|531662399|FG001|Stage 1|Rolled over to Stage 2 of the study|0|||
147464784|NCT03186989|531860346|FG006|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|1|||
147408709|NCT05000216|531662400|FG002|Stage 1|Rolled over to Stage 2 of the study|3|||
147408710|NCT05000216|531662401|FG003|Stage 1|Rolled over to Stage 2 of the study|3|||
147408711|NCT05000216|531662402|FG004|Stage 1|Rolled over to Stage 2 of the study|0|||
147408712|NCT05000216|531662403|FG005|Stage 1|Rolled over to Stage 2 of the study|1|||
147644005|NCT01447446|532516691|FG005|Overall Study|SVR12 Assessment|5|||
147408713|NCT05000216|531662404|FG006|Stage 1|Rolled over to Stage 2 of the study|0|||
147408714|NCT05000216|531662405|FG007|Stage 1|Rolled over to Stage 2 of the study|2|||
147408715|NCT05000216|531662406|FG008|Stage 1|Rolled over to Stage 2 of the study|0|||
147408716|NCT05000216|531662407|FG009|Stage 1|Rolled over to Stage 2 of the study|13|||
147464785|NCT03186989|531860347|FG007|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
147464786|NCT03186989|531860348|FG008|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
147464787|NCT03186989|531860349|FG009|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
147464788|NCT03186989|531860350|FG010|Part 2: LTE (Week 37 to Week 101)|Investigator Judgement|0|||
147464789|NCT03186989|531860340|FG000|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
147464790|NCT03186989|531860341|FG001|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
147464791|NCT03186989|531860342|FG002|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
147464792|NCT03186989|531860343|FG003|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
147464793|NCT03186989|531860344|FG004|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
147464794|NCT03186989|531860345|FG005|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|1|||
147464795|NCT03186989|531860346|FG006|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|1|||
147464796|NCT03186989|531860347|FG007|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
147464797|NCT03186989|531860348|FG008|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|1|||
147464798|NCT03186989|531860349|FG009|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
147464799|NCT03186989|531860350|FG010|Part 2: LTE (Week 37 to Week 101)|Adverse Event or Serious Adverse Event (SAE)|0|||
147464800|NCT02246621|531860354|FG000|Overall Study|Withdrawal by Subject|28|||
147464801|NCT02246621|531860355|FG001|Overall Study|Withdrawal by Subject|16|||
147464802|NCT02246621|531860354|FG000|Overall Study|Lost to Follow-up|1|||
147464803|NCT02246621|531860355|FG001|Overall Study|Lost to Follow-up|0|||
147464804|NCT02246621|531860354|FG000|Overall Study|On Study Treatment/ Follow Up|236|||
147616989|NCT00662649|532413712|FG001|Core Study (24 Months)|Abnormal test procedure result(s)|1|||
147616990|NCT00662649|532413713|FG002|Core Study (24 Months)|Abnormal test procedure result(s)|1|||
147616991|NCT00662649|532413714|FG003|Core Study (24 Months)|Abnormal test procedure result(s)|0|||
147616992|NCT00662649|532413715|FG004|Core Study (24 Months)|Abnormal test procedure result(s)|0|||
147616993|NCT00662649|532413711|FG000|Core Study (24 Months)|Death|1|||
147616994|NCT00662649|532413712|FG001|Core Study (24 Months)|Death|0|||
147616995|NCT00662649|532413713|FG002|Core Study (24 Months)|Death|2|||
147464805|NCT02246621|531860355|FG001|Overall Study|On Study Treatment/ Follow Up|119|||
147464806|NCT01292057|531860358|FG000|Overall Study|Protocol Violation|1|||
147464807|NCT01292057|531860359|FG001|Overall Study|Protocol Violation|1|||
147464808|NCT01292057|531860358|FG000|Overall Study|Lost to Follow-up|1|||
147464809|NCT01292057|531860359|FG001|Overall Study|Lost to Follow-up|1|||
147464810|NCT01459614|531860360|FG000|Overall Study|Adverse Event|1|||
147464811|NCT01459614|531860361|FG001|Overall Study|Adverse Event|0|||
147616996|NCT00662649|532413714|FG003|Core Study (24 Months)|Death|0|||
147616997|NCT00662649|532413715|FG004|Core Study (24 Months)|Death|0|||
147616998|NCT00662649|532413711|FG000|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|10|||
147616999|NCT00662649|532413712|FG001|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|5|||
147617000|NCT00662649|532413713|FG002|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|0|||
147617001|NCT00662649|532413714|FG003|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|8|||
147617002|NCT00662649|532413715|FG004|Extension Study (Month 24 to 60)|Abnormal laboratory value(s)|3|||
147617003|NCT00662649|532413711|FG000|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|3|||
147617004|NCT00662649|532413712|FG001|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|1|||
147617005|NCT00662649|532413713|FG002|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|0|||
147617006|NCT00662649|532413714|FG003|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|1|||
147617007|NCT00662649|532413715|FG004|Extension Study (Month 24 to 60)|Abnormal test procedure result(s)|3|||
147617008|NCT00662649|532413711|FG000|Extension Study (Month 24 to 60)|Administrative problems|0|||
147617009|NCT00662649|532413712|FG001|Extension Study (Month 24 to 60)|Administrative problems|0|||
147617010|NCT00662649|532413713|FG002|Extension Study (Month 24 to 60)|Administrative problems|0|||
147617011|NCT00662649|532413714|FG003|Extension Study (Month 24 to 60)|Administrative problems|1|||
147617012|NCT00662649|532413715|FG004|Extension Study (Month 24 to 60)|Administrative problems|0|||
147617013|NCT00662649|532413711|FG000|Extension Study (Month 24 to 60)|Adverse Event|6|||
147617014|NCT00662649|532413712|FG001|Extension Study (Month 24 to 60)|Adverse Event|9|||
147617015|NCT00662649|532413713|FG002|Extension Study (Month 24 to 60)|Adverse Event|0|||
147617016|NCT00662649|532413714|FG003|Extension Study (Month 24 to 60)|Adverse Event|6|||
147617017|NCT00662649|532413715|FG004|Extension Study (Month 24 to 60)|Adverse Event|10|||
147617018|NCT00662649|532413711|FG000|Extension Study (Month 24 to 60)|Lost to Follow-up|2|||
147464812|NCT00630331|531860365|FG000|Overall Study|Death|2|||
147464813|NCT00630331|531860366|FG001|Overall Study|Death|1|||
147464814|NCT00630331|531860367|FG002|Overall Study|Death|1|||
147464815|NCT00630331|531860365|FG000|Overall Study|Adverse Event|1|||
147464816|NCT00630331|531860366|FG001|Overall Study|Adverse Event|0|||
147464817|NCT00630331|531860367|FG002|Overall Study|Adverse Event|0|||
147464818|NCT00630331|531860365|FG000|Overall Study|Withdrawal by Subject|12|||
147464819|NCT00630331|531860366|FG001|Overall Study|Withdrawal by Subject|7|||
147464820|NCT00630331|531860367|FG002|Overall Study|Withdrawal by Subject|5|||
147617019|NCT00662649|532413712|FG001|Extension Study (Month 24 to 60)|Lost to Follow-up|0|||
147408717|NCT05000216|531662408|FG010|Stage 1|Rolled over to Stage 2 of the study|18|||
147408718|NCT05000216|531662409|FG011|Stage 1|Rolled over to Stage 2 of the study|2|||
147408719|NCT05000216|531662410|FG012|Stage 1|Rolled over to Stage 2 of the study|0|||
147408720|NCT05000216|531662411|FG013|Stage 1|Rolled over to Stage 2 of the study|0|||
147408721|NCT05000216|531662412|FG014|Stage 1|Rolled over to Stage 2 of the study|0|||
147408722|NCT05000216|531662413|FG015|Stage 1|Rolled over to Stage 2 of the study|0|||
147408723|NCT05000216|531662414|FG016|Stage 1|Rolled over to Stage 2 of the study|0|||
147408724|NCT05000216|531662415|FG017|Stage 1|Rolled over to Stage 2 of the study|0|||
147408725|NCT05000216|531662416|FG018|Stage 1|Rolled over to Stage 2 of the study|0|||
147408726|NCT05000216|531662417|FG019|Stage 1|Rolled over to Stage 2 of the study|0|||
147408727|NCT05000216|531662418|FG020|Stage 1|Rolled over to Stage 2 of the study|0|||
147408728|NCT05000216|531662419|FG021|Stage 1|Rolled over to Stage 2 of the study|0|||
147408729|NCT05000216|531662398|FG000|Stage 2|Lost to Follow-up|0|||
147408730|NCT05000216|531662399|FG001|Stage 2|Lost to Follow-up|0|||
147408731|NCT05000216|531662400|FG002|Stage 2|Lost to Follow-up|0|||
147408732|NCT05000216|531662401|FG003|Stage 2|Lost to Follow-up|0|||
147408733|NCT05000216|531662402|FG004|Stage 2|Lost to Follow-up|0|||
147408734|NCT05000216|531662403|FG005|Stage 2|Lost to Follow-up|0|||
147408735|NCT05000216|531662404|FG006|Stage 2|Lost to Follow-up|0|||
147408736|NCT05000216|531662405|FG007|Stage 2|Lost to Follow-up|0|||
147408737|NCT05000216|531662406|FG008|Stage 2|Lost to Follow-up|0|||
147408738|NCT05000216|531662407|FG009|Stage 2|Lost to Follow-up|0|||
147408739|NCT05000216|531662408|FG010|Stage 2|Lost to Follow-up|0|||
147408740|NCT05000216|531662409|FG011|Stage 2|Lost to Follow-up|0|||
147408741|NCT05000216|531662410|FG012|Stage 2|Lost to Follow-up|0|||
147408742|NCT05000216|531662411|FG013|Stage 2|Lost to Follow-up|0|||
147408743|NCT05000216|531662412|FG014|Stage 2|Lost to Follow-up|0|||
147408744|NCT05000216|531662413|FG015|Stage 2|Lost to Follow-up|0|||
147408745|NCT05000216|531662414|FG016|Stage 2|Lost to Follow-up|4|||
147408746|NCT05000216|531662415|FG017|Stage 2|Lost to Follow-up|0|||
147408747|NCT05000216|531662416|FG018|Stage 2|Lost to Follow-up|0|||
147408748|NCT05000216|531662417|FG019|Stage 2|Lost to Follow-up|0|||
147408749|NCT05000216|531662418|FG020|Stage 2|Lost to Follow-up|0|||
147408750|NCT05000216|531662419|FG021|Stage 2|Lost to Follow-up|0|||
147408751|NCT05000216|531662398|FG000|Stage 2|Physician Decision|0|||
147408752|NCT05000216|531662399|FG001|Stage 2|Physician Decision|0|||
147408753|NCT05000216|531662400|FG002|Stage 2|Physician Decision|0|||
147408754|NCT05000216|531662401|FG003|Stage 2|Physician Decision|0|||
147408755|NCT05000216|531662402|FG004|Stage 2|Physician Decision|0|||
147408756|NCT05000216|531662403|FG005|Stage 2|Physician Decision|0|||
147408757|NCT05000216|531662404|FG006|Stage 2|Physician Decision|0|||
147464821|NCT00630331|531860365|FG000|Overall Study|Lost to Follow-up|175|||
147464822|NCT00630331|531860366|FG001|Overall Study|Lost to Follow-up|143|||
147464823|NCT00630331|531860367|FG002|Overall Study|Lost to Follow-up|170|||
147464824|NCT00630331|531860365|FG000|Overall Study|Inappropriate enrollment|3|||
147464825|NCT00630331|531860366|FG001|Overall Study|Inappropriate enrollment|6|||
147464826|NCT00630331|531860367|FG002|Overall Study|Inappropriate enrollment|3|||
147464827|NCT00630331|531860365|FG000|Overall Study|Unable to classify|9|||
147464828|NCT00630331|531860366|FG001|Overall Study|Unable to classify|4|||
147464829|NCT00630331|531860367|FG002|Overall Study|Unable to classify|3|||
147464830|NCT00630331|531860365|FG000|Overall Study|Protocol Violation|4|||
147464831|NCT00630331|531860366|FG001|Overall Study|Protocol Violation|5|||
147464832|NCT00630331|531860367|FG002|Overall Study|Protocol Violation|6|||
147464833|NCT02425098|531860374|FG000|Overall Study|Lost to Follow-up|7|||
147464834|NCT02425098|531860375|FG001|Overall Study|Lost to Follow-up|7|||
147464835|NCT02425098|531860374|FG000|Overall Study|Withdrawal by Subject|4|||
147464836|NCT02425098|531860375|FG001|Overall Study|Withdrawal by Subject|8|||
147464837|NCT02425098|531860374|FG000|Overall Study|Pregnancy|2|||
147464838|NCT02425098|531860375|FG001|Overall Study|Pregnancy|0|||
147464839|NCT02425098|531860374|FG000|Overall Study|Reason not Specified|0|||
147464840|NCT02425098|531860375|FG001|Overall Study|Reason not Specified|1|||
147464841|NCT02078219|531860376|FG000|Overall Study|Other|2|||
147464842|NCT02078219|531860377|FG001|Overall Study|Other|2|||
147464843|NCT02078219|531860378|FG002|Overall Study|Other|3|||
147464844|NCT02078219|531860379|FG003|Overall Study|Other|0|||
147464845|NCT02078219|531860380|FG004|Overall Study|Other|1|||
147464846|NCT02078219|531860376|FG000|Overall Study|Withdrawal by Subject|0|||
147408758|NCT05000216|531662405|FG007|Stage 2|Physician Decision|0|||
147408759|NCT05000216|531662406|FG008|Stage 2|Physician Decision|0|||
147408760|NCT05000216|531662407|FG009|Stage 2|Physician Decision|0|||
147408761|NCT05000216|531662408|FG010|Stage 2|Physician Decision|0|||
147408762|NCT05000216|531662409|FG011|Stage 2|Physician Decision|0|||
147408763|NCT05000216|531662410|FG012|Stage 2|Physician Decision|1|||
147464847|NCT02078219|531860377|FG001|Overall Study|Withdrawal by Subject|1|||
147464848|NCT02078219|531860378|FG002|Overall Study|Withdrawal by Subject|0|||
147464849|NCT02078219|531860379|FG003|Overall Study|Withdrawal by Subject|1|||
147464850|NCT02078219|531860380|FG004|Overall Study|Withdrawal by Subject|1|||
147464851|NCT02078219|531860376|FG000|Overall Study|Protocol Violation|0|||
147464852|NCT02078219|531860377|FG001|Overall Study|Protocol Violation|0|||
147464853|NCT02078219|531860378|FG002|Overall Study|Protocol Violation|0|||
147464854|NCT02078219|531860379|FG003|Overall Study|Protocol Violation|1|||
147408764|NCT05000216|531662411|FG013|Stage 2|Physician Decision|0|||
147617020|NCT00662649|532413713|FG002|Extension Study (Month 24 to 60)|Lost to Follow-up|0|||
147617021|NCT00662649|532413714|FG003|Extension Study (Month 24 to 60)|Lost to Follow-up|1|||
147617022|NCT00662649|532413715|FG004|Extension Study (Month 24 to 60)|Lost to Follow-up|1|||
147617023|NCT00662649|532413711|FG000|Extension Study (Month 24 to 60)|Protocol Violation|1|||
147617024|NCT00662649|532413712|FG001|Extension Study (Month 24 to 60)|Protocol Violation|1|||
147617025|NCT00662649|532413713|FG002|Extension Study (Month 24 to 60)|Protocol Violation|0|||
147617026|NCT00662649|532413714|FG003|Extension Study (Month 24 to 60)|Protocol Violation|0|||
147617027|NCT00662649|532413715|FG004|Extension Study (Month 24 to 60)|Protocol Violation|0|||
147617028|NCT00662649|532413711|FG000|Extension Study (Month 24 to 60)|Subject withdrew consent|19|||
147617029|NCT00662649|532413712|FG001|Extension Study (Month 24 to 60)|Subject withdrew consent|23|||
147617030|NCT00662649|532413713|FG002|Extension Study (Month 24 to 60)|Subject withdrew consent|0|||
147617031|NCT00662649|532413714|FG003|Extension Study (Month 24 to 60)|Subject withdrew consent|15|||
147617032|NCT00662649|532413715|FG004|Extension Study (Month 24 to 60)|Subject withdrew consent|9|||
147617033|NCT00662649|532413711|FG000|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0|||
147408765|NCT05000216|531662412|FG014|Stage 2|Physician Decision|0|||
147408766|NCT05000216|531662413|FG015|Stage 2|Physician Decision|0|||
147408767|NCT05000216|531662414|FG016|Stage 2|Physician Decision|0|||
147408768|NCT05000216|531662415|FG017|Stage 2|Physician Decision|0|||
147408769|NCT05000216|531662416|FG018|Stage 2|Physician Decision|0|||
147408770|NCT05000216|531662417|FG019|Stage 2|Physician Decision|0|||
147408771|NCT05000216|531662418|FG020|Stage 2|Physician Decision|0|||
147408772|NCT05000216|531662419|FG021|Stage 2|Physician Decision|0|||
147408773|NCT05000216|531662398|FG000|Stage 2|Withdrawal by Subject|0|||
147408774|NCT05000216|531662399|FG001|Stage 2|Withdrawal by Subject|0|||
147408775|NCT05000216|531662400|FG002|Stage 2|Withdrawal by Subject|0|||
147408776|NCT05000216|531662401|FG003|Stage 2|Withdrawal by Subject|0|||
147408777|NCT05000216|531662402|FG004|Stage 2|Withdrawal by Subject|0|||
147408778|NCT05000216|531662403|FG005|Stage 2|Withdrawal by Subject|0|||
147408779|NCT05000216|531662404|FG006|Stage 2|Withdrawal by Subject|0|||
147408780|NCT05000216|531662405|FG007|Stage 2|Withdrawal by Subject|0|||
147408781|NCT05000216|531662406|FG008|Stage 2|Withdrawal by Subject|0|||
147408782|NCT05000216|531662407|FG009|Stage 2|Withdrawal by Subject|0|||
147408783|NCT05000216|531662408|FG010|Stage 2|Withdrawal by Subject|0|||
147408784|NCT05000216|531662409|FG011|Stage 2|Withdrawal by Subject|0|||
147408785|NCT05000216|531662410|FG012|Stage 2|Withdrawal by Subject|0|||
147408786|NCT05000216|531662411|FG013|Stage 2|Withdrawal by Subject|0|||
147408787|NCT05000216|531662412|FG014|Stage 2|Withdrawal by Subject|2|||
147408788|NCT05000216|531662413|FG015|Stage 2|Withdrawal by Subject|0|||
147408789|NCT05000216|531662414|FG016|Stage 2|Withdrawal by Subject|9|||
147408790|NCT05000216|531662415|FG017|Stage 2|Withdrawal by Subject|0|||
147408791|NCT05000216|531662416|FG018|Stage 2|Withdrawal by Subject|0|||
147408792|NCT05000216|531662417|FG019|Stage 2|Withdrawal by Subject|0|||
147408793|NCT05000216|531662418|FG020|Stage 2|Withdrawal by Subject|0|||
147408794|NCT05000216|531662419|FG021|Stage 2|Withdrawal by Subject|0|||
147408795|NCT05000216|531662398|FG000|Stage 2|Did not receive vaccine at Week 0|0|||
147408796|NCT05000216|531662399|FG001|Stage 2|Did not receive vaccine at Week 0|0|||
147408797|NCT05000216|531662400|FG002|Stage 2|Did not receive vaccine at Week 0|0|||
147408798|NCT05000216|531662401|FG003|Stage 2|Did not receive vaccine at Week 0|0|||
147408799|NCT05000216|531662402|FG004|Stage 2|Did not receive vaccine at Week 0|0|||
147408800|NCT05000216|531662403|FG005|Stage 2|Did not receive vaccine at Week 0|0|||
147408801|NCT05000216|531662404|FG006|Stage 2|Did not receive vaccine at Week 0|0|||
147408802|NCT05000216|531662405|FG007|Stage 2|Did not receive vaccine at Week 0|0|||
147408803|NCT05000216|531662406|FG008|Stage 2|Did not receive vaccine at Week 0|0|||
147408804|NCT05000216|531662407|FG009|Stage 2|Did not receive vaccine at Week 0|0|||
147408805|NCT05000216|531662408|FG010|Stage 2|Did not receive vaccine at Week 0|0|||
147408806|NCT05000216|531662409|FG011|Stage 2|Did not receive vaccine at Week 0|0|||
147408807|NCT05000216|531662410|FG012|Stage 2|Did not receive vaccine at Week 0|0|||
147408808|NCT05000216|531662411|FG013|Stage 2|Did not receive vaccine at Week 0|0|||
147408809|NCT05000216|531662412|FG014|Stage 2|Did not receive vaccine at Week 0|0|||
147408810|NCT05000216|531662413|FG015|Stage 2|Did not receive vaccine at Week 0|0|||
147408811|NCT05000216|531662414|FG016|Stage 2|Did not receive vaccine at Week 0|4|||
147408812|NCT05000216|531662415|FG017|Stage 2|Did not receive vaccine at Week 0|0|||
147408813|NCT05000216|531662416|FG018|Stage 2|Did not receive vaccine at Week 0|0|||
147408814|NCT05000216|531662417|FG019|Stage 2|Did not receive vaccine at Week 0|1|||
147408815|NCT05000216|531662418|FG020|Stage 2|Did not receive vaccine at Week 0|0|||
147408816|NCT05000216|531662419|FG021|Stage 2|Did not receive vaccine at Week 0|0|||
147408817|NCT05000216|531662398|FG000|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
147408818|NCT05000216|531662399|FG001|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
147408819|NCT05000216|531662400|FG002|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
147408820|NCT05000216|531662401|FG003|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
147408821|NCT05000216|531662402|FG004|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
147408822|NCT05000216|531662403|FG005|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
147464855|NCT02078219|531860380|FG004|Overall Study|Protocol Violation|0|||
147464856|NCT02078219|531860376|FG000|Overall Study|Death|0|||
147464857|NCT02078219|531860377|FG001|Overall Study|Death|0|||
147464858|NCT02078219|531860378|FG002|Overall Study|Death|0|||
147464859|NCT02078219|531860379|FG003|Overall Study|Death|1|||
147464860|NCT02078219|531860380|FG004|Overall Study|Death|0|||
147464861|NCT02078219|531860376|FG000|Overall Study|Adverse Event|1|||
147464862|NCT02078219|531860377|FG001|Overall Study|Adverse Event|1|||
147464863|NCT02078219|531860378|FG002|Overall Study|Adverse Event|3|||
147464864|NCT02078219|531860379|FG003|Overall Study|Adverse Event|1|||
147464865|NCT02078219|531860380|FG004|Overall Study|Adverse Event|0|||
147464866|NCT03283085|531860387|FG000|Overall Study|Adverse Event|18|||
147464867|NCT03283085|531860388|FG001|Overall Study|Adverse Event|3|||
147464868|NCT03283085|531860389|FG002|Overall Study|Adverse Event|13|||
147464869|NCT03283085|531860390|FG003|Overall Study|Adverse Event|0|||
147464870|NCT03283085|531860391|FG004|Overall Study|Adverse Event|0|||
147464871|NCT03283085|531860392|FG005|Overall Study|Adverse Event|5|||
147464872|NCT03283085|531860387|FG000|Overall Study|Death|0|||
147464873|NCT03283085|531860388|FG001|Overall Study|Death|0|||
147464874|NCT03283085|531860389|FG002|Overall Study|Death|3|||
147464875|NCT03283085|531860390|FG003|Overall Study|Death|1|||
147464876|NCT03283085|531860391|FG004|Overall Study|Death|0|||
147464877|NCT03283085|531860392|FG005|Overall Study|Death|0|||
147464878|NCT03283085|531860387|FG000|Overall Study|Withdrawal by Subject|42|||
147464879|NCT03283085|531860388|FG001|Overall Study|Withdrawal by Subject|21|||
147464880|NCT03283085|531860389|FG002|Overall Study|Withdrawal by Subject|66|||
147464881|NCT03283085|531860390|FG003|Overall Study|Withdrawal by Subject|3|||
147464882|NCT03283085|531860391|FG004|Overall Study|Withdrawal by Subject|3|||
147464883|NCT03283085|531860392|FG005|Overall Study|Withdrawal by Subject|5|||
147464884|NCT03283085|531860387|FG000|Overall Study|Physician Decision|14|||
147464885|NCT03283085|531860388|FG001|Overall Study|Physician Decision|8|||
147464886|NCT03283085|531860389|FG002|Overall Study|Physician Decision|19|||
147464887|NCT03283085|531860390|FG003|Overall Study|Physician Decision|0|||
147464888|NCT03283085|531860391|FG004|Overall Study|Physician Decision|0|||
147464889|NCT03283085|531860392|FG005|Overall Study|Physician Decision|2|||
147464890|NCT03283085|531860387|FG000|Overall Study|Site Terminated by Sponsor|1|||
147464891|NCT03283085|531860388|FG001|Overall Study|Site Terminated by Sponsor|0|||
147464892|NCT03283085|531860389|FG002|Overall Study|Site Terminated by Sponsor|3|||
147464893|NCT03283085|531860390|FG003|Overall Study|Site Terminated by Sponsor|0|||
147464894|NCT03283085|531860391|FG004|Overall Study|Site Terminated by Sponsor|0|||
147464895|NCT03283085|531860392|FG005|Overall Study|Site Terminated by Sponsor|0|||
147464896|NCT03283085|531860387|FG000|Overall Study|Lost to Follow-up|2|||
147464897|NCT03283085|531860388|FG001|Overall Study|Lost to Follow-up|0|||
147464898|NCT03283085|531860389|FG002|Overall Study|Lost to Follow-up|2|||
147464899|NCT03283085|531860390|FG003|Overall Study|Lost to Follow-up|0|||
147464900|NCT03283085|531860391|FG004|Overall Study|Lost to Follow-up|0|||
147464901|NCT03283085|531860392|FG005|Overall Study|Lost to Follow-up|1|||
147464902|NCT03283085|531860387|FG000|Overall Study|Pregnancy|0|||
147617034|NCT00662649|532413712|FG001|Extension Study (Month 24 to 60)|Subject no longer requires study drug|1|||
147617035|NCT00662649|532413713|FG002|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0|||
147617036|NCT00662649|532413714|FG003|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0|||
147464903|NCT03283085|531860388|FG001|Overall Study|Pregnancy|0|||
147464904|NCT03283085|531860389|FG002|Overall Study|Pregnancy|1|||
147464905|NCT03283085|531860390|FG003|Overall Study|Pregnancy|0|||
147464906|NCT03283085|531860391|FG004|Overall Study|Pregnancy|0|||
147464907|NCT03283085|531860392|FG005|Overall Study|Pregnancy|0|||
147464908|NCT03283085|531860387|FG000|Overall Study|Lack of Efficacy|12|||
147464909|NCT03283085|531860388|FG001|Overall Study|Lack of Efficacy|6|||
147464910|NCT03283085|531860389|FG002|Overall Study|Lack of Efficacy|24|||
147464911|NCT03283085|531860390|FG003|Overall Study|Lack of Efficacy|1|||
147464912|NCT03283085|531860391|FG004|Overall Study|Lack of Efficacy|1|||
147464913|NCT03283085|531860392|FG005|Overall Study|Lack of Efficacy|0|||
147464914|NCT03283085|531860387|FG000|Overall Study|Reason not Specified|0|||
147617037|NCT00662649|532413715|FG004|Extension Study (Month 24 to 60)|Subject no longer requires study drug|0|||
147617038|NCT00662649|532413711|FG000|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|3|||
147617039|NCT00662649|532413712|FG001|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|1|||
147617040|NCT00662649|532413713|FG002|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|0|||
147617041|NCT00662649|532413714|FG003|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|1|||
147617042|NCT00662649|532413715|FG004|Extension Study (Month 24 to 60)|Unsatisfactory therapeutic effect|3|||
147617043|NCT01026194|532413716|FG000|Period 1：Double Blind Period|Adverse Event|2|||
147617044|NCT01026194|532413717|FG001|Period 1：Double Blind Period|Adverse Event|1|||
147617045|NCT01026194|532413716|FG000|Period 1：Double Blind Period|Lack of Efficacy|1|||
147617046|NCT01026194|532413717|FG001|Period 1：Double Blind Period|Lack of Efficacy|0|||
147617047|NCT01026194|532413716|FG000|Period 1：Double Blind Period|Physician Decision|0|||
147617048|NCT01026194|532413717|FG001|Period 1：Double Blind Period|Physician Decision|4|||
147617049|NCT01026194|532413716|FG000|Period 2：Open-label Period|Adverse Event|4|||
147464915|NCT03283085|531860388|FG001|Overall Study|Reason not Specified|4|||
147464916|NCT03283085|531860389|FG002|Overall Study|Reason not Specified|8|||
147408823|NCT05000216|531662404|FG006|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
147408824|NCT05000216|531662405|FG007|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
147408825|NCT05000216|531662406|FG008|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
147408826|NCT05000216|531662407|FG009|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
147408827|NCT05000216|531662408|FG010|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
147408828|NCT05000216|531662409|FG011|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
147408829|NCT05000216|531662410|FG012|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
147408830|NCT05000216|531662411|FG013|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
147408831|NCT05000216|531662412|FG014|Stage 2|Received a SARS-CoV-2 vaccine off study|1|||
147408832|NCT05000216|531662413|FG015|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
147408833|NCT05000216|531662414|FG016|Stage 2|Received a SARS-CoV-2 vaccine off study|6|||
147408834|NCT05000216|531662415|FG017|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
147408835|NCT05000216|531662416|FG018|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
147408836|NCT05000216|531662417|FG019|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
147617050|NCT01026194|532413717|FG001|Period 2：Open-label Period|Adverse Event|5|||
147617051|NCT01026194|532413716|FG000|Period 2：Open-label Period|Physician Decision|3|||
147617052|NCT01026194|532413717|FG001|Period 2：Open-label Period|Physician Decision|1|||
147617053|NCT01026194|532413716|FG000|Period 2：Open-label Period|Withdrawal by Subject|0|||
147617054|NCT01026194|532413717|FG001|Period 2：Open-label Period|Withdrawal by Subject|4|||
147617055|NCT02515331|532413722|FG000|Overall Study|Withdrawal by Subject|0|||
147617056|NCT02515331|532413723|FG001|Overall Study|Withdrawal by Subject|0|||
147617057|NCT02515331|532413724|FG002|Overall Study|Withdrawal by Subject|1|||
147617058|NCT02515331|532413722|FG000|Overall Study|Protocol deviation|0|||
147617059|NCT02515331|532413723|FG001|Overall Study|Protocol deviation|0|||
147617060|NCT02515331|532413724|FG002|Overall Study|Protocol deviation|3|||
147617061|NCT02515331|532413722|FG000|Overall Study|Adverse Event|2|||
147617062|NCT02515331|532413723|FG001|Overall Study|Adverse Event|0|||
147617063|NCT02515331|532413724|FG002|Overall Study|Adverse Event|0|||
147617064|NCT00124748|532413725|FG000|Overall Study|Adverse Event|8|||
147617065|NCT00124748|532413726|FG001|Overall Study|Adverse Event|39|||
147617066|NCT00124748|532413725|FG000|Overall Study|Abnormal laboratory Value|2|||
147617067|NCT00124748|532413726|FG001|Overall Study|Abnormal laboratory Value|2|||
147617068|NCT00124748|532413725|FG000|Overall Study|Abnormal Procedure|0|||
147617069|NCT00124748|532413726|FG001|Overall Study|Abnormal Procedure|1|||
147617070|NCT00124748|532413725|FG000|Overall Study|Lack of Efficacy|20|||
147617071|NCT00124748|532413726|FG001|Overall Study|Lack of Efficacy|41|||
147617072|NCT00124748|532413725|FG000|Overall Study|No longer requires study drug|1|||
147617073|NCT00124748|532413726|FG001|Overall Study|No longer requires study drug|1|||
147617074|NCT00124748|532413725|FG000|Overall Study|Protocol Violation|3|||
147617075|NCT00124748|532413726|FG001|Overall Study|Protocol Violation|1|||
147617076|NCT00124748|532413725|FG000|Overall Study|Withdrawal by Subject|5|||
147617077|NCT00124748|532413726|FG001|Overall Study|Withdrawal by Subject|15|||
147617078|NCT00124748|532413725|FG000|Overall Study|Lost to Follow-up|2|||
147617079|NCT00124748|532413726|FG001|Overall Study|Lost to Follow-up|7|||
147617080|NCT00124748|532413725|FG000|Overall Study|Administrative Problem(Study Terminated)|101|||
147617081|NCT00124748|532413726|FG001|Overall Study|Administrative Problem(Study Terminated)|174|||
147617082|NCT00124748|532413725|FG000|Overall Study|Death|1|||
147617083|NCT00124748|532413726|FG001|Overall Study|Death|3|||
147617084|NCT00322712|532413727|FG000|Overall Study|treated with bevacizumab not cetuximab|1|||
147408837|NCT05000216|531662418|FG020|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
147408838|NCT05000216|531662419|FG021|Stage 2|Received a SARS-CoV-2 vaccine off study|0|||
147408839|NCT05000216|531662398|FG000|Stage 2|Other reason|0|||
147408840|NCT05000216|531662399|FG001|Stage 2|Other reason|0|||
147408841|NCT05000216|531662400|FG002|Stage 2|Other reason|0|||
147408842|NCT05000216|531662401|FG003|Stage 2|Other reason|0|||
147408843|NCT05000216|531662402|FG004|Stage 2|Other reason|0|||
147408844|NCT05000216|531662403|FG005|Stage 2|Other reason|0|||
147408845|NCT05000216|531662404|FG006|Stage 2|Other reason|0|||
147408846|NCT05000216|531662405|FG007|Stage 2|Other reason|0|||
147408847|NCT05000216|531662406|FG008|Stage 2|Other reason|0|||
147408848|NCT05000216|531662407|FG009|Stage 2|Other reason|0|||
147408849|NCT05000216|531662408|FG010|Stage 2|Other reason|0|||
147617085|NCT00758524|532413732|FG000|Core Period (Week 0 to Week 8)|Lack of Efficacy|3|||
147617086|NCT00758524|532413733|FG001|Core Period (Week 0 to Week 8)|Lack of Efficacy|2|||
147617087|NCT00758524|532413734|FG002|Core Period (Week 0 to Week 8)|Lack of Efficacy|4|||
147617088|NCT00758524|532413735|FG003|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
147617089|NCT00758524|532413736|FG004|Core Period (Week 0 to Week 8)|Lack of Efficacy|3|||
147617090|NCT00758524|532413737|FG005|Core Period (Week 0 to Week 8)|Lack of Efficacy|5|||
147408850|NCT05000216|531662409|FG011|Stage 2|Other reason|0|||
147408851|NCT05000216|531662410|FG012|Stage 2|Other reason|0|||
147408852|NCT05000216|531662411|FG013|Stage 2|Other reason|0|||
147408853|NCT05000216|531662412|FG014|Stage 2|Other reason|0|||
147408854|NCT05000216|531662413|FG015|Stage 2|Other reason|0|||
147408855|NCT05000216|531662414|FG016|Stage 2|Other reason|1|||
147617091|NCT00758524|532413738|FG006|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
147617092|NCT00758524|532413739|FG007|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
147617093|NCT00758524|532413740|FG008|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
147617094|NCT00758524|532413741|FG009|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
147408856|NCT05000216|531662415|FG017|Stage 2|Other reason|0|||
147408857|NCT05000216|531662416|FG018|Stage 2|Other reason|0|||
147408858|NCT05000216|531662417|FG019|Stage 2|Other reason|0|||
147408859|NCT05000216|531662418|FG020|Stage 2|Other reason|0|||
147408860|NCT05000216|531662419|FG021|Stage 2|Other reason|0|||
147408861|NCT05000216|531662398|FG000|Stage 2 Sanofi|Lost to Follow-up|0|||
147408862|NCT05000216|531662399|FG001|Stage 2 Sanofi|Lost to Follow-up|0|||
147408863|NCT05000216|531662400|FG002|Stage 2 Sanofi|Lost to Follow-up|0|||
147408864|NCT05000216|531662401|FG003|Stage 2 Sanofi|Lost to Follow-up|0|||
147408865|NCT05000216|531662402|FG004|Stage 2 Sanofi|Lost to Follow-up|0|||
147408866|NCT05000216|531662403|FG005|Stage 2 Sanofi|Lost to Follow-up|0|||
147408867|NCT05000216|531662404|FG006|Stage 2 Sanofi|Lost to Follow-up|0|||
147408868|NCT05000216|531662405|FG007|Stage 2 Sanofi|Lost to Follow-up|0|||
147408869|NCT05000216|531662406|FG008|Stage 2 Sanofi|Lost to Follow-up|0|||
147408870|NCT05000216|531662407|FG009|Stage 2 Sanofi|Lost to Follow-up|0|||
147408871|NCT05000216|531662408|FG010|Stage 2 Sanofi|Lost to Follow-up|0|||
147408872|NCT05000216|531662409|FG011|Stage 2 Sanofi|Lost to Follow-up|0|||
147408873|NCT05000216|531662410|FG012|Stage 2 Sanofi|Lost to Follow-up|0|||
147408874|NCT05000216|531662411|FG013|Stage 2 Sanofi|Lost to Follow-up|0|||
147408875|NCT05000216|531662412|FG014|Stage 2 Sanofi|Lost to Follow-up|0|||
147408876|NCT05000216|531662413|FG015|Stage 2 Sanofi|Lost to Follow-up|0|||
147408877|NCT05000216|531662414|FG016|Stage 2 Sanofi|Lost to Follow-up|0|||
147408878|NCT05000216|531662415|FG017|Stage 2 Sanofi|Lost to Follow-up|0|||
147408879|NCT05000216|531662416|FG018|Stage 2 Sanofi|Lost to Follow-up|1|||
147408880|NCT05000216|531662417|FG019|Stage 2 Sanofi|Lost to Follow-up|0|||
147617095|NCT00758524|532413742|FG010|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
147617096|NCT00758524|532413743|FG011|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
147408881|NCT05000216|531662418|FG020|Stage 2 Sanofi|Lost to Follow-up|0|||
147408882|NCT05000216|531662419|FG021|Stage 2 Sanofi|Lost to Follow-up|0|||
147408883|NCT05000216|531662398|FG000|Stage 2 Sanofi|Withdrawal by Subject|0|||
147408884|NCT05000216|531662399|FG001|Stage 2 Sanofi|Withdrawal by Subject|0|||
147408885|NCT05000216|531662400|FG002|Stage 2 Sanofi|Withdrawal by Subject|0|||
147408886|NCT05000216|531662401|FG003|Stage 2 Sanofi|Withdrawal by Subject|0|||
147408887|NCT05000216|531662402|FG004|Stage 2 Sanofi|Withdrawal by Subject|0|||
147408888|NCT05000216|531662403|FG005|Stage 2 Sanofi|Withdrawal by Subject|0|||
147408889|NCT05000216|531662404|FG006|Stage 2 Sanofi|Withdrawal by Subject|0|||
147408890|NCT05000216|531662405|FG007|Stage 2 Sanofi|Withdrawal by Subject|0|||
147408891|NCT05000216|531662406|FG008|Stage 2 Sanofi|Withdrawal by Subject|0|||
147408892|NCT05000216|531662407|FG009|Stage 2 Sanofi|Withdrawal by Subject|0|||
147408893|NCT05000216|531662408|FG010|Stage 2 Sanofi|Withdrawal by Subject|0|||
147408894|NCT05000216|531662409|FG011|Stage 2 Sanofi|Withdrawal by Subject|0|||
147408895|NCT05000216|531662410|FG012|Stage 2 Sanofi|Withdrawal by Subject|0|||
147408896|NCT05000216|531662411|FG013|Stage 2 Sanofi|Withdrawal by Subject|0|||
147408897|NCT05000216|531662412|FG014|Stage 2 Sanofi|Withdrawal by Subject|0|||
147408898|NCT05000216|531662413|FG015|Stage 2 Sanofi|Withdrawal by Subject|1|||
147408899|NCT05000216|531662414|FG016|Stage 2 Sanofi|Withdrawal by Subject|0|||
147408900|NCT05000216|531662415|FG017|Stage 2 Sanofi|Withdrawal by Subject|0|||
147408901|NCT05000216|531662416|FG018|Stage 2 Sanofi|Withdrawal by Subject|0|||
147408902|NCT05000216|531662417|FG019|Stage 2 Sanofi|Withdrawal by Subject|0|||
147408903|NCT05000216|531662418|FG020|Stage 2 Sanofi|Withdrawal by Subject|0|||
147408904|NCT05000216|531662419|FG021|Stage 2 Sanofi|Withdrawal by Subject|0|||
147408905|NCT05000216|531662398|FG000|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
147408906|NCT05000216|531662399|FG001|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
147408907|NCT05000216|531662400|FG002|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
147408908|NCT05000216|531662401|FG003|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
147408909|NCT05000216|531662402|FG004|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
147408910|NCT05000216|531662403|FG005|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
147408911|NCT05000216|531662404|FG006|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
147408912|NCT05000216|531662405|FG007|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
147408913|NCT05000216|531662406|FG008|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
147617097|NCT00758524|532413744|FG012|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
147408914|NCT05000216|531662407|FG009|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
147408915|NCT05000216|531662408|FG010|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
147408916|NCT05000216|531662409|FG011|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
147408917|NCT05000216|531662410|FG012|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
147408918|NCT05000216|531662411|FG013|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|1|||
147408919|NCT05000216|531662412|FG014|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
147408920|NCT05000216|531662413|FG015|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|2|||
147408921|NCT05000216|531662414|FG016|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
147408922|NCT05000216|531662415|FG017|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
147408923|NCT05000216|531662416|FG018|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|2|||
147408924|NCT05000216|531662417|FG019|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
147464917|NCT03283085|531860390|FG003|Overall Study|Reason not Specified|0|||
147617098|NCT00758524|532413745|FG013|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
147617099|NCT00758524|532413746|FG014|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
147408925|NCT05000216|531662418|FG020|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
147408926|NCT05000216|531662419|FG021|Stage 2 Sanofi|Received a SARS-CoV-2 vaccine off study|0|||
147408927|NCT02057575|531662421|FG000|Overall Study|Adverse Event|0|||
147408928|NCT02057575|531662422|FG001|Overall Study|Adverse Event|2|||
147408929|NCT02057575|531662423|FG002|Overall Study|Adverse Event|0|||
147408930|NCT02057575|531662424|FG003|Overall Study|Adverse Event|1|||
147408931|NCT02057575|531662421|FG000|Overall Study|Withdrawal by Subject|1|||
147408932|NCT02057575|531662422|FG001|Overall Study|Withdrawal by Subject|0|||
147408933|NCT02057575|531662423|FG002|Overall Study|Withdrawal by Subject|0|||
147408934|NCT02057575|531662424|FG003|Overall Study|Withdrawal by Subject|0|||
147408935|NCT02057575|531662421|FG000|Overall Study|Dissallowed Concurrent Medication|0|||
147408936|NCT02057575|531662422|FG001|Overall Study|Dissallowed Concurrent Medication|1|||
147408937|NCT02057575|531662423|FG002|Overall Study|Dissallowed Concurrent Medication|0|||
147408938|NCT02057575|531662424|FG003|Overall Study|Dissallowed Concurrent Medication|0|||
147408939|NCT02057575|531662421|FG000|Overall Study|Protocol Violation|0|||
147408940|NCT02057575|531662422|FG001|Overall Study|Protocol Violation|1|||
147408941|NCT02057575|531662423|FG002|Overall Study|Protocol Violation|0|||
147408942|NCT02057575|531662424|FG003|Overall Study|Protocol Violation|0|||
147408943|NCT00332462|531662425|FG000|Overall Study|Adverse Event|5|||
147408944|NCT00332462|531662425|FG000|Overall Study|Abnormal Lab Value|1|||
147408945|NCT00332462|531662425|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
147408946|NCT00332462|531662425|FG000|Overall Study|no longer requires study drug|1|||
147408947|NCT00332462|531662425|FG000|Overall Study|Death|3|||
147408948|NCT00332462|531662425|FG000|Overall Study|Graft Loss|2|||
147408949|NCT02922023|531662426|FG000|Overall Study|Lost to Follow-up|2|||
147408950|NCT02922023|531662427|FG001|Overall Study|Lost to Follow-up|0|||
147408951|NCT00863681|531662428|FG000|Overall Study|Other|2|||
147408952|NCT00863681|531662429|FG001|Overall Study|Other|0|||
147408953|NCT00863681|531662430|FG002|Overall Study|Other|0|||
147408954|NCT00863681|531662428|FG000|Overall Study|Missing|1|||
147408955|NCT00863681|531662429|FG001|Overall Study|Missing|0|||
147408956|NCT00863681|531662430|FG002|Overall Study|Missing|0|||
147408957|NCT00863681|531662428|FG000|Overall Study|Death|40|||
147408958|NCT00863681|531662429|FG001|Overall Study|Death|23|||
147408959|NCT00863681|531662430|FG002|Overall Study|Death|6|||
147408960|NCT00863681|531662428|FG000|Overall Study|Withdrawal by Subject|12|||
147408961|NCT00863681|531662429|FG001|Overall Study|Withdrawal by Subject|5|||
147408962|NCT00863681|531662430|FG002|Overall Study|Withdrawal by Subject|2|||
147408963|NCT00863681|531662428|FG000|Overall Study|Protocol Violation|2|||
147408964|NCT00863681|531662429|FG001|Overall Study|Protocol Violation|0|||
147408965|NCT00863681|531662430|FG002|Overall Study|Protocol Violation|0|||
147408966|NCT00863681|531662428|FG000|Overall Study|Lost to Follow-up|3|||
147408967|NCT00863681|531662429|FG001|Overall Study|Lost to Follow-up|0|||
147408968|NCT00863681|531662430|FG002|Overall Study|Lost to Follow-up|3|||
147408969|NCT00863681|531662428|FG000|Overall Study|Adverse Event|28|||
147408970|NCT00863681|531662429|FG001|Overall Study|Adverse Event|10|||
147408971|NCT00863681|531662430|FG002|Overall Study|Adverse Event|6|||
147408972|NCT00863681|531662428|FG000|Overall Study|Lack of Efficacy|2|||
147408973|NCT00863681|531662429|FG001|Overall Study|Lack of Efficacy|2|||
147408974|NCT00863681|531662430|FG002|Overall Study|Lack of Efficacy|1|||
147408975|NCT00863681|531662428|FG000|Overall Study|Non-compliance with study drug|1|||
147408976|NCT00863681|531662429|FG001|Overall Study|Non-compliance with study drug|3|||
147408977|NCT00863681|531662430|FG002|Overall Study|Non-compliance with study drug|0|||
147408978|NCT03842228|531662431|FG000|Overall Study|Adverse Event|1|||
147408979|NCT03842228|531662432|FG001|Overall Study|Adverse Event|1|||
147408980|NCT03842228|531662433|FG002|Overall Study|Adverse Event|1|||
147408981|NCT03842228|531662434|FG003|Overall Study|Adverse Event|0|||
147408982|NCT03842228|531662435|FG004|Overall Study|Adverse Event|0|||
147408983|NCT03842228|531662436|FG005|Overall Study|Adverse Event|0|||
147408984|NCT03842228|531662437|FG006|Overall Study|Adverse Event|0|||
147408985|NCT03842228|531662431|FG000|Overall Study|Death|0|||
147408986|NCT03842228|531662432|FG001|Overall Study|Death|1|||
147408987|NCT03842228|531662433|FG002|Overall Study|Death|0|||
147408988|NCT03842228|531662434|FG003|Overall Study|Death|0|||
147408989|NCT03842228|531662435|FG004|Overall Study|Death|0|||
147408990|NCT03842228|531662436|FG005|Overall Study|Death|0|||
147408991|NCT03842228|531662437|FG006|Overall Study|Death|0|||
147617100|NCT00758524|532413747|FG015|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
147408992|NCT03842228|531662431|FG000|Overall Study|Withdrawal by Subject|0|||
147464918|NCT03283085|531860391|FG004|Overall Study|Reason not Specified|0|||
147408993|NCT03842228|531662432|FG001|Overall Study|Withdrawal by Subject|0|||
147408994|NCT03842228|531662433|FG002|Overall Study|Withdrawal by Subject|2|||
147408995|NCT03842228|531662434|FG003|Overall Study|Withdrawal by Subject|1|||
147408996|NCT03842228|531662435|FG004|Overall Study|Withdrawal by Subject|0|||
147408997|NCT03842228|531662436|FG005|Overall Study|Withdrawal by Subject|0|||
147617101|NCT00758524|532413748|FG016|Core Period (Week 0 to Week 8)|Lack of Efficacy|0|||
147408998|NCT03842228|531662437|FG006|Overall Study|Withdrawal by Subject|2|||
147408999|NCT03842228|531662431|FG000|Overall Study|Progression|8|||
147409000|NCT03842228|531662432|FG001|Overall Study|Progression|1|||
147617102|NCT00758524|532413732|FG000|Core Period (Week 0 to Week 8)|Withdrawal by Subject|3|||
147617103|NCT00758524|532413733|FG001|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
147617104|NCT00758524|532413734|FG002|Core Period (Week 0 to Week 8)|Withdrawal by Subject|2|||
147617105|NCT00758524|532413735|FG003|Core Period (Week 0 to Week 8)|Withdrawal by Subject|3|||
147617106|NCT00758524|532413736|FG004|Core Period (Week 0 to Week 8)|Withdrawal by Subject|1|||
147409001|NCT03842228|531662433|FG002|Overall Study|Progression|7|||
147409002|NCT03842228|531662434|FG003|Overall Study|Progression|5|||
147409003|NCT03842228|531662435|FG004|Overall Study|Progression|4|||
147409004|NCT03842228|531662436|FG005|Overall Study|Progression|2|||
147409005|NCT03842228|531662437|FG006|Overall Study|Progression|3|||
147409006|NCT01263509|531662438|FG000|Entered - Long-Term Extension Study|Adverse Event|5|||
147409007|NCT01263509|531662439|FG001|Entered - Long-Term Extension Study|Adverse Event|5|||
147409008|NCT01263509|531662440|FG002|Entered - Long-Term Extension Study|Adverse Event|4|||
147409009|NCT01263509|531662441|FG003|Entered - Long-Term Extension Study|Adverse Event|1|||
147409010|NCT01263509|531662438|FG000|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
147409011|NCT01263509|531662439|FG001|Entered - Long-Term Extension Study|Lack of Efficacy|4|||
147409012|NCT01263509|531662440|FG002|Entered - Long-Term Extension Study|Lack of Efficacy|1|||
147409013|NCT01263509|531662441|FG003|Entered - Long-Term Extension Study|Lack of Efficacy|0|||
147409014|NCT01263509|531662438|FG000|Entered - Long-Term Extension Study|Withdrawal by Subject|1|||
147409015|NCT01263509|531662439|FG001|Entered - Long-Term Extension Study|Withdrawal by Subject|2|||
147409016|NCT01263509|531662440|FG002|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
147409017|NCT01263509|531662441|FG003|Entered - Long-Term Extension Study|Withdrawal by Subject|0|||
147409018|NCT01263509|531662438|FG000|Entered - Long-Term Extension Study|Participant Unavailability|1|||
147409019|NCT01263509|531662439|FG001|Entered - Long-Term Extension Study|Participant Unavailability|1|||
147409020|NCT01263509|531662440|FG002|Entered - Long-Term Extension Study|Participant Unavailability|0|||
147409021|NCT01263509|531662441|FG003|Entered - Long-Term Extension Study|Participant Unavailability|0|||
147409022|NCT01263509|531662438|FG000|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|0|||
147409023|NCT01263509|531662439|FG001|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|0|||
147409024|NCT01263509|531662440|FG002|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|0|||
147409025|NCT01263509|531662441|FG003|Entered - Long-Term Extension Study|Poor Glycosylated Hemoglobin Control|1|||
147409026|NCT05071053|531662442|FG000|Overall Study|Progressive disease|30|||
147409027|NCT05071053|531662442|FG000|Overall Study|Adverse Event|5|||
147409028|NCT02593123|531662443|FG000|Overall Study|Physician Decision|2|||
147409029|NCT02593123|531662444|FG001|Overall Study|Physician Decision|1|||
147409030|NCT02593123|531662443|FG000|Overall Study|Relapse|1|||
147409031|NCT02593123|531662444|FG001|Overall Study|Relapse|1|||
147409032|NCT01602510|531662452|FG000|Open Label Phase|Adverse Event|46|||
147409033|NCT01602510|531662453|FG001|Open Label Phase|Adverse Event|0|||
147409034|NCT01602510|531662454|FG002|Open Label Phase|Adverse Event|0|||
147409035|NCT01602510|531662452|FG000|Open Label Phase|Lack of Efficacy|22|||
147409036|NCT01602510|531662453|FG001|Open Label Phase|Lack of Efficacy|0|||
147409037|NCT01602510|531662454|FG002|Open Label Phase|Lack of Efficacy|0|||
147409038|NCT01602510|531662452|FG000|Open Label Phase|Protocol Violation|15|||
147409039|NCT01602510|531662453|FG001|Open Label Phase|Protocol Violation|0|||
147409040|NCT01602510|531662454|FG002|Open Label Phase|Protocol Violation|0|||
147409041|NCT01602510|531662452|FG000|Open Label Phase|Met protocol-defined stopping criteria|122|||
147409042|NCT01602510|531662453|FG001|Open Label Phase|Met protocol-defined stopping criteria|0|||
147409043|NCT01602510|531662454|FG002|Open Label Phase|Met protocol-defined stopping criteria|0|||
147409044|NCT01602510|531662452|FG000|Open Label Phase|Lost to Follow-up|22|||
147409045|NCT01602510|531662453|FG001|Open Label Phase|Lost to Follow-up|0|||
147409046|NCT01602510|531662454|FG002|Open Label Phase|Lost to Follow-up|0|||
147409047|NCT01602510|531662452|FG000|Open Label Phase|Physician Decision|19|||
147409048|NCT01602510|531662453|FG001|Open Label Phase|Physician Decision|0|||
147409049|NCT01602510|531662454|FG002|Open Label Phase|Physician Decision|0|||
147409050|NCT01602510|531662452|FG000|Open Label Phase|Withdrawal by Subject|57|||
147409051|NCT01602510|531662453|FG001|Open Label Phase|Withdrawal by Subject|0|||
147409052|NCT01602510|531662454|FG002|Open Label Phase|Withdrawal by Subject|0|||
147409053|NCT01602510|531662452|FG000|Randomized Phase|Adverse Event|0|||
147409054|NCT01602510|531662453|FG001|Randomized Phase|Adverse Event|2|||
147409055|NCT01602510|531662454|FG002|Randomized Phase|Adverse Event|6|||
147409056|NCT01602510|531662452|FG000|Randomized Phase|Lack of Efficacy|0|||
147409057|NCT01602510|531662453|FG001|Randomized Phase|Lack of Efficacy|4|||
147409058|NCT01602510|531662454|FG002|Randomized Phase|Lack of Efficacy|4|||
147409059|NCT01602510|531662452|FG000|Randomized Phase|Protocol Violation|0|||
147617107|NCT00758524|532413737|FG005|Core Period (Week 0 to Week 8)|Withdrawal by Subject|3|||
147409060|NCT01602510|531662453|FG001|Randomized Phase|Protocol Violation|3|||
147409061|NCT01602510|531662454|FG002|Randomized Phase|Protocol Violation|3|||
147409062|NCT01602510|531662452|FG000|Randomized Phase|Met protocol-defined stopping criteria|0|||
147409063|NCT01602510|531662453|FG001|Randomized Phase|Met protocol-defined stopping criteria|58|||
147464919|NCT03283085|531860392|FG005|Overall Study|Reason not Specified|1|||
147464920|NCT03136107|531860393|FG000|Overall Study|Other (Not specified)|1|||
147464921|NCT02292771|531860394|FG000|Overall Study|Withdrawal by Subject|2|||
147464922|NCT02292771|531860395|FG001|Overall Study|Withdrawal by Subject|1|||
147464923|NCT02292771|531860394|FG000|Overall Study|Lost to Follow-up|2|||
147464924|NCT02292771|531860395|FG001|Overall Study|Lost to Follow-up|1|||
147464925|NCT01468311|531860396|FG000|Overall Study|mobilization failure|1|||
147464926|NCT01468311|531860396|FG000|Overall Study|Withdrawal by Subject|1|||
147464927|NCT00110305|531862316|FG000|Overall Study|Adverse Event|46|||
147464928|NCT00110305|531862317|FG001|Overall Study|Adverse Event|13|||
147464929|NCT00110305|531862316|FG000|Overall Study|Sponsors Decision|1|||
147464930|NCT00110305|531862317|FG001|Overall Study|Sponsors Decision|0|||
147464931|NCT00110305|531862316|FG000|Overall Study|Subject Non-Compliant|9|||
147464932|NCT00110305|531862317|FG001|Overall Study|Subject Non-Compliant|2|||
147464933|NCT00110305|531862316|FG000|Overall Study|Subject Ineligible To Continue The Trial|2|||
147464934|NCT00110305|531862317|FG001|Overall Study|Subject Ineligible To Continue The Trial|1|||
147464935|NCT00110305|531862316|FG000|Overall Study|Subject Reached A Virologic Endpoint|21|||
147464936|NCT00110305|531862317|FG001|Overall Study|Subject Reached A Virologic Endpoint|3|||
147464937|NCT00110305|531862316|FG000|Overall Study|Protocol Violation|0|||
147464938|NCT00110305|531862317|FG001|Overall Study|Protocol Violation|1|||
147464939|NCT00110305|531862316|FG000|Overall Study|Withdrawal by Subject|7|||
147464940|NCT00110305|531862317|FG001|Overall Study|Withdrawal by Subject|7|||
147464941|NCT00110305|531862316|FG000|Overall Study|Lost to Follow-up|20|||
147464942|NCT00110305|531862317|FG001|Overall Study|Lost to Follow-up|3|||
147464943|NCT00110305|531862316|FG000|Overall Study|Other|8|||
147464944|NCT00110305|531862317|FG001|Overall Study|Other|2|||
147464945|NCT00224016|531862323|FG000|Titration Period|Withdrawal by Subject|0|||
147464946|NCT00224016|531862324|FG001|Titration Period|Withdrawal by Subject|1|||
147464947|NCT00224016|531862323|FG000|Titration Period|Lost to Follow-up|1|||
147464948|NCT00224016|531862324|FG001|Titration Period|Lost to Follow-up|0|||
147464949|NCT00224016|531862323|FG000|Maintenance Period|Withdrawal by Subject|2|||
147464950|NCT00224016|531862324|FG001|Maintenance Period|Withdrawal by Subject|0|||
147464951|NCT00224016|531862323|FG000|Maintenance Period|Lost to Follow-up|0|||
147464952|NCT00224016|531862324|FG001|Maintenance Period|Lost to Follow-up|1|||
147464953|NCT01524991|531862327|FG000|Overall Study|Adverse Event|12|||
147464954|NCT01524991|531862327|FG000|Overall Study|Death|1|||
147464955|NCT01524991|531862327|FG000|Overall Study|Disease ProgressionDu|17|||
147464956|NCT01524991|531862327|FG000|Overall Study|Other complicating disease|1|||
147464957|NCT01524991|531862327|FG000|Overall Study|Withdrawal by Subject|2|||
147464958|NCT01524991|531862327|FG000|Overall Study|Symptomatic Deterioration|1|||
147464959|NCT01805180|531862328|FG000|Lead-in Donor Phase|screen failure|1|||
147464960|NCT01805180|531862329|FG001|Lead-in Donor Phase|screen failure|0|||
147464961|NCT01805180|531862330|FG002|Lead-in Donor Phase|screen failure|0|||
147464962|NCT04574999|531862333|FG000|Overall Study|Adverse Event|1|||
147464963|NCT04574999|531862334|FG001|Overall Study|Adverse Event|0|||
147464964|NCT04574999|531862333|FG000|Overall Study|Lack of Efficacy|2|||
147464965|NCT04574999|531862334|FG001|Overall Study|Lack of Efficacy|3|||
147464966|NCT04574999|531862333|FG000|Overall Study|Protocol Violation|1|||
147464967|NCT04574999|531862334|FG001|Overall Study|Protocol Violation|0|||
147464968|NCT04574999|531862333|FG000|Overall Study|Withdrawal by Subject|2|||
147464969|NCT04574999|531862334|FG001|Overall Study|Withdrawal by Subject|2|||
147464970|NCT04574999|531862333|FG000|Overall Study|Lost to Follow-up|1|||
147464971|NCT04574999|531862334|FG001|Overall Study|Lost to Follow-up|0|||
147409064|NCT01602510|531662454|FG002|Randomized Phase|Met protocol-defined stopping criteria|48|||
147409065|NCT01602510|531662452|FG000|Randomized Phase|Lost to Follow-up|0|||
147409066|NCT01602510|531662453|FG001|Randomized Phase|Lost to Follow-up|1|||
147409067|NCT01602510|531662454|FG002|Randomized Phase|Lost to Follow-up|3|||
147409068|NCT01602510|531662452|FG000|Randomized Phase|Physician Decision|0|||
147409069|NCT01602510|531662453|FG001|Randomized Phase|Physician Decision|0|||
147409070|NCT01602510|531662454|FG002|Randomized Phase|Physician Decision|2|||
147409071|NCT01602510|531662452|FG000|Randomized Phase|Withdrawal by Subject|0|||
147409072|NCT01602510|531662453|FG001|Randomized Phase|Withdrawal by Subject|6|||
147409073|NCT01602510|531662454|FG002|Randomized Phase|Withdrawal by Subject|7|||
147409074|NCT00895895|531662455|FG000|Period 1|Adverse Event|7|||
147409075|NCT00895895|531662456|FG001|Period 1|Adverse Event|6|||
147409076|NCT00895895|531662457|FG002|Period 1|Adverse Event|4|||
147409077|NCT00895895|531662458|FG003|Period 1|Adverse Event|6|||
147409078|NCT00895895|531662459|FG004|Period 1|Adverse Event|7|||
147409079|NCT00895895|531662455|FG000|Period 1|Death|0|||
147409080|NCT00895895|531662456|FG001|Period 1|Death|0|||
147464972|NCT04574999|531862333|FG000|Overall Study|Personal problems|1|||
147464973|NCT04574999|531862334|FG001|Overall Study|Personal problems|0|||
147409081|NCT00895895|531662457|FG002|Period 1|Death|0|||
147464974|NCT04574999|531862333|FG000|Overall Study|Previous planned surgery|1|||
147464975|NCT04574999|531862334|FG001|Overall Study|Previous planned surgery|0|||
147464976|NCT00206726|531862338|FG000|Overall Study|Delayed recovery of blood counts|1|||
147464977|NCT00206726|531862338|FG000|Overall Study|Progressive disease or relapsed disease|18|||
147464978|NCT00206726|531862338|FG000|Overall Study|Placed on new protocol|1|||
147464979|NCT00206726|531862338|FG000|Overall Study|Bone marrow transplant|1|||
147464980|NCT00206726|531862338|FG000|Overall Study|Adverse Event|17|||
147464981|NCT00206726|531862338|FG000|Overall Study|Death|4|||
147464982|NCT00206726|531862338|FG000|Overall Study|Protocol Violation|1|||
147464983|NCT00206726|531862338|FG000|Overall Study|Withdrawal by Subject|8|||
147464984|NCT05148884|531862355|FG000|Overall Study|Withdrawal by Subject|3|||
147464985|NCT05148884|531862356|FG001|Overall Study|Withdrawal by Subject|0|||
147464986|NCT05148884|531862355|FG000|Overall Study|Deep brain stimulation operation|0|||
147464987|NCT05148884|531862356|FG001|Overall Study|Deep brain stimulation operation|1|||
147464988|NCT00365989|531862359|FG000|Overall Study|Withdrawal by Subject|1|||
147464989|NCT00365989|531862359|FG000|Overall Study|Non-compliance|1|||
147464990|NCT00832819|531862362|FG000|Overall Study|Adverse Event|0|||
147464991|NCT00832819|531862363|FG001|Overall Study|Adverse Event|1|||
147464992|NCT00832819|531862364|FG002|Overall Study|Adverse Event|0|||
147464993|NCT00832819|531862362|FG000|Overall Study|Protocol Violation|0|||
147464994|NCT00832819|531862363|FG001|Overall Study|Protocol Violation|0|||
147464995|NCT00832819|531862364|FG002|Overall Study|Protocol Violation|1|||
147464996|NCT00317044|531862365|FG000|Overall Study|Protocol Violation|28|||
147464997|NCT00317044|531862366|FG001|Overall Study|Protocol Violation|22|||
147464998|NCT00317044|531862367|FG002|Overall Study|Protocol Violation|20|||
147464999|NCT00317044|531862365|FG000|Overall Study|Adverse Event|4|||
147465000|NCT00317044|531862366|FG001|Overall Study|Adverse Event|7|||
147465001|NCT00317044|531862367|FG002|Overall Study|Adverse Event|4|||
147465002|NCT00317044|531862365|FG000|Overall Study|Withdrawal by Subject|10|||
147465003|NCT00317044|531862366|FG001|Overall Study|Withdrawal by Subject|7|||
147465004|NCT00317044|531862367|FG002|Overall Study|Withdrawal by Subject|12|||
147465005|NCT00317044|531862365|FG000|Overall Study|Lost to Follow-up|0|||
147465006|NCT00317044|531862366|FG001|Overall Study|Lost to Follow-up|2|||
147465007|NCT00317044|531862367|FG002|Overall Study|Lost to Follow-up|3|||
147465008|NCT00317044|531862365|FG000|Overall Study|Multiple Reasons|6|||
147465009|NCT00317044|531862366|FG001|Overall Study|Multiple Reasons|2|||
147465010|NCT00317044|531862367|FG002|Overall Study|Multiple Reasons|6|||
147465011|NCT02318095|531862368|FG000|Overall Study|Adverse Event|1|||
147465012|NCT01717638|531862369|FG000|Overall Study|Lost to Follow-up|0|||
147465013|NCT01717638|531862370|FG001|Overall Study|Lost to Follow-up|0|||
147465014|NCT01717638|531862371|FG002|Overall Study|Lost to Follow-up|0|||
147465015|NCT01717638|531862372|FG003|Overall Study|Lost to Follow-up|0|||
147465016|NCT01717638|531862373|FG004|Overall Study|Lost to Follow-up|0|||
147465017|NCT01717638|531862374|FG005|Overall Study|Lost to Follow-up|1|||
147465018|NCT01717638|531862375|FG006|Overall Study|Lost to Follow-up|0|||
147465019|NCT01717638|531862376|FG007|Overall Study|Lost to Follow-up|0|||
147465020|NCT01717638|531862377|FG008|Overall Study|Lost to Follow-up|0|||
147465021|NCT01717638|531862378|FG009|Overall Study|Lost to Follow-up|0|||
147465022|NCT01717638|531862379|FG010|Overall Study|Lost to Follow-up|0|||
147465023|NCT01717638|531862380|FG011|Overall Study|Lost to Follow-up|0|||
147465024|NCT01717638|531862381|FG012|Overall Study|Lost to Follow-up|0|||
147465025|NCT01717638|531862369|FG000|Overall Study|Father in hospital|0|||
147465026|NCT01717638|531862370|FG001|Overall Study|Father in hospital|0|||
147465027|NCT01717638|531862371|FG002|Overall Study|Father in hospital|0|||
147465028|NCT01717638|531862372|FG003|Overall Study|Father in hospital|0|||
147465029|NCT01717638|531862373|FG004|Overall Study|Father in hospital|0|||
147465030|NCT01717638|531862374|FG005|Overall Study|Father in hospital|0|||
147617108|NCT00758524|532413738|FG006|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
147617109|NCT00758524|532413739|FG007|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
147617110|NCT00758524|532413740|FG008|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
147617111|NCT00758524|532413741|FG009|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
147617112|NCT00758524|532413742|FG010|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
147617113|NCT00758524|532413743|FG011|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
147617114|NCT00758524|532413744|FG012|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
147617115|NCT00758524|532413745|FG013|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
147617116|NCT00758524|532413746|FG014|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
147465031|NCT01717638|531862375|FG006|Overall Study|Father in hospital|0|||
147465032|NCT01717638|531862376|FG007|Overall Study|Father in hospital|0|||
147465033|NCT01717638|531862377|FG008|Overall Study|Father in hospital|0|||
147465034|NCT01717638|531862378|FG009|Overall Study|Father in hospital|0|||
147465035|NCT01717638|531862379|FG010|Overall Study|Father in hospital|0|||
147617117|NCT00758524|532413747|FG015|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
147617118|NCT00758524|532413748|FG016|Core Period (Week 0 to Week 8)|Withdrawal by Subject|0|||
147465036|NCT01717638|531862380|FG011|Overall Study|Father in hospital|0|||
147465037|NCT01717638|531862381|FG012|Overall Study|Father in hospital|1|||
147465038|NCT01717638|531862369|FG000|Overall Study|Withdrawal by Subject|0|||
147465039|NCT01717638|531862370|FG001|Overall Study|Withdrawal by Subject|1|||
147465040|NCT01717638|531862371|FG002|Overall Study|Withdrawal by Subject|1|||
147465041|NCT01717638|531862372|FG003|Overall Study|Withdrawal by Subject|0|||
147465042|NCT01717638|531862373|FG004|Overall Study|Withdrawal by Subject|1|||
147465043|NCT01717638|531862374|FG005|Overall Study|Withdrawal by Subject|0|||
147617119|NCT00758524|532413732|FG000|Core Period (Week 0 to Week 8)|Adverse Event|2|||
147617120|NCT00758524|532413733|FG001|Core Period (Week 0 to Week 8)|Adverse Event|1|||
147617121|NCT00758524|532413734|FG002|Core Period (Week 0 to Week 8)|Adverse Event|1|||
147617122|NCT00758524|532413735|FG003|Core Period (Week 0 to Week 8)|Adverse Event|3|||
147617123|NCT00758524|532413736|FG004|Core Period (Week 0 to Week 8)|Adverse Event|2|||
147617124|NCT00758524|532413737|FG005|Core Period (Week 0 to Week 8)|Adverse Event|1|||
147617125|NCT00758524|532413738|FG006|Core Period (Week 0 to Week 8)|Adverse Event|0|||
147617126|NCT00758524|532413739|FG007|Core Period (Week 0 to Week 8)|Adverse Event|0|||
147617127|NCT00758524|532413740|FG008|Core Period (Week 0 to Week 8)|Adverse Event|0|||
147617128|NCT00758524|532413741|FG009|Core Period (Week 0 to Week 8)|Adverse Event|0|||
147617129|NCT00758524|532413742|FG010|Core Period (Week 0 to Week 8)|Adverse Event|0|||
147409082|NCT00895895|531662458|FG003|Period 1|Death|0|||
147409083|NCT00895895|531662459|FG004|Period 1|Death|1|||
147409084|NCT00895895|531662455|FG000|Period 1|discontinued by sponsor|2|||
147409085|NCT00895895|531662456|FG001|Period 1|discontinued by sponsor|1|||
147409086|NCT00895895|531662457|FG002|Period 1|discontinued by sponsor|2|||
147409087|NCT00895895|531662458|FG003|Period 1|discontinued by sponsor|1|||
147409088|NCT00895895|531662459|FG004|Period 1|discontinued by sponsor|1|||
147409089|NCT00895895|531662455|FG000|Period 1|failed to return|0|||
147409090|NCT00895895|531662456|FG001|Period 1|failed to return|0|||
147409091|NCT00895895|531662457|FG002|Period 1|failed to return|1|||
147409092|NCT00895895|531662458|FG003|Period 1|failed to return|0|||
147409093|NCT00895895|531662459|FG004|Period 1|failed to return|1|||
147409094|NCT00895895|531662455|FG000|Period 1|investigator request|0|||
147409095|NCT00895895|531662456|FG001|Period 1|investigator request|1|||
147409096|NCT00895895|531662457|FG002|Period 1|investigator request|0|||
147409097|NCT00895895|531662458|FG003|Period 1|investigator request|0|||
147409098|NCT00895895|531662459|FG004|Period 1|investigator request|0|||
147409099|NCT00895895|531662455|FG000|Period 1|Lost to Follow-up|2|||
147409100|NCT00895895|531662456|FG001|Period 1|Lost to Follow-up|1|||
147409101|NCT00895895|531662457|FG002|Period 1|Lost to Follow-up|3|||
147409102|NCT00895895|531662458|FG003|Period 1|Lost to Follow-up|2|||
147409103|NCT00895895|531662459|FG004|Period 1|Lost to Follow-up|3|||
147409104|NCT00895895|531662455|FG000|Period 1|Other|1|||
147409105|NCT00895895|531662456|FG001|Period 1|Other|2|||
147409106|NCT00895895|531662457|FG002|Period 1|Other|1|||
147409107|NCT00895895|531662458|FG003|Period 1|Other|1|||
147409108|NCT00895895|531662459|FG004|Period 1|Other|1|||
147409109|NCT00895895|531662455|FG000|Period 1|Protocol Violation|0|||
147409110|NCT00895895|531662456|FG001|Period 1|Protocol Violation|1|||
147409111|NCT00895895|531662457|FG002|Period 1|Protocol Violation|0|||
147409112|NCT00895895|531662458|FG003|Period 1|Protocol Violation|0|||
147409113|NCT00895895|531662459|FG004|Period 1|Protocol Violation|0|||
147409114|NCT00895895|531662455|FG000|Period 1|Withdrawal by Subject|6|||
147409115|NCT00895895|531662456|FG001|Period 1|Withdrawal by Subject|6|||
147409116|NCT00895895|531662457|FG002|Period 1|Withdrawal by Subject|8|||
147409117|NCT00895895|531662458|FG003|Period 1|Withdrawal by Subject|2|||
147409118|NCT00895895|531662459|FG004|Period 1|Withdrawal by Subject|4|||
147409119|NCT00895895|531662455|FG000|Period 1|unsatisfactory response-efficacy|2|||
147409120|NCT00895895|531662456|FG001|Period 1|unsatisfactory response-efficacy|0|||
147409121|NCT00895895|531662457|FG002|Period 1|unsatisfactory response-efficacy|0|||
147409122|NCT00895895|531662458|FG003|Period 1|unsatisfactory response-efficacy|0|||
147409123|NCT00895895|531662459|FG004|Period 1|unsatisfactory response-efficacy|0|||
147409124|NCT00895895|531662455|FG000|Period 1|randomized and not treated|1|||
147409125|NCT00895895|531662456|FG001|Period 1|randomized and not treated|3|||
147409126|NCT00895895|531662457|FG002|Period 1|randomized and not treated|1|||
147409127|NCT00895895|531662458|FG003|Period 1|randomized and not treated|1|||
147409128|NCT00895895|531662459|FG004|Period 1|randomized and not treated|2|||
147409129|NCT00895895|531662455|FG000|After Period 1, Prior to Period 2|Adverse Event|0|||
147409130|NCT00895895|531662456|FG001|After Period 1, Prior to Period 2|Adverse Event|0|||
147409131|NCT00895895|531662457|FG002|After Period 1, Prior to Period 2|Adverse Event|1|||
147409132|NCT00895895|531662458|FG003|After Period 1, Prior to Period 2|Adverse Event|0|||
147409133|NCT00895895|531662459|FG004|After Period 1, Prior to Period 2|Adverse Event|0|||
147409134|NCT00895895|531662455|FG000|After Period 1, Prior to Period 2|Other|0|||
147409135|NCT00895895|531662456|FG001|After Period 1, Prior to Period 2|Other|0|||
147409136|NCT00895895|531662457|FG002|After Period 1, Prior to Period 2|Other|1|||
147409137|NCT00895895|531662458|FG003|After Period 1, Prior to Period 2|Other|0|||
147409138|NCT00895895|531662459|FG004|After Period 1, Prior to Period 2|Other|0|||
147409139|NCT00895895|531662455|FG000|After Period 1, Prior to Period 2|Protocol Violation|0|||
147409140|NCT00895895|531662456|FG001|After Period 1, Prior to Period 2|Protocol Violation|0|||
147409141|NCT00895895|531662457|FG002|After Period 1, Prior to Period 2|Protocol Violation|0|||
147409142|NCT00895895|531662458|FG003|After Period 1, Prior to Period 2|Protocol Violation|0|||
147409143|NCT00895895|531662459|FG004|After Period 1, Prior to Period 2|Protocol Violation|1|||
147409144|NCT00895895|531662455|FG000|After Period 1, Prior to Period 2|Withdrawal by Subject|0|||
147409145|NCT00895895|531662456|FG001|After Period 1, Prior to Period 2|Withdrawal by Subject|0|||
147665528|NCT01103323|532599608|FG001|Without/Before Drug Switch|Adverse Event|7|||
147409146|NCT00895895|531662457|FG002|After Period 1, Prior to Period 2|Withdrawal by Subject|0|||
147409147|NCT00895895|531662458|FG003|After Period 1, Prior to Period 2|Withdrawal by Subject|0|||
147409148|NCT00895895|531662459|FG004|After Period 1, Prior to Period 2|Withdrawal by Subject|1|||
147409149|NCT00895895|531662455|FG000|Period 2|Adverse Event|3|||
147409150|NCT00895895|531662456|FG001|Period 2|Adverse Event|3|||
147409151|NCT00895895|531662457|FG002|Period 2|Adverse Event|5|||
147409152|NCT00895895|531662458|FG003|Period 2|Adverse Event|2|||
147409153|NCT00895895|531662459|FG004|Period 2|Adverse Event|5|||
147409154|NCT00895895|531662455|FG000|Period 2|Death|0|||
147409155|NCT00895895|531662456|FG001|Period 2|Death|0|||
147409156|NCT00895895|531662457|FG002|Period 2|Death|1|||
147409157|NCT00895895|531662458|FG003|Period 2|Death|0|||
147409158|NCT00895895|531662459|FG004|Period 2|Death|0|||
147409159|NCT00895895|531662455|FG000|Period 2|discontinued by sponsor|44|||
147409160|NCT00895895|531662456|FG001|Period 2|discontinued by sponsor|44|||
147409161|NCT00895895|531662457|FG002|Period 2|discontinued by sponsor|38|||
147409162|NCT00895895|531662458|FG003|Period 2|discontinued by sponsor|46|||
147409163|NCT00895895|531662459|FG004|Period 2|discontinued by sponsor|37|||
147409164|NCT00895895|531662455|FG000|Period 2|failed to return|2|||
147409165|NCT00895895|531662456|FG001|Period 2|failed to return|0|||
147409166|NCT00895895|531662457|FG002|Period 2|failed to return|0|||
147409167|NCT00895895|531662458|FG003|Period 2|failed to return|0|||
147409168|NCT00895895|531662459|FG004|Period 2|failed to return|0|||
147409169|NCT00895895|531662455|FG000|Period 2|investigator request|2|||
147409170|NCT00895895|531662456|FG001|Period 2|investigator request|0|||
147409171|NCT00895895|531662457|FG002|Period 2|investigator request|0|||
147409172|NCT00895895|531662458|FG003|Period 2|investigator request|0|||
147409173|NCT00895895|531662459|FG004|Period 2|investigator request|0|||
147409174|NCT00895895|531662455|FG000|Period 2|Lost to Follow-up|1|||
147409175|NCT00895895|531662456|FG001|Period 2|Lost to Follow-up|2|||
147409176|NCT00895895|531662457|FG002|Period 2|Lost to Follow-up|1|||
147409177|NCT00895895|531662458|FG003|Period 2|Lost to Follow-up|1|||
147409178|NCT00895895|531662459|FG004|Period 2|Lost to Follow-up|0|||
147409179|NCT00895895|531662455|FG000|Period 2|Other|1|||
147409180|NCT00895895|531662456|FG001|Period 2|Other|1|||
147409181|NCT00895895|531662457|FG002|Period 2|Other|3|||
147409182|NCT00895895|531662458|FG003|Period 2|Other|1|||
147409183|NCT00895895|531662459|FG004|Period 2|Other|1|||
147409184|NCT00895895|531662455|FG000|Period 2|Protocol Violation|1|||
147409185|NCT00895895|531662456|FG001|Period 2|Protocol Violation|0|||
147409186|NCT00895895|531662457|FG002|Period 2|Protocol Violation|1|||
147409187|NCT00895895|531662458|FG003|Period 2|Protocol Violation|1|||
147409188|NCT00895895|531662459|FG004|Period 2|Protocol Violation|1|||
147409189|NCT00895895|531662455|FG000|Period 2|Withdrawal by Subject|0|||
147409190|NCT00895895|531662456|FG001|Period 2|Withdrawal by Subject|2|||
147409191|NCT00895895|531662457|FG002|Period 2|Withdrawal by Subject|0|||
147409192|NCT00895895|531662458|FG003|Period 2|Withdrawal by Subject|3|||
147409193|NCT00895895|531662459|FG004|Period 2|Withdrawal by Subject|5|||
147409194|NCT00895895|531662455|FG000|Period 2|unsatisfactory response-efficacy|2|||
147409195|NCT00895895|531662456|FG001|Period 2|unsatisfactory response-efficacy|1|||
147409196|NCT00895895|531662457|FG002|Period 2|unsatisfactory response-efficacy|0|||
147409197|NCT00895895|531662458|FG003|Period 2|unsatisfactory response-efficacy|0|||
147409198|NCT00895895|531662459|FG004|Period 2|unsatisfactory response-efficacy|0|||
147409199|NCT01001390|531662460|FG000|Overall Study|Failure to wear AFO device|2|||
147409200|NCT01001390|531662461|FG001|Overall Study|Failure to wear AFO device|0|||
147409201|NCT01261000|531662462|FG000|Overall Study|Screen failure|1|||
147409202|NCT03019640|531662463|FG000|Overall Study|Screen Failures|4|||
147409203|NCT03019640|531662463|FG000|Overall Study|Adverse Event|3|||
147409204|NCT03019640|531662463|FG000|Overall Study|Participant Relapsed|1|||
147409205|NCT04916730|531662471|FG000|Overall Study|Withdrawal by Subject|4|||
147409206|NCT04916730|531662472|FG001|Overall Study|Withdrawal by Subject|2|||
147409207|NCT04916730|531662471|FG000|Overall Study|Lost to Follow-up|0|||
147409208|NCT04916730|531662472|FG001|Overall Study|Lost to Follow-up|2|||
147409209|NCT04916730|531662471|FG000|Overall Study|Physician Decision|1|||
147409210|NCT04916730|531662472|FG001|Overall Study|Physician Decision|0|||
147409211|NCT02514551|531662475|FG000|Overall Study|Lost to Follow-up|0|||
147409212|NCT02514551|531662476|FG001|Overall Study|Lost to Follow-up|1|||
147409213|NCT02514551|531662475|FG000|Overall Study|Participant Never Treated|0|||
147409214|NCT02514551|531662476|FG001|Overall Study|Participant Never Treated|2|||
147409215|NCT00996606|531662477|FG000|Overall Study|Adverse Event or Intercurrent Illness|2|||
147409216|NCT00996606|531662477|FG000|Overall Study|Insufficient Therapeutic Response|2|||
147409217|NCT00996606|531662477|FG000|Overall Study|Protocol Violation|1|||
147409218|NCT00996606|531662477|FG000|Overall Study|Withdrawal by Subject|3|||
147409219|NCT01213524|531662480|FG000|Baseline|Withdrawal by Subject|5|||
147409220|NCT01213524|531662480|FG000|Baseline|high breath alcohol levels|1|||
147409221|NCT01213524|531662480|FG000|Baseline|Physician Decision|1|||
147409222|NCT01213524|531662480|FG000|Session 2|Withdrawal by Subject|5|||
147409223|NCT01213524|531662480|FG000|Session 3|Withdrawal by Subject|4|||
147409224|NCT01213524|531662480|FG000|Session 4|Physician Decision|1|||
147409225|NCT01213524|531662480|FG000|Session 4|Withdrawal by Subject|2|||
147409226|NCT02519348|531662486|FG000|Overall Study|Death|31|||
147409227|NCT02519348|531662487|FG001|Overall Study|Death|74|||
147409228|NCT02519348|531662488|FG002|Overall Study|Death|47|||
147465044|NCT01717638|531862375|FG006|Overall Study|Withdrawal by Subject|2|||
147465045|NCT01717638|531862376|FG007|Overall Study|Withdrawal by Subject|1|||
147465046|NCT01717638|531862377|FG008|Overall Study|Withdrawal by Subject|2|||
147465047|NCT01717638|531862378|FG009|Overall Study|Withdrawal by Subject|1|||
147465048|NCT01717638|531862379|FG010|Overall Study|Withdrawal by Subject|0|||
147465049|NCT01717638|531862380|FG011|Overall Study|Withdrawal by Subject|0|||
147465050|NCT01717638|531862381|FG012|Overall Study|Withdrawal by Subject|18|||
147465051|NCT01901224|531862382|FG000|Overall Study|study was not funded and terminated|2|||
147465052|NCT02300129|531862383|FG000|Period 1 Session 2 (Day 3)|Withdrawal by Subject|0|||
147465053|NCT02300129|531862384|FG001|Period 1 Session 2 (Day 3)|Withdrawal by Subject|1|||
147465054|NCT02300129|531862385|FG002|Period 1 Session 2 (Day 3)|Withdrawal by Subject|0|||
147465055|NCT02300129|531862386|FG003|Period 1 Session 2 (Day 3)|Withdrawal by Subject|0|||
147465056|NCT02300129|531862383|FG000|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|0|||
147465057|NCT02300129|531862384|FG001|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|0|||
147465058|NCT02300129|531862385|FG002|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|0|||
147465059|NCT02300129|531862386|FG003|Period 2 Treatment 1 (2 Weeks)|Withdrawal by Subject|1|||
147465060|NCT02300129|531862383|FG000|Period 2 Treatment 1 (2 Weeks)|Adverse Event|1|||
147465061|NCT02300129|531862384|FG001|Period 2 Treatment 1 (2 Weeks)|Adverse Event|0|||
147465062|NCT02300129|531862385|FG002|Period 2 Treatment 1 (2 Weeks)|Adverse Event|0|||
147465063|NCT02300129|531862386|FG003|Period 2 Treatment 1 (2 Weeks)|Adverse Event|0|||
147465064|NCT00522392|531862390|FG000|Overall Study|Disease progression|0|||
147465065|NCT00522392|531862391|FG001|Overall Study|Disease progression|3|||
147465066|NCT00522392|531862390|FG000|Overall Study|Adverse Event|7|||
147465067|NCT00522392|531862391|FG001|Overall Study|Adverse Event|7|||
147465068|NCT00522392|531862390|FG000|Overall Study|Withdrawal by Subject|1|||
147465069|NCT00522392|531862391|FG001|Overall Study|Withdrawal by Subject|1|||
147465070|NCT00522392|531862390|FG000|Overall Study|Physician Decision|0|||
147465071|NCT00522392|531862391|FG001|Overall Study|Physician Decision|1|||
147465072|NCT00522392|531862390|FG000|Overall Study|Non-compliance|0|||
147465073|NCT00522392|531862391|FG001|Overall Study|Non-compliance|1|||
147465074|NCT00430755|531862394|FG000|Overall Study|Withdrawal by Subject|53|||
147465075|NCT02661594|531862403|FG000|Overall Study|Protocol Violation|1|||
147465076|NCT02661594|531862404|FG001|Overall Study|Protocol Violation|0|||
147465077|NCT02661594|531862405|FG002|Overall Study|Protocol Violation|1|||
147465078|NCT02661594|531862406|FG003|Overall Study|Protocol Violation|0|||
147465079|NCT01169779|531862407|FG000|Overall Study|Adverse Event|3|||
147465080|NCT01169779|531862408|FG001|Overall Study|Adverse Event|11|||
147465081|NCT01169779|531862407|FG000|Overall Study|Lack of Efficacy|1|||
147465082|NCT01169779|531862408|FG001|Overall Study|Lack of Efficacy|0|||
147465083|NCT01169779|531862407|FG000|Overall Study|Protocol Violation|1|||
147465084|NCT01169779|531862408|FG001|Overall Study|Protocol Violation|1|||
147465085|NCT01169779|531862407|FG000|Overall Study|Withdrawal by Subject|3|||
147465086|NCT01169779|531862408|FG001|Overall Study|Withdrawal by Subject|2|||
147465087|NCT01169779|531862407|FG000|Overall Study|Familial and personal reasons|3|||
147465088|NCT01169779|531862408|FG001|Overall Study|Familial and personal reasons|3|||
147465089|NCT00191854|531862409|FG000|Overall Study|Death|26|||
147465090|NCT00191854|531862410|FG001|Overall Study|Death|23|||
147465091|NCT00191854|531862411|FG002|Overall Study|Death|29|||
147465092|NCT00191854|531862409|FG000|Overall Study|Lost to Follow-up|7|||
147465093|NCT00191854|531862410|FG001|Overall Study|Lost to Follow-up|5|||
147465094|NCT00191854|531862411|FG002|Overall Study|Lost to Follow-up|5|||
147465095|NCT00191854|531862409|FG000|Overall Study|Withdrawal by Subject|4|||
147465096|NCT00191854|531862410|FG001|Overall Study|Withdrawal by Subject|2|||
147465097|NCT00191854|531862411|FG002|Overall Study|Withdrawal by Subject|3|||
147465098|NCT00191854|531862409|FG000|Overall Study|Sponsor Decision|0|||
147465099|NCT00191854|531862410|FG001|Overall Study|Sponsor Decision|0|||
147465100|NCT00191854|531862411|FG002|Overall Study|Sponsor Decision|1|||
147465101|NCT00191854|531862409|FG000|Overall Study|Screen Failure|0|||
147465102|NCT00191854|531862410|FG001|Overall Study|Screen Failure|0|||
147465103|NCT00191854|531862411|FG002|Overall Study|Screen Failure|1|||
147617130|NCT00758524|532413743|FG011|Core Period (Week 0 to Week 8)|Adverse Event|0|||
147465104|NCT00556426|531862413|FG000|Overall Study|Withdrawal by Subject|3|||
147465105|NCT00556426|531862413|FG000|Overall Study|Death|6|||
147465106|NCT00486603|531862415|FG000|Overall Study|Withdrawal by Subject|1|||
147465107|NCT00486603|531862416|FG001|Overall Study|Withdrawal by Subject|0|||
147465108|NCT00486603|531862417|FG002|Overall Study|Withdrawal by Subject|0|||
147465109|NCT00486603|531862418|FG003|Overall Study|Withdrawal by Subject|0|||
147465110|NCT00486603|531862419|FG004|Overall Study|Withdrawal by Subject|0|||
147465111|NCT00486603|531862415|FG000|Overall Study|Physician Decision|0|||
147465112|NCT00486603|531862416|FG001|Overall Study|Physician Decision|1|||
147465113|NCT00486603|531862417|FG002|Overall Study|Physician Decision|0|||
147465114|NCT00486603|531862418|FG003|Overall Study|Physician Decision|0|||
147465115|NCT00486603|531862419|FG004|Overall Study|Physician Decision|0|||
147617131|NCT00758524|532413744|FG012|Core Period (Week 0 to Week 8)|Adverse Event|0|||
147465116|NCT00763009|531862420|FG000|Overall Study|Coronary Anatomy unsuitable|1|||
147465117|NCT01355289|531862423|FG000|Core Study|Adverse Event, Non-Fatal|1|||
147465118|NCT01355289|531862424|FG001|Core Study|Adverse Event, Non-Fatal|0|||
147465119|NCT01355289|531862425|FG002|Core Study|Adverse Event, Non-Fatal|0|||
147465120|NCT01355289|531862426|FG003|Core Study|Adverse Event, Non-Fatal|0|||
147465121|NCT01355289|531862427|FG004|Core Study|Adverse Event, Non-Fatal|0|||
147465122|NCT01355289|531862423|FG000|Core Study|Inadequate Therapeutic Effect|0|||
147465123|NCT01355289|531862424|FG001|Core Study|Inadequate Therapeutic Effect|0|||
147465124|NCT01355289|531862425|FG002|Core Study|Inadequate Therapeutic Effect|0|||
147465125|NCT01355289|531862426|FG003|Core Study|Inadequate Therapeutic Effect|1|||
147465126|NCT01355289|531862427|FG004|Core Study|Inadequate Therapeutic Effect|0|||
147465127|NCT01355289|531862423|FG000|Core Study|Other|0|||
147465128|NCT01355289|531862424|FG001|Core Study|Other|0|||
147465129|NCT01355289|531862425|FG002|Core Study|Other|0|||
147465130|NCT01355289|531862426|FG003|Core Study|Other|1|||
147465131|NCT01355289|531862427|FG004|Core Study|Other|0|||
147465132|NCT01355289|531862423|FG000|Open Label Extension|Adverse Event, Non-Fatal|0|||
147465133|NCT01355289|531862424|FG001|Open Label Extension|Adverse Event, Non-Fatal|0|||
147465134|NCT01355289|531862425|FG002|Open Label Extension|Adverse Event, Non-Fatal|0|||
147465135|NCT01355289|531862426|FG003|Open Label Extension|Adverse Event, Non-Fatal|0|||
147465136|NCT01355289|531862427|FG004|Open Label Extension|Adverse Event, Non-Fatal|1|||
147465137|NCT01355289|531862423|FG000|Open Label Extension|Lost to Follow-up|0|||
147465138|NCT01355289|531862424|FG001|Open Label Extension|Lost to Follow-up|0|||
147465139|NCT01355289|531862425|FG002|Open Label Extension|Lost to Follow-up|0|||
147465140|NCT01355289|531862426|FG003|Open Label Extension|Lost to Follow-up|0|||
147465141|NCT01355289|531862427|FG004|Open Label Extension|Lost to Follow-up|1|||
147465142|NCT01355289|531862423|FG000|Open Label Extension|Inadequate Therapeutic Effect|0|||
147465143|NCT01355289|531862424|FG001|Open Label Extension|Inadequate Therapeutic Effect|0|||
147465144|NCT01355289|531862425|FG002|Open Label Extension|Inadequate Therapeutic Effect|0|||
147465145|NCT01355289|531862426|FG003|Open Label Extension|Inadequate Therapeutic Effect|0|||
147465146|NCT01355289|531862427|FG004|Open Label Extension|Inadequate Therapeutic Effect|29|||
147465147|NCT01355289|531862423|FG000|Open Label Extension|Other|0|||
147465148|NCT01355289|531862424|FG001|Open Label Extension|Other|0|||
147465149|NCT01355289|531862425|FG002|Open Label Extension|Other|0|||
147465150|NCT01355289|531862426|FG003|Open Label Extension|Other|0|||
147465151|NCT01355289|531862427|FG004|Open Label Extension|Other|3|||
147465152|NCT02706938|531862431|FG000|First Period, 6 Weeks|Adverse Event|8|||
147465153|NCT02706938|531862432|FG001|First Period, 6 Weeks|Adverse Event|0|||
147465154|NCT02706938|531862431|FG000|First Period, 6 Weeks|Lost to Follow-up|2|||
147465155|NCT02706938|531862432|FG001|First Period, 6 Weeks|Lost to Follow-up|2|||
147465156|NCT02706938|531862431|FG000|First Period, 6 Weeks|Withdrawal by Subject|1|||
147465157|NCT02706938|531862432|FG001|First Period, 6 Weeks|Withdrawal by Subject|0|||
147465158|NCT02706938|531862431|FG000|Second Period, 6 Weeks|Adverse Event|0|||
147465159|NCT02706938|531862432|FG001|Second Period, 6 Weeks|Adverse Event|7|||
147465160|NCT02706938|531862431|FG000|Second Period, 6 Weeks|Withdrawal by Subject|0|||
147465161|NCT02706938|531862432|FG001|Second Period, 6 Weeks|Withdrawal by Subject|3|||
147465162|NCT02507349|531862437|FG000|Overall Study|Death|12|||
147465163|NCT02507349|531862438|FG001|Overall Study|Death|16|||
147465164|NCT02507349|531862437|FG000|Overall Study|Withdrawal by Subject|1|||
147465165|NCT02507349|531862438|FG001|Overall Study|Withdrawal by Subject|1|||
147465166|NCT02507349|531862437|FG000|Overall Study|Lost to Follow-up|174|||
147465167|NCT02507349|531862438|FG001|Overall Study|Lost to Follow-up|144|||
147465168|NCT00813995|531862439|FG000|Overall Study|Clinical adverse event|9|||
147465169|NCT00813995|531862440|FG001|Overall Study|Clinical adverse event|3|||
147465170|NCT00813995|531862439|FG000|Overall Study|Laboratory adverse event|0|||
147465171|NCT00813995|531862440|FG001|Overall Study|Laboratory adverse event|2|||
147465172|NCT00813995|531862439|FG000|Overall Study|Lack of Efficacy|1|||
147465173|NCT00813995|531862440|FG001|Overall Study|Lack of Efficacy|0|||
147465174|NCT00813995|531862439|FG000|Overall Study|Lost to Follow-up|4|||
147465175|NCT00813995|531862440|FG001|Overall Study|Lost to Follow-up|2|||
147465176|NCT00813995|531862439|FG000|Overall Study|Other reason|2|||
147465177|NCT00813995|531862440|FG001|Overall Study|Other reason|2|||
147465178|NCT00813995|531862439|FG000|Overall Study|Protocol Violation|3|||
147465179|NCT00813995|531862440|FG001|Overall Study|Protocol Violation|2|||
147465180|NCT00813995|531862439|FG000|Overall Study|Subject moved|4|||
147465181|NCT00813995|531862440|FG001|Overall Study|Subject moved|0|||
147465182|NCT00813995|531862439|FG000|Overall Study|Withdrawal by Subject|0|||
147465183|NCT00813995|531862440|FG001|Overall Study|Withdrawal by Subject|5|||
147465184|NCT01614964|531862443|FG000|Overall Study|Withdrawal by Subject|2|||
147465185|NCT01614964|531862444|FG001|Overall Study|Withdrawal by Subject|0|||
147465186|NCT01614964|531862443|FG000|Overall Study|Lost to Follow-up|3|||
147465187|NCT01614964|531862444|FG001|Overall Study|Lost to Follow-up|0|||
147465188|NCT00860470|531862445|FG000|Overall Study|Death|6|||
147465189|NCT00860470|531862446|FG001|Overall Study|Death|10|||
147465190|NCT00860470|531862445|FG000|Overall Study|Moved away|8|||
147465191|NCT00860470|531862446|FG001|Overall Study|Moved away|10|||
147465192|NCT00860470|531862445|FG000|Overall Study|Lost to Follow-up|34|||
147465193|NCT00860470|531862446|FG001|Overall Study|Lost to Follow-up|39|||
147465194|NCT00348140|531862447|FG000|Overall Study|Adverse Event|46|||
147617132|NCT00758524|532413745|FG013|Core Period (Week 0 to Week 8)|Adverse Event|0|||
147617133|NCT00758524|532413746|FG014|Core Period (Week 0 to Week 8)|Adverse Event|0|||
147409229|NCT02519348|531662489|FG003|Overall Study|Death|54|||
147409230|NCT02519348|531662490|FG004|Overall Study|Death|63|||
147409231|NCT02519348|531662491|FG005|Overall Study|Death|18|||
147409232|NCT02519348|531662492|FG006|Overall Study|Death|2|||
147409233|NCT02519348|531662493|FG007|Overall Study|Death|5|||
147409234|NCT02519348|531662494|FG008|Overall Study|Death|5|||
147409235|NCT02519348|531662486|FG000|Overall Study|Withdrawal by Subject|4|||
147409236|NCT02519348|531662487|FG001|Overall Study|Withdrawal by Subject|7|||
147409237|NCT02519348|531662488|FG002|Overall Study|Withdrawal by Subject|4|||
147409238|NCT02519348|531662489|FG003|Overall Study|Withdrawal by Subject|3|||
147409239|NCT02519348|531662490|FG004|Overall Study|Withdrawal by Subject|3|||
147409240|NCT02519348|531662491|FG005|Overall Study|Withdrawal by Subject|2|||
147409241|NCT02519348|531662492|FG006|Overall Study|Withdrawal by Subject|0|||
147409242|NCT02519348|531662493|FG007|Overall Study|Withdrawal by Subject|0|||
147409243|NCT02519348|531662494|FG008|Overall Study|Withdrawal by Subject|1|||
147409244|NCT02519348|531662486|FG000|Overall Study|Lost to Follow-up|0|||
147409245|NCT02519348|531662487|FG001|Overall Study|Lost to Follow-up|0|||
147409246|NCT02519348|531662488|FG002|Overall Study|Lost to Follow-up|1|||
147409247|NCT02519348|531662489|FG003|Overall Study|Lost to Follow-up|0|||
147409248|NCT02519348|531662490|FG004|Overall Study|Lost to Follow-up|2|||
147409249|NCT02519348|531662491|FG005|Overall Study|Lost to Follow-up|1|||
147409250|NCT02519348|531662492|FG006|Overall Study|Lost to Follow-up|1|||
147409251|NCT02519348|531662493|FG007|Overall Study|Lost to Follow-up|0|||
147409252|NCT02519348|531662494|FG008|Overall Study|Lost to Follow-up|0|||
147409253|NCT02519348|531662486|FG000|Overall Study|Other|0|||
147409254|NCT02519348|531662487|FG001|Overall Study|Other|3|||
147409255|NCT02519348|531662488|FG002|Overall Study|Other|0|||
147409256|NCT02519348|531662489|FG003|Overall Study|Other|0|||
147409257|NCT02519348|531662490|FG004|Overall Study|Other|1|||
147409258|NCT02519348|531662491|FG005|Overall Study|Other|0|||
147409259|NCT02519348|531662492|FG006|Overall Study|Other|0|||
147409260|NCT02519348|531662493|FG007|Overall Study|Other|0|||
147409261|NCT02519348|531662494|FG008|Overall Study|Other|0|||
147409262|NCT02519348|531662486|FG000|Overall Study|Ongoing at the time of data cut-off date|5|||
147409263|NCT02519348|531662487|FG001|Overall Study|Ongoing at the time of data cut-off date|20|||
147409264|NCT02519348|531662488|FG002|Overall Study|Ongoing at the time of data cut-off date|23|||
147409265|NCT02519348|531662489|FG003|Overall Study|Ongoing at the time of data cut-off date|12|||
147409266|NCT02519348|531662490|FG004|Overall Study|Ongoing at the time of data cut-off date|15|||
147409267|NCT02519348|531662491|FG005|Overall Study|Ongoing at the time of data cut-off date|26|||
147409268|NCT02519348|531662492|FG006|Overall Study|Ongoing at the time of data cut-off date|0|||
147409269|NCT02519348|531662493|FG007|Overall Study|Ongoing at the time of data cut-off date|0|||
147409270|NCT02519348|531662494|FG008|Overall Study|Ongoing at the time of data cut-off date|0|||
147409271|NCT05415748|531662498|FG000|Wash-out #1 (1 Week)|Withdrawal by Subject|1|||
147409272|NCT05415748|531662499|FG001|Wash-out #1 (1 Week)|Withdrawal by Subject|1|||
147409273|NCT05415748|531662500|FG002|Wash-out #1 (1 Week)|Withdrawal by Subject|2|||
147409274|NCT05415748|531662501|FG003|Wash-out #1 (1 Week)|Withdrawal by Subject|0|||
147409275|NCT05415748|531662498|FG000|Intervention #2 (2 Weeks)|Withdrawal by Subject|1|||
147409276|NCT05415748|531662499|FG001|Intervention #2 (2 Weeks)|Withdrawal by Subject|0|||
147409277|NCT05415748|531662500|FG002|Intervention #2 (2 Weeks)|Withdrawal by Subject|0|||
147409278|NCT05415748|531662501|FG003|Intervention #2 (2 Weeks)|Withdrawal by Subject|0|||
147409279|NCT03075527|531662502|FG000|Overall Study|Death|1|||
147409280|NCT03075527|531662502|FG000|Overall Study|Withdrawal by Subject|1|||
147409281|NCT03075527|531662502|FG000|Overall Study|Physician Decision|3|||
147409282|NCT03075527|531662502|FG000|Overall Study|Progression/Relapse|14|||
147409283|NCT01447576|531662506|FG000|Overall Study|Lost to Follow-up|52|||
147409284|NCT01447576|531662506|FG000|Overall Study|Adverse Event|127|||
147409285|NCT01447576|531662506|FG000|Overall Study|Participant met withdrawal criteria|40|||
147409286|NCT01447576|531662506|FG000|Overall Study|Withdrawal by Subject|100|||
147409287|NCT01447576|531662506|FG000|Overall Study|Protocol deviation|83|||
147409288|NCT01447576|531662506|FG000|Overall Study|Lack of Efficacy|68|||
147409289|NCT01447576|531662506|FG000|Overall Study|Physician Decision|6|||
147409290|NCT05239598|531662507|FG000|Phase II (Open Label)|Lost to Follow-up|1|||
147409291|NCT05239598|531662508|FG001|Phase II (Open Label)|Lost to Follow-up|0|||
147409292|NCT05239598|531662507|FG000|Phase II (Open Label)|Withdrawal by Subject|1|||
147409293|NCT05239598|531662508|FG001|Phase II (Open Label)|Withdrawal by Subject|0|||
147409294|NCT02998476|531662511|FG000|Overall Study|Lost to Follow-up|1|||
147409295|NCT02998476|531662512|FG001|Overall Study|Lost to Follow-up|0|||
147409296|NCT02998476|531662511|FG000|Overall Study|Participants transferred to rollover study INCB50465-801|2|||
147409297|NCT02998476|531662512|FG001|Overall Study|Participants transferred to rollover study INCB50465-801|0|||
147409298|NCT02998476|531662511|FG000|Overall Study|Withdrawal by Subject|1|||
147409299|NCT02998476|531662512|FG001|Overall Study|Withdrawal by Subject|2|||
147409300|NCT02998476|531662511|FG000|Overall Study|Death|45|||
147409301|NCT02998476|531662512|FG001|Overall Study|Death|2|||
147409302|NCT02998476|531662511|FG000|Overall Study|Other|6|||
147465195|NCT00348140|531862448|FG001|Overall Study|Adverse Event|49|||
147465196|NCT00348140|531862449|FG002|Overall Study|Adverse Event|78|||
147465197|NCT00348140|531862447|FG000|Overall Study|Lost to Follow-up|4|||
147465198|NCT00348140|531862448|FG001|Overall Study|Lost to Follow-up|4|||
147465199|NCT00348140|531862449|FG002|Overall Study|Lost to Follow-up|4|||
147465200|NCT00348140|531862447|FG000|Overall Study|Protocol Violation|12|||
147465201|NCT00348140|531862448|FG001|Overall Study|Protocol Violation|13|||
147465202|NCT00348140|531862449|FG002|Overall Study|Protocol Violation|14|||
147465203|NCT00348140|531862447|FG000|Overall Study|Withdrawal by Subject|32|||
147465204|NCT00348140|531862448|FG001|Overall Study|Withdrawal by Subject|40|||
147465205|NCT00348140|531862449|FG002|Overall Study|Withdrawal by Subject|40|||
147465206|NCT00348140|531862447|FG000|Overall Study|Non-compliance|8|||
147465207|NCT00348140|531862448|FG001|Overall Study|Non-compliance|13|||
147465208|NCT00348140|531862449|FG002|Overall Study|Non-compliance|5|||
147465209|NCT00348140|531862447|FG000|Overall Study|Participant at risk due to study drug|2|||
147465210|NCT00348140|531862448|FG001|Overall Study|Participant at risk due to study drug|0|||
147465211|NCT00348140|531862449|FG002|Overall Study|Participant at risk due to study drug|0|||
147465212|NCT00348140|531862447|FG000|Overall Study|Conditional medication increased dose|1|||
147465213|NCT00348140|531862448|FG001|Overall Study|Conditional medication increased dose|0|||
147465214|NCT00348140|531862449|FG002|Overall Study|Conditional medication increased dose|0|||
147465215|NCT00348140|531862447|FG000|Overall Study|Caregiver related|4|||
147465216|NCT00348140|531862448|FG001|Overall Study|Caregiver related|7|||
147465217|NCT00348140|531862449|FG002|Overall Study|Caregiver related|3|||
147465218|NCT00348140|531862447|FG000|Overall Study|Participant hospitalised|3|||
147465219|NCT00348140|531862448|FG001|Overall Study|Participant hospitalised|0|||
147465220|NCT00348140|531862449|FG002|Overall Study|Participant hospitalised|0|||
147465221|NCT00348140|531862447|FG000|Overall Study|Efficacy related|1|||
147465222|NCT00348140|531862448|FG001|Overall Study|Efficacy related|1|||
147465223|NCT00348140|531862449|FG002|Overall Study|Efficacy related|0|||
147465224|NCT00348140|531862447|FG000|Overall Study|Administration related|3|||
147465225|NCT00348140|531862448|FG001|Overall Study|Administration related|1|||
147465226|NCT00348140|531862449|FG002|Overall Study|Administration related|1|||
147465227|NCT00348140|531862447|FG000|Overall Study|Unmet inclusion-exclusion criteria|1|||
147465228|NCT00348140|531862448|FG001|Overall Study|Unmet inclusion-exclusion criteria|0|||
147465229|NCT00348140|531862449|FG002|Overall Study|Unmet inclusion-exclusion criteria|1|||
147465230|NCT00348140|531862447|FG000|Overall Study|Participant unwell|1|||
147465231|NCT00348140|531862448|FG001|Overall Study|Participant unwell|0|||
147465232|NCT00348140|531862449|FG002|Overall Study|Participant unwell|0|||
147465233|NCT00348140|531862447|FG000|Overall Study|Screen failure|1|||
147465234|NCT00348140|531862448|FG001|Overall Study|Screen failure|0|||
147465235|NCT00348140|531862449|FG002|Overall Study|Screen failure|0|||
147465236|NCT00348140|531862447|FG000|Overall Study|Investigator decided to discontinue|4|||
147465237|NCT00348140|531862448|FG001|Overall Study|Investigator decided to discontinue|1|||
147465238|NCT00348140|531862449|FG002|Overall Study|Investigator decided to discontinue|4|||
147465239|NCT00348140|531862447|FG000|Overall Study|Decided to discontinue on their own|1|||
147465240|NCT00348140|531862448|FG001|Overall Study|Decided to discontinue on their own|4|||
147465241|NCT00348140|531862449|FG002|Overall Study|Decided to discontinue on their own|1|||
147465242|NCT00348140|531862447|FG000|Overall Study|Use of prohibited drug|1|||
147465243|NCT00348140|531862448|FG001|Overall Study|Use of prohibited drug|0|||
147465244|NCT00348140|531862449|FG002|Overall Study|Use of prohibited drug|2|||
147465245|NCT00348140|531862447|FG000|Overall Study|Disease progression|1|||
147465246|NCT00348140|531862448|FG001|Overall Study|Disease progression|2|||
147465247|NCT00348140|531862449|FG002|Overall Study|Disease progression|5|||
147465248|NCT00348140|531862447|FG000|Overall Study|Increased risk of cardiac infarction|0|||
147465249|NCT00348140|531862448|FG001|Overall Study|Increased risk of cardiac infarction|1|||
147465250|NCT00348140|531862449|FG002|Overall Study|Increased risk of cardiac infarction|0|||
147465251|NCT00348140|531862447|FG000|Overall Study|Serious adverse event|0|||
147465252|NCT00348140|531862448|FG001|Overall Study|Serious adverse event|1|||
147465253|NCT00348140|531862449|FG002|Overall Study|Serious adverse event|0|||
147465254|NCT00348140|531862447|FG000|Overall Study|Abnormal ECG|0|||
147465255|NCT00348140|531862448|FG001|Overall Study|Abnormal ECG|1|||
147465256|NCT00348140|531862449|FG002|Overall Study|Abnormal ECG|3|||
147465257|NCT00348140|531862447|FG000|Overall Study|Participant died|0|||
147465258|NCT00348140|531862448|FG001|Overall Study|Participant died|1|||
147465259|NCT00348140|531862449|FG002|Overall Study|Participant died|0|||
147465260|NCT00348140|531862447|FG000|Overall Study|Exclusion criteria met|0|||
147465261|NCT00348140|531862448|FG001|Overall Study|Exclusion criteria met|0|||
147465262|NCT00348140|531862449|FG002|Overall Study|Exclusion criteria met|1|||
147465263|NCT00348140|531862447|FG000|Overall Study|Memory declined|0|||
147465264|NCT00348140|531862448|FG001|Overall Study|Memory declined|0|||
147465265|NCT00348140|531862449|FG002|Overall Study|Memory declined|1|||
147465266|NCT01032629|531862450|FG000|Overall Study|Closed Site|21|||
147465267|NCT01032629|531862451|FG001|Overall Study|Closed Site|18|||
147465268|NCT01032629|531862452|FG002|Overall Study|Closed Site|16|||
147465269|NCT01032629|531862450|FG000|Overall Study|Withdrawal by Subject|50|||
147465270|NCT01032629|531862451|FG001|Overall Study|Withdrawal by Subject|36|||
147617134|NCT00758524|532413747|FG015|Core Period (Week 0 to Week 8)|Adverse Event|0|||
147617135|NCT00758524|532413748|FG016|Core Period (Week 0 to Week 8)|Adverse Event|0|||
147617136|NCT00758524|532413732|FG000|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
147617137|NCT00758524|532413733|FG001|Core Period (Week 0 to Week 8)|Lost to Follow-up|2|||
147617138|NCT00758524|532413734|FG002|Core Period (Week 0 to Week 8)|Lost to Follow-up|1|||
147409303|NCT02998476|531662512|FG001|Overall Study|Other|1|||
147409304|NCT05855967|531662513|FG000|Overall Study|Withdrawal by Subject|7|||
147409305|NCT05855967|531662514|FG001|Overall Study|Withdrawal by Subject|5|||
147409306|NCT05855967|531662513|FG000|Overall Study|Lost to Follow-up|2|||
147409307|NCT05855967|531662514|FG001|Overall Study|Lost to Follow-up|1|||
147409308|NCT01435772|531662516|FG000|Overall Study|Adverse Event|1|||
147409309|NCT01435772|531662517|FG001|Overall Study|Adverse Event|0|||
147409310|NCT01435772|531662518|FG002|Overall Study|Adverse Event|2|||
147409311|NCT01435772|531662516|FG000|Overall Study|Withdrawal by Subject|0|||
147409312|NCT01435772|531662517|FG001|Overall Study|Withdrawal by Subject|1|||
147409313|NCT01435772|531662518|FG002|Overall Study|Withdrawal by Subject|3|||
147409314|NCT01435772|531662516|FG000|Overall Study|Other - study termination|2|||
147409315|NCT01435772|531662517|FG001|Overall Study|Other - study termination|2|||
147409316|NCT01435772|531662518|FG002|Overall Study|Other - study termination|10|||
147409317|NCT03238963|531662519|FG000|Overall Study|Prohibited medication given due to hospital stay|1|||
147409318|NCT03238963|531662520|FG001|Overall Study|Prohibited medication given due to hospital stay|0|||
147409319|NCT03238963|531662519|FG000|Overall Study|Withdrawal by Subject|1|||
147409320|NCT03238963|531662520|FG001|Overall Study|Withdrawal by Subject|1|||
147409321|NCT03238963|531662519|FG000|Overall Study|Lost to Follow-up|1|||
147409322|NCT03238963|531662520|FG001|Overall Study|Lost to Follow-up|0|||
147409323|NCT03238963|531662519|FG000|Overall Study|Protocol Violation|1|||
147409324|NCT03238963|531662520|FG001|Overall Study|Protocol Violation|1|||
147409325|NCT03238963|531662519|FG000|Overall Study|Adverse Event|1|||
147409326|NCT03238963|531662520|FG001|Overall Study|Adverse Event|0|||
147409327|NCT01920477|531664059|FG000|Overall Study|Adverse Event|0|||
147409328|NCT01920477|531664060|FG001|Overall Study|Adverse Event|1|||
147409329|NCT01920477|531664059|FG000|Overall Study|Lack of Efficacy|1|||
147409330|NCT01920477|531664060|FG001|Overall Study|Lack of Efficacy|0|||
147409331|NCT01920477|531664059|FG000|Overall Study|Study closed/terminated|14|||
147409332|NCT01920477|531664060|FG001|Overall Study|Study closed/terminated|15|||
147409333|NCT01920477|531664059|FG000|Overall Study|Withdrawal by Subject|0|||
147409334|NCT01920477|531664060|FG001|Overall Study|Withdrawal by Subject|1|||
147409335|NCT01681277|531664061|FG000|Overall Study|Adverse Event|1|||
147409336|NCT01681277|531664062|FG001|Overall Study|Adverse Event|0|||
147409337|NCT01681277|531664063|FG002|Overall Study|Adverse Event|0|||
147409338|NCT01681277|531664064|FG003|Overall Study|Adverse Event|0|||
147409339|NCT01681277|531664065|FG004|Overall Study|Adverse Event|0|||
147409340|NCT03838731|531664066|FG000|Overall Study|Pregnancy|0|||
147409341|NCT03838731|531664067|FG001|Overall Study|Pregnancy|1|||
147409342|NCT03838731|531664066|FG000|Overall Study|Withdrawal of consent|1|||
147409343|NCT03838731|531664067|FG001|Overall Study|Withdrawal of consent|0|||
147409344|NCT04707664|531664068|FG000|Overall Study|Adverse Event|2|||
147409345|NCT04707664|531664069|FG001|Overall Study|Adverse Event|0|||
147409346|NCT04707664|531664068|FG000|Overall Study|Death|1|||
147409347|NCT04707664|531664069|FG001|Overall Study|Death|2|||
147409348|NCT04707664|531664068|FG000|Overall Study|Withdrawal by Subject|13|||
147409349|NCT04707664|531664069|FG001|Overall Study|Withdrawal by Subject|21|||
147409350|NCT04707664|531664068|FG000|Overall Study|Lost to Follow-up|11|||
147409351|NCT04707664|531664069|FG001|Overall Study|Lost to Follow-up|13|||
147409352|NCT04707664|531664068|FG000|Overall Study|Not treated|2|||
147409353|NCT04707664|531664069|FG001|Overall Study|Not treated|0|||
147409354|NCT01182441|531664070|FG000|Overall Study|Patient Still in Follow-up|152|||
147409355|NCT01182441|531664071|FG001|Overall Study|Patient Still in Follow-up|72|||
147409356|NCT01182441|531664070|FG000|Overall Study|Death|37|||
147409357|NCT01182441|531664071|FG001|Overall Study|Death|25|||
147409358|NCT01182441|531664070|FG000|Overall Study|Implant Attempt Unsuccessful|13|||
147409359|NCT01182441|531664071|FG001|Overall Study|Implant Attempt Unsuccessful|0|||
147409360|NCT01182441|531664070|FG000|Overall Study|Lost to Follow-up|5|||
147409361|NCT01182441|531664071|FG001|Overall Study|Lost to Follow-up|8|||
147409362|NCT01182441|531664070|FG000|Overall Study|Withdrawal by Subject|6|||
147409363|NCT01182441|531664071|FG001|Overall Study|Withdrawal by Subject|13|||
147409364|NCT01182441|531664070|FG000|Overall Study|Implant Not Attempted|4|||
147409365|NCT01182441|531664071|FG001|Overall Study|Implant Not Attempted|0|||
147409366|NCT01182441|531664070|FG000|Overall Study|Adverse Event|2|||
147409367|NCT01182441|531664071|FG001|Overall Study|Adverse Event|0|||
147409368|NCT01182441|531664070|FG000|Overall Study|Physician Decision|1|||
147409369|NCT01182441|531664071|FG001|Overall Study|Physician Decision|1|||
147409370|NCT05620108|531664072|FG000|Overall Study|Physician Decision|1|||
147409371|NCT05620108|531664073|FG001|Overall Study|Physician Decision|2|||
147617139|NCT00758524|532413735|FG003|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
147409372|NCT02038842|531664074|FG000|Overall Study|Withdrawal by Subject|2|||
147409373|NCT02038842|531664075|FG001|Overall Study|Withdrawal by Subject|2|||
147409374|NCT02038842|531664076|FG002|Overall Study|Withdrawal by Subject|0|||
147617140|NCT00758524|532413736|FG004|Core Period (Week 0 to Week 8)|Lost to Follow-up|2|||
147617141|NCT00758524|532413737|FG005|Core Period (Week 0 to Week 8)|Lost to Follow-up|1|||
147617142|NCT00758524|532413738|FG006|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
147617143|NCT00758524|532413739|FG007|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
147617144|NCT00758524|532413740|FG008|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
147617145|NCT00758524|532413741|FG009|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
147617146|NCT00758524|532413742|FG010|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
147617147|NCT00758524|532413743|FG011|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
147617148|NCT00758524|532413744|FG012|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
147617149|NCT00758524|532413745|FG013|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
147665529|NCT01103323|532599607|FG000|Without/Before Drug Switch|Withdrawal by Subject|17|||
147409375|NCT02038842|531664077|FG003|Overall Study|Withdrawal by Subject|0|||
147409376|NCT02038842|531664074|FG000|Overall Study|Participant decision|0|||
147409377|NCT02038842|531664075|FG001|Overall Study|Participant decision|0|||
147409378|NCT02038842|531664076|FG002|Overall Study|Participant decision|2|||
147409379|NCT02038842|531664077|FG003|Overall Study|Participant decision|1|||
147409380|NCT02038842|531664074|FG000|Overall Study|Adverse Event|0|||
147409381|NCT02038842|531664075|FG001|Overall Study|Adverse Event|0|||
147409382|NCT02038842|531664076|FG002|Overall Study|Adverse Event|3|||
147409383|NCT02038842|531664077|FG003|Overall Study|Adverse Event|1|||
147409384|NCT02038842|531664074|FG000|Overall Study|Other (professional impossibility, etc.)|0|||
147409385|NCT02038842|531664075|FG001|Overall Study|Other (professional impossibility, etc.)|0|||
147409386|NCT02038842|531664076|FG002|Overall Study|Other (professional impossibility, etc.)|0|||
147409387|NCT02038842|531664077|FG003|Overall Study|Other (professional impossibility, etc.)|2|||
147409388|NCT02088957|531664082|FG000|Overall Study|Lack of Efficacy|1|||
147409389|NCT02088957|531664083|FG001|Overall Study|Lack of Efficacy|0|||
147409390|NCT01923662|531664084|FG000|Overall Study|Withdrawal by Subject|1|||
147409391|NCT00677534|531664089|FG000|Washout (Weeks 1-4)|did not qualify after signing consent|1|||
147409392|NCT00677534|531664089|FG000|Washout (Weeks 1-4)|Withdrawal by Subject|1|||
147409393|NCT00677534|531664089|FG000|Washout (Weeks 1-4)|Withdrawal by Subject|1|||
147409394|NCT00667394|531664090|FG000|Overall Study|Adverse Event|3|||
147409395|NCT00667394|531664091|FG001|Overall Study|Adverse Event|0|||
147409396|NCT00667394|531664090|FG000|Overall Study|Progressive disease|1|||
147409397|NCT00667394|531664091|FG001|Overall Study|Progressive disease|0|||
147409398|NCT04638660|531664093|FG000|Overall Study|Withdrawal by Subject|2|||
147409399|NCT04638660|531664094|FG001|Overall Study|Withdrawal by Subject|0|||
147409400|NCT04638660|531664093|FG000|Overall Study|Lost to Follow-up|1|||
147409401|NCT04638660|531664094|FG001|Overall Study|Lost to Follow-up|0|||
147409402|NCT04481373|531664099|FG000|Overall Study|Protocol Violation|1|||
147409403|NCT04481373|531664100|FG001|Overall Study|Protocol Violation|0|||
147409404|NCT04481373|531664099|FG000|Overall Study|Viral load in hospital not over 1000|2|||
147409405|NCT04481373|531664100|FG001|Overall Study|Viral load in hospital not over 1000|1|||
147409406|NCT04481373|531664099|FG000|Overall Study|Death before hospital discharge|1|||
147409407|NCT04481373|531664100|FG001|Overall Study|Death before hospital discharge|0|||
147409408|NCT04076943|531664101|FG000|Overall Study|Withdrawal by Subject|12|||
147409409|NCT04076943|531664101|FG000|Overall Study|Adverse Event|1|||
147409410|NCT04076943|531664101|FG000|Overall Study|Progressive Disease|2|||
147409411|NCT04076943|531664101|FG000|Overall Study|Death|13|||
147409412|NCT04076943|531664101|FG000|Overall Study|Other than specified|6|||
147409413|NCT02224703|531664103|FG000|Overall Study|Adverse Event|0|||
147409414|NCT02224703|531664104|FG001|Overall Study|Adverse Event|5|||
147409415|NCT02224703|531664105|FG002|Overall Study|Adverse Event|0|||
147409416|NCT02224703|531664103|FG000|Overall Study|Withdrawn by investigator|1|||
147409417|NCT02224703|531664104|FG001|Overall Study|Withdrawn by investigator|0|||
147409418|NCT02224703|531664105|FG002|Overall Study|Withdrawn by investigator|0|||
147409419|NCT02224703|531664103|FG000|Overall Study|Advised by medical monitor|1|||
147409420|NCT02224703|531664104|FG001|Overall Study|Advised by medical monitor|0|||
147409421|NCT02224703|531664105|FG002|Overall Study|Advised by medical monitor|0|||
147409422|NCT02224703|531664103|FG000|Overall Study|Withdrawn by parent/guardian|0|||
147409423|NCT02224703|531664104|FG001|Overall Study|Withdrawn by parent/guardian|1|||
147409424|NCT02224703|531664105|FG002|Overall Study|Withdrawn by parent/guardian|0|||
147409425|NCT02224703|531664103|FG000|Overall Study|Lack of Efficacy|1|||
147409426|NCT02224703|531664104|FG001|Overall Study|Lack of Efficacy|0|||
147409427|NCT02224703|531664105|FG002|Overall Study|Lack of Efficacy|0|||
147409428|NCT01886287|531664120|FG000|Overall Study|Radiographic disease progression|1|||
147409429|NCT01886287|531664120|FG000|Overall Study|Clinical progression due to disease|1|||
147409430|NCT03596762|531664121|FG000|Overall Study|Protocol Violation|0|||
147409431|NCT03596762|531664122|FG001|Overall Study|Protocol Violation|0|||
147409432|NCT03596762|531664123|FG002|Overall Study|Protocol Violation|0|||
147409433|NCT03596762|531664124|FG003|Overall Study|Protocol Violation|0|||
147409434|NCT03596762|531664125|FG004|Overall Study|Protocol Violation|1|||
147409435|NCT03596762|531664121|FG000|Overall Study|Adverse Event|2|||
147409436|NCT03596762|531664122|FG001|Overall Study|Adverse Event|0|||
147409437|NCT03596762|531664123|FG002|Overall Study|Adverse Event|1|||
147409438|NCT03596762|531664124|FG003|Overall Study|Adverse Event|0|||
147465271|NCT01032629|531862452|FG002|Overall Study|Withdrawal by Subject|35|||
147465272|NCT01032629|531862450|FG000|Overall Study|Lost to Follow-up|74|||
147465273|NCT01032629|531862451|FG001|Overall Study|Lost to Follow-up|47|||
147465274|NCT01032629|531862452|FG002|Overall Study|Lost to Follow-up|37|||
147465275|NCT02868892|531862453|FG000|Overall Study|Investigator left site and no follow-up|6|||
147465276|NCT00619957|531862454|FG000|Month 24 Double-Blind|Adverse Event|9|||
147465277|NCT00619957|531862455|FG001|Month 24 Double-Blind|Adverse Event|7|||
147465278|NCT00619957|531862454|FG000|Month 24 Double-Blind|Protocol Violation|1|||
147465279|NCT00619957|531862455|FG001|Month 24 Double-Blind|Protocol Violation|0|||
147465280|NCT00619957|531862454|FG000|Month 24 Double-Blind|Withdrawal by Subject|7|||
147465281|NCT00619957|531862455|FG001|Month 24 Double-Blind|Withdrawal by Subject|9|||
147465282|NCT00619957|531862454|FG000|Month 24 Double-Blind|Lost to Follow-up|1|||
147465283|NCT00619957|531862455|FG001|Month 24 Double-Blind|Lost to Follow-up|0|||
147617150|NCT00758524|532413746|FG014|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
147617151|NCT00758524|532413747|FG015|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
147617152|NCT00758524|532413748|FG016|Core Period (Week 0 to Week 8)|Lost to Follow-up|0|||
147617153|NCT00758524|532413732|FG000|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
147617154|NCT00758524|532413733|FG001|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
147617155|NCT00758524|532413734|FG002|Core Period (Week 0 to Week 8)|Administrative Problems|1|||
147465284|NCT00619957|531862454|FG000|Month 24 Double-Blind|Did not take any study medication|0|||
147465285|NCT00619957|531862455|FG001|Month 24 Double-Blind|Did not take any study medication|1|||
147465286|NCT00619957|531862454|FG000|Month 48 Open-Label|Adverse Event|4|||
147465287|NCT00619957|531862455|FG001|Month 48 Open-Label|Adverse Event|4|||
147465288|NCT00619957|531862454|FG000|Month 48 Open-Label|Lost to Follow-up|2|||
147465289|NCT00619957|531862455|FG001|Month 48 Open-Label|Lost to Follow-up|4|||
147465290|NCT00619957|531862454|FG000|Month 48 Open-Label|Withdrawal by Subject|6|||
147465291|NCT00619957|531862455|FG001|Month 48 Open-Label|Withdrawal by Subject|9|||
147465292|NCT00723957|531862456|FG000|Overall Study|Adverse event unrelated to study drug|1|||
147465293|NCT00723957|531862457|FG001|Overall Study|Adverse event unrelated to study drug|4|||
147465294|NCT00723957|531862456|FG000|Overall Study|Death|3|||
147465295|NCT00723957|531862457|FG001|Overall Study|Death|4|||
147465296|NCT00723957|531862456|FG000|Overall Study|Disease progression|27|||
147465297|NCT00723957|531862457|FG001|Overall Study|Disease progression|25|||
147465298|NCT00723957|531862456|FG000|Overall Study|Maximum clinical benefit|4|||
147465299|NCT00723957|531862457|FG001|Overall Study|Maximum clinical benefit|5|||
147465300|NCT00723957|531862456|FG000|Overall Study|Investigator decision|1|||
147465301|NCT00723957|531862457|FG001|Overall Study|Investigator decision|1|||
147465302|NCT00723957|531862456|FG000|Overall Study|Study drug toxicity|4|||
147465303|NCT00723957|531862457|FG001|Overall Study|Study drug toxicity|6|||
147465304|NCT00723957|531862456|FG000|Overall Study|Withdrawal by Subject|7|||
147465305|NCT00723957|531862457|FG001|Overall Study|Withdrawal by Subject|5|||
147465306|NCT00723957|531862456|FG000|Overall Study|Reason not analyzed|1|||
147465307|NCT00723957|531862457|FG001|Overall Study|Reason not analyzed|0|||
147465308|NCT00723957|531862456|FG000|Overall Study|Never received treatment|3|||
147465309|NCT00723957|531862457|FG001|Overall Study|Never received treatment|3|||
147465310|NCT00868790|531862458|FG000|Period 1|Adverse Event|1|||
147465311|NCT00868790|531862459|FG001|Period 1|Adverse Event|0|||
147465312|NCT00868790|531862460|FG002|Period 1|Adverse Event|0|||
147465313|NCT00868790|531862461|FG003|Period 1|Adverse Event|0|||
147465314|NCT00868790|531862462|FG004|Period 1|Adverse Event|0|||
147465315|NCT00868790|531862463|FG005|Period 1|Adverse Event|0|||
147465316|NCT00868790|531862464|FG006|Period 1|Adverse Event|0|||
147465317|NCT00868790|531862465|FG007|Period 1|Adverse Event|3|||
147465318|NCT00868790|531862466|FG008|Period 1|Adverse Event|1|||
147465319|NCT00868790|531862467|FG009|Period 1|Adverse Event|0|||
147465320|NCT00868790|531862468|FG010|Period 1|Adverse Event|0|||
147465321|NCT00868790|531862469|FG011|Period 1|Adverse Event|0|||
147465322|NCT00868790|531862470|FG012|Period 1|Adverse Event|0|||
147465323|NCT00868790|531862471|FG013|Period 1|Adverse Event|1|||
147665530|NCT01103323|532599608|FG001|Without/Before Drug Switch|Withdrawal by Subject|5|||
147465324|NCT00868790|531862458|FG000|Period 1|Protocol Violation|1|||
147465325|NCT00868790|531862459|FG001|Period 1|Protocol Violation|0|||
147465326|NCT00868790|531862460|FG002|Period 1|Protocol Violation|0|||
147465327|NCT00868790|531862461|FG003|Period 1|Protocol Violation|0|||
147465328|NCT00868790|531862462|FG004|Period 1|Protocol Violation|0|||
147465329|NCT00868790|531862463|FG005|Period 1|Protocol Violation|0|||
147465330|NCT00868790|531862464|FG006|Period 1|Protocol Violation|0|||
147465331|NCT00868790|531862465|FG007|Period 1|Protocol Violation|0|||
147465332|NCT00868790|531862466|FG008|Period 1|Protocol Violation|0|||
147617156|NCT00758524|532413735|FG003|Core Period (Week 0 to Week 8)|Administrative Problems|1|||
147665531|NCT01103323|532599607|FG000|Without/Before Drug Switch|Protocol Violation|2|||
147465333|NCT00868790|531862467|FG009|Period 1|Protocol Violation|0|||
147465334|NCT00868790|531862468|FG010|Period 1|Protocol Violation|0|||
147465335|NCT00868790|531862469|FG011|Period 1|Protocol Violation|0|||
147465336|NCT00868790|531862470|FG012|Period 1|Protocol Violation|0|||
147465337|NCT00868790|531862471|FG013|Period 1|Protocol Violation|0|||
147465338|NCT00868790|531862458|FG000|Period 1|Withdrawal by Subject|0|||
147465339|NCT00868790|531862459|FG001|Period 1|Withdrawal by Subject|1|||
147465340|NCT00868790|531862460|FG002|Period 1|Withdrawal by Subject|0|||
147465341|NCT00868790|531862461|FG003|Period 1|Withdrawal by Subject|0|||
147465342|NCT00868790|531862462|FG004|Period 1|Withdrawal by Subject|0|||
147465343|NCT00868790|531862463|FG005|Period 1|Withdrawal by Subject|0|||
147465344|NCT00868790|531862464|FG006|Period 1|Withdrawal by Subject|0|||
147465345|NCT00868790|531862465|FG007|Period 1|Withdrawal by Subject|0|||
147465346|NCT00868790|531862466|FG008|Period 1|Withdrawal by Subject|0|||
147465347|NCT00868790|531862467|FG009|Period 1|Withdrawal by Subject|0|||
147465348|NCT00868790|531862468|FG010|Period 1|Withdrawal by Subject|0|||
147465349|NCT00868790|531862469|FG011|Period 1|Withdrawal by Subject|0|||
147465350|NCT00868790|531862470|FG012|Period 1|Withdrawal by Subject|0|||
147465351|NCT00868790|531862471|FG013|Period 1|Withdrawal by Subject|1|||
147465352|NCT00868790|531862458|FG000|Period 1|Abnormal Triglycerides|0|||
147617157|NCT00758524|532413736|FG004|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
147617158|NCT00758524|532413737|FG005|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
147617159|NCT00758524|532413738|FG006|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
147617160|NCT00758524|532413739|FG007|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
147617161|NCT00758524|532413740|FG008|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
147617162|NCT00758524|532413741|FG009|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
147617163|NCT00758524|532413742|FG010|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
147465353|NCT00868790|531862459|FG001|Period 1|Abnormal Triglycerides|0|||
147465354|NCT00868790|531862460|FG002|Period 1|Abnormal Triglycerides|0|||
147465355|NCT00868790|531862461|FG003|Period 1|Abnormal Triglycerides|0|||
147465356|NCT00868790|531862462|FG004|Period 1|Abnormal Triglycerides|1|||
147465357|NCT00868790|531862463|FG005|Period 1|Abnormal Triglycerides|0|||
147465358|NCT00868790|531862464|FG006|Period 1|Abnormal Triglycerides|0|||
147465359|NCT00868790|531862465|FG007|Period 1|Abnormal Triglycerides|0|||
147465360|NCT00868790|531862466|FG008|Period 1|Abnormal Triglycerides|0|||
147465361|NCT00868790|531862467|FG009|Period 1|Abnormal Triglycerides|0|||
147465362|NCT00868790|531862468|FG010|Period 1|Abnormal Triglycerides|0|||
147465363|NCT00868790|531862469|FG011|Period 1|Abnormal Triglycerides|0|||
147465364|NCT00868790|531862470|FG012|Period 1|Abnormal Triglycerides|0|||
147465365|NCT00868790|531862471|FG013|Period 1|Abnormal Triglycerides|0|||
147465366|NCT00868790|531862458|FG000|Period 1|Lost to Follow-up|0|||
147465367|NCT00868790|531862459|FG001|Period 1|Lost to Follow-up|0|||
147465368|NCT00868790|531862460|FG002|Period 1|Lost to Follow-up|0|||
147465369|NCT00868790|531862461|FG003|Period 1|Lost to Follow-up|0|||
147465370|NCT00868790|531862462|FG004|Period 1|Lost to Follow-up|0|||
147465371|NCT00868790|531862463|FG005|Period 1|Lost to Follow-up|1|||
147465372|NCT00868790|531862464|FG006|Period 1|Lost to Follow-up|0|||
147465373|NCT00868790|531862465|FG007|Period 1|Lost to Follow-up|0|||
147465374|NCT00868790|531862466|FG008|Period 1|Lost to Follow-up|0|||
147465375|NCT00868790|531862467|FG009|Period 1|Lost to Follow-up|0|||
147465376|NCT00868790|531862468|FG010|Period 1|Lost to Follow-up|0|||
147465377|NCT00868790|531862469|FG011|Period 1|Lost to Follow-up|0|||
147465378|NCT00868790|531862470|FG012|Period 1|Lost to Follow-up|0|||
147465379|NCT00868790|531862471|FG013|Period 1|Lost to Follow-up|0|||
147465380|NCT00868790|531862458|FG000|Period 2|Adverse Event|0|||
147465381|NCT00868790|531862459|FG001|Period 2|Adverse Event|0|||
147465382|NCT00868790|531862460|FG002|Period 2|Adverse Event|0|||
147465383|NCT00868790|531862461|FG003|Period 2|Adverse Event|0|||
147465384|NCT00868790|531862462|FG004|Period 2|Adverse Event|0|||
147465385|NCT00868790|531862463|FG005|Period 2|Adverse Event|0|||
147465386|NCT00868790|531862464|FG006|Period 2|Adverse Event|0|||
147465387|NCT00868790|531862465|FG007|Period 2|Adverse Event|0|||
147465388|NCT00868790|531862466|FG008|Period 2|Adverse Event|1|||
147465389|NCT00868790|531862467|FG009|Period 2|Adverse Event|0|||
147465390|NCT00868790|531862468|FG010|Period 2|Adverse Event|0|||
147465391|NCT00868790|531862469|FG011|Period 2|Adverse Event|0|||
147465392|NCT00868790|531862470|FG012|Period 2|Adverse Event|0|||
147465393|NCT00868790|531862471|FG013|Period 2|Adverse Event|0|||
147465394|NCT00868790|531862458|FG000|Period 2|Lost to Follow-up|0|||
147617164|NCT00758524|532413743|FG011|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
147617165|NCT00758524|532413744|FG012|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
147617166|NCT00758524|532413745|FG013|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
147617167|NCT00758524|532413746|FG014|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
147465395|NCT00868790|531862459|FG001|Period 2|Lost to Follow-up|1|||
147465396|NCT00868790|531862460|FG002|Period 2|Lost to Follow-up|0|||
147465397|NCT00868790|531862461|FG003|Period 2|Lost to Follow-up|0|||
147465398|NCT00868790|531862462|FG004|Period 2|Lost to Follow-up|0|||
147465399|NCT00868790|531862463|FG005|Period 2|Lost to Follow-up|1|||
147465400|NCT00868790|531862464|FG006|Period 2|Lost to Follow-up|0|||
147465401|NCT00868790|531862465|FG007|Period 2|Lost to Follow-up|0|||
147465402|NCT00868790|531862466|FG008|Period 2|Lost to Follow-up|0|||
147465403|NCT00868790|531862467|FG009|Period 2|Lost to Follow-up|0|||
147465404|NCT00868790|531862468|FG010|Period 2|Lost to Follow-up|0|||
147465405|NCT00868790|531862469|FG011|Period 2|Lost to Follow-up|0|||
147465406|NCT00868790|531862470|FG012|Period 2|Lost to Follow-up|0|||
147465407|NCT00868790|531862471|FG013|Period 2|Lost to Follow-up|0|||
147409439|NCT03596762|531664125|FG004|Overall Study|Adverse Event|5|||
147409440|NCT03596762|531664121|FG000|Overall Study|Withdrawal by Subject|2|||
147409441|NCT03596762|531664122|FG001|Overall Study|Withdrawal by Subject|1|||
147409442|NCT03596762|531664123|FG002|Overall Study|Withdrawal by Subject|0|||
147409443|NCT03596762|531664124|FG003|Overall Study|Withdrawal by Subject|1|||
147409444|NCT03596762|531664125|FG004|Overall Study|Withdrawal by Subject|1|||
147409445|NCT02195479|531664126|FG000|Overall Study|Lost to Follow-up|18|||
147409446|NCT02195479|531664127|FG001|Overall Study|Lost to Follow-up|15|||
147409447|NCT02195479|531664126|FG000|Overall Study|Death|217|||
147409448|NCT02195479|531664127|FG001|Overall Study|Death|171|||
147409449|NCT02195479|531664126|FG000|Overall Study|Physician Decision|1|||
147409450|NCT02195479|531664127|FG001|Overall Study|Physician Decision|0|||
147409451|NCT02195479|531664126|FG000|Overall Study|Withdrawal by Subject|30|||
147409452|NCT02195479|531664127|FG001|Overall Study|Withdrawal by Subject|30|||
147409453|NCT02195479|531664126|FG000|Overall Study|Other|3|||
147409454|NCT02195479|531664127|FG001|Overall Study|Other|4|||
147409455|NCT02195479|531664126|FG000|Overall Study|Discontinued at clinical cutoff (due to end of data collection period)|87|||
147409456|NCT02195479|531664127|FG001|Overall Study|Discontinued at clinical cutoff (due to end of data collection period)|130|||
147409457|NCT00504777|531664128|FG000|Overall Study|Adverse Event|1|||
147409458|NCT01195623|531664132|FG000|Overall Study|Lost to Follow-up|35|||
147409459|NCT01195623|531664133|FG001|Overall Study|Lost to Follow-up|37|||
147409460|NCT01572740|531664135|FG000|Overall Study|Adverse Event|1|||
147409461|NCT01572740|531664136|FG001|Overall Study|Adverse Event|1|||
147409462|NCT01572740|531664135|FG000|Overall Study|Withdrawal by Subject|1|||
147409463|NCT01572740|531664136|FG001|Overall Study|Withdrawal by Subject|1|||
147409464|NCT01572740|531664135|FG000|Overall Study|unclassified|4|||
147409465|NCT01572740|531664136|FG001|Overall Study|unclassified|3|||
147409466|NCT00214019|531664140|FG000|Overall Study|Lost to Follow-up|11|||
147409467|NCT00214019|531664140|FG000|Overall Study|Withdrawal by Subject|2|||
147409468|NCT00214019|531664140|FG000|Overall Study|Screen Failed prior to randomization|17|||
147409469|NCT00477490|531664141|FG000|Part I: 4 Week Efficacy|Adverse Event|1|||
147409470|NCT00477490|531664142|FG001|Part I: 4 Week Efficacy|Adverse Event|4|||
147409471|NCT00477490|531664143|FG002|Part I: 4 Week Efficacy|Adverse Event|0|||
147409472|NCT00477490|531664144|FG003|Part I: 4 Week Efficacy|Adverse Event|5|||
147409473|NCT00477490|531664145|FG004|Part I: 4 Week Efficacy|Adverse Event|6|||
147409474|NCT00477490|531664146|FG005|Part I: 4 Week Efficacy|Adverse Event|0|||
147409475|NCT00477490|531664147|FG006|Part I: 4 Week Efficacy|Adverse Event|0|||
147409476|NCT00477490|531664148|FG007|Part I: 4 Week Efficacy|Adverse Event|0|||
147409477|NCT00477490|531664149|FG008|Part I: 4 Week Efficacy|Adverse Event|0|||
147409478|NCT00477490|531664141|FG000|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|1|||
147409479|NCT00477490|531664142|FG001|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
147409480|NCT00477490|531664143|FG002|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
147409481|NCT00477490|531664144|FG003|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|5|||
147409482|NCT00477490|531664145|FG004|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|4|||
147409483|NCT00477490|531664146|FG005|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
147409484|NCT00477490|531664147|FG006|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
147409485|NCT00477490|531664148|FG007|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
147409486|NCT00477490|531664149|FG008|Part I: 4 Week Efficacy|Serum Sodium <= 125mmol/L|0|||
147409487|NCT00477490|531664141|FG000|Part I: 4 Week Efficacy|Protocol Violation|2|||
147409488|NCT00477490|531664142|FG001|Part I: 4 Week Efficacy|Protocol Violation|0|||
147409489|NCT00477490|531664143|FG002|Part I: 4 Week Efficacy|Protocol Violation|0|||
147409490|NCT00477490|531664144|FG003|Part I: 4 Week Efficacy|Protocol Violation|0|||
147409491|NCT00477490|531664145|FG004|Part I: 4 Week Efficacy|Protocol Violation|1|||
147409492|NCT00477490|531664146|FG005|Part I: 4 Week Efficacy|Protocol Violation|0|||
147409493|NCT00477490|531664147|FG006|Part I: 4 Week Efficacy|Protocol Violation|0|||
147409494|NCT00477490|531664148|FG007|Part I: 4 Week Efficacy|Protocol Violation|0|||
147409495|NCT00477490|531664149|FG008|Part I: 4 Week Efficacy|Protocol Violation|0|||
147409496|NCT00477490|531664141|FG000|Part I: 4 Week Efficacy|Withdrawal by Subject|6|||
147409497|NCT00477490|531664142|FG001|Part I: 4 Week Efficacy|Withdrawal by Subject|5|||
147409498|NCT00477490|531664143|FG002|Part I: 4 Week Efficacy|Withdrawal by Subject|6|||
147409499|NCT00477490|531664144|FG003|Part I: 4 Week Efficacy|Withdrawal by Subject|4|||
147409500|NCT00477490|531664145|FG004|Part I: 4 Week Efficacy|Withdrawal by Subject|9|||
147409501|NCT00477490|531664146|FG005|Part I: 4 Week Efficacy|Withdrawal by Subject|0|||
147409502|NCT00477490|531664147|FG006|Part I: 4 Week Efficacy|Withdrawal by Subject|0|||
147409503|NCT00477490|531664148|FG007|Part I: 4 Week Efficacy|Withdrawal by Subject|0|||
147409504|NCT00477490|531664149|FG008|Part I: 4 Week Efficacy|Withdrawal by Subject|0|||
147409505|NCT00477490|531664141|FG000|Part I: 4 Week Efficacy|Lost to Follow-up|2|||
147409506|NCT00477490|531664142|FG001|Part I: 4 Week Efficacy|Lost to Follow-up|4|||
147409507|NCT00477490|531664143|FG002|Part I: 4 Week Efficacy|Lost to Follow-up|1|||
147409508|NCT00477490|531664144|FG003|Part I: 4 Week Efficacy|Lost to Follow-up|5|||
147409509|NCT00477490|531664145|FG004|Part I: 4 Week Efficacy|Lost to Follow-up|3|||
147465408|NCT00868790|531862458|FG000|Period 2|Withdrawal by Subject|0|||
147465409|NCT00868790|531862459|FG001|Period 2|Withdrawal by Subject|0|||
147465410|NCT00868790|531862460|FG002|Period 2|Withdrawal by Subject|0|||
147465411|NCT00868790|531862461|FG003|Period 2|Withdrawal by Subject|0|||
147465412|NCT00868790|531862462|FG004|Period 2|Withdrawal by Subject|0|||
147465413|NCT00868790|531862463|FG005|Period 2|Withdrawal by Subject|0|||
147465414|NCT00868790|531862464|FG006|Period 2|Withdrawal by Subject|0|||
147465415|NCT00868790|531862465|FG007|Period 2|Withdrawal by Subject|0|||
147465416|NCT00868790|531862466|FG008|Period 2|Withdrawal by Subject|1|||
147465417|NCT00868790|531862467|FG009|Period 2|Withdrawal by Subject|0|||
147465418|NCT00868790|531862468|FG010|Period 2|Withdrawal by Subject|0|||
147465419|NCT00868790|531862469|FG011|Period 2|Withdrawal by Subject|0|||
147465420|NCT00868790|531862470|FG012|Period 2|Withdrawal by Subject|0|||
147465421|NCT00868790|531862471|FG013|Period 2|Withdrawal by Subject|1|||
147465422|NCT00868790|531862458|FG000|Period 3|Adverse Event|0|||
147465423|NCT00868790|531862459|FG001|Period 3|Adverse Event|0|||
147465424|NCT00868790|531862460|FG002|Period 3|Adverse Event|0|||
147465425|NCT00868790|531862461|FG003|Period 3|Adverse Event|0|||
147465426|NCT00868790|531862462|FG004|Period 3|Adverse Event|0|||
147465427|NCT00868790|531862463|FG005|Period 3|Adverse Event|0|||
147465428|NCT00868790|531862464|FG006|Period 3|Adverse Event|0|||
147465429|NCT00868790|531862465|FG007|Period 3|Adverse Event|0|||
147465430|NCT00868790|531862466|FG008|Period 3|Adverse Event|0|||
147465431|NCT00868790|531862467|FG009|Period 3|Adverse Event|1|||
147465432|NCT00868790|531862468|FG010|Period 3|Adverse Event|0|||
147465433|NCT00868790|531862469|FG011|Period 3|Adverse Event|0|||
147465434|NCT00868790|531862470|FG012|Period 3|Adverse Event|0|||
147465435|NCT00868790|531862471|FG013|Period 3|Adverse Event|0|||
147465436|NCT00868790|531862458|FG000|Period 3|Protocol Violation|0|||
147465437|NCT00868790|531862459|FG001|Period 3|Protocol Violation|0|||
147465438|NCT00868790|531862460|FG002|Period 3|Protocol Violation|0|||
147465439|NCT00868790|531862461|FG003|Period 3|Protocol Violation|0|||
147465440|NCT00868790|531862462|FG004|Period 3|Protocol Violation|0|||
147465441|NCT00868790|531862463|FG005|Period 3|Protocol Violation|0|||
147465442|NCT00868790|531862464|FG006|Period 3|Protocol Violation|0|||
147465443|NCT00868790|531862465|FG007|Period 3|Protocol Violation|0|||
147465444|NCT00868790|531862466|FG008|Period 3|Protocol Violation|0|||
147465445|NCT00868790|531862467|FG009|Period 3|Protocol Violation|0|||
147465446|NCT00868790|531862468|FG010|Period 3|Protocol Violation|1|||
147465447|NCT00868790|531862469|FG011|Period 3|Protocol Violation|0|||
147465448|NCT00868790|531862470|FG012|Period 3|Protocol Violation|0|||
147465449|NCT00868790|531862471|FG013|Period 3|Protocol Violation|0|||
147465450|NCT00868790|531862458|FG000|Period 3|Study Terminated by Sponsor|0|||
147465451|NCT00868790|531862459|FG001|Period 3|Study Terminated by Sponsor|0|||
147465452|NCT00868790|531862460|FG002|Period 3|Study Terminated by Sponsor|0|||
147465453|NCT00868790|531862461|FG003|Period 3|Study Terminated by Sponsor|1|||
147465454|NCT00868790|531862462|FG004|Period 3|Study Terminated by Sponsor|0|||
147465455|NCT00868790|531862463|FG005|Period 3|Study Terminated by Sponsor|0|||
147465456|NCT00868790|531862464|FG006|Period 3|Study Terminated by Sponsor|0|||
147465457|NCT00868790|531862465|FG007|Period 3|Study Terminated by Sponsor|0|||
147465458|NCT00868790|531862466|FG008|Period 3|Study Terminated by Sponsor|0|||
147465459|NCT00868790|531862467|FG009|Period 3|Study Terminated by Sponsor|0|||
147465460|NCT00868790|531862468|FG010|Period 3|Study Terminated by Sponsor|0|||
147465461|NCT00868790|531862469|FG011|Period 3|Study Terminated by Sponsor|0|||
147465462|NCT00868790|531862470|FG012|Period 3|Study Terminated by Sponsor|0|||
147465463|NCT00868790|531862471|FG013|Period 3|Study Terminated by Sponsor|0|||
147465464|NCT00868790|531862458|FG000|Period 4|Adverse Event|0|||
147465465|NCT00868790|531862459|FG001|Period 4|Adverse Event|0|||
147465466|NCT00868790|531862460|FG002|Period 4|Adverse Event|0|||
147465467|NCT00868790|531862461|FG003|Period 4|Adverse Event|0|||
147465468|NCT00868790|531862462|FG004|Period 4|Adverse Event|0|||
147465469|NCT00868790|531862463|FG005|Period 4|Adverse Event|0|||
147665532|NCT01103323|532599608|FG001|Without/Before Drug Switch|Protocol Violation|0|||
147465470|NCT00868790|531862464|FG006|Period 4|Adverse Event|0|||
147465471|NCT00868790|531862465|FG007|Period 4|Adverse Event|1|||
147465472|NCT00868790|531862466|FG008|Period 4|Adverse Event|0|||
147465473|NCT00868790|531862467|FG009|Period 4|Adverse Event|0|||
147465474|NCT00868790|531862468|FG010|Period 4|Adverse Event|1|||
147465475|NCT00868790|531862469|FG011|Period 4|Adverse Event|0|||
147465476|NCT00868790|531862470|FG012|Period 4|Adverse Event|1|||
147465477|NCT00868790|531862471|FG013|Period 4|Adverse Event|0|||
147465478|NCT00868790|531862458|FG000|Period 4|Lost to Follow-up|0|||
147465479|NCT00868790|531862459|FG001|Period 4|Lost to Follow-up|0|||
147465480|NCT00868790|531862460|FG002|Period 4|Lost to Follow-up|0|||
147465481|NCT00868790|531862461|FG003|Period 4|Lost to Follow-up|0|||
147465482|NCT00868790|531862462|FG004|Period 4|Lost to Follow-up|0|||
147465483|NCT00868790|531862463|FG005|Period 4|Lost to Follow-up|0|||
147465484|NCT00868790|531862464|FG006|Period 4|Lost to Follow-up|0|||
147465485|NCT00868790|531862465|FG007|Period 4|Lost to Follow-up|1|||
147465486|NCT00868790|531862466|FG008|Period 4|Lost to Follow-up|0|||
147465487|NCT00868790|531862467|FG009|Period 4|Lost to Follow-up|0|||
147465488|NCT00868790|531862468|FG010|Period 4|Lost to Follow-up|0|||
147465489|NCT00868790|531862469|FG011|Period 4|Lost to Follow-up|0|||
147465490|NCT00868790|531862470|FG012|Period 4|Lost to Follow-up|0|||
147465491|NCT00868790|531862471|FG013|Period 4|Lost to Follow-up|0|||
147465492|NCT00868790|531862458|FG000|Period 4|Study Terminated by Sponsor|2|||
147465493|NCT00868790|531862459|FG001|Period 4|Study Terminated by Sponsor|0|||
147465494|NCT00868790|531862460|FG002|Period 4|Study Terminated by Sponsor|0|||
147465495|NCT00868790|531862461|FG003|Period 4|Study Terminated by Sponsor|0|||
147465496|NCT00868790|531862462|FG004|Period 4|Study Terminated by Sponsor|0|||
147465497|NCT00868790|531862463|FG005|Period 4|Study Terminated by Sponsor|0|||
147465498|NCT00868790|531862464|FG006|Period 4|Study Terminated by Sponsor|0|||
147465499|NCT00868790|531862465|FG007|Period 4|Study Terminated by Sponsor|1|||
147465500|NCT00868790|531862466|FG008|Period 4|Study Terminated by Sponsor|2|||
147465501|NCT00868790|531862467|FG009|Period 4|Study Terminated by Sponsor|0|||
147465502|NCT00868790|531862468|FG010|Period 4|Study Terminated by Sponsor|2|||
147465503|NCT00868790|531862469|FG011|Period 4|Study Terminated by Sponsor|1|||
147465504|NCT00868790|531862470|FG012|Period 4|Study Terminated by Sponsor|0|||
147465505|NCT00868790|531862471|FG013|Period 4|Study Terminated by Sponsor|1|||
147465506|NCT00868790|531862458|FG000|Period 4|Abnormal ALT/AST|0|||
147465507|NCT00868790|531862459|FG001|Period 4|Abnormal ALT/AST|0|||
147465508|NCT00868790|531862460|FG002|Period 4|Abnormal ALT/AST|1|||
147465509|NCT00868790|531862461|FG003|Period 4|Abnormal ALT/AST|0|||
147465510|NCT00868790|531862462|FG004|Period 4|Abnormal ALT/AST|0|||
147465511|NCT00868790|531862463|FG005|Period 4|Abnormal ALT/AST|0|||
147465512|NCT00868790|531862464|FG006|Period 4|Abnormal ALT/AST|0|||
147465513|NCT00868790|531862465|FG007|Period 4|Abnormal ALT/AST|0|||
147465514|NCT00868790|531862466|FG008|Period 4|Abnormal ALT/AST|0|||
147465515|NCT00868790|531862467|FG009|Period 4|Abnormal ALT/AST|0|||
147465516|NCT00868790|531862468|FG010|Period 4|Abnormal ALT/AST|0|||
147465517|NCT00868790|531862469|FG011|Period 4|Abnormal ALT/AST|0|||
147465518|NCT00868790|531862470|FG012|Period 4|Abnormal ALT/AST|0|||
147465519|NCT00868790|531862471|FG013|Period 4|Abnormal ALT/AST|0|||
147465520|NCT00868790|531862458|FG000|Post-study|Withdrawal by Subject|0|||
147465521|NCT00868790|531862459|FG001|Post-study|Withdrawal by Subject|0|||
147465522|NCT00868790|531862460|FG002|Post-study|Withdrawal by Subject|0|||
147465523|NCT00868790|531862461|FG003|Post-study|Withdrawal by Subject|0|||
147465524|NCT00868790|531862462|FG004|Post-study|Withdrawal by Subject|1|||
147465525|NCT00868790|531862463|FG005|Post-study|Withdrawal by Subject|0|||
147465526|NCT00868790|531862464|FG006|Post-study|Withdrawal by Subject|0|||
147465527|NCT00868790|531862465|FG007|Post-study|Withdrawal by Subject|0|||
147465528|NCT00868790|531862466|FG008|Post-study|Withdrawal by Subject|0|||
147465529|NCT00868790|531862467|FG009|Post-study|Withdrawal by Subject|0|||
147465530|NCT00868790|531862468|FG010|Post-study|Withdrawal by Subject|0|||
147465531|NCT00868790|531862469|FG011|Post-study|Withdrawal by Subject|0|||
147465532|NCT00868790|531862470|FG012|Post-study|Withdrawal by Subject|0|||
147465533|NCT00868790|531862471|FG013|Post-study|Withdrawal by Subject|0|||
147465534|NCT00868790|531862458|FG000|Post-study|Excluded Medication|0|||
147465535|NCT00868790|531862459|FG001|Post-study|Excluded Medication|0|||
147465536|NCT00868790|531862460|FG002|Post-study|Excluded Medication|0|||
147465537|NCT00868790|531862461|FG003|Post-study|Excluded Medication|0|||
147465538|NCT00868790|531862462|FG004|Post-study|Excluded Medication|0|||
147465539|NCT00868790|531862463|FG005|Post-study|Excluded Medication|0|||
147465540|NCT00868790|531862464|FG006|Post-study|Excluded Medication|0|||
147465541|NCT00868790|531862465|FG007|Post-study|Excluded Medication|2|||
147465542|NCT00868790|531862466|FG008|Post-study|Excluded Medication|0|||
147465543|NCT00868790|531862467|FG009|Post-study|Excluded Medication|1|||
147465544|NCT00868790|531862468|FG010|Post-study|Excluded Medication|0|||
147465545|NCT00868790|531862469|FG011|Post-study|Excluded Medication|0|||
147465546|NCT00868790|531862470|FG012|Post-study|Excluded Medication|0|||
147465547|NCT00868790|531862471|FG013|Post-study|Excluded Medication|0|||
147465548|NCT01763164|531862472|FG000|Treatment Phase|Participant/Guardian decision|26|||
147465549|NCT01763164|531862473|FG001|Treatment Phase|Participant/Guardian decision|14|||
147465550|NCT01763164|531862472|FG000|Treatment Phase|Protocol Violation|1|||
147465551|NCT01763164|531862473|FG001|Treatment Phase|Protocol Violation|1|||
147465552|NCT01763164|531862472|FG000|Treatment Phase|Progressive Disease|142|||
147465553|NCT01763164|531862473|FG001|Treatment Phase|Progressive Disease|76|||
147465554|NCT01763164|531862472|FG000|Treatment Phase|Physician Decision|24|||
147465555|NCT01763164|531862473|FG001|Treatment Phase|Physician Decision|13|||
147465556|NCT01763164|531862472|FG000|Treatment Phase|Death|10|||
147465557|NCT01763164|531862473|FG001|Treatment Phase|Death|1|||
147465558|NCT01763164|531862472|FG000|Treatment Phase|Adverse Event|66|||
147465559|NCT01763164|531862473|FG001|Treatment Phase|Adverse Event|8|||
147465560|NCT01763164|531862472|FG000|Treatment Phase|Randomized but not Treated|0|||
147465561|NCT01763164|531862473|FG001|Treatment Phase|Randomized but not Treated|19|||
147465562|NCT01763164|531862472|FG000|Treatment Phase|Other|0|||
147465563|NCT01763164|531862473|FG001|Treatment Phase|Other|1|||
147465564|NCT01763164|531862472|FG000|Follow up Phase|New therapy for study indication|12|||
147465565|NCT01763164|531862473|FG001|Follow up Phase|New therapy for study indication|3|||
147465566|NCT01763164|531862472|FG000|Follow up Phase|Death|21|||
147465567|NCT01763164|531862473|FG001|Follow up Phase|Death|4|||
147465568|NCT01763164|531862472|FG000|Follow up Phase|Subject/guardian decision|9|||
147465569|NCT01763164|531862473|FG001|Follow up Phase|Subject/guardian decision|2|||
147465570|NCT01763164|531862472|FG000|Follow up Phase|Progressive disease|127|||
147465571|NCT01763164|531862473|FG001|Follow up Phase|Progressive disease|62|||
147465572|NCT01763164|531862472|FG000|Follow up Phase|Physician Decision|10|||
147465573|NCT01763164|531862473|FG001|Follow up Phase|Physician Decision|3|||
147465574|NCT01763164|531862472|FG000|Follow up Phase|Lost to Follow-up|1|||
147465575|NCT01763164|531862473|FG001|Follow up Phase|Lost to Follow-up|0|||
147465576|NCT01763164|531862472|FG000|Follow up Phase|Adverse Event|17|||
147465577|NCT01763164|531862473|FG001|Follow up Phase|Adverse Event|1|||
147465578|NCT03377634|531862474|FG000|Study Period|Adverse Event|1|||
147465579|NCT03377634|531862475|FG001|Study Period|Adverse Event|0|||
147465580|NCT03377634|531862474|FG000|Study Period|Withdrawal by Subject|1|||
147465581|NCT03377634|531862475|FG001|Study Period|Withdrawal by Subject|0|||
147465582|NCT01264939|531862476|FG000|Overall Study|Adverse Event|1|||
147465583|NCT01264939|531862477|FG001|Overall Study|Adverse Event|3|||
147465584|NCT01264939|531862476|FG000|Overall Study|Lost to Follow-up|0|||
147465585|NCT01264939|531862477|FG001|Overall Study|Lost to Follow-up|3|||
147465586|NCT01264939|531862476|FG000|Overall Study|Physician Decision|1|||
147465587|NCT01264939|531862477|FG001|Overall Study|Physician Decision|1|||
147465588|NCT01264939|531862476|FG000|Overall Study|Patient/Guardian Decision|8|||
147465589|NCT01264939|531862477|FG001|Overall Study|Patient/Guardian Decision|10|||
147465590|NCT01264939|531862476|FG000|Overall Study|Disease Progression|8|||
147465591|NCT01264939|531862477|FG001|Overall Study|Disease Progression|11|||
147465592|NCT01384292|531862485|FG000|Part B|Severe non-compliance to protocol|1|||
147465593|NCT01384292|531862486|FG001|Part B|Severe non-compliance to protocol|0|||
147465594|NCT01384292|531862487|FG002|Part B|Severe non-compliance to protocol|0|||
147465595|NCT01171612|531862489|FG000|Overall Study|Lost to Follow-up|51|||
147465596|NCT00737529|531862490|FG000|Overall Study|Disease Progression|95|||
147465597|NCT00737529|531862490|FG000|Overall Study|Adverse Event|24|||
147465598|NCT00737529|531862490|FG000|Overall Study|Withdrawal by Subject|5|||
147465599|NCT00737529|531862490|FG000|Overall Study|Death|4|||
147465600|NCT00737529|531862490|FG000|Overall Study|Protocol Violation|1|||
147465601|NCT00737529|531862490|FG000|Overall Study|Other|4|||
147465602|NCT04666038|531862491|FG000|Overall Study|Progressive Disease|2|||
147465603|NCT04666038|531862492|FG001|Overall Study|Progressive Disease|0|||
147465604|NCT04666038|531862491|FG000|Overall Study|Death|38|||
147465605|NCT04666038|531862492|FG001|Overall Study|Death|32|||
147465606|NCT04666038|531862491|FG000|Overall Study|Withdrawal by Subject|10|||
147465607|NCT04666038|531862492|FG001|Overall Study|Withdrawal by Subject|19|||
147465608|NCT04666038|531862491|FG000|Overall Study|Lost to Follow-up|0|||
147465609|NCT04666038|531862492|FG001|Overall Study|Lost to Follow-up|2|||
147465610|NCT04666038|531862491|FG000|Overall Study|On Study Treatment|46|||
147465611|NCT04666038|531862492|FG001|Overall Study|On Study Treatment|5|||
147465612|NCT04666038|531862491|FG000|Overall Study|Off treatment on post-treatment-discontinuation follow-up|23|||
147465613|NCT04666038|531862492|FG001|Overall Study|Off treatment on post-treatment-discontinuation follow-up|61|||
147465614|NCT04957290|531862494|FG000|Overall Study|Progressive disease|3|||
147465615|NCT04957290|531862495|FG001|Overall Study|Progressive disease|3|||
147465616|NCT04957290|531862496|FG002|Overall Study|Progressive disease|2|||
147465617|NCT04957290|531862497|FG003|Overall Study|Progressive disease|0|||
147465618|NCT04957290|531862498|FG004|Overall Study|Progressive disease|0|||
147465619|NCT04957290|531862499|FG005|Overall Study|Progressive disease|0|||
147465620|NCT04957290|531862494|FG000|Overall Study|Withdrawal by Subject|1|||
147465621|NCT04957290|531862495|FG001|Overall Study|Withdrawal by Subject|0|||
147465622|NCT04957290|531862496|FG002|Overall Study|Withdrawal by Subject|1|||
147465623|NCT04957290|531862497|FG003|Overall Study|Withdrawal by Subject|0|||
147465624|NCT04957290|531862498|FG004|Overall Study|Withdrawal by Subject|0|||
147465625|NCT04957290|531862499|FG005|Overall Study|Withdrawal by Subject|0|||
147465626|NCT04957290|531862494|FG000|Overall Study|Death|0|||
147465627|NCT04957290|531862495|FG001|Overall Study|Death|2|||
147465628|NCT04957290|531862496|FG002|Overall Study|Death|1|||
147465629|NCT04957290|531862497|FG003|Overall Study|Death|0|||
147465630|NCT04957290|531862498|FG004|Overall Study|Death|0|||
147465631|NCT04957290|531862499|FG005|Overall Study|Death|0|||
147465632|NCT04957290|531862494|FG000|Overall Study|non compliance with study drug|0|||
147465633|NCT04957290|531862495|FG001|Overall Study|non compliance with study drug|1|||
147465634|NCT04957290|531862496|FG002|Overall Study|non compliance with study drug|0|||
147465635|NCT04957290|531862497|FG003|Overall Study|non compliance with study drug|0|||
147465636|NCT04957290|531862498|FG004|Overall Study|non compliance with study drug|0|||
147465637|NCT04957290|531862499|FG005|Overall Study|non compliance with study drug|0|||
147465638|NCT04957290|531862494|FG000|Overall Study|none specified.|0|||
147617168|NCT00758524|532413747|FG015|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
147465639|NCT04957290|531862495|FG001|Overall Study|none specified.|1|||
147465640|NCT04957290|531862496|FG002|Overall Study|none specified.|2|||
147465641|NCT04957290|531862497|FG003|Overall Study|none specified.|0|||
147465642|NCT04957290|531862498|FG004|Overall Study|none specified.|0|||
147617169|NCT00758524|532413748|FG016|Core Period (Week 0 to Week 8)|Administrative Problems|0|||
147617170|NCT00758524|532413732|FG000|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
147465643|NCT04957290|531862499|FG005|Overall Study|none specified.|0|||
147465644|NCT04957290|531862494|FG000|Overall Study|unacceptable toxicity|0|||
147465645|NCT04957290|531862495|FG001|Overall Study|unacceptable toxicity|0|||
147465646|NCT04957290|531862496|FG002|Overall Study|unacceptable toxicity|1|||
147465647|NCT04957290|531862497|FG003|Overall Study|unacceptable toxicity|0|||
147465648|NCT04957290|531862498|FG004|Overall Study|unacceptable toxicity|0|||
147465649|NCT04957290|531862499|FG005|Overall Study|unacceptable toxicity|0|||
147465650|NCT04957290|531862494|FG000|Overall Study|Adverse Event|0|||
147465651|NCT04957290|531862495|FG001|Overall Study|Adverse Event|0|||
147465652|NCT04957290|531862496|FG002|Overall Study|Adverse Event|1|||
147465653|NCT04957290|531862497|FG003|Overall Study|Adverse Event|0|||
147465654|NCT04957290|531862498|FG004|Overall Study|Adverse Event|0|||
147465655|NCT04957290|531862499|FG005|Overall Study|Adverse Event|0|||
147465656|NCT04957290|531862494|FG000|Overall Study|study terminated by sponsor|0|||
147465657|NCT04957290|531862495|FG001|Overall Study|study terminated by sponsor|0|||
147465658|NCT04957290|531862496|FG002|Overall Study|study terminated by sponsor|2|||
147465659|NCT04957290|531862497|FG003|Overall Study|study terminated by sponsor|0|||
147465660|NCT04957290|531862498|FG004|Overall Study|study terminated by sponsor|0|||
147465661|NCT04957290|531862499|FG005|Overall Study|study terminated by sponsor|0|||
147465662|NCT00996203|531862500|FG000|Overall Study|Adverse Event|3|||
147465663|NCT00996203|531862500|FG000|Overall Study|Lost to Follow-up|1|||
147465664|NCT00996203|531862500|FG000|Overall Study|Lack of Efficacy|1|||
147465665|NCT00996203|531862500|FG000|Overall Study|Protocol Violation|2|||
147465666|NCT01959165|531862501|FG000|Overall Study|Adverse Event|0|||
147465667|NCT01959165|531862502|FG001|Overall Study|Adverse Event|0|||
147465668|NCT01959165|531862503|FG002|Overall Study|Adverse Event|0|||
147465669|NCT01959165|531862504|FG003|Overall Study|Adverse Event|1|||
147465670|NCT01959165|531862501|FG000|Overall Study|Lack of Efficacy|1|||
147465671|NCT01959165|531862502|FG001|Overall Study|Lack of Efficacy|0|||
147465672|NCT01959165|531862503|FG002|Overall Study|Lack of Efficacy|0|||
147465673|NCT01959165|531862504|FG003|Overall Study|Lack of Efficacy|0|||
147465674|NCT01959165|531862501|FG000|Overall Study|overdose|0|||
147465675|NCT01959165|531862502|FG001|Overall Study|overdose|0|||
147465676|NCT01959165|531862503|FG002|Overall Study|overdose|0|||
147465677|NCT01959165|531862504|FG003|Overall Study|overdose|1|||
147465678|NCT01959165|531862501|FG000|Overall Study|Welfare recipient|0|||
147465679|NCT01959165|531862502|FG001|Overall Study|Welfare recipient|1|||
147465680|NCT01959165|531862503|FG002|Overall Study|Welfare recipient|0|||
147465681|NCT01959165|531862504|FG003|Overall Study|Welfare recipient|0|||
147465682|NCT03094195|531862505|FG000|Double-Blind Treatment Period (DB)|Study terminated by sponsor|12|||
147465683|NCT03094195|531862506|FG001|Double-Blind Treatment Period (DB)|Study terminated by sponsor|10|||
147465684|NCT03094195|531862507|FG002|Double-Blind Treatment Period (DB)|Study terminated by sponsor|11|||
147465685|NCT03094195|531862508|FG003|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
147465686|NCT03094195|531862509|FG004|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
147465687|NCT03094195|531862510|FG005|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
147465688|NCT03094195|531862511|FG006|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
147465689|NCT03094195|531862512|FG007|Double-Blind Treatment Period (DB)|Study terminated by sponsor|0|||
147465690|NCT03094195|531862505|FG000|Double-Blind Treatment Period (DB)|Adverse Event|3|||
147465691|NCT03094195|531862506|FG001|Double-Blind Treatment Period (DB)|Adverse Event|2|||
147465692|NCT03094195|531862507|FG002|Double-Blind Treatment Period (DB)|Adverse Event|1|||
147465693|NCT03094195|531862508|FG003|Double-Blind Treatment Period (DB)|Adverse Event|0|||
147465694|NCT03094195|531862509|FG004|Double-Blind Treatment Period (DB)|Adverse Event|0|||
147465695|NCT03094195|531862510|FG005|Double-Blind Treatment Period (DB)|Adverse Event|0|||
147465696|NCT03094195|531862511|FG006|Double-Blind Treatment Period (DB)|Adverse Event|0|||
147465697|NCT03094195|531862512|FG007|Double-Blind Treatment Period (DB)|Adverse Event|0|||
147465698|NCT03094195|531862505|FG000|Double-Blind Treatment Period (DB)|Physician Decision|0|||
147465699|NCT03094195|531862506|FG001|Double-Blind Treatment Period (DB)|Physician Decision|0|||
147465700|NCT03094195|531862507|FG002|Double-Blind Treatment Period (DB)|Physician Decision|1|||
147465701|NCT03094195|531862508|FG003|Double-Blind Treatment Period (DB)|Physician Decision|0|||
147465702|NCT03094195|531862509|FG004|Double-Blind Treatment Period (DB)|Physician Decision|0|||
147465703|NCT03094195|531862510|FG005|Double-Blind Treatment Period (DB)|Physician Decision|0|||
147465704|NCT03094195|531862511|FG006|Double-Blind Treatment Period (DB)|Physician Decision|0|||
147465705|NCT03094195|531862512|FG007|Double-Blind Treatment Period (DB)|Physician Decision|0|||
147465706|NCT03094195|531862505|FG000|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
147465707|NCT03094195|531862506|FG001|Double-Blind Treatment Period (DB)|Withdrawal by Subject|1|||
147465708|NCT03094195|531862507|FG002|Double-Blind Treatment Period (DB)|Withdrawal by Subject|1|||
147465709|NCT03094195|531862508|FG003|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
147465710|NCT03094195|531862509|FG004|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
147465711|NCT03094195|531862510|FG005|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
147465712|NCT03094195|531862511|FG006|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
147465713|NCT03094195|531862512|FG007|Double-Blind Treatment Period (DB)|Withdrawal by Subject|0|||
147465714|NCT00927563|531862516|FG000|Overall Study|Lost to Follow-up|1|||
147465715|NCT00927563|531862516|FG000|Overall Study|Withdrawal by Subject|1|||
147465716|NCT02497001|531862517|FG000|Overall Study|Lost to Follow-up|10|||
147465717|NCT02497001|531862518|FG001|Overall Study|Lost to Follow-up|2|||
147465718|NCT02497001|531862519|FG002|Overall Study|Lost to Follow-up|0|||
147465719|NCT02497001|531862520|FG003|Overall Study|Lost to Follow-up|2|||
147465720|NCT02497001|531862517|FG000|Overall Study|Adverse Event|28|||
147465721|NCT02497001|531862518|FG001|Overall Study|Adverse Event|30|||
147465722|NCT02497001|531862519|FG002|Overall Study|Adverse Event|11|||
147465723|NCT02497001|531862520|FG003|Overall Study|Adverse Event|11|||
147465724|NCT02497001|531862517|FG000|Overall Study|Withdrawal by Subject|14|||
147465725|NCT02497001|531862518|FG001|Overall Study|Withdrawal by Subject|37|||
147465726|NCT02497001|531862519|FG002|Overall Study|Withdrawal by Subject|19|||
147465727|NCT02497001|531862520|FG003|Overall Study|Withdrawal by Subject|15|||
147465728|NCT02497001|531862517|FG000|Overall Study|Physician Decision|5|||
147465729|NCT02497001|531862518|FG001|Overall Study|Physician Decision|11|||
147465730|NCT02497001|531862519|FG002|Overall Study|Physician Decision|5|||
147465731|NCT02497001|531862520|FG003|Overall Study|Physician Decision|1|||
147465732|NCT02497001|531862517|FG000|Overall Study|subjects that were not treated|1|||
147465733|NCT02497001|531862518|FG001|Overall Study|subjects that were not treated|2|||
147465734|NCT02497001|531862519|FG002|Overall Study|subjects that were not treated|2|||
147465735|NCT02497001|531862520|FG003|Overall Study|subjects that were not treated|1|||
147465736|NCT02497001|531862517|FG000|Overall Study|Major Protocol Deviation|3|||
147465737|NCT02497001|531862518|FG001|Overall Study|Major Protocol Deviation|4|||
147465738|NCT02497001|531862519|FG002|Overall Study|Major Protocol Deviation|4|||
147465739|NCT02497001|531862520|FG003|Overall Study|Major Protocol Deviation|4|||
147465740|NCT02497001|531862517|FG000|Overall Study|Lack of Efficacy|10|||
147465741|NCT02497001|531862518|FG001|Overall Study|Lack of Efficacy|16|||
147465742|NCT02497001|531862519|FG002|Overall Study|Lack of Efficacy|6|||
147465743|NCT02497001|531862520|FG003|Overall Study|Lack of Efficacy|6|||
147465744|NCT02497001|531862517|FG000|Overall Study|Protocol Violation|3|||
147465745|NCT02497001|531862518|FG001|Overall Study|Protocol Violation|1|||
147465746|NCT02497001|531862519|FG002|Overall Study|Protocol Violation|3|||
147465747|NCT02497001|531862520|FG003|Overall Study|Protocol Violation|1|||
147465748|NCT02899156|531862524|FG000|Overall Study|Death|1|||
147465749|NCT02899156|531862525|FG001|Overall Study|Death|0|||
147465750|NCT02899156|531862524|FG000|Overall Study|Physician Decision|0|||
147465751|NCT02899156|531862525|FG001|Overall Study|Physician Decision|1|||
147617171|NCT00758524|532413733|FG001|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
147465752|NCT00787787|531862526|FG000|Overall Study|Lack of Efficacy|4|||
147465753|NCT00787787|531862526|FG000|Overall Study|Adverse Event|3|||
147465754|NCT02116621|531862528|FG000|Baseline|Withdrawal by Subject|0|||
147465755|NCT02116621|531862529|FG001|Baseline|Withdrawal by Subject|4|||
147465756|NCT02116621|531862528|FG000|Three Month Follow-up|Death|1|||
147465757|NCT02116621|531862529|FG001|Three Month Follow-up|Death|1|||
147465758|NCT02116621|531862528|FG000|Three Month Follow-up|Withdrawal by Subject|4|||
147465759|NCT02116621|531862529|FG001|Three Month Follow-up|Withdrawal by Subject|1|||
147465760|NCT02116621|531862528|FG000|Three Month Follow-up|Lost to Follow-up|0|||
147465761|NCT02116621|531862529|FG001|Three Month Follow-up|Lost to Follow-up|1|||
147465762|NCT02116621|531862528|FG000|Three Month Follow-up|Did not complete follow-up survey|14|||
147465763|NCT02116621|531862529|FG001|Three Month Follow-up|Did not complete follow-up survey|4|||
147465764|NCT02116621|531862528|FG000|Six Month Follow-up|Withdrawal by Subject|1|||
147465765|NCT02116621|531862529|FG001|Six Month Follow-up|Withdrawal by Subject|1|||
147465766|NCT02116621|531862528|FG000|Six Month Follow-up|Lost to Follow-up|2|||
147465767|NCT02116621|531862529|FG001|Six Month Follow-up|Lost to Follow-up|1|||
147465768|NCT02116621|531862528|FG000|Six Month Follow-up|Did not complete follow-up survey|1|||
147465769|NCT02116621|531862529|FG001|Six Month Follow-up|Did not complete follow-up survey|1|||
147465770|NCT02116621|531862528|FG000|Twelve Month Follow-up|Withdrawal by Subject|1|||
147465771|NCT02116621|531862529|FG001|Twelve Month Follow-up|Withdrawal by Subject|0|||
147465772|NCT02116621|531862528|FG000|Twelve Month Follow-up|Lost to Follow-up|0|||
147465773|NCT02116621|531862529|FG001|Twelve Month Follow-up|Lost to Follow-up|1|||
147465774|NCT02116621|531862528|FG000|Twelve Month Follow-up|Did not complete follow-up survey|1|||
147465775|NCT02116621|531862529|FG001|Twelve Month Follow-up|Did not complete follow-up survey|3|||
147465776|NCT02116621|531862528|FG000|Twelve Month Follow-up|Enrolled within 12 months of study end|14|||
147465777|NCT02116621|531862529|FG001|Twelve Month Follow-up|Enrolled within 12 months of study end|8|||
147465778|NCT01889602|531862530|FG000|First Intervention|Adverse Event|1|||
147617172|NCT00758524|532413734|FG002|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
147465779|NCT01889602|531862531|FG001|First Intervention|Adverse Event|1|||
147465780|NCT01889602|531862532|FG002|First Intervention|Adverse Event|1|||
147465781|NCT01889602|531862530|FG000|First Intervention|Protocol Violation|0|||
147465782|NCT01889602|531862531|FG001|First Intervention|Protocol Violation|1|||
147617173|NCT00758524|532413735|FG003|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
147465783|NCT01889602|531862532|FG002|First Intervention|Protocol Violation|1|||
147465784|NCT01889602|531862530|FG000|First Intervention|Study ending|0|||
147465785|NCT01889602|531862531|FG001|First Intervention|Study ending|1|||
147465786|NCT01889602|531862532|FG002|First Intervention|Study ending|0|||
147465787|NCT01889602|531862530|FG000|Second Intervention|Adverse Event|0|||
147465788|NCT01889602|531862531|FG001|Second Intervention|Adverse Event|0|||
147465789|NCT01889602|531862532|FG002|Second Intervention|Adverse Event|1|||
147465790|NCT01889602|531862530|FG000|Second Intervention|Study ending|1|||
147465791|NCT01889602|531862531|FG001|Second Intervention|Study ending|0|||
147465792|NCT01889602|531862532|FG002|Second Intervention|Study ending|0|||
147465793|NCT01889602|531862530|FG000|Second Intervention|Withdrawal by Subject|0|||
147465794|NCT01889602|531862531|FG001|Second Intervention|Withdrawal by Subject|0|||
147465795|NCT01889602|531862532|FG002|Second Intervention|Withdrawal by Subject|1|||
147465796|NCT01889602|531862530|FG000|Third Intervention|Protocol Violation|1|||
147465797|NCT01889602|531862531|FG001|Third Intervention|Protocol Violation|0|||
147465798|NCT01889602|531862532|FG002|Third Intervention|Protocol Violation|0|||
147465799|NCT01889602|531862530|FG000|Third Intervention|Withdrawal by Subject|2|||
147465800|NCT01889602|531862531|FG001|Third Intervention|Withdrawal by Subject|2|||
147465801|NCT01889602|531862532|FG002|Third Intervention|Withdrawal by Subject|0|||
147465802|NCT01412957|531862533|FG000|Overall Study|Withdrawal by Subject|6|||
147465803|NCT01412957|531862534|FG001|Overall Study|Withdrawal by Subject|22|||
147465804|NCT01412957|531862533|FG000|Overall Study|Lost to Follow-up|7|||
147465805|NCT01412957|531862534|FG001|Overall Study|Lost to Follow-up|2|||
147465806|NCT01412957|531862533|FG000|Overall Study|Death|136|||
147465807|NCT01412957|531862534|FG001|Overall Study|Death|133|||
147465808|NCT00484315|531862535|FG000|12-Month Clinical Follow-up|Death|6|||
147465809|NCT00484315|531862536|FG001|12-Month Clinical Follow-up|Death|2|||
147465810|NCT00484315|531862535|FG000|12-Month Clinical Follow-up|Withdrawal by Subject|4|||
147465811|NCT00484315|531862536|FG001|12-Month Clinical Follow-up|Withdrawal by Subject|0|||
147465812|NCT00484315|531862535|FG000|12-Month Clinical Follow-up|Lost to Follow-up|2|||
147465813|NCT00484315|531862536|FG001|12-Month Clinical Follow-up|Lost to Follow-up|1|||
147465814|NCT00484315|531862535|FG000|12-Month Clinical Follow-up|Missed 12-Month Visit|13|||
147465815|NCT00484315|531862536|FG001|12-Month Clinical Follow-up|Missed 12-Month Visit|4|||
147465816|NCT00484315|531862535|FG000|12-Month Clinical Follow-up|Withdrawn at Investigator's discretion|3|||
147465817|NCT00484315|531862536|FG001|12-Month Clinical Follow-up|Withdrawn at Investigator's discretion|2|||
147465818|NCT00484315|531862535|FG000|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|25|||
147465819|NCT00484315|531862536|FG001|9-Month Angiographic Follow-up|No 9-Month Angiography Performed|11|||
147465820|NCT00484315|531862535|FG000|9-Month Angiographic Follow-up|Not Evaluable for Angiography Analysis|3|||
147465821|NCT00484315|531862536|FG001|9-Month Angiographic Follow-up|Not Evaluable for Angiography Analysis|2|||
147465822|NCT00943683|531862537|FG000|Overall Study|Adverse Event|3|||
147465823|NCT00943683|531862538|FG001|Overall Study|Adverse Event|3|||
147465824|NCT00943683|531862537|FG000|Overall Study|Lost to Follow-up|1|||
147465825|NCT00943683|531862538|FG001|Overall Study|Lost to Follow-up|1|||
147465826|NCT00943683|531862537|FG000|Overall Study|Protocol Violation|1|||
147465827|NCT00943683|531862538|FG001|Overall Study|Protocol Violation|2|||
147465828|NCT00943683|531862537|FG000|Overall Study|Withdrawal by Subject|1|||
147465829|NCT00943683|531862538|FG001|Overall Study|Withdrawal by Subject|0|||
147465830|NCT00943683|531862537|FG000|Overall Study|Patient Moved|1|||
147465831|NCT00943683|531862538|FG001|Overall Study|Patient Moved|0|||
147465832|NCT04840667|531864031|FG000|Overall Study|Screen failures/ Failure to meet inclusion criteria|17|||
147465833|NCT03658889|531864033|FG000|Overall Study|Protocol Violation|2|||
147465834|NCT03658889|531864034|FG001|Overall Study|Protocol Violation|0|||
147465835|NCT04317690|531864036|FG000|Overall Study|did not have complete information for primary outcome|0|||
147465836|NCT04317690|531864037|FG001|Overall Study|did not have complete information for primary outcome|4|||
147465837|NCT04317690|531864038|FG002|Overall Study|did not have complete information for primary outcome|0|||
147465838|NCT04317690|531864039|FG003|Overall Study|did not have complete information for primary outcome|2|||
147465839|NCT04317690|531864040|FG004|Overall Study|did not have complete information for primary outcome|0|||
147465840|NCT03312218|531864046|FG000|Overall Study|Never signed in to access the app|54|||
147465841|NCT03312218|531864047|FG001|Overall Study|Never signed in to access the app|58|||
147465842|NCT02747927|531864048|FG000|Part 1: Vaccine Efficacy (Months 0-15)|Adverse Event|5|||
147465843|NCT02747927|531864049|FG001|Part 1: Vaccine Efficacy (Months 0-15)|Adverse Event|14|||
147465844|NCT02747927|531864048|FG000|Part 1: Vaccine Efficacy (Months 0-15)|Lost to Follow-up|13|||
147465845|NCT02747927|531864049|FG001|Part 1: Vaccine Efficacy (Months 0-15)|Lost to Follow-up|26|||
147465846|NCT02747927|531864048|FG000|Part 1: Vaccine Efficacy (Months 0-15)|Pregnancy|19|||
147465847|NCT02747927|531864049|FG001|Part 1: Vaccine Efficacy (Months 0-15)|Pregnancy|42|||
147465848|NCT02747927|531864048|FG000|Part 1: Vaccine Efficacy (Months 0-15)|Protocol Violation|2|||
147465849|NCT02747927|531864049|FG001|Part 1: Vaccine Efficacy (Months 0-15)|Protocol Violation|5|||
147465850|NCT02747927|531864048|FG000|Part 1: Vaccine Efficacy (Months 0-15)|Withdrawal by Participant and/or Participants Parent/Guardian|131|||
147465851|NCT02747927|531864049|FG001|Part 1: Vaccine Efficacy (Months 0-15)|Withdrawal by Participant and/or Participants Parent/Guardian|260|||
147465852|NCT02747927|531864048|FG000|Part 1: Vaccine Efficacy (Months 0-15)|Without Adult Consent in Place|1|||
147465853|NCT02747927|531864049|FG001|Part 1: Vaccine Efficacy (Months 0-15)|Without Adult Consent in Place|4|||
147465854|NCT02747927|531864048|FG000|Part 1: Vaccine Efficacy (Months 0-15)|Reason not Specified|7|||
147465855|NCT02747927|531864049|FG001|Part 1: Vaccine Efficacy (Months 0-15)|Reason not Specified|15|||
147465856|NCT02747927|531864048|FG000|Part 2: Additional VE (Months 16-21)|Adverse Event|0|||
147465857|NCT02747927|531864049|FG001|Part 2: Additional VE (Months 16-21)|Adverse Event|1|||
147465858|NCT02747927|531864048|FG000|Part 2: Additional VE (Months 16-21)|Lost to Follow-up|4|||
147465859|NCT02747927|531864049|FG001|Part 2: Additional VE (Months 16-21)|Lost to Follow-up|8|||
147465860|NCT02747927|531864048|FG000|Part 2: Additional VE (Months 16-21)|Pregnancy|11|||
147465861|NCT02747927|531864049|FG001|Part 2: Additional VE (Months 16-21)|Pregnancy|17|||
147465862|NCT02747927|531864048|FG000|Part 2: Additional VE (Months 16-21)|Withdrawal by Participant&/ortheir Parent/Guardian|13|||
147465863|NCT02747927|531864049|FG001|Part 2: Additional VE (Months 16-21)|Withdrawal by Participant&/ortheir Parent/Guardian|33|||
147465864|NCT02747927|531864048|FG000|Part 2: Additional VE (Months 16-21)|Without Adult Consent in Place|1|||
147465865|NCT02747927|531864049|FG001|Part 2: Additional VE (Months 16-21)|Without Adult Consent in Place|7|||
147465866|NCT02747927|531864048|FG000|Part 2: Additional VE (Months 16-21)|Reason Not Specified|3|||
147465867|NCT02747927|531864049|FG001|Part 2: Additional VE (Months 16-21)|Reason Not Specified|6|||
147465868|NCT02747927|531864048|FG000|Part 3: Long Term Safety & VE (3 Years)|Adverse Event|6|||
147465869|NCT02747927|531864049|FG001|Part 3: Long Term Safety & VE (3 Years)|Adverse Event|10|||
147465870|NCT02747927|531864048|FG000|Part 3: Long Term Safety & VE (3 Years)|Lost to Follow-up|67|||
147465871|NCT02747927|531864049|FG001|Part 3: Long Term Safety & VE (3 Years)|Lost to Follow-up|149|||
147465872|NCT02747927|531864048|FG000|Part 3: Long Term Safety & VE (3 Years)|Pregnancy|120|||
147465873|NCT02747927|531864049|FG001|Part 3: Long Term Safety & VE (3 Years)|Pregnancy|228|||
147465874|NCT02747927|531864048|FG000|Part 3: Long Term Safety & VE (3 Years)|Protocol Violation|1|||
147465875|NCT02747927|531864049|FG001|Part 3: Long Term Safety & VE (3 Years)|Protocol Violation|2|||
147465876|NCT02747927|531864048|FG000|Part 3: Long Term Safety & VE (3 Years)|Withdrawal by Participant and/or Participants Parent/Guardian|119|||
147465877|NCT02747927|531864049|FG001|Part 3: Long Term Safety & VE (3 Years)|Withdrawal by Participant and/or Participants Parent/Guardian|227|||
147465878|NCT02747927|531864048|FG000|Part 3: Long Term Safety & VE (3 Years)|Without Adult Consent in Place|82|||
147465879|NCT02747927|531864049|FG001|Part 3: Long Term Safety & VE (3 Years)|Without Adult Consent in Place|150|||
147465880|NCT02747927|531864048|FG000|Part 3: Long Term Safety & VE (3 Years)|Reason Not Specified|13|||
147465881|NCT02747927|531864049|FG001|Part 3: Long Term Safety & VE (3 Years)|Reason Not Specified|18|||
147465882|NCT02747927|531864048|FG000|Part 4: Booster VE & Safety (13 Months)|Adverse Event|1|||
147465883|NCT02747927|531864049|FG001|Part 4: Booster VE & Safety (13 Months)|Adverse Event|3|||
147465884|NCT02747927|531864048|FG000|Part 4: Booster VE & Safety (13 Months)|Lost to Follow-up|4|||
147465885|NCT02747927|531864049|FG001|Part 4: Booster VE & Safety (13 Months)|Lost to Follow-up|13|||
147465886|NCT02747927|531864048|FG000|Part 4: Booster VE & Safety (13 Months)|Pregnancy|8|||
147465887|NCT02747927|531864049|FG001|Part 4: Booster VE & Safety (13 Months)|Pregnancy|15|||
147465888|NCT02747927|531864048|FG000|Part 4: Booster VE & Safety (13 Months)|Withdrawal by Participant and/or Participants Parent/Guardian|29|||
147465889|NCT02747927|531864049|FG001|Part 4: Booster VE & Safety (13 Months)|Withdrawal by Participant and/or Participants Parent/Guardian|60|||
147465890|NCT02747927|531864048|FG000|Part 4: Booster VE & Safety (13 Months)|Without Adult Consent in Place|0|||
147465891|NCT02747927|531864049|FG001|Part 4: Booster VE & Safety (13 Months)|Without Adult Consent in Place|1|||
147465892|NCT02747927|531864048|FG000|Part 4: Booster VE & Safety (13 Months)|Reason Not Specified|4|||
147465893|NCT02747927|531864049|FG001|Part 4: Booster VE & Safety (13 Months)|Reason Not Specified|9|||
147465894|NCT02747927|531864048|FG000|Part 5: Booster VE & Safety (1 Year)|Adverse Event|0|||
147465895|NCT02747927|531864049|FG001|Part 5: Booster VE & Safety (1 Year)|Adverse Event|3|||
147465896|NCT02747927|531864048|FG000|Part 5: Booster VE & Safety (1 Year)|Lost to Follow-up|8|||
147465897|NCT02747927|531864049|FG001|Part 5: Booster VE & Safety (1 Year)|Lost to Follow-up|30|||
147465898|NCT02747927|531864048|FG000|Part 5: Booster VE & Safety (1 Year)|Pregnancy|18|||
147465899|NCT02747927|531864049|FG001|Part 5: Booster VE & Safety (1 Year)|Pregnancy|27|||
147465900|NCT02747927|531864048|FG000|Part 5: Booster VE & Safety (1 Year)|Withdrawal by Subject|18|||
147465901|NCT02747927|531864049|FG001|Part 5: Booster VE & Safety (1 Year)|Withdrawal by Subject|40|||
147465902|NCT02747927|531864048|FG000|Part 5: Booster VE & Safety (1 Year)|Without Adult Consent in Place|14|||
147465903|NCT02747927|531864049|FG001|Part 5: Booster VE & Safety (1 Year)|Without Adult Consent in Place|29|||
147465904|NCT02747927|531864048|FG000|Part 5: Booster VE & Safety (1 Year)|Reason Not Specified|40|||
147465905|NCT02747927|531864049|FG001|Part 5: Booster VE & Safety (1 Year)|Reason Not Specified|89|||
147465906|NCT01154101|531864050|FG000|Overall Study|Adverse Event|0|||
147465907|NCT01154101|531864051|FG001|Overall Study|Adverse Event|2|||
147465908|NCT01154101|531864052|FG002|Overall Study|Adverse Event|1|||
147465909|NCT01154101|531864053|FG003|Overall Study|Adverse Event|1|||
147465910|NCT01154101|531864054|FG004|Overall Study|Adverse Event|0|||
147465911|NCT01154101|531864050|FG000|Overall Study|Lost to Follow-up|0|||
147465912|NCT01154101|531864051|FG001|Overall Study|Lost to Follow-up|1|||
147465913|NCT01154101|531864052|FG002|Overall Study|Lost to Follow-up|0|||
147465914|NCT01154101|531864053|FG003|Overall Study|Lost to Follow-up|1|||
147465915|NCT01154101|531864054|FG004|Overall Study|Lost to Follow-up|0|||
147465916|NCT01154101|531864050|FG000|Overall Study|Withdrawal by Subject|0|||
147465917|NCT01154101|531864051|FG001|Overall Study|Withdrawal by Subject|1|||
147465918|NCT01154101|531864052|FG002|Overall Study|Withdrawal by Subject|2|||
147465919|NCT01154101|531864053|FG003|Overall Study|Withdrawal by Subject|0|||
147465920|NCT01154101|531864054|FG004|Overall Study|Withdrawal by Subject|1|||
147465921|NCT05019131|531864055|FG000|Overall Study|Lost to Follow-up|0|||
147465922|NCT05019131|531864056|FG001|Overall Study|Lost to Follow-up|3|||
147465923|NCT00432237|531864057|FG000|Overall Study|Adverse Event|0|||
147465924|NCT00432237|531864058|FG001|Overall Study|Adverse Event|0|||
147465925|NCT00432237|531864059|FG002|Overall Study|Adverse Event|0|||
147465926|NCT00432237|531864060|FG003|Overall Study|Adverse Event|1|||
147465927|NCT00432237|531864057|FG000|Overall Study|Lack of Efficacy|0|||
147465928|NCT00432237|531864058|FG001|Overall Study|Lack of Efficacy|0|||
147465929|NCT00432237|531864059|FG002|Overall Study|Lack of Efficacy|0|||
147465930|NCT00432237|531864060|FG003|Overall Study|Lack of Efficacy|1|||
147465931|NCT00432237|531864057|FG000|Overall Study|Lost to Follow-up|10|||
147465932|NCT00432237|531864058|FG001|Overall Study|Lost to Follow-up|10|||
147465933|NCT00432237|531864059|FG002|Overall Study|Lost to Follow-up|18|||
147465934|NCT00432237|531864060|FG003|Overall Study|Lost to Follow-up|18|||
147465935|NCT00432237|531864057|FG000|Overall Study|Physician Decision|1|||
147465936|NCT00432237|531864058|FG001|Overall Study|Physician Decision|3|||
147465937|NCT00432237|531864059|FG002|Overall Study|Physician Decision|2|||
147465938|NCT00432237|531864060|FG003|Overall Study|Physician Decision|1|||
147465939|NCT00432237|531864057|FG000|Overall Study|Pregnancy|0|||
147465940|NCT00432237|531864058|FG001|Overall Study|Pregnancy|1|||
147465941|NCT00432237|531864059|FG002|Overall Study|Pregnancy|0|||
147465942|NCT00432237|531864060|FG003|Overall Study|Pregnancy|0|||
147465943|NCT00432237|531864057|FG000|Overall Study|Protocol Violation|13|||
147465944|NCT00432237|531864058|FG001|Overall Study|Protocol Violation|10|||
147465945|NCT00432237|531864059|FG002|Overall Study|Protocol Violation|11|||
147465946|NCT00432237|531864060|FG003|Overall Study|Protocol Violation|8|||
147465947|NCT00432237|531864057|FG000|Overall Study|Withdrawal by Subject|5|||
147465948|NCT00432237|531864058|FG001|Overall Study|Withdrawal by Subject|6|||
147465949|NCT00432237|531864059|FG002|Overall Study|Withdrawal by Subject|9|||
147465950|NCT00432237|531864060|FG003|Overall Study|Withdrawal by Subject|11|||
147465951|NCT00432237|531864057|FG000|Overall Study|Lack of Qualifying Event|38|||
147465952|NCT00432237|531864058|FG001|Overall Study|Lack of Qualifying Event|71|||
147465953|NCT00432237|531864059|FG002|Overall Study|Lack of Qualifying Event|69|||
147465954|NCT00432237|531864060|FG003|Overall Study|Lack of Qualifying Event|84|||
147465955|NCT01354132|531864061|FG000|Randomization|Physician Decision|1|||
147465956|NCT01354132|531864062|FG001|Randomization|Physician Decision|0|||
147465957|NCT01354132|531864061|FG000|Randomization|Withdrawal by Subject|0|||
147465958|NCT01354132|531864062|FG001|Randomization|Withdrawal by Subject|1|||
147465959|NCT01354132|531864061|FG000|Double Blind (Visits 1-7)|Adverse Event|1|||
147465960|NCT01354132|531864062|FG001|Double Blind (Visits 1-7)|Adverse Event|0|||
147465961|NCT01354132|531864061|FG000|Double Blind (Visits 1-7)|Withdrawal by Subject|8|||
147465962|NCT01354132|531864062|FG001|Double Blind (Visits 1-7)|Withdrawal by Subject|11|||
147465963|NCT01354132|531864061|FG000|1 Month Post Study Medication|Withdrawal by Subject|1|||
147465964|NCT01354132|531864062|FG001|1 Month Post Study Medication|Withdrawal by Subject|3|||
147465965|NCT02360098|531864065|FG000|Overall Study|Physician Decision|7|||
147465966|NCT03293654|531864071|FG000|Overall Study|Lost to Follow-up|0|||
147465967|NCT03293654|531864072|FG001|Overall Study|Lost to Follow-up|1|||
147465968|NCT03293654|531864073|FG002|Overall Study|Lost to Follow-up|0|||
147465969|NCT01919307|531864074|FG000|Overall Study|Withdrawal by Subject|9|||
147465970|NCT02275533|531864076|FG000|Overall Study|Protocol Violation|2|||
147465971|NCT02275533|531864077|FG001|Overall Study|Protocol Violation|0|||
147465972|NCT02275533|531864076|FG000|Overall Study|Never received study treatment|1|||
147465973|NCT02275533|531864077|FG001|Overall Study|Never received study treatment|0|||
147465974|NCT02157883|531864081|FG000|Part A: Day 6-18 (AZD9291+Itraconozole)|Adverse Event|1|||
147465975|NCT02157883|531864081|FG000|Part B: Day 19 to End Part B (AZD9291)|Adverse Event|3|||
147465976|NCT02157883|531864081|FG000|Part B: Day 19 to End Part B (AZD9291)|Disease progression|15|||
147465977|NCT02157883|531864081|FG000|Part B: Day 19 to End Part B (AZD9291)|Withdrawal by Subject|1|||
147465978|NCT02157883|531864081|FG000|Part B: Day 19 to End Part B (AZD9291)|Death|3|||
147465979|NCT01323478|531864082|FG000|Overall Study|Adverse Event|7|||
147465980|NCT01323478|531864082|FG000|Overall Study|Lack of Efficacy|4|||
147465981|NCT01323478|531864082|FG000|Overall Study|Non-compliance With Study Product|3|||
147617174|NCT00758524|532413736|FG004|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|1|||
147617175|NCT00758524|532413737|FG005|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
147465982|NCT01323478|531864082|FG000|Overall Study|Protocol Violation|1|||
147465983|NCT01323478|531864082|FG000|Overall Study|Withdrawal of Consent|1|||
147465984|NCT01323478|531864082|FG000|Overall Study|Administrative or Other Reasons|8|||
147465985|NCT04067518|531864085|FG000|Overall Study|Adverse Event|1|||
147465986|NCT04067518|531864086|FG001|Overall Study|Adverse Event|3|||
147465987|NCT04067518|531864085|FG000|Overall Study|Screen failures|0|||
147617176|NCT00758524|532413738|FG006|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
147465988|NCT04067518|531864086|FG001|Overall Study|Screen failures|1|||
147465989|NCT04067518|531864085|FG000|Overall Study|Enrolled but not treated|0|||
147465990|NCT04067518|531864086|FG001|Overall Study|Enrolled but not treated|1|||
147465991|NCT02771522|531864087|FG000|Overall Study|Lost to Follow-up|3|||
147465992|NCT02771522|531864087|FG000|Overall Study|Withdrawal by Subject|2|||
147465993|NCT02771522|531864087|FG000|Overall Study|No white spot lesions|3|||
147465994|NCT02347631|531864089|FG000|First Intervention (2 Months)|Adverse Event|1|||
147465995|NCT02347631|531864090|FG001|First Intervention (2 Months)|Adverse Event|1|||
147465996|NCT02347631|531864089|FG000|First Intervention (2 Months)|Pregnancy|1|||
147617177|NCT00758524|532413739|FG007|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
147465997|NCT02347631|531864090|FG001|First Intervention (2 Months)|Pregnancy|0|||
147465998|NCT02347631|531864089|FG000|First Intervention (2 Months)|Moved out of area|0|||
147465999|NCT02347631|531864090|FG001|First Intervention (2 Months)|Moved out of area|2|||
147466000|NCT02347631|531864089|FG000|First Intervention (2 Months)|Lost to Follow-up|5|||
147466001|NCT02347631|531864090|FG001|First Intervention (2 Months)|Lost to Follow-up|3|||
147466002|NCT02347631|531864089|FG000|Washout 2 (1 Month)|Withdrawal by Subject|2|||
147466003|NCT02347631|531864090|FG001|Washout 2 (1 Month)|Withdrawal by Subject|2|||
147466004|NCT02347631|531864089|FG000|Washout 2 (1 Month)|Lost to Follow-up|0|||
147466005|NCT02347631|531864090|FG001|Washout 2 (1 Month)|Lost to Follow-up|1|||
147466006|NCT02347631|531864089|FG000|Second Intervention (2 Months)|Lost to Follow-up|7|||
147466007|NCT02347631|531864090|FG001|Second Intervention (2 Months)|Lost to Follow-up|4|||
147466008|NCT02347631|531864089|FG000|Second Intervention (2 Months)|Withdrawal by Subject|6|||
147466009|NCT02347631|531864090|FG001|Second Intervention (2 Months)|Withdrawal by Subject|0|||
147466010|NCT02318784|531864092|FG000|Overall Study|Adverse Event|13|||
147466011|NCT02318784|531864092|FG000|Overall Study|Death|2|||
147466012|NCT02318784|531864092|FG000|Overall Study|Progressive Disease|37|||
147466013|NCT02318784|531864092|FG000|Overall Study|Withdrawal by Subject|10|||
147466014|NCT00934102|531864093|FG000|Period 1, One Night of Wear|Personal Reasons|1|||
147466015|NCT00934102|531864094|FG001|Period 1, One Night of Wear|Personal Reasons|0|||
147466016|NCT00934102|531864095|FG002|Period 1, One Night of Wear|Personal Reasons|0|||
147466017|NCT02304926|531864096|FG000|Overall Study|Lost to Follow-up|2|||
147466018|NCT02304926|531864097|FG001|Overall Study|Lost to Follow-up|1|||
147466019|NCT04258579|531864098|FG000|Overall Study|Withdrawal by Subject|7|||
147466020|NCT04258579|531864098|FG000|Overall Study|Lost to Follow-up|3|||
147466021|NCT04258579|531864098|FG000|Overall Study|Protocol Violation|2|||
147466022|NCT04258579|531864098|FG000|Overall Study|Adverse Event|1|||
147466023|NCT02388295|531864099|FG000|Dose Escalation Week 1|Adverse Event|1|||
147466024|NCT02388295|531864100|FG001|Dose Escalation Week 1|Adverse Event|2|||
147466025|NCT02388295|531864101|FG002|Dose Escalation Week 1|Adverse Event|1|||
147466026|NCT02388295|531864099|FG000|Dose Escalation Week 1|Determined not eligible|1|||
147466027|NCT02388295|531864100|FG001|Dose Escalation Week 1|Determined not eligible|1|||
147466028|NCT02388295|531864101|FG002|Dose Escalation Week 1|Determined not eligible|1|||
147466029|NCT02388295|531864099|FG000|Dose Escalation Week 2|Protocol Violation|0|||
147466030|NCT02388295|531864100|FG001|Dose Escalation Week 2|Protocol Violation|1|||
147466031|NCT02388295|531864101|FG002|Dose Escalation Week 2|Protocol Violation|0|||
147466032|NCT02388295|531864099|FG000|Dose Escalation Week 2|Determined not eligible|1|||
147466033|NCT02388295|531864100|FG001|Dose Escalation Week 2|Determined not eligible|1|||
147466034|NCT02388295|531864101|FG002|Dose Escalation Week 2|Determined not eligible|1|||
147466035|NCT02388295|531864099|FG000|Treatment Weeks 3 to 12|Adverse Event|1|||
147466036|NCT02388295|531864100|FG001|Treatment Weeks 3 to 12|Adverse Event|1|||
147466037|NCT02388295|531864101|FG002|Treatment Weeks 3 to 12|Adverse Event|0|||
147466038|NCT04007159|531864102|FG000|Induction Phase|(missed study visits)|16|||
147466039|NCT04007159|531864102|FG000|Induction Phase|Withdrawal by Subject|4|||
147466040|NCT04007159|531864102|FG000|Induction Phase|Adverse Event|2|||
147466041|NCT04007159|531864102|FG000|Challenge Phase|missed study visits|3|||
147466042|NCT02076165|531864104|FG000|Overall Study|Lost to Follow-up|7|||
147466043|NCT02076165|531864105|FG001|Overall Study|Lost to Follow-up|5|||
147466044|NCT02076165|531864104|FG000|Overall Study|Refused follow-up assessment|1|||
147466045|NCT02076165|531864105|FG001|Overall Study|Refused follow-up assessment|1|||
147466046|NCT03804684|531864106|FG000|Overall Study|Subjects unable to perform testing or test reliability did not meet inclusion criteria.|3|||
147466047|NCT03804684|531864107|FG001|Overall Study|Subjects unable to perform testing or test reliability did not meet inclusion criteria.|18|||
147466048|NCT02429856|531864108|FG000|Overall Study|Death|12|||
147466049|NCT02429856|531864109|FG001|Overall Study|Death|13|||
147466050|NCT02429856|531864108|FG000|Overall Study|Lost to Follow-up|6|||
147466051|NCT02429856|531864109|FG001|Overall Study|Lost to Follow-up|5|||
147466052|NCT02429856|531864108|FG000|Overall Study|Withdrawal by Subject|1|||
147466053|NCT02429856|531864109|FG001|Overall Study|Withdrawal by Subject|1|||
147466054|NCT03838484|531864113|FG000|Overall Study|Lost to Follow-up|0|||
147466055|NCT03838484|531864114|FG001|Overall Study|Lost to Follow-up|1|||
147466056|NCT03838484|531864115|FG002|Overall Study|Lost to Follow-up|0|||
147466057|NCT03838484|531864116|FG003|Overall Study|Lost to Follow-up|0|||
147466058|NCT00888238|531864126|FG000|Washout Period After Period 2|Adverse Event|0|||
147466059|NCT00888238|531864127|FG001|Washout Period After Period 2|Adverse Event|0|||
147466060|NCT00888238|531864128|FG002|Washout Period After Period 2|Adverse Event|1|||
147466061|NCT02700984|531864129|FG000|Overall Study|Death|2|||
147466062|NCT02700984|531864130|FG001|Overall Study|Death|1|||
147466063|NCT02700984|531864129|FG000|Overall Study|Lost to Follow-up|2|||
147466064|NCT02700984|531864130|FG001|Overall Study|Lost to Follow-up|1|||
147466065|NCT02700984|531864129|FG000|Overall Study|Physician Decision|0|||
147466066|NCT02700984|531864130|FG001|Overall Study|Physician Decision|1|||
147466067|NCT02700984|531864129|FG000|Overall Study|Withdrawal by Subject|8|||
147466068|NCT02700984|531864130|FG001|Overall Study|Withdrawal by Subject|9|||
147466069|NCT02700984|531864129|FG000|Overall Study|Reason not specified|3|||
147466070|NCT02700984|531864130|FG001|Overall Study|Reason not specified|2|||
147466071|NCT00413959|531864135|FG000|Overall Study|Pt had only one cycle.|1|||
147466072|NCT01870739|531864136|FG000|Single Drug Treatment (12 Weeks)|Protocol deviation|0|||
147466073|NCT01870739|531864137|FG001|Single Drug Treatment (12 Weeks)|Protocol deviation|1|||
147466074|NCT01870739|531864136|FG000|Single Drug Treatment (12 Weeks)|Adverse Event|0|||
147466075|NCT01870739|531864137|FG001|Single Drug Treatment (12 Weeks)|Adverse Event|1|||
147466076|NCT01870739|531864136|FG000|Single Drug Treatment (12 Weeks)|Administrative problems|3|||
147466077|NCT01870739|531864137|FG001|Single Drug Treatment (12 Weeks)|Administrative problems|2|||
147466078|NCT01870739|531864136|FG000|Add-on Period (40 Weeks)|Adverse Event|0|||
147466079|NCT01870739|531864137|FG001|Add-on Period (40 Weeks)|Adverse Event|1|||
147466080|NCT01870739|531864136|FG000|Add-on Period (40 Weeks)|Unsatisfactory therapeutic effect|1|||
147466081|NCT01870739|531864137|FG001|Add-on Period (40 Weeks)|Unsatisfactory therapeutic effect|0|||
147466082|NCT01870739|531864136|FG000|Add-on Period (40 Weeks)|Protocol deviation|1|||
147466083|NCT01870739|531864137|FG001|Add-on Period (40 Weeks)|Protocol deviation|1|||
147466084|NCT01870739|531864136|FG000|Add-on Period (40 Weeks)|Patient withdrew consent|1|||
147466085|NCT01870739|531864137|FG001|Add-on Period (40 Weeks)|Patient withdrew consent|0|||
147466086|NCT01986062|531864138|FG000|Overall Study|Lost to Follow-up|1|||
147466087|NCT01986062|531864139|FG001|Overall Study|Lost to Follow-up|0|||
147466088|NCT01986062|531864138|FG000|Overall Study|Withdrawal by Subject|0|||
147466089|NCT01986062|531864139|FG001|Overall Study|Withdrawal by Subject|1|||
147466090|NCT03538743|531864140|FG000|Overall Study|Adverse Event|0|||
147466091|NCT03538743|531864141|FG001|Overall Study|Adverse Event|0|||
147466092|NCT03538743|531864142|FG002|Overall Study|Adverse Event|1|||
147466093|NCT03538743|531864143|FG003|Overall Study|Adverse Event|1|||
147466094|NCT03538743|531864144|FG004|Overall Study|Adverse Event|0|||
147466095|NCT03538743|531864145|FG005|Overall Study|Adverse Event|0|||
147466096|NCT03538743|531864146|FG006|Overall Study|Adverse Event|0|||
147466097|NCT03538743|531864147|FG007|Overall Study|Adverse Event|0|||
147466098|NCT03538743|531864148|FG008|Overall Study|Adverse Event|0|||
147466099|NCT03538743|531864140|FG000|Overall Study|Non-Treatment-Related Reasons|0|||
147466100|NCT03538743|531864141|FG001|Overall Study|Non-Treatment-Related Reasons|0|||
147466101|NCT03538743|531864142|FG002|Overall Study|Non-Treatment-Related Reasons|0|||
147466102|NCT03538743|531864143|FG003|Overall Study|Non-Treatment-Related Reasons|0|||
147466103|NCT03538743|531864144|FG004|Overall Study|Non-Treatment-Related Reasons|0|||
147466104|NCT03538743|531864145|FG005|Overall Study|Non-Treatment-Related Reasons|0|||
147466105|NCT03538743|531864146|FG006|Overall Study|Non-Treatment-Related Reasons|0|||
147466106|NCT03538743|531864147|FG007|Overall Study|Non-Treatment-Related Reasons|0|||
147466107|NCT03538743|531864148|FG008|Overall Study|Non-Treatment-Related Reasons|3|||
147466108|NCT03538743|531864140|FG000|Overall Study|Withdrawal by Subject|0|||
147466109|NCT03538743|531864141|FG001|Overall Study|Withdrawal by Subject|0|||
147466110|NCT03538743|531864142|FG002|Overall Study|Withdrawal by Subject|0|||
147466111|NCT03538743|531864143|FG003|Overall Study|Withdrawal by Subject|1|||
147466112|NCT03538743|531864144|FG004|Overall Study|Withdrawal by Subject|0|||
147466113|NCT03538743|531864145|FG005|Overall Study|Withdrawal by Subject|0|||
147466114|NCT03538743|531864146|FG006|Overall Study|Withdrawal by Subject|0|||
147466115|NCT03538743|531864147|FG007|Overall Study|Withdrawal by Subject|0|||
147466116|NCT03538743|531864148|FG008|Overall Study|Withdrawal by Subject|0|||
147466117|NCT01565980|531864150|FG000|Overall Study|Death|1|||
147466118|NCT01565980|531864151|FG001|Overall Study|Death|0|||
147466119|NCT01565980|531864150|FG000|Overall Study|Lost to Follow-up|1|||
147466120|NCT01565980|531864151|FG001|Overall Study|Lost to Follow-up|0|||
147466121|NCT01565980|531864150|FG000|Overall Study|health complications|1|||
147466122|NCT01565980|531864151|FG001|Overall Study|health complications|1|||
147466123|NCT01565980|531864150|FG000|Overall Study|stopped medical treatment|1|||
147466124|NCT01565980|531864151|FG001|Overall Study|stopped medical treatment|0|||
147466125|NCT01565980|531864150|FG000|Overall Study|Withdrawal by Subject|0|||
147466126|NCT01565980|531864151|FG001|Overall Study|Withdrawal by Subject|3|||
147466127|NCT01929135|531864154|FG000|Overall Study|Lost to Follow-up|1|||
147466128|NCT01929135|531864155|FG001|Overall Study|Lost to Follow-up|1|||
147466129|NCT01926626|531864166|FG000|Overall Study|Withdrawal by Subject|15|||
147466130|NCT01926626|531864166|FG000|Overall Study|Lost to Follow-up|7|||
147466131|NCT01817790|531864167|FG000|Overall Study|Adverse Event|0|||
147466132|NCT01817790|531864168|FG001|Overall Study|Adverse Event|2|||
147617178|NCT00758524|532413740|FG008|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
147466133|NCT01817790|531864167|FG000|Overall Study|Lost to Follow-up|0|||
147466134|NCT01817790|531864168|FG001|Overall Study|Lost to Follow-up|1|||
147466135|NCT01817790|531864167|FG000|Overall Study|Protocol Violation|2|||
147466136|NCT01817790|531864168|FG001|Overall Study|Protocol Violation|1|||
147466137|NCT01817790|531864167|FG000|Overall Study|Withdrawal by Subject|1|||
147466138|NCT01817790|531864168|FG001|Overall Study|Withdrawal by Subject|3|||
147466139|NCT01817790|531864167|FG000|Overall Study|Other: Could not attend appointment|1|||
147466140|NCT01817790|531864168|FG001|Overall Study|Other: Could not attend appointment|1|||
147466141|NCT01671345|531864169|FG000|Overall Study|Lost to Follow-up|10|||
147466142|NCT01671345|531864170|FG001|Overall Study|Lost to Follow-up|6|||
147466143|NCT01671345|531864169|FG000|Overall Study|visit with non-participating physician|3|||
147617179|NCT00758524|532413741|FG009|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
147617180|NCT00758524|532413742|FG010|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
147617181|NCT00758524|532413743|FG011|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
147617182|NCT00758524|532413744|FG012|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
147617183|NCT00758524|532413745|FG013|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
147617184|NCT00758524|532413746|FG014|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
147617185|NCT00758524|532413747|FG015|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
147617186|NCT00758524|532413748|FG016|Core Period (Week 0 to Week 8)|Abnormal Laboratory Values|0|||
147617187|NCT00758524|532413732|FG000|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
147617188|NCT00758524|532413733|FG001|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|1|||
147617189|NCT00758524|532413734|FG002|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
147617190|NCT00758524|532413735|FG003|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
147409510|NCT00477490|531664146|FG005|Part I: 4 Week Efficacy|Lost to Follow-up|0|||
147409511|NCT00477490|531664147|FG006|Part I: 4 Week Efficacy|Lost to Follow-up|0|||
147466144|NCT01671345|531864170|FG001|Overall Study|visit with non-participating physician|3|||
147466145|NCT06001307|531865925|FG000|Overall Study|Lost to Follow-up|1|||
147466146|NCT06001307|531865926|FG001|Overall Study|Lost to Follow-up|2|||
147466147|NCT03532100|531865927|FG000|Overall Study|Intervention malfunction|1|||
147466148|NCT04439279|531865928|FG000|Overall Study|Adverse Event|7|||
147466149|NCT04439279|531865928|FG000|Overall Study|Death|4|||
147466150|NCT04439279|531865928|FG000|Overall Study|Disease progression|17|||
147466151|NCT04439279|531865928|FG000|Overall Study|Complicating disease|3|||
147466152|NCT04439279|531865928|FG000|Overall Study|Withdrawal by Subject|2|||
147466153|NCT04439279|531865928|FG000|Overall Study|Ineligible|1|||
147466154|NCT04439279|531865928|FG000|Overall Study|Treatment still ongoing|1|||
147466155|NCT02031679|531865929|FG000|Overall Study|Protocol Violation|0|||
147466156|NCT02031679|531865930|FG001|Overall Study|Protocol Violation|1|||
147466157|NCT02031679|531865929|FG000|Overall Study|Lack of Efficacy|0|||
147466158|NCT02031679|531865930|FG001|Overall Study|Lack of Efficacy|1|||
147617191|NCT00758524|532413736|FG004|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
147409512|NCT00477490|531664148|FG007|Part I: 4 Week Efficacy|Lost to Follow-up|0|||
147409513|NCT00477490|531664149|FG008|Part I: 4 Week Efficacy|Lost to Follow-up|0|||
147409514|NCT00477490|531664141|FG000|Part I: 4 Week Efficacy|Other, not specified|2|||
147409515|NCT00477490|531664142|FG001|Part I: 4 Week Efficacy|Other, not specified|4|||
147409516|NCT00477490|531664143|FG002|Part I: 4 Week Efficacy|Other, not specified|0|||
147409517|NCT00477490|531664144|FG003|Part I: 4 Week Efficacy|Other, not specified|1|||
147409518|NCT00477490|531664145|FG004|Part I: 4 Week Efficacy|Other, not specified|1|||
147409519|NCT00477490|531664146|FG005|Part I: 4 Week Efficacy|Other, not specified|0|||
147409520|NCT00477490|531664147|FG006|Part I: 4 Week Efficacy|Other, not specified|0|||
147409521|NCT00477490|531664148|FG007|Part I: 4 Week Efficacy|Other, not specified|0|||
147409522|NCT00477490|531664149|FG008|Part I: 4 Week Efficacy|Other, not specified|0|||
147409523|NCT00477490|531664141|FG000|Part I: 4 Week Efficacy|Not Reported|1|||
147409524|NCT00477490|531664142|FG001|Part I: 4 Week Efficacy|Not Reported|2|||
147409525|NCT00477490|531664143|FG002|Part I: 4 Week Efficacy|Not Reported|3|||
147409526|NCT00477490|531664144|FG003|Part I: 4 Week Efficacy|Not Reported|0|||
147409527|NCT00477490|531664145|FG004|Part I: 4 Week Efficacy|Not Reported|1|||
147409528|NCT00477490|531664146|FG005|Part I: 4 Week Efficacy|Not Reported|0|||
147409529|NCT00477490|531664147|FG006|Part I: 4 Week Efficacy|Not Reported|0|||
147409530|NCT00477490|531664148|FG007|Part I: 4 Week Efficacy|Not Reported|0|||
147409531|NCT00477490|531664149|FG008|Part I: 4 Week Efficacy|Not Reported|0|||
147409532|NCT00477490|531664141|FG000|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|0|||
147409533|NCT00477490|531664142|FG001|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|15|||
147409534|NCT00477490|531664143|FG002|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|7|||
147409535|NCT00477490|531664144|FG003|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|7|||
147409536|NCT00477490|531664145|FG004|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|10|||
147409537|NCT00477490|531664146|FG005|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|4|||
147409538|NCT00477490|531664147|FG006|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|2|||
147409539|NCT00477490|531664148|FG007|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|3|||
147409540|NCT00477490|531664149|FG008|Part II: Extension Week 5 up to Day 169|Withdrawal by Subject|2|||
147409541|NCT00477490|531664141|FG000|Part II: Extension Week 5 up to Day 169|Adverse Event|0|||
147409542|NCT00477490|531664142|FG001|Part II: Extension Week 5 up to Day 169|Adverse Event|2|||
147409543|NCT00477490|531664143|FG002|Part II: Extension Week 5 up to Day 169|Adverse Event|3|||
147409544|NCT00477490|531664144|FG003|Part II: Extension Week 5 up to Day 169|Adverse Event|1|||
147409545|NCT00477490|531664145|FG004|Part II: Extension Week 5 up to Day 169|Adverse Event|1|||
147409546|NCT00477490|531664146|FG005|Part II: Extension Week 5 up to Day 169|Adverse Event|1|||
147466159|NCT02338843|531865937|FG000|Overall Study|Adverse Event|2|||
147409547|NCT00477490|531664147|FG006|Part II: Extension Week 5 up to Day 169|Adverse Event|1|||
147466160|NCT02338843|531865938|FG001|Overall Study|Adverse Event|1|||
147466161|NCT02338843|531865937|FG000|Overall Study|Death|40|||
147466162|NCT02338843|531865938|FG001|Overall Study|Death|53|||
147466163|NCT02338843|531865937|FG000|Overall Study|Physician Decision|1|||
147466164|NCT02338843|531865938|FG001|Overall Study|Physician Decision|0|||
147466165|NCT02338843|531865937|FG000|Overall Study|Withdrawal by Subject|0|||
147466166|NCT02338843|531865938|FG001|Overall Study|Withdrawal by Subject|2|||
147466167|NCT02338843|531865937|FG000|Overall Study|Subject Recovered|0|||
147466168|NCT02338843|531865938|FG001|Overall Study|Subject Recovered|2|||
147466169|NCT02338843|531865937|FG000|Overall Study|Discontinued prior to randomizat|1|||
147466170|NCT02338843|531865938|FG001|Overall Study|Discontinued prior to randomizat|0|||
147466171|NCT00023322|531865939|FG000|Overall Study|Lost to Follow-up|1|||
147466172|NCT01609933|531865942|FG000|Overall Study|Adverse Event|1|||
147466173|NCT01609933|531865942|FG000|Overall Study|Withdrawal by Subject|3|||
147466174|NCT01252966|531865943|FG000|Overall Study|Lost to Follow-up|16|||
147466175|NCT01252966|531865944|FG001|Overall Study|Lost to Follow-up|10|||
147466176|NCT01252966|531865943|FG000|Overall Study|Withdrawal by Subject|7|||
147617192|NCT00758524|532413737|FG005|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
147617193|NCT00758524|532413738|FG006|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
147617194|NCT00758524|532413739|FG007|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
147617195|NCT00758524|532413740|FG008|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
147617196|NCT00758524|532413741|FG009|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
147617197|NCT00758524|532413742|FG010|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
147617198|NCT00758524|532413743|FG011|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
147617199|NCT00758524|532413744|FG012|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
147617200|NCT00758524|532413745|FG013|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
147617201|NCT00758524|532413746|FG014|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
147617202|NCT00758524|532413747|FG015|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
147617203|NCT00758524|532413748|FG016|Core Period (Week 0 to Week 8)|Abnormal Test Procedure Results|0|||
147617204|NCT00758524|532413732|FG000|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
147617205|NCT00758524|532413733|FG001|Core Period (Week 0 to Week 8)|Reason not Specified|1|||
147617206|NCT00758524|532413734|FG002|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
147617207|NCT00758524|532413735|FG003|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
147617208|NCT00758524|532413736|FG004|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
147617209|NCT00758524|532413737|FG005|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
147617210|NCT00758524|532413738|FG006|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
147617211|NCT00758524|532413739|FG007|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
147617212|NCT00758524|532413740|FG008|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
147617213|NCT00758524|532413741|FG009|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
147617214|NCT00758524|532413742|FG010|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
147617215|NCT00758524|532413743|FG011|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
147617216|NCT00758524|532413744|FG012|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
147617217|NCT00758524|532413745|FG013|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
147617218|NCT00758524|532413746|FG014|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
147617219|NCT00758524|532413747|FG015|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
147466177|NCT01252966|531865944|FG001|Overall Study|Withdrawal by Subject|3|||
147466178|NCT05194345|531865946|FG000|Overall Study|Withdrawal by Subject|6|||
147466179|NCT05194345|531865947|FG001|Overall Study|Withdrawal by Subject|4|||
147466180|NCT05194345|531865948|FG002|Overall Study|Withdrawal by Subject|0|||
147466181|NCT05194345|531865946|FG000|Overall Study|Moved to another state, becoming ineligible.|0|||
147466182|NCT05194345|531865947|FG001|Overall Study|Moved to another state, becoming ineligible.|2|||
147466183|NCT05194345|531865948|FG002|Overall Study|Moved to another state, becoming ineligible.|0|||
147466184|NCT04854499|531865950|FG000|Overall Study|Study Terminated by Sponsor|5|||
147466185|NCT04854499|531865951|FG001|Overall Study|Study Terminated by Sponsor|27|||
147466186|NCT04854499|531865952|FG002|Overall Study|Study Terminated by Sponsor|28|||
147466187|NCT04854499|531865953|FG003|Overall Study|Study Terminated by Sponsor|19|||
147466188|NCT04854499|531865954|FG004|Overall Study|Study Terminated by Sponsor|1|||
147466189|NCT04854499|531865955|FG005|Overall Study|Study Terminated by Sponsor|10|||
147466190|NCT04854499|531865950|FG000|Overall Study|Death|1|||
147466191|NCT04854499|531865951|FG001|Overall Study|Death|23|||
147466192|NCT04854499|531865952|FG002|Overall Study|Death|21|||
147466193|NCT04854499|531865953|FG003|Overall Study|Death|7|||
147466194|NCT04854499|531865954|FG004|Overall Study|Death|6|||
147466195|NCT04854499|531865955|FG005|Overall Study|Death|24|||
147617220|NCT00758524|532413748|FG016|Core Period (Week 0 to Week 8)|Reason not Specified|0|||
147466196|NCT04854499|531865950|FG000|Overall Study|Investigator's Discretion|0|||
147466197|NCT04854499|531865951|FG001|Overall Study|Investigator's Discretion|1|||
147466198|NCT04854499|531865952|FG002|Overall Study|Investigator's Discretion|3|||
147466199|NCT04854499|531865953|FG003|Overall Study|Investigator's Discretion|4|||
147466200|NCT04854499|531865954|FG004|Overall Study|Investigator's Discretion|1|||
147466201|NCT04854499|531865955|FG005|Overall Study|Investigator's Discretion|5|||
147466202|NCT04854499|531865950|FG000|Overall Study|Withdrew Consent|0|||
147466203|NCT04854499|531865951|FG001|Overall Study|Withdrew Consent|1|||
147617221|NCT00758524|532413732|FG000|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
147617222|NCT00758524|532413733|FG001|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
147617223|NCT00758524|532413734|FG002|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
147617224|NCT00758524|532413735|FG003|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
147617225|NCT00758524|532413736|FG004|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
147617226|NCT00758524|532413737|FG005|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
147617227|NCT00758524|532413738|FG006|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
147617228|NCT00758524|532413739|FG007|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
147617229|NCT00758524|532413740|FG008|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|2|||
147617230|NCT00758524|532413741|FG009|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
147617231|NCT00758524|532413742|FG010|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
147617232|NCT00758524|532413743|FG011|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
147617233|NCT00758524|532413744|FG012|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
147617234|NCT00758524|532413745|FG013|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
147617235|NCT00758524|532413746|FG014|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
147409548|NCT00477490|531664148|FG007|Part II: Extension Week 5 up to Day 169|Adverse Event|1|||
147409549|NCT00477490|531664149|FG008|Part II: Extension Week 5 up to Day 169|Adverse Event|4|||
147409550|NCT00477490|531664141|FG000|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0|||
147409551|NCT00477490|531664142|FG001|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|3|||
147409552|NCT00477490|531664143|FG002|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|2|||
147409553|NCT00477490|531664144|FG003|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0|||
147617236|NCT00758524|532413747|FG015|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
147617237|NCT00758524|532413748|FG016|Withdrawal Period (Week 8 to Week 9)|Unsatisfactory Therapeutic Effect|0|||
147665533|NCT01103323|532599607|FG000|Without/Before Drug Switch|Physician Decision|2|||
147665534|NCT01103323|532599608|FG001|Without/Before Drug Switch|Physician Decision|0|||
147409554|NCT00477490|531664145|FG004|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|5|||
147409555|NCT00477490|531664146|FG005|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0|||
147409556|NCT00477490|531664147|FG006|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|1|||
147409557|NCT00477490|531664148|FG007|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0|||
147409558|NCT00477490|531664149|FG008|Part II: Extension Week 5 up to Day 169|Lost to Follow-up|0|||
147409559|NCT00477490|531664141|FG000|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
147409560|NCT00477490|531664142|FG001|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
147409561|NCT00477490|531664143|FG002|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
147409562|NCT00477490|531664144|FG003|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
147409563|NCT00477490|531664145|FG004|Part II: Extension Week 5 up to Day 169|Decreased sodium|1|||
147409564|NCT00477490|531664146|FG005|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
147409565|NCT00477490|531664147|FG006|Part II: Extension Week 5 up to Day 169|Decreased sodium|0|||
147409566|NCT00477490|531664148|FG007|Part II: Extension Week 5 up to Day 169|Decreased sodium|1|||
147409567|NCT00477490|531664149|FG008|Part II: Extension Week 5 up to Day 169|Decreased sodium|1|||
147409568|NCT00477490|531664141|FG000|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
147409569|NCT00477490|531664142|FG001|Part II: Extension Week 5 up to Day 169|Excluded medication|1|||
147409570|NCT00477490|531664143|FG002|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
147409571|NCT00477490|531664144|FG003|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
147409572|NCT00477490|531664145|FG004|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
147409573|NCT00477490|531664146|FG005|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
147409574|NCT00477490|531664147|FG006|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
147409575|NCT00477490|531664148|FG007|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
147409576|NCT00477490|531664149|FG008|Part II: Extension Week 5 up to Day 169|Excluded medication|0|||
147409577|NCT00477490|531664141|FG000|Part II: Extension Week 5 up to Day 169|Other, not specified|0|||
147409578|NCT00477490|531664142|FG001|Part II: Extension Week 5 up to Day 169|Other, not specified|4|||
147409579|NCT00477490|531664143|FG002|Part II: Extension Week 5 up to Day 169|Other, not specified|2|||
147409580|NCT00477490|531664144|FG003|Part II: Extension Week 5 up to Day 169|Other, not specified|4|||
147409581|NCT00477490|531664145|FG004|Part II: Extension Week 5 up to Day 169|Other, not specified|2|||
147409582|NCT00477490|531664146|FG005|Part II: Extension Week 5 up to Day 169|Other, not specified|1|||
147409583|NCT00477490|531664147|FG006|Part II: Extension Week 5 up to Day 169|Other, not specified|1|||
147409584|NCT00477490|531664148|FG007|Part II: Extension Week 5 up to Day 169|Other, not specified|0|||
147409585|NCT00477490|531664149|FG008|Part II: Extension Week 5 up to Day 169|Other, not specified|1|||
147409586|NCT00477490|531664141|FG000|Part II: Extension Week 5 up to Day 169|Not reported|0|||
147409587|NCT00477490|531664142|FG001|Part II: Extension Week 5 up to Day 169|Not reported|3|||
147409588|NCT00477490|531664143|FG002|Part II: Extension Week 5 up to Day 169|Not reported|1|||
147409589|NCT00477490|531664144|FG003|Part II: Extension Week 5 up to Day 169|Not reported|0|||
147466204|NCT04854499|531865952|FG002|Overall Study|Withdrew Consent|2|||
147617238|NCT00758524|532413732|FG000|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
147617239|NCT00758524|532413733|FG001|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
147617240|NCT00758524|532413734|FG002|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
147617241|NCT00758524|532413735|FG003|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
147617242|NCT00758524|532413736|FG004|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
147617243|NCT00758524|532413737|FG005|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
147617244|NCT00758524|532413738|FG006|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|1|||
147617245|NCT00758524|532413739|FG007|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
147617246|NCT00758524|532413740|FG008|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
147617247|NCT00758524|532413741|FG009|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
147617248|NCT00758524|532413742|FG010|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
147617249|NCT00758524|532413743|FG011|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
147617250|NCT00758524|532413744|FG012|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
147617251|NCT00758524|532413745|FG013|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
147617252|NCT00758524|532413746|FG014|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
147617253|NCT00758524|532413747|FG015|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
147617254|NCT00758524|532413748|FG016|Withdrawal Period (Week 8 to Week 9)|Lost to Follow-up|0|||
147617255|NCT04176250|532413749|FG000|Overall Study|Adverse Event|0|||
147617256|NCT04176250|532413750|FG001|Overall Study|Adverse Event|1|||
147617257|NCT04176250|532413751|FG002|Overall Study|Adverse Event|0|||
147617258|NCT04176250|532413752|FG003|Overall Study|Adverse Event|1|||
147617259|NCT04176250|532413753|FG004|Overall Study|Adverse Event|0|||
147617260|NCT04176250|532413754|FG005|Overall Study|Adverse Event|1|||
147617261|NCT04176250|532413749|FG000|Overall Study|Positive CoronaVIrus Disease(COVID)/Severe Acute Respiratory Syndrome CoronaVirus 2(SARS-CoV-2) test|0|||
147617262|NCT04176250|532413750|FG001|Overall Study|Positive CoronaVIrus Disease(COVID)/Severe Acute Respiratory Syndrome CoronaVirus 2(SARS-CoV-2) test|0|||
147617263|NCT04176250|532413751|FG002|Overall Study|Positive CoronaVIrus Disease(COVID)/Severe Acute Respiratory Syndrome CoronaVirus 2(SARS-CoV-2) test|1|||
147617264|NCT04176250|532413752|FG003|Overall Study|Positive CoronaVIrus Disease(COVID)/Severe Acute Respiratory Syndrome CoronaVirus 2(SARS-CoV-2) test|1|||
147617265|NCT04176250|532413753|FG004|Overall Study|Positive CoronaVIrus Disease(COVID)/Severe Acute Respiratory Syndrome CoronaVirus 2(SARS-CoV-2) test|0|||
147617266|NCT04176250|532413754|FG005|Overall Study|Positive CoronaVIrus Disease(COVID)/Severe Acute Respiratory Syndrome CoronaVirus 2(SARS-CoV-2) test|0|||
147617267|NCT04176250|532413749|FG000|Overall Study|Withdrawal by Subject|0|||
147617268|NCT04176250|532413750|FG001|Overall Study|Withdrawal by Subject|0|||
147617269|NCT04176250|532413751|FG002|Overall Study|Withdrawal by Subject|0|||
147617270|NCT04176250|532413752|FG003|Overall Study|Withdrawal by Subject|0|||
147617271|NCT04176250|532413753|FG004|Overall Study|Withdrawal by Subject|0|||
147617272|NCT04176250|532413754|FG005|Overall Study|Withdrawal by Subject|1|||
147617273|NCT04176250|532413749|FG000|Overall Study|Randomized in error|0|||
147617274|NCT04176250|532413750|FG001|Overall Study|Randomized in error|0|||
147617275|NCT04176250|532413751|FG002|Overall Study|Randomized in error|0|||
147617276|NCT04176250|532413752|FG003|Overall Study|Randomized in error|0|||
147617277|NCT04176250|532413753|FG004|Overall Study|Randomized in error|1|||
147617278|NCT04176250|532413754|FG005|Overall Study|Randomized in error|0|||
147617279|NCT01431079|532413768|FG000|Overall Study|Lost to Follow-up|35|||
147617280|NCT01431079|532413769|FG001|Overall Study|Lost to Follow-up|39|||
147617281|NCT01202175|532413770|FG000|Overall Study|Lost to Follow-up|2|||
147617282|NCT01202175|532413770|FG000|Overall Study|Withdrawal by Subject|1|||
147617283|NCT01202175|532413770|FG000|Overall Study|Adverse Event|2|||
147617284|NCT02790437|532413771|FG000|Overall Study|Patient graft failure - nephrectomy|1|||
147617285|NCT02790437|532413772|FG001|Overall Study|Patient graft failure - nephrectomy|0|||
147466205|NCT04854499|531865953|FG003|Overall Study|Withdrew Consent|2|||
147466206|NCT04854499|531865954|FG004|Overall Study|Withdrew Consent|0|||
147466207|NCT04854499|531865955|FG005|Overall Study|Withdrew Consent|1|||
147466208|NCT04854499|531865950|FG000|Overall Study|Lost to Follow-up|0|||
147466209|NCT04854499|531865951|FG001|Overall Study|Lost to Follow-up|0|||
147466210|NCT04854499|531865952|FG002|Overall Study|Lost to Follow-up|0|||
147466211|NCT04854499|531865953|FG003|Overall Study|Lost to Follow-up|0|||
147466212|NCT04854499|531865954|FG004|Overall Study|Lost to Follow-up|0|||
147466213|NCT04854499|531865955|FG005|Overall Study|Lost to Follow-up|1|||
147466214|NCT05415449|531865956|FG000|Overall Study|Lost to Follow-up|2|||
147466215|NCT05415449|531865956|FG000|Overall Study|Withdrawal by Subject|4|||
147617286|NCT02790437|532413771|FG000|Overall Study|Adverse Event|1|||
147617287|NCT02790437|532413772|FG001|Overall Study|Adverse Event|0|||
147617288|NCT02790437|532413771|FG000|Overall Study|Withdrawal by Subject|1|||
147617289|NCT02790437|532413772|FG001|Overall Study|Withdrawal by Subject|0|||
147617290|NCT01626690|532413776|FG000|Overall Study|Protocol Violation|1|||
147617291|NCT01626690|532413777|FG001|Overall Study|Protocol Violation|0|||
147466216|NCT02185521|531865960|FG000|Overall Study|Withdrawal by Subject|1|||
147617292|NCT01626690|532413776|FG000|Overall Study|Adverse Event|1|||
147617293|NCT01626690|532413777|FG001|Overall Study|Adverse Event|0|||
147466217|NCT02185521|531865960|FG000|Overall Study|Protocol Violation|1|||
147466218|NCT00398112|531865961|FG000|Overall Study|Adverse Event|4|||
147466219|NCT00398112|531865961|FG000|Overall Study|Disease progression|9|||
147466220|NCT00398112|531865961|FG000|Overall Study|Alternative treatment|1|||
147466221|NCT00398112|531865961|FG000|Overall Study|Withdrawal by Subject|3|||
147466222|NCT00398112|531865961|FG000|Overall Study|Death|1|||
147466223|NCT01887912|531865963|FG000|Overall Study|Serious adverse event|400|||
147466224|NCT01887912|531865964|FG001|Overall Study|Serious adverse event|198|||
147466225|NCT01887912|531865963|FG000|Overall Study|Other Adverse Event|34|||
147466226|NCT01887912|531865964|FG001|Overall Study|Other Adverse Event|15|||
147466227|NCT01887912|531865963|FG000|Overall Study|Protocol Violation|67|||
147466228|NCT01887912|531865964|FG001|Overall Study|Protocol Violation|37|||
147466229|NCT01887912|531865963|FG000|Overall Study|Lost to Follow-up|163|||
147466230|NCT01887912|531865964|FG001|Overall Study|Lost to Follow-up|74|||
147466231|NCT01887912|531865963|FG000|Overall Study|Withdrawal by Subject|606|||
147466232|NCT01887912|531865964|FG001|Overall Study|Withdrawal by Subject|349|||
147466233|NCT01887912|531865963|FG000|Overall Study|Other|122|||
147466234|NCT01887912|531865964|FG001|Overall Study|Other|58|||
147466235|NCT03932812|531865968|FG000|Overall Study|Lost to Follow-up|12|||
147466236|NCT03932812|531865969|FG001|Overall Study|Lost to Follow-up|14|||
147466237|NCT03932812|531865968|FG000|Overall Study|Death of care partner (person living with dementia)|5|||
147466238|NCT03932812|531865969|FG001|Overall Study|Death of care partner (person living with dementia)|1|||
147466239|NCT03155997|531865970|FG000|Overall Study|Withdrawal by Subject|119|||
147466240|NCT03155997|531865971|FG001|Overall Study|Withdrawal by Subject|134|||
147466241|NCT03155997|531865970|FG000|Overall Study|Lost to Follow-up|12|||
147466242|NCT03155997|531865971|FG001|Overall Study|Lost to Follow-up|13|||
147466243|NCT03155997|531865970|FG000|Overall Study|Missing disposition data|0|||
147466244|NCT03155997|531865971|FG001|Overall Study|Missing disposition data|1|||
147466245|NCT03155997|531865970|FG000|Overall Study|On study treatment|2027|||
147466246|NCT03155997|531865971|FG001|Overall Study|On study treatment|2074|||
147466247|NCT00862251|531865974|FG000|Overall Study|Adverse Event|8|||
147466248|NCT00862251|531865975|FG001|Overall Study|Adverse Event|3|||
147466249|NCT00862251|531865976|FG002|Overall Study|Adverse Event|1|||
147466250|NCT00862251|531865974|FG000|Overall Study|Lost to Follow-up|0|||
147466251|NCT00862251|531865975|FG001|Overall Study|Lost to Follow-up|0|||
147466252|NCT00862251|531865976|FG002|Overall Study|Lost to Follow-up|1|||
147466253|NCT00862251|531865974|FG000|Overall Study|Protocol Violation|2|||
147466254|NCT00862251|531865975|FG001|Overall Study|Protocol Violation|0|||
147466255|NCT00862251|531865976|FG002|Overall Study|Protocol Violation|1|||
147466256|NCT00862251|531865974|FG000|Overall Study|Withdrawal by Subject|9|||
147466257|NCT00862251|531865975|FG001|Overall Study|Withdrawal by Subject|2|||
147466258|NCT00862251|531865976|FG002|Overall Study|Withdrawal by Subject|6|||
147466259|NCT02796755|531865977|FG000|Overall Study|Adverse Event|2|||
147466260|NCT02796755|531865978|FG001|Overall Study|Adverse Event|0|||
147466261|NCT02054702|531865984|FG000|Overall Study|Lost to Follow-up|3|||
147466262|NCT02054702|531865985|FG001|Overall Study|Lost to Follow-up|5|||
147466263|NCT02054702|531865984|FG000|Overall Study|Adverse Event|3|||
147466264|NCT02054702|531865985|FG001|Overall Study|Adverse Event|1|||
147466265|NCT02054702|531865984|FG000|Overall Study|Met Withdrawal Criteria|4|||
147466266|NCT02054702|531865985|FG001|Overall Study|Met Withdrawal Criteria|1|||
147466267|NCT02054702|531865984|FG000|Overall Study|Physician Decision|0|||
147466268|NCT02054702|531865985|FG001|Overall Study|Physician Decision|1|||
147466269|NCT02054702|531865984|FG000|Overall Study|Withdrawal by Subject|14|||
147466270|NCT02054702|531865985|FG001|Overall Study|Withdrawal by Subject|4|||
147466271|NCT01111604|531865999|FG000|Overall Study|Lost to Follow-up|0|||
147466272|NCT01111604|531866000|FG001|Overall Study|Lost to Follow-up|0|||
147466273|NCT01111604|531866001|FG002|Overall Study|Lost to Follow-up|1|||
147466274|NCT01111604|531865999|FG000|Overall Study|Withdrew Consent|3|||
147466275|NCT01111604|531866000|FG001|Overall Study|Withdrew Consent|0|||
147466276|NCT01111604|531866001|FG002|Overall Study|Withdrew Consent|2|||
147617294|NCT04688671|532413778|FG000|Overall Study|Adverse Event|3|||
147617295|NCT04688671|532413779|FG001|Overall Study|Adverse Event|1|||
147466277|NCT01111604|531865999|FG000|Overall Study|Withdrawal by Subject|2|||
147617296|NCT04688671|532413778|FG000|Overall Study|Withdrawal by Subject|3|||
147466278|NCT01111604|531866000|FG001|Overall Study|Withdrawal by Subject|0|||
147617297|NCT04688671|532413779|FG001|Overall Study|Withdrawal by Subject|1|||
147466279|NCT01111604|531866001|FG002|Overall Study|Withdrawal by Subject|0|||
147466280|NCT01111604|531865999|FG000|Overall Study|Death|1|||
147466281|NCT01111604|531866000|FG001|Overall Study|Death|0|||
147466282|NCT01111604|531866001|FG002|Overall Study|Death|0|||
147466283|NCT01111604|531865999|FG000|Overall Study|Met Exclusion Criteria|2|||
147466284|NCT01111604|531866000|FG001|Overall Study|Met Exclusion Criteria|0|||
147617298|NCT04688671|532413778|FG000|Overall Study|Lack of Efficacy|1|||
147466285|NCT01111604|531866001|FG002|Overall Study|Met Exclusion Criteria|0|||
147466286|NCT01295125|531866003|FG000|Overall Study|Study stopped prematurely|9|||
147466287|NCT01360996|531866004|FG000|Overall Study|Withdrawal by Subject|4|||
147466288|NCT01360996|531866005|FG001|Overall Study|Withdrawal by Subject|3|||
147466289|NCT01360996|531866006|FG002|Overall Study|Withdrawal by Subject|2|||
147466290|NCT01360996|531866004|FG000|Overall Study|Noncompliant|2|||
147466291|NCT01360996|531866005|FG001|Overall Study|Noncompliant|0|||
147617299|NCT04688671|532413779|FG001|Overall Study|Lack of Efficacy|1|||
147617300|NCT04688671|532413778|FG000|Overall Study|Protocol Violation|1|||
147617301|NCT04688671|532413779|FG001|Overall Study|Protocol Violation|0|||
147617302|NCT04688671|532413778|FG000|Overall Study|Lost to Follow-up|0|||
147617303|NCT04688671|532413779|FG001|Overall Study|Lost to Follow-up|1|||
147617304|NCT04720053|532413780|FG000|Overall Study|Lost to Follow-up|12|||
147617305|NCT01960257|532413781|FG000|Stage 1 (1-3 Weeks)|Only participated in PK Substudy|12|||
147617306|NCT01960257|532413782|FG001|Stage 1 (1-3 Weeks)|Only participated in PK Substudy|0|||
147617307|NCT01960257|532413783|FG002|Stage 1 (1-3 Weeks)|Only participated in PK Substudy|0|||
147617308|NCT01960257|532413781|FG000|Stage 1 (1-3 Weeks)|Withdrawal by Subject|3|||
147665535|NCT01103323|532599607|FG000|Without/Before Drug Switch|did not receive study treatment|5|||
147409590|NCT00477490|531664145|FG004|Part II: Extension Week 5 up to Day 169|Not reported|1|||
147409591|NCT00477490|531664146|FG005|Part II: Extension Week 5 up to Day 169|Not reported|0|||
147409592|NCT00477490|531664147|FG006|Part II: Extension Week 5 up to Day 169|Not reported|0|||
147409593|NCT00477490|531664148|FG007|Part II: Extension Week 5 up to Day 169|Not reported|0|||
147409594|NCT00477490|531664149|FG008|Part II: Extension Week 5 up to Day 169|Not reported|0|||
147409595|NCT01465763|531664152|FG000|Overall Study|Withdrawal by Subject|4|||
147409596|NCT01465763|531664153|FG001|Overall Study|Withdrawal by Subject|0|||
147409597|NCT01465763|531664154|FG002|Overall Study|Withdrawal by Subject|1|||
147409598|NCT01465763|531664152|FG000|Overall Study|Insufficient Clinical Response|11|||
147409599|NCT01465763|531664153|FG001|Overall Study|Insufficient Clinical Response|0|||
147409600|NCT01465763|531664154|FG002|Overall Study|Insufficient Clinical Response|1|||
147409601|NCT01465763|531664152|FG000|Overall Study|Adverse Event|9|||
147409602|NCT01465763|531664153|FG001|Overall Study|Adverse Event|0|||
147409603|NCT01465763|531664154|FG002|Overall Study|Adverse Event|1|||
147409604|NCT01465763|531664152|FG000|Overall Study|Other|2|||
147409605|NCT01465763|531664153|FG001|Overall Study|Other|0|||
147409606|NCT01465763|531664154|FG002|Overall Study|Other|0|||
147409607|NCT01465763|531664152|FG000|Overall Study|Protocol Violation|4|||
147409608|NCT01465763|531664153|FG001|Overall Study|Protocol Violation|1|||
147409609|NCT01465763|531664154|FG002|Overall Study|Protocol Violation|1|||
147409610|NCT01465763|531664152|FG000|Overall Study|Death|1|||
147409611|NCT01465763|531664153|FG001|Overall Study|Death|0|||
147409612|NCT01465763|531664154|FG002|Overall Study|Death|0|||
147409613|NCT01646177|531664155|FG000|Blinded Induction Dosing (Week 0-12)|Adverse Event|2|||
147409614|NCT01646177|531664156|FG001|Blinded Induction Dosing (Week 0-12)|Adverse Event|4|||
147409615|NCT01646177|531664157|FG002|Blinded Induction Dosing (Week 0-12)|Adverse Event|9|||
147409616|NCT01646177|531664158|FG003|Blinded Induction Dosing (Week 0-12)|Adverse Event|8|||
147409617|NCT01646177|531664159|FG004|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
147409618|NCT01646177|531664160|FG005|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
147409619|NCT01646177|531664161|FG006|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
147409620|NCT01646177|531664162|FG007|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
147409621|NCT01646177|531664163|FG008|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
147409622|NCT01646177|531664164|FG009|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
147409623|NCT01646177|531664165|FG010|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
147409624|NCT01646177|531664166|FG011|Blinded Induction Dosing (Week 0-12)|Adverse Event|0|||
147409625|NCT01646177|531664155|FG000|Blinded Induction Dosing (Week 0-12)|Protocol Violation|1|||
147409626|NCT01646177|531664156|FG001|Blinded Induction Dosing (Week 0-12)|Protocol Violation|3|||
147409627|NCT01646177|531664157|FG002|Blinded Induction Dosing (Week 0-12)|Protocol Violation|8|||
147409628|NCT01646177|531664158|FG003|Blinded Induction Dosing (Week 0-12)|Protocol Violation|7|||
147409629|NCT01646177|531664159|FG004|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
147409630|NCT01646177|531664160|FG005|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
147409631|NCT01646177|531664161|FG006|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
147409632|NCT01646177|531664162|FG007|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
147409633|NCT01646177|531664163|FG008|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
147409634|NCT01646177|531664164|FG009|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
147409635|NCT01646177|531664165|FG010|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
147409636|NCT01646177|531664166|FG011|Blinded Induction Dosing (Week 0-12)|Protocol Violation|0|||
147409637|NCT01646177|531664155|FG000|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|3|||
147409638|NCT01646177|531664156|FG001|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|2|||
147409639|NCT01646177|531664157|FG002|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|4|||
147409640|NCT01646177|531664158|FG003|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|4|||
147409641|NCT01646177|531664159|FG004|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
147409642|NCT01646177|531664160|FG005|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
147409643|NCT01646177|531664161|FG006|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
147409644|NCT01646177|531664162|FG007|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
147409645|NCT01646177|531664163|FG008|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
147409646|NCT01646177|531664164|FG009|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
147409647|NCT01646177|531664165|FG010|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
147409648|NCT01646177|531664166|FG011|Blinded Induction Dosing (Week 0-12)|Withdrawal by Subject|0|||
147617309|NCT01960257|532413782|FG001|Stage 1 (1-3 Weeks)|Withdrawal by Subject|0|||
147617310|NCT01960257|532413783|FG002|Stage 1 (1-3 Weeks)|Withdrawal by Subject|0|||
147617311|NCT01960257|532413781|FG000|Stage 1 (1-3 Weeks)|Adverse Event|1|||
147617312|NCT01960257|532413782|FG001|Stage 1 (1-3 Weeks)|Adverse Event|0|||
147617313|NCT01960257|532413783|FG002|Stage 1 (1-3 Weeks)|Adverse Event|0|||
147617314|NCT03749330|532413784|FG000|Overall Study|Clinicians left work in the CICU|0|||
147617315|NCT03749330|532413785|FG001|Overall Study|Clinicians left work in the CICU|2|||
147617316|NCT03749330|532413786|FG002|Overall Study|Clinicians left work in the CICU|0|||
147617317|NCT03749330|532413787|FG003|Overall Study|Clinicians left work in the CICU|0|||
147617318|NCT03749330|532413788|FG004|Overall Study|Clinicians left work in the CICU|0|||
147617319|NCT03749330|532413789|FG005|Overall Study|Clinicians left work in the CICU|0|||
147617320|NCT03908125|532413790|FG000|Overall Study|Withdrawal by Subject|92|||
147665536|NCT01103323|532599608|FG001|Without/Before Drug Switch|did not receive study treatment|2|||
147466292|NCT01360996|531866006|FG002|Overall Study|Noncompliant|0|||
147466293|NCT01454076|531866007|FG000|Overall Study|Other|2|||
147466294|NCT01454076|531866008|FG001|Overall Study|Other|0|||
147466295|NCT01454076|531866009|FG002|Overall Study|Other|0|||
147466296|NCT01454076|531866010|FG003|Overall Study|Other|1|||
147466297|NCT01454076|531866011|FG004|Overall Study|Other|2|||
147466298|NCT01454076|531866007|FG000|Overall Study|Withdrawal by Subject|3|||
147466299|NCT01454076|531866008|FG001|Overall Study|Withdrawal by Subject|4|||
147665537|NCT01103323|532599607|FG000|Without/Before Drug Switch|Switch to Regorafenib|0|||
147409649|NCT01646177|531664155|FG000|Blinded Induction Dosing (Week 0-12)|Physician Decision|1|||
147409650|NCT01646177|531664156|FG001|Blinded Induction Dosing (Week 0-12)|Physician Decision|2|||
147409651|NCT01646177|531664157|FG002|Blinded Induction Dosing (Week 0-12)|Physician Decision|1|||
147409652|NCT01646177|531664158|FG003|Blinded Induction Dosing (Week 0-12)|Physician Decision|2|||
147409653|NCT01646177|531664159|FG004|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
147409654|NCT01646177|531664160|FG005|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
147409655|NCT01646177|531664161|FG006|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
147409656|NCT01646177|531664162|FG007|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
147409657|NCT01646177|531664163|FG008|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
147409658|NCT01646177|531664164|FG009|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
147409659|NCT01646177|531664165|FG010|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
147409660|NCT01646177|531664166|FG011|Blinded Induction Dosing (Week 0-12)|Physician Decision|0|||
147409661|NCT01646177|531664155|FG000|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
147409662|NCT01646177|531664156|FG001|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
147409663|NCT01646177|531664157|FG002|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|2|||
147409664|NCT01646177|531664158|FG003|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|1|||
147409665|NCT01646177|531664159|FG004|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
147409666|NCT01646177|531664160|FG005|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
147409667|NCT01646177|531664161|FG006|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
147409668|NCT01646177|531664162|FG007|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
147409669|NCT01646177|531664163|FG008|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
147409670|NCT01646177|531664164|FG009|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
147409671|NCT01646177|531664165|FG010|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
147409672|NCT01646177|531664166|FG011|Blinded Induction Dosing (Week 0-12)|Lack of Efficacy|0|||
147409673|NCT01646177|531664155|FG000|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|3|||
147409674|NCT01646177|531664156|FG001|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|2|||
147409675|NCT01646177|531664157|FG002|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|2|||
147409676|NCT01646177|531664158|FG003|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
147409677|NCT01646177|531664159|FG004|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
147409678|NCT01646177|531664160|FG005|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
147409679|NCT01646177|531664161|FG006|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
147409680|NCT01646177|531664162|FG007|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
147409681|NCT01646177|531664163|FG008|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
147409682|NCT01646177|531664164|FG009|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
147409683|NCT01646177|531664165|FG010|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
147409684|NCT01646177|531664166|FG011|Blinded Induction Dosing (Week 0-12)|Lost to Follow-up|0|||
147409685|NCT01646177|531664155|FG000|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
147409686|NCT01646177|531664156|FG001|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
147409687|NCT01646177|531664157|FG002|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
147409688|NCT01646177|531664158|FG003|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
147409689|NCT01646177|531664159|FG004|Long-Term Extension Period (Week 12-264)|Adverse Event|16|||
147409690|NCT01646177|531664160|FG005|Long-Term Extension Period (Week 12-264)|Adverse Event|34|||
147466300|NCT01454076|531866009|FG002|Overall Study|Withdrawal by Subject|2|||
147466301|NCT01454076|531866010|FG003|Overall Study|Withdrawal by Subject|1|||
147466302|NCT01454076|531866011|FG004|Overall Study|Withdrawal by Subject|2|||
147466303|NCT01454076|531866007|FG000|Overall Study|Adverse Event|8|||
147466304|NCT01454076|531866008|FG001|Overall Study|Adverse Event|2|||
147617321|NCT03908125|532413790|FG000|Overall Study|Lost to Follow-up|8|||
147617322|NCT02676882|532413791|FG000|Overall Study|Adverse Event|1|||
147617323|NCT02676882|532413792|FG001|Overall Study|Adverse Event|0|||
147617324|NCT02676882|532413791|FG000|Overall Study|Lost to Follow-up|1|||
147466305|NCT01454076|531866009|FG002|Overall Study|Adverse Event|7|||
147466306|NCT01454076|531866010|FG003|Overall Study|Adverse Event|0|||
147466307|NCT01454076|531866011|FG004|Overall Study|Adverse Event|2|||
147466308|NCT02965378|531866012|FG000|Overall Study|Progression|16|||
147466309|NCT02965378|531866013|FG001|Overall Study|Progression|4|||
147466310|NCT02965378|531866012|FG000|Overall Study|Adverse Event|5|||
147466311|NCT02965378|531866013|FG001|Overall Study|Adverse Event|2|||
147466312|NCT02965378|531866012|FG000|Overall Study|Death|2|||
147466313|NCT02965378|531866013|FG001|Overall Study|Death|0|||
147466314|NCT02965378|531866012|FG000|Overall Study|Refusal|2|||
147466315|NCT02965378|531866013|FG001|Overall Study|Refusal|1|||
147466316|NCT02965378|531866012|FG000|Overall Study|Not protocol specified|0|||
147466317|NCT02965378|531866013|FG001|Overall Study|Not protocol specified|2|||
147466318|NCT04964258|531866014|FG000|Overall Study|Lost to Follow-up|1|||
147466319|NCT04964258|531866015|FG001|Overall Study|Lost to Follow-up|0|||
147466320|NCT04964258|531866016|FG002|Overall Study|Lost to Follow-up|0|||
147466321|NCT04964258|531866017|FG003|Overall Study|Lost to Follow-up|0|||
147466322|NCT04964258|531866018|FG004|Overall Study|Lost to Follow-up|0|||
147466323|NCT04964258|531866019|FG005|Overall Study|Lost to Follow-up|1|||
147466324|NCT04964258|531866020|FG006|Overall Study|Lost to Follow-up|0|||
147466325|NCT04964258|531866021|FG007|Overall Study|Lost to Follow-up|0|||
147466326|NCT04964258|531866022|FG008|Overall Study|Lost to Follow-up|0|||
147466327|NCT04964258|531866023|FG009|Overall Study|Lost to Follow-up|0|||
147466328|NCT04964258|531866024|FG010|Overall Study|Lost to Follow-up|0|||
147466329|NCT04525703|531866025|FG000|Overall Study|Lost to Follow-up|6|||
147466330|NCT04525703|531866026|FG001|Overall Study|Lost to Follow-up|15|||
147466331|NCT04525703|531866027|FG002|Overall Study|Lost to Follow-up|8|||
147466332|NCT00291551|531866028|FG000|Overall Study|Death|7|||
147466333|NCT00291551|531866028|FG000|Overall Study|Withdrawal by Subject|6|||
147466334|NCT02452762|531866029|FG000|Overall Study|Received >1 loading dose of cholecalciferol and analyzed separately|4|||
147466335|NCT02452762|531866030|FG001|Overall Study|Received >1 loading dose of cholecalciferol and analyzed separately|3|||
147466336|NCT02452762|531866029|FG000|Overall Study|Withdrawal by Subject|1|||
147466337|NCT02452762|531866030|FG001|Overall Study|Withdrawal by Subject|0|||
147466338|NCT01957137|531866031|FG000|Randomized Portion|Adverse Event|1|||
147466339|NCT01957137|531866031|FG000|Randomized Portion|Withdrawal by Subject|1|||
147466340|NCT01651780|531866034|FG000|Overall Study|Physician decision: No 30-day visit|2|||
147466341|NCT01651780|531866035|FG001|Overall Study|Physician decision: No 30-day visit|1|||
147466342|NCT01651780|531866034|FG000|Overall Study|Reason Not Specified: No 30-day visit|2|||
147466343|NCT01651780|531866035|FG001|Overall Study|Reason Not Specified: No 30-day visit|2|||
147466344|NCT01651780|531866034|FG000|Overall Study|Withdrawal by Subject|2|||
147466345|NCT01651780|531866035|FG001|Overall Study|Withdrawal by Subject|0|||
147466346|NCT01651780|531866034|FG000|Overall Study|Inclusion/Exclusion Criteria Not Met|3|||
147466347|NCT01651780|531866035|FG001|Overall Study|Inclusion/Exclusion Criteria Not Met|0|||
147466348|NCT01651780|531866034|FG000|Overall Study|Lost to Follow-up|1|||
147466349|NCT01651780|531866035|FG001|Overall Study|Lost to Follow-up|2|||
147466350|NCT01651780|531866034|FG000|Overall Study|Physician decision: Day 30 visit <23 day|1|||
147466351|NCT01651780|531866035|FG001|Overall Study|Physician decision: Day 30 visit <23 day|5|||
147466352|NCT03898063|531866036|FG000|Overall Study|Withdrawal by Subject|10|||
147466353|NCT03898063|531866037|FG001|Overall Study|Withdrawal by Subject|8|||
147466354|NCT02949830|531866038|FG000|Overall Study|Adverse Event|1|||
147466355|NCT02949830|531866038|FG000|Overall Study|Withdrawal by Subject|1|||
147466356|NCT00054132|531866039|FG000|Overall Study|Not Treated|1|||
147466357|NCT01290887|531866040|FG000|Overall Study|Adverse Event|6|||
147466358|NCT01290887|531866041|FG001|Overall Study|Adverse Event|11|||
147466359|NCT01290887|531866040|FG000|Overall Study|Lack of Efficacy|4|||
147617325|NCT02676882|532413792|FG001|Overall Study|Lost to Follow-up|0|||
147617326|NCT02676882|532413791|FG000|Overall Study|Withdrawal by Subject|1|||
147617327|NCT02676882|532413792|FG001|Overall Study|Withdrawal by Subject|2|||
147466360|NCT01290887|531866041|FG001|Overall Study|Lack of Efficacy|5|||
147617328|NCT01518322|532413793|FG000|Overall Study|FeNO measurement was missing|13|||
147466361|NCT01290887|531866040|FG000|Overall Study|Withdrawal by Subject|26|||
147466362|NCT01290887|531866041|FG001|Overall Study|Withdrawal by Subject|32|||
147466363|NCT01290887|531866040|FG000|Overall Study|Protocol Violation|2|||
147466364|NCT01290887|531866041|FG001|Overall Study|Protocol Violation|1|||
147466365|NCT01290887|531866040|FG000|Overall Study|Lost to Follow-up|4|||
147466366|NCT01290887|531866041|FG001|Overall Study|Lost to Follow-up|4|||
147466367|NCT01290887|531866040|FG000|Overall Study|Non-compliance to study procedures|0|||
147466368|NCT01290887|531866041|FG001|Overall Study|Non-compliance to study procedures|1|||
147617329|NCT01269918|532413794|FG000|Overall Study|Did not receive study drug|0|||
147617330|NCT01269918|532413795|FG001|Overall Study|Did not receive study drug|3|||
147466369|NCT01290887|531866040|FG000|Overall Study|Non-compliance to study medications|1|||
147466370|NCT01290887|531866041|FG001|Overall Study|Non-compliance to study medications|0|||
147466371|NCT01290887|531866040|FG000|Overall Study|Sponsor closure of study|420|||
147617331|NCT00856193|532413799|FG000|Period 2|Abnormal test procedure results|0|||
147617332|NCT00856193|532413800|FG001|Period 2|Abnormal test procedure results|1|||
147617333|NCT00856193|532413799|FG000|Period 2|Lost to Follow-up|0|||
147617334|NCT00856193|532413800|FG001|Period 2|Lost to Follow-up|1|||
147617335|NCT04542057|532413803|FG000|Overall Study|Death|3|||
147617336|NCT04542057|532413804|FG001|Overall Study|Death|1|||
147617337|NCT04542057|532413803|FG000|Overall Study|COPD exacerbation withdrawal criteria|5|||
147617338|NCT04542057|532413804|FG001|Overall Study|COPD exacerbation withdrawal criteria|6|||
147617339|NCT04542057|532413803|FG000|Overall Study|Coronavirus disease 2019 (COVID-19)|10|||
147617340|NCT04542057|532413804|FG001|Overall Study|Coronavirus disease 2019 (COVID-19)|7|||
147617341|NCT04542057|532413803|FG000|Overall Study|Adverse Event|15|||
147617342|NCT04542057|532413804|FG001|Overall Study|Adverse Event|6|||
147617343|NCT04542057|532413803|FG000|Overall Study|COVID-19 adverse event|6|||
147617344|NCT04542057|532413804|FG001|Overall Study|COVID-19 adverse event|4|||
147617345|NCT04542057|532413803|FG000|Overall Study|Lack of Efficacy|2|||
147617346|NCT04542057|532413804|FG001|Overall Study|Lack of Efficacy|5|||
147617347|NCT04542057|532413803|FG000|Overall Study|Study terminated by sponsor|1|||
147617348|NCT04542057|532413804|FG001|Overall Study|Study terminated by sponsor|0|||
147617349|NCT04542057|532413803|FG000|Overall Study|Investigator discretion|2|||
147617350|NCT04542057|532413804|FG001|Overall Study|Investigator discretion|1|||
147617351|NCT04542057|532413803|FG000|Overall Study|Withdrawal by Subject|52|||
147617352|NCT04542057|532413804|FG001|Overall Study|Withdrawal by Subject|30|||
147617353|NCT04542057|532413803|FG000|Overall Study|Lost to Follow-up|8|||
147617354|NCT04542057|532413804|FG001|Overall Study|Lost to Follow-up|11|||
147617355|NCT04542057|532413803|FG000|Overall Study|Other|2|||
147617356|NCT04542057|532413804|FG001|Overall Study|Other|2|||
147617357|NCT03404674|532413806|FG000|Overall Study|Inability to Attend Future Visits|0|||
147617358|NCT03404674|532413807|FG001|Overall Study|Inability to Attend Future Visits|1|||
147617359|NCT03404674|532413808|FG002|Overall Study|Inability to Attend Future Visits|1|||
147617360|NCT03404674|532413809|FG003|Overall Study|Inability to Attend Future Visits|0|||
147617361|NCT03404674|532413810|FG004|Overall Study|Inability to Attend Future Visits|0|||
147617362|NCT03404674|532413811|FG005|Overall Study|Inability to Attend Future Visits|0|||
147617363|NCT03404674|532413806|FG000|Overall Study|Behavioral Problems|0|||
147617364|NCT03404674|532413807|FG001|Overall Study|Behavioral Problems|0|||
147466372|NCT01290887|531866041|FG001|Overall Study|Sponsor closure of study|476|||
147466373|NCT01290887|531866040|FG000|Overall Study|Other|3|||
147466374|NCT01290887|531866041|FG001|Overall Study|Other|6|||
147466375|NCT01628926|531866042|FG000|Overall Study|Adverse Event|13|||
147466376|NCT01628926|531866043|FG001|Overall Study|Adverse Event|11|||
147466377|NCT01628926|531866044|FG002|Overall Study|Adverse Event|9|||
147466378|NCT01628926|531866042|FG000|Overall Study|Lack of Efficacy|2|||
147466379|NCT01628926|531866043|FG001|Overall Study|Lack of Efficacy|1|||
147466380|NCT01628926|531866044|FG002|Overall Study|Lack of Efficacy|5|||
147466381|NCT01628926|531866042|FG000|Overall Study|Withdrawal by Subject|6|||
147466382|NCT01628926|531866043|FG001|Overall Study|Withdrawal by Subject|4|||
147466383|NCT01628926|531866044|FG002|Overall Study|Withdrawal by Subject|2|||
147466384|NCT01628926|531866042|FG000|Overall Study|Protocol Violation|0|||
147466385|NCT01628926|531866043|FG001|Overall Study|Protocol Violation|1|||
147466386|NCT01628926|531866044|FG002|Overall Study|Protocol Violation|0|||
147466387|NCT01628926|531866042|FG000|Overall Study|Discontinuation criteria|3|||
147466388|NCT01628926|531866043|FG001|Overall Study|Discontinuation criteria|4|||
147466389|NCT01628926|531866044|FG002|Overall Study|Discontinuation criteria|0|||
147466390|NCT01628926|531866042|FG000|Overall Study|Physician Decision|2|||
147466391|NCT01628926|531866043|FG001|Overall Study|Physician Decision|2|||
147466392|NCT01628926|531866044|FG002|Overall Study|Physician Decision|1|||
147466393|NCT03437447|531866049|FG000|Treatment Period 1|Withdrawal by Subject|0|||
147466394|NCT03437447|531866050|FG001|Treatment Period 1|Withdrawal by Subject|0|||
147466395|NCT03437447|531866051|FG002|Treatment Period 1|Withdrawal by Subject|1|||
147466396|NCT03952559|531866052|FG000|Double Blind Treatment Period|Adverse Event|0|||
147466397|NCT03952559|531866053|FG001|Double Blind Treatment Period|Adverse Event|2|||
147466398|NCT03952559|531866054|FG002|Double Blind Treatment Period|Adverse Event|1|||
147466399|NCT03952559|531866055|FG003|Double Blind Treatment Period|Adverse Event|0|||
147466400|NCT03952559|531866056|FG004|Double Blind Treatment Period|Adverse Event|1|||
147617365|NCT03404674|532413808|FG002|Overall Study|Behavioral Problems|1|||
147617366|NCT03404674|532413809|FG003|Overall Study|Behavioral Problems|0|||
147617367|NCT03404674|532413810|FG004|Overall Study|Behavioral Problems|0|||
147617368|NCT03404674|532413811|FG005|Overall Study|Behavioral Problems|0|||
147617369|NCT03404674|532413806|FG000|Overall Study|Started a Medication that Precluded Eligibility|0|||
147466401|NCT03952559|531866052|FG000|Double Blind Treatment Period|Lack of Efficacy|0|||
147466402|NCT03952559|531866053|FG001|Double Blind Treatment Period|Lack of Efficacy|4|||
147466403|NCT03952559|531866054|FG002|Double Blind Treatment Period|Lack of Efficacy|1|||
147466404|NCT03952559|531866055|FG003|Double Blind Treatment Period|Lack of Efficacy|1|||
147466405|NCT03952559|531866056|FG004|Double Blind Treatment Period|Lack of Efficacy|0|||
147466406|NCT03952559|531866052|FG000|Double Blind Treatment Period|Withdrawal by Subject|0|||
147466407|NCT03952559|531866053|FG001|Double Blind Treatment Period|Withdrawal by Subject|1|||
147466408|NCT03952559|531866054|FG002|Double Blind Treatment Period|Withdrawal by Subject|2|||
147466409|NCT03952559|531866055|FG003|Double Blind Treatment Period|Withdrawal by Subject|2|||
147466410|NCT03952559|531866056|FG004|Double Blind Treatment Period|Withdrawal by Subject|0|||
147466411|NCT03952559|531866052|FG000|Double Blind Treatment Period|Inadvertently randomized|0|||
147466412|NCT03952559|531866053|FG001|Double Blind Treatment Period|Inadvertently randomized|0|||
147466413|NCT03952559|531866054|FG002|Double Blind Treatment Period|Inadvertently randomized|1|||
147466414|NCT03952559|531866055|FG003|Double Blind Treatment Period|Inadvertently randomized|0|||
147466415|NCT03952559|531866056|FG004|Double Blind Treatment Period|Inadvertently randomized|0|||
147466416|NCT02875223|531866057|FG000|Overall Study|Other reasons|0|||
147466417|NCT02875223|531866058|FG001|Overall Study|Other reasons|0|||
147466418|NCT02875223|531866059|FG002|Overall Study|Other reasons|1|||
147466419|NCT02875223|531866060|FG003|Overall Study|Other reasons|0|||
147466420|NCT02875223|531866061|FG004|Overall Study|Other reasons|1|||
147466421|NCT02875223|531866062|FG005|Overall Study|Other reasons|2|||
147466422|NCT02875223|531866063|FG006|Overall Study|Other reasons|0|||
147466423|NCT02875223|531866064|FG007|Overall Study|Other reasons|2|||
147466424|NCT02875223|531866065|FG008|Overall Study|Other reasons|0|||
147466425|NCT02875223|531866066|FG009|Overall Study|Other reasons|0|||
147466426|NCT02875223|531866067|FG010|Overall Study|Other reasons|0|||
147466427|NCT02875223|531866068|FG011|Overall Study|Other reasons|0|||
147466428|NCT02875223|531866069|FG012|Overall Study|Other reasons|0|||
147466429|NCT02875223|531866057|FG000|Overall Study|Withdrawal by Subject|0|||
147466430|NCT02875223|531866058|FG001|Overall Study|Withdrawal by Subject|0|||
147466431|NCT02875223|531866059|FG002|Overall Study|Withdrawal by Subject|0|||
147466432|NCT02875223|531866060|FG003|Overall Study|Withdrawal by Subject|0|||
147466433|NCT02875223|531866061|FG004|Overall Study|Withdrawal by Subject|1|||
147466434|NCT02875223|531866062|FG005|Overall Study|Withdrawal by Subject|1|||
147466435|NCT02875223|531866063|FG006|Overall Study|Withdrawal by Subject|0|||
147466436|NCT02875223|531866064|FG007|Overall Study|Withdrawal by Subject|0|||
147466437|NCT02875223|531866065|FG008|Overall Study|Withdrawal by Subject|1|||
147466438|NCT02875223|531866066|FG009|Overall Study|Withdrawal by Subject|0|||
147466439|NCT02875223|531866067|FG010|Overall Study|Withdrawal by Subject|0|||
147466440|NCT02875223|531866068|FG011|Overall Study|Withdrawal by Subject|0|||
147466441|NCT02875223|531866069|FG012|Overall Study|Withdrawal by Subject|0|||
147466442|NCT02875223|531866057|FG000|Overall Study|Progressive disease|0|||
147466443|NCT02875223|531866058|FG001|Overall Study|Progressive disease|0|||
147466444|NCT02875223|531866059|FG002|Overall Study|Progressive disease|1|||
147466445|NCT02875223|531866060|FG003|Overall Study|Progressive disease|0|||
147466446|NCT02875223|531866061|FG004|Overall Study|Progressive disease|0|||
147466447|NCT02875223|531866062|FG005|Overall Study|Progressive disease|0|||
147466448|NCT02875223|531866063|FG006|Overall Study|Progressive disease|0|||
147466449|NCT02875223|531866064|FG007|Overall Study|Progressive disease|0|||
147466450|NCT02875223|531866065|FG008|Overall Study|Progressive disease|0|||
147466451|NCT02875223|531866066|FG009|Overall Study|Progressive disease|12|||
147466452|NCT02875223|531866067|FG010|Overall Study|Progressive disease|2|||
147466453|NCT02875223|531866068|FG011|Overall Study|Progressive disease|3|||
147466454|NCT02875223|531866069|FG012|Overall Study|Progressive disease|6|||
147466455|NCT02875223|531866057|FG000|Overall Study|Death|4|||
147466456|NCT02875223|531866058|FG001|Overall Study|Death|4|||
147466457|NCT02875223|531866059|FG002|Overall Study|Death|3|||
147466458|NCT02875223|531866060|FG003|Overall Study|Death|4|||
147466459|NCT02875223|531866061|FG004|Overall Study|Death|2|||
147466460|NCT02875223|531866062|FG005|Overall Study|Death|3|||
147466461|NCT02875223|531866063|FG006|Overall Study|Death|5|||
147466462|NCT02875223|531866064|FG007|Overall Study|Death|7|||
147466463|NCT02875223|531866065|FG008|Overall Study|Death|3|||
147466464|NCT02875223|531866066|FG009|Overall Study|Death|2|||
147466465|NCT02875223|531866067|FG010|Overall Study|Death|0|||
147466466|NCT02875223|531866068|FG011|Overall Study|Death|0|||
147466467|NCT02875223|531866069|FG012|Overall Study|Death|0|||
147466468|NCT02875223|531866057|FG000|Overall Study|Lost to Follow-up|0|||
147466469|NCT02875223|531866058|FG001|Overall Study|Lost to Follow-up|1|||
147466470|NCT02875223|531866059|FG002|Overall Study|Lost to Follow-up|1|||
147466471|NCT02875223|531866060|FG003|Overall Study|Lost to Follow-up|0|||
147466472|NCT02875223|531866061|FG004|Overall Study|Lost to Follow-up|1|||
147466473|NCT02875223|531866062|FG005|Overall Study|Lost to Follow-up|0|||
147466474|NCT02875223|531866063|FG006|Overall Study|Lost to Follow-up|1|||
147466475|NCT02875223|531866064|FG007|Overall Study|Lost to Follow-up|1|||
147617370|NCT03404674|532413807|FG001|Overall Study|Started a Medication that Precluded Eligibility|0|||
147466476|NCT02875223|531866065|FG008|Overall Study|Lost to Follow-up|0|||
147466477|NCT02875223|531866066|FG009|Overall Study|Lost to Follow-up|0|||
147466478|NCT02875223|531866067|FG010|Overall Study|Lost to Follow-up|0|||
147466479|NCT02875223|531866068|FG011|Overall Study|Lost to Follow-up|0|||
147466480|NCT02875223|531866069|FG012|Overall Study|Lost to Follow-up|0|||
147466481|NCT03636906|531866071|FG000|Overall Study|Adverse Event|0|||
147466482|NCT03636906|531866072|FG001|Overall Study|Adverse Event|0|||
147466483|NCT03636906|531866073|FG002|Overall Study|Adverse Event|1|||
147466484|NCT03636906|531866071|FG000|Overall Study|Lost to Follow-up|1|||
147466485|NCT03636906|531866072|FG001|Overall Study|Lost to Follow-up|0|||
147466486|NCT03636906|531866073|FG002|Overall Study|Lost to Follow-up|0|||
147466487|NCT03636906|531866071|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN ADVERSE EVENT AND/OR A SERIOUS ADVERSE EVENT|2|||
147466488|NCT03636906|531866072|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN ADVERSE EVENT AND/OR A SERIOUS ADVERSE EVENT|0|||
147466489|NCT03636906|531866073|FG002|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO AN ADVERSE EVENT AND/OR A SERIOUS ADVERSE EVENT|1|||
147466490|NCT03636906|531866071|FG000|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|1|||
147466491|NCT03636906|531866072|FG001|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|0|||
147466492|NCT03636906|531866073|FG002|Overall Study|NOT WILLING TO PARTICIPATE THIS VISIT|2|||
147466493|NCT03636906|531866071|FG000|Overall Study|Other|0|||
147466494|NCT03636906|531866072|FG001|Overall Study|Other|0|||
147466495|NCT03636906|531866073|FG002|Overall Study|Other|1|||
147466496|NCT00891202|531866074|FG000|PAP (Up To Week 39)|Withdrawal by Subject|1|||
147466497|NCT00891202|531866075|FG001|PAP (Up To Week 39)|Withdrawal by Subject|0|||
147466498|NCT00891202|531866076|FG002|PAP (Up To Week 39)|Withdrawal by Subject|0|||
147466499|NCT00891202|531866077|FG003|PAP (Up To Week 39)|Withdrawal by Subject|0|||
147466500|NCT00891202|531866074|FG000|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|0|||
147466501|NCT00891202|531866075|FG001|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|0|||
147466502|NCT00891202|531866076|FG002|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|4|||
147466503|NCT00891202|531866077|FG003|LTTP (Post-Week 39 up to Week 312)|Withdrawal by Subject|0|||
147466504|NCT00891202|531866074|FG000|LTTP (Post-Week 39 up to Week 312)|Pregnancy|0|||
147466505|NCT00891202|531866075|FG001|LTTP (Post-Week 39 up to Week 312)|Pregnancy|0|||
147466506|NCT00891202|531866076|FG002|LTTP (Post-Week 39 up to Week 312)|Pregnancy|1|||
147466507|NCT00891202|531866077|FG003|LTTP (Post-Week 39 up to Week 312)|Pregnancy|0|||
147466508|NCT00891202|531866074|FG000|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|0|||
147466509|NCT00891202|531866075|FG001|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|0|||
147466510|NCT00891202|531866076|FG002|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|2|||
147466511|NCT00891202|531866077|FG003|LTTP (Post-Week 39 up to Week 312)|Transitioned to commercial eliglustat|5|||
147466512|NCT03690869|531866081|FG000|Overall Study|Adverse Event|0|||
147466513|NCT03690869|531866082|FG001|Overall Study|Adverse Event|0|||
147466514|NCT03690869|531866083|FG002|Overall Study|Adverse Event|0|||
147466515|NCT03690869|531866084|FG003|Overall Study|Adverse Event|1|||
147466516|NCT03690869|531866085|FG004|Overall Study|Adverse Event|0|||
147466517|NCT03690869|531866086|FG005|Overall Study|Adverse Event|0|||
147466518|NCT03690869|531866087|FG006|Overall Study|Adverse Event|0|||
147466519|NCT03690869|531866088|FG007|Overall Study|Adverse Event|1|||
147466520|NCT03690869|531866089|FG008|Overall Study|Adverse Event|0|||
147466521|NCT03690869|531866090|FG009|Overall Study|Adverse Event|1|||
147466522|NCT03690869|531866081|FG000|Overall Study|Death|1|||
147466523|NCT03690869|531866082|FG001|Overall Study|Death|1|||
147466524|NCT03690869|531866083|FG002|Overall Study|Death|1|||
147466525|NCT03690869|531866084|FG003|Overall Study|Death|4|||
147466526|NCT03690869|531866085|FG004|Overall Study|Death|2|||
147466527|NCT03690869|531866086|FG005|Overall Study|Death|5|||
147466528|NCT03690869|531866087|FG006|Overall Study|Death|3|||
147466529|NCT03690869|531866088|FG007|Overall Study|Death|2|||
147466530|NCT03690869|531866089|FG008|Overall Study|Death|0|||
147466531|NCT03690869|531866090|FG009|Overall Study|Death|3|||
147466532|NCT03690869|531866081|FG000|Overall Study|Lost to Follow-up|0|||
147466533|NCT03690869|531866082|FG001|Overall Study|Lost to Follow-up|0|||
147466534|NCT03690869|531866083|FG002|Overall Study|Lost to Follow-up|1|||
147466535|NCT03690869|531866084|FG003|Overall Study|Lost to Follow-up|0|||
147466536|NCT03690869|531866085|FG004|Overall Study|Lost to Follow-up|0|||
147466537|NCT03690869|531866086|FG005|Overall Study|Lost to Follow-up|0|||
147466538|NCT03690869|531866087|FG006|Overall Study|Lost to Follow-up|0|||
147466539|NCT03690869|531866088|FG007|Overall Study|Lost to Follow-up|0|||
147466540|NCT03690869|531866089|FG008|Overall Study|Lost to Follow-up|0|||
147466541|NCT03690869|531866090|FG009|Overall Study|Lost to Follow-up|0|||
147466542|NCT03690869|531866081|FG000|Overall Study|Other Treatment|1|||
147466543|NCT03690869|531866082|FG001|Overall Study|Other Treatment|1|||
147466544|NCT03690869|531866083|FG002|Overall Study|Other Treatment|1|||
147466545|NCT03690869|531866084|FG003|Overall Study|Other Treatment|2|||
147466546|NCT03690869|531866085|FG004|Overall Study|Other Treatment|3|||
147466547|NCT03690869|531866086|FG005|Overall Study|Other Treatment|1|||
147466548|NCT03690869|531866087|FG006|Overall Study|Other Treatment|2|||
147466549|NCT03690869|531866088|FG007|Overall Study|Other Treatment|7|||
147617371|NCT03404674|532413808|FG002|Overall Study|Started a Medication that Precluded Eligibility|0|||
147466550|NCT03690869|531866089|FG008|Overall Study|Other Treatment|0|||
147466551|NCT03690869|531866090|FG009|Overall Study|Other Treatment|3|||
147466552|NCT03690869|531866081|FG000|Overall Study|Physician Decision|0|||
147466553|NCT03690869|531866082|FG001|Overall Study|Physician Decision|1|||
147466554|NCT03690869|531866083|FG002|Overall Study|Physician Decision|0|||
147466555|NCT03690869|531866084|FG003|Overall Study|Physician Decision|0|||
147466556|NCT03690869|531866085|FG004|Overall Study|Physician Decision|0|||
147466557|NCT03690869|531866086|FG005|Overall Study|Physician Decision|0|||
147466558|NCT03690869|531866087|FG006|Overall Study|Physician Decision|0|||
147466559|NCT03690869|531866088|FG007|Overall Study|Physician Decision|0|||
147466560|NCT03690869|531866089|FG008|Overall Study|Physician Decision|0|||
147466561|NCT03690869|531866090|FG009|Overall Study|Physician Decision|0|||
147466562|NCT03690869|531866081|FG000|Overall Study|Progressive Disease|1|||
147466563|NCT03690869|531866082|FG001|Overall Study|Progressive Disease|2|||
147466564|NCT03690869|531866083|FG002|Overall Study|Progressive Disease|0|||
147466565|NCT03690869|531866084|FG003|Overall Study|Progressive Disease|1|||
147466566|NCT03690869|531866085|FG004|Overall Study|Progressive Disease|0|||
147466567|NCT03690869|531866086|FG005|Overall Study|Progressive Disease|0|||
147466568|NCT03690869|531866087|FG006|Overall Study|Progressive Disease|0|||
147466569|NCT03690869|531866088|FG007|Overall Study|Progressive Disease|0|||
147466570|NCT03690869|531866089|FG008|Overall Study|Progressive Disease|1|||
147466571|NCT03690869|531866090|FG009|Overall Study|Progressive Disease|1|||
147466572|NCT03690869|531866081|FG000|Overall Study|Subject Decision|0|||
147466573|NCT03690869|531866082|FG001|Overall Study|Subject Decision|0|||
147466574|NCT03690869|531866083|FG002|Overall Study|Subject Decision|0|||
147466575|NCT03690869|531866084|FG003|Overall Study|Subject Decision|1|||
147466576|NCT03690869|531866085|FG004|Overall Study|Subject Decision|0|||
147466577|NCT03690869|531866086|FG005|Overall Study|Subject Decision|0|||
147466578|NCT03690869|531866087|FG006|Overall Study|Subject Decision|0|||
147466579|NCT03690869|531866088|FG007|Overall Study|Subject Decision|1|||
147466580|NCT03690869|531866089|FG008|Overall Study|Subject Decision|0|||
147466581|NCT03690869|531866090|FG009|Overall Study|Subject Decision|0|||
147466582|NCT04280081|531866092|FG000|Overall Study|Adverse Event|4|||
147466583|NCT04280081|531866092|FG000|Overall Study|Death|2|||
147466584|NCT04280081|531866092|FG000|Overall Study|Progressive Disease|6|||
147466585|NCT03896581|531867569|FG000|Overall Study|Other (Covid-19 Pandemic Circumstances)|1|||
147466586|NCT03896581|531867570|FG001|Overall Study|Other (Covid-19 Pandemic Circumstances)|0|||
147466587|NCT03896581|531867569|FG000|Overall Study|Withdrawal by Subject|4|||
147466588|NCT03896581|531867570|FG001|Overall Study|Withdrawal by Subject|1|||
147466589|NCT03896581|531867569|FG000|Overall Study|Lost to Follow-up|1|||
147466590|NCT03896581|531867570|FG001|Overall Study|Lost to Follow-up|0|||
147466591|NCT03896581|531867569|FG000|Overall Study|Lack of Efficacy|2|||
147466592|NCT03896581|531867570|FG001|Overall Study|Lack of Efficacy|1|||
147466593|NCT03896581|531867569|FG000|Overall Study|Adverse event, non-fatal|0|||
147466594|NCT03896581|531867570|FG001|Overall Study|Adverse event, non-fatal|2|||
147466595|NCT04063384|531867571|FG000|Overall Study|placebo manipulation issue|1|||
147466596|NCT04063384|531867572|FG001|Overall Study|placebo manipulation issue|2|||
147466597|NCT04063384|531867573|FG002|Overall Study|placebo manipulation issue|1|||
147466598|NCT04063384|531867574|FG003|Overall Study|placebo manipulation issue|1|||
147466599|NCT03263806|531867575|FG000|Overall Study|Elevated Troponin (failed screen)|1|||
147466600|NCT03263806|531867576|FG001|Overall Study|Elevated Troponin (failed screen)|0|||
147466601|NCT03263806|531867575|FG000|Overall Study|Withdrawal by Subject|0|||
147466602|NCT03263806|531867576|FG001|Overall Study|Withdrawal by Subject|1|||
147466603|NCT03263806|531867575|FG000|Overall Study|Study Termination|5|||
147466604|NCT03263806|531867576|FG001|Overall Study|Study Termination|6|||
147466605|NCT00450580|531867582|FG000|Overall Study|Adverse Event|5|||
147466606|NCT00450580|531867583|FG001|Overall Study|Adverse Event|7|||
147466607|NCT00450580|531867582|FG000|Overall Study|Lost to Follow-up|4|||
147466608|NCT00450580|531867583|FG001|Overall Study|Lost to Follow-up|5|||
147466609|NCT00450580|531867582|FG000|Overall Study|Withdrawal by Subject|2|||
147466610|NCT00450580|531867583|FG001|Overall Study|Withdrawal by Subject|2|||
147466611|NCT00450580|531867582|FG000|Overall Study|Protocol Violation|1|||
147466612|NCT00450580|531867583|FG001|Overall Study|Protocol Violation|1|||
147466613|NCT00450580|531867582|FG000|Overall Study|Protocol-defined virologic failure|1|||
147466614|NCT00450580|531867583|FG001|Overall Study|Protocol-defined virologic failure|0|||
147466615|NCT00450580|531867582|FG000|Overall Study|Could not comply with scheduled visits|1|||
147466616|NCT00450580|531867583|FG001|Overall Study|Could not comply with scheduled visits|0|||
147466617|NCT00450580|531867582|FG000|Overall Study|Patient went to Brazil|1|||
147466618|NCT00450580|531867583|FG001|Overall Study|Patient went to Brazil|0|||
147466619|NCT00450580|531867582|FG000|Overall Study|Patient could not swallow Norvir|1|||
147466620|NCT00450580|531867583|FG001|Overall Study|Patient could not swallow Norvir|0|||
147466621|NCT00450580|531867582|FG000|Overall Study|Withdrawal due to pregnancy|0|||
147466622|NCT00450580|531867583|FG001|Overall Study|Withdrawal due to pregnancy|1|||
147466623|NCT04572633|531867590|FG000|Overall Study|Participant in active follow-up at 30 days|47|||
147466624|NCT00332709|531867591|FG000|Overall Study|Adverse Event|11|||
147466625|NCT00332709|531867592|FG001|Overall Study|Adverse Event|14|||
147466626|NCT00332709|531867591|FG000|Overall Study|Withdrawal by Subject|2|||
147466627|NCT00332709|531867592|FG001|Overall Study|Withdrawal by Subject|3|||
147466628|NCT00332709|531867591|FG000|Overall Study|Lost to Follow-up|2|||
147617372|NCT03404674|532413809|FG003|Overall Study|Started a Medication that Precluded Eligibility|1|||
147466629|NCT00332709|531867592|FG001|Overall Study|Lost to Follow-up|0|||
147466630|NCT00332709|531867591|FG000|Overall Study|Administrative Problems|0|||
147466631|NCT00332709|531867592|FG001|Overall Study|Administrative Problems|3|||
147466632|NCT00332709|531867591|FG000|Overall Study|Abnormal test procedure result|1|||
147466633|NCT00332709|531867592|FG001|Overall Study|Abnormal test procedure result|0|||
147466634|NCT06161012|531867593|FG000|Period 1|Unsatisfactory Lens Fitting due to Test Article|1|||
147466635|NCT06161012|531867594|FG001|Period 1|Unsatisfactory Lens Fitting due to Test Article|0|||
147466636|NCT01933932|531867595|FG000|Overall Study|Death|173|||
147466637|NCT01933932|531867596|FG001|Overall Study|Death|163|||
147466638|NCT01933932|531867595|FG000|Overall Study|Withdrawal by Subject|11|||
147466639|NCT01933932|531867596|FG001|Overall Study|Withdrawal by Subject|14|||
147466640|NCT01933932|531867595|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
147466641|NCT01933932|531867596|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
147466642|NCT00408005|531867597|FG000|Induction|Adverse Event|19|||
147466643|NCT00408005|531867598|FG001|Induction|Adverse Event|3|||
147466644|NCT00408005|531867599|FG002|Induction|Adverse Event|0|||
147466645|NCT00408005|531867600|FG003|Induction|Adverse Event|0|||
147466646|NCT00408005|531867601|FG004|Induction|Adverse Event|0|||
147466647|NCT00408005|531867602|FG005|Induction|Adverse Event|0|||
147466648|NCT00408005|531867603|FG006|Induction|Adverse Event|0|||
147466649|NCT00408005|531867604|FG007|Induction|Adverse Event|0|||
147466650|NCT00408005|531867597|FG000|Induction|Death|6|||
147466651|NCT00408005|531867598|FG001|Induction|Death|0|||
147466652|NCT00408005|531867599|FG002|Induction|Death|0|||
147466653|NCT00408005|531867600|FG003|Induction|Death|0|||
147466654|NCT00408005|531867601|FG004|Induction|Death|0|||
147466655|NCT00408005|531867602|FG005|Induction|Death|0|||
147466656|NCT00408005|531867603|FG006|Induction|Death|0|||
147466657|NCT00408005|531867604|FG007|Induction|Death|0|||
147466658|NCT00408005|531867597|FG000|Induction|Physician Decision|83|||
147466659|NCT00408005|531867598|FG001|Induction|Physician Decision|9|||
147466660|NCT00408005|531867599|FG002|Induction|Physician Decision|0|||
147466661|NCT00408005|531867600|FG003|Induction|Physician Decision|0|||
147466662|NCT00408005|531867601|FG004|Induction|Physician Decision|0|||
147466663|NCT00408005|531867602|FG005|Induction|Physician Decision|0|||
147466664|NCT00408005|531867603|FG006|Induction|Physician Decision|0|||
147466665|NCT00408005|531867604|FG007|Induction|Physician Decision|0|||
147466666|NCT00408005|531867597|FG000|Induction|Withdrawal by Subject|2|||
147466667|NCT00408005|531867598|FG001|Induction|Withdrawal by Subject|4|||
147466668|NCT00408005|531867599|FG002|Induction|Withdrawal by Subject|0|||
147466669|NCT00408005|531867600|FG003|Induction|Withdrawal by Subject|0|||
147466670|NCT00408005|531867601|FG004|Induction|Withdrawal by Subject|0|||
147466671|NCT00408005|531867602|FG005|Induction|Withdrawal by Subject|0|||
147466672|NCT00408005|531867603|FG006|Induction|Withdrawal by Subject|0|||
147466673|NCT00408005|531867604|FG007|Induction|Withdrawal by Subject|0|||
147466674|NCT00408005|531867597|FG000|Induction|Ineligible|33|||
147466675|NCT00408005|531867598|FG001|Induction|Ineligible|14|||
147466676|NCT00408005|531867599|FG002|Induction|Ineligible|0|||
147466677|NCT00408005|531867600|FG003|Induction|Ineligible|0|||
147466678|NCT00408005|531867601|FG004|Induction|Ineligible|0|||
147466679|NCT00408005|531867602|FG005|Induction|Ineligible|0|||
147466680|NCT00408005|531867603|FG006|Induction|Ineligible|0|||
147466681|NCT00408005|531867604|FG007|Induction|Ineligible|0|||
147466682|NCT00408005|531867597|FG000|Induction|Refusal of Further Protocol Therapy|225|||
147466683|NCT00408005|531867598|FG001|Induction|Refusal of Further Protocol Therapy|44|||
147466684|NCT00408005|531867599|FG002|Induction|Refusal of Further Protocol Therapy|0|||
147466685|NCT00408005|531867600|FG003|Induction|Refusal of Further Protocol Therapy|0|||
147466686|NCT00408005|531867601|FG004|Induction|Refusal of Further Protocol Therapy|0|||
147466687|NCT00408005|531867602|FG005|Induction|Refusal of Further Protocol Therapy|0|||
147466688|NCT00408005|531867603|FG006|Induction|Refusal of Further Protocol Therapy|0|||
147466689|NCT00408005|531867604|FG007|Induction|Refusal of Further Protocol Therapy|0|||
147466690|NCT00408005|531867597|FG000|Induction|Entered another COG therapeutic protocol|4|||
147466691|NCT00408005|531867598|FG001|Induction|Entered another COG therapeutic protocol|0|||
147466692|NCT00408005|531867599|FG002|Induction|Entered another COG therapeutic protocol|0|||
147466693|NCT00408005|531867600|FG003|Induction|Entered another COG therapeutic protocol|0|||
147466694|NCT00408005|531867601|FG004|Induction|Entered another COG therapeutic protocol|0|||
147466695|NCT00408005|531867602|FG005|Induction|Entered another COG therapeutic protocol|0|||
147466696|NCT00408005|531867603|FG006|Induction|Entered another COG therapeutic protocol|0|||
147466697|NCT00408005|531867604|FG007|Induction|Entered another COG therapeutic protocol|0|||
147466698|NCT00408005|531867597|FG000|Induction|Patient transferred Tx to Non-COG Site|3|||
147466699|NCT00408005|531867598|FG001|Induction|Patient transferred Tx to Non-COG Site|2|||
147466700|NCT00408005|531867599|FG002|Induction|Patient transferred Tx to Non-COG Site|0|||
147466701|NCT00408005|531867600|FG003|Induction|Patient transferred Tx to Non-COG Site|0|||
147466702|NCT00408005|531867601|FG004|Induction|Patient transferred Tx to Non-COG Site|0|||
147466703|NCT00408005|531867602|FG005|Induction|Patient transferred Tx to Non-COG Site|0|||
147466704|NCT00408005|531867603|FG006|Induction|Patient transferred Tx to Non-COG Site|0|||
147466705|NCT00408005|531867604|FG007|Induction|Patient transferred Tx to Non-COG Site|0|||
147466706|NCT00408005|531867597|FG000|Induction|Identified as Philadelphia Chr. Positive|6|||
147466707|NCT00408005|531867598|FG001|Induction|Identified as Philadelphia Chr. Positive|0|||
147466708|NCT00408005|531867599|FG002|Induction|Identified as Philadelphia Chr. Positive|0|||
147466709|NCT00408005|531867600|FG003|Induction|Identified as Philadelphia Chr. Positive|0|||
147466710|NCT00408005|531867601|FG004|Induction|Identified as Philadelphia Chr. Positive|0|||
147466711|NCT00408005|531867602|FG005|Induction|Identified as Philadelphia Chr. Positive|0|||
147466712|NCT00408005|531867603|FG006|Induction|Identified as Philadelphia Chr. Positive|0|||
147466713|NCT00408005|531867604|FG007|Induction|Identified as Philadelphia Chr. Positive|0|||
147466714|NCT00408005|531867597|FG000|Induction|Progressive Disease|0|||
147466715|NCT00408005|531867598|FG001|Induction|Progressive Disease|1|||
147466716|NCT00408005|531867599|FG002|Induction|Progressive Disease|0|||
147466717|NCT00408005|531867600|FG003|Induction|Progressive Disease|0|||
147466718|NCT00408005|531867601|FG004|Induction|Progressive Disease|0|||
147466719|NCT00408005|531867602|FG005|Induction|Progressive Disease|0|||
147466720|NCT00408005|531867603|FG006|Induction|Progressive Disease|0|||
147466721|NCT00408005|531867604|FG007|Induction|Progressive Disease|0|||
147466722|NCT00408005|531867597|FG000|Induction|Inevaluable|18|||
147466723|NCT00408005|531867598|FG001|Induction|Inevaluable|14|||
147466724|NCT00408005|531867599|FG002|Induction|Inevaluable|0|||
147466725|NCT00408005|531867600|FG003|Induction|Inevaluable|0|||
147466726|NCT00408005|531867601|FG004|Induction|Inevaluable|0|||
147466727|NCT00408005|531867602|FG005|Induction|Inevaluable|0|||
147466728|NCT00408005|531867603|FG006|Induction|Inevaluable|0|||
147466729|NCT00408005|531867604|FG007|Induction|Inevaluable|0|||
147466730|NCT00408005|531867597|FG000|Induction|Failed to Complete Randomization|3|||
147466731|NCT00408005|531867598|FG001|Induction|Failed to Complete Randomization|2|||
147466732|NCT00408005|531867599|FG002|Induction|Failed to Complete Randomization|0|||
147466733|NCT00408005|531867600|FG003|Induction|Failed to Complete Randomization|0|||
147466734|NCT00408005|531867601|FG004|Induction|Failed to Complete Randomization|0|||
147466735|NCT00408005|531867602|FG005|Induction|Failed to Complete Randomization|0|||
147466736|NCT00408005|531867603|FG006|Induction|Failed to Complete Randomization|0|||
147466737|NCT00408005|531867604|FG007|Induction|Failed to Complete Randomization|0|||
147466738|NCT00408005|531867597|FG000|Induction|Protocol Deviation|3|||
147466739|NCT00408005|531867598|FG001|Induction|Protocol Deviation|1|||
147466740|NCT00408005|531867599|FG002|Induction|Protocol Deviation|0|||
147466741|NCT00408005|531867600|FG003|Induction|Protocol Deviation|0|||
147466742|NCT00408005|531867601|FG004|Induction|Protocol Deviation|0|||
147466743|NCT00408005|531867602|FG005|Induction|Protocol Deviation|0|||
147466744|NCT00408005|531867603|FG006|Induction|Protocol Deviation|0|||
147466745|NCT00408005|531867604|FG007|Induction|Protocol Deviation|0|||
147466746|NCT00408005|531867597|FG000|Induction|Hematopoietic Stem Cell Transplantation|1|||
147466747|NCT00408005|531867598|FG001|Induction|Hematopoietic Stem Cell Transplantation|0|||
147466748|NCT00408005|531867599|FG002|Induction|Hematopoietic Stem Cell Transplantation|0|||
147466749|NCT00408005|531867600|FG003|Induction|Hematopoietic Stem Cell Transplantation|0|||
147466750|NCT00408005|531867601|FG004|Induction|Hematopoietic Stem Cell Transplantation|0|||
147466751|NCT00408005|531867602|FG005|Induction|Hematopoietic Stem Cell Transplantation|0|||
147466752|NCT00408005|531867603|FG006|Induction|Hematopoietic Stem Cell Transplantation|0|||
147466753|NCT00408005|531867604|FG007|Induction|Hematopoietic Stem Cell Transplantation|0|||
147466754|NCT00408005|531867597|FG000|Induction|Recurrent leukemia|1|||
147466755|NCT00408005|531867598|FG001|Induction|Recurrent leukemia|0|||
147466756|NCT00408005|531867599|FG002|Induction|Recurrent leukemia|0|||
147466757|NCT00408005|531867600|FG003|Induction|Recurrent leukemia|0|||
147466758|NCT00408005|531867601|FG004|Induction|Recurrent leukemia|0|||
147466759|NCT00408005|531867602|FG005|Induction|Recurrent leukemia|0|||
147466760|NCT00408005|531867603|FG006|Induction|Recurrent leukemia|0|||
147466761|NCT00408005|531867604|FG007|Induction|Recurrent leukemia|0|||
147466762|NCT00408005|531867597|FG000|Post Induction Therapy by Tx Assignment|Adverse Event|0|||
147466763|NCT00408005|531867598|FG001|Post Induction Therapy by Tx Assignment|Adverse Event|0|||
147466764|NCT00408005|531867599|FG002|Post Induction Therapy by Tx Assignment|Adverse Event|7|||
147466765|NCT00408005|531867600|FG003|Post Induction Therapy by Tx Assignment|Adverse Event|4|||
147466766|NCT00408005|531867601|FG004|Post Induction Therapy by Tx Assignment|Adverse Event|8|||
147466767|NCT00408005|531867602|FG005|Post Induction Therapy by Tx Assignment|Adverse Event|12|||
147466768|NCT00408005|531867603|FG006|Post Induction Therapy by Tx Assignment|Adverse Event|2|||
147466769|NCT00408005|531867604|FG007|Post Induction Therapy by Tx Assignment|Adverse Event|0|||
147466770|NCT00408005|531867597|FG000|Post Induction Therapy by Tx Assignment|Death|0|||
147466771|NCT00408005|531867598|FG001|Post Induction Therapy by Tx Assignment|Death|0|||
147617373|NCT03404674|532413810|FG004|Overall Study|Started a Medication that Precluded Eligibility|0|||
147617374|NCT03404674|532413811|FG005|Overall Study|Started a Medication that Precluded Eligibility|1|||
147466772|NCT00408005|531867599|FG002|Post Induction Therapy by Tx Assignment|Death|3|||
147466773|NCT00408005|531867600|FG003|Post Induction Therapy by Tx Assignment|Death|0|||
147466774|NCT00408005|531867601|FG004|Post Induction Therapy by Tx Assignment|Death|5|||
147466775|NCT00408005|531867602|FG005|Post Induction Therapy by Tx Assignment|Death|5|||
147466776|NCT00408005|531867603|FG006|Post Induction Therapy by Tx Assignment|Death|3|||
147466777|NCT00408005|531867604|FG007|Post Induction Therapy by Tx Assignment|Death|1|||
147466778|NCT00408005|531867597|FG000|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
147466779|NCT00408005|531867598|FG001|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
147466780|NCT00408005|531867599|FG002|Post Induction Therapy by Tx Assignment|Lost to Follow-up|2|||
147466781|NCT00408005|531867600|FG003|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
147466782|NCT00408005|531867601|FG004|Post Induction Therapy by Tx Assignment|Lost to Follow-up|1|||
147617375|NCT04660331|532413812|FG000|PROMOTE Intervention (Aim 2)|Lost to Follow-up|0|||
147617376|NCT04660331|532413813|FG001|PROMOTE Intervention (Aim 2)|Lost to Follow-up|0|||
147617377|NCT04660331|532413814|FG002|PROMOTE Intervention (Aim 2)|Lost to Follow-up|5|||
147409691|NCT01646177|531664161|FG006|Long-Term Extension Period (Week 12-264)|Adverse Event|43|||
147409692|NCT01646177|531664162|FG007|Long-Term Extension Period (Week 12-264)|Adverse Event|30|||
147409693|NCT01646177|531664163|FG008|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
147409694|NCT01646177|531664164|FG009|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
147409695|NCT01646177|531664165|FG010|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
147409696|NCT01646177|531664166|FG011|Long-Term Extension Period (Week 12-264)|Adverse Event|0|||
147409697|NCT01646177|531664155|FG000|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
147409698|NCT01646177|531664156|FG001|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
147409699|NCT01646177|531664157|FG002|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
147409700|NCT01646177|531664158|FG003|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
147409701|NCT01646177|531664159|FG004|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|11|||
147409702|NCT01646177|531664160|FG005|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|30|||
147409703|NCT01646177|531664161|FG006|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|29|||
147409704|NCT01646177|531664162|FG007|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|27|||
147409705|NCT01646177|531664163|FG008|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
147409706|NCT01646177|531664164|FG009|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
147409707|NCT01646177|531664165|FG010|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
147409708|NCT01646177|531664166|FG011|Long-Term Extension Period (Week 12-264)|Withdrawal by Subject|0|||
147409709|NCT01646177|531664155|FG000|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
147409710|NCT01646177|531664156|FG001|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
147409711|NCT01646177|531664157|FG002|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
147409712|NCT01646177|531664158|FG003|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
147409713|NCT01646177|531664159|FG004|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|6|||
147409714|NCT01646177|531664160|FG005|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|17|||
147409715|NCT01646177|531664161|FG006|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|23|||
147409716|NCT01646177|531664162|FG007|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|18|||
147409717|NCT01646177|531664163|FG008|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
147409718|NCT01646177|531664164|FG009|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
147409719|NCT01646177|531664165|FG010|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
147409720|NCT01646177|531664166|FG011|Long-Term Extension Period (Week 12-264)|Lost to Follow-up|0|||
147409721|NCT01646177|531664155|FG000|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
147409722|NCT01646177|531664156|FG001|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
147409723|NCT01646177|531664157|FG002|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
147409724|NCT01646177|531664158|FG003|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
147409725|NCT01646177|531664159|FG004|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|6|||
147409726|NCT01646177|531664160|FG005|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|14|||
147409727|NCT01646177|531664161|FG006|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|10|||
147409728|NCT01646177|531664162|FG007|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|11|||
147409729|NCT01646177|531664163|FG008|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
147409730|NCT01646177|531664164|FG009|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
147409731|NCT01646177|531664165|FG010|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
147409732|NCT01646177|531664166|FG011|Long-Term Extension Period (Week 12-264)|Lack of Efficacy|0|||
147409733|NCT01646177|531664155|FG000|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
147409734|NCT01646177|531664156|FG001|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
147409735|NCT01646177|531664157|FG002|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
147409736|NCT01646177|531664158|FG003|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
147409737|NCT01646177|531664159|FG004|Long-Term Extension Period (Week 12-264)|Physician Decision|3|||
147409738|NCT01646177|531664160|FG005|Long-Term Extension Period (Week 12-264)|Physician Decision|5|||
147409739|NCT01646177|531664161|FG006|Long-Term Extension Period (Week 12-264)|Physician Decision|5|||
147409740|NCT01646177|531664162|FG007|Long-Term Extension Period (Week 12-264)|Physician Decision|5|||
147409741|NCT01646177|531664163|FG008|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
147409742|NCT01646177|531664164|FG009|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
147409743|NCT01646177|531664165|FG010|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
147409744|NCT01646177|531664166|FG011|Long-Term Extension Period (Week 12-264)|Physician Decision|0|||
147409745|NCT01646177|531664155|FG000|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
147409746|NCT01646177|531664156|FG001|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
147409747|NCT01646177|531664157|FG002|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
147409748|NCT01646177|531664158|FG003|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
147409749|NCT01646177|531664159|FG004|Long-Term Extension Period (Week 12-264)|Protocol Violation|1|||
147409750|NCT01646177|531664160|FG005|Long-Term Extension Period (Week 12-264)|Protocol Violation|4|||
147466783|NCT00408005|531867602|FG005|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
147617378|NCT01487525|532413817|FG000|Overall Study|Withdrawal by Subject|0|||
147466784|NCT00408005|531867603|FG006|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
147466785|NCT00408005|531867604|FG007|Post Induction Therapy by Tx Assignment|Lost to Follow-up|0|||
147466786|NCT00408005|531867597|FG000|Post Induction Therapy by Tx Assignment|Physician Decision|0|||
147466787|NCT00408005|531867598|FG001|Post Induction Therapy by Tx Assignment|Physician Decision|0|||
147466788|NCT00408005|531867599|FG002|Post Induction Therapy by Tx Assignment|Physician Decision|24|||
147466789|NCT00408005|531867600|FG003|Post Induction Therapy by Tx Assignment|Physician Decision|19|||
147466790|NCT00408005|531867601|FG004|Post Induction Therapy by Tx Assignment|Physician Decision|27|||
147466791|NCT00408005|531867602|FG005|Post Induction Therapy by Tx Assignment|Physician Decision|45|||
147466792|NCT00408005|531867603|FG006|Post Induction Therapy by Tx Assignment|Physician Decision|10|||
147466793|NCT00408005|531867604|FG007|Post Induction Therapy by Tx Assignment|Physician Decision|4|||
147466794|NCT00408005|531867597|FG000|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0|||
147466795|NCT00408005|531867598|FG001|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0|||
147466796|NCT00408005|531867599|FG002|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|1|||
147466797|NCT00408005|531867600|FG003|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|1|||
147466798|NCT00408005|531867601|FG004|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0|||
147466799|NCT00408005|531867602|FG005|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|2|||
147466800|NCT00408005|531867603|FG006|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0|||
147466801|NCT00408005|531867604|FG007|Post Induction Therapy by Tx Assignment|Withdrawal by Subject|0|||
147466802|NCT00408005|531867597|FG000|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|0|||
147466803|NCT00408005|531867598|FG001|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|0|||
147466804|NCT00408005|531867599|FG002|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|27|||
147466805|NCT00408005|531867600|FG003|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|10|||
147409751|NCT01646177|531664161|FG006|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
147409752|NCT01646177|531664162|FG007|Long-Term Extension Period (Week 12-264)|Protocol Violation|5|||
147409753|NCT01646177|531664163|FG008|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
147409754|NCT01646177|531664164|FG009|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
147409755|NCT01646177|531664165|FG010|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
147409756|NCT01646177|531664166|FG011|Long-Term Extension Period (Week 12-264)|Protocol Violation|0|||
147409757|NCT01646177|531664155|FG000|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
147409758|NCT01646177|531664156|FG001|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
147466806|NCT00408005|531867601|FG004|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|36|||
147466807|NCT00408005|531867602|FG005|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|16|||
147466808|NCT00408005|531867603|FG006|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|4|||
147466809|NCT00408005|531867604|FG007|Post Induction Therapy by Tx Assignment|Refusal of Further Protocol Therapy|2|||
147466810|NCT00408005|531867597|FG000|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
147466811|NCT00408005|531867598|FG001|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
147466812|NCT00408005|531867599|FG002|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
147466813|NCT00408005|531867600|FG003|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
147466814|NCT00408005|531867601|FG004|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|1|||
147466815|NCT00408005|531867602|FG005|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
147466816|NCT00408005|531867603|FG006|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
147466817|NCT00408005|531867604|FG007|Post Induction Therapy by Tx Assignment|Entered another COG therapeutic protocol|0|||
147466818|NCT00408005|531867597|FG000|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|0|||
147466819|NCT00408005|531867598|FG001|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|0|||
147466820|NCT00408005|531867599|FG002|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|3|||
147466821|NCT00408005|531867600|FG003|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|1|||
147466822|NCT00408005|531867601|FG004|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|1|||
147466823|NCT00408005|531867602|FG005|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|0|||
147466824|NCT00408005|531867603|FG006|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|1|||
147466825|NCT00408005|531867604|FG007|Post Induction Therapy by Tx Assignment|Patient transferred Tx to Non-COG Site|0|||
147466826|NCT00408005|531867597|FG000|Post Induction Therapy by Tx Assignment|Progressive Disease|0|||
147466827|NCT00408005|531867598|FG001|Post Induction Therapy by Tx Assignment|Progressive Disease|0|||
147466828|NCT00408005|531867599|FG002|Post Induction Therapy by Tx Assignment|Progressive Disease|0|||
147466829|NCT00408005|531867600|FG003|Post Induction Therapy by Tx Assignment|Progressive Disease|0|||
147466830|NCT00408005|531867601|FG004|Post Induction Therapy by Tx Assignment|Progressive Disease|1|||
147466831|NCT00408005|531867602|FG005|Post Induction Therapy by Tx Assignment|Progressive Disease|0|||
147466832|NCT00408005|531867603|FG006|Post Induction Therapy by Tx Assignment|Progressive Disease|7|||
147409759|NCT01646177|531664157|FG002|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
147409760|NCT01646177|531664158|FG003|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
147466833|NCT00408005|531867604|FG007|Post Induction Therapy by Tx Assignment|Progressive Disease|7|||
147466834|NCT00408005|531867597|FG000|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
147466835|NCT00408005|531867598|FG001|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
147466836|NCT00408005|531867599|FG002|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
147466837|NCT00408005|531867600|FG003|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
147466838|NCT00408005|531867601|FG004|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
147466839|NCT00408005|531867602|FG005|Post Induction Therapy by Tx Assignment|Inevaluable|1|||
147466840|NCT00408005|531867603|FG006|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
147466841|NCT00408005|531867604|FG007|Post Induction Therapy by Tx Assignment|Inevaluable|0|||
147466842|NCT00408005|531867597|FG000|Post Induction Therapy by Tx Assignment|Protocol Deviation|0|||
147466843|NCT00408005|531867598|FG001|Post Induction Therapy by Tx Assignment|Protocol Deviation|0|||
147466844|NCT00408005|531867599|FG002|Post Induction Therapy by Tx Assignment|Protocol Deviation|2|||
147466845|NCT00408005|531867600|FG003|Post Induction Therapy by Tx Assignment|Protocol Deviation|1|||
147466846|NCT00408005|531867601|FG004|Post Induction Therapy by Tx Assignment|Protocol Deviation|1|||
147466847|NCT00408005|531867602|FG005|Post Induction Therapy by Tx Assignment|Protocol Deviation|2|||
147466848|NCT00408005|531867603|FG006|Post Induction Therapy by Tx Assignment|Protocol Deviation|0|||
147466849|NCT00408005|531867604|FG007|Post Induction Therapy by Tx Assignment|Protocol Deviation|0|||
147466850|NCT00408005|531867597|FG000|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
147466851|NCT00408005|531867598|FG001|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
147466852|NCT00408005|531867599|FG002|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
147466853|NCT00408005|531867600|FG003|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
147466854|NCT00408005|531867601|FG004|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|1|||
147466855|NCT00408005|531867602|FG005|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|2|||
147466856|NCT00408005|531867603|FG006|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
147466857|NCT00408005|531867604|FG007|Post Induction Therapy by Tx Assignment|Hematopoietic Stem Cell Transplantation|0|||
147466858|NCT00408005|531867597|FG000|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|0|||
147466859|NCT00408005|531867598|FG001|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|0|||
147466860|NCT00408005|531867599|FG002|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|13|||
147466861|NCT00408005|531867600|FG003|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|7|||
147466862|NCT00408005|531867601|FG004|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|49|||
147466863|NCT00408005|531867602|FG005|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|15|||
147466864|NCT00408005|531867603|FG006|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|1|||
147466865|NCT00408005|531867604|FG007|Post Induction Therapy by Tx Assignment|Recurrent Leukemia After Total Remission|0|||
147466866|NCT00408005|531867597|FG000|Post Induction Therapy by Tx Assignment|Development of SMN|0|||
147466867|NCT00408005|531867598|FG001|Post Induction Therapy by Tx Assignment|Development of SMN|0|||
147466868|NCT00408005|531867599|FG002|Post Induction Therapy by Tx Assignment|Development of SMN|3|||
147466869|NCT00408005|531867600|FG003|Post Induction Therapy by Tx Assignment|Development of SMN|1|||
147466870|NCT00408005|531867601|FG004|Post Induction Therapy by Tx Assignment|Development of SMN|1|||
147665538|NCT01103323|532599608|FG001|Without/Before Drug Switch|Switch to Regorafenib|4|||
147665539|NCT01103323|532599607|FG000|Switched From Placebo to Regorafenib|Adverse Event|0|||
147665540|NCT01103323|532599608|FG001|Switched From Placebo to Regorafenib|Adverse Event|1|||
147665541|NCT00372424|532599609|FG000|Overall Study|Adverse Event|2|||
147665542|NCT00372424|532599609|FG000|Overall Study|Withdrawal by Subject|1|||
147665543|NCT00372424|532599609|FG000|Overall Study|Death|1|||
147665544|NCT00372424|532599609|FG000|Overall Study|Objective Progression or Relapse|14|||
147665545|NCT00372424|532599609|FG000|Overall Study|Other|7|||
147665546|NCT00372424|532599609|FG000|Overall Study|Enrolled, Not Treated|1|||
147665547|NCT05214118|532599619|FG000|Overall Study|Lost to Follow-up|0|||
147665548|NCT05214118|532599620|FG001|Overall Study|Lost to Follow-up|2|||
147665549|NCT05214118|532599619|FG000|Overall Study|delivered late preterm 34 wks gestation|1|||
147665550|NCT05214118|532599620|FG001|Overall Study|delivered late preterm 34 wks gestation|1|||
147665551|NCT05214118|532599619|FG000|Overall Study|moved|1|||
147665552|NCT05214118|532599620|FG001|Overall Study|moved|0|||
147665553|NCT03797898|532599621|FG000|Overall Study|Lost to Follow-up|60|||
147665554|NCT03797898|532599622|FG001|Overall Study|Lost to Follow-up|69|||
147665555|NCT03797898|532599621|FG000|Overall Study|Withdrawal by Subject|9|||
147665556|NCT03797898|532599622|FG001|Overall Study|Withdrawal by Subject|7|||
147665557|NCT03797898|532599621|FG000|Overall Study|Became ineligible|5|||
147665558|NCT03797898|532599622|FG001|Overall Study|Became ineligible|2|||
147665559|NCT02314728|532599623|FG000|Overall Study|Protocol Violation|1|||
147665560|NCT02314728|532599624|FG001|Overall Study|Protocol Violation|0|||
147665561|NCT02314728|532599623|FG000|Overall Study|Lost to Follow-up|0|||
147665562|NCT02314728|532599624|FG001|Overall Study|Lost to Follow-up|1|||
147665563|NCT01614470|532599625|FG000|Part 1: Treatment Period 1 (8 Weeks)|Lost to Follow-up|1|||
147665564|NCT01614470|532599626|FG001|Part 1: Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
147466871|NCT00408005|531867602|FG005|Post Induction Therapy by Tx Assignment|Development of SMN|1|||
147466872|NCT00408005|531867603|FG006|Post Induction Therapy by Tx Assignment|Development of SMN|0|||
147466873|NCT00408005|531867604|FG007|Post Induction Therapy by Tx Assignment|Development of SMN|0|||
147466874|NCT05424276|531867605|FG000|Overall Study|Adverse Event|1|||
147466875|NCT05424276|531867606|FG001|Overall Study|Adverse Event|0|||
147466876|NCT05424276|531867607|FG002|Overall Study|Adverse Event|0|||
147466877|NCT05424276|531867608|FG003|Overall Study|Adverse Event|2|||
147466878|NCT05424276|531867605|FG000|Overall Study|Withdrawal by Subject|0|||
147466879|NCT05424276|531867606|FG001|Overall Study|Withdrawal by Subject|0|||
147466880|NCT05424276|531867607|FG002|Overall Study|Withdrawal by Subject|2|||
147466881|NCT05424276|531867608|FG003|Overall Study|Withdrawal by Subject|0|||
147466882|NCT05424276|531867605|FG000|Overall Study|Protocol Violation|0|||
147466883|NCT05424276|531867606|FG001|Overall Study|Protocol Violation|1|||
147466884|NCT05424276|531867607|FG002|Overall Study|Protocol Violation|0|||
147466885|NCT05424276|531867608|FG003|Overall Study|Protocol Violation|0|||
147466886|NCT05424276|531867605|FG000|Overall Study|Subjects Withdrawn due to regulatory hold|3|||
147466887|NCT05424276|531867606|FG001|Overall Study|Subjects Withdrawn due to regulatory hold|2|||
147466888|NCT05424276|531867607|FG002|Overall Study|Subjects Withdrawn due to regulatory hold|3|||
147466889|NCT05424276|531867608|FG003|Overall Study|Subjects Withdrawn due to regulatory hold|3|||
147466890|NCT01701258|531867610|FG000|Assessment and Scheduling|Found to be Ineligible|57|||
147466891|NCT01701258|531867611|FG001|Assessment and Scheduling|Found to be Ineligible|0|||
147466892|NCT01701258|531867612|FG002|Assessment and Scheduling|Found to be Ineligible|0|||
147466893|NCT01701258|531867613|FG003|Assessment and Scheduling|Found to be Ineligible|0|||
147466894|NCT01701258|531867614|FG004|Assessment and Scheduling|Found to be Ineligible|0|||
147466895|NCT01701258|531867615|FG005|Assessment and Scheduling|Found to be Ineligible|0|||
147466896|NCT01701258|531867616|FG006|Assessment and Scheduling|Found to be Ineligible|0|||
147466897|NCT01701258|531867617|FG007|Assessment and Scheduling|Found to be Ineligible|0|||
147466898|NCT01701258|531867618|FG008|Assessment and Scheduling|Found to be Ineligible|0|||
147466899|NCT01701258|531867619|FG009|Assessment and Scheduling|Found to be Ineligible|0|||
147466900|NCT01701258|531867620|FG010|Assessment and Scheduling|Found to be Ineligible|0|||
147466901|NCT01701258|531867621|FG011|Assessment and Scheduling|Found to be Ineligible|0|||
147466902|NCT01701258|531867622|FG012|Assessment and Scheduling|Found to be Ineligible|0|||
147466903|NCT01701258|531867610|FG000|Assessment and Scheduling|Lost to Follow-up|10|||
147466904|NCT01701258|531867611|FG001|Assessment and Scheduling|Lost to Follow-up|0|||
147466905|NCT01701258|531867612|FG002|Assessment and Scheduling|Lost to Follow-up|0|||
147466906|NCT01701258|531867613|FG003|Assessment and Scheduling|Lost to Follow-up|0|||
147466907|NCT01701258|531867614|FG004|Assessment and Scheduling|Lost to Follow-up|0|||
147466908|NCT01701258|531867615|FG005|Assessment and Scheduling|Lost to Follow-up|0|||
147466909|NCT01701258|531867616|FG006|Assessment and Scheduling|Lost to Follow-up|0|||
147466910|NCT01701258|531867617|FG007|Assessment and Scheduling|Lost to Follow-up|0|||
147466911|NCT01701258|531867618|FG008|Assessment and Scheduling|Lost to Follow-up|0|||
147466912|NCT01701258|531867619|FG009|Assessment and Scheduling|Lost to Follow-up|0|||
147466913|NCT01701258|531867620|FG010|Assessment and Scheduling|Lost to Follow-up|0|||
147466914|NCT01701258|531867621|FG011|Assessment and Scheduling|Lost to Follow-up|0|||
147466915|NCT01701258|531867622|FG012|Assessment and Scheduling|Lost to Follow-up|0|||
147466916|NCT01701258|531867610|FG000|Assessment and Scheduling|Withdrawal by Subject|14|||
147466917|NCT01701258|531867611|FG001|Assessment and Scheduling|Withdrawal by Subject|0|||
147466918|NCT01701258|531867612|FG002|Assessment and Scheduling|Withdrawal by Subject|0|||
147466919|NCT01701258|531867613|FG003|Assessment and Scheduling|Withdrawal by Subject|0|||
147466920|NCT01701258|531867614|FG004|Assessment and Scheduling|Withdrawal by Subject|0|||
147466921|NCT01701258|531867615|FG005|Assessment and Scheduling|Withdrawal by Subject|0|||
147466922|NCT01701258|531867616|FG006|Assessment and Scheduling|Withdrawal by Subject|0|||
147466923|NCT01701258|531867617|FG007|Assessment and Scheduling|Withdrawal by Subject|0|||
147466924|NCT01701258|531867618|FG008|Assessment and Scheduling|Withdrawal by Subject|0|||
147466925|NCT01701258|531867619|FG009|Assessment and Scheduling|Withdrawal by Subject|0|||
147466926|NCT01701258|531867620|FG010|Assessment and Scheduling|Withdrawal by Subject|0|||
147466927|NCT01701258|531867621|FG011|Assessment and Scheduling|Withdrawal by Subject|0|||
147466928|NCT01701258|531867622|FG012|Assessment and Scheduling|Withdrawal by Subject|0|||
147466929|NCT01701258|531867610|FG000|Assessment and Scheduling|Investigator Terminated|2|||
147466930|NCT01701258|531867611|FG001|Assessment and Scheduling|Investigator Terminated|0|||
147466931|NCT01701258|531867612|FG002|Assessment and Scheduling|Investigator Terminated|0|||
147466932|NCT01701258|531867613|FG003|Assessment and Scheduling|Investigator Terminated|0|||
147466933|NCT01701258|531867614|FG004|Assessment and Scheduling|Investigator Terminated|0|||
147466934|NCT01701258|531867615|FG005|Assessment and Scheduling|Investigator Terminated|0|||
147466935|NCT01701258|531867616|FG006|Assessment and Scheduling|Investigator Terminated|0|||
147466936|NCT01701258|531867617|FG007|Assessment and Scheduling|Investigator Terminated|0|||
147466937|NCT01701258|531867618|FG008|Assessment and Scheduling|Investigator Terminated|0|||
147466938|NCT01701258|531867619|FG009|Assessment and Scheduling|Investigator Terminated|0|||
147466939|NCT01701258|531867620|FG010|Assessment and Scheduling|Investigator Terminated|0|||
147466940|NCT01701258|531867621|FG011|Assessment and Scheduling|Investigator Terminated|0|||
147466941|NCT01701258|531867622|FG012|Assessment and Scheduling|Investigator Terminated|0|||
147617379|NCT01487525|532413818|FG001|Overall Study|Withdrawal by Subject|1|||
147617380|NCT01640249|532413819|FG000|Period 1|Withdrawal by Subject|1|||
147617381|NCT01640249|532413820|FG001|Period 1|Withdrawal by Subject|0|||
147617382|NCT01640249|532413821|FG002|Period 1|Withdrawal by Subject|0|||
147617383|NCT01640249|532413822|FG003|Period 1|Withdrawal by Subject|0|||
147617384|NCT01640249|532413823|FG004|Period 1|Withdrawal by Subject|0|||
147300309|NCT04857034|531266031|FG002|Placebo-Controlled Period|Pregnancy|0|||
147300310|NCT04857034|531266032|FG003|Placebo-Controlled Period|Pregnancy|0|||
147300311|NCT04857034|531266033|FG004|Placebo-Controlled Period|Pregnancy|0|||
147300312|NCT04857034|531266029|FG000|Placebo-Controlled Period|Ongoing study period|0|||
147300313|NCT04857034|531266030|FG001|Placebo-Controlled Period|Ongoing study period|1|||
147300314|NCT04857034|531266031|FG002|Placebo-Controlled Period|Ongoing study period|0|||
147300315|NCT04857034|531266032|FG003|Placebo-Controlled Period|Ongoing study period|0|||
147300316|NCT04857034|531266033|FG004|Placebo-Controlled Period|Ongoing study period|0|||
147300317|NCT04857034|531266029|FG000|Active Treatment Period|Lack of Efficacy|1|||
147300318|NCT04857034|531266030|FG001|Active Treatment Period|Lack of Efficacy|0|||
147300319|NCT04857034|531266031|FG002|Active Treatment Period|Lack of Efficacy|0|||
147300320|NCT04857034|531266032|FG003|Active Treatment Period|Lack of Efficacy|0|||
147300321|NCT04857034|531266033|FG004|Active Treatment Period|Lack of Efficacy|0|||
147300322|NCT04857034|531266029|FG000|Active Treatment Period|request to discontinue|0|||
147300323|NCT04857034|531266030|FG001|Active Treatment Period|request to discontinue|1|||
147300324|NCT04857034|531266031|FG002|Active Treatment Period|request to discontinue|0|||
147300325|NCT04857034|531266032|FG003|Active Treatment Period|request to discontinue|1|||
147300326|NCT04857034|531266033|FG004|Active Treatment Period|request to discontinue|0|||
147300327|NCT04857034|531266029|FG000|Active Treatment Period|administrative reason by sponsor|1|||
147300328|NCT04857034|531266030|FG001|Active Treatment Period|administrative reason by sponsor|5|||
147300329|NCT04857034|531266031|FG002|Active Treatment Period|administrative reason by sponsor|0|||
147300330|NCT04857034|531266032|FG003|Active Treatment Period|administrative reason by sponsor|2|||
147300331|NCT04857034|531266033|FG004|Active Treatment Period|administrative reason by sponsor|2|||
147300332|NCT04857034|531266029|FG000|Active Treatment Period|other reasons|1|||
147300333|NCT04857034|531266030|FG001|Active Treatment Period|other reasons|1|||
147300334|NCT04857034|531266031|FG002|Active Treatment Period|other reasons|0|||
147300335|NCT04857034|531266032|FG003|Active Treatment Period|other reasons|0|||
147300336|NCT04857034|531266033|FG004|Active Treatment Period|other reasons|1|||
147300337|NCT04857034|531266029|FG000|Active Treatment Period|Ongoing Study Period|2|||
147300338|NCT04857034|531266030|FG001|Active Treatment Period|Ongoing Study Period|4|||
147300339|NCT04857034|531266031|FG002|Active Treatment Period|Ongoing Study Period|0|||
147300340|NCT04857034|531266032|FG003|Active Treatment Period|Ongoing Study Period|1|||
147300341|NCT04857034|531266033|FG004|Active Treatment Period|Ongoing Study Period|0|||
147300342|NCT00387894|531266034|FG000|Overall Study|Withdrawal by Subject|1|||
147300343|NCT00659490|531266035|FG000|Overall Study|Lost to Follow-up|2|||
147300344|NCT00659490|531266036|FG001|Overall Study|Lost to Follow-up|0|||
147300345|NCT00659490|531266037|FG002|Overall Study|Lost to Follow-up|1|||
147300346|NCT05674890|531266038|FG000|Overall Study|5 eyes were excluded due to poor reliability indices|2|||
147300347|NCT05674890|531266039|FG001|Overall Study|5 eyes were excluded due to poor reliability indices|3|||
147300348|NCT05674890|531266038|FG000|Overall Study|4 eyes were excluded due to neurocognitive disease interfering with testing capability.|2|||
147300349|NCT05674890|531266039|FG001|Overall Study|4 eyes were excluded due to neurocognitive disease interfering with testing capability.|2|||
147300350|NCT05674890|531266038|FG000|Overall Study|8 eyes were excluded due to systemic or ocular disease affecting central vision.|3|||
147409761|NCT01646177|531664159|FG004|Long-Term Extension Period (Week 12-264)|Sponsor Decision|3|||
147409762|NCT01646177|531664160|FG005|Long-Term Extension Period (Week 12-264)|Sponsor Decision|2|||
147409763|NCT01646177|531664161|FG006|Long-Term Extension Period (Week 12-264)|Sponsor Decision|2|||
147409764|NCT01646177|531664162|FG007|Long-Term Extension Period (Week 12-264)|Sponsor Decision|2|||
147409765|NCT01646177|531664163|FG008|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
147409766|NCT01646177|531664164|FG009|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
147409767|NCT01646177|531664165|FG010|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
147409768|NCT01646177|531664166|FG011|Long-Term Extension Period (Week 12-264)|Sponsor Decision|0|||
147409769|NCT01646177|531664155|FG000|Long-Term Extension Period (Week 12-264)|Death|0|||
147409770|NCT01646177|531664156|FG001|Long-Term Extension Period (Week 12-264)|Death|0|||
147409771|NCT01646177|531664157|FG002|Long-Term Extension Period (Week 12-264)|Death|0|||
147409772|NCT01646177|531664158|FG003|Long-Term Extension Period (Week 12-264)|Death|0|||
147409773|NCT01646177|531664159|FG004|Long-Term Extension Period (Week 12-264)|Death|1|||
147409774|NCT01646177|531664160|FG005|Long-Term Extension Period (Week 12-264)|Death|3|||
147409775|NCT01646177|531664161|FG006|Long-Term Extension Period (Week 12-264)|Death|1|||
147409776|NCT01646177|531664162|FG007|Long-Term Extension Period (Week 12-264)|Death|3|||
147409777|NCT01646177|531664163|FG008|Long-Term Extension Period (Week 12-264)|Death|0|||
147409778|NCT01646177|531664164|FG009|Long-Term Extension Period (Week 12-264)|Death|0|||
147409779|NCT01646177|531664165|FG010|Long-Term Extension Period (Week 12-264)|Death|0|||
147409780|NCT01646177|531664166|FG011|Long-Term Extension Period (Week 12-264)|Death|0|||
147409781|NCT01646177|531664155|FG000|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
147617385|NCT01640249|532413824|FG005|Period 1|Withdrawal by Subject|1|||
147617386|NCT01640249|532413825|FG006|Period 1|Withdrawal by Subject|0|||
147617387|NCT01870778|532413826|FG000|Overall Study|Withdrawal by Subject|8|||
147617388|NCT01870778|532413827|FG001|Overall Study|Withdrawal by Subject|7|||
147617389|NCT01870778|532413826|FG000|Overall Study|Lost to Follow-up|0|||
147617390|NCT01870778|532413827|FG001|Overall Study|Lost to Follow-up|2|||
147617391|NCT00065156|532413828|FG000|Overall Study|Adverse Event|37|||
147617392|NCT00065156|532413828|FG000|Overall Study|Lack of Efficacy|52|||
147617393|NCT00065156|532413828|FG000|Overall Study|Withdrawal by Subject|8|||
147617394|NCT00065156|532413828|FG000|Overall Study|Lost to Follow-up|1|||
147617395|NCT00065156|532413828|FG000|Overall Study|Death|11|||
147617396|NCT00065156|532413828|FG000|Overall Study|Study Closed by Sponsor|2|||
147617397|NCT00065156|532413828|FG000|Overall Study|Disease Progression|7|||
147617398|NCT00065156|532413828|FG000|Overall Study|Investigator Decision|2|||
147617399|NCT00065156|532413828|FG000|Overall Study|Non-Compliance|2|||
147617400|NCT00065156|532413828|FG000|Overall Study|Loss of Response|1|||
147617401|NCT00065156|532413828|FG000|Overall Study|Secondary Malign Disease|1|||
147617402|NCT02273388|532413833|FG000|Overall Study|Adverse Event|0|||
147617403|NCT02273388|532413834|FG001|Overall Study|Adverse Event|0|||
147617404|NCT02273388|532413835|FG002|Overall Study|Adverse Event|0|||
147617405|NCT02273388|532413836|FG003|Overall Study|Adverse Event|0|||
147617406|NCT02273388|532413837|FG004|Overall Study|Adverse Event|0|||
147617407|NCT02273388|532413838|FG005|Overall Study|Adverse Event|0|||
147617408|NCT02273388|532413839|FG006|Overall Study|Adverse Event|1|||
147617409|NCT02273388|532413840|FG007|Overall Study|Adverse Event|2|||
147617410|NCT02273388|532413841|FG008|Overall Study|Adverse Event|0|||
147617411|NCT02273388|532413842|FG009|Overall Study|Adverse Event|0|||
147617412|NCT02273388|532413843|FG010|Overall Study|Adverse Event|0|||
147617413|NCT02273388|532413844|FG011|Overall Study|Adverse Event|0|||
147617414|NCT02273388|532413833|FG000|Overall Study|Adverse Event study disease worse|4|||
147617415|NCT02273388|532413834|FG001|Overall Study|Adverse Event study disease worse|3|||
147617416|NCT02273388|532413835|FG002|Overall Study|Adverse Event study disease worse|3|||
147617417|NCT02273388|532413836|FG003|Overall Study|Adverse Event study disease worse|2|||
147617418|NCT02273388|532413837|FG004|Overall Study|Adverse Event study disease worse|4|||
147617419|NCT02273388|532413838|FG005|Overall Study|Adverse Event study disease worse|3|||
147617420|NCT02273388|532413839|FG006|Overall Study|Adverse Event study disease worse|14|||
147617421|NCT02273388|532413840|FG007|Overall Study|Adverse Event study disease worse|6|||
147617422|NCT02273388|532413841|FG008|Overall Study|Adverse Event study disease worse|6|||
147617423|NCT02273388|532413842|FG009|Overall Study|Adverse Event study disease worse|5|||
147617424|NCT02273388|532413843|FG010|Overall Study|Adverse Event study disease worse|10|||
147617425|NCT02273388|532413844|FG011|Overall Study|Adverse Event study disease worse|1|||
147617426|NCT02273388|532413833|FG000|Overall Study|Sponsor decision|0|||
147617427|NCT02273388|532413834|FG001|Overall Study|Sponsor decision|0|||
147617428|NCT02273388|532413835|FG002|Overall Study|Sponsor decision|0|||
147617429|NCT02273388|532413836|FG003|Overall Study|Sponsor decision|0|||
147617430|NCT02273388|532413837|FG004|Overall Study|Sponsor decision|0|||
147617431|NCT02273388|532413838|FG005|Overall Study|Sponsor decision|0|||
147617432|NCT02273388|532413839|FG006|Overall Study|Sponsor decision|0|||
147617433|NCT02273388|532413840|FG007|Overall Study|Sponsor decision|0|||
147617434|NCT02273388|532413841|FG008|Overall Study|Sponsor decision|0|||
147617435|NCT02273388|532413842|FG009|Overall Study|Sponsor decision|0|||
147617436|NCT02273388|532413843|FG010|Overall Study|Sponsor decision|0|||
147617437|NCT02273388|532413844|FG011|Overall Study|Sponsor decision|1|||
147617438|NCT04331808|532413845|FG000|Overall Study|Withdrew consent|1|||
147617439|NCT04331808|532413846|FG001|Overall Study|Withdrew consent|0|||
147617440|NCT04331808|532413847|FG002|Overall Study|Withdrew consent|2|||
147617441|NCT04331808|532413848|FG003|Overall Study|Withdrew consent|3|||
147617442|NCT00952731|532413852|FG000|Overall Study|Drug supply expired|1|||
147617443|NCT00952731|532413853|FG001|Overall Study|Drug supply expired|0|||
147617444|NCT01329900|532413854|FG000|Overall Study|Elevated creatinine/renal function|1|||
147617445|NCT01184079|532413855|FG000|Overall Study|Lost to Follow-up|14|||
147617446|NCT01184079|532413856|FG001|Overall Study|Lost to Follow-up|2|||
147617447|NCT04233073|532413857|FG000|Overall Study|Death|5|||
147617448|NCT01256502|532413862|FG000|Overall Study|Had scaffold removed|4|||
147300351|NCT05674890|531266039|FG001|Overall Study|8 eyes were excluded due to systemic or ocular disease affecting central vision.|5|||
147617449|NCT01256502|532413862|FG000|Overall Study|Personal reasons|5|||
147617450|NCT01256502|532413862|FG000|Overall Study|Protocol deviation|1|||
147617451|NCT01523002|532413863|FG000|Period 1|Withdrawal by Subject|1|||
147300352|NCT00827541|531266040|FG000|Overall Study|Exitus|1|||
147300353|NCT00827541|531266041|FG001|Overall Study|Exitus|8|||
147617452|NCT01523002|532413864|FG001|Period 1|Withdrawal by Subject|3|||
147617453|NCT01523002|532413863|FG000|Period 1|Lost to Follow-up|1|||
147617454|NCT01523002|532413864|FG001|Period 1|Lost to Follow-up|0|||
147617455|NCT01523002|532413863|FG000|Period 1|Adverse Event|0|||
147617456|NCT01523002|532413864|FG001|Period 1|Adverse Event|8|||
147617457|NCT01523002|532413863|FG000|Period 2|Withdrawal by Subject|4|||
147617458|NCT01523002|532413864|FG001|Period 2|Withdrawal by Subject|1|||
147617459|NCT01523002|532413863|FG000|Period 2|Adverse Event|2|||
147617460|NCT01523002|532413864|FG001|Period 2|Adverse Event|5|||
147617461|NCT01523002|532413863|FG000|Period 3|Withdrawal by Subject|1|||
147617462|NCT01523002|532413864|FG001|Period 3|Withdrawal by Subject|0|||
147617463|NCT01523002|532413863|FG000|Period 3|Adverse Event|3|||
147617464|NCT01523002|532413864|FG001|Period 3|Adverse Event|0|||
147617465|NCT05101343|532413869|FG000|Overall Study|Withdrawal by Subject|2|||
147617466|NCT05101343|532413870|FG001|Overall Study|Withdrawal by Subject|1|||
147617467|NCT04779879|532413871|FG000|Part B: Up to Week 36|Randomized, but did not receive treatment|0|||
147617468|NCT04779879|532413872|FG001|Part B: Up to Week 36|Randomized, but did not receive treatment|0|||
147617469|NCT04779879|532413873|FG002|Part B: Up to Week 36|Randomized, but did not receive treatment|0|||
147617470|NCT04779879|532413874|FG003|Part B: Up to Week 36|Randomized, but did not receive treatment|1|||
147617471|NCT04779879|532413875|FG004|Part B: Up to Week 36|Randomized, but did not receive treatment|0|||
147617472|NCT04779879|532413876|FG005|Part B: Up to Week 36|Randomized, but did not receive treatment|0|||
147617473|NCT04779879|532413871|FG000|Part B: Up to Week 36|Withdrawal by Subject|0|||
147617474|NCT04779879|532413872|FG001|Part B: Up to Week 36|Withdrawal by Subject|0|||
147617475|NCT04779879|532413873|FG002|Part B: Up to Week 36|Withdrawal by Subject|0|||
147617476|NCT04779879|532413874|FG003|Part B: Up to Week 36|Withdrawal by Subject|1|||
147617477|NCT04779879|532413875|FG004|Part B: Up to Week 36|Withdrawal by Subject|0|||
147300354|NCT00827541|531266040|FG000|Overall Study|Other|1|||
147300355|NCT00827541|531266041|FG001|Overall Study|Other|3|||
147300356|NCT00827541|531266040|FG000|Overall Study|Pathogen not susceptible|1|||
147300357|NCT00827541|531266041|FG001|Overall Study|Pathogen not susceptible|0|||
147300358|NCT00827541|531266040|FG000|Overall Study|Lack of effectiveness|1|||
147300359|NCT00827541|531266041|FG001|Overall Study|Lack of effectiveness|0|||
147300360|NCT01649232|531266042|FG000|Overall Study|Physician Decision|2|||
147300361|NCT01649232|531266043|FG001|Overall Study|Physician Decision|0|||
147300362|NCT02421666|531266044|FG000|6-month Follow-up|Lost to Follow-up|8|||
147617478|NCT04779879|532413876|FG005|Part B: Up to Week 36|Withdrawal by Subject|0|||
147617479|NCT04779879|532413871|FG000|Part C: Up to Week 36|Death|0|||
147617480|NCT04779879|532413872|FG001|Part C: Up to Week 36|Death|0|||
147617481|NCT04779879|532413873|FG002|Part C: Up to Week 36|Death|0|||
147617482|NCT04779879|532413874|FG003|Part C: Up to Week 36|Death|0|||
147300363|NCT02421666|531266045|FG001|6-month Follow-up|Lost to Follow-up|7|||
147300364|NCT02421666|531266044|FG000|6-month Follow-up|Withdrawal by Subject|5|||
147300365|NCT02421666|531266045|FG001|6-month Follow-up|Withdrawal by Subject|6|||
147300366|NCT02421666|531266044|FG000|12-month Follow-up|Lost to Follow-up|5|||
147300367|NCT02421666|531266045|FG001|12-month Follow-up|Lost to Follow-up|5|||
147300368|NCT02421666|531266044|FG000|12-month Follow-up|Withdrawal by Subject|6|||
147300369|NCT02421666|531266045|FG001|12-month Follow-up|Withdrawal by Subject|11|||
147300370|NCT00246337|531266046|FG000|Overall Study|Lost to Follow-up|3|||
147300371|NCT00246337|531266047|FG001|Overall Study|Lost to Follow-up|0|||
147300372|NCT00246337|531266048|FG002|Overall Study|Lost to Follow-up|0|||
147300373|NCT00246337|531266049|FG003|Overall Study|Lost to Follow-up|0|||
147300374|NCT00246337|531266050|FG004|Overall Study|Lost to Follow-up|2|||
147300375|NCT00246337|531266051|FG005|Overall Study|Lost to Follow-up|2|||
147300376|NCT00246337|531266052|FG006|Overall Study|Lost to Follow-up|1|||
147409782|NCT01646177|531664156|FG001|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
147617483|NCT04779879|532413875|FG004|Part C: Up to Week 36|Death|0|||
147617484|NCT04779879|532413876|FG005|Part C: Up to Week 36|Death|1|||
147617485|NCT04779879|532413871|FG000|Part C: Up to Week 36|Withdrawal by Subject|0|||
147617486|NCT04779879|532413872|FG001|Part C: Up to Week 36|Withdrawal by Subject|0|||
147409783|NCT01646177|531664157|FG002|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
147409784|NCT01646177|531664158|FG003|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
147409785|NCT01646177|531664159|FG004|Long-Term Extension Period (Week 12-264)|Clinical Relapse|1|||
147409786|NCT01646177|531664160|FG005|Long-Term Extension Period (Week 12-264)|Clinical Relapse|1|||
147409787|NCT01646177|531664161|FG006|Long-Term Extension Period (Week 12-264)|Clinical Relapse|1|||
147409788|NCT01646177|531664162|FG007|Long-Term Extension Period (Week 12-264)|Clinical Relapse|4|||
147409789|NCT01646177|531664163|FG008|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
147409790|NCT01646177|531664164|FG009|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
147409791|NCT01646177|531664165|FG010|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
147409792|NCT01646177|531664166|FG011|Long-Term Extension Period (Week 12-264)|Clinical Relapse|0|||
147409793|NCT01646177|531664155|FG000|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
147409794|NCT01646177|531664156|FG001|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
147409795|NCT01646177|531664157|FG002|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
147409796|NCT01646177|531664158|FG003|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
147409797|NCT01646177|531664159|FG004|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
147409798|NCT01646177|531664160|FG005|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
147409799|NCT01646177|531664161|FG006|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
147617487|NCT04779879|532413873|FG002|Part C: Up to Week 36|Withdrawal by Subject|0|||
147300377|NCT00246337|531266053|FG007|Overall Study|Lost to Follow-up|2|||
147300378|NCT00246337|531266054|FG008|Overall Study|Lost to Follow-up|0|||
147300379|NCT00246337|531266046|FG000|Overall Study|Protocol Violation|1|||
147300380|NCT00246337|531266047|FG001|Overall Study|Protocol Violation|0|||
147300381|NCT00246337|531266048|FG002|Overall Study|Protocol Violation|0|||
147300382|NCT00246337|531266049|FG003|Overall Study|Protocol Violation|0|||
147300383|NCT00246337|531266050|FG004|Overall Study|Protocol Violation|1|||
147300384|NCT00246337|531266051|FG005|Overall Study|Protocol Violation|0|||
147300385|NCT00246337|531266052|FG006|Overall Study|Protocol Violation|1|||
147300386|NCT00246337|531266053|FG007|Overall Study|Protocol Violation|1|||
147300387|NCT00246337|531266054|FG008|Overall Study|Protocol Violation|0|||
147300388|NCT00246337|531266046|FG000|Overall Study|Withdrawal by Subject|2|||
147300389|NCT00246337|531266047|FG001|Overall Study|Withdrawal by Subject|0|||
147300390|NCT00246337|531266048|FG002|Overall Study|Withdrawal by Subject|0|||
147300391|NCT00246337|531266049|FG003|Overall Study|Withdrawal by Subject|0|||
147300392|NCT00246337|531266050|FG004|Overall Study|Withdrawal by Subject|0|||
147300393|NCT00246337|531266051|FG005|Overall Study|Withdrawal by Subject|0|||
147300394|NCT00246337|531266052|FG006|Overall Study|Withdrawal by Subject|1|||
147300395|NCT00246337|531266053|FG007|Overall Study|Withdrawal by Subject|1|||
147300396|NCT00246337|531266054|FG008|Overall Study|Withdrawal by Subject|0|||
147300397|NCT00246337|531266046|FG000|Overall Study|Lack of Qualifying Event|8|||
147300398|NCT00246337|531266047|FG001|Overall Study|Lack of Qualifying Event|2|||
147300399|NCT00246337|531266048|FG002|Overall Study|Lack of Qualifying Event|1|||
147300400|NCT00246337|531266049|FG003|Overall Study|Lack of Qualifying Event|1|||
147300401|NCT00246337|531266050|FG004|Overall Study|Lack of Qualifying Event|1|||
147300402|NCT00246337|531266051|FG005|Overall Study|Lack of Qualifying Event|3|||
147300403|NCT00246337|531266052|FG006|Overall Study|Lack of Qualifying Event|3|||
147300404|NCT00246337|531266053|FG007|Overall Study|Lack of Qualifying Event|2|||
147300405|NCT00246337|531266054|FG008|Overall Study|Lack of Qualifying Event|5|||
147300406|NCT00246337|531266046|FG000|Overall Study|Site Terminated|10|||
147300407|NCT00246337|531266047|FG001|Overall Study|Site Terminated|0|||
147300408|NCT00246337|531266048|FG002|Overall Study|Site Terminated|0|||
147300409|NCT00246337|531266049|FG003|Overall Study|Site Terminated|0|||
147300410|NCT00246337|531266050|FG004|Overall Study|Site Terminated|0|||
147300411|NCT00246337|531266051|FG005|Overall Study|Site Terminated|7|||
147300412|NCT00246337|531266052|FG006|Overall Study|Site Terminated|1|||
147300413|NCT00246337|531266053|FG007|Overall Study|Site Terminated|6|||
147300414|NCT00246337|531266054|FG008|Overall Study|Site Terminated|2|||
147300415|NCT00246337|531266046|FG000|Overall Study|Abnormal baseline lab values|7|||
147300416|NCT00246337|531266047|FG001|Overall Study|Abnormal baseline lab values|0|||
147300417|NCT00246337|531266048|FG002|Overall Study|Abnormal baseline lab values|2|||
147300418|NCT00246337|531266049|FG003|Overall Study|Abnormal baseline lab values|0|||
147300419|NCT00246337|531266050|FG004|Overall Study|Abnormal baseline lab values|0|||
147300420|NCT00246337|531266051|FG005|Overall Study|Abnormal baseline lab values|2|||
147300421|NCT00246337|531266052|FG006|Overall Study|Abnormal baseline lab values|2|||
147300422|NCT00246337|531266053|FG007|Overall Study|Abnormal baseline lab values|0|||
147300423|NCT00246337|531266054|FG008|Overall Study|Abnormal baseline lab values|4|||
147300424|NCT00246337|531266046|FG000|Overall Study|Overwhelmed|0|||
147300425|NCT00246337|531266047|FG001|Overall Study|Overwhelmed|0|||
147300426|NCT00246337|531266048|FG002|Overall Study|Overwhelmed|0|||
147300427|NCT00246337|531266049|FG003|Overall Study|Overwhelmed|0|||
147300428|NCT00246337|531266050|FG004|Overall Study|Overwhelmed|0|||
147300429|NCT00246337|531266051|FG005|Overall Study|Overwhelmed|1|||
147300430|NCT00246337|531266052|FG006|Overall Study|Overwhelmed|0|||
147300431|NCT00246337|531266053|FG007|Overall Study|Overwhelmed|0|||
147300432|NCT00246337|531266054|FG008|Overall Study|Overwhelmed|0|||
147300433|NCT00246337|531266046|FG000|Overall Study|Protocol Violator|1|||
147300434|NCT00246337|531266047|FG001|Overall Study|Protocol Violator|0|||
147300435|NCT00246337|531266048|FG002|Overall Study|Protocol Violator|0|||
147300436|NCT00246337|531266049|FG003|Overall Study|Protocol Violator|0|||
147300437|NCT00246337|531266050|FG004|Overall Study|Protocol Violator|0|||
147300438|NCT00246337|531266051|FG005|Overall Study|Protocol Violator|0|||
147300439|NCT00246337|531266052|FG006|Overall Study|Protocol Violator|0|||
147300440|NCT00246337|531266053|FG007|Overall Study|Protocol Violator|0|||
147300441|NCT00246337|531266054|FG008|Overall Study|Protocol Violator|0|||
147300442|NCT00246337|531266046|FG000|Overall Study|Reported as completing trial in error|0|||
147300443|NCT00246337|531266047|FG001|Overall Study|Reported as completing trial in error|0|||
147300444|NCT00246337|531266048|FG002|Overall Study|Reported as completing trial in error|0|||
147300445|NCT00246337|531266049|FG003|Overall Study|Reported as completing trial in error|0|||
147300446|NCT00246337|531266050|FG004|Overall Study|Reported as completing trial in error|0|||
147300447|NCT00246337|531266051|FG005|Overall Study|Reported as completing trial in error|0|||
147300448|NCT00246337|531266052|FG006|Overall Study|Reported as completing trial in error|0|||
147300449|NCT00246337|531266053|FG007|Overall Study|Reported as completing trial in error|1|||
147300450|NCT00246337|531266054|FG008|Overall Study|Reported as completing trial in error|0|||
147300451|NCT01226511|531266059|FG000|Acute Treatment Period|Adverse Event|7|||
147300452|NCT01226511|531266060|FG001|Acute Treatment Period|Adverse Event|6|||
147300453|NCT01226511|531266059|FG000|Acute Treatment Period|Lack of Efficacy|2|||
147300454|NCT01226511|531266060|FG001|Acute Treatment Period|Lack of Efficacy|1|||
147300455|NCT01226511|531266059|FG000|Acute Treatment Period|Lost to Follow-up|3|||
147665565|NCT01614470|532599627|FG002|Part 1: Treatment Period 1 (8 Weeks)|Lost to Follow-up|0|||
147409800|NCT01646177|531664162|FG007|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|1|||
147409801|NCT01646177|531664163|FG008|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
147409802|NCT01646177|531664164|FG009|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
147409803|NCT01646177|531664165|FG010|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
147409804|NCT01646177|531664166|FG011|Long-Term Extension Period (Week 12-264)|Parent/Caregiver Decision|0|||
147409805|NCT01646177|531664155|FG000|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
147409806|NCT01646177|531664156|FG001|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
147409807|NCT01646177|531664157|FG002|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
147409808|NCT01646177|531664158|FG003|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
147409809|NCT01646177|531664159|FG004|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
147409810|NCT01646177|531664160|FG005|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|3|||
147409811|NCT01646177|531664161|FG006|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|2|||
147409812|NCT01646177|531664162|FG007|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|1|||
147409813|NCT01646177|531664163|FG008|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
147409814|NCT01646177|531664164|FG009|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
147409815|NCT01646177|531664165|FG010|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
147409816|NCT01646177|531664166|FG011|Long-Term Extension Period (Week 12-264)|Missing Disposition Form|0|||
147409817|NCT01646177|531664155|FG000|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
147409818|NCT01646177|531664156|FG001|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
147409819|NCT01646177|531664157|FG002|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
147409820|NCT01646177|531664158|FG003|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
147409821|NCT01646177|531664159|FG004|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
147409822|NCT01646177|531664160|FG005|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
147409823|NCT01646177|531664161|FG006|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
147409824|NCT01646177|531664162|FG007|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|0|||
147409825|NCT01646177|531664163|FG008|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|13|||
147409826|NCT01646177|531664164|FG009|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|28|||
147409827|NCT01646177|531664165|FG010|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|34|||
147409828|NCT01646177|531664166|FG011|Follow-Up Period (Minimum of 12 Weeks)|Adverse Event|30|||
147409829|NCT01646177|531664155|FG000|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
147409830|NCT01646177|531664156|FG001|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
147409831|NCT01646177|531664157|FG002|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
147409832|NCT01646177|531664158|FG003|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
147409833|NCT01646177|531664159|FG004|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
147409834|NCT01646177|531664160|FG005|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
147409835|NCT01646177|531664161|FG006|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
147409836|NCT01646177|531664162|FG007|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|0|||
147409837|NCT01646177|531664163|FG008|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|7|||
147409838|NCT01646177|531664164|FG009|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|21|||
147409839|NCT01646177|531664165|FG010|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|19|||
147409840|NCT01646177|531664166|FG011|Follow-Up Period (Minimum of 12 Weeks)|Withdrawal by Subject|19|||
147409841|NCT01646177|531664155|FG000|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
147409842|NCT01646177|531664156|FG001|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
147409843|NCT01646177|531664157|FG002|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
147409844|NCT01646177|531664158|FG003|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
147409845|NCT01646177|531664159|FG004|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
147409846|NCT01646177|531664160|FG005|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
147409847|NCT01646177|531664161|FG006|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
147409848|NCT01646177|531664162|FG007|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|0|||
147409849|NCT01646177|531664163|FG008|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|4|||
147409850|NCT01646177|531664164|FG009|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|8|||
147409851|NCT01646177|531664165|FG010|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|9|||
147409852|NCT01646177|531664166|FG011|Follow-Up Period (Minimum of 12 Weeks)|Lost to Follow-up|9|||
147409853|NCT01646177|531664155|FG000|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
147409854|NCT01646177|531664156|FG001|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
147409855|NCT01646177|531664157|FG002|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
147409856|NCT01646177|531664158|FG003|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
147409857|NCT01646177|531664159|FG004|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
147409858|NCT01646177|531664160|FG005|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
147409859|NCT01646177|531664161|FG006|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
147409860|NCT01646177|531664162|FG007|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|0|||
147466942|NCT04454489|531867623|FG000|Overall Study|Disease progression|12|||
147300456|NCT01226511|531266060|FG001|Acute Treatment Period|Lost to Follow-up|6|||
147300457|NCT01226511|531266059|FG000|Acute Treatment Period|Parent/caregiver decision|5|||
147300458|NCT01226511|531266060|FG001|Acute Treatment Period|Parent/caregiver decision|7|||
147300459|NCT01226511|531266059|FG000|Acute Treatment Period|Protocol Violation|5|||
147300460|NCT01226511|531266060|FG001|Acute Treatment Period|Protocol Violation|5|||
147300461|NCT01226511|531266059|FG000|Acute Treatment Period|Withdrawal by Subject|10|||
147300462|NCT01226511|531266060|FG001|Acute Treatment Period|Withdrawal by Subject|6|||
147300463|NCT01226511|531266059|FG000|Extension Treatment Period|Adverse Event|8|||
147300464|NCT01226511|531266060|FG001|Extension Treatment Period|Adverse Event|8|||
147300465|NCT01226511|531266059|FG000|Extension Treatment Period|Lack of Efficacy|3|||
147300466|NCT01226511|531266060|FG001|Extension Treatment Period|Lack of Efficacy|2|||
147300467|NCT01226511|531266059|FG000|Extension Treatment Period|Lost to Follow-up|4|||
147300468|NCT01226511|531266060|FG001|Extension Treatment Period|Lost to Follow-up|3|||
147300469|NCT01226511|531266059|FG000|Extension Treatment Period|Protocol Violation|2|||
147300470|NCT01226511|531266060|FG001|Extension Treatment Period|Protocol Violation|2|||
147300471|NCT01226511|531266059|FG000|Extension Treatment Period|Withdrawal by Subject|1|||
147300472|NCT01226511|531266060|FG001|Extension Treatment Period|Withdrawal by Subject|3|||
147300473|NCT01226511|531266059|FG000|Extension Treatment Period|Parent/Caregiver Decision|8|||
147300474|NCT01226511|531266060|FG001|Extension Treatment Period|Parent/Caregiver Decision|8|||
147300475|NCT01226511|531266059|FG000|Extension Treatment Period|Sponsor Decision|1|||
147300476|NCT01226511|531266060|FG001|Extension Treatment Period|Sponsor Decision|1|||
147300477|NCT01226511|531266059|FG000|Taper Period|Adverse Event|1|||
147300478|NCT01226511|531266060|FG001|Taper Period|Adverse Event|0|||
147300479|NCT01226511|531266059|FG000|Taper Period|Lost to Follow-up|2|||
147300480|NCT01226511|531266060|FG001|Taper Period|Lost to Follow-up|2|||
147300481|NCT01226511|531266059|FG000|Taper Period|Protocol Violation|1|||
147300482|NCT01226511|531266060|FG001|Taper Period|Protocol Violation|0|||
147300483|NCT01226511|531266059|FG000|Taper Period|Parent/Caregiver Decision|1|||
147300484|NCT01226511|531266060|FG001|Taper Period|Parent/Caregiver Decision|1|||
147300485|NCT00106184|531266068|FG000|Overall Study|Withdrawal by Subject|3|||
147300486|NCT00106184|531266069|FG001|Overall Study|Withdrawal by Subject|2|||
147300487|NCT02313909|531266073|FG000|Overall Study|Consent withdrawn by participant|33|||
147300488|NCT02313909|531266074|FG001|Overall Study|Consent withdrawn by participant|33|||
147300489|NCT02313909|531266073|FG000|Overall Study|Lost to Follow-up|24|||
147300490|NCT02313909|531266074|FG001|Overall Study|Lost to Follow-up|17|||
147300491|NCT00643123|531266080|FG000|Overall Study|Lost to Follow-up|4|||
147300492|NCT00643123|531266081|FG001|Overall Study|Lost to Follow-up|0|||
147300493|NCT00643123|531266080|FG000|Overall Study|Withdrawal by Subject|1|||
147300494|NCT00643123|531266081|FG001|Overall Study|Withdrawal by Subject|1|||
147300495|NCT05292534|531266082|FG000|Overall Study|Protocol Violation|3|||
147300496|NCT05292534|531266083|FG001|Overall Study|Protocol Violation|4|||
147300497|NCT05292534|531266082|FG000|Overall Study|Withdrawal by Subject|0|||
147300498|NCT05292534|531266083|FG001|Overall Study|Withdrawal by Subject|1|||
147300499|NCT01538472|531266084|FG000|Overall Study|Disease Progression|3|||
147300500|NCT01538472|531266084|FG000|Overall Study|Death|1|||
147300501|NCT02309112|531266085|FG000|Overall Study|Withdrawal by Subject|1|||
147300502|NCT02309112|531266086|FG001|Overall Study|Withdrawal by Subject|0|||
147300503|NCT02309112|531266087|FG002|Overall Study|Withdrawal by Subject|1|||
147300504|NCT02309112|531266085|FG000|Overall Study|Lost to Follow-up|0|||
147300505|NCT02309112|531266086|FG001|Overall Study|Lost to Follow-up|1|||
147300506|NCT02309112|531266087|FG002|Overall Study|Lost to Follow-up|0|||
147300507|NCT02133872|531266088|FG000|Overall Study|Withdrawal by Subject|5|||
147300508|NCT02133872|531266089|FG001|Overall Study|Withdrawal by Subject|3|||
147300509|NCT02133872|531266090|FG002|Overall Study|Withdrawal by Subject|0|||
147300510|NCT02923739|531266091|FG000|Overall Study|Withdrawal by Subject|2|||
147617488|NCT04779879|532413874|FG003|Part C: Up to Week 36|Withdrawal by Subject|0|||
147617489|NCT04779879|532413875|FG004|Part C: Up to Week 36|Withdrawal by Subject|4|||
147300511|NCT02923739|531266092|FG001|Overall Study|Withdrawal by Subject|0|||
147300512|NCT02923739|531266093|FG002|Overall Study|Withdrawal by Subject|0|||
147300513|NCT02923739|531266094|FG003|Overall Study|Withdrawal by Subject|0|||
147300514|NCT02923739|531266091|FG000|Overall Study|Failed Screening|3|||
147617490|NCT04779879|532413876|FG005|Part C: Up to Week 36|Withdrawal by Subject|2|||
147617491|NCT02854527|532413877|FG000|Overall Study|Adverse Event|0|||
147617492|NCT02854527|532413878|FG001|Overall Study|Adverse Event|0|||
147617493|NCT02854527|532413879|FG002|Overall Study|Adverse Event|0|||
147617494|NCT02854527|532413880|FG003|Overall Study|Adverse Event|0|||
147617495|NCT02854527|532413881|FG004|Overall Study|Adverse Event|1|||
147300515|NCT02923739|531266092|FG001|Overall Study|Failed Screening|0|||
147300516|NCT02923739|531266093|FG002|Overall Study|Failed Screening|0|||
147300517|NCT02923739|531266094|FG003|Overall Study|Failed Screening|0|||
147300518|NCT00948974|531266099|FG000|Overall Study|Lost to Follow-up|23|||
147409861|NCT01646177|531664163|FG008|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|4|||
147300519|NCT00948974|531266100|FG001|Overall Study|Lost to Follow-up|20|||
147300520|NCT02857426|531266108|FG000|Overall Study|Disease progression|34|||
147617496|NCT02854527|532413882|FG005|Overall Study|Adverse Event|0|||
147617497|NCT02854527|532413883|FG006|Overall Study|Adverse Event|0|||
147300521|NCT02857426|531266109|FG001|Overall Study|Disease progression|13|||
147300522|NCT02857426|531266108|FG000|Overall Study|Study drug toxicity|4|||
147300523|NCT02857426|531266109|FG001|Overall Study|Study drug toxicity|1|||
147300524|NCT02857426|531266108|FG000|Overall Study|Death|1|||
147300525|NCT02857426|531266109|FG001|Overall Study|Death|0|||
147300526|NCT02857426|531266108|FG000|Overall Study|Adverse event unrelated to study drug|6|||
147300527|NCT02857426|531266109|FG001|Overall Study|Adverse event unrelated to study drug|2|||
147300528|NCT02857426|531266108|FG000|Overall Study|Participant withdrew consent|1|||
147300529|NCT02857426|531266109|FG001|Overall Study|Participant withdrew consent|1|||
147300530|NCT02857426|531266108|FG000|Overall Study|Maximum clinical benefit|1|||
147300531|NCT02857426|531266109|FG001|Overall Study|Maximum clinical benefit|0|||
147300532|NCT02857426|531266108|FG000|Overall Study|Completed treatment|0|||
147300533|NCT02857426|531266109|FG001|Overall Study|Completed treatment|2|||
147300534|NCT02634788|531266113|FG000|Overall Study|Adverse Event|0|||
147300535|NCT02634788|531266114|FG001|Overall Study|Adverse Event|8|||
147300536|NCT02634788|531266115|FG002|Overall Study|Adverse Event|3|||
147300537|NCT02634788|531266116|FG003|Overall Study|Adverse Event|1|||
147300538|NCT02634788|531266113|FG000|Overall Study|Lack of Efficacy|4|||
147300539|NCT02634788|531266114|FG001|Overall Study|Lack of Efficacy|0|||
147300540|NCT02634788|531266115|FG002|Overall Study|Lack of Efficacy|1|||
147300541|NCT02634788|531266116|FG003|Overall Study|Lack of Efficacy|4|||
147300542|NCT02634788|531266113|FG000|Overall Study|Lost to Follow-up|0|||
147300543|NCT02634788|531266114|FG001|Overall Study|Lost to Follow-up|1|||
147300544|NCT02634788|531266115|FG002|Overall Study|Lost to Follow-up|0|||
147300545|NCT02634788|531266116|FG003|Overall Study|Lost to Follow-up|0|||
147300546|NCT02634788|531266113|FG000|Overall Study|Withdrawal by Subject|0|||
147300547|NCT02634788|531266114|FG001|Overall Study|Withdrawal by Subject|1|||
147300548|NCT02634788|531266115|FG002|Overall Study|Withdrawal by Subject|1|||
147300549|NCT02634788|531266116|FG003|Overall Study|Withdrawal by Subject|0|||
147300550|NCT00758459|531266117|FG000|Overall Study|Adverse Event|3|||
147300551|NCT00758459|531266118|FG001|Overall Study|Adverse Event|2|||
147300552|NCT00758459|531266117|FG000|Overall Study|Protocol Violation|0|||
147300553|NCT00758459|531266118|FG001|Overall Study|Protocol Violation|1|||
147300554|NCT00758459|531266117|FG000|Overall Study|Withdrawal by Subject|0|||
147300555|NCT00758459|531266118|FG001|Overall Study|Withdrawal by Subject|1|||
147300556|NCT02831257|531266120|FG000|Overall Study|Lack of Efficacy|3|||
147300557|NCT02831257|531266120|FG000|Overall Study|Adverse Event|2|||
147300558|NCT02831257|531266120|FG000|Overall Study|Physician Decision|1|||
147300559|NCT02831257|531266120|FG000|Overall Study|Withdrawal by Subject|6|||
147300560|NCT00611858|531266121|FG000|Overall Study|Adverse Event|2|||
147300561|NCT00611858|531266121|FG000|Overall Study|Withdrawal by Subject|2|||
147300562|NCT02703922|531266122|FG000|Overall Study|Death|5|||
147300563|NCT02703922|531266123|FG001|Overall Study|Death|8|||
147300564|NCT02703922|531266122|FG000|Overall Study|Lost to Follow-up|10|||
147300565|NCT02703922|531266123|FG001|Overall Study|Lost to Follow-up|10|||
147300566|NCT00717860|531266124|FG000|Overall Study|Clinical adverse experience|5|||
147300567|NCT00717860|531266125|FG001|Overall Study|Clinical adverse experience|9|||
147300568|NCT00717860|531266124|FG000|Overall Study|Laboratory adverse experience|2|||
147300569|NCT00717860|531266125|FG001|Overall Study|Laboratory adverse experience|2|||
147300570|NCT00717860|531266124|FG000|Overall Study|Lack of Efficacy|7|||
147300571|NCT00717860|531266125|FG001|Overall Study|Lack of Efficacy|13|||
147300572|NCT00717860|531266124|FG000|Overall Study|Discontinued for other reason|6|||
147300573|NCT00717860|531266125|FG001|Overall Study|Discontinued for other reason|1|||
147300574|NCT00717860|531266124|FG000|Overall Study|Withdrew consent|7|||
147300575|NCT00717860|531266125|FG001|Overall Study|Withdrew consent|3|||
147300576|NCT04058353|531266126|FG000|Overall Study|Adverse Event|2|||
147300577|NCT04058353|531266127|FG001|Overall Study|Adverse Event|1|||
147300578|NCT04058353|531266126|FG000|Overall Study|Physician Decision|1|||
147300579|NCT04058353|531266127|FG001|Overall Study|Physician Decision|0|||
147300580|NCT04058353|531266126|FG000|Overall Study|Other|1|||
147300581|NCT04058353|531266127|FG001|Overall Study|Other|0|||
147300582|NCT01728792|531267864|FG000|Overall Study|Withdrawal of Consent|1|||
147300583|NCT01728792|531267865|FG001|Overall Study|Withdrawal of Consent|1|||
147300584|NCT01728792|531267866|FG002|Overall Study|Withdrawal of Consent|0|||
147300585|NCT01728792|531267867|FG003|Overall Study|Withdrawal of Consent|1|||
147300586|NCT01728792|531267868|FG004|Overall Study|Withdrawal of Consent|0|||
147300587|NCT01728792|531267864|FG000|Overall Study|Lost to Follow-up|2|||
147300588|NCT01728792|531267865|FG001|Overall Study|Lost to Follow-up|1|||
147300589|NCT01728792|531267866|FG002|Overall Study|Lost to Follow-up|4|||
147300590|NCT01728792|531267867|FG003|Overall Study|Lost to Follow-up|2|||
147300591|NCT01728792|531267868|FG004|Overall Study|Lost to Follow-up|0|||
147300592|NCT03559218|531267869|FG000|Overall Study|Withdrawal by Subject|1|||
147300593|NCT03559218|531267870|FG001|Overall Study|Withdrawal by Subject|0|||
147300594|NCT04277455|531267871|FG000|Overall Study|Lost to Follow-up|1|||
147300595|NCT01679301|531267874|FG000|Screening Period|screen failure|3|||
147300596|NCT01679301|531267875|FG001|Screening Period|screen failure|0|||
147300597|NCT01679301|531267876|FG002|Screening Period|screen failure|0|||
147300598|NCT01564368|531267878|FG000|Overall Study|Ineligible|18|||
147300599|NCT01564368|531267878|FG000|Overall Study|Not Randomized in Parent study|116|||
147617498|NCT02854527|532413884|FG007|Overall Study|Adverse Event|0|||
147617499|NCT02854527|532413885|FG008|Overall Study|Adverse Event|0|||
147617500|NCT02854527|532413886|FG009|Overall Study|Adverse Event|0|||
147617501|NCT02854527|532413877|FG000|Overall Study|Lost to Follow-up|0|||
147617502|NCT02854527|532413878|FG001|Overall Study|Lost to Follow-up|0|||
147617503|NCT02854527|532413879|FG002|Overall Study|Lost to Follow-up|0|||
147617504|NCT02854527|532413880|FG003|Overall Study|Lost to Follow-up|1|||
147617505|NCT02854527|532413881|FG004|Overall Study|Lost to Follow-up|0|||
147617506|NCT02854527|532413882|FG005|Overall Study|Lost to Follow-up|0|||
147617507|NCT02854527|532413883|FG006|Overall Study|Lost to Follow-up|0|||
147617508|NCT02854527|532413884|FG007|Overall Study|Lost to Follow-up|0|||
147617509|NCT02854527|532413885|FG008|Overall Study|Lost to Follow-up|0|||
147617510|NCT02854527|532413886|FG009|Overall Study|Lost to Follow-up|0|||
147644006|NCT01447446|532516686|FG000|Overall Study|New Treatment Started|8|||
147644007|NCT01447446|532516687|FG001|Overall Study|New Treatment Started|2|||
147644008|NCT01447446|532516688|FG002|Overall Study|New Treatment Started|1|||
147644009|NCT01447446|532516689|FG003|Overall Study|New Treatment Started|0|||
147644010|NCT01447446|532516690|FG004|Overall Study|New Treatment Started|2|||
147644011|NCT01447446|532516691|FG005|Overall Study|New Treatment Started|0|||
147644012|NCT01447446|532516686|FG000|Overall Study|Reason not Specified|1|||
147644013|NCT01447446|532516687|FG001|Overall Study|Reason not Specified|1|||
147300600|NCT01564368|531267878|FG000|Overall Study|Baseline Imaging failed QC requirements|9|||
147300601|NCT01564368|531267878|FG000|Overall Study|No Acceptable post-baseline imaging|21|||
147300602|NCT01802437|531267882|FG000|Overall Study|Lost to Follow-up|1|||
147300603|NCT01802437|531267883|FG001|Overall Study|Lost to Follow-up|0|||
147300604|NCT01802437|531267882|FG000|Overall Study|Withdrawal by Subject|3|||
147300605|NCT01802437|531267883|FG001|Overall Study|Withdrawal by Subject|4|||
147300606|NCT02228967|531267884|FG000|Overall Study|Lost to Follow-up|146|||
147300607|NCT02228967|531267885|FG001|Overall Study|Lost to Follow-up|142|||
147300608|NCT02228967|531267884|FG000|Overall Study|Withdrawal by Subject|13|||
147300609|NCT02228967|531267885|FG001|Overall Study|Withdrawal by Subject|18|||
147300610|NCT00520975|531267886|FG000|Overall Study|Disease progression|31|||
147300611|NCT00520975|531267887|FG001|Overall Study|Disease progression|23|||
147300612|NCT00520975|531267886|FG000|Overall Study|Adverse Event|7|||
147300613|NCT00520975|531267887|FG001|Overall Study|Adverse Event|10|||
147300614|NCT00520975|531267886|FG000|Overall Study|Death|0|||
147300615|NCT00520975|531267887|FG001|Overall Study|Death|2|||
147300616|NCT00520975|531267886|FG000|Overall Study|Withdrawal by Subject|3|||
147300617|NCT00520975|531267887|FG001|Overall Study|Withdrawal by Subject|5|||
147300618|NCT00520975|531267886|FG000|Overall Study|Other therapy|2|||
147300619|NCT00520975|531267887|FG001|Overall Study|Other therapy|4|||
147300620|NCT00520975|531267886|FG000|Overall Study|Other reasons|4|||
147300621|NCT00520975|531267887|FG001|Overall Study|Other reasons|2|||
147300622|NCT00520975|531267886|FG000|Overall Study|Not start protocol therapy|1|||
147300623|NCT00520975|531267887|FG001|Overall Study|Not start protocol therapy|2|||
147300624|NCT00238433|531267889|FG000|Overall Study|Screen failure|1|||
147300625|NCT00238433|531267889|FG000|Overall Study|Lost to Follow-up|1|||
147300626|NCT00238433|531267889|FG000|Overall Study|Death|1|||
147300627|NCT00409682|531267895|FG000|Open-label Induction Period|Adverse Event|1|||
147300628|NCT00409682|531267896|FG001|Open-label Induction Period|Adverse Event|0|||
147300629|NCT00409682|531267897|FG002|Open-label Induction Period|Adverse Event|0|||
147300630|NCT00409682|531267895|FG000|Open-label Induction Period|Lack of Efficacy|1|||
147300631|NCT00409682|531267896|FG001|Open-label Induction Period|Lack of Efficacy|0|||
147300632|NCT00409682|531267897|FG002|Open-label Induction Period|Lack of Efficacy|0|||
147300633|NCT00409682|531267895|FG000|Open-label Induction Period|Protocol Violation|1|||
147300634|NCT00409682|531267896|FG001|Open-label Induction Period|Protocol Violation|0|||
147300635|NCT00409682|531267897|FG002|Open-label Induction Period|Protocol Violation|0|||
147300636|NCT00409682|531267895|FG000|Open-label Induction Period|Subject did not satisfy entry criteria|1|||
147644014|NCT01447446|532516688|FG002|Overall Study|Reason not Specified|1|||
147644015|NCT01447446|532516689|FG003|Overall Study|Reason not Specified|1|||
147644016|NCT01447446|532516690|FG004|Overall Study|Reason not Specified|1|||
147644017|NCT01447446|532516691|FG005|Overall Study|Reason not Specified|0|||
147644018|NCT04829331|532516694|FG000|Overall Study|Lost to Follow-up|1|||
147644019|NCT04829331|532516695|FG001|Overall Study|Lost to Follow-up|0|||
147300637|NCT00409682|531267896|FG001|Open-label Induction Period|Subject did not satisfy entry criteria|0|||
147300638|NCT00409682|531267897|FG002|Open-label Induction Period|Subject did not satisfy entry criteria|0|||
147300639|NCT00409682|531267895|FG000|EOW Double-blind Maintenance Period|Adverse Event|0|||
147300640|NCT00409682|531267896|FG001|EOW Double-blind Maintenance Period|Adverse Event|10|||
147300641|NCT00409682|531267897|FG002|EOW Double-blind Maintenance Period|Adverse Event|12|||
147300642|NCT00409682|531267895|FG000|EOW Double-blind Maintenance Period|Lack of Efficacy|0|||
147300643|NCT00409682|531267896|FG001|EOW Double-blind Maintenance Period|Lack of Efficacy|18|||
147466943|NCT04454489|531867623|FG000|Overall Study|Death|4|||
147644020|NCT03747302|532516698|FG000|Overall Study|Withdrawal by Subject|1|||
147644021|NCT03747302|532516699|FG001|Overall Study|Withdrawal by Subject|2|||
147644022|NCT01032070|532516700|FG000|Overall Study|Disease progression|13|||
147300644|NCT00409682|531267897|FG002|EOW Double-blind Maintenance Period|Lack of Efficacy|11|||
147300645|NCT00409682|531267895|FG000|EOW Double-blind Maintenance Period|Lost to Follow-up|0|||
147300646|NCT00409682|531267896|FG001|EOW Double-blind Maintenance Period|Lost to Follow-up|1|||
147300647|NCT00409682|531267897|FG002|EOW Double-blind Maintenance Period|Lost to Follow-up|0|||
147300648|NCT00409682|531267895|FG000|EOW Double-blind Maintenance Period|Withdrawal by Subject|0|||
147300649|NCT00409682|531267896|FG001|EOW Double-blind Maintenance Period|Withdrawal by Subject|4|||
147300650|NCT00409682|531267897|FG002|EOW Double-blind Maintenance Period|Withdrawal by Subject|2|||
147300651|NCT00409682|531267895|FG000|EOW Double-blind Maintenance Period|Protocol Violation|0|||
147300652|NCT00409682|531267896|FG001|EOW Double-blind Maintenance Period|Protocol Violation|4|||
147300653|NCT00409682|531267897|FG002|EOW Double-blind Maintenance Period|Protocol Violation|1|||
147300654|NCT00409682|531267895|FG000|EOW Double-blind Maintenance Period|Non-compliance|0|||
147300655|NCT00409682|531267896|FG001|EOW Double-blind Maintenance Period|Non-compliance|0|||
147300656|NCT00409682|531267897|FG002|EOW Double-blind Maintenance Period|Non-compliance|1|||
147300657|NCT01896869|531267899|FG000|Overall Study|Withdrawal by Subject|0|||
147300658|NCT01896869|531267900|FG001|Overall Study|Withdrawal by Subject|6|||
147300659|NCT01896869|531267899|FG000|Overall Study|Lost to Follow-up|1|||
147300660|NCT01896869|531267900|FG001|Overall Study|Lost to Follow-up|0|||
147300661|NCT04710927|531267908|FG000|Overall Study|Lost to Follow-up|7|||
147300662|NCT04710927|531267909|FG001|Overall Study|Lost to Follow-up|6|||
147300663|NCT04710927|531267910|FG002|Overall Study|Lost to Follow-up|5|||
147300664|NCT00118716|531267911|FG000|Overall Study|Adverse Event|2|||
147300665|NCT00118716|531267912|FG001|Overall Study|Adverse Event|7|||
147300666|NCT00118716|531267911|FG000|Overall Study|Protocol Violation|5|||
147300667|NCT00118716|531267912|FG001|Overall Study|Protocol Violation|4|||
147300668|NCT00118716|531267911|FG000|Overall Study|Withdrawal by Subject|0|||
147300669|NCT00118716|531267912|FG001|Overall Study|Withdrawal by Subject|1|||
147300670|NCT00118716|531267911|FG000|Overall Study|Exacerbation|2|||
147300671|NCT00118716|531267912|FG001|Overall Study|Exacerbation|2|||
147300672|NCT00118716|531267911|FG000|Overall Study|Discontinued by sponsor|1|||
147300673|NCT00118716|531267912|FG001|Overall Study|Discontinued by sponsor|1|||
147300674|NCT00118716|531267911|FG000|Overall Study|Non-compliance|1|||
147300675|NCT00118716|531267912|FG001|Overall Study|Non-compliance|3|||
147300676|NCT00118716|531267911|FG000|Overall Study|misrandomized|1|||
147300677|NCT00118716|531267912|FG001|Overall Study|misrandomized|1|||
147300678|NCT00118716|531267911|FG000|Overall Study|Expired drug use|1|||
147300679|NCT00118716|531267912|FG001|Overall Study|Expired drug use|2|||
147300680|NCT00118716|531267911|FG000|Overall Study|Investigator discretion|0|||
147300681|NCT00118716|531267912|FG001|Overall Study|Investigator discretion|1|||
147300682|NCT00855062|531267914|FG000|Step1|Early Study Closure|5|||
147300683|NCT00855062|531267915|FG001|Step1|Early Study Closure|7|||
147300684|NCT00855062|531267914|FG000|Step1|Adverse Event|1|||
147300685|NCT00855062|531267915|FG001|Step1|Adverse Event|1|||
147300686|NCT00855062|531267914|FG000|Step1|Protocol Violation|1|||
147300687|NCT00855062|531267915|FG001|Step1|Protocol Violation|0|||
147300688|NCT00855062|531267914|FG000|Step1|Pregnancy|1|||
147300689|NCT00855062|531267915|FG001|Step1|Pregnancy|0|||
147300690|NCT00855062|531267914|FG000|Step1|Withdrawal by Subject|2|||
147300691|NCT00855062|531267915|FG001|Step1|Withdrawal by Subject|3|||
147300692|NCT00855062|531267914|FG000|Step2|Early Study Closure|6|||
147300693|NCT00855062|531267915|FG001|Step2|Early Study Closure|2|||
147300694|NCT00855062|531267914|FG000|Step2|Adverse Event|0|||
147300695|NCT00855062|531267915|FG001|Step2|Adverse Event|3|||
147300696|NCT00855062|531267914|FG000|Step2|Initiation of antiretroviral therapy/ART|0|||
147300697|NCT00855062|531267915|FG001|Step2|Initiation of antiretroviral therapy/ART|1|||
147300698|NCT00454571|531267921|FG000|Overall Study|Adverse Event|2|||
147300699|NCT00454571|531267922|FG001|Overall Study|Adverse Event|0|||
147300700|NCT00454571|531267921|FG000|Overall Study|Physician Decision|0|||
147300701|NCT00454571|531267922|FG001|Overall Study|Physician Decision|1|||
147300702|NCT00454571|531267921|FG000|Overall Study|Protocol Violation|1|||
147300703|NCT00454571|531267922|FG001|Overall Study|Protocol Violation|0|||
147300704|NCT00454571|531267921|FG000|Overall Study|Withdrawal by Subject|10|||
147300705|NCT00454571|531267922|FG001|Overall Study|Withdrawal by Subject|5|||
147300706|NCT01376323|531267923|FG000|Overall Study|Adverse Event|1|||
147300707|NCT01376323|531267924|FG001|Overall Study|Adverse Event|0|||
147300708|NCT01376323|531267925|FG002|Overall Study|Adverse Event|0|||
147300709|NCT01376323|531267926|FG003|Overall Study|Adverse Event|2|||
147300710|NCT01376323|531267927|FG004|Overall Study|Adverse Event|0|||
147300711|NCT01376323|531267923|FG000|Overall Study|Lost to Follow-up|0|||
147300712|NCT01376323|531267924|FG001|Overall Study|Lost to Follow-up|0|||
147300713|NCT01376323|531267925|FG002|Overall Study|Lost to Follow-up|0|||
147300714|NCT01376323|531267926|FG003|Overall Study|Lost to Follow-up|2|||
147300715|NCT01376323|531267927|FG004|Overall Study|Lost to Follow-up|0|||
147300716|NCT01376323|531267923|FG000|Overall Study|Physician Decision|1|||
147300717|NCT01376323|531267924|FG001|Overall Study|Physician Decision|0|||
147300718|NCT01376323|531267925|FG002|Overall Study|Physician Decision|2|||
147300719|NCT01376323|531267926|FG003|Overall Study|Physician Decision|1|||
147300720|NCT01376323|531267927|FG004|Overall Study|Physician Decision|1|||
147300721|NCT01376323|531267923|FG000|Overall Study|Withdrawal by Subject|0|||
147300722|NCT01376323|531267924|FG001|Overall Study|Withdrawal by Subject|1|||
147300723|NCT01376323|531267925|FG002|Overall Study|Withdrawal by Subject|1|||
147300724|NCT01376323|531267926|FG003|Overall Study|Withdrawal by Subject|0|||
147300725|NCT01376323|531267927|FG004|Overall Study|Withdrawal by Subject|0|||
147300726|NCT04681729|531267928|FG000|Overall Study|Lack of Efficacy|2|||
147300727|NCT04681729|531267929|FG001|Overall Study|Lack of Efficacy|2|||
147300728|NCT04681729|531267928|FG000|Overall Study|Withdrawal by Subject|8|||
147300729|NCT04681729|531267929|FG001|Overall Study|Withdrawal by Subject|9|||
147300730|NCT02436811|531267930|FG000|Overall Study|Lost to Follow-up|2|||
147300731|NCT02436811|531267931|FG001|Overall Study|Lost to Follow-up|9|||
147300732|NCT02436811|531267932|FG002|Overall Study|Lost to Follow-up|7|||
147300733|NCT03595332|531267933|FG000|Overall Study|Lost to Follow-up|16|||
147300734|NCT03595332|531267934|FG001|Overall Study|Lost to Follow-up|22|||
147300735|NCT03595332|531267933|FG000|Overall Study|Unable to retrieve ID from school|0|||
147300736|NCT03595332|531267934|FG001|Overall Study|Unable to retrieve ID from school|2|||
147300737|NCT02227875|531267935|FG000|Overall Study|Protocol Violation|10|||
147300738|NCT02227875|531267936|FG001|Overall Study|Protocol Violation|7|||
147300739|NCT02227875|531267935|FG000|Overall Study|Other|1|||
147300740|NCT02227875|531267936|FG001|Overall Study|Other|3|||
147300741|NCT02227875|531267935|FG000|Overall Study|Physician Decision|1|||
147300742|NCT02227875|531267936|FG001|Overall Study|Physician Decision|0|||
147300743|NCT02227875|531267935|FG000|Overall Study|Adverse Event|3|||
147300744|NCT02227875|531267936|FG001|Overall Study|Adverse Event|0|||
147300745|NCT02227875|531267935|FG000|Overall Study|Withdrawal by Subject|12|||
147300746|NCT02227875|531267936|FG001|Overall Study|Withdrawal by Subject|13|||
147300747|NCT02227875|531267935|FG000|Overall Study|Lost to Follow-up|10|||
147300748|NCT02227875|531267936|FG001|Overall Study|Lost to Follow-up|10|||
147300749|NCT04209725|531267937|FG000|Overall Study|Adverse Event|1|||
147300750|NCT03494166|531267938|FG000|Overall Study|Death|0|||
147300751|NCT03494166|531267939|FG001|Overall Study|Death|0|||
147300752|NCT03494166|531267940|FG002|Overall Study|Death|0|||
147300753|NCT03494166|531267941|FG003|Overall Study|Death|1|||
147300754|NCT03494166|531267942|FG004|Overall Study|Death|3|||
147300755|NCT03494166|531267943|FG005|Overall Study|Death|0|||
147300756|NCT03494166|531267938|FG000|Overall Study|Lost to Follow-up|2|||
147300757|NCT03494166|531267939|FG001|Overall Study|Lost to Follow-up|2|||
147300758|NCT03494166|531267940|FG002|Overall Study|Lost to Follow-up|2|||
147300759|NCT03494166|531267941|FG003|Overall Study|Lost to Follow-up|2|||
147300760|NCT03494166|531267942|FG004|Overall Study|Lost to Follow-up|14|||
147300761|NCT03494166|531267943|FG005|Overall Study|Lost to Follow-up|0|||
147300762|NCT03494166|531267938|FG000|Overall Study|Withdrawal by Subject|10|||
147300763|NCT03494166|531267939|FG001|Overall Study|Withdrawal by Subject|7|||
147300764|NCT03494166|531267940|FG002|Overall Study|Withdrawal by Subject|0|||
147300765|NCT03494166|531267941|FG003|Overall Study|Withdrawal by Subject|5|||
147300766|NCT03494166|531267942|FG004|Overall Study|Withdrawal by Subject|3|||
147300767|NCT03494166|531267943|FG005|Overall Study|Withdrawal by Subject|17|||
147300768|NCT03494166|531267938|FG000|Overall Study|Screen failure|1|||
147300769|NCT03494166|531267939|FG001|Overall Study|Screen failure|0|||
147300770|NCT03494166|531267940|FG002|Overall Study|Screen failure|0|||
147300771|NCT03494166|531267941|FG003|Overall Study|Screen failure|0|||
147300772|NCT03494166|531267942|FG004|Overall Study|Screen failure|1|||
147300773|NCT03494166|531267943|FG005|Overall Study|Screen failure|0|||
147300774|NCT00855595|531267945|FG000|Overall Study|Withdrawal by Subject|1|||
147300775|NCT00855595|531267946|FG001|Overall Study|Withdrawal by Subject|2|||
147300776|NCT00855595|531267945|FG000|Overall Study|Lost to Follow-up|3|||
147300777|NCT00855595|531267946|FG001|Overall Study|Lost to Follow-up|3|||
147300778|NCT00855595|531267945|FG000|Overall Study|Adverse Event|1|||
147300779|NCT00855595|531267946|FG001|Overall Study|Adverse Event|1|||
147300780|NCT00855595|531267945|FG000|Overall Study|patient moved out of state|1|||
147617511|NCT02721732|532416063|FG000|Overall Study|Adverse Event|2|||
147617512|NCT02721732|532416064|FG001|Overall Study|Adverse Event|0|||
147617513|NCT02721732|532416065|FG002|Overall Study|Adverse Event|2|||
147617514|NCT02721732|532416066|FG003|Overall Study|Adverse Event|0|||
147617515|NCT02721732|532416067|FG004|Overall Study|Adverse Event|1|||
147617516|NCT02721732|532416068|FG005|Overall Study|Adverse Event|0|||
147617517|NCT02721732|532416069|FG006|Overall Study|Adverse Event|1|||
147617518|NCT02721732|532416070|FG007|Overall Study|Adverse Event|0|||
147300781|NCT00855595|531267946|FG001|Overall Study|patient moved out of state|0|||
147300782|NCT00855595|531267945|FG000|Overall Study|patient left country|0|||
147300783|NCT00855595|531267946|FG001|Overall Study|patient left country|1|||
147300784|NCT01780935|531267947|FG000|Overall Study|Admin problems due to early termination|321|||
147300785|NCT01780935|531267948|FG001|Overall Study|Admin problems due to early termination|309|||
147300786|NCT01780935|531267947|FG000|Overall Study|Adverse Event|2|||
147300787|NCT01780935|531267948|FG001|Overall Study|Adverse Event|4|||
147300788|NCT01780935|531267947|FG000|Overall Study|Death|1|||
147300789|NCT01780935|531267948|FG001|Overall Study|Death|6|||
147300790|NCT01780935|531267947|FG000|Overall Study|Lost to Follow-up|2|||
147300791|NCT01780935|531267948|FG001|Overall Study|Lost to Follow-up|6|||
147300792|NCT01780935|531267947|FG000|Overall Study|Physician Decision|1|||
147300793|NCT01780935|531267948|FG001|Overall Study|Physician Decision|1|||
147617519|NCT02721732|532416071|FG008|Overall Study|Adverse Event|1|||
147617520|NCT02721732|532416072|FG009|Overall Study|Adverse Event|1|||
147617521|NCT02721732|532416063|FG000|Overall Study|Death|0|||
147617522|NCT02721732|532416064|FG001|Overall Study|Death|0|||
147617523|NCT02721732|532416065|FG002|Overall Study|Death|0|||
147617524|NCT02721732|532416066|FG003|Overall Study|Death|0|||
147617525|NCT02721732|532416067|FG004|Overall Study|Death|1|||
147617526|NCT02721732|532416068|FG005|Overall Study|Death|0|||
147617527|NCT02721732|532416069|FG006|Overall Study|Death|1|||
147617528|NCT02721732|532416070|FG007|Overall Study|Death|0|||
147617529|NCT02721732|532416071|FG008|Overall Study|Death|0|||
147617530|NCT02721732|532416072|FG009|Overall Study|Death|1|||
147617531|NCT02721732|532416063|FG000|Overall Study|Lack of Efficacy|12|||
147617532|NCT02721732|532416064|FG001|Overall Study|Lack of Efficacy|11|||
147617533|NCT02721732|532416065|FG002|Overall Study|Lack of Efficacy|18|||
147617534|NCT02721732|532416066|FG003|Overall Study|Lack of Efficacy|5|||
147617535|NCT02721732|532416067|FG004|Overall Study|Lack of Efficacy|21|||
147617536|NCT02721732|532416068|FG005|Overall Study|Lack of Efficacy|2|||
147617537|NCT02721732|532416069|FG006|Overall Study|Lack of Efficacy|8|||
147617538|NCT02721732|532416070|FG007|Overall Study|Lack of Efficacy|11|||
147617539|NCT02721732|532416071|FG008|Overall Study|Lack of Efficacy|10|||
147617540|NCT02721732|532416072|FG009|Overall Study|Lack of Efficacy|20|||
147617541|NCT02721732|532416063|FG000|Overall Study|Physician Decision|0|||
147617542|NCT02721732|532416064|FG001|Overall Study|Physician Decision|0|||
147617543|NCT02721732|532416065|FG002|Overall Study|Physician Decision|1|||
147617544|NCT02721732|532416066|FG003|Overall Study|Physician Decision|0|||
147617545|NCT02721732|532416067|FG004|Overall Study|Physician Decision|0|||
147617546|NCT02721732|532416068|FG005|Overall Study|Physician Decision|0|||
147617547|NCT02721732|532416069|FG006|Overall Study|Physician Decision|0|||
147617548|NCT02721732|532416070|FG007|Overall Study|Physician Decision|0|||
147617549|NCT02721732|532416071|FG008|Overall Study|Physician Decision|0|||
147617550|NCT02721732|532416072|FG009|Overall Study|Physician Decision|0|||
147617551|NCT02721732|532416063|FG000|Overall Study|Withdrawal by Subject|1|||
147617552|NCT02721732|532416064|FG001|Overall Study|Withdrawal by Subject|0|||
147617553|NCT02721732|532416065|FG002|Overall Study|Withdrawal by Subject|0|||
147617554|NCT02721732|532416066|FG003|Overall Study|Withdrawal by Subject|0|||
147617555|NCT02721732|532416067|FG004|Overall Study|Withdrawal by Subject|3|||
147617556|NCT02721732|532416068|FG005|Overall Study|Withdrawal by Subject|0|||
147617557|NCT02721732|532416069|FG006|Overall Study|Withdrawal by Subject|1|||
147617558|NCT02721732|532416070|FG007|Overall Study|Withdrawal by Subject|1|||
147617559|NCT02721732|532416071|FG008|Overall Study|Withdrawal by Subject|0|||
147617560|NCT02721732|532416072|FG009|Overall Study|Withdrawal by Subject|1|||
147617561|NCT02721732|532416063|FG000|Overall Study|Participant Choice|1|||
147617562|NCT02721732|532416064|FG001|Overall Study|Participant Choice|0|||
147617563|NCT02721732|532416065|FG002|Overall Study|Participant Choice|0|||
147617564|NCT02721732|532416066|FG003|Overall Study|Participant Choice|0|||
147617565|NCT02721732|532416067|FG004|Overall Study|Participant Choice|0|||
147617566|NCT02721732|532416068|FG005|Overall Study|Participant Choice|0|||
147617567|NCT02721732|532416069|FG006|Overall Study|Participant Choice|0|||
147617568|NCT02721732|532416070|FG007|Overall Study|Participant Choice|0|||
147617569|NCT02721732|532416071|FG008|Overall Study|Participant Choice|0|||
147617570|NCT02721732|532416072|FG009|Overall Study|Participant Choice|1|||
147617571|NCT02721732|532416063|FG000|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
147617572|NCT02721732|532416064|FG001|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
147617573|NCT02721732|532416065|FG002|Overall Study|Progression and Exclusion from study due to changed diagnosis|1|||
147300794|NCT01780935|531267947|FG000|Overall Study|Protocol deviation|0|||
147300795|NCT01780935|531267948|FG001|Overall Study|Protocol deviation|1|||
147300796|NCT01780935|531267947|FG000|Overall Study|Patient withdrew consent|8|||
147300797|NCT01780935|531267948|FG001|Overall Study|Patient withdrew consent|9|||
147617574|NCT02721732|532416066|FG003|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
147617575|NCT02721732|532416067|FG004|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
147617576|NCT02721732|532416068|FG005|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
147617577|NCT02721732|532416069|FG006|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
147617578|NCT02721732|532416070|FG007|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
147617579|NCT02721732|532416071|FG008|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
147617580|NCT02721732|532416072|FG009|Overall Study|Progression and Exclusion from study due to changed diagnosis|0|||
147617581|NCT02721732|532416063|FG000|Overall Study|Progression and withdrew consent|1|||
147617582|NCT02721732|532416064|FG001|Overall Study|Progression and withdrew consent|1|||
147617583|NCT02721732|532416065|FG002|Overall Study|Progression and withdrew consent|0|||
147617584|NCT02721732|532416066|FG003|Overall Study|Progression and withdrew consent|0|||
147617585|NCT02721732|532416067|FG004|Overall Study|Progression and withdrew consent|0|||
147617586|NCT02721732|532416068|FG005|Overall Study|Progression and withdrew consent|0|||
147617587|NCT02721732|532416069|FG006|Overall Study|Progression and withdrew consent|0|||
147617588|NCT02721732|532416070|FG007|Overall Study|Progression and withdrew consent|0|||
147300798|NCT01844284|531267949|FG000|Overall Study|Lost to Follow-up|12|||
147665566|NCT01614470|532599625|FG000|Part 1: Treatment Period 1 (8 Weeks)|Need to extend washout period|1|||
147665567|NCT01614470|532599626|FG001|Part 1: Treatment Period 1 (8 Weeks)|Need to extend washout period|1|||
147409862|NCT01646177|531664164|FG009|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|9|||
147409863|NCT01646177|531664165|FG010|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|8|||
147409864|NCT01646177|531664166|FG011|Follow-Up Period (Minimum of 12 Weeks)|Lack of Efficacy|9|||
147409865|NCT01646177|531664155|FG000|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
147409866|NCT01646177|531664156|FG001|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
147409867|NCT01646177|531664157|FG002|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
147409868|NCT01646177|531664158|FG003|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
147409869|NCT01646177|531664159|FG004|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
147409870|NCT01646177|531664160|FG005|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
147409871|NCT01646177|531664161|FG006|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
147409872|NCT01646177|531664162|FG007|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|0|||
147409873|NCT01646177|531664163|FG008|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|1|||
147409874|NCT01646177|531664164|FG009|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|6|||
147409875|NCT01646177|531664165|FG010|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|4|||
147409876|NCT01646177|531664166|FG011|Follow-Up Period (Minimum of 12 Weeks)|Protocol Violation|7|||
147409877|NCT01646177|531664155|FG000|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
147409878|NCT01646177|531664156|FG001|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
147409879|NCT01646177|531664157|FG002|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
147409880|NCT01646177|531664158|FG003|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
147409881|NCT01646177|531664159|FG004|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
147409882|NCT01646177|531664160|FG005|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
147409883|NCT01646177|531664161|FG006|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
147409884|NCT01646177|531664162|FG007|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|0|||
147409885|NCT01646177|531664163|FG008|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|1|||
147409886|NCT01646177|531664164|FG009|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|2|||
147409887|NCT01646177|531664165|FG010|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|2|||
147409888|NCT01646177|531664166|FG011|Follow-Up Period (Minimum of 12 Weeks)|Physician Decision|3|||
147409889|NCT01646177|531664155|FG000|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
147409890|NCT01646177|531664156|FG001|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
147409891|NCT01646177|531664157|FG002|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
147409892|NCT01646177|531664158|FG003|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
147409893|NCT01646177|531664159|FG004|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
147409894|NCT01646177|531664160|FG005|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
147409895|NCT01646177|531664161|FG006|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
147409896|NCT01646177|531664162|FG007|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
147409897|NCT01646177|531664163|FG008|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|0|||
147409898|NCT01646177|531664164|FG009|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|1|||
147409899|NCT01646177|531664165|FG010|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|1|||
147409900|NCT01646177|531664166|FG011|Follow-Up Period (Minimum of 12 Weeks)|Clinical Relapse|3|||
147409901|NCT01646177|531664155|FG000|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
147409902|NCT01646177|531664156|FG001|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
147409903|NCT01646177|531664157|FG002|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
147409904|NCT01646177|531664158|FG003|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
147409905|NCT01646177|531664159|FG004|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
147409906|NCT01646177|531664160|FG005|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
147409907|NCT01646177|531664161|FG006|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
147409908|NCT01646177|531664162|FG007|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
147409909|NCT01646177|531664163|FG008|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|0|||
147409910|NCT01646177|531664164|FG009|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|1|||
147409911|NCT01646177|531664165|FG010|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|1|||
147409912|NCT01646177|531664166|FG011|Follow-Up Period (Minimum of 12 Weeks)|Sponsor Decision|1|||
147409913|NCT01646177|531664155|FG000|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
147409914|NCT01646177|531664156|FG001|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
147409915|NCT01646177|531664157|FG002|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
147409916|NCT01646177|531664158|FG003|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
147409917|NCT01646177|531664159|FG004|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
147409918|NCT01646177|531664160|FG005|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
147409919|NCT01646177|531664161|FG006|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
147409920|NCT01646177|531664162|FG007|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
147409921|NCT01646177|531664163|FG008|Follow-Up Period (Minimum of 12 Weeks)|Death|1|||
147409922|NCT01646177|531664164|FG009|Follow-Up Period (Minimum of 12 Weeks)|Death|0|||
147409923|NCT01646177|531664165|FG010|Follow-Up Period (Minimum of 12 Weeks)|Death|1|||
147409924|NCT01646177|531664166|FG011|Follow-Up Period (Minimum of 12 Weeks)|Death|1|||
147409925|NCT01646177|531664155|FG000|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
147617589|NCT02721732|532416071|FG008|Overall Study|Progression and withdrew consent|0|||
147617590|NCT02721732|532416072|FG009|Overall Study|Progression and withdrew consent|1|||
147617591|NCT02721732|532416063|FG000|Overall Study|No evidence of tumor following radical surgery|0|||
147617592|NCT02721732|532416064|FG001|Overall Study|No evidence of tumor following radical surgery|0|||
147617593|NCT02721732|532416065|FG002|Overall Study|No evidence of tumor following radical surgery|0|||
147617594|NCT02721732|532416066|FG003|Overall Study|No evidence of tumor following radical surgery|0|||
147617595|NCT02721732|532416067|FG004|Overall Study|No evidence of tumor following radical surgery|0|||
147300799|NCT01844284|531267950|FG001|Overall Study|Lost to Follow-up|7|||
147300800|NCT02755597|531267952|FG000|Overall Study|Withdrew consent|27|||
147300801|NCT02755597|531267953|FG001|Overall Study|Withdrew consent|11|||
147300802|NCT02755597|531267952|FG000|Overall Study|Lost to Follow-up|1|||
147300803|NCT02755597|531267953|FG001|Overall Study|Lost to Follow-up|0|||
147300804|NCT02755597|531267952|FG000|Overall Study|Death|78|||
147300805|NCT02755597|531267953|FG001|Overall Study|Death|36|||
147300806|NCT02755597|531267952|FG000|Overall Study|Study terminated by Sponsor|67|||
147300807|NCT02755597|531267953|FG001|Overall Study|Study terminated by Sponsor|47|||
147300808|NCT02755597|531267952|FG000|Overall Study|Other, not specified|20|||
147300809|NCT02755597|531267953|FG001|Overall Study|Other, not specified|3|||
147617596|NCT02721732|532416068|FG005|Overall Study|No evidence of tumor following radical surgery|1|||
147617597|NCT02721732|532416069|FG006|Overall Study|No evidence of tumor following radical surgery|0|||
147300810|NCT02755597|531267952|FG000|Overall Study|Participant missing reason for study discontinuation|1|||
147300811|NCT02755597|531267953|FG001|Overall Study|Participant missing reason for study discontinuation|0|||
147300812|NCT04252742|531267956|FG000|Overall Study|Decision by sponsor|0|||
147300813|NCT04252742|531267957|FG001|Overall Study|Decision by sponsor|2|||
147300814|NCT04252742|531267956|FG000|Overall Study|Withdrawal by Subject|15|||
147300815|NCT04252742|531267957|FG001|Overall Study|Withdrawal by Subject|9|||
147300816|NCT04252742|531267956|FG000|Overall Study|Lost to Follow-up|0|||
147300817|NCT04252742|531267957|FG001|Overall Study|Lost to Follow-up|1|||
147300818|NCT04179032|531267958|FG000|Part B (Up to Week 52)|Adverse Event|1|||
147300819|NCT04179032|531267958|FG000|Part B (Up to Week 52)|INVESTIGATOR DISCRETION|1|||
147300820|NCT04179032|531267958|FG000|Access Extension Phase|Ongoing|11|||
147300821|NCT02753595|531267960|FG000|Overall Study|Sponsor termination|2|||
147300822|NCT02753595|531267961|FG001|Overall Study|Sponsor termination|2|||
147300823|NCT01570868|531267962|FG000|Overall Study|Adverse Event|8|||
147300824|NCT01570868|531267963|FG001|Overall Study|Adverse Event|1|||
147300825|NCT01570868|531267962|FG000|Overall Study|FDA Recommendation|23|||
147300826|NCT01570868|531267963|FG001|Overall Study|FDA Recommendation|3|||
147300827|NCT01570868|531267962|FG000|Overall Study|Physician Decision|10|||
147300828|NCT01570868|531267963|FG001|Overall Study|Physician Decision|4|||
147300829|NCT01570868|531267962|FG000|Overall Study|Lost to Follow-up|1|||
147300830|NCT01570868|531267963|FG001|Overall Study|Lost to Follow-up|0|||
147300831|NCT01570868|531267962|FG000|Overall Study|Withdrawal by Subject|1|||
147300832|NCT01570868|531267963|FG001|Overall Study|Withdrawal by Subject|0|||
147300833|NCT03937219|531267967|FG000|Overall Study|Death|223|||
147300834|NCT03937219|531267968|FG001|Overall Study|Death|211|||
147300835|NCT03937219|531267967|FG000|Overall Study|Withdrawal by Subject|17|||
147300836|NCT03937219|531267968|FG001|Overall Study|Withdrawal by Subject|25|||
147300837|NCT03937219|531267967|FG000|Overall Study|Lost to Follow-up|3|||
147300838|NCT03937219|531267968|FG001|Overall Study|Lost to Follow-up|4|||
147300839|NCT02515279|531267971|FG000|Overall Study|Adverse Event|7|||
147300840|NCT02515279|531267971|FG000|Overall Study|Lack of Efficacy|31|||
147300841|NCT02515279|531267971|FG000|Overall Study|Lost to Follow-up|9|||
147300842|NCT02515279|531267971|FG000|Overall Study|Withdrawal by Subject|18|||
147300843|NCT02515279|531267971|FG000|Overall Study|End-of-treatment visit not attended|17|||
147300844|NCT02515279|531267971|FG000|Overall Study|Other|22|||
147300845|NCT01800968|531267972|FG000|Overall Study|Death|23|||
147300846|NCT01800968|531267973|FG001|Overall Study|Death|16|||
147300847|NCT01800968|531267972|FG000|Overall Study|Lost to Follow-up|5|||
147300848|NCT01800968|531267973|FG001|Overall Study|Lost to Follow-up|7|||
147300849|NCT01800968|531267972|FG000|Overall Study|Withdrawal by Subject|7|||
147300850|NCT01800968|531267973|FG001|Overall Study|Withdrawal by Subject|9|||
147300851|NCT01800968|531267972|FG000|Overall Study|Physician Decision|1|||
147617598|NCT02721732|532416070|FG007|Overall Study|No evidence of tumor following radical surgery|0|||
147644023|NCT01032070|532516701|FG001|Overall Study|Disease progression|8|||
147300852|NCT01800968|531267973|FG001|Overall Study|Physician Decision|0|||
147300853|NCT03185481|531267975|FG000|Overall Study|Adverse Event|1|||
147300854|NCT03185481|531267975|FG000|Overall Study|Study Terminated by Sponsor|4|||
147300855|NCT00701038|531267981|FG000|Overall Study|study amended pilot group of patients|4|||
147300856|NCT00701038|531267982|FG001|Overall Study|study amended pilot group of patients|4|||
147300857|NCT03371940|531267988|FG000|Overall Study|Withdrawal by Subject|8|||
147300858|NCT03371940|531267989|FG001|Overall Study|Withdrawal by Subject|1|||
147300859|NCT03371940|531267990|FG002|Overall Study|Withdrawal by Subject|3|||
147300860|NCT03371940|531267991|FG003|Overall Study|Withdrawal by Subject|4|||
147300861|NCT05099926|531267994|FG000|Overall Study|Lost to Follow-up|1|||
147300862|NCT00504426|531267997|FG000|Overall Study|Adverse Event|0|||
147300863|NCT00504426|531267998|FG001|Overall Study|Adverse Event|0|||
147300864|NCT00504426|531267999|FG002|Overall Study|Adverse Event|2|||
147300865|NCT00504426|531268000|FG003|Overall Study|Adverse Event|0|||
147300866|NCT00504426|531267997|FG000|Overall Study|Protocol Violation|1|||
147300867|NCT00504426|531267998|FG001|Overall Study|Protocol Violation|1|||
147300868|NCT00504426|531267999|FG002|Overall Study|Protocol Violation|2|||
147300869|NCT00504426|531268000|FG003|Overall Study|Protocol Violation|0|||
147300870|NCT00504426|531267997|FG000|Overall Study|Withdrawal by Subject|2|||
147300871|NCT00504426|531267998|FG001|Overall Study|Withdrawal by Subject|0|||
147300872|NCT00504426|531267999|FG002|Overall Study|Withdrawal by Subject|0|||
147300873|NCT00504426|531268000|FG003|Overall Study|Withdrawal by Subject|0|||
147300874|NCT00031486|531268006|FG000|Overall Study|Adverse Event|1|||
147300875|NCT00031486|531268007|FG001|Overall Study|Adverse Event|0|||
147300876|NCT00031486|531268006|FG000|Overall Study|Lost to Follow-up|0|||
147300877|NCT00031486|531268007|FG001|Overall Study|Lost to Follow-up|1|||
147300878|NCT00031486|531268006|FG000|Overall Study|Withdrawal by Subject|3|||
147300879|NCT00031486|531268007|FG001|Overall Study|Withdrawal by Subject|2|||
147300880|NCT00031486|531268006|FG000|Overall Study|Death|0|||
147300881|NCT00031486|531268007|FG001|Overall Study|Death|3|||
147300882|NCT00031486|531268006|FG000|Overall Study|Non-compliant|0|||
147300883|NCT00031486|531268007|FG001|Overall Study|Non-compliant|4|||
147300884|NCT00031486|531268006|FG000|Overall Study|Did not meet eligibility requirement|2|||
147300885|NCT00031486|531268007|FG001|Overall Study|Did not meet eligibility requirement|1|||
147300886|NCT00031486|531268006|FG000|Overall Study|Other|1|||
147300887|NCT00031486|531268007|FG001|Overall Study|Other|1|||
147300888|NCT03685591|531268008|FG000|Overall Study|Global Deterioration of Health Status|0|||
147300889|NCT03685591|531268009|FG001|Overall Study|Global Deterioration of Health Status|0|||
147300890|NCT03685591|531268010|FG002|Overall Study|Global Deterioration of Health Status|0|||
147300891|NCT03685591|531268011|FG003|Overall Study|Global Deterioration of Health Status|1|||
147300892|NCT03685591|531268012|FG004|Overall Study|Global Deterioration of Health Status|2|||
147300893|NCT03685591|531268013|FG005|Overall Study|Global Deterioration of Health Status|4|||
147300894|NCT03685591|531268014|FG006|Overall Study|Global Deterioration of Health Status|1|||
147300895|NCT03685591|531268015|FG007|Overall Study|Global Deterioration of Health Status|1|||
147300896|NCT03685591|531268016|FG008|Overall Study|Global Deterioration of Health Status|0|||
147300897|NCT03685591|531268008|FG000|Overall Study|Progressive Disease|1|||
147300898|NCT03685591|531268009|FG001|Overall Study|Progressive Disease|1|||
147300899|NCT03685591|531268010|FG002|Overall Study|Progressive Disease|0|||
147300900|NCT03685591|531268011|FG003|Overall Study|Progressive Disease|3|||
147300901|NCT03685591|531268012|FG004|Overall Study|Progressive Disease|5|||
147300902|NCT03685591|531268013|FG005|Overall Study|Progressive Disease|4|||
147300903|NCT03685591|531268014|FG006|Overall Study|Progressive Disease|3|||
147300904|NCT03685591|531268015|FG007|Overall Study|Progressive Disease|2|||
147300905|NCT03685591|531268016|FG008|Overall Study|Progressive Disease|1|||
147300906|NCT03685591|531268008|FG000|Overall Study|Other|0|||
147300907|NCT03685591|531268009|FG001|Overall Study|Other|0|||
147300908|NCT03685591|531268010|FG002|Overall Study|Other|1|||
147300909|NCT03685591|531268011|FG003|Overall Study|Other|0|||
147300910|NCT03685591|531268012|FG004|Overall Study|Other|2|||
147300911|NCT03685591|531268013|FG005|Overall Study|Other|3|||
147300912|NCT03685591|531268014|FG006|Overall Study|Other|0|||
147300913|NCT03685591|531268015|FG007|Overall Study|Other|0|||
147300914|NCT03685591|531268016|FG008|Overall Study|Other|0|||
147300915|NCT03685591|531268008|FG000|Overall Study|Withdrawal by Subject|0|||
147300916|NCT03685591|531268009|FG001|Overall Study|Withdrawal by Subject|0|||
147300917|NCT03685591|531268010|FG002|Overall Study|Withdrawal by Subject|0|||
147300918|NCT03685591|531268011|FG003|Overall Study|Withdrawal by Subject|0|||
147300919|NCT03685591|531268012|FG004|Overall Study|Withdrawal by Subject|3|||
147300920|NCT03685591|531268013|FG005|Overall Study|Withdrawal by Subject|2|||
147300921|NCT03685591|531268014|FG006|Overall Study|Withdrawal by Subject|0|||
147300922|NCT03685591|531268015|FG007|Overall Study|Withdrawal by Subject|0|||
147300923|NCT03685591|531268016|FG008|Overall Study|Withdrawal by Subject|1|||
147300924|NCT03685591|531268008|FG000|Overall Study|Adverse Event|0|||
147300925|NCT03685591|531268009|FG001|Overall Study|Adverse Event|0|||
147617599|NCT02721732|532416071|FG008|Overall Study|No evidence of tumor following radical surgery|0|||
147300926|NCT03685591|531268010|FG002|Overall Study|Adverse Event|0|||
147300927|NCT03685591|531268011|FG003|Overall Study|Adverse Event|1|||
147300928|NCT03685591|531268012|FG004|Overall Study|Adverse Event|1|||
147300929|NCT03685591|531268013|FG005|Overall Study|Adverse Event|4|||
147300930|NCT03685591|531268014|FG006|Overall Study|Adverse Event|0|||
147300931|NCT03685591|531268015|FG007|Overall Study|Adverse Event|1|||
147300932|NCT03685591|531268016|FG008|Overall Study|Adverse Event|1|||
147300933|NCT01685138|531268019|FG000|Overall Study|Lost to Follow-up|1|||
147300934|NCT01685138|531268019|FG000|Overall Study|Protocol Violation|1|||
147300935|NCT01685138|531268019|FG000|Overall Study|No longer requires treatment|1|||
147300936|NCT01685138|531268019|FG000|Overall Study|Subject/guardian decision|2|||
147300937|NCT01685138|531268019|FG000|Overall Study|Physician Decision|6|||
147300938|NCT01685138|531268019|FG000|Overall Study|Death|10|||
147300939|NCT01685138|531268019|FG000|Overall Study|Adverse Event|18|||
147300940|NCT01685138|531268019|FG000|Overall Study|Progressive disease|53|||
147300941|NCT02068495|531268020|FG000|Overall Study|Case Report Forms Uncollected|60|||
147300942|NCT02068495|531268020|FG000|Overall Study|Protocol Deviation|49|||
147300943|NCT03988166|531268021|FG000|Overall Study|Lost to Follow-up|2|||
147300944|NCT03988166|531268021|FG000|Overall Study|Death|1|||
147300945|NCT02220894|531268023|FG000|Overall Study|Adverse Event|127|||
147300946|NCT02220894|531268024|FG001|Overall Study|Adverse Event|74|||
147300947|NCT02220894|531268023|FG000|Overall Study|Death|418|||
147300948|NCT02220894|531268024|FG001|Overall Study|Death|508|||
147300949|NCT02220894|531268023|FG000|Overall Study|Lost to Follow-up|0|||
147300950|NCT02220894|531268024|FG001|Overall Study|Lost to Follow-up|4|||
147300951|NCT02220894|531268023|FG000|Overall Study|Site Terminated by Sponsor|2|||
147300952|NCT02220894|531268024|FG001|Overall Study|Site Terminated by Sponsor|0|||
147300953|NCT02220894|531268023|FG000|Overall Study|Participation in Study Terminated by Sponsor|80|||
147300954|NCT02220894|531268024|FG001|Overall Study|Participation in Study Terminated by Sponsor|41|||
147300955|NCT02220894|531268023|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
147300956|NCT02220894|531268024|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
147300957|NCT02220894|531268023|FG000|Overall Study|Withdrawal by Subject|10|||
147300958|NCT02220894|531268024|FG001|Overall Study|Withdrawal by Subject|9|||
147300959|NCT00698646|531268030|FG000|Overall Study|Adverse Event|8|||
147300960|NCT00698646|531268031|FG001|Overall Study|Adverse Event|7|||
147300961|NCT00698646|531268032|FG002|Overall Study|Adverse Event|8|||
147300962|NCT00698646|531268030|FG000|Overall Study|Unsatisfactory Therapeutic Effect|11|||
147300963|NCT00698646|531268031|FG001|Overall Study|Unsatisfactory Therapeutic Effect|11|||
147300964|NCT00698646|531268032|FG002|Overall Study|Unsatisfactory Therapeutic Effect|7|||
147300965|NCT00698646|531268030|FG000|Overall Study|Protocol Deviation|6|||
147300966|NCT00698646|531268031|FG001|Overall Study|Protocol Deviation|2|||
147300967|NCT00698646|531268032|FG002|Overall Study|Protocol Deviation|3|||
147300968|NCT00698646|531268030|FG000|Overall Study|Withdrawal by Subject|10|||
147300969|NCT00698646|531268031|FG001|Overall Study|Withdrawal by Subject|11|||
147300970|NCT00698646|531268032|FG002|Overall Study|Withdrawal by Subject|8|||
147300971|NCT00698646|531268030|FG000|Overall Study|Lost to Follow-up|0|||
147300972|NCT00698646|531268031|FG001|Overall Study|Lost to Follow-up|0|||
147300973|NCT00698646|531268032|FG002|Overall Study|Lost to Follow-up|2|||
147300974|NCT00698646|531268030|FG000|Overall Study|Administrative problems|1|||
147300975|NCT00698646|531268031|FG001|Overall Study|Administrative problems|0|||
147300976|NCT00698646|531268032|FG002|Overall Study|Administrative problems|1|||
147300977|NCT00511875|531268033|FG000|Overall Study|Lost to Follow-up|4|||
147300978|NCT00511875|531268034|FG001|Overall Study|Lost to Follow-up|0|||
147300979|NCT00511875|531268033|FG000|Overall Study|Missing variables|1|||
147300980|NCT00511875|531268034|FG001|Overall Study|Missing variables|0|||
147300981|NCT01951638|531268036|FG000|Treatment Period|Protocol Violation|0|||
147300982|NCT01951638|531268037|FG001|Treatment Period|Protocol Violation|0|||
147300983|NCT01951638|531268038|FG002|Treatment Period|Protocol Violation|0|||
147300984|NCT01951638|531268039|FG003|Treatment Period|Protocol Violation|2|||
147300985|NCT01951638|531268040|FG004|Treatment Period|Protocol Violation|0|||
147300986|NCT01951638|531268036|FG000|Treatment Period|Protocol-driven decision point|1|||
147300987|NCT01951638|531268037|FG001|Treatment Period|Protocol-driven decision point|3|||
147300988|NCT01951638|531268038|FG002|Treatment Period|Protocol-driven decision point|0|||
147300989|NCT01951638|531268039|FG003|Treatment Period|Protocol-driven decision point|0|||
147300990|NCT01951638|531268040|FG004|Treatment Period|Protocol-driven decision point|0|||
147300991|NCT01951638|531268036|FG000|Treatment Period|Logistical difficulties|0|||
147300992|NCT01951638|531268037|FG001|Treatment Period|Logistical difficulties|1|||
147300993|NCT01951638|531268038|FG002|Treatment Period|Logistical difficulties|1|||
147300994|NCT01951638|531268039|FG003|Treatment Period|Logistical difficulties|0|||
147300995|NCT01951638|531268040|FG004|Treatment Period|Logistical difficulties|0|||
147300996|NCT01951638|531268036|FG000|Treatment Period|Withdrawal by Subject|9|||
147300997|NCT01951638|531268037|FG001|Treatment Period|Withdrawal by Subject|6|||
147300998|NCT01951638|531268038|FG002|Treatment Period|Withdrawal by Subject|4|||
147300999|NCT01951638|531268039|FG003|Treatment Period|Withdrawal by Subject|5|||
147301000|NCT01951638|531268040|FG004|Treatment Period|Withdrawal by Subject|4|||
147301001|NCT01951638|531268036|FG000|Treatment Period|Death|0|||
147301002|NCT01951638|531268037|FG001|Treatment Period|Death|0|||
147301003|NCT01951638|531268038|FG002|Treatment Period|Death|0|||
147301004|NCT01951638|531268039|FG003|Treatment Period|Death|3|||
147301005|NCT01951638|531268040|FG004|Treatment Period|Death|1|||
147409926|NCT01646177|531664156|FG001|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
147301006|NCT01951638|531268036|FG000|Treatment Period|Adverse Event|3|||
147301007|NCT01951638|531268037|FG001|Treatment Period|Adverse Event|4|||
147301008|NCT01951638|531268038|FG002|Treatment Period|Adverse Event|8|||
147301009|NCT01951638|531268039|FG003|Treatment Period|Adverse Event|6|||
147301010|NCT01951638|531268040|FG004|Treatment Period|Adverse Event|5|||
147301011|NCT01951638|531268036|FG000|Follow-up Period|Protocol Violation|0|||
147301012|NCT01951638|531268037|FG001|Follow-up Period|Protocol Violation|0|||
147301013|NCT01951638|531268038|FG002|Follow-up Period|Protocol Violation|0|||
147301014|NCT01951638|531268039|FG003|Follow-up Period|Protocol Violation|1|||
147301015|NCT01951638|531268040|FG004|Follow-up Period|Protocol Violation|0|||
147617600|NCT02721732|532416072|FG009|Overall Study|No evidence of tumor following radical surgery|0|||
147617601|NCT02848001|532416078|FG000|Overall Study|other reasons|0|||
147617602|NCT02848001|532416079|FG001|Overall Study|other reasons|0|||
147617603|NCT02848001|532416080|FG002|Overall Study|other reasons|1|||
147617604|NCT02848001|532416081|FG003|Overall Study|other reasons|0|||
147617605|NCT02848001|532416082|FG004|Overall Study|other reasons|4|||
147617606|NCT02848001|532416083|FG005|Overall Study|other reasons|1|||
147617607|NCT02848001|532416084|FG006|Overall Study|other reasons|0|||
147617608|NCT02848001|532416085|FG007|Overall Study|other reasons|2|||
147409927|NCT01646177|531664157|FG002|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
147409928|NCT01646177|531664158|FG003|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
147409929|NCT01646177|531664159|FG004|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
147409930|NCT01646177|531664160|FG005|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
147409931|NCT01646177|531664161|FG006|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
147409932|NCT01646177|531664162|FG007|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
147409933|NCT01646177|531664163|FG008|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
147409934|NCT01646177|531664164|FG009|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|0|||
147409935|NCT01646177|531664165|FG010|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|1|||
147409936|NCT01646177|531664166|FG011|Follow-Up Period (Minimum of 12 Weeks)|Entry Criteria Not Met|1|||
147409937|NCT02920970|531664167|FG000|First Intervention|Protocol Violation|0|||
147409938|NCT02920970|531664168|FG001|First Intervention|Protocol Violation|1|||
147409939|NCT02920970|531664167|FG000|First Intervention|Adverse Event|0|||
147409940|NCT02920970|531664168|FG001|First Intervention|Adverse Event|1|||
147409941|NCT02920970|531664167|FG000|Second Intervention|Poor Lens Fit|1|||
147409942|NCT02920970|531664168|FG001|Second Intervention|Poor Lens Fit|0|||
147409943|NCT01711853|531664171|FG000|Overall Study|Not treated|3|||
147409944|NCT04230122|531664172|FG000|Overall Study|Lost to Follow-up|1|||
147409945|NCT04230122|531664173|FG001|Overall Study|Lost to Follow-up|0|||
147409946|NCT01277887|531664177|FG000|Pre-Quit Treatment Phase|No longer interested in treatment|1|||
147409947|NCT01277887|531664178|FG001|Pre-Quit Treatment Phase|No longer interested in treatment|0|||
147409948|NCT01277887|531664177|FG000|Pre-Quit Treatment Phase|Withdrawal by Subject|2|||
147409949|NCT01277887|531664178|FG001|Pre-Quit Treatment Phase|Withdrawal by Subject|0|||
147409950|NCT01277887|531664177|FG000|Post-Quit Treatment Phase|No longer interested in treatment|3|||
147409951|NCT01277887|531664178|FG001|Post-Quit Treatment Phase|No longer interested in treatment|5|||
147409952|NCT03651700|531664179|FG000|Overall Study|Withdrawal by Subject|1|||
147409953|NCT03651700|531664180|FG001|Overall Study|Withdrawal by Subject|0|||
147409954|NCT05479734|531664183|FG000|Week 1 App Use (1+ Survey and/or Tips)|No app interactions logged|1|||
147409955|NCT05479734|531664184|FG001|Week 1 App Use (1+ Survey and/or Tips)|No app interactions logged|0|||
147409956|NCT05479734|531664183|FG000|Week 3 App Use (1+ Survey and/or Tips)|No app interactions logged|0|||
147409957|NCT05479734|531664184|FG001|Week 3 App Use (1+ Survey and/or Tips)|No app interactions logged|3|||
147409958|NCT05479734|531664183|FG000|Week 4 App Use (1+ Survey and/or Tips)|No app interactions logged|0|||
147409959|NCT05479734|531664184|FG001|Week 4 App Use (1+ Survey and/or Tips)|No app interactions logged|5|||
147409960|NCT05479734|531664183|FG000|Post-Intervention Assessment|Lost to Follow-up|0|||
147409961|NCT05479734|531664184|FG001|Post-Intervention Assessment|Lost to Follow-up|1|||
147409962|NCT00600613|531664185|FG000|Overall Study|Protocol Deviation|1|||
147409963|NCT01509547|531664188|FG000|Overall Study|Lost to Follow-up|24|||
147409964|NCT01509547|531664189|FG001|Overall Study|Lost to Follow-up|14|||
147409965|NCT01509547|531664188|FG000|Overall Study|Withdrawal by Subject|11|||
147409966|NCT01509547|531664189|FG001|Overall Study|Withdrawal by Subject|24|||
147409967|NCT01509547|531664188|FG000|Overall Study|Physician Decision|0|||
147409968|NCT01509547|531664189|FG001|Overall Study|Physician Decision|1|||
147409969|NCT01399918|531664190|FG000|Overall Study|Not eligible and not enrolled in the study|2|||
147409970|NCT00570908|531664191|FG000|Overall Study|Adverse Event|5|||
147409971|NCT00570908|531664191|FG000|Overall Study|Withdrawal by Subject|2|||
147409972|NCT00669877|531664192|FG000|Overall Study|Disease Progression/Death|4|||
147409973|NCT01110408|531664193|FG000|Overall Study|Protocol Violation|1|||
147409974|NCT01110408|531664194|FG001|Overall Study|Protocol Violation|0|||
147409975|NCT03635099|531664195|FG000|Period 1|Adverse Event|1|||
147409976|NCT03635099|531664196|FG001|Period 1|Adverse Event|0|||
147409977|NCT03635099|531664197|FG002|Period 1|Adverse Event|0|||
147409978|NCT03635099|531664198|FG003|Period 1|Adverse Event|1|||
147409979|NCT03635099|531664199|FG004|Period 1|Adverse Event|0|||
147409980|NCT03635099|531664200|FG005|Period 1|Adverse Event|0|||
147617609|NCT02848001|532416086|FG008|Overall Study|other reasons|2|||
147409981|NCT03635099|531664201|FG006|Period 1|Adverse Event|0|||
147409982|NCT03635099|531664202|FG007|Period 1|Adverse Event|0|||
147409983|NCT03635099|531664195|FG000|Period 1|Protocol Violation|0|||
147409984|NCT03635099|531664196|FG001|Period 1|Protocol Violation|0|||
147409985|NCT03635099|531664197|FG002|Period 1|Protocol Violation|1|||
147409986|NCT03635099|531664198|FG003|Period 1|Protocol Violation|0|||
147409987|NCT03635099|531664199|FG004|Period 1|Protocol Violation|0|||
147617610|NCT02848001|532416087|FG009|Overall Study|other reasons|3|||
147617611|NCT02848001|532416088|FG010|Overall Study|other reasons|0|||
147617612|NCT02848001|532416089|FG011|Overall Study|other reasons|1|||
147617613|NCT02848001|532416090|FG012|Overall Study|other reasons|1|||
147301016|NCT01951638|531268036|FG000|Follow-up Period|Logistical difficulties|0|||
147301017|NCT01951638|531268037|FG001|Follow-up Period|Logistical difficulties|2|||
147301018|NCT01951638|531268038|FG002|Follow-up Period|Logistical difficulties|0|||
147301019|NCT01951638|531268039|FG003|Follow-up Period|Logistical difficulties|0|||
147301020|NCT01951638|531268040|FG004|Follow-up Period|Logistical difficulties|1|||
147301021|NCT01951638|531268036|FG000|Follow-up Period|Withdrawal by Subject|1|||
147301022|NCT01951638|531268037|FG001|Follow-up Period|Withdrawal by Subject|5|||
147301023|NCT01951638|531268038|FG002|Follow-up Period|Withdrawal by Subject|2|||
147301024|NCT01951638|531268039|FG003|Follow-up Period|Withdrawal by Subject|1|||
147301025|NCT01951638|531268040|FG004|Follow-up Period|Withdrawal by Subject|2|||
147301026|NCT01951638|531268036|FG000|Follow-up Period|Lost to Follow-up|0|||
147301027|NCT01951638|531268037|FG001|Follow-up Period|Lost to Follow-up|1|||
147301028|NCT01951638|531268038|FG002|Follow-up Period|Lost to Follow-up|0|||
147301029|NCT01951638|531268039|FG003|Follow-up Period|Lost to Follow-up|1|||
147301030|NCT01951638|531268040|FG004|Follow-up Period|Lost to Follow-up|0|||
147301031|NCT01951638|531268036|FG000|Follow-up Period|Death|1|||
147301032|NCT01951638|531268037|FG001|Follow-up Period|Death|0|||
147301033|NCT01951638|531268038|FG002|Follow-up Period|Death|1|||
147301034|NCT01951638|531268039|FG003|Follow-up Period|Death|4|||
147301035|NCT01951638|531268040|FG004|Follow-up Period|Death|1|||
147301036|NCT01951638|531268036|FG000|Follow-up Period|Adverse Event|0|||
147301037|NCT01951638|531268037|FG001|Follow-up Period|Adverse Event|1|||
147301038|NCT01951638|531268038|FG002|Follow-up Period|Adverse Event|2|||
147301039|NCT01951638|531268039|FG003|Follow-up Period|Adverse Event|1|||
147301040|NCT01951638|531268040|FG004|Follow-up Period|Adverse Event|1|||
147301041|NCT00766675|531269577|FG000|Overall Study|Adverse Event|16|||
147301042|NCT00766675|531269577|FG000|Overall Study|Lost to Follow-up|2|||
147301043|NCT00766675|531269577|FG000|Overall Study|Withdrawal by Subject|11|||
147301044|NCT00766675|531269577|FG000|Overall Study|Protocol Violation|8|||
147301045|NCT00766675|531269577|FG000|Overall Study|Participant took prohibited medication|1|||
147301046|NCT00766675|531269577|FG000|Overall Study|Receive other anti-neoplastic treatment|1|||
147301047|NCT00766675|531269577|FG000|Overall Study|Insufficient therapy|1|||
147301048|NCT03308825|531269578|FG000|Overall Study|Lost to Follow-up|2|||
147301049|NCT03308825|531269579|FG001|Overall Study|Lost to Follow-up|2|||
147301050|NCT03308825|531269580|FG002|Overall Study|Lost to Follow-up|1|||
147301051|NCT03308825|531269581|FG003|Overall Study|Lost to Follow-up|0|||
147301052|NCT03308825|531269578|FG000|Overall Study|Protocol Violation|0|||
147301053|NCT03308825|531269579|FG001|Overall Study|Protocol Violation|2|||
147301054|NCT03308825|531269580|FG002|Overall Study|Protocol Violation|0|||
147301055|NCT03308825|531269581|FG003|Overall Study|Protocol Violation|0|||
147301056|NCT02044848|531269582|FG000|Overall Study|Administrative Problems|2|||
147301057|NCT02044848|531269583|FG001|Overall Study|Administrative Problems|3|||
147301058|NCT00045708|531269584|FG000|Phase 1|early progressive disease|0|||
147301059|NCT00045708|531269585|FG001|Phase 1|early progressive disease|1|||
147301060|NCT00045708|531269586|FG002|Phase 1|early progressive disease|0|||
147301061|NCT00685945|531269588|FG000|L-NMMA + Bradykinin|Physician Decision|1|||
147301062|NCT03183388|531269589|FG000|Overall Study|Lost to Follow-up|3|||
147301063|NCT03183388|531269590|FG001|Overall Study|Lost to Follow-up|5|||
147301064|NCT03183388|531269589|FG000|Overall Study|Physician Decision|1|||
147301065|NCT03183388|531269590|FG001|Overall Study|Physician Decision|4|||
147301066|NCT03183388|531269589|FG000|Overall Study|Withdrawal by Subject|4|||
147301067|NCT03183388|531269590|FG001|Overall Study|Withdrawal by Subject|1|||
147301068|NCT03183388|531269589|FG000|Overall Study|Moved|1|||
147301069|NCT03183388|531269590|FG001|Overall Study|Moved|0|||
147617614|NCT02848001|532416091|FG013|Overall Study|other reasons|0|||
147617615|NCT02848001|532416092|FG014|Overall Study|other reasons|0|||
147301070|NCT03183388|531269589|FG000|Overall Study|Met Exclusion Criteria|2|||
147301071|NCT03183388|531269590|FG001|Overall Study|Met Exclusion Criteria|2|||
147301072|NCT03183388|531269589|FG000|Overall Study|COVID Pandemic Related|2|||
147301073|NCT03183388|531269590|FG001|Overall Study|COVID Pandemic Related|4|||
147301074|NCT01493960|531269593|FG000|Overall Study|Adverse Event|0|||
147617616|NCT02848001|532416093|FG015|Overall Study|other reasons|2|||
147301075|NCT01493960|531269594|FG001|Overall Study|Adverse Event|1|||
147301076|NCT01493960|531269593|FG000|Overall Study|Lack of Efficacy|15|||
147301077|NCT01493960|531269594|FG001|Overall Study|Lack of Efficacy|9|||
147301078|NCT01493960|531269593|FG000|Overall Study|Protocol Violation|3|||
147301079|NCT01493960|531269594|FG001|Overall Study|Protocol Violation|0|||
147301080|NCT01493960|531269593|FG000|Overall Study|Withdrawal by Subject|10|||
147301081|NCT01493960|531269594|FG001|Overall Study|Withdrawal by Subject|4|||
147301082|NCT01493960|531269593|FG000|Overall Study|Non-specified|4|||
147301083|NCT01493960|531269594|FG001|Overall Study|Non-specified|4|||
147301084|NCT01679236|531269599|FG000|Overall Study|Lost to Follow-up|15|||
147301085|NCT01679236|531269600|FG001|Overall Study|Lost to Follow-up|15|||
147301086|NCT03935217|531269603|FG000|Overall Study|Adverse Event|1|||
147301087|NCT03935217|531269604|FG001|Overall Study|Adverse Event|0|||
147301088|NCT03935217|531269603|FG000|Overall Study|Lost to Follow-up|0|||
147301089|NCT03935217|531269604|FG001|Overall Study|Lost to Follow-up|1|||
147617617|NCT02848001|532416094|FG016|Overall Study|other reasons|1|||
147617618|NCT02848001|532416078|FG000|Overall Study|Lack of Efficacy|0|||
147617619|NCT02848001|532416079|FG001|Overall Study|Lack of Efficacy|1|||
147617620|NCT02848001|532416080|FG002|Overall Study|Lack of Efficacy|1|||
147617621|NCT02848001|532416081|FG003|Overall Study|Lack of Efficacy|2|||
147617622|NCT02848001|532416082|FG004|Overall Study|Lack of Efficacy|3|||
147617623|NCT02848001|532416083|FG005|Overall Study|Lack of Efficacy|0|||
147617624|NCT02848001|532416084|FG006|Overall Study|Lack of Efficacy|1|||
147617625|NCT02848001|532416085|FG007|Overall Study|Lack of Efficacy|0|||
147665568|NCT01614470|532599627|FG002|Part 1: Treatment Period 1 (8 Weeks)|Need to extend washout period|0|||
147665569|NCT00249834|532599628|FG000|Overall Study|Ovarian stimulation failed|1|||
147665570|NCT00249834|532599629|FG001|Overall Study|Ovarian stimulation failed|0|||
147665571|NCT00249834|532599630|FG002|Overall Study|Ovarian stimulation failed|0|||
147665572|NCT00249834|532599631|FG003|Overall Study|Ovarian stimulation failed|0|||
147665573|NCT00249834|532599632|FG004|Overall Study|Ovarian stimulation failed|0|||
147665574|NCT00249834|532599633|FG005|Overall Study|Ovarian stimulation failed|0|||
147665575|NCT00249834|532599634|FG006|Overall Study|Ovarian stimulation failed|0|||
147665576|NCT00249834|532599635|FG007|Overall Study|Ovarian stimulation failed|0|||
147665577|NCT00249834|532599628|FG000|Overall Study|Failure of down-regulation|0|||
147665578|NCT00249834|532599629|FG001|Overall Study|Failure of down-regulation|0|||
147665579|NCT00249834|532599630|FG002|Overall Study|Failure of down-regulation|0|||
147665580|NCT00249834|532599631|FG003|Overall Study|Failure of down-regulation|0|||
147665581|NCT00249834|532599632|FG004|Overall Study|Failure of down-regulation|0|||
147665582|NCT00249834|532599633|FG005|Overall Study|Failure of down-regulation|0|||
147665583|NCT00249834|532599634|FG006|Overall Study|Failure of down-regulation|1|||
147665584|NCT00249834|532599635|FG007|Overall Study|Failure of down-regulation|0|||
147665585|NCT00249834|532599628|FG000|Overall Study|Protocol Violation|0|||
147665586|NCT00249834|532599629|FG001|Overall Study|Protocol Violation|19|||
147665587|NCT00249834|532599630|FG002|Overall Study|Protocol Violation|14|||
147665588|NCT00249834|532599631|FG003|Overall Study|Protocol Violation|8|||
147665589|NCT00249834|532599632|FG004|Overall Study|Protocol Violation|5|||
147665590|NCT00249834|532599633|FG005|Overall Study|Protocol Violation|2|||
147665591|NCT00249834|532599634|FG006|Overall Study|Protocol Violation|0|||
147665592|NCT00249834|532599635|FG007|Overall Study|Protocol Violation|0|||
147665593|NCT02848664|532599636|FG000|Overall Study|Withdrawal by Subject|2|||
147665594|NCT02848664|532599636|FG000|Overall Study|Adverse Event|1|||
147665595|NCT02848664|532599636|FG000|Overall Study|no assistance for device training|1|||
147665596|NCT01405898|532599637|FG000|Overall Study|Withdrawal by Subject|2|||
147665597|NCT01405898|532599638|FG001|Overall Study|Withdrawal by Subject|2|||
147665598|NCT01687218|532599640|FG000|Overall Study|Withdrawal by Subject|2|||
147665599|NCT01687218|532599641|FG001|Overall Study|Withdrawal by Subject|3|||
147665600|NCT01687218|532599642|FG002|Overall Study|Withdrawal by Subject|0|||
147665601|NCT01687218|532599643|FG003|Overall Study|Withdrawal by Subject|1|||
147665602|NCT01687218|532599644|FG004|Overall Study|Withdrawal by Subject|1|||
147665603|NCT01687218|532599645|FG005|Overall Study|Withdrawal by Subject|0|||
147665604|NCT01687218|532599640|FG000|Overall Study|Relocated, no follow-up planned|1|||
147665605|NCT01687218|532599641|FG001|Overall Study|Relocated, no follow-up planned|0|||
147665606|NCT01687218|532599642|FG002|Overall Study|Relocated, no follow-up planned|1|||
147665607|NCT01687218|532599643|FG003|Overall Study|Relocated, no follow-up planned|1|||
147665608|NCT01687218|532599644|FG004|Overall Study|Relocated, no follow-up planned|0|||
147665609|NCT01687218|532599645|FG005|Overall Study|Relocated, no follow-up planned|0|||
147665610|NCT02322749|532599646|FG000|Period 2|Adverse Event|0|||
147665611|NCT02322749|532599647|FG001|Period 2|Adverse Event|0|||
147665612|NCT02322749|532599648|FG002|Period 2|Adverse Event|0|||
147665613|NCT02322749|532599649|FG003|Period 2|Adverse Event|1|||
147665614|NCT02322749|532599650|FG004|Period 2|Adverse Event|0|||
147665615|NCT02322749|532599651|FG005|Period 2|Adverse Event|0|||
147665616|NCT02322749|532599646|FG000|Period 2|Withdrawal by Subject|0|||
147665617|NCT02322749|532599647|FG001|Period 2|Withdrawal by Subject|0|||
147665618|NCT02322749|532599648|FG002|Period 2|Withdrawal by Subject|0|||
147665619|NCT02322749|532599649|FG003|Period 2|Withdrawal by Subject|1|||
147665620|NCT02322749|532599650|FG004|Period 2|Withdrawal by Subject|0|||
147665621|NCT02322749|532599651|FG005|Period 2|Withdrawal by Subject|0|||
147665622|NCT02322749|532599646|FG000|Period 3|Withdrawal by Subject|0|||
147665623|NCT02322749|532599647|FG001|Period 3|Withdrawal by Subject|0|||
147665624|NCT02322749|532599648|FG002|Period 3|Withdrawal by Subject|1|||
147665625|NCT02322749|532599649|FG003|Period 3|Withdrawal by Subject|0|||
147665626|NCT02322749|532599650|FG004|Period 3|Withdrawal by Subject|0|||
147301090|NCT03935217|531269603|FG000|Overall Study|Withdrawal by Subject|0|||
147665627|NCT02322749|532599651|FG005|Period 3|Withdrawal by Subject|0|||
147665628|NCT02033759|532599652|FG000|Overall Study|Withdrawal by Subject|2|||
147665629|NCT02033759|532599653|FG001|Overall Study|Withdrawal by Subject|1|||
147665630|NCT02033759|532599652|FG000|Overall Study|Protocol Violation|1|||
147301091|NCT03935217|531269604|FG001|Overall Study|Withdrawal by Subject|2|||
147301092|NCT00847405|531269605|FG000|First Intervention|Adverse Event|0|||
147665631|NCT02033759|532599653|FG001|Overall Study|Protocol Violation|1|||
147665632|NCT00807365|532599658|FG000|Overall Study|Study Terminated|5|||
147617626|NCT02848001|532416086|FG008|Overall Study|Lack of Efficacy|0|||
147617627|NCT02848001|532416087|FG009|Overall Study|Lack of Efficacy|1|||
147301093|NCT00847405|531269606|FG001|First Intervention|Adverse Event|1|||
147301094|NCT00847405|531269605|FG000|Washout of 7 Days|Withdrawal by Subject|1|||
147301095|NCT00847405|531269606|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
147301096|NCT02259517|531269607|FG000|Overall Study|Psychiatric diagnosis (e.g., ADHD, MDD)|0|||
147301097|NCT02259517|531269608|FG001|Overall Study|Psychiatric diagnosis (e.g., ADHD, MDD)|0|||
147301098|NCT02259517|531269609|FG002|Overall Study|Psychiatric diagnosis (e.g., ADHD, MDD)|6|||
147301099|NCT02259517|531269607|FG000|Overall Study|Withdrawal by Subject|0|||
147301100|NCT02259517|531269608|FG001|Overall Study|Withdrawal by Subject|0|||
147301101|NCT02259517|531269609|FG002|Overall Study|Withdrawal by Subject|3|||
147301102|NCT02305381|531269610|FG000|Overall Study|Unclassified|5|||
147301103|NCT02305381|531269611|FG001|Overall Study|Unclassified|5|||
147301104|NCT02305381|531269612|FG002|Overall Study|Unclassified|7|||
147301105|NCT00514683|531269613|FG000|Overall Study|Not treated|2|||
147301106|NCT00514683|531269614|FG001|Overall Study|Not treated|1|||
147301107|NCT00514683|531269615|FG002|Overall Study|Not treated|0|||
147301108|NCT00514683|531269616|FG003|Overall Study|Not treated|0|||
147301109|NCT00514683|531269617|FG004|Overall Study|Not treated|1|||
147301110|NCT00514683|531269613|FG000|Overall Study|Adverse Event|21|||
147301111|NCT00514683|531269614|FG001|Overall Study|Adverse Event|20|||
147301112|NCT00514683|531269615|FG002|Overall Study|Adverse Event|15|||
147301113|NCT00514683|531269616|FG003|Overall Study|Adverse Event|13|||
147301114|NCT00514683|531269617|FG004|Overall Study|Adverse Event|27|||
147301115|NCT00514683|531269613|FG000|Overall Study|Protocol Violation|1|||
147301116|NCT00514683|531269614|FG001|Overall Study|Protocol Violation|1|||
147301117|NCT00514683|531269615|FG002|Overall Study|Protocol Violation|0|||
147301118|NCT00514683|531269616|FG003|Overall Study|Protocol Violation|1|||
147301119|NCT00514683|531269617|FG004|Overall Study|Protocol Violation|0|||
147301120|NCT00514683|531269613|FG000|Overall Study|Withdrawal by Subject|2|||
147301121|NCT00514683|531269614|FG001|Overall Study|Withdrawal by Subject|2|||
147301122|NCT00514683|531269615|FG002|Overall Study|Withdrawal by Subject|1|||
147301123|NCT00514683|531269616|FG003|Overall Study|Withdrawal by Subject|0|||
147301124|NCT00514683|531269617|FG004|Overall Study|Withdrawal by Subject|4|||
147301125|NCT00514683|531269613|FG000|Overall Study|Reason other than listed above|0|||
147301126|NCT00514683|531269614|FG001|Overall Study|Reason other than listed above|1|||
147301127|NCT00514683|531269615|FG002|Overall Study|Reason other than listed above|2|||
147301128|NCT00514683|531269616|FG003|Overall Study|Reason other than listed above|0|||
147301129|NCT00514683|531269617|FG004|Overall Study|Reason other than listed above|1|||
147301130|NCT04998604|531269624|FG000|Overall Study|Adverse Event|3|||
147301131|NCT04998604|531269625|FG001|Overall Study|Adverse Event|2|||
147301132|NCT04998604|531269624|FG000|Overall Study|Withdrawal by Subject|2|||
147301133|NCT04998604|531269625|FG001|Overall Study|Withdrawal by Subject|4|||
147301134|NCT04998604|531269624|FG000|Overall Study|Not related to coronavirus disease 2019 pandemic|2|||
147301135|NCT04998604|531269625|FG001|Overall Study|Not related to coronavirus disease 2019 pandemic|8|||
147301136|NCT00642902|531269626|FG000|Overall Study|Adverse Event|0|||
147301137|NCT00642902|531269627|FG001|Overall Study|Adverse Event|1|||
147301138|NCT00642902|531269628|FG002|Overall Study|Adverse Event|3|||
147301139|NCT00642902|531269629|FG003|Overall Study|Adverse Event|1|||
147301140|NCT00642902|531269626|FG000|Overall Study|Lost to Follow-up|1|||
147301141|NCT00642902|531269627|FG001|Overall Study|Lost to Follow-up|1|||
147301142|NCT00642902|531269628|FG002|Overall Study|Lost to Follow-up|0|||
147301143|NCT00642902|531269629|FG003|Overall Study|Lost to Follow-up|0|||
147301144|NCT00642902|531269626|FG000|Overall Study|Lack of Efficacy|0|||
147301145|NCT00642902|531269627|FG001|Overall Study|Lack of Efficacy|3|||
147301146|NCT00642902|531269628|FG002|Overall Study|Lack of Efficacy|3|||
147301147|NCT00642902|531269629|FG003|Overall Study|Lack of Efficacy|0|||
147301148|NCT00642902|531269626|FG000|Overall Study|Death|1|||
147301149|NCT00642902|531269627|FG001|Overall Study|Death|0|||
147301150|NCT00642902|531269628|FG002|Overall Study|Death|0|||
147301151|NCT00642902|531269629|FG003|Overall Study|Death|0|||
147301152|NCT00642902|531269626|FG000|Overall Study|Premature termination of clinical trial|37|||
147301153|NCT00642902|531269627|FG001|Overall Study|Premature termination of clinical trial|32|||
147301154|NCT00642902|531269628|FG002|Overall Study|Premature termination of clinical trial|35|||
147301155|NCT00642902|531269629|FG003|Overall Study|Premature termination of clinical trial|35|||
147301156|NCT00642902|531269626|FG000|Overall Study|Randomized, but not treated|0|||
147301157|NCT00642902|531269627|FG001|Overall Study|Randomized, but not treated|0|||
147301158|NCT00642902|531269628|FG002|Overall Study|Randomized, but not treated|1|||
147301159|NCT00642902|531269629|FG003|Overall Study|Randomized, but not treated|0|||
147301160|NCT00642902|531269626|FG000|Overall Study|Other|1|||
147301161|NCT00642902|531269627|FG001|Overall Study|Other|5|||
147301162|NCT00642902|531269628|FG002|Overall Study|Other|1|||
147301163|NCT00642902|531269629|FG003|Overall Study|Other|4|||
147301164|NCT00429663|531269630|FG000|Overall Study|Lost to Follow-up|24|||
147301165|NCT00429663|531269631|FG001|Overall Study|Lost to Follow-up|31|||
147301166|NCT00429663|531269630|FG000|Overall Study|Physician Decision|6|||
147301167|NCT00429663|531269631|FG001|Overall Study|Physician Decision|3|||
147301168|NCT00429663|531269630|FG000|Overall Study|Withdrawal by Subject|2|||
147301169|NCT00429663|531269631|FG001|Overall Study|Withdrawal by Subject|5|||
147301170|NCT00429663|531269630|FG000|Overall Study|Death|4|||
147617628|NCT02848001|532416088|FG010|Overall Study|Lack of Efficacy|0|||
147617629|NCT02848001|532416089|FG011|Overall Study|Lack of Efficacy|2|||
147617630|NCT02848001|532416090|FG012|Overall Study|Lack of Efficacy|0|||
147617631|NCT02848001|532416091|FG013|Overall Study|Lack of Efficacy|2|||
147617632|NCT02848001|532416092|FG014|Overall Study|Lack of Efficacy|2|||
147617633|NCT02848001|532416093|FG015|Overall Study|Lack of Efficacy|0|||
147617634|NCT02848001|532416094|FG016|Overall Study|Lack of Efficacy|0|||
147617635|NCT02848001|532416078|FG000|Overall Study|Progressive Disease|2|||
147617636|NCT02848001|532416079|FG001|Overall Study|Progressive Disease|1|||
147617637|NCT02848001|532416080|FG002|Overall Study|Progressive Disease|0|||
147617638|NCT02848001|532416081|FG003|Overall Study|Progressive Disease|4|||
147617639|NCT02848001|532416082|FG004|Overall Study|Progressive Disease|3|||
147617640|NCT02848001|532416083|FG005|Overall Study|Progressive Disease|0|||
147617641|NCT02848001|532416084|FG006|Overall Study|Progressive Disease|4|||
147617642|NCT02848001|532416085|FG007|Overall Study|Progressive Disease|1|||
147617643|NCT02848001|532416086|FG008|Overall Study|Progressive Disease|0|||
147617644|NCT02848001|532416087|FG009|Overall Study|Progressive Disease|2|||
147617645|NCT02848001|532416088|FG010|Overall Study|Progressive Disease|3|||
147617646|NCT02848001|532416089|FG011|Overall Study|Progressive Disease|2|||
147617647|NCT02848001|532416090|FG012|Overall Study|Progressive Disease|1|||
147617648|NCT02848001|532416091|FG013|Overall Study|Progressive Disease|0|||
147617649|NCT02848001|532416092|FG014|Overall Study|Progressive Disease|2|||
147617650|NCT02848001|532416093|FG015|Overall Study|Progressive Disease|4|||
147617651|NCT02848001|532416094|FG016|Overall Study|Progressive Disease|0|||
147617652|NCT02848001|532416078|FG000|Overall Study|Adverse Event|0|||
147617653|NCT02848001|532416079|FG001|Overall Study|Adverse Event|0|||
147617654|NCT02848001|532416080|FG002|Overall Study|Adverse Event|0|||
147617655|NCT02848001|532416081|FG003|Overall Study|Adverse Event|0|||
147617656|NCT02848001|532416082|FG004|Overall Study|Adverse Event|2|||
147617657|NCT02848001|532416083|FG005|Overall Study|Adverse Event|0|||
147617658|NCT02848001|532416084|FG006|Overall Study|Adverse Event|0|||
147617659|NCT02848001|532416085|FG007|Overall Study|Adverse Event|0|||
147617660|NCT02848001|532416086|FG008|Overall Study|Adverse Event|0|||
147617661|NCT02848001|532416087|FG009|Overall Study|Adverse Event|1|||
147617662|NCT02848001|532416088|FG010|Overall Study|Adverse Event|0|||
147617663|NCT02848001|532416089|FG011|Overall Study|Adverse Event|1|||
147617664|NCT02848001|532416090|FG012|Overall Study|Adverse Event|1|||
147617665|NCT02848001|532416091|FG013|Overall Study|Adverse Event|0|||
147617666|NCT02848001|532416092|FG014|Overall Study|Adverse Event|2|||
147617667|NCT02848001|532416093|FG015|Overall Study|Adverse Event|0|||
147617668|NCT02848001|532416094|FG016|Overall Study|Adverse Event|0|||
147617669|NCT02848001|532416078|FG000|Overall Study|Death|0|||
147617670|NCT02848001|532416079|FG001|Overall Study|Death|0|||
147617671|NCT02848001|532416080|FG002|Overall Study|Death|0|||
147617672|NCT02848001|532416081|FG003|Overall Study|Death|1|||
147617673|NCT02848001|532416082|FG004|Overall Study|Death|3|||
147617674|NCT02848001|532416083|FG005|Overall Study|Death|1|||
147617675|NCT02848001|532416084|FG006|Overall Study|Death|2|||
147617676|NCT02848001|532416085|FG007|Overall Study|Death|3|||
147617677|NCT02848001|532416086|FG008|Overall Study|Death|4|||
147617678|NCT02848001|532416087|FG009|Overall Study|Death|1|||
147617679|NCT02848001|532416088|FG010|Overall Study|Death|0|||
147617680|NCT02848001|532416089|FG011|Overall Study|Death|1|||
147617681|NCT02848001|532416090|FG012|Overall Study|Death|3|||
147617682|NCT02848001|532416091|FG013|Overall Study|Death|0|||
147617683|NCT02848001|532416092|FG014|Overall Study|Death|2|||
147617684|NCT02848001|532416093|FG015|Overall Study|Death|3|||
147617685|NCT02848001|532416094|FG016|Overall Study|Death|0|||
147617686|NCT02848001|532416078|FG000|Overall Study|Physician Decision|0|||
147617687|NCT02848001|532416079|FG001|Overall Study|Physician Decision|0|||
147617688|NCT02848001|532416080|FG002|Overall Study|Physician Decision|0|||
147617689|NCT02848001|532416081|FG003|Overall Study|Physician Decision|0|||
147617690|NCT02848001|532416082|FG004|Overall Study|Physician Decision|0|||
147617691|NCT02848001|532416083|FG005|Overall Study|Physician Decision|0|||
147409988|NCT03635099|531664200|FG005|Period 1|Protocol Violation|0|||
147409989|NCT03635099|531664201|FG006|Period 1|Protocol Violation|0|||
147409990|NCT03635099|531664202|FG007|Period 1|Protocol Violation|0|||
147617692|NCT02848001|532416084|FG006|Overall Study|Physician Decision|0|||
147617693|NCT02848001|532416085|FG007|Overall Study|Physician Decision|0|||
147617694|NCT02848001|532416086|FG008|Overall Study|Physician Decision|1|||
147617695|NCT02848001|532416087|FG009|Overall Study|Physician Decision|1|||
147617696|NCT02848001|532416088|FG010|Overall Study|Physician Decision|0|||
147617697|NCT02848001|532416089|FG011|Overall Study|Physician Decision|0|||
147617698|NCT02848001|532416090|FG012|Overall Study|Physician Decision|2|||
147617699|NCT02848001|532416091|FG013|Overall Study|Physician Decision|0|||
147617700|NCT02848001|532416092|FG014|Overall Study|Physician Decision|0|||
147617701|NCT02848001|532416093|FG015|Overall Study|Physician Decision|0|||
147617702|NCT02848001|532416094|FG016|Overall Study|Physician Decision|0|||
147617703|NCT02848001|532416078|FG000|Overall Study|Withdrawal by Subject|0|||
147617704|NCT02848001|532416079|FG001|Overall Study|Withdrawal by Subject|0|||
147617705|NCT02848001|532416080|FG002|Overall Study|Withdrawal by Subject|0|||
147617706|NCT02848001|532416081|FG003|Overall Study|Withdrawal by Subject|0|||
147617707|NCT02848001|532416082|FG004|Overall Study|Withdrawal by Subject|0|||
147617708|NCT02848001|532416083|FG005|Overall Study|Withdrawal by Subject|1|||
147617709|NCT02848001|532416084|FG006|Overall Study|Withdrawal by Subject|1|||
147617710|NCT02848001|532416085|FG007|Overall Study|Withdrawal by Subject|1|||
147617711|NCT02848001|532416086|FG008|Overall Study|Withdrawal by Subject|0|||
147617712|NCT02848001|532416087|FG009|Overall Study|Withdrawal by Subject|0|||
147617713|NCT02848001|532416088|FG010|Overall Study|Withdrawal by Subject|0|||
147617714|NCT02848001|532416089|FG011|Overall Study|Withdrawal by Subject|0|||
147617715|NCT02848001|532416090|FG012|Overall Study|Withdrawal by Subject|0|||
147617716|NCT02848001|532416091|FG013|Overall Study|Withdrawal by Subject|0|||
147617717|NCT02848001|532416092|FG014|Overall Study|Withdrawal by Subject|0|||
147617718|NCT02848001|532416093|FG015|Overall Study|Withdrawal by Subject|0|||
147617719|NCT02848001|532416094|FG016|Overall Study|Withdrawal by Subject|0|||
147617720|NCT00118157|532416098|FG000|Overall Study|Adverse Event|2|||
147617721|NCT00118157|532416098|FG000|Overall Study|Death|8|||
147617722|NCT00118157|532416098|FG000|Overall Study|Withdrawal by Subject|2|||
147617723|NCT05989672|532416099|FG000|Overall Study|Adverse Event|3|||
147301171|NCT00429663|531269631|FG001|Overall Study|Death|0|||
147301172|NCT03953898|531269637|FG000|Overall Study|Lack of Efficacy|8|||
147301173|NCT03953898|531269637|FG000|Overall Study|Death|3|||
147301174|NCT03953898|531269637|FG000|Overall Study|Withdrawal by Subject|2|||
147301175|NCT03953898|531269637|FG000|Overall Study|Adverse Event|1|||
147301176|NCT03261271|531269638|FG000|Overall Study|Treatment changed after surgery. Participants were removed from the study.|1|||
147301177|NCT03261271|531269639|FG001|Overall Study|Treatment changed after surgery. Participants were removed from the study.|1|||
147301178|NCT03420781|531269640|FG000|Treatment Period (40 Weeks)|Adverse Event|1|||
147301179|NCT03420781|531269641|FG001|Treatment Period (40 Weeks)|Adverse Event|6|||
147301180|NCT03420781|531269642|FG002|Treatment Period (40 Weeks)|Adverse Event|0|||
147301181|NCT03420781|531269643|FG003|Treatment Period (40 Weeks)|Adverse Event|0|||
147301182|NCT03420781|531269644|FG004|Treatment Period (40 Weeks)|Adverse Event|0|||
147301183|NCT03420781|531269640|FG000|Treatment Period (40 Weeks)|Lack of Efficacy|1|||
147301184|NCT03420781|531269641|FG001|Treatment Period (40 Weeks)|Lack of Efficacy|1|||
147301185|NCT03420781|531269642|FG002|Treatment Period (40 Weeks)|Lack of Efficacy|0|||
147301186|NCT03420781|531269643|FG003|Treatment Period (40 Weeks)|Lack of Efficacy|0|||
147301187|NCT03420781|531269644|FG004|Treatment Period (40 Weeks)|Lack of Efficacy|0|||
147301188|NCT03420781|531269640|FG000|Treatment Period (40 Weeks)|Withdrawal by Subject|22|||
147301189|NCT03420781|531269641|FG001|Treatment Period (40 Weeks)|Withdrawal by Subject|16|||
147301190|NCT03420781|531269642|FG002|Treatment Period (40 Weeks)|Withdrawal by Subject|0|||
147301191|NCT03420781|531269643|FG003|Treatment Period (40 Weeks)|Withdrawal by Subject|0|||
147301192|NCT03420781|531269644|FG004|Treatment Period (40 Weeks)|Withdrawal by Subject|0|||
147301193|NCT03420781|531269640|FG000|Treatment Period (40 Weeks)|Lost to Follow-up|10|||
147301194|NCT03420781|531269641|FG001|Treatment Period (40 Weeks)|Lost to Follow-up|6|||
147301195|NCT03420781|531269642|FG002|Treatment Period (40 Weeks)|Lost to Follow-up|0|||
147301196|NCT03420781|531269643|FG003|Treatment Period (40 Weeks)|Lost to Follow-up|0|||
147301197|NCT03420781|531269644|FG004|Treatment Period (40 Weeks)|Lost to Follow-up|0|||
147301198|NCT03420781|531269640|FG000|Treatment Period (40 Weeks)|Death|2|||
147301199|NCT03420781|531269641|FG001|Treatment Period (40 Weeks)|Death|2|||
147301200|NCT03420781|531269642|FG002|Treatment Period (40 Weeks)|Death|0|||
147301201|NCT03420781|531269643|FG003|Treatment Period (40 Weeks)|Death|0|||
147301202|NCT03420781|531269644|FG004|Treatment Period (40 Weeks)|Death|0|||
147301203|NCT03420781|531269640|FG000|Treatment Period (40 Weeks)|Physician Decision|3|||
147301204|NCT03420781|531269641|FG001|Treatment Period (40 Weeks)|Physician Decision|4|||
147301205|NCT03420781|531269642|FG002|Treatment Period (40 Weeks)|Physician Decision|0|||
147301206|NCT03420781|531269643|FG003|Treatment Period (40 Weeks)|Physician Decision|0|||
147301207|NCT03420781|531269644|FG004|Treatment Period (40 Weeks)|Physician Decision|0|||
147301208|NCT03420781|531269640|FG000|Treatment Period (40 Weeks)|Protocol Deviation|0|||
147301209|NCT03420781|531269641|FG001|Treatment Period (40 Weeks)|Protocol Deviation|2|||
147301210|NCT03420781|531269642|FG002|Treatment Period (40 Weeks)|Protocol Deviation|0|||
147301211|NCT03420781|531269643|FG003|Treatment Period (40 Weeks)|Protocol Deviation|0|||
147301212|NCT03420781|531269644|FG004|Treatment Period (40 Weeks)|Protocol Deviation|0|||
147301213|NCT03420781|531269640|FG000|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|101|||
147617724|NCT05989672|532416100|FG001|Overall Study|Adverse Event|0|||
147617725|NCT05989672|532416101|FG002|Overall Study|Adverse Event|0|||
147617726|NCT00696423|532416102|FG000|Overall Study|Lost to Follow-up|0|||
147617727|NCT00696423|532416103|FG001|Overall Study|Lost to Follow-up|5|||
147617728|NCT03989102|532416104|FG000|Year 1|Withdrawal by Subject|6|||
147301214|NCT03420781|531269641|FG001|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|89|||
147301215|NCT03420781|531269642|FG002|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|0|||
147301216|NCT03420781|531269643|FG003|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|0|||
147301217|NCT03420781|531269644|FG004|Treatment Period (40 Weeks)|Study Terminated by the Sponsor|0|||
147301218|NCT03420781|531269640|FG000|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|1|||
147301219|NCT03420781|531269641|FG001|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|0|||
147301220|NCT03420781|531269642|FG002|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|0|||
147617729|NCT03989102|532416105|FG001|Year 1|Withdrawal by Subject|2|||
147617730|NCT03989102|532416106|FG002|Year 1|Withdrawal by Subject|7|||
147617731|NCT03989102|532416104|FG000|Year 1|Lost to Follow-up|5|||
147617732|NCT03989102|532416105|FG001|Year 1|Lost to Follow-up|2|||
147617733|NCT03989102|532416106|FG002|Year 1|Lost to Follow-up|5|||
147617734|NCT03989102|532416104|FG000|Year 1|Subject met withdrawal criteria|1|||
147617735|NCT03989102|532416105|FG001|Year 1|Subject met withdrawal criteria|0|||
147617736|NCT03989102|532416106|FG002|Year 1|Subject met withdrawal criteria|1|||
147617737|NCT03989102|532416104|FG000|Year 2|Lost to Follow-up|7|||
147617738|NCT03989102|532416105|FG001|Year 2|Lost to Follow-up|3|||
147617739|NCT03989102|532416106|FG002|Year 2|Lost to Follow-up|4|||
147617740|NCT03989102|532416104|FG000|Year 2|Withdrawal by Subject|3|||
147617741|NCT03989102|532416105|FG001|Year 2|Withdrawal by Subject|1|||
147617742|NCT03989102|532416106|FG002|Year 2|Withdrawal by Subject|2|||
147617743|NCT03989102|532416104|FG000|Year 2|Subject non-compliant|3|||
147617744|NCT03989102|532416105|FG001|Year 2|Subject non-compliant|2|||
147617745|NCT03989102|532416106|FG002|Year 2|Subject non-compliant|0|||
147617746|NCT03989102|532416104|FG000|Year 2|Travel|1|||
147409991|NCT03635099|531664195|FG000|Period 1|Lost to Follow-up|0|||
147409992|NCT03635099|531664196|FG001|Period 1|Lost to Follow-up|0|||
147409993|NCT03635099|531664197|FG002|Period 1|Lost to Follow-up|1|||
147409994|NCT03635099|531664198|FG003|Period 1|Lost to Follow-up|2|||
147409995|NCT03635099|531664199|FG004|Period 1|Lost to Follow-up|1|||
147409996|NCT03635099|531664200|FG005|Period 1|Lost to Follow-up|0|||
147409997|NCT03635099|531664201|FG006|Period 1|Lost to Follow-up|1|||
147409998|NCT03635099|531664202|FG007|Period 1|Lost to Follow-up|2|||
147409999|NCT03635099|531664195|FG000|Period 1|Withdrawal by Subject|3|||
147410000|NCT03635099|531664196|FG001|Period 1|Withdrawal by Subject|3|||
147410001|NCT03635099|531664197|FG002|Period 1|Withdrawal by Subject|5|||
147410002|NCT03635099|531664198|FG003|Period 1|Withdrawal by Subject|2|||
147410003|NCT03635099|531664199|FG004|Period 1|Withdrawal by Subject|2|||
147410004|NCT03635099|531664200|FG005|Period 1|Withdrawal by Subject|0|||
147410005|NCT03635099|531664201|FG006|Period 1|Withdrawal by Subject|3|||
147410006|NCT03635099|531664202|FG007|Period 1|Withdrawal by Subject|0|||
147410007|NCT03635099|531664195|FG000|Period 1|History of suicidal ideation|0|||
147410008|NCT03635099|531664196|FG001|Period 1|History of suicidal ideation|0|||
147410009|NCT03635099|531664197|FG002|Period 1|History of suicidal ideation|1|||
147410010|NCT03635099|531664198|FG003|Period 1|History of suicidal ideation|0|||
147410011|NCT03635099|531664199|FG004|Period 1|History of suicidal ideation|0|||
147410012|NCT03635099|531664200|FG005|Period 1|History of suicidal ideation|0|||
147410013|NCT03635099|531664201|FG006|Period 1|History of suicidal ideation|0|||
147410014|NCT03635099|531664202|FG007|Period 1|History of suicidal ideation|0|||
147410015|NCT03635099|531664195|FG000|Period 1|pursue other treatment options|0|||
147410016|NCT03635099|531664196|FG001|Period 1|pursue other treatment options|0|||
147410017|NCT03635099|531664197|FG002|Period 1|pursue other treatment options|0|||
147410018|NCT03635099|531664198|FG003|Period 1|pursue other treatment options|0|||
147410019|NCT03635099|531664199|FG004|Period 1|pursue other treatment options|0|||
147410020|NCT03635099|531664200|FG005|Period 1|pursue other treatment options|1|||
147410021|NCT03635099|531664201|FG006|Period 1|pursue other treatment options|0|||
147410022|NCT03635099|531664202|FG007|Period 1|pursue other treatment options|0|||
147410023|NCT03635099|531664195|FG000|Not Eligible for Period 2|Pregnancy|0|||
147410024|NCT03635099|531664196|FG001|Not Eligible for Period 2|Pregnancy|0|||
147410025|NCT03635099|531664197|FG002|Not Eligible for Period 2|Pregnancy|0|||
147410026|NCT03635099|531664198|FG003|Not Eligible for Period 2|Pregnancy|1|||
147410027|NCT03635099|531664199|FG004|Not Eligible for Period 2|Pregnancy|0|||
147410028|NCT03635099|531664200|FG005|Not Eligible for Period 2|Pregnancy|0|||
147410029|NCT03635099|531664201|FG006|Not Eligible for Period 2|Pregnancy|0|||
147410030|NCT03635099|531664202|FG007|Not Eligible for Period 2|Pregnancy|0|||
147410031|NCT03635099|531664195|FG000|Not Eligible for Period 2|Withdrawal by Subject|1|||
147410032|NCT03635099|531664196|FG001|Not Eligible for Period 2|Withdrawal by Subject|0|||
147410033|NCT03635099|531664197|FG002|Not Eligible for Period 2|Withdrawal by Subject|0|||
147410034|NCT03635099|531664198|FG003|Not Eligible for Period 2|Withdrawal by Subject|0|||
147410035|NCT03635099|531664199|FG004|Not Eligible for Period 2|Withdrawal by Subject|0|||
147410036|NCT03635099|531664200|FG005|Not Eligible for Period 2|Withdrawal by Subject|0|||
147410037|NCT03635099|531664201|FG006|Not Eligible for Period 2|Withdrawal by Subject|0|||
147410038|NCT03635099|531664202|FG007|Not Eligible for Period 2|Withdrawal by Subject|0|||
147410039|NCT03635099|531664195|FG000|Not Eligible for Period 2|Part II subjects did not have a period 2.|0|||
147410040|NCT03635099|531664196|FG001|Not Eligible for Period 2|Part II subjects did not have a period 2.|0|||
147410041|NCT03635099|531664197|FG002|Not Eligible for Period 2|Part II subjects did not have a period 2.|0|||
147410042|NCT03635099|531664198|FG003|Not Eligible for Period 2|Part II subjects did not have a period 2.|0|||
147410043|NCT03635099|531664199|FG004|Not Eligible for Period 2|Part II subjects did not have a period 2.|0|||
147410044|NCT03635099|531664200|FG005|Not Eligible for Period 2|Part II subjects did not have a period 2.|9|||
147617747|NCT03989102|532416105|FG001|Year 2|Travel|0|||
147617748|NCT03989102|532416106|FG002|Year 2|Travel|1|||
147617749|NCT03989102|532416104|FG000|Year 2|P16 missing|4|||
147617750|NCT03989102|532416105|FG001|Year 2|P16 missing|2|||
147617751|NCT03989102|532416106|FG002|Year 2|P16 missing|1|||
147617752|NCT03989102|532416104|FG000|Year 2|P11 missing|1|||
147617753|NCT03989102|532416105|FG001|Year 2|P11 missing|3|||
147617754|NCT03989102|532416106|FG002|Year 2|P11 missing|7|||
147617755|NCT03989102|532416104|FG000|Year 2|Definitive displacement outside the study site|0|||
147617756|NCT03989102|532416105|FG001|Year 2|Definitive displacement outside the study site|1|||
147617757|NCT03989102|532416106|FG002|Year 2|Definitive displacement outside the study site|0|||
147617758|NCT03989102|532416104|FG000|Year 2|Subject missed last study visit|0|||
147617759|NCT03989102|532416105|FG001|Year 2|Subject missed last study visit|1|||
147617760|NCT03989102|532416106|FG002|Year 2|Subject missed last study visit|0|||
147617761|NCT03989102|532416104|FG000|Year 2|Death|0|||
147617762|NCT03989102|532416105|FG001|Year 2|Death|1|||
147617763|NCT03989102|532416106|FG002|Year 2|Death|0|||
147617764|NCT03989102|532416104|FG000|Year 2|Subject not reachable|0|||
147617765|NCT03989102|532416105|FG001|Year 2|Subject not reachable|0|||
147617766|NCT03989102|532416106|FG002|Year 2|Subject not reachable|1|||
147617767|NCT03989102|532416104|FG000|Post-Year 3 (up to 3 Years, 8 Months)|Lost to Follow-up|1|||
147617768|NCT03989102|532416105|FG001|Post-Year 3 (up to 3 Years, 8 Months)|Lost to Follow-up|2|||
147617769|NCT03989102|532416106|FG002|Post-Year 3 (up to 3 Years, 8 Months)|Lost to Follow-up|2|||
147617770|NCT03989102|532416104|FG000|Post-Year 3 (up to 3 Years, 8 Months)|Withdrawal by Subject|1|||
147617771|NCT03989102|532416105|FG001|Post-Year 3 (up to 3 Years, 8 Months)|Withdrawal by Subject|1|||
147617772|NCT03989102|532416106|FG002|Post-Year 3 (up to 3 Years, 8 Months)|Withdrawal by Subject|1|||
147617773|NCT03989102|532416104|FG000|Post-Year 3 (up to 3 Years, 8 Months)|Widowhood|1|||
147617774|NCT03989102|532416105|FG001|Post-Year 3 (up to 3 Years, 8 Months)|Widowhood|0|||
147617775|NCT03989102|532416106|FG002|Post-Year 3 (up to 3 Years, 8 Months)|Widowhood|0|||
147617776|NCT03989102|532416104|FG000|Post-Year 3 (up to 3 Years, 8 Months)|Missed last study visit|2|||
147617777|NCT03989102|532416105|FG001|Post-Year 3 (up to 3 Years, 8 Months)|Missed last study visit|1|||
147617778|NCT03989102|532416106|FG002|Post-Year 3 (up to 3 Years, 8 Months)|Missed last study visit|0|||
147617779|NCT03989102|532416104|FG000|Post-Year 3 (up to 3 Years, 8 Months)|Travel|0|||
147617780|NCT03989102|532416105|FG001|Post-Year 3 (up to 3 Years, 8 Months)|Travel|3|||
147617781|NCT03989102|532416106|FG002|Post-Year 3 (up to 3 Years, 8 Months)|Travel|0|||
147617782|NCT03989102|532416104|FG000|Post-Year 3 (up to 3 Years, 8 Months)|Relocated|0|||
147617783|NCT03989102|532416105|FG001|Post-Year 3 (up to 3 Years, 8 Months)|Relocated|0|||
147617784|NCT03989102|532416106|FG002|Post-Year 3 (up to 3 Years, 8 Months)|Relocated|1|||
147617785|NCT00818766|532416118|FG000|Overall Study|Could not be Contacted on Day 28|11|||
147617786|NCT00818766|532416119|FG001|Overall Study|Could not be Contacted on Day 28|10|||
147617787|NCT00818766|532416118|FG000|Overall Study|Death|1|||
147617788|NCT00818766|532416119|FG001|Overall Study|Death|0|||
147617789|NCT00818766|532416118|FG000|Overall Study|Did not Receive Allocated Intervention|3|||
147617790|NCT00818766|532416119|FG001|Overall Study|Did not Receive Allocated Intervention|0|||
147617791|NCT04515147|532416120|FG000|Overall Study|Withdrawal by Subject|1|||
147617792|NCT04515147|532416121|FG001|Overall Study|Withdrawal by Subject|0|||
147617793|NCT04515147|532416122|FG002|Overall Study|Withdrawal by Subject|10|||
147617794|NCT04515147|532416123|FG003|Overall Study|Withdrawal by Subject|18|||
147617795|NCT04515147|532416124|FG004|Overall Study|Withdrawal by Subject|1|||
147617796|NCT04515147|532416125|FG005|Overall Study|Withdrawal by Subject|8|||
147617797|NCT04515147|532416120|FG000|Overall Study|Lost to Follow-up|0|||
147617798|NCT04515147|532416121|FG001|Overall Study|Lost to Follow-up|1|||
147301221|NCT03420781|531269643|FG003|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|0|||
147301222|NCT03420781|531269644|FG004|Treatment Period (40 Weeks)|Site Terminated by the Sponsor|0|||
147301223|NCT03420781|531269640|FG000|Treatment Period (40 Weeks)|Reason Not Specified|3|||
147301224|NCT03420781|531269641|FG001|Treatment Period (40 Weeks)|Reason Not Specified|0|||
147301225|NCT03420781|531269642|FG002|Treatment Period (40 Weeks)|Reason Not Specified|0|||
147301226|NCT03420781|531269643|FG003|Treatment Period (40 Weeks)|Reason Not Specified|0|||
147301227|NCT03420781|531269644|FG004|Treatment Period (40 Weeks)|Reason Not Specified|0|||
147301228|NCT03420781|531269640|FG000|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|0|||
147301229|NCT03420781|531269641|FG001|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|0|||
147617799|NCT04515147|532416122|FG002|Overall Study|Lost to Follow-up|5|||
147617800|NCT04515147|532416123|FG003|Overall Study|Lost to Follow-up|6|||
147617801|NCT04515147|532416124|FG004|Overall Study|Lost to Follow-up|2|||
147617802|NCT04515147|532416125|FG005|Overall Study|Lost to Follow-up|1|||
147617803|NCT04515147|532416120|FG000|Overall Study|Adverse Event|0|||
147617804|NCT04515147|532416121|FG001|Overall Study|Adverse Event|0|||
147617805|NCT04515147|532416122|FG002|Overall Study|Adverse Event|0|||
147617806|NCT04515147|532416123|FG003|Overall Study|Adverse Event|2|||
147617807|NCT04515147|532416124|FG004|Overall Study|Adverse Event|0|||
147301230|NCT03420781|531269642|FG002|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|0|||
147617808|NCT04515147|532416125|FG005|Overall Study|Adverse Event|0|||
147617809|NCT04515147|532416120|FG000|Overall Study|Miscellaneous|0|||
147617810|NCT04515147|532416121|FG001|Overall Study|Miscellaneous|0|||
147617811|NCT04515147|532416122|FG002|Overall Study|Miscellaneous|0|||
147617812|NCT04515147|532416123|FG003|Overall Study|Miscellaneous|1|||
147617813|NCT04515147|532416124|FG004|Overall Study|Miscellaneous|0|||
147617814|NCT04515147|532416125|FG005|Overall Study|Miscellaneous|1|||
147617815|NCT02760004|532416129|FG000|Overall Study|Lost to Follow-up|13|||
147617816|NCT02760004|532416130|FG001|Overall Study|Lost to Follow-up|22|||
147617817|NCT00970593|532416133|FG000|Overall Study|Adverse Event|1|||
147617818|NCT00970593|532416134|FG001|Overall Study|Adverse Event|1|||
147617819|NCT00970593|532416135|FG002|Overall Study|Adverse Event|0|||
147617820|NCT00970593|532416136|FG003|Overall Study|Adverse Event|0|||
147617821|NCT00970593|532416137|FG004|Overall Study|Adverse Event|0|||
147617822|NCT00970593|532416138|FG005|Overall Study|Adverse Event|0|||
147617823|NCT00970593|532416139|FG006|Overall Study|Adverse Event|0|||
147617824|NCT00970593|532416133|FG000|Overall Study|Discontinuation of study by sponsor|0|||
147617825|NCT00970593|532416134|FG001|Overall Study|Discontinuation of study by sponsor|0|||
147410045|NCT03635099|531664201|FG006|Not Eligible for Period 2|Part II subjects did not have a period 2.|40|||
147410046|NCT03635099|531664202|FG007|Not Eligible for Period 2|Part II subjects did not have a period 2.|40|||
147410047|NCT03635099|531664195|FG000|Eligible for Period 2|Switch to higher dose at end of period 1|15|||
147410048|NCT03635099|531664196|FG001|Eligible for Period 2|Switch to higher dose at end of period 1|35|||
147410049|NCT03635099|531664197|FG002|Eligible for Period 2|Switch to higher dose at end of period 1|21|||
147410050|NCT03635099|531664198|FG003|Eligible for Period 2|Switch to higher dose at end of period 1|25|||
147410051|NCT03635099|531664199|FG004|Eligible for Period 2|Switch to higher dose at end of period 1|0|||
147410052|NCT03635099|531664200|FG005|Eligible for Period 2|Switch to higher dose at end of period 1|0|||
147410053|NCT03635099|531664201|FG006|Eligible for Period 2|Switch to higher dose at end of period 1|0|||
147410054|NCT03635099|531664202|FG007|Eligible for Period 2|Switch to higher dose at end of period 1|0|||
147410055|NCT03635099|531664195|FG000|Period 2|Adverse Event|0|||
147410056|NCT03635099|531664196|FG001|Period 2|Adverse Event|0|||
147410057|NCT03635099|531664197|FG002|Period 2|Adverse Event|1|||
147410058|NCT03635099|531664198|FG003|Period 2|Adverse Event|0|||
147410059|NCT03635099|531664199|FG004|Period 2|Adverse Event|1|||
147410060|NCT03635099|531664200|FG005|Period 2|Adverse Event|0|||
147410061|NCT03635099|531664201|FG006|Period 2|Adverse Event|0|||
147410062|NCT03635099|531664202|FG007|Period 2|Adverse Event|0|||
147410063|NCT03635099|531664195|FG000|Period 2|Lost to Follow-up|0|||
147410064|NCT03635099|531664196|FG001|Period 2|Lost to Follow-up|0|||
147410065|NCT03635099|531664197|FG002|Period 2|Lost to Follow-up|1|||
147410066|NCT03635099|531664198|FG003|Period 2|Lost to Follow-up|0|||
147410067|NCT03635099|531664199|FG004|Period 2|Lost to Follow-up|4|||
147410068|NCT03635099|531664200|FG005|Period 2|Lost to Follow-up|0|||
147410069|NCT03635099|531664201|FG006|Period 2|Lost to Follow-up|0|||
147410070|NCT03635099|531664202|FG007|Period 2|Lost to Follow-up|0|||
147410071|NCT03635099|531664195|FG000|Period 2|Withdrawal by Subject|0|||
147410072|NCT03635099|531664196|FG001|Period 2|Withdrawal by Subject|0|||
147410073|NCT03635099|531664197|FG002|Period 2|Withdrawal by Subject|7|||
147410074|NCT03635099|531664198|FG003|Period 2|Withdrawal by Subject|4|||
147410075|NCT03635099|531664199|FG004|Period 2|Withdrawal by Subject|7|||
147410076|NCT03635099|531664200|FG005|Period 2|Withdrawal by Subject|0|||
147410077|NCT03635099|531664201|FG006|Period 2|Withdrawal by Subject|0|||
147410078|NCT03635099|531664202|FG007|Period 2|Withdrawal by Subject|0|||
147410079|NCT04103892|531664203|FG000|Overall Study|Adverse Event|0|||
147410080|NCT04103892|531664204|FG001|Overall Study|Adverse Event|0|||
147410081|NCT04103892|531664205|FG002|Overall Study|Adverse Event|0|||
147410082|NCT04103892|531664206|FG003|Overall Study|Adverse Event|3|||
147410083|NCT04103892|531664203|FG000|Overall Study|Lost to Follow-up|0|||
147410084|NCT04103892|531664204|FG001|Overall Study|Lost to Follow-up|0|||
147410085|NCT04103892|531664205|FG002|Overall Study|Lost to Follow-up|2|||
147410086|NCT04103892|531664206|FG003|Overall Study|Lost to Follow-up|0|||
147410087|NCT04103892|531664203|FG000|Overall Study|Protocol Violation|0|||
147410088|NCT04103892|531664204|FG001|Overall Study|Protocol Violation|0|||
147410089|NCT04103892|531664205|FG002|Overall Study|Protocol Violation|1|||
147410090|NCT04103892|531664206|FG003|Overall Study|Protocol Violation|1|||
147410091|NCT04103892|531664203|FG000|Overall Study|Withdrawal by Subject|1|||
147410092|NCT04103892|531664204|FG001|Overall Study|Withdrawal by Subject|0|||
147410093|NCT04103892|531664205|FG002|Overall Study|Withdrawal by Subject|2|||
147410094|NCT04103892|531664206|FG003|Overall Study|Withdrawal by Subject|5|||
147410095|NCT04103892|531664203|FG000|Overall Study|Requirement of prohibited concomitant medication|0|||
147410096|NCT04103892|531664204|FG001|Overall Study|Requirement of prohibited concomitant medication|0|||
147410097|NCT04103892|531664205|FG002|Overall Study|Requirement of prohibited concomitant medication|1|||
147410098|NCT04103892|531664206|FG003|Overall Study|Requirement of prohibited concomitant medication|1|||
147410099|NCT03008005|531664207|FG000|Overall Study|Physician Decision|1|||
147410100|NCT03008005|531664208|FG001|Overall Study|Physician Decision|0|||
147410101|NCT03008005|531664209|FG002|Overall Study|Physician Decision|0|||
147410102|NCT03008005|531664207|FG000|Overall Study|Withdrawal by Subject|1|||
147410103|NCT03008005|531664208|FG001|Overall Study|Withdrawal by Subject|0|||
147410104|NCT03008005|531664209|FG002|Overall Study|Withdrawal by Subject|0|||
147410105|NCT03008005|531664207|FG000|Overall Study|Ineligible|0|||
147410106|NCT03008005|531664208|FG001|Overall Study|Ineligible|1|||
147410107|NCT03008005|531664209|FG002|Overall Study|Ineligible|0|||
147617826|NCT00970593|532416135|FG002|Overall Study|Discontinuation of study by sponsor|5|||
147617827|NCT00970593|532416136|FG003|Overall Study|Discontinuation of study by sponsor|0|||
147617828|NCT00970593|532416137|FG004|Overall Study|Discontinuation of study by sponsor|0|||
147617829|NCT00970593|532416138|FG005|Overall Study|Discontinuation of study by sponsor|0|||
147617830|NCT00970593|532416139|FG006|Overall Study|Discontinuation of study by sponsor|2|||
147617831|NCT00970593|532416133|FG000|Overall Study|Withdrawal by Subject|0|||
147617832|NCT00970593|532416134|FG001|Overall Study|Withdrawal by Subject|0|||
147617833|NCT00970593|532416135|FG002|Overall Study|Withdrawal by Subject|1|||
147617834|NCT00970593|532416136|FG003|Overall Study|Withdrawal by Subject|0|||
147617835|NCT00970593|532416137|FG004|Overall Study|Withdrawal by Subject|0|||
147617836|NCT00970593|532416138|FG005|Overall Study|Withdrawal by Subject|0|||
147617837|NCT00970593|532416139|FG006|Overall Study|Withdrawal by Subject|0|||
147617838|NCT00545714|532416146|FG000|Induction Phase (6 Months)|Physician Decision|3|||
147617839|NCT00545714|532416146|FG000|Induction Phase (6 Months)|Unacceptable Toxicity|6|||
147617840|NCT00545714|532416146|FG000|Induction Phase (6 Months)|Disease Progression|1|||
147617841|NCT00545714|532416146|FG000|Induction Phase (6 Months)|Eligibility Criteria Violation|2|||
147617842|NCT00545714|532416146|FG000|Maintenance Phase (36 Months)|Unacceptable Toxicity|16|||
147617843|NCT00545714|532416146|FG000|Maintenance Phase (36 Months)|Disease Progression|9|||
147617844|NCT00545714|532416146|FG000|Maintenance Phase (36 Months)|Physician Decision|1|||
147410108|NCT07149155|531664211|FG000|Overall Study|Lost to Follow-up|10|||
147410109|NCT03345576|531664212|FG000|Overall Study|Withdrawal by Subject|2|||
147410110|NCT03345576|531664213|FG001|Overall Study|Withdrawal by Subject|2|||
147410111|NCT03345576|531664212|FG000|Overall Study|Adverse Event|1|||
147410112|NCT03345576|531664213|FG001|Overall Study|Adverse Event|0|||
147410113|NCT04942366|531666275|FG000|Overall Study|Withdrawal by Subject|5|||
147410114|NCT04942366|531666276|FG001|Overall Study|Withdrawal by Subject|5|||
147410115|NCT02706405|531666282|FG000|Overall Study|Death|3|||
147410116|NCT02706405|531666283|FG001|Overall Study|Death|2|||
147410117|NCT02706405|531666284|FG002|Overall Study|Death|0|||
147410118|NCT02706405|531666285|FG003|Overall Study|Death|1|||
147410119|NCT02706405|531666286|FG004|Overall Study|Death|0|||
147410120|NCT02706405|531666287|FG005|Overall Study|Death|0|||
147410121|NCT02706405|531666288|FG006|Overall Study|Death|3|||
147410122|NCT02706405|531666289|FG007|Overall Study|Death|4|||
147410123|NCT02706405|531666282|FG000|Overall Study|Disease progression|0|||
147410124|NCT02706405|531666283|FG001|Overall Study|Disease progression|0|||
147410125|NCT02706405|531666284|FG002|Overall Study|Disease progression|0|||
147410126|NCT02706405|531666285|FG003|Overall Study|Disease progression|0|||
147410127|NCT02706405|531666286|FG004|Overall Study|Disease progression|0|||
147410128|NCT02706405|531666287|FG005|Overall Study|Disease progression|0|||
147410129|NCT02706405|531666288|FG006|Overall Study|Disease progression|0|||
147410130|NCT02706405|531666289|FG007|Overall Study|Disease progression|1|||
147410131|NCT02706405|531666282|FG000|Overall Study|Pt moved to new therapy|0|||
147410132|NCT02706405|531666283|FG001|Overall Study|Pt moved to new therapy|0|||
147410133|NCT02706405|531666284|FG002|Overall Study|Pt moved to new therapy|0|||
147410134|NCT02706405|531666285|FG003|Overall Study|Pt moved to new therapy|0|||
147410135|NCT02706405|531666286|FG004|Overall Study|Pt moved to new therapy|0|||
147410136|NCT02706405|531666287|FG005|Overall Study|Pt moved to new therapy|1|||
147410137|NCT02706405|531666288|FG006|Overall Study|Pt moved to new therapy|0|||
147410138|NCT02706405|531666289|FG007|Overall Study|Pt moved to new therapy|1|||
147410139|NCT02706405|531666282|FG000|Overall Study|Physician Decision|1|||
147410140|NCT02706405|531666283|FG001|Overall Study|Physician Decision|0|||
147410141|NCT02706405|531666284|FG002|Overall Study|Physician Decision|0|||
147410142|NCT02706405|531666285|FG003|Overall Study|Physician Decision|0|||
147410143|NCT02706405|531666286|FG004|Overall Study|Physician Decision|0|||
147410144|NCT02706405|531666287|FG005|Overall Study|Physician Decision|0|||
147410145|NCT02706405|531666288|FG006|Overall Study|Physician Decision|0|||
147410146|NCT02706405|531666289|FG007|Overall Study|Physician Decision|0|||
147410147|NCT02304705|531666290|FG000|Overall Study|Withdrawal by Subject|2|||
147410148|NCT02304705|531666291|FG001|Overall Study|Withdrawal by Subject|0|||
147410149|NCT02304705|531666290|FG000|Overall Study|Physician Decision|2|||
147410150|NCT02304705|531666291|FG001|Overall Study|Physician Decision|4|||
147410151|NCT02304705|531666290|FG000|Overall Study|Death|0|||
147410152|NCT02304705|531666291|FG001|Overall Study|Death|1|||
147410153|NCT02304705|531666290|FG000|Overall Study|Lost to Follow-up|0|||
147410154|NCT02304705|531666291|FG001|Overall Study|Lost to Follow-up|2|||
147410155|NCT01195948|531666292|FG000|Overall Study|Lost to Follow-up|0|||
147410156|NCT01195948|531666293|FG001|Overall Study|Lost to Follow-up|1|||
147410157|NCT01195948|531666294|FG002|Overall Study|Lost to Follow-up|2|||
147617845|NCT00545714|532416146|FG000|Maintenance Phase (36 Months)|Protocol Violation|1|||
147410158|NCT03140280|531666295|FG000|Overall Study|Physician Decision|5|||
147410159|NCT05577715|531666306|FG000|Overall Study|Withdrawal by Subject|1|||
147410160|NCT05577715|531666306|FG000|Overall Study|STUDY TERMINATED BY SPONSOR|16|||
147617846|NCT00545714|532416146|FG000|Maintenance Phase (36 Months)|Withdrawal by Subject|3|||
147617847|NCT00545714|532416146|FG000|Maintenance Phase (36 Months)|Death|2|||
147410161|NCT05577715|531666306|FG000|Overall Study|Lost to Follow-up|1|||
147410162|NCT05577715|531666306|FG000|Overall Study|Death|6|||
147410163|NCT03412773|531666307|FG000|Overall Study|Lost to Follow-up|0|||
147410164|NCT03412773|531666308|FG001|Overall Study|Lost to Follow-up|7|||
147410165|NCT03412773|531666309|FG002|Overall Study|Lost to Follow-up|6|||
147410166|NCT03412773|531666307|FG000|Overall Study|Withdrawal by Subject|0|||
147410167|NCT03412773|531666308|FG001|Overall Study|Withdrawal by Subject|15|||
147410168|NCT03412773|531666309|FG002|Overall Study|Withdrawal by Subject|19|||
147410169|NCT03412773|531666307|FG000|Overall Study|Study Closed By Sponsor|3|||
147410170|NCT03412773|531666308|FG001|Overall Study|Study Closed By Sponsor|46|||
147410171|NCT03412773|531666309|FG002|Overall Study|Study Closed By Sponsor|33|||
147410172|NCT03412773|531666307|FG000|Overall Study|Transfer to Long Term Extension (BGB-A317-290-LTE1) or Post Trial Supply (PTS)|0|||
147410173|NCT03412773|531666308|FG001|Overall Study|Transfer to Long Term Extension (BGB-A317-290-LTE1) or Post Trial Supply (PTS)|15|||
147410174|NCT03412773|531666309|FG002|Overall Study|Transfer to Long Term Extension (BGB-A317-290-LTE1) or Post Trial Supply (PTS)|0|||
147410175|NCT03412773|531666307|FG000|Overall Study|Death|7|||
147410176|NCT03412773|531666308|FG001|Overall Study|Death|259|||
147410177|NCT03412773|531666309|FG002|Overall Study|Death|273|||
147410178|NCT03412773|531666307|FG000|Overall Study|Physician Decision|0|||
147410179|NCT03412773|531666308|FG001|Overall Study|Physician Decision|0|||
147410180|NCT03412773|531666309|FG002|Overall Study|Physician Decision|1|||
147410181|NCT03057847|531666315|FG000|Overall Study|Lost to Follow-up|16|||
147410182|NCT01706705|531666319|FG000|Overall Study|Death|1|||
147410183|NCT01706705|531666319|FG000|Overall Study|Lack of Efficacy|13|||
147410184|NCT01706705|531666319|FG000|Overall Study|Non-clinical|6|||
147410185|NCT03510455|531666320|FG000|Overall Study|Physician Decision|1|||
147410186|NCT00384189|531666321|FG000|Overall Study|Reason Not Specified|50|||
147410187|NCT00384189|531666322|FG001|Overall Study|Reason Not Specified|57|||
147410188|NCT00384189|531666323|FG002|Overall Study|Reason Not Specified|58|||
147410189|NCT00384189|531666324|FG003|Overall Study|Reason Not Specified|40|||
147410190|NCT04958642|531666325|FG000|Overall Study|Transferred to OLEX program|3|||
147410191|NCT04958642|531666326|FG001|Overall Study|Transferred to OLEX program|0|||
147410192|NCT04958642|531666327|FG002|Overall Study|Transferred to OLEX program|5|||
147410193|NCT04958642|531666325|FG000|Overall Study|Death|0|||
147301231|NCT03420781|531269643|FG003|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|2|||
147301232|NCT03420781|531269644|FG004|RW Period: 6 Weeks (Week 41 to Week 46)|Adverse Event|0|||
147301233|NCT03420781|531269640|FG000|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|0|||
147301234|NCT03420781|531269641|FG001|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|0|||
147301235|NCT03420781|531269642|FG002|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|0|||
147301236|NCT03420781|531269643|FG003|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|0|||
147301237|NCT03420781|531269644|FG004|RW Period: 6 Weeks (Week 41 to Week 46)|Withdrawal by Subject|2|||
147301238|NCT03420781|531269640|FG000|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|0|||
147301239|NCT03420781|531269641|FG001|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|0|||
147301240|NCT03420781|531269642|FG002|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|6|||
147301241|NCT03420781|531269643|FG003|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|3|||
147301242|NCT03420781|531269644|FG004|RW Period: 6 Weeks (Week 41 to Week 46)|Study Terminated by the Sponsor|3|||
147301243|NCT05267600|531269645|FG000|Overall Study|Adverse Event|1|||
147301244|NCT05267600|531269646|FG001|Overall Study|Adverse Event|4|||
147301245|NCT05267600|531269645|FG000|Overall Study|Death|1|||
147301246|NCT05267600|531269646|FG001|Overall Study|Death|2|||
147301247|NCT05267600|531269645|FG000|Overall Study|Lack of Efficacy|1|||
147301248|NCT05267600|531269646|FG001|Overall Study|Lack of Efficacy|2|||
147301249|NCT05267600|531269645|FG000|Overall Study|Lost to Follow-up|3|||
147301250|NCT05267600|531269646|FG001|Overall Study|Lost to Follow-up|0|||
147301251|NCT05267600|531269645|FG000|Overall Study|Physician Decision|4|||
147301252|NCT05267600|531269646|FG001|Overall Study|Physician Decision|0|||
147301253|NCT05267600|531269645|FG000|Overall Study|Treatment Unblinded|0|||
147301254|NCT05267600|531269646|FG001|Overall Study|Treatment Unblinded|1|||
147301255|NCT05267600|531269645|FG000|Overall Study|Withdrawal by Subject|5|||
147301256|NCT05267600|531269646|FG001|Overall Study|Withdrawal by Subject|4|||
147301257|NCT04067401|531269647|FG000|Overall Study|Withdrawal by Subject|7|||
147301258|NCT04067401|531269648|FG001|Overall Study|Withdrawal by Subject|0|||
147301259|NCT04067401|531269647|FG000|Overall Study|no data provided|1|||
147301260|NCT04067401|531269648|FG001|Overall Study|no data provided|0|||
147301261|NCT01889186|531269650|FG000|Overall Study|Adverse event- not related to progression|18|||
147301262|NCT01889186|531269651|FG001|Overall Study|Adverse event- not related to progression|5|||
147301263|NCT01889186|531269650|FG000|Overall Study|Adverse event- related to progression|7|||
147301264|NCT01889186|531269651|FG001|Overall Study|Adverse event- related to progression|2|||
147301265|NCT01889186|531269650|FG000|Overall Study|COVID-19 logistical restrictions|1|||
147301266|NCT01889186|531269651|FG001|Overall Study|COVID-19 logistical restrictions|0|||
147301267|NCT01889186|531269650|FG000|Overall Study|Investigator request|1|||
147410194|NCT04958642|531666326|FG001|Overall Study|Death|0|||
147301268|NCT01889186|531269651|FG001|Overall Study|Investigator request|1|||
147301269|NCT01889186|531269650|FG000|Overall Study|Progressive disease- Richter's|12|||
147301270|NCT01889186|531269651|FG001|Overall Study|Progressive disease- Richter's|7|||
147301271|NCT01889186|531269650|FG000|Overall Study|Progressive disease per protocol|46|||
147301272|NCT01889186|531269651|FG001|Overall Study|Progressive disease per protocol|17|||
147301273|NCT01889186|531269650|FG000|Overall Study|Stem cell transplant|2|||
147617848|NCT03889886|532416149|FG000|Overall Study|Other|0|||
147617849|NCT03889886|532416150|FG001|Overall Study|Other|1|||
147617850|NCT03889886|532416151|FG002|Overall Study|Other|0|||
147617851|NCT03889886|532416152|FG003|Overall Study|Other|1|||
147617852|NCT03889886|532416149|FG000|Overall Study|Withdrawal by Subject|0|||
147617853|NCT03889886|532416150|FG001|Overall Study|Withdrawal by Subject|0|||
147301274|NCT01889186|531269651|FG001|Overall Study|Stem cell transplant|1|||
147301275|NCT01889186|531269650|FG000|Overall Study|Withdrew consent|2|||
147301276|NCT01889186|531269651|FG001|Overall Study|Withdrew consent|3|||
147301277|NCT01889186|531269650|FG000|Overall Study|Other, not specified|18|||
147301278|NCT01889186|531269651|FG001|Overall Study|Other, not specified|15|||
147301279|NCT02657317|531269654|FG000|Overall Study|Withdrawal by Subject|2|||
147301280|NCT02657317|531269655|FG001|Overall Study|Withdrawal by Subject|0|||
147617854|NCT03889886|532416151|FG002|Overall Study|Withdrawal by Subject|1|||
147617855|NCT03889886|532416152|FG003|Overall Study|Withdrawal by Subject|0|||
147617856|NCT03889886|532416149|FG000|Overall Study|Adverse Event|0|||
147617857|NCT03889886|532416150|FG001|Overall Study|Adverse Event|0|||
147617858|NCT03889886|532416151|FG002|Overall Study|Adverse Event|0|||
147617859|NCT03889886|532416152|FG003|Overall Study|Adverse Event|6|||
147617860|NCT00276484|532416153|FG000|Overall Study|Adverse Event|4|||
147617861|NCT00276484|532416154|FG001|Overall Study|Adverse Event|7|||
147617862|NCT00276484|532416153|FG000|Overall Study|Lost to Follow-up|1|||
147617863|NCT00276484|532416154|FG001|Overall Study|Lost to Follow-up|1|||
147617864|NCT00276484|532416153|FG000|Overall Study|Protocol Violation|0|||
147617865|NCT00276484|532416154|FG001|Overall Study|Protocol Violation|1|||
147410195|NCT04958642|531666327|FG002|Overall Study|Death|1|||
147410196|NCT04958642|531666325|FG000|Overall Study|Withdrawal by Subject|4|||
147410197|NCT04958642|531666326|FG001|Overall Study|Withdrawal by Subject|9|||
147410198|NCT04958642|531666327|FG002|Overall Study|Withdrawal by Subject|13|||
147410199|NCT04958642|531666325|FG000|Overall Study|Investigator's Decision|0|||
147410200|NCT04958642|531666326|FG001|Overall Study|Investigator's Decision|0|||
147410201|NCT04958642|531666327|FG002|Overall Study|Investigator's Decision|1|||
147410202|NCT04958642|531666325|FG000|Overall Study|Adverse Event|1|||
147410203|NCT04958642|531666326|FG001|Overall Study|Adverse Event|0|||
147410204|NCT04958642|531666327|FG002|Overall Study|Adverse Event|1|||
147410205|NCT04958642|531666325|FG000|Overall Study|Termination by Sponsor/Regulatory Authorities|8|||
147410206|NCT04958642|531666326|FG001|Overall Study|Termination by Sponsor/Regulatory Authorities|4|||
147410207|NCT04958642|531666327|FG002|Overall Study|Termination by Sponsor/Regulatory Authorities|13|||
147410208|NCT04958642|531666325|FG000|Overall Study|Lost to Follow-up|1|||
147410209|NCT04958642|531666326|FG001|Overall Study|Lost to Follow-up|0|||
147410210|NCT04958642|531666327|FG002|Overall Study|Lost to Follow-up|0|||
147410211|NCT04958642|531666325|FG000|Overall Study|Transferred to EAP following study termination|0|||
147410212|NCT04958642|531666326|FG001|Overall Study|Transferred to EAP following study termination|0|||
147410213|NCT04958642|531666327|FG002|Overall Study|Transferred to EAP following study termination|1|||
147410214|NCT04958642|531666325|FG000|Overall Study|Transferred to Expanded Access Program|1|||
147410215|NCT04958642|531666326|FG001|Overall Study|Transferred to Expanded Access Program|0|||
147410216|NCT04958642|531666327|FG002|Overall Study|Transferred to Expanded Access Program|0|||
147410217|NCT02942004|531666328|FG000|Overall Study|Withdrawal by Subject|0|||
147410218|NCT02942004|531666329|FG001|Overall Study|Withdrawal by Subject|2|||
147410219|NCT02942004|531666330|FG002|Overall Study|Withdrawal by Subject|3|||
147410220|NCT02942004|531666328|FG000|Overall Study|Lost to Follow-up|1|||
147410221|NCT02942004|531666329|FG001|Overall Study|Lost to Follow-up|1|||
147410222|NCT02942004|531666330|FG002|Overall Study|Lost to Follow-up|2|||
147410223|NCT02942004|531666328|FG000|Overall Study|Randomized but not dosed|3|||
147410224|NCT02942004|531666329|FG001|Overall Study|Randomized but not dosed|9|||
147410225|NCT02942004|531666330|FG002|Overall Study|Randomized but not dosed|4|||
147410226|NCT05627258|531666331|FG000|Overall Study|Lost to Follow-up|1|||
147410227|NCT05627258|531666332|FG001|Overall Study|Lost to Follow-up|0|||
147410228|NCT05627258|531666333|FG002|Overall Study|Lost to Follow-up|0|||
147410229|NCT05627258|531666334|FG003|Overall Study|Lost to Follow-up|0|||
147410230|NCT05627258|531666335|FG004|Overall Study|Lost to Follow-up|0|||
147410231|NCT05627258|531666336|FG005|Overall Study|Lost to Follow-up|0|||
147410232|NCT05627258|531666331|FG000|Overall Study|Withdrawal by Subject|0|||
147410233|NCT05627258|531666332|FG001|Overall Study|Withdrawal by Subject|0|||
147410234|NCT05627258|531666333|FG002|Overall Study|Withdrawal by Subject|0|||
147410235|NCT05627258|531666334|FG003|Overall Study|Withdrawal by Subject|0|||
147410236|NCT05627258|531666335|FG004|Overall Study|Withdrawal by Subject|2|||
147410237|NCT05627258|531666336|FG005|Overall Study|Withdrawal by Subject|0|||
147617866|NCT00276484|532416153|FG000|Overall Study|Withdrawal by Subject|4|||
147617867|NCT00276484|532416154|FG001|Overall Study|Withdrawal by Subject|3|||
147410238|NCT05627258|531666331|FG000|Overall Study|Enrolled, but product not administered|1|||
147410239|NCT05627258|531666332|FG001|Overall Study|Enrolled, but product not administered|0|||
147617868|NCT00276484|532416153|FG000|Overall Study|Could not take time off work|0|||
147617869|NCT00276484|532416154|FG001|Overall Study|Could not take time off work|1|||
147301281|NCT02657317|531269654|FG000|Overall Study|Lost to Follow-up|3|||
147301282|NCT02657317|531269655|FG001|Overall Study|Lost to Follow-up|3|||
147617870|NCT03624192|532416167|FG000|Overall Study|Lost to Follow-up|1|||
147301283|NCT02856113|531269656|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
147301284|NCT02856113|531269657|FG001|Overall Study|Pretreatment Event/Adverse Event|0|||
147301285|NCT02856113|531269656|FG000|Overall Study|Significant Protocol Deviation|1|||
147301286|NCT02856113|531269657|FG001|Overall Study|Significant Protocol Deviation|0|||
147301287|NCT02856113|531269656|FG000|Overall Study|Lost to Follow-up|3|||
147301288|NCT02856113|531269657|FG001|Overall Study|Lost to Follow-up|5|||
147301289|NCT02856113|531269656|FG000|Overall Study|Voluntary Withdrawal|3|||
147301290|NCT02856113|531269657|FG001|Overall Study|Voluntary Withdrawal|5|||
147301291|NCT02856113|531269656|FG000|Overall Study|Pregnancy|0|||
147301292|NCT02856113|531269657|FG001|Overall Study|Pregnancy|1|||
147301293|NCT02856113|531269656|FG000|Overall Study|Principal Investigator Discretion|2|||
147301294|NCT02856113|531269657|FG001|Overall Study|Principal Investigator Discretion|1|||
147301295|NCT02856113|531269656|FG000|Overall Study|Randomized but not Treated|1|||
147301296|NCT02856113|531269657|FG001|Overall Study|Randomized but not Treated|0|||
147301297|NCT02856113|531269656|FG000|Overall Study|Did not Complete Study but Contacted at Week 52|0|||
147301298|NCT02856113|531269657|FG001|Overall Study|Did not Complete Study but Contacted at Week 52|3|||
147301299|NCT01960725|531269658|FG000|Overall Study|Lost to Follow-up|4|||
147301300|NCT01960725|531269659|FG001|Overall Study|Lost to Follow-up|3|||
147301301|NCT01960725|531269658|FG000|Overall Study|Withdrawal by Subject|1|||
147301302|NCT01960725|531269659|FG001|Overall Study|Withdrawal by Subject|0|||
147301303|NCT01960725|531269658|FG000|Overall Study|unable to obtain blood sample|1|||
147301304|NCT01960725|531269659|FG001|Overall Study|unable to obtain blood sample|2|||
147301305|NCT02110901|531269660|FG000|Overall Study|Death|6|||
147301306|NCT02110901|531269661|FG001|Overall Study|Death|3|||
147301307|NCT02110901|531269660|FG000|Overall Study|Lost to Follow-up|12|||
147301308|NCT02110901|531269661|FG001|Overall Study|Lost to Follow-up|8|||
147301309|NCT02110901|531269660|FG000|Overall Study|Withdrawal by Subject|7|||
147301310|NCT02110901|531269661|FG001|Overall Study|Withdrawal by Subject|3|||
147301311|NCT02110901|531269660|FG000|Overall Study|received a kidney transplant|5|||
147301312|NCT02110901|531269661|FG001|Overall Study|received a kidney transplant|0|||
147301313|NCT01058304|531269674|FG000|Overall Study|Withdrawal by Subject|8|||
147301314|NCT01058304|531269675|FG001|Overall Study|Withdrawal by Subject|5|||
147301315|NCT01058304|531269674|FG000|Overall Study|Lost to Follow-up|13|||
147301316|NCT01058304|531269675|FG001|Overall Study|Lost to Follow-up|16|||
147301317|NCT01058304|531269674|FG000|Overall Study|Developed exclusion criterion|6|||
147301318|NCT01058304|531269675|FG001|Overall Study|Developed exclusion criterion|12|||
147301319|NCT02496767|531269676|FG000|Open-label Lead-in Phase|Adverse Event|176|||
147301320|NCT02496767|531269677|FG001|Open-label Lead-in Phase|Adverse Event|0|||
147301321|NCT02496767|531269678|FG002|Open-label Lead-in Phase|Adverse Event|0|||
147301322|NCT02496767|531269679|FG003|Open-label Lead-in Phase|Adverse Event|0|||
147301323|NCT02496767|531269680|FG004|Open-label Lead-in Phase|Adverse Event|0|||
147301324|NCT02496767|531269681|FG005|Open-label Lead-in Phase|Adverse Event|0|||
147301325|NCT02496767|531269682|FG006|Open-label Lead-in Phase|Adverse Event|0|||
147301326|NCT02496767|531269683|FG007|Open-label Lead-in Phase|Adverse Event|0|||
147301327|NCT02496767|531269676|FG000|Open-label Lead-in Phase|Protocol Violation|2|||
147301328|NCT02496767|531269677|FG001|Open-label Lead-in Phase|Protocol Violation|0|||
147301329|NCT02496767|531269678|FG002|Open-label Lead-in Phase|Protocol Violation|0|||
147301330|NCT02496767|531269679|FG003|Open-label Lead-in Phase|Protocol Violation|0|||
147301331|NCT02496767|531269680|FG004|Open-label Lead-in Phase|Protocol Violation|0|||
147301332|NCT02496767|531269681|FG005|Open-label Lead-in Phase|Protocol Violation|0|||
147301333|NCT02496767|531269682|FG006|Open-label Lead-in Phase|Protocol Violation|0|||
147301334|NCT02496767|531269683|FG007|Open-label Lead-in Phase|Protocol Violation|0|||
147301335|NCT02496767|531269676|FG000|Open-label Lead-in Phase|Lost to Follow-up|1|||
147301336|NCT02496767|531269677|FG001|Open-label Lead-in Phase|Lost to Follow-up|0|||
147301337|NCT02496767|531269678|FG002|Open-label Lead-in Phase|Lost to Follow-up|0|||
147301338|NCT02496767|531269679|FG003|Open-label Lead-in Phase|Lost to Follow-up|0|||
147301339|NCT02496767|531269680|FG004|Open-label Lead-in Phase|Lost to Follow-up|0|||
147301340|NCT02496767|531269681|FG005|Open-label Lead-in Phase|Lost to Follow-up|0|||
147301341|NCT02496767|531269682|FG006|Open-label Lead-in Phase|Lost to Follow-up|0|||
147301342|NCT02496767|531269683|FG007|Open-label Lead-in Phase|Lost to Follow-up|0|||
147617871|NCT03624192|532416168|FG001|Overall Study|Lost to Follow-up|1|||
147301343|NCT02496767|531269676|FG000|Double-blind, Placebo-controlled Phase|Adverse Event|0|||
147301344|NCT02496767|531269677|FG001|Double-blind, Placebo-controlled Phase|Adverse Event|13|||
147617872|NCT00100828|532416169|FG000|Overall Study|Physician Decision|6|||
147617873|NCT01176513|532416170|FG000|Overall Study|Withdrew subjects prior to dosing|3|||
147301345|NCT02496767|531269678|FG002|Double-blind, Placebo-controlled Phase|Adverse Event|23|||
147301346|NCT02496767|531269679|FG003|Double-blind, Placebo-controlled Phase|Adverse Event|43|||
147301347|NCT02496767|531269680|FG004|Double-blind, Placebo-controlled Phase|Adverse Event|43|||
147301348|NCT02496767|531269681|FG005|Double-blind, Placebo-controlled Phase|Adverse Event|0|||
147301349|NCT02496767|531269682|FG006|Double-blind, Placebo-controlled Phase|Adverse Event|0|||
147301350|NCT02496767|531269683|FG007|Double-blind, Placebo-controlled Phase|Adverse Event|0|||
147617874|NCT04583735|532416171|FG000|Double-masked Treatment Period|Adverse Event|0|||
147301351|NCT02496767|531269676|FG000|Double-blind, Placebo-controlled Phase|Progressive disease|0|||
147301352|NCT02496767|531269677|FG001|Double-blind, Placebo-controlled Phase|Progressive disease|13|||
147617875|NCT04583735|532416172|FG001|Double-masked Treatment Period|Adverse Event|1|||
147617876|NCT04583735|532416171|FG000|Double-masked Treatment Period|Lost to Follow-up|2|||
147617877|NCT04583735|532416172|FG001|Double-masked Treatment Period|Lost to Follow-up|0|||
147617878|NCT04583735|532416171|FG000|Double-masked Treatment Period|Withdrawal by Subject|1|||
147617879|NCT04583735|532416172|FG001|Double-masked Treatment Period|Withdrawal by Subject|0|||
147617880|NCT04583735|532416171|FG000|Open-label Treatment Period|Adverse Event|1|||
147617881|NCT04583735|532416172|FG001|Open-label Treatment Period|Adverse Event|1|||
147617882|NCT04583735|532416171|FG000|Open-label Treatment Period|Withdrawal by Subject|1|||
147617883|NCT04583735|532416172|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
147617884|NCT04583735|532416171|FG000|Open-label Treatment Period|Lost to Follow-up|0|||
147617885|NCT04583735|532416172|FG001|Open-label Treatment Period|Lost to Follow-up|1|||
147617886|NCT01215136|532416173|FG000|Overall Study|Adverse Event|2|||
147617887|NCT01215136|532416174|FG001|Overall Study|Adverse Event|9|||
147665633|NCT01526785|532599660|FG000|Overall Study|Study Terminated by Sponsor|8|||
147665634|NCT01526785|532599660|FG000|Overall Study|Death|2|||
147665635|NCT01526785|532599660|FG000|Overall Study|Physician Decision|1|||
147665636|NCT01526785|532599660|FG000|Overall Study|Withdrawal by Subject|2|||
147665637|NCT01121263|532599663|FG000|Overall Study|Death|3|||
147665638|NCT01121263|532599664|FG001|Overall Study|Death|2|||
147665639|NCT01121263|532599663|FG000|Overall Study|Lost to Follow-up|22|||
147665640|NCT01121263|532599664|FG001|Overall Study|Lost to Follow-up|12|||
147665641|NCT01121263|532599663|FG000|Overall Study|Withdrawal by Subject|0|||
147665642|NCT01121263|532599664|FG001|Overall Study|Withdrawal by Subject|1|||
147665643|NCT03810456|532599665|FG000|Treatment|Urgent Family Matters|3|||
147665644|NCT03810456|532599666|FG001|Treatment|Urgent Family Matters|0|||
147665645|NCT03810456|532599667|FG002|Treatment|Urgent Family Matters|0|||
147665646|NCT03810456|532599665|FG000|Treatment|Scheduling Conflicts|0|||
147665647|NCT03810456|532599666|FG001|Treatment|Scheduling Conflicts|11|||
147665648|NCT03810456|532599667|FG002|Treatment|Scheduling Conflicts|0|||
147665649|NCT03810456|532599665|FG000|Treatment|No Longer Interested|0|||
147665650|NCT03810456|532599666|FG001|Treatment|No Longer Interested|12|||
147665651|NCT03810456|532599667|FG002|Treatment|No Longer Interested|0|||
147665652|NCT03810456|532599665|FG000|Treatment|Transportation Issues|0|||
147301353|NCT02496767|531269678|FG002|Double-blind, Placebo-controlled Phase|Progressive disease|9|||
147301354|NCT02496767|531269679|FG003|Double-blind, Placebo-controlled Phase|Progressive disease|8|||
147301355|NCT02496767|531269680|FG004|Double-blind, Placebo-controlled Phase|Progressive disease|14|||
147301356|NCT02496767|531269681|FG005|Double-blind, Placebo-controlled Phase|Progressive disease|0|||
147301357|NCT02496767|531269682|FG006|Double-blind, Placebo-controlled Phase|Progressive disease|0|||
147301358|NCT02496767|531269683|FG007|Double-blind, Placebo-controlled Phase|Progressive disease|0|||
147301359|NCT02496767|531269676|FG000|Double-blind, Placebo-controlled Phase|Death|0|||
147301360|NCT02496767|531269677|FG001|Double-blind, Placebo-controlled Phase|Death|10|||
147301361|NCT02496767|531269678|FG002|Double-blind, Placebo-controlled Phase|Death|6|||
147301362|NCT02496767|531269679|FG003|Double-blind, Placebo-controlled Phase|Death|2|||
147301363|NCT02496767|531269680|FG004|Double-blind, Placebo-controlled Phase|Death|4|||
147301364|NCT02496767|531269681|FG005|Double-blind, Placebo-controlled Phase|Death|0|||
147301365|NCT02496767|531269682|FG006|Double-blind, Placebo-controlled Phase|Death|0|||
147301366|NCT02496767|531269683|FG007|Double-blind, Placebo-controlled Phase|Death|0|||
147301367|NCT02496767|531269676|FG000|Double-blind, Placebo-controlled Phase|Various|0|||
147301368|NCT02496767|531269677|FG001|Double-blind, Placebo-controlled Phase|Various|9|||
147301369|NCT02496767|531269678|FG002|Double-blind, Placebo-controlled Phase|Various|4|||
147301370|NCT02496767|531269679|FG003|Double-blind, Placebo-controlled Phase|Various|5|||
147301371|NCT02496767|531269680|FG004|Double-blind, Placebo-controlled Phase|Various|2|||
147301372|NCT02496767|531269681|FG005|Double-blind, Placebo-controlled Phase|Various|0|||
147301373|NCT02496767|531269682|FG006|Double-blind, Placebo-controlled Phase|Various|0|||
147301374|NCT02496767|531269683|FG007|Double-blind, Placebo-controlled Phase|Various|0|||
147301375|NCT02496767|531269676|FG000|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
147301376|NCT02496767|531269677|FG001|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|4|||
147301377|NCT02496767|531269678|FG002|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|3|||
147617888|NCT01215136|532416173|FG000|Overall Study|Disease Progression|3|||
147617889|NCT01215136|532416174|FG001|Overall Study|Disease Progression|14|||
147617890|NCT01215136|532416173|FG000|Overall Study|Symptomatic Deterioration|1|||
147617891|NCT01215136|532416174|FG001|Overall Study|Symptomatic Deterioration|1|||
147617892|NCT01215136|532416173|FG000|Overall Study|Death|0|||
147617893|NCT01215136|532416174|FG001|Overall Study|Death|2|||
147617894|NCT01215136|532416173|FG000|Overall Study|Withdrawal by Subject|0|||
147617895|NCT01215136|532416174|FG001|Overall Study|Withdrawal by Subject|1|||
147665653|NCT03810456|532599666|FG001|Treatment|Transportation Issues|1|||
147665654|NCT03810456|532599667|FG002|Treatment|Transportation Issues|0|||
147665655|NCT03810456|532599665|FG000|1 Month Follow-Up|Lost to Follow-up|7|||
147665656|NCT03810456|532599666|FG001|1 Month Follow-Up|Lost to Follow-up|4|||
147665657|NCT03810456|532599667|FG002|1 Month Follow-Up|Lost to Follow-up|15|||
147301378|NCT02496767|531269679|FG003|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|1|||
147301379|NCT02496767|531269680|FG004|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|2|||
147301380|NCT02496767|531269681|FG005|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
147301381|NCT02496767|531269682|FG006|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
147301382|NCT02496767|531269683|FG007|Double-blind, Placebo-controlled Phase|Withdrawal by Subject|0|||
147301383|NCT02496767|531269676|FG000|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
147301384|NCT02496767|531269677|FG001|Double-blind, Placebo-controlled Phase|Physician Decision|4|||
147301385|NCT02496767|531269678|FG002|Double-blind, Placebo-controlled Phase|Physician Decision|1|||
147301386|NCT02496767|531269679|FG003|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
147301387|NCT02496767|531269680|FG004|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
147301388|NCT02496767|531269681|FG005|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
147301389|NCT02496767|531269682|FG006|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
147301390|NCT02496767|531269683|FG007|Double-blind, Placebo-controlled Phase|Physician Decision|0|||
147301391|NCT02496767|531269676|FG000|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
147301392|NCT02496767|531269677|FG001|Double-blind, Placebo-controlled Phase|Lost to Follow-up|2|||
147301393|NCT02496767|531269678|FG002|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
147301394|NCT02496767|531269679|FG003|Double-blind, Placebo-controlled Phase|Lost to Follow-up|2|||
147301395|NCT02496767|531269680|FG004|Double-blind, Placebo-controlled Phase|Lost to Follow-up|1|||
147301396|NCT02496767|531269681|FG005|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
147301397|NCT02496767|531269682|FG006|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
147301398|NCT02496767|531269683|FG007|Double-blind, Placebo-controlled Phase|Lost to Follow-up|0|||
147301399|NCT02496767|531269676|FG000|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
147301400|NCT02496767|531269677|FG001|Double-blind, Placebo-controlled Phase|Protocol Violation|1|||
147301401|NCT02496767|531269678|FG002|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
147301402|NCT02496767|531269679|FG003|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
147301403|NCT02496767|531269680|FG004|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
147301404|NCT02496767|531269681|FG005|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
147301405|NCT02496767|531269682|FG006|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
147301406|NCT02496767|531269683|FG007|Double-blind, Placebo-controlled Phase|Protocol Violation|0|||
147301407|NCT02496767|531269676|FG000|Double-blind, Withdrawal Phase|Progressive disease|0|||
147301408|NCT02496767|531269677|FG001|Double-blind, Withdrawal Phase|Progressive disease|0|||
147301409|NCT02496767|531269678|FG002|Double-blind, Withdrawal Phase|Progressive disease|0|||
147301410|NCT02496767|531269679|FG003|Double-blind, Withdrawal Phase|Progressive disease|0|||
147301411|NCT02496767|531269680|FG004|Double-blind, Withdrawal Phase|Progressive disease|0|||
147301412|NCT02496767|531269681|FG005|Double-blind, Withdrawal Phase|Progressive disease|4|||
147301413|NCT02496767|531269682|FG006|Double-blind, Withdrawal Phase|Progressive disease|0|||
147301414|NCT02496767|531269683|FG007|Double-blind, Withdrawal Phase|Progressive disease|1|||
147301415|NCT02496767|531269676|FG000|Double-blind, Withdrawal Phase|Adverse Event|0|||
147301416|NCT02496767|531269677|FG001|Double-blind, Withdrawal Phase|Adverse Event|0|||
147301417|NCT02496767|531269678|FG002|Double-blind, Withdrawal Phase|Adverse Event|0|||
147301418|NCT02496767|531269679|FG003|Double-blind, Withdrawal Phase|Adverse Event|0|||
147301419|NCT02496767|531269680|FG004|Double-blind, Withdrawal Phase|Adverse Event|0|||
147301420|NCT02496767|531269681|FG005|Double-blind, Withdrawal Phase|Adverse Event|1|||
147301421|NCT02496767|531269682|FG006|Double-blind, Withdrawal Phase|Adverse Event|2|||
147301422|NCT02496767|531269683|FG007|Double-blind, Withdrawal Phase|Adverse Event|1|||
147301423|NCT02496767|531269676|FG000|Double-blind, Withdrawal Phase|Death|0|||
147301424|NCT02496767|531269677|FG001|Double-blind, Withdrawal Phase|Death|0|||
147301425|NCT02496767|531269678|FG002|Double-blind, Withdrawal Phase|Death|0|||
147301426|NCT02496767|531269679|FG003|Double-blind, Withdrawal Phase|Death|0|||
147301427|NCT02496767|531269680|FG004|Double-blind, Withdrawal Phase|Death|0|||
147301428|NCT02496767|531269681|FG005|Double-blind, Withdrawal Phase|Death|0|||
147301429|NCT02496767|531269682|FG006|Double-blind, Withdrawal Phase|Death|1|||
147301430|NCT02496767|531269683|FG007|Double-blind, Withdrawal Phase|Death|2|||
147301431|NCT02496767|531269676|FG000|Double-blind, Withdrawal Phase|Withdrawal by Subject|0|||
147301432|NCT02496767|531269677|FG001|Double-blind, Withdrawal Phase|Withdrawal by Subject|0|||
147301433|NCT02496767|531269678|FG002|Double-blind, Withdrawal Phase|Withdrawal by Subject|0|||
147301434|NCT02496767|531269679|FG003|Double-blind, Withdrawal Phase|Withdrawal by Subject|0|||
147301435|NCT02496767|531269680|FG004|Double-blind, Withdrawal Phase|Withdrawal by Subject|0|||
147301436|NCT02496767|531269681|FG005|Double-blind, Withdrawal Phase|Withdrawal by Subject|1|||
147301437|NCT02496767|531269682|FG006|Double-blind, Withdrawal Phase|Withdrawal by Subject|1|||
147301438|NCT02496767|531269683|FG007|Double-blind, Withdrawal Phase|Withdrawal by Subject|1|||
147301439|NCT02889133|531269684|FG000|Completed Primary Outcome|Lost to Follow-up|1|||
147301440|NCT02889133|531269685|FG001|Completed Primary Outcome|Lost to Follow-up|1|||
147301441|NCT02889133|531269684|FG000|Completed Primary Outcome|Manufacturing error|3|||
147301442|NCT02889133|531269685|FG001|Completed Primary Outcome|Manufacturing error|8|||
147301443|NCT02889133|531269684|FG000|Completed Primary Outcome|Chromium labeling failure|1|||
147301444|NCT02889133|531269685|FG001|Completed Primary Outcome|Chromium labeling failure|0|||
147617896|NCT02308124|532416175|FG000|Overall Study|Lost to Follow-up|6|||
147617897|NCT02308124|532416176|FG001|Overall Study|Lost to Follow-up|6|||
147617898|NCT02308124|532416177|FG002|Overall Study|Lost to Follow-up|6|||
147617899|NCT02308124|532416175|FG000|Overall Study|Adverse Event|0|||
147617900|NCT02308124|532416176|FG001|Overall Study|Adverse Event|2|||
147617901|NCT02308124|532416177|FG002|Overall Study|Adverse Event|2|||
147617902|NCT01042093|532416186|FG000|Overall Study|Protocol Violation|2|||
147617903|NCT01042093|532416187|FG001|Overall Study|Protocol Violation|2|||
147617904|NCT01042093|532416188|FG002|Overall Study|Protocol Violation|2|||
147617905|NCT01042093|532416189|FG003|Overall Study|Protocol Violation|3|||
147617906|NCT01042093|532416186|FG000|Overall Study|Withdrawal by Subject|0|||
147617907|NCT01042093|532416187|FG001|Overall Study|Withdrawal by Subject|0|||
147617908|NCT01042093|532416188|FG002|Overall Study|Withdrawal by Subject|0|||
147617909|NCT01042093|532416189|FG003|Overall Study|Withdrawal by Subject|1|||
147617910|NCT00243412|532416195|FG000|Overall Study|Death|0|||
147617911|NCT00243412|532416196|FG001|Overall Study|Death|1|||
147617912|NCT00243412|532416195|FG000|Overall Study|Adverse Event|4|||
147617913|NCT00243412|532416196|FG001|Overall Study|Adverse Event|2|||
147617914|NCT00243412|532416195|FG000|Overall Study|Lost to Follow-up|0|||
147410240|NCT05627258|531666333|FG002|Overall Study|Enrolled, but product not administered|0|||
147410241|NCT05627258|531666334|FG003|Overall Study|Enrolled, but product not administered|0|||
147410242|NCT05627258|531666335|FG004|Overall Study|Enrolled, but product not administered|0|||
147410243|NCT05627258|531666336|FG005|Overall Study|Enrolled, but product not administered|0|||
147301445|NCT02889133|531269684|FG000|Completed Primary Outcome|COVID-19/Illness|4|||
147301446|NCT02889133|531269685|FG001|Completed Primary Outcome|COVID-19/Illness|2|||
147301447|NCT02889133|531269684|FG000|Completed Primary Outcome|Protocol Violation|1|||
147301448|NCT02889133|531269685|FG001|Completed Primary Outcome|Protocol Violation|0|||
147301449|NCT02889133|531269684|FG000|Completed Primary Outcome|Subject did not meet donor criteria|0|||
147301450|NCT02889133|531269685|FG001|Completed Primary Outcome|Subject did not meet donor criteria|1|||
147301451|NCT02889133|531269684|FG000|Completed Secondary Outcomes|Lost to Follow-up|1|||
147301452|NCT02889133|531269685|FG001|Completed Secondary Outcomes|Lost to Follow-up|1|||
147301453|NCT02889133|531269684|FG000|Completed Secondary Outcomes|COVID-19/illness|4|||
147301454|NCT02889133|531269685|FG001|Completed Secondary Outcomes|COVID-19/illness|2|||
147301455|NCT02889133|531269684|FG000|Completed Secondary Outcomes|Subject could not donate blood after randomization|0|||
147301456|NCT02889133|531269685|FG001|Completed Secondary Outcomes|Subject could not donate blood after randomization|2|||
147301457|NCT02889133|531269684|FG000|Completed Secondary Outcomes|Protocol Violation|1|||
147301458|NCT02889133|531269685|FG001|Completed Secondary Outcomes|Protocol Violation|0|||
147301459|NCT04711603|531269686|FG000|Double-blind Period (6 Weeks)|Adverse Event|4|||
147301460|NCT04711603|531269687|FG001|Double-blind Period (6 Weeks)|Adverse Event|3|||
147301461|NCT04711603|531269688|FG002|Double-blind Period (6 Weeks)|Adverse Event|0|||
147301462|NCT04711603|531269689|FG003|Double-blind Period (6 Weeks)|Adverse Event|0|||
147301463|NCT04711603|531269686|FG000|Double-blind Period (6 Weeks)|Lack of Efficacy|0|||
147301464|NCT04711603|531269687|FG001|Double-blind Period (6 Weeks)|Lack of Efficacy|1|||
147301465|NCT04711603|531269688|FG002|Double-blind Period (6 Weeks)|Lack of Efficacy|0|||
147301466|NCT04711603|531269689|FG003|Double-blind Period (6 Weeks)|Lack of Efficacy|0|||
147301467|NCT04711603|531269686|FG000|Double-blind Period (6 Weeks)|Protocol Violation|0|||
147301468|NCT04711603|531269687|FG001|Double-blind Period (6 Weeks)|Protocol Violation|1|||
147301469|NCT04711603|531269688|FG002|Double-blind Period (6 Weeks)|Protocol Violation|0|||
147301470|NCT04711603|531269689|FG003|Double-blind Period (6 Weeks)|Protocol Violation|0|||
147301471|NCT04711603|531269686|FG000|Double-blind Period (6 Weeks)|4 consecutive missed doses of the study drug|0|||
147410244|NCT05627258|531666331|FG000|Overall Study|Other subject illness/injury|1|||
147410245|NCT05627258|531666332|FG001|Overall Study|Other subject illness/injury|0|||
147410246|NCT05627258|531666333|FG002|Overall Study|Other subject illness/injury|0|||
147410247|NCT05627258|531666334|FG003|Overall Study|Other subject illness/injury|0|||
147410248|NCT05627258|531666335|FG004|Overall Study|Other subject illness/injury|0|||
147410249|NCT05627258|531666336|FG005|Overall Study|Other subject illness/injury|0|||
147410250|NCT05627258|531666331|FG000|Overall Study|Subject moved from area|0|||
147410251|NCT05627258|531666332|FG001|Overall Study|Subject moved from area|0|||
147410252|NCT05627258|531666333|FG002|Overall Study|Subject moved from area|1|||
147410253|NCT05627258|531666334|FG003|Overall Study|Subject moved from area|0|||
147410254|NCT05627258|531666335|FG004|Overall Study|Subject moved from area|0|||
147410255|NCT05627258|531666336|FG005|Overall Study|Subject moved from area|0|||
147410256|NCT04517669|531666337|FG000|Overall Study|Lost to Follow-up|2|||
147410257|NCT04517669|531666337|FG000|Overall Study|Withdrawal by Subject|3|||
147301472|NCT04711603|531269687|FG001|Double-blind Period (6 Weeks)|4 consecutive missed doses of the study drug|1|||
147617915|NCT00243412|532416196|FG001|Overall Study|Lost to Follow-up|1|||
147617916|NCT00243412|532416195|FG000|Overall Study|Physician Decision|1|||
147617917|NCT00243412|532416196|FG001|Overall Study|Physician Decision|1|||
147617918|NCT00243412|532416195|FG000|Overall Study|Withdrawal by Subject|4|||
147617919|NCT00243412|532416196|FG001|Overall Study|Withdrawal by Subject|5|||
147617920|NCT00243412|532416195|FG000|Overall Study|Other|1|||
147617921|NCT00243412|532416196|FG001|Overall Study|Other|1|||
147410258|NCT04517669|531666337|FG000|Overall Study|Drug withdrawn|44|||
147410259|NCT04517669|531666337|FG000|Overall Study|Other|1|||
147410260|NCT04517669|531666337|FG000|Overall Study|Eligibility criteria not met|4|||
147410261|NCT04517669|531666337|FG000|Overall Study|Did not receive treatment|3|||
147410262|NCT02138786|531666338|FG000|Overall Study|Adverse Event|0|||
147410263|NCT02138786|531666339|FG001|Overall Study|Adverse Event|2|||
147410264|NCT02138786|531666340|FG002|Overall Study|Adverse Event|1|||
147410265|NCT02138786|531666338|FG000|Overall Study|Death|1|||
147410266|NCT02138786|531666339|FG001|Overall Study|Death|7|||
147410267|NCT02138786|531666340|FG002|Overall Study|Death|2|||
147410268|NCT02138786|531666338|FG000|Overall Study|Disease Progression|1|||
147410269|NCT02138786|531666339|FG001|Overall Study|Disease Progression|1|||
147410270|NCT02138786|531666340|FG002|Overall Study|Disease Progression|3|||
147410271|NCT02138786|531666338|FG000|Overall Study|Withdrawal by Subject|1|||
147410272|NCT02138786|531666339|FG001|Overall Study|Withdrawal by Subject|2|||
147410273|NCT02138786|531666340|FG002|Overall Study|Withdrawal by Subject|0|||
147410274|NCT02138786|531666338|FG000|Overall Study|Patient's Wish|0|||
147410275|NCT02138786|531666339|FG001|Overall Study|Patient's Wish|2|||
147410276|NCT02138786|531666340|FG002|Overall Study|Patient's Wish|0|||
147410277|NCT02138786|531666338|FG000|Overall Study|Sponsor Terminated Study|0|||
147410278|NCT02138786|531666339|FG001|Overall Study|Sponsor Terminated Study|1|||
147410279|NCT02138786|531666340|FG002|Overall Study|Sponsor Terminated Study|1|||
147410280|NCT02138786|531666338|FG000|Overall Study|Non-Compliance|0|||
147410281|NCT02138786|531666339|FG001|Overall Study|Non-Compliance|0|||
147410282|NCT02138786|531666340|FG002|Overall Study|Non-Compliance|1|||
147410283|NCT01199068|531666344|FG000|Overall Study|Unacceptable toxicity|0|||
147410284|NCT01199068|531666345|FG001|Overall Study|Unacceptable toxicity|0|||
147410285|NCT01199068|531666346|FG002|Overall Study|Unacceptable toxicity|2|||
147410286|NCT01199068|531666344|FG000|Overall Study|Progressive disease|3|||
147410287|NCT01199068|531666345|FG001|Overall Study|Progressive disease|3|||
147410288|NCT01199068|531666346|FG002|Overall Study|Progressive disease|6|||
147410289|NCT01199068|531666344|FG000|Overall Study|Withdrawal by Subject|0|||
147410290|NCT01199068|531666345|FG001|Overall Study|Withdrawal by Subject|0|||
147410291|NCT01199068|531666346|FG002|Overall Study|Withdrawal by Subject|1|||
147410292|NCT01250925|531666347|FG000|Overall Study|Lost to Follow-up|1|||
147410293|NCT01250925|531666348|FG001|Overall Study|Lost to Follow-up|1|||
147410294|NCT01250925|531666349|FG002|Overall Study|Lost to Follow-up|0|||
147410295|NCT01250925|531666347|FG000|Overall Study|Withdrawal by Subject|2|||
147410296|NCT01250925|531666348|FG001|Overall Study|Withdrawal by Subject|0|||
147410297|NCT01250925|531666349|FG002|Overall Study|Withdrawal by Subject|0|||
147410298|NCT01250925|531666347|FG000|Overall Study|Protocol Violation|2|||
147410299|NCT01250925|531666348|FG001|Overall Study|Protocol Violation|0|||
147410300|NCT01250925|531666349|FG002|Overall Study|Protocol Violation|0|||
147410301|NCT01250925|531666347|FG000|Overall Study|Physician Decision|0|||
147410302|NCT01250925|531666348|FG001|Overall Study|Physician Decision|2|||
147410303|NCT01250925|531666349|FG002|Overall Study|Physician Decision|1|||
147410304|NCT01250925|531666347|FG000|Overall Study|Adverse Event|0|||
147410305|NCT01250925|531666348|FG001|Overall Study|Adverse Event|0|||
147410306|NCT01250925|531666349|FG002|Overall Study|Adverse Event|1|||
147410307|NCT00678301|531666350|FG000|Overall Study|Non-compliance with study procedures|0|||
147410308|NCT00678301|531666351|FG001|Overall Study|Non-compliance with study procedures|1|||
147410309|NCT00678301|531666350|FG000|Overall Study|Adverse Event|1|||
147410310|NCT00678301|531666351|FG001|Overall Study|Adverse Event|0|||
147410311|NCT00678301|531666350|FG000|Overall Study|Withdrawal by Subject|4|||
147410312|NCT00678301|531666351|FG001|Overall Study|Withdrawal by Subject|0|||
147410313|NCT00678301|531666350|FG000|Overall Study|Lost to Follow-up|3|||
147410314|NCT00678301|531666351|FG001|Overall Study|Lost to Follow-up|1|||
147410315|NCT03338296|531666352|FG000|Overall Study|Adverse Event|0|||
147410316|NCT03338296|531666353|FG001|Overall Study|Adverse Event|1|||
147410317|NCT03338296|531666352|FG000|Overall Study|Withdrawal by Subject|14|||
147410318|NCT03338296|531666353|FG001|Overall Study|Withdrawal by Subject|13|||
147410319|NCT03338296|531666352|FG000|Overall Study|Lost to Follow-up|10|||
147617922|NCT00041132|532416198|FG000|Overall Study|Adverse Event|19|||
147617923|NCT00041132|532416198|FG000|Overall Study|Death|1|||
147617924|NCT00041132|532416198|FG000|Overall Study|Not Eligible|7|||
147617925|NCT00041132|532416198|FG000|Overall Study|Withdrawal by Subject|1|||
147410320|NCT03338296|531666353|FG001|Overall Study|Lost to Follow-up|10|||
147410321|NCT03338296|531666352|FG000|Overall Study|Study Terminated by Sponsor|77|||
147410322|NCT03338296|531666353|FG001|Overall Study|Study Terminated by Sponsor|76|||
147410323|NCT03338296|531666352|FG000|Overall Study|Other|2|||
147410324|NCT03338296|531666353|FG001|Overall Study|Other|7|||
147410325|NCT03338296|531666352|FG000|Overall Study|Missing|0|||
147617926|NCT00041132|532416198|FG000|Overall Study|Physician Decision|2|||
147617927|NCT00995774|532416202|FG000|Training Period 2|Withdrawal by Subject|2|||
147410326|NCT03338296|531666353|FG001|Overall Study|Missing|1|||
147410327|NCT01939353|531666354|FG000|Placebo Run-in (1 Week)|Withdrew Consent|3|||
147410328|NCT01939353|531666354|FG000|Placebo Run-in (1 Week)|Lost to Follow-up|1|||
147617928|NCT00995774|532416203|FG001|Training Period 2|Withdrawal by Subject|0|||
147617929|NCT01808573|532416204|FG000|Overall Study|Death|212|||
147617930|NCT01808573|532416205|FG001|Overall Study|Death|240|||
147617931|NCT01808573|532416204|FG000|Overall Study|Withdrawal by Subject|12|||
147617932|NCT01808573|532416205|FG001|Overall Study|Withdrawal by Subject|10|||
147617933|NCT01808573|532416204|FG000|Overall Study|Lost to Follow-up|3|||
147617934|NCT01808573|532416205|FG001|Overall Study|Lost to Follow-up|0|||
147617935|NCT01808573|532416204|FG000|Overall Study|Discontinuation of study by sponsor|79|||
147410329|NCT01939353|531666354|FG000|CTN SR Treatment Phase (4 Weeks)|Treatment Emergent Adverse Event (TEAE)/Serious Adverse Event (SAE)|2|||
147410330|NCT01939353|531666354|FG000|CTN SR Treatment Phase (4 Weeks)|Lost to Follow-up|1|||
147410331|NCT01939353|531666354|FG000|CTN SR Treatment Phase (4 Weeks)|Withdrew Consent|1|||
147410332|NCT04421950|531666360|FG000|Overall Study|Dropped or lost to follow up|4|||
147410333|NCT04421950|531666361|FG001|Overall Study|Dropped or lost to follow up|2|||
147410334|NCT05048238|531666362|FG000|Overall Study|Withdrawal by Subject|1|||
147410335|NCT00335140|531666367|FG000|Overall Study|Ineligible|1|||
147410336|NCT04546425|531666368|FG000|Overall Study|Protocol Violation|1|||
147410337|NCT04546425|531666369|FG001|Overall Study|Protocol Violation|1|||
147410338|NCT04546425|531666370|FG002|Overall Study|Protocol Violation|0|||
147410339|NCT04546425|531666371|FG003|Overall Study|Protocol Violation|0|||
147410340|NCT04546425|531666368|FG000|Overall Study|Adverse Event|3|||
147410341|NCT04546425|531666369|FG001|Overall Study|Adverse Event|0|||
147410342|NCT04546425|531666370|FG002|Overall Study|Adverse Event|0|||
147410343|NCT04546425|531666371|FG003|Overall Study|Adverse Event|0|||
147410344|NCT04546425|531666368|FG000|Overall Study|Lost to Follow-up|5|||
147410345|NCT04546425|531666369|FG001|Overall Study|Lost to Follow-up|4|||
147410346|NCT04546425|531666370|FG002|Overall Study|Lost to Follow-up|0|||
147410347|NCT04546425|531666371|FG003|Overall Study|Lost to Follow-up|0|||
147410348|NCT04546425|531666368|FG000|Overall Study|No Longer met eligibility criteria|3|||
147410349|NCT04546425|531666369|FG001|Overall Study|No Longer met eligibility criteria|3|||
147410350|NCT04546425|531666370|FG002|Overall Study|No Longer met eligibility criteria|1|||
147410351|NCT04546425|531666371|FG003|Overall Study|No Longer met eligibility criteria|1|||
147410352|NCT04546425|531666368|FG000|Overall Study|Withdrawal by parent/guardian|6|||
147410353|NCT04546425|531666369|FG001|Overall Study|Withdrawal by parent/guardian|5|||
147410354|NCT04546425|531666370|FG002|Overall Study|Withdrawal by parent/guardian|1|||
147410355|NCT04546425|531666371|FG003|Overall Study|Withdrawal by parent/guardian|1|||
147410356|NCT02687035|531666372|FG000|Overall Study|Withdrawal by Subject|1|||
147410357|NCT02687035|531666372|FG000|Overall Study|Death|87|||
147410358|NCT02687035|531666372|FG000|Overall Study|Lost to Follow-up|1|||
147410359|NCT02687035|531666372|FG000|Overall Study|Missed Visit|87|||
147410360|NCT02687035|531666372|FG000|Overall Study|Did not receive Study Device|8|||
147410361|NCT02766777|531666378|FG000|Overall Study|Adverse Event|12|||
147410362|NCT02766777|531666378|FG000|Overall Study|Lost to Follow-up|16|||
147410363|NCT02766777|531666378|FG000|Overall Study|Non-Compliance With Study Drug|1|||
147410364|NCT02766777|531666378|FG000|Overall Study|Protocol Violation|1|||
147410365|NCT02766777|531666378|FG000|Overall Study|Withdrawal by Subject|4|||
147410366|NCT00534495|531666379|FG000|Double Blind Placebo Phase Week 0-4|randomized in error|0|||
147410367|NCT00534495|531666380|FG001|Double Blind Placebo Phase Week 0-4|randomized in error|1|||
147410368|NCT00534495|531666381|FG002|Double Blind Placebo Phase Week 0-4|randomized in error|0|||
147410369|NCT00534495|531666379|FG000|All Active Treatment Phase Week 4-24|Adverse Event|1|||
147410370|NCT00534495|531666380|FG001|All Active Treatment Phase Week 4-24|Adverse Event|0|||
147410371|NCT00534495|531666381|FG002|All Active Treatment Phase Week 4-24|Adverse Event|0|||
147410372|NCT00534495|531666379|FG000|All Active Treatment Phase Week 4-24|Lack of Efficacy|1|||
147410373|NCT00534495|531666380|FG001|All Active Treatment Phase Week 4-24|Lack of Efficacy|7|||
147410374|NCT00534495|531666381|FG002|All Active Treatment Phase Week 4-24|Lack of Efficacy|0|||
147410375|NCT00534495|531666379|FG000|All Active Treatment Phase Week 4-24|Lost to Follow-up|1|||
147410376|NCT00534495|531666380|FG001|All Active Treatment Phase Week 4-24|Lost to Follow-up|1|||
147410377|NCT00534495|531666381|FG002|All Active Treatment Phase Week 4-24|Lost to Follow-up|0|||
147410378|NCT00534495|531666379|FG000|All Active Treatment Phase Week 4-24|Withdrawal by Subject|1|||
147410379|NCT00534495|531666380|FG001|All Active Treatment Phase Week 4-24|Withdrawal by Subject|1|||
147410380|NCT00534495|531666381|FG002|All Active Treatment Phase Week 4-24|Withdrawal by Subject|0|||
147410381|NCT00534495|531666379|FG000|Long Term Ext. Phase Week 24-month 21|Adverse Event|0|||
147410382|NCT00534495|531666380|FG001|Long Term Ext. Phase Week 24-month 21|Adverse Event|0|||
147410383|NCT00534495|531666381|FG002|Long Term Ext. Phase Week 24-month 21|Adverse Event|1|||
147410384|NCT00534495|531666379|FG000|Long Term Ext. Phase Week 24-month 21|Lack of Efficacy|0|||
147410385|NCT00534495|531666380|FG001|Long Term Ext. Phase Week 24-month 21|Lack of Efficacy|0|||
147410386|NCT00534495|531666381|FG002|Long Term Ext. Phase Week 24-month 21|Lack of Efficacy|5|||
147410387|NCT00534495|531666379|FG000|Long Term Ext. Phase Week 24-month 21|Withdrawal by Subject|0|||
147410388|NCT00534495|531666380|FG001|Long Term Ext. Phase Week 24-month 21|Withdrawal by Subject|0|||
147410389|NCT00534495|531666381|FG002|Long Term Ext. Phase Week 24-month 21|Withdrawal by Subject|3|||
147617936|NCT01808573|532416205|FG001|Overall Study|Discontinuation of study by sponsor|64|||
147410390|NCT00534495|531666379|FG000|Long Term Ext. Phase Week 24-month 21|non compliance|0|||
147410391|NCT00534495|531666380|FG001|Long Term Ext. Phase Week 24-month 21|non compliance|0|||
147617937|NCT01808573|532416204|FG000|Overall Study|Randomized in Error|1|||
147301473|NCT04711603|531269688|FG002|Double-blind Period (6 Weeks)|4 consecutive missed doses of the study drug|0|||
147301474|NCT04711603|531269689|FG003|Double-blind Period (6 Weeks)|4 consecutive missed doses of the study drug|0|||
147301475|NCT04711603|531269686|FG000|Extension Period (52 Weeks)|Adverse Event|0|||
147301476|NCT04711603|531269687|FG001|Extension Period (52 Weeks)|Adverse Event|0|||
147301477|NCT04711603|531269688|FG002|Extension Period (52 Weeks)|Adverse Event|6|||
147301478|NCT04711603|531269689|FG003|Extension Period (52 Weeks)|Adverse Event|18|||
147301479|NCT04711603|531269686|FG000|Extension Period (52 Weeks)|Lack of Efficacy|0|||
147301480|NCT04711603|531269687|FG001|Extension Period (52 Weeks)|Lack of Efficacy|0|||
147301481|NCT04711603|531269688|FG002|Extension Period (52 Weeks)|Lack of Efficacy|0|||
147301482|NCT04711603|531269689|FG003|Extension Period (52 Weeks)|Lack of Efficacy|1|||
147301483|NCT04711603|531269686|FG000|Extension Period (52 Weeks)|Withdrawal by Subject|0|||
147301484|NCT04711603|531269687|FG001|Extension Period (52 Weeks)|Withdrawal by Subject|0|||
147301485|NCT04711603|531269688|FG002|Extension Period (52 Weeks)|Withdrawal by Subject|4|||
147301486|NCT04711603|531269689|FG003|Extension Period (52 Weeks)|Withdrawal by Subject|5|||
147617938|NCT01808573|532416205|FG001|Overall Study|Randomized in Error|0|||
147301487|NCT04711603|531269686|FG000|Extension Period (52 Weeks)|7 consecutive missed doses of the study drug|0|||
147301488|NCT04711603|531269687|FG001|Extension Period (52 Weeks)|7 consecutive missed doses of the study drug|0|||
147301489|NCT04711603|531269688|FG002|Extension Period (52 Weeks)|7 consecutive missed doses of the study drug|5|||
147301490|NCT04711603|531269689|FG003|Extension Period (52 Weeks)|7 consecutive missed doses of the study drug|2|||
147301491|NCT04711603|531269686|FG000|Extension Period (52 Weeks)|Needed to prioritize the treatment of adverse events|0|||
147301492|NCT04711603|531269687|FG001|Extension Period (52 Weeks)|Needed to prioritize the treatment of adverse events|0|||
147301493|NCT04711603|531269688|FG002|Extension Period (52 Weeks)|Needed to prioritize the treatment of adverse events|0|||
147301494|NCT04711603|531269689|FG003|Extension Period (52 Weeks)|Needed to prioritize the treatment of adverse events|1|||
147301495|NCT04711603|531269686|FG000|Extension Period (52 Weeks)|Difficulty in using iPad for efficacy evaluation|0|||
147301496|NCT04711603|531269687|FG001|Extension Period (52 Weeks)|Difficulty in using iPad for efficacy evaluation|0|||
147301497|NCT04711603|531269688|FG002|Extension Period (52 Weeks)|Difficulty in using iPad for efficacy evaluation|0|||
147301498|NCT04711603|531269689|FG003|Extension Period (52 Weeks)|Difficulty in using iPad for efficacy evaluation|1|||
147301499|NCT04711603|531269686|FG000|Extension Period (52 Weeks)|The input rate of the symptom diary was low and no improvement|0|||
147301500|NCT04711603|531269687|FG001|Extension Period (52 Weeks)|The input rate of the symptom diary was low and no improvement|0|||
147617939|NCT03953612|532416208|FG000|Overall Study|Randomized but did not start|1|||
147617940|NCT03953612|532416209|FG001|Overall Study|Randomized but did not start|1|||
147617941|NCT03953612|532416210|FG002|Overall Study|Randomized but did not start|1|||
147617942|NCT03953612|532416208|FG000|Overall Study|Withdrawal by Subject|2|||
147617943|NCT03953612|532416209|FG001|Overall Study|Withdrawal by Subject|1|||
147617944|NCT03953612|532416210|FG002|Overall Study|Withdrawal by Subject|0|||
147617945|NCT00489255|532416211|FG000|Screening and Initial Randomization|Discontinued prior to taking study drug|9|||
147617946|NCT00489255|532416212|FG001|Screening and Initial Randomization|Discontinued prior to taking study drug|3|||
147617947|NCT00489255|532416211|FG000|Period 1: Days 1 to 28|Adverse Event|21|||
147617948|NCT00489255|532416212|FG001|Period 1: Days 1 to 28|Adverse Event|8|||
147617949|NCT00489255|532416211|FG000|Period 1: Days 1 to 28|Withdrawal by Subject|5|||
147617950|NCT00489255|532416212|FG001|Period 1: Days 1 to 28|Withdrawal by Subject|0|||
147617951|NCT00489255|532416211|FG000|Period 1: Days 1 to 28|Physician Decision|1|||
147617952|NCT00489255|532416212|FG001|Period 1: Days 1 to 28|Physician Decision|4|||
147617953|NCT00489255|532416211|FG000|Period 1: Days 1 to 28|Noncompliance|2|||
147617954|NCT00489255|532416212|FG001|Period 1: Days 1 to 28|Noncompliance|0|||
147617955|NCT00489255|532416211|FG000|Period 2: Days 29 to 56|Adverse Event|3|||
147617956|NCT00489255|532416212|FG001|Period 2: Days 29 to 56|Adverse Event|1|||
147617957|NCT00489255|532416211|FG000|Period 2: Days 29 to 56|Withdrawal by Subject|0|||
147617958|NCT00489255|532416212|FG001|Period 2: Days 29 to 56|Withdrawal by Subject|3|||
147617959|NCT00489255|532416211|FG000|Period 3: Days 57 to 84|Adverse Event|3|||
147617960|NCT00489255|532416212|FG001|Period 3: Days 57 to 84|Adverse Event|3|||
147617961|NCT00489255|532416211|FG000|Period 3: Days 57 to 84|Withdrawal by Subject|1|||
147617962|NCT00489255|532416212|FG001|Period 3: Days 57 to 84|Withdrawal by Subject|0|||
147617963|NCT00489255|532416211|FG000|Period 3: Days 57 to 84|Lost to Follow-up|0|||
147617964|NCT00489255|532416212|FG001|Period 3: Days 57 to 84|Lost to Follow-up|1|||
147617965|NCT03485352|532416213|FG000|Overall Study|Lost to Follow-up|9|||
147301501|NCT04711603|531269688|FG002|Extension Period (52 Weeks)|The input rate of the symptom diary was low and no improvement|0|||
147301502|NCT04711603|531269689|FG003|Extension Period (52 Weeks)|The input rate of the symptom diary was low and no improvement|1|||
147301503|NCT04711603|531269686|FG000|Extension Period (52 Weeks)|Transferred to another hospital|0|||
147617966|NCT01982955|532416226|FG000|Overall Study|Randomized but not treated|0|||
147617967|NCT01982955|532416227|FG001|Overall Study|Randomized but not treated|0|||
147665658|NCT03810456|532599665|FG000|1 Month Follow-Up|Relocated to Different State|1|||
147665659|NCT03810456|532599666|FG001|1 Month Follow-Up|Relocated to Different State|0|||
147665660|NCT03810456|532599667|FG002|1 Month Follow-Up|Relocated to Different State|1|||
147665661|NCT03810456|532599665|FG000|1 Month Follow-Up|Withdrawal by Subject|1|||
147617968|NCT01982955|532416228|FG002|Overall Study|Randomized but not treated|0|||
147301504|NCT04711603|531269687|FG001|Extension Period (52 Weeks)|Transferred to another hospital|0|||
147301505|NCT04711603|531269688|FG002|Extension Period (52 Weeks)|Transferred to another hospital|2|||
147301506|NCT04711603|531269689|FG003|Extension Period (52 Weeks)|Transferred to another hospital|0|||
147301507|NCT01089374|531269690|FG000|Overall Study|Lost to Follow-up|3|||
147301508|NCT01089374|531269691|FG001|Overall Study|Lost to Follow-up|0|||
147301509|NCT01089374|531269690|FG000|Overall Study|Withdrawal by Subject|1|||
147301510|NCT01089374|531269691|FG001|Overall Study|Withdrawal by Subject|0|||
147301511|NCT01089374|531269690|FG000|Overall Study|Study closed early - low accrual|6|||
147301512|NCT01089374|531269691|FG001|Overall Study|Study closed early - low accrual|0|||
147301513|NCT01591382|531269692|FG000|Overall Study|Discharged Prior to Study Completion|2|||
147301514|NCT01591382|531269693|FG001|Overall Study|Discharged Prior to Study Completion|1|||
147301515|NCT01591382|531269692|FG000|Overall Study|Participant Opted for Morphine PCA|1|||
147301516|NCT01591382|531269693|FG001|Overall Study|Participant Opted for Morphine PCA|1|||
147301517|NCT02597036|531269699|FG000|Overall Study|Progressive Disease|0|||
147301518|NCT02597036|531269700|FG001|Overall Study|Progressive Disease|0|||
147301519|NCT02597036|531269701|FG002|Overall Study|Progressive Disease|0|||
147301520|NCT02597036|531269702|FG003|Overall Study|Progressive Disease|0|||
147301521|NCT02597036|531269703|FG004|Overall Study|Progressive Disease|1|||
147301522|NCT02597036|531269704|FG005|Overall Study|Progressive Disease|1|||
147301523|NCT02597036|531269705|FG006|Overall Study|Progressive Disease|1|||
147301524|NCT02597036|531269706|FG007|Overall Study|Progressive Disease|0|||
147301525|NCT02597036|531269707|FG008|Overall Study|Progressive Disease|0|||
147301526|NCT02597036|531269708|FG009|Overall Study|Progressive Disease|0|||
147301527|NCT02597036|531269709|FG010|Overall Study|Progressive Disease|0|||
147301528|NCT02597036|531269710|FG011|Overall Study|Progressive Disease|0|||
147301529|NCT02597036|531269699|FG000|Overall Study|Adverse Event|0|||
147301530|NCT02597036|531269700|FG001|Overall Study|Adverse Event|0|||
147301531|NCT02597036|531269701|FG002|Overall Study|Adverse Event|0|||
147301532|NCT02597036|531269702|FG003|Overall Study|Adverse Event|0|||
147301533|NCT02597036|531269703|FG004|Overall Study|Adverse Event|0|||
147301534|NCT02597036|531269704|FG005|Overall Study|Adverse Event|0|||
147301535|NCT02597036|531269705|FG006|Overall Study|Adverse Event|0|||
147301536|NCT02597036|531269706|FG007|Overall Study|Adverse Event|1|||
147301537|NCT02597036|531269707|FG008|Overall Study|Adverse Event|0|||
147301538|NCT02597036|531269708|FG009|Overall Study|Adverse Event|0|||
147301539|NCT02597036|531269709|FG010|Overall Study|Adverse Event|0|||
147301540|NCT02597036|531269710|FG011|Overall Study|Adverse Event|1|||
147301541|NCT02597036|531269699|FG000|Overall Study|Death|0|||
147301542|NCT02597036|531269700|FG001|Overall Study|Death|0|||
147301543|NCT02597036|531269701|FG002|Overall Study|Death|0|||
147301544|NCT02597036|531269702|FG003|Overall Study|Death|0|||
147301545|NCT02597036|531269703|FG004|Overall Study|Death|0|||
147301546|NCT02597036|531269704|FG005|Overall Study|Death|0|||
147301547|NCT02597036|531269705|FG006|Overall Study|Death|0|||
147301548|NCT02597036|531269706|FG007|Overall Study|Death|0|||
147301549|NCT02597036|531269707|FG008|Overall Study|Death|0|||
147301550|NCT02597036|531269708|FG009|Overall Study|Death|1|||
147301551|NCT02597036|531269709|FG010|Overall Study|Death|1|||
147301552|NCT02597036|531269710|FG011|Overall Study|Death|0|||
147301553|NCT02597036|531269699|FG000|Overall Study|Lost to Follow-up|0|||
147301554|NCT02597036|531269700|FG001|Overall Study|Lost to Follow-up|0|||
147301555|NCT02597036|531269701|FG002|Overall Study|Lost to Follow-up|0|||
147301556|NCT02597036|531269702|FG003|Overall Study|Lost to Follow-up|0|||
147301557|NCT02597036|531269703|FG004|Overall Study|Lost to Follow-up|0|||
147301558|NCT02597036|531269704|FG005|Overall Study|Lost to Follow-up|0|||
147301559|NCT02597036|531269705|FG006|Overall Study|Lost to Follow-up|0|||
147301560|NCT02597036|531269706|FG007|Overall Study|Lost to Follow-up|0|||
147301561|NCT02597036|531269707|FG008|Overall Study|Lost to Follow-up|0|||
147301562|NCT02597036|531269708|FG009|Overall Study|Lost to Follow-up|0|||
147301563|NCT02597036|531269709|FG010|Overall Study|Lost to Follow-up|1|||
147301564|NCT02597036|531269710|FG011|Overall Study|Lost to Follow-up|0|||
147301565|NCT02597036|531269699|FG000|Overall Study|Withdrawal by Subject|0|||
147301566|NCT02597036|531269700|FG001|Overall Study|Withdrawal by Subject|0|||
147301567|NCT02597036|531269701|FG002|Overall Study|Withdrawal by Subject|0|||
147301568|NCT02597036|531269702|FG003|Overall Study|Withdrawal by Subject|0|||
147301569|NCT02597036|531269703|FG004|Overall Study|Withdrawal by Subject|0|||
147301570|NCT02597036|531269704|FG005|Overall Study|Withdrawal by Subject|0|||
147301571|NCT02597036|531269705|FG006|Overall Study|Withdrawal by Subject|0|||
147301572|NCT02597036|531269706|FG007|Overall Study|Withdrawal by Subject|0|||
147301573|NCT02597036|531269707|FG008|Overall Study|Withdrawal by Subject|0|||
147301574|NCT02597036|531269708|FG009|Overall Study|Withdrawal by Subject|0|||
147301575|NCT02597036|531269709|FG010|Overall Study|Withdrawal by Subject|0|||
147301576|NCT02597036|531269710|FG011|Overall Study|Withdrawal by Subject|1|||
147301577|NCT06351371|531269713|FG000|Overall Study|Mutation Status Not Confirmed|9|||
147301578|NCT06351371|531269713|FG000|Overall Study|Ineligible|1|||
147301579|NCT06351371|531269713|FG000|Overall Study|Adverse Event|4|||
147301580|NCT06351371|531269713|FG000|Overall Study|Death|1|||
147301581|NCT06351371|531269713|FG000|Overall Study|Disease progression|14|||
147301582|NCT06351371|531269713|FG000|Overall Study|Withdrawal by Subject|3|||
147617969|NCT01982955|532416229|FG003|Overall Study|Randomized but not treated|1|||
147617970|NCT01982955|532416230|FG004|Overall Study|Randomized but not treated|0|||
147617971|NCT03493685|532417446|FG000|Overall Study|Death|4|||
147617972|NCT03493685|532417447|FG001|Overall Study|Death|3|||
147617973|NCT03493685|532417446|FG000|Overall Study|Lost to Follow-up|3|||
147617974|NCT03493685|532417447|FG001|Overall Study|Lost to Follow-up|2|||
147617975|NCT03493685|532417446|FG000|Overall Study|Physician Decision|2|||
147617976|NCT03493685|532417447|FG001|Overall Study|Physician Decision|0|||
147617977|NCT03493685|532417446|FG000|Overall Study|Withdrawal by Subject|7|||
147617978|NCT03493685|532417447|FG001|Overall Study|Withdrawal by Subject|11|||
147617979|NCT04452669|532417448|FG000|Overall Study|Death|1|||
147617980|NCT04452669|532417449|FG001|Overall Study|Death|4|||
147617981|NCT05126693|532417456|FG000|Pre-BoNT/ Pre-3DfUS|Bad 3DGA data|2|||
147617982|NCT05126693|532417457|FG001|Pre-BoNT/ Pre-3DfUS|Bad 3DGA data|0|||
147617983|NCT05126693|532417456|FG000|Pre-BoNT/ Pre-3DfUS|No 3DGA|4|||
147617984|NCT05126693|532417457|FG001|Pre-BoNT/ Pre-3DfUS|No 3DGA|0|||
147617985|NCT05126693|532417456|FG000|Pre-BoNT/ Pre-3DfUS|Insufficient matching|0|||
147617986|NCT05126693|532417457|FG001|Pre-BoNT/ Pre-3DfUS|Insufficient matching|10|||
147617987|NCT05525520|532417458|FG000|DB Treatment Period (Weeks 1-6)|Withdrawal by Subject|0|||
147617988|NCT05525520|532417459|FG001|DB Treatment Period (Weeks 1-6)|Withdrawal by Subject|2|||
147617989|NCT05525520|532417458|FG000|DB Treatment Period (Weeks 1-6)|Protocol Violation|1|||
147617990|NCT05525520|532417459|FG001|DB Treatment Period (Weeks 1-6)|Protocol Violation|1|||
147617991|NCT05878093|532417462|FG000|Overall Study|Withdrawal by Subject|3|||
147617992|NCT05878093|532417463|FG001|Overall Study|Withdrawal by Subject|1|||
147617993|NCT04100018|532417464|FG000|Pre-Treatment Period|Not Reported|0|||
147617994|NCT04100018|532417465|FG001|Pre-Treatment Period|Not Reported|4|||
147617995|NCT04100018|532417464|FG000|Pre-Treatment Period|Subject no longer meets study criteria|1|||
147617996|NCT04100018|532417465|FG001|Pre-Treatment Period|Subject no longer meets study criteria|1|||
147617997|NCT04100018|532417464|FG000|Pre-Treatment Period|Poor/Non-compliance|1|||
147617998|NCT04100018|532417465|FG001|Pre-Treatment Period|Poor/Non-compliance|0|||
147301583|NCT06351371|531269713|FG000|Overall Study|Physician Decision|3|||
147301584|NCT04359784|531269715|FG000|Overall Study|Death|2|||
147617999|NCT04100018|532417464|FG000|Pre-Treatment Period|Participant withdrew consent|2|||
147618000|NCT04100018|532417465|FG001|Pre-Treatment Period|Participant withdrew consent|0|||
147618001|NCT04100018|532417464|FG000|Pre-Treatment Period|Participant request to discontinue study treatment|0|||
147618002|NCT04100018|532417465|FG001|Pre-Treatment Period|Participant request to discontinue study treatment|1|||
147618003|NCT04100018|532417464|FG000|Treatment Period|Ongoing Treatment|1|||
147618004|NCT04100018|532417465|FG001|Treatment Period|Ongoing Treatment|0|||
147618005|NCT04100018|532417464|FG000|Treatment Period|Other Reason|26|||
147618006|NCT04100018|532417465|FG001|Treatment Period|Other Reason|37|||
147618007|NCT04100018|532417464|FG000|Treatment Period|Completed treatment as per protocol|1|||
147618008|NCT04100018|532417465|FG001|Treatment Period|Completed treatment as per protocol|2|||
147618009|NCT04100018|532417464|FG000|Treatment Period|Maximum clinical benefit|3|||
147618010|NCT04100018|532417465|FG001|Treatment Period|Maximum clinical benefit|0|||
147618011|NCT04100018|532417464|FG000|Treatment Period|Adverse event unrelated to study drug|13|||
147618012|NCT04100018|532417465|FG001|Treatment Period|Adverse event unrelated to study drug|12|||
147618013|NCT04100018|532417464|FG000|Treatment Period|Study drug toxicity|67|||
147618014|NCT04100018|532417465|FG001|Treatment Period|Study drug toxicity|28|||
147618015|NCT04100018|532417464|FG000|Treatment Period|Disease Progression|284|||
147618016|NCT04100018|532417465|FG001|Treatment Period|Disease Progression|327|||
147618017|NCT04100018|532417464|FG000|Treatment Period|Administrative reasons by sponsor|16|||
147618018|NCT04100018|532417465|FG001|Treatment Period|Administrative reasons by sponsor|30|||
147618019|NCT04100018|532417464|FG000|Treatment Period|Poor/Non-Compliance|1|||
147618020|NCT04100018|532417465|FG001|Treatment Period|Poor/Non-Compliance|0|||
147618021|NCT04100018|532417464|FG000|Treatment Period|Lost to Follow-up|2|||
147301585|NCT02390531|531269726|FG000|Overall Study|Death|0|||
147301586|NCT02390531|531269727|FG001|Overall Study|Death|2|||
147301587|NCT02390531|531269728|FG002|Overall Study|Death|0|||
147301588|NCT02390531|531269729|FG003|Overall Study|Death|1|||
147301589|NCT02390531|531269730|FG004|Overall Study|Death|0|||
147301590|NCT02390531|531269731|FG005|Overall Study|Death|0|||
147301591|NCT02390531|531269732|FG006|Overall Study|Death|0|||
147301592|NCT02390531|531269733|FG007|Overall Study|Death|1|||
147618022|NCT04100018|532417465|FG001|Treatment Period|Lost to Follow-up|2|||
147301593|NCT02390531|531269726|FG000|Overall Study|Protocol Violation|0|||
147301594|NCT02390531|531269727|FG001|Overall Study|Protocol Violation|0|||
147618023|NCT04100018|532417464|FG000|Treatment Period|Death|16|||
147301595|NCT02390531|531269728|FG002|Overall Study|Protocol Violation|0|||
147301596|NCT02390531|531269729|FG003|Overall Study|Protocol Violation|0|||
147301597|NCT02390531|531269730|FG004|Overall Study|Protocol Violation|1|||
147301598|NCT02390531|531269731|FG005|Overall Study|Protocol Violation|0|||
147618024|NCT04100018|532417465|FG001|Treatment Period|Death|11|||
147618025|NCT04100018|532417464|FG000|Treatment Period|Participant withdrew consent|10|||
147618026|NCT04100018|532417465|FG001|Treatment Period|Participant withdrew consent|10|||
147618027|NCT04100018|532417464|FG000|Treatment Period|Participant request to discontinue study treatment|33|||
147618028|NCT04100018|532417465|FG001|Treatment Period|Participant request to discontinue study treatment|32|||
147618029|NCT04100018|532417464|FG000|Treatment Period|Adverse Event|14|||
147618030|NCT04100018|532417465|FG001|Treatment Period|Adverse Event|6|||
147618031|NCT04100018|532417464|FG000|Treatment Period|Lack of Efficacy|4|||
147618032|NCT04100018|532417465|FG001|Treatment Period|Lack of Efficacy|2|||
147618033|NCT00711243|532417466|FG000|Registed and Started Treatment|Withdrawal by Subject|0|||
147618034|NCT00711243|532417467|FG001|Registed and Started Treatment|Withdrawal by Subject|0|||
147618035|NCT00711243|532417468|FG002|Registed and Started Treatment|Withdrawal by Subject|0|||
147618036|NCT00711243|532417469|FG003|Registed and Started Treatment|Withdrawal by Subject|0|||
147618037|NCT00711243|532417470|FG004|Registed and Started Treatment|Withdrawal by Subject|0|||
147618038|NCT00711243|532417471|FG005|Registed and Started Treatment|Withdrawal by Subject|1|||
147618039|NCT00711243|532417466|FG000|Reached First Response/4 Cycles|Death|0|||
147618040|NCT00711243|532417467|FG001|Reached First Response/4 Cycles|Death|0|||
147618041|NCT00711243|532417468|FG002|Reached First Response/4 Cycles|Death|0|||
147618042|NCT00711243|532417469|FG003|Reached First Response/4 Cycles|Death|0|||
147618043|NCT00711243|532417470|FG004|Reached First Response/4 Cycles|Death|0|||
147618044|NCT00711243|532417471|FG005|Reached First Response/4 Cycles|Death|2|||
147618045|NCT00711243|532417466|FG000|Reached First Response/4 Cycles|Progressive disease|0|||
147618046|NCT00711243|532417467|FG001|Reached First Response/4 Cycles|Progressive disease|0|||
147618047|NCT00711243|532417468|FG002|Reached First Response/4 Cycles|Progressive disease|0|||
147618048|NCT00711243|532417469|FG003|Reached First Response/4 Cycles|Progressive disease|1|||
147618049|NCT00711243|532417470|FG004|Reached First Response/4 Cycles|Progressive disease|0|||
147618050|NCT00711243|532417471|FG005|Reached First Response/4 Cycles|Progressive disease|0|||
147618051|NCT00711243|532417466|FG000|Treated Cycle 5 After First Response|Progressive disease|1|||
147618052|NCT00711243|532417467|FG001|Treated Cycle 5 After First Response|Progressive disease|2|||
147618053|NCT00711243|532417468|FG002|Treated Cycle 5 After First Response|Progressive disease|0|||
147618054|NCT00711243|532417469|FG003|Treated Cycle 5 After First Response|Progressive disease|0|||
147618055|NCT00711243|532417470|FG004|Treated Cycle 5 After First Response|Progressive disease|1|||
147618056|NCT00711243|532417471|FG005|Treated Cycle 5 After First Response|Progressive disease|1|||
147618057|NCT00711243|532417466|FG000|Treated Cycle 5 After First Response|Death|0|||
147618058|NCT00711243|532417467|FG001|Treated Cycle 5 After First Response|Death|0|||
147618059|NCT00711243|532417468|FG002|Treated Cycle 5 After First Response|Death|0|||
147618060|NCT00711243|532417469|FG003|Treated Cycle 5 After First Response|Death|0|||
147618061|NCT00711243|532417470|FG004|Treated Cycle 5 After First Response|Death|0|||
147618062|NCT00711243|532417471|FG005|Treated Cycle 5 After First Response|Death|2|||
147618063|NCT00711243|532417466|FG000|Treated Cycle 5 After First Response|Decline in performance status|0|||
147618064|NCT00711243|532417467|FG001|Treated Cycle 5 After First Response|Decline in performance status|0|||
147618065|NCT00711243|532417468|FG002|Treated Cycle 5 After First Response|Decline in performance status|0|||
147618066|NCT00711243|532417469|FG003|Treated Cycle 5 After First Response|Decline in performance status|0|||
147618067|NCT00711243|532417470|FG004|Treated Cycle 5 After First Response|Decline in performance status|0|||
147618068|NCT00711243|532417471|FG005|Treated Cycle 5 After First Response|Decline in performance status|1|||
147618069|NCT00711243|532417466|FG000|Follow up Every 3 Months Until Death|Lost to Follow-up|0|||
147618070|NCT00711243|532417467|FG001|Follow up Every 3 Months Until Death|Lost to Follow-up|0|||
147618071|NCT00711243|532417468|FG002|Follow up Every 3 Months Until Death|Lost to Follow-up|0|||
147618072|NCT00711243|532417469|FG003|Follow up Every 3 Months Until Death|Lost to Follow-up|0|||
147618073|NCT00711243|532417470|FG004|Follow up Every 3 Months Until Death|Lost to Follow-up|0|||
147618074|NCT00711243|532417471|FG005|Follow up Every 3 Months Until Death|Lost to Follow-up|2|||
147301599|NCT02390531|531269732|FG006|Overall Study|Protocol Violation|2|||
147301600|NCT02390531|531269733|FG007|Overall Study|Protocol Violation|0|||
147301601|NCT02618616|531269734|FG000|Overall Study|Lack of Efficacy|4|||
147301602|NCT02618616|531269735|FG001|Overall Study|Lack of Efficacy|0|||
147301603|NCT02618616|531269734|FG000|Overall Study|Pregnancy|0|||
147301604|NCT02618616|531269735|FG001|Overall Study|Pregnancy|1|||
147301605|NCT02618616|531269734|FG000|Overall Study|Adverse Event|8|||
147301606|NCT02618616|531269735|FG001|Overall Study|Adverse Event|0|||
147301607|NCT02618616|531269734|FG000|Overall Study|Failure to comply with dosing/evaluation|1|||
147301608|NCT02618616|531269735|FG001|Overall Study|Failure to comply with dosing/evaluation|0|||
147618075|NCT01962103|532417475|FG000|Phase 1|Adverse Event|4|||
147618076|NCT01962103|532417476|FG001|Phase 1|Adverse Event|0|||
147301609|NCT02618616|531269734|FG000|Overall Study|Consent withdrawn by subject|8|||
147301610|NCT02618616|531269735|FG001|Overall Study|Consent withdrawn by subject|5|||
147301611|NCT02618616|531269734|FG000|Overall Study|Lost to Follow-up|0|||
147301612|NCT02618616|531269735|FG001|Overall Study|Lost to Follow-up|1|||
147618077|NCT01962103|532417477|FG002|Phase 1|Adverse Event|2|||
147618078|NCT01962103|532417478|FG003|Phase 1|Adverse Event|1|||
147618079|NCT01962103|532417479|FG004|Phase 1|Adverse Event|2|||
147301613|NCT04225988|531269736|FG000|Overall Study|Withdrawal by Subject|2|||
147301614|NCT04225988|531269737|FG001|Overall Study|Withdrawal by Subject|0|||
147301615|NCT00284141|531271037|FG000|Overall Study|Disease Progression / Lack of efficacy|51|||
147301616|NCT00284141|531271037|FG000|Overall Study|Adverse Event|19|||
147618080|NCT01962103|532417480|FG005|Phase 1|Adverse Event|2|||
147301617|NCT00284141|531271037|FG000|Overall Study|Participant's request|9|||
147301618|NCT00284141|531271037|FG000|Overall Study|Symptomatic / Clinical Progression|11|||
147301619|NCT00284141|531271037|FG000|Overall Study|Clinical deterioration / death|2|||
147301620|NCT00284141|531271037|FG000|Overall Study|General decline|1|||
147301621|NCT00284141|531271037|FG000|Overall Study|Pneumonia|1|||
147301622|NCT00284141|531271037|FG000|Overall Study|Did not take study medication|2|||
147301623|NCT00284141|531271037|FG000|Overall Study|Ongoing treatment|2|||
147301624|NCT01160484|531271047|FG000|Overall Study|Lack of Efficacy|9|||
147301625|NCT01160484|531271047|FG000|Overall Study|Adverse Event|6|||
147301626|NCT01160484|531271047|FG000|Overall Study|Withdrawal by Subject|2|||
147301627|NCT01160484|531271047|FG000|Overall Study|inclusion/exclusion criteria failure|1|||
147301628|NCT01782742|531271048|FG000|Double-blind Treatment Phase|Adverse Event|1|||
147301629|NCT01782742|531271049|FG001|Double-blind Treatment Phase|Adverse Event|0|||
147301630|NCT00803101|531271050|FG000|Overall Study|Death / Serious Adverse Event|4|||
147301631|NCT00803101|531271051|FG001|Overall Study|Death / Serious Adverse Event|6|||
147301632|NCT00803101|531271050|FG000|Overall Study|Withdrawal by Subject|6|||
147301633|NCT00803101|531271051|FG001|Overall Study|Withdrawal by Subject|4|||
147301634|NCT00803101|531271050|FG000|Overall Study|Lost to Follow-up|2|||
147301635|NCT00803101|531271051|FG001|Overall Study|Lost to Follow-up|2|||
147301636|NCT00803101|531271050|FG000|Overall Study|Protocol Violation|1|||
147301637|NCT00803101|531271051|FG001|Overall Study|Protocol Violation|7|||
147301638|NCT00803101|531271050|FG000|Overall Study|Surgery finished outside protocol window|1|||
147301639|NCT00803101|531271051|FG001|Overall Study|Surgery finished outside protocol window|1|||
147301640|NCT00803101|531271050|FG000|Overall Study|Patient died outside SAE report period|1|||
147301641|NCT00803101|531271051|FG001|Overall Study|Patient died outside SAE report period|0|||
147301642|NCT00803101|531271050|FG000|Overall Study|Patient did not attend scheduled visit|2|||
147301643|NCT00803101|531271051|FG001|Overall Study|Patient did not attend scheduled visit|1|||
147301644|NCT00803101|531271050|FG000|Overall Study|Patient did not have surgery|1|||
147301645|NCT00803101|531271051|FG001|Overall Study|Patient did not have surgery|1|||
147301646|NCT02790073|531271054|FG000|Overall Study|Death|1|||
147301647|NCT02790073|531271054|FG000|Overall Study|Withdrawal from HD|1|||
147301648|NCT02790073|531271054|FG000|Overall Study|Withdrawal by Subject|1|||
147301649|NCT04170686|531271055|FG000|Screening|Physician Decision|12|||
147301650|NCT04170686|531271056|FG001|Screening|Physician Decision|13|||
147301651|NCT04170686|531271055|FG000|Randomization and Treatment|Lost to Follow-up|26|||
147301652|NCT04170686|531271056|FG001|Randomization and Treatment|Lost to Follow-up|15|||
147301653|NCT03328143|531271057|FG000|Overall Study|Declined|3|||
147301654|NCT03328143|531271057|FG000|Overall Study|Required increased sedation|4|||
147301655|NCT03328143|531271057|FG000|Overall Study|Couldn't smell the lavender in the OR|1|||
147301656|NCT03328143|531271057|FG000|Overall Study|Surgery cancelled|1|||
147301657|NCT02882282|531271058|FG000|Overall Study|Adverse Event|1|||
147301658|NCT02882282|531271059|FG001|Overall Study|Adverse Event|0|||
147301659|NCT02487498|531271060|FG000|Period: Period 1|Adverse Event|2|||
147301660|NCT02487498|531271061|FG001|Period: Period 1|Adverse Event|4|||
147301661|NCT02487498|531271060|FG000|Period: Period 1|Subject/guardian decision|2|||
147301662|NCT02487498|531271061|FG001|Period: Period 1|Subject/guardian decision|4|||
147301663|NCT02487498|531271060|FG000|Period: Period 1|Lost to Follow-up|0|||
147301664|NCT02487498|531271061|FG001|Period: Period 1|Lost to Follow-up|2|||
147301665|NCT02487498|531271060|FG000|Period: Period 1|Lack of Efficacy|1|||
147301666|NCT02487498|531271061|FG001|Period: Period 1|Lack of Efficacy|0|||
147301667|NCT02487498|531271060|FG000|Period: Period 1|Physician Decision|0|||
147301668|NCT02487498|531271061|FG001|Period: Period 1|Physician Decision|1|||
147301669|NCT02487498|531271060|FG000|Period: Period 1|Protocol deviation|1|||
147301670|NCT02487498|531271061|FG001|Period: Period 1|Protocol deviation|0|||
147301671|NCT02487498|531271060|FG000|Period: Washout|Subject/guardian decision|0|||
147301672|NCT02487498|531271061|FG001|Period: Washout|Subject/guardian decision|5|||
147301673|NCT02487498|531271060|FG000|Period: Washout|Lack of Efficacy|1|||
147301674|NCT02487498|531271061|FG001|Period: Washout|Lack of Efficacy|1|||
147301675|NCT02487498|531271060|FG000|Period: Washout|Physician Decision|1|||
147301676|NCT02487498|531271061|FG001|Period: Washout|Physician Decision|0|||
147618081|NCT01962103|532417481|FG006|Phase 1|Adverse Event|0|||
147618082|NCT01962103|532417482|FG007|Phase 1|Adverse Event|0|||
147301677|NCT02487498|531271060|FG000|Period: Washout|Non-compliance with study treatment|0|||
147301678|NCT02487498|531271061|FG001|Period: Washout|Non-compliance with study treatment|1|||
147301679|NCT02487498|531271060|FG000|Period: Period 2|Adverse Event|2|||
147301680|NCT02487498|531271061|FG001|Period: Period 2|Adverse Event|2|||
147301681|NCT02487498|531271060|FG000|Period: Period 2|Subject/guardian decision|2|||
147301682|NCT02487498|531271061|FG001|Period: Period 2|Subject/guardian decision|1|||
147301683|NCT02487498|531271060|FG000|Period: Period 2|Lost to Follow-up|1|||
147301684|NCT02487498|531271061|FG001|Period: Period 2|Lost to Follow-up|1|||
147301685|NCT02487498|531271060|FG000|Period: Period 2|Death|0|||
147301686|NCT02487498|531271061|FG001|Period: Period 2|Death|1|||
147301687|NCT02487498|531271060|FG000|Period: Period 2|Physician Decision|1|||
147301688|NCT02487498|531271061|FG001|Period: Period 2|Physician Decision|0|||
147618083|NCT01962103|532417483|FG008|Phase 1|Adverse Event|0|||
147618084|NCT01962103|532417475|FG000|Phase 1|Progressive Disease|8|||
147618085|NCT01962103|532417476|FG001|Phase 1|Progressive Disease|6|||
147618086|NCT01962103|532417477|FG002|Phase 1|Progressive Disease|8|||
147618087|NCT01962103|532417478|FG003|Phase 1|Progressive Disease|4|||
147618088|NCT01962103|532417479|FG004|Phase 1|Progressive Disease|5|||
147618089|NCT01962103|532417480|FG005|Phase 1|Progressive Disease|4|||
147618090|NCT01962103|532417481|FG006|Phase 1|Progressive Disease|0|||
147618091|NCT01962103|532417482|FG007|Phase 1|Progressive Disease|0|||
147618092|NCT01962103|532417483|FG008|Phase 1|Progressive Disease|0|||
147618093|NCT01962103|532417475|FG000|Phase 1|Withdrawal by Subject|0|||
147618094|NCT01962103|532417476|FG001|Phase 1|Withdrawal by Subject|0|||
147618095|NCT01962103|532417477|FG002|Phase 1|Withdrawal by Subject|0|||
147618096|NCT01962103|532417478|FG003|Phase 1|Withdrawal by Subject|2|||
147618097|NCT01962103|532417479|FG004|Phase 1|Withdrawal by Subject|0|||
147618098|NCT01962103|532417480|FG005|Phase 1|Withdrawal by Subject|0|||
147618099|NCT01962103|532417481|FG006|Phase 1|Withdrawal by Subject|0|||
147618100|NCT01962103|532417482|FG007|Phase 1|Withdrawal by Subject|0|||
147618101|NCT01962103|532417483|FG008|Phase 1|Withdrawal by Subject|0|||
147618102|NCT01962103|532417475|FG000|Phase 1|Withdrawal by Parent/Guardian|0|||
147618103|NCT01962103|532417476|FG001|Phase 1|Withdrawal by Parent/Guardian|0|||
147618104|NCT01962103|532417477|FG002|Phase 1|Withdrawal by Parent/Guardian|2|||
147618105|NCT01962103|532417478|FG003|Phase 1|Withdrawal by Parent/Guardian|1|||
147618106|NCT01962103|532417479|FG004|Phase 1|Withdrawal by Parent/Guardian|0|||
147618107|NCT01962103|532417480|FG005|Phase 1|Withdrawal by Parent/Guardian|0|||
147618108|NCT01962103|532417481|FG006|Phase 1|Withdrawal by Parent/Guardian|0|||
147618109|NCT01962103|532417482|FG007|Phase 1|Withdrawal by Parent/Guardian|0|||
147618110|NCT01962103|532417483|FG008|Phase 1|Withdrawal by Parent/Guardian|0|||
147618111|NCT01962103|532417475|FG000|Phase 1|Physician Decision|0|||
147618112|NCT01962103|532417476|FG001|Phase 1|Physician Decision|0|||
147618113|NCT01962103|532417477|FG002|Phase 1|Physician Decision|0|||
147618114|NCT01962103|532417478|FG003|Phase 1|Physician Decision|1|||
147618115|NCT01962103|532417479|FG004|Phase 1|Physician Decision|0|||
147618116|NCT01962103|532417480|FG005|Phase 1|Physician Decision|0|||
147618117|NCT01962103|532417481|FG006|Phase 1|Physician Decision|0|||
147618118|NCT01962103|532417482|FG007|Phase 1|Physician Decision|0|||
147618119|NCT01962103|532417483|FG008|Phase 1|Physician Decision|0|||
147618120|NCT01962103|532417475|FG000|Phase 1|Symptomatic Deterioration|3|||
147618121|NCT01962103|532417476|FG001|Phase 1|Symptomatic Deterioration|2|||
147618122|NCT01962103|532417477|FG002|Phase 1|Symptomatic Deterioration|2|||
147618123|NCT01962103|532417478|FG003|Phase 1|Symptomatic Deterioration|2|||
147618124|NCT01962103|532417479|FG004|Phase 1|Symptomatic Deterioration|1|||
147618125|NCT01962103|532417480|FG005|Phase 1|Symptomatic Deterioration|1|||
147618126|NCT01962103|532417481|FG006|Phase 1|Symptomatic Deterioration|0|||
147618127|NCT01962103|532417482|FG007|Phase 1|Symptomatic Deterioration|0|||
147618128|NCT01962103|532417483|FG008|Phase 1|Symptomatic Deterioration|0|||
147618129|NCT01962103|532417475|FG000|Phase 1|Miscellaneous|1|||
147618130|NCT01962103|532417476|FG001|Phase 1|Miscellaneous|0|||
147618131|NCT01962103|532417477|FG002|Phase 1|Miscellaneous|0|||
147618132|NCT01962103|532417478|FG003|Phase 1|Miscellaneous|0|||
147618133|NCT01962103|532417479|FG004|Phase 1|Miscellaneous|0|||
147618134|NCT01962103|532417480|FG005|Phase 1|Miscellaneous|0|||
147618135|NCT01962103|532417481|FG006|Phase 1|Miscellaneous|0|||
147618136|NCT01962103|532417482|FG007|Phase 1|Miscellaneous|0|||
147618137|NCT01962103|532417483|FG008|Phase 1|Miscellaneous|0|||
147618138|NCT01962103|532417475|FG000|Phase 2|Adverse Event|0|||
147618139|NCT01962103|532417476|FG001|Phase 2|Adverse Event|0|||
147618140|NCT01962103|532417477|FG002|Phase 2|Adverse Event|0|||
147618141|NCT01962103|532417478|FG003|Phase 2|Adverse Event|0|||
147618142|NCT01962103|532417479|FG004|Phase 2|Adverse Event|0|||
147618143|NCT01962103|532417480|FG005|Phase 2|Adverse Event|0|||
147618144|NCT01962103|532417481|FG006|Phase 2|Adverse Event|1|||
147618145|NCT01962103|532417482|FG007|Phase 2|Adverse Event|0|||
147618146|NCT01962103|532417483|FG008|Phase 2|Adverse Event|3|||
147618147|NCT01962103|532417475|FG000|Phase 2|Progressive Disease|0|||
147618148|NCT01962103|532417476|FG001|Phase 2|Progressive Disease|0|||
147618149|NCT01962103|532417477|FG002|Phase 2|Progressive Disease|0|||
147618150|NCT01962103|532417478|FG003|Phase 2|Progressive Disease|0|||
147618151|NCT01962103|532417479|FG004|Phase 2|Progressive Disease|0|||
147618152|NCT01962103|532417480|FG005|Phase 2|Progressive Disease|0|||
147618153|NCT01962103|532417481|FG006|Phase 2|Progressive Disease|11|||
147618154|NCT01962103|532417482|FG007|Phase 2|Progressive Disease|12|||
147618155|NCT01962103|532417483|FG008|Phase 2|Progressive Disease|11|||
147618156|NCT01962103|532417475|FG000|Phase 2|Symptomatic Deterioration|0|||
147618157|NCT01962103|532417476|FG001|Phase 2|Symptomatic Deterioration|0|||
147618158|NCT01962103|532417477|FG002|Phase 2|Symptomatic Deterioration|0|||
147618159|NCT01962103|532417478|FG003|Phase 2|Symptomatic Deterioration|0|||
147618160|NCT01962103|532417479|FG004|Phase 2|Symptomatic Deterioration|0|||
147618161|NCT01962103|532417480|FG005|Phase 2|Symptomatic Deterioration|0|||
147618162|NCT01962103|532417481|FG006|Phase 2|Symptomatic Deterioration|2|||
147618163|NCT01962103|532417482|FG007|Phase 2|Symptomatic Deterioration|2|||
147618164|NCT01962103|532417483|FG008|Phase 2|Symptomatic Deterioration|0|||
147618165|NCT01321749|532417484|FG000|Overall Study|Lost to Follow-up|4|||
147618166|NCT01321749|532417485|FG001|Overall Study|Lost to Follow-up|11|||
147410392|NCT00534495|531666381|FG002|Long Term Ext. Phase Week 24-month 21|non compliance|2|||
147410393|NCT02807272|531666386|FG000|Overall Study|Death|9|||
147410394|NCT02807272|531666387|FG001|Overall Study|Death|5|||
147410395|NCT02807272|531666388|FG002|Overall Study|Death|2|||
147410396|NCT02807272|531666389|FG003|Overall Study|Death|0|||
147410397|NCT02807272|531666390|FG004|Overall Study|Death|1|||
147410398|NCT02807272|531666386|FG000|Overall Study|Lost to Follow-up|1|||
147618167|NCT01321749|532417484|FG000|Overall Study|Protocol Violation|4|||
147618168|NCT01321749|532417485|FG001|Overall Study|Protocol Violation|7|||
147618169|NCT01321749|532417484|FG000|Overall Study|Withdrawal by Subject|5|||
147618170|NCT01321749|532417485|FG001|Overall Study|Withdrawal by Subject|4|||
147618171|NCT04179838|532417489|FG000|First Intervention (1 Day)|Withdrawal by Subject|0|||
147618172|NCT04179838|532417490|FG001|First Intervention (1 Day)|Withdrawal by Subject|3|||
147618173|NCT04179838|532417489|FG000|Second Intervention (1 Day)|Protocol Violation|0|||
147618174|NCT04179838|532417490|FG001|Second Intervention (1 Day)|Protocol Violation|1|||
147618175|NCT01495000|532417495|FG000|Overall Study|Lost to Follow-up|2|||
147618176|NCT01495000|532417496|FG001|Overall Study|Lost to Follow-up|2|||
147618177|NCT01495000|532417495|FG000|Overall Study|Protocol Violation|1|||
147618178|NCT01495000|532417496|FG001|Overall Study|Protocol Violation|0|||
147618179|NCT01495000|532417495|FG000|Overall Study|Withdrawal by Subject|10|||
147618180|NCT01495000|532417496|FG001|Overall Study|Withdrawal by Subject|10|||
147618181|NCT03347110|532417507|FG000|Overall Study|Other (Participant is incarcerated)|1|||
147618182|NCT03347110|532417507|FG000|Overall Study|Withdrawal by Subject|9|||
147618183|NCT03347110|532417507|FG000|Overall Study|Lost to Follow-up|1|||
147618184|NCT03347110|532417507|FG000|Overall Study|Lack of Efficacy|2|||
147618185|NCT03347110|532417507|FG000|Overall Study|Adverse Event, non-fatal|9|||
147618186|NCT00811733|532417509|FG000|Overall Study|Investigator Discretion|10|||
147618187|NCT00811733|532417510|FG001|Overall Study|Investigator Discretion|8|||
147618188|NCT00811733|532417509|FG000|Overall Study|Withdrawal by Subject|1|||
147618189|NCT00811733|532417510|FG001|Overall Study|Withdrawal by Subject|2|||
147618190|NCT00793871|532417511|FG000|Overall Study|Death|50|||
147618191|NCT00793871|532417511|FG000|Overall Study|Lost to Follow-up|3|||
147618192|NCT00793871|532417511|FG000|Overall Study|Study terminated by the Sponsor|7|||
147618193|NCT02500589|532417512|FG000|Overall Study|Withdrawal by Subject|11|||
147618194|NCT02500589|532417513|FG001|Overall Study|Withdrawal by Subject|14|||
147618195|NCT02500589|532417512|FG000|Overall Study|Lost to Follow-up|10|||
147618196|NCT02500589|532417513|FG001|Overall Study|Lost to Follow-up|12|||
147618197|NCT02500589|532417512|FG000|Overall Study|Excluded post rand: cognitive impairment|0|||
147618198|NCT02500589|532417513|FG001|Overall Study|Excluded post rand: cognitive impairment|1|||
147618199|NCT02500589|532417512|FG000|Overall Study|Death|7|||
147618200|NCT02500589|532417513|FG001|Overall Study|Death|5|||
147618201|NCT00262028|532417516|FG000|Overall Study|Withdrawal by Subject|6|||
147618202|NCT00262028|532417517|FG001|Overall Study|Withdrawal by Subject|3|||
147618203|NCT00262028|532417518|FG002|Overall Study|Withdrawal by Subject|6|||
147618204|NCT00262028|532417519|FG003|Overall Study|Withdrawal by Subject|5|||
147618205|NCT00262028|532417520|FG004|Overall Study|Withdrawal by Subject|2|||
147618206|NCT00262028|532417521|FG005|Overall Study|Withdrawal by Subject|3|||
147618207|NCT00262028|532417522|FG006|Overall Study|Withdrawal by Subject|5|||
147618208|NCT00262028|532417523|FG007|Overall Study|Withdrawal by Subject|7|||
147618209|NCT00262028|532417524|FG008|Overall Study|Withdrawal by Subject|2|||
147618210|NCT00262028|532417516|FG000|Overall Study|Lost to Follow-up|7|||
147618211|NCT00262028|532417517|FG001|Overall Study|Lost to Follow-up|7|||
147618212|NCT00262028|532417518|FG002|Overall Study|Lost to Follow-up|5|||
147618213|NCT00262028|532417519|FG003|Overall Study|Lost to Follow-up|5|||
147618214|NCT00262028|532417520|FG004|Overall Study|Lost to Follow-up|4|||
147618215|NCT00262028|532417521|FG005|Overall Study|Lost to Follow-up|3|||
147618216|NCT00262028|532417522|FG006|Overall Study|Lost to Follow-up|3|||
147618217|NCT00262028|532417523|FG007|Overall Study|Lost to Follow-up|5|||
147618218|NCT00262028|532417524|FG008|Overall Study|Lost to Follow-up|6|||
147618219|NCT00262028|532417516|FG000|Overall Study|Administrative Reason|11|||
147618220|NCT00262028|532417517|FG001|Overall Study|Administrative Reason|14|||
147618221|NCT00262028|532417518|FG002|Overall Study|Administrative Reason|9|||
147618222|NCT00262028|532417519|FG003|Overall Study|Administrative Reason|12|||
147618223|NCT00262028|532417520|FG004|Overall Study|Administrative Reason|6|||
147618224|NCT00262028|532417521|FG005|Overall Study|Administrative Reason|7|||
147618225|NCT00262028|532417522|FG006|Overall Study|Administrative Reason|4|||
147618226|NCT00262028|532417523|FG007|Overall Study|Administrative Reason|6|||
147618227|NCT00262028|532417524|FG008|Overall Study|Administrative Reason|10|||
147618228|NCT00262028|532417516|FG000|Overall Study|Protocol Violation|0|||
147618229|NCT00262028|532417517|FG001|Overall Study|Protocol Violation|0|||
147618230|NCT00262028|532417518|FG002|Overall Study|Protocol Violation|0|||
147618231|NCT00262028|532417519|FG003|Overall Study|Protocol Violation|1|||
147618232|NCT00262028|532417520|FG004|Overall Study|Protocol Violation|0|||
147618233|NCT00262028|532417521|FG005|Overall Study|Protocol Violation|0|||
147618234|NCT00262028|532417522|FG006|Overall Study|Protocol Violation|0|||
147618235|NCT00262028|532417523|FG007|Overall Study|Protocol Violation|0|||
147618236|NCT00262028|532417524|FG008|Overall Study|Protocol Violation|0|||
147618237|NCT00262028|532417516|FG000|Overall Study|Unable to classify|0|||
147618238|NCT00262028|532417517|FG001|Overall Study|Unable to classify|3|||
147618239|NCT00262028|532417518|FG002|Overall Study|Unable to classify|0|||
147618240|NCT00262028|532417519|FG003|Overall Study|Unable to classify|0|||
147618241|NCT00262028|532417520|FG004|Overall Study|Unable to classify|0|||
147618242|NCT00262028|532417521|FG005|Overall Study|Unable to classify|0|||
147618243|NCT00262028|532417522|FG006|Overall Study|Unable to classify|0|||
147618244|NCT00262028|532417523|FG007|Overall Study|Unable to classify|0|||
147618245|NCT00262028|532417524|FG008|Overall Study|Unable to classify|1|||
147618246|NCT00613171|532417525|FG000|Overall Study|Adverse Event|7|||
147618247|NCT00613171|532417525|FG000|Overall Study|Withdrawal by Subject|3|||
147618248|NCT00613171|532417525|FG000|Overall Study|Reason not Specified|4|||
147618249|NCT01197911|532417526|FG000|Overall Study|Adverse Event|0|||
147618250|NCT01197911|532417527|FG001|Overall Study|Adverse Event|0|||
147618251|NCT01197911|532417528|FG002|Overall Study|Adverse Event|1|||
147618252|NCT01526057|532417531|FG000|Overall Study|Withdrawal by Subject|3|||
147618253|NCT01526057|532417532|FG001|Overall Study|Withdrawal by Subject|2|||
147618254|NCT01526057|532417533|FG002|Overall Study|Withdrawal by Subject|2|||
147618255|NCT01526057|532417531|FG000|Overall Study|Adverse Event|3|||
147301689|NCT00676130|531271062|FG000|Overall Study|Lost to Follow-up|0|||
147301690|NCT00676130|531271063|FG001|Overall Study|Lost to Follow-up|1|||
147301691|NCT00676130|531271062|FG000|Overall Study|Found ineligible|3|||
147618256|NCT01526057|532417532|FG001|Overall Study|Adverse Event|1|||
147618257|NCT01526057|532417533|FG002|Overall Study|Adverse Event|1|||
147618258|NCT01526057|532417531|FG000|Overall Study|Death|1|||
147618259|NCT01526057|532417532|FG001|Overall Study|Death|0|||
147410399|NCT02807272|531666387|FG001|Overall Study|Lost to Follow-up|0|||
147301692|NCT00676130|531271063|FG001|Overall Study|Found ineligible|2|||
147301693|NCT00676130|531271062|FG000|Overall Study|Withdrawal by Subject|0|||
147301694|NCT00676130|531271063|FG001|Overall Study|Withdrawal by Subject|1|||
147301695|NCT00331344|531271068|FG000|Phase I|Adverse Event|0|||
147301696|NCT00331344|531271069|FG001|Phase I|Adverse Event|0|||
147301697|NCT00331344|531271070|FG002|Phase I|Adverse Event|0|||
147301698|NCT00331344|531271071|FG003|Phase I|Adverse Event|1|||
147301699|NCT00331344|531271072|FG004|Phase I|Adverse Event|2|||
147301700|NCT00331344|531271073|FG005|Phase I|Adverse Event|2|||
147301701|NCT00331344|531271074|FG006|Phase I|Adverse Event|0|||
147301702|NCT00331344|531271075|FG007|Phase I|Adverse Event|1|||
147301703|NCT00331344|531271076|FG008|Phase I|Adverse Event|0|||
147301704|NCT00331344|531271068|FG000|Phase II|Death|0|||
147301705|NCT00331344|531271069|FG001|Phase II|Death|0|||
147301706|NCT00331344|531271070|FG002|Phase II|Death|0|||
147301707|NCT00331344|531271071|FG003|Phase II|Death|0|||
147301708|NCT00331344|531271072|FG004|Phase II|Death|0|||
147301709|NCT00331344|531271073|FG005|Phase II|Death|0|||
147301710|NCT00331344|531271074|FG006|Phase II|Death|0|||
147301711|NCT00331344|531271075|FG007|Phase II|Death|0|||
147301712|NCT00331344|531271076|FG008|Phase II|Death|4|||
147301713|NCT04538144|531271077|FG000|Washout (1 Week)|Withdrawal by Subject|0|||
147301714|NCT04538144|531271078|FG001|Washout (1 Week)|Withdrawal by Subject|0|||
147301715|NCT04538144|531271079|FG002|Washout (1 Week)|Withdrawal by Subject|0|||
147301716|NCT04538144|531271080|FG003|Washout (1 Week)|Withdrawal by Subject|1|||
147301717|NCT01181726|531271083|FG000|First Intervention|Adverse Event|1|||
147301718|NCT01181726|531271084|FG001|First Intervention|Adverse Event|0|||
147301719|NCT02696564|531271088|FG000|Overall Study|Death|1|||
147301720|NCT02696564|531271089|FG001|Overall Study|Death|2|||
147301721|NCT02696564|531271088|FG000|Overall Study|Withdrawal by Subject|3|||
147301722|NCT02696564|531271089|FG001|Overall Study|Withdrawal by Subject|2|||
147301723|NCT02696564|531271088|FG000|Overall Study|Lost to Follow-up|3|||
147301724|NCT02696564|531271089|FG001|Overall Study|Lost to Follow-up|3|||
147301725|NCT02696564|531271088|FG000|Overall Study|Missed final HRCT scan due to coronavirus disease pandemic|3|||
147301726|NCT02696564|531271089|FG001|Overall Study|Missed final HRCT scan due to coronavirus disease pandemic|1|||
147301727|NCT02696564|531271088|FG000|Overall Study|Baseline and final high-resolution computed tomography (HRCT) scans conducted on different scanners|2|||
147301728|NCT02696564|531271089|FG001|Overall Study|Baseline and final high-resolution computed tomography (HRCT) scans conducted on different scanners|2|||
147301729|NCT02696564|531271088|FG000|Overall Study|High-resolution computed tomography (HRCT) scan conducted on unknown scanner|1|||
147301730|NCT02696564|531271089|FG001|Overall Study|High-resolution computed tomography (HRCT) scan conducted on unknown scanner|1|||
147301731|NCT02696564|531271088|FG000|Overall Study|Participant diagnosed with lung cancer|1|||
147301732|NCT02696564|531271089|FG001|Overall Study|Participant diagnosed with lung cancer|0|||
147301733|NCT02696564|531271088|FG000|Overall Study|Incorrect kernel used in high-resolution computed tomography (HRCT) scan|0|||
147301734|NCT02696564|531271089|FG001|Overall Study|Incorrect kernel used in high-resolution computed tomography (HRCT) scan|2|||
147301735|NCT03633929|531271090|FG000|Overall Study|Lost to Follow-up|1|||
147301736|NCT03633929|531271090|FG000|Overall Study|Did not login to software. Did not participate|3|||
147618260|NCT01526057|532417533|FG002|Overall Study|Death|0|||
147618261|NCT01526057|532417531|FG000|Overall Study|Lost to Follow-up|1|||
147618262|NCT01526057|532417532|FG001|Overall Study|Lost to Follow-up|0|||
147618263|NCT01526057|532417533|FG002|Overall Study|Lost to Follow-up|1|||
147618264|NCT01526057|532417531|FG000|Overall Study|Other|1|||
147301737|NCT01520402|531271091|FG000|Overall Study|Withdrawal by Subject|2|||
147301738|NCT01520402|531271091|FG000|Overall Study|Physician Decision|3|||
147301739|NCT01722162|531271092|FG000|Overall Study|Withdrawal by Subject|1|||
147301740|NCT01722162|531271093|FG001|Overall Study|Withdrawal by Subject|1|||
147301741|NCT01722162|531271092|FG000|Overall Study|Found ineligible|1|||
147301742|NCT01722162|531271093|FG001|Overall Study|Found ineligible|0|||
147301743|NCT01722162|531271092|FG000|Overall Study|Unrelated to study adverse event|2|||
147301744|NCT01722162|531271093|FG001|Overall Study|Unrelated to study adverse event|2|||
147301745|NCT01722162|531271092|FG000|Overall Study|Adverse Event|1|||
147301746|NCT01722162|531271093|FG001|Overall Study|Adverse Event|1|||
147301747|NCT01722162|531271092|FG000|Overall Study|Insurance denial post enrollment|0|||
147301748|NCT01722162|531271093|FG001|Overall Study|Insurance denial post enrollment|1|||
147301749|NCT01722162|531271092|FG000|Overall Study|Noncompliance|0|||
147301750|NCT01722162|531271093|FG001|Overall Study|Noncompliance|1|||
147301751|NCT02487810|531271094|FG000|Overall Study|Withdrawal by Subject|1|||
147301752|NCT02487810|531271095|FG001|Overall Study|Withdrawal by Subject|0|||
147301753|NCT00077064|531271098|FG000|Overall Study|Adverse Event|0|||
147301754|NCT00077064|531271099|FG001|Overall Study|Adverse Event|4|||
147301755|NCT00077064|531271098|FG000|Overall Study|Patient refusal|0|||
147301756|NCT00077064|531271099|FG001|Overall Study|Patient refusal|2|||
147301757|NCT01281202|531271103|FG000|Overall Study|Adverse Event|2|||
147301758|NCT01281202|531271104|FG001|Overall Study|Adverse Event|0|||
147301759|NCT01281202|531271103|FG000|Overall Study|Withdrawal by Subject|2|||
147301760|NCT01281202|531271104|FG001|Overall Study|Withdrawal by Subject|2|||
147301761|NCT01281202|531271103|FG000|Overall Study|Protocol Violation|11|||
147301762|NCT01281202|531271104|FG001|Overall Study|Protocol Violation|10|||
147301763|NCT01281202|531271103|FG000|Overall Study|Administrative|2|||
147301764|NCT01281202|531271104|FG001|Overall Study|Administrative|8|||
147301765|NCT01281202|531271103|FG000|Overall Study|Lost to Follow-up|11|||
147301766|NCT01281202|531271104|FG001|Overall Study|Lost to Follow-up|13|||
147301767|NCT01281202|531271103|FG000|Overall Study|Incarceration|0|||
147301768|NCT01281202|531271104|FG001|Overall Study|Incarceration|3|||
147301769|NCT03759834|531271105|FG000|Overall Study|Withdrawal by Subject|1|||
147301770|NCT03217747|531271108|FG000|Overall Study|Adverse Event|0|||
147301771|NCT03217747|531271109|FG001|Overall Study|Adverse Event|1|||
147301772|NCT03217747|531271110|FG002|Overall Study|Adverse Event|0|||
147301773|NCT03217747|531271111|FG003|Overall Study|Adverse Event|0|||
147301774|NCT03217747|531271112|FG004|Overall Study|Adverse Event|0|||
147301775|NCT03217747|531271113|FG005|Overall Study|Adverse Event|0|||
147301776|NCT03217747|531271114|FG006|Overall Study|Adverse Event|0|||
147301777|NCT03217747|531271115|FG007|Overall Study|Adverse Event|0|||
147301778|NCT03217747|531271116|FG008|Overall Study|Adverse Event|0|||
147301779|NCT03217747|531271117|FG009|Overall Study|Adverse Event|0|||
147301780|NCT03217747|531271118|FG010|Overall Study|Adverse Event|0|||
147301781|NCT03217747|531271119|FG011|Overall Study|Adverse Event|0|||
147301782|NCT03217747|531271120|FG012|Overall Study|Adverse Event|1|||
147301783|NCT03217747|531271121|FG013|Overall Study|Adverse Event|1|||
147301784|NCT03217747|531271108|FG000|Overall Study|Death|0|||
147301785|NCT03217747|531271109|FG001|Overall Study|Death|0|||
147301786|NCT03217747|531271110|FG002|Overall Study|Death|0|||
147301787|NCT03217747|531271111|FG003|Overall Study|Death|0|||
147301788|NCT03217747|531271112|FG004|Overall Study|Death|0|||
147301789|NCT03217747|531271113|FG005|Overall Study|Death|0|||
147301790|NCT03217747|531271114|FG006|Overall Study|Death|0|||
147301791|NCT03217747|531271115|FG007|Overall Study|Death|0|||
147301792|NCT03217747|531271116|FG008|Overall Study|Death|1|||
147301793|NCT03217747|531271117|FG009|Overall Study|Death|0|||
147301794|NCT03217747|531271118|FG010|Overall Study|Death|0|||
147301795|NCT03217747|531271119|FG011|Overall Study|Death|0|||
147301796|NCT03217747|531271120|FG012|Overall Study|Death|0|||
147301797|NCT03217747|531271121|FG013|Overall Study|Death|0|||
147301798|NCT03217747|531271108|FG000|Overall Study|Lack of Efficacy|12|||
147301799|NCT03217747|531271109|FG001|Overall Study|Lack of Efficacy|6|||
147301800|NCT03217747|531271110|FG002|Overall Study|Lack of Efficacy|15|||
147301801|NCT03217747|531271111|FG003|Overall Study|Lack of Efficacy|11|||
147301802|NCT03217747|531271112|FG004|Overall Study|Lack of Efficacy|3|||
147301803|NCT03217747|531271113|FG005|Overall Study|Lack of Efficacy|14|||
147301804|NCT03217747|531271114|FG006|Overall Study|Lack of Efficacy|10|||
147301805|NCT03217747|531271115|FG007|Overall Study|Lack of Efficacy|4|||
147301806|NCT03217747|531271116|FG008|Overall Study|Lack of Efficacy|2|||
147301807|NCT03217747|531271117|FG009|Overall Study|Lack of Efficacy|7|||
147301808|NCT03217747|531271118|FG010|Overall Study|Lack of Efficacy|3|||
147301809|NCT03217747|531271119|FG011|Overall Study|Lack of Efficacy|1|||
147301810|NCT03217747|531271120|FG012|Overall Study|Lack of Efficacy|3|||
147301811|NCT03217747|531271121|FG013|Overall Study|Lack of Efficacy|1|||
147301812|NCT03217747|531271108|FG000|Overall Study|Withdrawal by Subject|2|||
147301813|NCT03217747|531271109|FG001|Overall Study|Withdrawal by Subject|1|||
147301814|NCT03217747|531271110|FG002|Overall Study|Withdrawal by Subject|1|||
147301815|NCT03217747|531271111|FG003|Overall Study|Withdrawal by Subject|1|||
147301816|NCT03217747|531271112|FG004|Overall Study|Withdrawal by Subject|1|||
147301817|NCT03217747|531271113|FG005|Overall Study|Withdrawal by Subject|2|||
147301818|NCT03217747|531271114|FG006|Overall Study|Withdrawal by Subject|1|||
147301819|NCT03217747|531271115|FG007|Overall Study|Withdrawal by Subject|0|||
147301820|NCT03217747|531271116|FG008|Overall Study|Withdrawal by Subject|0|||
147301821|NCT03217747|531271117|FG009|Overall Study|Withdrawal by Subject|0|||
147301822|NCT03217747|531271118|FG010|Overall Study|Withdrawal by Subject|0|||
147301823|NCT03217747|531271119|FG011|Overall Study|Withdrawal by Subject|1|||
147301824|NCT03217747|531271120|FG012|Overall Study|Withdrawal by Subject|0|||
147301825|NCT03217747|531271121|FG013|Overall Study|Withdrawal by Subject|1|||
147301826|NCT03217747|531271108|FG000|Overall Study|Toxicity and progression|1|||
147301827|NCT03217747|531271109|FG001|Overall Study|Toxicity and progression|0|||
147301828|NCT03217747|531271110|FG002|Overall Study|Toxicity and progression|0|||
147301829|NCT03217747|531271111|FG003|Overall Study|Toxicity and progression|0|||
147301830|NCT03217747|531271112|FG004|Overall Study|Toxicity and progression|0|||
147301831|NCT03217747|531271113|FG005|Overall Study|Toxicity and progression|0|||
147301832|NCT03217747|531271114|FG006|Overall Study|Toxicity and progression|0|||
147301833|NCT03217747|531271115|FG007|Overall Study|Toxicity and progression|0|||
147301834|NCT03217747|531271116|FG008|Overall Study|Toxicity and progression|0|||
147301835|NCT03217747|531271117|FG009|Overall Study|Toxicity and progression|0|||
147301836|NCT03217747|531271118|FG010|Overall Study|Toxicity and progression|0|||
147301837|NCT03217747|531271119|FG011|Overall Study|Toxicity and progression|0|||
147301838|NCT03217747|531271120|FG012|Overall Study|Toxicity and progression|0|||
147301839|NCT03217747|531271121|FG013|Overall Study|Toxicity and progression|0|||
147301840|NCT03217747|531271108|FG000|Overall Study|Removal of sole target lesion|1|||
147301841|NCT03217747|531271109|FG001|Overall Study|Removal of sole target lesion|0|||
147301842|NCT03217747|531271110|FG002|Overall Study|Removal of sole target lesion|0|||
147301843|NCT03217747|531271111|FG003|Overall Study|Removal of sole target lesion|0|||
147301844|NCT03217747|531271112|FG004|Overall Study|Removal of sole target lesion|0|||
147301845|NCT03217747|531271113|FG005|Overall Study|Removal of sole target lesion|0|||
147301846|NCT03217747|531271114|FG006|Overall Study|Removal of sole target lesion|0|||
147301847|NCT03217747|531271115|FG007|Overall Study|Removal of sole target lesion|0|||
147301848|NCT03217747|531271116|FG008|Overall Study|Removal of sole target lesion|0|||
147301849|NCT03217747|531271117|FG009|Overall Study|Removal of sole target lesion|0|||
147301850|NCT03217747|531271118|FG010|Overall Study|Removal of sole target lesion|0|||
147301851|NCT03217747|531271119|FG011|Overall Study|Removal of sole target lesion|0|||
147618265|NCT01526057|532417532|FG001|Overall Study|Other|0|||
147618266|NCT01526057|532417533|FG002|Overall Study|Other|1|||
147618267|NCT01526057|532417531|FG000|Overall Study|Protocol Violation|0|||
147618268|NCT01526057|532417532|FG001|Overall Study|Protocol Violation|0|||
147618269|NCT01526057|532417533|FG002|Overall Study|Protocol Violation|1|||
147618270|NCT02553772|532417538|FG000|Overall Study|Adverse Event|2|||
147618271|NCT02553772|532417539|FG001|Overall Study|Adverse Event|3|||
147618272|NCT02553772|532417538|FG000|Overall Study|Lost to Follow-up|2|||
147618273|NCT02553772|532417539|FG001|Overall Study|Lost to Follow-up|1|||
147618274|NCT02553772|532417538|FG000|Overall Study|Withdrawal of Consent|1|||
147618275|NCT02553772|532417539|FG001|Overall Study|Withdrawal of Consent|1|||
147301852|NCT03217747|531271120|FG012|Overall Study|Removal of sole target lesion|0|||
147301853|NCT03217747|531271121|FG013|Overall Study|Removal of sole target lesion|0|||
147301854|NCT03217747|531271108|FG000|Overall Study|Stroke|0|||
147301855|NCT03217747|531271109|FG001|Overall Study|Stroke|0|||
147301856|NCT03217747|531271110|FG002|Overall Study|Stroke|0|||
147301857|NCT03217747|531271111|FG003|Overall Study|Stroke|0|||
147301858|NCT03217747|531271112|FG004|Overall Study|Stroke|0|||
147301859|NCT03217747|531271113|FG005|Overall Study|Stroke|1|||
147301860|NCT03217747|531271114|FG006|Overall Study|Stroke|0|||
147301861|NCT03217747|531271115|FG007|Overall Study|Stroke|0|||
147301862|NCT03217747|531271116|FG008|Overall Study|Stroke|0|||
147301863|NCT03217747|531271117|FG009|Overall Study|Stroke|0|||
147301864|NCT03217747|531271118|FG010|Overall Study|Stroke|0|||
147301865|NCT03217747|531271119|FG011|Overall Study|Stroke|1|||
147301866|NCT03217747|531271120|FG012|Overall Study|Stroke|0|||
147301867|NCT03217747|531271121|FG013|Overall Study|Stroke|0|||
147301868|NCT03996291|531271122|FG000|Part A (Double-blind Period):39 Weeks|Other|1|||
147301869|NCT03996291|531271123|FG001|Part A (Double-blind Period):39 Weeks|Other|0|||
147301870|NCT03996291|531271124|FG002|Part A (Double-blind Period):39 Weeks|Other|0|||
147301871|NCT03996291|531271125|FG003|Part A (Double-blind Period):39 Weeks|Other|0|||
147301872|NCT03996291|531271126|FG004|Part A (Double-blind Period):39 Weeks|Other|0|||
147301873|NCT03996291|531271127|FG005|Part A (Double-blind Period):39 Weeks|Other|0|||
147301874|NCT03996291|531271128|FG006|Part A (Double-blind Period):39 Weeks|Other|0|||
147301875|NCT03996291|531271129|FG007|Part A (Double-blind Period):39 Weeks|Other|0|||
147301876|NCT03996291|531271122|FG000|Part B (Open-label Period):222 Weeks|Poor compliance to protocol|0|||
147301877|NCT03996291|531271123|FG001|Part B (Open-label Period):222 Weeks|Poor compliance to protocol|0|||
147301878|NCT03996291|531271124|FG002|Part B (Open-label Period):222 Weeks|Poor compliance to protocol|0|||
147301879|NCT03996291|531271125|FG003|Part B (Open-label Period):222 Weeks|Poor compliance to protocol|0|||
147301880|NCT03996291|531271126|FG004|Part B (Open-label Period):222 Weeks|Poor compliance to protocol|0|||
147410400|NCT02807272|531666388|FG002|Overall Study|Lost to Follow-up|0|||
147301881|NCT03996291|531271127|FG005|Part B (Open-label Period):222 Weeks|Poor compliance to protocol|1|||
147301882|NCT03996291|531271128|FG006|Part B (Open-label Period):222 Weeks|Poor compliance to protocol|1|||
147301883|NCT03996291|531271129|FG007|Part B (Open-label Period):222 Weeks|Poor compliance to protocol|0|||
147301884|NCT03996291|531271122|FG000|Part B (Open-label Period):222 Weeks|Adverse Event|0|||
147301885|NCT03996291|531271123|FG001|Part B (Open-label Period):222 Weeks|Adverse Event|0|||
147301886|NCT03996291|531271124|FG002|Part B (Open-label Period):222 Weeks|Adverse Event|0|||
147301887|NCT03996291|531271125|FG003|Part B (Open-label Period):222 Weeks|Adverse Event|0|||
147301888|NCT03996291|531271126|FG004|Part B (Open-label Period):222 Weeks|Adverse Event|1|||
147301889|NCT03996291|531271127|FG005|Part B (Open-label Period):222 Weeks|Adverse Event|0|||
147301890|NCT03996291|531271128|FG006|Part B (Open-label Period):222 Weeks|Adverse Event|1|||
147301891|NCT03996291|531271129|FG007|Part B (Open-label Period):222 Weeks|Adverse Event|0|||
147301892|NCT03996291|531271122|FG000|Part B (Open-label Period):222 Weeks|Other|0|||
147301893|NCT03996291|531271123|FG001|Part B (Open-label Period):222 Weeks|Other|0|||
147301894|NCT03996291|531271124|FG002|Part B (Open-label Period):222 Weeks|Other|0|||
147301895|NCT03996291|531271125|FG003|Part B (Open-label Period):222 Weeks|Other|0|||
147301896|NCT03996291|531271126|FG004|Part B (Open-label Period):222 Weeks|Other|8|||
147301897|NCT03996291|531271127|FG005|Part B (Open-label Period):222 Weeks|Other|7|||
147301898|NCT03996291|531271128|FG006|Part B (Open-label Period):222 Weeks|Other|10|||
147301899|NCT03996291|531271129|FG007|Part B (Open-label Period):222 Weeks|Other|5|||
147301900|NCT03996291|531271122|FG000|Part B (Open-label Period):222 Weeks|Withdrawal by Subject|0|||
147301901|NCT03996291|531271123|FG001|Part B (Open-label Period):222 Weeks|Withdrawal by Subject|0|||
147301902|NCT03996291|531271124|FG002|Part B (Open-label Period):222 Weeks|Withdrawal by Subject|0|||
147301903|NCT03996291|531271125|FG003|Part B (Open-label Period):222 Weeks|Withdrawal by Subject|0|||
147301904|NCT03996291|531271126|FG004|Part B (Open-label Period):222 Weeks|Withdrawal by Subject|1|||
147301905|NCT03996291|531271127|FG005|Part B (Open-label Period):222 Weeks|Withdrawal by Subject|0|||
147301906|NCT03996291|531271128|FG006|Part B (Open-label Period):222 Weeks|Withdrawal by Subject|0|||
147301907|NCT03996291|531271129|FG007|Part B (Open-label Period):222 Weeks|Withdrawal by Subject|0|||
147301908|NCT03248375|531271130|FG000|Overall Study|Lost to Follow-up|5|||
147301909|NCT04098250|531271131|FG000|Overall Study|Withdrawal by Subject|1|||
147301910|NCT04098250|531271132|FG001|Overall Study|Withdrawal by Subject|0|||
147301911|NCT04098250|531271131|FG000|Overall Study|Lost to Follow-up|0|||
147301912|NCT04098250|531271132|FG001|Overall Study|Lost to Follow-up|1|||
147301913|NCT00633464|531271133|FG000|Overall Study|Never Treated (Not met study criteria)|0|||
147301914|NCT00633464|531271134|FG001|Overall Study|Never Treated (Not met study criteria)|1|||
147618276|NCT02553772|532417538|FG000|Overall Study|Lack of Efficacy|1|||
147618277|NCT02553772|532417539|FG001|Overall Study|Lack of Efficacy|0|||
147618278|NCT02553772|532417538|FG000|Overall Study|Other Miscellaneous Reasons|0|||
147618279|NCT02553772|532417539|FG001|Overall Study|Other Miscellaneous Reasons|1|||
147618280|NCT00786409|532417540|FG000|Overall Study|Withdrawal by Subject|2|||
147618281|NCT00786409|532417540|FG000|Overall Study|Adverse Event|2|||
147618282|NCT00786409|532417540|FG000|Overall Study|Pregnancy|2|||
147618283|NCT00786409|532417540|FG000|Overall Study|Lost to Follow-up|1|||
147618284|NCT00610129|532417541|FG000|Overall Study|Not treated since patients ineligible|3|||
147618285|NCT00141778|532417544|FG000|Randomization Prior to Study Med|Withdrawal by Subject|5|||
147618286|NCT00141778|532417545|FG001|Randomization Prior to Study Med|Withdrawal by Subject|2|||
147618287|NCT00141778|532417546|FG002|Randomization Prior to Study Med|Withdrawal by Subject|6|||
147618288|NCT00141778|532417544|FG000|Started Study Medication|Met safety criteria for discontinuation|2|||
147618289|NCT00141778|532417545|FG001|Started Study Medication|Met safety criteria for discontinuation|4|||
147618290|NCT00141778|532417546|FG002|Started Study Medication|Met safety criteria for discontinuation|3|||
147618291|NCT00141778|532417544|FG000|Started Study Medication|Withdrawal by Subject|0|||
147618292|NCT00141778|532417545|FG001|Started Study Medication|Withdrawal by Subject|2|||
147618293|NCT00141778|532417546|FG002|Started Study Medication|Withdrawal by Subject|0|||
147618294|NCT00141778|532417544|FG000|Started Study Medication|Difficulty Swallowing|0|||
147301915|NCT00633464|531271133|FG000|Overall Study|Never Treated (Randomized in error)|0|||
147301916|NCT00633464|531271134|FG001|Overall Study|Never Treated (Randomized in error)|1|||
147301917|NCT00394355|531271135|FG000|Overall Study|Adverse Event|10|||
147301918|NCT00394355|531271136|FG001|Overall Study|Adverse Event|6|||
147301919|NCT00394355|531271137|FG002|Overall Study|Adverse Event|7|||
147301920|NCT00394355|531271138|FG003|Overall Study|Adverse Event|8|||
147301921|NCT00394355|531271135|FG000|Overall Study|Did not meet protocol eligibility|1|||
147618295|NCT00141778|532417545|FG001|Started Study Medication|Difficulty Swallowing|1|||
147618296|NCT00141778|532417546|FG002|Started Study Medication|Difficulty Swallowing|0|||
147618297|NCT00141778|532417544|FG000|Started Study Medication|Chest Discomfort|0|||
147301922|NCT00394355|531271136|FG001|Overall Study|Did not meet protocol eligibility|5|||
147301923|NCT00394355|531271137|FG002|Overall Study|Did not meet protocol eligibility|4|||
147301924|NCT00394355|531271138|FG003|Overall Study|Did not meet protocol eligibility|2|||
147618298|NCT00141778|532417545|FG001|Started Study Medication|Chest Discomfort|0|||
147618299|NCT00141778|532417546|FG002|Started Study Medication|Chest Discomfort|1|||
147618300|NCT05016960|532419059|FG000|Overall Study|Withdrawal by Subject|1|||
147301925|NCT00394355|531271135|FG000|Overall Study|Subject withdrawal - unrelated to drug|12|||
147301926|NCT00394355|531271136|FG001|Overall Study|Subject withdrawal - unrelated to drug|14|||
147301927|NCT00394355|531271137|FG002|Overall Study|Subject withdrawal - unrelated to drug|10|||
147301928|NCT00394355|531271138|FG003|Overall Study|Subject withdrawal - unrelated to drug|6|||
147301929|NCT00394355|531271135|FG000|Overall Study|Subject withdrawal - related to drug|1|||
147301930|NCT00394355|531271136|FG001|Overall Study|Subject withdrawal - related to drug|0|||
147301931|NCT00394355|531271137|FG002|Overall Study|Subject withdrawal - related to drug|0|||
147301932|NCT00394355|531271138|FG003|Overall Study|Subject withdrawal - related to drug|0|||
147301933|NCT00394355|531271135|FG000|Overall Study|Lost to Follow-up|7|||
147301934|NCT00394355|531271136|FG001|Overall Study|Lost to Follow-up|5|||
147301935|NCT00394355|531271137|FG002|Overall Study|Lost to Follow-up|4|||
147301936|NCT00394355|531271138|FG003|Overall Study|Lost to Follow-up|3|||
147301937|NCT00394355|531271135|FG000|Overall Study|Noncompliance with protocol|4|||
147301938|NCT00394355|531271136|FG001|Overall Study|Noncompliance with protocol|3|||
147301939|NCT00394355|531271137|FG002|Overall Study|Noncompliance with protocol|10|||
147301940|NCT00394355|531271138|FG003|Overall Study|Noncompliance with protocol|8|||
147301941|NCT00394355|531271135|FG000|Overall Study|Administrative|0|||
147301942|NCT00394355|531271136|FG001|Overall Study|Administrative|1|||
147301943|NCT00394355|531271137|FG002|Overall Study|Administrative|1|||
147301944|NCT00394355|531271138|FG003|Overall Study|Administrative|1|||
147301945|NCT00394355|531271135|FG000|Overall Study|Lack of Efficacy|0|||
147301946|NCT00394355|531271136|FG001|Overall Study|Lack of Efficacy|0|||
147301947|NCT00394355|531271137|FG002|Overall Study|Lack of Efficacy|2|||
147301948|NCT00394355|531271138|FG003|Overall Study|Lack of Efficacy|3|||
147301949|NCT02612064|531271141|FG000|Overall Study|Withdrawal by Subject|1|||
147301950|NCT02612064|531271142|FG001|Overall Study|Withdrawal by Subject|1|||
147301951|NCT02612064|531271141|FG000|Overall Study|Other|0|||
147301952|NCT02612064|531271142|FG001|Overall Study|Other|2|||
147301953|NCT05805657|531271147|FG000|Overall Study|Patients lost to post or 6-month follow-up|12|||
147301954|NCT05805657|531271148|FG001|Overall Study|Patients lost to post or 6-month follow-up|64|||
147301955|NCT03764072|531271149|FG000|Overall Study|Withdrawal of consent (due to lack of efficacy)|0|||
147301956|NCT03764072|531271150|FG001|Overall Study|Withdrawal of consent (due to lack of efficacy)|0|||
147301957|NCT03764072|531271151|FG002|Overall Study|Withdrawal of consent (due to lack of efficacy)|1|||
147301958|NCT03764072|531271152|FG003|Overall Study|Withdrawal of consent (due to lack of efficacy)|0|||
147301959|NCT03764072|531271153|FG004|Overall Study|Withdrawal of consent (due to lack of efficacy)|0|||
147301960|NCT03764072|531271154|FG005|Overall Study|Withdrawal of consent (due to lack of efficacy)|0|||
147301961|NCT03764072|531271149|FG000|Overall Study|Withdrawal of consent (for other reason)|0|||
147301962|NCT03764072|531271150|FG001|Overall Study|Withdrawal of consent (for other reason)|0|||
147301963|NCT03764072|531271151|FG002|Overall Study|Withdrawal of consent (for other reason)|0|||
147301964|NCT03764072|531271152|FG003|Overall Study|Withdrawal of consent (for other reason)|0|||
147301965|NCT03764072|531271153|FG004|Overall Study|Withdrawal of consent (for other reason)|0|||
147301966|NCT03764072|531271154|FG005|Overall Study|Withdrawal of consent (for other reason)|1|||
147301967|NCT03764072|531271149|FG000|Overall Study|Lost to Follow-up|0|||
147301968|NCT03764072|531271150|FG001|Overall Study|Lost to Follow-up|0|||
147301969|NCT03764072|531271151|FG002|Overall Study|Lost to Follow-up|0|||
147301970|NCT03764072|531271152|FG003|Overall Study|Lost to Follow-up|0|||
147301971|NCT03764072|531271153|FG004|Overall Study|Lost to Follow-up|1|||
147301972|NCT03764072|531271154|FG005|Overall Study|Lost to Follow-up|0|||
147301973|NCT02686034|531271156|FG000|Run-In Period 1|Eligibility|12|||
147301974|NCT02686034|531271157|FG001|Run-In Period 1|Eligibility|10|||
147301975|NCT02686034|531271156|FG000|Run-In Period 1|Withdrawal by Subject|4|||
147301976|NCT02686034|531271157|FG001|Run-In Period 1|Withdrawal by Subject|3|||
147301977|NCT02686034|531271156|FG000|Run-In Period 1|Lost to Follow-up|4|||
147301978|NCT02686034|531271157|FG001|Run-In Period 1|Lost to Follow-up|4|||
147301979|NCT02686034|531271156|FG000|Randomized Controlled Period 2|Lost to Follow-up|1|||
147301980|NCT02686034|531271157|FG001|Randomized Controlled Period 2|Lost to Follow-up|2|||
147301981|NCT02686034|531271156|FG000|Randomized Controlled Period 2|Withdrawal by Subject|3|||
147301982|NCT02686034|531271157|FG001|Randomized Controlled Period 2|Withdrawal by Subject|0|||
147301983|NCT02686034|531271156|FG000|Randomized Controlled Period 2|Adverse Event|0|||
147301984|NCT02686034|531271157|FG001|Randomized Controlled Period 2|Adverse Event|2|||
147301985|NCT02686034|531271156|FG000|Randomized Controlled Period 2|Spontaneous reduction in migraines|1|||
147301986|NCT02686034|531271157|FG001|Randomized Controlled Period 2|Spontaneous reduction in migraines|0|||
147618301|NCT05016960|532419060|FG001|Overall Study|Withdrawal by Subject|9|||
147618302|NCT05655546|532419063|FG000|Overall Study|Withdrawal by Subject|2|||
147301987|NCT02686034|531271156|FG000|Open Label Period 3|Lost to Follow-up|0|||
147301988|NCT02686034|531271157|FG001|Open Label Period 3|Lost to Follow-up|1|||
147301989|NCT00459342|531271158|FG000|Overall Study|Not eligible|1|||
147301990|NCT00542880|531271159|FG000|Period 1|Eligibility criteria not fulfilled|2|||
147301991|NCT00542880|531271160|FG001|Period 1|Eligibility criteria not fulfilled|6|||
147301992|NCT00542880|531271159|FG000|Period 1|Adverse Event|2|||
147301993|NCT00542880|531271160|FG001|Period 1|Adverse Event|2|||
147301994|NCT00542880|531271159|FG000|Period 1|Development of study-specific criteria|1|||
147301995|NCT00542880|531271160|FG001|Period 1|Development of study-specific criteria|2|||
147301996|NCT00542880|531271159|FG000|Period 1|Withdrawal by Subject|1|||
147301997|NCT00542880|531271160|FG001|Period 1|Withdrawal by Subject|1|||
147301998|NCT00542880|531271159|FG000|Period 1|Protocol Violation|0|||
147301999|NCT00542880|531271160|FG001|Period 1|Protocol Violation|1|||
147302000|NCT00542880|531271159|FG000|Period 2|Adverse Event|5|||
147302001|NCT00542880|531271160|FG001|Period 2|Adverse Event|7|||
147302002|NCT00542880|531271159|FG000|Period 2|Eligibility not fulfilled|0|||
147302003|NCT00542880|531271160|FG001|Period 2|Eligibility not fulfilled|1|||
147302004|NCT00542880|531271159|FG000|Period 2|Discontinuation criteria|2|||
147302005|NCT00542880|531271160|FG001|Period 2|Discontinuation criteria|0|||
147302006|NCT00542880|531271159|FG000|Period 2|Severe non-compliance|0|||
147618303|NCT05655546|532419064|FG001|Overall Study|Withdrawal by Subject|4|||
147410401|NCT02807272|531666389|FG003|Overall Study|Lost to Follow-up|0|||
147410402|NCT02807272|531666390|FG004|Overall Study|Lost to Follow-up|0|||
147410403|NCT02807272|531666386|FG000|Overall Study|Permanent Withdrawal of Consent|8|||
147410404|NCT02807272|531666387|FG001|Overall Study|Permanent Withdrawal of Consent|2|||
147410405|NCT02807272|531666388|FG002|Overall Study|Permanent Withdrawal of Consent|0|||
147410406|NCT02807272|531666389|FG003|Overall Study|Permanent Withdrawal of Consent|2|||
147410407|NCT02807272|531666390|FG004|Overall Study|Permanent Withdrawal of Consent|1|||
147410408|NCT02807272|531666386|FG000|Overall Study|Protocol-defined Disease Progression|0|||
147410409|NCT02807272|531666387|FG001|Overall Study|Protocol-defined Disease Progression|1|||
147410410|NCT02807272|531666388|FG002|Overall Study|Protocol-defined Disease Progression|0|||
147410411|NCT02807272|531666389|FG003|Overall Study|Protocol-defined Disease Progression|0|||
147410412|NCT02807272|531666390|FG004|Overall Study|Protocol-defined Disease Progression|1|||
147410413|NCT02807272|531666386|FG000|Overall Study|Study Terminated by Sponsor|1|||
147410414|NCT02807272|531666387|FG001|Overall Study|Study Terminated by Sponsor|0|||
147410415|NCT02807272|531666388|FG002|Overall Study|Study Terminated by Sponsor|0|||
147410416|NCT02807272|531666389|FG003|Overall Study|Study Terminated by Sponsor|1|||
147410417|NCT02807272|531666390|FG004|Overall Study|Study Terminated by Sponsor|0|||
147410418|NCT02807272|531666386|FG000|Overall Study|Other|1|||
147410419|NCT02807272|531666387|FG001|Overall Study|Other|0|||
147410420|NCT02807272|531666388|FG002|Overall Study|Other|0|||
147410421|NCT02807272|531666389|FG003|Overall Study|Other|0|||
147410422|NCT02807272|531666390|FG004|Overall Study|Other|1|||
147410423|NCT04191616|531666391|FG000|Pre-assignment Period|Did not receive study treatment|2|||
147410424|NCT04191616|531666391|FG000|Treatment Period|Death|37|||
147410425|NCT04191616|531666391|FG000|Treatment Period|Sponsor decision|11|||
147410426|NCT04191616|531666391|FG000|Treatment Period|Withdrawal by Subject|4|||
147410427|NCT00604708|531666392|FG000|Overall Study|Withdrawal by Subject|9|||
147410428|NCT00604708|531666393|FG001|Overall Study|Withdrawal by Subject|10|||
147410429|NCT00604708|531666392|FG000|Overall Study|Protocol Violation|2|||
147410430|NCT00604708|531666393|FG001|Overall Study|Protocol Violation|8|||
147410431|NCT00604708|531666392|FG000|Overall Study|Lost to Follow-up|5|||
147410432|NCT00604708|531666393|FG001|Overall Study|Lost to Follow-up|5|||
147410433|NCT00604708|531666392|FG000|Overall Study|administrative reasons|9|||
147410434|NCT00604708|531666393|FG001|Overall Study|administrative reasons|11|||
147410435|NCT00604708|531666392|FG000|Overall Study|Adverse Event|6|||
147410436|NCT00604708|531666393|FG001|Overall Study|Adverse Event|6|||
147410437|NCT02180243|531666394|FG000|Overall Study|Withdrawal by Subject|12|||
147410438|NCT02180243|531666395|FG001|Overall Study|Withdrawal by Subject|12|||
147410439|NCT02180243|531666394|FG000|Overall Study|Lost to Follow-up|12|||
147410440|NCT02180243|531666395|FG001|Overall Study|Lost to Follow-up|2|||
147410441|NCT02202785|531666396|FG000|Overall Study|Study Terminated by Sponsor|1|||
147410442|NCT02202785|531666397|FG001|Overall Study|Study Terminated by Sponsor|6|||
147410443|NCT02202785|531666398|FG002|Overall Study|Study Terminated by Sponsor|4|||
147410444|NCT02202785|531666396|FG000|Overall Study|Withdrawal by Subject|0|||
147410445|NCT02202785|531666397|FG001|Overall Study|Withdrawal by Subject|1|||
147410446|NCT02202785|531666398|FG002|Overall Study|Withdrawal by Subject|0|||
147410447|NCT02202785|531666396|FG000|Overall Study|Lost to Follow-up|0|||
147410448|NCT02202785|531666397|FG001|Overall Study|Lost to Follow-up|1|||
147410449|NCT02202785|531666398|FG002|Overall Study|Lost to Follow-up|0|||
147410450|NCT02202785|531666396|FG000|Overall Study|Reason not Specified|10|||
147410451|NCT02202785|531666397|FG001|Overall Study|Reason not Specified|7|||
147410452|NCT02202785|531666398|FG002|Overall Study|Reason not Specified|13|||
147410453|NCT01137578|531666399|FG000|Overall Study|Participant requested to Discontinue|3|||
147410454|NCT01137578|531666400|FG001|Overall Study|Participant requested to Discontinue|0|||
147410455|NCT01137578|531666401|FG002|Overall Study|Participant requested to Discontinue|0|||
147410456|NCT01137578|531666399|FG000|Overall Study|Withdrawal by Subject|1|||
147410457|NCT01137578|531666400|FG001|Overall Study|Withdrawal by Subject|0|||
147618304|NCT04576507|532419071|FG000|Overall Study|Adverse Event|4|||
147302007|NCT00542880|531271160|FG001|Period 2|Severe non-compliance|1|||
147302008|NCT00542880|531271159|FG000|Period 2|Other|0|||
147302009|NCT00542880|531271160|FG001|Period 2|Other|1|||
147410458|NCT01137578|531666401|FG002|Overall Study|Withdrawal by Subject|0|||
147410459|NCT01137578|531666399|FG000|Overall Study|Other|12|||
147302010|NCT00542880|531271159|FG000|Period 3|Adverse Event|0|||
147302011|NCT00542880|531271160|FG001|Period 3|Adverse Event|2|||
147302012|NCT00696384|531271161|FG000|Open Label Phase|Adverse Event|27|||
147302013|NCT00696384|531271162|FG001|Open Label Phase|Adverse Event|0|||
147302014|NCT00696384|531271163|FG002|Open Label Phase|Adverse Event|0|||
147302015|NCT00696384|531271161|FG000|Open Label Phase|Protocol Violation|18|||
147302016|NCT00696384|531271162|FG001|Open Label Phase|Protocol Violation|0|||
147302017|NCT00696384|531271163|FG002|Open Label Phase|Protocol Violation|0|||
147302018|NCT00696384|531271161|FG000|Open Label Phase|Lost to Follow-up|24|||
147302019|NCT00696384|531271162|FG001|Open Label Phase|Lost to Follow-up|0|||
147302020|NCT00696384|531271163|FG002|Open Label Phase|Lost to Follow-up|0|||
147302021|NCT00696384|531271161|FG000|Open Label Phase|Withdrawal by Subject|37|||
147302022|NCT00696384|531271162|FG001|Open Label Phase|Withdrawal by Subject|0|||
147302023|NCT00696384|531271163|FG002|Open Label Phase|Withdrawal by Subject|0|||
147302024|NCT00696384|531271161|FG000|Open Label Phase|Other|6|||
147302025|NCT00696384|531271162|FG001|Open Label Phase|Other|0|||
147302026|NCT00696384|531271163|FG002|Open Label Phase|Other|0|||
147302027|NCT00696384|531271161|FG000|Open Label Phase|Lack of Efficacy|3|||
147302028|NCT00696384|531271162|FG001|Open Label Phase|Lack of Efficacy|0|||
147302029|NCT00696384|531271163|FG002|Open Label Phase|Lack of Efficacy|0|||
147302030|NCT00696384|531271161|FG000|Open Label Phase|Physician Decision|4|||
147302031|NCT00696384|531271162|FG001|Open Label Phase|Physician Decision|0|||
147302032|NCT00696384|531271163|FG002|Open Label Phase|Physician Decision|0|||
147302033|NCT00696384|531271161|FG000|Double Blind Phase|Adverse Event|0|||
147302034|NCT00696384|531271162|FG001|Double Blind Phase|Adverse Event|2|||
147302035|NCT00696384|531271163|FG002|Double Blind Phase|Adverse Event|2|||
147302036|NCT00696384|531271161|FG000|Double Blind Phase|Lost to Follow-up|0|||
147302037|NCT00696384|531271162|FG001|Double Blind Phase|Lost to Follow-up|2|||
147302038|NCT00696384|531271163|FG002|Double Blind Phase|Lost to Follow-up|1|||
147302039|NCT00696384|531271161|FG000|Double Blind Phase|Withdrawal by Subject|0|||
147302040|NCT00696384|531271162|FG001|Double Blind Phase|Withdrawal by Subject|4|||
147302041|NCT00696384|531271163|FG002|Double Blind Phase|Withdrawal by Subject|3|||
147302042|NCT00696384|531271161|FG000|Double Blind Phase|Lack of Efficacy|0|||
147302043|NCT00696384|531271162|FG001|Double Blind Phase|Lack of Efficacy|1|||
147302044|NCT00696384|531271163|FG002|Double Blind Phase|Lack of Efficacy|0|||
147302045|NCT00696384|531271161|FG000|Double Blind Phase|Physician Decision|0|||
147302046|NCT00696384|531271162|FG001|Double Blind Phase|Physician Decision|2|||
147302047|NCT00696384|531271163|FG002|Double Blind Phase|Physician Decision|0|||
147302048|NCT01678131|531271164|FG000|Overall Study|Adverse Event|0|||
147302049|NCT01678131|531271165|FG001|Overall Study|Adverse Event|1|||
147302050|NCT01678131|531271166|FG002|Overall Study|Adverse Event|0|||
147302051|NCT01678131|531271164|FG000|Overall Study|Withdrawal by Subject|0|||
147302052|NCT01678131|531271165|FG001|Overall Study|Withdrawal by Subject|0|||
147302053|NCT01678131|531271166|FG002|Overall Study|Withdrawal by Subject|2|||
147302054|NCT00941798|531271169|FG000|Overall Study|Withdrawal by Subject|72|||
147302055|NCT00941798|531271170|FG001|Overall Study|Withdrawal by Subject|74|||
147302056|NCT00941798|531271169|FG000|Overall Study|Adverse Event|43|||
147302057|NCT00941798|531271170|FG001|Overall Study|Adverse Event|23|||
147302058|NCT00941798|531271169|FG000|Overall Study|Lost to Follow-up|29|||
147302059|NCT00941798|531271170|FG001|Overall Study|Lost to Follow-up|23|||
147302060|NCT00941798|531271169|FG000|Overall Study|Protocol Violation|17|||
147302061|NCT00941798|531271170|FG001|Overall Study|Protocol Violation|20|||
147302062|NCT00941798|531271169|FG000|Overall Study|Administrative problems|13|||
147302063|NCT00941798|531271170|FG001|Overall Study|Administrative problems|23|||
147302064|NCT00941798|531271169|FG000|Overall Study|Lack of Efficacy|10|||
147302065|NCT00941798|531271170|FG001|Overall Study|Lack of Efficacy|17|||
147302066|NCT00941798|531271169|FG000|Overall Study|Patient's inability to use device|6|||
147302067|NCT00941798|531271170|FG001|Overall Study|Patient's inability to use device|1|||
147302068|NCT00941798|531271169|FG000|Overall Study|Abnormal test procedure results|3|||
147618305|NCT04576507|532419071|FG000|Overall Study|Withdrawal by Subject|1|||
147618306|NCT04467840|532419072|FG000|Overall Study|Death|35|||
147618307|NCT04467840|532419073|FG001|Overall Study|Death|39|||
147618308|NCT04467840|532419072|FG000|Overall Study|Withdrawal by Subject|8|||
147302069|NCT00941798|531271170|FG001|Overall Study|Abnormal test procedure results|1|||
147302070|NCT00941798|531271169|FG000|Overall Study|Abnormal laboratory values|1|||
147302071|NCT00941798|531271170|FG001|Overall Study|Abnormal laboratory values|2|||
147302072|NCT00941798|531271169|FG000|Overall Study|Death|0|||
147302073|NCT00941798|531271170|FG001|Overall Study|Death|1|||
147302074|NCT04179721|531271173|FG000|Overall Study|COVID-19 Related Lost of Followup|11|||
147302075|NCT04179721|531271174|FG001|Overall Study|COVID-19 Related Lost of Followup|13|||
147302076|NCT04179721|531271173|FG000|Overall Study|Lost to Follow-up|0|||
147302077|NCT04179721|531271174|FG001|Overall Study|Lost to Follow-up|1|||
147302078|NCT01489189|531271175|FG000|Overall Study|Withdrawal by Subject|20|||
147302079|NCT01489189|531271176|FG001|Overall Study|Withdrawal by Subject|23|||
147302080|NCT01489189|531271175|FG000|Overall Study|Death|10|||
147302081|NCT01489189|531271176|FG001|Overall Study|Death|8|||
147302082|NCT01489189|531271175|FG000|Overall Study|Missed Visit|1|||
147302083|NCT01489189|531271176|FG001|Overall Study|Missed Visit|4|||
147618309|NCT04467840|532419073|FG001|Overall Study|Withdrawal by Subject|4|||
147302084|NCT00856167|531271180|FG000|Period 1|Withdrawal by Subject|1|||
147302085|NCT00856167|531271181|FG001|Period 1|Withdrawal by Subject|4|||
147302086|NCT00856167|531271182|FG002|Period 1|Withdrawal by Subject|0|||
147618310|NCT04467840|532419072|FG000|Overall Study|Adverse Event|2|||
147618311|NCT04467840|532419073|FG001|Overall Study|Adverse Event|0|||
147618312|NCT04467840|532419072|FG000|Overall Study|Lost to Follow-up|1|||
147618313|NCT04467840|532419073|FG001|Overall Study|Lost to Follow-up|3|||
147618314|NCT04467840|532419072|FG000|Overall Study|Physician Decision|1|||
147618315|NCT04467840|532419073|FG001|Overall Study|Physician Decision|0|||
147618316|NCT04467840|532419072|FG000|Overall Study|Other|1|||
147618317|NCT04467840|532419073|FG001|Overall Study|Other|5|||
147618318|NCT04467840|532419072|FG000|Overall Study|Missing study completion status|3|||
147618319|NCT04467840|532419073|FG001|Overall Study|Missing study completion status|1|||
147618320|NCT05201794|532419076|FG000|Overall Study|Withdrawal by Subject|13|||
147618321|NCT05201794|532419077|FG001|Overall Study|Withdrawal by Subject|12|||
147618322|NCT05201794|532419078|FG002|Overall Study|Withdrawal by Subject|14|||
147618323|NCT05201794|532419079|FG003|Overall Study|Withdrawal by Subject|0|||
147618324|NCT05201794|532419076|FG000|Overall Study|Adverse Event|5|||
147618325|NCT05201794|532419077|FG001|Overall Study|Adverse Event|5|||
147665662|NCT03810456|532599666|FG001|1 Month Follow-Up|Withdrawal by Subject|0|||
147665663|NCT03810456|532599667|FG002|1 Month Follow-Up|Withdrawal by Subject|0|||
147302087|NCT00856167|531271183|FG003|Period 1|Withdrawal by Subject|0|||
147302088|NCT00856167|531271180|FG000|Period 1|Lost to Follow-up|2|||
147302089|NCT00856167|531271181|FG001|Period 1|Lost to Follow-up|1|||
147302090|NCT00856167|531271182|FG002|Period 1|Lost to Follow-up|0|||
147302091|NCT00856167|531271183|FG003|Period 1|Lost to Follow-up|0|||
147302092|NCT00856167|531271180|FG000|Period 2|Lost to Follow-up|0|||
147302093|NCT00856167|531271181|FG001|Period 2|Lost to Follow-up|0|||
147302094|NCT00856167|531271182|FG002|Period 2|Lost to Follow-up|3|||
147302095|NCT00856167|531271183|FG003|Period 2|Lost to Follow-up|1|||
147302096|NCT00856167|531271180|FG000|Period 2|Withdrawal by Subject|0|||
147302097|NCT00856167|531271181|FG001|Period 2|Withdrawal by Subject|0|||
147302098|NCT00856167|531271182|FG002|Period 2|Withdrawal by Subject|2|||
147302099|NCT00856167|531271183|FG003|Period 2|Withdrawal by Subject|4|||
147302100|NCT01529008|531272507|FG000|Bone Marrow Harvesting|Physician Decision|1|||
147302101|NCT01529008|531272508|FG001|Bone Marrow Harvesting|Physician Decision|1|||
147302102|NCT01529008|531272507|FG000|Bone Marrow Harvesting|Withdrawal by Subject|0|||
147302103|NCT01529008|531272508|FG001|Bone Marrow Harvesting|Withdrawal by Subject|2|||
147302104|NCT01529008|531272507|FG000|Treatment|Adverse Event|6|||
147302105|NCT01529008|531272508|FG001|Treatment|Adverse Event|0|||
147302106|NCT01529008|531272507|FG000|Treatment|Other|3|||
147302107|NCT01529008|531272508|FG001|Treatment|Other|1|||
147302108|NCT01529008|531272507|FG000|Efficacy Analysis|Protocol Violation|2|||
147302109|NCT01529008|531272508|FG001|Efficacy Analysis|Protocol Violation|0|||
147302110|NCT01529008|531272507|FG000|Efficacy Analysis|Physician Decision|0|||
147302111|NCT01529008|531272508|FG001|Efficacy Analysis|Physician Decision|1|||
147302112|NCT01529008|531272507|FG000|Efficacy Analysis|Withdrawal by Subject|0|||
147302113|NCT01529008|531272508|FG001|Efficacy Analysis|Withdrawal by Subject|2|||
147302114|NCT00332332|531272509|FG000|Overall Study|Adverse Event|13|||
147302115|NCT00332332|531272509|FG000|Overall Study|Death|1|||
147302116|NCT00332332|531272509|FG000|Overall Study|Withdrawal by Subject|8|||
147302117|NCT00332332|531272509|FG000|Overall Study|Physician Decision|1|||
147302118|NCT00332332|531272509|FG000|Overall Study|Lost to Follow-up|3|||
147302119|NCT00332332|531272509|FG000|Overall Study|Protocol deviation|4|||
147302120|NCT00332332|531272509|FG000|Overall Study|Noncompliance|2|||
147302121|NCT00332332|531272509|FG000|Overall Study|Disease progression|2|||
147302122|NCT00332332|531272509|FG000|Overall Study|Other|18|||
147302123|NCT00332332|531272509|FG000|Overall Study|Did not receive study treatment|16|||
147302124|NCT01382602|531272510|FG000|Overall Study|Protocol Violation|0|||
147302125|NCT01382602|531272511|FG001|Overall Study|Protocol Violation|3|||
147302126|NCT01382602|531272510|FG000|Overall Study|Withdrawal by Subject|0|||
147302127|NCT01382602|531272511|FG001|Overall Study|Withdrawal by Subject|1|||
147302128|NCT04425902|531272516|FG000|Treatment Period 2 (Days 11 to 20)|Adverse Event|1|||
147302129|NCT01191840|531272517|FG000|Overall Study|withdrew consent|2|||
147302130|NCT01191840|531272518|FG001|Overall Study|withdrew consent|1|||
147302131|NCT01191840|531272517|FG000|Overall Study|Subject discontinued treatment|1|||
147302132|NCT01191840|531272518|FG001|Overall Study|Subject discontinued treatment|2|||
147302133|NCT01191840|531272517|FG000|Overall Study|Lost to Follow-up|4|||
147302134|NCT01191840|531272518|FG001|Overall Study|Lost to Follow-up|6|||
147618326|NCT05201794|532419078|FG002|Overall Study|Adverse Event|4|||
147618327|NCT05201794|532419079|FG003|Overall Study|Adverse Event|0|||
147618328|NCT05201794|532419076|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|5|||
147302135|NCT01191840|531272517|FG000|Overall Study|Non Staph Infection|4|||
147302136|NCT01191840|531272518|FG001|Overall Study|Non Staph Infection|3|||
147302137|NCT01191840|531272517|FG000|Overall Study|ineligible at enrollment|1|||
147302138|NCT01191840|531272518|FG001|Overall Study|ineligible at enrollment|0|||
147302139|NCT01191840|531272517|FG000|Overall Study|IRB approval lapse|0|||
147302140|NCT01191840|531272518|FG001|Overall Study|IRB approval lapse|2|||
147410460|NCT01137578|531666400|FG001|Overall Study|Other|2|||
147302141|NCT01191840|531272517|FG000|Overall Study|lab error speciation - non Staph infecti|0|||
147302142|NCT01191840|531272518|FG001|Overall Study|lab error speciation - non Staph infecti|1|||
147302143|NCT01191840|531272517|FG000|Overall Study|Withdrawal by Subject|2|||
147302144|NCT01191840|531272518|FG001|Overall Study|Withdrawal by Subject|0|||
147302145|NCT04669600|531272519|FG000|Overall Study|Withdrawal by Subject|1|||
147302146|NCT04669600|531272519|FG000|Overall Study|Other|6|||
147302147|NCT01373931|531272528|FG000|Lead-in Period|Adverse Event|2|||
147302148|NCT01373931|531272529|FG001|Lead-in Period|Adverse Event|0|||
147302149|NCT01373931|531272528|FG000|Period 1|Adverse Event|2|||
147302150|NCT01373931|531272529|FG001|Period 1|Adverse Event|0|||
147302151|NCT01373931|531272528|FG000|Period 1|Withdrawal by Subject|0|||
147302152|NCT01373931|531272529|FG001|Period 1|Withdrawal by Subject|2|||
147302153|NCT01995539|531272530|FG000|Overall Study|Screening Failure|1|||
147302154|NCT01995539|531272530|FG000|Overall Study|Withdrawal by Investigator|15|||
147302155|NCT01995539|531272530|FG000|Overall Study|Withdrawal by Subject|11|||
147302156|NCT01995539|531272530|FG000|Overall Study|Lost to Follow-up|5|||
147302157|NCT01995539|531272530|FG000|Overall Study|Subject missed visit 3,4, came in for V5|1|||
147302158|NCT01932697|531272533|FG000|Overall Study|Received a different amount of tx|1|||
147302159|NCT01932697|531272534|FG001|Overall Study|Received a different amount of tx|0|||
147302160|NCT01932697|531272533|FG000|Overall Study|Ineligible|1|||
147302161|NCT01932697|531272534|FG001|Overall Study|Ineligible|0|||
147302162|NCT00860067|531272537|FG000|Overall Study|Lost to Follow-up|46|||
147302163|NCT00860067|531272538|FG001|Overall Study|Lost to Follow-up|9|||
147302164|NCT00860067|531272539|FG002|Overall Study|Lost to Follow-up|9|||
147302165|NCT00860067|531272537|FG000|Overall Study|Withdrawal by Subject|4|||
147302166|NCT00860067|531272538|FG001|Overall Study|Withdrawal by Subject|0|||
147302167|NCT00860067|531272539|FG002|Overall Study|Withdrawal by Subject|0|||
147302168|NCT00860067|531272537|FG000|Overall Study|Pregnancy|1|||
147302169|NCT00860067|531272538|FG001|Overall Study|Pregnancy|0|||
147302170|NCT00860067|531272539|FG002|Overall Study|Pregnancy|0|||
147302171|NCT01282801|531272540|FG000|Second Intervention|Emesis During Critical Breakfast|0|||
147302172|NCT01282801|531272541|FG001|Second Intervention|Emesis During Critical Breakfast|1|||
147302173|NCT01862796|531272542|FG000|Overall Study|Prohibited medications|0|||
147302174|NCT01862796|531272543|FG001|Overall Study|Prohibited medications|0|||
147302175|NCT01862796|531272544|FG002|Overall Study|Prohibited medications|1|||
147302176|NCT03815019|531272545|FG000|Overall Study|Withdrawal by Subject|6|||
147302177|NCT03815019|531272546|FG001|Overall Study|Withdrawal by Subject|8|||
147302178|NCT05398796|531272547|FG000|Overall Study|Participant moved from the area|0|||
147302179|NCT05398796|531272548|FG001|Overall Study|Participant moved from the area|1|||
147302180|NCT05398796|531272549|FG002|Overall Study|Participant moved from the area|0|||
147302181|NCT05398796|531272550|FG003|Overall Study|Participant moved from the area|0|||
147302182|NCT04270747|531272552|FG000|Through Week 16|Adverse Event|1|||
147302183|NCT04270747|531272553|FG001|Through Week 16|Adverse Event|2|||
147302184|NCT04270747|531272554|FG002|Through Week 16|Adverse Event|0|||
147302185|NCT04270747|531272552|FG000|Through Week 16|Death|0|||
147302186|NCT04270747|531272553|FG001|Through Week 16|Death|2|||
147302187|NCT04270747|531272554|FG002|Through Week 16|Death|0|||
147302188|NCT04270747|531272552|FG000|Through Week 16|Consent Withdrawn|3|||
147302189|NCT04270747|531272553|FG001|Through Week 16|Consent Withdrawn|3|||
147302190|NCT04270747|531272554|FG002|Through Week 16|Consent Withdrawn|0|||
147302191|NCT04270747|531272552|FG000|Through Week 16|Physician Decision|1|||
147302192|NCT04270747|531272553|FG001|Through Week 16|Physician Decision|1|||
147302193|NCT04270747|531272554|FG002|Through Week 16|Physician Decision|0|||
147302194|NCT04270747|531272552|FG000|Through Week 16|Lost to Follow-up|2|||
147302195|NCT04270747|531272553|FG001|Through Week 16|Lost to Follow-up|0|||
147302196|NCT04270747|531272554|FG002|Through Week 16|Lost to Follow-up|0|||
147302197|NCT04270747|531272552|FG000|Through Week 16|Protocol Violation|1|||
147302198|NCT04270747|531272553|FG001|Through Week 16|Protocol Violation|2|||
147302199|NCT04270747|531272554|FG002|Through Week 16|Protocol Violation|0|||
147618329|NCT05201794|532419077|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|1|||
147302200|NCT04270747|531272552|FG000|Through Week 16|Protocol Specified Criteria|6|||
147302201|NCT04270747|531272553|FG001|Through Week 16|Protocol Specified Criteria|7|||
147618330|NCT05201794|532419078|FG002|Overall Study|Protocol-Specified Withdrawal Criterion Met|4|||
147618331|NCT05201794|532419079|FG003|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
147618332|NCT05201794|532419076|FG000|Overall Study|Non-Compliance With Study Drug|2|||
147302202|NCT04270747|531272554|FG002|Through Week 16|Protocol Specified Criteria|0|||
147302203|NCT04270747|531272552|FG000|Through Week 16|Miscellaneous|1|||
147302204|NCT04270747|531272553|FG001|Through Week 16|Miscellaneous|1|||
147302205|NCT04270747|531272554|FG002|Through Week 16|Miscellaneous|0|||
147302206|NCT04270747|531272552|FG000|Post Week 16|Adverse Event|7|||
147302207|NCT04270747|531272553|FG001|Post Week 16|Adverse Event|5|||
147302208|NCT04270747|531272554|FG002|Post Week 16|Adverse Event|1|||
147302209|NCT04270747|531272552|FG000|Post Week 16|Death|2|||
147302210|NCT04270747|531272553|FG001|Post Week 16|Death|0|||
147302211|NCT04270747|531272554|FG002|Post Week 16|Death|2|||
147302212|NCT04270747|531272552|FG000|Post Week 16|Consent Withdrawn|4|||
147302213|NCT04270747|531272553|FG001|Post Week 16|Consent Withdrawn|3|||
147302214|NCT04270747|531272554|FG002|Post Week 16|Consent Withdrawn|6|||
147302215|NCT04270747|531272552|FG000|Post Week 16|Physician Decision|3|||
147302216|NCT04270747|531272553|FG001|Post Week 16|Physician Decision|1|||
147302217|NCT04270747|531272554|FG002|Post Week 16|Physician Decision|1|||
147302218|NCT04270747|531272552|FG000|Post Week 16|Lost to Follow-up|2|||
147302219|NCT04270747|531272553|FG001|Post Week 16|Lost to Follow-up|1|||
147302220|NCT04270747|531272554|FG002|Post Week 16|Lost to Follow-up|0|||
147302221|NCT04270747|531272552|FG000|Post Week 16|Requirement for Alternative Therapy|1|||
147302222|NCT04270747|531272553|FG001|Post Week 16|Requirement for Alternative Therapy|0|||
147302223|NCT04270747|531272554|FG002|Post Week 16|Requirement for Alternative Therapy|0|||
147302224|NCT04270747|531272552|FG000|Post Week 16|Requirement for Alternative Dosing Schedule|2|||
147302225|NCT04270747|531272553|FG001|Post Week 16|Requirement for Alternative Dosing Schedule|1|||
147302226|NCT04270747|531272554|FG002|Post Week 16|Requirement for Alternative Dosing Schedule|0|||
147302227|NCT04270747|531272552|FG000|Post Week 16|Miscellaneous|1|||
147302228|NCT04270747|531272553|FG001|Post Week 16|Miscellaneous|0|||
147302229|NCT04270747|531272554|FG002|Post Week 16|Miscellaneous|1|||
147302230|NCT05960097|531272555|FG000|Overall Study|Lost to Follow-up|3|||
147302231|NCT05960097|531272556|FG001|Overall Study|Lost to Follow-up|1|||
147302232|NCT05960097|531272557|FG002|Overall Study|Lost to Follow-up|1|||
147302233|NCT05960097|531272558|FG003|Overall Study|Lost to Follow-up|2|||
147302234|NCT05960097|531272559|FG004|Overall Study|Lost to Follow-up|1|||
147302235|NCT05960097|531272560|FG005|Overall Study|Lost to Follow-up|1|||
147302236|NCT05960097|531272561|FG006|Overall Study|Lost to Follow-up|2|||
147302237|NCT05960097|531272562|FG007|Overall Study|Lost to Follow-up|3|||
147302238|NCT05960097|531272555|FG000|Overall Study|Physician Decision|0|||
147302239|NCT05960097|531272556|FG001|Overall Study|Physician Decision|0|||
147302240|NCT05960097|531272557|FG002|Overall Study|Physician Decision|0|||
147302241|NCT05960097|531272558|FG003|Overall Study|Physician Decision|0|||
147302242|NCT05960097|531272559|FG004|Overall Study|Physician Decision|0|||
147302243|NCT05960097|531272560|FG005|Overall Study|Physician Decision|0|||
147302244|NCT05960097|531272561|FG006|Overall Study|Physician Decision|1|||
147302245|NCT05960097|531272562|FG007|Overall Study|Physician Decision|0|||
147302246|NCT05960097|531272555|FG000|Overall Study|Withdrawal by Subject|1|||
147302247|NCT05960097|531272556|FG001|Overall Study|Withdrawal by Subject|0|||
147302248|NCT05960097|531272557|FG002|Overall Study|Withdrawal by Subject|0|||
147302249|NCT05960097|531272558|FG003|Overall Study|Withdrawal by Subject|1|||
147302250|NCT05960097|531272559|FG004|Overall Study|Withdrawal by Subject|1|||
147302251|NCT05960097|531272560|FG005|Overall Study|Withdrawal by Subject|0|||
147302252|NCT05960097|531272561|FG006|Overall Study|Withdrawal by Subject|0|||
147302253|NCT05960097|531272562|FG007|Overall Study|Withdrawal by Subject|0|||
147302254|NCT05960097|531272555|FG000|Overall Study|Early Withdrawal: Participant relocated and cannot attend the site|0|||
147302255|NCT05960097|531272556|FG001|Overall Study|Early Withdrawal: Participant relocated and cannot attend the site|0|||
147302256|NCT05960097|531272557|FG002|Overall Study|Early Withdrawal: Participant relocated and cannot attend the site|1|||
147302257|NCT05960097|531272558|FG003|Overall Study|Early Withdrawal: Participant relocated and cannot attend the site|0|||
147302258|NCT05960097|531272559|FG004|Overall Study|Early Withdrawal: Participant relocated and cannot attend the site|0|||
147302259|NCT05960097|531272560|FG005|Overall Study|Early Withdrawal: Participant relocated and cannot attend the site|0|||
147302260|NCT05960097|531272561|FG006|Overall Study|Early Withdrawal: Participant relocated and cannot attend the site|0|||
147302261|NCT05960097|531272562|FG007|Overall Study|Early Withdrawal: Participant relocated and cannot attend the site|0|||
147302262|NCT01784068|531272563|FG000|NTCS Phase|Adverse Event|5|||
147302263|NCT01784068|531272564|FG001|NTCS Phase|Adverse Event|0|||
147302264|NCT01784068|531272563|FG000|NTCS Phase|Physician Decision|2|||
147302265|NCT01784068|531272564|FG001|NTCS Phase|Physician Decision|0|||
147302266|NCT01784068|531272563|FG000|NTCS Phase|Patient/guardian decision|3|||
147302267|NCT01784068|531272564|FG001|NTCS Phase|Patient/guardian decision|0|||
147302268|NCT01784068|531272563|FG000|NTCS Phase|Death|2|||
147302269|NCT01784068|531272564|FG001|NTCS Phase|Death|0|||
147302270|NCT01784068|531272563|FG000|NTCS Phase|Completed phase = discontinuation of study except for TFR and TFR2 phases|203|||
147302271|NCT01784068|531272564|FG001|NTCS Phase|Completed phase = discontinuation of study except for TFR and TFR2 phases|0|||
147302272|NCT01784068|531272563|FG000|TFR Phase|Physician Decision|0|||
147302273|NCT01784068|531272564|FG001|TFR Phase|Physician Decision|1|||
147302274|NCT01784068|531272563|FG000|TFR Phase|Patient/guardian decision|0|||
147302275|NCT01784068|531272564|FG001|TFR Phase|Patient/guardian decision|3|||
147302276|NCT01784068|531272563|FG000|TFR Phase|Death|0|||
147302277|NCT01784068|531272564|FG001|TFR Phase|Death|1|||
147302278|NCT01784068|531272563|FG000|TFR Phase|Lack of Efficacy|0|||
147302279|NCT01784068|531272564|FG001|TFR Phase|Lack of Efficacy|88|||
147302280|NCT02063828|531272567|FG000|Overall Study|Withdrawal by Subject|4|||
147302281|NCT02063828|531272568|FG001|Overall Study|Withdrawal by Subject|6|||
147302282|NCT02063828|531272569|FG002|Overall Study|Withdrawal by Subject|3|||
147302283|NCT02063828|531272567|FG000|Overall Study|Death|0|||
147302284|NCT02063828|531272568|FG001|Overall Study|Death|0|||
147302285|NCT02063828|531272569|FG002|Overall Study|Death|1|||
147302286|NCT03483038|531272570|FG000|Overall Study|Subjects still in follow-up|18|||
147302287|NCT04987762|531272571|FG000|Overall Study|Study was Terminated by Sponsor|103|||
147410461|NCT01137578|531666401|FG002|Overall Study|Other|6|||
147410462|NCT03945825|531666403|FG000|Overall Study|Enrolled but treatment not administered|0|||
147410463|NCT03945825|531666404|FG001|Overall Study|Enrolled but treatment not administered|0|||
147410464|NCT03945825|531666405|FG002|Overall Study|Enrolled but treatment not administered|0|||
147410465|NCT03945825|531666406|FG003|Overall Study|Enrolled but treatment not administered|0|||
147410466|NCT03945825|531666407|FG004|Overall Study|Enrolled but treatment not administered|1|||
147410467|NCT03945825|531666408|FG005|Overall Study|Enrolled but treatment not administered|0|||
147410468|NCT03945825|531666403|FG000|Overall Study|Lost to Follow-up|1|||
147410469|NCT03945825|531666404|FG001|Overall Study|Lost to Follow-up|5|||
147410470|NCT03945825|531666405|FG002|Overall Study|Lost to Follow-up|0|||
147410471|NCT03945825|531666406|FG003|Overall Study|Lost to Follow-up|1|||
147410472|NCT03945825|531666407|FG004|Overall Study|Lost to Follow-up|2|||
147410473|NCT03945825|531666408|FG005|Overall Study|Lost to Follow-up|2|||
147410474|NCT03945825|531666403|FG000|Overall Study|Withdrawal by Subject|1|||
147410475|NCT03945825|531666404|FG001|Overall Study|Withdrawal by Subject|0|||
147410476|NCT03945825|531666405|FG002|Overall Study|Withdrawal by Subject|1|||
147410477|NCT03945825|531666406|FG003|Overall Study|Withdrawal by Subject|1|||
147410478|NCT03945825|531666407|FG004|Overall Study|Withdrawal by Subject|0|||
147410479|NCT03945825|531666408|FG005|Overall Study|Withdrawal by Subject|1|||
147410480|NCT01461005|531666409|FG000|Overall Study|FDA reclassified Dynamic Stabilization D|1|||
147410481|NCT03197766|531666410|FG000|Overall Study|Withdrawal by Subject|2|||
147410482|NCT03197766|531666411|FG001|Overall Study|Withdrawal by Subject|0|||
147410483|NCT01436253|531666412|FG000|Overall Study|Lost to Follow-up|182|||
147410484|NCT01436253|531666412|FG000|Overall Study|Not meeting all eligibility criteria|117|||
147410485|NCT04844879|531666415|FG000|Overall Study|Death|1|||
147410486|NCT04844879|531666415|FG000|Overall Study|Withdrawal by Subject|1|||
147410487|NCT04844879|531666415|FG000|Overall Study|Adverse Event|1|||
147410488|NCT04520659|531666416|FG000|RSV Surveillance Phase Oct. 16-March 31|Withdrawal by Subject|1|||
147410489|NCT04520659|531666417|FG001|RSV Surveillance Phase Oct. 16-March 31|Withdrawal by Subject|0|||
147410490|NCT04520659|531666418|FG002|RSV Surveillance Phase Oct. 16-March 31|Withdrawal by Subject|1|||
147410491|NCT04520659|531666419|FG003|RSV Surveillance Phase Oct. 16-March 31|Withdrawal by Subject|0|||
147410492|NCT04485611|531666424|FG000|Prehabilitation|Physician Decision|1|||
147410493|NCT04879849|531666425|FG000|Overall Study|Lost to Follow-up|0|||
147410494|NCT04879849|531666426|FG001|Overall Study|Lost to Follow-up|0|||
147410495|NCT04879849|531666427|FG002|Overall Study|Lost to Follow-up|0|||
147410496|NCT04879849|531666428|FG003|Overall Study|Lost to Follow-up|1|||
147410497|NCT04879849|531666429|FG004|Overall Study|Lost to Follow-up|0|||
147410498|NCT04879849|531666430|FG005|Overall Study|Lost to Follow-up|0|||
147410499|NCT04879849|531666431|FG006|Overall Study|Lost to Follow-up|0|||
147410500|NCT04879849|531666432|FG007|Overall Study|Lost to Follow-up|0|||
147410501|NCT04879849|531666425|FG000|Overall Study|Initiation of Another Systemic Anticancer Treatment|3|||
147410502|NCT04879849|531666426|FG001|Overall Study|Initiation of Another Systemic Anticancer Treatment|1|||
147410503|NCT04879849|531666427|FG002|Overall Study|Initiation of Another Systemic Anticancer Treatment|2|||
147410504|NCT04879849|531666428|FG003|Overall Study|Initiation of Another Systemic Anticancer Treatment|0|||
147410505|NCT04879849|531666429|FG004|Overall Study|Initiation of Another Systemic Anticancer Treatment|1|||
147410506|NCT04879849|531666430|FG005|Overall Study|Initiation of Another Systemic Anticancer Treatment|2|||
147410507|NCT04879849|531666431|FG006|Overall Study|Initiation of Another Systemic Anticancer Treatment|3|||
147410508|NCT04879849|531666432|FG007|Overall Study|Initiation of Another Systemic Anticancer Treatment|0|||
147410509|NCT04879849|531666425|FG000|Overall Study|Withdrawal by Subject|0|||
147410510|NCT04879849|531666426|FG001|Overall Study|Withdrawal by Subject|0|||
147410511|NCT04879849|531666427|FG002|Overall Study|Withdrawal by Subject|0|||
147410512|NCT04879849|531666428|FG003|Overall Study|Withdrawal by Subject|0|||
147410513|NCT04879849|531666429|FG004|Overall Study|Withdrawal by Subject|2|||
147410514|NCT04879849|531666430|FG005|Overall Study|Withdrawal by Subject|0|||
147410515|NCT04879849|531666431|FG006|Overall Study|Withdrawal by Subject|1|||
147410516|NCT04879849|531666432|FG007|Overall Study|Withdrawal by Subject|0|||
147410517|NCT04879849|531666425|FG000|Overall Study|Progressive Disease|0|||
147410518|NCT04879849|531666426|FG001|Overall Study|Progressive Disease|0|||
147410519|NCT04879849|531666427|FG002|Overall Study|Progressive Disease|1|||
147410520|NCT04879849|531666428|FG003|Overall Study|Progressive Disease|0|||
147410521|NCT04879849|531666429|FG004|Overall Study|Progressive Disease|0|||
147410522|NCT04879849|531666430|FG005|Overall Study|Progressive Disease|0|||
147410523|NCT04879849|531666431|FG006|Overall Study|Progressive Disease|0|||
147410524|NCT04879849|531666432|FG007|Overall Study|Progressive Disease|0|||
147410525|NCT04879849|531666425|FG000|Overall Study|Death|0|||
147410526|NCT04879849|531666426|FG001|Overall Study|Death|0|||
147410527|NCT04879849|531666427|FG002|Overall Study|Death|1|||
147410528|NCT04879849|531666428|FG003|Overall Study|Death|1|||
147410529|NCT04879849|531666429|FG004|Overall Study|Death|1|||
147410530|NCT04879849|531666430|FG005|Overall Study|Death|2|||
147410531|NCT04879849|531666431|FG006|Overall Study|Death|1|||
147410532|NCT04879849|531666432|FG007|Overall Study|Death|2|||
147410533|NCT04879849|531666425|FG000|Overall Study|Completion of Follow-up Period and Assessments|0|||
147410534|NCT04879849|531666426|FG001|Overall Study|Completion of Follow-up Period and Assessments|1|||
147302288|NCT01064297|531272572|FG000|Overall Study|Lost to Follow-up|791|||
147302289|NCT01064297|531272573|FG001|Overall Study|Lost to Follow-up|48|||
147302290|NCT01064297|531272574|FG002|Overall Study|Lost to Follow-up|133|||
147302291|NCT00316173|531272589|FG000|Run-in Phase|Adverse Event|1|||
147302292|NCT00316173|531272590|FG001|Run-in Phase|Adverse Event|0|||
147302293|NCT00316173|531272589|FG000|Run-in Phase|Protocol Violation|1|||
147302294|NCT00316173|531272590|FG001|Run-in Phase|Protocol Violation|0|||
147302295|NCT00316173|531272589|FG000|Run-in Phase|Study Follow-up Stopped|5|||
147302296|NCT00316173|531272590|FG001|Run-in Phase|Study Follow-up Stopped|0|||
147302297|NCT00316173|531272589|FG000|Treatment Phase|Adverse Event|0|||
147302298|NCT00316173|531272590|FG001|Treatment Phase|Adverse Event|1|||
147302299|NCT00316173|531272589|FG000|Treatment Phase|Lack of Efficacy|0|||
147302300|NCT00316173|531272590|FG001|Treatment Phase|Lack of Efficacy|3|||
147302301|NCT00316173|531272589|FG000|Treatment Phase|Lost to Follow-up|0|||
147302302|NCT00316173|531272590|FG001|Treatment Phase|Lost to Follow-up|3|||
147302303|NCT00316173|531272589|FG000|Treatment Phase|Withdrawal by Subject|0|||
147302304|NCT00316173|531272590|FG001|Treatment Phase|Withdrawal by Subject|1|||
147302305|NCT00316173|531272589|FG000|Treatment Phase|Study Follow-up Stopped|0|||
147302306|NCT00316173|531272590|FG001|Treatment Phase|Study Follow-up Stopped|34|||
147302307|NCT00558064|531272592|FG000|Overall Study|Adverse Event|3|||
147302308|NCT00558064|531272593|FG001|Overall Study|Adverse Event|2|||
147302309|NCT00558064|531272592|FG000|Overall Study|Lack of Efficacy|0|||
147302310|NCT00558064|531272593|FG001|Overall Study|Lack of Efficacy|1|||
147302311|NCT00558064|531272592|FG000|Overall Study|Protocol Violation|1|||
147302312|NCT00558064|531272593|FG001|Overall Study|Protocol Violation|0|||
147302313|NCT00558064|531272592|FG000|Overall Study|Lost to Follow-up|0|||
147302314|NCT00558064|531272593|FG001|Overall Study|Lost to Follow-up|1|||
147302315|NCT00558064|531272592|FG000|Overall Study|Withdrawal by Subject|0|||
147302316|NCT00558064|531272593|FG001|Overall Study|Withdrawal by Subject|1|||
147302317|NCT00558064|531272592|FG000|Overall Study|No visit within allowance period|1|||
147302318|NCT00558064|531272593|FG001|Overall Study|No visit within allowance period|0|||
147302319|NCT02027402|531272596|FG000|Overall Study|Withdrawal by Subject|4|||
147302320|NCT02027402|531272597|FG001|Overall Study|Withdrawal by Subject|1|||
147302321|NCT00982930|531272598|FG000|Overall Study|Adverse Event|1|||
147302322|NCT00982930|531272598|FG000|Overall Study|Withdrawal by Subject|1|||
147302323|NCT00982930|531272598|FG000|Overall Study|Administrative Problems|2|||
147302324|NCT00112580|531272599|FG000|Overall Study|Adverse Event|1|||
147302325|NCT00112580|531272600|FG001|Overall Study|Adverse Event|2|||
147302326|NCT00112580|531272599|FG000|Overall Study|Disease progression|5|||
147302327|NCT00112580|531272600|FG001|Overall Study|Disease progression|16|||
147302328|NCT00112580|531272599|FG000|Overall Study|Participant withdrew consent|2|||
147302329|NCT00112580|531272600|FG001|Overall Study|Participant withdrew consent|1|||
147302330|NCT05597722|531272603|FG000|Overall Study|Study was terminated|6|||
147618333|NCT05201794|532419077|FG001|Overall Study|Non-Compliance With Study Drug|3|||
147618334|NCT05201794|532419078|FG002|Overall Study|Non-Compliance With Study Drug|3|||
147618335|NCT05201794|532419079|FG003|Overall Study|Non-Compliance With Study Drug|0|||
147302331|NCT05597722|531272604|FG001|Overall Study|Study was terminated|1|||
147302332|NCT00404495|531272605|FG000|Overall Study|Death|37|||
147302333|NCT00404495|531272606|FG001|Overall Study|Death|11|||
147302334|NCT00404495|531272605|FG000|Overall Study|Lost to Follow-up|5|||
147302335|NCT00404495|531272606|FG001|Overall Study|Lost to Follow-up|0|||
147302336|NCT00404495|531272605|FG000|Overall Study|Other|1|||
147302337|NCT00404495|531272606|FG001|Overall Study|Other|0|||
147302338|NCT00404495|531272605|FG000|Overall Study|Withdrawal by Subject|1|||
147302339|NCT00404495|531272606|FG001|Overall Study|Withdrawal by Subject|0|||
147302340|NCT04108000|531272607|FG000|Overall Study|Death of patient|1|||
147302341|NCT04108000|531272608|FG001|Overall Study|Death of patient|0|||
147302342|NCT04108000|531272609|FG002|Overall Study|Death of patient|1|||
147302343|NCT04108000|531272610|FG003|Overall Study|Death of patient|0|||
147302344|NCT04108000|531272607|FG000|Overall Study|Withdrawal by Subject|2|||
147302345|NCT04108000|531272608|FG001|Overall Study|Withdrawal by Subject|2|||
147618336|NCT05201794|532419076|FG000|Overall Study|Physician Decision|1|||
147618337|NCT05201794|532419077|FG001|Overall Study|Physician Decision|3|||
147618338|NCT05201794|532419078|FG002|Overall Study|Physician Decision|2|||
147302346|NCT04108000|531272609|FG002|Overall Study|Withdrawal by Subject|0|||
147302347|NCT04108000|531272610|FG003|Overall Study|Withdrawal by Subject|0|||
147302348|NCT04108000|531272607|FG000|Overall Study|Death of surrogate partner|0|||
147302349|NCT04108000|531272608|FG001|Overall Study|Death of surrogate partner|1|||
147302350|NCT04108000|531272609|FG002|Overall Study|Death of surrogate partner|0|||
147302351|NCT04108000|531272610|FG003|Overall Study|Death of surrogate partner|1|||
147302352|NCT03904043|531272613|FG000|Overall Study|Adverse Event|1|||
147302353|NCT03904043|531272614|FG001|Overall Study|Adverse Event|1|||
147302354|NCT03904043|531272613|FG000|Overall Study|Withdrawal by Subject|1|||
147302355|NCT03904043|531272614|FG001|Overall Study|Withdrawal by Subject|0|||
147302356|NCT03904043|531272613|FG000|Overall Study|Non-compliance|1|||
147302357|NCT03904043|531272614|FG001|Overall Study|Non-compliance|0|||
147302358|NCT03904043|531272613|FG000|Overall Study|Did not start treatment|1|||
147618339|NCT05201794|532419079|FG003|Overall Study|Physician Decision|0|||
147665664|NCT03810456|532599665|FG000|3 Month Follow-Up|Lost to Follow-up|11|||
147665665|NCT03810456|532599666|FG001|3 Month Follow-Up|Lost to Follow-up|11|||
147665666|NCT03810456|532599667|FG002|3 Month Follow-Up|Lost to Follow-up|14|||
147665667|NCT03810456|532599665|FG000|3 Month Follow-Up|Withdrawal by Subject|1|||
147665668|NCT03810456|532599666|FG001|3 Month Follow-Up|Withdrawal by Subject|0|||
147665669|NCT03810456|532599667|FG002|3 Month Follow-Up|Withdrawal by Subject|0|||
147665670|NCT03810456|532599665|FG000|6 Month Follow-Up|Lost to Follow-up|12|||
147665671|NCT03810456|532599666|FG001|6 Month Follow-Up|Lost to Follow-up|9|||
147665672|NCT03810456|532599667|FG002|6 Month Follow-Up|Lost to Follow-up|18|||
147665673|NCT03810456|532599665|FG000|6 Month Follow-Up|Withdrawal by Subject|1|||
147665674|NCT03810456|532599666|FG001|6 Month Follow-Up|Withdrawal by Subject|0|||
147665675|NCT03810456|532599667|FG002|6 Month Follow-Up|Withdrawal by Subject|0|||
147665676|NCT02100124|532599672|FG000|Overall Study|Lost to Follow-up|5|||
147665677|NCT02100124|532599673|FG001|Overall Study|Lost to Follow-up|11|||
147665678|NCT02100124|532599674|FG002|Overall Study|Lost to Follow-up|3|||
147665679|NCT02100124|532599672|FG000|Overall Study|Withdrawal by Subject|1|||
147665680|NCT02100124|532599673|FG001|Overall Study|Withdrawal by Subject|0|||
147618340|NCT05201794|532419076|FG000|Overall Study|Lost to Follow-up|2|||
147618341|NCT05201794|532419077|FG001|Overall Study|Lost to Follow-up|2|||
147618342|NCT05201794|532419078|FG002|Overall Study|Lost to Follow-up|0|||
147618343|NCT05201794|532419079|FG003|Overall Study|Lost to Follow-up|0|||
147618344|NCT05201794|532419076|FG000|Overall Study|Non-Compliance With Study Schedule|1|||
147618345|NCT05201794|532419077|FG001|Overall Study|Non-Compliance With Study Schedule|1|||
147618346|NCT05201794|532419078|FG002|Overall Study|Non-Compliance With Study Schedule|1|||
147618347|NCT05201794|532419079|FG003|Overall Study|Non-Compliance With Study Schedule|0|||
147618348|NCT05201794|532419076|FG000|Overall Study|Protocol Violation|2|||
147618349|NCT05201794|532419077|FG001|Overall Study|Protocol Violation|0|||
147618350|NCT05201794|532419078|FG002|Overall Study|Protocol Violation|1|||
147618351|NCT05201794|532419079|FG003|Overall Study|Protocol Violation|0|||
147618352|NCT05201794|532419076|FG000|Overall Study|Death|1|||
147618353|NCT05201794|532419077|FG001|Overall Study|Death|0|||
147618354|NCT05201794|532419078|FG002|Overall Study|Death|0|||
147618355|NCT05201794|532419079|FG003|Overall Study|Death|0|||
147618356|NCT05201794|532419076|FG000|Overall Study|Site Terminated By Sponsor|0|||
147618357|NCT05201794|532419077|FG001|Overall Study|Site Terminated By Sponsor|1|||
147618358|NCT05201794|532419078|FG002|Overall Study|Site Terminated By Sponsor|0|||
147618359|NCT05201794|532419079|FG003|Overall Study|Site Terminated By Sponsor|0|||
147302359|NCT03904043|531272614|FG001|Overall Study|Did not start treatment|0|||
147302360|NCT05559866|531272615|FG000|Overall Study|Withdrawal by Subject|1|||
147302361|NCT05559866|531272616|FG001|Overall Study|Withdrawal by Subject|0|||
147302362|NCT05619003|531272617|FG000|Overall Study|Adverse Event|1|||
147302363|NCT03538951|531272618|FG000|Overall Study|Withdrawal by Subject|1|||
147302364|NCT03538951|531272619|FG001|Overall Study|Withdrawal by Subject|2|||
147302365|NCT07018999|531272625|FG000|Overall Study|Protocol Violation|0|||
147302366|NCT07018999|531272626|FG001|Overall Study|Protocol Violation|1|||
147302367|NCT07018999|531272625|FG000|Overall Study|Incomplete data entry|4|||
147302368|NCT07018999|531272626|FG001|Overall Study|Incomplete data entry|7|||
147302369|NCT03444376|531272627|FG000|Part A|Disease relapse or Progression|1|||
147302370|NCT03444376|531272627|FG000|Part A|Withdrawal by Subject|2|||
147302371|NCT03444376|531272627|FG000|Part A|Adverse Event|1|||
147618360|NCT05201794|532419076|FG000|Overall Study|Other|3|||
147618361|NCT05201794|532419077|FG001|Overall Study|Other|3|||
147618362|NCT05201794|532419078|FG002|Overall Study|Other|3|||
147618363|NCT05201794|532419079|FG003|Overall Study|Other|0|||
147618364|NCT05201794|532419076|FG000|Overall Study|Randomized But Not Treated|1|||
147618365|NCT05201794|532419077|FG001|Overall Study|Randomized But Not Treated|2|||
147618366|NCT05201794|532419078|FG002|Overall Study|Randomized But Not Treated|1|||
147618367|NCT05201794|532419079|FG003|Overall Study|Randomized But Not Treated|0|||
147618368|NCT04653454|532419082|FG000|Overall Study|Withdrawal by Subject|1|||
147665681|NCT02100124|532599674|FG002|Overall Study|Withdrawal by Subject|0|||
147665682|NCT04350827|532599679|FG000|Overall Study|Lost to Follow-up|1|||
147665683|NCT04350827|532599680|FG001|Overall Study|Lost to Follow-up|2|||
147618369|NCT04653454|532419082|FG000|Overall Study|Physician Decision|40|||
147302372|NCT03444376|531272627|FG000|Part B|Disease relapse or Progression|18|||
147302373|NCT03444376|531272627|FG000|Part B|Withdrawal by Subject|2|||
147302374|NCT03444376|531272627|FG000|Part B|Adverse Event|2|||
147302375|NCT03444376|531272627|FG000|Part B|Physician Decision|1|||
147302376|NCT03444376|531272627|FG000|Part C|Disease relapse or Progression|43|||
147618370|NCT02763046|532419083|FG000|Overall Study|Adverse Event|5|||
147618371|NCT02763046|532419084|FG001|Overall Study|Adverse Event|4|||
147618372|NCT02763046|532419085|FG002|Overall Study|Adverse Event|0|||
147618373|NCT02763046|532419083|FG000|Overall Study|Lack of Efficacy|1|||
147618374|NCT02763046|532419084|FG001|Overall Study|Lack of Efficacy|1|||
147618375|NCT02763046|532419085|FG002|Overall Study|Lack of Efficacy|3|||
147618376|NCT02763046|532419083|FG000|Overall Study|Physician Decision|1|||
147665684|NCT04265261|532599681|FG000|Overall Study|Adverse Event|2|||
147665685|NCT04265261|532599682|FG001|Overall Study|Adverse Event|0|||
147665686|NCT04265261|532599683|FG002|Overall Study|Adverse Event|0|||
147665687|NCT04265261|532599681|FG000|Overall Study|Death|1|||
147618377|NCT02763046|532419084|FG001|Overall Study|Physician Decision|0|||
147618378|NCT02763046|532419085|FG002|Overall Study|Physician Decision|1|||
147618379|NCT02763046|532419083|FG000|Overall Study|Subject/guardian decision|2|||
147618380|NCT02763046|532419084|FG001|Overall Study|Subject/guardian decision|0|||
147618381|NCT02763046|532419085|FG002|Overall Study|Subject/guardian decision|4|||
147618382|NCT00086684|532419088|FG000|Overall Study|Adverse Event|12|||
147302377|NCT03444376|531272627|FG000|Part C|Withdrawal by Subject|5|||
147302378|NCT03444376|531272627|FG000|Part C|Adverse Event|2|||
147302379|NCT03444376|531272627|FG000|Part C|Physician Decision|2|||
147302380|NCT03444376|531272627|FG000|Part C|Death|1|||
147302381|NCT06027619|531272628|FG000|Overall Study|Adverse Event|0|||
147302382|NCT06027619|531272629|FG001|Overall Study|Adverse Event|0|||
147302383|NCT06027619|531272630|FG002|Overall Study|Adverse Event|1|||
147302384|NCT00710606|531274359|FG000|Overall Study|Adverse Event|0|||
147302385|NCT00710606|531274360|FG001|Overall Study|Adverse Event|2|||
147302386|NCT01682213|531274371|FG000|Overall Study|Withdrawal by Subject|2|||
147302387|NCT01264380|531274372|FG000|Period C|Disease Progression|0|||
147302388|NCT01264380|531274373|FG001|Period C|Disease Progression|0|||
147302389|NCT01264380|531274374|FG002|Period C|Disease Progression|4|||
147302390|NCT01264380|531274372|FG000|Period C|Death|0|||
147302391|NCT01264380|531274373|FG001|Period C|Death|0|||
147302392|NCT01264380|531274374|FG002|Period C|Death|2|||
147302393|NCT01264380|531274372|FG000|Period C|Follow-up for survival status|0|||
147302394|NCT01264380|531274373|FG001|Period C|Follow-up for survival status|0|||
147302395|NCT01264380|531274374|FG002|Period C|Follow-up for survival status|6|||
147302396|NCT01264380|531274372|FG000|Period C|Withdrawal by Subject|0|||
147302397|NCT01264380|531274373|FG001|Period C|Withdrawal by Subject|0|||
147302398|NCT01264380|531274374|FG002|Period C|Withdrawal by Subject|1|||
147302399|NCT01264380|531274372|FG000|Period C|Adverse Event|0|||
147302400|NCT01264380|531274373|FG001|Period C|Adverse Event|0|||
147302401|NCT01264380|531274374|FG002|Period C|Adverse Event|1|||
147302402|NCT01147822|531274375|FG000|Overall Study|Lost to Follow-up|14|||
147302403|NCT01147822|531274376|FG001|Overall Study|Lost to Follow-up|6|||
147302404|NCT01147822|531274375|FG000|Overall Study|Withdrawal by Subject|10|||
147302405|NCT01147822|531274376|FG001|Overall Study|Withdrawal by Subject|16|||
147302406|NCT01147822|531274375|FG000|Overall Study|Physician Decision|9|||
147302407|NCT01147822|531274376|FG001|Overall Study|Physician Decision|8|||
147302408|NCT01147822|531274375|FG000|Overall Study|Transitioned to another mechanism of continuing pazopanib or sunitinib therapy after 30SEP2013|4|||
147302409|NCT01147822|531274376|FG001|Overall Study|Transitioned to another mechanism of continuing pazopanib or sunitinib therapy after 30SEP2013|5|||
147302410|NCT01147822|531274375|FG000|Overall Study|Protocol Violation|1|||
147302411|NCT01147822|531274376|FG001|Overall Study|Protocol Violation|1|||
147302412|NCT00261495|531274380|FG000|Titration Phase (Weeks 0 to 4)|Adverse Event|28|||
147302413|NCT00261495|531274381|FG001|Titration Phase (Weeks 0 to 4)|Adverse Event|36|||
147302414|NCT00261495|531274380|FG000|Titration Phase (Weeks 0 to 4)|Withdrawal by Subject|6|||
147302415|NCT00261495|531274381|FG001|Titration Phase (Weeks 0 to 4)|Withdrawal by Subject|11|||
147302416|NCT00261495|531274380|FG000|Titration Phase (Weeks 0 to 4)|Lack of Efficacy|8|||
147302417|NCT00261495|531274381|FG001|Titration Phase (Weeks 0 to 4)|Lack of Efficacy|8|||
147302418|NCT00261495|531274380|FG000|Titration Phase (Weeks 0 to 4)|Physician Decision|3|||
147302419|NCT00261495|531274381|FG001|Titration Phase (Weeks 0 to 4)|Physician Decision|1|||
147302420|NCT00261495|531274380|FG000|Titration Phase (Weeks 0 to 4)|Non-compliance|2|||
147302421|NCT00261495|531274381|FG001|Titration Phase (Weeks 0 to 4)|Non-compliance|5|||
147302422|NCT00261495|531274380|FG000|Titration Phase (Weeks 0 to 4)|Protocol Violation|1|||
147302423|NCT00261495|531274381|FG001|Titration Phase (Weeks 0 to 4)|Protocol Violation|4|||
147302424|NCT00261495|531274380|FG000|Maintenance Phase (Weeks 4 to 24)|Adverse Event|29|||
147302425|NCT00261495|531274381|FG001|Maintenance Phase (Weeks 4 to 24)|Adverse Event|20|||
147302426|NCT00261495|531274380|FG000|Maintenance Phase (Weeks 4 to 24)|Lack of Efficacy|14|||
147302427|NCT00261495|531274381|FG001|Maintenance Phase (Weeks 4 to 24)|Lack of Efficacy|10|||
147302428|NCT00261495|531274380|FG000|Maintenance Phase (Weeks 4 to 24)|Withdrawal by Subject|6|||
147618383|NCT00086684|532419089|FG001|Overall Study|Adverse Event|17|||
147618384|NCT00086684|532419090|FG002|Overall Study|Adverse Event|14|||
147302429|NCT00261495|531274381|FG001|Maintenance Phase (Weeks 4 to 24)|Withdrawal by Subject|5|||
147302430|NCT00261495|531274380|FG000|Maintenance Phase (Weeks 4 to 24)|Non-compliance|1|||
147302431|NCT00261495|531274381|FG001|Maintenance Phase (Weeks 4 to 24)|Non-compliance|5|||
147302432|NCT00261495|531274380|FG000|Maintenance Phase (Weeks 4 to 24)|Protocol Violation|5|||
147302433|NCT00261495|531274381|FG001|Maintenance Phase (Weeks 4 to 24)|Protocol Violation|2|||
147302434|NCT00261495|531274380|FG000|Maintenance Phase (Weeks 4 to 24)|Other|6|||
147302435|NCT00261495|531274381|FG001|Maintenance Phase (Weeks 4 to 24)|Other|5|||
147302436|NCT00261495|531274380|FG000|Maintenance Phase (Weeks 4 to 24)|Physician Decision|1|||
147302437|NCT00261495|531274381|FG001|Maintenance Phase (Weeks 4 to 24)|Physician Decision|1|||
147302438|NCT00261495|531274380|FG000|Maintenance Phase (Weeks 4 to 24)|Treatment completed, no follow-up|2|||
147302439|NCT00261495|531274381|FG001|Maintenance Phase (Weeks 4 to 24)|Treatment completed, no follow-up|0|||
147302440|NCT00261495|531274380|FG000|Maintenance Phase (Weeks 4 to 24)|Lost to Follow-up|2|||
147618385|NCT00086684|532419088|FG000|Overall Study|Lack of Efficacy|6|||
147618386|NCT00086684|532419089|FG001|Overall Study|Lack of Efficacy|6|||
147618387|NCT00086684|532419090|FG002|Overall Study|Lack of Efficacy|5|||
147618388|NCT00086684|532419088|FG000|Overall Study|Lost to Follow-up|15|||
147618389|NCT00086684|532419089|FG001|Overall Study|Lost to Follow-up|8|||
147618390|NCT00086684|532419090|FG002|Overall Study|Lost to Follow-up|10|||
147618391|NCT00086684|532419088|FG000|Overall Study|Protocol Violation|8|||
147618392|NCT00086684|532419089|FG001|Overall Study|Protocol Violation|3|||
147618393|NCT00086684|532419090|FG002|Overall Study|Protocol Violation|0|||
147618394|NCT00086684|532419088|FG000|Overall Study|Withdrawal by Subject|0|||
147618395|NCT00086684|532419089|FG001|Overall Study|Withdrawal by Subject|4|||
147618396|NCT00086684|532419090|FG002|Overall Study|Withdrawal by Subject|10|||
147618397|NCT00086684|532419088|FG000|Overall Study|NONCOMPLIANCE|5|||
147618398|NCT00086684|532419089|FG001|Overall Study|NONCOMPLIANCE|7|||
147618399|NCT00086684|532419090|FG002|Overall Study|NONCOMPLIANCE|6|||
147618400|NCT00086684|532419088|FG000|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
147618401|NCT00086684|532419089|FG001|Overall Study|STUDY TERMINATED BY SPONSOR|1|||
147618402|NCT00086684|532419090|FG002|Overall Study|STUDY TERMINATED BY SPONSOR|0|||
147618403|NCT00086684|532419088|FG000|Overall Study|WITHDRAWAL OF CONSENT|5|||
147618404|NCT00086684|532419089|FG001|Overall Study|WITHDRAWAL OF CONSENT|7|||
147618405|NCT00086684|532419090|FG002|Overall Study|WITHDRAWAL OF CONSENT|5|||
147618406|NCT00086684|532419088|FG000|Overall Study|Other|4|||
147618407|NCT00086684|532419089|FG001|Overall Study|Other|2|||
147302441|NCT00261495|531274381|FG001|Maintenance Phase (Weeks 4 to 24)|Lost to Follow-up|0|||
147410535|NCT04879849|531666427|FG002|Overall Study|Completion of Follow-up Period and Assessments|0|||
147410536|NCT04879849|531666428|FG003|Overall Study|Completion of Follow-up Period and Assessments|1|||
147618408|NCT00086684|532419090|FG002|Overall Study|Other|3|||
147302442|NCT00261495|531274380|FG000|Extension Phase (Weeks 24 to 52)|Other|4|||
147302443|NCT00261495|531274381|FG001|Extension Phase (Weeks 24 to 52)|Other|2|||
147302444|NCT00261495|531274380|FG000|Extension Phase (Weeks 24 to 52)|Adverse Event|4|||
147302445|NCT00261495|531274381|FG001|Extension Phase (Weeks 24 to 52)|Adverse Event|1|||
147302446|NCT00261495|531274380|FG000|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|0|||
147302447|NCT00261495|531274381|FG001|Extension Phase (Weeks 24 to 52)|Lack of Efficacy|1|||
147302448|NCT00261495|531274380|FG000|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|0|||
147302449|NCT00261495|531274381|FG001|Extension Phase (Weeks 24 to 52)|Withdrawal by Subject|1|||
147302450|NCT00261495|531274380|FG000|Extension Phase (Weeks 24 to 52)|Non-compliance|1|||
147302451|NCT00261495|531274381|FG001|Extension Phase (Weeks 24 to 52)|Non-compliance|0|||
147302452|NCT00261495|531274380|FG000|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|1|||
147302453|NCT00261495|531274381|FG001|Extension Phase (Weeks 24 to 52)|Lost to Follow-up|0|||
147302454|NCT03474107|531274382|FG000|Overall Study|Adverse Event|42|||
147302455|NCT03474107|531274383|FG001|Overall Study|Adverse Event|46|||
147302456|NCT03474107|531274382|FG000|Overall Study|Death|2|||
147302457|NCT03474107|531274383|FG001|Overall Study|Death|2|||
147302458|NCT03474107|531274382|FG000|Overall Study|Lost to Follow-up|0|||
147302459|NCT03474107|531274383|FG001|Overall Study|Lost to Follow-up|1|||
147302460|NCT03474107|531274382|FG000|Overall Study|Progressive Disease|177|||
147302461|NCT03474107|531274383|FG001|Overall Study|Progressive Disease|180|||
147302462|NCT03474107|531274382|FG000|Overall Study|Protocol Violation|1|||
147302463|NCT03474107|531274383|FG001|Overall Study|Protocol Violation|1|||
147302464|NCT03474107|531274382|FG000|Overall Study|Withdrawal by Subject|15|||
147302465|NCT03474107|531274383|FG001|Overall Study|Withdrawal by Subject|27|||
147302466|NCT03474107|531274382|FG000|Overall Study|Physician Decision|7|||
147302467|NCT03474107|531274383|FG001|Overall Study|Physician Decision|22|||
147302468|NCT03474107|531274382|FG000|Overall Study|Miscellaneous|1|||
147302469|NCT03474107|531274383|FG001|Overall Study|Miscellaneous|6|||
147302470|NCT01330316|531274387|FG000|Overall Study|Adverse Event|2|||
147302471|NCT01330316|531274388|FG001|Overall Study|Adverse Event|2|||
147302472|NCT01330316|531274387|FG000|Overall Study|Lack of Efficacy|0|||
147302473|NCT01330316|531274388|FG001|Overall Study|Lack of Efficacy|10|||
147302474|NCT01330316|531274387|FG000|Overall Study|Lost to Follow-up|0|||
147302475|NCT01330316|531274388|FG001|Overall Study|Lost to Follow-up|1|||
147302476|NCT01330316|531274387|FG000|Overall Study|Withdrawal by Subject|0|||
147302477|NCT01330316|531274388|FG001|Overall Study|Withdrawal by Subject|1|||
147302478|NCT01330316|531274387|FG000|Overall Study|other than above|0|||
147302479|NCT01330316|531274388|FG001|Overall Study|other than above|1|||
147302480|NCT01337986|531274389|FG000|Overall Study|Adverse Event|2|||
147302481|NCT01337986|531274390|FG001|Overall Study|Adverse Event|2|||
147302482|NCT01337986|531274389|FG000|Overall Study|Lost to Follow-up|1|||
147618409|NCT01067105|532419093|FG000|Overall Study|Adverse Event|14|||
147618410|NCT01067105|532419093|FG000|Overall Study|Protocol Violation|48|||
147302483|NCT01337986|531274390|FG001|Overall Study|Lost to Follow-up|0|||
147302484|NCT01337986|531274389|FG000|Overall Study|Protocol Violation|0|||
147302485|NCT01337986|531274390|FG001|Overall Study|Protocol Violation|3|||
147302486|NCT02287584|531274391|FG000|the Double-blind Phase|Adverse Event|17|||
147302487|NCT02287584|531274392|FG001|the Double-blind Phase|Adverse Event|17|||
147302488|NCT02287584|531274393|FG002|the Double-blind Phase|Adverse Event|12|||
147302489|NCT02287584|531274394|FG003|the Double-blind Phase|Adverse Event|0|||
147302490|NCT02287584|531274395|FG004|the Double-blind Phase|Adverse Event|0|||
147302491|NCT02287584|531274396|FG005|the Double-blind Phase|Adverse Event|0|||
147302492|NCT02287584|531274391|FG000|the Double-blind Phase|Lack of Efficacy|18|||
147302493|NCT02287584|531274392|FG001|the Double-blind Phase|Lack of Efficacy|8|||
147302494|NCT02287584|531274393|FG002|the Double-blind Phase|Lack of Efficacy|8|||
147302495|NCT02287584|531274394|FG003|the Double-blind Phase|Lack of Efficacy|0|||
147302496|NCT02287584|531274395|FG004|the Double-blind Phase|Lack of Efficacy|0|||
147302497|NCT02287584|531274396|FG005|the Double-blind Phase|Lack of Efficacy|0|||
147302498|NCT02287584|531274391|FG000|the Double-blind Phase|Lost to Follow-up|0|||
147302499|NCT02287584|531274392|FG001|the Double-blind Phase|Lost to Follow-up|1|||
147302500|NCT02287584|531274393|FG002|the Double-blind Phase|Lost to Follow-up|1|||
147302501|NCT02287584|531274394|FG003|the Double-blind Phase|Lost to Follow-up|0|||
147302502|NCT02287584|531274395|FG004|the Double-blind Phase|Lost to Follow-up|0|||
147302503|NCT02287584|531274396|FG005|the Double-blind Phase|Lost to Follow-up|0|||
147302504|NCT02287584|531274391|FG000|the Double-blind Phase|Withdrawal by Subject|17|||
147302505|NCT02287584|531274392|FG001|the Double-blind Phase|Withdrawal by Subject|17|||
147302506|NCT02287584|531274393|FG002|the Double-blind Phase|Withdrawal by Subject|11|||
147302507|NCT02287584|531274394|FG003|the Double-blind Phase|Withdrawal by Subject|0|||
147302508|NCT02287584|531274395|FG004|the Double-blind Phase|Withdrawal by Subject|0|||
147302509|NCT02287584|531274396|FG005|the Double-blind Phase|Withdrawal by Subject|0|||
147302510|NCT02287584|531274391|FG000|the Double-blind Phase|Pregnancy|0|||
147302511|NCT02287584|531274392|FG001|the Double-blind Phase|Pregnancy|1|||
147302512|NCT02287584|531274393|FG002|the Double-blind Phase|Pregnancy|0|||
147302513|NCT02287584|531274394|FG003|the Double-blind Phase|Pregnancy|0|||
147302514|NCT02287584|531274395|FG004|the Double-blind Phase|Pregnancy|0|||
147302515|NCT02287584|531274396|FG005|the Double-blind Phase|Pregnancy|0|||
147302516|NCT02287584|531274391|FG000|the Double-blind Phase|Protocol Violation|0|||
147302517|NCT02287584|531274392|FG001|the Double-blind Phase|Protocol Violation|3|||
147302518|NCT02287584|531274393|FG002|the Double-blind Phase|Protocol Violation|0|||
147302519|NCT02287584|531274394|FG003|the Double-blind Phase|Protocol Violation|0|||
147302520|NCT02287584|531274395|FG004|the Double-blind Phase|Protocol Violation|0|||
147302521|NCT02287584|531274396|FG005|the Double-blind Phase|Protocol Violation|0|||
147302522|NCT02287584|531274391|FG000|the Double-blind Phase|other reasons|0|||
147302523|NCT02287584|531274392|FG001|the Double-blind Phase|other reasons|0|||
147302524|NCT02287584|531274393|FG002|the Double-blind Phase|other reasons|1|||
147302525|NCT02287584|531274394|FG003|the Double-blind Phase|other reasons|0|||
147302526|NCT02287584|531274395|FG004|the Double-blind Phase|other reasons|0|||
147302527|NCT02287584|531274396|FG005|the Double-blind Phase|other reasons|0|||
147302528|NCT02287584|531274391|FG000|the Open-label Phase|Did not receive drug|0|||
147302529|NCT02287584|531274392|FG001|the Open-label Phase|Did not receive drug|0|||
147302530|NCT02287584|531274393|FG002|the Open-label Phase|Did not receive drug|0|||
147302531|NCT02287584|531274394|FG003|the Open-label Phase|Did not receive drug|7|||
147302532|NCT02287584|531274395|FG004|the Open-label Phase|Did not receive drug|6|||
147302533|NCT02287584|531274396|FG005|the Open-label Phase|Did not receive drug|4|||
147302534|NCT02287584|531274391|FG000|the Open-label Phase|Adverse Event|0|||
147302535|NCT02287584|531274392|FG001|the Open-label Phase|Adverse Event|0|||
147302536|NCT02287584|531274393|FG002|the Open-label Phase|Adverse Event|0|||
147302537|NCT02287584|531274394|FG003|the Open-label Phase|Adverse Event|15|||
147302538|NCT02287584|531274395|FG004|the Open-label Phase|Adverse Event|12|||
147302539|NCT02287584|531274396|FG005|the Open-label Phase|Adverse Event|16|||
147302540|NCT02287584|531274391|FG000|the Open-label Phase|Lack of Efficacy|0|||
147302541|NCT02287584|531274392|FG001|the Open-label Phase|Lack of Efficacy|0|||
147302542|NCT02287584|531274393|FG002|the Open-label Phase|Lack of Efficacy|0|||
147302543|NCT02287584|531274394|FG003|the Open-label Phase|Lack of Efficacy|8|||
147302544|NCT02287584|531274395|FG004|the Open-label Phase|Lack of Efficacy|3|||
147302545|NCT02287584|531274396|FG005|the Open-label Phase|Lack of Efficacy|7|||
147302546|NCT02287584|531274391|FG000|the Open-label Phase|Lost to Follow-up|0|||
147302547|NCT02287584|531274392|FG001|the Open-label Phase|Lost to Follow-up|0|||
147302548|NCT02287584|531274393|FG002|the Open-label Phase|Lost to Follow-up|0|||
147302549|NCT02287584|531274394|FG003|the Open-label Phase|Lost to Follow-up|4|||
147302550|NCT02287584|531274395|FG004|the Open-label Phase|Lost to Follow-up|1|||
147302551|NCT02287584|531274396|FG005|the Open-label Phase|Lost to Follow-up|2|||
147302552|NCT02287584|531274391|FG000|the Open-label Phase|Withdrawal by Subject|0|||
147302553|NCT02287584|531274392|FG001|the Open-label Phase|Withdrawal by Subject|0|||
147618411|NCT01067105|532419093|FG000|Overall Study|Withdrawal by Subject|36|||
147618412|NCT01067105|532419093|FG000|Overall Study|Lost to Follow-up|6|||
147618413|NCT01067105|532419093|FG000|Overall Study|Physician Decision|6|||
147618414|NCT01067105|532419093|FG000|Overall Study|Other|31|||
147618415|NCT02203357|532419097|FG000|Overall Study|Lost to Follow-up|58|||
147302554|NCT02287584|531274393|FG002|the Open-label Phase|Withdrawal by Subject|0|||
147302555|NCT02287584|531274394|FG003|the Open-label Phase|Withdrawal by Subject|18|||
147302556|NCT02287584|531274395|FG004|the Open-label Phase|Withdrawal by Subject|29|||
147302557|NCT02287584|531274396|FG005|the Open-label Phase|Withdrawal by Subject|21|||
147302558|NCT02287584|531274391|FG000|the Open-label Phase|non-compliance|0|||
147302559|NCT02287584|531274392|FG001|the Open-label Phase|non-compliance|0|||
147302560|NCT02287584|531274393|FG002|the Open-label Phase|non-compliance|0|||
147302561|NCT02287584|531274394|FG003|the Open-label Phase|non-compliance|2|||
147618416|NCT02203357|532419098|FG001|Overall Study|Lost to Follow-up|66|||
147618417|NCT02203357|532419099|FG002|Overall Study|Lost to Follow-up|70|||
147618418|NCT02439216|532419100|FG000|PartA(7 Day Open-Label Treatment Period)|Screen failure|1|||
147410537|NCT04879849|531666429|FG004|Overall Study|Completion of Follow-up Period and Assessments|3|||
147410538|NCT04879849|531666430|FG005|Overall Study|Completion of Follow-up Period and Assessments|2|||
147410539|NCT04879849|531666431|FG006|Overall Study|Completion of Follow-up Period and Assessments|0|||
147410540|NCT04879849|531666432|FG007|Overall Study|Completion of Follow-up Period and Assessments|0|||
147410541|NCT04879849|531666425|FG000|Overall Study|Transfer to long term safety study, single-patient Investigational New Drug application, or similar|0|||
147410542|NCT04879849|531666426|FG001|Overall Study|Transfer to long term safety study, single-patient Investigational New Drug application, or similar|0|||
147410543|NCT04879849|531666427|FG002|Overall Study|Transfer to long term safety study, single-patient Investigational New Drug application, or similar|0|||
147410544|NCT04879849|531666428|FG003|Overall Study|Transfer to long term safety study, single-patient Investigational New Drug application, or similar|0|||
147410545|NCT04879849|531666429|FG004|Overall Study|Transfer to long term safety study, single-patient Investigational New Drug application, or similar|0|||
147410546|NCT04879849|531666430|FG005|Overall Study|Transfer to long term safety study, single-patient Investigational New Drug application, or similar|0|||
147410547|NCT04879849|531666431|FG006|Overall Study|Transfer to long term safety study, single-patient Investigational New Drug application, or similar|1|||
147410548|NCT04879849|531666432|FG007|Overall Study|Transfer to long term safety study, single-patient Investigational New Drug application, or similar|0|||
147410549|NCT04879849|531666425|FG000|Overall Study|Reason Not Specified|1|||
147410550|NCT04879849|531666426|FG001|Overall Study|Reason Not Specified|0|||
147410551|NCT04879849|531666427|FG002|Overall Study|Reason Not Specified|0|||
147410552|NCT04879849|531666428|FG003|Overall Study|Reason Not Specified|0|||
147410553|NCT04879849|531666429|FG004|Overall Study|Reason Not Specified|0|||
147410554|NCT04879849|531666430|FG005|Overall Study|Reason Not Specified|0|||
147410555|NCT04879849|531666431|FG006|Overall Study|Reason Not Specified|0|||
147410556|NCT04879849|531666432|FG007|Overall Study|Reason Not Specified|0|||
147410557|NCT04201262|531666434|FG000|Primary Treatment Period|Adverse Event|1|||
147410558|NCT04201262|531666435|FG001|Primary Treatment Period|Adverse Event|2|||
147410559|NCT04201262|531666434|FG000|Primary Treatment Period|Physician Decision|1|||
147410560|NCT04201262|531666435|FG001|Primary Treatment Period|Physician Decision|1|||
147410561|NCT04201262|531666434|FG000|Long-term Extension Period|Death|1|||
147410562|NCT04201262|531666435|FG001|Long-term Extension Period|Death|0|||
147410563|NCT02397447|531666439|FG000|Overall Study|Lost to Follow-up|2|||
147410564|NCT02397447|531666440|FG001|Overall Study|Lost to Follow-up|2|||
147410565|NCT02994069|531666441|FG000|Overall Study|Death|7|||
147410566|NCT02994069|531666442|FG001|Overall Study|Death|13|||
147410567|NCT02994069|531666441|FG000|Overall Study|Adverse Event|1|||
147410568|NCT02994069|531666442|FG001|Overall Study|Adverse Event|0|||
147410569|NCT02994069|531666441|FG000|Overall Study|Other|2|||
147410570|NCT02994069|531666442|FG001|Overall Study|Other|0|||
147410571|NCT02994069|531666441|FG000|Overall Study|still on follow up/treatment|5|||
147410572|NCT02994069|531666442|FG001|Overall Study|still on follow up/treatment|6|||
147410573|NCT05823012|531666443|FG000|Titration Period|Adverse Event|1|||
147410574|NCT05823012|531666443|FG000|Titration Period|Inability to Achieve a tolerable replacement dosage|3|||
147410575|NCT05823012|531666443|FG000|Maintenance Period|Adverse Event|1|||
147410576|NCT05823012|531666443|FG000|Maintenance Period|Inability to achieve a tolerable replacement dosage|1|||
147410577|NCT05823012|531666443|FG000|Maintenance Period|Inability to achieve an adequate replacement dosage|1|||
147410578|NCT03829501|531667983|FG000|Overall Study|Withdrawal of Consent|2|||
147410579|NCT03829501|531667984|FG001|Overall Study|Withdrawal of Consent|0|||
147410580|NCT03829501|531667985|FG002|Overall Study|Withdrawal of Consent|3|||
147410581|NCT03829501|531667986|FG003|Overall Study|Withdrawal of Consent|0|||
147410582|NCT03829501|531667987|FG004|Overall Study|Withdrawal of Consent|1|||
147410583|NCT03829501|531667988|FG005|Overall Study|Withdrawal of Consent|1|||
147410584|NCT03829501|531667989|FG006|Overall Study|Withdrawal of Consent|0|||
147410585|NCT03829501|531667990|FG007|Overall Study|Withdrawal of Consent|10|||
147410586|NCT03829501|531667991|FG008|Overall Study|Withdrawal of Consent|10|||
147410587|NCT03829501|531667992|FG009|Overall Study|Withdrawal of Consent|3|||
147410588|NCT03829501|531667993|FG010|Overall Study|Withdrawal of Consent|4|||
147410589|NCT03829501|531667994|FG011|Overall Study|Withdrawal of Consent|4|||
147410590|NCT03829501|531667995|FG012|Overall Study|Withdrawal of Consent|4|||
147410591|NCT03829501|531667996|FG013|Overall Study|Withdrawal of Consent|0|||
147410592|NCT03829501|531667997|FG014|Overall Study|Withdrawal of Consent|3|||
147410593|NCT03829501|531667998|FG015|Overall Study|Withdrawal of Consent|0|||
147410594|NCT03829501|531667999|FG016|Overall Study|Withdrawal of Consent|1|||
147410595|NCT03829501|531668000|FG017|Overall Study|Withdrawal of Consent|1|||
147410596|NCT03829501|531668001|FG018|Overall Study|Withdrawal of Consent|0|||
147410597|NCT03829501|531668002|FG019|Overall Study|Withdrawal of Consent|0|||
147410598|NCT03829501|531668003|FG020|Overall Study|Withdrawal of Consent|3|||
147410599|NCT03829501|531668004|FG021|Overall Study|Withdrawal of Consent|0|||
147410600|NCT03829501|531668005|FG022|Overall Study|Withdrawal of Consent|1|||
147410601|NCT03829501|531667983|FG000|Overall Study|PD|0|||
147618419|NCT02439216|532419101|FG001|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
147410602|NCT03829501|531667984|FG001|Overall Study|PD|0|||
147410603|NCT03829501|531667985|FG002|Overall Study|PD|0|||
147410604|NCT03829501|531667986|FG003|Overall Study|PD|2|||
147410605|NCT03829501|531667987|FG004|Overall Study|PD|0|||
147410606|NCT03829501|531667988|FG005|Overall Study|PD|0|||
147410607|NCT03829501|531667989|FG006|Overall Study|PD|0|||
147410608|NCT03829501|531667990|FG007|Overall Study|PD|0|||
147410609|NCT03829501|531667991|FG008|Overall Study|PD|0|||
147410610|NCT03829501|531667992|FG009|Overall Study|PD|0|||
147410611|NCT03829501|531667993|FG010|Overall Study|PD|0|||
147410612|NCT03829501|531667994|FG011|Overall Study|PD|0|||
147410613|NCT03829501|531667995|FG012|Overall Study|PD|0|||
147410614|NCT03829501|531667996|FG013|Overall Study|PD|0|||
147410615|NCT03829501|531667997|FG014|Overall Study|PD|0|||
147410616|NCT03829501|531667998|FG015|Overall Study|PD|1|||
147410617|NCT03829501|531667999|FG016|Overall Study|PD|0|||
147410618|NCT03829501|531668000|FG017|Overall Study|PD|0|||
147410619|NCT03829501|531668001|FG018|Overall Study|PD|0|||
147410620|NCT03829501|531668002|FG019|Overall Study|PD|0|||
147410621|NCT03829501|531668003|FG020|Overall Study|PD|1|||
147410622|NCT03829501|531668004|FG021|Overall Study|PD|0|||
147410623|NCT03829501|531668005|FG022|Overall Study|PD|0|||
147410624|NCT03829501|531667983|FG000|Overall Study|Study Terminated by Sponsor|0|||
147410625|NCT03829501|531667984|FG001|Overall Study|Study Terminated by Sponsor|0|||
147410626|NCT03829501|531667985|FG002|Overall Study|Study Terminated by Sponsor|0|||
147410627|NCT03829501|531667986|FG003|Overall Study|Study Terminated by Sponsor|0|||
147410628|NCT03829501|531667987|FG004|Overall Study|Study Terminated by Sponsor|0|||
147410629|NCT03829501|531667988|FG005|Overall Study|Study Terminated by Sponsor|0|||
147410630|NCT03829501|531667989|FG006|Overall Study|Study Terminated by Sponsor|0|||
147410631|NCT03829501|531667990|FG007|Overall Study|Study Terminated by Sponsor|3|||
147410632|NCT03829501|531667991|FG008|Overall Study|Study Terminated by Sponsor|1|||
147410633|NCT03829501|531667992|FG009|Overall Study|Study Terminated by Sponsor|0|||
147410634|NCT03829501|531667993|FG010|Overall Study|Study Terminated by Sponsor|0|||
147410635|NCT03829501|531667994|FG011|Overall Study|Study Terminated by Sponsor|0|||
147410636|NCT03829501|531667995|FG012|Overall Study|Study Terminated by Sponsor|0|||
147410637|NCT03829501|531667996|FG013|Overall Study|Study Terminated by Sponsor|0|||
147410638|NCT03829501|531667997|FG014|Overall Study|Study Terminated by Sponsor|3|||
147410639|NCT03829501|531667998|FG015|Overall Study|Study Terminated by Sponsor|2|||
147410640|NCT03829501|531667999|FG016|Overall Study|Study Terminated by Sponsor|2|||
147410641|NCT03829501|531668000|FG017|Overall Study|Study Terminated by Sponsor|0|||
147410642|NCT03829501|531668001|FG018|Overall Study|Study Terminated by Sponsor|0|||
147410643|NCT03829501|531668002|FG019|Overall Study|Study Terminated by Sponsor|0|||
147410644|NCT03829501|531668003|FG020|Overall Study|Study Terminated by Sponsor|1|||
147410645|NCT03829501|531668004|FG021|Overall Study|Study Terminated by Sponsor|0|||
147410646|NCT03829501|531668005|FG022|Overall Study|Study Terminated by Sponsor|3|||
147410647|NCT03829501|531667983|FG000|Overall Study|Lost to Follow Up|0|||
147410648|NCT03829501|531667984|FG001|Overall Study|Lost to Follow Up|0|||
147410649|NCT03829501|531667985|FG002|Overall Study|Lost to Follow Up|0|||
147410650|NCT03829501|531667986|FG003|Overall Study|Lost to Follow Up|0|||
147410651|NCT03829501|531667987|FG004|Overall Study|Lost to Follow Up|1|||
147410652|NCT03829501|531667988|FG005|Overall Study|Lost to Follow Up|0|||
147410653|NCT03829501|531667989|FG006|Overall Study|Lost to Follow Up|0|||
147410654|NCT03829501|531667990|FG007|Overall Study|Lost to Follow Up|2|||
147410655|NCT03829501|531667991|FG008|Overall Study|Lost to Follow Up|2|||
147410656|NCT03829501|531667992|FG009|Overall Study|Lost to Follow Up|0|||
147410657|NCT03829501|531667993|FG010|Overall Study|Lost to Follow Up|2|||
147410658|NCT03829501|531667994|FG011|Overall Study|Lost to Follow Up|1|||
147410659|NCT03829501|531667995|FG012|Overall Study|Lost to Follow Up|0|||
147410660|NCT03829501|531667996|FG013|Overall Study|Lost to Follow Up|1|||
147410661|NCT03829501|531667997|FG014|Overall Study|Lost to Follow Up|1|||
147410662|NCT03829501|531667998|FG015|Overall Study|Lost to Follow Up|0|||
147410663|NCT03829501|531667999|FG016|Overall Study|Lost to Follow Up|0|||
147410664|NCT03829501|531668000|FG017|Overall Study|Lost to Follow Up|0|||
147410665|NCT03829501|531668001|FG018|Overall Study|Lost to Follow Up|0|||
147410666|NCT03829501|531668002|FG019|Overall Study|Lost to Follow Up|0|||
147410667|NCT03829501|531668003|FG020|Overall Study|Lost to Follow Up|0|||
147410668|NCT03829501|531668004|FG021|Overall Study|Lost to Follow Up|0|||
147410669|NCT03829501|531668005|FG022|Overall Study|Lost to Follow Up|1|||
147410670|NCT03829501|531667983|FG000|Overall Study|Death|2|||
147410671|NCT03829501|531667984|FG001|Overall Study|Death|4|||
147410672|NCT03829501|531667985|FG002|Overall Study|Death|5|||
147410673|NCT03829501|531667986|FG003|Overall Study|Death|6|||
147410674|NCT03829501|531667987|FG004|Overall Study|Death|5|||
147410675|NCT03829501|531667988|FG005|Overall Study|Death|4|||
147410676|NCT03829501|531667989|FG006|Overall Study|Death|5|||
147410677|NCT03829501|531667990|FG007|Overall Study|Death|24|||
147410678|NCT03829501|531667991|FG008|Overall Study|Death|22|||
147410679|NCT03829501|531667992|FG009|Overall Study|Death|6|||
147410680|NCT03829501|531667993|FG010|Overall Study|Death|3|||
147410681|NCT03829501|531667994|FG011|Overall Study|Death|10|||
147410682|NCT03829501|531667995|FG012|Overall Study|Death|10|||
147410683|NCT03829501|531667996|FG013|Overall Study|Death|5|||
147410684|NCT03829501|531667997|FG014|Overall Study|Death|7|||
147410685|NCT03829501|531667998|FG015|Overall Study|Death|2|||
147302562|NCT02287584|531274395|FG004|the Open-label Phase|non-compliance|5|||
147302563|NCT02287584|531274396|FG005|the Open-label Phase|non-compliance|1|||
147302564|NCT02287584|531274391|FG000|the Open-label Phase|other reasons|0|||
147302565|NCT02287584|531274392|FG001|the Open-label Phase|other reasons|0|||
147302566|NCT02287584|531274393|FG002|the Open-label Phase|other reasons|0|||
147618420|NCT02439216|532419102|FG002|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
147618421|NCT02439216|532419103|FG003|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
147618422|NCT02439216|532419104|FG004|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
147618423|NCT02439216|532419105|FG005|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
147618424|NCT02439216|532419106|FG006|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
147618425|NCT02439216|532419107|FG007|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
147618426|NCT02439216|532419108|FG008|PartA(7 Day Open-Label Treatment Period)|Screen failure|0|||
147618427|NCT02439216|532419100|FG000|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
147618428|NCT02439216|532419101|FG001|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
147618429|NCT02439216|532419102|FG002|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
147618430|NCT02439216|532419103|FG003|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
147618431|NCT02439216|532419104|FG004|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
147618432|NCT02439216|532419105|FG005|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
147618433|NCT02439216|532419106|FG006|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
147618434|NCT02439216|532419107|FG007|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|1|||
147618435|NCT02439216|532419108|FG008|Part C (138-week, Open-label Treatment)|Withdrawal by Subject|0|||
147618436|NCT02439216|532419100|FG000|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
147618437|NCT02439216|532419101|FG001|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
147618438|NCT02439216|532419102|FG002|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
147618439|NCT02439216|532419103|FG003|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
147618440|NCT02439216|532419104|FG004|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
147618441|NCT02439216|532419105|FG005|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
147618442|NCT02439216|532419106|FG006|Part C (138-week, Open-label Treatment)|Lost to Follow-up|0|||
147618443|NCT02439216|532419107|FG007|Part C (138-week, Open-label Treatment)|Lost to Follow-up|1|||
147618444|NCT02439216|532419108|FG008|Part C (138-week, Open-label Treatment)|Lost to Follow-up|2|||
147618445|NCT02439216|532419100|FG000|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
147302567|NCT02287584|531274394|FG003|the Open-label Phase|other reasons|3|||
147302568|NCT02287584|531274395|FG004|the Open-label Phase|other reasons|6|||
147302569|NCT02287584|531274396|FG005|the Open-label Phase|other reasons|6|||
147302570|NCT01492686|531274399|FG000|Double-blind Phase|Adverse Event|0|||
147302571|NCT01492686|531274400|FG001|Double-blind Phase|Adverse Event|2|||
147302572|NCT01492686|531274399|FG000|Double-blind Phase|Physician Decision|0|||
147302573|NCT01492686|531274400|FG001|Double-blind Phase|Physician Decision|1|||
147302574|NCT01492686|531274399|FG000|Double-blind Phase|Withdrawal by Subject|0|||
147302575|NCT01492686|531274400|FG001|Double-blind Phase|Withdrawal by Subject|2|||
147302576|NCT01492686|531274399|FG000|Double-blind Phase|Due to a discontinuation criterion|2|||
147302577|NCT01492686|531274400|FG001|Double-blind Phase|Due to a discontinuation criterion|3|||
147302578|NCT01492686|531274399|FG000|Open-label Phase|Adverse Event|1|||
147302579|NCT01492686|531274400|FG001|Open-label Phase|Adverse Event|2|||
147302580|NCT01492686|531274399|FG000|Open-label Phase|Physician Decision|1|||
147302581|NCT01492686|531274400|FG001|Open-label Phase|Physician Decision|0|||
147302582|NCT01492686|531274399|FG000|Open-label Phase|Withdrawal by Subject|6|||
147302583|NCT01492686|531274400|FG001|Open-label Phase|Withdrawal by Subject|7|||
147302584|NCT01492686|531274399|FG000|Open-label Phase|Due to a discontinuation criterion|4|||
147302585|NCT01492686|531274400|FG001|Open-label Phase|Due to a discontinuation criterion|9|||
147302586|NCT03430063|531274402|FG000|Overall Study|Adverse Event|0|||
147302587|NCT03430063|531274403|FG001|Overall Study|Adverse Event|1|||
147302588|NCT03430063|531274404|FG002|Overall Study|Adverse Event|0|||
147302589|NCT03430063|531274402|FG000|Overall Study|Death|3|||
147302590|NCT03430063|531274403|FG001|Overall Study|Death|2|||
147302591|NCT03430063|531274404|FG002|Overall Study|Death|3|||
147302592|NCT03430063|531274402|FG000|Overall Study|Lost to Follow-up|0|||
147302593|NCT03430063|531274403|FG001|Overall Study|Lost to Follow-up|1|||
147302594|NCT03430063|531274404|FG002|Overall Study|Lost to Follow-up|0|||
147302595|NCT03430063|531274402|FG000|Overall Study|Withdrawal by Subject|0|||
147302596|NCT03430063|531274403|FG001|Overall Study|Withdrawal by Subject|0|||
147302597|NCT03430063|531274404|FG002|Overall Study|Withdrawal by Subject|1|||
147302598|NCT03430063|531274402|FG000|Overall Study|Withdrawal of consent|3|||
147618446|NCT02439216|532419101|FG001|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
147618447|NCT02439216|532419102|FG002|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
147618448|NCT02439216|532419103|FG003|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
147302599|NCT03430063|531274403|FG001|Overall Study|Withdrawal of consent|1|||
147302600|NCT03430063|531274404|FG002|Overall Study|Withdrawal of consent|2|||
147302601|NCT03430063|531274402|FG000|Overall Study|Progressive disease|1|||
147302602|NCT03430063|531274403|FG001|Overall Study|Progressive disease|2|||
147618449|NCT02439216|532419104|FG004|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
147618450|NCT02439216|532419105|FG005|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
147618451|NCT02439216|532419106|FG006|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
147618452|NCT02439216|532419107|FG007|Part C (138-week, Open-label Treatment)|Progressive disease|0|||
147618453|NCT02439216|532419108|FG008|Part C (138-week, Open-label Treatment)|Progressive disease|3|||
147618454|NCT02439216|532419100|FG000|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
147618455|NCT02439216|532419101|FG001|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
147618456|NCT02439216|532419102|FG002|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
147618457|NCT02439216|532419103|FG003|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
147618458|NCT02439216|532419104|FG004|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
147618459|NCT02439216|532419105|FG005|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
147618460|NCT02439216|532419106|FG006|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|0|||
147618461|NCT02439216|532419107|FG007|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|5|||
147618462|NCT02439216|532419108|FG008|Part C (138-week, Open-label Treatment)|Withdrawal by Parent or Guardian|6|||
147618463|NCT02094300|532419109|FG000|Overall Study|Death|7|||
147618464|NCT02094300|532419109|FG000|Overall Study|Lost to Follow-up|10|||
147618465|NCT02094300|532419109|FG000|Overall Study|Still be eligible for follow-up|3|||
147618466|NCT02493660|532419114|FG000|Overall Study|Physician Decision|0|||
147618467|NCT02493660|532419115|FG001|Overall Study|Physician Decision|1|||
147618468|NCT02493660|532419114|FG000|Overall Study|Adverse Event|4|||
147618469|NCT02493660|532419115|FG001|Overall Study|Adverse Event|2|||
147618470|NCT02493660|532419114|FG000|Overall Study|Withdrawal by Subject|2|||
147618471|NCT02493660|532419115|FG001|Overall Study|Withdrawal by Subject|3|||
147618472|NCT02493660|532419114|FG000|Overall Study|Subject unable to return for follow-up visits|2|||
147618473|NCT02493660|532419115|FG001|Overall Study|Subject unable to return for follow-up visits|0|||
147618474|NCT02493660|532419114|FG000|Overall Study|Protocol Violation|0|||
147618475|NCT02493660|532419115|FG001|Overall Study|Protocol Violation|1|||
147618476|NCT02493660|532419114|FG000|Overall Study|Death|0|||
147618477|NCT02493660|532419115|FG001|Overall Study|Death|1|||
147618478|NCT02493660|532419114|FG000|Overall Study|Lost to Follow-up|2|||
147618479|NCT02493660|532419115|FG001|Overall Study|Lost to Follow-up|4|||
147618480|NCT01050530|532419118|FG000|Overall Study|Adverse Event|6|||
147618481|NCT01050530|532419119|FG001|Overall Study|Adverse Event|3|||
147618482|NCT01050530|532419118|FG000|Overall Study|Lack of Efficacy|1|||
147618483|NCT01050530|532419119|FG001|Overall Study|Lack of Efficacy|4|||
147618484|NCT01050530|532419118|FG000|Overall Study|Withdrawal by Subject|0|||
147618485|NCT01050530|532419119|FG001|Overall Study|Withdrawal by Subject|3|||
147618486|NCT01050530|532419118|FG000|Overall Study|Protocol Violation|1|||
147618487|NCT01050530|532419119|FG001|Overall Study|Protocol Violation|0|||
147618488|NCT02288312|532419122|FG000|Overall Study|Pregnancy|1|||
147618489|NCT02288312|532419123|FG001|Overall Study|Pregnancy|0|||
147618490|NCT02288312|532419124|FG002|Overall Study|Pregnancy|0|||
147618491|NCT01276041|532419125|FG000|Overall Study|Adverse Event|2|||
147618492|NCT01276041|532419125|FG000|Overall Study|Protocol Violation|1|||
147618493|NCT00725491|532419126|FG000|Overall Study|Adverse Event|3|||
147618494|NCT00725491|532419127|FG001|Overall Study|Adverse Event|2|||
147618495|NCT00725491|532419126|FG000|Overall Study|Pregnancy|0|||
147618496|NCT00725491|532419127|FG001|Overall Study|Pregnancy|3|||
147618497|NCT00725491|532419126|FG000|Overall Study|Risk for hyperstimulation|2|||
147618498|NCT00725491|532419127|FG001|Overall Study|Risk for hyperstimulation|9|||
147665688|NCT04265261|532599682|FG001|Overall Study|Death|0|||
147665689|NCT04265261|532599683|FG002|Overall Study|Death|0|||
147302603|NCT03430063|531274404|FG002|Overall Study|Progressive disease|1|||
147302604|NCT03430063|531274402|FG000|Overall Study|Other un-specified|1|||
147302605|NCT03430063|531274403|FG001|Overall Study|Other un-specified|1|||
147302606|NCT03430063|531274404|FG002|Overall Study|Other un-specified|0|||
147302607|NCT03430063|531274402|FG000|Overall Study|Randomized, but never treated|0|||
147302608|NCT03430063|531274403|FG001|Overall Study|Randomized, but never treated|0|||
147302609|NCT03430063|531274404|FG002|Overall Study|Randomized, but never treated|1|||
147302610|NCT03124199|531274405|FG000|Overall Study|Lost to Follow-up|4|||
147302611|NCT02798211|531274406|FG000|Period 1|Adverse Event|1|||
147302612|NCT02798211|531274407|FG001|Period 1|Adverse Event|1|||
147302613|NCT02798211|531274408|FG002|Period 1|Adverse Event|0|||
147618499|NCT00725491|532419126|FG000|Overall Study|No/too few oocytes/bad quality oocytes|1|||
147618500|NCT00725491|532419127|FG001|Overall Study|No/too few oocytes/bad quality oocytes|1|||
147665690|NCT04265261|532599681|FG000|Overall Study|Lost to Follow-up|4|||
147665691|NCT04265261|532599682|FG001|Overall Study|Lost to Follow-up|1|||
147618501|NCT00725491|532419126|FG000|Overall Study|Fertilization failure|0|||
147618502|NCT00725491|532419127|FG001|Overall Study|Fertilization failure|1|||
147618503|NCT00725491|532419126|FG000|Overall Study|No/too few embryos/ bad quality embryos|3|||
147665692|NCT04265261|532599683|FG002|Overall Study|Lost to Follow-up|3|||
147302614|NCT02798211|531274409|FG003|Period 1|Adverse Event|0|||
147302615|NCT02798211|531274410|FG004|Period 1|Adverse Event|0|||
147302616|NCT02798211|531274411|FG005|Period 1|Adverse Event|0|||
147302617|NCT02798211|531274406|FG000|Period 1|Lost to Follow-up|2|||
147302618|NCT02798211|531274407|FG001|Period 1|Lost to Follow-up|1|||
147302619|NCT02798211|531274408|FG002|Period 1|Lost to Follow-up|0|||
147302620|NCT02798211|531274409|FG003|Period 1|Lost to Follow-up|0|||
147302621|NCT02798211|531274410|FG004|Period 1|Lost to Follow-up|0|||
147302622|NCT02798211|531274411|FG005|Period 1|Lost to Follow-up|0|||
147302623|NCT02798211|531274406|FG000|Period 1|Protocol Violation|0|||
147302624|NCT02798211|531274407|FG001|Period 1|Protocol Violation|0|||
147302625|NCT02798211|531274408|FG002|Period 1|Protocol Violation|2|||
147302626|NCT02798211|531274409|FG003|Period 1|Protocol Violation|0|||
147302627|NCT02798211|531274410|FG004|Period 1|Protocol Violation|0|||
147302628|NCT02798211|531274411|FG005|Period 1|Protocol Violation|0|||
147302629|NCT02798211|531274406|FG000|Period 1|Withdrawal by Subject|1|||
147302630|NCT02798211|531274407|FG001|Period 1|Withdrawal by Subject|1|||
147302631|NCT02798211|531274408|FG002|Period 1|Withdrawal by Subject|0|||
147302632|NCT02798211|531274409|FG003|Period 1|Withdrawal by Subject|0|||
147302633|NCT02798211|531274410|FG004|Period 1|Withdrawal by Subject|0|||
147302634|NCT02798211|531274411|FG005|Period 1|Withdrawal by Subject|0|||
147302635|NCT02798211|531274406|FG000|Period 1|Death|0|||
147302636|NCT02798211|531274407|FG001|Period 1|Death|0|||
147302637|NCT02798211|531274408|FG002|Period 1|Death|1|||
147302638|NCT02798211|531274409|FG003|Period 1|Death|0|||
147302639|NCT02798211|531274410|FG004|Period 1|Death|0|||
147302640|NCT02798211|531274411|FG005|Period 1|Death|0|||
147302641|NCT02798211|531274406|FG000|Period 1|Withdrawal of Informed Consent|2|||
147302642|NCT02798211|531274407|FG001|Period 1|Withdrawal of Informed Consent|7|||
147302643|NCT02798211|531274408|FG002|Period 1|Withdrawal of Informed Consent|3|||
147302644|NCT02798211|531274409|FG003|Period 1|Withdrawal of Informed Consent|0|||
147302645|NCT02798211|531274410|FG004|Period 1|Withdrawal of Informed Consent|0|||
147302646|NCT02798211|531274411|FG005|Period 1|Withdrawal of Informed Consent|0|||
147302647|NCT02798211|531274406|FG000|Period 2|Withdrawal by Subject|2|||
147302648|NCT02798211|531274407|FG001|Period 2|Withdrawal by Subject|0|||
147302649|NCT02798211|531274408|FG002|Period 2|Withdrawal by Subject|0|||
147302650|NCT02798211|531274409|FG003|Period 2|Withdrawal by Subject|0|||
147302651|NCT02798211|531274410|FG004|Period 2|Withdrawal by Subject|2|||
147302652|NCT02798211|531274411|FG005|Period 2|Withdrawal by Subject|2|||
147302653|NCT02798211|531274406|FG000|Period 2|Adverse Event|5|||
147302654|NCT02798211|531274407|FG001|Period 2|Adverse Event|0|||
147302655|NCT02798211|531274408|FG002|Period 2|Adverse Event|0|||
147302656|NCT02798211|531274409|FG003|Period 2|Adverse Event|0|||
147302657|NCT02798211|531274410|FG004|Period 2|Adverse Event|1|||
147302658|NCT02798211|531274411|FG005|Period 2|Adverse Event|0|||
147302659|NCT02798211|531274406|FG000|Period 2|Lack of Efficacy|1|||
147302660|NCT02798211|531274407|FG001|Period 2|Lack of Efficacy|0|||
147302661|NCT02798211|531274408|FG002|Period 2|Lack of Efficacy|0|||
147302662|NCT02798211|531274409|FG003|Period 2|Lack of Efficacy|1|||
147302663|NCT02798211|531274410|FG004|Period 2|Lack of Efficacy|0|||
147302664|NCT02798211|531274411|FG005|Period 2|Lack of Efficacy|1|||
147302665|NCT02798211|531274406|FG000|Period 2|Lost to Follow-up|3|||
147302666|NCT02798211|531274407|FG001|Period 2|Lost to Follow-up|0|||
147302667|NCT02798211|531274408|FG002|Period 2|Lost to Follow-up|0|||
147302668|NCT02798211|531274409|FG003|Period 2|Lost to Follow-up|0|||
147302669|NCT02798211|531274410|FG004|Period 2|Lost to Follow-up|2|||
147302670|NCT02798211|531274411|FG005|Period 2|Lost to Follow-up|0|||
147302671|NCT02798211|531274406|FG000|Period 2|Physician Decision|1|||
147302672|NCT02798211|531274407|FG001|Period 2|Physician Decision|0|||
147302673|NCT02798211|531274408|FG002|Period 2|Physician Decision|0|||
147302674|NCT02798211|531274409|FG003|Period 2|Physician Decision|1|||
147302675|NCT02798211|531274410|FG004|Period 2|Physician Decision|1|||
147302676|NCT02798211|531274411|FG005|Period 2|Physician Decision|0|||
147618504|NCT00725491|532419127|FG001|Overall Study|No/too few embryos/ bad quality embryos|2|||
147618505|NCT02070965|532419130|FG000|Overall Study|Lost to Follow-up|0|||
147618506|NCT02070965|532419131|FG001|Overall Study|Lost to Follow-up|1|||
147302677|NCT02798211|531274406|FG000|Period 2|Pregnancy|0|||
147302678|NCT02798211|531274407|FG001|Period 2|Pregnancy|0|||
147302679|NCT02798211|531274408|FG002|Period 2|Pregnancy|0|||
147302680|NCT02798211|531274409|FG003|Period 2|Pregnancy|2|||
147302681|NCT02798211|531274410|FG004|Period 2|Pregnancy|0|||
147302682|NCT02798211|531274411|FG005|Period 2|Pregnancy|0|||
147302683|NCT02798211|531274406|FG000|Period 2|Technical problems|1|||
147302684|NCT02798211|531274407|FG001|Period 2|Technical problems|0|||
147302685|NCT02798211|531274408|FG002|Period 2|Technical problems|0|||
147302686|NCT02798211|531274409|FG003|Period 2|Technical problems|1|||
147302687|NCT02798211|531274410|FG004|Period 2|Technical problems|0|||
147302688|NCT02798211|531274411|FG005|Period 2|Technical problems|0|||
147302689|NCT02798211|531274406|FG000|Period 2|Withdrawal of Informed Consent|1|||
147302690|NCT02798211|531274407|FG001|Period 2|Withdrawal of Informed Consent|0|||
147302691|NCT02798211|531274408|FG002|Period 2|Withdrawal of Informed Consent|0|||
147302692|NCT02798211|531274409|FG003|Period 2|Withdrawal of Informed Consent|2|||
147302693|NCT02798211|531274410|FG004|Period 2|Withdrawal of Informed Consent|2|||
147302694|NCT02798211|531274411|FG005|Period 2|Withdrawal of Informed Consent|3|||
147302695|NCT03086018|531274412|FG000|Final Testing for End of Trial|Adverse Event|1|||
147302696|NCT03086018|531274412|FG000|Final Testing for End of Trial|Withdrawal by Subject|1|||
147302697|NCT01782872|531274413|FG000|Overall Study|Protocol Violation|0|||
147302698|NCT01782872|531274414|FG001|Overall Study|Protocol Violation|0|||
147302699|NCT01782872|531274415|FG002|Overall Study|Protocol Violation|0|||
147302700|NCT01782872|531274416|FG003|Overall Study|Protocol Violation|1|||
147302701|NCT01782872|531274413|FG000|Overall Study|Withdrawal by Subject|0|||
147302702|NCT01782872|531274414|FG001|Overall Study|Withdrawal by Subject|1|||
147302703|NCT01782872|531274415|FG002|Overall Study|Withdrawal by Subject|0|||
147302704|NCT01782872|531274416|FG003|Overall Study|Withdrawal by Subject|0|||
147302705|NCT01892345|531274417|FG000|Overall Study|Adverse Event|0|||
147302706|NCT01892345|531274418|FG001|Overall Study|Adverse Event|2|||
147302707|NCT01892345|531274417|FG000|Overall Study|Death|1|||
147302708|NCT01892345|531274418|FG001|Overall Study|Death|0|||
147302709|NCT01892345|531274417|FG000|Overall Study|Lost to Follow-up|3|||
147302710|NCT01892345|531274418|FG001|Overall Study|Lost to Follow-up|0|||
147302711|NCT01892345|531274417|FG000|Overall Study|Withdrawal by Subject|12|||
147302712|NCT01892345|531274418|FG001|Overall Study|Withdrawal by Subject|1|||
147302713|NCT03505476|531274420|FG000|Overall Study|Physician Decision|18|||
147302714|NCT03505476|531274420|FG000|Overall Study|Device Malfunctioned|101|||
147302715|NCT03505476|531274420|FG000|Overall Study|Data Corrupt|6|||
147302716|NCT03505476|531274420|FG000|Overall Study|Device application insufficiant|3|||
147302717|NCT02748694|531274421|FG000|Overall Study|Voluntary Withdrawal|0|||
147302718|NCT02748694|531274422|FG001|Overall Study|Voluntary Withdrawal|0|||
147302719|NCT02748694|531274423|FG002|Overall Study|Voluntary Withdrawal|0|||
147302720|NCT02748694|531274424|FG003|Overall Study|Voluntary Withdrawal|0|||
147466944|NCT04454489|531867623|FG000|Overall Study|Adverse Event|1|||
147466945|NCT04454489|531867623|FG000|Overall Study|Physician Decision|1|||
147466946|NCT03049449|531867624|FG000|Overall Study|Did not receive treatment.|0|||
147466947|NCT03049449|531867625|FG001|Overall Study|Did not receive treatment.|0|||
147466948|NCT03049449|531867626|FG002|Overall Study|Did not receive treatment.|0|||
147466949|NCT03049449|531867627|FG003|Overall Study|Did not receive treatment.|0|||
147466950|NCT03049449|531867628|FG004|Overall Study|Did not receive treatment.|0|||
147466951|NCT03049449|531867629|FG005|Overall Study|Did not receive treatment.|0|||
147466952|NCT03049449|531867630|FG006|Overall Study|Did not receive treatment.|0|||
147466953|NCT03049449|531867631|FG007|Overall Study|Did not receive treatment.|0|||
147466954|NCT03049449|531867632|FG008|Overall Study|Did not receive treatment.|1|||
147466955|NCT03049449|531867633|FG009|Overall Study|Did not receive treatment.|0|||
147466956|NCT03049449|531867624|FG000|Overall Study|Enrolled and removed from study with no treatment|0|||
147466957|NCT03049449|531867625|FG001|Overall Study|Enrolled and removed from study with no treatment|0|||
147466958|NCT03049449|531867626|FG002|Overall Study|Enrolled and removed from study with no treatment|1|||
147466959|NCT03049449|531867627|FG003|Overall Study|Enrolled and removed from study with no treatment|1|||
147466960|NCT03049449|531867628|FG004|Overall Study|Enrolled and removed from study with no treatment|0|||
147466961|NCT03049449|531867629|FG005|Overall Study|Enrolled and removed from study with no treatment|0|||
147466962|NCT03049449|531867630|FG006|Overall Study|Enrolled and removed from study with no treatment|0|||
147466963|NCT03049449|531867631|FG007|Overall Study|Enrolled and removed from study with no treatment|0|||
147466964|NCT03049449|531867632|FG008|Overall Study|Enrolled and removed from study with no treatment|0|||
147466965|NCT03049449|531867633|FG009|Overall Study|Enrolled and removed from study with no treatment|0|||
147466966|NCT03049449|531867624|FG000|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
147466967|NCT03049449|531867625|FG001|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
147466968|NCT03049449|531867626|FG002|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
147466969|NCT03049449|531867627|FG003|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
147466970|NCT03049449|531867628|FG004|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
147466971|NCT03049449|531867629|FG005|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
147466972|NCT03049449|531867630|FG006|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
147466973|NCT03049449|531867631|FG007|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|1|||
147466974|NCT03049449|531867632|FG008|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|0|||
147466975|NCT03049449|531867633|FG009|Overall Study|Chemotherapy was started and not finished & no Chimeric Antigen Receptor T-cells were administered.|1|||
147466976|NCT01262898|531867636|FG000|Overall Study|Protocol Violation|1|||
147466977|NCT01262898|531867637|FG001|Overall Study|Protocol Violation|1|||
147466978|NCT01262898|531867638|FG002|Overall Study|Protocol Violation|0|||
147466979|NCT01262898|531867639|FG003|Overall Study|Protocol Violation|0|||
147618507|NCT02070965|532419132|FG002|Overall Study|Lost to Follow-up|0|||
147618508|NCT02070965|532419130|FG000|Overall Study|Withdrawal by Subject|1|||
147618509|NCT02070965|532419131|FG001|Overall Study|Withdrawal by Subject|1|||
147466980|NCT01262898|531867636|FG000|Overall Study|Lost to Follow-up|1|||
147618510|NCT02070965|532419132|FG002|Overall Study|Withdrawal by Subject|1|||
147302721|NCT02748694|531274425|FG004|Overall Study|Voluntary Withdrawal|0|||
147618511|NCT02070965|532419130|FG000|Overall Study|Subject moved|1|||
147618512|NCT02070965|532419131|FG001|Overall Study|Subject moved|0|||
147618513|NCT02070965|532419132|FG002|Overall Study|Subject moved|0|||
147618514|NCT00942357|532419133|FG000|Overall Study|Ineligible|37|||
147618515|NCT00942357|532419134|FG001|Overall Study|Ineligible|40|||
147618516|NCT02105467|532419137|FG000|Period 1|Lost to Follow-up|1|||
147618517|NCT02105467|532419138|FG001|Period 1|Lost to Follow-up|0|||
147618518|NCT02105467|532419137|FG000|Period 1|Death|1|||
147618519|NCT02105467|532419138|FG001|Period 1|Death|0|||
147618520|NCT02105467|532419137|FG000|Period 2|Lost to Follow-up|1|||
147618521|NCT02105467|532419138|FG001|Period 2|Lost to Follow-up|0|||
147618522|NCT02105467|532419137|FG000|Period 2|Death|1|||
147618523|NCT02105467|532419138|FG001|Period 2|Death|0|||
147618524|NCT02105467|532419137|FG000|Period 2|Withdrawal by Subject|0|||
147618525|NCT02105467|532419138|FG001|Period 2|Withdrawal by Subject|2|||
147618526|NCT02105467|532419137|FG000|Period 3|Lost to Follow-up|0|||
147618527|NCT02105467|532419138|FG001|Period 3|Lost to Follow-up|1|||
147665693|NCT04265261|532599681|FG000|Overall Study|Non-Compliance with Study Drug|1|||
147466981|NCT01262898|531867637|FG001|Overall Study|Lost to Follow-up|0|||
147466982|NCT01262898|531867638|FG002|Overall Study|Lost to Follow-up|0|||
147466983|NCT01262898|531867639|FG003|Overall Study|Lost to Follow-up|0|||
147466984|NCT01262898|531867636|FG000|Overall Study|Withdrawal by Subject|1|||
147466985|NCT01262898|531867637|FG001|Overall Study|Withdrawal by Subject|1|||
147466986|NCT01262898|531867638|FG002|Overall Study|Withdrawal by Subject|0|||
147466987|NCT01262898|531867639|FG003|Overall Study|Withdrawal by Subject|0|||
147466988|NCT00792298|531867640|FG000|Treatment Period 1|Adverse Event|0|||
147466989|NCT00792298|531867641|FG001|Treatment Period 1|Adverse Event|1|||
147466990|NCT00792298|531867642|FG002|Treatment Period 1|Adverse Event|0|||
147466991|NCT00792298|531867643|FG003|Treatment Period 1|Adverse Event|1|||
147466992|NCT00792298|531867644|FG004|Treatment Period 1|Adverse Event|0|||
147466993|NCT00792298|531867645|FG005|Treatment Period 1|Adverse Event|1|||
147466994|NCT00792298|531867646|FG006|Treatment Period 1|Adverse Event|1|||
147466995|NCT00792298|531867647|FG007|Treatment Period 1|Adverse Event|0|||
147466996|NCT00792298|531867640|FG000|Treatment Period 1|Lack of Efficacy|0|||
147466997|NCT00792298|531867641|FG001|Treatment Period 1|Lack of Efficacy|0|||
147466998|NCT00792298|531867642|FG002|Treatment Period 1|Lack of Efficacy|1|||
147466999|NCT00792298|531867643|FG003|Treatment Period 1|Lack of Efficacy|0|||
147467000|NCT00792298|531867644|FG004|Treatment Period 1|Lack of Efficacy|0|||
147467001|NCT00792298|531867645|FG005|Treatment Period 1|Lack of Efficacy|0|||
147467002|NCT00792298|531867646|FG006|Treatment Period 1|Lack of Efficacy|0|||
147467003|NCT00792298|531867647|FG007|Treatment Period 1|Lack of Efficacy|0|||
147467004|NCT00792298|531867640|FG000|Treatment Period 1|Withdrawal by Subject|1|||
147467005|NCT00792298|531867641|FG001|Treatment Period 1|Withdrawal by Subject|0|||
147467006|NCT00792298|531867642|FG002|Treatment Period 1|Withdrawal by Subject|1|||
147467007|NCT00792298|531867643|FG003|Treatment Period 1|Withdrawal by Subject|2|||
147467008|NCT00792298|531867644|FG004|Treatment Period 1|Withdrawal by Subject|0|||
147467009|NCT00792298|531867645|FG005|Treatment Period 1|Withdrawal by Subject|2|||
147467010|NCT00792298|531867646|FG006|Treatment Period 1|Withdrawal by Subject|1|||
147467011|NCT00792298|531867647|FG007|Treatment Period 1|Withdrawal by Subject|0|||
147467012|NCT00792298|531867640|FG000|Treatment Period 1|Lost to Follow-up|0|||
147467013|NCT00792298|531867641|FG001|Treatment Period 1|Lost to Follow-up|0|||
147467014|NCT00792298|531867642|FG002|Treatment Period 1|Lost to Follow-up|0|||
147467015|NCT00792298|531867643|FG003|Treatment Period 1|Lost to Follow-up|0|||
147467016|NCT00792298|531867644|FG004|Treatment Period 1|Lost to Follow-up|0|||
147467017|NCT00792298|531867645|FG005|Treatment Period 1|Lost to Follow-up|0|||
147467018|NCT00792298|531867646|FG006|Treatment Period 1|Lost to Follow-up|1|||
147467019|NCT00792298|531867647|FG007|Treatment Period 1|Lost to Follow-up|0|||
147467020|NCT00792298|531867640|FG000|Treatment Period 1|Physician Decision|0|||
147467021|NCT00792298|531867641|FG001|Treatment Period 1|Physician Decision|0|||
147467022|NCT00792298|531867642|FG002|Treatment Period 1|Physician Decision|0|||
147467023|NCT00792298|531867643|FG003|Treatment Period 1|Physician Decision|1|||
147467024|NCT00792298|531867644|FG004|Treatment Period 1|Physician Decision|0|||
147467025|NCT00792298|531867645|FG005|Treatment Period 1|Physician Decision|0|||
147467026|NCT00792298|531867646|FG006|Treatment Period 1|Physician Decision|1|||
147467027|NCT00792298|531867647|FG007|Treatment Period 1|Physician Decision|0|||
147467028|NCT00792298|531867640|FG000|Treatment Period 1|Protocol Violation|0|||
147467029|NCT00792298|531867641|FG001|Treatment Period 1|Protocol Violation|0|||
147618528|NCT01321879|532419139|FG000|Overall Study|Lack of Efficacy|5|||
147618529|NCT01321879|532419139|FG000|Overall Study|Adverse Event|5|||
147618530|NCT01321879|532419139|FG000|Overall Study|Death|3|||
147665694|NCT04265261|532599682|FG001|Overall Study|Non-Compliance with Study Drug|1|||
147467030|NCT00792298|531867642|FG002|Treatment Period 1|Protocol Violation|0|||
147467031|NCT00792298|531867643|FG003|Treatment Period 1|Protocol Violation|0|||
147467032|NCT00792298|531867644|FG004|Treatment Period 1|Protocol Violation|0|||
147467033|NCT00792298|531867645|FG005|Treatment Period 1|Protocol Violation|0|||
147467034|NCT00792298|531867646|FG006|Treatment Period 1|Protocol Violation|0|||
147618531|NCT01321879|532419139|FG000|Overall Study|Withdrawal by Subject|1|||
147618532|NCT00958828|532419141|FG000|Period 1, 1 Week of Wear|Randomization break|0|||
147467035|NCT00792298|531867647|FG007|Treatment Period 1|Protocol Violation|1|||
147467036|NCT00792298|531867640|FG000|Washout|Adverse Event|0|||
147467037|NCT00792298|531867641|FG001|Washout|Adverse Event|0|||
147467038|NCT00792298|531867642|FG002|Washout|Adverse Event|0|||
147467039|NCT00792298|531867643|FG003|Washout|Adverse Event|0|||
147467040|NCT00792298|531867644|FG004|Washout|Adverse Event|0|||
147467041|NCT00792298|531867645|FG005|Washout|Adverse Event|1|||
147467042|NCT00792298|531867646|FG006|Washout|Adverse Event|0|||
147467043|NCT00792298|531867647|FG007|Washout|Adverse Event|0|||
147467044|NCT00792298|531867640|FG000|Washout|Withdrawal by Subject|0|||
147467045|NCT00792298|531867641|FG001|Washout|Withdrawal by Subject|0|||
147467046|NCT00792298|531867642|FG002|Washout|Withdrawal by Subject|1|||
147665695|NCT04265261|532599683|FG002|Overall Study|Non-Compliance with Study Drug|0|||
147467047|NCT00792298|531867643|FG003|Washout|Withdrawal by Subject|0|||
147467048|NCT00792298|531867644|FG004|Washout|Withdrawal by Subject|0|||
147467049|NCT00792298|531867645|FG005|Washout|Withdrawal by Subject|1|||
147467050|NCT00792298|531867646|FG006|Washout|Withdrawal by Subject|0|||
147467051|NCT00792298|531867647|FG007|Washout|Withdrawal by Subject|0|||
147467052|NCT00792298|531867640|FG000|Treatment Period 2|Lack of Efficacy|0|||
147467053|NCT00792298|531867641|FG001|Treatment Period 2|Lack of Efficacy|0|||
147467054|NCT00792298|531867642|FG002|Treatment Period 2|Lack of Efficacy|0|||
147467055|NCT00792298|531867643|FG003|Treatment Period 2|Lack of Efficacy|0|||
147467056|NCT00792298|531867644|FG004|Treatment Period 2|Lack of Efficacy|1|||
147467057|NCT00792298|531867645|FG005|Treatment Period 2|Lack of Efficacy|0|||
147467058|NCT00792298|531867646|FG006|Treatment Period 2|Lack of Efficacy|0|||
147467059|NCT00792298|531867647|FG007|Treatment Period 2|Lack of Efficacy|0|||
147467060|NCT00792298|531867640|FG000|Treatment Period 2|Physician Decision|0|||
147467061|NCT00792298|531867641|FG001|Treatment Period 2|Physician Decision|0|||
147467062|NCT00792298|531867642|FG002|Treatment Period 2|Physician Decision|0|||
147467063|NCT00792298|531867643|FG003|Treatment Period 2|Physician Decision|0|||
147467064|NCT00792298|531867644|FG004|Treatment Period 2|Physician Decision|0|||
147467065|NCT00792298|531867645|FG005|Treatment Period 2|Physician Decision|0|||
147467066|NCT00792298|531867646|FG006|Treatment Period 2|Physician Decision|1|||
147467067|NCT00792298|531867647|FG007|Treatment Period 2|Physician Decision|0|||
147467068|NCT00792298|531867640|FG000|Treatment Period 2|Pregnancy|0|||
147467069|NCT00792298|531867641|FG001|Treatment Period 2|Pregnancy|0|||
147467070|NCT00792298|531867642|FG002|Treatment Period 2|Pregnancy|1|||
147467071|NCT00792298|531867643|FG003|Treatment Period 2|Pregnancy|0|||
147467072|NCT00792298|531867644|FG004|Treatment Period 2|Pregnancy|0|||
147467073|NCT00792298|531867645|FG005|Treatment Period 2|Pregnancy|0|||
147467074|NCT00792298|531867646|FG006|Treatment Period 2|Pregnancy|0|||
147467075|NCT00792298|531867647|FG007|Treatment Period 2|Pregnancy|0|||
147467076|NCT00792298|531867640|FG000|Treatment Period 2|Withdrawal by Subject|1|||
147467077|NCT00792298|531867641|FG001|Treatment Period 2|Withdrawal by Subject|1|||
147467078|NCT00792298|531867642|FG002|Treatment Period 2|Withdrawal by Subject|0|||
147467079|NCT00792298|531867643|FG003|Treatment Period 2|Withdrawal by Subject|2|||
147467080|NCT00792298|531867644|FG004|Treatment Period 2|Withdrawal by Subject|1|||
147467081|NCT00792298|531867645|FG005|Treatment Period 2|Withdrawal by Subject|0|||
147467082|NCT00792298|531867646|FG006|Treatment Period 2|Withdrawal by Subject|0|||
147467083|NCT00792298|531867647|FG007|Treatment Period 2|Withdrawal by Subject|2|||
147467084|NCT01756274|531867650|FG000|Overall Study|Protocol Violation|2|||
147467085|NCT01756274|531867650|FG000|Overall Study|Laboratory error|1|||
147467086|NCT03371355|531867651|FG000|Overall Study|Investigator judgment|0|||
147467087|NCT03371355|531867652|FG001|Overall Study|Investigator judgment|0|||
147467088|NCT03371355|531867653|FG002|Overall Study|Investigator judgment|1|||
147467089|NCT03371355|531867654|FG003|Overall Study|Investigator judgment|1|||
147467090|NCT03371355|531867651|FG000|Overall Study|Voluntary withdrawal|1|||
147467091|NCT03371355|531867652|FG001|Overall Study|Voluntary withdrawal|0|||
147467092|NCT03371355|531867653|FG002|Overall Study|Voluntary withdrawal|1|||
147467093|NCT03371355|531867654|FG003|Overall Study|Voluntary withdrawal|2|||
147467094|NCT03371355|531867651|FG000|Overall Study|Adverse Event|0|||
147467095|NCT03371355|531867652|FG001|Overall Study|Adverse Event|1|||
147467096|NCT03371355|531867653|FG002|Overall Study|Adverse Event|2|||
147467097|NCT03371355|531867654|FG003|Overall Study|Adverse Event|3|||
147467098|NCT03371355|531867651|FG000|Overall Study|Reason not Specified|0|||
147467099|NCT03371355|531867652|FG001|Overall Study|Reason not Specified|1|||
147467100|NCT03371355|531867653|FG002|Overall Study|Reason not Specified|0|||
147467101|NCT03371355|531867654|FG003|Overall Study|Reason not Specified|1|||
147467102|NCT03040024|531867663|FG000|Overall Study|Adverse Event|0|||
147467103|NCT03040024|531867664|FG001|Overall Study|Adverse Event|1|||
147467104|NCT03040024|531867665|FG002|Overall Study|Adverse Event|0|||
147467105|NCT03040024|531867663|FG000|Overall Study|Death|0|||
147467106|NCT03040024|531867664|FG001|Overall Study|Death|1|||
147467107|NCT03040024|531867665|FG002|Overall Study|Death|0|||
147467108|NCT03040024|531867663|FG000|Overall Study|Physician Decision|0|||
147467109|NCT03040024|531867664|FG001|Overall Study|Physician Decision|0|||
147467110|NCT03040024|531867665|FG002|Overall Study|Physician Decision|1|||
147467111|NCT00584870|531867671|FG000|Overall Study|Adverse Event|4|||
147467112|NCT00584870|531867672|FG001|Overall Study|Adverse Event|3|||
147618533|NCT00958828|532419142|FG001|Period 1, 1 Week of Wear|Randomization break|1|||
147618534|NCT00958828|532419141|FG000|Period 2, 1 Week of Wear|Unacceptable lens fit|0|||
147618535|NCT00958828|532419142|FG001|Period 2, 1 Week of Wear|Unacceptable lens fit|1|||
147618536|NCT02687451|532419143|FG000|Overall Study|Withdrawal by Subject|1|||
147618537|NCT02687451|532419144|FG001|Overall Study|Withdrawal by Subject|0|||
147618538|NCT02687451|532419145|FG002|Overall Study|Withdrawal by Subject|0|||
147618539|NCT02687451|532419146|FG003|Overall Study|Withdrawal by Subject|0|||
147618540|NCT02687451|532419147|FG004|Overall Study|Withdrawal by Subject|0|||
147618541|NCT02687451|532419148|FG005|Overall Study|Withdrawal by Subject|1|||
147665696|NCT04265261|532599681|FG000|Overall Study|Physician Decision|0|||
147665697|NCT04265261|532599682|FG001|Overall Study|Physician Decision|0|||
147665698|NCT04265261|532599683|FG002|Overall Study|Physician Decision|1|||
147665699|NCT04265261|532599681|FG000|Overall Study|Protocol Deviation|0|||
147665700|NCT04265261|532599682|FG001|Overall Study|Protocol Deviation|2|||
147665701|NCT04265261|532599683|FG002|Overall Study|Protocol Deviation|0|||
147665702|NCT04265261|532599681|FG000|Overall Study|Withdrawal by Subject|2|||
147665703|NCT04265261|532599682|FG001|Overall Study|Withdrawal by Subject|1|||
147665704|NCT04265261|532599683|FG002|Overall Study|Withdrawal by Subject|4|||
147665705|NCT02997163|532601555|FG000|Overall Study|Adverse Event|1|||
147665706|NCT02997163|532601556|FG001|Overall Study|Adverse Event|0|||
147665707|NCT02997163|532601557|FG002|Overall Study|Adverse Event|0|||
147665708|NCT02997163|532601558|FG003|Overall Study|Adverse Event|1|||
147665709|NCT02990000|532601559|FG000|Overall Study|Failed to provide data beyond baseline|36|||
147665710|NCT02990000|532601560|FG001|Overall Study|Failed to provide data beyond baseline|34|||
147665711|NCT02812186|532601561|FG000|Period 1|Post randomization screen failure|5|||
147665712|NCT02812186|532601562|FG001|Period 1|Post randomization screen failure|9|||
147665713|NCT02812186|532601561|FG000|Period 1|nonevaluable data sets|6|||
147665714|NCT02812186|532601562|FG001|Period 1|nonevaluable data sets|6|||
147665715|NCT00161213|532601563|FG000|Overall Study|Withdrawal by Subject|1|||
147665716|NCT00161213|532601563|FG000|Overall Study|Evaluable for toxicity but not response|1|||
147665717|NCT03103503|532601564|FG000|Overall Study|Death|64|||
147665718|NCT03103503|532601564|FG000|Overall Study|Physician Decision|57|||
147665719|NCT03103503|532601564|FG000|Overall Study|Withdrawal by Subject|10|||
147665720|NCT03103503|532601564|FG000|Overall Study|Plexa Lead or Pulse Generator Extraction|10|||
147665721|NCT03103503|532601564|FG000|Overall Study|Lost to Follow-up|3|||
147665722|NCT03103503|532601564|FG000|Overall Study|Study Closure|757|||
147665723|NCT00183430|532601580|FG000|Overall Study|Adverse Event|1|||
147665724|NCT00183430|532601581|FG001|Overall Study|Adverse Event|0|||
147665725|NCT00183430|532601580|FG000|Overall Study|Lost to Follow-up|3|||
147665726|NCT00183430|532601581|FG001|Overall Study|Lost to Follow-up|0|||
147665727|NCT00183430|532601580|FG000|Overall Study|did not meet inclusion criteria|1|||
147665728|NCT00183430|532601581|FG001|Overall Study|did not meet inclusion criteria|0|||
147665729|NCT00183430|532601580|FG000|Overall Study|Withdrawal by Subject|1|||
147665730|NCT00183430|532601581|FG001|Overall Study|Withdrawal by Subject|0|||
147665731|NCT00883181|532601586|FG000|Overall Study|Hematological Adverse Event|26|||
147665732|NCT00883181|532601586|FG000|Overall Study|Non-hematological Adverse Event|55|||
147665733|NCT00883181|532601586|FG000|Overall Study|Disease Progression|94|||
147665734|NCT00883181|532601586|FG000|Overall Study|Administrative Reason|24|||
147665735|NCT00883181|532601586|FG000|Overall Study|Withdrawal by Subject|4|||
147665736|NCT00883181|532601586|FG000|Overall Study|Death|31|||
147665737|NCT00883181|532601586|FG000|Overall Study|Other|38|||
147665738|NCT00883181|532601586|FG000|Overall Study|Protocol Deviation|3|||
147665739|NCT00883181|532601586|FG000|Overall Study|Noncompliance|3|||
147665740|NCT01218308|532601587|FG000|Overall Study|Adverse Event|1|||
147665741|NCT01218308|532601588|FG001|Overall Study|Adverse Event|2|||
147665742|NCT01218308|532601587|FG000|Overall Study|Protocol Violation|0|||
147665743|NCT01218308|532601588|FG001|Overall Study|Protocol Violation|2|||
147665744|NCT01218308|532601587|FG000|Overall Study|Withdrawal by Subject|61|||
147665745|NCT01218308|532601588|FG001|Overall Study|Withdrawal by Subject|64|||
147410686|NCT03829501|531667999|FG016|Overall Study|Death|2|||
147665746|NCT01218308|532601587|FG000|Overall Study|Lost to Follow-up|27|||
147665747|NCT01218308|532601588|FG001|Overall Study|Lost to Follow-up|31|||
147665748|NCT01218308|532601587|FG000|Overall Study|Other|14|||
147665749|NCT01218308|532601588|FG001|Overall Study|Other|21|||
147665750|NCT00426270|532601589|FG000|Overall Study|Incorrectly Enrolled in the Study|1|||
147665751|NCT00426270|532601589|FG000|Overall Study|Adverse Event|5|||
147665752|NCT02709746|532601590|FG000|Phase A (Single-blind Treatment Period)|Protocol Violation|4|||
147410687|NCT03829501|531668000|FG017|Overall Study|Death|1|||
147410688|NCT03829501|531668001|FG018|Overall Study|Death|1|||
147410689|NCT03829501|531668002|FG019|Overall Study|Death|1|||
147410690|NCT03829501|531668003|FG020|Overall Study|Death|1|||
147618542|NCT00707239|532419155|FG000|Overall Study|Adverse Event|5|||
147618543|NCT00707239|532419156|FG001|Overall Study|Adverse Event|3|||
147665753|NCT02709746|532601591|FG001|Phase A (Single-blind Treatment Period)|Protocol Violation|0|||
147665754|NCT02709746|532601592|FG002|Phase A (Single-blind Treatment Period)|Protocol Violation|0|||
147665755|NCT02709746|532601593|FG003|Phase A (Single-blind Treatment Period)|Protocol Violation|0|||
147665756|NCT02709746|532601594|FG004|Phase A (Single-blind Treatment Period)|Protocol Violation|0|||
147618544|NCT00707239|532419157|FG002|Overall Study|Adverse Event|2|||
147618545|NCT00707239|532419155|FG000|Overall Study|Death|3|||
147618546|NCT00707239|532419156|FG001|Overall Study|Death|1|||
147618547|NCT00707239|532419157|FG002|Overall Study|Death|3|||
147618548|NCT00707239|532419155|FG000|Overall Study|Physician Decision|1|||
147618549|NCT00707239|532419156|FG001|Overall Study|Physician Decision|1|||
147618550|NCT00707239|532419157|FG002|Overall Study|Physician Decision|2|||
147618551|NCT00707239|532419155|FG000|Overall Study|Protocol Violation|0|||
147618552|NCT00707239|532419156|FG001|Overall Study|Protocol Violation|0|||
147618553|NCT00707239|532419157|FG002|Overall Study|Protocol Violation|1|||
147618554|NCT00707239|532419155|FG000|Overall Study|Lack of Efficacy|1|||
147618555|NCT00707239|532419156|FG001|Overall Study|Lack of Efficacy|2|||
147467113|NCT00584870|531867673|FG002|Overall Study|Adverse Event|2|||
147467114|NCT00584870|531867671|FG000|Overall Study|Lost to Follow-up|4|||
147467115|NCT00584870|531867672|FG001|Overall Study|Lost to Follow-up|1|||
147467116|NCT00584870|531867673|FG002|Overall Study|Lost to Follow-up|1|||
147467117|NCT00584870|531867671|FG000|Overall Study|Lack of Efficacy|7|||
147467118|NCT00584870|531867672|FG001|Overall Study|Lack of Efficacy|14|||
147467119|NCT00584870|531867673|FG002|Overall Study|Lack of Efficacy|8|||
147467120|NCT00584870|531867671|FG000|Overall Study|Withdrawal by Subject|10|||
147467121|NCT00584870|531867672|FG001|Overall Study|Withdrawal by Subject|5|||
147467122|NCT00584870|531867673|FG002|Overall Study|Withdrawal by Subject|3|||
147467123|NCT00584870|531867671|FG000|Overall Study|Protocol Violation|1|||
147467124|NCT00584870|531867672|FG001|Overall Study|Protocol Violation|1|||
147467125|NCT00584870|531867673|FG002|Overall Study|Protocol Violation|2|||
147467126|NCT00584870|531867671|FG000|Overall Study|Did not met entrance criteria|1|||
147467127|NCT00584870|531867672|FG001|Overall Study|Did not met entrance criteria|0|||
147467128|NCT00584870|531867673|FG002|Overall Study|Did not met entrance criteria|0|||
147467129|NCT00584870|531867671|FG000|Overall Study|Other|2|||
147467130|NCT00584870|531867672|FG001|Overall Study|Other|0|||
147467131|NCT00584870|531867673|FG002|Overall Study|Other|0|||
147467132|NCT00584870|531867671|FG000|Overall Study|Randomized but not treated|0|||
147467133|NCT00584870|531867672|FG001|Overall Study|Randomized but not treated|1|||
147467134|NCT00584870|531867673|FG002|Overall Study|Randomized but not treated|2|||
147467135|NCT03682120|531867674|FG000|Overall Study|Lost to Follow-up|11|||
147467136|NCT03682120|531867675|FG001|Overall Study|Lost to Follow-up|4|||
147467137|NCT03682120|531867676|FG002|Overall Study|Lost to Follow-up|5|||
147467138|NCT03682120|531867677|FG003|Overall Study|Lost to Follow-up|2|||
147467139|NCT03682120|531867674|FG000|Overall Study|Physician Decision|1|||
147467140|NCT03682120|531867675|FG001|Overall Study|Physician Decision|0|||
147467141|NCT03682120|531867676|FG002|Overall Study|Physician Decision|0|||
147467142|NCT03682120|531867677|FG003|Overall Study|Physician Decision|0|||
147467143|NCT03682120|531867674|FG000|Overall Study|Withdrawal by Subject|1|||
147467144|NCT03682120|531867675|FG001|Overall Study|Withdrawal by Subject|2|||
147467145|NCT03682120|531867676|FG002|Overall Study|Withdrawal by Subject|3|||
147467146|NCT03682120|531867677|FG003|Overall Study|Withdrawal by Subject|0|||
147467147|NCT03682120|531867674|FG000|Overall Study|Death|0|||
147467148|NCT03682120|531867675|FG001|Overall Study|Death|1|||
147467149|NCT03682120|531867676|FG002|Overall Study|Death|0|||
147467150|NCT03682120|531867677|FG003|Overall Study|Death|0|||
147467151|NCT03682120|531867674|FG000|Overall Study|Enrolled but Treatment Not Administered|0|||
147467152|NCT03682120|531867675|FG001|Overall Study|Enrolled but Treatment Not Administered|1|||
147467153|NCT03682120|531867676|FG002|Overall Study|Enrolled but Treatment Not Administered|0|||
147467154|NCT03682120|531867677|FG003|Overall Study|Enrolled but Treatment Not Administered|0|||
147467155|NCT01015833|531867678|FG000|Overall Study|Death|1|||
147467156|NCT01015833|531867679|FG001|Overall Study|Death|0|||
147467157|NCT01015833|531867678|FG000|Overall Study|Withdrawal by Subject|3|||
147467158|NCT01015833|531867679|FG001|Overall Study|Withdrawal by Subject|2|||
147467159|NCT01015833|531867678|FG000|Overall Study|Adverse Event|0|||
147467160|NCT01015833|531867679|FG001|Overall Study|Adverse Event|1|||
147467161|NCT01015833|531867678|FG000|Overall Study|Physician Decision|2|||
147467162|NCT01015833|531867679|FG001|Overall Study|Physician Decision|0|||
147467163|NCT01015833|531867678|FG000|Overall Study|Symptomatic deterioration|0|||
147467164|NCT01015833|531867679|FG001|Overall Study|Symptomatic deterioration|1|||
147467165|NCT01015833|531867678|FG000|Overall Study|Other|5|||
147467166|NCT01015833|531867679|FG001|Overall Study|Other|1|||
147467167|NCT01015833|531867678|FG000|Overall Study|Motor Vehicle Accidents|1|||
147467168|NCT01015833|531867679|FG001|Overall Study|Motor Vehicle Accidents|0|||
147467169|NCT01015833|531867678|FG000|Overall Study|Did not start treatment|1|||
147467170|NCT01015833|531867679|FG001|Overall Study|Did not start treatment|0|||
147467171|NCT03529409|531867693|FG000|Randomized|Lost to Follow-up|0|||
147618556|NCT00707239|532419157|FG002|Overall Study|Lack of Efficacy|0|||
147618557|NCT00707239|532419155|FG000|Overall Study|Randomized, but not treated|1|||
147618558|NCT00707239|532419156|FG001|Overall Study|Randomized, but not treated|1|||
147467172|NCT03529409|531867694|FG001|Randomized|Lost to Follow-up|0|||
147467173|NCT03529409|531867695|FG002|Randomized|Lost to Follow-up|4|||
147467174|NCT03529409|531867693|FG000|Randomized|Excluded|0|||
147467175|NCT03529409|531867694|FG001|Randomized|Excluded|0|||
147467176|NCT03529409|531867695|FG002|Randomized|Excluded|1|||
147467177|NCT03529409|531867693|FG000|Post-treatment Assessment|Death|1|||
147467178|NCT03529409|531867694|FG001|Post-treatment Assessment|Death|0|||
147467179|NCT03529409|531867695|FG002|Post-treatment Assessment|Death|0|||
147467180|NCT03529409|531867693|FG000|Post-treatment Assessment|Lost to Follow-up|1|||
147467181|NCT03529409|531867694|FG001|Post-treatment Assessment|Lost to Follow-up|1|||
147467182|NCT03529409|531867695|FG002|Post-treatment Assessment|Lost to Follow-up|0|||
147467183|NCT03529409|531867693|FG000|Post-treatment Assessment|Unable to contact for this assessment, but attended later assessments|2|||
147467184|NCT03529409|531867694|FG001|Post-treatment Assessment|Unable to contact for this assessment, but attended later assessments|4|||
147467185|NCT03529409|531867695|FG002|Post-treatment Assessment|Unable to contact for this assessment, but attended later assessments|0|||
147467186|NCT03529409|531867693|FG000|Follow-up Assessment|Death|1|||
147467187|NCT03529409|531867694|FG001|Follow-up Assessment|Death|0|||
147467188|NCT03529409|531867695|FG002|Follow-up Assessment|Death|0|||
147467189|NCT03529409|531867693|FG000|Follow-up Assessment|Withdrawal by Subject|0|||
147467190|NCT03529409|531867694|FG001|Follow-up Assessment|Withdrawal by Subject|1|||
147467191|NCT03529409|531867695|FG002|Follow-up Assessment|Withdrawal by Subject|0|||
147467192|NCT01497262|531867696|FG000|Overall Study|Abnormal Lab Values|4|||
147467193|NCT01497262|531867696|FG000|Overall Study|Abnormal Test Procedure Result|1|||
147467194|NCT01497262|531867696|FG000|Overall Study|Physician Decision|1|||
147467195|NCT01497262|531867696|FG000|Overall Study|Withdrawal by Subject|2|||
147467196|NCT01497262|531867696|FG000|Overall Study|Adverse Event|2|||
147467197|NCT01497262|531867696|FG000|Overall Study|Protocol Violation|1|||
147467198|NCT01795547|531867699|FG000|Overall Study|Adverse Event|16|||
147467199|NCT01795547|531867700|FG001|Overall Study|Adverse Event|27|||
147467200|NCT01795547|531867699|FG000|Overall Study|Lack of Efficacy|8|||
147467201|NCT01795547|531867700|FG001|Overall Study|Lack of Efficacy|3|||
147467202|NCT01795547|531867699|FG000|Overall Study|Protocol Violation|6|||
147467203|NCT01795547|531867700|FG001|Overall Study|Protocol Violation|4|||
147467204|NCT01795547|531867699|FG000|Overall Study|Lost to Follow-up|2|||
147467205|NCT01795547|531867700|FG001|Overall Study|Lost to Follow-up|5|||
147467206|NCT01795547|531867699|FG000|Overall Study|Withdrawal of consent|7|||
147467207|NCT01795547|531867700|FG001|Overall Study|Withdrawal of consent|12|||
147467208|NCT01795547|531867699|FG000|Overall Study|Not Treated|4|||
147467209|NCT01795547|531867700|FG001|Overall Study|Not Treated|10|||
147467210|NCT01795547|531867699|FG000|Overall Study|Non-compliance with IMP|1|||
147467211|NCT01795547|531867700|FG001|Overall Study|Non-compliance with IMP|1|||
147467212|NCT01795547|531867699|FG000|Overall Study|Others|4|||
147467213|NCT01795547|531867700|FG001|Overall Study|Others|1|||
147467214|NCT01795547|531867699|FG000|Overall Study|Not stated|0|||
147467215|NCT01795547|531867700|FG001|Overall Study|Not stated|1|||
147467216|NCT01551745|531867701|FG000|Overall Study|Withdrawal by Subject|1|||
147467217|NCT01551745|531867701|FG000|Overall Study|Disease Progression|2|||
147467218|NCT02764541|531867704|FG000|Overall Study|Withdrawal by Subject|0|||
147467219|NCT02764541|531867705|FG001|Overall Study|Withdrawal by Subject|0|||
147467220|NCT02764541|531867706|FG002|Overall Study|Withdrawal by Subject|0|||
147467221|NCT02764541|531867707|FG003|Overall Study|Withdrawal by Subject|0|||
147467222|NCT02764541|531867708|FG004|Overall Study|Withdrawal by Subject|1|||
147467223|NCT02764541|531867709|FG005|Overall Study|Withdrawal by Subject|1|||
147467224|NCT02764541|531867710|FG006|Overall Study|Withdrawal by Subject|0|||
147467225|NCT02764541|531867711|FG007|Overall Study|Withdrawal by Subject|1|||
147467226|NCT02764541|531867704|FG000|Overall Study|Adverse Event|1|||
147467227|NCT02764541|531867705|FG001|Overall Study|Adverse Event|0|||
147467228|NCT02764541|531867706|FG002|Overall Study|Adverse Event|0|||
147467229|NCT02764541|531867707|FG003|Overall Study|Adverse Event|0|||
147467230|NCT02764541|531867708|FG004|Overall Study|Adverse Event|0|||
147467231|NCT02764541|531867709|FG005|Overall Study|Adverse Event|0|||
147467232|NCT02764541|531867710|FG006|Overall Study|Adverse Event|1|||
147467233|NCT02764541|531867711|FG007|Overall Study|Adverse Event|0|||
147467234|NCT02764541|531867704|FG000|Overall Study|Metastasis|1|||
147467235|NCT02764541|531867705|FG001|Overall Study|Metastasis|0|||
147467236|NCT02764541|531867706|FG002|Overall Study|Metastasis|0|||
147467237|NCT02764541|531867707|FG003|Overall Study|Metastasis|0|||
147467238|NCT02764541|531867708|FG004|Overall Study|Metastasis|0|||
147618559|NCT00707239|532419157|FG002|Overall Study|Randomized, but not treated|1|||
147618560|NCT00707239|532419155|FG000|Overall Study|Other|8|||
147618561|NCT00707239|532419156|FG001|Overall Study|Other|3|||
147467239|NCT02764541|531867709|FG005|Overall Study|Metastasis|0|||
147467240|NCT02764541|531867710|FG006|Overall Study|Metastasis|0|||
147467241|NCT02764541|531867711|FG007|Overall Study|Metastasis|0|||
147467242|NCT02764541|531867704|FG000|Overall Study|Disease progression|1|||
147467243|NCT02764541|531867705|FG001|Overall Study|Disease progression|1|||
147467244|NCT02764541|531867706|FG002|Overall Study|Disease progression|0|||
147467245|NCT02764541|531867707|FG003|Overall Study|Disease progression|0|||
147467246|NCT02764541|531867708|FG004|Overall Study|Disease progression|0|||
147467247|NCT02764541|531867709|FG005|Overall Study|Disease progression|0|||
147467248|NCT02764541|531867710|FG006|Overall Study|Disease progression|0|||
147467249|NCT02764541|531867711|FG007|Overall Study|Disease progression|1|||
147467250|NCT02764541|531867704|FG000|Overall Study|Protocol Violation|0|||
147467251|NCT02764541|531867705|FG001|Overall Study|Protocol Violation|0|||
147410691|NCT03829501|531668004|FG021|Overall Study|Death|2|||
147410692|NCT03829501|531668005|FG022|Overall Study|Death|3|||
147410693|NCT03829501|531667983|FG000|Overall Study|Miscellaneous|0|||
147410694|NCT03829501|531667984|FG001|Overall Study|Miscellaneous|0|||
147410695|NCT03829501|531667985|FG002|Overall Study|Miscellaneous|1|||
147410696|NCT03829501|531667986|FG003|Overall Study|Miscellaneous|0|||
147410697|NCT03829501|531667987|FG004|Overall Study|Miscellaneous|0|||
147410698|NCT03829501|531667988|FG005|Overall Study|Miscellaneous|0|||
147410699|NCT03829501|531667989|FG006|Overall Study|Miscellaneous|0|||
147410700|NCT03829501|531667990|FG007|Overall Study|Miscellaneous|1|||
147410701|NCT03829501|531667991|FG008|Overall Study|Miscellaneous|0|||
147410702|NCT03829501|531667992|FG009|Overall Study|Miscellaneous|0|||
147410703|NCT03829501|531667993|FG010|Overall Study|Miscellaneous|0|||
147410704|NCT03829501|531667994|FG011|Overall Study|Miscellaneous|0|||
147410705|NCT03829501|531667995|FG012|Overall Study|Miscellaneous|0|||
147410706|NCT03829501|531667996|FG013|Overall Study|Miscellaneous|0|||
147410707|NCT03829501|531667997|FG014|Overall Study|Miscellaneous|0|||
147410708|NCT03829501|531667998|FG015|Overall Study|Miscellaneous|0|||
147410709|NCT03829501|531667999|FG016|Overall Study|Miscellaneous|0|||
147410710|NCT03829501|531668000|FG017|Overall Study|Miscellaneous|0|||
147410711|NCT03829501|531668001|FG018|Overall Study|Miscellaneous|0|||
147410712|NCT03829501|531668002|FG019|Overall Study|Miscellaneous|0|||
147410713|NCT03829501|531668003|FG020|Overall Study|Miscellaneous|0|||
147410714|NCT03829501|531668004|FG021|Overall Study|Miscellaneous|0|||
147410715|NCT03829501|531668005|FG022|Overall Study|Miscellaneous|1|||
147410716|NCT03301155|531668012|FG000|Overall Study|Сompliance with exclusion criteria|8|||
147410717|NCT03301155|531668013|FG001|Overall Study|Сompliance with exclusion criteria|7|||
147410718|NCT01685229|531668018|FG000|Overall Study|Subjects missing Study Exit form|3|||
147410719|NCT01685229|531668019|FG001|Overall Study|Subjects missing Study Exit form|1|||
147410720|NCT01685229|531668018|FG000|Overall Study|Lost to Follow-up|16|||
147410721|NCT01685229|531668019|FG001|Overall Study|Lost to Follow-up|10|||
147410722|NCT01685229|531668018|FG000|Overall Study|Withdrawal by Subject|6|||
147410723|NCT01685229|531668019|FG001|Overall Study|Withdrawal by Subject|5|||
147410724|NCT01685229|531668018|FG000|Overall Study|Death|1|||
147410725|NCT01685229|531668019|FG001|Overall Study|Death|0|||
147410726|NCT02964325|531668025|FG000|Overall Study|Lost to Follow-up|3|||
147410727|NCT02964325|531668026|FG001|Overall Study|Lost to Follow-up|3|||
147410728|NCT02964325|531668025|FG000|Overall Study|Physician Decision|5|||
147410729|NCT02964325|531668026|FG001|Overall Study|Physician Decision|4|||
147410730|NCT02964325|531668025|FG000|Overall Study|Death|1|||
147410731|NCT02964325|531668026|FG001|Overall Study|Death|3|||
147410732|NCT02964325|531668025|FG000|Overall Study|Withdrawal by Subject|2|||
147410733|NCT02964325|531668026|FG001|Overall Study|Withdrawal by Subject|1|||
147410734|NCT02964325|531668025|FG000|Overall Study|Did not require PLT transfusion, had HLA positive|10|||
147410735|NCT02964325|531668026|FG001|Overall Study|Did not require PLT transfusion, had HLA positive|12|||
147410736|NCT01371825|531668031|FG000|Overall Study|Death|4|||
147410737|NCT04868539|531668032|FG000|Overall Study|Unable to complete study due to poor IV access|1|||
147410738|NCT04868539|531668033|FG001|Overall Study|Unable to complete study due to poor IV access|1|||
147410739|NCT01038427|531668034|FG000|Overall Study|Lost to follow up|1|||
147410740|NCT01038427|531668035|FG001|Overall Study|Lost to follow up|1|||
147410741|NCT01038427|531668036|FG002|Overall Study|Lost to follow up|0|||
147410742|NCT01038427|531668034|FG000|Overall Study|Restricted medication for seasonal allergic rhinitis|0|||
147410743|NCT01038427|531668035|FG001|Overall Study|Restricted medication for seasonal allergic rhinitis|0|||
147410744|NCT01038427|531668036|FG002|Overall Study|Restricted medication for seasonal allergic rhinitis|1|||
147410745|NCT01038427|531668034|FG000|Overall Study|Withdrew consent|0|||
147410746|NCT01038427|531668035|FG001|Overall Study|Withdrew consent|0|||
147410747|NCT01038427|531668036|FG002|Overall Study|Withdrew consent|1|||
147410748|NCT01038427|531668034|FG000|Overall Study|Adverse Event|2|||
147410749|NCT01038427|531668035|FG001|Overall Study|Adverse Event|2|||
147410750|NCT01038427|531668036|FG002|Overall Study|Adverse Event|1|||
147410751|NCT01038427|531668034|FG000|Overall Study|Enrolled in error|0|||
147410752|NCT01038427|531668035|FG001|Overall Study|Enrolled in error|1|||
147410753|NCT01038427|531668036|FG002|Overall Study|Enrolled in error|1|||
147410754|NCT01038427|531668034|FG000|Overall Study|Other|0|||
147410755|NCT01038427|531668035|FG001|Overall Study|Other|2|||
147410756|NCT01038427|531668036|FG002|Overall Study|Other|0|||
147410757|NCT01162863|531668037|FG000|Overall Study|Lack of Efficacy|1|||
147410758|NCT01162863|531668038|FG001|Overall Study|Lack of Efficacy|0|||
147410759|NCT01162863|531668039|FG002|Overall Study|Lack of Efficacy|0|||
147410760|NCT01162863|531668037|FG000|Overall Study|Adverse Event|0|||
147410761|NCT01162863|531668038|FG001|Overall Study|Adverse Event|1|||
147410762|NCT01162863|531668039|FG002|Overall Study|Adverse Event|0|||
147410763|NCT00588692|531668040|FG000|Overall Study|Withdrawal by Subject|4|||
147410764|NCT00588692|531668041|FG001|Overall Study|Withdrawal by Subject|2|||
147410765|NCT00588692|531668040|FG000|Overall Study|Hip Surgery|0|||
147410766|NCT00588692|531668041|FG001|Overall Study|Hip Surgery|1|||
147410767|NCT00588692|531668040|FG000|Overall Study|Severe Peptic Ulcer Disease|1|||
147410768|NCT00588692|531668041|FG001|Overall Study|Severe Peptic Ulcer Disease|0|||
147410769|NCT00588692|531668040|FG000|Overall Study|Cancer|1|||
147410770|NCT00588692|531668041|FG001|Overall Study|Cancer|0|||
147410771|NCT00588692|531668040|FG000|Overall Study|Death|1|||
147410772|NCT00588692|531668041|FG001|Overall Study|Death|0|||
147410773|NCT00820170|531668042|FG000|Overall Study|Adverse Event|0|||
147410774|NCT00820170|531668043|FG001|Overall Study|Adverse Event|0|||
147410775|NCT00820170|531668044|FG002|Overall Study|Adverse Event|0|||
147410776|NCT00820170|531668045|FG003|Overall Study|Adverse Event|0|||
147410777|NCT00820170|531668046|FG004|Overall Study|Adverse Event|2|||
147410778|NCT00820170|531668042|FG000|Overall Study|Progressive Disease|0|||
147410779|NCT00820170|531668043|FG001|Overall Study|Progressive Disease|0|||
147410780|NCT00820170|531668044|FG002|Overall Study|Progressive Disease|0|||
147410781|NCT00820170|531668045|FG003|Overall Study|Progressive Disease|0|||
147410782|NCT00820170|531668046|FG004|Overall Study|Progressive Disease|2|||
147410783|NCT03995316|531668048|FG000|Overall Study|Lost to Follow-up|10|||
147410784|NCT03995316|531668049|FG001|Overall Study|Lost to Follow-up|3|||
147410785|NCT01361594|531668050|FG000|Overall Study|Withdrawal by Subject|1|||
147410786|NCT01361594|531668051|FG001|Overall Study|Withdrawal by Subject|2|||
147410787|NCT00415051|531668052|FG000|Overall Study|Protocol Violation|1|||
147410788|NCT03083665|531668054|FG000|Double-Blind Period|Adverse Event|5|||
147410789|NCT03083665|531668055|FG001|Double-Blind Period|Adverse Event|4|||
147410790|NCT03083665|531668056|FG002|Double-Blind Period|Adverse Event|5|||
147410791|NCT03083665|531668057|FG003|Double-Blind Period|Adverse Event|0|||
147410792|NCT03083665|531668058|FG004|Double-Blind Period|Adverse Event|0|||
147410793|NCT03083665|531668059|FG005|Double-Blind Period|Adverse Event|0|||
147410794|NCT03083665|531668054|FG000|Double-Blind Period|Lack of Efficacy|0|||
147410795|NCT03083665|531668055|FG001|Double-Blind Period|Lack of Efficacy|0|||
147410796|NCT03083665|531668056|FG002|Double-Blind Period|Lack of Efficacy|1|||
147410797|NCT03083665|531668057|FG003|Double-Blind Period|Lack of Efficacy|0|||
147410798|NCT03083665|531668058|FG004|Double-Blind Period|Lack of Efficacy|0|||
147410799|NCT03083665|531668059|FG005|Double-Blind Period|Lack of Efficacy|0|||
147410800|NCT03083665|531668054|FG000|Double-Blind Period|Protocol Violation|1|||
147410801|NCT03083665|531668055|FG001|Double-Blind Period|Protocol Violation|0|||
147410802|NCT03083665|531668056|FG002|Double-Blind Period|Protocol Violation|1|||
147410803|NCT03083665|531668057|FG003|Double-Blind Period|Protocol Violation|0|||
147410804|NCT03083665|531668058|FG004|Double-Blind Period|Protocol Violation|0|||
147410805|NCT03083665|531668059|FG005|Double-Blind Period|Protocol Violation|0|||
147410806|NCT03083665|531668054|FG000|Double-Blind Period|Lost to Follow-up|1|||
147410807|NCT03083665|531668055|FG001|Double-Blind Period|Lost to Follow-up|0|||
147410808|NCT03083665|531668056|FG002|Double-Blind Period|Lost to Follow-up|1|||
147410809|NCT03083665|531668057|FG003|Double-Blind Period|Lost to Follow-up|0|||
147410810|NCT03083665|531668058|FG004|Double-Blind Period|Lost to Follow-up|0|||
147410811|NCT03083665|531668059|FG005|Double-Blind Period|Lost to Follow-up|0|||
147410812|NCT03083665|531668054|FG000|Double-Blind Period|Withdrawal by Subject|3|||
147410813|NCT03083665|531668055|FG001|Double-Blind Period|Withdrawal by Subject|0|||
147410814|NCT03083665|531668056|FG002|Double-Blind Period|Withdrawal by Subject|0|||
147410815|NCT03083665|531668057|FG003|Double-Blind Period|Withdrawal by Subject|0|||
147410816|NCT03083665|531668058|FG004|Double-Blind Period|Withdrawal by Subject|0|||
147410817|NCT03083665|531668059|FG005|Double-Blind Period|Withdrawal by Subject|0|||
147410818|NCT03083665|531668054|FG000|Double-Blind Period|Consent withdrawn by subject due to concern on AE|1|||
147410819|NCT03083665|531668055|FG001|Double-Blind Period|Consent withdrawn by subject due to concern on AE|0|||
147410820|NCT03083665|531668056|FG002|Double-Blind Period|Consent withdrawn by subject due to concern on AE|0|||
147410821|NCT03083665|531668057|FG003|Double-Blind Period|Consent withdrawn by subject due to concern on AE|0|||
147410822|NCT03083665|531668058|FG004|Double-Blind Period|Consent withdrawn by subject due to concern on AE|0|||
147410823|NCT03083665|531668059|FG005|Double-Blind Period|Consent withdrawn by subject due to concern on AE|0|||
147410824|NCT03083665|531668054|FG000|Double-Blind Period|Subjects were able to never take a study drug|0|||
147410825|NCT03083665|531668055|FG001|Double-Blind Period|Subjects were able to never take a study drug|1|||
147410826|NCT03083665|531668056|FG002|Double-Blind Period|Subjects were able to never take a study drug|0|||
147410827|NCT03083665|531668057|FG003|Double-Blind Period|Subjects were able to never take a study drug|0|||
147410828|NCT03083665|531668058|FG004|Double-Blind Period|Subjects were able to never take a study drug|0|||
147410829|NCT03083665|531668059|FG005|Double-Blind Period|Subjects were able to never take a study drug|0|||
147410830|NCT03083665|531668054|FG000|Open-Label Temporary Period (OLTP)|Adverse Event|0|||
147410831|NCT03083665|531668055|FG001|Open-Label Temporary Period (OLTP)|Adverse Event|0|||
147410832|NCT03083665|531668056|FG002|Open-Label Temporary Period (OLTP)|Adverse Event|0|||
147410833|NCT03083665|531668057|FG003|Open-Label Temporary Period (OLTP)|Adverse Event|2|||
147410834|NCT03083665|531668058|FG004|Open-Label Temporary Period (OLTP)|Adverse Event|0|||
147410835|NCT03083665|531668059|FG005|Open-Label Temporary Period (OLTP)|Adverse Event|0|||
147410836|NCT03083665|531668054|FG000|Open-Label Temporary Period (OLTP)|Lack of Efficacy|0|||
147410837|NCT03083665|531668055|FG001|Open-Label Temporary Period (OLTP)|Lack of Efficacy|0|||
147410838|NCT03083665|531668056|FG002|Open-Label Temporary Period (OLTP)|Lack of Efficacy|0|||
147467252|NCT02764541|531867706|FG002|Overall Study|Protocol Violation|0|||
147467253|NCT02764541|531867707|FG003|Overall Study|Protocol Violation|1|||
147467254|NCT02764541|531867708|FG004|Overall Study|Protocol Violation|0|||
147467255|NCT02764541|531867709|FG005|Overall Study|Protocol Violation|1|||
147467256|NCT02764541|531867710|FG006|Overall Study|Protocol Violation|0|||
147467257|NCT02764541|531867711|FG007|Overall Study|Protocol Violation|0|||
147467258|NCT02764541|531867704|FG000|Overall Study|Physician Decision|0|||
147467259|NCT02764541|531867705|FG001|Overall Study|Physician Decision|0|||
147467260|NCT02764541|531867706|FG002|Overall Study|Physician Decision|0|||
147467261|NCT02764541|531867707|FG003|Overall Study|Physician Decision|1|||
147467262|NCT02764541|531867708|FG004|Overall Study|Physician Decision|0|||
147467263|NCT02764541|531867709|FG005|Overall Study|Physician Decision|0|||
147467264|NCT02764541|531867710|FG006|Overall Study|Physician Decision|0|||
147467265|NCT02764541|531867711|FG007|Overall Study|Physician Decision|1|||
147467266|NCT02764541|531867704|FG000|Overall Study|Three Cycles completed before surgery|0|||
147467267|NCT02764541|531867705|FG001|Overall Study|Three Cycles completed before surgery|0|||
147467268|NCT02764541|531867706|FG002|Overall Study|Three Cycles completed before surgery|0|||
147467269|NCT02764541|531867707|FG003|Overall Study|Three Cycles completed before surgery|1|||
147467270|NCT02764541|531867708|FG004|Overall Study|Three Cycles completed before surgery|0|||
147467271|NCT02764541|531867709|FG005|Overall Study|Three Cycles completed before surgery|0|||
147467272|NCT02764541|531867710|FG006|Overall Study|Three Cycles completed before surgery|0|||
147467273|NCT02764541|531867711|FG007|Overall Study|Three Cycles completed before surgery|0|||
147467274|NCT02764541|531867704|FG000|Overall Study|Patient Compliance|0|||
147467275|NCT02764541|531867705|FG001|Overall Study|Patient Compliance|0|||
147467276|NCT02764541|531867706|FG002|Overall Study|Patient Compliance|1|||
147467277|NCT02764541|531867707|FG003|Overall Study|Patient Compliance|0|||
147467278|NCT02764541|531867708|FG004|Overall Study|Patient Compliance|0|||
147467279|NCT02764541|531867709|FG005|Overall Study|Patient Compliance|0|||
147467280|NCT02764541|531867710|FG006|Overall Study|Patient Compliance|0|||
147467281|NCT02764541|531867711|FG007|Overall Study|Patient Compliance|0|||
147467282|NCT02764541|531867704|FG000|Overall Study|Death|0|||
147467283|NCT02764541|531867705|FG001|Overall Study|Death|0|||
147467284|NCT02764541|531867706|FG002|Overall Study|Death|0|||
147467285|NCT02764541|531867707|FG003|Overall Study|Death|0|||
147467286|NCT02764541|531867708|FG004|Overall Study|Death|0|||
147467287|NCT02764541|531867709|FG005|Overall Study|Death|0|||
147467288|NCT02764541|531867710|FG006|Overall Study|Death|1|||
147467289|NCT02764541|531867711|FG007|Overall Study|Death|0|||
147467290|NCT02764541|531867704|FG000|Overall Study|Insurance reasons|0|||
147467291|NCT02764541|531867705|FG001|Overall Study|Insurance reasons|0|||
147467292|NCT02764541|531867706|FG002|Overall Study|Insurance reasons|0|||
147467293|NCT02764541|531867707|FG003|Overall Study|Insurance reasons|0|||
147467294|NCT02764541|531867708|FG004|Overall Study|Insurance reasons|0|||
147467295|NCT02764541|531867709|FG005|Overall Study|Insurance reasons|0|||
147467296|NCT02764541|531867710|FG006|Overall Study|Insurance reasons|1|||
147467297|NCT02764541|531867711|FG007|Overall Study|Insurance reasons|0|||
147467298|NCT02040142|531867712|FG000|Overall Study|Lost to Follow-up|5|||
147467299|NCT02040142|531867712|FG000|Overall Study|Death|17|||
147467300|NCT02040142|531867712|FG000|Overall Study|Not Evaluable (Surgery and/or Treatment aborted but still enrolled)|14|||
147467301|NCT04752384|531867713|FG000|Overall Study|Withdrawal by Subject|1|||
147467302|NCT04752384|531867713|FG000|Overall Study|Death|1|||
147467303|NCT02330419|531867715|FG000|Overall Study|Lost to Follow-up|3|||
147467304|NCT02330419|531867716|FG001|Overall Study|Lost to Follow-up|7|||
147467305|NCT01955707|531867720|FG000|Overall Study|Adverse Event|1|||
147467306|NCT01955707|531867721|FG001|Overall Study|Adverse Event|2|||
147467307|NCT01955707|531867720|FG000|Overall Study|Lost to Follow-up|2|||
147467308|NCT01955707|531867721|FG001|Overall Study|Lost to Follow-up|1|||
147467309|NCT01955707|531867720|FG000|Overall Study|Withdrawal by Subject|0|||
147467310|NCT01955707|531867721|FG001|Overall Study|Withdrawal by Subject|3|||
147467311|NCT01955707|531867720|FG000|Overall Study|Death|13|||
147467312|NCT01955707|531867721|FG001|Overall Study|Death|14|||
147467313|NCT01955707|531867720|FG000|Overall Study|Other|4|||
147467314|NCT01955707|531867721|FG001|Overall Study|Other|2|||
147467315|NCT04167345|531867724|FG000|Overall Study|Other|1|||
147467316|NCT04167345|531867725|FG001|Overall Study|Other|1|||
147467317|NCT04167345|531867726|FG002|Overall Study|Other|0|||
147467318|NCT04167345|531867727|FG003|Overall Study|Other|0|||
147467319|NCT04167345|531867728|FG004|Overall Study|Other|0|||
147467320|NCT01445171|531868756|FG000|Overall Study|Lost to Follow-up|11|||
147467321|NCT01445171|531868756|FG000|Overall Study|Withdrawal by Subject|16|||
147467322|NCT01445171|531868756|FG000|Overall Study|Death|51|||
147467323|NCT01445171|531868756|FG000|Overall Study|Subjects declined to return for followup|9|||
147467324|NCT01445171|531868756|FG000|Overall Study|Consented but did not receive device|8|||
147467325|NCT03480802|531868760|FG000|Overall Study|Lost to Follow-up|5|||
147467326|NCT03480802|531868761|FG001|Overall Study|Lost to Follow-up|1|||
147467327|NCT03480802|531868760|FG000|Overall Study|Withdrawal by Subject|2|||
147467328|NCT03480802|531868761|FG001|Overall Study|Withdrawal by Subject|1|||
147467329|NCT03480802|531868760|FG000|Overall Study|Relocated|0|||
147467330|NCT03480802|531868761|FG001|Overall Study|Relocated|1|||
147467331|NCT02542267|531868764|FG000|Overall Study|Withdrawal by Subject|10|||
147467332|NCT02542267|531868764|FG000|Overall Study|Physician Decision|6|||
147467333|NCT02542267|531868764|FG000|Overall Study|Lost to Follow-up|4|||
147467334|NCT02542267|531868764|FG000|Overall Study|Death|13|||
147467335|NCT02542267|531868764|FG000|Overall Study|Surgical Bypass of All Study Devices|13|||
147467336|NCT02542267|531868764|FG000|Overall Study|Other|9|||
147467337|NCT00501228|531868765|FG000|Overall Study|Withdrawal by Subject|1|||
147467338|NCT03304522|531868768|FG000|Overall Study|Adverse Event|0|||
147467339|NCT03304522|531868769|FG001|Overall Study|Adverse Event|4|||
147467340|NCT03304522|531868768|FG000|Overall Study|Withdrawal of consent (due to lack of efficacy)|1|||
147467341|NCT03304522|531868769|FG001|Overall Study|Withdrawal of consent (due to lack of efficacy)|1|||
147467342|NCT03304522|531868768|FG000|Overall Study|Withdrawal of consent (for other reason)|0|||
147467343|NCT03304522|531868769|FG001|Overall Study|Withdrawal of consent (for other reason)|2|||
147467344|NCT03304522|531868768|FG000|Overall Study|Other|0|||
147467345|NCT03304522|531868769|FG001|Overall Study|Other|1|||
147467346|NCT00473876|531868777|FG000|Overall Study|Lost to Follow-up|3|||
147467347|NCT00473876|531868778|FG001|Overall Study|Lost to Follow-up|1|||
147467348|NCT00755079|531868781|FG000|Overall Study|Lost to Follow-up|1|||
147467349|NCT00755079|531868782|FG001|Overall Study|Lost to Follow-up|3|||
147467350|NCT00755079|531868781|FG000|Overall Study|Adverse Event|0|||
147467351|NCT00755079|531868782|FG001|Overall Study|Adverse Event|1|||
147467352|NCT00755079|531868781|FG000|Overall Study|Withdrawal by Subject|0|||
147467353|NCT00755079|531868782|FG001|Overall Study|Withdrawal by Subject|2|||
147467354|NCT03751111|531868783|FG000|Overall Study|Lack of Efficacy|9|||
147467355|NCT03751111|531868784|FG001|Overall Study|Lack of Efficacy|30|||
147467356|NCT03751111|531868783|FG000|Overall Study|Adverse Event|3|||
147467357|NCT03751111|531868784|FG001|Overall Study|Adverse Event|2|||
147467358|NCT01285349|531868785|FG000|Overall Study|Lost to Follow-up|27|||
147467359|NCT01285349|531868786|FG001|Overall Study|Lost to Follow-up|20|||
147467360|NCT01285349|531868787|FG002|Overall Study|Lost to Follow-up|27|||
147467361|NCT02909153|531868788|FG000|Overall Study|Withdrawal by Subject|0|||
147467362|NCT02909153|531868789|FG001|Overall Study|Withdrawal by Subject|1|||
147467363|NCT02909153|531868790|FG002|Overall Study|Withdrawal by Subject|0|||
147467364|NCT02909153|531868791|FG003|Overall Study|Withdrawal by Subject|0|||
147467365|NCT02909153|531868792|FG004|Overall Study|Withdrawal by Subject|0|||
147467366|NCT01526148|531868794|FG000|Overall Study|Adverse Event|6|||
147467367|NCT01526148|531868795|FG001|Overall Study|Adverse Event|5|||
147467368|NCT01526148|531868794|FG000|Overall Study|Lost to Follow-up|3|||
147467369|NCT01526148|531868795|FG001|Overall Study|Lost to Follow-up|6|||
147467370|NCT01526148|531868794|FG000|Overall Study|Withdrawal by Subject|2|||
147467371|NCT01526148|531868795|FG001|Overall Study|Withdrawal by Subject|0|||
147467372|NCT01526148|531868794|FG000|Overall Study|Unstable Medical Condition|1|||
147467373|NCT01526148|531868795|FG001|Overall Study|Unstable Medical Condition|0|||
147467374|NCT01526148|531868794|FG000|Overall Study|Unable to discontinue concomitant med|1|||
147467375|NCT01526148|531868795|FG001|Overall Study|Unable to discontinue concomitant med|0|||
147467376|NCT01526148|531868794|FG000|Overall Study|Moved out of state|1|||
147467377|NCT01526148|531868795|FG001|Overall Study|Moved out of state|0|||
147467378|NCT01526148|531868794|FG000|Overall Study|Incarcerated|0|||
147467379|NCT01526148|531868795|FG001|Overall Study|Incarcerated|2|||
147467380|NCT01173653|531868796|FG000|Overall Study|Pts unwilling to provide follow-up|53|||
147467381|NCT01173653|531868797|FG001|Overall Study|Pts unwilling to provide follow-up|41|||
147467382|NCT00631137|531868798|FG000|Overall Study|Withdrawal by Subject|1|||
147467383|NCT00631137|531868799|FG001|Overall Study|Withdrawal by Subject|0|||
147467384|NCT03308188|531868800|FG000|Overall Study|Withdrawal by Subject|0|||
147467385|NCT03308188|531868801|FG001|Overall Study|Withdrawal by Subject|3|||
147467386|NCT03308188|531868800|FG000|Overall Study|Death|0|||
147467387|NCT03308188|531868801|FG001|Overall Study|Death|1|||
147467388|NCT01791855|531868802|FG000|Overall Study|Adverse Event|0|||
147467389|NCT01791855|531868803|FG001|Overall Study|Adverse Event|0|||
147467390|NCT01791855|531868804|FG002|Overall Study|Adverse Event|0|||
147467391|NCT01791855|531868805|FG003|Overall Study|Adverse Event|1|||
147467392|NCT01791855|531868802|FG000|Overall Study|Randomized, not treated|0|||
147467393|NCT01791855|531868803|FG001|Overall Study|Randomized, not treated|1|||
147467394|NCT01791855|531868804|FG002|Overall Study|Randomized, not treated|0|||
147467395|NCT01791855|531868805|FG003|Overall Study|Randomized, not treated|0|||
147467396|NCT00481065|531868806|FG000|Overall Study|Adverse event or death|1|||
147467397|NCT00481065|531868807|FG001|Overall Study|Adverse event or death|1|||
147467398|NCT00481065|531868808|FG002|Overall Study|Adverse event or death|3|||
147467399|NCT00481065|531868809|FG003|Overall Study|Adverse event or death|0|||
147467400|NCT00481065|531868810|FG004|Overall Study|Adverse event or death|2|||
147467401|NCT00481065|531868811|FG005|Overall Study|Adverse event or death|0|||
147467402|NCT00481065|531868812|FG006|Overall Study|Adverse event or death|1|||
147467403|NCT00481065|531868813|FG007|Overall Study|Adverse event or death|1|||
147467404|NCT00481065|531868806|FG000|Overall Study|Withdrawal by Subject|11|||
147618562|NCT00707239|532419157|FG002|Overall Study|Other|5|||
147467405|NCT00481065|531868807|FG001|Overall Study|Withdrawal by Subject|12|||
147467406|NCT00481065|531868808|FG002|Overall Study|Withdrawal by Subject|7|||
147467407|NCT00481065|531868809|FG003|Overall Study|Withdrawal by Subject|11|||
147467408|NCT00481065|531868810|FG004|Overall Study|Withdrawal by Subject|13|||
147467409|NCT00481065|531868811|FG005|Overall Study|Withdrawal by Subject|12|||
147467410|NCT00481065|531868812|FG006|Overall Study|Withdrawal by Subject|9|||
147467411|NCT00481065|531868813|FG007|Overall Study|Withdrawal by Subject|10|||
147467412|NCT00481065|531868806|FG000|Overall Study|Lost to Follow-up|4|||
147467413|NCT00481065|531868807|FG001|Overall Study|Lost to Follow-up|2|||
147467414|NCT00481065|531868808|FG002|Overall Study|Lost to Follow-up|4|||
147467415|NCT00481065|531868809|FG003|Overall Study|Lost to Follow-up|3|||
147467416|NCT00481065|531868810|FG004|Overall Study|Lost to Follow-up|3|||
147467417|NCT00481065|531868811|FG005|Overall Study|Lost to Follow-up|3|||
147467418|NCT00481065|531868812|FG006|Overall Study|Lost to Follow-up|2|||
147467419|NCT00481065|531868813|FG007|Overall Study|Lost to Follow-up|5|||
147467420|NCT00481065|531868806|FG000|Overall Study|Inappropriate enrollment|4|||
147467421|NCT00481065|531868807|FG001|Overall Study|Inappropriate enrollment|0|||
147467422|NCT00481065|531868808|FG002|Overall Study|Inappropriate enrollment|2|||
147467423|NCT00481065|531868809|FG003|Overall Study|Inappropriate enrollment|0|||
147467424|NCT00481065|531868810|FG004|Overall Study|Inappropriate enrollment|2|||
147467425|NCT00481065|531868811|FG005|Overall Study|Inappropriate enrollment|1|||
147467426|NCT00481065|531868812|FG006|Overall Study|Inappropriate enrollment|0|||
147467427|NCT00481065|531868813|FG007|Overall Study|Inappropriate enrollment|1|||
147467428|NCT00481065|531868806|FG000|Overall Study|Administrative reason|0|||
147467429|NCT00481065|531868807|FG001|Overall Study|Administrative reason|0|||
147467430|NCT00481065|531868808|FG002|Overall Study|Administrative reason|0|||
147467431|NCT00481065|531868809|FG003|Overall Study|Administrative reason|0|||
147467432|NCT00481065|531868810|FG004|Overall Study|Administrative reason|0|||
147467433|NCT00481065|531868811|FG005|Overall Study|Administrative reason|2|||
147467434|NCT00481065|531868812|FG006|Overall Study|Administrative reason|1|||
147467435|NCT00481065|531868813|FG007|Overall Study|Administrative reason|0|||
147467436|NCT00481065|531868806|FG000|Overall Study|Protocol Violation|2|||
147467437|NCT00481065|531868807|FG001|Overall Study|Protocol Violation|1|||
147467438|NCT00481065|531868808|FG002|Overall Study|Protocol Violation|1|||
147467439|NCT00481065|531868809|FG003|Overall Study|Protocol Violation|1|||
147467440|NCT00481065|531868810|FG004|Overall Study|Protocol Violation|2|||
147467441|NCT00481065|531868811|FG005|Overall Study|Protocol Violation|6|||
147467442|NCT00481065|531868812|FG006|Overall Study|Protocol Violation|3|||
147467443|NCT00481065|531868813|FG007|Overall Study|Protocol Violation|2|||
147467444|NCT00481065|531868806|FG000|Overall Study|Unable to classify|0|||
147467445|NCT00481065|531868807|FG001|Overall Study|Unable to classify|1|||
147467446|NCT00481065|531868808|FG002|Overall Study|Unable to classify|2|||
147467447|NCT00481065|531868809|FG003|Overall Study|Unable to classify|0|||
147467448|NCT00481065|531868810|FG004|Overall Study|Unable to classify|1|||
147467449|NCT00481065|531868811|FG005|Overall Study|Unable to classify|0|||
147467450|NCT00481065|531868812|FG006|Overall Study|Unable to classify|0|||
147467451|NCT00481065|531868813|FG007|Overall Study|Unable to classify|0|||
147467452|NCT00772447|531868814|FG000|Overall Study|Withdrawal by Subject|9|||
147467453|NCT00772447|531868815|FG001|Overall Study|Withdrawal by Subject|5|||
147467454|NCT00772447|531868814|FG000|Overall Study|Physician Decision|4|||
147467455|NCT00772447|531868815|FG001|Overall Study|Physician Decision|8|||
147467456|NCT00772447|531868814|FG000|Overall Study|Lost to Follow-up|2|||
147467457|NCT00772447|531868815|FG001|Overall Study|Lost to Follow-up|4|||
147467458|NCT00772447|531868814|FG000|Overall Study|incorrect enrolment|3|||
147467459|NCT00772447|531868815|FG001|Overall Study|incorrect enrolment|4|||
147467460|NCT00772447|531868814|FG000|Overall Study|Protocol Violation|0|||
147467461|NCT00772447|531868815|FG001|Overall Study|Protocol Violation|1|||
147467462|NCT00772447|531868814|FG000|Overall Study|all others|2|||
147467463|NCT00772447|531868815|FG001|Overall Study|all others|2|||
147302722|NCT02748694|531274426|FG005|Overall Study|Voluntary Withdrawal|0|||
147467464|NCT00454207|531868816|FG000|Overall Study|Adverse Event|3|||
147467465|NCT00454207|531868817|FG001|Overall Study|Adverse Event|1|||
147467466|NCT00454207|531868816|FG000|Overall Study|Lack of Efficacy|1|||
147467467|NCT00454207|531868817|FG001|Overall Study|Lack of Efficacy|0|||
147467468|NCT00454207|531868816|FG000|Overall Study|Protocol Violation|0|||
147467469|NCT00454207|531868817|FG001|Overall Study|Protocol Violation|1|||
147467470|NCT01672957|531868818|FG000|Overall Study|Protocol Violation|48|||
147467471|NCT01672957|531868818|FG000|Overall Study|Death|2|||
147467472|NCT01672957|531868818|FG000|Overall Study|ICF Signed After Transplantation|5|||
147467473|NCT00151892|531868819|FG000|Overall Study|Lack of Efficacy|50|||
147467474|NCT00151892|531868820|FG001|Overall Study|Lack of Efficacy|57|||
147467475|NCT00151892|531868819|FG000|Overall Study|Patient request|10|||
147467476|NCT00151892|531868820|FG001|Overall Study|Patient request|7|||
147467477|NCT00151892|531868819|FG000|Overall Study|Lost to Follow-up|5|||
147467478|NCT00151892|531868820|FG001|Overall Study|Lost to Follow-up|10|||
147467479|NCT00151892|531868819|FG000|Overall Study|Adverse Event|6|||
147467480|NCT00151892|531868820|FG001|Overall Study|Adverse Event|3|||
147467481|NCT00151892|531868819|FG000|Overall Study|Protocol Violation|3|||
147467482|NCT00151892|531868820|FG001|Overall Study|Protocol Violation|3|||
147467483|NCT00151892|531868819|FG000|Overall Study|Non-compliance|0|||
147467484|NCT00151892|531868820|FG001|Overall Study|Non-compliance|1|||
147467485|NCT00151892|531868819|FG000|Overall Study|Pregnancy|0|||
147467486|NCT00151892|531868820|FG001|Overall Study|Pregnancy|1|||
147467487|NCT00151892|531868819|FG000|Overall Study|Did not return for a visit|1|||
147467488|NCT00151892|531868820|FG001|Overall Study|Did not return for a visit|0|||
147467489|NCT00151892|531868819|FG000|Overall Study|Used prohibited corticosteroids|1|||
147467490|NCT00151892|531868820|FG001|Overall Study|Used prohibited corticosteroids|0|||
147467491|NCT00151892|531868819|FG000|Overall Study|Lack of study medication at center|0|||
147467492|NCT00151892|531868820|FG001|Overall Study|Lack of study medication at center|1|||
147467493|NCT00749190|531868823|FG000|Overall Study|Adverse Event|0|||
147467494|NCT00749190|531868824|FG001|Overall Study|Adverse Event|2|||
147467495|NCT00749190|531868825|FG002|Overall Study|Adverse Event|0|||
147467496|NCT00749190|531868826|FG003|Overall Study|Adverse Event|4|||
147467497|NCT00749190|531868827|FG004|Overall Study|Adverse Event|0|||
147467498|NCT00749190|531868828|FG005|Overall Study|Adverse Event|3|||
147467499|NCT00749190|531868829|FG006|Overall Study|Adverse Event|0|||
147467500|NCT00749190|531868823|FG000|Overall Study|Lack of Efficacy|3|||
147467501|NCT00749190|531868824|FG001|Overall Study|Lack of Efficacy|1|||
147467502|NCT00749190|531868825|FG002|Overall Study|Lack of Efficacy|1|||
147467503|NCT00749190|531868826|FG003|Overall Study|Lack of Efficacy|0|||
147467504|NCT00749190|531868827|FG004|Overall Study|Lack of Efficacy|0|||
147467505|NCT00749190|531868828|FG005|Overall Study|Lack of Efficacy|1|||
147467506|NCT00749190|531868829|FG006|Overall Study|Lack of Efficacy|0|||
147467507|NCT00749190|531868823|FG000|Overall Study|Withdrawal by Subject|2|||
147467508|NCT00749190|531868824|FG001|Overall Study|Withdrawal by Subject|1|||
147467509|NCT00749190|531868825|FG002|Overall Study|Withdrawal by Subject|0|||
147467510|NCT00749190|531868826|FG003|Overall Study|Withdrawal by Subject|0|||
147467511|NCT00749190|531868827|FG004|Overall Study|Withdrawal by Subject|0|||
147467512|NCT00749190|531868828|FG005|Overall Study|Withdrawal by Subject|1|||
147467513|NCT00749190|531868829|FG006|Overall Study|Withdrawal by Subject|0|||
147467514|NCT00749190|531868823|FG000|Overall Study|Protocol Violation|0|||
147467515|NCT00749190|531868824|FG001|Overall Study|Protocol Violation|1|||
147467516|NCT00749190|531868825|FG002|Overall Study|Protocol Violation|0|||
147467517|NCT00749190|531868826|FG003|Overall Study|Protocol Violation|0|||
147467518|NCT00749190|531868827|FG004|Overall Study|Protocol Violation|0|||
147467519|NCT00749190|531868828|FG005|Overall Study|Protocol Violation|0|||
147467520|NCT00749190|531868829|FG006|Overall Study|Protocol Violation|1|||
147467521|NCT00749190|531868823|FG000|Overall Study|Other reason not defined above|0|||
147467522|NCT00749190|531868824|FG001|Overall Study|Other reason not defined above|0|||
147467523|NCT00749190|531868825|FG002|Overall Study|Other reason not defined above|0|||
147467524|NCT00749190|531868826|FG003|Overall Study|Other reason not defined above|1|||
147467525|NCT00749190|531868827|FG004|Overall Study|Other reason not defined above|0|||
147467526|NCT00749190|531868828|FG005|Overall Study|Other reason not defined above|0|||
147467527|NCT00749190|531868829|FG006|Overall Study|Other reason not defined above|0|||
147467528|NCT00784758|531868830|FG000|Overall Study|Withdrawal by Subject|3|||
147467529|NCT00784758|531868831|FG001|Overall Study|Withdrawal by Subject|0|||
147467530|NCT00784758|531868830|FG000|Overall Study|Adverse Event|1|||
147467531|NCT00784758|531868831|FG001|Overall Study|Adverse Event|0|||
147467532|NCT04439331|531868838|FG000|Overall Study|Never Start Protocol Therapy|2|||
147467533|NCT04439331|531868838|FG000|Overall Study|Ineligible|2|||
147467534|NCT04439331|531868838|FG000|Overall Study|Mutation Status Not Confirmed|1|||
147467535|NCT04439331|531868838|FG000|Overall Study|Adverse Event|1|||
147467536|NCT04439331|531868838|FG000|Overall Study|Death|1|||
147467537|NCT04439331|531868838|FG000|Overall Study|Disease Progression|20|||
147467538|NCT04439331|531868838|FG000|Overall Study|Withdrawal by Subject|6|||
147467539|NCT04439331|531868838|FG000|Overall Study|Physician Decision|1|||
147467540|NCT04439331|531868838|FG000|Overall Study|Other Complicating Disease|1|||
147467541|NCT03726268|531868840|FG000|Overall Study|Physician Decision|2|||
147467542|NCT03726268|531868841|FG001|Overall Study|Physician Decision|8|||
147467543|NCT03726268|531868842|FG002|Overall Study|Physician Decision|6|||
147467544|NCT03726268|531868843|FG003|Overall Study|Physician Decision|3|||
147467545|NCT03726268|531868840|FG000|Overall Study|Withdrawal by Subject|11|||
147467546|NCT03726268|531868841|FG001|Overall Study|Withdrawal by Subject|5|||
147467547|NCT03726268|531868842|FG002|Overall Study|Withdrawal by Subject|9|||
147467548|NCT03726268|531868843|FG003|Overall Study|Withdrawal by Subject|8|||
147467549|NCT04370509|531868847|FG000|Overall Study|Adverse Event|1|||
147467550|NCT04370509|531868848|FG001|Overall Study|Adverse Event|0|||
147467551|NCT04370509|531868847|FG000|Overall Study|Did not receive post-op Pembrolizumab|1|||
147467552|NCT04370509|531868848|FG001|Overall Study|Did not receive post-op Pembrolizumab|0|||
147467553|NCT04696861|531868849|FG000|Overall Study|Death|1|||
147467554|NCT04696861|531868850|FG001|Overall Study|Death|0|||
147467555|NCT04696861|531868849|FG000|Overall Study|Lost to Follow-up|3|||
147467556|NCT04696861|531868850|FG001|Overall Study|Lost to Follow-up|0|||
147467557|NCT01827384|531868851|FG000|Overall Study|Switched to alternative treatment|0|||
147467558|NCT01827384|531868852|FG001|Overall Study|Switched to alternative treatment|0|||
147467559|NCT01827384|531868853|FG002|Overall Study|Switched to alternative treatment|0|||
147467560|NCT01827384|531868854|FG003|Overall Study|Switched to alternative treatment|0|||
147467561|NCT01827384|531868855|FG004|Overall Study|Switched to alternative treatment|0|||
147467562|NCT01827384|531868856|FG005|Overall Study|Switched to alternative treatment|0|||
147467563|NCT01827384|531868857|FG006|Overall Study|Switched to alternative treatment|0|||
147467564|NCT01827384|531868858|FG007|Overall Study|Switched to alternative treatment|0|||
147467565|NCT01827384|531868859|FG008|Overall Study|Switched to alternative treatment|0|||
147467566|NCT01827384|531868860|FG009|Overall Study|Switched to alternative treatment|0|||
147467567|NCT01827384|531868861|FG010|Overall Study|Switched to alternative treatment|0|||
147467568|NCT01827384|531868862|FG011|Overall Study|Switched to alternative treatment|0|||
147467569|NCT01827384|531868863|FG012|Overall Study|Switched to alternative treatment|0|||
147467570|NCT01827384|531868864|FG013|Overall Study|Switched to alternative treatment|2|||
147467571|NCT01827384|531868851|FG000|Overall Study|Disease progression before treatment|0|||
147467572|NCT01827384|531868852|FG001|Overall Study|Disease progression before treatment|0|||
147467573|NCT01827384|531868853|FG002|Overall Study|Disease progression before treatment|0|||
147467574|NCT01827384|531868854|FG003|Overall Study|Disease progression before treatment|0|||
147467575|NCT01827384|531868855|FG004|Overall Study|Disease progression before treatment|0|||
147467576|NCT01827384|531868856|FG005|Overall Study|Disease progression before treatment|0|||
147467577|NCT01827384|531868857|FG006|Overall Study|Disease progression before treatment|0|||
147467578|NCT01827384|531868858|FG007|Overall Study|Disease progression before treatment|0|||
147467579|NCT01827384|531868859|FG008|Overall Study|Disease progression before treatment|0|||
147467580|NCT01827384|531868860|FG009|Overall Study|Disease progression before treatment|0|||
147467581|NCT01827384|531868861|FG010|Overall Study|Disease progression before treatment|0|||
147467582|NCT01827384|531868862|FG011|Overall Study|Disease progression before treatment|0|||
147467583|NCT01827384|531868863|FG012|Overall Study|Disease progression before treatment|0|||
147467584|NCT01827384|531868864|FG013|Overall Study|Disease progression before treatment|4|||
147467585|NCT01827384|531868851|FG000|Overall Study|Ineligible|0|||
147467586|NCT01827384|531868852|FG001|Overall Study|Ineligible|0|||
147467587|NCT01827384|531868853|FG002|Overall Study|Ineligible|0|||
147467588|NCT01827384|531868854|FG003|Overall Study|Ineligible|0|||
147467589|NCT01827384|531868855|FG004|Overall Study|Ineligible|0|||
147467590|NCT01827384|531868856|FG005|Overall Study|Ineligible|0|||
147467591|NCT01827384|531868857|FG006|Overall Study|Ineligible|0|||
147467592|NCT01827384|531868858|FG007|Overall Study|Ineligible|0|||
147467593|NCT01827384|531868859|FG008|Overall Study|Ineligible|0|||
147467594|NCT01827384|531868860|FG009|Overall Study|Ineligible|0|||
147467595|NCT01827384|531868861|FG010|Overall Study|Ineligible|0|||
147467596|NCT01827384|531868862|FG011|Overall Study|Ineligible|0|||
147467597|NCT01827384|531868863|FG012|Overall Study|Ineligible|0|||
147467598|NCT01827384|531868864|FG013|Overall Study|Ineligible|19|||
147467599|NCT01827384|531868851|FG000|Overall Study|Participant died before treatment|0|||
147618563|NCT01778530|532419162|FG000|Overall Study|Progression on study|1|||
147618564|NCT01778530|532419162|FG000|Overall Study|Adverse event/side effect|1|||
147618565|NCT03472014|532419163|FG000|Overall Study|Lost to Follow-up|4|||
147618566|NCT03652051|532419166|FG000|Stage 1|Adverse Event|0|||
147467600|NCT01827384|531868852|FG001|Overall Study|Participant died before treatment|0|||
147467601|NCT01827384|531868853|FG002|Overall Study|Participant died before treatment|0|||
147467602|NCT01827384|531868854|FG003|Overall Study|Participant died before treatment|0|||
147467603|NCT01827384|531868855|FG004|Overall Study|Participant died before treatment|0|||
147467604|NCT01827384|531868856|FG005|Overall Study|Participant died before treatment|0|||
147467605|NCT01827384|531868857|FG006|Overall Study|Participant died before treatment|0|||
147467606|NCT01827384|531868858|FG007|Overall Study|Participant died before treatment|0|||
147467607|NCT01827384|531868859|FG008|Overall Study|Participant died before treatment|0|||
147467608|NCT01827384|531868860|FG009|Overall Study|Participant died before treatment|0|||
147467609|NCT01827384|531868861|FG010|Overall Study|Participant died before treatment|0|||
147618567|NCT03652051|532419167|FG001|Stage 1|Adverse Event|5|||
147618568|NCT03652051|532419168|FG002|Stage 1|Adverse Event|7|||
147618569|NCT03652051|532419169|FG003|Stage 1|Adverse Event|1|||
147618570|NCT03652051|532419166|FG000|Stage 1|Withdrawal by Subject|0|||
147618571|NCT03652051|532419167|FG001|Stage 1|Withdrawal by Subject|0|||
147618572|NCT03652051|532419168|FG002|Stage 1|Withdrawal by Subject|1|||
147618573|NCT03652051|532419169|FG003|Stage 1|Withdrawal by Subject|0|||
147618574|NCT03652051|532419166|FG000|Stage 2|Adverse Event|0|||
147618575|NCT03652051|532419167|FG001|Stage 2|Adverse Event|2|||
147618576|NCT03652051|532419168|FG002|Stage 2|Adverse Event|1|||
147618577|NCT03652051|532419169|FG003|Stage 2|Adverse Event|0|||
147618578|NCT03652051|532419166|FG000|Stage 2|Protocol Violation|0|||
147618579|NCT03652051|532419167|FG001|Stage 2|Protocol Violation|1|||
147618580|NCT03652051|532419168|FG002|Stage 2|Protocol Violation|6|||
147618581|NCT03652051|532419169|FG003|Stage 2|Protocol Violation|0|||
147618582|NCT03652051|532419166|FG000|Stage 2|Lost to Follow-up|0|||
147618583|NCT03652051|532419167|FG001|Stage 2|Lost to Follow-up|2|||
147618584|NCT03652051|532419168|FG002|Stage 2|Lost to Follow-up|0|||
147467610|NCT01827384|531868862|FG011|Overall Study|Participant died before treatment|0|||
147467611|NCT01827384|531868863|FG012|Overall Study|Participant died before treatment|0|||
147618585|NCT03652051|532419169|FG003|Stage 2|Lost to Follow-up|3|||
147618586|NCT03652051|532419166|FG000|Stage 2|Withdrawal by Subject|0|||
147618587|NCT03652051|532419167|FG001|Stage 2|Withdrawal by Subject|11|||
147618588|NCT03652051|532419168|FG002|Stage 2|Withdrawal by Subject|9|||
147618589|NCT03652051|532419169|FG003|Stage 2|Withdrawal by Subject|3|||
147467612|NCT01827384|531868864|FG013|Overall Study|Participant died before treatment|5|||
147467613|NCT01827384|531868851|FG000|Overall Study|Insufficient tumor cells|0|||
147467614|NCT01827384|531868852|FG001|Overall Study|Insufficient tumor cells|0|||
147467615|NCT01827384|531868853|FG002|Overall Study|Insufficient tumor cells|0|||
147467616|NCT01827384|531868854|FG003|Overall Study|Insufficient tumor cells|0|||
147467617|NCT01827384|531868855|FG004|Overall Study|Insufficient tumor cells|0|||
147467618|NCT01827384|531868856|FG005|Overall Study|Insufficient tumor cells|0|||
147467619|NCT01827384|531868857|FG006|Overall Study|Insufficient tumor cells|0|||
147467620|NCT01827384|531868858|FG007|Overall Study|Insufficient tumor cells|0|||
147467621|NCT01827384|531868859|FG008|Overall Study|Insufficient tumor cells|0|||
147467622|NCT01827384|531868860|FG009|Overall Study|Insufficient tumor cells|0|||
147467623|NCT01827384|531868861|FG010|Overall Study|Insufficient tumor cells|0|||
147467624|NCT01827384|531868862|FG011|Overall Study|Insufficient tumor cells|0|||
147467625|NCT01827384|531868863|FG012|Overall Study|Insufficient tumor cells|0|||
147467626|NCT01827384|531868864|FG013|Overall Study|Insufficient tumor cells|13|||
147467627|NCT01827384|531868851|FG000|Overall Study|No actionable mutation|0|||
147467628|NCT01827384|531868852|FG001|Overall Study|No actionable mutation|0|||
147467629|NCT01827384|531868853|FG002|Overall Study|No actionable mutation|0|||
147467630|NCT01827384|531868854|FG003|Overall Study|No actionable mutation|0|||
147467631|NCT01827384|531868855|FG004|Overall Study|No actionable mutation|0|||
147467632|NCT01827384|531868856|FG005|Overall Study|No actionable mutation|0|||
147467633|NCT01827384|531868857|FG006|Overall Study|No actionable mutation|0|||
147467634|NCT01827384|531868858|FG007|Overall Study|No actionable mutation|0|||
147467635|NCT01827384|531868859|FG008|Overall Study|No actionable mutation|0|||
147467636|NCT01827384|531868860|FG009|Overall Study|No actionable mutation|0|||
147467637|NCT01827384|531868861|FG010|Overall Study|No actionable mutation|0|||
147467638|NCT01827384|531868862|FG011|Overall Study|No actionable mutation|0|||
147467639|NCT01827384|531868863|FG012|Overall Study|No actionable mutation|0|||
147467640|NCT01827384|531868864|FG013|Overall Study|No actionable mutation|73|||
147467641|NCT01827384|531868851|FG000|Overall Study|Participant declined to participate (before treatment started)|0|||
147467642|NCT01827384|531868852|FG001|Overall Study|Participant declined to participate (before treatment started)|0|||
147467643|NCT01827384|531868853|FG002|Overall Study|Participant declined to participate (before treatment started)|0|||
147467644|NCT01827384|531868854|FG003|Overall Study|Participant declined to participate (before treatment started)|0|||
147467645|NCT01827384|531868855|FG004|Overall Study|Participant declined to participate (before treatment started)|0|||
147467646|NCT01827384|531868856|FG005|Overall Study|Participant declined to participate (before treatment started)|0|||
147467647|NCT01827384|531868857|FG006|Overall Study|Participant declined to participate (before treatment started)|0|||
147467648|NCT01827384|531868858|FG007|Overall Study|Participant declined to participate (before treatment started)|0|||
147467649|NCT01827384|531868859|FG008|Overall Study|Participant declined to participate (before treatment started)|0|||
147467650|NCT01827384|531868860|FG009|Overall Study|Participant declined to participate (before treatment started)|0|||
147467651|NCT01827384|531868861|FG010|Overall Study|Participant declined to participate (before treatment started)|0|||
147467652|NCT01827384|531868862|FG011|Overall Study|Participant declined to participate (before treatment started)|0|||
147467653|NCT01827384|531868863|FG012|Overall Study|Participant declined to participate (before treatment started)|0|||
147467654|NCT01827384|531868864|FG013|Overall Study|Participant declined to participate (before treatment started)|15|||
147467655|NCT03498521|531868870|FG000|Overall Study|Death|227|||
147467656|NCT03498521|531868871|FG001|Overall Study|Death|79|||
147467657|NCT03498521|531868872|FG002|Overall Study|Death|84|||
147467658|NCT03498521|531868870|FG000|Overall Study|Exclusion criteria|1|||
147467659|NCT03498521|531868871|FG001|Overall Study|Exclusion criteria|0|||
147467660|NCT03498521|531868872|FG002|Overall Study|Exclusion criteria|0|||
147467661|NCT03498521|531868870|FG000|Overall Study|Lost to Follow-up|4|||
147467662|NCT03498521|531868871|FG001|Overall Study|Lost to Follow-up|3|||
147467663|NCT03498521|531868872|FG002|Overall Study|Lost to Follow-up|3|||
147467664|NCT03498521|531868870|FG000|Overall Study|No profile due to technical failure|1|||
147467665|NCT03498521|531868871|FG001|Overall Study|No profile due to technical failure|0|||
147467666|NCT03498521|531868872|FG002|Overall Study|No profile due to technical failure|0|||
147467667|NCT03498521|531868870|FG000|Overall Study|Physician Decision|3|||
147467668|NCT03498521|531868871|FG001|Overall Study|Physician Decision|1|||
147467669|NCT03498521|531868872|FG002|Overall Study|Physician Decision|0|||
147467670|NCT03498521|531868870|FG000|Overall Study|Withdrawal by Subject|11|||
147467671|NCT03498521|531868871|FG001|Overall Study|Withdrawal by Subject|6|||
147467672|NCT03498521|531868872|FG002|Overall Study|Withdrawal by Subject|2|||
147467673|NCT03498521|531868870|FG000|Overall Study|Study terminated by sponsor|79|||
147467674|NCT03498521|531868871|FG001|Overall Study|Study terminated by sponsor|21|||
147618590|NCT01958437|532419170|FG000|Overall Study|Incidental MRI findings|0|||
147618591|NCT01958437|532419171|FG001|Overall Study|Incidental MRI findings|0|||
147467675|NCT03498521|531868872|FG002|Overall Study|Study terminated by sponsor|4|||
147467676|NCT02029976|531870357|FG000|YR-1 Post Intervention vs Baseline|Lost to Follow-up|12|||
147467677|NCT02029976|531870358|FG001|YR-1 Post Intervention vs Baseline|Lost to Follow-up|8|||
147467678|NCT02029976|531870357|FG000|YR-2 Follow Up vs Baseline|Lost to Follow-up|8|||
147467679|NCT02029976|531870358|FG001|YR-2 Follow Up vs Baseline|Lost to Follow-up|4|||
147467680|NCT02029976|531870357|FG000|YR-2 Follow Up vs Baseline|Withdrawal by Subject|2|||
147467681|NCT02029976|531870358|FG001|YR-2 Follow Up vs Baseline|Withdrawal by Subject|2|||
147467682|NCT02029976|531870357|FG000|YR-2 Follow Up vs Baseline|Moved from area|0|||
147467683|NCT02029976|531870358|FG001|YR-2 Follow Up vs Baseline|Moved from area|2|||
147467684|NCT02660580|531870359|FG000|Core Treatment Period (Week 1 to 16)|Randomized, not treated|1|||
147467685|NCT02660580|531870360|FG001|Core Treatment Period (Week 1 to 16)|Randomized, not treated|1|||
147467686|NCT02660580|531870361|FG002|Core Treatment Period (Week 1 to 16)|Randomized, not treated|0|||
147467687|NCT02660580|531870362|FG003|Core Treatment Period (Week 1 to 16)|Randomized, not treated|0|||
147467688|NCT02660580|531870363|FG004|Core Treatment Period (Week 1 to 16)|Randomized, not treated|0|||
147467689|NCT02660580|531870359|FG000|Core Treatment Period (Week 1 to 16)|Protocol Violation|3|||
147467690|NCT02660580|531870360|FG001|Core Treatment Period (Week 1 to 16)|Protocol Violation|1|||
147467691|NCT02660580|531870361|FG002|Core Treatment Period (Week 1 to 16)|Protocol Violation|0|||
147467692|NCT02660580|531870362|FG003|Core Treatment Period (Week 1 to 16)|Protocol Violation|0|||
147467693|NCT02660580|531870363|FG004|Core Treatment Period (Week 1 to 16)|Protocol Violation|0|||
147467694|NCT02660580|531870359|FG000|Core Treatment Period (Week 1 to 16)|Other un-specified|1|||
147467695|NCT02660580|531870360|FG001|Core Treatment Period (Week 1 to 16)|Other un-specified|0|||
147467696|NCT02660580|531870361|FG002|Core Treatment Period (Week 1 to 16)|Other un-specified|0|||
147467697|NCT02660580|531870362|FG003|Core Treatment Period (Week 1 to 16)|Other un-specified|0|||
147467698|NCT02660580|531870363|FG004|Core Treatment Period (Week 1 to 16)|Other un-specified|0|||
147467699|NCT02660580|531870359|FG000|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|0|||
147467700|NCT02660580|531870360|FG001|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|2|||
147467701|NCT02660580|531870361|FG002|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|0|||
147467702|NCT02660580|531870362|FG003|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|0|||
147467703|NCT02660580|531870363|FG004|Core Treatment Period (Week 1 to 16)|Lack of Efficacy|0|||
147467704|NCT02660580|531870359|FG000|Core Treatment Period (Week 1 to 16)|Adverse Event|2|||
147467705|NCT02660580|531870360|FG001|Core Treatment Period (Week 1 to 16)|Adverse Event|9|||
147467706|NCT02660580|531870361|FG002|Core Treatment Period (Week 1 to 16)|Adverse Event|0|||
147467707|NCT02660580|531870362|FG003|Core Treatment Period (Week 1 to 16)|Adverse Event|0|||
147467708|NCT02660580|531870363|FG004|Core Treatment Period (Week 1 to 16)|Adverse Event|0|||
147467709|NCT02660580|531870359|FG000|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|1|||
147467710|NCT02660580|531870360|FG001|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|4|||
147467711|NCT02660580|531870361|FG002|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|0|||
147467712|NCT02660580|531870362|FG003|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|0|||
147467713|NCT02660580|531870363|FG004|Core Treatment Period (Week 1 to 16)|Withdrawal by Subject|0|||
147467714|NCT02660580|531870359|FG000|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|1|||
147467715|NCT02660580|531870360|FG001|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|2|||
147467716|NCT02660580|531870361|FG002|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|0|||
147467717|NCT02660580|531870362|FG003|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|0|||
147467718|NCT02660580|531870363|FG004|Core Treatment Period (Week 1 to 16)|Lost to Follow-up|0|||
147467719|NCT02660580|531870359|FG000|Extended Treatment Period(Week 16 to 52)|Protocol Violation|0|||
147467720|NCT02660580|531870360|FG001|Extended Treatment Period(Week 16 to 52)|Protocol Violation|0|||
147467721|NCT02660580|531870361|FG002|Extended Treatment Period(Week 16 to 52)|Protocol Violation|2|||
147467722|NCT02660580|531870362|FG003|Extended Treatment Period(Week 16 to 52)|Protocol Violation|0|||
147467723|NCT02660580|531870363|FG004|Extended Treatment Period(Week 16 to 52)|Protocol Violation|1|||
147467724|NCT02660580|531870359|FG000|Extended Treatment Period(Week 16 to 52)|Other un-specified|0|||
147467725|NCT02660580|531870360|FG001|Extended Treatment Period(Week 16 to 52)|Other un-specified|0|||
147467726|NCT02660580|531870361|FG002|Extended Treatment Period(Week 16 to 52)|Other un-specified|1|||
147467727|NCT02660580|531870362|FG003|Extended Treatment Period(Week 16 to 52)|Other un-specified|0|||
147467728|NCT02660580|531870363|FG004|Extended Treatment Period(Week 16 to 52)|Other un-specified|1|||
147467729|NCT02660580|531870359|FG000|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|0|||
147467730|NCT02660580|531870360|FG001|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|0|||
147467731|NCT02660580|531870361|FG002|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|4|||
147467732|NCT02660580|531870362|FG003|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|2|||
147467733|NCT02660580|531870363|FG004|Extended Treatment Period(Week 16 to 52)|Lack of Efficacy|2|||
147467734|NCT02660580|531870359|FG000|Extended Treatment Period(Week 16 to 52)|Adverse Event|0|||
147467735|NCT02660580|531870360|FG001|Extended Treatment Period(Week 16 to 52)|Adverse Event|0|||
147467736|NCT02660580|531870361|FG002|Extended Treatment Period(Week 16 to 52)|Adverse Event|8|||
147467737|NCT02660580|531870362|FG003|Extended Treatment Period(Week 16 to 52)|Adverse Event|6|||
147467738|NCT02660580|531870363|FG004|Extended Treatment Period(Week 16 to 52)|Adverse Event|4|||
147467739|NCT02660580|531870359|FG000|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|0|||
147467740|NCT02660580|531870360|FG001|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|0|||
147467741|NCT02660580|531870361|FG002|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|3|||
147467742|NCT02660580|531870362|FG003|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|2|||
147467743|NCT02660580|531870363|FG004|Extended Treatment Period(Week 16 to 52)|Withdrawal by Subject|2|||
147467744|NCT02660580|531870359|FG000|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|0|||
147467745|NCT02660580|531870360|FG001|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|0|||
147467746|NCT02660580|531870361|FG002|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|0|||
147665757|NCT02709746|532601590|FG000|Phase A (Single-blind Treatment Period)|Not sepcified|14|||
147665758|NCT02709746|532601591|FG001|Phase A (Single-blind Treatment Period)|Not sepcified|0|||
147665759|NCT02709746|532601592|FG002|Phase A (Single-blind Treatment Period)|Not sepcified|0|||
147467747|NCT02660580|531870362|FG003|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|1|||
147467748|NCT02660580|531870363|FG004|Extended Treatment Period(Week 16 to 52)|Lost to Follow-up|1|||
147467749|NCT01028352|531870364|FG000|Overall Study|Ineligible due to baseline average pain|5|||
147467750|NCT01028352|531870364|FG000|Overall Study|Withdrawal by Subject|1|||
147467751|NCT02612909|531870365|FG000|Phase 2|Withdrawal by Subject|2|||
147467752|NCT02612909|531870366|FG001|Phase 2|Withdrawal by Subject|5|||
147467753|NCT02612909|531870367|FG002|Phase 2|Withdrawal by Subject|0|||
147467754|NCT02612909|531870368|FG003|Phase 2|Withdrawal by Subject|0|||
147467755|NCT02612909|531870369|FG004|Phase 2|Withdrawal by Subject|0|||
147467756|NCT02612909|531870365|FG000|Phase 2|Pregnancy|0|||
147467757|NCT02612909|531870366|FG001|Phase 2|Pregnancy|0|||
147467758|NCT02612909|531870367|FG002|Phase 2|Pregnancy|1|||
147467759|NCT02612909|531870368|FG003|Phase 2|Pregnancy|0|||
147467760|NCT02612909|531870369|FG004|Phase 2|Pregnancy|0|||
147467761|NCT02612909|531870365|FG000|Phase 3|Withdrawal by Subject|0|||
147467762|NCT02612909|531870366|FG001|Phase 3|Withdrawal by Subject|0|||
147467763|NCT02612909|531870367|FG002|Phase 3|Withdrawal by Subject|0|||
147467764|NCT02612909|531870368|FG003|Phase 3|Withdrawal by Subject|1|||
147467765|NCT02612909|531870369|FG004|Phase 3|Withdrawal by Subject|0|||
147467766|NCT05224258|531870370|FG000|Overall Study|Withdrawal by Subject|1|||
147467767|NCT05224258|531870371|FG001|Overall Study|Withdrawal by Subject|1|||
147467768|NCT05224258|531870370|FG000|Overall Study|Physician Decision|1|||
147467769|NCT05224258|531870371|FG001|Overall Study|Physician Decision|1|||
147467770|NCT05224258|531870370|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
147467771|NCT05224258|531870371|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
147467772|NCT05224258|531870370|FG000|Overall Study|Study Product No Longer in Use|1|||
147467773|NCT05224258|531870371|FG001|Overall Study|Study Product No Longer in Use|0|||
147467774|NCT05224258|531870370|FG000|Overall Study|Adverse Event|0|||
147467775|NCT05224258|531870371|FG001|Overall Study|Adverse Event|1|||
147467776|NCT05224258|531870370|FG000|Overall Study|Protocol Deviation|0|||
147467777|NCT05224258|531870371|FG001|Overall Study|Protocol Deviation|1|||
147467778|NCT05067127|531870372|FG000|Randomized Controlled Period (26 Weeks)|Lost to Follow-up|0|||
147467779|NCT05067127|531870373|FG001|Randomized Controlled Period (26 Weeks)|Lost to Follow-up|1|||
147467780|NCT05067127|531870374|FG002|Randomized Controlled Period (26 Weeks)|Lost to Follow-up|0|||
147467781|NCT05067127|531870375|FG003|Randomized Controlled Period (26 Weeks)|Lost to Follow-up|0|||
147467782|NCT05067127|531870372|FG000|Randomized Controlled Period (26 Weeks)|Withdrawal by Subject|0|||
147467783|NCT05067127|531870373|FG001|Randomized Controlled Period (26 Weeks)|Withdrawal by Subject|2|||
147467784|NCT05067127|531870374|FG002|Randomized Controlled Period (26 Weeks)|Withdrawal by Subject|0|||
147467785|NCT05067127|531870375|FG003|Randomized Controlled Period (26 Weeks)|Withdrawal by Subject|0|||
147467786|NCT05067127|531870372|FG000|Randomized Controlled Period (26 Weeks)|Investigator or Medical Monitor Decision|1|||
147467787|NCT05067127|531870373|FG001|Randomized Controlled Period (26 Weeks)|Investigator or Medical Monitor Decision|0|||
147467788|NCT05067127|531870374|FG002|Randomized Controlled Period (26 Weeks)|Investigator or Medical Monitor Decision|0|||
147467789|NCT05067127|531870375|FG003|Randomized Controlled Period (26 Weeks)|Investigator or Medical Monitor Decision|0|||
147467790|NCT05067127|531870372|FG000|Randomized Controlled Period (26 Weeks)|Pregnancy|0|||
147467791|NCT05067127|531870373|FG001|Randomized Controlled Period (26 Weeks)|Pregnancy|1|||
147467792|NCT05067127|531870374|FG002|Randomized Controlled Period (26 Weeks)|Pregnancy|0|||
147467793|NCT05067127|531870375|FG003|Randomized Controlled Period (26 Weeks)|Pregnancy|0|||
147467794|NCT05067127|531870372|FG000|Randomized Controlled Period (26 Weeks)|Death|1|||
147467795|NCT05067127|531870373|FG001|Randomized Controlled Period (26 Weeks)|Death|0|||
147467796|NCT05067127|531870374|FG002|Randomized Controlled Period (26 Weeks)|Death|0|||
147467797|NCT05067127|531870375|FG003|Randomized Controlled Period (26 Weeks)|Death|0|||
147467798|NCT05067127|531870372|FG000|Open-Label Period (26 Weeks)|Withdrawal by Subject|0|||
147467799|NCT05067127|531870373|FG001|Open-Label Period (26 Weeks)|Withdrawal by Subject|0|||
147467800|NCT05067127|531870374|FG002|Open-Label Period (26 Weeks)|Withdrawal by Subject|0|||
147467801|NCT05067127|531870375|FG003|Open-Label Period (26 Weeks)|Withdrawal by Subject|1|||
147467802|NCT05067127|531870372|FG000|Open-Label Period (26 Weeks)|Investigator or Medical Monitor Decision|0|||
147467803|NCT05067127|531870373|FG001|Open-Label Period (26 Weeks)|Investigator or Medical Monitor Decision|0|||
147467804|NCT05067127|531870374|FG002|Open-Label Period (26 Weeks)|Investigator or Medical Monitor Decision|2|||
147467805|NCT05067127|531870375|FG003|Open-Label Period (26 Weeks)|Investigator or Medical Monitor Decision|1|||
147467806|NCT04462536|531870376|FG000|Overall Study|Withdrawal by Subject|3|||
147467807|NCT04462536|531870377|FG001|Overall Study|Withdrawal by Subject|9|||
147467808|NCT04462536|531870376|FG000|Overall Study|Lost to Follow-up|2|||
147467809|NCT04462536|531870377|FG001|Overall Study|Lost to Follow-up|4|||
147665760|NCT02709746|532601593|FG003|Phase A (Single-blind Treatment Period)|Not sepcified|0|||
147467810|NCT01562028|531870382|FG000|Overall Study|Withdrawal by Subject|1|||
147467811|NCT01562028|531870383|FG001|Overall Study|Withdrawal by Subject|1|||
147467812|NCT01562028|531870382|FG000|Overall Study|Lost to Follow-up|2|||
147467813|NCT01562028|531870383|FG001|Overall Study|Lost to Follow-up|1|||
147467814|NCT04439266|531870384|FG000|Overall Study|Ineligible|1|||
147467815|NCT04439266|531870384|FG000|Overall Study|Adverse Event|1|||
147467816|NCT04439266|531870384|FG000|Overall Study|Death|1|||
147467817|NCT04439266|531870384|FG000|Overall Study|Disease progression|1|||
147467818|NCT04439266|531870384|FG000|Overall Study|Still on treatment|1|||
147467819|NCT05052723|531870387|FG000|Overall Study|Death|19|||
147467820|NCT02601950|531870388|FG000|Overall Study|Participant enrolled in rollover study|0|||
147467821|NCT02601950|531870389|FG001|Overall Study|Participant enrolled in rollover study|0|||
147467822|NCT02601950|531870390|FG002|Overall Study|Participant enrolled in rollover study|1|||
147467823|NCT02601950|531870391|FG003|Overall Study|Participant enrolled in rollover study|0|||
147467824|NCT02601950|531870392|FG004|Overall Study|Participant enrolled in rollover study|1|||
147467825|NCT02601950|531870393|FG005|Overall Study|Participant enrolled in rollover study|1|||
147467826|NCT02601950|531870394|FG006|Overall Study|Participant enrolled in rollover study|1|||
147467827|NCT02601950|531870395|FG007|Overall Study|Participant enrolled in rollover study|0|||
147467828|NCT02601950|531870388|FG000|Overall Study|Disease progression - radiological|21|||
147467829|NCT02601950|531870389|FG001|Overall Study|Disease progression - radiological|26|||
147467830|NCT02601950|531870390|FG002|Overall Study|Disease progression - radiological|22|||
147467831|NCT02601950|531870391|FG003|Overall Study|Disease progression - radiological|11|||
147467832|NCT02601950|531870392|FG004|Overall Study|Disease progression - radiological|46|||
147467833|NCT02601950|531870393|FG005|Overall Study|Disease progression - radiological|52|||
147467834|NCT02601950|531870394|FG006|Overall Study|Disease progression - radiological|7|||
147467835|NCT02601950|531870395|FG007|Overall Study|Disease progression - radiological|5|||
147467836|NCT02601950|531870388|FG000|Overall Study|Disease progression - clinical|3|||
147467837|NCT02601950|531870389|FG001|Overall Study|Disease progression - clinical|5|||
147467838|NCT02601950|531870390|FG002|Overall Study|Disease progression - clinical|4|||
147467839|NCT02601950|531870391|FG003|Overall Study|Disease progression - clinical|2|||
147467840|NCT02601950|531870392|FG004|Overall Study|Disease progression - clinical|6|||
147467841|NCT02601950|531870393|FG005|Overall Study|Disease progression - clinical|6|||
147467842|NCT02601950|531870394|FG006|Overall Study|Disease progression - clinical|5|||
147467843|NCT02601950|531870395|FG007|Overall Study|Disease progression - clinical|1|||
147467844|NCT02601950|531870388|FG000|Overall Study|Death|6|||
147467845|NCT02601950|531870389|FG001|Overall Study|Death|0|||
147467846|NCT02601950|531870390|FG002|Overall Study|Death|3|||
147467847|NCT02601950|531870391|FG003|Overall Study|Death|1|||
147467848|NCT02601950|531870392|FG004|Overall Study|Death|4|||
147467849|NCT02601950|531870393|FG005|Overall Study|Death|1|||
147467850|NCT02601950|531870394|FG006|Overall Study|Death|0|||
147467851|NCT02601950|531870395|FG007|Overall Study|Death|0|||
147467852|NCT02601950|531870388|FG000|Overall Study|Unacceptable toxicity (related to study treatment)|0|||
147467853|NCT02601950|531870389|FG001|Overall Study|Unacceptable toxicity (related to study treatment)|0|||
147467854|NCT02601950|531870390|FG002|Overall Study|Unacceptable toxicity (related to study treatment)|0|||
147467855|NCT02601950|531870391|FG003|Overall Study|Unacceptable toxicity (related to study treatment)|0|||
147467856|NCT02601950|531870392|FG004|Overall Study|Unacceptable toxicity (related to study treatment)|0|||
147467857|NCT02601950|531870393|FG005|Overall Study|Unacceptable toxicity (related to study treatment)|1|||
147467858|NCT02601950|531870394|FG006|Overall Study|Unacceptable toxicity (related to study treatment)|0|||
147467859|NCT02601950|531870395|FG007|Overall Study|Unacceptable toxicity (related to study treatment)|0|||
147467860|NCT02601950|531870388|FG000|Overall Study|Adverse event (not related to study treatment)|1|||
147467861|NCT02601950|531870389|FG001|Overall Study|Adverse event (not related to study treatment)|0|||
147467862|NCT02601950|531870390|FG002|Overall Study|Adverse event (not related to study treatment)|0|||
147467863|NCT02601950|531870391|FG003|Overall Study|Adverse event (not related to study treatment)|0|||
147467864|NCT02601950|531870392|FG004|Overall Study|Adverse event (not related to study treatment)|0|||
147467865|NCT02601950|531870393|FG005|Overall Study|Adverse event (not related to study treatment)|2|||
147467866|NCT02601950|531870394|FG006|Overall Study|Adverse event (not related to study treatment)|0|||
147467867|NCT02601950|531870395|FG007|Overall Study|Adverse event (not related to study treatment)|0|||
147467868|NCT02601950|531870388|FG000|Overall Study|Non-compliance|0|||
147467869|NCT02601950|531870389|FG001|Overall Study|Non-compliance|1|||
147467870|NCT02601950|531870390|FG002|Overall Study|Non-compliance|0|||
147467871|NCT02601950|531870391|FG003|Overall Study|Non-compliance|0|||
147467872|NCT02601950|531870392|FG004|Overall Study|Non-compliance|0|||
147467873|NCT02601950|531870393|FG005|Overall Study|Non-compliance|1|||
147467874|NCT02601950|531870394|FG006|Overall Study|Non-compliance|1|||
147618592|NCT01958437|532419172|FG002|Overall Study|Incidental MRI findings|1|||
147467875|NCT02601950|531870395|FG007|Overall Study|Non-compliance|0|||
147467876|NCT02601950|531870388|FG000|Overall Study|Participant refused further study treatment|0|||
147467877|NCT02601950|531870389|FG001|Overall Study|Participant refused further study treatment|1|||
147467878|NCT02601950|531870390|FG002|Overall Study|Participant refused further study treatment|1|||
147467879|NCT02601950|531870391|FG003|Overall Study|Participant refused further study treatment|0|||
147467880|NCT02601950|531870392|FG004|Overall Study|Participant refused further study treatment|2|||
147467881|NCT02601950|531870393|FG005|Overall Study|Participant refused further study treatment|2|||
147467882|NCT02601950|531870394|FG006|Overall Study|Participant refused further study treatment|2|||
147467883|NCT02601950|531870395|FG007|Overall Study|Participant refused further study treatment|1|||
147467884|NCT02601950|531870388|FG000|Overall Study|Investigator discretion|1|||
147467885|NCT02601950|531870389|FG001|Overall Study|Investigator discretion|0|||
147467886|NCT02601950|531870390|FG002|Overall Study|Investigator discretion|1|||
147467887|NCT02601950|531870391|FG003|Overall Study|Investigator discretion|0|||
147467888|NCT02601950|531870392|FG004|Overall Study|Investigator discretion|1|||
147467889|NCT02601950|531870393|FG005|Overall Study|Investigator discretion|1|||
147467890|NCT02601950|531870394|FG006|Overall Study|Investigator discretion|1|||
147467891|NCT02601950|531870395|FG007|Overall Study|Investigator discretion|0|||
147467892|NCT02601950|531870388|FG000|Overall Study|Other|0|||
147467893|NCT02601950|531870389|FG001|Overall Study|Other|0|||
147467894|NCT02601950|531870390|FG002|Overall Study|Other|0|||
147467895|NCT02601950|531870391|FG003|Overall Study|Other|0|||
147467896|NCT02601950|531870392|FG004|Overall Study|Other|2|||
147467897|NCT02601950|531870393|FG005|Overall Study|Other|2|||
147467898|NCT02601950|531870394|FG006|Overall Study|Other|1|||
147467899|NCT02601950|531870395|FG007|Overall Study|Other|0|||
147467900|NCT05540652|531870396|FG000|Overall Study|Withdrawal by Subject|1|||
147467901|NCT05113940|531870397|FG000|Part A (18 Days)|Adverse Event|0|||
147467902|NCT05113940|531870398|FG001|Part A (18 Days)|Adverse Event|0|||
147467903|NCT05113940|531870399|FG002|Part A (18 Days)|Adverse Event|1|||
147467904|NCT05113940|531870400|FG003|Part A (18 Days)|Adverse Event|1|||
147467905|NCT05113940|531870401|FG004|Part A (18 Days)|Adverse Event|1|||
147467906|NCT05113940|531870402|FG005|Part A (18 Days)|Adverse Event|0|||
147467907|NCT05113940|531870403|FG006|Part A (18 Days)|Adverse Event|0|||
147467908|NCT05113940|531870404|FG007|Part A (18 Days)|Adverse Event|0|||
147467909|NCT05113940|531870405|FG008|Part A (18 Days)|Adverse Event|0|||
147467910|NCT05113940|531870406|FG009|Part A (18 Days)|Adverse Event|0|||
147467911|NCT05113940|531870407|FG010|Part A (18 Days)|Adverse Event|0|||
147467912|NCT05113940|531870408|FG011|Part A (18 Days)|Adverse Event|2|||
147467913|NCT05113940|531870409|FG012|Part A (18 Days)|Adverse Event|0|||
147467914|NCT05113940|531870410|FG013|Part A (18 Days)|Adverse Event|0|||
147467915|NCT05113940|531870411|FG014|Part A (18 Days)|Adverse Event|0|||
147467916|NCT05113940|531870397|FG000|Part B- Period 2 (8 Days)|Adverse Event|0|||
147467917|NCT05113940|531870398|FG001|Part B- Period 2 (8 Days)|Adverse Event|0|||
147467918|NCT05113940|531870399|FG002|Part B- Period 2 (8 Days)|Adverse Event|0|||
147467919|NCT05113940|531870400|FG003|Part B- Period 2 (8 Days)|Adverse Event|0|||
147467920|NCT05113940|531870401|FG004|Part B- Period 2 (8 Days)|Adverse Event|0|||
147467921|NCT05113940|531870402|FG005|Part B- Period 2 (8 Days)|Adverse Event|0|||
147467922|NCT05113940|531870403|FG006|Part B- Period 2 (8 Days)|Adverse Event|0|||
147467923|NCT05113940|531870404|FG007|Part B- Period 2 (8 Days)|Adverse Event|0|||
147467924|NCT05113940|531870405|FG008|Part B- Period 2 (8 Days)|Adverse Event|0|||
147467925|NCT05113940|531870406|FG009|Part B- Period 2 (8 Days)|Adverse Event|0|||
147467926|NCT05113940|531870407|FG010|Part B- Period 2 (8 Days)|Adverse Event|0|||
147467927|NCT05113940|531870408|FG011|Part B- Period 2 (8 Days)|Adverse Event|0|||
147467928|NCT05113940|531870409|FG012|Part B- Period 2 (8 Days)|Adverse Event|0|||
147467929|NCT05113940|531870410|FG013|Part B- Period 2 (8 Days)|Adverse Event|0|||
147467930|NCT05113940|531870411|FG014|Part B- Period 2 (8 Days)|Adverse Event|2|||
147467931|NCT00442598|531870414|FG000|Overall Study|Adverse Event|1|||
147467932|NCT00442598|531870415|FG001|Overall Study|Adverse Event|0|||
147467933|NCT00442598|531870416|FG002|Overall Study|Adverse Event|0|||
147467934|NCT00442598|531870414|FG000|Overall Study|Tumor progression|3|||
147467935|NCT00442598|531870415|FG001|Overall Study|Tumor progression|4|||
147467936|NCT00442598|531870416|FG002|Overall Study|Tumor progression|0|||
147467937|NCT00442598|531870414|FG000|Overall Study|Clinical deterioration|1|||
147467938|NCT00442598|531870415|FG001|Overall Study|Clinical deterioration|2|||
147467939|NCT00442598|531870416|FG002|Overall Study|Clinical deterioration|0|||
147467940|NCT00442598|531870414|FG000|Overall Study|CA125 progression|0|||
147467941|NCT00442598|531870415|FG001|Overall Study|CA125 progression|1|||
147467942|NCT00442598|531870416|FG002|Overall Study|CA125 progression|0|||
147467943|NCT00442598|531870414|FG000|Overall Study|Reduced creatinine clearance|1|||
147467944|NCT00442598|531870415|FG001|Overall Study|Reduced creatinine clearance|0|||
147467945|NCT00442598|531870416|FG002|Overall Study|Reduced creatinine clearance|0|||
147467946|NCT00442598|531870414|FG000|Overall Study|Death|0|||
147467947|NCT00442598|531870415|FG001|Overall Study|Death|1|||
147467948|NCT00442598|531870416|FG002|Overall Study|Death|0|||
147467949|NCT01147926|531870417|FG000|Overall Study|Subject Withdrew Consent|9|||
147467950|NCT01147926|531870418|FG001|Overall Study|Subject Withdrew Consent|10|||
147467951|NCT01147926|531870417|FG000|Overall Study|Adverse Event|7|||
147467952|NCT01147926|531870418|FG001|Overall Study|Adverse Event|6|||
147467953|NCT01147926|531870417|FG000|Overall Study|Subject Non-Compliant|5|||
147467954|NCT01147926|531870418|FG001|Overall Study|Subject Non-Compliant|4|||
147467955|NCT01147926|531870417|FG000|Overall Study|Principal investigator left hospital|1|||
147467956|NCT01147926|531870418|FG001|Overall Study|Principal investigator left hospital|3|||
147467957|NCT01147926|531870417|FG000|Overall Study|Selection criteria not met|3|||
147618593|NCT01958437|532419173|FG003|Overall Study|Incidental MRI findings|1|||
147618594|NCT02394600|532419174|FG000|Overall Study|Adverse Event|3|||
147618595|NCT02394600|532419175|FG001|Overall Study|Adverse Event|0|||
147618596|NCT02394600|532419174|FG000|Overall Study|Lost to Follow-up|0|||
147618597|NCT02394600|532419175|FG001|Overall Study|Lost to Follow-up|1|||
147618598|NCT02394600|532419174|FG000|Overall Study|Withdrawal by Subject|0|||
147467958|NCT01147926|531870418|FG001|Overall Study|Selection criteria not met|1|||
147467959|NCT01147926|531870417|FG000|Overall Study|Lost to Follow-up|0|||
147467960|NCT01147926|531870418|FG001|Overall Study|Lost to Follow-up|2|||
147467961|NCT01147926|531870417|FG000|Overall Study|Sponsor's Decision|0|||
147467962|NCT01147926|531870418|FG001|Overall Study|Sponsor's Decision|1|||
147467963|NCT01147926|531870417|FG000|Overall Study|Lack of Efficacy|1|||
147467964|NCT01147926|531870418|FG001|Overall Study|Lack of Efficacy|0|||
147467965|NCT01147926|531870417|FG000|Overall Study|Too busy, no time for study|1|||
147467966|NCT01147926|531870418|FG001|Overall Study|Too busy, no time for study|0|||
147467967|NCT01147926|531870417|FG000|Overall Study|Went on holiday|0|||
147467968|NCT01147926|531870418|FG001|Overall Study|Went on holiday|1|||
147467969|NCT01147926|531870417|FG000|Overall Study|Colonoscopy result|0|||
147467970|NCT01147926|531870418|FG001|Overall Study|Colonoscopy result|1|||
147467971|NCT01670994|531870419|FG000|Overall Study|Disease Progression and Switched to Alternative Treatment|0|||
147467972|NCT01670994|531870420|FG001|Overall Study|Disease Progression and Switched to Alternative Treatment|1|||
147467973|NCT01670994|531870419|FG000|Overall Study|Disease Progression and Did Not Qualify or Consent for Repeat Treatment|0|||
147467974|NCT01670994|531870420|FG001|Overall Study|Disease Progression and Did Not Qualify or Consent for Repeat Treatment|1|||
147467975|NCT01670994|531870419|FG000|Overall Study|Patient experienced DLT|0|||
147467976|NCT01670994|531870420|FG001|Overall Study|Patient experienced DLT|1|||
147467977|NCT00891735|531870422|FG000|Overall Study|Adverse Event|2|||
147467978|NCT00891735|531870423|FG001|Overall Study|Adverse Event|0|||
147467979|NCT00891735|531870424|FG002|Overall Study|Adverse Event|2|||
147467980|NCT00891735|531870425|FG003|Overall Study|Adverse Event|0|||
147467981|NCT00891735|531870422|FG000|Overall Study|Death|8|||
147467982|NCT00891735|531870423|FG001|Overall Study|Death|5|||
147467983|NCT00891735|531870424|FG002|Overall Study|Death|4|||
147467984|NCT00891735|531870425|FG003|Overall Study|Death|5|||
147467985|NCT00891735|531870422|FG000|Overall Study|Lost to Follow-up|2|||
147467986|NCT00891735|531870423|FG001|Overall Study|Lost to Follow-up|2|||
147467987|NCT00891735|531870424|FG002|Overall Study|Lost to Follow-up|2|||
147467988|NCT00891735|531870425|FG003|Overall Study|Lost to Follow-up|2|||
147467989|NCT00891735|531870422|FG000|Overall Study|Physician's decision to withdraw patient|1|||
147467990|NCT00891735|531870423|FG001|Overall Study|Physician's decision to withdraw patient|0|||
147467991|NCT00891735|531870424|FG002|Overall Study|Physician's decision to withdraw patient|0|||
147467992|NCT00891735|531870425|FG003|Overall Study|Physician's decision to withdraw patient|0|||
147467993|NCT00891735|531870422|FG000|Overall Study|Patient's decision to withdraw|4|||
147467994|NCT00891735|531870423|FG001|Overall Study|Patient's decision to withdraw|9|||
147467995|NCT00891735|531870424|FG002|Overall Study|Patient's decision to withdraw|4|||
147467996|NCT00891735|531870425|FG003|Overall Study|Patient's decision to withdraw|8|||
147467997|NCT00885365|531870426|FG000|4 Weeks ON Treatment|Adverse Event|2|||
147467998|NCT00885365|531870427|FG001|4 Weeks ON Treatment|Adverse Event|4|||
147467999|NCT00885365|531870426|FG000|4 Weeks ON Treatment|Protocol Violation|1|||
147468000|NCT00885365|531870427|FG001|4 Weeks ON Treatment|Protocol Violation|2|||
147468001|NCT00885365|531870426|FG000|4 Weeks ON Treatment|Withdrawal by Subject|1|||
147468002|NCT00885365|531870427|FG001|4 Weeks ON Treatment|Withdrawal by Subject|0|||
147468003|NCT01824979|531870428|FG000|Overall Study|Withdrawal by Subject|5|||
147468004|NCT01824979|531870429|FG001|Overall Study|Withdrawal by Subject|0|||
147468005|NCT01824979|531870428|FG000|Overall Study|Physician Decision|2|||
147468006|NCT01824979|531870429|FG001|Overall Study|Physician Decision|0|||
147468007|NCT01824979|531870428|FG000|Overall Study|Protocol Violation|6|||
147468008|NCT01824979|531870429|FG001|Overall Study|Protocol Violation|13|||
147618599|NCT02394600|532419175|FG001|Overall Study|Withdrawal by Subject|1|||
147618600|NCT02394600|532419174|FG000|Overall Study|Protocol Violation|1|||
147618601|NCT02394600|532419175|FG001|Overall Study|Protocol Violation|0|||
147618602|NCT02569801|532419176|FG000|Overall Study|Withdrawal by Subject|9|||
147618603|NCT02569801|532419177|FG001|Overall Study|Withdrawal by Subject|9|||
147618604|NCT02569801|532419176|FG000|Overall Study|Sponsor Decision|13|||
147618605|NCT02569801|532419177|FG001|Overall Study|Sponsor Decision|14|||
147618606|NCT02569801|532419176|FG000|Overall Study|Progressive Disease|2|||
147618607|NCT02569801|532419177|FG001|Overall Study|Progressive Disease|7|||
147618608|NCT02569801|532419176|FG000|Overall Study|Lost to Follow-up|0|||
147618609|NCT02569801|532419177|FG001|Overall Study|Lost to Follow-up|1|||
147618610|NCT02569801|532419176|FG000|Overall Study|Death|12|||
147618611|NCT02569801|532419177|FG001|Overall Study|Death|4|||
147468009|NCT01276288|531870435|FG000|Overall Study|Adverse Event|1|||
147468010|NCT01276288|531870436|FG001|Overall Study|Adverse Event|1|||
147468011|NCT01276288|531870437|FG002|Overall Study|Adverse Event|0|||
147468012|NCT01276288|531870438|FG003|Overall Study|Adverse Event|0|||
147468013|NCT01276288|531870435|FG000|Overall Study|not treated|1|||
147618612|NCT00428246|532419178|FG000|Overall Study|Withdrawal by Subject|0|||
147410839|NCT03083665|531668057|FG003|Open-Label Temporary Period (OLTP)|Lack of Efficacy|0|||
147410840|NCT03083665|531668058|FG004|Open-Label Temporary Period (OLTP)|Lack of Efficacy|0|||
147410841|NCT03083665|531668059|FG005|Open-Label Temporary Period (OLTP)|Lack of Efficacy|2|||
147410842|NCT03083665|531668054|FG000|Open-Label Temporary Period (OLTP)|Withdrawal by Subject|0|||
147410843|NCT03083665|531668055|FG001|Open-Label Temporary Period (OLTP)|Withdrawal by Subject|0|||
147410844|NCT03083665|531668056|FG002|Open-Label Temporary Period (OLTP)|Withdrawal by Subject|0|||
147410845|NCT03083665|531668057|FG003|Open-Label Temporary Period (OLTP)|Withdrawal by Subject|1|||
147410846|NCT03083665|531668058|FG004|Open-Label Temporary Period (OLTP)|Withdrawal by Subject|1|||
147410847|NCT03083665|531668059|FG005|Open-Label Temporary Period (OLTP)|Withdrawal by Subject|1|||
147410848|NCT03083665|531668054|FG000|Open-Label Temporary Period (OLTP)|Withdrawal by parent/guardian|0|||
147410849|NCT03083665|531668055|FG001|Open-Label Temporary Period (OLTP)|Withdrawal by parent/guardian|0|||
147410850|NCT03083665|531668056|FG002|Open-Label Temporary Period (OLTP)|Withdrawal by parent/guardian|0|||
147410851|NCT03083665|531668057|FG003|Open-Label Temporary Period (OLTP)|Withdrawal by parent/guardian|0|||
147410852|NCT03083665|531668058|FG004|Open-Label Temporary Period (OLTP)|Withdrawal by parent/guardian|0|||
147410853|NCT03083665|531668059|FG005|Open-Label Temporary Period (OLTP)|Withdrawal by parent/guardian|1|||
147410854|NCT03083665|531668054|FG000|Open-Label Temporary Period (OLTP)|Patient not keen to continue open label|0|||
147410855|NCT03083665|531668055|FG001|Open-Label Temporary Period (OLTP)|Patient not keen to continue open label|0|||
147410856|NCT03083665|531668056|FG002|Open-Label Temporary Period (OLTP)|Patient not keen to continue open label|0|||
147410857|NCT03083665|531668057|FG003|Open-Label Temporary Period (OLTP)|Patient not keen to continue open label|1|||
147410858|NCT03083665|531668058|FG004|Open-Label Temporary Period (OLTP)|Patient not keen to continue open label|0|||
147410859|NCT03083665|531668059|FG005|Open-Label Temporary Period (OLTP)|Patient not keen to continue open label|0|||
147410860|NCT03083665|531668054|FG000|Open-Label Temporary Period (OLTP)|Patient non compliant to open label study drug|0|||
147410861|NCT03083665|531668055|FG001|Open-Label Temporary Period (OLTP)|Patient non compliant to open label study drug|0|||
147410862|NCT03083665|531668056|FG002|Open-Label Temporary Period (OLTP)|Patient non compliant to open label study drug|0|||
147410863|NCT03083665|531668057|FG003|Open-Label Temporary Period (OLTP)|Patient non compliant to open label study drug|0|||
147410864|NCT03083665|531668058|FG004|Open-Label Temporary Period (OLTP)|Patient non compliant to open label study drug|0|||
147410865|NCT03083665|531668059|FG005|Open-Label Temporary Period (OLTP)|Patient non compliant to open label study drug|1|||
147410866|NCT03083665|531668054|FG000|Open-Label Temporary Period (OLTP)|Subject enrolled to compassionate use program|0|||
147410867|NCT03083665|531668055|FG001|Open-Label Temporary Period (OLTP)|Subject enrolled to compassionate use program|0|||
147410868|NCT03083665|531668056|FG002|Open-Label Temporary Period (OLTP)|Subject enrolled to compassionate use program|0|||
147410869|NCT03083665|531668057|FG003|Open-Label Temporary Period (OLTP)|Subject enrolled to compassionate use program|0|||
147410870|NCT03083665|531668058|FG004|Open-Label Temporary Period (OLTP)|Subject enrolled to compassionate use program|0|||
147410871|NCT03083665|531668059|FG005|Open-Label Temporary Period (OLTP)|Subject enrolled to compassionate use program|1|||
147410872|NCT06285240|531668060|FG000|Overall Study|Withdrawal by Subject|2|||
147410873|NCT06285240|531668061|FG001|Overall Study|Withdrawal by Subject|0|||
147410874|NCT06285240|531668062|FG002|Overall Study|Withdrawal by Subject|0|||
147410875|NCT06285240|531668063|FG003|Overall Study|Withdrawal by Subject|0|||
147410876|NCT06285240|531668060|FG000|Overall Study|Serious Adverse Event|0|||
147410877|NCT06285240|531668061|FG001|Overall Study|Serious Adverse Event|0|||
147410878|NCT06285240|531668062|FG002|Overall Study|Serious Adverse Event|1|||
147410879|NCT06285240|531668063|FG003|Overall Study|Serious Adverse Event|0|||
147410880|NCT05140915|531668064|FG000|Overall Study|Lost to Follow-up|2|||
147410881|NCT05140915|531668065|FG001|Overall Study|Lost to Follow-up|1|||
147410882|NCT03361865|531668066|FG000|Overall Study|Death|17|||
147410883|NCT03361865|531668067|FG001|Overall Study|Death|18|||
147410884|NCT03361865|531668066|FG000|Overall Study|Physician Decision|1|||
147410885|NCT03361865|531668067|FG001|Overall Study|Physician Decision|9|||
147410886|NCT03361865|531668066|FG000|Overall Study|Withdrawal by Subject|1|||
147410887|NCT03361865|531668067|FG001|Overall Study|Withdrawal by Subject|0|||
147410888|NCT02819024|531668069|FG000|Overall Study|Withdrawal by Subject|1|||
147410889|NCT05576662|531668070|FG000|Overall Study|Withdrawn by site within 15-day treatment period|0|||
147410890|NCT05576662|531668071|FG001|Overall Study|Withdrawn by site within 15-day treatment period|1|||
147410891|NCT05576662|531668070|FG000|Overall Study|Requested to withdraw within 15-day treatment period|0|||
147410892|NCT05576662|531668071|FG001|Overall Study|Requested to withdraw within 15-day treatment period|1|||
147410893|NCT05576662|531668070|FG000|Overall Study|Lost to follow-up within 15-day treatment period|2|||
147410894|NCT05576662|531668071|FG001|Overall Study|Lost to follow-up within 15-day treatment period|0|||
147410895|NCT05576662|531668070|FG000|Overall Study|Requested to withdraw after 15-day treatment period|2|||
147410896|NCT05576662|531668071|FG001|Overall Study|Requested to withdraw after 15-day treatment period|2|||
147410897|NCT05217641|531668076|FG000|Overall Study|Lost to Follow-up|1|||
147410898|NCT05217641|531668077|FG001|Overall Study|Lost to Follow-up|1|||
147410899|NCT05217641|531668078|FG002|Overall Study|Lost to Follow-up|0|||
147410900|NCT05217641|531668079|FG003|Overall Study|Lost to Follow-up|1|||
147410901|NCT05217641|531668080|FG004|Overall Study|Lost to Follow-up|1|||
147410902|NCT05217641|531668081|FG005|Overall Study|Lost to Follow-up|0|||
147410903|NCT05217641|531668076|FG000|Overall Study|Withdrawal by Subject|0|||
147618613|NCT00428246|532419179|FG001|Overall Study|Withdrawal by Subject|0|||
147618614|NCT00428246|532419180|FG002|Overall Study|Withdrawal by Subject|1|||
147618615|NCT00428246|532419178|FG000|Overall Study|Adverse Event|1|||
147618616|NCT00428246|532419179|FG001|Overall Study|Adverse Event|0|||
147618617|NCT00428246|532419180|FG002|Overall Study|Adverse Event|0|||
147618618|NCT03442751|532419182|FG000|Overall Study|Withdrawal by Subject|3|||
147618619|NCT03442751|532419183|FG001|Overall Study|Withdrawal by Subject|1|||
147618620|NCT03442751|532419182|FG000|Overall Study|Lost to Follow-up|3|||
147618621|NCT03442751|532419183|FG001|Overall Study|Lost to Follow-up|0|||
147618622|NCT01928472|532419185|FG000|Overall Study|Death|0|||
147618623|NCT01928472|532419186|FG001|Overall Study|Death|0|||
147618624|NCT01928472|532419187|FG002|Overall Study|Death|1|||
147618625|NCT01928472|532419188|FG003|Overall Study|Death|0|||
147618626|NCT01928472|532419185|FG000|Overall Study|Withdrawal by Subject|4|||
147618627|NCT01928472|532419186|FG001|Overall Study|Withdrawal by Subject|4|||
147618628|NCT01928472|532419187|FG002|Overall Study|Withdrawal by Subject|1|||
147618629|NCT01928472|532419188|FG003|Overall Study|Withdrawal by Subject|2|||
147618630|NCT01928472|532419185|FG000|Overall Study|Lost to Follow-up|2|||
147618631|NCT01928472|532419186|FG001|Overall Study|Lost to Follow-up|3|||
147618632|NCT01928472|532419187|FG002|Overall Study|Lost to Follow-up|4|||
147618633|NCT01928472|532419188|FG003|Overall Study|Lost to Follow-up|0|||
147618634|NCT01928472|532419185|FG000|Overall Study|Administrative Reason|2|||
147618635|NCT01928472|532419186|FG001|Overall Study|Administrative Reason|1|||
147618636|NCT01928472|532419187|FG002|Overall Study|Administrative Reason|0|||
147618637|NCT01928472|532419188|FG003|Overall Study|Administrative Reason|0|||
147618638|NCT01928472|532419185|FG000|Overall Study|Unclassified|0|||
147618639|NCT01928472|532419186|FG001|Overall Study|Unclassified|0|||
147618640|NCT01928472|532419187|FG002|Overall Study|Unclassified|1|||
147618641|NCT01928472|532419188|FG003|Overall Study|Unclassified|0|||
147618642|NCT02603887|532419190|FG000|Stage 1|Adverse Event|4|||
147618643|NCT02603887|532419190|FG000|Stage 1|Disease progression|1|||
147618644|NCT02603887|532419190|FG000|Stage 2|FDA guidance|1|||
147618645|NCT01308424|532419193|FG000|Baseline Eligibility|Screen Failures|71|||
147618646|NCT01308424|532419194|FG001|Baseline Eligibility|Screen Failures|0|||
147618647|NCT01308424|532419195|FG002|Baseline Eligibility|Screen Failures|0|||
147618648|NCT01308424|532419193|FG000|Randomization|Adverse Event|0|||
147618649|NCT01308424|532419194|FG001|Randomization|Adverse Event|1|||
147618650|NCT01308424|532419195|FG002|Randomization|Adverse Event|1|||
147618651|NCT01308424|532419193|FG000|Randomization|Lost to Follow-up|0|||
147618652|NCT01308424|532419194|FG001|Randomization|Lost to Follow-up|1|||
147618653|NCT01308424|532419195|FG002|Randomization|Lost to Follow-up|0|||
147618654|NCT01308424|532419193|FG000|Randomization|Physician Decision|0|||
147618655|NCT01308424|532419194|FG001|Randomization|Physician Decision|1|||
147618656|NCT01308424|532419195|FG002|Randomization|Physician Decision|1|||
147618657|NCT00948155|532419196|FG000|First Intervention 21 Days|Lost to Follow-up|2|||
147618658|NCT00948155|532419197|FG001|First Intervention 21 Days|Lost to Follow-up|2|||
147618659|NCT00948155|532419196|FG000|Washout 14 Days|Lost to Follow-up|1|||
147618660|NCT00948155|532419197|FG001|Washout 14 Days|Lost to Follow-up|2|||
147618661|NCT03411863|532419198|FG000|Overall Study|Withdrawal by Subject|3|||
147618662|NCT03411863|532419199|FG001|Overall Study|Withdrawal by Subject|1|||
147618663|NCT03411863|532419198|FG000|Overall Study|Physician Decision|0|||
147618664|NCT03411863|532419199|FG001|Overall Study|Physician Decision|1|||
147618665|NCT05767905|532419200|FG000|Overall Study|Adverse Event|0|||
147618666|NCT05767905|532419201|FG001|Overall Study|Adverse Event|0|||
147618667|NCT05767905|532419202|FG002|Overall Study|Adverse Event|1|||
147618668|NCT00307086|532419208|FG000|Overall Study|ineligible|5|||
147618669|NCT00312338|532419211|FG000|Overall Study|Adverse Event|7|||
147618670|NCT00312338|532419212|FG001|Overall Study|Adverse Event|2|||
147618671|NCT00312338|532419211|FG000|Overall Study|Lost to Follow-up|9|||
147618672|NCT00312338|532419212|FG001|Overall Study|Lost to Follow-up|1|||
147618673|NCT00312338|532419211|FG000|Overall Study|Withdrawal by Subject|4|||
147618674|NCT00312338|532419212|FG001|Overall Study|Withdrawal by Subject|0|||
147618675|NCT00312338|532419211|FG000|Overall Study|Subsequent infection|2|||
147618676|NCT00312338|532419212|FG001|Overall Study|Subsequent infection|0|||
147665761|NCT02709746|532601594|FG004|Phase A (Single-blind Treatment Period)|Not sepcified|0|||
147410904|NCT05217641|531668077|FG001|Overall Study|Withdrawal by Subject|0|||
147410905|NCT05217641|531668078|FG002|Overall Study|Withdrawal by Subject|0|||
147410906|NCT05217641|531668079|FG003|Overall Study|Withdrawal by Subject|3|||
147410907|NCT05217641|531668080|FG004|Overall Study|Withdrawal by Subject|1|||
147618677|NCT01125917|532419221|FG000|Overall Study|Adverse Event|43|||
147618678|NCT01125917|532419221|FG000|Overall Study|Lost to Follow-up|23|||
147618679|NCT01125917|532419221|FG000|Overall Study|Withdrawal by Subject|31|||
147410908|NCT05217641|531668081|FG005|Overall Study|Withdrawal by Subject|0|||
147618680|NCT01125917|532419221|FG000|Overall Study|Administrative|223|||
147618681|NCT01125917|532419221|FG000|Overall Study|Lack of Efficacy|19|||
147618682|NCT04421131|532419225|FG000|Overall Study|Lost to Follow-up|1|||
147618683|NCT04421131|532419225|FG000|Overall Study|Protocol Violation|2|||
147618684|NCT04421131|532419225|FG000|Overall Study|App crashed|5|||
147618685|NCT01169350|532419229|FG000|Overall Study|Physician Decision|3|||
147468014|NCT01276288|531870436|FG001|Overall Study|not treated|0|||
147468015|NCT01276288|531870437|FG002|Overall Study|not treated|0|||
147468016|NCT01276288|531870438|FG003|Overall Study|not treated|0|||
147468017|NCT00629083|531870445|FG000|Overall Study|Adverse Event|0|||
147468018|NCT00629083|531870446|FG001|Overall Study|Adverse Event|2|||
147468019|NCT00629083|531870445|FG000|Overall Study|Lack of Efficacy|3|||
147468020|NCT00629083|531870446|FG001|Overall Study|Lack of Efficacy|1|||
147468021|NCT00629083|531870445|FG000|Overall Study|Withdrawal by Subject|10|||
147468022|NCT00629083|531870446|FG001|Overall Study|Withdrawal by Subject|2|||
147468023|NCT00629083|531870445|FG000|Overall Study|Lost to Follow-up|12|||
147468024|NCT00629083|531870446|FG001|Overall Study|Lost to Follow-up|8|||
147468025|NCT00629083|531870445|FG000|Overall Study|Moved out of country/state|2|||
147468026|NCT00629083|531870446|FG001|Overall Study|Moved out of country/state|1|||
147468027|NCT00629083|531870445|FG000|Overall Study|Refused to return for 12 month visit|1|||
147468028|NCT00629083|531870446|FG001|Overall Study|Refused to return for 12 month visit|0|||
147468029|NCT01193686|531870447|FG000|Overall Study|Withdrawal by Subject|4|||
147618686|NCT01169350|532419229|FG000|Overall Study|Lost to Follow-up|2|||
147618687|NCT04870710|532419230|FG000|Overall Study|Lost to Follow-up|3|||
147618688|NCT05724589|532419232|FG000|Overall Study|Lost to Follow-up|1|||
147468030|NCT01193686|531870448|FG001|Overall Study|Withdrawal by Subject|1|||
147468031|NCT01193686|531870447|FG000|Overall Study|Removed by Investigators; unable to matc|3|||
147468032|NCT01193686|531870448|FG001|Overall Study|Removed by Investigators; unable to matc|0|||
147468033|NCT03401749|531870449|FG000|Overall Study|Lost to Follow-up|20|||
147468034|NCT03401749|531870450|FG001|Overall Study|Lost to Follow-up|16|||
147468035|NCT03401749|531870451|FG002|Overall Study|Lost to Follow-up|26|||
147468036|NCT03406962|531870456|FG000|Overall Study|Death|2|||
147468037|NCT03406962|531870456|FG000|Overall Study|Adverse Event|1|||
147468038|NCT03853694|531870457|FG000|Overall Study|Protocol Violation|3|||
147468039|NCT03853694|531870458|FG001|Overall Study|Protocol Violation|5|||
147468040|NCT03853694|531870459|FG002|Overall Study|Protocol Violation|3|||
147468041|NCT03853694|531870457|FG000|Overall Study|Delivered early|0|||
147468042|NCT03853694|531870458|FG001|Overall Study|Delivered early|1|||
147468043|NCT03853694|531870459|FG002|Overall Study|Delivered early|0|||
147468044|NCT03853694|531870457|FG000|Overall Study|not suitable to proceed|0|||
147468045|NCT03853694|531870458|FG001|Overall Study|not suitable to proceed|1|||
147468046|NCT03853694|531870459|FG002|Overall Study|not suitable to proceed|0|||
147468047|NCT03853694|531870457|FG000|Overall Study|difficult surgery|0|||
147468048|NCT03853694|531870458|FG001|Overall Study|difficult surgery|0|||
147468049|NCT03853694|531870459|FG002|Overall Study|difficult surgery|1|||
147468050|NCT03853694|531870457|FG000|Overall Study|Lost to Follow-up|0|||
147468051|NCT03853694|531870458|FG001|Overall Study|Lost to Follow-up|1|||
147468052|NCT03853694|531870459|FG002|Overall Study|Lost to Follow-up|0|||
147468053|NCT03853694|531870457|FG000|Overall Study|Withdrawal by Subject|0|||
147468054|NCT03853694|531870458|FG001|Overall Study|Withdrawal by Subject|1|||
147468055|NCT03853694|531870459|FG002|Overall Study|Withdrawal by Subject|0|||
147468056|NCT01818297|531870461|FG000|Blinded Phase (Randomization - 3 Months)|Adverse Event|0|||
147468057|NCT01818297|531870462|FG001|Blinded Phase (Randomization - 3 Months)|Adverse Event|1|||
147468058|NCT01818297|531870461|FG000|Open Label Phase (3-12 Months)|Physician Decision|1|||
147468059|NCT01818297|531870462|FG001|Open Label Phase (3-12 Months)|Physician Decision|0|||
147468060|NCT01818297|531870461|FG000|Open Label Phase (3-12 Months)|Early study closure|17|||
147468061|NCT01818297|531870462|FG001|Open Label Phase (3-12 Months)|Early study closure|10|||
147468062|NCT04439344|531870463|FG000|Overall Study|Never started threapy|3|||
147468063|NCT04439344|531870463|FG000|Overall Study|Ineligible|3|||
147468064|NCT04439344|531870463|FG000|Overall Study|Adverse Event|13|||
147468065|NCT04439344|531870463|FG000|Overall Study|Death|2|||
147468066|NCT04439344|531870463|FG000|Overall Study|Disease progression|29|||
147468067|NCT04439344|531870463|FG000|Overall Study|Withdrawal by Subject|2|||
147468068|NCT04439344|531870463|FG000|Overall Study|Alternative therapy|1|||
147468069|NCT03770403|531870464|FG000|Overall Study|Adverse Event|8|||
147618689|NCT04075487|532420824|FG000|Overall Study|Withdrawal by Subject|1|||
147618690|NCT00725283|532420827|FG000|Overall Study|Missing Code|3|||
147618691|NCT00725283|532420827|FG000|Overall Study|Death|5|||
147468070|NCT03770403|531870464|FG000|Overall Study|Death|5|||
147468071|NCT03770403|531870464|FG000|Overall Study|Physician Decision|1|||
147468072|NCT03770403|531870464|FG000|Overall Study|Sponsor decision|1|||
147468073|NCT03770403|531870464|FG000|Overall Study|Study terminated by Sponsor|1|||
147618692|NCT00725283|532420827|FG000|Overall Study|Other|6|||
147618693|NCT00725283|532420827|FG000|Overall Study|Withdrawal by Subject|10|||
147468074|NCT03770403|531870464|FG000|Overall Study|Withdrawal by Subject|13|||
147468075|NCT03770403|531870464|FG000|Overall Study|Other|88|||
147468076|NCT04373460|531870465|FG000|Overall Study|Did not receive tranfusion|18|||
147468077|NCT04373460|531870466|FG001|Overall Study|Did not receive tranfusion|26|||
147468078|NCT00591734|531870467|FG000|Overall Study|Lack of Efficacy|35|||
147468079|NCT00591734|531870467|FG000|Overall Study|Adverse Event|5|||
147468080|NCT00591734|531870467|FG000|Overall Study|Physician Decision|5|||
147618694|NCT00116779|532420828|FG000|Overall Study|Adverse Event|4|||
147618695|NCT00116779|532420829|FG001|Overall Study|Adverse Event|2|||
147468081|NCT00591734|531870467|FG000|Overall Study|Intercurrent Illness|8|||
147468082|NCT05775289|531870468|FG000|Overall Study|Study Ongoing|20|||
147468083|NCT05775289|531870469|FG001|Overall Study|Study Ongoing|53|||
147468084|NCT05775289|531870470|FG002|Overall Study|Study Ongoing|15|||
147468085|NCT05775289|531870471|FG003|Overall Study|Study Ongoing|55|||
147468086|NCT05775289|531870468|FG000|Overall Study|Death|4|||
147468087|NCT05775289|531870469|FG001|Overall Study|Death|11|||
147468088|NCT05775289|531870470|FG002|Overall Study|Death|8|||
147468089|NCT05775289|531870471|FG003|Overall Study|Death|12|||
147468090|NCT05775289|531870468|FG000|Overall Study|Lost to Follow-up|0|||
147468091|NCT05775289|531870469|FG001|Overall Study|Lost to Follow-up|1|||
147468092|NCT05775289|531870470|FG002|Overall Study|Lost to Follow-up|0|||
147468093|NCT05775289|531870471|FG003|Overall Study|Lost to Follow-up|0|||
147468094|NCT05775289|531870468|FG000|Overall Study|Progressive Disease|0|||
147468095|NCT05775289|531870469|FG001|Overall Study|Progressive Disease|0|||
147468096|NCT05775289|531870470|FG002|Overall Study|Progressive Disease|1|||
147468097|NCT05775289|531870471|FG003|Overall Study|Progressive Disease|0|||
147468098|NCT05775289|531870468|FG000|Overall Study|Withdrawal by Subject|1|||
147468099|NCT05775289|531870469|FG001|Overall Study|Withdrawal by Subject|1|||
147468100|NCT05775289|531870470|FG002|Overall Study|Withdrawal by Subject|0|||
147468101|NCT05775289|531870471|FG003|Overall Study|Withdrawal by Subject|0|||
147468102|NCT04743856|531870473|FG000|Overall Study|Lost to Follow-up|6|||
147468103|NCT04743856|531870474|FG001|Overall Study|Lost to Follow-up|7|||
147468104|NCT04743856|531870473|FG000|Overall Study|Withdrawal by Subject|1|||
147468105|NCT04743856|531870474|FG001|Overall Study|Withdrawal by Subject|0|||
147468106|NCT04439188|531870475|FG000|Overall Study|Ineligible|3|||
147468107|NCT04439188|531870475|FG000|Overall Study|Adverse Event|4|||
147618696|NCT00116779|532420828|FG000|Overall Study|Protocol Violation|1|||
147618697|NCT00116779|532420829|FG001|Overall Study|Protocol Violation|4|||
147618698|NCT00116779|532420828|FG000|Overall Study|Withdrawal by Subject|4|||
147618699|NCT00116779|532420829|FG001|Overall Study|Withdrawal by Subject|1|||
147618700|NCT00116779|532420828|FG000|Overall Study|Inadequate testosterone suppression|7|||
147618701|NCT00116779|532420829|FG001|Overall Study|Inadequate testosterone suppression|9|||
147618702|NCT00116779|532420828|FG000|Overall Study|Physician Decision|3|||
147618703|NCT00116779|532420829|FG001|Overall Study|Physician Decision|1|||
147618704|NCT00116779|532420828|FG000|Overall Study|Elevated PSA levels|2|||
147618705|NCT00116779|532420829|FG001|Overall Study|Elevated PSA levels|2|||
147618706|NCT03743051|532420830|FG000|Overall Study|Adverse Event|5|||
147618707|NCT03743051|532420831|FG001|Overall Study|Adverse Event|9|||
147618708|NCT03743051|532420830|FG000|Overall Study|Death|27|||
147618709|NCT03743051|532420831|FG001|Overall Study|Death|26|||
147618710|NCT03743051|532420830|FG000|Overall Study|Lost to Follow-up|4|||
147618711|NCT03743051|532420831|FG001|Overall Study|Lost to Follow-up|8|||
147618712|NCT03743051|532420830|FG000|Overall Study|Withdrawal by Subject|32|||
147618713|NCT03743051|532420831|FG001|Overall Study|Withdrawal by Subject|19|||
147618714|NCT03743051|532420830|FG000|Overall Study|Physician Decision|10|||
147618715|NCT03743051|532420831|FG001|Overall Study|Physician Decision|15|||
147618716|NCT03743051|532420830|FG000|Overall Study|"Reported as Other in Clinical Study Report"|3|||
147618717|NCT03743051|532420831|FG001|Overall Study|"Reported as Other in Clinical Study Report"|6|||
147618718|NCT00711087|532420832|FG000|Overall Study|Lost to Follow-up|1|||
147618719|NCT00711087|532420833|FG001|Overall Study|Lost to Follow-up|0|||
147618720|NCT00840749|532420836|FG000|Overall Study|Death|1|||
147618721|NCT00840749|532420837|FG001|Overall Study|Death|2|||
147618722|NCT00840749|532420836|FG000|Overall Study|not treated on study arm|11|||
147618723|NCT00840749|532420837|FG001|Overall Study|not treated on study arm|11|||
147618724|NCT00840749|532420836|FG000|Overall Study|study closed|19|||
147618725|NCT00840749|532420837|FG001|Overall Study|study closed|14|||
147618726|NCT01113892|532420844|FG000|Overall Study|Lost to Follow-up|2|||
147618727|NCT01113892|532420845|FG001|Overall Study|Lost to Follow-up|2|||
147618728|NCT01113892|532420844|FG000|Overall Study|Withdrawal by Subject|1|||
147618729|NCT01113892|532420845|FG001|Overall Study|Withdrawal by Subject|1|||
147618730|NCT01113892|532420844|FG000|Overall Study|Death|2|||
147618731|NCT01113892|532420845|FG001|Overall Study|Death|4|||
147618732|NCT01113892|532420844|FG000|Overall Study|Graft no longer evaluable|9|||
147618733|NCT01113892|532420845|FG001|Overall Study|Graft no longer evaluable|9|||
147618734|NCT03535740|532420848|FG000|Overall Study|Death|44|||
147618735|NCT03535740|532420848|FG000|Overall Study|Lost to Follow-up|1|||
147618736|NCT03535740|532420848|FG000|Overall Study|Withdrawal by Subject|13|||
147618737|NCT03535740|532420848|FG000|Overall Study|Site terminated by Sponsor|45|||
147618738|NCT05198518|532420853|FG000|Screening Visit|Deemed unable to participate|58|||
147468108|NCT04439188|531870475|FG000|Overall Study|Death|1|||
147468109|NCT04439188|531870475|FG000|Overall Study|Disease Progression|25|||
147468110|NCT04439188|531870475|FG000|Overall Study|Withdrawal by Subject|2|||
147468111|NCT01707992|531870476|FG000|Placebo-Controlled Phase (24 Months)|Adverse Event|8|||
147468112|NCT01707992|531870477|FG001|Placebo-Controlled Phase (24 Months)|Adverse Event|13|||
147468113|NCT01707992|531870478|FG002|Placebo-Controlled Phase (24 Months)|Adverse Event|9|||
147618739|NCT05198518|532420854|FG001|Screening Visit|Deemed unable to participate|0|||
147618740|NCT05198518|532420855|FG002|Screening Visit|Deemed unable to participate|0|||
147618741|NCT02766335|532420856|FG000|Initial Registration|Adverse Event|6|||
147618742|NCT02766335|532420857|FG001|Initial Registration|Adverse Event|3|||
147618743|NCT02766335|532420858|FG002|Initial Registration|Adverse Event|0|||
147618744|NCT02766335|532420856|FG000|Initial Registration|Refusal unrelated to adverse event|1|||
147618745|NCT02766335|532420857|FG001|Initial Registration|Refusal unrelated to adverse event|0|||
147618746|NCT02766335|532420858|FG002|Initial Registration|Refusal unrelated to adverse event|0|||
147618747|NCT02766335|532420856|FG000|Initial Registration|Progression/relapse|49|||
147410909|NCT05217641|531668076|FG000|Overall Study|Other: participant did not specify reason|0|||
147410910|NCT05217641|531668077|FG001|Overall Study|Other: participant did not specify reason|0|||
147410911|NCT05217641|531668078|FG002|Overall Study|Other: participant did not specify reason|0|||
147410912|NCT05217641|531668079|FG003|Overall Study|Other: participant did not specify reason|0|||
147410913|NCT05217641|531668080|FG004|Overall Study|Other: participant did not specify reason|1|||
147410914|NCT05217641|531668081|FG005|Overall Study|Other: participant did not specify reason|0|||
147410915|NCT05217641|531668076|FG000|Overall Study|Extended Follow up|1|||
147410916|NCT05217641|531668077|FG001|Overall Study|Extended Follow up|1|||
147410917|NCT05217641|531668078|FG002|Overall Study|Extended Follow up|0|||
147410918|NCT05217641|531668079|FG003|Overall Study|Extended Follow up|0|||
147410919|NCT05217641|531668080|FG004|Overall Study|Extended Follow up|1|||
147410920|NCT05217641|531668081|FG005|Overall Study|Extended Follow up|0|||
147410921|NCT05292586|531668082|FG000|Overall Study|Withdrawal by Subject|3|||
147410922|NCT05292586|531668083|FG001|Overall Study|Withdrawal by Subject|10|||
147410923|NCT05292586|531668082|FG000|Overall Study|Randomization error|3|||
147410924|NCT05292586|531668083|FG001|Overall Study|Randomization error|7|||
147410925|NCT05292586|531668082|FG000|Overall Study|Adverse Event|3|||
147410926|NCT05292586|531668083|FG001|Overall Study|Adverse Event|0|||
147410927|NCT05292586|531668082|FG000|Overall Study|Lost to Follow-up|0|||
147410928|NCT05292586|531668083|FG001|Overall Study|Lost to Follow-up|1|||
147410929|NCT05292586|531668082|FG000|Overall Study|Patient refused treatment|1|||
147410930|NCT05292586|531668083|FG001|Overall Study|Patient refused treatment|0|||
147410931|NCT05292586|531668082|FG000|Overall Study|Patient could not travel to the study site|1|||
147410932|NCT05292586|531668083|FG001|Overall Study|Patient could not travel to the study site|0|||
147410933|NCT05292586|531668082|FG000|Overall Study|Technical issues with the masterscope|0|||
147410934|NCT05292586|531668083|FG001|Overall Study|Technical issues with the masterscope|3|||
147410935|NCT05292586|531668082|FG000|Overall Study|Patient moved to a different state|0|||
147410936|NCT05292586|531668083|FG001|Overall Study|Patient moved to a different state|1|||
147410937|NCT03633799|531668100|FG000|Overall Study|Adverse Event|349|||
147410938|NCT03633799|531668100|FG000|Overall Study|Withdrawal by Subject|288|||
147410939|NCT03633799|531668100|FG000|Overall Study|Lost to Follow-up|97|||
147410940|NCT03633799|531668100|FG000|Overall Study|Physician Decision|9|||
147410941|NCT03633799|531668100|FG000|Overall Study|Protocol Violation|4|||
147410942|NCT03633799|531668100|FG000|Overall Study|Pregnancy|20|||
147410943|NCT03633799|531668100|FG000|Overall Study|other|39|||
147410944|NCT03633799|531668100|FG000|Overall Study|ongoing within third year of study|106|||
147410945|NCT03633799|531668100|FG000|Overall Study|unsuccessful study drug placement|19|||
147410946|NCT02367040|531668103|FG000|Overall Study|Lost to Follow-up|1|||
147410947|NCT02367040|531668104|FG001|Overall Study|Lost to Follow-up|1|||
147410948|NCT02367040|531668103|FG000|Overall Study|Lack of Efficacy|1|||
147410949|NCT02367040|531668104|FG001|Overall Study|Lack of Efficacy|0|||
147410950|NCT02367040|531668103|FG000|Overall Study|Additional primary malignancy|1|||
147410951|NCT02367040|531668104|FG001|Overall Study|Additional primary malignancy|1|||
147410952|NCT02367040|531668103|FG000|Overall Study|AE not associated with clinical disease progression|117|||
147410953|NCT02367040|531668104|FG001|Overall Study|AE not associated with clinical disease progression|12|||
147410954|NCT02367040|531668103|FG000|Overall Study|AE associated with clinical disease progression|1|||
147410955|NCT02367040|531668104|FG001|Overall Study|AE associated with clinical disease progression|4|||
147410956|NCT02367040|531668103|FG000|Overall Study|Physician Decision|2|||
147410957|NCT02367040|531668104|FG001|Overall Study|Physician Decision|8|||
147410958|NCT02367040|531668103|FG000|Overall Study|Non-compliance to study drug|1|||
147410959|NCT02367040|531668104|FG001|Overall Study|Non-compliance to study drug|0|||
147410960|NCT02367040|531668103|FG000|Overall Study|Failure to meet continuation criteria|1|||
147410961|NCT02367040|531668104|FG001|Overall Study|Failure to meet continuation criteria|0|||
147410962|NCT02367040|531668103|FG000|Overall Study|Switching to other therapy|2|||
147410963|NCT02367040|531668104|FG001|Overall Study|Switching to other therapy|0|||
147410964|NCT02367040|531668103|FG000|Overall Study|Withdrawal by Subject|51|||
147410965|NCT02367040|531668104|FG001|Overall Study|Withdrawal by Subject|16|||
147410966|NCT02367040|531668103|FG000|Overall Study|Patient decision: COVID-19 pandemic related|1|||
147410967|NCT02367040|531668104|FG001|Overall Study|Patient decision: COVID-19 pandemic related|0|||
147410968|NCT02367040|531668103|FG000|Overall Study|Patient decision|40|||
147410969|NCT02367040|531668104|FG001|Overall Study|Patient decision|14|||
147410970|NCT02367040|531668103|FG000|Overall Study|Required procedure failed|1|||
147410971|NCT02367040|531668104|FG001|Overall Study|Required procedure failed|0|||
147410972|NCT02367040|531668103|FG000|Overall Study|Randomized by mistake with study treatment|1|||
147410973|NCT02367040|531668104|FG001|Overall Study|Randomized by mistake with study treatment|0|||
147410974|NCT02367040|531668103|FG000|Overall Study|Protocol Violation|1|||
147618748|NCT02766335|532420857|FG001|Initial Registration|Progression/relapse|15|||
147618749|NCT02766335|532420858|FG002|Initial Registration|Progression/relapse|0|||
147618750|NCT02766335|532420856|FG000|Initial Registration|Death|1|||
147618751|NCT02766335|532420857|FG001|Initial Registration|Death|3|||
147618752|NCT02766335|532420858|FG002|Initial Registration|Death|0|||
147618753|NCT02766335|532420856|FG000|Initial Registration|not protocol specified|1|||
147618754|NCT02766335|532420857|FG001|Initial Registration|not protocol specified|9|||
147618755|NCT02766335|532420858|FG002|Initial Registration|not protocol specified|0|||
147618756|NCT02766335|532420856|FG000|Re-registration of Arm I to MEDI4738|Death|0|||
147618757|NCT02766335|532420857|FG001|Re-registration of Arm I to MEDI4738|Death|0|||
147618758|NCT02766335|532420858|FG002|Re-registration of Arm I to MEDI4738|Death|1|||
147618759|NCT02766335|532420856|FG000|Re-registration of Arm I to MEDI4738|Progression/relapse|0|||
147618760|NCT02766335|532420857|FG001|Re-registration of Arm I to MEDI4738|Progression/relapse|0|||
147618761|NCT02766335|532420858|FG002|Re-registration of Arm I to MEDI4738|Progression/relapse|1|||
147618762|NCT03645863|532420860|FG000|Overall Study|Withdrawal by Subject|1|||
147618763|NCT03645863|532420861|FG001|Overall Study|Withdrawal by Subject|0|||
147618764|NCT03645863|532420862|FG002|Overall Study|Withdrawal by Subject|0|||
147618765|NCT01841593|532420864|FG000|First Intervention (Days 1 to 7)|Protocol Violation|0|||
147618766|NCT01841593|532420865|FG001|First Intervention (Days 1 to 7)|Protocol Violation|1|||
147618767|NCT01841593|532420864|FG000|Second Intervention (Days 8 to 14)|Adverse Event|1|||
147618768|NCT01841593|532420865|FG001|Second Intervention (Days 8 to 14)|Adverse Event|0|||
147618769|NCT03125798|532420867|FG000|Overall Study|Lack of electrosurgical device in the operating room|2|||
147618770|NCT03125798|532420868|FG001|Overall Study|Lack of electrosurgical device in the operating room|0|||
147618771|NCT03125798|532420867|FG000|Overall Study|Conversion to thoracotomy|7|||
147618772|NCT03125798|532420868|FG001|Overall Study|Conversion to thoracotomy|7|||
147618773|NCT02635984|532420869|FG000|Overall Study|Lost to Follow-up|2|||
147618774|NCT02635984|532420870|FG001|Overall Study|Lost to Follow-up|4|||
147618775|NCT02635984|532420869|FG000|Overall Study|Study Arm Closed|1|||
147618776|NCT02635984|532420870|FG001|Overall Study|Study Arm Closed|0|||
147618777|NCT03164551|532420871|FG000|Overall Study|Imaging discontinued prior completion|8|||
147618778|NCT03164551|532420872|FG001|Overall Study|Imaging discontinued prior completion|0|||
147618779|NCT03164551|532420871|FG000|Overall Study|Participant was non-compliant|1|||
147618780|NCT03164551|532420872|FG001|Overall Study|Participant was non-compliant|0|||
147618781|NCT03164551|532420871|FG000|Overall Study|Cancellation of Fresh Embryo Transfer|12|||
147618782|NCT03164551|532420872|FG001|Overall Study|Cancellation of Fresh Embryo Transfer|14|||
147618783|NCT03164551|532420871|FG000|Overall Study|Other|8|||
147618784|NCT03164551|532420872|FG001|Overall Study|Other|2|||
147618785|NCT01515423|532420873|FG000|Open Label Phase|Adverse Event|57|||
147618786|NCT01515423|532420874|FG001|Open Label Phase|Adverse Event|0|||
147618787|NCT01515423|532420875|FG002|Open Label Phase|Adverse Event|0|||
147618788|NCT01515423|532420873|FG000|Open Label Phase|Death|2|||
147618789|NCT01515423|532420874|FG001|Open Label Phase|Death|0|||
147618790|NCT01515423|532420875|FG002|Open Label Phase|Death|0|||
147618791|NCT01515423|532420873|FG000|Open Label Phase|Lack of Efficacy|117|||
147618792|NCT01515423|532420874|FG001|Open Label Phase|Lack of Efficacy|0|||
147618793|NCT01515423|532420875|FG002|Open Label Phase|Lack of Efficacy|0|||
147618794|NCT01515423|532420873|FG000|Open Label Phase|Lost to Follow-up|21|||
147618795|NCT01515423|532420874|FG001|Open Label Phase|Lost to Follow-up|0|||
147618796|NCT01515423|532420875|FG002|Open Label Phase|Lost to Follow-up|0|||
147618797|NCT01515423|532420873|FG000|Open Label Phase|Withdrawal by Subject|118|||
147618798|NCT01515423|532420874|FG001|Open Label Phase|Withdrawal by Subject|0|||
147618799|NCT01515423|532420875|FG002|Open Label Phase|Withdrawal by Subject|0|||
147618800|NCT01515423|532420873|FG000|Open Label Phase|excluded from DB Phase|70|||
147618801|NCT01515423|532420874|FG001|Open Label Phase|excluded from DB Phase|0|||
147618802|NCT01515423|532420875|FG002|Open Label Phase|excluded from DB Phase|0|||
147618803|NCT01515423|532420873|FG000|Open Label Phase|Other|28|||
147618804|NCT01515423|532420874|FG001|Open Label Phase|Other|0|||
147618805|NCT01515423|532420875|FG002|Open Label Phase|Other|0|||
147618806|NCT01515423|532420873|FG000|DOUBLE BLIND|Adverse Event|0|||
147618807|NCT01515423|532420874|FG001|DOUBLE BLIND|Adverse Event|15|||
147618808|NCT01515423|532420875|FG002|DOUBLE BLIND|Adverse Event|13|||
147410975|NCT02367040|531668104|FG001|Overall Study|Protocol Violation|0|||
147410976|NCT02367040|531668103|FG000|Overall Study|Progressive disease - radiological progression|54|||
147618809|NCT01515423|532420873|FG000|DOUBLE BLIND|Death|0|||
147618810|NCT01515423|532420874|FG001|DOUBLE BLIND|Death|1|||
147618811|NCT01515423|532420875|FG002|DOUBLE BLIND|Death|2|||
147618812|NCT01515423|532420873|FG000|DOUBLE BLIND|Lost to Follow-up|0|||
147618813|NCT01515423|532420874|FG001|DOUBLE BLIND|Lost to Follow-up|7|||
147618814|NCT01515423|532420875|FG002|DOUBLE BLIND|Lost to Follow-up|12|||
147618815|NCT01515423|532420873|FG000|DOUBLE BLIND|Pregnancy|0|||
147618816|NCT01515423|532420874|FG001|DOUBLE BLIND|Pregnancy|2|||
147618817|NCT01515423|532420875|FG002|DOUBLE BLIND|Pregnancy|0|||
147618818|NCT01515423|532420873|FG000|DOUBLE BLIND|Withdrawal by Subject|0|||
147618819|NCT01515423|532420874|FG001|DOUBLE BLIND|Withdrawal by Subject|50|||
147618820|NCT01515423|532420875|FG002|DOUBLE BLIND|Withdrawal by Subject|53|||
147618821|NCT01515423|532420873|FG000|DOUBLE BLIND|Other|0|||
147410977|NCT02367040|531668104|FG001|Overall Study|Progressive disease - radiological progression|80|||
147410978|NCT02367040|531668103|FG000|Overall Study|Progressive disease - clinical progression|6|||
147410979|NCT02367040|531668104|FG001|Overall Study|Progressive disease - clinical progression|6|||
147410980|NCT02367040|531668103|FG000|Overall Study|Drug not administered|3|||
147410981|NCT02367040|531668104|FG001|Overall Study|Drug not administered|2|||
147410982|NCT02367040|531668103|FG000|Overall Study|Progressive disease|0|||
147410983|NCT02367040|531668104|FG001|Overall Study|Progressive disease|1|||
147410984|NCT02367040|531668103|FG000|Overall Study|Other reason: Covid-19 pandemic related|1|||
147410985|NCT02367040|531668104|FG001|Overall Study|Other reason: Covid-19 pandemic related|0|||
147410986|NCT02367040|531668103|FG000|Overall Study|Death|2|||
147410987|NCT02367040|531668104|FG001|Overall Study|Death|0|||
147468114|NCT01707992|531870479|FG003|Placebo-Controlled Phase (24 Months)|Adverse Event|0|||
147468115|NCT01707992|531870480|FG004|Placebo-Controlled Phase (24 Months)|Adverse Event|0|||
147468116|NCT01707992|531870481|FG005|Placebo-Controlled Phase (24 Months)|Adverse Event|0|||
147468117|NCT01707992|531870476|FG000|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|10|||
147468118|NCT01707992|531870477|FG001|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|3|||
147468119|NCT01707992|531870478|FG002|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|2|||
147468120|NCT01707992|531870479|FG003|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|0|||
147468121|NCT01707992|531870480|FG004|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|0|||
147468122|NCT01707992|531870481|FG005|Placebo-Controlled Phase (24 Months)|Lack of Efficacy|0|||
147468123|NCT01707992|531870476|FG000|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|88|||
147468124|NCT01707992|531870477|FG001|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|68|||
147468125|NCT01707992|531870478|FG002|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|154|||
147468126|NCT01707992|531870479|FG003|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|0|||
147468127|NCT01707992|531870480|FG004|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|0|||
147468128|NCT01707992|531870481|FG005|Placebo-Controlled Phase (24 Months)|Withdrawal by Subject|0|||
147468129|NCT01707992|531870476|FG000|Placebo-Controlled Phase (24 Months)|Protocol Violation|1|||
147468130|NCT01707992|531870477|FG001|Placebo-Controlled Phase (24 Months)|Protocol Violation|0|||
147468131|NCT01707992|531870478|FG002|Placebo-Controlled Phase (24 Months)|Protocol Violation|0|||
147468132|NCT01707992|531870479|FG003|Placebo-Controlled Phase (24 Months)|Protocol Violation|0|||
147468133|NCT01707992|531870480|FG004|Placebo-Controlled Phase (24 Months)|Protocol Violation|0|||
147468134|NCT01707992|531870481|FG005|Placebo-Controlled Phase (24 Months)|Protocol Violation|0|||
147468135|NCT01707992|531870476|FG000|Placebo-Controlled Phase (24 Months)|Pregnancy|12|||
147468136|NCT01707992|531870477|FG001|Placebo-Controlled Phase (24 Months)|Pregnancy|5|||
147468137|NCT01707992|531870478|FG002|Placebo-Controlled Phase (24 Months)|Pregnancy|9|||
147468138|NCT01707992|531870479|FG003|Placebo-Controlled Phase (24 Months)|Pregnancy|0|||
147468139|NCT01707992|531870480|FG004|Placebo-Controlled Phase (24 Months)|Pregnancy|0|||
147468140|NCT01707992|531870481|FG005|Placebo-Controlled Phase (24 Months)|Pregnancy|0|||
147468141|NCT01707992|531870476|FG000|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|10|||
147468142|NCT01707992|531870477|FG001|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|4|||
147468143|NCT01707992|531870478|FG002|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|9|||
147468144|NCT01707992|531870479|FG003|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|0|||
147468145|NCT01707992|531870480|FG004|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|0|||
147468146|NCT01707992|531870481|FG005|Placebo-Controlled Phase (24 Months)|Lost to Follow-up|0|||
147468147|NCT01707992|531870476|FG000|Placebo-Controlled Phase (24 Months)|Death|2|||
147468148|NCT01707992|531870477|FG001|Placebo-Controlled Phase (24 Months)|Death|1|||
147468149|NCT01707992|531870478|FG002|Placebo-Controlled Phase (24 Months)|Death|1|||
147468150|NCT01707992|531870479|FG003|Placebo-Controlled Phase (24 Months)|Death|0|||
147618822|NCT01515423|532420874|FG001|DOUBLE BLIND|Other|6|||
147618823|NCT01515423|532420875|FG002|DOUBLE BLIND|Other|12|||
147618824|NCT01515423|532420873|FG000|DOUBLE BLIND|Blind broken by investigator|0|||
147618825|NCT01515423|532420874|FG001|DOUBLE BLIND|Blind broken by investigator|1|||
147618826|NCT01515423|532420875|FG002|DOUBLE BLIND|Blind broken by investigator|0|||
147618827|NCT02501928|532420876|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
147618828|NCT02501928|532420877|FG001|Overall Study|Withdrawal By Parent/Guardian|0|||
147618829|NCT02501928|532420878|FG002|Overall Study|Withdrawal By Parent/Guardian|0|||
147618830|NCT02501928|532420879|FG003|Overall Study|Withdrawal By Parent/Guardian|0|||
147618831|NCT02501928|532420880|FG004|Overall Study|Withdrawal By Parent/Guardian|1|||
147618832|NCT02501928|532420881|FG005|Overall Study|Withdrawal By Parent/Guardian|0|||
147618833|NCT00951496|532420884|FG000|Overall Study|Did not initiate study treatment|10|||
147618834|NCT00951496|532420885|FG001|Overall Study|Did not initiate study treatment|8|||
147618835|NCT00951496|532420886|FG002|Overall Study|Did not initiate study treatment|13|||
147618836|NCT00838526|532420888|FG000|Overall Study|Adverse Event|3|||
147410988|NCT02367040|531668103|FG000|Overall Study|Study terminated by sponsor|19|||
147410989|NCT02367040|531668104|FG001|Overall Study|Study terminated by sponsor|2|||
147468151|NCT01707992|531870480|FG004|Placebo-Controlled Phase (24 Months)|Death|0|||
147618837|NCT00838526|532420889|FG001|Overall Study|Adverse Event|12|||
147618838|NCT00838526|532420888|FG000|Overall Study|Lost to Follow-up|4|||
147618839|NCT00838526|532420889|FG001|Overall Study|Lost to Follow-up|12|||
147468152|NCT01707992|531870481|FG005|Placebo-Controlled Phase (24 Months)|Death|0|||
147468153|NCT01707992|531870476|FG000|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|2|||
147468154|NCT01707992|531870477|FG001|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|1|||
147468155|NCT01707992|531870478|FG002|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|6|||
147468156|NCT01707992|531870479|FG003|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|0|||
147468157|NCT01707992|531870480|FG004|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|0|||
147468158|NCT01707992|531870481|FG005|Placebo-Controlled Phase (24 Months)|Noncompliance with drug administration|0|||
147468159|NCT01707992|531870476|FG000|Placebo-Controlled Phase (24 Months)|Other than specified|11|||
147468160|NCT01707992|531870477|FG001|Placebo-Controlled Phase (24 Months)|Other than specified|9|||
147468161|NCT01707992|531870478|FG002|Placebo-Controlled Phase (24 Months)|Other than specified|10|||
147468162|NCT01707992|531870479|FG003|Placebo-Controlled Phase (24 Months)|Other than specified|0|||
147468163|NCT01707992|531870480|FG004|Placebo-Controlled Phase (24 Months)|Other than specified|0|||
147468164|NCT01707992|531870481|FG005|Placebo-Controlled Phase (24 Months)|Other than specified|0|||
147468165|NCT01707992|531870476|FG000|Active Treatment Phase (24 Months)|Adverse Event|0|||
147468166|NCT01707992|531870477|FG001|Active Treatment Phase (24 Months)|Adverse Event|0|||
147468167|NCT01707992|531870478|FG002|Active Treatment Phase (24 Months)|Adverse Event|0|||
147468168|NCT01707992|531870479|FG003|Active Treatment Phase (24 Months)|Adverse Event|4|||
147468169|NCT01707992|531870480|FG004|Active Treatment Phase (24 Months)|Adverse Event|1|||
147468170|NCT01707992|531870481|FG005|Active Treatment Phase (24 Months)|Adverse Event|0|||
147468171|NCT01707992|531870476|FG000|Active Treatment Phase (24 Months)|Lack of Efficacy|0|||
147468172|NCT01707992|531870477|FG001|Active Treatment Phase (24 Months)|Lack of Efficacy|0|||
147468173|NCT01707992|531870478|FG002|Active Treatment Phase (24 Months)|Lack of Efficacy|0|||
147468174|NCT01707992|531870479|FG003|Active Treatment Phase (24 Months)|Lack of Efficacy|3|||
147468175|NCT01707992|531870480|FG004|Active Treatment Phase (24 Months)|Lack of Efficacy|1|||
147468176|NCT01707992|531870481|FG005|Active Treatment Phase (24 Months)|Lack of Efficacy|2|||
147468177|NCT01707992|531870476|FG000|Active Treatment Phase (24 Months)|Withdrawal by Subject|0|||
147468178|NCT01707992|531870477|FG001|Active Treatment Phase (24 Months)|Withdrawal by Subject|0|||
147468179|NCT01707992|531870478|FG002|Active Treatment Phase (24 Months)|Withdrawal by Subject|0|||
147468180|NCT01707992|531870479|FG003|Active Treatment Phase (24 Months)|Withdrawal by Subject|58|||
147468181|NCT01707992|531870480|FG004|Active Treatment Phase (24 Months)|Withdrawal by Subject|220|||
147468182|NCT01707992|531870481|FG005|Active Treatment Phase (24 Months)|Withdrawal by Subject|32|||
147468183|NCT01707992|531870476|FG000|Active Treatment Phase (24 Months)|Pregnancy|0|||
147468184|NCT01707992|531870477|FG001|Active Treatment Phase (24 Months)|Pregnancy|0|||
147468185|NCT01707992|531870478|FG002|Active Treatment Phase (24 Months)|Pregnancy|0|||
147468186|NCT01707992|531870479|FG003|Active Treatment Phase (24 Months)|Pregnancy|2|||
147468187|NCT01707992|531870480|FG004|Active Treatment Phase (24 Months)|Pregnancy|5|||
147468188|NCT01707992|531870481|FG005|Active Treatment Phase (24 Months)|Pregnancy|2|||
147468189|NCT01707992|531870476|FG000|Active Treatment Phase (24 Months)|Lost to Follow-up|0|||
147468190|NCT01707992|531870477|FG001|Active Treatment Phase (24 Months)|Lost to Follow-up|0|||
147468191|NCT01707992|531870478|FG002|Active Treatment Phase (24 Months)|Lost to Follow-up|0|||
147468192|NCT01707992|531870479|FG003|Active Treatment Phase (24 Months)|Lost to Follow-up|5|||
147468193|NCT01707992|531870480|FG004|Active Treatment Phase (24 Months)|Lost to Follow-up|11|||
147468194|NCT01707992|531870481|FG005|Active Treatment Phase (24 Months)|Lost to Follow-up|1|||
147468195|NCT01707992|531870476|FG000|Active Treatment Phase (24 Months)|Death|0|||
147468196|NCT01707992|531870477|FG001|Active Treatment Phase (24 Months)|Death|0|||
147468197|NCT01707992|531870478|FG002|Active Treatment Phase (24 Months)|Death|0|||
147468198|NCT01707992|531870479|FG003|Active Treatment Phase (24 Months)|Death|2|||
147468199|NCT01707992|531870480|FG004|Active Treatment Phase (24 Months)|Death|0|||
147468200|NCT01707992|531870481|FG005|Active Treatment Phase (24 Months)|Death|0|||
147468201|NCT01707992|531870476|FG000|Active Treatment Phase (24 Months)|Other than specified|0|||
147468202|NCT01707992|531870477|FG001|Active Treatment Phase (24 Months)|Other than specified|0|||
147468203|NCT01707992|531870478|FG002|Active Treatment Phase (24 Months)|Other than specified|0|||
147468204|NCT01707992|531870479|FG003|Active Treatment Phase (24 Months)|Other than specified|1|||
147468205|NCT01707992|531870480|FG004|Active Treatment Phase (24 Months)|Other than specified|5|||
147468206|NCT01707992|531870481|FG005|Active Treatment Phase (24 Months)|Other than specified|2|||
147468207|NCT01707992|531870476|FG000|Active Treatment Phase (24 Months)|Noncompliance|0|||
147468208|NCT01707992|531870477|FG001|Active Treatment Phase (24 Months)|Noncompliance|0|||
147468209|NCT01707992|531870478|FG002|Active Treatment Phase (24 Months)|Noncompliance|0|||
147468210|NCT01707992|531870479|FG003|Active Treatment Phase (24 Months)|Noncompliance|0|||
147468211|NCT01707992|531870480|FG004|Active Treatment Phase (24 Months)|Noncompliance|4|||
147468212|NCT01707992|531870481|FG005|Active Treatment Phase (24 Months)|Noncompliance|2|||
147468213|NCT01707992|531870476|FG000|Active Treatment Phase (24 Months)|Study terminated by sponsor|0|||
147468214|NCT01707992|531870477|FG001|Active Treatment Phase (24 Months)|Study terminated by sponsor|0|||
147468215|NCT01707992|531870478|FG002|Active Treatment Phase (24 Months)|Study terminated by sponsor|0|||
147468216|NCT01707992|531870479|FG003|Active Treatment Phase (24 Months)|Study terminated by sponsor|809|||
147468217|NCT01707992|531870480|FG004|Active Treatment Phase (24 Months)|Study terminated by sponsor|243|||
147410990|NCT02477618|531668105|FG000|Overall Study|Completed Visits but Discontinued Drug|2|||
147410991|NCT02477618|531668106|FG001|Overall Study|Completed Visits but Discontinued Drug|1|||
147410992|NCT02477618|531668105|FG000|Overall Study|Died in Double-Blind Treatment Period|11|||
147410993|NCT02477618|531668106|FG001|Overall Study|Died in Double-Blind Treatment Period|11|||
147410994|NCT02477618|531668105|FG000|Overall Study|Adverse Event|1|||
147410995|NCT02477618|531668106|FG001|Overall Study|Adverse Event|1|||
147410996|NCT02477618|531668105|FG000|Overall Study|Transferred Away from Study Site|1|||
147410997|NCT02477618|531668106|FG001|Overall Study|Transferred Away from Study Site|0|||
147410998|NCT02477618|531668105|FG000|Overall Study|Left Study Site for Rehabilitation|0|||
147410999|NCT02477618|531668106|FG001|Overall Study|Left Study Site for Rehabilitation|1|||
147411000|NCT02446821|531668107|FG000|Overall Study|Adverse Event|28|||
147411001|NCT02446821|531668107|FG000|Overall Study|Withdrawal by Subject|6|||
147411002|NCT02446821|531668107|FG000|Overall Study|Lost to Follow-up|22|||
147411003|NCT02446821|531668107|FG000|Overall Study|other|9|||
147411004|NCT02446821|531668107|FG000|Overall Study|insertion failure|3|||
147411005|NCT03007420|531668108|FG000|Overall Study|Withdrawal by Subject|0|||
147411006|NCT03007420|531668109|FG001|Overall Study|Withdrawal by Subject|2|||
147411007|NCT03007420|531668108|FG000|Overall Study|Physician Decision|0|||
147411008|NCT03007420|531668109|FG001|Overall Study|Physician Decision|1|||
147411009|NCT02284009|531668113|FG000|Overall Study|Adverse Event|3|||
147411010|NCT02284009|531668114|FG001|Overall Study|Adverse Event|0|||
147411011|NCT02284009|531668113|FG000|Overall Study|Lost to Follow-up|1|||
147411012|NCT02284009|531668114|FG001|Overall Study|Lost to Follow-up|3|||
147411013|NCT02284009|531668113|FG000|Overall Study|Physician Decision|0|||
147411014|NCT02284009|531668114|FG001|Overall Study|Physician Decision|2|||
147411015|NCT02284009|531668113|FG000|Overall Study|Withdrawal by Subject|2|||
147411016|NCT02284009|531668114|FG001|Overall Study|Withdrawal by Subject|5|||
147411017|NCT00747227|531669784|FG000|Overall Study|Death|3|||
147411018|NCT00747227|531669785|FG001|Overall Study|Death|1|||
147411019|NCT00747227|531669784|FG000|Overall Study|Withdrawal by Subject|1|||
147411020|NCT00747227|531669785|FG001|Overall Study|Withdrawal by Subject|0|||
147411021|NCT00747227|531669784|FG000|Overall Study|Lost to Follow-up|1|||
147411022|NCT00747227|531669785|FG001|Overall Study|Lost to Follow-up|2|||
147411023|NCT00747227|531669784|FG000|Overall Study|Illness|1|||
147411024|NCT00747227|531669785|FG001|Overall Study|Illness|1|||
147411025|NCT03554629|531669786|FG000|Overall Study|Inadequate data|6|||
147411026|NCT00663702|531669791|FG000|Overall Study|Adverse Event|8|||
147411027|NCT00663702|531669792|FG001|Overall Study|Adverse Event|4|||
147411028|NCT00663702|531669791|FG000|Overall Study|Withdrawal by Subject|3|||
147411029|NCT00663702|531669792|FG001|Overall Study|Withdrawal by Subject|1|||
147411030|NCT00663702|531669791|FG000|Overall Study|Pregnancy|0|||
147411031|NCT00663702|531669792|FG001|Overall Study|Pregnancy|1|||
147411032|NCT00663702|531669791|FG000|Overall Study|Lost to Follow-up|3|||
147411033|NCT00663702|531669792|FG001|Overall Study|Lost to Follow-up|0|||
147411034|NCT00663702|531669791|FG000|Overall Study|Death|1|||
147411035|NCT00663702|531669792|FG001|Overall Study|Death|1|||
147411036|NCT00663702|531669791|FG000|Overall Study|Lack of Efficacy|3|||
147411037|NCT00663702|531669792|FG001|Overall Study|Lack of Efficacy|3|||
147411038|NCT03056300|531669793|FG000|Overall Study|Surgical reason per study protocol|3|||
147411039|NCT04020185|531669798|FG000|Overall Study|Death|0|||
147411040|NCT04020185|531669799|FG001|Overall Study|Death|0|||
147411041|NCT04020185|531669800|FG002|Overall Study|Death|1|||
147411042|NCT04020185|531669801|FG003|Overall Study|Death|2|||
147411043|NCT04020185|531669802|FG004|Overall Study|Death|1|||
147411044|NCT04020185|531669803|FG005|Overall Study|Death|0|||
147411045|NCT04020185|531669804|FG006|Overall Study|Death|1|||
147411046|NCT04020185|531669805|FG007|Overall Study|Death|0|||
147411047|NCT04020185|531669798|FG000|Overall Study|Consent withdrawn|1|||
147411048|NCT04020185|531669799|FG001|Overall Study|Consent withdrawn|0|||
147411049|NCT04020185|531669800|FG002|Overall Study|Consent withdrawn|0|||
147411050|NCT04020185|531669801|FG003|Overall Study|Consent withdrawn|0|||
147411051|NCT04020185|531669802|FG004|Overall Study|Consent withdrawn|2|||
147411052|NCT04020185|531669803|FG005|Overall Study|Consent withdrawn|0|||
147411053|NCT04020185|531669804|FG006|Overall Study|Consent withdrawn|1|||
147411054|NCT04020185|531669805|FG007|Overall Study|Consent withdrawn|1|||
147411055|NCT04020185|531669798|FG000|Overall Study|Patient in hospice|0|||
147411056|NCT04020185|531669799|FG001|Overall Study|Patient in hospice|1|||
147411057|NCT04020185|531669800|FG002|Overall Study|Patient in hospice|0|||
147411058|NCT04020185|531669801|FG003|Overall Study|Patient in hospice|0|||
147411059|NCT04020185|531669802|FG004|Overall Study|Patient in hospice|0|||
147411060|NCT04020185|531669803|FG005|Overall Study|Patient in hospice|0|||
147411061|NCT04020185|531669804|FG006|Overall Study|Patient in hospice|0|||
147411062|NCT04020185|531669805|FG007|Overall Study|Patient in hospice|0|||
147411063|NCT04020185|531669798|FG000|Overall Study|Continuing on expanded access|0|||
147411064|NCT04020185|531669799|FG001|Overall Study|Continuing on expanded access|0|||
147411065|NCT04020185|531669800|FG002|Overall Study|Continuing on expanded access|0|||
147411066|NCT04020185|531669801|FG003|Overall Study|Continuing on expanded access|0|||
147411067|NCT04020185|531669802|FG004|Overall Study|Continuing on expanded access|0|||
147411068|NCT04020185|531669803|FG005|Overall Study|Continuing on expanded access|0|||
147411069|NCT04020185|531669804|FG006|Overall Study|Continuing on expanded access|1|||
147411070|NCT04020185|531669805|FG007|Overall Study|Continuing on expanded access|1|||
147411071|NCT02643303|531669807|FG000|Overall Study|Progressive Disease|4|||
147411072|NCT02643303|531669808|FG001|Overall Study|Progressive Disease|4|||
147411073|NCT02643303|531669809|FG002|Overall Study|Progressive Disease|1|||
147411074|NCT02643303|531669810|FG003|Overall Study|Progressive Disease|12|||
147411075|NCT02643303|531669811|FG004|Overall Study|Progressive Disease|6|||
147411076|NCT02643303|531669812|FG005|Overall Study|Progressive Disease|4|||
147411077|NCT02643303|531669813|FG006|Overall Study|Progressive Disease|8|||
147411078|NCT02643303|531669814|FG007|Overall Study|Progressive Disease|2|||
147411079|NCT02643303|531669815|FG008|Overall Study|Progressive Disease|6|||
147411080|NCT02643303|531669807|FG000|Overall Study|Adverse Event|0|||
147411081|NCT02643303|531669808|FG001|Overall Study|Adverse Event|1|||
147411082|NCT02643303|531669809|FG002|Overall Study|Adverse Event|0|||
147411083|NCT02643303|531669810|FG003|Overall Study|Adverse Event|0|||
147411084|NCT02643303|531669811|FG004|Overall Study|Adverse Event|1|||
147411085|NCT02643303|531669812|FG005|Overall Study|Adverse Event|0|||
147411086|NCT02643303|531669813|FG006|Overall Study|Adverse Event|0|||
147411087|NCT02643303|531669814|FG007|Overall Study|Adverse Event|0|||
147411088|NCT02643303|531669815|FG008|Overall Study|Adverse Event|0|||
147411089|NCT02643303|531669807|FG000|Overall Study|Withdrawal by Subject|0|||
147411090|NCT02643303|531669808|FG001|Overall Study|Withdrawal by Subject|0|||
147411091|NCT02643303|531669809|FG002|Overall Study|Withdrawal by Subject|0|||
147411092|NCT02643303|531669810|FG003|Overall Study|Withdrawal by Subject|1|||
147411093|NCT02643303|531669811|FG004|Overall Study|Withdrawal by Subject|0|||
147411094|NCT02643303|531669812|FG005|Overall Study|Withdrawal by Subject|0|||
147411095|NCT02643303|531669813|FG006|Overall Study|Withdrawal by Subject|1|||
147411096|NCT02643303|531669814|FG007|Overall Study|Withdrawal by Subject|1|||
147411097|NCT02643303|531669815|FG008|Overall Study|Withdrawal by Subject|1|||
147411098|NCT00626197|531669818|FG000|Overall Study|Did not cooperate|2|||
147411099|NCT00626197|531669819|FG001|Overall Study|Did not cooperate|6|||
147411100|NCT00626197|531669820|FG002|Overall Study|Did not cooperate|1|||
147411101|NCT00626197|531669818|FG000|Overall Study|Failure to return|6|||
147411102|NCT00626197|531669819|FG001|Overall Study|Failure to return|5|||
147411103|NCT00626197|531669820|FG002|Overall Study|Failure to return|6|||
147411104|NCT00626197|531669818|FG000|Overall Study|Adverse event, serious fatal|3|||
147411105|NCT00626197|531669819|FG001|Overall Study|Adverse event, serious fatal|6|||
147411106|NCT00626197|531669820|FG002|Overall Study|Adverse event, serious fatal|6|||
147411107|NCT00626197|531669818|FG000|Overall Study|Adverse Event|1|||
147411108|NCT00626197|531669819|FG001|Overall Study|Adverse Event|1|||
147411109|NCT00626197|531669820|FG002|Overall Study|Adverse Event|2|||
147411110|NCT00626197|531669818|FG000|Overall Study|Withdrawal by Subject|17|||
147411111|NCT00626197|531669819|FG001|Overall Study|Withdrawal by Subject|17|||
147411112|NCT00626197|531669820|FG002|Overall Study|Withdrawal by Subject|7|||
147411113|NCT00626197|531669818|FG000|Overall Study|Administrative reasons|15|||
147411114|NCT00626197|531669819|FG001|Overall Study|Administrative reasons|19|||
147411115|NCT00626197|531669820|FG002|Overall Study|Administrative reasons|55|||
147411116|NCT04833127|531669821|FG000|Overall Study|Lost to Follow-up|1|||
147411117|NCT04833127|531669822|FG001|Overall Study|Lost to Follow-up|1|||
147411118|NCT04335591|531669827|FG000|Overall Study|Adverse Event|5|||
147411119|NCT04335591|531669828|FG001|Overall Study|Adverse Event|2|||
147411120|NCT04335591|531669829|FG002|Overall Study|Adverse Event|3|||
147411121|NCT04335591|531669830|FG003|Overall Study|Adverse Event|2|||
147411122|NCT04335591|531669827|FG000|Overall Study|Protocol Violation|1|||
147411123|NCT04335591|531669828|FG001|Overall Study|Protocol Violation|0|||
147411124|NCT04335591|531669829|FG002|Overall Study|Protocol Violation|0|||
147411125|NCT04335591|531669830|FG003|Overall Study|Protocol Violation|0|||
147411126|NCT04335591|531669827|FG000|Overall Study|Withdrawal by Subject|8|||
147411127|NCT04335591|531669828|FG001|Overall Study|Withdrawal by Subject|4|||
147411128|NCT04335591|531669829|FG002|Overall Study|Withdrawal by Subject|4|||
147411129|NCT04335591|531669830|FG003|Overall Study|Withdrawal by Subject|5|||
147411130|NCT04335591|531669827|FG000|Overall Study|Subject planning pregnancy|0|||
147411131|NCT04335591|531669828|FG001|Overall Study|Subject planning pregnancy|1|||
147411132|NCT04335591|531669829|FG002|Overall Study|Subject planning pregnancy|0|||
147411133|NCT04335591|531669830|FG003|Overall Study|Subject planning pregnancy|0|||
147411134|NCT04335591|531669827|FG000|Overall Study|Ukrainian Russian war conflict|4|||
147411135|NCT04335591|531669828|FG001|Overall Study|Ukrainian Russian war conflict|5|||
147411136|NCT04335591|531669829|FG002|Overall Study|Ukrainian Russian war conflict|2|||
147411137|NCT04335591|531669830|FG003|Overall Study|Ukrainian Russian war conflict|0|||
147411138|NCT05282121|531669831|FG000|Overall Study|Adverse Event|1|||
147411139|NCT05282121|531669832|FG001|Overall Study|Adverse Event|1|||
147411140|NCT05282121|531669833|FG002|Overall Study|Adverse Event|4|||
147411141|NCT05282121|531669834|FG003|Overall Study|Adverse Event|1|||
147411142|NCT05282121|531669831|FG000|Overall Study|Study Terminated by Sponsor|1|||
147411143|NCT05282121|531669832|FG001|Overall Study|Study Terminated by Sponsor|2|||
147411144|NCT05282121|531669833|FG002|Overall Study|Study Terminated by Sponsor|2|||
147411145|NCT05282121|531669834|FG003|Overall Study|Study Terminated by Sponsor|2|||
147468218|NCT01707992|531870481|FG005|Active Treatment Phase (24 Months)|Study terminated by sponsor|174|||
147468219|NCT01707992|531870476|FG000|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0|||
147468220|NCT01707992|531870477|FG001|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0|||
147468221|NCT01707992|531870478|FG002|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0|||
147468222|NCT01707992|531870479|FG003|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0|||
147468223|NCT01707992|531870480|FG004|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|4|||
147468224|NCT01707992|531870481|FG005|Active Treatment Phase (24 Months)|Participant withdrew per Sponsor request|0|||
147468225|NCT00998738|531870483|FG000|Overall Study|Uknown|1|||
147468226|NCT04211337|531870484|FG000|Overall Study|On Treatment|175|||
147468227|NCT04211337|531870485|FG001|Overall Study|On Treatment|40|||
147468228|NCT04211337|531870484|FG000|Overall Study|Withdrawal by Subject|0|||
147468229|NCT04211337|531870485|FG001|Overall Study|Withdrawal by Subject|2|||
147468230|NCT00960076|531872424|FG000|Overall Study|Adverse Event|1|||
147468231|NCT00960076|531872425|FG001|Overall Study|Adverse Event|7|||
147468232|NCT00960076|531872424|FG000|Overall Study|No longer met study criteria|1|||
147468233|NCT00960076|531872425|FG001|Overall Study|No longer met study criteria|5|||
147468234|NCT00960076|531872424|FG000|Overall Study|Withdrawal by Subject|1|||
147468235|NCT00960076|531872425|FG001|Overall Study|Withdrawal by Subject|2|||
147468236|NCT00960076|531872424|FG000|Overall Study|Lost to Follow-up|3|||
147468237|NCT00960076|531872425|FG001|Overall Study|Lost to Follow-up|3|||
147468238|NCT00960076|531872424|FG000|Overall Study|Severe non-compliance to protocol|1|||
147468239|NCT00960076|531872425|FG001|Overall Study|Severe non-compliance to protocol|2|||
147468240|NCT00960076|531872424|FG000|Overall Study|Hyperglycemia|1|||
147468241|NCT00960076|531872425|FG001|Overall Study|Hyperglycemia|5|||
147468242|NCT00960076|531872424|FG000|Overall Study|Did not attend the termination visit|0|||
147468243|NCT00960076|531872425|FG001|Overall Study|Did not attend the termination visit|1|||
147468244|NCT03124459|531872435|FG000|Phase 2- Randomized Doubled-blind|Adverse Event|0|||
147468245|NCT03124459|531872436|FG001|Phase 2- Randomized Doubled-blind|Adverse Event|0|||
147468246|NCT03124459|531872437|FG002|Phase 2- Randomized Doubled-blind|Adverse Event|0|||
147468247|NCT03124459|531872438|FG003|Phase 2- Randomized Doubled-blind|Adverse Event|0|||
147468248|NCT03124459|531872439|FG004|Phase 2- Randomized Doubled-blind|Adverse Event|2|||
147468249|NCT03124459|531872440|FG005|Phase 2- Randomized Doubled-blind|Adverse Event|0|||
147468250|NCT03124459|531872435|FG000|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0|||
147468251|NCT03124459|531872436|FG001|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0|||
147468252|NCT03124459|531872437|FG002|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0|||
147468253|NCT03124459|531872438|FG003|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0|||
147468254|NCT03124459|531872439|FG004|Phase 2- Randomized Doubled-blind|Lost to Follow-up|1|||
147468255|NCT03124459|531872440|FG005|Phase 2- Randomized Doubled-blind|Lost to Follow-up|0|||
147468256|NCT03124459|531872435|FG000|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|0|||
147468257|NCT03124459|531872436|FG001|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|0|||
147468258|NCT03124459|531872437|FG002|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|0|||
147468259|NCT03124459|531872438|FG003|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|11|||
147468260|NCT03124459|531872439|FG004|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|12|||
147468261|NCT03124459|531872440|FG005|Phase 2- Randomized Doubled-blind|Study terminated by Sponsor|0|||
147468262|NCT03124459|531872435|FG000|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|0|||
147468263|NCT03124459|531872436|FG001|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|0|||
147468264|NCT03124459|531872437|FG002|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|0|||
147468265|NCT03124459|531872438|FG003|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|1|||
147468266|NCT03124459|531872439|FG004|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|4|||
147468267|NCT03124459|531872440|FG005|Phase 2- Randomized Doubled-blind|Withdrawal by Subject|0|||
147468268|NCT03124459|531872435|FG000|Part 2- Open Label ACE-083|Study terminated by Sponsor|0|||
147468269|NCT03124459|531872436|FG001|Part 2- Open Label ACE-083|Study terminated by Sponsor|0|||
147468270|NCT03124459|531872437|FG002|Part 2- Open Label ACE-083|Study terminated by Sponsor|0|||
147468271|NCT03124459|531872438|FG003|Part 2- Open Label ACE-083|Study terminated by Sponsor|0|||
147468272|NCT03124459|531872439|FG004|Part 2- Open Label ACE-083|Study terminated by Sponsor|0|||
147468273|NCT03124459|531872440|FG005|Part 2- Open Label ACE-083|Study terminated by Sponsor|22|||
147468274|NCT03124459|531872435|FG000|Part 2- Open Label ACE-083|Withdrawal by Subject|0|||
147468275|NCT03124459|531872436|FG001|Part 2- Open Label ACE-083|Withdrawal by Subject|0|||
147618840|NCT00838526|532420888|FG000|Overall Study|Withdrawal by Subject|4|||
147618841|NCT00838526|532420889|FG001|Overall Study|Withdrawal by Subject|5|||
147618842|NCT00838526|532420888|FG000|Overall Study|Lack of Efficacy|2|||
147618843|NCT00838526|532420889|FG001|Overall Study|Lack of Efficacy|3|||
147618844|NCT00838526|532420888|FG000|Overall Study|Other|11|||
147618845|NCT00838526|532420889|FG001|Overall Study|Other|7|||
147618846|NCT04338022|532420899|FG000|Double-blind Treatment Period: 156 Weeks|Adverse Event|56|||
147618847|NCT04338022|532420900|FG001|Double-blind Treatment Period: 156 Weeks|Adverse Event|72|||
147618848|NCT04338022|532420899|FG000|Double-blind Treatment Period: 156 Weeks|Lost to Follow-up|6|||
147618849|NCT04338022|532420900|FG001|Double-blind Treatment Period: 156 Weeks|Lost to Follow-up|5|||
147468276|NCT03124459|531872437|FG002|Part 2- Open Label ACE-083|Withdrawal by Subject|0|||
147468277|NCT03124459|531872438|FG003|Part 2- Open Label ACE-083|Withdrawal by Subject|0|||
147468278|NCT03124459|531872439|FG004|Part 2- Open Label ACE-083|Withdrawal by Subject|0|||
147468279|NCT03124459|531872440|FG005|Part 2- Open Label ACE-083|Withdrawal by Subject|1|||
147468280|NCT01903876|531872441|FG000|Baseline to Post-Intervention Period|Lost to Follow-up|184|||
147468281|NCT01903876|531872442|FG001|Baseline to Post-Intervention Period|Lost to Follow-up|108|||
147468282|NCT01903876|531872441|FG000|Six-Month Follow-up Period|Lost to Follow-up|91|||
147468283|NCT01903876|531872442|FG001|Six-Month Follow-up Period|Lost to Follow-up|145|||
147468284|NCT00278629|531872443|FG000|Overall Study|Non-CIDP Immune-Mediated Peripheral Neur|14|||
147468285|NCT00826748|531872446|FG000|Overall Study|Withdrawal by Subject|0|||
147468286|NCT00826748|531872447|FG001|Overall Study|Withdrawal by Subject|0|||
147468287|NCT00826748|531872448|FG002|Overall Study|Withdrawal by Subject|2|||
147468288|NCT00826748|531872446|FG000|Overall Study|Physician Decision|0|||
147468289|NCT00826748|531872447|FG001|Overall Study|Physician Decision|0|||
147468290|NCT00826748|531872448|FG002|Overall Study|Physician Decision|1|||
147468291|NCT00826748|531872446|FG000|Overall Study|Samples Did Not pass QC|0|||
147468292|NCT00826748|531872447|FG001|Overall Study|Samples Did Not pass QC|0|||
147468293|NCT00826748|531872448|FG002|Overall Study|Samples Did Not pass QC|1|||
147468294|NCT00603239|531872449|FG000|Overall Study|Adverse Event|4|||
147468295|NCT00603239|531872450|FG001|Overall Study|Adverse Event|1|||
147468296|NCT00603239|531872449|FG000|Overall Study|Entry criteria not met|0|||
147468297|NCT00603239|531872450|FG001|Overall Study|Entry criteria not met|1|||
147468298|NCT00603239|531872449|FG000|Overall Study|Loss of glucose control|3|||
147468299|NCT00603239|531872450|FG001|Overall Study|Loss of glucose control|0|||
147468300|NCT00603239|531872449|FG000|Overall Study|Lost to Follow-up|2|||
147468301|NCT00603239|531872450|FG001|Overall Study|Lost to Follow-up|1|||
147468302|NCT00603239|531872449|FG000|Overall Study|Physician Decision|2|||
147468303|NCT00603239|531872450|FG001|Overall Study|Physician Decision|0|||
147468304|NCT00603239|531872449|FG000|Overall Study|Protocol Violation|2|||
147468305|NCT00603239|531872450|FG001|Overall Study|Protocol Violation|0|||
147468306|NCT00603239|531872449|FG000|Overall Study|Subject decision|2|||
147618850|NCT04338022|532420899|FG000|Double-blind Treatment Period: 156 Weeks|Lack of Efficacy|19|||
147618851|NCT04338022|532420900|FG001|Double-blind Treatment Period: 156 Weeks|Lack of Efficacy|23|||
147468307|NCT00603239|531872450|FG001|Overall Study|Subject decision|1|||
147468308|NCT03367871|531872451|FG000|Overall Study|Lost to Follow-up|1|||
147468309|NCT02013544|531872453|FG000|Overall Study|Adverse Event|5|||
147468310|NCT02013544|531872454|FG001|Overall Study|Adverse Event|5|||
147468311|NCT02013544|531872453|FG000|Overall Study|Lost to Follow-up|2|||
147468312|NCT02013544|531872454|FG001|Overall Study|Lost to Follow-up|3|||
147468313|NCT02013544|531872453|FG000|Overall Study|Withdrawal by Subject|2|||
147468314|NCT02013544|531872454|FG001|Overall Study|Withdrawal by Subject|8|||
147468315|NCT02013544|531872453|FG000|Overall Study|Physician Decision|0|||
147302723|NCT02748694|531274427|FG006|Overall Study|Voluntary Withdrawal|0|||
147302724|NCT02748694|531274428|FG007|Overall Study|Voluntary Withdrawal|0|||
147302725|NCT02748694|531274429|FG008|Overall Study|Voluntary Withdrawal|0|||
147302726|NCT02748694|531274430|FG009|Overall Study|Voluntary Withdrawal|0|||
147302727|NCT02748694|531274431|FG010|Overall Study|Voluntary Withdrawal|0|||
147302728|NCT02748694|531274432|FG011|Overall Study|Voluntary Withdrawal|0|||
147302729|NCT02748694|531274433|FG012|Overall Study|Voluntary Withdrawal|0|||
147302730|NCT02748694|531274434|FG013|Overall Study|Voluntary Withdrawal|0|||
147302731|NCT02748694|531274435|FG014|Overall Study|Voluntary Withdrawal|2|||
147302732|NCT00659984|531274438|FG000|Overall Study|Adverse Event|1|||
147302733|NCT04026165|531274441|FG000|Run-in Placebo Period|Enrollment Error|13|||
147302734|NCT04026165|531274442|FG001|Run-in Placebo Period|Enrollment Error|0|||
147302735|NCT04026165|531274443|FG002|Run-in Placebo Period|Enrollment Error|0|||
147302736|NCT04026165|531274444|FG003|Run-in Placebo Period|Enrollment Error|0|||
147302737|NCT04026165|531274441|FG000|Run-in Placebo Period|Run-in Failure|4|||
147302738|NCT04026165|531274442|FG001|Run-in Placebo Period|Run-in Failure|0|||
147302739|NCT04026165|531274443|FG002|Run-in Placebo Period|Run-in Failure|0|||
147302740|NCT04026165|531274444|FG003|Run-in Placebo Period|Run-in Failure|0|||
147302741|NCT04026165|531274441|FG000|Run-in Placebo Period|Protocol Violation|2|||
147302742|NCT04026165|531274442|FG001|Run-in Placebo Period|Protocol Violation|0|||
147302743|NCT04026165|531274443|FG002|Run-in Placebo Period|Protocol Violation|0|||
147302744|NCT04026165|531274444|FG003|Run-in Placebo Period|Protocol Violation|0|||
147302745|NCT04026165|531274441|FG000|Run-in Placebo Period|Withdrew Consent|2|||
147302746|NCT04026165|531274442|FG001|Run-in Placebo Period|Withdrew Consent|0|||
147302747|NCT04026165|531274443|FG002|Run-in Placebo Period|Withdrew Consent|0|||
147302748|NCT04026165|531274444|FG003|Run-in Placebo Period|Withdrew Consent|0|||
147302749|NCT04026165|531274441|FG000|Run-in Placebo Period|Significant Non-Compliance with Study Drug|1|||
147468316|NCT02013544|531872454|FG001|Overall Study|Physician Decision|1|||
147468317|NCT02013544|531872453|FG000|Overall Study|Entry criteria not met/non-compliance|2|||
147468318|NCT02013544|531872454|FG001|Overall Study|Entry criteria not met/non-compliance|3|||
147468319|NCT03514914|531872455|FG000|Overall Study|Death|3|||
147468320|NCT03514914|531872456|FG001|Overall Study|Death|3|||
147618852|NCT04338022|532420899|FG000|Double-blind Treatment Period: 156 Weeks|Withdrawal by Subject|56|||
147411146|NCT05282121|531669831|FG000|Overall Study|Other than listed|0|||
147411147|NCT05282121|531669832|FG001|Overall Study|Other than listed|0|||
147411148|NCT05282121|531669833|FG002|Overall Study|Other than listed|1|||
147302750|NCT04026165|531274442|FG001|Run-in Placebo Period|Significant Non-Compliance with Study Drug|0|||
147302751|NCT04026165|531274443|FG002|Run-in Placebo Period|Significant Non-Compliance with Study Drug|0|||
147302752|NCT04026165|531274444|FG003|Run-in Placebo Period|Significant Non-Compliance with Study Drug|0|||
147302753|NCT04026165|531274441|FG000|Run-in SEL Period|Run-in Failure|0|||
147302754|NCT04026165|531274442|FG001|Run-in SEL Period|Run-in Failure|26|||
147302755|NCT04026165|531274443|FG002|Run-in SEL Period|Run-in Failure|0|||
147302756|NCT04026165|531274444|FG003|Run-in SEL Period|Run-in Failure|0|||
147302757|NCT04026165|531274441|FG000|Run-in SEL Period|Withdrew Consent|0|||
147302758|NCT04026165|531274442|FG001|Run-in SEL Period|Withdrew Consent|10|||
147302759|NCT04026165|531274443|FG002|Run-in SEL Period|Withdrew Consent|0|||
147302760|NCT04026165|531274444|FG003|Run-in SEL Period|Withdrew Consent|0|||
147302761|NCT04026165|531274441|FG000|Run-in SEL Period|Enrollment Error|0|||
147302762|NCT04026165|531274442|FG001|Run-in SEL Period|Enrollment Error|4|||
147302763|NCT04026165|531274443|FG002|Run-in SEL Period|Enrollment Error|0|||
147302764|NCT04026165|531274444|FG003|Run-in SEL Period|Enrollment Error|0|||
147302765|NCT04026165|531274441|FG000|Run-in SEL Period|Protocol Violation|0|||
147302766|NCT04026165|531274442|FG001|Run-in SEL Period|Protocol Violation|3|||
147302767|NCT04026165|531274443|FG002|Run-in SEL Period|Protocol Violation|0|||
147302768|NCT04026165|531274444|FG003|Run-in SEL Period|Protocol Violation|0|||
147302769|NCT04026165|531274441|FG000|Run-in SEL Period|Investigator's Discretion|0|||
147302770|NCT04026165|531274442|FG001|Run-in SEL Period|Investigator's Discretion|2|||
147302771|NCT04026165|531274443|FG002|Run-in SEL Period|Investigator's Discretion|0|||
147302772|NCT04026165|531274444|FG003|Run-in SEL Period|Investigator's Discretion|0|||
147302773|NCT04026165|531274441|FG000|Run-in SEL Period|Death|0|||
147302774|NCT04026165|531274442|FG001|Run-in SEL Period|Death|1|||
147302775|NCT04026165|531274443|FG002|Run-in SEL Period|Death|0|||
147302776|NCT04026165|531274444|FG003|Run-in SEL Period|Death|0|||
147302777|NCT04026165|531274441|FG000|Randomized Period|Withdrew Consent|0|||
147302778|NCT04026165|531274442|FG001|Randomized Period|Withdrew Consent|0|||
147302779|NCT04026165|531274443|FG002|Randomized Period|Withdrew Consent|5|||
147302780|NCT04026165|531274444|FG003|Randomized Period|Withdrew Consent|8|||
147302781|NCT04026165|531274441|FG000|Randomized Period|Death|0|||
147302782|NCT04026165|531274442|FG001|Randomized Period|Death|0|||
147302783|NCT04026165|531274443|FG002|Randomized Period|Death|5|||
147302784|NCT04026165|531274444|FG003|Randomized Period|Death|7|||
147302785|NCT04026165|531274441|FG000|Randomized Period|Investigator's Discretion|0|||
147302786|NCT04026165|531274442|FG001|Randomized Period|Investigator's Discretion|0|||
147302787|NCT04026165|531274443|FG002|Randomized Period|Investigator's Discretion|2|||
147302788|NCT04026165|531274444|FG003|Randomized Period|Investigator's Discretion|2|||
147302789|NCT04026165|531274441|FG000|Randomized Period|Lost to Follow-up|0|||
147302790|NCT04026165|531274442|FG001|Randomized Period|Lost to Follow-up|0|||
147302791|NCT04026165|531274443|FG002|Randomized Period|Lost to Follow-up|2|||
147302792|NCT04026165|531274444|FG003|Randomized Period|Lost to Follow-up|2|||
147302793|NCT01059630|531274445|FG000|Overall Study|Death|100|||
147302794|NCT01059630|531274446|FG001|Overall Study|Death|84|||
147302795|NCT01059630|531274445|FG000|Overall Study|Lost to Follow-up|4|||
147302796|NCT01059630|531274446|FG001|Overall Study|Lost to Follow-up|1|||
147302797|NCT01059630|531274445|FG000|Overall Study|Physician Decision|2|||
147302798|NCT01059630|531274446|FG001|Overall Study|Physician Decision|4|||
147302799|NCT01059630|531274445|FG000|Overall Study|Withdrawal by Subject|21|||
147302800|NCT01059630|531274446|FG001|Overall Study|Withdrawal by Subject|14|||
147302801|NCT03170375|531274447|FG000|Phase 1 - 4 Weeks|Withdrawal by Subject|5|||
147302802|NCT03170375|531274448|FG001|Phase 1 - 4 Weeks|Withdrawal by Subject|0|||
147302803|NCT03170375|531274449|FG002|Phase 1 - 4 Weeks|Withdrawal by Subject|0|||
147302804|NCT03170375|531274447|FG000|Phase 2 - 6 Months|Withdrawal by Subject|0|||
147302805|NCT03170375|531274448|FG001|Phase 2 - 6 Months|Withdrawal by Subject|3|||
147302806|NCT03170375|531274449|FG002|Phase 2 - 6 Months|Withdrawal by Subject|2|||
147302807|NCT00441701|531274450|FG000|Overall Study|Adverse Event|3|||
147302808|NCT00441701|531274451|FG001|Overall Study|Adverse Event|2|||
147302809|NCT00441701|531274452|FG002|Overall Study|Adverse Event|1|||
147302810|NCT00441701|531274453|FG003|Overall Study|Adverse Event|0|||
147302811|NCT00441701|531274454|FG004|Overall Study|Adverse Event|2|||
147302812|NCT00441701|531274455|FG005|Overall Study|Adverse Event|2|||
147302813|NCT00441701|531274456|FG006|Overall Study|Adverse Event|0|||
147302814|NCT00441701|531274457|FG007|Overall Study|Adverse Event|0|||
147302815|NCT00441701|531274458|FG008|Overall Study|Adverse Event|0|||
147302816|NCT00441701|531274459|FG009|Overall Study|Adverse Event|0|||
147302817|NCT00441701|531274450|FG000|Overall Study|Lack of Efficacy|2|||
147302818|NCT00441701|531274451|FG001|Overall Study|Lack of Efficacy|0|||
147302819|NCT00441701|531274452|FG002|Overall Study|Lack of Efficacy|2|||
147302820|NCT00441701|531274453|FG003|Overall Study|Lack of Efficacy|2|||
147302821|NCT00441701|531274454|FG004|Overall Study|Lack of Efficacy|0|||
147302822|NCT00441701|531274455|FG005|Overall Study|Lack of Efficacy|1|||
147411149|NCT05282121|531669834|FG003|Overall Study|Other than listed|0|||
147302823|NCT00441701|531274456|FG006|Overall Study|Lack of Efficacy|0|||
147302824|NCT00441701|531274457|FG007|Overall Study|Lack of Efficacy|0|||
147302825|NCT00441701|531274458|FG008|Overall Study|Lack of Efficacy|0|||
147302826|NCT00441701|531274459|FG009|Overall Study|Lack of Efficacy|0|||
147302827|NCT00441701|531274450|FG000|Overall Study|Withdrawal by Subject|0|||
147302828|NCT00441701|531274451|FG001|Overall Study|Withdrawal by Subject|2|||
147302829|NCT00441701|531274452|FG002|Overall Study|Withdrawal by Subject|1|||
147302830|NCT00441701|531274453|FG003|Overall Study|Withdrawal by Subject|1|||
147302831|NCT00441701|531274454|FG004|Overall Study|Withdrawal by Subject|0|||
147302832|NCT00441701|531274455|FG005|Overall Study|Withdrawal by Subject|0|||
147302833|NCT00441701|531274456|FG006|Overall Study|Withdrawal by Subject|0|||
147302834|NCT00441701|531274457|FG007|Overall Study|Withdrawal by Subject|0|||
147302835|NCT00441701|531274458|FG008|Overall Study|Withdrawal by Subject|0|||
147302836|NCT00441701|531274459|FG009|Overall Study|Withdrawal by Subject|0|||
147302837|NCT00621543|531274463|FG000|Overall Study|Lost to Follow-up|23|||
147302838|NCT01287611|531274468|FG000|Overall Study|Lost to Follow-up|29|||
147302839|NCT01287611|531274469|FG001|Overall Study|Lost to Follow-up|16|||
147302840|NCT01287611|531274468|FG000|Overall Study|Exclusion due to expanded Kerr incision|4|||
147302841|NCT01287611|531274469|FG001|Overall Study|Exclusion due to expanded Kerr incision|3|||
147302842|NCT00763958|531274470|FG000|Overall Study|did not meet final criteria|4|||
147302843|NCT00763958|531274471|FG001|Overall Study|did not meet final criteria|4|||
147302844|NCT00763958|531274470|FG000|Overall Study|Lost to Follow-up|10|||
147302845|NCT00763958|531274471|FG001|Overall Study|Lost to Follow-up|2|||
147302846|NCT00763958|531274470|FG000|Overall Study|Believed they were receiving placebo|0|||
147302847|NCT00763958|531274471|FG001|Overall Study|Believed they were receiving placebo|5|||
147302848|NCT02192970|531274472|FG000|Overall Study|Lost to Follow-up|6|||
147302849|NCT02192970|531274473|FG001|Overall Study|Lost to Follow-up|0|||
147302850|NCT03299686|531274474|FG000|Treatment Epoch|Subject/Guardian Decision|2|||
147302851|NCT03299686|531274475|FG001|Treatment Epoch|Subject/Guardian Decision|0|||
147302852|NCT03299686|531274474|FG000|Treatment Epoch|Physician Decision|1|||
147302853|NCT03299686|531274475|FG001|Treatment Epoch|Physician Decision|0|||
147302854|NCT03299686|531274474|FG000|Treatment Epoch|Adverse Event|8|||
147302855|NCT03299686|531274475|FG001|Treatment Epoch|Adverse Event|4|||
147302856|NCT03299686|531274474|FG000|Follow-up Epoch|Subject/Guardian Decision|0|||
147302857|NCT03299686|531274475|FG001|Follow-up Epoch|Subject/Guardian Decision|1|||
147302858|NCT02709005|531274476|FG000|Overall Study|Lost to Follow-up|1|||
147302859|NCT02709005|531274477|FG001|Overall Study|Lost to Follow-up|1|||
147302860|NCT02709005|531274476|FG000|Overall Study|Withdrawal by Subject|3|||
147302861|NCT02709005|531274477|FG001|Overall Study|Withdrawal by Subject|0|||
147302862|NCT00499863|531274483|FG000|Overall Study|Lack of Efficacy|21|||
147302863|NCT00499863|531274484|FG001|Overall Study|Lack of Efficacy|27|||
147302864|NCT00499863|531274483|FG000|Overall Study|Protocol Violation|12|||
147302865|NCT00499863|531274484|FG001|Overall Study|Protocol Violation|7|||
147302866|NCT00499863|531274483|FG000|Overall Study|Withdrawal by Subject|6|||
147302867|NCT00499863|531274484|FG001|Overall Study|Withdrawal by Subject|4|||
147302868|NCT00499863|531274483|FG000|Overall Study|Adverse Event|8|||
147302869|NCT00499863|531274484|FG001|Overall Study|Adverse Event|2|||
147302870|NCT00499863|531274483|FG000|Overall Study|Sponsor decision|2|||
147302871|NCT00499863|531274484|FG001|Overall Study|Sponsor decision|2|||
147302872|NCT00499863|531274483|FG000|Overall Study|Lost to Follow-up|1|||
147302873|NCT00499863|531274484|FG001|Overall Study|Lost to Follow-up|1|||
147302874|NCT00691132|531274485|FG000|Overall Study|Adverse Event|2|||
147302875|NCT00691132|531274486|FG001|Overall Study|Adverse Event|3|||
147302876|NCT00691132|531274485|FG000|Overall Study|Withdrawal by Subject|10|||
147302877|NCT00691132|531274486|FG001|Overall Study|Withdrawal by Subject|10|||
147302878|NCT01060553|531274489|FG000|Overall Study|Lost to Follow-up|3|||
147302879|NCT01060553|531274490|FG001|Overall Study|Lost to Follow-up|5|||
147302880|NCT01060553|531274489|FG000|Overall Study|Withdrawal by Subject|5|||
147302881|NCT01060553|531274490|FG001|Overall Study|Withdrawal by Subject|5|||
147302882|NCT01060553|531274489|FG000|Overall Study|Lack of Efficacy|1|||
147302883|NCT01060553|531274490|FG001|Overall Study|Lack of Efficacy|0|||
147302884|NCT01498822|531274492|FG000|Overall Study|Protocol Violation|8|||
147302885|NCT01498822|531274493|FG001|Overall Study|Protocol Violation|4|||
147302886|NCT01498822|531274492|FG000|Overall Study|Other Reason|5|||
147302887|NCT01498822|531274493|FG001|Overall Study|Other Reason|2|||
147302888|NCT01498822|531274492|FG000|Overall Study|Lack of Efficacy|7|||
147302889|NCT01498822|531274493|FG001|Overall Study|Lack of Efficacy|2|||
147302890|NCT01498822|531274492|FG000|Overall Study|AE, non-serious non-fatal|8|||
147302891|NCT01498822|531274493|FG001|Overall Study|AE, non-serious non-fatal|17|||
147302892|NCT01498822|531274492|FG000|Overall Study|SAE, non-fatal|2|||
147302893|NCT01498822|531274493|FG001|Overall Study|SAE, non-fatal|2|||
147302894|NCT01498822|531274492|FG000|Overall Study|Adverse Event, serious fatal|1|||
147302895|NCT01498822|531274493|FG001|Overall Study|Adverse Event, serious fatal|1|||
147302896|NCT01498822|531274492|FG000|Overall Study|Withdrawal by Subject|15|||
147302897|NCT01498822|531274493|FG001|Overall Study|Withdrawal by Subject|25|||
147302898|NCT01498822|531274492|FG000|Overall Study|Lost to Follow-up|8|||
147302899|NCT01498822|531274493|FG001|Overall Study|Lost to Follow-up|3|||
147411150|NCT05282121|531669831|FG000|Overall Study|No reason available|0|||
147411151|NCT05282121|531669832|FG001|Overall Study|No reason available|0|||
147411152|NCT05282121|531669833|FG002|Overall Study|No reason available|1|||
147411153|NCT05282121|531669834|FG003|Overall Study|No reason available|0|||
147411154|NCT00461981|531669839|FG000|Overall Study|Lost to Follow-up|9|||
147411155|NCT00461981|531669840|FG001|Overall Study|Lost to Follow-up|6|||
147411156|NCT00461981|531669839|FG000|Overall Study|Withdrawal by Subject|2|||
147411157|NCT00461981|531669840|FG001|Overall Study|Withdrawal by Subject|3|||
147411158|NCT01077128|531669846|FG000|Overall Study|Adverse Event|8|||
147411159|NCT01077128|531669846|FG000|Overall Study|Lack of Efficacy|1|||
147411160|NCT01077128|531669846|FG000|Overall Study|Disease exacerbation|1|||
147411161|NCT01077128|531669846|FG000|Overall Study|Adverse event and consent withdrawal|1|||
147411162|NCT01077128|531669846|FG000|Overall Study|Adverse event and disease exacerbation|1|||
147411163|NCT01077128|531669846|FG000|Overall Study|Lack of efficacy/disease exacerbation|1|||
147411164|NCT01077128|531669846|FG000|Overall Study|Other|54|||
147411165|NCT00847626|531669847|FG000|Overall Study|Adverse Event|10|||
147411166|NCT00847626|531669848|FG001|Overall Study|Adverse Event|10|||
147411167|NCT00847626|531669849|FG002|Overall Study|Adverse Event|6|||
147411168|NCT00847626|531669850|FG003|Overall Study|Adverse Event|19|||
147411169|NCT00847626|531669851|FG004|Overall Study|Adverse Event|11|||
147411170|NCT00847626|531669852|FG005|Overall Study|Adverse Event|22|||
147411171|NCT00847626|531669853|FG006|Overall Study|Adverse Event|4|||
147411172|NCT00847626|531669854|FG007|Overall Study|Adverse Event|6|||
147411173|NCT00847626|531669855|FG008|Overall Study|Adverse Event|3|||
147411174|NCT00847626|531669856|FG009|Overall Study|Adverse Event|6|||
147411175|NCT00847626|531669857|FG010|Overall Study|Adverse Event|6|||
147411176|NCT00847626|531669847|FG000|Overall Study|Protocol Violation|2|||
147411177|NCT00847626|531669848|FG001|Overall Study|Protocol Violation|1|||
147411178|NCT00847626|531669849|FG002|Overall Study|Protocol Violation|2|||
147411179|NCT00847626|531669850|FG003|Overall Study|Protocol Violation|1|||
147411180|NCT00847626|531669851|FG004|Overall Study|Protocol Violation|1|||
147411181|NCT00847626|531669852|FG005|Overall Study|Protocol Violation|1|||
147411182|NCT00847626|531669853|FG006|Overall Study|Protocol Violation|1|||
147411183|NCT00847626|531669854|FG007|Overall Study|Protocol Violation|1|||
147411184|NCT00847626|531669855|FG008|Overall Study|Protocol Violation|0|||
147411185|NCT00847626|531669856|FG009|Overall Study|Protocol Violation|1|||
147411186|NCT00847626|531669857|FG010|Overall Study|Protocol Violation|1|||
147411187|NCT00847626|531669847|FG000|Overall Study|Lost to Follow-up|0|||
147411188|NCT00847626|531669848|FG001|Overall Study|Lost to Follow-up|1|||
147411189|NCT00847626|531669849|FG002|Overall Study|Lost to Follow-up|1|||
147411190|NCT00847626|531669850|FG003|Overall Study|Lost to Follow-up|1|||
147411191|NCT00847626|531669851|FG004|Overall Study|Lost to Follow-up|0|||
147411192|NCT00847626|531669852|FG005|Overall Study|Lost to Follow-up|3|||
147411193|NCT00847626|531669853|FG006|Overall Study|Lost to Follow-up|1|||
147411194|NCT00847626|531669854|FG007|Overall Study|Lost to Follow-up|3|||
147411195|NCT00847626|531669855|FG008|Overall Study|Lost to Follow-up|1|||
147411196|NCT00847626|531669856|FG009|Overall Study|Lost to Follow-up|0|||
147411197|NCT00847626|531669857|FG010|Overall Study|Lost to Follow-up|1|||
147411198|NCT00847626|531669847|FG000|Overall Study|Withdrawal by Subject|5|||
147411199|NCT00847626|531669848|FG001|Overall Study|Withdrawal by Subject|5|||
147411200|NCT00847626|531669849|FG002|Overall Study|Withdrawal by Subject|3|||
147411201|NCT00847626|531669850|FG003|Overall Study|Withdrawal by Subject|8|||
147411202|NCT00847626|531669851|FG004|Overall Study|Withdrawal by Subject|12|||
147411203|NCT00847626|531669852|FG005|Overall Study|Withdrawal by Subject|9|||
147411204|NCT00847626|531669853|FG006|Overall Study|Withdrawal by Subject|8|||
147411205|NCT00847626|531669854|FG007|Overall Study|Withdrawal by Subject|4|||
147411206|NCT00847626|531669855|FG008|Overall Study|Withdrawal by Subject|4|||
147411207|NCT00847626|531669856|FG009|Overall Study|Withdrawal by Subject|5|||
147411208|NCT00847626|531669857|FG010|Overall Study|Withdrawal by Subject|2|||
147411209|NCT00847626|531669847|FG000|Overall Study|Lack of Efficacy|3|||
147411210|NCT00847626|531669848|FG001|Overall Study|Lack of Efficacy|1|||
147411211|NCT00847626|531669849|FG002|Overall Study|Lack of Efficacy|0|||
147411212|NCT00847626|531669850|FG003|Overall Study|Lack of Efficacy|1|||
147411213|NCT00847626|531669851|FG004|Overall Study|Lack of Efficacy|2|||
147411214|NCT00847626|531669852|FG005|Overall Study|Lack of Efficacy|0|||
147411215|NCT00847626|531669853|FG006|Overall Study|Lack of Efficacy|6|||
147411216|NCT00847626|531669854|FG007|Overall Study|Lack of Efficacy|2|||
147411217|NCT00847626|531669855|FG008|Overall Study|Lack of Efficacy|5|||
147411218|NCT00847626|531669856|FG009|Overall Study|Lack of Efficacy|1|||
147411219|NCT00847626|531669857|FG010|Overall Study|Lack of Efficacy|7|||
147411220|NCT00847626|531669847|FG000|Overall Study|Other|1|||
147411221|NCT00847626|531669848|FG001|Overall Study|Other|5|||
147411222|NCT00847626|531669849|FG002|Overall Study|Other|4|||
147411223|NCT00847626|531669850|FG003|Overall Study|Other|1|||
147411224|NCT00847626|531669851|FG004|Overall Study|Other|2|||
147411225|NCT00847626|531669852|FG005|Overall Study|Other|2|||
147411226|NCT00847626|531669853|FG006|Overall Study|Other|2|||
147411227|NCT00847626|531669854|FG007|Overall Study|Other|3|||
147411228|NCT00847626|531669855|FG008|Overall Study|Other|1|||
147411229|NCT00847626|531669856|FG009|Overall Study|Other|1|||
147411230|NCT00847626|531669857|FG010|Overall Study|Other|3|||
147618853|NCT04338022|532420900|FG001|Double-blind Treatment Period: 156 Weeks|Withdrawal by Subject|55|||
147618854|NCT04338022|532420899|FG000|Double-blind Treatment Period: 156 Weeks|Death|1|||
147618855|NCT04338022|532420900|FG001|Double-blind Treatment Period: 156 Weeks|Death|1|||
147618856|NCT04338022|532420899|FG000|Double-blind Treatment Period: 156 Weeks|Protocol Non-Compliance|5|||
147618857|NCT04338022|532420900|FG001|Double-blind Treatment Period: 156 Weeks|Protocol Non-Compliance|5|||
147618858|NCT04338022|532420899|FG000|Double-blind Treatment Period: 156 Weeks|Other Reason|24|||
147618859|NCT04338022|532420900|FG001|Double-blind Treatment Period: 156 Weeks|Other Reason|14|||
147618860|NCT04338022|532420899|FG000|Double-blind Treatment Period: 156 Weeks|Randomized, but not treated|1|||
147411231|NCT03031496|531669860|FG000|Period 1|Adverse Event|2|||
147411232|NCT03031496|531669861|FG001|Period 1|Adverse Event|0|||
147411233|NCT03031496|531669860|FG000|Period 1|Withdrawal by Subject|0|||
147411234|NCT03031496|531669861|FG001|Period 1|Withdrawal by Subject|2|||
147411235|NCT02979249|531669863|FG000|Overall Study|Lost to Follow-up|2|||
147411236|NCT02979249|531669863|FG000|Overall Study|Withdrawal by Subject|4|||
147411237|NCT01125046|531669864|FG000|First 6 Months of Treatment|Death|1|||
147411238|NCT01125046|531669864|FG000|First 6 Months of Treatment|Withdrawal by Subject|2|||
147411239|NCT01125046|531669864|FG000|First 6 Months of Treatment|Non-compliance|1|||
147411240|NCT01125046|531669864|FG000|First 6 Months of Treatment|Surgery|1|||
147411241|NCT01125046|531669864|FG000|First 6 Months of Treatment|Progressive Disease|7|||
147411242|NCT01125046|531669864|FG000|First 6 Months of Treatment|Adverse Event|2|||
147411243|NCT01125046|531669864|FG000|Continued Treatment After 6 Months|Progressive Disease|2|||
147411244|NCT01125046|531669864|FG000|Continued Treatment After 6 Months|Adverse Event|1|||
147411245|NCT01125046|531669864|FG000|Follow-up/Data Cut Off Point|Death|29|||
147411246|NCT01125046|531669864|FG000|Follow-up/Data Cut Off Point|Lost to Follow-up|4|||
147411247|NCT03868787|531669865|FG000|Overall Study|Withdrawal by Subject|2|||
147411248|NCT03868787|531669866|FG001|Overall Study|Withdrawal by Subject|1|||
147411249|NCT01399697|531669867|FG000|Overall Study|Adverse Event|13|||
147411250|NCT01399697|531669868|FG001|Overall Study|Adverse Event|3|||
147411251|NCT01399697|531669869|FG002|Overall Study|Adverse Event|1|||
147411252|NCT01399697|531669867|FG000|Overall Study|Lost to Follow-up|2|||
147411253|NCT01399697|531669868|FG001|Overall Study|Lost to Follow-up|0|||
147411254|NCT01399697|531669869|FG002|Overall Study|Lost to Follow-up|0|||
147411255|NCT01399697|531669867|FG000|Overall Study|Withdrawal by Subject|8|||
147411256|NCT01399697|531669868|FG001|Overall Study|Withdrawal by Subject|0|||
147411257|NCT01399697|531669869|FG002|Overall Study|Withdrawal by Subject|0|||
147411258|NCT01399697|531669867|FG000|Overall Study|Investigator Decisión|1|||
147411259|NCT01399697|531669868|FG001|Overall Study|Investigator Decisión|0|||
147411260|NCT01399697|531669869|FG002|Overall Study|Investigator Decisión|2|||
147411261|NCT01399697|531669867|FG000|Overall Study|Lack of Efficacy|9|||
147411262|NCT01399697|531669868|FG001|Overall Study|Lack of Efficacy|0|||
147411263|NCT01399697|531669869|FG002|Overall Study|Lack of Efficacy|1|||
147411264|NCT01399697|531669867|FG000|Overall Study|Protocol Violation|2|||
147411265|NCT01399697|531669868|FG001|Overall Study|Protocol Violation|0|||
147411266|NCT01399697|531669869|FG002|Overall Study|Protocol Violation|0|||
147411267|NCT01399697|531669867|FG000|Overall Study|Non-Compliant|1|||
147411268|NCT01399697|531669868|FG001|Overall Study|Non-Compliant|0|||
147411269|NCT01399697|531669869|FG002|Overall Study|Non-Compliant|0|||
147411270|NCT01399697|531669867|FG000|Overall Study|Inclusion Error|2|||
147411271|NCT01399697|531669868|FG001|Overall Study|Inclusion Error|0|||
147411272|NCT01399697|531669869|FG002|Overall Study|Inclusion Error|0|||
147411273|NCT01399697|531669867|FG000|Overall Study|Positive result for hepatitis B|1|||
147411274|NCT01399697|531669868|FG001|Overall Study|Positive result for hepatitis B|0|||
147411275|NCT01399697|531669869|FG002|Overall Study|Positive result for hepatitis B|0|||
147411276|NCT01399697|531669867|FG000|Overall Study|Clinical RA remission|1|||
147411277|NCT01399697|531669868|FG001|Overall Study|Clinical RA remission|0|||
147411278|NCT01399697|531669869|FG002|Overall Study|Clinical RA remission|0|||
147411279|NCT01399697|531669867|FG000|Overall Study|Sponsor Decision|1|||
147411280|NCT01399697|531669868|FG001|Overall Study|Sponsor Decision|0|||
147411281|NCT01399697|531669869|FG002|Overall Study|Sponsor Decision|0|||
147411282|NCT02510040|531669870|FG000|Overall Study|Deemed no longer eligible|18|||
147411283|NCT02510040|531669871|FG001|Overall Study|Deemed no longer eligible|3|||
147411284|NCT02510040|531669872|FG002|Overall Study|Deemed no longer eligible|1|||
147411285|NCT00967005|531669874|FG000|Overall Study|Lost to Follow-up|7|||
147411286|NCT00967005|531669875|FG001|Overall Study|Lost to Follow-up|10|||
147644024|NCT01032070|532516700|FG000|Overall Study|Medical or ethical reasons|0|||
147411287|NCT01401153|531669880|FG000|First Test Day|Learning disabilities; illness|1|||
147411288|NCT01401153|531669881|FG001|First Test Day|Learning disabilities; illness|10|||
147411289|NCT01401153|531669880|FG000|Second Test Day|illness|0|||
147411290|NCT01401153|531669881|FG001|Second Test Day|illness|5|||
147411291|NCT01818531|531669884|FG000|Overall Study|Withdrawn for case delay after block|1|||
147411292|NCT01818531|531669885|FG001|Overall Study|Withdrawn for case delay after block|0|||
147411293|NCT01818531|531669884|FG000|Overall Study|Withdrawn for long-acting opioid patch|0|||
147411294|NCT01818531|531669885|FG001|Overall Study|Withdrawn for long-acting opioid patch|1|||
147411295|NCT01818531|531669884|FG000|Overall Study|Withdrawn for failure to place block|0|||
147644025|NCT01032070|532516701|FG001|Overall Study|Medical or ethical reasons|2|||
147618861|NCT04338022|532420900|FG001|Double-blind Treatment Period: 156 Weeks|Randomized, but not treated|1|||
147618862|NCT04338022|532420899|FG000|Double-blind Extension: 96 Weeks|Lack of Efficacy|1|||
147618863|NCT04338022|532420900|FG001|Double-blind Extension: 96 Weeks|Lack of Efficacy|2|||
147618864|NCT04338022|532420899|FG000|Double-blind Extension: 96 Weeks|Withdrawal by Subject|0|||
147618865|NCT04338022|532420900|FG001|Double-blind Extension: 96 Weeks|Withdrawal by Subject|1|||
147618866|NCT04338022|532420899|FG000|Double-blind Extension: 96 Weeks|Adverse Event|2|||
147618867|NCT04338022|532420900|FG001|Double-blind Extension: 96 Weeks|Adverse Event|0|||
147618868|NCT04338022|532420899|FG000|Double-blind Extension: 96 Weeks|Lost to Follow-up|0|||
147618869|NCT04338022|532420900|FG001|Double-blind Extension: 96 Weeks|Lost to Follow-up|1|||
147618870|NCT04338022|532420899|FG000|Double-blind Extension: 96 Weeks|Other Reason|3|||
147618871|NCT04338022|532420900|FG001|Double-blind Extension: 96 Weeks|Other Reason|9|||
147618872|NCT04338022|532420899|FG000|Open Label Extension: 96 Weeks|Study Termination|0|||
147618873|NCT04338022|532420900|FG001|Open Label Extension: 96 Weeks|Study Termination|3|||
147618874|NCT02466321|532420901|FG000|Overall Study|Death|26|||
147618875|NCT02466321|532420901|FG000|Overall Study|Revision|6|||
147618876|NCT02466321|532420901|FG000|Overall Study|Lost to Follow-up|60|||
147618877|NCT02466321|532420901|FG000|Overall Study|Did not receive study device|1|||
147618878|NCT02189837|532420902|FG000|Overall Study|Withdrawal by Subject|2|||
147618879|NCT02189837|532420903|FG001|Overall Study|Withdrawal by Subject|1|||
147618880|NCT02189837|532420904|FG002|Overall Study|Withdrawal by Subject|3|||
147618881|NCT02189837|532420905|FG003|Overall Study|Withdrawal by Subject|1|||
147618882|NCT02189837|532420902|FG000|Overall Study|Sponsor Decision|0|||
147618883|NCT02189837|532420903|FG001|Overall Study|Sponsor Decision|0|||
147618884|NCT02189837|532420904|FG002|Overall Study|Sponsor Decision|0|||
147618885|NCT02189837|532420905|FG003|Overall Study|Sponsor Decision|1|||
147618886|NCT02198963|532420909|FG000|Overall Study|Adverse Event|1|||
147618887|NCT02198963|532420909|FG000|Overall Study|Withdrawal by Subject|6|||
147618888|NCT01876446|532420910|FG000|Overall Study|Death|0|||
147618889|NCT01876446|532420911|FG001|Overall Study|Death|1|||
147618890|NCT01876446|532420910|FG000|Overall Study|Withdrawal by Subject|1|||
147618891|NCT01876446|532420911|FG001|Overall Study|Withdrawal by Subject|2|||
147618892|NCT01876446|532420910|FG000|Overall Study|Physician Decision|1|||
147618893|NCT01876446|532420911|FG001|Overall Study|Physician Decision|3|||
147618894|NCT00683657|532420918|FG000|Overall Study|Adverse Event|0|||
147618895|NCT00683657|532420919|FG001|Overall Study|Adverse Event|1|||
147618896|NCT00683657|532420918|FG000|Overall Study|Subject Withdrew Consent|1|||
147618897|NCT00683657|532420919|FG001|Overall Study|Subject Withdrew Consent|0|||
147618898|NCT03200717|532420925|FG000|Overall Study|Progressive disease|24|||
147618899|NCT03200717|532420926|FG001|Overall Study|Progressive disease|5|||
147618900|NCT03200717|532420925|FG000|Overall Study|Adverse Event|11|||
147618901|NCT03200717|532420926|FG001|Overall Study|Adverse Event|8|||
147618902|NCT03200717|532420925|FG000|Overall Study|Physician Decision|3|||
147618903|NCT03200717|532420926|FG001|Overall Study|Physician Decision|2|||
147618904|NCT03200717|532420925|FG000|Overall Study|Death|2|||
147618905|NCT03200717|532420926|FG001|Overall Study|Death|0|||
147618906|NCT03200717|532420925|FG000|Overall Study|Subject/Guardian Decision|1|||
147618907|NCT03200717|532420926|FG001|Overall Study|Subject/Guardian Decision|0|||
147618908|NCT03629184|532420927|FG000|Overall Study|Withdrawal by Subject|2|||
147618909|NCT03629184|532420928|FG001|Overall Study|Withdrawal by Subject|1|||
147618910|NCT03629184|532420927|FG000|Overall Study|Physician Decision|1|||
147618911|NCT03629184|532420928|FG001|Overall Study|Physician Decision|0|||
147618912|NCT01461538|532420929|FG000|Overall Study|Death|15|||
147618913|NCT01461538|532420930|FG001|Overall Study|Death|6|||
147618914|NCT01461538|532420931|FG002|Overall Study|Death|2|||
147618915|NCT01461538|532420929|FG000|Overall Study|Study Stopped by Sponsor|2|||
147618916|NCT01461538|532420930|FG001|Overall Study|Study Stopped by Sponsor|1|||
147618917|NCT01461538|532420931|FG002|Overall Study|Study Stopped by Sponsor|0|||
147618918|NCT01461538|532420929|FG000|Overall Study|Withdrawal by Subject|1|||
147618919|NCT01461538|532420930|FG001|Overall Study|Withdrawal by Subject|1|||
147618920|NCT01461538|532420931|FG002|Overall Study|Withdrawal by Subject|0|||
147618921|NCT03552380|532420933|FG000|Study Treatment|Disease Progression|3|||
147618922|NCT03552380|532420934|FG001|Study Treatment|Disease Progression|4|||
147618923|NCT03552380|532420933|FG000|Study Treatment|Adverse Event|2|||
147618924|NCT03552380|532420934|FG001|Study Treatment|Adverse Event|2|||
147618925|NCT03552380|532420933|FG000|Follow up|PI request to move remaining patients on follow-up to Off study|2|||
147411296|NCT01818531|531669885|FG001|Overall Study|Withdrawn for failure to place block|1|||
147618926|NCT03552380|532420934|FG001|Follow up|PI request to move remaining patients on follow-up to Off study|2|||
147618927|NCT03552380|532420933|FG000|Follow up|Death|3|||
147618928|NCT03552380|532420934|FG001|Follow up|Death|4|||
147618929|NCT03552380|532420933|FG000|Follow up|Site IRB terminated|0|||
147618930|NCT03552380|532420934|FG001|Follow up|Site IRB terminated|1|||
147618931|NCT02046603|532420935|FG000|Overall Study|Other|11|||
147618932|NCT02046603|532420936|FG001|Overall Study|Other|66|||
147618933|NCT02046603|532420935|FG000|Overall Study|Protocol Violation|0|||
147618934|NCT02046603|532420936|FG001|Overall Study|Protocol Violation|1|||
147618935|NCT02046603|532420935|FG000|Overall Study|Participant/legal guardian decision|1|||
147618936|NCT02046603|532420936|FG001|Overall Study|Participant/legal guardian decision|3|||
147302900|NCT04707196|531274494|FG000|Overall Study|Withdrawal by Subject|9|||
147302901|NCT04707196|531274495|FG001|Overall Study|Withdrawal by Subject|6|||
147302902|NCT04707196|531274494|FG000|Overall Study|Lost to Follow-up|1|||
147302903|NCT04707196|531274495|FG001|Overall Study|Lost to Follow-up|0|||
147302904|NCT04707196|531274494|FG000|Overall Study|Protocol Violation|4|||
147302905|NCT04707196|531274495|FG001|Overall Study|Protocol Violation|1|||
147302906|NCT04707196|531274494|FG000|Overall Study|Adverse Event|2|||
147302907|NCT04707196|531274495|FG001|Overall Study|Adverse Event|2|||
147302908|NCT04707196|531274494|FG000|Overall Study|Death|3|||
147302909|NCT04707196|531274495|FG001|Overall Study|Death|1|||
147302910|NCT04707196|531274494|FG000|Overall Study|Non-compliance with study drug|1|||
147302911|NCT04707196|531274495|FG001|Overall Study|Non-compliance with study drug|0|||
147302912|NCT04707196|531274494|FG000|Overall Study|Progressive disease|9|||
147302913|NCT04707196|531274495|FG001|Overall Study|Progressive disease|10|||
147302914|NCT01462162|531274496|FG000|Overall Study|Adverse Event|5|||
147302915|NCT01462162|531274496|FG000|Overall Study|Lack of Efficacy|4|||
147302916|NCT01462162|531274496|FG000|Overall Study|Abnormal laboratory parameters|1|||
147302917|NCT01462162|531274496|FG000|Overall Study|Other|2|||
147302918|NCT03485911|531274497|FG000|Part 1|Perceived lack of efficacy|1|||
147302919|NCT03485911|531274498|FG001|Part 1|Perceived lack of efficacy|1|||
147302920|NCT03485911|531274499|FG002|Part 1|Perceived lack of efficacy|2|||
147302921|NCT03485911|531274500|FG003|Part 1|Perceived lack of efficacy|0|||
147302922|NCT03485911|531274497|FG000|Part 1|Subject withdrew consent|0|||
147302923|NCT03485911|531274498|FG001|Part 1|Subject withdrew consent|1|||
147302924|NCT03485911|531274499|FG002|Part 1|Subject withdrew consent|0|||
147302925|NCT03485911|531274500|FG003|Part 1|Subject withdrew consent|1|||
147302926|NCT03485911|531274497|FG000|Part 1|Lab abnormalities/AEs|3|||
147302927|NCT03485911|531274498|FG001|Part 1|Lab abnormalities/AEs|1|||
147302928|NCT03485911|531274499|FG002|Part 1|Lab abnormalities/AEs|1|||
147302929|NCT03485911|531274500|FG003|Part 1|Lab abnormalities/AEs|0|||
147302930|NCT03485911|531274497|FG000|Part 1|Withdrew Consent prior to dosing|0|||
147302931|NCT03485911|531274498|FG001|Part 1|Withdrew Consent prior to dosing|0|||
147302932|NCT03485911|531274499|FG002|Part 1|Withdrew Consent prior to dosing|0|||
147302933|NCT03485911|531274500|FG003|Part 1|Withdrew Consent prior to dosing|1|||
147302934|NCT03485911|531274497|FG000|Part 1|Other NOS|0|||
147302935|NCT03485911|531274498|FG001|Part 1|Other NOS|0|||
147302936|NCT03485911|531274499|FG002|Part 1|Other NOS|0|||
147302937|NCT03485911|531274500|FG003|Part 1|Other NOS|1|||
147302938|NCT03485911|531274497|FG000|Part 2|Perceived lack of efficacy|5|||
147302939|NCT03485911|531274498|FG001|Part 2|Perceived lack of efficacy|3|||
147302940|NCT03485911|531274499|FG002|Part 2|Perceived lack of efficacy|0|||
147302941|NCT03485911|531274500|FG003|Part 2|Perceived lack of efficacy|2|||
147302942|NCT03485911|531274497|FG000|Part 2|Subject withdrew consent|1|||
147302943|NCT03485911|531274498|FG001|Part 2|Subject withdrew consent|0|||
147302944|NCT03485911|531274499|FG002|Part 2|Subject withdrew consent|2|||
147302945|NCT03485911|531274500|FG003|Part 2|Subject withdrew consent|1|||
147302946|NCT03485911|531274497|FG000|Part 2|Lab abnormalities/AEs|1|||
147302947|NCT03485911|531274498|FG001|Part 2|Lab abnormalities/AEs|2|||
147302948|NCT03485911|531274499|FG002|Part 2|Lab abnormalities/AEs|0|||
147302949|NCT03485911|531274500|FG003|Part 2|Lab abnormalities/AEs|0|||
147302950|NCT03485911|531274497|FG000|Part 2|Other NOS|0|||
147302951|NCT03485911|531274498|FG001|Part 2|Other NOS|1|||
147302952|NCT03485911|531274499|FG002|Part 2|Other NOS|0|||
147302953|NCT03485911|531274500|FG003|Part 2|Other NOS|0|||
147302954|NCT03485911|531274497|FG000|Part 2|Intercurrent illness/new medical condition|1|||
147302955|NCT03485911|531274498|FG001|Part 2|Intercurrent illness/new medical condition|0|||
147302956|NCT03485911|531274499|FG002|Part 2|Intercurrent illness/new medical condition|0|||
147302957|NCT03485911|531274500|FG003|Part 2|Intercurrent illness/new medical condition|0|||
147302958|NCT03485911|531274497|FG000|Part 2|Investigator judgement|1|||
147302959|NCT03485911|531274498|FG001|Part 2|Investigator judgement|0|||
147302960|NCT03485911|531274499|FG002|Part 2|Investigator judgement|0|||
147302961|NCT03485911|531274500|FG003|Part 2|Investigator judgement|0|||
147302962|NCT03485911|531274497|FG000|Part 3|Perceived lack of efficacy|2|||
147302963|NCT03485911|531274498|FG001|Part 3|Perceived lack of efficacy|2|||
147302964|NCT03485911|531274499|FG002|Part 3|Perceived lack of efficacy|2|||
147302965|NCT03485911|531274500|FG003|Part 3|Perceived lack of efficacy|0|||
147618937|NCT02046603|532420935|FG000|Overall Study|Physician Decision|2|||
147618938|NCT02046603|532420936|FG001|Overall Study|Physician Decision|1|||
147618939|NCT02046603|532420935|FG000|Overall Study|Lost to Follow-up|1|||
147618940|NCT02046603|532420936|FG001|Overall Study|Lost to Follow-up|2|||
147618941|NCT02046603|532420935|FG000|Overall Study|Death|0|||
147302966|NCT03485911|531274497|FG000|Part 3|Subject withdrew consent|1|||
147302967|NCT03485911|531274498|FG001|Part 3|Subject withdrew consent|4|||
147302968|NCT03485911|531274499|FG002|Part 3|Subject withdrew consent|0|||
147302969|NCT03485911|531274500|FG003|Part 3|Subject withdrew consent|1|||
147302970|NCT03485911|531274497|FG000|Part 3|Lab abnormalities/AEs|1|||
147302971|NCT03485911|531274498|FG001|Part 3|Lab abnormalities/AEs|1|||
147302972|NCT03485911|531274499|FG002|Part 3|Lab abnormalities/AEs|0|||
147302973|NCT03485911|531274500|FG003|Part 3|Lab abnormalities/AEs|2|||
147302974|NCT03485911|531274497|FG000|Part 3|Other NOS|1|||
147302975|NCT03485911|531274498|FG001|Part 3|Other NOS|1|||
147302976|NCT03485911|531274499|FG002|Part 3|Other NOS|0|||
147302977|NCT03485911|531274500|FG003|Part 3|Other NOS|0|||
147302978|NCT03485911|531274497|FG000|Part 3|Intercurrent illness/new medical condition|0|||
147302979|NCT03485911|531274498|FG001|Part 3|Intercurrent illness/new medical condition|1|||
147302980|NCT03485911|531274499|FG002|Part 3|Intercurrent illness/new medical condition|1|||
147302981|NCT03485911|531274500|FG003|Part 3|Intercurrent illness/new medical condition|0|||
147302982|NCT03485911|531274497|FG000|Part 3|Sponsor discontinuation|1|||
147302983|NCT03485911|531274498|FG001|Part 3|Sponsor discontinuation|0|||
147302984|NCT03485911|531274499|FG002|Part 3|Sponsor discontinuation|0|||
147302985|NCT03485911|531274500|FG003|Part 3|Sponsor discontinuation|0|||
147302986|NCT03485911|531274497|FG000|Part 3|Berotralstat provided by alternative means|13|||
147302987|NCT03485911|531274498|FG001|Part 3|Berotralstat provided by alternative means|13|||
147302988|NCT03485911|531274499|FG002|Part 3|Berotralstat provided by alternative means|7|||
147302989|NCT03485911|531274500|FG003|Part 3|Berotralstat provided by alternative means|7|||
147302990|NCT03333928|531274501|FG000|Initial Dosing Period (Period 1)|Protocol Violation|0|||
147302991|NCT03333928|531274502|FG001|Initial Dosing Period (Period 1)|Protocol Violation|0|||
147302992|NCT03333928|531274503|FG002|Initial Dosing Period (Period 1)|Protocol Violation|1|||
147302993|NCT03333928|531274501|FG000|Initial Dosing Period (Period 1)|Withdrawal by Subject|0|||
147302994|NCT03333928|531274502|FG001|Initial Dosing Period (Period 1)|Withdrawal by Subject|1|||
147302995|NCT03333928|531274503|FG002|Initial Dosing Period (Period 1)|Withdrawal by Subject|1|||
147302996|NCT03333928|531274501|FG000|Initial Dosing Period (Period 1)|Corporate decision to not initiate dosing in new patients because of COVID-19|1|||
147302997|NCT03333928|531274502|FG001|Initial Dosing Period (Period 1)|Corporate decision to not initiate dosing in new patients because of COVID-19|0|||
147302998|NCT03333928|531274503|FG002|Initial Dosing Period (Period 1)|Corporate decision to not initiate dosing in new patients because of COVID-19|1|||
147302999|NCT03333928|531274501|FG000|Initial Dosing Period (Period 1)|Adverse Event|0|||
147303000|NCT03333928|531274502|FG001|Initial Dosing Period (Period 1)|Adverse Event|3|||
147303001|NCT03333928|531274503|FG002|Initial Dosing Period (Period 1)|Adverse Event|1|||
147303002|NCT03333928|531274501|FG000|Dose-controlled Extension (Period 2)|Adverse Event|2|||
147303003|NCT03333928|531274502|FG001|Dose-controlled Extension (Period 2)|Adverse Event|1|||
147303004|NCT03333928|531274503|FG002|Dose-controlled Extension (Period 2)|Adverse Event|0|||
147303005|NCT03333928|531274501|FG000|Dose-controlled Extension (Period 2)|Lost to Follow-up|1|||
147303006|NCT03333928|531274502|FG001|Dose-controlled Extension (Period 2)|Lost to Follow-up|0|||
147303007|NCT03333928|531274503|FG002|Dose-controlled Extension (Period 2)|Lost to Follow-up|0|||
147303008|NCT03333928|531274501|FG000|Randomized Withdrawal (Period 3)|Adverse Event|1|||
147303009|NCT03333928|531274502|FG001|Randomized Withdrawal (Period 3)|Adverse Event|0|||
147303010|NCT03333928|531274503|FG002|Randomized Withdrawal (Period 3)|Adverse Event|0|||
147303011|NCT03333928|531274501|FG000|Randomized Withdrawal (Period 3)|Lost to Follow-up|1|||
147303012|NCT03333928|531274502|FG001|Randomized Withdrawal (Period 3)|Lost to Follow-up|0|||
147303013|NCT03333928|531274503|FG002|Randomized Withdrawal (Period 3)|Lost to Follow-up|1|||
147303014|NCT01375205|531274514|FG000|Overall Study|Lost to Follow-up|15|||
147303015|NCT01375205|531274515|FG001|Overall Study|Lost to Follow-up|12|||
147303016|NCT01375205|531274514|FG000|Overall Study|Withdrawal by Subject|6|||
147303017|NCT01375205|531274515|FG001|Overall Study|Withdrawal by Subject|1|||
147303018|NCT01674621|531274516|FG000|Overall Study|Adverse Event|3|||
147303019|NCT01674621|531274517|FG001|Overall Study|Adverse Event|2|||
147303020|NCT01674621|531274518|FG002|Overall Study|Adverse Event|5|||
147303021|NCT01674621|531274519|FG003|Overall Study|Adverse Event|5|||
147303022|NCT01674621|531274520|FG004|Overall Study|Adverse Event|1|||
147303023|NCT01674621|531274516|FG000|Overall Study|Inability to Complete Study Procedures|0|||
147303024|NCT01674621|531274517|FG001|Overall Study|Inability to Complete Study Procedures|0|||
147303025|NCT01674621|531274518|FG002|Overall Study|Inability to Complete Study Procedures|0|||
147303026|NCT01674621|531274519|FG003|Overall Study|Inability to Complete Study Procedures|0|||
147303027|NCT01674621|531274520|FG004|Overall Study|Inability to Complete Study Procedures|2|||
147303028|NCT01674621|531274516|FG000|Overall Study|Severe Abaloparatide-SC Hypersensitivity|0|||
147303029|NCT01674621|531274517|FG001|Overall Study|Severe Abaloparatide-SC Hypersensitivity|0|||
147303030|NCT01674621|531274518|FG002|Overall Study|Severe Abaloparatide-SC Hypersensitivity|0|||
147303031|NCT01674621|531274519|FG003|Overall Study|Severe Abaloparatide-SC Hypersensitivity|1|||
147303032|NCT01674621|531274520|FG004|Overall Study|Severe Abaloparatide-SC Hypersensitivity|0|||
147303033|NCT01674621|531274516|FG000|Overall Study|Withdrawal by Subject|2|||
147303034|NCT01674621|531274517|FG001|Overall Study|Withdrawal by Subject|5|||
147303035|NCT01674621|531274518|FG002|Overall Study|Withdrawal by Subject|2|||
147303036|NCT01674621|531274519|FG003|Overall Study|Withdrawal by Subject|0|||
147665762|NCT02709746|532601590|FG000|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|12|||
147665763|NCT02709746|532601591|FG001|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|0|||
147665764|NCT02709746|532601592|FG002|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|0|||
147665765|NCT02709746|532601593|FG003|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|0|||
147303037|NCT01674621|531274520|FG004|Overall Study|Withdrawal by Subject|1|||
147303038|NCT01674621|531274516|FG000|Overall Study|Other than specified|0|||
147303039|NCT01674621|531274517|FG001|Overall Study|Other than specified|1|||
147303040|NCT01674621|531274518|FG002|Overall Study|Other than specified|0|||
147618942|NCT02046603|532420936|FG001|Overall Study|Death|1|||
147618943|NCT02046603|532420935|FG000|Overall Study|Adverse Event|0|||
147618944|NCT02046603|532420936|FG001|Overall Study|Adverse Event|1|||
147618945|NCT03447743|532420937|FG000|Overall Study|Withdrawal by Subject|2|||
147618946|NCT03447743|532420937|FG000|Overall Study|Lost to Follow-up|3|||
147618947|NCT03447743|532420937|FG000|Overall Study|Adverse Event|1|||
147618948|NCT03447743|532420937|FG000|Overall Study|Did not meet criteria to continue|1|||
147618949|NCT02461160|532420938|FG000|Overall Study|Lost to Follow-up|0|||
147618950|NCT02461160|532420939|FG001|Overall Study|Lost to Follow-up|0|||
147618951|NCT02461160|532420940|FG002|Overall Study|Lost to Follow-up|0|||
147618952|NCT02461160|532420941|FG003|Overall Study|Lost to Follow-up|0|||
147618953|NCT02461160|532420942|FG004|Overall Study|Lost to Follow-up|0|||
147618954|NCT02461160|532420943|FG005|Overall Study|Lost to Follow-up|0|||
147618955|NCT02461160|532420944|FG006|Overall Study|Lost to Follow-up|0|||
147618956|NCT02461160|532420945|FG007|Overall Study|Lost to Follow-up|1|||
147618957|NCT02461160|532420946|FG008|Overall Study|Lost to Follow-up|0|||
147618958|NCT02461160|532420947|FG009|Overall Study|Lost to Follow-up|0|||
147618959|NCT02461160|532420948|FG010|Overall Study|Lost to Follow-up|0|||
147618960|NCT02461160|532420949|FG011|Overall Study|Lost to Follow-up|0|||
147618961|NCT02461160|532420950|FG012|Overall Study|Lost to Follow-up|0|||
147618962|NCT01112059|532420951|FG000|Overall Study|Withdrawal by Subject|1|||
147618963|NCT01112059|532420952|FG001|Overall Study|Withdrawal by Subject|0|||
147618964|NCT05620082|532420955|FG000|Overall Study|Discharged before study end|1|||
147618965|NCT05620082|532420956|FG001|Overall Study|Discharged before study end|4|||
147618966|NCT05620082|532420957|FG002|Overall Study|Discharged before study end|0|||
147618967|NCT05620082|532420955|FG000|Overall Study|Moved to a different ward|1|||
147618968|NCT05620082|532420956|FG001|Overall Study|Moved to a different ward|0|||
147665766|NCT02709746|532601594|FG004|Phase A (Single-blind Treatment Period)|Non-compliance with study drug|0|||
147665767|NCT02709746|532601590|FG000|Phase A (Single-blind Treatment Period)|Lack of Efficacy|7|||
147618969|NCT05620082|532420957|FG002|Overall Study|Moved to a different ward|0|||
147618970|NCT05620082|532420955|FG000|Overall Study|Feeling too unwell|1|||
147618971|NCT05620082|532420956|FG001|Overall Study|Feeling too unwell|0|||
147618972|NCT05620082|532420957|FG002|Overall Study|Feeling too unwell|0|||
147618973|NCT02572570|532422422|FG000|Overall Study|Study Terminated|27|||
147618974|NCT01417156|532422423|FG000|Overall Study|Adverse Event|12|||
147618975|NCT01417156|532422423|FG000|Overall Study|Protocol Violation|2|||
147618976|NCT01866826|532422424|FG000|Phase I -Initial Randomization - 4 Weeks|Post Enrollment Withdrawal|1|||
147618977|NCT01866826|532422425|FG001|Phase I -Initial Randomization - 4 Weeks|Post Enrollment Withdrawal|0|||
147618978|NCT01866826|532422424|FG000|Wash-Out Period - 4 -6 Weeks|Withdrawal by Subject|0|||
147618979|NCT01866826|532422425|FG001|Wash-Out Period - 4 -6 Weeks|Withdrawal by Subject|2|||
147618980|NCT01866826|532422424|FG000|Wash-Out Period - 4 -6 Weeks|Post Enrollment Withdrawal|0|||
147618981|NCT01866826|532422425|FG001|Wash-Out Period - 4 -6 Weeks|Post Enrollment Withdrawal|1|||
147618982|NCT00742209|532422426|FG000|Overall Study|Adverse Event|11|||
147618983|NCT00742209|532422427|FG001|Overall Study|Adverse Event|4|||
147618984|NCT00742209|532422428|FG002|Overall Study|Adverse Event|17|||
147618985|NCT00742209|532422429|FG003|Overall Study|Adverse Event|16|||
147618986|NCT00742209|532422430|FG004|Overall Study|Adverse Event|13|||
147618987|NCT00742209|532422426|FG000|Overall Study|Participant Withdrew Consent|8|||
147618988|NCT00742209|532422427|FG001|Overall Study|Participant Withdrew Consent|4|||
147618989|NCT00742209|532422428|FG002|Overall Study|Participant Withdrew Consent|14|||
147618990|NCT00742209|532422429|FG003|Overall Study|Participant Withdrew Consent|7|||
147618991|NCT00742209|532422430|FG004|Overall Study|Participant Withdrew Consent|4|||
147618992|NCT00742209|532422426|FG000|Overall Study|Protocol Violation|6|||
147618993|NCT00742209|532422427|FG001|Overall Study|Protocol Violation|5|||
147618994|NCT00742209|532422428|FG002|Overall Study|Protocol Violation|4|||
147618995|NCT00742209|532422429|FG003|Overall Study|Protocol Violation|5|||
147618996|NCT00742209|532422430|FG004|Overall Study|Protocol Violation|3|||
147618997|NCT00742209|532422426|FG000|Overall Study|Lost to Follow-up|3|||
147618998|NCT00742209|532422427|FG001|Overall Study|Lost to Follow-up|4|||
147618999|NCT00742209|532422428|FG002|Overall Study|Lost to Follow-up|5|||
147411297|NCT01677767|531669886|FG000|Overall Study|Adverse Event|1|||
147411298|NCT01677767|531669886|FG000|Overall Study|Death|4|||
147411299|NCT01677767|531669886|FG000|Overall Study|Protocol Violation|4|||
147619000|NCT00742209|532422429|FG003|Overall Study|Lost to Follow-up|5|||
147619001|NCT00742209|532422430|FG004|Overall Study|Lost to Follow-up|3|||
147619002|NCT00742209|532422426|FG000|Overall Study|Lack of Efficacy|6|||
147619003|NCT00742209|532422427|FG001|Overall Study|Lack of Efficacy|1|||
147619004|NCT00742209|532422428|FG002|Overall Study|Lack of Efficacy|1|||
147619005|NCT00742209|532422429|FG003|Overall Study|Lack of Efficacy|3|||
147619006|NCT00742209|532422430|FG004|Overall Study|Lack of Efficacy|1|||
147619007|NCT00742209|532422426|FG000|Overall Study|Investigator Discretion|0|||
147619008|NCT00742209|532422427|FG001|Overall Study|Investigator Discretion|0|||
147619009|NCT00742209|532422428|FG002|Overall Study|Investigator Discretion|5|||
147619010|NCT00742209|532422429|FG003|Overall Study|Investigator Discretion|1|||
147619011|NCT00742209|532422430|FG004|Overall Study|Investigator Discretion|1|||
147468321|NCT03514914|531872455|FG000|Overall Study|Lost to Follow-up|117|||
147303041|NCT01674621|531274519|FG003|Overall Study|Other than specified|0|||
147303042|NCT01674621|531274520|FG004|Overall Study|Other than specified|2|||
147303043|NCT01148862|531274521|FG000|Second Intervention|Withdrawal by Subject|0|||
147303044|NCT01148862|531274522|FG001|Second Intervention|Withdrawal by Subject|2|||
147303045|NCT05031078|531274523|FG000|Overall Study|Withdrawal by Subject|0|||
147303046|NCT05031078|531274524|FG001|Overall Study|Withdrawal by Subject|1|||
147303047|NCT05031078|531274525|FG002|Overall Study|Withdrawal by Subject|0|||
147303048|NCT03750006|531274527|FG000|Overall Study|Withdrawal by Subject|8|||
147303049|NCT03750006|531274527|FG000|Overall Study|COVID PANDEMIC|11|||
147303050|NCT01108458|531276230|FG000|Overall Study|Withdrawal by Subject|1|||
147303051|NCT01392300|531276241|FG000|Main Period (MP)|Predefined discontinuation criteria|2|||
147303052|NCT01392300|531276242|FG001|Main Period (MP)|Predefined discontinuation criteria|3|||
147303053|NCT01392300|531276243|FG002|Main Period (MP)|Predefined discontinuation criteria|0|||
147303054|NCT01392300|531276241|FG000|Main Period (MP)|Withdrawal by Subject|5|||
147303055|NCT01392300|531276242|FG001|Main Period (MP)|Withdrawal by Subject|1|||
147303056|NCT01392300|531276243|FG002|Main Period (MP)|Withdrawal by Subject|0|||
147303057|NCT01392300|531276241|FG000|Main Period (MP)|Lost to Follow-up|3|||
147303058|NCT01392300|531276242|FG001|Main Period (MP)|Lost to Follow-up|3|||
147303059|NCT01392300|531276243|FG002|Main Period (MP)|Lost to Follow-up|0|||
147303060|NCT01392300|531276241|FG000|Main Period (MP)|Non-compliance|1|||
147303061|NCT01392300|531276242|FG001|Main Period (MP)|Non-compliance|0|||
147303062|NCT01392300|531276243|FG002|Main Period (MP)|Non-compliance|0|||
147303063|NCT01392300|531276241|FG000|Open Label Extension (OLEX) Period|Protocol Violation|0|||
147303064|NCT01392300|531276242|FG001|Open Label Extension (OLEX) Period|Protocol Violation|0|||
147303065|NCT01392300|531276243|FG002|Open Label Extension (OLEX) Period|Protocol Violation|13|||
147303066|NCT01392300|531276241|FG000|Open Label Extension (OLEX) Period|Lack of Efficacy|0|||
147303067|NCT01392300|531276242|FG001|Open Label Extension (OLEX) Period|Lack of Efficacy|0|||
147303068|NCT01392300|531276243|FG002|Open Label Extension (OLEX) Period|Lack of Efficacy|3|||
147619012|NCT04620746|532422433|FG000|Overall Study|Adverse Event|2|||
147619013|NCT04620746|532422434|FG001|Overall Study|Adverse Event|0|||
147619014|NCT04620746|532422433|FG000|Overall Study|Uniterpretable skin test|1|||
147619015|NCT04620746|532422434|FG001|Overall Study|Uniterpretable skin test|0|||
147619016|NCT04620746|532422433|FG000|Overall Study|Withdrawal by Subject|0|||
147619017|NCT04620746|532422434|FG001|Overall Study|Withdrawal by Subject|1|||
147619018|NCT03473925|532422435|FG000|Overall Study|Death|48|||
147619019|NCT03473925|532422436|FG001|Overall Study|Death|44|||
147619020|NCT03473925|532422435|FG000|Overall Study|Sponsor Decision|2|||
147619021|NCT03473925|532422436|FG001|Overall Study|Sponsor Decision|7|||
147619022|NCT03473925|532422435|FG000|Overall Study|Withdrawal by Subject|1|||
147619023|NCT03473925|532422436|FG001|Overall Study|Withdrawal by Subject|3|||
147619024|NCT03473925|532422435|FG000|Overall Study|Not Treated|1|||
147619025|NCT03473925|532422436|FG001|Overall Study|Not Treated|1|||
147619026|NCT02756611|532422437|FG000|Overall Study|Death|70|||
147619027|NCT02756611|532422437|FG000|Overall Study|Withdrawal by Subject|2|||
147303069|NCT01392300|531276241|FG000|Open Label Extension (OLEX) Period|Non-compliance|0|||
147303070|NCT01392300|531276242|FG001|Open Label Extension (OLEX) Period|Non-compliance|0|||
147303071|NCT01392300|531276243|FG002|Open Label Extension (OLEX) Period|Non-compliance|1|||
147303072|NCT01392300|531276241|FG000|Open Label Extension (OLEX) Period|Death|0|||
147303073|NCT01392300|531276242|FG001|Open Label Extension (OLEX) Period|Death|0|||
147303074|NCT01392300|531276243|FG002|Open Label Extension (OLEX) Period|Death|4|||
147303075|NCT01392300|531276241|FG000|Open Label Extension (OLEX) Period|Adverse Event|0|||
147303076|NCT01392300|531276242|FG001|Open Label Extension (OLEX) Period|Adverse Event|0|||
147303077|NCT01392300|531276243|FG002|Open Label Extension (OLEX) Period|Adverse Event|7|||
147303078|NCT01392300|531276241|FG000|Open Label Extension (OLEX) Period|Withdrawal by Subject|0|||
147303079|NCT01392300|531276242|FG001|Open Label Extension (OLEX) Period|Withdrawal by Subject|0|||
147303080|NCT01392300|531276243|FG002|Open Label Extension (OLEX) Period|Withdrawal by Subject|17|||
147303081|NCT01392300|531276241|FG000|Open Label Extension (OLEX) Period|Lost to Follow-up|0|||
147303082|NCT01392300|531276242|FG001|Open Label Extension (OLEX) Period|Lost to Follow-up|0|||
147303083|NCT01392300|531276243|FG002|Open Label Extension (OLEX) Period|Lost to Follow-up|6|||
147303084|NCT05056870|531276248|FG000|Period 1|Site COVID-19 Related|3|||
147303085|NCT05056870|531276249|FG001|Period 1|Site COVID-19 Related|3|||
147303086|NCT05056870|531276248|FG000|Period 1|Subject Withdrawn by PI due to Non Compliance to Protocol|0|||
147303087|NCT05056870|531276249|FG001|Period 1|Subject Withdrawn by PI due to Non Compliance to Protocol|1|||
147303088|NCT05056870|531276248|FG000|Period 1|Subject No Longer Meets Eligibility Criteria|1|||
147303089|NCT05056870|531276249|FG001|Period 1|Subject No Longer Meets Eligibility Criteria|0|||
147303090|NCT05056870|531276248|FG000|Period 2|COVID-19 Related|1|||
147619028|NCT02756611|532422437|FG000|Overall Study|Lost to Follow-up|3|||
147619029|NCT02756611|532422437|FG000|Overall Study|Transitioned to Long-term Extension Study M19-388 (NCT03844048)|49|||
147619030|NCT02756611|532422437|FG000|Overall Study|Other|10|||
147619031|NCT00124917|532422445|FG000|Overall Study|Physician Decision|3|||
147303091|NCT05056870|531276249|FG001|Period 2|COVID-19 Related|0|||
147303092|NCT05056870|531276248|FG000|Period 2|Subject No Longer Meets Eligibility Criteria|1|||
147619032|NCT03518008|532422446|FG000|Period 2, Second Week of Wear|Family emergency|0|||
147303093|NCT05056870|531276249|FG001|Period 2|Subject No Longer Meets Eligibility Criteria|0|||
147303094|NCT05044325|531276250|FG000|Part A:Treatment Period 1|Adverse Event|0|||
147303095|NCT05044325|531276251|FG001|Part A:Treatment Period 1|Adverse Event|0|||
147303096|NCT05044325|531276252|FG002|Part A:Treatment Period 1|Adverse Event|0|||
147303097|NCT05044325|531276253|FG003|Part A:Treatment Period 1|Adverse Event|0|||
147303098|NCT05044325|531276254|FG004|Part A:Treatment Period 1|Adverse Event|0|||
147303099|NCT05044325|531276255|FG005|Part A:Treatment Period 1|Adverse Event|1|||
147303100|NCT05044325|531276256|FG006|Part A:Treatment Period 1|Adverse Event|0|||
147303101|NCT05044325|531276257|FG007|Part A:Treatment Period 1|Adverse Event|1|||
147303102|NCT05044325|531276258|FG008|Part A:Treatment Period 1|Adverse Event|0|||
147303103|NCT05044325|531276259|FG009|Part A:Treatment Period 1|Adverse Event|0|||
147303104|NCT05044325|531276250|FG000|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
147303105|NCT05044325|531276251|FG001|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
147303106|NCT05044325|531276252|FG002|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
147303107|NCT05044325|531276253|FG003|Part A:Treatment Period 1|Sponsor Terminated study treatment|2|||
147303108|NCT05044325|531276254|FG004|Part A:Treatment Period 1|Sponsor Terminated study treatment|2|||
147303109|NCT05044325|531276255|FG005|Part A:Treatment Period 1|Sponsor Terminated study treatment|2|||
147303110|NCT05044325|531276256|FG006|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
147303111|NCT05044325|531276257|FG007|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
147303112|NCT05044325|531276258|FG008|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
147303113|NCT05044325|531276259|FG009|Part A:Treatment Period 1|Sponsor Terminated study treatment|0|||
147303114|NCT05044325|531276250|FG000|Part A:Treatment Period 1|Physician Decision|0|||
147303115|NCT05044325|531276251|FG001|Part A:Treatment Period 1|Physician Decision|0|||
147303116|NCT05044325|531276252|FG002|Part A:Treatment Period 1|Physician Decision|0|||
147303117|NCT05044325|531276253|FG003|Part A:Treatment Period 1|Physician Decision|0|||
147303118|NCT05044325|531276254|FG004|Part A:Treatment Period 1|Physician Decision|0|||
147303119|NCT05044325|531276255|FG005|Part A:Treatment Period 1|Physician Decision|0|||
147303120|NCT05044325|531276256|FG006|Part A:Treatment Period 1|Physician Decision|1|||
147303121|NCT05044325|531276257|FG007|Part A:Treatment Period 1|Physician Decision|0|||
147303122|NCT05044325|531276258|FG008|Part A:Treatment Period 1|Physician Decision|0|||
147468322|NCT03514914|531872456|FG001|Overall Study|Lost to Follow-up|89|||
147468323|NCT00826514|531872457|FG000|Overall Study|Adverse Event|1|||
147468324|NCT00826514|531872458|FG001|Overall Study|Adverse Event|1|||
147468325|NCT00826514|531872457|FG000|Overall Study|Lack of Efficacy|0|||
147468326|NCT00826514|531872458|FG001|Overall Study|Lack of Efficacy|1|||
147468327|NCT00826514|531872457|FG000|Overall Study|Withdrawal by Subject|2|||
147468328|NCT00826514|531872458|FG001|Overall Study|Withdrawal by Subject|3|||
147468329|NCT02209506|531872466|FG000|Overall Study|Withdrawal by Subject|0|||
147468330|NCT02209506|531872467|FG001|Overall Study|Withdrawal by Subject|0|||
147468331|NCT02209506|531872468|FG002|Overall Study|Withdrawal by Subject|0|||
147468332|NCT02209506|531872469|FG003|Overall Study|Withdrawal by Subject|0|||
147468333|NCT02209506|531872470|FG004|Overall Study|Withdrawal by Subject|1|||
147468334|NCT01147809|531872473|FG000|Phase I (168 Days)|Adverse Event|0|||
147468335|NCT01147809|531872474|FG001|Phase I (168 Days)|Adverse Event|0|||
147468336|NCT01147809|531872475|FG002|Phase I (168 Days)|Adverse Event|0|||
147468337|NCT01147809|531872476|FG003|Phase I (168 Days)|Adverse Event|1|||
147468338|NCT01147809|531872477|FG004|Phase I (168 Days)|Adverse Event|0|||
147468339|NCT01147809|531872478|FG005|Phase I (168 Days)|Adverse Event|0|||
147468340|NCT01147809|531872473|FG000|Phase I (168 Days)|Lost to Follow-up|1|||
147468341|NCT01147809|531872474|FG001|Phase I (168 Days)|Lost to Follow-up|0|||
147468342|NCT01147809|531872475|FG002|Phase I (168 Days)|Lost to Follow-up|0|||
147468343|NCT01147809|531872476|FG003|Phase I (168 Days)|Lost to Follow-up|1|||
147468344|NCT01147809|531872477|FG004|Phase I (168 Days)|Lost to Follow-up|0|||
147468345|NCT01147809|531872478|FG005|Phase I (168 Days)|Lost to Follow-up|0|||
147468346|NCT01147809|531872473|FG000|Phase I (168 Days)|Physician Decision|0|||
147468347|NCT01147809|531872474|FG001|Phase I (168 Days)|Physician Decision|1|||
147468348|NCT01147809|531872475|FG002|Phase I (168 Days)|Physician Decision|2|||
147468349|NCT01147809|531872476|FG003|Phase I (168 Days)|Physician Decision|0|||
147468350|NCT01147809|531872477|FG004|Phase I (168 Days)|Physician Decision|0|||
147468351|NCT01147809|531872478|FG005|Phase I (168 Days)|Physician Decision|0|||
147468352|NCT01147809|531872473|FG000|Phase I (168 Days)|Withdrawal by Subject|0|||
147468353|NCT01147809|531872474|FG001|Phase I (168 Days)|Withdrawal by Subject|0|||
147619033|NCT03518008|532422447|FG001|Period 2, Second Week of Wear|Family emergency|1|||
147619034|NCT00476190|532422452|FG000|Overall Study|Ineligible|1|||
147468354|NCT01147809|531872475|FG002|Phase I (168 Days)|Withdrawal by Subject|0|||
147468355|NCT01147809|531872476|FG003|Phase I (168 Days)|Withdrawal by Subject|3|||
147468356|NCT01147809|531872477|FG004|Phase I (168 Days)|Withdrawal by Subject|0|||
147468357|NCT01147809|531872478|FG005|Phase I (168 Days)|Withdrawal by Subject|0|||
147468358|NCT01147809|531872473|FG000|Phase II (168 Days)|Adverse Event|0|||
147468359|NCT01147809|531872474|FG001|Phase II (168 Days)|Adverse Event|0|||
147468360|NCT01147809|531872475|FG002|Phase II (168 Days)|Adverse Event|0|||
147468361|NCT01147809|531872476|FG003|Phase II (168 Days)|Adverse Event|0|||
147619035|NCT00476190|532422453|FG001|Overall Study|Ineligible|1|||
147619036|NCT00476190|532422452|FG000|Overall Study|Induction Death|2|||
147619037|NCT00476190|532422453|FG001|Overall Study|Induction Death|0|||
147619038|NCT00476190|532422452|FG000|Overall Study|Induction Failure|2|||
147619039|NCT00476190|532422453|FG001|Overall Study|Induction Failure|4|||
147619040|NCT00476190|532422452|FG000|Overall Study|Lost to Follow-up|1|||
147619041|NCT00476190|532422453|FG001|Overall Study|Lost to Follow-up|0|||
147619042|NCT00476190|532422452|FG000|Overall Study|Relapse/Progression|5|||
147619043|NCT00476190|532422453|FG001|Overall Study|Relapse/Progression|2|||
147619044|NCT00476190|532422452|FG000|Overall Study|Remission Death|0|||
147619045|NCT00476190|532422453|FG001|Overall Study|Remission Death|1|||
147619046|NCT00476190|532422452|FG000|Overall Study|Transplant in first Complete Remission (CR)|15|||
147619047|NCT00476190|532422453|FG001|Overall Study|Transplant in first Complete Remission (CR)|6|||
147619048|NCT00476190|532422452|FG000|Overall Study|Withdrawal by Subject|6|||
147619049|NCT00476190|532422453|FG001|Overall Study|Withdrawal by Subject|2|||
147619050|NCT00476190|532422452|FG000|Overall Study|Other|9|||
147619051|NCT00476190|532422453|FG001|Overall Study|Other|10|||
147619052|NCT04782076|532422456|FG000|Overall Study|Family Emergency|1|||
147619053|NCT02860546|532422461|FG000|Overall Study|Clinical Progression|6|||
147619054|NCT02860546|532422461|FG000|Overall Study|Radiological Progression|12|||
147619055|NCT00281957|532422463|FG000|Overall Study|Adverse Event|7|||
147619056|NCT00281957|532422464|FG001|Overall Study|Adverse Event|2|||
147619057|NCT00281957|532422463|FG000|Overall Study|Death|1|||
147619058|NCT00281957|532422464|FG001|Overall Study|Death|0|||
147619059|NCT00281957|532422463|FG000|Overall Study|Progression/relapse|47|||
147619060|NCT00281957|532422464|FG001|Overall Study|Progression/relapse|35|||
147619061|NCT00281957|532422463|FG000|Overall Study|Not protocol specified|8|||
147619062|NCT00281957|532422464|FG001|Overall Study|Not protocol specified|1|||
147619063|NCT00281957|532422463|FG000|Overall Study|Not eligible|1|||
147619064|NCT00281957|532422464|FG001|Overall Study|Not eligible|2|||
147619065|NCT00281957|532422463|FG000|Overall Study|Did not start treatment|3|||
147619066|NCT00281957|532422464|FG001|Overall Study|Did not start treatment|1|||
147619067|NCT00281957|532422463|FG000|Overall Study|Refusal unrelated to adverse events|0|||
147619068|NCT00281957|532422464|FG001|Overall Study|Refusal unrelated to adverse events|1|||
147619069|NCT00822692|532422474|FG000|Overall Study|Lost to Follow-up|17|||
147619070|NCT00822692|532422475|FG001|Overall Study|Lost to Follow-up|25|||
147619071|NCT03281876|532422477|FG000|Overall Study|Adverse Event|4|||
147619072|NCT03281876|532422478|FG001|Overall Study|Adverse Event|15|||
147619073|NCT03281876|532422477|FG000|Overall Study|Lost to Follow-up|1|||
147619074|NCT03281876|532422478|FG001|Overall Study|Lost to Follow-up|4|||
147619075|NCT03281876|532422477|FG000|Overall Study|Withdrawal by Subject|11|||
147619076|NCT03281876|532422478|FG001|Overall Study|Withdrawal by Subject|15|||
147619077|NCT03281876|532422477|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
147619078|NCT03281876|532422478|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
147619079|NCT03281876|532422477|FG000|Overall Study|OTHER|5|||
147619080|NCT03281876|532422478|FG001|Overall Study|OTHER|5|||
147619081|NCT02208089|532422479|FG000|Overall Study|Withdrawal by Subject|1|||
147619082|NCT02208089|532422480|FG001|Overall Study|Withdrawal by Subject|0|||
147619083|NCT02208089|532422479|FG000|Overall Study|Lost to Follow-up|6|||
147619084|NCT02208089|532422480|FG001|Overall Study|Lost to Follow-up|0|||
147619085|NCT02443740|532422481|FG000|Intervention Period 1 (3 Days)|Adverse Event|0|||
147619086|NCT02443740|532422482|FG001|Intervention Period 1 (3 Days)|Adverse Event|0|||
147619087|NCT02443740|532422483|FG002|Intervention Period 1 (3 Days)|Adverse Event|0|||
147619088|NCT02443740|532422484|FG003|Intervention Period 1 (3 Days)|Adverse Event|0|||
147619089|NCT02443740|532422485|FG004|Intervention Period 1 (3 Days)|Adverse Event|0|||
147619090|NCT02443740|532422486|FG005|Intervention Period 1 (3 Days)|Adverse Event|1|||
147619091|NCT02443740|532422487|FG006|Intervention Period 1 (3 Days)|Adverse Event|0|||
147619092|NCT02443740|532422488|FG007|Intervention Period 1 (3 Days)|Adverse Event|0|||
147619093|NCT02443740|532422489|FG008|Intervention Period 1 (3 Days)|Adverse Event|0|||
147619094|NCT02443740|532422490|FG009|Intervention Period 1 (3 Days)|Adverse Event|0|||
147619095|NCT02443740|532422491|FG010|Intervention Period 1 (3 Days)|Adverse Event|0|||
147619096|NCT02443740|532422481|FG000|Intervention Period 1 (3 Days)|Protocol Violation|1|||
147619097|NCT02443740|532422482|FG001|Intervention Period 1 (3 Days)|Protocol Violation|0|||
147619098|NCT02443740|532422483|FG002|Intervention Period 1 (3 Days)|Protocol Violation|0|||
147619099|NCT02443740|532422484|FG003|Intervention Period 1 (3 Days)|Protocol Violation|0|||
147619100|NCT02443740|532422485|FG004|Intervention Period 1 (3 Days)|Protocol Violation|0|||
147619101|NCT02443740|532422486|FG005|Intervention Period 1 (3 Days)|Protocol Violation|0|||
147619102|NCT02443740|532422487|FG006|Intervention Period 1 (3 Days)|Protocol Violation|1|||
147619103|NCT02443740|532422488|FG007|Intervention Period 1 (3 Days)|Protocol Violation|0|||
147619104|NCT02443740|532422489|FG008|Intervention Period 1 (3 Days)|Protocol Violation|0|||
147619105|NCT02443740|532422490|FG009|Intervention Period 1 (3 Days)|Protocol Violation|0|||
147619106|NCT02443740|532422491|FG010|Intervention Period 1 (3 Days)|Protocol Violation|0|||
147619107|NCT02443740|532422481|FG000|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
147619108|NCT02443740|532422482|FG001|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
147411300|NCT01677767|531669886|FG000|Overall Study|Withdrawal by Subject|10|||
147619109|NCT02443740|532422483|FG002|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
147619110|NCT02443740|532422484|FG003|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
147619111|NCT02443740|532422485|FG004|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
147619112|NCT02443740|532422486|FG005|Intervention Period 1 (3 Days)|Withdrawal by Subject|1|||
147619113|NCT02443740|532422487|FG006|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
147619114|NCT02443740|532422488|FG007|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
147619115|NCT02443740|532422489|FG008|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
147619116|NCT02443740|532422490|FG009|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
147619117|NCT02443740|532422491|FG010|Intervention Period 1 (3 Days)|Withdrawal by Subject|0|||
147619118|NCT00456300|532422492|FG000|Overall Study|Adverse Event|1|||
147619119|NCT00456300|532422493|FG001|Overall Study|Adverse Event|0|||
147619120|NCT02452476|532422496|FG000|Overall Study|Death|4|||
147619121|NCT02452476|532422497|FG001|Overall Study|Death|7|||
147619122|NCT02452476|532422496|FG000|Overall Study|Lost to Follow-up|1|||
147619123|NCT02452476|532422497|FG001|Overall Study|Lost to Follow-up|1|||
147619124|NCT02452476|532422496|FG000|Overall Study|Physician Decision|1|||
147619125|NCT02452476|532422497|FG001|Overall Study|Physician Decision|1|||
147619126|NCT02452476|532422496|FG000|Overall Study|Not treated|5|||
147619127|NCT02452476|532422497|FG001|Overall Study|Not treated|1|||
147665768|NCT02709746|532601591|FG001|Phase A (Single-blind Treatment Period)|Lack of Efficacy|0|||
147411301|NCT01677767|531669886|FG000|Overall Study|Non-compliance by the participants|3|||
147411302|NCT01068665|531669887|FG000|Overall Study|Adverse Event|5|||
147411303|NCT01068665|531669888|FG001|Overall Study|Adverse Event|4|||
147411304|NCT01068665|531669887|FG000|Overall Study|Lack of Efficacy|0|||
147411305|NCT01068665|531669888|FG001|Overall Study|Lack of Efficacy|2|||
147411306|NCT01068665|531669887|FG000|Overall Study|Protocol Violation|5|||
147411307|NCT01068665|531669888|FG001|Overall Study|Protocol Violation|2|||
147411308|NCT01068665|531669887|FG000|Overall Study|Withdrawal Criteria|3|||
147411309|NCT01068665|531669888|FG001|Overall Study|Withdrawal Criteria|9|||
147411310|NCT01068665|531669887|FG000|Overall Study|Other|17|||
147411311|NCT01068665|531669888|FG001|Overall Study|Other|12|||
147411312|NCT02992691|531669891|FG000|Overall Study|Adverse Event|2|||
147411313|NCT02992691|531669891|FG000|Overall Study|Withdrawal by Subject|1|||
147411314|NCT00392925|531669893|FG000|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|11|||
147411315|NCT00392925|531669894|FG001|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|0|||
147411316|NCT00392925|531669895|FG002|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|0|||
147411317|NCT00392925|531669896|FG003|4 Week Lead-In Period - Non-Randomized|Withdrawal by Subject|0|||
147411318|NCT00392925|531669893|FG000|4 Week Lead-In Period - Non-Randomized|Adverse Event|5|||
147411319|NCT00392925|531669894|FG001|4 Week Lead-In Period - Non-Randomized|Adverse Event|0|||
147411320|NCT00392925|531669895|FG002|4 Week Lead-In Period - Non-Randomized|Adverse Event|0|||
147411321|NCT00392925|531669896|FG003|4 Week Lead-In Period - Non-Randomized|Adverse Event|0|||
147411322|NCT00392925|531669893|FG000|4 Week Lead-In Period - Non-Randomized|Physician Decision|1|||
147411323|NCT00392925|531669894|FG001|4 Week Lead-In Period - Non-Randomized|Physician Decision|0|||
147411324|NCT00392925|531669895|FG002|4 Week Lead-In Period - Non-Randomized|Physician Decision|0|||
147411325|NCT00392925|531669896|FG003|4 Week Lead-In Period - Non-Randomized|Physician Decision|0|||
147411326|NCT00392925|531669893|FG000|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|5|||
147411327|NCT00392925|531669894|FG001|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|0|||
147411328|NCT00392925|531669895|FG002|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|0|||
147411329|NCT00392925|531669896|FG003|4 Week Lead-In Period - Non-Randomized|Lost to Follow-up|0|||
147411330|NCT00392925|531669893|FG000|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|16|||
147411331|NCT00392925|531669894|FG001|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|0|||
147411332|NCT00392925|531669895|FG002|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|0|||
147411333|NCT00392925|531669896|FG003|4 Week Lead-In Period - Non-Randomized|did not meet weight loss criteria|0|||
147411334|NCT00392925|531669893|FG000|Randomization to Treatment Group Period|Withdrawal by Subject|0|||
147411335|NCT00392925|531669894|FG001|Randomization to Treatment Group Period|Withdrawal by Subject|2|||
147411336|NCT00392925|531669895|FG002|Randomization to Treatment Group Period|Withdrawal by Subject|6|||
147411337|NCT00392925|531669896|FG003|Randomization to Treatment Group Period|Withdrawal by Subject|8|||
147411338|NCT00392925|531669893|FG000|Randomization to Treatment Group Period|Adverse Event|0|||
147411339|NCT00392925|531669894|FG001|Randomization to Treatment Group Period|Adverse Event|3|||
147411340|NCT00392925|531669895|FG002|Randomization to Treatment Group Period|Adverse Event|3|||
147411341|NCT00392925|531669896|FG003|Randomization to Treatment Group Period|Adverse Event|5|||
147411342|NCT00392925|531669893|FG000|Randomization to Treatment Group Period|Protocol Violation|0|||
147411343|NCT00392925|531669894|FG001|Randomization to Treatment Group Period|Protocol Violation|0|||
147411344|NCT00392925|531669895|FG002|Randomization to Treatment Group Period|Protocol Violation|2|||
147411345|NCT00392925|531669896|FG003|Randomization to Treatment Group Period|Protocol Violation|1|||
147411346|NCT00392925|531669893|FG000|Randomization to Treatment Group Period|Lost to Follow-up|0|||
147411347|NCT00392925|531669894|FG001|Randomization to Treatment Group Period|Lost to Follow-up|3|||
147411348|NCT00392925|531669895|FG002|Randomization to Treatment Group Period|Lost to Follow-up|8|||
147411349|NCT00392925|531669896|FG003|Randomization to Treatment Group Period|Lost to Follow-up|4|||
147411350|NCT03552523|531669897|FG000|Overall Study|Withdrawal by Subject|1|||
147468362|NCT01147809|531872477|FG004|Phase II (168 Days)|Adverse Event|3|||
147468363|NCT01147809|531872478|FG005|Phase II (168 Days)|Adverse Event|6|||
147468364|NCT01147809|531872473|FG000|Phase II (168 Days)|Protocol Violation|0|||
147468365|NCT01147809|531872474|FG001|Phase II (168 Days)|Protocol Violation|0|||
147468366|NCT01147809|531872475|FG002|Phase II (168 Days)|Protocol Violation|0|||
147468367|NCT01147809|531872476|FG003|Phase II (168 Days)|Protocol Violation|0|||
147468368|NCT01147809|531872477|FG004|Phase II (168 Days)|Protocol Violation|0|||
147468369|NCT01147809|531872478|FG005|Phase II (168 Days)|Protocol Violation|1|||
147468370|NCT01147809|531872473|FG000|Phase II (168 Days)|Physician Decision|0|||
147468371|NCT01147809|531872474|FG001|Phase II (168 Days)|Physician Decision|0|||
147468372|NCT01147809|531872475|FG002|Phase II (168 Days)|Physician Decision|0|||
147468373|NCT01147809|531872476|FG003|Phase II (168 Days)|Physician Decision|0|||
147468374|NCT01147809|531872477|FG004|Phase II (168 Days)|Physician Decision|5|||
147468375|NCT01147809|531872478|FG005|Phase II (168 Days)|Physician Decision|11|||
147468376|NCT01147809|531872473|FG000|Phase II (168 Days)|Withdrawal by Subject|0|||
147468377|NCT01147809|531872474|FG001|Phase II (168 Days)|Withdrawal by Subject|0|||
147468378|NCT01147809|531872475|FG002|Phase II (168 Days)|Withdrawal by Subject|0|||
147468379|NCT01147809|531872476|FG003|Phase II (168 Days)|Withdrawal by Subject|0|||
147468380|NCT01147809|531872477|FG004|Phase II (168 Days)|Withdrawal by Subject|7|||
147468381|NCT01147809|531872478|FG005|Phase II (168 Days)|Withdrawal by Subject|15|||
147468382|NCT01147809|531872473|FG000|Phase II (168 Days)|Ongoing|0|||
147468383|NCT01147809|531872474|FG001|Phase II (168 Days)|Ongoing|0|||
147468384|NCT01147809|531872475|FG002|Phase II (168 Days)|Ongoing|0|||
147468385|NCT01147809|531872476|FG003|Phase II (168 Days)|Ongoing|0|||
147468386|NCT01147809|531872477|FG004|Phase II (168 Days)|Ongoing|1|||
147468387|NCT01147809|531872478|FG005|Phase II (168 Days)|Ongoing|0|||
147468388|NCT01307423|531872479|FG000|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|4|||
147468389|NCT01307423|531872480|FG001|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|4|||
147468390|NCT01307423|531872481|FG002|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|6|||
147468391|NCT01307423|531872482|FG003|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
147468392|NCT01307423|531872483|FG004|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
147468393|NCT01307423|531872484|FG005|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
147468394|NCT01307423|531872485|FG006|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
147468395|NCT01307423|531872486|FG007|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
147468396|NCT01307423|531872487|FG008|Placebo-controlled Phase (Week 0 - 24)|Adverse Event|0|||
147468397|NCT01307423|531872479|FG000|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|1|||
147468398|NCT01307423|531872480|FG001|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|3|||
147468399|NCT01307423|531872481|FG002|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|2|||
147468400|NCT01307423|531872482|FG003|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
147468401|NCT01307423|531872483|FG004|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
147468402|NCT01307423|531872484|FG005|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
147468403|NCT01307423|531872485|FG006|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
147468404|NCT01307423|531872486|FG007|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
147468405|NCT01307423|531872487|FG008|Placebo-controlled Phase (Week 0 - 24)|Lack of Efficacy|0|||
147468406|NCT01307423|531872479|FG000|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|8|||
147468407|NCT01307423|531872480|FG001|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|4|||
147468408|NCT01307423|531872481|FG002|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|10|||
147468409|NCT01307423|531872482|FG003|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
147468410|NCT01307423|531872483|FG004|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
147468411|NCT01307423|531872484|FG005|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
147468412|NCT01307423|531872485|FG006|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
147468413|NCT01307423|531872486|FG007|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
147468414|NCT01307423|531872487|FG008|Placebo-controlled Phase (Week 0 - 24)|Withdrawal by Subject|0|||
147468415|NCT01307423|531872479|FG000|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
147468416|NCT01307423|531872480|FG001|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
147468417|NCT01307423|531872481|FG002|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|1|||
147468418|NCT01307423|531872482|FG003|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
147468419|NCT01307423|531872483|FG004|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
147468420|NCT01307423|531872484|FG005|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
147468421|NCT01307423|531872485|FG006|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
147619128|NCT03567980|532422498|FG000|Overall Study|Adverse Event|1|||
147619129|NCT02575833|532422499|FG000|Overall Study|Withdrawal by Subject|0|||
147619130|NCT02575833|532422500|FG001|Overall Study|Withdrawal by Subject|1|||
147468422|NCT01307423|531872486|FG007|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
147468423|NCT01307423|531872487|FG008|Placebo-controlled Phase (Week 0 - 24)|Randomization Error|0|||
147468424|NCT01307423|531872479|FG000|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|5|||
147468425|NCT01307423|531872480|FG001|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|1|||
147468426|NCT01307423|531872481|FG002|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|2|||
147468427|NCT01307423|531872482|FG003|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
147619131|NCT02575833|532422499|FG000|Overall Study|Lost to Follow-up|1|||
147411351|NCT03552523|531669898|FG001|Overall Study|Withdrawal by Subject|1|||
147411352|NCT03538938|531669899|FG000|Overall Study|Death|0|||
147411353|NCT03538938|531669900|FG001|Overall Study|Death|0|||
147411354|NCT03538938|531669901|FG002|Overall Study|Death|2|||
147411355|NCT03538938|531669902|FG003|Overall Study|Death|0|||
147411356|NCT03538938|531669903|FG004|Overall Study|Death|0|||
147411357|NCT03538938|531669904|FG005|Overall Study|Death|1|||
147411358|NCT03538938|531669905|FG006|Overall Study|Death|0|||
147411359|NCT03538938|531669906|FG007|Overall Study|Death|1|||
147411360|NCT03538938|531669907|FG008|Overall Study|Death|1|||
147411361|NCT03538938|531669908|FG009|Overall Study|Death|1|||
147411362|NCT03538938|531669909|FG010|Overall Study|Death|0|||
147411363|NCT03538938|531669910|FG011|Overall Study|Death|0|||
147411364|NCT03538938|531669911|FG012|Overall Study|Death|1|||
147411365|NCT03538938|531669912|FG013|Overall Study|Death|1|||
147411366|NCT03538938|531669913|FG014|Overall Study|Death|0|||
147411367|NCT03538938|531669914|FG015|Overall Study|Death|1|||
147411368|NCT03538938|531669899|FG000|Overall Study|Withdrawal by Subject|4|||
147411369|NCT03538938|531669900|FG001|Overall Study|Withdrawal by Subject|6|||
147411370|NCT03538938|531669901|FG002|Overall Study|Withdrawal by Subject|5|||
147411371|NCT03538938|531669902|FG003|Overall Study|Withdrawal by Subject|3|||
147411372|NCT03538938|531669903|FG004|Overall Study|Withdrawal by Subject|0|||
147411373|NCT03538938|531669904|FG005|Overall Study|Withdrawal by Subject|0|||
147411374|NCT03538938|531669905|FG006|Overall Study|Withdrawal by Subject|3|||
147411375|NCT03538938|531669906|FG007|Overall Study|Withdrawal by Subject|1|||
147411376|NCT03538938|531669907|FG008|Overall Study|Withdrawal by Subject|5|||
147411377|NCT03538938|531669908|FG009|Overall Study|Withdrawal by Subject|1|||
147411378|NCT03538938|531669909|FG010|Overall Study|Withdrawal by Subject|2|||
147411379|NCT03538938|531669910|FG011|Overall Study|Withdrawal by Subject|1|||
147411380|NCT03538938|531669911|FG012|Overall Study|Withdrawal by Subject|3|||
147411381|NCT03538938|531669912|FG013|Overall Study|Withdrawal by Subject|0|||
147411382|NCT03538938|531669913|FG014|Overall Study|Withdrawal by Subject|2|||
147411383|NCT03538938|531669914|FG015|Overall Study|Withdrawal by Subject|4|||
147411384|NCT03538938|531669899|FG000|Overall Study|Incarcerated|0|||
147411385|NCT03538938|531669900|FG001|Overall Study|Incarcerated|0|||
147411386|NCT03538938|531669901|FG002|Overall Study|Incarcerated|0|||
147411387|NCT03538938|531669902|FG003|Overall Study|Incarcerated|0|||
147411388|NCT03538938|531669903|FG004|Overall Study|Incarcerated|0|||
147411389|NCT03538938|531669904|FG005|Overall Study|Incarcerated|0|||
147411390|NCT03538938|531669905|FG006|Overall Study|Incarcerated|0|||
147411391|NCT03538938|531669906|FG007|Overall Study|Incarcerated|0|||
147411392|NCT03538938|531669907|FG008|Overall Study|Incarcerated|0|||
147411393|NCT03538938|531669908|FG009|Overall Study|Incarcerated|0|||
147411394|NCT03538938|531669909|FG010|Overall Study|Incarcerated|0|||
147411395|NCT03538938|531669910|FG011|Overall Study|Incarcerated|1|||
147411396|NCT03538938|531669911|FG012|Overall Study|Incarcerated|0|||
147411397|NCT03538938|531669912|FG013|Overall Study|Incarcerated|0|||
147411398|NCT03538938|531669913|FG014|Overall Study|Incarcerated|0|||
147411399|NCT03538938|531669914|FG015|Overall Study|Incarcerated|0|||
147411400|NCT00755105|531669915|FG000|Overall Study|Withdrawal by Subject|9|||
147411401|NCT00755105|531669916|FG001|Overall Study|Withdrawal by Subject|11|||
147411402|NCT00755105|531669917|FG002|Overall Study|Withdrawal by Subject|4|||
147411403|NCT01518153|531669922|FG000|Stem Cell Transplant|Active graft-vs-host disease (GvHD)|5|||
147411404|NCT01518153|531669923|FG001|Stem Cell Transplant|Active graft-vs-host disease (GvHD)|0|||
147411405|NCT01518153|531669924|FG002|Stem Cell Transplant|Active graft-vs-host disease (GvHD)|0|||
147411406|NCT01518153|531669922|FG000|Stem Cell Transplant|Death|2|||
147411407|NCT01518153|531669923|FG001|Stem Cell Transplant|Death|0|||
147411408|NCT01518153|531669924|FG002|Stem Cell Transplant|Death|0|||
147411409|NCT01518153|531669922|FG000|Stem Cell Transplant|Secondary graft failure|1|||
147411410|NCT01518153|531669923|FG001|Stem Cell Transplant|Secondary graft failure|0|||
147411411|NCT01518153|531669924|FG002|Stem Cell Transplant|Secondary graft failure|0|||
147411412|NCT01518153|531669922|FG000|Stem Cell Transplant|Adverse Event|1|||
147411413|NCT01518153|531669923|FG001|Stem Cell Transplant|Adverse Event|0|||
147411414|NCT01518153|531669924|FG002|Stem Cell Transplant|Adverse Event|0|||
147411415|NCT01518153|531669922|FG000|Donor Lymphocyte Infusion|Death|0|||
147411416|NCT01518153|531669923|FG001|Donor Lymphocyte Infusion|Death|2|||
147411417|NCT01518153|531669924|FG002|Donor Lymphocyte Infusion|Death|1|||
147411418|NCT01840410|531669926|FG000|Overall Study|Physician Decision|1|||
147411419|NCT01840410|531669927|FG001|Overall Study|Physician Decision|2|||
147411420|NCT01840410|531669926|FG000|Overall Study|Pregnancy|1|||
147411421|NCT01840410|531669927|FG001|Overall Study|Pregnancy|0|||
147411422|NCT01840410|531669926|FG000|Overall Study|Protocol deviation|1|||
147411423|NCT01840410|531669927|FG001|Overall Study|Protocol deviation|0|||
147411424|NCT01840410|531669926|FG000|Overall Study|Lost to Follow-up|1|||
147411425|NCT01840410|531669927|FG001|Overall Study|Lost to Follow-up|0|||
147411426|NCT01840410|531669926|FG000|Overall Study|Withdrawal by Subject|2|||
147411427|NCT01840410|531669927|FG001|Overall Study|Withdrawal by Subject|1|||
147411428|NCT01840410|531669926|FG000|Overall Study|Adverse Event|1|||
147411429|NCT01840410|531669927|FG001|Overall Study|Adverse Event|1|||
147619132|NCT02575833|532422500|FG001|Overall Study|Lost to Follow-up|0|||
147619133|NCT03367819|532422503|FG000|Overall Study|Adverse Event|4|||
147619134|NCT03367819|532422504|FG001|Overall Study|Adverse Event|4|||
147619135|NCT03367819|532422503|FG000|Overall Study|Progressive Disease|15|||
147619136|NCT03367819|532422504|FG001|Overall Study|Progressive Disease|13|||
147619137|NCT03367819|532422503|FG000|Overall Study|Withdrawal by Subject|1|||
147619138|NCT03367819|532422504|FG001|Overall Study|Withdrawal by Subject|0|||
147411430|NCT00839956|531669928|FG000|Overall Study|Adverse Event|2|||
147411431|NCT00839956|531669928|FG000|Overall Study|Lack of Efficacy|6|||
147411432|NCT00839956|531669928|FG000|Overall Study|Physician Decision|1|||
147411433|NCT00839956|531669928|FG000|Overall Study|Withdrawal by Subject|3|||
147411434|NCT01289210|531669930|FG000|Overall Study|Adverse Event|1|||
147411435|NCT01647542|531669931|FG000|Overall Study|Major Protocol Deviation|1|||
147411436|NCT01647542|531669932|FG001|Overall Study|Major Protocol Deviation|0|||
147411437|NCT01647542|531669933|FG002|Overall Study|Major Protocol Deviation|0|||
147411438|NCT01647542|531669931|FG000|Overall Study|Adverse Event|4|||
147411439|NCT01647542|531669932|FG001|Overall Study|Adverse Event|5|||
147411440|NCT01647542|531669933|FG002|Overall Study|Adverse Event|4|||
147411441|NCT01647542|531669931|FG000|Overall Study|Lost to Follow-up|0|||
147411442|NCT01647542|531669932|FG001|Overall Study|Lost to Follow-up|2|||
147411443|NCT01647542|531669933|FG002|Overall Study|Lost to Follow-up|2|||
147411444|NCT01647542|531669931|FG000|Overall Study|Withdrawal by Subject|6|||
147411445|NCT01647542|531669932|FG001|Overall Study|Withdrawal by Subject|4|||
147411446|NCT01647542|531669933|FG002|Overall Study|Withdrawal by Subject|0|||
147411447|NCT01647542|531669931|FG000|Overall Study|Study Termination|64|||
147411448|NCT01647542|531669932|FG001|Overall Study|Study Termination|61|||
147411449|NCT01647542|531669933|FG002|Overall Study|Study Termination|65|||
147411450|NCT01647542|531669931|FG000|Overall Study|Lack of Efficacy|1|||
147411451|NCT01647542|531669932|FG001|Overall Study|Lack of Efficacy|1|||
147411452|NCT01647542|531669933|FG002|Overall Study|Lack of Efficacy|0|||
147411453|NCT01647542|531669931|FG000|Overall Study|Death|0|||
147411454|NCT01647542|531669932|FG001|Overall Study|Death|0|||
147411455|NCT01647542|531669933|FG002|Overall Study|Death|1|||
147411456|NCT01040169|531669934|FG000|Overall Study|Lost to Follow-up|3|||
147411457|NCT01040169|531669935|FG001|Overall Study|Lost to Follow-up|8|||
147411458|NCT00350727|531669936|FG000|Phase I: Dose Escalation|Adverse Event|4|||
147411459|NCT00350727|531669937|FG001|Phase I: Dose Escalation|Adverse Event|0|||
147411460|NCT00350727|531669938|FG002|Phase I: Dose Escalation|Adverse Event|0|||
147411461|NCT00350727|531669936|FG000|Phase I: Dose Escalation|Lack of Efficacy|25|||
147411462|NCT00350727|531669937|FG001|Phase I: Dose Escalation|Lack of Efficacy|0|||
147411463|NCT00350727|531669938|FG002|Phase I: Dose Escalation|Lack of Efficacy|0|||
147411464|NCT00350727|531669936|FG000|Phase I: Dose Escalation|Death|1|||
147411465|NCT00350727|531669937|FG001|Phase I: Dose Escalation|Death|0|||
147411466|NCT00350727|531669938|FG002|Phase I: Dose Escalation|Death|0|||
147411467|NCT00350727|531669936|FG000|Phase I: Dose Escalation|Physician Decision|1|||
147411468|NCT00350727|531669937|FG001|Phase I: Dose Escalation|Physician Decision|0|||
147411469|NCT00350727|531669938|FG002|Phase I: Dose Escalation|Physician Decision|0|||
147411470|NCT00350727|531669936|FG000|Phase I: Dose Escalation|Transition to Extension Phase|3|||
147411471|NCT00350727|531669937|FG001|Phase I: Dose Escalation|Transition to Extension Phase|0|||
147411472|NCT00350727|531669938|FG002|Phase I: Dose Escalation|Transition to Extension Phase|0|||
147411473|NCT00350727|531669936|FG000|Phase II|Disease Progression|0|||
147411474|NCT00350727|531669937|FG001|Phase II|Disease Progression|15|||
147411475|NCT00350727|531669938|FG002|Phase II|Disease Progression|16|||
147411476|NCT00350727|531669936|FG000|Phase II|Clinical Deterioration|0|||
147411477|NCT00350727|531669937|FG001|Phase II|Clinical Deterioration|1|||
147411478|NCT00350727|531669938|FG002|Phase II|Clinical Deterioration|0|||
147411479|NCT00350727|531669936|FG000|Phase II|Withdrawal by Subject|0|||
147411480|NCT00350727|531669937|FG001|Phase II|Withdrawal by Subject|2|||
147411481|NCT00350727|531669938|FG002|Phase II|Withdrawal by Subject|1|||
147411482|NCT00350727|531669936|FG000|Phase II|Adverse Event|0|||
147411483|NCT00350727|531669937|FG001|Phase II|Adverse Event|1|||
147411484|NCT00350727|531669938|FG002|Phase II|Adverse Event|1|||
147411485|NCT00350727|531669936|FG000|Phase II|Death|0|||
147411486|NCT00350727|531669937|FG001|Phase II|Death|0|||
147411487|NCT00350727|531669938|FG002|Phase II|Death|2|||
147619139|NCT03367819|532422503|FG000|Overall Study|Other|4|||
147411488|NCT00350727|531669936|FG000|Phase II|Sponsor Terminated Study|0|||
147411489|NCT00350727|531669937|FG001|Phase II|Sponsor Terminated Study|0|||
147411490|NCT00350727|531669938|FG002|Phase II|Sponsor Terminated Study|1|||
147411491|NCT00350727|531669936|FG000|Phase II|Enrolled in Rollover Study|0|||
147619140|NCT03367819|532422504|FG001|Overall Study|Other|2|||
147411492|NCT00350727|531669937|FG001|Phase II|Enrolled in Rollover Study|0|||
147411493|NCT00350727|531669938|FG002|Phase II|Enrolled in Rollover Study|1|||
147411494|NCT03551691|531669943|FG000|Overall Study|Withdrawal by Subject|3|||
147411495|NCT03551691|531669944|FG001|Overall Study|Withdrawal by Subject|3|||
147411496|NCT01876082|531671448|FG000|Overall Study|Withdrawal by Subject|0|||
147411497|NCT01876082|531671449|FG001|Overall Study|Withdrawal by Subject|2|||
147411498|NCT01876082|531671448|FG000|Overall Study|Protocol Violation|1|||
147619141|NCT02633787|532422505|FG000|Overall Study|Withdrawal by Subject|1|||
147411499|NCT01876082|531671449|FG001|Overall Study|Protocol Violation|0|||
147411500|NCT01876082|531671448|FG000|Overall Study|Adverse Event|1|||
147411501|NCT01876082|531671449|FG001|Overall Study|Adverse Event|1|||
147411502|NCT01876082|531671448|FG000|Overall Study|treatment interruption of more than 21 consecutive days observed in cycle 1|0|||
147411503|NCT01876082|531671449|FG001|Overall Study|treatment interruption of more than 21 consecutive days observed in cycle 1|1|||
147411504|NCT02964013|531671450|FG000|Overall Study|Death|58|||
147411505|NCT02964013|531671451|FG001|Overall Study|Death|239|||
147411506|NCT02964013|531671452|FG002|Overall Study|Death|38|||
147411507|NCT02964013|531671453|FG003|Overall Study|Death|10|||
147411508|NCT02964013|531671454|FG004|Overall Study|Death|33|||
147411509|NCT02964013|531671450|FG000|Overall Study|Lost to Follow-up|1|||
147411510|NCT02964013|531671451|FG001|Overall Study|Lost to Follow-up|4|||
147411511|NCT02964013|531671452|FG002|Overall Study|Lost to Follow-up|2|||
147411512|NCT02964013|531671453|FG003|Overall Study|Lost to Follow-up|0|||
147411513|NCT02964013|531671454|FG004|Overall Study|Lost to Follow-up|0|||
147411514|NCT02964013|531671450|FG000|Overall Study|Physician Decision|0|||
147411515|NCT02964013|531671451|FG001|Overall Study|Physician Decision|1|||
147411516|NCT02964013|531671452|FG002|Overall Study|Physician Decision|0|||
147411517|NCT02964013|531671453|FG003|Overall Study|Physician Decision|0|||
147411518|NCT02964013|531671454|FG004|Overall Study|Physician Decision|0|||
147411519|NCT02964013|531671450|FG000|Overall Study|Sponsor Decision|3|||
147411520|NCT02964013|531671451|FG001|Overall Study|Sponsor Decision|22|||
147411521|NCT02964013|531671452|FG002|Overall Study|Sponsor Decision|11|||
147411522|NCT02964013|531671453|FG003|Overall Study|Sponsor Decision|0|||
147411523|NCT02964013|531671454|FG004|Overall Study|Sponsor Decision|7|||
147411524|NCT02964013|531671450|FG000|Overall Study|Withdrawal by Subject|6|||
147411525|NCT02964013|531671451|FG001|Overall Study|Withdrawal by Subject|27|||
147411526|NCT02964013|531671452|FG002|Overall Study|Withdrawal by Subject|9|||
147411527|NCT02964013|531671453|FG003|Overall Study|Withdrawal by Subject|0|||
147411528|NCT02964013|531671454|FG004|Overall Study|Withdrawal by Subject|0|||
147411529|NCT02964013|531671450|FG000|Overall Study|Not Treated|0|||
147411530|NCT02964013|531671451|FG001|Overall Study|Not Treated|2|||
147411531|NCT02964013|531671452|FG002|Overall Study|Not Treated|0|||
147411532|NCT02964013|531671453|FG003|Overall Study|Not Treated|1|||
147411533|NCT02964013|531671454|FG004|Overall Study|Not Treated|0|||
147411534|NCT01123070|531671455|FG000|Part B Double Blind Period|Protocol Violation|0|||
147411535|NCT01123070|531671456|FG001|Part B Double Blind Period|Protocol Violation|0|||
147411536|NCT01123070|531671457|FG002|Part B Double Blind Period|Protocol Violation|0|||
147411537|NCT01123070|531671458|FG003|Part B Double Blind Period|Protocol Violation|1|||
147411538|NCT01123070|531671455|FG000|Part B Double Blind Period|Adverse Event|0|||
147411539|NCT01123070|531671456|FG001|Part B Double Blind Period|Adverse Event|0|||
147411540|NCT01123070|531671457|FG002|Part B Double Blind Period|Adverse Event|2|||
147411541|NCT01123070|531671458|FG003|Part B Double Blind Period|Adverse Event|0|||
147411542|NCT01123070|531671455|FG000|Part B Double Blind Period|Sponsor's Decision|0|||
147411543|NCT01123070|531671456|FG001|Part B Double Blind Period|Sponsor's Decision|0|||
147411544|NCT01123070|531671457|FG002|Part B Double Blind Period|Sponsor's Decision|2|||
147411545|NCT01123070|531671458|FG003|Part B Double Blind Period|Sponsor's Decision|2|||
147411546|NCT03284229|531671459|FG000|Overall Study|Lost to Follow-up|3|||
147411547|NCT01977677|531671461|FG000|Overall Study|Unrelated Adverse Event|0|||
147411548|NCT01977677|531671462|FG001|Overall Study|Unrelated Adverse Event|0|||
147411549|NCT01977677|531671463|FG002|Overall Study|Unrelated Adverse Event|1|||
147411550|NCT01498887|531671464|FG000|Overall Study|Administrative problems|1|||
147411551|NCT01498887|531671465|FG001|Overall Study|Administrative problems|0|||
147411552|NCT01498887|531671464|FG000|Overall Study|Lost to Follow-up|1|||
147411553|NCT01498887|531671465|FG001|Overall Study|Lost to Follow-up|1|||
147411554|NCT01498887|531671464|FG000|Overall Study|Withdrawal by Subject|1|||
147411555|NCT01498887|531671465|FG001|Overall Study|Withdrawal by Subject|0|||
147411556|NCT01498887|531671464|FG000|Overall Study|Protocol Violation|1|||
147411557|NCT01498887|531671465|FG001|Overall Study|Protocol Violation|3|||
147411558|NCT01498887|531671464|FG000|Overall Study|Lack of Efficacy|5|||
147411559|NCT01498887|531671465|FG001|Overall Study|Lack of Efficacy|3|||
147411560|NCT01498887|531671464|FG000|Overall Study|Abnormal result from test procedure|1|||
147411561|NCT01498887|531671465|FG001|Overall Study|Abnormal result from test procedure|1|||
147411562|NCT01498887|531671464|FG000|Overall Study|Abnormal laboratory value|2|||
147411563|NCT01498887|531671465|FG001|Overall Study|Abnormal laboratory value|2|||
147411564|NCT01498887|531671464|FG000|Overall Study|Adverse Event|4|||
147411565|NCT01498887|531671465|FG001|Overall Study|Adverse Event|1|||
147411566|NCT00667225|531671470|FG000|Overall Study|Subject had no more lesions to treat.|1|||
147411567|NCT00667225|531671471|FG001|Overall Study|Subject had no more lesions to treat.|0|||
147411568|NCT00667225|531671470|FG000|Overall Study|Lost to Follow-up|0|||
147411569|NCT00667225|531671471|FG001|Overall Study|Lost to Follow-up|1|||
147411570|NCT02993406|531671478|FG000|Overall Study|Withdrawal by Subject|170|||
147411571|NCT02993406|531671479|FG001|Overall Study|Withdrawal by Subject|196|||
147411572|NCT02993406|531671478|FG000|Overall Study|Physician Decision|3|||
147411573|NCT02993406|531671479|FG001|Overall Study|Physician Decision|5|||
147411574|NCT02993406|531671478|FG000|Overall Study|Lost to Follow-up|12|||
147411575|NCT02993406|531671479|FG001|Overall Study|Lost to Follow-up|13|||
147468428|NCT01307423|531872483|FG004|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
147468429|NCT01307423|531872484|FG005|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
147303123|NCT05044325|531276259|FG009|Part A:Treatment Period 1|Physician Decision|0|||
147303124|NCT05044325|531276250|FG000|Part A:Treatment Period 1|Withdrawal by Subject|0|||
147303125|NCT05044325|531276251|FG001|Part A:Treatment Period 1|Withdrawal by Subject|0|||
147303126|NCT05044325|531276252|FG002|Part A:Treatment Period 1|Withdrawal by Subject|1|||
147303127|NCT05044325|531276253|FG003|Part A:Treatment Period 1|Withdrawal by Subject|0|||
147303128|NCT05044325|531276254|FG004|Part A:Treatment Period 1|Withdrawal by Subject|0|||
147468430|NCT01307423|531872485|FG006|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
147303129|NCT05044325|531276255|FG005|Part A:Treatment Period 1|Withdrawal by Subject|0|||
147303130|NCT05044325|531276256|FG006|Part A:Treatment Period 1|Withdrawal by Subject|0|||
147303131|NCT05044325|531276257|FG007|Part A:Treatment Period 1|Withdrawal by Subject|0|||
147303132|NCT05044325|531276258|FG008|Part A:Treatment Period 1|Withdrawal by Subject|0|||
147303133|NCT05044325|531276259|FG009|Part A:Treatment Period 1|Withdrawal by Subject|0|||
147303134|NCT05044325|531276250|FG000|Part A:Treatment Period 2|Adverse Event|0|||
147303135|NCT05044325|531276251|FG001|Part A:Treatment Period 2|Adverse Event|1|||
147303136|NCT05044325|531276252|FG002|Part A:Treatment Period 2|Adverse Event|0|||
147303137|NCT05044325|531276253|FG003|Part A:Treatment Period 2|Adverse Event|0|||
147303138|NCT05044325|531276254|FG004|Part A:Treatment Period 2|Adverse Event|1|||
147303139|NCT05044325|531276255|FG005|Part A:Treatment Period 2|Adverse Event|1|||
147303140|NCT05044325|531276256|FG006|Part A:Treatment Period 2|Adverse Event|0|||
147303141|NCT05044325|531276257|FG007|Part A:Treatment Period 2|Adverse Event|0|||
147303142|NCT05044325|531276258|FG008|Part A:Treatment Period 2|Adverse Event|0|||
147303143|NCT05044325|531276259|FG009|Part A:Treatment Period 2|Adverse Event|0|||
147303144|NCT05044325|531276250|FG000|Part A:Treatment Period 2|Physician Decision|0|||
147303145|NCT05044325|531276251|FG001|Part A:Treatment Period 2|Physician Decision|0|||
147303146|NCT05044325|531276252|FG002|Part A:Treatment Period 2|Physician Decision|0|||
147619142|NCT00550459|532422506|FG000|Overall Study|Adverse Event|0|||
147619143|NCT00550459|532422507|FG001|Overall Study|Adverse Event|2|||
147619144|NCT00550459|532422506|FG000|Overall Study|Withdrawal by Subject|1|||
147619145|NCT00550459|532422507|FG001|Overall Study|Withdrawal by Subject|1|||
147619146|NCT02404805|532422508|FG000|Overall Study|Withdrawal by Subject|1|||
147619147|NCT02404805|532422509|FG001|Overall Study|Withdrawal by Subject|0|||
147619148|NCT02404805|532422510|FG002|Overall Study|Withdrawal by Subject|0|||
147619149|NCT02404805|532422511|FG003|Overall Study|Withdrawal by Subject|0|||
147619150|NCT02404805|532422512|FG004|Overall Study|Withdrawal by Subject|0|||
147619151|NCT02404805|532422513|FG005|Overall Study|Withdrawal by Subject|0|||
147619152|NCT01742897|532422514|FG000|Overall Study|Adverse Event|3|||
147619153|NCT01742897|532422514|FG000|Overall Study|Withdrawal by Subject|1|||
147619154|NCT01742897|532422514|FG000|Overall Study|Other|1|||
147619155|NCT04211831|532422517|FG000|Overall Study|Withdrawal by Subject|4|||
147619156|NCT04211831|532422518|FG001|Overall Study|Withdrawal by Subject|1|||
147619157|NCT04211831|532422519|FG002|Overall Study|Withdrawal by Subject|1|||
147619158|NCT04211831|532422517|FG000|Overall Study|Protocol Violation|0|||
147619159|NCT04211831|532422518|FG001|Overall Study|Protocol Violation|0|||
147619160|NCT04211831|532422519|FG002|Overall Study|Protocol Violation|1|||
147619161|NCT04211831|532422517|FG000|Overall Study|Adverse Event|0|||
147619162|NCT04211831|532422518|FG001|Overall Study|Adverse Event|1|||
147619163|NCT04211831|532422519|FG002|Overall Study|Adverse Event|0|||
147619164|NCT04211831|532422517|FG000|Overall Study|Lack of Efficacy|0|||
147619165|NCT04211831|532422518|FG001|Overall Study|Lack of Efficacy|0|||
147619166|NCT04211831|532422519|FG002|Overall Study|Lack of Efficacy|1|||
147619167|NCT04211831|532422517|FG000|Overall Study|Lost to Follow-up|0|||
147619168|NCT04211831|532422518|FG001|Overall Study|Lost to Follow-up|0|||
147619169|NCT04211831|532422519|FG002|Overall Study|Lost to Follow-up|2|||
147619170|NCT04211831|532422517|FG000|Overall Study|Unable to Complete the Procedures Successfully|0|||
147619171|NCT04211831|532422518|FG001|Overall Study|Unable to Complete the Procedures Successfully|1|||
147619172|NCT04211831|532422519|FG002|Overall Study|Unable to Complete the Procedures Successfully|0|||
147619173|NCT04211831|532422517|FG000|Overall Study|Other|0|||
147619174|NCT04211831|532422518|FG001|Overall Study|Other|1|||
147619175|NCT04211831|532422519|FG002|Overall Study|Other|0|||
147619176|NCT00967330|532422520|FG000|Overall Study|Protocol Violation|3|||
147619177|NCT00967330|532422521|FG001|Overall Study|Protocol Violation|4|||
147619178|NCT00967330|532422520|FG000|Overall Study|Regular|10|||
147619179|NCT00967330|532422521|FG001|Overall Study|Regular|3|||
147619180|NCT00967330|532422520|FG000|Overall Study|Withdrawal by Subject|6|||
147619181|NCT00967330|532422521|FG001|Overall Study|Withdrawal by Subject|0|||
147619182|NCT00967330|532422520|FG000|Overall Study|Lost to Follow-up|1|||
147619183|NCT00967330|532422521|FG001|Overall Study|Lost to Follow-up|1|||
147619184|NCT00967330|532422520|FG000|Overall Study|Death|102|||
147619185|NCT00967330|532422521|FG001|Overall Study|Death|51|||
147619186|NCT00967330|532422520|FG000|Overall Study|Severe protocol deviation|0|||
147619187|NCT00967330|532422521|FG001|Overall Study|Severe protocol deviation|1|||
147619188|NCT02698163|532422525|FG000|Overall Study|Lost to Follow-up|0|||
147619189|NCT02698163|532422526|FG001|Overall Study|Lost to Follow-up|1|||
147619190|NCT05373108|532422527|FG000|Overall Study|Withdrawal by Subject|2|||
147619191|NCT01133067|532422528|FG000|Overall Study|Death|136|||
147619192|NCT01133067|532422528|FG000|Overall Study|Lost to Follow-up|3|||
147619193|NCT00752128|532422529|FG000|Overall Study|Withdrawal by Subject|4|||
147619194|NCT00349973|532422533|FG000|Overall Study|Adverse Event|3|||
147619195|NCT00349973|532422534|FG001|Overall Study|Adverse Event|3|||
147619196|NCT00349973|532422533|FG000|Overall Study|Withdrawal by Subject|1|||
147619197|NCT00349973|532422534|FG001|Overall Study|Withdrawal by Subject|0|||
147619198|NCT04135937|532422535|FG000|Overall Study|Lost to Follow-up|2|||
147619199|NCT04135937|532422535|FG000|Overall Study|Withdrawal by Subject|1|||
147619200|NCT02548143|532422536|FG000|Overall Study|Adverse Event|1|||
147619201|NCT02548143|532422537|FG001|Overall Study|Adverse Event|0|||
147619202|NCT02548143|532422536|FG000|Overall Study|Withdrawal by Subject|0|||
147619203|NCT02548143|532422537|FG001|Overall Study|Withdrawal by Subject|1|||
147619204|NCT04871776|532422539|FG000|Overall Study|Death after randomization but before intervention could have been administered|0|||
147619205|NCT04871776|532422540|FG001|Overall Study|Death after randomization but before intervention could have been administered|2|||
147619206|NCT04871776|532422541|FG002|Overall Study|Death after randomization but before intervention could have been administered|1|||
147619207|NCT04871776|532422539|FG000|Overall Study|Did not meet eligibility criteria|1|||
147619208|NCT04871776|532422540|FG001|Overall Study|Did not meet eligibility criteria|1|||
147619209|NCT04871776|532422541|FG002|Overall Study|Did not meet eligibility criteria|1|||
147619210|NCT06389487|532422547|FG000|Overall Study|Lost to Follow-up|9|||
147619211|NCT06389487|532422548|FG001|Overall Study|Lost to Follow-up|5|||
147619212|NCT06389487|532422549|FG002|Overall Study|Lost to Follow-up|13|||
147619213|NCT06389487|532422547|FG000|Overall Study|Protocol Violation|0|||
147619214|NCT06389487|532422548|FG001|Overall Study|Protocol Violation|0|||
147619215|NCT06389487|532422549|FG002|Overall Study|Protocol Violation|2|||
147619216|NCT06389487|532422547|FG000|Overall Study|Withdrawal by Subject|2|||
147619217|NCT06389487|532422548|FG001|Overall Study|Withdrawal by Subject|2|||
147619218|NCT06389487|532422549|FG002|Overall Study|Withdrawal by Subject|1|||
147619219|NCT06389487|532422547|FG000|Overall Study|Other|1|||
147619220|NCT06389487|532422548|FG001|Overall Study|Other|0|||
147619221|NCT06389487|532422549|FG002|Overall Study|Other|1|||
147468431|NCT01307423|531872486|FG007|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
147468432|NCT01307423|531872487|FG008|Placebo-controlled Phase (Week 0 - 24)|Lost to Follow-up|0|||
147468433|NCT01307423|531872479|FG000|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|1|||
147468434|NCT01307423|531872480|FG001|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
147468435|NCT01307423|531872481|FG002|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
147468436|NCT01307423|531872482|FG003|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
147468437|NCT01307423|531872483|FG004|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
147468438|NCT01307423|531872484|FG005|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
147468439|NCT01307423|531872485|FG006|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
147468440|NCT01307423|531872486|FG007|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
147468441|NCT01307423|531872487|FG008|Placebo-controlled Phase (Week 0 - 24)|Protocol Violation|0|||
147468442|NCT01307423|531872479|FG000|Placebo-controlled Phase (Week 0 - 24)|Other|1|||
147468443|NCT01307423|531872480|FG001|Placebo-controlled Phase (Week 0 - 24)|Other|2|||
147468444|NCT01307423|531872481|FG002|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
147468445|NCT01307423|531872482|FG003|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
147468446|NCT01307423|531872483|FG004|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
147468447|NCT01307423|531872484|FG005|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
147468448|NCT01307423|531872485|FG006|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
147468449|NCT01307423|531872486|FG007|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
147468450|NCT01307423|531872487|FG008|Placebo-controlled Phase (Week 0 - 24)|Other|0|||
147468451|NCT01307423|531872479|FG000|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
147468452|NCT01307423|531872480|FG001|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|1|||
147468453|NCT01307423|531872481|FG002|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|1|||
147468454|NCT01307423|531872482|FG003|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
147468455|NCT01307423|531872483|FG004|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
147468456|NCT01307423|531872484|FG005|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
147468457|NCT01307423|531872485|FG006|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
147468458|NCT01307423|531872486|FG007|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
147468459|NCT01307423|531872487|FG008|Placebo-controlled Phase (Week 0 - 24)|Non-compliance with Study Drug|0|||
147468460|NCT01307423|531872479|FG000|Active Treatment Phase (Week 25-52)|Adverse Event|0|||
147468461|NCT01307423|531872480|FG001|Active Treatment Phase (Week 25-52)|Adverse Event|3|||
147468462|NCT01307423|531872481|FG002|Active Treatment Phase (Week 25-52)|Adverse Event|2|||
147619222|NCT01168232|532424469|FG000|Overall Study|Ineligible-Second primary cancer site|1|||
147619223|NCT01168232|532424469|FG000|Overall Study|Ineligible- Wrong cell type|6|||
147619224|NCT01168232|532424469|FG000|Overall Study|Ineligible-Inadequate pathology|1|||
147619225|NCT04510090|532424472|FG000|FE-HS|Withdrawal by Subject|0|||
147619226|NCT04510090|532424473|FG001|FE-HS|Withdrawal by Subject|0|||
147619227|NCT04510090|532424474|FG002|FE-HS|Withdrawal by Subject|0|||
147619228|NCT04510090|532424475|FG003|FE-HS|Withdrawal by Subject|0|||
147619229|NCT04510090|532424476|FG004|FE-HS|Withdrawal by Subject|1|||
147619230|NCT04510090|532424477|FG005|FE-HS|Withdrawal by Subject|0|||
147619231|NCT04510090|532424478|FG006|FE-HS|Withdrawal by Subject|0|||
147619232|NCT04510090|532424479|FG007|FE-HS|Withdrawal by Subject|0|||
147619233|NCT01749826|532424480|FG000|Overall Study|Study Terminated|20|||
147619234|NCT01749826|532424481|FG001|Overall Study|Study Terminated|0|||
147619235|NCT01922037|532424482|FG000|Overall Study|Withdrawal by Subject|2|||
147619236|NCT01922037|532424483|FG001|Overall Study|Withdrawal by Subject|44|||
147411576|NCT02993406|531671478|FG000|Overall Study|Unclassifiable Response|105|||
147411577|NCT02993406|531671479|FG001|Overall Study|Unclassifiable Response|139|||
147411578|NCT02993406|531671478|FG000|Overall Study|Administrative decision|1|||
147411579|NCT02993406|531671479|FG001|Overall Study|Administrative decision|0|||
147411580|NCT02993406|531671478|FG000|Overall Study|Sponsor decision|4|||
147411581|NCT02993406|531671479|FG001|Overall Study|Sponsor decision|5|||
147411582|NCT03563157|531671480|FG000|Overall Study|Progressive Disease|2|||
147411583|NCT02248818|531671481|FG000|Screening|Protocol Violation|0|||
147411584|NCT02248818|531671482|FG001|Screening|Protocol Violation|0|||
147411585|NCT02248818|531671483|FG002|Screening|Protocol Violation|0|||
147411586|NCT02248818|531671484|FG003|Screening|Protocol Violation|0|||
147411587|NCT02248818|531671485|FG004|Screening|Protocol Violation|0|||
147411588|NCT02248818|531671486|FG005|Screening|Protocol Violation|0|||
147411589|NCT02248818|531671487|FG006|Screening|Protocol Violation|0|||
147411590|NCT02248818|531671488|FG007|Screening|Protocol Violation|0|||
147411591|NCT02248818|531671489|FG008|Screening|Protocol Violation|7|||
147411592|NCT02248818|531671481|FG000|Screening|Study fully enrolled|0|||
147411593|NCT02248818|531671482|FG001|Screening|Study fully enrolled|0|||
147411594|NCT02248818|531671483|FG002|Screening|Study fully enrolled|0|||
147411595|NCT02248818|531671484|FG003|Screening|Study fully enrolled|0|||
147411596|NCT02248818|531671485|FG004|Screening|Study fully enrolled|0|||
147411597|NCT02248818|531671486|FG005|Screening|Study fully enrolled|0|||
147411598|NCT02248818|531671487|FG006|Screening|Study fully enrolled|0|||
147411599|NCT02248818|531671488|FG007|Screening|Study fully enrolled|0|||
147411600|NCT02248818|531671489|FG008|Screening|Study fully enrolled|14|||
147411601|NCT02248818|531671481|FG000|Screening|Physician Decision|0|||
147411602|NCT02248818|531671482|FG001|Screening|Physician Decision|0|||
147411603|NCT02248818|531671483|FG002|Screening|Physician Decision|0|||
147411604|NCT02248818|531671484|FG003|Screening|Physician Decision|0|||
147411605|NCT02248818|531671485|FG004|Screening|Physician Decision|0|||
147411606|NCT02248818|531671486|FG005|Screening|Physician Decision|0|||
147411607|NCT02248818|531671487|FG006|Screening|Physician Decision|0|||
147411608|NCT02248818|531671488|FG007|Screening|Physician Decision|0|||
147411609|NCT02248818|531671489|FG008|Screening|Physician Decision|73|||
147411610|NCT02248818|531671481|FG000|Screening|Withdrawal by Subject|0|||
147411611|NCT02248818|531671482|FG001|Screening|Withdrawal by Subject|0|||
147411612|NCT02248818|531671483|FG002|Screening|Withdrawal by Subject|0|||
147411613|NCT02248818|531671484|FG003|Screening|Withdrawal by Subject|0|||
147411614|NCT02248818|531671485|FG004|Screening|Withdrawal by Subject|0|||
147411615|NCT02248818|531671486|FG005|Screening|Withdrawal by Subject|0|||
147411616|NCT02248818|531671487|FG006|Screening|Withdrawal by Subject|0|||
147411617|NCT02248818|531671488|FG007|Screening|Withdrawal by Subject|0|||
147411618|NCT02248818|531671489|FG008|Screening|Withdrawal by Subject|6|||
147411619|NCT02248818|531671481|FG000|Screening|Lost to Follow-up|0|||
147411620|NCT02248818|531671482|FG001|Screening|Lost to Follow-up|0|||
147411621|NCT02248818|531671483|FG002|Screening|Lost to Follow-up|0|||
147411622|NCT02248818|531671484|FG003|Screening|Lost to Follow-up|0|||
147411623|NCT02248818|531671485|FG004|Screening|Lost to Follow-up|0|||
147411624|NCT02248818|531671486|FG005|Screening|Lost to Follow-up|0|||
147411625|NCT02248818|531671487|FG006|Screening|Lost to Follow-up|0|||
147411626|NCT02248818|531671488|FG007|Screening|Lost to Follow-up|0|||
147411627|NCT02248818|531671489|FG008|Screening|Lost to Follow-up|7|||
147411628|NCT02248818|531671481|FG000|Randomised Study|Administrative - randomization error|0|||
147411629|NCT02248818|531671482|FG001|Randomised Study|Administrative - randomization error|0|||
147411630|NCT02248818|531671483|FG002|Randomised Study|Administrative - randomization error|0|||
147411631|NCT02248818|531671484|FG003|Randomised Study|Administrative - randomization error|0|||
147411632|NCT02248818|531671485|FG004|Randomised Study|Administrative - randomization error|0|||
147411633|NCT02248818|531671486|FG005|Randomised Study|Administrative - randomization error|8|||
147411634|NCT02248818|531671487|FG006|Randomised Study|Administrative - randomization error|0|||
147411635|NCT02248818|531671488|FG007|Randomised Study|Administrative - randomization error|0|||
147411636|NCT02248818|531671489|FG008|Randomised Study|Administrative - randomization error|0|||
147411637|NCT05262517|531671490|FG000|Overall Study|Randomized but not treated|5|||
147411638|NCT05262517|531671491|FG001|Overall Study|Randomized but not treated|11|||
147411639|NCT02942277|531671492|FG000|Year 1|Withdrawal by Subject|0|||
147411640|NCT02942277|531671493|FG001|Year 1|Withdrawal by Subject|0|||
147411641|NCT02942277|531671494|FG002|Year 1|Withdrawal by Subject|0|||
147411642|NCT02942277|531671495|FG003|Year 1|Withdrawal by Subject|0|||
147619237|NCT01922037|532424482|FG000|Overall Study|Adverse Event|1|||
147468463|NCT01307423|531872482|FG003|Active Treatment Phase (Week 25-52)|Adverse Event|2|||
147468464|NCT01307423|531872483|FG004|Active Treatment Phase (Week 25-52)|Adverse Event|2|||
147468465|NCT01307423|531872484|FG005|Active Treatment Phase (Week 25-52)|Adverse Event|0|||
147468466|NCT01307423|531872485|FG006|Active Treatment Phase (Week 25-52)|Adverse Event|0|||
147468467|NCT01307423|531872486|FG007|Active Treatment Phase (Week 25-52)|Adverse Event|0|||
147468468|NCT01307423|531872487|FG008|Active Treatment Phase (Week 25-52)|Adverse Event|0|||
147468469|NCT01307423|531872479|FG000|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0|||
147468470|NCT01307423|531872480|FG001|Active Treatment Phase (Week 25-52)|Lack of Efficacy|5|||
147468471|NCT01307423|531872481|FG002|Active Treatment Phase (Week 25-52)|Lack of Efficacy|5|||
147468472|NCT01307423|531872482|FG003|Active Treatment Phase (Week 25-52)|Lack of Efficacy|3|||
147468473|NCT01307423|531872483|FG004|Active Treatment Phase (Week 25-52)|Lack of Efficacy|1|||
147468474|NCT01307423|531872484|FG005|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0|||
147468475|NCT01307423|531872485|FG006|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0|||
147468476|NCT01307423|531872486|FG007|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0|||
147468477|NCT01307423|531872487|FG008|Active Treatment Phase (Week 25-52)|Lack of Efficacy|0|||
147468478|NCT01307423|531872479|FG000|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
147468479|NCT01307423|531872480|FG001|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
147468480|NCT01307423|531872481|FG002|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
147468481|NCT01307423|531872482|FG003|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
147468482|NCT01307423|531872483|FG004|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
147468483|NCT01307423|531872484|FG005|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|1|||
147468484|NCT01307423|531872485|FG006|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
147468485|NCT01307423|531872486|FG007|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
147468486|NCT01307423|531872487|FG008|Active Treatment Phase (Week 25-52)|Non-compliance with Study Drug|0|||
147468487|NCT01307423|531872479|FG000|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0|||
147468488|NCT01307423|531872480|FG001|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|11|||
147468489|NCT01307423|531872481|FG002|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|2|||
147468490|NCT01307423|531872482|FG003|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0|||
147468491|NCT01307423|531872483|FG004|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0|||
147468492|NCT01307423|531872484|FG005|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|1|||
147468493|NCT01307423|531872485|FG006|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|1|||
147468494|NCT01307423|531872486|FG007|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0|||
147468495|NCT01307423|531872487|FG008|Active Treatment Phase (Week 25-52)|Withdrawal by Subject|0|||
147468496|NCT01307423|531872479|FG000|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
147468497|NCT01307423|531872480|FG001|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
147468498|NCT01307423|531872481|FG002|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
147468499|NCT01307423|531872482|FG003|Active Treatment Phase (Week 25-52)|Lost to Follow-up|2|||
147468500|NCT01307423|531872483|FG004|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
147468501|NCT01307423|531872484|FG005|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
147468502|NCT01307423|531872485|FG006|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
147468503|NCT01307423|531872486|FG007|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
147468504|NCT01307423|531872487|FG008|Active Treatment Phase (Week 25-52)|Lost to Follow-up|0|||
147468505|NCT01307423|531872479|FG000|Active Treatment Phase (Week 25-52)|Other|0|||
147468506|NCT01307423|531872480|FG001|Active Treatment Phase (Week 25-52)|Other|0|||
147468507|NCT01307423|531872481|FG002|Active Treatment Phase (Week 25-52)|Other|0|||
147468508|NCT01307423|531872482|FG003|Active Treatment Phase (Week 25-52)|Other|1|||
147468509|NCT01307423|531872483|FG004|Active Treatment Phase (Week 25-52)|Other|0|||
147468510|NCT01307423|531872484|FG005|Active Treatment Phase (Week 25-52)|Other|0|||
147468511|NCT01307423|531872485|FG006|Active Treatment Phase (Week 25-52)|Other|0|||
147468512|NCT01307423|531872486|FG007|Active Treatment Phase (Week 25-52)|Other|0|||
147619238|NCT01922037|532424483|FG001|Overall Study|Adverse Event|7|||
147468513|NCT01307423|531872487|FG008|Active Treatment Phase (Week 25-52)|Other|0|||
147468514|NCT01307423|531872479|FG000|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
147468515|NCT01307423|531872480|FG001|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
147468516|NCT01307423|531872481|FG002|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
147468517|NCT01307423|531872482|FG003|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
147468518|NCT01307423|531872483|FG004|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
147468519|NCT01307423|531872484|FG005|Active Treatment Phase (Week 25-52)|Protocol Violation|1|||
147619239|NCT01922037|532424482|FG000|Overall Study|Death|0|||
147619240|NCT01922037|532424483|FG001|Overall Study|Death|5|||
147619241|NCT01922037|532424482|FG000|Overall Study|Pregnancy|0|||
147619242|NCT01922037|532424483|FG001|Overall Study|Pregnancy|2|||
147619243|NCT01922037|532424482|FG000|Overall Study|Participant non-compliance|4|||
147619244|NCT01922037|532424483|FG001|Overall Study|Participant non-compliance|46|||
147619245|NCT01922037|532424482|FG000|Overall Study|Investigator/Sponsor decision|1|||
147619246|NCT01922037|532424483|FG001|Overall Study|Investigator/Sponsor decision|4|||
147619247|NCT01922037|532424482|FG000|Overall Study|Other unspecified|2|||
147619248|NCT01922037|532424483|FG001|Overall Study|Other unspecified|66|||
147468520|NCT01307423|531872485|FG006|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
147468521|NCT01307423|531872486|FG007|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
147468522|NCT01307423|531872487|FG008|Active Treatment Phase (Week 25-52)|Protocol Violation|0|||
147468523|NCT01307423|531872479|FG000|Long-term Safety Phase (Year 2)|Adverse Event|0|||
147468524|NCT01307423|531872480|FG001|Long-term Safety Phase (Year 2)|Adverse Event|2|||
147468525|NCT01307423|531872481|FG002|Long-term Safety Phase (Year 2)|Adverse Event|7|||
147468526|NCT01307423|531872482|FG003|Long-term Safety Phase (Year 2)|Adverse Event|0|||
147468527|NCT01307423|531872483|FG004|Long-term Safety Phase (Year 2)|Adverse Event|0|||
147468528|NCT01307423|531872484|FG005|Long-term Safety Phase (Year 2)|Adverse Event|0|||
147468529|NCT01307423|531872485|FG006|Long-term Safety Phase (Year 2)|Adverse Event|0|||
147468530|NCT01307423|531872486|FG007|Long-term Safety Phase (Year 2)|Adverse Event|1|||
147468531|NCT01307423|531872487|FG008|Long-term Safety Phase (Year 2)|Adverse Event|1|||
147468532|NCT01307423|531872479|FG000|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
147468533|NCT01307423|531872480|FG001|Long-term Safety Phase (Year 2)|Lack of Efficacy|7|||
147468534|NCT01307423|531872481|FG002|Long-term Safety Phase (Year 2)|Lack of Efficacy|5|||
147468535|NCT01307423|531872482|FG003|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
147468536|NCT01307423|531872483|FG004|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
147468537|NCT01307423|531872484|FG005|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
147468538|NCT01307423|531872485|FG006|Long-term Safety Phase (Year 2)|Lack of Efficacy|0|||
147468539|NCT01307423|531872486|FG007|Long-term Safety Phase (Year 2)|Lack of Efficacy|4|||
147468540|NCT01307423|531872487|FG008|Long-term Safety Phase (Year 2)|Lack of Efficacy|3|||
147468541|NCT01307423|531872479|FG000|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
147468542|NCT01307423|531872480|FG001|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
147468543|NCT01307423|531872481|FG002|Long-term Safety Phase (Year 2)|Noncompliance with study drug|1|||
147468544|NCT01307423|531872482|FG003|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
147468545|NCT01307423|531872483|FG004|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
147468546|NCT01307423|531872484|FG005|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
147468547|NCT01307423|531872485|FG006|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
147468548|NCT01307423|531872486|FG007|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
147468549|NCT01307423|531872487|FG008|Long-term Safety Phase (Year 2)|Noncompliance with study drug|0|||
147468550|NCT01307423|531872479|FG000|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
147468551|NCT01307423|531872480|FG001|Long-term Safety Phase (Year 2)|Withdrawal by Subject|13|||
147468552|NCT01307423|531872481|FG002|Long-term Safety Phase (Year 2)|Withdrawal by Subject|12|||
147468553|NCT01307423|531872482|FG003|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
147468554|NCT01307423|531872483|FG004|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
147468555|NCT01307423|531872484|FG005|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
147468556|NCT01307423|531872485|FG006|Long-term Safety Phase (Year 2)|Withdrawal by Subject|0|||
147468557|NCT01307423|531872486|FG007|Long-term Safety Phase (Year 2)|Withdrawal by Subject|3|||
147468558|NCT01307423|531872487|FG008|Long-term Safety Phase (Year 2)|Withdrawal by Subject|2|||
147468559|NCT01307423|531872479|FG000|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
147468560|NCT01307423|531872480|FG001|Long-term Safety Phase (Year 2)|Miscellaneous|1|||
147468561|NCT01307423|531872481|FG002|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
147468562|NCT01307423|531872482|FG003|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
147468563|NCT01307423|531872483|FG004|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
147468564|NCT01307423|531872484|FG005|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
147468565|NCT01307423|531872485|FG006|Long-term Safety Phase (Year 2)|Miscellaneous|0|||
147468566|NCT01307423|531872486|FG007|Long-term Safety Phase (Year 2)|Miscellaneous|1|||
147468567|NCT01307423|531872487|FG008|Long-term Safety Phase (Year 2)|Miscellaneous|1|||
147468568|NCT01307423|531872479|FG000|Long-term Safety Phase (Year 3)|Adverse Event|0|||
147468569|NCT01307423|531872480|FG001|Long-term Safety Phase (Year 3)|Adverse Event|1|||
147468570|NCT01307423|531872481|FG002|Long-term Safety Phase (Year 3)|Adverse Event|2|||
147468571|NCT01307423|531872482|FG003|Long-term Safety Phase (Year 3)|Adverse Event|0|||
147468572|NCT01307423|531872483|FG004|Long-term Safety Phase (Year 3)|Adverse Event|0|||
147468573|NCT01307423|531872484|FG005|Long-term Safety Phase (Year 3)|Adverse Event|0|||
147468574|NCT01307423|531872485|FG006|Long-term Safety Phase (Year 3)|Adverse Event|0|||
147468575|NCT01307423|531872486|FG007|Long-term Safety Phase (Year 3)|Adverse Event|3|||
147468576|NCT01307423|531872487|FG008|Long-term Safety Phase (Year 3)|Adverse Event|4|||
147468577|NCT01307423|531872479|FG000|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
147468578|NCT01307423|531872480|FG001|Long-term Safety Phase (Year 3)|Lack of Efficacy|2|||
147468579|NCT01307423|531872481|FG002|Long-term Safety Phase (Year 3)|Lack of Efficacy|4|||
147468580|NCT01307423|531872482|FG003|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
147468581|NCT01307423|531872483|FG004|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
147468582|NCT01307423|531872484|FG005|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
147468583|NCT01307423|531872485|FG006|Long-term Safety Phase (Year 3)|Lack of Efficacy|0|||
147468584|NCT01307423|531872486|FG007|Long-term Safety Phase (Year 3)|Lack of Efficacy|1|||
147468585|NCT01307423|531872487|FG008|Long-term Safety Phase (Year 3)|Lack of Efficacy|2|||
147619249|NCT05085834|532424484|FG000|Overall Study|Lost to Follow-up|9|||
147619250|NCT05085834|532424485|FG001|Overall Study|Lost to Follow-up|2|||
147468586|NCT01307423|531872479|FG000|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
147468587|NCT01307423|531872480|FG001|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|1|||
147468588|NCT01307423|531872481|FG002|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|1|||
147468589|NCT01307423|531872482|FG003|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
147468590|NCT01307423|531872483|FG004|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
147468591|NCT01307423|531872484|FG005|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
147468592|NCT01307423|531872485|FG006|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
147468593|NCT01307423|531872486|FG007|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
147468594|NCT01307423|531872487|FG008|Long-term Safety Phase (Year 3)|Noncompliance with Study Drug|0|||
147468595|NCT01307423|531872479|FG000|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
147468596|NCT01307423|531872480|FG001|Long-term Safety Phase (Year 3)|Withdrawal by Subject|2|||
147468597|NCT01307423|531872481|FG002|Long-term Safety Phase (Year 3)|Withdrawal by Subject|8|||
147619251|NCT05085834|532424484|FG000|Overall Study|Adverse Event|6|||
147468598|NCT01307423|531872482|FG003|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
147468599|NCT01307423|531872483|FG004|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
147468600|NCT01307423|531872484|FG005|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
147468601|NCT01307423|531872485|FG006|Long-term Safety Phase (Year 3)|Withdrawal by Subject|0|||
147468602|NCT01307423|531872486|FG007|Long-term Safety Phase (Year 3)|Withdrawal by Subject|2|||
147468603|NCT01307423|531872487|FG008|Long-term Safety Phase (Year 3)|Withdrawal by Subject|4|||
147468604|NCT01307423|531872479|FG000|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
147468605|NCT01307423|531872480|FG001|Long-term Safety Phase (Year 3)|Lost to Follow-up|2|||
147468606|NCT01307423|531872481|FG002|Long-term Safety Phase (Year 3)|Lost to Follow-up|3|||
147468607|NCT01307423|531872482|FG003|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
147468608|NCT01307423|531872483|FG004|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
147468609|NCT01307423|531872484|FG005|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
147468610|NCT01307423|531872485|FG006|Long-term Safety Phase (Year 3)|Lost to Follow-up|0|||
147468611|NCT01307423|531872486|FG007|Long-term Safety Phase (Year 3)|Lost to Follow-up|1|||
147468612|NCT01307423|531872487|FG008|Long-term Safety Phase (Year 3)|Lost to Follow-up|1|||
147468613|NCT01307423|531872479|FG000|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
147468614|NCT01307423|531872480|FG001|Long-term Safety Phase (Year 3)|Miscellaneous|1|||
147468615|NCT01307423|531872481|FG002|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
147468616|NCT01307423|531872482|FG003|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
147468617|NCT01307423|531872483|FG004|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
147468618|NCT01307423|531872484|FG005|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
147468619|NCT01307423|531872485|FG006|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
147468620|NCT01307423|531872486|FG007|Long-term Safety Phase (Year 3)|Miscellaneous|1|||
147468621|NCT01307423|531872487|FG008|Long-term Safety Phase (Year 3)|Miscellaneous|0|||
147468622|NCT01307423|531872479|FG000|Long-term Safety Phase (Year 4)|Adverse Event|0|||
147468623|NCT01307423|531872480|FG001|Long-term Safety Phase (Year 4)|Adverse Event|2|||
147468624|NCT01307423|531872481|FG002|Long-term Safety Phase (Year 4)|Adverse Event|0|||
147468625|NCT01307423|531872482|FG003|Long-term Safety Phase (Year 4)|Adverse Event|0|||
147468626|NCT01307423|531872483|FG004|Long-term Safety Phase (Year 4)|Adverse Event|0|||
147468627|NCT01307423|531872484|FG005|Long-term Safety Phase (Year 4)|Adverse Event|0|||
147468628|NCT01307423|531872485|FG006|Long-term Safety Phase (Year 4)|Adverse Event|0|||
147468629|NCT01307423|531872486|FG007|Long-term Safety Phase (Year 4)|Adverse Event|0|||
147468630|NCT01307423|531872487|FG008|Long-term Safety Phase (Year 4)|Adverse Event|0|||
147468631|NCT01307423|531872479|FG000|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
147468632|NCT01307423|531872480|FG001|Long-term Safety Phase (Year 4)|Lack of Efficacy|1|||
147468633|NCT01307423|531872481|FG002|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
147468634|NCT01307423|531872482|FG003|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
147468635|NCT01307423|531872483|FG004|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
147468636|NCT01307423|531872484|FG005|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
147468637|NCT01307423|531872485|FG006|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
147468638|NCT01307423|531872486|FG007|Long-term Safety Phase (Year 4)|Lack of Efficacy|0|||
147468639|NCT01307423|531872487|FG008|Long-term Safety Phase (Year 4)|Lack of Efficacy|1|||
147468640|NCT01307423|531872479|FG000|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
147468641|NCT01307423|531872480|FG001|Long-term Safety Phase (Year 4)|Withdrawal by Subject|5|||
147468642|NCT01307423|531872481|FG002|Long-term Safety Phase (Year 4)|Withdrawal by Subject|4|||
147468643|NCT01307423|531872482|FG003|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
147468644|NCT01307423|531872483|FG004|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
147619252|NCT05085834|532424485|FG001|Overall Study|Adverse Event|0|||
147619253|NCT05085834|532424484|FG000|Overall Study|Death|1|||
147619254|NCT05085834|532424485|FG001|Overall Study|Death|0|||
147619255|NCT05085834|532424484|FG000|Overall Study|Inability to swallow the pill|0|||
147619256|NCT05085834|532424485|FG001|Overall Study|Inability to swallow the pill|1|||
147468645|NCT01307423|531872484|FG005|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
147468646|NCT01307423|531872485|FG006|Long-term Safety Phase (Year 4)|Withdrawal by Subject|0|||
147468647|NCT01307423|531872486|FG007|Long-term Safety Phase (Year 4)|Withdrawal by Subject|1|||
147468648|NCT01307423|531872487|FG008|Long-term Safety Phase (Year 4)|Withdrawal by Subject|4|||
147468649|NCT01307423|531872479|FG000|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
147468650|NCT01307423|531872480|FG001|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
147468651|NCT01307423|531872481|FG002|Long-term Safety Phase (Year 4)|Lost to Follow-up|1|||
147468652|NCT01307423|531872482|FG003|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
147468653|NCT01307423|531872483|FG004|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
147468654|NCT01307423|531872484|FG005|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
147468655|NCT01307423|531872485|FG006|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
147468656|NCT01307423|531872486|FG007|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
147468657|NCT01307423|531872487|FG008|Long-term Safety Phase (Year 4)|Lost to Follow-up|0|||
147468658|NCT01307423|531872479|FG000|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
147468659|NCT01307423|531872480|FG001|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
147468660|NCT01307423|531872481|FG002|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
147468661|NCT01307423|531872482|FG003|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
147468662|NCT01307423|531872483|FG004|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
147468663|NCT01307423|531872484|FG005|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
147468664|NCT01307423|531872485|FG006|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
147468665|NCT01307423|531872486|FG007|Long-term Safety Phase (Year 4)|Miscellaneous|1|||
147468666|NCT01307423|531872487|FG008|Long-term Safety Phase (Year 4)|Miscellaneous|0|||
147468667|NCT01307423|531872479|FG000|Long-term Safety Phase (Year 5)|Adverse Event|0|||
147468668|NCT01307423|531872480|FG001|Long-term Safety Phase (Year 5)|Adverse Event|1|||
147468669|NCT01307423|531872481|FG002|Long-term Safety Phase (Year 5)|Adverse Event|1|||
147468670|NCT01307423|531872482|FG003|Long-term Safety Phase (Year 5)|Adverse Event|0|||
147468671|NCT01307423|531872483|FG004|Long-term Safety Phase (Year 5)|Adverse Event|0|||
147468672|NCT01307423|531872484|FG005|Long-term Safety Phase (Year 5)|Adverse Event|0|||
147468673|NCT01307423|531872485|FG006|Long-term Safety Phase (Year 5)|Adverse Event|0|||
147468674|NCT01307423|531872486|FG007|Long-term Safety Phase (Year 5)|Adverse Event|0|||
147468675|NCT01307423|531872487|FG008|Long-term Safety Phase (Year 5)|Adverse Event|1|||
147468676|NCT01307423|531872479|FG000|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
147468677|NCT01307423|531872480|FG001|Long-term Safety Phase (Year 5)|Lack of Efficacy|2|||
147468678|NCT01307423|531872481|FG002|Long-term Safety Phase (Year 5)|Lack of Efficacy|1|||
147468679|NCT01307423|531872482|FG003|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
147468680|NCT01307423|531872483|FG004|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
147468681|NCT01307423|531872484|FG005|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
147468682|NCT01307423|531872485|FG006|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
147468683|NCT01307423|531872486|FG007|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
147468684|NCT01307423|531872487|FG008|Long-term Safety Phase (Year 5)|Lack of Efficacy|0|||
147468685|NCT01307423|531872479|FG000|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
147468686|NCT01307423|531872480|FG001|Long-term Safety Phase (Year 5)|Withdrawal by Subject|6|||
147468687|NCT01307423|531872481|FG002|Long-term Safety Phase (Year 5)|Withdrawal by Subject|2|||
147468688|NCT01307423|531872482|FG003|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
147468689|NCT01307423|531872483|FG004|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
147468690|NCT01307423|531872484|FG005|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
147468691|NCT01307423|531872485|FG006|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
147468692|NCT01307423|531872486|FG007|Long-term Safety Phase (Year 5)|Withdrawal by Subject|0|||
147468693|NCT01307423|531872487|FG008|Long-term Safety Phase (Year 5)|Withdrawal by Subject|1|||
147468694|NCT01307423|531872479|FG000|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
147468695|NCT01307423|531872480|FG001|Long-term Safety Phase (Year 5)|Lost to Follow-up|1|||
147468696|NCT01307423|531872481|FG002|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
147468697|NCT01307423|531872482|FG003|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
147468698|NCT01307423|531872483|FG004|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
147468699|NCT01307423|531872484|FG005|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
147468700|NCT01307423|531872485|FG006|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
147468701|NCT01307423|531872486|FG007|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
147468702|NCT01307423|531872487|FG008|Long-term Safety Phase (Year 5)|Lost to Follow-up|0|||
147468703|NCT01307423|531872479|FG000|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
147468704|NCT01307423|531872480|FG001|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
147468705|NCT01307423|531872481|FG002|Long-term Safety Phase (Year 5)|Miscellaneous|2|||
147468706|NCT01307423|531872482|FG003|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
147468707|NCT01307423|531872483|FG004|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
147468708|NCT01307423|531872484|FG005|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
147468709|NCT01307423|531872485|FG006|Long-term Safety Phase (Year 5)|Miscellaneous|0|||
147468710|NCT01307423|531872486|FG007|Long-term Safety Phase (Year 5)|Miscellaneous|1|||
147468711|NCT01307423|531872487|FG008|Long-term Safety Phase (Year 5)|Miscellaneous|1|||
147468712|NCT01499290|531872488|FG000|Overall Study|Withdrawal by Subject|22|||
147468713|NCT01499290|531872489|FG001|Overall Study|Withdrawal by Subject|15|||
147468714|NCT01499290|531872488|FG000|Overall Study|Not specified in study report|11|||
147468715|NCT01499290|531872489|FG001|Overall Study|Not specified in study report|5|||
147468716|NCT01499290|531872488|FG000|Overall Study|Condition improved/subject recovered|1|||
147468717|NCT01499290|531872489|FG001|Overall Study|Condition improved/subject recovered|0|||
147468718|NCT01499290|531872488|FG000|Overall Study|Lack of Efficacy|7|||
147468719|NCT01499290|531872489|FG001|Overall Study|Lack of Efficacy|8|||
147468720|NCT01499290|531872488|FG000|Overall Study|Adverse Event|14|||
147468721|NCT01499290|531872489|FG001|Overall Study|Adverse Event|7|||
147468722|NCT02209766|531872490|FG000|Overall Study|Withdrawal by Subject|0|||
147468723|NCT02209766|531872491|FG001|Overall Study|Withdrawal by Subject|0|||
147468724|NCT02209766|531872492|FG002|Overall Study|Withdrawal by Subject|0|||
147468725|NCT02209766|531872493|FG003|Overall Study|Withdrawal by Subject|1|||
147468726|NCT02209766|531872494|FG004|Overall Study|Withdrawal by Subject|0|||
147468727|NCT00327444|531872495|FG000|Double Blind Treatment (DB) Period|Disease progression|10|||
147468728|NCT00327444|531872496|FG001|Double Blind Treatment (DB) Period|Disease progression|13|||
147468729|NCT00327444|531872495|FG000|Double Blind Treatment (DB) Period|Adverse Event|5|||
147468730|NCT00327444|531872496|FG001|Double Blind Treatment (DB) Period|Adverse Event|5|||
147468731|NCT00327444|531872495|FG000|Double Blind Treatment (DB) Period|Subject request|0|||
147468732|NCT00327444|531872496|FG001|Double Blind Treatment (DB) Period|Subject request|1|||
147468733|NCT00327444|531872495|FG000|Double Blind Treatment (DB) Period|Withdrew DB and continued to OL|11|||
147468734|NCT00327444|531872496|FG001|Double Blind Treatment (DB) Period|Withdrew DB and continued to OL|10|||
147468735|NCT00327444|531872495|FG000|Open Label Treatment (OL) Period|Disease progression|8|||
147468736|NCT00327444|531872496|FG001|Open Label Treatment (OL) Period|Disease progression|7|||
147468737|NCT00327444|531872495|FG000|Open Label Treatment (OL) Period|Adverse Event|2|||
147468738|NCT00327444|531872496|FG001|Open Label Treatment (OL) Period|Adverse Event|2|||
147468739|NCT00327444|531872495|FG000|Open Label Treatment (OL) Period|Worsening dyspnea|0|||
147468740|NCT00327444|531872496|FG001|Open Label Treatment (OL) Period|Worsening dyspnea|1|||
147468741|NCT00327444|531872495|FG000|Open Label Treatment (OL) Period|Ongoing Treatment|1|||
147468742|NCT00327444|531872496|FG001|Open Label Treatment (OL) Period|Ongoing Treatment|0|||
147468743|NCT03896295|531872497|FG000|Overall Study|Adverse Event|0|||
147468744|NCT03896295|531872498|FG001|Overall Study|Adverse Event|1|||
147468745|NCT03896295|531872497|FG000|Overall Study|COVID-19|7|||
147468746|NCT03896295|531872498|FG001|Overall Study|COVID-19|29|||
147468747|NCT00552110|531872499|FG000|Overall Study|Serious or Life-Threatening AE|0|||
147468748|NCT00552110|531872500|FG001|Overall Study|Serious or Life-Threatening AE|0|||
147468749|NCT00552110|531872501|FG002|Overall Study|Serious or Life-Threatening AE|1|||
147468750|NCT00552110|531872502|FG003|Overall Study|Serious or Life-Threatening AE|0|||
147468751|NCT00552110|531872503|FG004|Overall Study|Serious or Life-Threatening AE|0|||
147468752|NCT00552110|531872499|FG000|Overall Study|Lack of Efficacy|1|||
147468753|NCT00552110|531872500|FG001|Overall Study|Lack of Efficacy|0|||
147468754|NCT00552110|531872501|FG002|Overall Study|Lack of Efficacy|0|||
147468755|NCT00552110|531872502|FG003|Overall Study|Lack of Efficacy|1|||
147468756|NCT00552110|531872503|FG004|Overall Study|Lack of Efficacy|4|||
147468757|NCT00552110|531872499|FG000|Overall Study|Withdrawal by Subject|0|||
147468758|NCT00552110|531872500|FG001|Overall Study|Withdrawal by Subject|2|||
147468759|NCT00552110|531872501|FG002|Overall Study|Withdrawal by Subject|0|||
147468760|NCT00552110|531872502|FG003|Overall Study|Withdrawal by Subject|3|||
147468761|NCT00552110|531872503|FG004|Overall Study|Withdrawal by Subject|2|||
147468762|NCT00552110|531872499|FG000|Overall Study|Lost to Follow-up|0|||
147468763|NCT00552110|531872500|FG001|Overall Study|Lost to Follow-up|0|||
147468764|NCT00552110|531872501|FG002|Overall Study|Lost to Follow-up|0|||
147468765|NCT00552110|531872502|FG003|Overall Study|Lost to Follow-up|1|||
147468766|NCT00552110|531872503|FG004|Overall Study|Lost to Follow-up|1|||
147468767|NCT00552110|531872499|FG000|Overall Study|Failed to Comply With Study Requirements|1|||
147468768|NCT00552110|531872500|FG001|Overall Study|Failed to Comply With Study Requirements|1|||
147468769|NCT00552110|531872501|FG002|Overall Study|Failed to Comply With Study Requirements|1|||
147468770|NCT00552110|531872502|FG003|Overall Study|Failed to Comply With Study Requirements|0|||
147468771|NCT00552110|531872503|FG004|Overall Study|Failed to Comply With Study Requirements|1|||
147468772|NCT00552110|531872499|FG000|Overall Study|Withdrawn per Sponsor|0|||
147468773|NCT00552110|531872500|FG001|Overall Study|Withdrawn per Sponsor|1|||
147468774|NCT00552110|531872501|FG002|Overall Study|Withdrawn per Sponsor|0|||
147468775|NCT00552110|531872502|FG003|Overall Study|Withdrawn per Sponsor|0|||
147468776|NCT00552110|531872503|FG004|Overall Study|Withdrawn per Sponsor|1|||
147468777|NCT00552110|531872499|FG000|Overall Study|Use of Prohibited Medication|1|||
147468778|NCT00552110|531872500|FG001|Overall Study|Use of Prohibited Medication|1|||
147468779|NCT00552110|531872501|FG002|Overall Study|Use of Prohibited Medication|0|||
147468780|NCT00552110|531872502|FG003|Overall Study|Use of Prohibited Medication|0|||
147468781|NCT00552110|531872503|FG004|Overall Study|Use of Prohibited Medication|0|||
147468782|NCT00552110|531872499|FG000|Overall Study|Delay of Study due to Relabeling|0|||
147468783|NCT00552110|531872500|FG001|Overall Study|Delay of Study due to Relabeling|0|||
147468784|NCT00552110|531872501|FG002|Overall Study|Delay of Study due to Relabeling|0|||
147468785|NCT00552110|531872502|FG003|Overall Study|Delay of Study due to Relabeling|1|||
147468786|NCT00552110|531872503|FG004|Overall Study|Delay of Study due to Relabeling|0|||
147468787|NCT00552110|531872499|FG000|Overall Study|Increased Blood Pressure at Visit 2|0|||
147468788|NCT00552110|531872500|FG001|Overall Study|Increased Blood Pressure at Visit 2|0|||
147619257|NCT03657797|532424491|FG000|Overall Study|Lost to Follow-up|0|||
147619258|NCT03657797|532424492|FG001|Overall Study|Lost to Follow-up|1|||
147619259|NCT03657797|532424493|FG002|Overall Study|Lost to Follow-up|1|||
147411643|NCT02942277|531671496|FG004|Year 1|Withdrawal by Subject|1|||
147411644|NCT02942277|531671497|FG005|Year 1|Withdrawal by Subject|3|||
147411645|NCT02942277|531671498|FG006|Year 1|Withdrawal by Subject|0|||
147411646|NCT02942277|531671499|FG007|Year 1|Withdrawal by Subject|1|||
147411647|NCT02942277|531671500|FG008|Year 1|Withdrawal by Subject|0|||
147411648|NCT02942277|531671501|FG009|Year 1|Withdrawal by Subject|0|||
147411649|NCT02942277|531671502|FG010|Year 1|Withdrawal by Subject|3|||
147411650|NCT02942277|531671492|FG000|Year 1|Travel|0|||
147411651|NCT02942277|531671493|FG001|Year 1|Travel|1|||
147411652|NCT02942277|531671494|FG002|Year 1|Travel|0|||
147411653|NCT02942277|531671495|FG003|Year 1|Travel|0|||
147411654|NCT02942277|531671496|FG004|Year 1|Travel|4|||
147411655|NCT02942277|531671497|FG005|Year 1|Travel|5|||
147411656|NCT02942277|531671498|FG006|Year 1|Travel|0|||
147411657|NCT02942277|531671499|FG007|Year 1|Travel|0|||
147411658|NCT02942277|531671500|FG008|Year 1|Travel|0|||
147411659|NCT02942277|531671501|FG009|Year 1|Travel|0|||
147411660|NCT02942277|531671502|FG010|Year 1|Travel|8|||
147411661|NCT02942277|531671492|FG000|Year 1|Joined Army|0|||
147411662|NCT02942277|531671493|FG001|Year 1|Joined Army|1|||
147411663|NCT02942277|531671494|FG002|Year 1|Joined Army|0|||
147411664|NCT02942277|531671495|FG003|Year 1|Joined Army|0|||
147411665|NCT02942277|531671496|FG004|Year 1|Joined Army|0|||
147411666|NCT02942277|531671497|FG005|Year 1|Joined Army|0|||
147411667|NCT02942277|531671498|FG006|Year 1|Joined Army|0|||
147411668|NCT02942277|531671499|FG007|Year 1|Joined Army|0|||
147411669|NCT02942277|531671500|FG008|Year 1|Joined Army|0|||
147411670|NCT02942277|531671501|FG009|Year 1|Joined Army|0|||
147411671|NCT02942277|531671502|FG010|Year 1|Joined Army|0|||
147411672|NCT02942277|531671492|FG000|Year 1|Subject met withdrawal criteria|0|||
147411673|NCT02942277|531671493|FG001|Year 1|Subject met withdrawal criteria|0|||
147411674|NCT02942277|531671494|FG002|Year 1|Subject met withdrawal criteria|0|||
147411675|NCT02942277|531671495|FG003|Year 1|Subject met withdrawal criteria|1|||
147411676|NCT02942277|531671496|FG004|Year 1|Subject met withdrawal criteria|0|||
147411677|NCT02942277|531671497|FG005|Year 1|Subject met withdrawal criteria|0|||
147411678|NCT02942277|531671498|FG006|Year 1|Subject met withdrawal criteria|0|||
147411679|NCT02942277|531671499|FG007|Year 1|Subject met withdrawal criteria|0|||
147411680|NCT02942277|531671500|FG008|Year 1|Subject met withdrawal criteria|0|||
147411681|NCT02942277|531671501|FG009|Year 1|Subject met withdrawal criteria|0|||
147411682|NCT02942277|531671502|FG010|Year 1|Subject met withdrawal criteria|0|||
147411683|NCT02942277|531671492|FG000|Year 1|Lost to Follow-up|0|||
147411684|NCT02942277|531671493|FG001|Year 1|Lost to Follow-up|0|||
147411685|NCT02942277|531671494|FG002|Year 1|Lost to Follow-up|0|||
147411686|NCT02942277|531671495|FG003|Year 1|Lost to Follow-up|0|||
147411687|NCT02942277|531671496|FG004|Year 1|Lost to Follow-up|1|||
147411688|NCT02942277|531671497|FG005|Year 1|Lost to Follow-up|0|||
147411689|NCT02942277|531671498|FG006|Year 1|Lost to Follow-up|0|||
147411690|NCT02942277|531671499|FG007|Year 1|Lost to Follow-up|0|||
147411691|NCT02942277|531671500|FG008|Year 1|Lost to Follow-up|0|||
147411692|NCT02942277|531671501|FG009|Year 1|Lost to Follow-up|0|||
147411693|NCT02942277|531671502|FG010|Year 1|Lost to Follow-up|2|||
147411694|NCT02942277|531671492|FG000|Year 1|Protocol Violation|0|||
147411695|NCT02942277|531671493|FG001|Year 1|Protocol Violation|0|||
147411696|NCT02942277|531671494|FG002|Year 1|Protocol Violation|0|||
147411697|NCT02942277|531671495|FG003|Year 1|Protocol Violation|0|||
147411698|NCT02942277|531671496|FG004|Year 1|Protocol Violation|1|||
147411699|NCT02942277|531671497|FG005|Year 1|Protocol Violation|1|||
147411700|NCT02942277|531671498|FG006|Year 1|Protocol Violation|0|||
147411701|NCT02942277|531671499|FG007|Year 1|Protocol Violation|0|||
147411702|NCT02942277|531671500|FG008|Year 1|Protocol Violation|0|||
147411703|NCT02942277|531671501|FG009|Year 1|Protocol Violation|0|||
147411704|NCT02942277|531671502|FG010|Year 1|Protocol Violation|2|||
147411705|NCT02942277|531671492|FG000|Year 1|Pregnancy|0|||
147411706|NCT02942277|531671493|FG001|Year 1|Pregnancy|0|||
147411707|NCT02942277|531671494|FG002|Year 1|Pregnancy|0|||
147411708|NCT02942277|531671495|FG003|Year 1|Pregnancy|0|||
147411709|NCT02942277|531671496|FG004|Year 1|Pregnancy|0|||
147411710|NCT02942277|531671497|FG005|Year 1|Pregnancy|1|||
147411711|NCT02942277|531671498|FG006|Year 1|Pregnancy|0|||
147411712|NCT02942277|531671499|FG007|Year 1|Pregnancy|0|||
147411713|NCT02942277|531671500|FG008|Year 1|Pregnancy|0|||
147411714|NCT02942277|531671501|FG009|Year 1|Pregnancy|0|||
147411715|NCT02942277|531671502|FG010|Year 1|Pregnancy|0|||
147411716|NCT02942277|531671492|FG000|Year 2|Lost to Follow-up|0|||
147411717|NCT02942277|531671493|FG001|Year 2|Lost to Follow-up|0|||
147411718|NCT02942277|531671494|FG002|Year 2|Lost to Follow-up|0|||
147411719|NCT02942277|531671495|FG003|Year 2|Lost to Follow-up|0|||
147411720|NCT02942277|531671496|FG004|Year 2|Lost to Follow-up|2|||
147411721|NCT02942277|531671497|FG005|Year 2|Lost to Follow-up|1|||
147411722|NCT02942277|531671498|FG006|Year 2|Lost to Follow-up|0|||
147411723|NCT02942277|531671499|FG007|Year 2|Lost to Follow-up|0|||
147411724|NCT02942277|531671500|FG008|Year 2|Lost to Follow-up|0|||
147411725|NCT02942277|531671501|FG009|Year 2|Lost to Follow-up|0|||
147411726|NCT02942277|531671502|FG010|Year 2|Lost to Follow-up|0|||
147468789|NCT00552110|531872501|FG002|Overall Study|Increased Blood Pressure at Visit 2|0|||
147468790|NCT00552110|531872502|FG003|Overall Study|Increased Blood Pressure at Visit 2|1|||
147468791|NCT00552110|531872503|FG004|Overall Study|Increased Blood Pressure at Visit 2|0|||
147468792|NCT00552110|531872499|FG000|Overall Study|Nonserious Adverse Event (AE)|1|||
147468793|NCT00552110|531872500|FG001|Overall Study|Nonserious Adverse Event (AE)|0|||
147468794|NCT00552110|531872501|FG002|Overall Study|Nonserious Adverse Event (AE)|0|||
147468795|NCT00552110|531872502|FG003|Overall Study|Nonserious Adverse Event (AE)|1|||
147468796|NCT00552110|531872503|FG004|Overall Study|Nonserious Adverse Event (AE)|0|||
147468797|NCT03029832|531872504|FG000|Overall Study|Safety Follow-Up Completed|2|||
147468798|NCT03029832|531872505|FG001|Overall Study|Safety Follow-Up Completed|0|||
147468799|NCT03029832|531872504|FG000|Overall Study|Death due to Disease Progression|1|||
147468800|NCT03029832|531872505|FG001|Overall Study|Death due to Disease Progression|0|||
147468801|NCT03029832|531872504|FG000|Overall Study|Study Terminated By Sponsor|1|||
147468802|NCT03029832|531872505|FG001|Overall Study|Study Terminated By Sponsor|1|||
147468803|NCT01412229|531872506|FG000|Overall Study|Physician Decision|1|||
147468804|NCT00700804|531872509|FG000|Overall Study|Withdrawal by Subject|1|||
147468805|NCT00700804|531872510|FG001|Overall Study|Withdrawal by Subject|2|||
147468806|NCT00700804|531872509|FG000|Overall Study|Protocol Violation|1|||
147468807|NCT00700804|531872510|FG001|Overall Study|Protocol Violation|1|||
147468808|NCT00700804|531872509|FG000|Overall Study|Loose Stools|1|||
147468809|NCT00700804|531872510|FG001|Overall Study|Loose Stools|1|||
147468810|NCT02901431|531872511|FG000|PK Part|Adverse Event|0|||
147468811|NCT02901431|531872512|FG001|PK Part|Adverse Event|1|||
147468812|NCT02901431|531872513|FG002|PK Part|Adverse Event|0|||
147468813|NCT02901431|531872514|FG003|PK Part|Adverse Event|0|||
147468814|NCT02901431|531872515|FG004|PK Part|Adverse Event|0|||
147468815|NCT02901431|531872516|FG005|PK Part|Adverse Event|0|||
147468816|NCT02901431|531872517|FG006|PK Part|Adverse Event|0|||
147468817|NCT02901431|531872518|FG007|PK Part|Adverse Event|0|||
147468818|NCT02901431|531872519|FG008|PK Part|Adverse Event|0|||
147468819|NCT02901431|531872520|FG009|PK Part|Adverse Event|0|||
147468820|NCT02901431|531872521|FG010|PK Part|Adverse Event|0|||
147468821|NCT02901431|531872522|FG011|PK Part|Adverse Event|0|||
147468822|NCT02901431|531872523|FG012|PK Part|Adverse Event|0|||
147468823|NCT02901431|531872511|FG000|PK Part|Lost to Follow-up|0|||
147468824|NCT02901431|531872512|FG001|PK Part|Lost to Follow-up|0|||
147468825|NCT02901431|531872513|FG002|PK Part|Lost to Follow-up|1|||
147468826|NCT02901431|531872514|FG003|PK Part|Lost to Follow-up|0|||
147468827|NCT02901431|531872515|FG004|PK Part|Lost to Follow-up|0|||
147468828|NCT02901431|531872516|FG005|PK Part|Lost to Follow-up|0|||
147468829|NCT02901431|531872517|FG006|PK Part|Lost to Follow-up|0|||
147468830|NCT02901431|531872518|FG007|PK Part|Lost to Follow-up|0|||
147468831|NCT02901431|531872519|FG008|PK Part|Lost to Follow-up|0|||
147468832|NCT02901431|531872520|FG009|PK Part|Lost to Follow-up|0|||
147468833|NCT02901431|531872521|FG010|PK Part|Lost to Follow-up|0|||
147468834|NCT02901431|531872522|FG011|PK Part|Lost to Follow-up|0|||
147468835|NCT02901431|531872523|FG012|PK Part|Lost to Follow-up|0|||
147468836|NCT02901431|531872511|FG000|PK Part|Pending IMC/SOC Dose Confirmation|2|||
147468837|NCT02901431|531872512|FG001|PK Part|Pending IMC/SOC Dose Confirmation|0|||
147468838|NCT02901431|531872513|FG002|PK Part|Pending IMC/SOC Dose Confirmation|0|||
147468839|NCT02901431|531872514|FG003|PK Part|Pending IMC/SOC Dose Confirmation|0|||
147468840|NCT02901431|531872515|FG004|PK Part|Pending IMC/SOC Dose Confirmation|0|||
147468841|NCT02901431|531872516|FG005|PK Part|Pending IMC/SOC Dose Confirmation|0|||
147468842|NCT02901431|531872517|FG006|PK Part|Pending IMC/SOC Dose Confirmation|0|||
147468843|NCT02901431|531872518|FG007|PK Part|Pending IMC/SOC Dose Confirmation|0|||
147468844|NCT02901431|531872519|FG008|PK Part|Pending IMC/SOC Dose Confirmation|0|||
147468845|NCT02901431|531872520|FG009|PK Part|Pending IMC/SOC Dose Confirmation|0|||
147468846|NCT02901431|531872521|FG010|PK Part|Pending IMC/SOC Dose Confirmation|0|||
147468847|NCT02901431|531872522|FG011|PK Part|Pending IMC/SOC Dose Confirmation|0|||
147468848|NCT02901431|531872523|FG012|PK Part|Pending IMC/SOC Dose Confirmation|0|||
147468849|NCT02901431|531872511|FG000|PK Part|Pending dose confirmation|0|||
147619260|NCT03657797|532424494|FG003|Overall Study|Lost to Follow-up|0|||
147468850|NCT02901431|531872512|FG001|PK Part|Pending dose confirmation|1|||
147468851|NCT02901431|531872513|FG002|PK Part|Pending dose confirmation|0|||
147468852|NCT02901431|531872514|FG003|PK Part|Pending dose confirmation|0|||
147619261|NCT03657797|532424491|FG000|Overall Study|Physician Decision|0|||
147468853|NCT02901431|531872515|FG004|PK Part|Pending dose confirmation|0|||
147619262|NCT03657797|532424492|FG001|Overall Study|Physician Decision|1|||
147619263|NCT03657797|532424493|FG002|Overall Study|Physician Decision|0|||
147619264|NCT03657797|532424494|FG003|Overall Study|Physician Decision|0|||
147468854|NCT02901431|531872516|FG005|PK Part|Pending dose confirmation|0|||
147468855|NCT02901431|531872517|FG006|PK Part|Pending dose confirmation|0|||
147619265|NCT03657797|532424491|FG000|Overall Study|Withdrawal by Subject|0|||
147468856|NCT02901431|531872518|FG007|PK Part|Pending dose confirmation|0|||
147468857|NCT02901431|531872519|FG008|PK Part|Pending dose confirmation|0|||
147468858|NCT02901431|531872520|FG009|PK Part|Pending dose confirmation|0|||
147468859|NCT02901431|531872521|FG010|PK Part|Pending dose confirmation|0|||
147468860|NCT02901431|531872522|FG011|PK Part|Pending dose confirmation|0|||
147619266|NCT03657797|532424492|FG001|Overall Study|Withdrawal by Subject|1|||
147619267|NCT03657797|532424493|FG002|Overall Study|Withdrawal by Subject|2|||
147619268|NCT03657797|532424494|FG003|Overall Study|Withdrawal by Subject|0|||
147619269|NCT03657797|532424491|FG000|Overall Study|Adverse Event|0|||
147619270|NCT03657797|532424492|FG001|Overall Study|Adverse Event|0|||
147619271|NCT03657797|532424493|FG002|Overall Study|Adverse Event|2|||
147619272|NCT03657797|532424494|FG003|Overall Study|Adverse Event|0|||
147619273|NCT00413699|532424495|FG000|Initial Period|Death|25|||
147619274|NCT00413699|532424496|FG001|Initial Period|Death|30|||
147619275|NCT00413699|532424497|FG002|Initial Period|Death|0|||
147619276|NCT00413699|532424495|FG000|Initial Period|Lack of Efficacy|59|||
147619277|NCT00413699|532424496|FG001|Initial Period|Lack of Efficacy|115|||
147619278|NCT00413699|532424497|FG002|Initial Period|Lack of Efficacy|0|||
147619279|NCT00413699|532424495|FG000|Initial Period|Lost to Follow-up|31|||
147619280|NCT00413699|532424496|FG001|Initial Period|Lost to Follow-up|101|||
147411727|NCT02942277|531671492|FG000|Year 2|Did not rescreen|0|||
147411728|NCT02942277|531671493|FG001|Year 2|Did not rescreen|0|||
147411729|NCT02942277|531671494|FG002|Year 2|Did not rescreen|1|||
147411730|NCT02942277|531671495|FG003|Year 2|Did not rescreen|1|||
147411731|NCT02942277|531671496|FG004|Year 2|Did not rescreen|9|||
147411732|NCT02942277|531671497|FG005|Year 2|Did not rescreen|6|||
147411733|NCT02942277|531671498|FG006|Year 2|Did not rescreen|0|||
147411734|NCT02942277|531671499|FG007|Year 2|Did not rescreen|1|||
147411735|NCT02942277|531671500|FG008|Year 2|Did not rescreen|0|||
147411736|NCT02942277|531671501|FG009|Year 2|Did not rescreen|0|||
147411737|NCT02942277|531671502|FG010|Year 2|Did not rescreen|21|||
147411738|NCT02942277|531671492|FG000|Year 2|Met withdrawal criteria|0|||
147411739|NCT02942277|531671493|FG001|Year 2|Met withdrawal criteria|0|||
147411740|NCT02942277|531671494|FG002|Year 2|Met withdrawal criteria|0|||
147411741|NCT02942277|531671495|FG003|Year 2|Met withdrawal criteria|0|||
147411742|NCT02942277|531671496|FG004|Year 2|Met withdrawal criteria|1|||
147411743|NCT02942277|531671497|FG005|Year 2|Met withdrawal criteria|2|||
147411744|NCT02942277|531671498|FG006|Year 2|Met withdrawal criteria|0|||
147411745|NCT02942277|531671499|FG007|Year 2|Met withdrawal criteria|0|||
147411746|NCT02942277|531671500|FG008|Year 2|Met withdrawal criteria|0|||
147411747|NCT02942277|531671501|FG009|Year 2|Met withdrawal criteria|0|||
147411748|NCT02942277|531671502|FG010|Year 2|Met withdrawal criteria|1|||
147411749|NCT02942277|531671492|FG000|Year 2|Travel|0|||
147411750|NCT02942277|531671493|FG001|Year 2|Travel|1|||
147411751|NCT02942277|531671494|FG002|Year 2|Travel|0|||
147411752|NCT02942277|531671495|FG003|Year 2|Travel|0|||
147411753|NCT02942277|531671496|FG004|Year 2|Travel|0|||
147411754|NCT02942277|531671497|FG005|Year 2|Travel|1|||
147411755|NCT02942277|531671498|FG006|Year 2|Travel|0|||
147411756|NCT02942277|531671499|FG007|Year 2|Travel|0|||
147411757|NCT02942277|531671500|FG008|Year 2|Travel|0|||
147411758|NCT02942277|531671501|FG009|Year 2|Travel|1|||
147411759|NCT02942277|531671502|FG010|Year 2|Travel|3|||
147411760|NCT02942277|531671492|FG000|Year 2|Non-compliant|0|||
147411761|NCT02942277|531671493|FG001|Year 2|Non-compliant|0|||
147411762|NCT02942277|531671494|FG002|Year 2|Non-compliant|0|||
147411763|NCT02942277|531671495|FG003|Year 2|Non-compliant|0|||
147411764|NCT02942277|531671496|FG004|Year 2|Non-compliant|1|||
147411765|NCT02942277|531671497|FG005|Year 2|Non-compliant|1|||
147411766|NCT02942277|531671498|FG006|Year 2|Non-compliant|0|||
147411767|NCT02942277|531671499|FG007|Year 2|Non-compliant|0|||
147411768|NCT02942277|531671500|FG008|Year 2|Non-compliant|0|||
147411769|NCT02942277|531671501|FG009|Year 2|Non-compliant|0|||
147411770|NCT02942277|531671502|FG010|Year 2|Non-compliant|0|||
147411771|NCT02942277|531671492|FG000|Year 2|Withdrawal by Subject|0|||
147411772|NCT02942277|531671493|FG001|Year 2|Withdrawal by Subject|0|||
147411773|NCT02942277|531671494|FG002|Year 2|Withdrawal by Subject|0|||
147411774|NCT02942277|531671495|FG003|Year 2|Withdrawal by Subject|0|||
147411775|NCT02942277|531671496|FG004|Year 2|Withdrawal by Subject|0|||
147411776|NCT02942277|531671497|FG005|Year 2|Withdrawal by Subject|0|||
147411777|NCT02942277|531671498|FG006|Year 2|Withdrawal by Subject|1|||
147411778|NCT02942277|531671499|FG007|Year 2|Withdrawal by Subject|0|||
147411779|NCT02942277|531671500|FG008|Year 2|Withdrawal by Subject|0|||
147411780|NCT02942277|531671501|FG009|Year 2|Withdrawal by Subject|0|||
147411781|NCT02942277|531671502|FG010|Year 2|Withdrawal by Subject|0|||
147411782|NCT05602727|531671503|FG000|Overall Study|Physician Decision|0|||
147411783|NCT05602727|531671504|FG001|Overall Study|Physician Decision|1|||
147411784|NCT05602727|531671505|FG002|Overall Study|Physician Decision|0|||
147411785|NCT05602727|531671503|FG000|Overall Study|Randomized by mistake without study medication|1|||
147619281|NCT00413699|532424497|FG002|Initial Period|Lost to Follow-up|0|||
147665769|NCT02709746|532601592|FG002|Phase A (Single-blind Treatment Period)|Lack of Efficacy|0|||
147411786|NCT05602727|531671504|FG001|Overall Study|Randomized by mistake without study medication|0|||
147411787|NCT05602727|531671505|FG002|Overall Study|Randomized by mistake without study medication|0|||
147411788|NCT05602727|531671503|FG000|Overall Study|Study termination by Sponsor|18|||
147411789|NCT05602727|531671504|FG001|Overall Study|Study termination by Sponsor|15|||
147411790|NCT05602727|531671505|FG002|Overall Study|Study termination by Sponsor|19|||
147411791|NCT05602727|531671503|FG000|Overall Study|Withdrawal by Subject|2|||
147619282|NCT00413699|532424495|FG000|Initial Period|Protocol Violation|38|||
147619283|NCT00413699|532424496|FG001|Initial Period|Protocol Violation|89|||
147619284|NCT00413699|532424497|FG002|Initial Period|Protocol Violation|0|||
147468861|NCT02901431|531872523|FG012|PK Part|Pending dose confirmation|0|||
147468862|NCT02901431|531872511|FG000|PK Part|8 weeks of treatment ran out|2|||
147468863|NCT02901431|531872512|FG001|PK Part|8 weeks of treatment ran out|0|||
147468864|NCT02901431|531872513|FG002|PK Part|8 weeks of treatment ran out|0|||
147468865|NCT02901431|531872514|FG003|PK Part|8 weeks of treatment ran out|0|||
147468866|NCT02901431|531872515|FG004|PK Part|8 weeks of treatment ran out|0|||
147468867|NCT02901431|531872516|FG005|PK Part|8 weeks of treatment ran out|0|||
147468868|NCT02901431|531872517|FG006|PK Part|8 weeks of treatment ran out|0|||
147468869|NCT02901431|531872518|FG007|PK Part|8 weeks of treatment ran out|0|||
147468870|NCT02901431|531872519|FG008|PK Part|8 weeks of treatment ran out|0|||
147468871|NCT02901431|531872520|FG009|PK Part|8 weeks of treatment ran out|0|||
147468872|NCT02901431|531872521|FG010|PK Part|8 weeks of treatment ran out|0|||
147468873|NCT02901431|531872522|FG011|PK Part|8 weeks of treatment ran out|0|||
147468874|NCT02901431|531872523|FG012|PK Part|8 weeks of treatment ran out|0|||
147468875|NCT02901431|531872511|FG000|PK Part|Stopped treatment after 8 weeks|1|||
147468876|NCT02901431|531872512|FG001|PK Part|Stopped treatment after 8 weeks|0|||
147468877|NCT02901431|531872513|FG002|PK Part|Stopped treatment after 8 weeks|1|||
147468878|NCT02901431|531872514|FG003|PK Part|Stopped treatment after 8 weeks|0|||
147468879|NCT02901431|531872515|FG004|PK Part|Stopped treatment after 8 weeks|0|||
147468880|NCT02901431|531872516|FG005|PK Part|Stopped treatment after 8 weeks|0|||
147468881|NCT02901431|531872517|FG006|PK Part|Stopped treatment after 8 weeks|0|||
147468882|NCT02901431|531872518|FG007|PK Part|Stopped treatment after 8 weeks|0|||
147468883|NCT02901431|531872519|FG008|PK Part|Stopped treatment after 8 weeks|0|||
147468884|NCT02901431|531872520|FG009|PK Part|Stopped treatment after 8 weeks|0|||
147468885|NCT02901431|531872521|FG010|PK Part|Stopped treatment after 8 weeks|0|||
147468886|NCT02901431|531872522|FG011|PK Part|Stopped treatment after 8 weeks|0|||
147468887|NCT02901431|531872523|FG012|PK Part|Stopped treatment after 8 weeks|0|||
147468888|NCT02901431|531872511|FG000|PK Part|Stopped on Sponsor instruction pending dose confirmation|1|||
147468889|NCT02901431|531872512|FG001|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
147468890|NCT02901431|531872513|FG002|PK Part|Stopped on Sponsor instruction pending dose confirmation|4|||
147468891|NCT02901431|531872514|FG003|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
147468892|NCT02901431|531872515|FG004|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
147468893|NCT02901431|531872516|FG005|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
147468894|NCT02901431|531872517|FG006|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
147468895|NCT02901431|531872518|FG007|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
147468896|NCT02901431|531872519|FG008|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
147468897|NCT02901431|531872520|FG009|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
147468898|NCT02901431|531872521|FG010|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
147468899|NCT02901431|531872522|FG011|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
147468900|NCT02901431|531872523|FG012|PK Part|Stopped on Sponsor instruction pending dose confirmation|0|||
147468901|NCT02901431|531872511|FG000|PK Part|Discontinued per Sponsor|0|||
147468902|NCT02901431|531872512|FG001|PK Part|Discontinued per Sponsor|3|||
147468903|NCT02901431|531872513|FG002|PK Part|Discontinued per Sponsor|0|||
147468904|NCT02901431|531872514|FG003|PK Part|Discontinued per Sponsor|0|||
147468905|NCT02901431|531872515|FG004|PK Part|Discontinued per Sponsor|0|||
147468906|NCT02901431|531872516|FG005|PK Part|Discontinued per Sponsor|0|||
147468907|NCT02901431|531872517|FG006|PK Part|Discontinued per Sponsor|0|||
147468908|NCT02901431|531872518|FG007|PK Part|Discontinued per Sponsor|0|||
147468909|NCT02901431|531872519|FG008|PK Part|Discontinued per Sponsor|0|||
147468910|NCT02901431|531872520|FG009|PK Part|Discontinued per Sponsor|0|||
147468911|NCT02901431|531872521|FG010|PK Part|Discontinued per Sponsor|0|||
147468912|NCT02901431|531872522|FG011|PK Part|Discontinued per Sponsor|0|||
147468913|NCT02901431|531872523|FG012|PK Part|Discontinued per Sponsor|0|||
147468914|NCT02901431|531872511|FG000|PK Part|Withdrawal by Subject|1|||
147468915|NCT02901431|531872512|FG001|PK Part|Withdrawal by Subject|1|||
147468916|NCT02901431|531872513|FG002|PK Part|Withdrawal by Subject|3|||
147468917|NCT02901431|531872514|FG003|PK Part|Withdrawal by Subject|0|||
147468918|NCT02901431|531872515|FG004|PK Part|Withdrawal by Subject|0|||
147468919|NCT02901431|531872516|FG005|PK Part|Withdrawal by Subject|0|||
147468920|NCT02901431|531872517|FG006|PK Part|Withdrawal by Subject|0|||
147468921|NCT02901431|531872518|FG007|PK Part|Withdrawal by Subject|0|||
147411792|NCT05602727|531671504|FG001|Overall Study|Withdrawal by Subject|1|||
147411793|NCT05602727|531671505|FG002|Overall Study|Withdrawal by Subject|1|||
147411794|NCT05602727|531671503|FG000|Overall Study|Various reasons|1|||
147411795|NCT05602727|531671504|FG001|Overall Study|Various reasons|6|||
147411796|NCT05602727|531671505|FG002|Overall Study|Various reasons|1|||
147411797|NCT02187159|531671506|FG000|Overall Study|Protocol Violation|4|||
147411798|NCT02187159|531671507|FG001|Overall Study|Protocol Violation|6|||
147411799|NCT02187159|531671508|FG002|Overall Study|Protocol Violation|3|||
147411800|NCT02187159|531671509|FG003|Overall Study|Protocol Violation|4|||
147411801|NCT02187159|531671506|FG000|Overall Study|Lack of Efficacy|10|||
147411802|NCT02187159|531671507|FG001|Overall Study|Lack of Efficacy|5|||
147468922|NCT02901431|531872519|FG008|PK Part|Withdrawal by Subject|0|||
147468923|NCT02901431|531872520|FG009|PK Part|Withdrawal by Subject|0|||
147411803|NCT02187159|531671508|FG002|Overall Study|Lack of Efficacy|4|||
147468924|NCT02901431|531872521|FG010|PK Part|Withdrawal by Subject|0|||
147468925|NCT02901431|531872522|FG011|PK Part|Withdrawal by Subject|0|||
147468926|NCT02901431|531872523|FG012|PK Part|Withdrawal by Subject|0|||
147468927|NCT02901431|531872511|FG000|Main Treatment Part|Adverse Event|0|||
147468928|NCT02901431|531872512|FG001|Main Treatment Part|Adverse Event|0|||
147468929|NCT02901431|531872513|FG002|Main Treatment Part|Adverse Event|0|||
147468930|NCT02901431|531872514|FG003|Main Treatment Part|Adverse Event|3|||
147468931|NCT02901431|531872515|FG004|Main Treatment Part|Adverse Event|3|||
147468932|NCT02901431|531872516|FG005|Main Treatment Part|Adverse Event|4|||
147468933|NCT02901431|531872517|FG006|Main Treatment Part|Adverse Event|1|||
147468934|NCT02901431|531872518|FG007|Main Treatment Part|Adverse Event|0|||
147468935|NCT02901431|531872519|FG008|Main Treatment Part|Adverse Event|0|||
147468936|NCT02901431|531872520|FG009|Main Treatment Part|Adverse Event|0|||
147468937|NCT02901431|531872521|FG010|Main Treatment Part|Adverse Event|0|||
147468938|NCT02901431|531872522|FG011|Main Treatment Part|Adverse Event|0|||
147468939|NCT02901431|531872523|FG012|Main Treatment Part|Adverse Event|0|||
147468940|NCT02901431|531872511|FG000|Main Treatment Part|Lack of Efficacy|0|||
147468941|NCT02901431|531872512|FG001|Main Treatment Part|Lack of Efficacy|0|||
147468942|NCT02901431|531872513|FG002|Main Treatment Part|Lack of Efficacy|0|||
147468943|NCT02901431|531872514|FG003|Main Treatment Part|Lack of Efficacy|1|||
147468944|NCT02901431|531872515|FG004|Main Treatment Part|Lack of Efficacy|0|||
147468945|NCT02901431|531872516|FG005|Main Treatment Part|Lack of Efficacy|0|||
147468946|NCT02901431|531872517|FG006|Main Treatment Part|Lack of Efficacy|0|||
147468947|NCT02901431|531872518|FG007|Main Treatment Part|Lack of Efficacy|0|||
147468948|NCT02901431|531872519|FG008|Main Treatment Part|Lack of Efficacy|0|||
147468949|NCT02901431|531872520|FG009|Main Treatment Part|Lack of Efficacy|0|||
147468950|NCT02901431|531872521|FG010|Main Treatment Part|Lack of Efficacy|0|||
147468951|NCT02901431|531872522|FG011|Main Treatment Part|Lack of Efficacy|0|||
147468952|NCT02901431|531872523|FG012|Main Treatment Part|Lack of Efficacy|0|||
147468953|NCT02901431|531872511|FG000|Main Treatment Part|Lost to Follow-up|0|||
147468954|NCT02901431|531872512|FG001|Main Treatment Part|Lost to Follow-up|0|||
147468955|NCT02901431|531872513|FG002|Main Treatment Part|Lost to Follow-up|0|||
147468956|NCT02901431|531872514|FG003|Main Treatment Part|Lost to Follow-up|3|||
147468957|NCT02901431|531872515|FG004|Main Treatment Part|Lost to Follow-up|1|||
147468958|NCT02901431|531872516|FG005|Main Treatment Part|Lost to Follow-up|2|||
147468959|NCT02901431|531872517|FG006|Main Treatment Part|Lost to Follow-up|3|||
147468960|NCT02901431|531872518|FG007|Main Treatment Part|Lost to Follow-up|0|||
147468961|NCT02901431|531872519|FG008|Main Treatment Part|Lost to Follow-up|0|||
147468962|NCT02901431|531872520|FG009|Main Treatment Part|Lost to Follow-up|0|||
147468963|NCT02901431|531872521|FG010|Main Treatment Part|Lost to Follow-up|0|||
147468964|NCT02901431|531872522|FG011|Main Treatment Part|Lost to Follow-up|0|||
147468965|NCT02901431|531872523|FG012|Main Treatment Part|Lost to Follow-up|0|||
147468966|NCT02901431|531872511|FG000|Main Treatment Part|Withdrawal by Caregiver|0|||
147468967|NCT02901431|531872512|FG001|Main Treatment Part|Withdrawal by Caregiver|0|||
147468968|NCT02901431|531872513|FG002|Main Treatment Part|Withdrawal by Caregiver|0|||
147468969|NCT02901431|531872514|FG003|Main Treatment Part|Withdrawal by Caregiver|0|||
147468970|NCT02901431|531872515|FG004|Main Treatment Part|Withdrawal by Caregiver|0|||
147468971|NCT02901431|531872516|FG005|Main Treatment Part|Withdrawal by Caregiver|1|||
147468972|NCT02901431|531872517|FG006|Main Treatment Part|Withdrawal by Caregiver|0|||
147468973|NCT02901431|531872518|FG007|Main Treatment Part|Withdrawal by Caregiver|0|||
147468974|NCT02901431|531872519|FG008|Main Treatment Part|Withdrawal by Caregiver|0|||
147468975|NCT02901431|531872520|FG009|Main Treatment Part|Withdrawal by Caregiver|0|||
147468976|NCT02901431|531872521|FG010|Main Treatment Part|Withdrawal by Caregiver|0|||
147468977|NCT02901431|531872522|FG011|Main Treatment Part|Withdrawal by Caregiver|0|||
147468978|NCT02901431|531872523|FG012|Main Treatment Part|Withdrawal by Caregiver|0|||
147468979|NCT02901431|531872511|FG000|Main Treatment Part|Physician Decision|0|||
147468980|NCT02901431|531872512|FG001|Main Treatment Part|Physician Decision|0|||
147468981|NCT02901431|531872513|FG002|Main Treatment Part|Physician Decision|0|||
147468982|NCT02901431|531872514|FG003|Main Treatment Part|Physician Decision|1|||
147468983|NCT02901431|531872515|FG004|Main Treatment Part|Physician Decision|0|||
147468984|NCT02901431|531872516|FG005|Main Treatment Part|Physician Decision|0|||
147468985|NCT02901431|531872517|FG006|Main Treatment Part|Physician Decision|1|||
147468986|NCT02901431|531872518|FG007|Main Treatment Part|Physician Decision|0|||
147468987|NCT02901431|531872519|FG008|Main Treatment Part|Physician Decision|0|||
147468988|NCT02901431|531872520|FG009|Main Treatment Part|Physician Decision|0|||
147468989|NCT02901431|531872521|FG010|Main Treatment Part|Physician Decision|0|||
147468990|NCT02901431|531872522|FG011|Main Treatment Part|Physician Decision|0|||
147468991|NCT02901431|531872523|FG012|Main Treatment Part|Physician Decision|0|||
147468992|NCT02901431|531872511|FG000|Main Treatment Part|Withdrawal by Subject|0|||
147665770|NCT02709746|532601593|FG003|Phase A (Single-blind Treatment Period)|Lack of Efficacy|0|||
147468993|NCT02901431|531872512|FG001|Main Treatment Part|Withdrawal by Subject|0|||
147468994|NCT02901431|531872513|FG002|Main Treatment Part|Withdrawal by Subject|0|||
147468995|NCT02901431|531872514|FG003|Main Treatment Part|Withdrawal by Subject|18|||
147468996|NCT02901431|531872515|FG004|Main Treatment Part|Withdrawal by Subject|3|||
147468997|NCT02901431|531872516|FG005|Main Treatment Part|Withdrawal by Subject|5|||
147619285|NCT00413699|532424495|FG000|Initial Period|Pregnancy|10|||
147619286|NCT00413699|532424496|FG001|Initial Period|Pregnancy|8|||
147619287|NCT00413699|532424497|FG002|Initial Period|Pregnancy|0|||
147619288|NCT00413699|532424495|FG000|Initial Period|Did not meet entrance criteria|2|||
147619289|NCT00413699|532424496|FG001|Initial Period|Did not meet entrance criteria|2|||
147619290|NCT00413699|532424497|FG002|Initial Period|Did not meet entrance criteria|0|||
147619291|NCT00413699|532424495|FG000|Initial Period|Medication error without adverse event|0|||
147619292|NCT00413699|532424496|FG001|Initial Period|Medication error without adverse event|1|||
147619293|NCT00413699|532424497|FG002|Initial Period|Medication error without adverse event|0|||
147619294|NCT00413699|532424495|FG000|Initial Period|Study terminated by Sponsor|0|||
147411804|NCT02187159|531671509|FG003|Overall Study|Lack of Efficacy|7|||
147411805|NCT02187159|531671506|FG000|Overall Study|Adverse Event|28|||
147411806|NCT02187159|531671507|FG001|Overall Study|Adverse Event|33|||
147411807|NCT02187159|531671508|FG002|Overall Study|Adverse Event|42|||
147411808|NCT02187159|531671509|FG003|Overall Study|Adverse Event|50|||
147411809|NCT02187159|531671506|FG000|Overall Study|Withdrawal by Subject|24|||
147411810|NCT02187159|531671507|FG001|Overall Study|Withdrawal by Subject|28|||
147411811|NCT02187159|531671508|FG002|Overall Study|Withdrawal by Subject|25|||
147411812|NCT02187159|531671509|FG003|Overall Study|Withdrawal by Subject|26|||
147411813|NCT02187159|531671506|FG000|Overall Study|Other|3|||
147411814|NCT02187159|531671507|FG001|Overall Study|Other|7|||
147411815|NCT02187159|531671508|FG002|Overall Study|Other|3|||
147411816|NCT02187159|531671509|FG003|Overall Study|Other|9|||
147411817|NCT04325282|531671510|FG000|First Intervention (1 Day)|Withdrawal by Subject|0|||
147411818|NCT04325282|531671511|FG001|First Intervention (1 Day)|Withdrawal by Subject|1|||
147411819|NCT04325282|531671510|FG000|Second Intervention (1 Day)|Withdrawal by Subject|0|||
147411820|NCT04325282|531671511|FG001|Second Intervention (1 Day)|Withdrawal by Subject|1|||
147411821|NCT01283152|531671515|FG000|Overall Study|Discharged prior to 24 hr assessment|1|||
147411822|NCT01283152|531671516|FG001|Overall Study|Discharged prior to 24 hr assessment|0|||
147411823|NCT01283152|531671515|FG000|Overall Study|Refused HESA|1|||
147411824|NCT01283152|531671516|FG001|Overall Study|Refused HESA|0|||
147411825|NCT01736189|531671520|FG000|Overall Study|Violation of registration criteria|41|||
147411826|NCT01736189|531671520|FG000|Overall Study|Protocol Violation|4|||
147411827|NCT01736189|531671520|FG000|Overall Study|Criteria and protocol violations|1|||
147411828|NCT01499303|531671521|FG000|Overall Study|Ongoing|2|||
147411829|NCT01499303|531671522|FG001|Overall Study|Ongoing|1|||
147411830|NCT01499303|531671521|FG000|Overall Study|Withdrawal by Subject|0|||
147411831|NCT01499303|531671522|FG001|Overall Study|Withdrawal by Subject|1|||
147411832|NCT01499303|531671521|FG000|Overall Study|Adverse Event|1|||
147411833|NCT01499303|531671522|FG001|Overall Study|Adverse Event|4|||
147411834|NCT01499303|531671521|FG000|Overall Study|Other|0|||
147411835|NCT01499303|531671522|FG001|Overall Study|Other|1|||
147411836|NCT03809039|531671523|FG000|Part 1|Withdrawal by Subject|1|||
147411837|NCT03809039|531671524|FG001|Part 1|Withdrawal by Subject|0|||
147411838|NCT03809039|531671525|FG002|Part 1|Withdrawal by Subject|0|||
147411839|NCT03809039|531671526|FG003|Part 1|Withdrawal by Subject|1|||
147411840|NCT03809039|531671527|FG004|Part 1|Withdrawal by Subject|0|||
147411841|NCT03809039|531671528|FG005|Part 1|Withdrawal by Subject|0|||
147411842|NCT03809039|531671529|FG006|Part 1|Withdrawal by Subject|0|||
147411843|NCT03809039|531671530|FG007|Part 1|Withdrawal by Subject|0|||
147411844|NCT03809039|531671531|FG008|Part 1|Withdrawal by Subject|0|||
147411845|NCT03809039|531671523|FG000|Part 3|Withdrawn by study termination|0|||
147411846|NCT03809039|531671524|FG001|Part 3|Withdrawn by study termination|0|||
147411847|NCT03809039|531671525|FG002|Part 3|Withdrawn by study termination|0|||
147411848|NCT03809039|531671526|FG003|Part 3|Withdrawn by study termination|0|||
147411849|NCT03809039|531671527|FG004|Part 3|Withdrawn by study termination|0|||
147411850|NCT03809039|531671528|FG005|Part 3|Withdrawn by study termination|0|||
147411851|NCT03809039|531671529|FG006|Part 3|Withdrawn by study termination|0|||
147411852|NCT03809039|531671530|FG007|Part 3|Withdrawn by study termination|2|||
147411853|NCT03809039|531671531|FG008|Part 3|Withdrawn by study termination|6|||
147411854|NCT00608868|531671534|FG000|Overall Study|Withdrawal by Subject|7|||
147411855|NCT00608868|531671534|FG000|Overall Study|Protocol Violation|3|||
147411856|NCT00608868|531671534|FG000|Overall Study|Lost to Follow-up|2|||
147411857|NCT00608868|531671534|FG000|Overall Study|Adverse Event|1|||
147411858|NCT00608868|531671534|FG000|Overall Study|Physician Decision|2|||
147411859|NCT03853551|531671538|FG000|Overall Study|Death|2|||
147411860|NCT03853551|531671538|FG000|Overall Study|7 patients discontinued the study because of disease progression.|7|||
147619295|NCT00413699|532424496|FG001|Initial Period|Study terminated by Sponsor|1|||
147619296|NCT00413699|532424497|FG002|Initial Period|Study terminated by Sponsor|0|||
147411861|NCT02476175|531671539|FG000|Overall Study|Adverse Event|2|||
147411862|NCT00879775|531671544|FG000|Overall Study|Lost to Follow-up|2|||
147411863|NCT00879775|531671545|FG001|Overall Study|Lost to Follow-up|1|||
147411864|NCT02440425|531671546|FG000|Overall Study|Death likely due to disease progression|1|||
147411865|NCT02440425|531671546|FG000|Overall Study|Withdrawal by Subject|2|||
147411866|NCT02440425|531671546|FG000|Overall Study|Adverse Event|1|||
147411867|NCT02440425|531671546|FG000|Overall Study|Adverse Event/Ineligible|1|||
147411868|NCT00842244|531671547|FG000|Overall Study|Death|3|||
147619297|NCT00413699|532424495|FG000|Initial Period|Other|67|||
147619298|NCT00413699|532424496|FG001|Initial Period|Other|211|||
147619299|NCT00413699|532424497|FG002|Initial Period|Other|0|||
147619300|NCT00413699|532424495|FG000|Initial Period|Adverse event related to study drug|178|||
147619301|NCT00413699|532424496|FG001|Initial Period|Adverse event related to study drug|527|||
147619302|NCT00413699|532424497|FG002|Initial Period|Adverse event related to study drug|0|||
147619303|NCT00413699|532424495|FG000|Initial Period|Adverse event not related to study drug|113|||
147619304|NCT00413699|532424496|FG001|Initial Period|Adverse event not related to study drug|248|||
147619305|NCT00413699|532424497|FG002|Initial Period|Adverse event not related to study drug|0|||
147619306|NCT00413699|532424495|FG000|Initial Period|Missing end of study page|0|||
147619307|NCT00413699|532424496|FG001|Initial Period|Missing end of study page|4|||
147619308|NCT00413699|532424497|FG002|Initial Period|Missing end of study page|0|||
147619309|NCT00413699|532424495|FG000|Initial Period|No longer willing to participate|116|||
147619310|NCT00413699|532424496|FG001|Initial Period|No longer willing to participate|368|||
147619311|NCT00413699|532424497|FG002|Initial Period|No longer willing to participate|0|||
147619312|NCT00413699|532424495|FG000|Extension Period|No Longer Willing to Participate|0|||
147619313|NCT00413699|532424496|FG001|Extension Period|No Longer Willing to Participate|0|||
147619314|NCT00413699|532424497|FG002|Extension Period|No Longer Willing to Participate|2|||
147619315|NCT00413699|532424495|FG000|Extension Period|Protocol Violation|0|||
147619316|NCT00413699|532424496|FG001|Extension Period|Protocol Violation|0|||
147619317|NCT00413699|532424497|FG002|Extension Period|Protocol Violation|1|||
147619318|NCT00413699|532424495|FG000|Extension Period|Adverse Event|0|||
147619319|NCT00413699|532424496|FG001|Extension Period|Adverse Event|0|||
147619320|NCT00413699|532424497|FG002|Extension Period|Adverse Event|2|||
147619321|NCT02115269|532424498|FG000|Overall Study|Lost to Follow-up|43|||
147619322|NCT02115269|532424498|FG000|Overall Study|Did not complete patient diary|3|||
147619323|NCT02115269|532424498|FG000|Overall Study|Moved to another city|7|||
147619324|NCT02115269|532424498|FG000|Overall Study|Withdrawal by Subject|2|||
147619325|NCT02115269|532424498|FG000|Overall Study|Didn't take study drug|2|||
147619326|NCT02810457|532424499|FG000|Overall Study|Randomised but no treatment received|2|||
147619327|NCT02810457|532424500|FG001|Overall Study|Randomised but no treatment received|1|||
147619328|NCT02810457|532424499|FG000|Overall Study|Objective PD assessed by RECIST v1.1|191|||
147619329|NCT02810457|532424500|FG001|Overall Study|Objective PD assessed by RECIST v1.1|199|||
147619330|NCT02810457|532424499|FG000|Overall Study|Adverse Event|37|||
147619331|NCT02810457|532424500|FG001|Overall Study|Adverse Event|43|||
147619332|NCT02810457|532424499|FG000|Overall Study|Patient decision|31|||
147619333|NCT02810457|532424500|FG001|Overall Study|Patient decision|35|||
147619334|NCT02810457|532424499|FG000|Overall Study|Patient lost to follow-up|2|||
147619335|NCT02810457|532424500|FG001|Overall Study|Patient lost to follow-up|2|||
147619336|NCT02810457|532424499|FG000|Overall Study|Death|39|||
147619337|NCT02810457|532424500|FG001|Overall Study|Death|28|||
147619338|NCT02810457|532424499|FG000|Overall Study|Ongoing at data cutoff and discontinued|3|||
147619339|NCT02810457|532424500|FG001|Overall Study|Ongoing at data cutoff and discontinued|2|||
147619340|NCT02810457|532424499|FG000|Overall Study|Clinical progression|15|||
147411869|NCT00842244|531671547|FG000|Overall Study|Withdrawal by Subject|1|||
147411870|NCT00842244|531671547|FG000|Overall Study|Other|17|||
147411871|NCT04145700|531671548|FG000|Overall Study|Withdrawal by Subject|8|||
147411872|NCT04145700|531671549|FG001|Overall Study|Withdrawal by Subject|3|||
147411873|NCT00780559|531671550|FG000|Overall Study|Lost to Follow-up|2|||
147411874|NCT00780559|531671551|FG001|Overall Study|Lost to Follow-up|7|||
147411875|NCT00780559|531671550|FG000|Overall Study|Death|1|||
147411876|NCT00780559|531671551|FG001|Overall Study|Death|0|||
147411877|NCT00818779|531671552|FG000|Overall Study|Protocol Violation|1|||
147411878|NCT00818779|531671553|FG001|Overall Study|Protocol Violation|0|||
147411879|NCT00818779|531671552|FG000|Overall Study|Lost to Follow-up|1|||
147411880|NCT00818779|531671553|FG001|Overall Study|Lost to Follow-up|0|||
147411881|NCT00818779|531671552|FG000|Overall Study|Adverse Event|4|||
147411882|NCT00818779|531671553|FG001|Overall Study|Adverse Event|1|||
147411883|NCT01327846|531671557|FG000|Core Phase|Subject decision (vital status: missing)|1|||
147411884|NCT01327846|531671558|FG001|Core Phase|Subject decision (vital status: missing)|2|||
147411885|NCT01327846|531671559|FG002|Core Phase|Subject decision (vital status: missing)|2|||
147411886|NCT01327846|531671560|FG003|Core Phase|Subject decision (vital status: missing)|1|||
147411887|NCT01327846|531671557|FG000|Core Phase|Subject decision (vital stat: unkn)|0|||
147411888|NCT01327846|531671558|FG001|Core Phase|Subject decision (vital stat: unkn)|0|||
147411889|NCT01327846|531671559|FG002|Core Phase|Subject decision (vital stat: unkn)|3|||
147411890|NCT01327846|531671560|FG003|Core Phase|Subject decision (vital stat: unkn)|3|||
147411891|NCT01327846|531671557|FG000|Core Phase|Subject decision (vital stat: dead)|1|||
147619341|NCT02810457|532424500|FG001|Overall Study|Clinical progression|16|||
147619342|NCT02810457|532424499|FG000|Overall Study|Investigator decision|3|||
147619343|NCT02810457|532424500|FG001|Overall Study|Investigator decision|2|||
147411892|NCT01327846|531671558|FG001|Core Phase|Subject decision (vital stat: dead)|3|||
147411893|NCT01327846|531671559|FG002|Core Phase|Subject decision (vital stat: dead)|4|||
147411894|NCT01327846|531671560|FG003|Core Phase|Subject decision (vital stat: dead)|4|||
147411895|NCT01327846|531671557|FG000|Core Phase|Subject decision (vital stat: alive)|23|||
147468998|NCT02901431|531872517|FG006|Main Treatment Part|Withdrawal by Subject|6|||
147468999|NCT02901431|531872518|FG007|Main Treatment Part|Withdrawal by Subject|0|||
147619344|NCT02810457|532424499|FG000|Overall Study|Patient ineligibility|3|||
147619345|NCT02810457|532424500|FG001|Overall Study|Patient ineligibility|0|||
147619346|NCT02810457|532424499|FG000|Overall Study|Miscalculated PD|1|||
147619347|NCT02810457|532424500|FG001|Overall Study|Miscalculated PD|0|||
147619348|NCT02810457|532424499|FG000|Overall Study|Physician Decision|0|||
147619349|NCT02810457|532424500|FG001|Overall Study|Physician Decision|1|||
147619350|NCT01402570|532424501|FG000|Overall Study|Adverse Event|1|||
147619351|NCT03642262|532424504|FG000|Period 1|Withdrawal by Subject|1|||
147619352|NCT03642262|532424505|FG001|Period 1|Withdrawal by Subject|1|||
147619353|NCT03642262|532424504|FG000|Period 1|Adverse Event|0|||
147619354|NCT03642262|532424505|FG001|Period 1|Adverse Event|1|||
147619355|NCT01557504|532424506|FG000|Overall Study|Physician Decision|1|||
147619356|NCT01557504|532424507|FG001|Overall Study|Physician Decision|0|||
147619357|NCT02750618|532424510|FG000|Overall Study|Withdrawal by Subject|1|||
147619358|NCT01103180|532424514|FG000|Overall Study|Withdrawal by Subject|8|||
147619359|NCT01103180|532424515|FG001|Overall Study|Withdrawal by Subject|13|||
147619360|NCT01103180|532424514|FG000|Overall Study|Lost to Follow-up|13|||
147619361|NCT01103180|532424515|FG001|Overall Study|Lost to Follow-up|7|||
147619362|NCT01103180|532424514|FG000|Overall Study|Physician Decision|1|||
147619363|NCT01103180|532424515|FG001|Overall Study|Physician Decision|0|||
147619364|NCT01103180|532424514|FG000|Overall Study|Protocol Violation|0|||
147619365|NCT01103180|532424515|FG001|Overall Study|Protocol Violation|1|||
147619366|NCT03499067|532424521|FG000|First Intervention|Physician Decision|2|||
147619367|NCT03499067|532424522|FG001|First Intervention|Physician Decision|1|||
147619368|NCT03499067|532424521|FG000|First Intervention|Withdrawal by Subject|3|||
147619369|NCT03499067|532424522|FG001|First Intervention|Withdrawal by Subject|6|||
147619370|NCT02440464|532424523|FG000|Overall Study|Withdrawal by Subject|3|||
147619371|NCT02440464|532424524|FG001|Overall Study|Withdrawal by Subject|2|||
147619372|NCT00324987|532424525|FG000|Overall Study|Adverse Event|2|||
147619373|NCT00324987|532424526|FG001|Overall Study|Adverse Event|1|||
147619374|NCT00324987|532424525|FG000|Overall Study|Withdrawal by Subject|1|||
147619375|NCT00324987|532424526|FG001|Overall Study|Withdrawal by Subject|1|||
147619376|NCT00324987|532424525|FG000|Overall Study|Progression|1|||
147619377|NCT00324987|532424526|FG001|Overall Study|Progression|1|||
147619378|NCT00324987|532424525|FG000|Overall Study|symptomatic deterioration, toxicity, etc|2|||
147619379|NCT00324987|532424526|FG001|Overall Study|symptomatic deterioration, toxicity, etc|3|||
147619380|NCT01199939|532424532|FG000|Overall Study|Adverse Event|4|||
147619381|NCT01199939|532424532|FG000|Overall Study|Protocol Violation|3|||
147619382|NCT01199939|532424532|FG000|Overall Study|Lost to Follow-up|2|||
147619383|NCT01199939|532424532|FG000|Overall Study|Reached a virologic endpoint|4|||
147619384|NCT00882518|532424533|FG000|Overall Study|Adverse Event|9|||
147469000|NCT02901431|531872519|FG008|Main Treatment Part|Withdrawal by Subject|0|||
147469001|NCT02901431|531872520|FG009|Main Treatment Part|Withdrawal by Subject|0|||
147469002|NCT02901431|531872521|FG010|Main Treatment Part|Withdrawal by Subject|0|||
147469003|NCT02901431|531872522|FG011|Main Treatment Part|Withdrawal by Subject|0|||
147469004|NCT02901431|531872523|FG012|Main Treatment Part|Withdrawal by Subject|0|||
147469005|NCT02901431|531872511|FG000|Open Label Part|Adverse Event|0|||
147469006|NCT02901431|531872512|FG001|Open Label Part|Adverse Event|0|||
147469007|NCT02901431|531872513|FG002|Open Label Part|Adverse Event|0|||
147469008|NCT02901431|531872514|FG003|Open Label Part|Adverse Event|0|||
147469009|NCT02901431|531872515|FG004|Open Label Part|Adverse Event|0|||
147469010|NCT02901431|531872516|FG005|Open Label Part|Adverse Event|0|||
147469011|NCT02901431|531872517|FG006|Open Label Part|Adverse Event|0|||
147469012|NCT02901431|531872518|FG007|Open Label Part|Adverse Event|0|||
147469013|NCT02901431|531872519|FG008|Open Label Part|Adverse Event|4|||
147619385|NCT00882518|532424534|FG001|Overall Study|Adverse Event|18|||
147619386|NCT00882518|532424533|FG000|Overall Study|Withdrawal by Subject|9|||
147619387|NCT00882518|532424534|FG001|Overall Study|Withdrawal by Subject|13|||
147469014|NCT02901431|531872520|FG009|Open Label Part|Adverse Event|4|||
147469015|NCT02901431|531872521|FG010|Open Label Part|Adverse Event|0|||
147469016|NCT02901431|531872522|FG011|Open Label Part|Adverse Event|4|||
147469017|NCT02901431|531872523|FG012|Open Label Part|Adverse Event|1|||
147469018|NCT02901431|531872511|FG000|Open Label Part|Lost to Follow-up|0|||
147619388|NCT00882518|532424533|FG000|Overall Study|Lack of Efficacy|12|||
147619389|NCT00882518|532424534|FG001|Overall Study|Lack of Efficacy|9|||
147619390|NCT00882518|532424533|FG000|Overall Study|Severe non-compliance to protocol|3|||
147469019|NCT02901431|531872512|FG001|Open Label Part|Lost to Follow-up|0|||
147619391|NCT00882518|532424534|FG001|Overall Study|Severe non-compliance to protocol|1|||
147469020|NCT02901431|531872513|FG002|Open Label Part|Lost to Follow-up|0|||
147469021|NCT02901431|531872514|FG003|Open Label Part|Lost to Follow-up|0|||
147619392|NCT00882518|532424533|FG000|Overall Study|Incorrect enrolment|4|||
147469022|NCT02901431|531872515|FG004|Open Label Part|Lost to Follow-up|0|||
147469023|NCT02901431|531872516|FG005|Open Label Part|Lost to Follow-up|0|||
147469024|NCT02901431|531872517|FG006|Open Label Part|Lost to Follow-up|0|||
147469025|NCT02901431|531872518|FG007|Open Label Part|Lost to Follow-up|0|||
147619393|NCT00882518|532424534|FG001|Overall Study|Incorrect enrolment|2|||
147619394|NCT00882518|532424533|FG000|Overall Study|Central lab closure for National day|1|||
147411896|NCT01327846|531671558|FG001|Core Phase|Subject decision (vital stat: alive)|24|||
147411897|NCT01327846|531671559|FG002|Core Phase|Subject decision (vital stat: alive)|13|||
147411898|NCT01327846|531671560|FG003|Core Phase|Subject decision (vital stat: alive)|20|||
147411899|NCT01327846|531671557|FG000|Core Phase|Lost to Follow-up|3|||
147411900|NCT01327846|531671558|FG001|Core Phase|Lost to Follow-up|3|||
147411901|NCT01327846|531671559|FG002|Core Phase|Lost to Follow-up|4|||
147411902|NCT01327846|531671560|FG003|Core Phase|Lost to Follow-up|5|||
147411903|NCT01327846|531671557|FG000|Extension Phase|Study terminated by sponsor|1073|||
147411904|NCT01327846|531671558|FG001|Extension Phase|Study terminated by sponsor|1124|||
147411905|NCT01327846|531671559|FG002|Extension Phase|Study terminated by sponsor|1067|||
147411906|NCT01327846|531671560|FG003|Extension Phase|Study terminated by sponsor|1660|||
147411907|NCT01327846|531671557|FG000|Extension Phase|Withdrawal by Subject|20|||
147411908|NCT01327846|531671558|FG001|Extension Phase|Withdrawal by Subject|13|||
147411909|NCT01327846|531671559|FG002|Extension Phase|Withdrawal by Subject|19|||
147411910|NCT01327846|531671560|FG003|Extension Phase|Withdrawal by Subject|37|||
147411911|NCT01327846|531671557|FG000|Extension Phase|Lost to Follow-up|4|||
147411912|NCT01327846|531671558|FG001|Extension Phase|Lost to Follow-up|3|||
147411913|NCT01327846|531671559|FG002|Extension Phase|Lost to Follow-up|4|||
147411914|NCT01327846|531671560|FG003|Extension Phase|Lost to Follow-up|7|||
147411915|NCT01327846|531671557|FG000|Extension Phase|Technical Problems|2|||
147411916|NCT01327846|531671558|FG001|Extension Phase|Technical Problems|4|||
147411917|NCT01327846|531671559|FG002|Extension Phase|Technical Problems|2|||
147411918|NCT01327846|531671560|FG003|Extension Phase|Technical Problems|2|||
147411919|NCT00245960|531671563|FG000|Period 1 (Double Blind): 1-12 Weeks|Adverse Event|6|||
147411920|NCT00245960|531671564|FG001|Period 1 (Double Blind): 1-12 Weeks|Adverse Event|7|||
147411921|NCT00245960|531671563|FG000|Period 1 (Double Blind): 1-12 Weeks|Pregnancy|0|||
147411922|NCT00245960|531671564|FG001|Period 1 (Double Blind): 1-12 Weeks|Pregnancy|1|||
147411923|NCT00245960|531671563|FG000|Period 1 (Double Blind): 1-12 Weeks|Withdrawal of consent|2|||
147411924|NCT00245960|531671564|FG001|Period 1 (Double Blind): 1-12 Weeks|Withdrawal of consent|0|||
147411925|NCT00245960|531671563|FG000|Period 1 (Double Blind): 1-12 Weeks|Unsatisfactory Response|2|||
147411926|NCT00245960|531671564|FG001|Period 1 (Double Blind): 1-12 Weeks|Unsatisfactory Response|1|||
147411927|NCT00245960|531671563|FG000|Period 1 (Double Blind): 1-12 Weeks|Protocol Violation|3|||
147411928|NCT00245960|531671564|FG001|Period 1 (Double Blind): 1-12 Weeks|Protocol Violation|0|||
147411929|NCT00245960|531671563|FG000|Period 1 (Double Blind): 1-12 Weeks|Withdrawal by Subject|2|||
147411930|NCT00245960|531671564|FG001|Period 1 (Double Blind): 1-12 Weeks|Withdrawal by Subject|2|||
147411931|NCT00245960|531671563|FG000|Period 2 (Open Label): 13-24 Weeks|Adverse Event|8|||
147411932|NCT00245960|531671564|FG001|Period 2 (Open Label): 13-24 Weeks|Adverse Event|4|||
147411933|NCT00245960|531671563|FG000|Period 2 (Open Label): 13-24 Weeks|Lost to Follow-up|2|||
147411934|NCT00245960|531671564|FG001|Period 2 (Open Label): 13-24 Weeks|Lost to Follow-up|2|||
147411935|NCT00245960|531671563|FG000|Period 2 (Open Label): 13-24 Weeks|Unsatisfactory Response|2|||
147411936|NCT00245960|531671564|FG001|Period 2 (Open Label): 13-24 Weeks|Unsatisfactory Response|5|||
147411937|NCT00245960|531671563|FG000|Period 2 (Open Label): 13-24 Weeks|Withdrawal by Subject|1|||
147411938|NCT00245960|531671564|FG001|Period 2 (Open Label): 13-24 Weeks|Withdrawal by Subject|3|||
147411939|NCT00245960|531671563|FG000|Period 2 (Open Label): 13-24 Weeks|Protocol Violation|1|||
147411940|NCT00245960|531671564|FG001|Period 2 (Open Label): 13-24 Weeks|Protocol Violation|3|||
147411941|NCT00245960|531671563|FG000|Period 2 (Open Label): 13-24 Weeks|Withdrawal of consent|0|||
147411942|NCT00245960|531671564|FG001|Period 2 (Open Label): 13-24 Weeks|Withdrawal of consent|1|||
147411943|NCT01077518|531671566|FG000|Treatment Phase - no Optional Ofa|Lost to Follow-up|8|||
147411944|NCT01077518|531671567|FG001|Treatment Phase - no Optional Ofa|Lost to Follow-up|4|||
147411945|NCT01077518|531671568|FG002|Treatment Phase - no Optional Ofa|Lost to Follow-up|0|||
147411946|NCT01077518|531671566|FG000|Treatment Phase - no Optional Ofa|Physician Decision|10|||
147411947|NCT01077518|531671567|FG001|Treatment Phase - no Optional Ofa|Physician Decision|11|||
147411948|NCT01077518|531671568|FG002|Treatment Phase - no Optional Ofa|Physician Decision|0|||
147411949|NCT01077518|531671566|FG000|Treatment Phase - no Optional Ofa|Study Terminated by Sponsor|28|||
147411950|NCT01077518|531671567|FG001|Treatment Phase - no Optional Ofa|Study Terminated by Sponsor|22|||
147411951|NCT01077518|531671568|FG002|Treatment Phase - no Optional Ofa|Study Terminated by Sponsor|0|||
147411952|NCT01077518|531671566|FG000|Treatment Phase - no Optional Ofa|Withdrawal by Subject|32|||
147411953|NCT01077518|531671567|FG001|Treatment Phase - no Optional Ofa|Withdrawal by Subject|28|||
147411954|NCT01077518|531671568|FG002|Treatment Phase - no Optional Ofa|Withdrawal by Subject|0|||
147411955|NCT01077518|531671566|FG000|Optional Ofa Phase|Physician Decision|0|||
147411956|NCT01077518|531671567|FG001|Optional Ofa Phase|Physician Decision|0|||
147411957|NCT01077518|531671568|FG002|Optional Ofa Phase|Physician Decision|1|||
147411958|NCT01077518|531671566|FG000|Optional Ofa Phase|Study Terminated by Sponsor|0|||
147411959|NCT01077518|531671567|FG001|Optional Ofa Phase|Study Terminated by Sponsor|0|||
147411960|NCT01077518|531671568|FG002|Optional Ofa Phase|Study Terminated by Sponsor|12|||
147411961|NCT01077518|531671566|FG000|Optional Ofa Phase|Withdrawal by Subject|0|||
147411962|NCT01077518|531671567|FG001|Optional Ofa Phase|Withdrawal by Subject|0|||
147411963|NCT01077518|531671568|FG002|Optional Ofa Phase|Withdrawal by Subject|3|||
147411964|NCT01495598|531671569|FG000|Overall Study|Death during follow up period|2|||
147411965|NCT01495598|531671569|FG000|Overall Study|Death on study|1|||
147665771|NCT02709746|532601594|FG004|Phase A (Single-blind Treatment Period)|Lack of Efficacy|0|||
147665772|NCT02709746|532601590|FG000|Phase A (Single-blind Treatment Period)|Adverse Event|2|||
147665773|NCT02709746|532601591|FG001|Phase A (Single-blind Treatment Period)|Adverse Event|0|||
147665774|NCT02709746|532601592|FG002|Phase A (Single-blind Treatment Period)|Adverse Event|0|||
147665775|NCT02709746|532601593|FG003|Phase A (Single-blind Treatment Period)|Adverse Event|0|||
147665776|NCT02709746|532601594|FG004|Phase A (Single-blind Treatment Period)|Adverse Event|0|||
147665777|NCT02709746|532601590|FG000|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|12|||
147665778|NCT02709746|532601591|FG001|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|0|||
147665779|NCT02709746|532601592|FG002|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|0|||
147665780|NCT02709746|532601593|FG003|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|0|||
147665781|NCT02709746|532601594|FG004|Phase A (Single-blind Treatment Period)|Withdrawal by Subject|0|||
147665782|NCT02709746|532601590|FG000|Phase A (Single-blind Treatment Period)|Enrolled not treated|7|||
147665783|NCT02709746|532601591|FG001|Phase A (Single-blind Treatment Period)|Enrolled not treated|0|||
147665784|NCT02709746|532601592|FG002|Phase A (Single-blind Treatment Period)|Enrolled not treated|0|||
147665785|NCT02709746|532601593|FG003|Phase A (Single-blind Treatment Period)|Enrolled not treated|0|||
147665786|NCT02709746|532601594|FG004|Phase A (Single-blind Treatment Period)|Enrolled not treated|0|||
147665787|NCT02709746|532601590|FG000|Phase A (Single-blind Treatment Period)|Lost to Follow-up|7|||
147665788|NCT02709746|532601591|FG001|Phase A (Single-blind Treatment Period)|Lost to Follow-up|0|||
147665789|NCT02709746|532601592|FG002|Phase A (Single-blind Treatment Period)|Lost to Follow-up|0|||
147665790|NCT02709746|532601593|FG003|Phase A (Single-blind Treatment Period)|Lost to Follow-up|0|||
147665791|NCT02709746|532601594|FG004|Phase A (Single-blind Treatment Period)|Lost to Follow-up|0|||
147665792|NCT02709746|532601590|FG000|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|103|||
147665793|NCT02709746|532601591|FG001|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|0|||
147411966|NCT01495598|531671569|FG000|Overall Study|Lost to Follow-up|3|||
147411967|NCT01495598|531671569|FG000|Overall Study|Physician Decision|8|||
147411968|NCT03852719|531671570|FG000|Overall Study|Withdrawal of consent|8|||
147411969|NCT03852719|531671571|FG001|Overall Study|Withdrawal of consent|8|||
147411970|NCT03852719|531671572|FG002|Overall Study|Withdrawal of consent|9|||
147411971|NCT03852719|531671570|FG000|Overall Study|Physician Decision|5|||
147619395|NCT00882518|532424534|FG001|Overall Study|Central lab closure for National day|0|||
147619396|NCT00882518|532424533|FG000|Overall Study|Allocating random number by mistake|0|||
147619397|NCT00882518|532424534|FG001|Overall Study|Allocating random number by mistake|1|||
147619398|NCT03238651|532424535|FG000|Overall Study|Other|0|||
147619399|NCT03238651|532424536|FG001|Overall Study|Other|0|||
147619400|NCT03238651|532424537|FG002|Overall Study|Other|0|||
147619401|NCT03238651|532424538|FG003|Overall Study|Other|0|||
147619402|NCT03238651|532424539|FG004|Overall Study|Other|1|||
147619403|NCT03238651|532424535|FG000|Overall Study|Progressive Disease|2|||
147619404|NCT03238651|532424536|FG001|Overall Study|Progressive Disease|2|||
147619405|NCT03238651|532424537|FG002|Overall Study|Progressive Disease|2|||
147619406|NCT03238651|532424538|FG003|Overall Study|Progressive Disease|2|||
147619407|NCT03238651|532424539|FG004|Overall Study|Progressive Disease|0|||
147619408|NCT03238651|532424535|FG000|Overall Study|Withdrawal by Subject|0|||
147619409|NCT03238651|532424536|FG001|Overall Study|Withdrawal by Subject|1|||
147619410|NCT03238651|532424537|FG002|Overall Study|Withdrawal by Subject|0|||
147619411|NCT03238651|532424538|FG003|Overall Study|Withdrawal by Subject|1|||
147619412|NCT03238651|532424539|FG004|Overall Study|Withdrawal by Subject|0|||
147619413|NCT03238651|532424535|FG000|Overall Study|Adverse Event|1|||
147619414|NCT03238651|532424536|FG001|Overall Study|Adverse Event|3|||
147619415|NCT03238651|532424537|FG002|Overall Study|Adverse Event|2|||
147619416|NCT03238651|532424538|FG003|Overall Study|Adverse Event|0|||
147619417|NCT03238651|532424539|FG004|Overall Study|Adverse Event|0|||
147619418|NCT01960413|532424540|FG000|Overall Study|Withdrawal by Subject|1|||
147619419|NCT01960413|532424541|FG001|Overall Study|Withdrawal by Subject|1|||
147619420|NCT01960413|532424540|FG000|Overall Study|Physician Decision|1|||
147619421|NCT01960413|532424541|FG001|Overall Study|Physician Decision|0|||
147619422|NCT01960413|532424540|FG000|Overall Study|Lost to Follow-up|2|||
147619423|NCT01960413|532424541|FG001|Overall Study|Lost to Follow-up|0|||
147619424|NCT00791778|532424542|FG000|Double-blind Treatment|Adverse Event|49|||
147619425|NCT00791778|532424543|FG001|Double-blind Treatment|Adverse Event|9|||
147619426|NCT00791778|532424542|FG000|Double-blind Treatment|Physician Decision|6|||
147619427|NCT00791778|532424543|FG001|Double-blind Treatment|Physician Decision|26|||
147619428|NCT00791778|532424542|FG000|Double-blind Treatment|Protocol Violation|0|||
147619429|NCT00791778|532424543|FG001|Double-blind Treatment|Protocol Violation|4|||
147619430|NCT00791778|532424542|FG000|Double-blind Treatment|Withdrawal by Subject|20|||
147619431|NCT00791778|532424543|FG001|Double-blind Treatment|Withdrawal by Subject|9|||
147619432|NCT00791778|532424542|FG000|Double-blind Treatment|Non-compliant with study medication|2|||
147619433|NCT00791778|532424543|FG001|Double-blind Treatment|Non-compliant with study medication|0|||
147619434|NCT00791778|532424542|FG000|Follow-up|Withdrawal by Subject|3|||
147619435|NCT00791778|532424543|FG001|Follow-up|Withdrawal by Subject|0|||
147619436|NCT00791778|532424542|FG000|Follow-up|Lost to Follow-up|2|||
147619437|NCT00791778|532424543|FG001|Follow-up|Lost to Follow-up|1|||
147619438|NCT04886596|532424546|FG000|Overall Study|Adverse Event|442|||
147619439|NCT04886596|532424547|FG001|Overall Study|Adverse Event|441|||
147619440|NCT04886596|532424546|FG000|Overall Study|Lost to Follow-up|448|||
147619441|NCT04886596|532424547|FG001|Overall Study|Lost to Follow-up|465|||
147619442|NCT04886596|532424546|FG000|Overall Study|Consent withdrawal, not due to a (S)AE|1715|||
147619443|NCT04886596|532424547|FG001|Overall Study|Consent withdrawal, not due to a (S)AE|1726|||
147619444|NCT04886596|532424546|FG000|Overall Study|Migrated/moved from the study area|201|||
147619445|NCT04886596|532424547|FG001|Overall Study|Migrated/moved from the study area|184|||
147619446|NCT04886596|532424546|FG000|Overall Study|Other|298|||
147619447|NCT04886596|532424547|FG001|Overall Study|Other|326|||
147619448|NCT01074944|532424548|FG000|Lead-in Period (up to 78 Weeks)|Adverse Event|2|||
147619449|NCT01074944|532424549|FG001|Lead-in Period (up to 78 Weeks)|Adverse Event|0|||
147619450|NCT01074944|532424550|FG002|Lead-in Period (up to 78 Weeks)|Adverse Event|0|||
147619451|NCT01074944|532424551|FG003|Lead-in Period (up to 78 Weeks)|Adverse Event|0|||
147619452|NCT01074944|532424552|FG004|Lead-in Period (up to 78 Weeks)|Adverse Event|0|||
147619453|NCT01074944|532424548|FG000|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|1|||
147619454|NCT01074944|532424549|FG001|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0|||
147619455|NCT01074944|532424550|FG002|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0|||
147619456|NCT01074944|532424551|FG003|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0|||
147619457|NCT01074944|532424552|FG004|Lead-in Period (up to 78 Weeks)|Non-Compliance With Protocol|0|||
147619458|NCT01074944|532424548|FG000|Lead-in Period (up to 78 Weeks)|Pregnancy|4|||
147619459|NCT01074944|532424549|FG001|Lead-in Period (up to 78 Weeks)|Pregnancy|0|||
147619460|NCT01074944|532424550|FG002|Lead-in Period (up to 78 Weeks)|Pregnancy|0|||
147619461|NCT01074944|532424551|FG003|Lead-in Period (up to 78 Weeks)|Pregnancy|0|||
147619462|NCT01074944|532424552|FG004|Lead-in Period (up to 78 Weeks)|Pregnancy|0|||
147619463|NCT01074944|532424548|FG000|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|6|||
147619464|NCT01074944|532424549|FG001|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0|||
147619465|NCT01074944|532424550|FG002|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0|||
147619466|NCT01074944|532424551|FG003|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0|||
147619467|NCT01074944|532424552|FG004|Lead-in Period (up to 78 Weeks)|Withdrawal by Subject|0|||
147619468|NCT01074944|532424548|FG000|Primary Analysis Period (up to 52 Weeks)|Adverse Event|0|||
147619469|NCT01074944|532424549|FG001|Primary Analysis Period (up to 52 Weeks)|Adverse Event|2|||
147619470|NCT01074944|532424550|FG002|Primary Analysis Period (up to 52 Weeks)|Adverse Event|3|||
147619471|NCT01074944|532424551|FG003|Primary Analysis Period (up to 52 Weeks)|Adverse Event|0|||
147619472|NCT01074944|532424552|FG004|Primary Analysis Period (up to 52 Weeks)|Adverse Event|0|||
147619473|NCT01074944|532424548|FG000|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|0|||
147619474|NCT01074944|532424549|FG001|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|6|||
147619475|NCT01074944|532424550|FG002|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|1|||
147619476|NCT01074944|532424551|FG003|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|0|||
147619477|NCT01074944|532424552|FG004|Primary Analysis Period (up to 52 Weeks)|Treatment Failure|0|||
147619478|NCT01074944|532424548|FG000|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|0|||
147619479|NCT01074944|532424549|FG001|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|1|||
147619480|NCT01074944|532424550|FG002|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|1|||
147619481|NCT01074944|532424551|FG003|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|0|||
147619482|NCT01074944|532424552|FG004|Primary Analysis Period (up to 52 Weeks)|Withdrawal by Subject|0|||
147619483|NCT01074944|532424548|FG000|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0|||
147619484|NCT01074944|532424549|FG001|Primary Analysis Period (up to 52 Weeks)|Pregnancy|1|||
147619485|NCT01074944|532424550|FG002|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0|||
147619486|NCT01074944|532424551|FG003|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0|||
147619487|NCT01074944|532424552|FG004|Primary Analysis Period (up to 52 Weeks)|Pregnancy|0|||
147619488|NCT01074944|532424548|FG000|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|0|||
147619489|NCT01074944|532424549|FG001|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|1|||
147619490|NCT01074944|532424550|FG002|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|1|||
147619491|NCT01074944|532424551|FG003|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|0|||
147619492|NCT01074944|532424552|FG004|Primary Analysis Period (up to 52 Weeks)|Non-Compliant to Protocol|0|||
147619493|NCT01074944|532424548|FG000|Long Term Treatment|Adverse Event|0|||
147619494|NCT01074944|532424549|FG001|Long Term Treatment|Adverse Event|0|||
147619495|NCT01074944|532424550|FG002|Long Term Treatment|Adverse Event|0|||
147619496|NCT01074944|532424551|FG003|Long Term Treatment|Adverse Event|3|||
147619497|NCT01074944|532424552|FG004|Long Term Treatment|Adverse Event|0|||
147619498|NCT01074944|532424548|FG000|Long Term Treatment|Lost to Follow-up|0|||
147619499|NCT01074944|532424549|FG001|Long Term Treatment|Lost to Follow-up|0|||
147619500|NCT01074944|532424550|FG002|Long Term Treatment|Lost to Follow-up|0|||
147619501|NCT01074944|532424551|FG003|Long Term Treatment|Lost to Follow-up|2|||
147619502|NCT01074944|532424552|FG004|Long Term Treatment|Lost to Follow-up|0|||
147619503|NCT01074944|532424548|FG000|Long Term Treatment|Transitioned to Commercial Eliglustat|0|||
147619504|NCT01074944|532424549|FG001|Long Term Treatment|Transitioned to Commercial Eliglustat|0|||
147619505|NCT01074944|532424550|FG002|Long Term Treatment|Transitioned to Commercial Eliglustat|0|||
147619506|NCT01074944|532424551|FG003|Long Term Treatment|Transitioned to Commercial Eliglustat|18|||
147619507|NCT01074944|532424552|FG004|Long Term Treatment|Transitioned to Commercial Eliglustat|0|||
147619508|NCT01074944|532424548|FG000|Long Term Treatment|Entered in Period, But Not Treated|0|||
147619509|NCT01074944|532424549|FG001|Long Term Treatment|Entered in Period, But Not Treated|0|||
147619510|NCT01074944|532424550|FG002|Long Term Treatment|Entered in Period, But Not Treated|0|||
147619511|NCT01074944|532424551|FG003|Long Term Treatment|Entered in Period, But Not Treated|1|||
147619512|NCT01074944|532424552|FG004|Long Term Treatment|Entered in Period, But Not Treated|0|||
147619513|NCT01074944|532424548|FG000|Long Term Treatment|Withdrawal by Subject|0|||
147619514|NCT01074944|532424549|FG001|Long Term Treatment|Withdrawal by Subject|0|||
147619515|NCT01074944|532424550|FG002|Long Term Treatment|Withdrawal by Subject|0|||
147619516|NCT01074944|532424551|FG003|Long Term Treatment|Withdrawal by Subject|2|||
147619517|NCT01074944|532424552|FG004|Long Term Treatment|Withdrawal by Subject|0|||
147619518|NCT01074944|532424548|FG000|Extended Treatment (up to 42 Months)|Pregnancy|0|||
147619519|NCT01074944|532424549|FG001|Extended Treatment (up to 42 Months)|Pregnancy|0|||
147619520|NCT01074944|532424550|FG002|Extended Treatment (up to 42 Months)|Pregnancy|0|||
147619521|NCT01074944|532424551|FG003|Extended Treatment (up to 42 Months)|Pregnancy|0|||
147619522|NCT01074944|532424552|FG004|Extended Treatment (up to 42 Months)|Pregnancy|2|||
147619523|NCT01074944|532424548|FG000|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0|||
147619524|NCT01074944|532424549|FG001|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0|||
147619525|NCT01074944|532424550|FG002|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0|||
147619526|NCT01074944|532424551|FG003|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|0|||
147619527|NCT01074944|532424552|FG004|Extended Treatment (up to 42 Months)|Transitioned to Commercial Eliglustat|3|||
147619528|NCT02348112|532424554|FG000|Overall Study|Withdrawal by Subject|32|||
147619529|NCT02348112|532424555|FG001|Overall Study|Withdrawal by Subject|29|||
147619530|NCT02348112|532424554|FG000|Overall Study|Lost to Follow-up|24|||
147619531|NCT02348112|532424555|FG001|Overall Study|Lost to Follow-up|20|||
147619532|NCT02348112|532424554|FG000|Overall Study|Physician Decision|17|||
147619533|NCT02348112|532424555|FG001|Overall Study|Physician Decision|15|||
147619534|NCT02348112|532424554|FG000|Overall Study|Site closed due to PI leaving|0|||
147619535|NCT02348112|532424555|FG001|Overall Study|Site closed due to PI leaving|30|||
147619536|NCT02348112|532424554|FG000|Overall Study|Sponsor withdrawal|0|||
147619537|NCT02348112|532424555|FG001|Overall Study|Sponsor withdrawal|7|||
147619538|NCT02348112|532424554|FG000|Overall Study|Death|0|||
147619539|NCT02348112|532424555|FG001|Overall Study|Death|1|||
147619540|NCT01998841|532424560|FG000|Study Period A|Reason Not Disclosed to Prevent Genetic Unblinding|6|||
147619541|NCT01998841|532424561|FG001|Study Period A|Reason Not Disclosed to Prevent Genetic Unblinding|6|||
147619542|NCT01998841|532424562|FG002|Study Period A|Reason Not Disclosed to Prevent Genetic Unblinding|3|||
147619543|NCT01998841|532424563|FG003|Study Period A|Reason Not Disclosed to Prevent Genetic Unblinding|0|||
147619544|NCT01998841|532424564|FG004|Study Period A|Reason Not Disclosed to Prevent Genetic Unblinding|0|||
147619545|NCT01998841|532424560|FG000|Study Period B|Reason Not Disclosed to Prevent Genetic Unblinding|0|||
147619546|NCT01998841|532424561|FG001|Study Period B|Reason Not Disclosed to Prevent Genetic Unblinding|0|||
147619547|NCT01998841|532424562|FG002|Study Period B|Reason Not Disclosed to Prevent Genetic Unblinding|0|||
147619548|NCT01998841|532424563|FG003|Study Period B|Reason Not Disclosed to Prevent Genetic Unblinding|7|||
147619549|NCT01998841|532424564|FG004|Study Period B|Reason Not Disclosed to Prevent Genetic Unblinding|2|||
147619550|NCT02586155|532424565|FG000|Overall Study|Adverse Event|2|||
147619551|NCT02586155|532424566|FG001|Overall Study|Adverse Event|3|||
147619552|NCT02586155|532424565|FG000|Overall Study|Withdrawal by Subject|31|||
147619553|NCT02586155|532424566|FG001|Overall Study|Withdrawal by Subject|24|||
147619554|NCT02586155|532424565|FG000|Overall Study|Lost to Follow-up|7|||
147619555|NCT02586155|532424566|FG001|Overall Study|Lost to Follow-up|13|||
147619556|NCT02586155|532424565|FG000|Overall Study|Death|61|||
147619557|NCT02586155|532424566|FG001|Overall Study|Death|72|||
147619558|NCT02586155|532424565|FG000|Overall Study|Other reasons|26|||
147619559|NCT02586155|532424566|FG001|Overall Study|Other reasons|15|||
147619560|NCT02552121|532424567|FG000|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|2|||
147619561|NCT02552121|532424568|FG001|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
147619562|NCT02552121|532424569|FG002|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
147619563|NCT02552121|532424570|FG003|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
147619564|NCT02552121|532424571|FG004|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
147619565|NCT02552121|532424572|FG005|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
147619566|NCT02552121|532424573|FG006|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
147619567|NCT02552121|532424574|FG007|Part 1: Dose Level 1 (Weeks 1-16)|Disease Progression|0|||
147619568|NCT02552121|532424567|FG000|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|1|||
147619569|NCT02552121|532424568|FG001|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
147619570|NCT02552121|532424569|FG002|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
147619571|NCT02552121|532424570|FG003|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
147619572|NCT02552121|532424571|FG004|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
147619573|NCT02552121|532424572|FG005|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
147469026|NCT02901431|531872519|FG008|Open Label Part|Lost to Follow-up|2|||
147469027|NCT02901431|531872520|FG009|Open Label Part|Lost to Follow-up|2|||
147469028|NCT02901431|531872521|FG010|Open Label Part|Lost to Follow-up|1|||
147469029|NCT02901431|531872522|FG011|Open Label Part|Lost to Follow-up|1|||
147469030|NCT02901431|531872523|FG012|Open Label Part|Lost to Follow-up|1|||
147469031|NCT02901431|531872511|FG000|Open Label Part|Physician Decision|0|||
147469032|NCT02901431|531872512|FG001|Open Label Part|Physician Decision|0|||
147469033|NCT02901431|531872513|FG002|Open Label Part|Physician Decision|0|||
147469034|NCT02901431|531872514|FG003|Open Label Part|Physician Decision|0|||
147469035|NCT02901431|531872515|FG004|Open Label Part|Physician Decision|0|||
147469036|NCT02901431|531872516|FG005|Open Label Part|Physician Decision|0|||
147469037|NCT02901431|531872517|FG006|Open Label Part|Physician Decision|0|||
147469038|NCT02901431|531872518|FG007|Open Label Part|Physician Decision|0|||
147469039|NCT02901431|531872519|FG008|Open Label Part|Physician Decision|1|||
147469040|NCT02901431|531872520|FG009|Open Label Part|Physician Decision|1|||
147469041|NCT02901431|531872521|FG010|Open Label Part|Physician Decision|0|||
147469042|NCT02901431|531872522|FG011|Open Label Part|Physician Decision|0|||
147469043|NCT02901431|531872523|FG012|Open Label Part|Physician Decision|0|||
147469044|NCT02901431|531872511|FG000|Open Label Part|Study Terminated By Sponsor|0|||
147469045|NCT02901431|531872512|FG001|Open Label Part|Study Terminated By Sponsor|0|||
147469046|NCT02901431|531872513|FG002|Open Label Part|Study Terminated By Sponsor|0|||
147469047|NCT02901431|531872514|FG003|Open Label Part|Study Terminated By Sponsor|0|||
147469048|NCT02901431|531872515|FG004|Open Label Part|Study Terminated By Sponsor|0|||
147469049|NCT02901431|531872516|FG005|Open Label Part|Study Terminated By Sponsor|0|||
147469050|NCT02901431|531872517|FG006|Open Label Part|Study Terminated By Sponsor|0|||
147469051|NCT02901431|531872518|FG007|Open Label Part|Study Terminated By Sponsor|0|||
147469052|NCT02901431|531872519|FG008|Open Label Part|Study Terminated By Sponsor|35|||
147469053|NCT02901431|531872520|FG009|Open Label Part|Study Terminated By Sponsor|12|||
147469054|NCT02901431|531872521|FG010|Open Label Part|Study Terminated By Sponsor|21|||
147469055|NCT02901431|531872522|FG011|Open Label Part|Study Terminated By Sponsor|31|||
147469056|NCT02901431|531872523|FG012|Open Label Part|Study Terminated By Sponsor|0|||
147469057|NCT02901431|531872511|FG000|Open Label Part|Withdrawal by Subject|0|||
147469058|NCT02901431|531872512|FG001|Open Label Part|Withdrawal by Subject|0|||
147469059|NCT02901431|531872513|FG002|Open Label Part|Withdrawal by Subject|0|||
147469060|NCT02901431|531872514|FG003|Open Label Part|Withdrawal by Subject|0|||
147469061|NCT02901431|531872515|FG004|Open Label Part|Withdrawal by Subject|0|||
147469062|NCT02901431|531872516|FG005|Open Label Part|Withdrawal by Subject|0|||
147469063|NCT02901431|531872517|FG006|Open Label Part|Withdrawal by Subject|0|||
147469064|NCT02901431|531872518|FG007|Open Label Part|Withdrawal by Subject|0|||
147469065|NCT02901431|531872519|FG008|Open Label Part|Withdrawal by Subject|6|||
147469066|NCT02901431|531872520|FG009|Open Label Part|Withdrawal by Subject|5|||
147469067|NCT02901431|531872521|FG010|Open Label Part|Withdrawal by Subject|7|||
147469068|NCT02901431|531872522|FG011|Open Label Part|Withdrawal by Subject|3|||
147469069|NCT02901431|531872523|FG012|Open Label Part|Withdrawal by Subject|1|||
147469070|NCT04223609|531872524|FG000|Overall Study|Adverse Event|0|||
147469071|NCT04223609|531872525|FG001|Overall Study|Adverse Event|1|||
147469072|NCT04223609|531872524|FG000|Overall Study|Missed last visit|0|||
147469073|NCT04223609|531872525|FG001|Overall Study|Missed last visit|1|||
147469074|NCT03440944|531872526|FG000|Overall Study|Physician Decision|1|||
147469075|NCT03440944|531872527|FG001|Overall Study|Physician Decision|0|||
147469076|NCT03440944|531872526|FG000|Overall Study|No Acceptable Vasculature|0|||
147469077|NCT03440944|531872527|FG001|Overall Study|No Acceptable Vasculature|1|||
147469078|NCT04672083|531872528|FG000|Overall Study|Lost to Follow-up|1|||
147469079|NCT04672083|531872529|FG001|Overall Study|Lost to Follow-up|0|||
147469080|NCT04672083|531872530|FG002|Overall Study|Lost to Follow-up|0|||
147469081|NCT04672083|531872531|FG003|Overall Study|Lost to Follow-up|0|||
147469082|NCT04672083|531872532|FG004|Overall Study|Lost to Follow-up|0|||
147469083|NCT02500537|531872533|FG000|Overall Study|Death|2|||
147469084|NCT02500537|531872534|FG001|Overall Study|Death|0|||
147469085|NCT02500537|531872533|FG000|Overall Study|Lost to Follow-up|0|||
147469086|NCT02500537|531872534|FG001|Overall Study|Lost to Follow-up|1|||
147619574|NCT02552121|532424573|FG006|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
147619575|NCT02552121|532424574|FG007|Part 1: Dose Level 1 (Weeks 1-16)|Adverse Event|0|||
147619576|NCT02552121|532424567|FG000|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
147619577|NCT02552121|532424568|FG001|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|1|||
147469087|NCT02500537|531872533|FG000|Overall Study|Withdrawal by Subject|1|||
147469088|NCT02500537|531872534|FG001|Overall Study|Withdrawal by Subject|0|||
147469089|NCT01661790|531872535|FG000|Overall Study|Lost to Follow-up|0|||
147469090|NCT01661790|531872536|FG001|Overall Study|Lost to Follow-up|2|||
147469091|NCT02048904|531872539|FG000|Overall Study|Withdrawal by Subject|7|||
147469092|NCT02048904|531872539|FG000|Overall Study|Physician Decision|70|||
147469093|NCT03832387|531872542|FG000|Overall Study|Protocol Violation|2|||
147469094|NCT03832387|531872543|FG001|Overall Study|Protocol Violation|6|||
147469095|NCT03832387|531872542|FG000|Overall Study|EXCLUSION CRITERIA|3|||
147469096|NCT03832387|531872543|FG001|Overall Study|EXCLUSION CRITERIA|1|||
147619578|NCT02552121|532424569|FG002|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
147469097|NCT00355121|531872544|FG000|Overall Study|Did not receive study vaccine|1|||
147469098|NCT00355121|531872545|FG001|Overall Study|Did not receive study vaccine|0|||
147469099|NCT00355121|531872546|FG002|Overall Study|Did not receive study vaccine|1|||
147469100|NCT00355121|531872544|FG000|Overall Study|Adverse Event|0|||
147469101|NCT00355121|531872545|FG001|Overall Study|Adverse Event|1|||
147469102|NCT00355121|531872546|FG002|Overall Study|Adverse Event|0|||
147469103|NCT00355121|531872544|FG000|Overall Study|Protocol Violation|7|||
147469104|NCT00355121|531872545|FG001|Overall Study|Protocol Violation|9|||
147469105|NCT00355121|531872546|FG002|Overall Study|Protocol Violation|1|||
147469106|NCT00355121|531872544|FG000|Overall Study|Lost to Follow-up|4|||
147469107|NCT00355121|531872545|FG001|Overall Study|Lost to Follow-up|7|||
147469108|NCT00355121|531872546|FG002|Overall Study|Lost to Follow-up|1|||
147469109|NCT00355121|531872544|FG000|Overall Study|Withdrawal by Subject|9|||
147469110|NCT00355121|531872545|FG001|Overall Study|Withdrawal by Subject|10|||
147469111|NCT00355121|531872546|FG002|Overall Study|Withdrawal by Subject|2|||
147469112|NCT00355121|531872544|FG000|Overall Study|Serious adverse events|0|||
147469113|NCT00355121|531872545|FG001|Overall Study|Serious adverse events|2|||
147469114|NCT00355121|531872546|FG002|Overall Study|Serious adverse events|0|||
147469115|NCT00490542|531872547|FG000|Overall Study|Lost to Follow-up|3|||
147469116|NCT00490542|531872548|FG001|Overall Study|Lost to Follow-up|0|||
147469117|NCT00490542|531872547|FG000|Overall Study|Adverse Event|3|||
147469118|NCT00490542|531872548|FG001|Overall Study|Adverse Event|3|||
147469119|NCT00490542|531872547|FG000|Overall Study|Lack of Efficacy|1|||
147469120|NCT00490542|531872548|FG001|Overall Study|Lack of Efficacy|1|||
147469121|NCT01813890|531872551|FG000|Overall Study|Adverse Event|0|||
147469122|NCT01813890|531872552|FG001|Overall Study|Adverse Event|3|||
147469123|NCT01813890|531872553|FG002|Overall Study|Adverse Event|4|||
147469124|NCT01813890|531872551|FG000|Overall Study|Lack of Efficacy|9|||
147469125|NCT01813890|531872552|FG001|Overall Study|Lack of Efficacy|1|||
147469126|NCT01813890|531872553|FG002|Overall Study|Lack of Efficacy|2|||
147469127|NCT04482647|531872554|FG000|Overall Study|Time constraints|2|||
147469128|NCT04482647|531872554|FG000|Overall Study|Health issues|1|||
147469129|NCT04482647|531872554|FG000|Overall Study|Death in the family|1|||
147469130|NCT04482647|531872554|FG000|Overall Study|Disliked the intervention|1|||
147469131|NCT04482647|531872554|FG000|Overall Study|No reasons specified|7|||
147469132|NCT00655928|531872558|FG000|Overall Study|Withdrawal by Subject|2|||
147469133|NCT00655928|531872559|FG001|Overall Study|Withdrawal by Subject|1|||
147469134|NCT00655928|531872558|FG000|Overall Study|Physician Decision|1|||
147469135|NCT00655928|531872559|FG001|Overall Study|Physician Decision|1|||
147469136|NCT04980391|531872560|FG000|Overall Study|Death|0|||
147469137|NCT04980391|531872561|FG001|Overall Study|Death|0|||
147469138|NCT04980391|531872562|FG002|Overall Study|Death|1|||
147469139|NCT04980391|531872563|FG003|Overall Study|Death|1|||
147469140|NCT04980391|531872560|FG000|Overall Study|Lost to Follow-up|3|||
147469141|NCT04980391|531872561|FG001|Overall Study|Lost to Follow-up|3|||
147469142|NCT04980391|531872562|FG002|Overall Study|Lost to Follow-up|2|||
147469143|NCT04980391|531872563|FG003|Overall Study|Lost to Follow-up|3|||
147469144|NCT04980391|531872560|FG000|Overall Study|WITHDRAWAL BY SUBJECT, NOT DUE TO AN ADVERSE EVENT|2|||
147469145|NCT04980391|531872561|FG001|Overall Study|WITHDRAWAL BY SUBJECT, NOT DUE TO AN ADVERSE EVENT|0|||
147469146|NCT04980391|531872562|FG002|Overall Study|WITHDRAWAL BY SUBJECT, NOT DUE TO AN ADVERSE EVENT|0|||
147469147|NCT04980391|531872563|FG003|Overall Study|WITHDRAWAL BY SUBJECT, NOT DUE TO AN ADVERSE EVENT|0|||
147469148|NCT04980391|531872560|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
147469149|NCT04980391|531872561|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
147469150|NCT04980391|531872562|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|2|||
147469151|NCT04980391|531872563|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
147469152|NCT04980391|531872560|FG000|Overall Study|WITHDRAWAL BY SUBJECT'S PARENT(S)/LAR(S)|0|||
147469153|NCT04980391|531872561|FG001|Overall Study|WITHDRAWAL BY SUBJECT'S PARENT(S)/LAR(S)|0|||
147469154|NCT04980391|531872562|FG002|Overall Study|WITHDRAWAL BY SUBJECT'S PARENT(S)/LAR(S)|3|||
147469155|NCT04980391|531872563|FG003|Overall Study|WITHDRAWAL BY SUBJECT'S PARENT(S)/LAR(S)|0|||
147469156|NCT00500266|531874611|FG000|Overall Study|Death|3|||
147469157|NCT00500266|531874611|FG000|Overall Study|Lost to Follow-up|3|||
147469158|NCT00500266|531874611|FG000|Overall Study|Withdrawal by Subject|3|||
147469159|NCT00500266|531874611|FG000|Overall Study|Assigned, not treated|4|||
147469160|NCT01431287|531874612|FG000|Overall Study|not treated|0|||
147619579|NCT02552121|532424570|FG003|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
147619580|NCT02552121|532424571|FG004|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
147619581|NCT02552121|532424572|FG005|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
147619582|NCT02552121|532424573|FG006|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
147469161|NCT01431287|531874613|FG001|Overall Study|not treated|0|||
147619583|NCT02552121|532424574|FG007|Part 1: Dose Level 2 (Week 17-48)|Patient Choice|0|||
147469162|NCT01431287|531874614|FG002|Overall Study|not treated|1|||
147469163|NCT01431287|531874615|FG003|Overall Study|not treated|0|||
147469164|NCT01431287|531874616|FG004|Overall Study|not treated|0|||
147469165|NCT01431287|531874612|FG000|Overall Study|Adverse Event|59|||
147469166|NCT01431287|531874613|FG001|Overall Study|Adverse Event|57|||
147469167|NCT01431287|531874614|FG002|Overall Study|Adverse Event|53|||
147469168|NCT01431287|531874615|FG003|Overall Study|Adverse Event|33|||
147469169|NCT01431287|531874616|FG004|Overall Study|Adverse Event|41|||
147469170|NCT01431287|531874612|FG000|Overall Study|Non compliant with protocol|6|||
147469171|NCT01431287|531874613|FG001|Overall Study|Non compliant with protocol|6|||
147469172|NCT01431287|531874614|FG002|Overall Study|Non compliant with protocol|5|||
147469173|NCT01431287|531874615|FG003|Overall Study|Non compliant with protocol|6|||
147469174|NCT01431287|531874616|FG004|Overall Study|Non compliant with protocol|5|||
147469175|NCT01431287|531874612|FG000|Overall Study|Lost to Follow-up|0|||
147469176|NCT01431287|531874613|FG001|Overall Study|Lost to Follow-up|3|||
147469177|NCT01431287|531874614|FG002|Overall Study|Lost to Follow-up|2|||
147469178|NCT01431287|531874615|FG003|Overall Study|Lost to Follow-up|3|||
147469179|NCT01431287|531874616|FG004|Overall Study|Lost to Follow-up|1|||
147469180|NCT01431287|531874612|FG000|Overall Study|Consent withdrawn not due to AE|29|||
147469181|NCT01431287|531874613|FG001|Overall Study|Consent withdrawn not due to AE|30|||
147469182|NCT01431287|531874614|FG002|Overall Study|Consent withdrawn not due to AE|34|||
147469183|NCT01431287|531874615|FG003|Overall Study|Consent withdrawn not due to AE|19|||
147469184|NCT01431287|531874616|FG004|Overall Study|Consent withdrawn not due to AE|29|||
147469185|NCT01431287|531874612|FG000|Overall Study|not stated above|4|||
147469186|NCT01431287|531874613|FG001|Overall Study|not stated above|2|||
147469187|NCT01431287|531874614|FG002|Overall Study|not stated above|2|||
147469188|NCT01431287|531874615|FG003|Overall Study|not stated above|2|||
147469189|NCT01431287|531874616|FG004|Overall Study|not stated above|1|||
147469190|NCT00162773|531874617|FG000|Overall Study|P.I, Left institution. Study terminated|22|||
147469191|NCT02251743|531874618|FG000|Overall Study|Withdrawal by Subject|1|||
147469192|NCT02251743|531874619|FG001|Overall Study|Withdrawal by Subject|1|||
147469193|NCT00215150|531874620|FG000|Open Label Phase|Lost to Follow-up|7|||
147469194|NCT00215150|531874620|FG000|Open Label Phase|Withdrawal by Subject|1|||
147469195|NCT00215150|531874620|FG000|Open Label Phase|Did not complete a post base visit|13|||
147469196|NCT00215150|531874620|FG000|Open Label Phase|Did not meet randomization criteria|9|||
147469197|NCT00215150|531874620|FG000|Randomization Phase Ziprasidone|Lost to Follow-up|2|||
147469198|NCT00215150|531874620|FG000|Randomization Phase Ziprasidone|Withdrawal by Subject|1|||
147469199|NCT00215150|531874620|FG000|Randomization Phase Placebo|Withdrawal by Subject|1|||
147469200|NCT00496366|531874621|FG000|Overall Study|Death|1|||
147469201|NCT03323749|531874636|FG000|Double-blind Period|Lost to Follow-up|4|||
147469202|NCT03323749|531874637|FG001|Double-blind Period|Lost to Follow-up|5|||
147469203|NCT03323749|531874636|FG000|Double-blind Period|Adverse Event|3|||
147469204|NCT03323749|531874637|FG001|Double-blind Period|Adverse Event|1|||
147469205|NCT03323749|531874636|FG000|Open-Label Period|Termination of the Clinical Development of Elamipretide in Subjects with PMM|83|||
147469206|NCT03323749|531874637|FG001|Open-Label Period|Termination of the Clinical Development of Elamipretide in Subjects with PMM|88|||
147469207|NCT03323749|531874636|FG000|Open-Label Period|Adverse Event|3|||
147469208|NCT03323749|531874637|FG001|Open-Label Period|Adverse Event|10|||
147469209|NCT03323749|531874636|FG000|Open-Label Period|Withdrawal by Subject|7|||
147469210|NCT03323749|531874637|FG001|Open-Label Period|Withdrawal by Subject|5|||
147469211|NCT00824564|531874643|FG000|Overall Study|Lost to Follow-up|5|||
147469212|NCT00824564|531874644|FG001|Overall Study|Lost to Follow-up|7|||
147469213|NCT00824564|531874643|FG000|Overall Study|Withdrawal by Subject|1|||
147469214|NCT00824564|531874644|FG001|Overall Study|Withdrawal by Subject|1|||
147469215|NCT00824564|531874643|FG000|Overall Study|Other|1|||
147469216|NCT00824564|531874644|FG001|Overall Study|Other|2|||
147469217|NCT00824564|531874643|FG000|Overall Study|Randomized, but not treated|1|||
147469218|NCT00824564|531874644|FG001|Overall Study|Randomized, but not treated|0|||
147469219|NCT03895203|531874649|FG000|Double-Blind Treatment Period: 16 Weeks|Adverse Event|2|||
147469220|NCT03895203|531874650|FG001|Double-Blind Treatment Period: 16 Weeks|Adverse Event|8|||
147469221|NCT03895203|531874651|FG002|Double-Blind Treatment Period: 16 Weeks|Adverse Event|2|||
147469222|NCT03895203|531874652|FG003|Double-Blind Treatment Period: 16 Weeks|Adverse Event|0|||
147469223|NCT03895203|531874653|FG004|Double-Blind Treatment Period: 16 Weeks|Adverse Event|0|||
147411972|NCT03852719|531671571|FG001|Overall Study|Physician Decision|4|||
147411973|NCT03852719|531671572|FG002|Overall Study|Physician Decision|1|||
147411974|NCT03852719|531671570|FG000|Overall Study|Pregnancy|2|||
147411975|NCT03852719|531671571|FG001|Overall Study|Pregnancy|1|||
147411976|NCT03852719|531671572|FG002|Overall Study|Pregnancy|0|||
147411977|NCT03852719|531671570|FG000|Overall Study|Death|1|||
147411978|NCT03852719|531671571|FG001|Overall Study|Death|0|||
147411979|NCT03852719|531671572|FG002|Overall Study|Death|0|||
147411980|NCT03852719|531671570|FG000|Overall Study|Reason not Specified|3|||
147411981|NCT03852719|531671571|FG001|Overall Study|Reason not Specified|3|||
147411982|NCT03852719|531671572|FG002|Overall Study|Reason not Specified|5|||
147411983|NCT03852719|531671570|FG000|Overall Study|Adverse Event|2|||
147411984|NCT03852719|531671571|FG001|Overall Study|Adverse Event|1|||
147411985|NCT03852719|531671572|FG002|Overall Study|Adverse Event|4|||
147411986|NCT03852719|531671570|FG000|Overall Study|Progressive disease|1|||
147411987|NCT03852719|531671571|FG001|Overall Study|Progressive disease|4|||
147411988|NCT03852719|531671572|FG002|Overall Study|Progressive disease|1|||
147469224|NCT03895203|531874654|FG005|Double-Blind Treatment Period: 16 Weeks|Adverse Event|0|||
147469225|NCT03895203|531874649|FG000|Double-Blind Treatment Period: 16 Weeks|Lack of Efficacy|2|||
147469226|NCT03895203|531874650|FG001|Double-Blind Treatment Period: 16 Weeks|Lack of Efficacy|0|||
147469227|NCT03895203|531874651|FG002|Double-Blind Treatment Period: 16 Weeks|Lack of Efficacy|0|||
147469228|NCT03895203|531874652|FG003|Double-Blind Treatment Period: 16 Weeks|Lack of Efficacy|0|||
147469229|NCT03895203|531874653|FG004|Double-Blind Treatment Period: 16 Weeks|Lack of Efficacy|0|||
147619584|NCT02552121|532424567|FG000|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
147619585|NCT02552121|532424568|FG001|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|2|||
147619586|NCT02552121|532424569|FG002|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
147619587|NCT02552121|532424570|FG003|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
147619588|NCT02552121|532424571|FG004|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
147619589|NCT02552121|532424572|FG005|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
147619590|NCT02552121|532424573|FG006|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
147619591|NCT02552121|532424574|FG007|Part 1: Dose Level 2 (Week 17-48)|Investigator Judgment|0|||
147619592|NCT02552121|532424567|FG000|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
147619593|NCT02552121|532424568|FG001|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|2|||
147619594|NCT02552121|532424569|FG002|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
147619595|NCT02552121|532424570|FG003|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
147619596|NCT02552121|532424571|FG004|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
147619597|NCT02552121|532424572|FG005|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
147619598|NCT02552121|532424573|FG006|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
147619599|NCT02552121|532424574|FG007|Part 1: Dose Level 2 (Week 17-48)|Disease Progression|0|||
147619600|NCT02552121|532424567|FG000|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
147619601|NCT02552121|532424568|FG001|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|1|||
147619602|NCT02552121|532424569|FG002|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
147619603|NCT02552121|532424570|FG003|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
147619604|NCT02552121|532424571|FG004|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
147619605|NCT02552121|532424572|FG005|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
147619606|NCT02552121|532424573|FG006|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
147619607|NCT02552121|532424574|FG007|Part 1: Dose Level 2 (Week 17-48)|Miscellaneous|0|||
147619608|NCT02552121|532424567|FG000|Part 2: Cohort Expansion|Patient Choice|0|||
147619609|NCT02552121|532424568|FG001|Part 2: Cohort Expansion|Patient Choice|0|||
147619610|NCT02552121|532424569|FG002|Part 2: Cohort Expansion|Patient Choice|1|||
147619611|NCT02552121|532424570|FG003|Part 2: Cohort Expansion|Patient Choice|0|||
147619612|NCT02552121|532424571|FG004|Part 2: Cohort Expansion|Patient Choice|0|||
147619613|NCT02552121|532424572|FG005|Part 2: Cohort Expansion|Patient Choice|0|||
147619614|NCT02552121|532424573|FG006|Part 2: Cohort Expansion|Patient Choice|1|||
147619615|NCT02552121|532424574|FG007|Part 2: Cohort Expansion|Patient Choice|0|||
147619616|NCT02552121|532424567|FG000|Part 2: Cohort Expansion|Disease Progression|0|||
147619617|NCT02552121|532424568|FG001|Part 2: Cohort Expansion|Disease Progression|0|||
147619618|NCT02552121|532424569|FG002|Part 2: Cohort Expansion|Disease Progression|3|||
147619619|NCT02552121|532424570|FG003|Part 2: Cohort Expansion|Disease Progression|2|||
147619620|NCT02552121|532424571|FG004|Part 2: Cohort Expansion|Disease Progression|1|||
147619621|NCT02552121|532424572|FG005|Part 2: Cohort Expansion|Disease Progression|4|||
147619622|NCT02552121|532424573|FG006|Part 2: Cohort Expansion|Disease Progression|0|||
147619623|NCT02552121|532424574|FG007|Part 2: Cohort Expansion|Disease Progression|3|||
147619624|NCT02552121|532424567|FG000|Part 2: Cohort Expansion|Adverse Event|0|||
147619625|NCT02552121|532424568|FG001|Part 2: Cohort Expansion|Adverse Event|0|||
147619626|NCT02552121|532424569|FG002|Part 2: Cohort Expansion|Adverse Event|6|||
147619627|NCT02552121|532424570|FG003|Part 2: Cohort Expansion|Adverse Event|1|||
147619628|NCT02552121|532424571|FG004|Part 2: Cohort Expansion|Adverse Event|0|||
147619629|NCT02552121|532424572|FG005|Part 2: Cohort Expansion|Adverse Event|0|||
147619630|NCT02552121|532424573|FG006|Part 2: Cohort Expansion|Adverse Event|0|||
147619631|NCT02552121|532424574|FG007|Part 2: Cohort Expansion|Adverse Event|0|||
147619632|NCT02552121|532424567|FG000|Part 2: Cohort Expansion|Death|0|||
147619633|NCT02552121|532424568|FG001|Part 2: Cohort Expansion|Death|0|||
147619634|NCT02552121|532424569|FG002|Part 2: Cohort Expansion|Death|1|||
147619635|NCT02552121|532424570|FG003|Part 2: Cohort Expansion|Death|0|||
147619636|NCT02552121|532424571|FG004|Part 2: Cohort Expansion|Death|0|||
147619637|NCT02552121|532424572|FG005|Part 2: Cohort Expansion|Death|0|||
147619638|NCT02552121|532424573|FG006|Part 2: Cohort Expansion|Death|0|||
147619639|NCT02552121|532424574|FG007|Part 2: Cohort Expansion|Death|0|||
147619640|NCT00972595|532424575|FG000|Period 1|Adverse Event|1|||
147619641|NCT00972595|532424576|FG001|Period 1|Adverse Event|0|||
147619642|NCT01522456|532424578|FG000|Overall Study|Adverse Event|2|||
147303147|NCT05044325|531276253|FG003|Part A:Treatment Period 2|Physician Decision|0|||
147469230|NCT03895203|531874654|FG005|Double-Blind Treatment Period: 16 Weeks|Lack of Efficacy|0|||
147619643|NCT01522456|532424578|FG000|Overall Study|Lost to Follow-up|2|||
147619644|NCT01522456|532424578|FG000|Overall Study|Withdrawal by Subject|2|||
147619645|NCT01522456|532424578|FG000|Overall Study|Pregnancy|1|||
147619646|NCT01522456|532424578|FG000|Overall Study|Tolerability Assessment|1|||
147619647|NCT04052620|532424579|FG000|Overall Study|aspartate aminotransferase (AST) >= 2 times upper limit of normal (ULN)|1|||
147619648|NCT04052620|532424580|FG001|Overall Study|aspartate aminotransferase (AST) >= 2 times upper limit of normal (ULN)|0|||
147411989|NCT03852719|531671570|FG000|Overall Study|Lost to Follow-up|1|||
147411990|NCT03852719|531671571|FG001|Overall Study|Lost to Follow-up|0|||
147411991|NCT03852719|531671572|FG002|Overall Study|Lost to Follow-up|0|||
147411992|NCT03086655|531671573|FG000|3 Month Follow-up Assessment|Lost to Follow-up|5|||
147411993|NCT03086655|531671574|FG001|3 Month Follow-up Assessment|Lost to Follow-up|4|||
147411994|NCT03086655|531671573|FG000|3 Month Follow-up Assessment|Withdrawal by Subject|2|||
147411995|NCT03086655|531671574|FG001|3 Month Follow-up Assessment|Withdrawal by Subject|0|||
147411996|NCT03086655|531671573|FG000|6 Month Follow-up Assessment|Lost to Follow-up|7|||
147411997|NCT03086655|531671574|FG001|6 Month Follow-up Assessment|Lost to Follow-up|6|||
147411998|NCT03086655|531671573|FG000|6 Month Follow-up Assessment|Withdrawal by Subject|2|||
147411999|NCT03086655|531671574|FG001|6 Month Follow-up Assessment|Withdrawal by Subject|1|||
147412000|NCT03086655|531671573|FG000|9 Month Follow-up Assessment|Lost to Follow-up|9|||
147412001|NCT03086655|531671574|FG001|9 Month Follow-up Assessment|Lost to Follow-up|4|||
147412002|NCT03086655|531671573|FG000|12 Month Follow-up = Final Assessment|Lost to Follow-up|7|||
147412003|NCT03086655|531671574|FG001|12 Month Follow-up = Final Assessment|Lost to Follow-up|3|||
147412004|NCT03086655|531671573|FG000|12 Month Follow-up = Final Assessment|Death|0|||
147412005|NCT03086655|531671574|FG001|12 Month Follow-up = Final Assessment|Death|1|||
147412006|NCT03841526|531671576|FG000|CRC Phase: Second Treatment|Withdrawal by Subject|1|||
147412007|NCT03841526|531671577|FG001|CRC Phase: Second Treatment|Withdrawal by Subject|0|||
147412008|NCT03841526|531671578|FG002|CRC Phase: Second Treatment|Withdrawal by Subject|0|||
147412009|NCT03841526|531671579|FG003|CRC Phase: Second Treatment|Withdrawal by Subject|1|||
147412010|NCT03841526|531671580|FG004|CRC Phase: Second Treatment|Withdrawal by Subject|0|||
147412011|NCT03841526|531671581|FG005|CRC Phase: Second Treatment|Withdrawal by Subject|0|||
147412012|NCT03841526|531671576|FG000|CRC Phase: Second Treatment|Adverse Event|0|||
147412013|NCT03841526|531671577|FG001|CRC Phase: Second Treatment|Adverse Event|0|||
147412014|NCT03841526|531671578|FG002|CRC Phase: Second Treatment|Adverse Event|0|||
147412015|NCT03841526|531671579|FG003|CRC Phase: Second Treatment|Adverse Event|1|||
147412016|NCT03841526|531671580|FG004|CRC Phase: Second Treatment|Adverse Event|0|||
147412017|NCT03841526|531671581|FG005|CRC Phase: Second Treatment|Adverse Event|0|||
147412018|NCT03841526|531671576|FG000|Outpatient Phase Treatment|Physician Decision|0|||
147412019|NCT03841526|531671577|FG001|Outpatient Phase Treatment|Physician Decision|1|||
147412020|NCT03841526|531671578|FG002|Outpatient Phase Treatment|Physician Decision|0|||
147412021|NCT03841526|531671579|FG003|Outpatient Phase Treatment|Physician Decision|0|||
147412022|NCT03841526|531671580|FG004|Outpatient Phase Treatment|Physician Decision|0|||
147412023|NCT03841526|531671581|FG005|Outpatient Phase Treatment|Physician Decision|0|||
147412024|NCT03841526|531671576|FG000|Outpatient Phase Treatment|Withdrawal by Subject|0|||
147412025|NCT03841526|531671577|FG001|Outpatient Phase Treatment|Withdrawal by Subject|0|||
147412026|NCT03841526|531671578|FG002|Outpatient Phase Treatment|Withdrawal by Subject|1|||
147412027|NCT03841526|531671579|FG003|Outpatient Phase Treatment|Withdrawal by Subject|0|||
147412028|NCT03841526|531671580|FG004|Outpatient Phase Treatment|Withdrawal by Subject|0|||
147412029|NCT03841526|531671581|FG005|Outpatient Phase Treatment|Withdrawal by Subject|1|||
147412030|NCT03524092|531671586|FG000|Blinded Maintenance Period (Wk 0-40)|Adverse Event|16|||
147412031|NCT03524092|531671587|FG001|Blinded Maintenance Period (Wk 0-40)|Adverse Event|6|||
147412032|NCT03524092|531671588|FG002|Blinded Maintenance Period (Wk 0-40)|Adverse Event|1|||
147412033|NCT03524092|531671589|FG003|Blinded Maintenance Period (Wk 0-40)|Adverse Event|0|||
147412034|NCT03524092|531671590|FG004|Blinded Maintenance Period (Wk 0-40)|Adverse Event|0|||
147412035|NCT03524092|531671591|FG005|Blinded Maintenance Period (Wk 0-40)|Adverse Event|0|||
147412036|NCT03524092|531671586|FG000|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|8|||
147412037|NCT03524092|531671587|FG001|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|6|||
147412038|NCT03524092|531671588|FG002|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|7|||
147412039|NCT03524092|531671589|FG003|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|0|||
147412040|NCT03524092|531671590|FG004|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|0|||
147412041|NCT03524092|531671591|FG005|Blinded Maintenance Period (Wk 0-40)|Lack of Efficacy|0|||
147412042|NCT03524092|531671586|FG000|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|0|||
147412043|NCT03524092|531671587|FG001|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|1|||
147412044|NCT03524092|531671588|FG002|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|0|||
147412045|NCT03524092|531671589|FG003|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|0|||
147412046|NCT03524092|531671590|FG004|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|0|||
147412047|NCT03524092|531671591|FG005|Blinded Maintenance Period (Wk 0-40)|Lost to Follow-up|0|||
147412048|NCT03524092|531671586|FG000|Blinded Maintenance Period (Wk 0-40)|Physician Decision|0|||
147412049|NCT03524092|531671587|FG001|Blinded Maintenance Period (Wk 0-40)|Physician Decision|1|||
147412050|NCT03524092|531671588|FG002|Blinded Maintenance Period (Wk 0-40)|Physician Decision|0|||
147412051|NCT03524092|531671589|FG003|Blinded Maintenance Period (Wk 0-40)|Physician Decision|0|||
147469231|NCT03895203|531874649|FG000|Double-Blind Treatment Period: 16 Weeks|Lost to Follow-up|2|||
147469232|NCT03895203|531874650|FG001|Double-Blind Treatment Period: 16 Weeks|Lost to Follow-up|0|||
147619649|NCT04052620|532424579|FG000|Overall Study|Withdrawal by Subject|1|||
147619650|NCT04052620|532424580|FG001|Overall Study|Withdrawal by Subject|0|||
147619651|NCT04052620|532424579|FG000|Overall Study|Lost to Follow-up|1|||
147619652|NCT04052620|532424580|FG001|Overall Study|Lost to Follow-up|1|||
147469233|NCT03895203|531874651|FG002|Double-Blind Treatment Period: 16 Weeks|Lost to Follow-up|0|||
147469234|NCT03895203|531874652|FG003|Double-Blind Treatment Period: 16 Weeks|Lost to Follow-up|0|||
147469235|NCT03895203|531874653|FG004|Double-Blind Treatment Period: 16 Weeks|Lost to Follow-up|0|||
147469236|NCT03895203|531874654|FG005|Double-Blind Treatment Period: 16 Weeks|Lost to Follow-up|0|||
147469237|NCT03895203|531874649|FG000|Double-Blind Treatment Period: 16 Weeks|Withdrawal by Subject|4|||
147469238|NCT03895203|531874650|FG001|Double-Blind Treatment Period: 16 Weeks|Withdrawal by Subject|6|||
147469239|NCT03895203|531874651|FG002|Double-Blind Treatment Period: 16 Weeks|Withdrawal by Subject|1|||
147469240|NCT03895203|531874652|FG003|Double-Blind Treatment Period: 16 Weeks|Withdrawal by Subject|0|||
147469241|NCT03895203|531874653|FG004|Double-Blind Treatment Period: 16 Weeks|Withdrawal by Subject|0|||
147469242|NCT03895203|531874654|FG005|Double-Blind Treatment Period: 16 Weeks|Withdrawal by Subject|0|||
147469243|NCT03895203|531874649|FG000|Double-Blind Treatment Period: 16 Weeks|PHQ-9 Score elevated|0|||
147469244|NCT03895203|531874650|FG001|Double-Blind Treatment Period: 16 Weeks|PHQ-9 Score elevated|1|||
147469245|NCT03895203|531874651|FG002|Double-Blind Treatment Period: 16 Weeks|PHQ-9 Score elevated|0|||
147469246|NCT03895203|531874652|FG003|Double-Blind Treatment Period: 16 Weeks|PHQ-9 Score elevated|0|||
147469247|NCT03895203|531874653|FG004|Double-Blind Treatment Period: 16 Weeks|PHQ-9 Score elevated|0|||
147469248|NCT03895203|531874654|FG005|Double-Blind Treatment Period: 16 Weeks|PHQ-9 Score elevated|0|||
147469249|NCT03895203|531874649|FG000|Double-Blind Treatment Period: 16 Weeks|Site terminated|0|||
147469250|NCT03895203|531874650|FG001|Double-Blind Treatment Period: 16 Weeks|Site terminated|1|||
147469251|NCT03895203|531874651|FG002|Double-Blind Treatment Period: 16 Weeks|Site terminated|0|||
147469252|NCT03895203|531874652|FG003|Double-Blind Treatment Period: 16 Weeks|Site terminated|0|||
147469253|NCT03895203|531874653|FG004|Double-Blind Treatment Period: 16 Weeks|Site terminated|0|||
147469254|NCT03895203|531874654|FG005|Double-Blind Treatment Period: 16 Weeks|Site terminated|0|||
147469255|NCT03895203|531874649|FG000|Active Treatment-Blind Period: 36 Weeks|Death|0|||
147469256|NCT03895203|531874650|FG001|Active Treatment-Blind Period: 36 Weeks|Death|0|||
147469257|NCT03895203|531874651|FG002|Active Treatment-Blind Period: 36 Weeks|Death|0|||
147469258|NCT03895203|531874652|FG003|Active Treatment-Blind Period: 36 Weeks|Death|1|||
147469259|NCT03895203|531874653|FG004|Active Treatment-Blind Period: 36 Weeks|Death|0|||
147469260|NCT03895203|531874654|FG005|Active Treatment-Blind Period: 36 Weeks|Death|0|||
147469261|NCT03895203|531874649|FG000|Active Treatment-Blind Period: 36 Weeks|Adverse Event|0|||
147469262|NCT03895203|531874650|FG001|Active Treatment-Blind Period: 36 Weeks|Adverse Event|0|||
147469263|NCT03895203|531874651|FG002|Active Treatment-Blind Period: 36 Weeks|Adverse Event|0|||
147469264|NCT03895203|531874652|FG003|Active Treatment-Blind Period: 36 Weeks|Adverse Event|5|||
147469265|NCT03895203|531874653|FG004|Active Treatment-Blind Period: 36 Weeks|Adverse Event|9|||
147469266|NCT03895203|531874654|FG005|Active Treatment-Blind Period: 36 Weeks|Adverse Event|4|||
147469267|NCT03895203|531874649|FG000|Active Treatment-Blind Period: 36 Weeks|Lack of Efficacy|0|||
147469268|NCT03895203|531874650|FG001|Active Treatment-Blind Period: 36 Weeks|Lack of Efficacy|0|||
147469269|NCT03895203|531874651|FG002|Active Treatment-Blind Period: 36 Weeks|Lack of Efficacy|0|||
147469270|NCT03895203|531874652|FG003|Active Treatment-Blind Period: 36 Weeks|Lack of Efficacy|1|||
147469271|NCT03895203|531874653|FG004|Active Treatment-Blind Period: 36 Weeks|Lack of Efficacy|6|||
147469272|NCT03895203|531874654|FG005|Active Treatment-Blind Period: 36 Weeks|Lack of Efficacy|4|||
147469273|NCT03895203|531874649|FG000|Active Treatment-Blind Period: 36 Weeks|Lost to Follow-up|0|||
147469274|NCT03895203|531874650|FG001|Active Treatment-Blind Period: 36 Weeks|Lost to Follow-up|0|||
147469275|NCT03895203|531874651|FG002|Active Treatment-Blind Period: 36 Weeks|Lost to Follow-up|0|||
147469276|NCT03895203|531874652|FG003|Active Treatment-Blind Period: 36 Weeks|Lost to Follow-up|1|||
147469277|NCT03895203|531874653|FG004|Active Treatment-Blind Period: 36 Weeks|Lost to Follow-up|3|||
147469278|NCT03895203|531874654|FG005|Active Treatment-Blind Period: 36 Weeks|Lost to Follow-up|0|||
147469279|NCT03895203|531874649|FG000|Active Treatment-Blind Period: 36 Weeks|Withdrawal by Subject|0|||
147469280|NCT03895203|531874650|FG001|Active Treatment-Blind Period: 36 Weeks|Withdrawal by Subject|0|||
147469281|NCT03895203|531874651|FG002|Active Treatment-Blind Period: 36 Weeks|Withdrawal by Subject|0|||
147469282|NCT03895203|531874652|FG003|Active Treatment-Blind Period: 36 Weeks|Withdrawal by Subject|4|||
147469283|NCT03895203|531874653|FG004|Active Treatment-Blind Period: 36 Weeks|Withdrawal by Subject|9|||
147469284|NCT03895203|531874654|FG005|Active Treatment-Blind Period: 36 Weeks|Withdrawal by Subject|2|||
147469285|NCT03895203|531874649|FG000|Active Treatment-Blind Period: 36 Weeks|COVID-19 Pandemic Circumstances|0|||
147469286|NCT03895203|531874650|FG001|Active Treatment-Blind Period: 36 Weeks|COVID-19 Pandemic Circumstances|0|||
147469287|NCT03895203|531874651|FG002|Active Treatment-Blind Period: 36 Weeks|COVID-19 Pandemic Circumstances|0|||
147469288|NCT03895203|531874652|FG003|Active Treatment-Blind Period: 36 Weeks|COVID-19 Pandemic Circumstances|1|||
147469289|NCT03895203|531874653|FG004|Active Treatment-Blind Period: 36 Weeks|COVID-19 Pandemic Circumstances|0|||
147469290|NCT03895203|531874654|FG005|Active Treatment-Blind Period: 36 Weeks|COVID-19 Pandemic Circumstances|0|||
147469291|NCT03895203|531874649|FG000|Active Treatment-Blind Period: 36 Weeks|Withdrawal due to Subject Decision|0|||
147469292|NCT03895203|531874650|FG001|Active Treatment-Blind Period: 36 Weeks|Withdrawal due to Subject Decision|0|||
147469293|NCT03895203|531874651|FG002|Active Treatment-Blind Period: 36 Weeks|Withdrawal due to Subject Decision|0|||
147469294|NCT03895203|531874652|FG003|Active Treatment-Blind Period: 36 Weeks|Withdrawal due to Subject Decision|1|||
147469295|NCT03895203|531874653|FG004|Active Treatment-Blind Period: 36 Weeks|Withdrawal due to Subject Decision|0|||
147469296|NCT03895203|531874654|FG005|Active Treatment-Blind Period: 36 Weeks|Withdrawal due to Subject Decision|0|||
147619653|NCT04052620|532424579|FG000|Overall Study|Adverse Event|1|||
147619654|NCT04052620|532424580|FG001|Overall Study|Adverse Event|0|||
147619655|NCT04052620|532424579|FG000|Overall Study|Subject did not meet study Criteria|0|||
147619656|NCT04052620|532424580|FG001|Overall Study|Subject did not meet study Criteria|1|||
147619657|NCT04052620|532424579|FG000|Overall Study|Screened failure, randomized by mistake|0|||
147619658|NCT04052620|532424580|FG001|Overall Study|Screened failure, randomized by mistake|1|||
147619659|NCT04052620|532424579|FG000|Overall Study|Personal reasons|2|||
147619660|NCT04052620|532424580|FG001|Overall Study|Personal reasons|4|||
147619661|NCT04052620|532424579|FG000|Overall Study|alanine aminotransferase (ALT) >= 2 times ULN|1|||
147619662|NCT04052620|532424580|FG001|Overall Study|alanine aminotransferase (ALT) >= 2 times ULN|0|||
147619663|NCT02201784|532424582|FG000|Overall Study|Failure to achieve adequate block|2|||
147619664|NCT02201784|532424583|FG001|Overall Study|Failure to achieve adequate block|0|||
147619665|NCT02072980|532424584|FG000|Period 2, Second Wear|Adverse Event|0|||
147619666|NCT02072980|532424585|FG001|Period 2, Second Wear|Adverse Event|1|||
147619667|NCT00193050|532424586|FG000|Neoadjuvant Treatment|Lack of Efficacy|2|||
147619668|NCT00193050|532424586|FG000|Neoadjuvant Treatment|Intercurrent Illness|3|||
147619669|NCT00193050|532424586|FG000|Neoadjuvant Treatment|Physician Decision|2|||
147619670|NCT00193050|532424586|FG000|Neoadjuvant Treatment|Adverse Event|2|||
147619671|NCT00193050|532424586|FG000|Adjuvant|Physician Decision|5|||
147619672|NCT00193050|532424586|FG000|Adjuvant|Intercurrent Hospitalization|3|||
147619673|NCT00193050|532424586|FG000|Adjuvant|Lack of Efficacy|2|||
147619674|NCT02431364|532424587|FG000|Overall Study|Adverse Event|0|||
147619675|NCT02431364|532424588|FG001|Overall Study|Adverse Event|1|||
147619676|NCT02431364|532424589|FG002|Overall Study|Adverse Event|0|||
147619677|NCT02431364|532424590|FG003|Overall Study|Adverse Event|0|||
147619678|NCT02431364|532424591|FG004|Overall Study|Adverse Event|0|||
147619679|NCT02431364|532424587|FG000|Overall Study|Randomized but never treated|0|||
147619680|NCT02431364|532424588|FG001|Overall Study|Randomized but never treated|0|||
147619681|NCT02431364|532424589|FG002|Overall Study|Randomized but never treated|0|||
147619682|NCT02431364|532424590|FG003|Overall Study|Randomized but never treated|1|||
147619683|NCT02431364|532424591|FG004|Overall Study|Randomized but never treated|0|||
147619684|NCT00061932|532424592|FG000|Overall Study|Withdrawal by Subject|13|||
147619685|NCT00061932|532424593|FG001|Overall Study|Withdrawal by Subject|4|||
147619686|NCT00916383|532424594|FG000|Overall Study|Adverse Event|1|||
147619687|NCT00916383|532424594|FG000|Overall Study|Death|1|||
147619688|NCT00916383|532424594|FG000|Overall Study|Protocol Violation|1|||
147619689|NCT02899962|532424595|FG000|Open-label Phase|Adverse Event|2|||
147619690|NCT02899962|532424596|FG001|Open-label Phase|Adverse Event|0|||
147619691|NCT02899962|532424597|FG002|Open-label Phase|Adverse Event|0|||
147619692|NCT02899962|532424595|FG000|Open-label Phase|Lost to Follow-up|9|||
147619693|NCT02899962|532424596|FG001|Open-label Phase|Lost to Follow-up|0|||
147619694|NCT02899962|532424597|FG002|Open-label Phase|Lost to Follow-up|0|||
147619695|NCT02899962|532424595|FG000|Open-label Phase|Other reasons|9|||
147619696|NCT02899962|532424596|FG001|Open-label Phase|Other reasons|0|||
147619697|NCT02899962|532424597|FG002|Open-label Phase|Other reasons|0|||
147619698|NCT02899962|532424595|FG000|Open-label Phase|Withdrawal by Subject|7|||
147619699|NCT02899962|532424596|FG001|Open-label Phase|Withdrawal by Subject|0|||
147619700|NCT02899962|532424597|FG002|Open-label Phase|Withdrawal by Subject|0|||
147619701|NCT02899962|532424595|FG000|Maintenance Phase|Adverse Event|0|||
147619702|NCT02899962|532424596|FG001|Maintenance Phase|Adverse Event|2|||
147619703|NCT02899962|532424597|FG002|Maintenance Phase|Adverse Event|1|||
147619704|NCT02899962|532424595|FG000|Maintenance Phase|Death|0|||
147619705|NCT02899962|532424596|FG001|Maintenance Phase|Death|0|||
147619706|NCT02899962|532424597|FG002|Maintenance Phase|Death|1|||
147619707|NCT02899962|532424595|FG000|Maintenance Phase|Lack of Efficacy|0|||
147619708|NCT02899962|532424596|FG001|Maintenance Phase|Lack of Efficacy|20|||
147619709|NCT02899962|532424597|FG002|Maintenance Phase|Lack of Efficacy|16|||
147619710|NCT02899962|532424595|FG000|Maintenance Phase|Lost to Follow-up|0|||
147619711|NCT02899962|532424596|FG001|Maintenance Phase|Lost to Follow-up|12|||
147619712|NCT02899962|532424597|FG002|Maintenance Phase|Lost to Follow-up|14|||
147619713|NCT02899962|532424595|FG000|Maintenance Phase|Other reasons|0|||
147619714|NCT02899962|532424596|FG001|Maintenance Phase|Other reasons|9|||
147619715|NCT02899962|532424597|FG002|Maintenance Phase|Other reasons|13|||
147619716|NCT02899962|532424595|FG000|Maintenance Phase|Not achieve treatment success after Wk 4|0|||
147619717|NCT02899962|532424596|FG001|Maintenance Phase|Not achieve treatment success after Wk 4|3|||
147619718|NCT02899962|532424597|FG002|Maintenance Phase|Not achieve treatment success after Wk 4|2|||
147619719|NCT02899962|532424595|FG000|Maintenance Phase|Not clear/almost clear after rescue med|0|||
147665794|NCT02709746|532601592|FG002|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|0|||
147619720|NCT02899962|532424596|FG001|Maintenance Phase|Not clear/almost clear after rescue med|65|||
147619721|NCT02899962|532424597|FG002|Maintenance Phase|Not clear/almost clear after rescue med|70|||
147619722|NCT02899962|532424595|FG000|Maintenance Phase|Withdrawal by Subject|0|||
147619723|NCT02899962|532424596|FG001|Maintenance Phase|Withdrawal by Subject|30|||
147619724|NCT02899962|532424597|FG002|Maintenance Phase|Withdrawal by Subject|36|||
147469297|NCT03895203|531874649|FG000|Active Treatment-Blind Period: 36 Weeks|Subject Moving Out of Area|0|||
147469298|NCT03895203|531874650|FG001|Active Treatment-Blind Period: 36 Weeks|Subject Moving Out of Area|0|||
147469299|NCT03895203|531874651|FG002|Active Treatment-Blind Period: 36 Weeks|Subject Moving Out of Area|0|||
147469300|NCT03895203|531874652|FG003|Active Treatment-Blind Period: 36 Weeks|Subject Moving Out of Area|0|||
147469301|NCT03895203|531874653|FG004|Active Treatment-Blind Period: 36 Weeks|Subject Moving Out of Area|0|||
147469302|NCT03895203|531874654|FG005|Active Treatment-Blind Period: 36 Weeks|Subject Moving Out of Area|1|||
147469303|NCT04125680|531874655|FG000|Overall Study|Lost to Follow-up|15|||
147469304|NCT04938648|531874656|FG000|Overall Study|Patient admitted to SNF hospice/LTC|2|||
147469305|NCT04938648|531874657|FG001|Overall Study|Patient admitted to SNF hospice/LTC|1|||
147469306|NCT04938648|531874656|FG000|Overall Study|Patient too ill|0|||
147469307|NCT04938648|531874657|FG001|Overall Study|Patient too ill|1|||
147469308|NCT04938648|531874656|FG000|Overall Study|Patient in rehab at the time of intervention|1|||
147469309|NCT04938648|531874657|FG001|Overall Study|Patient in rehab at the time of intervention|0|||
147469310|NCT04938648|531874656|FG000|Overall Study|Patient did not have memory problems|1|||
147469311|NCT04938648|531874657|FG001|Overall Study|Patient did not have memory problems|1|||
147469312|NCT04938648|531874656|FG000|Overall Study|Intervention could not be scheduled within protocol window|1|||
147469313|NCT04938648|531874657|FG001|Overall Study|Intervention could not be scheduled within protocol window|0|||
147469314|NCT04938648|531874656|FG000|Overall Study|Care partner could not be reached|0|||
147469315|NCT04938648|531874657|FG001|Overall Study|Care partner could not be reached|1|||
147469316|NCT04938648|531874656|FG000|Overall Study|Patient no longer receiving care at an eligible clinic|0|||
147469317|NCT04938648|531874657|FG001|Overall Study|Patient no longer receiving care at an eligible clinic|2|||
147469318|NCT04938648|531874656|FG000|Overall Study|Withdrawal by Subject|2|||
147469319|NCT04938648|531874657|FG001|Overall Study|Withdrawal by Subject|1|||
147469320|NCT00364793|531874658|FG000|Overall Study|Adverse Event|2|||
147469321|NCT00364793|531874659|FG001|Overall Study|Adverse Event|0|||
147469322|NCT00364793|531874660|FG002|Overall Study|Adverse Event|0|||
147469323|NCT00364793|531874661|FG003|Overall Study|Adverse Event|0|||
147469324|NCT00364793|531874658|FG000|Overall Study|Death|1|||
147469325|NCT00364793|531874659|FG001|Overall Study|Death|0|||
147469326|NCT00364793|531874660|FG002|Overall Study|Death|1|||
147469327|NCT00364793|531874661|FG003|Overall Study|Death|0|||
147469328|NCT00364793|531874658|FG000|Overall Study|Lack of Efficacy|3|||
147469329|NCT00364793|531874659|FG001|Overall Study|Lack of Efficacy|3|||
147469330|NCT00364793|531874660|FG002|Overall Study|Lack of Efficacy|1|||
147469331|NCT00364793|531874661|FG003|Overall Study|Lack of Efficacy|1|||
147469332|NCT00364793|531874658|FG000|Overall Study|Lost to Follow-up|1|||
147469333|NCT00364793|531874659|FG001|Overall Study|Lost to Follow-up|0|||
147469334|NCT00364793|531874660|FG002|Overall Study|Lost to Follow-up|2|||
147469335|NCT00364793|531874661|FG003|Overall Study|Lost to Follow-up|0|||
147469336|NCT00364793|531874658|FG000|Overall Study|Poor or non-compliance|1|||
147469337|NCT00364793|531874659|FG001|Overall Study|Poor or non-compliance|1|||
147469338|NCT00364793|531874660|FG002|Overall Study|Poor or non-compliance|0|||
147469339|NCT00364793|531874661|FG003|Overall Study|Poor or non-compliance|1|||
147469340|NCT00364793|531874658|FG000|Overall Study|No longer meets criteria|0|||
147469341|NCT00364793|531874659|FG001|Overall Study|No longer meets criteria|0|||
147469342|NCT00364793|531874660|FG002|Overall Study|No longer meets criteria|0|||
147469343|NCT00364793|531874661|FG003|Overall Study|No longer meets criteria|1|||
147469344|NCT00364793|531874658|FG000|Overall Study|Withdrawal by Subject|0|||
147469345|NCT00364793|531874659|FG001|Overall Study|Withdrawal by Subject|1|||
147469346|NCT00364793|531874660|FG002|Overall Study|Withdrawal by Subject|0|||
147469347|NCT00364793|531874661|FG003|Overall Study|Withdrawal by Subject|0|||
147469348|NCT00391976|531874662|FG000|Overall Study|Adverse Event|0|||
147469349|NCT00391976|531874663|FG001|Overall Study|Adverse Event|0|||
147469350|NCT00391976|531874664|FG002|Overall Study|Adverse Event|1|||
147469351|NCT00391976|531874662|FG000|Overall Study|Withdrawal of consent|0|||
147469352|NCT00391976|531874663|FG001|Overall Study|Withdrawal of consent|1|||
147469353|NCT00391976|531874664|FG002|Overall Study|Withdrawal of consent|1|||
147469354|NCT00391976|531874662|FG000|Overall Study|Lost to Follow-up|1|||
147469355|NCT00391976|531874663|FG001|Overall Study|Lost to Follow-up|2|||
147469356|NCT00391976|531874664|FG002|Overall Study|Lost to Follow-up|0|||
147469357|NCT00391976|531874662|FG000|Overall Study|Inappropriate enrollment|1|||
147469358|NCT00391976|531874663|FG001|Overall Study|Inappropriate enrollment|1|||
147469359|NCT00391976|531874664|FG002|Overall Study|Inappropriate enrollment|0|||
147469360|NCT00391976|531874662|FG000|Overall Study|Protocol deviation/violation|4|||
147469361|NCT00391976|531874663|FG001|Overall Study|Protocol deviation/violation|2|||
147469362|NCT00391976|531874664|FG002|Overall Study|Protocol deviation/violation|1|||
147469363|NCT00391976|531874662|FG000|Overall Study|Recurrence/no eradication of infection|21|||
147469364|NCT00391976|531874663|FG001|Overall Study|Recurrence/no eradication of infection|19|||
147469365|NCT00391976|531874664|FG002|Overall Study|Recurrence/no eradication of infection|0|||
147469366|NCT00391976|531874662|FG000|Overall Study|Unable to classify|0|||
147469367|NCT00391976|531874663|FG001|Overall Study|Unable to classify|0|||
147469368|NCT00391976|531874664|FG002|Overall Study|Unable to classify|1|||
147619725|NCT00258960|532424598|FG000|Overall Study|Death|2|||
147619726|NCT00258960|532424598|FG000|Overall Study|Disease Progression|7|||
147619727|NCT00258960|532424598|FG000|Overall Study|Adverse Event|4|||
147619728|NCT00258960|532424598|FG000|Overall Study|Physician Decision|1|||
147619729|NCT00258960|532424598|FG000|Overall Study|Withdrawal by Subject|1|||
147619730|NCT00258960|532424598|FG000|Overall Study|Mistake|2|||
147619731|NCT00473590|532424599|FG000|Overall Study|Adverse Event|3|||
147619732|NCT00473590|532424600|FG001|Overall Study|Adverse Event|3|||
147619733|NCT00473590|532424599|FG000|Overall Study|Death|4|||
147619734|NCT00473590|532424600|FG001|Overall Study|Death|2|||
147619735|NCT00473590|532424599|FG000|Overall Study|Progression not resulting in death|24|||
147619736|NCT00473590|532424600|FG001|Overall Study|Progression not resulting in death|20|||
147619737|NCT00473590|532424599|FG000|Overall Study|Non-protocol-specified therapy|7|||
147619738|NCT00473590|532424600|FG001|Overall Study|Non-protocol-specified therapy|5|||
147619739|NCT00473590|532424599|FG000|Overall Study|Physician Decision|2|||
147619740|NCT00473590|532424600|FG001|Overall Study|Physician Decision|4|||
147619741|NCT00473590|532424599|FG000|Overall Study|Withdrawal by Subject|5|||
147619742|NCT00473590|532424600|FG001|Overall Study|Withdrawal by Subject|3|||
147619743|NCT00473590|532424599|FG000|Overall Study|Other|0|||
147619744|NCT00473590|532424600|FG001|Overall Study|Other|1|||
147619745|NCT01245283|532424603|FG000|Overall Study|Lost to Follow-up|14|||
147619746|NCT01245283|532424604|FG001|Overall Study|Lost to Follow-up|11|||
147619747|NCT01245283|532424605|FG002|Overall Study|Lost to Follow-up|11|||
147619748|NCT01610492|532424614|FG000|Overall Study|Adverse Event|1|||
147469369|NCT00391976|531874662|FG000|Overall Study|Positive P. aeruginosa antibody test|0|||
147469370|NCT00391976|531874663|FG001|Overall Study|Positive P. aeruginosa antibody test|0|||
147469371|NCT00391976|531874664|FG002|Overall Study|Positive P. aeruginosa antibody test|31|||
147469372|NCT00049127|531874665|FG000|Overall Study|Withdrawal by Subject|0|||
147469373|NCT00049127|531874666|FG001|Overall Study|Withdrawal by Subject|0|||
147469374|NCT00049127|531874667|FG002|Overall Study|Withdrawal by Subject|1|||
147469375|NCT00049127|531874668|FG003|Overall Study|Withdrawal by Subject|0|||
147469376|NCT00049127|531874669|FG004|Overall Study|Withdrawal by Subject|0|||
147469377|NCT01287754|531874675|FG000|Overall Study|Death|2|||
147469378|NCT01287754|531874676|FG001|Overall Study|Death|12|||
147469379|NCT01287754|531874675|FG000|Overall Study|Lost to Follow-up|1|||
147469380|NCT01287754|531874676|FG001|Overall Study|Lost to Follow-up|6|||
147469381|NCT01287754|531874675|FG000|Overall Study|Protocol Violation|0|||
147469382|NCT01287754|531874676|FG001|Overall Study|Protocol Violation|3|||
147469383|NCT00001337|531874688|FG000|Overall Study|Switched to alternate treatment|2|||
147469384|NCT00001337|531874689|FG001|Overall Study|Switched to alternate treatment|2|||
147469385|NCT00001337|531874690|FG002|Overall Study|Switched to alternate treatment|0|||
147469386|NCT00001337|531874688|FG000|Overall Study|Refused further treatment|2|||
147469387|NCT00001337|531874689|FG001|Overall Study|Refused further treatment|1|||
147469388|NCT00001337|531874690|FG002|Overall Study|Refused further treatment|0|||
147469389|NCT00001337|531874688|FG000|Overall Study|Began other Tx|1|||
147469390|NCT00001337|531874689|FG001|Overall Study|Began other Tx|0|||
147469391|NCT00001337|531874690|FG002|Overall Study|Began other Tx|0|||
147469392|NCT00001337|531874688|FG000|Overall Study|Physician Decision|3|||
147469393|NCT00001337|531874689|FG001|Overall Study|Physician Decision|1|||
147469394|NCT00001337|531874690|FG002|Overall Study|Physician Decision|0|||
147469395|NCT00001337|531874688|FG000|Overall Study|Doesn't have NHL|0|||
147469396|NCT00001337|531874689|FG001|Overall Study|Doesn't have NHL|1|||
147469397|NCT00001337|531874690|FG002|Overall Study|Doesn't have NHL|0|||
147469398|NCT00001337|531874688|FG000|Overall Study|Non protocol tx needed|3|||
147469399|NCT00001337|531874689|FG001|Overall Study|Non protocol tx needed|1|||
147469400|NCT00001337|531874690|FG002|Overall Study|Non protocol tx needed|0|||
147469401|NCT00001337|531874688|FG000|Overall Study|Protocol change|1|||
147469402|NCT00001337|531874689|FG001|Overall Study|Protocol change|0|||
147469403|NCT00001337|531874690|FG002|Overall Study|Protocol change|0|||
147469404|NCT00001337|531874688|FG000|Overall Study|2nd primary disease|0|||
147469405|NCT00001337|531874689|FG001|Overall Study|2nd primary disease|0|||
147469406|NCT00001337|531874690|FG002|Overall Study|2nd primary disease|1|||
147469407|NCT00001337|531874688|FG000|Overall Study|Death during follow up period|9|||
147469408|NCT00001337|531874689|FG001|Overall Study|Death during follow up period|4|||
147469409|NCT00001337|531874690|FG002|Overall Study|Death during follow up period|0|||
147469410|NCT00001337|531874688|FG000|Overall Study|Death on study|19|||
147469411|NCT00001337|531874689|FG001|Overall Study|Death on study|9|||
147469412|NCT00001337|531874690|FG002|Overall Study|Death on study|0|||
147469413|NCT00001337|531874688|FG000|Overall Study|Disease progression during follow-up period|3|||
147469414|NCT00001337|531874689|FG001|Overall Study|Disease progression during follow-up period|1|||
147469415|NCT00001337|531874690|FG002|Overall Study|Disease progression during follow-up period|0|||
147469416|NCT00001337|531874688|FG000|Overall Study|Disease progression on study|33|||
147469417|NCT00001337|531874689|FG001|Overall Study|Disease progression on study|41|||
147619749|NCT01610492|532424614|FG000|Overall Study|Lack of Efficacy|3|||
147619750|NCT01610492|532424614|FG000|Overall Study|Other: Reached stopping criteria|1|||
147619751|NCT01610492|532424614|FG000|Overall Study|Other:Treatment stopped due to remission|1|||
147619752|NCT03093259|532424616|FG000|Overall Study|Adverse Event|1|||
147412052|NCT03524092|531671590|FG004|Blinded Maintenance Period (Wk 0-40)|Physician Decision|0|||
147412053|NCT03524092|531671591|FG005|Blinded Maintenance Period (Wk 0-40)|Physician Decision|0|||
147412054|NCT03524092|531671586|FG000|Blinded Maintenance Period (Wk 0-40)|Pregnancy|0|||
147412055|NCT03524092|531671587|FG001|Blinded Maintenance Period (Wk 0-40)|Pregnancy|0|||
147412056|NCT03524092|531671588|FG002|Blinded Maintenance Period (Wk 0-40)|Pregnancy|1|||
147412057|NCT03524092|531671589|FG003|Blinded Maintenance Period (Wk 0-40)|Pregnancy|0|||
147412058|NCT03524092|531671590|FG004|Blinded Maintenance Period (Wk 0-40)|Pregnancy|0|||
147412059|NCT03524092|531671591|FG005|Blinded Maintenance Period (Wk 0-40)|Pregnancy|0|||
147412060|NCT03524092|531671586|FG000|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|0|||
147412061|NCT03524092|531671587|FG001|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|1|||
147412062|NCT03524092|531671588|FG002|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|1|||
147412063|NCT03524092|531671589|FG003|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|0|||
147412064|NCT03524092|531671590|FG004|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|0|||
147412065|NCT03524092|531671591|FG005|Blinded Maintenance Period (Wk 0-40)|Protocol Violation|0|||
147412066|NCT03524092|531671586|FG000|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|7|||
147412067|NCT03524092|531671587|FG001|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|8|||
147412068|NCT03524092|531671588|FG002|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|6|||
147412069|NCT03524092|531671589|FG003|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|0|||
147412070|NCT03524092|531671590|FG004|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|0|||
147412071|NCT03524092|531671591|FG005|Blinded Maintenance Period (Wk 0-40)|Withdrawal by Subject|0|||
147412072|NCT03524092|531671586|FG000|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|42|||
147412073|NCT03524092|531671587|FG001|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|19|||
147412074|NCT03524092|531671588|FG002|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|29|||
147412075|NCT03524092|531671589|FG003|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|0|||
147412076|NCT03524092|531671590|FG004|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|0|||
147412077|NCT03524092|531671591|FG005|Blinded Maintenance Period (Wk 0-40)|Loss of Response Rescue Period|0|||
147412078|NCT03524092|531671586|FG000|Loss of Response Rescue Period|Adverse Event|0|||
147412079|NCT03524092|531671587|FG001|Loss of Response Rescue Period|Adverse Event|0|||
147412080|NCT03524092|531671588|FG002|Loss of Response Rescue Period|Adverse Event|0|||
147412081|NCT03524092|531671589|FG003|Loss of Response Rescue Period|Adverse Event|2|||
147412082|NCT03524092|531671590|FG004|Loss of Response Rescue Period|Adverse Event|0|||
147412083|NCT03524092|531671591|FG005|Loss of Response Rescue Period|Adverse Event|0|||
147412084|NCT03524092|531671586|FG000|Loss of Response Rescue Period|Lack of Efficacy|0|||
147412085|NCT03524092|531671587|FG001|Loss of Response Rescue Period|Lack of Efficacy|0|||
147412086|NCT03524092|531671588|FG002|Loss of Response Rescue Period|Lack of Efficacy|0|||
147412087|NCT03524092|531671589|FG003|Loss of Response Rescue Period|Lack of Efficacy|5|||
147412088|NCT03524092|531671590|FG004|Loss of Response Rescue Period|Lack of Efficacy|0|||
147412089|NCT03524092|531671591|FG005|Loss of Response Rescue Period|Lack of Efficacy|0|||
147412090|NCT03524092|531671586|FG000|Loss of Response Rescue Period|Pregnancy|0|||
147412091|NCT03524092|531671587|FG001|Loss of Response Rescue Period|Pregnancy|0|||
147412092|NCT03524092|531671588|FG002|Loss of Response Rescue Period|Pregnancy|0|||
147412093|NCT03524092|531671589|FG003|Loss of Response Rescue Period|Pregnancy|1|||
147412094|NCT03524092|531671590|FG004|Loss of Response Rescue Period|Pregnancy|0|||
147412095|NCT03524092|531671591|FG005|Loss of Response Rescue Period|Pregnancy|0|||
147412096|NCT03524092|531671586|FG000|Loss of Response Rescue Period|Withdrawal by Subject|0|||
147412097|NCT03524092|531671587|FG001|Loss of Response Rescue Period|Withdrawal by Subject|0|||
147412098|NCT03524092|531671588|FG002|Loss of Response Rescue Period|Withdrawal by Subject|0|||
147412099|NCT03524092|531671589|FG003|Loss of Response Rescue Period|Withdrawal by Subject|1|||
147412100|NCT03524092|531671590|FG004|Loss of Response Rescue Period|Withdrawal by Subject|0|||
147412101|NCT03524092|531671591|FG005|Loss of Response Rescue Period|Withdrawal by Subject|0|||
147412102|NCT03524092|531671586|FG000|Open Label Extended Induction (Wk 0-12)|Adverse Event|0|||
147412103|NCT03524092|531671587|FG001|Open Label Extended Induction (Wk 0-12)|Adverse Event|0|||
147412104|NCT03524092|531671588|FG002|Open Label Extended Induction (Wk 0-12)|Adverse Event|0|||
147412105|NCT03524092|531671589|FG003|Open Label Extended Induction (Wk 0-12)|Adverse Event|0|||
147412106|NCT03524092|531671590|FG004|Open Label Extended Induction (Wk 0-12)|Adverse Event|11|||
147412107|NCT03524092|531671591|FG005|Open Label Extended Induction (Wk 0-12)|Adverse Event|0|||
147412108|NCT03524092|531671586|FG000|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|0|||
147412109|NCT03524092|531671587|FG001|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|0|||
147412110|NCT03524092|531671588|FG002|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|0|||
147412111|NCT03524092|531671589|FG003|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|0|||
147412112|NCT03524092|531671590|FG004|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|4|||
147412113|NCT03524092|531671591|FG005|Open Label Extended Induction (Wk 0-12)|Covid-19 related study disruption|0|||
147412114|NCT03524092|531671586|FG000|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|0|||
147412115|NCT03524092|531671587|FG001|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|0|||
147412116|NCT03524092|531671588|FG002|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|0|||
147665795|NCT02709746|532601593|FG003|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|0|||
147665796|NCT02709746|532601594|FG004|Phase A (Single-blind Treatment Period)|Do not fulfill rand criteria for DBT|0|||
147665797|NCT02709746|532601590|FG000|Phase B (Double-blind Treatment Period)|Protocol Violation|0|||
147412117|NCT03524092|531671589|FG003|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|0|||
147412118|NCT03524092|531671590|FG004|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|162|||
147412119|NCT03524092|531671591|FG005|Open Label Extended Induction (Wk 0-12)|Lack of Efficacy|0|||
147412120|NCT03524092|531671586|FG000|Open Label Extended Induction (Wk 0-12)|Physician Decision|0|||
147412121|NCT03524092|531671587|FG001|Open Label Extended Induction (Wk 0-12)|Physician Decision|0|||
147412122|NCT03524092|531671588|FG002|Open Label Extended Induction (Wk 0-12)|Physician Decision|0|||
147412123|NCT03524092|531671589|FG003|Open Label Extended Induction (Wk 0-12)|Physician Decision|0|||
147412124|NCT03524092|531671590|FG004|Open Label Extended Induction (Wk 0-12)|Physician Decision|1|||
147412125|NCT03524092|531671591|FG005|Open Label Extended Induction (Wk 0-12)|Physician Decision|0|||
147412126|NCT03524092|531671586|FG000|Open Label Extended Induction (Wk 0-12)|Protocol Violation|0|||
147412127|NCT03524092|531671587|FG001|Open Label Extended Induction (Wk 0-12)|Protocol Violation|0|||
147412128|NCT03524092|531671588|FG002|Open Label Extended Induction (Wk 0-12)|Protocol Violation|0|||
147412129|NCT03524092|531671589|FG003|Open Label Extended Induction (Wk 0-12)|Protocol Violation|0|||
147412130|NCT03524092|531671590|FG004|Open Label Extended Induction (Wk 0-12)|Protocol Violation|5|||
147412131|NCT03524092|531671591|FG005|Open Label Extended Induction (Wk 0-12)|Protocol Violation|0|||
147412132|NCT03524092|531671586|FG000|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|0|||
147412133|NCT03524092|531671587|FG001|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|0|||
147412134|NCT03524092|531671588|FG002|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|0|||
147412135|NCT03524092|531671589|FG003|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|0|||
147412136|NCT03524092|531671590|FG004|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|6|||
147412137|NCT03524092|531671591|FG005|Open Label Extended Induction (Wk 0-12)|Withdrawal by Subject|0|||
147412138|NCT03524092|531671586|FG000|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|0|||
147412139|NCT03524092|531671587|FG001|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|0|||
147412140|NCT03524092|531671588|FG002|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|0|||
147412141|NCT03524092|531671589|FG003|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|0|||
147412142|NCT03524092|531671590|FG004|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|1|||
147412143|NCT03524092|531671591|FG005|Open Label Extended Induction (Wk 0-12)|Lack of capacity due to lack of staff|0|||
147412144|NCT03524092|531671586|FG000|Open Label Maintenance Period (Wk 12-40)|Adverse Event|0|||
147412145|NCT03524092|531671587|FG001|Open Label Maintenance Period (Wk 12-40)|Adverse Event|0|||
147412146|NCT03524092|531671588|FG002|Open Label Maintenance Period (Wk 12-40)|Adverse Event|0|||
147412147|NCT03524092|531671589|FG003|Open Label Maintenance Period (Wk 12-40)|Adverse Event|0|||
147412148|NCT03524092|531671590|FG004|Open Label Maintenance Period (Wk 12-40)|Adverse Event|0|||
147412149|NCT03524092|531671591|FG005|Open Label Maintenance Period (Wk 12-40)|Adverse Event|4|||
147412150|NCT03524092|531671586|FG000|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|0|||
147412151|NCT03524092|531671587|FG001|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|0|||
147412152|NCT03524092|531671588|FG002|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|0|||
147412153|NCT03524092|531671589|FG003|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|0|||
147412154|NCT03524092|531671590|FG004|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|0|||
147412155|NCT03524092|531671591|FG005|Open Label Maintenance Period (Wk 12-40)|Covid-19 related study disruption|1|||
147412156|NCT03524092|531671586|FG000|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|0|||
147412157|NCT03524092|531671587|FG001|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|0|||
147412158|NCT03524092|531671588|FG002|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|0|||
147412159|NCT03524092|531671589|FG003|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|0|||
147412160|NCT03524092|531671590|FG004|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|0|||
147412161|NCT03524092|531671591|FG005|Open Label Maintenance Period (Wk 12-40)|Lack of Efficacy|9|||
147412162|NCT03524092|531671586|FG000|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|0|||
147412163|NCT03524092|531671587|FG001|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|0|||
147412164|NCT03524092|531671588|FG002|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|0|||
147412165|NCT03524092|531671589|FG003|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|0|||
147412166|NCT03524092|531671590|FG004|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|0|||
147412167|NCT03524092|531671591|FG005|Open Label Maintenance Period (Wk 12-40)|Protocol Violation|1|||
147412168|NCT04303780|531671592|FG000|Overall Study|Death|104|||
147412169|NCT04303780|531671593|FG001|Overall Study|Death|85|||
147412170|NCT04303780|531671592|FG000|Overall Study|Lost to Follow-up|5|||
147412171|NCT04303780|531671593|FG001|Overall Study|Lost to Follow-up|2|||
147412172|NCT04303780|531671592|FG000|Overall Study|Withdrawal by Subject|12|||
147412173|NCT04303780|531671593|FG001|Overall Study|Withdrawal by Subject|39|||
147412174|NCT04303780|531671592|FG000|Overall Study|Ongoing in study|50|||
147412175|NCT04303780|531671593|FG001|Overall Study|Ongoing in study|45|||
147412176|NCT04893460|531671594|FG000|Overall Study|Lost to Follow-up|18|||
147469418|NCT00001337|531874690|FG002|Overall Study|Disease progression on study|0|||
147469419|NCT00001337|531874688|FG000|Overall Study|Lost to further follow-up|10|||
147469420|NCT00001337|531874689|FG001|Overall Study|Lost to further follow-up|6|||
147469421|NCT00001337|531874690|FG002|Overall Study|Lost to further follow-up|0|||
147469422|NCT00001337|531874688|FG000|Overall Study|2nd malignancy|1|||
147469423|NCT00001337|531874689|FG001|Overall Study|2nd malignancy|0|||
147469424|NCT00001337|531874690|FG002|Overall Study|2nd malignancy|0|||
147469425|NCT00001337|531874688|FG000|Overall Study|Treatment for second lymphoma|0|||
147469426|NCT00001337|531874689|FG001|Overall Study|Treatment for second lymphoma|1|||
147469427|NCT00001337|531874690|FG002|Overall Study|Treatment for second lymphoma|0|||
147469428|NCT00001337|531874688|FG000|Overall Study|Transfer to transplant|0|||
147469429|NCT00001337|531874689|FG001|Overall Study|Transfer to transplant|1|||
147469430|NCT00001337|531874690|FG002|Overall Study|Transfer to transplant|0|||
147469431|NCT05817045|531874695|FG000|Overall Study|Protocol Violation|0|||
147469432|NCT05817045|531874696|FG001|Overall Study|Protocol Violation|3|||
147469433|NCT05817045|531874695|FG000|Overall Study|Withdrawal by Subject|10|||
147469434|NCT05817045|531874696|FG001|Overall Study|Withdrawal by Subject|7|||
147469435|NCT05817045|531874695|FG000|Overall Study|Physician Decision|3|||
147469436|NCT05817045|531874696|FG001|Overall Study|Physician Decision|0|||
147469437|NCT05817045|531874695|FG000|Overall Study|Lost to Follow-up|0|||
147469438|NCT05817045|531874696|FG001|Overall Study|Lost to Follow-up|1|||
147469439|NCT05817045|531874695|FG000|Overall Study|Device Deficiency|1|||
147469440|NCT05817045|531874696|FG001|Overall Study|Device Deficiency|0|||
147469441|NCT05817045|531874695|FG000|Overall Study|System Error|1|||
147469442|NCT05817045|531874696|FG001|Overall Study|System Error|0|||
147469443|NCT03093402|531874698|FG000|Overall Study|Lost to Follow-up|1|||
147469444|NCT03093402|531874699|FG001|Overall Study|Lost to Follow-up|0|||
147469445|NCT03093402|531874700|FG002|Overall Study|Lost to Follow-up|0|||
147469446|NCT03093402|531874701|FG003|Overall Study|Lost to Follow-up|0|||
147469447|NCT03093402|531874698|FG000|Overall Study|Withdrawal by Subject|3|||
147469448|NCT03093402|531874699|FG001|Overall Study|Withdrawal by Subject|3|||
147469449|NCT03093402|531874700|FG002|Overall Study|Withdrawal by Subject|0|||
147469450|NCT03093402|531874701|FG003|Overall Study|Withdrawal by Subject|1|||
147469451|NCT03093402|531874698|FG000|Overall Study|Withdrew prior to dosing|2|||
147469452|NCT03093402|531874699|FG001|Overall Study|Withdrew prior to dosing|1|||
147469453|NCT03093402|531874700|FG002|Overall Study|Withdrew prior to dosing|2|||
147469454|NCT03093402|531874701|FG003|Overall Study|Withdrew prior to dosing|3|||
147469455|NCT03093402|531874698|FG000|Overall Study|Ineligible for study|1|||
147469456|NCT03093402|531874699|FG001|Overall Study|Ineligible for study|0|||
147469457|NCT03093402|531874700|FG002|Overall Study|Ineligible for study|0|||
147469458|NCT03093402|531874701|FG003|Overall Study|Ineligible for study|0|||
147469459|NCT03093402|531874698|FG000|Overall Study|Prescribed a prohibited concomitant medication|0|||
147469460|NCT03093402|531874699|FG001|Overall Study|Prescribed a prohibited concomitant medication|1|||
147469461|NCT03093402|531874700|FG002|Overall Study|Prescribed a prohibited concomitant medication|0|||
147469462|NCT03093402|531874701|FG003|Overall Study|Prescribed a prohibited concomitant medication|0|||
147469463|NCT02731742|531874704|FG000|Overall Study|Death|1|||
147469464|NCT02731742|531874705|FG001|Overall Study|Death|2|||
147469465|NCT02731742|531874706|FG002|Overall Study|Death|5|||
147469466|NCT02731742|531874707|FG003|Overall Study|Death|0|||
147469467|NCT02731742|531874704|FG000|Overall Study|Physician Decision|0|||
147469468|NCT02731742|531874705|FG001|Overall Study|Physician Decision|0|||
147469469|NCT02731742|531874706|FG002|Overall Study|Physician Decision|0|||
147469470|NCT02731742|531874707|FG003|Overall Study|Physician Decision|1|||
147469471|NCT02731742|531874704|FG000|Overall Study|Study Terminated by Sponsor|2|||
147469472|NCT02731742|531874705|FG001|Overall Study|Study Terminated by Sponsor|1|||
147469473|NCT02731742|531874706|FG002|Overall Study|Study Terminated by Sponsor|1|||
147469474|NCT02731742|531874707|FG003|Overall Study|Study Terminated by Sponsor|1|||
147469475|NCT00461175|531874710|FG000|Overall Study|Protocol Violation|522|||
147469476|NCT00461175|531874711|FG001|Overall Study|Protocol Violation|365|||
147469477|NCT03093155|531874712|FG000|Overall Study|Not Eligible|1|||
147469478|NCT03093155|531874713|FG001|Overall Study|Not Eligible|0|||
147469479|NCT03093155|531874712|FG000|Overall Study|Withdrawal by Subject|0|||
147469480|NCT03093155|531874713|FG001|Overall Study|Withdrawal by Subject|1|||
147469481|NCT02786901|531874714|FG000|Overall Study|Adverse Event|1|||
147303148|NCT05044325|531276254|FG004|Part A:Treatment Period 2|Physician Decision|0|||
147469482|NCT02786901|531874715|FG001|Overall Study|Adverse Event|1|||
147469483|NCT02786901|531874716|FG002|Overall Study|Adverse Event|2|||
147469484|NCT02786901|531874714|FG000|Overall Study|Physician Decision|1|||
147469485|NCT02786901|531874715|FG001|Overall Study|Physician Decision|0|||
147469486|NCT02786901|531874716|FG002|Overall Study|Physician Decision|0|||
147469487|NCT02786901|531874714|FG000|Overall Study|Rescue Therapy Use|71|||
147469488|NCT02786901|531874715|FG001|Overall Study|Rescue Therapy Use|49|||
147469489|NCT02786901|531874716|FG002|Overall Study|Rescue Therapy Use|33|||
147469490|NCT02786901|531874714|FG000|Overall Study|Subject Request/Lost to Follow up|1|||
147469491|NCT02786901|531874715|FG001|Overall Study|Subject Request/Lost to Follow up|5|||
147469492|NCT02786901|531874716|FG002|Overall Study|Subject Request/Lost to Follow up|5|||
147469493|NCT02786901|531874714|FG000|Overall Study|Disallowed medication|1|||
147469494|NCT02786901|531874715|FG001|Overall Study|Disallowed medication|1|||
147469495|NCT02786901|531874716|FG002|Overall Study|Disallowed medication|0|||
147469496|NCT02786901|531874714|FG000|Overall Study|Randomized in error|2|||
147469497|NCT02786901|531874715|FG001|Overall Study|Randomized in error|0|||
147469498|NCT02786901|531874716|FG002|Overall Study|Randomized in error|1|||
147469499|NCT00607048|531874717|FG000|Overall Study|Adverse Event|0|||
147469500|NCT00607048|531874718|FG001|Overall Study|Adverse Event|1|||
147469501|NCT00607048|531874719|FG002|Overall Study|Adverse Event|0|||
147469502|NCT00607048|531874720|FG003|Overall Study|Adverse Event|0|||
147469503|NCT00607048|531874721|FG004|Overall Study|Adverse Event|4|||
147469504|NCT00607048|531874722|FG005|Overall Study|Adverse Event|0|||
147469505|NCT00607048|531874717|FG000|Overall Study|Global deterioration of health|1|||
147469506|NCT00607048|531874718|FG001|Overall Study|Global deterioration of health|0|||
147469507|NCT00607048|531874719|FG002|Overall Study|Global deterioration of health|0|||
147469508|NCT00607048|531874720|FG003|Overall Study|Global deterioration of health|0|||
147469509|NCT00607048|531874721|FG004|Overall Study|Global deterioration of health|0|||
147665798|NCT02709746|532601591|FG001|Phase B (Double-blind Treatment Period)|Protocol Violation|1|||
147665799|NCT02709746|532601592|FG002|Phase B (Double-blind Treatment Period)|Protocol Violation|0|||
147665800|NCT02709746|532601593|FG003|Phase B (Double-blind Treatment Period)|Protocol Violation|0|||
147665801|NCT02709746|532601594|FG004|Phase B (Double-blind Treatment Period)|Protocol Violation|2|||
147665802|NCT02709746|532601590|FG000|Phase B (Double-blind Treatment Period)|Other|0|||
147665803|NCT02709746|532601591|FG001|Phase B (Double-blind Treatment Period)|Other|6|||
147665804|NCT02709746|532601592|FG002|Phase B (Double-blind Treatment Period)|Other|5|||
147665805|NCT02709746|532601593|FG003|Phase B (Double-blind Treatment Period)|Other|6|||
147665806|NCT02709746|532601594|FG004|Phase B (Double-blind Treatment Period)|Other|7|||
147665807|NCT02709746|532601590|FG000|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|0|||
147665808|NCT02709746|532601591|FG001|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|1|||
147665809|NCT02709746|532601592|FG002|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|4|||
147665810|NCT02709746|532601593|FG003|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|1|||
147665811|NCT02709746|532601594|FG004|Phase B (Double-blind Treatment Period)|Non-compliance with study drug|0|||
147665812|NCT02709746|532601590|FG000|Phase B (Double-blind Treatment Period)|Lack of Efficacy|0|||
147665813|NCT02709746|532601591|FG001|Phase B (Double-blind Treatment Period)|Lack of Efficacy|3|||
147665814|NCT02709746|532601592|FG002|Phase B (Double-blind Treatment Period)|Lack of Efficacy|0|||
147665815|NCT02709746|532601593|FG003|Phase B (Double-blind Treatment Period)|Lack of Efficacy|1|||
147665816|NCT02709746|532601594|FG004|Phase B (Double-blind Treatment Period)|Lack of Efficacy|2|||
147665817|NCT02709746|532601590|FG000|Phase B (Double-blind Treatment Period)|Adverse Event|0|||
147665818|NCT02709746|532601591|FG001|Phase B (Double-blind Treatment Period)|Adverse Event|4|||
147665819|NCT02709746|532601592|FG002|Phase B (Double-blind Treatment Period)|Adverse Event|8|||
147412177|NCT05718466|531672902|FG000|Overall Study|Withdrawal by Subject|1|||
147412178|NCT05718466|531672903|FG001|Overall Study|Withdrawal by Subject|2|||
147412179|NCT05718466|531672902|FG000|Overall Study|Death|0|||
147412180|NCT05718466|531672903|FG001|Overall Study|Death|1|||
147412181|NCT00387426|531672904|FG000|Overall Study|Lack of Response|7|||
147412182|NCT00387426|531672904|FG000|Overall Study|Toxicities|4|||
147412183|NCT00387426|531672904|FG000|Overall Study|Disease Progression|3|||
147412184|NCT01253135|531672905|FG000|Original Protocol|Protocol Amendment|15|||
147412185|NCT01253135|531672905|FG000|Amended Protocol|Non-compliance|1|||
147412186|NCT01901432|531672906|FG000|Overall Study|Adverse Event|0|||
147412187|NCT01901432|531672907|FG001|Overall Study|Adverse Event|1|||
147412188|NCT01901432|531672908|FG002|Overall Study|Adverse Event|1|||
147412189|NCT01901432|531672909|FG003|Overall Study|Adverse Event|0|||
147412190|NCT01901432|531672910|FG004|Overall Study|Adverse Event|1|||
147412191|NCT01901432|531672906|FG000|Overall Study|Withdrawal by Subject|0|||
147412192|NCT01901432|531672907|FG001|Overall Study|Withdrawal by Subject|0|||
147412193|NCT01901432|531672908|FG002|Overall Study|Withdrawal by Subject|1|||
147412194|NCT01901432|531672909|FG003|Overall Study|Withdrawal by Subject|0|||
147412195|NCT01901432|531672910|FG004|Overall Study|Withdrawal by Subject|5|||
147412196|NCT01901432|531672906|FG000|Overall Study|Physician Decision|0|||
147412197|NCT01901432|531672907|FG001|Overall Study|Physician Decision|0|||
147412198|NCT01901432|531672908|FG002|Overall Study|Physician Decision|0|||
147412199|NCT01901432|531672909|FG003|Overall Study|Physician Decision|0|||
147412200|NCT01901432|531672910|FG004|Overall Study|Physician Decision|2|||
147412201|NCT01901432|531672906|FG000|Overall Study|Patient decision to stop study drug|0|||
147412202|NCT01901432|531672907|FG001|Overall Study|Patient decision to stop study drug|0|||
147412203|NCT01901432|531672908|FG002|Overall Study|Patient decision to stop study drug|0|||
147412204|NCT01901432|531672909|FG003|Overall Study|Patient decision to stop study drug|0|||
147412205|NCT01901432|531672910|FG004|Overall Study|Patient decision to stop study drug|1|||
147412206|NCT00379288|531672911|FG000|Overall Study|Adverse Event|5|||
147412207|NCT00379288|531672912|FG001|Overall Study|Adverse Event|6|||
147469510|NCT00607048|531874722|FG005|Overall Study|Global deterioration of health|0|||
147469511|NCT00607048|531874717|FG000|Overall Study|Objective disease progression - relapse|1|||
147469512|NCT00607048|531874718|FG001|Overall Study|Objective disease progression - relapse|2|||
147469513|NCT00607048|531874719|FG002|Overall Study|Objective disease progression - relapse|4|||
147469514|NCT00607048|531874720|FG003|Overall Study|Objective disease progression - relapse|2|||
147469515|NCT00607048|531874721|FG004|Overall Study|Objective disease progression - relapse|2|||
147469516|NCT00607048|531874722|FG005|Overall Study|Objective disease progression - relapse|2|||
147469517|NCT00607048|531874717|FG000|Overall Study|Withdrawal by Subject|0|||
147469518|NCT00607048|531874718|FG001|Overall Study|Withdrawal by Subject|0|||
147469519|NCT00607048|531874719|FG002|Overall Study|Withdrawal by Subject|0|||
147469520|NCT00607048|531874720|FG003|Overall Study|Withdrawal by Subject|1|||
147469521|NCT00607048|531874721|FG004|Overall Study|Withdrawal by Subject|0|||
147469522|NCT00607048|531874722|FG005|Overall Study|Withdrawal by Subject|2|||
147469523|NCT00607048|531874717|FG000|Overall Study|Other|1|||
147469524|NCT00607048|531874718|FG001|Overall Study|Other|1|||
147469525|NCT00607048|531874719|FG002|Overall Study|Other|0|||
147469526|NCT00607048|531874720|FG003|Overall Study|Other|0|||
147469527|NCT00607048|531874721|FG004|Overall Study|Other|0|||
147469528|NCT00607048|531874722|FG005|Overall Study|Other|1|||
147469529|NCT04336163|531874723|FG000|Overall Study|Lost to Follow-up|55|||
147469530|NCT04336163|531874724|FG001|Overall Study|Lost to Follow-up|0|||
147619753|NCT03093259|532424617|FG001|Overall Study|Adverse Event|0|||
147619754|NCT03093259|532424616|FG000|Overall Study|Withdrawal by Subject|1|||
147619755|NCT03093259|532424617|FG001|Overall Study|Withdrawal by Subject|0|||
147619756|NCT01757275|532424618|FG000|Overall Study|Lost to Follow-up|1|||
147619757|NCT01757275|532424619|FG001|Overall Study|Lost to Follow-up|2|||
147619758|NCT01757275|532424618|FG000|Overall Study|Adverse Event|3|||
147619759|NCT01757275|532424619|FG001|Overall Study|Adverse Event|3|||
147619760|NCT01757275|532424618|FG000|Overall Study|Withdrawal by Subject|2|||
147619761|NCT01757275|532424619|FG001|Overall Study|Withdrawal by Subject|4|||
147619762|NCT01757275|532424618|FG000|Overall Study|Not treated|3|||
147619763|NCT01757275|532424619|FG001|Overall Study|Not treated|4|||
147619764|NCT01821807|532424620|FG000|Overall Study|Lost to Follow-up|3|||
147619765|NCT01821807|532424621|FG001|Overall Study|Lost to Follow-up|1|||
147619766|NCT01401452|532424623|FG000|Overall Study|Adverse reaction|9|||
147619767|NCT01401452|532424623|FG000|Overall Study|Lost to Follow-up|12|||
147619768|NCT01401452|532424623|FG000|Overall Study|Lack of Efficacy|30|||
147619769|NCT01401452|532424623|FG000|Overall Study|Participant developed breast cancer|1|||
147619770|NCT01401452|532424623|FG000|Overall Study|Tx stopped due to financial reasons|1|||
147619771|NCT01401452|532424623|FG000|Overall Study|Tx stopped by psychiatrist|1|||
147619772|NCT01401452|532424623|FG000|Overall Study|No more visits within the 36 wk followup|4|||
147619773|NCT01401452|532424623|FG000|Overall Study|Subject did not come to follow up visits|2|||
147619774|NCT01401452|532424623|FG000|Overall Study|Subject didn't return for routine visits|1|||
147619775|NCT01401452|532424623|FG000|Overall Study|Subject moved to another city|1|||
147619776|NCT01401452|532424623|FG000|Overall Study|Subject's wife wants to get pregnant|1|||
147619777|NCT01401452|532424623|FG000|Overall Study|Psoriatic arthritis|1|||
147619778|NCT01401452|532424623|FG000|Overall Study|Participant stopped Tx|2|||
147619779|NCT01401452|532424623|FG000|Overall Study|Discontinuation for personal reasons|1|||
147619780|NCT01401452|532424623|FG000|Overall Study|Treatment failure|1|||
147619781|NCT01401452|532424623|FG000|Overall Study|Unsatisfactory output|1|||
147619782|NCT01401452|532424623|FG000|Overall Study|Subject withdrew because of Tx success|1|||
147619783|NCT01401452|532424623|FG000|Overall Study|Subject chose to discontinue treatment|1|||
147619784|NCT01401452|532424623|FG000|Overall Study|Participant withdrew consent|1|||
147619785|NCT00584454|532424624|FG000|Overall Study|Adverse Event|1|||
147619786|NCT00584454|532424624|FG000|Overall Study|Relocation|1|||
147619787|NCT00584454|532424624|FG000|Overall Study|Clinical Hold|2|||
147619788|NCT01459783|532424626|FG000|Baseline to 6 Months|Death|1|||
147619789|NCT01459783|532424627|FG001|Baseline to 6 Months|Death|0|||
147619790|NCT01459783|532424626|FG000|Baseline to 6 Months|Withdrawal by Subject|12|||
147619791|NCT01459783|532424627|FG001|Baseline to 6 Months|Withdrawal by Subject|6|||
147619792|NCT01459783|532424626|FG000|Baseline to 6 Months|Lost to Follow-up|19|||
147619793|NCT01459783|532424627|FG001|Baseline to 6 Months|Lost to Follow-up|14|||
147469531|NCT01773473|531874725|FG000|Overall Study|Adverse Event|3|||
147619794|NCT01459783|532424626|FG000|6 Months to 12 Months|Death|0|||
147619795|NCT01459783|532424627|FG001|6 Months to 12 Months|Death|1|||
147619796|NCT01459783|532424626|FG000|6 Months to 12 Months|Withdrawal by Subject|6|||
147619797|NCT01459783|532424627|FG001|6 Months to 12 Months|Withdrawal by Subject|5|||
147619798|NCT01459783|532424626|FG000|6 Months to 12 Months|Lost to Follow-up|2|||
147619799|NCT01459783|532424627|FG001|6 Months to 12 Months|Lost to Follow-up|7|||
147619800|NCT01459783|532424626|FG000|6 Months to 12 Months|Study ended before 12-month follow-up|11|||
147619801|NCT01459783|532424627|FG001|6 Months to 12 Months|Study ended before 12-month follow-up|17|||
147665820|NCT02709746|532601593|FG003|Phase B (Double-blind Treatment Period)|Adverse Event|5|||
147665821|NCT02709746|532601594|FG004|Phase B (Double-blind Treatment Period)|Adverse Event|2|||
147469532|NCT01773473|531874726|FG001|Overall Study|Adverse Event|2|||
147469533|NCT01773473|531874725|FG000|Overall Study|Protocol Violation|0|||
147469534|NCT01773473|531874726|FG001|Overall Study|Protocol Violation|4|||
147619802|NCT02601014|532424628|FG000|Overall Study|Adverse Event|3|||
147619803|NCT02601014|532424629|FG001|Overall Study|Adverse Event|3|||
147619804|NCT02601014|532424628|FG000|Overall Study|Death|3|||
147665822|NCT02709746|532601590|FG000|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|0|||
147665823|NCT02709746|532601591|FG001|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|2|||
147469535|NCT01773473|531874725|FG000|Overall Study|Physician Decision|3|||
147469536|NCT01773473|531874726|FG001|Overall Study|Physician Decision|5|||
147469537|NCT01773473|531874725|FG000|Overall Study|Sponsor Decision|2|||
147469538|NCT01773473|531874726|FG001|Overall Study|Sponsor Decision|0|||
147469539|NCT01773473|531874725|FG000|Overall Study|Lack of Efficacy|0|||
147469540|NCT01773473|531874726|FG001|Overall Study|Lack of Efficacy|1|||
147469541|NCT01773473|531874725|FG000|Overall Study|Non-Compliance with study drug|1|||
147469542|NCT01773473|531874726|FG001|Overall Study|Non-Compliance with study drug|4|||
147469543|NCT01773473|531874725|FG000|Overall Study|Withdrawal by Subject|5|||
147469544|NCT01773473|531874726|FG001|Overall Study|Withdrawal by Subject|3|||
147469545|NCT01773473|531874725|FG000|Overall Study|Lost to Follow-up|2|||
147469546|NCT01773473|531874726|FG001|Overall Study|Lost to Follow-up|0|||
147469547|NCT01085682|531874727|FG000|Overall Study|Withdrawal by Subject|25|||
147469548|NCT01085682|531874728|FG001|Overall Study|Withdrawal by Subject|25|||
147469549|NCT01451645|531874729|FG000|Overall Study|Protocol Violation|1|||
147469550|NCT01451645|531874730|FG001|Overall Study|Protocol Violation|0|||
147469551|NCT01451645|531874729|FG000|Overall Study|Adverse Event|0|||
147469552|NCT01451645|531874730|FG001|Overall Study|Adverse Event|3|||
147469553|NCT01451645|531874729|FG000|Overall Study|Withdrawal by Subject|4|||
147469554|NCT01451645|531874730|FG001|Overall Study|Withdrawal by Subject|2|||
147469555|NCT01451645|531874729|FG000|Overall Study|Lost to Follow-up|4|||
147469556|NCT01451645|531874730|FG001|Overall Study|Lost to Follow-up|3|||
147469557|NCT03926143|531874731|FG000|Overall Study|Physician Decision|3|||
147469558|NCT03926143|531874731|FG000|Overall Study|Subject decision: Covid-19 Pandemic related|1|||
147469559|NCT03926143|531874731|FG000|Overall Study|Adverse Event|2|||
147469560|NCT03926143|531874731|FG000|Overall Study|Progressive disease|3|||
147469561|NCT02207907|531874737|FG000|Overall Study|Lost to Follow-up|3|||
147469562|NCT02207907|531874738|FG001|Overall Study|Lost to Follow-up|1|||
147469563|NCT02207907|531874737|FG000|Overall Study|Withdrawal by Subject|5|||
147469564|NCT02207907|531874738|FG001|Overall Study|Withdrawal by Subject|6|||
147469565|NCT02207907|531874737|FG000|Overall Study|Did not meet study criteria|3|||
147469566|NCT02207907|531874738|FG001|Overall Study|Did not meet study criteria|0|||
147469567|NCT02207907|531874737|FG000|Overall Study|Pregnancy|0|||
147469568|NCT02207907|531874738|FG001|Overall Study|Pregnancy|1|||
147469569|NCT01025635|531874742|FG000|Overall Study|Withdrawal by Subject|6|||
147469570|NCT01025635|531874743|FG001|Overall Study|Withdrawal by Subject|7|||
147469571|NCT01025635|531874742|FG000|Overall Study|Protocol Violation|4|||
147469572|NCT01025635|531874743|FG001|Overall Study|Protocol Violation|2|||
147469573|NCT01025635|531874742|FG000|Overall Study|Lack of Efficacy|0|||
147469574|NCT01025635|531874743|FG001|Overall Study|Lack of Efficacy|1|||
147469575|NCT01025635|531874742|FG000|Overall Study|Lost to Follow-up|9|||
147469576|NCT01025635|531874743|FG001|Overall Study|Lost to Follow-up|13|||
147469577|NCT01025635|531874742|FG000|Overall Study|Reason not known|4|||
147469578|NCT01025635|531874743|FG001|Overall Study|Reason not known|2|||
147469579|NCT02393209|531874744|FG000|Overall Study|Study Terminated by Sponsor|1|||
147469580|NCT02393209|531874745|FG001|Overall Study|Study Terminated by Sponsor|1|||
147469581|NCT02393209|531874746|FG002|Overall Study|Study Terminated by Sponsor|0|||
147469582|NCT02393209|531874747|FG003|Overall Study|Study Terminated by Sponsor|0|||
147469583|NCT02393209|531874744|FG000|Overall Study|Withdrawal by Patient|1|||
147469584|NCT02393209|531874745|FG001|Overall Study|Withdrawal by Patient|0|||
147469585|NCT02393209|531874746|FG002|Overall Study|Withdrawal by Patient|0|||
147469586|NCT02393209|531874747|FG003|Overall Study|Withdrawal by Patient|0|||
147469587|NCT02393209|531874744|FG000|Overall Study|Death|2|||
147469588|NCT02393209|531874745|FG001|Overall Study|Death|2|||
147469589|NCT02393209|531874746|FG002|Overall Study|Death|0|||
147469590|NCT02393209|531874747|FG003|Overall Study|Death|0|||
147469591|NCT02393209|531874744|FG000|Overall Study|Death due to Disease Progression|2|||
147469592|NCT02393209|531874745|FG001|Overall Study|Death due to Disease Progression|2|||
147469593|NCT02393209|531874746|FG002|Overall Study|Death due to Disease Progression|0|||
147469594|NCT02393209|531874747|FG003|Overall Study|Death due to Disease Progression|0|||
147469595|NCT02393209|531874744|FG000|Overall Study|Death from Legionella Infection|0|||
147469596|NCT02393209|531874745|FG001|Overall Study|Death from Legionella Infection|1|||
147469597|NCT02393209|531874746|FG002|Overall Study|Death from Legionella Infection|0|||
147469598|NCT02393209|531874747|FG003|Overall Study|Death from Legionella Infection|0|||
147469599|NCT02393209|531874744|FG000|Overall Study|Patient Seen by Another Oncologist|0|||
147303149|NCT05044325|531276255|FG005|Part A:Treatment Period 2|Physician Decision|1|||
147469600|NCT02393209|531874745|FG001|Overall Study|Patient Seen by Another Oncologist|1|||
147469601|NCT02393209|531874746|FG002|Overall Study|Patient Seen by Another Oncologist|0|||
147469602|NCT02393209|531874747|FG003|Overall Study|Patient Seen by Another Oncologist|0|||
147469603|NCT02393209|531874744|FG000|Overall Study|Lost to Follow-up|0|||
147469604|NCT02393209|531874745|FG001|Overall Study|Lost to Follow-up|1|||
147469605|NCT02393209|531874746|FG002|Overall Study|Lost to Follow-up|0|||
147469606|NCT02393209|531874747|FG003|Overall Study|Lost to Follow-up|0|||
147469607|NCT00727402|531874748|FG000|Overall Study|Physician Decision|116|||
147469608|NCT03545282|531874749|FG000|Overall Study|Lost to Follow-up|15|||
147469609|NCT03545282|531874750|FG001|Overall Study|Lost to Follow-up|10|||
147469610|NCT03545282|531874749|FG000|Overall Study|Withdrawal by Subject|2|||
147469611|NCT03545282|531874750|FG001|Overall Study|Withdrawal by Subject|2|||
147469612|NCT02582671|531874751|FG000|Overall Study|Failure to return|1|||
147469613|NCT02582671|531874751|FG000|Overall Study|Other, not specified|1|||
147469614|NCT02537678|531874756|FG000|Baseline to Post-treatment|Parent/Guardian- child dyads: Never started|4|||
147469615|NCT02537678|531874757|FG001|Baseline to Post-treatment|Parent/Guardian- child dyads: Never started|3|||
147469616|NCT02537678|531874756|FG000|Baseline to Post-treatment|Parent/Guardian-child dyads: Withdrew|4|||
147469617|NCT02537678|531874757|FG001|Baseline to Post-treatment|Parent/Guardian-child dyads: Withdrew|4|||
147469618|NCT02537678|531874756|FG000|Baseline to Post-treatment|Parent/Guardian-child dyads: Unknown|6|||
147469619|NCT02537678|531874757|FG001|Baseline to Post-treatment|Parent/Guardian-child dyads: Unknown|5|||
147469620|NCT02537678|531874756|FG000|Baseline to Post-treatment|Parent/Guardian-child: Dislike therapy|2|||
147469621|NCT02537678|531874757|FG001|Baseline to Post-treatment|Parent/Guardian-child: Dislike therapy|3|||
147469622|NCT02537678|531874756|FG000|Baseline to Post-treatment|Parent/Guardian barriers: work, moved, homeless, illness, transportation, perpetrator in home|14|||
147469623|NCT02537678|531874757|FG001|Baseline to Post-treatment|Parent/Guardian barriers: work, moved, homeless, illness, transportation, perpetrator in home|6|||
147469624|NCT02537678|531874756|FG000|Post-treatment to 6 Month Assessment|Lost to Follow-up|8|||
147469625|NCT02537678|531874757|FG001|Post-treatment to 6 Month Assessment|Lost to Follow-up|7|||
147469626|NCT02537678|531874756|FG000|6 Month to 12 Month Assessment|Lost to Follow-up|0|||
147469627|NCT02537678|531874757|FG001|6 Month to 12 Month Assessment|Lost to Follow-up|1|||
147469628|NCT00805207|531874758|FG000|Overall Study|Protocol Violation|0|||
147469629|NCT00805207|531874759|FG001|Overall Study|Protocol Violation|0|||
147469630|NCT00805207|531874760|FG002|Overall Study|Protocol Violation|1|||
147469631|NCT00805207|531874761|FG003|Overall Study|Protocol Violation|0|||
147469632|NCT00805207|531874762|FG004|Overall Study|Protocol Violation|0|||
147469633|NCT00805207|531874763|FG005|Overall Study|Protocol Violation|0|||
147469634|NCT00805207|531874764|FG006|Overall Study|Protocol Violation|0|||
147469635|NCT00805207|531874765|FG007|Overall Study|Protocol Violation|0|||
147469636|NCT00805207|531874766|FG008|Overall Study|Protocol Violation|0|||
147469637|NCT00805207|531874758|FG000|Overall Study|Physician Decision|0|||
147469638|NCT00805207|531874759|FG001|Overall Study|Physician Decision|1|||
147469639|NCT00805207|531874760|FG002|Overall Study|Physician Decision|0|||
147469640|NCT00805207|531874761|FG003|Overall Study|Physician Decision|0|||
147469641|NCT00805207|531874762|FG004|Overall Study|Physician Decision|0|||
147469642|NCT00805207|531874763|FG005|Overall Study|Physician Decision|1|||
147469643|NCT00805207|531874764|FG006|Overall Study|Physician Decision|0|||
147469644|NCT00805207|531874765|FG007|Overall Study|Physician Decision|0|||
147469645|NCT00805207|531874766|FG008|Overall Study|Physician Decision|0|||
147469646|NCT00805207|531874758|FG000|Overall Study|Withdrawal by Subject|0|||
147469647|NCT00805207|531874759|FG001|Overall Study|Withdrawal by Subject|1|||
147469648|NCT00805207|531874760|FG002|Overall Study|Withdrawal by Subject|0|||
147469649|NCT00805207|531874761|FG003|Overall Study|Withdrawal by Subject|0|||
147469650|NCT00805207|531874762|FG004|Overall Study|Withdrawal by Subject|1|||
147469651|NCT00805207|531874763|FG005|Overall Study|Withdrawal by Subject|2|||
147469652|NCT00805207|531874764|FG006|Overall Study|Withdrawal by Subject|0|||
147469653|NCT00805207|531874765|FG007|Overall Study|Withdrawal by Subject|0|||
147469654|NCT00805207|531874766|FG008|Overall Study|Withdrawal by Subject|0|||
147469655|NCT00064701|531874767|FG000|One Year Post-transplant|Did not receive study drug|7|||
147469656|NCT00064701|531874768|FG001|One Year Post-transplant|Did not receive study drug|12|||
147469657|NCT00064701|531874769|FG002|One Year Post-transplant|Did not receive study drug|11|||
147469658|NCT00064701|531874767|FG000|One Year Post-transplant|Adverse Event|23|||
147469659|NCT00064701|531874768|FG001|One Year Post-transplant|Adverse Event|19|||
147469660|NCT00064701|531874769|FG002|One Year Post-transplant|Adverse Event|37|||
147469661|NCT00064701|531874767|FG000|One Year Post-transplant|Rejection|0|||
147619805|NCT02601014|532424629|FG001|Overall Study|Death|1|||
147619806|NCT02601014|532424628|FG000|Overall Study|Disease progression|4|||
147619807|NCT02601014|532424629|FG001|Overall Study|Disease progression|8|||
147619808|NCT01168427|532424630|FG000|Overall Study|Patient exited prior to implant|1|||
147619809|NCT02456740|532424631|FG000|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|1|||
147619810|NCT02456740|532424632|FG001|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|1|||
147619811|NCT02456740|532424633|FG002|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|1|||
147619812|NCT02456740|532424634|FG003|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
147619813|NCT02456740|532424635|FG004|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
147619814|NCT02456740|532424636|FG005|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
147619815|NCT02456740|532424637|FG006|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
147619816|NCT02456740|532424638|FG007|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
147619817|NCT02456740|532424639|FG008|Double-blind Treatment Phase (24 Weeks)|Decision by Sponsor|0|||
147619818|NCT02456740|532424631|FG000|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|27|||
147619819|NCT02456740|532424632|FG001|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|28|||
147619820|NCT02456740|532424633|FG002|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|21|||
147469662|NCT00064701|531874768|FG001|One Year Post-transplant|Rejection|1|||
147469663|NCT00064701|531874769|FG002|One Year Post-transplant|Rejection|16|||
147469664|NCT00064701|531874767|FG000|One Year Post-transplant|Non-compliance|4|||
147469665|NCT00064701|531874768|FG001|One Year Post-transplant|Non-compliance|2|||
147469666|NCT00064701|531874769|FG002|One Year Post-transplant|Non-compliance|5|||
147469667|NCT00064701|531874767|FG000|One Year Post-transplant|Graft Failure|3|||
147469668|NCT00064701|531874768|FG001|One Year Post-transplant|Graft Failure|2|||
147469669|NCT00064701|531874769|FG002|One Year Post-transplant|Graft Failure|1|||
147469670|NCT00064701|531874767|FG000|One Year Post-transplant|Withdrawal by Subject|0|||
147469671|NCT00064701|531874768|FG001|One Year Post-transplant|Withdrawal by Subject|4|||
147469672|NCT00064701|531874769|FG002|One Year Post-transplant|Withdrawal by Subject|1|||
147469673|NCT00064701|531874767|FG000|One Year Post-transplant|Lost to Follow-up|1|||
147469674|NCT00064701|531874768|FG001|One Year Post-transplant|Lost to Follow-up|0|||
147469675|NCT00064701|531874769|FG002|One Year Post-transplant|Lost to Follow-up|0|||
147469676|NCT00064701|531874767|FG000|One Year Post-transplant|Converted to rapamycin|1|||
147469677|NCT00064701|531874768|FG001|One Year Post-transplant|Converted to rapamycin|0|||
147469678|NCT00064701|531874769|FG002|One Year Post-transplant|Converted to rapamycin|0|||
147469679|NCT00064701|531874767|FG000|One Year Post-transplant|Acute tubular necrosis|1|||
147469680|NCT00064701|531874768|FG001|One Year Post-transplant|Acute tubular necrosis|0|||
147469681|NCT00064701|531874769|FG002|One Year Post-transplant|Acute tubular necrosis|0|||
147469682|NCT00064701|531874767|FG000|One Year Post-transplant|Incorrect study drug dispensed|0|||
147469683|NCT00064701|531874768|FG001|One Year Post-transplant|Incorrect study drug dispensed|1|||
147469684|NCT00064701|531874769|FG002|One Year Post-transplant|Incorrect study drug dispensed|0|||
147469685|NCT00064701|531874767|FG000|One Year Post-transplant|Crossover secondary to possible toxicity|0|||
147469686|NCT00064701|531874768|FG001|One Year Post-transplant|Crossover secondary to possible toxicity|1|||
147469687|NCT00064701|531874769|FG002|One Year Post-transplant|Crossover secondary to possible toxicity|0|||
147469688|NCT00064701|531874767|FG000|One Year Post-transplant|Poor absorption|0|||
147469689|NCT00064701|531874768|FG001|One Year Post-transplant|Poor absorption|1|||
147469690|NCT00064701|531874769|FG002|One Year Post-transplant|Poor absorption|0|||
147469691|NCT00064701|531874767|FG000|One Year Post-transplant|Pancreas transplant|0|||
147469692|NCT00064701|531874768|FG001|One Year Post-transplant|Pancreas transplant|0|||
147469693|NCT00064701|531874769|FG002|One Year Post-transplant|Pancreas transplant|1|||
147469694|NCT00064701|531874767|FG000|Clinical Continuation Phase|Adverse Event|12|||
147469695|NCT00064701|531874768|FG001|Clinical Continuation Phase|Adverse Event|21|||
147469696|NCT00064701|531874769|FG002|Clinical Continuation Phase|Adverse Event|14|||
147469697|NCT00064701|531874767|FG000|Clinical Continuation Phase|Non-compliance|8|||
147469698|NCT00064701|531874768|FG001|Clinical Continuation Phase|Non-compliance|6|||
147469699|NCT00064701|531874769|FG002|Clinical Continuation Phase|Non-compliance|7|||
147469700|NCT00064701|531874767|FG000|Clinical Continuation Phase|Withdrawal by Subject|22|||
147469701|NCT00064701|531874768|FG001|Clinical Continuation Phase|Withdrawal by Subject|3|||
147469702|NCT00064701|531874769|FG002|Clinical Continuation Phase|Withdrawal by Subject|22|||
147469703|NCT00064701|531874767|FG000|Clinical Continuation Phase|Lost to Follow-up|6|||
147469704|NCT00064701|531874768|FG001|Clinical Continuation Phase|Lost to Follow-up|3|||
147469705|NCT00064701|531874769|FG002|Clinical Continuation Phase|Lost to Follow-up|6|||
147469706|NCT00064701|531874767|FG000|Clinical Continuation Phase|Graft Failure|5|||
147469707|NCT00064701|531874768|FG001|Clinical Continuation Phase|Graft Failure|5|||
147469708|NCT00064701|531874769|FG002|Clinical Continuation Phase|Graft Failure|2|||
147469709|NCT00064701|531874767|FG000|Clinical Continuation Phase|Rejection|1|||
147619821|NCT02456740|532424634|FG003|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
147619822|NCT02456740|532424635|FG004|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
147619823|NCT02456740|532424636|FG005|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
147619824|NCT02456740|532424637|FG006|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
147619825|NCT02456740|532424638|FG007|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
147619826|NCT02456740|532424639|FG008|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|0|||
147619827|NCT02456740|532424631|FG000|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|9|||
147619828|NCT02456740|532424632|FG001|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|4|||
147619829|NCT02456740|532424633|FG002|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|5|||
147619830|NCT02456740|532424634|FG003|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
147619831|NCT02456740|532424635|FG004|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
147619832|NCT02456740|532424636|FG005|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
147619833|NCT02456740|532424637|FG006|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
147619834|NCT02456740|532424638|FG007|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
147619835|NCT02456740|532424639|FG008|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|0|||
147469710|NCT00064701|531874768|FG001|Clinical Continuation Phase|Rejection|2|||
147469711|NCT00064701|531874769|FG002|Clinical Continuation Phase|Rejection|2|||
147469712|NCT00064701|531874767|FG000|Clinical Continuation Phase|Sponsor discontinued study|113|||
147469713|NCT00064701|531874768|FG001|Clinical Continuation Phase|Sponsor discontinued study|129|||
147469714|NCT00064701|531874769|FG002|Clinical Continuation Phase|Sponsor discontinued study|79|||
147469715|NCT00064701|531874767|FG000|Clinical Continuation Phase|Immunosuppressive treatment crossover|0|||
147469716|NCT00064701|531874768|FG001|Clinical Continuation Phase|Immunosuppressive treatment crossover|3|||
147469717|NCT00064701|531874769|FG002|Clinical Continuation Phase|Immunosuppressive treatment crossover|6|||
147469718|NCT00064701|531874767|FG000|Clinical Continuation Phase|Physician Decision|1|||
147469719|NCT00064701|531874768|FG001|Clinical Continuation Phase|Physician Decision|3|||
147469720|NCT00064701|531874769|FG002|Clinical Continuation Phase|Physician Decision|0|||
147469721|NCT00064701|531874767|FG000|Clinical Continuation Phase|Unable to return to site for study visit|1|||
147469722|NCT00064701|531874768|FG001|Clinical Continuation Phase|Unable to return to site for study visit|0|||
147469723|NCT00064701|531874769|FG002|Clinical Continuation Phase|Unable to return to site for study visit|1|||
147469724|NCT00064701|531874767|FG000|Clinical Continuation Phase|Pancreas transplant|1|||
147469725|NCT00064701|531874768|FG001|Clinical Continuation Phase|Pancreas transplant|0|||
147469726|NCT00064701|531874769|FG002|Clinical Continuation Phase|Pancreas transplant|0|||
147469727|NCT00064701|531874767|FG000|Clinical Continuation Phase|Ran out of study drug due to Hurricane|0|||
147469728|NCT00064701|531874768|FG001|Clinical Continuation Phase|Ran out of study drug due to Hurricane|1|||
147469729|NCT00064701|531874769|FG002|Clinical Continuation Phase|Ran out of study drug due to Hurricane|0|||
147469730|NCT00064701|531874767|FG000|Clinical Continuation Phase|Discharged to nursing home|0|||
147469731|NCT00064701|531874768|FG001|Clinical Continuation Phase|Discharged to nursing home|1|||
147469732|NCT00064701|531874769|FG002|Clinical Continuation Phase|Discharged to nursing home|0|||
147469733|NCT00064701|531874767|FG000|Clinical Continuation Phase|Incorrect study drug dispensed|0|||
147469734|NCT00064701|531874768|FG001|Clinical Continuation Phase|Incorrect study drug dispensed|1|||
147469735|NCT00064701|531874769|FG002|Clinical Continuation Phase|Incorrect study drug dispensed|0|||
147469736|NCT00064701|531874767|FG000|Clinical Continuation Phase|Patient opted out|0|||
147469737|NCT00064701|531874768|FG001|Clinical Continuation Phase|Patient opted out|0|||
147469738|NCT00064701|531874769|FG002|Clinical Continuation Phase|Patient opted out|1|||
147469739|NCT01587989|531874782|FG000|12-Week Open-Label Run-In Period|Physician Decision|7|||
147469740|NCT01587989|531874783|FG001|12-Week Open-Label Run-In Period|Physician Decision|0|||
147469741|NCT01587989|531874784|FG002|12-Week Open-Label Run-In Period|Physician Decision|0|||
147469742|NCT01587989|531874782|FG000|12-Week Open-Label Run-In Period|Withdrawal by Subject|1|||
147469743|NCT01587989|531874783|FG001|12-Week Open-Label Run-In Period|Withdrawal by Subject|0|||
147469744|NCT01587989|531874784|FG002|12-Week Open-Label Run-In Period|Withdrawal by Subject|0|||
147469745|NCT01587989|531874782|FG000|12-Week Open-Label Run-In Period|No EULAR Response|4|||
147469746|NCT01587989|531874783|FG001|12-Week Open-Label Run-In Period|No EULAR Response|0|||
147469747|NCT01587989|531874784|FG002|12-Week Open-Label Run-In Period|No EULAR Response|0|||
147469748|NCT01587989|531874782|FG000|Randomized Study Treatment|Withdrawal by Subject|0|||
147469749|NCT01587989|531874783|FG001|Randomized Study Treatment|Withdrawal by Subject|1|||
147469750|NCT01587989|531874784|FG002|Randomized Study Treatment|Withdrawal by Subject|0|||
147469751|NCT01587989|531874782|FG000|Randomized Study Treatment|Screening failure|0|||
147469752|NCT01587989|531874783|FG001|Randomized Study Treatment|Screening failure|1|||
147469753|NCT01587989|531874784|FG002|Randomized Study Treatment|Screening failure|0|||
147469754|NCT01587989|531874782|FG000|Randomized Study Treatment|Physician Decision|0|||
147469755|NCT01587989|531874783|FG001|Randomized Study Treatment|Physician Decision|0|||
147469756|NCT01587989|531874784|FG002|Randomized Study Treatment|Physician Decision|1|||
147469757|NCT03313050|531874786|FG000|Stage 2: 12 Months|Adverse Event|0|||
147469758|NCT03313050|531874787|FG001|Stage 2: 12 Months|Adverse Event|0|||
147469759|NCT03313050|531874788|FG002|Stage 2: 12 Months|Adverse Event|0|||
147469760|NCT03313050|531874789|FG003|Stage 2: 12 Months|Adverse Event|1|||
147469761|NCT03313050|531874786|FG000|Stage 2: 12 Months|Death|0|||
147469762|NCT03313050|531874787|FG001|Stage 2: 12 Months|Death|0|||
147469763|NCT03313050|531874788|FG002|Stage 2: 12 Months|Death|3|||
147469764|NCT03313050|531874789|FG003|Stage 2: 12 Months|Death|0|||
147469765|NCT03313050|531874786|FG000|Stage 2: 12 Months|Lost to Follow-up|0|||
147469766|NCT03313050|531874787|FG001|Stage 2: 12 Months|Lost to Follow-up|0|||
147619836|NCT02456740|532424631|FG000|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
147412208|NCT00379288|531672913|FG002|Overall Study|Adverse Event|2|||
147412209|NCT00379288|531672914|FG003|Overall Study|Adverse Event|0|||
147412210|NCT00379288|531672911|FG000|Overall Study|Treatment Failure|0|||
147412211|NCT00379288|531672912|FG001|Overall Study|Treatment Failure|1|||
147412212|NCT00379288|531672913|FG002|Overall Study|Treatment Failure|0|||
147412213|NCT00379288|531672914|FG003|Overall Study|Treatment Failure|1|||
147412214|NCT00379288|531672911|FG000|Overall Study|Lost to Follow-up|3|||
147412215|NCT00379288|531672912|FG001|Overall Study|Lost to Follow-up|3|||
147412216|NCT00379288|531672913|FG002|Overall Study|Lost to Follow-up|2|||
147412217|NCT00379288|531672914|FG003|Overall Study|Lost to Follow-up|0|||
147412218|NCT00379288|531672911|FG000|Overall Study|Subject withdrew-unrelated to study drug|0|||
147412219|NCT00379288|531672912|FG001|Overall Study|Subject withdrew-unrelated to study drug|3|||
147412220|NCT00379288|531672913|FG002|Overall Study|Subject withdrew-unrelated to study drug|4|||
147412221|NCT00379288|531672914|FG003|Overall Study|Subject withdrew-unrelated to study drug|2|||
147412222|NCT00379288|531672911|FG000|Overall Study|Subject withdrew-related to study drug|1|||
147412223|NCT00379288|531672912|FG001|Overall Study|Subject withdrew-related to study drug|0|||
147412224|NCT00379288|531672913|FG002|Overall Study|Subject withdrew-related to study drug|0|||
147665824|NCT02709746|532601592|FG002|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|2|||
147665825|NCT02709746|532601593|FG003|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|2|||
147665826|NCT02709746|532601594|FG004|Phase B (Double-blind Treatment Period)|Withdrawal by Subject|1|||
147665827|NCT02709746|532601590|FG000|Phase B (Double-blind Treatment Period)|enrolled not treated|0|||
147665828|NCT02709746|532601591|FG001|Phase B (Double-blind Treatment Period)|enrolled not treated|0|||
147665829|NCT02709746|532601592|FG002|Phase B (Double-blind Treatment Period)|enrolled not treated|1|||
147665830|NCT02709746|532601593|FG003|Phase B (Double-blind Treatment Period)|enrolled not treated|0|||
147665831|NCT02709746|532601594|FG004|Phase B (Double-blind Treatment Period)|enrolled not treated|0|||
147665832|NCT02709746|532601590|FG000|Phase B (Double-blind Treatment Period)|Lost to Follow-up|0|||
147665833|NCT02709746|532601591|FG001|Phase B (Double-blind Treatment Period)|Lost to Follow-up|4|||
147665834|NCT02709746|532601592|FG002|Phase B (Double-blind Treatment Period)|Lost to Follow-up|2|||
147665835|NCT02709746|532601593|FG003|Phase B (Double-blind Treatment Period)|Lost to Follow-up|0|||
147665836|NCT02709746|532601594|FG004|Phase B (Double-blind Treatment Period)|Lost to Follow-up|2|||
147665837|NCT00752089|532601595|FG000|Overall Study|Adverse Event|1|||
147665838|NCT00752089|532601595|FG000|Overall Study|Protocol Deviation|2|||
147665839|NCT00752089|532601595|FG000|Overall Study|Could not attend visit 9|1|||
147665840|NCT00752089|532601595|FG000|Overall Study|Not capable of wearing partial denture|1|||
147665841|NCT00752089|532601595|FG000|Overall Study|Cannot continue the study|1|||
147665842|NCT02446691|532601597|FG000|Overall Study|Withdrawal by Subject|2|||
147665843|NCT02446691|532601597|FG000|Overall Study|Lost to Follow-up|8|||
147665844|NCT02446691|532601597|FG000|Overall Study|Protocol Violation|1|||
147665845|NCT04210986|532601598|FG000|Overall Study|Lost to Follow-up|5|||
147665846|NCT04210986|532601599|FG001|Overall Study|Lost to Follow-up|2|||
147665847|NCT04210986|532601598|FG000|Overall Study|Withdrawal by Subject|3|||
147665848|NCT04210986|532601599|FG001|Overall Study|Withdrawal by Subject|1|||
147665849|NCT04210986|532601598|FG000|Overall Study|Protocol Violation|1|||
147665850|NCT04210986|532601599|FG001|Overall Study|Protocol Violation|1|||
147665851|NCT04210986|532601598|FG000|Overall Study|Physician Decision|0|||
147665852|NCT04210986|532601599|FG001|Overall Study|Physician Decision|1|||
147665853|NCT02378662|532601600|FG000|Overall Study|Early Discontinuation|2|||
147665854|NCT02378662|532601601|FG001|Overall Study|Early Discontinuation|0|||
147665855|NCT02295644|532601616|FG000|Overall Study|Did not meet inclusion criterion|0|||
147665856|NCT02295644|532601617|FG001|Overall Study|Did not meet inclusion criterion|0|||
147665857|NCT02295644|532601618|FG002|Overall Study|Did not meet inclusion criterion|1|||
147665858|NCT02295644|532601619|FG003|Overall Study|Did not meet inclusion criterion|2|||
147665859|NCT04219189|532601621|FG000|Overall Study|Withdrawal by Subject|1|||
147665860|NCT04219189|532601622|FG001|Overall Study|Withdrawal by Subject|2|||
147665861|NCT04219189|532601621|FG000|Overall Study|Protocol Violation|0|||
147665862|NCT04219189|532601622|FG001|Overall Study|Protocol Violation|1|||
147665863|NCT04219189|532601621|FG000|Overall Study|Lost to Follow-up|0|||
147665864|NCT04219189|532601622|FG001|Overall Study|Lost to Follow-up|1|||
147665865|NCT04219189|532601621|FG000|Overall Study|Participant blood pressure out of range for the study , withdrawn by PI|0|||
147665866|NCT04219189|532601622|FG001|Overall Study|Participant blood pressure out of range for the study , withdrawn by PI|1|||
147665867|NCT03863353|532601623|FG000|Overall Study|incomplete baseline; surgical complication; no opioid prescription|24|||
147665868|NCT03863353|532601624|FG001|Overall Study|incomplete baseline; surgical complication; no opioid prescription|20|||
147665869|NCT04079790|532601625|FG000|Part 1, Period 1(Day 1 to Day 4)|Withdrawal by Subject|1|||
147665870|NCT04079790|532601626|FG001|Part 1, Period 1(Day 1 to Day 4)|Withdrawal by Subject|0|||
147665871|NCT04079790|532601627|FG002|Part 1, Period 1(Day 1 to Day 4)|Withdrawal by Subject|0|||
147665872|NCT04079790|532601628|FG003|Part 1, Period 1(Day 1 to Day 4)|Withdrawal by Subject|0|||
147665873|NCT04079790|532601625|FG000|Part 2, Period 1 (Day 1 to Day 3)|Withdrawal by Subject|0|||
147665874|NCT04079790|532601626|FG001|Part 2, Period 1 (Day 1 to Day 3)|Withdrawal by Subject|0|||
147665875|NCT04079790|532601627|FG002|Part 2, Period 1 (Day 1 to Day 3)|Withdrawal by Subject|1|||
147665876|NCT04079790|532601628|FG003|Part 2, Period 1 (Day 1 to Day 3)|Withdrawal by Subject|0|||
147665877|NCT04079790|532601625|FG000|Part 2, Period 1 (Day 1 to Day 3)|Unable to swallow|0|||
147665878|NCT04079790|532601626|FG001|Part 2, Period 1 (Day 1 to Day 3)|Unable to swallow|0|||
147665879|NCT04079790|532601627|FG002|Part 2, Period 1 (Day 1 to Day 3)|Unable to swallow|2|||
147665880|NCT04079790|532601628|FG003|Part 2, Period 1 (Day 1 to Day 3)|Unable to swallow|0|||
147665881|NCT00324155|532601629|FG000|Enrolled and Randomized|No longer met study criteria|3|||
147665882|NCT00324155|532601630|FG001|Enrolled and Randomized|No longer met study criteria|0|||
147665883|NCT00324155|532601629|FG000|Enrolled and Randomized|Lost to Follow-up|0|||
147665884|NCT00324155|532601630|FG001|Enrolled and Randomized|Lost to Follow-up|1|||
147665885|NCT00324155|532601629|FG000|Received Treatment in Induction Phase|Disease Progression|88|||
147665886|NCT00324155|532601630|FG001|Received Treatment in Induction Phase|Disease Progression|152|||
147665887|NCT00324155|532601629|FG000|Received Treatment in Induction Phase|Study Drug Toxicity|83|||
147665888|NCT00324155|532601630|FG001|Received Treatment in Induction Phase|Study Drug Toxicity|10|||
147665889|NCT00324155|532601629|FG000|Received Treatment in Induction Phase|Death|8|||
147665890|NCT00324155|532601630|FG001|Received Treatment in Induction Phase|Death|15|||
147665891|NCT00324155|532601629|FG000|Received Treatment in Induction Phase|Deterioration/Undocumented Progression|9|||
147469767|NCT03313050|531874788|FG002|Stage 2: 12 Months|Lost to Follow-up|1|||
147469768|NCT03313050|531874789|FG003|Stage 2: 12 Months|Lost to Follow-up|5|||
147469769|NCT03313050|531874786|FG000|Stage 2: 12 Months|No Longer Meets Eligibility Criteria|0|||
147469770|NCT03313050|531874787|FG001|Stage 2: 12 Months|No Longer Meets Eligibility Criteria|0|||
147469771|NCT03313050|531874788|FG002|Stage 2: 12 Months|No Longer Meets Eligibility Criteria|0|||
147469772|NCT03313050|531874789|FG003|Stage 2: 12 Months|No Longer Meets Eligibility Criteria|3|||
147469773|NCT03313050|531874786|FG000|Stage 2: 12 Months|Protocol deviation|0|||
147469774|NCT03313050|531874787|FG001|Stage 2: 12 Months|Protocol deviation|0|||
147469775|NCT03313050|531874788|FG002|Stage 2: 12 Months|Protocol deviation|7|||
147469776|NCT03313050|531874789|FG003|Stage 2: 12 Months|Protocol deviation|7|||
147469777|NCT03313050|531874786|FG000|Stage 2: 12 Months|Withdrawal by Subject|0|||
147469778|NCT03313050|531874787|FG001|Stage 2: 12 Months|Withdrawal by Subject|0|||
147469779|NCT03313050|531874788|FG002|Stage 2: 12 Months|Withdrawal by Subject|0|||
147469780|NCT03313050|531874789|FG003|Stage 2: 12 Months|Withdrawal by Subject|3|||
147469781|NCT03313050|531874786|FG000|Stage 2: 12 Months|Other|0|||
147469782|NCT03313050|531874787|FG001|Stage 2: 12 Months|Other|0|||
147469783|NCT03313050|531874788|FG002|Stage 2: 12 Months|Other|0|||
147469784|NCT03313050|531874789|FG003|Stage 2: 12 Months|Other|1|||
147469785|NCT01291017|531874790|FG000|Overall Study|Lost to Follow-up|2|||
147469786|NCT01291017|531874790|FG000|Overall Study|Withdrawal by Subject|3|||
147469787|NCT02848833|531874797|FG000|Overall Study|subject who are duplicated|1|||
147469788|NCT02848833|531874797|FG000|Overall Study|have not taken the study drug|11|||
147469789|NCT02848833|531874797|FG000|Overall Study|follow-up failure|6|||
147469790|NCT02848833|531874797|FG000|Overall Study|Protocol Violation|119|||
147469791|NCT02847598|531874798|FG000|Overall Study|Adverse Event|0|||
147469792|NCT02847598|531874799|FG001|Overall Study|Adverse Event|0|||
147469793|NCT02847598|531874800|FG002|Overall Study|Adverse Event|0|||
147469794|NCT02847598|531874801|FG003|Overall Study|Adverse Event|0|||
147469795|NCT02847598|531874802|FG004|Overall Study|Adverse Event|0|||
147469796|NCT02847598|531874803|FG005|Overall Study|Adverse Event|0|||
147469797|NCT02847598|531874804|FG006|Overall Study|Adverse Event|0|||
147469798|NCT02847598|531874805|FG007|Overall Study|Adverse Event|1|||
147469799|NCT02847598|531874798|FG000|Overall Study|Consent withdrawn|2|||
147469800|NCT02847598|531874799|FG001|Overall Study|Consent withdrawn|0|||
147469801|NCT02847598|531874800|FG002|Overall Study|Consent withdrawn|0|||
147469802|NCT02847598|531874801|FG003|Overall Study|Consent withdrawn|4|||
147469803|NCT02847598|531874802|FG004|Overall Study|Consent withdrawn|3|||
147469804|NCT02847598|531874803|FG005|Overall Study|Consent withdrawn|2|||
147469805|NCT02847598|531874804|FG006|Overall Study|Consent withdrawn|1|||
147469806|NCT02847598|531874805|FG007|Overall Study|Consent withdrawn|3|||
147469807|NCT02847598|531874798|FG000|Overall Study|Death|3|||
147469808|NCT02847598|531874799|FG001|Overall Study|Death|0|||
147469809|NCT02847598|531874800|FG002|Overall Study|Death|0|||
147469810|NCT02847598|531874801|FG003|Overall Study|Death|0|||
147469811|NCT02847598|531874802|FG004|Overall Study|Death|0|||
147469812|NCT02847598|531874803|FG005|Overall Study|Death|0|||
147469813|NCT02847598|531874804|FG006|Overall Study|Death|0|||
147469814|NCT02847598|531874805|FG007|Overall Study|Death|0|||
147469815|NCT02847598|531874798|FG000|Overall Study|Lost to Follow-up|0|||
147469816|NCT02847598|531874799|FG001|Overall Study|Lost to Follow-up|0|||
147469817|NCT02847598|531874800|FG002|Overall Study|Lost to Follow-up|0|||
147469818|NCT02847598|531874801|FG003|Overall Study|Lost to Follow-up|0|||
147469819|NCT02847598|531874802|FG004|Overall Study|Lost to Follow-up|0|||
147469820|NCT02847598|531874803|FG005|Overall Study|Lost to Follow-up|1|||
147469821|NCT02847598|531874804|FG006|Overall Study|Lost to Follow-up|1|||
147469822|NCT02847598|531874805|FG007|Overall Study|Lost to Follow-up|0|||
147469823|NCT04375761|531876737|FG000|Overall Study|Death|1|||
147469824|NCT04375761|531876738|FG001|Overall Study|Death|2|||
147469825|NCT04375761|531876737|FG000|Overall Study|Lost to Follow-up|203|||
147469826|NCT04375761|531876738|FG001|Overall Study|Lost to Follow-up|380|||
147469827|NCT04375761|531876737|FG000|Overall Study|Withdrawal by Subject|47|||
147469828|NCT04375761|531876738|FG001|Overall Study|Withdrawal by Subject|98|||
147469829|NCT04375761|531876737|FG000|Overall Study|Noncompliance with study procedure|121|||
147469830|NCT04375761|531876738|FG001|Overall Study|Noncompliance with study procedure|251|||
147469831|NCT04375761|531876737|FG000|Overall Study|Reimbursement not enough|1|||
147469832|NCT04375761|531876738|FG001|Overall Study|Reimbursement not enough|2|||
147469833|NCT04375761|531876737|FG000|Overall Study|Unforeseen family circumstances|1|||
147469834|NCT04375761|531876738|FG001|Overall Study|Unforeseen family circumstances|3|||
147469835|NCT04375761|531876737|FG000|Overall Study|Test too painful|1|||
147469836|NCT04375761|531876738|FG001|Overall Study|Test too painful|1|||
147469837|NCT04375761|531876737|FG000|Overall Study|Moved|0|||
147469838|NCT04375761|531876738|FG001|Overall Study|Moved|2|||
147469839|NCT04375761|531876737|FG000|Overall Study|Nonresponsive|0|||
147469840|NCT04375761|531876738|FG001|Overall Study|Nonresponsive|5|||
147469841|NCT03797001|531876739|FG000|Overall Study|Withdrawn due to COVID19|4|||
147469842|NCT03797001|531876740|FG001|Overall Study|Withdrawn due to COVID19|0|||
147469843|NCT03797001|531876739|FG000|Overall Study|Withdrawal by Subject|7|||
147619837|NCT02456740|532424632|FG001|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
147619838|NCT02456740|532424633|FG002|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
147619839|NCT02456740|532424634|FG003|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|1|||
147619840|NCT02456740|532424635|FG004|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|4|||
147619841|NCT02456740|532424636|FG005|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
147619842|NCT02456740|532424637|FG006|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
147619843|NCT02456740|532424638|FG007|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|0|||
147619844|NCT02456740|532424639|FG008|Active Treatment Phase (Weeks 24 - 52)|Protocol Specified Criteria|5|||
147619845|NCT02456740|532424631|FG000|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
147619846|NCT02456740|532424632|FG001|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
147619847|NCT02456740|532424633|FG002|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|0|||
147619848|NCT02456740|532424634|FG003|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|10|||
147619849|NCT02456740|532424635|FG004|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|11|||
147619850|NCT02456740|532424636|FG005|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|9|||
147469844|NCT03797001|531876740|FG001|Overall Study|Withdrawal by Subject|6|||
147469845|NCT03797001|531876739|FG000|Overall Study|Adverse Event|0|||
147469846|NCT03797001|531876740|FG001|Overall Study|Adverse Event|1|||
147469847|NCT05630846|531876743|FG000|Overall Study|Death|1|||
147469848|NCT05630846|531876744|FG001|Overall Study|Death|0|||
147469849|NCT05630846|531876745|FG002|Overall Study|Death|0|||
147469850|NCT05630846|531876746|FG003|Overall Study|Death|0|||
147469851|NCT05630846|531876743|FG000|Overall Study|Withdrawal by Subject|3|||
147469852|NCT05630846|531876744|FG001|Overall Study|Withdrawal by Subject|3|||
147469853|NCT05630846|531876745|FG002|Overall Study|Withdrawal by Subject|4|||
147469854|NCT05630846|531876746|FG003|Overall Study|Withdrawal by Subject|1|||
147469855|NCT05630846|531876743|FG000|Overall Study|Lost to Follow-up|6|||
147469856|NCT05630846|531876744|FG001|Overall Study|Lost to Follow-up|5|||
147469857|NCT05630846|531876745|FG002|Overall Study|Lost to Follow-up|2|||
147469858|NCT05630846|531876746|FG003|Overall Study|Lost to Follow-up|5|||
147469859|NCT05630846|531876743|FG000|Overall Study|Other|1|||
147469860|NCT05630846|531876744|FG001|Overall Study|Other|0|||
147469861|NCT05630846|531876745|FG002|Overall Study|Other|0|||
147469862|NCT05630846|531876746|FG003|Overall Study|Other|0|||
147469863|NCT05556616|531876747|FG000|Overall Study|Withdrawal by Subject|1|||
147469864|NCT05556616|531876748|FG001|Overall Study|Withdrawal by Subject|0|||
147469865|NCT05556616|531876749|FG002|Overall Study|Withdrawal by Subject|0|||
147469866|NCT05556616|531876750|FG003|Overall Study|Withdrawal by Subject|0|||
147469867|NCT05556616|531876751|FG004|Overall Study|Withdrawal by Subject|0|||
147469868|NCT05556616|531876752|FG005|Overall Study|Withdrawal by Subject|0|||
147469869|NCT05556616|531876753|FG006|Overall Study|Withdrawal by Subject|0|||
147469870|NCT05556616|531876747|FG000|Overall Study|Death|0|||
147469871|NCT05556616|531876748|FG001|Overall Study|Death|0|||
147469872|NCT05556616|531876749|FG002|Overall Study|Death|2|||
147469873|NCT05556616|531876750|FG003|Overall Study|Death|1|||
147469874|NCT05556616|531876751|FG004|Overall Study|Death|0|||
147469875|NCT05556616|531876752|FG005|Overall Study|Death|0|||
147469876|NCT05556616|531876753|FG006|Overall Study|Death|0|||
147469877|NCT05556616|531876747|FG000|Overall Study|Study Terminated by Sponsor|0|||
147469878|NCT05556616|531876748|FG001|Overall Study|Study Terminated by Sponsor|3|||
147469879|NCT05556616|531876749|FG002|Overall Study|Study Terminated by Sponsor|0|||
147469880|NCT05556616|531876750|FG003|Overall Study|Study Terminated by Sponsor|0|||
147469881|NCT05556616|531876751|FG004|Overall Study|Study Terminated by Sponsor|0|||
147469882|NCT05556616|531876752|FG005|Overall Study|Study Terminated by Sponsor|0|||
147469883|NCT05556616|531876753|FG006|Overall Study|Study Terminated by Sponsor|0|||
147469884|NCT00075881|531876756|FG000|Overall Study|Lack of Efficacy|18|||
147469885|NCT00075881|531876756|FG000|Overall Study|Adverse Event|7|||
147469886|NCT00075881|531876756|FG000|Overall Study|Death|1|||
147469887|NCT00075881|531876756|FG000|Overall Study|Withdrawal by Subject|2|||
147469888|NCT00075881|531876756|FG000|Overall Study|Protocol Violation|4|||
147469889|NCT00075881|531876756|FG000|Overall Study|other complicating disease|3|||
147469890|NCT00075881|531876756|FG000|Overall Study|other|4|||
147469891|NCT00075881|531876756|FG000|Overall Study|missing data|2|||
147469892|NCT00075881|531876756|FG000|Overall Study|Ineligible|1|||
147469893|NCT00075881|531876756|FG000|Overall Study|never start protocol therapy|1|||
147469894|NCT02224664|531876757|FG000|Lead-in Period (3 Days)|Does not meet entrance criteria|5|||
147619851|NCT02456740|532424637|FG006|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|8|||
147469895|NCT02224664|531876758|FG001|Lead-in Period (3 Days)|Does not meet entrance criteria|0|||
147469896|NCT02224664|531876759|FG002|Lead-in Period (3 Days)|Does not meet entrance criteria|0|||
147469897|NCT02224664|531876760|FG003|Lead-in Period (3 Days)|Does not meet entrance criteria|0|||
147469898|NCT02224664|531876761|FG004|Lead-in Period (3 Days)|Does not meet entrance criteria|0|||
147469899|NCT02224664|531876757|FG000|Dose Escalation Period (21 Days)|Adverse Event|0|||
147469900|NCT02224664|531876758|FG001|Dose Escalation Period (21 Days)|Adverse Event|0|||
147469901|NCT02224664|531876759|FG002|Dose Escalation Period (21 Days)|Adverse Event|2|||
147469902|NCT02224664|531876760|FG003|Dose Escalation Period (21 Days)|Adverse Event|2|||
147469903|NCT02224664|531876761|FG004|Dose Escalation Period (21 Days)|Adverse Event|7|||
147469904|NCT02224664|531876757|FG000|Dose Escalation Period (21 Days)|Withdrawal by Subject|0|||
147469905|NCT02224664|531876758|FG001|Dose Escalation Period (21 Days)|Withdrawal by Subject|0|||
147469906|NCT02224664|531876759|FG002|Dose Escalation Period (21 Days)|Withdrawal by Subject|0|||
147469907|NCT02224664|531876760|FG003|Dose Escalation Period (21 Days)|Withdrawal by Subject|1|||
147469908|NCT02224664|531876761|FG004|Dose Escalation Period (21 Days)|Withdrawal by Subject|4|||
147469909|NCT03019549|531876762|FG000|Washout|DId not meet genotype criteria|11|||
147469910|NCT03019549|531876762|FG000|Period 2|Adverse Event|2|||
147469911|NCT03019549|531876762|FG000|Period 2|Physician Decision|2|||
147469912|NCT03019549|531876762|FG000|Period 2|Withdrawal by Subject|1|||
147469913|NCT04030195|531876765|FG000|Overall Study|Withdrawal by Subject|2|||
147469914|NCT04030195|531876766|FG001|Overall Study|Withdrawal by Subject|0|||
147469915|NCT04030195|531876767|FG002|Overall Study|Withdrawal by Subject|0|||
147469916|NCT01412879|531876768|FG000|Initial Registration (Induction Therapy)|Adverse Event|5|||
147469917|NCT01412879|531876769|FG001|Initial Registration (Induction Therapy)|Adverse Event|3|||
147469918|NCT01412879|531876770|FG002|Initial Registration (Induction Therapy)|Adverse Event|0|||
147469919|NCT01412879|531876768|FG000|Initial Registration (Induction Therapy)|Refusal Unrelated to Adverse Event|1|||
147469920|NCT01412879|531876769|FG001|Initial Registration (Induction Therapy)|Refusal Unrelated to Adverse Event|3|||
147469921|NCT01412879|531876770|FG002|Initial Registration (Induction Therapy)|Refusal Unrelated to Adverse Event|0|||
147469922|NCT01412879|531876768|FG000|Initial Registration (Induction Therapy)|Progression/Relapse|0|||
147469923|NCT01412879|531876769|FG001|Initial Registration (Induction Therapy)|Progression/Relapse|1|||
147469924|NCT01412879|531876770|FG002|Initial Registration (Induction Therapy)|Progression/Relapse|0|||
147469925|NCT01412879|531876768|FG000|Initial Registration (Induction Therapy)|Reasons not Protocol Specified|6|||
147469926|NCT01412879|531876769|FG001|Initial Registration (Induction Therapy)|Reasons not Protocol Specified|1|||
147469927|NCT01412879|531876770|FG002|Initial Registration (Induction Therapy)|Reasons not Protocol Specified|0|||
147469928|NCT01412879|531876768|FG000|Initial Registration (Induction Therapy)|Treatment not Given|1|||
147469929|NCT01412879|531876769|FG001|Initial Registration (Induction Therapy)|Treatment not Given|0|||
147469930|NCT01412879|531876770|FG002|Initial Registration (Induction Therapy)|Treatment not Given|0|||
147469931|NCT03195894|531876771|FG000|Overall Study|"An example is Started other treatment."|4|||
147469932|NCT03195894|531876772|FG001|Overall Study|"An example is Started other treatment."|5|||
147469933|NCT03195894|531876771|FG000|Overall Study|Withdrawal by Subject|15|||
147469934|NCT03195894|531876772|FG001|Overall Study|Withdrawal by Subject|4|||
147469935|NCT03195894|531876771|FG000|Overall Study|Lost to Follow-up|14|||
147469936|NCT03195894|531876772|FG001|Overall Study|Lost to Follow-up|19|||
147469937|NCT03263091|531876777|FG000|OL Component|Withdrawal by Subject|1|||
147469938|NCT03263091|531876778|FG001|OL Component|Withdrawal by Subject|1|||
147469939|NCT03263091|531876779|FG002|OL Component|Withdrawal by Subject|0|||
147469940|NCT03263091|531876780|FG003|OL Component|Withdrawal by Subject|0|||
147469941|NCT03263091|531876781|FG004|OL Component|Withdrawal by Subject|0|||
147469942|NCT03263091|531876782|FG005|OL Component|Withdrawal by Subject|0|||
147469943|NCT03263091|531876777|FG000|OL Component|Physician Decision|0|||
147469944|NCT03263091|531876778|FG001|OL Component|Physician Decision|1|||
147469945|NCT03263091|531876779|FG002|OL Component|Physician Decision|2|||
147469946|NCT03263091|531876780|FG003|OL Component|Physician Decision|0|||
147469947|NCT03263091|531876781|FG004|OL Component|Physician Decision|0|||
147469948|NCT03263091|531876782|FG005|OL Component|Physician Decision|0|||
147469949|NCT03263091|531876777|FG000|OL Component|Death|1|||
147469950|NCT03263091|531876778|FG001|OL Component|Death|0|||
147469951|NCT03263091|531876779|FG002|OL Component|Death|0|||
147469952|NCT03263091|531876780|FG003|OL Component|Death|0|||
147469953|NCT03263091|531876781|FG004|OL Component|Death|0|||
147469954|NCT03263091|531876782|FG005|OL Component|Death|0|||
147469955|NCT03263091|531876777|FG000|OL High-EPO Component|Withdrawal by Subject|0|||
147469956|NCT03263091|531876778|FG001|OL High-EPO Component|Withdrawal by Subject|0|||
147469957|NCT03263091|531876779|FG002|OL High-EPO Component|Withdrawal by Subject|0|||
147469958|NCT03263091|531876780|FG003|OL High-EPO Component|Withdrawal by Subject|6|||
147469959|NCT03263091|531876781|FG004|OL High-EPO Component|Withdrawal by Subject|0|||
147469960|NCT03263091|531876782|FG005|OL High-EPO Component|Withdrawal by Subject|0|||
147469961|NCT03263091|531876777|FG000|OL High-EPO Component|Physician Decision|0|||
147469962|NCT03263091|531876778|FG001|OL High-EPO Component|Physician Decision|0|||
147469963|NCT03263091|531876779|FG002|OL High-EPO Component|Physician Decision|0|||
147469964|NCT03263091|531876780|FG003|OL High-EPO Component|Physician Decision|1|||
147619852|NCT02456740|532424638|FG007|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|8|||
147619853|NCT02456740|532424639|FG008|Active Treatment Phase (Weeks 24 - 52)|Withdrawal by Subject|9|||
147619854|NCT02456740|532424631|FG000|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
147619855|NCT02456740|532424632|FG001|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
147469965|NCT03263091|531876781|FG004|OL High-EPO Component|Physician Decision|0|||
147469966|NCT03263091|531876782|FG005|OL High-EPO Component|Physician Decision|0|||
147469967|NCT03263091|531876777|FG000|OL High-EPO Component|Death|0|||
147469968|NCT03263091|531876778|FG001|OL High-EPO Component|Death|0|||
147619856|NCT02456740|532424633|FG002|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
147469969|NCT03263091|531876779|FG002|OL High-EPO Component|Death|0|||
147619857|NCT02456740|532424634|FG003|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
147619858|NCT02456740|532424635|FG004|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
147619859|NCT02456740|532424636|FG005|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
147619860|NCT02456740|532424637|FG006|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
147412225|NCT00379288|531672914|FG003|Overall Study|Subject withdrew-related to study drug|1|||
147412226|NCT00379288|531672911|FG000|Overall Study|Noncompliance with protocol|8|||
147412227|NCT00379288|531672912|FG001|Overall Study|Noncompliance with protocol|6|||
147412228|NCT00379288|531672913|FG002|Overall Study|Noncompliance with protocol|2|||
147412229|NCT00379288|531672914|FG003|Overall Study|Noncompliance with protocol|1|||
147412230|NCT00379288|531672911|FG000|Overall Study|Did not meet protocol eligibility|0|||
147619861|NCT02456740|532424638|FG007|Active Treatment Phase (Weeks 24 - 52)|Death|1|||
147619862|NCT02456740|532424639|FG008|Active Treatment Phase (Weeks 24 - 52)|Death|0|||
147412231|NCT00379288|531672912|FG001|Overall Study|Did not meet protocol eligibility|1|||
147412232|NCT00379288|531672913|FG002|Overall Study|Did not meet protocol eligibility|0|||
147412233|NCT00379288|531672914|FG003|Overall Study|Did not meet protocol eligibility|2|||
147412234|NCT00379288|531672911|FG000|Overall Study|Administrative|2|||
147412235|NCT00379288|531672912|FG001|Overall Study|Administrative|2|||
147412236|NCT00379288|531672913|FG002|Overall Study|Administrative|0|||
147412237|NCT00379288|531672914|FG003|Overall Study|Administrative|1|||
147412238|NCT00918879|531672915|FG000|Overall Study|Withdrawal by Subject|4|||
147412239|NCT00918879|531672916|FG001|Overall Study|Withdrawal by Subject|4|||
147412240|NCT00918879|531672915|FG000|Overall Study|Lost to Follow-up|1|||
147412241|NCT00918879|531672916|FG001|Overall Study|Lost to Follow-up|1|||
147412242|NCT00918879|531672915|FG000|Overall Study|Severe non-compliance to protocol|1|||
147412243|NCT00918879|531672916|FG001|Overall Study|Severe non-compliance to protocol|1|||
147412244|NCT00357110|531672919|FG000|Overall Study|Early study termination|5|||
147412245|NCT00357110|531672920|FG001|Overall Study|Early study termination|5|||
147412246|NCT01255631|531672924|FG000|Overall Study|poor enrollment, no data analyzed|9|||
147412247|NCT01255631|531672925|FG001|Overall Study|poor enrollment, no data analyzed|6|||
147412248|NCT03339245|531672926|FG000|Overall Study|Adverse Event|1|||
147412249|NCT03339245|531672927|FG001|Overall Study|Adverse Event|1|||
147412250|NCT03339245|531672926|FG000|Overall Study|Withdrawal by Subject|1|||
147412251|NCT03339245|531672927|FG001|Overall Study|Withdrawal by Subject|0|||
147412252|NCT00515671|531672928|FG000|Overall Study|Lost to Follow-up|13|||
147412253|NCT00515671|531672929|FG001|Overall Study|Lost to Follow-up|10|||
147412254|NCT00515671|531672928|FG000|Overall Study|Withdrawal by Subject|3|||
147412255|NCT00515671|531672929|FG001|Overall Study|Withdrawal by Subject|5|||
147412256|NCT00515671|531672928|FG000|Overall Study|incarcerated|1|||
147412257|NCT00515671|531672929|FG001|Overall Study|incarcerated|2|||
147412258|NCT00288639|531672941|FG000|Overall Study|Adverse Event|5|||
147412259|NCT00288639|531672941|FG000|Overall Study|Lack of Efficacy|4|||
147412260|NCT00288639|531672941|FG000|Overall Study|Withdrawal by Subject|2|||
147412261|NCT00288639|531672941|FG000|Overall Study|Other|1|||
147412262|NCT00527787|531672947|FG000|Overall Study|Adverse Event|14|||
147412263|NCT00527787|531672948|FG001|Overall Study|Adverse Event|24|||
147412264|NCT00527787|531672947|FG000|Overall Study|Withdrawal by Subject|13|||
147412265|NCT00527787|531672948|FG001|Overall Study|Withdrawal by Subject|25|||
147412266|NCT00527787|531672947|FG000|Overall Study|Lost to Follow-up|5|||
147412267|NCT00527787|531672948|FG001|Overall Study|Lost to Follow-up|2|||
147412268|NCT00527787|531672947|FG000|Overall Study|Duodenal Ulcer|1|||
147412269|NCT00527787|531672948|FG001|Overall Study|Duodenal Ulcer|10|||
147412270|NCT00527787|531672947|FG000|Overall Study|misc|5|||
147412271|NCT00527787|531672948|FG001|Overall Study|misc|2|||
147412272|NCT01252355|531672951|FG000|Overall Study|Adverse Event|9|||
147412273|NCT01252355|531672952|FG001|Overall Study|Adverse Event|17|||
147412274|NCT01252355|531672953|FG002|Overall Study|Adverse Event|22|||
147412275|NCT01252355|531672951|FG000|Overall Study|Lack of Efficacy|6|||
147412276|NCT01252355|531672952|FG001|Overall Study|Lack of Efficacy|4|||
147412277|NCT01252355|531672953|FG002|Overall Study|Lack of Efficacy|2|||
147412278|NCT01252355|531672951|FG000|Overall Study|Lost to Follow-up|0|||
147412279|NCT01252355|531672952|FG001|Overall Study|Lost to Follow-up|0|||
147412280|NCT01252355|531672953|FG002|Overall Study|Lost to Follow-up|1|||
147412281|NCT01252355|531672951|FG000|Overall Study|Poor Compliance to Protocol|1|||
147412282|NCT01252355|531672952|FG001|Overall Study|Poor Compliance to Protocol|1|||
147412283|NCT01252355|531672953|FG002|Overall Study|Poor Compliance to Protocol|1|||
147412284|NCT01252355|531672951|FG000|Overall Study|Progressive Disease|2|||
147619863|NCT02456740|532424631|FG000|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
147412285|NCT01252355|531672952|FG001|Overall Study|Progressive Disease|0|||
147412286|NCT01252355|531672953|FG002|Overall Study|Progressive Disease|0|||
147412287|NCT01252355|531672951|FG000|Overall Study|Sponsor Early Termination of Study|149|||
147412288|NCT01252355|531672952|FG001|Overall Study|Sponsor Early Termination of Study|149|||
147412289|NCT01252355|531672953|FG002|Overall Study|Sponsor Early Termination of Study|146|||
147412290|NCT01252355|531672951|FG000|Overall Study|Randomized but not Treated|2|||
147412291|NCT01252355|531672952|FG001|Overall Study|Randomized but not Treated|0|||
147412292|NCT01252355|531672953|FG002|Overall Study|Randomized but not Treated|0|||
147412293|NCT01252355|531672951|FG000|Overall Study|Other Than Above|8|||
147412294|NCT01252355|531672952|FG001|Overall Study|Other Than Above|7|||
147412295|NCT01252355|531672953|FG002|Overall Study|Other Than Above|7|||
147412296|NCT01876901|531672954|FG000|Overall Study|Protocol Violation|10|||
147412297|NCT01876901|531672955|FG001|Overall Study|Protocol Violation|2|||
147412298|NCT01876901|531672954|FG000|Overall Study|No or other surgical intervention|7|||
147412299|NCT01876901|531672955|FG001|Overall Study|No or other surgical intervention|5|||
147412300|NCT02242097|531672956|FG000|Ibrutinib Treatment|Adverse Event|16|||
147412301|NCT02242097|531672956|FG000|Ibrutinib Treatment|Physician Decision|1|||
147412302|NCT02242097|531672956|FG000|Ibrutinib Treatment|Lack of Efficacy|1|||
147412303|NCT02242097|531672956|FG000|Ibrutinib Treatment|Death|1|||
147412304|NCT02242097|531672956|FG000|Ibrutinib Treatment|Patient Ineligible to start treatment|1|||
147412305|NCT02242097|531672956|FG000|Post Therapy Follow Up|Death|3|||
147412306|NCT02242097|531672956|FG000|Post Therapy Follow Up|Lost to Follow-up|1|||
147412307|NCT03435692|531672959|FG000|Overall Study|Lack of Efficacy|2|||
147412308|NCT03435692|531672960|FG001|Overall Study|Lack of Efficacy|2|||
147412309|NCT03435692|531672961|FG002|Overall Study|Lack of Efficacy|0|||
147412310|NCT04313608|531672962|FG000|Overall Study|Death|12|||
147412311|NCT04313608|531672963|FG001|Overall Study|Death|3|||
147412312|NCT01145898|531672964|FG000|3-year Treatment|medication change by treating physician|3|||
147412313|NCT01145898|531672965|FG001|3-year Treatment|medication change by treating physician|16|||
147412314|NCT01712061|531672966|FG000|Overall Study|Adverse Event|4|||
147412315|NCT01712061|531672967|FG001|Overall Study|Adverse Event|9|||
147412316|NCT01712061|531672968|FG002|Overall Study|Adverse Event|5|||
147412317|NCT01712061|531672966|FG000|Overall Study|Death|0|||
147412318|NCT01712061|531672967|FG001|Overall Study|Death|0|||
147412319|NCT01712061|531672968|FG002|Overall Study|Death|1|||
147412320|NCT01712061|531672966|FG000|Overall Study|Lost to Follow-up|1|||
147412321|NCT01712061|531672967|FG001|Overall Study|Lost to Follow-up|0|||
147412322|NCT01712061|531672968|FG002|Overall Study|Lost to Follow-up|1|||
147412323|NCT01712061|531672966|FG000|Overall Study|Did Not Meet Entrance Criteria|4|||
147412324|NCT01712061|531672967|FG001|Overall Study|Did Not Meet Entrance Criteria|6|||
147412325|NCT01712061|531672968|FG002|Overall Study|Did Not Meet Entrance Criteria|3|||
147412326|NCT01712061|531672966|FG000|Overall Study|Medication Error Without Associated AE|0|||
147412327|NCT01712061|531672967|FG001|Overall Study|Medication Error Without Associated AE|1|||
147412328|NCT01712061|531672968|FG002|Overall Study|Medication Error Without Associated AE|0|||
147412329|NCT01712061|531672966|FG000|Overall Study|Withdrawal by Subject|1|||
147412330|NCT01712061|531672967|FG001|Overall Study|Withdrawal by Subject|7|||
147412331|NCT01712061|531672968|FG002|Overall Study|Withdrawal by Subject|1|||
147412332|NCT01712061|531672966|FG000|Overall Study|Other|0|||
147412333|NCT01712061|531672967|FG001|Overall Study|Other|3|||
147412334|NCT01712061|531672968|FG002|Overall Study|Other|0|||
147412335|NCT00203268|531672976|FG000|Early Treatment|only treated one headache|2|||
147412336|NCT00203268|531672976|FG000|Early Treatment|Lost to Follow-up|1|||
147412337|NCT00203268|531672976|FG000|Early Treatment|Withdrawal by Subject|1|||
147412338|NCT04343976|531672977|FG000|Overall Study|Withdrawal by Subject|0|||
147412339|NCT04343976|531672978|FG001|Overall Study|Withdrawal by Subject|1|||
147619864|NCT02456740|532424632|FG001|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
147619865|NCT02456740|532424633|FG002|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|0|||
147619866|NCT02456740|532424634|FG003|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|3|||
147619867|NCT02456740|532424635|FG004|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|2|||
147619868|NCT02456740|532424636|FG005|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|4|||
147619869|NCT02456740|532424637|FG006|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|1|||
147619870|NCT02456740|532424638|FG007|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|3|||
147619871|NCT02456740|532424639|FG008|Active Treatment Phase (Weeks 24 - 52)|Lost to Follow-up|4|||
147619872|NCT00858273|532424640|FG000|Overall Study|Protocol Violation|3|||
147619873|NCT00858273|532424641|FG001|Overall Study|Protocol Violation|5|||
147619874|NCT00625820|532424642|FG000|Overall Study|Withdrawal by Subject|1|||
147619875|NCT00982657|532424643|FG000|Overall Study|Death|1|||
147619876|NCT00982657|532424644|FG001|Overall Study|Death|0|||
147619877|NCT00982657|532424645|FG002|Overall Study|Death|1|||
147619878|NCT00982657|532424646|FG003|Overall Study|Death|1|||
147619879|NCT00982657|532424643|FG000|Overall Study|Withdrawal by Subject|0|||
147619880|NCT00982657|532424644|FG001|Overall Study|Withdrawal by Subject|0|||
147619881|NCT00982657|532424645|FG002|Overall Study|Withdrawal by Subject|1|||
147619882|NCT00982657|532424646|FG003|Overall Study|Withdrawal by Subject|3|||
147619883|NCT00982657|532424643|FG000|Overall Study|Other|0|||
147619884|NCT00982657|532424644|FG001|Overall Study|Other|0|||
147619885|NCT00982657|532424645|FG002|Overall Study|Other|0|||
147619886|NCT00982657|532424646|FG003|Overall Study|Other|4|||
147412340|NCT02807883|531672979|FG000|Overall Study|Withdrawal by Subject|2|||
147412341|NCT00594880|531672980|FG000|Overall Study|Withdrawal by Subject|1|||
147412342|NCT00594880|531672981|FG001|Overall Study|Withdrawal by Subject|1|||
147619887|NCT00982657|532424643|FG000|Overall Study|On going at date of cut-off|0|||
147412343|NCT00594880|531672980|FG000|Overall Study|Lost to Follow-up|1|||
147412344|NCT00594880|531672981|FG001|Overall Study|Lost to Follow-up|0|||
147412345|NCT00694109|531672982|FG000|Overall Study|Physician Decision|3|||
147619888|NCT00982657|532424644|FG001|Overall Study|On going at date of cut-off|0|||
147412346|NCT00694109|531672982|FG000|Overall Study|Adverse Event|74|||
147412347|NCT00694109|531672982|FG000|Overall Study|Not consent of more 2 years of treatment|18|||
147412348|NCT00694109|531672982|FG000|Overall Study|Lack of Efficacy|2|||
147412349|NCT00694109|531672982|FG000|Overall Study|Withdrawal by Subject|13|||
147412350|NCT00694109|531672982|FG000|Overall Study|Pregnancy|1|||
147412351|NCT00694109|531672982|FG000|Overall Study|Enrolled but not treated|1|||
147412352|NCT00694109|531672982|FG000|Overall Study|Other|2|||
147412353|NCT00694109|531672982|FG000|Overall Study|Consented but no additional treatment|3|||
147412354|NCT01254747|531672985|FG000|Overall Study|Unacceptable subjective vision|0|||
147412355|NCT01254747|531672986|FG001|Overall Study|Unacceptable subjective vision|0|||
147412356|NCT01254747|531672987|FG002|Overall Study|Unacceptable subjective vision|0|||
147412357|NCT01254747|531672988|FG003|Overall Study|Unacceptable subjective vision|2|||
147412358|NCT01254747|531672985|FG000|Overall Study|Difficult removal handling|0|||
147412359|NCT01254747|531672986|FG001|Overall Study|Difficult removal handling|0|||
147412360|NCT01254747|531672987|FG002|Overall Study|Difficult removal handling|1|||
147412361|NCT01254747|531672988|FG003|Overall Study|Difficult removal handling|0|||
147412362|NCT01254747|531672985|FG000|Overall Study|Symptoms and problems|0|||
147412363|NCT01254747|531672986|FG001|Overall Study|Symptoms and problems|2|||
147412364|NCT01254747|531672987|FG002|Overall Study|Symptoms and problems|1|||
147412365|NCT01254747|531672988|FG003|Overall Study|Symptoms and problems|0|||
147412366|NCT01254747|531672985|FG000|Overall Study|Lost to Follow-up|0|||
147412367|NCT01254747|531672986|FG001|Overall Study|Lost to Follow-up|0|||
147412368|NCT01254747|531672987|FG002|Overall Study|Lost to Follow-up|1|||
147412369|NCT01254747|531672988|FG003|Overall Study|Lost to Follow-up|0|||
147412370|NCT01254747|531672985|FG000|Overall Study|Biomicroscopy|0|||
147412371|NCT01254747|531672986|FG001|Overall Study|Biomicroscopy|0|||
147412372|NCT01254747|531672987|FG002|Overall Study|Biomicroscopy|1|||
147412373|NCT01254747|531672988|FG003|Overall Study|Biomicroscopy|0|||
147412374|NCT01254747|531672985|FG000|Overall Study|Discomfort|0|||
147412375|NCT01254747|531672986|FG001|Overall Study|Discomfort|4|||
147412376|NCT01254747|531672987|FG002|Overall Study|Discomfort|0|||
147412377|NCT01254747|531672988|FG003|Overall Study|Discomfort|0|||
147412378|NCT00846807|531672989|FG000|Overall Study|Adverse Event|270|||
147412379|NCT00846807|531672989|FG000|Overall Study|Lost to Follow-up|94|||
147412380|NCT00846807|531672989|FG000|Overall Study|Withdrawal by Subject|56|||
147412381|NCT00846807|531672989|FG000|Overall Study|Non compliant with European label|7|||
147412382|NCT00846807|531672989|FG000|Overall Study|Switch to other anticoagulants|89|||
147412383|NCT00846807|531672989|FG000|Overall Study|No prescription after hospital discharge|56|||
147412384|NCT00846807|531672989|FG000|Overall Study|Other|60|||
147412385|NCT00737698|531672990|FG000|Overall Study|Withdrawal by Subject|6|||
147412386|NCT00737698|531672991|FG001|Overall Study|Withdrawal by Subject|5|||
147412387|NCT00737698|531672992|FG002|Overall Study|Withdrawal by Subject|3|||
147412388|NCT00737698|531672990|FG000|Overall Study|Death|0|||
147412389|NCT00737698|531672991|FG001|Overall Study|Death|0|||
147412390|NCT00737698|531672992|FG002|Overall Study|Death|1|||
147412391|NCT01067846|531672993|FG000|Overall Study|Lost to Follow-up|17|||
147412392|NCT01067846|531672994|FG001|Overall Study|Lost to Follow-up|19|||
147412393|NCT01067846|531672993|FG000|Overall Study|Withdrawal by Subject|1|||
147412394|NCT01067846|531672994|FG001|Overall Study|Withdrawal by Subject|0|||
147412395|NCT01067846|531672993|FG000|Overall Study|participation in other tx study|1|||
147412396|NCT01067846|531672994|FG001|Overall Study|participation in other tx study|0|||
147412397|NCT02817906|531672995|FG000|Overall Study|Adverse Event|3|||
147412398|NCT02817906|531672996|FG001|Overall Study|Adverse Event|0|||
147412399|NCT02817906|531672995|FG000|Overall Study|Lack of Efficacy|1|||
147412400|NCT02817906|531672996|FG001|Overall Study|Lack of Efficacy|0|||
147412401|NCT02817906|531672995|FG000|Overall Study|Protocol Violation|1|||
147412402|NCT02817906|531672996|FG001|Overall Study|Protocol Violation|1|||
147412403|NCT02817906|531672995|FG000|Overall Study|Study Terminated by Sponsor|2|||
147412404|NCT02817906|531672996|FG001|Overall Study|Study Terminated by Sponsor|2|||
147412405|NCT02817906|531672995|FG000|Overall Study|Withdrawal by Subject|7|||
147412406|NCT02817906|531672996|FG001|Overall Study|Withdrawal by Subject|0|||
147412407|NCT02817906|531672995|FG000|Overall Study|Other|2|||
147412408|NCT02817906|531672996|FG001|Overall Study|Other|2|||
147412409|NCT03686423|531673004|FG000|Overall Study|Withdrawal by Subject|9|||
147412410|NCT03686423|531673004|FG000|Overall Study|lost to follow up (study interrupted by COVID)|6|||
147412411|NCT02833077|531673005|FG000|Overall Study|Adverse Event|1|||
147412412|NCT02833077|531673006|FG001|Overall Study|Adverse Event|2|||
147412413|NCT02833077|531673005|FG000|Overall Study|Lost to Follow-up|10|||
147412414|NCT02833077|531673006|FG001|Overall Study|Lost to Follow-up|1|||
147412415|NCT02833077|531673005|FG000|Overall Study|Personal Reasons|6|||
147412416|NCT02833077|531673006|FG001|Overall Study|Personal Reasons|4|||
147412417|NCT02833077|531673005|FG000|Overall Study|Protocol Deviation|0|||
147412418|NCT02833077|531673006|FG001|Overall Study|Protocol Deviation|1|||
147412419|NCT04608773|531673007|FG000|First Wash Out (1 Week)|Withdrawal by Subject|12|||
147412420|NCT04608773|531673008|FG001|First Wash Out (1 Week)|Withdrawal by Subject|6|||
147412421|NCT04608773|531673007|FG000|First Intervention (2 Weeks)|Lost to Follow-up|3|||
147412422|NCT04608773|531673008|FG001|First Intervention (2 Weeks)|Lost to Follow-up|1|||
147469970|NCT03263091|531876780|FG003|OL High-EPO Component|Death|3|||
147469971|NCT03263091|531876781|FG004|OL High-EPO Component|Death|0|||
147469972|NCT03263091|531876782|FG005|OL High-EPO Component|Death|0|||
147469973|NCT03263091|531876777|FG000|DB Component|Withdrawal by Subject|0|||
147469974|NCT03263091|531876778|FG001|DB Component|Withdrawal by Subject|0|||
147469975|NCT03263091|531876779|FG002|DB Component|Withdrawal by Subject|0|||
147469976|NCT03263091|531876780|FG003|DB Component|Withdrawal by Subject|0|||
147469977|NCT03263091|531876781|FG004|DB Component|Withdrawal by Subject|22|||
147469978|NCT03263091|531876782|FG005|DB Component|Withdrawal by Subject|8|||
147469979|NCT03263091|531876777|FG000|DB Component|Physician Decision|0|||
147469980|NCT03263091|531876778|FG001|DB Component|Physician Decision|0|||
147469981|NCT03263091|531876779|FG002|DB Component|Physician Decision|0|||
147619889|NCT00982657|532424645|FG002|Overall Study|On going at date of cut-off|0|||
147619890|NCT00982657|532424646|FG003|Overall Study|On going at date of cut-off|1|||
147619891|NCT00070564|532427179|FG000|Overall Study|Progression|2|||
147619892|NCT00070564|532427180|FG001|Overall Study|Progression|4|||
147619893|NCT00070564|532427181|FG002|Overall Study|Progression|7|||
147619894|NCT00070564|532427182|FG003|Overall Study|Progression|7|||
147619895|NCT00070564|532427183|FG004|Overall Study|Progression|1|||
147619896|NCT00070564|532427184|FG005|Overall Study|Progression|0|||
147619897|NCT00070564|532427179|FG000|Overall Study|Delinquent|1|||
147619898|NCT00070564|532427180|FG001|Overall Study|Delinquent|4|||
147619899|NCT00070564|532427181|FG002|Overall Study|Delinquent|2|||
147619900|NCT00070564|532427182|FG003|Overall Study|Delinquent|0|||
147619901|NCT00070564|532427183|FG004|Overall Study|Delinquent|0|||
147619902|NCT00070564|532427184|FG005|Overall Study|Delinquent|0|||
147619903|NCT00070564|532427179|FG000|Overall Study|Adverse Event|150|||
147619904|NCT00070564|532427180|FG001|Overall Study|Adverse Event|142|||
147619905|NCT00070564|532427181|FG002|Overall Study|Adverse Event|120|||
147619906|NCT00070564|532427182|FG003|Overall Study|Adverse Event|108|||
147619907|NCT00070564|532427183|FG004|Overall Study|Adverse Event|63|||
147619908|NCT00070564|532427184|FG005|Overall Study|Adverse Event|36|||
147619909|NCT00070564|532427179|FG000|Overall Study|Death|4|||
147619910|NCT00070564|532427180|FG001|Overall Study|Death|1|||
147619911|NCT00070564|532427181|FG002|Overall Study|Death|5|||
147619912|NCT00070564|532427182|FG003|Overall Study|Death|3|||
147619913|NCT00070564|532427183|FG004|Overall Study|Death|0|||
147619914|NCT00070564|532427184|FG005|Overall Study|Death|1|||
147619915|NCT00070564|532427179|FG000|Overall Study|Other, not protocol specified|17|||
147619916|NCT00070564|532427180|FG001|Overall Study|Other, not protocol specified|15|||
147619917|NCT00070564|532427181|FG002|Overall Study|Other, not protocol specified|14|||
147619918|NCT00070564|532427182|FG003|Overall Study|Other, not protocol specified|19|||
147619919|NCT00070564|532427183|FG004|Overall Study|Other, not protocol specified|6|||
147619920|NCT00070564|532427184|FG005|Overall Study|Other, not protocol specified|7|||
147619921|NCT00070564|532427179|FG000|Overall Study|Withdrawal by Subject|26|||
147619922|NCT00070564|532427180|FG001|Overall Study|Withdrawal by Subject|37|||
147619923|NCT00070564|532427181|FG002|Overall Study|Withdrawal by Subject|23|||
147619924|NCT00070564|532427182|FG003|Overall Study|Withdrawal by Subject|30|||
147619925|NCT00070564|532427183|FG004|Overall Study|Withdrawal by Subject|8|||
147619926|NCT00070564|532427184|FG005|Overall Study|Withdrawal by Subject|8|||
147619927|NCT00070564|532427179|FG000|Overall Study|Not reported|0|||
147619928|NCT00070564|532427180|FG001|Overall Study|Not reported|0|||
147619929|NCT00070564|532427181|FG002|Overall Study|Not reported|0|||
147619930|NCT00070564|532427182|FG003|Overall Study|Not reported|0|||
147619931|NCT00070564|532427183|FG004|Overall Study|Not reported|1|||
147469982|NCT03263091|531876780|FG003|DB Component|Physician Decision|0|||
147469983|NCT03263091|531876781|FG004|DB Component|Physician Decision|3|||
147469984|NCT03263091|531876782|FG005|DB Component|Physician Decision|1|||
147469985|NCT03263091|531876777|FG000|DB Component|Adverse Event|0|||
147469986|NCT03263091|531876778|FG001|DB Component|Adverse Event|0|||
147469987|NCT03263091|531876779|FG002|DB Component|Adverse Event|0|||
147469988|NCT03263091|531876780|FG003|DB Component|Adverse Event|0|||
147469989|NCT03263091|531876781|FG004|DB Component|Adverse Event|2|||
147619932|NCT00070564|532427184|FG005|Overall Study|Not reported|0|||
147619933|NCT04796961|532427185|FG000|Overall Study|Lost to Follow-up|10|||
147619934|NCT04796961|532427185|FG000|Overall Study|Withdrawal by Subject|3|||
147469990|NCT03263091|531876782|FG005|DB Component|Adverse Event|1|||
147469991|NCT03263091|531876777|FG000|DB Component|Lost to Follow-up|0|||
147619935|NCT04796961|532427185|FG000|Overall Study|Left Organization|10|||
147619936|NCT03018288|532427186|FG000|Overall Study|Participants withdrew consent before surgery.|0|||
147469992|NCT03263091|531876778|FG001|DB Component|Lost to Follow-up|0|||
147469993|NCT03263091|531876779|FG002|DB Component|Lost to Follow-up|0|||
147619937|NCT03018288|532427187|FG001|Overall Study|Participants withdrew consent before surgery.|0|||
147619938|NCT03018288|532427188|FG002|Overall Study|Participants withdrew consent before surgery.|0|||
147619939|NCT03018288|532427189|FG003|Overall Study|Participants withdrew consent before surgery.|1|||
147619940|NCT03018288|532427186|FG000|Overall Study|Participant withdrew consent.|0|||
147619941|NCT03018288|532427187|FG001|Overall Study|Participant withdrew consent.|0|||
147619942|NCT03018288|532427188|FG002|Overall Study|Participant withdrew consent.|1|||
147619943|NCT03018288|532427189|FG003|Overall Study|Participant withdrew consent.|0|||
147469994|NCT03263091|531876780|FG003|DB Component|Lost to Follow-up|0|||
147619944|NCT03018288|532427186|FG000|Overall Study|Switched to alternative treatment.|0|||
147619945|NCT03018288|532427187|FG001|Overall Study|Switched to alternative treatment.|0|||
147619946|NCT03018288|532427188|FG002|Overall Study|Switched to alternative treatment.|1|||
147619947|NCT03018288|532427189|FG003|Overall Study|Switched to alternative treatment.|0|||
147619948|NCT03018288|532427186|FG000|Overall Study|Participant withdrew consent for personal reasons.|0|||
147619949|NCT03018288|532427187|FG001|Overall Study|Participant withdrew consent for personal reasons.|0|||
147619950|NCT03018288|532427188|FG002|Overall Study|Participant withdrew consent for personal reasons.|1|||
147619951|NCT03018288|532427189|FG003|Overall Study|Participant withdrew consent for personal reasons.|0|||
147619952|NCT03018288|532427186|FG000|Overall Study|Screen failures|0|||
147619953|NCT03018288|532427187|FG001|Overall Study|Screen failures|0|||
147619954|NCT03018288|532427188|FG002|Overall Study|Screen failures|0|||
147619955|NCT03018288|532427189|FG003|Overall Study|Screen failures|51|||
147619956|NCT03018288|532427186|FG000|Overall Study|Chose treatment outside of UNC|0|||
147619957|NCT03018288|532427187|FG001|Overall Study|Chose treatment outside of UNC|0|||
147619958|NCT03018288|532427188|FG002|Overall Study|Chose treatment outside of UNC|0|||
147619959|NCT03018288|532427189|FG003|Overall Study|Chose treatment outside of UNC|1|||
147619960|NCT03018288|532427186|FG000|Overall Study|Unable to comply with protocol requirements|1|||
147619961|NCT03018288|532427187|FG001|Overall Study|Unable to comply with protocol requirements|1|||
147619962|NCT03018288|532427188|FG002|Overall Study|Unable to comply with protocol requirements|0|||
147619963|NCT03018288|532427189|FG003|Overall Study|Unable to comply with protocol requirements|1|||
147619964|NCT03018288|532427186|FG000|Overall Study|Participant declined to participate (before treatment started)|0|||
147619965|NCT03018288|532427187|FG001|Overall Study|Participant declined to participate (before treatment started)|0|||
147619966|NCT03018288|532427188|FG002|Overall Study|Participant declined to participate (before treatment started)|0|||
147619967|NCT03018288|532427189|FG003|Overall Study|Participant declined to participate (before treatment started)|3|||
147619968|NCT03018288|532427186|FG000|Overall Study|Physician Decision|0|||
147619969|NCT03018288|532427187|FG001|Overall Study|Physician Decision|0|||
147619970|NCT03018288|532427188|FG002|Overall Study|Physician Decision|0|||
147619971|NCT03018288|532427189|FG003|Overall Study|Physician Decision|1|||
147469995|NCT03263091|531876781|FG004|DB Component|Lost to Follow-up|2|||
147469996|NCT03263091|531876782|FG005|DB Component|Lost to Follow-up|1|||
147469997|NCT03263091|531876777|FG000|DB Component|Death|0|||
147469998|NCT03263091|531876778|FG001|DB Component|Death|0|||
147469999|NCT03263091|531876779|FG002|DB Component|Death|0|||
147470000|NCT03263091|531876780|FG003|DB Component|Death|0|||
147470001|NCT03263091|531876781|FG004|DB Component|Death|7|||
147470002|NCT03263091|531876782|FG005|DB Component|Death|4|||
147470003|NCT03263091|531876777|FG000|DB Component|Other than specified|0|||
147470004|NCT03263091|531876778|FG001|DB Component|Other than specified|0|||
147470005|NCT03263091|531876779|FG002|DB Component|Other than specified|0|||
147470006|NCT03263091|531876780|FG003|DB Component|Other than specified|0|||
147470007|NCT03263091|531876781|FG004|DB Component|Other than specified|8|||
147470008|NCT03263091|531876782|FG005|DB Component|Other than specified|6|||
147470009|NCT01821963|531876784|FG000|Overall Study|Adverse Event|1|||
147470010|NCT00506389|531876785|FG000|In-treatment Period|Other|3|||
147470011|NCT00506389|531876786|FG001|In-treatment Period|Other|3|||
147470012|NCT00506389|531876787|FG002|In-treatment Period|Other|4|||
147470013|NCT00506389|531876785|FG000|In-treatment Period|Lost to Follow-up|0|||
147470014|NCT00506389|531876786|FG001|In-treatment Period|Lost to Follow-up|0|||
147470015|NCT00506389|531876787|FG002|In-treatment Period|Lost to Follow-up|1|||
147470016|NCT00506389|531876785|FG000|In-treatment Period|Lack of compliance|1|||
147470017|NCT00506389|531876786|FG001|In-treatment Period|Lack of compliance|0|||
147470018|NCT00506389|531876787|FG002|In-treatment Period|Lack of compliance|0|||
147470019|NCT00506389|531876785|FG000|In-treatment Period|Reasons not related to trial|4|||
147470020|NCT00506389|531876786|FG001|In-treatment Period|Reasons not related to trial|1|||
147470021|NCT00506389|531876787|FG002|In-treatment Period|Reasons not related to trial|0|||
147470022|NCT00506389|531876785|FG000|In-treatment Period|Withdrawal by Subject|3|||
147470023|NCT00506389|531876786|FG001|In-treatment Period|Withdrawal by Subject|3|||
147470024|NCT00506389|531876787|FG002|In-treatment Period|Withdrawal by Subject|4|||
147470025|NCT00506389|531876785|FG000|In-treatment Period|Lack of Efficacy|0|||
147470026|NCT00506389|531876786|FG001|In-treatment Period|Lack of Efficacy|2|||
147470027|NCT00506389|531876787|FG002|In-treatment Period|Lack of Efficacy|0|||
147470028|NCT00506389|531876785|FG000|In-treatment Period|Adverse Event|11|||
147470029|NCT00506389|531876786|FG001|In-treatment Period|Adverse Event|5|||
147470030|NCT00506389|531876787|FG002|In-treatment Period|Adverse Event|2|||
147470031|NCT00506389|531876785|FG000|In-treatment Period|Randomized but not treated|4|||
147470032|NCT00506389|531876786|FG001|In-treatment Period|Randomized but not treated|1|||
147470033|NCT00506389|531876787|FG002|In-treatment Period|Randomized but not treated|1|||
147470034|NCT03095703|531876789|FG000|Overall Study|Withdrawal by Subject|1|||
147619972|NCT01490086|532427193|FG000|Overall Study|Consent withdrawn|4|||
147619973|NCT01490086|532427194|FG001|Overall Study|Consent withdrawn|4|||
147470035|NCT02443402|531876794|FG000|Overall Study|Withdrawal by Subject|3|||
147470036|NCT02443402|531876795|FG001|Overall Study|Withdrawal by Subject|1|||
147470037|NCT02443402|531876794|FG000|Overall Study|Screen Failure|1|||
147470038|NCT02443402|531876795|FG001|Overall Study|Screen Failure|2|||
147470039|NCT01934504|531876797|FG000|Overall Study|Protocol Deviation|0|||
147470040|NCT01934504|531876798|FG001|Overall Study|Protocol Deviation|0|||
147470041|NCT01934504|531876799|FG002|Overall Study|Protocol Deviation|0|||
147470042|NCT01934504|531876800|FG003|Overall Study|Protocol Deviation|2|||
147470043|NCT01934504|531876797|FG000|Overall Study|Study Terminated by Sponsor|1|||
147470044|NCT01934504|531876798|FG001|Overall Study|Study Terminated by Sponsor|0|||
147470045|NCT01934504|531876799|FG002|Overall Study|Study Terminated by Sponsor|5|||
147470046|NCT01934504|531876800|FG003|Overall Study|Study Terminated by Sponsor|5|||
147470047|NCT02665689|531876807|FG000|Overall Study|Adverse Event|1|||
147470048|NCT02665689|531876808|FG001|Overall Study|Adverse Event|0|||
147470049|NCT02665689|531876807|FG000|Overall Study|Trial termination|1|||
147470050|NCT02665689|531876808|FG001|Overall Study|Trial termination|1|||
147470051|NCT02665689|531876807|FG000|Overall Study|Lost to Follow-up|0|||
147470052|NCT02665689|531876808|FG001|Overall Study|Lost to Follow-up|1|||
147470053|NCT00486902|531876809|FG000|Overall Study|Withdrawal by Subject|1|||
147470054|NCT00486902|531876810|FG001|Overall Study|Withdrawal by Subject|2|||
147470055|NCT00486902|531876809|FG000|Overall Study|decision for postpartum tubal ligation|3|||
147470056|NCT00486902|531876810|FG001|Overall Study|decision for postpartum tubal ligation|1|||
147470057|NCT00486902|531876809|FG000|Overall Study|spinal anesthetic protocal violation|1|||
147470058|NCT00486902|531876810|FG001|Overall Study|spinal anesthetic protocal violation|1|||
147470059|NCT00486902|531876809|FG000|Overall Study|Did not meet inclusion criteria|1|||
147470060|NCT00486902|531876810|FG001|Overall Study|Did not meet inclusion criteria|0|||
147470061|NCT00486902|531876809|FG000|Overall Study|No toradol due to hemmorhage or allergy|3|||
147470062|NCT00486902|531876810|FG001|Overall Study|No toradol due to hemmorhage or allergy|1|||
147470063|NCT01217606|531876811|FG000|Initial Treatment Phase|Other Reasons|0|||
147470064|NCT01217606|531876812|FG001|Initial Treatment Phase|Other Reasons|2|||
147470065|NCT01217606|531876811|FG000|Initial Treatment Phase|Protocol Violation|3|||
147470066|NCT01217606|531876812|FG001|Initial Treatment Phase|Protocol Violation|2|||
147470067|NCT01217606|531876811|FG000|Initial Treatment Phase|Personal Reasons|0|||
147470068|NCT01217606|531876812|FG001|Initial Treatment Phase|Personal Reasons|2|||
147470069|NCT01217606|531876811|FG000|Initial Treatment Phase|Lack of Efficacy|1|||
147470070|NCT01217606|531876812|FG001|Initial Treatment Phase|Lack of Efficacy|0|||
147470071|NCT01217606|531876811|FG000|Initial Treatment Phase|Adverse Event|10|||
147470072|NCT01217606|531876812|FG001|Initial Treatment Phase|Adverse Event|6|||
147470073|NCT01217606|531876811|FG000|9-Month Masked Extension|Adverse Event|3|||
147470074|NCT01217606|531876812|FG001|9-Month Masked Extension|Adverse Event|6|||
147470075|NCT01217606|531876811|FG000|9-Month Masked Extension|Other Reasons|4|||
147470076|NCT01217606|531876812|FG001|9-Month Masked Extension|Other Reasons|4|||
147470077|NCT01217606|531876811|FG000|9-Month Masked Extension|Personal Reasons|2|||
147470078|NCT01217606|531876812|FG001|9-Month Masked Extension|Personal Reasons|1|||
147470079|NCT01217606|531876811|FG000|9-Month Masked Extension|Lost to Follow-up|1|||
147470080|NCT01217606|531876812|FG001|9-Month Masked Extension|Lost to Follow-up|0|||
147470081|NCT01217606|531876811|FG000|9-Month Masked Extension|Pregnancy|1|||
147470082|NCT01217606|531876812|FG001|9-Month Masked Extension|Pregnancy|0|||
147470083|NCT01217606|531876811|FG000|9-Month Masked Extension|Lack of Efficacy|2|||
147470084|NCT01217606|531876812|FG001|9-Month Masked Extension|Lack of Efficacy|0|||
147470085|NCT03615222|531876813|FG000|Overall Study|Ineligible|26|||
147470086|NCT03615222|531876813|FG000|Overall Study|Withdrawal by Subject|7|||
147470087|NCT03615222|531876813|FG000|Overall Study|Death|1|||
147470088|NCT01552057|531876814|FG000|Overall Study|Adverse Event|14|||
147470089|NCT01552057|531876815|FG001|Overall Study|Adverse Event|15|||
147470090|NCT01552057|531876814|FG000|Overall Study|Lack of Efficacy|8|||
147470091|NCT01552057|531876815|FG001|Overall Study|Lack of Efficacy|23|||
147470092|NCT01552057|531876814|FG000|Overall Study|Withdrawal by Subject|5|||
147470093|NCT01552057|531876815|FG001|Overall Study|Withdrawal by Subject|8|||
147470094|NCT01552057|531876814|FG000|Overall Study|Entry Criteria Not Met|2|||
147470095|NCT01552057|531876815|FG001|Overall Study|Entry Criteria Not Met|2|||
147470096|NCT01552057|531876814|FG000|Overall Study|Physician Decision|1|||
147470097|NCT01552057|531876815|FG001|Overall Study|Physician Decision|0|||
147470098|NCT00476086|531876816|FG000|Overall Study|Alternative therapy|1|||
147470099|NCT00476086|531876816|FG000|Overall Study|Progressive Disease|4|||
147619974|NCT01490086|532427195|FG002|Overall Study|Consent withdrawn|3|||
147619975|NCT01490086|532427196|FG003|Overall Study|Consent withdrawn|0|||
147619976|NCT01490086|532427197|FG004|Overall Study|Consent withdrawn|1|||
147470100|NCT02900092|531876817|FG000|Overall Study|Adverse Event|1|||
147470101|NCT01389245|531876818|FG000|Overall Study|Protocol Violation|10|||
147470102|NCT01389245|531876818|FG000|Overall Study|Lost to Follow-up|3|||
147470103|NCT01389245|531876818|FG000|Overall Study|Withdrawal by Subject|2|||
147470104|NCT02292849|531876819|FG000|Overall Study|Lost to Follow-up|0|||
147470105|NCT02292849|531876820|FG001|Overall Study|Lost to Follow-up|2|||
147470106|NCT02292849|531876821|FG002|Overall Study|Lost to Follow-up|2|||
147470107|NCT02292849|531876819|FG000|Overall Study|Physician Decision|4|||
147619977|NCT01490086|532427193|FG000|Overall Study|Non-compliance|0|||
147470108|NCT02292849|531876820|FG001|Overall Study|Physician Decision|0|||
147470109|NCT02292849|531876821|FG002|Overall Study|Physician Decision|0|||
147619978|NCT01490086|532427194|FG001|Overall Study|Non-compliance|1|||
147619979|NCT01490086|532427195|FG002|Overall Study|Non-compliance|0|||
147470110|NCT00097539|531876822|FG000|Overall Study|Status Unknown (Or no final evaluation)|11959|||
147470111|NCT00097539|531876823|FG001|Overall Study|Status Unknown (Or no final evaluation)|3948|||
147470112|NCT00097539|531876824|FG002|Overall Study|Status Unknown (Or no final evaluation)|5646|||
147470113|NCT00097539|531876825|FG003|Overall Study|Status Unknown (Or no final evaluation)|2170|||
147470114|NCT00097539|531876826|FG004|Overall Study|Status Unknown (Or no final evaluation)|1106|||
147470115|NCT00097539|531876827|FG005|Overall Study|Status Unknown (Or no final evaluation)|3546|||
147470116|NCT00097539|531876828|FG006|Overall Study|Status Unknown (Or no final evaluation)|108|||
147470117|NCT00097539|531876822|FG000|Overall Study|Withdrawal by Subject|925|||
147470118|NCT00097539|531876823|FG001|Overall Study|Withdrawal by Subject|323|||
147470119|NCT00097539|531876824|FG002|Overall Study|Withdrawal by Subject|346|||
147470120|NCT00097539|531876825|FG003|Overall Study|Withdrawal by Subject|217|||
147470121|NCT00097539|531876826|FG004|Overall Study|Withdrawal by Subject|68|||
147470122|NCT00097539|531876827|FG005|Overall Study|Withdrawal by Subject|229|||
147470123|NCT00097539|531876828|FG006|Overall Study|Withdrawal by Subject|3|||
147470124|NCT00097539|531876822|FG000|Overall Study|Participant Non-compliant|2140|||
147470125|NCT00097539|531876823|FG001|Overall Study|Participant Non-compliant|567|||
147470126|NCT00097539|531876824|FG002|Overall Study|Participant Non-compliant|1067|||
147470127|NCT00097539|531876825|FG003|Overall Study|Participant Non-compliant|353|||
147470128|NCT00097539|531876826|FG004|Overall Study|Participant Non-compliant|136|||
147470129|NCT00097539|531876827|FG005|Overall Study|Participant Non-compliant|543|||
147470130|NCT00097539|531876828|FG006|Overall Study|Participant Non-compliant|18|||
147470131|NCT00097539|531876822|FG000|Overall Study|Lack of Efficacy|249|||
147470132|NCT00097539|531876823|FG001|Overall Study|Lack of Efficacy|122|||
147470133|NCT00097539|531876824|FG002|Overall Study|Lack of Efficacy|202|||
147470134|NCT00097539|531876825|FG003|Overall Study|Lack of Efficacy|105|||
147470135|NCT00097539|531876826|FG004|Overall Study|Lack of Efficacy|45|||
147470136|NCT00097539|531876827|FG005|Overall Study|Lack of Efficacy|228|||
147470137|NCT00097539|531876828|FG006|Overall Study|Lack of Efficacy|5|||
147470138|NCT00097539|531876822|FG000|Overall Study|Adverse Event|78|||
147470139|NCT00097539|531876823|FG001|Overall Study|Adverse Event|133|||
147470140|NCT00097539|531876824|FG002|Overall Study|Adverse Event|37|||
147470141|NCT00097539|531876825|FG003|Overall Study|Adverse Event|27|||
147470142|NCT00097539|531876826|FG004|Overall Study|Adverse Event|30|||
147470143|NCT00097539|531876827|FG005|Overall Study|Adverse Event|59|||
147470144|NCT00097539|531876828|FG006|Overall Study|Adverse Event|1|||
147470145|NCT00097539|531876822|FG000|Overall Study|Death|2|||
147470146|NCT00097539|531876823|FG001|Overall Study|Death|7|||
147470147|NCT00097539|531876824|FG002|Overall Study|Death|0|||
147470148|NCT00097539|531876825|FG003|Overall Study|Death|0|||
147470149|NCT00097539|531876826|FG004|Overall Study|Death|1|||
147470150|NCT00097539|531876827|FG005|Overall Study|Death|3|||
147470151|NCT00097539|531876828|FG006|Overall Study|Death|0|||
147470152|NCT00097539|531876822|FG000|Overall Study|Reasons Other Than Above|3602|||
147470153|NCT00097539|531876823|FG001|Overall Study|Reasons Other Than Above|1382|||
147470154|NCT00097539|531876824|FG002|Overall Study|Reasons Other Than Above|1757|||
147470155|NCT00097539|531876825|FG003|Overall Study|Reasons Other Than Above|692|||
147470156|NCT00097539|531876826|FG004|Overall Study|Reasons Other Than Above|361|||
147470157|NCT00097539|531876827|FG005|Overall Study|Reasons Other Than Above|1244|||
147470158|NCT00097539|531876828|FG006|Overall Study|Reasons Other Than Above|34|||
147470159|NCT00097539|531876822|FG000|Overall Study|Reason not Specified|111|||
147470160|NCT00097539|531876823|FG001|Overall Study|Reason not Specified|49|||
147470161|NCT00097539|531876824|FG002|Overall Study|Reason not Specified|53|||
147470162|NCT00097539|531876825|FG003|Overall Study|Reason not Specified|21|||
147470163|NCT00097539|531876826|FG004|Overall Study|Reason not Specified|11|||
147470164|NCT00097539|531876827|FG005|Overall Study|Reason not Specified|40|||
147470165|NCT00097539|531876828|FG006|Overall Study|Reason not Specified|2|||
147470166|NCT05127486|531876829|FG000|Overall Study|Adverse Event|2|||
147470167|NCT05127486|531876830|FG001|Overall Study|Adverse Event|4|||
147470168|NCT05127486|531876829|FG000|Overall Study|Lack of Efficacy|1|||
147470169|NCT05127486|531876830|FG001|Overall Study|Lack of Efficacy|0|||
147470170|NCT05127486|531876829|FG000|Overall Study|Pregnancy|0|||
147470171|NCT05127486|531876830|FG001|Overall Study|Pregnancy|1|||
147470172|NCT05127486|531876829|FG000|Overall Study|Physician Decision|4|||
147470173|NCT05127486|531876830|FG001|Overall Study|Physician Decision|1|||
147619980|NCT01490086|532427196|FG003|Overall Study|Non-compliance|0|||
147619981|NCT01490086|532427197|FG004|Overall Study|Non-compliance|0|||
147619982|NCT01490086|532427193|FG000|Overall Study|Abnormal laboratory findings|1|||
147470174|NCT05127486|531876829|FG000|Overall Study|Withdrawal by Subject|14|||
147470175|NCT05127486|531876830|FG001|Overall Study|Withdrawal by Subject|13|||
147470176|NCT05127486|531876829|FG000|Overall Study|Lost to Follow-up|5|||
147470177|NCT05127486|531876830|FG001|Overall Study|Lost to Follow-up|8|||
147470178|NCT02582515|531876831|FG000|Overall Study|Withdrawal by Subject|0|||
147470179|NCT02582515|531876832|FG001|Overall Study|Withdrawal by Subject|1|||
147470180|NCT05027802|531876833|FG000|Overall Study|Adverse Event|2|||
147470181|NCT05027802|531876833|FG000|Overall Study|Withdrawal by Subject|18|||
147470182|NCT05027802|531876833|FG000|Overall Study|Death|2|||
147470183|NCT05027802|531876833|FG000|Overall Study|Other|1|||
147470184|NCT01725165|531876846|FG000|Overall Study|Death|11|||
147470185|NCT01725165|531876847|FG001|Overall Study|Death|18|||
147470186|NCT05590377|531876848|FG000|Overall Study|Death|1|||
147470187|NCT05590377|531876849|FG001|Overall Study|Death|1|||
147470188|NCT05590377|531876850|FG002|Overall Study|Death|2|||
147470189|NCT05590377|531876851|FG003|Overall Study|Death|0|||
147470190|NCT05590377|531876852|FG004|Overall Study|Death|0|||
147470191|NCT05590377|531876848|FG000|Overall Study|Study Terminated by Sponsor|1|||
147470192|NCT05590377|531876849|FG001|Overall Study|Study Terminated by Sponsor|5|||
147470193|NCT05590377|531876850|FG002|Overall Study|Study Terminated by Sponsor|4|||
147470194|NCT05590377|531876851|FG003|Overall Study|Study Terminated by Sponsor|0|||
147470195|NCT05590377|531876852|FG004|Overall Study|Study Terminated by Sponsor|0|||
147470196|NCT05590377|531876848|FG000|Overall Study|Withdrawal by Subject|1|||
147470197|NCT05590377|531876849|FG001|Overall Study|Withdrawal by Subject|0|||
147470198|NCT05590377|531876850|FG002|Overall Study|Withdrawal by Subject|0|||
147470199|NCT05590377|531876851|FG003|Overall Study|Withdrawal by Subject|0|||
147470200|NCT05590377|531876852|FG004|Overall Study|Withdrawal by Subject|0|||
147470201|NCT02688647|531876853|FG000|Initial Treatment Period (24 Weeks)|Death|0|||
147470202|NCT02688647|531876854|FG001|Initial Treatment Period (24 Weeks)|Death|1|||
147470203|NCT02688647|531876853|FG000|Initial Treatment Period (24 Weeks)|Cross-overed before Initial Treatment Period (24 Weeks)|0|||
147470204|NCT02688647|531876854|FG001|Initial Treatment Period (24 Weeks)|Cross-overed before Initial Treatment Period (24 Weeks)|5|||
147470205|NCT02688647|531876853|FG000|Initial Treatment Period (24 Weeks)|Subject was randomized but did not receive treatment|1|||
147470206|NCT02688647|531876854|FG001|Initial Treatment Period (24 Weeks)|Subject was randomized but did not receive treatment|0|||
147470207|NCT02688647|531876853|FG000|Post Switch Treatment Period (72 Weeks)|Death|7|||
147470208|NCT02688647|531876854|FG001|Post Switch Treatment Period (72 Weeks)|Death|2|||
147470209|NCT02688647|531876853|FG000|Post Switch Treatment Period (72 Weeks)|Lost to Follow-up|1|||
147470210|NCT02688647|531876854|FG001|Post Switch Treatment Period (72 Weeks)|Lost to Follow-up|0|||
147470211|NCT02688647|531876853|FG000|Post Switch Treatment Period (72 Weeks)|Other|10|||
147470212|NCT02688647|531876854|FG001|Post Switch Treatment Period (72 Weeks)|Other|6|||
147470213|NCT02688647|531876853|FG000|Post Switch Treatment Period (72 Weeks)|Withdrawal by Subject|10|||
147470214|NCT02688647|531876854|FG001|Post Switch Treatment Period (72 Weeks)|Withdrawal by Subject|6|||
147470215|NCT03619213|531876855|FG000|Overall Study|Lost to Follow-up|2|||
147470216|NCT03619213|531876856|FG001|Overall Study|Lost to Follow-up|1|||
147470217|NCT03619213|531876855|FG000|Overall Study|Withdrawal by Subject|8|||
147470218|NCT03619213|531876856|FG001|Overall Study|Withdrawal by Subject|10|||
147470219|NCT00382967|531876857|FG000|Overall Study|Protocol Violation|1|||
147470220|NCT00382967|531876858|FG001|Overall Study|Protocol Violation|1|||
147470221|NCT02886702|531876859|FG000|Overall Study|Other|4|||
147470222|NCT02886702|531876860|FG001|Overall Study|Other|3|||
147470223|NCT02886702|531876861|FG002|Overall Study|Other|9|||
147470224|NCT02886702|531876859|FG000|Overall Study|Withdrawal by Subject|24|||
147470225|NCT02886702|531876860|FG001|Overall Study|Withdrawal by Subject|18|||
147470226|NCT02886702|531876861|FG002|Overall Study|Withdrawal by Subject|22|||
147470227|NCT02886702|531876859|FG000|Overall Study|Significant Worsening of Condition|0|||
147470228|NCT02886702|531876860|FG001|Overall Study|Significant Worsening of Condition|1|||
147470229|NCT02886702|531876861|FG002|Overall Study|Significant Worsening of Condition|0|||
147470230|NCT02886702|531876859|FG000|Overall Study|Protocol Violation|2|||
147470231|NCT02886702|531876860|FG001|Overall Study|Protocol Violation|2|||
147470232|NCT02886702|531876861|FG002|Overall Study|Protocol Violation|1|||
147470233|NCT02886702|531876859|FG000|Overall Study|Non-Compliance With Study Drug|0|||
147470234|NCT02886702|531876860|FG001|Overall Study|Non-Compliance With Study Drug|1|||
147470235|NCT02886702|531876861|FG002|Overall Study|Non-Compliance With Study Drug|4|||
147470236|NCT02886702|531876859|FG000|Overall Study|Lost to Follow-up|11|||
147470237|NCT02886702|531876860|FG001|Overall Study|Lost to Follow-up|13|||
147470238|NCT02886702|531876861|FG002|Overall Study|Lost to Follow-up|8|||
147470239|NCT02886702|531876859|FG000|Overall Study|Lack of Efficacy|3|||
147470240|NCT02886702|531876860|FG001|Overall Study|Lack of Efficacy|4|||
147470241|NCT02886702|531876861|FG002|Overall Study|Lack of Efficacy|5|||
147470242|NCT02886702|531876859|FG000|Overall Study|Adverse Event|4|||
147470243|NCT02886702|531876860|FG001|Overall Study|Adverse Event|9|||
147470244|NCT02886702|531876861|FG002|Overall Study|Adverse Event|3|||
147412423|NCT04608773|531673007|FG000|First Intervention (2 Weeks)|mild adverse effects|1|||
147412424|NCT04608773|531673008|FG001|First Intervention (2 Weeks)|mild adverse effects|3|||
147412425|NCT04608773|531673007|FG000|Second Intervention (2 Week)|Lost to Follow-up|2|||
147412426|NCT04608773|531673008|FG001|Second Intervention (2 Week)|Lost to Follow-up|4|||
147412427|NCT04608773|531673007|FG000|Second Intervention (2 Week)|mild adverse effect|0|||
147412428|NCT04608773|531673008|FG001|Second Intervention (2 Week)|mild adverse effect|1|||
147412429|NCT00972322|531673011|FG000|Overall Study|Adverse Event|2|||
147412430|NCT00972322|531673012|FG001|Overall Study|Adverse Event|1|||
147412431|NCT00972322|531673011|FG000|Overall Study|Positive drug screen|0|||
147412432|NCT00972322|531673012|FG001|Overall Study|Positive drug screen|1|||
147412433|NCT00972322|531673011|FG000|Overall Study|Lost to Follow-up|0|||
147470245|NCT02886702|531876859|FG000|Overall Study|Administrative Reasons|0|||
147412434|NCT00972322|531673012|FG001|Overall Study|Lost to Follow-up|1|||
147470246|NCT02886702|531876860|FG001|Overall Study|Administrative Reasons|0|||
147470247|NCT02886702|531876861|FG002|Overall Study|Administrative Reasons|1|||
147470248|NCT01147497|531876867|FG000|Overall Study|failed insertion|2|||
147470249|NCT01147497|531876868|FG001|Overall Study|failed insertion|0|||
147470250|NCT04026568|531876871|FG000|Overall Study|study terminated|0|||
147470251|NCT04026568|531876872|FG001|Overall Study|study terminated|1|||
147470252|NCT00331760|531876873|FG000|Overall Study|Ineligible / no protocol treatment|15|||
147470253|NCT00331760|531876874|FG001|Overall Study|Ineligible / no protocol treatment|8|||
147470254|NCT03417440|531876876|FG000|Overall Study|Lost to Follow-up|0|||
147470255|NCT03417440|531876877|FG001|Overall Study|Lost to Follow-up|1|||
147470256|NCT03417440|531876878|FG002|Overall Study|Lost to Follow-up|0|||
147470257|NCT03417440|531876879|FG003|Overall Study|Lost to Follow-up|0|||
147470258|NCT03417440|531876880|FG004|Overall Study|Lost to Follow-up|1|||
147470259|NCT03417440|531876881|FG005|Overall Study|Lost to Follow-up|0|||
147470260|NCT03417440|531876882|FG006|Overall Study|Lost to Follow-up|0|||
147470261|NCT03417440|531876883|FG007|Overall Study|Lost to Follow-up|0|||
147470262|NCT03417440|531876876|FG000|Overall Study|Withdrawal by Subject|2|||
147470263|NCT03417440|531876877|FG001|Overall Study|Withdrawal by Subject|0|||
147470264|NCT03417440|531876878|FG002|Overall Study|Withdrawal by Subject|2|||
147470265|NCT03417440|531876879|FG003|Overall Study|Withdrawal by Subject|1|||
147470266|NCT03417440|531876880|FG004|Overall Study|Withdrawal by Subject|1|||
147470267|NCT03417440|531876881|FG005|Overall Study|Withdrawal by Subject|0|||
147470268|NCT03417440|531876882|FG006|Overall Study|Withdrawal by Subject|0|||
147470269|NCT03417440|531876883|FG007|Overall Study|Withdrawal by Subject|1|||
147470270|NCT03663166|531876887|FG000|Overall Study|Withdrawal by Subject|1|||
147470271|NCT02561156|531876893|FG000|Part 2|Adverse Event|0|||
147470272|NCT02561156|531876894|FG001|Part 2|Adverse Event|0|||
147470273|NCT02561156|531876895|FG002|Part 2|Adverse Event|0|||
147470274|NCT02561156|531876896|FG003|Part 2|Adverse Event|0|||
147470275|NCT02561156|531876897|FG004|Part 2|Adverse Event|0|||
147470276|NCT02561156|531876898|FG005|Part 2|Adverse Event|0|||
147470277|NCT02561156|531876899|FG006|Part 2|Adverse Event|0|||
147470278|NCT02561156|531876900|FG007|Part 2|Adverse Event|0|||
147470279|NCT02561156|531876901|FG008|Part 2|Adverse Event|0|||
147470280|NCT02561156|531876902|FG009|Part 2|Adverse Event|0|||
147470281|NCT02561156|531876903|FG010|Part 2|Adverse Event|0|||
147470282|NCT02561156|531876904|FG011|Part 2|Adverse Event|1|||
147470283|NCT02561156|531876905|FG012|Part 2|Adverse Event|0|||
147470284|NCT01071070|531876907|FG000|Overall Study|Adverse Event|0|||
147470285|NCT01071070|531876908|FG001|Overall Study|Adverse Event|3|||
147470286|NCT01071070|531876907|FG000|Overall Study|Withdrawal by Subject|1|||
147470287|NCT01071070|531876908|FG001|Overall Study|Withdrawal by Subject|0|||
147470288|NCT01071070|531876907|FG000|Overall Study|Missed 3 consecutive doses of study drug|2|||
147470289|NCT01071070|531876908|FG001|Overall Study|Missed 3 consecutive doses of study drug|0|||
147470290|NCT01071070|531876907|FG000|Overall Study|Hypercalcemia|1|||
147470291|NCT01071070|531876908|FG001|Overall Study|Hypercalcemia|0|||
147470292|NCT00158184|531876909|FG000|Overall Study|personal issues|3|||
147470293|NCT00158184|531876910|FG001|Overall Study|personal issues|1|||
147470294|NCT00158184|531876909|FG000|Overall Study|failed for follow unit/study rules|2|||
147470295|NCT00158184|531876910|FG001|Overall Study|failed for follow unit/study rules|0|||
147470296|NCT00158184|531876909|FG000|Overall Study|Adverse Event|1|||
147470297|NCT00158184|531876910|FG001|Overall Study|Adverse Event|1|||
147470298|NCT02620020|531876919|FG000|Overall Study|Adverse Event|8|||
147470299|NCT02620020|531876920|FG001|Overall Study|Adverse Event|4|||
147470300|NCT02620020|531876921|FG002|Overall Study|Adverse Event|3|||
147470301|NCT02620020|531876922|FG003|Overall Study|Adverse Event|5|||
147470302|NCT02620020|531876919|FG000|Overall Study|Lost to Follow-up|4|||
147470303|NCT02620020|531876920|FG001|Overall Study|Lost to Follow-up|8|||
147470304|NCT02620020|531876921|FG002|Overall Study|Lost to Follow-up|1|||
147470305|NCT02620020|531876922|FG003|Overall Study|Lost to Follow-up|4|||
147470306|NCT02620020|531876919|FG000|Overall Study|Physician Decision|7|||
147470307|NCT02620020|531876920|FG001|Overall Study|Physician Decision|4|||
147470308|NCT02620020|531876921|FG002|Overall Study|Physician Decision|3|||
147470309|NCT02620020|531876922|FG003|Overall Study|Physician Decision|4|||
147470310|NCT02620020|531876919|FG000|Overall Study|Protocol Violation|5|||
147470311|NCT02620020|531876920|FG001|Overall Study|Protocol Violation|2|||
147470312|NCT02620020|531876921|FG002|Overall Study|Protocol Violation|1|||
147470313|NCT02620020|531876922|FG003|Overall Study|Protocol Violation|1|||
147470314|NCT02620020|531876919|FG000|Overall Study|Withdrawal by Subject|20|||
147470315|NCT02620020|531876920|FG001|Overall Study|Withdrawal by Subject|16|||
147470316|NCT02620020|531876921|FG002|Overall Study|Withdrawal by Subject|17|||
147470317|NCT02620020|531876922|FG003|Overall Study|Withdrawal by Subject|12|||
147470318|NCT02620020|531876919|FG000|Overall Study|Death|0|||
147470319|NCT02620020|531876920|FG001|Overall Study|Death|1|||
147470320|NCT02620020|531876921|FG002|Overall Study|Death|0|||
147470321|NCT02620020|531876922|FG003|Overall Study|Death|0|||
147470322|NCT03168867|531876925|FG000|Overall Study|Withdrawal by Subject|1|||
147470323|NCT03168867|531876926|FG001|Overall Study|Withdrawal by Subject|5|||
147470324|NCT04348851|531876927|FG000|Post-Test 1|Withdrawal by Subject|0|||
147470325|NCT04348851|531876928|FG001|Post-Test 1|Withdrawal by Subject|1|||
147470326|NCT04348851|531876929|FG002|Post-Test 1|Withdrawal by Subject|0|||
147470327|NCT04348851|531876930|FG003|Post-Test 1|Withdrawal by Subject|0|||
147470328|NCT04348851|531876927|FG000|Post-Test 1|Lost to Follow-up|0|||
147470329|NCT04348851|531876928|FG001|Post-Test 1|Lost to Follow-up|1|||
147470330|NCT04348851|531876929|FG002|Post-Test 1|Lost to Follow-up|0|||
147470331|NCT04348851|531876930|FG003|Post-Test 1|Lost to Follow-up|0|||
147470332|NCT04348851|531876927|FG000|Post-Test 2|Stroke survivor death|0|||
147470333|NCT04348851|531876928|FG001|Post-Test 2|Stroke survivor death|1|||
147470334|NCT04348851|531876929|FG002|Post-Test 2|Stroke survivor death|0|||
147470335|NCT04348851|531876930|FG003|Post-Test 2|Stroke survivor death|1|||
147470336|NCT00195650|531876931|FG000|Overall Study|Adverse Event|194|||
147470337|NCT00195650|531876931|FG000|Overall Study|Lack of Efficacy|99|||
147470338|NCT00195650|531876931|FG000|Overall Study|Withdrawal by Subject|67|||
147470339|NCT00195650|531876931|FG000|Overall Study|Lost to Follow-up|44|||
147470340|NCT00195650|531876931|FG000|Overall Study|Death|23|||
147470341|NCT00195650|531876931|FG000|Overall Study|Protocol Violation|15|||
147470342|NCT00195650|531876931|FG000|Overall Study|Administrative reasons|83|||
147470343|NCT01478958|531876932|FG000|Overall Study|Withdrawal by Subject|1|||
147470344|NCT01478958|531876933|FG001|Overall Study|Withdrawal by Subject|1|||
147470345|NCT01478958|531876934|FG002|Overall Study|Withdrawal by Subject|1|||
147470346|NCT01478958|531876932|FG000|Overall Study|Weight loss|1|||
147470347|NCT01478958|531876933|FG001|Overall Study|Weight loss|0|||
147470348|NCT01478958|531876934|FG002|Overall Study|Weight loss|0|||
147470349|NCT01478958|531876932|FG000|Overall Study|Re-located|0|||
147470350|NCT01478958|531876933|FG001|Overall Study|Re-located|1|||
147470351|NCT01478958|531876934|FG002|Overall Study|Re-located|0|||
147470352|NCT01478958|531876932|FG000|Overall Study|Unable to comply|0|||
147470353|NCT01478958|531876933|FG001|Overall Study|Unable to comply|0|||
147470354|NCT01478958|531876934|FG002|Overall Study|Unable to comply|2|||
147470355|NCT00642642|531876935|FG000|Treatment & Follow Up|Adverse Event|2|||
147470356|NCT00642642|531876935|FG000|Treatment & Follow Up|Withdrawal by Subject|5|||
147470357|NCT00642642|531876935|FG000|Treatment & Follow Up|Lost to Follow-up|10|||
147470358|NCT04640766|531876936|FG000|Overall Study|Withdrawn for inconsistency with visits and change in current medication|2|||
147470359|NCT02654002|531876939|FG000|Overall Study|Adverse Event|0|||
147470360|NCT02654002|531876940|FG001|Overall Study|Adverse Event|0|||
147470361|NCT02654002|531876941|FG002|Overall Study|Adverse Event|0|||
147470362|NCT02654002|531876942|FG003|Overall Study|Adverse Event|0|||
147470363|NCT02654002|531876943|FG004|Overall Study|Adverse Event|0|||
147470364|NCT02654002|531876944|FG005|Overall Study|Adverse Event|0|||
147470365|NCT02654002|531876945|FG006|Overall Study|Adverse Event|1|||
147470366|NCT02654002|531876946|FG007|Overall Study|Adverse Event|0|||
147470367|NCT02654002|531876947|FG008|Overall Study|Adverse Event|0|||
147470368|NCT02654002|531876939|FG000|Overall Study|Withdrew Consent|0|||
147470369|NCT02654002|531876940|FG001|Overall Study|Withdrew Consent|0|||
147470370|NCT02654002|531876941|FG002|Overall Study|Withdrew Consent|0|||
147470371|NCT02654002|531876942|FG003|Overall Study|Withdrew Consent|0|||
147470372|NCT02654002|531876943|FG004|Overall Study|Withdrew Consent|0|||
147470373|NCT02654002|531876944|FG005|Overall Study|Withdrew Consent|1|||
147470374|NCT02654002|531876945|FG006|Overall Study|Withdrew Consent|0|||
147470375|NCT02654002|531876946|FG007|Overall Study|Withdrew Consent|1|||
147470376|NCT02654002|531876947|FG008|Overall Study|Withdrew Consent|0|||
147470377|NCT06119191|531876948|FG000|Overall Study|Adverse Event|0|||
147470378|NCT06119191|531876949|FG001|Overall Study|Adverse Event|1|||
147470379|NCT06119191|531876948|FG000|Overall Study|Protocol Violation|1|||
147470380|NCT06119191|531876949|FG001|Overall Study|Protocol Violation|0|||
147470381|NCT02109029|531879667|FG000|Part B|Adverse Event|0|||
147470382|NCT02109029|531879668|FG001|Part B|Adverse Event|0|||
147470383|NCT02109029|531879669|FG002|Part B|Adverse Event|0|||
147470384|NCT02109029|531879670|FG003|Part B|Adverse Event|0|||
147619983|NCT01490086|532427194|FG001|Overall Study|Abnormal laboratory findings|0|||
147619984|NCT01490086|532427195|FG002|Overall Study|Abnormal laboratory findings|0|||
147619985|NCT01490086|532427196|FG003|Overall Study|Abnormal laboratory findings|0|||
147470385|NCT02109029|531879671|FG004|Part B|Adverse Event|1|||
147470386|NCT02109029|531879672|FG005|Part B|Adverse Event|1|||
147470387|NCT01056107|531879673|FG000|Overall Study|Withdrawal by Subject|0|||
147470388|NCT01056107|531879674|FG001|Overall Study|Withdrawal by Subject|1|||
147470389|NCT01056107|531879675|FG002|Overall Study|Withdrawal by Subject|3|||
147470390|NCT01056107|531879676|FG003|Overall Study|Withdrawal by Subject|0|||
147470391|NCT00260208|531879682|FG000|Overall Study|Subject withdrew consent|11|||
147470392|NCT00260208|531879683|FG001|Overall Study|Subject withdrew consent|7|||
147470393|NCT00260208|531879682|FG000|Overall Study|Lost to Follow-up|6|||
147470394|NCT00260208|531879683|FG001|Overall Study|Lost to Follow-up|1|||
147470395|NCT00260208|531879682|FG000|Overall Study|Death|12|||
147470396|NCT00260208|531879683|FG001|Overall Study|Death|10|||
147470397|NCT00260208|531879682|FG000|Overall Study|Missing|18|||
147470398|NCT00260208|531879683|FG001|Overall Study|Missing|16|||
147470399|NCT02091440|531879684|FG000|Overall Study|Death|2|||
147470400|NCT00768222|531879685|FG000|Overall Study|Lost to Follow-up|1|||
147470401|NCT00768222|531879686|FG001|Overall Study|Lost to Follow-up|1|||
147470402|NCT00768222|531879685|FG000|Overall Study|Withdrawal by Subject|3|||
147470403|NCT00768222|531879686|FG001|Overall Study|Withdrawal by Subject|1|||
147470404|NCT00768222|531879685|FG000|Overall Study|Protocol Violation|0|||
147470405|NCT00768222|531879686|FG001|Overall Study|Protocol Violation|2|||
147470406|NCT03539432|531879687|FG000|Overall Study|Lost to Follow-up|0|||
147470407|NCT03539432|531879688|FG001|Overall Study|Lost to Follow-up|1|||
147470408|NCT01381094|531879689|FG000|Overall Study|Adverse Event|1|||
147470409|NCT01381094|531879690|FG001|Overall Study|Adverse Event|2|||
147470410|NCT01381094|531879691|FG002|Overall Study|Adverse Event|0|||
147470411|NCT01381094|531879692|FG003|Overall Study|Adverse Event|1|||
147470412|NCT01381094|531879693|FG004|Overall Study|Adverse Event|0|||
147470413|NCT01381094|531879689|FG000|Overall Study|Lost to Follow-up|0|||
147470414|NCT01381094|531879690|FG001|Overall Study|Lost to Follow-up|0|||
147470415|NCT01381094|531879691|FG002|Overall Study|Lost to Follow-up|0|||
147470416|NCT01381094|531879692|FG003|Overall Study|Lost to Follow-up|0|||
147470417|NCT01381094|531879693|FG004|Overall Study|Lost to Follow-up|1|||
147470418|NCT01381094|531879689|FG000|Overall Study|Withdrawal of informed consent|0|||
147470419|NCT01381094|531879690|FG001|Overall Study|Withdrawal of informed consent|1|||
147470420|NCT01381094|531879691|FG002|Overall Study|Withdrawal of informed consent|0|||
147470421|NCT01381094|531879692|FG003|Overall Study|Withdrawal of informed consent|0|||
147470422|NCT01381094|531879693|FG004|Overall Study|Withdrawal of informed consent|0|||
147470423|NCT01381094|531879689|FG000|Overall Study|Participant given Aranesp injection|1|||
147470424|NCT01381094|531879690|FG001|Overall Study|Participant given Aranesp injection|0|||
147470425|NCT01381094|531879691|FG002|Overall Study|Participant given Aranesp injection|0|||
147470426|NCT01381094|531879692|FG003|Overall Study|Participant given Aranesp injection|0|||
147470427|NCT01381094|531879693|FG004|Overall Study|Participant given Aranesp injection|0|||
147470428|NCT04178590|531879706|FG000|Overall Study|Pregnancy|1|||
147470429|NCT04178590|531879706|FG000|Overall Study|Lost to Follow-up|1|||
147470430|NCT00775021|531879707|FG000|First Intervention|Lost to Follow-up|1|||
147470431|NCT00775021|531879708|FG001|First Intervention|Lost to Follow-up|0|||
147470432|NCT00775021|531879707|FG000|Second Intervention|Adverse Event|0|||
147470433|NCT00775021|531879708|FG001|Second Intervention|Adverse Event|1|||
147470434|NCT00363415|531879709|FG000|Overall Study|Progressive Disease|196|||
147470435|NCT00363415|531879710|FG001|Overall Study|Progressive Disease|107|||
147470436|NCT00363415|531879709|FG000|Overall Study|Sponsor Decision|67|||
147470437|NCT00363415|531879710|FG001|Overall Study|Sponsor Decision|31|||
147470438|NCT00363415|531879709|FG000|Overall Study|Death|32|||
147470439|NCT00363415|531879710|FG001|Overall Study|Death|29|||
147470440|NCT00363415|531879709|FG000|Overall Study|Adverse Event|24|||
147470441|NCT00363415|531879710|FG001|Overall Study|Adverse Event|15|||
147470442|NCT00363415|531879709|FG000|Overall Study|Physician Decision|18|||
147470443|NCT00363415|531879710|FG001|Overall Study|Physician Decision|35|||
147470444|NCT00363415|531879709|FG000|Overall Study|Entry Criteria Not Met|11|||
147470445|NCT00363415|531879710|FG001|Overall Study|Entry Criteria Not Met|10|||
147470446|NCT00363415|531879709|FG000|Overall Study|Withdrawal by Subject|9|||
147470447|NCT00363415|531879710|FG001|Overall Study|Withdrawal by Subject|15|||
147470448|NCT00363415|531879709|FG000|Overall Study|Lost to Follow-up|3|||
147470449|NCT00363415|531879710|FG001|Overall Study|Lost to Follow-up|3|||
147470450|NCT00363415|531879709|FG000|Overall Study|Protocol Violation|1|||
147470451|NCT00363415|531879710|FG001|Overall Study|Protocol Violation|4|||
147470452|NCT01506141|531879713|FG000|Overall Study|Adverse Event|0|||
147470453|NCT01506141|531879714|FG001|Overall Study|Adverse Event|2|||
147470454|NCT01506141|531879713|FG000|Overall Study|Participation Terminated by Investigator|1|||
147470455|NCT01506141|531879714|FG001|Overall Study|Participation Terminated by Investigator|1|||
147470456|NCT01506141|531879713|FG000|Overall Study|Site Terminated by Sponsor|2|||
147470457|NCT01506141|531879714|FG001|Overall Study|Site Terminated by Sponsor|0|||
147470458|NCT01506141|531879713|FG000|Overall Study|Reason Not Specified|4|||
147470459|NCT01506141|531879714|FG001|Overall Study|Reason Not Specified|2|||
147470460|NCT04889209|531879715|FG000|All Cohorts Except 15E|Adverse Event|0|||
147470461|NCT04889209|531879716|FG001|All Cohorts Except 15E|Adverse Event|0|||
147619986|NCT01490086|532427197|FG004|Overall Study|Abnormal laboratory findings|0|||
147470462|NCT04889209|531879717|FG002|All Cohorts Except 15E|Adverse Event|0|||
147470463|NCT04889209|531879718|FG003|All Cohorts Except 15E|Adverse Event|0|||
147470464|NCT04889209|531879719|FG004|All Cohorts Except 15E|Adverse Event|0|||
147470465|NCT04889209|531879720|FG005|All Cohorts Except 15E|Adverse Event|0|||
147470466|NCT04889209|531879721|FG006|All Cohorts Except 15E|Adverse Event|1|||
147470467|NCT04889209|531879722|FG007|All Cohorts Except 15E|Adverse Event|0|||
147470468|NCT04889209|531879723|FG008|All Cohorts Except 15E|Adverse Event|0|||
147619987|NCT01490086|532427193|FG000|Overall Study|Lost to Follow-up|0|||
147619988|NCT01490086|532427194|FG001|Overall Study|Lost to Follow-up|0|||
147619989|NCT01490086|532427195|FG002|Overall Study|Lost to Follow-up|0|||
147470469|NCT04889209|531879724|FG009|All Cohorts Except 15E|Adverse Event|0|||
147470470|NCT04889209|531879725|FG010|All Cohorts Except 15E|Adverse Event|0|||
147470471|NCT04889209|531879726|FG011|All Cohorts Except 15E|Adverse Event|0|||
147470472|NCT04889209|531879727|FG012|All Cohorts Except 15E|Adverse Event|0|||
147470473|NCT04889209|531879728|FG013|All Cohorts Except 15E|Adverse Event|0|||
147470474|NCT04889209|531879729|FG014|All Cohorts Except 15E|Adverse Event|0|||
147470475|NCT04889209|531879730|FG015|All Cohorts Except 15E|Adverse Event|0|||
147470476|NCT04889209|531879731|FG016|All Cohorts Except 15E|Adverse Event|0|||
147470477|NCT04889209|531879732|FG017|All Cohorts Except 15E|Adverse Event|0|||
147470478|NCT04889209|531879715|FG000|All Cohorts Except 15E|Death|0|||
147470479|NCT04889209|531879716|FG001|All Cohorts Except 15E|Death|1|||
147470480|NCT04889209|531879717|FG002|All Cohorts Except 15E|Death|0|||
147470481|NCT04889209|531879718|FG003|All Cohorts Except 15E|Death|0|||
147470482|NCT04889209|531879719|FG004|All Cohorts Except 15E|Death|0|||
147470483|NCT04889209|531879720|FG005|All Cohorts Except 15E|Death|0|||
147470484|NCT04889209|531879721|FG006|All Cohorts Except 15E|Death|0|||
147470485|NCT04889209|531879722|FG007|All Cohorts Except 15E|Death|0|||
147470486|NCT04889209|531879723|FG008|All Cohorts Except 15E|Death|0|||
147470487|NCT04889209|531879724|FG009|All Cohorts Except 15E|Death|0|||
147470488|NCT04889209|531879725|FG010|All Cohorts Except 15E|Death|0|||
147470489|NCT04889209|531879726|FG011|All Cohorts Except 15E|Death|0|||
147470490|NCT04889209|531879727|FG012|All Cohorts Except 15E|Death|0|||
147470491|NCT04889209|531879728|FG013|All Cohorts Except 15E|Death|0|||
147470492|NCT04889209|531879729|FG014|All Cohorts Except 15E|Death|0|||
147470493|NCT04889209|531879730|FG015|All Cohorts Except 15E|Death|0|||
147470494|NCT04889209|531879731|FG016|All Cohorts Except 15E|Death|0|||
147470495|NCT04889209|531879732|FG017|All Cohorts Except 15E|Death|0|||
147470496|NCT04889209|531879715|FG000|All Cohorts Except 15E|Lost to Follow-up|0|||
147470497|NCT04889209|531879716|FG001|All Cohorts Except 15E|Lost to Follow-up|0|||
147470498|NCT04889209|531879717|FG002|All Cohorts Except 15E|Lost to Follow-up|1|||
147470499|NCT04889209|531879718|FG003|All Cohorts Except 15E|Lost to Follow-up|2|||
147470500|NCT04889209|531879719|FG004|All Cohorts Except 15E|Lost to Follow-up|4|||
147470501|NCT04889209|531879720|FG005|All Cohorts Except 15E|Lost to Follow-up|1|||
147470502|NCT04889209|531879721|FG006|All Cohorts Except 15E|Lost to Follow-up|0|||
147470503|NCT04889209|531879722|FG007|All Cohorts Except 15E|Lost to Follow-up|1|||
147470504|NCT04889209|531879723|FG008|All Cohorts Except 15E|Lost to Follow-up|2|||
147470505|NCT04889209|531879724|FG009|All Cohorts Except 15E|Lost to Follow-up|2|||
147470506|NCT04889209|531879725|FG010|All Cohorts Except 15E|Lost to Follow-up|2|||
147470507|NCT04889209|531879726|FG011|All Cohorts Except 15E|Lost to Follow-up|4|||
147470508|NCT04889209|531879727|FG012|All Cohorts Except 15E|Lost to Follow-up|2|||
147470509|NCT04889209|531879728|FG013|All Cohorts Except 15E|Lost to Follow-up|2|||
147470510|NCT04889209|531879729|FG014|All Cohorts Except 15E|Lost to Follow-up|0|||
147470511|NCT04889209|531879730|FG015|All Cohorts Except 15E|Lost to Follow-up|5|||
147470512|NCT04889209|531879731|FG016|All Cohorts Except 15E|Lost to Follow-up|5|||
147470513|NCT04889209|531879732|FG017|All Cohorts Except 15E|Lost to Follow-up|28|||
147470514|NCT04889209|531879715|FG000|All Cohorts Except 15E|Physician Decision|0|||
147470515|NCT04889209|531879716|FG001|All Cohorts Except 15E|Physician Decision|0|||
147470516|NCT04889209|531879717|FG002|All Cohorts Except 15E|Physician Decision|0|||
147470517|NCT04889209|531879718|FG003|All Cohorts Except 15E|Physician Decision|0|||
147470518|NCT04889209|531879719|FG004|All Cohorts Except 15E|Physician Decision|1|||
147470519|NCT04889209|531879720|FG005|All Cohorts Except 15E|Physician Decision|0|||
147470520|NCT04889209|531879721|FG006|All Cohorts Except 15E|Physician Decision|0|||
147470521|NCT04889209|531879722|FG007|All Cohorts Except 15E|Physician Decision|1|||
147470522|NCT04889209|531879723|FG008|All Cohorts Except 15E|Physician Decision|0|||
147470523|NCT04889209|531879724|FG009|All Cohorts Except 15E|Physician Decision|1|||
147470524|NCT04889209|531879725|FG010|All Cohorts Except 15E|Physician Decision|0|||
147470525|NCT04889209|531879726|FG011|All Cohorts Except 15E|Physician Decision|1|||
147470526|NCT04889209|531879727|FG012|All Cohorts Except 15E|Physician Decision|1|||
147470527|NCT04889209|531879728|FG013|All Cohorts Except 15E|Physician Decision|0|||
147470528|NCT04889209|531879729|FG014|All Cohorts Except 15E|Physician Decision|0|||
147470529|NCT04889209|531879730|FG015|All Cohorts Except 15E|Physician Decision|0|||
147470530|NCT04889209|531879731|FG016|All Cohorts Except 15E|Physician Decision|0|||
147470531|NCT04889209|531879732|FG017|All Cohorts Except 15E|Physician Decision|0|||
147470532|NCT04889209|531879715|FG000|All Cohorts Except 15E|Withdrawal by Subject|1|||
147470533|NCT04889209|531879716|FG001|All Cohorts Except 15E|Withdrawal by Subject|1|||
147470534|NCT04889209|531879717|FG002|All Cohorts Except 15E|Withdrawal by Subject|2|||
147470535|NCT04889209|531879718|FG003|All Cohorts Except 15E|Withdrawal by Subject|5|||
147470536|NCT04889209|531879719|FG004|All Cohorts Except 15E|Withdrawal by Subject|2|||
147470537|NCT04889209|531879720|FG005|All Cohorts Except 15E|Withdrawal by Subject|3|||
147470538|NCT04889209|531879721|FG006|All Cohorts Except 15E|Withdrawal by Subject|3|||
147470539|NCT04889209|531879722|FG007|All Cohorts Except 15E|Withdrawal by Subject|1|||
147470540|NCT04889209|531879723|FG008|All Cohorts Except 15E|Withdrawal by Subject|3|||
147470541|NCT04889209|531879724|FG009|All Cohorts Except 15E|Withdrawal by Subject|3|||
147470542|NCT04889209|531879725|FG010|All Cohorts Except 15E|Withdrawal by Subject|3|||
147470543|NCT04889209|531879726|FG011|All Cohorts Except 15E|Withdrawal by Subject|3|||
147470544|NCT04889209|531879727|FG012|All Cohorts Except 15E|Withdrawal by Subject|3|||
147470545|NCT04889209|531879728|FG013|All Cohorts Except 15E|Withdrawal by Subject|0|||
147470546|NCT04889209|531879729|FG014|All Cohorts Except 15E|Withdrawal by Subject|0|||
147470547|NCT04889209|531879730|FG015|All Cohorts Except 15E|Withdrawal by Subject|1|||
147470548|NCT04889209|531879731|FG016|All Cohorts Except 15E|Withdrawal by Subject|3|||
147470549|NCT04889209|531879732|FG017|All Cohorts Except 15E|Withdrawal by Subject|16|||
147470550|NCT04889209|531879715|FG000|All Cohorts Except 15E|Participant relocated, no follow-up planned|2|||
147619990|NCT01490086|532427196|FG003|Overall Study|Lost to Follow-up|0|||
147470551|NCT04889209|531879716|FG001|All Cohorts Except 15E|Participant relocated, no follow-up planned|2|||
147470552|NCT04889209|531879717|FG002|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
147470553|NCT04889209|531879718|FG003|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
147470554|NCT04889209|531879719|FG004|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
147470555|NCT04889209|531879720|FG005|All Cohorts Except 15E|Participant relocated, no follow-up planned|1|||
147470556|NCT04889209|531879721|FG006|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
147470557|NCT04889209|531879722|FG007|All Cohorts Except 15E|Participant relocated, no follow-up planned|1|||
147470558|NCT04889209|531879723|FG008|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
147470559|NCT04889209|531879724|FG009|All Cohorts Except 15E|Participant relocated, no follow-up planned|1|||
147470560|NCT04889209|531879725|FG010|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
147470561|NCT04889209|531879726|FG011|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
147470562|NCT04889209|531879727|FG012|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
147470563|NCT04889209|531879728|FG013|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
147470564|NCT04889209|531879729|FG014|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
147470565|NCT04889209|531879730|FG015|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
147470566|NCT04889209|531879731|FG016|All Cohorts Except 15E|Participant relocated, no follow-up planned|0|||
147470567|NCT04889209|531879732|FG017|All Cohorts Except 15E|Participant relocated, no follow-up planned|1|||
147470568|NCT04889209|531879715|FG000|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
147470569|NCT04889209|531879716|FG001|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
147470570|NCT04889209|531879717|FG002|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
147470571|NCT04889209|531879718|FG003|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|12|||
147470572|NCT04889209|531879719|FG004|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
147470573|NCT04889209|531879720|FG005|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
147470574|NCT04889209|531879721|FG006|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
147470575|NCT04889209|531879722|FG007|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
147470576|NCT04889209|531879723|FG008|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
147470577|NCT04889209|531879724|FG009|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
147470578|NCT04889209|531879725|FG010|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
147470579|NCT04889209|531879726|FG011|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
147470580|NCT04889209|531879727|FG012|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
147470581|NCT04889209|531879728|FG013|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
147470582|NCT04889209|531879729|FG014|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
147470583|NCT04889209|531879730|FG015|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
147470584|NCT04889209|531879731|FG016|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
147470585|NCT04889209|531879732|FG017|All Cohorts Except 15E|Cohort 1 group 4E Participant rolled over into Cohort 1 group 15E|0|||
147470586|NCT04889209|531879715|FG000|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
147470587|NCT04889209|531879716|FG001|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
147470588|NCT04889209|531879717|FG002|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
147470589|NCT04889209|531879718|FG003|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
147470590|NCT04889209|531879719|FG004|All Cohorts Except 15E|Participant unable to adhere to visit schedule|1|||
147470591|NCT04889209|531879720|FG005|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
147470592|NCT04889209|531879721|FG006|All Cohorts Except 15E|Participant unable to adhere to visit schedule|1|||
147470593|NCT04889209|531879722|FG007|All Cohorts Except 15E|Participant unable to adhere to visit schedule|1|||
147470594|NCT04889209|531879723|FG008|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
147470595|NCT04889209|531879724|FG009|All Cohorts Except 15E|Participant unable to adhere to visit schedule|1|||
147470596|NCT04889209|531879725|FG010|All Cohorts Except 15E|Participant unable to adhere to visit schedule|1|||
147470597|NCT04889209|531879726|FG011|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
147470598|NCT04889209|531879727|FG012|All Cohorts Except 15E|Participant unable to adhere to visit schedule|1|||
147470599|NCT04889209|531879728|FG013|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
147470600|NCT04889209|531879729|FG014|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
147470601|NCT04889209|531879730|FG015|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
147470602|NCT04889209|531879731|FG016|All Cohorts Except 15E|Participant unable to adhere to visit schedule|1|||
147470603|NCT04889209|531879732|FG017|All Cohorts Except 15E|Participant unable to adhere to visit schedule|0|||
147470604|NCT04889209|531879715|FG000|All Cohorts Except 15E|Became ineligible after enrollment|0|||
147470605|NCT04889209|531879716|FG001|All Cohorts Except 15E|Became ineligible after enrollment|0|||
147619991|NCT01490086|532427197|FG004|Overall Study|Lost to Follow-up|1|||
147619992|NCT01490086|532427193|FG000|Overall Study|Physician Decision|3|||
147619993|NCT01490086|532427194|FG001|Overall Study|Physician Decision|4|||
147619994|NCT01490086|532427195|FG002|Overall Study|Physician Decision|2|||
147619995|NCT01490086|532427196|FG003|Overall Study|Physician Decision|3|||
147619996|NCT01490086|532427197|FG004|Overall Study|Physician Decision|1|||
147619997|NCT01490086|532427193|FG000|Overall Study|Adverse Event|0|||
147619998|NCT01490086|532427194|FG001|Overall Study|Adverse Event|0|||
147619999|NCT01490086|532427195|FG002|Overall Study|Adverse Event|1|||
147620000|NCT01490086|532427196|FG003|Overall Study|Adverse Event|2|||
147620001|NCT01490086|532427197|FG004|Overall Study|Adverse Event|0|||
147620002|NCT01490086|532427193|FG000|Overall Study|Lack of Efficacy|0|||
147620003|NCT01490086|532427194|FG001|Overall Study|Lack of Efficacy|3|||
147620004|NCT01490086|532427195|FG002|Overall Study|Lack of Efficacy|1|||
147620005|NCT01490086|532427196|FG003|Overall Study|Lack of Efficacy|0|||
147620006|NCT01490086|532427197|FG004|Overall Study|Lack of Efficacy|8|||
147620007|NCT01490086|532427193|FG000|Overall Study|Worsening of symptoms|0|||
147620008|NCT01490086|532427194|FG001|Overall Study|Worsening of symptoms|1|||
147620009|NCT01490086|532427195|FG002|Overall Study|Worsening of symptoms|0|||
147620010|NCT01490086|532427196|FG003|Overall Study|Worsening of symptoms|1|||
147620011|NCT01490086|532427197|FG004|Overall Study|Worsening of symptoms|0|||
147620012|NCT01490086|532427193|FG000|Overall Study|Subject uncontrollable and abusive|0|||
147620013|NCT01490086|532427194|FG001|Overall Study|Subject uncontrollable and abusive|1|||
147620014|NCT01490086|532427195|FG002|Overall Study|Subject uncontrollable and abusive|0|||
147620015|NCT01490086|532427196|FG003|Overall Study|Subject uncontrollable and abusive|0|||
147620016|NCT01490086|532427197|FG004|Overall Study|Subject uncontrollable and abusive|0|||
147620017|NCT01490086|532427193|FG000|Overall Study|Subject left hospital|0|||
147620018|NCT01490086|532427194|FG001|Overall Study|Subject left hospital|1|||
147620019|NCT01490086|532427195|FG002|Overall Study|Subject left hospital|0|||
147620020|NCT01490086|532427196|FG003|Overall Study|Subject left hospital|1|||
147620021|NCT01490086|532427197|FG004|Overall Study|Subject left hospital|0|||
147620022|NCT05825404|532427198|FG000|First Intervention (Weeks 2-5)|Death|0|||
147620023|NCT05825404|532427199|FG001|First Intervention (Weeks 2-5)|Death|1|||
147620024|NCT05825404|532427198|FG000|Second Intervention (Weeks 8-11)|Death|0|||
147620025|NCT05825404|532427199|FG001|Second Intervention (Weeks 8-11)|Death|1|||
147620026|NCT01127256|532427200|FG000|Overall Study|Adverse Event|13|||
147620027|NCT01127256|532427201|FG001|Overall Study|Adverse Event|13|||
147620028|NCT01127256|532427200|FG000|Overall Study|Lack of Efficacy|4|||
147620029|NCT01127256|532427201|FG001|Overall Study|Lack of Efficacy|0|||
147620030|NCT01127256|532427200|FG000|Overall Study|Lost to Follow-up|16|||
147620031|NCT01127256|532427201|FG001|Overall Study|Lost to Follow-up|17|||
147620032|NCT01127256|532427200|FG000|Overall Study|Withdrawal by Subject|5|||
147620033|NCT01127256|532427201|FG001|Overall Study|Withdrawal by Subject|9|||
147620034|NCT01127256|532427200|FG000|Overall Study|Protocol Violation|1|||
147620035|NCT01127256|532427201|FG001|Overall Study|Protocol Violation|0|||
147620036|NCT00679211|532427202|FG000|Overall Study|Progressive disease|82|||
147620037|NCT00679211|532427202|FG000|Overall Study|Adverse Event|7|||
147620038|NCT00679211|532427202|FG000|Overall Study|Withdrawal by Subject|2|||
147620039|NCT00679211|532427202|FG000|Overall Study|Physician Decision|5|||
147620040|NCT00679211|532427202|FG000|Overall Study|Refused to undergo protocol procedures|1|||
147620041|NCT00679211|532427202|FG000|Overall Study|Transferred to extension study TDM4529g|12|||
147620042|NCT00679211|532427202|FG000|Overall Study|Other|1|||
147620043|NCT00931528|532427203|FG000|Overall Study|Protocol Violation|9|||
147620044|NCT00931528|532427204|FG001|Overall Study|Protocol Violation|12|||
147620045|NCT00931528|532427203|FG000|Overall Study|Withdrawal by Subject|4|||
147470606|NCT04889209|531879717|FG002|All Cohorts Except 15E|Became ineligible after enrollment|0|||
147470607|NCT04889209|531879718|FG003|All Cohorts Except 15E|Became ineligible after enrollment|0|||
147470608|NCT04889209|531879719|FG004|All Cohorts Except 15E|Became ineligible after enrollment|0|||
147470609|NCT04889209|531879720|FG005|All Cohorts Except 15E|Became ineligible after enrollment|0|||
147470610|NCT04889209|531879721|FG006|All Cohorts Except 15E|Became ineligible after enrollment|0|||
147470611|NCT04889209|531879722|FG007|All Cohorts Except 15E|Became ineligible after enrollment|0|||
147470612|NCT04889209|531879723|FG008|All Cohorts Except 15E|Became ineligible after enrollment|0|||
147470613|NCT04889209|531879724|FG009|All Cohorts Except 15E|Became ineligible after enrollment|0|||
147470614|NCT04889209|531879725|FG010|All Cohorts Except 15E|Became ineligible after enrollment|0|||
147470615|NCT04889209|531879726|FG011|All Cohorts Except 15E|Became ineligible after enrollment|0|||
147470616|NCT04889209|531879727|FG012|All Cohorts Except 15E|Became ineligible after enrollment|0|||
147470617|NCT04889209|531879728|FG013|All Cohorts Except 15E|Became ineligible after enrollment|0|||
147620046|NCT00931528|532427204|FG001|Overall Study|Withdrawal by Subject|12|||
147620047|NCT00931528|532427203|FG000|Overall Study|Lost to Follow-up|6|||
147620048|NCT00931528|532427204|FG001|Overall Study|Lost to Follow-up|13|||
147620049|NCT00931528|532427203|FG000|Overall Study|Assessment outside of Time Frame|22|||
147620050|NCT00931528|532427204|FG001|Overall Study|Assessment outside of Time Frame|23|||
147470618|NCT04889209|531879729|FG014|All Cohorts Except 15E|Became ineligible after enrollment|0|||
147470619|NCT04889209|531879730|FG015|All Cohorts Except 15E|Became ineligible after enrollment|0|||
147620051|NCT01730053|532427205|FG000|Overall Study|Participant moved|0|||
147620052|NCT01730053|532427206|FG001|Overall Study|Participant moved|0|||
147620053|NCT01730053|532427207|FG002|Overall Study|Participant moved|1|||
147470620|NCT04889209|531879731|FG016|All Cohorts Except 15E|Became ineligible after enrollment|0|||
147470621|NCT04889209|531879732|FG017|All Cohorts Except 15E|Became ineligible after enrollment|1|||
147470622|NCT04889209|531879715|FG000|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
147470623|NCT04889209|531879716|FG001|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
147470624|NCT04889209|531879717|FG002|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
147470625|NCT04889209|531879718|FG003|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
147470626|NCT04889209|531879719|FG004|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
147470627|NCT04889209|531879720|FG005|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
147470628|NCT04889209|531879721|FG006|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
147470629|NCT04889209|531879722|FG007|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
147470630|NCT04889209|531879723|FG008|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
147470631|NCT04889209|531879724|FG009|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
147470632|NCT04889209|531879725|FG010|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
147470633|NCT04889209|531879726|FG011|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
147470634|NCT04889209|531879727|FG012|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
147470635|NCT04889209|531879728|FG013|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
147470636|NCT04889209|531879729|FG014|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
147470637|NCT04889209|531879730|FG015|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
147470638|NCT04889209|531879731|FG016|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|0|||
147470639|NCT04889209|531879732|FG017|All Cohorts Except 15E|Confirmed SARS CoV-2 infection|4|||
147470640|NCT04889209|531879715|FG000|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
147470641|NCT04889209|531879716|FG001|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
147470642|NCT04889209|531879717|FG002|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
147470643|NCT04889209|531879718|FG003|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
147470644|NCT04889209|531879719|FG004|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
147470645|NCT04889209|531879720|FG005|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
147470646|NCT04889209|531879721|FG006|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
147470647|NCT04889209|531879722|FG007|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
147470648|NCT04889209|531879723|FG008|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
147470649|NCT04889209|531879724|FG009|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
147470650|NCT04889209|531879725|FG010|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
147470651|NCT04889209|531879726|FG011|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
147470652|NCT04889209|531879727|FG012|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
147470653|NCT04889209|531879728|FG013|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
147470654|NCT04889209|531879729|FG014|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|2|||
147470655|NCT04889209|531879730|FG015|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
147470656|NCT04889209|531879731|FG016|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
147470657|NCT04889209|531879732|FG017|Direct Enroll, Rollover to Co 1 Gr 15E|Withdrawal by Subject|0|||
147470658|NCT04607408|531879733|FG000|Overall Study|Lost to Follow-up|0|||
147470659|NCT04607408|531879734|FG001|Overall Study|Lost to Follow-up|0|||
147470660|NCT04607408|531879735|FG002|Overall Study|Lost to Follow-up|0|||
147470661|NCT04607408|531879736|FG003|Overall Study|Lost to Follow-up|1|||
147470662|NCT04607408|531879737|FG004|Overall Study|Lost to Follow-up|0|||
147470663|NCT04607408|531879733|FG000|Overall Study|Withdrawal by Subject|0|||
147470664|NCT04607408|531879734|FG001|Overall Study|Withdrawal by Subject|1|||
147470665|NCT04607408|531879735|FG002|Overall Study|Withdrawal by Subject|0|||
147470666|NCT04607408|531879736|FG003|Overall Study|Withdrawal by Subject|1|||
147470667|NCT04607408|531879737|FG004|Overall Study|Withdrawal by Subject|0|||
147470668|NCT02725788|531879746|FG000|Overall Study|Lost to Follow-up|1|||
147470669|NCT02725788|531879747|FG001|Overall Study|Lost to Follow-up|1|||
147470670|NCT02725788|531879746|FG000|Overall Study|Protocol Violation|0|||
147470671|NCT02725788|531879747|FG001|Overall Study|Protocol Violation|1|||
147470672|NCT00474240|531879748|FG000|Overall Study|Withdrawal by Subject|1|||
147470673|NCT00474240|531879749|FG001|Overall Study|Withdrawal by Subject|1|||
147470674|NCT00474240|531879750|FG002|Overall Study|Withdrawal by Subject|0|||
147470675|NCT00474240|531879751|FG003|Overall Study|Withdrawal by Subject|2|||
147470676|NCT00474240|531879752|FG004|Overall Study|Withdrawal by Subject|3|||
147470677|NCT00474240|531879753|FG005|Overall Study|Withdrawal by Subject|1|||
147470678|NCT00474240|531879748|FG000|Overall Study|Adverse Event|0|||
147470679|NCT00474240|531879749|FG001|Overall Study|Adverse Event|0|||
147470680|NCT00474240|531879750|FG002|Overall Study|Adverse Event|9|||
147470681|NCT00474240|531879751|FG003|Overall Study|Adverse Event|14|||
147470682|NCT00474240|531879752|FG004|Overall Study|Adverse Event|5|||
147470683|NCT00474240|531879753|FG005|Overall Study|Adverse Event|16|||
147470684|NCT00474240|531879748|FG000|Overall Study|Removed due to lab value|0|||
147470685|NCT00474240|531879749|FG001|Overall Study|Removed due to lab value|0|||
147470686|NCT00474240|531879750|FG002|Overall Study|Removed due to lab value|0|||
147470687|NCT00474240|531879751|FG003|Overall Study|Removed due to lab value|0|||
147470688|NCT00474240|531879752|FG004|Overall Study|Removed due to lab value|0|||
147412435|NCT00972322|531673011|FG000|Overall Study|Consistently high glucose values|1|||
147412436|NCT00972322|531673012|FG001|Overall Study|Consistently high glucose values|0|||
147412437|NCT04958200|531673013|FG000|Overall Study|Withdrawal by Subject|0|||
147412438|NCT04958200|531673014|FG001|Overall Study|Withdrawal by Subject|2|||
147412439|NCT04958200|531673013|FG000|Overall Study|Lost to Follow-up|3|||
147412440|NCT04958200|531673014|FG001|Overall Study|Lost to Follow-up|2|||
147412441|NCT02387970|531673015|FG000|Overall Study|Did not complete 1-year follow up|1|||
147412442|NCT02387970|531673016|FG001|Overall Study|Did not complete 1-year follow up|2|||
147412443|NCT00316017|531673023|FG000|Overall Study|Protocol Violation|11|||
147412444|NCT00316017|531673024|FG001|Overall Study|Protocol Violation|13|||
147412445|NCT00316017|531673025|FG002|Overall Study|Protocol Violation|19|||
147412446|NCT05511038|531673037|FG000|Overall|Withdrawal by Subject|5|||
147412447|NCT05511038|531673038|FG001|Overall|Withdrawal by Subject|3|||
147412448|NCT05511038|531673037|FG000|Overall|Screen Failure|20|||
147412449|NCT05511038|531673038|FG001|Overall|Screen Failure|1|||
147412450|NCT05511038|531673037|FG000|Overall|Physician Decision|3|||
147412451|NCT05511038|531673038|FG001|Overall|Physician Decision|0|||
147412452|NCT05511038|531673037|FG000|Overall|Lost to Follow-up|3|||
147412453|NCT05511038|531673038|FG001|Overall|Lost to Follow-up|0|||
147412454|NCT05511038|531673037|FG000|Overall|Death|1|||
147412455|NCT05511038|531673038|FG001|Overall|Death|0|||
147412456|NCT05511038|531673037|FG000|Screening|Withdrawal by Subject|1|||
147412457|NCT05511038|531673038|FG001|Screening|Withdrawal by Subject|0|||
147412458|NCT05511038|531673037|FG000|Screening|Lost to Follow Up (1 participant)|1|||
147412459|NCT05511038|531673038|FG001|Screening|Lost to Follow Up (1 participant)|0|||
147412460|NCT05511038|531673037|FG000|Screening|Screen Failure|3|||
147412461|NCT05511038|531673038|FG001|Screening|Screen Failure|0|||
147412462|NCT05511038|531673037|FG000|Screening|Screen Failure that was identified after screening (1 participant)|1|||
147412463|NCT05511038|531673038|FG001|Screening|Screen Failure that was identified after screening (1 participant)|0|||
147412464|NCT05511038|531673037|FG000|Treatment|Withdrawal by Subject|5|||
147412465|NCT05511038|531673038|FG001|Treatment|Withdrawal by Subject|3|||
147412466|NCT05511038|531673037|FG000|Treatment|Physician Decision|4|||
147412467|NCT05511038|531673038|FG001|Treatment|Physician Decision|0|||
147412468|NCT05511038|531673037|FG000|Treatment|Lost to Follow-up|2|||
147412469|NCT05511038|531673038|FG001|Treatment|Lost to Follow-up|0|||
147412470|NCT05511038|531673037|FG000|Treatment|Death|1|||
147412471|NCT05511038|531673038|FG001|Treatment|Death|0|||
147412472|NCT05511038|531673037|FG000|Treatment|Subject did nod visit the site despite multiple follow-up|3|||
147412473|NCT05511038|531673038|FG001|Treatment|Subject did nod visit the site despite multiple follow-up|1|||
147412474|NCT05511038|531673037|FG000|Treatment|Refuse by subject|1|||
147412475|NCT05511038|531673038|FG001|Treatment|Refuse by subject|0|||
147412476|NCT05511038|531673037|FG000|Treatment|Subject did not go to the site for visit|1|||
147412477|NCT05511038|531673038|FG001|Treatment|Subject did not go to the site for visit|0|||
147412478|NCT05543187|531673041|FG000|Overall Study|Ongoing|3|||
147412479|NCT05543187|531673042|FG001|Overall Study|Ongoing|2|||
147412480|NCT04777864|531673043|FG000|Overall Study|Lost to Follow-up|8|||
147412481|NCT04777864|531673044|FG001|Overall Study|Lost to Follow-up|19|||
147412482|NCT02815579|531674605|FG000|Overall Study|Non-payment of loan down-payment|16|||
147412483|NCT02815579|531674606|FG001|Overall Study|Non-payment of loan down-payment|0|||
147412484|NCT02815579|531674605|FG000|Overall Study|Withdrawal by Subject|7|||
147412485|NCT02815579|531674606|FG001|Overall Study|Withdrawal by Subject|1|||
147412486|NCT02815579|531674605|FG000|Overall Study|Moved out of study area before receiving any study activities|9|||
147412487|NCT02815579|531674606|FG001|Overall Study|Moved out of study area before receiving any study activities|11|||
147412488|NCT02815579|531674605|FG000|Overall Study|Lost to Follow-up|7|||
147412489|NCT02815579|531674606|FG001|Overall Study|Lost to Follow-up|4|||
147412490|NCT02815579|531674605|FG000|Overall Study|Hospitalized before receipt of any study activities|1|||
147412491|NCT02815579|531674606|FG001|Overall Study|Hospitalized before receipt of any study activities|0|||
147412492|NCT02815579|531674605|FG000|Overall Study|Uncomfortable with MEMS adherence monitoring cap|1|||
147412493|NCT02815579|531674606|FG001|Overall Study|Uncomfortable with MEMS adherence monitoring cap|0|||
147412494|NCT02815579|531674605|FG000|Overall Study|Death|5|||
147412495|NCT02815579|531674606|FG001|Overall Study|Death|4|||
147412496|NCT02815579|531674605|FG000|Overall Study|Imprisoned|0|||
147412497|NCT02815579|531674606|FG001|Overall Study|Imprisoned|2|||
147412498|NCT02815579|531674605|FG000|Overall Study|Did not meet enrollment criteria|0|||
147412499|NCT02815579|531674606|FG001|Overall Study|Did not meet enrollment criteria|1|||
147412500|NCT02311673|531674610|FG000|Double-blind Randomized Period 2 (4 Wks)|Withdrawal by participant and Investigator decision|0|||
147412501|NCT02311673|531674611|FG001|Double-blind Randomized Period 2 (4 Wks)|Withdrawal by participant and Investigator decision|0|||
147412502|NCT02311673|531674612|FG002|Double-blind Randomized Period 2 (4 Wks)|Withdrawal by participant and Investigator decision|1|||
147412503|NCT02311673|531674613|FG003|Double-blind Randomized Period 2 (4 Wks)|Withdrawal by participant and Investigator decision|0|||
147412504|NCT01014208|531674614|FG000|Overall Study|Lost to Follow-up|2|||
147412505|NCT01014208|531674615|FG001|Overall Study|Lost to Follow-up|5|||
147412506|NCT01014208|531674614|FG000|Overall Study|Participant Withdrew Consent|12|||
147412507|NCT01014208|531674615|FG001|Overall Study|Participant Withdrew Consent|12|||
147620054|NCT01730053|532427208|FG003|Overall Study|Participant moved|0|||
147470689|NCT00474240|531879753|FG005|Overall Study|Removed due to lab value|1|||
147470690|NCT00809133|531879754|FG000|Overall Study|Progressive disease|2|||
147470691|NCT00809133|531879755|FG001|Overall Study|Progressive disease|5|||
147470692|NCT00809133|531879756|FG002|Overall Study|Progressive disease|5|||
147470693|NCT00809133|531879757|FG003|Overall Study|Progressive disease|3|||
147470694|NCT00809133|531879758|FG004|Overall Study|Progressive disease|4|||
147470695|NCT00809133|531879759|FG005|Overall Study|Progressive disease|1|||
147470696|NCT00809133|531879760|FG006|Overall Study|Progressive disease|3|||
147470697|NCT00809133|531879761|FG007|Overall Study|Progressive disease|3|||
147470698|NCT00809133|531879762|FG008|Overall Study|Progressive disease|3|||
147470699|NCT00809133|531879763|FG009|Overall Study|Progressive disease|9|||
147470700|NCT00809133|531879764|FG010|Overall Study|Progressive disease|5|||
147470701|NCT00809133|531879765|FG011|Overall Study|Progressive disease|7|||
147470702|NCT00809133|531879766|FG012|Overall Study|Progressive disease|5|||
147470703|NCT00809133|531879767|FG013|Overall Study|Progressive disease|4|||
147470704|NCT00809133|531879754|FG000|Overall Study|Dose Limiting Toxicity (DLT)|0|||
147470705|NCT00809133|531879755|FG001|Overall Study|Dose Limiting Toxicity (DLT)|0|||
147470706|NCT00809133|531879756|FG002|Overall Study|Dose Limiting Toxicity (DLT)|0|||
147470707|NCT00809133|531879757|FG003|Overall Study|Dose Limiting Toxicity (DLT)|0|||
147470708|NCT00809133|531879758|FG004|Overall Study|Dose Limiting Toxicity (DLT)|0|||
147470709|NCT00809133|531879759|FG005|Overall Study|Dose Limiting Toxicity (DLT)|1|||
147470710|NCT00809133|531879760|FG006|Overall Study|Dose Limiting Toxicity (DLT)|1|||
147470711|NCT00809133|531879761|FG007|Overall Study|Dose Limiting Toxicity (DLT)|1|||
147470712|NCT00809133|531879762|FG008|Overall Study|Dose Limiting Toxicity (DLT)|0|||
147470713|NCT00809133|531879763|FG009|Overall Study|Dose Limiting Toxicity (DLT)|0|||
147470714|NCT00809133|531879764|FG010|Overall Study|Dose Limiting Toxicity (DLT)|0|||
147470715|NCT00809133|531879765|FG011|Overall Study|Dose Limiting Toxicity (DLT)|0|||
147470716|NCT00809133|531879766|FG012|Overall Study|Dose Limiting Toxicity (DLT)|0|||
147470717|NCT00809133|531879767|FG013|Overall Study|Dose Limiting Toxicity (DLT)|2|||
147470718|NCT00809133|531879754|FG000|Overall Study|Other adverse event|1|||
147470719|NCT00809133|531879755|FG001|Overall Study|Other adverse event|1|||
147470720|NCT00809133|531879756|FG002|Overall Study|Other adverse event|1|||
147470721|NCT00809133|531879757|FG003|Overall Study|Other adverse event|0|||
147470722|NCT00809133|531879758|FG004|Overall Study|Other adverse event|0|||
147470723|NCT00809133|531879759|FG005|Overall Study|Other adverse event|3|||
147470724|NCT00809133|531879760|FG006|Overall Study|Other adverse event|2|||
147470725|NCT00809133|531879761|FG007|Overall Study|Other adverse event|4|||
147470726|NCT00809133|531879762|FG008|Overall Study|Other adverse event|0|||
147470727|NCT00809133|531879763|FG009|Overall Study|Other adverse event|0|||
147470728|NCT00809133|531879764|FG010|Overall Study|Other adverse event|1|||
147470729|NCT00809133|531879765|FG011|Overall Study|Other adverse event|1|||
147470730|NCT00809133|531879766|FG012|Overall Study|Other adverse event|0|||
147470731|NCT00809133|531879767|FG013|Overall Study|Other adverse event|1|||
147470732|NCT00809133|531879754|FG000|Overall Study|Lost to Follow-up|0|||
147470733|NCT00809133|531879755|FG001|Overall Study|Lost to Follow-up|0|||
147470734|NCT00809133|531879756|FG002|Overall Study|Lost to Follow-up|0|||
147470735|NCT00809133|531879757|FG003|Overall Study|Lost to Follow-up|0|||
147470736|NCT00809133|531879758|FG004|Overall Study|Lost to Follow-up|0|||
147470737|NCT00809133|531879759|FG005|Overall Study|Lost to Follow-up|1|||
147470738|NCT00809133|531879760|FG006|Overall Study|Lost to Follow-up|0|||
147470739|NCT00809133|531879761|FG007|Overall Study|Lost to Follow-up|0|||
147470740|NCT00809133|531879762|FG008|Overall Study|Lost to Follow-up|0|||
147470741|NCT00809133|531879763|FG009|Overall Study|Lost to Follow-up|0|||
147470742|NCT00809133|531879764|FG010|Overall Study|Lost to Follow-up|0|||
147470743|NCT00809133|531879765|FG011|Overall Study|Lost to Follow-up|0|||
147470744|NCT00809133|531879766|FG012|Overall Study|Lost to Follow-up|0|||
147470745|NCT00809133|531879767|FG013|Overall Study|Lost to Follow-up|0|||
147470746|NCT00809133|531879754|FG000|Overall Study|Consent withdrawn|0|||
147470747|NCT00809133|531879755|FG001|Overall Study|Consent withdrawn|0|||
147470748|NCT00809133|531879756|FG002|Overall Study|Consent withdrawn|0|||
147470749|NCT00809133|531879757|FG003|Overall Study|Consent withdrawn|0|||
147470750|NCT00809133|531879758|FG004|Overall Study|Consent withdrawn|1|||
147470751|NCT00809133|531879759|FG005|Overall Study|Consent withdrawn|0|||
147470752|NCT00809133|531879760|FG006|Overall Study|Consent withdrawn|0|||
147470753|NCT00809133|531879761|FG007|Overall Study|Consent withdrawn|0|||
147470754|NCT00809133|531879762|FG008|Overall Study|Consent withdrawn|0|||
147470755|NCT00809133|531879763|FG009|Overall Study|Consent withdrawn|0|||
147470756|NCT00809133|531879764|FG010|Overall Study|Consent withdrawn|0|||
147470757|NCT00809133|531879765|FG011|Overall Study|Consent withdrawn|0|||
147470758|NCT00809133|531879766|FG012|Overall Study|Consent withdrawn|0|||
147470759|NCT00809133|531879767|FG013|Overall Study|Consent withdrawn|0|||
147470760|NCT00809133|531879754|FG000|Overall Study|Other not mentioned above|0|||
147470761|NCT00809133|531879755|FG001|Overall Study|Other not mentioned above|1|||
147470762|NCT00809133|531879756|FG002|Overall Study|Other not mentioned above|0|||
147470763|NCT00809133|531879757|FG003|Overall Study|Other not mentioned above|0|||
147470764|NCT00809133|531879758|FG004|Overall Study|Other not mentioned above|0|||
147470765|NCT00809133|531879759|FG005|Overall Study|Other not mentioned above|1|||
147470766|NCT00809133|531879760|FG006|Overall Study|Other not mentioned above|0|||
147470767|NCT00809133|531879761|FG007|Overall Study|Other not mentioned above|0|||
147470768|NCT00809133|531879762|FG008|Overall Study|Other not mentioned above|0|||
147470769|NCT00809133|531879763|FG009|Overall Study|Other not mentioned above|0|||
147470770|NCT00809133|531879764|FG010|Overall Study|Other not mentioned above|0|||
147470771|NCT00809133|531879765|FG011|Overall Study|Other not mentioned above|0|||
147470772|NCT00809133|531879766|FG012|Overall Study|Other not mentioned above|0|||
147470773|NCT00809133|531879767|FG013|Overall Study|Other not mentioned above|0|||
147470774|NCT00833092|531879768|FG000|Overall Study|Withdrawal by Subject|2|||
147470775|NCT00833092|531879769|FG001|Overall Study|Withdrawal by Subject|3|||
147470776|NCT00833092|531879768|FG000|Overall Study|Protocol Violation|2|||
147470777|NCT00833092|531879769|FG001|Overall Study|Protocol Violation|1|||
147470778|NCT00833092|531879768|FG000|Overall Study|Diarrhea|0|||
147470779|NCT00833092|531879769|FG001|Overall Study|Diarrhea|2|||
147470780|NCT00833092|531879768|FG000|Overall Study|constipation|0|||
147470781|NCT00833092|531879769|FG001|Overall Study|constipation|1|||
147470782|NCT00619229|531879770|FG000|Overall Study|Withdrawal by Subject|1|||
147470783|NCT00619229|531879771|FG001|Overall Study|Withdrawal by Subject|1|||
147470784|NCT00619229|531879770|FG000|Overall Study|Lost to Follow-up|1|||
147470785|NCT00619229|531879771|FG001|Overall Study|Lost to Follow-up|0|||
147470786|NCT00619229|531879770|FG000|Overall Study|Termination of the Study by the Sponsor|1|||
147470787|NCT00619229|531879771|FG001|Overall Study|Termination of the Study by the Sponsor|1|||
147470788|NCT00619229|531879770|FG000|Overall Study|Investigator planned Cataract Operation|1|||
147470789|NCT00619229|531879771|FG001|Overall Study|Investigator planned Cataract Operation|0|||
147470790|NCT01700829|531879772|FG000|Overall Study|Withdrawal by Subject|1|||
147470791|NCT01700829|531879773|FG001|Overall Study|Withdrawal by Subject|1|||
147470792|NCT00316264|531879774|FG000|Overall Study|Lost to Follow-up|0|||
147470793|NCT00316264|531879775|FG001|Overall Study|Lost to Follow-up|1|||
147470794|NCT00316264|531879776|FG002|Overall Study|Lost to Follow-up|0|||
147470795|NCT00316264|531879774|FG000|Overall Study|Withdrawal of Consent|3|||
147470796|NCT00316264|531879775|FG001|Overall Study|Withdrawal of Consent|5|||
147470797|NCT00316264|531879776|FG002|Overall Study|Withdrawal of Consent|6|||
147470798|NCT00316264|531879774|FG000|Overall Study|Death|2|||
147470799|NCT00316264|531879775|FG001|Overall Study|Death|0|||
147470800|NCT00316264|531879776|FG002|Overall Study|Death|0|||
147470801|NCT00316264|531879774|FG000|Overall Study|Other|1|||
147470802|NCT00316264|531879775|FG001|Overall Study|Other|1|||
147470803|NCT00316264|531879776|FG002|Overall Study|Other|0|||
147470804|NCT04927312|531879777|FG000|Overall Study|Adverse Event|1|||
147470805|NCT04927312|531879777|FG000|Overall Study|Death|1|||
147470806|NCT04927312|531879777|FG000|Overall Study|Withdrawal by Subject|1|||
147470807|NCT04927312|531879777|FG000|Overall Study|Other|1|||
147470808|NCT04919564|531879779|FG000|Overall Study|Lost to Follow-up|1|||
147470809|NCT04919564|531879780|FG001|Overall Study|Lost to Follow-up|0|||
147470810|NCT04919564|531879779|FG000|Overall Study|Physician Decision|1|||
147470811|NCT04919564|531879780|FG001|Overall Study|Physician Decision|1|||
147470812|NCT00929240|531879781|FG000|Initial Treatment Phase|Adverse Event|31|||
147470813|NCT00929240|531879782|FG001|Initial Treatment Phase|Adverse Event|0|||
147470814|NCT00929240|531879783|FG002|Initial Treatment Phase|Adverse Event|0|||
147470815|NCT00929240|531879781|FG000|Initial Treatment Phase|Disease progression|41|||
147470816|NCT00929240|531879782|FG001|Initial Treatment Phase|Disease progression|0|||
147470817|NCT00929240|531879783|FG002|Initial Treatment Phase|Disease progression|0|||
147470818|NCT00929240|531879781|FG000|Initial Treatment Phase|Withdrawal by Subject|13|||
147470819|NCT00929240|531879782|FG001|Initial Treatment Phase|Withdrawal by Subject|0|||
147470820|NCT00929240|531879783|FG002|Initial Treatment Phase|Withdrawal by Subject|0|||
147470821|NCT00929240|531879781|FG000|Initial Treatment Phase|Protocol Violation|5|||
147470822|NCT00929240|531879782|FG001|Initial Treatment Phase|Protocol Violation|0|||
147470823|NCT00929240|531879783|FG002|Initial Treatment Phase|Protocol Violation|0|||
147470824|NCT00929240|531879781|FG000|Initial Treatment Phase|Death|2|||
147470825|NCT00929240|531879782|FG001|Initial Treatment Phase|Death|0|||
147470826|NCT00929240|531879783|FG002|Initial Treatment Phase|Death|0|||
147470827|NCT00929240|531879781|FG000|Initial Treatment Phase|Health authority/Study termination|3|||
147470828|NCT00929240|531879782|FG001|Initial Treatment Phase|Health authority/Study termination|0|||
147470829|NCT00929240|531879783|FG002|Initial Treatment Phase|Health authority/Study termination|0|||
147470830|NCT00929240|531879781|FG000|Initial Treatment Phase|Physician Decision|4|||
147470831|NCT00929240|531879782|FG001|Initial Treatment Phase|Physician Decision|0|||
147470832|NCT00929240|531879783|FG002|Initial Treatment Phase|Physician Decision|0|||
147470833|NCT00929240|531879781|FG000|Maintenance Phase|Disease progression|0|||
147470834|NCT00929240|531879782|FG001|Maintenance Phase|Disease progression|73|||
147470835|NCT00929240|531879783|FG002|Maintenance Phase|Disease progression|60|||
147470836|NCT00929240|531879781|FG000|Maintenance Phase|Adverse Event|0|||
147470837|NCT00929240|531879782|FG001|Maintenance Phase|Adverse Event|9|||
147470838|NCT00929240|531879783|FG002|Maintenance Phase|Adverse Event|12|||
147470839|NCT00929240|531879781|FG000|Maintenance Phase|Withdrawal by Subject|0|||
147470840|NCT00929240|531879782|FG001|Maintenance Phase|Withdrawal by Subject|2|||
147470841|NCT00929240|531879783|FG002|Maintenance Phase|Withdrawal by Subject|6|||
147470842|NCT00929240|531879781|FG000|Maintenance Phase|Protocol Violation|0|||
147470843|NCT00929240|531879782|FG001|Maintenance Phase|Protocol Violation|1|||
147470844|NCT00929240|531879783|FG002|Maintenance Phase|Protocol Violation|0|||
147470845|NCT00929240|531879781|FG000|Maintenance Phase|Health authority/Study termination|0|||
147470846|NCT00929240|531879782|FG001|Maintenance Phase|Health authority/Study termination|1|||
147470847|NCT00929240|531879783|FG002|Maintenance Phase|Health authority/Study termination|2|||
147470848|NCT00929240|531879781|FG000|Maintenance Phase|Physician Decision|0|||
147470849|NCT00929240|531879782|FG001|Maintenance Phase|Physician Decision|2|||
147470850|NCT00929240|531879783|FG002|Maintenance Phase|Physician Decision|1|||
147620055|NCT01730053|532427209|FG004|Overall Study|Participant moved|0|||
147470851|NCT00929240|531879781|FG000|Maintenance Phase|Change of treatment|0|||
147470852|NCT00929240|531879782|FG001|Maintenance Phase|Change of treatment|4|||
147470853|NCT00929240|531879783|FG002|Maintenance Phase|Change of treatment|0|||
147470854|NCT00929240|531879781|FG000|Maintenance Phase|Treatment ongoing at study closure|0|||
147470855|NCT00929240|531879782|FG001|Maintenance Phase|Treatment ongoing at study closure|0|||
147470856|NCT00929240|531879783|FG002|Maintenance Phase|Treatment ongoing at study closure|10|||
147470857|NCT00929240|531879781|FG000|Maintenance Phase|Participant not treated|0|||
147470858|NCT00929240|531879782|FG001|Maintenance Phase|Participant not treated|2|||
147470859|NCT00929240|531879783|FG002|Maintenance Phase|Participant not treated|0|||
147470860|NCT01287104|531879784|FG000|Overall Study|Patient developed progressive disease|1|||
147470861|NCT01287104|531879785|FG001|Overall Study|Patient developed progressive disease|1|||
147470862|NCT01287104|531879786|FG002|Overall Study|Patient developed progressive disease|3|||
147470863|NCT01287104|531879787|FG003|Overall Study|Patient developed progressive disease|2|||
147470864|NCT01287104|531879784|FG000|Overall Study|Donor anaphylaxis|0|||
147470865|NCT01287104|531879785|FG001|Overall Study|Donor anaphylaxis|1|||
147470866|NCT01287104|531879786|FG002|Overall Study|Donor anaphylaxis|0|||
147470867|NCT01287104|531879787|FG003|Overall Study|Donor anaphylaxis|1|||
147470868|NCT01287104|531879784|FG000|Overall Study|Developed GVHD or complications of BMT|0|||
147470869|NCT01287104|531879785|FG001|Overall Study|Developed GVHD or complications of BMT|1|||
147470870|NCT01287104|531879786|FG002|Overall Study|Developed GVHD or complications of BMT|4|||
147470871|NCT01287104|531879787|FG003|Overall Study|Developed GVHD or complications of BMT|0|||
147470872|NCT01287104|531879784|FG000|Overall Study|Low donor chimerism|0|||
147470873|NCT01287104|531879785|FG001|Overall Study|Low donor chimerism|1|||
147470874|NCT01287104|531879786|FG002|Overall Study|Low donor chimerism|0|||
147470875|NCT01287104|531879787|FG003|Overall Study|Low donor chimerism|0|||
147470876|NCT01287104|531879784|FG000|Overall Study|NK cells did not meet release criteria|0|||
147470877|NCT01287104|531879785|FG001|Overall Study|NK cells did not meet release criteria|1|||
147470878|NCT01287104|531879786|FG002|Overall Study|NK cells did not meet release criteria|0|||
147470879|NCT01287104|531879787|FG003|Overall Study|NK cells did not meet release criteria|0|||
147470880|NCT00098787|531879790|FG000|Overall Study|Never started treatment|3|||
147470881|NCT00098787|531879791|FG001|Overall Study|Never started treatment|2|||
147470882|NCT00098787|531879792|FG002|Overall Study|Never started treatment|1|||
147470883|NCT00098787|531879790|FG000|Overall Study|Ineligible|9|||
147470884|NCT00098787|531879791|FG001|Overall Study|Ineligible|7|||
147470885|NCT00098787|531879792|FG002|Overall Study|Ineligible|3|||
147470886|NCT00098787|531879790|FG000|Overall Study|Disease progression|28|||
147470887|NCT00098787|531879791|FG001|Overall Study|Disease progression|17|||
147470888|NCT00098787|531879792|FG002|Overall Study|Disease progression|23|||
147470889|NCT00098787|531879790|FG000|Overall Study|Adverse Event|8|||
147470890|NCT00098787|531879791|FG001|Overall Study|Adverse Event|17|||
147470891|NCT00098787|531879792|FG002|Overall Study|Adverse Event|8|||
147470892|NCT00098787|531879790|FG000|Overall Study|Death|6|||
147470893|NCT00098787|531879791|FG001|Overall Study|Death|1|||
147470894|NCT00098787|531879792|FG002|Overall Study|Death|0|||
147470895|NCT00098787|531879790|FG000|Overall Study|Withdrawal by Subject|4|||
147470896|NCT00098787|531879791|FG001|Overall Study|Withdrawal by Subject|12|||
147470897|NCT00098787|531879792|FG002|Overall Study|Withdrawal by Subject|6|||
147470898|NCT00098787|531879790|FG000|Overall Study|Alternative therapy|8|||
147620056|NCT01730053|532427210|FG005|Overall Study|Participant moved|0|||
147620057|NCT01730053|532427205|FG000|Overall Study|Physician Decision|0|||
147620058|NCT01730053|532427206|FG001|Overall Study|Physician Decision|0|||
147620059|NCT01730053|532427207|FG002|Overall Study|Physician Decision|0|||
147620060|NCT01730053|532427208|FG003|Overall Study|Physician Decision|1|||
147620061|NCT01730053|532427209|FG004|Overall Study|Physician Decision|0|||
147620062|NCT01730053|532427210|FG005|Overall Study|Physician Decision|0|||
147620063|NCT01730053|532427205|FG000|Overall Study|Adverse Event|2|||
147620064|NCT01730053|532427206|FG001|Overall Study|Adverse Event|6|||
147620065|NCT01730053|532427207|FG002|Overall Study|Adverse Event|3|||
147620066|NCT01730053|532427208|FG003|Overall Study|Adverse Event|3|||
147620067|NCT01730053|532427209|FG004|Overall Study|Adverse Event|2|||
147470899|NCT00098787|531879791|FG001|Overall Study|Alternative therapy|13|||
147470900|NCT00098787|531879792|FG002|Overall Study|Alternative therapy|13|||
147470901|NCT00098787|531879790|FG000|Overall Study|Other|7|||
147470902|NCT00098787|531879791|FG001|Overall Study|Other|6|||
147470903|NCT00098787|531879792|FG002|Overall Study|Other|9|||
147620068|NCT01730053|532427210|FG005|Overall Study|Adverse Event|2|||
147620069|NCT01730053|532427205|FG000|Overall Study|Poor compliance to protocol|1|||
147470904|NCT00684814|531879793|FG000|Washout Period of 7 Days|Adverse Event|1|||
147470905|NCT00684814|531879794|FG001|Washout Period of 7 Days|Adverse Event|2|||
147470906|NCT00684814|531879793|FG000|Washout Period of 7 Days|Withdrawal by Subject|1|||
147470907|NCT00684814|531879794|FG001|Washout Period of 7 Days|Withdrawal by Subject|2|||
147470908|NCT00684814|531879793|FG000|Second Intervention|Adverse Event|1|||
147470909|NCT00684814|531879794|FG001|Second Intervention|Adverse Event|0|||
147470910|NCT02203149|531879795|FG000|Part 1|Adverse Event|0|||
147470911|NCT02203149|531879796|FG001|Part 1|Adverse Event|1|||
147470912|NCT02203149|531879797|FG002|Part 1|Adverse Event|0|||
147470913|NCT02203149|531879798|FG003|Part 1|Adverse Event|0|||
147470914|NCT02203149|531879799|FG004|Part 1|Adverse Event|0|||
147470915|NCT02203149|531879795|FG000|Part 2|Death|0|||
147470916|NCT02203149|531879796|FG001|Part 2|Death|0|||
147470917|NCT02203149|531879797|FG002|Part 2|Death|1|||
147470918|NCT02203149|531879798|FG003|Part 2|Death|1|||
147470919|NCT02203149|531879799|FG004|Part 2|Death|0|||
147470920|NCT02203149|531879795|FG000|Part 2|Withdrawal by Subject|0|||
147470921|NCT02203149|531879796|FG001|Part 2|Withdrawal by Subject|0|||
147470922|NCT02203149|531879797|FG002|Part 2|Withdrawal by Subject|0|||
147470923|NCT02203149|531879798|FG003|Part 2|Withdrawal by Subject|1|||
147470924|NCT02203149|531879799|FG004|Part 2|Withdrawal by Subject|0|||
147470925|NCT02203149|531879795|FG000|Part 2|Adverse Event|0|||
147470926|NCT02203149|531879796|FG001|Part 2|Adverse Event|0|||
147470927|NCT02203149|531879797|FG002|Part 2|Adverse Event|0|||
147470928|NCT02203149|531879798|FG003|Part 2|Adverse Event|1|||
147470929|NCT02203149|531879799|FG004|Part 2|Adverse Event|1|||
147470930|NCT00446030|531879802|FG000|TREATMENT (up to 52 Weeks)|Adverse Event|29|||
147470931|NCT00446030|531879803|FG001|TREATMENT (up to 52 Weeks)|Adverse Event|8|||
147470932|NCT00446030|531879802|FG000|TREATMENT (up to 52 Weeks)|Subject Request|9|||
147470933|NCT00446030|531879803|FG001|TREATMENT (up to 52 Weeks)|Subject Request|1|||
147470934|NCT00446030|531879802|FG000|TREATMENT (up to 52 Weeks)|Poor compliance|1|||
147470935|NCT00446030|531879803|FG001|TREATMENT (up to 52 Weeks)|Poor compliance|0|||
147470936|NCT00446030|531879802|FG000|TREATMENT (up to 52 Weeks)|Suspicious meningioma|1|||
147470937|NCT00446030|531879803|FG001|TREATMENT (up to 52 Weeks)|Suspicious meningioma|0|||
147470938|NCT00446030|531879802|FG000|TREATMENT (up to 52 Weeks)|Protocol Violation|1|||
147470939|NCT00446030|531879803|FG001|TREATMENT (up to 52 Weeks)|Protocol Violation|0|||
147470940|NCT00446030|531879802|FG000|TREATMENT (up to 52 Weeks)|Physician Decision|1|||
147470941|NCT00446030|531879803|FG001|TREATMENT (up to 52 Weeks)|Physician Decision|0|||
147470942|NCT00446030|531879802|FG000|TREATMENT (up to 52 Weeks)|Patient concern|1|||
147470943|NCT00446030|531879803|FG001|TREATMENT (up to 52 Weeks)|Patient concern|0|||
147470944|NCT00446030|531879802|FG000|TREATMENT (up to 52 Weeks)|No treatment, but went to follow-up|1|||
147470945|NCT00446030|531879803|FG001|TREATMENT (up to 52 Weeks)|No treatment, but went to follow-up|0|||
147470946|NCT00446030|531879802|FG000|FOLLOW-UP (up to 2-years)|Subject's request|9|||
147470947|NCT00446030|531879803|FG001|FOLLOW-UP (up to 2-years)|Subject's request|4|||
147470948|NCT00446030|531879802|FG000|FOLLOW-UP (up to 2-years)|Poor compliance to protocol|5|||
147470949|NCT00446030|531879803|FG001|FOLLOW-UP (up to 2-years)|Poor compliance to protocol|0|||
147470950|NCT00446030|531879802|FG000|FOLLOW-UP (up to 2-years)|Lost to Follow-up|4|||
147470951|NCT00446030|531879803|FG001|FOLLOW-UP (up to 2-years)|Lost to Follow-up|0|||
147470952|NCT00446030|531879802|FG000|FOLLOW-UP (up to 2-years)|Death|2|||
147470953|NCT00446030|531879803|FG001|FOLLOW-UP (up to 2-years)|Death|2|||
147470954|NCT00446030|531879802|FG000|FOLLOW-UP (up to 2-years)|Disease/Breast cancer recurrence/relapse|3|||
147470955|NCT00446030|531879803|FG001|FOLLOW-UP (up to 2-years)|Disease/Breast cancer recurrence/relapse|2|||
147470956|NCT00446030|531879802|FG000|FOLLOW-UP (up to 2-years)|Investigator decision to close the study|2|||
147470957|NCT00446030|531879803|FG001|FOLLOW-UP (up to 2-years)|Investigator decision to close the study|0|||
147470958|NCT00446030|531879802|FG000|FOLLOW-UP (up to 2-years)|Per physician discretion|2|||
147470959|NCT00446030|531879803|FG001|FOLLOW-UP (up to 2-years)|Per physician discretion|0|||
147470960|NCT00446030|531879802|FG000|FOLLOW-UP (up to 2-years)|Protocol Violation|1|||
147470961|NCT00446030|531879803|FG001|FOLLOW-UP (up to 2-years)|Protocol Violation|0|||
147470962|NCT00446030|531879802|FG000|FOLLOW-UP (up to 2-years)|Patient concern|1|||
147470963|NCT00446030|531879803|FG001|FOLLOW-UP (up to 2-years)|Patient concern|0|||
147470964|NCT00446030|531879802|FG000|FOLLOW-UP (up to 2-years)|Right axilla wound|1|||
147470965|NCT00446030|531879803|FG001|FOLLOW-UP (up to 2-years)|Right axilla wound|0|||
147470966|NCT00446030|531879802|FG000|FOLLOW-UP (up to 2-years)|Missed last visit due to hysterectomy|0|||
147470967|NCT00446030|531879803|FG001|FOLLOW-UP (up to 2-years)|Missed last visit due to hysterectomy|1|||
147470968|NCT00858832|531879806|FG000|Overall Study|became ineligible: delivered vaginally|1|||
147470969|NCT00858832|531879807|FG001|Overall Study|became ineligible: delivered vaginally|0|||
147470970|NCT00858832|531879806|FG000|Overall Study|Adverse Event|0|||
147470971|NCT00858832|531879807|FG001|Overall Study|Adverse Event|1|||
147470972|NCT05292755|531879808|FG000|Overall Study|Lost to Follow-up|5|||
147470973|NCT05292755|531879809|FG001|Overall Study|Lost to Follow-up|9|||
147470974|NCT00432809|531879810|FG000|1 Year Follow-up|Misses 9 and 12 month visit|2|||
147470975|NCT00432809|531879811|FG001|1 Year Follow-up|Misses 9 and 12 month visit|0|||
147470976|NCT00432809|531879812|FG002|1 Year Follow-up|Misses 9 and 12 month visit|0|||
147620070|NCT01730053|532427206|FG001|Overall Study|Poor compliance to protocol|2|||
147470977|NCT00432809|531879810|FG000|1 Year Follow-up|Withdrawal by Subject|7|||
147470978|NCT00432809|531879811|FG001|1 Year Follow-up|Withdrawal by Subject|0|||
147665892|NCT00324155|532601630|FG001|Received Treatment in Induction Phase|Deterioration/Undocumented Progression|8|||
147470979|NCT00432809|531879812|FG002|1 Year Follow-up|Withdrawal by Subject|1|||
147470980|NCT04052139|531879813|FG000|Overall Study|Lost to Follow-up|2|||
147470981|NCT04052139|531879814|FG001|Overall Study|Lost to Follow-up|0|||
147470982|NCT04052139|531879815|FG002|Overall Study|Lost to Follow-up|0|||
147470983|NCT04052139|531879813|FG000|Overall Study|Withdrawal by Subject|1|||
147470984|NCT04052139|531879814|FG001|Overall Study|Withdrawal by Subject|0|||
147470985|NCT04052139|531879815|FG002|Overall Study|Withdrawal by Subject|0|||
147470986|NCT00707577|531879816|FG000|Overall Study|Withdrawal by Subject|3|||
147470987|NCT00707577|531879817|FG001|Overall Study|Withdrawal by Subject|2|||
147470988|NCT00707577|531879816|FG000|Overall Study|Lost to Follow-up|34|||
147470989|NCT00707577|531879817|FG001|Overall Study|Lost to Follow-up|25|||
147470990|NCT00707577|531879816|FG000|Overall Study|Left employment|13|||
147470991|NCT00707577|531879817|FG001|Overall Study|Left employment|10|||
147470992|NCT00707577|531879816|FG000|Overall Study|Pregnancy|4|||
147470993|NCT00707577|531879817|FG001|Overall Study|Pregnancy|1|||
147470994|NCT00519077|531879818|FG000|Overall Study|Death|6|||
147470995|NCT00519077|531879818|FG000|Overall Study|Other|2|||
147470996|NCT01967225|531879819|FG000|Overall Study|Adverse Event|3|||
147470997|NCT01967225|531879820|FG001|Overall Study|Adverse Event|1|||
147470998|NCT01967225|531879819|FG000|Overall Study|Withdrawal by Subject|2|||
147470999|NCT01967225|531879820|FG001|Overall Study|Withdrawal by Subject|1|||
147471000|NCT01967225|531879819|FG000|Overall Study|Lack of Efficacy|1|||
147471001|NCT01967225|531879820|FG001|Overall Study|Lack of Efficacy|1|||
147471002|NCT01967225|531879819|FG000|Overall Study|Switching to other therapy|2|||
147471003|NCT01967225|531879820|FG001|Overall Study|Switching to other therapy|0|||
147471004|NCT01967225|531879819|FG000|Overall Study|Protocol driven decision point|1|||
147471005|NCT01967225|531879820|FG001|Overall Study|Protocol driven decision point|0|||
147471006|NCT01967225|531879819|FG000|Overall Study|Logistical difficulties|1|||
147471007|NCT01967225|531879820|FG001|Overall Study|Logistical difficulties|0|||
147471008|NCT01967225|531879819|FG000|Overall Study|Protocol Violation|2|||
147471009|NCT01967225|531879820|FG001|Overall Study|Protocol Violation|0|||
147471010|NCT01709331|531879821|FG000|Overall Study|Adverse Event|1|||
147471011|NCT02305563|531879823|FG000|Treatment Period|Disease progression|0|||
147471012|NCT02305563|531879824|FG001|Treatment Period|Disease progression|0|||
147471013|NCT02305563|531879825|FG002|Treatment Period|Disease progression|15|||
147471014|NCT02305563|531879826|FG003|Treatment Period|Disease progression|6|||
147471015|NCT02305563|531879827|FG004|Treatment Period|Disease progression|6|||
147471016|NCT02305563|531879823|FG000|Treatment Period|Study drug toxicity|0|||
147471017|NCT02305563|531879824|FG001|Treatment Period|Study drug toxicity|0|||
147471018|NCT02305563|531879825|FG002|Treatment Period|Study drug toxicity|0|||
147471019|NCT02305563|531879826|FG003|Treatment Period|Study drug toxicity|1|||
147471020|NCT02305563|531879827|FG004|Treatment Period|Study drug toxicity|2|||
147471021|NCT02305563|531879823|FG000|Treatment Period|Death|0|||
147471022|NCT02305563|531879824|FG001|Treatment Period|Death|0|||
147471023|NCT02305563|531879825|FG002|Treatment Period|Death|1|||
147471024|NCT02305563|531879826|FG003|Treatment Period|Death|2|||
147471025|NCT02305563|531879827|FG004|Treatment Period|Death|1|||
147471026|NCT02305563|531879823|FG000|Treatment Period|Adverse Event (AE) unrelated to drug|0|||
147471027|NCT02305563|531879824|FG001|Treatment Period|Adverse Event (AE) unrelated to drug|0|||
147471028|NCT02305563|531879825|FG002|Treatment Period|Adverse Event (AE) unrelated to drug|7|||
147471029|NCT02305563|531879826|FG003|Treatment Period|Adverse Event (AE) unrelated to drug|1|||
147471030|NCT02305563|531879827|FG004|Treatment Period|Adverse Event (AE) unrelated to drug|2|||
147471031|NCT02305563|531879823|FG000|Treatment Period|Participant request to stop therapy|0|||
147471032|NCT02305563|531879824|FG001|Treatment Period|Participant request to stop therapy|2|||
147471033|NCT02305563|531879825|FG002|Treatment Period|Participant request to stop therapy|0|||
147471034|NCT02305563|531879826|FG003|Treatment Period|Participant request to stop therapy|1|||
147471035|NCT02305563|531879827|FG004|Treatment Period|Participant request to stop therapy|0|||
147471036|NCT02305563|531879823|FG000|Treatment Period|Participant withdrew consent|0|||
147471037|NCT02305563|531879824|FG001|Treatment Period|Participant withdrew consent|0|||
147471038|NCT02305563|531879825|FG002|Treatment Period|Participant withdrew consent|1|||
147471039|NCT02305563|531879826|FG003|Treatment Period|Participant withdrew consent|1|||
147471040|NCT02305563|531879827|FG004|Treatment Period|Participant withdrew consent|1|||
147471041|NCT02305563|531879823|FG000|Treatment Period|Maximum clinical benefit|0|||
147471042|NCT02305563|531879824|FG001|Treatment Period|Maximum clinical benefit|0|||
147471043|NCT02305563|531879825|FG002|Treatment Period|Maximum clinical benefit|0|||
147471044|NCT02305563|531879826|FG003|Treatment Period|Maximum clinical benefit|0|||
147471045|NCT02305563|531879827|FG004|Treatment Period|Maximum clinical benefit|1|||
147471046|NCT02305563|531879823|FG000|Treatment Period|Poor/non-compliance|0|||
147471047|NCT02305563|531879824|FG001|Treatment Period|Poor/non-compliance|0|||
147471048|NCT02305563|531879825|FG002|Treatment Period|Poor/non-compliance|0|||
147471049|NCT02305563|531879826|FG003|Treatment Period|Poor/non-compliance|0|||
147471050|NCT02305563|531879827|FG004|Treatment Period|Poor/non-compliance|1|||
147412508|NCT01014208|531674614|FG000|Overall Study|Did Not Receive Study Drug|2|||
147412509|NCT01014208|531674615|FG001|Overall Study|Did Not Receive Study Drug|0|||
147412510|NCT01014208|531674614|FG000|Overall Study|Study Closed/terminated|78|||
147412511|NCT01014208|531674615|FG001|Overall Study|Study Closed/terminated|83|||
147412512|NCT00414908|531674618|FG000|Overall Study|Protocol Violation|1|||
147412513|NCT00414908|531674619|FG001|Overall Study|Protocol Violation|1|||
147412514|NCT01076153|531674620|FG000|Overall Study|Symptoms improved/resolved|10|||
147412515|NCT01076153|531674620|FG000|Overall Study|Adverse Event|1|||
147412516|NCT00567567|531674621|FG000|Overall Study|Adverse Event|0|||
147412517|NCT00567567|531674622|FG001|Overall Study|Adverse Event|2|||
147412518|NCT00567567|531674623|FG002|Overall Study|Adverse Event|5|||
147412519|NCT00567567|531674621|FG000|Overall Study|Death|8|||
147412520|NCT00567567|531674622|FG001|Overall Study|Death|1|||
147412521|NCT00567567|531674623|FG002|Overall Study|Death|5|||
147412522|NCT00567567|531674621|FG000|Overall Study|Lack of Efficacy|16|||
147412523|NCT00567567|531674622|FG001|Overall Study|Lack of Efficacy|17|||
147412524|NCT00567567|531674623|FG002|Overall Study|Lack of Efficacy|48|||
147412525|NCT00567567|531674621|FG000|Overall Study|Lost to Follow-up|0|||
147412526|NCT00567567|531674622|FG001|Overall Study|Lost to Follow-up|0|||
147412527|NCT00567567|531674623|FG002|Overall Study|Lost to Follow-up|1|||
147412528|NCT00567567|531674621|FG000|Overall Study|Physician Decision|16|||
147412529|NCT00567567|531674622|FG001|Overall Study|Physician Decision|18|||
147412530|NCT00567567|531674623|FG002|Overall Study|Physician Decision|84|||
147412531|NCT00567567|531674621|FG000|Overall Study|Withdrawal by Subject|0|||
147412532|NCT00567567|531674622|FG001|Overall Study|Withdrawal by Subject|0|||
147412533|NCT00567567|531674623|FG002|Overall Study|Withdrawal by Subject|2|||
147412534|NCT00567567|531674621|FG000|Overall Study|Ineligible|4|||
147412535|NCT00567567|531674622|FG001|Overall Study|Ineligible|0|||
147412536|NCT00567567|531674623|FG002|Overall Study|Ineligible|9|||
147412537|NCT00567567|531674621|FG000|Overall Study|Refusal by patient/parent/guardian|9|||
147412538|NCT00567567|531674622|FG001|Overall Study|Refusal by patient/parent/guardian|16|||
147412539|NCT00567567|531674623|FG002|Overall Study|Refusal by patient/parent/guardian|122|||
147412540|NCT00567567|531674621|FG000|Overall Study|Enrolled another COG therapeutic study|99|||
147412541|NCT00567567|531674622|FG001|Overall Study|Enrolled another COG therapeutic study|80|||
147412542|NCT00567567|531674623|FG002|Overall Study|Enrolled another COG therapeutic study|0|||
147412543|NCT00567567|531674621|FG000|Overall Study|Unable adequate stem cell for transplant|0|||
147412544|NCT00567567|531674622|FG001|Overall Study|Unable adequate stem cell for transplant|0|||
147412545|NCT00567567|531674623|FG002|Overall Study|Unable adequate stem cell for transplant|2|||
147412546|NCT03433677|531674624|FG000|Period 1|Protocol Violation|1|||
147412547|NCT03433677|531674625|FG001|Period 1|Protocol Violation|0|||
147412548|NCT03433677|531674624|FG000|Period 2|Withdrawal by Subject|1|||
147412549|NCT03433677|531674625|FG001|Period 2|Withdrawal by Subject|1|||
147412550|NCT03330405|531674626|FG000|Overall Study|Other|1|||
147412551|NCT03330405|531674627|FG001|Overall Study|Other|3|||
147412552|NCT03330405|531674628|FG002|Overall Study|Other|1|||
147412553|NCT03330405|531674629|FG003|Overall Study|Other|0|||
147412554|NCT03330405|531674630|FG004|Overall Study|Other|2|||
147412555|NCT03330405|531674631|FG005|Overall Study|Other|0|||
147412556|NCT03330405|531674632|FG006|Overall Study|Other|1|||
147412557|NCT03330405|531674633|FG007|Overall Study|Other|0|||
147412558|NCT03330405|531674634|FG008|Overall Study|Other|0|||
147412559|NCT03330405|531674635|FG009|Overall Study|Other|0|||
147412560|NCT03330405|531674636|FG010|Overall Study|Other|0|||
147412561|NCT03330405|531674626|FG000|Overall Study|Progressive disease|8|||
147412562|NCT03330405|531674627|FG001|Overall Study|Progressive disease|27|||
147412563|NCT03330405|531674628|FG002|Overall Study|Progressive disease|4|||
147412564|NCT03330405|531674629|FG003|Overall Study|Progressive disease|18|||
147412565|NCT03330405|531674630|FG004|Overall Study|Progressive disease|16|||
147412566|NCT03330405|531674631|FG005|Overall Study|Progressive disease|14|||
147412567|NCT03330405|531674632|FG006|Overall Study|Progressive disease|7|||
147412568|NCT03330405|531674633|FG007|Overall Study|Progressive disease|29|||
147412569|NCT03330405|531674634|FG008|Overall Study|Progressive disease|9|||
147412570|NCT03330405|531674635|FG009|Overall Study|Progressive disease|11|||
147412571|NCT03330405|531674636|FG010|Overall Study|Progressive disease|5|||
147412572|NCT03330405|531674626|FG000|Overall Study|Withdrawal by Subject|1|||
147412573|NCT03330405|531674627|FG001|Overall Study|Withdrawal by Subject|4|||
147620071|NCT01730053|532427207|FG002|Overall Study|Poor compliance to protocol|2|||
147620072|NCT01730053|532427208|FG003|Overall Study|Poor compliance to protocol|0|||
147412574|NCT03330405|531674628|FG002|Overall Study|Withdrawal by Subject|0|||
147620073|NCT01730053|532427209|FG004|Overall Study|Poor compliance to protocol|0|||
147620074|NCT01730053|532427210|FG005|Overall Study|Poor compliance to protocol|2|||
147412575|NCT03330405|531674629|FG003|Overall Study|Withdrawal by Subject|1|||
147412576|NCT03330405|531674630|FG004|Overall Study|Withdrawal by Subject|1|||
147412577|NCT03330405|531674631|FG005|Overall Study|Withdrawal by Subject|1|||
147412578|NCT03330405|531674632|FG006|Overall Study|Withdrawal by Subject|0|||
147412579|NCT03330405|531674633|FG007|Overall Study|Withdrawal by Subject|2|||
147412580|NCT03330405|531674634|FG008|Overall Study|Withdrawal by Subject|2|||
147412581|NCT03330405|531674635|FG009|Overall Study|Withdrawal by Subject|1|||
147412582|NCT03330405|531674636|FG010|Overall Study|Withdrawal by Subject|1|||
147412583|NCT03330405|531674626|FG000|Overall Study|Global deterioration of health status|2|||
147412584|NCT03330405|531674627|FG001|Overall Study|Global deterioration of health status|3|||
147412585|NCT03330405|531674628|FG002|Overall Study|Global deterioration of health status|0|||
147412586|NCT03330405|531674629|FG003|Overall Study|Global deterioration of health status|2|||
147412587|NCT03330405|531674630|FG004|Overall Study|Global deterioration of health status|3|||
147412588|NCT03330405|531674631|FG005|Overall Study|Global deterioration of health status|3|||
147412589|NCT03330405|531674632|FG006|Overall Study|Global deterioration of health status|0|||
147412590|NCT03330405|531674633|FG007|Overall Study|Global deterioration of health status|2|||
147412591|NCT03330405|531674634|FG008|Overall Study|Global deterioration of health status|8|||
147412592|NCT03330405|531674635|FG009|Overall Study|Global deterioration of health status|4|||
147412593|NCT03330405|531674636|FG010|Overall Study|Global deterioration of health status|1|||
147412594|NCT03330405|531674626|FG000|Overall Study|Adverse Event|0|||
147412595|NCT03330405|531674627|FG001|Overall Study|Adverse Event|1|||
147412596|NCT03330405|531674628|FG002|Overall Study|Adverse Event|0|||
147412597|NCT03330405|531674629|FG003|Overall Study|Adverse Event|1|||
147412598|NCT03330405|531674630|FG004|Overall Study|Adverse Event|1|||
147412599|NCT03330405|531674631|FG005|Overall Study|Adverse Event|1|||
147412600|NCT03330405|531674632|FG006|Overall Study|Adverse Event|3|||
147412601|NCT03330405|531674633|FG007|Overall Study|Adverse Event|4|||
147412602|NCT03330405|531674634|FG008|Overall Study|Adverse Event|2|||
147412603|NCT03330405|531674635|FG009|Overall Study|Adverse Event|2|||
147412604|NCT03330405|531674636|FG010|Overall Study|Adverse Event|2|||
147412605|NCT03330405|531674626|FG000|Overall Study|Death|0|||
147412606|NCT03330405|531674627|FG001|Overall Study|Death|4|||
147412607|NCT03330405|531674628|FG002|Overall Study|Death|0|||
147412608|NCT03330405|531674629|FG003|Overall Study|Death|0|||
147412609|NCT03330405|531674630|FG004|Overall Study|Death|0|||
147412610|NCT03330405|531674631|FG005|Overall Study|Death|1|||
147412611|NCT03330405|531674632|FG006|Overall Study|Death|0|||
147412612|NCT03330405|531674633|FG007|Overall Study|Death|2|||
147412613|NCT03330405|531674634|FG008|Overall Study|Death|0|||
147412614|NCT03330405|531674635|FG009|Overall Study|Death|0|||
147412615|NCT03330405|531674636|FG010|Overall Study|Death|0|||
147412616|NCT03330405|531674626|FG000|Overall Study|Physician Decision|0|||
147412617|NCT03330405|531674627|FG001|Overall Study|Physician Decision|0|||
147412618|NCT03330405|531674628|FG002|Overall Study|Physician Decision|0|||
147412619|NCT03330405|531674629|FG003|Overall Study|Physician Decision|0|||
147412620|NCT03330405|531674630|FG004|Overall Study|Physician Decision|0|||
147412621|NCT03330405|531674631|FG005|Overall Study|Physician Decision|0|||
147412622|NCT03330405|531674632|FG006|Overall Study|Physician Decision|0|||
147412623|NCT03330405|531674633|FG007|Overall Study|Physician Decision|1|||
147412624|NCT03330405|531674634|FG008|Overall Study|Physician Decision|0|||
147412625|NCT03330405|531674635|FG009|Overall Study|Physician Decision|0|||
147412626|NCT03330405|531674636|FG010|Overall Study|Physician Decision|0|||
147412627|NCT00702962|531674637|FG000|Overall Study|Progressive disease|0|||
147412628|NCT00702962|531674638|FG001|Overall Study|Progressive disease|1|||
147412629|NCT00702962|531674637|FG000|Overall Study|Hospitalized for other health disorder|1|||
147412630|NCT00702962|531674638|FG001|Overall Study|Hospitalized for other health disorder|0|||
147412631|NCT02175641|531674640|FG000|Overall Study|Death|3|||
147412632|NCT02175641|531674641|FG001|Overall Study|Death|4|||
147412633|NCT02175641|531674640|FG000|Overall Study|Lost to Follow-up|4|||
147412634|NCT02175641|531674641|FG001|Overall Study|Lost to Follow-up|4|||
147412635|NCT02175641|531674640|FG000|Overall Study|Withdrawal by Subject|7|||
147412636|NCT02175641|531674641|FG001|Overall Study|Withdrawal by Subject|4|||
147412637|NCT02175641|531674640|FG000|Overall Study|Discharged from Supportive Housing Agenc|13|||
147412638|NCT02175641|531674641|FG001|Overall Study|Discharged from Supportive Housing Agenc|15|||
147412639|NCT02175641|531674640|FG000|Overall Study|Developed Contraindicated Condition|8|||
147412640|NCT02175641|531674641|FG001|Overall Study|Developed Contraindicated Condition|0|||
147412641|NCT01923467|531674646|FG000|Overall Study|Lost to Follow-up|62|||
147412642|NCT01923467|531674646|FG000|Overall Study|Subject non-interest|479|||
147412643|NCT04462289|531674649|FG000|Overall Study|Lost to Follow-up|4|||
147412644|NCT04462289|531674650|FG001|Overall Study|Lost to Follow-up|5|||
147412645|NCT04462289|531674649|FG000|Overall Study|Death|0|||
147412646|NCT04462289|531674650|FG001|Overall Study|Death|3|||
147412647|NCT04462289|531674649|FG000|Overall Study|Withdrawal by Subject|1|||
147412648|NCT04462289|531674650|FG001|Overall Study|Withdrawal by Subject|3|||
147412649|NCT02206061|531674651|FG000|Overall Study|Withdrawal by Subject|4|||
147412650|NCT02206061|531674652|FG001|Overall Study|Withdrawal by Subject|7|||
147412651|NCT02206061|531674653|FG002|Overall Study|Withdrawal by Subject|1|||
147412652|NCT02206061|531674651|FG000|Overall Study|Lost to Follow-up|14|||
147412653|NCT02206061|531674652|FG001|Overall Study|Lost to Follow-up|7|||
147412654|NCT02206061|531674653|FG002|Overall Study|Lost to Follow-up|20|||
147412655|NCT04187326|531674654|FG000|Overall Study|Lost to Follow-up|2|||
147412656|NCT04187326|531674655|FG001|Overall Study|Lost to Follow-up|1|||
147665893|NCT00324155|532601629|FG000|Received Treatment in Induction Phase|Adverse Event|6|||
147665894|NCT00324155|532601630|FG001|Received Treatment in Induction Phase|Adverse Event|7|||
147412657|NCT04187326|531674654|FG000|Overall Study|Computer error- task was only partially completed.|0|||
147620075|NCT01730053|532427205|FG000|Overall Study|Other than specified|2|||
147620076|NCT01730053|532427206|FG001|Overall Study|Other than specified|6|||
147412658|NCT04187326|531674655|FG001|Overall Study|Computer error- task was only partially completed.|1|||
147412659|NCT05235269|531674664|FG000|Overall Study|Adverse Event|1|||
147412660|NCT05235269|531674664|FG000|Overall Study|Participant elected to drop out (i.e., not undergo second scan) but did not withdraw consent|1|||
147412661|NCT05235269|531674664|FG000|Overall Study|Protocol-specified withdrawal criterion met|5|||
147412662|NCT03810235|531674665|FG000|Overall Study|Withdrawal by Subject|2|||
147412663|NCT03810235|531674666|FG001|Overall Study|Withdrawal by Subject|0|||
147412664|NCT00798434|531674667|FG000|Double-Blind|Adverse Event|22|||
147412665|NCT00798434|531674668|FG001|Double-Blind|Adverse Event|46|||
147412666|NCT00798434|531674667|FG000|Double-Blind|Death|0|||
147412667|NCT00798434|531674668|FG001|Double-Blind|Death|1|||
147412668|NCT00798434|531674667|FG000|Double-Blind|Lost to Follow-up|1|||
147412669|NCT00798434|531674668|FG001|Double-Blind|Lost to Follow-up|0|||
147412670|NCT00798434|531674667|FG000|Double-Blind|Lack of Efficacy|8|||
147412671|NCT00798434|531674668|FG001|Double-Blind|Lack of Efficacy|12|||
147412672|NCT00798434|531674667|FG000|Double-Blind|Withdrawal by Subject|17|||
147412673|NCT00798434|531674668|FG001|Double-Blind|Withdrawal by Subject|14|||
147412674|NCT00798434|531674667|FG000|Double-Blind|Protocol Violation|1|||
147412675|NCT00798434|531674668|FG001|Double-Blind|Protocol Violation|4|||
147412676|NCT00798434|531674667|FG000|Double-Blind|Did Not Meet Entrance Criteria|2|||
147412677|NCT00798434|531674668|FG001|Double-Blind|Did Not Meet Entrance Criteria|1|||
147412678|NCT00798434|531674667|FG000|Double-Blind|Other|1|||
147412679|NCT00798434|531674668|FG001|Double-Blind|Other|0|||
147412680|NCT00798434|531674667|FG000|Double-Blind|Not Treated|3|||
147412681|NCT00798434|531674668|FG001|Double-Blind|Not Treated|6|||
147412682|NCT00798434|531674667|FG000|Open-Label|Adverse Event|33|||
147412683|NCT00798434|531674668|FG001|Open-Label|Adverse Event|11|||
147412684|NCT00798434|531674667|FG000|Open-Label|Lack of Efficacy|5|||
147412685|NCT00798434|531674668|FG001|Open-Label|Lack of Efficacy|11|||
147412686|NCT00798434|531674667|FG000|Open-Label|Withdrawal by Subject|2|||
147412687|NCT00798434|531674668|FG001|Open-Label|Withdrawal by Subject|7|||
147412688|NCT00798434|531674667|FG000|Open-Label|Protocol Violation|1|||
147412689|NCT00798434|531674668|FG001|Open-Label|Protocol Violation|0|||
147412690|NCT00798434|531674667|FG000|Open-Label|Other|1|||
147412691|NCT00798434|531674668|FG001|Open-Label|Other|2|||
147412692|NCT00798434|531674667|FG000|Open-Label|Not Treated|0|||
147412693|NCT00798434|531674668|FG001|Open-Label|Not Treated|1|||
147412694|NCT03682185|531674674|FG000|Overall Study|Lost to Follow-up|4|||
147412695|NCT03682185|531674675|FG001|Overall Study|Lost to Follow-up|7|||
147412696|NCT03682185|531674676|FG002|Overall Study|Lost to Follow-up|4|||
147412697|NCT03682185|531674677|FG003|Overall Study|Lost to Follow-up|7|||
147412698|NCT03682185|531674678|FG004|Overall Study|Lost to Follow-up|1|||
147412699|NCT03682185|531674674|FG000|Overall Study|Withdrawal by Subject|7|||
147412700|NCT03682185|531674675|FG001|Overall Study|Withdrawal by Subject|3|||
147412701|NCT03682185|531674676|FG002|Overall Study|Withdrawal by Subject|7|||
147412702|NCT03682185|531674677|FG003|Overall Study|Withdrawal by Subject|3|||
147412703|NCT03682185|531674678|FG004|Overall Study|Withdrawal by Subject|0|||
147412704|NCT04908631|531674679|FG000|Overall Study|Lost to Follow-up|1|||
147412705|NCT04908631|531674679|FG000|Overall Study|Physician Decision|1|||
147412706|NCT04908631|531674679|FG000|Overall Study|Received a second implant after the 1 month visit|1|||
147412707|NCT02336451|531674683|FG000|Overall Study|Adverse Event|1|||
147412708|NCT02336451|531674684|FG001|Overall Study|Adverse Event|2|||
147412709|NCT02336451|531674685|FG002|Overall Study|Adverse Event|0|||
147412710|NCT02336451|531674686|FG003|Overall Study|Adverse Event|6|||
147412711|NCT02336451|531674687|FG004|Overall Study|Adverse Event|4|||
147412712|NCT02336451|531674683|FG000|Overall Study|Death|6|||
147412713|NCT02336451|531674684|FG001|Overall Study|Death|2|||
147412714|NCT02336451|531674685|FG002|Overall Study|Death|3|||
147412715|NCT02336451|531674686|FG003|Overall Study|Death|6|||
147412716|NCT02336451|531674687|FG004|Overall Study|Death|6|||
147412717|NCT02336451|531674683|FG000|Overall Study|Physician Decision|9|||
147412718|NCT02336451|531674684|FG001|Overall Study|Physician Decision|6|||
147412719|NCT02336451|531674685|FG002|Overall Study|Physician Decision|7|||
147412720|NCT02336451|531674686|FG003|Overall Study|Physician Decision|16|||
147412721|NCT02336451|531674687|FG004|Overall Study|Physician Decision|3|||
147620077|NCT01730053|532427207|FG002|Overall Study|Other than specified|5|||
147412722|NCT02336451|531674683|FG000|Overall Study|Progressive disease|23|||
147412723|NCT02336451|531674684|FG001|Overall Study|Progressive disease|26|||
147412724|NCT02336451|531674685|FG002|Overall Study|Progressive disease|2|||
147412725|NCT02336451|531674686|FG003|Overall Study|Progressive disease|14|||
147412726|NCT02336451|531674687|FG004|Overall Study|Progressive disease|4|||
147412727|NCT02336451|531674683|FG000|Overall Study|Protocol Violation|1|||
147412728|NCT02336451|531674684|FG001|Overall Study|Protocol Violation|0|||
147412729|NCT02336451|531674685|FG002|Overall Study|Protocol Violation|0|||
147412730|NCT02336451|531674686|FG003|Overall Study|Protocol Violation|0|||
147412731|NCT02336451|531674687|FG004|Overall Study|Protocol Violation|0|||
147412732|NCT02336451|531674683|FG000|Overall Study|Patient/guardian decision|2|||
147412733|NCT02336451|531674684|FG001|Overall Study|Patient/guardian decision|4|||
147412734|NCT02336451|531674685|FG002|Overall Study|Patient/guardian decision|0|||
147412735|NCT02336451|531674686|FG003|Overall Study|Patient/guardian decision|2|||
147412736|NCT02336451|531674687|FG004|Overall Study|Patient/guardian decision|1|||
147412737|NCT03520712|531674689|FG000|Overall Study|Early termination of the study by Sponsor|2|||
147412738|NCT02344290|531674696|FG000|Overall Study|Withdrawal by Subject|315|||
147412739|NCT02344290|531674697|FG001|Overall Study|Withdrawal by Subject|324|||
147412740|NCT02344290|531674696|FG000|Overall Study|Lost to Follow-up|258|||
147412741|NCT02344290|531674697|FG001|Overall Study|Lost to Follow-up|249|||
147412742|NCT02344290|531674696|FG000|Overall Study|Unable to get to clinic|69|||
147412743|NCT02344290|531674697|FG001|Overall Study|Unable to get to clinic|60|||
147412744|NCT02344290|531674696|FG000|Overall Study|Physician Decision|25|||
147412745|NCT02344290|531674697|FG001|Overall Study|Physician Decision|25|||
147412746|NCT02344290|531674696|FG000|Overall Study|Site Closure|15|||
147412747|NCT02344290|531674697|FG001|Overall Study|Site Closure|19|||
147412748|NCT02344290|531674696|FG000|Overall Study|Other|5|||
147412749|NCT02344290|531674697|FG001|Overall Study|Other|3|||
147412750|NCT04998812|531674698|FG000|Pregnancy and Early Post-Partum Period|Participant switches to another treatment of MS|1|||
147412751|NCT04998812|531674699|FG001|Pregnancy and Early Post-Partum Period|Participant switches to another treatment of MS|0|||
147412752|NCT04998812|531674698|FG000|Pregnancy and Early Post-Partum Period|Lost to Follow-up|1|||
147412753|NCT04998812|531674699|FG001|Pregnancy and Early Post-Partum Period|Lost to Follow-up|0|||
147412754|NCT04998812|531674698|FG000|Pregnancy and Early Post-Partum Period|Other|0|||
147412755|NCT04998812|531674699|FG001|Pregnancy and Early Post-Partum Period|Other|1|||
147412756|NCT04998812|531674698|FG000|Vaccination Period|Ongoing in study|23|||
147412757|NCT04998812|531674699|FG001|Vaccination Period|Ongoing in study|23|||
147412758|NCT04047862|531674703|FG000|Overall Study|Death|0|||
147412759|NCT04047862|531674704|FG001|Overall Study|Death|0|||
147412760|NCT04047862|531674705|FG002|Overall Study|Death|4|||
147412761|NCT04047862|531674706|FG003|Overall Study|Death|7|||
147412762|NCT04047862|531674707|FG004|Overall Study|Death|2|||
147412763|NCT04047862|531674708|FG005|Overall Study|Death|4|||
147412764|NCT04047862|531674709|FG006|Overall Study|Death|3|||
147412765|NCT04047862|531674710|FG007|Overall Study|Death|24|||
147412766|NCT04047862|531674711|FG008|Overall Study|Death|24|||
147412767|NCT04047862|531674712|FG009|Overall Study|Death|22|||
147412768|NCT04047862|531674713|FG010|Overall Study|Death|35|||
147412769|NCT04047862|531674714|FG011|Overall Study|Death|18|||
147412770|NCT04047862|531674715|FG012|Overall Study|Death|14|||
147412771|NCT04047862|531674716|FG013|Overall Study|Death|6|||
147412772|NCT04047862|531674717|FG014|Overall Study|Death|19|||
147412773|NCT04047862|531674718|FG015|Overall Study|Death|42|||
147412774|NCT04047862|531674719|FG016|Overall Study|Death|9|||
147412775|NCT04047862|531674720|FG017|Overall Study|Death|8|||
147412776|NCT04047862|531674721|FG018|Overall Study|Death|10|||
147620078|NCT01730053|532427208|FG003|Overall Study|Other than specified|4|||
147620079|NCT01730053|532427209|FG004|Overall Study|Other than specified|7|||
147303150|NCT05044325|531276256|FG006|Part A:Treatment Period 2|Physician Decision|0|||
147303151|NCT05044325|531276257|FG007|Part A:Treatment Period 2|Physician Decision|0|||
147303152|NCT05044325|531276258|FG008|Part A:Treatment Period 2|Physician Decision|0|||
147303153|NCT05044325|531276259|FG009|Part A:Treatment Period 2|Physician Decision|0|||
147303154|NCT05044325|531276250|FG000|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
147303155|NCT05044325|531276251|FG001|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
147303156|NCT05044325|531276252|FG002|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
147303157|NCT05044325|531276253|FG003|Part A:Treatment Period 2|Sponsor Terminated study treatment|1|||
147303158|NCT05044325|531276254|FG004|Part A:Treatment Period 2|Sponsor Terminated study treatment|1|||
147303159|NCT05044325|531276255|FG005|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
147303160|NCT05044325|531276256|FG006|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
147303161|NCT05044325|531276257|FG007|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
147303162|NCT05044325|531276258|FG008|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
147303163|NCT05044325|531276259|FG009|Part A:Treatment Period 2|Sponsor Terminated study treatment|0|||
147303164|NCT00755222|531276260|FG000|Overall Study|Withdrawal by Subject|4|||
147303165|NCT00755222|531276261|FG001|Overall Study|Withdrawal by Subject|2|||
147303166|NCT00755222|531276260|FG000|Overall Study|Adverse Event|2|||
147303167|NCT00755222|531276261|FG001|Overall Study|Adverse Event|0|||
147303168|NCT00755222|531276260|FG000|Overall Study|Protocol Violation|2|||
147303169|NCT00755222|531276261|FG001|Overall Study|Protocol Violation|0|||
147303170|NCT00742079|531276262|FG000|Overall Study|Lost to Follow-up|0|||
147303171|NCT00742079|531276263|FG001|Overall Study|Lost to Follow-up|1|||
147303172|NCT02243202|531276264|FG000|Overall Study|Adverse Event|5|||
147303173|NCT02243202|531276265|FG001|Overall Study|Adverse Event|6|||
147303174|NCT02243202|531276266|FG002|Overall Study|Adverse Event|10|||
147303175|NCT02243202|531276267|FG003|Overall Study|Adverse Event|4|||
147412777|NCT04047862|531674703|FG000|Overall Study|Withdrawal by Subject|0|||
147412778|NCT04047862|531674704|FG001|Overall Study|Withdrawal by Subject|0|||
147412779|NCT04047862|531674705|FG002|Overall Study|Withdrawal by Subject|0|||
147412780|NCT04047862|531674706|FG003|Overall Study|Withdrawal by Subject|5|||
147412781|NCT04047862|531674707|FG004|Overall Study|Withdrawal by Subject|2|||
147412782|NCT04047862|531674708|FG005|Overall Study|Withdrawal by Subject|0|||
147412783|NCT04047862|531674709|FG006|Overall Study|Withdrawal by Subject|1|||
147412784|NCT04047862|531674710|FG007|Overall Study|Withdrawal by Subject|0|||
147412785|NCT04047862|531674711|FG008|Overall Study|Withdrawal by Subject|4|||
147412786|NCT04047862|531674712|FG009|Overall Study|Withdrawal by Subject|4|||
147412787|NCT04047862|531674713|FG010|Overall Study|Withdrawal by Subject|4|||
147412788|NCT04047862|531674714|FG011|Overall Study|Withdrawal by Subject|2|||
147412789|NCT04047862|531674715|FG012|Overall Study|Withdrawal by Subject|3|||
147412790|NCT04047862|531674716|FG013|Overall Study|Withdrawal by Subject|0|||
147412791|NCT04047862|531674717|FG014|Overall Study|Withdrawal by Subject|9|||
147412792|NCT04047862|531674718|FG015|Overall Study|Withdrawal by Subject|5|||
147412793|NCT04047862|531674719|FG016|Overall Study|Withdrawal by Subject|1|||
147412794|NCT04047862|531674720|FG017|Overall Study|Withdrawal by Subject|3|||
147412795|NCT04047862|531674721|FG018|Overall Study|Withdrawal by Subject|1|||
147412796|NCT04047862|531674703|FG000|Overall Study|Lost to Follow-up|0|||
147412797|NCT04047862|531674704|FG001|Overall Study|Lost to Follow-up|0|||
147412798|NCT04047862|531674705|FG002|Overall Study|Lost to Follow-up|1|||
147412799|NCT04047862|531674706|FG003|Overall Study|Lost to Follow-up|0|||
147412800|NCT04047862|531674707|FG004|Overall Study|Lost to Follow-up|0|||
147412801|NCT04047862|531674708|FG005|Overall Study|Lost to Follow-up|0|||
147412802|NCT04047862|531674709|FG006|Overall Study|Lost to Follow-up|0|||
147412803|NCT04047862|531674710|FG007|Overall Study|Lost to Follow-up|1|||
147412804|NCT04047862|531674711|FG008|Overall Study|Lost to Follow-up|0|||
147412805|NCT04047862|531674712|FG009|Overall Study|Lost to Follow-up|1|||
147412806|NCT04047862|531674713|FG010|Overall Study|Lost to Follow-up|0|||
147412807|NCT04047862|531674714|FG011|Overall Study|Lost to Follow-up|3|||
147412808|NCT04047862|531674715|FG012|Overall Study|Lost to Follow-up|0|||
147412809|NCT04047862|531674716|FG013|Overall Study|Lost to Follow-up|0|||
147412810|NCT04047862|531674717|FG014|Overall Study|Lost to Follow-up|2|||
147412811|NCT04047862|531674718|FG015|Overall Study|Lost to Follow-up|2|||
147412812|NCT04047862|531674719|FG016|Overall Study|Lost to Follow-up|1|||
147412813|NCT04047862|531674720|FG017|Overall Study|Lost to Follow-up|0|||
147412814|NCT04047862|531674721|FG018|Overall Study|Lost to Follow-up|0|||
147412815|NCT04047862|531674703|FG000|Overall Study|Physician Decision|0|||
147412816|NCT04047862|531674704|FG001|Overall Study|Physician Decision|0|||
147412817|NCT04047862|531674705|FG002|Overall Study|Physician Decision|0|||
147412818|NCT04047862|531674706|FG003|Overall Study|Physician Decision|1|||
147412819|NCT04047862|531674707|FG004|Overall Study|Physician Decision|0|||
147412820|NCT04047862|531674708|FG005|Overall Study|Physician Decision|0|||
147412821|NCT04047862|531674709|FG006|Overall Study|Physician Decision|0|||
147412822|NCT04047862|531674710|FG007|Overall Study|Physician Decision|0|||
147412823|NCT04047862|531674711|FG008|Overall Study|Physician Decision|0|||
147412824|NCT04047862|531674712|FG009|Overall Study|Physician Decision|0|||
147412825|NCT04047862|531674713|FG010|Overall Study|Physician Decision|0|||
147412826|NCT04047862|531674714|FG011|Overall Study|Physician Decision|0|||
147412827|NCT04047862|531674715|FG012|Overall Study|Physician Decision|0|||
147412828|NCT04047862|531674716|FG013|Overall Study|Physician Decision|0|||
147412829|NCT04047862|531674717|FG014|Overall Study|Physician Decision|1|||
147412830|NCT04047862|531674718|FG015|Overall Study|Physician Decision|0|||
147412831|NCT04047862|531674719|FG016|Overall Study|Physician Decision|1|||
147412832|NCT04047862|531674720|FG017|Overall Study|Physician Decision|0|||
147412833|NCT04047862|531674721|FG018|Overall Study|Physician Decision|0|||
147412834|NCT04047862|531674703|FG000|Overall Study|Completed all Assessments|1|||
147412835|NCT04047862|531674704|FG001|Overall Study|Completed all Assessments|3|||
147412836|NCT04047862|531674705|FG002|Overall Study|Completed all Assessments|1|||
147412837|NCT04047862|531674706|FG003|Overall Study|Completed all Assessments|3|||
147412838|NCT04047862|531674707|FG004|Overall Study|Completed all Assessments|2|||
147412839|NCT04047862|531674708|FG005|Overall Study|Completed all Assessments|5|||
147412840|NCT04047862|531674709|FG006|Overall Study|Completed all Assessments|7|||
147412841|NCT04047862|531674710|FG007|Overall Study|Completed all Assessments|0|||
147412842|NCT04047862|531674711|FG008|Overall Study|Completed all Assessments|0|||
147412843|NCT04047862|531674712|FG009|Overall Study|Completed all Assessments|0|||
147412844|NCT04047862|531674713|FG010|Overall Study|Completed all Assessments|0|||
147412845|NCT04047862|531674714|FG011|Overall Study|Completed all Assessments|0|||
147412846|NCT04047862|531674715|FG012|Overall Study|Completed all Assessments|0|||
147412847|NCT04047862|531674716|FG013|Overall Study|Completed all Assessments|0|||
147412848|NCT04047862|531674717|FG014|Overall Study|Completed all Assessments|0|||
147412849|NCT04047862|531674718|FG015|Overall Study|Completed all Assessments|0|||
147412850|NCT04047862|531674719|FG016|Overall Study|Completed all Assessments|0|||
147412851|NCT04047862|531674720|FG017|Overall Study|Completed all Assessments|0|||
147412852|NCT04047862|531674721|FG018|Overall Study|Completed all Assessments|0|||
147412853|NCT04047862|531674703|FG000|Overall Study|Sponsor Decision|0|||
147412854|NCT04047862|531674704|FG001|Overall Study|Sponsor Decision|0|||
147412855|NCT04047862|531674705|FG002|Overall Study|Sponsor Decision|0|||
147412856|NCT04047862|531674706|FG003|Overall Study|Sponsor Decision|0|||
147412857|NCT04047862|531674707|FG004|Overall Study|Sponsor Decision|0|||
147412858|NCT04047862|531674708|FG005|Overall Study|Sponsor Decision|0|||
147412859|NCT04047862|531674709|FG006|Overall Study|Sponsor Decision|0|||
147412860|NCT04047862|531674710|FG007|Overall Study|Sponsor Decision|13|||
147412861|NCT04047862|531674711|FG008|Overall Study|Sponsor Decision|10|||
147412862|NCT04047862|531674712|FG009|Overall Study|Sponsor Decision|18|||
147412863|NCT04047862|531674713|FG010|Overall Study|Sponsor Decision|3|||
147412864|NCT04047862|531674714|FG011|Overall Study|Sponsor Decision|3|||
147620080|NCT01730053|532427210|FG005|Overall Study|Other than specified|9|||
147620081|NCT01470248|532427211|FG000|Overall Study|Withdrawal by Subject|1|||
147620082|NCT05842967|532427214|FG000|Period 1: SSA|Adverse Event|1|||
147412865|NCT04047862|531674715|FG012|Overall Study|Sponsor Decision|4|||
147412866|NCT04047862|531674716|FG013|Overall Study|Sponsor Decision|0|||
147412867|NCT04047862|531674717|FG014|Overall Study|Sponsor Decision|7|||
147412868|NCT04047862|531674718|FG015|Overall Study|Sponsor Decision|8|||
147412869|NCT04047862|531674719|FG016|Overall Study|Sponsor Decision|9|||
147412870|NCT04047862|531674720|FG017|Overall Study|Sponsor Decision|7|||
147412871|NCT04047862|531674721|FG018|Overall Study|Sponsor Decision|8|||
147412872|NCT04047862|531674703|FG000|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
147412873|NCT04047862|531674704|FG001|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
147412874|NCT04047862|531674705|FG002|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
147412875|NCT04047862|531674706|FG003|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
147412876|NCT04047862|531674707|FG004|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
147412877|NCT04047862|531674708|FG005|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
147412878|NCT04047862|531674709|FG006|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
147412879|NCT04047862|531674710|FG007|Overall Study|Transfer to a Company Sponsored Clinical Trial|3|||
147412880|NCT04047862|531674711|FG008|Overall Study|Transfer to a Company Sponsored Clinical Trial|5|||
147412881|NCT04047862|531674712|FG009|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
147412882|NCT04047862|531674713|FG010|Overall Study|Transfer to a Company Sponsored Clinical Trial|1|||
147412883|NCT04047862|531674714|FG011|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
147412884|NCT04047862|531674715|FG012|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
147412885|NCT04047862|531674716|FG013|Overall Study|Transfer to a Company Sponsored Clinical Trial|0|||
147412886|NCT04047862|531674717|FG014|Overall Study|Transfer to a Company Sponsored Clinical Trial|1|||
147412887|NCT04047862|531674718|FG015|Overall Study|Transfer to a Company Sponsored Clinical Trial|1|||
147412888|NCT04047862|531674719|FG016|Overall Study|Transfer to a Company Sponsored Clinical Trial|2|||
147412889|NCT04047862|531674720|FG017|Overall Study|Transfer to a Company Sponsored Clinical Trial|2|||
147412890|NCT04047862|531674721|FG018|Overall Study|Transfer to a Company Sponsored Clinical Trial|2|||
147412891|NCT04047862|531674703|FG000|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
147412892|NCT04047862|531674704|FG001|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
147412893|NCT04047862|531674705|FG002|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
147412894|NCT04047862|531674706|FG003|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
147412895|NCT04047862|531674707|FG004|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
147412896|NCT04047862|531674708|FG005|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
147412897|NCT04047862|531674709|FG006|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
147412898|NCT04047862|531674710|FG007|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
147412899|NCT04047862|531674711|FG008|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
147412900|NCT04047862|531674712|FG009|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
147412901|NCT04047862|531674713|FG010|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
147412902|NCT04047862|531674714|FG011|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
147412903|NCT04047862|531674715|FG012|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
147412904|NCT04047862|531674716|FG013|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
147412905|NCT04047862|531674717|FG014|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
147412906|NCT04047862|531674718|FG015|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|1|||
147412907|NCT04047862|531674719|FG016|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
147412908|NCT04047862|531674720|FG017|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|0|||
147412909|NCT04047862|531674721|FG018|Overall Study|Transfer to Patient Supply Treatment Program (PTS)|2|||
147412910|NCT04047862|531674703|FG000|Overall Study|Other|0|||
147412911|NCT04047862|531674704|FG001|Overall Study|Other|0|||
147412912|NCT04047862|531674705|FG002|Overall Study|Other|0|||
147412913|NCT04047862|531674706|FG003|Overall Study|Other|0|||
147412914|NCT04047862|531674707|FG004|Overall Study|Other|0|||
147412915|NCT04047862|531674708|FG005|Overall Study|Other|0|||
147412916|NCT04047862|531674709|FG006|Overall Study|Other|0|||
147412917|NCT04047862|531674710|FG007|Overall Study|Other|0|||
147412918|NCT04047862|531674711|FG008|Overall Study|Other|0|||
147412919|NCT04047862|531674712|FG009|Overall Study|Other|0|||
147412920|NCT04047862|531674713|FG010|Overall Study|Other|0|||
147412921|NCT04047862|531674714|FG011|Overall Study|Other|0|||
147412922|NCT04047862|531674715|FG012|Overall Study|Other|0|||
147620083|NCT05842967|532427215|FG001|Period 1: SSA|Adverse Event|1|||
147620084|NCT05842967|532427216|FG002|Period 1: SSA|Adverse Event|0|||
147620085|NCT05842967|532427217|FG003|Period 1: SSA|Adverse Event|0|||
147412923|NCT04047862|531674716|FG013|Overall Study|Other|0|||
147412924|NCT04047862|531674717|FG014|Overall Study|Other|2|||
147412925|NCT04047862|531674718|FG015|Overall Study|Other|1|||
147412926|NCT04047862|531674719|FG016|Overall Study|Other|1|||
147412927|NCT04047862|531674720|FG017|Overall Study|Other|1|||
147412928|NCT04047862|531674721|FG018|Overall Study|Other|0|||
147412929|NCT06748729|531674726|FG000|Overall Study|Withdrawal by Subject|1|||
147412930|NCT03578887|531674727|FG000|Overall Study|Withdrawal by Subject|7|||
147412931|NCT03578887|531674728|FG001|Overall Study|Withdrawal by Subject|2|||
147412932|NCT03578887|531674729|FG002|Overall Study|Withdrawal by Subject|1|||
147412933|NCT03578887|531674727|FG000|Overall Study|Lost to Follow-up|13|||
147412934|NCT03578887|531674728|FG001|Overall Study|Lost to Follow-up|1|||
147412935|NCT03578887|531674729|FG002|Overall Study|Lost to Follow-up|4|||
147412936|NCT03578887|531674727|FG000|Overall Study|Physician Decision|0|||
147412937|NCT03578887|531674728|FG001|Overall Study|Physician Decision|1|||
147412938|NCT03578887|531674729|FG002|Overall Study|Physician Decision|1|||
147412939|NCT01015560|531676029|FG000|Overall Study|Adverse Event|1|||
147412940|NCT01015560|531676029|FG000|Overall Study|Not protocol specified|1|||
147412941|NCT01015560|531676029|FG000|Overall Study|Withdrawal by Subject|1|||
147412942|NCT00264303|531676034|FG000|Overall Study|Adverse Event|4|||
147412943|NCT00264303|531676035|FG001|Overall Study|Adverse Event|3|||
147412944|NCT00264303|531676034|FG000|Overall Study|Lack of Efficacy|10|||
147412945|NCT00264303|531676035|FG001|Overall Study|Lack of Efficacy|13|||
147412946|NCT00264303|531676034|FG000|Overall Study|Lost to Follow-up|3|||
147412947|NCT00264303|531676035|FG001|Overall Study|Lost to Follow-up|3|||
147412948|NCT00264303|531676034|FG000|Overall Study|Withdrawal by Subject|2|||
147412949|NCT00264303|531676035|FG001|Overall Study|Withdrawal by Subject|3|||
147412950|NCT00264303|531676034|FG000|Overall Study|Various reasons listed in study report|6|||
147412951|NCT00264303|531676035|FG001|Overall Study|Various reasons listed in study report|7|||
147412952|NCT02389452|531676036|FG000|Overall Study|Lost to Follow-up|13|||
147412953|NCT02389452|531676036|FG000|Overall Study|Adverse Event|1|||
147412954|NCT02389452|531676036|FG000|Overall Study|Withdrawal by Subject|5|||
147412955|NCT02389452|531676036|FG000|Overall Study|Enrolled but Not Eligible for Study|6|||
147412956|NCT04165031|531676044|FG000|Overall Study|Adverse Event|1|||
147412957|NCT04165031|531676045|FG001|Overall Study|Adverse Event|1|||
147412958|NCT04165031|531676046|FG002|Overall Study|Adverse Event|0|||
147412959|NCT04165031|531676047|FG003|Overall Study|Adverse Event|0|||
147412960|NCT04165031|531676048|FG004|Overall Study|Adverse Event|0|||
147412961|NCT04165031|531676049|FG005|Overall Study|Adverse Event|0|||
147412962|NCT04165031|531676044|FG000|Overall Study|Withdrawal by Subject|0|||
147412963|NCT04165031|531676045|FG001|Overall Study|Withdrawal by Subject|0|||
147412964|NCT04165031|531676046|FG002|Overall Study|Withdrawal by Subject|1|||
147412965|NCT04165031|531676047|FG003|Overall Study|Withdrawal by Subject|0|||
147412966|NCT04165031|531676048|FG004|Overall Study|Withdrawal by Subject|0|||
147412967|NCT04165031|531676049|FG005|Overall Study|Withdrawal by Subject|0|||
147412968|NCT00818168|531676050|FG000|Overall Study|Lack of Efficacy|18|||
147471051|NCT02305563|531879823|FG000|Treatment Period|Administrative reason by Sponsor|0|||
147471052|NCT02305563|531879824|FG001|Treatment Period|Administrative reason by Sponsor|0|||
147471053|NCT02305563|531879825|FG002|Treatment Period|Administrative reason by Sponsor|0|||
147471054|NCT02305563|531879826|FG003|Treatment Period|Administrative reason by Sponsor|0|||
147471055|NCT02305563|531879827|FG004|Treatment Period|Administrative reason by Sponsor|1|||
147471056|NCT02305563|531879823|FG000|Treatment Period|other reason|2|||
147471057|NCT02305563|531879824|FG001|Treatment Period|other reason|0|||
147471058|NCT02305563|531879825|FG002|Treatment Period|other reason|2|||
147471059|NCT02305563|531879826|FG003|Treatment Period|other reason|2|||
147471060|NCT02305563|531879827|FG004|Treatment Period|other reason|1|||
147412969|NCT00818168|531676050|FG000|Overall Study|Pregnancy|2|||
147412970|NCT00818168|531676050|FG000|Overall Study|Withdrawal by Subject|16|||
147412971|NCT00818168|531676050|FG000|Overall Study|Lost to Follow-up|7|||
147412972|NCT00818168|531676050|FG000|Overall Study|Adverse Event|19|||
147412973|NCT00818168|531676050|FG000|Overall Study|Reason for Non-completion Not reported|6|||
147412974|NCT00818168|531676050|FG000|Overall Study|Participant Moved|2|||
147412975|NCT01332630|531676051|FG000|Overall Study|Withdrawal by Subject|3|||
147412976|NCT01008553|531676052|FG000|Period 1 (Titration Period)|Physician Decision|2|||
147412977|NCT01008553|531676053|FG001|Period 1 (Titration Period)|Physician Decision|0|||
147412978|NCT01008553|531676054|FG002|Period 1 (Titration Period)|Physician Decision|0|||
147412979|NCT01008553|531676052|FG000|Period 1 (Titration Period)|Adverse Event|33|||
147412980|NCT01008553|531676053|FG001|Period 1 (Titration Period)|Adverse Event|0|||
147412981|NCT01008553|531676054|FG002|Period 1 (Titration Period)|Adverse Event|0|||
147412982|NCT01008553|531676052|FG000|Period 1 (Titration Period)|Withdrawal by Subject|6|||
147412983|NCT01008553|531676053|FG001|Period 1 (Titration Period)|Withdrawal by Subject|0|||
147412984|NCT01008553|531676054|FG002|Period 1 (Titration Period)|Withdrawal by Subject|0|||
147412985|NCT01008553|531676052|FG000|Period 1 (Titration Period)|Determined to increase dosage|3|||
147471061|NCT02305563|531879823|FG000|Treatment Period|Randomized but not treated|0|||
147471062|NCT02305563|531879824|FG001|Treatment Period|Randomized but not treated|0|||
147412986|NCT01008553|531676053|FG001|Period 1 (Titration Period)|Determined to increase dosage|0|||
147412987|NCT01008553|531676054|FG002|Period 1 (Titration Period)|Determined to increase dosage|0|||
147412988|NCT01008553|531676052|FG000|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|50|||
147412989|NCT01008553|531676053|FG001|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0|||
147412990|NCT01008553|531676054|FG002|Period 1 (Titration Period)|Not satisfied criteria to enter Period 2|0|||
147412991|NCT01008553|531676052|FG000|Period 1 (Titration Period)|Not appropriate for this study|1|||
147412992|NCT01008553|531676053|FG001|Period 1 (Titration Period)|Not appropriate for this study|0|||
147412993|NCT01008553|531676054|FG002|Period 1 (Titration Period)|Not appropriate for this study|0|||
147412994|NCT01008553|531676052|FG000|Period 2 (Double-Blind Period)|Physician Decision|0|||
147412995|NCT01008553|531676053|FG001|Period 2 (Double-Blind Period)|Physician Decision|1|||
147412996|NCT01008553|531676054|FG002|Period 2 (Double-Blind Period)|Physician Decision|2|||
147412997|NCT01008553|531676052|FG000|Period 2 (Double-Blind Period)|Adverse Event|0|||
147412998|NCT01008553|531676053|FG001|Period 2 (Double-Blind Period)|Adverse Event|14|||
147412999|NCT01008553|531676054|FG002|Period 2 (Double-Blind Period)|Adverse Event|4|||
147413000|NCT01008553|531676052|FG000|Period 2 (Double-Blind Period)|Withdrawal by Subject|0|||
147413001|NCT01008553|531676053|FG001|Period 2 (Double-Blind Period)|Withdrawal by Subject|2|||
147413002|NCT01008553|531676054|FG002|Period 2 (Double-Blind Period)|Withdrawal by Subject|2|||
147413003|NCT01008553|531676052|FG000|Period 2 (Double-Blind Period)|Impossible to perform required tests|0|||
147413004|NCT01008553|531676053|FG001|Period 2 (Double-Blind Period)|Impossible to perform required tests|1|||
147413005|NCT01008553|531676054|FG002|Period 2 (Double-Blind Period)|Impossible to perform required tests|0|||
147471063|NCT02305563|531879825|FG002|Treatment Period|Randomized but not treated|0|||
147471064|NCT02305563|531879826|FG003|Treatment Period|Randomized but not treated|0|||
147471065|NCT02305563|531879827|FG004|Treatment Period|Randomized but not treated|2|||
147471066|NCT02305563|531879823|FG000|Treatment Period|added ULO, then disease progression|0|||
147471067|NCT02305563|531879824|FG001|Treatment Period|added ULO, then disease progression|0|||
147471068|NCT02305563|531879825|FG002|Treatment Period|added ULO, then disease progression|0|||
147471069|NCT02305563|531879826|FG003|Treatment Period|added ULO, then disease progression|0|||
147471070|NCT02305563|531879827|FG004|Treatment Period|added ULO, then disease progression|4|||
147471071|NCT02305563|531879823|FG000|Treatment Period|added ULO; then other reason|0|||
147471072|NCT02305563|531879824|FG001|Treatment Period|added ULO; then other reason|0|||
147471073|NCT02305563|531879825|FG002|Treatment Period|added ULO; then other reason|0|||
147471074|NCT02305563|531879826|FG003|Treatment Period|added ULO; then other reason|0|||
147471075|NCT02305563|531879827|FG004|Treatment Period|added ULO; then other reason|1|||
147471076|NCT02305563|531879823|FG000|Treatment Period|added ULO, then request to stop|0|||
147471077|NCT02305563|531879824|FG001|Treatment Period|added ULO, then request to stop|0|||
147471078|NCT02305563|531879825|FG002|Treatment Period|added ULO, then request to stop|0|||
147471079|NCT02305563|531879826|FG003|Treatment Period|added ULO, then request to stop|0|||
147471080|NCT02305563|531879827|FG004|Treatment Period|added ULO, then request to stop|1|||
147471081|NCT02305563|531879823|FG000|Follow-up Period|Death|0|||
147471082|NCT02305563|531879824|FG001|Follow-up Period|Death|0|||
147471083|NCT02305563|531879825|FG002|Follow-up Period|Death|5|||
147471084|NCT02305563|531879826|FG003|Follow-up Period|Death|4|||
147471085|NCT02305563|531879827|FG004|Follow-up Period|Death|7|||
147471086|NCT02305563|531879823|FG000|Follow-up Period|Participant withdrew consent|0|||
147471087|NCT02305563|531879824|FG001|Follow-up Period|Participant withdrew consent|0|||
147471088|NCT02305563|531879825|FG002|Follow-up Period|Participant withdrew consent|2|||
147471089|NCT02305563|531879826|FG003|Follow-up Period|Participant withdrew consent|1|||
147471090|NCT02305563|531879827|FG004|Follow-up Period|Participant withdrew consent|0|||
147471091|NCT02305563|531879823|FG000|Follow-up Period|other reason|0|||
147471092|NCT02305563|531879824|FG001|Follow-up Period|other reason|0|||
147471093|NCT02305563|531879825|FG002|Follow-up Period|other reason|0|||
147471094|NCT02305563|531879826|FG003|Follow-up Period|other reason|0|||
147471095|NCT02305563|531879827|FG004|Follow-up Period|other reason|1|||
147471096|NCT02305563|531879823|FG000|Follow-up Period|Followup no longer required per protocol|3|||
147665895|NCT00324155|532601629|FG000|Received Treatment in Induction Phase|Withdrawal by Subject|6|||
147413006|NCT01008553|531676052|FG000|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|0|||
147471097|NCT02305563|531879824|FG001|Follow-up Period|Followup no longer required per protocol|3|||
147471098|NCT02305563|531879825|FG002|Follow-up Period|Followup no longer required per protocol|4|||
147471099|NCT02305563|531879826|FG003|Follow-up Period|Followup no longer required per protocol|1|||
147471100|NCT02305563|531879827|FG004|Follow-up Period|Followup no longer required per protocol|4|||
147471101|NCT04906707|531879830|FG000|Overall Study|Withdrawal by Subject|2|||
147471102|NCT04906707|531879831|FG001|Overall Study|Withdrawal by Subject|0|||
147471103|NCT04906707|531879830|FG000|Overall Study|Withdrawal due to PI decision|1|||
147471104|NCT04906707|531879831|FG001|Overall Study|Withdrawal due to PI decision|0|||
147471105|NCT04906707|531879830|FG000|Overall Study|Lost to Follow-up|0|||
147471106|NCT04906707|531879831|FG001|Overall Study|Lost to Follow-up|1|||
147471107|NCT01976806|531879832|FG000|Overall Study|Lost to Follow-up|1|||
147471108|NCT01976806|531879833|FG001|Overall Study|Lost to Follow-up|4|||
147471109|NCT01976806|531879832|FG000|Overall Study|Adverse Event|1|||
147471110|NCT01976806|531879833|FG001|Overall Study|Adverse Event|1|||
147471111|NCT01976806|531879832|FG000|Overall Study|Withdrawal by Subject|1|||
147471112|NCT01976806|531879833|FG001|Overall Study|Withdrawal by Subject|1|||
147471113|NCT04429022|531879837|FG000|Overall Study|Protocol Violation|18|||
147471114|NCT04429022|531879838|FG001|Overall Study|Protocol Violation|1|||
147471115|NCT01769105|531879843|FG000|First Intervention|Protocol Violation|2|||
147471116|NCT01769105|531879844|FG001|First Intervention|Protocol Violation|2|||
147471117|NCT01769105|531879843|FG000|Cross-over|Lost to Follow-up|5|||
147471118|NCT01769105|531879844|FG001|Cross-over|Lost to Follow-up|0|||
147471119|NCT00963807|531879845|FG000|Overall Study|Physician Decision|2|||
147471120|NCT00963807|531879845|FG000|Overall Study|Reaction to study chemotherapy regimen|1|||
147471121|NCT00963807|531879845|FG000|Overall Study|Disease progression|15|||
147471122|NCT00684177|531879847|FG000|Overall Study|Adverse Event|4|||
147471123|NCT00684177|531879848|FG001|Overall Study|Adverse Event|3|||
147471124|NCT00684177|531879847|FG000|Overall Study|Lack of Efficacy|10|||
147471125|NCT00684177|531879848|FG001|Overall Study|Lack of Efficacy|15|||
147471126|NCT00684177|531879847|FG000|Overall Study|Protocol Violation|1|||
147471127|NCT00684177|531879848|FG001|Overall Study|Protocol Violation|0|||
147471128|NCT00684177|531879847|FG000|Overall Study|Lost to Follow-up|2|||
147471129|NCT00684177|531879848|FG001|Overall Study|Lost to Follow-up|1|||
147471130|NCT00684177|531879847|FG000|Overall Study|Physician Decision|2|||
147471131|NCT00684177|531879848|FG001|Overall Study|Physician Decision|0|||
147471132|NCT00684177|531879847|FG000|Overall Study|Withdrawal by Subject|1|||
147471133|NCT00684177|531879848|FG001|Overall Study|Withdrawal by Subject|2|||
147471134|NCT00684177|531879847|FG000|Overall Study|Other|1|||
147471135|NCT00684177|531879848|FG001|Overall Study|Other|2|||
147471136|NCT00783289|531881382|FG000|Overall Study|Protocol Violation|0|||
147471137|NCT00783289|531881383|FG001|Overall Study|Protocol Violation|1|||
147471138|NCT00783289|531881384|FG002|Overall Study|Protocol Violation|0|||
147471139|NCT00783289|531881385|FG003|Overall Study|Protocol Violation|0|||
147471140|NCT00996840|531881391|FG000|Overall Study|Adverse Event|0|||
147471141|NCT00996840|531881392|FG001|Overall Study|Adverse Event|1|||
147471142|NCT00996840|531881393|FG002|Overall Study|Adverse Event|0|||
147471143|NCT00996840|531881394|FG003|Overall Study|Adverse Event|0|||
147471144|NCT00996840|531881395|FG004|Overall Study|Adverse Event|0|||
147471145|NCT00996840|531881391|FG000|Overall Study|Physician Decision|0|||
147471146|NCT00996840|531881392|FG001|Overall Study|Physician Decision|0|||
147471147|NCT00996840|531881393|FG002|Overall Study|Physician Decision|1|||
147471148|NCT00996840|531881394|FG003|Overall Study|Physician Decision|1|||
147471149|NCT00996840|531881395|FG004|Overall Study|Physician Decision|2|||
147471150|NCT00996840|531881391|FG000|Overall Study|Withdrawal by Subject|1|||
147471151|NCT00996840|531881392|FG001|Overall Study|Withdrawal by Subject|1|||
147471152|NCT00996840|531881393|FG002|Overall Study|Withdrawal by Subject|0|||
147471153|NCT00996840|531881394|FG003|Overall Study|Withdrawal by Subject|0|||
147471154|NCT00996840|531881395|FG004|Overall Study|Withdrawal by Subject|0|||
147471155|NCT01075178|531881396|FG000|Subject Matching|eligible but not matched|130|||
147471156|NCT01075178|531881397|FG001|Subject Matching|eligible but not matched|403|||
147471157|NCT01075178|531881396|FG000|Subject Chart Review|died before chart review period|0|||
147471158|NCT01075178|531881397|FG001|Subject Chart Review|died before chart review period|2|||
147471159|NCT01075178|531881396|FG000|Subject Chart Review|no data collected due to site closure|3|||
147471160|NCT01075178|531881397|FG001|Subject Chart Review|no data collected due to site closure|4|||
147471161|NCT01075178|531881396|FG000|Subject Chart Review|matched partner excluded (reasons above)|6|||
147471162|NCT01075178|531881397|FG001|Subject Chart Review|matched partner excluded (reasons above)|3|||
147471163|NCT02983604|531881398|FG000|Overall Study|Enrolled but not Treated|0|||
147471164|NCT02983604|531881399|FG001|Overall Study|Enrolled but not Treated|0|||
147471165|NCT02983604|531881400|FG002|Overall Study|Enrolled but not Treated|1|||
147471166|NCT02983604|531881401|FG003|Overall Study|Enrolled but not Treated|0|||
147471167|NCT00355264|531881402|FG000|Extension (Variable Duration)|Adverse Event|1|||
147471168|NCT00355264|531881402|FG000|Extension (Variable Duration)|Withdrew Consent|1|||
147471169|NCT00699192|531881403|FG000|Overall Study|Missing|1|||
147471170|NCT00699192|531881404|FG001|Overall Study|Missing|1|||
147471171|NCT00699192|531881405|FG002|Overall Study|Missing|1|||
147471172|NCT00699192|531881403|FG000|Overall Study|Adverse Event|9|||
147620086|NCT05842967|532427214|FG000|Period 1: SSA|Death|1|||
147620087|NCT05842967|532427215|FG001|Period 1: SSA|Death|0|||
147620088|NCT05842967|532427216|FG002|Period 1: SSA|Death|0|||
147620089|NCT05842967|532427217|FG003|Period 1: SSA|Death|0|||
147620090|NCT05842967|532427214|FG000|Period 1: SSA|Lost to Follow-up|16|||
147620091|NCT05842967|532427215|FG001|Period 1: SSA|Lost to Follow-up|4|||
147620092|NCT05842967|532427216|FG002|Period 1: SSA|Lost to Follow-up|0|||
147620093|NCT05842967|532427217|FG003|Period 1: SSA|Lost to Follow-up|0|||
147620094|NCT05842967|532427214|FG000|Period 1: SSA|Physician Decision|1|||
147620095|NCT05842967|532427215|FG001|Period 1: SSA|Physician Decision|0|||
147620096|NCT05842967|532427216|FG002|Period 1: SSA|Physician Decision|0|||
147471173|NCT00699192|531881404|FG001|Overall Study|Adverse Event|4|||
147471174|NCT00699192|531881405|FG002|Overall Study|Adverse Event|3|||
147620097|NCT05842967|532427217|FG003|Period 1: SSA|Physician Decision|0|||
147620098|NCT05842967|532427214|FG000|Period 1: SSA|Withdrawal by Subject|2|||
147471175|NCT00699192|531881403|FG000|Overall Study|Abnormal test procedure result(s)|0|||
147620099|NCT05842967|532427215|FG001|Period 1: SSA|Withdrawal by Subject|2|||
147471176|NCT00699192|531881404|FG001|Overall Study|Abnormal test procedure result(s)|0|||
147471177|NCT00699192|531881405|FG002|Overall Study|Abnormal test procedure result(s)|1|||
147471178|NCT00699192|531881403|FG000|Overall Study|Lack of Efficacy|0|||
147471179|NCT00699192|531881404|FG001|Overall Study|Lack of Efficacy|0|||
147471180|NCT00699192|531881405|FG002|Overall Study|Lack of Efficacy|1|||
147471181|NCT00699192|531881403|FG000|Overall Study|Withdrawal by Subject|3|||
147471182|NCT00699192|531881404|FG001|Overall Study|Withdrawal by Subject|2|||
147471183|NCT00699192|531881405|FG002|Overall Study|Withdrawal by Subject|4|||
147471184|NCT00699192|531881403|FG000|Overall Study|Administrative problems|1|||
147471185|NCT00699192|531881404|FG001|Overall Study|Administrative problems|3|||
147471186|NCT00699192|531881405|FG002|Overall Study|Administrative problems|1|||
147471187|NCT00699192|531881403|FG000|Overall Study|Protocol Violation|2|||
147471188|NCT00699192|531881404|FG001|Overall Study|Protocol Violation|2|||
147471189|NCT00699192|531881405|FG002|Overall Study|Protocol Violation|0|||
147471190|NCT04433117|531881408|FG000|Overall Study|Withdrawal by Subject|1|||
147471191|NCT04433117|531881409|FG001|Overall Study|Withdrawal by Subject|0|||
147471192|NCT00190775|531881410|FG000|Overall Study|Adverse Event|57|||
147471193|NCT00190775|531881411|FG001|Overall Study|Adverse Event|22|||
147471194|NCT00190775|531881410|FG000|Overall Study|Satisfactory Response|1|||
147471195|NCT00190775|531881411|FG001|Overall Study|Satisfactory Response|0|||
147471196|NCT00190775|531881410|FG000|Overall Study|Lack of Efficacy|28|||
147471197|NCT00190775|531881411|FG001|Overall Study|Lack of Efficacy|32|||
147471198|NCT00190775|531881410|FG000|Overall Study|Lost to Follow-up|31|||
147471199|NCT00190775|531881411|FG001|Overall Study|Lost to Follow-up|23|||
147471200|NCT00190775|531881410|FG000|Overall Study|Participant Moved|0|||
147471201|NCT00190775|531881411|FG001|Overall Study|Participant Moved|1|||
147471202|NCT00190775|531881410|FG000|Overall Study|Withdrawal by Subject|24|||
147471203|NCT00190775|531881411|FG001|Overall Study|Withdrawal by Subject|13|||
147471204|NCT00190775|531881410|FG000|Overall Study|Sponsor Decision|1|||
147471205|NCT00190775|531881411|FG001|Overall Study|Sponsor Decision|0|||
147471206|NCT00190775|531881410|FG000|Overall Study|Physician Decision|3|||
147471207|NCT00190775|531881411|FG001|Overall Study|Physician Decision|0|||
147471208|NCT00190775|531881410|FG000|Overall Study|Noncompliance|3|||
147471209|NCT00190775|531881411|FG001|Overall Study|Noncompliance|5|||
147471210|NCT00190775|531881410|FG000|Overall Study|Protocol Violation|0|||
147471211|NCT00190775|531881411|FG001|Overall Study|Protocol Violation|1|||
147471212|NCT00190775|531881410|FG000|Overall Study|Exclusion Criteria Met|1|||
147471213|NCT00190775|531881411|FG001|Overall Study|Exclusion Criteria Met|3|||
147471214|NCT01794780|531881412|FG000|Overall Study|Adverse Event|0|||
147471215|NCT01794780|531881413|FG001|Overall Study|Adverse Event|1|||
147471216|NCT01794780|531881414|FG002|Overall Study|Adverse Event|2|||
147413007|NCT01008553|531676053|FG001|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|1|||
147413008|NCT01008553|531676054|FG002|Period 2 (Double-Blind Period)|Insufficient analgesic efficacy|4|||
147413009|NCT01008553|531676052|FG000|Period 2 (Double-Blind Period)|Rescue drugs increased more than 1 times|0|||
147413010|NCT01008553|531676053|FG001|Period 2 (Double-Blind Period)|Rescue drugs increased more than 1 times|0|||
147413011|NCT01008553|531676054|FG002|Period 2 (Double-Blind Period)|Rescue drugs increased more than 1 times|3|||
147413012|NCT01008553|531676052|FG000|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0|||
147413013|NCT01008553|531676053|FG001|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|0|||
147413014|NCT01008553|531676054|FG002|Period 2 (Double-Blind Period)|More than 3 times a day rescue treatment|1|||
147413015|NCT01008553|531676052|FG000|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|0|||
147413016|NCT01008553|531676053|FG001|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|18|||
147413017|NCT01008553|531676054|FG002|Period 2 (Double-Blind Period)|More than 15mm increase in Mean VAS|35|||
147413018|NCT01008410|531676058|FG000|Overall Study|Adverse Event|13|||
147413019|NCT01008410|531676059|FG001|Overall Study|Adverse Event|7|||
147413020|NCT01008410|531676058|FG000|Overall Study|Withdrawal by Subject|6|||
147413021|NCT01008410|531676059|FG001|Overall Study|Withdrawal by Subject|2|||
147413022|NCT01008410|531676058|FG000|Overall Study|Lost to Follow-up|1|||
147413023|NCT01008410|531676059|FG001|Overall Study|Lost to Follow-up|0|||
147413024|NCT01008410|531676058|FG000|Overall Study|Noncompliance|1|||
147471217|NCT01794780|531881415|FG003|Overall Study|Adverse Event|0|||
147471218|NCT01794780|531881416|FG004|Overall Study|Adverse Event|0|||
147471219|NCT01794780|531881417|FG005|Overall Study|Adverse Event|0|||
147471220|NCT01794780|531881418|FG006|Overall Study|Adverse Event|0|||
147471221|NCT01794780|531881419|FG007|Overall Study|Adverse Event|0|||
147665896|NCT00324155|532601630|FG001|Received Treatment in Induction Phase|Withdrawal by Subject|5|||
147413025|NCT01008410|531676059|FG001|Overall Study|Noncompliance|0|||
147471222|NCT01794780|531881412|FG000|Overall Study|Death|0|||
147471223|NCT01794780|531881413|FG001|Overall Study|Death|2|||
147471224|NCT01794780|531881414|FG002|Overall Study|Death|14|||
147471225|NCT01794780|531881415|FG003|Overall Study|Death|1|||
147471226|NCT01794780|531881416|FG004|Overall Study|Death|0|||
147471227|NCT01794780|531881417|FG005|Overall Study|Death|9|||
147471228|NCT01794780|531881418|FG006|Overall Study|Death|4|||
147471229|NCT01794780|531881419|FG007|Overall Study|Death|0|||
147471230|NCT01794780|531881412|FG000|Overall Study|Lost to Follow-up|10|||
147665897|NCT00324155|532601629|FG000|Received Treatment in Induction Phase|Physician Decision|2|||
147665898|NCT00324155|532601630|FG001|Received Treatment in Induction Phase|Physician Decision|0|||
147665899|NCT00324155|532601629|FG000|Received Treatment in Maintenance Phase|Disease Progression|26|||
147665900|NCT00324155|532601630|FG001|Received Treatment in Maintenance Phase|Disease Progression|41|||
147665901|NCT00324155|532601629|FG000|Received Treatment in Maintenance Phase|Study Drug Toxicity|4|||
147665902|NCT00324155|532601630|FG001|Received Treatment in Maintenance Phase|Study Drug Toxicity|0|||
147665903|NCT00324155|532601629|FG000|Received Treatment in Maintenance Phase|Withdrawal by Subject|1|||
147665904|NCT00324155|532601630|FG001|Received Treatment in Maintenance Phase|Withdrawal by Subject|3|||
147665905|NCT00324155|532601629|FG000|Received Treatment in Maintenance Phase|Adverse Event|0|||
147665906|NCT00324155|532601630|FG001|Received Treatment in Maintenance Phase|Adverse Event|3|||
147665907|NCT00324155|532601629|FG000|Received Treatment in Maintenance Phase|Deterioration/Undocumented Progression|1|||
147665908|NCT00324155|532601630|FG001|Received Treatment in Maintenance Phase|Deterioration/Undocumented Progression|0|||
147665909|NCT00324155|532601629|FG000|Follow-up Phase|On-going participants still on drug|11|||
147665910|NCT00324155|532601630|FG001|Follow-up Phase|On-going participants still on drug|6|||
147665911|NCT01253161|532601631|FG000|Overall Study|Adverse Event|1|||
147665912|NCT05817669|532601632|FG000|Overall Study|Prohibited medication used|1|||
147665913|NCT05817669|532601633|FG001|Overall Study|Prohibited medication used|2|||
147665914|NCT05817669|532601632|FG000|Overall Study|Adverse Event|1|||
147665915|NCT05817669|532601633|FG001|Overall Study|Adverse Event|0|||
147665916|NCT05817669|532601632|FG000|Overall Study|Withdrawal by Subject|1|||
147665917|NCT05817669|532601633|FG001|Overall Study|Withdrawal by Subject|2|||
147665918|NCT03810183|532601635|FG000|Overall Study|Study terminated by Sponsor|2|||
147665919|NCT03810183|532601636|FG001|Overall Study|Study terminated by Sponsor|1|||
147413026|NCT01008410|531676058|FG000|Overall Study|Low Cortisol|2|||
147413027|NCT01008410|531676059|FG001|Overall Study|Low Cortisol|0|||
147413028|NCT01008410|531676058|FG000|Overall Study|Lack of Efficacy|2|||
147413029|NCT01008410|531676059|FG001|Overall Study|Lack of Efficacy|6|||
147413030|NCT01008410|531676058|FG000|Overall Study|Met Exclusion Criterion|0|||
147413031|NCT01008410|531676059|FG001|Overall Study|Met Exclusion Criterion|1|||
147413032|NCT02787044|531676068|FG000|Overall Study|Lost to Follow-up|15|||
147413033|NCT02787044|531676069|FG001|Overall Study|Lost to Follow-up|19|||
147413034|NCT03889704|531676071|FG000|Overall Study|Study terminated due to pandemic|1|||
147413035|NCT03482466|531676072|FG000|Overall Study|Protocol Violation|2|||
147413036|NCT04552899|531676073|FG000|Overall Study|Adverse Event|4|||
147413037|NCT04552899|531676074|FG001|Overall Study|Adverse Event|3|||
147413038|NCT04552899|531676073|FG000|Overall Study|Death|4|||
147413039|NCT04552899|531676074|FG001|Overall Study|Death|4|||
147413040|NCT04552899|531676073|FG000|Overall Study|Lost to Follow-up|8|||
147413041|NCT04552899|531676074|FG001|Overall Study|Lost to Follow-up|13|||
147413042|NCT04552899|531676073|FG000|Overall Study|Lung Transplant|4|||
147413043|NCT04552899|531676074|FG001|Overall Study|Lung Transplant|3|||
147413044|NCT04552899|531676073|FG000|Overall Study|Participant and physician wanted to withdraw participant from study|0|||
147413045|NCT04552899|531676074|FG001|Overall Study|Participant and physician wanted to withdraw participant from study|1|||
147413046|NCT04552899|531676073|FG000|Overall Study|Physician Decision|3|||
147413047|NCT04552899|531676074|FG001|Overall Study|Physician Decision|4|||
147413048|NCT04552899|531676073|FG000|Overall Study|Study Terminated By Sponsor|237|||
147413049|NCT04552899|531676074|FG001|Overall Study|Study Terminated By Sponsor|239|||
147413050|NCT04552899|531676073|FG000|Overall Study|Withdrawal by Subject|15|||
147413051|NCT04552899|531676074|FG001|Overall Study|Withdrawal by Subject|17|||
147413052|NCT00731133|531676077|FG000|Overall Study|Withdrawal by Subject|10|||
147413053|NCT02383940|531676078|FG000|Overall Study|Adverse Event|1|||
147413054|NCT02383940|531676079|FG001|Overall Study|Adverse Event|0|||
147413055|NCT02383940|531676078|FG000|Overall Study|Lost to Follow-up|2|||
147413056|NCT02383940|531676079|FG001|Overall Study|Lost to Follow-up|2|||
147413057|NCT02383940|531676078|FG000|Overall Study|Physician Decision|2|||
147413058|NCT02383940|531676079|FG001|Overall Study|Physician Decision|0|||
147413059|NCT02383940|531676078|FG000|Overall Study|Withdrawal by Subject|1|||
147413060|NCT02383940|531676079|FG001|Overall Study|Withdrawal by Subject|1|||
147413061|NCT02383940|531676078|FG000|Overall Study|Randomized but not treated|2|||
147413062|NCT02383940|531676079|FG001|Overall Study|Randomized but not treated|0|||
147413063|NCT02383940|531676078|FG000|Overall Study|Other than specified above|1|||
147413064|NCT02383940|531676079|FG001|Overall Study|Other than specified above|0|||
147413065|NCT02672852|531676081|FG000|Part A1|Disease Worsening|1|||
147413066|NCT02672852|531676082|FG001|Part A1|Disease Worsening|0|||
147413067|NCT02672852|531676083|FG002|Part A1|Disease Worsening|0|||
147413068|NCT02672852|531676084|FG003|Part A1|Disease Worsening|0|||
147413069|NCT02672852|531676085|FG004|Part A1|Disease Worsening|0|||
147413070|NCT02672852|531676086|FG005|Part A1|Disease Worsening|0|||
147413071|NCT02672852|531676087|FG006|Part A1|Disease Worsening|0|||
147413072|NCT02672852|531676081|FG000|Part A1|Adverse Event|0|||
147413073|NCT02672852|531676082|FG001|Part A1|Adverse Event|1|||
147413074|NCT02672852|531676083|FG002|Part A1|Adverse Event|0|||
147413075|NCT02672852|531676084|FG003|Part A1|Adverse Event|0|||
147413076|NCT02672852|531676085|FG004|Part A1|Adverse Event|0|||
147413077|NCT02672852|531676086|FG005|Part A1|Adverse Event|0|||
147413078|NCT02672852|531676087|FG006|Part A1|Adverse Event|0|||
147413079|NCT02672852|531676081|FG000|Part A1|Lost to Follow-up|1|||
147413080|NCT02672852|531676082|FG001|Part A1|Lost to Follow-up|2|||
147413081|NCT02672852|531676083|FG002|Part A1|Lost to Follow-up|0|||
147413082|NCT02672852|531676084|FG003|Part A1|Lost to Follow-up|0|||
147413083|NCT02672852|531676085|FG004|Part A1|Lost to Follow-up|0|||
147413084|NCT02672852|531676086|FG005|Part A1|Lost to Follow-up|0|||
147413085|NCT02672852|531676087|FG006|Part A1|Lost to Follow-up|0|||
147413086|NCT02672852|531676081|FG000|Part A1|Withdrawal by Subject|1|||
147413087|NCT02672852|531676082|FG001|Part A1|Withdrawal by Subject|1|||
147413088|NCT02672852|531676083|FG002|Part A1|Withdrawal by Subject|0|||
147413089|NCT02672852|531676084|FG003|Part A1|Withdrawal by Subject|0|||
147413090|NCT02672852|531676085|FG004|Part A1|Withdrawal by Subject|0|||
147413091|NCT02672852|531676086|FG005|Part A1|Withdrawal by Subject|0|||
147413092|NCT02672852|531676087|FG006|Part A1|Withdrawal by Subject|0|||
147413093|NCT02672852|531676081|FG000|Part A2|Disease worsening|0|||
147413094|NCT02672852|531676082|FG001|Part A2|Disease worsening|0|||
147413095|NCT02672852|531676083|FG002|Part A2|Disease worsening|1|||
147413096|NCT02672852|531676084|FG003|Part A2|Disease worsening|0|||
147413097|NCT02672852|531676085|FG004|Part A2|Disease worsening|0|||
147413098|NCT02672852|531676086|FG005|Part A2|Disease worsening|0|||
147413099|NCT02672852|531676087|FG006|Part A2|Disease worsening|0|||
147413100|NCT02672852|531676081|FG000|Part A2|Adverse Event|0|||
147413101|NCT02672852|531676082|FG001|Part A2|Adverse Event|0|||
147413102|NCT02672852|531676083|FG002|Part A2|Adverse Event|3|||
147413103|NCT02672852|531676084|FG003|Part A2|Adverse Event|0|||
147413104|NCT02672852|531676085|FG004|Part A2|Adverse Event|0|||
147413105|NCT02672852|531676086|FG005|Part A2|Adverse Event|0|||
147413106|NCT02672852|531676087|FG006|Part A2|Adverse Event|0|||
147413107|NCT02672852|531676081|FG000|Part A2|Lost to Follow-up|0|||
147413108|NCT02672852|531676082|FG001|Part A2|Lost to Follow-up|0|||
147413109|NCT02672852|531676083|FG002|Part A2|Lost to Follow-up|2|||
147413110|NCT02672852|531676084|FG003|Part A2|Lost to Follow-up|0|||
147413111|NCT02672852|531676085|FG004|Part A2|Lost to Follow-up|0|||
147413112|NCT02672852|531676086|FG005|Part A2|Lost to Follow-up|0|||
147471231|NCT01794780|531881413|FG001|Overall Study|Lost to Follow-up|64|||
147471232|NCT01794780|531881414|FG002|Overall Study|Lost to Follow-up|165|||
147471233|NCT01794780|531881415|FG003|Overall Study|Lost to Follow-up|53|||
147471234|NCT01794780|531881416|FG004|Overall Study|Lost to Follow-up|2|||
147471235|NCT01794780|531881417|FG005|Overall Study|Lost to Follow-up|99|||
147471236|NCT01794780|531881418|FG006|Overall Study|Lost to Follow-up|30|||
147471237|NCT01794780|531881419|FG007|Overall Study|Lost to Follow-up|5|||
147471238|NCT01794780|531881412|FG000|Overall Study|Withdrew informed consent|7|||
147471239|NCT01794780|531881413|FG001|Overall Study|Withdrew informed consent|17|||
147471240|NCT01794780|531881414|FG002|Overall Study|Withdrew informed consent|36|||
147471241|NCT01794780|531881415|FG003|Overall Study|Withdrew informed consent|9|||
147471242|NCT01794780|531881416|FG004|Overall Study|Withdrew informed consent|0|||
147471243|NCT01794780|531881417|FG005|Overall Study|Withdrew informed consent|48|||
147620100|NCT05842967|532427216|FG002|Period 1: SSA|Withdrawal by Subject|0|||
147620101|NCT05842967|532427217|FG003|Period 1: SSA|Withdrawal by Subject|0|||
147620102|NCT05842967|532427214|FG000|Period 1: SSA|Randomized but not vaccinated|1|||
147620103|NCT05842967|532427215|FG001|Period 1: SSA|Randomized but not vaccinated|2|||
147620104|NCT05842967|532427216|FG002|Period 1: SSA|Randomized but not vaccinated|0|||
147620105|NCT05842967|532427217|FG003|Period 1: SSA|Randomized but not vaccinated|0|||
147620106|NCT05842967|532427214|FG000|Period 2: SSB|Adverse Event|0|||
147620107|NCT05842967|532427215|FG001|Period 2: SSB|Adverse Event|0|||
147620108|NCT05842967|532427216|FG002|Period 2: SSB|Adverse Event|2|||
147620109|NCT05842967|532427217|FG003|Period 2: SSB|Adverse Event|0|||
147620110|NCT05842967|532427214|FG000|Period 2: SSB|Lost to Follow-up|0|||
147620111|NCT05842967|532427215|FG001|Period 2: SSB|Lost to Follow-up|0|||
147620112|NCT05842967|532427216|FG002|Period 2: SSB|Lost to Follow-up|4|||
147620113|NCT05842967|532427217|FG003|Period 2: SSB|Lost to Follow-up|3|||
147620114|NCT05842967|532427214|FG000|Period 2: SSB|Withdrawal by Subject|0|||
147620115|NCT05842967|532427215|FG001|Period 2: SSB|Withdrawal by Subject|0|||
147413113|NCT02672852|531676087|FG006|Part A2|Lost to Follow-up|0|||
147471244|NCT01794780|531881418|FG006|Overall Study|Withdrew informed consent|4|||
147471245|NCT01794780|531881419|FG007|Overall Study|Withdrew informed consent|3|||
147413114|NCT02672852|531676081|FG000|Part A2|Withdrawal by Subject|0|||
147413115|NCT02672852|531676082|FG001|Part A2|Withdrawal by Subject|0|||
147413116|NCT02672852|531676083|FG002|Part A2|Withdrawal by Subject|1|||
147413117|NCT02672852|531676084|FG003|Part A2|Withdrawal by Subject|0|||
147413118|NCT02672852|531676085|FG004|Part A2|Withdrawal by Subject|0|||
147413119|NCT02672852|531676086|FG005|Part A2|Withdrawal by Subject|0|||
147413120|NCT02672852|531676087|FG006|Part A2|Withdrawal by Subject|0|||
147413121|NCT02672852|531676081|FG000|Part A2|Other|0|||
147471246|NCT01794780|531881412|FG000|Overall Study|Other|0|||
147620116|NCT05842967|532427216|FG002|Period 2: SSB|Withdrawal by Subject|1|||
147413122|NCT02672852|531676082|FG001|Part A2|Other|0|||
147413123|NCT02672852|531676083|FG002|Part A2|Other|3|||
147413124|NCT02672852|531676084|FG003|Part A2|Other|0|||
147413125|NCT02672852|531676085|FG004|Part A2|Other|0|||
147471247|NCT01794780|531881413|FG001|Overall Study|Other|12|||
147620117|NCT05842967|532427217|FG003|Period 2: SSB|Withdrawal by Subject|0|||
147471248|NCT01794780|531881414|FG002|Overall Study|Other|25|||
147665920|NCT00323063|532601637|FG000|Overall Study|Adverse Event|1|||
147665921|NCT00323063|532601638|FG001|Overall Study|Adverse Event|0|||
147471249|NCT01794780|531881415|FG003|Overall Study|Other|20|||
147471250|NCT01794780|531881416|FG004|Overall Study|Other|1|||
147471251|NCT01794780|531881417|FG005|Overall Study|Other|24|||
147471252|NCT01794780|531881418|FG006|Overall Study|Other|4|||
147471253|NCT01794780|531881419|FG007|Overall Study|Other|1|||
147471254|NCT01658514|531881425|FG000|Overall Study|Protocol Violation|1|||
147413126|NCT02672852|531676086|FG005|Part A2|Other|0|||
147413127|NCT02672852|531676087|FG006|Part A2|Other|0|||
147413128|NCT02672852|531676081|FG000|Part A2|Not entered in Part B|0|||
147413129|NCT02672852|531676082|FG001|Part A2|Not entered in Part B|0|||
147413130|NCT02672852|531676083|FG002|Part A2|Not entered in Part B|0|||
147413131|NCT02672852|531676084|FG003|Part A2|Not entered in Part B|4|||
147413132|NCT02672852|531676085|FG004|Part A2|Not entered in Part B|0|||
147413133|NCT02672852|531676086|FG005|Part A2|Not entered in Part B|0|||
147413134|NCT02672852|531676087|FG006|Part A2|Not entered in Part B|0|||
147413135|NCT02672852|531676081|FG000|Part B|Disease worsening|0|||
147471255|NCT01658514|531881426|FG001|Overall Study|Protocol Violation|0|||
147471256|NCT01658514|531881427|FG002|Overall Study|Protocol Violation|2|||
147471257|NCT01275222|531881428|FG000|Phase l by Treatment|Adverse Event|1|||
147471258|NCT01275222|531881429|FG001|Phase l by Treatment|Adverse Event|4|||
147413136|NCT02672852|531676082|FG001|Part B|Disease worsening|0|||
147413137|NCT02672852|531676083|FG002|Part B|Disease worsening|0|||
147620118|NCT05842967|532427214|FG000|Period 2: SSB|Enrolled but not vaccinated|0|||
147620119|NCT05842967|532427215|FG001|Period 2: SSB|Enrolled but not vaccinated|0|||
147620120|NCT05842967|532427216|FG002|Period 2: SSB|Enrolled but not vaccinated|5|||
147620121|NCT05842967|532427217|FG003|Period 2: SSB|Enrolled but not vaccinated|9|||
147620122|NCT05842967|532427214|FG000|Period 2: SSB|Protocol Violation|0|||
147620123|NCT05842967|532427215|FG001|Period 2: SSB|Protocol Violation|0|||
147620124|NCT05842967|532427216|FG002|Period 2: SSB|Protocol Violation|0|||
147620125|NCT05842967|532427217|FG003|Period 2: SSB|Protocol Violation|1|||
147620126|NCT01173523|532427225|FG000|Overall Study|Clinical Progression|1|||
147620127|NCT01173523|532427226|FG001|Overall Study|Clinical Progression|1|||
147620128|NCT01173523|532427225|FG000|Overall Study|Progressive Disease|10|||
147620129|NCT01173523|532427226|FG001|Overall Study|Progressive Disease|8|||
147620130|NCT01173523|532427225|FG000|Overall Study|Other|2|||
147620131|NCT01173523|532427226|FG001|Overall Study|Other|3|||
147620132|NCT04429503|532427231|FG000|Main Study (Up to Wk 96)|Non-compliance with protocol by the subject|2|||
147620133|NCT04429503|532427232|FG001|Main Study (Up to Wk 96)|Non-compliance with protocol by the subject|1|||
147620134|NCT04429503|532427233|FG002|Main Study (Up to Wk 96)|Non-compliance with protocol by the subject|0|||
147620135|NCT04429503|532427234|FG003|Main Study (Up to Wk 96)|Non-compliance with protocol by the subject|0|||
147620136|NCT04429503|532427235|FG004|Main Study (Up to Wk 96)|Non-compliance with protocol by the subject|0|||
147620137|NCT04429503|532427236|FG005|Main Study (Up to Wk 96)|Non-compliance with protocol by the subject|0|||
147620138|NCT04429503|532427231|FG000|Main Study (Up to Wk 96)|Adverse Event|1|||
147620139|NCT04429503|532427232|FG001|Main Study (Up to Wk 96)|Adverse Event|9|||
147620140|NCT04429503|532427233|FG002|Main Study (Up to Wk 96)|Adverse Event|2|||
147620141|NCT04429503|532427234|FG003|Main Study (Up to Wk 96)|Adverse Event|0|||
147620142|NCT04429503|532427235|FG004|Main Study (Up to Wk 96)|Adverse Event|0|||
147620143|NCT04429503|532427236|FG005|Main Study (Up to Wk 96)|Adverse Event|0|||
147620144|NCT04429503|532427231|FG000|Main Study (Up to Wk 96)|Decision by the investigator/sponsor|2|||
147620145|NCT04429503|532427232|FG001|Main Study (Up to Wk 96)|Decision by the investigator/sponsor|9|||
147620146|NCT04429503|532427233|FG002|Main Study (Up to Wk 96)|Decision by the investigator/sponsor|3|||
147413138|NCT02672852|531676084|FG003|Part B|Disease worsening|0|||
147413139|NCT02672852|531676085|FG004|Part B|Disease worsening|1|||
147471259|NCT01275222|531881430|FG002|Phase l by Treatment|Adverse Event|2|||
147471260|NCT01275222|531881431|FG003|Phase l by Treatment|Adverse Event|3|||
147471261|NCT01275222|531881432|FG004|Phase l by Treatment|Adverse Event|0|||
147620147|NCT04429503|532427234|FG003|Main Study (Up to Wk 96)|Decision by the investigator/sponsor|0|||
147620148|NCT04429503|532427235|FG004|Main Study (Up to Wk 96)|Decision by the investigator/sponsor|0|||
147620149|NCT04429503|532427236|FG005|Main Study (Up to Wk 96)|Decision by the investigator/sponsor|0|||
147620150|NCT04429503|532427231|FG000|Main Study (Up to Wk 96)|Withdrawal by Subject|9|||
147665922|NCT00323063|532601637|FG000|Overall Study|brain mets discovered prior to treatment|1|||
147413140|NCT02672852|531676086|FG005|Part B|Disease worsening|0|||
147413141|NCT02672852|531676087|FG006|Part B|Disease worsening|1|||
147471262|NCT01275222|531881433|FG005|Phase l by Treatment|Adverse Event|0|||
147620151|NCT04429503|532427232|FG001|Main Study (Up to Wk 96)|Withdrawal by Subject|17|||
147620152|NCT04429503|532427233|FG002|Main Study (Up to Wk 96)|Withdrawal by Subject|8|||
147620153|NCT04429503|532427234|FG003|Main Study (Up to Wk 96)|Withdrawal by Subject|0|||
147665923|NCT00323063|532601638|FG001|Overall Study|brain mets discovered prior to treatment|0|||
147413142|NCT02672852|531676081|FG000|Part B|Worsening pre-existing condition|0|||
147413143|NCT02672852|531676082|FG001|Part B|Worsening pre-existing condition|0|||
147471263|NCT01275222|531881428|FG000|Phase l by Treatment|Abnormal laboratory value(s)|0|||
147471264|NCT01275222|531881429|FG001|Phase l by Treatment|Abnormal laboratory value(s)|0|||
147413144|NCT02672852|531676083|FG002|Part B|Worsening pre-existing condition|0|||
147413145|NCT02672852|531676084|FG003|Part B|Worsening pre-existing condition|0|||
147413146|NCT02672852|531676085|FG004|Part B|Worsening pre-existing condition|0|||
147413147|NCT02672852|531676086|FG005|Part B|Worsening pre-existing condition|1|||
147413148|NCT02672852|531676087|FG006|Part B|Worsening pre-existing condition|0|||
147413149|NCT02672852|531676081|FG000|Part B|Other adverse event|0|||
147413150|NCT02672852|531676082|FG001|Part B|Other adverse event|0|||
147413151|NCT02672852|531676083|FG002|Part B|Other adverse event|0|||
147413152|NCT02672852|531676084|FG003|Part B|Other adverse event|0|||
147413153|NCT02672852|531676085|FG004|Part B|Other adverse event|3|||
147413154|NCT02672852|531676086|FG005|Part B|Other adverse event|5|||
147413155|NCT02672852|531676087|FG006|Part B|Other adverse event|1|||
147413156|NCT02672852|531676081|FG000|Part B|Lost to Follow-up|0|||
147413157|NCT02672852|531676082|FG001|Part B|Lost to Follow-up|0|||
147413158|NCT02672852|531676083|FG002|Part B|Lost to Follow-up|0|||
147471265|NCT01275222|531881430|FG002|Phase l by Treatment|Abnormal laboratory value(s)|1|||
147471266|NCT01275222|531881431|FG003|Phase l by Treatment|Abnormal laboratory value(s)|0|||
147471267|NCT01275222|531881432|FG004|Phase l by Treatment|Abnormal laboratory value(s)|0|||
147471268|NCT01275222|531881433|FG005|Phase l by Treatment|Abnormal laboratory value(s)|0|||
147471269|NCT01275222|531881428|FG000|Phase l by Treatment|Abnormal test procedure result(s)|0|||
147471270|NCT01275222|531881429|FG001|Phase l by Treatment|Abnormal test procedure result(s)|0|||
147471271|NCT01275222|531881430|FG002|Phase l by Treatment|Abnormal test procedure result(s)|0|||
147471272|NCT01275222|531881431|FG003|Phase l by Treatment|Abnormal test procedure result(s)|1|||
147471273|NCT01275222|531881432|FG004|Phase l by Treatment|Abnormal test procedure result(s)|0|||
147471274|NCT01275222|531881433|FG005|Phase l by Treatment|Abnormal test procedure result(s)|0|||
147471275|NCT01275222|531881428|FG000|Phase l by Treatment|Disease progression|12|||
147471276|NCT01275222|531881429|FG001|Phase l by Treatment|Disease progression|8|||
147471277|NCT01275222|531881430|FG002|Phase l by Treatment|Disease progression|2|||
147471278|NCT01275222|531881431|FG003|Phase l by Treatment|Disease progression|5|||
147471279|NCT01275222|531881432|FG004|Phase l by Treatment|Disease progression|0|||
147471280|NCT01275222|531881433|FG005|Phase l by Treatment|Disease progression|0|||
147471281|NCT01275222|531881428|FG000|Phase l by Treatment|Withdrawal by Subject|0|||
147471282|NCT01275222|531881429|FG001|Phase l by Treatment|Withdrawal by Subject|0|||
147665924|NCT04275336|532601639|FG000|Overall Study|First venipuncture failed|4|||
147665925|NCT04275336|532601640|FG001|Overall Study|First venipuncture failed|6|||
147665926|NCT04275336|532601641|FG002|Overall Study|First venipuncture failed|5|||
147665927|NCT04275336|532601639|FG000|Overall Study|Unscheduled venipuncture|9|||
147665928|NCT04275336|532601640|FG001|Overall Study|Unscheduled venipuncture|13|||
147665929|NCT04275336|532601641|FG002|Overall Study|Unscheduled venipuncture|7|||
147665930|NCT04275336|532601639|FG000|Overall Study|Failed specimen of saliva|4|||
147665931|NCT04275336|532601640|FG001|Overall Study|Failed specimen of saliva|3|||
147665932|NCT04275336|532601641|FG002|Overall Study|Failed specimen of saliva|4|||
147665933|NCT03055936|532601642|FG000|Overall Study|Adverse Event|0|||
147665934|NCT03055936|532601643|FG001|Overall Study|Adverse Event|1|||
147665935|NCT03055936|532601644|FG002|Overall Study|Adverse Event|1|||
147665936|NCT03055936|532601645|FG003|Overall Study|Adverse Event|1|||
147665937|NCT03055936|532601642|FG000|Overall Study|Personal reason|2|||
147665938|NCT03055936|532601643|FG001|Overall Study|Personal reason|0|||
147665939|NCT03055936|532601644|FG002|Overall Study|Personal reason|1|||
147665940|NCT03055936|532601645|FG003|Overall Study|Personal reason|0|||
147665941|NCT03167242|532601646|FG000|Overall Study|Patient/Guardian Decision|0|||
147665942|NCT03167242|532601647|FG001|Overall Study|Patient/Guardian Decision|1|||
147665943|NCT03167242|532601648|FG002|Overall Study|Patient/Guardian Decision|2|||
147665944|NCT03167242|532601649|FG003|Overall Study|Patient/Guardian Decision|1|||
147665945|NCT03167242|532601650|FG004|Overall Study|Patient/Guardian Decision|1|||
147665946|NCT03167242|532601651|FG005|Overall Study|Patient/Guardian Decision|1|||
147665947|NCT03167242|532601652|FG006|Overall Study|Patient/Guardian Decision|0|||
147665948|NCT03167242|532601653|FG007|Overall Study|Patient/Guardian Decision|0|||
147665949|NCT03167242|532601654|FG008|Overall Study|Patient/Guardian Decision|0|||
147665950|NCT03167242|532601655|FG009|Overall Study|Patient/Guardian Decision|0|||
147665951|NCT03167242|532601656|FG010|Overall Study|Patient/Guardian Decision|1|||
147665952|NCT03167242|532601657|FG011|Overall Study|Patient/Guardian Decision|0|||
147665953|NCT03167242|532601646|FG000|Overall Study|Lost to Follow-up|0|||
147665954|NCT03167242|532601647|FG001|Overall Study|Lost to Follow-up|0|||
147665955|NCT03167242|532601648|FG002|Overall Study|Lost to Follow-up|1|||
147665956|NCT03167242|532601649|FG003|Overall Study|Lost to Follow-up|0|||
147665957|NCT03167242|532601650|FG004|Overall Study|Lost to Follow-up|0|||
147413159|NCT02672852|531676084|FG003|Part B|Lost to Follow-up|0|||
147413160|NCT02672852|531676085|FG004|Part B|Lost to Follow-up|3|||
147471283|NCT01275222|531881430|FG002|Phase l by Treatment|Withdrawal by Subject|0|||
147471284|NCT01275222|531881431|FG003|Phase l by Treatment|Withdrawal by Subject|1|||
147413161|NCT02672852|531676086|FG005|Part B|Lost to Follow-up|4|||
147413162|NCT02672852|531676087|FG006|Part B|Lost to Follow-up|1|||
147413163|NCT02672852|531676081|FG000|Part B|Withdrawal by Subject|0|||
147413164|NCT02672852|531676082|FG001|Part B|Withdrawal by Subject|0|||
147413165|NCT02672852|531676083|FG002|Part B|Withdrawal by Subject|0|||
147471285|NCT01275222|531881432|FG004|Phase l by Treatment|Withdrawal by Subject|0|||
147471286|NCT01275222|531881433|FG005|Phase l by Treatment|Withdrawal by Subject|0|||
147471287|NCT01275222|531881428|FG000|Phase l by Treatment|Death|0|||
147471288|NCT01275222|531881429|FG001|Phase l by Treatment|Death|1|||
147471289|NCT01275222|531881430|FG002|Phase l by Treatment|Death|0|||
147471290|NCT01275222|531881431|FG003|Phase l by Treatment|Death|1|||
147471291|NCT01275222|531881432|FG004|Phase l by Treatment|Death|0|||
147471292|NCT01275222|531881433|FG005|Phase l by Treatment|Death|0|||
147471293|NCT01275222|531881428|FG000|Phase ll by Stratum|Adverse Event|0|||
147471294|NCT01275222|531881429|FG001|Phase ll by Stratum|Adverse Event|0|||
147471295|NCT01275222|531881430|FG002|Phase ll by Stratum|Adverse Event|0|||
147471296|NCT01275222|531881431|FG003|Phase ll by Stratum|Adverse Event|0|||
147471297|NCT01275222|531881432|FG004|Phase ll by Stratum|Adverse Event|2|||
147471298|NCT01275222|531881433|FG005|Phase ll by Stratum|Adverse Event|10|||
147471299|NCT01275222|531881428|FG000|Phase ll by Stratum|Abnormal laboratory values|0|||
147413166|NCT02672852|531676084|FG003|Part B|Withdrawal by Subject|0|||
147413167|NCT02672852|531676085|FG004|Part B|Withdrawal by Subject|5|||
147471300|NCT01275222|531881429|FG001|Phase ll by Stratum|Abnormal laboratory values|0|||
147471301|NCT01275222|531881430|FG002|Phase ll by Stratum|Abnormal laboratory values|0|||
147471302|NCT01275222|531881431|FG003|Phase ll by Stratum|Abnormal laboratory values|0|||
147471303|NCT01275222|531881432|FG004|Phase ll by Stratum|Abnormal laboratory values|0|||
147471304|NCT01275222|531881433|FG005|Phase ll by Stratum|Abnormal laboratory values|1|||
147471305|NCT01275222|531881428|FG000|Phase ll by Stratum|Disease progression|0|||
147471306|NCT01275222|531881429|FG001|Phase ll by Stratum|Disease progression|0|||
147620154|NCT04429503|532427235|FG004|Main Study (Up to Wk 96)|Withdrawal by Subject|0|||
147413168|NCT02672852|531676086|FG005|Part B|Withdrawal by Subject|0|||
147413169|NCT02672852|531676087|FG006|Part B|Withdrawal by Subject|7|||
147413170|NCT02672852|531676081|FG000|Part B|Other|0|||
147413171|NCT02672852|531676082|FG001|Part B|Other|0|||
147413172|NCT02672852|531676083|FG002|Part B|Other|0|||
147413173|NCT02672852|531676084|FG003|Part B|Other|0|||
147413174|NCT02672852|531676085|FG004|Part B|Other|4|||
147413175|NCT02672852|531676086|FG005|Part B|Other|1|||
147413176|NCT02672852|531676087|FG006|Part B|Other|2|||
147413177|NCT01725126|531676088|FG000|Overall Study|Protocol Violation|0|||
147413178|NCT01725126|531676089|FG001|Overall Study|Protocol Violation|1|||
147413179|NCT01725126|531676090|FG002|Overall Study|Protocol Violation|0|||
147413180|NCT01725126|531676091|FG003|Overall Study|Protocol Violation|0|||
147413181|NCT01725126|531676092|FG004|Overall Study|Protocol Violation|0|||
147413182|NCT01725126|531676093|FG005|Overall Study|Protocol Violation|0|||
147413183|NCT01725126|531676088|FG000|Overall Study|Withdrawal by Subject|0|||
147413184|NCT01725126|531676089|FG001|Overall Study|Withdrawal by Subject|0|||
147413185|NCT01725126|531676090|FG002|Overall Study|Withdrawal by Subject|0|||
147413186|NCT01725126|531676091|FG003|Overall Study|Withdrawal by Subject|1|||
147620155|NCT04429503|532427236|FG005|Main Study (Up to Wk 96)|Withdrawal by Subject|0|||
147620156|NCT04429503|532427231|FG000|Main Study (Up to Wk 96)|Lost to Follow-up|5|||
147620157|NCT04429503|532427232|FG001|Main Study (Up to Wk 96)|Lost to Follow-up|19|||
147620158|NCT04429503|532427233|FG002|Main Study (Up to Wk 96)|Lost to Follow-up|7|||
147620159|NCT04429503|532427234|FG003|Main Study (Up to Wk 96)|Lost to Follow-up|0|||
147620160|NCT04429503|532427235|FG004|Main Study (Up to Wk 96)|Lost to Follow-up|0|||
147620161|NCT04429503|532427236|FG005|Main Study (Up to Wk 96)|Lost to Follow-up|0|||
147620162|NCT04429503|532427231|FG000|Main Study (Up to Wk 96)|Death|9|||
147620163|NCT04429503|532427232|FG001|Main Study (Up to Wk 96)|Death|18|||
147620164|NCT04429503|532427233|FG002|Main Study (Up to Wk 96)|Death|5|||
147620165|NCT04429503|532427234|FG003|Main Study (Up to Wk 96)|Death|0|||
147620166|NCT04429503|532427235|FG004|Main Study (Up to Wk 96)|Death|0|||
147620167|NCT04429503|532427236|FG005|Main Study (Up to Wk 96)|Death|0|||
147620168|NCT04429503|532427231|FG000|Extension Phase (Wk 96 to Wk 156)|Protocol Violation|0|||
147620169|NCT04429503|532427232|FG001|Extension Phase (Wk 96 to Wk 156)|Protocol Violation|0|||
147620170|NCT04429503|532427233|FG002|Extension Phase (Wk 96 to Wk 156)|Protocol Violation|0|||
147620171|NCT04429503|532427234|FG003|Extension Phase (Wk 96 to Wk 156)|Protocol Violation|1|||
147620172|NCT04429503|532427235|FG004|Extension Phase (Wk 96 to Wk 156)|Protocol Violation|0|||
147413187|NCT01725126|531676092|FG004|Overall Study|Withdrawal by Subject|0|||
147413188|NCT01725126|531676093|FG005|Overall Study|Withdrawal by Subject|0|||
147413189|NCT01240915|531676096|FG000|Overall Study|Adverse Event|0|||
147471307|NCT01275222|531881430|FG002|Phase ll by Stratum|Disease progression|0|||
147471308|NCT01275222|531881431|FG003|Phase ll by Stratum|Disease progression|0|||
147620173|NCT04429503|532427236|FG005|Extension Phase (Wk 96 to Wk 156)|Protocol Violation|0|||
147620174|NCT04429503|532427231|FG000|Extension Phase (Wk 96 to Wk 156)|Adverse Event|0|||
147413190|NCT01240915|531676097|FG001|Overall Study|Adverse Event|0|||
147413191|NCT01240915|531676098|FG002|Overall Study|Adverse Event|0|||
147413192|NCT01240915|531676099|FG003|Overall Study|Adverse Event|1|||
147413193|NCT01240915|531676100|FG004|Overall Study|Adverse Event|0|||
147413194|NCT01240915|531676101|FG005|Overall Study|Adverse Event|2|||
147471309|NCT01275222|531881432|FG004|Phase ll by Stratum|Disease progression|23|||
147471310|NCT01275222|531881433|FG005|Phase ll by Stratum|Disease progression|31|||
147413195|NCT01240915|531676102|FG006|Overall Study|Adverse Event|0|||
147471311|NCT01275222|531881428|FG000|Phase ll by Stratum|Withdrawal by Subject|0|||
147471312|NCT01275222|531881429|FG001|Phase ll by Stratum|Withdrawal by Subject|0|||
147471313|NCT01275222|531881430|FG002|Phase ll by Stratum|Withdrawal by Subject|0|||
147471314|NCT01275222|531881431|FG003|Phase ll by Stratum|Withdrawal by Subject|0|||
147471315|NCT01275222|531881432|FG004|Phase ll by Stratum|Withdrawal by Subject|2|||
147471316|NCT01275222|531881433|FG005|Phase ll by Stratum|Withdrawal by Subject|3|||
147471317|NCT01275222|531881428|FG000|Phase ll by Stratum|Death|0|||
147471318|NCT01275222|531881429|FG001|Phase ll by Stratum|Death|0|||
147471319|NCT01275222|531881430|FG002|Phase ll by Stratum|Death|0|||
147471320|NCT01275222|531881431|FG003|Phase ll by Stratum|Death|0|||
147471321|NCT01275222|531881432|FG004|Phase ll by Stratum|Death|1|||
147471322|NCT01275222|531881433|FG005|Phase ll by Stratum|Death|1|||
147471323|NCT01511445|531881434|FG000|Overall Study|Lost to Follow-up|3|||
147471324|NCT01511445|531881435|FG001|Overall Study|Lost to Follow-up|1|||
147471325|NCT01511445|531881434|FG000|Overall Study|Protocol Violation|1|||
147471326|NCT01511445|531881435|FG001|Overall Study|Protocol Violation|3|||
147471327|NCT01511445|531881434|FG000|Overall Study|Protocol Violation|1|||
147471328|NCT01511445|531881435|FG001|Overall Study|Protocol Violation|0|||
147471329|NCT01856114|531881437|FG000|Overall Study|Withdrawal by Subject|1|||
147471330|NCT01856114|531881438|FG001|Overall Study|Withdrawal by Subject|0|||
147471331|NCT01856114|531881437|FG000|Overall Study|Adverse Event|1|||
147471332|NCT01856114|531881438|FG001|Overall Study|Adverse Event|0|||
147471333|NCT00144170|531881439|FG000|Overall Study|Adverse Event|84|||
147471334|NCT00144170|531881440|FG001|Overall Study|Adverse Event|41|||
147471335|NCT00144170|531881439|FG000|Overall Study|Protocol Violation|23|||
147471336|NCT00144170|531881440|FG001|Overall Study|Protocol Violation|16|||
147471337|NCT00144170|531881439|FG000|Overall Study|Lost to Follow-up|5|||
147471338|NCT00144170|531881440|FG001|Overall Study|Lost to Follow-up|10|||
147471339|NCT00144170|531881439|FG000|Overall Study|Withdrawal by Subject|29|||
147471340|NCT00144170|531881440|FG001|Overall Study|Withdrawal by Subject|13|||
147471341|NCT00144170|531881439|FG000|Overall Study|Other reason not defined above|211|||
147471342|NCT00144170|531881440|FG001|Overall Study|Other reason not defined above|316|||
147471343|NCT00332202|531881441|FG000|Overall Study|Adverse Event|72|||
147471344|NCT00332202|531881442|FG001|Overall Study|Adverse Event|28|||
147471345|NCT00332202|531881441|FG000|Overall Study|Lost to Follow-up|2|||
147471346|NCT00332202|531881442|FG001|Overall Study|Lost to Follow-up|1|||
147471347|NCT00332202|531881441|FG000|Overall Study|Physician Decision|6|||
147471348|NCT00332202|531881442|FG001|Overall Study|Physician Decision|8|||
147471349|NCT00332202|531881441|FG000|Overall Study|Protocol Entry Criteria Not Met|6|||
147471350|NCT00332202|531881442|FG001|Overall Study|Protocol Entry Criteria Not Met|5|||
147471351|NCT00332202|531881441|FG000|Overall Study|Protocol Violation|7|||
147471352|NCT00332202|531881442|FG001|Overall Study|Protocol Violation|2|||
147471353|NCT00332202|531881441|FG000|Overall Study|Sponsor Decision|1|||
147471354|NCT00332202|531881442|FG001|Overall Study|Sponsor Decision|2|||
147471355|NCT00332202|531881441|FG000|Overall Study|Withdrawal by Subject|36|||
147471356|NCT00332202|531881442|FG001|Overall Study|Withdrawal by Subject|17|||
147471357|NCT00332202|531881441|FG000|Overall Study|Progressive Disease|106|||
147471358|NCT00332202|531881442|FG001|Overall Study|Progressive Disease|60|||
147471359|NCT00332202|531881441|FG000|Overall Study|Death|5|||
147471360|NCT00332202|531881442|FG001|Overall Study|Death|2|||
147471361|NCT00957853|531881443|FG000|Overall Study|Withdrawal by Subject|1|||
147471362|NCT00957853|531881444|FG001|Overall Study|Withdrawal by Subject|0|||
147471363|NCT00957853|531881445|FG002|Overall Study|Withdrawal by Subject|0|||
147471364|NCT05202808|531881448|FG000|Overall Study|Lost to Follow-up|3|||
147471365|NCT05202808|531881449|FG001|Overall Study|Lost to Follow-up|1|||
147471366|NCT04091217|531881450|FG000|Overall Study|Lost to Follow-up|2|||
147471367|NCT00100048|531881451|FG000|Cohort I & II-Combination Therapy Phase|Never Treated|2|||
147471368|NCT00100048|531881452|FG001|Cohort I & II-Combination Therapy Phase|Never Treated|0|||
147471369|NCT00100048|531881453|FG002|Cohort I & II-Combination Therapy Phase|Never Treated|0|||
147471370|NCT00100048|531881454|FG003|Cohort I & II-Combination Therapy Phase|Never Treated|0|||
147471371|NCT00100048|531881455|FG004|Cohort I & II-Combination Therapy Phase|Never Treated|0|||
147471372|NCT00100048|531881456|FG005|Cohort I & II-Combination Therapy Phase|Never Treated|1|||
147471373|NCT00100048|531881451|FG000|Cohort I & II-Combination Therapy Phase|Adverse Event|0|||
147665958|NCT03167242|532601651|FG005|Overall Study|Lost to Follow-up|1|||
147665959|NCT03167242|532601652|FG006|Overall Study|Lost to Follow-up|2|||
147471374|NCT00100048|531881452|FG001|Cohort I & II-Combination Therapy Phase|Adverse Event|1|||
147471375|NCT00100048|531881453|FG002|Cohort I & II-Combination Therapy Phase|Adverse Event|2|||
147471376|NCT00100048|531881454|FG003|Cohort I & II-Combination Therapy Phase|Adverse Event|0|||
147665960|NCT03167242|532601653|FG007|Overall Study|Lost to Follow-up|1|||
147471377|NCT00100048|531881455|FG004|Cohort I & II-Combination Therapy Phase|Adverse Event|0|||
147471378|NCT00100048|531881456|FG005|Cohort I & II-Combination Therapy Phase|Adverse Event|1|||
147471379|NCT00100048|531881451|FG000|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|1|||
147471380|NCT00100048|531881452|FG001|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|3|||
147471381|NCT00100048|531881453|FG002|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|0|||
147471382|NCT00100048|531881454|FG003|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|0|||
147471383|NCT00100048|531881455|FG004|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|0|||
147471384|NCT00100048|531881456|FG005|Cohort I & II-Combination Therapy Phase|Lack of Efficacy|2|||
147471385|NCT00100048|531881451|FG000|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|2|||
147471386|NCT00100048|531881452|FG001|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|1|||
147471387|NCT00100048|531881453|FG002|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|3|||
147471388|NCT00100048|531881454|FG003|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|2|||
147471389|NCT00100048|531881455|FG004|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|0|||
147620175|NCT04429503|532427232|FG001|Extension Phase (Wk 96 to Wk 156)|Adverse Event|0|||
147620176|NCT04429503|532427233|FG002|Extension Phase (Wk 96 to Wk 156)|Adverse Event|0|||
147471390|NCT00100048|531881456|FG005|Cohort I & II-Combination Therapy Phase|Lost to Follow-up|3|||
147471391|NCT00100048|531881451|FG000|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|1|||
147471392|NCT00100048|531881452|FG001|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|2|||
147471393|NCT00100048|531881453|FG002|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|2|||
147471394|NCT00100048|531881454|FG003|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|5|||
147471395|NCT00100048|531881455|FG004|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|0|||
147471396|NCT00100048|531881456|FG005|Cohort I & II-Combination Therapy Phase|Withdrawal by Subject|4|||
147471397|NCT00100048|531881451|FG000|Cohort I & II-Combination Therapy Phase|Other Reason|7|||
147471398|NCT00100048|531881452|FG001|Cohort I & II-Combination Therapy Phase|Other Reason|1|||
147471399|NCT00100048|531881453|FG002|Cohort I & II-Combination Therapy Phase|Other Reason|4|||
147471400|NCT00100048|531881454|FG003|Cohort I & II-Combination Therapy Phase|Other Reason|2|||
147471401|NCT00100048|531881455|FG004|Cohort I & II-Combination Therapy Phase|Other Reason|0|||
147471402|NCT00100048|531881456|FG005|Cohort I & II-Combination Therapy Phase|Other Reason|0|||
147471403|NCT00100048|531881451|FG000|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|1|||
147471404|NCT00100048|531881452|FG001|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|1|||
147471405|NCT00100048|531881453|FG002|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|2|||
147471406|NCT00100048|531881454|FG003|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|0|||
147471407|NCT00100048|531881455|FG004|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|0|||
147471408|NCT00100048|531881456|FG005|Cohort I & II-Combination Therapy Phase|Completed Base Study, Did Not Continue|2|||
147471409|NCT00100048|531881451|FG000|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0|||
147471410|NCT00100048|531881452|FG001|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0|||
147471411|NCT00100048|531881453|FG002|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0|||
147471412|NCT00100048|531881454|FG003|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|1|||
147471413|NCT00100048|531881455|FG004|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0|||
147471414|NCT00100048|531881456|FG005|Cohort I & II-Combination Therapy Phase|Laboratory Adverse Experience|0|||
147471415|NCT01822561|531881458|FG000|Overall Study|Withdrawal by Subject|2|||
147471416|NCT02747004|531881459|FG000|Overall Study|Withdrawal by Subject|8|||
147471417|NCT02747004|531881460|FG001|Overall Study|Withdrawal by Subject|5|||
147471418|NCT02747004|531881461|FG002|Overall Study|Withdrawal by Subject|4|||
147471419|NCT02747004|531881459|FG000|Overall Study|Lost to Follow-up|1|||
147471420|NCT02747004|531881460|FG001|Overall Study|Lost to Follow-up|2|||
147471421|NCT02747004|531881461|FG002|Overall Study|Lost to Follow-up|2|||
147471422|NCT02747004|531881459|FG000|Overall Study|on study treatment/follow-up|48|||
147471423|NCT02747004|531881460|FG001|Overall Study|on study treatment/follow-up|42|||
147413196|NCT01240915|531676103|FG007|Overall Study|Adverse Event|0|||
147413197|NCT01240915|531676104|FG008|Overall Study|Adverse Event|1|||
147413198|NCT01240915|531676096|FG000|Overall Study|Lost to Follow-up|0|||
147413199|NCT01240915|531676097|FG001|Overall Study|Lost to Follow-up|0|||
147413200|NCT01240915|531676098|FG002|Overall Study|Lost to Follow-up|0|||
147413201|NCT01240915|531676099|FG003|Overall Study|Lost to Follow-up|0|||
147413202|NCT01240915|531676100|FG004|Overall Study|Lost to Follow-up|1|||
147413203|NCT01240915|531676101|FG005|Overall Study|Lost to Follow-up|1|||
147413204|NCT01240915|531676102|FG006|Overall Study|Lost to Follow-up|0|||
147413205|NCT01240915|531676103|FG007|Overall Study|Lost to Follow-up|1|||
147413206|NCT01240915|531676104|FG008|Overall Study|Lost to Follow-up|1|||
147413207|NCT01240915|531676096|FG000|Overall Study|Withdrawal by Subject|2|||
147413208|NCT01240915|531676097|FG001|Overall Study|Withdrawal by Subject|1|||
147413209|NCT01240915|531676098|FG002|Overall Study|Withdrawal by Subject|0|||
147413210|NCT01240915|531676099|FG003|Overall Study|Withdrawal by Subject|2|||
147413211|NCT01240915|531676100|FG004|Overall Study|Withdrawal by Subject|0|||
147471424|NCT02747004|531881461|FG002|Overall Study|on study treatment/follow-up|41|||
147471425|NCT05087030|531881462|FG000|Main Period (Week 0 to Week 52)|Withdrawal by Subject|8|||
147471426|NCT05087030|531881463|FG001|Main Period (Week 0 to Week 52)|Withdrawal by Subject|13|||
147471427|NCT05087030|531881464|FG002|Main Period (Week 0 to Week 52)|Withdrawal by Subject|0|||
147471428|NCT05087030|531881465|FG003|Main Period (Week 0 to Week 52)|Withdrawal by Subject|0|||
147471429|NCT05087030|531881466|FG004|Main Period (Week 0 to Week 52)|Withdrawal by Subject|0|||
147413212|NCT01240915|531676101|FG005|Overall Study|Withdrawal by Subject|4|||
147413213|NCT01240915|531676102|FG006|Overall Study|Withdrawal by Subject|2|||
147413214|NCT01240915|531676103|FG007|Overall Study|Withdrawal by Subject|3|||
147413215|NCT01240915|531676104|FG008|Overall Study|Withdrawal by Subject|3|||
147413216|NCT01240915|531676096|FG000|Overall Study|Other|0|||
147413217|NCT01240915|531676097|FG001|Overall Study|Other|0|||
147413218|NCT01240915|531676098|FG002|Overall Study|Other|0|||
147413219|NCT01240915|531676099|FG003|Overall Study|Other|0|||
147413220|NCT01240915|531676100|FG004|Overall Study|Other|2|||
147413221|NCT01240915|531676101|FG005|Overall Study|Other|0|||
147413222|NCT01240915|531676102|FG006|Overall Study|Other|0|||
147413223|NCT01240915|531676103|FG007|Overall Study|Other|0|||
147413224|NCT01240915|531676104|FG008|Overall Study|Other|0|||
147413225|NCT01240915|531676096|FG000|Overall Study|Insufficient Clinical Response|0|||
147413226|NCT01240915|531676097|FG001|Overall Study|Insufficient Clinical Response|0|||
147413227|NCT01240915|531676098|FG002|Overall Study|Insufficient Clinical Response|0|||
147413228|NCT01240915|531676099|FG003|Overall Study|Insufficient Clinical Response|0|||
147413229|NCT01240915|531676100|FG004|Overall Study|Insufficient Clinical Response|1|||
147413230|NCT01240915|531676101|FG005|Overall Study|Insufficient Clinical Response|3|||
147413231|NCT01240915|531676102|FG006|Overall Study|Insufficient Clinical Response|6|||
147413232|NCT01240915|531676103|FG007|Overall Study|Insufficient Clinical Response|0|||
147413233|NCT01240915|531676104|FG008|Overall Study|Insufficient Clinical Response|3|||
147413234|NCT01598662|531676106|FG000|Overall Study|Lost to Follow-up|10|||
147413235|NCT01598662|531676107|FG001|Overall Study|Lost to Follow-up|17|||
147413236|NCT01598662|531676106|FG000|Overall Study|Physician Decision|1|||
147413237|NCT01598662|531676107|FG001|Overall Study|Physician Decision|2|||
147413238|NCT01598662|531676106|FG000|Overall Study|IUD expelled before month 6|0|||
147413239|NCT01598662|531676107|FG001|Overall Study|IUD expelled before month 6|2|||
147413240|NCT02574845|531676108|FG000|Overall Study|Consent withdrawn further participation|0|||
147413241|NCT02574845|531676109|FG001|Overall Study|Consent withdrawn further participation|0|||
147413242|NCT02574845|531676110|FG002|Overall Study|Consent withdrawn further participation|0|||
147413243|NCT02574845|531676111|FG003|Overall Study|Consent withdrawn further participation|0|||
147413244|NCT02574845|531676112|FG004|Overall Study|Consent withdrawn further participation|1|||
147413245|NCT02574845|531676113|FG005|Overall Study|Consent withdrawn further participation|0|||
147413246|NCT02574845|531676108|FG000|Overall Study|Adverse Event|0|||
147413247|NCT02574845|531676109|FG001|Overall Study|Adverse Event|1|||
147413248|NCT02574845|531676110|FG002|Overall Study|Adverse Event|0|||
147413249|NCT02574845|531676111|FG003|Overall Study|Adverse Event|0|||
147413250|NCT02574845|531676112|FG004|Overall Study|Adverse Event|0|||
147413251|NCT02574845|531676113|FG005|Overall Study|Adverse Event|1|||
147413252|NCT02781090|531676117|FG000|3-Month Follow-Up|Missed Visit|20|||
147413253|NCT02781090|531676118|FG001|3-Month Follow-Up|Missed Visit|20|||
147413254|NCT02781090|531676117|FG000|3-Month Follow-Up|Lost to Follow-up|40|||
147413255|NCT02781090|531676118|FG001|3-Month Follow-Up|Lost to Follow-up|34|||
147413256|NCT02781090|531676117|FG000|3-Month Follow-Up|Withdrawal by Subject|4|||
147413257|NCT02781090|531676118|FG001|3-Month Follow-Up|Withdrawal by Subject|3|||
147413258|NCT02781090|531676117|FG000|3-Month Follow-Up|Death|1|||
147413259|NCT02781090|531676118|FG001|3-Month Follow-Up|Death|0|||
147413260|NCT02781090|531676117|FG000|6-Month Follow-Up|Withdrawal by Subject|1|||
147413261|NCT02781090|531676118|FG001|6-Month Follow-Up|Withdrawal by Subject|2|||
147413262|NCT02781090|531676117|FG000|6-Month Follow-Up|Lost to Follow-up|20|||
147413263|NCT02781090|531676118|FG001|6-Month Follow-Up|Lost to Follow-up|22|||
147413264|NCT02781090|531676117|FG000|6-Month Follow-Up|Death|0|||
147413265|NCT02781090|531676118|FG001|6-Month Follow-Up|Death|1|||
147413266|NCT01867333|531676119|FG000|Overall Study|Withdrawal by Subject|1|||
147413267|NCT01867333|531676120|FG001|Overall Study|Withdrawal by Subject|0|||
147413268|NCT01867333|531676119|FG000|Overall Study|Adverse Event|1|||
147413269|NCT01867333|531676120|FG001|Overall Study|Adverse Event|0|||
147413270|NCT01867333|531676119|FG000|Overall Study|Participant choice|1|||
147413271|NCT01867333|531676120|FG001|Overall Study|Participant choice|2|||
147413272|NCT01867333|531676119|FG000|Overall Study|Complicating disease/intercurrent illness|1|||
147413273|NCT01867333|531676120|FG001|Overall Study|Complicating disease/intercurrent illness|0|||
147413274|NCT01867333|531676119|FG000|Overall Study|Death|0|||
147413275|NCT01867333|531676120|FG001|Overall Study|Death|1|||
147413276|NCT01867333|531676119|FG000|Overall Study|Physician Decision|3|||
147413277|NCT01867333|531676120|FG001|Overall Study|Physician Decision|2|||
147413278|NCT01867333|531676119|FG000|Overall Study|Switched to alternative treatment|1|||
147413279|NCT01867333|531676120|FG001|Overall Study|Switched to alternative treatment|0|||
147413280|NCT02683785|531676123|FG000|Overall Study|Withdrawal by Subject|1|||
147413281|NCT02683785|531676124|FG001|Overall Study|Withdrawal by Subject|1|||
147413282|NCT02683785|531676123|FG000|Overall Study|Lost to Follow-up|0|||
147413283|NCT02683785|531676124|FG001|Overall Study|Lost to Follow-up|1|||
147413284|NCT02683785|531676123|FG000|Overall Study|Adverse Event|0|||
147413285|NCT02683785|531676124|FG001|Overall Study|Adverse Event|2|||
147413286|NCT01696045|531676127|FG000|Overall Study|Study drug toxicity|1|||
147413287|NCT01696045|531676128|FG001|Overall Study|Study drug toxicity|5|||
147413288|NCT01696045|531676127|FG000|Overall Study|Disease progression|2|||
147413289|NCT01696045|531676128|FG001|Overall Study|Disease progression|2|||
147413290|NCT00368927|531676129|FG000|Overall Study|Lost to Follow-up|2|||
147413291|NCT00368927|531676130|FG001|Overall Study|Lost to Follow-up|0|||
147413292|NCT00368927|531676129|FG000|Overall Study|Adverse Event|1|||
147413293|NCT00368927|531676130|FG001|Overall Study|Adverse Event|1|||
147413294|NCT00368927|531676129|FG000|Overall Study|Withdrawal by Subject|1|||
147413295|NCT00368927|531676130|FG001|Overall Study|Withdrawal by Subject|2|||
147413296|NCT00368927|531676129|FG000|Overall Study|Physician Decision|1|||
147413297|NCT00368927|531676130|FG001|Overall Study|Physician Decision|0|||
147413298|NCT03525392|531676131|FG000|Overall Study|Adverse Event|1|||
147413299|NCT03525392|531676132|FG001|Overall Study|Adverse Event|0|||
147413300|NCT03525392|531676133|FG002|Overall Study|Adverse Event|2|||
147413301|NCT03525392|531676134|FG003|Overall Study|Adverse Event|0|||
147413302|NCT03525392|531676135|FG004|Overall Study|Adverse Event|0|||
147413303|NCT03525392|531676131|FG000|Overall Study|Progressive disease|0|||
147413304|NCT03525392|531676132|FG001|Overall Study|Progressive disease|1|||
147413305|NCT03525392|531676133|FG002|Overall Study|Progressive disease|1|||
147413306|NCT03525392|531676134|FG003|Overall Study|Progressive disease|3|||
147413307|NCT03525392|531676135|FG004|Overall Study|Progressive disease|1|||
147413308|NCT03284203|531676136|FG000|Overall Study|Lost to Follow-up|3|||
147413309|NCT03309813|531676139|FG000|Main Randomized Study|Withdrawal by Subject|1|||
147413310|NCT03309813|531676140|FG001|Main Randomized Study|Withdrawal by Subject|0|||
147413311|NCT04978493|531676141|FG000|Overall Study|No reason available|0|||
147413312|NCT04978493|531676142|FG001|Overall Study|No reason available|1|||
147413313|NCT04978493|531676141|FG000|Overall Study|Adverse Event|1|||
147413314|NCT04978493|531676142|FG001|Overall Study|Adverse Event|0|||
147413315|NCT01128114|531676143|FG000|Overall Study|Treatment Withdrawn|6|||
147413316|NCT01128114|531676143|FG000|Overall Study|Screening Failed|2|||
147413317|NCT02738853|531676146|FG000|Enrollment|Inclusion/Exclusion not met|21|||
147413318|NCT02738853|531676146|FG000|Enrollment|Withdrawal by Subject|3|||
147413319|NCT02738853|531676146|FG000|Enrollment|Subject treated with commercially available device|6|||
147413320|NCT02738853|531676146|FG000|Enrollment|Study Enrollment Closed|3|||
147413321|NCT02738853|531676146|FG000|Procedure|Death|1|||
147413322|NCT02738853|531676146|FG000|1 Month|Death|2|||
147413323|NCT02738853|531676146|FG000|6 Month|Death|4|||
147413324|NCT02738853|531676146|FG000|6 Month|Withdrawal by Subject|2|||
147413325|NCT02738853|531676146|FG000|1 Year|Death|6|||
147413326|NCT02738853|531676146|FG000|1 Year|Withdrawal by Subject|1|||
147413327|NCT02738853|531676146|FG000|2 Year|Death|2|||
147413328|NCT02738853|531676146|FG000|2 Year|Lost to Follow-up|1|||
147413329|NCT02738853|531676146|FG000|3 Year|Death|2|||
147413330|NCT02738853|531676146|FG000|3 Year|Withdrawal by Subject|1|||
147413331|NCT02738853|531676146|FG000|4 Year|Death|9|||
147413332|NCT02738853|531676146|FG000|5 Year|Lost to Follow-up|4|||
147413333|NCT04157400|531676148|FG000|Overall Study|Withdrawal by Subject|1|||
147413334|NCT04157400|531676148|FG000|Overall Study|Lost to Follow-up|3|||
147413335|NCT01803282|531676150|FG000|Overall Study|Progressive Disease|4|||
147413336|NCT01803282|531676151|FG001|Overall Study|Progressive Disease|3|||
147413337|NCT01803282|531676152|FG002|Overall Study|Progressive Disease|6|||
147413338|NCT01803282|531676153|FG003|Overall Study|Progressive Disease|22|||
147413339|NCT01803282|531676154|FG004|Overall Study|Progressive Disease|5|||
147413340|NCT01803282|531676155|FG005|Overall Study|Progressive Disease|8|||
147413341|NCT01803282|531676156|FG006|Overall Study|Progressive Disease|23|||
147413342|NCT01803282|531676157|FG007|Overall Study|Progressive Disease|24|||
147413343|NCT01803282|531676158|FG008|Overall Study|Progressive Disease|3|||
147413344|NCT01803282|531676159|FG009|Overall Study|Progressive Disease|29|||
147413345|NCT01803282|531676160|FG010|Overall Study|Progressive Disease|6|||
147413346|NCT01803282|531676161|FG011|Overall Study|Progressive Disease|11|||
147413347|NCT01803282|531676150|FG000|Overall Study|Death|0|||
147413348|NCT01803282|531676151|FG001|Overall Study|Death|0|||
147413349|NCT01803282|531676152|FG002|Overall Study|Death|0|||
147413350|NCT01803282|531676153|FG003|Overall Study|Death|0|||
147413351|NCT01803282|531676154|FG004|Overall Study|Death|2|||
147413352|NCT01803282|531676155|FG005|Overall Study|Death|1|||
147413353|NCT01803282|531676156|FG006|Overall Study|Death|1|||
147620177|NCT04429503|532427234|FG003|Extension Phase (Wk 96 to Wk 156)|Adverse Event|1|||
147413354|NCT01803282|531676157|FG007|Overall Study|Death|5|||
147413355|NCT01803282|531676158|FG008|Overall Study|Death|1|||
147413356|NCT01803282|531676159|FG009|Overall Study|Death|1|||
147413357|NCT01803282|531676160|FG010|Overall Study|Death|0|||
147413358|NCT01803282|531676161|FG011|Overall Study|Death|0|||
147413359|NCT01803282|531676150|FG000|Overall Study|Withdrew Consent|0|||
147413360|NCT01803282|531676151|FG001|Overall Study|Withdrew Consent|0|||
147413361|NCT01803282|531676152|FG002|Overall Study|Withdrew Consent|0|||
147620178|NCT04429503|532427235|FG004|Extension Phase (Wk 96 to Wk 156)|Adverse Event|1|||
147413362|NCT01803282|531676153|FG003|Overall Study|Withdrew Consent|6|||
147413363|NCT01803282|531676154|FG004|Overall Study|Withdrew Consent|1|||
147413364|NCT01803282|531676155|FG005|Overall Study|Withdrew Consent|0|||
147413365|NCT01803282|531676156|FG006|Overall Study|Withdrew Consent|8|||
147413366|NCT01803282|531676157|FG007|Overall Study|Withdrew Consent|3|||
147413367|NCT01803282|531676158|FG008|Overall Study|Withdrew Consent|1|||
147413368|NCT01803282|531676159|FG009|Overall Study|Withdrew Consent|5|||
147413369|NCT01803282|531676160|FG010|Overall Study|Withdrew Consent|0|||
147413370|NCT01803282|531676161|FG011|Overall Study|Withdrew Consent|1|||
147413371|NCT01803282|531676150|FG000|Overall Study|Investigator's Discretion|0|||
147413372|NCT01803282|531676151|FG001|Overall Study|Investigator's Discretion|0|||
147413373|NCT01803282|531676152|FG002|Overall Study|Investigator's Discretion|0|||
147413374|NCT01803282|531676153|FG003|Overall Study|Investigator's Discretion|7|||
147413375|NCT01803282|531676154|FG004|Overall Study|Investigator's Discretion|2|||
147413376|NCT01803282|531676155|FG005|Overall Study|Investigator's Discretion|1|||
147413377|NCT01803282|531676156|FG006|Overall Study|Investigator's Discretion|7|||
147413378|NCT01803282|531676157|FG007|Overall Study|Investigator's Discretion|10|||
147413379|NCT01803282|531676158|FG008|Overall Study|Investigator's Discretion|6|||
147413380|NCT01803282|531676159|FG009|Overall Study|Investigator's Discretion|7|||
147413381|NCT01803282|531676160|FG010|Overall Study|Investigator's Discretion|1|||
147413382|NCT01803282|531676161|FG011|Overall Study|Investigator's Discretion|0|||
147413383|NCT01803282|531676150|FG000|Overall Study|Adverse Event|0|||
147413384|NCT01803282|531676151|FG001|Overall Study|Adverse Event|0|||
147413385|NCT01803282|531676152|FG002|Overall Study|Adverse Event|0|||
147413386|NCT01803282|531676153|FG003|Overall Study|Adverse Event|0|||
147413387|NCT01803282|531676154|FG004|Overall Study|Adverse Event|0|||
147413388|NCT01803282|531676155|FG005|Overall Study|Adverse Event|0|||
147413389|NCT01803282|531676156|FG006|Overall Study|Adverse Event|1|||
147413390|NCT01803282|531676157|FG007|Overall Study|Adverse Event|2|||
147413391|NCT01803282|531676158|FG008|Overall Study|Adverse Event|0|||
147413392|NCT01803282|531676159|FG009|Overall Study|Adverse Event|1|||
147413393|NCT01803282|531676160|FG010|Overall Study|Adverse Event|0|||
147413394|NCT01803282|531676161|FG011|Overall Study|Adverse Event|3|||
147413395|NCT01803282|531676150|FG000|Overall Study|Non-Compliance with Study Drug|0|||
147413396|NCT01803282|531676151|FG001|Overall Study|Non-Compliance with Study Drug|0|||
147413397|NCT01803282|531676152|FG002|Overall Study|Non-Compliance with Study Drug|0|||
147413398|NCT01803282|531676153|FG003|Overall Study|Non-Compliance with Study Drug|1|||
147413399|NCT01803282|531676154|FG004|Overall Study|Non-Compliance with Study Drug|0|||
147413400|NCT01803282|531676155|FG005|Overall Study|Non-Compliance with Study Drug|0|||
147413401|NCT01803282|531676156|FG006|Overall Study|Non-Compliance with Study Drug|0|||
147413402|NCT01803282|531676157|FG007|Overall Study|Non-Compliance with Study Drug|0|||
147413403|NCT01803282|531676158|FG008|Overall Study|Non-Compliance with Study Drug|0|||
147413404|NCT01803282|531676159|FG009|Overall Study|Non-Compliance with Study Drug|0|||
147413405|NCT01803282|531676160|FG010|Overall Study|Non-Compliance with Study Drug|0|||
147413406|NCT01803282|531676161|FG011|Overall Study|Non-Compliance with Study Drug|0|||
147413407|NCT01803282|531676150|FG000|Overall Study|Unknown Reason|0|||
147413408|NCT01803282|531676151|FG001|Overall Study|Unknown Reason|0|||
147413409|NCT01803282|531676152|FG002|Overall Study|Unknown Reason|0|||
147413410|NCT01803282|531676153|FG003|Overall Study|Unknown Reason|0|||
147413411|NCT01803282|531676154|FG004|Overall Study|Unknown Reason|0|||
147413412|NCT01803282|531676155|FG005|Overall Study|Unknown Reason|0|||
147413413|NCT01803282|531676156|FG006|Overall Study|Unknown Reason|0|||
147413414|NCT01803282|531676157|FG007|Overall Study|Unknown Reason|1|||
147413415|NCT01803282|531676158|FG008|Overall Study|Unknown Reason|0|||
147413416|NCT01803282|531676159|FG009|Overall Study|Unknown Reason|0|||
147413417|NCT01803282|531676160|FG010|Overall Study|Unknown Reason|0|||
147413418|NCT01803282|531676161|FG011|Overall Study|Unknown Reason|0|||
147413419|NCT01803282|531676150|FG000|Overall Study|Specified Criteria for Withdrawal|0|||
147413420|NCT01803282|531676151|FG001|Overall Study|Specified Criteria for Withdrawal|0|||
147413421|NCT01803282|531676152|FG002|Overall Study|Specified Criteria for Withdrawal|0|||
147413422|NCT01803282|531676153|FG003|Overall Study|Specified Criteria for Withdrawal|0|||
147413423|NCT01803282|531676154|FG004|Overall Study|Specified Criteria for Withdrawal|0|||
147413424|NCT01803282|531676155|FG005|Overall Study|Specified Criteria for Withdrawal|0|||
147413425|NCT01803282|531676156|FG006|Overall Study|Specified Criteria for Withdrawal|0|||
147413426|NCT01803282|531676157|FG007|Overall Study|Specified Criteria for Withdrawal|0|||
147413427|NCT01803282|531676158|FG008|Overall Study|Specified Criteria for Withdrawal|0|||
147413428|NCT01803282|531676159|FG009|Overall Study|Specified Criteria for Withdrawal|1|||
147413429|NCT01803282|531676160|FG010|Overall Study|Specified Criteria for Withdrawal|1|||
147413430|NCT01803282|531676161|FG011|Overall Study|Specified Criteria for Withdrawal|0|||
147413431|NCT01803282|531676150|FG000|Overall Study|Enrolled but Never Treated|0|||
147413432|NCT01803282|531676151|FG001|Overall Study|Enrolled but Never Treated|0|||
147413433|NCT01803282|531676152|FG002|Overall Study|Enrolled but Never Treated|0|||
147413434|NCT01803282|531676153|FG003|Overall Study|Enrolled but Never Treated|0|||
147471430|NCT05087030|531881462|FG000|Main Period (Week 0 to Week 52)|Adverse Event|2|||
147413435|NCT01803282|531676154|FG004|Overall Study|Enrolled but Never Treated|1|||
147413436|NCT01803282|531676155|FG005|Overall Study|Enrolled but Never Treated|0|||
147413437|NCT01803282|531676156|FG006|Overall Study|Enrolled but Never Treated|1|||
147413438|NCT01803282|531676157|FG007|Overall Study|Enrolled but Never Treated|1|||
147413439|NCT01803282|531676158|FG008|Overall Study|Enrolled but Never Treated|0|||
147413440|NCT01803282|531676159|FG009|Overall Study|Enrolled but Never Treated|1|||
147413441|NCT01803282|531676160|FG010|Overall Study|Enrolled but Never Treated|0|||
147413442|NCT01803282|531676161|FG011|Overall Study|Enrolled but Never Treated|0|||
147413443|NCT02671500|531676162|FG000|Overall Study|Lack of Efficacy|12|||
147413444|NCT02671500|531676162|FG000|Overall Study|Lost to Follow-up|2|||
147413445|NCT01217437|531676163|FG000|Overall Study|Adverse Event|0|||
147413446|NCT01217437|531676164|FG001|Overall Study|Adverse Event|8|||
147413447|NCT01217437|531676163|FG000|Overall Study|Death|5|||
147665961|NCT03167242|532601654|FG008|Overall Study|Lost to Follow-up|0|||
147413448|NCT01217437|531676164|FG001|Overall Study|Death|0|||
147413449|NCT01217437|531676163|FG000|Overall Study|Lack of Efficacy|29|||
147413450|NCT01217437|531676164|FG001|Overall Study|Lack of Efficacy|25|||
147413451|NCT01217437|531676163|FG000|Overall Study|Physician Decision|8|||
147413452|NCT01217437|531676164|FG001|Overall Study|Physician Decision|5|||
147413453|NCT01217437|531676163|FG000|Overall Study|Withdrawal by Subject|0|||
147413454|NCT01217437|531676164|FG001|Overall Study|Withdrawal by Subject|2|||
147413455|NCT01217437|531676163|FG000|Overall Study|Ineligible|1|||
147413456|NCT01217437|531676164|FG001|Overall Study|Ineligible|1|||
147413457|NCT04531982|531676167|FG000|Overall Study|Withdrawal by Subject|10|||
147413458|NCT04531982|531676168|FG001|Overall Study|Withdrawal by Subject|11|||
147413459|NCT04531982|531676167|FG000|Overall Study|Adverse Event|6|||
147413460|NCT04531982|531676168|FG001|Overall Study|Adverse Event|14|||
147413461|NCT04531982|531676167|FG000|Overall Study|Protocol Violation|6|||
147413462|NCT04531982|531676168|FG001|Overall Study|Protocol Violation|9|||
147413463|NCT04531982|531676167|FG000|Overall Study|Non-compliance with study drug|3|||
147413464|NCT04531982|531676168|FG001|Overall Study|Non-compliance with study drug|2|||
147413465|NCT04531982|531676167|FG000|Overall Study|Use of prohibited medication|2|||
147413466|NCT04531982|531676168|FG001|Overall Study|Use of prohibited medication|0|||
147413467|NCT04531982|531676167|FG000|Overall Study|Lost to Follow-up|0|||
147413468|NCT04531982|531676168|FG001|Overall Study|Lost to Follow-up|1|||
147413469|NCT04531982|531676167|FG000|Overall Study|Geopolitical conflict|2|||
147413470|NCT04531982|531676168|FG001|Overall Study|Geopolitical conflict|0|||
147413471|NCT04531982|531676167|FG000|Overall Study|Lack of Efficacy|3|||
147413472|NCT04531982|531676168|FG001|Overall Study|Lack of Efficacy|1|||
147413473|NCT06655558|531676169|FG000|Overall Study|Protocol Violation|1|||
147413474|NCT00890695|531678385|FG000|Overall Study|Protocol Violation|1|||
147413475|NCT00890695|531678386|FG001|Overall Study|Protocol Violation|0|||
147413476|NCT00833261|531678395|FG000|Overall Study|Withdrawal by Subject|4|||
147413477|NCT03439254|531678396|FG000|Double-blind Phase (18 Months)|Adverse Event|11|||
147413478|NCT03439254|531678397|FG001|Double-blind Phase (18 Months)|Adverse Event|12|||
147413479|NCT03439254|531678398|FG002|Double-blind Phase (18 Months)|Adverse Event|15|||
147413480|NCT03439254|531678399|FG003|Double-blind Phase (18 Months)|Adverse Event|0|||
147413481|NCT03439254|531678400|FG004|Double-blind Phase (18 Months)|Adverse Event|0|||
147413482|NCT03439254|531678401|FG005|Double-blind Phase (18 Months)|Adverse Event|0|||
147413483|NCT03439254|531678396|FG000|Double-blind Phase (18 Months)|Covid-19 Non Adverse Event (AE) Related Issues|1|||
147413484|NCT03439254|531678397|FG001|Double-blind Phase (18 Months)|Covid-19 Non Adverse Event (AE) Related Issues|0|||
147413485|NCT03439254|531678398|FG002|Double-blind Phase (18 Months)|Covid-19 Non Adverse Event (AE) Related Issues|0|||
147413486|NCT03439254|531678399|FG003|Double-blind Phase (18 Months)|Covid-19 Non Adverse Event (AE) Related Issues|0|||
147413487|NCT03439254|531678400|FG004|Double-blind Phase (18 Months)|Covid-19 Non Adverse Event (AE) Related Issues|0|||
147413488|NCT03439254|531678401|FG005|Double-blind Phase (18 Months)|Covid-19 Non Adverse Event (AE) Related Issues|0|||
147413489|NCT03439254|531678396|FG000|Double-blind Phase (18 Months)|Death|1|||
147413490|NCT03439254|531678397|FG001|Double-blind Phase (18 Months)|Death|2|||
147413491|NCT03439254|531678398|FG002|Double-blind Phase (18 Months)|Death|2|||
147413492|NCT03439254|531678399|FG003|Double-blind Phase (18 Months)|Death|0|||
147413493|NCT03439254|531678400|FG004|Double-blind Phase (18 Months)|Death|0|||
147413494|NCT03439254|531678401|FG005|Double-blind Phase (18 Months)|Death|0|||
147413495|NCT03439254|531678396|FG000|Double-blind Phase (18 Months)|Lost to Follow-up|0|||
147413496|NCT03439254|531678397|FG001|Double-blind Phase (18 Months)|Lost to Follow-up|1|||
147413497|NCT03439254|531678398|FG002|Double-blind Phase (18 Months)|Lost to Follow-up|5|||
147413498|NCT03439254|531678399|FG003|Double-blind Phase (18 Months)|Lost to Follow-up|0|||
147413499|NCT03439254|531678400|FG004|Double-blind Phase (18 Months)|Lost to Follow-up|0|||
147471431|NCT05087030|531881463|FG001|Main Period (Week 0 to Week 52)|Adverse Event|2|||
147471432|NCT05087030|531881464|FG002|Main Period (Week 0 to Week 52)|Adverse Event|0|||
147471433|NCT05087030|531881465|FG003|Main Period (Week 0 to Week 52)|Adverse Event|0|||
147471434|NCT05087030|531881466|FG004|Main Period (Week 0 to Week 52)|Adverse Event|0|||
147471435|NCT05087030|531881462|FG000|Main Period (Week 0 to Week 52)|Lost to Follow-up|3|||
147665962|NCT03167242|532601655|FG009|Overall Study|Lost to Follow-up|0|||
147413500|NCT03439254|531678401|FG005|Double-blind Phase (18 Months)|Lost to Follow-up|0|||
147413501|NCT03439254|531678396|FG000|Double-blind Phase (18 Months)|Non-Compliance With Study Drug|1|||
147413502|NCT03439254|531678397|FG001|Double-blind Phase (18 Months)|Non-Compliance With Study Drug|0|||
147413503|NCT03439254|531678398|FG002|Double-blind Phase (18 Months)|Non-Compliance With Study Drug|0|||
147413504|NCT03439254|531678399|FG003|Double-blind Phase (18 Months)|Non-Compliance With Study Drug|0|||
147413505|NCT03439254|531678400|FG004|Double-blind Phase (18 Months)|Non-Compliance With Study Drug|0|||
147413506|NCT03439254|531678401|FG005|Double-blind Phase (18 Months)|Non-Compliance With Study Drug|0|||
147413507|NCT03439254|531678396|FG000|Double-blind Phase (18 Months)|Participant moved to Kansas|1|||
147413508|NCT03439254|531678397|FG001|Double-blind Phase (18 Months)|Participant moved to Kansas|0|||
147413509|NCT03439254|531678398|FG002|Double-blind Phase (18 Months)|Participant moved to Kansas|0|||
147413510|NCT03439254|531678399|FG003|Double-blind Phase (18 Months)|Participant moved to Kansas|0|||
147471436|NCT05087030|531881463|FG001|Main Period (Week 0 to Week 52)|Lost to Follow-up|0|||
147665963|NCT03167242|532601656|FG010|Overall Study|Lost to Follow-up|1|||
147471437|NCT05087030|531881464|FG002|Main Period (Week 0 to Week 52)|Lost to Follow-up|0|||
147471438|NCT05087030|531881465|FG003|Main Period (Week 0 to Week 52)|Lost to Follow-up|0|||
147471439|NCT05087030|531881466|FG004|Main Period (Week 0 to Week 52)|Lost to Follow-up|0|||
147471440|NCT05087030|531881462|FG000|Main Period (Week 0 to Week 52)|Protocol Deviation|1|||
147471441|NCT05087030|531881463|FG001|Main Period (Week 0 to Week 52)|Protocol Deviation|0|||
147471442|NCT05087030|531881464|FG002|Main Period (Week 0 to Week 52)|Protocol Deviation|0|||
147471443|NCT05087030|531881465|FG003|Main Period (Week 0 to Week 52)|Protocol Deviation|0|||
147471444|NCT05087030|531881466|FG004|Main Period (Week 0 to Week 52)|Protocol Deviation|0|||
147471445|NCT05087030|531881462|FG000|Main Period (Week 0 to Week 52)|Death|0|||
147471446|NCT05087030|531881463|FG001|Main Period (Week 0 to Week 52)|Death|1|||
147471447|NCT05087030|531881464|FG002|Main Period (Week 0 to Week 52)|Death|0|||
147471448|NCT05087030|531881465|FG003|Main Period (Week 0 to Week 52)|Death|0|||
147471449|NCT05087030|531881466|FG004|Main Period (Week 0 to Week 52)|Death|0|||
147471450|NCT05087030|531881462|FG000|Main Period (Week 0 to Week 52)|Subject's Personal Reason|0|||
147471451|NCT05087030|531881463|FG001|Main Period (Week 0 to Week 52)|Subject's Personal Reason|2|||
147471452|NCT05087030|531881464|FG002|Main Period (Week 0 to Week 52)|Subject's Personal Reason|0|||
147471453|NCT05087030|531881465|FG003|Main Period (Week 0 to Week 52)|Subject's Personal Reason|0|||
147471454|NCT05087030|531881466|FG004|Main Period (Week 0 to Week 52)|Subject's Personal Reason|0|||
147471455|NCT05087030|531881462|FG000|Main Period (Week 0 to Week 52)|Exclusion criteria met|1|||
147471456|NCT05087030|531881463|FG001|Main Period (Week 0 to Week 52)|Exclusion criteria met|0|||
147471457|NCT05087030|531881464|FG002|Main Period (Week 0 to Week 52)|Exclusion criteria met|0|||
147471458|NCT05087030|531881465|FG003|Main Period (Week 0 to Week 52)|Exclusion criteria met|0|||
147471459|NCT05087030|531881466|FG004|Main Period (Week 0 to Week 52)|Exclusion criteria met|0|||
147471460|NCT05087030|531881462|FG000|Main Period (Week 0 to Week 52)|Study Objective Confounded By Monoclonal Gammopathy|1|||
147471461|NCT05087030|531881463|FG001|Main Period (Week 0 to Week 52)|Study Objective Confounded By Monoclonal Gammopathy|0|||
147471462|NCT05087030|531881464|FG002|Main Period (Week 0 to Week 52)|Study Objective Confounded By Monoclonal Gammopathy|0|||
147471463|NCT05087030|531881465|FG003|Main Period (Week 0 to Week 52)|Study Objective Confounded By Monoclonal Gammopathy|0|||
147471464|NCT05087030|531881466|FG004|Main Period (Week 0 to Week 52)|Study Objective Confounded By Monoclonal Gammopathy|0|||
147471465|NCT05087030|531881462|FG000|Main Period (Week 0 to Week 52)|Other|1|||
147471466|NCT05087030|531881463|FG001|Main Period (Week 0 to Week 52)|Other|2|||
147471467|NCT05087030|531881464|FG002|Main Period (Week 0 to Week 52)|Other|0|||
147471468|NCT05087030|531881465|FG003|Main Period (Week 0 to Week 52)|Other|0|||
147471469|NCT05087030|531881466|FG004|Main Period (Week 0 to Week 52)|Other|0|||
147471470|NCT05087030|531881462|FG000|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|0|||
147471471|NCT05087030|531881463|FG001|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|0|||
147471472|NCT05087030|531881464|FG002|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|0|||
147471473|NCT05087030|531881465|FG003|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|0|||
147471474|NCT05087030|531881466|FG004|Transition Period (Week 52 to Week 78)|Withdrawal by Subject|1|||
147471475|NCT02722044|531881467|FG000|Overall Study|Adverse Event|2|||
147471476|NCT02722044|531881467|FG000|Overall Study|Physician Decision|1|||
147471477|NCT02722044|531881467|FG000|Overall Study|Withdrawal by Subject|1|||
147471478|NCT02722044|531881467|FG000|Overall Study|Did Not Meet Criteria at Week 14|1|||
147471479|NCT00818259|531881471|FG000|Part I|Withdrawal by Subject|1|||
147471480|NCT00818259|531881472|FG001|Part I|Withdrawal by Subject|0|||
147471481|NCT00818259|531881473|FG002|Part I|Withdrawal by Subject|0|||
147471482|NCT00818259|531881474|FG003|Part I|Withdrawal by Subject|0|||
147471483|NCT00818259|531881475|FG004|Part I|Withdrawal by Subject|0|||
147471484|NCT00818259|531881476|FG005|Part I|Withdrawal by Subject|0|||
147471485|NCT00818259|531881477|FG006|Part I|Withdrawal by Subject|0|||
147471486|NCT00818259|531881478|FG007|Part I|Withdrawal by Subject|0|||
147471487|NCT00818259|531881479|FG008|Part I|Withdrawal by Subject|0|||
147471488|NCT00818259|531881471|FG000|Part II|Physician Decision|0|||
147471489|NCT00818259|531881472|FG001|Part II|Physician Decision|0|||
147471490|NCT00818259|531881473|FG002|Part II|Physician Decision|1|||
147471491|NCT00818259|531881474|FG003|Part II|Physician Decision|0|||
147471492|NCT00818259|531881475|FG004|Part II|Physician Decision|0|||
147471493|NCT00818259|531881476|FG005|Part II|Physician Decision|0|||
147471494|NCT00818259|531881477|FG006|Part II|Physician Decision|0|||
147471495|NCT00818259|531881478|FG007|Part II|Physician Decision|0|||
147471496|NCT00818259|531881479|FG008|Part II|Physician Decision|0|||
147471497|NCT00818259|531881471|FG000|Part II|Lack of Efficacy|0|||
147471498|NCT00818259|531881472|FG001|Part II|Lack of Efficacy|0|||
147471499|NCT00818259|531881473|FG002|Part II|Lack of Efficacy|0|||
147471500|NCT00818259|531881474|FG003|Part II|Lack of Efficacy|1|||
147471501|NCT00818259|531881475|FG004|Part II|Lack of Efficacy|0|||
147471502|NCT00818259|531881476|FG005|Part II|Lack of Efficacy|0|||
147471503|NCT00818259|531881477|FG006|Part II|Lack of Efficacy|0|||
147471504|NCT00818259|531881478|FG007|Part II|Lack of Efficacy|0|||
147471505|NCT00818259|531881479|FG008|Part II|Lack of Efficacy|0|||
147471506|NCT00818259|531881471|FG000|Part II|Not Treated|0|||
147471507|NCT00818259|531881472|FG001|Part II|Not Treated|0|||
147471508|NCT00818259|531881473|FG002|Part II|Not Treated|0|||
147471509|NCT00818259|531881474|FG003|Part II|Not Treated|1|||
147471510|NCT00818259|531881475|FG004|Part II|Not Treated|0|||
147471511|NCT00818259|531881476|FG005|Part II|Not Treated|0|||
147471512|NCT00818259|531881477|FG006|Part II|Not Treated|0|||
147471513|NCT00818259|531881478|FG007|Part II|Not Treated|0|||
147471514|NCT00818259|531881479|FG008|Part II|Not Treated|0|||
147471515|NCT00818259|531881471|FG000|Part IV|Physician Decision|0|||
147471516|NCT00818259|531881472|FG001|Part IV|Physician Decision|0|||
147471517|NCT00818259|531881473|FG002|Part IV|Physician Decision|0|||
147471518|NCT00818259|531881474|FG003|Part IV|Physician Decision|0|||
147471519|NCT00818259|531881475|FG004|Part IV|Physician Decision|0|||
147471520|NCT00818259|531881476|FG005|Part IV|Physician Decision|1|||
147471521|NCT00818259|531881477|FG006|Part IV|Physician Decision|0|||
147471522|NCT00818259|531881478|FG007|Part IV|Physician Decision|0|||
147471523|NCT00818259|531881479|FG008|Part IV|Physician Decision|0|||
147471524|NCT00818259|531881471|FG000|Part V|Adverse Event|0|||
147471525|NCT00818259|531881472|FG001|Part V|Adverse Event|0|||
147471526|NCT00818259|531881473|FG002|Part V|Adverse Event|0|||
147471527|NCT00818259|531881474|FG003|Part V|Adverse Event|0|||
147471528|NCT00818259|531881475|FG004|Part V|Adverse Event|0|||
147471529|NCT00818259|531881476|FG005|Part V|Adverse Event|0|||
147471530|NCT00818259|531881477|FG006|Part V|Adverse Event|0|||
147471531|NCT00818259|531881478|FG007|Part V|Adverse Event|1|||
147471532|NCT00818259|531881479|FG008|Part V|Adverse Event|0|||
147471533|NCT03372941|531881480|FG000|Overall Study|Lost to Follow-up|2|||
147471534|NCT03372941|531881481|FG001|Overall Study|Lost to Follow-up|4|||
147471535|NCT00741819|531881482|FG000|Overall Study|Adverse Event|3|||
147471536|NCT00741819|531881482|FG000|Overall Study|Withdrawal by Subject|3|||
147471537|NCT00741819|531881482|FG000|Overall Study|Death|1|||
147471538|NCT00741819|531881482|FG000|Overall Study|Disease progression|1|||
147471539|NCT00609622|531881485|FG000|Overall Study|Adverse Event|14|||
147471540|NCT00609622|531881486|FG001|Overall Study|Adverse Event|10|||
147471541|NCT00609622|531881485|FG000|Overall Study|Withdrawal by Subject|4|||
147471542|NCT00609622|531881486|FG001|Overall Study|Withdrawal by Subject|20|||
147471543|NCT00609622|531881485|FG000|Overall Study|Death|1|||
147471544|NCT00609622|531881486|FG001|Overall Study|Death|4|||
147471545|NCT00609622|531881485|FG000|Overall Study|Protocol Violation|1|||
147471546|NCT00609622|531881486|FG001|Overall Study|Protocol Violation|1|||
147471547|NCT00609622|531881485|FG000|Overall Study|Objective progression or relapse|47|||
147471548|NCT00609622|531881486|FG001|Overall Study|Objective progression or relapse|41|||
147471549|NCT00609622|531881485|FG000|Overall Study|Study terminated by sponsor|16|||
147471550|NCT00609622|531881486|FG001|Overall Study|Study terminated by sponsor|3|||
147471551|NCT00609622|531881485|FG000|Overall Study|Other|7|||
147471552|NCT00609622|531881486|FG001|Overall Study|Other|14|||
147471553|NCT00609622|531881485|FG000|Overall Study|Global deterioration of health status|6|||
147471554|NCT00609622|531881486|FG001|Overall Study|Global deterioration of health status|2|||
147471555|NCT00686543|531881487|FG000|Overall Study|Adverse Event|9|||
147471556|NCT00686543|531881488|FG001|Overall Study|Adverse Event|1|||
147471557|NCT00686543|531881489|FG002|Overall Study|Adverse Event|3|||
147471558|NCT00686543|531881490|FG003|Overall Study|Adverse Event|2|||
147471559|NCT00686543|531881487|FG000|Overall Study|Withdrawal by Subject|2|||
147471560|NCT00686543|531881488|FG001|Overall Study|Withdrawal by Subject|0|||
147471561|NCT00686543|531881489|FG002|Overall Study|Withdrawal by Subject|0|||
147471562|NCT00686543|531881490|FG003|Overall Study|Withdrawal by Subject|0|||
147471563|NCT00686543|531881487|FG000|Overall Study|Protocol Violation|3|||
147471564|NCT00686543|531881488|FG001|Overall Study|Protocol Violation|0|||
147471565|NCT00686543|531881489|FG002|Overall Study|Protocol Violation|2|||
147471566|NCT00686543|531881490|FG003|Overall Study|Protocol Violation|1|||
147471567|NCT01237951|531881493|FG000|Overall Study|Death|1|||
147471568|NCT00752986|531881494|FG000|Overall Study|Withdrawal by Subject|2|||
147471569|NCT00752986|531881495|FG001|Overall Study|Withdrawal by Subject|1|||
147471570|NCT00752986|531881496|FG002|Overall Study|Withdrawal by Subject|2|||
147471571|NCT00752986|531881494|FG000|Overall Study|Protocol Violation|3|||
147471572|NCT00752986|531881495|FG001|Overall Study|Protocol Violation|0|||
147471573|NCT00752986|531881496|FG002|Overall Study|Protocol Violation|0|||
147471574|NCT00924703|531881502|FG000|Overall Study|Withdrawal by Subject|11|||
147471575|NCT00924703|531881502|FG000|Overall Study|Physician Decision|5|||
147471576|NCT00924703|531881502|FG000|Overall Study|Lost to Follow-up|3|||
147471577|NCT00924703|531881502|FG000|Overall Study|Adverse Event|2|||
147471578|NCT00924703|531881502|FG000|Overall Study|Withdrawal by Sponsor|1|||
147471579|NCT00666562|531881503|FG000|Overall Study|Withdrawal by Subject|0|||
147471580|NCT00666562|531881504|FG001|Overall Study|Withdrawal by Subject|1|||
147471581|NCT00666562|531881505|FG002|Overall Study|Withdrawal by Subject|0|||
147471582|NCT00666562|531881503|FG000|Overall Study|Concomitant Medication|0|||
147471583|NCT00666562|531881504|FG001|Overall Study|Concomitant Medication|1|||
147471584|NCT00666562|531881505|FG002|Overall Study|Concomitant Medication|0|||
147471585|NCT01523873|531881506|FG000|Overall Study|Protocol Violation|422|||
147471586|NCT00275561|531881509|FG000|Overall Study|Withdrawal by Subject|0|||
147471587|NCT00275561|531881510|FG001|Overall Study|Withdrawal by Subject|1|||
147471588|NCT00275561|531881509|FG000|Overall Study|Travel|1|||
147471589|NCT00275561|531881510|FG001|Overall Study|Travel|1|||
147413511|NCT03439254|531678400|FG004|Double-blind Phase (18 Months)|Participant moved to Kansas|0|||
147413512|NCT03439254|531678401|FG005|Double-blind Phase (18 Months)|Participant moved to Kansas|0|||
147413513|NCT03439254|531678396|FG000|Double-blind Phase (18 Months)|Site cover and participant was not willing to be transferred|1|||
147413514|NCT03439254|531678397|FG001|Double-blind Phase (18 Months)|Site cover and participant was not willing to be transferred|0|||
147413515|NCT03439254|531678398|FG002|Double-blind Phase (18 Months)|Site cover and participant was not willing to be transferred|0|||
147413516|NCT03439254|531678399|FG003|Double-blind Phase (18 Months)|Site cover and participant was not willing to be transferred|0|||
147413517|NCT03439254|531678400|FG004|Double-blind Phase (18 Months)|Site cover and participant was not willing to be transferred|0|||
147413518|NCT03439254|531678401|FG005|Double-blind Phase (18 Months)|Site cover and participant was not willing to be transferred|0|||
147413519|NCT03439254|531678396|FG000|Double-blind Phase (18 Months)|Stopped Investigational product (IP) due to an AE in Australia|0|||
147413520|NCT03439254|531678397|FG001|Double-blind Phase (18 Months)|Stopped Investigational product (IP) due to an AE in Australia|1|||
147413521|NCT03439254|531678398|FG002|Double-blind Phase (18 Months)|Stopped Investigational product (IP) due to an AE in Australia|0|||
147413522|NCT03439254|531678399|FG003|Double-blind Phase (18 Months)|Stopped Investigational product (IP) due to an AE in Australia|0|||
147413523|NCT03439254|531678400|FG004|Double-blind Phase (18 Months)|Stopped Investigational product (IP) due to an AE in Australia|0|||
147413524|NCT03439254|531678401|FG005|Double-blind Phase (18 Months)|Stopped Investigational product (IP) due to an AE in Australia|0|||
147413525|NCT03439254|531678396|FG000|Double-blind Phase (18 Months)|Drug Holiday|0|||
147413526|NCT03439254|531678397|FG001|Double-blind Phase (18 Months)|Drug Holiday|0|||
147413527|NCT03439254|531678398|FG002|Double-blind Phase (18 Months)|Drug Holiday|1|||
147413528|NCT03439254|531678399|FG003|Double-blind Phase (18 Months)|Drug Holiday|0|||
147413529|NCT03439254|531678400|FG004|Double-blind Phase (18 Months)|Drug Holiday|0|||
147413530|NCT03439254|531678401|FG005|Double-blind Phase (18 Months)|Drug Holiday|0|||
147413531|NCT03439254|531678396|FG000|Double-blind Phase (18 Months)|Spouse underwent surgery and participant was unable to take IP regularly|0|||
147413532|NCT03439254|531678397|FG001|Double-blind Phase (18 Months)|Spouse underwent surgery and participant was unable to take IP regularly|0|||
147413533|NCT03439254|531678398|FG002|Double-blind Phase (18 Months)|Spouse underwent surgery and participant was unable to take IP regularly|1|||
147413534|NCT03439254|531678399|FG003|Double-blind Phase (18 Months)|Spouse underwent surgery and participant was unable to take IP regularly|0|||
147413535|NCT03439254|531678400|FG004|Double-blind Phase (18 Months)|Spouse underwent surgery and participant was unable to take IP regularly|0|||
147413536|NCT03439254|531678401|FG005|Double-blind Phase (18 Months)|Spouse underwent surgery and participant was unable to take IP regularly|0|||
147413537|NCT03439254|531678396|FG000|Double-blind Phase (18 Months)|Site closure|0|||
147413538|NCT03439254|531678397|FG001|Double-blind Phase (18 Months)|Site closure|0|||
147413539|NCT03439254|531678398|FG002|Double-blind Phase (18 Months)|Site closure|1|||
147413540|NCT03439254|531678399|FG003|Double-blind Phase (18 Months)|Site closure|0|||
147413541|NCT03439254|531678400|FG004|Double-blind Phase (18 Months)|Site closure|0|||
147413542|NCT03439254|531678401|FG005|Double-blind Phase (18 Months)|Site closure|0|||
147413543|NCT03439254|531678396|FG000|Double-blind Phase (18 Months)|Physician Decision|0|||
147413544|NCT03439254|531678397|FG001|Double-blind Phase (18 Months)|Physician Decision|0|||
147413545|NCT03439254|531678398|FG002|Double-blind Phase (18 Months)|Physician Decision|1|||
147413546|NCT03439254|531678399|FG003|Double-blind Phase (18 Months)|Physician Decision|0|||
147413547|NCT03439254|531678400|FG004|Double-blind Phase (18 Months)|Physician Decision|0|||
147413548|NCT03439254|531678401|FG005|Double-blind Phase (18 Months)|Physician Decision|0|||
147413549|NCT03439254|531678396|FG000|Double-blind Phase (18 Months)|Progressive Disease|1|||
147413550|NCT03439254|531678397|FG001|Double-blind Phase (18 Months)|Progressive Disease|0|||
147413551|NCT03439254|531678398|FG002|Double-blind Phase (18 Months)|Progressive Disease|0|||
147413552|NCT03439254|531678399|FG003|Double-blind Phase (18 Months)|Progressive Disease|0|||
147413553|NCT03439254|531678400|FG004|Double-blind Phase (18 Months)|Progressive Disease|0|||
147413554|NCT03439254|531678401|FG005|Double-blind Phase (18 Months)|Progressive Disease|0|||
147413555|NCT03439254|531678396|FG000|Double-blind Phase (18 Months)|Withdrawal by Subject|12|||
147413556|NCT03439254|531678397|FG001|Double-blind Phase (18 Months)|Withdrawal by Subject|6|||
147413557|NCT03439254|531678398|FG002|Double-blind Phase (18 Months)|Withdrawal by Subject|9|||
147413558|NCT03439254|531678399|FG003|Double-blind Phase (18 Months)|Withdrawal by Subject|0|||
147413559|NCT03439254|531678400|FG004|Double-blind Phase (18 Months)|Withdrawal by Subject|0|||
147413560|NCT03439254|531678401|FG005|Double-blind Phase (18 Months)|Withdrawal by Subject|0|||
147413561|NCT03439254|531678396|FG000|Open Label Extension Phase (12 Months)|Adverse Event|0|||
147413562|NCT03439254|531678397|FG001|Open Label Extension Phase (12 Months)|Adverse Event|0|||
147413563|NCT03439254|531678398|FG002|Open Label Extension Phase (12 Months)|Adverse Event|0|||
147413564|NCT03439254|531678399|FG003|Open Label Extension Phase (12 Months)|Adverse Event|8|||
147413565|NCT03439254|531678400|FG004|Open Label Extension Phase (12 Months)|Adverse Event|5|||
147413566|NCT03439254|531678401|FG005|Open Label Extension Phase (12 Months)|Adverse Event|7|||
147413567|NCT03439254|531678396|FG000|Open Label Extension Phase (12 Months)|Bariatric Surgery|0|||
147413568|NCT03439254|531678397|FG001|Open Label Extension Phase (12 Months)|Bariatric Surgery|0|||
147413569|NCT03439254|531678398|FG002|Open Label Extension Phase (12 Months)|Bariatric Surgery|0|||
147413570|NCT03439254|531678399|FG003|Open Label Extension Phase (12 Months)|Bariatric Surgery|1|||
147413571|NCT03439254|531678400|FG004|Open Label Extension Phase (12 Months)|Bariatric Surgery|0|||
147413572|NCT03439254|531678401|FG005|Open Label Extension Phase (12 Months)|Bariatric Surgery|1|||
147413573|NCT03439254|531678396|FG000|Open Label Extension Phase (12 Months)|Covid-19 Non-AE Related Issues|0|||
147413574|NCT03439254|531678397|FG001|Open Label Extension Phase (12 Months)|Covid-19 Non-AE Related Issues|0|||
147413575|NCT03439254|531678398|FG002|Open Label Extension Phase (12 Months)|Covid-19 Non-AE Related Issues|0|||
147413576|NCT03439254|531678399|FG003|Open Label Extension Phase (12 Months)|Covid-19 Non-AE Related Issues|0|||
147413577|NCT03439254|531678400|FG004|Open Label Extension Phase (12 Months)|Covid-19 Non-AE Related Issues|0|||
147303176|NCT02243202|531276264|FG000|Overall Study|Lost to Follow-up|9|||
147303177|NCT02243202|531276265|FG001|Overall Study|Lost to Follow-up|9|||
147303178|NCT02243202|531276266|FG002|Overall Study|Lost to Follow-up|14|||
147303179|NCT02243202|531276267|FG003|Overall Study|Lost to Follow-up|11|||
147303180|NCT02243202|531276264|FG000|Overall Study|Protocol Violation|3|||
147303181|NCT02243202|531276265|FG001|Overall Study|Protocol Violation|1|||
147303182|NCT02243202|531276266|FG002|Overall Study|Protocol Violation|2|||
147303183|NCT02243202|531276267|FG003|Overall Study|Protocol Violation|1|||
147303184|NCT02243202|531276264|FG000|Overall Study|Withdrawal by Subject|7|||
147303185|NCT02243202|531276265|FG001|Overall Study|Withdrawal by Subject|6|||
147413578|NCT03439254|531678401|FG005|Open Label Extension Phase (12 Months)|Covid-19 Non-AE Related Issues|1|||
147413579|NCT03439254|531678396|FG000|Open Label Extension Phase (12 Months)|Lost to Follow-up|0|||
147471590|NCT00275561|531881509|FG000|Overall Study|Scheduling|1|||
147471591|NCT00275561|531881510|FG001|Overall Study|Scheduling|2|||
147471592|NCT00275561|531881509|FG000|Overall Study|Family Issues|0|||
147471593|NCT00275561|531881510|FG001|Overall Study|Family Issues|2|||
147471594|NCT00377962|531882957|FG000|Core Study: 0-12 Months|Adverse Event|18|||
147471595|NCT00377962|531882958|FG001|Core Study: 0-12 Months|Adverse Event|2|||
147471596|NCT00377962|531882957|FG000|Core Study: 0-12 Months|Death|3|||
147471597|NCT00377962|531882958|FG001|Core Study: 0-12 Months|Death|0|||
147471598|NCT00377962|531882957|FG000|Core Study: 0-12 Months|Withdrew Consent|5|||
147471599|NCT00377962|531882958|FG001|Core Study: 0-12 Months|Withdrew Consent|2|||
147471600|NCT00377962|531882957|FG000|Core Study: 0-12 Months|Administrative Reason|1|||
147471601|NCT00377962|531882958|FG001|Core Study: 0-12 Months|Administrative Reason|1|||
147471602|NCT00377962|531882957|FG000|Core Study: 0-12 Months|Unspecified reasons|1|||
147471603|NCT00377962|531882958|FG001|Core Study: 0-12 Months|Unspecified reasons|4|||
147471604|NCT00377962|531882957|FG000|Extension Study: 12-24 Months|Death|1|||
147471605|NCT00377962|531882958|FG001|Extension Study: 12-24 Months|Death|1|||
147471606|NCT00377962|531882957|FG000|Extension Study: 12-24 Months|Adverse Event|8|||
147471607|NCT00377962|531882958|FG001|Extension Study: 12-24 Months|Adverse Event|0|||
147413580|NCT03439254|531678397|FG001|Open Label Extension Phase (12 Months)|Lost to Follow-up|0|||
147413581|NCT03439254|531678398|FG002|Open Label Extension Phase (12 Months)|Lost to Follow-up|0|||
147413582|NCT03439254|531678399|FG003|Open Label Extension Phase (12 Months)|Lost to Follow-up|0|||
147413583|NCT03439254|531678400|FG004|Open Label Extension Phase (12 Months)|Lost to Follow-up|2|||
147413584|NCT03439254|531678401|FG005|Open Label Extension Phase (12 Months)|Lost to Follow-up|0|||
147413585|NCT03439254|531678396|FG000|Open Label Extension Phase (12 Months)|Increase CR from Baseline|0|||
147413586|NCT03439254|531678397|FG001|Open Label Extension Phase (12 Months)|Increase CR from Baseline|0|||
147413587|NCT03439254|531678398|FG002|Open Label Extension Phase (12 Months)|Increase CR from Baseline|0|||
147413588|NCT03439254|531678399|FG003|Open Label Extension Phase (12 Months)|Increase CR from Baseline|0|||
147413589|NCT03439254|531678400|FG004|Open Label Extension Phase (12 Months)|Increase CR from Baseline|1|||
147413590|NCT03439254|531678401|FG005|Open Label Extension Phase (12 Months)|Increase CR from Baseline|0|||
147413591|NCT03439254|531678396|FG000|Open Label Extension Phase (12 Months)|Medical reasons by Sponsor|0|||
147413592|NCT03439254|531678397|FG001|Open Label Extension Phase (12 Months)|Medical reasons by Sponsor|0|||
147413593|NCT03439254|531678398|FG002|Open Label Extension Phase (12 Months)|Medical reasons by Sponsor|0|||
147413594|NCT03439254|531678399|FG003|Open Label Extension Phase (12 Months)|Medical reasons by Sponsor|0|||
147413595|NCT03439254|531678400|FG004|Open Label Extension Phase (12 Months)|Medical reasons by Sponsor|0|||
147413596|NCT03439254|531678401|FG005|Open Label Extension Phase (12 Months)|Medical reasons by Sponsor|1|||
147413597|NCT03439254|531678396|FG000|Open Label Extension Phase (12 Months)|Physician Decision|0|||
147413598|NCT03439254|531678397|FG001|Open Label Extension Phase (12 Months)|Physician Decision|0|||
147413599|NCT03439254|531678398|FG002|Open Label Extension Phase (12 Months)|Physician Decision|0|||
147413600|NCT03439254|531678399|FG003|Open Label Extension Phase (12 Months)|Physician Decision|1|||
147413601|NCT03439254|531678400|FG004|Open Label Extension Phase (12 Months)|Physician Decision|0|||
147413602|NCT03439254|531678401|FG005|Open Label Extension Phase (12 Months)|Physician Decision|0|||
147413603|NCT03439254|531678396|FG000|Open Label Extension Phase (12 Months)|Progressive Disease|0|||
147413604|NCT03439254|531678397|FG001|Open Label Extension Phase (12 Months)|Progressive Disease|0|||
147413605|NCT03439254|531678398|FG002|Open Label Extension Phase (12 Months)|Progressive Disease|0|||
147413606|NCT03439254|531678399|FG003|Open Label Extension Phase (12 Months)|Progressive Disease|1|||
147413607|NCT03439254|531678400|FG004|Open Label Extension Phase (12 Months)|Progressive Disease|2|||
147471608|NCT00377962|531882957|FG000|Extension Study: 12-24 Months|Abnormal laboratory value|1|||
147471609|NCT00377962|531882958|FG001|Extension Study: 12-24 Months|Abnormal laboratory value|0|||
147471610|NCT00377962|531882957|FG000|Extension Study: 12-24 Months|Unspecified reason|0|||
147413608|NCT03439254|531678401|FG005|Open Label Extension Phase (12 Months)|Progressive Disease|0|||
147413609|NCT03439254|531678396|FG000|Open Label Extension Phase (12 Months)|Withdrawal by Subject|0|||
147413610|NCT03439254|531678397|FG001|Open Label Extension Phase (12 Months)|Withdrawal by Subject|0|||
147413611|NCT03439254|531678398|FG002|Open Label Extension Phase (12 Months)|Withdrawal by Subject|0|||
147413612|NCT03439254|531678399|FG003|Open Label Extension Phase (12 Months)|Withdrawal by Subject|5|||
147413613|NCT03439254|531678400|FG004|Open Label Extension Phase (12 Months)|Withdrawal by Subject|3|||
147413614|NCT03439254|531678401|FG005|Open Label Extension Phase (12 Months)|Withdrawal by Subject|5|||
147413615|NCT00568178|531678402|FG000|Double Blind Base Study|Adverse Event|0|||
147413616|NCT00568178|531678403|FG001|Double Blind Base Study|Adverse Event|2|||
147413617|NCT00568178|531678404|FG002|Double Blind Base Study|Adverse Event|1|||
147413618|NCT00568178|531678405|FG003|Double Blind Base Study|Adverse Event|2|||
147413619|NCT00568178|531678406|FG004|Double Blind Base Study|Adverse Event|0|||
147413620|NCT00568178|531678407|FG005|Double Blind Base Study|Adverse Event|0|||
147413621|NCT00568178|531678402|FG000|Double Blind Base Study|Lost to Follow-up|1|||
147413622|NCT00568178|531678403|FG001|Double Blind Base Study|Lost to Follow-up|0|||
147413623|NCT00568178|531678404|FG002|Double Blind Base Study|Lost to Follow-up|0|||
147413624|NCT00568178|531678405|FG003|Double Blind Base Study|Lost to Follow-up|1|||
147413625|NCT00568178|531678406|FG004|Double Blind Base Study|Lost to Follow-up|0|||
147413626|NCT00568178|531678407|FG005|Double Blind Base Study|Lost to Follow-up|0|||
147413627|NCT00568178|531678402|FG000|Double Blind Base Study|Physician Decision|1|||
147413628|NCT00568178|531678403|FG001|Double Blind Base Study|Physician Decision|1|||
147413629|NCT00568178|531678404|FG002|Double Blind Base Study|Physician Decision|0|||
147413630|NCT00568178|531678405|FG003|Double Blind Base Study|Physician Decision|1|||
147413631|NCT00568178|531678406|FG004|Double Blind Base Study|Physician Decision|0|||
147413632|NCT00568178|531678407|FG005|Double Blind Base Study|Physician Decision|0|||
147413633|NCT00568178|531678402|FG000|Double Blind Base Study|Protocol Violation|3|||
147413634|NCT00568178|531678403|FG001|Double Blind Base Study|Protocol Violation|2|||
147413635|NCT00568178|531678404|FG002|Double Blind Base Study|Protocol Violation|0|||
147413636|NCT00568178|531678405|FG003|Double Blind Base Study|Protocol Violation|0|||
147413637|NCT00568178|531678406|FG004|Double Blind Base Study|Protocol Violation|0|||
147413638|NCT00568178|531678407|FG005|Double Blind Base Study|Protocol Violation|0|||
147413639|NCT00568178|531678402|FG000|Double Blind Base Study|Withdrawal by Subject|1|||
147413640|NCT00568178|531678403|FG001|Double Blind Base Study|Withdrawal by Subject|1|||
147413641|NCT00568178|531678404|FG002|Double Blind Base Study|Withdrawal by Subject|0|||
147413642|NCT00568178|531678405|FG003|Double Blind Base Study|Withdrawal by Subject|0|||
147413643|NCT00568178|531678406|FG004|Double Blind Base Study|Withdrawal by Subject|0|||
147413644|NCT00568178|531678407|FG005|Double Blind Base Study|Withdrawal by Subject|0|||
147413645|NCT00568178|531678402|FG000|Double Blind Base Study|Progressive Disease|0|||
147413646|NCT00568178|531678403|FG001|Double Blind Base Study|Progressive Disease|0|||
147413647|NCT00568178|531678404|FG002|Double Blind Base Study|Progressive Disease|0|||
147413648|NCT00568178|531678405|FG003|Double Blind Base Study|Progressive Disease|1|||
147413649|NCT00568178|531678406|FG004|Double Blind Base Study|Progressive Disease|0|||
147413650|NCT00568178|531678407|FG005|Double Blind Base Study|Progressive Disease|0|||
147413651|NCT00568178|531678402|FG000|Open Label Extension|Adverse Event|0|||
147413652|NCT00568178|531678403|FG001|Open Label Extension|Adverse Event|0|||
147413653|NCT00568178|531678404|FG002|Open Label Extension|Adverse Event|0|||
147413654|NCT00568178|531678405|FG003|Open Label Extension|Adverse Event|0|||
147413655|NCT00568178|531678406|FG004|Open Label Extension|Adverse Event|11|||
147413656|NCT00568178|531678407|FG005|Open Label Extension|Adverse Event|8|||
147413657|NCT00568178|531678402|FG000|Open Label Extension|Protocol Violation|0|||
147413658|NCT00568178|531678403|FG001|Open Label Extension|Protocol Violation|0|||
147413659|NCT00568178|531678404|FG002|Open Label Extension|Protocol Violation|0|||
147413660|NCT00568178|531678405|FG003|Open Label Extension|Protocol Violation|0|||
147413661|NCT00568178|531678406|FG004|Open Label Extension|Protocol Violation|1|||
147413662|NCT00568178|531678407|FG005|Open Label Extension|Protocol Violation|0|||
147413663|NCT00568178|531678402|FG000|Open Label Extension|Lost to Follow-up|0|||
147413664|NCT00568178|531678403|FG001|Open Label Extension|Lost to Follow-up|0|||
147413665|NCT00568178|531678404|FG002|Open Label Extension|Lost to Follow-up|0|||
147413666|NCT00568178|531678405|FG003|Open Label Extension|Lost to Follow-up|0|||
147413667|NCT00568178|531678406|FG004|Open Label Extension|Lost to Follow-up|6|||
147413668|NCT00568178|531678407|FG005|Open Label Extension|Lost to Follow-up|11|||
147413669|NCT00568178|531678402|FG000|Open Label Extension|Physician Decision|0|||
147413670|NCT00568178|531678403|FG001|Open Label Extension|Physician Decision|0|||
147413671|NCT00568178|531678404|FG002|Open Label Extension|Physician Decision|0|||
147413672|NCT00568178|531678405|FG003|Open Label Extension|Physician Decision|0|||
147413673|NCT00568178|531678406|FG004|Open Label Extension|Physician Decision|9|||
147413674|NCT00568178|531678407|FG005|Open Label Extension|Physician Decision|8|||
147471611|NCT00377962|531882958|FG001|Extension Study: 12-24 Months|Unspecified reason|3|||
147471612|NCT02432807|531882961|FG000|Overall Study|Adverse Event|0|||
147413675|NCT00568178|531678402|FG000|Open Label Extension|Pregnancy|0|||
147413676|NCT00568178|531678403|FG001|Open Label Extension|Pregnancy|0|||
147471613|NCT02432807|531882962|FG001|Overall Study|Adverse Event|2|||
147413677|NCT00568178|531678404|FG002|Open Label Extension|Pregnancy|0|||
147413678|NCT00568178|531678405|FG003|Open Label Extension|Pregnancy|0|||
147413679|NCT00568178|531678406|FG004|Open Label Extension|Pregnancy|0|||
147413680|NCT00568178|531678407|FG005|Open Label Extension|Pregnancy|1|||
147413681|NCT00568178|531678402|FG000|Open Label Extension|Progressive Disease|0|||
147413682|NCT00568178|531678403|FG001|Open Label Extension|Progressive Disease|0|||
147413683|NCT00568178|531678404|FG002|Open Label Extension|Progressive Disease|0|||
147413684|NCT00568178|531678405|FG003|Open Label Extension|Progressive Disease|0|||
147413685|NCT00568178|531678406|FG004|Open Label Extension|Progressive Disease|3|||
147413686|NCT00568178|531678407|FG005|Open Label Extension|Progressive Disease|1|||
147413687|NCT00568178|531678402|FG000|Open Label Extension|Termination of Trial|0|||
147413688|NCT00568178|531678403|FG001|Open Label Extension|Termination of Trial|0|||
147413689|NCT00568178|531678404|FG002|Open Label Extension|Termination of Trial|0|||
147413690|NCT00568178|531678405|FG003|Open Label Extension|Termination of Trial|0|||
147413691|NCT00568178|531678406|FG004|Open Label Extension|Termination of Trial|45|||
147413692|NCT00568178|531678407|FG005|Open Label Extension|Termination of Trial|47|||
147413693|NCT00568178|531678402|FG000|Open Label Extension|Withdrawal by Subject|0|||
147413694|NCT00568178|531678403|FG001|Open Label Extension|Withdrawal by Subject|0|||
147413695|NCT00568178|531678404|FG002|Open Label Extension|Withdrawal by Subject|0|||
147413696|NCT00568178|531678405|FG003|Open Label Extension|Withdrawal by Subject|0|||
147413697|NCT00568178|531678406|FG004|Open Label Extension|Withdrawal by Subject|4|||
147413698|NCT00568178|531678407|FG005|Open Label Extension|Withdrawal by Subject|4|||
147413699|NCT01531673|531678408|FG000|Overall Study|Non-Compliance|0|||
147413700|NCT01531673|531678409|FG001|Overall Study|Non-Compliance|0|||
147413701|NCT01531673|531678410|FG002|Overall Study|Non-Compliance|0|||
147413702|NCT01531673|531678411|FG003|Overall Study|Non-Compliance|0|||
147413703|NCT01531673|531678412|FG004|Overall Study|Non-Compliance|0|||
147413704|NCT01531673|531678413|FG005|Overall Study|Non-Compliance|1|||
147413705|NCT01531673|531678414|FG006|Overall Study|Non-Compliance|0|||
147413706|NCT01531673|531678415|FG007|Overall Study|Non-Compliance|0|||
147471614|NCT02432807|531882961|FG000|Overall Study|Lost to Follow-up|1|||
147471615|NCT02432807|531882962|FG001|Overall Study|Lost to Follow-up|0|||
147471616|NCT02432807|531882961|FG000|Overall Study|Withdrawal by Subject|1|||
147471617|NCT02432807|531882962|FG001|Overall Study|Withdrawal by Subject|1|||
147471618|NCT02432807|531882961|FG000|Overall Study|Other|1|||
147471619|NCT02432807|531882962|FG001|Overall Study|Other|1|||
147471620|NCT02966314|531882963|FG000|Overall Study|Lost to Follow-up|1|||
147471621|NCT02966314|531882964|FG001|Overall Study|Lost to Follow-up|0|||
147471622|NCT00828464|531882967|FG000|Overall Study|Withdrawal by Subject|1|||
147471623|NCT00502840|531882968|FG000|Overall Study|Adverse Event|5|||
147471624|NCT00502840|531882968|FG000|Overall Study|Additional or changed therapy|48|||
147471625|NCT00502840|531882968|FG000|Overall Study|Lack of Efficacy|11|||
147471626|NCT00502840|531882968|FG000|Overall Study|Protocol Violation|4|||
147471627|NCT00502840|531882968|FG000|Overall Study|Withdrawal by Subject|5|||
147471628|NCT00502840|531882968|FG000|Overall Study|Lost to Follow-up|6|||
147471629|NCT00502840|531882968|FG000|Overall Study|Administrative problems|1|||
147471630|NCT00502840|531882968|FG000|Overall Study|Other|20|||
147471631|NCT02197377|531882969|FG000|Overall Study|Insertion Failure|0|||
147471632|NCT02197377|531882970|FG001|Overall Study|Insertion Failure|3|||
147471633|NCT01974323|531882971|FG000|Overall Study|Other Reasons|25|||
147471634|NCT01974323|531882972|FG001|Overall Study|Other Reasons|28|||
147471635|NCT01974323|531882971|FG000|Overall Study|Protocol Violation|2|||
147471636|NCT01974323|531882972|FG001|Overall Study|Protocol Violation|2|||
147471637|NCT01974323|531882971|FG000|Overall Study|Personal Reasons|15|||
147471638|NCT01974323|531882972|FG001|Overall Study|Personal Reasons|19|||
147471639|NCT01974323|531882971|FG000|Overall Study|Lost to Follow-up|45|||
147471640|NCT01974323|531882972|FG001|Overall Study|Lost to Follow-up|40|||
147471641|NCT01974323|531882971|FG000|Overall Study|Pregnancy|2|||
147471642|NCT01974323|531882972|FG001|Overall Study|Pregnancy|1|||
147471643|NCT01974323|531882971|FG000|Overall Study|Lack of Efficacy|1|||
147471644|NCT01974323|531882972|FG001|Overall Study|Lack of Efficacy|1|||
147471645|NCT01974323|531882971|FG000|Overall Study|Adverse Event|2|||
147665964|NCT03167242|532601657|FG011|Overall Study|Lost to Follow-up|1|||
147471646|NCT01974323|531882972|FG001|Overall Study|Adverse Event|2|||
147471647|NCT01241786|531882978|FG000|Overall Study|Lack of Efficacy|5|||
147471648|NCT05340504|531882983|FG000|Overall Study|Withdrawal by Subject|1|||
147413707|NCT01531673|531678416|FG008|Overall Study|Non-Compliance|0|||
147413708|NCT01531673|531678417|FG009|Overall Study|Non-Compliance|0|||
147413709|NCT01531673|531678418|FG010|Overall Study|Non-Compliance|0|||
147413710|NCT01531673|531678419|FG011|Overall Study|Non-Compliance|0|||
147413711|NCT01531673|531678420|FG012|Overall Study|Non-Compliance|0|||
147413712|NCT01531673|531678408|FG000|Overall Study|Adverse Event|0|||
147413713|NCT01531673|531678409|FG001|Overall Study|Adverse Event|1|||
147413714|NCT01531673|531678410|FG002|Overall Study|Adverse Event|0|||
147413715|NCT01531673|531678411|FG003|Overall Study|Adverse Event|0|||
147471649|NCT05340504|531882984|FG001|Overall Study|Withdrawal by Subject|0|||
147471650|NCT03068715|531882985|FG000|Overall Study|No longer met inclusion criteria|1|||
147471651|NCT03068715|531882986|FG001|Overall Study|No longer met inclusion criteria|0|||
147471652|NCT00503399|531882987|FG000|Overall Study|Death|2|||
147413716|NCT01531673|531678412|FG004|Overall Study|Adverse Event|0|||
147413717|NCT01531673|531678413|FG005|Overall Study|Adverse Event|0|||
147413718|NCT01531673|531678414|FG006|Overall Study|Adverse Event|0|||
147413719|NCT01531673|531678415|FG007|Overall Study|Adverse Event|0|||
147471653|NCT00503399|531882988|FG001|Overall Study|Death|1|||
147471654|NCT00503399|531882987|FG000|Overall Study|Protocol Violation|1|||
147413720|NCT01531673|531678416|FG008|Overall Study|Adverse Event|0|||
147413721|NCT01531673|531678417|FG009|Overall Study|Adverse Event|0|||
147413722|NCT01531673|531678418|FG010|Overall Study|Adverse Event|0|||
147413723|NCT01531673|531678419|FG011|Overall Study|Adverse Event|0|||
147413724|NCT01531673|531678420|FG012|Overall Study|Adverse Event|0|||
147413725|NCT01531673|531678408|FG000|Overall Study|Lost to Follow-up|0|||
147413726|NCT01531673|531678409|FG001|Overall Study|Lost to Follow-up|0|||
147413727|NCT01531673|531678410|FG002|Overall Study|Lost to Follow-up|0|||
147413728|NCT01531673|531678411|FG003|Overall Study|Lost to Follow-up|0|||
147413729|NCT01531673|531678412|FG004|Overall Study|Lost to Follow-up|1|||
147413730|NCT01531673|531678413|FG005|Overall Study|Lost to Follow-up|0|||
147471655|NCT00503399|531882988|FG001|Overall Study|Protocol Violation|0|||
147471656|NCT00503399|531882987|FG000|Overall Study|Withdrawal by Subject|4|||
147471657|NCT00503399|531882988|FG001|Overall Study|Withdrawal by Subject|2|||
147471658|NCT00503399|531882987|FG000|Overall Study|Adverse Event|0|||
147471659|NCT00503399|531882988|FG001|Overall Study|Adverse Event|3|||
147471660|NCT00503399|531882987|FG000|Overall Study|Lost to Follow-up|0|||
147471661|NCT00503399|531882988|FG001|Overall Study|Lost to Follow-up|2|||
147471662|NCT03075839|531882989|FG000|Overall Study|Lost to Follow-up|4|||
147471663|NCT02469246|531882990|FG000|Double-Blind Phase|Randomized and Never Treated|5|||
147471664|NCT02469246|531882991|FG001|Double-Blind Phase|Randomized and Never Treated|6|||
147413731|NCT01531673|531678414|FG006|Overall Study|Lost to Follow-up|0|||
147413732|NCT01531673|531678415|FG007|Overall Study|Lost to Follow-up|0|||
147413733|NCT01531673|531678416|FG008|Overall Study|Lost to Follow-up|0|||
147413734|NCT01531673|531678417|FG009|Overall Study|Lost to Follow-up|0|||
147413735|NCT01531673|531678418|FG010|Overall Study|Lost to Follow-up|0|||
147413736|NCT01531673|531678419|FG011|Overall Study|Lost to Follow-up|0|||
147413737|NCT01531673|531678420|FG012|Overall Study|Lost to Follow-up|0|||
147413738|NCT01531673|531678408|FG000|Overall Study|Other|0|||
147413739|NCT01531673|531678409|FG001|Overall Study|Other|0|||
147413740|NCT01531673|531678410|FG002|Overall Study|Other|0|||
147471665|NCT02469246|531882990|FG000|Double-Blind Phase|Adverse Event|12|||
147471666|NCT02469246|531882991|FG001|Double-Blind Phase|Adverse Event|9|||
147471667|NCT02469246|531882990|FG000|Double-Blind Phase|Death|2|||
147471668|NCT02469246|531882991|FG001|Double-Blind Phase|Death|0|||
147471669|NCT02469246|531882990|FG000|Double-Blind Phase|Lack of Efficacy|2|||
147471670|NCT02469246|531882991|FG001|Double-Blind Phase|Lack of Efficacy|1|||
147471671|NCT02469246|531882990|FG000|Double-Blind Phase|Investigator's Discretion|8|||
147471672|NCT02469246|531882991|FG001|Double-Blind Phase|Investigator's Discretion|8|||
147471673|NCT02469246|531882990|FG000|Double-Blind Phase|Non-Compliance with Study Drug|3|||
147471674|NCT02469246|531882991|FG001|Double-Blind Phase|Non-Compliance with Study Drug|1|||
147471675|NCT02469246|531882990|FG000|Double-Blind Phase|Protocol Violation|1|||
147471676|NCT02469246|531882991|FG001|Double-Blind Phase|Protocol Violation|1|||
147471677|NCT02469246|531882990|FG000|Double-Blind Phase|Withdrew Consent|25|||
147471678|NCT02469246|531882991|FG001|Double-Blind Phase|Withdrew Consent|25|||
147413741|NCT01531673|531678411|FG003|Overall Study|Other|1|||
147413742|NCT01531673|531678412|FG004|Overall Study|Other|0|||
147413743|NCT01531673|531678413|FG005|Overall Study|Other|0|||
147413744|NCT01531673|531678414|FG006|Overall Study|Other|0|||
147413745|NCT01531673|531678415|FG007|Overall Study|Other|0|||
147413746|NCT01531673|531678416|FG008|Overall Study|Other|0|||
147413747|NCT01531673|531678417|FG009|Overall Study|Other|1|||
147413748|NCT01531673|531678418|FG010|Overall Study|Other|0|||
147413749|NCT01531673|531678419|FG011|Overall Study|Other|0|||
147413750|NCT01531673|531678420|FG012|Overall Study|Other|0|||
147413751|NCT00837694|531678421|FG000|Overall Study|Lost to Follow-up|2|||
147471679|NCT02469246|531882990|FG000|Double-Blind Phase|Lost to Follow-up|9|||
147471680|NCT02469246|531882991|FG001|Double-Blind Phase|Lost to Follow-up|5|||
147620179|NCT04429503|532427236|FG005|Extension Phase (Wk 96 to Wk 156)|Adverse Event|1|||
147471681|NCT04325503|531882994|FG000|Overall Study|Withdrawal by Subject|1|||
147620180|NCT04429503|532427231|FG000|Extension Phase (Wk 96 to Wk 156)|Decision by the Investigator/Sponsor|0|||
147620181|NCT04429503|532427232|FG001|Extension Phase (Wk 96 to Wk 156)|Decision by the Investigator/Sponsor|0|||
147413752|NCT00837694|531678422|FG001|Overall Study|Lost to Follow-up|0|||
147413753|NCT00837694|531678423|FG002|Overall Study|Lost to Follow-up|2|||
147413754|NCT00837694|531678424|FG003|Overall Study|Lost to Follow-up|1|||
147413755|NCT00837694|531678425|FG004|Overall Study|Lost to Follow-up|1|||
147413756|NCT00837694|531678426|FG005|Overall Study|Lost to Follow-up|1|||
147413757|NCT03268603|531678427|FG000|Overall Study|Withdrawal by Subject|6|||
147471682|NCT04325503|531882994|FG000|Overall Study|PI decided to remove them from trial as they lacked motor symptoms being studied.|2|||
147413758|NCT03268603|531678427|FG000|Overall Study|Physician Decision|1|||
147413759|NCT03268603|531678427|FG000|Overall Study|Withdrawn due to disease progression|2|||
147413760|NCT02591953|531678428|FG000|Overall Study|Lost to Follow-up|6|||
147413761|NCT02591953|531678429|FG001|Overall Study|Lost to Follow-up|6|||
147413762|NCT02060370|531678430|FG000|Overall Study|Physician Decision|1|||
147413763|NCT04939701|531678431|FG000|Phase 1: Dose Escalation (168 Days)|Progressive disease|0|||
147413764|NCT04939701|531678432|FG001|Phase 1: Dose Escalation (168 Days)|Progressive disease|5|||
147413765|NCT04939701|531678433|FG002|Phase 1: Dose Escalation (168 Days)|Progressive disease|0|||
147413766|NCT04939701|531678431|FG000|Phase 1: Dose Escalation (168 Days)|Lost to Follow-up|0|||
147413767|NCT04939701|531678432|FG001|Phase 1: Dose Escalation (168 Days)|Lost to Follow-up|1|||
147413768|NCT04939701|531678433|FG002|Phase 1: Dose Escalation (168 Days)|Lost to Follow-up|0|||
147413769|NCT04939701|531678431|FG000|Phase 1: Dose Escalation (168 Days)|Lack of Efficacy|2|||
147413770|NCT04939701|531678432|FG001|Phase 1: Dose Escalation (168 Days)|Lack of Efficacy|0|||
147413771|NCT04939701|531678433|FG002|Phase 1: Dose Escalation (168 Days)|Lack of Efficacy|0|||
147413772|NCT04939701|531678431|FG000|Phase 1: Dose Escalation (168 Days)|Death|1|||
147413773|NCT04939701|531678432|FG001|Phase 1: Dose Escalation (168 Days)|Death|0|||
147413774|NCT04939701|531678433|FG002|Phase 1: Dose Escalation (168 Days)|Death|0|||
147413775|NCT04939701|531678431|FG000|Phase 1: Dose Escalation (168 Days)|Adverse Event|0|||
147413776|NCT04939701|531678432|FG001|Phase 1: Dose Escalation (168 Days)|Adverse Event|1|||
147413777|NCT04939701|531678433|FG002|Phase 1: Dose Escalation (168 Days)|Adverse Event|0|||
147413778|NCT04939701|531678431|FG000|Phase 2: Dose Expansion (168 Days)|Progressive disease|0|||
147413779|NCT04939701|531678432|FG001|Phase 2: Dose Expansion (168 Days)|Progressive disease|0|||
147413780|NCT04939701|531678433|FG002|Phase 2: Dose Expansion (168 Days)|Progressive disease|3|||
147413781|NCT04939701|531678431|FG000|Phase 2: Dose Expansion (168 Days)|Death|0|||
147413782|NCT04939701|531678432|FG001|Phase 2: Dose Expansion (168 Days)|Death|0|||
147413783|NCT04939701|531678433|FG002|Phase 2: Dose Expansion (168 Days)|Death|1|||
147413784|NCT01517295|531678438|FG000|Overall Study|Physician Decision|1|||
147413785|NCT01517295|531678439|FG001|Overall Study|Physician Decision|0|||
147413786|NCT03248882|531678440|FG000|Overall Study|Adverse Event|3|||
147413787|NCT03248882|531678441|FG001|Overall Study|Adverse Event|3|||
147413788|NCT03248882|531678442|FG002|Overall Study|Adverse Event|2|||
147413789|NCT03248882|531678443|FG003|Overall Study|Adverse Event|6|||
147413790|NCT03248882|531678444|FG004|Overall Study|Adverse Event|9|||
147413791|NCT03248882|531678440|FG000|Overall Study|Lost to Follow-up|0|||
147413792|NCT03248882|531678441|FG001|Overall Study|Lost to Follow-up|0|||
147413793|NCT03248882|531678442|FG002|Overall Study|Lost to Follow-up|0|||
147413794|NCT03248882|531678443|FG003|Overall Study|Lost to Follow-up|0|||
147413795|NCT03248882|531678444|FG004|Overall Study|Lost to Follow-up|1|||
147413796|NCT03248882|531678440|FG000|Overall Study|Protocol Violation|2|||
147413797|NCT03248882|531678441|FG001|Overall Study|Protocol Violation|0|||
147413798|NCT03248882|531678442|FG002|Overall Study|Protocol Violation|2|||
147413799|NCT03248882|531678443|FG003|Overall Study|Protocol Violation|0|||
147413800|NCT03248882|531678444|FG004|Overall Study|Protocol Violation|1|||
147413801|NCT03248882|531678440|FG000|Overall Study|Withdrawal by Subject|2|||
147413802|NCT03248882|531678441|FG001|Overall Study|Withdrawal by Subject|2|||
147413803|NCT03248882|531678442|FG002|Overall Study|Withdrawal by Subject|3|||
147413804|NCT03248882|531678443|FG003|Overall Study|Withdrawal by Subject|4|||
147413805|NCT03248882|531678444|FG004|Overall Study|Withdrawal by Subject|2|||
147413806|NCT04308590|531678445|FG000|Overall Study|Adverse Event|12|||
147413807|NCT04308590|531678446|FG001|Overall Study|Adverse Event|2|||
147413808|NCT04308590|531678445|FG000|Overall Study|Withdrawal by Subject|10|||
147413809|NCT04308590|531678446|FG001|Overall Study|Withdrawal by Subject|4|||
147413810|NCT04308590|531678445|FG000|Overall Study|Death|1|||
147413811|NCT04308590|531678446|FG001|Overall Study|Death|0|||
147413812|NCT04308590|531678445|FG000|Overall Study|Lost to Follow-up|1|||
147413813|NCT04308590|531678446|FG001|Overall Study|Lost to Follow-up|1|||
147413814|NCT04308590|531678445|FG000|Overall Study|Physician Decision|1|||
147413815|NCT04308590|531678446|FG001|Overall Study|Physician Decision|0|||
147413816|NCT04308590|531678445|FG000|Overall Study|Subject does not want to continue with Pi|0|||
147413817|NCT04308590|531678446|FG001|Overall Study|Subject does not want to continue with Pi|1|||
147413818|NCT00356408|531678447|FG000|Overall Study|Adverse Event|9|||
147413819|NCT00356408|531678447|FG000|Overall Study|Lack of Efficacy|36|||
147413820|NCT00356408|531678447|FG000|Overall Study|Lost to Follow-up|2|||
147413821|NCT00356408|531678447|FG000|Overall Study|Withdrawal by Subject|6|||
147413822|NCT00356408|531678447|FG000|Overall Study|Other: Principal investigator discretion|3|||
147413823|NCT00356408|531678447|FG000|Overall Study|Other: Sponsor request|1|||
147413824|NCT00356408|531678447|FG000|Overall Study|Other: Azathioprine stopped|1|||
147413825|NCT00356408|531678447|FG000|Overall Study|Other: Failed to meet Inc/Exc criteria|1|||
147413826|NCT00356408|531678447|FG000|Overall Study|Other: Subject chose commerical dosing|1|||
147413827|NCT01156376|531678449|FG000|Overall Study|Adverse Event|1|||
147413828|NCT01156376|531678450|FG001|Overall Study|Adverse Event|0|||
147471683|NCT02337387|531882995|FG000|Overall Study|Adverse Event|0|||
147620182|NCT04429503|532427233|FG002|Extension Phase (Wk 96 to Wk 156)|Decision by the Investigator/Sponsor|0|||
147413829|NCT01156376|531678451|FG002|Overall Study|Adverse Event|1|||
147413830|NCT01156376|531678449|FG000|Overall Study|Withdrawal by Subject|0|||
147413831|NCT01156376|531678450|FG001|Overall Study|Withdrawal by Subject|0|||
147413832|NCT01156376|531678451|FG002|Overall Study|Withdrawal by Subject|3|||
147413833|NCT05487586|531678452|FG000|Overall Study|Death|22|||
147413834|NCT05487586|531678452|FG000|Overall Study|Physician Decision|1|||
147413835|NCT05487586|531678452|FG000|Overall Study|Transfer to another hospital|4|||
147413836|NCT05487586|531678452|FG000|Overall Study|Other|1|||
147413837|NCT01493427|531678453|FG000|Overall Study|Adverse Event|10|||
147413838|NCT01493427|531678453|FG000|Overall Study|Personal Reasons|4|||
147413839|NCT01493427|531678453|FG000|Overall Study|Lost to Follow-up|2|||
147413840|NCT01493427|531678453|FG000|Overall Study|Inability to Follow Instructions|2|||
147413841|NCT01493427|531678453|FG000|Overall Study|Other|2|||
147413842|NCT00565773|531678454|FG000|Overall Study|Withdrawal by Subject|1|||
147413843|NCT00565773|531678454|FG000|Overall Study|Physician Decision|1|||
147413844|NCT05775991|531678455|FG000|Overall Study|Withdrawal by Subject|0|||
147413845|NCT05775991|531678456|FG001|Overall Study|Withdrawal by Subject|0|||
147413846|NCT05775991|531678457|FG002|Overall Study|Withdrawal by Subject|2|||
147413847|NCT01075958|531678458|FG000|Overall Study|Blood sample could not be obtained|44|||
147413848|NCT01072630|531678459|FG000|Overall Study|Adverse Event|11|||
147413849|NCT01072630|531678460|FG001|Overall Study|Adverse Event|19|||
147413850|NCT01072630|531678461|FG002|Overall Study|Adverse Event|2|||
147413851|NCT01072630|531678459|FG000|Overall Study|Lack of Efficacy|10|||
147413852|NCT01072630|531678460|FG001|Overall Study|Lack of Efficacy|10|||
147413853|NCT01072630|531678461|FG002|Overall Study|Lack of Efficacy|1|||
147413854|NCT01072630|531678459|FG000|Overall Study|Withdrawal by Subject|8|||
147413855|NCT01072630|531678460|FG001|Overall Study|Withdrawal by Subject|7|||
147413856|NCT01072630|531678461|FG002|Overall Study|Withdrawal by Subject|2|||
147413857|NCT01072630|531678459|FG000|Overall Study|Protocol Violation|10|||
147413858|NCT01072630|531678460|FG001|Overall Study|Protocol Violation|8|||
147413859|NCT01072630|531678461|FG002|Overall Study|Protocol Violation|4|||
147413860|NCT01072630|531678459|FG000|Overall Study|Lost to Follow-up|11|||
147413861|NCT01072630|531678460|FG001|Overall Study|Lost to Follow-up|11|||
147413862|NCT01072630|531678461|FG002|Overall Study|Lost to Follow-up|1|||
147413863|NCT01072630|531678459|FG000|Overall Study|Noncompliance with study medication|1|||
147413864|NCT01072630|531678460|FG001|Overall Study|Noncompliance with study medication|1|||
147413865|NCT01072630|531678461|FG002|Overall Study|Noncompliance with study medication|1|||
147413866|NCT01072630|531678459|FG000|Overall Study|Noncompliance with study procedures|1|||
147413867|NCT01072630|531678460|FG001|Overall Study|Noncompliance with study procedures|2|||
147413868|NCT01072630|531678461|FG002|Overall Study|Noncompliance with study procedures|1|||
147413869|NCT01072630|531678459|FG000|Overall Study|Other|3|||
147413870|NCT01072630|531678460|FG001|Overall Study|Other|2|||
147413871|NCT01072630|531678461|FG002|Overall Study|Other|1|||
147413872|NCT00643617|531678462|FG000|Overall Study|Death|6|||
147413873|NCT00643617|531678463|FG001|Overall Study|Death|9|||
147413874|NCT00643617|531678462|FG000|Overall Study|Lost to Follow-up|42|||
147413875|NCT00643617|531678463|FG001|Overall Study|Lost to Follow-up|51|||
147413876|NCT02075073|531678464|FG000|Overall Study|Withdrawal by Subject|0|||
147413877|NCT02075073|531678465|FG001|Overall Study|Withdrawal by Subject|1|||
147413878|NCT02075073|531678466|FG002|Overall Study|Withdrawal by Subject|0|||
147413879|NCT02530970|531678467|FG000|Overall Study|Adverse Event|8|||
147413880|NCT02530970|531678467|FG000|Overall Study|Lost to Follow-up|88|||
147413881|NCT02530970|531678467|FG000|Overall Study|Physician Decision|5|||
147413882|NCT02530970|531678467|FG000|Overall Study|Withdrawal by Subject|14|||
147413883|NCT02530970|531678467|FG000|Overall Study|Death|6|||
147413884|NCT02530970|531678467|FG000|Overall Study|Hospitalization|1|||
147413885|NCT02530970|531678467|FG000|Overall Study|Insurance|2|||
147413886|NCT02530970|531678467|FG000|Overall Study|Explant|2|||
147413887|NCT02530970|531678467|FG000|Overall Study|Change in Provider|5|||
147413888|NCT02530970|531678467|FG000|Overall Study|Relocation|3|||
147413889|NCT02233803|531678469|FG000|Treatment Period 1 (4-Wks)|Protocol-defined stopping criteria reach|1|||
147413890|NCT02233803|531678470|FG001|Treatment Period 1 (4-Wks)|Protocol-defined stopping criteria reach|0|||
147413891|NCT02233803|531678469|FG000|Treatment Period 1 (4-Wks)|Adverse Event|0|||
147413892|NCT02233803|531678470|FG001|Treatment Period 1 (4-Wks)|Adverse Event|1|||
147413893|NCT02233803|531678469|FG000|Treatment Period 1 (4-Wks)|Protocol Violation|2|||
147413894|NCT02233803|531678470|FG001|Treatment Period 1 (4-Wks)|Protocol Violation|2|||
147413895|NCT02233803|531678469|FG000|Treatment Period 1 (4-Wks)|Withdrawal by Subject|0|||
147413896|NCT02233803|531678470|FG001|Treatment Period 1 (4-Wks)|Withdrawal by Subject|1|||
147413897|NCT02233803|531678469|FG000|Washout Period (4-Wks)|Lost to Follow-up|0|||
147413898|NCT02233803|531678470|FG001|Washout Period (4-Wks)|Lost to Follow-up|1|||
147413899|NCT02233803|531678469|FG000|Washout Period (4-Wks)|Physician Decision|1|||
147413900|NCT02233803|531678470|FG001|Washout Period (4-Wks)|Physician Decision|0|||
147413901|NCT02233803|531678469|FG000|Washout Period (4-Wks)|Withdrawal by Subject|1|||
147413902|NCT02233803|531678470|FG001|Washout Period (4-Wks)|Withdrawal by Subject|1|||
147413903|NCT02233803|531678469|FG000|Treatment Period 2 (4-Wks)|Lost to Follow-up|1|||
147413904|NCT02233803|531678470|FG001|Treatment Period 2 (4-Wks)|Lost to Follow-up|0|||
147413905|NCT02233803|531678469|FG000|Treatment Period 2 (4-Wks)|Withdrawal by Subject|1|||
147413906|NCT02233803|531678470|FG001|Treatment Period 2 (4-Wks)|Withdrawal by Subject|2|||
147413907|NCT03846453|531678471|FG000|Placebo Run-in (14 Days)|Eligibility Criteria Not Met|465|||
147413908|NCT03846453|531678472|FG001|Placebo Run-in (14 Days)|Eligibility Criteria Not Met|0|||
147413909|NCT03846453|531678473|FG002|Placebo Run-in (14 Days)|Eligibility Criteria Not Met|0|||
147413910|NCT03846453|531678471|FG000|Placebo Run-in (14 Days)|Withdrawal by Subject|3|||
147413911|NCT03846453|531678472|FG001|Placebo Run-in (14 Days)|Withdrawal by Subject|0|||
147413912|NCT03846453|531678473|FG002|Placebo Run-in (14 Days)|Withdrawal by Subject|0|||
147413913|NCT03846453|531678471|FG000|Placebo Run-in (14 Days)|Physician Decision|1|||
147413914|NCT03846453|531678472|FG001|Placebo Run-in (14 Days)|Physician Decision|0|||
147413915|NCT03846453|531678473|FG002|Placebo Run-in (14 Days)|Physician Decision|0|||
147413916|NCT03846453|531678471|FG000|Placebo Run-in (14 Days)|Other|2|||
147413917|NCT03846453|531678472|FG001|Placebo Run-in (14 Days)|Other|0|||
147413918|NCT03846453|531678473|FG002|Placebo Run-in (14 Days)|Other|0|||
147413919|NCT03846453|531678471|FG000|Randomized Treatment Period (Days 57±3)|Adverse Event|0|||
147413920|NCT03846453|531678472|FG001|Randomized Treatment Period (Days 57±3)|Adverse Event|16|||
147413921|NCT03846453|531678473|FG002|Randomized Treatment Period (Days 57±3)|Adverse Event|8|||
147413922|NCT03846453|531678471|FG000|Randomized Treatment Period (Days 57±3)|Protocol Violation|0|||
147413923|NCT03846453|531678472|FG001|Randomized Treatment Period (Days 57±3)|Protocol Violation|6|||
147413924|NCT03846453|531678473|FG002|Randomized Treatment Period (Days 57±3)|Protocol Violation|5|||
147413925|NCT03846453|531678471|FG000|Randomized Treatment Period (Days 57±3)|Administrative Reasons|0|||
147413926|NCT03846453|531678472|FG001|Randomized Treatment Period (Days 57±3)|Administrative Reasons|2|||
147413927|NCT03846453|531678473|FG002|Randomized Treatment Period (Days 57±3)|Administrative Reasons|4|||
147413928|NCT03846453|531678471|FG000|Randomized Treatment Period (Days 57±3)|Withdrawal by Subject|0|||
147413929|NCT03846453|531678472|FG001|Randomized Treatment Period (Days 57±3)|Withdrawal by Subject|2|||
147413930|NCT03846453|531678473|FG002|Randomized Treatment Period (Days 57±3)|Withdrawal by Subject|4|||
147413931|NCT03846453|531678471|FG000|Randomized Treatment Period (Days 57±3)|Other|0|||
147413932|NCT03846453|531678472|FG001|Randomized Treatment Period (Days 57±3)|Other|1|||
147413933|NCT03846453|531678473|FG002|Randomized Treatment Period (Days 57±3)|Other|4|||
147413934|NCT00468143|531678474|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|3|||
147413935|NCT00468143|531678475|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|4|||
147413936|NCT00468143|531678474|FG000|Second Intervention (3 Weeks)|Withdrawal by Subject|3|||
147413937|NCT00468143|531678475|FG001|Second Intervention (3 Weeks)|Withdrawal by Subject|3|||
147413938|NCT01606670|531678476|FG000|Overall Study|Adverse Event|6|||
147413939|NCT01606670|531678476|FG000|Overall Study|Lack of Efficacy|2|||
147413940|NCT01606670|531678476|FG000|Overall Study|Lost to Follow-up|3|||
147413941|NCT01606670|531678476|FG000|Overall Study|Withdrawal by Subject|3|||
147413942|NCT01606670|531678476|FG000|Overall Study|Other Reason|2|||
147413943|NCT01559129|531678482|FG000|Treatment Phase|Adverse Event|0|||
147413944|NCT01559129|531678483|FG001|Treatment Phase|Adverse Event|2|||
147413945|NCT01559129|531678482|FG000|Treatment Phase|Progressive Disease|1|||
147413946|NCT01559129|531678483|FG001|Treatment Phase|Progressive Disease|1|||
147413947|NCT01559129|531678482|FG000|Treatment Phase|Lack of Efficacy|0|||
147413948|NCT01559129|531678483|FG001|Treatment Phase|Lack of Efficacy|1|||
147413949|NCT01559129|531678482|FG000|Treatment Phase|Study Terminated by Sponsor|3|||
147413950|NCT01559129|531678483|FG001|Treatment Phase|Study Terminated by Sponsor|2|||
147413951|NCT01559129|531678482|FG000|Treatment Phase|Protocol Exclusion Criteria|1|||
147413952|NCT01559129|531678483|FG001|Treatment Phase|Protocol Exclusion Criteria|0|||
147413953|NCT01559129|531678482|FG000|Treatment Phase|Did Not Receive Study Drug|0|||
147413954|NCT01559129|531678483|FG001|Treatment Phase|Did Not Receive Study Drug|1|||
147413955|NCT01559129|531678482|FG000|Open-label Extension Period|Adverse Event|1|||
147413956|NCT01559129|531678483|FG001|Open-label Extension Period|Adverse Event|0|||
147413957|NCT01559129|531678482|FG000|Open-label Extension Period|Study Terminated by Sponsor|5|||
147413958|NCT01559129|531678483|FG001|Open-label Extension Period|Study Terminated by Sponsor|2|||
147413959|NCT01152814|531678484|FG000|Overall Study|Lost to Follow-up|2|||
147413960|NCT00831129|531678485|FG000|Overall Study|Adverse Event|0|||
147413961|NCT00831129|531678486|FG001|Overall Study|Adverse Event|1|||
147413962|NCT00831129|531678485|FG000|Overall Study|9 lost to follow-up reasons uknown|0|||
147413963|NCT00831129|531678486|FG001|Overall Study|9 lost to follow-up reasons uknown|9|||
147413964|NCT01877239|531678487|FG000|Overall Study|Adverse Event|4|||
147413965|NCT01877239|531678487|FG000|Overall Study|Disease Remission|1|||
147413966|NCT01877239|531678487|FG000|Overall Study|Withdrawal by Subject|4|||
147413967|NCT01877239|531678487|FG000|Overall Study|Other|2|||
147413968|NCT01877239|531678487|FG000|Overall Study|Lack of Efficacy|4|||
147413969|NCT01877239|531678487|FG000|Overall Study|Data not available|35|||
147413970|NCT01204710|531678491|FG000|Randomization Treatment|Lost to Follow-up|1|||
147413971|NCT01204710|531678492|FG001|Randomization Treatment|Lost to Follow-up|0|||
147413972|NCT01204710|531678491|FG000|Randomization Treatment|Withdrawal by Subject|6|||
147413973|NCT01204710|531678492|FG001|Randomization Treatment|Withdrawal by Subject|5|||
147413974|NCT01204710|531678491|FG000|Randomization Treatment|Physician Decision|3|||
147413975|NCT01204710|531678492|FG001|Randomization Treatment|Physician Decision|2|||
147413976|NCT01204710|531678491|FG000|Randomization Treatment|Entry criteria not met|0|||
147413977|NCT01204710|531678492|FG001|Randomization Treatment|Entry criteria not met|1|||
147413978|NCT01204710|531678491|FG000|Randomization Treatment|Adverse Event|4|||
147413979|NCT01204710|531678492|FG001|Randomization Treatment|Adverse Event|2|||
147413980|NCT01204710|531678491|FG000|Randomization Treatment|Sponsor Decision|0|||
147413981|NCT01204710|531678492|FG001|Randomization Treatment|Sponsor Decision|1|||
147413982|NCT01204710|531678491|FG000|Randomization Treatment|Worsening of General condition|0|||
147413983|NCT01204710|531678492|FG001|Randomization Treatment|Worsening of General condition|1|||
147413984|NCT01204710|531678491|FG000|Randomization Treatment|Moved and Followed for Survival|0|||
147413985|NCT01204710|531678492|FG001|Randomization Treatment|Moved and Followed for Survival|1|||
147413986|NCT01204710|531678491|FG000|Optional Olaratumab Monotherapy|Olaratumab Intolerance|0|||
147413987|NCT01204710|531678492|FG001|Optional Olaratumab Monotherapy|Olaratumab Intolerance|1|||
147413988|NCT01204710|531678491|FG000|Optional Olaratumab Monotherapy|Physician Decision|0|||
147413989|NCT01204710|531678492|FG001|Optional Olaratumab Monotherapy|Physician Decision|1|||
147413990|NCT01204710|531678491|FG000|Optional Olaratumab Monotherapy|Withdrawal by Subject|0|||
147413991|NCT01204710|531678492|FG001|Optional Olaratumab Monotherapy|Withdrawal by Subject|1|||
147413992|NCT00743431|531678493|FG000|Overall Study|Toxicity|6|||
147413993|NCT00743431|531678493|FG000|Overall Study|Tumor progression|56|||
147413994|NCT00743431|531678493|FG000|Overall Study|Withdrawal by Subject|13|||
147413995|NCT00743431|531678493|FG000|Overall Study|Death|9|||
147413996|NCT00743431|531678493|FG000|Overall Study|Reason for discontinuation not specified|29|||
147413997|NCT00743431|531678493|FG000|Overall Study|No documentation available|13|||
147413998|NCT03291288|531678494|FG000|Drug-drug Interaction Phase|Adverse Event|2|||
147413999|NCT03291288|531678495|FG001|Drug-drug Interaction Phase|Adverse Event|0|||
147414000|NCT03291288|531678494|FG000|Drug-drug Interaction Phase|Disease progression|1|||
147414001|NCT03291288|531678495|FG001|Drug-drug Interaction Phase|Disease progression|0|||
147414002|NCT03291288|531678494|FG000|Drug-drug Interaction Phase|Other|3|||
147414003|NCT03291288|531678495|FG001|Drug-drug Interaction Phase|Other|0|||
147414004|NCT03291288|531678494|FG000|Pexidartinib Only|Ongoing|0|||
147414005|NCT03291288|531678495|FG001|Pexidartinib Only|Ongoing|2|||
147414006|NCT04276415|531678496|FG000|Overall Study|Adverse Event|0|||
147414007|NCT04276415|531678497|FG001|Overall Study|Adverse Event|0|||
147414008|NCT04276415|531678498|FG002|Overall Study|Adverse Event|0|||
147414009|NCT04276415|531678499|FG003|Overall Study|Adverse Event|3|||
147414010|NCT04276415|531678500|FG004|Overall Study|Adverse Event|0|||
147414011|NCT04276415|531678501|FG005|Overall Study|Adverse Event|0|||
147414012|NCT04276415|531678496|FG000|Overall Study|Clinical progression|1|||
147414013|NCT04276415|531678497|FG001|Overall Study|Clinical progression|1|||
147414014|NCT04276415|531678498|FG002|Overall Study|Clinical progression|0|||
147414015|NCT04276415|531678499|FG003|Overall Study|Clinical progression|0|||
147414016|NCT04276415|531678500|FG004|Overall Study|Clinical progression|1|||
147414017|NCT04276415|531678501|FG005|Overall Study|Clinical progression|0|||
147414018|NCT04276415|531678496|FG000|Overall Study|Other|0|||
147414019|NCT04276415|531678497|FG001|Overall Study|Other|0|||
147414020|NCT04276415|531678498|FG002|Overall Study|Other|0|||
147414021|NCT04276415|531678499|FG003|Overall Study|Other|1|||
147414022|NCT04276415|531678500|FG004|Overall Study|Other|0|||
147414023|NCT04276415|531678501|FG005|Overall Study|Other|0|||
147414024|NCT04276415|531678496|FG000|Overall Study|Physician Decision|0|||
147414025|NCT04276415|531678497|FG001|Overall Study|Physician Decision|0|||
147414026|NCT04276415|531678498|FG002|Overall Study|Physician Decision|1|||
147414027|NCT04276415|531678499|FG003|Overall Study|Physician Decision|3|||
147414028|NCT04276415|531678500|FG004|Overall Study|Physician Decision|2|||
147414029|NCT04276415|531678501|FG005|Overall Study|Physician Decision|0|||
147414030|NCT04276415|531678496|FG000|Overall Study|Progressive disease|3|||
147414031|NCT04276415|531678497|FG001|Overall Study|Progressive disease|3|||
147414032|NCT04276415|531678498|FG002|Overall Study|Progressive disease|4|||
147414033|NCT04276415|531678499|FG003|Overall Study|Progressive disease|5|||
147414034|NCT04276415|531678500|FG004|Overall Study|Progressive disease|1|||
147414035|NCT04276415|531678501|FG005|Overall Study|Progressive disease|2|||
147414036|NCT04276415|531678496|FG000|Overall Study|Withdrawal by patient|0|||
147414037|NCT04276415|531678497|FG001|Overall Study|Withdrawal by patient|0|||
147414038|NCT04276415|531678498|FG002|Overall Study|Withdrawal by patient|0|||
147414039|NCT04276415|531678499|FG003|Overall Study|Withdrawal by patient|1|||
147414040|NCT04276415|531678500|FG004|Overall Study|Withdrawal by patient|2|||
147414041|NCT04276415|531678501|FG005|Overall Study|Withdrawal by patient|0|||
147414042|NCT00208325|531678502|FG000|Overall Study|Death|18|||
147414043|NCT00208325|531678503|FG001|Overall Study|Death|19|||
147414044|NCT00208325|531678504|FG002|Overall Study|Death|7|||
147414045|NCT00208325|531678505|FG003|Overall Study|Death|5|||
147414046|NCT00208325|531678502|FG000|Overall Study|Withdrawal by Subject|0|||
147414047|NCT00208325|531678503|FG001|Overall Study|Withdrawal by Subject|1|||
147414048|NCT00208325|531678504|FG002|Overall Study|Withdrawal by Subject|0|||
147414049|NCT00208325|531678505|FG003|Overall Study|Withdrawal by Subject|0|||
147414050|NCT00208325|531678502|FG000|Overall Study|Revision|4|||
147414051|NCT00208325|531678503|FG001|Overall Study|Revision|1|||
147414052|NCT00208325|531678504|FG002|Overall Study|Revision|0|||
147644026|NCT01032070|532516700|FG000|Overall Study|Withdrawal by Subject|0|||
147414053|NCT00208325|531678505|FG003|Overall Study|Revision|4|||
147414054|NCT00208325|531678502|FG000|Overall Study|Lost to Follow-up|1|||
147414055|NCT00208325|531678503|FG001|Overall Study|Lost to Follow-up|0|||
147414056|NCT00208325|531678504|FG002|Overall Study|Lost to Follow-up|2|||
147414057|NCT00208325|531678505|FG003|Overall Study|Lost to Follow-up|0|||
147414058|NCT00208325|531678502|FG000|Overall Study|Unsurfaced to Resurfaced Patella|4|||
147414059|NCT00208325|531678503|FG001|Overall Study|Unsurfaced to Resurfaced Patella|4|||
147414060|NCT00208325|531678504|FG002|Overall Study|Unsurfaced to Resurfaced Patella|1|||
147414061|NCT00208325|531678505|FG003|Overall Study|Unsurfaced to Resurfaced Patella|3|||
147414062|NCT00208325|531678502|FG000|Overall Study|Does not wish to Continue in Study|5|||
147414063|NCT00208325|531678503|FG001|Overall Study|Does not wish to Continue in Study|8|||
147414064|NCT00208325|531678504|FG002|Overall Study|Does not wish to Continue in Study|3|||
147414065|NCT00208325|531678505|FG003|Overall Study|Does not wish to Continue in Study|2|||
147414066|NCT00208325|531678502|FG000|Overall Study|Other|2|||
147414067|NCT00208325|531678503|FG001|Overall Study|Other|1|||
147414068|NCT00208325|531678504|FG002|Overall Study|Other|1|||
147414069|NCT00208325|531678505|FG003|Overall Study|Other|0|||
147414070|NCT00208325|531678502|FG000|Overall Study|Mis-Randomized|17|||
147414071|NCT00208325|531678503|FG001|Overall Study|Mis-Randomized|20|||
147414072|NCT00208325|531678504|FG002|Overall Study|Mis-Randomized|0|||
147414073|NCT00208325|531678505|FG003|Overall Study|Mis-Randomized|0|||
147414074|NCT02145468|531678506|FG000|Overall Study|Withdrawal by Subject|5|||
147414075|NCT02145468|531678507|FG001|Overall Study|Withdrawal by Subject|8|||
147414076|NCT00586612|531678508|FG000|Primary Phase|Protocol Violation|1|||
147414077|NCT00586612|531678509|FG001|Primary Phase|Protocol Violation|0|||
147414078|NCT00586612|531678508|FG000|Primary Phase|Lost to Follow-up|0|||
147414079|NCT00586612|531678509|FG001|Primary Phase|Lost to Follow-up|1|||
147414080|NCT00586612|531678508|FG000|Primary Phase|Withdrawal by Subject|0|||
147414081|NCT00586612|531678509|FG001|Primary Phase|Withdrawal by Subject|2|||
147414082|NCT00586612|531678508|FG000|Booster Phase|Lost to Follow-up|3|||
147414083|NCT00586612|531678509|FG001|Booster Phase|Lost to Follow-up|1|||
147414084|NCT00623805|531678510|FG000|Overall Study|Adverse Event|9|||
147414085|NCT00623805|531678511|FG001|Overall Study|Adverse Event|6|||
147414086|NCT00623805|531678510|FG000|Overall Study|Death|2|||
147414087|NCT00623805|531678511|FG001|Overall Study|Death|0|||
147414088|NCT00623805|531678510|FG000|Overall Study|Lack of Efficacy|3|||
147414089|NCT00623805|531678511|FG001|Overall Study|Lack of Efficacy|7|||
147414090|NCT00623805|531678510|FG000|Overall Study|Lost to Follow-up|2|||
147414091|NCT00623805|531678511|FG001|Overall Study|Lost to Follow-up|2|||
147414092|NCT00623805|531678510|FG000|Overall Study|Protocol Violation|1|||
147414093|NCT00623805|531678511|FG001|Overall Study|Protocol Violation|1|||
147414094|NCT00623805|531678510|FG000|Overall Study|Reason not Specified|3|||
147414095|NCT00623805|531678511|FG001|Overall Study|Reason not Specified|6|||
147414096|NCT03548220|531678520|FG000|Overall Study|Lost to Follow-up|1|||
147414097|NCT03548220|531678521|FG001|Overall Study|Lost to Follow-up|0|||
147414098|NCT03548220|531678522|FG002|Overall Study|Lost to Follow-up|0|||
147414099|NCT03548220|531678523|FG003|Overall Study|Lost to Follow-up|0|||
147414100|NCT02906007|531678524|FG000|Overall Study|Physician Decision|0|||
147414101|NCT02906007|531678525|FG001|Overall Study|Physician Decision|0|||
147414102|NCT02906007|531678526|FG002|Overall Study|Physician Decision|1|||
147414103|NCT02906007|531678524|FG000|Overall Study|Died|1|||
147414104|NCT02906007|531678525|FG001|Overall Study|Died|0|||
147414105|NCT02906007|531678526|FG002|Overall Study|Died|0|||
147414106|NCT04372121|531678527|FG000|Overall Study|Lost to Follow-up|0|||
147414107|NCT04372121|531678528|FG001|Overall Study|Lost to Follow-up|0|||
147414108|NCT04372121|531678529|FG002|Overall Study|Lost to Follow-up|0|||
147414109|NCT04372121|531678530|FG003|Overall Study|Lost to Follow-up|1|||
147414110|NCT04372121|531678527|FG000|Overall Study|Protocol Violation|0|||
147414111|NCT04372121|531678528|FG001|Overall Study|Protocol Violation|0|||
147414112|NCT04372121|531678529|FG002|Overall Study|Protocol Violation|1|||
147414113|NCT04372121|531678530|FG003|Overall Study|Protocol Violation|0|||
147414114|NCT04372121|531678527|FG000|Overall Study|Withdrawal by Subject|3|||
147414115|NCT04372121|531678528|FG001|Overall Study|Withdrawal by Subject|1|||
147414116|NCT04372121|531678529|FG002|Overall Study|Withdrawal by Subject|0|||
147414117|NCT04372121|531678530|FG003|Overall Study|Withdrawal by Subject|0|||
147414118|NCT04372121|531678527|FG000|Overall Study|Study termination|6|||
147414119|NCT04372121|531678528|FG001|Overall Study|Study termination|5|||
147414120|NCT04372121|531678529|FG002|Overall Study|Study termination|1|||
147414121|NCT04372121|531678530|FG003|Overall Study|Study termination|1|||
147414122|NCT04372121|531678527|FG000|Overall Study|Hysterectomy planned|1|||
147414123|NCT04372121|531678528|FG001|Overall Study|Hysterectomy planned|0|||
147414124|NCT04372121|531678529|FG002|Overall Study|Hysterectomy planned|0|||
147414125|NCT04372121|531678530|FG003|Overall Study|Hysterectomy planned|0|||
147414126|NCT03820947|531678537|FG000|Overall Study|Physician Decision|0|||
147414127|NCT03820947|531678538|FG001|Overall Study|Physician Decision|1|||
147414128|NCT03820947|531678539|FG002|Overall Study|Physician Decision|1|||
147414129|NCT03820947|531678540|FG003|Overall Study|Physician Decision|0|||
147414130|NCT03820947|531678541|FG004|Overall Study|Physician Decision|3|||
147414131|NCT03820947|531678537|FG000|Overall Study|Withdrawal by Subject|6|||
147414132|NCT03820947|531678538|FG001|Overall Study|Withdrawal by Subject|10|||
147414133|NCT03820947|531678539|FG002|Overall Study|Withdrawal by Subject|3|||
147414134|NCT03820947|531678540|FG003|Overall Study|Withdrawal by Subject|8|||
147414135|NCT03820947|531678541|FG004|Overall Study|Withdrawal by Subject|5|||
147414136|NCT03820947|531678537|FG000|Overall Study|Procedure Not Attempted|0|||
147414137|NCT03820947|531678538|FG001|Overall Study|Procedure Not Attempted|2|||
147414138|NCT03820947|531678539|FG002|Overall Study|Procedure Not Attempted|1|||
147414139|NCT03820947|531678540|FG003|Overall Study|Procedure Not Attempted|0|||
147414140|NCT03820947|531678541|FG004|Overall Study|Procedure Not Attempted|0|||
147471684|NCT02337387|531882996|FG001|Overall Study|Adverse Event|1|||
147471685|NCT02337387|531882997|FG002|Overall Study|Adverse Event|0|||
147471686|NCT02337387|531882998|FG003|Overall Study|Adverse Event|0|||
147471687|NCT02337387|531882995|FG000|Overall Study|Sponsor Decision to Terminate Study|14|||
147471688|NCT02337387|531882996|FG001|Overall Study|Sponsor Decision to Terminate Study|7|||
147665965|NCT03167242|532601646|FG000|Overall Study|Reason not provided|0|||
147471689|NCT02337387|531882997|FG002|Overall Study|Sponsor Decision to Terminate Study|3|||
147471690|NCT02337387|531882998|FG003|Overall Study|Sponsor Decision to Terminate Study|3|||
147471691|NCT02853760|531882999|FG000|Washout (1 Week)|acute illness (not connected with the study)|0|||
147471692|NCT02853760|531883000|FG001|Washout (1 Week)|acute illness (not connected with the study)|0|||
147471693|NCT02853760|531883001|FG002|Washout (1 Week)|acute illness (not connected with the study)|1|||
147471694|NCT02853760|531883002|FG003|Washout (1 Week)|acute illness (not connected with the study)|2|||
147471695|NCT02853760|531883003|FG004|Washout (1 Week)|acute illness (not connected with the study)|0|||
147471696|NCT02853760|531883004|FG005|Washout (1 Week)|acute illness (not connected with the study)|2|||
147471697|NCT01642212|531883005|FG000|Single-blind Baseline|Did Not Meet Eligibility Criteria|26|||
147471698|NCT01642212|531883006|FG001|Single-blind Baseline|Did Not Meet Eligibility Criteria|0|||
147471699|NCT01642212|531883007|FG002|Single-blind Baseline|Did Not Meet Eligibility Criteria|0|||
147471700|NCT01642212|531883008|FG003|Single-blind Baseline|Did Not Meet Eligibility Criteria|0|||
147471701|NCT01642212|531883009|FG004|Single-blind Baseline|Did Not Meet Eligibility Criteria|0|||
147665966|NCT03167242|532601647|FG001|Overall Study|Reason not provided|0|||
147665967|NCT03167242|532601648|FG002|Overall Study|Reason not provided|0|||
147665968|NCT03167242|532601649|FG003|Overall Study|Reason not provided|0|||
147665969|NCT03167242|532601650|FG004|Overall Study|Reason not provided|0|||
147665970|NCT03167242|532601651|FG005|Overall Study|Reason not provided|0|||
147665971|NCT03167242|532601652|FG006|Overall Study|Reason not provided|0|||
147414141|NCT03820947|531678537|FG000|Overall Study|Other Exit|1|||
147414142|NCT03820947|531678538|FG001|Overall Study|Other Exit|3|||
147414143|NCT03820947|531678539|FG002|Overall Study|Other Exit|3|||
147414144|NCT03820947|531678540|FG003|Overall Study|Other Exit|3|||
147414145|NCT03820947|531678541|FG004|Overall Study|Other Exit|0|||
147414146|NCT03820947|531678537|FG000|Overall Study|Follow-up Not Done|10|||
147414147|NCT03820947|531678538|FG001|Overall Study|Follow-up Not Done|13|||
147414148|NCT03820947|531678539|FG002|Overall Study|Follow-up Not Done|2|||
147414149|NCT03820947|531678540|FG003|Overall Study|Follow-up Not Done|3|||
147414150|NCT03820947|531678541|FG004|Overall Study|Follow-up Not Done|12|||
147414151|NCT03820947|531678537|FG000|Overall Study|Death|0|||
147414152|NCT03820947|531678538|FG001|Overall Study|Death|0|||
147414153|NCT03820947|531678539|FG002|Overall Study|Death|0|||
147414154|NCT03820947|531678540|FG003|Overall Study|Death|0|||
147414155|NCT03820947|531678541|FG004|Overall Study|Death|9|||
147414156|NCT03820947|531678537|FG000|Overall Study|Lost to Follow-up|4|||
147414157|NCT03820947|531678538|FG001|Overall Study|Lost to Follow-up|6|||
147414158|NCT03820947|531678539|FG002|Overall Study|Lost to Follow-up|0|||
147414159|NCT03820947|531678540|FG003|Overall Study|Lost to Follow-up|0|||
147414160|NCT03820947|531678541|FG004|Overall Study|Lost to Follow-up|9|||
147414161|NCT04500769|531680251|FG000|Overall Study|Withdrawal by Subject|5|||
147414162|NCT01967147|531680252|FG000|Overall Study|Adverse Event|5|||
147414163|NCT01967147|531680253|FG001|Overall Study|Adverse Event|2|||
147414164|NCT01967147|531680252|FG000|Overall Study|Lack of Efficacy|1|||
147414165|NCT01967147|531680253|FG001|Overall Study|Lack of Efficacy|4|||
147414166|NCT01967147|531680252|FG000|Overall Study|Lost to Follow-up|1|||
147414167|NCT01967147|531680253|FG001|Overall Study|Lost to Follow-up|2|||
147414168|NCT01967147|531680252|FG000|Overall Study|Withdrawal by Subject|2|||
147414169|NCT01967147|531680253|FG001|Overall Study|Withdrawal by Subject|4|||
147414170|NCT01967147|531680252|FG000|Overall Study|Non-compliance with Study Drug|0|||
147414171|NCT01967147|531680253|FG001|Overall Study|Non-compliance with Study Drug|3|||
147414172|NCT01967147|531680252|FG000|Overall Study|Other|4|||
147414173|NCT01967147|531680253|FG001|Overall Study|Other|5|||
147414174|NCT03843554|531680254|FG000|Overall Study|Physician Decision|0|||
147665972|NCT03167242|532601653|FG007|Overall Study|Reason not provided|0|||
147414175|NCT03843554|531680255|FG001|Overall Study|Physician Decision|2|||
147414176|NCT01099215|531680256|FG000|Overall Study|Withdrawal by Subject|1|||
147414177|NCT01099215|531680257|FG001|Overall Study|Withdrawal by Subject|0|||
147414178|NCT01099215|531680256|FG000|Overall Study|Adverse Event|0|||
147471702|NCT01642212|531883005|FG000|Double-blind Treatment|Other|0|||
147414179|NCT01099215|531680257|FG001|Overall Study|Adverse Event|1|||
147414180|NCT04396366|531680261|FG000|Overall Study|Adverse Event|1|||
147414181|NCT04396366|531680262|FG001|Overall Study|Adverse Event|0|||
147414182|NCT00166712|531680263|FG000|Overall Study|Death|0|||
147414183|NCT00166712|531680264|FG001|Overall Study|Death|1|||
147414184|NCT00166712|531680263|FG000|Overall Study|Adverse Event|1|||
147414185|NCT00166712|531680264|FG001|Overall Study|Adverse Event|0|||
147414186|NCT00166712|531680263|FG000|Overall Study|Withdrawal by Subject|1|||
147414187|NCT00166712|531680264|FG001|Overall Study|Withdrawal by Subject|2|||
147414188|NCT00166712|531680263|FG000|Overall Study|Physician Decision|0|||
147471703|NCT01642212|531883006|FG001|Double-blind Treatment|Other|2|||
147471704|NCT01642212|531883007|FG002|Double-blind Treatment|Other|1|||
147665973|NCT03167242|532601654|FG008|Overall Study|Reason not provided|1|||
147665974|NCT03167242|532601655|FG009|Overall Study|Reason not provided|0|||
147414189|NCT00166712|531680264|FG001|Overall Study|Physician Decision|2|||
147414190|NCT04684394|531680265|FG000|Overall Study|Death|1|||
147414191|NCT04684394|531680266|FG001|Overall Study|Death|2|||
147414192|NCT04684394|531680265|FG000|Overall Study|Lost to Follow-up|1|||
147414193|NCT04684394|531680266|FG001|Overall Study|Lost to Follow-up|0|||
147414194|NCT04684394|531680265|FG000|Overall Study|Withdrawal by Subject|2|||
147414195|NCT04684394|531680266|FG001|Overall Study|Withdrawal by Subject|0|||
147414196|NCT04684394|531680265|FG000|Overall Study|Study discontinued per Sponsor decision|25|||
147414197|NCT04684394|531680266|FG001|Overall Study|Study discontinued per Sponsor decision|13|||
147414198|NCT03986944|531680267|FG000|Overall Study|Adverse Event|1|||
147414199|NCT03986944|531680268|FG001|Overall Study|Adverse Event|2|||
147414200|NCT03986944|531680269|FG002|Overall Study|Adverse Event|3|||
147414201|NCT03986944|531680267|FG000|Overall Study|Protocol Violation|0|||
147414202|NCT03986944|531680268|FG001|Overall Study|Protocol Violation|1|||
147414203|NCT03986944|531680269|FG002|Overall Study|Protocol Violation|1|||
147414204|NCT03986944|531680267|FG000|Overall Study|Withdrawal by Subject|3|||
147414205|NCT03986944|531680268|FG001|Overall Study|Withdrawal by Subject|5|||
147414206|NCT03986944|531680269|FG002|Overall Study|Withdrawal by Subject|5|||
147414207|NCT03986944|531680267|FG000|Overall Study|Study termination|10|||
147414208|NCT03986944|531680268|FG001|Overall Study|Study termination|10|||
147414209|NCT03986944|531680269|FG002|Overall Study|Study termination|10|||
147414210|NCT03986944|531680267|FG000|Overall Study|Discontinuation after moving to Follow-up Period [Study termination per Sponsor]|1|||
147414211|NCT03986944|531680268|FG001|Overall Study|Discontinuation after moving to Follow-up Period [Study termination per Sponsor]|0|||
147414212|NCT03986944|531680269|FG002|Overall Study|Discontinuation after moving to Follow-up Period [Study termination per Sponsor]|0|||
147414213|NCT03986944|531680267|FG000|Overall Study|Discontinuation after moving to Follow-up Period [Subject's Request (Family Issue)]|0|||
147414214|NCT03986944|531680268|FG001|Overall Study|Discontinuation after moving to Follow-up Period [Subject's Request (Family Issue)]|1|||
147414215|NCT03986944|531680269|FG002|Overall Study|Discontinuation after moving to Follow-up Period [Subject's Request (Family Issue)]|0|||
147414216|NCT03002220|531680271|FG000|Overall Study|Lack of Efficacy|2|||
147414217|NCT03002220|531680271|FG000|Overall Study|Withdrawal by Subject|3|||
147414218|NCT03002220|531680271|FG000|Overall Study|Adverse Event|2|||
147414219|NCT03002220|531680271|FG000|Overall Study|Disease progression|13|||
147414220|NCT03002220|531680271|FG000|Overall Study|Physician Decision|1|||
147414221|NCT01183260|531680273|FG000|Overall Study|Intraop screen failure|2|||
147414222|NCT01183260|531680274|FG001|Overall Study|Intraop screen failure|0|||
147414223|NCT01183260|531680273|FG000|Overall Study|Withdrawal by Subject|1|||
147414224|NCT01183260|531680274|FG001|Overall Study|Withdrawal by Subject|1|||
147414225|NCT01183260|531680273|FG000|Overall Study|Revised within 30 days|0|||
147414226|NCT01183260|531680274|FG001|Overall Study|Revised within 30 days|1|||
147414227|NCT01183260|531680273|FG000|Overall Study|Death|1|||
147414228|NCT01183260|531680274|FG001|Overall Study|Death|0|||
147414229|NCT01202903|531680278|FG000|Overall Study|Administrative Probelms|1|||
147414230|NCT01202903|531680279|FG001|Overall Study|Administrative Probelms|4|||
147414231|NCT01202903|531680278|FG000|Overall Study|Protocol Violation|0|||
147414232|NCT01202903|531680279|FG001|Overall Study|Protocol Violation|1|||
147414233|NCT01202903|531680278|FG000|Overall Study|Death|1|||
147414234|NCT01202903|531680279|FG001|Overall Study|Death|0|||
147414235|NCT01202903|531680278|FG000|Overall Study|Lost to Follow-up|1|||
147414236|NCT01202903|531680279|FG001|Overall Study|Lost to Follow-up|1|||
147414237|NCT01202903|531680278|FG000|Overall Study|Lack of Efficacy|1|||
147414238|NCT01202903|531680279|FG001|Overall Study|Lack of Efficacy|3|||
147414239|NCT01202903|531680278|FG000|Overall Study|Adverse Event|3|||
147414240|NCT01202903|531680279|FG001|Overall Study|Adverse Event|3|||
147414241|NCT01202903|531680278|FG000|Overall Study|Withdrawal by Subject|4|||
147414242|NCT01202903|531680279|FG001|Overall Study|Withdrawal by Subject|4|||
147414243|NCT01302080|531680280|FG000|Overall Study|Withdrew Consent|92|||
147414244|NCT01302080|531680281|FG001|Overall Study|Withdrew Consent|39|||
147414245|NCT01302080|531680280|FG000|Overall Study|Patient/Family Moved|28|||
147414246|NCT01302080|531680281|FG001|Overall Study|Patient/Family Moved|3|||
147414247|NCT01302080|531680280|FG000|Overall Study|Lost to Follow-up|192|||
147414248|NCT01302080|531680281|FG001|Overall Study|Lost to Follow-up|93|||
147414249|NCT01302080|531680280|FG000|Overall Study|Death|1|||
147414250|NCT01302080|531680281|FG001|Overall Study|Death|0|||
147414251|NCT01302080|531680280|FG000|Overall Study|Other|52|||
147471705|NCT01642212|531883008|FG003|Double-blind Treatment|Other|0|||
147471706|NCT01642212|531883009|FG004|Double-blind Treatment|Other|0|||
147471707|NCT01642212|531883005|FG000|Double-blind Treatment|Non-compliance|0|||
147414252|NCT01302080|531680281|FG001|Overall Study|Other|8|||
147414253|NCT01302080|531680280|FG000|Overall Study|Reason Missing For Discontinuation|1|||
147414254|NCT01302080|531680281|FG001|Overall Study|Reason Missing For Discontinuation|0|||
147414255|NCT00297427|531680289|FG000|Phase 1: Initial Intervention|Withdrawal by Subject|8|||
147471708|NCT01642212|531883006|FG001|Double-blind Treatment|Non-compliance|1|||
147665975|NCT03167242|532601656|FG010|Overall Study|Reason not provided|0|||
147620183|NCT04429503|532427234|FG003|Extension Phase (Wk 96 to Wk 156)|Decision by the Investigator/Sponsor|0|||
147414256|NCT00297427|531680290|FG001|Phase 1: Initial Intervention|Withdrawal by Subject|5|||
147414257|NCT00297427|531680289|FG000|Phase 1: Initial Intervention|Lost to Follow-up|0|||
147414258|NCT00297427|531680290|FG001|Phase 1: Initial Intervention|Lost to Follow-up|3|||
147414259|NCT00297427|531680289|FG000|Phase 1: Initial Intervention|Death|0|||
147414260|NCT00297427|531680290|FG001|Phase 1: Initial Intervention|Death|1|||
147414261|NCT00297427|531680289|FG000|Phase 2: Optional Crossover for Sham|Withdrawal by Subject|15|||
147414262|NCT00297427|531680290|FG001|Phase 2: Optional Crossover for Sham|Withdrawal by Subject|0|||
147414263|NCT00297427|531680289|FG000|Phase 2: Optional Crossover for Sham|Lost to Follow-up|1|||
147414264|NCT00297427|531680290|FG001|Phase 2: Optional Crossover for Sham|Lost to Follow-up|0|||
147414265|NCT00297427|531680289|FG000|Phase 3: Follow-up Post-True Acupuncture|Withdrawal by Subject|29|||
147414266|NCT00297427|531680290|FG001|Phase 3: Follow-up Post-True Acupuncture|Withdrawal by Subject|0|||
147414267|NCT00297427|531680289|FG000|Phase 3: Follow-up Post-True Acupuncture|Lost to Follow-up|3|||
147414268|NCT00297427|531680290|FG001|Phase 3: Follow-up Post-True Acupuncture|Lost to Follow-up|0|||
147414269|NCT00297427|531680289|FG000|Phase 3: Follow-up Post-True Acupuncture|Could not complete outcome diary|2|||
147414270|NCT00297427|531680290|FG001|Phase 3: Follow-up Post-True Acupuncture|Could not complete outcome diary|0|||
147414271|NCT01896557|531680295|FG000|Clopidogrel Alone|Adverse Event|1|||
147414272|NCT01896557|531680296|FG001|Clopidogrel Alone|Adverse Event|0|||
147414273|NCT01896557|531680295|FG000|Clopidogrel + GI Protector|low adherence|1|||
147414274|NCT01896557|531680296|FG001|Clopidogrel + GI Protector|low adherence|1|||
147414275|NCT01896557|531680295|FG000|Clopidogrel + GI Protector|Reading error|1|||
147414276|NCT01896557|531680296|FG001|Clopidogrel + GI Protector|Reading error|3|||
147414277|NCT02182947|531680297|FG000|Overall Study|Withdrawal by Subject|7|||
147414278|NCT02182947|531680297|FG000|Overall Study|Lost to Follow-up|3|||
147414279|NCT02182947|531680297|FG000|Overall Study|Failed screening activities|8|||
147414280|NCT00416195|531680324|FG000|Overall Study|Adverse Event|1|||
147414281|NCT00416195|531680325|FG001|Overall Study|Adverse Event|2|||
147414282|NCT00416195|531680324|FG000|Overall Study|Protocol Violation|1|||
147414283|NCT00416195|531680325|FG001|Overall Study|Protocol Violation|1|||
147414284|NCT00416195|531680324|FG000|Overall Study|Other|0|||
147414285|NCT00416195|531680325|FG001|Overall Study|Other|1|||
147414286|NCT01305408|531680330|FG000|Overall Study|Adverse Event|10|||
147414287|NCT01305408|531680331|FG001|Overall Study|Adverse Event|7|||
147414288|NCT01305408|531680330|FG000|Overall Study|Lack of Efficacy|3|||
147414289|NCT01305408|531680331|FG001|Overall Study|Lack of Efficacy|4|||
147414290|NCT01305408|531680330|FG000|Overall Study|Withdrawal by Subject|9|||
147414291|NCT01305408|531680331|FG001|Overall Study|Withdrawal by Subject|9|||
147414292|NCT01305408|531680330|FG000|Overall Study|Protocol Violation|4|||
147414293|NCT01305408|531680331|FG001|Overall Study|Protocol Violation|6|||
147414294|NCT01305408|531680330|FG000|Overall Study|Lost to Follow-up|5|||
147414295|NCT01305408|531680331|FG001|Overall Study|Lost to Follow-up|3|||
147414296|NCT01305408|531680330|FG000|Overall Study|Noncompliance with study medication|0|||
147414297|NCT01305408|531680331|FG001|Overall Study|Noncompliance with study medication|1|||
147414298|NCT01305408|531680330|FG000|Overall Study|Noncompliance with study procedures|0|||
147414299|NCT01305408|531680331|FG001|Overall Study|Noncompliance with study procedures|1|||
147414300|NCT01305408|531680330|FG000|Overall Study|Other|1|||
147414301|NCT01305408|531680331|FG001|Overall Study|Other|0|||
147414302|NCT03101462|531680332|FG000|Overall Study|Missed Visit 02 and/or Visit 03|1|||
147414303|NCT03101462|531680333|FG001|Overall Study|Missed Visit 02 and/or Visit 03|1|||
147414304|NCT02770612|531680335|FG000|Overall Study|Met exclusion criteria (postop LOS>7d)|1|||
147414305|NCT02636725|531680336|FG000|Overall Study|Adverse Event|1|||
147414306|NCT03653208|531680339|FG000|Overall Study|Withdrawal by Subject|0|||
147414307|NCT03653208|531680340|FG001|Overall Study|Withdrawal by Subject|0|||
147414308|NCT03653208|531680341|FG002|Overall Study|Withdrawal by Subject|0|||
147414309|NCT03653208|531680342|FG003|Overall Study|Withdrawal by Subject|0|||
147414310|NCT03653208|531680343|FG004|Overall Study|Withdrawal by Subject|1|||
147414311|NCT03653208|531680344|FG005|Overall Study|Withdrawal by Subject|0|||
147414312|NCT03653208|531680345|FG006|Overall Study|Withdrawal by Subject|0|||
147414313|NCT03653208|531680346|FG007|Overall Study|Withdrawal by Subject|1|||
147414314|NCT03653208|531680347|FG008|Overall Study|Withdrawal by Subject|1|||
147414315|NCT00886795|531680349|FG000|Overall Study|Lack of Efficacy|1|||
147414316|NCT01669577|531680355|FG000|Overall Study|Death|22|||
147414317|NCT01669577|531680355|FG000|Overall Study|Lost to Follow-up|78|||
147414318|NCT01669577|531680355|FG000|Overall Study|Physician Decision|34|||
147414319|NCT01283516|531680356|FG000|Overall Study|Adverse Event|0|||
147414320|NCT01283516|531680357|FG001|Overall Study|Adverse Event|0|||
147414321|NCT01283516|531680358|FG002|Overall Study|Adverse Event|0|||
147414322|NCT01283516|531680359|FG003|Overall Study|Adverse Event|0|||
147414323|NCT01283516|531680360|FG004|Overall Study|Adverse Event|0|||
147414324|NCT01283516|531680361|FG005|Overall Study|Adverse Event|0|||
147620184|NCT04429503|532427235|FG004|Extension Phase (Wk 96 to Wk 156)|Decision by the Investigator/Sponsor|3|||
147414325|NCT01283516|531680362|FG006|Overall Study|Adverse Event|2|||
147620185|NCT04429503|532427236|FG005|Extension Phase (Wk 96 to Wk 156)|Decision by the Investigator/Sponsor|2|||
147414326|NCT01283516|531680363|FG007|Overall Study|Adverse Event|0|||
147414327|NCT01283516|531680364|FG008|Overall Study|Adverse Event|28|||
147414328|NCT01283516|531680356|FG000|Overall Study|Death|0|||
147414329|NCT01283516|531680357|FG001|Overall Study|Death|0|||
147414330|NCT01283516|531680358|FG002|Overall Study|Death|0|||
147414331|NCT01283516|531680359|FG003|Overall Study|Death|0|||
147414332|NCT01283516|531680360|FG004|Overall Study|Death|0|||
147414333|NCT01283516|531680361|FG005|Overall Study|Death|1|||
147414334|NCT01283516|531680362|FG006|Overall Study|Death|0|||
147414335|NCT01283516|531680363|FG007|Overall Study|Death|1|||
147414336|NCT01283516|531680364|FG008|Overall Study|Death|12|||
147414337|NCT01283516|531680356|FG000|Overall Study|Disease Progression|2|||
147414338|NCT01283516|531680357|FG001|Overall Study|Disease Progression|2|||
147414339|NCT01283516|531680358|FG002|Overall Study|Disease Progression|3|||
147414340|NCT01283516|531680359|FG003|Overall Study|Disease Progression|3|||
147414341|NCT01283516|531680360|FG004|Overall Study|Disease Progression|13|||
147414342|NCT01283516|531680361|FG005|Overall Study|Disease Progression|8|||
147414343|NCT01283516|531680362|FG006|Overall Study|Disease Progression|6|||
147414344|NCT01283516|531680363|FG007|Overall Study|Disease Progression|3|||
147414345|NCT01283516|531680364|FG008|Overall Study|Disease Progression|139|||
147414346|NCT01283516|531680356|FG000|Overall Study|Withdrawal by Subject|0|||
147414347|NCT01283516|531680357|FG001|Overall Study|Withdrawal by Subject|0|||
147414348|NCT01283516|531680358|FG002|Overall Study|Withdrawal by Subject|0|||
147414349|NCT01283516|531680359|FG003|Overall Study|Withdrawal by Subject|0|||
147414350|NCT01283516|531680360|FG004|Overall Study|Withdrawal by Subject|1|||
147414351|NCT01283516|531680361|FG005|Overall Study|Withdrawal by Subject|0|||
147414352|NCT01283516|531680362|FG006|Overall Study|Withdrawal by Subject|1|||
147414353|NCT01283516|531680363|FG007|Overall Study|Withdrawal by Subject|0|||
147414354|NCT01283516|531680364|FG008|Overall Study|Withdrawal by Subject|36|||
147414355|NCT01283516|531680356|FG000|Overall Study|Administrative problems|0|||
147414356|NCT01283516|531680357|FG001|Overall Study|Administrative problems|0|||
147414357|NCT01283516|531680358|FG002|Overall Study|Administrative problems|0|||
147414358|NCT01283516|531680359|FG003|Overall Study|Administrative problems|0|||
147414359|NCT01283516|531680360|FG004|Overall Study|Administrative problems|0|||
147414360|NCT01283516|531680361|FG005|Overall Study|Administrative problems|1|||
147414361|NCT01283516|531680362|FG006|Overall Study|Administrative problems|1|||
147414362|NCT01283516|531680363|FG007|Overall Study|Administrative problems|1|||
147414363|NCT01283516|531680364|FG008|Overall Study|Administrative problems|39|||
147414364|NCT01283516|531680356|FG000|Overall Study|Lost to Follow-up|0|||
147414365|NCT01283516|531680357|FG001|Overall Study|Lost to Follow-up|0|||
147414366|NCT01283516|531680358|FG002|Overall Study|Lost to Follow-up|0|||
147414367|NCT01283516|531680359|FG003|Overall Study|Lost to Follow-up|0|||
147414368|NCT01283516|531680360|FG004|Overall Study|Lost to Follow-up|0|||
147414369|NCT01283516|531680361|FG005|Overall Study|Lost to Follow-up|0|||
147414370|NCT01283516|531680362|FG006|Overall Study|Lost to Follow-up|0|||
147414371|NCT01283516|531680363|FG007|Overall Study|Lost to Follow-up|0|||
147414372|NCT01283516|531680364|FG008|Overall Study|Lost to Follow-up|1|||
147414373|NCT00444275|531680370|FG000|Maintenance Treatment Phase|Didn'r receive the treatment|0|||
147414374|NCT00444275|531680371|FG001|Maintenance Treatment Phase|Didn'r receive the treatment|0|||
147414375|NCT00444275|531680372|FG002|Maintenance Treatment Phase|Didn'r receive the treatment|22|||
147414376|NCT00444275|531680373|FG003|Maintenance Treatment Phase|Didn'r receive the treatment|17|||
147414377|NCT00444275|531680374|FG004|Maintenance Treatment Phase|Didn'r receive the treatment|29|||
147414378|NCT00444275|531680370|FG000|Maintenance Treatment Phase|Lost to Follow-up|0|||
147414379|NCT00444275|531680371|FG001|Maintenance Treatment Phase|Lost to Follow-up|0|||
147414380|NCT00444275|531680372|FG002|Maintenance Treatment Phase|Lost to Follow-up|8|||
147414381|NCT00444275|531680373|FG003|Maintenance Treatment Phase|Lost to Follow-up|14|||
147414382|NCT00444275|531680374|FG004|Maintenance Treatment Phase|Lost to Follow-up|10|||
147414383|NCT00444275|531680370|FG000|Maintenance Treatment Phase|Adverse Event|0|||
147414384|NCT00444275|531680371|FG001|Maintenance Treatment Phase|Adverse Event|0|||
147414385|NCT00444275|531680372|FG002|Maintenance Treatment Phase|Adverse Event|3|||
147414386|NCT00444275|531680373|FG003|Maintenance Treatment Phase|Adverse Event|2|||
147414387|NCT00444275|531680374|FG004|Maintenance Treatment Phase|Adverse Event|13|||
147620186|NCT04429503|532427231|FG000|Extension Phase (Wk 96 to Wk 156)|Withdrawal by Subject|0|||
147620187|NCT04429503|532427232|FG001|Extension Phase (Wk 96 to Wk 156)|Withdrawal by Subject|0|||
147620188|NCT04429503|532427233|FG002|Extension Phase (Wk 96 to Wk 156)|Withdrawal by Subject|0|||
147620189|NCT04429503|532427234|FG003|Extension Phase (Wk 96 to Wk 156)|Withdrawal by Subject|5|||
147414388|NCT00444275|531680370|FG000|Maintenance Treatment Phase|Protocol specific criteria's development|0|||
147414389|NCT00444275|531680371|FG001|Maintenance Treatment Phase|Protocol specific criteria's development|0|||
147414390|NCT00444275|531680372|FG002|Maintenance Treatment Phase|Protocol specific criteria's development|1|||
147414391|NCT00444275|531680373|FG003|Maintenance Treatment Phase|Protocol specific criteria's development|0|||
147414392|NCT00444275|531680374|FG004|Maintenance Treatment Phase|Protocol specific criteria's development|6|||
147414393|NCT00444275|531680370|FG000|Maintenance Treatment Phase|Patient's wish|0|||
147414394|NCT00444275|531680371|FG001|Maintenance Treatment Phase|Patient's wish|0|||
147414395|NCT00444275|531680372|FG002|Maintenance Treatment Phase|Patient's wish|19|||
147414396|NCT00444275|531680373|FG003|Maintenance Treatment Phase|Patient's wish|9|||
147414397|NCT00444275|531680374|FG004|Maintenance Treatment Phase|Patient's wish|20|||
147414398|NCT00444275|531680370|FG000|Maintenance Treatment Phase|Protocol Violation|0|||
147414399|NCT00444275|531680371|FG001|Maintenance Treatment Phase|Protocol Violation|0|||
147414400|NCT00444275|531680372|FG002|Maintenance Treatment Phase|Protocol Violation|103|||
147414401|NCT00444275|531680373|FG003|Maintenance Treatment Phase|Protocol Violation|88|||
147414402|NCT00444275|531680374|FG004|Maintenance Treatment Phase|Protocol Violation|87|||
147414403|NCT00444275|531680370|FG000|Maintenance Treatment Phase|Ineffectiveness|0|||
147414404|NCT00444275|531680371|FG001|Maintenance Treatment Phase|Ineffectiveness|0|||
147414405|NCT00444275|531680372|FG002|Maintenance Treatment Phase|Ineffectiveness|5|||
147414406|NCT00444275|531680373|FG003|Maintenance Treatment Phase|Ineffectiveness|3|||
147414407|NCT00444275|531680374|FG004|Maintenance Treatment Phase|Ineffectiveness|14|||
147414408|NCT00132873|531680375|FG000|Overall Study|Adverse Event|3|||
147414409|NCT00132873|531680375|FG000|Overall Study|Lost to Follow-up|1|||
147414410|NCT00132873|531680375|FG000|Overall Study|Lack of Efficacy|1|||
147414411|NCT00132873|531680375|FG000|Overall Study|Withdrawal by Subject|3|||
147414412|NCT00132873|531680375|FG000|Overall Study|Planned Pregnancy|1|||
147414413|NCT01896726|531680379|FG000|Treatment Period 2 (Days 23-31)|Adverse Event|1|||
147414414|NCT01896726|531680379|FG000|Treatment Period 2 (Days 23-31)|Lost to Follow-up|1|||
147414415|NCT04662931|531680382|FG000|Overall Study|Withdrawal by Subject|17|||
147414416|NCT04662931|531680382|FG000|Overall Study|Death|3|||
147414417|NCT04662931|531680382|FG000|Overall Study|Lost to Follow-up|3|||
147414418|NCT04662931|531680382|FG000|Overall Study|Guardian Decision|1|||
147414419|NCT02406677|531680383|FG000|Overall Study|Death|16|||
147414420|NCT02406677|531680384|FG001|Overall Study|Death|8|||
147414421|NCT02406677|531680383|FG000|Overall Study|Discharged without P2Y12|1|||
147414422|NCT02406677|531680384|FG001|Overall Study|Discharged without P2Y12|3|||
147414423|NCT02406677|531680383|FG000|Overall Study|Discharged on prasugrel|283|||
147471709|NCT01642212|531883007|FG002|Double-blind Treatment|Non-compliance|0|||
147471710|NCT01642212|531883008|FG003|Double-blind Treatment|Non-compliance|0|||
147414424|NCT02406677|531680384|FG001|Overall Study|Discharged on prasugrel|587|||
147471711|NCT01642212|531883009|FG004|Double-blind Treatment|Non-compliance|0|||
147471712|NCT01642212|531883005|FG000|Double-blind Treatment|Adverse Event|0|||
147471713|NCT01642212|531883006|FG001|Double-blind Treatment|Adverse Event|0|||
147471714|NCT01642212|531883007|FG002|Double-blind Treatment|Adverse Event|1|||
147471715|NCT01642212|531883008|FG003|Double-blind Treatment|Adverse Event|0|||
147471716|NCT01642212|531883009|FG004|Double-blind Treatment|Adverse Event|0|||
147471717|NCT01642212|531883005|FG000|Open-label Extension|Adverse Event|0|||
147471718|NCT01642212|531883006|FG001|Open-label Extension|Adverse Event|0|||
147471719|NCT01642212|531883007|FG002|Open-label Extension|Adverse Event|0|||
147471720|NCT01642212|531883008|FG003|Open-label Extension|Adverse Event|3|||
147471721|NCT01642212|531883009|FG004|Open-label Extension|Adverse Event|0|||
147471722|NCT01642212|531883005|FG000|Open-label Extension|Sponsor Decision|0|||
147471723|NCT01642212|531883006|FG001|Open-label Extension|Sponsor Decision|0|||
147471724|NCT01642212|531883007|FG002|Open-label Extension|Sponsor Decision|0|||
147471725|NCT01642212|531883008|FG003|Open-label Extension|Sponsor Decision|7|||
147471726|NCT01642212|531883009|FG004|Open-label Extension|Sponsor Decision|4|||
147471727|NCT01642212|531883005|FG000|Open-label Extension|Consent Withdrawn|0|||
147471728|NCT01642212|531883006|FG001|Open-label Extension|Consent Withdrawn|0|||
147471729|NCT01642212|531883007|FG002|Open-label Extension|Consent Withdrawn|0|||
147620190|NCT04429503|532427235|FG004|Extension Phase (Wk 96 to Wk 156)|Withdrawal by Subject|10|||
147620191|NCT04429503|532427236|FG005|Extension Phase (Wk 96 to Wk 156)|Withdrawal by Subject|5|||
147620192|NCT04429503|532427231|FG000|Extension Phase (Wk 96 to Wk 156)|Lost to Follow-up|0|||
147414425|NCT02406677|531680383|FG000|Overall Study|Withdrawal by Subject|1|||
147414426|NCT02406677|531680384|FG001|Overall Study|Withdrawal by Subject|0|||
147414427|NCT01114880|531680385|FG000|Period 1 (Week 0 to Week 12)|Adverse Event|4|||
147414428|NCT01114880|531680386|FG001|Period 1 (Week 0 to Week 12)|Adverse Event|0|||
147414429|NCT01114880|531680385|FG000|Period 1 (Week 0 to Week 12)|Withdrawal by Subject|1|||
147414430|NCT01114880|531680386|FG001|Period 1 (Week 0 to Week 12)|Withdrawal by Subject|0|||
147620193|NCT04429503|532427232|FG001|Extension Phase (Wk 96 to Wk 156)|Lost to Follow-up|0|||
147620194|NCT04429503|532427233|FG002|Extension Phase (Wk 96 to Wk 156)|Lost to Follow-up|0|||
147620195|NCT04429503|532427234|FG003|Extension Phase (Wk 96 to Wk 156)|Lost to Follow-up|3|||
147620196|NCT04429503|532427235|FG004|Extension Phase (Wk 96 to Wk 156)|Lost to Follow-up|6|||
147620197|NCT04429503|532427236|FG005|Extension Phase (Wk 96 to Wk 156)|Lost to Follow-up|6|||
147414431|NCT01114880|531680385|FG000|Period 1 (Week 0 to Week 12)|Lost to Follow-up|0|||
147414432|NCT01114880|531680386|FG001|Period 1 (Week 0 to Week 12)|Lost to Follow-up|1|||
147414433|NCT01114880|531680385|FG000|Period 1 (Week 0 to Week 12)|Poor subject compliance|0|||
147620198|NCT04429503|532427231|FG000|Extension Phase (Wk 96 to Wk 156)|Death|0|||
147414434|NCT01114880|531680386|FG001|Period 1 (Week 0 to Week 12)|Poor subject compliance|1|||
147414435|NCT01114880|531680385|FG000|Period 2 (Week 12 to Week 24)|Adverse Event|3|||
147471730|NCT01642212|531883008|FG003|Open-label Extension|Consent Withdrawn|0|||
147414436|NCT01114880|531680386|FG001|Period 2 (Week 12 to Week 24)|Adverse Event|0|||
147471731|NCT01642212|531883009|FG004|Open-label Extension|Consent Withdrawn|2|||
147471732|NCT01642212|531883005|FG000|Open-label Extension|Lost to Follow-up|0|||
147414437|NCT01114880|531680385|FG000|Period 2 (Week 12 to Week 24)|Lost to Follow-up|0|||
147414438|NCT01114880|531680386|FG001|Period 2 (Week 12 to Week 24)|Lost to Follow-up|2|||
147414439|NCT04531904|531680390|FG000|Overall Study|Lost to Follow-up|1|||
147414440|NCT04531904|531680390|FG000|Overall Study|Death|14|||
147414441|NCT04531098|531680391|FG000|Stage I|Adverse Event|0|||
147414442|NCT04531098|531680392|FG001|Stage I|Adverse Event|0|||
147414443|NCT04531098|531680393|FG002|Stage I|Adverse Event|3|||
147414444|NCT04531098|531680391|FG000|Stage I|Protocol Violation|0|||
147414445|NCT04531098|531680392|FG001|Stage I|Protocol Violation|0|||
147414446|NCT04531098|531680393|FG002|Stage I|Protocol Violation|5|||
147414447|NCT04531098|531680391|FG000|Stage I|Withdrawal by Subject|0|||
147414448|NCT04531098|531680392|FG001|Stage I|Withdrawal by Subject|5|||
147414449|NCT04531098|531680393|FG002|Stage I|Withdrawal by Subject|10|||
147414450|NCT04531098|531680391|FG000|Stage II|Adverse Event|1|||
147414451|NCT04531098|531680392|FG001|Stage II|Adverse Event|2|||
147414452|NCT04531098|531680393|FG002|Stage II|Adverse Event|0|||
147414453|NCT04531098|531680391|FG000|Stage II|Protocol Violation|1|||
147414454|NCT04531098|531680392|FG001|Stage II|Protocol Violation|2|||
147414455|NCT04531098|531680393|FG002|Stage II|Protocol Violation|0|||
147414456|NCT04531098|531680391|FG000|Stage II|Withdrawal by Subject|3|||
147414457|NCT04531098|531680392|FG001|Stage II|Withdrawal by Subject|1|||
147414458|NCT04531098|531680393|FG002|Stage II|Withdrawal by Subject|0|||
147414459|NCT04531098|531680391|FG000|Stage II|Moved from study area|8|||
147414460|NCT04531098|531680392|FG001|Stage II|Moved from study area|5|||
147414461|NCT04531098|531680393|FG002|Stage II|Moved from study area|0|||
147414462|NCT02628028|531680394|FG000|Dosing Period|Withdrawal by Subject|0|||
147414463|NCT02628028|531680395|FG001|Dosing Period|Withdrawal by Subject|0|||
147414464|NCT02628028|531680396|FG002|Dosing Period|Withdrawal by Subject|1|||
147414465|NCT02628028|531680397|FG003|Dosing Period|Withdrawal by Subject|0|||
147414466|NCT02628028|531680398|FG004|Dosing Period|Withdrawal by Subject|2|||
147414467|NCT02628028|531680399|FG005|Dosing Period|Withdrawal by Subject|4|||
147414468|NCT02628028|531680400|FG006|Dosing Period|Withdrawal by Subject|1|||
147414469|NCT02628028|531680401|FG007|Dosing Period|Withdrawal by Subject|1|||
147414470|NCT02628028|531680394|FG000|Dosing Period|Adverse Event|0|||
147414471|NCT02628028|531680395|FG001|Dosing Period|Adverse Event|0|||
147414472|NCT02628028|531680396|FG002|Dosing Period|Adverse Event|0|||
147414473|NCT02628028|531680397|FG003|Dosing Period|Adverse Event|0|||
147414474|NCT02628028|531680398|FG004|Dosing Period|Adverse Event|2|||
147414475|NCT02628028|531680399|FG005|Dosing Period|Adverse Event|1|||
147414476|NCT02628028|531680400|FG006|Dosing Period|Adverse Event|3|||
147414477|NCT02628028|531680401|FG007|Dosing Period|Adverse Event|2|||
147414478|NCT02628028|531680394|FG000|Dosing Period|Death|0|||
147414479|NCT02628028|531680395|FG001|Dosing Period|Death|0|||
147414480|NCT02628028|531680396|FG002|Dosing Period|Death|0|||
147414481|NCT02628028|531680397|FG003|Dosing Period|Death|0|||
147414482|NCT02628028|531680398|FG004|Dosing Period|Death|0|||
147414483|NCT02628028|531680399|FG005|Dosing Period|Death|0|||
147414484|NCT02628028|531680400|FG006|Dosing Period|Death|0|||
147414485|NCT02628028|531680401|FG007|Dosing Period|Death|1|||
147414486|NCT02628028|531680394|FG000|Dosing Period|Lack of Efficacy|0|||
147414487|NCT02628028|531680395|FG001|Dosing Period|Lack of Efficacy|0|||
147414488|NCT02628028|531680396|FG002|Dosing Period|Lack of Efficacy|0|||
147414489|NCT02628028|531680397|FG003|Dosing Period|Lack of Efficacy|0|||
147414490|NCT02628028|531680398|FG004|Dosing Period|Lack of Efficacy|3|||
147414491|NCT02628028|531680399|FG005|Dosing Period|Lack of Efficacy|0|||
147414492|NCT02628028|531680400|FG006|Dosing Period|Lack of Efficacy|1|||
147414493|NCT02628028|531680401|FG007|Dosing Period|Lack of Efficacy|0|||
147414494|NCT02628028|531680394|FG000|Dosing Period|Study Terminated by Sponsor|0|||
147414495|NCT02628028|531680395|FG001|Dosing Period|Study Terminated by Sponsor|0|||
147414496|NCT02628028|531680396|FG002|Dosing Period|Study Terminated by Sponsor|0|||
147414497|NCT02628028|531680397|FG003|Dosing Period|Study Terminated by Sponsor|0|||
147414498|NCT02628028|531680398|FG004|Dosing Period|Study Terminated by Sponsor|7|||
147414499|NCT02628028|531680399|FG005|Dosing Period|Study Terminated by Sponsor|6|||
147414500|NCT02628028|531680400|FG006|Dosing Period|Study Terminated by Sponsor|7|||
147414501|NCT02628028|531680401|FG007|Dosing Period|Study Terminated by Sponsor|7|||
147414502|NCT02628028|531680394|FG000|Dosing Period|Physician Decision|0|||
147414503|NCT02628028|531680395|FG001|Dosing Period|Physician Decision|0|||
147414504|NCT02628028|531680396|FG002|Dosing Period|Physician Decision|0|||
147414505|NCT02628028|531680397|FG003|Dosing Period|Physician Decision|0|||
147414506|NCT02628028|531680398|FG004|Dosing Period|Physician Decision|0|||
147414507|NCT02628028|531680399|FG005|Dosing Period|Physician Decision|1|||
147414508|NCT02628028|531680400|FG006|Dosing Period|Physician Decision|0|||
147414509|NCT02628028|531680401|FG007|Dosing Period|Physician Decision|0|||
147414510|NCT02628028|531680394|FG000|Dosing Period|Site Terminated by Sponsor|0|||
147665976|NCT03167242|532601657|FG011|Overall Study|Reason not provided|0|||
147414511|NCT02628028|531680395|FG001|Dosing Period|Site Terminated by Sponsor|0|||
147414512|NCT02628028|531680396|FG002|Dosing Period|Site Terminated by Sponsor|0|||
147414513|NCT02628028|531680397|FG003|Dosing Period|Site Terminated by Sponsor|0|||
147414514|NCT02628028|531680398|FG004|Dosing Period|Site Terminated by Sponsor|0|||
147414515|NCT02628028|531680399|FG005|Dosing Period|Site Terminated by Sponsor|1|||
147414516|NCT02628028|531680400|FG006|Dosing Period|Site Terminated by Sponsor|1|||
147414517|NCT02628028|531680401|FG007|Dosing Period|Site Terminated by Sponsor|0|||
147414518|NCT02628028|531680394|FG000|Dosing Period|Lost to Follow-up|0|||
147414519|NCT02628028|531680395|FG001|Dosing Period|Lost to Follow-up|0|||
147414520|NCT02628028|531680396|FG002|Dosing Period|Lost to Follow-up|0|||
147414521|NCT02628028|531680397|FG003|Dosing Period|Lost to Follow-up|0|||
147414522|NCT02628028|531680398|FG004|Dosing Period|Lost to Follow-up|0|||
147414523|NCT02628028|531680399|FG005|Dosing Period|Lost to Follow-up|0|||
147414524|NCT02628028|531680400|FG006|Dosing Period|Lost to Follow-up|1|||
147414525|NCT02628028|531680401|FG007|Dosing Period|Lost to Follow-up|0|||
147414526|NCT02628028|531680394|FG000|Dosing Period|Other|0|||
147414527|NCT02628028|531680395|FG001|Dosing Period|Other|0|||
147414528|NCT02628028|531680396|FG002|Dosing Period|Other|0|||
147414529|NCT02628028|531680397|FG003|Dosing Period|Other|0|||
147414530|NCT02628028|531680398|FG004|Dosing Period|Other|2|||
147414531|NCT02628028|531680399|FG005|Dosing Period|Other|1|||
147414532|NCT02628028|531680400|FG006|Dosing Period|Other|2|||
147414533|NCT02628028|531680401|FG007|Dosing Period|Other|4|||
147414534|NCT02628028|531680394|FG000|Long-term Extension (LTE) Period|Adverse Event|0|||
147414535|NCT02628028|531680395|FG001|Long-term Extension (LTE) Period|Adverse Event|0|||
147414536|NCT02628028|531680396|FG002|Long-term Extension (LTE) Period|Adverse Event|0|||
147414537|NCT02628028|531680397|FG003|Long-term Extension (LTE) Period|Adverse Event|0|||
147414538|NCT02628028|531680398|FG004|Long-term Extension (LTE) Period|Adverse Event|0|||
147414539|NCT02628028|531680399|FG005|Long-term Extension (LTE) Period|Adverse Event|1|||
147414540|NCT02628028|531680400|FG006|Long-term Extension (LTE) Period|Adverse Event|0|||
147414541|NCT02628028|531680401|FG007|Long-term Extension (LTE) Period|Adverse Event|3|||
147414542|NCT02628028|531680394|FG000|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
147414543|NCT02628028|531680395|FG001|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
147414544|NCT02628028|531680396|FG002|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
147414545|NCT02628028|531680397|FG003|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
147414546|NCT02628028|531680398|FG004|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
147414547|NCT02628028|531680399|FG005|Long-term Extension (LTE) Period|Lack of Efficacy|2|||
147414548|NCT02628028|531680400|FG006|Long-term Extension (LTE) Period|Lack of Efficacy|0|||
147414549|NCT02628028|531680401|FG007|Long-term Extension (LTE) Period|Lack of Efficacy|1|||
147414550|NCT02628028|531680394|FG000|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0|||
147414551|NCT02628028|531680395|FG001|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0|||
147414552|NCT02628028|531680396|FG002|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0|||
147414553|NCT02628028|531680397|FG003|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0|||
147414554|NCT02628028|531680398|FG004|Long-term Extension (LTE) Period|Study Terminated by Sponsor|0|||
147414555|NCT02628028|531680399|FG005|Long-term Extension (LTE) Period|Study Terminated by Sponsor|52|||
147414556|NCT02628028|531680400|FG006|Long-term Extension (LTE) Period|Study Terminated by Sponsor|51|||
147414557|NCT02628028|531680401|FG007|Long-term Extension (LTE) Period|Study Terminated by Sponsor|51|||
147414558|NCT02628028|531680394|FG000|Long-term Extension (LTE) Period|Withdrawal by Subject|0|||
147414559|NCT02628028|531680395|FG001|Long-term Extension (LTE) Period|Withdrawal by Subject|0|||
147414560|NCT02628028|531680396|FG002|Long-term Extension (LTE) Period|Withdrawal by Subject|0|||
147414561|NCT02628028|531680397|FG003|Long-term Extension (LTE) Period|Withdrawal by Subject|0|||
147414562|NCT02628028|531680398|FG004|Long-term Extension (LTE) Period|Withdrawal by Subject|0|||
147414563|NCT02628028|531680399|FG005|Long-term Extension (LTE) Period|Withdrawal by Subject|2|||
147414564|NCT02628028|531680400|FG006|Long-term Extension (LTE) Period|Withdrawal by Subject|3|||
147414565|NCT02628028|531680401|FG007|Long-term Extension (LTE) Period|Withdrawal by Subject|3|||
147414566|NCT02628028|531680394|FG000|Long-term Extension (LTE) Period|Other|0|||
147414567|NCT02628028|531680395|FG001|Long-term Extension (LTE) Period|Other|0|||
147414568|NCT02628028|531680396|FG002|Long-term Extension (LTE) Period|Other|0|||
147414569|NCT02628028|531680397|FG003|Long-term Extension (LTE) Period|Other|0|||
147414570|NCT02628028|531680398|FG004|Long-term Extension (LTE) Period|Other|0|||
147414571|NCT02628028|531680399|FG005|Long-term Extension (LTE) Period|Other|3|||
147414572|NCT02628028|531680400|FG006|Long-term Extension (LTE) Period|Other|4|||
147414573|NCT02628028|531680401|FG007|Long-term Extension (LTE) Period|Other|3|||
147414574|NCT00283244|531680402|FG000|Overall Study|Adverse Event|0|||
147414575|NCT00283244|531680403|FG001|Overall Study|Adverse Event|8|||
147414576|NCT00283244|531680404|FG002|Overall Study|Adverse Event|11|||
147414577|NCT00283244|531680402|FG000|Overall Study|Death|4|||
147414578|NCT00283244|531680403|FG001|Overall Study|Death|3|||
147414579|NCT00283244|531680404|FG002|Overall Study|Death|2|||
147414580|NCT00283244|531680402|FG000|Overall Study|Lack of Efficacy|8|||
147414581|NCT00283244|531680403|FG001|Overall Study|Lack of Efficacy|32|||
147414582|NCT00283244|531680404|FG002|Overall Study|Lack of Efficacy|26|||
147414583|NCT00283244|531680402|FG000|Overall Study|Withdrawal by Subject|1|||
147414584|NCT00283244|531680403|FG001|Overall Study|Withdrawal by Subject|2|||
147414585|NCT00283244|531680404|FG002|Overall Study|Withdrawal by Subject|2|||
147414586|NCT00283244|531680402|FG000|Overall Study|Physician Decision|0|||
147414587|NCT00283244|531680403|FG001|Overall Study|Physician Decision|0|||
147414588|NCT00283244|531680404|FG002|Overall Study|Physician Decision|1|||
147665977|NCT05222880|532601661|FG000|Overall Study|Unsatisfactory Visual Response due to Test Article|1|||
147414589|NCT00283244|531680402|FG000|Overall Study|Medical illness (other complicating dz)|4|||
147414590|NCT00283244|531680403|FG001|Overall Study|Medical illness (other complicating dz)|3|||
147414591|NCT00283244|531680404|FG002|Overall Study|Medical illness (other complicating dz)|6|||
147414592|NCT00283244|531680402|FG000|Overall Study|Clinical deterioration|1|||
147414593|NCT00283244|531680403|FG001|Overall Study|Clinical deterioration|3|||
147414594|NCT00283244|531680404|FG002|Overall Study|Clinical deterioration|3|||
147414595|NCT03361605|531680407|FG000|Overall Study|Analyzable data not available|3|||
147414596|NCT03826030|531680408|FG000|Overall Study|Withdrawal by Subject|2|||
147414597|NCT03826030|531680409|FG001|Overall Study|Withdrawal by Subject|0|||
147414598|NCT03826030|531680410|FG002|Overall Study|Withdrawal by Subject|1|||
147414599|NCT03826030|531680408|FG000|Overall Study|Lost to Follow-up|1|||
147414600|NCT03826030|531680409|FG001|Overall Study|Lost to Follow-up|1|||
147414601|NCT03826030|531680410|FG002|Overall Study|Lost to Follow-up|1|||
147414602|NCT03826030|531680408|FG000|Overall Study|Too busy to return for visits|1|||
147414603|NCT03826030|531680409|FG001|Overall Study|Too busy to return for visits|0|||
147414604|NCT03826030|531680410|FG002|Overall Study|Too busy to return for visits|0|||
147414605|NCT03333876|531682068|FG000|Screening Period|Screen Failure|4|||
147414606|NCT03333876|531682068|FG000|Nasal Dilator|Bed Partner Lost to follow up|6|||
147414607|NCT03333876|531682068|FG000|Mandibular Advancement|Adverse Event|2|||
147471733|NCT01642212|531883006|FG001|Open-label Extension|Lost to Follow-up|0|||
147471734|NCT01642212|531883007|FG002|Open-label Extension|Lost to Follow-up|0|||
147471735|NCT01642212|531883008|FG003|Open-label Extension|Lost to Follow-up|0|||
147471736|NCT01642212|531883009|FG004|Open-label Extension|Lost to Follow-up|1|||
147471737|NCT01642212|531883005|FG000|Open-label Extension|Other|0|||
147471738|NCT01642212|531883006|FG001|Open-label Extension|Other|0|||
147471739|NCT01642212|531883007|FG002|Open-label Extension|Other|0|||
147471740|NCT01642212|531883008|FG003|Open-label Extension|Other|0|||
147471741|NCT01642212|531883009|FG004|Open-label Extension|Other|1|||
147471742|NCT00981526|531883010|FG000|Overall Study|Withdrawal by Subject|0|||
147471743|NCT00981526|531883011|FG001|Overall Study|Withdrawal by Subject|2|||
147471744|NCT00981526|531883010|FG000|Overall Study|Physician Decision|4|||
147471745|NCT00981526|531883011|FG001|Overall Study|Physician Decision|4|||
147471746|NCT01243268|531883012|FG000|Overall Study|Lost to Follow-up|4|||
147471747|NCT01243268|531883012|FG000|Overall Study|Protocol Violation|51|||
147471748|NCT01243268|531883012|FG000|Overall Study|Deviation with contract date|7|||
147471749|NCT01243268|531883012|FG000|Overall Study|Duplicate subject|2|||
147471750|NCT01564784|531883013|FG000|Overall Study|Other|1|||
147414608|NCT03333876|531682068|FG000|Mandibular Advancement|Product Damage|2|||
147414609|NCT05020327|531682071|FG000|Overall Study|Physician Decision|3|||
147414610|NCT05020327|531682072|FG001|Overall Study|Physician Decision|0|||
147414611|NCT05020327|531682073|FG002|Overall Study|Physician Decision|0|||
147414612|NCT05020327|531682071|FG000|Overall Study|Withdrawal by Subject|1|||
147414613|NCT05020327|531682072|FG001|Overall Study|Withdrawal by Subject|1|||
147414614|NCT05020327|531682073|FG002|Overall Study|Withdrawal by Subject|0|||
147414615|NCT05020327|531682071|FG000|Overall Study|personal/cultural, ineligible|12|||
147414616|NCT05020327|531682072|FG001|Overall Study|personal/cultural, ineligible|0|||
147414617|NCT05020327|531682073|FG002|Overall Study|personal/cultural, ineligible|0|||
147414618|NCT01127893|531682076|FG000|Overall Study|Study Termination by the Sponsor|1|||
147414619|NCT01262677|531682077|FG000|Overall Study|Does not meet entrance criteria|0|||
147471751|NCT01564784|531883014|FG001|Overall Study|Other|0|||
147471752|NCT01564784|531883013|FG000|Overall Study|Subject refused further follow-up|1|||
147471753|NCT01564784|531883014|FG001|Overall Study|Subject refused further follow-up|6|||
147471754|NCT01564784|531883013|FG000|Overall Study|Lost to Follow-up|1|||
147471755|NCT01564784|531883014|FG001|Overall Study|Lost to Follow-up|1|||
147471756|NCT01564784|531883013|FG000|Overall Study|Death|131|||
147471757|NCT01564784|531883014|FG001|Overall Study|Death|126|||
147471758|NCT02272790|531883015|FG000|Overall Study|Physician Decision|0|||
147471759|NCT02272790|531883016|FG001|Overall Study|Physician Decision|1|||
147471760|NCT02272790|531883017|FG002|Overall Study|Physician Decision|0|||
147471761|NCT02272790|531883018|FG003|Overall Study|Physician Decision|0|||
147414620|NCT01262677|531682078|FG001|Overall Study|Does not meet entrance criteria|2|||
147414621|NCT01262677|531682079|FG002|Overall Study|Does not meet entrance criteria|0|||
147414622|NCT01262677|531682077|FG000|Overall Study|Insufficient clinical response|0|||
147471762|NCT02272790|531883019|FG004|Overall Study|Physician Decision|0|||
147471763|NCT02272790|531883020|FG005|Overall Study|Physician Decision|0|||
147471764|NCT03871491|531883021|FG000|Overall Study|Withdrawal by Subject|14|||
147471765|NCT03871491|531883022|FG001|Overall Study|Withdrawal by Subject|14|||
147471766|NCT03871491|531883023|FG002|Overall Study|Withdrawal by Subject|14|||
147414623|NCT01262677|531682078|FG001|Overall Study|Insufficient clinical response|0|||
147414624|NCT01262677|531682079|FG002|Overall Study|Insufficient clinical response|1|||
147471767|NCT03871491|531883024|FG003|Overall Study|Withdrawal by Subject|14|||
147471768|NCT03871491|531883021|FG000|Overall Study|Physician Decision|0|||
147471769|NCT03871491|531883022|FG001|Overall Study|Physician Decision|0|||
147471770|NCT03871491|531883023|FG002|Overall Study|Physician Decision|1|||
147471771|NCT03871491|531883024|FG003|Overall Study|Physician Decision|1|||
147471772|NCT03871491|531883021|FG000|Overall Study|Lost to Follow-up|50|||
147414625|NCT01262677|531682077|FG000|Overall Study|Lost to Follow-up|1|||
147414626|NCT01262677|531682078|FG001|Overall Study|Lost to Follow-up|0|||
147414627|NCT01262677|531682079|FG002|Overall Study|Lost to Follow-up|2|||
147414628|NCT01262677|531682077|FG000|Overall Study|No longer willing to participate|3|||
147414629|NCT01262677|531682078|FG001|Overall Study|No longer willing to participate|3|||
147414630|NCT01262677|531682079|FG002|Overall Study|No longer willing to participate|2|||
147414631|NCT01262677|531682077|FG000|Overall Study|Reason not provided|2|||
147414632|NCT01262677|531682078|FG001|Overall Study|Reason not provided|1|||
147414633|NCT01262677|531682079|FG002|Overall Study|Reason not provided|3|||
147414634|NCT01262677|531682077|FG000|Overall Study|Protocol Violation|0|||
147414635|NCT01262677|531682078|FG001|Overall Study|Protocol Violation|1|||
147414636|NCT01262677|531682079|FG002|Overall Study|Protocol Violation|1|||
147414637|NCT01262677|531682077|FG000|Overall Study|Adverse Event (AE) related to study drug|3|||
147414638|NCT01262677|531682078|FG001|Overall Study|Adverse Event (AE) related to study drug|8|||
147414639|NCT01262677|531682079|FG002|Overall Study|Adverse Event (AE) related to study drug|3|||
147414640|NCT05816330|531682085|FG000|Overall Study|Withdrawal by Subject|4|||
147414641|NCT05816330|531682086|FG001|Overall Study|Withdrawal by Subject|1|||
147414642|NCT01470001|531682093|FG000|Overall Study|Lost to Follow-up|1|||
147414643|NCT01470001|531682094|FG001|Overall Study|Lost to Follow-up|1|||
147414644|NCT01470001|531682093|FG000|Overall Study|Physician Decision|2|||
147414645|NCT01470001|531682094|FG001|Overall Study|Physician Decision|0|||
147414646|NCT01470001|531682093|FG000|Overall Study|Withdrawal by Subject|2|||
147414647|NCT01470001|531682094|FG001|Overall Study|Withdrawal by Subject|1|||
147414648|NCT03896152|531682098|FG000|Overall Study|Patient/guardian decision|1|||
147414649|NCT03896152|531682099|FG001|Overall Study|Patient/guardian decision|1|||
147414650|NCT03896152|531682098|FG000|Overall Study|Adverse Event|0|||
147414651|NCT03896152|531682099|FG001|Overall Study|Adverse Event|1|||
147414652|NCT03896152|531682098|FG000|Overall Study|Physician Decision|1|||
147414653|NCT03896152|531682099|FG001|Overall Study|Physician Decision|0|||
147414654|NCT03896152|531682098|FG000|Overall Study|Technical problems|1|||
147414655|NCT03896152|531682099|FG001|Overall Study|Technical problems|0|||
147414656|NCT04514510|531682100|FG000|Overall Study|Lost to Follow-up|0|||
147414657|NCT04514510|531682101|FG001|Overall Study|Lost to Follow-up|1|||
147414658|NCT04514510|531682100|FG000|Overall Study|Randomized but did not receive Isoquercetin|1|||
147414659|NCT04514510|531682101|FG001|Overall Study|Randomized but did not receive Isoquercetin|0|||
147414660|NCT00821587|531682106|FG000|Overall Study|Physician Decision|0|||
147414661|NCT00821587|531682107|FG001|Overall Study|Physician Decision|1|||
147414662|NCT04488770|531682110|FG000|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
147414663|NCT04488770|531682111|FG001|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
147414664|NCT04488770|531682112|FG002|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
147414665|NCT04488770|531682113|FG003|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|1|||
147414666|NCT04488770|531682114|FG004|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
147414667|NCT04488770|531682115|FG005|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
147414668|NCT04488770|531682116|FG006|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
147414669|NCT04488770|531682117|FG007|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
147414670|NCT04488770|531682118|FG008|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
147414671|NCT04488770|531682119|FG009|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
147414672|NCT04488770|531682120|FG010|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
147414673|NCT04488770|531682121|FG011|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
147414674|NCT04488770|531682122|FG012|Part 1-Cohort 1: Period 1 (Up to 5 Days)|Adverse Event|0|||
147414675|NCT04488770|531682110|FG000|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|1|||
147414676|NCT04488770|531682111|FG001|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
147414677|NCT04488770|531682112|FG002|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
147414678|NCT04488770|531682113|FG003|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
147414679|NCT04488770|531682114|FG004|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
147414680|NCT04488770|531682115|FG005|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
147414681|NCT04488770|531682116|FG006|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
147414682|NCT04488770|531682117|FG007|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
147414683|NCT04488770|531682118|FG008|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
147414684|NCT04488770|531682119|FG009|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
147414685|NCT04488770|531682120|FG010|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
147414686|NCT04488770|531682121|FG011|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
147414687|NCT04488770|531682122|FG012|Part 1-Cohort 1: Period 3 (Up to 5 Days)|Adverse Event|0|||
147414688|NCT04488770|531682110|FG000|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
147414689|NCT04488770|531682111|FG001|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
147414690|NCT04488770|531682112|FG002|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
147414691|NCT04488770|531682113|FG003|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
147414692|NCT04488770|531682114|FG004|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
147414693|NCT04488770|531682115|FG005|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|1|||
147414694|NCT04488770|531682116|FG006|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|1|||
147471773|NCT03871491|531883022|FG001|Overall Study|Lost to Follow-up|15|||
147414695|NCT04488770|531682117|FG007|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
147414696|NCT04488770|531682118|FG008|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
147414697|NCT04488770|531682119|FG009|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
147414698|NCT04488770|531682120|FG010|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
147414699|NCT04488770|531682121|FG011|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
147414700|NCT04488770|531682122|FG012|Part 1-Cohort 2: Period 1 (Up to 5 Days)|Withdrawal by Subject|0|||
147414701|NCT04488770|531682110|FG000|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
147414702|NCT04488770|531682111|FG001|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
147414703|NCT04488770|531682112|FG002|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
147414704|NCT04488770|531682113|FG003|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
147414705|NCT04488770|531682114|FG004|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|1|||
147414706|NCT04488770|531682115|FG005|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
147414707|NCT04488770|531682116|FG006|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
147414708|NCT04488770|531682117|FG007|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
147414709|NCT04488770|531682118|FG008|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
147414710|NCT04488770|531682119|FG009|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
147414711|NCT04488770|531682120|FG010|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
147414712|NCT04488770|531682121|FG011|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
147414713|NCT04488770|531682122|FG012|Part 1-Cohort 2: Period 2 (Up to 5 Days)|Physician Decision|0|||
147414714|NCT01208103|531682123|FG000|Overall Study|Adverse Event|1|||
147414715|NCT01208103|531682123|FG000|Overall Study|Withdrawal by Subject|1|||
147414716|NCT02045875|531682124|FG000|Overall Study|Lost to Follow-up|3|||
147414717|NCT02045875|531682125|FG001|Overall Study|Lost to Follow-up|0|||
147414718|NCT02045875|531682124|FG000|Overall Study|Withdrawal by Subject|4|||
147414719|NCT02045875|531682125|FG001|Overall Study|Withdrawal by Subject|3|||
147414720|NCT01276379|531682126|FG000|Overall Study|Screening failure|40|||
147414721|NCT00864253|531682127|FG000|Overall Study|Adverse Event|56|||
147414722|NCT00864253|531682128|FG001|Overall Study|Adverse Event|11|||
147414723|NCT00864253|531682127|FG000|Overall Study|Unrelated Adverse Event|3|||
147414724|NCT00864253|531682128|FG001|Overall Study|Unrelated Adverse Event|1|||
147414725|NCT00864253|531682127|FG000|Overall Study|Physician Decision|11|||
147414726|NCT00864253|531682128|FG001|Overall Study|Physician Decision|15|||
147414727|NCT00864253|531682127|FG000|Overall Study|Protocol Violation|0|||
147414728|NCT00864253|531682128|FG001|Overall Study|Protocol Violation|2|||
147414729|NCT00864253|531682127|FG000|Overall Study|Lost to Follow-up|1|||
147414730|NCT00864253|531682128|FG001|Overall Study|Lost to Follow-up|1|||
147414731|NCT00864253|531682127|FG000|Overall Study|Withdrawal by Subject|18|||
147414732|NCT00864253|531682128|FG001|Overall Study|Withdrawal by Subject|18|||
147414733|NCT00864253|531682127|FG000|Overall Study|Death|1|||
147414734|NCT00864253|531682128|FG001|Overall Study|Death|0|||
147414735|NCT00864253|531682127|FG000|Overall Study|Ongoing|2|||
147414736|NCT00864253|531682128|FG001|Overall Study|Ongoing|3|||
147414737|NCT00864253|531682127|FG000|Overall Study|Untreated|7|||
147414738|NCT00864253|531682128|FG001|Overall Study|Untreated|7|||
147414739|NCT01111240|531682129|FG000|Overall Study|Adverse Event|190|||
147414740|NCT01111240|531682129|FG000|Overall Study|Lack of Efficacy|545|||
147414741|NCT01111240|531682129|FG000|Overall Study|Lack of Efficacy and Adverse Event|19|||
147414742|NCT01111240|531682129|FG000|Overall Study|Other|312|||
147414743|NCT01989169|531682130|FG000|Period 2|Adverse Event|0|||
147414744|NCT01989169|531682131|FG001|Period 2|Adverse Event|1|||
147414745|NCT01585155|531682132|FG000|Overall Study|Adverse Event|1|||
147414746|NCT01585155|531682132|FG000|Overall Study|Lack of Efficacy|2|||
147414747|NCT01585155|531682132|FG000|Overall Study|Worsening ulcerative colitis|2|||
147414748|NCT01743989|531682133|FG000|Treatment Phase|Unstable MR4.0|0|||
147414749|NCT01743989|531682134|FG001|Treatment Phase|Unstable MR4.0|6|||
147414750|NCT01743989|531682135|FG002|Treatment Phase|Unstable MR4.0|263|||
147414751|NCT01743989|531682133|FG000|Treatment Phase|Adverse Event|0|||
147414752|NCT01743989|531682134|FG001|Treatment Phase|Adverse Event|4|||
147414753|NCT01743989|531682135|FG002|Treatment Phase|Adverse Event|67|||
147414754|NCT01743989|531682133|FG000|Treatment Phase|Withdrawal by Subject|1|||
147414755|NCT01743989|531682134|FG001|Treatment Phase|Withdrawal by Subject|3|||
147414756|NCT01743989|531682135|FG002|Treatment Phase|Withdrawal by Subject|28|||
147414757|NCT01743989|531682133|FG000|Treatment Phase|Death|0|||
147414758|NCT01743989|531682134|FG001|Treatment Phase|Death|1|||
147414759|NCT01743989|531682135|FG002|Treatment Phase|Death|3|||
147471774|NCT03871491|531883023|FG002|Overall Study|Lost to Follow-up|36|||
147414760|NCT01743989|531682133|FG000|Treatment Phase|Abnormal laboratory value(s)|0|||
147414761|NCT01743989|531682134|FG001|Treatment Phase|Abnormal laboratory value(s)|0|||
147414762|NCT01743989|531682135|FG002|Treatment Phase|Abnormal laboratory value(s)|3|||
147414763|NCT01743989|531682133|FG000|Treatment Phase|Protocol deviation|0|||
147414764|NCT01743989|531682134|FG001|Treatment Phase|Protocol deviation|0|||
147414765|NCT01743989|531682135|FG002|Treatment Phase|Protocol deviation|3|||
147414766|NCT01743989|531682133|FG000|Treatment Phase|Pregnancy|0|||
147414767|NCT01743989|531682134|FG001|Treatment Phase|Pregnancy|0|||
147620199|NCT04429503|532427232|FG001|Extension Phase (Wk 96 to Wk 156)|Death|0|||
147620200|NCT04429503|532427233|FG002|Extension Phase (Wk 96 to Wk 156)|Death|0|||
147620201|NCT04429503|532427234|FG003|Extension Phase (Wk 96 to Wk 156)|Death|2|||
147620202|NCT04429503|532427235|FG004|Extension Phase (Wk 96 to Wk 156)|Death|7|||
147620203|NCT04429503|532427236|FG005|Extension Phase (Wk 96 to Wk 156)|Death|2|||
147620204|NCT05516108|532427237|FG000|Overall Study|Time Commitment|3|||
147620205|NCT05516108|532427238|FG001|Overall Study|Time Commitment|1|||
147620206|NCT05516108|532427237|FG000|Overall Study|Reason Unknown|2|||
147620207|NCT05516108|532427238|FG001|Overall Study|Reason Unknown|4|||
147620208|NCT00709995|532427239|FG000|Overall Study|Adverse Event|4|||
147620209|NCT00709995|532427240|FG001|Overall Study|Adverse Event|2|||
147620210|NCT00709995|532427239|FG000|Overall Study|Withdrawal by Subject|1|||
147620211|NCT00709995|532427240|FG001|Overall Study|Withdrawal by Subject|3|||
147620212|NCT02392481|532427241|FG000|Overall Study|Adverse Event|0|||
147620213|NCT02392481|532427242|FG001|Overall Study|Adverse Event|0|||
147620214|NCT02392481|532427243|FG002|Overall Study|Adverse Event|1|||
147620215|NCT02392481|532427244|FG003|Overall Study|Adverse Event|2|||
147620216|NCT02392481|532427241|FG000|Overall Study|Withdrawal by Subject|0|||
147620217|NCT02392481|532427242|FG001|Overall Study|Withdrawal by Subject|0|||
147620218|NCT02392481|532427243|FG002|Overall Study|Withdrawal by Subject|1|||
147620219|NCT02392481|532427244|FG003|Overall Study|Withdrawal by Subject|0|||
147620220|NCT03565900|532427245|FG000|Overall Study|Disposition Unknown|4|||
147620221|NCT03565900|532427246|FG001|Overall Study|Disposition Unknown|1|||
147620222|NCT03565900|532427245|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
147620223|NCT03565900|532427246|FG001|Overall Study|Withdrawal By Parent/Guardian|1|||
147620224|NCT03565900|532427245|FG000|Overall Study|Withdrawal by Subject|4|||
147620225|NCT03565900|532427246|FG001|Overall Study|Withdrawal by Subject|5|||
147620226|NCT03565900|532427245|FG000|Overall Study|Randomized By Mistake|0|||
147620227|NCT03565900|532427246|FG001|Overall Study|Randomized By Mistake|2|||
147620228|NCT03565900|532427245|FG000|Overall Study|Physician Decision|7|||
147620229|NCT03565900|532427246|FG001|Overall Study|Physician Decision|11|||
147620230|NCT03565900|532427245|FG000|Overall Study|Death|9|||
147620231|NCT03565900|532427246|FG001|Overall Study|Death|7|||
147620232|NCT02058069|532427249|FG000|Overall Study|Exclusion due to implant size|5|||
147620233|NCT02058069|532427249|FG000|Overall Study|Withdrawal by Subject|6|||
147620234|NCT02222922|532427250|FG000|Overall Study|Death|0|||
147620235|NCT02222922|532427251|FG001|Overall Study|Death|0|||
147620236|NCT02222922|532427252|FG002|Overall Study|Death|0|||
147620237|NCT02222922|532427253|FG003|Overall Study|Death|0|||
147620238|NCT02222922|532427254|FG004|Overall Study|Death|13|||
147620239|NCT02222922|532427255|FG005|Overall Study|Death|0|||
147620240|NCT02222922|532427256|FG006|Overall Study|Death|0|||
147620241|NCT02222922|532427257|FG007|Overall Study|Death|0|||
147620242|NCT02222922|532427258|FG008|Overall Study|Death|2|||
147620243|NCT02222922|532427250|FG000|Overall Study|Lost to Follow-up|0|||
147620244|NCT02222922|532427251|FG001|Overall Study|Lost to Follow-up|0|||
147620245|NCT02222922|532427252|FG002|Overall Study|Lost to Follow-up|1|||
147620246|NCT02222922|532427253|FG003|Overall Study|Lost to Follow-up|0|||
147620247|NCT02222922|532427254|FG004|Overall Study|Lost to Follow-up|9|||
147620248|NCT02222922|532427255|FG005|Overall Study|Lost to Follow-up|1|||
147620249|NCT02222922|532427256|FG006|Overall Study|Lost to Follow-up|0|||
147620250|NCT02222922|532427257|FG007|Overall Study|Lost to Follow-up|0|||
147620251|NCT02222922|532427258|FG008|Overall Study|Lost to Follow-up|0|||
147620252|NCT02222922|532427250|FG000|Overall Study|Other|0|||
147620253|NCT02222922|532427251|FG001|Overall Study|Other|0|||
147620254|NCT02222922|532427252|FG002|Overall Study|Other|0|||
147620255|NCT02222922|532427253|FG003|Overall Study|Other|2|||
147620256|NCT02222922|532427254|FG004|Overall Study|Other|10|||
147620257|NCT02222922|532427255|FG005|Overall Study|Other|2|||
147620258|NCT02222922|532427256|FG006|Overall Study|Other|2|||
147620259|NCT02222922|532427257|FG007|Overall Study|Other|4|||
147620260|NCT02222922|532427258|FG008|Overall Study|Other|1|||
147620261|NCT02222922|532427250|FG000|Overall Study|Participant refused further follow-up|1|||
147620262|NCT02222922|532427251|FG001|Overall Study|Participant refused further follow-up|0|||
147620263|NCT02222922|532427252|FG002|Overall Study|Participant refused further follow-up|0|||
147620264|NCT02222922|532427253|FG003|Overall Study|Participant refused further follow-up|1|||
147620265|NCT02222922|532427254|FG004|Overall Study|Participant refused further follow-up|6|||
147620266|NCT02222922|532427255|FG005|Overall Study|Participant refused further follow-up|0|||
147620267|NCT02222922|532427256|FG006|Overall Study|Participant refused further follow-up|0|||
147620268|NCT02222922|532427257|FG007|Overall Study|Participant refused further follow-up|0|||
147665978|NCT05222880|532601661|FG000|Overall Study|Withdrew Consent during Study|1|||
147414768|NCT01743989|531682135|FG002|Treatment Phase|Pregnancy|2|||
147620269|NCT02222922|532427258|FG008|Overall Study|Participant refused further follow-up|3|||
147620270|NCT01254643|532427259|FG000|Overall Study|Withdrawal by Subject|1|||
147620271|NCT03359850|532427260|FG000|PK Phase (Up to Day 8)|Physician Decision|0|||
147620272|NCT03359850|532427261|FG001|PK Phase (Up to Day 8)|Physician Decision|1|||
147620273|NCT03359850|532427260|FG000|PK Phase (Up to Day 8)|Adverse Event|1|||
147620274|NCT03359850|532427261|FG001|PK Phase (Up to Day 8)|Adverse Event|0|||
147414769|NCT01743989|531682133|FG000|Treatment Phase|Lost to Follow-up|0|||
147471775|NCT03871491|531883024|FG003|Overall Study|Lost to Follow-up|11|||
147471776|NCT04996797|531883025|FG000|Overall Study|Adverse Event|0|||
147471777|NCT04996797|531883026|FG001|Overall Study|Adverse Event|2|||
147471778|NCT04996797|531883027|FG002|Overall Study|Adverse Event|0|||
147414770|NCT01743989|531682134|FG001|Treatment Phase|Lost to Follow-up|0|||
147414771|NCT01743989|531682135|FG002|Treatment Phase|Lost to Follow-up|2|||
147414772|NCT01743989|531682133|FG000|Treatment Phase|Abnormal test procedure result(s)|0|||
147414773|NCT01743989|531682134|FG001|Treatment Phase|Abnormal test procedure result(s)|0|||
147414774|NCT01743989|531682135|FG002|Treatment Phase|Abnormal test procedure result(s)|1|||
147414775|NCT01743989|531682133|FG000|Treatment Phase|Administrative problems|0|||
147414776|NCT01743989|531682134|FG001|Treatment Phase|Administrative problems|0|||
147414777|NCT01743989|531682135|FG002|Treatment Phase|Administrative problems|1|||
147414778|NCT01743989|531682133|FG000|Treatment Phase|New cancer (CML) therapy|0|||
147414779|NCT01743989|531682134|FG001|Treatment Phase|New cancer (CML) therapy|1|||
147414780|NCT01743989|531682135|FG002|Treatment Phase|New cancer (CML) therapy|0|||
147414781|NCT01743989|531682133|FG000|Treatment Phase|Physician Decision|0|||
147414782|NCT01743989|531682134|FG001|Treatment Phase|Physician Decision|0|||
147414783|NCT01743989|531682135|FG002|Treatment Phase|Physician Decision|3|||
147414784|NCT01743989|531682133|FG000|Treatment Phase|Patient non-compliance to treatment|0|||
147414785|NCT01743989|531682134|FG001|Treatment Phase|Patient non-compliance to treatment|0|||
147414786|NCT01743989|531682135|FG002|Treatment Phase|Patient non-compliance to treatment|3|||
147414787|NCT01743989|531682133|FG000|Treatment Phase|Not randomized by mistake|0|||
147414788|NCT01743989|531682134|FG001|Treatment Phase|Not randomized by mistake|0|||
147414789|NCT01743989|531682135|FG002|Treatment Phase|Not randomized by mistake|1|||
147414790|NCT01743989|531682133|FG000|Treatment Phase|Included by mistake|0|||
147414791|NCT01743989|531682134|FG001|Treatment Phase|Included by mistake|0|||
147414792|NCT01743989|531682135|FG002|Treatment Phase|Included by mistake|1|||
147414793|NCT01743989|531682133|FG000|TFR Phase|Relapse (Loss of MMR/Confirmed loss of MR4.0)|82|||
147414794|NCT01743989|531682134|FG001|TFR Phase|Relapse (Loss of MMR/Confirmed loss of MR4.0)|59|||
147414795|NCT01743989|531682135|FG002|TFR Phase|Relapse (Loss of MMR/Confirmed loss of MR4.0)|0|||
147414796|NCT01743989|531682133|FG000|TFR Phase|Adverse Event|0|||
147414797|NCT01743989|531682134|FG001|TFR Phase|Adverse Event|1|||
147414798|NCT01743989|531682135|FG002|TFR Phase|Adverse Event|0|||
147414799|NCT01743989|531682133|FG000|TFR Phase|Lost to Follow-up|0|||
147414800|NCT01743989|531682134|FG001|TFR Phase|Lost to Follow-up|2|||
147414801|NCT01743989|531682135|FG002|TFR Phase|Lost to Follow-up|0|||
147414802|NCT01743989|531682133|FG000|TFR Phase|Physician Decision|0|||
147414803|NCT01743989|531682134|FG001|TFR Phase|Physician Decision|1|||
147414804|NCT01743989|531682135|FG002|TFR Phase|Physician Decision|0|||
147414805|NCT01743989|531682133|FG000|TFR Phase|Logistical problems|0|||
147414806|NCT01743989|531682134|FG001|TFR Phase|Logistical problems|2|||
147414807|NCT01743989|531682135|FG002|TFR Phase|Logistical problems|0|||
147414808|NCT01743989|531682133|FG000|TFR Phase|Protocol deviation|0|||
147414809|NCT01743989|531682134|FG001|TFR Phase|Protocol deviation|1|||
147414810|NCT01743989|531682135|FG002|TFR Phase|Protocol deviation|0|||
147414811|NCT01743989|531682133|FG000|TFR Phase|Withdrawal by Subject|0|||
147414812|NCT01743989|531682134|FG001|TFR Phase|Withdrawal by Subject|2|||
147414813|NCT01743989|531682135|FG002|TFR Phase|Withdrawal by Subject|0|||
147414814|NCT01743989|531682133|FG000|Re-treatment Phase|Adverse Event|8|||
147414815|NCT01743989|531682134|FG001|Re-treatment Phase|Adverse Event|4|||
147414816|NCT01743989|531682135|FG002|Re-treatment Phase|Adverse Event|0|||
147414817|NCT01743989|531682133|FG000|Re-treatment Phase|Death|1|||
147414818|NCT01743989|531682134|FG001|Re-treatment Phase|Death|1|||
147414819|NCT01743989|531682135|FG002|Re-treatment Phase|Death|0|||
147414820|NCT01743989|531682133|FG000|Re-treatment Phase|Administrative problems|1|||
147414821|NCT01743989|531682134|FG001|Re-treatment Phase|Administrative problems|1|||
147620275|NCT03359850|532427260|FG000|Extension Phase (Up to 28 Months)|Death|2|||
147414822|NCT01743989|531682135|FG002|Re-treatment Phase|Administrative problems|0|||
147414823|NCT01743989|531682133|FG000|Re-treatment Phase|Withdrawal by Subject|5|||
147414824|NCT01743989|531682134|FG001|Re-treatment Phase|Withdrawal by Subject|1|||
147471779|NCT04996797|531883028|FG003|Overall Study|Adverse Event|1|||
147471780|NCT04996797|531883025|FG000|Overall Study|Lack of Efficacy|0|||
147471781|NCT04996797|531883026|FG001|Overall Study|Lack of Efficacy|2|||
147471782|NCT04996797|531883027|FG002|Overall Study|Lack of Efficacy|0|||
147471783|NCT04996797|531883028|FG003|Overall Study|Lack of Efficacy|0|||
147471784|NCT04996797|531883025|FG000|Overall Study|Prohibited Medication|0|||
147471785|NCT04996797|531883026|FG001|Overall Study|Prohibited Medication|1|||
147471786|NCT04996797|531883027|FG002|Overall Study|Prohibited Medication|0|||
147414825|NCT01743989|531682135|FG002|Re-treatment Phase|Withdrawal by Subject|0|||
147414826|NCT01743989|531682133|FG000|Re-treatment Phase|Unstable MR|1|||
147414827|NCT01743989|531682134|FG001|Re-treatment Phase|Unstable MR|0|||
147414828|NCT01743989|531682135|FG002|Re-treatment Phase|Unstable MR|0|||
147414829|NCT01743989|531682133|FG000|Re-treatment Phase|Physician Decision|0|||
147471787|NCT04996797|531883028|FG003|Overall Study|Prohibited Medication|0|||
147471788|NCT04996797|531883025|FG000|Overall Study|Ongoing|68|||
147620276|NCT03359850|532427261|FG001|Extension Phase (Up to 28 Months)|Death|4|||
147471789|NCT04996797|531883026|FG001|Overall Study|Ongoing|60|||
147471790|NCT04996797|531883027|FG002|Overall Study|Ongoing|22|||
147471791|NCT04996797|531883028|FG003|Overall Study|Ongoing|20|||
147471792|NCT04996797|531883025|FG000|Overall Study|Withdrawal by Subject|0|||
147471793|NCT04996797|531883026|FG001|Overall Study|Withdrawal by Subject|2|||
147471794|NCT04996797|531883027|FG002|Overall Study|Withdrawal by Subject|0|||
147471795|NCT04996797|531883028|FG003|Overall Study|Withdrawal by Subject|0|||
147471796|NCT02793544|531883029|FG000|Overall Study|Death|10|||
147471797|NCT02793544|531883030|FG001|Overall Study|Death|8|||
147471798|NCT02793544|531883029|FG000|Overall Study|Lost to Follow-up|2|||
147471799|NCT02793544|531883030|FG001|Overall Study|Lost to Follow-up|0|||
147471800|NCT02793544|531883029|FG000|Overall Study|Withdrawal by Subject|1|||
147471801|NCT02793544|531883030|FG001|Overall Study|Withdrawal by Subject|0|||
147471802|NCT02495948|531883035|FG000|Period 1, First 30 Days of Wear|Adverse Event|0|||
147471803|NCT02495948|531883036|FG001|Period 1, First 30 Days of Wear|Adverse Event|1|||
147471804|NCT02495948|531883035|FG000|Period 2, Second 30 Days of Wear|Withdrawal by Subject|1|||
147471805|NCT02495948|531883036|FG001|Period 2, Second 30 Days of Wear|Withdrawal by Subject|1|||
147471806|NCT01444300|531883038|FG000|Overall Study|Adverse Event|4|||
147471807|NCT01444300|531883039|FG001|Overall Study|Adverse Event|0|||
147471808|NCT04826900|531883040|FG000|Overall Study|Family factor|1|||
147471809|NCT04826900|531883041|FG001|Overall Study|Family factor|1|||
147471810|NCT04885257|531883042|FG000|Overall Study|Withdrawal by Subject|1|||
147471811|NCT04885257|531883043|FG001|Overall Study|Withdrawal by Subject|0|||
147471812|NCT02597062|531883044|FG000|Overall Study|Ineligible|1|||
147471813|NCT01708057|531883045|FG000|Overall Study|Withdrawal due to study termination.|1|||
147471814|NCT01708057|531883046|FG001|Overall Study|Withdrawal due to study termination.|1|||
147471815|NCT01708057|531883047|FG002|Overall Study|Withdrawal due to study termination.|1|||
147471816|NCT01697345|531883048|FG000|Overall Study|Withdrawal by Subject|1|||
147471817|NCT02970929|531883049|FG000|Overall Study|Adverse Event|18|||
147471818|NCT02970929|531883049|FG000|Overall Study|Lack of Efficacy|8|||
147471819|NCT02970929|531883049|FG000|Overall Study|NON-COMPLIANCE WITH STUDY DRUG|1|||
147471820|NCT02970929|531883049|FG000|Overall Study|INVESTIGATOR CONSIDERS SUBJECT CLINICALLY UNSTABLE, NOT APPROPRIATE FOR DISCHARGE TO AN OUTPATIENT|1|||
147471821|NCT02970929|531883049|FG000|Overall Study|SPONSOR REQUEST THAT SUBJECT BE WITHDRAWN DUE TO POSITIVE DRUG RESULTS AND FOR THE SUBJECT'S SAFETY|1|||
147471822|NCT02970929|531883049|FG000|Overall Study|LOST TO FOLLOWUP|6|||
147471823|NCT02970929|531883049|FG000|Overall Study|MOVED OUT OF STATE|1|||
147471824|NCT02970929|531883049|FG000|Overall Study|Withdrawal by Subject|16|||
147471825|NCT02382133|531883052|FG000|Overall Study|Death|22|||
147471826|NCT02382133|531883052|FG000|Overall Study|transfer out of ICU|4|||
147471827|NCT02382133|531883052|FG000|Overall Study|Physician Decision|2|||
147471828|NCT02382133|531883052|FG000|Overall Study|arterial catheter loss|4|||
147471829|NCT02382133|531883052|FG000|Overall Study|pressure injury both sites|1|||
147471830|NCT02370121|531883059|FG000|Overall Study|Lost to Follow-up|1|||
147471831|NCT02370121|531883060|FG001|Overall Study|Lost to Follow-up|1|||
147471832|NCT03929250|531883065|FG000|Overall Study|Blood draws could not be successfully obtained|0|||
147471833|NCT03929250|531883066|FG001|Overall Study|Blood draws could not be successfully obtained|1|||
147471834|NCT05262764|531883068|FG000|Overall Study|Case report form not collected|9|||
147471835|NCT05262764|531883068|FG000|Overall Study|No patient visits after entry|23|||
147471836|NCT05262764|531883068|FG000|Overall Study|Registration rule not followed|2|||
147665979|NCT05222880|532601661|FG000|Overall Study|COVID-19 Related|1|||
147414830|NCT01743989|531682134|FG001|Re-treatment Phase|Physician Decision|1|||
147414831|NCT01743989|531682135|FG002|Re-treatment Phase|Physician Decision|0|||
147414832|NCT01743989|531682133|FG000|Re-treatment Phase|Lost to Follow-up|0|||
147414833|NCT01743989|531682134|FG001|Re-treatment Phase|Lost to Follow-up|1|||
147414834|NCT01743989|531682135|FG002|Re-treatment Phase|Lost to Follow-up|0|||
147414835|NCT02235311|531682140|FG000|Overall Study|Lost to Follow-up|0|||
147414836|NCT02235311|531682141|FG001|Overall Study|Lost to Follow-up|1|||
147414837|NCT02235311|531682140|FG000|Overall Study|Protocol Violation|0|||
147414838|NCT02235311|531682141|FG001|Overall Study|Protocol Violation|1|||
147414839|NCT04655027|531682142|FG000|Overall Study|Failure to meet inclusion/exclusion criteria/ Due to COVID-19 pandemic|1|||
147414840|NCT04655027|531682143|FG001|Overall Study|Failure to meet inclusion/exclusion criteria/ Due to COVID-19 pandemic|0|||
147414841|NCT00658788|531682144|FG000|Overall Study|Adverse Event|11|||
147414842|NCT00658788|531682144|FG000|Overall Study|Withdrawal by Subject|13|||
147414843|NCT00658788|531682144|FG000|Overall Study|Lost to Follow-up|18|||
147414844|NCT00658788|531682144|FG000|Overall Study|Treatment Discontinuation|32|||
147414845|NCT00653523|531682145|FG000|Overall Study|Drop in low density lipoprotein (1)|2|||
147414846|NCT00653523|531682145|FG000|Overall Study|Elevated creatine phosphokinase (2)|1|||
147414847|NCT00653523|531682145|FG000|Overall Study|Adverse Event|7|||
147414848|NCT00653523|531682145|FG000|Overall Study|Withdrawal by Subject|6|||
147414849|NCT00653523|531682145|FG000|Overall Study|Elevated alanine aminotransferase (3)|2|||
147471837|NCT05262764|531883068|FG000|Overall Study|Patient of non-chronic heart failure|1|||
147471838|NCT01392183|531883069|FG000|First Drug Administration|Adverse Event|3|||
147471839|NCT01392183|531883070|FG001|First Drug Administration|Adverse Event|2|||
147471840|NCT01392183|531883069|FG000|First Drug Administration|Death|1|||
147665980|NCT03327324|532601666|FG000|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|0|||
147665981|NCT03327324|532601667|FG001|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|1|||
147665982|NCT03327324|532601668|FG002|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|0|||
147665983|NCT03327324|532601669|FG003|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|1|||
147665984|NCT03327324|532601670|FG004|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|0|||
147665985|NCT03327324|532601671|FG005|Baseline (Month 0-Month 3)|Incomplete (participant did not complete all data items collected during study visit)|5|||
147665986|NCT03327324|532601666|FG000|Baseline (Month 0-Month 3)|Refused|0|||
147665987|NCT03327324|532601667|FG001|Baseline (Month 0-Month 3)|Refused|0|||
147665988|NCT03327324|532601668|FG002|Baseline (Month 0-Month 3)|Refused|0|||
147665989|NCT03327324|532601669|FG003|Baseline (Month 0-Month 3)|Refused|0|||
147665990|NCT03327324|532601670|FG004|Baseline (Month 0-Month 3)|Refused|1|||
147665991|NCT03327324|532601671|FG005|Baseline (Month 0-Month 3)|Refused|0|||
147665992|NCT03327324|532601666|FG000|Baseline (Month 0-Month 3)|Withdrawal by Subject|0|||
147665993|NCT03327324|532601667|FG001|Baseline (Month 0-Month 3)|Withdrawal by Subject|2|||
147665994|NCT03327324|532601668|FG002|Baseline (Month 0-Month 3)|Withdrawal by Subject|0|||
147665995|NCT03327324|532601669|FG003|Baseline (Month 0-Month 3)|Withdrawal by Subject|0|||
147665996|NCT03327324|532601670|FG004|Baseline (Month 0-Month 3)|Withdrawal by Subject|0|||
147665997|NCT03327324|532601671|FG005|Baseline (Month 0-Month 3)|Withdrawal by Subject|0|||
147665998|NCT03327324|532601666|FG000|Baseline (Month 0-Month 3)|Death|0|||
147665999|NCT03327324|532601667|FG001|Baseline (Month 0-Month 3)|Death|0|||
147666000|NCT03327324|532601668|FG002|Baseline (Month 0-Month 3)|Death|0|||
147666001|NCT03327324|532601669|FG003|Baseline (Month 0-Month 3)|Death|0|||
147666002|NCT03327324|532601670|FG004|Baseline (Month 0-Month 3)|Death|1|||
147666003|NCT03327324|532601671|FG005|Baseline (Month 0-Month 3)|Death|0|||
147666004|NCT03327324|532601666|FG000|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
147666005|NCT03327324|532601667|FG001|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
147666006|NCT03327324|532601668|FG002|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
147666007|NCT03327324|532601669|FG003|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
147666008|NCT03327324|532601670|FG004|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
147666009|NCT03327324|532601671|FG005|Baseline (Month 0-Month 3)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|1|||
147666010|NCT03327324|532601666|FG000|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|0|||
147666011|NCT03327324|532601667|FG001|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|0|||
147666012|NCT03327324|532601668|FG002|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|1|||
147666013|NCT03327324|532601669|FG003|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|0|||
147666014|NCT03327324|532601670|FG004|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|0|||
147666015|NCT03327324|532601671|FG005|Intervention (Month 3-Month 6)|Incomplete (participant did not complete all data items collected during study visit)|0|||
147666016|NCT03327324|532601666|FG000|Intervention (Month 3-Month 6)|Withdrawal by Subject|2|||
147666017|NCT03327324|532601667|FG001|Intervention (Month 3-Month 6)|Withdrawal by Subject|1|||
147666018|NCT03327324|532601668|FG002|Intervention (Month 3-Month 6)|Withdrawal by Subject|1|||
147666019|NCT03327324|532601669|FG003|Intervention (Month 3-Month 6)|Withdrawal by Subject|0|||
147666020|NCT03327324|532601670|FG004|Intervention (Month 3-Month 6)|Withdrawal by Subject|1|||
147471841|NCT01392183|531883070|FG001|First Drug Administration|Death|0|||
147620277|NCT03359850|532427260|FG000|Extension Phase (Up to 28 Months)|Withdrawal by Subject|1|||
147620278|NCT03359850|532427261|FG001|Extension Phase (Up to 28 Months)|Withdrawal by Subject|2|||
147620279|NCT03359850|532427260|FG000|Extension Phase (Up to 28 Months)|Disease Progression|5|||
147620280|NCT03359850|532427261|FG001|Extension Phase (Up to 28 Months)|Disease Progression|0|||
147620281|NCT03817125|532427279|FG000|Overall Study|Adverse Event|1|||
147620282|NCT03817125|532427280|FG001|Overall Study|Adverse Event|0|||
147620283|NCT03817125|532427279|FG000|Overall Study|Physician Decision|0|||
147620284|NCT03817125|532427280|FG001|Overall Study|Physician Decision|1|||
147620285|NCT03817125|532427279|FG000|Overall Study|Lack of Efficacy|1|||
147620286|NCT03817125|532427280|FG001|Overall Study|Lack of Efficacy|5|||
147620287|NCT02002221|532427281|FG000|Overall Study|Adverse Event|2|||
147620288|NCT02002221|532427282|FG001|Overall Study|Adverse Event|1|||
147620289|NCT02002221|532427281|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
147620290|NCT02002221|532427282|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
147620291|NCT02002221|532427281|FG000|Overall Study|Patient withdrew consent|0|||
147471842|NCT01392183|531883069|FG000|First Drug Administration|Withdrawal by Subject|10|||
147620292|NCT02002221|532427282|FG001|Overall Study|Patient withdrew consent|1|||
147620293|NCT00942084|532427283|FG000|Overall Study|Death|2|||
147620294|NCT01037218|532427287|FG000|Overall Study|Adverse Event|4|||
147471843|NCT01392183|531883070|FG001|First Drug Administration|Withdrawal by Subject|17|||
147471844|NCT00045032|531883076|FG000|Overall Study|Adverse Event/Intercurrent Illness|2|||
147471845|NCT00045032|531883077|FG001|Overall Study|Adverse Event/Intercurrent Illness|2|||
147471846|NCT00045032|531883078|FG002|Overall Study|Adverse Event/Intercurrent Illness|7|||
147471847|NCT00045032|531883076|FG000|Overall Study|Death|22|||
147471848|NCT00045032|531883077|FG001|Overall Study|Death|24|||
147471849|NCT00045032|531883078|FG002|Overall Study|Death|17|||
147471850|NCT00045032|531883076|FG000|Overall Study|Insufficient Therapeutic Response|542|||
147471851|NCT00045032|531883077|FG001|Overall Study|Insufficient Therapeutic Response|437|||
147471852|NCT00045032|531883078|FG002|Overall Study|Insufficient Therapeutic Response|445|||
147471853|NCT00045032|531883076|FG000|Overall Study|Violation of Selection Criteria at Entry|3|||
147471854|NCT00045032|531883077|FG001|Overall Study|Violation of Selection Criteria at Entry|6|||
147471855|NCT00045032|531883078|FG002|Overall Study|Violation of Selection Criteria at Entry|6|||
147471856|NCT00045032|531883076|FG000|Overall Study|Other Protocol Violation|2|||
147471857|NCT00045032|531883077|FG001|Overall Study|Other Protocol Violation|0|||
147471858|NCT00045032|531883078|FG002|Overall Study|Other Protocol Violation|1|||
147471859|NCT00045032|531883076|FG000|Overall Study|Refused/Did Not Cooperate/Withdrew|142|||
147471860|NCT00045032|531883077|FG001|Overall Study|Refused/Did Not Cooperate/Withdrew|93|||
147471861|NCT00045032|531883078|FG002|Overall Study|Refused/Did Not Cooperate/Withdrew|84|||
147471862|NCT00045032|531883076|FG000|Overall Study|Failure to Return|57|||
147471863|NCT00045032|531883077|FG001|Overall Study|Failure to Return|62|||
147471864|NCT00045032|531883078|FG002|Overall Study|Failure to Return|61|||
147471865|NCT00045032|531883076|FG000|Overall Study|Other|93|||
147471866|NCT00045032|531883077|FG001|Overall Study|Other|84|||
147471867|NCT00045032|531883078|FG002|Overall Study|Other|105|||
147471868|NCT02582658|531883079|FG000|Overall Study|Failure to Return|10|||
147471869|NCT02582658|531883079|FG000|Overall Study|Insufficient Virological Response|2|||
147471870|NCT02582658|531883079|FG000|Overall Study|Withdrawn Consent|1|||
147471871|NCT02582658|531883079|FG000|Overall Study|Death|1|||
147471872|NCT02582658|531883079|FG000|Overall Study|Not further specified|11|||
147471873|NCT03277196|531883083|FG000|Overall Study|Commercial Drug is Available for Participants|20|||
147471874|NCT03277196|531883083|FG000|Overall Study|Lost to Follow-up|3|||
147471875|NCT03277196|531883083|FG000|Overall Study|Withdrawal of Consent (not due to AE)|3|||
147471876|NCT03277196|531883083|FG000|Overall Study|Other|2|||
147471877|NCT00686205|531884585|FG000|Overall Study|Protocol Violation|127|||
147471878|NCT00686205|531884586|FG001|Overall Study|Protocol Violation|0|||
147471879|NCT00686205|531884585|FG000|Overall Study|Withdrawal by Subject|2|||
147471880|NCT00686205|531884586|FG001|Overall Study|Withdrawal by Subject|0|||
147471881|NCT00686205|531884585|FG000|Overall Study|Specimen handling procedure altered|5878|||
147471882|NCT00686205|531884586|FG001|Overall Study|Specimen handling procedure altered|0|||
147471883|NCT00686205|531884585|FG000|Overall Study|Specimens not confirmed HIV positive|0|||
147471884|NCT00686205|531884586|FG001|Overall Study|Specimens not confirmed HIV positive|981|||
147471885|NCT00265941|531884587|FG000|Overall Study|Protocol Violation|22|||
147471886|NCT00265941|531884588|FG001|Overall Study|Protocol Violation|25|||
147471887|NCT00265941|531884587|FG000|Overall Study|Lost to Follow-up|1|||
147471888|NCT00265941|531884588|FG001|Overall Study|Lost to Follow-up|1|||
147471889|NCT03976401|531884589|FG000|Overall Study|Adverse Event|2|||
147471890|NCT03976401|531884590|FG001|Overall Study|Adverse Event|0|||
147471891|NCT03976401|531884591|FG002|Overall Study|Adverse Event|4|||
147471892|NCT03976401|531884592|FG003|Overall Study|Adverse Event|1|||
147471893|NCT03976401|531884593|FG004|Overall Study|Adverse Event|1|||
147471894|NCT03976401|531884594|FG005|Overall Study|Adverse Event|0|||
147414850|NCT00653523|531682145|FG000|Overall Study|Adverse reaction did not improve (4)|1|||
147414851|NCT03519997|531682148|FG000|Overall Study|Adverse Event|4|||
147414852|NCT03519997|531682148|FG000|Overall Study|Withdrawal by Subject|2|||
147414853|NCT03519997|531682148|FG000|Overall Study|Protocol Violation|1|||
147414854|NCT05543707|531682149|FG000|Overall Study|Study drug non-compliance/|5|||
147414855|NCT05543707|531682150|FG001|Overall Study|Study drug non-compliance/|0|||
147414856|NCT05543707|531682149|FG000|Overall Study|Withdrawal by Subject|1|||
147471895|NCT03976401|531884589|FG000|Overall Study|Withdrawal by Subject|0|||
147471896|NCT03976401|531884590|FG001|Overall Study|Withdrawal by Subject|1|||
147471897|NCT03976401|531884591|FG002|Overall Study|Withdrawal by Subject|0|||
147471898|NCT03976401|531884592|FG003|Overall Study|Withdrawal by Subject|0|||
147471899|NCT03976401|531884593|FG004|Overall Study|Withdrawal by Subject|0|||
147471900|NCT03976401|531884594|FG005|Overall Study|Withdrawal by Subject|1|||
147471901|NCT03976401|531884589|FG000|Overall Study|Physician Decision|0|||
147471902|NCT03976401|531884590|FG001|Overall Study|Physician Decision|0|||
147471903|NCT03976401|531884591|FG002|Overall Study|Physician Decision|1|||
147471904|NCT03976401|531884592|FG003|Overall Study|Physician Decision|0|||
147414857|NCT05543707|531682150|FG001|Overall Study|Withdrawal by Subject|1|||
147414858|NCT05543707|531682149|FG000|Overall Study|Adverse Event|1|||
147414859|NCT05543707|531682150|FG001|Overall Study|Adverse Event|0|||
147414860|NCT05543707|531682149|FG000|Overall Study|concurrent illness|0|||
147471905|NCT03976401|531884593|FG004|Overall Study|Physician Decision|0|||
147471906|NCT03976401|531884594|FG005|Overall Study|Physician Decision|0|||
147471907|NCT03976401|531884589|FG000|Overall Study|Lost to Follow-up|1|||
147471908|NCT03976401|531884590|FG001|Overall Study|Lost to Follow-up|2|||
147471909|NCT03976401|531884591|FG002|Overall Study|Lost to Follow-up|0|||
147471910|NCT03976401|531884592|FG003|Overall Study|Lost to Follow-up|0|||
147471911|NCT03976401|531884593|FG004|Overall Study|Lost to Follow-up|0|||
147471912|NCT03976401|531884594|FG005|Overall Study|Lost to Follow-up|0|||
147471913|NCT03976401|531884589|FG000|Overall Study|Protocol Violation|0|||
147471914|NCT03976401|531884590|FG001|Overall Study|Protocol Violation|1|||
147471915|NCT03976401|531884591|FG002|Overall Study|Protocol Violation|0|||
147471916|NCT03976401|531884592|FG003|Overall Study|Protocol Violation|0|||
147471917|NCT03976401|531884593|FG004|Overall Study|Protocol Violation|0|||
147471918|NCT03976401|531884594|FG005|Overall Study|Protocol Violation|0|||
147471919|NCT03976401|531884589|FG000|Overall Study|Withdrew Consent|0|||
147471920|NCT03976401|531884590|FG001|Overall Study|Withdrew Consent|0|||
147471921|NCT03976401|531884591|FG002|Overall Study|Withdrew Consent|0|||
147471922|NCT03976401|531884592|FG003|Overall Study|Withdrew Consent|1|||
147471923|NCT03976401|531884593|FG004|Overall Study|Withdrew Consent|0|||
147471924|NCT03976401|531884594|FG005|Overall Study|Withdrew Consent|0|||
147471925|NCT00942409|531884595|FG000|Overall Study|Lack of Efficacy|1|||
147471926|NCT00942409|531884595|FG000|Overall Study|study drug unavailable|2|||
147471927|NCT02015819|531884596|FG000|Overall Study|Rickham catheter was misaligned|0|||
147471928|NCT02015819|531884597|FG001|Overall Study|Rickham catheter was misaligned|0|||
147471929|NCT02015819|531884598|FG002|Overall Study|Rickham catheter was misaligned|0|||
147471930|NCT02015819|531884599|FG003|Overall Study|Rickham catheter was misaligned|1|||
147471931|NCT01697215|531884602|FG000|Overall Study|Physician Decision|5|||
147471932|NCT01697215|531884602|FG000|Overall Study|Malfunction|9|||
147471933|NCT01697215|531884602|FG000|Overall Study|CXR not available|9|||
147471934|NCT00466505|531884604|FG000|Overall Study|disease progression|13|||
147471935|NCT00466505|531884604|FG000|Overall Study|Adverse Event|4|||
147471936|NCT02886715|531884605|FG000|Overall Study|Non-Compliance With Study Drug|0|||
147471937|NCT02886715|531884606|FG001|Overall Study|Non-Compliance With Study Drug|2|||
147471938|NCT02886715|531884607|FG002|Overall Study|Non-Compliance With Study Drug|0|||
147471939|NCT02886715|531884605|FG000|Overall Study|Adverse Event|4|||
147471940|NCT02886715|531884606|FG001|Overall Study|Adverse Event|2|||
147471941|NCT02886715|531884607|FG002|Overall Study|Adverse Event|0|||
147471942|NCT02886715|531884605|FG000|Overall Study|Lack of Efficacy|0|||
147471943|NCT02886715|531884606|FG001|Overall Study|Lack of Efficacy|2|||
147471944|NCT02886715|531884607|FG002|Overall Study|Lack of Efficacy|1|||
147471945|NCT02886715|531884605|FG000|Overall Study|Lost to Follow-up|29|||
147471946|NCT02886715|531884606|FG001|Overall Study|Lost to Follow-up|26|||
147471947|NCT02886715|531884607|FG002|Overall Study|Lost to Follow-up|10|||
147471948|NCT02886715|531884605|FG000|Overall Study|Pregnancy|1|||
147471949|NCT02886715|531884606|FG001|Overall Study|Pregnancy|1|||
147471950|NCT02886715|531884607|FG002|Overall Study|Pregnancy|1|||
147471951|NCT02886715|531884605|FG000|Overall Study|Protocol Violation|3|||
147471952|NCT02886715|531884606|FG001|Overall Study|Protocol Violation|2|||
147471953|NCT02886715|531884607|FG002|Overall Study|Protocol Violation|1|||
147471954|NCT02886715|531884605|FG000|Overall Study|Withdrawal by Subject|20|||
147471955|NCT02886715|531884606|FG001|Overall Study|Withdrawal by Subject|18|||
147471956|NCT02886715|531884607|FG002|Overall Study|Withdrawal by Subject|5|||
147471957|NCT02886715|531884605|FG000|Overall Study|missing|7|||
147471958|NCT02886715|531884606|FG001|Overall Study|missing|2|||
147471959|NCT02886715|531884607|FG002|Overall Study|missing|2|||
147471960|NCT01676961|531884608|FG000|Overall Study|Death|3|||
147471961|NCT01676961|531884608|FG000|Overall Study|Lost to Follow-up|1|||
147471962|NCT01676961|531884608|FG000|Overall Study|Withdrawal by Subject|1|||
147471963|NCT03812510|531884609|FG000|Overall Study|Lost to Follow-up|39|||
147471964|NCT03812510|531884609|FG000|Overall Study|Withdrawal by Subject|42|||
147471965|NCT03812510|531884609|FG000|Overall Study|Physician Decision|2|||
147471966|NCT03812510|531884609|FG000|Overall Study|Study Terminated by Sponsor|9|||
147471967|NCT03812510|531884609|FG000|Overall Study|Did Not Start Study Medication|55|||
147471968|NCT03812510|531884609|FG000|Overall Study|Adverse Event|5|||
147471969|NCT00768560|531884612|FG000|Intervention Set 1|Adverse Event|0|||
147471970|NCT00768560|531884613|FG001|Intervention Set 1|Adverse Event|1|||
147471971|NCT00768560|531884614|FG002|Intervention Set 1|Adverse Event|0|||
147471972|NCT00768560|531884615|FG003|Intervention Set 1|Adverse Event|0|||
147471973|NCT00768560|531884616|FG004|Intervention Set 1|Adverse Event|0|||
147471974|NCT00768560|531884617|FG005|Intervention Set 1|Adverse Event|0|||
147471975|NCT00117312|531884618|FG000|Overall Study|Testosterone >1.0 ng/mL|9|||
147471976|NCT00117312|531884619|FG001|Overall Study|Testosterone >1.0 ng/mL|9|||
147471977|NCT00117312|531884620|FG002|Overall Study|Testosterone >1.0 ng/mL|5|||
147471978|NCT00117312|531884621|FG003|Overall Study|Testosterone >1.0 ng/mL|9|||
147471979|NCT00117312|531884618|FG000|Overall Study|Testosterone 0.5 - 1.0 ng/mL|1|||
147471980|NCT00117312|531884619|FG001|Overall Study|Testosterone 0.5 - 1.0 ng/mL|0|||
147471981|NCT00117312|531884620|FG002|Overall Study|Testosterone 0.5 - 1.0 ng/mL|3|||
147471982|NCT00117312|531884621|FG003|Overall Study|Testosterone 0.5 - 1.0 ng/mL|2|||
147471983|NCT00117312|531884618|FG000|Overall Study|Prostate-specific antigen increase >=25%|0|||
147471984|NCT00117312|531884619|FG001|Overall Study|Prostate-specific antigen increase >=25%|1|||
147471985|NCT00117312|531884620|FG002|Overall Study|Prostate-specific antigen increase >=25%|5|||
147471986|NCT00117312|531884621|FG003|Overall Study|Prostate-specific antigen increase >=25%|3|||
147471987|NCT00117312|531884618|FG000|Overall Study|Other|0|||
147471988|NCT00117312|531884619|FG001|Overall Study|Other|1|||
147471989|NCT00117312|531884620|FG002|Overall Study|Other|3|||
147471990|NCT00117312|531884621|FG003|Overall Study|Other|1|||
147471991|NCT00117312|531884618|FG000|Overall Study|Patient choice|0|||
147471992|NCT00117312|531884619|FG001|Overall Study|Patient choice|0|||
147471993|NCT00117312|531884620|FG002|Overall Study|Patient choice|2|||
147471994|NCT00117312|531884621|FG003|Overall Study|Patient choice|1|||
147471995|NCT00117312|531884618|FG000|Overall Study|Adverse Event|0|||
147471996|NCT00117312|531884619|FG001|Overall Study|Adverse Event|2|||
147471997|NCT00117312|531884620|FG002|Overall Study|Adverse Event|0|||
147471998|NCT00117312|531884621|FG003|Overall Study|Adverse Event|0|||
147471999|NCT00117312|531884618|FG000|Overall Study|Protocol Violation|0|||
147472000|NCT00117312|531884619|FG001|Overall Study|Protocol Violation|1|||
147472001|NCT00117312|531884620|FG002|Overall Study|Protocol Violation|3|||
147472002|NCT00117312|531884621|FG003|Overall Study|Protocol Violation|0|||
147472003|NCT00117312|531884618|FG000|Overall Study|PSA decrease <=50%|0|||
147472004|NCT00117312|531884619|FG001|Overall Study|PSA decrease <=50%|2|||
147472005|NCT00117312|531884620|FG002|Overall Study|PSA decrease <=50%|2|||
147472006|NCT00117312|531884621|FG003|Overall Study|PSA decrease <=50%|4|||
147472007|NCT00117312|531884618|FG000|Overall Study|PSA increase >= 10ng/mL|0|||
147472008|NCT00117312|531884619|FG001|Overall Study|PSA increase >= 10ng/mL|1|||
147472009|NCT00117312|531884620|FG002|Overall Study|PSA increase >= 10ng/mL|1|||
147472010|NCT00117312|531884621|FG003|Overall Study|PSA increase >= 10ng/mL|0|||
147472011|NCT00117312|531884618|FG000|Overall Study|Hepatic abnormality|0|||
147472012|NCT00117312|531884619|FG001|Overall Study|Hepatic abnormality|1|||
147472013|NCT00117312|531884620|FG002|Overall Study|Hepatic abnormality|0|||
147472014|NCT00117312|531884621|FG003|Overall Study|Hepatic abnormality|1|||
147472015|NCT00117312|531884618|FG000|Overall Study|Withdrawal by Subject|0|||
147472016|NCT00117312|531884619|FG001|Overall Study|Withdrawal by Subject|2|||
147472017|NCT00117312|531884620|FG002|Overall Study|Withdrawal by Subject|0|||
147472018|NCT00117312|531884621|FG003|Overall Study|Withdrawal by Subject|0|||
147472019|NCT01128387|531884622|FG000|Overall Study|Physician Decision|0|||
147472020|NCT01128387|531884623|FG001|Overall Study|Physician Decision|1|||
147472021|NCT02635204|531884624|FG000|Overall Study|Adverse Event|1|||
147472022|NCT02635204|531884625|FG001|Overall Study|Adverse Event|0|||
147472023|NCT02635204|531884624|FG000|Overall Study|Lost to Follow-up|1|||
147472024|NCT02635204|531884625|FG001|Overall Study|Lost to Follow-up|1|||
147472025|NCT01535235|531884626|FG000|Overall Study|Adverse Event|1|||
147472026|NCT01535235|531884627|FG001|Overall Study|Adverse Event|0|||
147472027|NCT00824421|531884639|FG000|Overall Study|Adverse Event|6|||
147472028|NCT00824421|531884640|FG001|Overall Study|Adverse Event|6|||
147472029|NCT00824421|531884641|FG002|Overall Study|Adverse Event|6|||
147472030|NCT00824421|531884639|FG000|Overall Study|Death|0|||
147472031|NCT00824421|531884640|FG001|Overall Study|Death|1|||
147472032|NCT00824421|531884641|FG002|Overall Study|Death|0|||
147472033|NCT00824421|531884639|FG000|Overall Study|Lack of Efficacy|5|||
147472034|NCT00824421|531884640|FG001|Overall Study|Lack of Efficacy|7|||
147472035|NCT00824421|531884641|FG002|Overall Study|Lack of Efficacy|4|||
147472036|NCT00824421|531884639|FG000|Overall Study|Lost to Follow-up|2|||
147472037|NCT00824421|531884640|FG001|Overall Study|Lost to Follow-up|3|||
147472038|NCT00824421|531884641|FG002|Overall Study|Lost to Follow-up|0|||
147472039|NCT00824421|531884639|FG000|Overall Study|Pregnancy|1|||
147472040|NCT00824421|531884640|FG001|Overall Study|Pregnancy|0|||
147472041|NCT00824421|531884641|FG002|Overall Study|Pregnancy|1|||
147472042|NCT00824421|531884639|FG000|Overall Study|Withdrawal by Subject|2|||
147472043|NCT00824421|531884640|FG001|Overall Study|Withdrawal by Subject|3|||
147472044|NCT00824421|531884641|FG002|Overall Study|Withdrawal by Subject|3|||
147472045|NCT00824421|531884639|FG000|Overall Study|Randomized but not Treated|1|||
147472046|NCT00824421|531884640|FG001|Overall Study|Randomized but not Treated|1|||
147472047|NCT00824421|531884641|FG002|Overall Study|Randomized but not Treated|0|||
147472048|NCT00824421|531884639|FG000|Overall Study|Other|0|||
147472049|NCT00824421|531884640|FG001|Overall Study|Other|1|||
147472050|NCT00824421|531884641|FG002|Overall Study|Other|0|||
147472051|NCT02499952|531884642|FG000|Overall Study|Lost to Follow-up|1|||
147472052|NCT02499952|531884642|FG000|Overall Study|Death|9|||
147472053|NCT05089708|531884643|FG000|Overall Study|Lost to Follow-up|9|||
147472054|NCT05089708|531884644|FG001|Overall Study|Lost to Follow-up|7|||
147472055|NCT05089708|531884643|FG000|Overall Study|Withdrawal by Subject|3|||
147472056|NCT05089708|531884644|FG001|Overall Study|Withdrawal by Subject|1|||
147472057|NCT05089708|531884643|FG000|Overall Study|Non-Compliance with Investigational Product|1|||
147472058|NCT05089708|531884644|FG001|Overall Study|Non-Compliance with Investigational Product|1|||
147472059|NCT05089708|531884643|FG000|Overall Study|Withdrawal by Parent or Guardian|2|||
147472060|NCT05089708|531884644|FG001|Overall Study|Withdrawal by Parent or Guardian|1|||
147472061|NCT02120417|531884645|FG000|Overall Study|Death|5|||
147472062|NCT02120417|531884646|FG001|Overall Study|Death|1|||
147472063|NCT02120417|531884645|FG000|Overall Study|Adverse Event|3|||
147472064|NCT02120417|531884646|FG001|Overall Study|Adverse Event|9|||
147472065|NCT02120417|531884645|FG000|Overall Study|Participant decision|4|||
147414861|NCT05543707|531682150|FG001|Overall Study|concurrent illness|1|||
147414862|NCT05543707|531682149|FG000|Overall Study|Pregnancy|1|||
147414863|NCT05543707|531682150|FG001|Overall Study|Pregnancy|1|||
147414864|NCT00186888|531682151|FG000|Overall Study|Toxicity|0|||
147414865|NCT00186888|531682152|FG001|Overall Study|Toxicity|1|||
147414866|NCT00186888|531682153|FG002|Overall Study|Toxicity|0|||
147414867|NCT00186888|531682151|FG000|Overall Study|Relapse or progression of disease|4|||
147414868|NCT00186888|531682152|FG001|Overall Study|Relapse or progression of disease|2|||
147414869|NCT00186888|531682153|FG002|Overall Study|Relapse or progression of disease|0|||
147414870|NCT02108964|531682154|FG000|Overall Study|Progressive disease|15|||
147414871|NCT02108964|531682155|FG001|Overall Study|Progressive disease|31|||
147414872|NCT02108964|531682156|FG002|Overall Study|Progressive disease|54|||
147414873|NCT02108964|531682157|FG003|Overall Study|Progressive disease|7|||
147414874|NCT02108964|531682158|FG004|Overall Study|Progressive disease|20|||
147414875|NCT02108964|531682159|FG005|Overall Study|Progressive disease|4|||
147414876|NCT02108964|531682160|FG006|Overall Study|Progressive disease|6|||
147414877|NCT02108964|531682161|FG007|Overall Study|Progressive disease|33|||
147414878|NCT02108964|531682154|FG000|Overall Study|Physician Decision|1|||
147414879|NCT02108964|531682155|FG001|Overall Study|Physician Decision|5|||
147414880|NCT02108964|531682156|FG002|Overall Study|Physician Decision|7|||
147414881|NCT02108964|531682157|FG003|Overall Study|Physician Decision|1|||
147414882|NCT02108964|531682158|FG004|Overall Study|Physician Decision|2|||
147414883|NCT02108964|531682159|FG005|Overall Study|Physician Decision|1|||
147414884|NCT02108964|531682160|FG006|Overall Study|Physician Decision|1|||
147414885|NCT02108964|531682161|FG007|Overall Study|Physician Decision|3|||
147414886|NCT02108964|531682154|FG000|Overall Study|Adverse Event|0|||
147414887|NCT02108964|531682155|FG001|Overall Study|Adverse Event|0|||
147414888|NCT02108964|531682156|FG002|Overall Study|Adverse Event|4|||
147414889|NCT02108964|531682157|FG003|Overall Study|Adverse Event|0|||
147414890|NCT02108964|531682158|FG004|Overall Study|Adverse Event|1|||
147414891|NCT02108964|531682159|FG005|Overall Study|Adverse Event|0|||
147414892|NCT02108964|531682160|FG006|Overall Study|Adverse Event|3|||
147414893|NCT02108964|531682161|FG007|Overall Study|Adverse Event|2|||
147414894|NCT02108964|531682154|FG000|Overall Study|Death|1|||
147414895|NCT02108964|531682155|FG001|Overall Study|Death|1|||
147414896|NCT02108964|531682156|FG002|Overall Study|Death|4|||
147414897|NCT02108964|531682157|FG003|Overall Study|Death|0|||
147414898|NCT02108964|531682158|FG004|Overall Study|Death|3|||
147414899|NCT02108964|531682159|FG005|Overall Study|Death|0|||
147414900|NCT02108964|531682160|FG006|Overall Study|Death|0|||
147414901|NCT02108964|531682161|FG007|Overall Study|Death|2|||
147414902|NCT02108964|531682154|FG000|Overall Study|Subject/Guardian decision|0|||
147414903|NCT02108964|531682155|FG001|Overall Study|Subject/Guardian decision|1|||
147414904|NCT02108964|531682156|FG002|Overall Study|Subject/Guardian decision|4|||
147414905|NCT02108964|531682157|FG003|Overall Study|Subject/Guardian decision|0|||
147414906|NCT02108964|531682158|FG004|Overall Study|Subject/Guardian decision|2|||
147414907|NCT02108964|531682159|FG005|Overall Study|Subject/Guardian decision|0|||
147414908|NCT02108964|531682160|FG006|Overall Study|Subject/Guardian decision|1|||
147414909|NCT02108964|531682161|FG007|Overall Study|Subject/Guardian decision|2|||
147414910|NCT02108964|531682154|FG000|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|0|||
147414911|NCT02108964|531682155|FG001|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|0|||
147414912|NCT02108964|531682156|FG002|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|0|||
147414913|NCT02108964|531682157|FG003|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|0|||
147414914|NCT02108964|531682158|FG004|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|0|||
147414915|NCT02108964|531682159|FG005|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|0|||
147414916|NCT02108964|531682160|FG006|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|0|||
147414917|NCT02108964|531682161|FG007|Overall Study|Study terminated by Sponsor: remaining participants benefiting from drug were transitioned to PSDS|3|||
147414918|NCT03006848|531682162|FG000|Overall Study|Adverse Event|1|||
147414919|NCT03006848|531682162|FG000|Overall Study|Physician Decision|1|||
147414920|NCT03006848|531682162|FG000|Overall Study|Lack of Efficacy|16|||
147414921|NCT05384938|531682163|FG000|Overall Study|Withdrawal by Subject|8|||
147414922|NCT05384938|531682163|FG000|Overall Study|Lost to Follow-up|6|||
147414923|NCT05384938|531682163|FG000|Overall Study|One participant included in study but not included in analysis as did not meet eligibility criteria|1|||
147414924|NCT03898167|531682164|FG000|Overall Study|Terminated phone call early|7|||
147414925|NCT03898167|531682165|FG001|Overall Study|Terminated phone call early|0|||
147414926|NCT03898167|531682166|FG002|Overall Study|Terminated phone call early|0|||
147414927|NCT03898167|531682164|FG000|Overall Study|Terminated phone call early or requested to not receive a kit|0|||
147414928|NCT03898167|531682165|FG001|Overall Study|Terminated phone call early or requested to not receive a kit|91|||
147414929|NCT03898167|531682166|FG002|Overall Study|Terminated phone call early or requested to not receive a kit|103|||
147414930|NCT00384397|531682169|FG000|Overall Study|Adverse Event|0|||
147620295|NCT01037218|532427288|FG001|Overall Study|Adverse Event|2|||
147620296|NCT01037218|532427289|FG002|Overall Study|Adverse Event|2|||
147620297|NCT01037218|532427290|FG003|Overall Study|Adverse Event|1|||
147620298|NCT01037218|532427287|FG000|Overall Study|Lack of Efficacy|0|||
147620299|NCT01037218|532427288|FG001|Overall Study|Lack of Efficacy|2|||
147620300|NCT01037218|532427289|FG002|Overall Study|Lack of Efficacy|1|||
147414931|NCT00384397|531682170|FG001|Overall Study|Adverse Event|1|||
147414932|NCT00384397|531682171|FG002|Overall Study|Adverse Event|2|||
147414933|NCT00384397|531682169|FG000|Overall Study|Protocol Violation|7|||
147414934|NCT00384397|531682170|FG001|Overall Study|Protocol Violation|15|||
147414935|NCT00384397|531682171|FG002|Overall Study|Protocol Violation|13|||
147414936|NCT00384397|531682169|FG000|Overall Study|Lost to Follow-up|11|||
147414937|NCT00384397|531682170|FG001|Overall Study|Lost to Follow-up|13|||
147414938|NCT00384397|531682171|FG002|Overall Study|Lost to Follow-up|3|||
147414939|NCT00384397|531682169|FG000|Overall Study|Withdrawal by Subject|14|||
147414940|NCT00384397|531682170|FG001|Overall Study|Withdrawal by Subject|17|||
147414941|NCT00384397|531682171|FG002|Overall Study|Withdrawal by Subject|15|||
147414942|NCT01525238|531682172|FG000|Overall Study|Withdrawal by Subject|1|||
147414943|NCT01525238|531682173|FG001|Overall Study|Withdrawal by Subject|0|||
147414944|NCT01525238|531682174|FG002|Overall Study|Withdrawal by Subject|0|||
147414945|NCT01214642|531682175|FG000|Overall Study|Progressive Disease|3|||
147414946|NCT01214642|531682176|FG001|Overall Study|Progressive Disease|2|||
147414947|NCT01214642|531682177|FG002|Overall Study|Progressive Disease|3|||
147414948|NCT01214642|531682178|FG003|Overall Study|Progressive Disease|5|||
147414949|NCT01214642|531682179|FG004|Overall Study|Progressive Disease|5|||
147414950|NCT01214642|531682180|FG005|Overall Study|Progressive Disease|3|||
147414951|NCT01214642|531682181|FG006|Overall Study|Progressive Disease|5|||
147414952|NCT01214642|531682182|FG007|Overall Study|Progressive Disease|3|||
147414953|NCT01214642|531682183|FG008|Overall Study|Progressive Disease|10|||
147414954|NCT01214642|531682184|FG009|Overall Study|Progressive Disease|2|||
147414955|NCT01214642|531682185|FG010|Overall Study|Progressive Disease|1|||
147414956|NCT01214642|531682186|FG011|Overall Study|Progressive Disease|4|||
147414957|NCT01214642|531682175|FG000|Overall Study|Adverse Event|0|||
147414958|NCT01214642|531682176|FG001|Overall Study|Adverse Event|1|||
147414959|NCT01214642|531682177|FG002|Overall Study|Adverse Event|0|||
147414960|NCT01214642|531682178|FG003|Overall Study|Adverse Event|0|||
147414961|NCT01214642|531682179|FG004|Overall Study|Adverse Event|0|||
147414962|NCT01214642|531682180|FG005|Overall Study|Adverse Event|0|||
147414963|NCT01214642|531682181|FG006|Overall Study|Adverse Event|1|||
147414964|NCT01214642|531682182|FG007|Overall Study|Adverse Event|0|||
147414965|NCT01214642|531682183|FG008|Overall Study|Adverse Event|0|||
147414966|NCT01214642|531682184|FG009|Overall Study|Adverse Event|1|||
147414967|NCT01214642|531682185|FG010|Overall Study|Adverse Event|1|||
147414968|NCT01214642|531682186|FG011|Overall Study|Adverse Event|0|||
147414969|NCT01214642|531682175|FG000|Overall Study|Death|0|||
147414970|NCT01214642|531682176|FG001|Overall Study|Death|0|||
147414971|NCT01214642|531682177|FG002|Overall Study|Death|1|||
147414972|NCT01214642|531682178|FG003|Overall Study|Death|0|||
147414973|NCT01214642|531682179|FG004|Overall Study|Death|0|||
147414974|NCT01214642|531682180|FG005|Overall Study|Death|0|||
147414975|NCT01214642|531682181|FG006|Overall Study|Death|0|||
147414976|NCT01214642|531682182|FG007|Overall Study|Death|0|||
147414977|NCT01214642|531682183|FG008|Overall Study|Death|0|||
147414978|NCT01214642|531682184|FG009|Overall Study|Death|0|||
147414979|NCT01214642|531682185|FG010|Overall Study|Death|1|||
147414980|NCT01214642|531682186|FG011|Overall Study|Death|0|||
147414981|NCT01214642|531682175|FG000|Overall Study|Withdrawal by Subject|0|||
147414982|NCT01214642|531682176|FG001|Overall Study|Withdrawal by Subject|0|||
147414983|NCT01214642|531682177|FG002|Overall Study|Withdrawal by Subject|1|||
147414984|NCT01214642|531682178|FG003|Overall Study|Withdrawal by Subject|0|||
147414985|NCT01214642|531682179|FG004|Overall Study|Withdrawal by Subject|0|||
147414986|NCT01214642|531682180|FG005|Overall Study|Withdrawal by Subject|0|||
147414987|NCT01214642|531682181|FG006|Overall Study|Withdrawal by Subject|0|||
147414988|NCT01214642|531682182|FG007|Overall Study|Withdrawal by Subject|0|||
147414989|NCT01214642|531682183|FG008|Overall Study|Withdrawal by Subject|3|||
147414990|NCT01214642|531682184|FG009|Overall Study|Withdrawal by Subject|1|||
147414991|NCT01214642|531682185|FG010|Overall Study|Withdrawal by Subject|1|||
147414992|NCT01214642|531682186|FG011|Overall Study|Withdrawal by Subject|0|||
147414993|NCT01214642|531682175|FG000|Overall Study|Physician Decision|0|||
147414994|NCT01214642|531682176|FG001|Overall Study|Physician Decision|0|||
147414995|NCT01214642|531682177|FG002|Overall Study|Physician Decision|1|||
147414996|NCT01214642|531682178|FG003|Overall Study|Physician Decision|1|||
147414997|NCT01214642|531682179|FG004|Overall Study|Physician Decision|1|||
147414998|NCT01214642|531682180|FG005|Overall Study|Physician Decision|0|||
147414999|NCT01214642|531682181|FG006|Overall Study|Physician Decision|0|||
147415000|NCT01214642|531682182|FG007|Overall Study|Physician Decision|0|||
147415001|NCT01214642|531682183|FG008|Overall Study|Physician Decision|0|||
147415002|NCT01214642|531682184|FG009|Overall Study|Physician Decision|0|||
147415003|NCT01214642|531682185|FG010|Overall Study|Physician Decision|0|||
147620301|NCT01037218|532427290|FG003|Overall Study|Lack of Efficacy|5|||
147620302|NCT01037218|532427287|FG000|Overall Study|Lost to Follow-up|3|||
147472066|NCT02120417|531884646|FG001|Overall Study|Participant decision|4|||
147472067|NCT02120417|531884645|FG000|Overall Study|Disease progression|41|||
147472068|NCT02120417|531884646|FG001|Overall Study|Disease progression|45|||
147472069|NCT02120417|531884645|FG000|Overall Study|Noncompliance with study treatment|0|||
147472070|NCT02120417|531884646|FG001|Overall Study|Noncompliance with study treatment|2|||
147472071|NCT02120417|531884645|FG000|Overall Study|Physician Decision|2|||
147472072|NCT02120417|531884646|FG001|Overall Study|Physician Decision|3|||
147472073|NCT02120417|531884645|FG000|Overall Study|Other unspecified|5|||
147472074|NCT02120417|531884646|FG001|Overall Study|Other unspecified|4|||
147472075|NCT02286102|531884647|FG000|Overall Study|Screen Failure|1|||
147472076|NCT02286102|531884648|FG001|Overall Study|Screen Failure|1|||
147472077|NCT00927485|531884649|FG000|Overall Study|Adverse Event|4|||
147472078|NCT00927485|531884650|FG001|Overall Study|Adverse Event|2|||
147472079|NCT00927485|531884649|FG000|Overall Study|noncompliance, prophylactic surgery, inc|2|||
147472080|NCT00927485|531884650|FG001|Overall Study|noncompliance, prophylactic surgery, inc|2|||
147472081|NCT03830281|531884651|FG000|Lead-in Period (2 Weeks)|Adverse Event|2|||
147472082|NCT03830281|531884652|FG001|Lead-in Period (2 Weeks)|Adverse Event|0|||
147472083|NCT03830281|531884651|FG000|Lead-in Period (2 Weeks)|Not Met Eligibility Criteria|6|||
147472084|NCT03830281|531884652|FG001|Lead-in Period (2 Weeks)|Not Met Eligibility Criteria|0|||
147472085|NCT03830281|531884651|FG000|Lead-in Period (2 Weeks)|Physician Decision|2|||
147472086|NCT03830281|531884652|FG001|Lead-in Period (2 Weeks)|Physician Decision|0|||
147472087|NCT03830281|531884651|FG000|Lead-in Period (2 Weeks)|Withdrawal by Subject|29|||
147472088|NCT03830281|531884652|FG001|Lead-in Period (2 Weeks)|Withdrawal by Subject|0|||
147472089|NCT03830281|531884651|FG000|Treatment Period (16 Weeks)|Adverse Event|1|||
147472090|NCT03830281|531884652|FG001|Treatment Period (16 Weeks)|Adverse Event|7|||
147472091|NCT03830281|531884651|FG000|Treatment Period (16 Weeks)|Lost to Follow-up|4|||
147472092|NCT03830281|531884652|FG001|Treatment Period (16 Weeks)|Lost to Follow-up|3|||
147472093|NCT03830281|531884651|FG000|Treatment Period (16 Weeks)|Sponsor Decision|1|||
147472094|NCT03830281|531884652|FG001|Treatment Period (16 Weeks)|Sponsor Decision|1|||
147472095|NCT03830281|531884651|FG000|Treatment Period (16 Weeks)|Physician Decision|1|||
147472096|NCT03830281|531884652|FG001|Treatment Period (16 Weeks)|Physician Decision|0|||
147472097|NCT03830281|531884651|FG000|Treatment Period (16 Weeks)|Withdrawal by Subject|5|||
147472098|NCT03830281|531884652|FG001|Treatment Period (16 Weeks)|Withdrawal by Subject|6|||
147472099|NCT00594399|531884653|FG000|Initial 3 Month Counseling|Not ready to exercise|1|||
147472100|NCT00594399|531884654|FG001|Initial 3 Month Counseling|Not ready to exercise|0|||
147472101|NCT00594399|531884655|FG002|Initial 3 Month Counseling|Not ready to exercise|0|||
147472102|NCT00594399|531884653|FG000|Initial 3 Month Counseling|Lack of Interest|3|||
147472103|NCT00594399|531884654|FG001|Initial 3 Month Counseling|Lack of Interest|3|||
147472104|NCT00594399|531884655|FG002|Initial 3 Month Counseling|Lack of Interest|0|||
147472105|NCT00594399|531884653|FG000|Initial 3 Month Counseling|Personal issues|2|||
147472106|NCT00594399|531884654|FG001|Initial 3 Month Counseling|Personal issues|0|||
147472107|NCT00594399|531884655|FG002|Initial 3 Month Counseling|Personal issues|0|||
147472108|NCT00594399|531884653|FG000|Initial 3 Month Counseling|Too busy|7|||
147472109|NCT00594399|531884654|FG001|Initial 3 Month Counseling|Too busy|1|||
147472110|NCT00594399|531884655|FG002|Initial 3 Month Counseling|Too busy|0|||
147472111|NCT00594399|531884653|FG000|Initial 3 Month Counseling|Pain|2|||
147472112|NCT00594399|531884654|FG001|Initial 3 Month Counseling|Pain|0|||
147472113|NCT00594399|531884655|FG002|Initial 3 Month Counseling|Pain|0|||
147472114|NCT00594399|531884653|FG000|Initial 3 Month Counseling|Moved|1|||
147472115|NCT00594399|531884654|FG001|Initial 3 Month Counseling|Moved|0|||
147472116|NCT00594399|531884655|FG002|Initial 3 Month Counseling|Moved|0|||
147472117|NCT00594399|531884653|FG000|Initial 3 Month Counseling|Family illness|1|||
147472118|NCT00594399|531884654|FG001|Initial 3 Month Counseling|Family illness|0|||
147472119|NCT00594399|531884655|FG002|Initial 3 Month Counseling|Family illness|0|||
147472120|NCT00594399|531884653|FG000|Rerandomization Arm 1 Only|Death|2|||
147472121|NCT00594399|531884654|FG001|Rerandomization Arm 1 Only|Death|1|||
147472122|NCT00594399|531884655|FG002|Rerandomization Arm 1 Only|Death|0|||
147472123|NCT00594399|531884653|FG000|Rerandomization Arm 1 Only|Withdrawal by Subject|0|||
147472124|NCT00594399|531884654|FG001|Rerandomization Arm 1 Only|Withdrawal by Subject|3|||
147472125|NCT00594399|531884655|FG002|Rerandomization Arm 1 Only|Withdrawal by Subject|0|||
147472126|NCT01440101|531884656|FG000|Overall Study|Adverse Event|2|||
147472127|NCT01440101|531884657|FG001|Overall Study|Adverse Event|0|||
147472128|NCT01440101|531884658|FG002|Overall Study|Adverse Event|0|||
147472129|NCT01440101|531884656|FG000|Overall Study|Withdrawal by Subject|0|||
147472130|NCT01440101|531884657|FG001|Overall Study|Withdrawal by Subject|3|||
147472131|NCT01440101|531884658|FG002|Overall Study|Withdrawal by Subject|1|||
147472132|NCT01440101|531884656|FG000|Overall Study|Other|0|||
147472133|NCT01440101|531884657|FG001|Overall Study|Other|1|||
147472134|NCT01440101|531884658|FG002|Overall Study|Other|0|||
147472135|NCT00659438|531884659|FG000|Overall Study|Withdrawal by Subject|2|||
147472136|NCT00659438|531884660|FG001|Overall Study|Withdrawal by Subject|2|||
147472137|NCT00659438|531884659|FG000|Overall Study|Death|11|||
147472138|NCT00659438|531884660|FG001|Overall Study|Death|6|||
147472139|NCT00659438|531884659|FG000|Overall Study|Lost to Follow-up|1|||
147472140|NCT00659438|531884660|FG001|Overall Study|Lost to Follow-up|0|||
147666021|NCT03327324|532601671|FG005|Intervention (Month 3-Month 6)|Withdrawal by Subject|0|||
147666022|NCT03327324|532601666|FG000|Intervention (Month 3-Month 6)|Left Nursing Home Facility|2|||
147666023|NCT03327324|532601667|FG001|Intervention (Month 3-Month 6)|Left Nursing Home Facility|0|||
147415004|NCT01214642|531682186|FG011|Overall Study|Physician Decision|2|||
147415005|NCT04696653|531682189|FG000|Overall Study|left organization|18|||
147415006|NCT04696653|531682189|FG000|Overall Study|Lost to Follow-up|3|||
147415007|NCT01946529|531682190|FG000|End of Window Therapy (2 Courses)|Physician Decision|0|||
147415008|NCT01946529|531682191|FG001|End of Window Therapy (2 Courses)|Physician Decision|1|||
147415009|NCT01946529|531682192|FG002|End of Window Therapy (2 Courses)|Physician Decision|0|||
147415010|NCT01946529|531682190|FG000|Completion of All Therapy|Some pts. still receiving study therapy|1|||
147415011|NCT01946529|531682191|FG001|Completion of All Therapy|Some pts. still receiving study therapy|16|||
147415012|NCT01946529|531682192|FG002|Completion of All Therapy|Some pts. still receiving study therapy|6|||
147415013|NCT02218606|531684745|FG000|Overall Study|Adverse Event|1|||
147415014|NCT02218606|531684746|FG001|Overall Study|Adverse Event|1|||
147415015|NCT02218606|531684745|FG000|Overall Study|Death|15|||
147415016|NCT02218606|531684746|FG001|Overall Study|Death|28|||
147415017|NCT02218606|531684745|FG000|Overall Study|Physician Decision|0|||
147415018|NCT02218606|531684746|FG001|Overall Study|Physician Decision|1|||
147415019|NCT02218606|531684745|FG000|Overall Study|Withdrawal by Subject|4|||
147415020|NCT02218606|531684746|FG001|Overall Study|Withdrawal by Subject|0|||
147415021|NCT02218606|531684745|FG000|Overall Study|Noncompliance|1|||
147415022|NCT02218606|531684746|FG001|Overall Study|Noncompliance|0|||
147415023|NCT02218606|531684745|FG000|Overall Study|Initiation of new drug for prostate cancer|2|||
147415024|NCT02218606|531684746|FG001|Overall Study|Initiation of new drug for prostate cancer|0|||
147415025|NCT02218606|531684745|FG000|Overall Study|Other|2|||
147415026|NCT02218606|531684746|FG001|Overall Study|Other|1|||
147415027|NCT02218606|531684745|FG000|Overall Study|Never started treatment|0|||
147415028|NCT02218606|531684746|FG001|Overall Study|Never started treatment|1|||
147415029|NCT03203473|531684747|FG000|Induction Phase|Never started primary treatment|2|||
147415030|NCT03203473|531684748|FG001|Induction Phase|Never started primary treatment|0|||
147415031|NCT03203473|531684749|FG002|Induction Phase|Never started primary treatment|0|||
147415032|NCT03203473|531684747|FG000|Induction Phase|Withdrew from study due to progressive disease|7|||
147415033|NCT03203473|531684748|FG001|Induction Phase|Withdrew from study due to progressive disease|0|||
147415034|NCT03203473|531684749|FG002|Induction Phase|Withdrew from study due to progressive disease|0|||
147415035|NCT03203473|531684747|FG000|Induction Phase|Withdrew from study due to toxicity|7|||
147415036|NCT03203473|531684748|FG001|Induction Phase|Withdrew from study due to toxicity|0|||
147415037|NCT03203473|531684749|FG002|Induction Phase|Withdrew from study due to toxicity|0|||
147415038|NCT03203473|531684747|FG000|Arm Allocation Phase|Still on Arm A-observation|0|||
147415039|NCT03203473|531684748|FG001|Arm Allocation Phase|Still on Arm A-observation|7|||
147415040|NCT03203473|531684749|FG002|Arm Allocation Phase|Still on Arm A-observation|0|||
147415041|NCT03203473|531684747|FG000|Arm Allocation Phase|started salvage therapy|0|||
147415042|NCT03203473|531684748|FG001|Arm Allocation Phase|started salvage therapy|5|||
147415043|NCT03203473|531684749|FG002|Arm Allocation Phase|started salvage therapy|0|||
147415044|NCT03203473|531684747|FG000|Arm Allocation Phase|Disease progression|0|||
147415045|NCT03203473|531684748|FG001|Arm Allocation Phase|Disease progression|0|||
147415046|NCT03203473|531684749|FG002|Arm Allocation Phase|Disease progression|37|||
147415047|NCT03203473|531684747|FG000|Arm Allocation Phase|Adverse Event|0|||
147415048|NCT03203473|531684748|FG001|Arm Allocation Phase|Adverse Event|0|||
147415049|NCT03203473|531684749|FG002|Arm Allocation Phase|Adverse Event|11|||
147415050|NCT03203473|531684747|FG000|Arm Allocation Phase|Physician Decision|0|||
147415051|NCT03203473|531684748|FG001|Arm Allocation Phase|Physician Decision|0|||
147415052|NCT03203473|531684749|FG002|Arm Allocation Phase|Physician Decision|3|||
147415053|NCT03203473|531684747|FG000|Arm Allocation Phase|Death|0|||
147415054|NCT03203473|531684748|FG001|Arm Allocation Phase|Death|0|||
147415055|NCT03203473|531684749|FG002|Arm Allocation Phase|Death|1|||
147415056|NCT03203473|531684747|FG000|Arm Allocation Phase|Developed 2nd cancer|0|||
147415057|NCT03203473|531684748|FG001|Arm Allocation Phase|Developed 2nd cancer|0|||
147415058|NCT03203473|531684749|FG002|Arm Allocation Phase|Developed 2nd cancer|1|||
147415059|NCT03203473|531684747|FG000|Arm Allocation Phase|Intercurrent illness|0|||
147415060|NCT03203473|531684748|FG001|Arm Allocation Phase|Intercurrent illness|0|||
147415061|NCT03203473|531684749|FG002|Arm Allocation Phase|Intercurrent illness|1|||
147415062|NCT03203473|531684747|FG000|Arm Allocation Phase|Still on arm-B treatment|0|||
147415063|NCT03203473|531684748|FG001|Arm Allocation Phase|Still on arm-B treatment|0|||
147415064|NCT03203473|531684749|FG002|Arm Allocation Phase|Still on arm-B treatment|3|||
147415065|NCT02314780|531684754|FG000|Overall Study|organizational reasons|0|||
147415066|NCT02314780|531684755|FG001|Overall Study|organizational reasons|2|||
147415067|NCT02314780|531684756|FG002|Overall Study|organizational reasons|0|||
147415068|NCT02314780|531684754|FG000|Overall Study|Adverse Event|0|||
147415069|NCT02314780|531684755|FG001|Overall Study|Adverse Event|1|||
147415070|NCT02314780|531684756|FG002|Overall Study|Adverse Event|0|||
147415071|NCT01077271|531684760|FG000|Overall Study|Parental desire|8|||
147415072|NCT01077271|531684760|FG000|Overall Study|Screen failure, did not take palivizumab|4|||
147666024|NCT03327324|532601668|FG002|Intervention (Month 3-Month 6)|Left Nursing Home Facility|0|||
147415073|NCT01077271|531684760|FG000|Overall Study|Noncompliance|2|||
147415074|NCT01077271|531684760|FG000|Overall Study|Quota used up (insurance reimb issue)|2|||
147415075|NCT01077271|531684760|FG000|Overall Study|Changed doctors|2|||
147415076|NCT01077271|531684760|FG000|Overall Study|Parents thought too many injections|2|||
147415077|NCT01077271|531684760|FG000|Overall Study|End of RSV season nearly reached|1|||
147415078|NCT01077271|531684760|FG000|Overall Study|Mother unconvinced of the necessity|1|||
147415079|NCT00215137|531684761|FG000|Open Label Escitalopram|Lack of Efficacy|1|||
147415080|NCT00215137|531684762|FG001|Open Label Escitalopram|Lack of Efficacy|0|||
147415081|NCT00215137|531684763|FG002|Open Label Escitalopram|Lack of Efficacy|0|||
147415082|NCT00215137|531684761|FG000|Randomization Period|Lost to Follow-up|0|||
147415083|NCT00215137|531684762|FG001|Randomization Period|Lost to Follow-up|1|||
147415084|NCT00215137|531684763|FG002|Randomization Period|Lost to Follow-up|0|||
147415085|NCT00215137|531684761|FG000|Randomization Period|Withdrawal by Subject|0|||
147415086|NCT00215137|531684762|FG001|Randomization Period|Withdrawal by Subject|1|||
147415087|NCT00215137|531684763|FG002|Randomization Period|Withdrawal by Subject|0|||
147415088|NCT00095498|531684765|FG000|Overall Study|Physician Decision|9|||
147415089|NCT00095498|531684766|FG001|Overall Study|Physician Decision|10|||
147415090|NCT00095498|531684767|FG002|Overall Study|Physician Decision|8|||
147415091|NCT00095498|531684765|FG000|Overall Study|Adverse Event|1|||
147415092|NCT00095498|531684766|FG001|Overall Study|Adverse Event|0|||
147415093|NCT00095498|531684767|FG002|Overall Study|Adverse Event|1|||
147415094|NCT00095498|531684765|FG000|Overall Study|Withdrawal by Subject|15|||
147415095|NCT00095498|531684766|FG001|Overall Study|Withdrawal by Subject|16|||
147415096|NCT00095498|531684767|FG002|Overall Study|Withdrawal by Subject|15|||
147415097|NCT00095498|531684765|FG000|Overall Study|Disease progression|0|||
147415098|NCT00095498|531684766|FG001|Overall Study|Disease progression|1|||
147415099|NCT00095498|531684767|FG002|Overall Study|Disease progression|1|||
147415100|NCT00095498|531684765|FG000|Overall Study|Ineligibility determined|3|||
147415101|NCT00095498|531684766|FG001|Overall Study|Ineligibility determined|0|||
147415102|NCT00095498|531684767|FG002|Overall Study|Ineligibility determined|2|||
147415103|NCT00095498|531684765|FG000|Overall Study|Lost to Follow-up|1|||
147415104|NCT00095498|531684766|FG001|Overall Study|Lost to Follow-up|1|||
147415105|NCT00095498|531684767|FG002|Overall Study|Lost to Follow-up|2|||
147415106|NCT00095498|531684765|FG000|Overall Study|Noncompliance|1|||
147415107|NCT00095498|531684766|FG001|Overall Study|Noncompliance|0|||
147415108|NCT00095498|531684767|FG002|Overall Study|Noncompliance|1|||
147415109|NCT00095498|531684765|FG000|Overall Study|Other|6|||
147415110|NCT00095498|531684766|FG001|Overall Study|Other|7|||
147415111|NCT00095498|531684767|FG002|Overall Study|Other|6|||
147415112|NCT00095498|531684765|FG000|Overall Study|Protocol Violation|0|||
147415113|NCT00095498|531684766|FG001|Overall Study|Protocol Violation|0|||
147415114|NCT00095498|531684767|FG002|Overall Study|Protocol Violation|1|||
147415115|NCT00095498|531684765|FG000|Overall Study|Requirement for alternative therapy|1|||
147415116|NCT00095498|531684766|FG001|Overall Study|Requirement for alternative therapy|0|||
147415117|NCT00095498|531684767|FG002|Overall Study|Requirement for alternative therapy|2|||
147415118|NCT00640133|531684769|FG000|Open Label Phase (Month 4-12)|Lack of Efficacy|1|||
147415119|NCT00640133|531684770|FG001|Open Label Phase (Month 4-12)|Lack of Efficacy|0|||
147415120|NCT00640133|531684769|FG000|Open Label Phase (Month 4-12)|Withdrawal by Subject|1|||
147415121|NCT00640133|531684770|FG001|Open Label Phase (Month 4-12)|Withdrawal by Subject|0|||
147415122|NCT00640133|531684769|FG000|Open Label Phase (Month 4-12)|Adverse Event|1|||
147415123|NCT00640133|531684770|FG001|Open Label Phase (Month 4-12)|Adverse Event|0|||
147415124|NCT00128102|531684771|FG000|Overall Study|Site Discontinued|3|||
147415125|NCT00128102|531684772|FG001|Overall Study|Site Discontinued|6|||
147415126|NCT00128102|531684771|FG000|Overall Study|Other|0|||
147415127|NCT00128102|531684772|FG001|Overall Study|Other|1|||
147415128|NCT00128102|531684771|FG000|Overall Study|Progressive Disease|255|||
147415129|NCT00128102|531684772|FG001|Overall Study|Progressive Disease|285|||
147415130|NCT00128102|531684771|FG000|Overall Study|Adverse Event|34|||
147415131|NCT00128102|531684772|FG001|Overall Study|Adverse Event|11|||
147415132|NCT00128102|531684771|FG000|Overall Study|Death|12|||
147415133|NCT00128102|531684772|FG001|Overall Study|Death|13|||
147415134|NCT00128102|531684771|FG000|Overall Study|Physician Decision|3|||
147415135|NCT00128102|531684772|FG001|Overall Study|Physician Decision|3|||
147415136|NCT00128102|531684771|FG000|Overall Study|Withdrawal by Subject|19|||
147415137|NCT00128102|531684772|FG001|Overall Study|Withdrawal by Subject|11|||
147415138|NCT00128102|531684771|FG000|Overall Study|Protocol Violation|2|||
147415139|NCT00128102|531684772|FG001|Overall Study|Protocol Violation|2|||
147415140|NCT00306670|531684777|FG000|Overall Study|patients recruited; Genentech, the st|0|||
147415141|NCT00306670|531684778|FG001|Overall Study|patients recruited; Genentech, the st|2|||
147415142|NCT00503139|531684779|FG000|Overall Study|Case Report Forms were not collected|4|||
147415143|NCT00503139|531684779|FG000|Overall Study|Protocol Violation|4|||
147415144|NCT00833833|531684783|FG000|Phase 1 (as of 01 April 2011)|Still active in study|0|||
147415145|NCT00833833|531684784|FG001|Phase 1 (as of 01 April 2011)|Still active in study|0|||
147415146|NCT00833833|531684785|FG002|Phase 1 (as of 01 April 2011)|Still active in study|2|||
147666025|NCT03327324|532601669|FG003|Intervention (Month 3-Month 6)|Left Nursing Home Facility|0|||
147666026|NCT03327324|532601670|FG004|Intervention (Month 3-Month 6)|Left Nursing Home Facility|0|||
147666027|NCT03327324|532601671|FG005|Intervention (Month 3-Month 6)|Left Nursing Home Facility|0|||
147666028|NCT03327324|532601666|FG000|Intervention (Month 3-Month 6)|Death|1|||
147666029|NCT03327324|532601667|FG001|Intervention (Month 3-Month 6)|Death|0|||
147666030|NCT03327324|532601668|FG002|Intervention (Month 3-Month 6)|Death|1|||
147415147|NCT00833833|531684786|FG003|Phase 1 (as of 01 April 2011)|Still active in study|2|||
147415148|NCT00833833|531684787|FG004|Phase 1 (as of 01 April 2011)|Still active in study|0|||
147415149|NCT00833833|531684788|FG005|Phase 1 (as of 01 April 2011)|Still active in study|0|||
147415150|NCT00833833|531684783|FG000|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|1|||
147415151|NCT00833833|531684784|FG001|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|1|||
147415152|NCT00833833|531684785|FG002|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|2|||
147415153|NCT00833833|531684786|FG003|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|2|||
147415154|NCT00833833|531684787|FG004|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|0|||
147415155|NCT00833833|531684788|FG005|Phase 1 (as of 01 April 2011)|Withdrawal by Subject|0|||
147415156|NCT00833833|531684783|FG000|Phase 1 (as of 01 April 2011)|Adverse Event|1|||
147415157|NCT00833833|531684784|FG001|Phase 1 (as of 01 April 2011)|Adverse Event|0|||
147415158|NCT00833833|531684785|FG002|Phase 1 (as of 01 April 2011)|Adverse Event|2|||
147415159|NCT00833833|531684786|FG003|Phase 1 (as of 01 April 2011)|Adverse Event|1|||
147415160|NCT00833833|531684787|FG004|Phase 1 (as of 01 April 2011)|Adverse Event|0|||
147415161|NCT00833833|531684788|FG005|Phase 1 (as of 01 April 2011)|Adverse Event|0|||
147415162|NCT00833833|531684783|FG000|Phase 1 (as of 01 April 2011)|Death|0|||
147415163|NCT00833833|531684784|FG001|Phase 1 (as of 01 April 2011)|Death|1|||
147415164|NCT00833833|531684785|FG002|Phase 1 (as of 01 April 2011)|Death|2|||
147415165|NCT00833833|531684786|FG003|Phase 1 (as of 01 April 2011)|Death|0|||
147415166|NCT00833833|531684787|FG004|Phase 1 (as of 01 April 2011)|Death|0|||
147415167|NCT00833833|531684788|FG005|Phase 1 (as of 01 April 2011)|Death|0|||
147415168|NCT00833833|531684783|FG000|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|1|||
147415169|NCT00833833|531684784|FG001|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
147415170|NCT00833833|531684785|FG002|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|1|||
147415171|NCT00833833|531684786|FG003|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
147415172|NCT00833833|531684787|FG004|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
147415173|NCT00833833|531684788|FG005|Phase 1 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
147415174|NCT00833833|531684783|FG000|Phase 1 (as of 01 April 2011)|Other|1|||
147415175|NCT00833833|531684784|FG001|Phase 1 (as of 01 April 2011)|Other|3|||
147415176|NCT00833833|531684785|FG002|Phase 1 (as of 01 April 2011)|Other|0|||
147415177|NCT00833833|531684786|FG003|Phase 1 (as of 01 April 2011)|Other|1|||
147415178|NCT00833833|531684787|FG004|Phase 1 (as of 01 April 2011)|Other|0|||
147415179|NCT00833833|531684788|FG005|Phase 1 (as of 01 April 2011)|Other|0|||
147415180|NCT00833833|531684783|FG000|Phase 2 (as of 01 April 2011)|Still active in study|0|||
147415181|NCT00833833|531684784|FG001|Phase 2 (as of 01 April 2011)|Still active in study|0|||
147415182|NCT00833833|531684785|FG002|Phase 2 (as of 01 April 2011)|Still active in study|0|||
147415183|NCT00833833|531684786|FG003|Phase 2 (as of 01 April 2011)|Still active in study|0|||
147415184|NCT00833833|531684787|FG004|Phase 2 (as of 01 April 2011)|Still active in study|23|||
147415185|NCT00833833|531684788|FG005|Phase 2 (as of 01 April 2011)|Still active in study|22|||
147415186|NCT00833833|531684783|FG000|Phase 2 (as of 01 April 2011)|Adverse Event|0|||
147415187|NCT00833833|531684784|FG001|Phase 2 (as of 01 April 2011)|Adverse Event|0|||
147415188|NCT00833833|531684785|FG002|Phase 2 (as of 01 April 2011)|Adverse Event|0|||
147415189|NCT00833833|531684786|FG003|Phase 2 (as of 01 April 2011)|Adverse Event|0|||
147415190|NCT00833833|531684787|FG004|Phase 2 (as of 01 April 2011)|Adverse Event|8|||
147415191|NCT00833833|531684788|FG005|Phase 2 (as of 01 April 2011)|Adverse Event|13|||
147415192|NCT00833833|531684783|FG000|Phase 2 (as of 01 April 2011)|Death|0|||
147415193|NCT00833833|531684784|FG001|Phase 2 (as of 01 April 2011)|Death|0|||
147415194|NCT00833833|531684785|FG002|Phase 2 (as of 01 April 2011)|Death|0|||
147415195|NCT00833833|531684786|FG003|Phase 2 (as of 01 April 2011)|Death|0|||
147415196|NCT00833833|531684787|FG004|Phase 2 (as of 01 April 2011)|Death|8|||
147415197|NCT00833833|531684788|FG005|Phase 2 (as of 01 April 2011)|Death|9|||
147415198|NCT00833833|531684783|FG000|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
147415199|NCT00833833|531684784|FG001|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
147415200|NCT00833833|531684785|FG002|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
147415201|NCT00833833|531684786|FG003|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|0|||
147415202|NCT00833833|531684787|FG004|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|7|||
147415203|NCT00833833|531684788|FG005|Phase 2 (as of 01 April 2011)|Disease progression - unconfirmed|6|||
147415204|NCT00833833|531684783|FG000|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0|||
147415205|NCT00833833|531684784|FG001|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0|||
147415206|NCT00833833|531684785|FG002|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0|||
147415207|NCT00833833|531684786|FG003|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|0|||
147472141|NCT00201851|531884662|FG000|Overall Study|Lost to Follow-up|2|||
147472142|NCT00201851|531884663|FG001|Overall Study|Lost to Follow-up|1|||
147472143|NCT00201851|531884664|FG002|Overall Study|Lost to Follow-up|0|||
147472144|NCT00201851|531884662|FG000|Overall Study|Ineligible post enrollment|6|||
147472145|NCT00201851|531884663|FG001|Overall Study|Ineligible post enrollment|1|||
147472146|NCT00201851|531884664|FG002|Overall Study|Ineligible post enrollment|1|||
147472147|NCT03293680|531884668|FG000|Overall Study|Death|1|||
147472148|NCT03293680|531884668|FG000|Overall Study|Did not meet inclusion criteria|8|||
147472149|NCT00922935|531884669|FG000|Overall Study|Protocol Violation|0|||
147472150|NCT00922935|531884670|FG001|Overall Study|Protocol Violation|3|||
147472151|NCT00922935|531884671|FG002|Overall Study|Protocol Violation|0|||
147472152|NCT00922935|531884669|FG000|Overall Study|Physician Decision|1|||
147472153|NCT00922935|531884670|FG001|Overall Study|Physician Decision|1|||
147472154|NCT00922935|531884671|FG002|Overall Study|Physician Decision|0|||
147472155|NCT00922935|531884669|FG000|Overall Study|Lost to Follow-up|0|||
147472156|NCT00922935|531884670|FG001|Overall Study|Lost to Follow-up|1|||
147472157|NCT00922935|531884671|FG002|Overall Study|Lost to Follow-up|0|||
147472158|NCT01491945|531884672|FG000|Overall Study|Death|30|||
147472159|NCT01491945|531884672|FG000|Overall Study|Withdrwan/LTF|16|||
147472160|NCT01491945|531884672|FG000|Overall Study|Conversion|4|||
147472161|NCT01491945|531884672|FG000|Overall Study|Missed Visit|1|||
147472162|NCT00636818|531884673|FG000|Overall Study|Adverse Event|1|||
147472163|NCT00636818|531884673|FG000|Overall Study|Lost to Follow-up|2|||
147472164|NCT00636818|531884673|FG000|Overall Study|Entry Criteria Exclusion|3|||
147472165|NCT00636818|531884673|FG000|Overall Study|Protocol Violation|1|||
147472166|NCT00636818|531884673|FG000|Overall Study|Withdrawal by Subject|4|||
147472167|NCT02201940|531884674|FG000|Overall Study|Randomized/Enrolled but Never Treated|1|||
147472168|NCT02201940|531884675|FG001|Overall Study|Randomized/Enrolled but Never Treated|0|||
147472169|NCT02201940|531884674|FG000|Overall Study|Lack of Efficacy|2|||
147472170|NCT02201940|531884675|FG001|Overall Study|Lack of Efficacy|113|||
147472171|NCT02201940|531884674|FG000|Overall Study|Lost to Follow-up|5|||
147472172|NCT02201940|531884675|FG001|Overall Study|Lost to Follow-up|0|||
147472173|NCT02201940|531884674|FG000|Overall Study|Withdrew Consent|2|||
147472174|NCT02201940|531884675|FG001|Overall Study|Withdrew Consent|1|||
147472175|NCT02201940|531884674|FG000|Overall Study|Investigator's Discretion|1|||
147472176|NCT02201940|531884675|FG001|Overall Study|Investigator's Discretion|1|||
147472177|NCT02201940|531884674|FG000|Overall Study|Death|1|||
147472178|NCT02201940|531884675|FG001|Overall Study|Death|0|||
147472179|NCT02201940|531884674|FG000|Overall Study|Adverse Event|0|||
147472180|NCT02201940|531884675|FG001|Overall Study|Adverse Event|1|||
147472181|NCT00074958|531884677|FG000|Overall Study|Adverse Event|1|||
147472182|NCT02690701|531884681|FG000|Treatment Period 1|Adverse Event|2|||
147472183|NCT02690701|531884682|FG001|Treatment Period 1|Adverse Event|2|||
147472184|NCT02690701|531884681|FG000|Treatment Period 1|Withdrawal by Subject|0|||
147472185|NCT02690701|531884682|FG001|Treatment Period 1|Withdrawal by Subject|1|||
147472186|NCT02690701|531884681|FG000|Treatment Period 2|Adverse Event|2|||
147472187|NCT02690701|531884682|FG001|Treatment Period 2|Adverse Event|0|||
147472188|NCT02690701|531884681|FG000|Treatment Period 2|Lack of Efficacy|1|||
147472189|NCT02690701|531884682|FG001|Treatment Period 2|Lack of Efficacy|0|||
147415208|NCT00833833|531684787|FG004|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|5|||
147415209|NCT00833833|531684788|FG005|Phase 2 (as of 01 April 2011)|Withdrawal by Subject|7|||
147415210|NCT00833833|531684783|FG000|Phase 2 (as of 01 April 2011)|Other|0|||
147415211|NCT00833833|531684784|FG001|Phase 2 (as of 01 April 2011)|Other|0|||
147415212|NCT00833833|531684785|FG002|Phase 2 (as of 01 April 2011)|Other|0|||
147415213|NCT00833833|531684786|FG003|Phase 2 (as of 01 April 2011)|Other|0|||
147415214|NCT00833833|531684787|FG004|Phase 2 (as of 01 April 2011)|Other|4|||
147415215|NCT00833833|531684788|FG005|Phase 2 (as of 01 April 2011)|Other|3|||
147415216|NCT00833833|531684783|FG000|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0|||
147415217|NCT00833833|531684784|FG001|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0|||
147415218|NCT00833833|531684785|FG002|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0|||
147415219|NCT00833833|531684786|FG003|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0|||
147415220|NCT00833833|531684787|FG004|Phase 2 (as of 01 April 2011)|Lost to Follow-up|0|||
147415221|NCT00833833|531684788|FG005|Phase 2 (as of 01 April 2011)|Lost to Follow-up|1|||
147415222|NCT02040259|531684789|FG000|Overall Study|Death|280|||
147415223|NCT02040259|531684789|FG000|Overall Study|Lost to Follow-up|76|||
147415224|NCT02040259|531684789|FG000|Overall Study|Assessment not completed|3|||
147415225|NCT02040259|531684789|FG000|Overall Study|Withdrawal by Subject|4|||
147415226|NCT04476251|531684790|FG000|Overall Study|Not treated|1|||
147472190|NCT02690701|531884681|FG000|Treatment Period 2|Lost to Follow-up|0|||
147472191|NCT02690701|531884682|FG001|Treatment Period 2|Lost to Follow-up|2|||
147472192|NCT02690701|531884681|FG000|Treatment Period 2|Withdrawal by Subject|0|||
147472193|NCT02690701|531884682|FG001|Treatment Period 2|Withdrawal by Subject|2|||
147472194|NCT02690701|531884681|FG000|Treatment Period 2|Protocol Violation|0|||
147472195|NCT02690701|531884682|FG001|Treatment Period 2|Protocol Violation|1|||
147472196|NCT02700451|531884683|FG000|Overall Study|Protocol Violation|2|||
147472197|NCT02700451|531884684|FG001|Overall Study|Protocol Violation|2|||
147472198|NCT02700451|531884685|FG002|Overall Study|Protocol Violation|3|||
147472199|NCT02700451|531884683|FG000|Overall Study|Discontinued intervention|14|||
147472200|NCT02700451|531884684|FG001|Overall Study|Discontinued intervention|15|||
147415227|NCT03446781|531684799|FG000|Overall Study|Lost to Follow-up|11|||
147415228|NCT03446781|531684800|FG001|Overall Study|Lost to Follow-up|5|||
147415229|NCT03446781|531684799|FG000|Overall Study|Withdrawal by Subject|9|||
147415230|NCT03446781|531684800|FG001|Overall Study|Withdrawal by Subject|7|||
147415231|NCT03446781|531684799|FG000|Overall Study|Adverse Event|8|||
147415232|NCT03446781|531684800|FG001|Overall Study|Adverse Event|2|||
147415233|NCT03446781|531684799|FG000|Overall Study|Protocol Violation|0|||
147415234|NCT03446781|531684800|FG001|Overall Study|Protocol Violation|3|||
147415235|NCT03568318|531684803|FG000|Overall Study|Adverse Event|3|||
147415236|NCT03568318|531684804|FG001|Overall Study|Adverse Event|1|||
147415237|NCT03568318|531684805|FG002|Overall Study|Adverse Event|1|||
147415238|NCT03568318|531684806|FG003|Overall Study|Adverse Event|0|||
147415239|NCT03568318|531684807|FG004|Overall Study|Adverse Event|1|||
147415240|NCT03568318|531684808|FG005|Overall Study|Adverse Event|0|||
147415241|NCT03568318|531684803|FG000|Overall Study|Withdrawal by Subject|6|||
147415242|NCT03568318|531684804|FG001|Overall Study|Withdrawal by Subject|5|||
147415243|NCT03568318|531684805|FG002|Overall Study|Withdrawal by Subject|2|||
147415244|NCT03568318|531684806|FG003|Overall Study|Withdrawal by Subject|1|||
147415245|NCT03568318|531684807|FG004|Overall Study|Withdrawal by Subject|0|||
147415246|NCT03568318|531684808|FG005|Overall Study|Withdrawal by Subject|0|||
147415247|NCT03568318|531684803|FG000|Overall Study|Lost to Follow-up|3|||
147415248|NCT03568318|531684804|FG001|Overall Study|Lost to Follow-up|2|||
147415249|NCT03568318|531684805|FG002|Overall Study|Lost to Follow-up|2|||
147415250|NCT03568318|531684806|FG003|Overall Study|Lost to Follow-up|2|||
147415251|NCT03568318|531684807|FG004|Overall Study|Lost to Follow-up|1|||
147415252|NCT03568318|531684808|FG005|Overall Study|Lost to Follow-up|0|||
147415253|NCT03568318|531684803|FG000|Overall Study|Other|3|||
147415254|NCT03568318|531684804|FG001|Overall Study|Other|1|||
147415255|NCT03568318|531684805|FG002|Overall Study|Other|3|||
147415256|NCT03568318|531684806|FG003|Overall Study|Other|0|||
147415257|NCT03568318|531684807|FG004|Overall Study|Other|0|||
147415258|NCT03568318|531684808|FG005|Overall Study|Other|0|||
147415259|NCT03568318|531684803|FG000|Overall Study|Ongoing at Time of Analysis|5|||
147415260|NCT03568318|531684804|FG001|Overall Study|Ongoing at Time of Analysis|3|||
147415261|NCT03568318|531684805|FG002|Overall Study|Ongoing at Time of Analysis|2|||
147415262|NCT03568318|531684806|FG003|Overall Study|Ongoing at Time of Analysis|1|||
147415263|NCT03568318|531684807|FG004|Overall Study|Ongoing at Time of Analysis|0|||
147415264|NCT03568318|531684808|FG005|Overall Study|Ongoing at Time of Analysis|0|||
147415265|NCT04410523|531684809|FG000|Overall Study|Study terminated by sponsor|1|||
147415266|NCT04410523|531684810|FG001|Overall Study|Study terminated by sponsor|3|||
147415267|NCT04410523|531684811|FG002|Overall Study|Study terminated by sponsor|2|||
147415268|NCT04410523|531684812|FG003|Overall Study|Study terminated by sponsor|6|||
147415269|NCT04410523|531684813|FG004|Overall Study|Study terminated by sponsor|3|||
147415270|NCT04410523|531684814|FG005|Overall Study|Study terminated by sponsor|4|||
147415271|NCT04410523|531684809|FG000|Overall Study|Adverse Event|1|||
147415272|NCT04410523|531684810|FG001|Overall Study|Adverse Event|0|||
147415273|NCT04410523|531684811|FG002|Overall Study|Adverse Event|0|||
147415274|NCT04410523|531684812|FG003|Overall Study|Adverse Event|0|||
147415275|NCT04410523|531684813|FG004|Overall Study|Adverse Event|0|||
147415276|NCT04410523|531684814|FG005|Overall Study|Adverse Event|2|||
147415277|NCT04410523|531684809|FG000|Overall Study|Lost to Follow-up|0|||
147415278|NCT04410523|531684810|FG001|Overall Study|Lost to Follow-up|1|||
147415279|NCT04410523|531684811|FG002|Overall Study|Lost to Follow-up|0|||
147415280|NCT04410523|531684812|FG003|Overall Study|Lost to Follow-up|0|||
147415281|NCT04410523|531684813|FG004|Overall Study|Lost to Follow-up|0|||
147415282|NCT04410523|531684814|FG005|Overall Study|Lost to Follow-up|0|||
147415283|NCT04410523|531684809|FG000|Overall Study|Physician Decision|0|||
147415284|NCT04410523|531684810|FG001|Overall Study|Physician Decision|1|||
147415285|NCT04410523|531684811|FG002|Overall Study|Physician Decision|0|||
147415286|NCT04410523|531684812|FG003|Overall Study|Physician Decision|0|||
147415287|NCT04410523|531684813|FG004|Overall Study|Physician Decision|0|||
147415288|NCT04410523|531684814|FG005|Overall Study|Physician Decision|0|||
147415289|NCT04410523|531684809|FG000|Overall Study|Pregnancy|0|||
147415290|NCT04410523|531684810|FG001|Overall Study|Pregnancy|0|||
147415291|NCT04410523|531684811|FG002|Overall Study|Pregnancy|0|||
147415292|NCT04410523|531684812|FG003|Overall Study|Pregnancy|0|||
147415293|NCT04410523|531684813|FG004|Overall Study|Pregnancy|0|||
147415294|NCT04410523|531684814|FG005|Overall Study|Pregnancy|1|||
147415295|NCT04410523|531684809|FG000|Overall Study|Protocol deviation|0|||
147415296|NCT04410523|531684810|FG001|Overall Study|Protocol deviation|0|||
147415297|NCT04410523|531684811|FG002|Overall Study|Protocol deviation|0|||
147415298|NCT04410523|531684812|FG003|Overall Study|Protocol deviation|0|||
147415299|NCT04410523|531684813|FG004|Overall Study|Protocol deviation|0|||
147415300|NCT04410523|531684814|FG005|Overall Study|Protocol deviation|2|||
147415301|NCT04410523|531684809|FG000|Overall Study|Subject decision|2|||
147415302|NCT04410523|531684810|FG001|Overall Study|Subject decision|0|||
147415303|NCT04410523|531684811|FG002|Overall Study|Subject decision|0|||
147415304|NCT04410523|531684812|FG003|Overall Study|Subject decision|1|||
147415305|NCT04410523|531684813|FG004|Overall Study|Subject decision|0|||
147415306|NCT04410523|531684814|FG005|Overall Study|Subject decision|1|||
147620303|NCT01037218|532427288|FG001|Overall Study|Lost to Follow-up|5|||
147415307|NCT01638429|531684817|FG000|Overall Study|Withdrawal by Subject|1|||
147415308|NCT02040584|531684819|FG000|Overall Study|Adverse Event|13|||
147415309|NCT02040584|531684820|FG001|Overall Study|Adverse Event|6|||
147415310|NCT02040584|531684819|FG000|Overall Study|Protocol Violation|9|||
147415311|NCT02040584|531684820|FG001|Overall Study|Protocol Violation|11|||
147415312|NCT02040584|531684819|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
147415313|NCT02040584|531684820|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
147415314|NCT02040584|531684819|FG000|Overall Study|Death|6|||
147415315|NCT02040584|531684820|FG001|Overall Study|Death|3|||
147415316|NCT02040584|531684819|FG000|Overall Study|Transplant rejection/retransplant|0|||
147415317|NCT02040584|531684820|FG001|Overall Study|Transplant rejection/retransplant|1|||
147415318|NCT02040584|531684819|FG000|Overall Study|Immunosuppressant/prohibited med use|7|||
147415319|NCT02040584|531684820|FG001|Overall Study|Immunosuppressant/prohibited med use|10|||
147415320|NCT00996476|531684821|FG000|Overall Study|Withdrawal by Subject|1|||
147415321|NCT00996476|531684822|FG001|Overall Study|Withdrawal by Subject|2|||
147415322|NCT00996476|531684823|FG002|Overall Study|Withdrawal by Subject|1|||
147415323|NCT00996476|531684824|FG003|Overall Study|Withdrawal by Subject|0|||
147415324|NCT00996476|531684825|FG004|Overall Study|Withdrawal by Subject|1|||
147415325|NCT00996476|531684821|FG000|Overall Study|Adverse Event|0|||
147415326|NCT00996476|531684822|FG001|Overall Study|Adverse Event|1|||
147415327|NCT00996476|531684823|FG002|Overall Study|Adverse Event|0|||
147415328|NCT00996476|531684824|FG003|Overall Study|Adverse Event|0|||
147415329|NCT00996476|531684825|FG004|Overall Study|Adverse Event|1|||
147415330|NCT01802567|531684826|FG000|Overall Study|Withdrawal by Subject|2|||
147415331|NCT01802567|531684826|FG000|Overall Study|Physician Decision|1|||
147415332|NCT01802567|531684826|FG000|Overall Study|Lack of Efficacy|7|||
147415333|NCT01802567|531684826|FG000|Overall Study|Consented but did not start therapy|7|||
147415334|NCT01802567|531684826|FG000|Overall Study|Protocol Violation|1|||
147415335|NCT01940939|531684827|FG000|Overall Study|Withdrawal by Subject|2|||
147415336|NCT01940939|531684828|FG001|Overall Study|Withdrawal by Subject|8|||
147415337|NCT01895101|531684829|FG000|Overall Study|OPCAB procedure|1|||
147415338|NCT01895101|531684830|FG001|Overall Study|OPCAB procedure|1|||
147415339|NCT01895101|531684831|FG002|Overall Study|OPCAB procedure|3|||
147415340|NCT01895101|531684829|FG000|Overall Study|Withdrawal by Subject|0|||
147415341|NCT01895101|531684830|FG001|Overall Study|Withdrawal by Subject|1|||
147415342|NCT01895101|531684831|FG002|Overall Study|Withdrawal by Subject|2|||
147415343|NCT01895101|531684829|FG000|Overall Study|another study, enrolled in other study|0|||
147415344|NCT01895101|531684830|FG001|Overall Study|another study, enrolled in other study|1|||
147415345|NCT01895101|531684831|FG002|Overall Study|another study, enrolled in other study|0|||
147415346|NCT01895101|531684829|FG000|Overall Study|Death|0|||
147415347|NCT01895101|531684830|FG001|Overall Study|Death|1|||
147415348|NCT01895101|531684831|FG002|Overall Study|Death|0|||
147415349|NCT01895101|531684829|FG000|Overall Study|coagulation disorder|0|||
147415350|NCT01895101|531684830|FG001|Overall Study|coagulation disorder|1|||
147415351|NCT01895101|531684831|FG002|Overall Study|coagulation disorder|0|||
147415352|NCT00436852|531684832|FG000|Overall Study|Death|23|||
147415353|NCT00436852|531684833|FG001|Overall Study|Death|34|||
147415354|NCT00436852|531684832|FG000|Overall Study|Lack of Efficacy|9|||
147415355|NCT00436852|531684833|FG001|Overall Study|Lack of Efficacy|7|||
147415356|NCT00436852|531684832|FG000|Overall Study|Withdrawal by Subject|2|||
147415357|NCT00436852|531684833|FG001|Overall Study|Withdrawal by Subject|4|||
147415358|NCT00436852|531684832|FG000|Overall Study|Ineligible|1|||
147415359|NCT00436852|531684833|FG001|Overall Study|Ineligible|0|||
147415360|NCT00370682|531684834|FG000|Overall Study|Moved from area|0|||
147415361|NCT00370682|531684835|FG001|Overall Study|Moved from area|2|||
147415362|NCT00370682|531684836|FG002|Overall Study|Moved from area|0|||
147415363|NCT00370682|531684834|FG000|Overall Study|Lost to Follow-up|0|||
147415364|NCT00370682|531684835|FG001|Overall Study|Lost to Follow-up|1|||
147415365|NCT00370682|531684836|FG002|Overall Study|Lost to Follow-up|1|||
147415366|NCT03167359|531684837|FG000|Overall Study|Physician Decision|1|||
147415367|NCT03167359|531684837|FG000|Overall Study|Lost to Follow-up|1|||
147415368|NCT03339583|531684838|FG000|First Intervention (14 Days)|Adverse Event|1|||
147415369|NCT03339583|531684839|FG001|First Intervention (14 Days)|Adverse Event|0|||
147415370|NCT03339583|531684838|FG000|Second Intervention (14 Days)|unrelated acute exacerbation|0|||
147415371|NCT03339583|531684839|FG001|Second Intervention (14 Days)|unrelated acute exacerbation|1|||
147415372|NCT03339583|531684838|FG000|Second Intervention (14 Days)|Adverse Event|0|||
147415373|NCT03339583|531684839|FG001|Second Intervention (14 Days)|Adverse Event|1|||
147415374|NCT03339583|531684838|FG000|Follow-up (14 Days)|Physician Decision|6|||
147415375|NCT03339583|531684839|FG001|Follow-up (14 Days)|Physician Decision|3|||
147415376|NCT00943852|531684840|FG000|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
147415377|NCT00943852|531684841|FG001|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
147415378|NCT00943852|531684842|FG002|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
147415379|NCT00943852|531684843|FG003|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|1|||
147415380|NCT00943852|531684844|FG004|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
147620304|NCT01037218|532427289|FG002|Overall Study|Lost to Follow-up|4|||
147415381|NCT00943852|531684845|FG005|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
147415382|NCT00943852|531684846|FG006|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
147415383|NCT00943852|531684847|FG007|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
147415384|NCT00943852|531684848|FG008|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
147415385|NCT00943852|531684849|FG009|Washout Period After Period 1 Treatment|BP too low for dosing at the next period|0|||
147415386|NCT00943852|531684840|FG000|Washout Period After Period 2 Treatment|Trial stopped early|0|||
147415387|NCT00943852|531684841|FG001|Washout Period After Period 2 Treatment|Trial stopped early|0|||
147415388|NCT00943852|531684842|FG002|Washout Period After Period 2 Treatment|Trial stopped early|0|||
147415389|NCT00943852|531684843|FG003|Washout Period After Period 2 Treatment|Trial stopped early|0|||
147415390|NCT00943852|531684844|FG004|Washout Period After Period 2 Treatment|Trial stopped early|0|||
147415391|NCT00943852|531684845|FG005|Washout Period After Period 2 Treatment|Trial stopped early|1|||
147415392|NCT00943852|531684846|FG006|Washout Period After Period 2 Treatment|Trial stopped early|0|||
147415393|NCT00943852|531684847|FG007|Washout Period After Period 2 Treatment|Trial stopped early|0|||
147415394|NCT00943852|531684848|FG008|Washout Period After Period 2 Treatment|Trial stopped early|0|||
147415395|NCT00943852|531684849|FG009|Washout Period After Period 2 Treatment|Trial stopped early|0|||
147415396|NCT00943852|531684840|FG000|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
147415397|NCT00943852|531684841|FG001|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
147415398|NCT00943852|531684842|FG002|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
147415399|NCT00943852|531684843|FG003|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
147415400|NCT00943852|531684844|FG004|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
147415401|NCT00943852|531684845|FG005|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
147415402|NCT00943852|531684846|FG006|Washout Period After Period 3 Treatment|Did not meet criteria for next period|1|||
147415403|NCT00943852|531684847|FG007|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
147415404|NCT00943852|531684848|FG008|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
147415405|NCT00943852|531684849|FG009|Washout Period After Period 3 Treatment|Did not meet criteria for next period|0|||
147415406|NCT00943852|531684840|FG000|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
147415407|NCT00943852|531684841|FG001|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
147415408|NCT00943852|531684842|FG002|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
147415409|NCT00943852|531684843|FG003|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
147415410|NCT00943852|531684844|FG004|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
147415411|NCT00943852|531684845|FG005|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
147415412|NCT00943852|531684846|FG006|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
147415413|NCT00943852|531684847|FG007|Washout Period After Period 4 Treatment|Not taking medication per protocol|1|||
147415414|NCT00943852|531684848|FG008|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
147415415|NCT00943852|531684849|FG009|Washout Period After Period 4 Treatment|Not taking medication per protocol|0|||
147415416|NCT00943852|531684840|FG000|Washout Period After Period 4 Treatment|Trial stopped early|1|||
147415417|NCT00943852|531684841|FG001|Washout Period After Period 4 Treatment|Trial stopped early|0|||
147415418|NCT00943852|531684842|FG002|Washout Period After Period 4 Treatment|Trial stopped early|1|||
147415419|NCT00943852|531684843|FG003|Washout Period After Period 4 Treatment|Trial stopped early|1|||
147415420|NCT00943852|531684844|FG004|Washout Period After Period 4 Treatment|Trial stopped early|0|||
147415421|NCT00943852|531684845|FG005|Washout Period After Period 4 Treatment|Trial stopped early|0|||
147415422|NCT00943852|531684846|FG006|Washout Period After Period 4 Treatment|Trial stopped early|1|||
147415423|NCT00943852|531684847|FG007|Washout Period After Period 4 Treatment|Trial stopped early|0|||
147415424|NCT00943852|531684848|FG008|Washout Period After Period 4 Treatment|Trial stopped early|0|||
147415425|NCT00943852|531684849|FG009|Washout Period After Period 4 Treatment|Trial stopped early|0|||
147415426|NCT00734591|531684850|FG000|Screening for Prospective Period|Site did not participate|1604|||
147415427|NCT00734591|531684851|FG001|Screening for Prospective Period|Site did not participate|1488|||
147415428|NCT00734591|531684850|FG000|Screening for Prospective Period|Patient at partic. site not enrolled|913|||
147415429|NCT00734591|531684851|FG001|Screening for Prospective Period|Patient at partic. site not enrolled|803|||
147415430|NCT00734591|531684850|FG000|Prospective Period|Withdrawal by Subject|11|||
147415431|NCT00734591|531684851|FG001|Prospective Period|Withdrawal by Subject|9|||
147415432|NCT00734591|531684850|FG000|Prospective Period|Lost to Follow-up|37|||
147415433|NCT00734591|531684851|FG001|Prospective Period|Lost to Follow-up|33|||
147415434|NCT00734591|531684850|FG000|Prospective Period|Study Terminated|1|||
147415435|NCT00734591|531684851|FG001|Prospective Period|Study Terminated|0|||
147415436|NCT00734591|531684850|FG000|Prospective Period|Other|2|||
147415437|NCT00734591|531684851|FG001|Prospective Period|Other|2|||
147415438|NCT01656200|531684852|FG000|Overall Study|Withdrawal by Subject|1|||
147415439|NCT02236988|531684853|FG000|Overall Study|Lost to Follow-up|0|||
147415440|NCT02236988|531684854|FG001|Overall Study|Lost to Follow-up|0|||
147415441|NCT02236988|531684855|FG002|Overall Study|Lost to Follow-up|0|||
147472201|NCT02700451|531884685|FG002|Overall Study|Discontinued intervention|14|||
147472202|NCT02115308|531884691|FG000|Overall Study|Safety Screening|2|||
147472203|NCT02115308|531884692|FG001|Overall Study|Safety Screening|2|||
147472204|NCT00404092|531884693|FG000|Overall Study|Death|1|||
147472205|NCT00404092|531884694|FG001|Overall Study|Death|0|||
147472206|NCT00404092|531884695|FG002|Overall Study|Death|0|||
147472207|NCT00404092|531884696|FG003|Overall Study|Death|0|||
147472208|NCT00404092|531884693|FG000|Overall Study|Adverse Event|0|||
147472209|NCT00404092|531884694|FG001|Overall Study|Adverse Event|0|||
147472210|NCT00404092|531884695|FG002|Overall Study|Adverse Event|1|||
147472211|NCT00404092|531884696|FG003|Overall Study|Adverse Event|0|||
147472212|NCT00749203|531884697|FG000|no Infusion at Week 1|Lost to Follow-up|0|||
147472213|NCT00749203|531884698|FG001|no Infusion at Week 1|Lost to Follow-up|1|||
147472214|NCT00749203|531884697|FG000|no Infusion at Week 1|Withdrawal by Subject|0|||
147472215|NCT00749203|531884698|FG001|no Infusion at Week 1|Withdrawal by Subject|1|||
147472216|NCT00749203|531884697|FG000|no Infusion at Week 1|delayed-onset sedation|0|||
147472217|NCT00749203|531884698|FG001|no Infusion at Week 1|delayed-onset sedation|1|||
147472218|NCT00749203|531884697|FG000|no Infusion at Week 1|low baseline PTSD symptoms level|0|||
147472219|NCT00749203|531884698|FG001|no Infusion at Week 1|low baseline PTSD symptoms level|1|||
147472220|NCT00749203|531884697|FG000|Second Infusion at 2 Weeks|Protocol Violation|0|||
147472221|NCT00749203|531884698|FG001|Second Infusion at 2 Weeks|Protocol Violation|1|||
147472222|NCT00749203|531884697|FG000|Second Infusion at 2 Weeks|pt felt uncomfortable after infusion|0|||
147472223|NCT00749203|531884698|FG001|Second Infusion at 2 Weeks|pt felt uncomfortable after infusion|1|||
147472224|NCT02344576|531884702|FG000|Enrollment|Agreed to Medical Record Review Only|7|||
147472225|NCT02344576|531884703|FG001|Enrollment|Agreed to Medical Record Review Only|8|||
147472226|NCT02344576|531884704|FG002|Enrollment|Agreed to Medical Record Review Only|0|||
147472227|NCT02344576|531884705|FG003|Enrollment|Agreed to Medical Record Review Only|0|||
147472228|NCT02344576|531884702|FG000|1-Month Follow-Up|Death|13|||
147472229|NCT02344576|531884703|FG001|1-Month Follow-Up|Death|8|||
147472230|NCT02344576|531884704|FG002|1-Month Follow-Up|Death|0|||
147472231|NCT02344576|531884705|FG003|1-Month Follow-Up|Death|0|||
147472232|NCT02344576|531884702|FG000|1-Month Follow-Up|Withdrawal by Subject|3|||
147472233|NCT02344576|531884703|FG001|1-Month Follow-Up|Withdrawal by Subject|14|||
147472234|NCT02344576|531884704|FG002|1-Month Follow-Up|Withdrawal by Subject|8|||
147472235|NCT02344576|531884705|FG003|1-Month Follow-Up|Withdrawal by Subject|10|||
147472236|NCT02344576|531884702|FG000|1-Month Follow-Up|Lost to Follow-up|2|||
147472237|NCT02344576|531884703|FG001|1-Month Follow-Up|Lost to Follow-up|5|||
147472238|NCT02344576|531884704|FG002|1-Month Follow-Up|Lost to Follow-up|11|||
147472239|NCT02344576|531884705|FG003|1-Month Follow-Up|Lost to Follow-up|3|||
147472240|NCT02344576|531884702|FG000|6-Month Follow-Up|Death|14|||
147472241|NCT02344576|531884703|FG001|6-Month Follow-Up|Death|14|||
147472242|NCT02344576|531884704|FG002|6-Month Follow-Up|Death|0|||
147472243|NCT02344576|531884705|FG003|6-Month Follow-Up|Death|0|||
147472244|NCT02344576|531884702|FG000|6-Month Follow-Up|Withdrawal by Subject|1|||
147472245|NCT02344576|531884703|FG001|6-Month Follow-Up|Withdrawal by Subject|0|||
147472246|NCT02344576|531884704|FG002|6-Month Follow-Up|Withdrawal by Subject|1|||
147472247|NCT02344576|531884705|FG003|6-Month Follow-Up|Withdrawal by Subject|2|||
147472248|NCT02344576|531884702|FG000|6-Month Follow-Up|Lost to Follow-up|4|||
147472249|NCT02344576|531884703|FG001|6-Month Follow-Up|Lost to Follow-up|5|||
147472250|NCT02344576|531884704|FG002|6-Month Follow-Up|Lost to Follow-up|13|||
147472251|NCT02344576|531884705|FG003|6-Month Follow-Up|Lost to Follow-up|6|||
147472252|NCT04233424|531884707|FG000|Overall Study|Death|15|||
147472253|NCT04233424|531884708|FG001|Overall Study|Death|16|||
147472254|NCT04233424|531884707|FG000|Overall Study|Withdrawal by Subject|2|||
147472255|NCT04233424|531884708|FG001|Overall Study|Withdrawal by Subject|8|||
147472256|NCT04233424|531884707|FG000|Overall Study|Physician Decision|1|||
147472257|NCT04233424|531884708|FG001|Overall Study|Physician Decision|3|||
147472258|NCT04233424|531884707|FG000|Overall Study|Protocol Violation|3|||
147472259|NCT04233424|531884708|FG001|Overall Study|Protocol Violation|1|||
147472260|NCT04233424|531884707|FG000|Overall Study|Lost to Follow-up|1|||
147472261|NCT04233424|531884708|FG001|Overall Study|Lost to Follow-up|3|||
147472262|NCT04233424|531884707|FG000|Overall Study|subject refuse to visit site|2|||
147472263|NCT04233424|531884708|FG001|Overall Study|subject refuse to visit site|0|||
147472264|NCT02698189|531884709|FG000|Overall Study|Physician Decision|3|||
147472265|NCT02698189|531884710|FG001|Overall Study|Physician Decision|0|||
147472266|NCT02698189|531884709|FG000|Overall Study|Progressive disease|0|||
147472267|NCT02698189|531884710|FG001|Overall Study|Progressive disease|5|||
147472268|NCT02698189|531884709|FG000|Overall Study|Study terminated by sponsor|0|||
147472269|NCT02698189|531884710|FG001|Overall Study|Study terminated by sponsor|1|||
147472270|NCT00702143|531884724|FG000|Overall Study|Lost to Follow-up|0|||
147472271|NCT00702143|531884725|FG001|Overall Study|Lost to Follow-up|0|||
147472272|NCT00702143|531884726|FG002|Overall Study|Lost to Follow-up|1|||
147472273|NCT01624142|531884731|FG000|Overall Study|Withdrawal by Subject|14|||
147472274|NCT01624142|531884732|FG001|Overall Study|Withdrawal by Subject|4|||
147472275|NCT01624142|531884731|FG000|Overall Study|Death|3|||
147472276|NCT01624142|531884732|FG001|Overall Study|Death|6|||
147472277|NCT01624142|531884731|FG000|Overall Study|Study Closure|12|||
147472278|NCT01624142|531884732|FG001|Overall Study|Study Closure|6|||
147472279|NCT01624142|531884731|FG000|Overall Study|Lost to Follow-up|2|||
147472280|NCT01624142|531884732|FG001|Overall Study|Lost to Follow-up|0|||
147472281|NCT01624142|531884731|FG000|Overall Study|Other|1|||
147472282|NCT01624142|531884732|FG001|Overall Study|Other|0|||
147472283|NCT01053429|531884733|FG000|Overall Study|Adverse Event|64|||
147472284|NCT01053429|531884733|FG000|Overall Study|Other|309|||
147472285|NCT00947349|531884734|FG000|Triple Treatment Combination Period|Adverse Event|0|||
147472286|NCT00947349|531884735|FG001|Triple Treatment Combination Period|Adverse Event|1|||
147472287|NCT00947349|531884736|FG002|Triple Treatment Combination Period|Adverse Event|0|||
147472288|NCT00947349|531884737|FG003|Triple Treatment Combination Period|Adverse Event|0|||
147472289|NCT00947349|531884734|FG000|Overall Study Standard of Care|Lack of Efficacy|0|||
147472290|NCT00947349|531884735|FG001|Overall Study Standard of Care|Lack of Efficacy|0|||
147472291|NCT00947349|531884736|FG002|Overall Study Standard of Care|Lack of Efficacy|1|||
147472292|NCT00947349|531884737|FG003|Overall Study Standard of Care|Lack of Efficacy|1|||
147472293|NCT00947349|531884734|FG000|Overall Study Standard of Care|Withdrawal by Subject|0|||
147472294|NCT00947349|531884735|FG001|Overall Study Standard of Care|Withdrawal by Subject|0|||
147472295|NCT00947349|531884736|FG002|Overall Study Standard of Care|Withdrawal by Subject|1|||
147472296|NCT00947349|531884737|FG003|Overall Study Standard of Care|Withdrawal by Subject|0|||
147472297|NCT00947349|531884734|FG000|Overall Study Standard of Care|Other|0|||
147472298|NCT00947349|531884735|FG001|Overall Study Standard of Care|Other|0|||
147472299|NCT00947349|531884736|FG002|Overall Study Standard of Care|Other|0|||
147472300|NCT00947349|531884737|FG003|Overall Study Standard of Care|Other|1|||
147472301|NCT03972488|531884738|FG000|Overall Study|Progressive disease|42|||
147472302|NCT03972488|531884739|FG001|Overall Study|Progressive disease|44|||
147472303|NCT03972488|531884738|FG000|Overall Study|Physician Decision|13|||
147472304|NCT03972488|531884739|FG001|Overall Study|Physician Decision|7|||
147472305|NCT03972488|531884738|FG000|Overall Study|Adverse Event|8|||
147472306|NCT03972488|531884739|FG001|Overall Study|Adverse Event|1|||
147472307|NCT03972488|531884738|FG000|Overall Study|Death|4|||
147472308|NCT03972488|531884739|FG001|Overall Study|Death|4|||
147472309|NCT03972488|531884738|FG000|Overall Study|Withdrawal by Subject|3|||
147472310|NCT03972488|531884739|FG001|Overall Study|Withdrawal by Subject|4|||
147472311|NCT03972488|531884738|FG000|Overall Study|Other = untreated or stopped treatment by patient decision but agreed to be followed-up|3|||
147472312|NCT03972488|531884739|FG001|Overall Study|Other = untreated or stopped treatment by patient decision but agreed to be followed-up|0|||
147472313|NCT02770807|531884741|FG000|Overall Study|Adverse Event|3|||
147472314|NCT02770807|531884742|FG001|Overall Study|Adverse Event|3|||
147472315|NCT02770807|531884743|FG002|Overall Study|Adverse Event|1|||
147472316|NCT02770807|531884741|FG000|Overall Study|Withdrawal by Subject|7|||
147472317|NCT02770807|531884742|FG001|Overall Study|Withdrawal by Subject|3|||
147472318|NCT02770807|531884743|FG002|Overall Study|Withdrawal by Subject|4|||
147472319|NCT02770807|531884741|FG000|Overall Study|Other|0|||
147472320|NCT02770807|531884742|FG001|Overall Study|Other|1|||
147472321|NCT02770807|531884743|FG002|Overall Study|Other|0|||
147472322|NCT02770807|531884741|FG000|Overall Study|Covid-Related Treatment/Visit Delay|15|||
147472323|NCT02770807|531884742|FG001|Overall Study|Covid-Related Treatment/Visit Delay|13|||
147472324|NCT02770807|531884743|FG002|Overall Study|Covid-Related Treatment/Visit Delay|17|||
147472325|NCT02770807|531884741|FG000|Overall Study|Physician Decision|0|||
147472326|NCT02770807|531884742|FG001|Overall Study|Physician Decision|0|||
147472327|NCT02770807|531884743|FG002|Overall Study|Physician Decision|1|||
147472328|NCT00222105|531884746|FG000|Overall Study|Removed due to wrong diagnosis|1|||
147472329|NCT00222105|531884746|FG000|Overall Study|Withdrawal by Subject|1|||
147472330|NCT00222105|531884746|FG000|Overall Study|Adverse Event|8|||
147472331|NCT00222105|531884746|FG000|Overall Study|Treatment delays|2|||
147472332|NCT00222105|531884746|FG000|Overall Study|Death|2|||
147472333|NCT01024244|531886401|FG000|Overall Study|Adverse Event|1|||
147472334|NCT01024244|531886402|FG001|Overall Study|Adverse Event|2|||
147472335|NCT01024244|531886403|FG002|Overall Study|Adverse Event|0|||
147472336|NCT01024244|531886404|FG003|Overall Study|Adverse Event|1|||
147472337|NCT01024244|531886405|FG004|Overall Study|Adverse Event|2|||
147472338|NCT01024244|531886401|FG000|Overall Study|Entry Criteria Not Met|0|||
147472339|NCT01024244|531886402|FG001|Overall Study|Entry Criteria Not Met|1|||
147472340|NCT01024244|531886403|FG002|Overall Study|Entry Criteria Not Met|0|||
147472341|NCT01024244|531886404|FG003|Overall Study|Entry Criteria Not Met|0|||
147472342|NCT01024244|531886405|FG004|Overall Study|Entry Criteria Not Met|0|||
147472343|NCT01024244|531886401|FG000|Overall Study|Lack of Efficacy|1|||
147472344|NCT01024244|531886402|FG001|Overall Study|Lack of Efficacy|0|||
147472345|NCT01024244|531886403|FG002|Overall Study|Lack of Efficacy|0|||
147472346|NCT01024244|531886404|FG003|Overall Study|Lack of Efficacy|0|||
147472347|NCT01024244|531886405|FG004|Overall Study|Lack of Efficacy|0|||
147472348|NCT01024244|531886401|FG000|Overall Study|Protocol Violation|1|||
147472349|NCT01024244|531886402|FG001|Overall Study|Protocol Violation|0|||
147472350|NCT01024244|531886403|FG002|Overall Study|Protocol Violation|0|||
147472351|NCT01024244|531886404|FG003|Overall Study|Protocol Violation|0|||
147472352|NCT01024244|531886405|FG004|Overall Study|Protocol Violation|2|||
147472353|NCT01024244|531886401|FG000|Overall Study|Sponsor Decision|14|||
147472354|NCT01024244|531886402|FG001|Overall Study|Sponsor Decision|7|||
147472355|NCT01024244|531886403|FG002|Overall Study|Sponsor Decision|14|||
147472356|NCT01024244|531886404|FG003|Overall Study|Sponsor Decision|12|||
147472357|NCT01024244|531886405|FG004|Overall Study|Sponsor Decision|10|||
147472358|NCT01024244|531886401|FG000|Overall Study|Withdrawal by Subject|0|||
147472359|NCT01024244|531886402|FG001|Overall Study|Withdrawal by Subject|1|||
147472360|NCT01024244|531886403|FG002|Overall Study|Withdrawal by Subject|0|||
147472361|NCT01024244|531886404|FG003|Overall Study|Withdrawal by Subject|0|||
147472362|NCT01024244|531886405|FG004|Overall Study|Withdrawal by Subject|0|||
147472363|NCT00374556|531886409|FG000|Overall Study|Lost to Follow-up|1|||
147472364|NCT00374556|531886410|FG001|Overall Study|Lost to Follow-up|0|||
147472365|NCT00374556|531886409|FG000|Overall Study|Removed at baseline due to medical cond|0|||
147472366|NCT00374556|531886410|FG001|Overall Study|Removed at baseline due to medical cond|1|||
147472367|NCT00473694|531886411|FG000|Overall Study|Adverse Event|0|||
147472368|NCT00473694|531886412|FG001|Overall Study|Adverse Event|1|||
147472369|NCT00473694|531886413|FG002|Overall Study|Adverse Event|0|||
147472370|NCT00473694|531886414|FG003|Overall Study|Adverse Event|0|||
147472371|NCT00473694|531886411|FG000|Overall Study|Participants did not receive treatment|11|||
147472372|NCT00473694|531886412|FG001|Overall Study|Participants did not receive treatment|3|||
147472373|NCT00473694|531886413|FG002|Overall Study|Participants did not receive treatment|5|||
147472374|NCT00473694|531886414|FG003|Overall Study|Participants did not receive treatment|6|||
147472375|NCT00473694|531886411|FG000|Overall Study|Lost to Follow-up|0|||
147472376|NCT00473694|531886412|FG001|Overall Study|Lost to Follow-up|0|||
147472377|NCT00473694|531886413|FG002|Overall Study|Lost to Follow-up|0|||
147472378|NCT00473694|531886414|FG003|Overall Study|Lost to Follow-up|1|||
147472379|NCT02468193|531886417|FG000|Overall Study|Adverse Event|4|||
147472380|NCT02468193|531886417|FG000|Overall Study|Subject/ Guardian decision|2|||
147472381|NCT00742781|531886418|FG000|Overall Study|Withdrawal by Subject|3|||
147472382|NCT01416181|531886419|FG000|Part 1|Other|10|||
147472383|NCT01416181|531886420|FG001|Part 1|Other|24|||
147472384|NCT01416181|531886419|FG000|Part 1|Death|0|||
147472385|NCT01416181|531886420|FG001|Part 1|Death|1|||
147472386|NCT01416181|531886419|FG000|Part 1|Investigator Decision|7|||
147472387|NCT01416181|531886420|FG001|Part 1|Investigator Decision|6|||
147472388|NCT01416181|531886419|FG000|Part 1|Withdrawal by Subject|74|||
147472389|NCT01416181|531886420|FG001|Part 1|Withdrawal by Subject|48|||
147472390|NCT01416181|531886419|FG000|Part 1|Lack of Efficacy|16|||
147472391|NCT01416181|531886420|FG001|Part 1|Lack of Efficacy|8|||
147472392|NCT01416181|531886419|FG000|Part 1|Lost to Follow-up|1|||
147472393|NCT01416181|531886420|FG001|Part 1|Lost to Follow-up|1|||
147472394|NCT01416181|531886419|FG000|Part 1|Adverse Event|15|||
147472395|NCT01416181|531886420|FG001|Part 1|Adverse Event|18|||
147472396|NCT01416181|531886419|FG000|Part 1|Ongoing in Follow-Up|14|||
147472397|NCT01416181|531886420|FG001|Part 1|Ongoing in Follow-Up|8|||
147472398|NCT01416181|531886419|FG000|Part 2|Adverse Event|11|||
147472399|NCT01416181|531886420|FG001|Part 2|Adverse Event|4|||
147472400|NCT01416181|531886419|FG000|Part 2|Other|234|||
147472401|NCT01416181|531886420|FG001|Part 2|Other|267|||
147472402|NCT01416181|531886419|FG000|Part 2|Investigator Decision|6|||
147472403|NCT01416181|531886420|FG001|Part 2|Investigator Decision|7|||
147472404|NCT01416181|531886419|FG000|Part 2|Withdrawal by Subject|14|||
147472405|NCT01416181|531886420|FG001|Part 2|Withdrawal by Subject|5|||
147472406|NCT01416181|531886419|FG000|Part 2|Lack of Efficacy|4|||
147472407|NCT01416181|531886420|FG001|Part 2|Lack of Efficacy|1|||
147472408|NCT01416181|531886419|FG000|Part 2|Lost to Follow-up|2|||
147472409|NCT01416181|531886420|FG001|Part 2|Lost to Follow-up|2|||
147472410|NCT00541307|531886422|FG000|Overall Study|Death|5|||
147666031|NCT03327324|532601669|FG003|Intervention (Month 3-Month 6)|Death|1|||
147666032|NCT03327324|532601670|FG004|Intervention (Month 3-Month 6)|Death|1|||
147666033|NCT03327324|532601671|FG005|Intervention (Month 3-Month 6)|Death|0|||
147472411|NCT00541307|531886422|FG000|Overall Study|Physician Decision|3|||
147472412|NCT00541307|531886422|FG000|Overall Study|Withdrawal by Subject|6|||
147472413|NCT00541307|531886422|FG000|Overall Study|Lost to Follow-up|4|||
147472414|NCT00541307|531886422|FG000|Overall Study|Subject returned early (outside window)|1|||
147472415|NCT00541307|531886422|FG000|Overall Study|Surgical Bypass|5|||
147472416|NCT04723537|531886423|FG000|Overall Study|Withdrawal by Subject|3|||
147472417|NCT04723537|531886424|FG001|Overall Study|Withdrawal by Subject|0|||
147472418|NCT04723537|531886425|FG002|Overall Study|Withdrawal by Subject|0|||
147472419|NCT04723537|531886423|FG000|Overall Study|Physician Decision|0|||
147472420|NCT04723537|531886424|FG001|Overall Study|Physician Decision|0|||
147472421|NCT04723537|531886425|FG002|Overall Study|Physician Decision|1|||
147472422|NCT04723537|531886423|FG000|Overall Study|Medical monitor decision, sponsor decision and other|1|||
147472423|NCT04723537|531886424|FG001|Overall Study|Medical monitor decision, sponsor decision and other|1|||
147472424|NCT04723537|531886425|FG002|Overall Study|Medical monitor decision, sponsor decision and other|1|||
147472425|NCT04645797|531886432|FG000|Overall Study|Disease Progression|3|||
147472426|NCT04645797|531886433|FG001|Overall Study|Disease Progression|3|||
147472427|NCT04645797|531886434|FG002|Overall Study|Disease Progression|1|||
147472428|NCT04645797|531886435|FG003|Overall Study|Disease Progression|0|||
147620305|NCT01037218|532427290|FG003|Overall Study|Lost to Follow-up|2|||
147620306|NCT01037218|532427287|FG000|Overall Study|Withdrawal by Subject|6|||
147620307|NCT01037218|532427288|FG001|Overall Study|Withdrawal by Subject|7|||
147620308|NCT01037218|532427289|FG002|Overall Study|Withdrawal by Subject|7|||
147620309|NCT01037218|532427290|FG003|Overall Study|Withdrawal by Subject|4|||
147415442|NCT02236988|531684856|FG003|Overall Study|Lost to Follow-up|1|||
147415443|NCT02236988|531684853|FG000|Overall Study|Unable to Comply with Study Visits|0|||
147415444|NCT02236988|531684854|FG001|Overall Study|Unable to Comply with Study Visits|0|||
147415445|NCT02236988|531684855|FG002|Overall Study|Unable to Comply with Study Visits|0|||
147415446|NCT02236988|531684856|FG003|Overall Study|Unable to Comply with Study Visits|2|||
147415447|NCT00730275|531684857|FG000|Overall Study|Withdrawal by Subject|0|||
147415448|NCT00730275|531684858|FG001|Overall Study|Withdrawal by Subject|0|||
147415449|NCT00730275|531684859|FG002|Overall Study|Withdrawal by Subject|0|||
147415450|NCT00730275|531684860|FG003|Overall Study|Withdrawal by Subject|1|||
147415451|NCT03921723|531684866|FG000|Period 2 (4 Days)|Withdrawal by Subject|3|||
147415452|NCT03921723|531684866|FG000|Period 3 (4 Days)|Withdrawal by Subject|1|||
147415453|NCT01461811|531684867|FG000|Overall Study|Adverse Event|2|||
147415454|NCT01461811|531684868|FG001|Overall Study|Adverse Event|1|||
147415455|NCT01461811|531684867|FG000|Overall Study|Subject decision unrelated to an AE|1|||
147415456|NCT01461811|531684868|FG001|Overall Study|Subject decision unrelated to an AE|1|||
147415457|NCT01461811|531684867|FG000|Overall Study|Noncompliance|1|||
147415458|NCT01461811|531684868|FG001|Overall Study|Noncompliance|1|||
147415459|NCT03015129|531684869|FG000|Overall Study|Death|2|||
147415460|NCT03015129|531684870|FG001|Overall Study|Death|2|||
147415461|NCT03015129|531684869|FG000|Overall Study|Lost to Follow-up|0|||
147415462|NCT03015129|531684870|FG001|Overall Study|Lost to Follow-up|1|||
147415463|NCT03015129|531684869|FG000|Overall Study|Progression of disease|38|||
147415464|NCT03015129|531684870|FG001|Overall Study|Progression of disease|33|||
147415465|NCT03015129|531684869|FG000|Overall Study|Adverse Event|0|||
147415466|NCT03015129|531684870|FG001|Overall Study|Adverse Event|4|||
147415467|NCT00338962|531684872|FG000|Overall Study|Lost to Follow-up|3|||
147415468|NCT00338962|531684873|FG001|Overall Study|Lost to Follow-up|3|||
147415469|NCT00338962|531684874|FG002|Overall Study|Lost to Follow-up|2|||
147415470|NCT00338962|531684875|FG003|Overall Study|Lost to Follow-up|3|||
147415471|NCT00338962|531684872|FG000|Overall Study|Withdrawal by Subject|1|||
147415472|NCT00338962|531684873|FG001|Overall Study|Withdrawal by Subject|0|||
147415473|NCT00338962|531684874|FG002|Overall Study|Withdrawal by Subject|0|||
147415474|NCT00338962|531684875|FG003|Overall Study|Withdrawal by Subject|0|||
147415475|NCT00338962|531684872|FG000|Overall Study|No Transportation|2|||
147415476|NCT00338962|531684873|FG001|Overall Study|No Transportation|0|||
147415477|NCT00338962|531684874|FG002|Overall Study|No Transportation|0|||
147415478|NCT00338962|531684875|FG003|Overall Study|No Transportation|0|||
147415479|NCT00338962|531684872|FG000|Overall Study|Time Constraint|2|||
147415480|NCT00338962|531684873|FG001|Overall Study|Time Constraint|0|||
147415481|NCT00338962|531684874|FG002|Overall Study|Time Constraint|0|||
147415482|NCT00338962|531684875|FG003|Overall Study|Time Constraint|0|||
147415483|NCT00338962|531684872|FG000|Overall Study|Moved|0|||
147415484|NCT00338962|531684873|FG001|Overall Study|Moved|1|||
147415485|NCT00338962|531684874|FG002|Overall Study|Moved|0|||
147415486|NCT00338962|531684875|FG003|Overall Study|Moved|0|||
147415487|NCT00338962|531684872|FG000|Overall Study|Adverse Event|0|||
147415488|NCT00338962|531684873|FG001|Overall Study|Adverse Event|0|||
147415489|NCT00338962|531684874|FG002|Overall Study|Adverse Event|2|||
147415490|NCT00338962|531684875|FG003|Overall Study|Adverse Event|0|||
147415491|NCT00338962|531684872|FG000|Overall Study|Poor Compliance|0|||
147415492|NCT00338962|531684873|FG001|Overall Study|Poor Compliance|0|||
147415493|NCT00338962|531684874|FG002|Overall Study|Poor Compliance|2|||
147415494|NCT00338962|531684875|FG003|Overall Study|Poor Compliance|0|||
147415495|NCT03733314|531684876|FG000|Remission-induction Period: (Weeks 0-12)|Withdrawal by Subject|2|||
147415496|NCT03733314|531684877|FG001|Remission-induction Period: (Weeks 0-12)|Withdrawal by Subject|0|||
147415497|NCT03733314|531684876|FG000|Rescue Period: (Weeks 12 to 24)|Withdrawal by Subject|1|||
147415498|NCT03733314|531684877|FG001|Rescue Period: (Weeks 12 to 24)|Withdrawal by Subject|2|||
147415499|NCT03733314|531684876|FG000|Rescue Period: (Weeks 12 to 24)|Progressive disease|0|||
147415500|NCT03733314|531684877|FG001|Rescue Period: (Weeks 12 to 24)|Progressive disease|2|||
147415501|NCT03733314|531684876|FG000|Extension Period:(Week 12-52/Week 24-64)|Lack of Efficacy|1|||
147415502|NCT03733314|531684877|FG001|Extension Period:(Week 12-52/Week 24-64)|Lack of Efficacy|1|||
147415503|NCT03733314|531684876|FG000|Extension Period:(Week 12-52/Week 24-64)|Progressive Disease|1|||
147415504|NCT03733314|531684877|FG001|Extension Period:(Week 12-52/Week 24-64)|Progressive Disease|0|||
147415505|NCT03733314|531684876|FG000|Extension Period:(Week 12-52/Week 24-64)|Other|3|||
147415506|NCT03733314|531684877|FG001|Extension Period:(Week 12-52/Week 24-64)|Other|2|||
147415507|NCT03046121|531684878|FG000|Overall Study|Death|32|||
147415508|NCT03046121|531684879|FG001|Overall Study|Death|60|||
147620310|NCT01037218|532427287|FG000|Overall Study|Partner Withdrew Consent|0|||
147415509|NCT03046121|531684878|FG000|Overall Study|Withdrawal by Subject|14|||
147620311|NCT01037218|532427288|FG001|Overall Study|Partner Withdrew Consent|3|||
147620312|NCT01037218|532427289|FG002|Overall Study|Partner Withdrew Consent|2|||
147666034|NCT03327324|532601666|FG000|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
147666035|NCT03327324|532601667|FG001|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
147666036|NCT03327324|532601668|FG002|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
147666037|NCT03327324|532601669|FG003|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
147666038|NCT03327324|532601670|FG004|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
147666039|NCT03327324|532601671|FG005|Intervention (Month 3-Month 6)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|14|||
147666040|NCT03327324|532601666|FG000|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|1|||
147666041|NCT03327324|532601667|FG001|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|0|||
147666042|NCT03327324|532601668|FG002|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|0|||
147666043|NCT03327324|532601669|FG003|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|0|||
147666044|NCT03327324|532601670|FG004|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|0|||
147666045|NCT03327324|532601671|FG005|Sustainability Follow-Up 1 (Month 6-9)|Incomplete (participant did not complete all data items collected during study visit)|0|||
147666046|NCT03327324|532601666|FG000|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|2|||
147666047|NCT03327324|532601667|FG001|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|1|||
147666048|NCT03327324|532601668|FG002|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|0|||
147666049|NCT03327324|532601669|FG003|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|0|||
147666050|NCT03327324|532601670|FG004|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|0|||
147666051|NCT03327324|532601671|FG005|Sustainability Follow-Up 1 (Month 6-9)|Left Nursing Home Facility|0|||
147666052|NCT03327324|532601666|FG000|Sustainability Follow-Up 1 (Month 6-9)|Death|1|||
147666053|NCT03327324|532601667|FG001|Sustainability Follow-Up 1 (Month 6-9)|Death|1|||
147666054|NCT03327324|532601668|FG002|Sustainability Follow-Up 1 (Month 6-9)|Death|1|||
147666055|NCT03327324|532601669|FG003|Sustainability Follow-Up 1 (Month 6-9)|Death|0|||
147666056|NCT03327324|532601670|FG004|Sustainability Follow-Up 1 (Month 6-9)|Death|0|||
147666057|NCT03327324|532601671|FG005|Sustainability Follow-Up 1 (Month 6-9)|Death|0|||
147666058|NCT03327324|532601666|FG000|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
147666059|NCT03327324|532601667|FG001|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
147666060|NCT03327324|532601668|FG002|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
147666061|NCT03327324|532601669|FG003|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|3|||
147666062|NCT03327324|532601670|FG004|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|5|||
147666063|NCT03327324|532601671|FG005|Sustainability Follow-Up 1 (Month 6-9)|COVID-Incomplete (couldn't collect all subject data due to Nursing Home COVID shutdown)|0|||
147666064|NCT03327324|532601666|FG000|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|1|||
147666065|NCT03327324|532601667|FG001|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|0|||
147666066|NCT03327324|532601668|FG002|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|0|||
147666067|NCT03327324|532601669|FG003|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|0|||
147666068|NCT03327324|532601670|FG004|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|0|||
147666069|NCT03327324|532601671|FG005|Sustainability Follow-Up 2 (Month 9-12)|Left Nursing Home|0|||
147666070|NCT03327324|532601666|FG000|Sustainability Follow-Up 2 (Month 9-12)|Death|1|||
147666071|NCT03327324|532601667|FG001|Sustainability Follow-Up 2 (Month 9-12)|Death|0|||
147666072|NCT03327324|532601668|FG002|Sustainability Follow-Up 2 (Month 9-12)|Death|0|||
147620313|NCT01037218|532427290|FG003|Overall Study|Partner Withdrew Consent|1|||
147620314|NCT01037218|532427287|FG000|Overall Study|Protocol Violation|0|||
147620315|NCT01037218|532427288|FG001|Overall Study|Protocol Violation|0|||
147620316|NCT01037218|532427289|FG002|Overall Study|Protocol Violation|2|||
147620317|NCT01037218|532427290|FG003|Overall Study|Protocol Violation|2|||
147620318|NCT01037218|532427287|FG000|Overall Study|Various|3|||
147620319|NCT01037218|532427288|FG001|Overall Study|Various|2|||
147620320|NCT01037218|532427289|FG002|Overall Study|Various|3|||
147620321|NCT01037218|532427290|FG003|Overall Study|Various|1|||
147620322|NCT02568072|532427291|FG000|Overall Study|Unavailable for appointment|23|||
147666073|NCT03327324|532601669|FG003|Sustainability Follow-Up 2 (Month 9-12)|Death|0|||
147666074|NCT03327324|532601670|FG004|Sustainability Follow-Up 2 (Month 9-12)|Death|0|||
147666075|NCT03327324|532601671|FG005|Sustainability Follow-Up 2 (Month 9-12)|Death|0|||
147666076|NCT00069264|532601684|FG000|Overall Study|Adverse Event|3|||
147666077|NCT00069264|532601684|FG000|Overall Study|Progressive Disease|23|||
147666078|NCT00069264|532601684|FG000|Overall Study|Withdrawal by Subject|3|||
147620323|NCT02568072|532427291|FG000|Overall Study|Unable to contact|3|||
147620324|NCT02568072|532427291|FG000|Overall Study|Diagnosis of Long QT Syndrome|1|||
147620325|NCT02568072|532427291|FG000|Overall Study|Withdrawal by Subject|1|||
147415510|NCT03046121|531684879|FG001|Overall Study|Withdrawal by Subject|12|||
147415511|NCT03214640|531684880|FG000|Overall Study|Protocol Violation|1|||
147415512|NCT03214640|531684881|FG001|Overall Study|Protocol Violation|2|||
147415513|NCT03214640|531684882|FG002|Overall Study|Protocol Violation|1|||
147415514|NCT03214640|531684883|FG003|Overall Study|Protocol Violation|4|||
147415515|NCT04155047|531684884|FG000|Overall Study|Adverse Event|1|||
147415516|NCT04155047|531684885|FG001|Overall Study|Adverse Event|0|||
147415517|NCT04155047|531684884|FG000|Overall Study|COVID-19: SUBJECT REFUSED STUDY VISITS DUE TO COVID-19 THREAT|1|||
147415518|NCT04155047|531684885|FG001|Overall Study|COVID-19: SUBJECT REFUSED STUDY VISITS DUE TO COVID-19 THREAT|0|||
147415519|NCT00403767|531684886|FG000|Overall Study|Adverse Event|993|||
147415520|NCT00403767|531684887|FG001|Overall Study|Adverse Event|919|||
147415521|NCT00403767|531684886|FG000|Overall Study|Non-compliant with study medication|134|||
147415522|NCT00403767|531684887|FG001|Overall Study|Non-compliant with study medication|164|||
147415523|NCT00403767|531684886|FG000|Overall Study|Consent withdrawn|671|||
147415524|NCT00403767|531684887|FG001|Overall Study|Consent withdrawn|673|||
147415525|NCT00403767|531684886|FG000|Overall Study|Investigator dec./not protocol-related|191|||
147415526|NCT00403767|531684887|FG001|Overall Study|Investigator dec./not protocol-related|178|||
147415527|NCT00403767|531684886|FG000|Overall Study|Lost to Follow-up|6|||
147415528|NCT00403767|531684887|FG001|Overall Study|Lost to Follow-up|8|||
147415529|NCT00403767|531684886|FG000|Overall Study|Protocol Violation|142|||
147415530|NCT00403767|531684887|FG001|Overall Study|Protocol Violation|124|||
147415531|NCT00403767|531684886|FG000|Overall Study|Clinical efficacy endpoint reached|300|||
147415532|NCT00403767|531684887|FG001|Overall Study|Clinical efficacy endpoint reached|332|||
147415533|NCT00403767|531684886|FG000|Overall Study|Study terminated by sponsor|82|||
147415534|NCT00403767|531684887|FG001|Overall Study|Study terminated by sponsor|69|||
147415535|NCT00403767|531684886|FG000|Overall Study|Missing/incomplete data|1|||
147415536|NCT00403767|531684887|FG001|Overall Study|Missing/incomplete data|1|||
147415537|NCT02229851|531684894|FG000|Main Phase (Double-blind Phase)|Unclassified|1|||
147415538|NCT02229851|531684895|FG001|Main Phase (Double-blind Phase)|Unclassified|2|||
147415539|NCT02229851|531684896|FG002|Main Phase (Double-blind Phase)|Unclassified|0|||
147415540|NCT02229851|531684897|FG003|Main Phase (Double-blind Phase)|Unclassified|0|||
147415541|NCT02229851|531684898|FG004|Main Phase (Double-blind Phase)|Unclassified|0|||
147415542|NCT02229851|531684899|FG005|Main Phase (Double-blind Phase)|Unclassified|0|||
147415543|NCT02229851|531684900|FG006|Main Phase (Double-blind Phase)|Unclassified|0|||
147415544|NCT02229851|531684894|FG000|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
147415545|NCT02229851|531684895|FG001|Main Phase (Double-blind Phase)|Lost to Follow-up|1|||
147415546|NCT02229851|531684896|FG002|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
147415547|NCT02229851|531684897|FG003|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
147472429|NCT04645797|531886436|FG004|Overall Study|Disease Progression|0|||
147472430|NCT04645797|531886437|FG005|Overall Study|Disease Progression|0|||
147472431|NCT04645797|531886438|FG006|Overall Study|Disease Progression|0|||
147472432|NCT04645797|531886432|FG000|Overall Study|Death|3|||
147472433|NCT04645797|531886433|FG001|Overall Study|Death|1|||
147472434|NCT04645797|531886434|FG002|Overall Study|Death|0|||
147472435|NCT04645797|531886435|FG003|Overall Study|Death|0|||
147472436|NCT04645797|531886436|FG004|Overall Study|Death|0|||
147472437|NCT04645797|531886437|FG005|Overall Study|Death|0|||
147472438|NCT04645797|531886438|FG006|Overall Study|Death|0|||
147472439|NCT01929083|531886441|FG000|Intervention 1|Lost to Follow-up|2|||
147472440|NCT01929083|531886442|FG001|Intervention 1|Lost to Follow-up|0|||
147472441|NCT01929083|531886441|FG000|Intervention 1|Nonadherent to study medications|1|||
147472442|NCT01929083|531886442|FG001|Intervention 1|Nonadherent to study medications|0|||
147472443|NCT01929083|531886441|FG000|Intervention 2|Adverse Event|0|||
147472444|NCT01929083|531886442|FG001|Intervention 2|Adverse Event|1|||
147472445|NCT02599402|531886443|FG000|Overall Study|Disease progression|153|||
147472446|NCT02599402|531886443|FG000|Overall Study|Study drug toxicity|201|||
147472447|NCT02599402|531886443|FG000|Overall Study|Death|26|||
147472448|NCT02599402|531886443|FG000|Overall Study|Adverse Event unrelated to study drug|23|||
147472449|NCT02599402|531886443|FG000|Overall Study|Participant request to discontinue study treatment|13|||
147472450|NCT02599402|531886443|FG000|Overall Study|Participant withdrew consent|5|||
147472451|NCT02599402|531886443|FG000|Overall Study|Lost to Follow-up|1|||
147472452|NCT02599402|531886443|FG000|Overall Study|Maximum Clinical Benefit|7|||
147472453|NCT02599402|531886443|FG000|Overall Study|Poor/non-compliance|1|||
147620326|NCT02568072|532427291|FG000|Overall Study|Sustained injury, marathon not run|24|||
147620327|NCT00897715|532427295|FG000|Overall Study|Lost to Follow-up|0|||
147620328|NCT00897715|532427296|FG001|Overall Study|Lost to Follow-up|1|||
147620329|NCT00897715|532427295|FG000|Overall Study|Physician Decision|1|||
147415548|NCT02229851|531684898|FG004|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
147415549|NCT02229851|531684899|FG005|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
147472454|NCT02599402|531886443|FG000|Overall Study|Pregnancy|1|||
147472455|NCT02599402|531886443|FG000|Overall Study|Participant no longer met study criteria|7|||
147472456|NCT02599402|531886443|FG000|Overall Study|Other Reasons|95|||
147472457|NCT01486264|531886450|FG000|Overall Study|Death|1|||
147472458|NCT01486264|531886451|FG001|Overall Study|Death|1|||
147472459|NCT01486264|531886450|FG000|Overall Study|Adverse Event|3|||
147620330|NCT00897715|532427296|FG001|Overall Study|Physician Decision|0|||
147666079|NCT00069264|532601684|FG000|Overall Study|Discon Therapy|3|||
147666080|NCT03177148|532601685|FG000|Overall Study|Lost to Follow-up|50|||
147666081|NCT03177148|532601686|FG001|Overall Study|Lost to Follow-up|1|||
147666082|NCT03177148|532601685|FG000|Overall Study|Death|1|||
147666083|NCT03177148|532601686|FG001|Overall Study|Death|0|||
147666084|NCT00732069|532601689|FG000|Washout After First Study Drug|Adverse Event|1|||
147666085|NCT00732069|532601690|FG001|Washout After First Study Drug|Adverse Event|0|||
147666086|NCT00732069|532601691|FG002|Washout After First Study Drug|Adverse Event|0|||
147666087|NCT00732069|532601692|FG003|Washout After First Study Drug|Adverse Event|0|||
147666088|NCT00732069|532601693|FG004|Washout After First Study Drug|Adverse Event|0|||
147666089|NCT00732069|532601694|FG005|Washout After First Study Drug|Adverse Event|0|||
147666090|NCT00577317|532601695|FG000|Overall Study|Study Terminated|0|||
147666091|NCT00577317|532601696|FG001|Overall Study|Study Terminated|2|||
147666092|NCT00846586|532601706|FG000|Overall Study|Adverse Event|20|||
147666093|NCT00846586|532601707|FG001|Overall Study|Adverse Event|10|||
147666094|NCT00846586|532601706|FG000|Overall Study|Subject withdrew consent|8|||
147666095|NCT00846586|532601707|FG001|Overall Study|Subject withdrew consent|10|||
147666096|NCT00846586|532601706|FG000|Overall Study|Administrative problems|5|||
147666097|NCT00846586|532601707|FG001|Overall Study|Administrative problems|4|||
147666098|NCT00846586|532601706|FG000|Overall Study|Death|2|||
147666099|NCT00846586|532601707|FG001|Overall Study|Death|0|||
147666100|NCT00846586|532601706|FG000|Overall Study|Protocol deviation|2|||
147666101|NCT00846586|532601707|FG001|Overall Study|Protocol deviation|6|||
147666102|NCT00846586|532601706|FG000|Overall Study|Abnormal test procedure result(s)|1|||
147666103|NCT00846586|532601707|FG001|Overall Study|Abnormal test procedure result(s)|0|||
147666104|NCT00846586|532601706|FG000|Overall Study|Lost to Follow-up|1|||
147666105|NCT00846586|532601707|FG001|Overall Study|Lost to Follow-up|4|||
147666106|NCT00846586|532601706|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
147666107|NCT00846586|532601707|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
147666108|NCT00875810|532601708|FG000|Overall Study|Withdrawal by Subject|1|||
147666109|NCT00875810|532601708|FG000|Overall Study|Physician Decision|3|||
147666110|NCT00875810|532601708|FG000|Overall Study|Lost to Follow-up|39|||
147666111|NCT00875810|532601708|FG000|Overall Study|Patient enroled but not implanted|2|||
147666112|NCT00875810|532601708|FG000|Overall Study|Device explanted|1|||
147666113|NCT00780975|532601709|FG000|Overall Study|Progressive disease|3|||
147666114|NCT00780975|532601709|FG000|Overall Study|Toxicity|5|||
147666115|NCT01061606|532601710|FG000|Overall Study|Adverse Event|1|||
147666116|NCT01061606|532601710|FG000|Overall Study|Death|1|||
147666117|NCT01061606|532601710|FG000|Overall Study|Disease Progression|4|||
147666118|NCT01061606|532601710|FG000|Overall Study|alternative therapy|2|||
147666119|NCT01204671|532601711|FG000|Overall Study|Adverse Event|4|||
147666120|NCT01204671|532601712|FG001|Overall Study|Adverse Event|3|||
147666121|NCT01204671|532601713|FG002|Overall Study|Adverse Event|3|||
147666122|NCT01204671|532601714|FG003|Overall Study|Adverse Event|3|||
147666123|NCT01204671|532601715|FG004|Overall Study|Adverse Event|1|||
147666124|NCT01204671|532601711|FG000|Overall Study|Withdrawal by Subject|2|||
147666125|NCT01204671|532601712|FG001|Overall Study|Withdrawal by Subject|3|||
147666126|NCT01204671|532601713|FG002|Overall Study|Withdrawal by Subject|4|||
147666127|NCT01204671|532601714|FG003|Overall Study|Withdrawal by Subject|5|||
147666128|NCT01204671|532601715|FG004|Overall Study|Withdrawal by Subject|3|||
147666129|NCT01204671|532601711|FG000|Overall Study|Lost to Follow-up|7|||
147666130|NCT01204671|532601712|FG001|Overall Study|Lost to Follow-up|8|||
147666131|NCT01204671|532601713|FG002|Overall Study|Lost to Follow-up|6|||
147666132|NCT01204671|532601714|FG003|Overall Study|Lost to Follow-up|4|||
147666133|NCT01204671|532601715|FG004|Overall Study|Lost to Follow-up|0|||
147666134|NCT01204671|532601711|FG000|Overall Study|Unknown Completion Status|1|||
147666135|NCT01204671|532601712|FG001|Overall Study|Unknown Completion Status|1|||
147666136|NCT01204671|532601713|FG002|Overall Study|Unknown Completion Status|0|||
147666137|NCT01204671|532601714|FG003|Overall Study|Unknown Completion Status|0|||
147666138|NCT01204671|532601715|FG004|Overall Study|Unknown Completion Status|0|||
147666139|NCT01204671|532601711|FG000|Overall Study|Physician Decision|0|||
147666140|NCT01204671|532601712|FG001|Overall Study|Physician Decision|0|||
147666141|NCT01204671|532601713|FG002|Overall Study|Physician Decision|0|||
147666142|NCT01204671|532601714|FG003|Overall Study|Physician Decision|1|||
147666143|NCT01204671|532601715|FG004|Overall Study|Physician Decision|0|||
147666144|NCT03106077|532601718|FG000|Overall Study|Screen Failure|94|||
147666145|NCT03106077|532601719|FG001|Overall Study|Screen Failure|0|||
147666146|NCT01274533|532601720|FG000|Overall Study|Withdrawal by Subject|1|||
147666147|NCT01274533|532601720|FG000|Overall Study|Non-compliance|1|||
147666148|NCT01274533|532601720|FG000|Overall Study|Disease progression|2|||
147666149|NCT03669588|532601721|FG000|Overall Study|Adverse Event|1|||
147666150|NCT03669588|532601722|FG001|Overall Study|Adverse Event|0|||
147666151|NCT03669588|532601721|FG000|Overall Study|Physician Decision|0|||
147666152|NCT03669588|532601722|FG001|Overall Study|Physician Decision|1|||
147666153|NCT03669588|532601721|FG000|Overall Study|Protocol Violation|1|||
147666154|NCT03669588|532601722|FG001|Overall Study|Protocol Violation|0|||
147666155|NCT03669588|532601721|FG000|Overall Study|Sponsor Decision|1|||
147666156|NCT03669588|532601722|FG001|Overall Study|Sponsor Decision|1|||
147666157|NCT03669588|532601721|FG000|Overall Study|Withdrawal by Subject|1|||
147620331|NCT00897715|532427295|FG000|Overall Study|increased risk of infection|1|||
147620332|NCT00897715|532427296|FG001|Overall Study|increased risk of infection|0|||
147620333|NCT00513240|532427298|FG000|Overall Study|Did not have intended surgery|3|||
147620334|NCT00513240|532427299|FG001|Overall Study|Did not have intended surgery|0|||
147620335|NCT00513240|532427298|FG000|Overall Study|Death|3|||
147415550|NCT02229851|531684900|FG006|Main Phase (Double-blind Phase)|Lost to Follow-up|0|||
147415551|NCT02229851|531684894|FG000|Main Phase (Double-blind Phase)|Withdrawal by Subject|4|||
147415552|NCT02229851|531684895|FG001|Main Phase (Double-blind Phase)|Withdrawal by Subject|12|||
147415553|NCT02229851|531684896|FG002|Main Phase (Double-blind Phase)|Withdrawal by Subject|4|||
147415554|NCT02229851|531684897|FG003|Main Phase (Double-blind Phase)|Withdrawal by Subject|0|||
147415555|NCT02229851|531684898|FG004|Main Phase (Double-blind Phase)|Withdrawal by Subject|0|||
147415556|NCT02229851|531684899|FG005|Main Phase (Double-blind Phase)|Withdrawal by Subject|0|||
147415557|NCT02229851|531684900|FG006|Main Phase (Double-blind Phase)|Withdrawal by Subject|0|||
147415558|NCT02229851|531684894|FG000|Main Phase (Double-blind Phase)|Protocol Violation|0|||
147415559|NCT02229851|531684895|FG001|Main Phase (Double-blind Phase)|Protocol Violation|0|||
147415560|NCT02229851|531684896|FG002|Main Phase (Double-blind Phase)|Protocol Violation|2|||
147415561|NCT02229851|531684897|FG003|Main Phase (Double-blind Phase)|Protocol Violation|0|||
147415562|NCT02229851|531684898|FG004|Main Phase (Double-blind Phase)|Protocol Violation|0|||
147415563|NCT02229851|531684899|FG005|Main Phase (Double-blind Phase)|Protocol Violation|0|||
147415564|NCT02229851|531684900|FG006|Main Phase (Double-blind Phase)|Protocol Violation|0|||
147415565|NCT02229851|531684894|FG000|Main Phase (Double-blind Phase)|Death|1|||
147415566|NCT02229851|531684895|FG001|Main Phase (Double-blind Phase)|Death|1|||
147415567|NCT02229851|531684896|FG002|Main Phase (Double-blind Phase)|Death|0|||
147415568|NCT02229851|531684897|FG003|Main Phase (Double-blind Phase)|Death|0|||
147415569|NCT02229851|531684898|FG004|Main Phase (Double-blind Phase)|Death|0|||
147415570|NCT02229851|531684899|FG005|Main Phase (Double-blind Phase)|Death|0|||
147415571|NCT02229851|531684900|FG006|Main Phase (Double-blind Phase)|Death|0|||
147415572|NCT02229851|531684894|FG000|Extension Phase (Open-label Phase)|Lost to Follow-up|0|||
147415573|NCT02229851|531684895|FG001|Extension Phase (Open-label Phase)|Lost to Follow-up|0|||
147415574|NCT02229851|531684896|FG002|Extension Phase (Open-label Phase)|Lost to Follow-up|0|||
147415575|NCT02229851|531684897|FG003|Extension Phase (Open-label Phase)|Lost to Follow-up|0|||
147415576|NCT02229851|531684898|FG004|Extension Phase (Open-label Phase)|Lost to Follow-up|1|||
147415577|NCT02229851|531684899|FG005|Extension Phase (Open-label Phase)|Lost to Follow-up|1|||
147415578|NCT02229851|531684900|FG006|Extension Phase (Open-label Phase)|Lost to Follow-up|1|||
147415579|NCT02229851|531684894|FG000|Extension Phase (Open-label Phase)|Withdrawal by Subject|0|||
147415580|NCT02229851|531684895|FG001|Extension Phase (Open-label Phase)|Withdrawal by Subject|0|||
147415581|NCT02229851|531684896|FG002|Extension Phase (Open-label Phase)|Withdrawal by Subject|0|||
147415582|NCT02229851|531684897|FG003|Extension Phase (Open-label Phase)|Withdrawal by Subject|1|||
147415583|NCT02229851|531684898|FG004|Extension Phase (Open-label Phase)|Withdrawal by Subject|4|||
147415584|NCT02229851|531684899|FG005|Extension Phase (Open-label Phase)|Withdrawal by Subject|3|||
147415585|NCT02229851|531684900|FG006|Extension Phase (Open-label Phase)|Withdrawal by Subject|1|||
147415586|NCT02229851|531684894|FG000|Extension Phase (Open-label Phase)|Death|0|||
147415587|NCT02229851|531684895|FG001|Extension Phase (Open-label Phase)|Death|0|||
147415588|NCT02229851|531684896|FG002|Extension Phase (Open-label Phase)|Death|0|||
147415589|NCT02229851|531684897|FG003|Extension Phase (Open-label Phase)|Death|1|||
147415590|NCT02229851|531684898|FG004|Extension Phase (Open-label Phase)|Death|0|||
147415591|NCT02229851|531684899|FG005|Extension Phase (Open-label Phase)|Death|1|||
147415592|NCT02229851|531684900|FG006|Extension Phase (Open-label Phase)|Death|1|||
147415593|NCT03541200|531684901|FG000|Overall Study|Adverse Event|19|||
147415594|NCT03541200|531684901|FG000|Overall Study|Death|1|||
147415595|NCT03541200|531684901|FG000|Overall Study|Lost to Follow-up|10|||
147415596|NCT03541200|531684901|FG000|Overall Study|Physician Decision|1|||
147415597|NCT03541200|531684901|FG000|Overall Study|Protocol Violation|51|||
147415598|NCT03541200|531684901|FG000|Overall Study|Withdrawal by Subject|23|||
147415599|NCT03541200|531684901|FG000|Overall Study|other|8|||
147415600|NCT03466073|531684902|FG000|Overall Study|Death|1|||
147415601|NCT03466073|531684903|FG001|Overall Study|Death|0|||
147415602|NCT03466073|531684904|FG002|Overall Study|Death|0|||
147415603|NCT03466073|531684905|FG003|Overall Study|Death|0|||
147415604|NCT03466073|531684906|FG004|Overall Study|Death|0|||
147415605|NCT03466073|531684907|FG005|Overall Study|Death|1|||
147415606|NCT02425904|531684911|FG000|Overall Study|Lost to Follow-up|1|||
147415607|NCT02425904|531684912|FG001|Overall Study|Lost to Follow-up|0|||
147415608|NCT02425904|531684911|FG000|Overall Study|Withdrawal by Subject|2|||
147415609|NCT02425904|531684912|FG001|Overall Study|Withdrawal by Subject|0|||
147415610|NCT02425904|531684911|FG000|Overall Study|Death|0|||
147415611|NCT02425904|531684912|FG001|Overall Study|Death|3|||
147415612|NCT01732822|531686915|FG000|Overall Study|Withdrawal by Subject|123|||
147415613|NCT01732822|531686916|FG001|Overall Study|Withdrawal by Subject|113|||
147415614|NCT00591370|531686917|FG000|Overall Study|Not Treated|2|||
147415615|NCT02735577|531686920|FG000|Disulfiram Treatment|Lost to Follow-up|1|||
147415616|NCT02735577|531686920|FG000|Optional 28 Days of Disulfiram Treatment|Lost to Follow-up|2|||
147415617|NCT00316602|531686921|FG000|Overall Study|Withdrawal by Subject|3|||
147472460|NCT01486264|531886451|FG001|Overall Study|Adverse Event|3|||
147472461|NCT01486264|531886450|FG000|Overall Study|Lack of Efficacy|6|||
147620336|NCT00513240|532427299|FG001|Overall Study|Death|3|||
147620337|NCT00513240|532427298|FG000|Overall Study|Withdrawal by Subject|7|||
147620338|NCT00513240|532427299|FG001|Overall Study|Withdrawal by Subject|4|||
147620339|NCT02714218|532427300|FG000|Pre-Treatment Period|Participant no longer meets study criteria|0|||
147620340|NCT02714218|532427301|FG001|Pre-Treatment Period|Participant no longer meets study criteria|1|||
147620341|NCT02714218|532427302|FG002|Pre-Treatment Period|Participant no longer meets study criteria|0|||
147620342|NCT02714218|532427300|FG000|Pre-Treatment Period|Other reasons|0|||
147620343|NCT02714218|532427301|FG001|Pre-Treatment Period|Other reasons|1|||
147620344|NCT02714218|532427302|FG002|Pre-Treatment Period|Other reasons|0|||
147620345|NCT02714218|532427300|FG000|Treatment Period|Disease Progression|55|||
147620346|NCT02714218|532427301|FG001|Treatment Period|Disease Progression|52|||
147620347|NCT02714218|532427302|FG002|Treatment Period|Disease Progression|14|||
147620348|NCT02714218|532427300|FG000|Treatment Period|Study drug toxicity|46|||
147620349|NCT02714218|532427301|FG001|Treatment Period|Study drug toxicity|70|||
147620350|NCT02714218|532427302|FG002|Treatment Period|Study drug toxicity|6|||
147620351|NCT02714218|532427300|FG000|Treatment Period|Adverse event unrelated to study drug|13|||
147620352|NCT02714218|532427301|FG001|Treatment Period|Adverse event unrelated to study drug|6|||
147620353|NCT02714218|532427302|FG002|Treatment Period|Adverse event unrelated to study drug|1|||
147620354|NCT02714218|532427300|FG000|Treatment Period|Request to discontinue treatment|1|||
147620355|NCT02714218|532427301|FG001|Treatment Period|Request to discontinue treatment|4|||
147620356|NCT02714218|532427302|FG002|Treatment Period|Request to discontinue treatment|1|||
147620357|NCT02714218|532427300|FG000|Treatment Period|Participant withdrew consent|2|||
147620358|NCT02714218|532427301|FG001|Treatment Period|Participant withdrew consent|2|||
147620359|NCT02714218|532427302|FG002|Treatment Period|Participant withdrew consent|0|||
147620360|NCT02714218|532427300|FG000|Treatment Period|Maximum clinical benefit|4|||
147620361|NCT02714218|532427301|FG001|Treatment Period|Maximum clinical benefit|2|||
147620362|NCT02714218|532427302|FG002|Treatment Period|Maximum clinical benefit|0|||
147620363|NCT02714218|532427300|FG000|Treatment Period|Administrative reason by sponsor|2|||
147620364|NCT02714218|532427301|FG001|Treatment Period|Administrative reason by sponsor|1|||
147620365|NCT02714218|532427302|FG002|Treatment Period|Administrative reason by sponsor|0|||
147620366|NCT02714218|532427300|FG000|Treatment Period|Other reasons|6|||
147620367|NCT02714218|532427301|FG001|Treatment Period|Other reasons|6|||
147620368|NCT02714218|532427302|FG002|Treatment Period|Other reasons|0|||
147620369|NCT02714218|532427300|FG000|Treatment Period|Completed treatment as per protocol|36|||
147620370|NCT02714218|532427301|FG001|Treatment Period|Completed treatment as per protocol|27|||
147620371|NCT02714218|532427302|FG002|Treatment Period|Completed treatment as per protocol|3|||
147620372|NCT02714218|532427300|FG000|Treatment Period|Not reported|9|||
147620373|NCT02714218|532427301|FG001|Treatment Period|Not reported|6|||
147620374|NCT02714218|532427302|FG002|Treatment Period|Not reported|0|||
147620375|NCT01930162|532427303|FG000|Overall Study|Abnormal test procedure result(s)|4|||
147620376|NCT01930162|532427303|FG000|Overall Study|Death|1|||
147620377|NCT02550561|532427304|FG000|Overall Study|Lost to Follow-up|5|||
147620378|NCT02550561|532427304|FG000|Overall Study|Withdrawal by Subject|1|||
147620379|NCT02285361|532427311|FG000|Overall Study|Protocol Violation|43|||
147620380|NCT02285361|532427311|FG000|Overall Study|Lost to Follow-up|5|||
147620381|NCT02285361|532427311|FG000|Overall Study|Not taken GIOTRIF|2|||
147620382|NCT02285361|532427311|FG000|Overall Study|Consented prior to the contract date|1|||
147620383|NCT01283464|532427312|FG000|Overall Study|Lost to Follow-up|0|||
147620384|NCT01283464|532427313|FG001|Overall Study|Lost to Follow-up|1|||
147620385|NCT01283464|532427312|FG000|Overall Study|Withdrawal by Subject|1|||
147620386|NCT01283464|532427313|FG001|Overall Study|Withdrawal by Subject|0|||
147620387|NCT01283464|532427312|FG000|Overall Study|Physician Decision|1|||
147620388|NCT01283464|532427313|FG001|Overall Study|Physician Decision|0|||
147620389|NCT03051100|532427314|FG000|Overall Study|Withdrawal by Subject|1|||
147620390|NCT03051100|532427315|FG001|Overall Study|Withdrawal by Subject|0|||
147620391|NCT01778855|532427316|FG000|Overall Study|Death|0|||
147620392|NCT01778855|532427317|FG001|Overall Study|Death|1|||
147620393|NCT02059135|532427318|FG000|Maternal Follow-up (ITT Population)|Withdrawal by Subject|3|||
147620394|NCT02059135|532427319|FG001|Maternal Follow-up (ITT Population)|Withdrawal by Subject|2|||
147620395|NCT02059135|532427318|FG000|Maternal Follow-up (ITT Population)|Lost to Follow-up|0|||
147620396|NCT02059135|532427319|FG001|Maternal Follow-up (ITT Population)|Lost to Follow-up|3|||
147472462|NCT01486264|531886451|FG001|Overall Study|Lack of Efficacy|10|||
147620397|NCT02059135|532427318|FG000|Maternal Follow-up (ITT Population)|declined to see site staff|0|||
147620398|NCT02059135|532427319|FG001|Maternal Follow-up (ITT Population)|declined to see site staff|1|||
147472463|NCT01486264|531886450|FG000|Overall Study|Withdrawal by Subject|7|||
147472464|NCT01486264|531886451|FG001|Overall Study|Withdrawal by Subject|18|||
147620399|NCT02059135|532427318|FG000|Maternal Follow-up (ITT Population)|didn't return to site (f/u elsewhere)|0|||
147620400|NCT02059135|532427319|FG001|Maternal Follow-up (ITT Population)|didn't return to site (f/u elsewhere)|1|||
147620401|NCT02059135|532427318|FG000|Neonatal Follow-up (Safety Population)|Lost to Follow-up|1|||
147472465|NCT01486264|531886450|FG000|Overall Study|Physician Decision|1|||
147472466|NCT01486264|531886451|FG001|Overall Study|Physician Decision|1|||
147472467|NCT01486264|531886450|FG000|Overall Study|Protocol Violation|3|||
147472468|NCT01486264|531886451|FG001|Overall Study|Protocol Violation|0|||
147472469|NCT01486264|531886450|FG000|Overall Study|Lost to Follow-up|3|||
147472470|NCT01486264|531886451|FG001|Overall Study|Lost to Follow-up|2|||
147472471|NCT01486264|531886450|FG000|Overall Study|Other|5|||
147472472|NCT01486264|531886451|FG001|Overall Study|Other|11|||
147472473|NCT01486264|531886450|FG000|Overall Study|Not treated|0|||
147472474|NCT01486264|531886451|FG001|Overall Study|Not treated|1|||
147472475|NCT00283387|531886452|FG000|First Intervention|Subject non-compliant|1|||
147472476|NCT00283387|531886453|FG001|First Intervention|Subject non-compliant|1|||
147472477|NCT00283387|531886452|FG000|First Intervention|Withdrawal by Subject|0|||
147666158|NCT03669588|532601722|FG001|Overall Study|Withdrawal by Subject|4|||
147415618|NCT00316602|531686922|FG001|Overall Study|Withdrawal by Subject|2|||
147415619|NCT00316602|531686921|FG000|Overall Study|Subject unwilling/unable to comply with|3|||
147415620|NCT00316602|531686922|FG001|Overall Study|Subject unwilling/unable to comply with|17|||
147415621|NCT00316602|531686921|FG000|Overall Study|Adverse Event|1|||
147415622|NCT00316602|531686922|FG001|Overall Study|Adverse Event|0|||
147415623|NCT00316602|531686921|FG000|Overall Study|Other|3|||
147415624|NCT00316602|531686922|FG001|Overall Study|Other|6|||
147415625|NCT01142232|531686923|FG000|Overall Study|Adverse Event|1|||
147415626|NCT01142232|531686924|FG001|Overall Study|Adverse Event|2|||
147415627|NCT01142232|531686925|FG002|Overall Study|Adverse Event|1|||
147415628|NCT01142232|531686926|FG003|Overall Study|Adverse Event|0|||
147415629|NCT01142232|531686927|FG004|Overall Study|Adverse Event|4|||
147415630|NCT01142232|531686923|FG000|Overall Study|Death|0|||
147415631|NCT01142232|531686924|FG001|Overall Study|Death|0|||
147415632|NCT01142232|531686925|FG002|Overall Study|Death|0|||
147415633|NCT01142232|531686926|FG003|Overall Study|Death|0|||
147415634|NCT01142232|531686927|FG004|Overall Study|Death|1|||
147415635|NCT01142232|531686923|FG000|Overall Study|Disease Progression|2|||
147415636|NCT01142232|531686924|FG001|Overall Study|Disease Progression|0|||
147415637|NCT01142232|531686925|FG002|Overall Study|Disease Progression|1|||
147415638|NCT01142232|531686926|FG003|Overall Study|Disease Progression|2|||
147415639|NCT01142232|531686927|FG004|Overall Study|Disease Progression|12|||
147415640|NCT01142232|531686923|FG000|Overall Study|Withdrawal by Subject|0|||
147415641|NCT01142232|531686924|FG001|Overall Study|Withdrawal by Subject|0|||
147415642|NCT01142232|531686925|FG002|Overall Study|Withdrawal by Subject|0|||
147415643|NCT01142232|531686926|FG003|Overall Study|Withdrawal by Subject|1|||
147415644|NCT01142232|531686927|FG004|Overall Study|Withdrawal by Subject|3|||
147415645|NCT01142232|531686923|FG000|Overall Study|Physician Decision|0|||
147415646|NCT01142232|531686924|FG001|Overall Study|Physician Decision|1|||
147415647|NCT01142232|531686925|FG002|Overall Study|Physician Decision|0|||
147415648|NCT01142232|531686926|FG003|Overall Study|Physician Decision|2|||
147415649|NCT01142232|531686927|FG004|Overall Study|Physician Decision|10|||
147415650|NCT01142232|531686923|FG000|Overall Study|Alternative Therapy|0|||
147415651|NCT01142232|531686924|FG001|Overall Study|Alternative Therapy|1|||
147415652|NCT01142232|531686925|FG002|Overall Study|Alternative Therapy|1|||
147415653|NCT01142232|531686926|FG003|Overall Study|Alternative Therapy|0|||
147415654|NCT01142232|531686927|FG004|Overall Study|Alternative Therapy|1|||
147415655|NCT01142232|531686923|FG000|Overall Study|Off Trt for other complicating disease|0|||
147415656|NCT01142232|531686924|FG001|Overall Study|Off Trt for other complicating disease|0|||
147415657|NCT01142232|531686925|FG002|Overall Study|Off Trt for other complicating disease|0|||
147415658|NCT01142232|531686926|FG003|Overall Study|Off Trt for other complicating disease|0|||
147415659|NCT01142232|531686927|FG004|Overall Study|Off Trt for other complicating disease|1|||
147415660|NCT01142232|531686923|FG000|Overall Study|Noncompliance|0|||
147415661|NCT01142232|531686924|FG001|Overall Study|Noncompliance|0|||
147415662|NCT01142232|531686925|FG002|Overall Study|Noncompliance|0|||
147415663|NCT01142232|531686926|FG003|Overall Study|Noncompliance|0|||
147415664|NCT01142232|531686927|FG004|Overall Study|Noncompliance|2|||
147415665|NCT00626990|531686928|FG000|Overall Study|Lack of Efficacy|6|||
147415666|NCT00626990|531686929|FG001|Overall Study|Lack of Efficacy|7|||
147415667|NCT00626990|531686930|FG002|Overall Study|Lack of Efficacy|49|||
147415668|NCT00626990|531686931|FG003|Overall Study|Lack of Efficacy|40|||
147415669|NCT00626990|531686928|FG000|Overall Study|Adverse Event|1|||
147415670|NCT00626990|531686929|FG001|Overall Study|Adverse Event|7|||
147415671|NCT00626990|531686930|FG002|Overall Study|Adverse Event|14|||
147415672|NCT00626990|531686931|FG003|Overall Study|Adverse Event|28|||
147415673|NCT00626990|531686928|FG000|Overall Study|Death|0|||
147415674|NCT00626990|531686929|FG001|Overall Study|Death|1|||
147472478|NCT00283387|531886453|FG001|First Intervention|Withdrawal by Subject|1|||
147472479|NCT00500071|531886457|FG000|Screening and Washout Phase|Protocol Violation|1|||
147415675|NCT00626990|531686930|FG002|Overall Study|Death|0|||
147415676|NCT00626990|531686931|FG003|Overall Study|Death|0|||
147415677|NCT00626990|531686928|FG000|Overall Study|Withdrawal by Subject|3|||
147415678|NCT00626990|531686929|FG001|Overall Study|Withdrawal by Subject|1|||
147415679|NCT00626990|531686930|FG002|Overall Study|Withdrawal by Subject|5|||
147415680|NCT00626990|531686931|FG003|Overall Study|Withdrawal by Subject|11|||
147472480|NCT00500071|531886457|FG000|Dose-optimization and Maintenance Phase|Adverse Event|13|||
147472481|NCT00500071|531886457|FG000|Dose-optimization and Maintenance Phase|Protocol Violation|2|||
147472482|NCT00500071|531886457|FG000|Dose-optimization and Maintenance Phase|Lack of Efficacy|2|||
147472483|NCT00500071|531886457|FG000|Dose-optimization and Maintenance Phase|Withdrawal by Subject|1|||
147472484|NCT00500071|531886457|FG000|Dose-optimization and Maintenance Phase|Lack of protocol compliance|4|||
147472485|NCT00500071|531886457|FG000|30-day Safety Follow-up|Lost to Follow-up|17|||
147472486|NCT01122927|531886458|FG000|Period 1 - Conversion Phase|Adverse Event|3|||
147472487|NCT01122927|531886459|FG001|Period 1 - Conversion Phase|Adverse Event|0|||
147472488|NCT01122927|531886458|FG000|Period 1 - Conversion Phase|Met Withdrawal Criteria|1|||
147472489|NCT01122927|531886459|FG001|Period 1 - Conversion Phase|Met Withdrawal Criteria|0|||
147472490|NCT01122927|531886458|FG000|Period 1 - Conversion Phase|Physician Decision|2|||
147472491|NCT01122927|531886459|FG001|Period 1 - Conversion Phase|Physician Decision|0|||
147472492|NCT01122927|531886458|FG000|Period 1 - Conversion Phase|Withdrawal by Subject|7|||
147472493|NCT01122927|531886459|FG001|Period 1 - Conversion Phase|Withdrawal by Subject|0|||
147472494|NCT01122927|531886458|FG000|Period 1 - Conversion Phase|Protocol Deviation|1|||
147472495|NCT01122927|531886459|FG001|Period 1 - Conversion Phase|Protocol Deviation|0|||
147472496|NCT01122927|531886458|FG000|Period 2- Open-label Treatment Phase|Lost to Follow-up|0|||
147472497|NCT01122927|531886459|FG001|Period 2- Open-label Treatment Phase|Lost to Follow-up|21|||
147472498|NCT01122927|531886458|FG000|Period 2- Open-label Treatment Phase|Adverse Event|0|||
147472499|NCT01122927|531886459|FG001|Period 2- Open-label Treatment Phase|Adverse Event|33|||
147472500|NCT01122927|531886458|FG000|Period 2- Open-label Treatment Phase|Sponsor Discontinued Trial|0|||
147472501|NCT01122927|531886459|FG001|Period 2- Open-label Treatment Phase|Sponsor Discontinued Trial|165|||
147472502|NCT01122927|531886458|FG000|Period 2- Open-label Treatment Phase|Met Withdrawal Criteria|0|||
147472503|NCT01122927|531886459|FG001|Period 2- Open-label Treatment Phase|Met Withdrawal Criteria|9|||
147472504|NCT01122927|531886458|FG000|Period 2- Open-label Treatment Phase|Physician Decision|0|||
147472505|NCT01122927|531886459|FG001|Period 2- Open-label Treatment Phase|Physician Decision|12|||
147472506|NCT01122927|531886458|FG000|Period 2- Open-label Treatment Phase|Withdrawal by Subject|0|||
147472507|NCT01122927|531886459|FG001|Period 2- Open-label Treatment Phase|Withdrawal by Subject|65|||
147472508|NCT01122927|531886458|FG000|Period 2- Open-label Treatment Phase|Lack of Efficacy|0|||
147472509|NCT01122927|531886459|FG001|Period 2- Open-label Treatment Phase|Lack of Efficacy|7|||
147472510|NCT03182738|531886460|FG000|Overall Study|Lost to Follow-up|9|||
147472511|NCT03182738|531886461|FG001|Overall Study|Lost to Follow-up|3|||
147472512|NCT03182738|531886460|FG000|Overall Study|Pregnancy|0|||
147472513|NCT03182738|531886461|FG001|Overall Study|Pregnancy|1|||
147472514|NCT03182738|531886460|FG000|Overall Study|Withdrawal by Subject|0|||
147472515|NCT03182738|531886461|FG001|Overall Study|Withdrawal by Subject|1|||
147472516|NCT03584009|531886462|FG000|Overall Study|Death|25|||
147472517|NCT03584009|531886463|FG001|Overall Study|Death|18|||
147472518|NCT03584009|531886462|FG000|Overall Study|Lost to Follow-up|0|||
147472519|NCT03584009|531886463|FG001|Overall Study|Lost to Follow-up|1|||
147472520|NCT03584009|531886462|FG000|Overall Study|Physician Decision|1|||
147472521|NCT03584009|531886463|FG001|Overall Study|Physician Decision|1|||
147472522|NCT03584009|531886462|FG000|Overall Study|Study Terminated by Sponsor|22|||
147472523|NCT03584009|531886463|FG001|Overall Study|Study Terminated by Sponsor|30|||
147472524|NCT03584009|531886462|FG000|Overall Study|Withdrawal by Subject|3|||
147472525|NCT03584009|531886463|FG001|Overall Study|Withdrawal by Subject|2|||
147472526|NCT00389207|531886464|FG000|Overall Study|Adverse Event|26|||
147472527|NCT00389207|531886465|FG001|Overall Study|Adverse Event|32|||
147472528|NCT00389207|531886466|FG002|Overall Study|Adverse Event|10|||
147472529|NCT00389207|531886464|FG000|Overall Study|Protocol Violation|3|||
147472530|NCT00389207|531886465|FG001|Overall Study|Protocol Violation|1|||
147472531|NCT00389207|531886466|FG002|Overall Study|Protocol Violation|4|||
147472532|NCT00389207|531886464|FG000|Overall Study|Lost to Follow-up|12|||
147472533|NCT00389207|531886465|FG001|Overall Study|Lost to Follow-up|9|||
147472534|NCT00389207|531886466|FG002|Overall Study|Lost to Follow-up|7|||
147472535|NCT00389207|531886464|FG000|Overall Study|Withdrawal by Subject|5|||
147472536|NCT00389207|531886465|FG001|Overall Study|Withdrawal by Subject|7|||
147472537|NCT00389207|531886466|FG002|Overall Study|Withdrawal by Subject|11|||
147472538|NCT00389207|531886464|FG000|Overall Study|Other|17|||
147472539|NCT00389207|531886465|FG001|Overall Study|Other|23|||
147472540|NCT00389207|531886466|FG002|Overall Study|Other|9|||
147472541|NCT00509106|531886469|FG000|Overall Study|Adverse Event|3|||
147472542|NCT00509106|531886470|FG001|Overall Study|Adverse Event|2|||
147620402|NCT02059135|532427319|FG001|Neonatal Follow-up (Safety Population)|Lost to Follow-up|0|||
147472543|NCT00509106|531886469|FG000|Overall Study|Noncompliance|0|||
147472544|NCT00509106|531886470|FG001|Overall Study|Noncompliance|1|||
147472545|NCT00509106|531886469|FG000|Overall Study|At the request of sponsor/investigator|1|||
147472546|NCT00509106|531886470|FG001|Overall Study|At the request of sponsor/investigator|2|||
147472547|NCT00509106|531886469|FG000|Overall Study|Withdrew consent|4|||
147472548|NCT00509106|531886470|FG001|Overall Study|Withdrew consent|8|||
147472549|NCT00509106|531886469|FG000|Overall Study|Lost to Follow-up|16|||
147472550|NCT00509106|531886470|FG001|Overall Study|Lost to Follow-up|10|||
147472551|NCT00509106|531886469|FG000|Overall Study|Other|1|||
147472552|NCT00509106|531886470|FG001|Overall Study|Other|0|||
147472553|NCT00509106|531886469|FG000|Overall Study|Death|6|||
147472554|NCT00509106|531886470|FG001|Overall Study|Death|6|||
147472555|NCT01309737|531886471|FG000|Week 0 to 16|Death|1|||
147472556|NCT01309737|531886472|FG001|Week 0 to 16|Death|0|||
147472557|NCT01309737|531886473|FG002|Week 0 to 16|Death|1|||
147472558|NCT01309737|531886474|FG003|Week 0 to 16|Death|0|||
147472559|NCT01309737|531886475|FG004|Week 0 to 16|Death|0|||
147472560|NCT01309737|531886471|FG000|Week 0 to 16|Adverse Event|11|||
147472561|NCT01309737|531886472|FG001|Week 0 to 16|Adverse Event|10|||
147472562|NCT01309737|531886473|FG002|Week 0 to 16|Adverse Event|5|||
147472563|NCT01309737|531886474|FG003|Week 0 to 16|Adverse Event|0|||
147472564|NCT01309737|531886475|FG004|Week 0 to 16|Adverse Event|0|||
147472565|NCT01309737|531886471|FG000|Week 0 to 16|Lack of Efficacy|15|||
147472566|NCT01309737|531886472|FG001|Week 0 to 16|Lack of Efficacy|2|||
147472567|NCT01309737|531886473|FG002|Week 0 to 16|Lack of Efficacy|24|||
147472568|NCT01309737|531886474|FG003|Week 0 to 16|Lack of Efficacy|0|||
147472569|NCT01309737|531886475|FG004|Week 0 to 16|Lack of Efficacy|0|||
147472570|NCT01309737|531886471|FG000|Week 0 to 16|Lost to Follow-up|7|||
147472571|NCT01309737|531886472|FG001|Week 0 to 16|Lost to Follow-up|8|||
147472572|NCT01309737|531886473|FG002|Week 0 to 16|Lost to Follow-up|3|||
147472573|NCT01309737|531886474|FG003|Week 0 to 16|Lost to Follow-up|0|||
147472574|NCT01309737|531886475|FG004|Week 0 to 16|Lost to Follow-up|0|||
147472575|NCT01309737|531886471|FG000|Week 0 to 16|Withdrawal by Subject|7|||
147472576|NCT01309737|531886472|FG001|Week 0 to 16|Withdrawal by Subject|6|||
147472577|NCT01309737|531886473|FG002|Week 0 to 16|Withdrawal by Subject|7|||
147472578|NCT01309737|531886474|FG003|Week 0 to 16|Withdrawal by Subject|0|||
147472579|NCT01309737|531886475|FG004|Week 0 to 16|Withdrawal by Subject|0|||
147472580|NCT01309737|531886471|FG000|Week 0 to 16|Other|10|||
147472581|NCT01309737|531886472|FG001|Week 0 to 16|Other|14|||
147472582|NCT01309737|531886473|FG002|Week 0 to 16|Other|4|||
147472583|NCT01309737|531886474|FG003|Week 0 to 16|Other|0|||
147472584|NCT01309737|531886475|FG004|Week 0 to 16|Other|0|||
147472585|NCT01309737|531886471|FG000|Week 0 to 16|Randomized, but not treated|1|||
147472586|NCT01309737|531886472|FG001|Week 0 to 16|Randomized, but not treated|0|||
147472587|NCT01309737|531886473|FG002|Week 0 to 16|Randomized, but not treated|0|||
147472588|NCT01309737|531886474|FG003|Week 0 to 16|Randomized, but not treated|0|||
147620403|NCT02059135|532427318|FG000|Neonatal Follow-up (Safety Population)|Death|3|||
147620404|NCT02059135|532427319|FG001|Neonatal Follow-up (Safety Population)|Death|2|||
147620405|NCT02059135|532427318|FG000|Neonatal Follow-up (Safety Population)|delivered at another hospital|0|||
147620406|NCT02059135|532427319|FG001|Neonatal Follow-up (Safety Population)|delivered at another hospital|1|||
147620407|NCT02059135|532427318|FG000|Neonatal Follow-up (Safety Population)|Withdrawal by Subject|0|||
147620408|NCT02059135|532427319|FG001|Neonatal Follow-up (Safety Population)|Withdrawal by Subject|1|||
147620409|NCT02289729|532427320|FG000|Overall Study|Lack of Efficacy|3|||
147620410|NCT02289729|532427320|FG000|Overall Study|Very Narrow Therapeutic Margin|1|||
147620411|NCT02289729|532427320|FG000|Overall Study|Withdrawal by Subject|1|||
147620412|NCT02289729|532427320|FG000|Overall Study|Death|1|||
147620413|NCT00931411|532427321|FG000|First Intervention - 42 Days|Adverse Event|2|||
147620414|NCT00931411|532427322|FG001|First Intervention - 42 Days|Adverse Event|3|||
147620415|NCT00931411|532427321|FG000|First Intervention - 42 Days|Lost to Follow-up|2|||
147620416|NCT00931411|532427322|FG001|First Intervention - 42 Days|Lost to Follow-up|0|||
147620417|NCT00931411|532427321|FG000|After Crossover - 14 Days (up to Day 56)|Adverse Event|0|||
147620418|NCT00931411|532427322|FG001|After Crossover - 14 Days (up to Day 56)|Adverse Event|1|||
147620419|NCT01949662|532427323|FG000|Overall Study|Death|9|||
147620420|NCT01949662|532427324|FG001|Overall Study|Death|7|||
147620421|NCT01949662|532427323|FG000|Overall Study|Discharged before an agitation event|8|||
147620422|NCT01949662|532427324|FG001|Overall Study|Discharged before an agitation event|3|||
147620423|NCT01949662|532427323|FG000|Overall Study|Dropped out|1|||
147620424|NCT01949662|532427324|FG001|Overall Study|Dropped out|3|||
147620425|NCT01949662|532427323|FG000|Overall Study|Ineligible|0|||
147620426|NCT01949662|532427324|FG001|Overall Study|Ineligible|1|||
147620427|NCT02291237|532427325|FG000|Overall Study|Study Terminated by Sponsor|72|||
147620428|NCT02291237|532427326|FG001|Overall Study|Study Terminated by Sponsor|67|||
147620429|NCT02291237|532427325|FG000|Overall Study|Adverse Event|1|||
147620430|NCT02291237|532427326|FG001|Overall Study|Adverse Event|3|||
147620431|NCT02291237|532427325|FG000|Overall Study|Investigator's Discretion|0|||
147620432|NCT02291237|532427326|FG001|Overall Study|Investigator's Discretion|3|||
147620433|NCT02291237|532427325|FG000|Overall Study|Withdrew Consent|11|||
147666159|NCT03669588|532601721|FG000|Overall Study|Rescue Therapy Needed|0|||
147472589|NCT01309737|531886475|FG004|Week 0 to 16|Randomized, but not treated|0|||
147620434|NCT02291237|532427326|FG001|Overall Study|Withdrew Consent|11|||
147620435|NCT02291237|532427325|FG000|Overall Study|Lost to Follow-up|0|||
147620436|NCT02291237|532427326|FG001|Overall Study|Lost to Follow-up|2|||
147620437|NCT02291237|532427325|FG000|Overall Study|Subject Required Prohibited Medication|2|||
147472590|NCT01309737|531886471|FG000|Week 16 to 52|Death|0|||
147472591|NCT01309737|531886472|FG001|Week 16 to 52|Death|0|||
147472592|NCT01309737|531886473|FG002|Week 16 to 52|Death|0|||
147472593|NCT01309737|531886474|FG003|Week 16 to 52|Death|0|||
147472594|NCT01309737|531886475|FG004|Week 16 to 52|Death|1|||
147472595|NCT01309737|531886471|FG000|Week 16 to 52|Adverse Event|7|||
147472596|NCT01309737|531886472|FG001|Week 16 to 52|Adverse Event|7|||
147472597|NCT01309737|531886473|FG002|Week 16 to 52|Adverse Event|0|||
147472598|NCT01309737|531886474|FG003|Week 16 to 52|Adverse Event|6|||
147472599|NCT01309737|531886475|FG004|Week 16 to 52|Adverse Event|5|||
147472600|NCT01309737|531886471|FG000|Week 16 to 52|Lack of Efficacy|107|||
147472601|NCT01309737|531886472|FG001|Week 16 to 52|Lack of Efficacy|76|||
147472602|NCT01309737|531886473|FG002|Week 16 to 52|Lack of Efficacy|0|||
147472603|NCT01309737|531886474|FG003|Week 16 to 52|Lack of Efficacy|25|||
147472604|NCT01309737|531886475|FG004|Week 16 to 52|Lack of Efficacy|21|||
147472605|NCT01309737|531886471|FG000|Week 16 to 52|Lost to Follow-up|4|||
147472606|NCT01309737|531886472|FG001|Week 16 to 52|Lost to Follow-up|2|||
147472607|NCT01309737|531886473|FG002|Week 16 to 52|Lost to Follow-up|0|||
147472608|NCT01309737|531886474|FG003|Week 16 to 52|Lost to Follow-up|1|||
147472609|NCT01309737|531886475|FG004|Week 16 to 52|Lost to Follow-up|4|||
147472610|NCT01309737|531886471|FG000|Week 16 to 52|Withdrawal by Subject|5|||
147472611|NCT01309737|531886472|FG001|Week 16 to 52|Withdrawal by Subject|6|||
147472612|NCT01309737|531886473|FG002|Week 16 to 52|Withdrawal by Subject|0|||
147472613|NCT01309737|531886474|FG003|Week 16 to 52|Withdrawal by Subject|0|||
147472614|NCT01309737|531886475|FG004|Week 16 to 52|Withdrawal by Subject|2|||
147472615|NCT01309737|531886471|FG000|Week 16 to 52|Other|10|||
147472616|NCT01309737|531886472|FG001|Week 16 to 52|Other|12|||
147472617|NCT01309737|531886473|FG002|Week 16 to 52|Other|0|||
147472618|NCT01309737|531886474|FG003|Week 16 to 52|Other|2|||
147472619|NCT01309737|531886475|FG004|Week 16 to 52|Other|0|||
147472620|NCT02240706|531886482|FG000|Overall Study|Lack of Efficacy|2|||
147472621|NCT02240706|531886483|FG001|Overall Study|Lack of Efficacy|2|||
147472622|NCT02240706|531886484|FG002|Overall Study|Lack of Efficacy|2|||
147472623|NCT02240706|531886485|FG003|Overall Study|Lack of Efficacy|2|||
147472624|NCT02240706|531886486|FG004|Overall Study|Lack of Efficacy|5|||
147472625|NCT02240706|531886487|FG005|Overall Study|Lack of Efficacy|0|||
147472626|NCT02240706|531886488|FG006|Overall Study|Lack of Efficacy|0|||
147472627|NCT02240706|531886482|FG000|Overall Study|Adverse Event|1|||
147472628|NCT02240706|531886483|FG001|Overall Study|Adverse Event|0|||
147472629|NCT02240706|531886484|FG002|Overall Study|Adverse Event|1|||
147472630|NCT02240706|531886485|FG003|Overall Study|Adverse Event|0|||
147472631|NCT02240706|531886486|FG004|Overall Study|Adverse Event|2|||
147472632|NCT02240706|531886487|FG005|Overall Study|Adverse Event|0|||
147472633|NCT02240706|531886488|FG006|Overall Study|Adverse Event|0|||
147472634|NCT02240706|531886482|FG000|Overall Study|Progressive disease|0|||
147472635|NCT02240706|531886483|FG001|Overall Study|Progressive disease|0|||
147472636|NCT02240706|531886484|FG002|Overall Study|Progressive disease|0|||
147472637|NCT02240706|531886485|FG003|Overall Study|Progressive disease|0|||
147472638|NCT02240706|531886486|FG004|Overall Study|Progressive disease|1|||
147472639|NCT02240706|531886487|FG005|Overall Study|Progressive disease|0|||
147472640|NCT02240706|531886488|FG006|Overall Study|Progressive disease|0|||
147472641|NCT02240706|531886482|FG000|Overall Study|Dose limiting toxicity|0|||
147472642|NCT02240706|531886483|FG001|Overall Study|Dose limiting toxicity|0|||
147472643|NCT02240706|531886484|FG002|Overall Study|Dose limiting toxicity|0|||
147472644|NCT02240706|531886485|FG003|Overall Study|Dose limiting toxicity|0|||
147472645|NCT02240706|531886486|FG004|Overall Study|Dose limiting toxicity|1|||
147472646|NCT02240706|531886487|FG005|Overall Study|Dose limiting toxicity|0|||
147472647|NCT02240706|531886488|FG006|Overall Study|Dose limiting toxicity|0|||
147472648|NCT02240706|531886482|FG000|Overall Study|Refused to continue taking medication|0|||
147472649|NCT02240706|531886483|FG001|Overall Study|Refused to continue taking medication|1|||
147472650|NCT02240706|531886484|FG002|Overall Study|Refused to continue taking medication|3|||
147472651|NCT02240706|531886485|FG003|Overall Study|Refused to continue taking medication|1|||
147472652|NCT02240706|531886486|FG004|Overall Study|Refused to continue taking medication|2|||
147472653|NCT02240706|531886487|FG005|Overall Study|Refused to continue taking medication|0|||
147472654|NCT02240706|531886488|FG006|Overall Study|Refused to continue taking medication|0|||
147472655|NCT02240706|531886482|FG000|Overall Study|Insurance billing concerns|0|||
147472656|NCT02240706|531886483|FG001|Overall Study|Insurance billing concerns|0|||
147472657|NCT02240706|531886484|FG002|Overall Study|Insurance billing concerns|0|||
147472658|NCT02240706|531886485|FG003|Overall Study|Insurance billing concerns|1|||
147472659|NCT02240706|531886486|FG004|Overall Study|Insurance billing concerns|0|||
147472660|NCT02240706|531886487|FG005|Overall Study|Insurance billing concerns|0|||
147472661|NCT02240706|531886488|FG006|Overall Study|Insurance billing concerns|0|||
147620438|NCT02291237|532427326|FG001|Overall Study|Subject Required Prohibited Medication|0|||
147472662|NCT01126580|531886494|FG000|Overall Study|Adverse Event|14|||
147472663|NCT01126580|531886495|FG001|Overall Study|Adverse Event|8|||
147472664|NCT01126580|531886496|FG002|Overall Study|Adverse Event|12|||
147472665|NCT01126580|531886494|FG000|Overall Study|Withdrawal by Subject|11|||
147472666|NCT01126580|531886495|FG001|Overall Study|Withdrawal by Subject|19|||
147472667|NCT01126580|531886496|FG002|Overall Study|Withdrawal by Subject|14|||
147472668|NCT01126580|531886494|FG000|Overall Study|Sponsor Decision|5|||
147472669|NCT01126580|531886495|FG001|Overall Study|Sponsor Decision|4|||
147472670|NCT01126580|531886496|FG002|Overall Study|Sponsor Decision|7|||
147472671|NCT01126580|531886494|FG000|Overall Study|Physician Decision|1|||
147666160|NCT03669588|532601722|FG001|Overall Study|Rescue Therapy Needed|1|||
147666161|NCT02008526|532601723|FG000|Overall Study|Death|0|||
147666162|NCT02008526|532601724|FG001|Overall Study|Death|2|||
147666163|NCT02008526|532601725|FG002|Overall Study|Death|1|||
147666164|NCT02008526|532601723|FG000|Overall Study|Withdrawal by Subject|3|||
147666165|NCT02008526|532601724|FG001|Overall Study|Withdrawal by Subject|3|||
147666166|NCT02008526|532601725|FG002|Overall Study|Withdrawal by Subject|2|||
147666167|NCT02008526|532601723|FG000|Overall Study|Lost to Follow-up|5|||
147666168|NCT02008526|532601724|FG001|Overall Study|Lost to Follow-up|9|||
147666169|NCT02008526|532601725|FG002|Overall Study|Lost to Follow-up|6|||
147666170|NCT00492726|532601726|FG000|Overall Study|Adverse Event|10|||
147666171|NCT00492726|532601727|FG001|Overall Study|Adverse Event|6|||
147666172|NCT00492726|532601726|FG000|Overall Study|Death|7|||
147666173|NCT00492726|532601727|FG001|Overall Study|Death|2|||
147666174|NCT00492726|532601726|FG000|Overall Study|Lack of Efficacy|0|||
147666175|NCT00492726|532601727|FG001|Overall Study|Lack of Efficacy|2|||
147666176|NCT00492726|532601726|FG000|Overall Study|Lost to Follow-up|27|||
147666177|NCT00492726|532601727|FG001|Overall Study|Lost to Follow-up|19|||
147666178|NCT00492726|532601726|FG000|Overall Study|Physician Decision|0|||
147666179|NCT00492726|532601727|FG001|Overall Study|Physician Decision|1|||
147666180|NCT00492726|532601726|FG000|Overall Study|Withdrawal by Subject|6|||
147666181|NCT00492726|532601727|FG001|Overall Study|Withdrawal by Subject|3|||
147666182|NCT00492726|532601726|FG000|Overall Study|Non compliant with study medication|0|||
147666183|NCT00492726|532601727|FG001|Overall Study|Non compliant with study medication|3|||
147666184|NCT01100502|532601729|FG000|Overall Study|Withdrawal by Subject|18|||
147666185|NCT01100502|532601730|FG001|Overall Study|Withdrawal by Subject|25|||
147666186|NCT01100502|532601729|FG000|Overall Study|Lost to Follow-up|13|||
147666187|NCT01100502|532601730|FG001|Overall Study|Lost to Follow-up|28|||
147666188|NCT01100502|532601729|FG000|Overall Study|Site request to end participation in study|0|||
147666189|NCT01100502|532601730|FG001|Overall Study|Site request to end participation in study|1|||
147666190|NCT01100502|532601729|FG000|Overall Study|Death|45|||
147666191|NCT01100502|532601730|FG001|Overall Study|Death|40|||
147666192|NCT04386902|532601731|FG000|Overall Study|Withdrawal by Subject|5|||
147666193|NCT04386902|532601731|FG000|Overall Study|Technical problems in the recording|5|||
147666194|NCT00721799|532601734|FG000|Overall Study|Withdrawal by Subject|7|||
147666195|NCT00721799|532601734|FG000|Overall Study|withdraw by subject after scan 1|1|||
147666196|NCT05158140|532601735|FG000|Overall Study|Death|0|||
147666197|NCT05158140|532601736|FG001|Overall Study|Death|0|||
147666198|NCT05158140|532601737|FG002|Overall Study|Death|0|||
147666199|NCT05158140|532601738|FG003|Overall Study|Death|1|||
147666200|NCT05158140|532601735|FG000|Overall Study|Lost to Follow-up|3|||
147666201|NCT05158140|532601736|FG001|Overall Study|Lost to Follow-up|6|||
147666202|NCT05158140|532601737|FG002|Overall Study|Lost to Follow-up|4|||
147666203|NCT05158140|532601738|FG003|Overall Study|Lost to Follow-up|3|||
147666204|NCT05158140|532601735|FG000|Overall Study|Randomized By Mistake Without Study Treatment|0|||
147666205|NCT05158140|532601736|FG001|Overall Study|Randomized By Mistake Without Study Treatment|0|||
147666206|NCT05158140|532601737|FG002|Overall Study|Randomized By Mistake Without Study Treatment|4|||
147666207|NCT05158140|532601738|FG003|Overall Study|Randomized By Mistake Without Study Treatment|1|||
147666208|NCT05158140|532601735|FG000|Overall Study|Withdrawal by Subject|3|||
147666209|NCT05158140|532601736|FG001|Overall Study|Withdrawal by Subject|7|||
147666210|NCT05158140|532601737|FG002|Overall Study|Withdrawal by Subject|3|||
147666211|NCT05158140|532601738|FG003|Overall Study|Withdrawal by Subject|7|||
147666212|NCT02337764|532603836|FG000|Overall Study|Pretreatment Event/Adverse Event|46|||
147666213|NCT02337764|532603836|FG000|Overall Study|Voluntary Withdrawal|12|||
147666214|NCT02337764|532603836|FG000|Overall Study|Lack of Efficacy|2|||
147666215|NCT02579629|532603847|FG000|Overall Study|Withdrawal by Subject|0|||
147666216|NCT02579629|532603848|FG001|Overall Study|Withdrawal by Subject|1|||
147666217|NCT02579629|532603849|FG002|Overall Study|Withdrawal by Subject|0|||
147666218|NCT02579629|532603847|FG000|Overall Study|Screen Failure|2|||
147666219|NCT02579629|532603848|FG001|Overall Study|Screen Failure|0|||
147666220|NCT02579629|532603849|FG002|Overall Study|Screen Failure|2|||
147666221|NCT01930539|532603850|FG000|Overall Study|Withdrawal by Subject|2|||
147666222|NCT01930539|532603851|FG001|Overall Study|Withdrawal by Subject|2|||
147666223|NCT01190891|532603852|FG000|Overall Study|Protocol Violation|1|||
147666224|NCT01190891|532603853|FG001|Overall Study|Protocol Violation|0|||
147666225|NCT01190891|532603852|FG000|Overall Study|Withdrawal by Subject|5|||
147666226|NCT01190891|532603853|FG001|Overall Study|Withdrawal by Subject|0|||
147666227|NCT01926028|532603854|FG000|Overall Study|Lost to Follow-up|7|||
147666228|NCT01926028|532603855|FG001|Overall Study|Lost to Follow-up|6|||
147415681|NCT00626990|531686928|FG000|Overall Study|Protocol Violation|0|||
147415682|NCT00626990|531686929|FG001|Overall Study|Protocol Violation|1|||
147415683|NCT00626990|531686930|FG002|Overall Study|Protocol Violation|1|||
147415684|NCT00626990|531686931|FG003|Overall Study|Protocol Violation|0|||
147415685|NCT00626990|531686928|FG000|Overall Study|Various different reasons/missing|4|||
147415686|NCT00626990|531686929|FG001|Overall Study|Various different reasons/missing|8|||
147415687|NCT00626990|531686930|FG002|Overall Study|Various different reasons/missing|8|||
147415688|NCT00626990|531686931|FG003|Overall Study|Various different reasons/missing|16|||
147415689|NCT04138576|531686932|FG000|Overall Study|Due to epidemiological situation (COVID-19) patients were dropped out from the study.|16|||
147415690|NCT01994837|531686933|FG000|Overall Study|Progressive disease per protocol|23|||
147415691|NCT01994837|531686933|FG000|Overall Study|Adv event related to progressive disease|3|||
147415692|NCT01994837|531686933|FG000|Overall Study|Fatal progressive disease|2|||
147415693|NCT01994837|531686933|FG000|Overall Study|Adverse event not related to progression|1|||
147415694|NCT01994837|531686933|FG000|Overall Study|Chose palliative care|1|||
147415695|NCT01994837|531686933|FG000|Overall Study|Proceeded to transplant|1|||
147415696|NCT01994837|531686933|FG000|Overall Study|Removed from study due to no response|1|||
147415697|NCT00574873|531686935|FG000|Overall Study|Withdrawal by Subject|18|||
147415698|NCT00574873|531686936|FG001|Overall Study|Withdrawal by Subject|19|||
147415699|NCT00574873|531686935|FG000|Overall Study|Investigator request|18|||
147415700|NCT00574873|531686936|FG001|Overall Study|Investigator request|8|||
147415701|NCT00574873|531686935|FG000|Overall Study|Death|15|||
147415702|NCT00574873|531686936|FG001|Overall Study|Death|14|||
147415703|NCT00574873|531686935|FG000|Overall Study|Lost to Follow-up|14|||
147415704|NCT00574873|531686936|FG001|Overall Study|Lost to Follow-up|5|||
147415705|NCT00574873|531686935|FG000|Overall Study|Other|40|||
147415706|NCT00574873|531686936|FG001|Overall Study|Other|4|||
147415707|NCT00574873|531686935|FG000|Overall Study|Discontinuation of study by sponsor|5|||
147415708|NCT00574873|531686936|FG001|Overall Study|Discontinuation of study by sponsor|199|||
147415709|NCT00574873|531686935|FG000|Overall Study|Blank, site closed per local regulations|2|||
147415710|NCT00574873|531686936|FG001|Overall Study|Blank, site closed per local regulations|2|||
147415711|NCT00574873|531686935|FG000|Overall Study|Extension Study|126|||
147415712|NCT00574873|531686936|FG001|Overall Study|Extension Study|0|||
147415713|NCT00581555|531686937|FG000|Overall Study|Adverse Event|4|||
147415714|NCT00581555|531686938|FG001|Overall Study|Adverse Event|3|||
147415715|NCT00581555|531686937|FG000|Overall Study|Physician Decision|3|||
147415716|NCT00581555|531686938|FG001|Overall Study|Physician Decision|2|||
147415717|NCT00581555|531686937|FG000|Overall Study|Withdrawal by Subject|18|||
147415718|NCT00581555|531686938|FG001|Overall Study|Withdrawal by Subject|9|||
147415719|NCT00581555|531686937|FG000|Overall Study|Lost to Follow-up|2|||
147415720|NCT00581555|531686938|FG001|Overall Study|Lost to Follow-up|2|||
147415721|NCT00581555|531686937|FG000|Overall Study|Other reasons|16|||
147415722|NCT00581555|531686938|FG001|Overall Study|Other reasons|4|||
147415723|NCT00201643|531686939|FG000|Overall Study|Withdrawal by Subject|5|||
147415724|NCT00201643|531686940|FG001|Overall Study|Withdrawal by Subject|4|||
147415725|NCT02898077|531686944|FG000|Overall Study|Enrolled/randomized, but never treated|1|||
147415726|NCT02898077|531686945|FG001|Overall Study|Enrolled/randomized, but never treated|1|||
147415727|NCT02898077|531686944|FG000|Overall Study|Lost to Follow-up|4|||
147415728|NCT02898077|531686945|FG001|Overall Study|Lost to Follow-up|3|||
147415729|NCT02898077|531686944|FG000|Overall Study|Physician Decision|0|||
147415730|NCT02898077|531686945|FG001|Overall Study|Physician Decision|2|||
147415731|NCT02898077|531686944|FG000|Overall Study|Sponsor Decision|32|||
147415732|NCT02898077|531686945|FG001|Overall Study|Sponsor Decision|13|||
147415733|NCT02898077|531686944|FG000|Overall Study|Withdrawal by Subject|6|||
147415734|NCT02898077|531686945|FG001|Overall Study|Withdrawal by Subject|3|||
147415735|NCT02898077|531686944|FG000|Overall Study|Discontinued from treatment but refused follow-up|2|||
147415736|NCT02898077|531686945|FG001|Overall Study|Discontinued from treatment but refused follow-up|1|||
147415737|NCT02898077|531686944|FG000|Overall Study|Ended extension period|3|||
147415738|NCT02898077|531686945|FG001|Overall Study|Ended extension period|0|||
147415739|NCT03207451|531686946|FG000|Overall Study|scheduling conflict|1|||
147415740|NCT03207451|531686947|FG001|Overall Study|scheduling conflict|0|||
147415741|NCT03207451|531686948|FG002|Overall Study|scheduling conflict|2|||
147415742|NCT03207451|531686949|FG003|Overall Study|scheduling conflict|2|||
147415743|NCT03207451|531686946|FG000|Overall Study|Adverse Event|0|||
147415744|NCT03207451|531686947|FG001|Overall Study|Adverse Event|0|||
147415745|NCT03207451|531686948|FG002|Overall Study|Adverse Event|0|||
147415746|NCT03207451|531686949|FG003|Overall Study|Adverse Event|1|||
147415747|NCT00772330|531686950|FG000|Overall Study|Lost to Follow-up|3|||
147415748|NCT01519089|531686951|FG000|Overall Study|Adverse Event|4|||
147415749|NCT01519089|531686952|FG001|Overall Study|Adverse Event|4|||
147415750|NCT01519089|531686951|FG000|Overall Study|Lack of Efficacy|0|||
147415751|NCT01519089|531686952|FG001|Overall Study|Lack of Efficacy|2|||
147415752|NCT01519089|531686951|FG000|Overall Study|Lost to Follow-up|1|||
147415753|NCT01519089|531686952|FG001|Overall Study|Lost to Follow-up|0|||
147415754|NCT01519089|531686951|FG000|Overall Study|Withdrawal by Subject|0|||
147415755|NCT01519089|531686952|FG001|Overall Study|Withdrawal by Subject|2|||
147415756|NCT01519089|531686951|FG000|Overall Study|Other|2|||
147415757|NCT01519089|531686952|FG001|Overall Study|Other|6|||
147415758|NCT01519089|531686951|FG000|Overall Study|Not received study drug|0|||
147415759|NCT01519089|531686952|FG001|Overall Study|Not received study drug|1|||
147415760|NCT00127205|531686953|FG000|Overall Study|Adverse Event|228|||
147472672|NCT01126580|531886495|FG001|Overall Study|Physician Decision|1|||
147415761|NCT00127205|531686954|FG001|Overall Study|Adverse Event|387|||
147415762|NCT00127205|531686955|FG002|Overall Study|Adverse Event|273|||
147415763|NCT00127205|531686953|FG000|Overall Study|Death|8|||
147415764|NCT00127205|531686954|FG001|Overall Study|Death|6|||
147472673|NCT01126580|531886496|FG002|Overall Study|Physician Decision|2|||
147472674|NCT01126580|531886494|FG000|Overall Study|Entry Criteria Not Met|1|||
147472675|NCT01126580|531886495|FG001|Overall Study|Entry Criteria Not Met|1|||
147472676|NCT01126580|531886496|FG002|Overall Study|Entry Criteria Not Met|2|||
147472677|NCT01126580|531886494|FG000|Overall Study|Lack of Efficacy|2|||
147472678|NCT01126580|531886495|FG001|Overall Study|Lack of Efficacy|3|||
147472679|NCT01126580|531886496|FG002|Overall Study|Lack of Efficacy|4|||
147472680|NCT01126580|531886494|FG000|Overall Study|Protocol Violation|0|||
147472681|NCT01126580|531886495|FG001|Overall Study|Protocol Violation|1|||
147472682|NCT01126580|531886496|FG002|Overall Study|Protocol Violation|2|||
147472683|NCT01126580|531886494|FG000|Overall Study|Lost to Follow-up|15|||
147472684|NCT01126580|531886495|FG001|Overall Study|Lost to Follow-up|13|||
147472685|NCT01126580|531886496|FG002|Overall Study|Lost to Follow-up|9|||
147472686|NCT01126580|531886494|FG000|Overall Study|Treatment Non-compliance|0|||
147472687|NCT01126580|531886495|FG001|Overall Study|Treatment Non-compliance|2|||
147472688|NCT01126580|531886496|FG002|Overall Study|Treatment Non-compliance|3|||
147472689|NCT01731002|531886506|FG000|Overall Study|Adverse Event|0|||
147472690|NCT01731002|531886507|FG001|Overall Study|Adverse Event|2|||
147472691|NCT01731002|531886508|FG002|Overall Study|Adverse Event|2|||
147472692|NCT01731002|531886506|FG000|Overall Study|Non-Compliant|0|||
147472693|NCT01731002|531886507|FG001|Overall Study|Non-Compliant|1|||
147472694|NCT01731002|531886508|FG002|Overall Study|Non-Compliant|0|||
147472695|NCT01731002|531886506|FG000|Overall Study|Lost to Follow-up|1|||
147472696|NCT01731002|531886507|FG001|Overall Study|Lost to Follow-up|0|||
147472697|NCT01731002|531886508|FG002|Overall Study|Lost to Follow-up|0|||
147472698|NCT01731002|531886506|FG000|Overall Study|Test Agent Discontinuation|0|||
147472699|NCT01731002|531886507|FG001|Overall Study|Test Agent Discontinuation|1|||
147472700|NCT01731002|531886508|FG002|Overall Study|Test Agent Discontinuation|0|||
147472701|NCT01731002|531886506|FG000|Overall Study|Uncontrolled Intraocular Pressure (IOP)|2|||
147472702|NCT01731002|531886507|FG001|Overall Study|Uncontrolled Intraocular Pressure (IOP)|0|||
147472703|NCT01731002|531886508|FG002|Overall Study|Uncontrolled Intraocular Pressure (IOP)|0|||
147472704|NCT01731002|531886506|FG000|Overall Study|Elevated IOP|1|||
147472705|NCT01731002|531886507|FG001|Overall Study|Elevated IOP|0|||
147472706|NCT01731002|531886508|FG002|Overall Study|Elevated IOP|0|||
147472707|NCT01731002|531886506|FG000|Overall Study|Inappropriate use of study medications|0|||
147472708|NCT01731002|531886507|FG001|Overall Study|Inappropriate use of study medications|0|||
147472709|NCT01731002|531886508|FG002|Overall Study|Inappropriate use of study medications|1|||
147472710|NCT03430310|531886511|FG000|Overall Study|Protocol Violation|2|||
147472711|NCT03430310|531886512|FG001|Overall Study|Protocol Violation|0|||
147472712|NCT03430310|531886511|FG000|Overall Study|Withdrawal by Subject|3|||
147472713|NCT03430310|531886512|FG001|Overall Study|Withdrawal by Subject|2|||
147472714|NCT03430310|531886511|FG000|Overall Study|COVID shutdown March 2020|0|||
147472715|NCT03430310|531886512|FG001|Overall Study|COVID shutdown March 2020|1|||
147472716|NCT01446809|531886513|FG000|Overall Study|Adverse Event|0|||
147472717|NCT01446809|531886514|FG001|Overall Study|Adverse Event|0|||
147472718|NCT01446809|531886515|FG002|Overall Study|Adverse Event|1|||
147472719|NCT01446809|531886513|FG000|Overall Study|Failure to complete study procedures|0|||
147472720|NCT01446809|531886514|FG001|Overall Study|Failure to complete study procedures|0|||
147472721|NCT01446809|531886515|FG002|Overall Study|Failure to complete study procedures|1|||
147472722|NCT01331161|531886516|FG000|Overall Study|Physician Decision|1|||
147472723|NCT01331161|531886517|FG001|Overall Study|Physician Decision|0|||
147472724|NCT01331161|531886516|FG000|Overall Study|Lost to Follow-up|0|||
147472725|NCT01331161|531886517|FG001|Overall Study|Lost to Follow-up|1|||
147472726|NCT01331161|531886516|FG000|Overall Study|Pregnancy|0|||
147472727|NCT01331161|531886517|FG001|Overall Study|Pregnancy|1|||
147472728|NCT02581995|531886518|FG000|Overall Study|Unspecified other|3|||
147472729|NCT02581995|531886518|FG000|Overall Study|Adverse Event|6|||
147472730|NCT02581995|531886518|FG000|Overall Study|Lost to Follow-up|5|||
147472731|NCT02581995|531886518|FG000|Overall Study|Withdrawal by participant|12|||
147472732|NCT02581995|531886518|FG000|Overall Study|Physician Decision|1|||
147472733|NCT02581995|531886518|FG000|Overall Study|Death|4|||
147472734|NCT03874234|531888551|FG000|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
147472735|NCT03874234|531888552|FG001|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
147472736|NCT03874234|531888553|FG002|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
147472737|NCT03874234|531888554|FG003|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|1|||
147472738|NCT03874234|531888555|FG004|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
147472739|NCT03874234|531888556|FG005|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
147472740|NCT03874234|531888557|FG006|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
147472741|NCT03874234|531888558|FG007|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
147472742|NCT03874234|531888559|FG008|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
147472743|NCT03874234|531888560|FG009|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
147472744|NCT03874234|531888561|FG010|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
147472745|NCT03874234|531888562|FG011|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
147472746|NCT03874234|531888563|FG012|Part A: Cohort 1-Period 1 (Day1)|Physician Decision|0|||
147620439|NCT00729937|532427329|FG000|Overall Study|Lost to Follow-up|49|||
147666229|NCT01926028|532603856|FG002|Overall Study|Lost to Follow-up|0|||
147666230|NCT01926028|532603854|FG000|Overall Study|Physician Decision|1|||
147415765|NCT00127205|531686955|FG002|Overall Study|Death|5|||
147415766|NCT00127205|531686953|FG000|Overall Study|Withdrawal by Subject|318|||
147415767|NCT00127205|531686954|FG001|Overall Study|Withdrawal by Subject|310|||
147415768|NCT00127205|531686955|FG002|Overall Study|Withdrawal by Subject|172|||
147415769|NCT00127205|531686953|FG000|Overall Study|Other-non protocol specified|142|||
147415770|NCT00127205|531686954|FG001|Overall Study|Other-non protocol specified|129|||
147415771|NCT00127205|531686955|FG002|Overall Study|Other-non protocol specified|77|||
147415772|NCT00127205|531686953|FG000|Overall Study|Data not reported|6|||
147415773|NCT00127205|531686954|FG001|Overall Study|Data not reported|10|||
147415774|NCT00127205|531686955|FG002|Overall Study|Data not reported|1|||
147415775|NCT00127205|531686953|FG000|Overall Study|Progression|127|||
147415776|NCT00127205|531686954|FG001|Overall Study|Progression|131|||
147415777|NCT00127205|531686955|FG002|Overall Study|Progression|84|||
147415778|NCT01353859|531686958|FG000|Overall Study|Adverse Event|3|||
147415779|NCT01353859|531686958|FG000|Overall Study|Lack of Efficacy|1|||
147415780|NCT01659853|531686959|FG000|Washout , 3 to 7 Days|Adverse Event|1|||
147415781|NCT01659853|531686960|FG001|Washout , 3 to 7 Days|Adverse Event|0|||
147415782|NCT01659853|531686959|FG000|Washout , 3 to 7 Days|Protocol Violation|1|||
147415783|NCT01659853|531686960|FG001|Washout , 3 to 7 Days|Protocol Violation|0|||
147415784|NCT05032872|531686961|FG000|Overall Study|Adverse Event|1|||
147415785|NCT05032872|531686962|FG001|Overall Study|Adverse Event|0|||
147415786|NCT05032872|531686961|FG000|Overall Study|Lost to Follow-up|2|||
147415787|NCT05032872|531686962|FG001|Overall Study|Lost to Follow-up|4|||
147415788|NCT05032872|531686961|FG000|Overall Study|Withdrawal by Subject|4|||
147415789|NCT05032872|531686962|FG001|Overall Study|Withdrawal by Subject|3|||
147415790|NCT00910039|531686963|FG000|Overall Study|Physician Decision|1|||
147415791|NCT00406692|531686968|FG000|Overall Study|Withdrawal by Subject|4|||
147415792|NCT00406692|531686968|FG000|Overall Study|Physician Decision|1|||
147415793|NCT00406692|531686968|FG000|Overall Study|Adverse Event|1|||
147415794|NCT00406692|531686968|FG000|Overall Study|Lack of Efficacy|1|||
147415795|NCT00400725|531686969|FG000|Initial Phase (up to 4 Weeks)|Adverse Event|1|||
147415796|NCT00400725|531686970|FG001|Initial Phase (up to 4 Weeks)|Adverse Event|0|||
147415797|NCT00400725|531686971|FG002|Initial Phase (up to 4 Weeks)|Adverse Event|0|||
147415798|NCT00400725|531686969|FG000|Initial Phase (up to 4 Weeks)|Withdrawal by Subject|14|||
147415799|NCT00400725|531686970|FG001|Initial Phase (up to 4 Weeks)|Withdrawal by Subject|0|||
147415800|NCT00400725|531686971|FG002|Initial Phase (up to 4 Weeks)|Withdrawal by Subject|0|||
147415801|NCT00400725|531686969|FG000|Initial Phase (up to 4 Weeks)|Lost to Follow-up|1|||
147415802|NCT00400725|531686970|FG001|Initial Phase (up to 4 Weeks)|Lost to Follow-up|0|||
147415803|NCT00400725|531686971|FG002|Initial Phase (up to 4 Weeks)|Lost to Follow-up|0|||
147415804|NCT00400725|531686969|FG000|Initial Phase (up to 4 Weeks)|Other|1|||
147415805|NCT00400725|531686970|FG001|Initial Phase (up to 4 Weeks)|Other|0|||
147415806|NCT00400725|531686971|FG002|Initial Phase (up to 4 Weeks)|Other|0|||
147415807|NCT00400725|531686969|FG000|Maintenance Phase (up to 6 Months)|Lack of Efficacy|0|||
147415808|NCT00400725|531686970|FG001|Maintenance Phase (up to 6 Months)|Lack of Efficacy|1|||
147415809|NCT00400725|531686971|FG002|Maintenance Phase (up to 6 Months)|Lack of Efficacy|0|||
147415810|NCT00400725|531686969|FG000|Maintenance Phase (up to 6 Months)|Adverse Event|0|||
147415811|NCT00400725|531686970|FG001|Maintenance Phase (up to 6 Months)|Adverse Event|2|||
147415812|NCT00400725|531686971|FG002|Maintenance Phase (up to 6 Months)|Adverse Event|4|||
147415813|NCT00400725|531686969|FG000|Maintenance Phase (up to 6 Months)|Withdrawal by Subject|0|||
147415814|NCT00400725|531686970|FG001|Maintenance Phase (up to 6 Months)|Withdrawal by Subject|11|||
147415815|NCT00400725|531686971|FG002|Maintenance Phase (up to 6 Months)|Withdrawal by Subject|21|||
147415816|NCT00400725|531686969|FG000|Maintenance Phase (up to 6 Months)|Lost to Follow-up|0|||
147415817|NCT00400725|531686970|FG001|Maintenance Phase (up to 6 Months)|Lost to Follow-up|1|||
147415818|NCT00400725|531686971|FG002|Maintenance Phase (up to 6 Months)|Lost to Follow-up|2|||
147415819|NCT00400725|531686969|FG000|Maintenance Phase (up to 6 Months)|Other|0|||
147415820|NCT00400725|531686970|FG001|Maintenance Phase (up to 6 Months)|Other|1|||
147415821|NCT00400725|531686971|FG002|Maintenance Phase (up to 6 Months)|Other|2|||
147415822|NCT03547739|531686972|FG000|Overall Study|Death|0|||
147415823|NCT03547739|531686973|FG001|Overall Study|Death|1|||
147415824|NCT03547739|531686974|FG002|Overall Study|Death|5|||
147415825|NCT03547739|531686972|FG000|Overall Study|Adverse Event|24|||
147415826|NCT03547739|531686973|FG001|Overall Study|Adverse Event|11|||
147415827|NCT03547739|531686974|FG002|Overall Study|Adverse Event|13|||
147415828|NCT03547739|531686972|FG000|Overall Study|Partner discontinued due to the death of the female participant or adverse event|24|||
147415829|NCT03547739|531686973|FG001|Overall Study|Partner discontinued due to the death of the female participant or adverse event|12|||
147415830|NCT03547739|531686974|FG002|Overall Study|Partner discontinued due to the death of the female participant or adverse event|18|||
147415831|NCT03547739|531686972|FG000|Overall Study|Lost to Follow-up|80|||
147415832|NCT03547739|531686973|FG001|Overall Study|Lost to Follow-up|84|||
147415833|NCT03547739|531686974|FG002|Overall Study|Lost to Follow-up|116|||
147415834|NCT01744392|531686981|FG000|Overall Study|Physician Decision|1|||
147415835|NCT00635661|531686987|FG000|Overall Study|Withdrawal by Subject|4|||
147666231|NCT01926028|532603855|FG001|Overall Study|Physician Decision|5|||
147620440|NCT00729937|532427330|FG001|Overall Study|Lost to Follow-up|58|||
147620441|NCT00729937|532427331|FG002|Overall Study|Lost to Follow-up|18|||
147620442|NCT00729937|532427332|FG003|Overall Study|Lost to Follow-up|33|||
147620443|NCT00729937|532427333|FG004|Overall Study|Lost to Follow-up|18|||
147620444|NCT00729937|532427334|FG005|Overall Study|Lost to Follow-up|23|||
147620445|NCT00729937|532427329|FG000|Overall Study|Physician Decision|7|||
147620446|NCT00729937|532427330|FG001|Overall Study|Physician Decision|16|||
147620447|NCT00729937|532427331|FG002|Overall Study|Physician Decision|2|||
147620448|NCT00729937|532427332|FG003|Overall Study|Physician Decision|0|||
147620449|NCT00729937|532427333|FG004|Overall Study|Physician Decision|5|||
147620450|NCT00729937|532427334|FG005|Overall Study|Physician Decision|8|||
147620451|NCT00729937|532427329|FG000|Overall Study|Death|1|||
147620452|NCT00729937|532427330|FG001|Overall Study|Death|0|||
147620453|NCT00729937|532427331|FG002|Overall Study|Death|1|||
147620454|NCT00729937|532427332|FG003|Overall Study|Death|0|||
147620455|NCT00729937|532427333|FG004|Overall Study|Death|0|||
147620456|NCT00729937|532427334|FG005|Overall Study|Death|1|||
147620457|NCT00729937|532427329|FG000|Overall Study|Withdrawal by Subject|3|||
147620458|NCT00729937|532427330|FG001|Overall Study|Withdrawal by Subject|5|||
147620459|NCT00729937|532427331|FG002|Overall Study|Withdrawal by Subject|6|||
147620460|NCT00729937|532427332|FG003|Overall Study|Withdrawal by Subject|0|||
147620461|NCT00729937|532427333|FG004|Overall Study|Withdrawal by Subject|4|||
147620462|NCT00729937|532427334|FG005|Overall Study|Withdrawal by Subject|2|||
147620463|NCT00729937|532427329|FG000|Overall Study|Randomized but not treated|12|||
147620464|NCT00729937|532427330|FG001|Overall Study|Randomized but not treated|6|||
147620465|NCT00729937|532427331|FG002|Overall Study|Randomized but not treated|1|||
147620466|NCT00729937|532427332|FG003|Overall Study|Randomized but not treated|0|||
147620467|NCT00729937|532427333|FG004|Overall Study|Randomized but not treated|1|||
147620468|NCT00729937|532427334|FG005|Overall Study|Randomized but not treated|3|||
147620469|NCT00729937|532427329|FG000|Overall Study|Did not meet eligibility criteria|2|||
147620470|NCT00729937|532427330|FG001|Overall Study|Did not meet eligibility criteria|1|||
147620471|NCT00729937|532427331|FG002|Overall Study|Did not meet eligibility criteria|0|||
147620472|NCT00729937|532427332|FG003|Overall Study|Did not meet eligibility criteria|0|||
147620473|NCT00729937|532427333|FG004|Overall Study|Did not meet eligibility criteria|0|||
147620474|NCT00729937|532427334|FG005|Overall Study|Did not meet eligibility criteria|0|||
147620475|NCT00729937|532427329|FG000|Overall Study|Incarcerated|0|||
147620476|NCT00729937|532427330|FG001|Overall Study|Incarcerated|2|||
147620477|NCT00729937|532427331|FG002|Overall Study|Incarcerated|1|||
147620478|NCT00729937|532427332|FG003|Overall Study|Incarcerated|1|||
147620479|NCT00729937|532427333|FG004|Overall Study|Incarcerated|0|||
147620480|NCT00729937|532427334|FG005|Overall Study|Incarcerated|0|||
147620481|NCT01478373|532427336|FG000|Treatment Phase|Protocol Violation|1|||
147620482|NCT01478373|532427336|FG000|Survival Phase|Adverse Event|8|||
147620483|NCT01478373|532427336|FG000|Survival Phase|Protocol Violation|1|||
147620484|NCT01478373|532427336|FG000|Survival Phase|crossover to another study|2|||
147620485|NCT01478373|532427336|FG000|Survival Phase|Progressive Disease|27|||
147620486|NCT01408043|532427339|FG000|Overall Study|unable to collect cells|1|||
147620487|NCT01256879|532427345|FG000|Overall Study|Withdrawal by Subject|1|||
147620488|NCT00397514|532427346|FG000|Overall Study|Withdrawal by Subject|1|||
147666232|NCT01926028|532603856|FG002|Overall Study|Physician Decision|0|||
147415836|NCT03192475|531686995|FG000|Overall Study|Death|0|||
147415837|NCT03192475|531686996|FG001|Overall Study|Death|1|||
147415838|NCT03192475|531686995|FG000|Overall Study|Lost to Follow-up|13|||
147415839|NCT03192475|531686996|FG001|Overall Study|Lost to Follow-up|8|||
147415840|NCT01641159|531686997|FG000|Overall Study|Lost to Follow-up|2|||
147415841|NCT01641159|531686998|FG001|Overall Study|Lost to Follow-up|1|||
147415842|NCT01641159|531686997|FG000|Overall Study|Withdrawal by Subject|0|||
147415843|NCT01641159|531686998|FG001|Overall Study|Withdrawal by Subject|1|||
147415844|NCT00798590|531686999|FG000|Overall Study|P.I, Left institution. Study terminated|11|||
147415845|NCT00798590|531687000|FG001|Overall Study|P.I, Left institution. Study terminated|8|||
147415846|NCT05330676|531687003|FG000|Overall Study|Inadequate imaging quality for final analysis|2|||
147415847|NCT05330676|531687004|FG001|Overall Study|Inadequate imaging quality for final analysis|9|||
147415848|NCT00573859|531687009|FG000|Medication Versus Placebo|Scheduling conflicts|12|||
147415849|NCT00573859|531687009|FG000|Smoking Versus Abstinence|Scheduling conflicts|12|||
147415850|NCT00744757|531687010|FG000|Overall Study|Objective disease progression|7|||
147415851|NCT00744757|531687010|FG000|Overall Study|Physician Decision|5|||
147415852|NCT00744757|531687010|FG000|Overall Study|Withdrawal by Subject|1|||
147415853|NCT00744757|531687010|FG000|Overall Study|Death|6|||
147415854|NCT00744757|531687010|FG000|Overall Study|Adverse Event|2|||
147415855|NCT03682302|531687011|FG000|Overall Study|Lost to Follow-up|1|||
147415856|NCT03682302|531687012|FG001|Overall Study|Lost to Follow-up|2|||
147415857|NCT03682302|531687013|FG002|Overall Study|Lost to Follow-up|0|||
147415858|NCT03682302|531687014|FG003|Overall Study|Lost to Follow-up|1|||
147415859|NCT03682302|531687011|FG000|Overall Study|Study drug was not administered|0|||
147415860|NCT03682302|531687012|FG001|Overall Study|Study drug was not administered|0|||
147415861|NCT03682302|531687013|FG002|Overall Study|Study drug was not administered|1|||
147620489|NCT00397514|532427346|FG000|Overall Study|Pacing wire malfunction|1|||
147472747|NCT03874234|531888551|FG000|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|1|||
147472748|NCT03874234|531888552|FG001|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
147472749|NCT03874234|531888553|FG002|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
147472750|NCT03874234|531888554|FG003|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
147472751|NCT03874234|531888555|FG004|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
147472752|NCT03874234|531888556|FG005|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
147472753|NCT03874234|531888557|FG006|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
147472754|NCT03874234|531888558|FG007|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
147472755|NCT03874234|531888559|FG008|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
147472756|NCT03874234|531888560|FG009|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
147472757|NCT03874234|531888561|FG010|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
147472758|NCT03874234|531888562|FG011|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
147472759|NCT03874234|531888563|FG012|Part A: Cohort 1-Period 2 (Day1)|Physician Decision|0|||
147472760|NCT03874234|531888551|FG000|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
147472761|NCT03874234|531888552|FG001|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
147472762|NCT03874234|531888553|FG002|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
147472763|NCT03874234|531888554|FG003|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|1|||
147472764|NCT03874234|531888555|FG004|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
147472765|NCT03874234|531888556|FG005|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
147472766|NCT03874234|531888557|FG006|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
147472767|NCT03874234|531888558|FG007|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
147472768|NCT03874234|531888559|FG008|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
147472769|NCT03874234|531888560|FG009|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
147472770|NCT03874234|531888561|FG010|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
147472771|NCT03874234|531888562|FG011|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
147472772|NCT03874234|531888563|FG012|Part A: Cohort 1-Period 3 (Day1)|Adverse Event|0|||
147472773|NCT03874234|531888551|FG000|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
147472774|NCT03874234|531888552|FG001|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
147472775|NCT03874234|531888553|FG002|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
147472776|NCT03874234|531888554|FG003|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
147472777|NCT03874234|531888555|FG004|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|1|||
147472778|NCT03874234|531888556|FG005|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
147472779|NCT03874234|531888557|FG006|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
147472780|NCT03874234|531888558|FG007|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
147472781|NCT03874234|531888559|FG008|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
147472782|NCT03874234|531888560|FG009|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
147472783|NCT03874234|531888561|FG010|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
147620490|NCT00397514|532427346|FG000|Overall Study|Not able to capture & pace LV intraoper.|4|||
147620491|NCT00397514|532427346|FG000|Overall Study|early extubation|2|||
147620492|NCT00397514|532427346|FG000|Overall Study|poor echocardiographic windows|1|||
147620493|NCT00445146|532427347|FG000|Overall Study|Withdrew Consent|29|||
147620494|NCT00445146|532427347|FG000|Overall Study|Lack of Efficacy|28|||
147620495|NCT00445146|532427347|FG000|Overall Study|Investigator's Discretion|22|||
147620496|NCT00445146|532427347|FG000|Overall Study|Adverse Event|13|||
147666233|NCT01926028|532603854|FG000|Overall Study|Withdrawal by Subject|9|||
147666234|NCT01926028|532603855|FG001|Overall Study|Withdrawal by Subject|9|||
147472784|NCT03874234|531888562|FG011|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
147620497|NCT00445146|532427347|FG000|Overall Study|Lost to Follow-up|13|||
147620498|NCT00445146|532427347|FG000|Overall Study|Death|9|||
147620499|NCT00445146|532427347|FG000|Overall Study|Protocol Violation|4|||
147415862|NCT03682302|531687014|FG003|Overall Study|Study drug was not administered|1|||
147415863|NCT00532493|531687015|FG000|Overall Study|Death|1|||
147415864|NCT00532493|531687016|FG001|Overall Study|Death|1|||
147415865|NCT00532493|531687015|FG000|Overall Study|Lost to Follow-up|10|||
147415866|NCT00532493|531687016|FG001|Overall Study|Lost to Follow-up|7|||
147415867|NCT00532493|531687015|FG000|Overall Study|Withdrawal by Subject|7|||
147415868|NCT00532493|531687016|FG001|Overall Study|Withdrawal by Subject|9|||
147415869|NCT00532493|531687015|FG000|Overall Study|Physician Decision|1|||
147415870|NCT00532493|531687016|FG001|Overall Study|Physician Decision|6|||
147415871|NCT00532493|531687015|FG000|Overall Study|Adverse Event|6|||
147415872|NCT00532493|531687016|FG001|Overall Study|Adverse Event|5|||
147415873|NCT00532493|531687015|FG000|Overall Study|Protocol Deviation|1|||
147415874|NCT00532493|531687016|FG001|Overall Study|Protocol Deviation|0|||
147472785|NCT03874234|531888563|FG012|Part A: Cohort 2-Period 1 (Day1)|Randomized in error|0|||
147472786|NCT03874234|531888551|FG000|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
147472787|NCT03874234|531888552|FG001|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
147472788|NCT03874234|531888553|FG002|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
147620500|NCT00445146|532427347|FG000|Overall Study|Pregnancy|1|||
147415875|NCT00532493|531687015|FG000|Overall Study|Subject Moved Away|3|||
147415876|NCT00532493|531687016|FG001|Overall Study|Subject Moved Away|1|||
147620501|NCT00640315|532427348|FG000|Overall Study|Withdrawal by Subject|0|||
147472789|NCT03874234|531888554|FG003|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
147472790|NCT03874234|531888555|FG004|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
147472791|NCT03874234|531888556|FG005|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
147472792|NCT03874234|531888557|FG006|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
147472793|NCT03874234|531888558|FG007|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|1|||
147472794|NCT03874234|531888559|FG008|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
147472795|NCT03874234|531888560|FG009|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
147472796|NCT03874234|531888561|FG010|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
147472797|NCT03874234|531888562|FG011|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
147472798|NCT03874234|531888563|FG012|Part A: Cohort 2-Period 1 (Day1)|Withdrawal by Subject|0|||
147472799|NCT03874234|531888551|FG000|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
147472800|NCT03874234|531888552|FG001|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
147472801|NCT03874234|531888553|FG002|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
147472802|NCT03874234|531888554|FG003|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
147472803|NCT03874234|531888555|FG004|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|1|||
147472804|NCT03874234|531888556|FG005|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|1|||
147472805|NCT03874234|531888557|FG006|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
147472806|NCT03874234|531888558|FG007|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
147472807|NCT03874234|531888559|FG008|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
147472808|NCT03874234|531888560|FG009|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
147472809|NCT03874234|531888561|FG010|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
147472810|NCT03874234|531888562|FG011|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
147472811|NCT03874234|531888563|FG012|Part A: Cohort 2-Period 1 (Day1)|Physician Decision|0|||
147472812|NCT03874234|531888551|FG000|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
147472813|NCT03874234|531888552|FG001|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
147472814|NCT03874234|531888553|FG002|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
147472815|NCT03874234|531888554|FG003|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
147472816|NCT03874234|531888555|FG004|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
147472817|NCT03874234|531888556|FG005|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
147472818|NCT03874234|531888557|FG006|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|1|||
147472819|NCT03874234|531888558|FG007|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
147472820|NCT03874234|531888559|FG008|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
147472821|NCT03874234|531888560|FG009|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
147472822|NCT03874234|531888561|FG010|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
147472823|NCT03874234|531888562|FG011|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
147472824|NCT03874234|531888563|FG012|Part A: Cohort 2-Period 2 (Day1)|Withdrawal by Subject|0|||
147472825|NCT03874234|531888551|FG000|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
147472826|NCT03874234|531888552|FG001|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
147472827|NCT03874234|531888553|FG002|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
147472828|NCT03874234|531888554|FG003|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
147472829|NCT03874234|531888555|FG004|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|1|||
147472830|NCT03874234|531888556|FG005|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
147472831|NCT03874234|531888557|FG006|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
147472832|NCT03874234|531888558|FG007|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
147472833|NCT03874234|531888559|FG008|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
147472834|NCT03874234|531888560|FG009|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
147472835|NCT03874234|531888561|FG010|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
147472836|NCT03874234|531888562|FG011|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
147472837|NCT03874234|531888563|FG012|Part A: Cohort 2-Period 2 (Day1)|Physician Decision|0|||
147472838|NCT01896232|531888566|FG000|Overall Study|Death|6|||
147472839|NCT01896232|531888567|FG001|Overall Study|Death|10|||
147472840|NCT01896232|531888566|FG000|Overall Study|Withdrawal by Subject|32|||
147472841|NCT01896232|531888567|FG001|Overall Study|Withdrawal by Subject|31|||
147472842|NCT01896232|531888566|FG000|Overall Study|Sponsor Decision|2|||
147472843|NCT01896232|531888567|FG001|Overall Study|Sponsor Decision|0|||
147472844|NCT01896232|531888566|FG000|Overall Study|Lost to Follow-up|9|||
147472845|NCT01896232|531888567|FG001|Overall Study|Lost to Follow-up|12|||
147472846|NCT03816995|531888578|FG000|Overall Study|Withdrawal by Subject|3|||
147472847|NCT03816995|531888579|FG001|Overall Study|Withdrawal by Subject|1|||
147472848|NCT03816995|531888578|FG000|Overall Study|Cancelled Surgery|8|||
147472849|NCT03816995|531888579|FG001|Overall Study|Cancelled Surgery|12|||
147472850|NCT03816995|531888578|FG000|Overall Study|No wound protector used|11|||
147472851|NCT03816995|531888579|FG001|Overall Study|No wound protector used|17|||
147472852|NCT03816995|531888578|FG000|Overall Study|Protocol Violation|2|||
147472853|NCT03816995|531888579|FG001|Overall Study|Protocol Violation|3|||
147472854|NCT01324830|531888580|FG000|Overall Study|Progressive Disease|3|||
147472855|NCT01324830|531888581|FG001|Overall Study|Progressive Disease|2|||
147472856|NCT01324830|531888582|FG002|Overall Study|Progressive Disease|3|||
147472857|NCT01324830|531888583|FG003|Overall Study|Progressive Disease|3|||
147472858|NCT01324830|531888584|FG004|Overall Study|Progressive Disease|6|||
147620502|NCT00640315|532427349|FG001|Overall Study|Withdrawal by Subject|1|||
147415877|NCT00532493|531687015|FG000|Overall Study|Contraindicative Medication|1|||
147415878|NCT00532493|531687016|FG001|Overall Study|Contraindicative Medication|0|||
147415879|NCT00888927|531687022|FG000|Overall Study|Adverse Event|0|||
147415880|NCT00888927|531687023|FG001|Overall Study|Adverse Event|0|||
147415881|NCT00888927|531687024|FG002|Overall Study|Adverse Event|0|||
147415882|NCT00888927|531687025|FG003|Overall Study|Adverse Event|1|||
147415883|NCT00888927|531687022|FG000|Overall Study|Withdrawal of consent|0|||
147415884|NCT00888927|531687023|FG001|Overall Study|Withdrawal of consent|0|||
147415885|NCT00888927|531687024|FG002|Overall Study|Withdrawal of consent|0|||
147415886|NCT00888927|531687025|FG003|Overall Study|Withdrawal of consent|1|||
147415887|NCT02153073|531687026|FG000|Overall Study|Case Report Forms Uncollected|230|||
147415888|NCT02153073|531687026|FG000|Overall Study|Protocol Deviation|68|||
147415889|NCT01607476|531687027|FG000|Overall Study|Withdrawal by Subject|1|||
147415890|NCT01607476|531687028|FG001|Overall Study|Withdrawal by Subject|0|||
147415891|NCT01607476|531687029|FG002|Overall Study|Withdrawal by Subject|1|||
147415892|NCT01607476|531687027|FG000|Overall Study|Lost to Follow-up|0|||
147415893|NCT01607476|531687028|FG001|Overall Study|Lost to Follow-up|0|||
147415894|NCT01607476|531687029|FG002|Overall Study|Lost to Follow-up|2|||
147415895|NCT04445987|531687030|FG000|Overall Study|Adverse Event|0|||
147415896|NCT04445987|531687031|FG001|Overall Study|Adverse Event|0|||
147415897|NCT04445987|531687032|FG002|Overall Study|Adverse Event|1|||
147415898|NCT04445987|531687033|FG003|Overall Study|Adverse Event|0|||
147415899|NCT04445987|531687034|FG004|Overall Study|Adverse Event|4|||
147415900|NCT04445987|531687035|FG005|Overall Study|Adverse Event|0|||
147415901|NCT04445987|531687030|FG000|Overall Study|Lost to Follow-up|4|||
147415902|NCT04445987|531687031|FG001|Overall Study|Lost to Follow-up|3|||
147415903|NCT04445987|531687032|FG002|Overall Study|Lost to Follow-up|1|||
147415904|NCT04445987|531687033|FG003|Overall Study|Lost to Follow-up|1|||
147415905|NCT04445987|531687034|FG004|Overall Study|Lost to Follow-up|29|||
147415906|NCT04445987|531687035|FG005|Overall Study|Lost to Follow-up|0|||
147415907|NCT04445987|531687030|FG000|Overall Study|Physician Decision|0|||
147415908|NCT04445987|531687031|FG001|Overall Study|Physician Decision|0|||
147415909|NCT04445987|531687032|FG002|Overall Study|Physician Decision|0|||
147472859|NCT01324830|531888585|FG005|Overall Study|Progressive Disease|6|||
147472860|NCT01324830|531888586|FG006|Overall Study|Progressive Disease|3|||
147472861|NCT01324830|531888587|FG007|Overall Study|Progressive Disease|3|||
147472862|NCT01324830|531888588|FG008|Overall Study|Progressive Disease|3|||
147472863|NCT01324830|531888589|FG009|Overall Study|Progressive Disease|6|||
147472864|NCT01324830|531888590|FG010|Overall Study|Progressive Disease|2|||
147472865|NCT01324830|531888591|FG011|Overall Study|Progressive Disease|1|||
147472866|NCT01324830|531888592|FG012|Overall Study|Progressive Disease|1|||
147472867|NCT01324830|531888593|FG013|Overall Study|Progressive Disease|1|||
147472868|NCT01324830|531888594|FG014|Overall Study|Progressive Disease|1|||
147472869|NCT01324830|531888595|FG015|Overall Study|Progressive Disease|3|||
147472870|NCT01324830|531888596|FG016|Overall Study|Progressive Disease|2|||
147472871|NCT01324830|531888597|FG017|Overall Study|Progressive Disease|3|||
147472872|NCT01324830|531888598|FG018|Overall Study|Progressive Disease|4|||
147472873|NCT01324830|531888580|FG000|Overall Study|Dose limiting toxicity|0|||
147472874|NCT01324830|531888581|FG001|Overall Study|Dose limiting toxicity|0|||
147472875|NCT01324830|531888582|FG002|Overall Study|Dose limiting toxicity|0|||
147472876|NCT01324830|531888583|FG003|Overall Study|Dose limiting toxicity|0|||
147472877|NCT01324830|531888584|FG004|Overall Study|Dose limiting toxicity|1|||
147472878|NCT01324830|531888585|FG005|Overall Study|Dose limiting toxicity|0|||
147472879|NCT01324830|531888586|FG006|Overall Study|Dose limiting toxicity|0|||
147472880|NCT01324830|531888587|FG007|Overall Study|Dose limiting toxicity|0|||
147472881|NCT01324830|531888588|FG008|Overall Study|Dose limiting toxicity|0|||
147472882|NCT01324830|531888589|FG009|Overall Study|Dose limiting toxicity|0|||
147472883|NCT01324830|531888590|FG010|Overall Study|Dose limiting toxicity|0|||
147472884|NCT01324830|531888591|FG011|Overall Study|Dose limiting toxicity|0|||
147620503|NCT00725920|532427351|FG000|Overall Study|Lack of Efficacy|3|||
147620504|NCT00725920|532427352|FG001|Overall Study|Lack of Efficacy|6|||
147472885|NCT01324830|531888592|FG012|Overall Study|Dose limiting toxicity|0|||
147620505|NCT02623725|532427353|FG000|Overall Study|Non compliance with protocol|9|||
147415910|NCT04445987|531687033|FG003|Overall Study|Physician Decision|0|||
147415911|NCT04445987|531687034|FG004|Overall Study|Physician Decision|1|||
147415912|NCT04445987|531687035|FG005|Overall Study|Physician Decision|0|||
147415913|NCT04445987|531687030|FG000|Overall Study|Protocol Violation|1|||
147415914|NCT04445987|531687031|FG001|Overall Study|Protocol Violation|0|||
147415915|NCT04445987|531687032|FG002|Overall Study|Protocol Violation|0|||
147415916|NCT04445987|531687033|FG003|Overall Study|Protocol Violation|0|||
147415917|NCT04445987|531687034|FG004|Overall Study|Protocol Violation|2|||
147415918|NCT04445987|531687035|FG005|Overall Study|Protocol Violation|0|||
147472886|NCT01324830|531888593|FG013|Overall Study|Dose limiting toxicity|0|||
147472887|NCT01324830|531888594|FG014|Overall Study|Dose limiting toxicity|0|||
147472888|NCT01324830|531888595|FG015|Overall Study|Dose limiting toxicity|0|||
147415919|NCT04445987|531687030|FG000|Overall Study|Withdrawal by Subject|4|||
147472889|NCT01324830|531888596|FG016|Overall Study|Dose limiting toxicity|1|||
147472890|NCT01324830|531888597|FG017|Overall Study|Dose limiting toxicity|1|||
147472891|NCT01324830|531888598|FG018|Overall Study|Dose limiting toxicity|1|||
147472892|NCT01324830|531888580|FG000|Overall Study|Reason not mentioned above|0|||
147472893|NCT01324830|531888581|FG001|Overall Study|Reason not mentioned above|0|||
147472894|NCT01324830|531888582|FG002|Overall Study|Reason not mentioned above|0|||
147472895|NCT01324830|531888583|FG003|Overall Study|Reason not mentioned above|0|||
147472896|NCT01324830|531888584|FG004|Overall Study|Reason not mentioned above|0|||
147472897|NCT01324830|531888585|FG005|Overall Study|Reason not mentioned above|0|||
147472898|NCT01324830|531888586|FG006|Overall Study|Reason not mentioned above|0|||
147472899|NCT01324830|531888587|FG007|Overall Study|Reason not mentioned above|0|||
147472900|NCT01324830|531888588|FG008|Overall Study|Reason not mentioned above|0|||
147472901|NCT01324830|531888589|FG009|Overall Study|Reason not mentioned above|0|||
147472902|NCT01324830|531888590|FG010|Overall Study|Reason not mentioned above|0|||
147472903|NCT01324830|531888591|FG011|Overall Study|Reason not mentioned above|0|||
147472904|NCT01324830|531888592|FG012|Overall Study|Reason not mentioned above|0|||
147620506|NCT02623725|532427354|FG001|Overall Study|Non compliance with protocol|3|||
147620507|NCT02623725|532427353|FG000|Overall Study|Serious adverse event|0|||
147620508|NCT02623725|532427354|FG001|Overall Study|Serious adverse event|2|||
147620509|NCT02623725|532427353|FG000|Overall Study|Withdrawal by Subject|7|||
147620510|NCT02623725|532427354|FG001|Overall Study|Withdrawal by Subject|1|||
147620511|NCT04720105|532427357|FG000|Overall Study|Lack of Efficacy|1|||
147620512|NCT04720105|532427357|FG000|Overall Study|Lost to Follow-up|1|||
147620513|NCT04720105|532427357|FG000|Overall Study|Withdrawal by Subject|3|||
147620514|NCT02892331|532427358|FG000|Overall Study|Withdrawal by Subject|0|||
147620515|NCT02892331|532427359|FG001|Overall Study|Withdrawal by Subject|1|||
147620516|NCT02892331|532427360|FG002|Overall Study|Withdrawal by Subject|1|||
147620517|NCT02892331|532427358|FG000|Overall Study|Sick family member|0|||
147620518|NCT02892331|532427359|FG001|Overall Study|Sick family member|0|||
147620519|NCT02892331|532427360|FG002|Overall Study|Sick family member|1|||
147620520|NCT02892331|532427358|FG000|Overall Study|Corona virus pandemic|1|||
147620521|NCT02892331|532427359|FG001|Overall Study|Corona virus pandemic|0|||
147620522|NCT02892331|532427360|FG002|Overall Study|Corona virus pandemic|1|||
147620523|NCT02892331|532427358|FG000|Overall Study|Lost to Follow-up|1|||
147620524|NCT02892331|532427359|FG001|Overall Study|Lost to Follow-up|0|||
147620525|NCT02892331|532427360|FG002|Overall Study|Lost to Follow-up|1|||
147620526|NCT02892331|532427358|FG000|Overall Study|Blood pressure was too elevated|0|||
147620527|NCT02892331|532427359|FG001|Overall Study|Blood pressure was too elevated|1|||
147620528|NCT02892331|532427360|FG002|Overall Study|Blood pressure was too elevated|0|||
147620529|NCT02892331|532427358|FG000|Overall Study|participant did not disclose she had an excluded medical condition and was disenrolled|0|||
147620530|NCT02892331|532427359|FG001|Overall Study|participant did not disclose she had an excluded medical condition and was disenrolled|1|||
147620531|NCT02892331|532427360|FG002|Overall Study|participant did not disclose she had an excluded medical condition and was disenrolled|0|||
147620532|NCT02286713|532427362|FG000|One Week Follow-Up|Death|1|||
147620533|NCT02286713|532427363|FG001|One Week Follow-Up|Death|0|||
147620534|NCT02286713|532427362|FG000|One Week Follow-Up|Lost to Follow-up|17|||
147620535|NCT02286713|532427363|FG001|One Week Follow-Up|Lost to Follow-up|21|||
147620536|NCT02286713|532427362|FG000|One Week Follow-Up|Withdrawal by Subject|6|||
147620537|NCT02286713|532427363|FG001|One Week Follow-Up|Withdrawal by Subject|3|||
147620538|NCT02286713|532427362|FG000|Three Month Follow-Up|Death|1|||
147620539|NCT02286713|532427363|FG001|Three Month Follow-Up|Death|1|||
147620540|NCT02286713|532427362|FG000|Three Month Follow-Up|Lost to Follow-up|26|||
147620541|NCT02286713|532427363|FG001|Three Month Follow-Up|Lost to Follow-up|24|||
147620542|NCT02286713|532427362|FG000|Three Month Follow-Up|Withdrawal by Subject|1|||
147620543|NCT02286713|532427363|FG001|Three Month Follow-Up|Withdrawal by Subject|1|||
147620544|NCT02286713|532427362|FG000|Six Month Follow-Up|Death|2|||
147620545|NCT02286713|532427363|FG001|Six Month Follow-Up|Death|0|||
147620546|NCT02286713|532427362|FG000|Six Month Follow-Up|Lost to Follow-up|30|||
147620547|NCT02286713|532427363|FG001|Six Month Follow-Up|Lost to Follow-up|27|||
147620548|NCT02654054|532427364|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|2|||
147620549|NCT02654054|532427365|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|6|||
147620550|NCT02654054|532427366|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|7|||
147620551|NCT02654054|532427364|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|3|||
147620552|NCT02654054|532427365|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
147620553|NCT02654054|532427366|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|13|||
147620554|NCT02654054|532427364|FG000|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|2|||
147472905|NCT01324830|531888593|FG013|Overall Study|Reason not mentioned above|0|||
147472906|NCT01324830|531888594|FG014|Overall Study|Reason not mentioned above|0|||
147620555|NCT02654054|532427365|FG001|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|2|||
147620556|NCT02654054|532427366|FG002|Post-Treatment Follow-Up Period|Required Surgery/Invasive Intervention|2|||
147620557|NCT02654054|532427364|FG000|Post-Treatment Follow-Up Period|Other|1|||
147620558|NCT02654054|532427365|FG001|Post-Treatment Follow-Up Period|Other|0|||
147620559|NCT02654054|532427366|FG002|Post-Treatment Follow-Up Period|Other|4|||
147620560|NCT02654054|532427364|FG000|Post-Treatment Follow-Up Period|Non-Compliance|0|||
147472907|NCT01324830|531888595|FG015|Overall Study|Reason not mentioned above|0|||
147472908|NCT01324830|531888596|FG016|Overall Study|Reason not mentioned above|0|||
147472909|NCT01324830|531888597|FG017|Overall Study|Reason not mentioned above|1|||
147472910|NCT01324830|531888598|FG018|Overall Study|Reason not mentioned above|0|||
147472911|NCT01324830|531888580|FG000|Overall Study|Adverse Event, serious fatal|0|||
147472912|NCT01324830|531888581|FG001|Overall Study|Adverse Event, serious fatal|1|||
147472913|NCT01324830|531888582|FG002|Overall Study|Adverse Event, serious fatal|0|||
147472914|NCT01324830|531888583|FG003|Overall Study|Adverse Event, serious fatal|0|||
147472915|NCT01324830|531888584|FG004|Overall Study|Adverse Event, serious fatal|0|||
147472916|NCT01324830|531888585|FG005|Overall Study|Adverse Event, serious fatal|0|||
147472917|NCT01324830|531888586|FG006|Overall Study|Adverse Event, serious fatal|0|||
147472918|NCT01324830|531888587|FG007|Overall Study|Adverse Event, serious fatal|0|||
147472919|NCT01324830|531888588|FG008|Overall Study|Adverse Event, serious fatal|0|||
147472920|NCT01324830|531888589|FG009|Overall Study|Adverse Event, serious fatal|0|||
147472921|NCT01324830|531888590|FG010|Overall Study|Adverse Event, serious fatal|0|||
147472922|NCT01324830|531888591|FG011|Overall Study|Adverse Event, serious fatal|0|||
147472923|NCT01324830|531888592|FG012|Overall Study|Adverse Event, serious fatal|0|||
147472924|NCT01324830|531888593|FG013|Overall Study|Adverse Event, serious fatal|0|||
147472925|NCT01324830|531888594|FG014|Overall Study|Adverse Event, serious fatal|0|||
147472926|NCT01324830|531888595|FG015|Overall Study|Adverse Event, serious fatal|0|||
147472927|NCT01324830|531888596|FG016|Overall Study|Adverse Event, serious fatal|0|||
147472928|NCT01324830|531888597|FG017|Overall Study|Adverse Event, serious fatal|0|||
147472929|NCT01324830|531888598|FG018|Overall Study|Adverse Event, serious fatal|0|||
147472930|NCT01324830|531888580|FG000|Overall Study|Adverse Event, non-fatal|0|||
147472931|NCT01324830|531888581|FG001|Overall Study|Adverse Event, non-fatal|0|||
147472932|NCT01324830|531888582|FG002|Overall Study|Adverse Event, non-fatal|0|||
147472933|NCT01324830|531888583|FG003|Overall Study|Adverse Event, non-fatal|0|||
147472934|NCT01324830|531888584|FG004|Overall Study|Adverse Event, non-fatal|0|||
147472935|NCT01324830|531888585|FG005|Overall Study|Adverse Event, non-fatal|0|||
147472936|NCT01324830|531888586|FG006|Overall Study|Adverse Event, non-fatal|0|||
147472937|NCT01324830|531888587|FG007|Overall Study|Adverse Event, non-fatal|0|||
147472938|NCT01324830|531888588|FG008|Overall Study|Adverse Event, non-fatal|2|||
147472939|NCT01324830|531888589|FG009|Overall Study|Adverse Event, non-fatal|0|||
147472940|NCT01324830|531888590|FG010|Overall Study|Adverse Event, non-fatal|1|||
147472941|NCT01324830|531888591|FG011|Overall Study|Adverse Event, non-fatal|0|||
147620561|NCT02654054|532427365|FG001|Post-Treatment Follow-Up Period|Non-Compliance|0|||
147415920|NCT04445987|531687031|FG001|Overall Study|Withdrawal by Subject|0|||
147415921|NCT04445987|531687032|FG002|Overall Study|Withdrawal by Subject|1|||
147415922|NCT04445987|531687033|FG003|Overall Study|Withdrawal by Subject|0|||
147415923|NCT04445987|531687034|FG004|Overall Study|Withdrawal by Subject|18|||
147415924|NCT04445987|531687035|FG005|Overall Study|Withdrawal by Subject|1|||
147415925|NCT04445987|531687030|FG000|Overall Study|Other reason|0|||
147415926|NCT04445987|531687031|FG001|Overall Study|Other reason|0|||
147415927|NCT04445987|531687032|FG002|Overall Study|Other reason|1|||
147415928|NCT04445987|531687033|FG003|Overall Study|Other reason|0|||
147620562|NCT02654054|532427366|FG002|Post-Treatment Follow-Up Period|Non-Compliance|4|||
147620563|NCT06018129|532427369|FG000|Overall Study|Death|1|||
147620564|NCT06018129|532427370|FG001|Overall Study|Death|1|||
147620565|NCT06018129|532427371|FG002|Overall Study|Death|2|||
147620566|NCT06018129|532427369|FG000|Overall Study|Sponsor Decision|2|||
147620567|NCT06018129|532427370|FG001|Overall Study|Sponsor Decision|2|||
147620568|NCT06018129|532427371|FG002|Overall Study|Sponsor Decision|1|||
147620569|NCT02325973|532429536|FG000|Overall Study|Death|5|||
147620570|NCT02325973|532429536|FG000|Overall Study|Withdrawal by subject or investigator|16|||
147620571|NCT02513160|532429537|FG000|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|33|||
147620572|NCT02513160|532429538|FG001|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|0|||
147620573|NCT02513160|532429539|FG002|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|0|||
147620574|NCT02513160|532429540|FG003|Run-In Period (Days -14 to Day -1)|Inclusion criteria not met|0|||
147415929|NCT04445987|531687034|FG004|Overall Study|Other reason|2|||
147415930|NCT04445987|531687035|FG005|Overall Study|Other reason|0|||
147415931|NCT00293059|531687038|FG000|Overall Study|Adverse Event|12|||
147415932|NCT00293059|531687039|FG001|Overall Study|Adverse Event|4|||
147415933|NCT00293059|531687038|FG000|Overall Study|Lack of Efficacy|2|||
147415934|NCT00293059|531687039|FG001|Overall Study|Lack of Efficacy|0|||
147415935|NCT00293059|531687038|FG000|Overall Study|Lost to Follow-up|2|||
147620575|NCT02513160|532429537|FG000|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|214|||
147620576|NCT02513160|532429538|FG001|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|0|||
147620577|NCT02513160|532429539|FG002|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|0|||
147415936|NCT00293059|531687039|FG001|Overall Study|Lost to Follow-up|3|||
147415937|NCT00293059|531687038|FG000|Overall Study|Pregnancy|1|||
147415938|NCT00293059|531687039|FG001|Overall Study|Pregnancy|1|||
147415939|NCT00293059|531687038|FG000|Overall Study|Protocol Violation|2|||
147415940|NCT00293059|531687039|FG001|Overall Study|Protocol Violation|0|||
147415941|NCT00293059|531687038|FG000|Overall Study|Withdrawal by Subject|11|||
147415942|NCT00293059|531687039|FG001|Overall Study|Withdrawal by Subject|5|||
147415943|NCT00293059|531687038|FG000|Overall Study|Participant moved out of state|1|||
147415944|NCT00293059|531687039|FG001|Overall Study|Participant moved out of state|0|||
147415945|NCT00293059|531687038|FG000|Overall Study|Participant stopped study drug|1|||
147415946|NCT00293059|531687039|FG001|Overall Study|Participant stopped study drug|0|||
147415947|NCT00293059|531687038|FG000|Overall Study|Noncompliant - sanitary pads collection|0|||
147415948|NCT00293059|531687039|FG001|Overall Study|Noncompliant - sanitary pads collection|1|||
147415949|NCT00293059|531687038|FG000|Overall Study|missing|3|||
147415950|NCT00293059|531687039|FG001|Overall Study|missing|5|||
147415951|NCT02001064|531687043|FG000|Overall Study|Withdrawal by Subject|2|||
147415952|NCT02001064|531687044|FG001|Overall Study|Withdrawal by Subject|1|||
147415953|NCT01609062|531687045|FG000|Extension Phase|Terminated by Sponsor|14|||
147415954|NCT01609062|531687046|FG001|Extension Phase|Terminated by Sponsor|9|||
147415955|NCT01609062|531687045|FG000|Extension Phase|Discontinued drug and then was pregnant|1|||
147415956|NCT01609062|531687046|FG001|Extension Phase|Discontinued drug and then was pregnant|0|||
147415957|NCT01609062|531687045|FG000|Extension Phase|Anticipated surgery & transition to EAP|0|||
147415958|NCT01609062|531687046|FG001|Extension Phase|Anticipated surgery & transition to EAP|1|||
147415959|NCT00680992|531687047|FG000|Overall Study|Complete Resection (as per protocol)|25|||
147415960|NCT00680992|531687048|FG001|Overall Study|Complete Resection (as per protocol)|121|||
147415961|NCT00680992|531687049|FG002|Overall Study|Complete Resection (as per protocol)|0|||
147415962|NCT00680992|531687047|FG000|Overall Study|Administrative Decision|83|||
147415963|NCT00680992|531687048|FG001|Overall Study|Administrative Decision|42|||
147415964|NCT00680992|531687049|FG002|Overall Study|Administrative Decision|5|||
147415965|NCT00680992|531687047|FG000|Overall Study|End of Trial|32|||
147415966|NCT00680992|531687048|FG001|Overall Study|End of Trial|12|||
147415967|NCT00680992|531687049|FG002|Overall Study|End of Trial|3|||
147415968|NCT00680992|531687047|FG000|Overall Study|Withdrawal by Subject|33|||
147415969|NCT00680992|531687048|FG001|Overall Study|Withdrawal by Subject|11|||
147415970|NCT00680992|531687049|FG002|Overall Study|Withdrawal by Subject|1|||
147472942|NCT01324830|531888592|FG012|Overall Study|Adverse Event, non-fatal|0|||
147472943|NCT01324830|531888593|FG013|Overall Study|Adverse Event, non-fatal|0|||
147472944|NCT01324830|531888594|FG014|Overall Study|Adverse Event, non-fatal|0|||
147472945|NCT01324830|531888595|FG015|Overall Study|Adverse Event, non-fatal|0|||
147472946|NCT01324830|531888596|FG016|Overall Study|Adverse Event, non-fatal|0|||
147472947|NCT01324830|531888597|FG017|Overall Study|Adverse Event, non-fatal|1|||
147472948|NCT01324830|531888598|FG018|Overall Study|Adverse Event, non-fatal|0|||
147472949|NCT01324830|531888580|FG000|Overall Study|Withdrawal by Subject|0|||
147472950|NCT01324830|531888581|FG001|Overall Study|Withdrawal by Subject|0|||
147472951|NCT01324830|531888582|FG002|Overall Study|Withdrawal by Subject|0|||
147472952|NCT01324830|531888583|FG003|Overall Study|Withdrawal by Subject|0|||
147472953|NCT01324830|531888584|FG004|Overall Study|Withdrawal by Subject|0|||
147472954|NCT01324830|531888585|FG005|Overall Study|Withdrawal by Subject|1|||
147472955|NCT01324830|531888586|FG006|Overall Study|Withdrawal by Subject|0|||
147472956|NCT01324830|531888587|FG007|Overall Study|Withdrawal by Subject|0|||
147472957|NCT01324830|531888588|FG008|Overall Study|Withdrawal by Subject|0|||
147472958|NCT01324830|531888589|FG009|Overall Study|Withdrawal by Subject|0|||
147472959|NCT01324830|531888590|FG010|Overall Study|Withdrawal by Subject|1|||
147472960|NCT01324830|531888591|FG011|Overall Study|Withdrawal by Subject|0|||
147472961|NCT01324830|531888592|FG012|Overall Study|Withdrawal by Subject|0|||
147472962|NCT01324830|531888593|FG013|Overall Study|Withdrawal by Subject|0|||
147472963|NCT01324830|531888594|FG014|Overall Study|Withdrawal by Subject|0|||
147472964|NCT01324830|531888595|FG015|Overall Study|Withdrawal by Subject|0|||
147472965|NCT01324830|531888596|FG016|Overall Study|Withdrawal by Subject|0|||
147472966|NCT01324830|531888597|FG017|Overall Study|Withdrawal by Subject|0|||
147472967|NCT01324830|531888598|FG018|Overall Study|Withdrawal by Subject|1|||
147472968|NCT01485614|531888599|FG000|Randomization|Not Treated|1|||
147472969|NCT01485614|531888600|FG001|Randomization|Not Treated|0|||
147472970|NCT01485614|531888601|FG002|Randomization|Not Treated|0|||
147472971|NCT01485614|531888602|FG003|Randomization|Not Treated|0|||
147472972|NCT01485614|531888599|FG000|Weeks 0-20|Lost to Follow-up|2|||
147472973|NCT01485614|531888600|FG001|Weeks 0-20|Lost to Follow-up|0|||
147472974|NCT01485614|531888601|FG002|Weeks 0-20|Lost to Follow-up|0|||
147472975|NCT01485614|531888602|FG003|Weeks 0-20|Lost to Follow-up|0|||
147472976|NCT01485614|531888599|FG000|Weeks 0-20|Withdrawal by Parent/Guardian|5|||
147472977|NCT01485614|531888600|FG001|Weeks 0-20|Withdrawal by Parent/Guardian|2|||
147472978|NCT01485614|531888601|FG002|Weeks 0-20|Withdrawal by Parent/Guardian|0|||
147415971|NCT00680992|531687047|FG000|Overall Study|Adverse Event|21|||
147415972|NCT00680992|531687048|FG001|Overall Study|Adverse Event|19|||
147415973|NCT00680992|531687049|FG002|Overall Study|Adverse Event|1|||
147415974|NCT00680992|531687047|FG000|Overall Study|Other|19|||
147415975|NCT00680992|531687048|FG001|Overall Study|Other|14|||
147472979|NCT01485614|531888602|FG003|Weeks 0-20|Withdrawal by Parent/Guardian|0|||
147472980|NCT01485614|531888599|FG000|Weeks 0-20|Withdrawal by Subject|3|||
147472981|NCT01485614|531888600|FG001|Weeks 0-20|Withdrawal by Subject|2|||
147472982|NCT01485614|531888601|FG002|Weeks 0-20|Withdrawal by Subject|1|||
147472983|NCT01485614|531888602|FG003|Weeks 0-20|Withdrawal by Subject|0|||
147415976|NCT00680992|531687049|FG002|Overall Study|Other|1|||
147472984|NCT01485614|531888599|FG000|Weeks 20-54|Lost to Follow-up|4|||
147472985|NCT01485614|531888600|FG001|Weeks 20-54|Lost to Follow-up|3|||
147472986|NCT01485614|531888601|FG002|Weeks 20-54|Lost to Follow-up|1|||
147472987|NCT01485614|531888602|FG003|Weeks 20-54|Lost to Follow-up|0|||
147472988|NCT01485614|531888599|FG000|Weeks 20-54|Withdrawal by Parent/Guardian|2|||
147472989|NCT01485614|531888600|FG001|Weeks 20-54|Withdrawal by Parent/Guardian|2|||
147472990|NCT01485614|531888601|FG002|Weeks 20-54|Withdrawal by Parent/Guardian|1|||
147472991|NCT01485614|531888602|FG003|Weeks 20-54|Withdrawal by Parent/Guardian|0|||
147472992|NCT01485614|531888599|FG000|Weeks 20-54|Withdrawal by Subject|5|||
147472993|NCT01485614|531888600|FG001|Weeks 20-54|Withdrawal by Subject|3|||
147472994|NCT01485614|531888601|FG002|Weeks 20-54|Withdrawal by Subject|0|||
147472995|NCT01485614|531888602|FG003|Weeks 20-54|Withdrawal by Subject|0|||
147472996|NCT00733902|531888603|FG000|Overall Study|Death|0|||
147472997|NCT00733902|531888604|FG001|Overall Study|Death|0|||
147472998|NCT00733902|531888605|FG002|Overall Study|Death|0|||
147472999|NCT00733902|531888606|FG003|Overall Study|Death|1|||
147473000|NCT00733902|531888603|FG000|Overall Study|Adverse Event|3|||
147473001|NCT00733902|531888604|FG001|Overall Study|Adverse Event|4|||
147473002|NCT00733902|531888605|FG002|Overall Study|Adverse Event|7|||
147473003|NCT00733902|531888606|FG003|Overall Study|Adverse Event|11|||
147473004|NCT00733902|531888603|FG000|Overall Study|Lack of Efficacy|56|||
147473005|NCT00733902|531888604|FG001|Overall Study|Lack of Efficacy|21|||
147473006|NCT00733902|531888605|FG002|Overall Study|Lack of Efficacy|34|||
147473007|NCT00733902|531888606|FG003|Overall Study|Lack of Efficacy|23|||
147473008|NCT00733902|531888603|FG000|Overall Study|Protocol Violation|4|||
147473009|NCT00733902|531888604|FG001|Overall Study|Protocol Violation|6|||
147473010|NCT00733902|531888605|FG002|Overall Study|Protocol Violation|3|||
147473011|NCT00733902|531888606|FG003|Overall Study|Protocol Violation|3|||
147473012|NCT00733902|531888603|FG000|Overall Study|Withdrawal by Subject|10|||
147473013|NCT00733902|531888604|FG001|Overall Study|Withdrawal by Subject|5|||
147473014|NCT00733902|531888605|FG002|Overall Study|Withdrawal by Subject|4|||
147473015|NCT00733902|531888606|FG003|Overall Study|Withdrawal by Subject|16|||
147473016|NCT00733902|531888603|FG000|Overall Study|Entered extension study|89|||
147473017|NCT00733902|531888604|FG001|Overall Study|Entered extension study|124|||
147473018|NCT00733902|531888605|FG002|Overall Study|Entered extension study|111|||
147473019|NCT00733902|531888606|FG003|Overall Study|Entered extension study|109|||
147620578|NCT02513160|532429540|FG003|Run-In Period (Days -14 to Day -1)|Failure to meet randomization criteria|0|||
147415977|NCT00680992|531687047|FG000|Overall Study|Disease Progression|21|||
147415978|NCT00680992|531687048|FG001|Overall Study|Disease Progression|9|||
147415979|NCT00680992|531687049|FG002|Overall Study|Disease Progression|0|||
147415980|NCT00680992|531687047|FG000|Overall Study|Lost to Follow-up|12|||
147415981|NCT00680992|531687048|FG001|Overall Study|Lost to Follow-up|14|||
147415982|NCT00680992|531687049|FG002|Overall Study|Lost to Follow-up|0|||
147415983|NCT00680992|531687047|FG000|Overall Study|Noncompliance|4|||
147415984|NCT00680992|531687048|FG001|Overall Study|Noncompliance|6|||
147415985|NCT00680992|531687049|FG002|Overall Study|Noncompliance|0|||
147415986|NCT00680992|531687047|FG000|Overall Study|Requirement for Alternative Therapy|8|||
147415987|NCT00680992|531687048|FG001|Overall Study|Requirement for Alternative Therapy|2|||
147415988|NCT00680992|531687049|FG002|Overall Study|Requirement for Alternative Therapy|0|||
147415989|NCT00680992|531687047|FG000|Overall Study|Pregnancy|5|||
147415990|NCT00680992|531687048|FG001|Overall Study|Pregnancy|0|||
147415991|NCT00680992|531687049|FG002|Overall Study|Pregnancy|1|||
147415992|NCT00680992|531687047|FG000|Overall Study|Death|5|||
147415993|NCT00680992|531687048|FG001|Overall Study|Death|1|||
147415994|NCT00680992|531687049|FG002|Overall Study|Death|0|||
147415995|NCT00680992|531687047|FG000|Overall Study|Ineligibility Determined|0|||
147415996|NCT00680992|531687048|FG001|Overall Study|Ineligibility Determined|1|||
147415997|NCT00680992|531687049|FG002|Overall Study|Ineligibility Determined|0|||
147415998|NCT03772587|531687050|FG000|Overall Study|COVID-19|0|||
147415999|NCT03772587|531687051|FG001|Overall Study|COVID-19|0|||
147416000|NCT03772587|531687052|FG002|Overall Study|COVID-19|1|||
147416001|NCT03772587|531687053|FG003|Overall Study|COVID-19|1|||
147416002|NCT03772587|531687054|FG004|Overall Study|COVID-19|0|||
147416003|NCT03772587|531687050|FG000|Overall Study|Withdrawal by Subject|1|||
147416004|NCT03772587|531687051|FG001|Overall Study|Withdrawal by Subject|0|||
147416005|NCT03772587|531687052|FG002|Overall Study|Withdrawal by Subject|0|||
147416006|NCT03772587|531687053|FG003|Overall Study|Withdrawal by Subject|0|||
147416007|NCT03772587|531687054|FG004|Overall Study|Withdrawal by Subject|0|||
147416008|NCT05148962|531687055|FG000|Overall Study|Withdrawal by Subject|1|||
147416009|NCT05148962|531687056|FG001|Overall Study|Withdrawal by Subject|1|||
147416010|NCT05148962|531687057|FG002|Overall Study|Withdrawal by Subject|0|||
147416011|NCT05148962|531687058|FG003|Overall Study|Withdrawal by Subject|1|||
147473020|NCT00733902|531888603|FG000|Overall Study|Randomized but not treated|2|||
147473021|NCT00733902|531888604|FG001|Overall Study|Randomized but not treated|2|||
147473022|NCT00733902|531888605|FG002|Overall Study|Randomized but not treated|2|||
147473023|NCT00733902|531888606|FG003|Overall Study|Randomized but not treated|1|||
147473024|NCT02210780|531888607|FG000|Overall Study|Adverse Event|0|||
147416012|NCT05148962|531687059|FG004|Overall Study|Withdrawal by Subject|0|||
147473025|NCT02210780|531888608|FG001|Overall Study|Adverse Event|5|||
147416013|NCT05148962|531687055|FG000|Overall Study|Participant was early terminated per protocol|0|||
147416014|NCT05148962|531687056|FG001|Overall Study|Participant was early terminated per protocol|0|||
147416015|NCT05148962|531687057|FG002|Overall Study|Participant was early terminated per protocol|3|||
147416016|NCT05148962|531687058|FG003|Overall Study|Participant was early terminated per protocol|5|||
147416017|NCT05148962|531687059|FG004|Overall Study|Participant was early terminated per protocol|2|||
147416018|NCT05148962|531687055|FG000|Overall Study|Miscellaneous|0|||
147416019|NCT05148962|531687056|FG001|Overall Study|Miscellaneous|0|||
147416020|NCT05148962|531687057|FG002|Overall Study|Miscellaneous|0|||
147416021|NCT05148962|531687058|FG003|Overall Study|Miscellaneous|1|||
147416022|NCT05148962|531687059|FG004|Overall Study|Miscellaneous|0|||
147416023|NCT04362189|531687060|FG000|Overall Study|Lost to Follow-up|0|||
147416024|NCT04362189|531687061|FG001|Overall Study|Lost to Follow-up|1|||
147416025|NCT04362189|531687060|FG000|Overall Study|Withdrawal by Subject|1|||
147416026|NCT04362189|531687061|FG001|Overall Study|Withdrawal by Subject|0|||
147416027|NCT04362189|531687060|FG000|Overall Study|FDA Clinical Hold|7|||
147416028|NCT04362189|531687061|FG001|Overall Study|FDA Clinical Hold|2|||
147416029|NCT04362189|531687060|FG000|Overall Study|Discharge or Transfer to other Hospital|3|||
147416030|NCT04362189|531687061|FG001|Overall Study|Discharge or Transfer to other Hospital|0|||
147416031|NCT04362189|531687060|FG000|Overall Study|Adverse Event|0|||
147416032|NCT04362189|531687061|FG001|Overall Study|Adverse Event|2|||
147416033|NCT04362189|531687060|FG000|Overall Study|Death|4|||
147416034|NCT04362189|531687061|FG001|Overall Study|Death|1|||
147416035|NCT02111681|531687062|FG000|Overall Study|Death|5|||
147416036|NCT02111681|531687062|FG000|Overall Study|Lack of Efficacy|2|||
147416037|NCT02111681|531687062|FG000|Overall Study|Progression of disease|4|||
147416038|NCT00095056|531688276|FG000|Phase A (Weeks 0-12)|Adverse Event|1|||
147416039|NCT00095056|531688277|FG001|Phase A (Weeks 0-12)|Adverse Event|1|||
147416040|NCT00095056|531688276|FG000|Phase A (Weeks 0-12)|Withdrawal by Subject|3|||
147416041|NCT00095056|531688277|FG001|Phase A (Weeks 0-12)|Withdrawal by Subject|0|||
147416042|NCT00095056|531688276|FG000|Phase A (Weeks 0-12)|Death|1|||
147416043|NCT00095056|531688277|FG001|Phase A (Weeks 0-12)|Death|0|||
147416044|NCT00095056|531688276|FG000|Phase A (Weeks 0-12)|Protocol specific criteria|2|||
147416045|NCT00095056|531688277|FG001|Phase A (Weeks 0-12)|Protocol specific criteria|0|||
147416046|NCT00095056|531688276|FG000|Phase B (Weeks 12-54)|Adverse Event|2|||
147416047|NCT00095056|531688277|FG001|Phase B (Weeks 12-54)|Adverse Event|2|||
147416048|NCT00095056|531688276|FG000|Phase B (Weeks 12-54)|Lost to Follow-up|1|||
147416049|NCT00095056|531688277|FG001|Phase B (Weeks 12-54)|Lost to Follow-up|0|||
147416050|NCT00095056|531688276|FG000|Phase B (Weeks 12-54)|Withdrawal by Subject|2|||
147416051|NCT00095056|531688277|FG001|Phase B (Weeks 12-54)|Withdrawal by Subject|1|||
147416052|NCT00095056|531688276|FG000|Phase B (Weeks 12-54)|Patient Moved|1|||
147416053|NCT00095056|531688277|FG001|Phase B (Weeks 12-54)|Patient Moved|0|||
147416054|NCT00095056|531688276|FG000|Phase B (Weeks 12-54)|Death|3|||
147416055|NCT00095056|531688277|FG001|Phase B (Weeks 12-54)|Death|1|||
147416056|NCT00095056|531688276|FG000|Phase B (Weeks 12-54)|Protocol specific criteria|1|||
147416057|NCT00095056|531688277|FG001|Phase B (Weeks 12-54)|Protocol specific criteria|0|||
147416058|NCT00095056|531688276|FG000|Phase B (Weeks 12-54)|Protocol Violation|0|||
147416059|NCT00095056|531688277|FG001|Phase B (Weeks 12-54)|Protocol Violation|1|||
147416060|NCT02731690|531688281|FG000|Overall Study|Adverse Event|1|||
147416061|NCT02731690|531688281|FG000|Overall Study|Withdrawal by Subject|3|||
147416062|NCT02731690|531688281|FG000|Overall Study|Discontinuation of Study by Sponsor|26|||
147416063|NCT03828747|531688282|FG000|Double-Blind Treatment Period|Adverse Event|6|||
147416064|NCT03828747|531688283|FG001|Double-Blind Treatment Period|Adverse Event|6|||
147416065|NCT03828747|531688282|FG000|Double-Blind Treatment Period|Death|1|||
147416066|NCT03828747|531688283|FG001|Double-Blind Treatment Period|Death|1|||
147416067|NCT03828747|531688282|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
147416068|NCT03828747|531688283|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
147416069|NCT03828747|531688282|FG000|Double-Blind Treatment Period|Withdrawal by Subject|17|||
147416070|NCT03828747|531688283|FG001|Double-Blind Treatment Period|Withdrawal by Subject|19|||
147416071|NCT03828747|531688282|FG000|Double-Blind Treatment Period|Physician Decision|1|||
147416072|NCT03828747|531688283|FG001|Double-Blind Treatment Period|Physician Decision|4|||
147416073|NCT03828747|531688282|FG000|Double-Blind Treatment Period|Various reasons|5|||
147416074|NCT03828747|531688283|FG001|Double-Blind Treatment Period|Various reasons|3|||
147620579|NCT02513160|532429537|FG000|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|6|||
147620580|NCT02513160|532429538|FG001|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|0|||
147416075|NCT03828747|531688282|FG000|Open-Label Extension|Adverse Event|9|||
147416076|NCT03828747|531688283|FG001|Open-Label Extension|Adverse Event|7|||
147416077|NCT03828747|531688282|FG000|Open-Label Extension|Death|0|||
147416078|NCT03828747|531688283|FG001|Open-Label Extension|Death|2|||
147416079|NCT03828747|531688282|FG000|Open-Label Extension|Lost to Follow-up|4|||
147416080|NCT03828747|531688283|FG001|Open-Label Extension|Lost to Follow-up|0|||
147416081|NCT03828747|531688282|FG000|Open-Label Extension|Withdrawal by Subject|31|||
147416082|NCT03828747|531688283|FG001|Open-Label Extension|Withdrawal by Subject|30|||
147416083|NCT03828747|531688282|FG000|Open-Label Extension|Various reasons|4|||
147416084|NCT03828747|531688283|FG001|Open-Label Extension|Various reasons|4|||
147416085|NCT03828747|531688282|FG000|Open-Label Extension|Physician Decision|6|||
147416086|NCT03828747|531688283|FG001|Open-Label Extension|Physician Decision|2|||
147416087|NCT00490490|531688284|FG000|Completed Assessment for TTP|Withdrawal by Subject|1|||
147416088|NCT00490490|531688284|FG000|Completed Assessment for TTP|Lost to Follow-up|2|||
147416089|NCT02141620|531688285|FG000|Treatment Condition 1 (7 Days)|Adverse Event|1|||
147416090|NCT02141620|531688286|FG001|Treatment Condition 1 (7 Days)|Adverse Event|0|||
147416091|NCT03582943|531688289|FG000|Allocated to Groups|Withdrawal by Subject|1|||
147416092|NCT03582943|531688290|FG001|Allocated to Groups|Withdrawal by Subject|1|||
147416093|NCT03582943|531688289|FG000|Intervention and Follow up|Withdrawal by Subject|4|||
147416094|NCT03582943|531688290|FG001|Intervention and Follow up|Withdrawal by Subject|2|||
147416095|NCT03582943|531688289|FG000|Analyzed|Protocol Violation|4|||
147416096|NCT03582943|531688290|FG001|Analyzed|Protocol Violation|1|||
147416097|NCT03527550|531688291|FG000|Overall Study|Lost to Follow-up|4|||
147416098|NCT03527550|531688292|FG001|Overall Study|Lost to Follow-up|2|||
147416099|NCT03527550|531688291|FG000|Overall Study|Withdrawal by Subject|4|||
147416100|NCT03527550|531688292|FG001|Overall Study|Withdrawal by Subject|1|||
147416101|NCT03527550|531688291|FG000|Overall Study|Participant reported exclusion criterion after study enrollment.|1|||
147416102|NCT03527550|531688292|FG001|Overall Study|Participant reported exclusion criterion after study enrollment.|0|||
147416103|NCT03053518|531688295|FG000|Overall Study|Withdrawal by Subject|3|||
147416104|NCT03053518|531688295|FG000|Overall Study|Lost to Follow-up|2|||
147416105|NCT03053518|531688295|FG000|Overall Study|Ineligible|5|||
147416106|NCT02683876|531688296|FG000|Overall Study|samples damaged during shipping|2|||
147416107|NCT02683876|531688297|FG001|Overall Study|samples damaged during shipping|0|||
147416108|NCT02071290|531688298|FG000|Overall Study|Death|1|||
147416109|NCT02071290|531688299|FG001|Overall Study|Death|0|||
147416110|NCT02071290|531688298|FG000|Overall Study|Withdrawal by Subject|0|||
147416111|NCT02071290|531688299|FG001|Overall Study|Withdrawal by Subject|1|||
147416112|NCT02071290|531688298|FG000|Overall Study|Protocol Violation|3|||
147473026|NCT02210780|531888607|FG000|Overall Study|Lost to Follow-up|2|||
147473027|NCT02210780|531888608|FG001|Overall Study|Lost to Follow-up|1|||
147473028|NCT02210780|531888607|FG000|Overall Study|Withdrawal by Subject|1|||
147473029|NCT02210780|531888608|FG001|Overall Study|Withdrawal by Subject|1|||
147473030|NCT02210780|531888607|FG000|Overall Study|Physician Decision|1|||
147473031|NCT02210780|531888608|FG001|Overall Study|Physician Decision|0|||
147473032|NCT02210780|531888607|FG000|Overall Study|Protocol Violation|1|||
147473033|NCT02210780|531888608|FG001|Overall Study|Protocol Violation|0|||
147473034|NCT02210780|531888607|FG000|Overall Study|Other than specified above|0|||
147473035|NCT02210780|531888608|FG001|Overall Study|Other than specified above|1|||
147473036|NCT01503021|531888615|FG000|Overall Study|Adverse Event|7|||
147473037|NCT01503021|531888616|FG001|Overall Study|Adverse Event|6|||
147473038|NCT01503021|531888615|FG000|Overall Study|Death|0|||
147473039|NCT01503021|531888616|FG001|Overall Study|Death|2|||
147473040|NCT01503021|531888615|FG000|Overall Study|Lost to Follow-up|2|||
147473041|NCT01503021|531888616|FG001|Overall Study|Lost to Follow-up|0|||
147473042|NCT01503021|531888615|FG000|Overall Study|Physician Decision|3|||
147473043|NCT01503021|531888616|FG001|Overall Study|Physician Decision|0|||
147473044|NCT01503021|531888615|FG000|Overall Study|Protocol Violation|1|||
147473045|NCT01503021|531888616|FG001|Overall Study|Protocol Violation|3|||
147473046|NCT01503021|531888615|FG000|Overall Study|Withdrawal by Subject|9|||
147473047|NCT01503021|531888616|FG001|Overall Study|Withdrawal by Subject|8|||
147473048|NCT01503021|531888615|FG000|Overall Study|Moved, received transplant, etc.|5|||
147473049|NCT01503021|531888616|FG001|Overall Study|Moved, received transplant, etc.|7|||
147473050|NCT03941548|531888617|FG000|Overall Study|Adverse Event|0|||
147473051|NCT03941548|531888618|FG001|Overall Study|Adverse Event|1|||
147473052|NCT03941548|531888617|FG000|Overall Study|Lost to Follow-up|0|||
147473053|NCT03941548|531888618|FG001|Overall Study|Lost to Follow-up|1|||
147473054|NCT03941548|531888617|FG000|Overall Study|Withdrawal of Informed Consent due to an Adverse Event|1|||
147473055|NCT03941548|531888618|FG001|Overall Study|Withdrawal of Informed Consent due to an Adverse Event|0|||
147473056|NCT01242111|531888619|FG000|Overall Study|Adverse Event|1|||
147473057|NCT01242111|531888619|FG000|Overall Study|Withdrawal by Subject|1|||
147473058|NCT01242111|531888619|FG000|Overall Study|Did not consent to MOR-100 follow-up|1|||
147473059|NCT00870688|531888620|FG000|Overall Study|Lost to Follow-up|2|||
147416113|NCT02071290|531688299|FG001|Overall Study|Protocol Violation|5|||
147416114|NCT02071290|531688298|FG000|Overall Study|Physician Decision|0|||
147416115|NCT02071290|531688299|FG001|Overall Study|Physician Decision|1|||
147416116|NCT00939822|531688300|FG000|Overall Study|Lost to Follow-up|1|||
147416117|NCT00939822|531688301|FG001|Overall Study|Lost to Follow-up|0|||
147473060|NCT00870688|531888620|FG000|Overall Study|Death, Unrelated|1|||
147473061|NCT00870688|531888620|FG000|Overall Study|Granules in the Stools|1|||
147473062|NCT02945657|531888623|FG000|Overall Study|Adverse Event|1|||
147473063|NCT02945657|531888623|FG000|Overall Study|Withdrawal by Parent/Guardian|3|||
147473064|NCT00087438|531888624|FG000|Overall Study|Ineligible / No protocol treatment|4|||
147473065|NCT02371629|531888641|FG000|Overall Study|Patient decision|14|||
147473066|NCT02371629|531888642|FG001|Overall Study|Patient decision|10|||
147473067|NCT02371629|531888641|FG000|Overall Study|Adverse Event|8|||
147473068|NCT02371629|531888642|FG001|Overall Study|Adverse Event|8|||
147666235|NCT01926028|532603856|FG002|Overall Study|Withdrawal by Subject|2|||
147666236|NCT01926028|532603854|FG000|Overall Study|Non compliance or other reasons|4|||
147666237|NCT01926028|532603855|FG001|Overall Study|Non compliance or other reasons|2|||
147473069|NCT02371629|531888641|FG000|Overall Study|Physician Decision|2|||
147473070|NCT02371629|531888642|FG001|Overall Study|Physician Decision|3|||
147473071|NCT02371629|531888641|FG000|Overall Study|Death|1|||
147473072|NCT02371629|531888642|FG001|Overall Study|Death|1|||
147473073|NCT02371629|531888641|FG000|Overall Study|Noncompliance with study treatment|1|||
147473074|NCT02371629|531888642|FG001|Overall Study|Noncompliance with study treatment|0|||
147473075|NCT02371629|531888641|FG000|Overall Study|Lack of Efficacy|0|||
147473076|NCT02371629|531888642|FG001|Overall Study|Lack of Efficacy|2|||
147473077|NCT02371629|531888641|FG000|Overall Study|Protocol deviation|0|||
147473078|NCT02371629|531888642|FG001|Overall Study|Protocol deviation|1|||
147473079|NCT01073943|531888649|FG000|Overall Study|Withdrawal by Subject|8|||
147473080|NCT01073943|531888650|FG001|Overall Study|Withdrawal by Subject|2|||
147473081|NCT01073943|531888649|FG000|Overall Study|Protocol Violation|2|||
147473082|NCT01073943|531888650|FG001|Overall Study|Protocol Violation|1|||
147473083|NCT01073943|531888649|FG000|Overall Study|Adverse Event|1|||
147473084|NCT01073943|531888650|FG001|Overall Study|Adverse Event|1|||
147473085|NCT01073943|531888649|FG000|Overall Study|Lost to Follow-up|0|||
147473086|NCT01073943|531888650|FG001|Overall Study|Lost to Follow-up|2|||
147473087|NCT01073943|531888649|FG000|Overall Study|Power outage; colonoscopy not done|1|||
147473088|NCT01073943|531888650|FG001|Overall Study|Power outage; colonoscopy not done|0|||
147473089|NCT01073943|531888649|FG000|Overall Study|Subject forgot|0|||
147473090|NCT01073943|531888650|FG001|Overall Study|Subject forgot|1|||
147473091|NCT01073943|531888649|FG000|Overall Study|Unable to return for follow-up|0|||
147473092|NCT01073943|531888650|FG001|Overall Study|Unable to return for follow-up|1|||
147473093|NCT01073943|531888649|FG000|Overall Study|Could not tolerate prep|1|||
147473094|NCT01073943|531888650|FG001|Overall Study|Could not tolerate prep|0|||
147473095|NCT01051739|531888653|FG000|Overall Study|Death|3|||
147473096|NCT01051739|531888654|FG001|Overall Study|Death|3|||
147473097|NCT01051739|531888653|FG000|Overall Study|Withdrawal by Subject|25|||
147473098|NCT01051739|531888654|FG001|Overall Study|Withdrawal by Subject|10|||
147473099|NCT03527043|531888655|FG000|Overall Study|Withdrawal by Subject|1|||
147473100|NCT03527043|531888656|FG001|Overall Study|Withdrawal by Subject|0|||
147473101|NCT01772134|531888662|FG000|Overall Study|Adverse Event|6|||
147473102|NCT01772134|531888663|FG001|Overall Study|Adverse Event|5|||
147473103|NCT01772134|531888664|FG002|Overall Study|Adverse Event|10|||
147473104|NCT01772134|531888662|FG000|Overall Study|Withdrew Consent|3|||
147473105|NCT01772134|531888663|FG001|Overall Study|Withdrew Consent|1|||
147473106|NCT01772134|531888664|FG002|Overall Study|Withdrew Consent|5|||
147473107|NCT01772134|531888662|FG000|Overall Study|Lost to Follow-up|2|||
147473108|NCT01772134|531888663|FG001|Overall Study|Lost to Follow-up|0|||
147473109|NCT01772134|531888664|FG002|Overall Study|Lost to Follow-up|0|||
147473110|NCT01772134|531888662|FG000|Overall Study|Protocol Deviation|4|||
147473111|NCT01772134|531888663|FG001|Overall Study|Protocol Deviation|3|||
147473112|NCT01772134|531888664|FG002|Overall Study|Protocol Deviation|3|||
147473113|NCT01772134|531888662|FG000|Overall Study|Lack of Efficacy|11|||
147473114|NCT01772134|531888663|FG001|Overall Study|Lack of Efficacy|5|||
147473115|NCT01772134|531888664|FG002|Overall Study|Lack of Efficacy|3|||
147473116|NCT01772134|531888662|FG000|Overall Study|Protocol-defined Stopping Criteria|1|||
147473117|NCT01772134|531888663|FG001|Overall Study|Protocol-defined Stopping Criteria|0|||
147473118|NCT01772134|531888664|FG002|Overall Study|Protocol-defined Stopping Criteria|0|||
147620581|NCT02513160|532429539|FG002|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|0|||
147620582|NCT02513160|532429540|FG003|Run-In Period (Days -14 to Day -1)|Exclusion criteria met|0|||
147620583|NCT02513160|532429537|FG000|Run-In Period (Days -14 to Day -1)|Adverse Event|4|||
147620584|NCT02513160|532429538|FG001|Run-In Period (Days -14 to Day -1)|Adverse Event|0|||
147620585|NCT02513160|532429539|FG002|Run-In Period (Days -14 to Day -1)|Adverse Event|0|||
147620586|NCT02513160|532429540|FG003|Run-In Period (Days -14 to Day -1)|Adverse Event|0|||
147620587|NCT02513160|532429537|FG000|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|20|||
147666238|NCT01926028|532603856|FG002|Overall Study|Non compliance or other reasons|0|||
147666239|NCT00737048|532603857|FG000|Overall Study|Physician Decision|0|||
147666240|NCT00737048|532603858|FG001|Overall Study|Physician Decision|0|||
147666241|NCT00737048|532603859|FG002|Overall Study|Physician Decision|1|||
147666242|NCT00737048|532603857|FG000|Overall Study|Adverse Event|0|||
147473119|NCT01772134|531888662|FG000|Overall Study|Randomized Study Medication Not Received|2|||
147473120|NCT01772134|531888663|FG001|Overall Study|Randomized Study Medication Not Received|0|||
147473121|NCT01772134|531888664|FG002|Overall Study|Randomized Study Medication Not Received|1|||
147473122|NCT02500550|531888665|FG000|Overall Study|Death|7|||
147473123|NCT00424398|531888668|FG000|Overall Study|Withdrawal by Subject|2|||
147473124|NCT00424398|531888669|FG001|Overall Study|Withdrawal by Subject|1|||
147473125|NCT00424398|531888670|FG002|Overall Study|Withdrawal by Subject|0|||
147473126|NCT00424398|531888668|FG000|Overall Study|Subject met exclusion criteria|1|||
147473127|NCT00424398|531888669|FG001|Overall Study|Subject met exclusion criteria|0|||
147473128|NCT00424398|531888670|FG002|Overall Study|Subject met exclusion criteria|0|||
147473129|NCT01023789|531888671|FG000|3 - Year Visit|Death|29|||
147473130|NCT01023789|531888671|FG000|3 - Year Visit|Withdrawal of consent|1|||
147473131|NCT01023789|531888671|FG000|3 - Year Visit|Lost to Follow-up|13|||
147473132|NCT00246259|531888674|FG000|Overall Study|Other|3|||
147473133|NCT00246259|531888675|FG001|Overall Study|Other|3|||
147473134|NCT00246259|531888674|FG000|Overall Study|Not stable by Week 18|2|||
147473135|NCT00246259|531888675|FG001|Overall Study|Not stable by Week 18|1|||
147473136|NCT00246259|531888674|FG000|Overall Study|Participant non-compliant|4|||
147473137|NCT00246259|531888675|FG001|Overall Study|Participant non-compliant|9|||
147473138|NCT00246259|531888674|FG000|Overall Study|Lack of Efficacy|2|||
147473139|NCT00246259|531888675|FG001|Overall Study|Lack of Efficacy|2|||
147473140|NCT00246259|531888674|FG000|Overall Study|Investigator withdrew participant|2|||
147473141|NCT00246259|531888675|FG001|Overall Study|Investigator withdrew participant|0|||
147473142|NCT00246259|531888674|FG000|Overall Study|Adverse Event|5|||
147473143|NCT00246259|531888675|FG001|Overall Study|Adverse Event|0|||
147473144|NCT00246259|531888674|FG000|Overall Study|Lost to Follow-up|3|||
147473145|NCT00246259|531888675|FG001|Overall Study|Lost to Follow-up|4|||
147473146|NCT00246259|531888674|FG000|Overall Study|Withdrawal by Subject|5|||
147473147|NCT00246259|531888675|FG001|Overall Study|Withdrawal by Subject|1|||
147473148|NCT00246259|531888674|FG000|Overall Study|randomly assigned, not eligible for ITT|2|||
147473149|NCT00246259|531888675|FG001|Overall Study|randomly assigned, not eligible for ITT|6|||
147473150|NCT03022461|531888676|FG000|Overall Study|Death|3|||
147473151|NCT01076179|531888677|FG000|Overall Study|Withdrawal by Subject|1|||
147473152|NCT03459040|531888678|FG000|Overall Study|Death|8|||
147473153|NCT03459040|531888678|FG000|Overall Study|Withdrawal by Subject|1|||
147473154|NCT00986349|531888679|FG000|Overall Study|Unsuccessful implant procedure|3|||
147473155|NCT00986349|531888679|FG000|Overall Study|Adverse Event|2|||
147473156|NCT00986349|531888679|FG000|Overall Study|Physician Decision|1|||
147473157|NCT00986349|531888679|FG000|Overall Study|device migration|1|||
147473158|NCT02299934|531888680|FG000|Overall Study|Termination of study|13|||
147473159|NCT03815175|531888681|FG000|Overall Study|Subject Lost to Follow-up|6|||
147473160|NCT03815175|531888681|FG000|Overall Study|Subject Withdrew Consent|48|||
147473161|NCT03815175|531888681|FG000|Overall Study|Subject Withdrawn by Physician/Site|10|||
147473162|NCT03815175|531888681|FG000|Overall Study|Death|86|||
147473163|NCT03815175|531888681|FG000|Overall Study|Improper/Duplicate SubjectEnrollment|1|||
147473164|NCT03815175|531888681|FG000|Overall Study|Subject Discontinued by Sponsor|2|||
147473165|NCT03815175|531888681|FG000|Overall Study|Other Status Change Reason|1|||
147473166|NCT03815175|531888681|FG000|Overall Study|Missed Visit|12|||
147473167|NCT03577990|531888682|FG000|Overall Study|Lost to Follow-up|4|||
147473168|NCT03577990|531888683|FG001|Overall Study|Lost to Follow-up|6|||
147473169|NCT03577990|531888682|FG000|Overall Study|Withdrawal by Subject|4|||
147473170|NCT03577990|531888683|FG001|Overall Study|Withdrawal by Subject|7|||
147473171|NCT05662332|531888684|FG000|Overall Study|Death|3|||
147473172|NCT05662332|531888685|FG001|Overall Study|Death|3|||
147473173|NCT05662332|531888684|FG000|Overall Study|Lost to Follow-up|3|||
147473174|NCT05662332|531888685|FG001|Overall Study|Lost to Follow-up|8|||
147473175|NCT05662332|531888684|FG000|Overall Study|Physician Decision|1|||
147473176|NCT05662332|531888685|FG001|Overall Study|Physician Decision|2|||
147473177|NCT05662332|531888684|FG000|Overall Study|Protocol Deviation|2|||
147473178|NCT05662332|531888685|FG001|Overall Study|Protocol Deviation|1|||
147473179|NCT05662332|531888684|FG000|Overall Study|Withdrawal by Subject|14|||
147473180|NCT05662332|531888685|FG001|Overall Study|Withdrawal by Subject|14|||
147473181|NCT05662332|531888684|FG000|Overall Study|Assigned Treatment by Mistake|5|||
147473182|NCT05662332|531888685|FG001|Overall Study|Assigned Treatment by Mistake|7|||
147473183|NCT05662332|531888684|FG000|Overall Study|Non-compliance with study drug|4|||
147473184|NCT05662332|531888685|FG001|Overall Study|Non-compliance with study drug|1|||
147473185|NCT05662332|531888684|FG000|Overall Study|Due to Bariatric surgery|1|||
147620588|NCT02513160|532429538|FG001|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|0|||
147620589|NCT02513160|532429539|FG002|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|0|||
147620590|NCT02513160|532429540|FG003|Run-In Period (Days -14 to Day -1)|Withdrawal by Subject|0|||
147620591|NCT02513160|532429537|FG000|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|1|||
147620592|NCT02513160|532429538|FG001|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|0|||
147666243|NCT00737048|532603858|FG001|Overall Study|Adverse Event|1|||
147473186|NCT05662332|531888685|FG001|Overall Study|Due to Bariatric surgery|0|||
147473187|NCT05662332|531888684|FG000|Overall Study|Subject Moving out of State|0|||
147473188|NCT05662332|531888685|FG001|Overall Study|Subject Moving out of State|1|||
147473189|NCT05662332|531888684|FG000|Overall Study|Subject Missed the Schedule|1|||
147473190|NCT05662332|531888685|FG001|Overall Study|Subject Missed the Schedule|0|||
147473191|NCT05662332|531888684|FG000|Overall Study|The Patient Moved to Another City|1|||
147473192|NCT05662332|531888685|FG001|Overall Study|The Patient Moved to Another City|0|||
147473193|NCT03248128|531888686|FG000|Overall Study|Lost to Follow-up|1|||
147473194|NCT03248128|531888687|FG001|Overall Study|Lost to Follow-up|0|||
147473195|NCT03248128|531888686|FG000|Overall Study|Withdrawal by Subject|16|||
147473196|NCT03248128|531888687|FG001|Overall Study|Withdrawal by Subject|14|||
147473197|NCT03248128|531888686|FG000|Overall Study|Site Closed|4|||
147473198|NCT03248128|531888687|FG001|Overall Study|Site Closed|3|||
147473199|NCT03248128|531888686|FG000|Overall Study|Randomized, but did not receive treatment|1|||
147666244|NCT00737048|532603859|FG002|Overall Study|Adverse Event|0|||
147666245|NCT00737048|532603857|FG000|Overall Study|Worsening of the symptoms|3|||
147666246|NCT00737048|532603858|FG001|Overall Study|Worsening of the symptoms|5|||
147666247|NCT00737048|532603859|FG002|Overall Study|Worsening of the symptoms|3|||
147666248|NCT04635839|532603860|FG000|Overall Study|Delivered prior to second dose of heparin|1|||
147666249|NCT04635839|532603861|FG001|Overall Study|Delivered prior to second dose of heparin|0|||
147666250|NCT02737358|532603862|FG000|Overall Study|Withdrawal by Subject|7|||
147666251|NCT02737358|532603863|FG001|Overall Study|Withdrawal by Subject|12|||
147666252|NCT02737358|532603862|FG000|Overall Study|Lost to Follow-up|2|||
147666253|NCT02737358|532603863|FG001|Overall Study|Lost to Follow-up|3|||
147666254|NCT00744939|532603865|FG000|Overall Study|Withdrawal by Subject|9|||
147666255|NCT00744939|532603865|FG000|Overall Study|Protocol Violation|13|||
147666256|NCT00744939|532603865|FG000|Overall Study|Death|24|||
147666257|NCT00744939|532603865|FG000|Overall Study|distance|4|||
147666258|NCT00744939|532603865|FG000|Overall Study|Lost to Follow-up|12|||
147666259|NCT00744939|532603865|FG000|Overall Study|Medical history exclusionary|1|||
147666260|NCT00744939|532603865|FG000|Overall Study|Did not receive Magnevist|7|||
147666261|NCT00744939|532603865|FG000|Overall Study|Failed inclusion/exclusion criteria|19|||
147666262|NCT00744939|532603865|FG000|Overall Study|coma|1|||
147666263|NCT00744939|532603865|FG000|Overall Study|incorrect race|1|||
147666264|NCT01739335|532603866|FG000|Overall Study|Lost to Follow-up|7|||
147666265|NCT01739335|532603867|FG001|Overall Study|Lost to Follow-up|4|||
147666266|NCT01739335|532603866|FG000|Overall Study|Ineligible patient randomized|0|||
147666267|NCT01739335|532603867|FG001|Overall Study|Ineligible patient randomized|1|||
147666268|NCT00288912|532603868|FG000|Overall Study|Developed exclusion criterion|4|||
147666269|NCT00288912|532603869|FG001|Overall Study|Developed exclusion criterion|6|||
147666270|NCT00288912|532603870|FG002|Overall Study|Developed exclusion criterion|7|||
147666271|NCT00288912|532603868|FG000|Overall Study|Lost to Follow-up|9|||
147666272|NCT00288912|532603869|FG001|Overall Study|Lost to Follow-up|6|||
147666273|NCT00288912|532603870|FG002|Overall Study|Lost to Follow-up|9|||
147666274|NCT00288912|532603868|FG000|Overall Study|Withdrawal by Subject|4|||
147666275|NCT00288912|532603869|FG001|Overall Study|Withdrawal by Subject|5|||
147666276|NCT00288912|532603870|FG002|Overall Study|Withdrawal by Subject|12|||
147666277|NCT01587885|532603885|FG000|Treatment Period 1|Failure to Return|0|||
147666278|NCT01587885|532603886|FG001|Treatment Period 1|Failure to Return|1|||
147666279|NCT01587885|532603885|FG000|Treatment Period 1|Protocol Violation|0|||
147666280|NCT01587885|532603886|FG001|Treatment Period 1|Protocol Violation|2|||
147666281|NCT02062437|532603888|FG000|Overall Study|Pt. didn't want to come for the 2y visit|31|||
147666282|NCT02062437|532603888|FG000|Overall Study|Patient not available for the 2y visit|18|||
147666283|NCT02062437|532603888|FG000|Overall Study|Death|2|||
147666284|NCT02062437|532603888|FG000|Overall Study|Pt. couldn't come due to med. condition|1|||
147666285|NCT02900352|532603889|FG000|Overall Study|Lost to Follow-up|28|||
147666286|NCT02900352|532603890|FG001|Overall Study|Lost to Follow-up|17|||
147666287|NCT00386334|532603893|FG000|Double Blind Period|Adverse Event|9|||
147666288|NCT00386334|532603894|FG001|Double Blind Period|Adverse Event|14|||
147666289|NCT00386334|532603893|FG000|Double Blind Period|Protocol Violation|1|||
147666290|NCT00386334|532603894|FG001|Double Blind Period|Protocol Violation|1|||
147666291|NCT00386334|532603893|FG000|Double Blind Period|Withdrawal by Subject|9|||
147666292|NCT00386334|532603894|FG001|Double Blind Period|Withdrawal by Subject|13|||
147666293|NCT00386334|532603893|FG000|Double Blind Period|Lack of Efficacy|20|||
147666294|NCT00386334|532603894|FG001|Double Blind Period|Lack of Efficacy|11|||
147473200|NCT03248128|531888687|FG001|Overall Study|Randomized, but did not receive treatment|3|||
147473201|NCT01914679|531888688|FG000|Overall Study|Lack of Efficacy|1|||
147473202|NCT01914679|531888688|FG000|Overall Study|Sponsor terminated study|4|||
147473203|NCT00538681|531888694|FG000|Overall Study|Progressive Disease|7|||
147473204|NCT00538681|531888695|FG001|Overall Study|Progressive Disease|0|||
147473205|NCT00538681|531888696|FG002|Overall Study|Progressive Disease|1|||
147473206|NCT00538681|531888697|FG003|Overall Study|Progressive Disease|0|||
147473207|NCT00538681|531888694|FG000|Overall Study|Sponsor Decision|1|||
147473208|NCT00538681|531888695|FG001|Overall Study|Sponsor Decision|3|||
147473209|NCT00538681|531888696|FG002|Overall Study|Sponsor Decision|8|||
147473210|NCT00538681|531888697|FG003|Overall Study|Sponsor Decision|9|||
147473211|NCT00538681|531888694|FG000|Overall Study|Adverse Event|1|||
147473212|NCT00538681|531888695|FG001|Overall Study|Adverse Event|1|||
147473213|NCT00538681|531888696|FG002|Overall Study|Adverse Event|1|||
147473214|NCT00538681|531888697|FG003|Overall Study|Adverse Event|0|||
147473215|NCT00538681|531888694|FG000|Overall Study|Death|0|||
147473216|NCT00538681|531888695|FG001|Overall Study|Death|0|||
147473217|NCT00538681|531888696|FG002|Overall Study|Death|1|||
147473218|NCT00538681|531888697|FG003|Overall Study|Death|1|||
147473219|NCT00538681|531888694|FG000|Overall Study|Investigator Decision|0|||
147473220|NCT00538681|531888695|FG001|Overall Study|Investigator Decision|0|||
147473221|NCT00538681|531888696|FG002|Overall Study|Investigator Decision|0|||
147473222|NCT00538681|531888697|FG003|Overall Study|Investigator Decision|1|||
147473223|NCT05369806|531888700|FG000|Overall Study|Lost to Follow-up|1|||
147473224|NCT00628355|531888701|FG000|Overall Study|Withdrawal by Subject|1|||
147666295|NCT00386334|532603893|FG000|Double Blind Period|Didnt Meet Entry/Randomization Criteria|4|||
147620593|NCT02513160|532429539|FG002|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|0|||
147620594|NCT02513160|532429540|FG003|Run-In Period (Days -14 to Day -1)|Site reached randomization limit|0|||
147620595|NCT02513160|532429537|FG000|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|10|||
147620596|NCT02513160|532429538|FG001|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|0|||
147620597|NCT02513160|532429539|FG002|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|0|||
147620598|NCT02513160|532429540|FG003|Run-In Period (Days -14 to Day -1)|Lost to Follow-up|0|||
147620599|NCT02513160|532429537|FG000|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|2|||
147620600|NCT02513160|532429538|FG001|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|2|||
147620601|NCT02513160|532429539|FG002|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|0|||
147620602|NCT02513160|532429540|FG003|Treatment Period (Day 0 to Week 6)|Withdrawal by Subject|1|||
147620603|NCT02513160|532429537|FG000|Treatment Period (Day 0 to Week 6)|Noncompliance|1|||
147620604|NCT02513160|532429538|FG001|Treatment Period (Day 0 to Week 6)|Noncompliance|0|||
147620605|NCT02513160|532429539|FG002|Treatment Period (Day 0 to Week 6)|Noncompliance|0|||
147620606|NCT02513160|532429540|FG003|Treatment Period (Day 0 to Week 6)|Noncompliance|0|||
147620607|NCT02513160|532429537|FG000|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|2|||
147620608|NCT02513160|532429538|FG001|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|1|||
147620609|NCT02513160|532429539|FG002|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|1|||
147620610|NCT02513160|532429540|FG003|Treatment Period (Day 0 to Week 6)|Lost to Follow-up|1|||
147620611|NCT02513160|532429537|FG000|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|1|||
147620612|NCT02513160|532429538|FG001|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|0|||
147620613|NCT02513160|532429539|FG002|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|0|||
147620614|NCT02513160|532429540|FG003|Treatment Period (Day 0 to Week 6)|Lack of Efficacy|0|||
147620615|NCT02513160|532429537|FG000|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|0|||
147620616|NCT02513160|532429538|FG001|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|1|||
147473225|NCT00628355|531888702|FG001|Overall Study|Withdrawal by Subject|1|||
147473226|NCT00140855|531888703|FG000|Overall Study|Progressive disease|2|||
147473227|NCT00817414|531890320|FG000|Overall Study|Adverse Event|1|||
147473228|NCT00817414|531890321|FG001|Overall Study|Adverse Event|1|||
147473229|NCT00817414|531890322|FG002|Overall Study|Adverse Event|1|||
147473230|NCT00817414|531890323|FG003|Overall Study|Adverse Event|0|||
147473231|NCT00817414|531890324|FG004|Overall Study|Adverse Event|0|||
147473232|NCT00817414|531890320|FG000|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|0|||
147473233|NCT00817414|531890321|FG001|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|1|||
147473234|NCT00817414|531890322|FG002|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|2|||
147473235|NCT00817414|531890323|FG003|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|4|||
147473236|NCT00817414|531890324|FG004|Overall Study|Low Adrenocorticotropic Hormone (ACTH)- Stimulated Cortisol|0|||
147473237|NCT00817414|531890320|FG000|Overall Study|Withdrawal by Subject|1|||
147473238|NCT00817414|531890321|FG001|Overall Study|Withdrawal by Subject|1|||
147473239|NCT00817414|531890322|FG002|Overall Study|Withdrawal by Subject|0|||
147473240|NCT00817414|531890323|FG003|Overall Study|Withdrawal by Subject|0|||
147473241|NCT00817414|531890324|FG004|Overall Study|Withdrawal by Subject|0|||
147473242|NCT00817414|531890320|FG000|Overall Study|Lost to Follow-up|0|||
147473243|NCT00817414|531890321|FG001|Overall Study|Lost to Follow-up|0|||
147473244|NCT00817414|531890322|FG002|Overall Study|Lost to Follow-up|1|||
147473245|NCT00817414|531890323|FG003|Overall Study|Lost to Follow-up|1|||
147473246|NCT00817414|531890324|FG004|Overall Study|Lost to Follow-up|1|||
147473247|NCT00817414|531890320|FG000|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|0|||
147473248|NCT00817414|531890321|FG001|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|0|||
147473249|NCT00817414|531890322|FG002|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|0|||
147473250|NCT00817414|531890323|FG003|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|7|||
147473251|NCT00817414|531890324|FG004|Overall Study|Dose Arm Exceeds Maximum Tolerated Dose (MTD)|0|||
147473252|NCT00817414|531890320|FG000|Overall Study|Protocol Violation|0|||
147473253|NCT00817414|531890321|FG001|Overall Study|Protocol Violation|0|||
147473254|NCT00817414|531890322|FG002|Overall Study|Protocol Violation|0|||
147473255|NCT00817414|531890323|FG003|Overall Study|Protocol Violation|0|||
147473256|NCT00817414|531890324|FG004|Overall Study|Protocol Violation|1|||
147473257|NCT00886938|531890325|FG000|Overall Study|Adverse Event|1|||
147473258|NCT00886938|531890325|FG000|Overall Study|Withdrawal by Subject|1|||
147473259|NCT03872180|531890331|FG000|Overall Study|Adverse Event|4|||
147473260|NCT03872180|531890331|FG000|Overall Study|Lack of Efficacy|2|||
147473261|NCT01157117|531890334|FG000|Overall Study|Dosing Symptoms|0|||
147473262|NCT01157117|531890335|FG001|Overall Study|Dosing Symptoms|4|||
147473263|NCT01157117|531890336|FG002|Overall Study|Dosing Symptoms|0|||
147473264|NCT01157117|531890334|FG000|Overall Study|Withdrawal by Subject|4|||
147473265|NCT01157117|531890335|FG001|Overall Study|Withdrawal by Subject|1|||
147473266|NCT01157117|531890336|FG002|Overall Study|Withdrawal by Subject|1|||
147473267|NCT01157117|531890334|FG000|Overall Study|Lack of Efficacy|1|||
147473268|NCT01157117|531890335|FG001|Overall Study|Lack of Efficacy|1|||
147473269|NCT01157117|531890336|FG002|Overall Study|Lack of Efficacy|0|||
147473270|NCT01157117|531890334|FG000|Overall Study|Lost to Follow-up|0|||
147473271|NCT01157117|531890335|FG001|Overall Study|Lost to Follow-up|0|||
147473272|NCT01157117|531890336|FG002|Overall Study|Lost to Follow-up|1|||
147473273|NCT01157117|531890334|FG000|Overall Study|Unknown (Pending Final Form Submission)|4|||
147473274|NCT01157117|531890335|FG001|Overall Study|Unknown (Pending Final Form Submission)|5|||
147473275|NCT01157117|531890336|FG002|Overall Study|Unknown (Pending Final Form Submission)|13|||
147473276|NCT01931865|531890337|FG000|Overall Study|Lost to Follow-up|2|||
147473277|NCT01931865|531890337|FG000|Overall Study|Withdrawal by Subject|2|||
147473278|NCT01531725|531890341|FG000|Overall Study|Protocol Violation|5|||
147473279|NCT03215277|531890342|FG000|Overall Study|Adverse Event|2|||
147473280|NCT03215277|531890343|FG001|Overall Study|Adverse Event|3|||
147473281|NCT03215277|531890342|FG000|Overall Study|Death|1|||
147473282|NCT03215277|531890343|FG001|Overall Study|Death|0|||
147473283|NCT03215277|531890342|FG000|Overall Study|Lost to Follow-up|0|||
147473284|NCT03215277|531890343|FG001|Overall Study|Lost to Follow-up|1|||
147473285|NCT03215277|531890342|FG000|Overall Study|Participant was unable to attend clinic visit|0|||
147473286|NCT03215277|531890343|FG001|Overall Study|Participant was unable to attend clinic visit|1|||
147473287|NCT00728416|531890345|FG000|Overall Study|Adverse Event|1|||
147473288|NCT00728416|531890346|FG001|Overall Study|Adverse Event|1|||
147473289|NCT00728416|531890345|FG000|Overall Study|Treatment Failure|0|||
147473290|NCT00728416|531890346|FG001|Overall Study|Treatment Failure|1|||
147473291|NCT00728416|531890345|FG000|Overall Study|Withdrawal by Subject|1|||
147473292|NCT00728416|531890346|FG001|Overall Study|Withdrawal by Subject|0|||
147473293|NCT03596164|531890347|FG000|Overall Study|Adverse Event|0|||
147473294|NCT03596164|531890348|FG001|Overall Study|Adverse Event|1|||
147473295|NCT03596164|531890347|FG000|Overall Study|Death|1|||
147473296|NCT03596164|531890348|FG001|Overall Study|Death|0|||
147473297|NCT01120626|531890349|FG000|Overall Study|Withdrawal by Subject|1|||
147473298|NCT01120626|531890350|FG001|Overall Study|Withdrawal by Subject|0|||
147473299|NCT00488631|531890351|FG000|Double Blind Period (Week 0-54)|Adverse Event|17|||
147473300|NCT00488631|531890352|FG001|Double Blind Period (Week 0-54)|Adverse Event|12|||
147473301|NCT00488631|531890353|FG002|Double Blind Period (Week 0-54)|Adverse Event|12|||
147473302|NCT00488631|531890354|FG003|Double Blind Period (Week 0-54)|Adverse Event|12|||
147473303|NCT00488631|531890355|FG004|Double Blind Period (Week 0-54)|Adverse Event|30|||
147473304|NCT00488631|531890356|FG005|Double Blind Period (Week 0-54)|Adverse Event|50|||
147473305|NCT00488631|531890357|FG006|Double Blind Period (Week 0-54)|Adverse Event|0|||
147473306|NCT00488631|531890358|FG007|Double Blind Period (Week 0-54)|Adverse Event|0|||
147473307|NCT00488631|531890359|FG008|Double Blind Period (Week 0-54)|Adverse Event|0|||
147473308|NCT00488631|531890360|FG009|Double Blind Period (Week 0-54)|Adverse Event|0|||
147473309|NCT00488631|531890351|FG000|Double Blind Period (Week 0-54)|Death|0|||
147473310|NCT00488631|531890352|FG001|Double Blind Period (Week 0-54)|Death|0|||
147473311|NCT00488631|531890353|FG002|Double Blind Period (Week 0-54)|Death|0|||
147473312|NCT00488631|531890354|FG003|Double Blind Period (Week 0-54)|Death|0|||
147473313|NCT00488631|531890355|FG004|Double Blind Period (Week 0-54)|Death|0|||
147473314|NCT00488631|531890356|FG005|Double Blind Period (Week 0-54)|Death|1|||
147473315|NCT00488631|531890357|FG006|Double Blind Period (Week 0-54)|Death|0|||
147473316|NCT00488631|531890358|FG007|Double Blind Period (Week 0-54)|Death|0|||
147473317|NCT00488631|531890359|FG008|Double Blind Period (Week 0-54)|Death|0|||
147473318|NCT00488631|531890360|FG009|Double Blind Period (Week 0-54)|Death|0|||
147473319|NCT00488631|531890351|FG000|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|19|||
147473320|NCT00488631|531890352|FG001|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|17|||
147473321|NCT00488631|531890353|FG002|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|22|||
147473322|NCT00488631|531890354|FG003|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|18|||
147473323|NCT00488631|531890355|FG004|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|56|||
147473324|NCT00488631|531890356|FG005|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|124|||
147473325|NCT00488631|531890357|FG006|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0|||
147473326|NCT00488631|531890358|FG007|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0|||
147473327|NCT00488631|531890359|FG008|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0|||
147473328|NCT00488631|531890360|FG009|Double Blind Period (Week 0-54)|Unsatisfactory therapeutic effect|0|||
147473329|NCT00488631|531890351|FG000|Double Blind Period (Week 0-54)|Lost to Follow-up|1|||
147473330|NCT00488631|531890352|FG001|Double Blind Period (Week 0-54)|Lost to Follow-up|2|||
147620617|NCT02513160|532429539|FG002|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|0|||
147620618|NCT02513160|532429540|FG003|Treatment Period (Day 0 to Week 6)|Did not meet exclusion criteria|0|||
147620619|NCT03428958|532429544|FG000|Overall Study|Adverse Event|0|||
147620620|NCT03428958|532429545|FG001|Overall Study|Adverse Event|0|||
147620621|NCT03428958|532429546|FG002|Overall Study|Adverse Event|0|||
147473331|NCT00488631|531890353|FG002|Double Blind Period (Week 0-54)|Lost to Follow-up|1|||
147473332|NCT00488631|531890354|FG003|Double Blind Period (Week 0-54)|Lost to Follow-up|0|||
147473333|NCT00488631|531890355|FG004|Double Blind Period (Week 0-54)|Lost to Follow-up|3|||
147473334|NCT00488631|531890356|FG005|Double Blind Period (Week 0-54)|Lost to Follow-up|7|||
147473335|NCT00488631|531890357|FG006|Double Blind Period (Week 0-54)|Lost to Follow-up|0|||
147473336|NCT00488631|531890358|FG007|Double Blind Period (Week 0-54)|Lost to Follow-up|0|||
147473337|NCT00488631|531890359|FG008|Double Blind Period (Week 0-54)|Lost to Follow-up|0|||
147473338|NCT00488631|531890360|FG009|Double Blind Period (Week 0-54)|Lost to Follow-up|0|||
147620622|NCT03428958|532429547|FG003|Overall Study|Adverse Event|1|||
147620623|NCT03428958|532429548|FG004|Overall Study|Adverse Event|0|||
147620624|NCT03428958|532429549|FG005|Overall Study|Adverse Event|2|||
147620625|NCT03428958|532429550|FG006|Overall Study|Adverse Event|1|||
147620626|NCT03428958|532429551|FG007|Overall Study|Adverse Event|0|||
147620627|NCT03428958|532429552|FG008|Overall Study|Adverse Event|0|||
147620628|NCT03428958|532429553|FG009|Overall Study|Adverse Event|0|||
147620629|NCT03428958|532429554|FG010|Overall Study|Adverse Event|0|||
147620630|NCT03428958|532429555|FG011|Overall Study|Adverse Event|0|||
147620631|NCT03428958|532429556|FG012|Overall Study|Adverse Event|0|||
147620632|NCT03428958|532429557|FG013|Overall Study|Adverse Event|0|||
147620633|NCT03428958|532429558|FG014|Overall Study|Adverse Event|0|||
147620634|NCT03428958|532429559|FG015|Overall Study|Adverse Event|0|||
147620635|NCT03428958|532429560|FG016|Overall Study|Adverse Event|0|||
147620636|NCT03428958|532429544|FG000|Overall Study|Clinical Progression|2|||
147620637|NCT03428958|532429545|FG001|Overall Study|Clinical Progression|3|||
147620638|NCT03428958|532429546|FG002|Overall Study|Clinical Progression|2|||
147620639|NCT03428958|532429547|FG003|Overall Study|Clinical Progression|1|||
147620640|NCT03428958|532429548|FG004|Overall Study|Clinical Progression|0|||
147620641|NCT03428958|532429549|FG005|Overall Study|Clinical Progression|2|||
147620642|NCT03428958|532429550|FG006|Overall Study|Clinical Progression|0|||
147620643|NCT03428958|532429551|FG007|Overall Study|Clinical Progression|0|||
147620644|NCT03428958|532429552|FG008|Overall Study|Clinical Progression|0|||
147620645|NCT03428958|532429553|FG009|Overall Study|Clinical Progression|0|||
147620646|NCT03428958|532429554|FG010|Overall Study|Clinical Progression|0|||
147620647|NCT03428958|532429555|FG011|Overall Study|Clinical Progression|0|||
147620648|NCT03428958|532429556|FG012|Overall Study|Clinical Progression|0|||
147620649|NCT03428958|532429557|FG013|Overall Study|Clinical Progression|0|||
147620650|NCT03428958|532429558|FG014|Overall Study|Clinical Progression|0|||
147620651|NCT03428958|532429559|FG015|Overall Study|Clinical Progression|0|||
147620652|NCT03428958|532429560|FG016|Overall Study|Clinical Progression|0|||
147620653|NCT03428958|532429544|FG000|Overall Study|Progression per RECIST|6|||
147620654|NCT03428958|532429545|FG001|Overall Study|Progression per RECIST|6|||
147620655|NCT03428958|532429546|FG002|Overall Study|Progression per RECIST|7|||
147620656|NCT03428958|532429547|FG003|Overall Study|Progression per RECIST|4|||
147620657|NCT03428958|532429548|FG004|Overall Study|Progression per RECIST|0|||
147620658|NCT03428958|532429549|FG005|Overall Study|Progression per RECIST|7|||
147620659|NCT03428958|532429550|FG006|Overall Study|Progression per RECIST|8|||
147620660|NCT03428958|532429551|FG007|Overall Study|Progression per RECIST|0|||
147620661|NCT03428958|532429552|FG008|Overall Study|Progression per RECIST|0|||
147620662|NCT03428958|532429553|FG009|Overall Study|Progression per RECIST|0|||
147620663|NCT03428958|532429554|FG010|Overall Study|Progression per RECIST|0|||
147620664|NCT03428958|532429555|FG011|Overall Study|Progression per RECIST|0|||
147620665|NCT03428958|532429556|FG012|Overall Study|Progression per RECIST|1|||
147620666|NCT03428958|532429557|FG013|Overall Study|Progression per RECIST|0|||
147620667|NCT03428958|532429558|FG014|Overall Study|Progression per RECIST|0|||
147620668|NCT03428958|532429559|FG015|Overall Study|Progression per RECIST|0|||
147620669|NCT03428958|532429560|FG016|Overall Study|Progression per RECIST|0|||
147620670|NCT03428958|532429544|FG000|Overall Study|Death|2|||
147620671|NCT03428958|532429545|FG001|Overall Study|Death|2|||
147620672|NCT03428958|532429546|FG002|Overall Study|Death|0|||
147620673|NCT03428958|532429547|FG003|Overall Study|Death|0|||
147620674|NCT03428958|532429548|FG004|Overall Study|Death|0|||
147620675|NCT03428958|532429549|FG005|Overall Study|Death|7|||
147473339|NCT00488631|531890351|FG000|Double Blind Period (Week 0-54)|Other|6|||
147473340|NCT00488631|531890352|FG001|Double Blind Period (Week 0-54)|Other|12|||
147473341|NCT00488631|531890353|FG002|Double Blind Period (Week 0-54)|Other|10|||
147473342|NCT00488631|531890354|FG003|Double Blind Period (Week 0-54)|Other|11|||
147473343|NCT00488631|531890355|FG004|Double Blind Period (Week 0-54)|Other|14|||
147473344|NCT00488631|531890356|FG005|Double Blind Period (Week 0-54)|Other|34|||
147473345|NCT00488631|531890357|FG006|Double Blind Period (Week 0-54)|Other|0|||
147473346|NCT00488631|531890358|FG007|Double Blind Period (Week 0-54)|Other|0|||
147473347|NCT00488631|531890359|FG008|Double Blind Period (Week 0-54)|Other|0|||
147473348|NCT00488631|531890360|FG009|Double Blind Period (Week 0-54)|Other|0|||
147473349|NCT00488631|531890351|FG000|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
147473350|NCT00488631|531890352|FG001|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
147620676|NCT03428958|532429550|FG006|Overall Study|Death|9|||
147620677|NCT03428958|532429551|FG007|Overall Study|Death|6|||
147620678|NCT03428958|532429552|FG008|Overall Study|Death|0|||
147620679|NCT03428958|532429553|FG009|Overall Study|Death|0|||
147620680|NCT03428958|532429554|FG010|Overall Study|Death|3|||
147620681|NCT03428958|532429555|FG011|Overall Study|Death|0|||
147620682|NCT03428958|532429556|FG012|Overall Study|Death|4|||
147620683|NCT03428958|532429557|FG013|Overall Study|Death|0|||
147620684|NCT03428958|532429558|FG014|Overall Study|Death|0|||
147620685|NCT03428958|532429559|FG015|Overall Study|Death|0|||
147620686|NCT03428958|532429560|FG016|Overall Study|Death|0|||
147620687|NCT03428958|532429544|FG000|Overall Study|Lost to Follow-up|0|||
147620688|NCT03428958|532429545|FG001|Overall Study|Lost to Follow-up|0|||
147473351|NCT00488631|531890353|FG002|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
147473352|NCT00488631|531890354|FG003|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
147473353|NCT00488631|531890355|FG004|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
147620689|NCT03428958|532429546|FG002|Overall Study|Lost to Follow-up|0|||
147620690|NCT03428958|532429547|FG003|Overall Study|Lost to Follow-up|0|||
147620691|NCT03428958|532429548|FG004|Overall Study|Lost to Follow-up|0|||
147620692|NCT03428958|532429549|FG005|Overall Study|Lost to Follow-up|1|||
147620693|NCT03428958|532429550|FG006|Overall Study|Lost to Follow-up|1|||
147620694|NCT03428958|532429551|FG007|Overall Study|Lost to Follow-up|0|||
147620695|NCT03428958|532429552|FG008|Overall Study|Lost to Follow-up|0|||
147620696|NCT03428958|532429553|FG009|Overall Study|Lost to Follow-up|0|||
147620697|NCT03428958|532429554|FG010|Overall Study|Lost to Follow-up|0|||
147620698|NCT03428958|532429555|FG011|Overall Study|Lost to Follow-up|0|||
147620699|NCT03428958|532429556|FG012|Overall Study|Lost to Follow-up|0|||
147620700|NCT03428958|532429557|FG013|Overall Study|Lost to Follow-up|0|||
147620701|NCT03428958|532429558|FG014|Overall Study|Lost to Follow-up|0|||
147620702|NCT03428958|532429559|FG015|Overall Study|Lost to Follow-up|0|||
147620703|NCT03428958|532429560|FG016|Overall Study|Lost to Follow-up|0|||
147620704|NCT03428958|532429544|FG000|Overall Study|Physician/Sponsor Decision|1|||
147620705|NCT03428958|532429545|FG001|Overall Study|Physician/Sponsor Decision|0|||
147620706|NCT03428958|532429546|FG002|Overall Study|Physician/Sponsor Decision|1|||
147620707|NCT03428958|532429547|FG003|Overall Study|Physician/Sponsor Decision|0|||
147620708|NCT03428958|532429548|FG004|Overall Study|Physician/Sponsor Decision|0|||
147620709|NCT03428958|532429549|FG005|Overall Study|Physician/Sponsor Decision|2|||
147620710|NCT03428958|532429550|FG006|Overall Study|Physician/Sponsor Decision|2|||
147620711|NCT03428958|532429551|FG007|Overall Study|Physician/Sponsor Decision|2|||
147620712|NCT03428958|532429552|FG008|Overall Study|Physician/Sponsor Decision|0|||
147620713|NCT03428958|532429553|FG009|Overall Study|Physician/Sponsor Decision|0|||
147620714|NCT03428958|532429554|FG010|Overall Study|Physician/Sponsor Decision|2|||
147620715|NCT03428958|532429555|FG011|Overall Study|Physician/Sponsor Decision|0|||
147620716|NCT03428958|532429556|FG012|Overall Study|Physician/Sponsor Decision|4|||
147620717|NCT03428958|532429557|FG013|Overall Study|Physician/Sponsor Decision|0|||
147620718|NCT03428958|532429558|FG014|Overall Study|Physician/Sponsor Decision|0|||
147620719|NCT03428958|532429559|FG015|Overall Study|Physician/Sponsor Decision|0|||
147620720|NCT03428958|532429560|FG016|Overall Study|Physician/Sponsor Decision|0|||
147620721|NCT03428958|532429544|FG000|Overall Study|Withdrawal by Subject|0|||
147620722|NCT03428958|532429545|FG001|Overall Study|Withdrawal by Subject|0|||
147620723|NCT03428958|532429546|FG002|Overall Study|Withdrawal by Subject|2|||
147620724|NCT03428958|532429547|FG003|Overall Study|Withdrawal by Subject|0|||
147620725|NCT03428958|532429548|FG004|Overall Study|Withdrawal by Subject|0|||
147620726|NCT03428958|532429549|FG005|Overall Study|Withdrawal by Subject|2|||
147620727|NCT03428958|532429550|FG006|Overall Study|Withdrawal by Subject|4|||
147620728|NCT03428958|532429551|FG007|Overall Study|Withdrawal by Subject|1|||
147620729|NCT03428958|532429552|FG008|Overall Study|Withdrawal by Subject|0|||
147620730|NCT03428958|532429553|FG009|Overall Study|Withdrawal by Subject|0|||
147620731|NCT03428958|532429554|FG010|Overall Study|Withdrawal by Subject|0|||
147620732|NCT03428958|532429555|FG011|Overall Study|Withdrawal by Subject|0|||
147620733|NCT03428958|532429556|FG012|Overall Study|Withdrawal by Subject|0|||
147620734|NCT03428958|532429557|FG013|Overall Study|Withdrawal by Subject|0|||
147620735|NCT03428958|532429558|FG014|Overall Study|Withdrawal by Subject|0|||
147620736|NCT03428958|532429559|FG015|Overall Study|Withdrawal by Subject|0|||
147620737|NCT03428958|532429560|FG016|Overall Study|Withdrawal by Subject|0|||
147620738|NCT03874117|532429561|FG000|First Intervention (4 Weeks)|received kidney transplant|1|||
147620739|NCT03874117|532429562|FG001|First Intervention (4 Weeks)|received kidney transplant|0|||
147620740|NCT03874117|532429561|FG000|First Intervention (4 Weeks)|Coronavirus Disease 2019 (COVID-19) imposed restrictions on research|1|||
147620741|NCT03874117|532429562|FG001|First Intervention (4 Weeks)|Coronavirus Disease 2019 (COVID-19) imposed restrictions on research|1|||
147620742|NCT03874117|532429561|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|0|||
147620743|NCT03874117|532429562|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
147620744|NCT03874117|532429561|FG000|First Intervention (4 Weeks)|hospitalized for infection|0|||
147620745|NCT03874117|532429562|FG001|First Intervention (4 Weeks)|hospitalized for infection|1|||
147620746|NCT03874117|532429561|FG000|Second Intervention (4 Weeks)|Withdrawal by Subject|1|||
147620747|NCT03874117|532429562|FG001|Second Intervention (4 Weeks)|Withdrawal by Subject|0|||
147620748|NCT05012098|532429563|FG000|Overall Study|Disease progression|5|||
147620749|NCT05012098|532429564|FG001|Overall Study|Disease progression|2|||
147620750|NCT05012098|532429563|FG000|Overall Study|Adverse Event|1|||
147620751|NCT05012098|532429564|FG001|Overall Study|Adverse Event|0|||
147620752|NCT05012098|532429563|FG000|Overall Study|Withdrawal by Subject|1|||
147620753|NCT05012098|532429564|FG001|Overall Study|Withdrawal by Subject|0|||
147620754|NCT05012098|532429563|FG000|Overall Study|Discontinuation per protocol|1|||
147620755|NCT05012098|532429564|FG001|Overall Study|Discontinuation per protocol|0|||
147620756|NCT05258773|532429565|FG000|Overall Study|Screen Failure|1|||
147620757|NCT05258773|532429566|FG001|Overall Study|Screen Failure|1|||
147473354|NCT00488631|531890356|FG005|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
147620758|NCT05258773|532429565|FG000|Overall Study|Adverse Event|1|||
147620759|NCT05258773|532429566|FG001|Overall Study|Adverse Event|0|||
147620760|NCT05258773|532429565|FG000|Overall Study|Withdrawal by Subject|0|||
147620761|NCT05258773|532429566|FG001|Overall Study|Withdrawal by Subject|1|||
147620762|NCT05364931|532429571|FG000|Overall Study|Adverse Event|0|||
147620763|NCT05364931|532429572|FG001|Overall Study|Adverse Event|2|||
147620764|NCT05364931|532429573|FG002|Overall Study|Adverse Event|1|||
147473355|NCT00488631|531890357|FG006|Open Label Study Extension (Week 54-228)|Adverse Event|10|||
147473356|NCT00488631|531890358|FG007|Open Label Study Extension (Week 54-228)|Adverse Event|8|||
147473357|NCT00488631|531890359|FG008|Open Label Study Extension (Week 54-228)|Adverse Event|54|||
147473358|NCT00488631|531890360|FG009|Open Label Study Extension (Week 54-228)|Adverse Event|0|||
147473359|NCT00488631|531890351|FG000|Open Label Study Extension (Week 54-228)|Death|0|||
147473360|NCT00488631|531890352|FG001|Open Label Study Extension (Week 54-228)|Death|0|||
147473361|NCT00488631|531890353|FG002|Open Label Study Extension (Week 54-228)|Death|0|||
147473362|NCT00488631|531890354|FG003|Open Label Study Extension (Week 54-228)|Death|0|||
147473363|NCT00488631|531890355|FG004|Open Label Study Extension (Week 54-228)|Death|0|||
147473364|NCT00488631|531890356|FG005|Open Label Study Extension (Week 54-228)|Death|0|||
147473365|NCT00488631|531890357|FG006|Open Label Study Extension (Week 54-228)|Death|0|||
147473366|NCT00488631|531890358|FG007|Open Label Study Extension (Week 54-228)|Death|0|||
147473367|NCT00488631|531890359|FG008|Open Label Study Extension (Week 54-228)|Death|1|||
147473368|NCT00488631|531890360|FG009|Open Label Study Extension (Week 54-228)|Death|0|||
147473369|NCT00488631|531890351|FG000|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
147473370|NCT00488631|531890352|FG001|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
147473371|NCT00488631|531890353|FG002|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
147473372|NCT00488631|531890354|FG003|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
147473373|NCT00488631|531890355|FG004|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
147473374|NCT00488631|531890356|FG005|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|0|||
147473375|NCT00488631|531890357|FG006|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|5|||
147473376|NCT00488631|531890358|FG007|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|5|||
147473377|NCT00488631|531890359|FG008|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|34|||
147473378|NCT00488631|531890360|FG009|Open Label Study Extension (Week 54-228)|Unsatisfactory therapeutic effect|3|||
147473379|NCT00488631|531890351|FG000|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
147473380|NCT00488631|531890352|FG001|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
147473381|NCT00488631|531890353|FG002|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
147473382|NCT00488631|531890354|FG003|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
147473383|NCT00488631|531890355|FG004|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
147473384|NCT00488631|531890356|FG005|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
147473385|NCT00488631|531890357|FG006|Open Label Study Extension (Week 54-228)|Lost to Follow-up|2|||
147473386|NCT00488631|531890358|FG007|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
147473387|NCT00488631|531890359|FG008|Open Label Study Extension (Week 54-228)|Lost to Follow-up|6|||
147473388|NCT00488631|531890360|FG009|Open Label Study Extension (Week 54-228)|Lost to Follow-up|0|||
147473389|NCT00488631|531890351|FG000|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
147473390|NCT00488631|531890352|FG001|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
147473391|NCT00488631|531890353|FG002|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
147473392|NCT00488631|531890354|FG003|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
147473393|NCT00488631|531890355|FG004|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
147473394|NCT00488631|531890356|FG005|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
147473395|NCT00488631|531890357|FG006|Open Label Study Extension (Week 54-228)|Unspecified reasons|63|||
147473396|NCT00488631|531890358|FG007|Open Label Study Extension (Week 54-228)|Unspecified reasons|14|||
147473397|NCT00488631|531890359|FG008|Open Label Study Extension (Week 54-228)|Unspecified reasons|87|||
147473398|NCT00488631|531890360|FG009|Open Label Study Extension (Week 54-228)|Unspecified reasons|0|||
147473399|NCT05421754|531890361|FG000|Overall Study|Technical issue with sensor|1|||
147473400|NCT02604264|531890368|FG000|Intervention|Didn't use CVC for at least 21 days|200|||
147473401|NCT02604264|531890369|FG001|Intervention|Didn't use CVC for at least 21 days|242|||
147473402|NCT03192904|531890370|FG000|Overall Study|Physician Decision|3|||
147473403|NCT03192904|531890371|FG001|Overall Study|Physician Decision|1|||
147473404|NCT03192904|531890370|FG000|Overall Study|Lost to Follow-up|0|||
147473405|NCT03192904|531890371|FG001|Overall Study|Lost to Follow-up|1|||
147473406|NCT02034123|531890374|FG000|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
147473407|NCT02034123|531890375|FG001|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
147473408|NCT02034123|531890376|FG002|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
147473409|NCT02034123|531890377|FG003|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
147473410|NCT02034123|531890378|FG004|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|1|||
147620765|NCT05364931|532429574|FG003|Overall Study|Adverse Event|0|||
147620766|NCT05364931|532429571|FG000|Overall Study|Lost to Follow-up|1|||
147620767|NCT05364931|532429572|FG001|Overall Study|Lost to Follow-up|0|||
147620768|NCT05364931|532429573|FG002|Overall Study|Lost to Follow-up|0|||
147620769|NCT05364931|532429574|FG003|Overall Study|Lost to Follow-up|0|||
147620770|NCT05364931|532429571|FG000|Overall Study|Withdrawal by Subject|1|||
147620771|NCT05364931|532429572|FG001|Overall Study|Withdrawal by Subject|1|||
147620772|NCT05364931|532429573|FG002|Overall Study|Withdrawal by Subject|3|||
147620773|NCT05364931|532429574|FG003|Overall Study|Withdrawal by Subject|2|||
147620774|NCT05364931|532429571|FG000|Overall Study|study terminated by sponsor (reason as collected in database, study was not terminated)|0|||
147620775|NCT05364931|532429572|FG001|Overall Study|study terminated by sponsor (reason as collected in database, study was not terminated)|1|||
147620776|NCT05364931|532429573|FG002|Overall Study|study terminated by sponsor (reason as collected in database, study was not terminated)|0|||
147620777|NCT05364931|532429574|FG003|Overall Study|study terminated by sponsor (reason as collected in database, study was not terminated)|0|||
147620778|NCT05364931|532429571|FG000|Overall Study|Discontinued|1|||
147620779|NCT05364931|532429572|FG001|Overall Study|Discontinued|0|||
147620780|NCT05364931|532429573|FG002|Overall Study|Discontinued|0|||
147620781|NCT05364931|532429574|FG003|Overall Study|Discontinued|0|||
147620782|NCT02243605|532429575|FG000|Stage 1 - Interim Analysis Population|Protocol Violation|1|||
147620783|NCT02243605|532429576|FG001|Stage 1 - Interim Analysis Population|Protocol Violation|1|||
147620784|NCT02243605|532429575|FG000|Stage 1 - Interim Analysis Population|Adverse Event|1|||
147620785|NCT02243605|532429576|FG001|Stage 1 - Interim Analysis Population|Adverse Event|0|||
147620786|NCT02243605|532429575|FG000|Stage 2 - Final Analysis Population|Protocol Violation|5|||
147620787|NCT02243605|532429576|FG001|Stage 2 - Final Analysis Population|Protocol Violation|1|||
147620788|NCT02243605|532429575|FG000|Stage 2 - Final Analysis Population|Adverse Event|1|||
147620789|NCT02243605|532429576|FG001|Stage 2 - Final Analysis Population|Adverse Event|1|||
147620790|NCT02243605|532429575|FG000|Stage 2 - Final Analysis Population|Progression|0|||
147620791|NCT02243605|532429576|FG001|Stage 2 - Final Analysis Population|Progression|1|||
147620792|NCT03103087|532429577|FG000|Overall Study|Did not receive any study drug|1|||
147620793|NCT03103087|532429578|FG001|Overall Study|Did not receive any study drug|0|||
147620794|NCT03103087|532429579|FG002|Overall Study|Did not receive any study drug|0|||
147620795|NCT03103087|532429577|FG000|Overall Study|Protocol Violation|1|||
147620796|NCT03103087|532429578|FG001|Overall Study|Protocol Violation|2|||
147620797|NCT03103087|532429579|FG002|Overall Study|Protocol Violation|1|||
147620798|NCT03103087|532429577|FG000|Overall Study|Lack of Efficacy|2|||
147620799|NCT03103087|532429578|FG001|Overall Study|Lack of Efficacy|1|||
147620800|NCT03103087|532429579|FG002|Overall Study|Lack of Efficacy|1|||
147620801|NCT03103087|532429577|FG000|Overall Study|Pregnancy|0|||
147620802|NCT03103087|532429578|FG001|Overall Study|Pregnancy|0|||
147620803|NCT03103087|532429579|FG002|Overall Study|Pregnancy|1|||
147620804|NCT03103087|532429577|FG000|Overall Study|Adverse Event|2|||
147620805|NCT03103087|532429578|FG001|Overall Study|Adverse Event|15|||
147620806|NCT03103087|532429579|FG002|Overall Study|Adverse Event|6|||
147620807|NCT03103087|532429577|FG000|Overall Study|Withdrawal by Subject|13|||
147620808|NCT03103087|532429578|FG001|Overall Study|Withdrawal by Subject|6|||
147620809|NCT03103087|532429579|FG002|Overall Study|Withdrawal by Subject|6|||
147620810|NCT03103087|532429577|FG000|Overall Study|Lost to Follow-up|4|||
147620811|NCT03103087|532429578|FG001|Overall Study|Lost to Follow-up|2|||
147620812|NCT03103087|532429579|FG002|Overall Study|Lost to Follow-up|7|||
147620813|NCT03103087|532429577|FG000|Overall Study|Other reason not reported|1|||
147620814|NCT03103087|532429578|FG001|Overall Study|Other reason not reported|3|||
147620815|NCT03103087|532429579|FG002|Overall Study|Other reason not reported|5|||
147620816|NCT03511105|532429580|FG000|Overall Study|Adverse Event|1|||
147620817|NCT03511105|532429581|FG001|Overall Study|Adverse Event|0|||
147620818|NCT03511105|532429580|FG000|Overall Study|Withdrew consent|1|||
147620819|NCT03511105|532429581|FG001|Overall Study|Withdrew consent|0|||
147620820|NCT00075816|532429582|FG000|Overall Study|Did not undergo transplantation|14|||
147620821|NCT00075816|532429583|FG001|Overall Study|Did not undergo transplantation|11|||
147620822|NCT01823328|532429584|FG000|Overall Study|Withdrawal by Subject|8|||
147620823|NCT01823328|532429585|FG001|Overall Study|Withdrawal by Subject|6|||
147620824|NCT02019472|532429588|FG000|Overall Study|Adverse Event|14|||
147620825|NCT02019472|532429589|FG001|Overall Study|Adverse Event|23|||
147620826|NCT02019472|532429590|FG002|Overall Study|Adverse Event|17|||
147620827|NCT02019472|532429588|FG000|Overall Study|Death|0|||
147620828|NCT02019472|532429589|FG001|Overall Study|Death|1|||
147620829|NCT02019472|532429590|FG002|Overall Study|Death|1|||
147620830|NCT02019472|532429588|FG000|Overall Study|Lack of Efficacy|7|||
147620831|NCT02019472|532429589|FG001|Overall Study|Lack of Efficacy|4|||
147620832|NCT02019472|532429590|FG002|Overall Study|Lack of Efficacy|4|||
147666296|NCT00386334|532603894|FG001|Double Blind Period|Didnt Meet Entry/Randomization Criteria|5|||
147666297|NCT00386334|532603893|FG000|Double Blind Period|Other|3|||
147666298|NCT00386334|532603894|FG001|Double Blind Period|Other|3|||
147620833|NCT02019472|532429588|FG000|Overall Study|Lost to Follow-up|0|||
147620834|NCT02019472|532429589|FG001|Overall Study|Lost to Follow-up|2|||
147620835|NCT02019472|532429590|FG002|Overall Study|Lost to Follow-up|1|||
147620836|NCT02019472|532429588|FG000|Overall Study|Physician Decision|1|||
147620837|NCT02019472|532429589|FG001|Overall Study|Physician Decision|2|||
147620838|NCT02019472|532429590|FG002|Overall Study|Physician Decision|0|||
147620839|NCT02019472|532429588|FG000|Overall Study|Pregnancy|1|||
147620840|NCT02019472|532429589|FG001|Overall Study|Pregnancy|2|||
147666299|NCT00386334|532603893|FG000|Follow up:2 Week Placebo, 2 Week no Drug|Withdrawal by Subject|3|||
147666300|NCT00386334|532603894|FG001|Follow up:2 Week Placebo, 2 Week no Drug|Withdrawal by Subject|1|||
147666301|NCT00975416|532603899|FG000|Overall Study|early discharge from tx|3|||
147473411|NCT02034123|531890379|FG005|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
147473412|NCT02034123|531890380|FG006|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
147473413|NCT02034123|531890381|FG007|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|1|||
147473414|NCT02034123|531890382|FG008|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|1|||
147473415|NCT02034123|531890383|FG009|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
147473416|NCT02034123|531890384|FG010|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
147473417|NCT02034123|531890385|FG011|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
147473418|NCT02034123|531890386|FG012|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
147473419|NCT02034123|531890387|FG013|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
147473420|NCT02034123|531890388|FG014|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
147473421|NCT02034123|531890389|FG015|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
147473422|NCT02034123|531890390|FG016|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
147473423|NCT02034123|531890391|FG017|Part1(Median of 7.286 Weeks of Exposure)|Adverse Event|0|||
147473424|NCT02034123|531890374|FG000|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
147473425|NCT02034123|531890375|FG001|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
147473426|NCT02034123|531890376|FG002|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
147473427|NCT02034123|531890377|FG003|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|1|||
147473428|NCT02034123|531890378|FG004|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
147473429|NCT02034123|531890379|FG005|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
147473430|NCT02034123|531890380|FG006|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
147473431|NCT02034123|531890381|FG007|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
147473432|NCT02034123|531890382|FG008|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
147473433|NCT02034123|531890383|FG009|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
147473434|NCT02034123|531890384|FG010|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
147473435|NCT02034123|531890385|FG011|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
147473436|NCT02034123|531890386|FG012|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
147473437|NCT02034123|531890387|FG013|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
147473438|NCT02034123|531890388|FG014|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
147473439|NCT02034123|531890389|FG015|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
147473440|NCT02034123|531890390|FG016|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
147473441|NCT02034123|531890391|FG017|Part1(Median of 7.286 Weeks of Exposure)|Lack of Efficacy|0|||
147473442|NCT02034123|531890374|FG000|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
147473443|NCT02034123|531890375|FG001|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
147473444|NCT02034123|531890376|FG002|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
147473445|NCT02034123|531890377|FG003|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
147473446|NCT02034123|531890378|FG004|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
147473447|NCT02034123|531890379|FG005|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
147473448|NCT02034123|531890380|FG006|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
147473449|NCT02034123|531890381|FG007|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
147473450|NCT02034123|531890382|FG008|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|1|||
147473451|NCT02034123|531890383|FG009|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
147473452|NCT02034123|531890384|FG010|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
147473453|NCT02034123|531890385|FG011|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
147473454|NCT02034123|531890386|FG012|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
147473455|NCT02034123|531890387|FG013|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
147473456|NCT02034123|531890388|FG014|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
147473457|NCT02034123|531890389|FG015|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
147473458|NCT02034123|531890390|FG016|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
147473459|NCT02034123|531890391|FG017|Part1(Median of 7.286 Weeks of Exposure)|Other-Study closed/terminated|0|||
147473460|NCT02034123|531890374|FG000|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
147473461|NCT02034123|531890375|FG001|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
147473462|NCT02034123|531890376|FG002|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
147473463|NCT02034123|531890377|FG003|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|1|||
147473464|NCT02034123|531890378|FG004|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|1|||
147473465|NCT02034123|531890379|FG005|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
147473466|NCT02034123|531890380|FG006|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
147473467|NCT02034123|531890381|FG007|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
147473468|NCT02034123|531890382|FG008|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
147666302|NCT00975416|532603900|FG001|Overall Study|early discharge from tx|5|||
147666303|NCT00106002|532603901|FG000|Overall Study|Did not take any study drug|1|||
147473469|NCT02034123|531890383|FG009|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
147473470|NCT02034123|531890384|FG010|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
147473471|NCT02034123|531890385|FG011|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
147473472|NCT02034123|531890386|FG012|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
147473473|NCT02034123|531890387|FG013|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
147473474|NCT02034123|531890388|FG014|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
147473475|NCT02034123|531890389|FG015|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
147473476|NCT02034123|531890390|FG016|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
147473477|NCT02034123|531890391|FG017|Part1(Median of 7.286 Weeks of Exposure)|Withdrawal by Subject|0|||
147473478|NCT02333227|531890397|FG000|Overall Study|Lost to Follow-up|137|||
147473479|NCT02333227|531890398|FG001|Overall Study|Lost to Follow-up|106|||
147473480|NCT02333227|531890397|FG000|Overall Study|Pregnancy Interrupted|42|||
147473481|NCT02333227|531890398|FG001|Overall Study|Pregnancy Interrupted|89|||
147473482|NCT02333227|531890397|FG000|Overall Study|Enrolled prepregnant without neonatal outcome data available|20|||
147473483|NCT02333227|531890398|FG001|Overall Study|Enrolled prepregnant without neonatal outcome data available|5|||
147473484|NCT01982630|531890399|FG000|Overall Study|Adverse Event|2|||
147473485|NCT01982630|531890400|FG001|Overall Study|Adverse Event|0|||
147473486|NCT01982630|531890401|FG002|Overall Study|Adverse Event|1|||
147473487|NCT01982630|531890402|FG003|Overall Study|Adverse Event|0|||
147473488|NCT01982630|531890403|FG004|Overall Study|Adverse Event|1|||
147473489|NCT01982630|531890404|FG005|Overall Study|Adverse Event|2|||
147473490|NCT01982630|531890405|FG006|Overall Study|Adverse Event|1|||
147473491|NCT01982630|531890406|FG007|Overall Study|Adverse Event|0|||
147473492|NCT01982630|531890399|FG000|Overall Study|Physician Decision|1|||
147473493|NCT01982630|531890400|FG001|Overall Study|Physician Decision|0|||
147473494|NCT01982630|531890401|FG002|Overall Study|Physician Decision|2|||
147473495|NCT01982630|531890402|FG003|Overall Study|Physician Decision|1|||
147473496|NCT01982630|531890403|FG004|Overall Study|Physician Decision|2|||
147473497|NCT01982630|531890404|FG005|Overall Study|Physician Decision|0|||
147473498|NCT01982630|531890405|FG006|Overall Study|Physician Decision|0|||
147473499|NCT01982630|531890406|FG007|Overall Study|Physician Decision|0|||
147473500|NCT01982630|531890399|FG000|Overall Study|Did Not Receive Drug-Technical Issues|0|||
147473501|NCT01982630|531890400|FG001|Overall Study|Did Not Receive Drug-Technical Issues|0|||
147473502|NCT01982630|531890401|FG002|Overall Study|Did Not Receive Drug-Technical Issues|2|||
147473503|NCT01982630|531890402|FG003|Overall Study|Did Not Receive Drug-Technical Issues|0|||
147473504|NCT01982630|531890403|FG004|Overall Study|Did Not Receive Drug-Technical Issues|0|||
147473505|NCT01982630|531890404|FG005|Overall Study|Did Not Receive Drug-Technical Issues|0|||
147473506|NCT01982630|531890405|FG006|Overall Study|Did Not Receive Drug-Technical Issues|0|||
147473507|NCT01982630|531890406|FG007|Overall Study|Did Not Receive Drug-Technical Issues|0|||
147473508|NCT01982630|531890399|FG000|Overall Study|Withdrawal by Subject|0|||
147473509|NCT01982630|531890400|FG001|Overall Study|Withdrawal by Subject|0|||
147473510|NCT01982630|531890401|FG002|Overall Study|Withdrawal by Subject|0|||
147473511|NCT01982630|531890402|FG003|Overall Study|Withdrawal by Subject|0|||
147473512|NCT01982630|531890403|FG004|Overall Study|Withdrawal by Subject|0|||
147473513|NCT01982630|531890404|FG005|Overall Study|Withdrawal by Subject|1|||
147473514|NCT01982630|531890405|FG006|Overall Study|Withdrawal by Subject|0|||
147473515|NCT01982630|531890406|FG007|Overall Study|Withdrawal by Subject|0|||
147473516|NCT00561353|531890407|FG000|Overall Study|Subject reached a virologic endpoint|2|||
147473517|NCT00561353|531890408|FG001|Overall Study|Subject reached a virologic endpoint|1|||
147473518|NCT00561353|531890409|FG002|Overall Study|Subject reached a virologic endpoint|1|||
147473519|NCT00561353|531890410|FG003|Overall Study|Subject reached a virologic endpoint|4|||
147473520|NCT00561353|531890411|FG004|Overall Study|Subject reached a virologic endpoint|1|||
147473521|NCT00561353|531890412|FG005|Overall Study|Subject reached a virologic endpoint|3|||
147473522|NCT00561353|531890413|FG006|Overall Study|Subject reached a virologic endpoint|4|||
147473523|NCT00561353|531890414|FG007|Overall Study|Subject reached a virologic endpoint|4|||
147473524|NCT00561353|531890415|FG008|Overall Study|Subject reached a virologic endpoint|5|||
147473525|NCT00561353|531890416|FG009|Overall Study|Subject reached a virologic endpoint|0|||
147473526|NCT00561353|531890407|FG000|Overall Study|Subject ineligible to continue the trial|0|||
147473527|NCT00561353|531890408|FG001|Overall Study|Subject ineligible to continue the trial|0|||
147473528|NCT00561353|531890409|FG002|Overall Study|Subject ineligible to continue the trial|0|||
147473529|NCT00561353|531890410|FG003|Overall Study|Subject ineligible to continue the trial|0|||
147473530|NCT00561353|531890411|FG004|Overall Study|Subject ineligible to continue the trial|0|||
147473531|NCT00561353|531890412|FG005|Overall Study|Subject ineligible to continue the trial|1|||
147473532|NCT00561353|531890413|FG006|Overall Study|Subject ineligible to continue the trial|1|||
147620841|NCT02019472|532429590|FG002|Overall Study|Pregnancy|2|||
147620842|NCT02019472|532429588|FG000|Overall Study|Withdrawal by Subject|11|||
147620843|NCT02019472|532429589|FG001|Overall Study|Withdrawal by Subject|10|||
147473533|NCT00561353|531890414|FG007|Overall Study|Subject ineligible to continue the trial|0|||
147620844|NCT02019472|532429590|FG002|Overall Study|Withdrawal by Subject|11|||
147620845|NCT02019472|532429588|FG000|Overall Study|Other|3|||
147620846|NCT02019472|532429589|FG001|Overall Study|Other|8|||
147620847|NCT02019472|532429590|FG002|Overall Study|Other|6|||
147620848|NCT00513695|532429591|FG000|Overall Study|Discontinued therapy|2|||
147620849|NCT00513695|532429591|FG000|Overall Study|Progression prior to surgery|3|||
147620850|NCT02157935|532429592|FG000|Overall Study|Withdrawal by Subject|25|||
147620851|NCT02157935|532429593|FG001|Overall Study|Withdrawal by Subject|39|||
147620852|NCT02157935|532429592|FG000|Overall Study|Screen failure|1|||
147666304|NCT00106002|532603901|FG000|Overall Study|Ineligible after Registration|1|||
147473534|NCT00561353|531890415|FG008|Overall Study|Subject ineligible to continue the trial|2|||
147473535|NCT00561353|531890416|FG009|Overall Study|Subject ineligible to continue the trial|1|||
147473536|NCT00561353|531890407|FG000|Overall Study|Other|1|||
147473537|NCT00561353|531890408|FG001|Overall Study|Other|0|||
147473538|NCT00561353|531890409|FG002|Overall Study|Other|1|||
147473539|NCT00561353|531890410|FG003|Overall Study|Other|0|||
147473540|NCT00561353|531890411|FG004|Overall Study|Other|0|||
147473541|NCT00561353|531890412|FG005|Overall Study|Other|2|||
147473542|NCT00561353|531890413|FG006|Overall Study|Other|0|||
147473543|NCT00561353|531890414|FG007|Overall Study|Other|0|||
147473544|NCT00561353|531890415|FG008|Overall Study|Other|0|||
147473545|NCT00561353|531890416|FG009|Overall Study|Other|0|||
147473546|NCT00561353|531890407|FG000|Overall Study|Adverse Event|0|||
147473547|NCT00561353|531890408|FG001|Overall Study|Adverse Event|0|||
147473548|NCT00561353|531890409|FG002|Overall Study|Adverse Event|0|||
147473549|NCT00561353|531890410|FG003|Overall Study|Adverse Event|2|||
147473550|NCT00561353|531890411|FG004|Overall Study|Adverse Event|0|||
147473551|NCT00561353|531890412|FG005|Overall Study|Adverse Event|0|||
147473552|NCT00561353|531890413|FG006|Overall Study|Adverse Event|1|||
147473553|NCT00561353|531890414|FG007|Overall Study|Adverse Event|0|||
147473554|NCT00561353|531890415|FG008|Overall Study|Adverse Event|0|||
147473555|NCT00561353|531890416|FG009|Overall Study|Adverse Event|1|||
147473556|NCT00561353|531890407|FG000|Overall Study|Lost to Follow-up|2|||
147473557|NCT00561353|531890408|FG001|Overall Study|Lost to Follow-up|0|||
147473558|NCT00561353|531890409|FG002|Overall Study|Lost to Follow-up|1|||
147473559|NCT00561353|531890410|FG003|Overall Study|Lost to Follow-up|0|||
147473560|NCT00561353|531890411|FG004|Overall Study|Lost to Follow-up|0|||
147473561|NCT00561353|531890412|FG005|Overall Study|Lost to Follow-up|0|||
147473562|NCT00561353|531890413|FG006|Overall Study|Lost to Follow-up|0|||
147473563|NCT00561353|531890414|FG007|Overall Study|Lost to Follow-up|0|||
147473564|NCT00561353|531890415|FG008|Overall Study|Lost to Follow-up|0|||
147473565|NCT00561353|531890416|FG009|Overall Study|Lost to Follow-up|0|||
147473566|NCT00561353|531890407|FG000|Overall Study|Withdrawal by Subject|0|||
147473567|NCT00561353|531890408|FG001|Overall Study|Withdrawal by Subject|2|||
147473568|NCT00561353|531890409|FG002|Overall Study|Withdrawal by Subject|0|||
147473569|NCT00561353|531890410|FG003|Overall Study|Withdrawal by Subject|0|||
147473570|NCT00561353|531890411|FG004|Overall Study|Withdrawal by Subject|0|||
147473571|NCT00561353|531890412|FG005|Overall Study|Withdrawal by Subject|0|||
147473572|NCT00561353|531890413|FG006|Overall Study|Withdrawal by Subject|0|||
147473573|NCT00561353|531890414|FG007|Overall Study|Withdrawal by Subject|0|||
147473574|NCT00561353|531890415|FG008|Overall Study|Withdrawal by Subject|0|||
147473575|NCT00561353|531890416|FG009|Overall Study|Withdrawal by Subject|0|||
147473576|NCT01273818|531890417|FG000|Overall Study|Physician Decision|13|||
147473577|NCT01273818|531890418|FG001|Overall Study|Physician Decision|2|||
147473578|NCT01273818|531890419|FG002|Overall Study|Physician Decision|9|||
147473579|NCT03934684|531890420|FG000|Overall Study|Participants continuing in study|11|||
147473580|NCT03934684|531890421|FG001|Overall Study|Participants continuing in study|4|||
147473581|NCT03934684|531890420|FG000|Overall Study|Discontinuation of carfilzomib|20|||
147473582|NCT03934684|531890421|FG001|Overall Study|Discontinuation of carfilzomib|30|||
147473583|NCT03934684|531890420|FG000|Overall Study|Death|2|||
147473584|NCT03934684|531890421|FG001|Overall Study|Death|2|||
147473585|NCT03934684|531890420|FG000|Overall Study|Lost to Follow-up|2|||
147473586|NCT03934684|531890421|FG001|Overall Study|Lost to Follow-up|5|||
147473587|NCT03934684|531890420|FG000|Overall Study|Withdrawal by Subject|7|||
147473588|NCT03934684|531890421|FG001|Overall Study|Withdrawal by Subject|8|||
147666305|NCT01245101|532603902|FG000|Period 1 (Treatment)|Withdrawal by Subject|2|||
147473589|NCT05300087|531890422|FG000|Overall Study|Withdrawal by Subject|0|||
147473590|NCT05300087|531890423|FG001|Overall Study|Withdrawal by Subject|1|||
147473591|NCT00761215|531890424|FG000|Overall Study|Randomized but didn't receive drug|1|||
147473592|NCT00761215|531890425|FG001|Overall Study|Randomized but didn't receive drug|1|||
147473593|NCT00761215|531890426|FG002|Overall Study|Randomized but didn't receive drug|2|||
147473594|NCT00761215|531890424|FG000|Overall Study|Lost to Follow-up|6|||
147473595|NCT00761215|531890425|FG001|Overall Study|Lost to Follow-up|3|||
147473596|NCT00761215|531890426|FG002|Overall Study|Lost to Follow-up|6|||
147473597|NCT00761215|531890424|FG000|Overall Study|Withdrawal by Subject|1|||
147473598|NCT00761215|531890425|FG001|Overall Study|Withdrawal by Subject|0|||
147473599|NCT00761215|531890426|FG002|Overall Study|Withdrawal by Subject|0|||
147620853|NCT02157935|532429593|FG001|Overall Study|Screen failure|2|||
147620854|NCT02157935|532429592|FG000|Overall Study|Protocol Violation|1|||
147620855|NCT02157935|532429593|FG001|Overall Study|Protocol Violation|0|||
147620856|NCT02157935|532429592|FG000|Overall Study|Progressive disease|0|||
147620857|NCT02157935|532429593|FG001|Overall Study|Progressive disease|2|||
147473600|NCT00761215|531890424|FG000|Overall Study|Bacteremia|1|||
147473601|NCT00761215|531890425|FG001|Overall Study|Bacteremia|0|||
147473602|NCT00761215|531890426|FG002|Overall Study|Bacteremia|0|||
147473603|NCT00519532|531890427|FG000|Overall Study|Adverse Event|11|||
147473604|NCT00519532|531890427|FG000|Overall Study|Withdrawal by Subject|5|||
147473605|NCT00519532|531890427|FG000|Overall Study|Lost to Follow-up|2|||
147473606|NCT00667277|531890428|FG000|Overall Study|Withdrawal by Subject|2|||
147473607|NCT00256295|531890430|FG000|Overall Study|Withdrawal by Subject|3|||
147473608|NCT00256295|531890430|FG000|Overall Study|Death|1|||
147473609|NCT03542682|531890432|FG000|Overall Study|COVID-19 Protocol|0|||
147473610|NCT03542682|531890433|FG001|Overall Study|COVID-19 Protocol|1|||
147473611|NCT04321343|531890434|FG000|Overall Study|Adverse Event|0|||
147473612|NCT04321343|531890435|FG001|Overall Study|Adverse Event|0|||
147473613|NCT04321343|531890436|FG002|Overall Study|Adverse Event|1|||
147473614|NCT04321343|531890437|FG003|Overall Study|Adverse Event|0|||
147473615|NCT04321343|531890434|FG000|Overall Study|Death|0|||
147473616|NCT04321343|531890435|FG001|Overall Study|Death|0|||
147473617|NCT04321343|531890436|FG002|Overall Study|Death|0|||
147473618|NCT04321343|531890437|FG003|Overall Study|Death|1|||
147473619|NCT04321343|531890434|FG000|Overall Study|Pregnancy|1|||
147473620|NCT04321343|531890435|FG001|Overall Study|Pregnancy|0|||
147473621|NCT04321343|531890436|FG002|Overall Study|Pregnancy|0|||
147473622|NCT04321343|531890437|FG003|Overall Study|Pregnancy|0|||
147473623|NCT04321343|531890434|FG000|Overall Study|Protocol Violation|1|||
147473624|NCT04321343|531890435|FG001|Overall Study|Protocol Violation|1|||
147473625|NCT04321343|531890436|FG002|Overall Study|Protocol Violation|1|||
147473626|NCT04321343|531890437|FG003|Overall Study|Protocol Violation|1|||
147473627|NCT04321343|531890434|FG000|Overall Study|Withdrawal by Subject|0|||
147473628|NCT04321343|531890435|FG001|Overall Study|Withdrawal by Subject|6|||
147473629|NCT04321343|531890436|FG002|Overall Study|Withdrawal by Subject|0|||
147473630|NCT04321343|531890437|FG003|Overall Study|Withdrawal by Subject|2|||
147473631|NCT04321343|531890434|FG000|Overall Study|Lost to Follow-up|2|||
147473632|NCT04321343|531890435|FG001|Overall Study|Lost to Follow-up|2|||
147473633|NCT04321343|531890436|FG002|Overall Study|Lost to Follow-up|1|||
147473634|NCT04321343|531890437|FG003|Overall Study|Lost to Follow-up|3|||
147473635|NCT01097044|531890442|FG000|Overall Study|Withdrawal by Subject|4|||
147473636|NCT01097044|531890443|FG001|Overall Study|Withdrawal by Subject|4|||
147473637|NCT01097044|531890442|FG000|Overall Study|Lost to Follow-up|1|||
147473638|NCT01097044|531890443|FG001|Overall Study|Lost to Follow-up|0|||
147473639|NCT01097044|531890442|FG000|Overall Study|Withdrawal by Sponsor|0|||
147473640|NCT01097044|531890443|FG001|Overall Study|Withdrawal by Sponsor|1|||
147473641|NCT01682044|531890447|FG000|Overall Study|Death|1|||
147473642|NCT01682044|531890447|FG000|Overall Study|Progression|3|||
147473643|NCT04865731|531890451|FG000|Overall Study|Physician Decision|2|||
147473644|NCT04865731|531890452|FG001|Overall Study|Physician Decision|1|||
147473645|NCT04865731|531890451|FG000|Overall Study|Adverse Event|1|||
147473646|NCT04865731|531890452|FG001|Overall Study|Adverse Event|0|||
147473647|NCT04865731|531890451|FG000|Overall Study|Withdrawal by Subject|0|||
147473648|NCT04865731|531890452|FG001|Overall Study|Withdrawal by Subject|1|||
147473649|NCT04909463|531892101|FG000|Overall Study|Withdrawal by Subject|0|||
147473650|NCT04909463|531892102|FG001|Overall Study|Withdrawal by Subject|1|||
147473651|NCT04909463|531892103|FG002|Overall Study|Withdrawal by Subject|0|||
147473652|NCT04909463|531892104|FG003|Overall Study|Withdrawal by Subject|0|||
147473653|NCT04909463|531892101|FG000|Overall Study|Lost to Follow-up|2|||
147473654|NCT04909463|531892102|FG001|Overall Study|Lost to Follow-up|1|||
147473655|NCT04909463|531892103|FG002|Overall Study|Lost to Follow-up|1|||
147473656|NCT04909463|531892104|FG003|Overall Study|Lost to Follow-up|0|||
147620858|NCT02157935|532429592|FG000|Overall Study|Other|5|||
147620859|NCT02157935|532429593|FG001|Overall Study|Other|12|||
147620860|NCT02157935|532429592|FG000|Overall Study|Lack of Efficacy|0|||
147620861|NCT02157935|532429593|FG001|Overall Study|Lack of Efficacy|1|||
147620862|NCT02157935|532429592|FG000|Overall Study|Death|4|||
147473657|NCT01672892|531892105|FG000|Overall Study|Protocol Violation|7|||
147473658|NCT01672892|531892106|FG001|Overall Study|Protocol Violation|3|||
147473659|NCT03528681|531892114|FG000|Open-Label Phase|Physician Decision|2|||
147473660|NCT03528681|531892115|FG001|Open-Label Phase|Physician Decision|0|||
147473661|NCT03528681|531892116|FG002|Open-Label Phase|Physician Decision|0|||
147473662|NCT03528681|531892117|FG003|Open-Label Phase|Physician Decision|0|||
147473663|NCT03528681|531892114|FG000|Open-Label Phase|Withdrawal by Subject|8|||
147473664|NCT03528681|531892115|FG001|Open-Label Phase|Withdrawal by Subject|0|||
147473665|NCT03528681|531892116|FG002|Open-Label Phase|Withdrawal by Subject|0|||
147473666|NCT03528681|531892117|FG003|Open-Label Phase|Withdrawal by Subject|0|||
147473667|NCT03528681|531892114|FG000|Open-Label Phase|(Not collected)|4|||
147473668|NCT03528681|531892115|FG001|Open-Label Phase|(Not collected)|0|||
147473669|NCT03528681|531892116|FG002|Open-Label Phase|(Not collected)|0|||
147473670|NCT03528681|531892117|FG003|Open-Label Phase|(Not collected)|0|||
147473671|NCT03528681|531892114|FG000|Randomized Treatment Phase|Lost to Follow-up|0|||
147620863|NCT02157935|532429593|FG001|Overall Study|Death|4|||
147473672|NCT03528681|531892115|FG001|Randomized Treatment Phase|Lost to Follow-up|0|||
147473673|NCT03528681|531892116|FG002|Randomized Treatment Phase|Lost to Follow-up|1|||
147473674|NCT03528681|531892117|FG003|Randomized Treatment Phase|Lost to Follow-up|0|||
147473675|NCT03528681|531892114|FG000|Randomized Treatment Phase|Physician Decision|0|||
147473676|NCT03528681|531892115|FG001|Randomized Treatment Phase|Physician Decision|5|||
147473677|NCT03528681|531892116|FG002|Randomized Treatment Phase|Physician Decision|1|||
147473678|NCT03528681|531892117|FG003|Randomized Treatment Phase|Physician Decision|2|||
147473679|NCT03528681|531892114|FG000|Randomized Treatment Phase|Withdrawal by Subject|0|||
147473680|NCT03528681|531892115|FG001|Randomized Treatment Phase|Withdrawal by Subject|7|||
147473681|NCT03528681|531892116|FG002|Randomized Treatment Phase|Withdrawal by Subject|4|||
147473682|NCT03528681|531892117|FG003|Randomized Treatment Phase|Withdrawal by Subject|1|||
147473683|NCT03528681|531892114|FG000|Randomized Treatment Phase|(Study specific withdrawal criteria)|0|||
147473684|NCT03528681|531892115|FG001|Randomized Treatment Phase|(Study specific withdrawal criteria)|3|||
147473685|NCT03528681|531892116|FG002|Randomized Treatment Phase|(Study specific withdrawal criteria)|3|||
147473686|NCT03528681|531892117|FG003|Randomized Treatment Phase|(Study specific withdrawal criteria)|4|||
147473687|NCT03528681|531892114|FG000|Randomized Treatment Phase|(Not collected)|0|||
147473688|NCT03528681|531892115|FG001|Randomized Treatment Phase|(Not collected)|4|||
147473689|NCT03528681|531892116|FG002|Randomized Treatment Phase|(Not collected)|6|||
147473690|NCT03528681|531892117|FG003|Randomized Treatment Phase|(Not collected)|5|||
147473691|NCT02017444|531892123|FG000|Overall Study|Physician Decision|1|||
147473692|NCT02017444|531892124|FG001|Overall Study|Physician Decision|0|||
147473693|NCT02017444|531892123|FG000|Overall Study|Patient withdrawn day after randomisation as found to be ineligible. Did not return for follow up.|1|||
147473694|NCT02017444|531892124|FG001|Overall Study|Patient withdrawn day after randomisation as found to be ineligible. Did not return for follow up.|0|||
147473695|NCT01614457|531892125|FG000|Overall Study|Non-Compliance|1|||
147473696|NCT01614457|531892126|FG001|Overall Study|Non-Compliance|0|||
147473697|NCT01614457|531892125|FG000|Overall Study|Pregnancy (Self or Partner)|1|||
147473698|NCT01614457|531892126|FG001|Overall Study|Pregnancy (Self or Partner)|0|||
147473699|NCT02342171|531892128|FG000|Overall Study|Death|4|||
147473700|NCT02342171|531892129|FG001|Overall Study|Death|87|||
147473701|NCT02342171|531892128|FG000|Overall Study|Received favipiravir|10|||
147473702|NCT02342171|531892129|FG001|Overall Study|Received favipiravir|0|||
147473703|NCT02342171|531892128|FG000|Overall Study|Missing cycle treshold value|1|||
147473704|NCT02342171|531892129|FG001|Overall Study|Missing cycle treshold value|0|||
147473705|NCT02342171|531892128|FG000|Overall Study|Unknown outcome|0|||
147473706|NCT02342171|531892129|FG001|Overall Study|Unknown outcome|1|||
147473707|NCT02342171|531892128|FG000|Overall Study|Missing age data|0|||
147473708|NCT02342171|531892129|FG001|Overall Study|Missing age data|1|||
147473709|NCT03518840|531892132|FG000|Overall Study|Lost to Follow-up|6|||
147473710|NCT00875420|531892135|FG000|Overall Study|Adverse Event|0|||
147473711|NCT00875420|531892136|FG001|Overall Study|Adverse Event|1|||
147473712|NCT00875420|531892137|FG002|Overall Study|Adverse Event|1|||
147473713|NCT00875420|531892138|FG003|Overall Study|Adverse Event|0|||
147473714|NCT00875420|531892139|FG004|Overall Study|Adverse Event|0|||
147473715|NCT00875420|531892135|FG000|Overall Study|Inability to complete study procedures|1|||
147473716|NCT00875420|531892136|FG001|Overall Study|Inability to complete study procedures|0|||
147473717|NCT00875420|531892137|FG002|Overall Study|Inability to complete study procedures|1|||
147473718|NCT00875420|531892138|FG003|Overall Study|Inability to complete study procedures|1|||
147473719|NCT00875420|531892139|FG004|Overall Study|Inability to complete study procedures|1|||
147473720|NCT00875420|531892135|FG000|Overall Study|Lost to Follow-up|1|||
147473721|NCT00875420|531892136|FG001|Overall Study|Lost to Follow-up|0|||
147473722|NCT00875420|531892137|FG002|Overall Study|Lost to Follow-up|0|||
147473723|NCT00875420|531892138|FG003|Overall Study|Lost to Follow-up|0|||
147473724|NCT00875420|531892139|FG004|Overall Study|Lost to Follow-up|0|||
147473725|NCT00875420|531892135|FG000|Overall Study|Personal reason|0|||
147473726|NCT00875420|531892136|FG001|Overall Study|Personal reason|0|||
147473727|NCT00875420|531892137|FG002|Overall Study|Personal reason|0|||
147473728|NCT00875420|531892138|FG003|Overall Study|Personal reason|0|||
147473729|NCT00875420|531892139|FG004|Overall Study|Personal reason|1|||
147473730|NCT00875420|531892135|FG000|Overall Study|Prohibited medication|0|||
147473731|NCT00875420|531892136|FG001|Overall Study|Prohibited medication|0|||
147473732|NCT00875420|531892137|FG002|Overall Study|Prohibited medication|0|||
147473733|NCT00875420|531892138|FG003|Overall Study|Prohibited medication|1|||
147473734|NCT00875420|531892139|FG004|Overall Study|Prohibited medication|0|||
147473735|NCT00875420|531892135|FG000|Overall Study|Sponsor decision|0|||
147473736|NCT00875420|531892136|FG001|Overall Study|Sponsor decision|1|||
147473737|NCT00875420|531892137|FG002|Overall Study|Sponsor decision|0|||
147473738|NCT00875420|531892138|FG003|Overall Study|Sponsor decision|0|||
147473739|NCT00875420|531892139|FG004|Overall Study|Sponsor decision|0|||
147473740|NCT00875420|531892135|FG000|Overall Study|Withdrawal by Subject|0|||
147473741|NCT00875420|531892136|FG001|Overall Study|Withdrawal by Subject|0|||
147473742|NCT00875420|531892137|FG002|Overall Study|Withdrawal by Subject|1|||
147473743|NCT00875420|531892138|FG003|Overall Study|Withdrawal by Subject|0|||
147473744|NCT00875420|531892139|FG004|Overall Study|Withdrawal by Subject|0|||
147473745|NCT00886821|531892142|FG000|Stage 2|Adverse Event|0|||
147666306|NCT01245101|532603903|FG001|Period 1 (Treatment)|Withdrawal by Subject|0|||
147473746|NCT00886821|531892143|FG001|Stage 2|Adverse Event|0|||
147473747|NCT00886821|531892144|FG002|Stage 2|Adverse Event|0|||
147473748|NCT00886821|531892145|FG003|Stage 2|Adverse Event|0|||
147473749|NCT00886821|531892146|FG004|Stage 2|Adverse Event|0|||
147473750|NCT00886821|531892147|FG005|Stage 2|Adverse Event|0|||
147473751|NCT00886821|531892148|FG006|Stage 2|Adverse Event|0|||
147473752|NCT00886821|531892149|FG007|Stage 2|Adverse Event|0|||
147473753|NCT00886821|531892150|FG008|Stage 2|Adverse Event|0|||
147473754|NCT00886821|531892151|FG009|Stage 2|Adverse Event|0|||
147473755|NCT00886821|531892152|FG010|Stage 2|Adverse Event|0|||
147473756|NCT00886821|531892153|FG011|Stage 2|Adverse Event|1|||
147473757|NCT00886821|531892154|FG012|Stage 2|Adverse Event|3|||
147473758|NCT00886821|531892155|FG013|Stage 2|Adverse Event|0|||
147473759|NCT00886821|531892142|FG000|Stage 2|Lost to Follow-up|0|||
147473760|NCT00886821|531892143|FG001|Stage 2|Lost to Follow-up|0|||
147473761|NCT00886821|531892144|FG002|Stage 2|Lost to Follow-up|0|||
147473762|NCT00886821|531892145|FG003|Stage 2|Lost to Follow-up|0|||
147473763|NCT00886821|531892146|FG004|Stage 2|Lost to Follow-up|0|||
147473764|NCT00886821|531892147|FG005|Stage 2|Lost to Follow-up|0|||
147473765|NCT00886821|531892148|FG006|Stage 2|Lost to Follow-up|0|||
147473766|NCT00886821|531892149|FG007|Stage 2|Lost to Follow-up|0|||
147473767|NCT00886821|531892150|FG008|Stage 2|Lost to Follow-up|0|||
147473768|NCT00886821|531892151|FG009|Stage 2|Lost to Follow-up|0|||
147473769|NCT00886821|531892152|FG010|Stage 2|Lost to Follow-up|0|||
147473770|NCT00886821|531892153|FG011|Stage 2|Lost to Follow-up|0|||
147473771|NCT00886821|531892154|FG012|Stage 2|Lost to Follow-up|2|||
147473772|NCT00886821|531892155|FG013|Stage 2|Lost to Follow-up|1|||
147473773|NCT00914628|531892156|FG000|Overall Study|Death|35|||
147473774|NCT00914628|531892157|FG001|Overall Study|Death|17|||
147473775|NCT00914628|531892156|FG000|Overall Study|Medical decision|4|||
147473776|NCT00914628|531892157|FG001|Overall Study|Medical decision|0|||
147473777|NCT00914628|531892156|FG000|Overall Study|Protocol Violation|1|||
147473778|NCT00914628|531892157|FG001|Overall Study|Protocol Violation|0|||
147473779|NCT00914628|531892156|FG000|Overall Study|Lack of Efficacy|1|||
147473780|NCT00914628|531892157|FG001|Overall Study|Lack of Efficacy|0|||
147473781|NCT00914628|531892156|FG000|Overall Study|non-randomized|1|||
147473782|NCT00914628|531892157|FG001|Overall Study|non-randomized|0|||
147473783|NCT00914628|531892156|FG000|Overall Study|Relapse|1|||
147473784|NCT00914628|531892157|FG001|Overall Study|Relapse|2|||
147473785|NCT00914628|531892156|FG000|Overall Study|Study terminated by Sponsor|14|||
147473786|NCT00914628|531892157|FG001|Overall Study|Study terminated by Sponsor|8|||
147473787|NCT00914628|531892156|FG000|Overall Study|Patients who did not receive a single dose|7|||
147473788|NCT00914628|531892157|FG001|Overall Study|Patients who did not receive a single dose|1|||
147473789|NCT03311126|531892158|FG000|Induction|Death|1|||
147473790|NCT03311126|531892158|FG000|Restaging Imaging|Radiographic Complete Response moved to Observation rather than Maintenance|10|||
147473791|NCT00942162|531892159|FG000|Overall Study|Death|45|||
147473792|NCT00942162|531892160|FG001|Overall Study|Death|35|||
147473793|NCT00942162|531892161|FG002|Overall Study|Death|0|||
147473794|NCT00942162|531892159|FG000|Overall Study|Withdrawal by Subject|7|||
147473795|NCT00942162|531892160|FG001|Overall Study|Withdrawal by Subject|2|||
147473796|NCT00942162|531892161|FG002|Overall Study|Withdrawal by Subject|0|||
147473797|NCT00942162|531892159|FG000|Overall Study|Lost to Follow-up|4|||
147473798|NCT00942162|531892160|FG001|Overall Study|Lost to Follow-up|0|||
147473799|NCT00942162|531892161|FG002|Overall Study|Lost to Follow-up|0|||
147473800|NCT00942162|531892159|FG000|Overall Study|Other|14|||
147473801|NCT00942162|531892160|FG001|Overall Study|Other|13|||
147473802|NCT00942162|531892161|FG002|Overall Study|Other|2|||
147473803|NCT02799381|531892162|FG000|Overall Study|Withdrew consent|3|||
147473804|NCT02799381|531892163|FG001|Overall Study|Withdrew consent|2|||
147473805|NCT02799381|531892162|FG000|Overall Study|Adverse Event|0|||
147473806|NCT02799381|531892163|FG001|Overall Study|Adverse Event|1|||
147473807|NCT02799381|531892162|FG000|Overall Study|Participant did not take any study drug|1|||
147473808|NCT02799381|531892163|FG001|Overall Study|Participant did not take any study drug|0|||
147473809|NCT03368859|531892164|FG000|Overall Study|Withdrew Consent|5|||
147473810|NCT03368859|531892165|FG001|Overall Study|Withdrew Consent|4|||
147473811|NCT03368859|531892164|FG000|Overall Study|Death|12|||
147473812|NCT03368859|531892165|FG001|Overall Study|Death|6|||
147473813|NCT03368859|531892164|FG000|Overall Study|Study terminated by Sponsor|18|||
147473814|NCT03368859|531892165|FG001|Overall Study|Study terminated by Sponsor|23|||
147473815|NCT03368859|531892164|FG000|Overall Study|Other|1|||
147473816|NCT03368859|531892165|FG001|Overall Study|Other|1|||
147473817|NCT02698410|531892166|FG000|Overall Study|Adverse Event|2|||
147473818|NCT02698410|531892166|FG000|Overall Study|Withdrawal by Subject|1|||
147473819|NCT02698410|531892166|FG000|Overall Study|Other|1|||
147473820|NCT01713348|531892167|FG000|Overall Study|Withdrawal by Subject|3|||
147473821|NCT01713348|531892168|FG001|Overall Study|Withdrawal by Subject|2|||
147473822|NCT01713348|531892169|FG002|Overall Study|Withdrawal by Subject|2|||
147473823|NCT01713348|531892170|FG003|Overall Study|Withdrawal by Subject|0|||
147473824|NCT01713348|531892167|FG000|Overall Study|Lost to Follow-up|1|||
147473825|NCT01713348|531892168|FG001|Overall Study|Lost to Follow-up|0|||
147473826|NCT01713348|531892169|FG002|Overall Study|Lost to Follow-up|0|||
147473827|NCT01713348|531892170|FG003|Overall Study|Lost to Follow-up|0|||
147473828|NCT00621023|531892171|FG000|Overall Study|Death|5|||
147473829|NCT00621023|531892171|FG000|Overall Study|Follow up discontinued|1|||
147473830|NCT00698516|531892180|FG000|Overall Study|Study Termination|2|||
147473831|NCT00698516|531892180|FG000|Overall Study|Withdrawal by Subject|3|||
147473832|NCT04331899|531892182|FG000|Trial Period (28 Days)|Withdrawal by Subject|2|||
147473833|NCT04331899|531892183|FG001|Trial Period (28 Days)|Withdrawal by Subject|2|||
147473834|NCT02424539|531892186|FG000|Overall Study|Adverse Event|0|||
147473835|NCT02424539|531892187|FG001|Overall Study|Adverse Event|0|||
147473836|NCT02424539|531892188|FG002|Overall Study|Adverse Event|1|||
147473837|NCT02424539|531892186|FG000|Overall Study|Physician Decision|0|||
147473838|NCT02424539|531892187|FG001|Overall Study|Physician Decision|0|||
147473839|NCT02424539|531892188|FG002|Overall Study|Physician Decision|1|||
147473840|NCT02424539|531892186|FG000|Overall Study|Withdrawal by Subject|3|||
147473841|NCT02424539|531892187|FG001|Overall Study|Withdrawal by Subject|1|||
147473842|NCT02424539|531892188|FG002|Overall Study|Withdrawal by Subject|0|||
147473843|NCT02424539|531892186|FG000|Overall Study|Other: Reached stopping criteria|11|||
147473844|NCT02424539|531892187|FG001|Overall Study|Other: Reached stopping criteria|7|||
147473845|NCT02424539|531892188|FG002|Overall Study|Other: Reached stopping criteria|6|||
147473846|NCT00719810|531892189|FG000|Overall Study|Adverse Event|0|||
147473847|NCT00719810|531892190|FG001|Overall Study|Adverse Event|2|||
147473848|NCT00719810|531892191|FG002|Overall Study|Adverse Event|3|||
147473849|NCT00719810|531892189|FG000|Overall Study|Lost to Follow-up|2|||
147473850|NCT00719810|531892190|FG001|Overall Study|Lost to Follow-up|0|||
147473851|NCT00719810|531892191|FG002|Overall Study|Lost to Follow-up|3|||
147473852|NCT00719810|531892189|FG000|Overall Study|Physician Decision|0|||
147473853|NCT00719810|531892190|FG001|Overall Study|Physician Decision|1|||
147473854|NCT00719810|531892191|FG002|Overall Study|Physician Decision|0|||
147473855|NCT00719810|531892189|FG000|Overall Study|Withdrawal by Subject|1|||
147473856|NCT00719810|531892190|FG001|Overall Study|Withdrawal by Subject|1|||
147473857|NCT00719810|531892191|FG002|Overall Study|Withdrawal by Subject|2|||
147473858|NCT04893265|531892194|FG000|Overall Study|Withdrawal by Subject|2|||
147473859|NCT04893265|531892195|FG001|Overall Study|Withdrawal by Subject|5|||
147473860|NCT04893265|531892194|FG000|Overall Study|Lost to Follow-up|0|||
147473861|NCT04893265|531892195|FG001|Overall Study|Lost to Follow-up|4|||
147473862|NCT00573131|531892197|FG000|Overall Study|Withdrawal by Subject|10|||
147473863|NCT00573131|531892198|FG001|Overall Study|Withdrawal by Subject|8|||
147473864|NCT03090191|531892199|FG000|Overall Study|Adverse Event|90|||
147473865|NCT03090191|531892200|FG001|Overall Study|Adverse Event|72|||
147473866|NCT03090191|531892199|FG000|Overall Study|Death|365|||
147473867|NCT03090191|531892200|FG001|Overall Study|Death|358|||
147473868|NCT03090191|531892199|FG000|Overall Study|Lost to Follow-up|382|||
147473869|NCT03090191|531892200|FG001|Overall Study|Lost to Follow-up|394|||
147473870|NCT03090191|531892199|FG000|Overall Study|Physician Decision|77|||
147473871|NCT03090191|531892200|FG001|Overall Study|Physician Decision|66|||
147473872|NCT03090191|531892199|FG000|Overall Study|Protocol Violation|43|||
147473873|NCT03090191|531892200|FG001|Overall Study|Protocol Violation|52|||
147473874|NCT03090191|531892199|FG000|Overall Study|Withdrawal by Subject|2160|||
147473875|NCT03090191|531892200|FG001|Overall Study|Withdrawal by Subject|2133|||
147473876|NCT03090191|531892199|FG000|Overall Study|Site terminated|7|||
147473877|NCT03090191|531892200|FG001|Overall Study|Site terminated|8|||
147473878|NCT03090191|531892199|FG000|Overall Study|Other|66|||
147473879|NCT03090191|531892200|FG001|Overall Study|Other|60|||
147473880|NCT03090191|531892199|FG000|Overall Study|Withdrawn before any study vaccination|43|||
147473881|NCT03090191|531892200|FG001|Overall Study|Withdrawn before any study vaccination|52|||
147473882|NCT00472303|531892217|FG000|Titration Phase|Adverse Event|22|||
147473883|NCT00472303|531892218|FG001|Titration Phase|Adverse Event|12|||
147473884|NCT00472303|531892219|FG002|Titration Phase|Adverse Event|0|||
147473885|NCT00472303|531892217|FG000|Titration Phase|Death|4|||
147473886|NCT00472303|531892218|FG001|Titration Phase|Death|2|||
147473887|NCT00472303|531892219|FG002|Titration Phase|Death|0|||
147473888|NCT00472303|531892217|FG000|Titration Phase|Lack of Efficacy|10|||
147473889|NCT00472303|531892218|FG001|Titration Phase|Lack of Efficacy|0|||
147473890|NCT00472303|531892219|FG002|Titration Phase|Lack of Efficacy|0|||
147473891|NCT00472303|531892217|FG000|Titration Phase|Withdrawal by Subject|16|||
147473892|NCT00472303|531892218|FG001|Titration Phase|Withdrawal by Subject|13|||
147473893|NCT00472303|531892219|FG002|Titration Phase|Withdrawal by Subject|0|||
147473894|NCT00472303|531892217|FG000|Titration Phase|Trial Medication non-compliant|4|||
147666307|NCT01245101|532603902|FG000|Period 2 (Washout)|Withdrawal by Subject|1|||
147666308|NCT01245101|532603903|FG001|Period 2 (Washout)|Withdrawal by Subject|0|||
147473895|NCT00472303|531892218|FG001|Titration Phase|Trial Medication non-compliant|1|||
147473896|NCT00472303|531892219|FG002|Titration Phase|Trial Medication non-compliant|0|||
147473897|NCT00472303|531892217|FG000|Titration Phase|Other|3|||
147666309|NCT01245101|532603902|FG000|Period 3 (Treatment)|Withdrawal by Subject|1|||
147473898|NCT00472303|531892218|FG001|Titration Phase|Other|1|||
147473899|NCT00472303|531892219|FG002|Titration Phase|Other|0|||
147473900|NCT00472303|531892217|FG000|Discontinuations After Titration Phase|Adverse Event|6|||
147473901|NCT00472303|531892218|FG001|Discontinuations After Titration Phase|Adverse Event|0|||
147620864|NCT02157935|532429592|FG000|Overall Study|Adverse Event|3|||
147620865|NCT02157935|532429593|FG001|Overall Study|Adverse Event|5|||
147620866|NCT03192488|532429594|FG000|First Washout (>6d)|Withdrawal by Subject|0|||
147620867|NCT03192488|532429595|FG001|First Washout (>6d)|Withdrawal by Subject|0|||
147620868|NCT03192488|532429596|FG002|First Washout (>6d)|Withdrawal by Subject|1|||
147620869|NCT03192488|532429597|FG003|First Washout (>6d)|Withdrawal by Subject|0|||
147620870|NCT03192488|532429598|FG004|First Washout (>6d)|Withdrawal by Subject|0|||
147620871|NCT03192488|532429599|FG005|First Washout (>6d)|Withdrawal by Subject|1|||
147620872|NCT03192488|532429594|FG000|Third Intervention (d1)|Adverse Event|0|||
147620873|NCT03192488|532429595|FG001|Third Intervention (d1)|Adverse Event|0|||
147620874|NCT03192488|532429596|FG002|Third Intervention (d1)|Adverse Event|0|||
147620875|NCT03192488|532429597|FG003|Third Intervention (d1)|Adverse Event|0|||
147620876|NCT03192488|532429598|FG004|Third Intervention (d1)|Adverse Event|1|||
147620877|NCT03192488|532429599|FG005|Third Intervention (d1)|Adverse Event|0|||
147620878|NCT03588910|532429601|FG000|Overall Study|Withdrawal by Subject|1|||
147620879|NCT03588910|532429602|FG001|Overall Study|Withdrawal by Subject|0|||
147620880|NCT03588910|532429601|FG000|Overall Study|Allergy|2|||
147620881|NCT03588910|532429602|FG001|Overall Study|Allergy|0|||
147620882|NCT03588910|532429601|FG000|Overall Study|Protocol Violation|0|||
147620883|NCT03588910|532429602|FG001|Overall Study|Protocol Violation|3|||
147620884|NCT03588910|532429601|FG000|Overall Study|Did not complete Day 1 Survey|5|||
147620885|NCT03588910|532429602|FG001|Overall Study|Did not complete Day 1 Survey|10|||
147620886|NCT03588910|532429601|FG000|Overall Study|Did not complete Day 7 Survey|5|||
147620887|NCT03588910|532429602|FG001|Overall Study|Did not complete Day 7 Survey|2|||
147620888|NCT02547428|532429603|FG000|Period 1- Treatment Sequence 1 (3 Weeks)|Adverse Event|8|||
147620889|NCT02547428|532429604|FG001|Period 1- Treatment Sequence 1 (3 Weeks)|Adverse Event|1|||
147620890|NCT02547428|532429603|FG000|Period 1- Treatment Sequence 1 (3 Weeks)|Lost to Follow-up|1|||
147620891|NCT02547428|532429604|FG001|Period 1- Treatment Sequence 1 (3 Weeks)|Lost to Follow-up|1|||
147620892|NCT02547428|532429603|FG000|Period 1- Treatment Sequence 1 (3 Weeks)|Withdrawal by Subject|1|||
147620893|NCT02547428|532429604|FG001|Period 1- Treatment Sequence 1 (3 Weeks)|Withdrawal by Subject|1|||
147620894|NCT02547428|532429603|FG000|Period 1- Treatment Sequence 1 (3 Weeks)|Dosing Suspension|1|||
147620895|NCT02547428|532429604|FG001|Period 1- Treatment Sequence 1 (3 Weeks)|Dosing Suspension|3|||
147620896|NCT02547428|532429603|FG000|Period 2- Treatment Sequence 2 (3 Weeks)|Adverse Event|0|||
147620897|NCT02547428|532429604|FG001|Period 2- Treatment Sequence 2 (3 Weeks)|Adverse Event|3|||
147620898|NCT02547428|532429603|FG000|Period 2- Treatment Sequence 2 (3 Weeks)|Lost to Follow-up|0|||
147620899|NCT02547428|532429604|FG001|Period 2- Treatment Sequence 2 (3 Weeks)|Lost to Follow-up|3|||
147620900|NCT02547428|532429603|FG000|Period 2- Treatment Sequence 2 (3 Weeks)|Withdrawal by Subject|0|||
147620901|NCT02547428|532429604|FG001|Period 2- Treatment Sequence 2 (3 Weeks)|Withdrawal by Subject|1|||
147620902|NCT02547428|532429603|FG000|Period 2- Treatment Sequence 2 (3 Weeks)|Investigator Discretion|1|||
147620903|NCT02547428|532429604|FG001|Period 2- Treatment Sequence 2 (3 Weeks)|Investigator Discretion|0|||
147620904|NCT02302833|532429605|FG000|Overall Study|Lost to Follow-up|3|||
147620905|NCT03664232|532429610|FG000|Overall Study|Withdrawal by Subject|0|||
147620906|NCT03664232|532429611|FG001|Overall Study|Withdrawal by Subject|1|||
147620907|NCT03664232|532429612|FG002|Overall Study|Withdrawal by Subject|0|||
147620908|NCT03664232|532429613|FG003|Overall Study|Withdrawal by Subject|1|||
147620909|NCT03664232|532429610|FG000|Overall Study|Adverse Event|0|||
147620910|NCT03664232|532429611|FG001|Overall Study|Adverse Event|0|||
147620911|NCT03664232|532429612|FG002|Overall Study|Adverse Event|1|||
147620912|NCT03664232|532429613|FG003|Overall Study|Adverse Event|0|||
147620913|NCT03664232|532429610|FG000|Overall Study|Other-Non-compliance with study drug|0|||
147620914|NCT03664232|532429611|FG001|Overall Study|Other-Non-compliance with study drug|1|||
147620915|NCT03664232|532429612|FG002|Overall Study|Other-Non-compliance with study drug|0|||
147620916|NCT03664232|532429613|FG003|Overall Study|Other-Non-compliance with study drug|2|||
147620917|NCT03664232|532429610|FG000|Overall Study|Other-Unspecified|0|||
147620918|NCT03664232|532429611|FG001|Overall Study|Other-Unspecified|3|||
147620919|NCT03664232|532429612|FG002|Overall Study|Other-Unspecified|0|||
147620920|NCT03664232|532429613|FG003|Overall Study|Other-Unspecified|1|||
147620921|NCT03664232|532429610|FG000|Overall Study|- Withdrawal by Parent/Guardian|0|||
147620922|NCT03664232|532429611|FG001|Overall Study|- Withdrawal by Parent/Guardian|0|||
147620923|NCT03664232|532429612|FG002|Overall Study|- Withdrawal by Parent/Guardian|0|||
147620924|NCT03664232|532429613|FG003|Overall Study|- Withdrawal by Parent/Guardian|1|||
147620925|NCT02717507|532429614|FG000|Overall Study|Lost to Follow-up|5|||
147620926|NCT02717507|532429615|FG001|Overall Study|Lost to Follow-up|8|||
147620927|NCT02717507|532429614|FG000|Overall Study|Pregnancy|1|||
147620928|NCT02717507|532429615|FG001|Overall Study|Pregnancy|1|||
147620929|NCT02717507|532429614|FG000|Overall Study|Protocol Violation|2|||
147620930|NCT02717507|532429615|FG001|Overall Study|Protocol Violation|2|||
147620931|NCT02717507|532429614|FG000|Overall Study|Withdrawal by Subject|20|||
147620932|NCT02717507|532429615|FG001|Overall Study|Withdrawal by Subject|20|||
147620933|NCT02717507|532429614|FG000|Overall Study|Relapse|1|||
147620934|NCT02717507|532429615|FG001|Overall Study|Relapse|1|||
147620935|NCT02717507|532429614|FG000|Overall Study|Cardiac Event|2|||
147620936|NCT02717507|532429615|FG001|Overall Study|Cardiac Event|6|||
147473902|NCT00472303|531892219|FG002|Discontinuations After Titration Phase|Adverse Event|0|||
147473903|NCT00472303|531892217|FG000|Discontinuations After Titration Phase|Lack of Efficacy|48|||
147473904|NCT00472303|531892218|FG001|Discontinuations After Titration Phase|Lack of Efficacy|17|||
147473905|NCT00472303|531892219|FG002|Discontinuations After Titration Phase|Lack of Efficacy|0|||
147473906|NCT00472303|531892217|FG000|Discontinuations After Titration Phase|Withdrawal by Subject|2|||
147473907|NCT00472303|531892218|FG001|Discontinuations After Titration Phase|Withdrawal by Subject|2|||
147473908|NCT00472303|531892219|FG002|Discontinuations After Titration Phase|Withdrawal by Subject|0|||
147473909|NCT00472303|531892217|FG000|Discontinuations After Titration Phase|Trial Medication non-compliant|0|||
147473910|NCT00472303|531892218|FG001|Discontinuations After Titration Phase|Trial Medication non-compliant|1|||
147473911|NCT00472303|531892219|FG002|Discontinuations After Titration Phase|Trial Medication non-compliant|0|||
147473912|NCT00472303|531892217|FG000|Discontinuations After Titration Phase|Other|5|||
147473913|NCT00472303|531892218|FG001|Discontinuations After Titration Phase|Other|0|||
147620937|NCT05017246|532429616|FG000|Overall Study|Withdrawal by Subject|5|||
147620938|NCT05017246|532429617|FG001|Overall Study|Withdrawal by Subject|3|||
147620939|NCT05017246|532429616|FG000|Overall Study|Determined to be ineligible|0|||
147620940|NCT05017246|532429617|FG001|Overall Study|Determined to be ineligible|1|||
147620941|NCT05017246|532429616|FG000|Overall Study|Withdrawn due to patient being given heparin|0|||
147620942|NCT05017246|532429617|FG001|Overall Study|Withdrawn due to patient being given heparin|1|||
147620943|NCT05017246|532429616|FG000|Overall Study|Technical failure|1|||
147620944|NCT05017246|532429617|FG001|Overall Study|Technical failure|3|||
147620945|NCT02003209|532429625|FG000|Overall Study|Patient not at risk for primary endpoint|5|||
147620946|NCT02003209|532429626|FG001|Overall Study|Patient not at risk for primary endpoint|2|||
147620947|NCT00638508|532429627|FG000|Overall Study|Physician Decision|5|||
147620948|NCT00638508|532429628|FG001|Overall Study|Physician Decision|2|||
147620949|NCT00485264|532429629|FG000|Overall Study|Enrolled But Not Given Treatment|0|||
147620950|NCT00485264|532429630|FG001|Overall Study|Enrolled But Not Given Treatment|0|||
147620951|NCT00485264|532429631|FG002|Overall Study|Enrolled But Not Given Treatment|0|||
147620952|NCT00485264|532429632|FG003|Overall Study|Enrolled But Not Given Treatment|0|||
147620953|NCT00485264|532429633|FG004|Overall Study|Enrolled But Not Given Treatment|1|||
147620954|NCT00485264|532429634|FG005|Overall Study|Enrolled But Not Given Treatment|0|||
147620955|NCT00485264|532429629|FG000|Overall Study|Death|1|||
147620956|NCT00485264|532429630|FG001|Overall Study|Death|0|||
147620957|NCT00485264|532429631|FG002|Overall Study|Death|0|||
147620958|NCT00485264|532429632|FG003|Overall Study|Death|0|||
147620959|NCT00485264|532429633|FG004|Overall Study|Death|1|||
147416118|NCT00939822|531688300|FG000|Overall Study|withdrew from study due to busy schedule|1|||
147416119|NCT00939822|531688301|FG001|Overall Study|withdrew from study due to busy schedule|1|||
147416120|NCT00939822|531688300|FG000|Overall Study|Mental health issues|0|||
147416121|NCT00939822|531688301|FG001|Overall Study|Mental health issues|2|||
147416122|NCT01232738|531688302|FG000|Overall Study|Death|3|||
147416123|NCT01232738|531688302|FG000|Overall Study|Physician Decision|2|||
147416124|NCT01232738|531688302|FG000|Overall Study|Lost to Follow-up|1|||
147416125|NCT01232738|531688302|FG000|Overall Study|Withdrawal by Subject|2|||
147416126|NCT01232738|531688302|FG000|Overall Study|Adverse Event|5|||
147416127|NCT01365481|531688310|FG000|Overall Study|Adverse Event|6|||
147416128|NCT01365481|531688311|FG001|Overall Study|Adverse Event|9|||
147416129|NCT01365481|531688312|FG002|Overall Study|Adverse Event|0|||
147416130|NCT01365481|531688313|FG003|Overall Study|Adverse Event|2|||
147416131|NCT01365481|531688310|FG000|Overall Study|Withdrawal by Subject|0|||
147416132|NCT01365481|531688311|FG001|Overall Study|Withdrawal by Subject|2|||
147416133|NCT01365481|531688312|FG002|Overall Study|Withdrawal by Subject|1|||
147416134|NCT01365481|531688313|FG003|Overall Study|Withdrawal by Subject|1|||
147416135|NCT01365481|531688310|FG000|Overall Study|Lost to Follow-up|1|||
147416136|NCT01365481|531688311|FG001|Overall Study|Lost to Follow-up|1|||
147416137|NCT01365481|531688312|FG002|Overall Study|Lost to Follow-up|2|||
147416138|NCT01365481|531688313|FG003|Overall Study|Lost to Follow-up|3|||
147416139|NCT01365481|531688310|FG000|Overall Study|Abnormal laboratory value(s)|0|||
147416140|NCT01365481|531688311|FG001|Overall Study|Abnormal laboratory value(s)|1|||
147416141|NCT01365481|531688312|FG002|Overall Study|Abnormal laboratory value(s)|0|||
147416142|NCT01365481|531688313|FG003|Overall Study|Abnormal laboratory value(s)|0|||
147416143|NCT01365481|531688310|FG000|Overall Study|Administrative problems|0|||
147416144|NCT01365481|531688311|FG001|Overall Study|Administrative problems|1|||
147416145|NCT01365481|531688312|FG002|Overall Study|Administrative problems|0|||
147416146|NCT01365481|531688313|FG003|Overall Study|Administrative problems|0|||
147416147|NCT01365481|531688310|FG000|Overall Study|Protocol deviation|0|||
147416148|NCT01365481|531688311|FG001|Overall Study|Protocol deviation|1|||
147416149|NCT01365481|531688312|FG002|Overall Study|Protocol deviation|0|||
147416150|NCT01365481|531688313|FG003|Overall Study|Protocol deviation|1|||
147416151|NCT01365481|531688310|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
147416152|NCT01365481|531688311|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
147416153|NCT01365481|531688312|FG002|Overall Study|Unsatisfactory therapeutic effect|1|||
147416154|NCT01365481|531688313|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
147620960|NCT00485264|532429634|FG005|Overall Study|Death|0|||
147666310|NCT01245101|532603903|FG001|Period 3 (Treatment)|Withdrawal by Subject|0|||
147666311|NCT01122173|532603904|FG000|Overall Study|Lost to Follow-up|3|||
147666312|NCT01122173|532603904|FG000|Overall Study|Withdrawal by Subject|3|||
147666313|NCT01122173|532603904|FG000|Overall Study|Left study for other reasons|3|||
147666314|NCT02133508|532603907|FG000|Overall Study|Decision of Investigator or Sponsor|1|||
147666315|NCT02133508|532603907|FG000|Overall Study|Death|12|||
147666316|NCT02133508|532603907|FG000|Overall Study|Lost to Follow-up|2|||
147666317|NCT01026493|532603914|FG000|Overall Study|Protocol Violation|0|||
147666318|NCT01026493|532603915|FG001|Overall Study|Protocol Violation|1|||
147666319|NCT01026493|532603916|FG002|Overall Study|Protocol Violation|0|||
147666320|NCT01026493|532603917|FG003|Overall Study|Protocol Violation|0|||
147666321|NCT01026493|532603918|FG004|Overall Study|Protocol Violation|2|||
147666322|NCT01026493|532603919|FG005|Overall Study|Protocol Violation|3|||
147620961|NCT00485264|532429629|FG000|Overall Study|Adverse Event|1|||
147620962|NCT00485264|532429630|FG001|Overall Study|Adverse Event|0|||
147620963|NCT00485264|532429631|FG002|Overall Study|Adverse Event|2|||
147620964|NCT00485264|532429632|FG003|Overall Study|Adverse Event|3|||
147620965|NCT00485264|532429633|FG004|Overall Study|Adverse Event|1|||
147620966|NCT00485264|532429634|FG005|Overall Study|Adverse Event|3|||
147620967|NCT00485264|532429629|FG000|Overall Study|Pregnancy|4|||
147620968|NCT00485264|532429630|FG001|Overall Study|Pregnancy|0|||
147620969|NCT00485264|532429631|FG002|Overall Study|Pregnancy|0|||
147620970|NCT00485264|532429632|FG003|Overall Study|Pregnancy|0|||
147620971|NCT00485264|532429633|FG004|Overall Study|Pregnancy|0|||
147620972|NCT00485264|532429634|FG005|Overall Study|Pregnancy|0|||
147620973|NCT00485264|532429629|FG000|Overall Study|Disallowed Medication|0|||
147620974|NCT00485264|532429630|FG001|Overall Study|Disallowed Medication|0|||
147620975|NCT00485264|532429631|FG002|Overall Study|Disallowed Medication|0|||
147620976|NCT00485264|532429632|FG003|Overall Study|Disallowed Medication|0|||
147620977|NCT00485264|532429633|FG004|Overall Study|Disallowed Medication|0|||
147620978|NCT00485264|532429634|FG005|Overall Study|Disallowed Medication|1|||
147620979|NCT00485264|532429629|FG000|Overall Study|Number/Volume/Timing of Study Meds|2|||
147620980|NCT00485264|532429630|FG001|Overall Study|Number/Volume/Timing of Study Meds|1|||
147620981|NCT00485264|532429631|FG002|Overall Study|Number/Volume/Timing of Study Meds|1|||
147620982|NCT00485264|532429632|FG003|Overall Study|Number/Volume/Timing of Study Meds|0|||
147620983|NCT00485264|532429633|FG004|Overall Study|Number/Volume/Timing of Study Meds|0|||
147620984|NCT00485264|532429634|FG005|Overall Study|Number/Volume/Timing of Study Meds|0|||
147620985|NCT00485264|532429629|FG000|Overall Study|Lack of Efficacy|0|||
147620986|NCT00485264|532429630|FG001|Overall Study|Lack of Efficacy|1|||
147620987|NCT00485264|532429631|FG002|Overall Study|Lack of Efficacy|0|||
147620988|NCT00485264|532429632|FG003|Overall Study|Lack of Efficacy|0|||
147620989|NCT00485264|532429633|FG004|Overall Study|Lack of Efficacy|0|||
147620990|NCT00485264|532429634|FG005|Overall Study|Lack of Efficacy|0|||
147620991|NCT00485264|532429629|FG000|Overall Study|Guardian Consent Withdrawn|1|||
147620992|NCT00485264|532429630|FG001|Overall Study|Guardian Consent Withdrawn|0|||
147620993|NCT00485264|532429631|FG002|Overall Study|Guardian Consent Withdrawn|0|||
147620994|NCT00485264|532429632|FG003|Overall Study|Guardian Consent Withdrawn|0|||
147620995|NCT00485264|532429633|FG004|Overall Study|Guardian Consent Withdrawn|1|||
147620996|NCT00485264|532429634|FG005|Overall Study|Guardian Consent Withdrawn|0|||
147620997|NCT00485264|532429629|FG000|Overall Study|Physician Decision|0|||
147620998|NCT00485264|532429630|FG001|Overall Study|Physician Decision|2|||
147620999|NCT00485264|532429631|FG002|Overall Study|Physician Decision|0|||
147621000|NCT00485264|532429632|FG003|Overall Study|Physician Decision|0|||
147621001|NCT00485264|532429633|FG004|Overall Study|Physician Decision|0|||
147621002|NCT00485264|532429634|FG005|Overall Study|Physician Decision|0|||
147621003|NCT00485264|532429629|FG000|Overall Study|Intolerance/Unable to Tolerate Dose|0|||
147621004|NCT00485264|532429630|FG001|Overall Study|Intolerance/Unable to Tolerate Dose|0|||
147666323|NCT01026493|532603920|FG006|Overall Study|Protocol Violation|4|||
147666324|NCT01026493|532603921|FG007|Overall Study|Protocol Violation|1|||
147666325|NCT03093181|532603927|FG000|Overall Study|Withdrawal by Subject|2|||
147416155|NCT00958841|531688318|FG000|Overall Study|Abnormal laboratory value(s)|1|||
147416156|NCT00958841|531688318|FG000|Overall Study|Abnormal test procedure result(s)|3|||
147416157|NCT00958841|531688318|FG000|Overall Study|Administrative problems|1|||
147416158|NCT00958841|531688318|FG000|Overall Study|Adverse Event|8|||
147666326|NCT03093181|532603928|FG001|Overall Study|Withdrawal by Subject|1|||
147666327|NCT03093181|532603929|FG002|Overall Study|Withdrawal by Subject|2|||
147416159|NCT00958841|531688318|FG000|Overall Study|New cancer therapy|5|||
147416160|NCT00958841|531688318|FG000|Overall Study|Withdrawal by Subject|1|||
147416161|NCT00958841|531688318|FG000|Overall Study|Unsatisfactory therapeutic effect|22|||
147621005|NCT00485264|532429631|FG002|Overall Study|Intolerance/Unable to Tolerate Dose|1|||
147621006|NCT00485264|532429632|FG003|Overall Study|Intolerance/Unable to Tolerate Dose|0|||
147621007|NCT00485264|532429633|FG004|Overall Study|Intolerance/Unable to Tolerate Dose|0|||
147621008|NCT00485264|532429634|FG005|Overall Study|Intolerance/Unable to Tolerate Dose|0|||
147621009|NCT00485264|532429629|FG000|Overall Study|Not Able to Attend Clinic|5|||
147621010|NCT00485264|532429630|FG001|Overall Study|Not Able to Attend Clinic|0|||
147621011|NCT00485264|532429631|FG002|Overall Study|Not Able to Attend Clinic|0|||
147621012|NCT00485264|532429632|FG003|Overall Study|Not Able to Attend Clinic|1|||
147473914|NCT00472303|531892219|FG002|Discontinuations After Titration Phase|Other|0|||
147473915|NCT00472303|531892217|FG000|Maintenance Phase|Adverse Event|5|||
147473916|NCT00472303|531892218|FG001|Maintenance Phase|Adverse Event|6|||
147473917|NCT00472303|531892219|FG002|Maintenance Phase|Adverse Event|6|||
147473918|NCT00472303|531892217|FG000|Maintenance Phase|Death|3|||
147473919|NCT00472303|531892218|FG001|Maintenance Phase|Death|0|||
147473920|NCT00472303|531892219|FG002|Maintenance Phase|Death|2|||
147473921|NCT00472303|531892217|FG000|Maintenance Phase|Lack of Efficacy|2|||
147473922|NCT00472303|531892218|FG001|Maintenance Phase|Lack of Efficacy|2|||
147473923|NCT00472303|531892219|FG002|Maintenance Phase|Lack of Efficacy|4|||
147473924|NCT00472303|531892217|FG000|Maintenance Phase|Withdrawal by Subject|6|||
147473925|NCT00472303|531892218|FG001|Maintenance Phase|Withdrawal by Subject|7|||
147473926|NCT00472303|531892219|FG002|Maintenance Phase|Withdrawal by Subject|3|||
147473927|NCT00472303|531892217|FG000|Maintenance Phase|Trial medication non-compliant|0|||
147473928|NCT00472303|531892218|FG001|Maintenance Phase|Trial medication non-compliant|0|||
147473929|NCT00472303|531892219|FG002|Maintenance Phase|Trial medication non-compliant|1|||
147473930|NCT00472303|531892217|FG000|Maintenance Phase|Resolution of pain|0|||
147473931|NCT00472303|531892218|FG001|Maintenance Phase|Resolution of pain|0|||
147473932|NCT00472303|531892219|FG002|Maintenance Phase|Resolution of pain|1|||
147473933|NCT00472303|531892217|FG000|Maintenance Phase|Other|1|||
147473934|NCT00472303|531892218|FG001|Maintenance Phase|Other|1|||
147473935|NCT00472303|531892219|FG002|Maintenance Phase|Other|0|||
147473936|NCT04112914|531892221|FG000|Overall Study|Lost to Follow-up|13|||
147473937|NCT04112914|531892222|FG001|Overall Study|Lost to Follow-up|9|||
147473938|NCT04112914|531892221|FG000|Overall Study|Withdrawal by Subject|1|||
147473939|NCT04112914|531892222|FG001|Overall Study|Withdrawal by Subject|0|||
147473940|NCT01244737|531892230|FG000|Overall Study|Physician Decision|2|||
147473941|NCT01244737|531892231|FG001|Overall Study|Physician Decision|18|||
147473942|NCT01244737|531892232|FG002|Overall Study|Physician Decision|5|||
147473943|NCT01244737|531892230|FG000|Overall Study|Radiopharmaceutical FLT (18F-fluorothymidine) unavailable to perform PET scan before surgery|1|||
147473944|NCT01244737|531892231|FG001|Overall Study|Radiopharmaceutical FLT (18F-fluorothymidine) unavailable to perform PET scan before surgery|1|||
147473945|NCT01244737|531892232|FG002|Overall Study|Radiopharmaceutical FLT (18F-fluorothymidine) unavailable to perform PET scan before surgery|0|||
147473946|NCT01244737|531892230|FG000|Overall Study|Surgical pathology did not confirm evaluable brain tumor|2|||
147473947|NCT01244737|531892231|FG001|Overall Study|Surgical pathology did not confirm evaluable brain tumor|1|||
147473948|NCT01244737|531892232|FG002|Overall Study|Surgical pathology did not confirm evaluable brain tumor|0|||
147473949|NCT01244737|531892230|FG000|Overall Study|MIB immunopathology results not available|3|||
147473950|NCT01244737|531892231|FG001|Overall Study|MIB immunopathology results not available|2|||
147473951|NCT01244737|531892232|FG002|Overall Study|MIB immunopathology results not available|0|||
147473952|NCT01244737|531892230|FG000|Overall Study|PET data failure|0|||
147473953|NCT01244737|531892231|FG001|Overall Study|PET data failure|1|||
147473954|NCT01244737|531892232|FG002|Overall Study|PET data failure|0|||
147416162|NCT00958841|531688318|FG000|Overall Study|Completed M6/did not enter extension|27|||
147416163|NCT00958841|531688318|FG000|Overall Study|Discontinued prior to M*|28|||
147416164|NCT00436605|531688322|FG000|Overall Study|Protocol Violation|3|||
147416165|NCT03014011|531688323|FG000|First Intervention|Withdrawal by Subject|1|||
147416166|NCT03014011|531688324|FG001|First Intervention|Withdrawal by Subject|0|||
147416167|NCT03014011|531688323|FG000|Washout|Withdrawal by Subject|1|||
147416168|NCT03014011|531688324|FG001|Washout|Withdrawal by Subject|0|||
147416169|NCT02755818|531688325|FG000|Overall Study|Withdrawal by Subject|0|||
147416170|NCT02755818|531688326|FG001|Overall Study|Withdrawal by Subject|0|||
147416171|NCT02755818|531688327|FG002|Overall Study|Withdrawal by Subject|0|||
147416172|NCT02755818|531688328|FG003|Overall Study|Withdrawal by Subject|2|||
147416173|NCT02755818|531688325|FG000|Overall Study|withdrawal by PI|0|||
147416174|NCT02755818|531688326|FG001|Overall Study|withdrawal by PI|0|||
147416175|NCT02755818|531688327|FG002|Overall Study|withdrawal by PI|1|||
147416176|NCT02755818|531688328|FG003|Overall Study|withdrawal by PI|1|||
147416177|NCT01280357|531688342|FG000|Overall Study|Excluded no internal monitoring|14|||
147416178|NCT01280357|531688342|FG000|Overall Study|IInsufficient data/No data supplied|12|||
147416179|NCT01259089|531688343|FG000|Reached First Response at 4 Weeks|Patient not treated on study|0|||
147416180|NCT01259089|531688344|FG001|Reached First Response at 4 Weeks|Patient not treated on study|0|||
147416181|NCT01259089|531688345|FG002|Reached First Response at 4 Weeks|Patient not treated on study|0|||
147416182|NCT01259089|531688346|FG003|Reached First Response at 4 Weeks|Patient not treated on study|0|||
147416183|NCT01259089|531688347|FG004|Reached First Response at 4 Weeks|Patient not treated on study|0|||
147416184|NCT01259089|531688348|FG005|Reached First Response at 4 Weeks|Patient not treated on study|1|||
147416185|NCT01259089|531688343|FG000|Reached First Response at 4 Weeks|Adverse Event|0|||
147416186|NCT01259089|531688344|FG001|Reached First Response at 4 Weeks|Adverse Event|0|||
147416187|NCT01259089|531688345|FG002|Reached First Response at 4 Weeks|Adverse Event|0|||
147416188|NCT01259089|531688346|FG003|Reached First Response at 4 Weeks|Adverse Event|0|||
147416189|NCT01259089|531688347|FG004|Reached First Response at 4 Weeks|Adverse Event|0|||
147416190|NCT01259089|531688348|FG005|Reached First Response at 4 Weeks|Adverse Event|1|||
147416191|NCT01259089|531688343|FG000|Confirmed Response at 8 Weeks|Withdrawal by Subject|0|||
147473955|NCT01244737|531892230|FG000|Overall Study|Withdrawal by Subject|0|||
147473956|NCT01244737|531892231|FG001|Overall Study|Withdrawal by Subject|0|||
147473957|NCT01244737|531892232|FG002|Overall Study|Withdrawal by Subject|1|||
147473958|NCT02835495|531892237|FG000|Overall Study|Cancer diagnosis prior intervention|1|||
147473959|NCT02835495|531892238|FG001|Overall Study|Cancer diagnosis prior intervention|0|||
147473960|NCT02835495|531892237|FG000|Overall Study|Declined in-person follow-up visit|4|||
147473961|NCT02835495|531892238|FG001|Overall Study|Declined in-person follow-up visit|2|||
147473962|NCT00356915|531892239|FG000|Overall Study|Non compliance|1|||
147473963|NCT00356915|531892240|FG001|Overall Study|Non compliance|2|||
147473964|NCT00356915|531892241|FG002|Overall Study|Non compliance|1|||
147473965|NCT00356915|531892239|FG000|Overall Study|Protocol Violation|2|||
147473966|NCT00356915|531892240|FG001|Overall Study|Protocol Violation|3|||
147473967|NCT00356915|531892241|FG002|Overall Study|Protocol Violation|2|||
147473968|NCT00356915|531892239|FG000|Overall Study|Withdrawal by Subject|14|||
147473969|NCT00356915|531892240|FG001|Overall Study|Withdrawal by Subject|14|||
147473970|NCT00356915|531892241|FG002|Overall Study|Withdrawal by Subject|10|||
147473971|NCT00356915|531892239|FG000|Overall Study|Lack of Efficacy|0|||
147473972|NCT00356915|531892240|FG001|Overall Study|Lack of Efficacy|0|||
147473973|NCT00356915|531892241|FG002|Overall Study|Lack of Efficacy|3|||
147473974|NCT00356915|531892239|FG000|Overall Study|Lost to Follow-up|27|||
147473975|NCT00356915|531892240|FG001|Overall Study|Lost to Follow-up|34|||
147473976|NCT00356915|531892241|FG002|Overall Study|Lost to Follow-up|14|||
147473977|NCT00356915|531892239|FG000|Overall Study|Administrative Decision|0|||
147473978|NCT00356915|531892240|FG001|Overall Study|Administrative Decision|0|||
147473979|NCT00356915|531892241|FG002|Overall Study|Administrative Decision|1|||
147473980|NCT00356915|531892239|FG000|Overall Study|Physician Decision|0|||
147473981|NCT00356915|531892240|FG001|Overall Study|Physician Decision|2|||
147473982|NCT00356915|531892241|FG002|Overall Study|Physician Decision|0|||
147473983|NCT00356915|531892239|FG000|Overall Study|Adverse Event|21|||
147473984|NCT00356915|531892240|FG001|Overall Study|Adverse Event|31|||
147473985|NCT00356915|531892241|FG002|Overall Study|Adverse Event|8|||
147473986|NCT00356915|531892239|FG000|Overall Study|Miscellaneous reasons|11|||
147473987|NCT00356915|531892240|FG001|Overall Study|Miscellaneous reasons|8|||
147473988|NCT00356915|531892241|FG002|Overall Study|Miscellaneous reasons|3|||
147473989|NCT01442181|531892247|FG000|Overall Study|patient refused surgery|1|||
147473990|NCT01442181|531892248|FG001|Overall Study|patient refused surgery|0|||
147473991|NCT01442181|531892247|FG000|Overall Study|no insurance for surgery|1|||
147473992|NCT01442181|531892248|FG001|Overall Study|no insurance for surgery|0|||
147473993|NCT01442181|531892247|FG000|Overall Study|low ejection factor|0|||
147473994|NCT01442181|531892248|FG001|Overall Study|low ejection factor|1|||
147473995|NCT01442181|531892247|FG000|Overall Study|Lost to Follow-up|1|||
147473996|NCT01442181|531892248|FG001|Overall Study|Lost to Follow-up|1|||
147473997|NCT01442181|531892247|FG000|Overall Study|patient in an additional study|1|||
147473998|NCT01442181|531892248|FG001|Overall Study|patient in an additional study|0|||
147473999|NCT01442181|531892247|FG000|Overall Study|atrial fibrillation not noted|0|||
147474000|NCT01442181|531892248|FG001|Overall Study|atrial fibrillation not noted|1|||
147474001|NCT00709202|531892249|FG000|Overall Study|Withdrawal by Subject|6|||
147474002|NCT00709202|531892250|FG001|Overall Study|Withdrawal by Subject|6|||
147474003|NCT03133767|531892251|FG000|Overall Study|Lost to Follow-up|38|||
147474004|NCT03133767|531892252|FG001|Overall Study|Lost to Follow-up|24|||
147474005|NCT03133767|531892251|FG000|Overall Study|Protocol Violation|0|||
147474006|NCT03133767|531892252|FG001|Overall Study|Protocol Violation|1|||
147474007|NCT03301857|531892257|FG000|Overall Study|Death|0|||
147474008|NCT03301857|531892258|FG001|Overall Study|Death|2|||
147474009|NCT03301857|531892257|FG000|Overall Study|Lost to Follow-up|4|||
147474010|NCT03301857|531892258|FG001|Overall Study|Lost to Follow-up|2|||
147474011|NCT03301857|531892257|FG000|Overall Study|Decision by Sponsor|6|||
147474012|NCT03301857|531892258|FG001|Overall Study|Decision by Sponsor|0|||
147474013|NCT03301857|531892257|FG000|Overall Study|Withdrawal by Subject|12|||
147474014|NCT03301857|531892258|FG001|Overall Study|Withdrawal by Subject|4|||
147474015|NCT00855439|531892259|FG000|Overall Study|Withdrawal by Subject|2|||
147474016|NCT00855439|531892260|FG001|Overall Study|Withdrawal by Subject|0|||
147474017|NCT00855439|531892259|FG000|Overall Study|Pregnancy|1|||
147474018|NCT00855439|531892260|FG001|Overall Study|Pregnancy|0|||
147474019|NCT05502289|531892261|FG000|Period 1|Out Of Window|1|||
147474020|NCT05502289|531892262|FG001|Period 1|Out Of Window|0|||
147474021|NCT00613626|531892263|FG000|Overall Study|Ineligible|0|||
147474022|NCT00613626|531892264|FG001|Overall Study|Ineligible|1|||
147474023|NCT00613626|531892265|FG002|Overall Study|Ineligible|0|||
147474024|NCT04375878|531892268|FG000|Crossover First and Second Interventions|Withdrawal by Subject|1|||
147474025|NCT04375878|531892269|FG001|Crossover First and Second Interventions|Withdrawal by Subject|1|||
147474026|NCT04375878|531892270|FG002|Crossover First and Second Interventions|Withdrawal by Subject|0|||
147474027|NCT04375878|531892271|FG003|Crossover First and Second Interventions|Withdrawal by Subject|0|||
147474028|NCT04375878|531892272|FG004|Crossover First and Second Interventions|Withdrawal by Subject|0|||
147474029|NCT04375878|531892273|FG005|Crossover First and Second Interventions|Withdrawal by Subject|0|||
147474030|NCT04375878|531892268|FG000|Crossover First and Second Interventions|Adverse Event|0|||
147474031|NCT04375878|531892269|FG001|Crossover First and Second Interventions|Adverse Event|0|||
147474032|NCT04375878|531892270|FG002|Crossover First and Second Interventions|Adverse Event|1|||
147474033|NCT04375878|531892271|FG003|Crossover First and Second Interventions|Adverse Event|0|||
147474034|NCT04375878|531892272|FG004|Crossover First and Second Interventions|Adverse Event|0|||
147474035|NCT04375878|531892273|FG005|Crossover First and Second Interventions|Adverse Event|0|||
147474036|NCT04375878|531892268|FG000|Extension Phase|Withdrawal by Subject|0|||
147474037|NCT04375878|531892269|FG001|Extension Phase|Withdrawal by Subject|0|||
147474038|NCT04375878|531892270|FG002|Extension Phase|Withdrawal by Subject|0|||
147474039|NCT04375878|531892271|FG003|Extension Phase|Withdrawal by Subject|0|||
147474040|NCT04375878|531892272|FG004|Extension Phase|Withdrawal by Subject|1|||
147474041|NCT04375878|531892273|FG005|Extension Phase|Withdrawal by Subject|0|||
147474042|NCT05480514|531892274|FG000|Period 1|Pd-Incorrect Lens Power Assigned|2|||
147474043|NCT05480514|531892275|FG001|Period 1|Pd-Incorrect Lens Power Assigned|3|||
147474044|NCT05480514|531892274|FG000|Period 1|Unsatisfactory Lens Fitting Due to Test Article|3|||
147474045|NCT05480514|531892275|FG001|Period 1|Unsatisfactory Lens Fitting Due to Test Article|5|||
147474046|NCT05480514|531892274|FG000|Period 1|Subject No Longer Meets Eligibility Criteria|0|||
147474047|NCT05480514|531892275|FG001|Period 1|Subject No Longer Meets Eligibility Criteria|1|||
147474048|NCT05480514|531892274|FG000|Period 1|Covid-19 Related|1|||
147474049|NCT05480514|531892275|FG001|Period 1|Covid-19 Related|0|||
147474050|NCT05480514|531892274|FG000|Period 2|Unsatisfactory Lens Fitting Due to Test Article|4|||
147474051|NCT05480514|531892275|FG001|Period 2|Unsatisfactory Lens Fitting Due to Test Article|4|||
147474052|NCT03232073|531892276|FG000|Overall Study|Death|1|||
147474053|NCT03232073|531892277|FG001|Overall Study|Death|0|||
147474054|NCT03232073|531892276|FG000|Overall Study|Adverse Event|7|||
147474055|NCT03232073|531892277|FG001|Overall Study|Adverse Event|12|||
147474056|NCT03232073|531892276|FG000|Overall Study|Lost to Follow-up|6|||
147474057|NCT03232073|531892277|FG001|Overall Study|Lost to Follow-up|6|||
147474058|NCT03232073|531892276|FG000|Overall Study|Lack of Efficacy|10|||
147474059|NCT03232073|531892277|FG001|Overall Study|Lack of Efficacy|8|||
147474060|NCT03232073|531892276|FG000|Overall Study|Physician Decision|9|||
147474061|NCT03232073|531892277|FG001|Overall Study|Physician Decision|2|||
147474062|NCT03232073|531892276|FG000|Overall Study|Withdrawal by Subject|54|||
147474063|NCT03232073|531892277|FG001|Overall Study|Withdrawal by Subject|39|||
147474064|NCT03395210|531894221|FG000|Overall Study|Other|0|||
147474065|NCT03395210|531894222|FG001|Overall Study|Other|0|||
147474066|NCT03395210|531894223|FG002|Overall Study|Other|0|||
147474067|NCT03395210|531894224|FG003|Overall Study|Other|0|||
147474068|NCT03395210|531894225|FG004|Overall Study|Other|1|||
147474069|NCT03395210|531894221|FG000|Overall Study|Participant Uncooperative or Noncompliant|0|||
147474070|NCT03395210|531894222|FG001|Overall Study|Participant Uncooperative or Noncompliant|0|||
147474071|NCT03395210|531894223|FG002|Overall Study|Participant Uncooperative or Noncompliant|0|||
147474072|NCT03395210|531894224|FG003|Overall Study|Participant Uncooperative or Noncompliant|0|||
147474073|NCT03395210|531894225|FG004|Overall Study|Participant Uncooperative or Noncompliant|1|||
147474074|NCT03395210|531894221|FG000|Overall Study|Adverse Event|1|||
147474075|NCT03395210|531894222|FG001|Overall Study|Adverse Event|0|||
147474076|NCT03395210|531894223|FG002|Overall Study|Adverse Event|2|||
147474077|NCT03395210|531894224|FG003|Overall Study|Adverse Event|4|||
147474078|NCT03395210|531894225|FG004|Overall Study|Adverse Event|3|||
147474079|NCT03395210|531894221|FG000|Overall Study|Need of Rescue Medication|1|||
147474080|NCT03395210|531894222|FG001|Overall Study|Need of Rescue Medication|0|||
147474081|NCT03395210|531894223|FG002|Overall Study|Need of Rescue Medication|1|||
147474082|NCT03395210|531894224|FG003|Overall Study|Need of Rescue Medication|4|||
147474083|NCT03395210|531894225|FG004|Overall Study|Need of Rescue Medication|0|||
147474084|NCT03395210|531894221|FG000|Overall Study|Lack of Response|0|||
147474085|NCT03395210|531894222|FG001|Overall Study|Lack of Response|0|||
147474086|NCT03395210|531894223|FG002|Overall Study|Lack of Response|0|||
147474087|NCT03395210|531894224|FG003|Overall Study|Lack of Response|5|||
147474088|NCT03395210|531894225|FG004|Overall Study|Lack of Response|5|||
147474089|NCT03395210|531894221|FG000|Overall Study|Participant was Erroneously Enrolled in the Study|1|||
147474090|NCT03395210|531894222|FG001|Overall Study|Participant was Erroneously Enrolled in the Study|0|||
147474091|NCT03395210|531894223|FG002|Overall Study|Participant was Erroneously Enrolled in the Study|0|||
147474092|NCT03395210|531894224|FG003|Overall Study|Participant was Erroneously Enrolled in the Study|0|||
147474093|NCT03395210|531894225|FG004|Overall Study|Participant was Erroneously Enrolled in the Study|1|||
147474094|NCT03395210|531894221|FG000|Overall Study|Participant Decision|1|||
147474095|NCT03395210|531894222|FG001|Overall Study|Participant Decision|1|||
147474096|NCT03395210|531894223|FG002|Overall Study|Participant Decision|0|||
147474097|NCT03395210|531894224|FG003|Overall Study|Participant Decision|4|||
147621013|NCT00485264|532429633|FG004|Overall Study|Not Able to Attend Clinic|1|||
147474098|NCT03395210|531894225|FG004|Overall Study|Participant Decision|0|||
147621014|NCT00485264|532429634|FG005|Overall Study|Not Able to Attend Clinic|2|||
147474099|NCT03395210|531894221|FG000|Overall Study|Ongoing at the Time of Primary Completion Date|1|||
147621015|NCT00485264|532429629|FG000|Overall Study|Non-Compliant|17|||
147621016|NCT00485264|532429630|FG001|Overall Study|Non-Compliant|2|||
147621017|NCT00485264|532429631|FG002|Overall Study|Non-Compliant|1|||
147666328|NCT03093181|532603927|FG000|Overall Study|Other (Not specified)|1|||
147666329|NCT03093181|532603928|FG001|Overall Study|Other (Not specified)|0|||
147666330|NCT03093181|532603929|FG002|Overall Study|Other (Not specified)|0|||
147666331|NCT03093181|532603927|FG000|Overall Study|Adverse Event|0|||
147666332|NCT03093181|532603928|FG001|Overall Study|Adverse Event|1|||
147666333|NCT03093181|532603929|FG002|Overall Study|Adverse Event|0|||
147666334|NCT03093181|532603927|FG000|Overall Study|Other (Protocol violation)|0|||
147666335|NCT03093181|532603928|FG001|Overall Study|Other (Protocol violation)|0|||
147666336|NCT03093181|532603929|FG002|Overall Study|Other (Protocol violation)|1|||
147666337|NCT03154086|532603932|FG000|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
147666338|NCT03154086|532603933|FG001|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
147666339|NCT03154086|532603934|FG002|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
147666340|NCT03154086|532603935|FG003|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|1|||
147666341|NCT03154086|532603936|FG004|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
147666342|NCT03154086|532603937|FG005|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
147474100|NCT03395210|531894222|FG001|Overall Study|Ongoing at the Time of Primary Completion Date|0|||
147666343|NCT03154086|532603938|FG006|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
147666344|NCT03154086|532603939|FG007|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
147666345|NCT03154086|532603940|FG008|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
147666346|NCT03154086|532603941|FG009|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
147666347|NCT03154086|532603942|FG010|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
147666348|NCT03154086|532603943|FG011|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
147666349|NCT03154086|532603944|FG012|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
147666350|NCT03154086|532603945|FG013|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
147666351|NCT03154086|532603946|FG014|Part A: Cohort1 Washout1 (Up to 14 Days)|Protocol Violation|0|||
147666352|NCT03154086|532603932|FG000|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
147666353|NCT03154086|532603933|FG001|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|1|||
147666354|NCT03154086|532603934|FG002|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
147666355|NCT03154086|532603935|FG003|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
147666356|NCT03154086|532603936|FG004|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
147666357|NCT03154086|532603937|FG005|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
147666358|NCT03154086|532603938|FG006|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
147666359|NCT03154086|532603939|FG007|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
147666360|NCT03154086|532603940|FG008|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
147666361|NCT03154086|532603941|FG009|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
147666362|NCT03154086|532603942|FG010|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
147666363|NCT03154086|532603943|FG011|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
147666364|NCT03154086|532603944|FG012|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
147666365|NCT03154086|532603945|FG013|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
147666366|NCT03154086|532603946|FG014|PartA: Cohort1 Washout2 (Up to 14 Days)|Adverse Event|0|||
147666367|NCT03154086|532603932|FG000|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
147666368|NCT03154086|532603933|FG001|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
147666369|NCT03154086|532603934|FG002|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|1|||
147666370|NCT03154086|532603935|FG003|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
147666371|NCT03154086|532603936|FG004|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
147666372|NCT03154086|532603937|FG005|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
147666373|NCT03154086|532603938|FG006|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
147666374|NCT03154086|532603939|FG007|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
147666375|NCT03154086|532603940|FG008|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
147666376|NCT03154086|532603941|FG009|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
147666377|NCT03154086|532603942|FG010|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
147666378|NCT03154086|532603943|FG011|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
147666379|NCT03154086|532603944|FG012|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
147666380|NCT03154086|532603945|FG013|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
147666381|NCT03154086|532603946|FG014|Part A: Cohort1 Washout3 (Up to 14 Days)|Adverse Event|0|||
147666382|NCT03154086|532603932|FG000|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|1|||
147474101|NCT03395210|531894223|FG002|Overall Study|Ongoing at the Time of Primary Completion Date|2|||
147474102|NCT03395210|531894224|FG003|Overall Study|Ongoing at the Time of Primary Completion Date|13|||
147474103|NCT03395210|531894225|FG004|Overall Study|Ongoing at the Time of Primary Completion Date|11|||
147474104|NCT00853632|531894226|FG000|Overall Study|Death|88|||
147474105|NCT00853632|531894226|FG000|Overall Study|Withdrawal by Subject|45|||
147474106|NCT00853632|531894226|FG000|Overall Study|Lost to Follow-up|30|||
147474107|NCT00853632|531894226|FG000|Overall Study|Reoperation/Explant|17|||
147474108|NCT00853632|531894226|FG000|Overall Study|Exit with other reason|22|||
147474109|NCT04364854|531894227|FG000|Overall Study|Withdrawal by Subject|1|||
147474110|NCT04364854|531894228|FG001|Overall Study|Withdrawal by Subject|0|||
147474111|NCT04364854|531894229|FG002|Overall Study|Withdrawal by Subject|1|||
147474112|NCT04364854|531894230|FG003|Overall Study|Withdrawal by Subject|3|||
147474113|NCT04364854|531894227|FG000|Overall Study|Death|1|||
147474114|NCT04364854|531894228|FG001|Overall Study|Death|0|||
147474115|NCT04364854|531894229|FG002|Overall Study|Death|0|||
147474116|NCT04364854|531894230|FG003|Overall Study|Death|0|||
147474117|NCT04364854|531894227|FG000|Overall Study|Lost to Follow-up|0|||
147474118|NCT04364854|531894228|FG001|Overall Study|Lost to Follow-up|0|||
147474119|NCT04364854|531894229|FG002|Overall Study|Lost to Follow-up|0|||
147474120|NCT04364854|531894230|FG003|Overall Study|Lost to Follow-up|1|||
147474121|NCT04493619|531894232|FG000|Overall Study|Death|4|||
147621018|NCT00485264|532429632|FG003|Overall Study|Non-Compliant|0|||
147621019|NCT00485264|532429633|FG004|Overall Study|Non-Compliant|1|||
147621020|NCT00485264|532429634|FG005|Overall Study|Non-Compliant|0|||
147621021|NCT00485264|532429629|FG000|Overall Study|Lost to Follow-up|2|||
147621022|NCT00485264|532429630|FG001|Overall Study|Lost to Follow-up|1|||
147621023|NCT00485264|532429631|FG002|Overall Study|Lost to Follow-up|1|||
147474122|NCT04493619|531894233|FG001|Overall Study|Death|3|||
147474123|NCT04493619|531894234|FG002|Overall Study|Death|3|||
147474124|NCT04493619|531894235|FG003|Overall Study|Death|4|||
147474125|NCT04493619|531894232|FG000|Overall Study|Study discontinued early|10|||
147474126|NCT04493619|531894233|FG001|Overall Study|Study discontinued early|0|||
147474127|NCT04493619|531894234|FG002|Overall Study|Study discontinued early|4|||
147474128|NCT04493619|531894235|FG003|Overall Study|Study discontinued early|8|||
147474129|NCT04493619|531894232|FG000|Overall Study|Lost to Follow-up|0|||
147474130|NCT04493619|531894233|FG001|Overall Study|Lost to Follow-up|0|||
147474131|NCT04493619|531894234|FG002|Overall Study|Lost to Follow-up|0|||
147474132|NCT04493619|531894235|FG003|Overall Study|Lost to Follow-up|1|||
147474133|NCT03716726|531894244|FG000|Completed Baseline Assessment|Did not complete baseline assessment|10|||
147474134|NCT03716726|531894245|FG001|Completed Baseline Assessment|Did not complete baseline assessment|12|||
147474135|NCT03716726|531894244|FG000|12 Months Followup|Lost to Follow-up|10|||
147474136|NCT03716726|531894245|FG001|12 Months Followup|Lost to Follow-up|17|||
147474137|NCT01006356|531894249|FG000|Overall Study|Adverse Event|6|||
147474138|NCT01006356|531894249|FG000|Overall Study|Physician Decision|1|||
147474139|NCT01006356|531894249|FG000|Overall Study|Paticipants did not cooperate|6|||
147474140|NCT01006356|531894249|FG000|Overall Study|Withdrawal by Subject|1|||
147474141|NCT01006356|531894249|FG000|Overall Study|Choice by participants|2|||
147474142|NCT01006356|531894249|FG000|Overall Study|Protocol Violation|3|||
147474143|NCT01006356|531894249|FG000|Overall Study|Other|23|||
147474144|NCT01756157|531894251|FG000|First Intervention Period|Withdrawal by Subject|1|||
147474145|NCT01756157|531894252|FG001|First Intervention Period|Withdrawal by Subject|0|||
147474146|NCT01756157|531894251|FG000|First Intervention Period|Lost to Follow-up|0|||
147474147|NCT01756157|531894252|FG001|First Intervention Period|Lost to Follow-up|2|||
147474148|NCT03952130|531894255|FG000|Overall Study|Adverse Event|0|||
147474149|NCT03952130|531894256|FG001|Overall Study|Adverse Event|1|||
147474150|NCT03952130|531894255|FG000|Overall Study|Lost to Follow-up|1|||
147474151|NCT03952130|531894256|FG001|Overall Study|Lost to Follow-up|0|||
147474152|NCT03952130|531894255|FG000|Overall Study|Withdrawal by Subject|1|||
147474153|NCT03952130|531894256|FG001|Overall Study|Withdrawal by Subject|5|||
147474154|NCT02638012|531894258|FG000|Overall Study|Lost to Follow-up|1|||
147474155|NCT02559505|531894260|FG000|Overall Study|Lost to Follow-up|23|||
147621024|NCT00485264|532429632|FG003|Overall Study|Lost to Follow-up|0|||
147621025|NCT00485264|532429633|FG004|Overall Study|Lost to Follow-up|0|||
147621026|NCT00485264|532429634|FG005|Overall Study|Lost to Follow-up|1|||
147621027|NCT00485264|532429629|FG000|Overall Study|Other Reason|3|||
147621028|NCT00485264|532429630|FG001|Overall Study|Other Reason|0|||
147621029|NCT00485264|532429631|FG002|Overall Study|Other Reason|0|||
147621030|NCT00485264|532429632|FG003|Overall Study|Other Reason|0|||
147621031|NCT00485264|532429633|FG004|Overall Study|Other Reason|0|||
147621032|NCT00485264|532429634|FG005|Overall Study|Other Reason|0|||
147621033|NCT03500198|532429635|FG000|Overall Study|Lost to Follow-up|0|||
147621034|NCT03500198|532429636|FG001|Overall Study|Lost to Follow-up|1|||
147474156|NCT02559505|531894261|FG001|Overall Study|Lost to Follow-up|20|||
147474157|NCT02559505|531894260|FG000|Overall Study|Withdrawal by Subject|4|||
147474158|NCT02559505|531894261|FG001|Overall Study|Withdrawal by Subject|2|||
147474159|NCT03523585|531894262|FG000|Overall Study|Progressive Disease|174|||
147621035|NCT01514461|532429637|FG000|Overall Study|Adverse Event|2|||
147666383|NCT03154086|532603933|FG001|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
147666384|NCT03154086|532603934|FG002|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
147621036|NCT01514461|532429638|FG001|Overall Study|Adverse Event|1|||
147621037|NCT01514461|532429639|FG002|Overall Study|Adverse Event|3|||
147621038|NCT01514461|532429637|FG000|Overall Study|Physician Decision|1|||
147621039|NCT01514461|532429638|FG001|Overall Study|Physician Decision|1|||
147474160|NCT03523585|531894263|FG001|Overall Study|Progressive Disease|64|||
147474161|NCT03523585|531894264|FG002|Overall Study|Progressive Disease|77|||
147474162|NCT03523585|531894262|FG000|Overall Study|Adverse Event|74|||
147474163|NCT03523585|531894263|FG001|Overall Study|Adverse Event|5|||
147474164|NCT03523585|531894264|FG002|Overall Study|Adverse Event|9|||
147474165|NCT03523585|531894262|FG000|Overall Study|Withdrawal by Subject|30|||
147474166|NCT03523585|531894263|FG001|Overall Study|Withdrawal by Subject|11|||
147474167|NCT03523585|531894264|FG002|Overall Study|Withdrawal by Subject|6|||
147474168|NCT03523585|531894262|FG000|Overall Study|Clinical Progression|23|||
147474169|NCT03523585|531894263|FG001|Overall Study|Clinical Progression|5|||
147474170|NCT03523585|531894264|FG002|Overall Study|Clinical Progression|10|||
147474171|NCT03523585|531894262|FG000|Overall Study|Death|4|||
147474172|NCT03523585|531894263|FG001|Overall Study|Death|0|||
147474173|NCT03523585|531894264|FG002|Overall Study|Death|1|||
147474174|NCT03523585|531894262|FG000|Overall Study|Physician Decision|2|||
147474175|NCT03523585|531894263|FG001|Overall Study|Physician Decision|1|||
147474176|NCT03523585|531894264|FG002|Overall Study|Physician Decision|0|||
147474177|NCT03523585|531894262|FG000|Overall Study|Lost to Follow-up|1|||
147474178|NCT03523585|531894263|FG001|Overall Study|Lost to Follow-up|0|||
147474179|NCT03523585|531894264|FG002|Overall Study|Lost to Follow-up|0|||
147474180|NCT03523585|531894262|FG000|Overall Study|Miscellaneous|1|||
147474181|NCT03523585|531894263|FG001|Overall Study|Miscellaneous|0|||
147474182|NCT03523585|531894264|FG002|Overall Study|Miscellaneous|0|||
147474183|NCT03523585|531894262|FG000|Overall Study|Protocol Deviation|1|||
147474184|NCT03523585|531894263|FG001|Overall Study|Protocol Deviation|0|||
147474185|NCT03523585|531894264|FG002|Overall Study|Protocol Deviation|1|||
147474186|NCT03523585|531894262|FG000|Overall Study|Randomized But Not Treated|2|||
147474187|NCT03523585|531894263|FG001|Overall Study|Randomized But Not Treated|4|||
147474188|NCT03523585|531894264|FG002|Overall Study|Randomized But Not Treated|3|||
147474189|NCT01473004|531894265|FG000|Overall Study|Incomplete Lobar Treatment|1|||
147474190|NCT01473004|531894266|FG001|Overall Study|Incomplete Lobar Treatment|0|||
147474191|NCT05882890|531894267|FG000|Overall Study|Exclusion was due to a score in xerostomia VASscale < 4.|1|||
147474192|NCT01062399|531894274|FG000|Overall Study|Protocol Violation|0|||
147474193|NCT01062399|531894275|FG001|Overall Study|Protocol Violation|1|||
147474194|NCT01062399|531894276|FG002|Overall Study|Protocol Violation|0|||
147474195|NCT01062399|531894277|FG003|Overall Study|Protocol Violation|6|||
147474196|NCT01062399|531894278|FG004|Overall Study|Protocol Violation|4|||
147474197|NCT00893789|531894299|FG000|Overall Study|Withdrawal by Subject|3|||
147474198|NCT00893789|531894300|FG001|Overall Study|Withdrawal by Subject|1|||
147474199|NCT00893789|531894301|FG002|Overall Study|Withdrawal by Subject|3|||
147474200|NCT00893789|531894302|FG003|Overall Study|Withdrawal by Subject|1|||
147474201|NCT00893789|531894299|FG000|Overall Study|Noncompliance With Study Drug|1|||
147474202|NCT00893789|531894300|FG001|Overall Study|Noncompliance With Study Drug|0|||
147474203|NCT00893789|531894301|FG002|Overall Study|Noncompliance With Study Drug|1|||
147474204|NCT00893789|531894302|FG003|Overall Study|Noncompliance With Study Drug|2|||
147474205|NCT00893789|531894299|FG000|Overall Study|Noncompliance With Study Procedures|1|||
147474206|NCT00893789|531894300|FG001|Overall Study|Noncompliance With Study Procedures|0|||
147474207|NCT00893789|531894301|FG002|Overall Study|Noncompliance With Study Procedures|0|||
147474208|NCT00893789|531894302|FG003|Overall Study|Noncompliance With Study Procedures|0|||
147474209|NCT00893789|531894299|FG000|Overall Study|Taking Excluded Concomitant Medication|1|||
147474210|NCT00893789|531894300|FG001|Overall Study|Taking Excluded Concomitant Medication|0|||
147474211|NCT00893789|531894301|FG002|Overall Study|Taking Excluded Concomitant Medication|1|||
147474212|NCT00893789|531894302|FG003|Overall Study|Taking Excluded Concomitant Medication|0|||
147474213|NCT00893789|531894299|FG000|Overall Study|Adverse Event|0|||
147474214|NCT00893789|531894300|FG001|Overall Study|Adverse Event|2|||
147474215|NCT00893789|531894301|FG002|Overall Study|Adverse Event|1|||
147474216|NCT00893789|531894302|FG003|Overall Study|Adverse Event|5|||
147474217|NCT00893789|531894299|FG000|Overall Study|Protocol Violation|0|||
147474218|NCT00893789|531894300|FG001|Overall Study|Protocol Violation|1|||
147474219|NCT00893789|531894301|FG002|Overall Study|Protocol Violation|1|||
147474220|NCT00893789|531894302|FG003|Overall Study|Protocol Violation|4|||
147474221|NCT00893789|531894299|FG000|Overall Study|Lost to Follow-up|0|||
147474222|NCT00893789|531894300|FG001|Overall Study|Lost to Follow-up|0|||
147474223|NCT00893789|531894301|FG002|Overall Study|Lost to Follow-up|0|||
147474224|NCT00893789|531894302|FG003|Overall Study|Lost to Follow-up|1|||
147474225|NCT02024464|531894303|FG000|Overall Study|Discontinued|5|||
147474226|NCT02024464|531894304|FG001|Overall Study|Discontinued|4|||
147621040|NCT01514461|532429639|FG002|Overall Study|Physician Decision|0|||
147621041|NCT01514461|532429637|FG000|Overall Study|Patient/guardian decision|1|||
147621042|NCT01514461|532429638|FG001|Overall Study|Patient/guardian decision|1|||
147621043|NCT01514461|532429639|FG002|Overall Study|Patient/guardian decision|1|||
147621044|NCT01514461|532429637|FG000|Overall Study|Death|1|||
147621045|NCT01514461|532429638|FG001|Overall Study|Death|0|||
147474227|NCT02024464|531894303|FG000|Overall Study|Missed Visits|1|||
147474228|NCT02024464|531894304|FG001|Overall Study|Missed Visits|0|||
147474229|NCT02024464|531894303|FG000|Overall Study|Lost to Follow-up|4|||
147474230|NCT02024464|531894304|FG001|Overall Study|Lost to Follow-up|7|||
147474231|NCT01845025|531894305|FG000|Overall Study|Adverse Event|6|||
147474232|NCT01845025|531894306|FG001|Overall Study|Adverse Event|3|||
147474233|NCT01845025|531894305|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
147474234|NCT01845025|531894306|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
147474235|NCT01845025|531894305|FG000|Overall Study|Withdrawal by Subject|48|||
147474236|NCT01845025|531894306|FG001|Overall Study|Withdrawal by Subject|44|||
147621046|NCT01514461|532429639|FG002|Overall Study|Death|0|||
147474237|NCT01845025|531894305|FG000|Overall Study|Lost to Follow-up|13|||
147474238|NCT01845025|531894306|FG001|Overall Study|Lost to Follow-up|13|||
147474239|NCT01845025|531894305|FG000|Overall Study|Administrative problems|8|||
147474240|NCT01845025|531894306|FG001|Overall Study|Administrative problems|8|||
147474241|NCT01845025|531894305|FG000|Overall Study|Death|2|||
147474242|NCT01845025|531894306|FG001|Overall Study|Death|0|||
147474243|NCT01845025|531894305|FG000|Overall Study|Protocol deviation|3|||
147474244|NCT01845025|531894306|FG001|Overall Study|Protocol deviation|6|||
147474245|NCT01845025|531894305|FG000|Overall Study|Missing|1|||
147474246|NCT01845025|531894306|FG001|Overall Study|Missing|1|||
147474247|NCT01973283|531894307|FG000|Overall Study|Lost to Follow-up|4|||
147474248|NCT01126619|531894308|FG000|Overall Study|Not eligible for the study|2|||
147474249|NCT01126619|531894308|FG000|Overall Study|Investigator decision|4|||
147474250|NCT01126619|531894308|FG000|Overall Study|Serious adverse event|1|||
147474251|NCT01126619|531894308|FG000|Overall Study|Withdrawal by Subject|9|||
147474252|NCT01126619|531894308|FG000|Overall Study|Non-compliance|1|||
147474253|NCT00947154|531894309|FG000|Overall Study|Lost to Follow-up|1|||
147474254|NCT00900796|531894310|FG000|Phase 1|Lacked sufficient information|4|||
147474255|NCT00900796|531894310|FG000|Phase 1|Missing information at Week 16|7|||
147474256|NCT00900796|531894310|FG000|Between Phase 1 and Phase 2|Responded to therapy- ineligible for Ph2|110|||
147474257|NCT00900796|531894310|FG000|Phase 2|Lost to Follow-up|5|||
147474258|NCT02586805|531894316|FG000|Overall Study|Withdrawal by Subject|3|||
147474259|NCT02586805|531894317|FG001|Overall Study|Withdrawal by Subject|1|||
147474260|NCT02586805|531894318|FG002|Overall Study|Withdrawal by Subject|1|||
147474261|NCT02586805|531894319|FG003|Overall Study|Withdrawal by Subject|2|||
147474262|NCT02586805|531894316|FG000|Overall Study|Adverse Event|2|||
147474263|NCT02586805|531894317|FG001|Overall Study|Adverse Event|0|||
147474264|NCT02586805|531894318|FG002|Overall Study|Adverse Event|1|||
147474265|NCT02586805|531894319|FG003|Overall Study|Adverse Event|0|||
147474266|NCT02586805|531894316|FG000|Overall Study|Lost to Follow-up|0|||
147474267|NCT02586805|531894317|FG001|Overall Study|Lost to Follow-up|0|||
147474268|NCT02586805|531894318|FG002|Overall Study|Lost to Follow-up|1|||
147474269|NCT02586805|531894319|FG003|Overall Study|Lost to Follow-up|0|||
147474270|NCT02586805|531894316|FG000|Overall Study|Physician Decision|1|||
147474271|NCT02586805|531894317|FG001|Overall Study|Physician Decision|0|||
147474272|NCT02586805|531894318|FG002|Overall Study|Physician Decision|0|||
147474273|NCT02586805|531894319|FG003|Overall Study|Physician Decision|0|||
147474274|NCT01859403|531894320|FG000|Primary Endpoint Measure|Lost to Follow-up|0|||
147474275|NCT01859403|531894321|FG001|Primary Endpoint Measure|Lost to Follow-up|2|||
147474276|NCT01859403|531894320|FG000|Primary Endpoint Measure|Withdrawal by Subject|1|||
147474277|NCT01859403|531894321|FG001|Primary Endpoint Measure|Withdrawal by Subject|1|||
147474278|NCT01859403|531894320|FG000|Primary Endpoint Measure|Physician Decision|0|||
147474279|NCT01859403|531894321|FG001|Primary Endpoint Measure|Physician Decision|1|||
147474280|NCT01859403|531894320|FG000|Secondary Endpoint Measure|Withdrawal by Subject|6|||
147474281|NCT01859403|531894321|FG001|Secondary Endpoint Measure|Withdrawal by Subject|8|||
147474282|NCT00811252|531894322|FG000|Overall Study|Adverse Event|6|||
147474283|NCT00811252|531894323|FG001|Overall Study|Adverse Event|10|||
147474284|NCT00811252|531894324|FG002|Overall Study|Adverse Event|15|||
147474285|NCT00811252|531894322|FG000|Overall Study|Lack of Efficacy|7|||
147474286|NCT00811252|531894323|FG001|Overall Study|Lack of Efficacy|2|||
147474287|NCT00811252|531894324|FG002|Overall Study|Lack of Efficacy|0|||
147474288|NCT00811252|531894322|FG000|Overall Study|Protocol Violation|3|||
147474289|NCT00811252|531894323|FG001|Overall Study|Protocol Violation|3|||
147474290|NCT00811252|531894324|FG002|Overall Study|Protocol Violation|2|||
147474291|NCT00811252|531894322|FG000|Overall Study|Withdrawal of Consent|1|||
147474292|NCT00811252|531894323|FG001|Overall Study|Withdrawal of Consent|2|||
147474293|NCT00811252|531894324|FG002|Overall Study|Withdrawal of Consent|2|||
147474294|NCT00811252|531894322|FG000|Overall Study|Lost to Follow-up|0|||
147474295|NCT00811252|531894323|FG001|Overall Study|Lost to Follow-up|0|||
147474296|NCT00811252|531894324|FG002|Overall Study|Lost to Follow-up|2|||
147474297|NCT00811252|531894322|FG000|Overall Study|Administrative or Other Reasons|0|||
147474298|NCT00811252|531894323|FG001|Overall Study|Administrative or Other Reasons|3|||
147474299|NCT00811252|531894324|FG002|Overall Study|Administrative or Other Reasons|2|||
147474300|NCT00813748|531894326|FG000|Skin Test Substudy|Physician Decision|0|||
147474301|NCT00813748|531894327|FG001|Skin Test Substudy|Physician Decision|1|||
147474302|NCT01829048|531894330|FG000|Overall Study|Withdrawal by Subject|0|||
147474303|NCT01829048|531894331|FG001|Overall Study|Withdrawal by Subject|0|||
147474304|NCT01829048|531894332|FG002|Overall Study|Withdrawal by Subject|0|||
147474305|NCT01829048|531894333|FG003|Overall Study|Withdrawal by Subject|2|||
147474306|NCT01829048|531894334|FG004|Overall Study|Withdrawal by Subject|0|||
147474307|NCT01121406|531894335|FG000|Overall Study|Progressive disease RECIST|44|||
147474308|NCT01121406|531894336|FG001|Overall Study|Progressive disease RECIST|28|||
147474309|NCT01121406|531894335|FG000|Overall Study|Wors. or AE of underlying cancer disease|4|||
147474310|NCT01121406|531894336|FG001|Overall Study|Wors. or AE of underlying cancer disease|6|||
147474311|NCT01121406|531894335|FG000|Overall Study|Other AE|3|||
147474312|NCT01121406|531894336|FG001|Overall Study|Other AE|10|||
147474313|NCT01121406|531894335|FG000|Overall Study|Non-compliant with protocol|0|||
147621047|NCT00654095|532429640|FG000|Overall Study|Drop in low density lipoprotein (1)|2|||
147621048|NCT00654095|532429640|FG000|Overall Study|Elevated triglyceride level (2)|1|||
147621049|NCT00654095|532429640|FG000|Overall Study|Elevated alanine aminotransferase (3)|1|||
147621050|NCT00654095|532429640|FG000|Overall Study|Adverse Event|11|||
147621051|NCT00654095|532429640|FG000|Overall Study|Withdrawal by Subject|5|||
147621052|NCT00654095|532429640|FG000|Overall Study|Elevated alanine aminotransferase (4)|7|||
147621053|NCT00654095|532429640|FG000|Overall Study|Adverse reaction did not improve (5)|4|||
147621054|NCT00654095|532429640|FG000|Overall Study|Did not meet inclusion criteria|1|||
147621055|NCT00595621|532429646|FG000|Open Label Run in|Adverse Event|1|||
147621056|NCT00595621|532429647|FG001|Open Label Run in|Adverse Event|0|||
147621057|NCT00595621|532429646|FG000|Open Label Run in|Physician Decision|1|||
147621058|NCT00595621|532429647|FG001|Open Label Run in|Physician Decision|0|||
147621059|NCT00595621|532429646|FG000|Open Label Run in|Withdrawal by Subject|1|||
147621060|NCT00595621|532429647|FG001|Open Label Run in|Withdrawal by Subject|0|||
147621061|NCT00595621|532429646|FG000|Randomization and Study|Adverse Event|2|||
147621062|NCT00595621|532429647|FG001|Randomization and Study|Adverse Event|0|||
147621063|NCT00595621|532429646|FG000|Randomization and Study|Withdrawal by Subject|0|||
147474314|NCT01121406|531894336|FG001|Overall Study|Non-compliant with protocol|2|||
147474315|NCT01121406|531894335|FG000|Overall Study|Lost to Follow-up|0|||
147474316|NCT01121406|531894336|FG001|Overall Study|Lost to Follow-up|1|||
147474317|NCT01121406|531894335|FG000|Overall Study|Refused continuation of study med.|1|||
147474318|NCT01121406|531894336|FG001|Overall Study|Refused continuation of study med.|2|||
147474319|NCT01121406|531894335|FG000|Overall Study|Reason other than specified above|2|||
147474320|NCT01121406|531894336|FG001|Overall Study|Reason other than specified above|6|||
147474321|NCT01121406|531894335|FG000|Overall Study|Not treated|1|||
147474322|NCT01121406|531894336|FG001|Overall Study|Not treated|0|||
147474323|NCT00504257|531894337|FG000|Overall Study|Withdrawal by Subject|2|||
147474324|NCT00504257|531894337|FG000|Overall Study|ineligible histology|2|||
147474325|NCT00892437|531894338|FG000|Randomized Phase|Randomized but not treated|6|||
147474326|NCT00892437|531894339|FG001|Randomized Phase|Randomized but not treated|0|||
147474327|NCT00892437|531894338|FG000|Randomized Phase|Adverse Event|2|||
147474328|NCT00892437|531894339|FG001|Randomized Phase|Adverse Event|2|||
147474329|NCT00892437|531894338|FG000|Randomized Phase|Lost to Follow-up|1|||
147474330|NCT00892437|531894339|FG001|Randomized Phase|Lost to Follow-up|3|||
147474331|NCT00892437|531894338|FG000|Randomized Phase|Investigator's Discretion|1|||
147474332|NCT00892437|531894339|FG001|Randomized Phase|Investigator's Discretion|0|||
147474333|NCT00892437|531894338|FG000|Randomized Phase|Withdrew Consent|1|||
147474334|NCT00892437|531894339|FG001|Randomized Phase|Withdrew Consent|0|||
147474335|NCT00892437|531894338|FG000|Open-Label Extension Phase|Adverse Event|4|||
147474336|NCT00892437|531894339|FG001|Open-Label Extension Phase|Adverse Event|2|||
147474337|NCT00892437|531894338|FG000|Open-Label Extension Phase|Lack of Efficacy|1|||
147474338|NCT00892437|531894339|FG001|Open-Label Extension Phase|Lack of Efficacy|0|||
147474339|NCT00892437|531894338|FG000|Open-Label Extension Phase|Lost to Follow-up|3|||
147474340|NCT00892437|531894339|FG001|Open-Label Extension Phase|Lost to Follow-up|1|||
147474341|NCT00892437|531894338|FG000|Open-Label Extension Phase|Investigator's Discretion|1|||
147474342|NCT00892437|531894339|FG001|Open-Label Extension Phase|Investigator's Discretion|0|||
147474343|NCT00892437|531894338|FG000|Open-Label Extension Phase|Withdrew Consent|3|||
147474344|NCT00892437|531894339|FG001|Open-Label Extension Phase|Withdrew Consent|1|||
147474345|NCT03185130|531894341|FG000|Overall Study|Withdrawal by Subject|0|||
147474346|NCT03185130|531894342|FG001|Overall Study|Withdrawal by Subject|2|||
147474347|NCT02750410|531894344|FG000|Double-Blind Treatment Period|Adverse Event|2|||
147474348|NCT02750410|531894345|FG001|Double-Blind Treatment Period|Adverse Event|2|||
147474349|NCT02750410|531894344|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
147474350|NCT02750410|531894345|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
147474351|NCT02750410|531894344|FG000|Open-Label Extension Period|Adverse Event|5|||
147474352|NCT02750410|531894345|FG001|Open-Label Extension Period|Adverse Event|3|||
147474353|NCT02750410|531894344|FG000|Open-Label Extension Period|Protocol Violation|0|||
147474354|NCT02750410|531894345|FG001|Open-Label Extension Period|Protocol Violation|1|||
147474355|NCT02750410|531894344|FG000|Open-Label Extension Period|Withdrawal by Subject|1|||
147474356|NCT02750410|531894345|FG001|Open-Label Extension Period|Withdrawal by Subject|2|||
147474357|NCT02504541|531894346|FG000|Overall Study|Adverse Event|4|||
147474358|NCT02504541|531894346|FG000|Overall Study|Withdrawal by Subject|4|||
147474359|NCT02504541|531894346|FG000|Overall Study|Lost to Follow-up|1|||
147474360|NCT02504541|531894346|FG000|Overall Study|Met Stopping Criteria|1|||
147474361|NCT02504541|531894346|FG000|Overall Study|Protocol Violation|2|||
147474362|NCT02504541|531894346|FG000|Overall Study|Termination by Sponsor|1|||
147474363|NCT02504541|531894346|FG000|Overall Study|Other|2|||
147474364|NCT02504541|531894346|FG000|Overall Study|Multiple|5|||
147474365|NCT02318602|531894350|FG000|Overall Study|Adverse Event|0|||
147474366|NCT02318602|531894351|FG001|Overall Study|Adverse Event|1|||
147474367|NCT02318602|531894352|FG002|Overall Study|Adverse Event|1|||
147474368|NCT02318602|531894350|FG000|Overall Study|Withdrawal by Subject|0|||
147474369|NCT02318602|531894351|FG001|Overall Study|Withdrawal by Subject|3|||
147474370|NCT02318602|531894352|FG002|Overall Study|Withdrawal by Subject|0|||
147474371|NCT02318602|531894350|FG000|Overall Study|Death|1|||
147474372|NCT02318602|531894351|FG001|Overall Study|Death|0|||
147474373|NCT02318602|531894352|FG002|Overall Study|Death|0|||
147474374|NCT02318602|531894350|FG000|Overall Study|Guardian decision to withdraw|0|||
147474375|NCT02318602|531894351|FG001|Overall Study|Guardian decision to withdraw|0|||
147474376|NCT02318602|531894352|FG002|Overall Study|Guardian decision to withdraw|1|||
147474377|NCT02580058|531894353|FG000|Overall Study|Adverse Event|16|||
147474378|NCT02580058|531894354|FG001|Overall Study|Adverse Event|30|||
147474379|NCT02580058|531894355|FG002|Overall Study|Adverse Event|20|||
147474380|NCT02580058|531894353|FG000|Overall Study|Death|4|||
147474381|NCT02580058|531894354|FG001|Overall Study|Death|4|||
147474382|NCT02580058|531894355|FG002|Overall Study|Death|5|||
147474383|NCT02580058|531894353|FG000|Overall Study|Physician Decision|1|||
147474384|NCT02580058|531894354|FG001|Overall Study|Physician Decision|3|||
147474385|NCT02580058|531894355|FG002|Overall Study|Physician Decision|11|||
147474386|NCT02580058|531894353|FG000|Overall Study|Other|5|||
147474387|NCT02580058|531894354|FG001|Overall Study|Other|1|||
147474388|NCT02580058|531894355|FG002|Overall Study|Other|3|||
147474389|NCT02580058|531894353|FG000|Overall Study|Withdrawal by Subject|4|||
147474390|NCT02580058|531894354|FG001|Overall Study|Withdrawal by Subject|7|||
147474391|NCT02580058|531894355|FG002|Overall Study|Withdrawal by Subject|31|||
147474392|NCT02580058|531894353|FG000|Overall Study|Global Deterioration of Health Status|19|||
147474393|NCT02580058|531894354|FG001|Overall Study|Global Deterioration of Health Status|18|||
147474394|NCT02580058|531894355|FG002|Overall Study|Global Deterioration of Health Status|24|||
147474395|NCT02580058|531894353|FG000|Overall Study|No Longer Meets Eligibility Criteria|1|||
147474396|NCT02580058|531894354|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
147474397|NCT02580058|531894355|FG002|Overall Study|No Longer Meets Eligibility Criteria|2|||
147474398|NCT02580058|531894353|FG000|Overall Study|Progressive Disease|137|||
147474399|NCT02580058|531894354|FG001|Overall Study|Progressive Disease|125|||
147474400|NCT02580058|531894355|FG002|Overall Study|Progressive Disease|94|||
147474401|NCT02580058|531894353|FG000|Overall Study|Non-Compliance With Study Drug|1|||
147474402|NCT02580058|531894354|FG001|Overall Study|Non-Compliance With Study Drug|0|||
147474403|NCT02580058|531894355|FG002|Overall Study|Non-Compliance With Study Drug|0|||
147474404|NCT00730236|531894356|FG000|Overall Study|Adverse Event|4|||
147474405|NCT00730236|531894356|FG000|Overall Study|Withdrawal by Subject|1|||
147474406|NCT00730236|531894356|FG000|Overall Study|Non-compliance|1|||
147474407|NCT03486314|531894358|FG000|Part A|Adverse Event|1|||
147474408|NCT03486314|531894359|FG001|Part A|Adverse Event|0|||
147474409|NCT03486314|531894360|FG002|Part A|Adverse Event|0|||
147474410|NCT03486314|531894358|FG000|Part A|Symptomatic Deterioration|2|||
147474411|NCT03486314|531894359|FG001|Part A|Symptomatic Deterioration|0|||
147474412|NCT03486314|531894360|FG002|Part A|Symptomatic Deterioration|0|||
147474413|NCT00465569|531894361|FG000|Overall Study|persistent eczema during dose escalation|1|||
147474414|NCT00465569|531894362|FG001|Overall Study|persistent eczema during dose escalation|0|||
147474415|NCT01985321|531894364|FG000|Overall Study|Protocol Violation|4|||
147474416|NCT01985321|531894365|FG001|Overall Study|Protocol Violation|3|||
147474417|NCT01985321|531894364|FG000|Overall Study|Withdrawal by Subject|1|||
147474418|NCT01985321|531894365|FG001|Overall Study|Withdrawal by Subject|0|||
147474419|NCT01985321|531894364|FG000|Overall Study|Lost to Follow-up|5|||
147474420|NCT01985321|531894365|FG001|Overall Study|Lost to Follow-up|2|||
147474421|NCT01985321|531894364|FG000|Overall Study|Subject treated wrong type of sore|1|||
147474422|NCT01985321|531894365|FG001|Overall Study|Subject treated wrong type of sore|0|||
147474423|NCT00482001|531894366|FG000|Overall Study|Protocol Violation|1|||
147474424|NCT00482001|531894367|FG001|Overall Study|Protocol Violation|1|||
147474425|NCT03826914|531894368|FG000|Overall Study|Withdrawal by Subject|1|||
147474426|NCT03826914|531894369|FG001|Overall Study|Withdrawal by Subject|1|||
147474427|NCT05139030|531894376|FG000|Overall Study|Withdrawal by Subject|1|||
147474428|NCT05139030|531894377|FG001|Overall Study|Withdrawal by Subject|3|||
147666385|NCT03154086|532603935|FG003|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
147666386|NCT03154086|532603936|FG004|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
147666387|NCT03154086|532603937|FG005|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
147666388|NCT03154086|532603938|FG006|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
147666389|NCT03154086|532603939|FG007|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
147666390|NCT03154086|532603940|FG008|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
147666391|NCT03154086|532603941|FG009|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
147666392|NCT03154086|532603942|FG010|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
147666393|NCT03154086|532603943|FG011|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
147666394|NCT03154086|532603944|FG012|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
147474429|NCT05139030|531894376|FG000|Overall Study|Adverse Event|0|||
147474430|NCT05139030|531894377|FG001|Overall Study|Adverse Event|1|||
147474431|NCT05139030|531894376|FG000|Overall Study|Failure to meet continuation criteria|0|||
147474432|NCT05139030|531894377|FG001|Overall Study|Failure to meet continuation criteria|1|||
147474433|NCT00816036|531894382|FG000|Overall Study|Death|47|||
147474434|NCT00816036|531894383|FG001|Overall Study|Death|28|||
147474435|NCT00816036|531894382|FG000|Overall Study|Lost to Follow-up|75|||
147666395|NCT03154086|532603945|FG013|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
147666396|NCT03154086|532603946|FG014|Part A: Cohort1 Period4 (Up to 3 Days)|Protocol Violation|0|||
147666397|NCT03154086|532603932|FG000|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
147666398|NCT03154086|532603933|FG001|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
147666399|NCT03154086|532603934|FG002|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
147666400|NCT03154086|532603935|FG003|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
147666401|NCT03154086|532603936|FG004|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
147666402|NCT03154086|532603937|FG005|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
147666403|NCT03154086|532603938|FG006|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
147666404|NCT03154086|532603939|FG007|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
147666405|NCT03154086|532603940|FG008|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|1|||
147666406|NCT03154086|532603941|FG009|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
147666407|NCT03154086|532603942|FG010|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
147666408|NCT03154086|532603943|FG011|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
147474436|NCT00816036|531894383|FG001|Overall Study|Lost to Follow-up|57|||
147474437|NCT00816036|531894382|FG000|Overall Study|Withdrawal by Subject|54|||
147474438|NCT00816036|531894383|FG001|Overall Study|Withdrawal by Subject|23|||
147474439|NCT01299025|531894384|FG000|Overall Study|Withdrawal by Subject|2|||
147474440|NCT01299025|531894385|FG001|Overall Study|Withdrawal by Subject|1|||
147474441|NCT01299025|531894384|FG000|Overall Study|Lost to Follow-up|1|||
147474442|NCT01299025|531894385|FG001|Overall Study|Lost to Follow-up|0|||
147474443|NCT00004980|531894386|FG000|Overall Study|Withdrawal by Subject|1|||
147474444|NCT00004980|531894387|FG001|Overall Study|Withdrawal by Subject|0|||
147474445|NCT00004980|531894386|FG000|Overall Study|memory difficulties|1|||
147474446|NCT00004980|531894387|FG001|Overall Study|memory difficulties|1|||
147474447|NCT00004980|531894386|FG000|Overall Study|Physician Decision|0|||
147474448|NCT00004980|531894387|FG001|Overall Study|Physician Decision|1|||
147474449|NCT01624194|531894388|FG000|Overall Study|Lost to Follow-up|1|||
147474450|NCT01624194|531894389|FG001|Overall Study|Lost to Follow-up|0|||
147474451|NCT01624194|531894388|FG000|Overall Study|Withdrawal by Subject|1|||
147474452|NCT01624194|531894389|FG001|Overall Study|Withdrawal by Subject|0|||
147474453|NCT03212261|531894390|FG000|Overall Study|Became ineligible d/t tech|2|||
147474454|NCT03212261|531894390|FG000|Overall Study|Tech Trouble- No first study visit|1|||
147474455|NCT03212261|531894390|FG000|Overall Study|Lost to Follow-up|7|||
147474456|NCT03212261|531894390|FG000|Overall Study|Family Emergency|1|||
147474457|NCT03212261|531894390|FG000|Overall Study|Too busy/ No time|5|||
147474458|NCT00820040|531894391|FG000|Overall Study|Death|1|||
147474459|NCT00820040|531894391|FG000|Overall Study|Sponsor terminated study|1|||
147474460|NCT00820040|531894391|FG000|Overall Study|Screen failure|1|||
147474461|NCT01259466|531894396|FG000|Overall Study|Withdrawal by Subject|1|||
147474462|NCT01259466|531894397|FG001|Overall Study|Withdrawal by Subject|9|||
147474463|NCT02296840|531894398|FG000|Overall Study|Adverse Event|1|||
147474464|NCT02296840|531894399|FG001|Overall Study|Adverse Event|1|||
147474465|NCT02296840|531894398|FG000|Overall Study|Protocol Violation|2|||
147474466|NCT02296840|531894399|FG001|Overall Study|Protocol Violation|1|||
147474467|NCT02296840|531894398|FG000|Overall Study|Lost to Follow-up|6|||
147474468|NCT02296840|531894399|FG001|Overall Study|Lost to Follow-up|17|||
147474469|NCT00814710|531894404|FG000|Overall Study|Adverse Event|1|||
147474470|NCT00814710|531894405|FG001|Overall Study|Adverse Event|0|||
147474471|NCT00814710|531894404|FG000|Overall Study|Lost to Follow-up|7|||
147474472|NCT00814710|531894405|FG001|Overall Study|Lost to Follow-up|3|||
147474473|NCT03885284|531894406|FG000|Overall Study|Disease Progression|1|||
147474474|NCT03885284|531894407|FG001|Overall Study|Disease Progression|3|||
147474475|NCT03885284|531894406|FG000|Overall Study|Physician Decision|0|||
147474476|NCT03885284|531894407|FG001|Overall Study|Physician Decision|1|||
147474477|NCT00002850|531894412|FG000|Overall Study|Death|4|||
147474478|NCT00002850|531894413|FG001|Overall Study|Death|1|||
147474479|NCT00002850|531894414|FG002|Overall Study|Death|3|||
147474480|NCT00002850|531894412|FG000|Overall Study|Protocol Violation|1|||
147474481|NCT00002850|531894413|FG001|Overall Study|Protocol Violation|0|||
147474482|NCT00002850|531894414|FG002|Overall Study|Protocol Violation|1|||
147474483|NCT00002850|531894412|FG000|Overall Study|Withdrawal by Subject|0|||
147474484|NCT00002850|531894413|FG001|Overall Study|Withdrawal by Subject|1|||
147474485|NCT00002850|531894414|FG002|Overall Study|Withdrawal by Subject|0|||
147474486|NCT02932267|531894415|FG000|Overall Study|Withdrawal by Subject|3|||
147474487|NCT02932267|531894415|FG000|Overall Study|Lost to Follow-up|4|||
147474488|NCT02932267|531894415|FG000|Overall Study|Pregnancy|1|||
147474489|NCT03476239|531894416|FG000|Overall Study|Withdrawal by Subject|10|||
147474490|NCT03476239|531894416|FG000|Overall Study|Death|80|||
147474491|NCT03476239|531894416|FG000|Overall Study|Lost to Follow-up|8|||
147474492|NCT05405166|531896181|FG000|Overall Study|Death|49|||
147474493|NCT05405166|531896182|FG001|Overall Study|Death|50|||
147474494|NCT05405166|531896181|FG000|Overall Study|Withdrawal by Subject|10|||
147474495|NCT05405166|531896182|FG001|Overall Study|Withdrawal by Subject|3|||
147474496|NCT05405166|531896181|FG000|Overall Study|Ongoing at the time of PCD|209|||
147474497|NCT05405166|531896182|FG001|Overall Study|Ongoing at the time of PCD|210|||
147474498|NCT01386385|531896183|FG000|Phase I 40mg: Concurrent CRT|Progression/relapse|1|||
147474499|NCT01386385|531896184|FG001|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
147474500|NCT01386385|531896185|FG002|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
147474501|NCT01386385|531896186|FG003|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
147474502|NCT01386385|531896187|FG004|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
147474503|NCT01386385|531896188|FG005|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
147474504|NCT01386385|531896189|FG006|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
147474505|NCT01386385|531896190|FG007|Phase I 40mg: Concurrent CRT|Progression/relapse|0|||
147474506|NCT01386385|531896183|FG000|Phase I 40mg: Concurrent CRT|Other- not protocol specified|1|||
147474507|NCT01386385|531896184|FG001|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
147474508|NCT01386385|531896185|FG002|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
147474509|NCT01386385|531896186|FG003|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
147474510|NCT01386385|531896187|FG004|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
147474511|NCT01386385|531896188|FG005|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
147474512|NCT01386385|531896189|FG006|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
147474513|NCT01386385|531896190|FG007|Phase I 40mg: Concurrent CRT|Other- not protocol specified|0|||
147474514|NCT01386385|531896183|FG000|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
147474515|NCT01386385|531896184|FG001|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
147474516|NCT01386385|531896185|FG002|Phase I 80mg: Concurrent CRT|Adverse Event|2|||
147474517|NCT01386385|531896186|FG003|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
147474518|NCT01386385|531896187|FG004|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
147474519|NCT01386385|531896188|FG005|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
147474520|NCT01386385|531896189|FG006|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
147474521|NCT01386385|531896190|FG007|Phase I 80mg: Concurrent CRT|Adverse Event|0|||
147474522|NCT01386385|531896183|FG000|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
147474523|NCT01386385|531896184|FG001|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
147474524|NCT01386385|531896185|FG002|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
147474525|NCT01386385|531896186|FG003|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
147474526|NCT01386385|531896187|FG004|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|1|||
147474527|NCT01386385|531896188|FG005|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
147474528|NCT01386385|531896189|FG006|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
147474529|NCT01386385|531896190|FG007|Phase I 120mg: Concurrent CRT|Refusal unrelated to AE|0|||
147474530|NCT01386385|531896183|FG000|Phase II Concurrent CRT|Adverse Event|0|||
147474531|NCT01386385|531896184|FG001|Phase II Concurrent CRT|Adverse Event|0|||
147474532|NCT01386385|531896185|FG002|Phase II Concurrent CRT|Adverse Event|0|||
147474533|NCT01386385|531896186|FG003|Phase II Concurrent CRT|Adverse Event|0|||
147474534|NCT01386385|531896187|FG004|Phase II Concurrent CRT|Adverse Event|0|||
147474535|NCT01386385|531896188|FG005|Phase II Concurrent CRT|Adverse Event|0|||
147474536|NCT01386385|531896189|FG006|Phase II Concurrent CRT|Adverse Event|3|||
147474537|NCT01386385|531896190|FG007|Phase II Concurrent CRT|Adverse Event|3|||
147474538|NCT01386385|531896183|FG000|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
147474539|NCT01386385|531896184|FG001|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
147474540|NCT01386385|531896185|FG002|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
147474541|NCT01386385|531896186|FG003|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
147474542|NCT01386385|531896187|FG004|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
147474543|NCT01386385|531896188|FG005|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
147474544|NCT01386385|531896189|FG006|Phase II Concurrent CRT|Refusal unrelated to AE|3|||
147474545|NCT01386385|531896190|FG007|Phase II Concurrent CRT|Refusal unrelated to AE|0|||
147474546|NCT01386385|531896183|FG000|Phase II: Consolidation Therapy|Adverse Event|0|||
147474547|NCT01386385|531896184|FG001|Phase II: Consolidation Therapy|Adverse Event|0|||
147474548|NCT01386385|531896185|FG002|Phase II: Consolidation Therapy|Adverse Event|0|||
147474549|NCT01386385|531896186|FG003|Phase II: Consolidation Therapy|Adverse Event|0|||
147474550|NCT01386385|531896187|FG004|Phase II: Consolidation Therapy|Adverse Event|0|||
147474551|NCT01386385|531896188|FG005|Phase II: Consolidation Therapy|Adverse Event|0|||
147474552|NCT01386385|531896189|FG006|Phase II: Consolidation Therapy|Adverse Event|2|||
147474553|NCT01386385|531896190|FG007|Phase II: Consolidation Therapy|Adverse Event|1|||
147474554|NCT01386385|531896183|FG000|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
147474555|NCT01386385|531896184|FG001|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
147474556|NCT01386385|531896185|FG002|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
147474557|NCT01386385|531896186|FG003|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
147474558|NCT01386385|531896187|FG004|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
147474559|NCT01386385|531896188|FG005|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
147474560|NCT01386385|531896189|FG006|Phase II: Consolidation Therapy|Refusal unrelated to AE|2|||
147474561|NCT01386385|531896190|FG007|Phase II: Consolidation Therapy|Refusal unrelated to AE|0|||
147474562|NCT01386385|531896183|FG000|Phase II: Consolidation Therapy|Progression/relapse|0|||
147474563|NCT01386385|531896184|FG001|Phase II: Consolidation Therapy|Progression/relapse|0|||
147474564|NCT01386385|531896185|FG002|Phase II: Consolidation Therapy|Progression/relapse|0|||
147474565|NCT01386385|531896186|FG003|Phase II: Consolidation Therapy|Progression/relapse|0|||
147474566|NCT01386385|531896187|FG004|Phase II: Consolidation Therapy|Progression/relapse|0|||
147621064|NCT00595621|532429647|FG001|Randomization and Study|Withdrawal by Subject|1|||
147621065|NCT02502149|532429649|FG000|Intermediate|Discontinued prematurely|1|||
147621066|NCT02502149|532429650|FG001|Intermediate|Discontinued prematurely|0|||
147621067|NCT02502149|532429651|FG002|Intermediate|Discontinued prematurely|0|||
147621068|NCT02502149|532429652|FG003|Intermediate|Discontinued prematurely|0|||
147621069|NCT02502149|532429653|FG004|Intermediate|Discontinued prematurely|0|||
147621070|NCT02548832|532429654|FG000|Overall Study|Lost to Follow-up|2|||
147621071|NCT02548832|532429655|FG001|Overall Study|Lost to Follow-up|2|||
147621072|NCT02548832|532429656|FG002|Overall Study|Lost to Follow-up|2|||
147621073|NCT02968576|532429657|FG000|Overall Study|Pregnancy|0|||
147621074|NCT02968576|532429658|FG001|Overall Study|Pregnancy|1|||
147621075|NCT01998919|532429659|FG000|Overall Study|Death|2|||
147621076|NCT01998919|532429660|FG001|Overall Study|Death|2|||
147621077|NCT01998919|532429659|FG000|Overall Study|Adverse Event|0|||
147621078|NCT01998919|532429660|FG001|Overall Study|Adverse Event|5|||
147474567|NCT01386385|531896188|FG005|Phase II: Consolidation Therapy|Progression/relapse|0|||
147474568|NCT01386385|531896189|FG006|Phase II: Consolidation Therapy|Progression/relapse|1|||
147474569|NCT01386385|531896190|FG007|Phase II: Consolidation Therapy|Progression/relapse|1|||
147474570|NCT01084252|531896191|FG000|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
147474571|NCT01084252|531896192|FG001|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
147474572|NCT01084252|531896193|FG002|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
147474573|NCT01084252|531896194|FG003|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
147474574|NCT01084252|531896195|FG004|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
147474575|NCT01084252|531896196|FG005|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
147474576|NCT01084252|531896197|FG006|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
147474577|NCT01084252|531896198|FG007|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
147474578|NCT01084252|531896199|FG008|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
147474579|NCT01084252|531896200|FG009|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
147474580|NCT01084252|531896201|FG010|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
147474581|NCT01084252|531896202|FG011|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
147474582|NCT01084252|531896203|FG012|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|1|||
147474583|NCT01084252|531896204|FG013|Phase 2 Stage 2 (301 Weeks)|Enrolled, but not treated|0|||
147474584|NCT02579603|531896210|FG000|Overall Study|Not treated|1|||
147474585|NCT02579603|531896211|FG001|Overall Study|Not treated|0|||
147474586|NCT02579603|531896210|FG000|Overall Study|Adverse Event|2|||
147474587|NCT02579603|531896211|FG001|Overall Study|Adverse Event|2|||
147474588|NCT02579603|531896210|FG000|Overall Study|Other than stated|1|||
147474589|NCT02579603|531896211|FG001|Overall Study|Other than stated|0|||
147474590|NCT00469079|531896212|FG000|Overall Study|Lack of Efficacy|3|||
147474591|NCT00469079|531896213|FG001|Overall Study|Lack of Efficacy|8|||
147474592|NCT00469079|531896214|FG002|Overall Study|Lack of Efficacy|5|||
147474593|NCT00469079|531896212|FG000|Overall Study|Adverse Event|1|||
147474594|NCT00469079|531896213|FG001|Overall Study|Adverse Event|3|||
147474595|NCT00469079|531896214|FG002|Overall Study|Adverse Event|2|||
147474596|NCT00469079|531896212|FG000|Overall Study|Lost to Follow-up|4|||
147474597|NCT00469079|531896213|FG001|Overall Study|Lost to Follow-up|8|||
147474598|NCT00469079|531896214|FG002|Overall Study|Lost to Follow-up|10|||
147474599|NCT00469079|531896212|FG000|Overall Study|Withdrawal by Subject|1|||
147474600|NCT00469079|531896213|FG001|Overall Study|Withdrawal by Subject|2|||
147474601|NCT00469079|531896214|FG002|Overall Study|Withdrawal by Subject|2|||
147474602|NCT00469079|531896212|FG000|Overall Study|Ineligible|0|||
147474603|NCT00469079|531896213|FG001|Overall Study|Ineligible|1|||
147474604|NCT00469079|531896214|FG002|Overall Study|Ineligible|0|||
147474605|NCT02981472|531896215|FG000|Pre-Treatment Period|Participant withdrew consent|2|||
147474606|NCT02981472|531896216|FG001|Pre-Treatment Period|Participant withdrew consent|1|||
147474607|NCT02981472|531896215|FG000|Pre-Treatment Period|Participant no longer meets study criteria|1|||
147474608|NCT02981472|531896216|FG001|Pre-Treatment Period|Participant no longer meets study criteria|0|||
147474609|NCT02981472|531896215|FG000|Treatment Period|Adverse Event|6|||
147474610|NCT02981472|531896216|FG001|Treatment Period|Adverse Event|1|||
147474611|NCT02981472|531896215|FG000|Treatment Period|Participant withdrew consent|1|||
147474612|NCT02981472|531896216|FG001|Treatment Period|Participant withdrew consent|0|||
147474613|NCT02981472|531896215|FG000|Treatment Period|Lost to Follow-up|0|||
147474614|NCT02981472|531896216|FG001|Treatment Period|Lost to Follow-up|1|||
147474615|NCT03199911|531896222|FG000|Overall Study|Lost to Follow-up|5|||
147621079|NCT01998919|532429659|FG000|Overall Study|Disease progression|31|||
147474616|NCT03199911|531896223|FG001|Overall Study|Lost to Follow-up|5|||
147474617|NCT03199911|531896222|FG000|Overall Study|Did not proceed with surgery|2|||
147474618|NCT03199911|531896223|FG001|Overall Study|Did not proceed with surgery|1|||
147474619|NCT05309668|531896227|FG000|Overall Study|Ongoing at data cut-off|14|||
147474620|NCT05309668|531896228|FG001|Overall Study|Ongoing at data cut-off|17|||
147621080|NCT01998919|532429660|FG001|Overall Study|Disease progression|22|||
147621081|NCT01998919|532429659|FG000|Overall Study|Withdrawal by Subject|2|||
147621082|NCT01998919|532429660|FG001|Overall Study|Withdrawal by Subject|4|||
147621083|NCT01998919|532429659|FG000|Overall Study|Lost to Follow-up|2|||
147474621|NCT05309668|531896229|FG002|Overall Study|Ongoing at data cut-off|4|||
147474622|NCT01584024|531896230|FG000|Overall Study|Lost to Follow-up|10|||
147474623|NCT01584024|531896230|FG000|Overall Study|Withdrawal by Subject|3|||
147474624|NCT00613314|531896231|FG000|Overall Study|Adverse Event|5|||
147474625|NCT00613314|531896231|FG000|Overall Study|Protocol Violation|14|||
147474626|NCT00613314|531896231|FG000|Overall Study|Lost to Follow-up|46|||
147474627|NCT00613314|531896231|FG000|Overall Study|Other reason not defined above|90|||
147474628|NCT02465034|531896237|FG000|Overall Study|Withdrawal by Subject|1|||
147474629|NCT02465034|531896238|FG001|Overall Study|Withdrawal by Subject|1|||
147474630|NCT02465034|531896237|FG000|Overall Study|Screen fail|2|||
147474631|NCT02465034|531896238|FG001|Overall Study|Screen fail|0|||
147474632|NCT02465034|531896237|FG000|Overall Study|Could not be scheduled for study visit|0|||
147474633|NCT02465034|531896238|FG001|Overall Study|Could not be scheduled for study visit|5|||
147474634|NCT02401256|531896241|FG000|Overall Study|Adverse Event|5|||
147474635|NCT02401256|531896241|FG000|Overall Study|Withdrawal by Subject|12|||
147474636|NCT04419506|531896242|FG000|Overall Study|Adverse Event|0|||
147474637|NCT04419506|531896243|FG001|Overall Study|Adverse Event|10|||
147474638|NCT04419506|531896244|FG002|Overall Study|Adverse Event|0|||
147474639|NCT04419506|531896245|FG003|Overall Study|Adverse Event|3|||
147474640|NCT04419506|531896242|FG000|Overall Study|Withdrawal by Subject|0|||
147474641|NCT04419506|531896243|FG001|Overall Study|Withdrawal by Subject|0|||
147474642|NCT04419506|531896244|FG002|Overall Study|Withdrawal by Subject|0|||
147474643|NCT04419506|531896245|FG003|Overall Study|Withdrawal by Subject|1|||
147474644|NCT04419506|531896242|FG000|Overall Study|poor-compliance|0|||
147474645|NCT04419506|531896243|FG001|Overall Study|poor-compliance|0|||
147474646|NCT04419506|531896244|FG002|Overall Study|poor-compliance|0|||
147474647|NCT04419506|531896245|FG003|Overall Study|poor-compliance|1|||
147474648|NCT01021007|531896249|FG000|Overall Study|Lost to Follow-up|1|||
147474649|NCT01021007|531896250|FG001|Overall Study|Lost to Follow-up|1|||
147474650|NCT01021007|531896249|FG000|Overall Study|Adverse Event|1|||
147474651|NCT01021007|531896250|FG001|Overall Study|Adverse Event|3|||
147474652|NCT03293030|531896255|FG000|Overall Study|Withdrawal by Subject|3|||
147474653|NCT04899271|531896256|FG000|Overall Study|Lost to Follow-up|1|||
147474654|NCT04899271|531896257|FG001|Overall Study|Lost to Follow-up|0|||
147474655|NCT04899271|531896256|FG000|Overall Study|Subject request/consent withdrawal|2|||
147474656|NCT04899271|531896257|FG001|Overall Study|Subject request/consent withdrawal|0|||
147474657|NCT02388776|531896258|FG000|Overall Study|Death|1|||
147474658|NCT02388776|531896258|FG000|Overall Study|Lost to Follow-up|1|||
147474659|NCT00542828|531896261|FG000|Overall Study|Physician Decision|1|||
147474660|NCT00542828|531896261|FG000|Overall Study|Need for Prohibited Treatment|3|||
147474661|NCT00542828|531896261|FG000|Overall Study|Study Prematurely Discontinued|7|||
147474662|NCT00542828|531896261|FG000|Overall Study|Did Not Receive Thymoglobulin Treatment|2|||
147474663|NCT00095303|531896262|FG000|Main Study|Lost to Follow-up|91|||
147474664|NCT00095303|531896263|FG001|Main Study|Lost to Follow-up|87|||
147474665|NCT00095303|531896262|FG000|Follow Up Study|Lost to Follow-up|59|||
147474666|NCT00095303|531896263|FG001|Follow Up Study|Lost to Follow-up|58|||
147474667|NCT01364467|531896266|FG000|Overall Study|Lost to Follow-up|1|||
147474668|NCT01364467|531896267|FG001|Overall Study|Lost to Follow-up|2|||
147474669|NCT03228186|531896268|FG000|Overall Study|Patient never started treatment|1|||
147474670|NCT01634243|531896269|FG000|Overall Study|Adverse Event|5|||
147474671|NCT01634243|531896270|FG001|Overall Study|Adverse Event|5|||
147474672|NCT01634243|531896269|FG000|Overall Study|Lack of Efficacy|1|||
147474673|NCT01634243|531896270|FG001|Overall Study|Lack of Efficacy|0|||
147474674|NCT03953118|531896273|FG000|Overall Study|Study terminated due to lack of funding prior to data collection for for outcomes and adverse events|1|||
147474675|NCT03953118|531896274|FG001|Overall Study|Study terminated due to lack of funding prior to data collection for for outcomes and adverse events|1|||
147474676|NCT04283461|531896275|FG000|Overall Study|Enrolled in separate trial|0|||
147474677|NCT04283461|531896276|FG001|Overall Study|Enrolled in separate trial|0|||
147474678|NCT04283461|531896277|FG002|Overall Study|Enrolled in separate trial|8|||
147474679|NCT04283461|531896278|FG003|Overall Study|Enrolled in separate trial|13|||
147474680|NCT04283461|531896279|FG004|Overall Study|Enrolled in separate trial|12|||
147474681|NCT04283461|531896280|FG005|Overall Study|Enrolled in separate trial|0|||
147474682|NCT04283461|531896281|FG006|Overall Study|Enrolled in separate trial|0|||
147474683|NCT04283461|531896282|FG007|Overall Study|Enrolled in separate trial|8|||
147474684|NCT04283461|531896283|FG008|Overall Study|Enrolled in separate trial|0|||
147474685|NCT04283461|531896284|FG009|Overall Study|Enrolled in separate trial|0|||
147474686|NCT04283461|531896285|FG010|Overall Study|Enrolled in separate trial|0|||
147474687|NCT04283461|531896286|FG011|Overall Study|Enrolled in separate trial|7|||
147474688|NCT04283461|531896287|FG012|Overall Study|Enrolled in separate trial|0|||
147474689|NCT05490771|531896288|FG000|Overall Study|Disease progression|18|||
147474690|NCT05490771|531896288|FG000|Overall Study|Adverse Event|3|||
147474691|NCT05490771|531896288|FG000|Overall Study|Other complicating disease|1|||
147474692|NCT05490771|531896288|FG000|Overall Study|Withdrawal by Subject|3|||
147474693|NCT05490771|531896288|FG000|Overall Study|Physician Decision|1|||
147474694|NCT05490771|531896288|FG000|Overall Study|Still on treatment|2|||
147474695|NCT05490771|531896288|FG000|Overall Study|Never start protocol therapy|5|||
147474696|NCT05490771|531896288|FG000|Overall Study|Ineligible|2|||
147621084|NCT01998919|532429660|FG001|Overall Study|Lost to Follow-up|0|||
147621085|NCT01998919|532429659|FG000|Overall Study|Other|5|||
147621086|NCT01998919|532429660|FG001|Overall Study|Other|2|||
147621087|NCT01068860|532429661|FG000|Overall Study|Withdrawal by Subject|0|||
147621088|NCT01068860|532429662|FG001|Overall Study|Withdrawal by Subject|0|||
147621089|NCT01068860|532429663|FG002|Overall Study|Withdrawal by Subject|0|||
147621090|NCT01068860|532429664|FG003|Overall Study|Withdrawal by Subject|0|||
147621091|NCT01068860|532429665|FG004|Overall Study|Withdrawal by Subject|0|||
147621092|NCT01068860|532429666|FG005|Overall Study|Withdrawal by Subject|2|||
147621093|NCT01068860|532429667|FG006|Overall Study|Withdrawal by Subject|0|||
147621094|NCT01068860|532429668|FG007|Overall Study|Withdrawal by Subject|0|||
147621095|NCT01068860|532429669|FG008|Overall Study|Withdrawal by Subject|0|||
147621096|NCT01068860|532429670|FG009|Overall Study|Withdrawal by Subject|3|||
147621097|NCT01068860|532429661|FG000|Overall Study|Administrative problems; misrandomized|0|||
147621098|NCT01068860|532429662|FG001|Overall Study|Administrative problems; misrandomized|0|||
147621099|NCT01068860|532429663|FG002|Overall Study|Administrative problems; misrandomized|0|||
147621100|NCT01068860|532429664|FG003|Overall Study|Administrative problems; misrandomized|1|||
147621101|NCT01068860|532429665|FG004|Overall Study|Administrative problems; misrandomized|0|||
147621102|NCT01068860|532429666|FG005|Overall Study|Administrative problems; misrandomized|0|||
147621103|NCT01068860|532429667|FG006|Overall Study|Administrative problems; misrandomized|0|||
147621104|NCT01068860|532429668|FG007|Overall Study|Administrative problems; misrandomized|0|||
147621105|NCT01068860|532429669|FG008|Overall Study|Administrative problems; misrandomized|0|||
147621106|NCT01068860|532429670|FG009|Overall Study|Administrative problems; misrandomized|1|||
147621107|NCT01068860|532429661|FG000|Overall Study|Lost to Follow-up|0|||
147621108|NCT01068860|532429662|FG001|Overall Study|Lost to Follow-up|1|||
147621109|NCT01068860|532429663|FG002|Overall Study|Lost to Follow-up|0|||
147621110|NCT01068860|532429664|FG003|Overall Study|Lost to Follow-up|0|||
147621111|NCT01068860|532429665|FG004|Overall Study|Lost to Follow-up|0|||
147621112|NCT01068860|532429666|FG005|Overall Study|Lost to Follow-up|0|||
147621113|NCT01068860|532429667|FG006|Overall Study|Lost to Follow-up|0|||
147621114|NCT01068860|532429668|FG007|Overall Study|Lost to Follow-up|0|||
147621115|NCT01068860|532429669|FG008|Overall Study|Lost to Follow-up|0|||
147621116|NCT01068860|532429670|FG009|Overall Study|Lost to Follow-up|0|||
147621117|NCT05263908|532429671|FG000|Overall Study|No informed consent for publication of study results|397|||
147621118|NCT05263908|532429671|FG000|Overall Study|CRF not collected|1|||
147621119|NCT01433471|532429674|FG000|Overall Study|Withdrawal by Subject|0|||
147621120|NCT01433471|532429675|FG001|Overall Study|Withdrawal by Subject|1|||
147621121|NCT03711188|532429676|FG000|Overall Study|Disease progression|11|||
147621122|NCT03711188|532429676|FG000|Overall Study|Adverse Event|1|||
147621123|NCT03875508|532429679|FG000|Overall Study|Adverse Event|1|||
147621124|NCT03875508|532429679|FG000|Overall Study|Lost to Follow-up|8|||
147621125|NCT03875508|532429679|FG000|Overall Study|Lack of Efficacy|1|||
147621126|NCT03875508|532429679|FG000|Overall Study|Other, not specified|2|||
147621127|NCT02137252|532429680|FG000|Overall Study|trial terminated early|2|||
147621128|NCT02137252|532429681|FG001|Overall Study|trial terminated early|1|||
147621129|NCT00063934|532429683|FG000|Overall Study|Ineligible|1|||
147621130|NCT04341363|532429684|FG000|Overall Study|Adverse Event|1|||
147621131|NCT04341363|532429684|FG000|Overall Study|Withdrawal by Subject|1|||
147621132|NCT00923013|532429687|FG000|Overall Study|Refused further treatment|0|||
147621133|NCT00923013|532429688|FG001|Overall Study|Refused further treatment|1|||
147621134|NCT00923013|532429689|FG002|Overall Study|Refused further treatment|2|||
147621135|NCT00923013|532429690|FG003|Overall Study|Refused further treatment|0|||
147621136|NCT00923013|532429691|FG004|Overall Study|Refused further treatment|0|||
147621137|NCT00923013|532429692|FG005|Overall Study|Refused further treatment|0|||
147621138|NCT00923013|532429687|FG000|Overall Study|Switched to alternative treatment|0|||
147621139|NCT00923013|532429688|FG001|Overall Study|Switched to alternative treatment|1|||
147621140|NCT00923013|532429689|FG002|Overall Study|Switched to alternative treatment|0|||
147621141|NCT00923013|532429690|FG003|Overall Study|Switched to alternative treatment|0|||
147621142|NCT00923013|532429691|FG004|Overall Study|Switched to alternative treatment|0|||
147621143|NCT00923013|532429692|FG005|Overall Study|Switched to alternative treatment|0|||
147621144|NCT00923013|532429687|FG000|Overall Study|Death on study|2|||
147621145|NCT00923013|532429688|FG001|Overall Study|Death on study|2|||
147621146|NCT00923013|532429689|FG002|Overall Study|Death on study|0|||
147621147|NCT00923013|532429690|FG003|Overall Study|Death on study|1|||
147621148|NCT00923013|532429691|FG004|Overall Study|Death on study|0|||
147621149|NCT00923013|532429692|FG005|Overall Study|Death on study|0|||
147621150|NCT05366010|532429694|FG000|Overall Study|Withdrawal by Subject|1|||
147621151|NCT05366010|532429694|FG000|Overall Study|Protocol Violation|1|||
147621152|NCT05366010|532429694|FG000|Overall Study|Lost to Follow-up|2|||
147621153|NCT05366010|532429694|FG000|Overall Study|Screen Failure|2|||
147621154|NCT01108718|532429695|FG000|Received Second Intervention (2 Months)|Withdrawal by Subject|1|||
147621155|NCT01108718|532429696|FG001|Received Second Intervention (2 Months)|Withdrawal by Subject|0|||
147621156|NCT05317312|532429697|FG000|Overall Study|Withdrawal by Subject|0|||
147621157|NCT05317312|532429698|FG001|Overall Study|Withdrawal by Subject|1|||
147621158|NCT05317312|532429699|FG002|Overall Study|Withdrawal by Subject|0|||
147621159|NCT05317312|532429700|FG003|Overall Study|Withdrawal by Subject|0|||
147621160|NCT05317312|532429697|FG000|Overall Study|Lost to Follow-up|0|||
147621161|NCT05317312|532429698|FG001|Overall Study|Lost to Follow-up|0|||
147621162|NCT05317312|532429699|FG002|Overall Study|Lost to Follow-up|0|||
147621163|NCT05317312|532429700|FG003|Overall Study|Lost to Follow-up|1|||
147621164|NCT05317312|532429697|FG000|Overall Study|Excluded as exclusion criteria was met.|0|||
147621165|NCT05317312|532429698|FG001|Overall Study|Excluded as exclusion criteria was met.|0|||
147621166|NCT05317312|532429699|FG002|Overall Study|Excluded as exclusion criteria was met.|1|||
147621167|NCT05317312|532429700|FG003|Overall Study|Excluded as exclusion criteria was met.|0|||
147621168|NCT00837148|532429701|FG000|Overall Study|Adverse Event|1|||
147621169|NCT00837148|532429701|FG000|Overall Study|Death|1|||
147621170|NCT02301169|532429702|FG000|Overall Study|Adverse Event|1|||
147621171|NCT02301169|532429703|FG001|Overall Study|Adverse Event|0|||
147621172|NCT01422213|532429706|FG000|Overall Study|Adverse Event|8|||
147621173|NCT01422213|532429707|FG001|Overall Study|Adverse Event|7|||
147621174|NCT01422213|532429708|FG002|Overall Study|Adverse Event|11|||
147621175|NCT01422213|532429706|FG000|Overall Study|Lack of Efficacy|10|||
147621176|NCT01422213|532429707|FG001|Overall Study|Lack of Efficacy|2|||
147621177|NCT01422213|532429708|FG002|Overall Study|Lack of Efficacy|2|||
147621178|NCT01422213|532429706|FG000|Overall Study|Non-compliance with study drug|0|||
147621179|NCT01422213|532429707|FG001|Overall Study|Non-compliance with study drug|1|||
147621180|NCT01422213|532429708|FG002|Overall Study|Non-compliance with study drug|0|||
147621181|NCT01422213|532429706|FG000|Overall Study|Protocol Violation|0|||
147621182|NCT01422213|532429707|FG001|Overall Study|Protocol Violation|2|||
147621183|NCT01422213|532429708|FG002|Overall Study|Protocol Violation|4|||
147621184|NCT01422213|532429706|FG000|Overall Study|Withdrawal of Consent|7|||
147621185|NCT01422213|532429707|FG001|Overall Study|Withdrawal of Consent|3|||
147621186|NCT01422213|532429708|FG002|Overall Study|Withdrawal of Consent|5|||
147621187|NCT01422213|532429706|FG000|Overall Study|Lost to Follow-up|3|||
147621188|NCT01422213|532429707|FG001|Overall Study|Lost to Follow-up|3|||
147621189|NCT01422213|532429708|FG002|Overall Study|Lost to Follow-up|5|||
147621190|NCT01422213|532429706|FG000|Overall Study|Administrative or Other Reason(s)|5|||
147621191|NCT01422213|532429707|FG001|Overall Study|Administrative or Other Reason(s)|4|||
147621192|NCT01422213|532429708|FG002|Overall Study|Administrative or Other Reason(s)|2|||
147621193|NCT03762265|532429709|FG000|BT Period: Weeks 1 to 37|Adverse Event|7|||
147621194|NCT03762265|532429710|FG001|BT Period: Weeks 1 to 37|Adverse Event|2|||
147621195|NCT03762265|532429709|FG000|BT Period: Weeks 1 to 37|Lack of Efficacy|1|||
147621196|NCT03762265|532429710|FG001|BT Period: Weeks 1 to 37|Lack of Efficacy|0|||
147621197|NCT03762265|532429709|FG000|BT Period: Weeks 1 to 37|Physician Decision|1|||
147621198|NCT03762265|532429710|FG001|BT Period: Weeks 1 to 37|Physician Decision|0|||
147621199|NCT03762265|532429709|FG000|BT Period: Weeks 1 to 37|Required prohibited medication|2|||
147621200|NCT03762265|532429710|FG001|BT Period: Weeks 1 to 37|Required prohibited medication|0|||
147621201|NCT03762265|532429709|FG000|BT Period: Weeks 1 to 37|Withdrawal by Subject|4|||
147621202|NCT03762265|532429710|FG001|BT Period: Weeks 1 to 37|Withdrawal by Subject|0|||
147621203|NCT03762265|532429709|FG000|BT Period: Weeks 1 to 37|Other|0|||
147621204|NCT03762265|532429710|FG001|BT Period: Weeks 1 to 37|Other|1|||
147621205|NCT03762265|532429709|FG000|OLE Period: Weeks 37 to 61|Adverse Event|1|||
147621206|NCT03762265|532429710|FG001|OLE Period: Weeks 37 to 61|Adverse Event|2|||
147621207|NCT03762265|532429709|FG000|OLE Period: Weeks 37 to 61|Lack of Efficacy|3|||
147621208|NCT03762265|532429710|FG001|OLE Period: Weeks 37 to 61|Lack of Efficacy|2|||
147621209|NCT03762265|532429709|FG000|OLE Period: Weeks 37 to 61|Non-compliance with study drug|1|||
147621210|NCT03762265|532429710|FG001|OLE Period: Weeks 37 to 61|Non-compliance with study drug|0|||
147621211|NCT03762265|532429709|FG000|OLE Period: Weeks 37 to 61|Study terminated by sponsor|8|||
147621212|NCT03762265|532429710|FG001|OLE Period: Weeks 37 to 61|Study terminated by sponsor|10|||
147621213|NCT03762265|532429709|FG000|OLE Period: Weeks 37 to 61|Withdrawal by Subject|3|||
147621214|NCT03762265|532429710|FG001|OLE Period: Weeks 37 to 61|Withdrawal by Subject|2|||
147621215|NCT03762265|532429709|FG000|LTE Period: Weeks 61 to 109|Lack of Efficacy|0|||
147621216|NCT03762265|532429710|FG001|LTE Period: Weeks 61 to 109|Lack of Efficacy|1|||
147621217|NCT03762265|532429709|FG000|LTE Period: Weeks 61 to 109|Study terminated by sponsor|28|||
147621218|NCT03762265|532429710|FG001|LTE Period: Weeks 61 to 109|Study terminated by sponsor|25|||
147621219|NCT03762265|532429709|FG000|LTE Period: Weeks 61 to 109|Withdrawal by Subject|0|||
147621220|NCT03762265|532429710|FG001|LTE Period: Weeks 61 to 109|Withdrawal by Subject|2|||
147621221|NCT03762265|532429709|FG000|LTE Period: Weeks 61 to 109|Other|1|||
147621222|NCT03762265|532429710|FG001|LTE Period: Weeks 61 to 109|Other|0|||
147621223|NCT02857816|532429713|FG000|Overall Study|Screen Failure|33|||
147621224|NCT02857816|532429713|FG000|Overall Study|Withdrawal by Subject|4|||
147621225|NCT02857816|532429713|FG000|Overall Study|Lost to Follow-up|1|||
147621226|NCT01149863|532429714|FG000|Overall Study|Missing data or Not receiveing studydrug|3|||
147621227|NCT03326193|532429715|FG000|Overall Study|Sponsor decision|35|||
147621228|NCT01964976|532429718|FG000|Overall Study|Protocol Violation|31|||
147621229|NCT03918629|532429719|FG000|Overall Study|Adverse Event|19|||
147621230|NCT03918629|532429720|FG001|Overall Study|Adverse Event|20|||
147621231|NCT03918629|532429719|FG000|Overall Study|Death|14|||
147621232|NCT03918629|532429720|FG001|Overall Study|Death|7|||
147621233|NCT03918629|532429719|FG000|Overall Study|Lost to Follow-up|36|||
147474697|NCT04246047|531896289|FG000|Overall Study|Death|50|||
147474698|NCT04246047|531896290|FG001|Overall Study|Death|77|||
147474699|NCT04246047|531896289|FG000|Overall Study|Lost to Follow-up|1|||
147474700|NCT04246047|531896290|FG001|Overall Study|Lost to Follow-up|3|||
147474701|NCT04246047|531896289|FG000|Overall Study|Physician Decision|4|||
147474702|NCT04246047|531896290|FG001|Overall Study|Physician Decision|10|||
147474703|NCT04246047|531896289|FG000|Overall Study|Withdrawal by Subject|19|||
147474704|NCT04246047|531896290|FG001|Overall Study|Withdrawal by Subject|26|||
147474705|NCT04246047|531896289|FG000|Overall Study|Ongoing|169|||
147474706|NCT04246047|531896290|FG001|Overall Study|Ongoing|135|||
147474707|NCT02502864|531896296|FG000|Overall Study|Withdrawal by Subject|1|||
147474708|NCT01824602|531896308|FG000|Overall Study|Withdrawal by Subject|0|||
147474709|NCT01824602|531896309|FG001|Overall Study|Withdrawal by Subject|0|||
147474710|NCT01824602|531896310|FG002|Overall Study|Withdrawal by Subject|1|||
147474711|NCT01824602|531896311|FG003|Overall Study|Withdrawal by Subject|2|||
147474712|NCT01824602|531896308|FG000|Overall Study|Patient non-compliance|0|||
147474713|NCT01824602|531896309|FG001|Overall Study|Patient non-compliance|0|||
147474714|NCT01824602|531896310|FG002|Overall Study|Patient non-compliance|1|||
147474715|NCT01824602|531896311|FG003|Overall Study|Patient non-compliance|0|||
147474716|NCT01824602|531896308|FG000|Overall Study|Adverse Event|1|||
147474717|NCT01824602|531896309|FG001|Overall Study|Adverse Event|0|||
147474718|NCT01824602|531896310|FG002|Overall Study|Adverse Event|2|||
147474719|NCT01824602|531896311|FG003|Overall Study|Adverse Event|2|||
147474720|NCT01824602|531896308|FG000|Overall Study|Treatment failure|0|||
147474721|NCT01824602|531896309|FG001|Overall Study|Treatment failure|0|||
147474722|NCT01824602|531896310|FG002|Overall Study|Treatment failure|0|||
147474723|NCT01824602|531896311|FG003|Overall Study|Treatment failure|1|||
147474724|NCT00104871|531896312|FG000|Overall Study|Not evaluable|1|||
147474725|NCT00457639|531896316|FG000|Intervention 1 (6 Months)|Lost to Follow-up|3|||
147474726|NCT00457639|531896317|FG001|Intervention 1 (6 Months)|Lost to Follow-up|0|||
147474727|NCT00457639|531896316|FG000|Intervention 1 (6 Months)|unrelated illness|0|||
147474728|NCT00457639|531896317|FG001|Intervention 1 (6 Months)|unrelated illness|2|||
147474729|NCT00457639|531896316|FG000|Intervention 2 (6 Months)|Unrelated illness ineligible for MRS|0|||
147474730|NCT00457639|531896317|FG001|Intervention 2 (6 Months)|Unrelated illness ineligible for MRS|1|||
147474731|NCT02117687|531896318|FG000|Overall Study|Lost to Follow-up|0|||
147474732|NCT02117687|531896319|FG001|Overall Study|Lost to Follow-up|1|||
147474733|NCT02117687|531896318|FG000|Overall Study|Adverse Event|0|||
147474734|NCT02117687|531896319|FG001|Overall Study|Adverse Event|2|||
147474735|NCT02117687|531896318|FG000|Overall Study|Other Reasons|1|||
147474736|NCT02117687|531896319|FG001|Overall Study|Other Reasons|1|||
147474737|NCT01687673|531896325|FG000|Overall Study|Physician Decision|1|||
147474738|NCT02234622|531896326|FG000|Overall Study|Withdrawal by Subject|16|||
147621234|NCT03918629|532429720|FG001|Overall Study|Lost to Follow-up|28|||
147621235|NCT03918629|532429719|FG000|Overall Study|Physician Decision|1|||
147474739|NCT02234622|531896327|FG001|Overall Study|Withdrawal by Subject|22|||
147474740|NCT02234622|531896326|FG000|Overall Study|Lost to Follow-up|27|||
147474741|NCT02234622|531896327|FG001|Overall Study|Lost to Follow-up|14|||
147474742|NCT00618956|531896328|FG000|Overall Study|Adverse Event|10|||
147474743|NCT00618956|531896329|FG001|Overall Study|Adverse Event|34|||
147474744|NCT00618956|531896328|FG000|Overall Study|Lack of Efficacy|2|||
147474745|NCT00618956|531896329|FG001|Overall Study|Lack of Efficacy|1|||
147474746|NCT00618956|531896328|FG000|Overall Study|Withdrawal by Subject|5|||
147474747|NCT00618956|531896329|FG001|Overall Study|Withdrawal by Subject|7|||
147474748|NCT00618956|531896328|FG000|Overall Study|Lost to Follow-up|4|||
147474749|NCT00618956|531896329|FG001|Overall Study|Lost to Follow-up|5|||
147474750|NCT00618956|531896328|FG000|Overall Study|Protocol Violation|2|||
147474751|NCT00618956|531896329|FG001|Overall Study|Protocol Violation|2|||
147474752|NCT00618956|531896328|FG000|Overall Study|did not meet criteria, non-compliance|2|||
147474753|NCT00618956|531896329|FG001|Overall Study|did not meet criteria, non-compliance|1|||
147474754|NCT01887210|531896332|FG000|Overall Study|Withdrawal by Subject|1|||
147474755|NCT01887210|531896333|FG001|Overall Study|Withdrawal by Subject|3|||
147474756|NCT01887210|531896332|FG000|Overall Study|Lost to Follow-up|0|||
147474757|NCT01887210|531896333|FG001|Overall Study|Lost to Follow-up|1|||
147474758|NCT02452359|531896334|FG000|Overall Study|Adverse Event|1|||
147474759|NCT02452359|531896334|FG000|Overall Study|Lost to Follow-up|15|||
147474760|NCT02452359|531896334|FG000|Overall Study|Pregnancy|1|||
147474761|NCT02452359|531896334|FG000|Overall Study|Withdrawal by Subject|4|||
147474762|NCT02515669|531896339|FG000|228 Week Open-Label Phase|Other|0|||
147474763|NCT02515669|531896340|FG001|228 Week Open-Label Phase|Other|0|||
147474764|NCT02515669|531896341|FG002|228 Week Open-Label Phase|Other|1|||
147474765|NCT02515669|531896342|FG003|228 Week Open-Label Phase|Other|4|||
147474766|NCT02515669|531896339|FG000|228 Week Open-Label Phase|Lack of Efficacy|0|||
147474767|NCT02515669|531896340|FG001|228 Week Open-Label Phase|Lack of Efficacy|0|||
147474768|NCT02515669|531896341|FG002|228 Week Open-Label Phase|Lack of Efficacy|1|||
147474769|NCT02515669|531896342|FG003|228 Week Open-Label Phase|Lack of Efficacy|0|||
147621236|NCT03918629|532429720|FG001|Overall Study|Physician Decision|0|||
147621237|NCT03918629|532429719|FG000|Overall Study|Protocol Violation|7|||
147621238|NCT03918629|532429720|FG001|Overall Study|Protocol Violation|4|||
147666409|NCT03154086|532603944|FG012|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
147666410|NCT03154086|532603945|FG013|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
147666411|NCT03154086|532603946|FG014|Part A: Cohort3 Period2 (Up to 3 Days)|Withdrawal by Subject|0|||
147666412|NCT03154086|532603932|FG000|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
147666413|NCT03154086|532603933|FG001|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
147666414|NCT03154086|532603934|FG002|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
147666415|NCT03154086|532603935|FG003|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
147666416|NCT03154086|532603936|FG004|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
147666417|NCT03154086|532603937|FG005|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
147666418|NCT03154086|532603938|FG006|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
147666419|NCT03154086|532603939|FG007|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|1|||
147666420|NCT03154086|532603940|FG008|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
147666421|NCT03154086|532603941|FG009|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
147666422|NCT03154086|532603942|FG010|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
147666423|NCT03154086|532603943|FG011|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
147666424|NCT03154086|532603944|FG012|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
147666425|NCT03154086|532603945|FG013|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
147666426|NCT03154086|532603946|FG014|Part A: Cohort3 Period2 (Up to 3 Days)|Protocol Violation|0|||
147666427|NCT03154086|532603932|FG000|Part B (Up to 25 Days)|Adverse Event|0|||
147666428|NCT03154086|532603933|FG001|Part B (Up to 25 Days)|Adverse Event|0|||
147666429|NCT03154086|532603934|FG002|Part B (Up to 25 Days)|Adverse Event|0|||
147666430|NCT03154086|532603935|FG003|Part B (Up to 25 Days)|Adverse Event|0|||
147666431|NCT03154086|532603936|FG004|Part B (Up to 25 Days)|Adverse Event|0|||
147666432|NCT03154086|532603937|FG005|Part B (Up to 25 Days)|Adverse Event|0|||
147666433|NCT03154086|532603938|FG006|Part B (Up to 25 Days)|Adverse Event|0|||
147666434|NCT03154086|532603939|FG007|Part B (Up to 25 Days)|Adverse Event|0|||
147666435|NCT03154086|532603940|FG008|Part B (Up to 25 Days)|Adverse Event|0|||
147666436|NCT03154086|532603941|FG009|Part B (Up to 25 Days)|Adverse Event|0|||
147666437|NCT03154086|532603942|FG010|Part B (Up to 25 Days)|Adverse Event|1|||
147666438|NCT03154086|532603943|FG011|Part B (Up to 25 Days)|Adverse Event|0|||
147666439|NCT03154086|532603944|FG012|Part B (Up to 25 Days)|Adverse Event|0|||
147666440|NCT03154086|532603945|FG013|Part B (Up to 25 Days)|Adverse Event|0|||
147666441|NCT03154086|532603946|FG014|Part B (Up to 25 Days)|Adverse Event|0|||
147666442|NCT04076917|532603947|FG000|Overall Study|No AF episodes detected during Pre-Holter Observation period|49|||
147666443|NCT04076917|532603947|FG000|Overall Study|Study closure|13|||
147666444|NCT04076917|532603947|FG000|Overall Study|Physician Decision|3|||
147666445|NCT04076917|532603947|FG000|Overall Study|Death|1|||
147666446|NCT04076917|532603947|FG000|Overall Study|Lost to Follow-up|1|||
147666447|NCT04076917|532603947|FG000|Overall Study|Withdrawal by Subject|1|||
147666448|NCT04076917|532603947|FG000|Overall Study|Mean R-wave sensing is < 0.25 mV during Pre-Holter observation period|1|||
147666449|NCT01774591|532603950|FG000|Overall Study|Physician Decision|1|||
147666450|NCT01774591|532603951|FG001|Overall Study|Physician Decision|1|||
147666451|NCT01774591|532603950|FG000|Overall Study|Withdrawal by Subject|0|||
147666452|NCT01774591|532603951|FG001|Overall Study|Withdrawal by Subject|1|||
147666453|NCT01774591|532603950|FG000|Overall Study|Adverse Event|0|||
147666454|NCT01774591|532603951|FG001|Overall Study|Adverse Event|2|||
147666455|NCT01701245|532603953|FG000|Overall Study|Protocol Violation|1|||
147666456|NCT01701245|532603954|FG001|Overall Study|Protocol Violation|3|||
147666457|NCT01701245|532603953|FG000|Overall Study|Did not complete the open label period|11|||
147666458|NCT01701245|532603954|FG001|Overall Study|Did not complete the open label period|12|||
147666459|NCT01159574|532603955|FG000|Treatment Phase|non-evaluable/not included in analysis|1|||
147666460|NCT01159574|532603955|FG000|Treatment Phase|Adverse Event|3|||
147666461|NCT01159574|532603955|FG000|Treatment Phase|Death|6|||
147666462|NCT01159574|532603955|FG000|Treatment Phase|Physician Decision|2|||
147666463|NCT01159574|532603955|FG000|Treatment Phase|Withdrawal by Subject|7|||
147666464|NCT01159574|532603955|FG000|Treatment Phase|still on treatment|2|||
147666465|NCT01159574|532603955|FG000|Follow Up Phase|Lost to Follow-up|2|||
147666466|NCT01159574|532603955|FG000|Follow Up Phase|still being followed for overall surviva|18|||
147666467|NCT03555149|532603958|FG000|Overall Study|Death|18|||
147666468|NCT03555149|532603959|FG001|Overall Study|Death|15|||
147666469|NCT03555149|532603960|FG002|Overall Study|Death|15|||
147666470|NCT03555149|532603961|FG003|Overall Study|Death|4|||
147666471|NCT03555149|532603962|FG004|Overall Study|Death|4|||
147666472|NCT03555149|532603963|FG005|Overall Study|Death|11|||
147666473|NCT03555149|532603964|FG006|Overall Study|Death|12|||
147666474|NCT03555149|532603965|FG007|Overall Study|Death|1|||
147666475|NCT03555149|532603958|FG000|Overall Study|Lost to Follow-up|1|||
147666476|NCT03555149|532603959|FG001|Overall Study|Lost to Follow-up|0|||
147666477|NCT03555149|532603960|FG002|Overall Study|Lost to Follow-up|0|||
147666478|NCT03555149|532603961|FG003|Overall Study|Lost to Follow-up|0|||
147666479|NCT03555149|532603962|FG004|Overall Study|Lost to Follow-up|0|||
147666480|NCT03555149|532603963|FG005|Overall Study|Lost to Follow-up|1|||
147666481|NCT03555149|532603964|FG006|Overall Study|Lost to Follow-up|0|||
147666482|NCT03555149|532603965|FG007|Overall Study|Lost to Follow-up|0|||
147666483|NCT03555149|532603958|FG000|Overall Study|Physician Decision|1|||
147666484|NCT03555149|532603959|FG001|Overall Study|Physician Decision|0|||
147666485|NCT03555149|532603960|FG002|Overall Study|Physician Decision|0|||
147666486|NCT03555149|532603961|FG003|Overall Study|Physician Decision|0|||
147666487|NCT03555149|532603962|FG004|Overall Study|Physician Decision|0|||
147666488|NCT03555149|532603963|FG005|Overall Study|Physician Decision|0|||
147666489|NCT03555149|532603964|FG006|Overall Study|Physician Decision|0|||
147666490|NCT03555149|532603965|FG007|Overall Study|Physician Decision|0|||
147666491|NCT03555149|532603958|FG000|Overall Study|Study Terminated By Sponsor|1|||
147666492|NCT03555149|532603959|FG001|Overall Study|Study Terminated By Sponsor|0|||
147666493|NCT03555149|532603960|FG002|Overall Study|Study Terminated By Sponsor|0|||
147666494|NCT03555149|532603961|FG003|Overall Study|Study Terminated By Sponsor|0|||
147666495|NCT03555149|532603962|FG004|Overall Study|Study Terminated By Sponsor|0|||
147666496|NCT03555149|532603963|FG005|Overall Study|Study Terminated By Sponsor|2|||
147666497|NCT03555149|532603964|FG006|Overall Study|Study Terminated By Sponsor|3|||
147666498|NCT03555149|532603965|FG007|Overall Study|Study Terminated By Sponsor|1|||
147666499|NCT03555149|532603958|FG000|Overall Study|Withdrawal by Subject|3|||
147666500|NCT03555149|532603959|FG001|Overall Study|Withdrawal by Subject|0|||
147666501|NCT03555149|532603960|FG002|Overall Study|Withdrawal by Subject|0|||
147666502|NCT03555149|532603961|FG003|Overall Study|Withdrawal by Subject|2|||
147666503|NCT03555149|532603962|FG004|Overall Study|Withdrawal by Subject|0|||
147666504|NCT03555149|532603963|FG005|Overall Study|Withdrawal by Subject|1|||
147666505|NCT03555149|532603964|FG006|Overall Study|Withdrawal by Subject|0|||
147666506|NCT03555149|532603965|FG007|Overall Study|Withdrawal by Subject|0|||
147666507|NCT02666222|532603968|FG000|Overall Study|Death|2|||
147666508|NCT00630916|532603969|FG000|Overall Study|Death|110|||
147621239|NCT03918629|532429719|FG000|Overall Study|Withdrawal by Subject|47|||
147621240|NCT03918629|532429720|FG001|Overall Study|Withdrawal by Subject|47|||
147621241|NCT03918629|532429719|FG000|Overall Study|Other|7|||
147621242|NCT03918629|532429720|FG001|Overall Study|Other|11|||
147621243|NCT03918629|532429719|FG000|Overall Study|Randomized but not vaccinated|2|||
147621244|NCT03918629|532429720|FG001|Overall Study|Randomized but not vaccinated|1|||
147621245|NCT01891864|532429722|FG000|Treatment Period 1|Protocol Violation / IMP non-compliance|1|||
147621246|NCT01891864|532429723|FG001|Treatment Period 1|Protocol Violation / IMP non-compliance|1|||
147621247|NCT01891864|532429724|FG002|Treatment Period 1|Protocol Violation / IMP non-compliance|0|||
147621248|NCT01891864|532429725|FG003|Treatment Period 1|Protocol Violation / IMP non-compliance|0|||
147621249|NCT01891864|532429726|FG004|Treatment Period 1|Protocol Violation / IMP non-compliance|0|||
147621250|NCT01891864|532429727|FG005|Treatment Period 1|Protocol Violation / IMP non-compliance|0|||
147621251|NCT01891864|532429722|FG000|Treatment Period 1|Physician Decision|0|||
147621252|NCT01891864|532429723|FG001|Treatment Period 1|Physician Decision|1|||
147621253|NCT01891864|532429724|FG002|Treatment Period 1|Physician Decision|0|||
147621254|NCT01891864|532429725|FG003|Treatment Period 1|Physician Decision|0|||
147621255|NCT01891864|532429726|FG004|Treatment Period 1|Physician Decision|0|||
147621256|NCT01891864|532429727|FG005|Treatment Period 1|Physician Decision|0|||
147621257|NCT01891864|532429722|FG000|Treatment Period 1|Adverse Event, Serious, Fatal|0|||
147621258|NCT01891864|532429723|FG001|Treatment Period 1|Adverse Event, Serious, Fatal|1|||
147621259|NCT01891864|532429724|FG002|Treatment Period 1|Adverse Event, Serious, Fatal|0|||
147621260|NCT01891864|532429725|FG003|Treatment Period 1|Adverse Event, Serious, Fatal|0|||
147621261|NCT01891864|532429726|FG004|Treatment Period 1|Adverse Event, Serious, Fatal|0|||
147621262|NCT01891864|532429727|FG005|Treatment Period 1|Adverse Event, Serious, Fatal|0|||
147621263|NCT01891864|532429722|FG000|Treatment Period 1|Adverse Event / Injection Site Reaction|4|||
147621264|NCT01891864|532429723|FG001|Treatment Period 1|Adverse Event / Injection Site Reaction|4|||
147621265|NCT01891864|532429724|FG002|Treatment Period 1|Adverse Event / Injection Site Reaction|0|||
147621266|NCT01891864|532429725|FG003|Treatment Period 1|Adverse Event / Injection Site Reaction|0|||
147621267|NCT01891864|532429726|FG004|Treatment Period 1|Adverse Event / Injection Site Reaction|0|||
147621268|NCT01891864|532429727|FG005|Treatment Period 1|Adverse Event / Injection Site Reaction|0|||
147621269|NCT01891864|532429722|FG000|Treatment Period 1|Withdrawal by Subject|2|||
147621270|NCT01891864|532429723|FG001|Treatment Period 1|Withdrawal by Subject|5|||
147621271|NCT01891864|532429724|FG002|Treatment Period 1|Withdrawal by Subject|0|||
147621272|NCT01891864|532429725|FG003|Treatment Period 1|Withdrawal by Subject|0|||
147621273|NCT01891864|532429726|FG004|Treatment Period 1|Withdrawal by Subject|0|||
147621274|NCT01891864|532429727|FG005|Treatment Period 1|Withdrawal by Subject|0|||
147621275|NCT01891864|532429722|FG000|Treatment Period 1|Lost to Follow-up|1|||
147621276|NCT01891864|532429723|FG001|Treatment Period 1|Lost to Follow-up|0|||
147621277|NCT01891864|532429724|FG002|Treatment Period 1|Lost to Follow-up|0|||
147621278|NCT01891864|532429725|FG003|Treatment Period 1|Lost to Follow-up|0|||
147666509|NCT00630916|532603969|FG000|Overall Study|Explant|8|||
147666510|NCT00630916|532603969|FG000|Overall Study|Lost to Follow-up|5|||
147666511|NCT00630916|532603969|FG000|Overall Study|Withdrawal by Subject|30|||
147666512|NCT00630916|532603969|FG000|Overall Study|Protocol Violation|7|||
147666513|NCT00630916|532603969|FG000|Overall Study|Physician Decision|47|||
147666514|NCT00630916|532603969|FG000|Overall Study|Lack of Efficacy|3|||
147666515|NCT02147626|532603970|FG000|Overall Study|Lost to Follow-up|4|||
147666516|NCT02147626|532603971|FG001|Overall Study|Lost to Follow-up|4|||
147666517|NCT02147626|532603970|FG000|Overall Study|Pregnancy|1|||
147666518|NCT02147626|532603971|FG001|Overall Study|Pregnancy|2|||
147666519|NCT02147626|532603970|FG000|Overall Study|Withdrawal by Subject|0|||
147666520|NCT02147626|532603971|FG001|Overall Study|Withdrawal by Subject|1|||
147666521|NCT03504917|532603972|FG000|Blinded Treatment Period|Protocol Violation|1|||
147666522|NCT03504917|532603973|FG001|Blinded Treatment Period|Protocol Violation|0|||
147666523|NCT03504917|532603972|FG000|Blinded Treatment Period|Withdrawal by Subject|12|||
147666524|NCT03504917|532603973|FG001|Blinded Treatment Period|Withdrawal by Subject|9|||
147666525|NCT03504917|532603972|FG000|Blinded Treatment Period|Lack of Efficacy|1|||
147666526|NCT03504917|532603973|FG001|Blinded Treatment Period|Lack of Efficacy|1|||
147666527|NCT03504917|532603972|FG000|Blinded Treatment Period|Lost to Follow-up|1|||
147666528|NCT03504917|532603973|FG001|Blinded Treatment Period|Lost to Follow-up|4|||
147666529|NCT03504917|532603972|FG000|Blinded Treatment Period|Adverse Event|4|||
147666530|NCT03504917|532603973|FG001|Blinded Treatment Period|Adverse Event|4|||
147666531|NCT03504917|532603972|FG000|Blinded Treatment Period|Physician Decision|1|||
147666532|NCT03504917|532603973|FG001|Blinded Treatment Period|Physician Decision|0|||
147666533|NCT03504917|532603972|FG000|Blinded Treatment Period|Unable due to leaving the study site, non-interest, withdrawal, and a partner inability|1|||
147666534|NCT03504917|532603973|FG001|Blinded Treatment Period|Unable due to leaving the study site, non-interest, withdrawal, and a partner inability|3|||
147666535|NCT03504917|532603972|FG000|Blinded Treatment Period|Study terminated by sponsor|39|||
147666536|NCT03504917|532603973|FG001|Blinded Treatment Period|Study terminated by sponsor|34|||
147666537|NCT03504917|532603972|FG000|Blinded Treatment Period|Non-compliance with study drug|0|||
147666538|NCT03504917|532603973|FG001|Blinded Treatment Period|Non-compliance with study drug|1|||
147666539|NCT03504917|532603972|FG000|Open Label Extension Treatment Period|The participant left the study site|0|||
147666540|NCT03504917|532603973|FG001|Open Label Extension Treatment Period|The participant left the study site|1|||
147666541|NCT03504917|532603972|FG000|Open Label Extension Treatment Period|Withdrawal by Subject|8|||
147474770|NCT02515669|531896339|FG000|228 Week Open-Label Phase|Subject Request to Discontinue Treatment|0|||
147474771|NCT02515669|531896340|FG001|228 Week Open-Label Phase|Subject Request to Discontinue Treatment|0|||
147474772|NCT02515669|531896341|FG002|228 Week Open-Label Phase|Subject Request to Discontinue Treatment|2|||
147474773|NCT02515669|531896342|FG003|228 Week Open-Label Phase|Subject Request to Discontinue Treatment|3|||
147474774|NCT02515669|531896339|FG000|228 Week Open-Label Phase|Administrative Reason by Sponsor|0|||
147474775|NCT02515669|531896340|FG001|228 Week Open-Label Phase|Administrative Reason by Sponsor|7|||
147474776|NCT02515669|531896341|FG002|228 Week Open-Label Phase|Administrative Reason by Sponsor|2|||
147474777|NCT02515669|531896342|FG003|228 Week Open-Label Phase|Administrative Reason by Sponsor|17|||
147474778|NCT02515669|531896339|FG000|228 Week Open-Label Phase|Missing|0|||
147474779|NCT02515669|531896340|FG001|228 Week Open-Label Phase|Missing|2|||
147474780|NCT02515669|531896341|FG002|228 Week Open-Label Phase|Missing|2|||
147474781|NCT02515669|531896342|FG003|228 Week Open-Label Phase|Missing|2|||
147666542|NCT03504917|532603973|FG001|Open Label Extension Treatment Period|Withdrawal by Subject|2|||
147666543|NCT03504917|532603972|FG000|Open Label Extension Treatment Period|Lost to Follow-up|1|||
147666544|NCT03504917|532603973|FG001|Open Label Extension Treatment Period|Lost to Follow-up|4|||
147666545|NCT03504917|532603972|FG000|Open Label Extension Treatment Period|Lack of Efficacy|3|||
147474782|NCT00630032|531896345|FG000|Overall Study|Death|55|||
147666546|NCT03504917|532603973|FG001|Open Label Extension Treatment Period|Lack of Efficacy|1|||
147666547|NCT03504917|532603972|FG000|Open Label Extension Treatment Period|Adverse Event|7|||
147666548|NCT03504917|532603973|FG001|Open Label Extension Treatment Period|Adverse Event|0|||
147666549|NCT03504917|532603972|FG000|Open Label Extension Treatment Period|Non-compliance with study drug|0|||
147666550|NCT03504917|532603973|FG001|Open Label Extension Treatment Period|Non-compliance with study drug|1|||
147666551|NCT03504917|532603972|FG000|Open Label Extension Treatment Period|Study terminated by sponsor|81|||
147666552|NCT03504917|532603973|FG001|Open Label Extension Treatment Period|Study terminated by sponsor|88|||
147666553|NCT01299584|532603974|FG000|Overall Study|Protocol Violation|9|||
147666554|NCT00572832|532603975|FG000|Overall Study|Lost to Follow-up|0|||
147666555|NCT00572832|532603976|FG001|Overall Study|Lost to Follow-up|11|||
147666556|NCT00572832|532603975|FG000|Overall Study|Pregnancy|0|||
147666557|NCT00572832|532603976|FG001|Overall Study|Pregnancy|1|||
147666558|NCT00390689|532603980|FG000|Overall Study|Adverse Event|2|||
147666559|NCT00390689|532603981|FG001|Overall Study|Adverse Event|5|||
147666560|NCT00390689|532603982|FG002|Overall Study|Adverse Event|2|||
147666561|NCT00390689|532603980|FG000|Overall Study|Lack of Efficacy|0|||
147666562|NCT00390689|532603981|FG001|Overall Study|Lack of Efficacy|0|||
147666563|NCT00390689|532603982|FG002|Overall Study|Lack of Efficacy|1|||
147666564|NCT00390689|532603980|FG000|Overall Study|Protocol Violation|1|||
147474783|NCT00630032|531896346|FG001|Overall Study|Death|49|||
147474784|NCT00630032|531896345|FG000|Overall Study|Withdrawal by Subject|3|||
147474785|NCT00630032|531896346|FG001|Overall Study|Withdrawal by Subject|2|||
147474786|NCT00630032|531896345|FG000|Overall Study|Lost to Follow-up|18|||
147666565|NCT00390689|532603981|FG001|Overall Study|Protocol Violation|0|||
147666566|NCT00390689|532603982|FG002|Overall Study|Protocol Violation|0|||
147666567|NCT00390689|532603980|FG000|Overall Study|Investigator's judgement|2|||
147666568|NCT00390689|532603981|FG001|Overall Study|Investigator's judgement|0|||
147666569|NCT00390689|532603982|FG002|Overall Study|Investigator's judgement|0|||
147474787|NCT00630032|531896346|FG001|Overall Study|Lost to Follow-up|31|||
147474788|NCT00630032|531896345|FG000|Overall Study|Protocol Violation|1|||
147474789|NCT00630032|531896346|FG001|Overall Study|Protocol Violation|0|||
147474790|NCT00630032|531896345|FG000|Overall Study|Patient has moved|1|||
147474791|NCT00630032|531896346|FG001|Overall Study|Patient has moved|1|||
147666570|NCT03101020|532603984|FG000|Overall Study|Lack of time to participate|1|||
147666571|NCT03101020|532603985|FG001|Overall Study|Lack of time to participate|0|||
147666572|NCT03101020|532603984|FG000|Overall Study|Ran over by a car|0|||
147666573|NCT03101020|532603985|FG001|Overall Study|Ran over by a car|1|||
147666574|NCT03101020|532603984|FG000|Overall Study|Withdrawal by Subject|0|||
147666575|NCT03101020|532603985|FG001|Overall Study|Withdrawal by Subject|2|||
147666576|NCT01924533|532603986|FG000|Overall Study|Death|181|||
147666577|NCT01924533|532603987|FG001|Overall Study|Death|200|||
147666578|NCT01924533|532603986|FG000|Overall Study|Lost to Follow-up|0|||
147666579|NCT01924533|532603987|FG001|Overall Study|Lost to Follow-up|1|||
147666580|NCT01924533|532603986|FG000|Overall Study|Withdrawal by Subject|7|||
147666581|NCT01924533|532603987|FG001|Overall Study|Withdrawal by Subject|3|||
147666582|NCT01924533|532603986|FG000|Overall Study|Other Eligibility criteria|1|||
147666583|NCT01924533|532603987|FG001|Overall Study|Other Eligibility criteria|1|||
147666584|NCT04233879|532603988|FG000|Overall Study|Death|2|||
147666585|NCT04233879|532603989|FG001|Overall Study|Death|0|||
147666586|NCT04233879|532603988|FG000|Overall Study|Lost to Follow-up|3|||
147666587|NCT04233879|532603989|FG001|Overall Study|Lost to Follow-up|8|||
147666588|NCT04233879|532603988|FG000|Overall Study|Physician Decision|4|||
147666589|NCT04233879|532603989|FG001|Overall Study|Physician Decision|4|||
147666590|NCT04233879|532603988|FG000|Overall Study|Withdrawal by Subject|7|||
147474792|NCT00630032|531896345|FG000|Overall Study|Disease progression|1|||
147474793|NCT00630032|531896346|FG001|Overall Study|Disease progression|1|||
147474794|NCT00630032|531896345|FG000|Overall Study|End of monitoring in US centers|11|||
147474795|NCT00630032|531896346|FG001|Overall Study|End of monitoring in US centers|11|||
147474796|NCT03746080|531897991|FG000|Overall Study|In follow up|2|||
147474797|NCT03746080|531897991|FG000|Overall Study|Death|15|||
147474798|NCT05738486|531897992|FG000|Overall Study|Continuing Study|194|||
147474799|NCT05738486|531897993|FG001|Overall Study|Continuing Study|196|||
147474800|NCT05738486|531897994|FG002|Overall Study|Continuing Study|193|||
147474801|NCT05738486|531897995|FG003|Overall Study|Continuing Study|191|||
147474802|NCT05738486|531897992|FG000|Overall Study|Withdrawal by Subject|8|||
147474803|NCT05738486|531897993|FG001|Overall Study|Withdrawal by Subject|5|||
147474804|NCT05738486|531897994|FG002|Overall Study|Withdrawal by Subject|7|||
147474805|NCT05738486|531897995|FG003|Overall Study|Withdrawal by Subject|13|||
147474806|NCT05738486|531897992|FG000|Overall Study|Adverse Event|4|||
147474807|NCT05738486|531897993|FG001|Overall Study|Adverse Event|6|||
147474808|NCT05738486|531897994|FG002|Overall Study|Adverse Event|4|||
147621279|NCT01891864|532429726|FG004|Treatment Period 1|Lost to Follow-up|0|||
147621280|NCT01891864|532429727|FG005|Treatment Period 1|Lost to Follow-up|0|||
147621281|NCT01891864|532429722|FG000|Treatment Period 2|Protocol Violation|0|||
147474809|NCT05738486|531897995|FG003|Overall Study|Adverse Event|5|||
147474810|NCT05738486|531897992|FG000|Overall Study|Physician Decision|0|||
147474811|NCT05738486|531897993|FG001|Overall Study|Physician Decision|2|||
147474812|NCT05738486|531897994|FG002|Overall Study|Physician Decision|4|||
147474813|NCT05738486|531897995|FG003|Overall Study|Physician Decision|1|||
147474814|NCT05738486|531897992|FG000|Overall Study|Lost to Follow-up|1|||
147474815|NCT05738486|531897993|FG001|Overall Study|Lost to Follow-up|1|||
147621282|NCT01891864|532429723|FG001|Treatment Period 2|Protocol Violation|0|||
147621283|NCT01891864|532429724|FG002|Treatment Period 2|Protocol Violation|0|||
147621284|NCT01891864|532429725|FG003|Treatment Period 2|Protocol Violation|1|||
147621285|NCT01891864|532429726|FG004|Treatment Period 2|Protocol Violation|0|||
147621286|NCT01891864|532429727|FG005|Treatment Period 2|Protocol Violation|0|||
147621287|NCT01891864|532429722|FG000|Treatment Period 2|Physician Decision|0|||
147621288|NCT01891864|532429723|FG001|Treatment Period 2|Physician Decision|0|||
147621289|NCT01891864|532429724|FG002|Treatment Period 2|Physician Decision|1|||
147621290|NCT01891864|532429725|FG003|Treatment Period 2|Physician Decision|0|||
147474816|NCT05738486|531897994|FG002|Overall Study|Lost to Follow-up|2|||
147474817|NCT05738486|531897995|FG003|Overall Study|Lost to Follow-up|1|||
147474818|NCT05738486|531897992|FG000|Overall Study|Participant was Non-ambulatory|0|||
147474819|NCT05738486|531897993|FG001|Overall Study|Participant was Non-ambulatory|0|||
147474820|NCT05738486|531897994|FG002|Overall Study|Participant was Non-ambulatory|1|||
147474821|NCT05738486|531897995|FG003|Overall Study|Participant was Non-ambulatory|0|||
147621291|NCT01891864|532429726|FG004|Treatment Period 2|Physician Decision|0|||
147621292|NCT01891864|532429727|FG005|Treatment Period 2|Physician Decision|0|||
147666591|NCT04233879|532603989|FG001|Overall Study|Withdrawal by Subject|10|||
147666592|NCT04233879|532603988|FG000|Overall Study|Other|281|||
147666593|NCT04233879|532603989|FG001|Overall Study|Other|279|||
147474822|NCT05738486|531897992|FG000|Overall Study|Participant had Poor Venous Access|0|||
147474823|NCT05738486|531897993|FG001|Overall Study|Participant had Poor Venous Access|0|||
147474824|NCT05738486|531897994|FG002|Overall Study|Participant had Poor Venous Access|0|||
147474825|NCT05738486|531897995|FG003|Overall Study|Participant had Poor Venous Access|1|||
147666594|NCT03292016|532603990|FG000|Second Washout|Adverse Event|0|||
147474826|NCT05738486|531897992|FG000|Overall Study|Assigned Treatment by Mistake|0|||
147474827|NCT05738486|531897993|FG001|Overall Study|Assigned Treatment by Mistake|0|||
147474828|NCT05738486|531897994|FG002|Overall Study|Assigned Treatment by Mistake|0|||
147474829|NCT05738486|531897995|FG003|Overall Study|Assigned Treatment by Mistake|1|||
147474830|NCT05738486|531897992|FG000|Overall Study|Death|0|||
147474831|NCT05738486|531897993|FG001|Overall Study|Death|0|||
147474832|NCT05738486|531897994|FG002|Overall Study|Death|1|||
147474833|NCT05738486|531897995|FG003|Overall Study|Death|0|||
147474834|NCT05738486|531897992|FG000|Overall Study|Withdrawal Due to Caregiver Circumstances|1|||
147474835|NCT05738486|531897993|FG001|Overall Study|Withdrawal Due to Caregiver Circumstances|0|||
147474836|NCT05738486|531897994|FG002|Overall Study|Withdrawal Due to Caregiver Circumstances|0|||
147474837|NCT05738486|531897995|FG003|Overall Study|Withdrawal Due to Caregiver Circumstances|0|||
147474838|NCT01826214|531897999|FG000|Overall Study|Adverse Event|7|||
147474839|NCT01826214|531898000|FG001|Overall Study|Adverse Event|6|||
147474840|NCT01826214|531897999|FG000|Overall Study|Death|3|||
147474841|NCT01826214|531898000|FG001|Overall Study|Death|1|||
147474842|NCT01826214|531897999|FG000|Overall Study|Lost to Follow-up|1|||
147474843|NCT01826214|531898000|FG001|Overall Study|Lost to Follow-up|0|||
147474844|NCT01826214|531897999|FG000|Overall Study|Physician Decision|0|||
147474845|NCT01826214|531898000|FG001|Overall Study|Physician Decision|2|||
147474846|NCT01826214|531897999|FG000|Overall Study|Progressive disease|22|||
147474847|NCT01826214|531898000|FG001|Overall Study|Progressive disease|21|||
147474848|NCT01826214|531897999|FG000|Overall Study|Study terminated by Sponsor|0|||
147474849|NCT01826214|531898000|FG001|Overall Study|Study terminated by Sponsor|1|||
147474850|NCT01826214|531897999|FG000|Overall Study|Subject/guardian decision|2|||
147474851|NCT01826214|531898000|FG001|Overall Study|Subject/guardian decision|3|||
147474852|NCT00955110|531898001|FG000|Qualification Phase|Did not meet eligibility criteria|24|||
147474853|NCT00955110|531898001|FG000|Treatment Phase|Adverse Event|2|||
147474854|NCT00955110|531898001|FG000|Treatment Phase|Administrative reasons|2|||
147474855|NCT00955110|531898001|FG000|Treatment Phase|Non-compliance with study restrictions|1|||
147474856|NCT00955110|531898001|FG000|Treatment Phase|Withdrawn by physician pre-treatment|1|||
147474857|NCT02128490|531898002|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
147474858|NCT02128490|531898003|FG001|Overall Study|Pretreatment Event/Adverse Event|0|||
147474859|NCT02128490|531898004|FG002|Overall Study|Pretreatment Event/Adverse Event|1|||
147474860|NCT02128490|531898005|FG003|Overall Study|Pretreatment Event/Adverse Event|1|||
147474861|NCT02128490|531898006|FG004|Overall Study|Pretreatment Event/Adverse Event|0|||
147474862|NCT02128490|531898002|FG000|Overall Study|Major Protocol Deviation|1|||
147474863|NCT02128490|531898003|FG001|Overall Study|Major Protocol Deviation|2|||
147474864|NCT02128490|531898004|FG002|Overall Study|Major Protocol Deviation|0|||
147474865|NCT02128490|531898005|FG003|Overall Study|Major Protocol Deviation|2|||
147474866|NCT02128490|531898006|FG004|Overall Study|Major Protocol Deviation|2|||
147474867|NCT02128490|531898002|FG000|Overall Study|Lost to Follow-up|0|||
147474868|NCT02128490|531898003|FG001|Overall Study|Lost to Follow-up|0|||
147474869|NCT02128490|531898004|FG002|Overall Study|Lost to Follow-up|1|||
147474870|NCT02128490|531898005|FG003|Overall Study|Lost to Follow-up|1|||
147474871|NCT02128490|531898006|FG004|Overall Study|Lost to Follow-up|1|||
147474872|NCT02128490|531898002|FG000|Overall Study|Voluntary Withdrawal|3|||
147474873|NCT02128490|531898003|FG001|Overall Study|Voluntary Withdrawal|3|||
147474874|NCT02128490|531898004|FG002|Overall Study|Voluntary Withdrawal|1|||
147474875|NCT02128490|531898005|FG003|Overall Study|Voluntary Withdrawal|1|||
147474876|NCT02128490|531898006|FG004|Overall Study|Voluntary Withdrawal|2|||
147474877|NCT02128490|531898002|FG000|Overall Study|Lack of Efficacy|0|||
147474878|NCT02128490|531898003|FG001|Overall Study|Lack of Efficacy|1|||
147474879|NCT02128490|531898004|FG002|Overall Study|Lack of Efficacy|0|||
147474880|NCT02128490|531898005|FG003|Overall Study|Lack of Efficacy|0|||
147474881|NCT02128490|531898006|FG004|Overall Study|Lack of Efficacy|0|||
147474882|NCT02128490|531898002|FG000|Overall Study|Withdraw from Study Drug, Gout Flare|0|||
147474883|NCT02128490|531898003|FG001|Overall Study|Withdraw from Study Drug, Gout Flare|0|||
147474884|NCT02128490|531898004|FG002|Overall Study|Withdraw from Study Drug, Gout Flare|0|||
147474885|NCT02128490|531898005|FG003|Overall Study|Withdraw from Study Drug, Gout Flare|0|||
147621293|NCT01891864|532429722|FG000|Treatment Period 2|Site Termination|0|||
147621294|NCT01891864|532429723|FG001|Treatment Period 2|Site Termination|0|||
147621295|NCT01891864|532429724|FG002|Treatment Period 2|Site Termination|1|||
147474886|NCT02128490|531898006|FG004|Overall Study|Withdraw from Study Drug, Gout Flare|1|||
147474887|NCT02128490|531898002|FG000|Overall Study|Other Miscellaneous Reasons|0|||
147474888|NCT02128490|531898003|FG001|Overall Study|Other Miscellaneous Reasons|0|||
147474889|NCT02128490|531898004|FG002|Overall Study|Other Miscellaneous Reasons|2|||
147474890|NCT02128490|531898005|FG003|Overall Study|Other Miscellaneous Reasons|1|||
147474891|NCT02128490|531898006|FG004|Overall Study|Other Miscellaneous Reasons|1|||
147474892|NCT02243176|531898007|FG000|Overall Study|Other reason|1|||
147474893|NCT02243176|531898008|FG001|Overall Study|Other reason|2|||
147474894|NCT02243176|531898007|FG000|Overall Study|protocol specified withdrawal critera|1|||
147474895|NCT02243176|531898008|FG001|Overall Study|protocol specified withdrawal critera|3|||
147474896|NCT02243176|531898007|FG000|Overall Study|Protocol Violation|2|||
147474897|NCT02243176|531898008|FG001|Overall Study|Protocol Violation|1|||
147474898|NCT02243176|531898007|FG000|Overall Study|Withdrawal by Subject|8|||
147474899|NCT02243176|531898008|FG001|Overall Study|Withdrawal by Subject|7|||
147474900|NCT02243176|531898007|FG000|Overall Study|Adverse Event|2|||
147474901|NCT02243176|531898008|FG001|Overall Study|Adverse Event|2|||
147474902|NCT03113500|531898009|FG000|Overall Study|Withdrawal by Subject|1|||
147474903|NCT02517515|531898012|FG000|Overall Study|Adverse Event|0|||
147474904|NCT02517515|531898013|FG001|Overall Study|Adverse Event|1|||
147474905|NCT02517515|531898012|FG000|Overall Study|Withdrew Consent|0|||
147474906|NCT02517515|531898013|FG001|Overall Study|Withdrew Consent|1|||
147474907|NCT02517515|531898012|FG000|Overall Study|Lost to Follow-up|1|||
147474908|NCT02517515|531898013|FG001|Overall Study|Lost to Follow-up|0|||
147474909|NCT02517515|531898012|FG000|Overall Study|Other|1|||
147474910|NCT02517515|531898013|FG001|Overall Study|Other|0|||
147303186|NCT02243202|531276266|FG002|Overall Study|Withdrawal by Subject|4|||
147303187|NCT02243202|531276267|FG003|Overall Study|Withdrawal by Subject|4|||
147303188|NCT02243202|531276264|FG000|Overall Study|Other|1|||
147303189|NCT02243202|531276265|FG001|Overall Study|Other|3|||
147303190|NCT02243202|531276266|FG002|Overall Study|Other|1|||
147303191|NCT02243202|531276267|FG003|Overall Study|Other|2|||
147303192|NCT02243202|531276264|FG000|Overall Study|Randomized but not received treatment|0|||
147474911|NCT06400238|531898016|FG000|Overall Study|Started Protocol Therapy|2|||
147474912|NCT06400238|531898016|FG000|Overall Study|Adverse Event|1|||
147474913|NCT06400238|531898016|FG000|Overall Study|Death|1|||
147474914|NCT06400238|531898016|FG000|Overall Study|Disease Progression|27|||
147474915|NCT06400238|531898016|FG000|Overall Study|Withdrawal by Subject|2|||
147474916|NCT06400238|531898016|FG000|Overall Study|Physician Decision|2|||
147474917|NCT01009463|531898021|FG000|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|373|||
147474918|NCT01009463|531898022|FG001|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
147474919|NCT01009463|531898023|FG002|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
147474920|NCT01009463|531898024|FG003|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
147474921|NCT01009463|531898025|FG004|4-week, Open-label Run-In Period|Did Not Meet Continuation Criteria|0|||
147474922|NCT01009463|531898021|FG000|4-week, Open-label Run-In Period|Adverse Event|10|||
147474923|NCT01009463|531898022|FG001|4-week, Open-label Run-In Period|Adverse Event|0|||
147474924|NCT01009463|531898023|FG002|4-week, Open-label Run-In Period|Adverse Event|0|||
147474925|NCT01009463|531898024|FG003|4-week, Open-label Run-In Period|Adverse Event|0|||
147474926|NCT01009463|531898025|FG004|4-week, Open-label Run-In Period|Adverse Event|0|||
147474927|NCT01009463|531898021|FG000|4-week, Open-label Run-In Period|Lost to Follow-up|6|||
147474928|NCT01009463|531898022|FG001|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
147474929|NCT01009463|531898023|FG002|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
147474930|NCT01009463|531898024|FG003|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
147474931|NCT01009463|531898025|FG004|4-week, Open-label Run-In Period|Lost to Follow-up|0|||
147474932|NCT01009463|531898021|FG000|4-week, Open-label Run-In Period|Physician Decision|10|||
147474933|NCT01009463|531898022|FG001|4-week, Open-label Run-In Period|Physician Decision|0|||
147474934|NCT01009463|531898023|FG002|4-week, Open-label Run-In Period|Physician Decision|0|||
147474935|NCT01009463|531898024|FG003|4-week, Open-label Run-In Period|Physician Decision|0|||
147474936|NCT01009463|531898025|FG004|4-week, Open-label Run-In Period|Physician Decision|0|||
147474937|NCT01009463|531898021|FG000|4-week, Open-label Run-In Period|Withdrawal by Subject|50|||
147474938|NCT01009463|531898022|FG001|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
147474939|NCT01009463|531898023|FG002|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
147474940|NCT01009463|531898024|FG003|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
147474941|NCT01009463|531898025|FG004|4-week, Open-label Run-In Period|Withdrawal by Subject|0|||
147474942|NCT01009463|531898021|FG000|52-week, Double-blind Treatment Period|Adverse Event|0|||
147474943|NCT01009463|531898022|FG001|52-week, Double-blind Treatment Period|Adverse Event|22|||
147474944|NCT01009463|531898023|FG002|52-week, Double-blind Treatment Period|Adverse Event|25|||
147474945|NCT01009463|531898024|FG003|52-week, Double-blind Treatment Period|Adverse Event|29|||
147474946|NCT01009463|531898025|FG004|52-week, Double-blind Treatment Period|Adverse Event|31|||
147474947|NCT01009463|531898021|FG000|52-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
147474948|NCT01009463|531898022|FG001|52-week, Double-blind Treatment Period|Withdrawal by Subject|34|||
147474949|NCT01009463|531898023|FG002|52-week, Double-blind Treatment Period|Withdrawal by Subject|18|||
147474950|NCT01009463|531898024|FG003|52-week, Double-blind Treatment Period|Withdrawal by Subject|17|||
147474951|NCT01009463|531898025|FG004|52-week, Double-blind Treatment Period|Withdrawal by Subject|22|||
147474952|NCT01009463|531898021|FG000|52-week, Double-blind Treatment Period|Lack of Efficacy|0|||
147474953|NCT01009463|531898022|FG001|52-week, Double-blind Treatment Period|Lack of Efficacy|24|||
147474954|NCT01009463|531898023|FG002|52-week, Double-blind Treatment Period|Lack of Efficacy|16|||
147474955|NCT01009463|531898024|FG003|52-week, Double-blind Treatment Period|Lack of Efficacy|11|||
147474956|NCT01009463|531898025|FG004|52-week, Double-blind Treatment Period|Lack of Efficacy|18|||
147474957|NCT01009463|531898021|FG000|52-week, Double-blind Treatment Period|Protocol Violation|0|||
147666595|NCT03292016|532603991|FG001|Second Washout|Adverse Event|1|||
147303193|NCT02243202|531276265|FG001|Overall Study|Randomized but not received treatment|0|||
147303194|NCT02243202|531276266|FG002|Overall Study|Randomized but not received treatment|0|||
147621296|NCT01891864|532429725|FG003|Treatment Period 2|Site Termination|2|||
147621297|NCT01891864|532429726|FG004|Treatment Period 2|Site Termination|0|||
147621298|NCT01891864|532429727|FG005|Treatment Period 2|Site Termination|0|||
147621299|NCT01891864|532429722|FG000|Treatment Period 2|Lack of Efficacy|0|||
147621300|NCT01891864|532429723|FG001|Treatment Period 2|Lack of Efficacy|0|||
147621301|NCT01891864|532429724|FG002|Treatment Period 2|Lack of Efficacy|1|||
147621302|NCT01891864|532429725|FG003|Treatment Period 2|Lack of Efficacy|0|||
147621303|NCT01891864|532429726|FG004|Treatment Period 2|Lack of Efficacy|1|||
147621304|NCT01891864|532429727|FG005|Treatment Period 2|Lack of Efficacy|0|||
147621305|NCT01891864|532429722|FG000|Treatment Period 2|Adverse Event|0|||
147621306|NCT01891864|532429723|FG001|Treatment Period 2|Adverse Event|0|||
147621307|NCT01891864|532429724|FG002|Treatment Period 2|Adverse Event|1|||
147621308|NCT01891864|532429725|FG003|Treatment Period 2|Adverse Event|2|||
147621309|NCT01891864|532429726|FG004|Treatment Period 2|Adverse Event|0|||
147621310|NCT01891864|532429727|FG005|Treatment Period 2|Adverse Event|4|||
147621311|NCT01891864|532429722|FG000|Treatment Period 2|Termination of Site|0|||
147621312|NCT01891864|532429723|FG001|Treatment Period 2|Termination of Site|0|||
147621313|NCT01891864|532429724|FG002|Treatment Period 2|Termination of Site|0|||
147621314|NCT01891864|532429725|FG003|Treatment Period 2|Termination of Site|0|||
147621315|NCT01891864|532429726|FG004|Treatment Period 2|Termination of Site|2|||
147621316|NCT01891864|532429727|FG005|Treatment Period 2|Termination of Site|0|||
147621317|NCT01891864|532429722|FG000|Treatment Period 2|Withdrawal by Subject|0|||
147621318|NCT01891864|532429723|FG001|Treatment Period 2|Withdrawal by Subject|0|||
147621319|NCT01891864|532429724|FG002|Treatment Period 2|Withdrawal by Subject|3|||
147621320|NCT01891864|532429725|FG003|Treatment Period 2|Withdrawal by Subject|4|||
147621321|NCT01891864|532429726|FG004|Treatment Period 2|Withdrawal by Subject|1|||
147621322|NCT01891864|532429727|FG005|Treatment Period 2|Withdrawal by Subject|1|||
147621323|NCT01891864|532429722|FG000|Extension Period|Lack of Efficacy|0|||
147621324|NCT01891864|532429723|FG001|Extension Period|Lack of Efficacy|0|||
147621325|NCT01891864|532429724|FG002|Extension Period|Lack of Efficacy|0|||
147621326|NCT01891864|532429725|FG003|Extension Period|Lack of Efficacy|1|||
147621327|NCT01891864|532429726|FG004|Extension Period|Lack of Efficacy|1|||
147621328|NCT01891864|532429727|FG005|Extension Period|Lack of Efficacy|0|||
147621329|NCT01891864|532429722|FG000|Extension Period|Pregnancy|0|||
147621330|NCT01891864|532429723|FG001|Extension Period|Pregnancy|0|||
147621331|NCT01891864|532429724|FG002|Extension Period|Pregnancy|1|||
147621332|NCT01891864|532429725|FG003|Extension Period|Pregnancy|0|||
147621333|NCT01891864|532429726|FG004|Extension Period|Pregnancy|0|||
147621334|NCT01891864|532429727|FG005|Extension Period|Pregnancy|0|||
147621335|NCT01891864|532429722|FG000|Extension Period|Adverse Event|0|||
147621336|NCT01891864|532429723|FG001|Extension Period|Adverse Event|0|||
147621337|NCT01891864|532429724|FG002|Extension Period|Adverse Event|4|||
147621338|NCT01891864|532429725|FG003|Extension Period|Adverse Event|2|||
147621339|NCT01891864|532429726|FG004|Extension Period|Adverse Event|2|||
147621340|NCT01891864|532429727|FG005|Extension Period|Adverse Event|0|||
147621341|NCT01891864|532429722|FG000|Extension Period|Withdrawal by Subject|0|||
147621342|NCT01891864|532429723|FG001|Extension Period|Withdrawal by Subject|0|||
147621343|NCT01891864|532429724|FG002|Extension Period|Withdrawal by Subject|1|||
147621344|NCT01891864|532429725|FG003|Extension Period|Withdrawal by Subject|2|||
147621345|NCT01891864|532429726|FG004|Extension Period|Withdrawal by Subject|4|||
147621346|NCT01891864|532429727|FG005|Extension Period|Withdrawal by Subject|0|||
147621347|NCT01891864|532429722|FG000|Extension Period|Lost to Follow-up|0|||
147621348|NCT01891864|532429723|FG001|Extension Period|Lost to Follow-up|0|||
147621349|NCT01891864|532429724|FG002|Extension Period|Lost to Follow-up|2|||
147621350|NCT01891864|532429725|FG003|Extension Period|Lost to Follow-up|0|||
147621351|NCT01891864|532429726|FG004|Extension Period|Lost to Follow-up|0|||
147621352|NCT01891864|532429727|FG005|Extension Period|Lost to Follow-up|0|||
147621353|NCT05479435|532429730|FG000|Overall Study|Withdrawal by Subject|1|||
147621354|NCT05479435|532429731|FG001|Overall Study|Withdrawal by Subject|0|||
147621355|NCT05479435|532429732|FG002|Overall Study|Withdrawal by Subject|0|||
147621356|NCT05479435|532429730|FG000|Overall Study|Covid 19|0|||
147621357|NCT05479435|532429731|FG001|Overall Study|Covid 19|0|||
147621358|NCT05479435|532429732|FG002|Overall Study|Covid 19|2|||
147621359|NCT00955617|532429735|FG000|Second MRA (Between Day 1 and Day 51)|Withdrawal by Subject|2|||
147621360|NCT00955617|532429736|FG001|Second MRA (Between Day 1 and Day 51)|Withdrawal by Subject|1|||
147621361|NCT00955617|532429735|FG000|Second MRA (Between Day 1 and Day 51)|Lost to Follow-up|0|||
147621362|NCT00955617|532429736|FG001|Second MRA (Between Day 1 and Day 51)|Lost to Follow-up|1|||
147621363|NCT00955617|532429735|FG000|Second MRA (Between Day 1 and Day 51)|technical incident|0|||
147621364|NCT00955617|532429736|FG001|Second MRA (Between Day 1 and Day 51)|technical incident|1|||
147621365|NCT00955617|532429735|FG000|Second MRA (Between Day 1 and Day 51)|conventional angiography|1|||
147621366|NCT00955617|532429736|FG001|Second MRA (Between Day 1 and Day 51)|conventional angiography|0|||
147621367|NCT04199104|532431426|FG000|Overall Study|Death|148|||
147621368|NCT04199104|532431427|FG001|Overall Study|Death|134|||
147621369|NCT04199104|532431426|FG000|Overall Study|Lost to Follow-up|1|||
147621370|NCT04199104|532431427|FG001|Overall Study|Lost to Follow-up|1|||
147621371|NCT04199104|532431426|FG000|Overall Study|Withdrawal by Subject|4|||
147474958|NCT01009463|531898022|FG001|52-week, Double-blind Treatment Period|Protocol Violation|8|||
147474959|NCT01009463|531898023|FG002|52-week, Double-blind Treatment Period|Protocol Violation|7|||
147474960|NCT01009463|531898024|FG003|52-week, Double-blind Treatment Period|Protocol Violation|8|||
147474961|NCT01009463|531898025|FG004|52-week, Double-blind Treatment Period|Protocol Violation|7|||
147474962|NCT01009463|531898021|FG000|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0|||
147474963|NCT01009463|531898022|FG001|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|10|||
147474964|NCT01009463|531898023|FG002|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|14|||
147474965|NCT01009463|531898024|FG003|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|13|||
147474966|NCT01009463|531898025|FG004|52-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|10|||
147474967|NCT01009463|531898021|FG000|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
147474968|NCT01009463|531898022|FG001|52-week, Double-blind Treatment Period|Study Closed/Terminated|2|||
147474969|NCT01009463|531898023|FG002|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
147474970|NCT01009463|531898024|FG003|52-week, Double-blind Treatment Period|Study Closed/Terminated|1|||
147474971|NCT01009463|531898025|FG004|52-week, Double-blind Treatment Period|Study Closed/Terminated|0|||
147474972|NCT01009463|531898021|FG000|52-week, Double-blind Treatment Period|Lost to Follow-up|0|||
147474973|NCT01009463|531898022|FG001|52-week, Double-blind Treatment Period|Lost to Follow-up|11|||
147474974|NCT01009463|531898023|FG002|52-week, Double-blind Treatment Period|Lost to Follow-up|7|||
147474975|NCT01009463|531898024|FG003|52-week, Double-blind Treatment Period|Lost to Follow-up|6|||
147474976|NCT01009463|531898025|FG004|52-week, Double-blind Treatment Period|Lost to Follow-up|5|||
147474977|NCT01009463|531898021|FG000|52-week, Double-blind Treatment Period|Physician Decision|0|||
147474978|NCT01009463|531898022|FG001|52-week, Double-blind Treatment Period|Physician Decision|4|||
147474979|NCT01009463|531898023|FG002|52-week, Double-blind Treatment Period|Physician Decision|6|||
147474980|NCT01009463|531898024|FG003|52-week, Double-blind Treatment Period|Physician Decision|6|||
147474981|NCT01009463|531898025|FG004|52-week, Double-blind Treatment Period|Physician Decision|8|||
147474982|NCT04430348|531898026|FG000|Overall Study|Death|3|||
147474983|NCT04430348|531898027|FG001|Overall Study|Death|2|||
147474984|NCT04430348|531898028|FG002|Overall Study|Death|2|||
147474985|NCT04430348|531898029|FG003|Overall Study|Death|2|||
147474986|NCT04430348|531898030|FG004|Overall Study|Death|2|||
147474987|NCT04430348|531898031|FG005|Overall Study|Death|3|||
147474988|NCT04430348|531898026|FG000|Overall Study|Lost to Follow-up|0|||
147474989|NCT04430348|531898027|FG001|Overall Study|Lost to Follow-up|0|||
147474990|NCT04430348|531898028|FG002|Overall Study|Lost to Follow-up|0|||
147474991|NCT04430348|531898029|FG003|Overall Study|Lost to Follow-up|1|||
147474992|NCT04430348|531898030|FG004|Overall Study|Lost to Follow-up|0|||
147474993|NCT04430348|531898031|FG005|Overall Study|Lost to Follow-up|0|||
147474994|NCT04430348|531898026|FG000|Overall Study|Adverse Event|0|||
147474995|NCT04430348|531898027|FG001|Overall Study|Adverse Event|0|||
147474996|NCT04430348|531898028|FG002|Overall Study|Adverse Event|0|||
147474997|NCT04430348|531898029|FG003|Overall Study|Adverse Event|0|||
147474998|NCT04430348|531898030|FG004|Overall Study|Adverse Event|0|||
147474999|NCT04430348|531898031|FG005|Overall Study|Adverse Event|1|||
147475000|NCT04430348|531898026|FG000|Overall Study|Withdrawal by Subject|0|||
147475001|NCT04430348|531898027|FG001|Overall Study|Withdrawal by Subject|1|||
147475002|NCT04430348|531898028|FG002|Overall Study|Withdrawal by Subject|0|||
147475003|NCT04430348|531898029|FG003|Overall Study|Withdrawal by Subject|0|||
147475004|NCT04430348|531898030|FG004|Overall Study|Withdrawal by Subject|0|||
147475005|NCT04430348|531898031|FG005|Overall Study|Withdrawal by Subject|1|||
147475006|NCT04430348|531898026|FG000|Overall Study|Study Terminated by Sponsor|0|||
147475007|NCT04430348|531898027|FG001|Overall Study|Study Terminated by Sponsor|0|||
147475008|NCT04430348|531898028|FG002|Overall Study|Study Terminated by Sponsor|2|||
147475009|NCT04430348|531898029|FG003|Overall Study|Study Terminated by Sponsor|0|||
147475010|NCT04430348|531898030|FG004|Overall Study|Study Terminated by Sponsor|1|||
147621372|NCT04199104|532431427|FG001|Overall Study|Withdrawal by Subject|4|||
147621373|NCT04199104|532431426|FG000|Overall Study|Participants Ongoing|103|||
147621374|NCT04199104|532431427|FG001|Overall Study|Participants Ongoing|116|||
147621375|NCT04563754|532431429|FG000|HRME Procedure|No HRA and/or HRME data due to technical difficulties or quality control issues with HRME imaging|11|||
147621376|NCT04563754|532431430|FG001|HRME Procedure|No HRA and/or HRME data due to technical difficulties or quality control issues with HRME imaging|6|||
147621377|NCT04563754|532431431|FG002|HRME Procedure|No HRA and/or HRME data due to technical difficulties or quality control issues with HRME imaging|0|||
147621378|NCT04563754|532431429|FG000|HRME Procedure|Optimization/validation of 3D imaging and HRME|0|||
147621379|NCT04563754|532431430|FG001|HRME Procedure|Optimization/validation of 3D imaging and HRME|0|||
147621380|NCT04563754|532431431|FG002|HRME Procedure|Optimization/validation of 3D imaging and HRME|18|||
147621381|NCT04563754|532431429|FG000|Follow up|Lost to Follow-up|61|||
147475011|NCT04430348|531898031|FG005|Overall Study|Study Terminated by Sponsor|1|||
147475012|NCT05408858|531898043|FG000|Overall Study|no longer met eligibility criteria|1|||
147475013|NCT04329949|531898045|FG000|Overall Study|Death|36|||
147621382|NCT04563754|532431430|FG001|Follow up|Lost to Follow-up|23|||
147475014|NCT04329949|531898045|FG000|Overall Study|Withdrawal by Subject|4|||
147621383|NCT04563754|532431431|FG002|Follow up|Lost to Follow-up|5|||
147621384|NCT04563754|532431429|FG000|Follow up|Death|0|||
147475015|NCT04329949|531898045|FG000|Overall Study|Termination of study by sponsor|3|||
147621385|NCT04563754|532431430|FG001|Follow up|Death|2|||
147621386|NCT04563754|532431431|FG002|Follow up|Death|0|||
147621387|NCT04563754|532431429|FG000|Follow up|Ongoing|0|||
147621388|NCT04563754|532431430|FG001|Follow up|Ongoing|28|||
147621389|NCT04563754|532431431|FG002|Follow up|Ongoing|0|||
147621390|NCT04023396|532431432|FG000|Overall Study|Adverse Event|16|||
147621391|NCT04023396|532431432|FG000|Overall Study|Death|1|||
147621392|NCT04023396|532431432|FG000|Overall Study|Lost to Follow-up|1|||
147621393|NCT04023396|532431432|FG000|Overall Study|Withdrawal by Subject|14|||
147621394|NCT04023396|532431432|FG000|Overall Study|Pregnancy|4|||
147621395|NCT04023396|532431432|FG000|Overall Study|Lack of Efficacy|3|||
147621396|NCT04023396|532431432|FG000|Overall Study|Physician Decision|4|||
147621397|NCT04023396|532431432|FG000|Overall Study|Other reason (e.g., Ukraine Crisis)|10|||
147621398|NCT04075825|532431435|FG000|Overall Study|Withdrawal by Subject|6|||
147621399|NCT04075825|532431436|FG001|Overall Study|Withdrawal by Subject|8|||
147621400|NCT04075825|532431435|FG000|Overall Study|Physician Decision|3|||
147621401|NCT04075825|532431436|FG001|Overall Study|Physician Decision|1|||
147621402|NCT04075825|532431435|FG000|Overall Study|Lost to Follow-up|5|||
147621403|NCT04075825|532431436|FG001|Overall Study|Lost to Follow-up|1|||
147621404|NCT04075825|532431435|FG000|Overall Study|Participation in New Clinical Trial|1|||
147621405|NCT04075825|532431436|FG001|Overall Study|Participation in New Clinical Trial|1|||
147621406|NCT04075825|532431435|FG000|Overall Study|Reason Not Specified|2|||
147621407|NCT04075825|532431436|FG001|Overall Study|Reason Not Specified|2|||
147475016|NCT01458340|531898053|FG000|Overall Study|Adverse Event|5|||
147475017|NCT01458340|531898054|FG001|Overall Study|Adverse Event|4|||
147475018|NCT01458340|531898055|FG002|Overall Study|Adverse Event|2|||
147475019|NCT01458340|531898053|FG000|Overall Study|Lost to Follow-up|3|||
147475020|NCT01458340|531898054|FG001|Overall Study|Lost to Follow-up|3|||
147475021|NCT01458340|531898055|FG002|Overall Study|Lost to Follow-up|10|||
147475022|NCT01458340|531898053|FG000|Overall Study|Miscellaneous|0|||
147475023|NCT01458340|531898054|FG001|Overall Study|Miscellaneous|1|||
147475024|NCT01458340|531898055|FG002|Overall Study|Miscellaneous|0|||
147475025|NCT01458340|531898053|FG000|Overall Study|Physician Decision|1|||
147475026|NCT01458340|531898054|FG001|Overall Study|Physician Decision|1|||
147475027|NCT01458340|531898055|FG002|Overall Study|Physician Decision|2|||
147475028|NCT01458340|531898053|FG000|Overall Study|Protocol Violation|6|||
147475029|NCT01458340|531898054|FG001|Overall Study|Protocol Violation|6|||
147475030|NCT01458340|531898055|FG002|Overall Study|Protocol Violation|5|||
147475031|NCT01458340|531898053|FG000|Overall Study|Withdrawal by Subject|12|||
147621408|NCT02861586|532431440|FG000|Overall Study|Withdrawal by Subject|1|||
147621409|NCT02861586|532431441|FG001|Overall Study|Withdrawal by Subject|2|||
147621410|NCT02861586|532431442|FG002|Overall Study|Withdrawal by Subject|0|||
147621411|NCT02861586|532431443|FG003|Overall Study|Withdrawal by Subject|0|||
147621412|NCT02861586|532431444|FG004|Overall Study|Withdrawal by Subject|0|||
147621413|NCT02861586|532431445|FG005|Overall Study|Withdrawal by Subject|1|||
147621414|NCT02861586|532431446|FG006|Overall Study|Withdrawal by Subject|1|||
147621415|NCT02861586|532431447|FG007|Overall Study|Withdrawal by Subject|0|||
147621416|NCT02861586|532431440|FG000|Overall Study|Lost to Follow-up|3|||
147621417|NCT02861586|532431441|FG001|Overall Study|Lost to Follow-up|1|||
147621418|NCT02861586|532431442|FG002|Overall Study|Lost to Follow-up|1|||
147621419|NCT02861586|532431443|FG003|Overall Study|Lost to Follow-up|0|||
147621420|NCT02861586|532431444|FG004|Overall Study|Lost to Follow-up|0|||
147621421|NCT02861586|532431445|FG005|Overall Study|Lost to Follow-up|3|||
147621422|NCT02861586|532431446|FG006|Overall Study|Lost to Follow-up|0|||
147621423|NCT02861586|532431447|FG007|Overall Study|Lost to Follow-up|0|||
147621424|NCT02861586|532431440|FG000|Overall Study|Adverse Event|0|||
147621425|NCT02861586|532431441|FG001|Overall Study|Adverse Event|0|||
147621426|NCT02861586|532431442|FG002|Overall Study|Adverse Event|0|||
147621427|NCT02861586|532431443|FG003|Overall Study|Adverse Event|0|||
147475032|NCT01458340|531898054|FG001|Overall Study|Withdrawal by Subject|6|||
147475033|NCT01458340|531898055|FG002|Overall Study|Withdrawal by Subject|4|||
147475034|NCT01702805|531898060|FG000|Overall Study|Data withdrawn prior to hospital discharge|3|||
147475035|NCT01702805|531898061|FG001|Overall Study|Data withdrawn prior to hospital discharge|7|||
147475036|NCT01702805|531898060|FG000|Overall Study|Incomplete Follow-up|18|||
147475037|NCT01702805|531898061|FG001|Overall Study|Incomplete Follow-up|15|||
147621428|NCT02861586|532431444|FG004|Overall Study|Adverse Event|0|||
147621429|NCT02861586|532431445|FG005|Overall Study|Adverse Event|1|||
147666596|NCT03292016|532603992|FG002|Second Washout|Adverse Event|0|||
147475038|NCT01702805|531898060|FG000|Overall Study|Vital Status Assessment Only|40|||
147621430|NCT02861586|532431446|FG006|Overall Study|Adverse Event|0|||
147621431|NCT02861586|532431447|FG007|Overall Study|Adverse Event|0|||
147621432|NCT04581824|532431449|FG000|Overall Study|Lost to Follow-up|1|||
147621433|NCT04581824|532431450|FG001|Overall Study|Lost to Follow-up|0|||
147621434|NCT04581824|532431449|FG000|Overall Study|Withdrawal by Subject|2|||
147475039|NCT01702805|531898061|FG001|Overall Study|Vital Status Assessment Only|39|||
147621435|NCT04581824|532431450|FG001|Overall Study|Withdrawal by Subject|7|||
147621436|NCT04581824|532431449|FG000|Overall Study|Study terminated by sponsor|37|||
147621437|NCT04581824|532431450|FG001|Overall Study|Study terminated by sponsor|23|||
147666597|NCT03292016|532603993|FG003|Second Washout|Adverse Event|0|||
147666598|NCT03292016|532603994|FG004|Second Washout|Adverse Event|0|||
147666599|NCT03292016|532603995|FG005|Second Washout|Adverse Event|0|||
147666600|NCT01909804|532604000|FG000|Overall Study|Randomized but Never Treated|0|||
147666601|NCT01909804|532604001|FG001|Overall Study|Randomized but Never Treated|0|||
147666602|NCT01909804|532604002|FG002|Overall Study|Randomized but Never Treated|0|||
147666603|NCT01909804|532604003|FG003|Overall Study|Randomized but Never Treated|0|||
147666604|NCT01909804|532604004|FG004|Overall Study|Randomized but Never Treated|0|||
147666605|NCT01909804|532604005|FG005|Overall Study|Randomized but Never Treated|0|||
147666606|NCT01909804|532604006|FG006|Overall Study|Randomized but Never Treated|1|||
147666607|NCT01909804|532604007|FG007|Overall Study|Randomized but Never Treated|0|||
147666608|NCT01909804|532604008|FG008|Overall Study|Randomized but Never Treated|0|||
147666609|NCT01909804|532604009|FG009|Overall Study|Randomized but Never Treated|0|||
147666610|NCT01909804|532604010|FG010|Overall Study|Randomized but Never Treated|0|||
147666611|NCT01909804|532604011|FG011|Overall Study|Randomized but Never Treated|1|||
147666612|NCT01909804|532604000|FG000|Overall Study|Death|0|||
147666613|NCT01909804|532604001|FG001|Overall Study|Death|0|||
147666614|NCT01909804|532604002|FG002|Overall Study|Death|0|||
147666615|NCT01909804|532604003|FG003|Overall Study|Death|0|||
147666616|NCT01909804|532604004|FG004|Overall Study|Death|0|||
147666617|NCT01909804|532604005|FG005|Overall Study|Death|0|||
147666618|NCT01909804|532604006|FG006|Overall Study|Death|0|||
147666619|NCT01909804|532604007|FG007|Overall Study|Death|0|||
147666620|NCT01909804|532604008|FG008|Overall Study|Death|0|||
147666621|NCT01909804|532604009|FG009|Overall Study|Death|0|||
147666622|NCT01909804|532604010|FG010|Overall Study|Death|1|||
147666623|NCT01909804|532604011|FG011|Overall Study|Death|0|||
147666624|NCT01909804|532604000|FG000|Overall Study|Lack of Efficacy|4|||
147666625|NCT01909804|532604001|FG001|Overall Study|Lack of Efficacy|1|||
147666626|NCT01909804|532604002|FG002|Overall Study|Lack of Efficacy|0|||
147666627|NCT01909804|532604003|FG003|Overall Study|Lack of Efficacy|0|||
147666628|NCT01909804|532604004|FG004|Overall Study|Lack of Efficacy|7|||
147666629|NCT01909804|532604005|FG005|Overall Study|Lack of Efficacy|3|||
147666630|NCT01909804|532604006|FG006|Overall Study|Lack of Efficacy|1|||
147666631|NCT01909804|532604007|FG007|Overall Study|Lack of Efficacy|1|||
147666632|NCT01909804|532604008|FG008|Overall Study|Lack of Efficacy|0|||
147666633|NCT01909804|532604009|FG009|Overall Study|Lack of Efficacy|1|||
147666634|NCT01909804|532604010|FG010|Overall Study|Lack of Efficacy|0|||
147666635|NCT01909804|532604011|FG011|Overall Study|Lack of Efficacy|1|||
147666636|NCT01909804|532604000|FG000|Overall Study|Withdrew Consent|0|||
147666637|NCT01909804|532604001|FG001|Overall Study|Withdrew Consent|0|||
147666638|NCT01909804|532604002|FG002|Overall Study|Withdrew Consent|0|||
147666639|NCT01909804|532604003|FG003|Overall Study|Withdrew Consent|0|||
147666640|NCT01909804|532604004|FG004|Overall Study|Withdrew Consent|1|||
147666641|NCT01909804|532604005|FG005|Overall Study|Withdrew Consent|1|||
147666642|NCT01909804|532604006|FG006|Overall Study|Withdrew Consent|0|||
147666643|NCT01909804|532604007|FG007|Overall Study|Withdrew Consent|0|||
147666644|NCT01909804|532604008|FG008|Overall Study|Withdrew Consent|0|||
147666645|NCT01909804|532604009|FG009|Overall Study|Withdrew Consent|0|||
147666646|NCT01909804|532604010|FG010|Overall Study|Withdrew Consent|0|||
147666647|NCT01909804|532604011|FG011|Overall Study|Withdrew Consent|0|||
147666648|NCT01909804|532604000|FG000|Overall Study|Protocol Violation|0|||
147666649|NCT01909804|532604001|FG001|Overall Study|Protocol Violation|0|||
147666650|NCT01909804|532604002|FG002|Overall Study|Protocol Violation|0|||
147666651|NCT01909804|532604003|FG003|Overall Study|Protocol Violation|0|||
147666652|NCT01909804|532604004|FG004|Overall Study|Protocol Violation|0|||
147666653|NCT01909804|532604005|FG005|Overall Study|Protocol Violation|0|||
147666654|NCT01909804|532604006|FG006|Overall Study|Protocol Violation|0|||
147666655|NCT01909804|532604007|FG007|Overall Study|Protocol Violation|0|||
147666656|NCT01909804|532604008|FG008|Overall Study|Protocol Violation|0|||
147666657|NCT01909804|532604009|FG009|Overall Study|Protocol Violation|0|||
147666658|NCT01909804|532604010|FG010|Overall Study|Protocol Violation|0|||
147666659|NCT01909804|532604011|FG011|Overall Study|Protocol Violation|1|||
147666660|NCT01038687|532604012|FG000|Overall Study|Adverse Event|0|||
147666661|NCT01038687|532604013|FG001|Overall Study|Adverse Event|2|||
147666662|NCT01038687|532604014|FG002|Overall Study|Adverse Event|1|||
147666663|NCT05401565|532604015|FG000|Overall Study|Lost to Follow-up|1|||
147666664|NCT05401565|532604016|FG001|Overall Study|Lost to Follow-up|0|||
147666665|NCT05401565|532604015|FG000|Overall Study|Adverse Event|2|||
147666666|NCT05401565|532604016|FG001|Overall Study|Adverse Event|0|||
147666667|NCT03118934|532605793|FG000|Overall Study|Adverse Event|0|||
147666668|NCT03118934|532605794|FG001|Overall Study|Adverse Event|0|||
147666669|NCT03118934|532605795|FG002|Overall Study|Adverse Event|0|||
147666670|NCT03118934|532605796|FG003|Overall Study|Adverse Event|0|||
147666671|NCT03118934|532605797|FG004|Overall Study|Adverse Event|0|||
147666672|NCT03118934|532605798|FG005|Overall Study|Adverse Event|1|||
147666673|NCT03118934|532605793|FG000|Overall Study|Physician Decision|0|||
147666674|NCT03118934|532605794|FG001|Overall Study|Physician Decision|0|||
147666675|NCT03118934|532605795|FG002|Overall Study|Physician Decision|0|||
147666676|NCT03118934|532605796|FG003|Overall Study|Physician Decision|0|||
147475040|NCT01702805|531898060|FG000|Overall Study|Lost to Follow-up|5|||
147475041|NCT01702805|531898061|FG001|Overall Study|Lost to Follow-up|5|||
147475042|NCT04876391|531898062|FG000|Overall Study|Withdrawal by Subject|1|||
147475043|NCT04876391|531898063|FG001|Overall Study|Withdrawal by Subject|10|||
147475044|NCT04876391|531898062|FG000|Overall Study|Lost to Follow-up|2|||
147475045|NCT04876391|531898063|FG001|Overall Study|Lost to Follow-up|4|||
147475046|NCT04876391|531898062|FG000|Overall Study|Lack of Efficacy|0|||
147475047|NCT04876391|531898063|FG001|Overall Study|Lack of Efficacy|2|||
147475048|NCT04876391|531898062|FG000|Overall Study|Adverse Event|3|||
147475049|NCT04876391|531898063|FG001|Overall Study|Adverse Event|1|||
147475050|NCT04876391|531898062|FG000|Overall Study|Patient non-compliance|0|||
147475051|NCT04876391|531898063|FG001|Overall Study|Patient non-compliance|1|||
147475052|NCT04876391|531898062|FG000|Overall Study|Personal reasons|0|||
147475053|NCT04876391|531898063|FG001|Overall Study|Personal reasons|1|||
147475054|NCT04876391|531898062|FG000|Overall Study|Withdrawn as per protocol|2|||
147475055|NCT04876391|531898063|FG001|Overall Study|Withdrawn as per protocol|2|||
147475056|NCT02286960|531898064|FG000|Overall Study|Lost to Follow-up|3|||
147475057|NCT02286960|531898065|FG001|Overall Study|Lost to Follow-up|3|||
147475058|NCT02317510|531898067|FG000|Overall Study|Adverse Event|0|||
147475059|NCT02317510|531898068|FG001|Overall Study|Adverse Event|1|||
147475060|NCT03427073|531898069|FG000|Overall Study|Disease Progression|1|||
147475061|NCT03427073|531898070|FG001|Overall Study|Disease Progression|1|||
147475062|NCT03427073|531898071|FG002|Overall Study|Disease Progression|1|||
147475063|NCT03427073|531898072|FG003|Overall Study|Disease Progression|3|||
147475064|NCT03427073|531898073|FG004|Overall Study|Disease Progression|3|||
147475065|NCT03427073|531898074|FG005|Overall Study|Disease Progression|4|||
147475066|NCT03427073|531898075|FG006|Overall Study|Disease Progression|2|||
147475067|NCT03427073|531898076|FG007|Overall Study|Disease Progression|3|||
147475068|NCT03427073|531898069|FG000|Overall Study|Physician Decision|0|||
147475069|NCT03427073|531898070|FG001|Overall Study|Physician Decision|0|||
147475070|NCT03427073|531898071|FG002|Overall Study|Physician Decision|0|||
147475071|NCT03427073|531898072|FG003|Overall Study|Physician Decision|0|||
147475072|NCT03427073|531898073|FG004|Overall Study|Physician Decision|0|||
147475073|NCT03427073|531898074|FG005|Overall Study|Physician Decision|0|||
147475074|NCT03427073|531898075|FG006|Overall Study|Physician Decision|1|||
147475075|NCT03427073|531898076|FG007|Overall Study|Physician Decision|1|||
147475076|NCT01193335|531898079|FG000|After Infant Series|Lost to Follow-up|1|||
147475077|NCT01193335|531898080|FG001|After Infant Series|Lost to Follow-up|2|||
147475078|NCT01193335|531898079|FG000|After Infant Series|No Longer Met Eligibility Criteria|0|||
147475079|NCT01193335|531898080|FG001|After Infant Series|No Longer Met Eligibility Criteria|1|||
147475080|NCT01193335|531898079|FG000|1-Year Follow-up|No Longer Willing to Participate|7|||
147475081|NCT01193335|531898080|FG001|1-Year Follow-up|No Longer Willing to Participate|9|||
147475082|NCT01193335|531898079|FG000|1-Year Follow-up|Lost to Follow-up|4|||
147475083|NCT01193335|531898080|FG001|1-Year Follow-up|Lost to Follow-up|0|||
147475084|NCT01193335|531898079|FG000|2-Year Follow-up|No Longer Willing to Participate|5|||
147475085|NCT01193335|531898080|FG001|2-Year Follow-up|No Longer Willing to Participate|6|||
147475086|NCT01193335|531898079|FG000|2-Year Follow-up|No Longer Met Eligibility Criteria|2|||
147475087|NCT01193335|531898080|FG001|2-Year Follow-up|No Longer Met Eligibility Criteria|2|||
147475088|NCT01733329|531898081|FG000|Overall Study|Protocol Violation|1|||
147475089|NCT01733329|531898082|FG001|Overall Study|Protocol Violation|1|||
147475090|NCT01733329|531898081|FG000|Overall Study|Uterine artery injury|1|||
147475091|NCT01733329|531898082|FG001|Overall Study|Uterine artery injury|0|||
147475092|NCT02493751|531898090|FG000|Overall Study|Withdrawal by Subject|2|||
147475093|NCT02493751|531898091|FG001|Overall Study|Withdrawal by Subject|8|||
147621438|NCT04796909|532431451|FG000|Overall Study|Withdrawal by Subject|1|||
147621439|NCT04796909|532431452|FG001|Overall Study|Withdrawal by Subject|1|||
147621440|NCT04162847|532431453|FG000|Overall Study|Withdrawal by Subject|7|||
147621441|NCT04162847|532431454|FG001|Overall Study|Withdrawal by Subject|1|||
147621442|NCT04815083|532431455|FG000|Overall Study|Physician Decision|1|||
147621443|NCT04815083|532431455|FG000|Overall Study|Study pause|2|||
147621444|NCT04815083|532431455|FG000|Overall Study|Screening failure|4|||
147666677|NCT03118934|532605797|FG004|Overall Study|Physician Decision|0|||
147475094|NCT02493751|531898090|FG000|Overall Study|Death|6|||
147475095|NCT02493751|531898091|FG001|Overall Study|Death|13|||
147475096|NCT02493751|531898090|FG000|Overall Study|Lost to Follow-up|2|||
147475097|NCT02493751|531898091|FG001|Overall Study|Lost to Follow-up|3|||
147475098|NCT02493751|531898090|FG000|Overall Study|Study closed by Sponsor due to an internal decision with no safety concerns related.|6|||
147475099|NCT02493751|531898091|FG001|Overall Study|Study closed by Sponsor due to an internal decision with no safety concerns related.|15|||
147475100|NCT00184054|531898092|FG000|Overall Study|Adverse Event|1|||
147475101|NCT02485717|531898097|FG000|Overall Study|Lost to Follow-up|6|||
147475102|NCT02485717|531898098|FG001|Overall Study|Lost to Follow-up|0|||
147621445|NCT01892501|532431456|FG000|Overall Study|Protocol Violation|2|||
147475103|NCT02485717|531898099|FG002|Overall Study|Lost to Follow-up|0|||
147475104|NCT02485717|531898097|FG000|Overall Study|Withdrawal by Subject|0|||
147475105|NCT02485717|531898098|FG001|Overall Study|Withdrawal by Subject|0|||
147621446|NCT01892501|532431456|FG000|Overall Study|Puncture not carried out|9|||
147666678|NCT03118934|532605798|FG005|Overall Study|Physician Decision|1|||
147475106|NCT02485717|531898099|FG002|Overall Study|Withdrawal by Subject|1|||
147475107|NCT02485717|531898097|FG000|Overall Study|Did Not Meet Exclusion Criteria #2|0|||
147475108|NCT02485717|531898098|FG001|Overall Study|Did Not Meet Exclusion Criteria #2|1|||
147475109|NCT02485717|531898099|FG002|Overall Study|Did Not Meet Exclusion Criteria #2|0|||
147475110|NCT02485717|531898097|FG000|Overall Study|Did Not Meet Exclusion Criteria #12|0|||
147475111|NCT02485717|531898098|FG001|Overall Study|Did Not Meet Exclusion Criteria #12|1|||
147475112|NCT02485717|531898099|FG002|Overall Study|Did Not Meet Exclusion Criteria #12|0|||
147475113|NCT02192359|531898100|FG000|Overall Study|Taken off study treatment due to persistent gr 2 decreased platelets requiring transfusions|0|||
147475114|NCT02192359|531898101|FG001|Overall Study|Taken off study treatment due to persistent gr 2 decreased platelets requiring transfusions|0|||
147475115|NCT02192359|531898102|FG002|Overall Study|Taken off study treatment due to persistent gr 2 decreased platelets requiring transfusions|1|||
147475116|NCT02192359|531898103|FG003|Overall Study|Taken off study treatment due to persistent gr 2 decreased platelets requiring transfusions|0|||
147475117|NCT02192359|531898100|FG000|Overall Study|Could not receive irinotecan due to low KPS score post surgery|1|||
147475118|NCT02192359|531898101|FG001|Overall Study|Could not receive irinotecan due to low KPS score post surgery|0|||
147475119|NCT02192359|531898102|FG002|Overall Study|Could not receive irinotecan due to low KPS score post surgery|0|||
147475120|NCT02192359|531898103|FG003|Overall Study|Could not receive irinotecan due to low KPS score post surgery|0|||
147475121|NCT02192359|531898100|FG000|Overall Study|Taken off study treatment to catheter infection not related to treatment|0|||
147475122|NCT02192359|531898101|FG001|Overall Study|Taken off study treatment to catheter infection not related to treatment|0|||
147475123|NCT02192359|531898102|FG002|Overall Study|Taken off study treatment to catheter infection not related to treatment|0|||
147475124|NCT02192359|531898103|FG003|Overall Study|Taken off study treatment to catheter infection not related to treatment|1|||
147475125|NCT01450540|531898104|FG000|Overall Study|Withdrawal by Subject|19|||
147475126|NCT01450540|531898105|FG001|Overall Study|Withdrawal by Subject|13|||
147475127|NCT01450540|531898104|FG000|Overall Study|protocol deviation|3|||
147475128|NCT01450540|531898105|FG001|Overall Study|protocol deviation|23|||
147475129|NCT03598777|531898112|FG000|Overall Study|Study Terminated by Sponsor|3|||
147475130|NCT03598777|531898113|FG001|Overall Study|Study Terminated by Sponsor|0|||
147475131|NCT03598777|531898114|FG002|Overall Study|Study Terminated by Sponsor|0|||
147475132|NCT03598777|531898115|FG003|Overall Study|Study Terminated by Sponsor|0|||
147475133|NCT03598777|531898116|FG004|Overall Study|Study Terminated by Sponsor|15|||
147475134|NCT03598777|531898112|FG000|Overall Study|Withdrawal by Subject|1|||
147475135|NCT03598777|531898113|FG001|Overall Study|Withdrawal by Subject|1|||
147475136|NCT03598777|531898114|FG002|Overall Study|Withdrawal by Subject|0|||
147475137|NCT03598777|531898115|FG003|Overall Study|Withdrawal by Subject|0|||
147475138|NCT03598777|531898116|FG004|Overall Study|Withdrawal by Subject|0|||
147475139|NCT03598777|531898112|FG000|Overall Study|Adverse Event|1|||
147475140|NCT03598777|531898113|FG001|Overall Study|Adverse Event|0|||
147475141|NCT03598777|531898114|FG002|Overall Study|Adverse Event|0|||
147475142|NCT03598777|531898115|FG003|Overall Study|Adverse Event|0|||
147475143|NCT03598777|531898116|FG004|Overall Study|Adverse Event|0|||
147475144|NCT03598777|531898112|FG000|Overall Study|Lost to Follow-up|1|||
147475145|NCT03598777|531898113|FG001|Overall Study|Lost to Follow-up|0|||
147475146|NCT03598777|531898114|FG002|Overall Study|Lost to Follow-up|0|||
147475147|NCT03598777|531898115|FG003|Overall Study|Lost to Follow-up|0|||
147475148|NCT03598777|531898116|FG004|Overall Study|Lost to Follow-up|0|||
147475149|NCT02006576|531898117|FG000|Overall Study|Withdrawal by Subject|4|||
147475150|NCT02006576|531898118|FG001|Overall Study|Withdrawal by Subject|6|||
147475151|NCT02006576|531898119|FG002|Overall Study|Withdrawal by Subject|2|||
147475152|NCT02006576|531898117|FG000|Overall Study|Death|0|||
147475153|NCT02006576|531898118|FG001|Overall Study|Death|0|||
147475154|NCT02006576|531898119|FG002|Overall Study|Death|1|||
147475155|NCT02006576|531898117|FG000|Overall Study|Lost to Follow-up|1|||
147475156|NCT02006576|531898118|FG001|Overall Study|Lost to Follow-up|0|||
147475157|NCT02006576|531898119|FG002|Overall Study|Lost to Follow-up|1|||
147475158|NCT02006576|531898117|FG000|Overall Study|Screen Failure, too sick, other|13|||
147475159|NCT02006576|531898118|FG001|Overall Study|Screen Failure, too sick, other|1|||
147475160|NCT02006576|531898119|FG002|Overall Study|Screen Failure, too sick, other|13|||
147475161|NCT00785577|531898120|FG000|Study Period 2: Therapy Phase|Adverse Event|5|||
147475162|NCT00785577|531898121|FG001|Study Period 2: Therapy Phase|Adverse Event|7|||
147475163|NCT00785577|531898122|FG002|Study Period 2: Therapy Phase|Adverse Event|14|||
147475164|NCT00785577|531898123|FG003|Study Period 2: Therapy Phase|Adverse Event|10|||
147475165|NCT00785577|531898124|FG004|Study Period 2: Therapy Phase|Adverse Event|17|||
147475166|NCT00785577|531898120|FG000|Study Period 2: Therapy Phase|Lack of Efficacy|0|||
147475167|NCT00785577|531898121|FG001|Study Period 2: Therapy Phase|Lack of Efficacy|0|||
147475168|NCT00785577|531898122|FG002|Study Period 2: Therapy Phase|Lack of Efficacy|0|||
147475169|NCT00785577|531898123|FG003|Study Period 2: Therapy Phase|Lack of Efficacy|0|||
147475170|NCT00785577|531898124|FG004|Study Period 2: Therapy Phase|Lack of Efficacy|1|||
147475171|NCT00785577|531898120|FG000|Study Period 2: Therapy Phase|Lost to Follow-up|0|||
147475172|NCT00785577|531898121|FG001|Study Period 2: Therapy Phase|Lost to Follow-up|0|||
147475173|NCT00785577|531898122|FG002|Study Period 2: Therapy Phase|Lost to Follow-up|0|||
147475174|NCT00785577|531898123|FG003|Study Period 2: Therapy Phase|Lost to Follow-up|1|||
147475175|NCT00785577|531898124|FG004|Study Period 2: Therapy Phase|Lost to Follow-up|0|||
147475176|NCT00785577|531898120|FG000|Study Period 2: Therapy Phase|Physician Decision|1|||
147475177|NCT00785577|531898121|FG001|Study Period 2: Therapy Phase|Physician Decision|0|||
147475178|NCT00785577|531898122|FG002|Study Period 2: Therapy Phase|Physician Decision|0|||
147475179|NCT00785577|531898123|FG003|Study Period 2: Therapy Phase|Physician Decision|0|||
147475180|NCT00785577|531898124|FG004|Study Period 2: Therapy Phase|Physician Decision|0|||
147475181|NCT00785577|531898120|FG000|Study Period 2: Therapy Phase|Protocol Violation|1|||
147475182|NCT00785577|531898121|FG001|Study Period 2: Therapy Phase|Protocol Violation|1|||
147475183|NCT00785577|531898122|FG002|Study Period 2: Therapy Phase|Protocol Violation|1|||
147475184|NCT00785577|531898123|FG003|Study Period 2: Therapy Phase|Protocol Violation|0|||
147475185|NCT00785577|531898124|FG004|Study Period 2: Therapy Phase|Protocol Violation|1|||
147475186|NCT00785577|531898120|FG000|Study Period 2: Therapy Phase|Withdrawal by Subject|2|||
147475187|NCT00785577|531898121|FG001|Study Period 2: Therapy Phase|Withdrawal by Subject|1|||
147475188|NCT00785577|531898122|FG002|Study Period 2: Therapy Phase|Withdrawal by Subject|1|||
147475189|NCT00785577|531898123|FG003|Study Period 2: Therapy Phase|Withdrawal by Subject|0|||
147475190|NCT00785577|531898124|FG004|Study Period 2: Therapy Phase|Withdrawal by Subject|1|||
147475191|NCT00785577|531898120|FG000|Study Period 2: Therapy Phase|Entry Criteria Exclusion|1|||
147475192|NCT00785577|531898121|FG001|Study Period 2: Therapy Phase|Entry Criteria Exclusion|0|||
147475193|NCT00785577|531898122|FG002|Study Period 2: Therapy Phase|Entry Criteria Exclusion|1|||
147475194|NCT00785577|531898123|FG003|Study Period 2: Therapy Phase|Entry Criteria Exclusion|1|||
147475195|NCT00785577|531898124|FG004|Study Period 2: Therapy Phase|Entry Criteria Exclusion|0|||
147475196|NCT00785577|531898120|FG000|Study Period 2: Therapy Phase|Sponsor Decision|1|||
147475197|NCT00785577|531898121|FG001|Study Period 2: Therapy Phase|Sponsor Decision|0|||
147475198|NCT00785577|531898122|FG002|Study Period 2: Therapy Phase|Sponsor Decision|1|||
147475199|NCT00785577|531898123|FG003|Study Period 2: Therapy Phase|Sponsor Decision|1|||
147475200|NCT00785577|531898124|FG004|Study Period 2: Therapy Phase|Sponsor Decision|0|||
147475201|NCT00785577|531898120|FG000|Study Period 3: 1-Week Washout Phase|Adverse Event|0|||
147475202|NCT00785577|531898121|FG001|Study Period 3: 1-Week Washout Phase|Adverse Event|0|||
147475203|NCT00785577|531898122|FG002|Study Period 3: 1-Week Washout Phase|Adverse Event|0|||
147475204|NCT00785577|531898123|FG003|Study Period 3: 1-Week Washout Phase|Adverse Event|1|||
147475205|NCT00785577|531898124|FG004|Study Period 3: 1-Week Washout Phase|Adverse Event|0|||
147475206|NCT00785577|531898120|FG000|Study Period 3: 1-Week Washout Phase|Death|0|||
147475207|NCT00785577|531898121|FG001|Study Period 3: 1-Week Washout Phase|Death|0|||
147475208|NCT00785577|531898122|FG002|Study Period 3: 1-Week Washout Phase|Death|0|||
147475209|NCT00785577|531898123|FG003|Study Period 3: 1-Week Washout Phase|Death|0|||
147475210|NCT00785577|531898124|FG004|Study Period 3: 1-Week Washout Phase|Death|1|||
147475211|NCT01650805|531898127|FG000|Overall Study|Withdrawal by Subject|1|||
147475212|NCT01650805|531898128|FG001|Overall Study|Withdrawal by Subject|0|||
147475213|NCT02332915|531898129|FG000|Overall Study|Moved out of region|3|||
147475214|NCT02332915|531898130|FG001|Overall Study|Moved out of region|0|||
147475215|NCT02332915|531898129|FG000|Overall Study|Unrelated illness|1|||
147475216|NCT02332915|531898130|FG001|Overall Study|Unrelated illness|1|||
147475217|NCT02332915|531898129|FG000|Overall Study|Travel distance prohibitive|0|||
147475218|NCT02332915|531898130|FG001|Overall Study|Travel distance prohibitive|1|||
147475219|NCT02332915|531898129|FG000|Overall Study|did not meet inclusion criteria|2|||
147475220|NCT02332915|531898130|FG001|Overall Study|did not meet inclusion criteria|4|||
147475221|NCT01901328|531898134|FG000|Overall Study|Lost to Follow-up|1|||
147475222|NCT01901328|531898135|FG001|Overall Study|Lost to Follow-up|0|||
147475223|NCT01901328|531898134|FG000|Overall Study|Physician Decision|0|||
147475224|NCT01901328|531898135|FG001|Overall Study|Physician Decision|1|||
147475225|NCT01901328|531898134|FG000|Overall Study|Protocol Violation|1|||
147475226|NCT01901328|531898135|FG001|Overall Study|Protocol Violation|1|||
147475227|NCT01901328|531898134|FG000|Overall Study|Study Terminated by Sponsor|19|||
147475228|NCT01901328|531898135|FG001|Overall Study|Study Terminated by Sponsor|16|||
147475229|NCT01901328|531898134|FG000|Overall Study|Withdrawal by Subject|1|||
147475230|NCT01901328|531898135|FG001|Overall Study|Withdrawal by Subject|2|||
147475231|NCT01901328|531898134|FG000|Overall Study|Lack of Efficacy|0|||
147475232|NCT01901328|531898135|FG001|Overall Study|Lack of Efficacy|1|||
147527292|NCT04120116|532084205|FG003|Overall Study|Subject was deemed to not meet the inclusion criteria for SNHL after dose was administered|0|||
147527293|NCT00965458|532084206|FG000|Overall Study|Adverse Event|1|||
147527294|NCT00965458|532084207|FG001|Overall Study|Adverse Event|0|||
147527295|NCT00965458|532084206|FG000|Overall Study|Lost to Follow-up|1|||
147527296|NCT00965458|532084207|FG001|Overall Study|Lost to Follow-up|3|||
147527297|NCT00965458|532084206|FG000|Overall Study|Withdrawal by Subject|0|||
147527298|NCT00965458|532084207|FG001|Overall Study|Withdrawal by Subject|1|||
147527299|NCT05111548|532084209|FG000|Overall Study|Withdrawal by Subject|2|||
147527300|NCT05111548|532084210|FG001|Overall Study|Withdrawal by Subject|1|||
147527301|NCT05111548|532084209|FG000|Overall Study|Adverse Event|1|||
147527302|NCT05111548|532084210|FG001|Overall Study|Adverse Event|0|||
147527303|NCT01846039|532084211|FG000|Overall Study|Protocol Violation|1|||
147527304|NCT01846039|532084211|FG000|Overall Study|Subject Withdrew Consent|1|||
147527305|NCT00594958|532084212|FG000|Overall Study|Withdrawal by Subject|1|||
147666679|NCT03118934|532605793|FG000|Overall Study|Discontinued prior to exposure|0|||
147666680|NCT03118934|532605794|FG001|Overall Study|Discontinued prior to exposure|1|||
147666681|NCT03118934|532605795|FG002|Overall Study|Discontinued prior to exposure|1|||
147666682|NCT03118934|532605796|FG003|Overall Study|Discontinued prior to exposure|1|||
147666683|NCT03118934|532605797|FG004|Overall Study|Discontinued prior to exposure|2|||
147666684|NCT03118934|532605798|FG005|Overall Study|Discontinued prior to exposure|0|||
147666685|NCT03080935|532605799|FG000|Overall Study|Death|34|||
147666686|NCT03080935|532605800|FG001|Overall Study|Death|50|||
147666687|NCT03080935|532605799|FG000|Overall Study|Lost to Follow-up|5|||
147666688|NCT03080935|532605800|FG001|Overall Study|Lost to Follow-up|4|||
147666689|NCT03080935|532605799|FG000|Overall Study|Withdrawal by Subject|11|||
147666690|NCT03080935|532605800|FG001|Overall Study|Withdrawal by Subject|15|||
147666691|NCT04249427|532605803|FG000|Overall Study|Adverse Event|3|||
147666692|NCT04249427|532605804|FG001|Overall Study|Adverse Event|1|||
147666693|NCT04249427|532605803|FG000|Overall Study|Lack of Efficacy|0|||
147666694|NCT04249427|532605804|FG001|Overall Study|Lack of Efficacy|1|||
147666695|NCT04249427|532605803|FG000|Overall Study|Withdrawal by Subject|1|||
147666696|NCT04249427|532605804|FG001|Overall Study|Withdrawal by Subject|2|||
147666697|NCT03886272|532605805|FG000|Period 1|Withdrawal by Subject|0|||
147666698|NCT03886272|532605806|FG001|Period 1|Withdrawal by Subject|0|||
147666699|NCT03886272|532605807|FG002|Period 1|Withdrawal by Subject|0|||
147666700|NCT03886272|532605808|FG003|Period 1|Withdrawal by Subject|0|||
147666701|NCT03886272|532605809|FG004|Period 1|Withdrawal by Subject|0|||
147666702|NCT03886272|532605810|FG005|Period 1|Withdrawal by Subject|1|||
147666703|NCT03886272|532605811|FG006|Period 1|Withdrawal by Subject|0|||
147666704|NCT02895347|532605814|FG000|Overall Study|Withdrawal by Subject|3|||
147666705|NCT02895347|532605815|FG001|Overall Study|Withdrawal by Subject|1|||
147666706|NCT01673178|532605819|FG000|Overall Study|Lost to Follow-up|0|||
147666707|NCT01673178|532605820|FG001|Overall Study|Lost to Follow-up|1|||
147666708|NCT01673178|532605821|FG002|Overall Study|Lost to Follow-up|0|||
147666709|NCT01673178|532605822|FG003|Overall Study|Lost to Follow-up|0|||
147666710|NCT01673178|532605823|FG004|Overall Study|Lost to Follow-up|0|||
147666711|NCT01673178|532605819|FG000|Overall Study|Withdrawal by Subject|0|||
147666712|NCT01673178|532605820|FG001|Overall Study|Withdrawal by Subject|0|||
147666713|NCT01673178|532605821|FG002|Overall Study|Withdrawal by Subject|1|||
147666714|NCT01673178|532605822|FG003|Overall Study|Withdrawal by Subject|4|||
147666715|NCT01673178|532605823|FG004|Overall Study|Withdrawal by Subject|2|||
147666716|NCT01673178|532605819|FG000|Overall Study|Protocol Violation|1|||
147666717|NCT01673178|532605820|FG001|Overall Study|Protocol Violation|1|||
147666718|NCT01673178|532605821|FG002|Overall Study|Protocol Violation|0|||
147666719|NCT01673178|532605822|FG003|Overall Study|Protocol Violation|1|||
147666720|NCT01673178|532605823|FG004|Overall Study|Protocol Violation|0|||
147666721|NCT01673178|532605819|FG000|Overall Study|Adverse Event|1|||
147666722|NCT01673178|532605820|FG001|Overall Study|Adverse Event|0|||
147666723|NCT01673178|532605821|FG002|Overall Study|Adverse Event|0|||
147666724|NCT01673178|532605822|FG003|Overall Study|Adverse Event|2|||
147666725|NCT01673178|532605823|FG004|Overall Study|Adverse Event|0|||
147666726|NCT01673178|532605819|FG000|Overall Study|Other|1|||
147666727|NCT01673178|532605820|FG001|Overall Study|Other|0|||
147475233|NCT01981187|531899802|FG000|Overall Study|Participant/guardian decision|2|||
147475234|NCT01981187|531899802|FG000|Overall Study|Physician Decision|1|||
147475235|NCT01981187|531899802|FG000|Overall Study|Disease progression|2|||
147475236|NCT01981187|531899802|FG000|Overall Study|Adverse Event|7|||
147475237|NCT01362322|531899803|FG000|Overall Study|Withdrawal by Subject|3|||
147475238|NCT01362322|531899804|FG001|Overall Study|Withdrawal by Subject|1|||
147475239|NCT01362322|531899803|FG000|Overall Study|Lost to Follow-up|2|||
147475240|NCT01362322|531899804|FG001|Overall Study|Lost to Follow-up|6|||
147475241|NCT02874794|531899807|FG000|Overall Study|Physician Decision|3|||
147475242|NCT02874794|531899808|FG001|Overall Study|Physician Decision|2|||
147475243|NCT02874794|531899807|FG000|Overall Study|Withdrawal by Subject|2|||
147475244|NCT02874794|531899808|FG001|Overall Study|Withdrawal by Subject|8|||
147475245|NCT02874794|531899807|FG000|Overall Study|Death|2|||
147475246|NCT02874794|531899808|FG001|Overall Study|Death|1|||
147666728|NCT01673178|532605821|FG002|Overall Study|Other|2|||
147666729|NCT01673178|532605822|FG003|Overall Study|Other|1|||
147666730|NCT01673178|532605823|FG004|Overall Study|Other|0|||
147666731|NCT02557399|532605824|FG000|Overall Study|Adverse Event|6|||
147666732|NCT02557399|532605825|FG001|Overall Study|Adverse Event|5|||
147666733|NCT02557399|532605824|FG000|Overall Study|Protocol Violation|0|||
147666734|NCT02557399|532605825|FG001|Overall Study|Protocol Violation|1|||
147666735|NCT02557399|532605824|FG000|Overall Study|Protocol-defined stopping criteria|0|||
147666736|NCT02557399|532605825|FG001|Overall Study|Protocol-defined stopping criteria|1|||
147666737|NCT02557399|532605824|FG000|Overall Study|Withdrawal by Subject|1|||
147666738|NCT02557399|532605825|FG001|Overall Study|Withdrawal by Subject|1|||
147666739|NCT00931632|532605827|FG000|Overall Study|Withdrawal by Subject|2|||
147666740|NCT00931632|532605828|FG001|Overall Study|Withdrawal by Subject|3|||
147666741|NCT00931632|532605827|FG000|Overall Study|Adverse Event|19|||
147475247|NCT03839524|531899810|FG000|Overall Study|Adverse Event|1|||
147475248|NCT03715465|531899811|FG000|Overall Study|Withdrawal by Subject|1|||
147475249|NCT03715465|531899812|FG001|Overall Study|Withdrawal by Subject|2|||
147475250|NCT00917384|531899815|FG000|Overall Study|Lost to Follow-up|4|||
147475251|NCT00917384|531899816|FG001|Overall Study|Lost to Follow-up|2|||
147475252|NCT00917384|531899815|FG000|Overall Study|Withdrawal by Subject|10|||
147475253|NCT00917384|531899816|FG001|Overall Study|Withdrawal by Subject|2|||
147475254|NCT01451515|531899819|FG000|Overall Study|Death|0|||
147475255|NCT01451515|531899820|FG001|Overall Study|Death|1|||
147475256|NCT01451515|531899821|FG002|Overall Study|Death|0|||
147475257|NCT01451515|531899819|FG000|Overall Study|Withdrawal by Subject|0|||
147475258|NCT01451515|531899820|FG001|Overall Study|Withdrawal by Subject|1|||
147475259|NCT01451515|531899821|FG002|Overall Study|Withdrawal by Subject|0|||
147475260|NCT01451515|531899819|FG000|Overall Study|Development of unacceptable toxicity during treatment|0|||
147475261|NCT01451515|531899820|FG001|Overall Study|Development of unacceptable toxicity during treatment|0|||
147475262|NCT01451515|531899821|FG002|Overall Study|Development of unacceptable toxicity during treatment|1|||
147303195|NCT02243202|531276267|FG003|Overall Study|Randomized but not received treatment|1|||
147303196|NCT04382924|531276268|FG000|Overall Study|Death|2|||
147303197|NCT04382924|531276269|FG001|Overall Study|Death|5|||
147303198|NCT04382924|531276270|FG002|Overall Study|Death|4|||
147475263|NCT01451515|531899819|FG000|Overall Study|Relapse (except CNS)|1|||
147475264|NCT01451515|531899820|FG001|Overall Study|Relapse (except CNS)|1|||
147475265|NCT01451515|531899821|FG002|Overall Study|Relapse (except CNS)|0|||
147475266|NCT03717922|531899822|FG000|Overall Study|Lost to Follow-up|2|||
147475267|NCT03717922|531899823|FG001|Overall Study|Lost to Follow-up|2|||
147475268|NCT01575548|531899828|FG000|Overall Study|Adverse Event|15|||
147475269|NCT01575548|531899829|FG001|Overall Study|Adverse Event|2|||
147475270|NCT01575548|531899828|FG000|Overall Study|Disease progression|12|||
147475271|NCT01575548|531899829|FG001|Overall Study|Disease progression|25|||
147475272|NCT01575548|531899828|FG000|Overall Study|Death|1|||
147475273|NCT01575548|531899829|FG001|Overall Study|Death|0|||
147475274|NCT01575548|531899828|FG000|Overall Study|Other complicating disease|1|||
147475275|NCT01575548|531899829|FG001|Overall Study|Other complicating disease|0|||
147475276|NCT01575548|531899828|FG000|Overall Study|Withdrawal by Subject|7|||
147475277|NCT01575548|531899829|FG001|Overall Study|Withdrawal by Subject|3|||
147475278|NCT01575548|531899828|FG000|Overall Study|Noncompliance|1|||
147475279|NCT01575548|531899829|FG001|Overall Study|Noncompliance|0|||
147475280|NCT01575548|531899828|FG000|Overall Study|Anticipated surgery|0|||
147475281|NCT01575548|531899829|FG001|Overall Study|Anticipated surgery|1|||
147475282|NCT01575548|531899828|FG000|Overall Study|Never started protocol therapy|3|||
147475283|NCT01575548|531899829|FG001|Overall Study|Never started protocol therapy|2|||
147475284|NCT01486238|531899838|FG000|Overall Study|Death|0|||
147475285|NCT01486238|531899839|FG001|Overall Study|Death|2|||
147475286|NCT01486238|531899838|FG000|Overall Study|Withdrawal by Subject|2|||
147475287|NCT01486238|531899839|FG001|Overall Study|Withdrawal by Subject|1|||
147475288|NCT01486238|531899838|FG000|Overall Study|Lost to Follow-up|0|||
147621447|NCT01892501|532431456|FG000|Overall Study|Radiological monitoring not carried out|5|||
147621448|NCT01892501|532431456|FG000|Overall Study|Non-contributory histological result|12|||
147621449|NCT01439802|532431458|FG000|6 Weeks Postpartum Status|Lost to Follow-up|36|||
147621450|NCT01439802|532431458|FG000|6 Months Postpartum Status|Lost to Follow-up|12|||
147621451|NCT02383017|532431464|FG000|Overall Study|Injury Sustained Outside Study|1|||
147621452|NCT02383017|532431465|FG001|Overall Study|Injury Sustained Outside Study|0|||
147621453|NCT02383017|532431464|FG000|Overall Study|Compliance|3|||
147621454|NCT02383017|532431465|FG001|Overall Study|Compliance|2|||
147621455|NCT02383017|532431464|FG000|Overall Study|Found to be Hypogonadal|1|||
147621456|NCT02383017|532431465|FG001|Overall Study|Found to be Hypogonadal|0|||
147621457|NCT00927589|532431466|FG000|Overall Study|Death|1|||
147621458|NCT00927589|532431466|FG000|Overall Study|Physician Decision|1|||
147621459|NCT00927589|532431466|FG000|Overall Study|Withdrawal by Subject|3|||
147621460|NCT00927589|532431466|FG000|Overall Study|Adverse Event|2|||
147621461|NCT00927589|532431466|FG000|Overall Study|Disease Progression|8|||
147475289|NCT01486238|531899839|FG001|Overall Study|Lost to Follow-up|3|||
147475290|NCT00693706|531899844|FG000|Overall Study|Protocol Violation|0|||
147475291|NCT00693706|531899845|FG001|Overall Study|Protocol Violation|1|||
147475292|NCT04786210|531899847|FG000|Overall Study|Lost to Follow-up|2|||
147475293|NCT04786210|531899847|FG000|Overall Study|Withdrawal by Subject|4|||
147475294|NCT04334148|531899848|FG000|Overall Study|positive nasal swab at baseline|0|||
147475295|NCT04334148|531899849|FG001|Overall Study|positive nasal swab at baseline|1|||
147475296|NCT00498173|531899850|FG000|Phase 1-Blinded Randomization (8 weeks)|no post-baseline ratings|2|||
147475297|NCT00498173|531899851|FG001|Phase 1-Blinded Randomization (8 weeks)|no post-baseline ratings|1|||
147475298|NCT00498173|531899852|FG002|Phase 1-Blinded Randomization (8 weeks)|no post-baseline ratings|0|||
147475299|NCT06129487|531899853|FG000|Overall Study|Data loss was due to technical issues related to eye tracking.|198|||
147475300|NCT06129487|531899854|FG001|Overall Study|Data loss was due to technical issues related to eye tracking.|206|||
147621462|NCT00927589|532431466|FG000|Overall Study|Non-compliance|1|||
147621463|NCT01651117|532431470|FG000|Overall Study|Death|2|||
147621464|NCT01651117|532431471|FG001|Overall Study|Death|3|||
147621465|NCT01651117|532431472|FG002|Overall Study|Death|2|||
147621466|NCT01651117|532431473|FG003|Overall Study|Death|2|||
147475301|NCT00258154|531899855|FG000|Overall Study|Adverse Event|1|||
147475302|NCT00258154|531899856|FG001|Overall Study|Adverse Event|0|||
147475303|NCT00258154|531899855|FG000|Overall Study|Lost to Follow-up|0|||
147475304|NCT00258154|531899856|FG001|Overall Study|Lost to Follow-up|1|||
147475305|NCT00258154|531899855|FG000|Overall Study|Protocol Violation|2|||
147475306|NCT00258154|531899856|FG001|Overall Study|Protocol Violation|1|||
147475307|NCT00258154|531899855|FG000|Overall Study|Withdrawal by Subject|3|||
147475308|NCT00258154|531899856|FG001|Overall Study|Withdrawal by Subject|4|||
147475309|NCT00258154|531899855|FG000|Overall Study|Patient Moved|3|||
147475310|NCT00258154|531899856|FG001|Overall Study|Patient Moved|1|||
147475311|NCT03772327|531899857|FG000|Overall Study|Lost to Follow-up|3|||
147475312|NCT03772327|531899858|FG001|Overall Study|Lost to Follow-up|4|||
147475313|NCT03772327|531899857|FG000|Overall Study|Withdrawal by Subject|2|||
147475314|NCT03772327|531899858|FG001|Overall Study|Withdrawal by Subject|3|||
147475315|NCT04689828|531899859|FG000|Overall Study|Subject decision|5|||
147475316|NCT04689828|531899860|FG001|Overall Study|Subject decision|5|||
147475317|NCT04689828|531899859|FG000|Overall Study|Adverse Event|12|||
147475318|NCT04689828|531899860|FG001|Overall Study|Adverse Event|12|||
147475319|NCT04689828|531899859|FG000|Overall Study|Physician Decision|24|||
147475320|NCT04689828|531899860|FG001|Overall Study|Physician Decision|32|||
147475321|NCT04689828|531899859|FG000|Overall Study|Progressive disease|54|||
147475322|NCT04689828|531899860|FG001|Overall Study|Progressive disease|173|||
147475323|NCT04689828|531899859|FG000|Overall Study|Death|0|||
147475324|NCT04689828|531899860|FG001|Overall Study|Death|1|||
147475325|NCT04689828|531899859|FG000|Overall Study|Lost to Follow-up|1|||
147475326|NCT04689828|531899860|FG001|Overall Study|Lost to Follow-up|0|||
147475327|NCT04689828|531899859|FG000|Overall Study|Treated but excluded from FAS because of protocol deviation|1|||
147475328|NCT04689828|531899860|FG001|Overall Study|Treated but excluded from FAS because of protocol deviation|0|||
147475329|NCT04689828|531899859|FG000|Overall Study|Treatment ongoing at the data cut-off date of 1-Jan-2025|0|||
147475330|NCT04689828|531899860|FG001|Overall Study|Treatment ongoing at the data cut-off date of 1-Jan-2025|9|||
147475331|NCT04689828|531899859|FG000|Overall Study|Participants not treated|7|||
147475332|NCT04689828|531899860|FG001|Overall Study|Participants not treated|2|||
147475333|NCT00754390|531899867|FG000|Ca/Phytate Test Meal 1 (Randomized)|Withdrawal by Subject|3|||
147475334|NCT00754390|531899867|FG000|Ca/Phytate Test Meal 1 (Randomized)|Protocol Violation|2|||
147475335|NCT00754390|531899867|FG000|Ca/Phytate Test Meal 3 (Randomized)|Protocol Violation|1|||
147475336|NCT00754390|531899867|FG000|Ca/Phytate Test Meal 4 (Randomized)|Protocol Violation|1|||
147475337|NCT00847613|531899868|FG000|Overall Study|Ongoing at cut-off date|250|||
147475338|NCT00847613|531899869|FG001|Overall Study|Ongoing at cut-off date|265|||
147475339|NCT00847613|531899870|FG002|Overall Study|Ongoing at cut-off date|64|||
147475340|NCT00847613|531899871|FG003|Overall Study|Ongoing at cut-off date|64|||
147475341|NCT00847613|531899868|FG000|Overall Study|Death|1|||
147475342|NCT00847613|531899869|FG001|Overall Study|Death|1|||
147475343|NCT00847613|531899870|FG002|Overall Study|Death|0|||
147475344|NCT00847613|531899871|FG003|Overall Study|Death|0|||
147475345|NCT00847613|531899868|FG000|Overall Study|Adverse Event|36|||
147475346|NCT00847613|531899869|FG001|Overall Study|Adverse Event|26|||
147475347|NCT00847613|531899870|FG002|Overall Study|Adverse Event|5|||
147475348|NCT00847613|531899871|FG003|Overall Study|Adverse Event|6|||
147475349|NCT00847613|531899868|FG000|Overall Study|Lack of Efficacy|7|||
147475350|NCT00847613|531899869|FG001|Overall Study|Lack of Efficacy|3|||
147475351|NCT00847613|531899870|FG002|Overall Study|Lack of Efficacy|3|||
147475352|NCT00847613|531899871|FG003|Overall Study|Lack of Efficacy|1|||
147475353|NCT00847613|531899868|FG000|Overall Study|Study terminated by Sponsor|1|||
147475354|NCT00847613|531899869|FG001|Overall Study|Study terminated by Sponsor|0|||
147475355|NCT00847613|531899870|FG002|Overall Study|Study terminated by Sponsor|2|||
147475356|NCT00847613|531899871|FG003|Overall Study|Study terminated by Sponsor|1|||
147475357|NCT00847613|531899868|FG000|Overall Study|Lost to Follow-up|5|||
147666742|NCT00931632|532605828|FG001|Overall Study|Adverse Event|15|||
147666743|NCT01419314|532605830|FG000|Follow-up at Week 3 of the Trial|Withdrawal by Subject|3|||
147666744|NCT01419314|532605831|FG001|Follow-up at Week 3 of the Trial|Withdrawal by Subject|1|||
147666745|NCT01419314|532605830|FG000|Follow-up at Week 3 of the Trial|Lost to Follow-up|3|||
147475358|NCT00847613|531899869|FG001|Overall Study|Lost to Follow-up|0|||
147475359|NCT00847613|531899870|FG002|Overall Study|Lost to Follow-up|0|||
147475360|NCT00847613|531899871|FG003|Overall Study|Lost to Follow-up|3|||
147475361|NCT00847613|531899868|FG000|Overall Study|Protocol Violation|6|||
147475362|NCT00847613|531899869|FG001|Overall Study|Protocol Violation|6|||
147475363|NCT00847613|531899870|FG002|Overall Study|Protocol Violation|3|||
147475364|NCT00847613|531899871|FG003|Overall Study|Protocol Violation|1|||
147475365|NCT00847613|531899868|FG000|Overall Study|Pregnancy|1|||
147475366|NCT00847613|531899869|FG001|Overall Study|Pregnancy|1|||
147475367|NCT00847613|531899870|FG002|Overall Study|Pregnancy|0|||
147475368|NCT00847613|531899871|FG003|Overall Study|Pregnancy|0|||
147475369|NCT00847613|531899868|FG000|Overall Study|Site closure|1|||
147475370|NCT00847613|531899869|FG001|Overall Study|Site closure|0|||
147475371|NCT00847613|531899870|FG002|Overall Study|Site closure|0|||
147475372|NCT00847613|531899871|FG003|Overall Study|Site closure|1|||
147475373|NCT00847613|531899868|FG000|Overall Study|Withdrawal by Subject|8|||
147475374|NCT00847613|531899869|FG001|Overall Study|Withdrawal by Subject|11|||
147666746|NCT01419314|532605831|FG001|Follow-up at Week 3 of the Trial|Lost to Follow-up|0|||
147666747|NCT01419314|532605830|FG000|Follow-up at Week 6 of the Trial|Lost to Follow-up|1|||
147666748|NCT01419314|532605831|FG001|Follow-up at Week 6 of the Trial|Lost to Follow-up|2|||
147666749|NCT00402727|532605834|FG000|Overall Study|Adverse Event|10|||
147666750|NCT00402727|532605835|FG001|Overall Study|Adverse Event|6|||
147666751|NCT00402727|532605834|FG000|Overall Study|Death|1|||
147666752|NCT00402727|532605835|FG001|Overall Study|Death|0|||
147666753|NCT00402727|532605834|FG000|Overall Study|Lack of Efficacy|1|||
147666754|NCT00402727|532605835|FG001|Overall Study|Lack of Efficacy|3|||
147666755|NCT00402727|532605834|FG000|Overall Study|Lost to Follow-up|24|||
147666756|NCT00402727|532605835|FG001|Overall Study|Lost to Follow-up|11|||
147666757|NCT00402727|532605834|FG000|Overall Study|Physician Decision|1|||
147666758|NCT00402727|532605835|FG001|Overall Study|Physician Decision|1|||
147666759|NCT00402727|532605834|FG000|Overall Study|Protocol Violation|0|||
147666760|NCT00402727|532605835|FG001|Overall Study|Protocol Violation|4|||
147666761|NCT00402727|532605834|FG000|Overall Study|Withdrawal by Subject|3|||
147666762|NCT00402727|532605835|FG001|Overall Study|Withdrawal by Subject|7|||
147666763|NCT00402727|532605834|FG000|Overall Study|supply problems|2|||
147666764|NCT00402727|532605835|FG001|Overall Study|supply problems|1|||
147666765|NCT00402727|532605834|FG000|Overall Study|non-compliance|0|||
147666766|NCT00402727|532605835|FG001|Overall Study|non-compliance|1|||
147666767|NCT03372798|532605836|FG000|Overall Study|Patient not attending post-procedural CT scan|1|||
147666768|NCT03372798|532605837|FG001|Overall Study|Patient not attending post-procedural CT scan|0|||
147666769|NCT03372798|532605836|FG000|Overall Study|Failure of imaging probe|0|||
147666770|NCT03372798|532605837|FG001|Overall Study|Failure of imaging probe|1|||
147666771|NCT03608826|532605838|FG000|Overall Study|Death|3|||
147666772|NCT03608826|532605838|FG000|Overall Study|Heart Transplant|3|||
147666773|NCT03608826|532605838|FG000|Overall Study|Physician Decision|4|||
147666774|NCT03139552|532605850|FG000|Overall Study|unable to attend tasting due to schedule|3|||
147666775|NCT00887484|532605868|FG000|Full Face Treatment (Weeks 5 and 8)|Adverse Event|1|||
147666776|NCT00887484|532605868|FG000|Full Face Treatment (Weeks 5 and 8)|Lost to Follow-up|1|||
147666777|NCT00887484|532605868|FG000|Full Face Treatment (Weeks 5 and 8)|Pregnancy|1|||
147666778|NCT03044314|532605874|FG000|Overall Study|Physician Decision|2|||
147666779|NCT03044314|532605874|FG000|Overall Study|Withdrawal by Subject|1|||
147666780|NCT03044314|532605874|FG000|Overall Study|Connector tubing not available|1|||
147666781|NCT03122171|532605875|FG000|Overall Study|Withdrawal by Subject|1|||
147666782|NCT01316224|532605876|FG000|Overall Study|Protocol Violation|3|||
147666783|NCT01316224|532605876|FG000|Overall Study|Adverse Event|3|||
147666784|NCT01316224|532605876|FG000|Overall Study|Lack of Efficacy|1|||
147666785|NCT01316224|532605876|FG000|Overall Study|Withdrawal by Subject|1|||
147666786|NCT01316224|532605876|FG000|Overall Study|Adverse Event With Treatment Failure|1|||
147666787|NCT01316224|532605876|FG000|Overall Study|Other|1|||
147666788|NCT00264147|532605877|FG000|Treatment I Period|Adverse Event|3|||
147666789|NCT00264147|532605878|FG001|Treatment I Period|Adverse Event|6|||
147666790|NCT00264147|532605879|FG002|Treatment I Period|Adverse Event|3|||
147475375|NCT00847613|531899870|FG002|Overall Study|Withdrawal by Subject|2|||
147475376|NCT00847613|531899871|FG003|Overall Study|Withdrawal by Subject|2|||
147475377|NCT00847613|531899868|FG000|Overall Study|Participant moved|4|||
147475378|NCT00847613|531899869|FG001|Overall Study|Participant moved|1|||
147475379|NCT00847613|531899870|FG002|Overall Study|Participant moved|0|||
147475380|NCT00847613|531899871|FG003|Overall Study|Participant moved|0|||
147475381|NCT00847613|531899868|FG000|Overall Study|Sponsor request|0|||
147475382|NCT00847613|531899869|FG001|Overall Study|Sponsor request|1|||
147475383|NCT00847613|531899870|FG002|Overall Study|Sponsor request|0|||
147475384|NCT00847613|531899871|FG003|Overall Study|Sponsor request|0|||
147475385|NCT00847613|531899868|FG000|Overall Study|Randomized, but not treated|0|||
147475386|NCT00847613|531899869|FG001|Overall Study|Randomized, but not treated|3|||
147666791|NCT00264147|532605880|FG003|Treatment I Period|Adverse Event|5|||
147666792|NCT00264147|532605881|FG004|Treatment I Period|Adverse Event|7|||
147666793|NCT00264147|532605882|FG005|Treatment I Period|Adverse Event|0|||
147475387|NCT00847613|531899870|FG002|Overall Study|Randomized, but not treated|0|||
147666794|NCT00264147|532605877|FG000|Treatment I Period|Laboratory Adverse Event|0|||
147666795|NCT00264147|532605878|FG001|Treatment I Period|Laboratory Adverse Event|0|||
147475388|NCT00847613|531899871|FG003|Overall Study|Randomized, but not treated|0|||
147475389|NCT00847613|531899868|FG000|Overall Study|Other|1|||
147475390|NCT00847613|531899869|FG001|Overall Study|Other|1|||
147666796|NCT00264147|532605879|FG002|Treatment I Period|Laboratory Adverse Event|0|||
147666797|NCT00264147|532605880|FG003|Treatment I Period|Laboratory Adverse Event|1|||
147666798|NCT00264147|532605881|FG004|Treatment I Period|Laboratory Adverse Event|0|||
147666799|NCT00264147|532605882|FG005|Treatment I Period|Laboratory Adverse Event|0|||
147666800|NCT00264147|532605877|FG000|Treatment I Period|Lack of Efficacy|6|||
147475391|NCT00847613|531899870|FG002|Overall Study|Other|2|||
147475392|NCT00847613|531899871|FG003|Overall Study|Other|0|||
147666801|NCT00264147|532605878|FG001|Treatment I Period|Lack of Efficacy|2|||
147666802|NCT00264147|532605879|FG002|Treatment I Period|Lack of Efficacy|8|||
147666803|NCT00264147|532605880|FG003|Treatment I Period|Lack of Efficacy|0|||
147475393|NCT01480180|531899872|FG000|Main Phase|Withdrawal criteria|12|||
147475394|NCT01480180|531899873|FG001|Main Phase|Withdrawal criteria|1|||
147475395|NCT01480180|531899874|FG002|Main Phase|Withdrawal criteria|0|||
147475396|NCT01480180|531899875|FG003|Main Phase|Withdrawal criteria|0|||
147475397|NCT01480180|531899876|FG004|Main Phase|Withdrawal criteria|0|||
147475398|NCT01480180|531899877|FG005|Main Phase|Withdrawal criteria|0|||
147475399|NCT01480180|531899872|FG000|Main Phase|Lack of Efficacy|1|||
147475400|NCT01480180|531899873|FG001|Main Phase|Lack of Efficacy|0|||
147475401|NCT01480180|531899874|FG002|Main Phase|Lack of Efficacy|0|||
147475402|NCT01480180|531899875|FG003|Main Phase|Lack of Efficacy|0|||
147475403|NCT01480180|531899876|FG004|Main Phase|Lack of Efficacy|0|||
147475404|NCT01480180|531899877|FG005|Main Phase|Lack of Efficacy|0|||
147475405|NCT01480180|531899872|FG000|Main Phase|Non-compliance|3|||
147475406|NCT01480180|531899873|FG001|Main Phase|Non-compliance|0|||
147475407|NCT01480180|531899874|FG002|Main Phase|Non-compliance|0|||
147475408|NCT01480180|531899875|FG003|Main Phase|Non-compliance|0|||
147475409|NCT01480180|531899876|FG004|Main Phase|Non-compliance|0|||
147475410|NCT01480180|531899877|FG005|Main Phase|Non-compliance|0|||
147475411|NCT01480180|531899872|FG000|Main Phase|Unclassified|3|||
147475412|NCT01480180|531899873|FG001|Main Phase|Unclassified|0|||
147475413|NCT01480180|531899874|FG002|Main Phase|Unclassified|0|||
147475414|NCT01480180|531899875|FG003|Main Phase|Unclassified|0|||
147475415|NCT01480180|531899876|FG004|Main Phase|Unclassified|0|||
147475416|NCT01480180|531899877|FG005|Main Phase|Unclassified|0|||
147475417|NCT01480180|531899872|FG000|Extension Phase, Part 1|Withdrawal criteria|0|||
147475418|NCT01480180|531899873|FG001|Extension Phase, Part 1|Withdrawal criteria|0|||
147475419|NCT01480180|531899874|FG002|Extension Phase, Part 1|Withdrawal criteria|5|||
147475420|NCT01480180|531899875|FG003|Extension Phase, Part 1|Withdrawal criteria|0|||
147475421|NCT01480180|531899876|FG004|Extension Phase, Part 1|Withdrawal criteria|0|||
147475422|NCT01480180|531899877|FG005|Extension Phase, Part 1|Withdrawal criteria|0|||
147475423|NCT01480180|531899872|FG000|Extension Phase, Part 1|Unclassified|0|||
147475424|NCT01480180|531899873|FG001|Extension Phase, Part 1|Unclassified|0|||
147475425|NCT01480180|531899874|FG002|Extension Phase, Part 1|Unclassified|1|||
147475426|NCT01480180|531899875|FG003|Extension Phase, Part 1|Unclassified|0|||
147475427|NCT01480180|531899876|FG004|Extension Phase, Part 1|Unclassified|0|||
147475428|NCT01480180|531899877|FG005|Extension Phase, Part 1|Unclassified|0|||
147475429|NCT01480180|531899872|FG000|Extension Phase, Part 1|Adverse Event|0|||
147475430|NCT01480180|531899873|FG001|Extension Phase, Part 1|Adverse Event|0|||
147475431|NCT01480180|531899874|FG002|Extension Phase, Part 1|Adverse Event|4|||
147475432|NCT01480180|531899875|FG003|Extension Phase, Part 1|Adverse Event|1|||
147475433|NCT01480180|531899876|FG004|Extension Phase, Part 1|Adverse Event|0|||
147475434|NCT01480180|531899877|FG005|Extension Phase, Part 1|Adverse Event|0|||
147475435|NCT01480180|531899872|FG000|Extension Phase, Part 1|Change of treatment|0|||
147475436|NCT01480180|531899873|FG001|Extension Phase, Part 1|Change of treatment|0|||
147475437|NCT01480180|531899874|FG002|Extension Phase, Part 1|Change of treatment|0|||
147475438|NCT01480180|531899875|FG003|Extension Phase, Part 1|Change of treatment|9|||
147475439|NCT01480180|531899876|FG004|Extension Phase, Part 1|Change of treatment|0|||
147475440|NCT01480180|531899877|FG005|Extension Phase, Part 1|Change of treatment|0|||
147475441|NCT01480180|531899872|FG000|Extension Phase, Part 2|Withdrawal criteria|0|||
147475442|NCT01480180|531899873|FG001|Extension Phase, Part 2|Withdrawal criteria|0|||
147475443|NCT01480180|531899874|FG002|Extension Phase, Part 2|Withdrawal criteria|10|||
147475444|NCT01480180|531899875|FG003|Extension Phase, Part 2|Withdrawal criteria|6|||
147475445|NCT01480180|531899876|FG004|Extension Phase, Part 2|Withdrawal criteria|1|||
147475446|NCT01480180|531899877|FG005|Extension Phase, Part 2|Withdrawal criteria|0|||
147475447|NCT01480180|531899872|FG000|Extension Phase, Part 2|Lack of Efficacy|0|||
147475448|NCT01480180|531899873|FG001|Extension Phase, Part 2|Lack of Efficacy|0|||
147475449|NCT01480180|531899874|FG002|Extension Phase, Part 2|Lack of Efficacy|4|||
147475450|NCT01480180|531899875|FG003|Extension Phase, Part 2|Lack of Efficacy|0|||
147475451|NCT01480180|531899876|FG004|Extension Phase, Part 2|Lack of Efficacy|0|||
147475452|NCT01480180|531899877|FG005|Extension Phase, Part 2|Lack of Efficacy|0|||
147475453|NCT01480180|531899872|FG000|Extension Phase, Part 2|Unclassified|0|||
147475454|NCT01480180|531899873|FG001|Extension Phase, Part 2|Unclassified|0|||
147475455|NCT01480180|531899874|FG002|Extension Phase, Part 2|Unclassified|3|||
147475456|NCT01480180|531899875|FG003|Extension Phase, Part 2|Unclassified|1|||
147475457|NCT01480180|531899876|FG004|Extension Phase, Part 2|Unclassified|1|||
147475458|NCT01480180|531899877|FG005|Extension Phase, Part 2|Unclassified|0|||
147475459|NCT03914300|531899881|FG000|Overall Study|Adverse Event|1|||
147475460|NCT05445843|531899887|FG000|Overall Study|Treatment ongoing at the time of the data cut-off date 04NOV2024|25|||
147475461|NCT05445843|531899888|FG001|Overall Study|Treatment ongoing at the time of the data cut-off date 04NOV2024|5|||
147475462|NCT05445843|531899887|FG000|Overall Study|Progressive disease|17|||
147475463|NCT05445843|531899888|FG001|Overall Study|Progressive disease|9|||
147475464|NCT05445843|531899887|FG000|Overall Study|Physician Decision|16|||
147475465|NCT05445843|531899888|FG001|Overall Study|Physician Decision|4|||
147475466|NCT05445843|531899887|FG000|Overall Study|Death|6|||
147475467|NCT05445843|531899888|FG001|Overall Study|Death|3|||
147475468|NCT05445843|531899887|FG000|Overall Study|Subject decision|6|||
147475469|NCT05445843|531899888|FG001|Overall Study|Subject decision|2|||
147475470|NCT05445843|531899887|FG000|Overall Study|Adverse Event|2|||
147475471|NCT05445843|531899888|FG001|Overall Study|Adverse Event|0|||
147475472|NCT04090164|531899891|FG000|Overall Study|incomplete data on file|245|||
147475473|NCT04090164|531899892|FG001|Overall Study|incomplete data on file|0|||
147475474|NCT00840463|531899895|FG000|Overall Study|Adverse Event|1|||
147475475|NCT00840463|531899896|FG001|Overall Study|Adverse Event|0|||
147475476|NCT03414359|531899900|FG000|Overall Study|Lack of Efficacy|1|||
147475477|NCT03414359|531899901|FG001|Overall Study|Lack of Efficacy|1|||
147475478|NCT03414359|531899900|FG000|Overall Study|Protocol Violation|0|||
147475479|NCT03414359|531899901|FG001|Overall Study|Protocol Violation|1|||
147475480|NCT03750838|531899906|FG000|Overall Study|Lost to Follow-up|10|||
147475481|NCT03750838|531899907|FG001|Overall Study|Lost to Follow-up|6|||
147475482|NCT02462889|531899908|FG000|Overall Study|Withdrawal by Subject|2|||
147475483|NCT02462889|531899909|FG001|Overall Study|Withdrawal by Subject|6|||
147475484|NCT02462889|531899908|FG000|Overall Study|Death|1|||
147475485|NCT02462889|531899909|FG001|Overall Study|Death|5|||
147475486|NCT03497689|531899915|FG000|Overall Study|Adverse Event|2|||
147475487|NCT03497689|531899915|FG000|Overall Study|Death|1|||
147475488|NCT03497689|531899915|FG000|Overall Study|Physician Decision|1|||
147475489|NCT03497689|531899915|FG000|Overall Study|Withdrawal by Subject|1|||
147475490|NCT03497689|531899915|FG000|Overall Study|Protocol Violation|2|||
147475491|NCT02032875|531899916|FG000|Treatment Period|Adverse Event|1|||
147475492|NCT02032875|531899917|FG001|Treatment Period|Adverse Event|0|||
147475493|NCT02032875|531899916|FG000|Treatment Period|Liver transplant, No extension needed|0|||
147475494|NCT02032875|531899917|FG001|Treatment Period|Liver transplant, No extension needed|1|||
147475495|NCT02032875|531899916|FG000|Treatment Period|Liver transplant, Treatment extension|0|||
147475496|NCT02032875|531899917|FG001|Treatment Period|Liver transplant, Treatment extension|3|||
147475497|NCT02032875|531899916|FG000|Follow-up Period|Death|0|||
147475498|NCT02032875|531899917|FG001|Follow-up Period|Death|1|||
147475499|NCT02032875|531899916|FG000|Follow-up Period|Virologic Relapse|3|||
147475500|NCT02032875|531899917|FG001|Follow-up Period|Virologic Relapse|10|||
147475501|NCT04636177|531899922|FG000|Two-arm, randomization portion|Withdrawal by Subject|1|||
147475502|NCT04636177|531899923|FG001|Two-arm, randomization portion|Withdrawal by Subject|1|||
147475503|NCT04636177|531899922|FG000|Two-arm, randomization portion|Lost to Follow-up|0|||
147475504|NCT04636177|531899923|FG001|Two-arm, randomization portion|Lost to Follow-up|1|||
147475505|NCT04636177|531899922|FG000|Single-arm portion|Withdrawal by Subject|1|||
147475506|NCT04636177|531899923|FG001|Single-arm portion|Withdrawal by Subject|0|||
147475507|NCT04636177|531899922|FG000|Single-arm portion|Adverse Event|1|||
147475508|NCT04636177|531899923|FG001|Single-arm portion|Adverse Event|0|||
147475509|NCT03191786|531899924|FG000|Overall Study|Death|236|||
147475510|NCT03191786|531899925|FG001|Overall Study|Death|127|||
147475511|NCT03191786|531899924|FG000|Overall Study|Lost to Follow-up|9|||
147475512|NCT03191786|531899925|FG001|Overall Study|Lost to Follow-up|3|||
147475513|NCT03191786|531899924|FG000|Overall Study|Physician Decision|1|||
147475514|NCT03191786|531899925|FG001|Overall Study|Physician Decision|0|||
147475515|NCT03191786|531899924|FG000|Overall Study|Moved to Post Trial Access Program|30|||
147475516|NCT03191786|531899925|FG001|Overall Study|Moved to Post Trial Access Program|5|||
147475517|NCT03191786|531899924|FG000|Overall Study|Withdrawal by Subject|26|||
147475518|NCT03191786|531899925|FG001|Overall Study|Withdrawal by Subject|16|||
147475519|NCT05847881|531899926|FG000|Overall Study|Principal Investigator Decision|8|||
147475520|NCT05847881|531899926|FG000|Overall Study|Withdrawal by Subject|2|||
147475521|NCT02277444|531899928|FG000|Treatment Period (Week 0-52)|Adverse Event|11|||
147475522|NCT02277444|531899928|FG000|Treatment Period (Week 0-52)|Withdrawal by Subject|3|||
147475523|NCT02277444|531899928|FG000|Treatment Period (Week 0-52)|Other|1|||
147475524|NCT02277444|531899928|FG000|Treatment Period (Week 0-52)|Enrolled and not Treated|3|||
147475525|NCT02277444|531899928|FG000|LTE Period (Week 52 to Week 252)|Other|43|||
147475526|NCT02277444|531899928|FG000|ETP Period (Week 252 to Week 420)|Adverse Event|1|||
147475527|NCT02277444|531899928|FG000|ETP Period (Week 252 to Week 420)|Physician Decision|3|||
147475528|NCT02277444|531899928|FG000|ETP Period (Week 252 to Week 420)|Withdrawal by Subject|2|||
147475529|NCT02277444|531899928|FG000|ETP Period (Week 252 to Week 420)|Other|8|||
147475530|NCT05278104|531899929|FG000|Overall Study|Not treated|1|||
147475531|NCT05278104|531899930|FG001|Overall Study|Not treated|0|||
147475532|NCT05278104|531899929|FG000|Overall Study|Adverse Event|2|||
147666804|NCT00264147|532605881|FG004|Treatment I Period|Lack of Efficacy|1|||
147475533|NCT05278104|531899930|FG001|Overall Study|Adverse Event|1|||
147475534|NCT05278104|531899929|FG000|Overall Study|Exclusion criteria not met|1|||
147475535|NCT05278104|531899930|FG001|Overall Study|Exclusion criteria not met|0|||
147475536|NCT03439345|531901336|FG000|Overall Study|Lost to Follow-up|0|||
147666805|NCT00264147|532605882|FG005|Treatment I Period|Lack of Efficacy|0|||
147666806|NCT00264147|532605877|FG000|Treatment I Period|Lost to Follow-up|1|||
147475537|NCT03439345|531901337|FG001|Overall Study|Lost to Follow-up|1|||
147475538|NCT03439345|531901336|FG000|Overall Study|Consent withdrawn|0|||
147475539|NCT03439345|531901337|FG001|Overall Study|Consent withdrawn|1|||
147475540|NCT05781542|531901338|FG000|Overall Study|Lost to Follow-up|1|||
147475541|NCT05781542|531901339|FG001|Overall Study|Lost to Follow-up|0|||
147475542|NCT05781542|531901340|FG002|Overall Study|Lost to Follow-up|1|||
147475543|NCT01843374|531901343|FG000|Overall Study|Death|155|||
147621467|NCT02088177|532431476|FG000|Overall Study|Lost to Follow-up|3|||
147621468|NCT01641640|532431478|FG000|Overall Study|Enrolled but not treated|1|||
147621469|NCT01641640|532431478|FG000|Overall Study|Efficacy failure|29|||
147621470|NCT01641640|532431478|FG000|Overall Study|Lost to Follow-up|3|||
147621471|NCT01641640|532431478|FG000|Overall Study|Withdrawal by Subject|2|||
147621472|NCT01641640|532431478|FG000|Overall Study|Adverse Event|1|||
147621473|NCT00289848|532431479|FG000|Overall Study|Adverse Event|6|||
147621474|NCT00289848|532431480|FG001|Overall Study|Adverse Event|4|||
147621475|NCT00289848|532431479|FG000|Overall Study|Death|1|||
147621476|NCT00289848|532431480|FG001|Overall Study|Death|0|||
147621477|NCT00289848|532431479|FG000|Overall Study|Lack of Efficacy|20|||
147621478|NCT00289848|532431480|FG001|Overall Study|Lack of Efficacy|24|||
147621479|NCT00289848|532431479|FG000|Overall Study|Lost to Follow-up|3|||
147621480|NCT00289848|532431480|FG001|Overall Study|Lost to Follow-up|1|||
147621481|NCT00289848|532431479|FG000|Overall Study|Protocol Violation|5|||
147621482|NCT00289848|532431480|FG001|Overall Study|Protocol Violation|2|||
147621483|NCT00289848|532431479|FG000|Overall Study|Withdrawal by Subject|5|||
147621484|NCT00289848|532431480|FG001|Overall Study|Withdrawal by Subject|11|||
147621485|NCT00289848|532431479|FG000|Overall Study|Patient Moved|6|||
147621486|NCT00289848|532431480|FG001|Overall Study|Patient Moved|2|||
147621487|NCT00289848|532431479|FG000|Overall Study|Open-Label AHA Treatment Requested|0|||
147621488|NCT00289848|532431480|FG001|Overall Study|Open-Label AHA Treatment Requested|1|||
147621489|NCT01234350|532431482|FG000|Overall Study|Adverse Event|277|||
147621490|NCT01234350|532431483|FG001|Overall Study|Adverse Event|92|||
147621491|NCT01234350|532431482|FG000|Overall Study|Withdrawal by Subject|61|||
147621492|NCT01234350|532431483|FG001|Overall Study|Withdrawal by Subject|36|||
147621493|NCT01234350|532431482|FG000|Overall Study|Lost to Follow-up|115|||
147621494|NCT01234350|532431483|FG001|Overall Study|Lost to Follow-up|47|||
147621495|NCT01234350|532431482|FG000|Overall Study|Covers a diverse set of reasons|234|||
147621496|NCT01234350|532431483|FG001|Overall Study|Covers a diverse set of reasons|92|||
147621497|NCT01894919|532431491|FG000|Overall Study|Withdrawal by Subject|1|||
147621498|NCT01894919|532431492|FG001|Overall Study|Withdrawal by Subject|0|||
147621499|NCT01894919|532431493|FG002|Overall Study|Withdrawal by Subject|0|||
147621500|NCT01894919|532431494|FG003|Overall Study|Withdrawal by Subject|0|||
147621501|NCT01894919|532431495|FG004|Overall Study|Withdrawal by Subject|1|||
147621502|NCT01894919|532431496|FG005|Overall Study|Withdrawal by Subject|0|||
147621503|NCT01894919|532431497|FG006|Overall Study|Withdrawal by Subject|0|||
147621504|NCT01894919|532431498|FG007|Overall Study|Withdrawal by Subject|0|||
147621505|NCT01894919|532431499|FG008|Overall Study|Withdrawal by Subject|0|||
147621506|NCT01894919|532431500|FG009|Overall Study|Withdrawal by Subject|1|||
147621507|NCT01894919|532431501|FG010|Overall Study|Withdrawal by Subject|1|||
147621508|NCT01894919|532431502|FG011|Overall Study|Withdrawal by Subject|0|||
147621509|NCT01894919|532431503|FG012|Overall Study|Withdrawal by Subject|0|||
147621510|NCT01894919|532431491|FG000|Overall Study|Adverse Event|0|||
147621511|NCT01894919|532431492|FG001|Overall Study|Adverse Event|0|||
147621512|NCT01894919|532431493|FG002|Overall Study|Adverse Event|0|||
147621513|NCT01894919|532431494|FG003|Overall Study|Adverse Event|0|||
147621514|NCT01894919|532431495|FG004|Overall Study|Adverse Event|0|||
147621515|NCT01894919|532431496|FG005|Overall Study|Adverse Event|0|||
147621516|NCT01894919|532431497|FG006|Overall Study|Adverse Event|0|||
147621517|NCT01894919|532431498|FG007|Overall Study|Adverse Event|0|||
147621518|NCT01894919|532431499|FG008|Overall Study|Adverse Event|0|||
147621519|NCT01894919|532431500|FG009|Overall Study|Adverse Event|0|||
147621520|NCT01894919|532431501|FG010|Overall Study|Adverse Event|1|||
147621521|NCT01894919|532431502|FG011|Overall Study|Adverse Event|0|||
147621522|NCT01894919|532431503|FG012|Overall Study|Adverse Event|0|||
147621523|NCT01894919|532431491|FG000|Overall Study|Other-Unspecified|1|||
147621524|NCT01894919|532431492|FG001|Overall Study|Other-Unspecified|0|||
147621525|NCT01894919|532431493|FG002|Overall Study|Other-Unspecified|0|||
147621526|NCT01894919|532431494|FG003|Overall Study|Other-Unspecified|0|||
147621527|NCT01894919|532431495|FG004|Overall Study|Other-Unspecified|0|||
147621528|NCT01894919|532431496|FG005|Overall Study|Other-Unspecified|0|||
147621529|NCT01894919|532431497|FG006|Overall Study|Other-Unspecified|0|||
147621530|NCT01894919|532431498|FG007|Overall Study|Other-Unspecified|0|||
147621531|NCT01894919|532431499|FG008|Overall Study|Other-Unspecified|0|||
147621532|NCT01894919|532431500|FG009|Overall Study|Other-Unspecified|0|||
147621533|NCT01894919|532431501|FG010|Overall Study|Other-Unspecified|0|||
147621534|NCT01894919|532431502|FG011|Overall Study|Other-Unspecified|0|||
147621535|NCT01894919|532431503|FG012|Overall Study|Other-Unspecified|0|||
147621536|NCT01894919|532431491|FG000|Overall Study|Lost to Follow-up|0|||
147621537|NCT01894919|532431492|FG001|Overall Study|Lost to Follow-up|0|||
147621538|NCT01894919|532431493|FG002|Overall Study|Lost to Follow-up|0|||
147621539|NCT01894919|532431494|FG003|Overall Study|Lost to Follow-up|0|||
147621540|NCT01894919|532431495|FG004|Overall Study|Lost to Follow-up|2|||
147621541|NCT01894919|532431496|FG005|Overall Study|Lost to Follow-up|0|||
147621542|NCT01894919|532431497|FG006|Overall Study|Lost to Follow-up|0|||
147621543|NCT01894919|532431498|FG007|Overall Study|Lost to Follow-up|0|||
147621544|NCT01894919|532431499|FG008|Overall Study|Lost to Follow-up|0|||
147621545|NCT01894919|532431500|FG009|Overall Study|Lost to Follow-up|0|||
147475544|NCT01843374|531901344|FG001|Overall Study|Death|313|||
147475545|NCT01843374|531901343|FG000|Overall Study|Withdrawal by Subject|14|||
147475546|NCT01843374|531901344|FG001|Overall Study|Withdrawal by Subject|20|||
147475547|NCT01843374|531901343|FG000|Overall Study|Withdrawing due to Other reason|20|||
147475548|NCT01843374|531901344|FG001|Overall Study|Withdrawing due to Other reason|46|||
147475549|NCT03704051|531901345|FG000|Overall Study|Withdrawal by Subject|4|||
147475550|NCT03704051|531901346|FG001|Overall Study|Withdrawal by Subject|0|||
147475551|NCT02495077|531901347|FG000|Overall Study|Adverse Event|0|||
147475552|NCT02495077|531901348|FG001|Overall Study|Adverse Event|1|||
147475553|NCT02495077|531901349|FG002|Overall Study|Adverse Event|1|||
147475554|NCT02495077|531901350|FG003|Overall Study|Adverse Event|0|||
147475555|NCT02495077|531901347|FG000|Overall Study|Death|3|||
147475556|NCT02495077|531901348|FG001|Overall Study|Death|5|||
147475557|NCT02495077|531901349|FG002|Overall Study|Death|0|||
147475558|NCT02495077|531901350|FG003|Overall Study|Death|0|||
147475559|NCT02495077|531901347|FG000|Overall Study|Lost to Follow-up|6|||
147475560|NCT02495077|531901348|FG001|Overall Study|Lost to Follow-up|4|||
147475561|NCT02495077|531901349|FG002|Overall Study|Lost to Follow-up|0|||
147475562|NCT02495077|531901350|FG003|Overall Study|Lost to Follow-up|0|||
147475563|NCT02495077|531901347|FG000|Overall Study|Physician Decision|2|||
147475564|NCT02495077|531901348|FG001|Overall Study|Physician Decision|1|||
147475565|NCT02495077|531901349|FG002|Overall Study|Physician Decision|4|||
147475566|NCT02495077|531901350|FG003|Overall Study|Physician Decision|0|||
147475567|NCT02495077|531901347|FG000|Overall Study|Protocol Violation|0|||
147475568|NCT02495077|531901348|FG001|Overall Study|Protocol Violation|1|||
147475569|NCT02495077|531901349|FG002|Overall Study|Protocol Violation|0|||
147475570|NCT02495077|531901350|FG003|Overall Study|Protocol Violation|0|||
147475571|NCT02495077|531901347|FG000|Overall Study|Screen Failure|0|||
147475572|NCT02495077|531901348|FG001|Overall Study|Screen Failure|0|||
147475573|NCT02495077|531901349|FG002|Overall Study|Screen Failure|0|||
147475574|NCT02495077|531901350|FG003|Overall Study|Screen Failure|48|||
147475575|NCT02495077|531901347|FG000|Overall Study|Withdrawal by Subject|7|||
147475576|NCT02495077|531901348|FG001|Overall Study|Withdrawal by Subject|7|||
147475577|NCT02495077|531901349|FG002|Overall Study|Withdrawal by Subject|7|||
147475578|NCT02495077|531901350|FG003|Overall Study|Withdrawal by Subject|0|||
147475579|NCT02495077|531901347|FG000|Overall Study|Covid-19 research restrictions|1|||
147475580|NCT02495077|531901348|FG001|Overall Study|Covid-19 research restrictions|0|||
147475581|NCT02495077|531901349|FG002|Overall Study|Covid-19 research restrictions|0|||
147475582|NCT02495077|531901350|FG003|Overall Study|Covid-19 research restrictions|0|||
147475583|NCT02495077|531901347|FG000|Overall Study|Visit 14 scheduling difficulties|1|||
147475584|NCT02495077|531901348|FG001|Overall Study|Visit 14 scheduling difficulties|0|||
147475585|NCT02495077|531901349|FG002|Overall Study|Visit 14 scheduling difficulties|0|||
147475586|NCT02495077|531901350|FG003|Overall Study|Visit 14 scheduling difficulties|0|||
147475587|NCT02495077|531901347|FG000|Overall Study|Incarcerated|0|||
147475588|NCT02495077|531901348|FG001|Overall Study|Incarcerated|1|||
147475589|NCT02495077|531901349|FG002|Overall Study|Incarcerated|0|||
147475590|NCT02495077|531901350|FG003|Overall Study|Incarcerated|0|||
147475591|NCT02495077|531901347|FG000|Overall Study|Transplant nephrectomy, patient decision|0|||
147475592|NCT02495077|531901348|FG001|Overall Study|Transplant nephrectomy, patient decision|1|||
147475593|NCT02495077|531901349|FG002|Overall Study|Transplant nephrectomy, patient decision|0|||
147475594|NCT02495077|531901350|FG003|Overall Study|Transplant nephrectomy, patient decision|0|||
147475595|NCT02495077|531901347|FG000|Overall Study|Timing of transplant and randomization|0|||
147475596|NCT02495077|531901348|FG001|Overall Study|Timing of transplant and randomization|0|||
147475597|NCT02495077|531901349|FG002|Overall Study|Timing of transplant and randomization|5|||
147475598|NCT02495077|531901350|FG003|Overall Study|Timing of transplant and randomization|0|||
147475599|NCT01943539|531901351|FG000|Overall Study|Non-compliance with at-home intervention|4|||
147475600|NCT01943539|531901352|FG001|Overall Study|Non-compliance with at-home intervention|0|||
147475601|NCT02333331|531901353|FG000|Overall Study|Adverse Event|1|||
147475602|NCT02333331|531901354|FG001|Overall Study|Adverse Event|0|||
147475603|NCT02333331|531901355|FG002|Overall Study|Adverse Event|4|||
147475604|NCT02333331|531901356|FG003|Overall Study|Adverse Event|1|||
147475605|NCT02333331|531901353|FG000|Overall Study|Death|0|||
147475606|NCT02333331|531901354|FG001|Overall Study|Death|0|||
147475607|NCT02333331|531901355|FG002|Overall Study|Death|2|||
147475608|NCT02333331|531901356|FG003|Overall Study|Death|0|||
147475609|NCT02333331|531901353|FG000|Overall Study|Lost to Follow-up|0|||
147475610|NCT02333331|531901354|FG001|Overall Study|Lost to Follow-up|0|||
147475611|NCT02333331|531901355|FG002|Overall Study|Lost to Follow-up|1|||
147475612|NCT02333331|531901356|FG003|Overall Study|Lost to Follow-up|0|||
147475613|NCT02333331|531901353|FG000|Overall Study|Physician Decision|0|||
147475614|NCT02333331|531901354|FG001|Overall Study|Physician Decision|1|||
147475615|NCT02333331|531901355|FG002|Overall Study|Physician Decision|0|||
147475616|NCT02333331|531901356|FG003|Overall Study|Physician Decision|0|||
147475617|NCT02333331|531901353|FG000|Overall Study|Protocol Deviation|0|||
147475618|NCT02333331|531901354|FG001|Overall Study|Protocol Deviation|3|||
147475619|NCT02333331|531901355|FG002|Overall Study|Protocol Deviation|2|||
147475620|NCT02333331|531901356|FG003|Overall Study|Protocol Deviation|1|||
147475621|NCT02333331|531901353|FG000|Overall Study|Patient/Guardian Decision|1|||
147475622|NCT02333331|531901354|FG001|Overall Study|Patient/Guardian Decision|2|||
147475623|NCT02333331|531901355|FG002|Overall Study|Patient/Guardian Decision|9|||
147475624|NCT02333331|531901356|FG003|Overall Study|Patient/Guardian Decision|1|||
147475625|NCT00430781|531901359|FG000|Interim Analysis; 11 February 2008|Adverse Event|10|||
147475626|NCT00430781|531901360|FG001|Interim Analysis; 11 February 2008|Adverse Event|3|||
147475627|NCT00430781|531901361|FG002|Interim Analysis; 11 February 2008|Adverse Event|7|||
147475628|NCT00430781|531901359|FG000|Interim Analysis; 11 February 2008|Lost to Follow-up|1|||
147475629|NCT00430781|531901360|FG001|Interim Analysis; 11 February 2008|Lost to Follow-up|0|||
147475630|NCT00430781|531901361|FG002|Interim Analysis; 11 February 2008|Lost to Follow-up|1|||
147475631|NCT00430781|531901359|FG000|Interim Analysis; 11 February 2008|Protocol Violation|0|||
147475632|NCT00430781|531901360|FG001|Interim Analysis; 11 February 2008|Protocol Violation|1|||
147475633|NCT00430781|531901361|FG002|Interim Analysis; 11 February 2008|Protocol Violation|0|||
147475634|NCT00430781|531901359|FG000|Interim Analysis; 11 February 2008|Withdrawal by Subject|4|||
147475635|NCT00430781|531901360|FG001|Interim Analysis; 11 February 2008|Withdrawal by Subject|0|||
147475636|NCT00430781|531901361|FG002|Interim Analysis; 11 February 2008|Withdrawal by Subject|2|||
147475637|NCT00430781|531901359|FG000|Interim Analysis; 11 February 2008|Sponsor Terminated Study|1|||
147475638|NCT00430781|531901360|FG001|Interim Analysis; 11 February 2008|Sponsor Terminated Study|0|||
147475639|NCT00430781|531901361|FG002|Interim Analysis; 11 February 2008|Sponsor Terminated Study|0|||
147475640|NCT00430781|531901359|FG000|Interim Analysis; 11 February 2008|Disease Progression|16|||
147475641|NCT00430781|531901360|FG001|Interim Analysis; 11 February 2008|Disease Progression|30|||
147475642|NCT00430781|531901361|FG002|Interim Analysis; 11 February 2008|Disease Progression|22|||
147475643|NCT00430781|531901359|FG000|Interim Analysis; 11 February 2008|Death|0|||
147475644|NCT00430781|531901360|FG001|Interim Analysis; 11 February 2008|Death|1|||
147475645|NCT00430781|531901361|FG002|Interim Analysis; 11 February 2008|Death|0|||
147475646|NCT00430781|531901359|FG000|Interim Analysis; 11 February 2008|Par. Withdrew; Followed for Survival|2|||
147475647|NCT00430781|531901360|FG001|Interim Analysis; 11 February 2008|Par. Withdrew; Followed for Survival|0|||
147475648|NCT00430781|531901361|FG002|Interim Analysis; 11 February 2008|Par. Withdrew; Followed for Survival|0|||
147475649|NCT00430781|531901359|FG000|Interim Analysis; 11 February 2008|Physician Decision|2|||
147475650|NCT00430781|531901360|FG001|Interim Analysis; 11 February 2008|Physician Decision|3|||
147475651|NCT00430781|531901361|FG002|Interim Analysis; 11 February 2008|Physician Decision|3|||
147475652|NCT00430781|531901359|FG000|Interim Analysis; 11 February 2008|Ongoing|23|||
147475653|NCT00430781|531901360|FG001|Interim Analysis; 11 February 2008|Ongoing|20|||
147475654|NCT00430781|531901361|FG002|Interim Analysis; 11 February 2008|Ongoing|25|||
147475655|NCT00430781|531901359|FG000|Final Analysis; 31 July 2008|Lost to Follow-up|0|||
147475656|NCT00430781|531901360|FG001|Final Analysis; 31 July 2008|Lost to Follow-up|0|||
147475657|NCT00430781|531901361|FG002|Final Analysis; 31 July 2008|Lost to Follow-up|3|||
147475658|NCT00430781|531901359|FG000|Final Analysis; 31 July 2008|Protocol Violation|0|||
147475659|NCT00430781|531901360|FG001|Final Analysis; 31 July 2008|Protocol Violation|1|||
147475660|NCT00430781|531901361|FG002|Final Analysis; 31 July 2008|Protocol Violation|0|||
147475661|NCT00430781|531901359|FG000|Final Analysis; 31 July 2008|Withdrawal by Subject|0|||
147475662|NCT00430781|531901360|FG001|Final Analysis; 31 July 2008|Withdrawal by Subject|2|||
147475663|NCT00430781|531901361|FG002|Final Analysis; 31 July 2008|Withdrawal by Subject|7|||
147475664|NCT00430781|531901359|FG000|Final Analysis; 31 July 2008|Physician Decision|0|||
147475665|NCT00430781|531901360|FG001|Final Analysis; 31 July 2008|Physician Decision|6|||
147475666|NCT00430781|531901361|FG002|Final Analysis; 31 July 2008|Physician Decision|6|||
147475667|NCT00430781|531901359|FG000|Final Analysis; 31 July 2008|Other|0|||
147475668|NCT00430781|531901360|FG001|Final Analysis; 31 July 2008|Other|1|||
147475669|NCT00430781|531901361|FG002|Final Analysis; 31 July 2008|Other|0|||
147621546|NCT01894919|532431501|FG010|Overall Study|Lost to Follow-up|0|||
147621547|NCT01894919|532431502|FG011|Overall Study|Lost to Follow-up|0|||
147621548|NCT01894919|532431503|FG012|Overall Study|Lost to Follow-up|0|||
147621549|NCT02792517|532431504|FG000|Overall Study|Withdrawal by Subject|10|||
147621550|NCT02792517|532431504|FG000|Overall Study|Decision by Sponsor|7|||
147621551|NCT02792517|532431504|FG000|Overall Study|Lost to Follow-up|3|||
147621552|NCT02570308|532431507|FG000|Overall Study|Death|1|||
147621553|NCT02570308|532431508|FG001|Overall Study|Death|5|||
147621554|NCT02570308|532431509|FG002|Overall Study|Death|4|||
147621555|NCT02570308|532431510|FG003|Overall Study|Death|4|||
147621556|NCT02570308|532431511|FG004|Overall Study|Death|69|||
147621557|NCT02570308|532431507|FG000|Overall Study|Lost to Follow-up|0|||
147621558|NCT02570308|532431508|FG001|Overall Study|Lost to Follow-up|0|||
147475670|NCT00430781|531901359|FG000|Final Analysis; 31 July 2008|Ongoing|0|||
147475671|NCT00430781|531901360|FG001|Final Analysis; 31 July 2008|Ongoing|29|||
147475672|NCT00430781|531901361|FG002|Final Analysis; 31 July 2008|Ongoing|32|||
147621559|NCT02570308|532431509|FG002|Overall Study|Lost to Follow-up|0|||
147621560|NCT02570308|532431510|FG003|Overall Study|Lost to Follow-up|0|||
147621561|NCT02570308|532431511|FG004|Overall Study|Lost to Follow-up|2|||
147621562|NCT02570308|532431507|FG000|Overall Study|Withdrawal by Subject|0|||
147621563|NCT02570308|532431508|FG001|Overall Study|Withdrawal by Subject|0|||
147621564|NCT02570308|532431509|FG002|Overall Study|Withdrawal by Subject|0|||
147475673|NCT00430781|531901359|FG000|End-of-Study Analysis; 28 July 2011|Lost to Follow-up|5|||
147475674|NCT00430781|531901360|FG001|End-of-Study Analysis; 28 July 2011|Lost to Follow-up|3|||
147475675|NCT00430781|531901361|FG002|End-of-Study Analysis; 28 July 2011|Lost to Follow-up|3|||
147475676|NCT00430781|531901359|FG000|End-of-Study Analysis; 28 July 2011|Protocol Violation|0|||
147475677|NCT00430781|531901360|FG001|End-of-Study Analysis; 28 July 2011|Protocol Violation|1|||
147475678|NCT00430781|531901361|FG002|End-of-Study Analysis; 28 July 2011|Protocol Violation|0|||
147475679|NCT00430781|531901359|FG000|End-of-Study Analysis; 28 July 2011|Withdrawal by Subject|7|||
147475680|NCT00430781|531901360|FG001|End-of-Study Analysis; 28 July 2011|Withdrawal by Subject|2|||
147475681|NCT00430781|531901361|FG002|End-of-Study Analysis; 28 July 2011|Withdrawal by Subject|7|||
147475682|NCT00430781|531901359|FG000|End-of-Study Analysis; 28 July 2011|Sponsor Terminated Study|4|||
147475683|NCT00430781|531901360|FG001|End-of-Study Analysis; 28 July 2011|Sponsor Terminated Study|5|||
147475684|NCT00430781|531901361|FG002|End-of-Study Analysis; 28 July 2011|Sponsor Terminated Study|4|||
147475685|NCT00430781|531901359|FG000|End-of-Study Analysis; 28 July 2011|Physician Decision|4|||
147475686|NCT00430781|531901360|FG001|End-of-Study Analysis; 28 July 2011|Physician Decision|6|||
147475687|NCT00430781|531901361|FG002|End-of-Study Analysis; 28 July 2011|Physician Decision|6|||
147475688|NCT00430781|531901359|FG000|End-of-Study Analysis; 28 July 2011|Other|4|||
147475689|NCT00430781|531901360|FG001|End-of-Study Analysis; 28 July 2011|Other|1|||
147475690|NCT00430781|531901361|FG002|End-of-Study Analysis; 28 July 2011|Other|0|||
147475691|NCT02158533|531901364|FG000|Stage 1|Adverse Event|6|||
147475692|NCT02158533|531901365|FG001|Stage 1|Adverse Event|4|||
147475693|NCT02158533|531901366|FG002|Stage 1|Adverse Event|7|||
147475694|NCT02158533|531901367|FG003|Stage 1|Adverse Event|0|||
147475695|NCT02158533|531901368|FG004|Stage 1|Adverse Event|0|||
147475696|NCT02158533|531901369|FG005|Stage 1|Adverse Event|0|||
147475697|NCT02158533|531901364|FG000|Stage 1|Withdrawal by Subject|3|||
147475698|NCT02158533|531901365|FG001|Stage 1|Withdrawal by Subject|2|||
147475699|NCT02158533|531901366|FG002|Stage 1|Withdrawal by Subject|1|||
147475700|NCT02158533|531901367|FG003|Stage 1|Withdrawal by Subject|0|||
147475701|NCT02158533|531901368|FG004|Stage 1|Withdrawal by Subject|0|||
147475702|NCT02158533|531901369|FG005|Stage 1|Withdrawal by Subject|0|||
147475703|NCT02158533|531901364|FG000|Stage 1|Lack of Efficacy|1|||
147475704|NCT02158533|531901365|FG001|Stage 1|Lack of Efficacy|0|||
147475705|NCT02158533|531901366|FG002|Stage 1|Lack of Efficacy|0|||
147475706|NCT02158533|531901367|FG003|Stage 1|Lack of Efficacy|0|||
147475707|NCT02158533|531901368|FG004|Stage 1|Lack of Efficacy|0|||
147475708|NCT02158533|531901369|FG005|Stage 1|Lack of Efficacy|0|||
147475709|NCT02158533|531901364|FG000|Stage 1|Lost to Follow-up|3|||
147475710|NCT02158533|531901365|FG001|Stage 1|Lost to Follow-up|1|||
147475711|NCT02158533|531901366|FG002|Stage 1|Lost to Follow-up|0|||
147475712|NCT02158533|531901367|FG003|Stage 1|Lost to Follow-up|0|||
147475713|NCT02158533|531901368|FG004|Stage 1|Lost to Follow-up|0|||
147475714|NCT02158533|531901369|FG005|Stage 1|Lost to Follow-up|0|||
147475715|NCT02158533|531901364|FG000|Stage 1|Failure to Meet Eligibility Criteria|0|||
147475716|NCT02158533|531901365|FG001|Stage 1|Failure to Meet Eligibility Criteria|1|||
147475717|NCT02158533|531901366|FG002|Stage 1|Failure to Meet Eligibility Criteria|0|||
147475718|NCT02158533|531901367|FG003|Stage 1|Failure to Meet Eligibility Criteria|0|||
147475719|NCT02158533|531901368|FG004|Stage 1|Failure to Meet Eligibility Criteria|0|||
147475720|NCT02158533|531901369|FG005|Stage 1|Failure to Meet Eligibility Criteria|0|||
147475721|NCT02158533|531901364|FG000|Stage 1|Non-compliance with study visits|1|||
147475722|NCT02158533|531901365|FG001|Stage 1|Non-compliance with study visits|0|||
147475723|NCT02158533|531901366|FG002|Stage 1|Non-compliance with study visits|0|||
147475724|NCT02158533|531901367|FG003|Stage 1|Non-compliance with study visits|0|||
147475725|NCT02158533|531901368|FG004|Stage 1|Non-compliance with study visits|0|||
147475726|NCT02158533|531901369|FG005|Stage 1|Non-compliance with study visits|0|||
147475727|NCT02158533|531901364|FG000|Stage 2|Adverse Event|0|||
147475728|NCT02158533|531901365|FG001|Stage 2|Adverse Event|0|||
147475729|NCT02158533|531901366|FG002|Stage 2|Adverse Event|0|||
147475730|NCT02158533|531901367|FG003|Stage 2|Adverse Event|0|||
147475731|NCT02158533|531901368|FG004|Stage 2|Adverse Event|0|||
147475732|NCT02158533|531901369|FG005|Stage 2|Adverse Event|1|||
147475733|NCT02158533|531901364|FG000|Stage 2|Lack of Efficacy|0|||
147475734|NCT02158533|531901365|FG001|Stage 2|Lack of Efficacy|0|||
147475735|NCT02158533|531901366|FG002|Stage 2|Lack of Efficacy|0|||
147475736|NCT02158533|531901367|FG003|Stage 2|Lack of Efficacy|0|||
147475737|NCT02158533|531901368|FG004|Stage 2|Lack of Efficacy|1|||
147475738|NCT02158533|531901369|FG005|Stage 2|Lack of Efficacy|0|||
147475739|NCT02158533|531901364|FG000|Stage 2|Lost to Follow-up|0|||
147475740|NCT02158533|531901365|FG001|Stage 2|Lost to Follow-up|0|||
147475741|NCT02158533|531901366|FG002|Stage 2|Lost to Follow-up|0|||
147475742|NCT02158533|531901367|FG003|Stage 2|Lost to Follow-up|1|||
147475743|NCT02158533|531901368|FG004|Stage 2|Lost to Follow-up|1|||
147475744|NCT02158533|531901369|FG005|Stage 2|Lost to Follow-up|2|||
147475745|NCT02158533|531901364|FG000|Stage 2|Withdrawal by Subject|0|||
147475746|NCT02158533|531901365|FG001|Stage 2|Withdrawal by Subject|0|||
147475747|NCT02158533|531901366|FG002|Stage 2|Withdrawal by Subject|0|||
147475748|NCT02158533|531901367|FG003|Stage 2|Withdrawal by Subject|0|||
147475749|NCT02158533|531901368|FG004|Stage 2|Withdrawal by Subject|1|||
147475750|NCT02158533|531901369|FG005|Stage 2|Withdrawal by Subject|2|||
147475751|NCT02158533|531901364|FG000|Stage 2|Physician Decision|0|||
147475752|NCT02158533|531901365|FG001|Stage 2|Physician Decision|0|||
147475753|NCT02158533|531901366|FG002|Stage 2|Physician Decision|0|||
147475754|NCT02158533|531901367|FG003|Stage 2|Physician Decision|0|||
147475755|NCT02158533|531901368|FG004|Stage 2|Physician Decision|1|||
147475756|NCT02158533|531901369|FG005|Stage 2|Physician Decision|0|||
147475757|NCT02158533|531901364|FG000|Stage 2|Pregnancy|0|||
147475758|NCT02158533|531901365|FG001|Stage 2|Pregnancy|0|||
147475759|NCT02158533|531901366|FG002|Stage 2|Pregnancy|0|||
147475760|NCT02158533|531901367|FG003|Stage 2|Pregnancy|1|||
147475761|NCT02158533|531901368|FG004|Stage 2|Pregnancy|0|||
147475762|NCT02158533|531901369|FG005|Stage 2|Pregnancy|0|||
147475763|NCT02158533|531901364|FG000|Stage 2|Psychiatrist decision to try new tx|0|||
147475764|NCT02158533|531901365|FG001|Stage 2|Psychiatrist decision to try new tx|0|||
147475765|NCT02158533|531901366|FG002|Stage 2|Psychiatrist decision to try new tx|0|||
147475766|NCT02158533|531901367|FG003|Stage 2|Psychiatrist decision to try new tx|1|||
147475767|NCT02158533|531901368|FG004|Stage 2|Psychiatrist decision to try new tx|0|||
147475768|NCT02158533|531901369|FG005|Stage 2|Psychiatrist decision to try new tx|0|||
147475769|NCT02158533|531901364|FG000|Stage 2|Non-adherence with study visits|0|||
147475770|NCT02158533|531901365|FG001|Stage 2|Non-adherence with study visits|0|||
147475771|NCT02158533|531901366|FG002|Stage 2|Non-adherence with study visits|0|||
147475772|NCT02158533|531901367|FG003|Stage 2|Non-adherence with study visits|0|||
147475773|NCT02158533|531901368|FG004|Stage 2|Non-adherence with study visits|0|||
147475774|NCT02158533|531901369|FG005|Stage 2|Non-adherence with study visits|1|||
147475775|NCT02037919|531901374|FG000|Overall Study|Lost to Follow-up|30|||
147475776|NCT02037919|531901375|FG001|Overall Study|Lost to Follow-up|45|||
147475777|NCT00345605|531901376|FG000|Arm 1|Adverse Event|0|||
147475778|NCT00345605|531901377|FG001|Arm 1|Adverse Event|1|||
147475779|NCT00345605|531901376|FG000|Arm 2, Opposite Treatment|Adverse Event|1|||
147475780|NCT00345605|531901377|FG001|Arm 2, Opposite Treatment|Adverse Event|0|||
147475781|NCT01335971|531901378|FG000|Overall Study|Withdrawal by Subject|1|||
147475782|NCT01335971|531901379|FG001|Overall Study|Withdrawal by Subject|0|||
147475783|NCT01335971|531901380|FG002|Overall Study|Withdrawal by Subject|0|||
147475784|NCT01335971|531901378|FG000|Overall Study|Did not complete bronchoscopy|1|||
147475785|NCT01335971|531901379|FG001|Overall Study|Did not complete bronchoscopy|1|||
147475786|NCT01335971|531901380|FG002|Overall Study|Did not complete bronchoscopy|1|||
147475787|NCT00384956|531901381|FG000|Overall Study|Ineligible (acute myeloid leukemia)|3|||
147475788|NCT03126227|531901382|FG000|Overall Study|Adverse Event|43|||
147475789|NCT03126227|531901383|FG001|Overall Study|Adverse Event|4|||
147475790|NCT03126227|531901382|FG000|Overall Study|Death|0|||
147475791|NCT03126227|531901383|FG001|Overall Study|Death|1|||
147475792|NCT03126227|531901382|FG000|Overall Study|Lost to Follow-up|0|||
147475793|NCT03126227|531901383|FG001|Overall Study|Lost to Follow-up|1|||
147475794|NCT03126227|531901382|FG000|Overall Study|Physician Decision|2|||
147475795|NCT03126227|531901383|FG001|Overall Study|Physician Decision|0|||
147475796|NCT03126227|531901382|FG000|Overall Study|Protocol Violation|1|||
147475797|NCT03126227|531901383|FG001|Overall Study|Protocol Violation|0|||
147475798|NCT03126227|531901382|FG000|Overall Study|Withdrawal by Subject|19|||
147475799|NCT03126227|531901383|FG001|Overall Study|Withdrawal by Subject|3|||
147475800|NCT03126227|531901382|FG000|Overall Study|Discontinued due to early termination and continuation in follow-on study due to study closure|8|||
147475801|NCT03126227|531901383|FG001|Overall Study|Discontinued due to early termination and continuation in follow-on study due to study closure|1|||
147475802|NCT03126227|531901382|FG000|Overall Study|Lack of dosing compliance|2|||
147475803|NCT03126227|531901383|FG001|Overall Study|Lack of dosing compliance|0|||
147475804|NCT03126227|531901382|FG000|Overall Study|Did not meet eligibility criteria subsequent to enrollment|2|||
147475805|NCT03126227|531901383|FG001|Overall Study|Did not meet eligibility criteria subsequent to enrollment|0|||
147475806|NCT03126227|531901382|FG000|Overall Study|Scheduling conflict|1|||
147475807|NCT03126227|531901383|FG001|Overall Study|Scheduling conflict|0|||
147475808|NCT03230097|531901386|FG000|Overall Study|Adverse Event|2|||
147475809|NCT03230097|531901387|FG001|Overall Study|Adverse Event|1|||
147475810|NCT03230097|531901386|FG000|Overall Study|non-compliance|0|||
147475811|NCT03230097|531901387|FG001|Overall Study|non-compliance|1|||
147475812|NCT03230097|531901386|FG000|Overall Study|Lost to Follow-up|2|||
147475813|NCT03230097|531901387|FG001|Overall Study|Lost to Follow-up|4|||
147475814|NCT03230097|531901386|FG000|Overall Study|Withdrawal by Subject|7|||
147475815|NCT03230097|531901387|FG001|Overall Study|Withdrawal by Subject|3|||
147475816|NCT03230097|531901386|FG000|Overall Study|Trial termination|4|||
147475817|NCT03230097|531901387|FG001|Overall Study|Trial termination|5|||
147475818|NCT03230097|531901386|FG000|Overall Study|Covid-19 pandemic outbreak|0|||
147475819|NCT03230097|531901387|FG001|Overall Study|Covid-19 pandemic outbreak|1|||
147475820|NCT03230097|531901386|FG000|Overall Study|outcome event|0|||
147475821|NCT03230097|531901387|FG001|Overall Study|outcome event|1|||
147475822|NCT03056287|531901388|FG000|Overall Study|Withdrawal by Subject|0|||
147475823|NCT03056287|531901389|FG001|Overall Study|Withdrawal by Subject|1|||
147475824|NCT03056287|531901390|FG002|Overall Study|Withdrawal by Subject|0|||
147475825|NCT03056287|531901391|FG003|Overall Study|Withdrawal by Subject|0|||
147475826|NCT03056287|531901388|FG000|Overall Study|move out of area|0|||
147475827|NCT03056287|531901389|FG001|Overall Study|move out of area|0|||
147475828|NCT03056287|531901390|FG002|Overall Study|move out of area|1|||
147475829|NCT03056287|531901391|FG003|Overall Study|move out of area|1|||
147475830|NCT00635102|531901401|FG000|Overall Study|Withdrawal by Subject|7|||
147475831|NCT00635102|531901402|FG001|Overall Study|Withdrawal by Subject|8|||
147475832|NCT00440401|531901404|FG000|Overall Study|Adverse Event|2|||
147475833|NCT00440401|531901405|FG001|Overall Study|Adverse Event|1|||
147475834|NCT00440401|531901404|FG000|Overall Study|Other|2|||
147475835|NCT00440401|531901405|FG001|Overall Study|Other|5|||
147475836|NCT01238120|531901407|FG000|Overall Study|Withdrawal by Subject|4|||
147475837|NCT01238120|531901408|FG001|Overall Study|Withdrawal by Subject|1|||
147475838|NCT01238120|531901409|FG002|Overall Study|Withdrawal by Subject|2|||
147475839|NCT01238120|531901410|FG003|Overall Study|Withdrawal by Subject|5|||
147475840|NCT01238120|531901407|FG000|Overall Study|Lost to Follow-up|2|||
147475841|NCT01238120|531901408|FG001|Overall Study|Lost to Follow-up|0|||
147475842|NCT01238120|531901409|FG002|Overall Study|Lost to Follow-up|1|||
147475843|NCT01238120|531901410|FG003|Overall Study|Lost to Follow-up|1|||
147475844|NCT01238120|531901407|FG000|Overall Study|Withdrawn due to Medical Problem|2|||
147475845|NCT01238120|531901408|FG001|Overall Study|Withdrawn due to Medical Problem|0|||
147475846|NCT01238120|531901409|FG002|Overall Study|Withdrawn due to Medical Problem|1|||
147475847|NCT01238120|531901410|FG003|Overall Study|Withdrawn due to Medical Problem|0|||
147475848|NCT00881205|531901411|FG000|Overall Study|Adverse Event|8|||
147475849|NCT00881205|531901412|FG001|Overall Study|Adverse Event|3|||
147475850|NCT00881205|531901411|FG000|Overall Study|Withdrawal by Subject|1|||
147475851|NCT00881205|531901412|FG001|Overall Study|Withdrawal by Subject|2|||
147475852|NCT00881205|531901411|FG000|Overall Study|Lost to Follow-up|0|||
147475853|NCT00881205|531901412|FG001|Overall Study|Lost to Follow-up|1|||
147475854|NCT00881205|531901411|FG000|Overall Study|Administrative problems|1|||
147475855|NCT00881205|531901412|FG001|Overall Study|Administrative problems|1|||
147475856|NCT00881205|531901411|FG000|Overall Study|Condition no longer requires drug|1|||
147475857|NCT00881205|531901412|FG001|Overall Study|Condition no longer requires drug|0|||
147475858|NCT02498652|531901415|FG000|Overall Study|Protocol Violation|0|||
147475859|NCT02498652|531901416|FG001|Overall Study|Protocol Violation|1|||
147475860|NCT00845429|531901419|FG000|Overall Study|Protocol Violation|5|||
147475861|NCT00845429|531901420|FG001|Overall Study|Protocol Violation|4|||
147475862|NCT00845429|531901421|FG002|Overall Study|Protocol Violation|7|||
147475863|NCT00845429|531901419|FG000|Overall Study|Lost to Follow-up|7|||
147475864|NCT00845429|531901420|FG001|Overall Study|Lost to Follow-up|9|||
147475865|NCT00845429|531901421|FG002|Overall Study|Lost to Follow-up|10|||
147475866|NCT00845429|531901419|FG000|Overall Study|Withdrawal by Subject|2|||
147475867|NCT00845429|531901420|FG001|Overall Study|Withdrawal by Subject|2|||
147475868|NCT00845429|531901421|FG002|Overall Study|Withdrawal by Subject|2|||
147475869|NCT00845429|531901419|FG000|Overall Study|Serious adverse event|0|||
147475870|NCT00845429|531901420|FG001|Overall Study|Serious adverse event|0|||
147475871|NCT00845429|531901421|FG002|Overall Study|Serious adverse event|1|||
147475872|NCT00587223|531901427|FG000|Overall Study|Adverse Event|1|||
147475873|NCT00195351|531901428|FG000|Overall Study|Lost to Follow-up|9|||
147475874|NCT00195351|531901429|FG001|Overall Study|Lost to Follow-up|9|||
147475875|NCT00195351|531901428|FG000|Overall Study|Withdrawal by Subject|6|||
147475876|NCT00195351|531901429|FG001|Overall Study|Withdrawal by Subject|3|||
147475877|NCT00195351|531901428|FG000|Overall Study|Protocol Deviation|3|||
147475878|NCT00195351|531901429|FG001|Overall Study|Protocol Deviation|2|||
147475879|NCT00195351|531901428|FG000|Overall Study|Death|3|||
147475880|NCT00195351|531901429|FG001|Overall Study|Death|1|||
147475881|NCT00195351|531901428|FG000|Overall Study|Lack of Efficacy|0|||
147475882|NCT00195351|531901429|FG001|Overall Study|Lack of Efficacy|1|||
147475883|NCT02111369|531901430|FG000|Overall Study|Lost to Follow-up|2|||
147475884|NCT02111369|531901430|FG000|Overall Study|Withdrawal by Subject|1|||
147475885|NCT04332419|531901436|FG000|Overall Study|Withdrawal by Subject|1|||
147475886|NCT03256539|531901439|FG000|Overall Study|Withdrawal by Subject|0|||
147475887|NCT03256539|531901440|FG001|Overall Study|Withdrawal by Subject|3|||
147475888|NCT03256539|531901439|FG000|Overall Study|Unexpected closure of study components|8|||
147475889|NCT03256539|531901440|FG001|Overall Study|Unexpected closure of study components|4|||
147475890|NCT00828451|531901441|FG000|Overall Study|Death|2|||
147475891|NCT00828451|531901441|FG000|Overall Study|Lack of intravenous line|7|||
147475892|NCT00828451|531901441|FG000|Overall Study|Withdrawal by Subject|1|||
147475893|NCT00828451|531901441|FG000|Overall Study|Deterioration in clinical status|1|||
147621565|NCT02570308|532431510|FG003|Overall Study|Withdrawal by Subject|0|||
147621566|NCT02570308|532431511|FG004|Overall Study|Withdrawal by Subject|1|||
147621567|NCT02570308|532431507|FG000|Overall Study|Other|0|||
147475894|NCT02827877|531901442|FG000|Overall Study|Withdrawal by Subject|1|||
147475895|NCT05755438|531901443|FG000|12-week DBVC Period|Adverse Event|4|||
147475896|NCT05755438|531901444|FG001|12-week DBVC Period|Adverse Event|1|||
147475897|NCT05755438|531901443|FG000|12-week DBVC Period|Physician Decision|1|||
147475898|NCT05755438|531901444|FG001|12-week DBVC Period|Physician Decision|1|||
147475899|NCT05755438|531901443|FG000|12-week DBVC Period|Protocol Violation|4|||
147475900|NCT05755438|531901444|FG001|12-week DBVC Period|Protocol Violation|2|||
147475901|NCT05755438|531901443|FG000|12-week DBVC Period|Withdrawal by Subject|9|||
147475902|NCT05755438|531901444|FG001|12-week DBVC Period|Withdrawal by Subject|7|||
147621568|NCT02570308|532431508|FG001|Overall Study|Other|0|||
147475903|NCT05755438|531901443|FG000|12-week DBVC Period|Sponsor Decision|1|||
147475904|NCT05755438|531901444|FG001|12-week DBVC Period|Sponsor Decision|0|||
147475905|NCT05755438|531901443|FG000|40-week OLE Period|Adverse Event|0|||
147475906|NCT05755438|531901444|FG001|40-week OLE Period|Adverse Event|2|||
147475907|NCT05755438|531901443|FG000|40-week OLE Period|Lack of Efficacy|1|||
147475908|NCT05755438|531901444|FG001|40-week OLE Period|Lack of Efficacy|1|||
147475909|NCT05755438|531901443|FG000|40-week OLE Period|Lost to Follow-up|1|||
147475910|NCT05755438|531901444|FG001|40-week OLE Period|Lost to Follow-up|0|||
147475911|NCT05755438|531901443|FG000|40-week OLE Period|Physician Decision|1|||
147475912|NCT05755438|531901444|FG001|40-week OLE Period|Physician Decision|1|||
147475913|NCT05755438|531901443|FG000|40-week OLE Period|Protocol Violation|1|||
147475914|NCT05755438|531901444|FG001|40-week OLE Period|Protocol Violation|1|||
147475915|NCT05755438|531901443|FG000|40-week OLE Period|Withdrawal by Subject|6|||
147475916|NCT05755438|531901444|FG001|40-week OLE Period|Withdrawal by Subject|6|||
147475917|NCT05755438|531901443|FG000|40-week OLE Period|Sponsor Decision|3|||
147475918|NCT05755438|531901444|FG001|40-week OLE Period|Sponsor Decision|0|||
147475919|NCT05755438|531901443|FG000|40-week OLE Period|Did Not Complete Safety Follow-up Period|0|||
147475920|NCT05755438|531901444|FG001|40-week OLE Period|Did Not Complete Safety Follow-up Period|1|||
147475921|NCT05755438|531901443|FG000|40-week OLE Period|Ongoing|46|||
147475922|NCT05755438|531901444|FG001|40-week OLE Period|Ongoing|58|||
147475923|NCT01548638|531901447|FG000|Overall Study|Protocol Violation|3|||
147475924|NCT01548638|531901447|FG000|Overall Study|Withdrawal by Subject|1|||
147475925|NCT01919411|531901458|FG000|Overall Study|Lost to Follow-up|2|||
147475926|NCT01919411|531901459|FG001|Overall Study|Lost to Follow-up|4|||
147475927|NCT01919411|531901458|FG000|Overall Study|Physician Decision|1|||
147475928|NCT01919411|531901459|FG001|Overall Study|Physician Decision|0|||
147475929|NCT01919411|531901458|FG000|Overall Study|Protocol Violation|2|||
147475930|NCT01919411|531901459|FG001|Overall Study|Protocol Violation|1|||
147475931|NCT00144300|531901460|FG000|Overall Study|Adverse Event|18|||
147475932|NCT00144300|531901461|FG001|Overall Study|Adverse Event|16|||
147475933|NCT00144300|531901460|FG000|Overall Study|Protocol Violation|1|||
147475934|NCT00144300|531901461|FG001|Overall Study|Protocol Violation|3|||
147475935|NCT00144300|531901460|FG000|Overall Study|Lost to Follow-up|3|||
147475936|NCT00144300|531901461|FG001|Overall Study|Lost to Follow-up|0|||
147475937|NCT00144300|531901460|FG000|Overall Study|Withdrawal by Subject|6|||
147475938|NCT00144300|531901461|FG001|Overall Study|Withdrawal by Subject|6|||
147475939|NCT00144300|531901460|FG000|Overall Study|Other reason (not specified)|1|||
147475940|NCT00144300|531901461|FG001|Overall Study|Other reason (not specified)|3|||
147475941|NCT03478683|531901464|FG000|Overall Study|Adverse Event|5|||
147475942|NCT03478683|531901465|FG001|Overall Study|Adverse Event|3|||
147475943|NCT03478683|531901464|FG000|Overall Study|Lost to Follow-up|0|||
147475944|NCT03478683|531901465|FG001|Overall Study|Lost to Follow-up|5|||
147475945|NCT03478683|531901464|FG000|Overall Study|Physician Decision|1|||
147475946|NCT03478683|531901465|FG001|Overall Study|Physician Decision|3|||
147475947|NCT03478683|531901464|FG000|Overall Study|Withdrawal by Subject|7|||
147475948|NCT03478683|531901465|FG001|Overall Study|Withdrawal by Subject|7|||
147475949|NCT02742649|531903151|FG000|Pre-Randomization Washout Period|Washout/Randomization Failure|5|||
147475950|NCT02742649|531903152|FG001|Pre-Randomization Washout Period|Washout/Randomization Failure|0|||
147475951|NCT02742649|531903153|FG002|Pre-Randomization Washout Period|Washout/Randomization Failure|0|||
147475952|NCT02742649|531903154|FG003|Pre-Randomization Washout Period|Washout/Randomization Failure|0|||
147475953|NCT02742649|531903155|FG004|Pre-Randomization Washout Period|Washout/Randomization Failure|0|||
147475954|NCT02742649|531903151|FG000|Double-Blind Treatment Period|Adverse Event|0|||
147475955|NCT02742649|531903152|FG001|Double-Blind Treatment Period|Adverse Event|1|||
147475956|NCT02742649|531903153|FG002|Double-Blind Treatment Period|Adverse Event|0|||
147475957|NCT02742649|531903154|FG003|Double-Blind Treatment Period|Adverse Event|0|||
147475958|NCT02742649|531903155|FG004|Double-Blind Treatment Period|Adverse Event|0|||
147475959|NCT02742649|531903151|FG000|Open-Label Period|Lost to Follow-up|0|||
147475960|NCT02742649|531903152|FG001|Open-Label Period|Lost to Follow-up|0|||
147475961|NCT02742649|531903153|FG002|Open-Label Period|Lost to Follow-up|0|||
147621569|NCT02570308|532431509|FG002|Overall Study|Other|0|||
147621570|NCT02570308|532431510|FG003|Overall Study|Other|0|||
147621571|NCT02570308|532431511|FG004|Overall Study|Other|2|||
147475962|NCT02742649|531903154|FG003|Open-Label Period|Lost to Follow-up|0|||
147475963|NCT02742649|531903155|FG004|Open-Label Period|Lost to Follow-up|1|||
147475964|NCT03167619|531903162|FG000|Overall Study|Death|11|||
147475965|NCT03167619|531903163|FG001|Overall Study|Death|8|||
147475966|NCT03167619|531903162|FG000|Overall Study|Withdrawal by Subject|1|||
147475967|NCT03167619|531903163|FG001|Overall Study|Withdrawal by Subject|2|||
147475968|NCT03167619|531903162|FG000|Overall Study|Physician Decision|0|||
147475969|NCT03167619|531903163|FG001|Overall Study|Physician Decision|1|||
147475970|NCT01348919|531903167|FG000|Overall Study|Adverse Event|3|||
147475971|NCT01348919|531903168|FG001|Overall Study|Adverse Event|1|||
147475972|NCT01348919|531903169|FG002|Overall Study|Adverse Event|0|||
147475973|NCT01348919|531903167|FG000|Overall Study|Withdrawal by Subject|0|||
147475974|NCT01348919|531903168|FG001|Overall Study|Withdrawal by Subject|1|||
147475975|NCT01348919|531903169|FG002|Overall Study|Withdrawal by Subject|0|||
147475976|NCT01348919|531903167|FG000|Overall Study|Disease progression|0|||
147475977|NCT01348919|531903168|FG001|Overall Study|Disease progression|1|||
147475978|NCT01348919|531903169|FG002|Overall Study|Disease progression|1|||
147475979|NCT01389128|531903172|FG000|Overall Study|Fetal distress|1|||
147475980|NCT01389128|531903173|FG001|Overall Study|Fetal distress|0|||
147475981|NCT01389128|531903172|FG000|Overall Study|Cervix dilation stop|1|||
147475982|NCT01389128|531903173|FG001|Overall Study|Cervix dilation stop|2|||
147475983|NCT01389128|531903172|FG000|Overall Study|Rapid labor evolution|3|||
147475984|NCT01389128|531903173|FG001|Overall Study|Rapid labor evolution|2|||
147475985|NCT01389128|531903172|FG000|Overall Study|Intolerance to procedure|0|||
147475986|NCT01389128|531903173|FG001|Overall Study|Intolerance to procedure|2|||
147475987|NCT05299892|531903174|FG000|Overall Study|Withdrawal by Subject|2|||
147475988|NCT03180736|531903175|FG000|Overall Study|Adverse Event|3|||
147475989|NCT03180736|531903176|FG001|Overall Study|Adverse Event|4|||
147475990|NCT03180736|531903175|FG000|Overall Study|Death|10|||
147475991|NCT03180736|531903176|FG001|Overall Study|Death|7|||
147475992|NCT03180736|531903175|FG000|Overall Study|Withdrawal by Subject|5|||
147475993|NCT03180736|531903176|FG001|Overall Study|Withdrawal by Subject|12|||
147475994|NCT03180736|531903175|FG000|Overall Study|Lost to Follow-up|1|||
147475995|NCT03180736|531903176|FG001|Overall Study|Lost to Follow-up|0|||
147475996|NCT03180736|531903175|FG000|Overall Study|Lack of Efficacy|66|||
147475997|NCT03180736|531903176|FG001|Overall Study|Lack of Efficacy|87|||
147475998|NCT03180736|531903175|FG000|Overall Study|Physician Decision|4|||
147475999|NCT03180736|531903176|FG001|Overall Study|Physician Decision|7|||
147476000|NCT03180736|531903175|FG000|Overall Study|randomized but not treated|2|||
147476001|NCT03180736|531903176|FG001|Overall Study|randomized but not treated|3|||
147476002|NCT01059812|531903177|FG000|Overall Study|Adverse Event|9|||
147476003|NCT01059812|531903178|FG001|Overall Study|Adverse Event|5|||
147476004|NCT01059812|531903177|FG000|Overall Study|Lack of Efficacy|2|||
147476005|NCT01059812|531903178|FG001|Overall Study|Lack of Efficacy|2|||
147476006|NCT01059812|531903177|FG000|Overall Study|Protocol Violation|3|||
147476007|NCT01059812|531903178|FG001|Overall Study|Protocol Violation|1|||
147476008|NCT01059812|531903177|FG000|Overall Study|Withdrawal Criteria|9|||
147476009|NCT01059812|531903178|FG001|Overall Study|Withdrawal Criteria|4|||
147476010|NCT01059812|531903177|FG000|Overall Study|Unclassified|14|||
147476011|NCT01059812|531903178|FG001|Overall Study|Unclassified|4|||
147476012|NCT00149214|531903180|FG000|Overall Study|Adverse Event|12|||
147476013|NCT00149214|531903181|FG001|Overall Study|Adverse Event|9|||
147476014|NCT00149214|531903180|FG000|Overall Study|Withdrawal by Subject|4|||
147476015|NCT00149214|531903181|FG001|Overall Study|Withdrawal by Subject|1|||
147476016|NCT00149214|531903180|FG000|Overall Study|Physician Decision|3|||
147476017|NCT00149214|531903181|FG001|Overall Study|Physician Decision|3|||
147476018|NCT00149214|531903180|FG000|Overall Study|Sponsor Decision|0|||
147476019|NCT00149214|531903181|FG001|Overall Study|Sponsor Decision|1|||
147476020|NCT00149214|531903180|FG000|Overall Study|Progressive Disease|7|||
147476021|NCT00149214|531903181|FG001|Overall Study|Progressive Disease|3|||
147476022|NCT00756002|531903185|FG000|Double-Blind Treatment Period|Lack of Efficacy|1|||
147476023|NCT00756002|531903186|FG001|Double-Blind Treatment Period|Lack of Efficacy|1|||
147476024|NCT00756002|531903185|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
147476025|NCT00756002|531903186|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
147476026|NCT00756002|531903185|FG000|Double-Blind Treatment Period|Withdrawal by Subject|6|||
147476027|NCT00756002|531903186|FG001|Double-Blind Treatment Period|Withdrawal by Subject|6|||
147476028|NCT00756002|531903185|FG000|Double-Blind Treatment Period|Protocol Violation|6|||
147476029|NCT00756002|531903186|FG001|Double-Blind Treatment Period|Protocol Violation|5|||
147476030|NCT00756002|531903185|FG000|Double-Blind Treatment Period|Other|2|||
147476031|NCT00756002|531903186|FG001|Double-Blind Treatment Period|Other|2|||
147476032|NCT00174941|531903192|FG000|Overall Study|Adverse Event|1|||
147476033|NCT00174941|531903193|FG001|Overall Study|Adverse Event|10|||
147476034|NCT00174941|531903194|FG002|Overall Study|Adverse Event|2|||
147621572|NCT02069015|532431512|FG000|Overall Study|Lost to Follow-up|39|||
147621573|NCT02069015|532431513|FG001|Overall Study|Lost to Follow-up|32|||
147621574|NCT02069015|532431512|FG000|Overall Study|Withdrawal by Subject|1|||
147621575|NCT02069015|532431513|FG001|Overall Study|Withdrawal by Subject|1|||
147476035|NCT00174941|531903195|FG003|Overall Study|Adverse Event|13|||
147476036|NCT00174941|531903192|FG000|Overall Study|Protocol Violation|0|||
147476037|NCT00174941|531903193|FG001|Overall Study|Protocol Violation|1|||
147476038|NCT00174941|531903194|FG002|Overall Study|Protocol Violation|0|||
147476039|NCT00174941|531903195|FG003|Overall Study|Protocol Violation|1|||
147621576|NCT03335475|532431516|FG000|Overall Study|Did not wear accelerometer|4|||
147476040|NCT00174941|531903192|FG000|Overall Study|Lost to Follow-up|0|||
147476041|NCT00174941|531903193|FG001|Overall Study|Lost to Follow-up|3|||
147476042|NCT00174941|531903194|FG002|Overall Study|Lost to Follow-up|2|||
147476043|NCT00174941|531903195|FG003|Overall Study|Lost to Follow-up|5|||
147476044|NCT00174941|531903192|FG000|Overall Study|Personal Reason(s)|0|||
147476045|NCT00174941|531903193|FG001|Overall Study|Personal Reason(s)|14|||
147476046|NCT00174941|531903194|FG002|Overall Study|Personal Reason(s)|8|||
147476047|NCT00174941|531903195|FG003|Overall Study|Personal Reason(s)|22|||
147476048|NCT00174941|531903192|FG000|Overall Study|Gout Flare|0|||
147476049|NCT00174941|531903193|FG001|Overall Study|Gout Flare|4|||
147621577|NCT03335475|532431517|FG001|Overall Study|Did not wear accelerometer|0|||
147621578|NCT03335475|532431516|FG000|Overall Study|Withdrawal by Subject|0|||
147476050|NCT00174941|531903194|FG002|Overall Study|Gout Flare|4|||
147476051|NCT00174941|531903195|FG003|Overall Study|Gout Flare|8|||
147476052|NCT00174941|531903192|FG000|Overall Study|Reason Not Specified|1|||
147476053|NCT00174941|531903193|FG001|Overall Study|Reason Not Specified|6|||
147476054|NCT00174941|531903194|FG002|Overall Study|Reason Not Specified|2|||
147476055|NCT00174941|531903195|FG003|Overall Study|Reason Not Specified|9|||
147476056|NCT04329923|531903196|FG000|Overall Study|Withdrawal by Subject|1|||
147476057|NCT04329923|531903197|FG001|Overall Study|Withdrawal by Subject|4|||
147476058|NCT04329923|531903198|FG002|Overall Study|Withdrawal by Subject|1|||
147476059|NCT04329923|531903199|FG003|Overall Study|Withdrawal by Subject|1|||
147476060|NCT04329923|531903200|FG004|Overall Study|Withdrawal by Subject|1|||
147476061|NCT04329923|531903201|FG005|Overall Study|Withdrawal by Subject|1|||
147476062|NCT04329923|531903196|FG000|Overall Study|early termination of study|0|||
147476063|NCT04329923|531903197|FG001|Overall Study|early termination of study|0|||
147476064|NCT04329923|531903198|FG002|Overall Study|early termination of study|0|||
147476065|NCT04329923|531903199|FG003|Overall Study|early termination of study|0|||
147476066|NCT04329923|531903200|FG004|Overall Study|early termination of study|1|||
147476067|NCT04329923|531903201|FG005|Overall Study|early termination of study|2|||
147476068|NCT04329923|531903196|FG000|Overall Study|positive SARS-COV2 PCR at baseline|0|||
147476069|NCT04329923|531903197|FG001|Overall Study|positive SARS-COV2 PCR at baseline|0|||
147476070|NCT04329923|531903198|FG002|Overall Study|positive SARS-COV2 PCR at baseline|0|||
147476071|NCT04329923|531903199|FG003|Overall Study|positive SARS-COV2 PCR at baseline|0|||
147476072|NCT04329923|531903200|FG004|Overall Study|positive SARS-COV2 PCR at baseline|0|||
147476073|NCT04329923|531903201|FG005|Overall Study|positive SARS-COV2 PCR at baseline|2|||
147476074|NCT01844076|531903213|FG000|Overall Study|Adverse Event|1|||
147476075|NCT01844076|531903214|FG001|Overall Study|Adverse Event|0|||
147476076|NCT01844076|531903215|FG002|Overall Study|Adverse Event|0|||
147476077|NCT01844076|531903216|FG003|Overall Study|Adverse Event|0|||
147476078|NCT01844076|531903213|FG000|Overall Study|Withdrawal by Subject|1|||
147476079|NCT01844076|531903214|FG001|Overall Study|Withdrawal by Subject|0|||
147476080|NCT01844076|531903215|FG002|Overall Study|Withdrawal by Subject|0|||
147476081|NCT01844076|531903216|FG003|Overall Study|Withdrawal by Subject|0|||
147476082|NCT01925703|531903225|FG000|Overall Study|Physician Decision|1|||
147476083|NCT01925703|531903225|FG000|Overall Study|Lost to Follow-up|2|||
147476084|NCT01925703|531903225|FG000|Overall Study|Discharge prior to full iron repletion|1|||
147476085|NCT01938625|531903226|FG000|Overall Study|Withdrawal by Subject|0|||
147476086|NCT01938625|531903227|FG001|Overall Study|Withdrawal by Subject|1|||
147476087|NCT01938625|531903226|FG000|Overall Study|Adverse Event|0|||
147476088|NCT01938625|531903227|FG001|Overall Study|Adverse Event|1|||
147476089|NCT01937312|531903228|FG000|Overall Study|Adverse Event|10|||
147476090|NCT01937312|531903229|FG001|Overall Study|Adverse Event|1|||
147476091|NCT01937312|531903228|FG000|Overall Study|Lack of Efficacy|0|||
147476092|NCT01937312|531903229|FG001|Overall Study|Lack of Efficacy|1|||
147476093|NCT01937312|531903228|FG000|Overall Study|Withdrawal of subject prior to treatment|1|||
147476094|NCT01937312|531903229|FG001|Overall Study|Withdrawal of subject prior to treatment|1|||
147476095|NCT05309083|531903230|FG000|Overall Study|Withdrawal by Subject|2|||
147476096|NCT01165229|531903231|FG000|Overall Study|Serious Adverse Event|456|||
147476097|NCT01165229|531903232|FG001|Overall Study|Serious Adverse Event|487|||
147476098|NCT01165229|531903231|FG000|Overall Study|Non-Serious Adverse Event|47|||
147476099|NCT01165229|531903232|FG001|Overall Study|Non-Serious Adverse Event|15|||
147476100|NCT01165229|531903231|FG000|Overall Study|Protocol Violation|6|||
147476101|NCT01165229|531903232|FG001|Overall Study|Protocol Violation|8|||
147476102|NCT01165229|531903231|FG000|Overall Study|Withdrawal by Subject|387|||
147476103|NCT01165229|531903232|FG001|Overall Study|Withdrawal by Subject|396|||
147476104|NCT01165229|531903231|FG000|Overall Study|Migrated/moved from study area|51|||
147476105|NCT01165229|531903232|FG001|Overall Study|Migrated/moved from study area|46|||
147476106|NCT01165229|531903231|FG000|Overall Study|Lost to Follow-up|123|||
147476107|NCT01165229|531903232|FG001|Overall Study|Lost to Follow-up|133|||
147476108|NCT01165229|531903231|FG000|Overall Study|Suspected HZ Episode|2|||
147621579|NCT03335475|532431517|FG001|Overall Study|Withdrawal by Subject|1|||
147621580|NCT02411656|532431518|FG000|Overall Study|Adverse Event|4|||
147476109|NCT01165229|531903232|FG001|Overall Study|Suspected HZ Episode|2|||
147476110|NCT01165229|531903231|FG000|Overall Study|No reason from the subject|108|||
147476111|NCT01165229|531903232|FG001|Overall Study|No reason from the subject|102|||
147476112|NCT01165229|531903231|FG000|Overall Study|Unknown completion status|0|||
147476113|NCT01165229|531903232|FG001|Overall Study|Unknown completion status|1|||
147476114|NCT00474253|531903233|FG000|Overall Study|Withdrew consent|2|||
147476115|NCT00474253|531903234|FG001|Overall Study|Withdrew consent|0|||
147476116|NCT00474253|531903233|FG000|Overall Study|Withdrew due to surgery-related issues|0|||
147476117|NCT00474253|531903234|FG001|Overall Study|Withdrew due to surgery-related issues|3|||
147476118|NCT00474253|531903233|FG000|Overall Study|Lost to Follow-up|1|||
147476119|NCT00474253|531903234|FG001|Overall Study|Lost to Follow-up|0|||
147476120|NCT00474253|531903233|FG000|Overall Study|Discharged prior to study completion|0|||
147621581|NCT02411656|532431518|FG000|Overall Study|Clinical Progression|33|||
147476121|NCT00474253|531903234|FG001|Overall Study|Discharged prior to study completion|1|||
147476122|NCT00550238|531903238|FG000|Overall Study|Adverse Event|88|||
147476123|NCT00550238|531903238|FG000|Overall Study|Death|34|||
147476124|NCT00550238|531903238|FG000|Overall Study|Disease progression|46|||
147476125|NCT00550238|531903238|FG000|Overall Study|Withdrawal by Subject|167|||
147476126|NCT00550238|531903238|FG000|Overall Study|Physician Decision|31|||
147476127|NCT00550238|531903238|FG000|Overall Study|Patient noncompliance|25|||
147476128|NCT00550238|531903238|FG000|Overall Study|Lost to Follow-up|13|||
147476129|NCT00550238|531903238|FG000|Overall Study|Sponsor decision|55|||
147476130|NCT03133481|531903239|FG000|Overall Study|FC Catheter fell out post operative day1|0|||
147476131|NCT03133481|531903240|FG001|Overall Study|FC Catheter fell out post operative day1|4|||
147476132|NCT01184989|531903245|FG000|Overall Study|Adverse Event|11|||
147476133|NCT01184989|531903245|FG000|Overall Study|Withdrawal by Subject|1|||
147476134|NCT01570491|531903246|FG000|Overall Study|Lost to Follow-up|3|||
147476135|NCT01570491|531903247|FG001|Overall Study|Lost to Follow-up|1|||
147476136|NCT01570491|531903246|FG000|Overall Study|treatment: not given or discontinued|2|||
147476137|NCT01570491|531903247|FG001|Overall Study|treatment: not given or discontinued|0|||
147476138|NCT05370157|531903250|FG000|Participants Entering at Baseline|Lost to Follow-up|11|||
147476139|NCT05370157|531903251|FG001|Participants Entering at Baseline|Lost to Follow-up|11|||
147476140|NCT05370157|531903250|FG000|Participants Entering at Baseline|Not eligible for followup - no longer member of team|17|||
147476141|NCT05370157|531903251|FG001|Participants Entering at Baseline|Not eligible for followup - no longer member of team|4|||
147476142|NCT01508676|531903252|FG000|Phase I (2 Weeks)|Medication Exclusion|1|||
147476143|NCT01508676|531903253|FG001|Phase I (2 Weeks)|Medication Exclusion|1|||
147476144|NCT01508676|531903252|FG000|Phase I (2 Weeks)|Wrong Pain Type|1|||
147476145|NCT01508676|531903253|FG001|Phase I (2 Weeks)|Wrong Pain Type|0|||
147476146|NCT01508676|531903252|FG000|Phase I (2 Weeks)|Positive Drug Screen|0|||
147476147|NCT01508676|531903253|FG001|Phase I (2 Weeks)|Positive Drug Screen|2|||
147476148|NCT01508676|531903252|FG000|Phase II (2 Weeks)|Skin Sensitivity|0|||
147476149|NCT01508676|531903253|FG001|Phase II (2 Weeks)|Skin Sensitivity|1|||
147476150|NCT01508676|531903252|FG000|Phase II (2 Weeks)|Medication Exclusion|1|||
147476151|NCT01508676|531903253|FG001|Phase II (2 Weeks)|Medication Exclusion|0|||
147476152|NCT03700892|531903254|FG000|Second Intervention (Single 1-Day Visit)|Withdrawal by Subject|0|||
147476153|NCT03700892|531903255|FG001|Second Intervention (Single 1-Day Visit)|Withdrawal by Subject|1|||
147476154|NCT03700892|531903256|FG002|Second Intervention (Single 1-Day Visit)|Withdrawal by Subject|0|||
147476155|NCT00849212|531903258|FG000|Overall Study|Lack of Efficacy|1|||
147476156|NCT00849212|531903258|FG000|Overall Study|Withdrawal by Subject|3|||
147476157|NCT00849212|531903258|FG000|Overall Study|Adverse Event|2|||
147476158|NCT00849212|531903258|FG000|Overall Study|Miscellaneous|1|||
147476159|NCT04407507|531903259|FG000|Overall Study|Withdrawal by Subject|0|||
147476160|NCT04407507|531903260|FG001|Overall Study|Withdrawal by Subject|1|||
147476161|NCT01499576|531903261|FG000|Overall Study|Physician Decision|12|||
147476162|NCT01499576|531903261|FG000|Overall Study|Withdrawal by Subject|9|||
147476163|NCT00971321|531903265|FG000|Up to Month 7|Withdrawal by Subject|1|||
147476164|NCT00971321|531903266|FG001|Up to Month 7|Withdrawal by Subject|0|||
147476165|NCT00971321|531903265|FG000|Up to Month 7|Migrated/moved from study area|3|||
147476166|NCT00971321|531903266|FG001|Up to Month 7|Migrated/moved from study area|2|||
147476167|NCT00971321|531903265|FG000|Up to Month 11-12|Withdrawal by Subject|2|||
147476168|NCT00971321|531903266|FG001|Up to Month 11-12|Withdrawal by Subject|1|||
147476169|NCT00971321|531903265|FG000|Up to Month 11-12|Migrated/moved from study area|2|||
147476170|NCT00971321|531903266|FG001|Up to Month 11-12|Migrated/moved from study area|2|||
147476171|NCT00971321|531903265|FG000|Up to Month 11-12|Lost to Follow-up|1|||
147476172|NCT00971321|531903266|FG001|Up to Month 11-12|Lost to Follow-up|0|||
147476173|NCT00519623|531903267|FG000|Overall Study|Adverse Event|1|||
147476174|NCT04222725|531903268|FG000|Overall Study|Adverse Event|0|||
147476175|NCT04222725|531903269|FG001|Overall Study|Adverse Event|1|||
147476176|NCT04222725|531903270|FG002|Overall Study|Adverse Event|0|||
147476177|NCT04222725|531903271|FG003|Overall Study|Adverse Event|0|||
147621582|NCT06481709|532431519|FG000|Overall Study|Withdrawal by Subject|0|||
147476178|NCT03819140|531903272|FG000|Overall Study|Lost to Follow-up|1|||
147476179|NCT03819140|531903273|FG001|Overall Study|Lost to Follow-up|2|||
147476180|NCT03819140|531903272|FG000|Overall Study|Withdrawal by Subject|3|||
147476181|NCT03819140|531903273|FG001|Overall Study|Withdrawal by Subject|2|||
147621583|NCT06481709|532431520|FG001|Overall Study|Withdrawal by Subject|0|||
147621584|NCT06481709|532431521|FG002|Overall Study|Withdrawal by Subject|2|||
147621585|NCT06481709|532431522|FG003|Overall Study|Withdrawal by Subject|0|||
147621586|NCT05921903|532431523|FG000|Overall Study|Unsolicited non-SAE|0|||
147621587|NCT05921903|532431524|FG001|Overall Study|Unsolicited non-SAE|1|||
147476182|NCT03819140|531903272|FG000|Overall Study|Adverse Event|0|||
147476183|NCT03819140|531903273|FG001|Overall Study|Adverse Event|1|||
147476184|NCT03819140|531903272|FG000|Overall Study|Unable to attend visit(s) due to contracting COVID|2|||
147476185|NCT03819140|531903273|FG001|Overall Study|Unable to attend visit(s) due to contracting COVID|1|||
147476186|NCT03819140|531903272|FG000|Overall Study|Unable to attend visit(s) due to UCSF pandemic policies restricting non-essential visits|1|||
147476187|NCT03819140|531903273|FG001|Overall Study|Unable to attend visit(s) due to UCSF pandemic policies restricting non-essential visits|3|||
147621588|NCT05921903|532431525|FG002|Overall Study|Unsolicited non-SAE|0|||
147621589|NCT05921903|532431523|FG000|Overall Study|SAEs/pIMDs/AESIs specific to SOT|0|||
147621590|NCT05921903|532431524|FG001|Overall Study|SAEs/pIMDs/AESIs specific to SOT|3|||
147621591|NCT05921903|532431525|FG002|Overall Study|SAEs/pIMDs/AESIs specific to SOT|1|||
147621592|NCT05921903|532431523|FG000|Overall Study|Ongoing at the time of Primary Completion Analysis|129|||
147621593|NCT05921903|532431524|FG001|Overall Study|Ongoing at the time of Primary Completion Analysis|126|||
147621594|NCT05921903|532431525|FG002|Overall Study|Ongoing at the time of Primary Completion Analysis|112|||
147621595|NCT03305848|532431526|FG000|Overall Study|Symptom resolution after consent, but before study drug administration|1|||
147621596|NCT03305848|532431526|FG000|Overall Study|Physician Decision|2|||
147621597|NCT00789854|532431527|FG000|Overall Study|Adverse Event|28|||
147621598|NCT00789854|532431528|FG001|Overall Study|Adverse Event|23|||
147621599|NCT00789854|532431529|FG002|Overall Study|Adverse Event|18|||
147621600|NCT00789854|532431527|FG000|Overall Study|Lost to Follow-up|1|||
147621601|NCT00789854|532431528|FG001|Overall Study|Lost to Follow-up|1|||
147621602|NCT00789854|532431529|FG002|Overall Study|Lost to Follow-up|4|||
147621603|NCT00789854|532431527|FG000|Overall Study|Withdrawal by Subject|9|||
147621604|NCT00789854|532431528|FG001|Overall Study|Withdrawal by Subject|6|||
147621605|NCT00789854|532431529|FG002|Overall Study|Withdrawal by Subject|17|||
147621606|NCT00789854|532431527|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
147621607|NCT00789854|532431528|FG001|Overall Study|Eligibility criteria not fulfilled|5|||
147621608|NCT00789854|532431529|FG002|Overall Study|Eligibility criteria not fulfilled|1|||
147621609|NCT00789854|532431527|FG000|Overall Study|Severe non-compliance to the protocol|3|||
147621610|NCT00789854|532431528|FG001|Overall Study|Severe non-compliance to the protocol|0|||
147621611|NCT00789854|532431529|FG002|Overall Study|Severe non-compliance to the protocol|0|||
147621612|NCT00789854|532431527|FG000|Overall Study|Safety reasons|0|||
147621613|NCT00789854|532431528|FG001|Overall Study|Safety reasons|0|||
147621614|NCT00789854|532431529|FG002|Overall Study|Safety reasons|2|||
147621615|NCT00789854|532431527|FG000|Overall Study|Other|6|||
147621616|NCT00789854|532431528|FG001|Overall Study|Other|0|||
147621617|NCT00789854|532431529|FG002|Overall Study|Other|5|||
147621618|NCT02224157|532431531|FG000|Overall Study|Severe non-compliance to protocol|2|||
147621619|NCT02224157|532431532|FG001|Overall Study|Severe non-compliance to protocol|2|||
147621620|NCT02224157|532431531|FG000|Overall Study|Other|13|||
147621621|NCT02224157|532431532|FG001|Overall Study|Other|10|||
147621622|NCT02224157|532431531|FG000|Overall Study|Subject decision|58|||
147621623|NCT02224157|532431532|FG001|Overall Study|Subject decision|50|||
147621624|NCT02224157|532431531|FG000|Overall Study|Prematurely closed site|4|||
147621625|NCT02224157|532431532|FG001|Overall Study|Prematurely closed site|2|||
147621626|NCT02224157|532431531|FG000|Overall Study|Eligibility criteria not fulfilled|4|||
147621627|NCT02224157|532431532|FG001|Overall Study|Eligibility criteria not fulfilled|8|||
147621628|NCT02224157|532431531|FG000|Overall Study|Lost to Follow-up|27|||
147621629|NCT02224157|532431532|FG001|Overall Study|Lost to Follow-up|35|||
147621630|NCT02224157|532431531|FG000|Overall Study|Death|1|||
147621631|NCT02224157|532431532|FG001|Overall Study|Death|1|||
147621632|NCT02224157|532431531|FG000|Overall Study|Adverse Event|1|||
147621633|NCT02224157|532431532|FG001|Overall Study|Adverse Event|3|||
147621634|NCT05906628|532431533|FG000|16-Week DBVC Period|Lack of Efficacy|0|||
147621635|NCT05906628|532431534|FG001|16-Week DBVC Period|Lack of Efficacy|1|||
147621636|NCT05906628|532431533|FG000|16-Week DBVC Period|Lost to Follow-up|2|||
147621637|NCT05906628|532431534|FG001|16-Week DBVC Period|Lost to Follow-up|1|||
147621638|NCT05906628|532431533|FG000|16-Week DBVC Period|Protocol Violation|4|||
147621639|NCT05906628|532431534|FG001|16-Week DBVC Period|Protocol Violation|2|||
147621640|NCT05906628|532431533|FG000|16-Week DBVC Period|Withdrawal by Subject|4|||
147621641|NCT05906628|532431534|FG001|16-Week DBVC Period|Withdrawal by Subject|11|||
147621642|NCT05906628|532431533|FG000|16-Week OLE Period|Death|1|||
147621643|NCT05906628|532431534|FG001|16-Week OLE Period|Death|0|||
147621644|NCT05906628|532431533|FG000|16-Week OLE Period|Lost to Follow-up|1|||
147621645|NCT05906628|532431534|FG001|16-Week OLE Period|Lost to Follow-up|1|||
147621646|NCT05906628|532431533|FG000|16-Week OLE Period|Protocol Violation|0|||
147621647|NCT05906628|532431534|FG001|16-Week OLE Period|Protocol Violation|1|||
147621648|NCT05906628|532431533|FG000|16-Week OLE Period|Withdrawal by Subject|6|||
147621649|NCT05906628|532431534|FG001|16-Week OLE Period|Withdrawal by Subject|4|||
147476188|NCT00658333|531903274|FG000|Overall Study|Adverse Event|2|||
147476189|NCT00658333|531903275|FG001|Overall Study|Adverse Event|1|||
147476190|NCT03519178|531903276|FG000|PF-06873600 Treatment|Adverse Event|0|||
147621650|NCT01320293|532431536|FG000|Overall Study|Lack of Efficacy|1|||
147621651|NCT01320293|532431536|FG000|Overall Study|Adverse Event|1|||
147621652|NCT00470470|532431537|FG000|Overall Study|Adverse Event|2|||
147621653|NCT00470470|532431537|FG000|Overall Study|Death|2|||
147476191|NCT03519178|531903277|FG001|PF-06873600 Treatment|Adverse Event|0|||
147621654|NCT00470470|532431537|FG000|Overall Study|Not treated|1|||
147621655|NCT01532934|532431538|FG000|Overall Study|Lost to Follow-up|11|||
147621656|NCT01532934|532431539|FG001|Overall Study|Lost to Follow-up|11|||
147621657|NCT01532934|532431538|FG000|Overall Study|In controlled environment|3|||
147666807|NCT00264147|532605878|FG001|Treatment I Period|Lost to Follow-up|0|||
147476192|NCT03519178|531903278|FG002|PF-06873600 Treatment|Adverse Event|0|||
147666808|NCT00264147|532605879|FG002|Treatment I Period|Lost to Follow-up|0|||
147666809|NCT00264147|532605880|FG003|Treatment I Period|Lost to Follow-up|1|||
147666810|NCT00264147|532605881|FG004|Treatment I Period|Lost to Follow-up|1|||
147666811|NCT00264147|532605882|FG005|Treatment I Period|Lost to Follow-up|0|||
147666812|NCT00264147|532605877|FG000|Treatment I Period|Protocol Violation|2|||
147666813|NCT00264147|532605878|FG001|Treatment I Period|Protocol Violation|2|||
147666814|NCT00264147|532605879|FG002|Treatment I Period|Protocol Violation|0|||
147666815|NCT00264147|532605880|FG003|Treatment I Period|Protocol Violation|0|||
147666816|NCT00264147|532605881|FG004|Treatment I Period|Protocol Violation|0|||
147666817|NCT00264147|532605882|FG005|Treatment I Period|Protocol Violation|0|||
147666818|NCT00264147|532605877|FG000|Treatment I Period|Withdrawal by Subject|2|||
147666819|NCT00264147|532605878|FG001|Treatment I Period|Withdrawal by Subject|0|||
147666820|NCT00264147|532605879|FG002|Treatment I Period|Withdrawal by Subject|0|||
147666821|NCT00264147|532605880|FG003|Treatment I Period|Withdrawal by Subject|2|||
147666822|NCT00264147|532605881|FG004|Treatment I Period|Withdrawal by Subject|2|||
147666823|NCT00264147|532605882|FG005|Treatment I Period|Withdrawal by Subject|0|||
147666824|NCT00264147|532605877|FG000|Treatment I Period|Patient out of town for an extended time|0|||
147666825|NCT00264147|532605878|FG001|Treatment I Period|Patient out of town for an extended time|1|||
147666826|NCT00264147|532605879|FG002|Treatment I Period|Patient out of town for an extended time|0|||
147666827|NCT00264147|532605880|FG003|Treatment I Period|Patient out of town for an extended time|0|||
147666828|NCT00264147|532605881|FG004|Treatment I Period|Patient out of town for an extended time|0|||
147666829|NCT00264147|532605882|FG005|Treatment I Period|Patient out of town for an extended time|0|||
147666830|NCT00264147|532605877|FG000|Treatment I Period|Unblinded due to Serious Adverse Event|0|||
147666831|NCT00264147|532605878|FG001|Treatment I Period|Unblinded due to Serious Adverse Event|0|||
147666832|NCT00264147|532605879|FG002|Treatment I Period|Unblinded due to Serious Adverse Event|1|||
147666833|NCT00264147|532605880|FG003|Treatment I Period|Unblinded due to Serious Adverse Event|0|||
147666834|NCT00264147|532605881|FG004|Treatment I Period|Unblinded due to Serious Adverse Event|0|||
147666835|NCT00264147|532605882|FG005|Treatment I Period|Unblinded due to Serious Adverse Event|0|||
147666836|NCT00264147|532605877|FG000|Treatment I Period|Reassigned to Treatment II Period|84|||
147666837|NCT00264147|532605878|FG001|Treatment I Period|Reassigned to Treatment II Period|72|||
147666838|NCT00264147|532605879|FG002|Treatment I Period|Reassigned to Treatment II Period|65|||
147666839|NCT00264147|532605880|FG003|Treatment I Period|Reassigned to Treatment II Period|63|||
147666840|NCT00264147|532605881|FG004|Treatment I Period|Reassigned to Treatment II Period|45|||
147476193|NCT03519178|531903279|FG003|PF-06873600 Treatment|Adverse Event|0|||
147476194|NCT03519178|531903280|FG004|PF-06873600 Treatment|Adverse Event|0|||
147476195|NCT03519178|531903281|FG005|PF-06873600 Treatment|Adverse Event|0|||
147476196|NCT03519178|531903282|FG006|PF-06873600 Treatment|Adverse Event|0|||
147476197|NCT03519178|531903283|FG007|PF-06873600 Treatment|Adverse Event|2|||
147476198|NCT03519178|531903284|FG008|PF-06873600 Treatment|Adverse Event|1|||
147476199|NCT03519178|531903285|FG009|PF-06873600 Treatment|Adverse Event|0|||
147476200|NCT03519178|531903286|FG010|PF-06873600 Treatment|Adverse Event|0|||
147476201|NCT03519178|531903287|FG011|PF-06873600 Treatment|Adverse Event|0|||
147476202|NCT03519178|531903288|FG012|PF-06873600 Treatment|Adverse Event|1|||
147476203|NCT03519178|531903289|FG013|PF-06873600 Treatment|Adverse Event|3|||
147476204|NCT03519178|531903290|FG014|PF-06873600 Treatment|Adverse Event|2|||
147476205|NCT03519178|531903276|FG000|PF-06873600 Treatment|Death|0|||
147476206|NCT03519178|531903277|FG001|PF-06873600 Treatment|Death|0|||
147476207|NCT03519178|531903278|FG002|PF-06873600 Treatment|Death|0|||
147476208|NCT03519178|531903279|FG003|PF-06873600 Treatment|Death|0|||
147476209|NCT03519178|531903280|FG004|PF-06873600 Treatment|Death|0|||
147476210|NCT03519178|531903281|FG005|PF-06873600 Treatment|Death|0|||
147476211|NCT03519178|531903282|FG006|PF-06873600 Treatment|Death|0|||
147476212|NCT03519178|531903283|FG007|PF-06873600 Treatment|Death|0|||
147476213|NCT03519178|531903284|FG008|PF-06873600 Treatment|Death|1|||
147476214|NCT03519178|531903285|FG009|PF-06873600 Treatment|Death|1|||
147476215|NCT03519178|531903286|FG010|PF-06873600 Treatment|Death|0|||
147476216|NCT03519178|531903287|FG011|PF-06873600 Treatment|Death|0|||
147476217|NCT03519178|531903288|FG012|PF-06873600 Treatment|Death|0|||
147476218|NCT03519178|531903289|FG013|PF-06873600 Treatment|Death|0|||
147476219|NCT03519178|531903290|FG014|PF-06873600 Treatment|Death|1|||
147476220|NCT03519178|531903276|FG000|PF-06873600 Treatment|Physician Decision|0|||
147476221|NCT03519178|531903277|FG001|PF-06873600 Treatment|Physician Decision|0|||
147666841|NCT00264147|532605882|FG005|Treatment I Period|Reassigned to Treatment II Period|0|||
147476222|NCT03519178|531903278|FG002|PF-06873600 Treatment|Physician Decision|0|||
147476223|NCT03519178|531903279|FG003|PF-06873600 Treatment|Physician Decision|0|||
147476224|NCT03519178|531903280|FG004|PF-06873600 Treatment|Physician Decision|0|||
147476225|NCT03519178|531903281|FG005|PF-06873600 Treatment|Physician Decision|0|||
147476226|NCT03519178|531903282|FG006|PF-06873600 Treatment|Physician Decision|0|||
147476227|NCT03519178|531903283|FG007|PF-06873600 Treatment|Physician Decision|1|||
147476228|NCT03519178|531903284|FG008|PF-06873600 Treatment|Physician Decision|0|||
147476229|NCT03519178|531903285|FG009|PF-06873600 Treatment|Physician Decision|0|||
147476230|NCT03519178|531903286|FG010|PF-06873600 Treatment|Physician Decision|1|||
147476231|NCT03519178|531903287|FG011|PF-06873600 Treatment|Physician Decision|0|||
147476232|NCT03519178|531903288|FG012|PF-06873600 Treatment|Physician Decision|0|||
147476233|NCT03519178|531903289|FG013|PF-06873600 Treatment|Physician Decision|4|||
147476234|NCT03519178|531903290|FG014|PF-06873600 Treatment|Physician Decision|1|||
147476235|NCT03519178|531903276|FG000|PF-06873600 Treatment|Progressive disease|1|||
147476236|NCT03519178|531903277|FG001|PF-06873600 Treatment|Progressive disease|1|||
147476237|NCT03519178|531903278|FG002|PF-06873600 Treatment|Progressive disease|1|||
147476238|NCT03519178|531903279|FG003|PF-06873600 Treatment|Progressive disease|1|||
147476239|NCT03519178|531903280|FG004|PF-06873600 Treatment|Progressive disease|6|||
147476240|NCT03519178|531903281|FG005|PF-06873600 Treatment|Progressive disease|7|||
147476241|NCT03519178|531903282|FG006|PF-06873600 Treatment|Progressive disease|3|||
147476242|NCT03519178|531903283|FG007|PF-06873600 Treatment|Progressive disease|7|||
147476243|NCT03519178|531903284|FG008|PF-06873600 Treatment|Progressive disease|3|||
147476244|NCT03519178|531903285|FG009|PF-06873600 Treatment|Progressive disease|5|||
147476245|NCT03519178|531903286|FG010|PF-06873600 Treatment|Progressive disease|4|||
147476246|NCT03519178|531903287|FG011|PF-06873600 Treatment|Progressive disease|3|||
147476247|NCT03519178|531903288|FG012|PF-06873600 Treatment|Progressive disease|4|||
147476248|NCT03519178|531903289|FG013|PF-06873600 Treatment|Progressive disease|28|||
147476249|NCT03519178|531903290|FG014|PF-06873600 Treatment|Progressive disease|8|||
147476250|NCT03519178|531903276|FG000|PF-06873600 Treatment|Withdrawal by Subject|0|||
147476251|NCT03519178|531903277|FG001|PF-06873600 Treatment|Withdrawal by Subject|0|||
147476252|NCT03519178|531903278|FG002|PF-06873600 Treatment|Withdrawal by Subject|1|||
147476253|NCT03519178|531903279|FG003|PF-06873600 Treatment|Withdrawal by Subject|0|||
147476254|NCT03519178|531903280|FG004|PF-06873600 Treatment|Withdrawal by Subject|2|||
147476255|NCT03519178|531903281|FG005|PF-06873600 Treatment|Withdrawal by Subject|0|||
147476256|NCT03519178|531903282|FG006|PF-06873600 Treatment|Withdrawal by Subject|0|||
147476257|NCT03519178|531903283|FG007|PF-06873600 Treatment|Withdrawal by Subject|1|||
147476258|NCT03519178|531903284|FG008|PF-06873600 Treatment|Withdrawal by Subject|3|||
147476259|NCT03519178|531903285|FG009|PF-06873600 Treatment|Withdrawal by Subject|2|||
147476260|NCT03519178|531903286|FG010|PF-06873600 Treatment|Withdrawal by Subject|0|||
147476261|NCT03519178|531903287|FG011|PF-06873600 Treatment|Withdrawal by Subject|2|||
147476262|NCT03519178|531903288|FG012|PF-06873600 Treatment|Withdrawal by Subject|1|||
147476263|NCT03519178|531903289|FG013|PF-06873600 Treatment|Withdrawal by Subject|1|||
147476264|NCT03519178|531903290|FG014|PF-06873600 Treatment|Withdrawal by Subject|2|||
147476265|NCT03519178|531903276|FG000|PF-06873600 Treatment|Global deterioration of health status|0|||
147476266|NCT03519178|531903277|FG001|PF-06873600 Treatment|Global deterioration of health status|0|||
147476267|NCT03519178|531903278|FG002|PF-06873600 Treatment|Global deterioration of health status|0|||
147476268|NCT03519178|531903279|FG003|PF-06873600 Treatment|Global deterioration of health status|2|||
147476269|NCT03519178|531903280|FG004|PF-06873600 Treatment|Global deterioration of health status|0|||
147476270|NCT03519178|531903281|FG005|PF-06873600 Treatment|Global deterioration of health status|0|||
147476271|NCT03519178|531903282|FG006|PF-06873600 Treatment|Global deterioration of health status|1|||
147476272|NCT03519178|531903283|FG007|PF-06873600 Treatment|Global deterioration of health status|2|||
147476273|NCT03519178|531903284|FG008|PF-06873600 Treatment|Global deterioration of health status|1|||
147476274|NCT03519178|531903285|FG009|PF-06873600 Treatment|Global deterioration of health status|1|||
147476275|NCT03519178|531903286|FG010|PF-06873600 Treatment|Global deterioration of health status|2|||
147476276|NCT03519178|531903287|FG011|PF-06873600 Treatment|Global deterioration of health status|0|||
147476277|NCT03519178|531903288|FG012|PF-06873600 Treatment|Global deterioration of health status|0|||
147476278|NCT03519178|531903289|FG013|PF-06873600 Treatment|Global deterioration of health status|3|||
147476279|NCT03519178|531903290|FG014|PF-06873600 Treatment|Global deterioration of health status|0|||
147476280|NCT03519178|531903276|FG000|PF-06873600 Treatment|Refused further treatment|0|||
147476281|NCT03519178|531903277|FG001|PF-06873600 Treatment|Refused further treatment|1|||
147476282|NCT03519178|531903278|FG002|PF-06873600 Treatment|Refused further treatment|0|||
147476283|NCT03519178|531903279|FG003|PF-06873600 Treatment|Refused further treatment|0|||
147476284|NCT03519178|531903280|FG004|PF-06873600 Treatment|Refused further treatment|1|||
147476285|NCT03519178|531903281|FG005|PF-06873600 Treatment|Refused further treatment|0|||
147476286|NCT03519178|531903282|FG006|PF-06873600 Treatment|Refused further treatment|0|||
147476287|NCT03519178|531903283|FG007|PF-06873600 Treatment|Refused further treatment|0|||
147476288|NCT03519178|531903284|FG008|PF-06873600 Treatment|Refused further treatment|0|||
147476289|NCT03519178|531903285|FG009|PF-06873600 Treatment|Refused further treatment|0|||
147476290|NCT03519178|531903286|FG010|PF-06873600 Treatment|Refused further treatment|0|||
147476291|NCT03519178|531903287|FG011|PF-06873600 Treatment|Refused further treatment|0|||
147476292|NCT03519178|531903288|FG012|PF-06873600 Treatment|Refused further treatment|0|||
147476293|NCT03519178|531903289|FG013|PF-06873600 Treatment|Refused further treatment|0|||
147476294|NCT03519178|531903290|FG014|PF-06873600 Treatment|Refused further treatment|1|||
147476295|NCT03519178|531903276|FG000|PF-06873600 Treatment|Other|0|||
147476296|NCT03519178|531903277|FG001|PF-06873600 Treatment|Other|0|||
147476297|NCT03519178|531903278|FG002|PF-06873600 Treatment|Other|0|||
147476298|NCT03519178|531903279|FG003|PF-06873600 Treatment|Other|0|||
147476299|NCT03519178|531903280|FG004|PF-06873600 Treatment|Other|0|||
147476300|NCT03519178|531903281|FG005|PF-06873600 Treatment|Other|0|||
147476301|NCT03519178|531903282|FG006|PF-06873600 Treatment|Other|0|||
147476302|NCT03519178|531903283|FG007|PF-06873600 Treatment|Other|0|||
147476303|NCT03519178|531903284|FG008|PF-06873600 Treatment|Other|1|||
147476304|NCT03519178|531903285|FG009|PF-06873600 Treatment|Other|0|||
147476305|NCT03519178|531903286|FG010|PF-06873600 Treatment|Other|0|||
147476306|NCT03519178|531903287|FG011|PF-06873600 Treatment|Other|0|||
147476307|NCT03519178|531903288|FG012|PF-06873600 Treatment|Other|0|||
147476308|NCT03519178|531903289|FG013|PF-06873600 Treatment|Other|1|||
147476309|NCT03519178|531903290|FG014|PF-06873600 Treatment|Other|3|||
147476310|NCT03519178|531903276|FG000|PF-06873600 Treatment|Lost to Follow-up|0|||
147476311|NCT03519178|531903277|FG001|PF-06873600 Treatment|Lost to Follow-up|0|||
147476312|NCT03519178|531903278|FG002|PF-06873600 Treatment|Lost to Follow-up|0|||
147476313|NCT03519178|531903279|FG003|PF-06873600 Treatment|Lost to Follow-up|0|||
147476314|NCT03519178|531903280|FG004|PF-06873600 Treatment|Lost to Follow-up|0|||
147476315|NCT03519178|531903281|FG005|PF-06873600 Treatment|Lost to Follow-up|0|||
147476316|NCT03519178|531903282|FG006|PF-06873600 Treatment|Lost to Follow-up|0|||
147476317|NCT03519178|531903283|FG007|PF-06873600 Treatment|Lost to Follow-up|0|||
147476318|NCT03519178|531903284|FG008|PF-06873600 Treatment|Lost to Follow-up|0|||
147476319|NCT03519178|531903285|FG009|PF-06873600 Treatment|Lost to Follow-up|0|||
147476320|NCT03519178|531903286|FG010|PF-06873600 Treatment|Lost to Follow-up|0|||
147476321|NCT03519178|531903287|FG011|PF-06873600 Treatment|Lost to Follow-up|0|||
147476322|NCT03519178|531903288|FG012|PF-06873600 Treatment|Lost to Follow-up|0|||
147476323|NCT03519178|531903289|FG013|PF-06873600 Treatment|Lost to Follow-up|0|||
147476324|NCT03519178|531903290|FG014|PF-06873600 Treatment|Lost to Follow-up|1|||
147476325|NCT03519178|531903276|FG000|PF-06873600 Treatment|Study terminated by sponsor|0|||
147476326|NCT03519178|531903277|FG001|PF-06873600 Treatment|Study terminated by sponsor|0|||
147476327|NCT03519178|531903278|FG002|PF-06873600 Treatment|Study terminated by sponsor|0|||
147476328|NCT03519178|531903279|FG003|PF-06873600 Treatment|Study terminated by sponsor|0|||
147476329|NCT03519178|531903280|FG004|PF-06873600 Treatment|Study terminated by sponsor|0|||
147476330|NCT03519178|531903281|FG005|PF-06873600 Treatment|Study terminated by sponsor|0|||
147476331|NCT03519178|531903282|FG006|PF-06873600 Treatment|Study terminated by sponsor|0|||
147476332|NCT03519178|531903283|FG007|PF-06873600 Treatment|Study terminated by sponsor|0|||
147476333|NCT03519178|531903284|FG008|PF-06873600 Treatment|Study terminated by sponsor|0|||
147476334|NCT03519178|531903285|FG009|PF-06873600 Treatment|Study terminated by sponsor|0|||
147476335|NCT03519178|531903286|FG010|PF-06873600 Treatment|Study terminated by sponsor|0|||
147476336|NCT03519178|531903287|FG011|PF-06873600 Treatment|Study terminated by sponsor|0|||
147476337|NCT03519178|531903288|FG012|PF-06873600 Treatment|Study terminated by sponsor|0|||
147476338|NCT03519178|531903289|FG013|PF-06873600 Treatment|Study terminated by sponsor|5|||
147476339|NCT03519178|531903290|FG014|PF-06873600 Treatment|Study terminated by sponsor|9|||
147476340|NCT03519178|531903276|FG000|Fulvestrant. Treatment|Adverse Event|0|||
147476341|NCT03519178|531903277|FG001|Fulvestrant. Treatment|Adverse Event|0|||
147476342|NCT03519178|531903278|FG002|Fulvestrant. Treatment|Adverse Event|0|||
147476343|NCT03519178|531903279|FG003|Fulvestrant. Treatment|Adverse Event|0|||
147476344|NCT03519178|531903280|FG004|Fulvestrant. Treatment|Adverse Event|0|||
147476345|NCT03519178|531903281|FG005|Fulvestrant. Treatment|Adverse Event|0|||
147476346|NCT03519178|531903282|FG006|Fulvestrant. Treatment|Adverse Event|0|||
147476347|NCT03519178|531903283|FG007|Fulvestrant. Treatment|Adverse Event|0|||
147476348|NCT03519178|531903284|FG008|Fulvestrant. Treatment|Adverse Event|0|||
147476349|NCT03519178|531903285|FG009|Fulvestrant. Treatment|Adverse Event|0|||
147476350|NCT03519178|531903286|FG010|Fulvestrant. Treatment|Adverse Event|0|||
147476351|NCT03519178|531903287|FG011|Fulvestrant. Treatment|Adverse Event|0|||
147476352|NCT03519178|531903288|FG012|Fulvestrant. Treatment|Adverse Event|0|||
147476353|NCT03519178|531903289|FG013|Fulvestrant. Treatment|Adverse Event|1|||
147476354|NCT03519178|531903290|FG014|Fulvestrant. Treatment|Adverse Event|0|||
147476355|NCT03519178|531903276|FG000|Fulvestrant. Treatment|Death|0|||
147476356|NCT03519178|531903277|FG001|Fulvestrant. Treatment|Death|0|||
147476357|NCT03519178|531903278|FG002|Fulvestrant. Treatment|Death|0|||
147476358|NCT03519178|531903279|FG003|Fulvestrant. Treatment|Death|0|||
147476359|NCT03519178|531903280|FG004|Fulvestrant. Treatment|Death|0|||
147476360|NCT03519178|531903281|FG005|Fulvestrant. Treatment|Death|0|||
147476361|NCT03519178|531903282|FG006|Fulvestrant. Treatment|Death|0|||
147476362|NCT03519178|531903283|FG007|Fulvestrant. Treatment|Death|0|||
147476363|NCT03519178|531903284|FG008|Fulvestrant. Treatment|Death|0|||
147476364|NCT03519178|531903285|FG009|Fulvestrant. Treatment|Death|1|||
147476365|NCT03519178|531903286|FG010|Fulvestrant. Treatment|Death|0|||
147666842|NCT00264147|532605877|FG000|Treatment II Period|Adverse Event|0|||
147476366|NCT03519178|531903287|FG011|Fulvestrant. Treatment|Death|0|||
147476367|NCT03519178|531903288|FG012|Fulvestrant. Treatment|Death|0|||
147476368|NCT03519178|531903289|FG013|Fulvestrant. Treatment|Death|0|||
147476369|NCT03519178|531903290|FG014|Fulvestrant. Treatment|Death|1|||
147476370|NCT03519178|531903276|FG000|Fulvestrant. Treatment|Lost to Follow-up|0|||
147476371|NCT03519178|531903277|FG001|Fulvestrant. Treatment|Lost to Follow-up|0|||
147476372|NCT03519178|531903278|FG002|Fulvestrant. Treatment|Lost to Follow-up|0|||
147476373|NCT03519178|531903279|FG003|Fulvestrant. Treatment|Lost to Follow-up|0|||
147476374|NCT03519178|531903280|FG004|Fulvestrant. Treatment|Lost to Follow-up|0|||
147666843|NCT00264147|532605878|FG001|Treatment II Period|Adverse Event|0|||
147666844|NCT00264147|532605879|FG002|Treatment II Period|Adverse Event|0|||
147476375|NCT03519178|531903281|FG005|Fulvestrant. Treatment|Lost to Follow-up|0|||
147476376|NCT03519178|531903282|FG006|Fulvestrant. Treatment|Lost to Follow-up|0|||
147476377|NCT03519178|531903283|FG007|Fulvestrant. Treatment|Lost to Follow-up|0|||
147476378|NCT03519178|531903284|FG008|Fulvestrant. Treatment|Lost to Follow-up|0|||
147476379|NCT03519178|531903285|FG009|Fulvestrant. Treatment|Lost to Follow-up|0|||
147476380|NCT03519178|531903286|FG010|Fulvestrant. Treatment|Lost to Follow-up|0|||
147476381|NCT03519178|531903287|FG011|Fulvestrant. Treatment|Lost to Follow-up|0|||
147476382|NCT03519178|531903288|FG012|Fulvestrant. Treatment|Lost to Follow-up|0|||
147476383|NCT03519178|531903289|FG013|Fulvestrant. Treatment|Lost to Follow-up|0|||
147476384|NCT03519178|531903290|FG014|Fulvestrant. Treatment|Lost to Follow-up|1|||
147476385|NCT03519178|531903276|FG000|Fulvestrant. Treatment|Physician Decision|0|||
147476386|NCT03519178|531903277|FG001|Fulvestrant. Treatment|Physician Decision|0|||
147476387|NCT03519178|531903278|FG002|Fulvestrant. Treatment|Physician Decision|0|||
147476388|NCT03519178|531903279|FG003|Fulvestrant. Treatment|Physician Decision|0|||
147476389|NCT03519178|531903280|FG004|Fulvestrant. Treatment|Physician Decision|0|||
147476390|NCT03519178|531903281|FG005|Fulvestrant. Treatment|Physician Decision|0|||
147476391|NCT03519178|531903282|FG006|Fulvestrant. Treatment|Physician Decision|0|||
147476392|NCT03519178|531903283|FG007|Fulvestrant. Treatment|Physician Decision|0|||
147476393|NCT03519178|531903284|FG008|Fulvestrant. Treatment|Physician Decision|0|||
147476394|NCT03519178|531903285|FG009|Fulvestrant. Treatment|Physician Decision|0|||
147476395|NCT03519178|531903286|FG010|Fulvestrant. Treatment|Physician Decision|0|||
147476396|NCT03519178|531903287|FG011|Fulvestrant. Treatment|Physician Decision|0|||
147476397|NCT03519178|531903288|FG012|Fulvestrant. Treatment|Physician Decision|0|||
147476398|NCT03519178|531903289|FG013|Fulvestrant. Treatment|Physician Decision|4|||
147476399|NCT03519178|531903290|FG014|Fulvestrant. Treatment|Physician Decision|2|||
147476400|NCT03519178|531903276|FG000|Fulvestrant. Treatment|Progressive disease|0|||
147476401|NCT03519178|531903277|FG001|Fulvestrant. Treatment|Progressive disease|0|||
147476402|NCT03519178|531903278|FG002|Fulvestrant. Treatment|Progressive disease|0|||
147476403|NCT03519178|531903279|FG003|Fulvestrant. Treatment|Progressive disease|0|||
147476404|NCT03519178|531903280|FG004|Fulvestrant. Treatment|Progressive disease|0|||
147476405|NCT03519178|531903281|FG005|Fulvestrant. Treatment|Progressive disease|0|||
147476406|NCT03519178|531903282|FG006|Fulvestrant. Treatment|Progressive disease|0|||
147476407|NCT03519178|531903283|FG007|Fulvestrant. Treatment|Progressive disease|0|||
147476408|NCT03519178|531903284|FG008|Fulvestrant. Treatment|Progressive disease|0|||
147476409|NCT03519178|531903285|FG009|Fulvestrant. Treatment|Progressive disease|5|||
147476410|NCT03519178|531903286|FG010|Fulvestrant. Treatment|Progressive disease|0|||
147476411|NCT03519178|531903287|FG011|Fulvestrant. Treatment|Progressive disease|0|||
147476412|NCT03519178|531903288|FG012|Fulvestrant. Treatment|Progressive disease|0|||
147476413|NCT03519178|531903289|FG013|Fulvestrant. Treatment|Progressive disease|30|||
147476414|NCT03519178|531903290|FG014|Fulvestrant. Treatment|Progressive disease|8|||
147476415|NCT03519178|531903276|FG000|Fulvestrant. Treatment|Study terminated by sponsor|0|||
147476416|NCT03519178|531903277|FG001|Fulvestrant. Treatment|Study terminated by sponsor|0|||
147476417|NCT03519178|531903278|FG002|Fulvestrant. Treatment|Study terminated by sponsor|0|||
147476418|NCT03519178|531903279|FG003|Fulvestrant. Treatment|Study terminated by sponsor|0|||
147476419|NCT03519178|531903280|FG004|Fulvestrant. Treatment|Study terminated by sponsor|0|||
147476420|NCT03519178|531903281|FG005|Fulvestrant. Treatment|Study terminated by sponsor|0|||
147476421|NCT03519178|531903282|FG006|Fulvestrant. Treatment|Study terminated by sponsor|0|||
147476422|NCT03519178|531903283|FG007|Fulvestrant. Treatment|Study terminated by sponsor|0|||
147476423|NCT03519178|531903284|FG008|Fulvestrant. Treatment|Study terminated by sponsor|0|||
147476424|NCT03519178|531903285|FG009|Fulvestrant. Treatment|Study terminated by sponsor|0|||
147476425|NCT03519178|531903286|FG010|Fulvestrant. Treatment|Study terminated by sponsor|0|||
147476426|NCT03519178|531903287|FG011|Fulvestrant. Treatment|Study terminated by sponsor|0|||
147476427|NCT03519178|531903288|FG012|Fulvestrant. Treatment|Study terminated by sponsor|0|||
147476428|NCT03519178|531903289|FG013|Fulvestrant. Treatment|Study terminated by sponsor|5|||
147476429|NCT03519178|531903290|FG014|Fulvestrant. Treatment|Study terminated by sponsor|9|||
147476430|NCT03519178|531903276|FG000|Fulvestrant. Treatment|Withdrawal by Subject|0|||
147476431|NCT03519178|531903277|FG001|Fulvestrant. Treatment|Withdrawal by Subject|0|||
147476432|NCT03519178|531903278|FG002|Fulvestrant. Treatment|Withdrawal by Subject|0|||
147476433|NCT03519178|531903279|FG003|Fulvestrant. Treatment|Withdrawal by Subject|0|||
147476434|NCT03519178|531903280|FG004|Fulvestrant. Treatment|Withdrawal by Subject|0|||
147476435|NCT03519178|531903281|FG005|Fulvestrant. Treatment|Withdrawal by Subject|0|||
147476436|NCT03519178|531903282|FG006|Fulvestrant. Treatment|Withdrawal by Subject|0|||
147476437|NCT03519178|531903283|FG007|Fulvestrant. Treatment|Withdrawal by Subject|0|||
147476438|NCT03519178|531903284|FG008|Fulvestrant. Treatment|Withdrawal by Subject|0|||
147621658|NCT01532934|532431539|FG001|Overall Study|In controlled environment|2|||
147621659|NCT03483012|532431540|FG000|Overall Study|Lack of Efficacy|6|||
147621660|NCT01597778|532431545|FG000|Overall Study|Death|7|||
147621661|NCT01597778|532431546|FG001|Overall Study|Death|10|||
147476439|NCT03519178|531903285|FG009|Fulvestrant. Treatment|Withdrawal by Subject|2|||
147476440|NCT03519178|531903286|FG010|Fulvestrant. Treatment|Withdrawal by Subject|0|||
147476441|NCT03519178|531903287|FG011|Fulvestrant. Treatment|Withdrawal by Subject|0|||
147476442|NCT03519178|531903288|FG012|Fulvestrant. Treatment|Withdrawal by Subject|0|||
147476443|NCT03519178|531903289|FG013|Fulvestrant. Treatment|Withdrawal by Subject|1|||
147476444|NCT03519178|531903290|FG014|Fulvestrant. Treatment|Withdrawal by Subject|2|||
147476445|NCT03519178|531903276|FG000|Fulvestrant. Treatment|Global deterioration of health status|0|||
147476446|NCT03519178|531903277|FG001|Fulvestrant. Treatment|Global deterioration of health status|0|||
147476447|NCT03519178|531903278|FG002|Fulvestrant. Treatment|Global deterioration of health status|0|||
147476448|NCT03519178|531903279|FG003|Fulvestrant. Treatment|Global deterioration of health status|0|||
147476449|NCT03519178|531903280|FG004|Fulvestrant. Treatment|Global deterioration of health status|0|||
147476450|NCT03519178|531903281|FG005|Fulvestrant. Treatment|Global deterioration of health status|0|||
147476451|NCT03519178|531903282|FG006|Fulvestrant. Treatment|Global deterioration of health status|0|||
147476452|NCT03519178|531903283|FG007|Fulvestrant. Treatment|Global deterioration of health status|0|||
147476453|NCT03519178|531903284|FG008|Fulvestrant. Treatment|Global deterioration of health status|0|||
147476454|NCT03519178|531903285|FG009|Fulvestrant. Treatment|Global deterioration of health status|1|||
147476455|NCT03519178|531903286|FG010|Fulvestrant. Treatment|Global deterioration of health status|0|||
147476456|NCT03519178|531903287|FG011|Fulvestrant. Treatment|Global deterioration of health status|0|||
147476457|NCT03519178|531903288|FG012|Fulvestrant. Treatment|Global deterioration of health status|0|||
147476458|NCT03519178|531903289|FG013|Fulvestrant. Treatment|Global deterioration of health status|3|||
147476459|NCT03519178|531903290|FG014|Fulvestrant. Treatment|Global deterioration of health status|0|||
147476460|NCT03519178|531903276|FG000|Fulvestrant. Treatment|Refused further treatment|0|||
147476461|NCT03519178|531903277|FG001|Fulvestrant. Treatment|Refused further treatment|0|||
147476462|NCT03519178|531903278|FG002|Fulvestrant. Treatment|Refused further treatment|0|||
147476463|NCT03519178|531903279|FG003|Fulvestrant. Treatment|Refused further treatment|0|||
147476464|NCT03519178|531903280|FG004|Fulvestrant. Treatment|Refused further treatment|0|||
147476465|NCT03519178|531903281|FG005|Fulvestrant. Treatment|Refused further treatment|0|||
147476466|NCT03519178|531903282|FG006|Fulvestrant. Treatment|Refused further treatment|0|||
147476467|NCT03519178|531903283|FG007|Fulvestrant. Treatment|Refused further treatment|0|||
147476468|NCT03519178|531903284|FG008|Fulvestrant. Treatment|Refused further treatment|0|||
147476469|NCT03519178|531903285|FG009|Fulvestrant. Treatment|Refused further treatment|0|||
147476470|NCT03519178|531903286|FG010|Fulvestrant. Treatment|Refused further treatment|0|||
147476471|NCT03519178|531903287|FG011|Fulvestrant. Treatment|Refused further treatment|0|||
147476472|NCT03519178|531903288|FG012|Fulvestrant. Treatment|Refused further treatment|0|||
147476473|NCT03519178|531903289|FG013|Fulvestrant. Treatment|Refused further treatment|0|||
147476474|NCT03519178|531903290|FG014|Fulvestrant. Treatment|Refused further treatment|2|||
147476475|NCT03519178|531903276|FG000|Fulvestrant. Treatment|Other|0|||
147476476|NCT03519178|531903277|FG001|Fulvestrant. Treatment|Other|0|||
147476477|NCT03519178|531903278|FG002|Fulvestrant. Treatment|Other|0|||
147476478|NCT03519178|531903279|FG003|Fulvestrant. Treatment|Other|0|||
147476479|NCT03519178|531903280|FG004|Fulvestrant. Treatment|Other|0|||
147476480|NCT03519178|531903281|FG005|Fulvestrant. Treatment|Other|0|||
147476481|NCT03519178|531903282|FG006|Fulvestrant. Treatment|Other|0|||
147476482|NCT03519178|531903283|FG007|Fulvestrant. Treatment|Other|0|||
147476483|NCT03519178|531903284|FG008|Fulvestrant. Treatment|Other|0|||
147476484|NCT03519178|531903285|FG009|Fulvestrant. Treatment|Other|0|||
147476485|NCT03519178|531903286|FG010|Fulvestrant. Treatment|Other|0|||
147476486|NCT03519178|531903287|FG011|Fulvestrant. Treatment|Other|0|||
147476487|NCT03519178|531903288|FG012|Fulvestrant. Treatment|Other|0|||
147476488|NCT03519178|531903289|FG013|Fulvestrant. Treatment|Other|1|||
147476489|NCT03519178|531903290|FG014|Fulvestrant. Treatment|Other|3|||
147476490|NCT03519178|531903276|FG000|Letrozole Treatment|Physician Decision|0|||
147476491|NCT03519178|531903277|FG001|Letrozole Treatment|Physician Decision|0|||
147476492|NCT03519178|531903278|FG002|Letrozole Treatment|Physician Decision|0|||
147476493|NCT03519178|531903279|FG003|Letrozole Treatment|Physician Decision|0|||
147476494|NCT03519178|531903280|FG004|Letrozole Treatment|Physician Decision|0|||
147476495|NCT03519178|531903281|FG005|Letrozole Treatment|Physician Decision|0|||
147476496|NCT03519178|531903282|FG006|Letrozole Treatment|Physician Decision|0|||
147476497|NCT03519178|531903283|FG007|Letrozole Treatment|Physician Decision|0|||
147476498|NCT03519178|531903284|FG008|Letrozole Treatment|Physician Decision|0|||
147476499|NCT03519178|531903285|FG009|Letrozole Treatment|Physician Decision|0|||
147476500|NCT03519178|531903286|FG010|Letrozole Treatment|Physician Decision|1|||
147476501|NCT03519178|531903287|FG011|Letrozole Treatment|Physician Decision|0|||
147476502|NCT03519178|531903288|FG012|Letrozole Treatment|Physician Decision|0|||
147476503|NCT03519178|531903289|FG013|Letrozole Treatment|Physician Decision|0|||
147476504|NCT03519178|531903290|FG014|Letrozole Treatment|Physician Decision|0|||
147476505|NCT03519178|531903276|FG000|Letrozole Treatment|Progressive disease|0|||
147476506|NCT03519178|531903277|FG001|Letrozole Treatment|Progressive disease|0|||
147476507|NCT03519178|531903278|FG002|Letrozole Treatment|Progressive disease|0|||
147476508|NCT03519178|531903279|FG003|Letrozole Treatment|Progressive disease|0|||
147476509|NCT03519178|531903280|FG004|Letrozole Treatment|Progressive disease|0|||
147476510|NCT03519178|531903281|FG005|Letrozole Treatment|Progressive disease|0|||
147476511|NCT03519178|531903282|FG006|Letrozole Treatment|Progressive disease|0|||
147476512|NCT03519178|531903283|FG007|Letrozole Treatment|Progressive disease|0|||
147476513|NCT03519178|531903284|FG008|Letrozole Treatment|Progressive disease|0|||
147476514|NCT03519178|531903285|FG009|Letrozole Treatment|Progressive disease|0|||
147476515|NCT03519178|531903286|FG010|Letrozole Treatment|Progressive disease|4|||
147476516|NCT03519178|531903287|FG011|Letrozole Treatment|Progressive disease|0|||
147476517|NCT03519178|531903288|FG012|Letrozole Treatment|Progressive disease|0|||
147476518|NCT03519178|531903289|FG013|Letrozole Treatment|Progressive disease|0|||
147476519|NCT03519178|531903290|FG014|Letrozole Treatment|Progressive disease|0|||
147476520|NCT03519178|531903276|FG000|Letrozole Treatment|Global deterioration of health status|0|||
147476521|NCT03519178|531903277|FG001|Letrozole Treatment|Global deterioration of health status|0|||
147476522|NCT03519178|531903278|FG002|Letrozole Treatment|Global deterioration of health status|0|||
147476523|NCT03519178|531903279|FG003|Letrozole Treatment|Global deterioration of health status|0|||
147476524|NCT03519178|531903280|FG004|Letrozole Treatment|Global deterioration of health status|0|||
147476525|NCT03519178|531903281|FG005|Letrozole Treatment|Global deterioration of health status|0|||
147476526|NCT03519178|531903282|FG006|Letrozole Treatment|Global deterioration of health status|0|||
147476527|NCT03519178|531903283|FG007|Letrozole Treatment|Global deterioration of health status|0|||
147476528|NCT03519178|531903284|FG008|Letrozole Treatment|Global deterioration of health status|0|||
147476529|NCT03519178|531903285|FG009|Letrozole Treatment|Global deterioration of health status|0|||
147476530|NCT03519178|531903286|FG010|Letrozole Treatment|Global deterioration of health status|2|||
147476531|NCT03519178|531903287|FG011|Letrozole Treatment|Global deterioration of health status|0|||
147476532|NCT03519178|531903288|FG012|Letrozole Treatment|Global deterioration of health status|0|||
147476533|NCT03519178|531903289|FG013|Letrozole Treatment|Global deterioration of health status|0|||
147476534|NCT03519178|531903290|FG014|Letrozole Treatment|Global deterioration of health status|0|||
147476535|NCT03519178|531903276|FG000|Follow-Up|Death|0|||
147476536|NCT03519178|531903277|FG001|Follow-Up|Death|0|||
147476537|NCT03519178|531903278|FG002|Follow-Up|Death|0|||
147476538|NCT03519178|531903279|FG003|Follow-Up|Death|0|||
147476539|NCT03519178|531903280|FG004|Follow-Up|Death|0|||
147476540|NCT03519178|531903281|FG005|Follow-Up|Death|0|||
147476541|NCT03519178|531903282|FG006|Follow-Up|Death|0|||
147476542|NCT03519178|531903283|FG007|Follow-Up|Death|0|||
147476543|NCT03519178|531903284|FG008|Follow-Up|Death|3|||
147476544|NCT03519178|531903285|FG009|Follow-Up|Death|1|||
147476545|NCT03519178|531903286|FG010|Follow-Up|Death|0|||
147476546|NCT03519178|531903287|FG011|Follow-Up|Death|0|||
147476547|NCT03519178|531903288|FG012|Follow-Up|Death|2|||
147476548|NCT03519178|531903289|FG013|Follow-Up|Death|0|||
147476549|NCT03519178|531903290|FG014|Follow-Up|Death|0|||
147476550|NCT03519178|531903276|FG000|Follow-Up|Lost to Follow-up|0|||
147476551|NCT03519178|531903277|FG001|Follow-Up|Lost to Follow-up|0|||
147476552|NCT03519178|531903278|FG002|Follow-Up|Lost to Follow-up|0|||
147476553|NCT03519178|531903279|FG003|Follow-Up|Lost to Follow-up|0|||
147476554|NCT03519178|531903280|FG004|Follow-Up|Lost to Follow-up|0|||
147666845|NCT00264147|532605880|FG003|Treatment II Period|Adverse Event|0|||
147666846|NCT00264147|532605881|FG004|Treatment II Period|Adverse Event|9|||
147666847|NCT00264147|532605882|FG005|Treatment II Period|Adverse Event|9|||
147666848|NCT00264147|532605877|FG000|Treatment II Period|Laboratory Adverse Event|0|||
147666849|NCT00264147|532605878|FG001|Treatment II Period|Laboratory Adverse Event|0|||
147666850|NCT00264147|532605879|FG002|Treatment II Period|Laboratory Adverse Event|0|||
147666851|NCT00264147|532605880|FG003|Treatment II Period|Laboratory Adverse Event|0|||
147666852|NCT00264147|532605881|FG004|Treatment II Period|Laboratory Adverse Event|0|||
147666853|NCT00264147|532605882|FG005|Treatment II Period|Laboratory Adverse Event|1|||
147666854|NCT00264147|532605877|FG000|Treatment II Period|Lack of Efficacy|0|||
147666855|NCT00264147|532605878|FG001|Treatment II Period|Lack of Efficacy|0|||
147666856|NCT00264147|532605879|FG002|Treatment II Period|Lack of Efficacy|0|||
147666857|NCT00264147|532605880|FG003|Treatment II Period|Lack of Efficacy|0|||
147666858|NCT00264147|532605881|FG004|Treatment II Period|Lack of Efficacy|20|||
147666859|NCT00264147|532605882|FG005|Treatment II Period|Lack of Efficacy|19|||
147666860|NCT00264147|532605877|FG000|Treatment II Period|Lost to Follow-up|0|||
147666861|NCT00264147|532605878|FG001|Treatment II Period|Lost to Follow-up|0|||
147476555|NCT03519178|531903281|FG005|Follow-Up|Lost to Follow-up|3|||
147666862|NCT00264147|532605879|FG002|Treatment II Period|Lost to Follow-up|0|||
147666863|NCT00264147|532605880|FG003|Treatment II Period|Lost to Follow-up|0|||
147666864|NCT00264147|532605881|FG004|Treatment II Period|Lost to Follow-up|1|||
147666865|NCT00264147|532605882|FG005|Treatment II Period|Lost to Follow-up|1|||
147666866|NCT00264147|532605877|FG000|Treatment II Period|Withdrawal by Subject|0|||
147666867|NCT00264147|532605878|FG001|Treatment II Period|Withdrawal by Subject|0|||
147666868|NCT00264147|532605879|FG002|Treatment II Period|Withdrawal by Subject|0|||
147666869|NCT00264147|532605880|FG003|Treatment II Period|Withdrawal by Subject|0|||
147666870|NCT00264147|532605881|FG004|Treatment II Period|Withdrawal by Subject|3|||
147476556|NCT03519178|531903282|FG006|Follow-Up|Lost to Follow-up|1|||
147476557|NCT03519178|531903283|FG007|Follow-Up|Lost to Follow-up|4|||
147476558|NCT03519178|531903284|FG008|Follow-Up|Lost to Follow-up|1|||
147476559|NCT03519178|531903285|FG009|Follow-Up|Lost to Follow-up|0|||
147476560|NCT03519178|531903286|FG010|Follow-Up|Lost to Follow-up|0|||
147666871|NCT00264147|532605882|FG005|Treatment II Period|Withdrawal by Subject|2|||
147476561|NCT03519178|531903287|FG011|Follow-Up|Lost to Follow-up|0|||
147476562|NCT03519178|531903288|FG012|Follow-Up|Lost to Follow-up|0|||
147476563|NCT03519178|531903289|FG013|Follow-Up|Lost to Follow-up|0|||
147476564|NCT03519178|531903290|FG014|Follow-Up|Lost to Follow-up|0|||
147476565|NCT03519178|531903276|FG000|Follow-Up|Withdrawal by Subject|1|||
147476566|NCT03519178|531903277|FG001|Follow-Up|Withdrawal by Subject|2|||
147476567|NCT03519178|531903278|FG002|Follow-Up|Withdrawal by Subject|2|||
147476568|NCT03519178|531903279|FG003|Follow-Up|Withdrawal by Subject|3|||
147476569|NCT03519178|531903280|FG004|Follow-Up|Withdrawal by Subject|5|||
147476570|NCT03519178|531903281|FG005|Follow-Up|Withdrawal by Subject|1|||
147476571|NCT03519178|531903282|FG006|Follow-Up|Withdrawal by Subject|2|||
147476572|NCT03519178|531903283|FG007|Follow-Up|Withdrawal by Subject|6|||
147476573|NCT03519178|531903284|FG008|Follow-Up|Withdrawal by Subject|5|||
147476574|NCT03519178|531903285|FG009|Follow-Up|Withdrawal by Subject|2|||
147476575|NCT03519178|531903286|FG010|Follow-Up|Withdrawal by Subject|3|||
147476576|NCT03519178|531903287|FG011|Follow-Up|Withdrawal by Subject|5|||
147476577|NCT03519178|531903288|FG012|Follow-Up|Withdrawal by Subject|2|||
147476578|NCT03519178|531903289|FG013|Follow-Up|Withdrawal by Subject|0|||
147476579|NCT03519178|531903290|FG014|Follow-Up|Withdrawal by Subject|0|||
147476580|NCT03519178|531903276|FG000|Follow-Up|Other|0|||
147476581|NCT03519178|531903277|FG001|Follow-Up|Other|0|||
147476582|NCT03519178|531903278|FG002|Follow-Up|Other|0|||
147476583|NCT03519178|531903279|FG003|Follow-Up|Other|0|||
147476584|NCT03519178|531903280|FG004|Follow-Up|Other|0|||
147476585|NCT03519178|531903281|FG005|Follow-Up|Other|0|||
147476586|NCT03519178|531903282|FG006|Follow-Up|Other|0|||
147476587|NCT03519178|531903283|FG007|Follow-Up|Other|1|||
147476588|NCT03519178|531903284|FG008|Follow-Up|Other|0|||
147476589|NCT03519178|531903285|FG009|Follow-Up|Other|0|||
147476590|NCT03519178|531903286|FG010|Follow-Up|Other|0|||
147476591|NCT03519178|531903287|FG011|Follow-Up|Other|0|||
147476592|NCT03519178|531903288|FG012|Follow-Up|Other|0|||
147476593|NCT03519178|531903289|FG013|Follow-Up|Other|0|||
147476594|NCT03519178|531903290|FG014|Follow-Up|Other|0|||
147476595|NCT03519178|531903276|FG000|Long-term Follow-up|Death|0|||
147476596|NCT03519178|531903277|FG001|Long-term Follow-up|Death|0|||
147476597|NCT03519178|531903278|FG002|Long-term Follow-up|Death|0|||
147476598|NCT03519178|531903279|FG003|Long-term Follow-up|Death|0|||
147476599|NCT03519178|531903280|FG004|Long-term Follow-up|Death|0|||
147476600|NCT03519178|531903281|FG005|Long-term Follow-up|Death|0|||
147476601|NCT03519178|531903282|FG006|Long-term Follow-up|Death|0|||
147476602|NCT03519178|531903283|FG007|Long-term Follow-up|Death|0|||
147476603|NCT03519178|531903284|FG008|Long-term Follow-up|Death|0|||
147476604|NCT03519178|531903285|FG009|Long-term Follow-up|Death|0|||
147476605|NCT03519178|531903286|FG010|Long-term Follow-up|Death|0|||
147476606|NCT03519178|531903287|FG011|Long-term Follow-up|Death|0|||
147476607|NCT03519178|531903288|FG012|Long-term Follow-up|Death|0|||
147476608|NCT03519178|531903289|FG013|Long-term Follow-up|Death|4|||
147476609|NCT03519178|531903290|FG014|Long-term Follow-up|Death|4|||
147476610|NCT03519178|531903276|FG000|Long-term Follow-up|Lost to Follow-up|0|||
147476611|NCT03519178|531903277|FG001|Long-term Follow-up|Lost to Follow-up|0|||
147476612|NCT03519178|531903278|FG002|Long-term Follow-up|Lost to Follow-up|0|||
147476613|NCT03519178|531903279|FG003|Long-term Follow-up|Lost to Follow-up|0|||
147476614|NCT03519178|531903280|FG004|Long-term Follow-up|Lost to Follow-up|0|||
147476615|NCT03519178|531903281|FG005|Long-term Follow-up|Lost to Follow-up|0|||
147476616|NCT03519178|531903282|FG006|Long-term Follow-up|Lost to Follow-up|0|||
147476617|NCT03519178|531903283|FG007|Long-term Follow-up|Lost to Follow-up|0|||
147476618|NCT03519178|531903284|FG008|Long-term Follow-up|Lost to Follow-up|0|||
147476619|NCT03519178|531903285|FG009|Long-term Follow-up|Lost to Follow-up|0|||
147476620|NCT03519178|531903286|FG010|Long-term Follow-up|Lost to Follow-up|0|||
147476621|NCT03519178|531903287|FG011|Long-term Follow-up|Lost to Follow-up|0|||
147476622|NCT03519178|531903288|FG012|Long-term Follow-up|Lost to Follow-up|0|||
147476623|NCT03519178|531903289|FG013|Long-term Follow-up|Lost to Follow-up|1|||
147476624|NCT03519178|531903290|FG014|Long-term Follow-up|Lost to Follow-up|1|||
147476625|NCT03519178|531903276|FG000|Long-term Follow-up|Study terminated by sponsor|0|||
147476626|NCT03519178|531903277|FG001|Long-term Follow-up|Study terminated by sponsor|0|||
147476627|NCT03519178|531903278|FG002|Long-term Follow-up|Study terminated by sponsor|0|||
147476628|NCT03519178|531903279|FG003|Long-term Follow-up|Study terminated by sponsor|0|||
147476629|NCT03519178|531903280|FG004|Long-term Follow-up|Study terminated by sponsor|0|||
147476630|NCT03519178|531903281|FG005|Long-term Follow-up|Study terminated by sponsor|0|||
147476631|NCT03519178|531903282|FG006|Long-term Follow-up|Study terminated by sponsor|0|||
147476632|NCT03519178|531903283|FG007|Long-term Follow-up|Study terminated by sponsor|0|||
147476633|NCT03519178|531903284|FG008|Long-term Follow-up|Study terminated by sponsor|0|||
147476634|NCT03519178|531903285|FG009|Long-term Follow-up|Study terminated by sponsor|0|||
147666872|NCT00264147|532605877|FG000|Treatment II Period|Pre-scheduled total hip replacement|0|||
147476635|NCT03519178|531903286|FG010|Long-term Follow-up|Study terminated by sponsor|0|||
147476636|NCT03519178|531903287|FG011|Long-term Follow-up|Study terminated by sponsor|0|||
147476637|NCT03519178|531903288|FG012|Long-term Follow-up|Study terminated by sponsor|0|||
147476638|NCT03519178|531903289|FG013|Long-term Follow-up|Study terminated by sponsor|32|||
147476639|NCT03519178|531903290|FG014|Long-term Follow-up|Study terminated by sponsor|19|||
147476640|NCT03519178|531903276|FG000|Long-term Follow-up|Withdrawal by Subject|0|||
147476641|NCT03519178|531903277|FG001|Long-term Follow-up|Withdrawal by Subject|0|||
147476642|NCT03519178|531903278|FG002|Long-term Follow-up|Withdrawal by Subject|0|||
147476643|NCT03519178|531903279|FG003|Long-term Follow-up|Withdrawal by Subject|0|||
147476644|NCT03519178|531903280|FG004|Long-term Follow-up|Withdrawal by Subject|0|||
147476645|NCT03519178|531903281|FG005|Long-term Follow-up|Withdrawal by Subject|0|||
147476646|NCT03519178|531903282|FG006|Long-term Follow-up|Withdrawal by Subject|0|||
147476647|NCT03519178|531903283|FG007|Long-term Follow-up|Withdrawal by Subject|0|||
147476648|NCT03519178|531903284|FG008|Long-term Follow-up|Withdrawal by Subject|0|||
147476649|NCT03519178|531903285|FG009|Long-term Follow-up|Withdrawal by Subject|0|||
147476650|NCT03519178|531903286|FG010|Long-term Follow-up|Withdrawal by Subject|0|||
147476651|NCT03519178|531903287|FG011|Long-term Follow-up|Withdrawal by Subject|0|||
147476652|NCT03519178|531903288|FG012|Long-term Follow-up|Withdrawal by Subject|0|||
147476653|NCT03519178|531903289|FG013|Long-term Follow-up|Withdrawal by Subject|7|||
147476654|NCT03519178|531903290|FG014|Long-term Follow-up|Withdrawal by Subject|3|||
147476655|NCT03519178|531903276|FG000|Long-term Follow-up|Other|0|||
147476656|NCT03519178|531903277|FG001|Long-term Follow-up|Other|0|||
147476657|NCT03519178|531903278|FG002|Long-term Follow-up|Other|0|||
147476658|NCT03519178|531903279|FG003|Long-term Follow-up|Other|0|||
147476659|NCT03519178|531903280|FG004|Long-term Follow-up|Other|0|||
147476660|NCT03519178|531903281|FG005|Long-term Follow-up|Other|0|||
147476661|NCT03519178|531903282|FG006|Long-term Follow-up|Other|0|||
147476662|NCT03519178|531903283|FG007|Long-term Follow-up|Other|0|||
147476663|NCT03519178|531903284|FG008|Long-term Follow-up|Other|0|||
147476664|NCT03519178|531903285|FG009|Long-term Follow-up|Other|0|||
147476665|NCT03519178|531903286|FG010|Long-term Follow-up|Other|0|||
147476666|NCT03519178|531903287|FG011|Long-term Follow-up|Other|0|||
147476667|NCT03519178|531903288|FG012|Long-term Follow-up|Other|0|||
147476668|NCT03519178|531903289|FG013|Long-term Follow-up|Other|0|||
147476669|NCT03519178|531903290|FG014|Long-term Follow-up|Other|1|||
147476670|NCT03519178|531903276|FG000|Long-term Follow-up|Global deterioration of health status|0|||
147476671|NCT03519178|531903277|FG001|Long-term Follow-up|Global deterioration of health status|0|||
147476672|NCT03519178|531903278|FG002|Long-term Follow-up|Global deterioration of health status|0|||
147476673|NCT03519178|531903279|FG003|Long-term Follow-up|Global deterioration of health status|0|||
147476674|NCT03519178|531903280|FG004|Long-term Follow-up|Global deterioration of health status|0|||
147476675|NCT03519178|531903281|FG005|Long-term Follow-up|Global deterioration of health status|0|||
147476676|NCT03519178|531903282|FG006|Long-term Follow-up|Global deterioration of health status|0|||
147476677|NCT03519178|531903283|FG007|Long-term Follow-up|Global deterioration of health status|0|||
147476678|NCT03519178|531903284|FG008|Long-term Follow-up|Global deterioration of health status|0|||
147476679|NCT03519178|531903285|FG009|Long-term Follow-up|Global deterioration of health status|0|||
147476680|NCT03519178|531903286|FG010|Long-term Follow-up|Global deterioration of health status|0|||
147476681|NCT03519178|531903287|FG011|Long-term Follow-up|Global deterioration of health status|0|||
147476682|NCT03519178|531903288|FG012|Long-term Follow-up|Global deterioration of health status|0|||
147476683|NCT03519178|531903289|FG013|Long-term Follow-up|Global deterioration of health status|1|||
147476684|NCT03519178|531903290|FG014|Long-term Follow-up|Global deterioration of health status|0|||
147476685|NCT02426086|531903291|FG000|Overall Study|Death|33|||
147476686|NCT02426086|531903292|FG001|Overall Study|Death|36|||
147476687|NCT02426086|531903291|FG000|Overall Study|Lost to Follow-up|2|||
147476688|NCT02426086|531903292|FG001|Overall Study|Lost to Follow-up|0|||
147476689|NCT02426086|531903291|FG000|Overall Study|Study Terminated by Sponsor|5|||
147476690|NCT02426086|531903292|FG001|Overall Study|Study Terminated by Sponsor|14|||
147476691|NCT02426086|531903291|FG000|Overall Study|Withdrawal by Subject|8|||
147476692|NCT02426086|531903292|FG001|Overall Study|Withdrawal by Subject|9|||
147476693|NCT00524303|531903293|FG000|Overall Study|Lost to Follow-up|6|||
147476694|NCT00524303|531903294|FG001|Overall Study|Lost to Follow-up|0|||
147476695|NCT00524303|531903295|FG002|Overall Study|Lost to Follow-up|3|||
147476696|NCT00524303|531903293|FG000|Overall Study|Protocol Violation|0|||
147476697|NCT00524303|531903294|FG001|Overall Study|Protocol Violation|1|||
147476698|NCT00524303|531903295|FG002|Overall Study|Protocol Violation|1|||
147476699|NCT00524303|531903293|FG000|Overall Study|Withdrawal by Subject|3|||
147476700|NCT00524303|531903294|FG001|Overall Study|Withdrawal by Subject|0|||
147476701|NCT00524303|531903295|FG002|Overall Study|Withdrawal by Subject|4|||
147476702|NCT00524303|531903293|FG000|Overall Study|Death|0|||
147476703|NCT00524303|531903294|FG001|Overall Study|Death|2|||
147476704|NCT00524303|531903295|FG002|Overall Study|Death|3|||
147476705|NCT00524303|531903293|FG000|Overall Study|Adverse Event|1|||
147476706|NCT00524303|531903294|FG001|Overall Study|Adverse Event|2|||
147476707|NCT00524303|531903295|FG002|Overall Study|Adverse Event|3|||
147476708|NCT00524303|531903293|FG000|Overall Study|Did not Complete Study Dosing|1|||
147476709|NCT00524303|531903294|FG001|Overall Study|Did not Complete Study Dosing|0|||
147476710|NCT00524303|531903295|FG002|Overall Study|Did not Complete Study Dosing|0|||
147476711|NCT00524303|531903293|FG000|Overall Study|Worsening Peripheral Neuropathy|1|||
147476712|NCT00524303|531903294|FG001|Overall Study|Worsening Peripheral Neuropathy|0|||
147476713|NCT00524303|531903295|FG002|Overall Study|Worsening Peripheral Neuropathy|0|||
147476714|NCT00524303|531903293|FG000|Overall Study|Disease Progression|0|||
147476715|NCT00524303|531903294|FG001|Overall Study|Disease Progression|4|||
147476716|NCT00524303|531903295|FG002|Overall Study|Disease Progression|1|||
147476717|NCT00524303|531903293|FG000|Overall Study|Disease Recurrence|0|||
147476718|NCT00524303|531903294|FG001|Overall Study|Disease Recurrence|1|||
147476719|NCT00524303|531903295|FG002|Overall Study|Disease Recurrence|0|||
147476720|NCT00524303|531903293|FG000|Overall Study|Sponsor Request|0|||
147476721|NCT00524303|531903294|FG001|Overall Study|Sponsor Request|0|||
147476722|NCT00524303|531903295|FG002|Overall Study|Sponsor Request|1|||
147476723|NCT00524303|531903293|FG000|Overall Study|Physician Decision|0|||
147476724|NCT00524303|531903294|FG001|Overall Study|Physician Decision|0|||
147476725|NCT00524303|531903295|FG002|Overall Study|Physician Decision|1|||
147476726|NCT00524303|531903293|FG000|Overall Study|Completed 5 years|0|||
147476727|NCT00524303|531903294|FG001|Overall Study|Completed 5 years|0|||
147476728|NCT00524303|531903295|FG002|Overall Study|Completed 5 years|1|||
147476729|NCT01877655|531903298|FG000|Overall Study|Death|57|||
147476730|NCT01877655|531903299|FG001|Overall Study|Death|52|||
147476731|NCT01877655|531903298|FG000|Overall Study|Withdrawal by Subject|18|||
147621662|NCT01597778|532431545|FG000|Overall Study|Withdrawal by Subject|3|||
147621663|NCT01597778|532431546|FG001|Overall Study|Withdrawal by Subject|4|||
147621664|NCT01597778|532431545|FG000|Overall Study|Adverse Event|1|||
147621665|NCT01597778|532431546|FG001|Overall Study|Adverse Event|1|||
147621666|NCT01597778|532431545|FG000|Overall Study|Protocol Violation|1|||
147621667|NCT01597778|532431546|FG001|Overall Study|Protocol Violation|11|||
147621668|NCT01597778|532431545|FG000|Overall Study|Transplanted off protocol|2|||
147621669|NCT01597778|532431546|FG001|Overall Study|Transplanted off protocol|3|||
147621670|NCT04740918|532431554|FG000|Overall Study|Study Terminated by Sponsor|41|||
147621671|NCT04740918|532431555|FG001|Overall Study|Study Terminated by Sponsor|32|||
147621672|NCT04740918|532431554|FG000|Overall Study|Death|3|||
147621673|NCT04740918|532431555|FG001|Overall Study|Death|6|||
147621674|NCT04740918|532431554|FG000|Overall Study|Withdrawal by Subject|5|||
147621675|NCT04740918|532431555|FG001|Overall Study|Withdrawal by Subject|4|||
147621676|NCT04740918|532431554|FG000|Overall Study|Lost to Follow-up|1|||
147621677|NCT04740918|532431555|FG001|Overall Study|Lost to Follow-up|3|||
147621678|NCT04740918|532431554|FG000|Overall Study|Progressive disease|0|||
147621679|NCT04740918|532431555|FG001|Overall Study|Progressive disease|1|||
147621680|NCT04314037|532431560|FG000|Treatment Period 2|Adverse Event|1|||
147621681|NCT04314037|532431561|FG001|Treatment Period 2|Adverse Event|0|||
147621682|NCT04314037|532431560|FG000|Treatment Period 3|Protocol Violation|1|||
147621683|NCT04314037|532431561|FG001|Treatment Period 3|Protocol Violation|0|||
147621684|NCT04314037|532431560|FG000|Treatment Period 3|Adverse Event|0|||
147621685|NCT04314037|532431561|FG001|Treatment Period 3|Adverse Event|1|||
147621686|NCT00273182|532431562|FG000|Overall Study|Death|450|||
147621687|NCT00273182|532431562|FG000|Overall Study|Lost to Follow-up|88|||
147621688|NCT00273182|532431562|FG000|Overall Study|Withdrawal by Subject|257|||
147621689|NCT00273182|532431562|FG000|Overall Study|Device/System Explant|154|||
147621690|NCT00273182|532431562|FG000|Overall Study|Site exit, system change, 36 m FU missed|36|||
147621691|NCT00856492|532431565|FG000|Overall Study|Ineligible or withdrew consent|1|||
147621692|NCT00856492|532431566|FG001|Overall Study|Ineligible or withdrew consent|1|||
147621693|NCT00856492|532431567|FG002|Overall Study|Ineligible or withdrew consent|2|||
147621694|NCT03832686|532431568|FG000|Overall Study|Lost to Follow-up|6|||
147621695|NCT03832686|532431569|FG001|Overall Study|Lost to Follow-up|9|||
147621696|NCT03832686|532431568|FG000|Overall Study|Discontinued Intervention|5|||
147621697|NCT03832686|532431569|FG001|Overall Study|Discontinued Intervention|4|||
147621698|NCT03323398|532431570|FG000|Overall Study|Other than Specified|0|||
147621699|NCT03323398|532431571|FG001|Overall Study|Other than Specified|1|||
147621700|NCT03323398|532431572|FG002|Overall Study|Other than Specified|2|||
147621701|NCT03323398|532431573|FG003|Overall Study|Other than Specified|0|||
147621702|NCT03323398|532431574|FG004|Overall Study|Other than Specified|0|||
147621703|NCT03323398|532431575|FG005|Overall Study|Other than Specified|0|||
147621704|NCT03323398|532431576|FG006|Overall Study|Other than Specified|1|||
147621705|NCT03323398|532431577|FG007|Overall Study|Other than Specified|0|||
147621706|NCT03323398|532431578|FG008|Overall Study|Other than Specified|2|||
147621707|NCT03323398|532431570|FG000|Overall Study|Lost to Follow-up|1|||
147621708|NCT03323398|532431571|FG001|Overall Study|Lost to Follow-up|2|||
147621709|NCT03323398|532431572|FG002|Overall Study|Lost to Follow-up|1|||
147621710|NCT03323398|532431573|FG003|Overall Study|Lost to Follow-up|0|||
147621711|NCT03323398|532431574|FG004|Overall Study|Lost to Follow-up|0|||
147621712|NCT03323398|532431575|FG005|Overall Study|Lost to Follow-up|0|||
147621713|NCT03323398|532431576|FG006|Overall Study|Lost to Follow-up|0|||
147621714|NCT03323398|532431577|FG007|Overall Study|Lost to Follow-up|0|||
147621715|NCT03323398|532431578|FG008|Overall Study|Lost to Follow-up|0|||
147621716|NCT03323398|532431570|FG000|Overall Study|Death|4|||
147621717|NCT03323398|532431571|FG001|Overall Study|Death|6|||
147621718|NCT03323398|532431572|FG002|Overall Study|Death|2|||
147621719|NCT03323398|532431573|FG003|Overall Study|Death|2|||
147621720|NCT03323398|532431574|FG004|Overall Study|Death|1|||
147621721|NCT03323398|532431575|FG005|Overall Study|Death|2|||
147621722|NCT03323398|532431576|FG006|Overall Study|Death|0|||
147621723|NCT03323398|532431577|FG007|Overall Study|Death|0|||
147621724|NCT03323398|532431578|FG008|Overall Study|Death|6|||
147621725|NCT03323398|532431570|FG000|Overall Study|Received Alternative Anticancer Therapy|2|||
147621726|NCT03323398|532431571|FG001|Overall Study|Received Alternative Anticancer Therapy|1|||
147621727|NCT03323398|532431572|FG002|Overall Study|Received Alternative Anticancer Therapy|2|||
147476732|NCT01877655|531903299|FG001|Overall Study|Withdrawal by Subject|26|||
147476733|NCT01877655|531903298|FG000|Overall Study|Physician Decision|11|||
147666873|NCT00264147|532605878|FG001|Treatment II Period|Pre-scheduled total hip replacement|0|||
147666874|NCT00264147|532605879|FG002|Treatment II Period|Pre-scheduled total hip replacement|0|||
147476734|NCT01877655|531903299|FG001|Overall Study|Physician Decision|10|||
147476735|NCT01877655|531903298|FG000|Overall Study|Miscellaneous|4|||
147476736|NCT01877655|531903299|FG001|Overall Study|Miscellaneous|4|||
147476737|NCT01877655|531903298|FG000|Overall Study|Randomized but Never Received Drug|8|||
147476738|NCT01877655|531903299|FG001|Overall Study|Randomized but Never Received Drug|5|||
147476739|NCT00095121|531903302|FG000|Double-Blind (Study Weeks 0 Through 48)|Adverse Event|1|||
147476740|NCT00095121|531903303|FG001|Double-Blind (Study Weeks 0 Through 48)|Adverse Event|0|||
147476741|NCT00095121|531903302|FG000|Double-Blind (Study Weeks 0 Through 48)|Not Compliant|2|||
147476742|NCT00095121|531903303|FG001|Double-Blind (Study Weeks 0 Through 48)|Not Compliant|0|||
147476743|NCT04070378|531903306|FG000|Overall Study|Withdrawal by Subject|2|||
147476744|NCT04070378|531903306|FG000|Overall Study|Screen Failure|6|||
147476745|NCT04070378|531903306|FG000|Overall Study|Physician Decision|1|||
147476746|NCT04070378|531903306|FG000|Overall Study|Adverse Event|1|||
147476747|NCT00443560|531905178|FG000|Overall Study|No intrathecal dose|58|||
147476748|NCT00443560|531905179|FG001|Overall Study|No intrathecal dose|26|||
147476749|NCT00443560|531905178|FG000|Overall Study|Multiple pregnancies or fetal demise|2|||
147476750|NCT00443560|531905179|FG001|Overall Study|Multiple pregnancies or fetal demise|4|||
147476751|NCT02082184|531905180|FG000|Overall Study|Adverse Event|1|||
147476752|NCT02082184|531905181|FG001|Overall Study|Adverse Event|0|||
147476753|NCT02082184|531905180|FG000|Overall Study|Medical diagnosis|1|||
147476754|NCT02082184|531905181|FG001|Overall Study|Medical diagnosis|2|||
147476755|NCT02082184|531905180|FG000|Overall Study|Device associated symptoms|5|||
147476756|NCT02082184|531905181|FG001|Overall Study|Device associated symptoms|0|||
147476757|NCT02082184|531905180|FG000|Overall Study|Withdrawal by Subject|3|||
147476758|NCT02082184|531905181|FG001|Overall Study|Withdrawal by Subject|2|||
147476759|NCT02082184|531905180|FG000|Overall Study|Protocol Violation|0|||
147476760|NCT02082184|531905181|FG001|Overall Study|Protocol Violation|6|||
147476761|NCT02082184|531905180|FG000|Overall Study|Lost to Follow-up|0|||
147476762|NCT02082184|531905181|FG001|Overall Study|Lost to Follow-up|2|||
147476763|NCT02082184|531905180|FG000|Overall Study|Subject non-compliance|0|||
147476764|NCT02082184|531905181|FG001|Overall Study|Subject non-compliance|1|||
147476765|NCT00537940|531905186|FG000|Overall Study|Adverse Event|20|||
147476766|NCT00537940|531905187|FG001|Overall Study|Adverse Event|19|||
147476767|NCT00537940|531905186|FG000|Overall Study|Lack of Efficacy|8|||
147476768|NCT00537940|531905187|FG001|Overall Study|Lack of Efficacy|16|||
147476769|NCT00537940|531905186|FG000|Overall Study|Lost to Follow-up|23|||
147476770|NCT00537940|531905187|FG001|Overall Study|Lost to Follow-up|29|||
147476771|NCT00537940|531905186|FG000|Overall Study|Withdrawal by Subject|113|||
147476772|NCT00537940|531905187|FG001|Overall Study|Withdrawal by Subject|95|||
147476773|NCT00537940|531905186|FG000|Overall Study|Protocol Violation|6|||
147476774|NCT00537940|531905187|FG001|Overall Study|Protocol Violation|4|||
147476775|NCT00537940|531905186|FG000|Overall Study|Pregnancy|1|||
147476776|NCT00537940|531905187|FG001|Overall Study|Pregnancy|1|||
147476777|NCT00537940|531905186|FG000|Overall Study|Study terminated by sponsor|2|||
147476778|NCT00537940|531905187|FG001|Overall Study|Study terminated by sponsor|3|||
147476779|NCT00537940|531905186|FG000|Overall Study|Other|10|||
147476780|NCT00537940|531905187|FG001|Overall Study|Other|12|||
147476781|NCT01978912|531905190|FG000|Overall Study|Adverse Event|0|||
147476782|NCT01978912|531905191|FG001|Overall Study|Adverse Event|1|||
147476783|NCT01978912|531905192|FG002|Overall Study|Adverse Event|0|||
147476784|NCT01978912|531905193|FG003|Overall Study|Adverse Event|0|||
147476785|NCT01978912|531905190|FG000|Overall Study|Lost to Follow-up|1|||
147476786|NCT01978912|531905191|FG001|Overall Study|Lost to Follow-up|1|||
147476787|NCT01978912|531905192|FG002|Overall Study|Lost to Follow-up|0|||
147476788|NCT01978912|531905193|FG003|Overall Study|Lost to Follow-up|1|||
147476789|NCT01978912|531905190|FG000|Overall Study|Withdrawal by Subject|1|||
147666875|NCT00264147|532605880|FG003|Treatment II Period|Pre-scheduled total hip replacement|0|||
147666876|NCT00264147|532605881|FG004|Treatment II Period|Pre-scheduled total hip replacement|0|||
147666877|NCT00264147|532605882|FG005|Treatment II Period|Pre-scheduled total hip replacement|1|||
147476790|NCT01978912|531905191|FG001|Overall Study|Withdrawal by Subject|0|||
147476791|NCT01978912|531905192|FG002|Overall Study|Withdrawal by Subject|2|||
147476792|NCT01978912|531905193|FG003|Overall Study|Withdrawal by Subject|2|||
147476793|NCT01978912|531905190|FG000|Overall Study|Lumbar Surgery|1|||
147476794|NCT01978912|531905191|FG001|Overall Study|Lumbar Surgery|0|||
147476795|NCT01978912|531905192|FG002|Overall Study|Lumbar Surgery|1|||
147476796|NCT01978912|531905193|FG003|Overall Study|Lumbar Surgery|0|||
147476797|NCT01978912|531905190|FG000|Overall Study|Intradiscal Steroid Injection|0|||
147666878|NCT03234465|532605883|FG000|Overall Study|Adverse Event|4|||
147666879|NCT03234465|532605884|FG001|Overall Study|Adverse Event|2|||
147666880|NCT03234465|532605883|FG000|Overall Study|Death|0|||
147476798|NCT01978912|531905191|FG001|Overall Study|Intradiscal Steroid Injection|1|||
147476799|NCT01978912|531905192|FG002|Overall Study|Intradiscal Steroid Injection|0|||
147476800|NCT01978912|531905193|FG003|Overall Study|Intradiscal Steroid Injection|0|||
147476801|NCT00077623|531905199|FG000|Overall Study|Adverse Event|1|||
147476802|NCT00077623|531905200|FG001|Overall Study|Adverse Event|0|||
147476803|NCT00077623|531905201|FG002|Overall Study|Adverse Event|1|||
147476804|NCT00077623|531905199|FG000|Overall Study|Withdrawal by Subject|2|||
147476805|NCT00077623|531905200|FG001|Overall Study|Withdrawal by Subject|10|||
147476806|NCT00077623|531905201|FG002|Overall Study|Withdrawal by Subject|1|||
147476807|NCT00077623|531905199|FG000|Overall Study|Other-Non safety reason|18|||
147476808|NCT00077623|531905200|FG001|Overall Study|Other-Non safety reason|15|||
147476809|NCT00077623|531905201|FG002|Overall Study|Other-Non safety reason|19|||
147476810|NCT00077623|531905199|FG000|Overall Study|Insufficient therapeutic response|2|||
147476811|NCT00077623|531905200|FG001|Overall Study|Insufficient therapeutic response|0|||
147476812|NCT00077623|531905201|FG002|Overall Study|Insufficient therapeutic response|0|||
147476813|NCT00077623|531905199|FG000|Overall Study|Death|12|||
147476814|NCT00077623|531905200|FG001|Overall Study|Death|18|||
147476815|NCT00077623|531905201|FG002|Overall Study|Death|11|||
147476816|NCT00077623|531905199|FG000|Overall Study|Failure to return|1|||
147476817|NCT00077623|531905200|FG001|Overall Study|Failure to return|0|||
147476818|NCT00077623|531905201|FG002|Overall Study|Failure to return|0|||
147476819|NCT00882713|531905202|FG000|Overall Study|Adverse Event|2|||
147476820|NCT00882713|531905202|FG000|Overall Study|Death|3|||
147476821|NCT00882713|531905202|FG000|Overall Study|Administrative reasons|4|||
147476822|NCT00882713|531905202|FG000|Overall Study|refused treatment/withdrew consent|4|||
147476823|NCT00882713|531905202|FG000|Overall Study|Blood transfusion|2|||
147476824|NCT00882713|531905202|FG000|Overall Study|Insufficient therapeutic response|3|||
147476825|NCT00882713|531905202|FG000|Overall Study|Failure to return|2|||
147476826|NCT00882713|531905202|FG000|Overall Study|Other - Reasons|2|||
147476827|NCT00401973|531905205|FG000|Overall Study|Adverse Event|2|||
147476828|NCT00401973|531905206|FG001|Overall Study|Adverse Event|8|||
147476829|NCT00401973|531905207|FG002|Overall Study|Adverse Event|4|||
147476830|NCT00401973|531905205|FG000|Overall Study|Clinical Relapse|0|||
147476831|NCT00401973|531905206|FG001|Overall Study|Clinical Relapse|1|||
147476832|NCT00401973|531905207|FG002|Overall Study|Clinical Relapse|1|||
147476833|NCT00401973|531905205|FG000|Overall Study|Lack of Efficacy|0|||
147476834|NCT00401973|531905206|FG001|Overall Study|Lack of Efficacy|0|||
147476835|NCT00401973|531905207|FG002|Overall Study|Lack of Efficacy|3|||
147476836|NCT00401973|531905205|FG000|Overall Study|Lost to Follow-up|2|||
147476837|NCT00401973|531905206|FG001|Overall Study|Lost to Follow-up|2|||
147476838|NCT00401973|531905207|FG002|Overall Study|Lost to Follow-up|2|||
147476839|NCT00401973|531905205|FG000|Overall Study|Physician Decision|2|||
147476840|NCT00401973|531905206|FG001|Overall Study|Physician Decision|0|||
147476841|NCT00401973|531905207|FG002|Overall Study|Physician Decision|1|||
147476842|NCT00401973|531905205|FG000|Overall Study|Protocol Violation|1|||
147476843|NCT00401973|531905206|FG001|Overall Study|Protocol Violation|2|||
147476844|NCT00401973|531905207|FG002|Overall Study|Protocol Violation|3|||
147476845|NCT00401973|531905205|FG000|Overall Study|Sponsor Decision|0|||
147476846|NCT00401973|531905206|FG001|Overall Study|Sponsor Decision|1|||
147476847|NCT00401973|531905207|FG002|Overall Study|Sponsor Decision|0|||
147476848|NCT00401973|531905205|FG000|Overall Study|Withdrawal by Subject|4|||
147476849|NCT00401973|531905206|FG001|Overall Study|Withdrawal by Subject|12|||
147476850|NCT00401973|531905207|FG002|Overall Study|Withdrawal by Subject|9|||
147476851|NCT01408537|531905208|FG000|Overall Study|Withdrawal by Subject|2|||
147476852|NCT01408537|531905208|FG000|Overall Study|Protocol Violation|3|||
147476853|NCT01408537|531905208|FG000|Overall Study|Lost to Follow-up|3|||
147476854|NCT05523362|531905211|FG000|Phase 1- Blinded (10 Days)|Unable to contact|2|||
147476855|NCT05523362|531905211|FG000|Phase 1- Blinded (10 Days)|High stress, did not want to continue|1|||
147476856|NCT05523362|531905211|FG000|Phase 1- Blinded (10 Days)|Technical issues with device|4|||
147476857|NCT05523362|531905211|FG000|Phase 1- Blinded (10 Days)|did not meet eligibility criteria|2|||
147476858|NCT01588197|531905218|FG000|Overall Study|Lack of Efficacy|0|||
147476859|NCT01588197|531905219|FG001|Overall Study|Lack of Efficacy|1|||
147666881|NCT03234465|532605884|FG001|Overall Study|Death|1|||
147666882|NCT03234465|532605883|FG000|Overall Study|Lost to Follow-up|1|||
147666883|NCT03234465|532605884|FG001|Overall Study|Lost to Follow-up|1|||
147476860|NCT01588197|531905218|FG000|Overall Study|No MRI|1|||
147666884|NCT03234465|532605883|FG000|Overall Study|Withdrawal by Subject|12|||
147666885|NCT03234465|532605884|FG001|Overall Study|Withdrawal by Subject|27|||
147666886|NCT03234465|532605883|FG000|Overall Study|Symptomatic deterioration|0|||
147666887|NCT03234465|532605884|FG001|Overall Study|Symptomatic deterioration|1|||
147666888|NCT03234465|532605883|FG000|Overall Study|Non-compliance|2|||
147666889|NCT03234465|532605884|FG001|Overall Study|Non-compliance|0|||
147476861|NCT01588197|531905219|FG001|Overall Study|No MRI|0|||
147476862|NCT03351244|531905220|FG000|Overall Study|Adverse Event|7|||
147476863|NCT03351244|531905221|FG001|Overall Study|Adverse Event|11|||
147476864|NCT03351244|531905222|FG002|Overall Study|Adverse Event|12|||
147476865|NCT03351244|531905220|FG000|Overall Study|Investigator's decision|0|||
147476866|NCT03351244|531905221|FG001|Overall Study|Investigator's decision|0|||
147476867|NCT03351244|531905222|FG002|Overall Study|Investigator's decision|2|||
147476868|NCT03351244|531905220|FG000|Overall Study|System error|0|||
147476869|NCT03351244|531905221|FG001|Overall Study|System error|0|||
147476870|NCT03351244|531905222|FG002|Overall Study|System error|2|||
147666890|NCT03234465|532605883|FG000|Overall Study|Other|14|||
147666891|NCT03234465|532605884|FG001|Overall Study|Other|8|||
147476871|NCT03351244|531905220|FG000|Overall Study|COVID-19 restrictions|3|||
147476872|NCT03351244|531905221|FG001|Overall Study|COVID-19 restrictions|0|||
147476873|NCT03351244|531905222|FG002|Overall Study|COVID-19 restrictions|1|||
147476874|NCT03351244|531905220|FG000|Overall Study|Non-compliance|2|||
147476875|NCT03351244|531905221|FG001|Overall Study|Non-compliance|5|||
147476876|NCT03351244|531905222|FG002|Overall Study|Non-compliance|0|||
147476877|NCT03351244|531905220|FG000|Overall Study|Withdrawal by Subject|11|||
147476878|NCT03351244|531905221|FG001|Overall Study|Withdrawal by Subject|16|||
147476879|NCT03351244|531905222|FG002|Overall Study|Withdrawal by Subject|13|||
147476880|NCT03351244|531905220|FG000|Overall Study|Lost to Follow-up|2|||
147476881|NCT03351244|531905221|FG001|Overall Study|Lost to Follow-up|6|||
147476882|NCT03351244|531905222|FG002|Overall Study|Lost to Follow-up|4|||
147476883|NCT03351244|531905220|FG000|Overall Study|Protocol Violation|2|||
147476884|NCT03351244|531905221|FG001|Overall Study|Protocol Violation|2|||
147476885|NCT03351244|531905222|FG002|Overall Study|Protocol Violation|0|||
147476886|NCT00091793|531905226|FG000|Overall Study|Adverse Event|1|||
147476887|NCT00091793|531905227|FG001|Overall Study|Adverse Event|2|||
147476888|NCT00091793|531905226|FG000|Overall Study|Withdrawal by Subject|10|||
147476889|NCT00091793|531905227|FG001|Overall Study|Withdrawal by Subject|15|||
147476890|NCT00091793|531905226|FG000|Overall Study|Ineligibility determined|2|||
147476891|NCT00091793|531905227|FG001|Overall Study|Ineligibility determined|0|||
147476892|NCT00091793|531905226|FG000|Overall Study|Lost to Follow-up|7|||
147476893|NCT00091793|531905227|FG001|Overall Study|Lost to Follow-up|5|||
147476894|NCT00091793|531905226|FG000|Overall Study|Noncompliance|2|||
147476895|NCT00091793|531905227|FG001|Overall Study|Noncompliance|0|||
147476896|NCT00091793|531905226|FG000|Overall Study|Other|2|||
147476897|NCT00091793|531905227|FG001|Overall Study|Other|0|||
147476898|NCT01025336|531905228|FG000|Overall Study|Protocol Violation|0|||
147476899|NCT01025336|531905229|FG001|Overall Study|Protocol Violation|0|||
147476900|NCT01025336|531905230|FG002|Overall Study|Protocol Violation|0|||
147476901|NCT01025336|531905231|FG003|Overall Study|Protocol Violation|2|||
147476902|NCT01025336|531905232|FG004|Overall Study|Protocol Violation|0|||
147476903|NCT03794986|531905233|FG000|Overall Study|0 Sessions Attended|34|||
147476904|NCT03794986|531905234|FG001|Overall Study|0 Sessions Attended|37|||
147476905|NCT03794986|531905233|FG000|Overall Study|Withdrawal by Subject|4|||
147476906|NCT03794986|531905234|FG001|Overall Study|Withdrawal by Subject|6|||
147476907|NCT03794986|531905233|FG000|Overall Study|Protocol Violation|1|||
147476908|NCT03794986|531905234|FG001|Overall Study|Protocol Violation|0|||
147476909|NCT03000452|531905235|FG000|Treatment Period|Death|1|||
147476910|NCT03000452|531905235|FG000|Treatment Period|Progressive Disease (PD)|14|||
147476911|NCT03000452|531905235|FG000|Treatment Period|Physician Decision|1|||
147476912|NCT03000452|531905235|FG000|Treatment Period|Miscellaneous|2|||
147476913|NCT03000452|531905235|FG000|Follow-Up Period|Study Terminated by Sponsor|1|||
147476914|NCT03000452|531905235|FG000|Follow-Up Period|Death|3|||
147476915|NCT03000452|531905235|FG000|Follow-Up Period|Withdrawal by Subject|3|||
147476916|NCT05372315|531905238|FG000|Overall Study|Withdrawal by Subject|1|||
147476917|NCT05372315|531905239|FG001|Overall Study|Withdrawal by Subject|0|||
147476918|NCT00537745|531905240|FG000|Overall Study|Did not meet eligibility criteria|2|||
147476919|NCT00537745|531905240|FG000|Overall Study|Withdrawal by Subject|2|||
147476920|NCT00537745|531905240|FG000|Overall Study|Subject unable to provide Interlock info|1|||
147476921|NCT01512368|531905241|FG000|Overall Study|Protocol Violation|3|||
147476922|NCT01254344|531905246|FG000|Overall Study|Adverse Event|2|||
147476923|NCT01254344|531905247|FG001|Overall Study|Adverse Event|5|||
147476924|NCT01254344|531905246|FG000|Overall Study|Physician Decision|7|||
147476925|NCT01254344|531905247|FG001|Overall Study|Physician Decision|4|||
147476926|NCT01254344|531905246|FG000|Overall Study|Protocol Violation|1|||
147476927|NCT01254344|531905247|FG001|Overall Study|Protocol Violation|4|||
147476928|NCT01254344|531905246|FG000|Overall Study|Withdrawal by Subject|3|||
147476929|NCT01254344|531905247|FG001|Overall Study|Withdrawal by Subject|6|||
147476930|NCT03249350|531905248|FG000|Overall Study|Participant did not initiate treatment|5|||
147476931|NCT03249350|531905249|FG001|Overall Study|Participant did not initiate treatment|8|||
147476932|NCT00624338|531905253|FG000|Overall Study|Adverse Event|14|||
147476933|NCT00624338|531905254|FG001|Overall Study|Adverse Event|14|||
147476934|NCT00624338|531905255|FG002|Overall Study|Adverse Event|18|||
147476935|NCT00624338|531905253|FG000|Overall Study|Lost to Follow-up|1|||
147476936|NCT00624338|531905254|FG001|Overall Study|Lost to Follow-up|0|||
147476937|NCT00624338|531905255|FG002|Overall Study|Lost to Follow-up|0|||
147476938|NCT00624338|531905253|FG000|Overall Study|Lack of Efficacy|11|||
147476939|NCT00624338|531905254|FG001|Overall Study|Lack of Efficacy|3|||
147476940|NCT00624338|531905255|FG002|Overall Study|Lack of Efficacy|14|||
147476941|NCT00624338|531905253|FG000|Overall Study|Protocol Violation|3|||
147476942|NCT00624338|531905254|FG001|Overall Study|Protocol Violation|3|||
147476943|NCT00624338|531905255|FG002|Overall Study|Protocol Violation|2|||
147476944|NCT00624338|531905253|FG000|Overall Study|Death|0|||
147476945|NCT00624338|531905254|FG001|Overall Study|Death|2|||
147476946|NCT00624338|531905255|FG002|Overall Study|Death|0|||
147476947|NCT00624338|531905253|FG000|Overall Study|Immunoglobulin less than 3gram per liter|1|||
147476948|NCT00624338|531905254|FG001|Overall Study|Immunoglobulin less than 3gram per liter|0|||
147666892|NCT00449163|532605885|FG000|Overall Study|Physician Decision|3|||
147666893|NCT00606307|532605890|FG000|Overall Study|Adverse Event|2|||
147666894|NCT00606307|532605890|FG000|Overall Study|Withdrawal by Subject|2|||
147666895|NCT00606307|532605890|FG000|Overall Study|Disease progression|6|||
147666896|NCT00606307|532605890|FG000|Overall Study|QTc prolongation|1|||
147666897|NCT02563899|532605891|FG000|Overall Study|Protocol Violation|1|||
147666898|NCT02563899|532605892|FG001|Overall Study|Protocol Violation|0|||
147666899|NCT02563899|532605893|FG002|Overall Study|Protocol Violation|0|||
147666900|NCT02563899|532605894|FG003|Overall Study|Protocol Violation|0|||
147666901|NCT02563899|532605891|FG000|Overall Study|Withdrawal by Subject|0|||
147666902|NCT02563899|532605892|FG001|Overall Study|Withdrawal by Subject|0|||
147666903|NCT02563899|532605893|FG002|Overall Study|Withdrawal by Subject|1|||
147666904|NCT02563899|532605894|FG003|Overall Study|Withdrawal by Subject|0|||
147666905|NCT03368807|532605895|FG000|Period 1 (Blinded CGM)|Withdrawal by Subject|3|||
147666906|NCT03368807|532605895|FG000|Period 1 (Blinded CGM)|Protocol Violation|1|||
147666907|NCT03368807|532605895|FG000|Period 1 (Blinded CGM)|Sponsor Decision|1|||
147666908|NCT03368807|532605895|FG000|Period 1 (Blinded CGM)|Lost to Follow-up|1|||
147666909|NCT02949947|532605922|FG000|Overall Study|Non Compliance|0|||
147666910|NCT02949947|532605923|FG001|Overall Study|Non Compliance|1|||
147666911|NCT02949947|532605922|FG000|Overall Study|Insurance change|1|||
147666912|NCT02949947|532605923|FG001|Overall Study|Insurance change|0|||
147666913|NCT01677741|532605924|FG000|Overall Study|Death|0|||
147666914|NCT01677741|532605925|FG001|Overall Study|Death|0|||
147666915|NCT01677741|532605926|FG002|Overall Study|Death|0|||
147666916|NCT01677741|532605927|FG003|Overall Study|Death|1|||
147666917|NCT01677741|532605928|FG004|Overall Study|Death|0|||
147666918|NCT01677741|532605929|FG005|Overall Study|Death|1|||
147666919|NCT01677741|532605930|FG006|Overall Study|Death|0|||
147666920|NCT01677741|532605931|FG007|Overall Study|Death|0|||
147666921|NCT01677741|532605924|FG000|Overall Study|Withdrawal by Subject|2|||
147666922|NCT01677741|532605925|FG001|Overall Study|Withdrawal by Subject|7|||
147666923|NCT01677741|532605926|FG002|Overall Study|Withdrawal by Subject|5|||
147666924|NCT01677741|532605927|FG003|Overall Study|Withdrawal by Subject|4|||
147666925|NCT01677741|532605928|FG004|Overall Study|Withdrawal by Subject|11|||
147666926|NCT01677741|532605929|FG005|Overall Study|Withdrawal by Subject|20|||
147666927|NCT01677741|532605930|FG006|Overall Study|Withdrawal by Subject|4|||
147666928|NCT01677741|532605931|FG007|Overall Study|Withdrawal by Subject|2|||
147666929|NCT01677741|532605924|FG000|Overall Study|Enrolled in a rollover study|0|||
147666930|NCT01677741|532605925|FG001|Overall Study|Enrolled in a rollover study|3|||
147666931|NCT01677741|532605926|FG002|Overall Study|Enrolled in a rollover study|2|||
147666932|NCT01677741|532605927|FG003|Overall Study|Enrolled in a rollover study|1|||
147666933|NCT01677741|532605928|FG004|Overall Study|Enrolled in a rollover study|6|||
147666934|NCT01677741|532605929|FG005|Overall Study|Enrolled in a rollover study|6|||
147666935|NCT01677741|532605930|FG006|Overall Study|Enrolled in a rollover study|7|||
147666936|NCT01677741|532605931|FG007|Overall Study|Enrolled in a rollover study|0|||
147666937|NCT01677741|532605924|FG000|Overall Study|Progressive disease|1|||
147666938|NCT01677741|532605925|FG001|Overall Study|Progressive disease|0|||
147666939|NCT01677741|532605926|FG002|Overall Study|Progressive disease|1|||
147666940|NCT01677741|532605927|FG003|Overall Study|Progressive disease|0|||
147666941|NCT01677741|532605928|FG004|Overall Study|Progressive disease|0|||
147666942|NCT01677741|532605929|FG005|Overall Study|Progressive disease|1|||
147666943|NCT01677741|532605930|FG006|Overall Study|Progressive disease|0|||
147666944|NCT01677741|532605931|FG007|Overall Study|Progressive disease|0|||
147666945|NCT00720499|532605932|FG000|Treatment Period 1 (4 Weeks)|Adverse Event|2|||
147666946|NCT00720499|532605933|FG001|Treatment Period 1 (4 Weeks)|Adverse Event|0|||
147666947|NCT00720499|532605932|FG000|Treatment Period 1 (4 Weeks)|Protocol Violation|1|||
147666948|NCT00720499|532605933|FG001|Treatment Period 1 (4 Weeks)|Protocol Violation|2|||
147476949|NCT00624338|531905255|FG002|Overall Study|Immunoglobulin less than 3gram per liter|0|||
147666949|NCT00720499|532605932|FG000|Treatment Period 2 (4 Weeks)|Adverse Event|2|||
147666950|NCT00720499|532605933|FG001|Treatment Period 2 (4 Weeks)|Adverse Event|3|||
147666951|NCT01973218|532605934|FG000|Overall Study|Adverse Event|1|||
147666952|NCT01973218|532605935|FG001|Overall Study|Adverse Event|0|||
147666953|NCT01973218|532605934|FG000|Overall Study|Withdrawal by Subject|1|||
147666954|NCT01973218|532605935|FG001|Overall Study|Withdrawal by Subject|0|||
147666955|NCT02247466|532605936|FG000|Overall Study|Procedure changed to open surgery|0|||
147666956|NCT02247466|532605937|FG001|Overall Study|Procedure changed to open surgery|3|||
147666957|NCT02230891|532605946|FG000|Baseline|Did not meet inclusion|0|||
147666958|NCT02230891|532605947|FG001|Baseline|Did not meet inclusion|1|||
147666959|NCT02230891|532605948|FG002|Baseline|Did not meet inclusion|1|||
147666960|NCT02230891|532605946|FG000|2 Week|Withdrawal by Subject|2|||
147666961|NCT02230891|532605947|FG001|2 Week|Withdrawal by Subject|2|||
147666962|NCT02230891|532605948|FG002|2 Week|Withdrawal by Subject|0|||
147666963|NCT02230891|532605946|FG000|2 Week|Consent withdrawn|1|||
147666964|NCT02230891|532605947|FG001|2 Week|Consent withdrawn|0|||
147666965|NCT02230891|532605948|FG002|2 Week|Consent withdrawn|0|||
147666966|NCT02230891|532605946|FG000|6 Month|Withdrawal by Subject|1|||
147666967|NCT02230891|532605947|FG001|6 Month|Withdrawal by Subject|1|||
147666968|NCT02230891|532605948|FG002|6 Month|Withdrawal by Subject|1|||
147666969|NCT02230891|532605946|FG000|6 Month|Physician Decision|0|||
147476950|NCT00624338|531905253|FG000|Overall Study|Termination of 150 mg group by Sponsor|0|||
147476951|NCT00624338|531905254|FG001|Overall Study|Termination of 150 mg group by Sponsor|55|||
147476952|NCT00624338|531905255|FG002|Overall Study|Termination of 150 mg group by Sponsor|0|||
147476953|NCT00624338|531905253|FG000|Overall Study|Other|15|||
147476954|NCT00624338|531905254|FG001|Overall Study|Other|5|||
147476955|NCT00624338|531905255|FG002|Overall Study|Other|9|||
147476956|NCT00624338|531905253|FG000|Overall Study|Randomized but not treated|2|||
147476957|NCT00624338|531905254|FG001|Overall Study|Randomized but not treated|1|||
147476958|NCT00624338|531905255|FG002|Overall Study|Randomized but not treated|3|||
147476959|NCT01476787|531905256|FG000|Treatment|Progression|64|||
147476960|NCT01476787|531905257|FG001|Treatment|Progression|71|||
147476961|NCT01476787|531905256|FG000|Treatment|Toxicity|44|||
147476962|NCT01476787|531905257|FG001|Treatment|Toxicity|16|||
147476963|NCT01476787|531905256|FG000|Treatment|Death|0|||
147476964|NCT01476787|531905257|FG001|Treatment|Death|1|||
147476965|NCT01476787|531905256|FG000|Treatment|Withdrawal by Subject|3|||
147476966|NCT01476787|531905257|FG001|Treatment|Withdrawal by Subject|14|||
147476967|NCT01476787|531905256|FG000|Treatment|Major protocol violation|1|||
147476968|NCT01476787|531905257|FG001|Treatment|Major protocol violation|6|||
147476969|NCT01476787|531905256|FG000|Treatment|Other reasons|10|||
147476970|NCT01476787|531905257|FG001|Treatment|Other reasons|22|||
147476971|NCT01476787|531905256|FG000|Treatment|Concurrent illness|12|||
147476972|NCT01476787|531905257|FG001|Treatment|Concurrent illness|9|||
147476973|NCT01476787|531905256|FG000|Treatment|Insufficient response|15|||
147476974|NCT01476787|531905257|FG001|Treatment|Insufficient response|3|||
147476975|NCT01476787|531905256|FG000|Treatment|Voluntary treatment discontinuation|8|||
147476976|NCT01476787|531905257|FG001|Treatment|Voluntary treatment discontinuation|4|||
147476977|NCT01591330|531905258|FG000|Period 1|Adverse Event|1|||
147476978|NCT01591330|531905259|FG001|Period 1|Adverse Event|0|||
147476979|NCT01591330|531905260|FG002|Period 1|Adverse Event|0|||
147476980|NCT01591330|531905261|FG003|Period 1|Adverse Event|0|||
147476981|NCT01591330|531905258|FG000|Washout of at Least 3 Days|Withdrawal by Subject|1|||
147476982|NCT01591330|531905259|FG001|Washout of at Least 3 Days|Withdrawal by Subject|0|||
147476983|NCT01591330|531905260|FG002|Washout of at Least 3 Days|Withdrawal by Subject|0|||
147476984|NCT01591330|531905261|FG003|Washout of at Least 3 Days|Withdrawal by Subject|0|||
147476985|NCT01591330|531905258|FG000|Period 2|Adverse Event|1|||
147476986|NCT01591330|531905259|FG001|Period 2|Adverse Event|0|||
147476987|NCT01591330|531905260|FG002|Period 2|Adverse Event|0|||
147476988|NCT01591330|531905261|FG003|Period 2|Adverse Event|0|||
147476989|NCT01450137|531905262|FG000|Up to Week 12|Adverse Event|2|||
147476990|NCT01450137|531905263|FG001|Up to Week 12|Adverse Event|1|||
147476991|NCT01450137|531905262|FG000|Up to Week 12|Withdrawal by Subject|0|||
147476992|NCT01450137|531905263|FG001|Up to Week 12|Withdrawal by Subject|2|||
147476993|NCT01450137|531905262|FG000|Week 12 to Study End|Death|0|||
147476994|NCT01450137|531905263|FG001|Week 12 to Study End|Death|1|||
147476995|NCT01450137|531905262|FG000|Week 12 to Study End|Withdrawal by Subject|0|||
147476996|NCT01450137|531905263|FG001|Week 12 to Study End|Withdrawal by Subject|1|||
147476997|NCT02782715|531905264|FG000|Overall Study|Withdrawal by Subject|1|||
147476998|NCT02986373|531905265|FG000|Overall Study|Adverse Event|4|||
147476999|NCT02986373|531905265|FG000|Overall Study|Lost to Follow-up|1|||
147477000|NCT02986373|531905265|FG000|Overall Study|Withdrawal by Subject|10|||
147477001|NCT02986373|531905265|FG000|Overall Study|Other|24|||
147477002|NCT01662999|531905274|FG000|Period 3|Withdrawal by Subject|0|||
147477003|NCT01662999|531905275|FG001|Period 3|Withdrawal by Subject|1|||
147477004|NCT01662999|531905276|FG002|Period 3|Withdrawal by Subject|0|||
147477005|NCT01662999|531905277|FG003|Period 3|Withdrawal by Subject|0|||
147477006|NCT01662999|531905278|FG004|Period 3|Withdrawal by Subject|0|||
147477007|NCT01662999|531905279|FG005|Period 3|Withdrawal by Subject|0|||
147477008|NCT01151137|531905286|FG000|Overall Study|Death|15|||
147477009|NCT01151137|531905287|FG001|Overall Study|Death|27|||
147477010|NCT01151137|531905286|FG000|Overall Study|Lost to Follow-up|1|||
147477011|NCT01151137|531905287|FG001|Overall Study|Lost to Follow-up|1|||
147477012|NCT01933672|531905288|FG000|Metformin Run-in Period|Adverse Event|1|||
147477013|NCT01933672|531905289|FG001|Metformin Run-in Period|Adverse Event|0|||
147477014|NCT01933672|531905290|FG002|Metformin Run-in Period|Adverse Event|0|||
147477015|NCT01933672|531905291|FG003|Metformin Run-in Period|Adverse Event|0|||
147477016|NCT01933672|531905292|FG004|Metformin Run-in Period|Adverse Event|0|||
147477017|NCT01933672|531905293|FG005|Metformin Run-in Period|Adverse Event|0|||
147477018|NCT01933672|531905294|FG006|Metformin Run-in Period|Adverse Event|0|||
147477019|NCT01933672|531905288|FG000|Metformin Run-in Period|No longer meets eligibility criteria|4|||
147477020|NCT01933672|531905289|FG001|Metformin Run-in Period|No longer meets eligibility criteria|0|||
147477021|NCT01933672|531905290|FG002|Metformin Run-in Period|No longer meets eligibility criteria|0|||
147477022|NCT01933672|531905291|FG003|Metformin Run-in Period|No longer meets eligibility criteria|0|||
147621728|NCT03323398|532431573|FG003|Overall Study|Received Alternative Anticancer Therapy|0|||
147477023|NCT01933672|531905292|FG004|Metformin Run-in Period|No longer meets eligibility criteria|0|||
147477024|NCT01933672|531905293|FG005|Metformin Run-in Period|No longer meets eligibility criteria|0|||
147621729|NCT03323398|532431574|FG004|Overall Study|Received Alternative Anticancer Therapy|0|||
147477025|NCT01933672|531905294|FG006|Metformin Run-in Period|No longer meets eligibility criteria|0|||
147477026|NCT01933672|531905288|FG000|Metformin Run-in Period|Other|5|||
147477027|NCT01933672|531905289|FG001|Metformin Run-in Period|Other|0|||
147477028|NCT01933672|531905290|FG002|Metformin Run-in Period|Other|0|||
147477029|NCT01933672|531905291|FG003|Metformin Run-in Period|Other|0|||
147477030|NCT01933672|531905292|FG004|Metformin Run-in Period|Other|0|||
147477031|NCT01933672|531905293|FG005|Metformin Run-in Period|Other|0|||
147477032|NCT01933672|531905294|FG006|Metformin Run-in Period|Other|0|||
147477033|NCT01933672|531905288|FG000|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
147477034|NCT01933672|531905289|FG001|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
147477035|NCT01933672|531905290|FG002|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
147477036|NCT01933672|531905291|FG003|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
147477037|NCT01933672|531905292|FG004|First Intervention Period (12-16 Days)|Lost to Follow-up|1|||
147477038|NCT01933672|531905293|FG005|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
147477039|NCT01933672|531905294|FG006|First Intervention Period (12-16 Days)|Lost to Follow-up|0|||
147477040|NCT01933672|531905288|FG000|First Intervention Period (12-16 Days)|Other|0|||
147477041|NCT01933672|531905289|FG001|First Intervention Period (12-16 Days)|Other|0|||
147477042|NCT01933672|531905290|FG002|First Intervention Period (12-16 Days)|Other|1|||
147477043|NCT01933672|531905291|FG003|First Intervention Period (12-16 Days)|Other|0|||
147477044|NCT01933672|531905292|FG004|First Intervention Period (12-16 Days)|Other|0|||
147477045|NCT01933672|531905293|FG005|First Intervention Period (12-16 Days)|Other|1|||
147477046|NCT01933672|531905294|FG006|First Intervention Period (12-16 Days)|Other|0|||
147477047|NCT01933672|531905288|FG000|Second Intervention Period (12-16 Days)|Other|0|||
147477048|NCT01933672|531905289|FG001|Second Intervention Period (12-16 Days)|Other|1|||
147477049|NCT01933672|531905290|FG002|Second Intervention Period (12-16 Days)|Other|1|||
147477050|NCT01933672|531905291|FG003|Second Intervention Period (12-16 Days)|Other|0|||
147477051|NCT01933672|531905292|FG004|Second Intervention Period (12-16 Days)|Other|0|||
147477052|NCT01933672|531905293|FG005|Second Intervention Period (12-16 Days)|Other|0|||
147477053|NCT01933672|531905294|FG006|Second Intervention Period (12-16 Days)|Other|0|||
147477054|NCT01933672|531905288|FG000|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
147477055|NCT01933672|531905289|FG001|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
147477056|NCT01933672|531905290|FG002|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
147477057|NCT01933672|531905291|FG003|Third Intervention Period (12-16 Days)|Lost to Follow-up|1|||
147477058|NCT01933672|531905292|FG004|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
147477059|NCT01933672|531905293|FG005|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
147477060|NCT01933672|531905294|FG006|Third Intervention Period (12-16 Days)|Lost to Follow-up|0|||
147477061|NCT01933672|531905288|FG000|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
147477062|NCT01933672|531905289|FG001|Third Intervention Period (12-16 Days)|Withdrawal by Subject|1|||
147477063|NCT01933672|531905290|FG002|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
147477064|NCT01933672|531905291|FG003|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
147477065|NCT01933672|531905292|FG004|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
147477066|NCT01933672|531905293|FG005|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
147477067|NCT01933672|531905294|FG006|Third Intervention Period (12-16 Days)|Withdrawal by Subject|0|||
147477068|NCT01607892|531905298|FG000|Overall Study|Need of treatment not allowed per protocol|0|||
147477069|NCT01607892|531905299|FG001|Overall Study|Need of treatment not allowed per protocol|0|||
147477070|NCT01607892|531905300|FG002|Overall Study|Need of treatment not allowed per protocol|0|||
147477071|NCT01607892|531905301|FG003|Overall Study|Need of treatment not allowed per protocol|1|||
147477072|NCT01607892|531905302|FG004|Overall Study|Need of treatment not allowed per protocol|0|||
147477073|NCT01607892|531905298|FG000|Overall Study|Death|4|||
147477074|NCT01607892|531905299|FG001|Overall Study|Death|2|||
147477075|NCT01607892|531905300|FG002|Overall Study|Death|8|||
147477076|NCT01607892|531905301|FG003|Overall Study|Death|10|||
147477077|NCT01607892|531905302|FG004|Overall Study|Death|3|||
147477078|NCT01607892|531905298|FG000|Overall Study|Investigator discretion|2|||
147477079|NCT01607892|531905299|FG001|Overall Study|Investigator discretion|4|||
147477080|NCT01607892|531905300|FG002|Overall Study|Investigator discretion|4|||
147477081|NCT01607892|531905301|FG003|Overall Study|Investigator discretion|8|||
147477082|NCT01607892|531905302|FG004|Overall Study|Investigator discretion|0|||
147477083|NCT01607892|531905298|FG000|Overall Study|Other treatments became available|1|||
147477084|NCT01607892|531905299|FG001|Overall Study|Other treatments became available|1|||
147477085|NCT01607892|531905300|FG002|Overall Study|Other treatments became available|0|||
147477086|NCT01607892|531905301|FG003|Overall Study|Other treatments became available|0|||
147477087|NCT01607892|531905302|FG004|Overall Study|Other treatments became available|2|||
147477088|NCT01607892|531905298|FG000|Overall Study|Intercurrent illness|1|||
147477089|NCT01607892|531905299|FG001|Overall Study|Intercurrent illness|0|||
147477090|NCT01607892|531905300|FG002|Overall Study|Intercurrent illness|0|||
147477091|NCT01607892|531905301|FG003|Overall Study|Intercurrent illness|3|||
147477092|NCT01607892|531905302|FG004|Overall Study|Intercurrent illness|0|||
147477093|NCT01607892|531905298|FG000|Overall Study|Non-Compliance with study procedures|0|||
147477094|NCT01607892|531905299|FG001|Overall Study|Non-Compliance with study procedures|0|||
147477095|NCT01607892|531905300|FG002|Overall Study|Non-Compliance with study procedures|1|||
147477096|NCT01607892|531905301|FG003|Overall Study|Non-Compliance with study procedures|0|||
147477097|NCT01607892|531905302|FG004|Overall Study|Non-Compliance with study procedures|0|||
147477098|NCT01607892|531905298|FG000|Overall Study|Consent withdrawn by participant|9|||
147477099|NCT01607892|531905299|FG001|Overall Study|Consent withdrawn by participant|4|||
147477100|NCT01607892|531905300|FG002|Overall Study|Consent withdrawn by participant|24|||
147477101|NCT01607892|531905301|FG003|Overall Study|Consent withdrawn by participant|14|||
147477102|NCT01607892|531905302|FG004|Overall Study|Consent withdrawn by participant|4|||
147477103|NCT01607892|531905298|FG000|Overall Study|Disease progression|38|||
147477104|NCT01607892|531905299|FG001|Overall Study|Disease progression|13|||
147477105|NCT01607892|531905300|FG002|Overall Study|Disease progression|37|||
147477106|NCT01607892|531905301|FG003|Overall Study|Disease progression|57|||
147477107|NCT01607892|531905302|FG004|Overall Study|Disease progression|9|||
147477108|NCT01607892|531905298|FG000|Overall Study|Incidence or severity of Adverse events|3|||
147477109|NCT01607892|531905299|FG001|Overall Study|Incidence or severity of Adverse events|3|||
147477110|NCT01607892|531905300|FG002|Overall Study|Incidence or severity of Adverse events|7|||
147477111|NCT01607892|531905301|FG003|Overall Study|Incidence or severity of Adverse events|2|||
147477112|NCT01607892|531905302|FG004|Overall Study|Incidence or severity of Adverse events|6|||
147477113|NCT02273973|531905305|FG000|Overall Study|Adverse Event|4|||
147477114|NCT02273973|531905306|FG001|Overall Study|Adverse Event|0|||
147477115|NCT02273973|531905305|FG000|Overall Study|Withdrawal by Subject|2|||
147477116|NCT02273973|531905306|FG001|Overall Study|Withdrawal by Subject|3|||
147477117|NCT02273973|531905305|FG000|Overall Study|Death|1|||
147477118|NCT02273973|531905306|FG001|Overall Study|Death|0|||
147477119|NCT02273973|531905305|FG000|Overall Study|Non-compliance|1|||
147477120|NCT02273973|531905306|FG001|Overall Study|Non-compliance|0|||
147477121|NCT02273973|531905305|FG000|Overall Study|Protocol Violation|1|||
147477122|NCT02273973|531905306|FG001|Overall Study|Protocol Violation|0|||
147477123|NCT02273973|531905305|FG000|Overall Study|Progression of disease|0|||
147477124|NCT02273973|531905306|FG001|Overall Study|Progression of disease|2|||
147477125|NCT02273973|531905305|FG000|Overall Study|Lost to Follow-up|0|||
147477126|NCT02273973|531905306|FG001|Overall Study|Lost to Follow-up|1|||
147477127|NCT02273973|531905305|FG000|Overall Study|Physician Decision|0|||
147477128|NCT02273973|531905306|FG001|Overall Study|Physician Decision|1|||
147477129|NCT02273973|531905305|FG000|Overall Study|Reason not specified|0|||
147477130|NCT02273973|531905306|FG001|Overall Study|Reason not specified|1|||
147477131|NCT00957372|531905308|FG000|PART I|Lost to Follow-up|0|||
147477132|NCT00957372|531905309|FG001|PART I|Lost to Follow-up|0|||
147477133|NCT00957372|531905310|FG002|PART I|Lost to Follow-up|1|||
147477134|NCT00957372|531905311|FG003|PART I|Lost to Follow-up|0|||
147477135|NCT00957372|531905308|FG000|PART II|Withdrawal by Subject|0|||
147477136|NCT00957372|531905309|FG001|PART II|Withdrawal by Subject|0|||
147477137|NCT00957372|531905310|FG002|PART II|Withdrawal by Subject|0|||
147477138|NCT00957372|531905311|FG003|PART II|Withdrawal by Subject|8|||
147477139|NCT00957372|531905308|FG000|PART II|Physician Decision|0|||
147477140|NCT00957372|531905309|FG001|PART II|Physician Decision|0|||
147477141|NCT00957372|531905310|FG002|PART II|Physician Decision|0|||
147477142|NCT00957372|531905311|FG003|PART II|Physician Decision|1|||
147477143|NCT00957372|531905308|FG000|PART II|Pregnancy|0|||
147477144|NCT00957372|531905309|FG001|PART II|Pregnancy|0|||
147477145|NCT00957372|531905310|FG002|PART II|Pregnancy|0|||
147477146|NCT00957372|531905311|FG003|PART II|Pregnancy|1|||
147477147|NCT00957372|531905308|FG000|PART II|Not Know|0|||
147477148|NCT00957372|531905309|FG001|PART II|Not Know|0|||
147477149|NCT00957372|531905310|FG002|PART II|Not Know|0|||
147477150|NCT00957372|531905311|FG003|PART II|Not Know|20|||
147477151|NCT00957372|531905308|FG000|PART II|Adverse Event|0|||
147477152|NCT00957372|531905309|FG001|PART II|Adverse Event|0|||
147477153|NCT00957372|531905310|FG002|PART II|Adverse Event|0|||
147477154|NCT00957372|531905311|FG003|PART II|Adverse Event|10|||
147477155|NCT00957372|531905308|FG000|PART II|Patient non-compliance|0|||
147477156|NCT00957372|531905309|FG001|PART II|Patient non-compliance|0|||
147477157|NCT00957372|531905310|FG002|PART II|Patient non-compliance|0|||
147477158|NCT00957372|531905311|FG003|PART II|Patient non-compliance|4|||
147477159|NCT01444391|531905314|FG000|Overall Study|Death|1|||
147477160|NCT01287117|531905315|FG000|Overall Study|Adverse Event|2|||
147477161|NCT01287117|531905316|FG001|Overall Study|Adverse Event|1|||
147477162|NCT01287117|531905317|FG002|Overall Study|Adverse Event|1|||
147477163|NCT01287117|531905318|FG003|Overall Study|Adverse Event|1|||
147477164|NCT01287117|531905315|FG000|Overall Study|Lost to Follow-up|1|||
147477165|NCT01287117|531905316|FG001|Overall Study|Lost to Follow-up|1|||
147477166|NCT01287117|531905317|FG002|Overall Study|Lost to Follow-up|0|||
147477167|NCT01287117|531905318|FG003|Overall Study|Lost to Follow-up|0|||
147477168|NCT01287117|531905315|FG000|Overall Study|Physician Decision|0|||
147477169|NCT01287117|531905316|FG001|Overall Study|Physician Decision|1|||
147477170|NCT01287117|531905317|FG002|Overall Study|Physician Decision|1|||
147477171|NCT01287117|531905318|FG003|Overall Study|Physician Decision|1|||
147477172|NCT01287117|531905315|FG000|Overall Study|Patient/Legal Guardian's Decision|2|||
147477173|NCT01287117|531905316|FG001|Overall Study|Patient/Legal Guardian's Decision|6|||
147477174|NCT01287117|531905317|FG002|Overall Study|Patient/Legal Guardian's Decision|8|||
147477175|NCT01287117|531905318|FG003|Overall Study|Patient/Legal Guardian's Decision|5|||
147477176|NCT01287117|531905315|FG000|Overall Study|Disease Progression|10|||
147477177|NCT01287117|531905316|FG001|Overall Study|Disease Progression|5|||
147477178|NCT01287117|531905317|FG002|Overall Study|Disease Progression|6|||
147477179|NCT01287117|531905318|FG003|Overall Study|Disease Progression|5|||
147477180|NCT01769404|531905321|FG000|Treatment Period 1|Did not meet eligibility criteria|1|||
147477181|NCT01769404|531905322|FG001|Treatment Period 1|Did not meet eligibility criteria|0|||
147477182|NCT01769404|531905321|FG000|Treatment Period 1|Withdrawal by Subject|3|||
147477183|NCT01769404|531905322|FG001|Treatment Period 1|Withdrawal by Subject|0|||
147477184|NCT01769404|531905321|FG000|Treatment Period 1|Sponsor decision|1|||
147477185|NCT01769404|531905322|FG001|Treatment Period 1|Sponsor decision|0|||
147477186|NCT01769404|531905321|FG000|Treatment Period 2|Sponsor decision|7|||
147477187|NCT01769404|531905322|FG001|Treatment Period 2|Sponsor decision|0|||
147477188|NCT00538733|531905323|FG000|Overall Study|Adverse Event|8|||
147477189|NCT00538733|531905323|FG000|Overall Study|Death|1|||
147477190|NCT00538733|531905323|FG000|Overall Study|declined to participate|2|||
147477191|NCT00538733|531905323|FG000|Overall Study|still on therapy|1|||
147477192|NCT02032524|531905328|FG000|Period 1: TDR12857 Study|Adverse Event|1|||
147477193|NCT02032524|531905329|FG001|Period 1: TDR12857 Study|Adverse Event|0|||
147477194|NCT02032524|531905330|FG002|Period 1: TDR12857 Study|Adverse Event|0|||
147477195|NCT02032524|531905331|FG003|Period 1: TDR12857 Study|Adverse Event|0|||
147477196|NCT02032524|531905332|FG004|Period 1: TDR12857 Study|Adverse Event|0|||
147477197|NCT02032524|531905333|FG005|Period 1: TDR12857 Study|Adverse Event|0|||
147477198|NCT02032524|531905328|FG000|Period 1: TDR12857 Study|Wishes To Withdraw|0|||
147477199|NCT02032524|531905329|FG001|Period 1: TDR12857 Study|Wishes To Withdraw|0|||
147477200|NCT02032524|531905330|FG002|Period 1: TDR12857 Study|Wishes To Withdraw|0|||
147477201|NCT02032524|531905331|FG003|Period 1: TDR12857 Study|Wishes To Withdraw|1|||
147477202|NCT02032524|531905332|FG004|Period 1: TDR12857 Study|Wishes To Withdraw|0|||
147477203|NCT02032524|531905333|FG005|Period 1: TDR12857 Study|Wishes To Withdraw|1|||
147477204|NCT02032524|531905328|FG000|Period 2: LTS13769 Study|Adverse Event|0|||
147477205|NCT02032524|531905329|FG001|Period 2: LTS13769 Study|Adverse Event|0|||
147477206|NCT02032524|531905330|FG002|Period 2: LTS13769 Study|Adverse Event|1|||
147477207|NCT02032524|531905331|FG003|Period 2: LTS13769 Study|Adverse Event|0|||
147477208|NCT02032524|531905332|FG004|Period 2: LTS13769 Study|Adverse Event|0|||
147477209|NCT02032524|531905333|FG005|Period 2: LTS13769 Study|Adverse Event|0|||
147477210|NCT02032524|531905328|FG000|Period 2: LTS13769 Study|Wishes To Withdraw|0|||
147477211|NCT02032524|531905329|FG001|Period 2: LTS13769 Study|Wishes To Withdraw|1|||
147477212|NCT02032524|531905330|FG002|Period 2: LTS13769 Study|Wishes To Withdraw|0|||
147477213|NCT02032524|531905331|FG003|Period 2: LTS13769 Study|Wishes To Withdraw|0|||
147477214|NCT02032524|531905332|FG004|Period 2: LTS13769 Study|Wishes To Withdraw|1|||
147477215|NCT02032524|531905333|FG005|Period 2: LTS13769 Study|Wishes To Withdraw|0|||
147477216|NCT02032524|531905328|FG000|Period 2: LTS13769 Study|Other|0|||
147477217|NCT02032524|531905329|FG001|Period 2: LTS13769 Study|Other|0|||
147477218|NCT02032524|531905330|FG002|Period 2: LTS13769 Study|Other|0|||
147477219|NCT02032524|531905331|FG003|Period 2: LTS13769 Study|Other|0|||
147477220|NCT02032524|531905332|FG004|Period 2: LTS13769 Study|Other|0|||
147477221|NCT02032524|531905333|FG005|Period 2: LTS13769 Study|Other|1|||
147477222|NCT03567187|531905334|FG000|Overall Study|Lost to Follow-up|18|||
147477223|NCT03596645|531905337|FG000|Overall Study|Adverse Event|17|||
147477224|NCT03596645|531905338|FG001|Overall Study|Adverse Event|0|||
147477225|NCT03596645|531905337|FG000|Overall Study|Lack of Efficacy|8|||
147477226|NCT03596645|531905338|FG001|Overall Study|Lack of Efficacy|0|||
147477227|NCT03596645|531905337|FG000|Overall Study|Lost to Follow-up|1|||
147477228|NCT03596645|531905338|FG001|Overall Study|Lost to Follow-up|1|||
147477229|NCT03596645|531905337|FG000|Overall Study|Physician Decision|1|||
147477230|NCT03596645|531905338|FG001|Overall Study|Physician Decision|1|||
147477231|NCT03596645|531905337|FG000|Overall Study|Protocol Violation|1|||
147477232|NCT03596645|531905338|FG001|Overall Study|Protocol Violation|0|||
147477233|NCT03596645|531905337|FG000|Overall Study|Initiated Prohibited Medication|1|||
147477234|NCT03596645|531905338|FG001|Overall Study|Initiated Prohibited Medication|0|||
147477235|NCT03596645|531905337|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
147477236|NCT03596645|531905338|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
147477237|NCT03596645|531905337|FG000|Overall Study|No mucosal healing achieved|1|||
147477238|NCT03596645|531905338|FG001|Overall Study|No mucosal healing achieved|0|||
147666970|NCT02230891|532605947|FG001|6 Month|Physician Decision|2|||
147477239|NCT03596645|531905337|FG000|Overall Study|Disease progression|1|||
147477240|NCT03596645|531905338|FG001|Overall Study|Disease progression|0|||
147477241|NCT03596645|531905337|FG000|Overall Study|Ongoing|37|||
147477242|NCT03596645|531905338|FG001|Overall Study|Ongoing|12|||
147477243|NCT03596645|531905337|FG000|Overall Study|Randomized but not treated|0|||
147477244|NCT03596645|531905338|FG001|Overall Study|Randomized but not treated|1|||
147477245|NCT04358458|531905339|FG000|Overall Study|Death|1|||
147477246|NCT04358458|531905340|FG001|Overall Study|Death|1|||
147477247|NCT04358458|531905341|FG002|Overall Study|Death|3|||
147477248|NCT04358458|531905342|FG003|Overall Study|Death|8|||
147477249|NCT04358458|531905343|FG004|Overall Study|Death|1|||
147477250|NCT04358458|531905344|FG005|Overall Study|Death|6|||
147477251|NCT04358458|531905345|FG006|Overall Study|Death|2|||
147477252|NCT04358458|531905346|FG007|Overall Study|Death|3|||
147477253|NCT04358458|531905339|FG000|Overall Study|Lost to Follow-up|0|||
147477254|NCT04358458|531905340|FG001|Overall Study|Lost to Follow-up|0|||
147477255|NCT04358458|531905341|FG002|Overall Study|Lost to Follow-up|0|||
147477256|NCT04358458|531905342|FG003|Overall Study|Lost to Follow-up|0|||
147477257|NCT04358458|531905343|FG004|Overall Study|Lost to Follow-up|0|||
147477258|NCT04358458|531905344|FG005|Overall Study|Lost to Follow-up|0|||
147477259|NCT04358458|531905345|FG006|Overall Study|Lost to Follow-up|0|||
147477260|NCT04358458|531905346|FG007|Overall Study|Lost to Follow-up|1|||
147477261|NCT04358458|531905339|FG000|Overall Study|Site is closing study participation|0|||
147477262|NCT04358458|531905340|FG001|Overall Study|Site is closing study participation|0|||
147477263|NCT04358458|531905341|FG002|Overall Study|Site is closing study participation|0|||
147477264|NCT04358458|531905342|FG003|Overall Study|Site is closing study participation|1|||
147477265|NCT04358458|531905343|FG004|Overall Study|Site is closing study participation|0|||
147477266|NCT04358458|531905344|FG005|Overall Study|Site is closing study participation|0|||
147477267|NCT04358458|531905345|FG006|Overall Study|Site is closing study participation|0|||
147477268|NCT04358458|531905346|FG007|Overall Study|Site is closing study participation|0|||
147477269|NCT04358458|531905339|FG000|Overall Study|Sponsor request|2|||
147477270|NCT04358458|531905340|FG001|Overall Study|Sponsor request|3|||
147477271|NCT04358458|531905341|FG002|Overall Study|Sponsor request|3|||
147477272|NCT04358458|531905342|FG003|Overall Study|Sponsor request|0|||
147477273|NCT04358458|531905343|FG004|Overall Study|Sponsor request|2|||
147477274|NCT04358458|531905344|FG005|Overall Study|Sponsor request|3|||
147477275|NCT04358458|531905345|FG006|Overall Study|Sponsor request|1|||
147477276|NCT04358458|531905346|FG007|Overall Study|Sponsor request|1|||
147477277|NCT04358458|531905339|FG000|Overall Study|Withdrawal by Subject|0|||
147477278|NCT04358458|531905340|FG001|Overall Study|Withdrawal by Subject|0|||
147477279|NCT04358458|531905341|FG002|Overall Study|Withdrawal by Subject|1|||
147477280|NCT04358458|531905342|FG003|Overall Study|Withdrawal by Subject|1|||
147477281|NCT04358458|531905343|FG004|Overall Study|Withdrawal by Subject|0|||
147477282|NCT04358458|531905344|FG005|Overall Study|Withdrawal by Subject|1|||
147477283|NCT04358458|531905345|FG006|Overall Study|Withdrawal by Subject|0|||
147477284|NCT04358458|531905346|FG007|Overall Study|Withdrawal by Subject|1|||
147477285|NCT04513158|531905349|FG000|Overall Study|Screen Failure|1|||
147477286|NCT01123889|531907461|FG000|Overall Study|Lost to Follow-up|3|||
147477287|NCT01123889|531907462|FG001|Overall Study|Lost to Follow-up|1|||
147477288|NCT02413255|531907467|FG000|Overall Study|Voluntary Withdrawal|0|||
147477289|NCT02413255|531907468|FG001|Overall Study|Voluntary Withdrawal|0|||
147477290|NCT02413255|531907469|FG002|Overall Study|Voluntary Withdrawal|0|||
147477291|NCT02413255|531907470|FG003|Overall Study|Voluntary Withdrawal|0|||
147477292|NCT02413255|531907471|FG004|Overall Study|Voluntary Withdrawal|0|||
147477293|NCT02413255|531907472|FG005|Overall Study|Voluntary Withdrawal|0|||
147477294|NCT02413255|531907473|FG006|Overall Study|Voluntary Withdrawal|0|||
147477295|NCT02413255|531907474|FG007|Overall Study|Voluntary Withdrawal|0|||
147477296|NCT02413255|531907475|FG008|Overall Study|Voluntary Withdrawal|0|||
147477297|NCT02413255|531907476|FG009|Overall Study|Voluntary Withdrawal|0|||
147477298|NCT02413255|531907477|FG010|Overall Study|Voluntary Withdrawal|0|||
147477299|NCT02413255|531907478|FG011|Overall Study|Voluntary Withdrawal|0|||
147477300|NCT02413255|531907479|FG012|Overall Study|Voluntary Withdrawal|0|||
147477301|NCT02413255|531907480|FG013|Overall Study|Voluntary Withdrawal|0|||
147477302|NCT02413255|531907481|FG014|Overall Study|Voluntary Withdrawal|1|||
147477303|NCT02413255|531907482|FG015|Overall Study|Voluntary Withdrawal|0|||
147477304|NCT02413255|531907483|FG016|Overall Study|Voluntary Withdrawal|0|||
147477305|NCT02413398|531907484|FG000|Overall Study|Lost to Follow-up|2|||
147477306|NCT02413398|531907485|FG001|Overall Study|Lost to Follow-up|4|||
147477307|NCT02413398|531907484|FG000|Overall Study|Withdrawal by Subject|1|||
147477308|NCT02413398|531907485|FG001|Overall Study|Withdrawal by Subject|1|||
147477309|NCT02413398|531907484|FG000|Overall Study|Other Eligibility criteria|1|||
147477310|NCT02413398|531907485|FG001|Overall Study|Other Eligibility criteria|2|||
147477311|NCT01494038|531907486|FG000|Overall Study|Protocol Violation|1|||
147477312|NCT01494038|531907487|FG001|Overall Study|Protocol Violation|1|||
147477313|NCT01494038|531907486|FG000|Overall Study|Lost to Follow-up|18|||
147477314|NCT01494038|531907487|FG001|Overall Study|Lost to Follow-up|20|||
147477315|NCT01494038|531907486|FG000|Overall Study|Withdrawal by Subject|44|||
147477316|NCT01494038|531907487|FG001|Overall Study|Withdrawal by Subject|34|||
147477317|NCT01494038|531907486|FG000|Overall Study|Not able to get to clinic|21|||
147477318|NCT01494038|531907487|FG001|Overall Study|Not able to get to clinic|15|||
147477319|NCT01494038|531907486|FG000|Overall Study|Not willing to adhere to reqs|2|||
147477320|NCT01494038|531907487|FG001|Overall Study|Not willing to adhere to reqs|9|||
147477321|NCT01494038|531907486|FG000|Overall Study|Death|2|||
147477322|NCT01494038|531907487|FG001|Overall Study|Death|4|||
147477323|NCT00685178|531907492|FG000|Overall Study|Adverse Event|1|||
147477324|NCT00685178|531907493|FG001|Overall Study|Adverse Event|5|||
147477325|NCT00685178|531907494|FG002|Overall Study|Adverse Event|2|||
147477326|NCT00685178|531907495|FG003|Overall Study|Adverse Event|4|||
147477327|NCT00685178|531907492|FG000|Overall Study|missed 3 consecutive methadone clin days|7|||
147666971|NCT02230891|532605948|FG002|6 Month|Physician Decision|0|||
147666972|NCT02230891|532605946|FG000|12 Month|Death|1|||
147666973|NCT02230891|532605947|FG001|12 Month|Death|0|||
147666974|NCT02230891|532605948|FG002|12 Month|Death|0|||
147666975|NCT02230891|532605946|FG000|12 Month|Lost to Follow-up|0|||
147666976|NCT02230891|532605947|FG001|12 Month|Lost to Follow-up|1|||
147666977|NCT02230891|532605948|FG002|12 Month|Lost to Follow-up|0|||
147666978|NCT02230891|532605946|FG000|12 Month|Withdrawal by Subject|0|||
147666979|NCT02230891|532605947|FG001|12 Month|Withdrawal by Subject|2|||
147666980|NCT02230891|532605948|FG002|12 Month|Withdrawal by Subject|0|||
147666981|NCT02230891|532605946|FG000|18 Month End of Study|Death|0|||
147666982|NCT02230891|532605947|FG001|18 Month End of Study|Death|0|||
147666983|NCT02230891|532605948|FG002|18 Month End of Study|Death|1|||
147666984|NCT02230891|532605946|FG000|18 Month End of Study|Hear failure, lost to follow up|1|||
147621730|NCT03323398|532431575|FG005|Overall Study|Received Alternative Anticancer Therapy|0|||
147621731|NCT03323398|532431576|FG006|Overall Study|Received Alternative Anticancer Therapy|0|||
147621732|NCT03323398|532431577|FG007|Overall Study|Received Alternative Anticancer Therapy|0|||
147621733|NCT03323398|532431578|FG008|Overall Study|Received Alternative Anticancer Therapy|0|||
147621734|NCT03323398|532431570|FG000|Overall Study|Withdrawal by Subject|2|||
147621735|NCT03323398|532431571|FG001|Overall Study|Withdrawal by Subject|1|||
147621736|NCT03323398|532431572|FG002|Overall Study|Withdrawal by Subject|3|||
147621737|NCT03323398|532431573|FG003|Overall Study|Withdrawal by Subject|0|||
147621738|NCT03323398|532431574|FG004|Overall Study|Withdrawal by Subject|0|||
147621739|NCT03323398|532431575|FG005|Overall Study|Withdrawal by Subject|1|||
147621740|NCT03323398|532431576|FG006|Overall Study|Withdrawal by Subject|0|||
147666985|NCT02230891|532605947|FG001|18 Month End of Study|Hear failure, lost to follow up|0|||
147666986|NCT02230891|532605948|FG002|18 Month End of Study|Hear failure, lost to follow up|0|||
147666987|NCT04356937|532605949|FG000|Treatment (mITT Population)|Intubated before receiving study treatment|0|||
147666988|NCT04356937|532605950|FG001|Treatment (mITT Population)|Intubated before receiving study treatment|1|||
147666989|NCT04158219|532605951|FG000|Overall Study|Lost to Follow-up|1|||
147666990|NCT01814007|532605953|FG000|Overall Study|Withdrawal by Subject|1|||
147666991|NCT01324947|532605954|FG000|Overall Study|Adverse Event|7|||
147666992|NCT01324947|532605954|FG000|Overall Study|Death|10|||
147666993|NCT01324947|532605954|FG000|Overall Study|Other|3|||
147666994|NCT01324947|532605954|FG000|Overall Study|Progressive Disease|50|||
147666995|NCT01324947|532605954|FG000|Overall Study|Withdrawal by Subject|3|||
147666996|NCT01324947|532605954|FG000|Overall Study|1 discontinued before starting drug|1|||
147621741|NCT03323398|532431577|FG007|Overall Study|Withdrawal by Subject|0|||
147621742|NCT03323398|532431578|FG008|Overall Study|Withdrawal by Subject|0|||
147621743|NCT03323398|532431570|FG000|Overall Study|Participant was Put on Hospice|0|||
147621744|NCT03323398|532431571|FG001|Overall Study|Participant was Put on Hospice|0|||
147621745|NCT03323398|532431572|FG002|Overall Study|Participant was Put on Hospice|0|||
147621746|NCT03323398|532431573|FG003|Overall Study|Participant was Put on Hospice|0|||
147621747|NCT03323398|532431574|FG004|Overall Study|Participant was Put on Hospice|0|||
147621748|NCT03323398|532431575|FG005|Overall Study|Participant was Put on Hospice|0|||
147621749|NCT03323398|532431576|FG006|Overall Study|Participant was Put on Hospice|1|||
147621750|NCT03323398|532431577|FG007|Overall Study|Participant was Put on Hospice|0|||
147621751|NCT03323398|532431578|FG008|Overall Study|Participant was Put on Hospice|0|||
147621752|NCT03323398|532431570|FG000|Overall Study|Discontinued Following Discussion with Physician|0|||
147621753|NCT03323398|532431571|FG001|Overall Study|Discontinued Following Discussion with Physician|0|||
147621754|NCT03323398|532431572|FG002|Overall Study|Discontinued Following Discussion with Physician|0|||
147621755|NCT03323398|532431573|FG003|Overall Study|Discontinued Following Discussion with Physician|0|||
147621756|NCT03323398|532431574|FG004|Overall Study|Discontinued Following Discussion with Physician|0|||
147666997|NCT04194814|532605957|FG000|Overall Study|Physician Decision|3|||
147477328|NCT00685178|531907493|FG001|Overall Study|missed 3 consecutive methadone clin days|5|||
147477329|NCT00685178|531907494|FG002|Overall Study|missed 3 consecutive methadone clin days|2|||
147477330|NCT00685178|531907495|FG003|Overall Study|missed 3 consecutive methadone clin days|6|||
147477331|NCT00685178|531907492|FG000|Overall Study|voluntary study discharge|4|||
147477332|NCT00685178|531907493|FG001|Overall Study|voluntary study discharge|5|||
147477333|NCT00685178|531907494|FG002|Overall Study|voluntary study discharge|1|||
147477334|NCT00685178|531907495|FG003|Overall Study|voluntary study discharge|1|||
147477335|NCT00685178|531907492|FG000|Overall Study|incarcerated|1|||
147477336|NCT00685178|531907493|FG001|Overall Study|incarcerated|3|||
147477337|NCT00685178|531907494|FG002|Overall Study|incarcerated|7|||
147477338|NCT00685178|531907495|FG003|Overall Study|incarcerated|0|||
147477339|NCT00685178|531907492|FG000|Overall Study|administrative (disciplinary) discharge|0|||
147621757|NCT03323398|532431575|FG005|Overall Study|Discontinued Following Discussion with Physician|0|||
147621758|NCT03323398|532431576|FG006|Overall Study|Discontinued Following Discussion with Physician|0|||
147621759|NCT03323398|532431577|FG007|Overall Study|Discontinued Following Discussion with Physician|1|||
147666998|NCT04194814|532605958|FG001|Overall Study|Physician Decision|0|||
147666999|NCT04194814|532605957|FG000|Overall Study|Withdrawal by Subject|0|||
147667000|NCT04194814|532605958|FG001|Overall Study|Withdrawal by Subject|2|||
147667001|NCT00434252|532607929|FG000|Overall Study|Lack of Efficacy|50|||
147477340|NCT00685178|531907493|FG001|Overall Study|administrative (disciplinary) discharge|1|||
147477341|NCT00685178|531907494|FG002|Overall Study|administrative (disciplinary) discharge|0|||
147477342|NCT00685178|531907495|FG003|Overall Study|administrative (disciplinary) discharge|2|||
147477343|NCT00685178|531907492|FG000|Overall Study|Pregnancy|0|||
147477344|NCT00685178|531907493|FG001|Overall Study|Pregnancy|0|||
147477345|NCT00685178|531907494|FG002|Overall Study|Pregnancy|0|||
147477346|NCT00685178|531907495|FG003|Overall Study|Pregnancy|1|||
147477347|NCT01334125|531907498|FG000|Overall Study|Lost to Follow-up|3|||
147477348|NCT01334125|531907499|FG001|Overall Study|Lost to Follow-up|3|||
147477349|NCT02138110|531907503|FG000|Enrolled for Scaffold Implantation|Physician Decision|1|||
147477350|NCT02138110|531907503|FG000|Overall Scaffold Implantation|Death|3|||
147477351|NCT04075604|531907507|FG000|Overall Study|Adverse Event|0|||
147477352|NCT04075604|531907508|FG001|Overall Study|Adverse Event|0|||
147477353|NCT04075604|531907509|FG002|Overall Study|Adverse Event|3|||
147477354|NCT04075604|531907507|FG000|Overall Study|Participant request to discontinue study treatment|0|||
147477355|NCT04075604|531907508|FG001|Overall Study|Participant request to discontinue study treatment|0|||
147477356|NCT04075604|531907509|FG002|Overall Study|Participant request to discontinue study treatment|1|||
147477357|NCT04075604|531907507|FG000|Overall Study|Participant withdrew consent|0|||
147477358|NCT04075604|531907508|FG001|Overall Study|Participant withdrew consent|0|||
147477359|NCT04075604|531907509|FG002|Overall Study|Participant withdrew consent|1|||
147477360|NCT04075604|531907507|FG000|Overall Study|Other reasons|1|||
147477361|NCT04075604|531907508|FG001|Overall Study|Other reasons|0|||
147477362|NCT04075604|531907509|FG002|Overall Study|Other reasons|0|||
147477363|NCT04075604|531907507|FG000|Overall Study|Disease progression|0|||
147477364|NCT04075604|531907508|FG001|Overall Study|Disease progression|1|||
147477365|NCT04075604|531907509|FG002|Overall Study|Disease progression|0|||
147477366|NCT04075604|531907507|FG000|Overall Study|Study drug toxicity|0|||
147477367|NCT04075604|531907508|FG001|Overall Study|Study drug toxicity|5|||
147477368|NCT04075604|531907509|FG002|Overall Study|Study drug toxicity|1|||
147477369|NCT02760602|531907510|FG000|Overall Study|Withdrawal by Subject|1|||
147477370|NCT02760602|531907511|FG001|Overall Study|Withdrawal by Subject|0|||
147477371|NCT02760602|531907510|FG000|Overall Study|Terminated by sponsor|12|||
147477372|NCT02760602|531907511|FG001|Overall Study|Terminated by sponsor|13|||
147477373|NCT01272180|531907516|FG000|Overall Study|Adverse Event|0|||
147477374|NCT01272180|531907517|FG001|Overall Study|Adverse Event|0|||
147477375|NCT01272180|531907518|FG002|Overall Study|Adverse Event|1|||
147477376|NCT01272180|531907519|FG003|Overall Study|Adverse Event|0|||
147477377|NCT01272180|531907516|FG000|Overall Study|Withdrawal by Subject|2|||
147477378|NCT01272180|531907517|FG001|Overall Study|Withdrawal by Subject|6|||
147477379|NCT01272180|531907518|FG002|Overall Study|Withdrawal by Subject|3|||
147477380|NCT01272180|531907519|FG003|Overall Study|Withdrawal by Subject|2|||
147477381|NCT01272180|531907516|FG000|Overall Study|Lost to Follow-up|15|||
147477382|NCT01272180|531907517|FG001|Overall Study|Lost to Follow-up|14|||
147477383|NCT01272180|531907518|FG002|Overall Study|Lost to Follow-up|8|||
147477384|NCT01272180|531907519|FG003|Overall Study|Lost to Follow-up|10|||
147477385|NCT01272180|531907516|FG000|Overall Study|Inappropriate enrollment|0|||
147477386|NCT01272180|531907517|FG001|Overall Study|Inappropriate enrollment|0|||
147477387|NCT01272180|531907518|FG002|Overall Study|Inappropriate enrollment|1|||
147477388|NCT01272180|531907519|FG003|Overall Study|Inappropriate enrollment|1|||
147477389|NCT01272180|531907516|FG000|Overall Study|Protocol Violation|0|||
147477390|NCT01272180|531907517|FG001|Overall Study|Protocol Violation|1|||
147477391|NCT01272180|531907518|FG002|Overall Study|Protocol Violation|0|||
147477392|NCT01272180|531907519|FG003|Overall Study|Protocol Violation|1|||
147477393|NCT03334214|531907520|FG000|Overall Study|Adverse Event or Serious Adverse Event|0|||
147477394|NCT03334214|531907521|FG001|Overall Study|Adverse Event or Serious Adverse Event|1|||
147477395|NCT03334214|531907520|FG000|Overall Study|Withdrawal by Subject|0|||
147477396|NCT03334214|531907521|FG001|Overall Study|Withdrawal by Subject|1|||
147621760|NCT03323398|532431578|FG008|Overall Study|Discontinued Following Discussion with Physician|0|||
147621761|NCT02235454|532431579|FG000|Overall Study|Withdrawal by Subject|2|||
147621762|NCT03641469|532431580|FG000|Overall Study|Ineligible|2|||
147621763|NCT03641469|532431580|FG000|Overall Study|Withdrawal by Subject|5|||
147621764|NCT03641469|532431580|FG000|Overall Study|Physician Decision|1|||
147621765|NCT03641469|532431580|FG000|Overall Study|Protocol Violation|1|||
147621766|NCT03641469|532431580|FG000|Overall Study|Lost to Follow-up|2|||
147477397|NCT03334214|531907520|FG000|Overall Study|Other|1|||
147477398|NCT03334214|531907521|FG001|Overall Study|Other|0|||
147477399|NCT01260181|531907523|FG000|Overall Study|Decision of Investigator|1|||
147477400|NCT02088034|531907524|FG000|Overall Study|Lost to Follow-up|1|||
147621767|NCT03879135|532433027|FG000|Overall Study|Physician Decision|0|||
147621768|NCT03879135|532433028|FG001|Overall Study|Physician Decision|0|||
147477401|NCT02088034|531907525|FG001|Overall Study|Lost to Follow-up|1|||
147477402|NCT02088034|531907526|FG002|Overall Study|Lost to Follow-up|0|||
147621769|NCT03879135|532433029|FG002|Overall Study|Physician Decision|0|||
147621770|NCT03879135|532433030|FG003|Overall Study|Physician Decision|1|||
147621771|NCT03879135|532433031|FG004|Overall Study|Physician Decision|0|||
147477403|NCT02088034|531907524|FG000|Overall Study|Pregnancy|2|||
147477404|NCT02088034|531907525|FG001|Overall Study|Pregnancy|1|||
147477405|NCT02088034|531907526|FG002|Overall Study|Pregnancy|2|||
147477406|NCT00308620|531907529|FG000|Overall Study|Death|1|||
147477407|NCT00308620|531907530|FG001|Overall Study|Death|1|||
147477408|NCT00308620|531907531|FG002|Overall Study|Death|0|||
147477409|NCT00308620|531907529|FG000|Overall Study|Lost to Follow-up|0|||
147477410|NCT00308620|531907530|FG001|Overall Study|Lost to Follow-up|0|||
147477411|NCT00308620|531907531|FG002|Overall Study|Lost to Follow-up|1|||
147477412|NCT00637728|531907536|FG000|Double-blind Phase|Adverse Event|1|||
147477413|NCT00637728|531907537|FG001|Double-blind Phase|Adverse Event|0|||
147477414|NCT00637728|531907538|FG002|Double-blind Phase|Adverse Event|0|||
147477415|NCT00637728|531907536|FG000|Double-blind Phase|Non-compliance|2|||
147477416|NCT00637728|531907537|FG001|Double-blind Phase|Non-compliance|0|||
147477417|NCT00637728|531907538|FG002|Double-blind Phase|Non-compliance|0|||
147477418|NCT00637728|531907536|FG000|Double-blind Phase|Study Discontinued|1|||
147477419|NCT00637728|531907537|FG001|Double-blind Phase|Study Discontinued|1|||
147477420|NCT00637728|531907538|FG002|Double-blind Phase|Study Discontinued|0|||
147477421|NCT01050062|531907539|FG000|Overall Study|Adverse Event|75|||
147477422|NCT01050062|531907540|FG001|Overall Study|Adverse Event|22|||
147477423|NCT01050062|531907539|FG000|Overall Study|Lost to Follow-up|83|||
147477424|NCT01050062|531907540|FG001|Overall Study|Lost to Follow-up|35|||
147477425|NCT01050062|531907539|FG000|Overall Study|Lack of Efficacy|22|||
147477426|NCT01050062|531907540|FG001|Overall Study|Lack of Efficacy|35|||
147477427|NCT01050062|531907539|FG000|Overall Study|Physician Decision|74|||
147477428|NCT01050062|531907540|FG001|Overall Study|Physician Decision|9|||
147477429|NCT01050062|531907539|FG000|Overall Study|Others|17|||
147477430|NCT01050062|531907540|FG001|Overall Study|Others|11|||
147477431|NCT01873950|531907543|FG000|Period 5|Withdrawal by Subject|0|||
147477432|NCT01873950|531907544|FG001|Period 5|Withdrawal by Subject|0|||
147477433|NCT01873950|531907545|FG002|Period 5|Withdrawal by Subject|0|||
147477434|NCT01873950|531907546|FG003|Period 5|Withdrawal by Subject|1|||
147477435|NCT01873950|531907547|FG004|Period 5|Withdrawal by Subject|0|||
147477436|NCT03894540|531907548|FG000|Overall Study|Adverse Event|0|||
147477437|NCT03894540|531907549|FG001|Overall Study|Adverse Event|0|||
147477438|NCT03894540|531907550|FG002|Overall Study|Adverse Event|0|||
147477439|NCT03894540|531907551|FG003|Overall Study|Adverse Event|0|||
147477440|NCT03894540|531907552|FG004|Overall Study|Adverse Event|1|||
147477441|NCT03894540|531907553|FG005|Overall Study|Adverse Event|0|||
147477442|NCT03894540|531907548|FG000|Overall Study|Withdrawal by Subject|0|||
147477443|NCT03894540|531907549|FG001|Overall Study|Withdrawal by Subject|0|||
147477444|NCT03894540|531907550|FG002|Overall Study|Withdrawal by Subject|0|||
147477445|NCT03894540|531907551|FG003|Overall Study|Withdrawal by Subject|0|||
147477446|NCT03894540|531907552|FG004|Overall Study|Withdrawal by Subject|1|||
147477447|NCT03894540|531907553|FG005|Overall Study|Withdrawal by Subject|0|||
147477448|NCT03894540|531907548|FG000|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|0|||
147477449|NCT03894540|531907549|FG001|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|0|||
147477450|NCT03894540|531907550|FG002|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|1|||
147477451|NCT03894540|531907551|FG003|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|3|||
147477452|NCT03894540|531907552|FG004|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|2|||
147477453|NCT03894540|531907553|FG005|Overall Study|Progressive Disease Per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1|3|||
147477454|NCT03894540|531907548|FG000|Overall Study|Progressive Disease Clinical|1|||
147477455|NCT03894540|531907549|FG001|Overall Study|Progressive Disease Clinical|1|||
147477456|NCT03894540|531907550|FG002|Overall Study|Progressive Disease Clinical|0|||
147477457|NCT03894540|531907551|FG003|Overall Study|Progressive Disease Clinical|1|||
147477458|NCT03894540|531907552|FG004|Overall Study|Progressive Disease Clinical|5|||
147477459|NCT03894540|531907553|FG005|Overall Study|Progressive Disease Clinical|1|||
147477460|NCT03894540|531907548|FG000|Overall Study|Study termination by sponsor|0|||
147477461|NCT03894540|531907549|FG001|Overall Study|Study termination by sponsor|0|||
147477462|NCT03894540|531907550|FG002|Overall Study|Study termination by sponsor|0|||
147477463|NCT03894540|531907551|FG003|Overall Study|Study termination by sponsor|0|||
147477464|NCT03894540|531907552|FG004|Overall Study|Study termination by sponsor|2|||
147477465|NCT03894540|531907553|FG005|Overall Study|Study termination by sponsor|0|||
147477466|NCT00593112|531907554|FG000|Overall Study|Scan Anxiety|3|||
147477467|NCT00593112|531907555|FG001|Overall Study|Scan Anxiety|0|||
147477468|NCT00593112|531907554|FG000|Overall Study|Abnormal Scan|1|||
147477469|NCT00593112|531907555|FG001|Overall Study|Abnormal Scan|0|||
147477470|NCT00593112|531907554|FG000|Overall Study|Unreadable Scan|1|||
147477471|NCT00593112|531907555|FG001|Overall Study|Unreadable Scan|0|||
147477472|NCT00593112|531907554|FG000|Overall Study|Withdrawal by Subject|5|||
147477473|NCT00593112|531907555|FG001|Overall Study|Withdrawal by Subject|0|||
147477474|NCT03043365|531907556|FG000|Weeks 0 to Week 8|Adverse Event|1|||
147477475|NCT03043365|531907557|FG001|Weeks 0 to Week 8|Adverse Event|3|||
147477476|NCT03043365|531907556|FG000|Weeks 0 to Week 8|Lost to Follow-up|2|||
147477477|NCT03043365|531907557|FG001|Weeks 0 to Week 8|Lost to Follow-up|0|||
147477478|NCT03043365|531907556|FG000|Week 8 to Week 16 - Washout Period|Lost to Follow-up|1|||
147621772|NCT03879135|532433032|FG005|Overall Study|Physician Decision|0|||
147477479|NCT03043365|531907557|FG001|Week 8 to Week 16 - Washout Period|Lost to Follow-up|0|||
147477480|NCT02723630|531907558|FG000|Intervention Period 1|Adverse Event|1|||
147477481|NCT02723630|531907559|FG001|Intervention Period 1|Adverse Event|0|||
147477482|NCT02723630|531907560|FG002|Intervention Period 1|Adverse Event|0|||
147477483|NCT02723630|531907561|FG003|Intervention Period 1|Adverse Event|0|||
147477484|NCT02723630|531907562|FG004|Intervention Period 1|Adverse Event|0|||
147477485|NCT02723630|531907563|FG005|Intervention Period 1|Adverse Event|0|||
147477486|NCT02723630|531907558|FG000|Intervention Period 3|consumption of restricted item|0|||
147477487|NCT02723630|531907559|FG001|Intervention Period 3|consumption of restricted item|1|||
147477488|NCT02723630|531907560|FG002|Intervention Period 3|consumption of restricted item|0|||
147477489|NCT02723630|531907561|FG003|Intervention Period 3|consumption of restricted item|0|||
147477490|NCT02723630|531907562|FG004|Intervention Period 3|consumption of restricted item|0|||
147477491|NCT02723630|531907563|FG005|Intervention Period 3|consumption of restricted item|0|||
147477492|NCT00650585|531907564|FG000|Overall Study|Lost to Follow-up|505|||
147477493|NCT00650585|531907565|FG001|Overall Study|Lost to Follow-up|482|||
147477494|NCT00650585|531907564|FG000|Overall Study|No parental consent|935|||
147477495|NCT00650585|531907565|FG001|Overall Study|No parental consent|866|||
147477496|NCT00650585|531907564|FG000|Overall Study|Excluded/ruled ineligible|357|||
147477497|NCT00650585|531907565|FG001|Overall Study|Excluded/ruled ineligible|129|||
147477498|NCT02532543|531907566|FG000|Overall Study|Lost to Follow-up|0|||
147477499|NCT02532543|531907567|FG001|Overall Study|Lost to Follow-up|0|||
147477500|NCT02532543|531907568|FG002|Overall Study|Lost to Follow-up|1|||
147477501|NCT02532543|531907569|FG003|Overall Study|Lost to Follow-up|0|||
147477502|NCT02640612|531907570|FG000|Overall Study|Adverse Event|6|||
147477503|NCT02640612|531907571|FG001|Overall Study|Adverse Event|7|||
147477504|NCT02640612|531907572|FG002|Overall Study|Adverse Event|2|||
147477505|NCT02640612|531907570|FG000|Overall Study|Death|1|||
147477506|NCT02640612|531907571|FG001|Overall Study|Death|0|||
147477507|NCT02640612|531907572|FG002|Overall Study|Death|0|||
147477508|NCT02640612|531907570|FG000|Overall Study|Withdrawal by Subject|10|||
147477509|NCT02640612|531907571|FG001|Overall Study|Withdrawal by Subject|3|||
147477510|NCT02640612|531907572|FG002|Overall Study|Withdrawal by Subject|3|||
147477511|NCT02640612|531907570|FG000|Overall Study|Lost to Follow-up|4|||
147477512|NCT02640612|531907571|FG001|Overall Study|Lost to Follow-up|1|||
147477513|NCT02640612|531907572|FG002|Overall Study|Lost to Follow-up|1|||
147477514|NCT02640612|531907570|FG000|Overall Study|Protocol Violation|0|||
147477515|NCT02640612|531907571|FG001|Overall Study|Protocol Violation|2|||
147477516|NCT02640612|531907572|FG002|Overall Study|Protocol Violation|0|||
147477517|NCT02640612|531907570|FG000|Overall Study|Lack of Efficacy|1|||
147477518|NCT02640612|531907571|FG001|Overall Study|Lack of Efficacy|1|||
147477519|NCT02640612|531907572|FG002|Overall Study|Lack of Efficacy|0|||
147477520|NCT00923091|531907583|FG000|PeriodI-II (Randomized, Double-Blind)|Adverse Event|11|||
147477521|NCT00923091|531907584|FG001|PeriodI-II (Randomized, Double-Blind)|Adverse Event|3|||
147477522|NCT00923091|531907585|FG002|PeriodI-II (Randomized, Double-Blind)|Adverse Event|7|||
147477523|NCT00923091|531907586|FG003|PeriodI-II (Randomized, Double-Blind)|Adverse Event|13|||
147477524|NCT00923091|531907587|FG004|PeriodI-II (Randomized, Double-Blind)|Adverse Event|10|||
147477525|NCT00923091|531907588|FG005|PeriodI-II (Randomized, Double-Blind)|Adverse Event|5|||
147477526|NCT00923091|531907589|FG006|PeriodI-II (Randomized, Double-Blind)|Adverse Event|9|||
147477527|NCT00923091|531907590|FG007|PeriodI-II (Randomized, Double-Blind)|Adverse Event|17|||
147477528|NCT00923091|531907591|FG008|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0|||
147477529|NCT00923091|531907592|FG009|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0|||
147477530|NCT00923091|531907593|FG010|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0|||
147477531|NCT00923091|531907594|FG011|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0|||
147477532|NCT00923091|531907595|FG012|PeriodI-II (Randomized, Double-Blind)|Adverse Event|0|||
147477533|NCT00923091|531907583|FG000|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|4|||
147477534|NCT00923091|531907584|FG001|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|6|||
147477535|NCT00923091|531907585|FG002|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|5|||
147477536|NCT00923091|531907586|FG003|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|8|||
147621773|NCT03879135|532433027|FG000|Overall Study|Withdrawal by Subject|0|||
147621774|NCT03879135|532433028|FG001|Overall Study|Withdrawal by Subject|0|||
147621775|NCT03879135|532433029|FG002|Overall Study|Withdrawal by Subject|0|||
147621776|NCT03879135|532433030|FG003|Overall Study|Withdrawal by Subject|0|||
147621777|NCT03879135|532433031|FG004|Overall Study|Withdrawal by Subject|0|||
147621778|NCT03879135|532433032|FG005|Overall Study|Withdrawal by Subject|1|||
147621779|NCT03879135|532433027|FG000|Overall Study|Site Closed by Sponsor|0|||
147621780|NCT03879135|532433028|FG001|Overall Study|Site Closed by Sponsor|0|||
147621781|NCT03879135|532433029|FG002|Overall Study|Site Closed by Sponsor|0|||
147621782|NCT03879135|532433030|FG003|Overall Study|Site Closed by Sponsor|1|||
147477537|NCT00923091|531907587|FG004|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|7|||
147477538|NCT00923091|531907588|FG005|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|6|||
147477539|NCT00923091|531907589|FG006|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|5|||
147477540|NCT00923091|531907590|FG007|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|5|||
147477541|NCT00923091|531907591|FG008|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0|||
147477542|NCT00923091|531907592|FG009|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0|||
147477543|NCT00923091|531907593|FG010|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0|||
147477544|NCT00923091|531907594|FG011|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0|||
147477545|NCT00923091|531907595|FG012|PeriodI-II (Randomized, Double-Blind)|Withdrawal by Subject|0|||
147477546|NCT00923091|531907583|FG000|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|1|||
147477547|NCT00923091|531907584|FG001|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|1|||
147477548|NCT00923091|531907585|FG002|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|1|||
147477549|NCT00923091|531907586|FG003|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|5|||
147477550|NCT00923091|531907587|FG004|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|4|||
147477551|NCT00923091|531907588|FG005|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|2|||
147477552|NCT00923091|531907589|FG006|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|4|||
147477553|NCT00923091|531907590|FG007|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|3|||
147477554|NCT00923091|531907591|FG008|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0|||
147477555|NCT00923091|531907592|FG009|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0|||
147477556|NCT00923091|531907593|FG010|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0|||
147477557|NCT00923091|531907594|FG011|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0|||
147477558|NCT00923091|531907595|FG012|PeriodI-II (Randomized, Double-Blind)|Protocol Violation|0|||
147477559|NCT00923091|531907583|FG000|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
147477560|NCT00923091|531907584|FG001|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
147477561|NCT00923091|531907585|FG002|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
147621783|NCT03879135|532433031|FG004|Overall Study|Site Closed by Sponsor|1|||
147621784|NCT03879135|532433032|FG005|Overall Study|Site Closed by Sponsor|0|||
147621785|NCT03985800|532433033|FG000|Overall Study|Death|1|||
147621786|NCT03985800|532433034|FG001|Overall Study|Death|2|||
147621787|NCT03985800|532433033|FG000|Overall Study|Withdrawal by Subject|3|||
147477562|NCT00923091|531907586|FG003|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
147477563|NCT00923091|531907587|FG004|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
147477564|NCT00923091|531907588|FG005|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|1|||
147477565|NCT00923091|531907589|FG006|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
147477566|NCT00923091|531907590|FG007|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
147477567|NCT00923091|531907591|FG008|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
147477568|NCT00923091|531907592|FG009|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
147477569|NCT00923091|531907593|FG010|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
147477570|NCT00923091|531907594|FG011|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
147477571|NCT00923091|531907595|FG012|PeriodI-II (Randomized, Double-Blind)|Lost to Follow-up|0|||
147477572|NCT00923091|531907583|FG000|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
147477573|NCT00923091|531907584|FG001|PeriodI-II (Randomized, Double-Blind)|Other Reason|1|||
147477574|NCT00923091|531907585|FG002|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
147477575|NCT00923091|531907586|FG003|PeriodI-II (Randomized, Double-Blind)|Other Reason|1|||
147477576|NCT00923091|531907587|FG004|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
147477577|NCT00923091|531907588|FG005|PeriodI-II (Randomized, Double-Blind)|Other Reason|1|||
147477578|NCT00923091|531907589|FG006|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
147477579|NCT00923091|531907590|FG007|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
147477580|NCT00923091|531907591|FG008|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
147477581|NCT00923091|531907592|FG009|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
147477582|NCT00923091|531907593|FG010|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
147477583|NCT00923091|531907594|FG011|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
147477584|NCT00923091|531907595|FG012|PeriodI-II (Randomized, Double-Blind)|Other Reason|0|||
147477585|NCT00923091|531907583|FG000|Period III (Single-Blind)|Adverse Event|5|||
147477586|NCT00923091|531907584|FG001|Period III (Single-Blind)|Adverse Event|0|||
147477587|NCT00923091|531907585|FG002|Period III (Single-Blind)|Adverse Event|0|||
147477588|NCT00923091|531907586|FG003|Period III (Single-Blind)|Adverse Event|0|||
147477589|NCT00923091|531907587|FG004|Period III (Single-Blind)|Adverse Event|0|||
147477590|NCT00923091|531907588|FG005|Period III (Single-Blind)|Adverse Event|0|||
147477591|NCT00923091|531907589|FG006|Period III (Single-Blind)|Adverse Event|0|||
147477592|NCT00923091|531907590|FG007|Period III (Single-Blind)|Adverse Event|0|||
147477593|NCT00923091|531907591|FG008|Period III (Single-Blind)|Adverse Event|0|||
147477594|NCT00923091|531907592|FG009|Period III (Single-Blind)|Adverse Event|0|||
147477595|NCT00923091|531907593|FG010|Period III (Single-Blind)|Adverse Event|0|||
147477596|NCT00923091|531907594|FG011|Period III (Single-Blind)|Adverse Event|0|||
147477597|NCT00923091|531907595|FG012|Period III (Single-Blind)|Adverse Event|0|||
147477598|NCT00923091|531907583|FG000|Period III (Single-Blind)|Withdrawal by Subject|10|||
147477599|NCT00923091|531907584|FG001|Period III (Single-Blind)|Withdrawal by Subject|0|||
147477600|NCT00923091|531907585|FG002|Period III (Single-Blind)|Withdrawal by Subject|0|||
147477601|NCT00923091|531907586|FG003|Period III (Single-Blind)|Withdrawal by Subject|0|||
147477602|NCT00923091|531907587|FG004|Period III (Single-Blind)|Withdrawal by Subject|0|||
147477603|NCT00923091|531907588|FG005|Period III (Single-Blind)|Withdrawal by Subject|0|||
147477604|NCT00923091|531907589|FG006|Period III (Single-Blind)|Withdrawal by Subject|0|||
147477605|NCT00923091|531907590|FG007|Period III (Single-Blind)|Withdrawal by Subject|0|||
147477606|NCT00923091|531907591|FG008|Period III (Single-Blind)|Withdrawal by Subject|0|||
147477607|NCT00923091|531907592|FG009|Period III (Single-Blind)|Withdrawal by Subject|0|||
147477608|NCT00923091|531907593|FG010|Period III (Single-Blind)|Withdrawal by Subject|0|||
147477609|NCT00923091|531907594|FG011|Period III (Single-Blind)|Withdrawal by Subject|0|||
147477610|NCT00923091|531907595|FG012|Period III (Single-Blind)|Withdrawal by Subject|0|||
147477611|NCT00923091|531907583|FG000|Period III (Single-Blind)|Protocol Violation|3|||
147477612|NCT00923091|531907584|FG001|Period III (Single-Blind)|Protocol Violation|0|||
147477613|NCT00923091|531907585|FG002|Period III (Single-Blind)|Protocol Violation|0|||
147477614|NCT00923091|531907586|FG003|Period III (Single-Blind)|Protocol Violation|0|||
147477615|NCT00923091|531907587|FG004|Period III (Single-Blind)|Protocol Violation|0|||
147477616|NCT00923091|531907588|FG005|Period III (Single-Blind)|Protocol Violation|0|||
147477617|NCT00923091|531907589|FG006|Period III (Single-Blind)|Protocol Violation|0|||
147477618|NCT00923091|531907590|FG007|Period III (Single-Blind)|Protocol Violation|0|||
147477619|NCT00923091|531907591|FG008|Period III (Single-Blind)|Protocol Violation|0|||
147477620|NCT00923091|531907592|FG009|Period III (Single-Blind)|Protocol Violation|0|||
147477621|NCT00923091|531907593|FG010|Period III (Single-Blind)|Protocol Violation|0|||
147477622|NCT00923091|531907594|FG011|Period III (Single-Blind)|Protocol Violation|0|||
147477623|NCT00923091|531907595|FG012|Period III (Single-Blind)|Protocol Violation|0|||
147477624|NCT00923091|531907583|FG000|Period III (Single-Blind)|Lost to Follow-up|2|||
147477625|NCT00923091|531907584|FG001|Period III (Single-Blind)|Lost to Follow-up|0|||
147477626|NCT00923091|531907585|FG002|Period III (Single-Blind)|Lost to Follow-up|0|||
147477627|NCT00923091|531907586|FG003|Period III (Single-Blind)|Lost to Follow-up|0|||
147477628|NCT00923091|531907587|FG004|Period III (Single-Blind)|Lost to Follow-up|0|||
147477629|NCT00923091|531907588|FG005|Period III (Single-Blind)|Lost to Follow-up|0|||
147477630|NCT00923091|531907589|FG006|Period III (Single-Blind)|Lost to Follow-up|0|||
147477631|NCT00923091|531907590|FG007|Period III (Single-Blind)|Lost to Follow-up|0|||
147477632|NCT00923091|531907591|FG008|Period III (Single-Blind)|Lost to Follow-up|0|||
147477633|NCT00923091|531907592|FG009|Period III (Single-Blind)|Lost to Follow-up|0|||
147477634|NCT00923091|531907593|FG010|Period III (Single-Blind)|Lost to Follow-up|0|||
147477635|NCT00923091|531907594|FG011|Period III (Single-Blind)|Lost to Follow-up|0|||
147477636|NCT00923091|531907595|FG012|Period III (Single-Blind)|Lost to Follow-up|0|||
147477637|NCT00923091|531907583|FG000|Period IV (Double-Blind)|Adverse Event|2|||
147477638|NCT00923091|531907584|FG001|Period IV (Double-Blind)|Adverse Event|0|||
147477639|NCT00923091|531907585|FG002|Period IV (Double-Blind)|Adverse Event|0|||
147477640|NCT00923091|531907586|FG003|Period IV (Double-Blind)|Adverse Event|0|||
147477641|NCT00923091|531907587|FG004|Period IV (Double-Blind)|Adverse Event|0|||
147477642|NCT00923091|531907588|FG005|Period IV (Double-Blind)|Adverse Event|0|||
147477643|NCT00923091|531907589|FG006|Period IV (Double-Blind)|Adverse Event|0|||
147477644|NCT00923091|531907590|FG007|Period IV (Double-Blind)|Adverse Event|0|||
147477645|NCT00923091|531907591|FG008|Period IV (Double-Blind)|Adverse Event|0|||
147477646|NCT00923091|531907592|FG009|Period IV (Double-Blind)|Adverse Event|0|||
147477647|NCT00923091|531907593|FG010|Period IV (Double-Blind)|Adverse Event|0|||
147477648|NCT00923091|531907594|FG011|Period IV (Double-Blind)|Adverse Event|0|||
147477649|NCT00923091|531907595|FG012|Period IV (Double-Blind)|Adverse Event|0|||
147477650|NCT00923091|531907583|FG000|Period IV (Double-Blind)|Withdrawal by Subject|0|||
147477651|NCT00923091|531907584|FG001|Period IV (Double-Blind)|Withdrawal by Subject|1|||
147477652|NCT00923091|531907585|FG002|Period IV (Double-Blind)|Withdrawal by Subject|0|||
147477653|NCT00923091|531907586|FG003|Period IV (Double-Blind)|Withdrawal by Subject|0|||
147477654|NCT00923091|531907587|FG004|Period IV (Double-Blind)|Withdrawal by Subject|0|||
147477655|NCT00923091|531907588|FG005|Period IV (Double-Blind)|Withdrawal by Subject|0|||
147477656|NCT00923091|531907589|FG006|Period IV (Double-Blind)|Withdrawal by Subject|0|||
147477657|NCT00923091|531907590|FG007|Period IV (Double-Blind)|Withdrawal by Subject|0|||
147477658|NCT00923091|531907591|FG008|Period IV (Double-Blind)|Withdrawal by Subject|0|||
147477659|NCT00923091|531907592|FG009|Period IV (Double-Blind)|Withdrawal by Subject|0|||
147477660|NCT00923091|531907593|FG010|Period IV (Double-Blind)|Withdrawal by Subject|0|||
147477661|NCT00923091|531907594|FG011|Period IV (Double-Blind)|Withdrawal by Subject|0|||
147477662|NCT00923091|531907595|FG012|Period IV (Double-Blind)|Withdrawal by Subject|0|||
147477663|NCT00923091|531907583|FG000|Period IV (Double-Blind)|Protocol Violation|0|||
147477664|NCT00923091|531907584|FG001|Period IV (Double-Blind)|Protocol Violation|1|||
147477665|NCT00923091|531907585|FG002|Period IV (Double-Blind)|Protocol Violation|0|||
147477666|NCT00923091|531907586|FG003|Period IV (Double-Blind)|Protocol Violation|0|||
147477667|NCT00923091|531907587|FG004|Period IV (Double-Blind)|Protocol Violation|0|||
147477668|NCT00923091|531907588|FG005|Period IV (Double-Blind)|Protocol Violation|0|||
147477669|NCT00923091|531907589|FG006|Period IV (Double-Blind)|Protocol Violation|0|||
147477670|NCT00923091|531907590|FG007|Period IV (Double-Blind)|Protocol Violation|0|||
147621788|NCT03985800|532433034|FG001|Overall Study|Withdrawal by Subject|6|||
147621789|NCT03985800|532433033|FG000|Overall Study|Protocol Violation|2|||
147621790|NCT03985800|532433034|FG001|Overall Study|Protocol Violation|0|||
147477671|NCT00923091|531907591|FG008|Period IV (Double-Blind)|Protocol Violation|0|||
147667002|NCT00434252|532607930|FG001|Overall Study|Lack of Efficacy|100|||
147477672|NCT00923091|531907592|FG009|Period IV (Double-Blind)|Protocol Violation|0|||
147477673|NCT00923091|531907593|FG010|Period IV (Double-Blind)|Protocol Violation|0|||
147477674|NCT00923091|531907594|FG011|Period IV (Double-Blind)|Protocol Violation|0|||
147477675|NCT00923091|531907595|FG012|Period IV (Double-Blind)|Protocol Violation|0|||
147477676|NCT00923091|531907583|FG000|Period V (Double -Blind)|Withdrawal by Subject|0|||
147477677|NCT00923091|531907584|FG001|Period V (Double -Blind)|Withdrawal by Subject|0|||
147477678|NCT00923091|531907585|FG002|Period V (Double -Blind)|Withdrawal by Subject|0|||
147477679|NCT00923091|531907586|FG003|Period V (Double -Blind)|Withdrawal by Subject|0|||
147477680|NCT00923091|531907587|FG004|Period V (Double -Blind)|Withdrawal by Subject|0|||
147477681|NCT00923091|531907588|FG005|Period V (Double -Blind)|Withdrawal by Subject|0|||
147477682|NCT00923091|531907589|FG006|Period V (Double -Blind)|Withdrawal by Subject|0|||
147477683|NCT00923091|531907590|FG007|Period V (Double -Blind)|Withdrawal by Subject|0|||
147477684|NCT00923091|531907591|FG008|Period V (Double -Blind)|Withdrawal by Subject|1|||
147477685|NCT00923091|531907592|FG009|Period V (Double -Blind)|Withdrawal by Subject|0|||
147477686|NCT00923091|531907593|FG010|Period V (Double -Blind)|Withdrawal by Subject|0|||
147477687|NCT00923091|531907594|FG011|Period V (Double -Blind)|Withdrawal by Subject|0|||
147477688|NCT00923091|531907595|FG012|Period V (Double -Blind)|Withdrawal by Subject|1|||
147477689|NCT00923091|531907583|FG000|Period V (Double -Blind)|Protocol Violation|0|||
147477690|NCT00923091|531907584|FG001|Period V (Double -Blind)|Protocol Violation|0|||
147477691|NCT00923091|531907585|FG002|Period V (Double -Blind)|Protocol Violation|0|||
147477692|NCT00923091|531907586|FG003|Period V (Double -Blind)|Protocol Violation|0|||
147477693|NCT00923091|531907587|FG004|Period V (Double -Blind)|Protocol Violation|0|||
147477694|NCT00923091|531907588|FG005|Period V (Double -Blind)|Protocol Violation|0|||
147477695|NCT00923091|531907589|FG006|Period V (Double -Blind)|Protocol Violation|0|||
147477696|NCT00923091|531907590|FG007|Period V (Double -Blind)|Protocol Violation|0|||
147477697|NCT00923091|531907591|FG008|Period V (Double -Blind)|Protocol Violation|0|||
147477698|NCT00923091|531907592|FG009|Period V (Double -Blind)|Protocol Violation|0|||
147477699|NCT00923091|531907593|FG010|Period V (Double -Blind)|Protocol Violation|0|||
147477700|NCT00923091|531907594|FG011|Period V (Double -Blind)|Protocol Violation|0|||
147477701|NCT00923091|531907595|FG012|Period V (Double -Blind)|Protocol Violation|1|||
147477702|NCT00923091|531907583|FG000|Period V (Double -Blind)|Lost to Follow-up|0|||
147477703|NCT00923091|531907584|FG001|Period V (Double -Blind)|Lost to Follow-up|0|||
147477704|NCT00923091|531907585|FG002|Period V (Double -Blind)|Lost to Follow-up|0|||
147477705|NCT00923091|531907586|FG003|Period V (Double -Blind)|Lost to Follow-up|0|||
147477706|NCT00923091|531907587|FG004|Period V (Double -Blind)|Lost to Follow-up|0|||
147477707|NCT00923091|531907588|FG005|Period V (Double -Blind)|Lost to Follow-up|0|||
147477708|NCT00923091|531907589|FG006|Period V (Double -Blind)|Lost to Follow-up|0|||
147477709|NCT00923091|531907590|FG007|Period V (Double -Blind)|Lost to Follow-up|0|||
147477710|NCT00923091|531907591|FG008|Period V (Double -Blind)|Lost to Follow-up|0|||
147477711|NCT00923091|531907592|FG009|Period V (Double -Blind)|Lost to Follow-up|0|||
147477712|NCT00923091|531907593|FG010|Period V (Double -Blind)|Lost to Follow-up|1|||
147477713|NCT00923091|531907594|FG011|Period V (Double -Blind)|Lost to Follow-up|0|||
147477714|NCT00923091|531907595|FG012|Period V (Double -Blind)|Lost to Follow-up|0|||
147477715|NCT00923091|531907583|FG000|Period VI (Open-Label)|Adverse Event|17|||
147477716|NCT00923091|531907584|FG001|Period VI (Open-Label)|Adverse Event|0|||
147477717|NCT00923091|531907585|FG002|Period VI (Open-Label)|Adverse Event|4|||
147477718|NCT00923091|531907586|FG003|Period VI (Open-Label)|Adverse Event|1|||
147477719|NCT00923091|531907587|FG004|Period VI (Open-Label)|Adverse Event|1|||
147477720|NCT00923091|531907588|FG005|Period VI (Open-Label)|Adverse Event|0|||
147477721|NCT00923091|531907589|FG006|Period VI (Open-Label)|Adverse Event|0|||
147477722|NCT00923091|531907590|FG007|Period VI (Open-Label)|Adverse Event|0|||
147477723|NCT00923091|531907591|FG008|Period VI (Open-Label)|Adverse Event|0|||
147477724|NCT00923091|531907592|FG009|Period VI (Open-Label)|Adverse Event|0|||
147477725|NCT00923091|531907593|FG010|Period VI (Open-Label)|Adverse Event|0|||
147477726|NCT00923091|531907594|FG011|Period VI (Open-Label)|Adverse Event|0|||
147477727|NCT00923091|531907595|FG012|Period VI (Open-Label)|Adverse Event|0|||
147477728|NCT00923091|531907583|FG000|Period VI (Open-Label)|Withdrawal by Subject|15|||
147477729|NCT00923091|531907584|FG001|Period VI (Open-Label)|Withdrawal by Subject|7|||
147477730|NCT00923091|531907585|FG002|Period VI (Open-Label)|Withdrawal by Subject|5|||
147477731|NCT00923091|531907586|FG003|Period VI (Open-Label)|Withdrawal by Subject|0|||
147477732|NCT00923091|531907587|FG004|Period VI (Open-Label)|Withdrawal by Subject|1|||
147477733|NCT00923091|531907588|FG005|Period VI (Open-Label)|Withdrawal by Subject|0|||
147477734|NCT00923091|531907589|FG006|Period VI (Open-Label)|Withdrawal by Subject|0|||
147477735|NCT00923091|531907590|FG007|Period VI (Open-Label)|Withdrawal by Subject|0|||
147477736|NCT00923091|531907591|FG008|Period VI (Open-Label)|Withdrawal by Subject|0|||
147477737|NCT00923091|531907592|FG009|Period VI (Open-Label)|Withdrawal by Subject|0|||
147477738|NCT00923091|531907593|FG010|Period VI (Open-Label)|Withdrawal by Subject|0|||
147477739|NCT00923091|531907594|FG011|Period VI (Open-Label)|Withdrawal by Subject|0|||
147477740|NCT00923091|531907595|FG012|Period VI (Open-Label)|Withdrawal by Subject|0|||
147477741|NCT00923091|531907583|FG000|Period VI (Open-Label)|Protocol Violation|6|||
147477742|NCT00923091|531907584|FG001|Period VI (Open-Label)|Protocol Violation|1|||
147477743|NCT00923091|531907585|FG002|Period VI (Open-Label)|Protocol Violation|3|||
147477744|NCT00923091|531907586|FG003|Period VI (Open-Label)|Protocol Violation|1|||
147477745|NCT00923091|531907587|FG004|Period VI (Open-Label)|Protocol Violation|4|||
147477746|NCT00923091|531907588|FG005|Period VI (Open-Label)|Protocol Violation|0|||
147477747|NCT00923091|531907589|FG006|Period VI (Open-Label)|Protocol Violation|0|||
147477748|NCT00923091|531907590|FG007|Period VI (Open-Label)|Protocol Violation|0|||
147477749|NCT00923091|531907591|FG008|Period VI (Open-Label)|Protocol Violation|0|||
147477750|NCT00923091|531907592|FG009|Period VI (Open-Label)|Protocol Violation|0|||
147477751|NCT00923091|531907593|FG010|Period VI (Open-Label)|Protocol Violation|0|||
147477752|NCT00923091|531907594|FG011|Period VI (Open-Label)|Protocol Violation|0|||
147477753|NCT00923091|531907595|FG012|Period VI (Open-Label)|Protocol Violation|0|||
147477754|NCT00923091|531907583|FG000|Period VI (Open-Label)|Lost to Follow-up|1|||
147477755|NCT00923091|531907584|FG001|Period VI (Open-Label)|Lost to Follow-up|0|||
147477756|NCT00923091|531907585|FG002|Period VI (Open-Label)|Lost to Follow-up|1|||
147477757|NCT00923091|531907586|FG003|Period VI (Open-Label)|Lost to Follow-up|0|||
147477758|NCT00923091|531907587|FG004|Period VI (Open-Label)|Lost to Follow-up|0|||
147477759|NCT00923091|531907588|FG005|Period VI (Open-Label)|Lost to Follow-up|0|||
147477760|NCT00923091|531907589|FG006|Period VI (Open-Label)|Lost to Follow-up|0|||
147477761|NCT00923091|531907590|FG007|Period VI (Open-Label)|Lost to Follow-up|0|||
147477762|NCT00923091|531907591|FG008|Period VI (Open-Label)|Lost to Follow-up|0|||
147477763|NCT00923091|531907592|FG009|Period VI (Open-Label)|Lost to Follow-up|0|||
147477764|NCT00923091|531907593|FG010|Period VI (Open-Label)|Lost to Follow-up|0|||
147477765|NCT00923091|531907594|FG011|Period VI (Open-Label)|Lost to Follow-up|0|||
147477766|NCT00923091|531907595|FG012|Period VI (Open-Label)|Lost to Follow-up|0|||
147477767|NCT00923091|531907583|FG000|Period VI (Open-Label)|Other Reason|0|||
147477768|NCT00923091|531907584|FG001|Period VI (Open-Label)|Other Reason|0|||
147477769|NCT00923091|531907585|FG002|Period VI (Open-Label)|Other Reason|0|||
147477770|NCT00923091|531907586|FG003|Period VI (Open-Label)|Other Reason|1|||
147477771|NCT00923091|531907587|FG004|Period VI (Open-Label)|Other Reason|1|||
147477772|NCT00923091|531907588|FG005|Period VI (Open-Label)|Other Reason|0|||
147477773|NCT00923091|531907589|FG006|Period VI (Open-Label)|Other Reason|0|||
147477774|NCT00923091|531907590|FG007|Period VI (Open-Label)|Other Reason|0|||
147477775|NCT00923091|531907591|FG008|Period VI (Open-Label)|Other Reason|0|||
147477776|NCT00923091|531907592|FG009|Period VI (Open-Label)|Other Reason|0|||
147477777|NCT00923091|531907593|FG010|Period VI (Open-Label)|Other Reason|0|||
147477778|NCT00923091|531907594|FG011|Period VI (Open-Label)|Other Reason|0|||
147477779|NCT00923091|531907595|FG012|Period VI (Open-Label)|Other Reason|0|||
147477780|NCT02460822|531907598|FG000|Overall Study|Withdrawal by Subject|1|||
147477781|NCT00467649|531907599|FG000|Phase 1 (Randomized Population)|Adverse Event|2|||
147477782|NCT00467649|531907600|FG001|Phase 1 (Randomized Population)|Adverse Event|0|||
147477783|NCT00467649|531907601|FG002|Phase 1 (Randomized Population)|Adverse Event|0|||
147477784|NCT00467649|531907602|FG003|Phase 1 (Randomized Population)|Adverse Event|0|||
147477785|NCT00467649|531907603|FG004|Phase 1 (Randomized Population)|Adverse Event|0|||
147477786|NCT00467649|531907604|FG005|Phase 1 (Randomized Population)|Adverse Event|0|||
147477787|NCT00467649|531907599|FG000|Phase 1 (Randomized Population)|Investigator Decision|1|||
147477788|NCT00467649|531907600|FG001|Phase 1 (Randomized Population)|Investigator Decision|0|||
147477789|NCT00467649|531907601|FG002|Phase 1 (Randomized Population)|Investigator Decision|0|||
147477790|NCT00467649|531907602|FG003|Phase 1 (Randomized Population)|Investigator Decision|0|||
147477791|NCT00467649|531907603|FG004|Phase 1 (Randomized Population)|Investigator Decision|0|||
147477792|NCT00467649|531907604|FG005|Phase 1 (Randomized Population)|Investigator Decision|0|||
147477793|NCT00467649|531907599|FG000|Phase 1 (Randomized Population)|Lost to Follow-up|2|||
147477794|NCT00467649|531907600|FG001|Phase 1 (Randomized Population)|Lost to Follow-up|4|||
147477795|NCT00467649|531907601|FG002|Phase 1 (Randomized Population)|Lost to Follow-up|0|||
147477796|NCT00467649|531907602|FG003|Phase 1 (Randomized Population)|Lost to Follow-up|0|||
147477797|NCT00467649|531907603|FG004|Phase 1 (Randomized Population)|Lost to Follow-up|0|||
147477798|NCT00467649|531907604|FG005|Phase 1 (Randomized Population)|Lost to Follow-up|0|||
147477799|NCT00467649|531907599|FG000|Phase 1 (Randomized Population)|Withdrawal of Consent|4|||
147477800|NCT00467649|531907600|FG001|Phase 1 (Randomized Population)|Withdrawal of Consent|2|||
147477801|NCT00467649|531907601|FG002|Phase 1 (Randomized Population)|Withdrawal of Consent|0|||
147477802|NCT00467649|531907602|FG003|Phase 1 (Randomized Population)|Withdrawal of Consent|0|||
147477803|NCT00467649|531907603|FG004|Phase 1 (Randomized Population)|Withdrawal of Consent|0|||
147477804|NCT00467649|531907604|FG005|Phase 1 (Randomized Population)|Withdrawal of Consent|0|||
147477805|NCT00467649|531907599|FG000|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0|||
147477806|NCT00467649|531907600|FG001|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0|||
147477807|NCT00467649|531907601|FG002|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0|||
147477808|NCT00467649|531907602|FG003|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|1|||
147477809|NCT00467649|531907603|FG004|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0|||
147477810|NCT00467649|531907604|FG005|Phase 2 (Intent-to-Treat Population)|Lost to Follow-up|0|||
147477811|NCT00467649|531907599|FG000|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0|||
147477812|NCT00467649|531907600|FG001|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0|||
147477813|NCT00467649|531907601|FG002|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0|||
147477814|NCT00467649|531907602|FG003|Phase 2 (Intent-to-Treat Population)|Protocol Violation|1|||
147477815|NCT00467649|531907603|FG004|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0|||
147477816|NCT00467649|531907604|FG005|Phase 2 (Intent-to-Treat Population)|Protocol Violation|0|||
147477817|NCT00467649|531907599|FG000|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0|||
147477818|NCT00467649|531907600|FG001|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0|||
147477819|NCT00467649|531907601|FG002|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0|||
147477820|NCT00467649|531907602|FG003|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0|||
147477821|NCT00467649|531907603|FG004|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|0|||
147477822|NCT00467649|531907604|FG005|Phase 2 (Intent-to-Treat Population)|Withdrawal of Consent|1|||
147477823|NCT03240081|531907605|FG000|Overall Study|Withdrawal by Subject|0|||
147477824|NCT03240081|531907606|FG001|Overall Study|Withdrawal by Subject|2|||
147477825|NCT03240081|531907605|FG000|Overall Study|Lost to Follow-up|0|||
147477826|NCT03240081|531907606|FG001|Overall Study|Lost to Follow-up|1|||
147477827|NCT04925570|531907611|FG000|Overall Study|Protocol Violation|24|||
147477828|NCT04925570|531907612|FG001|Overall Study|Protocol Violation|30|||
147477829|NCT04925570|531907611|FG000|Overall Study|Withdrawal by Subject|0|||
147477830|NCT04925570|531907612|FG001|Overall Study|Withdrawal by Subject|2|||
147477831|NCT05897853|531907613|FG000|Overall Study|Lost to Follow-up|2|||
147477832|NCT05897853|531907614|FG001|Overall Study|Lost to Follow-up|0|||
147477833|NCT05897853|531907613|FG000|Overall Study|Diagnostic criteria not met at baseline|0|||
147477834|NCT05897853|531907614|FG001|Overall Study|Diagnostic criteria not met at baseline|8|||
147477835|NCT04458857|531907621|FG000|Overall Study|Adverse Event|0|||
147477836|NCT04458857|531907622|FG001|Overall Study|Adverse Event|1|||
147477837|NCT04458857|531907623|FG002|Overall Study|Adverse Event|0|||
147477838|NCT04458857|531907621|FG000|Overall Study|Withdrawal by Subject|2|||
147477839|NCT04458857|531907622|FG001|Overall Study|Withdrawal by Subject|0|||
147477840|NCT04458857|531907623|FG002|Overall Study|Withdrawal by Subject|0|||
147477841|NCT04458857|531907621|FG000|Overall Study|Withdrawal by parent/guardian|0|||
147477842|NCT04458857|531907622|FG001|Overall Study|Withdrawal by parent/guardian|0|||
147477843|NCT04458857|531907623|FG002|Overall Study|Withdrawal by parent/guardian|1|||
147477844|NCT04458857|531907621|FG000|Overall Study|Non-compliance with study drug|0|||
147477845|NCT04458857|531907622|FG001|Overall Study|Non-compliance with study drug|1|||
147477846|NCT04458857|531907623|FG002|Overall Study|Non-compliance with study drug|0|||
147477847|NCT04458857|531907621|FG000|Overall Study|Lost to Follow-up|4|||
147477848|NCT04458857|531907622|FG001|Overall Study|Lost to Follow-up|1|||
147477849|NCT04458857|531907623|FG002|Overall Study|Lost to Follow-up|0|||
147477850|NCT04800315|531907625|FG000|Randomization|Did not receive study treatment|1|||
147477851|NCT04800315|531907626|FG001|Randomization|Did not receive study treatment|0|||
147477852|NCT04800315|531907627|FG002|Randomization|Did not receive study treatment|0|||
147477853|NCT04800315|531907628|FG003|Randomization|Did not receive study treatment|0|||
147477854|NCT04800315|531907625|FG000|Treatment Period|Adverse Event|4|||
147477855|NCT04800315|531907626|FG001|Treatment Period|Adverse Event|2|||
147477856|NCT04800315|531907627|FG002|Treatment Period|Adverse Event|1|||
147477857|NCT04800315|531907628|FG003|Treatment Period|Adverse Event|2|||
147477858|NCT04800315|531907625|FG000|Treatment Period|Lack of Efficacy|1|||
147477859|NCT04800315|531907626|FG001|Treatment Period|Lack of Efficacy|0|||
147477860|NCT04800315|531907627|FG002|Treatment Period|Lack of Efficacy|0|||
147477861|NCT04800315|531907628|FG003|Treatment Period|Lack of Efficacy|3|||
147477862|NCT04800315|531907625|FG000|Treatment Period|Lost to Follow-up|0|||
147477863|NCT04800315|531907626|FG001|Treatment Period|Lost to Follow-up|1|||
147477864|NCT04800315|531907627|FG002|Treatment Period|Lost to Follow-up|2|||
147477865|NCT04800315|531907628|FG003|Treatment Period|Lost to Follow-up|2|||
147477866|NCT04800315|531907625|FG000|Treatment Period|Withdrawal by participant|0|||
147477867|NCT04800315|531907626|FG001|Treatment Period|Withdrawal by participant|0|||
147477868|NCT04800315|531907627|FG002|Treatment Period|Withdrawal by participant|0|||
147477869|NCT04800315|531907628|FG003|Treatment Period|Withdrawal by participant|4|||
147621791|NCT06025721|532433037|FG000|Overall Study|Physician Decision|1|||
147621792|NCT06025721|532433037|FG000|Overall Study|Protocol Violation|1|||
147621793|NCT06025721|532433037|FG000|Overall Study|Incarceration|1|||
147621794|NCT04173507|532433038|FG000|Overall Study|On Treatment|3|||
147477870|NCT04800315|531907625|FG000|Treatment Period|Other Reasons|0|||
147477871|NCT04800315|531907626|FG001|Treatment Period|Other Reasons|2|||
147477872|NCT04800315|531907627|FG002|Treatment Period|Other Reasons|0|||
147621795|NCT04173507|532433038|FG000|Overall Study|Adverse Event|3|||
147621796|NCT04173507|532433038|FG000|Overall Study|Progression/Relapse|34|||
147621797|NCT04173507|532433038|FG000|Overall Study|Death|2|||
147477873|NCT04800315|531907628|FG003|Treatment Period|Other Reasons|1|||
147477874|NCT00753922|531907629|FG000|Overall Study|Lost to Follow-up|155|||
147477875|NCT00753922|531907630|FG001|Overall Study|Lost to Follow-up|24|||
147477876|NCT00753922|531907631|FG002|Overall Study|Lost to Follow-up|28|||
147477877|NCT00753922|531907632|FG003|Overall Study|Lost to Follow-up|5|||
147477878|NCT00753922|531907629|FG000|Overall Study|Withdrawal by Subject|9|||
147477879|NCT00753922|531907630|FG001|Overall Study|Withdrawal by Subject|11|||
147621798|NCT02832687|532433039|FG000|Overall Study|Adverse Event|0|||
147477880|NCT00753922|531907631|FG002|Overall Study|Withdrawal by Subject|4|||
147477881|NCT00753922|531907632|FG003|Overall Study|Withdrawal by Subject|2|||
147477882|NCT00753922|531907629|FG000|Overall Study|Patient Non-compliance|55|||
147477883|NCT00753922|531907630|FG001|Overall Study|Patient Non-compliance|22|||
147477884|NCT00753922|531907631|FG002|Overall Study|Patient Non-compliance|14|||
147477885|NCT00753922|531907632|FG003|Overall Study|Patient Non-compliance|11|||
147477886|NCT00753922|531907629|FG000|Overall Study|Patients Not Completing Visit|11|||
147477887|NCT00753922|531907630|FG001|Overall Study|Patients Not Completing Visit|0|||
147477888|NCT00753922|531907631|FG002|Overall Study|Patients Not Completing Visit|1|||
147477889|NCT00753922|531907632|FG003|Overall Study|Patients Not Completing Visit|0|||
147477890|NCT00753922|531907629|FG000|Overall Study|Death|2|||
147477891|NCT00753922|531907630|FG001|Overall Study|Death|23|||
147477892|NCT00753922|531907631|FG002|Overall Study|Death|2|||
147477893|NCT00753922|531907632|FG003|Overall Study|Death|1|||
147477894|NCT00753922|531907629|FG000|Overall Study|Discontinuation Due to Explantation|14|||
147477895|NCT00753922|531907630|FG001|Overall Study|Discontinuation Due to Explantation|14|||
147477896|NCT00753922|531907631|FG002|Overall Study|Discontinuation Due to Explantation|14|||
147477897|NCT00753922|531907632|FG003|Overall Study|Discontinuation Due to Explantation|4|||
147477898|NCT00196937|531907633|FG000|Overall Study|Serious Adverse Event|1|||
147477899|NCT00196937|531907634|FG001|Overall Study|Serious Adverse Event|0|||
147477900|NCT00196937|531907635|FG002|Overall Study|Serious Adverse Event|0|||
147477901|NCT00196937|531907633|FG000|Overall Study|Non-serious adverse event|1|||
147477902|NCT00196937|531907634|FG001|Overall Study|Non-serious adverse event|1|||
147477903|NCT00196937|531907635|FG002|Overall Study|Non-serious adverse event|1|||
147477904|NCT00196937|531907633|FG000|Overall Study|Withdrawal by Subject|0|||
147477905|NCT00196937|531907634|FG001|Overall Study|Withdrawal by Subject|0|||
147477906|NCT00196937|531907635|FG002|Overall Study|Withdrawal by Subject|2|||
147477907|NCT00196937|531907633|FG000|Overall Study|Lost to Follow-up|4|||
147477908|NCT00196937|531907634|FG001|Overall Study|Lost to Follow-up|3|||
147477909|NCT00196937|531907635|FG002|Overall Study|Lost to Follow-up|3|||
147477910|NCT00196937|531907633|FG000|Overall Study|Other|3|||
147477911|NCT00196937|531907634|FG001|Overall Study|Other|1|||
147477912|NCT00196937|531907635|FG002|Overall Study|Other|1|||
147477913|NCT03368404|531907643|FG000|Overall Study|Adverse Event|2|||
147477914|NCT03368404|531907644|FG001|Overall Study|Adverse Event|1|||
147477915|NCT03368404|531907643|FG000|Overall Study|Withdrawal by Subject|1|||
147477916|NCT03368404|531907644|FG001|Overall Study|Withdrawal by Subject|1|||
147477917|NCT02983292|531907645|FG000|Overall Study|Participant unwell & cannot travel|2|||
147477918|NCT02983292|531907645|FG000|Overall Study|Lost to Follow-up|3|||
147477919|NCT02983292|531907645|FG000|Overall Study|Participant withdrew consent|2|||
147477920|NCT02983292|531907645|FG000|Overall Study|Revision|7|||
147477921|NCT02983292|531907645|FG000|Overall Study|Death|1|||
147477922|NCT02983292|531907645|FG000|Overall Study|Participant did not return due to COVID-19 related lockdown|30|||
147477923|NCT02983292|531907645|FG000|Overall Study|Participant failed to return for follow-up visits|6|||
147477924|NCT02983292|531907645|FG000|Overall Study|Participant relocation|1|||
147477925|NCT00586690|531907650|FG000|Overall Study|Death|2|||
147477926|NCT00586690|531907651|FG001|Overall Study|Death|0|||
147477927|NCT00586690|531907650|FG000|Overall Study|Disease Progression|10|||
147477928|NCT00586690|531907651|FG001|Overall Study|Disease Progression|0|||
147477929|NCT00586690|531907650|FG000|Overall Study|Adverse Event|1|||
147477930|NCT00586690|531907651|FG001|Overall Study|Adverse Event|0|||
147477931|NCT00586690|531907650|FG000|Overall Study|Lack of Efficacy|2|||
147477932|NCT00586690|531907651|FG001|Overall Study|Lack of Efficacy|0|||
147477933|NCT00586690|531907650|FG000|Overall Study|Lab can't accommodate|1|||
147477934|NCT00586690|531907651|FG001|Overall Study|Lab can't accommodate|0|||
147477935|NCT01751646|531907652|FG000|Overall Study|Lost to Follow-up|5|||
147477936|NCT01751646|531907653|FG001|Overall Study|Lost to Follow-up|1|||
147477937|NCT01751646|531907652|FG000|Overall Study|Withdrawal by Subject|0|||
147477938|NCT01751646|531907653|FG001|Overall Study|Withdrawal by Subject|4|||
147477939|NCT01751646|531907652|FG000|Overall Study|Starting hormone therapy|1|||
147477940|NCT01751646|531907653|FG001|Overall Study|Starting hormone therapy|0|||
147477941|NCT01751646|531907652|FG000|Overall Study|Missed 4 or more consecutive DOT visits|2|||
147477942|NCT01751646|531907653|FG001|Overall Study|Missed 4 or more consecutive DOT visits|3|||
147477943|NCT01751646|531907652|FG000|Overall Study|Inadvertent enrollment|1|||
147621799|NCT02832687|532433040|FG001|Overall Study|Adverse Event|2|||
147621800|NCT00210210|532433041|FG000|Overall Study|Withdrawal by Subject|3|||
147621801|NCT00210210|532433042|FG001|Overall Study|Withdrawal by Subject|2|||
147477944|NCT01751646|531907653|FG001|Overall Study|Inadvertent enrollment|1|||
147477945|NCT01751646|531907652|FG000|Overall Study|Moved out of the area|1|||
147477946|NCT01751646|531907653|FG001|Overall Study|Moved out of the area|5|||
147477947|NCT01751646|531907652|FG000|Overall Study|Inability to attend required visits|0|||
147477948|NCT01751646|531907653|FG001|Overall Study|Inability to attend required visits|1|||
147621802|NCT00210210|532433041|FG000|Overall Study|absence of lymph node dissection after intraoperative frozen section of the specimen|3|||
147621803|NCT00210210|532433042|FG001|Overall Study|absence of lymph node dissection after intraoperative frozen section of the specimen|9|||
147477949|NCT01751646|531907652|FG000|Overall Study|Off study due to multiple obligations|0|||
147477950|NCT01751646|531907653|FG001|Overall Study|Off study due to multiple obligations|1|||
147477951|NCT01751646|531907652|FG000|Overall Study|Fails to comply with study requirements|0|||
147477952|NCT01751646|531907653|FG001|Overall Study|Fails to comply with study requirements|1|||
147477953|NCT01751646|531907652|FG000|Overall Study|Childcare issues|1|||
147477954|NCT01751646|531907653|FG001|Overall Study|Childcare issues|1|||
147477955|NCT02190591|531907654|FG000|Overall Study|Withdrawal by Subject|1|||
147477956|NCT02190591|531907655|FG001|Overall Study|Withdrawal by Subject|8|||
147477957|NCT02190591|531907654|FG000|Overall Study|Protocol Violation|1|||
147477958|NCT02190591|531907655|FG001|Overall Study|Protocol Violation|0|||
147477959|NCT02190591|531907654|FG000|Overall Study|did not use peanut ball as instructed|0|||
147477960|NCT02190591|531907655|FG001|Overall Study|did not use peanut ball as instructed|2|||
147477961|NCT02190591|531907654|FG000|Overall Study|face presentation so she was ineligible|0|||
147477962|NCT02190591|531907655|FG001|Overall Study|face presentation so she was ineligible|1|||
147477963|NCT03022422|531907656|FG000|Overall Study|3 subjects consented but not vaccinated|0|||
147477964|NCT03022422|531907657|FG001|Overall Study|3 subjects consented but not vaccinated|0|||
147477965|NCT03022422|531907658|FG002|Overall Study|3 subjects consented but not vaccinated|3|||
147477966|NCT03022422|531907659|FG003|Overall Study|3 subjects consented but not vaccinated|0|||
147477967|NCT03022422|531907660|FG004|Overall Study|3 subjects consented but not vaccinated|0|||
147477968|NCT03022422|531907661|FG005|Overall Study|3 subjects consented but not vaccinated|0|||
147477969|NCT01282814|531907662|FG000|First Intervention|Emesis During Dosing Interval|0|||
147477970|NCT01282814|531907663|FG001|First Intervention|Emesis During Dosing Interval|3|||
147477971|NCT01282814|531907662|FG000|Washout of 7 Days|Withdrawal by Subject|2|||
147477972|NCT01282814|531907663|FG001|Washout of 7 Days|Withdrawal by Subject|0|||
147477973|NCT02403206|531907664|FG000|Overall Study|Lost to Follow-up|4|||
147477974|NCT02403206|531907665|FG001|Overall Study|Lost to Follow-up|3|||
147477975|NCT02403206|531907664|FG000|Overall Study|Physician Decision|2|||
147477976|NCT02403206|531907665|FG001|Overall Study|Physician Decision|0|||
147477977|NCT02403206|531907664|FG000|Overall Study|Withdrawal by Subject|3|||
147477978|NCT02403206|531907665|FG001|Overall Study|Withdrawal by Subject|3|||
147477979|NCT02403206|531907664|FG000|Overall Study|Reason not given|2|||
147477980|NCT02403206|531907665|FG001|Overall Study|Reason not given|4|||
147477981|NCT01524289|531907666|FG000|Overall Study|Lost to Follow-up|0|||
147477982|NCT01524289|531907667|FG001|Overall Study|Lost to Follow-up|1|||
147477983|NCT01524289|531907666|FG000|Overall Study|Physician Decision|1|||
147477984|NCT01524289|531907667|FG001|Overall Study|Physician Decision|0|||
147477985|NCT01524289|531907666|FG000|Overall Study|Protocol Violation|5|||
147477986|NCT01524289|531907667|FG001|Overall Study|Protocol Violation|1|||
147477987|NCT01524289|531907666|FG000|Overall Study|Withdrawal by Subject|11|||
147477988|NCT01524289|531907667|FG001|Overall Study|Withdrawal by Subject|7|||
147477989|NCT01524289|531907666|FG000|Overall Study|Adverse Event|12|||
147477990|NCT01524289|531907667|FG001|Overall Study|Adverse Event|5|||
147477991|NCT01524289|531907666|FG000|Overall Study|Did not take study medication|1|||
147621804|NCT04231825|532433043|FG000|Overall Study|Protocol Violation|3|||
147621805|NCT04231825|532433044|FG001|Overall Study|Protocol Violation|3|||
147621806|NCT04231825|532433043|FG000|Overall Study|Lost to Follow-up|0|||
147621807|NCT04231825|532433044|FG001|Overall Study|Lost to Follow-up|1|||
147621808|NCT01662635|532433045|FG000|Overall Study|scarce samples for evaluation|30|||
147621809|NCT03428152|532433048|FG000|Overall Study|Physician Decision|4|||
147621810|NCT03428152|532433049|FG001|Overall Study|Physician Decision|2|||
147621811|NCT03428152|532433048|FG000|Overall Study|Protocol Violation|3|||
147621812|NCT03428152|532433049|FG001|Overall Study|Protocol Violation|5|||
147621813|NCT03428152|532433048|FG000|Overall Study|Lack of Efficacy|0|||
147621814|NCT03428152|532433049|FG001|Overall Study|Lack of Efficacy|4|||
147621815|NCT01836471|532433056|FG000|Overall Study|Pregnancy|1|||
147477992|NCT01524289|531907667|FG001|Overall Study|Did not take study medication|0|||
147477993|NCT01676116|531907668|FG000|Overall Study|Withdrawal criteria|2|||
147477994|NCT01676116|531907669|FG001|Overall Study|Withdrawal criteria|14|||
147621816|NCT01836471|532433057|FG001|Overall Study|Pregnancy|0|||
147621817|NCT01836471|532433058|FG002|Overall Study|Pregnancy|0|||
147621818|NCT01836471|532433059|FG003|Overall Study|Pregnancy|0|||
147621819|NCT01836471|532433060|FG004|Overall Study|Pregnancy|0|||
147621820|NCT01836471|532433056|FG000|Overall Study|Withdrawal by Subject|3|||
147621821|NCT01836471|532433057|FG001|Overall Study|Withdrawal by Subject|4|||
147477995|NCT01676116|531907668|FG000|Overall Study|Adverse Event|1|||
147477996|NCT01676116|531907669|FG001|Overall Study|Adverse Event|2|||
147477997|NCT01676116|531907668|FG000|Overall Study|Unclassified|4|||
147477998|NCT01676116|531907669|FG001|Overall Study|Unclassified|10|||
147621822|NCT01836471|532433058|FG002|Overall Study|Withdrawal by Subject|1|||
147303199|NCT04382924|531276268|FG000|Overall Study|Protocol Violation|0|||
147477999|NCT01676116|531907668|FG000|Overall Study|Protocol Violation|9|||
147478000|NCT01676116|531907669|FG001|Overall Study|Protocol Violation|3|||
147478001|NCT01821677|531907676|FG000|Overall Study|Adverse Event|4|||
147478002|NCT01821677|531907677|FG001|Overall Study|Adverse Event|6|||
147478003|NCT01821677|531907678|FG002|Overall Study|Adverse Event|5|||
147621823|NCT01836471|532433059|FG003|Overall Study|Withdrawal by Subject|0|||
147621824|NCT01836471|532433060|FG004|Overall Study|Withdrawal by Subject|2|||
147621825|NCT01836471|532433056|FG000|Overall Study|Physician Decision|0|||
147478004|NCT01821677|531907676|FG000|Overall Study|Physician Decision|1|||
147478005|NCT01821677|531907677|FG001|Overall Study|Physician Decision|4|||
147478006|NCT01821677|531907678|FG002|Overall Study|Physician Decision|1|||
147478007|NCT01821677|531907676|FG000|Overall Study|Non-compliance|0|||
147478008|NCT01821677|531907677|FG001|Overall Study|Non-compliance|1|||
147478009|NCT01821677|531907678|FG002|Overall Study|Non-compliance|2|||
147478010|NCT01821677|531907676|FG000|Overall Study|Lost to Follow-up|2|||
147478011|NCT01821677|531907677|FG001|Overall Study|Lost to Follow-up|1|||
147478012|NCT01821677|531907678|FG002|Overall Study|Lost to Follow-up|3|||
147478013|NCT01821677|531907676|FG000|Overall Study|Protocol Violation|0|||
147478014|NCT01821677|531907677|FG001|Overall Study|Protocol Violation|0|||
147478015|NCT01821677|531907678|FG002|Overall Study|Protocol Violation|2|||
147478016|NCT01821677|531907676|FG000|Overall Study|Withdrawal by Subject|7|||
147478017|NCT01821677|531907677|FG001|Overall Study|Withdrawal by Subject|3|||
147478018|NCT01821677|531907678|FG002|Overall Study|Withdrawal by Subject|2|||
147478019|NCT01821677|531907676|FG000|Overall Study|Other|9|||
147478020|NCT01821677|531907677|FG001|Overall Study|Other|0|||
147478021|NCT01821677|531907678|FG002|Overall Study|Other|0|||
147478022|NCT05635838|531909255|FG000|16-Week DBVC Period|Adverse Event|2|||
147478023|NCT05635838|531909256|FG001|16-Week DBVC Period|Adverse Event|0|||
147478024|NCT05635838|531909257|FG002|16-Week DBVC Period|Adverse Event|0|||
147478025|NCT05635838|531909258|FG003|16-Week DBVC Period|Adverse Event|0|||
147478026|NCT05635838|531909255|FG000|16-Week DBVC Period|Lost to Follow-up|5|||
147478027|NCT05635838|531909256|FG001|16-Week DBVC Period|Lost to Follow-up|1|||
147478028|NCT05635838|531909257|FG002|16-Week DBVC Period|Lost to Follow-up|0|||
147478029|NCT05635838|531909258|FG003|16-Week DBVC Period|Lost to Follow-up|0|||
147478030|NCT05635838|531909255|FG000|16-Week DBVC Period|Physician Decision|0|||
147478031|NCT05635838|531909256|FG001|16-Week DBVC Period|Physician Decision|1|||
147478032|NCT05635838|531909257|FG002|16-Week DBVC Period|Physician Decision|0|||
147478033|NCT05635838|531909258|FG003|16-Week DBVC Period|Physician Decision|0|||
147478034|NCT05635838|531909255|FG000|16-Week DBVC Period|Protocol Violation|1|||
147478035|NCT05635838|531909256|FG001|16-Week DBVC Period|Protocol Violation|0|||
147478036|NCT05635838|531909257|FG002|16-Week DBVC Period|Protocol Violation|0|||
147478037|NCT05635838|531909258|FG003|16-Week DBVC Period|Protocol Violation|0|||
147478038|NCT05635838|531909255|FG000|16-Week DBVC Period|Withdrawal by Subject|1|||
147478039|NCT05635838|531909256|FG001|16-Week DBVC Period|Withdrawal by Subject|0|||
147478040|NCT05635838|531909257|FG002|16-Week DBVC Period|Withdrawal by Subject|0|||
147478041|NCT05635838|531909258|FG003|16-Week DBVC Period|Withdrawal by Subject|0|||
147478042|NCT05635838|531909255|FG000|16-Week DBVC Period|Presence of Disease Tunnel|1|||
147478043|NCT05635838|531909256|FG001|16-Week DBVC Period|Presence of Disease Tunnel|0|||
147478044|NCT05635838|531909257|FG002|16-Week DBVC Period|Presence of Disease Tunnel|0|||
147478045|NCT05635838|531909258|FG003|16-Week DBVC Period|Presence of Disease Tunnel|0|||
147478046|NCT05635838|531909255|FG000|16-Week DBVC Period|Developed Draining Fistula|0|||
147478047|NCT05635838|531909256|FG001|16-Week DBVC Period|Developed Draining Fistula|1|||
147478048|NCT05635838|531909257|FG002|16-Week DBVC Period|Developed Draining Fistula|0|||
147478049|NCT05635838|531909258|FG003|16-Week DBVC Period|Developed Draining Fistula|0|||
147478050|NCT05635838|531909255|FG000|16-Week OLE Period|Adverse Event|0|||
147478051|NCT05635838|531909256|FG001|16-Week OLE Period|Adverse Event|0|||
147478052|NCT05635838|531909257|FG002|16-Week OLE Period|Adverse Event|0|||
147478053|NCT05635838|531909258|FG003|16-Week OLE Period|Adverse Event|2|||
147478054|NCT05635838|531909255|FG000|16-Week OLE Period|Lost to Follow-up|0|||
147478055|NCT05635838|531909256|FG001|16-Week OLE Period|Lost to Follow-up|0|||
147478056|NCT05635838|531909257|FG002|16-Week OLE Period|Lost to Follow-up|1|||
147478057|NCT05635838|531909258|FG003|16-Week OLE Period|Lost to Follow-up|3|||
147478058|NCT05635838|531909255|FG000|16-Week OLE Period|Physician Decision|0|||
147478059|NCT05635838|531909256|FG001|16-Week OLE Period|Physician Decision|0|||
147478060|NCT05635838|531909257|FG002|16-Week OLE Period|Physician Decision|0|||
147478061|NCT05635838|531909258|FG003|16-Week OLE Period|Physician Decision|1|||
147478062|NCT05635838|531909255|FG000|16-Week OLE Period|Protocol Violation|0|||
147478063|NCT05635838|531909256|FG001|16-Week OLE Period|Protocol Violation|0|||
147478064|NCT05635838|531909257|FG002|16-Week OLE Period|Protocol Violation|1|||
147478065|NCT05635838|531909258|FG003|16-Week OLE Period|Protocol Violation|1|||
147478066|NCT05635838|531909255|FG000|16-Week OLE Period|Withdrawal by Subject|0|||
147478067|NCT05635838|531909256|FG001|16-Week OLE Period|Withdrawal by Subject|0|||
147478068|NCT05635838|531909257|FG002|16-Week OLE Period|Withdrawal by Subject|0|||
147478069|NCT05635838|531909258|FG003|16-Week OLE Period|Withdrawal by Subject|1|||
147478070|NCT05635838|531909255|FG000|16-Week OLE Period|Pregnancy|0|||
147478071|NCT05635838|531909256|FG001|16-Week OLE Period|Pregnancy|0|||
147478072|NCT05635838|531909257|FG002|16-Week OLE Period|Pregnancy|1|||
147478073|NCT05635838|531909258|FG003|16-Week OLE Period|Pregnancy|0|||
147478074|NCT02031146|531909261|FG000|Overall Study|Did not meet criteria for inclusion in data analysis|0|||
147478075|NCT02031146|531909262|FG001|Overall Study|Did not meet criteria for inclusion in data analysis|0|||
147478076|NCT02031146|531909263|FG002|Overall Study|Did not meet criteria for inclusion in data analysis|0|||
147478077|NCT02031146|531909264|FG003|Overall Study|Did not meet criteria for inclusion in data analysis|100|||
147478078|NCT02031146|531909265|FG004|Overall Study|Did not meet criteria for inclusion in data analysis|26|||
147478079|NCT02031146|531909266|FG005|Overall Study|Did not meet criteria for inclusion in data analysis|4|||
147478080|NCT02031146|531909267|FG006|Overall Study|Did not meet criteria for inclusion in data analysis|5|||
147478081|NCT05165394|531909268|FG000|Overall Study|Withdrawal by Subject|5|||
147478082|NCT05165394|531909269|FG001|Overall Study|Withdrawal by Subject|1|||
147478083|NCT05165394|531909268|FG000|Overall Study|Lost to Follow-up|1|||
147478084|NCT05165394|531909269|FG001|Overall Study|Lost to Follow-up|2|||
147478085|NCT05165394|531909268|FG000|Overall Study|Other Than Specified|0|||
147478086|NCT05165394|531909269|FG001|Overall Study|Other Than Specified|1|||
147478087|NCT00001259|531909272|FG000|Study 2|Adverse Event|0|||
147478088|NCT00001259|531909273|FG001|Study 2|Adverse Event|0|||
147478089|NCT00001259|531909274|FG002|Study 2|Adverse Event|0|||
147478090|NCT00001259|531909275|FG003|Study 2|Adverse Event|0|||
147478091|NCT00001259|531909276|FG004|Study 2|Adverse Event|2|||
147478092|NCT00001259|531909277|FG005|Study 2|Adverse Event|0|||
147478093|NCT00001259|531909278|FG006|Study 2|Adverse Event|0|||
147478094|NCT03705494|531909279|FG000|Overall Study|Lost to Follow-up|2|||
147478095|NCT03705494|531909280|FG001|Overall Study|Lost to Follow-up|1|||
147478096|NCT03705494|531909279|FG000|Overall Study|Withdrawal by Subject|5|||
147478097|NCT03705494|531909280|FG001|Overall Study|Withdrawal by Subject|2|||
147478098|NCT01582282|531909281|FG000|Overall Study|Adverse Event|1|||
147478099|NCT01582282|531909282|FG001|Overall Study|Adverse Event|1|||
147478100|NCT01582282|531909283|FG002|Overall Study|Adverse Event|0|||
147478101|NCT01582282|531909281|FG000|Overall Study|Lost to Follow-up|1|||
147478102|NCT01582282|531909282|FG001|Overall Study|Lost to Follow-up|0|||
147478103|NCT01582282|531909283|FG002|Overall Study|Lost to Follow-up|0|||
147478104|NCT01582282|531909281|FG000|Overall Study|fasting blood glucose outside Protocol|0|||
147478105|NCT01582282|531909282|FG001|Overall Study|fasting blood glucose outside Protocol|1|||
147478106|NCT01582282|531909283|FG002|Overall Study|fasting blood glucose outside Protocol|0|||
147478107|NCT02629393|531909285|FG000|Overall Study|MOCD Type A not genetically confirmed|2|||
147478108|NCT02629393|531909285|FG000|Overall Study|Physician Decision|1|||
147478109|NCT03937986|531909286|FG000|Overall Study|COVID-19 Pandemic|1|||
147478110|NCT01853228|531909287|FG000|Phase 1|Lack of Efficacy|8|||
147478111|NCT01853228|531909288|FG001|Phase 1|Lack of Efficacy|0|||
147478112|NCT01853228|531909287|FG000|Phase 1|Other|1|||
147478113|NCT01853228|531909288|FG001|Phase 1|Other|0|||
147478114|NCT01853228|531909287|FG000|Phase 2|Physician Decision|0|||
147478115|NCT01853228|531909288|FG001|Phase 2|Physician Decision|1|||
147478116|NCT01853228|531909287|FG000|Phase 2|Proceed To Transplant|0|||
147478117|NCT01853228|531909288|FG001|Phase 2|Proceed To Transplant|3|||
147478118|NCT01853228|531909287|FG000|Phase 2|Lack of Efficacy|0|||
147478119|NCT01853228|531909288|FG001|Phase 2|Lack of Efficacy|4|||
147478120|NCT02786537|531909290|FG000|As Randomized|Adverse Event|0|||
147478121|NCT02786537|531909291|FG001|As Randomized|Adverse Event|11|||
147478122|NCT02786537|531909292|FG002|As Randomized|Adverse Event|0|||
147478123|NCT02786537|531909293|FG003|As Randomized|Adverse Event|4|||
147478124|NCT02786537|531909294|FG004|As Randomized|Adverse Event|6|||
147478125|NCT02786537|531909295|FG005|As Randomized|Adverse Event|2|||
147478126|NCT02786537|531909290|FG000|As Randomized|Lack of Efficacy|0|||
147478127|NCT02786537|531909291|FG001|As Randomized|Lack of Efficacy|0|||
147478128|NCT02786537|531909292|FG002|As Randomized|Lack of Efficacy|0|||
147478129|NCT02786537|531909293|FG003|As Randomized|Lack of Efficacy|1|||
147478130|NCT02786537|531909294|FG004|As Randomized|Lack of Efficacy|0|||
147478131|NCT02786537|531909295|FG005|As Randomized|Lack of Efficacy|0|||
147478132|NCT02786537|531909290|FG000|As Randomized|Withdrawal by Subject|1|||
147478133|NCT02786537|531909291|FG001|As Randomized|Withdrawal by Subject|2|||
147478134|NCT02786537|531909292|FG002|As Randomized|Withdrawal by Subject|0|||
147478135|NCT02786537|531909293|FG003|As Randomized|Withdrawal by Subject|1|||
147478136|NCT02786537|531909294|FG004|As Randomized|Withdrawal by Subject|1|||
147478137|NCT02786537|531909295|FG005|As Randomized|Withdrawal by Subject|0|||
147478138|NCT02786537|531909290|FG000|As Randomized|Death|0|||
147478139|NCT02786537|531909291|FG001|As Randomized|Death|2|||
147478140|NCT02786537|531909292|FG002|As Randomized|Death|0|||
147478141|NCT02786537|531909293|FG003|As Randomized|Death|3|||
147478142|NCT02786537|531909294|FG004|As Randomized|Death|1|||
147478143|NCT02786537|531909295|FG005|As Randomized|Death|0|||
147478144|NCT02786537|531909290|FG000|As Randomized|Non-compliance with study drug|1|||
147478145|NCT02786537|531909291|FG001|As Randomized|Non-compliance with study drug|11|||
147478146|NCT02786537|531909292|FG002|As Randomized|Non-compliance with study drug|0|||
147478147|NCT02786537|531909293|FG003|As Randomized|Non-compliance with study drug|1|||
147478148|NCT02786537|531909294|FG004|As Randomized|Non-compliance with study drug|0|||
147478149|NCT02786537|531909295|FG005|As Randomized|Non-compliance with study drug|1|||
147478150|NCT02786537|531909290|FG000|As Randomized|Lost to treatment follow-up|4|||
147478151|NCT02786537|531909291|FG001|As Randomized|Lost to treatment follow-up|32|||
147478152|NCT02786537|531909292|FG002|As Randomized|Lost to treatment follow-up|0|||
147478153|NCT02786537|531909293|FG003|As Randomized|Lost to treatment follow-up|24|||
147478154|NCT02786537|531909294|FG004|As Randomized|Lost to treatment follow-up|4|||
147478155|NCT02786537|531909295|FG005|As Randomized|Lost to treatment follow-up|4|||
147478156|NCT02786537|531909290|FG000|As Randomized|Incarceration|0|||
147478157|NCT02786537|531909291|FG001|As Randomized|Incarceration|1|||
147478158|NCT02786537|531909292|FG002|As Randomized|Incarceration|0|||
147478159|NCT02786537|531909293|FG003|As Randomized|Incarceration|0|||
147478160|NCT02786537|531909294|FG004|As Randomized|Incarceration|0|||
147478161|NCT02786537|531909295|FG005|As Randomized|Incarceration|0|||
147478162|NCT02786537|531909290|FG000|As Randomized|Opiate Dependency Relapse|0|||
147478163|NCT02786537|531909291|FG001|As Randomized|Opiate Dependency Relapse|1|||
147478164|NCT02786537|531909292|FG002|As Randomized|Opiate Dependency Relapse|0|||
147478165|NCT02786537|531909293|FG003|As Randomized|Opiate Dependency Relapse|0|||
147478166|NCT02786537|531909294|FG004|As Randomized|Opiate Dependency Relapse|0|||
147478167|NCT02786537|531909295|FG005|As Randomized|Opiate Dependency Relapse|0|||
147478168|NCT02786537|531909290|FG000|As Randomized|HCV drugs stolen from pt|0|||
147478169|NCT02786537|531909291|FG001|As Randomized|HCV drugs stolen from pt|1|||
147478170|NCT02786537|531909292|FG002|As Randomized|HCV drugs stolen from pt|0|||
147478171|NCT02786537|531909293|FG003|As Randomized|HCV drugs stolen from pt|0|||
147478172|NCT02786537|531909294|FG004|As Randomized|HCV drugs stolen from pt|0|||
147478173|NCT02786537|531909295|FG005|As Randomized|HCV drugs stolen from pt|0|||
147478174|NCT02786537|531909290|FG000|As Randomized|Advised to stop after lapse in dosing|0|||
147478175|NCT02786537|531909291|FG001|As Randomized|Advised to stop after lapse in dosing|1|||
147478176|NCT02786537|531909292|FG002|As Randomized|Advised to stop after lapse in dosing|0|||
147478177|NCT02786537|531909293|FG003|As Randomized|Advised to stop after lapse in dosing|0|||
147478178|NCT02786537|531909294|FG004|As Randomized|Advised to stop after lapse in dosing|0|||
147478179|NCT02786537|531909295|FG005|As Randomized|Advised to stop after lapse in dosing|0|||
147478180|NCT02786537|531909290|FG000|As Randomized|Subject lost insurance|0|||
147478181|NCT02786537|531909291|FG001|As Randomized|Subject lost insurance|0|||
147478182|NCT02786537|531909292|FG002|As Randomized|Subject lost insurance|0|||
147478183|NCT02786537|531909293|FG003|As Randomized|Subject lost insurance|1|||
147478184|NCT02786537|531909294|FG004|As Randomized|Subject lost insurance|0|||
147478185|NCT02786537|531909295|FG005|As Randomized|Subject lost insurance|0|||
147478186|NCT02786537|531909290|FG000|As Treated|Adverse Event|0|||
147478187|NCT02786537|531909291|FG001|As Treated|Adverse Event|11|||
147478188|NCT02786537|531909292|FG002|As Treated|Adverse Event|0|||
147478189|NCT02786537|531909293|FG003|As Treated|Adverse Event|4|||
147478190|NCT02786537|531909294|FG004|As Treated|Adverse Event|6|||
147478191|NCT02786537|531909295|FG005|As Treated|Adverse Event|2|||
147478192|NCT02786537|531909290|FG000|As Treated|Death|0|||
147478193|NCT02786537|531909291|FG001|As Treated|Death|2|||
147478194|NCT02786537|531909292|FG002|As Treated|Death|0|||
147478195|NCT02786537|531909293|FG003|As Treated|Death|3|||
147478196|NCT02786537|531909294|FG004|As Treated|Death|1|||
147478197|NCT02786537|531909295|FG005|As Treated|Death|0|||
147478198|NCT02786537|531909290|FG000|As Treated|Lack of Efficacy|0|||
147478199|NCT02786537|531909291|FG001|As Treated|Lack of Efficacy|0|||
147478200|NCT02786537|531909292|FG002|As Treated|Lack of Efficacy|0|||
147478201|NCT02786537|531909293|FG003|As Treated|Lack of Efficacy|1|||
147478202|NCT02786537|531909294|FG004|As Treated|Lack of Efficacy|0|||
147478203|NCT02786537|531909295|FG005|As Treated|Lack of Efficacy|0|||
147478204|NCT02786537|531909290|FG000|As Treated|Lost to Follow-up|4|||
147478205|NCT02786537|531909291|FG001|As Treated|Lost to Follow-up|32|||
147478206|NCT02786537|531909292|FG002|As Treated|Lost to Follow-up|0|||
147478207|NCT02786537|531909293|FG003|As Treated|Lost to Follow-up|25|||
147478208|NCT02786537|531909294|FG004|As Treated|Lost to Follow-up|4|||
147478209|NCT02786537|531909295|FG005|As Treated|Lost to Follow-up|4|||
147478210|NCT02786537|531909290|FG000|As Treated|Non-compliance with study drug|1|||
147478211|NCT02786537|531909291|FG001|As Treated|Non-compliance with study drug|11|||
147478212|NCT02786537|531909292|FG002|As Treated|Non-compliance with study drug|0|||
147478213|NCT02786537|531909293|FG003|As Treated|Non-compliance with study drug|1|||
147478214|NCT02786537|531909294|FG004|As Treated|Non-compliance with study drug|0|||
147478215|NCT02786537|531909295|FG005|As Treated|Non-compliance with study drug|1|||
147478216|NCT02786537|531909290|FG000|As Treated|Lost insurance|0|||
147621826|NCT01836471|532433057|FG001|Overall Study|Physician Decision|1|||
147478217|NCT02786537|531909291|FG001|As Treated|Lost insurance|0|||
147478218|NCT02786537|531909292|FG002|As Treated|Lost insurance|0|||
147478219|NCT02786537|531909293|FG003|As Treated|Lost insurance|1|||
147478220|NCT02786537|531909294|FG004|As Treated|Lost insurance|0|||
147478221|NCT02786537|531909295|FG005|As Treated|Lost insurance|0|||
147478222|NCT02786537|531909290|FG000|As Treated|Withdrawal by Subject|1|||
147478223|NCT02786537|531909291|FG001|As Treated|Withdrawal by Subject|2|||
147478224|NCT02786537|531909292|FG002|As Treated|Withdrawal by Subject|0|||
147478225|NCT02786537|531909293|FG003|As Treated|Withdrawal by Subject|0|||
147478226|NCT02786537|531909294|FG004|As Treated|Withdrawal by Subject|1|||
147478227|NCT02786537|531909295|FG005|As Treated|Withdrawal by Subject|0|||
147478228|NCT02786537|531909290|FG000|As Treated|Incarceration|0|||
147478229|NCT02786537|531909291|FG001|As Treated|Incarceration|1|||
147478230|NCT02786537|531909292|FG002|As Treated|Incarceration|0|||
147478231|NCT02786537|531909293|FG003|As Treated|Incarceration|0|||
147478232|NCT02786537|531909294|FG004|As Treated|Incarceration|0|||
147478233|NCT02786537|531909295|FG005|As Treated|Incarceration|0|||
147478234|NCT02786537|531909290|FG000|As Treated|Opiate dependency relapse|0|||
147478235|NCT02786537|531909291|FG001|As Treated|Opiate dependency relapse|1|||
147478236|NCT02786537|531909292|FG002|As Treated|Opiate dependency relapse|0|||
147478237|NCT02786537|531909293|FG003|As Treated|Opiate dependency relapse|0|||
147478238|NCT02786537|531909294|FG004|As Treated|Opiate dependency relapse|0|||
147478239|NCT02786537|531909295|FG005|As Treated|Opiate dependency relapse|0|||
147478240|NCT02786537|531909290|FG000|As Treated|Drugs stolen from patient|0|||
147478241|NCT02786537|531909291|FG001|As Treated|Drugs stolen from patient|1|||
147478242|NCT02786537|531909292|FG002|As Treated|Drugs stolen from patient|0|||
147478243|NCT02786537|531909293|FG003|As Treated|Drugs stolen from patient|0|||
147478244|NCT02786537|531909294|FG004|As Treated|Drugs stolen from patient|0|||
147478245|NCT02786537|531909295|FG005|As Treated|Drugs stolen from patient|0|||
147478246|NCT02786537|531909290|FG000|As Treated|Advised to stop tx after loss of meds|0|||
147478247|NCT02786537|531909291|FG001|As Treated|Advised to stop tx after loss of meds|1|||
147478248|NCT02786537|531909292|FG002|As Treated|Advised to stop tx after loss of meds|0|||
147478249|NCT02786537|531909293|FG003|As Treated|Advised to stop tx after loss of meds|0|||
147478250|NCT02786537|531909294|FG004|As Treated|Advised to stop tx after loss of meds|0|||
147478251|NCT02786537|531909295|FG005|As Treated|Advised to stop tx after loss of meds|0|||
147478252|NCT01330381|531909296|FG000|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|5|||
147478253|NCT01330381|531909297|FG001|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|4|||
147478254|NCT01330381|531909298|FG002|Double-blind Treatment Period (8 Weeks)|Withdrawal by Subject|0|||
147478255|NCT01330381|531909296|FG000|Double-blind Treatment Period (8 Weeks)|Non-compliance|2|||
147478256|NCT01330381|531909297|FG001|Double-blind Treatment Period (8 Weeks)|Non-compliance|1|||
147478257|NCT01330381|531909298|FG002|Double-blind Treatment Period (8 Weeks)|Non-compliance|0|||
147478258|NCT01330381|531909296|FG000|Double-blind Treatment Period (8 Weeks)|Adverse Event|1|||
147478259|NCT01330381|531909297|FG001|Double-blind Treatment Period (8 Weeks)|Adverse Event|1|||
147478260|NCT01330381|531909298|FG002|Double-blind Treatment Period (8 Weeks)|Adverse Event|0|||
147478261|NCT01330381|531909296|FG000|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|1|||
147478262|NCT01330381|531909297|FG001|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|0|||
147478263|NCT01330381|531909298|FG002|Double-blind Treatment Period (8 Weeks)|Lost to Follow-up|0|||
147478264|NCT01330381|531909296|FG000|Double-blind Treatment Period (8 Weeks)|Did not fulfill inclusion/exclusion|1|||
147478265|NCT01330381|531909297|FG001|Double-blind Treatment Period (8 Weeks)|Did not fulfill inclusion/exclusion|0|||
147478266|NCT01330381|531909298|FG002|Double-blind Treatment Period (8 Weeks)|Did not fulfill inclusion/exclusion|0|||
147478267|NCT01330381|531909296|FG000|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|1|||
147478268|NCT01330381|531909297|FG001|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|1|||
147478269|NCT01330381|531909298|FG002|Double-blind Treatment Period (8 Weeks)|Lack of Efficacy|0|||
147478270|NCT01330381|531909296|FG000|Open-label Treatment Period (16 Weeks)|Withdrawal by Subject|7|||
147478271|NCT01330381|531909297|FG001|Open-label Treatment Period (16 Weeks)|Withdrawal by Subject|0|||
147478272|NCT01330381|531909298|FG002|Open-label Treatment Period (16 Weeks)|Withdrawal by Subject|16|||
147478273|NCT01330381|531909296|FG000|Open-label Treatment Period (16 Weeks)|Adverse Event|2|||
147478274|NCT01330381|531909297|FG001|Open-label Treatment Period (16 Weeks)|Adverse Event|0|||
147478275|NCT01330381|531909298|FG002|Open-label Treatment Period (16 Weeks)|Adverse Event|0|||
147478276|NCT01330381|531909296|FG000|Open-label Treatment Period (16 Weeks)|Sponsor's decision|1|||
147478277|NCT01330381|531909297|FG001|Open-label Treatment Period (16 Weeks)|Sponsor's decision|0|||
147478278|NCT01330381|531909298|FG002|Open-label Treatment Period (16 Weeks)|Sponsor's decision|1|||
147478279|NCT01330381|531909296|FG000|Open-label Treatment Period (16 Weeks)|Non-compliance|0|||
147478280|NCT01330381|531909297|FG001|Open-label Treatment Period (16 Weeks)|Non-compliance|0|||
147478281|NCT01330381|531909298|FG002|Open-label Treatment Period (16 Weeks)|Non-compliance|1|||
147478282|NCT01357239|531909302|FG000|Stratum: All Patients|Adverse Event|0|||
147478283|NCT01357239|531909303|FG001|Stratum: All Patients|Adverse Event|0|||
147478284|NCT01357239|531909304|FG002|Stratum: All Patients|Adverse Event|1|||
147478285|NCT01357239|531909305|FG003|Stratum: All Patients|Adverse Event|1|||
147478286|NCT01357239|531909302|FG000|Stratum: All Patients|Subject withdrew consent|0|||
147478287|NCT01357239|531909303|FG001|Stratum: All Patients|Subject withdrew consent|0|||
147478288|NCT01357239|531909304|FG002|Stratum: All Patients|Subject withdrew consent|1|||
147478289|NCT01357239|531909305|FG003|Stratum: All Patients|Subject withdrew consent|1|||
147478290|NCT01357239|531909302|FG000|Stratum I: Fully-Methylated|Adverse Event|0|||
147478291|NCT01357239|531909303|FG001|Stratum I: Fully-Methylated|Adverse Event|0|||
147478292|NCT01357239|531909304|FG002|Stratum I: Fully-Methylated|Adverse Event|1|||
147478293|NCT01357239|531909305|FG003|Stratum I: Fully-Methylated|Adverse Event|0|||
147478294|NCT01357239|531909302|FG000|Stratum II: Partially-Methylated|Adverse Event|0|||
147478295|NCT01357239|531909303|FG001|Stratum II: Partially-Methylated|Adverse Event|0|||
147478296|NCT01357239|531909304|FG002|Stratum II: Partially-Methylated|Adverse Event|0|||
147478297|NCT01357239|531909305|FG003|Stratum II: Partially-Methylated|Adverse Event|1|||
147478298|NCT01357239|531909302|FG000|Stratum II: Partially-Methylated|Subject withdrew consent|0|||
147478299|NCT01357239|531909303|FG001|Stratum II: Partially-Methylated|Subject withdrew consent|0|||
147478300|NCT01357239|531909304|FG002|Stratum II: Partially-Methylated|Subject withdrew consent|1|||
147478301|NCT01357239|531909305|FG003|Stratum II: Partially-Methylated|Subject withdrew consent|1|||
147478302|NCT03455543|531909310|FG000|Part A: Randomized Treatment (17 Weeks)|Adverse Event|2|||
147478303|NCT03455543|531909311|FG001|Part A: Randomized Treatment (17 Weeks)|Adverse Event|5|||
147478304|NCT03455543|531909312|FG002|Part A: Randomized Treatment (17 Weeks)|Adverse Event|0|||
147478305|NCT03455543|531909310|FG000|Part A: Randomized Treatment (17 Weeks)|Withdrawal by Subject|7|||
147478306|NCT03455543|531909311|FG001|Part A: Randomized Treatment (17 Weeks)|Withdrawal by Subject|2|||
147478307|NCT03455543|531909312|FG002|Part A: Randomized Treatment (17 Weeks)|Withdrawal by Subject|0|||
147478308|NCT03455543|531909310|FG000|Part A: Randomized Treatment (17 Weeks)|Physician Decision|2|||
147478309|NCT03455543|531909311|FG001|Part A: Randomized Treatment (17 Weeks)|Physician Decision|0|||
147478310|NCT03455543|531909312|FG002|Part A: Randomized Treatment (17 Weeks)|Physician Decision|0|||
147478311|NCT03455543|531909310|FG000|Part B: Open-label Extension (24 Weeks)|Adverse Event|0|||
147478312|NCT03455543|531909311|FG001|Part B: Open-label Extension (24 Weeks)|Adverse Event|0|||
147478313|NCT03455543|531909312|FG002|Part B: Open-label Extension (24 Weeks)|Adverse Event|3|||
147478314|NCT03455543|531909310|FG000|Part B: Open-label Extension (24 Weeks)|Withdrawal by Subject|0|||
147478315|NCT03455543|531909311|FG001|Part B: Open-label Extension (24 Weeks)|Withdrawal by Subject|0|||
147478316|NCT03455543|531909312|FG002|Part B: Open-label Extension (24 Weeks)|Withdrawal by Subject|20|||
147478317|NCT03455543|531909310|FG000|Part B: Open-label Extension (24 Weeks)|Lack of Efficacy|0|||
147478318|NCT03455543|531909311|FG001|Part B: Open-label Extension (24 Weeks)|Lack of Efficacy|0|||
147478319|NCT03455543|531909312|FG002|Part B: Open-label Extension (24 Weeks)|Lack of Efficacy|7|||
147478320|NCT03455543|531909310|FG000|Part B: Open-label Extension (24 Weeks)|Lost to Follow-up|0|||
147478321|NCT03455543|531909311|FG001|Part B: Open-label Extension (24 Weeks)|Lost to Follow-up|0|||
147478322|NCT03455543|531909312|FG002|Part B: Open-label Extension (24 Weeks)|Lost to Follow-up|4|||
147478323|NCT03455543|531909310|FG000|Part B: Open-label Extension (24 Weeks)|Out of window for visits|0|||
147478324|NCT03455543|531909311|FG001|Part B: Open-label Extension (24 Weeks)|Out of window for visits|0|||
147478325|NCT03455543|531909312|FG002|Part B: Open-label Extension (24 Weeks)|Out of window for visits|2|||
147478326|NCT03455543|531909310|FG000|Part B: Open-label Extension (24 Weeks)|Device interfered with home speakers|0|||
147478327|NCT03455543|531909311|FG001|Part B: Open-label Extension (24 Weeks)|Device interfered with home speakers|0|||
147478328|NCT03455543|531909312|FG002|Part B: Open-label Extension (24 Weeks)|Device interfered with home speakers|1|||
147478329|NCT00852930|531909313|FG000|Overall Study|Withdrawal by Subject|1|||
147478330|NCT00852930|531909314|FG001|Overall Study|Withdrawal by Subject|1|||
147478331|NCT00852930|531909315|FG002|Overall Study|Withdrawal by Subject|1|||
147478332|NCT00852930|531909313|FG000|Overall Study|Physician Decision|0|||
147478333|NCT00852930|531909314|FG001|Overall Study|Physician Decision|0|||
147478334|NCT00852930|531909315|FG002|Overall Study|Physician Decision|1|||
147478335|NCT00779038|531909316|FG000|Overall Study|Study Prematurely Terminated|13|||
147478336|NCT01221233|531909319|FG000|Overall Study|Withdrawal by Subject|3|||
147478337|NCT01221233|531909320|FG001|Overall Study|Withdrawal by Subject|1|||
147478338|NCT01645280|531909322|FG000|Overall Study|Death|0|||
147478339|NCT01645280|531909323|FG001|Overall Study|Death|1|||
147478340|NCT01645280|531909324|FG002|Overall Study|Death|0|||
147478341|NCT01645280|531909325|FG003|Overall Study|Death|0|||
147478342|NCT01645280|531909326|FG004|Overall Study|Death|0|||
147478343|NCT01645280|531909322|FG000|Overall Study|Withdrawal by Subject|4|||
147478344|NCT01645280|531909323|FG001|Overall Study|Withdrawal by Subject|0|||
147478345|NCT01645280|531909324|FG002|Overall Study|Withdrawal by Subject|2|||
147478346|NCT01645280|531909325|FG003|Overall Study|Withdrawal by Subject|4|||
147478347|NCT01645280|531909326|FG004|Overall Study|Withdrawal by Subject|5|||
147478348|NCT01645280|531909322|FG000|Overall Study|Lost to Follow-up|0|||
147478349|NCT01645280|531909323|FG001|Overall Study|Lost to Follow-up|0|||
147478350|NCT01645280|531909324|FG002|Overall Study|Lost to Follow-up|0|||
147478351|NCT01645280|531909325|FG003|Overall Study|Lost to Follow-up|2|||
147478352|NCT01645280|531909326|FG004|Overall Study|Lost to Follow-up|1|||
147478353|NCT01645280|531909322|FG000|Overall Study|Other|1|||
147478354|NCT01645280|531909323|FG001|Overall Study|Other|1|||
147478355|NCT01645280|531909324|FG002|Overall Study|Other|2|||
147478356|NCT01645280|531909325|FG003|Overall Study|Other|0|||
147478357|NCT01645280|531909326|FG004|Overall Study|Other|0|||
147478358|NCT01645280|531909322|FG000|Overall Study|Treatment not completed/Completed f/u|1|||
147478359|NCT01645280|531909323|FG001|Overall Study|Treatment not completed/Completed f/u|1|||
147478360|NCT01645280|531909324|FG002|Overall Study|Treatment not completed/Completed f/u|2|||
147478361|NCT01645280|531909325|FG003|Overall Study|Treatment not completed/Completed f/u|0|||
147621827|NCT01836471|532433058|FG002|Overall Study|Physician Decision|0|||
147621828|NCT01836471|532433059|FG003|Overall Study|Physician Decision|0|||
147621829|NCT01836471|532433060|FG004|Overall Study|Physician Decision|0|||
147621830|NCT01836471|532433056|FG000|Overall Study|Lost to Follow-up|0|||
147621831|NCT01836471|532433057|FG001|Overall Study|Lost to Follow-up|0|||
147621832|NCT01836471|532433058|FG002|Overall Study|Lost to Follow-up|0|||
147621833|NCT01836471|532433059|FG003|Overall Study|Lost to Follow-up|1|||
147478362|NCT01645280|531909326|FG004|Overall Study|Treatment not completed/Completed f/u|2|||
147478363|NCT00234104|531909331|FG000|Overall Study|Adverse Event|4|||
147478364|NCT00234104|531909332|FG001|Overall Study|Adverse Event|0|||
147478365|NCT00234104|531909333|FG002|Overall Study|Adverse Event|3|||
147478366|NCT00234104|531909334|FG003|Overall Study|Adverse Event|5|||
147621834|NCT01836471|532433060|FG004|Overall Study|Lost to Follow-up|1|||
147621835|NCT01836471|532433056|FG000|Overall Study|Adverse Event|6|||
147621836|NCT01836471|532433057|FG001|Overall Study|Adverse Event|3|||
147621837|NCT01836471|532433058|FG002|Overall Study|Adverse Event|1|||
147621838|NCT01836471|532433059|FG003|Overall Study|Adverse Event|1|||
147621839|NCT01836471|532433060|FG004|Overall Study|Adverse Event|2|||
147621840|NCT01836471|532433056|FG000|Overall Study|Non compliance with tx|1|||
147621841|NCT01836471|532433057|FG001|Overall Study|Non compliance with tx|1|||
147621842|NCT01836471|532433058|FG002|Overall Study|Non compliance with tx|0|||
147621843|NCT01836471|532433059|FG003|Overall Study|Non compliance with tx|0|||
147621844|NCT01836471|532433060|FG004|Overall Study|Non compliance with tx|0|||
147621845|NCT05506046|532433061|FG000|Overall Study|Lost to Follow-up|89|||
147621846|NCT05506046|532433062|FG001|Overall Study|Lost to Follow-up|101|||
147621847|NCT05506046|532433063|FG002|Overall Study|Lost to Follow-up|102|||
147621848|NCT05506046|532433064|FG003|Overall Study|Lost to Follow-up|99|||
147621849|NCT00191477|532433065|FG000|Overall Study|Tumor Recurrence|49|||
147621850|NCT00191477|532433066|FG001|Overall Study|Tumor Recurrence|48|||
147621851|NCT00191477|532433065|FG000|Overall Study|Death, Study Disease|1|||
147621852|NCT00191477|532433066|FG001|Overall Study|Death, Study Disease|1|||
147621853|NCT00191477|532433065|FG000|Overall Study|Death, Other Cause|3|||
147621854|NCT00191477|532433066|FG001|Overall Study|Death, Other Cause|6|||
147621855|NCT00191477|532433065|FG000|Overall Study|Lost to Follow-up|23|||
147621856|NCT00191477|532433066|FG001|Overall Study|Lost to Follow-up|21|||
147621857|NCT00191477|532433065|FG000|Overall Study|Protocol Violation|1|||
147621858|NCT00191477|532433066|FG001|Overall Study|Protocol Violation|1|||
147621859|NCT00191477|532433065|FG000|Overall Study|Treatment Change|2|||
147621860|NCT00191477|532433066|FG001|Overall Study|Treatment Change|0|||
147621861|NCT00191477|532433065|FG000|Overall Study|Withdrawal by Subject|2|||
147621862|NCT00191477|532433066|FG001|Overall Study|Withdrawal by Subject|0|||
147621863|NCT00191477|532433065|FG000|Overall Study|Other|2|||
147621864|NCT00191477|532433066|FG001|Overall Study|Other|0|||
147621865|NCT00191477|532433065|FG000|Overall Study|Not Eligible|41|||
147621866|NCT00191477|532433066|FG001|Overall Study|Not Eligible|38|||
147621867|NCT00191477|532433065|FG000|Overall Study|Pathological Specimen Lost|1|||
147621868|NCT00191477|532433066|FG001|Overall Study|Pathological Specimen Lost|0|||
147621869|NCT00191477|532433065|FG000|Overall Study|Discontinued Prior to Instillation|13|||
147621870|NCT00191477|532433066|FG001|Overall Study|Discontinued Prior to Instillation|14|||
147621871|NCT03776357|532433073|FG000|Overall Study|Lost to Follow-up|3|||
147621872|NCT01286467|532433076|FG000|Overall Study|Death|1|||
147621873|NCT01286467|532433077|FG001|Overall Study|Death|1|||
147621874|NCT01286467|532433078|FG002|Overall Study|Death|1|||
147621875|NCT01286467|532433079|FG003|Overall Study|Death|0|||
147621876|NCT01286467|532433076|FG000|Overall Study|Lost to Follow-up|0|||
147621877|NCT01286467|532433077|FG001|Overall Study|Lost to Follow-up|0|||
147621878|NCT01286467|532433078|FG002|Overall Study|Lost to Follow-up|0|||
147621879|NCT01286467|532433079|FG003|Overall Study|Lost to Follow-up|1|||
147621880|NCT01286467|532433076|FG000|Overall Study|Withdrawal by Subject|0|||
147621881|NCT01286467|532433077|FG001|Overall Study|Withdrawal by Subject|0|||
147621882|NCT01286467|532433078|FG002|Overall Study|Withdrawal by Subject|1|||
147621883|NCT01286467|532433079|FG003|Overall Study|Withdrawal by Subject|0|||
147621884|NCT01286467|532433076|FG000|Overall Study|Physician Decision|0|||
147621885|NCT01286467|532433077|FG001|Overall Study|Physician Decision|0|||
147621886|NCT01286467|532433078|FG002|Overall Study|Physician Decision|0|||
147621887|NCT01286467|532433079|FG003|Overall Study|Physician Decision|1|||
147621888|NCT01286467|532433076|FG000|Overall Study|Disease progression|3|||
147621889|NCT01286467|532433077|FG001|Overall Study|Disease progression|2|||
147621890|NCT01286467|532433078|FG002|Overall Study|Disease progression|2|||
147621891|NCT01286467|532433079|FG003|Overall Study|Disease progression|3|||
147621892|NCT01286467|532433076|FG000|Overall Study|Adverse Event|0|||
147621893|NCT01286467|532433077|FG001|Overall Study|Adverse Event|1|||
147621894|NCT01286467|532433078|FG002|Overall Study|Adverse Event|2|||
147621895|NCT01286467|532433079|FG003|Overall Study|Adverse Event|3|||
147621896|NCT01286467|532433076|FG000|Overall Study|Study drug stop longer than 14 days|0|||
147621897|NCT01286467|532433077|FG001|Overall Study|Study drug stop longer than 14 days|0|||
147621898|NCT01286467|532433078|FG002|Overall Study|Study drug stop longer than 14 days|1|||
147621899|NCT01286467|532433079|FG003|Overall Study|Study drug stop longer than 14 days|0|||
147621900|NCT01058642|532433080|FG000|Treatment Period 1|Adverse Event|0|||
147621901|NCT01058642|532433081|FG001|Treatment Period 1|Adverse Event|1|||
147621902|NCT01058642|532433082|FG002|Treatment Period 1|Adverse Event|1|||
147621903|NCT01058642|532433083|FG003|Treatment Period 1|Adverse Event|0|||
147621904|NCT01058642|532433080|FG000|Treatment Period 1|Physician Decision|0|||
147621905|NCT01058642|532433081|FG001|Treatment Period 1|Physician Decision|0|||
147621906|NCT01058642|532433082|FG002|Treatment Period 1|Physician Decision|1|||
147621907|NCT01058642|532433083|FG003|Treatment Period 1|Physician Decision|0|||
147621908|NCT01058642|532433080|FG000|Treatment Period 1|Withdrawal by Subject|1|||
147621909|NCT01058642|532433081|FG001|Treatment Period 1|Withdrawal by Subject|0|||
147621910|NCT01058642|532433082|FG002|Treatment Period 1|Withdrawal by Subject|0|||
147621911|NCT01058642|532433083|FG003|Treatment Period 1|Withdrawal by Subject|0|||
147621912|NCT01058642|532433080|FG000|Treatment Period 1|Lack of Efficacy|0|||
147621913|NCT01058642|532433081|FG001|Treatment Period 1|Lack of Efficacy|0|||
147621914|NCT01058642|532433082|FG002|Treatment Period 1|Lack of Efficacy|0|||
147621915|NCT01058642|532433083|FG003|Treatment Period 1|Lack of Efficacy|1|||
147621916|NCT01058642|532433080|FG000|Treatment Period 1|Protocol Violation|0|||
147621917|NCT01058642|532433081|FG001|Treatment Period 1|Protocol Violation|0|||
147621918|NCT01058642|532433082|FG002|Treatment Period 1|Protocol Violation|0|||
147621919|NCT01058642|532433083|FG003|Treatment Period 1|Protocol Violation|1|||
147621920|NCT01058642|532433080|FG000|Treatment Period 1|Lack of Compliance with Study Drug|1|||
147621921|NCT01058642|532433081|FG001|Treatment Period 1|Lack of Compliance with Study Drug|0|||
147621922|NCT01058642|532433082|FG002|Treatment Period 1|Lack of Compliance with Study Drug|0|||
147621923|NCT01058642|532433083|FG003|Treatment Period 1|Lack of Compliance with Study Drug|0|||
147621924|NCT01060072|532433089|FG000|Overall Study|Adverse Event|1|||
147621925|NCT01060072|532433090|FG001|Overall Study|Adverse Event|1|||
147621926|NCT01060072|532433089|FG000|Overall Study|Physician Decision|0|||
147621927|NCT01060072|532433090|FG001|Overall Study|Physician Decision|2|||
147621928|NCT01060072|532433089|FG000|Overall Study|Protocol Violation|0|||
147621929|NCT01060072|532433090|FG001|Overall Study|Protocol Violation|1|||
147621930|NCT01060072|532433089|FG000|Overall Study|Acute cholecystitis|1|||
147621931|NCT01060072|532433090|FG001|Overall Study|Acute cholecystitis|0|||
147621932|NCT01060072|532433089|FG000|Overall Study|Excluded Medications|0|||
147621933|NCT01060072|532433090|FG001|Overall Study|Excluded Medications|1|||
147621934|NCT01147068|532433093|FG000|Subjects That Received 2nd Dose|Lost to Follow-up|1|||
147621935|NCT01147068|532433094|FG001|Subjects That Received 2nd Dose|Lost to Follow-up|0|||
147621936|NCT01147068|532433095|FG002|Subjects That Received 2nd Dose|Lost to Follow-up|0|||
147621937|NCT01147068|532433096|FG003|Subjects That Received 2nd Dose|Lost to Follow-up|0|||
147621938|NCT01147068|532433097|FG004|Subjects That Received 2nd Dose|Lost to Follow-up|0|||
147621939|NCT01147068|532433098|FG005|Subjects That Received 2nd Dose|Lost to Follow-up|1|||
147621940|NCT01147068|532433099|FG006|Subjects That Received 2nd Dose|Lost to Follow-up|0|||
147621941|NCT01147068|532433093|FG000|Subjects That Received 2nd Dose|Ineligible|0|||
147621942|NCT01147068|532433094|FG001|Subjects That Received 2nd Dose|Ineligible|1|||
147621943|NCT01147068|532433095|FG002|Subjects That Received 2nd Dose|Ineligible|0|||
147621944|NCT01147068|532433096|FG003|Subjects That Received 2nd Dose|Ineligible|0|||
147621945|NCT01147068|532433097|FG004|Subjects That Received 2nd Dose|Ineligible|0|||
147621946|NCT01147068|532433098|FG005|Subjects That Received 2nd Dose|Ineligible|0|||
147621947|NCT01147068|532433099|FG006|Subjects That Received 2nd Dose|Ineligible|0|||
147621948|NCT01147068|532433093|FG000|Subjects That Received 2nd Dose|Did not complete the study|0|||
147621949|NCT01147068|532433094|FG001|Subjects That Received 2nd Dose|Did not complete the study|1|||
147621950|NCT01147068|532433095|FG002|Subjects That Received 2nd Dose|Did not complete the study|0|||
147621951|NCT01147068|532433096|FG003|Subjects That Received 2nd Dose|Did not complete the study|0|||
147621952|NCT01147068|532433097|FG004|Subjects That Received 2nd Dose|Did not complete the study|0|||
147621953|NCT01147068|532433098|FG005|Subjects That Received 2nd Dose|Did not complete the study|1|||
147621954|NCT01147068|532433099|FG006|Subjects That Received 2nd Dose|Did not complete the study|0|||
147621955|NCT01147068|532433093|FG000|Subjects That Received 2nd Dose|Other|0|||
147621956|NCT01147068|532433094|FG001|Subjects That Received 2nd Dose|Other|3|||
147621957|NCT01147068|532433095|FG002|Subjects That Received 2nd Dose|Other|3|||
147621958|NCT01147068|532433096|FG003|Subjects That Received 2nd Dose|Other|0|||
147621959|NCT01147068|532433097|FG004|Subjects That Received 2nd Dose|Other|1|||
147621960|NCT01147068|532433098|FG005|Subjects That Received 2nd Dose|Other|0|||
147621961|NCT01147068|532433099|FG006|Subjects That Received 2nd Dose|Other|0|||
147621962|NCT01147068|532433093|FG000|Subjects That Completed Safety Follow-up|Lost to Follow-up|1|||
147621963|NCT01147068|532433094|FG001|Subjects That Completed Safety Follow-up|Lost to Follow-up|0|||
147621964|NCT01147068|532433095|FG002|Subjects That Completed Safety Follow-up|Lost to Follow-up|0|||
147621965|NCT01147068|532433096|FG003|Subjects That Completed Safety Follow-up|Lost to Follow-up|0|||
147621966|NCT01147068|532433097|FG004|Subjects That Completed Safety Follow-up|Lost to Follow-up|0|||
147621967|NCT01147068|532433098|FG005|Subjects That Completed Safety Follow-up|Lost to Follow-up|1|||
147621968|NCT01147068|532433099|FG006|Subjects That Completed Safety Follow-up|Lost to Follow-up|1|||
147621969|NCT01147068|532433093|FG000|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
147621970|NCT01147068|532433094|FG001|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
147621971|NCT01147068|532433095|FG002|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
147621972|NCT01147068|532433096|FG003|Subjects That Completed Safety Follow-up|Withdrawal by Subject|2|||
147621973|NCT01147068|532433097|FG004|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
147621974|NCT01147068|532433098|FG005|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
147621975|NCT01147068|532433099|FG006|Subjects That Completed Safety Follow-up|Withdrawal by Subject|0|||
147621976|NCT01147068|532433093|FG000|Subjects That Completed Safety Follow-up|Ineligible|0|||
147621977|NCT01147068|532433094|FG001|Subjects That Completed Safety Follow-up|Ineligible|1|||
147478367|NCT00234104|531909331|FG000|Overall Study|Protocol Violation|0|||
147478368|NCT00234104|531909332|FG001|Overall Study|Protocol Violation|0|||
147621978|NCT01147068|532433095|FG002|Subjects That Completed Safety Follow-up|Ineligible|0|||
147621979|NCT01147068|532433096|FG003|Subjects That Completed Safety Follow-up|Ineligible|0|||
147621980|NCT01147068|532433097|FG004|Subjects That Completed Safety Follow-up|Ineligible|0|||
147478369|NCT00234104|531909333|FG002|Overall Study|Protocol Violation|0|||
147303200|NCT04382924|531276269|FG001|Overall Study|Protocol Violation|1|||
147621981|NCT01147068|532433098|FG005|Subjects That Completed Safety Follow-up|Ineligible|0|||
147621982|NCT01147068|532433099|FG006|Subjects That Completed Safety Follow-up|Ineligible|0|||
147621983|NCT03181633|532433100|FG000|Overall Study|Withdrawal by Subject|1|||
147621984|NCT03181633|532433100|FG000|Overall Study|Missing follow-up visit|1|||
147621985|NCT00699998|532433103|FG000|Overall Study|Withdrawal by Subject|194|||
147621986|NCT00699998|532433104|FG001|Overall Study|Withdrawal by Subject|83|||
147621987|NCT00699998|532433105|FG002|Overall Study|Withdrawal by Subject|202|||
147621988|NCT00699998|532433106|FG003|Overall Study|Withdrawal by Subject|80|||
147621989|NCT00699998|532433103|FG000|Overall Study|Physician Decision|3|||
147621990|NCT00699998|532433104|FG001|Overall Study|Physician Decision|2|||
147621991|NCT00699998|532433105|FG002|Overall Study|Physician Decision|1|||
147621992|NCT00699998|532433106|FG003|Overall Study|Physician Decision|1|||
147621993|NCT00699998|532433103|FG000|Overall Study|Lost to Follow-up|2|||
147621994|NCT00699998|532433104|FG001|Overall Study|Lost to Follow-up|1|||
147621995|NCT00699998|532433105|FG002|Overall Study|Lost to Follow-up|3|||
147621996|NCT00699998|532433106|FG003|Overall Study|Lost to Follow-up|1|||
147621997|NCT01406574|532433107|FG000|Overall Study|Adverse Event|0|||
147621998|NCT01406574|532433108|FG001|Overall Study|Adverse Event|0|||
147621999|NCT01406574|532433109|FG002|Overall Study|Adverse Event|1|||
147622000|NCT01406574|532433110|FG003|Overall Study|Adverse Event|3|||
147622001|NCT01406574|532433107|FG000|Overall Study|Physician Decision|0|||
147622002|NCT01406574|532433108|FG001|Overall Study|Physician Decision|0|||
147622003|NCT01406574|532433109|FG002|Overall Study|Physician Decision|0|||
147622004|NCT01406574|532433110|FG003|Overall Study|Physician Decision|1|||
147622005|NCT01406574|532433107|FG000|Overall Study|Withdrawal by Subject|0|||
147622006|NCT01406574|532433108|FG001|Overall Study|Withdrawal by Subject|1|||
147622007|NCT01406574|532433109|FG002|Overall Study|Withdrawal by Subject|0|||
147622008|NCT01406574|532433110|FG003|Overall Study|Withdrawal by Subject|0|||
147622009|NCT01406574|532433107|FG000|Overall Study|Definite progression of primary disease|1|||
147622010|NCT01406574|532433108|FG001|Overall Study|Definite progression of primary disease|0|||
147622011|NCT01406574|532433109|FG002|Overall Study|Definite progression of primary disease|0|||
147622012|NCT01406574|532433110|FG003|Overall Study|Definite progression of primary disease|0|||
147622013|NCT00946920|532433115|FG000|Overall Study|Withdrawal by Subject|28|||
147622014|NCT00946920|532433116|FG001|Overall Study|Withdrawal by Subject|15|||
147622015|NCT00946920|532433115|FG000|Overall Study|Lost to Follow-up|2|||
147622016|NCT00946920|532433116|FG001|Overall Study|Lost to Follow-up|2|||
147622017|NCT00946920|532433115|FG000|Overall Study|Physician Decision|5|||
147622018|NCT00946920|532433116|FG001|Overall Study|Physician Decision|2|||
147622019|NCT00946920|532433115|FG000|Overall Study|Adverse Event|41|||
147622020|NCT00946920|532433116|FG001|Overall Study|Adverse Event|14|||
147622021|NCT00946920|532433115|FG000|Overall Study|Protocol Violation|16|||
147622022|NCT00946920|532433116|FG001|Overall Study|Protocol Violation|8|||
147622023|NCT00946920|532433115|FG000|Overall Study|Miscellaneous reasons|18|||
147622024|NCT00946920|532433116|FG001|Overall Study|Miscellaneous reasons|3|||
147622025|NCT04616612|532433119|FG000|Overall Study|Lost to Follow-up|6|||
147622026|NCT04616612|532433120|FG001|Overall Study|Lost to Follow-up|3|||
147622027|NCT02964247|532433123|FG000|Overall Study|Lost to Follow-up|2|||
147622028|NCT02964247|532433124|FG001|Overall Study|Lost to Follow-up|0|||
147622029|NCT02964247|532433123|FG000|Overall Study|Withdrawal by Subject|1|||
147622030|NCT02964247|532433124|FG001|Overall Study|Withdrawal by Subject|2|||
147622031|NCT03759392|532433125|FG000|Overall Study|Adverse Event|12|||
147478370|NCT00234104|531909334|FG003|Overall Study|Protocol Violation|1|||
147478371|NCT00234104|531909331|FG000|Overall Study|Physician Decision|0|||
147478372|NCT00234104|531909332|FG001|Overall Study|Physician Decision|1|||
147478373|NCT00234104|531909333|FG002|Overall Study|Physician Decision|2|||
147478374|NCT00234104|531909334|FG003|Overall Study|Physician Decision|2|||
147478375|NCT00546819|531909337|FG000|Overall Study|Adverse Event|2|||
147478376|NCT00546819|531909338|FG001|Overall Study|Adverse Event|3|||
147478377|NCT00546819|531909337|FG000|Overall Study|Lost to Follow-up|2|||
147478378|NCT00546819|531909338|FG001|Overall Study|Lost to Follow-up|1|||
147622032|NCT03759392|532433126|FG001|Overall Study|Adverse Event|4|||
147622033|NCT03759392|532433125|FG000|Overall Study|Death|2|||
147622034|NCT03759392|532433126|FG001|Overall Study|Death|1|||
147622035|NCT03759392|532433125|FG000|Overall Study|Withdrawal by Subject|2|||
147622036|NCT03759392|532433126|FG001|Overall Study|Withdrawal by Subject|0|||
147478379|NCT00546819|531909337|FG000|Overall Study|Withdrawal by Subject|4|||
147478380|NCT00546819|531909338|FG001|Overall Study|Withdrawal by Subject|2|||
147478381|NCT04045613|531909339|FG000|Overall Study|Adverse Event|2|||
147478382|NCT04045613|531909340|FG001|Overall Study|Adverse Event|2|||
147478383|NCT04045613|531909341|FG002|Overall Study|Adverse Event|1|||
147622037|NCT03759392|532433125|FG000|Overall Study|Protocol Violation|2|||
147622038|NCT03759392|532433126|FG001|Overall Study|Protocol Violation|0|||
147622039|NCT03759392|532433125|FG000|Overall Study|Physician Decision|0|||
147622040|NCT03759392|532433126|FG001|Overall Study|Physician Decision|1|||
147622041|NCT03759392|532433125|FG000|Overall Study|Consistently forgot to bring study drug kits to site visits (for compliance check)|1|||
147622042|NCT03759392|532433126|FG001|Overall Study|Consistently forgot to bring study drug kits to site visits (for compliance check)|0|||
147622043|NCT03759392|532433125|FG000|Overall Study|No longer able to take medicines|1|||
147478384|NCT04045613|531909342|FG003|Overall Study|Adverse Event|1|||
147478385|NCT04045613|531909343|FG004|Overall Study|Adverse Event|0|||
147478386|NCT04045613|531909344|FG005|Overall Study|Adverse Event|0|||
147478387|NCT04045613|531909345|FG006|Overall Study|Adverse Event|1|||
147478388|NCT04045613|531909339|FG000|Overall Study|Withdrawal by Subject|0|||
147478389|NCT04045613|531909340|FG001|Overall Study|Withdrawal by Subject|5|||
147478390|NCT04045613|531909341|FG002|Overall Study|Withdrawal by Subject|0|||
147478391|NCT04045613|531909342|FG003|Overall Study|Withdrawal by Subject|0|||
147478392|NCT04045613|531909343|FG004|Overall Study|Withdrawal by Subject|0|||
147478393|NCT04045613|531909344|FG005|Overall Study|Withdrawal by Subject|1|||
147478394|NCT04045613|531909345|FG006|Overall Study|Withdrawal by Subject|0|||
147478395|NCT04045613|531909339|FG000|Overall Study|Physician Decision|2|||
147478396|NCT04045613|531909340|FG001|Overall Study|Physician Decision|0|||
147478397|NCT04045613|531909341|FG002|Overall Study|Physician Decision|0|||
147478398|NCT04045613|531909342|FG003|Overall Study|Physician Decision|0|||
147478399|NCT04045613|531909343|FG004|Overall Study|Physician Decision|1|||
147478400|NCT04045613|531909344|FG005|Overall Study|Physician Decision|0|||
147478401|NCT04045613|531909345|FG006|Overall Study|Physician Decision|0|||
147478402|NCT04045613|531909339|FG000|Overall Study|Death|3|||
147478403|NCT04045613|531909340|FG001|Overall Study|Death|0|||
147478404|NCT04045613|531909341|FG002|Overall Study|Death|0|||
147478405|NCT04045613|531909342|FG003|Overall Study|Death|0|||
147478406|NCT04045613|531909343|FG004|Overall Study|Death|0|||
147478407|NCT04045613|531909344|FG005|Overall Study|Death|0|||
147478408|NCT04045613|531909345|FG006|Overall Study|Death|1|||
147478409|NCT04045613|531909339|FG000|Overall Study|Other reasons|0|||
147478410|NCT04045613|531909340|FG001|Overall Study|Other reasons|1|||
147478411|NCT04045613|531909341|FG002|Overall Study|Other reasons|0|||
147622044|NCT03759392|532433126|FG001|Overall Study|No longer able to take medicines|0|||
147622045|NCT03759392|532433125|FG000|Overall Study|Stopped taking study drug|1|||
147622046|NCT03759392|532433126|FG001|Overall Study|Stopped taking study drug|0|||
147622047|NCT01288079|532433127|FG000|Overall Study|Withdrawal by Subject|2|||
147622048|NCT01288079|532433128|FG001|Overall Study|Withdrawal by Subject|4|||
147622049|NCT01288079|532433129|FG002|Overall Study|Withdrawal by Subject|1|||
147622050|NCT01288079|532433130|FG003|Overall Study|Withdrawal by Subject|0|||
147622051|NCT01288079|532433127|FG000|Overall Study|Adverse Event|2|||
147622052|NCT01288079|532433128|FG001|Overall Study|Adverse Event|1|||
147622053|NCT01288079|532433129|FG002|Overall Study|Adverse Event|2|||
147622054|NCT01288079|532433130|FG003|Overall Study|Adverse Event|3|||
147622055|NCT01288079|532433127|FG000|Overall Study|Severe Non-Compliance to Protocol|1|||
147622056|NCT01288079|532433128|FG001|Overall Study|Severe Non-Compliance to Protocol|3|||
147622057|NCT01288079|532433129|FG002|Overall Study|Severe Non-Compliance to Protocol|1|||
147622058|NCT01288079|532433130|FG003|Overall Study|Severe Non-Compliance to Protocol|3|||
147622059|NCT01288079|532433127|FG000|Overall Study|Condition under Investigation Worsened|0|||
147622060|NCT01288079|532433128|FG001|Overall Study|Condition under Investigation Worsened|0|||
147622061|NCT01288079|532433129|FG002|Overall Study|Condition under Investigation Worsened|0|||
147622062|NCT01288079|532433130|FG003|Overall Study|Condition under Investigation Worsened|1|||
147622063|NCT01288079|532433127|FG000|Overall Study|Lack of Efficacy|2|||
147622064|NCT01288079|532433128|FG001|Overall Study|Lack of Efficacy|2|||
147622065|NCT01288079|532433129|FG002|Overall Study|Lack of Efficacy|0|||
147622066|NCT01288079|532433130|FG003|Overall Study|Lack of Efficacy|2|||
147622067|NCT01288079|532433127|FG000|Overall Study|Study-Specific Withdrawal Criteria|1|||
147622068|NCT01288079|532433128|FG001|Overall Study|Study-Specific Withdrawal Criteria|1|||
147622069|NCT01288079|532433129|FG002|Overall Study|Study-Specific Withdrawal Criteria|0|||
147622070|NCT01288079|532433130|FG003|Overall Study|Study-Specific Withdrawal Criteria|0|||
147622071|NCT01288079|532433127|FG000|Overall Study|Lost to Follow-up|1|||
147622072|NCT01288079|532433128|FG001|Overall Study|Lost to Follow-up|1|||
147622073|NCT01288079|532433129|FG002|Overall Study|Lost to Follow-up|1|||
147622074|NCT01288079|532433130|FG003|Overall Study|Lost to Follow-up|0|||
147622075|NCT01288079|532433127|FG000|Overall Study|Other or Study Termination|11|||
147622076|NCT01288079|532433128|FG001|Overall Study|Other or Study Termination|15|||
147622077|NCT01288079|532433129|FG002|Overall Study|Other or Study Termination|14|||
147622078|NCT01288079|532433130|FG003|Overall Study|Other or Study Termination|8|||
147622079|NCT01530464|532433131|FG000|Washout (24h)|Withdrawal by Subject|1|||
147622080|NCT01530464|532433132|FG001|Washout (24h)|Withdrawal by Subject|0|||
147622081|NCT01530464|532433131|FG000|Washout (24h)|Withdrawal by Subject|0|||
147622082|NCT01530464|532433132|FG001|Washout (24h)|Withdrawal by Subject|1|||
147622083|NCT01709500|532433133|FG000|Overall Study|Randomized but not treated|0|||
147478412|NCT04045613|531909342|FG003|Overall Study|Other reasons|0|||
147478413|NCT04045613|531909343|FG004|Overall Study|Other reasons|0|||
147478414|NCT04045613|531909344|FG005|Overall Study|Other reasons|0|||
147478415|NCT04045613|531909345|FG006|Overall Study|Other reasons|1|||
147478416|NCT04045613|531909339|FG000|Overall Study|Progressive disease: Clinical progression|1|||
147478417|NCT04045613|531909340|FG001|Overall Study|Progressive disease: Clinical progression|0|||
147478418|NCT04045613|531909341|FG002|Overall Study|Progressive disease: Clinical progression|3|||
147478419|NCT04045613|531909342|FG003|Overall Study|Progressive disease: Clinical progression|1|||
147478420|NCT04045613|531909343|FG004|Overall Study|Progressive disease: Clinical progression|1|||
147478421|NCT04045613|531909344|FG005|Overall Study|Progressive disease: Clinical progression|3|||
147478422|NCT04045613|531909345|FG006|Overall Study|Progressive disease: Clinical progression|3|||
147478423|NCT04045613|531909339|FG000|Overall Study|Progressive disease: Radiological progression|24|||
147478424|NCT04045613|531909340|FG001|Overall Study|Progressive disease: Radiological progression|6|||
147478425|NCT04045613|531909341|FG002|Overall Study|Progressive disease: Radiological progression|8|||
147478426|NCT04045613|531909342|FG003|Overall Study|Progressive disease: Radiological progression|0|||
147478427|NCT04045613|531909343|FG004|Overall Study|Progressive disease: Radiological progression|6|||
147478428|NCT04045613|531909344|FG005|Overall Study|Progressive disease: Radiological progression|6|||
147478429|NCT04045613|531909345|FG006|Overall Study|Progressive disease: Radiological progression|11|||
147478430|NCT03114969|531909352|FG000|Overall Study|Lost to Follow-up|0|||
147478431|NCT03114969|531909353|FG001|Overall Study|Lost to Follow-up|0|||
147478432|NCT03114969|531909354|FG002|Overall Study|Lost to Follow-up|3|||
147478433|NCT03114969|531909355|FG003|Overall Study|Lost to Follow-up|2|||
147478434|NCT03114969|531909356|FG004|Overall Study|Lost to Follow-up|0|||
147478435|NCT03114969|531909357|FG005|Overall Study|Lost to Follow-up|0|||
147478436|NCT03114969|531909358|FG006|Overall Study|Lost to Follow-up|0|||
147478437|NCT03114969|531909359|FG007|Overall Study|Lost to Follow-up|0|||
147478438|NCT03114969|531909360|FG008|Overall Study|Lost to Follow-up|0|||
147478439|NCT03114969|531909352|FG000|Overall Study|Adverse Event|0|||
147478440|NCT03114969|531909353|FG001|Overall Study|Adverse Event|0|||
147622084|NCT01709500|532433134|FG001|Overall Study|Randomized but not treated|1|||
147622085|NCT01709500|532433133|FG000|Overall Study|Adverse Event|5|||
147622086|NCT01709500|532433134|FG001|Overall Study|Adverse Event|1|||
147622087|NCT01709500|532433133|FG000|Overall Study|Poor compliance to protocol|2|||
147622088|NCT01709500|532433134|FG001|Overall Study|Poor compliance to protocol|1|||
147622089|NCT01709500|532433133|FG000|Overall Study|Other|3|||
147622090|NCT01709500|532433134|FG001|Overall Study|Other|1|||
147622091|NCT01709500|532433133|FG000|Overall Study|Related to IMP administration|1|||
147622092|NCT01709500|532433134|FG001|Overall Study|Related to IMP administration|0|||
147622093|NCT01709500|532433133|FG000|Overall Study|Treatment ongoing|156|||
147622094|NCT01709500|532433134|FG001|Overall Study|Treatment ongoing|78|||
147622095|NCT03170544|532433135|FG000|Part 1|Lost to Follow-up|1|||
147622096|NCT03170544|532433136|FG001|Part 1|Lost to Follow-up|0|||
147622097|NCT03170544|532433137|FG002|Part 1|Lost to Follow-up|0|||
147622098|NCT03170544|532433138|FG003|Part 1|Lost to Follow-up|0|||
147622099|NCT03170544|532433139|FG004|Part 1|Lost to Follow-up|0|||
147622100|NCT03170544|532433140|FG005|Part 1|Lost to Follow-up|0|||
147622101|NCT03170544|532433141|FG006|Part 1|Lost to Follow-up|0|||
147622102|NCT03170544|532433142|FG007|Part 1|Lost to Follow-up|0|||
147622103|NCT03170544|532433143|FG008|Part 1|Lost to Follow-up|0|||
147622104|NCT03170544|532433144|FG009|Part 1|Lost to Follow-up|0|||
147622105|NCT03170544|532433145|FG010|Part 1|Lost to Follow-up|0|||
147622106|NCT03170544|532433146|FG011|Part 1|Lost to Follow-up|0|||
147622107|NCT03170544|532433135|FG000|Part 1|Not treated|0|||
147622108|NCT03170544|532433136|FG001|Part 1|Not treated|0|||
147622109|NCT03170544|532433137|FG002|Part 1|Not treated|0|||
147622110|NCT03170544|532433138|FG003|Part 1|Not treated|1|||
147622111|NCT03170544|532433139|FG004|Part 1|Not treated|0|||
147622112|NCT03170544|532433140|FG005|Part 1|Not treated|0|||
147622113|NCT03170544|532433141|FG006|Part 1|Not treated|0|||
147622114|NCT03170544|532433142|FG007|Part 1|Not treated|0|||
147622115|NCT03170544|532433143|FG008|Part 1|Not treated|0|||
147622116|NCT03170544|532433144|FG009|Part 1|Not treated|0|||
147622117|NCT03170544|532433145|FG010|Part 1|Not treated|0|||
147622118|NCT03170544|532433146|FG011|Part 1|Not treated|0|||
147622119|NCT02387840|532433147|FG000|Overall Study|Death|0|||
147622120|NCT02387840|532433148|FG001|Overall Study|Death|0|||
147622121|NCT02387840|532433149|FG002|Overall Study|Death|0|||
147622122|NCT02387840|532433150|FG003|Overall Study|Death|0|||
147622123|NCT02387840|532433151|FG004|Overall Study|Death|0|||
147622124|NCT02387840|532433152|FG005|Overall Study|Death|1|||
147622125|NCT00420420|532433155|FG000|Overall Study|Adverse Event|5|||
147622126|NCT00420420|532433156|FG001|Overall Study|Adverse Event|3|||
147622127|NCT00420420|532433155|FG000|Overall Study|Protocol Violation|1|||
147478441|NCT03114969|531909354|FG002|Overall Study|Adverse Event|1|||
147622128|NCT00420420|532433156|FG001|Overall Study|Protocol Violation|1|||
147622129|NCT00420420|532433155|FG000|Overall Study|Withdrawal by Subject|1|||
147622130|NCT00420420|532433156|FG001|Overall Study|Withdrawal by Subject|0|||
147622131|NCT00420420|532433155|FG000|Overall Study|sponsor decision (abnormal ECG @ screen)|1|||
147622132|NCT00420420|532433156|FG001|Overall Study|sponsor decision (abnormal ECG @ screen)|0|||
147622133|NCT02208362|532433157|FG000|Overall Study|Participant did not complete treatment|0|||
147622134|NCT02208362|532433158|FG001|Overall Study|Participant did not complete treatment|1|||
147622135|NCT02208362|532433159|FG002|Overall Study|Participant did not complete treatment|0|||
147622136|NCT02208362|532433160|FG003|Overall Study|Participant did not complete treatment|0|||
147622137|NCT02208362|532433161|FG004|Overall Study|Participant did not complete treatment|0|||
147622138|NCT02208362|532433162|FG005|Overall Study|Participant did not complete treatment|0|||
147622139|NCT02208362|532433163|FG006|Overall Study|Participant did not complete treatment|1|||
147478442|NCT03114969|531909355|FG003|Overall Study|Adverse Event|0|||
147478443|NCT03114969|531909356|FG004|Overall Study|Adverse Event|0|||
147478444|NCT03114969|531909357|FG005|Overall Study|Adverse Event|1|||
147478445|NCT03114969|531909358|FG006|Overall Study|Adverse Event|1|||
147478446|NCT03114969|531909359|FG007|Overall Study|Adverse Event|0|||
147478447|NCT03114969|531909360|FG008|Overall Study|Adverse Event|2|||
147478448|NCT01743027|531909365|FG000|Overall Study|Adverse Event|2|||
147478449|NCT01743027|531909366|FG001|Overall Study|Adverse Event|0|||
147478450|NCT01743027|531909367|FG002|Overall Study|Adverse Event|0|||
147478451|NCT01743027|531909368|FG003|Overall Study|Adverse Event|0|||
147478452|NCT01743027|531909365|FG000|Overall Study|Lost to Follow-up|0|||
147478453|NCT01743027|531909366|FG001|Overall Study|Lost to Follow-up|0|||
147478454|NCT01743027|531909367|FG002|Overall Study|Lost to Follow-up|2|||
147478455|NCT01743027|531909368|FG003|Overall Study|Lost to Follow-up|0|||
147478456|NCT01743027|531909365|FG000|Overall Study|Progressive Disease|1|||
147478457|NCT01743027|531909366|FG001|Overall Study|Progressive Disease|4|||
147478458|NCT01743027|531909367|FG002|Overall Study|Progressive Disease|3|||
147478459|NCT01743027|531909368|FG003|Overall Study|Progressive Disease|0|||
147478460|NCT01743027|531909365|FG000|Overall Study|Protocol Violation|1|||
147478461|NCT01743027|531909366|FG001|Overall Study|Protocol Violation|1|||
147478462|NCT01743027|531909367|FG002|Overall Study|Protocol Violation|1|||
147478463|NCT01743027|531909368|FG003|Overall Study|Protocol Violation|0|||
147478464|NCT01743027|531909365|FG000|Overall Study|Withdrawal by Subject|1|||
147478465|NCT01743027|531909366|FG001|Overall Study|Withdrawal by Subject|0|||
147478466|NCT01743027|531909367|FG002|Overall Study|Withdrawal by Subject|3|||
147478467|NCT01743027|531909368|FG003|Overall Study|Withdrawal by Subject|1|||
147478468|NCT00450866|531909369|FG000|Overall Study|Adverse Event|0|||
147478469|NCT00450866|531909370|FG001|Overall Study|Adverse Event|1|||
147478470|NCT00450866|531909369|FG000|Overall Study|Withdrawal by Subject|5|||
147478471|NCT00450866|531909370|FG001|Overall Study|Withdrawal by Subject|2|||
147478472|NCT00450866|531909369|FG000|Overall Study|Death|1|||
147478473|NCT00450866|531909370|FG001|Overall Study|Death|0|||
147478474|NCT00450866|531909369|FG000|Overall Study|Physician Decision|1|||
147478475|NCT00450866|531909370|FG001|Overall Study|Physician Decision|0|||
147478476|NCT05121103|531909371|FG000|Overall Study|Progressive disease|2|||
147478477|NCT05121103|531909372|FG001|Overall Study|Progressive disease|1|||
147478478|NCT05121103|531909373|FG002|Overall Study|Progressive disease|6|||
147478479|NCT05121103|531909371|FG000|Overall Study|Physician Decision|2|||
147478480|NCT05121103|531909372|FG001|Overall Study|Physician Decision|1|||
147478481|NCT05121103|531909373|FG002|Overall Study|Physician Decision|0|||
147478482|NCT05121103|531909371|FG000|Overall Study|Withdrawal by Subject|0|||
147478483|NCT05121103|531909372|FG001|Overall Study|Withdrawal by Subject|1|||
147478484|NCT05121103|531909373|FG002|Overall Study|Withdrawal by Subject|0|||
147478485|NCT02111811|531909374|FG000|Treatment Phase|Lost to Follow-up|22|||
147478486|NCT02111811|531909375|FG001|Treatment Phase|Lost to Follow-up|18|||
147478487|NCT02111811|531909374|FG000|Treatment Phase|Death|2|||
147478488|NCT02111811|531909375|FG001|Treatment Phase|Death|0|||
147478489|NCT02111811|531909374|FG000|Follow up Period (Aim 2)|Lost to Follow-up|26|||
147478490|NCT02111811|531909375|FG001|Follow up Period (Aim 2)|Lost to Follow-up|17|||
147478491|NCT02111811|531909374|FG000|Follow up Period (Aim 2)|Death|2|||
147478492|NCT02111811|531909375|FG001|Follow up Period (Aim 2)|Death|0|||
147478493|NCT03443024|531909380|FG000|Overall Study|Adverse Event|2|||
147478494|NCT03443024|531909381|FG001|Overall Study|Adverse Event|4|||
147478495|NCT03443024|531909382|FG002|Overall Study|Adverse Event|3|||
147478496|NCT03443024|531909383|FG003|Overall Study|Adverse Event|1|||
147478497|NCT03443024|531909380|FG000|Overall Study|Lost to Follow-up|9|||
147478498|NCT03443024|531909381|FG001|Overall Study|Lost to Follow-up|9|||
147478499|NCT03443024|531909382|FG002|Overall Study|Lost to Follow-up|7|||
147478500|NCT03443024|531909383|FG003|Overall Study|Lost to Follow-up|5|||
147478501|NCT03443024|531909380|FG000|Overall Study|Withdrawal by Subject|8|||
147478502|NCT03443024|531909381|FG001|Overall Study|Withdrawal by Subject|15|||
147478503|NCT03443024|531909382|FG002|Overall Study|Withdrawal by Subject|9|||
147478504|NCT03443024|531909383|FG003|Overall Study|Withdrawal by Subject|23|||
147478505|NCT03443024|531909380|FG000|Overall Study|Physician Decision|1|||
147478506|NCT03443024|531909381|FG001|Overall Study|Physician Decision|2|||
147478507|NCT03443024|531909382|FG002|Overall Study|Physician Decision|0|||
147478508|NCT03443024|531909383|FG003|Overall Study|Physician Decision|1|||
147478509|NCT03443024|531909380|FG000|Overall Study|Sponsor Decision|1|||
147478510|NCT03443024|531909381|FG001|Overall Study|Sponsor Decision|1|||
147622140|NCT02208362|532433164|FG007|Overall Study|Participant did not complete treatment|1|||
147622141|NCT02208362|532433165|FG008|Overall Study|Participant did not complete treatment|2|||
147303201|NCT04382924|531276270|FG002|Overall Study|Protocol Violation|1|||
147478511|NCT03443024|531909382|FG002|Overall Study|Sponsor Decision|0|||
147478512|NCT03443024|531909383|FG003|Overall Study|Sponsor Decision|0|||
147478513|NCT03443024|531909380|FG000|Overall Study|Protocol Deviation|0|||
147478514|NCT03443024|531909381|FG001|Overall Study|Protocol Deviation|0|||
147478515|NCT03443024|531909382|FG002|Overall Study|Protocol Deviation|0|||
147478516|NCT03443024|531909383|FG003|Overall Study|Protocol Deviation|2|||
147478517|NCT01359982|531909384|FG000|Overall Study|Adverse Event|2|||
147478518|NCT01359982|531909385|FG001|Overall Study|Adverse Event|0|||
147478519|NCT01359982|531909386|FG002|Overall Study|Adverse Event|0|||
147478520|NCT01359982|531909387|FG003|Overall Study|Adverse Event|1|||
147478521|NCT01359982|531909388|FG004|Overall Study|Adverse Event|0|||
147478522|NCT01359982|531909389|FG005|Overall Study|Adverse Event|0|||
147478523|NCT01359982|531909384|FG000|Overall Study|Death|1|||
147478524|NCT01359982|531909385|FG001|Overall Study|Death|0|||
147478525|NCT01359982|531909386|FG002|Overall Study|Death|0|||
147478526|NCT01359982|531909387|FG003|Overall Study|Death|0|||
147478527|NCT01359982|531909388|FG004|Overall Study|Death|0|||
147478528|NCT01359982|531909389|FG005|Overall Study|Death|0|||
147478529|NCT05593432|531909390|FG000|16-Week DBVC Period|Withdrawal by Subject|2|||
147478530|NCT05593432|531909391|FG001|16-Week DBVC Period|Withdrawal by Subject|3|||
147478531|NCT05593432|531909392|FG002|16-Week DBVC Period|Withdrawal by Subject|0|||
147478532|NCT05593432|531909393|FG003|16-Week DBVC Period|Withdrawal by Subject|0|||
147478533|NCT05593432|531909390|FG000|16-Week OLE Period|Lack of Efficacy|0|||
147478534|NCT05593432|531909391|FG001|16-Week OLE Period|Lack of Efficacy|0|||
147478535|NCT05593432|531909392|FG002|16-Week OLE Period|Lack of Efficacy|0|||
147478536|NCT05593432|531909393|FG003|16-Week OLE Period|Lack of Efficacy|1|||
147478537|NCT05593432|531909390|FG000|16-Week OLE Period|Lost to Follow-up|0|||
147478538|NCT05593432|531909391|FG001|16-Week OLE Period|Lost to Follow-up|0|||
147478539|NCT05593432|531909392|FG002|16-Week OLE Period|Lost to Follow-up|1|||
147478540|NCT05593432|531909393|FG003|16-Week OLE Period|Lost to Follow-up|2|||
147478541|NCT05593432|531909390|FG000|16-Week OLE Period|Withdrawal by Subject|0|||
147478542|NCT05593432|531909391|FG001|16-Week OLE Period|Withdrawal by Subject|0|||
147478543|NCT05593432|531909392|FG002|16-Week OLE Period|Withdrawal by Subject|0|||
147478544|NCT05593432|531909393|FG003|16-Week OLE Period|Withdrawal by Subject|3|||
147478545|NCT01926886|531909396|FG000|Overall Study|Administrative/other|1|||
147478546|NCT01926886|531909397|FG001|Overall Study|Administrative/other|0|||
147478547|NCT01926886|531909396|FG000|Overall Study|Adverse event/intercurrent illness|4|||
147478548|NCT01926886|531909397|FG001|Overall Study|Adverse event/intercurrent illness|0|||
147478549|NCT01926886|531909396|FG000|Overall Study|Disease progression/recurrence|4|||
147478550|NCT01926886|531909397|FG001|Overall Study|Disease progression/recurrence|0|||
147478551|NCT01926886|531909396|FG000|Overall Study|Withdrawal by Subject|15|||
147478552|NCT01926886|531909397|FG001|Overall Study|Withdrawal by Subject|0|||
147478553|NCT01926886|531909396|FG000|Overall Study|Failure to return|3|||
147478554|NCT01926886|531909397|FG001|Overall Study|Failure to return|0|||
147478555|NCT01926886|531909396|FG000|Overall Study|Recurrence of disease|1|||
147478556|NCT01926886|531909397|FG001|Overall Study|Recurrence of disease|0|||
147478557|NCT01926886|531909396|FG000|Overall Study|Progression of disease|2|||
147478558|NCT01926886|531909397|FG001|Overall Study|Progression of disease|0|||
147478559|NCT01926886|531909396|FG000|Overall Study|Death|1|||
147478560|NCT01926886|531909397|FG001|Overall Study|Death|0|||
147478561|NCT01926886|531909396|FG000|Overall Study|Did not cooperate|1|||
147478562|NCT01926886|531909397|FG001|Overall Study|Did not cooperate|0|||
147478563|NCT02609399|531909401|FG000|Influenza Season 2015-2016|Lost to Follow-up|3|||
147478564|NCT02609399|531909402|FG001|Influenza Season 2015-2016|Lost to Follow-up|2|||
147478565|NCT02609399|531909401|FG000|Influenza Season 2016-2017|Lost to Follow-up|8|||
147478566|NCT02609399|531909402|FG001|Influenza Season 2016-2017|Lost to Follow-up|5|||
147478567|NCT02609399|531909401|FG000|Influenza Season 2016-2017|Found ineligible after randomization|1|||
147478568|NCT02609399|531909402|FG001|Influenza Season 2016-2017|Found ineligible after randomization|0|||
147478569|NCT04725682|531909405|FG000|Overall Study|Withdrawal by Subject|7|||
147478570|NCT04725682|531909406|FG001|Overall Study|Withdrawal by Subject|5|||
147478571|NCT04725682|531909405|FG000|Overall Study|Failed to comply with the requirements|2|||
147478572|NCT04725682|531909406|FG001|Overall Study|Failed to comply with the requirements|1|||
147478573|NCT04725682|531909405|FG000|Overall Study|Adverse Event|1|||
147478574|NCT04725682|531909406|FG001|Overall Study|Adverse Event|1|||
147478575|NCT04725682|531909405|FG000|Overall Study|Death|0|||
147478576|NCT04725682|531909406|FG001|Overall Study|Death|1|||
147478577|NCT00964795|531909407|FG000|Overall Study|Withdrawal by Subject|79|||
147478578|NCT00964795|531909407|FG000|Overall Study|Adverse Event|12|||
147478579|NCT00964795|531909407|FG000|Overall Study|Death|14|||
147478580|NCT00964795|531909407|FG000|Overall Study|Lost to Follow-up|7|||
147478581|NCT00964795|531909407|FG000|Overall Study|Termination of Study by Sponsor|169|||
147478582|NCT00964795|531909407|FG000|Overall Study|Unwilling to sign ICF for amendment 4|3|||
147478583|NCT00964795|531909407|FG000|Overall Study|Other|23|||
147478584|NCT02453841|531909411|FG000|Overall Study|Protocol Violation|1|||
147478585|NCT02453841|531909411|FG000|Overall Study|Unable to obtain blood samples|2|||
147478586|NCT00857246|531909412|FG000|Induction Regimen|Adverse Event|1|||
147478587|NCT00857246|531909412|FG000|Induction Regimen|disease-related complications|1|||
147478588|NCT00857246|531909412|FG000|Induction Regimen|Withdrawal by Subject|1|||
147622142|NCT02208362|532433166|FG009|Overall Study|Participant did not complete treatment|0|||
147622143|NCT02208362|532433167|FG010|Overall Study|Participant did not complete treatment|1|||
147622144|NCT02208362|532433168|FG011|Overall Study|Participant did not complete treatment|0|||
147478589|NCT00857246|531909412|FG000|Surgery (Curative)|disease progression|6|||
147478590|NCT00857246|531909412|FG000|ChemoRT|Withdrawal by Subject|1|||
147478591|NCT00857246|531909412|FG000|ChemoRT|Adverse Event|2|||
147478592|NCT00072189|531909413|FG000|Overall Study|Withdrawal by Subject|1|||
147478593|NCT02973815|531909414|FG000|Post Intervention|Death|1|||
147478594|NCT02973815|531909415|FG001|Post Intervention|Death|0|||
147478595|NCT02973815|531909414|FG000|Post Intervention|Lost to Follow-up|7|||
147478596|NCT02973815|531909415|FG001|Post Intervention|Lost to Follow-up|24|||
147478597|NCT02973815|531909414|FG000|Follow-up|Lost to Follow-up|2|||
147478598|NCT02973815|531909415|FG001|Follow-up|Lost to Follow-up|0|||
147478599|NCT04542291|531909416|FG000|Overall Study|Adverse Event|1|||
147478600|NCT04542291|531909416|FG000|Overall Study|Physician Decision|2|||
147478601|NCT01855789|531909426|FG000|1) Baseline up to Week 24|Adverse Event|37|||
147478602|NCT01855789|531909427|FG001|1) Baseline up to Week 24|Adverse Event|0|||
147478603|NCT01855789|531909428|FG002|1) Baseline up to Week 24|Adverse Event|0|||
147478604|NCT01855789|531909429|FG003|1) Baseline up to Week 24|Adverse Event|0|||
147478605|NCT01855789|531909426|FG000|1) Baseline up to Week 24|Death|2|||
147478606|NCT01855789|531909427|FG001|1) Baseline up to Week 24|Death|0|||
147478607|NCT01855789|531909428|FG002|1) Baseline up to Week 24|Death|0|||
147478608|NCT01855789|531909429|FG003|1) Baseline up to Week 24|Death|0|||
147478609|NCT01855789|531909426|FG000|1) Baseline up to Week 24|Lack of Efficacy|16|||
147478610|NCT01855789|531909427|FG001|1) Baseline up to Week 24|Lack of Efficacy|0|||
147478611|NCT01855789|531909428|FG002|1) Baseline up to Week 24|Lack of Efficacy|0|||
147478612|NCT01855789|531909429|FG003|1) Baseline up to Week 24|Lack of Efficacy|0|||
147478613|NCT01855789|531909426|FG000|1) Baseline up to Week 24|Lost to Follow-up|11|||
147478614|NCT01855789|531909427|FG001|1) Baseline up to Week 24|Lost to Follow-up|0|||
147478615|NCT01855789|531909428|FG002|1) Baseline up to Week 24|Lost to Follow-up|0|||
147478616|NCT01855789|531909429|FG003|1) Baseline up to Week 24|Lost to Follow-up|0|||
147478617|NCT01855789|531909426|FG000|1) Baseline up to Week 24|Protocol Violation|4|||
147478618|NCT01855789|531909427|FG001|1) Baseline up to Week 24|Protocol Violation|0|||
147478619|NCT01855789|531909428|FG002|1) Baseline up to Week 24|Protocol Violation|0|||
147478620|NCT01855789|531909429|FG003|1) Baseline up to Week 24|Protocol Violation|0|||
147478621|NCT01855789|531909426|FG000|1) Baseline up to Week 24|Withdrawal by Subject|31|||
147478622|NCT01855789|531909427|FG001|1) Baseline up to Week 24|Withdrawal by Subject|0|||
147478623|NCT01855789|531909428|FG002|1) Baseline up to Week 24|Withdrawal by Subject|0|||
147478624|NCT01855789|531909429|FG003|1) Baseline up to Week 24|Withdrawal by Subject|0|||
147478625|NCT01855789|531909426|FG000|1) Baseline up to Week 24|Physician Decision|4|||
147478626|NCT01855789|531909427|FG001|1) Baseline up to Week 24|Physician Decision|0|||
147478627|NCT01855789|531909428|FG002|1) Baseline up to Week 24|Physician Decision|0|||
147478628|NCT01855789|531909429|FG003|1) Baseline up to Week 24|Physician Decision|0|||
147478629|NCT01855789|531909426|FG000|1) Baseline up to Week 24|Pregnancy|1|||
147478630|NCT01855789|531909427|FG001|1) Baseline up to Week 24|Pregnancy|0|||
147478631|NCT01855789|531909428|FG002|1) Baseline up to Week 24|Pregnancy|0|||
147478632|NCT01855789|531909429|FG003|1) Baseline up to Week 24|Pregnancy|0|||
147478633|NCT01855789|531909426|FG000|1) Baseline up to Week 24|Participant Non-compliance|3|||
147478634|NCT01855789|531909427|FG001|1) Baseline up to Week 24|Participant Non-compliance|0|||
147478635|NCT01855789|531909428|FG002|1) Baseline up to Week 24|Participant Non-compliance|0|||
147478636|NCT01855789|531909429|FG003|1) Baseline up to Week 24|Participant Non-compliance|0|||
147478637|NCT01855789|531909426|FG000|1) Baseline up to Week 24|Sponsor Decision|3|||
147478638|NCT01855789|531909427|FG001|1) Baseline up to Week 24|Sponsor Decision|0|||
147478639|NCT01855789|531909428|FG002|1) Baseline up to Week 24|Sponsor Decision|0|||
147478640|NCT01855789|531909429|FG003|1) Baseline up to Week 24|Sponsor Decision|0|||
147478641|NCT01855789|531909426|FG000|1) Baseline up to Week 24|Other|4|||
147478642|NCT01855789|531909427|FG001|1) Baseline up to Week 24|Other|0|||
147478643|NCT01855789|531909428|FG002|1) Baseline up to Week 24|Other|0|||
147478644|NCT01855789|531909429|FG003|1) Baseline up to Week 24|Other|0|||
147478645|NCT01855789|531909426|FG000|2) Week 24 up to End of Study|Adverse Event|0|||
147478646|NCT01855789|531909427|FG001|2) Week 24 up to End of Study|Adverse Event|4|||
147478647|NCT01855789|531909428|FG002|2) Week 24 up to End of Study|Adverse Event|5|||
147478648|NCT01855789|531909429|FG003|2) Week 24 up to End of Study|Adverse Event|21|||
147478649|NCT01855789|531909426|FG000|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|0|||
147478650|NCT01855789|531909427|FG001|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|0|||
147478651|NCT01855789|531909428|FG002|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|0|||
147478652|NCT01855789|531909429|FG003|2) Week 24 up to End of Study|Serious Hypersensitivity Reaction|1|||
147478653|NCT01855789|531909426|FG000|2) Week 24 up to End of Study|Lack of Efficacy|0|||
147478654|NCT01855789|531909427|FG001|2) Week 24 up to End of Study|Lack of Efficacy|2|||
147478655|NCT01855789|531909428|FG002|2) Week 24 up to End of Study|Lack of Efficacy|5|||
147478656|NCT01855789|531909429|FG003|2) Week 24 up to End of Study|Lack of Efficacy|16|||
147478657|NCT01855789|531909426|FG000|2) Week 24 up to End of Study|Lost to Follow-up|0|||
147478658|NCT01855789|531909427|FG001|2) Week 24 up to End of Study|Lost to Follow-up|1|||
147478659|NCT01855789|531909428|FG002|2) Week 24 up to End of Study|Lost to Follow-up|1|||
147478660|NCT01855789|531909429|FG003|2) Week 24 up to End of Study|Lost to Follow-up|4|||
147478661|NCT01855789|531909426|FG000|2) Week 24 up to End of Study|Protocol Violation|0|||
147478662|NCT01855789|531909427|FG001|2) Week 24 up to End of Study|Protocol Violation|0|||
147478663|NCT01855789|531909428|FG002|2) Week 24 up to End of Study|Protocol Violation|0|||
147478664|NCT01855789|531909429|FG003|2) Week 24 up to End of Study|Protocol Violation|1|||
147478665|NCT01855789|531909426|FG000|2) Week 24 up to End of Study|Withdrawal by Subject|0|||
147478666|NCT01855789|531909427|FG001|2) Week 24 up to End of Study|Withdrawal by Subject|7|||
147478667|NCT01855789|531909428|FG002|2) Week 24 up to End of Study|Withdrawal by Subject|5|||
147478668|NCT01855789|531909429|FG003|2) Week 24 up to End of Study|Withdrawal by Subject|8|||
147478669|NCT01855789|531909426|FG000|2) Week 24 up to End of Study|Physician Decision|0|||
147478670|NCT01855789|531909427|FG001|2) Week 24 up to End of Study|Physician Decision|0|||
147478671|NCT01855789|531909428|FG002|2) Week 24 up to End of Study|Physician Decision|2|||
147478672|NCT01855789|531909429|FG003|2) Week 24 up to End of Study|Physician Decision|4|||
147478673|NCT01855789|531909426|FG000|2) Week 24 up to End of Study|Participant Non-compliance|0|||
147478674|NCT01855789|531909427|FG001|2) Week 24 up to End of Study|Participant Non-compliance|1|||
147478675|NCT01855789|531909428|FG002|2) Week 24 up to End of Study|Participant Non-compliance|0|||
147478676|NCT01855789|531909429|FG003|2) Week 24 up to End of Study|Participant Non-compliance|1|||
147478677|NCT01855789|531909426|FG000|2) Week 24 up to End of Study|Sponsor Decision|0|||
147478678|NCT01855789|531909427|FG001|2) Week 24 up to End of Study|Sponsor Decision|0|||
147478679|NCT01855789|531909428|FG002|2) Week 24 up to End of Study|Sponsor Decision|0|||
147478680|NCT01855789|531909429|FG003|2) Week 24 up to End of Study|Sponsor Decision|1|||
147478681|NCT01855789|531909426|FG000|2) Week 24 up to End of Study|Other|0|||
147478682|NCT01855789|531909427|FG001|2) Week 24 up to End of Study|Other|0|||
147478683|NCT01855789|531909428|FG002|2) Week 24 up to End of Study|Other|0|||
147478684|NCT01855789|531909429|FG003|2) Week 24 up to End of Study|Other|1|||
147478685|NCT01863758|531909430|FG000|Prophylactic Treatment-Phase II|investigator Error of Early Termination|1|||
147478686|NCT01863758|531909430|FG000|Prophylactic Treatment-Phase II|Lost to Follow-up|1|||
147478687|NCT02606877|531909431|FG000|Overall Study|Adverse Event|3|||
147478688|NCT02606877|531909432|FG001|Overall Study|Adverse Event|0|||
147478689|NCT02606877|531909431|FG000|Overall Study|Non-compliance with protocol|0|||
147478690|NCT02606877|531909432|FG001|Overall Study|Non-compliance with protocol|1|||
147478691|NCT02606877|531909431|FG000|Overall Study|Other than listed above|1|||
147478692|NCT02606877|531909432|FG001|Overall Study|Other than listed above|0|||
147478693|NCT04952389|531909435|FG000|Overall Study|Withdrawal by Subject|8|||
147478694|NCT04952389|531909436|FG001|Overall Study|Withdrawal by Subject|4|||
147478695|NCT00778999|531909437|FG000|Overall Study|Discontinuation: no embryo transfer|14|||
147478696|NCT00778999|531909438|FG001|Overall Study|Discontinuation: no embryo transfer|14|||
147478697|NCT00778999|531909437|FG000|Overall Study|Did not receive recFSH|14|||
147478698|NCT00778999|531909438|FG001|Overall Study|Did not receive recFSH|20|||
147478699|NCT02839746|531910507|FG000|Overall Study|Not met selection criteria|12|||
147478700|NCT02089737|531910508|FG000|Overall Study|Survey form not completed|5|||
147478701|NCT02089737|531910508|FG000|Overall Study|Not treated|1|||
147478702|NCT01300286|531910509|FG000|Overall Study|did not get dosed|1|||
147478703|NCT00744055|531910510|FG000|Overall Study|Withdrawal by Subject|6|||
147478704|NCT00744055|531910511|FG001|Overall Study|Withdrawal by Subject|9|||
147478705|NCT00744055|531910510|FG000|Overall Study|Lack of Efficacy|0|||
147478706|NCT00744055|531910511|FG001|Overall Study|Lack of Efficacy|1|||
147478707|NCT00744055|531910510|FG000|Overall Study|Physician Decision|0|||
147478708|NCT00744055|531910511|FG001|Overall Study|Physician Decision|2|||
147478709|NCT00744055|531910510|FG000|Overall Study|Protocol Violation|1|||
147478710|NCT00744055|531910511|FG001|Overall Study|Protocol Violation|1|||
147478711|NCT00744055|531910510|FG000|Overall Study|Lost to Follow-up|0|||
147478712|NCT00744055|531910511|FG001|Overall Study|Lost to Follow-up|1|||
147478713|NCT02767570|531910512|FG000|Overall Study|Lost to Follow-up|3|||
147478714|NCT02767570|531910513|FG001|Overall Study|Lost to Follow-up|0|||
147478715|NCT02767570|531910512|FG000|Overall Study|COVID shutdown|2|||
147478716|NCT02767570|531910513|FG001|Overall Study|COVID shutdown|5|||
147478717|NCT02767570|531910512|FG000|Overall Study|Increased pain|2|||
147478718|NCT02767570|531910513|FG001|Overall Study|Increased pain|0|||
147478719|NCT02767570|531910512|FG000|Overall Study|Withdrawal by Subject|1|||
147478720|NCT02767570|531910513|FG001|Overall Study|Withdrawal by Subject|3|||
147478721|NCT02767570|531910512|FG000|Overall Study|Unrelated medical issue|1|||
147478722|NCT02767570|531910513|FG001|Overall Study|Unrelated medical issue|1|||
147478723|NCT02767570|531910512|FG000|Overall Study|Received intra-articular injection|0|||
147478724|NCT02767570|531910513|FG001|Overall Study|Received intra-articular injection|1|||
147478725|NCT04426630|531910514|FG000|Overall Study|Death|4|||
147478726|NCT04426630|531910514|FG000|Overall Study|Lost to Follow-up|2|||
147478727|NCT01306058|531910515|FG000|Overall Study|Death|1|||
147478728|NCT01306058|531910515|FG000|Overall Study|Enrolled but did not get treatment|1|||
147478729|NCT03842709|531910516|FG000|Overall Study|Withdrawal by Subject|3|||
147478730|NCT03842709|531910517|FG001|Overall Study|Withdrawal by Subject|3|||
147478731|NCT03842709|531910516|FG000|Overall Study|Lost to Follow-up|1|||
147478732|NCT03842709|531910517|FG001|Overall Study|Lost to Follow-up|0|||
147478733|NCT00984659|531910518|FG000|2-week Run-in Period|Adverse Event|8|||
147478734|NCT00984659|531910519|FG001|2-week Run-in Period|Adverse Event|0|||
147478735|NCT00984659|531910520|FG002|2-week Run-in Period|Adverse Event|0|||
147478736|NCT00984659|531910521|FG003|2-week Run-in Period|Adverse Event|0|||
147478737|NCT00984659|531910518|FG000|2-week Run-in Period|Protocol Violation|5|||
147478738|NCT00984659|531910519|FG001|2-week Run-in Period|Protocol Violation|0|||
147478739|NCT00984659|531910520|FG002|2-week Run-in Period|Protocol Violation|0|||
147478740|NCT00984659|531910521|FG003|2-week Run-in Period|Protocol Violation|0|||
147478741|NCT00984659|531910518|FG000|2-week Run-in Period|Study Closed/Terminated|2|||
147478742|NCT00984659|531910519|FG001|2-week Run-in Period|Study Closed/Terminated|0|||
147478743|NCT00984659|531910520|FG002|2-week Run-in Period|Study Closed/Terminated|0|||
147478744|NCT00984659|531910521|FG003|2-week Run-in Period|Study Closed/Terminated|0|||
147478745|NCT00984659|531910518|FG000|2-week Run-in Period|Lost to Follow-up|3|||
147478746|NCT00984659|531910519|FG001|2-week Run-in Period|Lost to Follow-up|0|||
147478747|NCT00984659|531910520|FG002|2-week Run-in Period|Lost to Follow-up|0|||
147478748|NCT00984659|531910521|FG003|2-week Run-in Period|Lost to Follow-up|0|||
147478749|NCT00984659|531910518|FG000|2-week Run-in Period|Physician Decision|10|||
147478750|NCT00984659|531910519|FG001|2-week Run-in Period|Physician Decision|0|||
147478751|NCT00984659|531910520|FG002|2-week Run-in Period|Physician Decision|0|||
147478752|NCT00984659|531910521|FG003|2-week Run-in Period|Physician Decision|0|||
147478753|NCT00984659|531910518|FG000|2-week Run-in Period|Withdrawal by Subject|10|||
147478754|NCT00984659|531910519|FG001|2-week Run-in Period|Withdrawal by Subject|0|||
147478755|NCT00984659|531910520|FG002|2-week Run-in Period|Withdrawal by Subject|0|||
147478756|NCT00984659|531910521|FG003|2-week Run-in Period|Withdrawal by Subject|0|||
147478757|NCT00984659|531910518|FG000|2-week Run-in Period|Did Not Meet Continuation Criteria|14|||
147478758|NCT00984659|531910519|FG001|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
147478759|NCT00984659|531910520|FG002|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
147478760|NCT00984659|531910521|FG003|2-week Run-in Period|Did Not Meet Continuation Criteria|0|||
147478761|NCT00984659|531910518|FG000|6-week Double-blind Treatment Period|Adverse Event|0|||
147478762|NCT00984659|531910519|FG001|6-week Double-blind Treatment Period|Adverse Event|3|||
147478763|NCT00984659|531910520|FG002|6-week Double-blind Treatment Period|Adverse Event|3|||
147478764|NCT00984659|531910521|FG003|6-week Double-blind Treatment Period|Adverse Event|7|||
147478765|NCT00984659|531910518|FG000|6-week Double-blind Treatment Period|Lack of Efficacy|0|||
147478766|NCT00984659|531910519|FG001|6-week Double-blind Treatment Period|Lack of Efficacy|2|||
147478767|NCT00984659|531910520|FG002|6-week Double-blind Treatment Period|Lack of Efficacy|0|||
147478768|NCT00984659|531910521|FG003|6-week Double-blind Treatment Period|Lack of Efficacy|1|||
147478769|NCT00984659|531910518|FG000|6-week Double-blind Treatment Period|Protocol Violation|0|||
147478770|NCT00984659|531910519|FG001|6-week Double-blind Treatment Period|Protocol Violation|0|||
147478771|NCT00984659|531910520|FG002|6-week Double-blind Treatment Period|Protocol Violation|0|||
147478772|NCT00984659|531910521|FG003|6-week Double-blind Treatment Period|Protocol Violation|4|||
147478773|NCT00984659|531910518|FG000|6-week Double-blind Treatment Period|Study Closed/Terminated|0|||
147478774|NCT00984659|531910519|FG001|6-week Double-blind Treatment Period|Study Closed/Terminated|0|||
147478775|NCT00984659|531910520|FG002|6-week Double-blind Treatment Period|Study Closed/Terminated|1|||
147478776|NCT00984659|531910521|FG003|6-week Double-blind Treatment Period|Study Closed/Terminated|0|||
147478777|NCT00984659|531910518|FG000|6-week Double-blind Treatment Period|Withdrawal by Subject|0|||
147478778|NCT00984659|531910519|FG001|6-week Double-blind Treatment Period|Withdrawal by Subject|1|||
147478779|NCT00984659|531910520|FG002|6-week Double-blind Treatment Period|Withdrawal by Subject|7|||
147478780|NCT00984659|531910521|FG003|6-week Double-blind Treatment Period|Withdrawal by Subject|1|||
147478781|NCT02424149|531910523|FG000|Overall Study|surgery cancelled|2|||
147478782|NCT02424149|531910524|FG001|Overall Study|surgery cancelled|0|||
147478783|NCT02424149|531910523|FG000|Overall Study|Withdrawal by Subject|0|||
147478784|NCT02424149|531910524|FG001|Overall Study|Withdrawal by Subject|1|||
147478785|NCT01633060|531910527|FG000|Randomization Phase|Protocol deviation|1|||
147478786|NCT01633060|531910528|FG001|Randomization Phase|Protocol deviation|2|||
147478787|NCT01633060|531910527|FG000|Randomization Phase|Technical problem|0|||
147478788|NCT01633060|531910528|FG001|Randomization Phase|Technical problem|1|||
147478789|NCT01633060|531910527|FG000|Treatment Phase|Adverse Event|24|||
147478790|NCT01633060|531910528|FG001|Treatment Phase|Adverse Event|3|||
147478791|NCT01633060|531910527|FG000|Treatment Phase|Lost to Follow-up|1|||
147478792|NCT01633060|531910528|FG001|Treatment Phase|Lost to Follow-up|0|||
147478793|NCT01633060|531910527|FG000|Treatment Phase|Physician Decision|16|||
147478794|NCT01633060|531910528|FG001|Treatment Phase|Physician Decision|7|||
147478795|NCT01633060|531910527|FG000|Treatment Phase|Progressive Disease|210|||
147478796|NCT01633060|531910528|FG001|Treatment Phase|Progressive Disease|120|||
147478797|NCT01633060|531910527|FG000|Treatment Phase|Protocol Deviation|1|||
147478798|NCT01633060|531910528|FG001|Treatment Phase|Protocol Deviation|0|||
147478799|NCT01633060|531910527|FG000|Treatment Phase|Study Terminated by sponsor|7|||
147478800|NCT01633060|531910528|FG001|Treatment Phase|Study Terminated by sponsor|3|||
147478801|NCT01633060|531910527|FG000|Treatment Phase|Subject/guardian decision|25|||
147478802|NCT01633060|531910528|FG001|Treatment Phase|Subject/guardian decision|4|||
147478803|NCT01633060|531910527|FG000|Treatment Phase|Death|4|||
147478804|NCT01633060|531910528|FG001|Treatment Phase|Death|3|||
147478805|NCT01633060|531910527|FG000|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|2|||
147478806|NCT01633060|531910528|FG001|Post-Treatment Efficacy Follow-Up Phase|Adverse Event|0|||
147478807|NCT01633060|531910527|FG000|Post-Treatment Efficacy Follow-Up Phase|Physician Decision|1|||
147667003|NCT00434252|532607929|FG000|Overall Study|Adverse Event|6|||
147478808|NCT01633060|531910528|FG001|Post-Treatment Efficacy Follow-Up Phase|Physician Decision|0|||
147478809|NCT01633060|531910527|FG000|Post-Treatment Efficacy Follow-Up Phase|Progressive Disease|10|||
147478810|NCT01633060|531910528|FG001|Post-Treatment Efficacy Follow-Up Phase|Progressive Disease|1|||
147478811|NCT01633060|531910527|FG000|Post-Treatment Efficacy Follow-Up Phase|Study terminated by sponsor|1|||
147478812|NCT01633060|531910528|FG001|Post-Treatment Efficacy Follow-Up Phase|Study terminated by sponsor|0|||
147478813|NCT01633060|531910527|FG000|Post-Treatment Efficacy Follow-Up Phase|Subject/Guardian Decision|1|||
147478814|NCT01633060|531910528|FG001|Post-Treatment Efficacy Follow-Up Phase|Subject/Guardian Decision|1|||
147478815|NCT01633060|531910527|FG000|Post-Treatment Efficacy Follow-Up Phase|Death|1|||
147478816|NCT01633060|531910528|FG001|Post-Treatment Efficacy Follow-Up Phase|Death|0|||
147478817|NCT03633331|531910536|FG000|Overall Study|Withdrawal by Subject|1|||
147478818|NCT01009294|531910537|FG000|Overall Study|Study discontinued by Sponsor|6|||
147478819|NCT01856673|531910538|FG000|Overall Study|Withdrawal by Subject|44|||
147478820|NCT01856673|531910539|FG001|Overall Study|Withdrawal by Subject|50|||
147478821|NCT01856673|531910540|FG002|Overall Study|Withdrawal by Subject|33|||
147478822|NCT01856673|531910538|FG000|Overall Study|Lost to Follow-up|31|||
147478823|NCT01856673|531910539|FG001|Overall Study|Lost to Follow-up|34|||
147478824|NCT01856673|531910540|FG002|Overall Study|Lost to Follow-up|0|||
147478825|NCT01856673|531910538|FG000|Overall Study|Unknown reasons|9|||
147478826|NCT01856673|531910539|FG001|Overall Study|Unknown reasons|0|||
147478827|NCT01856673|531910540|FG002|Overall Study|Unknown reasons|0|||
147478828|NCT01856673|531910538|FG000|Overall Study|Psychologist decision|1|||
147478829|NCT01856673|531910539|FG001|Overall Study|Psychologist decision|0|||
147478830|NCT01856673|531910540|FG002|Overall Study|Psychologist decision|0|||
147478831|NCT01856673|531910538|FG000|Overall Study|Paperwork errors|8|||
147478832|NCT01856673|531910539|FG001|Overall Study|Paperwork errors|0|||
147478833|NCT01856673|531910540|FG002|Overall Study|Paperwork errors|0|||
147478834|NCT01856673|531910538|FG000|Overall Study|Death|1|||
147478835|NCT01856673|531910539|FG001|Overall Study|Death|1|||
147478836|NCT01856673|531910540|FG002|Overall Study|Death|0|||
147478837|NCT01856673|531910538|FG000|Overall Study|Protocol Violation|1|||
147478838|NCT01856673|531910539|FG001|Overall Study|Protocol Violation|0|||
147478839|NCT01856673|531910540|FG002|Overall Study|Protocol Violation|1|||
147478840|NCT02168946|531910541|FG000|Overall Study|Adverse Event|8|||
147478841|NCT02168946|531910542|FG001|Overall Study|Adverse Event|5|||
147478842|NCT02168946|531910541|FG000|Overall Study|Lost to Follow-up|3|||
147478843|NCT02168946|531910542|FG001|Overall Study|Lost to Follow-up|0|||
147478844|NCT02168946|531910541|FG000|Overall Study|Subject unable to come back for visits|1|||
147478845|NCT02168946|531910542|FG001|Overall Study|Subject unable to come back for visits|0|||
147478846|NCT00138151|531910548|FG000|Overall Study|Withdrawal by Subject|3|||
147478847|NCT00138151|531910548|FG000|Overall Study|Physician Decision|1|||
147478848|NCT02675517|531910551|FG000|Overall Study|No evaluable PF-10 questionnaire at all|8|||
147478849|NCT02675517|531910551|FG000|Overall Study|Evaluable PF-10 questionnaire at visit1|151|||
147478850|NCT00301067|531910554|FG000|Completed DLT Period/1st Cycle|Progressive Disease|1|||
147478851|NCT00301067|531910555|FG001|Completed DLT Period/1st Cycle|Progressive Disease|0|||
147478852|NCT00301067|531910556|FG002|Completed DLT Period/1st Cycle|Progressive Disease|0|||
147478853|NCT00301067|531910557|FG003|Completed DLT Period/1st Cycle|Progressive Disease|1|||
147478854|NCT00301067|531910554|FG000|Reached 1st Response/2 Cycles|Progressive Disease|2|||
147478855|NCT00301067|531910555|FG001|Reached 1st Response/2 Cycles|Progressive Disease|1|||
147478856|NCT00301067|531910556|FG002|Reached 1st Response/2 Cycles|Progressive Disease|1|||
147478857|NCT00301067|531910557|FG003|Reached 1st Response/2 Cycles|Progressive Disease|2|||
147478858|NCT00301067|531910554|FG000|Completed 4 Cycles of Treatment|Progressive disease|1|||
147478859|NCT00301067|531910555|FG001|Completed 4 Cycles of Treatment|Progressive disease|1|||
147478860|NCT00301067|531910556|FG002|Completed 4 Cycles of Treatment|Progressive disease|2|||
147478861|NCT00301067|531910557|FG003|Completed 4 Cycles of Treatment|Progressive disease|5|||
147478862|NCT00301067|531910554|FG000|Completed 12 Cycles of Treatment|Progressive Disease|0|||
147478863|NCT00301067|531910555|FG001|Completed 12 Cycles of Treatment|Progressive Disease|1|||
147478864|NCT00301067|531910556|FG002|Completed 12 Cycles of Treatment|Progressive Disease|0|||
147478865|NCT00301067|531910557|FG003|Completed 12 Cycles of Treatment|Progressive Disease|1|||
147478866|NCT00301067|531910554|FG000|Completed 12 Cycles of Treatment|Adverse Event|0|||
147478867|NCT00301067|531910555|FG001|Completed 12 Cycles of Treatment|Adverse Event|0|||
147478868|NCT00301067|531910556|FG002|Completed 12 Cycles of Treatment|Adverse Event|0|||
147478869|NCT00301067|531910557|FG003|Completed 12 Cycles of Treatment|Adverse Event|1|||
147478870|NCT00301067|531910554|FG000|Follow up Until Death|Alive at last data cut point|1|||
147478871|NCT00301067|531910555|FG001|Follow up Until Death|Alive at last data cut point|0|||
147478872|NCT00301067|531910556|FG002|Follow up Until Death|Alive at last data cut point|0|||
147478873|NCT00301067|531910557|FG003|Follow up Until Death|Alive at last data cut point|1|||
147478874|NCT00149825|531910558|FG000|Overall Study|Intolerance to medication side effects|1|||
147478875|NCT00149825|531910559|FG001|Overall Study|Intolerance to medication side effects|2|||
147478876|NCT00149825|531910558|FG000|Overall Study|Time commitments|2|||
147478877|NCT00149825|531910559|FG001|Overall Study|Time commitments|1|||
147478878|NCT00149825|531910558|FG000|Overall Study|Not liking insomnia therapy|1|||
147622145|NCT02208362|532433157|FG000|Overall Study|Participant received disallowed treatment|0|||
147622146|NCT02208362|532433158|FG001|Overall Study|Participant received disallowed treatment|0|||
147416192|NCT01259089|531688344|FG001|Confirmed Response at 8 Weeks|Withdrawal by Subject|0|||
147416193|NCT01259089|531688345|FG002|Confirmed Response at 8 Weeks|Withdrawal by Subject|0|||
147416194|NCT01259089|531688346|FG003|Confirmed Response at 8 Weeks|Withdrawal by Subject|0|||
147416195|NCT01259089|531688347|FG004|Confirmed Response at 8 Weeks|Withdrawal by Subject|0|||
147416196|NCT01259089|531688348|FG005|Confirmed Response at 8 Weeks|Withdrawal by Subject|1|||
147416197|NCT01259089|531688343|FG000|Confirmed Response at 8 Weeks|Adverse Event|0|||
147416198|NCT01259089|531688344|FG001|Confirmed Response at 8 Weeks|Adverse Event|0|||
147416199|NCT01259089|531688345|FG002|Confirmed Response at 8 Weeks|Adverse Event|0|||
147416200|NCT01259089|531688346|FG003|Confirmed Response at 8 Weeks|Adverse Event|0|||
147416201|NCT01259089|531688347|FG004|Confirmed Response at 8 Weeks|Adverse Event|1|||
147416202|NCT01259089|531688348|FG005|Confirmed Response at 8 Weeks|Adverse Event|2|||
147416203|NCT01259089|531688343|FG000|Confirmed Response at 8 Weeks|Progressive disease|0|||
147416204|NCT01259089|531688344|FG001|Confirmed Response at 8 Weeks|Progressive disease|0|||
147416205|NCT01259089|531688345|FG002|Confirmed Response at 8 Weeks|Progressive disease|1|||
147416206|NCT01259089|531688346|FG003|Confirmed Response at 8 Weeks|Progressive disease|1|||
147416207|NCT01259089|531688347|FG004|Confirmed Response at 8 Weeks|Progressive disease|3|||
147416208|NCT01259089|531688348|FG005|Confirmed Response at 8 Weeks|Progressive disease|7|||
147416209|NCT01259089|531688343|FG000|Continued Treatment After 8 Weeks|Withdrawal by Subject|1|||
147416210|NCT01259089|531688344|FG001|Continued Treatment After 8 Weeks|Withdrawal by Subject|0|||
147416211|NCT01259089|531688345|FG002|Continued Treatment After 8 Weeks|Withdrawal by Subject|0|||
147416212|NCT01259089|531688346|FG003|Continued Treatment After 8 Weeks|Withdrawal by Subject|0|||
147416213|NCT01259089|531688347|FG004|Continued Treatment After 8 Weeks|Withdrawal by Subject|0|||
147416214|NCT01259089|531688348|FG005|Continued Treatment After 8 Weeks|Withdrawal by Subject|0|||
147416215|NCT01259089|531688343|FG000|Continued Treatment After 8 Weeks|Adverse Event|0|||
147416216|NCT01259089|531688344|FG001|Continued Treatment After 8 Weeks|Adverse Event|0|||
147416217|NCT01259089|531688345|FG002|Continued Treatment After 8 Weeks|Adverse Event|0|||
147416218|NCT01259089|531688346|FG003|Continued Treatment After 8 Weeks|Adverse Event|0|||
147416219|NCT01259089|531688347|FG004|Continued Treatment After 8 Weeks|Adverse Event|2|||
147416220|NCT01259089|531688348|FG005|Continued Treatment After 8 Weeks|Adverse Event|1|||
147416221|NCT01259089|531688343|FG000|Continued Treatment After 8 Weeks|Progressive disease|1|||
147416222|NCT01259089|531688344|FG001|Continued Treatment After 8 Weeks|Progressive disease|1|||
147416223|NCT01259089|531688345|FG002|Continued Treatment After 8 Weeks|Progressive disease|1|||
147416224|NCT01259089|531688346|FG003|Continued Treatment After 8 Weeks|Progressive disease|1|||
147416225|NCT01259089|531688347|FG004|Continued Treatment After 8 Weeks|Progressive disease|0|||
147416226|NCT01259089|531688348|FG005|Continued Treatment After 8 Weeks|Progressive disease|0|||
147416227|NCT01259089|531688343|FG000|Survival Follow up for Two Years|Death|3|||
147416228|NCT01259089|531688344|FG001|Survival Follow up for Two Years|Death|2|||
147416229|NCT01259089|531688345|FG002|Survival Follow up for Two Years|Death|2|||
147416230|NCT01259089|531688346|FG003|Survival Follow up for Two Years|Death|3|||
147416231|NCT01259089|531688347|FG004|Survival Follow up for Two Years|Death|6|||
147416232|NCT01259089|531688348|FG005|Survival Follow up for Two Years|Death|13|||
147416233|NCT01259089|531688343|FG000|Survival Follow up for Two Years|Lost to Follow-up|0|||
147416234|NCT01259089|531688344|FG001|Survival Follow up for Two Years|Lost to Follow-up|0|||
147416235|NCT01259089|531688345|FG002|Survival Follow up for Two Years|Lost to Follow-up|0|||
147416236|NCT01259089|531688346|FG003|Survival Follow up for Two Years|Lost to Follow-up|0|||
147416237|NCT01259089|531688347|FG004|Survival Follow up for Two Years|Lost to Follow-up|0|||
147416238|NCT01259089|531688348|FG005|Survival Follow up for Two Years|Lost to Follow-up|2|||
147416239|NCT01259089|531688343|FG000|Survival Follow up for Two Years|stopped being followed as study closed|0|||
147416240|NCT01259089|531688344|FG001|Survival Follow up for Two Years|stopped being followed as study closed|0|||
147416241|NCT01259089|531688345|FG002|Survival Follow up for Two Years|stopped being followed as study closed|0|||
147416242|NCT01259089|531688346|FG003|Survival Follow up for Two Years|stopped being followed as study closed|0|||
147416243|NCT01259089|531688347|FG004|Survival Follow up for Two Years|stopped being followed as study closed|0|||
147416244|NCT01259089|531688348|FG005|Survival Follow up for Two Years|stopped being followed as study closed|4|||
147416245|NCT02310100|531688353|FG000|Overall Study|Physician Decision|3|||
147416246|NCT02310100|531688353|FG000|Overall Study|Withdrawal by Subject|10|||
147416247|NCT02310100|531688353|FG000|Overall Study|Enrollment closure|1|||
147416248|NCT02310100|531688353|FG000|Overall Study|Unapproved ablation operator|1|||
147416249|NCT02310100|531688353|FG000|Overall Study|Visit compliance|1|||
147416250|NCT02310100|531688353|FG000|Overall Study|Lost to Follow-up|2|||
147416251|NCT00688870|531688354|FG000|Infant Series|Parent or legal guardian request|4|||
147416252|NCT00688870|531688355|FG001|Infant Series|Parent or legal guardian request|0|||
147416253|NCT00992225|531688359|FG000|Overall Study|Entry Criteria Not Met|8|||
147416254|NCT00992225|531688359|FG000|Overall Study|Adverse Event|2|||
147416255|NCT01253018|531688360|FG000|Overall Study|Lost to Follow-up|1|||
147622147|NCT02208362|532433159|FG002|Overall Study|Participant received disallowed treatment|0|||
147622148|NCT02208362|532433160|FG003|Overall Study|Participant received disallowed treatment|0|||
147622149|NCT02208362|532433161|FG004|Overall Study|Participant received disallowed treatment|0|||
147622150|NCT02208362|532433162|FG005|Overall Study|Participant received disallowed treatment|0|||
147622151|NCT02208362|532433163|FG006|Overall Study|Participant received disallowed treatment|0|||
147478879|NCT00149825|531910559|FG001|Overall Study|Not liking insomnia therapy|0|||
147478880|NCT00149825|531910558|FG000|Overall Study|Other|1|||
147478881|NCT00149825|531910559|FG001|Overall Study|Other|0|||
147478882|NCT00069121|531910560|FG000|Overall Study|Death|286|||
147478883|NCT00069121|531910561|FG001|Overall Study|Death|242|||
147478884|NCT00069121|531910560|FG000|Overall Study|Withdrawal by Subject|18|||
147478885|NCT00069121|531910561|FG001|Overall Study|Withdrawal by Subject|20|||
147478886|NCT00069121|531910560|FG000|Overall Study|Lost to Follow-up|63|||
147478887|NCT00069121|531910561|FG001|Overall Study|Lost to Follow-up|63|||
147478888|NCT00942708|531910562|FG000|Overall Study|Withdrawal by Subject|1|||
147478889|NCT00995371|531910563|FG000|After ESI Cross-over to Mild, 26 Weeks|Withdrawal by Subject|5|||
147478890|NCT00995371|531910564|FG001|After ESI Cross-over to Mild, 26 Weeks|Withdrawal by Subject|5|||
147478891|NCT00673673|531910565|FG000|Overall Study|Progressive disease|27|||
147478892|NCT00673673|531910565|FG000|Overall Study|Adverse Event|4|||
147478893|NCT00673673|531910565|FG000|Overall Study|Withdrawal by Subject|3|||
147478894|NCT00673673|531910565|FG000|Overall Study|Investigators' discretion|2|||
147478895|NCT03851510|531910566|FG000|Overall Study|Screen Fail|1|||
147478896|NCT03851510|531910566|FG000|Overall Study|Adverse Event|1|||
147478897|NCT03851510|531910566|FG000|Overall Study|Withdrawal by Subject|1|||
147478898|NCT02613572|531910567|FG000|Phase I: Tolerability, 600, 800, 1200 mg|Physician Decision|1|||
147478899|NCT02613572|531910568|FG001|Phase I: Tolerability, 600, 800, 1200 mg|Physician Decision|0|||
147478900|NCT02613572|531910569|FG002|Phase I: Tolerability, 600, 800, 1200 mg|Physician Decision|0|||
147478901|NCT02613572|531910567|FG000|Phase II: Double-Blind Rand Plac Control|Death|0|||
147478902|NCT02613572|531910568|FG001|Phase II: Double-Blind Rand Plac Control|Death|1|||
147478903|NCT02613572|531910569|FG002|Phase II: Double-Blind Rand Plac Control|Death|0|||
147478904|NCT00970294|531910575|FG000|Overall Study|Physician Decision|4|||
147478905|NCT00970294|531910575|FG000|Overall Study|Withdrawal by Subject|1|||
147478906|NCT04579393|531910578|FG000|Overall Study|Withdrawal by Subject|2|||
147478907|NCT04579393|531910579|FG001|Overall Study|Withdrawal by Subject|2|||
147478908|NCT04579393|531910578|FG000|Overall Study|Death|1|||
147478909|NCT04579393|531910579|FG001|Overall Study|Death|3|||
147478910|NCT01333189|531910580|FG000|Overall Study|Time constraints|1|||
147478911|NCT01333189|531910581|FG001|Overall Study|Time constraints|0|||
147478912|NCT01333189|531910580|FG000|Overall Study|Adverse Event|1|||
147478913|NCT01333189|531910581|FG001|Overall Study|Adverse Event|0|||
147478914|NCT01333189|531910580|FG000|Overall Study|Transportation difficulties|0|||
147478915|NCT01333189|531910581|FG001|Overall Study|Transportation difficulties|1|||
147478916|NCT01333189|531910580|FG000|Overall Study|Moved from region|0|||
147478917|NCT01333189|531910581|FG001|Overall Study|Moved from region|1|||
147478918|NCT00393458|531910583|FG000|Overall Study|Adverse Event|35|||
147478919|NCT00393458|531910584|FG001|Overall Study|Adverse Event|24|||
147478920|NCT00393458|531910585|FG002|Overall Study|Adverse Event|40|||
147478921|NCT00393458|531910586|FG003|Overall Study|Adverse Event|35|||
147478922|NCT00393458|531910583|FG000|Overall Study|Subject withdrew consent|27|||
147478923|NCT00393458|531910584|FG001|Overall Study|Subject withdrew consent|40|||
147478924|NCT00393458|531910585|FG002|Overall Study|Subject withdrew consent|33|||
147478925|NCT00393458|531910586|FG003|Overall Study|Subject withdrew consent|50|||
147478926|NCT00393458|531910583|FG000|Overall Study|Unsatisfactory therapeutic effect|12|||
147478927|NCT00393458|531910584|FG001|Overall Study|Unsatisfactory therapeutic effect|9|||
147478928|NCT00393458|531910585|FG002|Overall Study|Unsatisfactory therapeutic effect|12|||
147478929|NCT00393458|531910586|FG003|Overall Study|Unsatisfactory therapeutic effect|30|||
147478930|NCT00393458|531910583|FG000|Overall Study|Protocol deviation|11|||
147478931|NCT00393458|531910584|FG001|Overall Study|Protocol deviation|11|||
147478932|NCT00393458|531910585|FG002|Overall Study|Protocol deviation|11|||
147478933|NCT00393458|531910586|FG003|Overall Study|Protocol deviation|10|||
147478934|NCT00393458|531910583|FG000|Overall Study|Administrative problems|7|||
147478935|NCT00393458|531910584|FG001|Overall Study|Administrative problems|8|||
147478936|NCT00393458|531910585|FG002|Overall Study|Administrative problems|5|||
147478937|NCT00393458|531910586|FG003|Overall Study|Administrative problems|2|||
147478938|NCT00393458|531910583|FG000|Overall Study|Lost to Follow-up|5|||
147478939|NCT00393458|531910584|FG001|Overall Study|Lost to Follow-up|6|||
147478940|NCT00393458|531910585|FG002|Overall Study|Lost to Follow-up|5|||
147478941|NCT00393458|531910586|FG003|Overall Study|Lost to Follow-up|3|||
147478942|NCT00393458|531910583|FG000|Overall Study|Abnormal laboratory value(s)|1|||
147478943|NCT00393458|531910584|FG001|Overall Study|Abnormal laboratory value(s)|1|||
147478944|NCT00393458|531910585|FG002|Overall Study|Abnormal laboratory value(s)|0|||
147478945|NCT00393458|531910586|FG003|Overall Study|Abnormal laboratory value(s)|0|||
147478946|NCT00393458|531910583|FG000|Overall Study|Death|1|||
147478947|NCT00393458|531910584|FG001|Overall Study|Death|1|||
147478948|NCT00393458|531910585|FG002|Overall Study|Death|5|||
147478949|NCT00393458|531910586|FG003|Overall Study|Death|5|||
147622152|NCT02208362|532433164|FG007|Overall Study|Participant received disallowed treatment|0|||
147622153|NCT02208362|532433165|FG008|Overall Study|Participant received disallowed treatment|1|||
147622154|NCT02208362|532433166|FG009|Overall Study|Participant received disallowed treatment|0|||
147622155|NCT02208362|532433167|FG010|Overall Study|Participant received disallowed treatment|0|||
147622156|NCT02208362|532433168|FG011|Overall Study|Participant received disallowed treatment|0|||
147622157|NCT00868530|532433171|FG000|Overall Study|Adverse Event|3|||
147622158|NCT00868530|532433171|FG000|Overall Study|Lost to Follow-up|1|||
147622159|NCT01609790|532433172|FG000|Overall Study|Protocol Violation|1|||
147622160|NCT01609790|532433173|FG001|Overall Study|Protocol Violation|7|||
147622161|NCT01609790|532433174|FG002|Overall Study|Protocol Violation|8|||
147622162|NCT00739882|532434791|FG000|Double-blind Period|Adverse Event|1|||
147622163|NCT00739882|532434792|FG001|Double-blind Period|Adverse Event|2|||
147622164|NCT00739882|532434791|FG000|Double-blind Period|Protocol Violation|1|||
147622165|NCT00739882|532434792|FG001|Double-blind Period|Protocol Violation|0|||
147622166|NCT00739882|532434791|FG000|Double-blind Period|Lack of Efficacy|1|||
147622167|NCT00739882|532434792|FG001|Double-blind Period|Lack of Efficacy|1|||
147622168|NCT00739882|532434791|FG000|Double-blind Period|Other|16|||
147622169|NCT00739882|532434792|FG001|Double-blind Period|Other|8|||
147622170|NCT00739882|532434791|FG000|Open-label Period|Adverse Event|1|||
147622171|NCT00739882|532434792|FG001|Open-label Period|Adverse Event|0|||
147622172|NCT00739882|532434791|FG000|Open-label Period|Other|9|||
147622173|NCT00739882|532434792|FG001|Open-label Period|Other|5|||
147622174|NCT04021914|532434793|FG000|Overall Study|Did not meet inclusion criteria on confirmatory testing|1|||
147622175|NCT02844543|532434794|FG000|Overall Study|Withdrawal by Subject|4|||
147622176|NCT02844543|532434794|FG000|Overall Study|Did not meet eligibility criteria|1|||
147622177|NCT00955409|532434795|FG000|Overall Study|Lack of Efficacy|1|||
147622178|NCT00955409|532434796|FG001|Overall Study|Lack of Efficacy|0|||
147622179|NCT00955409|532434797|FG002|Overall Study|Lack of Efficacy|0|||
147622180|NCT00955409|532434798|FG003|Overall Study|Lack of Efficacy|0|||
147622181|NCT00955409|532434799|FG004|Overall Study|Lack of Efficacy|0|||
147622182|NCT00955409|532434800|FG005|Overall Study|Lack of Efficacy|0|||
147622183|NCT00955409|532434801|FG006|Overall Study|Lack of Efficacy|0|||
147622184|NCT00955409|532434802|FG007|Overall Study|Lack of Efficacy|0|||
147622185|NCT00955409|532434803|FG008|Overall Study|Lack of Efficacy|0|||
147622186|NCT00955409|532434804|FG009|Overall Study|Lack of Efficacy|0|||
147622187|NCT00955409|532434795|FG000|Overall Study|Withdrawal by Subject|1|||
147622188|NCT00955409|532434796|FG001|Overall Study|Withdrawal by Subject|0|||
147622189|NCT00955409|532434797|FG002|Overall Study|Withdrawal by Subject|5|||
147622190|NCT00955409|532434798|FG003|Overall Study|Withdrawal by Subject|2|||
147622191|NCT00955409|532434799|FG004|Overall Study|Withdrawal by Subject|0|||
147622192|NCT00955409|532434800|FG005|Overall Study|Withdrawal by Subject|0|||
147622193|NCT00955409|532434801|FG006|Overall Study|Withdrawal by Subject|2|||
147622194|NCT00955409|532434802|FG007|Overall Study|Withdrawal by Subject|0|||
147622195|NCT00955409|532434803|FG008|Overall Study|Withdrawal by Subject|1|||
147622196|NCT00955409|532434804|FG009|Overall Study|Withdrawal by Subject|0|||
147622197|NCT00955409|532434795|FG000|Overall Study|Caregiver Request|2|||
147622198|NCT00955409|532434796|FG001|Overall Study|Caregiver Request|0|||
147622199|NCT00955409|532434797|FG002|Overall Study|Caregiver Request|6|||
147622200|NCT00955409|532434798|FG003|Overall Study|Caregiver Request|5|||
147622201|NCT00955409|532434799|FG004|Overall Study|Caregiver Request|0|||
147622202|NCT00955409|532434800|FG005|Overall Study|Caregiver Request|2|||
147622203|NCT00955409|532434801|FG006|Overall Study|Caregiver Request|3|||
147622204|NCT00955409|532434802|FG007|Overall Study|Caregiver Request|1|||
147622205|NCT00955409|532434803|FG008|Overall Study|Caregiver Request|3|||
147622206|NCT00955409|532434804|FG009|Overall Study|Caregiver Request|0|||
147622207|NCT00955409|532434795|FG000|Overall Study|Investigator Request|0|||
147622208|NCT00955409|532434796|FG001|Overall Study|Investigator Request|0|||
147622209|NCT00955409|532434797|FG002|Overall Study|Investigator Request|1|||
147622210|NCT00955409|532434798|FG003|Overall Study|Investigator Request|0|||
147622211|NCT00955409|532434799|FG004|Overall Study|Investigator Request|0|||
147622212|NCT00955409|532434800|FG005|Overall Study|Investigator Request|0|||
147622213|NCT00955409|532434801|FG006|Overall Study|Investigator Request|0|||
147622214|NCT00955409|532434802|FG007|Overall Study|Investigator Request|0|||
147622215|NCT00955409|532434803|FG008|Overall Study|Investigator Request|0|||
147622216|NCT00955409|532434804|FG009|Overall Study|Investigator Request|0|||
147622217|NCT00955409|532434795|FG000|Overall Study|Discontinuation of Study by Sponsor|0|||
147622218|NCT00955409|532434796|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
147622219|NCT00955409|532434797|FG002|Overall Study|Discontinuation of Study by Sponsor|0|||
147622220|NCT00955409|532434798|FG003|Overall Study|Discontinuation of Study by Sponsor|0|||
147622221|NCT00955409|532434799|FG004|Overall Study|Discontinuation of Study by Sponsor|0|||
147622222|NCT00955409|532434800|FG005|Overall Study|Discontinuation of Study by Sponsor|0|||
147622223|NCT00955409|532434801|FG006|Overall Study|Discontinuation of Study by Sponsor|0|||
147622224|NCT00955409|532434802|FG007|Overall Study|Discontinuation of Study by Sponsor|1|||
147622225|NCT00955409|532434803|FG008|Overall Study|Discontinuation of Study by Sponsor|0|||
147622226|NCT00955409|532434804|FG009|Overall Study|Discontinuation of Study by Sponsor|0|||
147416256|NCT01253018|531688361|FG001|Overall Study|Lost to Follow-up|1|||
147622227|NCT00955409|532434795|FG000|Overall Study|Lost to Follow-up|0|||
147622228|NCT00955409|532434796|FG001|Overall Study|Lost to Follow-up|0|||
147622229|NCT00955409|532434797|FG002|Overall Study|Lost to Follow-up|1|||
147622230|NCT00955409|532434798|FG003|Overall Study|Lost to Follow-up|0|||
147622231|NCT00955409|532434799|FG004|Overall Study|Lost to Follow-up|0|||
147622232|NCT00955409|532434800|FG005|Overall Study|Lost to Follow-up|0|||
147622233|NCT00955409|532434801|FG006|Overall Study|Lost to Follow-up|1|||
147622234|NCT00955409|532434802|FG007|Overall Study|Lost to Follow-up|0|||
147622235|NCT00955409|532434803|FG008|Overall Study|Lost to Follow-up|0|||
147622236|NCT00955409|532434804|FG009|Overall Study|Lost to Follow-up|0|||
147622237|NCT00955409|532434795|FG000|Overall Study|Failed to Return|2|||
147622238|NCT00955409|532434796|FG001|Overall Study|Failed to Return|0|||
147622239|NCT00955409|532434797|FG002|Overall Study|Failed to Return|0|||
147622240|NCT00955409|532434798|FG003|Overall Study|Failed to Return|0|||
147622241|NCT00955409|532434799|FG004|Overall Study|Failed to Return|0|||
147622242|NCT00955409|532434800|FG005|Overall Study|Failed to Return|0|||
147622243|NCT00955409|532434801|FG006|Overall Study|Failed to Return|0|||
147622244|NCT00955409|532434802|FG007|Overall Study|Failed to Return|2|||
147622245|NCT00955409|532434803|FG008|Overall Study|Failed to Return|0|||
147622246|NCT00955409|532434804|FG009|Overall Study|Failed to Return|0|||
147622247|NCT00955409|532434795|FG000|Overall Study|Adverse Event (AE)|2|||
147622248|NCT00955409|532434796|FG001|Overall Study|Adverse Event (AE)|0|||
147622249|NCT00955409|532434797|FG002|Overall Study|Adverse Event (AE)|0|||
147622250|NCT00955409|532434798|FG003|Overall Study|Adverse Event (AE)|0|||
147622251|NCT00955409|532434799|FG004|Overall Study|Adverse Event (AE)|0|||
147622252|NCT00955409|532434800|FG005|Overall Study|Adverse Event (AE)|1|||
147622253|NCT00955409|532434801|FG006|Overall Study|Adverse Event (AE)|2|||
147622254|NCT00955409|532434802|FG007|Overall Study|Adverse Event (AE)|0|||
147622255|NCT00955409|532434803|FG008|Overall Study|Adverse Event (AE)|2|||
147622256|NCT00955409|532434804|FG009|Overall Study|Adverse Event (AE)|0|||
147622257|NCT00955409|532434795|FG000|Overall Study|Reason not Specified|2|||
147622258|NCT00955409|532434796|FG001|Overall Study|Reason not Specified|1|||
147622259|NCT00955409|532434797|FG002|Overall Study|Reason not Specified|13|||
147622260|NCT00955409|532434798|FG003|Overall Study|Reason not Specified|1|||
147622261|NCT00955409|532434799|FG004|Overall Study|Reason not Specified|2|||
147622262|NCT00955409|532434800|FG005|Overall Study|Reason not Specified|0|||
147622263|NCT00955409|532434801|FG006|Overall Study|Reason not Specified|16|||
147622264|NCT00955409|532434802|FG007|Overall Study|Reason not Specified|0|||
147622265|NCT00955409|532434803|FG008|Overall Study|Reason not Specified|8|||
147622266|NCT00955409|532434804|FG009|Overall Study|Reason not Specified|1|||
147622267|NCT00803790|532434805|FG000|Period 1|Adverse Event|0|||
147622268|NCT00803790|532434806|FG001|Period 1|Adverse Event|1|||
147416257|NCT01253018|531688360|FG000|Overall Study|Robot Repair Issues|2|||
147416258|NCT01253018|531688361|FG001|Overall Study|Robot Repair Issues|0|||
147416259|NCT01253018|531688360|FG000|Overall Study|Withdrawal by Subject|1|||
147416260|NCT01253018|531688361|FG001|Overall Study|Withdrawal by Subject|1|||
147416261|NCT03449901|531688362|FG000|Overall Study|Progression|57|||
147416262|NCT03449901|531688363|FG001|Overall Study|Progression|12|||
147416263|NCT03449901|531688362|FG000|Overall Study|Adverse Event|3|||
147416264|NCT03449901|531688363|FG001|Overall Study|Adverse Event|0|||
147416265|NCT03449901|531688362|FG000|Overall Study|Death|6|||
147416266|NCT03449901|531688363|FG001|Overall Study|Death|2|||
147416267|NCT03449901|531688362|FG000|Overall Study|Withdrawal by Subject|12|||
147416268|NCT03449901|531688363|FG001|Overall Study|Withdrawal by Subject|1|||
147416269|NCT03449901|531688362|FG000|Overall Study|Physician Decision|1|||
147416270|NCT03449901|531688363|FG001|Overall Study|Physician Decision|0|||
147416271|NCT03449901|531688362|FG000|Overall Study|Patient elected for surgical intervention|1|||
147416272|NCT03449901|531688363|FG001|Overall Study|Patient elected for surgical intervention|0|||
147416273|NCT03449901|531688362|FG000|Overall Study|Patient off for other complicating disease|1|||
147416274|NCT03449901|531688363|FG001|Overall Study|Patient off for other complicating disease|0|||
147416275|NCT01769326|531688364|FG000|Overall Study|Lost to Follow-up|1|||
147416276|NCT01769326|531688365|FG001|Overall Study|Lost to Follow-up|2|||
147416277|NCT01769326|531688366|FG002|Overall Study|Lost to Follow-up|0|||
147416278|NCT01769326|531688367|FG003|Overall Study|Lost to Follow-up|0|||
147416279|NCT01769326|531688364|FG000|Overall Study|unrelated injry|1|||
147416280|NCT01769326|531688365|FG001|Overall Study|unrelated injry|1|||
147416281|NCT01769326|531688366|FG002|Overall Study|unrelated injry|0|||
147416282|NCT01769326|531688367|FG003|Overall Study|unrelated injry|0|||
147416283|NCT01769326|531688364|FG000|Overall Study|got a job|0|||
147416284|NCT01769326|531688365|FG001|Overall Study|got a job|1|||
147416285|NCT01769326|531688366|FG002|Overall Study|got a job|0|||
147416286|NCT01769326|531688367|FG003|Overall Study|got a job|0|||
147416287|NCT01769326|531688364|FG000|Overall Study|Got sick and could not complete study|0|||
147416288|NCT01769326|531688365|FG001|Overall Study|Got sick and could not complete study|0|||
147416289|NCT01769326|531688366|FG002|Overall Study|Got sick and could not complete study|1|||
147416290|NCT01769326|531688367|FG003|Overall Study|Got sick and could not complete study|0|||
147416291|NCT03459443|531688368|FG000|Overall Study|Lack of Efficacy|3|||
147416292|NCT03459443|531688368|FG000|Overall Study|Adverse Event|1|||
147622269|NCT00803790|532434807|FG002|Period 1|Adverse Event|0|||
147622270|NCT00803790|532434808|FG003|Period 1|Adverse Event|0|||
147622271|NCT00803790|532434805|FG000|Period 1|Lost to Follow-up|1|||
147622272|NCT00803790|532434806|FG001|Period 1|Lost to Follow-up|2|||
147622273|NCT00803790|532434807|FG002|Period 1|Lost to Follow-up|0|||
147622274|NCT00803790|532434808|FG003|Period 1|Lost to Follow-up|0|||
147622275|NCT00803790|532434805|FG000|Period 1|Withdrawal by Subject|8|||
147622276|NCT00803790|532434806|FG001|Period 1|Withdrawal by Subject|6|||
147622277|NCT00803790|532434807|FG002|Period 1|Withdrawal by Subject|0|||
147622278|NCT00803790|532434808|FG003|Period 1|Withdrawal by Subject|0|||
147622279|NCT00803790|532434805|FG000|Period 1|positive drug screen or personal reasons|0|||
147622280|NCT00803790|532434806|FG001|Period 1|positive drug screen or personal reasons|3|||
147622281|NCT00803790|532434807|FG002|Period 1|positive drug screen or personal reasons|0|||
147622282|NCT00803790|532434808|FG003|Period 1|positive drug screen or personal reasons|4|||
147622283|NCT00803790|532434805|FG000|Period 1|Protocol Violation|0|||
147622284|NCT00803790|532434806|FG001|Period 1|Protocol Violation|0|||
147622285|NCT00803790|532434807|FG002|Period 1|Protocol Violation|1|||
147622286|NCT00803790|532434808|FG003|Period 1|Protocol Violation|0|||
147622287|NCT00803790|532434805|FG000|Period 2|Adverse Event|0|||
147622288|NCT00803790|532434806|FG001|Period 2|Adverse Event|0|||
147622289|NCT00803790|532434807|FG002|Period 2|Adverse Event|1|||
147622290|NCT00803790|532434808|FG003|Period 2|Adverse Event|1|||
147622291|NCT00803790|532434805|FG000|Period 2|Withdrawal by Subject|1|||
147622292|NCT00803790|532434806|FG001|Period 2|Withdrawal by Subject|0|||
147622293|NCT00803790|532434807|FG002|Period 2|Withdrawal by Subject|0|||
147622294|NCT00803790|532434808|FG003|Period 2|Withdrawal by Subject|0|||
147622295|NCT00803790|532434805|FG000|Period 2|Positive Drug Screen or Personal Reasons|1|||
147622296|NCT00803790|532434806|FG001|Period 2|Positive Drug Screen or Personal Reasons|0|||
147622297|NCT00803790|532434807|FG002|Period 2|Positive Drug Screen or Personal Reasons|0|||
147622298|NCT00803790|532434808|FG003|Period 2|Positive Drug Screen or Personal Reasons|0|||
147622299|NCT04710576|532434809|FG000|Overall Study|Participants still in the study|73|||
147478950|NCT00393458|531910583|FG000|Overall Study|Abnormal test procedure result(s)|0|||
147478951|NCT00393458|531910584|FG001|Overall Study|Abnormal test procedure result(s)|1|||
147478952|NCT00393458|531910585|FG002|Overall Study|Abnormal test procedure result(s)|1|||
147478953|NCT00393458|531910586|FG003|Overall Study|Abnormal test procedure result(s)|2|||
147478954|NCT00393458|531910583|FG000|Overall Study|Subject no longer requires study drug|0|||
147478955|NCT00393458|531910584|FG001|Overall Study|Subject no longer requires study drug|1|||
147478956|NCT00393458|531910585|FG002|Overall Study|Subject no longer requires study drug|0|||
147478957|NCT00393458|531910586|FG003|Overall Study|Subject no longer requires study drug|0|||
147478958|NCT01739595|531910587|FG000|Overall Study|Adverse Event|3|||
147478959|NCT01739595|531910588|FG001|Overall Study|Adverse Event|0|||
147478960|NCT01739595|531910589|FG002|Overall Study|Adverse Event|0|||
147478961|NCT01739595|531910587|FG000|Overall Study|Lost to Follow-up|2|||
147478962|NCT01739595|531910588|FG001|Overall Study|Lost to Follow-up|0|||
147478963|NCT01739595|531910589|FG002|Overall Study|Lost to Follow-up|0|||
147478964|NCT01739595|531910587|FG000|Overall Study|Withdrawal by Subject|2|||
147478965|NCT01739595|531910588|FG001|Overall Study|Withdrawal by Subject|1|||
147478966|NCT01739595|531910589|FG002|Overall Study|Withdrawal by Subject|2|||
147478967|NCT01739595|531910587|FG000|Overall Study|Eligibility issue|3|||
147478968|NCT01739595|531910588|FG001|Overall Study|Eligibility issue|0|||
147478969|NCT01739595|531910589|FG002|Overall Study|Eligibility issue|0|||
147478970|NCT01739595|531910587|FG000|Overall Study|Protocol Violation|1|||
147478971|NCT01739595|531910588|FG001|Overall Study|Protocol Violation|0|||
147478972|NCT01739595|531910589|FG002|Overall Study|Protocol Violation|0|||
147478973|NCT01739595|531910587|FG000|Overall Study|Lab assessment|1|||
147478974|NCT01739595|531910588|FG001|Overall Study|Lab assessment|0|||
147478975|NCT01739595|531910589|FG002|Overall Study|Lab assessment|0|||
147478976|NCT01739595|531910587|FG000|Overall Study|Drug discrepancy|1|||
147478977|NCT01739595|531910588|FG001|Overall Study|Drug discrepancy|0|||
147478978|NCT01739595|531910589|FG002|Overall Study|Drug discrepancy|0|||
147478979|NCT02104180|531910596|FG000|Overall Study|Protocol Violation|1|||
147478980|NCT02104180|531910597|FG001|Overall Study|Protocol Violation|0|||
147478981|NCT02704429|531910600|FG000|Part A: 24 Weeks|Adverse Event|3|||
147478982|NCT02704429|531910601|FG001|Part A: 24 Weeks|Adverse Event|0|||
147478983|NCT02704429|531910600|FG000|Part B: 28 Weeks|Worsening of pemphigus|0|||
147478984|NCT02704429|531910601|FG001|Part B: 28 Weeks|Worsening of pemphigus|1|||
147478985|NCT00104104|531910603|FG000|Overall Study|Adverse Event|8|||
147478986|NCT00104104|531910604|FG001|Overall Study|Adverse Event|8|||
147478987|NCT00104104|531910603|FG000|Overall Study|Abnormal laboratory value(s)|20|||
147478988|NCT00104104|531910604|FG001|Overall Study|Abnormal laboratory value(s)|14|||
147478989|NCT00104104|531910603|FG000|Overall Study|Lack of Efficacy|0|||
147478990|NCT00104104|531910604|FG001|Overall Study|Lack of Efficacy|3|||
147622300|NCT04710576|532434810|FG001|Overall Study|Participants still in the study|70|||
147622301|NCT04710576|532434811|FG002|Overall Study|Participants still in the study|60|||
147478991|NCT00104104|531910603|FG000|Overall Study|Condition no longer requires study drug|7|||
147478992|NCT00104104|531910604|FG001|Overall Study|Condition no longer requires study drug|4|||
147478993|NCT00104104|531910603|FG000|Overall Study|Protocol Violation|5|||
147478994|NCT00104104|531910604|FG001|Overall Study|Protocol Violation|2|||
147478995|NCT00104104|531910603|FG000|Overall Study|Withdrawal by Subject|11|||
147478996|NCT00104104|531910604|FG001|Overall Study|Withdrawal by Subject|15|||
147478997|NCT00104104|531910603|FG000|Overall Study|Lost to Follow-up|3|||
147478998|NCT00104104|531910604|FG001|Overall Study|Lost to Follow-up|7|||
147478999|NCT00104104|531910603|FG000|Overall Study|Administrative problems|12|||
147479000|NCT00104104|531910604|FG001|Overall Study|Administrative problems|13|||
147479001|NCT00104104|531910603|FG000|Overall Study|Death|9|||
147479002|NCT00104104|531910604|FG001|Overall Study|Death|6|||
147479003|NCT01326962|531910605|FG000|Overall Study|Adverse Event|1|||
147479004|NCT01326962|531910605|FG000|Overall Study|Withdrawal by Subject|1|||
147479005|NCT01326962|531910605|FG000|Overall Study|Lost to Follow-up|3|||
147479006|NCT01326962|531910605|FG000|Overall Study|Other|2|||
147479007|NCT00793585|531910606|FG000|Overall Study|Adverse Event|1|||
147479008|NCT00793585|531910607|FG001|Overall Study|Adverse Event|1|||
147479009|NCT00793585|531910606|FG000|Overall Study|Protocol Violation|1|||
147479010|NCT00793585|531910607|FG001|Overall Study|Protocol Violation|2|||
147479011|NCT00035815|531910610|FG000|Overall Study|Withdrawal by Subject|17|||
147479012|NCT00035815|531910611|FG001|Overall Study|Withdrawal by Subject|11|||
147479013|NCT02209597|531910612|FG000|Phase 1 Current Tx (Non-randomized)|Withdrawal by Subject|2|||
147479014|NCT02209597|531910612|FG000|Phase 1 Current Tx (Non-randomized)|Adverse Event|1|||
147479015|NCT02209597|531910612|FG000|Phase 2 (Randomized: 1 Brand, 3 Generic)|Withdrawal by Subject|3|||
147479016|NCT02209597|531910612|FG000|Phase 2 (Randomized: 1 Brand, 3 Generic)|Adverse Event|1|||
147479017|NCT01089725|531910617|FG000|Overall Study|Adverse Event|1|||
147479018|NCT01089725|531910618|FG001|Overall Study|Adverse Event|1|||
147479019|NCT01089725|531910619|FG002|Overall Study|Adverse Event|0|||
147479020|NCT01089725|531910620|FG003|Overall Study|Adverse Event|0|||
147479021|NCT01089725|531910621|FG004|Overall Study|Adverse Event|2|||
147479022|NCT01089725|531910617|FG000|Overall Study|Lack of Efficacy|4|||
147479023|NCT01089725|531910618|FG001|Overall Study|Lack of Efficacy|3|||
147479024|NCT01089725|531910619|FG002|Overall Study|Lack of Efficacy|1|||
147479025|NCT01089725|531910620|FG003|Overall Study|Lack of Efficacy|0|||
147479026|NCT01089725|531910621|FG004|Overall Study|Lack of Efficacy|4|||
147479027|NCT01089725|531910617|FG000|Overall Study|Lost to Follow-up|2|||
147479028|NCT01089725|531910618|FG001|Overall Study|Lost to Follow-up|2|||
147479029|NCT01089725|531910619|FG002|Overall Study|Lost to Follow-up|0|||
147479030|NCT01089725|531910620|FG003|Overall Study|Lost to Follow-up|3|||
147479031|NCT01089725|531910621|FG004|Overall Study|Lost to Follow-up|0|||
147479032|NCT01089725|531910617|FG000|Overall Study|Protocol Violation|0|||
147479033|NCT01089725|531910618|FG001|Overall Study|Protocol Violation|0|||
147479034|NCT01089725|531910619|FG002|Overall Study|Protocol Violation|1|||
147479035|NCT01089725|531910620|FG003|Overall Study|Protocol Violation|1|||
147479036|NCT01089725|531910621|FG004|Overall Study|Protocol Violation|0|||
147479037|NCT01089725|531910617|FG000|Overall Study|Withdrawal by Subject|5|||
147479038|NCT01089725|531910618|FG001|Overall Study|Withdrawal by Subject|5|||
147479039|NCT01089725|531910619|FG002|Overall Study|Withdrawal by Subject|4|||
147479040|NCT01089725|531910620|FG003|Overall Study|Withdrawal by Subject|5|||
147479041|NCT01089725|531910621|FG004|Overall Study|Withdrawal by Subject|4|||
147479042|NCT01089725|531910617|FG000|Overall Study|Study Terminated by Sponsor|51|||
147479043|NCT01089725|531910618|FG001|Overall Study|Study Terminated by Sponsor|56|||
147479044|NCT01089725|531910619|FG002|Overall Study|Study Terminated by Sponsor|53|||
147479045|NCT01089725|531910620|FG003|Overall Study|Study Terminated by Sponsor|68|||
147479046|NCT01089725|531910621|FG004|Overall Study|Study Terminated by Sponsor|68|||
147479047|NCT01089725|531910617|FG000|Overall Study|Randomized, but not treated|0|||
147479048|NCT01089725|531910618|FG001|Overall Study|Randomized, but not treated|1|||
147479049|NCT01089725|531910619|FG002|Overall Study|Randomized, but not treated|2|||
147479050|NCT01089725|531910620|FG003|Overall Study|Randomized, but not treated|1|||
147479051|NCT01089725|531910621|FG004|Overall Study|Randomized, but not treated|2|||
147479052|NCT01089725|531910617|FG000|Overall Study|Other|3|||
147479053|NCT01089725|531910618|FG001|Overall Study|Other|0|||
147479054|NCT01089725|531910619|FG002|Overall Study|Other|0|||
147479055|NCT01089725|531910620|FG003|Overall Study|Other|1|||
147479056|NCT01089725|531910621|FG004|Overall Study|Other|0|||
147479057|NCT01266148|531912026|FG000|Overall Study|Adverse Event|2|||
147479058|NCT01266148|531912027|FG001|Overall Study|Adverse Event|0|||
147479059|NCT01266148|531912026|FG000|Overall Study|Ongoing rejection|1|||
147479060|NCT01266148|531912027|FG001|Overall Study|Ongoing rejection|0|||
147479061|NCT01266148|531912026|FG000|Overall Study|2 2R rejections|1|||
147479062|NCT01266148|531912027|FG001|Overall Study|2 2R rejections|0|||
147479063|NCT01266148|531912026|FG000|Overall Study|Death|2|||
147479064|NCT01266148|531912027|FG001|Overall Study|Death|3|||
147479065|NCT01266148|531912026|FG000|Overall Study|missing mGFR value + AE|1|||
147479066|NCT01266148|531912027|FG001|Overall Study|missing mGFR value + AE|0|||
147479067|NCT01269125|531912028|FG000|Overall Study|Adverse Event|3|||
147479068|NCT01269125|531912029|FG001|Overall Study|Adverse Event|5|||
147479069|NCT01269125|531912030|FG002|Overall Study|Adverse Event|0|||
147479070|NCT01269125|531912028|FG000|Overall Study|Lost to Follow-up|4|||
147479071|NCT01269125|531912029|FG001|Overall Study|Lost to Follow-up|0|||
147479072|NCT01269125|531912030|FG002|Overall Study|Lost to Follow-up|0|||
147479073|NCT03635190|531912031|FG000|Overall Study|Lost to Follow-up|4|||
147479074|NCT03635190|531912031|FG000|Overall Study|Death|3|||
147479075|NCT03635190|531912031|FG000|Overall Study|Withdrawal by Subject|1|||
147479076|NCT03635190|531912031|FG000|Overall Study|Patient moved and did not return for follow up|1|||
147479077|NCT00417612|531912034|FG000|Overall Study|Errant diagnosis|0|||
147479078|NCT00417612|531912035|FG001|Overall Study|Errant diagnosis|1|||
147479079|NCT00417612|531912034|FG000|Overall Study|Adverse Event|2|||
147479080|NCT00417612|531912035|FG001|Overall Study|Adverse Event|0|||
147479081|NCT00417612|531912034|FG000|Overall Study|Protocol Violation|0|||
147479082|NCT00417612|531912035|FG001|Overall Study|Protocol Violation|2|||
147479083|NCT00417612|531912034|FG000|Overall Study|Lost to Follow-up|1|||
147479084|NCT00417612|531912035|FG001|Overall Study|Lost to Follow-up|0|||
147479085|NCT01712438|531912038|FG000|Overall Study|Not treated with Human-cl rhFVIII|2|||
147479086|NCT01712438|531912038|FG000|Overall Study|Ongoing ITI treatment|6|||
147479087|NCT01712438|531912038|FG000|Overall Study|Violated inclusion & exclusion criteria|4|||
147479088|NCT01712438|531912038|FG000|Overall Study|Prematurely Discontinued|25|||
147479089|NCT03216265|531912039|FG000|Overall Study|Adverse Event|2|||
147479090|NCT03216265|531912040|FG001|Overall Study|Adverse Event|0|||
147479091|NCT03216265|531912041|FG002|Overall Study|Adverse Event|2|||
147479092|NCT03216265|531912039|FG000|Overall Study|Lost to Follow-up|0|||
147479093|NCT03216265|531912040|FG001|Overall Study|Lost to Follow-up|1|||
147479094|NCT03216265|531912041|FG002|Overall Study|Lost to Follow-up|0|||
147479095|NCT03216265|531912039|FG000|Overall Study|Withdrawal by Subject|0|||
147479096|NCT03216265|531912040|FG001|Overall Study|Withdrawal by Subject|0|||
147479097|NCT03216265|531912041|FG002|Overall Study|Withdrawal by Subject|1|||
147479098|NCT01539837|531912042|FG000|Overall Study|reduce neutrophil level|0|||
147479099|NCT01539837|531912043|FG001|Overall Study|reduce neutrophil level|1|||
147479100|NCT01539837|531912044|FG002|Overall Study|reduce neutrophil level|1|||
147479101|NCT01539837|531912042|FG000|Overall Study|bad compliance|0|||
147479102|NCT01539837|531912043|FG001|Overall Study|bad compliance|0|||
147479103|NCT01539837|531912044|FG002|Overall Study|bad compliance|1|||
147479104|NCT00849693|531912045|FG000|Acute Treatment Phase|Adverse Event|12|||
147479105|NCT00849693|531912046|FG001|Acute Treatment Phase|Adverse Event|7|||
147479106|NCT00849693|531912047|FG002|Acute Treatment Phase|Adverse Event|6|||
147479107|NCT00849693|531912048|FG003|Acute Treatment Phase|Adverse Event|4|||
147479108|NCT00849693|531912045|FG000|Acute Treatment Phase|Lost to Follow-up|5|||
147479109|NCT00849693|531912046|FG001|Acute Treatment Phase|Lost to Follow-up|8|||
147479110|NCT00849693|531912047|FG002|Acute Treatment Phase|Lost to Follow-up|11|||
147479111|NCT00849693|531912048|FG003|Acute Treatment Phase|Lost to Follow-up|9|||
147479112|NCT00849693|531912045|FG000|Acute Treatment Phase|Protocol Violation|1|||
147479113|NCT00849693|531912046|FG001|Acute Treatment Phase|Protocol Violation|5|||
147479114|NCT00849693|531912047|FG002|Acute Treatment Phase|Protocol Violation|2|||
147479115|NCT00849693|531912048|FG003|Acute Treatment Phase|Protocol Violation|6|||
147479116|NCT00849693|531912045|FG000|Acute Treatment Phase|Withdrawal by Subject|5|||
147479117|NCT00849693|531912046|FG001|Acute Treatment Phase|Withdrawal by Subject|5|||
147479118|NCT00849693|531912047|FG002|Acute Treatment Phase|Withdrawal by Subject|3|||
147479119|NCT00849693|531912048|FG003|Acute Treatment Phase|Withdrawal by Subject|8|||
147479120|NCT00849693|531912045|FG000|Acute Treatment Phase|Parent or caregiver decision|7|||
147479121|NCT00849693|531912046|FG001|Acute Treatment Phase|Parent or caregiver decision|6|||
147479122|NCT00849693|531912047|FG002|Acute Treatment Phase|Parent or caregiver decision|7|||
147479123|NCT00849693|531912048|FG003|Acute Treatment Phase|Parent or caregiver decision|7|||
147479124|NCT00849693|531912045|FG000|Acute Treatment Phase|Physician Decision|2|||
147479125|NCT00849693|531912046|FG001|Acute Treatment Phase|Physician Decision|1|||
147479126|NCT00849693|531912047|FG002|Acute Treatment Phase|Physician Decision|2|||
147479127|NCT00849693|531912048|FG003|Acute Treatment Phase|Physician Decision|1|||
147479128|NCT00849693|531912045|FG000|Acute Treatment Phase|Sponsor decision|0|||
147479129|NCT00849693|531912046|FG001|Acute Treatment Phase|Sponsor decision|0|||
147479130|NCT00849693|531912047|FG002|Acute Treatment Phase|Sponsor decision|1|||
147479131|NCT00849693|531912048|FG003|Acute Treatment Phase|Sponsor decision|0|||
147479132|NCT00849693|531912045|FG000|Acute Treatment Phase|Lack of Efficacy|1|||
147479133|NCT00849693|531912046|FG001|Acute Treatment Phase|Lack of Efficacy|3|||
147479134|NCT00849693|531912047|FG002|Acute Treatment Phase|Lack of Efficacy|1|||
147479135|NCT00849693|531912048|FG003|Acute Treatment Phase|Lack of Efficacy|2|||
147479136|NCT00849693|531912045|FG000|Extension Phase|Adverse Event|4|||
147479137|NCT00849693|531912046|FG001|Extension Phase|Adverse Event|6|||
147479138|NCT00849693|531912047|FG002|Extension Phase|Adverse Event|3|||
147479139|NCT00849693|531912048|FG003|Extension Phase|Adverse Event|7|||
147479140|NCT00849693|531912045|FG000|Extension Phase|Lost to Follow-up|7|||
147479141|NCT00849693|531912046|FG001|Extension Phase|Lost to Follow-up|5|||
147479142|NCT00849693|531912047|FG002|Extension Phase|Lost to Follow-up|6|||
147479143|NCT00849693|531912048|FG003|Extension Phase|Lost to Follow-up|6|||
147479144|NCT00849693|531912045|FG000|Extension Phase|Protocol Violation|0|||
147479145|NCT00849693|531912046|FG001|Extension Phase|Protocol Violation|3|||
147479146|NCT00849693|531912047|FG002|Extension Phase|Protocol Violation|2|||
147479147|NCT00849693|531912048|FG003|Extension Phase|Protocol Violation|3|||
147479148|NCT00849693|531912045|FG000|Extension Phase|Withdrawal by Subject|6|||
147479149|NCT00849693|531912046|FG001|Extension Phase|Withdrawal by Subject|9|||
147479150|NCT00849693|531912047|FG002|Extension Phase|Withdrawal by Subject|10|||
147479151|NCT00849693|531912048|FG003|Extension Phase|Withdrawal by Subject|15|||
147479152|NCT00849693|531912045|FG000|Extension Phase|Parent or caregiver decision|9|||
147479153|NCT00849693|531912046|FG001|Extension Phase|Parent or caregiver decision|4|||
147479154|NCT00849693|531912047|FG002|Extension Phase|Parent or caregiver decision|10|||
147479155|NCT00849693|531912048|FG003|Extension Phase|Parent or caregiver decision|5|||
147479156|NCT00849693|531912045|FG000|Extension Phase|Physician Decision|1|||
147479157|NCT00849693|531912046|FG001|Extension Phase|Physician Decision|1|||
147479158|NCT00849693|531912047|FG002|Extension Phase|Physician Decision|2|||
147479159|NCT00849693|531912048|FG003|Extension Phase|Physician Decision|0|||
147479160|NCT00849693|531912045|FG000|Extension Phase|Sponsor decision|1|||
147479161|NCT00849693|531912046|FG001|Extension Phase|Sponsor decision|0|||
147479162|NCT00849693|531912047|FG002|Extension Phase|Sponsor decision|0|||
147479163|NCT00849693|531912048|FG003|Extension Phase|Sponsor decision|1|||
147479164|NCT00849693|531912045|FG000|Extension Phase|Lack of Efficacy|2|||
147479165|NCT00849693|531912046|FG001|Extension Phase|Lack of Efficacy|2|||
147479166|NCT00849693|531912047|FG002|Extension Phase|Lack of Efficacy|2|||
147479167|NCT00849693|531912048|FG003|Extension Phase|Lack of Efficacy|1|||
147479168|NCT00224107|531912049|FG000|Overall Study|Adverse Event|20|||
147479169|NCT00224107|531912050|FG001|Overall Study|Adverse Event|6|||
147479170|NCT00224107|531912049|FG000|Overall Study|Protocol Violation|2|||
147479171|NCT00224107|531912050|FG001|Overall Study|Protocol Violation|3|||
147479172|NCT00224107|531912049|FG000|Overall Study|Withdrawal by Subject|1|||
147479173|NCT00224107|531912050|FG001|Overall Study|Withdrawal by Subject|4|||
147479174|NCT00224107|531912049|FG000|Overall Study|Lack of Efficacy|2|||
147479175|NCT00224107|531912050|FG001|Overall Study|Lack of Efficacy|0|||
147479176|NCT00224107|531912049|FG000|Overall Study|Lost to Follow-up|4|||
147479177|NCT00224107|531912050|FG001|Overall Study|Lost to Follow-up|0|||
147479178|NCT00224107|531912049|FG000|Overall Study|Physician Decision|1|||
147479179|NCT00224107|531912050|FG001|Overall Study|Physician Decision|0|||
147479180|NCT00224107|531912049|FG000|Overall Study|Other|1|||
147479181|NCT00224107|531912050|FG001|Overall Study|Other|1|||
147479182|NCT00098345|531912053|FG000|Overall Study|Adverse Event|7|||
147479183|NCT00098345|531912053|FG000|Overall Study|Withdrawal by Subject|2|||
147667004|NCT00434252|532607930|FG001|Overall Study|Adverse Event|13|||
147667005|NCT00434252|532607929|FG000|Overall Study|Death|1|||
147667006|NCT00434252|532607930|FG001|Overall Study|Death|2|||
147667007|NCT00434252|532607929|FG000|Overall Study|Lost to Follow-up|0|||
147667008|NCT00434252|532607930|FG001|Overall Study|Lost to Follow-up|1|||
147667009|NCT00434252|532607929|FG000|Overall Study|Physician Decision|4|||
147667010|NCT00434252|532607930|FG001|Overall Study|Physician Decision|8|||
147667011|NCT00434252|532607929|FG000|Overall Study|Withdrawal by Subject|3|||
147667012|NCT00434252|532607930|FG001|Overall Study|Withdrawal by Subject|7|||
147667013|NCT04745351|532607937|FG000|Overall Study|Death|51|||
147667014|NCT04745351|532607938|FG001|Overall Study|Death|25|||
147667015|NCT04745351|532607937|FG000|Overall Study|Lost to Follow-up|9|||
147667016|NCT04745351|532607938|FG001|Overall Study|Lost to Follow-up|3|||
147667017|NCT04745351|532607937|FG000|Overall Study|Randomized but Never Treated|3|||
147667018|NCT04745351|532607938|FG001|Overall Study|Randomized but Never Treated|3|||
147667019|NCT04745351|532607937|FG000|Overall Study|Adverse Event|4|||
147667020|NCT04745351|532607938|FG001|Overall Study|Adverse Event|0|||
147667021|NCT04745351|532607937|FG000|Overall Study|Withdrew Consent|1|||
147667022|NCT04745351|532607938|FG001|Overall Study|Withdrew Consent|2|||
147667023|NCT04745351|532607937|FG000|Overall Study|Investigator's Discretion|2|||
147667024|NCT04745351|532607938|FG001|Overall Study|Investigator's Discretion|0|||
147667025|NCT04745351|532607937|FG000|Overall Study|Protocol Violation|1|||
147667026|NCT04745351|532607938|FG001|Overall Study|Protocol Violation|0|||
147667027|NCT01863771|532607939|FG000|Induction Phase|Adverse Event|9|||
147667028|NCT01863771|532607940|FG001|Induction Phase|Adverse Event|0|||
147667029|NCT01863771|532607941|FG002|Induction Phase|Adverse Event|0|||
147667030|NCT01863771|532607942|FG003|Induction Phase|Adverse Event|0|||
147667031|NCT01863771|532607939|FG000|Induction Phase|Lack of Efficacy|10|||
147479184|NCT00098345|531912053|FG000|Overall Study|progression|4|||
147479185|NCT01183858|531912054|FG000|Overall Study|Death not related to Progressive Disease|5|||
147667032|NCT01863771|532607940|FG001|Induction Phase|Lack of Efficacy|0|||
147667033|NCT01863771|532607941|FG002|Induction Phase|Lack of Efficacy|0|||
147667034|NCT01863771|532607942|FG003|Induction Phase|Lack of Efficacy|0|||
147667035|NCT01863771|532607939|FG000|Induction Phase|Withdrawal by Subject|2|||
147667036|NCT01863771|532607940|FG001|Induction Phase|Withdrawal by Subject|0|||
147667037|NCT01863771|532607941|FG002|Induction Phase|Withdrawal by Subject|0|||
147667038|NCT01863771|532607942|FG003|Induction Phase|Withdrawal by Subject|0|||
147667039|NCT01863771|532607939|FG000|Maintenance Phase|Adverse Event|0|||
147667040|NCT01863771|532607940|FG001|Maintenance Phase|Adverse Event|0|||
147667041|NCT01863771|532607941|FG002|Maintenance Phase|Adverse Event|1|||
147667042|NCT01863771|532607942|FG003|Maintenance Phase|Adverse Event|1|||
147479186|NCT01183858|531912055|FG001|Overall Study|Death not related to Progressive Disease|6|||
147479187|NCT01183858|531912054|FG000|Overall Study|Adverse Event|14|||
147479188|NCT01183858|531912055|FG001|Overall Study|Adverse Event|11|||
147479189|NCT01183858|531912054|FG000|Overall Study|Investigator's Decision|0|||
147479190|NCT01183858|531912055|FG001|Overall Study|Investigator's Decision|3|||
147479191|NCT01183858|531912054|FG000|Overall Study|Insufficient Therapeutic Response|2|||
147479192|NCT01183858|531912055|FG001|Overall Study|Insufficient Therapeutic Response|0|||
147479193|NCT01183858|531912054|FG000|Overall Study|Refused Treatment|1|||
147479194|NCT01183858|531912055|FG001|Overall Study|Refused Treatment|4|||
147479195|NCT01183858|531912054|FG000|Overall Study|Withdrew Consent|4|||
147479196|NCT01183858|531912055|FG001|Overall Study|Withdrew Consent|4|||
147479197|NCT01183858|531912054|FG000|Overall Study|Discontinued Smoking|3|||
147479198|NCT01183858|531912055|FG001|Overall Study|Discontinued Smoking|1|||
147479199|NCT01183858|531912054|FG000|Overall Study|Protocol Violation|1|||
147479200|NCT01183858|531912055|FG001|Overall Study|Protocol Violation|0|||
147479201|NCT01183858|531912054|FG000|Overall Study|Administrative/Other|6|||
147622302|NCT04710576|532434809|FG000|Overall Study|Death|2|||
147622303|NCT04710576|532434810|FG001|Overall Study|Death|7|||
147622304|NCT04710576|532434811|FG002|Overall Study|Death|12|||
147622305|NCT04710576|532434809|FG000|Overall Study|Withdrawal by Subject|4|||
147622306|NCT04710576|532434810|FG001|Overall Study|Withdrawal by Subject|3|||
147622307|NCT04710576|532434811|FG002|Overall Study|Withdrawal by Subject|7|||
147622308|NCT04710576|532434809|FG000|Overall Study|Sponsor decision|1|||
147622309|NCT04710576|532434810|FG001|Overall Study|Sponsor decision|0|||
147622310|NCT04710576|532434811|FG002|Overall Study|Sponsor decision|0|||
147622311|NCT02068508|532434814|FG000|Overall Study|Case report forms uncollected|27|||
147622312|NCT02068508|532434814|FG000|Overall Study|Patient did not visit the study site|1|||
147622313|NCT02068508|532434814|FG000|Overall Study|Protocol Violation|4|||
147622314|NCT00813150|532434815|FG000|Treatment Period|Adverse Event|16|||
147622315|NCT00813150|532434816|FG001|Treatment Period|Adverse Event|15|||
147622316|NCT00813150|532434815|FG000|Treatment Period|Death|2|||
147622317|NCT00813150|532434816|FG001|Treatment Period|Death|0|||
147622318|NCT00813150|532434815|FG000|Treatment Period|Progressive disease|1|||
147622319|NCT00813150|532434816|FG001|Treatment Period|Progressive disease|0|||
147622320|NCT00813150|532434815|FG000|Treatment Period|Complete response|0|||
147622321|NCT00813150|532434816|FG001|Treatment Period|Complete response|1|||
147622322|NCT00813150|532434815|FG000|Treatment Period|Stable disease|1|||
147622323|NCT00813150|532434816|FG001|Treatment Period|Stable disease|2|||
147622324|NCT00813150|532434815|FG000|Treatment Period|Protocol Violation|3|||
147622325|NCT00813150|532434816|FG001|Treatment Period|Protocol Violation|4|||
147622326|NCT00813150|532434815|FG000|Treatment Period|Withdrawal by Subject|5|||
147622327|NCT00813150|532434816|FG001|Treatment Period|Withdrawal by Subject|3|||
147622328|NCT00813150|532434815|FG000|Treatment Period|Non compliance|0|||
147622329|NCT00813150|532434816|FG001|Treatment Period|Non compliance|1|||
147622330|NCT00813150|532434815|FG000|Treatment Period|Reason not specified|3|||
147622331|NCT00813150|532434816|FG001|Treatment Period|Reason not specified|4|||
147622332|NCT00813150|532434815|FG000|Treatment Period|Data not available|1|||
147622333|NCT00813150|532434816|FG001|Treatment Period|Data not available|2|||
147622334|NCT00813150|532434815|FG000|Long Term Follow-up|Death|0|||
147622335|NCT00813150|532434816|FG001|Long Term Follow-up|Death|4|||
147622336|NCT00813150|532434815|FG000|Long Term Follow-up|Other|0|||
147622337|NCT00813150|532434816|FG001|Long Term Follow-up|Other|3|||
147622338|NCT00813150|532434815|FG000|Long Term Follow-up|Lost to Follow-up|2|||
147622339|NCT00813150|532434816|FG001|Long Term Follow-up|Lost to Follow-up|0|||
147622340|NCT00813150|532434815|FG000|Long Term Follow-up|Progression/Relapse|22|||
147622341|NCT00813150|532434816|FG001|Long Term Follow-up|Progression/Relapse|24|||
147622342|NCT05423093|532434824|FG000|Consented Participants - Baseline Comple|Lost to Follow-up|2|||
147622343|NCT05423093|532434824|FG000|Consented Participants - Baseline Comple|Withdrawal by Subject|2|||
147622344|NCT05423093|532434824|FG000|Attended Intervention Session|Lost to Follow-up|3|||
147622345|NCT05423093|532434824|FG000|Completed Post-intervention Measures|Lost to Follow-up|3|||
147622346|NCT05423093|532434824|FG000|6-month Post Intervention Data Collected|Lost to Follow-up|2|||
147622347|NCT03593525|532434825|FG000|Overall Study|Withdrawal by Subject|1|||
147622348|NCT03593525|532434826|FG001|Overall Study|Withdrawal by Subject|0|||
147622349|NCT03593525|532434825|FG000|Overall Study|Lost to Follow-up|7|||
147622350|NCT03593525|532434826|FG001|Overall Study|Lost to Follow-up|5|||
147622351|NCT01217112|532434834|FG000|Overall Study|Adverse Event|0|||
147622352|NCT01217112|532434835|FG001|Overall Study|Adverse Event|2|||
147622353|NCT01217112|532434836|FG002|Overall Study|Adverse Event|0|||
147622354|NCT01217112|532434837|FG003|Overall Study|Adverse Event|2|||
147622355|NCT01217112|532434838|FG004|Overall Study|Adverse Event|0|||
147479202|NCT01183858|531912055|FG001|Overall Study|Administrative/Other|6|||
147479203|NCT01183858|531912054|FG000|Overall Study|Progressive Disease|112|||
147622356|NCT01217112|532434834|FG000|Overall Study|Withdrawal by Subject|0|||
147622357|NCT01217112|532434835|FG001|Overall Study|Withdrawal by Subject|0|||
147479204|NCT01183858|531912055|FG001|Overall Study|Progressive Disease|115|||
147622358|NCT01217112|532434836|FG002|Overall Study|Withdrawal by Subject|1|||
147622359|NCT01217112|532434837|FG003|Overall Study|Withdrawal by Subject|0|||
147622360|NCT01217112|532434838|FG004|Overall Study|Withdrawal by Subject|0|||
147479205|NCT01183858|531912054|FG000|Overall Study|Death related to Progressive Disease|4|||
147479206|NCT01183858|531912055|FG001|Overall Study|Death related to Progressive Disease|5|||
147667043|NCT01863771|532607939|FG000|Maintenance Phase|Lack of Efficacy|0|||
147667044|NCT01863771|532607940|FG001|Maintenance Phase|Lack of Efficacy|3|||
147667045|NCT01863771|532607941|FG002|Maintenance Phase|Lack of Efficacy|7|||
147667046|NCT01863771|532607942|FG003|Maintenance Phase|Lack of Efficacy|38|||
147667047|NCT01863771|532607939|FG000|Maintenance Phase|Physician Decision|0|||
147667048|NCT01863771|532607940|FG001|Maintenance Phase|Physician Decision|0|||
147667049|NCT01863771|532607941|FG002|Maintenance Phase|Physician Decision|2|||
147667050|NCT01863771|532607942|FG003|Maintenance Phase|Physician Decision|1|||
147667051|NCT01863771|532607939|FG000|Maintenance Phase|Pregnancy|0|||
147667052|NCT01863771|532607940|FG001|Maintenance Phase|Pregnancy|1|||
147667053|NCT01863771|532607941|FG002|Maintenance Phase|Pregnancy|0|||
147667054|NCT01863771|532607942|FG003|Maintenance Phase|Pregnancy|0|||
147667055|NCT01863771|532607939|FG000|Maintenance Phase|Withdrawal by Subject|0|||
147667056|NCT01863771|532607940|FG001|Maintenance Phase|Withdrawal by Subject|1|||
147667057|NCT01863771|532607941|FG002|Maintenance Phase|Withdrawal by Subject|2|||
147667058|NCT01863771|532607942|FG003|Maintenance Phase|Withdrawal by Subject|3|||
147667059|NCT03499795|532607943|FG000|Overall Study|Adverse Event|1|||
147667060|NCT03499795|532607943|FG000|Overall Study|Lost to Follow-up|1|||
147667061|NCT03636256|532607944|FG000|Overall Study|Lost to Follow-up|3|||
147667062|NCT03636256|532607945|FG001|Overall Study|Lost to Follow-up|0|||
147667063|NCT03636256|532607946|FG002|Overall Study|Lost to Follow-up|2|||
147667064|NCT03636256|532607947|FG003|Overall Study|Lost to Follow-up|1|||
147667065|NCT03636256|532607948|FG004|Overall Study|Lost to Follow-up|0|||
147667066|NCT03636256|532607949|FG005|Overall Study|Lost to Follow-up|4|||
147667067|NCT03636256|532607950|FG006|Overall Study|Lost to Follow-up|2|||
147667068|NCT03636256|532607951|FG007|Overall Study|Lost to Follow-up|0|||
147667069|NCT03636256|532607952|FG008|Overall Study|Lost to Follow-up|4|||
147667070|NCT03636256|532607944|FG000|Overall Study|Withdrawal by Subject|0|||
147667071|NCT03636256|532607945|FG001|Overall Study|Withdrawal by Subject|0|||
147667072|NCT03636256|532607946|FG002|Overall Study|Withdrawal by Subject|0|||
147667073|NCT03636256|532607947|FG003|Overall Study|Withdrawal by Subject|0|||
147667074|NCT03636256|532607948|FG004|Overall Study|Withdrawal by Subject|0|||
147667075|NCT03636256|532607949|FG005|Overall Study|Withdrawal by Subject|0|||
147667076|NCT03636256|532607950|FG006|Overall Study|Withdrawal by Subject|0|||
147667077|NCT03636256|532607951|FG007|Overall Study|Withdrawal by Subject|0|||
147667078|NCT03636256|532607952|FG008|Overall Study|Withdrawal by Subject|1|||
147667079|NCT02426684|532607953|FG000|Overall Study|Physician Decision|1|||
147667080|NCT04748718|532607956|FG000|Overall Study|Lost to Follow-up|50|||
147667081|NCT01450813|532607957|FG000|Overall Study|Physician Decision|1|||
147667082|NCT01450813|532607958|FG001|Overall Study|Physician Decision|1|||
147667083|NCT01450813|532607959|FG002|Overall Study|Physician Decision|0|||
147667084|NCT01450813|532607960|FG003|Overall Study|Physician Decision|3|||
147667085|NCT01118299|532607962|FG000|Overall Study|Death|7|||
147667086|NCT01118299|532607963|FG001|Overall Study|Death|5|||
147667087|NCT01118299|532607962|FG000|Overall Study|Withdrawal by Subject|8|||
147667088|NCT01118299|532607963|FG001|Overall Study|Withdrawal by Subject|8|||
147667089|NCT01118299|532607962|FG000|Overall Study|Lost to Follow-up|2|||
147667090|NCT01118299|532607963|FG001|Overall Study|Lost to Follow-up|1|||
147479207|NCT01183858|531912054|FG000|Overall Study|Lost to Follow-up|1|||
147479208|NCT01183858|531912055|FG001|Overall Study|Lost to Follow-up|1|||
147479209|NCT02046564|531912058|FG000|Overall Study|Adverse Event|6|||
147479210|NCT02046564|531912059|FG001|Overall Study|Adverse Event|3|||
147479211|NCT02046564|531912058|FG000|Overall Study|Physician Decision|0|||
147479212|NCT02046564|531912059|FG001|Overall Study|Physician Decision|1|||
147479213|NCT02046564|531912058|FG000|Overall Study|Protocol Violation|3|||
147479214|NCT02046564|531912059|FG001|Overall Study|Protocol Violation|1|||
147667091|NCT01118299|532607962|FG000|Overall Study|Enrollment Closure, Protocol Amendment|6|||
147667092|NCT01118299|532607963|FG001|Overall Study|Enrollment Closure, Protocol Amendment|15|||
147667093|NCT01935089|532607964|FG000|Overall Study|Adverse Event|2|||
147667094|NCT01935089|532607964|FG000|Overall Study|Withdrawal by Subject|1|||
147667095|NCT02932943|532607965|FG000|Overall Study|Lost to Follow-up|0|||
147667096|NCT02932943|532607966|FG001|Overall Study|Lost to Follow-up|2|||
147667097|NCT02932943|532607965|FG000|Overall Study|Adverse Event|2|||
147667098|NCT02932943|532607966|FG001|Overall Study|Adverse Event|2|||
147667099|NCT02932943|532607965|FG000|Overall Study|Withdrawal by Subject|3|||
147667100|NCT02932943|532607966|FG001|Overall Study|Withdrawal by Subject|3|||
147667101|NCT02337491|532607967|FG000|Overall Study|Death|1|||
147667102|NCT02337491|532607968|FG001|Overall Study|Death|1|||
147479215|NCT02046564|531912058|FG000|Overall Study|Withdrawal by Subject|4|||
147479216|NCT02046564|531912059|FG001|Overall Study|Withdrawal by Subject|10|||
147667103|NCT02337491|532607967|FG000|Overall Study|Adverse Event|0|||
147667104|NCT02337491|532607968|FG001|Overall Study|Adverse Event|1|||
147667105|NCT02337491|532607967|FG000|Overall Study|Withdrawal by Subject|3|||
147667106|NCT02337491|532607968|FG001|Overall Study|Withdrawal by Subject|0|||
147667107|NCT02337491|532607967|FG000|Overall Study|Progressive Disease|44|||
147667108|NCT02337491|532607968|FG001|Overall Study|Progressive Disease|28|||
147479217|NCT02046564|531912058|FG000|Overall Study|Subject met withdrawal criteria|2|||
147667109|NCT02337491|532607967|FG000|Overall Study|On Treatment|2|||
147479218|NCT02046564|531912059|FG001|Overall Study|Subject met withdrawal criteria|5|||
147479219|NCT01295905|531912062|FG000|Overall Study|Did not meet inclusion criteria|1|||
147479220|NCT01295905|531912063|FG001|Overall Study|Did not meet inclusion criteria|0|||
147479221|NCT01295905|531912062|FG000|Overall Study|Met exclusion criteria|1|||
147479222|NCT01295905|531912063|FG001|Overall Study|Met exclusion criteria|0|||
147479223|NCT03707977|531912064|FG000|Steps 1 (ART+bNAbs)|HIV-1 RNA >40 copies/mL while receiving ART + bNAbs in Step 1|0|||
147479224|NCT03707977|531912065|FG001|Steps 1 (ART+bNAbs)|HIV-1 RNA >40 copies/mL while receiving ART + bNAbs in Step 1|0|||
147479225|NCT03707977|531912066|FG002|Steps 1 (ART+bNAbs)|HIV-1 RNA >40 copies/mL while receiving ART + bNAbs in Step 1|3|||
147479226|NCT03707977|531912064|FG000|Step 2 (bNAbs Only)|HIV-1 RNA >400 copies/mL while receiving bNAbs alone in Step 2|0|||
147479227|NCT03707977|531912065|FG001|Step 2 (bNAbs Only)|HIV-1 RNA >400 copies/mL while receiving bNAbs alone in Step 2|0|||
147479228|NCT03707977|531912066|FG002|Step 2 (bNAbs Only)|HIV-1 RNA >400 copies/mL while receiving bNAbs alone in Step 2|14|||
147479229|NCT00641147|531912067|FG000|Completed 4 Months.|Physician Decision|1|||
147479230|NCT00641147|531912068|FG001|Completed 4 Months.|Physician Decision|0|||
147479231|NCT00641147|531912067|FG000|Completed 4 Months.|Adverse Event|1|||
147479232|NCT00641147|531912068|FG001|Completed 4 Months.|Adverse Event|0|||
147479233|NCT00641147|531912067|FG000|Completed 8 Months.|Physician Decision|2|||
147479234|NCT00641147|531912068|FG001|Completed 8 Months.|Physician Decision|1|||
147479235|NCT00641147|531912067|FG000|Completed 8 Months.|non compliance|1|||
147479236|NCT00641147|531912068|FG001|Completed 8 Months.|non compliance|0|||
147479237|NCT00641147|531912067|FG000|Completed 8 Months.|Withdrawal by Subject|0|||
147479238|NCT00641147|531912068|FG001|Completed 8 Months.|Withdrawal by Subject|1|||
147479239|NCT00641147|531912067|FG000|Completed 12 Months.|Physician Decision|1|||
147479240|NCT00641147|531912068|FG001|Completed 12 Months.|Physician Decision|1|||
147479241|NCT00641147|531912067|FG000|Completed 12 Months.|Withdrawal by Subject|0|||
147479242|NCT00641147|531912068|FG001|Completed 12 Months.|Withdrawal by Subject|1|||
147479243|NCT00641147|531912067|FG000|Completed 16 Months.|Physician Decision|1|||
147479244|NCT00641147|531912068|FG001|Completed 16 Months.|Physician Decision|0|||
147479245|NCT00641147|531912067|FG000|Completed 16 Months.|Lost to Follow-up|1|||
147479246|NCT00641147|531912068|FG001|Completed 16 Months.|Lost to Follow-up|0|||
147479247|NCT00791128|531912069|FG000|Overall Study|Adverse Event|4|||
147479248|NCT00791128|531912069|FG000|Overall Study|Device migration|2|||
147479249|NCT00791128|531912069|FG000|Overall Study|non-compliance by subject|2|||
147479250|NCT00791128|531912069|FG000|Overall Study|abdominal tumor, unrelated to device|1|||
147479251|NCT01629667|531912070|FG000|Overall Study|Lost to Follow-up|0|||
147479252|NCT01629667|531912071|FG001|Overall Study|Lost to Follow-up|1|||
147479253|NCT01629667|531912072|FG002|Overall Study|Lost to Follow-up|1|||
147479254|NCT01629667|531912070|FG000|Overall Study|Withdrawal by Subject|31|||
147479255|NCT01629667|531912071|FG001|Overall Study|Withdrawal by Subject|20|||
147479256|NCT01629667|531912072|FG002|Overall Study|Withdrawal by Subject|28|||
147479257|NCT01629667|531912070|FG000|Overall Study|Death|1|||
147479258|NCT01629667|531912071|FG001|Overall Study|Death|5|||
147479259|NCT01629667|531912072|FG002|Overall Study|Death|3|||
147479260|NCT01629667|531912070|FG000|Overall Study|Randomized, not treated|2|||
147479261|NCT01629667|531912071|FG001|Overall Study|Randomized, not treated|1|||
147479262|NCT01629667|531912072|FG002|Overall Study|Randomized, not treated|0|||
147479263|NCT01629667|531912070|FG000|Overall Study|Ongoing AE worsening right heart failure|0|||
147479264|NCT01629667|531912071|FG001|Overall Study|Ongoing AE worsening right heart failure|1|||
147479265|NCT01629667|531912072|FG002|Overall Study|Ongoing AE worsening right heart failure|0|||
147479266|NCT01629667|531912070|FG000|Overall Study|Requiring lung transplant|2|||
147479267|NCT01629667|531912071|FG001|Overall Study|Requiring lung transplant|1|||
147479268|NCT01629667|531912072|FG002|Overall Study|Requiring lung transplant|3|||
147479269|NCT01629667|531912070|FG000|Overall Study|Early tretmt termntd, cmpltd safety f-up|9|||
147479270|NCT01629667|531912071|FG001|Overall Study|Early tretmt termntd, cmpltd safety f-up|11|||
147479271|NCT01629667|531912072|FG002|Overall Study|Early tretmt termntd, cmpltd safety f-up|8|||
147479272|NCT01629667|531912070|FG000|Overall Study|Started other medicine|1|||
147479273|NCT01629667|531912071|FG001|Overall Study|Started other medicine|0|||
147479274|NCT01629667|531912072|FG002|Overall Study|Started other medicine|1|||
147479275|NCT01629667|531912070|FG000|Overall Study|Site error in safety follow-up|0|||
147479276|NCT01629667|531912071|FG001|Overall Study|Site error in safety follow-up|0|||
147479277|NCT01629667|531912072|FG002|Overall Study|Site error in safety follow-up|1|||
147479278|NCT01629667|531912070|FG000|Overall Study|Enrolled in another clinical study|0|||
147479279|NCT01629667|531912071|FG001|Overall Study|Enrolled in another clinical study|1|||
147479280|NCT01629667|531912072|FG002|Overall Study|Enrolled in another clinical study|0|||
147479281|NCT01629667|531912070|FG000|Overall Study|Code break|1|||
147622361|NCT01217112|532434834|FG000|Overall Study|Physician Decision|0|||
147479282|NCT01629667|531912071|FG001|Overall Study|Code break|0|||
147479283|NCT01629667|531912072|FG002|Overall Study|Code break|0|||
147479284|NCT03472534|531912075|FG000|Overall Study|Withdrawal by Subject|9|||
147479285|NCT03472534|531912075|FG000|Overall Study|Adverse Event|2|||
147479286|NCT02614794|531912076|FG000|Overall Study|Death|258|||
147479287|NCT02614794|531912077|FG001|Overall Study|Death|151|||
147479288|NCT02614794|531912076|FG000|Overall Study|Study closure by Sponsor|119|||
147479289|NCT02614794|531912077|FG001|Overall Study|Study closure by Sponsor|45|||
147622362|NCT01217112|532434835|FG001|Overall Study|Physician Decision|0|||
147479290|NCT02614794|531912076|FG000|Overall Study|Withdrawal by Subject|24|||
147479291|NCT02614794|531912077|FG001|Overall Study|Withdrawal by Subject|5|||
147479292|NCT02614794|531912076|FG000|Overall Study|Lost to Follow-up|7|||
147479293|NCT02614794|531912077|FG001|Overall Study|Lost to Follow-up|0|||
147479294|NCT02614794|531912076|FG000|Overall Study|Physician Decision|1|||
147479295|NCT02614794|531912077|FG001|Overall Study|Physician Decision|1|||
147479296|NCT02614794|531912076|FG000|Overall Study|Hospital closure|1|||
147479297|NCT02614794|531912077|FG001|Overall Study|Hospital closure|0|||
147479298|NCT03396471|531912082|FG000|Study Treatment - Up to 22 Months|Disease Progression|6|||
147479299|NCT03396471|531912082|FG000|Study Treatment - Up to 22 Months|Alternative Cancer Therapy|2|||
147479300|NCT03396471|531912082|FG000|Study Treatment - Up to 22 Months|AE / Side Effects / Complications|3|||
147479301|NCT03396471|531912082|FG000|Study Treatment - Up to 22 Months|Death|2|||
147479302|NCT03396471|531912082|FG000|Study Treatment - Up to 22 Months|Symptomatic Deterioration|1|||
147479303|NCT03396471|531912082|FG000|Follow up - Up to 2 Years|Death|9|||
147479304|NCT03396471|531912082|FG000|Follow up - Up to 2 Years|Patient lost to follow up|1|||
147479305|NCT03396471|531912082|FG000|Follow up - Up to 2 Years|Patient Refused to follow up|1|||
147479306|NCT03396471|531912082|FG000|Follow up - Up to 2 Years|study terminated|1|||
147479307|NCT03396471|531912082|FG000|Follow up - Up to 2 Years|Patient would like to seek treatments locally.|1|||
147479308|NCT03396471|531912082|FG000|Follow up - Up to 2 Years|Patient stopped protocol treatment due to lack of response to treatment regimen.|1|||
147479309|NCT01319929|531912086|FG000|First Treatment Period (4 Weeks)|Adverse Event|2|||
147479310|NCT01319929|531912087|FG001|First Treatment Period (4 Weeks)|Adverse Event|0|||
147479311|NCT01319929|531912086|FG000|First Treatment Period (4 Weeks)|Withdrawal by Subject|1|||
147479312|NCT01319929|531912087|FG001|First Treatment Period (4 Weeks)|Withdrawal by Subject|1|||
147479313|NCT01319929|531912086|FG000|First Treatment Period (4 Weeks)|Protocol Violation|0|||
147479314|NCT01319929|531912087|FG001|First Treatment Period (4 Weeks)|Protocol Violation|1|||
147479315|NCT01319929|531912086|FG000|Second Treatment Period (4 Weeks)|Adverse Event|1|||
147479316|NCT01319929|531912087|FG001|Second Treatment Period (4 Weeks)|Adverse Event|0|||
147479317|NCT01319929|531912086|FG000|Second Treatment Period (4 Weeks)|Sponsor Decision|0|||
147479318|NCT01319929|531912087|FG001|Second Treatment Period (4 Weeks)|Sponsor Decision|1|||
147479319|NCT03237845|531912088|FG000|Overall Study|Adverse Event|0|||
147479320|NCT03237845|531912089|FG001|Overall Study|Adverse Event|1|||
147479321|NCT03237845|531912088|FG000|Overall Study|Lost to Follow-up|13|||
147479322|NCT03237845|531912089|FG001|Overall Study|Lost to Follow-up|10|||
147479323|NCT03237845|531912088|FG000|Overall Study|Not Experienced Moderate/Severe Migraine|26|||
147479324|NCT03237845|531912089|FG001|Overall Study|Not Experienced Moderate/Severe Migraine|31|||
147479325|NCT03237845|531912088|FG000|Overall Study|Non-Compliance With Study Treatment|0|||
147479326|NCT03237845|531912089|FG001|Overall Study|Non-Compliance With Study Treatment|1|||
147479327|NCT03237845|531912088|FG000|Overall Study|Physician Decision|1|||
147479328|NCT03237845|531912089|FG001|Overall Study|Physician Decision|2|||
147479329|NCT03237845|531912088|FG000|Overall Study|Pregnancy|1|||
147479330|NCT03237845|531912089|FG001|Overall Study|Pregnancy|0|||
147479331|NCT03237845|531912088|FG000|Overall Study|Protocol Deviation|0|||
147479332|NCT03237845|531912089|FG001|Overall Study|Protocol Deviation|1|||
147479333|NCT03237845|531912088|FG000|Overall Study|Technical Problems|8|||
147479334|NCT03237845|531912089|FG001|Overall Study|Technical Problems|1|||
147479335|NCT03237845|531912088|FG000|Overall Study|Withdrawal by Subject|3|||
147479336|NCT03237845|531912089|FG001|Overall Study|Withdrawal by Subject|3|||
147479337|NCT03237845|531912088|FG000|Overall Study|Other Reasons|4|||
147479338|NCT03237845|531912089|FG001|Overall Study|Other Reasons|0|||
147479339|NCT03865407|531912091|FG000|Overall Study|Adverse Event|1|||
147479340|NCT03865407|531912092|FG001|Overall Study|Adverse Event|0|||
147479341|NCT03865407|531912091|FG000|Overall Study|Withdrawal by Subject|1|||
147479342|NCT03865407|531912092|FG001|Overall Study|Withdrawal by Subject|0|||
147479343|NCT03865407|531912091|FG000|Overall Study|Medical change caused patient to no longer meet inclusion/exclusion criteria|1|||
147479344|NCT03865407|531912092|FG001|Overall Study|Medical change caused patient to no longer meet inclusion/exclusion criteria|0|||
147479345|NCT03233048|531912093|FG000|Overall Study|Withdrawal by Subject|1|||
147479346|NCT00491530|531912094|FG000|Overall Study|Adverse Event|6|||
147479347|NCT00491530|531912095|FG001|Overall Study|Adverse Event|1|||
147479348|NCT00491530|531912096|FG002|Overall Study|Adverse Event|2|||
147479349|NCT00491530|531912094|FG000|Overall Study|Withdrawal by Subject|3|||
147479350|NCT00491530|531912095|FG001|Overall Study|Withdrawal by Subject|0|||
147479351|NCT00491530|531912096|FG002|Overall Study|Withdrawal by Subject|0|||
147479352|NCT00491530|531912094|FG000|Overall Study|Lost to Follow-up|3|||
147479353|NCT00491530|531912095|FG001|Overall Study|Lost to Follow-up|2|||
147479354|NCT00491530|531912096|FG002|Overall Study|Lost to Follow-up|2|||
147479355|NCT00491530|531912094|FG000|Overall Study|Lack of Efficacy|0|||
147479356|NCT00491530|531912095|FG001|Overall Study|Lack of Efficacy|1|||
147622363|NCT01217112|532434836|FG002|Overall Study|Physician Decision|0|||
147479357|NCT00491530|531912096|FG002|Overall Study|Lack of Efficacy|0|||
147479358|NCT00491530|531912094|FG000|Overall Study|Investigator Discretion|0|||
147479359|NCT00491530|531912095|FG001|Overall Study|Investigator Discretion|1|||
147479360|NCT00491530|531912096|FG002|Overall Study|Investigator Discretion|0|||
147667110|NCT02337491|532607968|FG001|Overall Study|On Treatment|0|||
147667111|NCT01483118|532607969|FG000|Overall Study|Lost to Follow-up|12|||
147667112|NCT01483118|532607970|FG001|Overall Study|Lost to Follow-up|16|||
147667113|NCT00785356|532607971|FG000|Overall Study|Study prematurely terminated|8|||
147667114|NCT01079780|532607972|FG000|Overall Study|Disease progression|43|||
147667115|NCT01079780|532607973|FG001|Overall Study|Disease progression|7|||
147667116|NCT01079780|532607974|FG002|Overall Study|Disease progression|31|||
147667117|NCT01079780|532607972|FG000|Overall Study|Adverse Event|13|||
147479361|NCT00491530|531912094|FG000|Overall Study|Patient Request|0|||
147479362|NCT00491530|531912095|FG001|Overall Study|Patient Request|1|||
147479363|NCT00491530|531912096|FG002|Overall Study|Patient Request|0|||
147479364|NCT00491530|531912094|FG000|Overall Study|Use of Prohibited Medication|0|||
147479365|NCT00491530|531912095|FG001|Overall Study|Use of Prohibited Medication|0|||
147479366|NCT00491530|531912096|FG002|Overall Study|Use of Prohibited Medication|1|||
147479367|NCT00883753|531912097|FG000|Overall Study|Adverse Event|37|||
147479368|NCT00883753|531912097|FG000|Overall Study|Death|2|||
147479369|NCT00883753|531912097|FG000|Overall Study|Insufficient therapeutic response|16|||
147479370|NCT00883753|531912097|FG000|Overall Study|Lost to Follow-up|4|||
147479371|NCT00883753|531912097|FG000|Overall Study|Violation of selection criteria at entry|7|||
147479372|NCT00883753|531912097|FG000|Overall Study|Protocol Violation|2|||
147479373|NCT00883753|531912097|FG000|Overall Study|Refused treatment|4|||
147479374|NCT00883753|531912097|FG000|Overall Study|Withdrew consent|10|||
147479375|NCT00883753|531912097|FG000|Overall Study|Investigator's decision|17|||
147479376|NCT00883753|531912097|FG000|Overall Study|Administrative/Other|8|||
147479377|NCT02859415|531912098|FG000|Overall Study|Physician Decision|1|||
147479378|NCT02859415|531912099|FG001|Overall Study|Physician Decision|0|||
147479379|NCT02859415|531912098|FG000|Overall Study|Off treatment due to cardiac event|0|||
147622364|NCT01217112|532434837|FG003|Overall Study|Physician Decision|0|||
147622365|NCT01217112|532434838|FG004|Overall Study|Physician Decision|1|||
147622366|NCT02596971|532434839|FG000|Overall Study|Death|5|||
147622367|NCT02596971|532434840|FG001|Overall Study|Death|1|||
147622368|NCT02596971|532434841|FG002|Overall Study|Death|5|||
147622369|NCT02596971|532434839|FG000|Overall Study|Withdrawal by Subject|5|||
147622370|NCT02596971|532434840|FG001|Overall Study|Withdrawal by Subject|1|||
147622371|NCT02596971|532434841|FG002|Overall Study|Withdrawal by Subject|4|||
147622372|NCT01401361|532434842|FG000|Overall Study|Withdrawal by Subject|16|||
147622373|NCT01401361|532434842|FG000|Overall Study|Lack of Efficacy|6|||
147622374|NCT01401361|532434842|FG000|Overall Study|Physician Decision|1|||
147622375|NCT01401361|532434842|FG000|Overall Study|Lost to Follow-up|3|||
147622376|NCT01401361|532434842|FG000|Overall Study|Subject/family decision post procedure|2|||
147622377|NCT00595920|532434843|FG000|Overall Study|The OLTERMS study was discontinued by th|116|||
147622378|NCT00351468|532434844|FG000|Overall Study|Adverse Event|42|||
147622379|NCT00351468|532434844|FG000|Overall Study|Withdrawal by Subject|39|||
147622380|NCT00351468|532434844|FG000|Overall Study|Various -follow up w clinical team|39|||
147622381|NCT00351468|532434844|FG000|Overall Study|Lack of Efficacy|32|||
147622382|NCT00351468|532434844|FG000|Overall Study|Non-compliance|8|||
147622383|NCT00351468|532434844|FG000|Overall Study|Lost to Follow-up|4|||
147622384|NCT00351468|532434844|FG000|Overall Study|Protocol Violation|3|||
147622385|NCT00611923|532434845|FG000|Overall Study|Withdrawal by Subject|2|||
147622386|NCT00611923|532434846|FG001|Overall Study|Withdrawal by Subject|2|||
147622387|NCT04565145|532434847|FG000|Overall Study|Withdrawal by Subject|1|||
147622388|NCT04565145|532434848|FG001|Overall Study|Withdrawal by Subject|1|||
147622389|NCT03096314|532434849|FG000|Screened Vitamin D Deficient|Lost to Follow-up|9|||
147622390|NCT03096314|532434850|FG001|Screened Vitamin D Deficient|Lost to Follow-up|12|||
147622391|NCT02764762|532434851|FG000|Overall Study|Pretreatment Event/Adverse Event|9|||
147622392|NCT02764762|532434851|FG000|Overall Study|Lost to Follow-up|4|||
147622393|NCT02764762|532434851|FG000|Overall Study|Voluntary Withdrawal|8|||
147622394|NCT02764762|532434851|FG000|Overall Study|Site Termination|1|||
147622395|NCT02764762|532434851|FG000|Overall Study|Lack of Efficacy|16|||
147622396|NCT02764762|532434851|FG000|Overall Study|Reason not Specified|1|||
147622397|NCT03318861|532434855|FG000|Overall Study|Death|2|||
147622398|NCT03318861|532434856|FG001|Overall Study|Death|3|||
147622399|NCT03318861|532434857|FG002|Overall Study|Death|3|||
147622400|NCT03318861|532434858|FG003|Overall Study|Death|2|||
147622401|NCT03318861|532434859|FG004|Overall Study|Death|2|||
147622402|NCT03318861|532434855|FG000|Overall Study|Enrolled But Never Treated|0|||
147622403|NCT03318861|532434856|FG001|Overall Study|Enrolled But Never Treated|1|||
147622404|NCT03318861|532434857|FG002|Overall Study|Enrolled But Never Treated|0|||
147622405|NCT03318861|532434858|FG003|Overall Study|Enrolled But Never Treated|1|||
147622406|NCT03318861|532434859|FG004|Overall Study|Enrolled But Never Treated|1|||
147622407|NCT03318861|532434855|FG000|Overall Study|Informed Consent Withdraw|0|||
147479380|NCT02859415|531912099|FG001|Overall Study|Off treatment due to cardiac event|1|||
147479381|NCT00949650|531912102|FG000|Overall Study|Progressive disease|188|||
147479382|NCT00949650|531912103|FG001|Overall Study|Progressive disease|19|||
147479383|NCT00949650|531912102|FG000|Overall Study|Completed 6 courses of chemotherapy|0|||
147622408|NCT03318861|532434856|FG001|Overall Study|Informed Consent Withdraw|0|||
147667118|NCT01079780|532607973|FG001|Overall Study|Adverse Event|5|||
147667119|NCT01079780|532607974|FG002|Overall Study|Adverse Event|7|||
147479384|NCT00949650|531912103|FG001|Overall Study|Completed 6 courses of chemotherapy|60|||
147479385|NCT00949650|531912102|FG000|Overall Study|Other Adverse Event (AE)|28|||
147479386|NCT00949650|531912103|FG001|Overall Study|Other Adverse Event (AE)|17|||
147479387|NCT00949650|531912102|FG000|Overall Study|Protocol Violation|1|||
147479388|NCT00949650|531912103|FG001|Overall Study|Protocol Violation|4|||
147479389|NCT00949650|531912102|FG000|Overall Study|Refusal to continue medication|7|||
147479390|NCT00949650|531912103|FG001|Overall Study|Refusal to continue medication|11|||
147479391|NCT00949650|531912102|FG000|Overall Study|Not treated|1|||
147479392|NCT00949650|531912103|FG001|Overall Study|Not treated|4|||
147479393|NCT00949650|531912102|FG000|Overall Study|Other not specified above|5|||
147479394|NCT00949650|531912103|FG001|Overall Study|Other not specified above|0|||
147479395|NCT02436239|531912107|FG000|Open-Lable Treatment Period|Adverse Event|12|||
147479396|NCT02436239|531912108|FG001|Open-Lable Treatment Period|Adverse Event|3|||
147479397|NCT02436239|531912109|FG002|Open-Lable Treatment Period|Adverse Event|4|||
147479398|NCT02436239|531912110|FG003|Open-Lable Treatment Period|Adverse Event|2|||
147479399|NCT02436239|531912107|FG000|Open-Lable Treatment Period|Lack of Efficacy|1|||
147479400|NCT02436239|531912108|FG001|Open-Lable Treatment Period|Lack of Efficacy|6|||
147479401|NCT02436239|531912109|FG002|Open-Lable Treatment Period|Lack of Efficacy|6|||
147479402|NCT02436239|531912110|FG003|Open-Lable Treatment Period|Lack of Efficacy|1|||
147479403|NCT02436239|531912107|FG000|Open-Lable Treatment Period|Withdrawal by Subject|10|||
147479404|NCT02436239|531912108|FG001|Open-Lable Treatment Period|Withdrawal by Subject|15|||
147479405|NCT02436239|531912109|FG002|Open-Lable Treatment Period|Withdrawal by Subject|9|||
147479406|NCT02436239|531912110|FG003|Open-Lable Treatment Period|Withdrawal by Subject|0|||
147479407|NCT02436239|531912107|FG000|Open-Lable Treatment Period|Lost to Follow-up|4|||
147479408|NCT02436239|531912108|FG001|Open-Lable Treatment Period|Lost to Follow-up|2|||
147479409|NCT02436239|531912109|FG002|Open-Lable Treatment Period|Lost to Follow-up|4|||
147479410|NCT02436239|531912110|FG003|Open-Lable Treatment Period|Lost to Follow-up|1|||
147479411|NCT02436239|531912107|FG000|Open-Lable Treatment Period|Protocol Violation|0|||
147479412|NCT02436239|531912108|FG001|Open-Lable Treatment Period|Protocol Violation|1|||
147479413|NCT02436239|531912109|FG002|Open-Lable Treatment Period|Protocol Violation|1|||
147479414|NCT02436239|531912110|FG003|Open-Lable Treatment Period|Protocol Violation|0|||
147479415|NCT02436239|531912107|FG000|Open-Lable Treatment Period|Noncompliance with Study Drug|5|||
147479416|NCT02436239|531912108|FG001|Open-Lable Treatment Period|Noncompliance with Study Drug|6|||
147479417|NCT02436239|531912109|FG002|Open-Lable Treatment Period|Noncompliance with Study Drug|3|||
147479418|NCT02436239|531912110|FG003|Open-Lable Treatment Period|Noncompliance with Study Drug|1|||
147479419|NCT02436239|531912107|FG000|Open-Lable Treatment Period|Other Reason|1|||
147479420|NCT02436239|531912108|FG001|Open-Lable Treatment Period|Other Reason|1|||
147479421|NCT02436239|531912109|FG002|Open-Lable Treatment Period|Other Reason|0|||
147479422|NCT02436239|531912110|FG003|Open-Lable Treatment Period|Other Reason|0|||
147479423|NCT02436239|531912107|FG000|Down-Taper Period|Withdrawal by Subject|4|||
147479424|NCT02436239|531912108|FG001|Down-Taper Period|Withdrawal by Subject|4|||
147479425|NCT02436239|531912109|FG002|Down-Taper Period|Withdrawal by Subject|1|||
147479426|NCT02436239|531912110|FG003|Down-Taper Period|Withdrawal by Subject|2|||
147479427|NCT03671369|531912111|FG000|Overall Study|Other|1|||
147479428|NCT03671369|531912111|FG000|Overall Study|Withdrawal by Subject|289|||
147479429|NCT03671369|531912111|FG000|Overall Study|Not willing to be vaccinated|1|||
147479430|NCT02612077|531912113|FG000|Overall Study|Adverse Event|3|||
147479431|NCT02612077|531912113|FG000|Overall Study|Withdrawal by Subject|9|||
147479432|NCT02612077|531912113|FG000|Overall Study|Protocol Violation|28|||
147479433|NCT02612077|531912113|FG000|Overall Study|Lost to Follow-up|20|||
147479434|NCT02612077|531912113|FG000|Overall Study|Death|377|||
147479435|NCT02612077|531912113|FG000|Overall Study|Moved or Changed Medical Team|23|||
147479436|NCT02612077|531912113|FG000|Overall Study|Enrollment in a Clinical Trial|1|||
147479437|NCT02612077|531912113|FG000|Overall Study|Disease Progression|3|||
147479438|NCT02612077|531912113|FG000|Overall Study|Unknown reason|2|||
147479439|NCT01971476|531912114|FG000|Cohort 1: 2 to <12 Years|Other not defined|3|||
147479440|NCT01971476|531912115|FG001|Cohort 1: 2 to <12 Years|Other not defined|3|||
147479441|NCT01971476|531912116|FG002|Cohort 1: 2 to <12 Years|Other not defined|6|||
147622409|NCT03318861|532434857|FG002|Overall Study|Informed Consent Withdraw|0|||
147622410|NCT03318861|532434858|FG003|Overall Study|Informed Consent Withdraw|1|||
147622411|NCT03318861|532434859|FG004|Overall Study|Informed Consent Withdraw|0|||
147622412|NCT03318861|532434855|FG000|Overall Study|Withdrawal of Consent From Further Follow-up|1|||
147479442|NCT01971476|531912114|FG000|Cohort 2: 12 to <18 Years|Other not defined|6|||
147622413|NCT03318861|532434856|FG001|Overall Study|Withdrawal of Consent From Further Follow-up|0|||
147622414|NCT03318861|532434857|FG002|Overall Study|Withdrawal of Consent From Further Follow-up|0|||
147479443|NCT01971476|531912115|FG001|Cohort 2: 12 to <18 Years|Other not defined|3|||
147479444|NCT01971476|531912116|FG002|Cohort 2: 12 to <18 Years|Other not defined|0|||
147479445|NCT01971476|531912114|FG000|Cohort 2: 12 to <18 Years|Adverse Event|0|||
147479446|NCT01971476|531912115|FG001|Cohort 2: 12 to <18 Years|Adverse Event|1|||
147479447|NCT01971476|531912116|FG002|Cohort 2: 12 to <18 Years|Adverse Event|0|||
147622415|NCT03318861|532434858|FG003|Overall Study|Withdrawal of Consent From Further Follow-up|0|||
147479448|NCT02498821|531912117|FG000|Overall Study|Screen failure|3|||
147479449|NCT02498821|531912118|FG001|Overall Study|Screen failure|5|||
147667120|NCT01079780|532607972|FG000|Overall Study|Death|2|||
147667121|NCT01079780|532607973|FG001|Overall Study|Death|0|||
147667122|NCT01079780|532607974|FG002|Overall Study|Death|2|||
147479450|NCT01716169|531912120|FG000|Overall Study|Adverse Event|1|||
147479451|NCT01716169|531912120|FG000|Overall Study|Lost to Follow-up|1|||
147479452|NCT01716169|531912120|FG000|Overall Study|Withdrawal by Subject|1|||
147479453|NCT01716169|531912120|FG000|Overall Study|inconsistent dressing application|1|||
147479454|NCT00306891|531912123|FG000|Part A|Withdrawal by Subject|1|||
147479455|NCT00306891|531912124|FG001|Part A|Withdrawal by Subject|1|||
147479456|NCT00306891|531912125|FG002|Part A|Withdrawal by Subject|0|||
147479457|NCT00306891|531912126|FG003|Part A|Withdrawal by Subject|0|||
147479458|NCT00306891|531912123|FG000|Part A|Condition under investigation worsened|2|||
147667123|NCT01079780|532607972|FG000|Overall Study|Withdrawal by Subject|6|||
147667124|NCT01079780|532607973|FG001|Overall Study|Withdrawal by Subject|4|||
147667125|NCT01079780|532607974|FG002|Overall Study|Withdrawal by Subject|4|||
147479459|NCT00306891|531912124|FG001|Part A|Condition under investigation worsened|2|||
147479460|NCT00306891|531912125|FG002|Part A|Condition under investigation worsened|0|||
147479461|NCT00306891|531912126|FG003|Part A|Condition under investigation worsened|0|||
147479462|NCT00306891|531912123|FG000|Part A|Incorrect enrol/entry crit not fulfilled|0|||
147479463|NCT00306891|531912124|FG001|Part A|Incorrect enrol/entry crit not fulfilled|1|||
147479464|NCT00306891|531912125|FG002|Part A|Incorrect enrol/entry crit not fulfilled|0|||
147479465|NCT00306891|531912126|FG003|Part A|Incorrect enrol/entry crit not fulfilled|0|||
147479466|NCT00306891|531912123|FG000|Part A|Partial bowel obstruction|1|||
147479467|NCT00306891|531912124|FG001|Part A|Partial bowel obstruction|0|||
147479468|NCT00306891|531912125|FG002|Part A|Partial bowel obstruction|0|||
147667126|NCT01079780|532607972|FG000|Overall Study|Alternative therapy|2|||
147667127|NCT01079780|532607973|FG001|Overall Study|Alternative therapy|0|||
147667128|NCT01079780|532607974|FG002|Overall Study|Alternative therapy|2|||
147667129|NCT01079780|532607972|FG000|Overall Study|Physician Decision|1|||
147667130|NCT01079780|532607973|FG001|Overall Study|Physician Decision|0|||
147667131|NCT01079780|532607974|FG002|Overall Study|Physician Decision|1|||
147667132|NCT01079780|532607972|FG000|Overall Study|Error made in lesion measurement|1|||
147667133|NCT01079780|532607973|FG001|Overall Study|Error made in lesion measurement|0|||
147667134|NCT01079780|532607974|FG002|Overall Study|Error made in lesion measurement|0|||
147667135|NCT01079780|532607972|FG000|Overall Study|Patient had surgery|1|||
147667136|NCT01079780|532607973|FG001|Overall Study|Patient had surgery|0|||
147667137|NCT01079780|532607974|FG002|Overall Study|Patient had surgery|0|||
147667138|NCT01079780|532607972|FG000|Overall Study|Treatment cycle delay|0|||
147667139|NCT01079780|532607973|FG001|Overall Study|Treatment cycle delay|0|||
147667140|NCT01079780|532607974|FG002|Overall Study|Treatment cycle delay|1|||
147667141|NCT01079780|532607972|FG000|Overall Study|Never started treatment|1|||
147667142|NCT01079780|532607973|FG001|Overall Study|Never started treatment|0|||
147667143|NCT01079780|532607974|FG002|Overall Study|Never started treatment|2|||
147667144|NCT01178294|532607980|FG000|Overall Study|Adverse Event|4|||
147667145|NCT01178294|532607980|FG000|Overall Study|Lost to Follow-up|2|||
147667146|NCT01178294|532607980|FG000|Overall Study|Lack of Efficacy|1|||
147667147|NCT01178294|532607980|FG000|Overall Study|Death|1|||
147667148|NCT01178294|532607980|FG000|Overall Study|Development of inhibitors to OBI-1|1|||
147667149|NCT01178294|532607980|FG000|Overall Study|Subject status is terminal|1|||
147667150|NCT01178294|532607980|FG000|Overall Study|Completion status could not be verified|1|||
147667151|NCT02783066|532607981|FG000|Overall Study|Withdrawal by Subject|13|||
147667152|NCT00551369|532607982|FG000|Overall Study|Protocol Violation|5|||
147667153|NCT00551369|532607982|FG000|Overall Study|Withdrawal by Subject|1|||
147667154|NCT00551369|532607982|FG000|Overall Study|Not treated per protocol and re|1|||
147667155|NCT02051296|532607983|FG000|Overall Study|Lost to Follow-up|1|||
147667156|NCT02051296|532607984|FG001|Overall Study|Lost to Follow-up|2|||
147479469|NCT00306891|531912126|FG003|Part A|Partial bowel obstruction|0|||
147479470|NCT00306891|531912123|FG000|Part A|Reaccumul. of ascites following drainage|0|||
147479471|NCT00306891|531912124|FG001|Part A|Reaccumul. of ascites following drainage|1|||
147479472|NCT00306891|531912125|FG002|Part A|Reaccumul. of ascites following drainage|0|||
147479473|NCT00306891|531912126|FG003|Part A|Reaccumul. of ascites following drainage|0|||
147479474|NCT00306891|531912123|FG000|Part A|Suspicion of second malignancy|0|||
147479475|NCT00306891|531912124|FG001|Part A|Suspicion of second malignancy|1|||
147667157|NCT02051296|532607983|FG000|Overall Study|withdraw prior to treatment|7|||
147667158|NCT02051296|532607984|FG001|Overall Study|withdraw prior to treatment|7|||
147667159|NCT05379920|532607985|FG000|Overall Study|Lost to Follow-up|0|||
147479476|NCT00306891|531912125|FG002|Part A|Suspicion of second malignancy|0|||
147479477|NCT00306891|531912126|FG003|Part A|Suspicion of second malignancy|0|||
147479478|NCT00306891|531912123|FG000|Part A|QTC interval outwith elig. criteria|1|||
147479479|NCT00306891|531912124|FG001|Part A|QTC interval outwith elig. criteria|0|||
147667160|NCT05379920|532607986|FG001|Overall Study|Lost to Follow-up|5|||
147667161|NCT05379920|532607987|FG002|Overall Study|Lost to Follow-up|0|||
147667162|NCT05379920|532607988|FG003|Overall Study|Lost to Follow-up|0|||
147667163|NCT03176771|532607991|FG000|Double-Blind Placebo-Controlled Period|Adverse Event|3|||
147667164|NCT03176771|532607992|FG001|Double-Blind Placebo-Controlled Period|Adverse Event|5|||
147667165|NCT03176771|532607993|FG002|Double-Blind Placebo-Controlled Period|Adverse Event|14|||
147479480|NCT00306891|531912125|FG002|Part A|QTC interval outwith elig. criteria|0|||
147479481|NCT00306891|531912126|FG003|Part A|QTC interval outwith elig. criteria|0|||
147479482|NCT00306891|531912123|FG000|Part B|Death|0|||
147479483|NCT00306891|531912124|FG001|Part B|Death|0|||
147479484|NCT00306891|531912125|FG002|Part B|Death|1|||
147479485|NCT00306891|531912126|FG003|Part B|Death|2|||
147479486|NCT00306891|531912123|FG000|Part B|Adverse Event|0|||
147479487|NCT00306891|531912124|FG001|Part B|Adverse Event|0|||
147479488|NCT00306891|531912125|FG002|Part B|Adverse Event|5|||
147479489|NCT00306891|531912126|FG003|Part B|Adverse Event|5|||
147479490|NCT00306891|531912123|FG000|Part B|Withdrawal by Subject|0|||
147479491|NCT00306891|531912124|FG001|Part B|Withdrawal by Subject|0|||
147479492|NCT00306891|531912125|FG002|Part B|Withdrawal by Subject|3|||
147479493|NCT00306891|531912126|FG003|Part B|Withdrawal by Subject|1|||
147479494|NCT00306891|531912123|FG000|Part B|Condition under investigation worsened|0|||
147479495|NCT00306891|531912124|FG001|Part B|Condition under investigation worsened|0|||
147479496|NCT00306891|531912125|FG002|Part B|Condition under investigation worsened|2|||
147479497|NCT00306891|531912126|FG003|Part B|Condition under investigation worsened|8|||
147479498|NCT00306891|531912123|FG000|Part B|Development of study specific disc crit.|0|||
147479499|NCT00306891|531912124|FG001|Part B|Development of study specific disc crit.|0|||
147479500|NCT00306891|531912125|FG002|Part B|Development of study specific disc crit.|0|||
147479501|NCT00306891|531912126|FG003|Part B|Development of study specific disc crit.|1|||
147479502|NCT00231478|531912128|FG000|Overall Study|Protocol Violation|3|||
147479503|NCT00231478|531912129|FG001|Overall Study|Protocol Violation|2|||
147479504|NCT00231478|531912128|FG000|Overall Study|Refused Treatment|1|||
147479505|NCT00231478|531912129|FG001|Overall Study|Refused Treatment|1|||
147479506|NCT00231478|531912128|FG000|Overall Study|Withdrawal by Subject|1|||
147479507|NCT00231478|531912129|FG001|Overall Study|Withdrawal by Subject|0|||
147479508|NCT00231478|531912128|FG000|Overall Study|Adverse Event|0|||
147479509|NCT00231478|531912129|FG001|Overall Study|Adverse Event|1|||
147479510|NCT00231478|531912128|FG000|Overall Study|Administrative|3|||
147479511|NCT00231478|531912129|FG001|Overall Study|Administrative|2|||
147479512|NCT02053246|531912131|FG000|Overall Study|Withdrawal by Subject|3|||
147479513|NCT02053246|531912131|FG000|Overall Study|Physician Decision|1|||
147479514|NCT02369510|531912134|FG000|Overall Study|Spilled Medication|1|||
147479515|NCT02369510|531912135|FG001|Overall Study|Spilled Medication|2|||
147479516|NCT02369510|531912136|FG002|Overall Study|Spilled Medication|1|||
147479517|NCT02369510|531912134|FG000|Overall Study|Epidural Activation|1|||
147479518|NCT02369510|531912135|FG001|Overall Study|Epidural Activation|1|||
147479519|NCT02369510|531912136|FG002|Overall Study|Epidural Activation|5|||
147479520|NCT04285723|531912143|FG000|Overall Study|Subject decision|1|||
147479521|NCT04285723|531912144|FG001|Overall Study|Subject decision|2|||
147479522|NCT04285723|531912143|FG000|Overall Study|Physician Decision|1|||
147479523|NCT04285723|531912144|FG001|Overall Study|Physician Decision|0|||
147479524|NCT04285723|531912143|FG000|Overall Study|No efficiency|1|||
147479525|NCT04285723|531912144|FG001|Overall Study|No efficiency|0|||
147479526|NCT03067311|531912145|FG000|Overall Study|Lost to Follow-up|1|||
147479527|NCT03067311|531912146|FG001|Overall Study|Lost to Follow-up|1|||
147479528|NCT03067311|531912145|FG000|Overall Study|Moved away|1|||
147479529|NCT03067311|531912146|FG001|Overall Study|Moved away|1|||
147479530|NCT02903511|531912147|FG000|Overall Study|Withdrawal by Subject|1|||
147479531|NCT02903511|531912148|FG001|Overall Study|Withdrawal by Subject|0|||
147479532|NCT02903511|531912147|FG000|Overall Study|Lost to Follow-up|3|||
147479533|NCT02903511|531912148|FG001|Overall Study|Lost to Follow-up|2|||
147622416|NCT03318861|532434859|FG004|Overall Study|Withdrawal of Consent From Further Follow-up|0|||
147622417|NCT00917852|532434860|FG000|Overall Study|Death|6|||
147622418|NCT00471081|532434861|FG000|Active Phase|Protocol Violation|1|||
147622419|NCT00471081|532434862|FG001|Active Phase|Protocol Violation|1|||
147622420|NCT00471081|532434861|FG000|Active Phase|Withdrawal by Subject|0|||
147479534|NCT00907738|531912149|FG000|Overall Study|Adverse Event|2|||
147479535|NCT00907738|531912150|FG001|Overall Study|Adverse Event|0|||
147479536|NCT00907738|531912151|FG002|Overall Study|Adverse Event|1|||
147479537|NCT00907738|531912152|FG003|Overall Study|Adverse Event|0|||
147479538|NCT00907738|531912153|FG004|Overall Study|Adverse Event|0|||
147479539|NCT00907738|531912149|FG000|Overall Study|not specified or withdrew consent|3|||
147479540|NCT00907738|531912150|FG001|Overall Study|not specified or withdrew consent|0|||
147479541|NCT00907738|531912151|FG002|Overall Study|not specified or withdrew consent|0|||
147479542|NCT00907738|531912152|FG003|Overall Study|not specified or withdrew consent|0|||
147479543|NCT00907738|531912153|FG004|Overall Study|not specified or withdrew consent|0|||
147479544|NCT00907738|531912149|FG000|Overall Study|Disease progression|8|||
147479545|NCT00907738|531912150|FG001|Overall Study|Disease progression|1|||
147479546|NCT00907738|531912151|FG002|Overall Study|Disease progression|6|||
147479547|NCT00907738|531912152|FG003|Overall Study|Disease progression|4|||
147622421|NCT00471081|532434862|FG001|Active Phase|Withdrawal by Subject|3|||
147622422|NCT00471081|532434861|FG000|Active Phase|Lost to Follow-up|0|||
147479548|NCT00907738|531912153|FG004|Overall Study|Disease progression|2|||
147479549|NCT05363293|531912154|FG000|Overall Study|Withdrawal by Subject|1|||
147479550|NCT05363293|531912155|FG001|Overall Study|Withdrawal by Subject|0|||
147479551|NCT05363293|531912156|FG002|Overall Study|Withdrawal by Subject|0|||
147622423|NCT00471081|532434862|FG001|Active Phase|Lost to Follow-up|1|||
147622424|NCT00471081|532434861|FG000|Active Phase|Lost health plan/insurance|1|||
147622425|NCT00471081|532434862|FG001|Active Phase|Lost health plan/insurance|8|||
147622426|NCT00471081|532434861|FG000|Extended Safety Follow-Up|Withdrawal by Subject|1|||
147622427|NCT00471081|532434862|FG001|Extended Safety Follow-Up|Withdrawal by Subject|4|||
147622428|NCT00471081|532434861|FG000|Extended Safety Follow-Up|Lost to Follow-up|1|||
147622429|NCT00471081|532434862|FG001|Extended Safety Follow-Up|Lost to Follow-up|8|||
147622430|NCT00471081|532434861|FG000|Extended Safety Follow-Up|Missing confirmed|0|||
147622431|NCT00471081|532434862|FG001|Extended Safety Follow-Up|Missing confirmed|1|||
147622432|NCT02844933|532434863|FG000|Overall Study|Discontinued due to premature termination of study|3|||
147622433|NCT02844933|532434864|FG001|Overall Study|Discontinued due to premature termination of study|2|||
147622434|NCT01479465|532434865|FG000|Overall Study|Disease Progression|9|||
147622435|NCT01479465|532434866|FG001|Overall Study|Disease Progression|61|||
147622436|NCT01479465|532434867|FG002|Overall Study|Disease Progression|65|||
147622437|NCT01479465|532434868|FG003|Overall Study|Disease Progression|70|||
147622438|NCT01479465|532434865|FG000|Overall Study|Study Discontinued by Sponsor|0|||
147622439|NCT01479465|532434866|FG001|Overall Study|Study Discontinued by Sponsor|7|||
147622440|NCT01479465|532434867|FG002|Overall Study|Study Discontinued by Sponsor|5|||
147622441|NCT01479465|532434868|FG003|Overall Study|Study Discontinued by Sponsor|3|||
147622442|NCT01479465|532434865|FG000|Overall Study|Adverse Event|0|||
147622443|NCT01479465|532434866|FG001|Overall Study|Adverse Event|3|||
147622444|NCT01479465|532434867|FG002|Overall Study|Adverse Event|6|||
147622445|NCT01479465|532434868|FG003|Overall Study|Adverse Event|4|||
147622446|NCT01479465|532434865|FG000|Overall Study|Investigator Discretion|1|||
147622447|NCT01479465|532434866|FG001|Overall Study|Investigator Discretion|4|||
147622448|NCT01479465|532434867|FG002|Overall Study|Investigator Discretion|2|||
147622449|NCT01479465|532434868|FG003|Overall Study|Investigator Discretion|4|||
147622450|NCT01479465|532434865|FG000|Overall Study|Subject Request|1|||
147622451|NCT01479465|532434866|FG001|Overall Study|Subject Request|3|||
147622452|NCT01479465|532434867|FG002|Overall Study|Subject Request|4|||
147622453|NCT01479465|532434868|FG003|Overall Study|Subject Request|2|||
147622454|NCT01479465|532434865|FG000|Overall Study|Subject Withdrew Consent|0|||
147622455|NCT01479465|532434866|FG001|Overall Study|Subject Withdrew Consent|5|||
147622456|NCT01479465|532434867|FG002|Overall Study|Subject Withdrew Consent|2|||
147622457|NCT01479465|532434868|FG003|Overall Study|Subject Withdrew Consent|1|||
147622458|NCT01479465|532434865|FG000|Overall Study|Protocol Violation|0|||
147622459|NCT01479465|532434866|FG001|Overall Study|Protocol Violation|1|||
147622460|NCT01479465|532434867|FG002|Overall Study|Protocol Violation|1|||
147622461|NCT01479465|532434868|FG003|Overall Study|Protocol Violation|0|||
147622462|NCT01479465|532434865|FG000|Overall Study|Death|0|||
147622463|NCT01479465|532434866|FG001|Overall Study|Death|0|||
147622464|NCT01479465|532434867|FG002|Overall Study|Death|0|||
147622465|NCT01479465|532434868|FG003|Overall Study|Death|1|||
147622466|NCT01479465|532434865|FG000|Overall Study|Lost to Follow-up|0|||
147622467|NCT01479465|532434866|FG001|Overall Study|Lost to Follow-up|0|||
147622468|NCT01479465|532434867|FG002|Overall Study|Lost to Follow-up|1|||
147622469|NCT01479465|532434868|FG003|Overall Study|Lost to Follow-up|0|||
147622470|NCT02393950|532434873|FG000|Overall Study|Adverse Event|1|||
147622471|NCT02393950|532434874|FG001|Overall Study|Adverse Event|0|||
147622472|NCT02393950|532434873|FG000|Overall Study|Withdrawal by Subject|0|||
147622473|NCT02393950|532434874|FG001|Overall Study|Withdrawal by Subject|1|||
147622474|NCT05486091|532434875|FG000|Overall Study|Withdrawal by Subject|1|||
147622475|NCT05486091|532434875|FG000|Overall Study|Lost to Follow-up|2|||
147622476|NCT00370552|532434876|FG000|Overall Study|Adverse Event|2|||
147622477|NCT00370552|532434877|FG001|Overall Study|Adverse Event|2|||
147622478|NCT00370552|532434878|FG002|Overall Study|Adverse Event|2|||
147622479|NCT00370552|532434876|FG000|Overall Study|Disease progression|23|||
147622480|NCT00370552|532434877|FG001|Overall Study|Disease progression|23|||
147622481|NCT00370552|532434878|FG002|Overall Study|Disease progression|15|||
147622482|NCT00370552|532434876|FG000|Overall Study|Maximum clinical benefit|3|||
147622483|NCT00370552|532434877|FG001|Overall Study|Maximum clinical benefit|5|||
147622484|NCT00370552|532434878|FG002|Overall Study|Maximum clinical benefit|5|||
147479552|NCT05363293|531912157|FG003|Overall Study|Withdrawal by Subject|0|||
147622485|NCT00370552|532434876|FG000|Overall Study|Poor or noncompliance|0|||
147479553|NCT05363293|531912158|FG004|Overall Study|Withdrawal by Subject|0|||
147479554|NCT05363293|531912159|FG005|Overall Study|Withdrawal by Subject|0|||
147622486|NCT00370552|532434877|FG001|Overall Study|Poor or noncompliance|0|||
147622487|NCT00370552|532434878|FG002|Overall Study|Poor or noncompliance|1|||
147622488|NCT00370552|532434876|FG000|Overall Study|Study drug toxicity|11|||
147622489|NCT00370552|532434877|FG001|Overall Study|Study drug toxicity|8|||
147622490|NCT00370552|532434878|FG002|Overall Study|Study drug toxicity|6|||
147622491|NCT00370552|532434876|FG000|Overall Study|Withdrawal by Subject|2|||
147622492|NCT00370552|532434877|FG001|Overall Study|Withdrawal by Subject|0|||
147479555|NCT05363293|531912160|FG006|Overall Study|Withdrawal by Subject|0|||
147622493|NCT00370552|532434878|FG002|Overall Study|Withdrawal by Subject|1|||
147622494|NCT00370552|532434876|FG000|Overall Study|Still on treatment|1|||
147622495|NCT00370552|532434877|FG001|Overall Study|Still on treatment|3|||
147622496|NCT00370552|532434878|FG002|Overall Study|Still on treatment|2|||
147622497|NCT00370552|532434876|FG000|Overall Study|Never treated|1|||
147622498|NCT00370552|532434877|FG001|Overall Study|Never treated|0|||
147622499|NCT00370552|532434878|FG002|Overall Study|Never treated|0|||
147622500|NCT00370552|532434876|FG000|Overall Study|Physician Decision|1|||
147622501|NCT00370552|532434877|FG001|Overall Study|Physician Decision|1|||
147622502|NCT00370552|532434878|FG002|Overall Study|Physician Decision|0|||
147622503|NCT00370552|532434876|FG000|Overall Study|Investigator decision|2|||
147622504|NCT00370552|532434877|FG001|Overall Study|Investigator decision|1|||
147622505|NCT00370552|532434878|FG002|Overall Study|Investigator decision|0|||
147622506|NCT00370552|532434876|FG000|Overall Study|High risk of allergic reaction|0|||
147622507|NCT00370552|532434877|FG001|Overall Study|High risk of allergic reaction|1|||
147622508|NCT00370552|532434878|FG002|Overall Study|High risk of allergic reaction|0|||
147622509|NCT00370552|532434876|FG000|Overall Study|Planned radiation for palliation|0|||
147622510|NCT00370552|532434877|FG001|Overall Study|Planned radiation for palliation|1|||
147622511|NCT00370552|532434878|FG002|Overall Study|Planned radiation for palliation|0|||
147622512|NCT01062425|532434886|FG000|Overall Study|Protocol Violation|3|||
147622513|NCT01062425|532434887|FG001|Overall Study|Protocol Violation|6|||
147622514|NCT00395629|532434891|FG000|Core Study|Adverse Event|0|||
147622515|NCT00395629|532434892|FG001|Core Study|Adverse Event|3|||
147622516|NCT00395629|532434893|FG002|Core Study|Adverse Event|4|||
147622517|NCT00395629|532434891|FG000|Core Study|Abnormal laboratory value(s)|0|||
147622518|NCT00395629|532434892|FG001|Core Study|Abnormal laboratory value(s)|0|||
147622519|NCT00395629|532434893|FG002|Core Study|Abnormal laboratory value(s)|1|||
147622520|NCT00395629|532434891|FG000|Core Study|Protocol Violation|1|||
147622521|NCT00395629|532434892|FG001|Core Study|Protocol Violation|0|||
147622522|NCT00395629|532434893|FG002|Core Study|Protocol Violation|0|||
147622523|NCT00395629|532434891|FG000|Core Study|Withdrawal by Subject|0|||
147622524|NCT00395629|532434892|FG001|Core Study|Withdrawal by Subject|1|||
147622525|NCT00395629|532434893|FG002|Core Study|Withdrawal by Subject|1|||
147622526|NCT00395629|532434891|FG000|Core Study|Lost to Follow-up|0|||
147622527|NCT00395629|532434892|FG001|Core Study|Lost to Follow-up|0|||
147622528|NCT00395629|532434893|FG002|Core Study|Lost to Follow-up|1|||
147622529|NCT00395629|532434891|FG000|Extension Study|Adverse Event|0|||
147622530|NCT00395629|532434892|FG001|Extension Study|Adverse Event|0|||
147622531|NCT00395629|532434893|FG002|Extension Study|Adverse Event|2|||
147622532|NCT00395629|532434891|FG000|Extension Study|Administrative problems|0|||
147622533|NCT00395629|532434892|FG001|Extension Study|Administrative problems|0|||
147622534|NCT00395629|532434893|FG002|Extension Study|Administrative problems|1|||
147622535|NCT03534687|532434894|FG000|Overall Study|Lost to Follow-up|7|||
147622536|NCT03534687|532434895|FG001|Overall Study|Lost to Follow-up|2|||
147622537|NCT01686373|532434896|FG000|Overall Study|Lost to Follow-up|3|||
147622538|NCT01686373|532434897|FG001|Overall Study|Lost to Follow-up|0|||
147622539|NCT01686373|532434896|FG000|Overall Study|Withdrawal by Subject|0|||
147622540|NCT01686373|532434897|FG001|Overall Study|Withdrawal by Subject|1|||
147622541|NCT01686373|532434896|FG000|Overall Study|Adverse Event|0|||
147622542|NCT01686373|532434897|FG001|Overall Study|Adverse Event|1|||
147622543|NCT00314340|532434898|FG000|Overall Study|lost interest|1|||
147622544|NCT03751098|532434902|FG000|Overall Study|Withdrawal by Subject|0|||
147622545|NCT03751098|532434903|FG001|Overall Study|Withdrawal by Subject|1|||
147622546|NCT01592786|532434904|FG000|Overall Study|Adverse Event|60|||
147622547|NCT01592786|532434904|FG000|Overall Study|Lack of Efficacy|19|||
147622548|NCT01592786|532434904|FG000|Overall Study|Protocol Violation|14|||
147622549|NCT01592786|532434904|FG000|Overall Study|Withdrawal by Subject|23|||
147622550|NCT01592786|532434904|FG000|Overall Study|Lost to Follow-up|19|||
147622551|NCT01592786|532434904|FG000|Overall Study|Other|3|||
147622552|NCT03810092|532434905|FG000|Overall Study|no ground support|17|||
147622553|NCT03810092|532434905|FG000|Overall Study|ADL not done at J0|16|||
147622554|NCT03810092|532434905|FG000|Overall Study|No hemoglobin measure at J5|27|||
147622555|NCT04578535|532434909|FG000|Overall Study|Lost to Follow-up|1|||
147622556|NCT04578535|532434910|FG001|Overall Study|Lost to Follow-up|0|||
147622557|NCT04578535|532434911|FG002|Overall Study|Lost to Follow-up|0|||
147622558|NCT04578535|532434912|FG003|Overall Study|Lost to Follow-up|1|||
147622559|NCT04578535|532434913|FG004|Overall Study|Lost to Follow-up|0|||
147622560|NCT04578535|532434914|FG005|Overall Study|Lost to Follow-up|2|||
147622561|NCT04578535|532434909|FG000|Overall Study|Pregnancy|1|||
147622562|NCT04578535|532434910|FG001|Overall Study|Pregnancy|0|||
147622563|NCT04578535|532434911|FG002|Overall Study|Pregnancy|0|||
147622564|NCT04578535|532434912|FG003|Overall Study|Pregnancy|0|||
147622565|NCT04578535|532434913|FG004|Overall Study|Pregnancy|0|||
147622566|NCT04578535|532434914|FG005|Overall Study|Pregnancy|0|||
147622567|NCT04578535|532434909|FG000|Overall Study|Withdrawal by Subject|0|||
147622568|NCT04578535|532434910|FG001|Overall Study|Withdrawal by Subject|0|||
147622569|NCT04578535|532434911|FG002|Overall Study|Withdrawal by Subject|0|||
147622570|NCT04578535|532434912|FG003|Overall Study|Withdrawal by Subject|1|||
147622571|NCT04578535|532434913|FG004|Overall Study|Withdrawal by Subject|1|||
147622572|NCT04578535|532434914|FG005|Overall Study|Withdrawal by Subject|5|||
147622573|NCT04578535|532434909|FG000|Overall Study|Non-Compliance with Study Procedures|0|||
147622574|NCT04578535|532434910|FG001|Overall Study|Non-Compliance with Study Procedures|0|||
147667166|NCT03176771|532607994|FG003|Double-Blind Placebo-Controlled Period|Adverse Event|0|||
147667167|NCT03176771|532607995|FG004|Double-Blind Placebo-Controlled Period|Adverse Event|0|||
147667168|NCT03176771|532607991|FG000|Double-Blind Placebo-Controlled Period|Physician Decision|0|||
147667169|NCT03176771|532607992|FG001|Double-Blind Placebo-Controlled Period|Physician Decision|2|||
147667170|NCT03176771|532607993|FG002|Double-Blind Placebo-Controlled Period|Physician Decision|0|||
147479556|NCT05363293|531912161|FG007|Overall Study|Withdrawal by Subject|0|||
147479557|NCT05363293|531912162|FG008|Overall Study|Withdrawal by Subject|0|||
147479558|NCT05363293|531912163|FG009|Overall Study|Withdrawal by Subject|0|||
147479559|NCT02452970|531913513|FG000|Overall Study|Adverse Event|1|||
147479560|NCT01040832|531913523|FG000|Overall Study|Adverse Event|4|||
147479561|NCT01040832|531913524|FG001|Overall Study|Adverse Event|5|||
147479562|NCT01040832|531913523|FG000|Overall Study|Death|4|||
147479563|NCT01040832|531913524|FG001|Overall Study|Death|6|||
147479564|NCT01040832|531913523|FG000|Overall Study|Withdrawal by Subject|2|||
147479565|NCT01040832|531913524|FG001|Overall Study|Withdrawal by Subject|3|||
147479566|NCT01040832|531913523|FG000|Overall Study|Progressive disease|32|||
147479567|NCT01040832|531913524|FG001|Overall Study|Progressive disease|17|||
147479568|NCT01040832|531913523|FG000|Overall Study|Symptomatic deterioration|2|||
147479569|NCT01040832|531913524|FG001|Overall Study|Symptomatic deterioration|5|||
147479570|NCT01040832|531913523|FG000|Overall Study|Other|2|||
147479571|NCT01040832|531913524|FG001|Overall Study|Other|1|||
147479572|NCT03692910|531913526|FG000|Overall Study|Lost to Follow-up|4|||
147479573|NCT03692910|531913527|FG001|Overall Study|Lost to Follow-up|0|||
147479574|NCT03692910|531913528|FG002|Overall Study|Lost to Follow-up|0|||
147479575|NCT03692910|531913526|FG000|Overall Study|Withdrawal by Subject|2|||
147479576|NCT03692910|531913527|FG001|Overall Study|Withdrawal by Subject|0|||
147479577|NCT03692910|531913528|FG002|Overall Study|Withdrawal by Subject|0|||
147479578|NCT00151411|531913531|FG000|Overall Study|Lost to Follow-up|15|||
147479579|NCT00151411|531913532|FG001|Overall Study|Lost to Follow-up|19|||
147479580|NCT00151411|531913531|FG000|Overall Study|Withdrawal by Subject|12|||
147479581|NCT00151411|531913532|FG001|Overall Study|Withdrawal by Subject|20|||
147479582|NCT00151411|531913531|FG000|Overall Study|Adverse Event|6|||
147479583|NCT00151411|531913532|FG001|Overall Study|Adverse Event|0|||
147479584|NCT00151411|531913531|FG000|Overall Study|Pregnancy|0|||
147479585|NCT00151411|531913532|FG001|Overall Study|Pregnancy|4|||
147479586|NCT01283581|531913533|FG000|Overall Study|Lost to Follow-up|8|||
147479587|NCT01283581|531913534|FG001|Overall Study|Lost to Follow-up|6|||
147479588|NCT01283581|531913535|FG002|Overall Study|Lost to Follow-up|8|||
147479589|NCT01283581|531913533|FG000|Overall Study|Withdrawal by Subject|2|||
147479590|NCT01283581|531913534|FG001|Overall Study|Withdrawal by Subject|5|||
147479591|NCT01283581|531913535|FG002|Overall Study|Withdrawal by Subject|2|||
147479592|NCT01283581|531913533|FG000|Overall Study|Adverse Event|1|||
147479593|NCT01283581|531913534|FG001|Overall Study|Adverse Event|1|||
147479594|NCT01283581|531913535|FG002|Overall Study|Adverse Event|4|||
147479595|NCT01283581|531913533|FG000|Overall Study|Physician Decision|0|||
147479596|NCT01283581|531913534|FG001|Overall Study|Physician Decision|1|||
147479597|NCT01283581|531913535|FG002|Overall Study|Physician Decision|2|||
147479598|NCT01283581|531913533|FG000|Overall Study|Protocol Violation|0|||
147479599|NCT01283581|531913534|FG001|Overall Study|Protocol Violation|1|||
147479600|NCT01283581|531913535|FG002|Overall Study|Protocol Violation|2|||
147479601|NCT01283581|531913533|FG000|Overall Study|Noncompliance|1|||
147667171|NCT03176771|532607994|FG003|Double-Blind Placebo-Controlled Period|Physician Decision|0|||
147667172|NCT03176771|532607995|FG004|Double-Blind Placebo-Controlled Period|Physician Decision|0|||
147667173|NCT03176771|532607991|FG000|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|2|||
147667174|NCT03176771|532607992|FG001|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|8|||
147667175|NCT03176771|532607993|FG002|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|10|||
147479602|NCT01283581|531913534|FG001|Overall Study|Noncompliance|0|||
147479603|NCT01283581|531913535|FG002|Overall Study|Noncompliance|0|||
147479604|NCT01283581|531913533|FG000|Overall Study|Investigator unblinded|0|||
147479605|NCT01283581|531913534|FG001|Overall Study|Investigator unblinded|0|||
147479606|NCT01283581|531913535|FG002|Overall Study|Investigator unblinded|1|||
147479607|NCT01283581|531913533|FG000|Overall Study|"Early termination"|0|||
147479608|NCT01283581|531913534|FG001|Overall Study|"Early termination"|0|||
147667176|NCT03176771|532607994|FG003|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|0|||
147667177|NCT03176771|532607995|FG004|Double-Blind Placebo-Controlled Period|Withdrawal by Subject|0|||
147667178|NCT03176771|532607991|FG000|Double-Blind Placebo-Controlled Period|Incorrect allocation|0|||
147667179|NCT03176771|532607992|FG001|Double-Blind Placebo-Controlled Period|Incorrect allocation|0|||
147479609|NCT01283581|531913535|FG002|Overall Study|"Early termination"|1|||
147479610|NCT00486226|531913536|FG000|Overall Study|Death|3|||
147479611|NCT00486226|531913536|FG000|Overall Study|Adverse Event|1|||
147479612|NCT00486226|531913536|FG000|Overall Study|Withdrawal by Subject|1|||
147479613|NCT00486226|531913536|FG000|Overall Study|Lost to Follow-up|8|||
147479614|NCT01259492|531913537|FG000|Period 1 (9 Weeks)|Adverse Event|13|||
147479615|NCT01259492|531913538|FG001|Period 1 (9 Weeks)|Adverse Event|18|||
147479616|NCT01259492|531913539|FG002|Period 1 (9 Weeks)|Adverse Event|26|||
147479617|NCT01259492|531913540|FG003|Period 1 (9 Weeks)|Adverse Event|3|||
147479618|NCT01259492|531913537|FG000|Period 1 (9 Weeks)|Lack of Efficacy|2|||
147479619|NCT01259492|531913538|FG001|Period 1 (9 Weeks)|Lack of Efficacy|2|||
147479620|NCT01259492|531913539|FG002|Period 1 (9 Weeks)|Lack of Efficacy|4|||
147479621|NCT01259492|531913540|FG003|Period 1 (9 Weeks)|Lack of Efficacy|11|||
147479622|NCT01259492|531913537|FG000|Period 1 (9 Weeks)|Withdrawal by Subject|5|||
147479623|NCT01259492|531913538|FG001|Period 1 (9 Weeks)|Withdrawal by Subject|8|||
147479624|NCT01259492|531913539|FG002|Period 1 (9 Weeks)|Withdrawal by Subject|6|||
147479625|NCT01259492|531913540|FG003|Period 1 (9 Weeks)|Withdrawal by Subject|7|||
147479626|NCT01259492|531913537|FG000|Period 1 (9 Weeks)|Lost to Follow-up|4|||
147479627|NCT01259492|531913538|FG001|Period 1 (9 Weeks)|Lost to Follow-up|6|||
147479628|NCT01259492|531913539|FG002|Period 1 (9 Weeks)|Lost to Follow-up|3|||
147479629|NCT01259492|531913540|FG003|Period 1 (9 Weeks)|Lost to Follow-up|4|||
147479630|NCT01259492|531913537|FG000|Period 1 (9 Weeks)|Administrative Problems|0|||
147479631|NCT01259492|531913538|FG001|Period 1 (9 Weeks)|Administrative Problems|1|||
147479632|NCT01259492|531913539|FG002|Period 1 (9 Weeks)|Administrative Problems|1|||
147479633|NCT01259492|531913540|FG003|Period 1 (9 Weeks)|Administrative Problems|2|||
147479634|NCT01259492|531913537|FG000|Period 1 (9 Weeks)|Protocol Violation|5|||
147479635|NCT01259492|531913538|FG001|Period 1 (9 Weeks)|Protocol Violation|6|||
147479636|NCT01259492|531913539|FG002|Period 1 (9 Weeks)|Protocol Violation|3|||
147479637|NCT01259492|531913540|FG003|Period 1 (9 Weeks)|Protocol Violation|1|||
147479638|NCT01259492|531913537|FG000|Period 2 (Week 10 to Week 14)|Adverse Event|3|||
147479639|NCT01259492|531913538|FG001|Period 2 (Week 10 to Week 14)|Adverse Event|4|||
147479640|NCT01259492|531913539|FG002|Period 2 (Week 10 to Week 14)|Adverse Event|7|||
147479641|NCT01259492|531913540|FG003|Period 2 (Week 10 to Week 14)|Adverse Event|8|||
147479642|NCT01259492|531913537|FG000|Period 2 (Week 10 to Week 14)|Lack of Efficacy|13|||
147479643|NCT01259492|531913538|FG001|Period 2 (Week 10 to Week 14)|Lack of Efficacy|7|||
147479644|NCT01259492|531913539|FG002|Period 2 (Week 10 to Week 14)|Lack of Efficacy|7|||
147479645|NCT01259492|531913540|FG003|Period 2 (Week 10 to Week 14)|Lack of Efficacy|13|||
147479646|NCT01259492|531913537|FG000|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|6|||
147479647|NCT01259492|531913538|FG001|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|2|||
147479648|NCT01259492|531913539|FG002|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|8|||
147479649|NCT01259492|531913540|FG003|Period 2 (Week 10 to Week 14)|Withdrawal by Subject|4|||
147479650|NCT01259492|531913537|FG000|Period 2 (Week 10 to Week 14)|Lost to Follow-up|3|||
147479651|NCT01259492|531913538|FG001|Period 2 (Week 10 to Week 14)|Lost to Follow-up|3|||
147479652|NCT01259492|531913539|FG002|Period 2 (Week 10 to Week 14)|Lost to Follow-up|1|||
147479653|NCT01259492|531913540|FG003|Period 2 (Week 10 to Week 14)|Lost to Follow-up|3|||
147479654|NCT01259492|531913537|FG000|Period 2 (Week 10 to Week 14)|Protocol Violation|0|||
147479655|NCT01259492|531913538|FG001|Period 2 (Week 10 to Week 14)|Protocol Violation|2|||
147479656|NCT01259492|531913539|FG002|Period 2 (Week 10 to Week 14)|Protocol Violation|1|||
147479657|NCT01259492|531913540|FG003|Period 2 (Week 10 to Week 14)|Protocol Violation|0|||
147479658|NCT01259492|531913537|FG000|Period 3 (Week 15 to End of Week 40)|Adverse Event|5|||
147479659|NCT01259492|531913538|FG001|Period 3 (Week 15 to End of Week 40)|Adverse Event|11|||
147479660|NCT01259492|531913539|FG002|Period 3 (Week 15 to End of Week 40)|Adverse Event|6|||
147479661|NCT01259492|531913540|FG003|Period 3 (Week 15 to End of Week 40)|Adverse Event|5|||
147479662|NCT01259492|531913537|FG000|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|0|||
147479663|NCT01259492|531913538|FG001|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|0|||
147479664|NCT01259492|531913539|FG002|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|0|||
147479665|NCT01259492|531913540|FG003|Period 3 (Week 15 to End of Week 40)|Abnormal Lab value(s)|1|||
147479666|NCT01259492|531913537|FG000|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|0|||
147479667|NCT01259492|531913538|FG001|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|0|||
147479668|NCT01259492|531913539|FG002|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|1|||
147479669|NCT01259492|531913540|FG003|Period 3 (Week 15 to End of Week 40)|Abnormal Test Procedure Result(s)|0|||
147479670|NCT01259492|531913537|FG000|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|28|||
147479671|NCT01259492|531913538|FG001|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|42|||
147479672|NCT01259492|531913539|FG002|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|29|||
147479673|NCT01259492|531913540|FG003|Period 3 (Week 15 to End of Week 40)|Lack of Efficacy|62|||
147479674|NCT01259492|531913537|FG000|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|1|||
147479675|NCT01259492|531913538|FG001|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|0|||
147479676|NCT01259492|531913539|FG002|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|0|||
147479677|NCT01259492|531913540|FG003|Period 3 (Week 15 to End of Week 40)|Patient no longer requires study drug|0|||
147479678|NCT01259492|531913537|FG000|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|12|||
147479679|NCT01259492|531913538|FG001|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|6|||
147479680|NCT01259492|531913539|FG002|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|4|||
147479681|NCT01259492|531913540|FG003|Period 3 (Week 15 to End of Week 40)|Withdrawal by Subject|3|||
147479682|NCT01259492|531913537|FG000|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|3|||
147479683|NCT01259492|531913538|FG001|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|4|||
147479684|NCT01259492|531913539|FG002|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|6|||
147479685|NCT01259492|531913540|FG003|Period 3 (Week 15 to End of Week 40)|Lost to Follow-up|3|||
147479686|NCT01259492|531913537|FG000|Period 3 (Week 15 to End of Week 40)|Administrative Problems|0|||
147479687|NCT01259492|531913538|FG001|Period 3 (Week 15 to End of Week 40)|Administrative Problems|0|||
147479688|NCT01259492|531913539|FG002|Period 3 (Week 15 to End of Week 40)|Administrative Problems|1|||
147479689|NCT01259492|531913540|FG003|Period 3 (Week 15 to End of Week 40)|Administrative Problems|0|||
147479690|NCT01259492|531913537|FG000|Period 3 (Week 15 to End of Week 40)|Protocol Violation|5|||
147479691|NCT01259492|531913538|FG001|Period 3 (Week 15 to End of Week 40)|Protocol Violation|6|||
147479692|NCT01259492|531913539|FG002|Period 3 (Week 15 to End of Week 40)|Protocol Violation|3|||
147479693|NCT01259492|531913540|FG003|Period 3 (Week 15 to End of Week 40)|Protocol Violation|7|||
147479694|NCT01981122|531913541|FG000|Overall Study|Withdrawal by Subject|0|||
147479695|NCT01981122|531913542|FG001|Overall Study|Withdrawal by Subject|2|||
147479696|NCT01981122|531913541|FG000|Overall Study|Protocol Violation|0|||
147479697|NCT01981122|531913542|FG001|Overall Study|Protocol Violation|1|||
147479698|NCT01981122|531913541|FG000|Overall Study|Lost to Follow-up|0|||
147479699|NCT01981122|531913542|FG001|Overall Study|Lost to Follow-up|1|||
147479700|NCT01981122|531913541|FG000|Overall Study|Investigator Or Dendreon Discretion|0|||
147479701|NCT01981122|531913542|FG001|Overall Study|Investigator Or Dendreon Discretion|1|||
147479702|NCT01981122|531913541|FG000|Overall Study|Death|14|||
147479703|NCT01981122|531913542|FG001|Overall Study|Death|15|||
147479704|NCT03846947|531913545|FG000|Overall Study|technical issues with imaging sequence|2|||
147479705|NCT00634543|531913546|FG000|Overall Study|Other|1|||
147479706|NCT00634543|531913547|FG001|Overall Study|Other|2|||
147479707|NCT00634543|531913546|FG000|Overall Study|Protocol Violation|3|||
147479708|NCT00634543|531913547|FG001|Overall Study|Protocol Violation|3|||
147479709|NCT00634543|531913546|FG000|Overall Study|Adverse Event|11|||
147479710|NCT00634543|531913547|FG001|Overall Study|Adverse Event|11|||
147479711|NCT00634543|531913546|FG000|Overall Study|Withdrawal by Subject|4|||
147479712|NCT00634543|531913547|FG001|Overall Study|Withdrawal by Subject|4|||
147479713|NCT00634543|531913546|FG000|Overall Study|Lost to Follow-up|0|||
147479714|NCT00634543|531913547|FG001|Overall Study|Lost to Follow-up|1|||
147479715|NCT03515538|531913548|FG000|Overall Study|Lack of Efficacy|2|||
147479716|NCT03515538|531913549|FG001|Overall Study|Lack of Efficacy|0|||
147479717|NCT03515538|531913550|FG002|Overall Study|Lack of Efficacy|2|||
147479718|NCT03515538|531913551|FG003|Overall Study|Lack of Efficacy|0|||
147479719|NCT03515538|531913548|FG000|Overall Study|Death|0|||
147479720|NCT03515538|531913549|FG001|Overall Study|Death|0|||
147479721|NCT03515538|531913550|FG002|Overall Study|Death|1|||
147479722|NCT03515538|531913551|FG003|Overall Study|Death|0|||
147479723|NCT03515538|531913548|FG000|Overall Study|Protocol Violation|0|||
147479724|NCT03515538|531913549|FG001|Overall Study|Protocol Violation|0|||
147479725|NCT03515538|531913550|FG002|Overall Study|Protocol Violation|0|||
147479726|NCT03515538|531913551|FG003|Overall Study|Protocol Violation|1|||
147479727|NCT03515538|531913548|FG000|Overall Study|Screen failure (baseline dropout)|0|||
147479728|NCT03515538|531913549|FG001|Overall Study|Screen failure (baseline dropout)|1|||
147479729|NCT03515538|531913550|FG002|Overall Study|Screen failure (baseline dropout)|0|||
147479730|NCT03515538|531913551|FG003|Overall Study|Screen failure (baseline dropout)|0|||
147479731|NCT03515538|531913548|FG000|Overall Study|Withdrawal by Subject|2|||
147479732|NCT03515538|531913549|FG001|Overall Study|Withdrawal by Subject|2|||
147479733|NCT03515538|531913550|FG002|Overall Study|Withdrawal by Subject|1|||
147479734|NCT03515538|531913551|FG003|Overall Study|Withdrawal by Subject|3|||
147479735|NCT03515538|531913548|FG000|Overall Study|Physician Decision|1|||
147479736|NCT03515538|531913549|FG001|Overall Study|Physician Decision|0|||
147479737|NCT03515538|531913550|FG002|Overall Study|Physician Decision|0|||
147479738|NCT03515538|531913551|FG003|Overall Study|Physician Decision|1|||
147479739|NCT01736683|531913558|FG000|Overall Study|Disease Relapse|0|||
147479740|NCT01736683|531913559|FG001|Overall Study|Disease Relapse|0|||
147479741|NCT01736683|531913560|FG002|Overall Study|Disease Relapse|2|||
147479742|NCT01736683|531913561|FG003|Overall Study|Disease Relapse|1|||
147479743|NCT01736683|531913562|FG004|Overall Study|Disease Relapse|0|||
147479744|NCT01736683|531913558|FG000|Overall Study|Adverse Event|0|||
147479745|NCT01736683|531913559|FG001|Overall Study|Adverse Event|2|||
147479746|NCT01736683|531913560|FG002|Overall Study|Adverse Event|2|||
147479747|NCT01736683|531913561|FG003|Overall Study|Adverse Event|3|||
147479748|NCT01736683|531913562|FG004|Overall Study|Adverse Event|2|||
147479749|NCT01736683|531913558|FG000|Overall Study|Withdrawal by Subject|0|||
147479750|NCT01736683|531913559|FG001|Overall Study|Withdrawal by Subject|0|||
147479751|NCT01736683|531913560|FG002|Overall Study|Withdrawal by Subject|3|||
147479752|NCT01736683|531913561|FG003|Overall Study|Withdrawal by Subject|1|||
147479753|NCT01736683|531913562|FG004|Overall Study|Withdrawal by Subject|1|||
147479754|NCT01736683|531913558|FG000|Overall Study|Lack of Therapeutic Effect|7|||
147479755|NCT01736683|531913559|FG001|Overall Study|Lack of Therapeutic Effect|4|||
147479756|NCT01736683|531913560|FG002|Overall Study|Lack of Therapeutic Effect|13|||
147479757|NCT01736683|531913561|FG003|Overall Study|Lack of Therapeutic Effect|20|||
147479758|NCT01736683|531913562|FG004|Overall Study|Lack of Therapeutic Effect|1|||
147479759|NCT01736683|531913558|FG000|Overall Study|Progressive Disease|0|||
147479760|NCT01736683|531913559|FG001|Overall Study|Progressive Disease|0|||
147479761|NCT01736683|531913560|FG002|Overall Study|Progressive Disease|0|||
147479762|NCT01736683|531913561|FG003|Overall Study|Progressive Disease|1|||
147479763|NCT01736683|531913562|FG004|Overall Study|Progressive Disease|0|||
147479764|NCT01736683|531913558|FG000|Overall Study|Other|0|||
147479765|NCT01736683|531913559|FG001|Overall Study|Other|0|||
147479766|NCT01736683|531913560|FG002|Overall Study|Other|1|||
147479767|NCT01736683|531913561|FG003|Overall Study|Other|9|||
147479768|NCT01736683|531913562|FG004|Overall Study|Other|1|||
147479769|NCT03069690|531913564|FG000|Pregnancy Intervention|Pregnancy loss|9|||
147479770|NCT03069690|531913565|FG001|Pregnancy Intervention|Pregnancy loss|4|||
147479771|NCT03069690|531913566|FG002|Pregnancy Intervention|Pregnancy loss|0|||
147479772|NCT03069690|531913567|FG003|Pregnancy Intervention|Pregnancy loss|0|||
147479773|NCT03069690|531913568|FG004|Pregnancy Intervention|Pregnancy loss|0|||
147479774|NCT03069690|531913569|FG005|Pregnancy Intervention|Pregnancy loss|0|||
147479775|NCT03069690|531913564|FG000|Pregnancy Intervention|Lost to Follow-up|16|||
147479776|NCT03069690|531913565|FG001|Pregnancy Intervention|Lost to Follow-up|14|||
147479777|NCT03069690|531913566|FG002|Pregnancy Intervention|Lost to Follow-up|0|||
147479778|NCT03069690|531913567|FG003|Pregnancy Intervention|Lost to Follow-up|0|||
147479779|NCT03069690|531913568|FG004|Pregnancy Intervention|Lost to Follow-up|0|||
147479780|NCT03069690|531913569|FG005|Pregnancy Intervention|Lost to Follow-up|0|||
147479781|NCT03069690|531913564|FG000|Postpartum Intervention|Lost to Follow-up|0|||
147479782|NCT03069690|531913565|FG001|Postpartum Intervention|Lost to Follow-up|0|||
147479783|NCT03069690|531913566|FG002|Postpartum Intervention|Lost to Follow-up|5|||
147479784|NCT03069690|531913567|FG003|Postpartum Intervention|Lost to Follow-up|5|||
147479785|NCT03069690|531913568|FG004|Postpartum Intervention|Lost to Follow-up|2|||
147479786|NCT03069690|531913569|FG005|Postpartum Intervention|Lost to Follow-up|4|||
147479787|NCT00670111|531913573|FG000|Enrollment to One Month|Testing Failure|0|||
147479788|NCT00670111|531913574|FG001|Enrollment to One Month|Testing Failure|0|||
147479789|NCT00670111|531913575|FG002|Enrollment to One Month|Testing Failure|13|||
147479790|NCT00670111|531913573|FG000|Enrollment to One Month|Ebrolled Patients but not Implanted|0|||
147479791|NCT00670111|531913574|FG001|Enrollment to One Month|Ebrolled Patients but not Implanted|0|||
147479792|NCT00670111|531913575|FG002|Enrollment to One Month|Ebrolled Patients but not Implanted|6|||
147479793|NCT00670111|531913573|FG000|Enrollment to One Month|Physician Decision|1|||
147479794|NCT00670111|531913574|FG001|Enrollment to One Month|Physician Decision|0|||
147479795|NCT00670111|531913575|FG002|Enrollment to One Month|Physician Decision|0|||
147479796|NCT00844883|531913576|FG000|Overall Study|Bridged to liver transplant|3|||
147479797|NCT00844883|531913576|FG000|Overall Study|Bridged to resection|1|||
147479798|NCT00537823|531913582|FG000|Overall Study|Adverse Event|2|||
147479799|NCT00537823|531913583|FG001|Overall Study|Adverse Event|0|||
147479800|NCT02873221|531913584|FG000|Treatment Period|Other Miscellaneous Reasons|0|||
147479801|NCT02873221|531913585|FG001|Treatment Period|Other Miscellaneous Reasons|2|||
147479802|NCT02873221|531913586|FG002|Treatment Period|Other Miscellaneous Reasons|1|||
147479803|NCT02873221|531913584|FG000|Treatment Period|Non-Compliance with Study Drug|0|||
147479804|NCT02873221|531913585|FG001|Treatment Period|Non-Compliance with Study Drug|3|||
147479805|NCT02873221|531913586|FG002|Treatment Period|Non-Compliance with Study Drug|2|||
147479806|NCT02873221|531913584|FG000|Treatment Period|Protocol Violation|2|||
147479807|NCT02873221|531913585|FG001|Treatment Period|Protocol Violation|5|||
147479808|NCT02873221|531913586|FG002|Treatment Period|Protocol Violation|8|||
147479809|NCT02873221|531913584|FG000|Treatment Period|Pregnancy|4|||
147479810|NCT02873221|531913585|FG001|Treatment Period|Pregnancy|6|||
147303202|NCT04382924|531276268|FG000|Overall Study|Transferred to other hospital/declined in person visits|0|||
147303203|NCT04382924|531276269|FG001|Overall Study|Transferred to other hospital/declined in person visits|1|||
147303204|NCT04382924|531276270|FG002|Overall Study|Transferred to other hospital/declined in person visits|1|||
147303205|NCT04382924|531276268|FG000|Overall Study|Withdrawal by Subject|6|||
147479811|NCT02873221|531913586|FG002|Treatment Period|Pregnancy|3|||
147479812|NCT02873221|531913584|FG000|Treatment Period|Lack of Qualifying Event|0|||
147479813|NCT02873221|531913585|FG001|Treatment Period|Lack of Qualifying Event|3|||
147479814|NCT02873221|531913586|FG002|Treatment Period|Lack of Qualifying Event|1|||
147479815|NCT02873221|531913584|FG000|Treatment Period|Withdrawal of Consent|52|||
147479816|NCT02873221|531913585|FG001|Treatment Period|Withdrawal of Consent|51|||
147479817|NCT02873221|531913586|FG002|Treatment Period|Withdrawal of Consent|41|||
147479818|NCT02873221|531913584|FG000|Treatment Period|Lack of Efficacy|0|||
147479819|NCT02873221|531913585|FG001|Treatment Period|Lack of Efficacy|17|||
147479820|NCT02873221|531913586|FG002|Treatment Period|Lack of Efficacy|12|||
147479821|NCT02873221|531913584|FG000|Treatment Period|Adverse Event|4|||
147479822|NCT02873221|531913585|FG001|Treatment Period|Adverse Event|9|||
147479823|NCT02873221|531913586|FG002|Treatment Period|Adverse Event|11|||
147479824|NCT02873221|531913584|FG000|Treatment Period|Lost to Follow-up|26|||
147479825|NCT02873221|531913585|FG001|Treatment Period|Lost to Follow-up|30|||
147479826|NCT02873221|531913586|FG002|Treatment Period|Lost to Follow-up|26|||
147479827|NCT02873221|531913584|FG000|Safety Follow-up Period|Other Miscellaneous Reasons|0|||
147479828|NCT02873221|531913585|FG001|Safety Follow-up Period|Other Miscellaneous Reasons|2|||
147479829|NCT02873221|531913586|FG002|Safety Follow-up Period|Other Miscellaneous Reasons|0|||
147479830|NCT02873221|531913584|FG000|Safety Follow-up Period|Protocol Violation|0|||
147479831|NCT02873221|531913585|FG001|Safety Follow-up Period|Protocol Violation|0|||
147479832|NCT02873221|531913586|FG002|Safety Follow-up Period|Protocol Violation|1|||
147622575|NCT04578535|532434911|FG002|Overall Study|Non-Compliance with Study Procedures|0|||
147622576|NCT04578535|532434912|FG003|Overall Study|Non-Compliance with Study Procedures|0|||
147622577|NCT04578535|532434913|FG004|Overall Study|Non-Compliance with Study Procedures|1|||
147622578|NCT04578535|532434914|FG005|Overall Study|Non-Compliance with Study Procedures|0|||
147622579|NCT00235755|532434915|FG000|4-Week Titration Phase|Adverse Event|6|||
147622580|NCT00235755|532434916|FG001|4-Week Titration Phase|Adverse Event|14|||
147622581|NCT00235755|532434917|FG002|4-Week Titration Phase|Adverse Event|20|||
147622582|NCT00235755|532434915|FG000|4-Week Titration Phase|Lost to Follow-up|0|||
147622583|NCT00235755|532434916|FG001|4-Week Titration Phase|Lost to Follow-up|1|||
147622584|NCT00235755|532434917|FG002|4-Week Titration Phase|Lost to Follow-up|1|||
147622585|NCT00235755|532434915|FG000|4-Week Titration Phase|Protocol Violation|2|||
147622586|NCT00235755|532434916|FG001|4-Week Titration Phase|Protocol Violation|2|||
147622587|NCT00235755|532434917|FG002|4-Week Titration Phase|Protocol Violation|1|||
147622588|NCT00235755|532434915|FG000|4-Week Titration Phase|Withdrawal by Subject|1|||
147622589|NCT00235755|532434916|FG001|4-Week Titration Phase|Withdrawal by Subject|2|||
147622590|NCT00235755|532434917|FG002|4-Week Titration Phase|Withdrawal by Subject|3|||
147622591|NCT00235755|532434915|FG000|4-Week Titration Phase|Participant Did Not Receive Study Drug|0|||
147622592|NCT00235755|532434916|FG001|4-Week Titration Phase|Participant Did Not Receive Study Drug|0|||
147622593|NCT00235755|532434917|FG002|4-Week Titration Phase|Participant Did Not Receive Study Drug|1|||
147622594|NCT00235755|532434915|FG000|4-Week Titration Phase|Randomization Occurred in Error|1|||
147622595|NCT00235755|532434916|FG001|4-Week Titration Phase|Randomization Occurred in Error|0|||
147622596|NCT00235755|532434917|FG002|4-Week Titration Phase|Randomization Occurred in Error|0|||
147622597|NCT00235755|532434915|FG000|4-Week Titration Phase|Prolonged QT Interval at Visit 3|1|||
147622598|NCT00235755|532434916|FG001|4-Week Titration Phase|Prolonged QT Interval at Visit 3|0|||
147622599|NCT00235755|532434917|FG002|4-Week Titration Phase|Prolonged QT Interval at Visit 3|0|||
147622600|NCT00235755|532434915|FG000|12-Week Maintenance Phase|Adverse Event|8|||
147622601|NCT00235755|532434916|FG001|12-Week Maintenance Phase|Adverse Event|12|||
147622602|NCT00235755|532434917|FG002|12-Week Maintenance Phase|Adverse Event|26|||
147622603|NCT00235755|532434915|FG000|12-Week Maintenance Phase|Lost to Follow-up|2|||
147622604|NCT00235755|532434916|FG001|12-Week Maintenance Phase|Lost to Follow-up|3|||
147622605|NCT00235755|532434917|FG002|12-Week Maintenance Phase|Lost to Follow-up|0|||
147622606|NCT00235755|532434915|FG000|12-Week Maintenance Phase|Lack of Efficacy|5|||
147622607|NCT00235755|532434916|FG001|12-Week Maintenance Phase|Lack of Efficacy|0|||
147622608|NCT00235755|532434917|FG002|12-Week Maintenance Phase|Lack of Efficacy|0|||
147622609|NCT00235755|532434915|FG000|12-Week Maintenance Phase|Protocol Violation|0|||
147622610|NCT00235755|532434916|FG001|12-Week Maintenance Phase|Protocol Violation|4|||
147622611|NCT00235755|532434917|FG002|12-Week Maintenance Phase|Protocol Violation|2|||
147622612|NCT00235755|532434915|FG000|12-Week Maintenance Phase|Withdrawal by Subject|0|||
147622613|NCT00235755|532434916|FG001|12-Week Maintenance Phase|Withdrawal by Subject|8|||
147622614|NCT00235755|532434917|FG002|12-Week Maintenance Phase|Withdrawal by Subject|3|||
147622615|NCT00235755|532434915|FG000|12-Week Maintenance Phase|Abnormal Electrocardiogram Test Result|1|||
147622616|NCT00235755|532434916|FG001|12-Week Maintenance Phase|Abnormal Electrocardiogram Test Result|0|||
147622617|NCT00235755|532434917|FG002|12-Week Maintenance Phase|Abnormal Electrocardiogram Test Result|0|||
147622618|NCT03839628|532434918|FG000|Overall Study|Withdrawal by Subject|1|||
147622619|NCT01306305|532434925|FG000|Overall Study|Lost to Follow-up|1|||
147622620|NCT01306305|532434926|FG001|Overall Study|Lost to Follow-up|0|||
147622621|NCT01306305|532434925|FG000|Overall Study|Withdrew consent|1|||
147622622|NCT01306305|532434926|FG001|Overall Study|Withdrew consent|0|||
147622623|NCT04030299|532434927|FG000|Overall Study|Coronavirus disease 2019 (COVID-19)|7|||
147622624|NCT04030299|532434927|FG000|Overall Study|Withdrawal by Subject|3|||
147622625|NCT03539302|532434928|FG000|Overall Study|Spontaneous cardio version|0|||
147622626|NCT03539302|532434929|FG001|Overall Study|Spontaneous cardio version|0|||
147622627|NCT03539302|532434930|FG002|Overall Study|Spontaneous cardio version|0|||
147622628|NCT03539302|532434931|FG003|Overall Study|Spontaneous cardio version|0|||
147622629|NCT03539302|532434932|FG004|Overall Study|Spontaneous cardio version|0|||
147622630|NCT03539302|532434933|FG005|Overall Study|Spontaneous cardio version|1|||
147622631|NCT03539302|532434934|FG006|Overall Study|Spontaneous cardio version|1|||
147622632|NCT02107131|532434939|FG000|Overall Study|Lost to Follow-up|4|||
147622633|NCT02107131|532434940|FG001|Overall Study|Lost to Follow-up|4|||
147479833|NCT02873221|531913584|FG000|Safety Follow-up Period|Lost to Follow-up|3|||
147479834|NCT02873221|531913585|FG001|Safety Follow-up Period|Lost to Follow-up|5|||
147622634|NCT02107131|532434939|FG000|Overall Study|Physician Decision|1|||
147622635|NCT02107131|532434940|FG001|Overall Study|Physician Decision|0|||
147622636|NCT02107131|532434939|FG000|Overall Study|Withdrawal by Subject|2|||
147622637|NCT02107131|532434940|FG001|Overall Study|Withdrawal by Subject|0|||
147622638|NCT02107131|532434939|FG000|Overall Study|mental instability|1|||
147622639|NCT02107131|532434940|FG001|Overall Study|mental instability|0|||
147622640|NCT02107131|532434939|FG000|Overall Study|Death|0|||
147622641|NCT02107131|532434940|FG001|Overall Study|Death|1|||
147479835|NCT02873221|531913586|FG002|Safety Follow-up Period|Lost to Follow-up|5|||
147479836|NCT02873221|531913584|FG000|Safety Follow-up Period|Withdrawal of Consent|4|||
147479837|NCT02873221|531913585|FG001|Safety Follow-up Period|Withdrawal of Consent|10|||
147479838|NCT02873221|531913586|FG002|Safety Follow-up Period|Withdrawal of Consent|8|||
147479839|NCT01325493|531913589|FG000|Overall Study|Protocol Violation|0|||
147479840|NCT01325493|531913590|FG001|Overall Study|Protocol Violation|1|||
147479841|NCT01325493|531913589|FG000|Overall Study|loss of neuromonitoring signals|0|||
147622642|NCT02107131|532434939|FG000|Overall Study|Protocol Violation|0|||
147479842|NCT01325493|531913590|FG001|Overall Study|loss of neuromonitoring signals|2|||
147479843|NCT01325493|531913589|FG000|Overall Study|Allergy|1|||
147479844|NCT01325493|531913590|FG001|Overall Study|Allergy|0|||
147479845|NCT00328198|531913595|FG000|Treatment|Adverse Event|21|||
147479846|NCT00328198|531913595|FG000|Treatment|Death|1|||
147479847|NCT00328198|531913595|FG000|Treatment|Physician Decision|5|||
147479848|NCT00328198|531913595|FG000|Treatment|Withdrawal by Subject|5|||
147479849|NCT00328198|531913595|FG000|Treatment|Evidence of disease progression|2|||
147479850|NCT00328198|531913595|FG000|Treatment|Non-compliance|1|||
147479851|NCT00328198|531913595|FG000|Treatment|Confirmed complete response, MRD -|3|||
147479852|NCT00328198|531913595|FG000|Follow-up|Lost to Follow-up|4|||
147479853|NCT00328198|531913595|FG000|Follow-up|Death|31|||
147479854|NCT02717546|531913599|FG000|Overall Study|Lost to Follow-up|12|||
147479855|NCT01720667|531913602|FG000|Overall Study|Adverse Event|1|||
147479856|NCT01720667|531913603|FG001|Overall Study|Adverse Event|1|||
147479857|NCT01720667|531913602|FG000|Overall Study|Withdrawal by Subject|3|||
147479858|NCT01720667|531913603|FG001|Overall Study|Withdrawal by Subject|0|||
147479859|NCT02117050|531913606|FG000|Overall Study|Subject Enrolled but not Dosed|1|||
147479860|NCT02052960|531913608|FG000|Overall Study|Adverse Event|19|||
147479861|NCT02052960|531913609|FG001|Overall Study|Adverse Event|17|||
147479862|NCT02052960|531913608|FG000|Overall Study|Protocol Violation|4|||
147479863|NCT02052960|531913609|FG001|Overall Study|Protocol Violation|3|||
147479864|NCT02052960|531913608|FG000|Overall Study|Withdrawal by Subject|6|||
147479865|NCT02052960|531913609|FG001|Overall Study|Withdrawal by Subject|11|||
147479866|NCT02052960|531913608|FG000|Overall Study|Other|25|||
147479867|NCT02052960|531913609|FG001|Overall Study|Other|15|||
147479868|NCT03849560|531913610|FG000|Overall Study|Withdrawal by Subject|1|||
147479869|NCT03849560|531913611|FG001|Overall Study|Withdrawal by Subject|0|||
147479870|NCT03849560|531913612|FG002|Overall Study|Withdrawal by Subject|0|||
147479871|NCT01396525|531913615|FG000|Overall Study|Withdrawal by Subject|8|||
147479872|NCT01396525|531913615|FG000|Overall Study|Death|14|||
147479873|NCT01396525|531913615|FG000|Overall Study|Lost to Follow-up|4|||
147479874|NCT01753518|531913617|FG000|Intention-to-Treat Analysis|Missing consent form|5|||
147479875|NCT01753518|531913618|FG001|Intention-to-Treat Analysis|Missing consent form|3|||
147479876|NCT01753518|531913617|FG000|Intention-to-Treat Analysis|Multifetal gestation|2|||
147479877|NCT01753518|531913618|FG001|Intention-to-Treat Analysis|Multifetal gestation|3|||
147622643|NCT02107131|532434940|FG001|Overall Study|Protocol Violation|4|||
147622644|NCT05207865|532436440|FG000|Open-Label Treatment Phase|Adverse Event|7|||
147479878|NCT01753518|531913617|FG000|Intention-to-Treat Analysis|Body Mass Index>50|0|||
147479879|NCT01753518|531913618|FG001|Intention-to-Treat Analysis|Body Mass Index>50|1|||
147479880|NCT01753518|531913617|FG000|Postpartum Follow-up|Lost to Follow-up|22|||
147479881|NCT01753518|531913618|FG001|Postpartum Follow-up|Lost to Follow-up|15|||
147479882|NCT00940342|531913619|FG000|Overall Study|Adverse Event|0|||
147479883|NCT00940342|531913620|FG001|Overall Study|Adverse Event|2|||
147479884|NCT00940342|531913621|FG002|Overall Study|Adverse Event|1|||
147479885|NCT00553787|531913622|FG000|Overall Study|Adverse Event|34|||
147479886|NCT00553787|531913623|FG001|Overall Study|Adverse Event|21|||
147479887|NCT00553787|531913624|FG002|Overall Study|Adverse Event|67|||
147479888|NCT00553787|531913622|FG000|Overall Study|Lost to Follow-up|132|||
147479889|NCT00553787|531913623|FG001|Overall Study|Lost to Follow-up|44|||
147479890|NCT00553787|531913624|FG002|Overall Study|Lost to Follow-up|78|||
147479891|NCT00553787|531913622|FG000|Overall Study|Withdrawal by Subject|151|||
147479892|NCT00553787|531913623|FG001|Overall Study|Withdrawal by Subject|40|||
147622645|NCT05207865|532436440|FG000|Open-Label Treatment Phase|Lost to Follow-up|8|||
147622646|NCT05207865|532436440|FG000|Open-Label Treatment Phase|Non-compliance|3|||
147622647|NCT05207865|532436440|FG000|Open-Label Treatment Phase|Other|17|||
147479893|NCT00553787|531913624|FG002|Overall Study|Withdrawal by Subject|83|||
147479894|NCT00553787|531913622|FG000|Overall Study|Lack of Efficacy|31|||
147479895|NCT00553787|531913623|FG001|Overall Study|Lack of Efficacy|1|||
147479896|NCT00553787|531913624|FG002|Overall Study|Lack of Efficacy|3|||
147622648|NCT05207865|532436440|FG000|Open-Label Treatment Phase|Physician Decision|2|||
147479897|NCT00553787|531913622|FG000|Overall Study|Pregnancy|0|||
147479898|NCT00553787|531913623|FG001|Overall Study|Pregnancy|1|||
147479899|NCT00553787|531913624|FG002|Overall Study|Pregnancy|2|||
147479900|NCT00553787|531913622|FG000|Overall Study|non compliance|4|||
147479901|NCT00553787|531913623|FG001|Overall Study|non compliance|0|||
147479902|NCT00553787|531913624|FG002|Overall Study|non compliance|11|||
147479903|NCT00553787|531913622|FG000|Overall Study|Requirement for restricted medication|8|||
147479904|NCT00553787|531913623|FG001|Overall Study|Requirement for restricted medication|7|||
147479905|NCT00553787|531913624|FG002|Overall Study|Requirement for restricted medication|5|||
147622649|NCT05207865|532436440|FG000|Open-Label Treatment Phase|Pregnancy|1|||
147667180|NCT03176771|532607993|FG002|Double-Blind Placebo-Controlled Period|Incorrect allocation|1|||
147667181|NCT03176771|532607994|FG003|Double-Blind Placebo-Controlled Period|Incorrect allocation|0|||
147667182|NCT03176771|532607995|FG004|Double-Blind Placebo-Controlled Period|Incorrect allocation|0|||
147667183|NCT03176771|532607991|FG000|Double-Blind Extension Period|Adverse Event|0|||
147667184|NCT03176771|532607992|FG001|Double-Blind Extension Period|Adverse Event|0|||
147667185|NCT03176771|532607993|FG002|Double-Blind Extension Period|Adverse Event|0|||
147667186|NCT03176771|532607994|FG003|Double-Blind Extension Period|Adverse Event|15|||
147667187|NCT03176771|532607995|FG004|Double-Blind Extension Period|Adverse Event|18|||
147667188|NCT03176771|532607991|FG000|Double-Blind Extension Period|Death|0|||
147667189|NCT03176771|532607992|FG001|Double-Blind Extension Period|Death|0|||
147667190|NCT03176771|532607993|FG002|Double-Blind Extension Period|Death|0|||
147667191|NCT03176771|532607994|FG003|Double-Blind Extension Period|Death|3|||
147667192|NCT03176771|532607995|FG004|Double-Blind Extension Period|Death|4|||
147667193|NCT03176771|532607991|FG000|Double-Blind Extension Period|Physician Decision|0|||
147667194|NCT03176771|532607992|FG001|Double-Blind Extension Period|Physician Decision|0|||
147667195|NCT03176771|532607993|FG002|Double-Blind Extension Period|Physician Decision|0|||
147667196|NCT03176771|532607994|FG003|Double-Blind Extension Period|Physician Decision|3|||
147667197|NCT03176771|532607995|FG004|Double-Blind Extension Period|Physician Decision|1|||
147667198|NCT03176771|532607991|FG000|Double-Blind Extension Period|Withdrawal by Subject|0|||
147667199|NCT03176771|532607992|FG001|Double-Blind Extension Period|Withdrawal by Subject|0|||
147667200|NCT03176771|532607993|FG002|Double-Blind Extension Period|Withdrawal by Subject|0|||
147667201|NCT03176771|532607994|FG003|Double-Blind Extension Period|Withdrawal by Subject|24|||
147667202|NCT03176771|532607995|FG004|Double-Blind Extension Period|Withdrawal by Subject|26|||
147667203|NCT02251275|532607996|FG000|Overall Study|Adverse Event|23|||
147667204|NCT02251275|532607997|FG001|Overall Study|Adverse Event|60|||
147667205|NCT02251275|532607998|FG002|Overall Study|Adverse Event|28|||
147667206|NCT02251275|532607999|FG003|Overall Study|Adverse Event|0|||
147667207|NCT02251275|532608000|FG004|Overall Study|Adverse Event|0|||
147667208|NCT02251275|532607996|FG000|Overall Study|Lost to Follow-up|5|||
147667209|NCT02251275|532607997|FG001|Overall Study|Lost to Follow-up|6|||
147667210|NCT02251275|532607998|FG002|Overall Study|Lost to Follow-up|4|||
147667211|NCT02251275|532607999|FG003|Overall Study|Lost to Follow-up|0|||
147667212|NCT02251275|532608000|FG004|Overall Study|Lost to Follow-up|0|||
147667213|NCT02251275|532607996|FG000|Overall Study|Physician Decision|19|||
147667214|NCT02251275|532607997|FG001|Overall Study|Physician Decision|30|||
147667215|NCT02251275|532607998|FG002|Overall Study|Physician Decision|26|||
147667216|NCT02251275|532607999|FG003|Overall Study|Physician Decision|0|||
147667217|NCT02251275|532608000|FG004|Overall Study|Physician Decision|1|||
147667218|NCT02251275|532607996|FG000|Overall Study|Protocol Deviation|0|||
147667219|NCT02251275|532607997|FG001|Overall Study|Protocol Deviation|0|||
147667220|NCT02251275|532607998|FG002|Overall Study|Protocol Deviation|1|||
147667221|NCT02251275|532607999|FG003|Overall Study|Protocol Deviation|0|||
147667222|NCT02251275|532608000|FG004|Overall Study|Protocol Deviation|0|||
147667223|NCT02251275|532607996|FG000|Overall Study|Withdrawal by Subject|25|||
147667224|NCT02251275|532607997|FG001|Overall Study|Withdrawal by Subject|51|||
147667225|NCT02251275|532607998|FG002|Overall Study|Withdrawal by Subject|35|||
147667226|NCT02251275|532607999|FG003|Overall Study|Withdrawal by Subject|1|||
147667227|NCT02251275|532608000|FG004|Overall Study|Withdrawal by Subject|0|||
147667228|NCT02265510|532608002|FG000|Overall Study|Withdrawal by Subject|1|||
147667229|NCT02265510|532608003|FG001|Overall Study|Withdrawal by Subject|1|||
147667230|NCT02265510|532608004|FG002|Overall Study|Withdrawal by Subject|2|||
147667231|NCT02265510|532608005|FG003|Overall Study|Withdrawal by Subject|1|||
147667232|NCT02265510|532608006|FG004|Overall Study|Withdrawal by Subject|0|||
147667233|NCT02265510|532608007|FG005|Overall Study|Withdrawal by Subject|2|||
147667234|NCT02265510|532608008|FG006|Overall Study|Withdrawal by Subject|0|||
147667235|NCT02265510|532608009|FG007|Overall Study|Withdrawal by Subject|2|||
147667236|NCT02265510|532608010|FG008|Overall Study|Withdrawal by Subject|0|||
147667237|NCT02265510|532608011|FG009|Overall Study|Withdrawal by Subject|0|||
147667238|NCT02265510|532608012|FG010|Overall Study|Withdrawal by Subject|0|||
147667239|NCT02265510|532608013|FG011|Overall Study|Withdrawal by Subject|0|||
147667240|NCT02265510|532608014|FG012|Overall Study|Withdrawal by Subject|1|||
147667241|NCT02265510|532608015|FG013|Overall Study|Withdrawal by Subject|0|||
147667242|NCT02265510|532608002|FG000|Overall Study|Disease Progression|0|||
147667243|NCT02265510|532608003|FG001|Overall Study|Disease Progression|1|||
147667244|NCT02265510|532608004|FG002|Overall Study|Disease Progression|2|||
147667245|NCT02265510|532608005|FG003|Overall Study|Disease Progression|1|||
147667246|NCT02265510|532608006|FG004|Overall Study|Disease Progression|1|||
147667247|NCT02265510|532608007|FG005|Overall Study|Disease Progression|0|||
147667248|NCT02265510|532608008|FG006|Overall Study|Disease Progression|0|||
147667249|NCT02265510|532608009|FG007|Overall Study|Disease Progression|0|||
147667250|NCT02265510|532608010|FG008|Overall Study|Disease Progression|0|||
147667251|NCT02265510|532608011|FG009|Overall Study|Disease Progression|0|||
147667252|NCT02265510|532608012|FG010|Overall Study|Disease Progression|0|||
147667253|NCT02265510|532608013|FG011|Overall Study|Disease Progression|0|||
147667254|NCT02265510|532608014|FG012|Overall Study|Disease Progression|0|||
147667255|NCT02265510|532608015|FG013|Overall Study|Disease Progression|0|||
147479906|NCT00553787|531913622|FG000|Overall Study|Other|18|||
147479907|NCT00553787|531913623|FG001|Overall Study|Other|10|||
147479908|NCT00553787|531913624|FG002|Overall Study|Other|13|||
147479909|NCT01088412|531913625|FG000|Overall Study|Adverse Event|38|||
147479910|NCT01088412|531913626|FG001|Overall Study|Adverse Event|0|||
147479911|NCT01088412|531913627|FG002|Overall Study|Adverse Event|0|||
147479912|NCT01088412|531913625|FG000|Overall Study|Death|42|||
147479913|NCT01088412|531913626|FG001|Overall Study|Death|6|||
147479914|NCT01088412|531913627|FG002|Overall Study|Death|0|||
147479915|NCT01088412|531913625|FG000|Overall Study|Other Reason per Case Report Form|2089|||
147479916|NCT01088412|531913626|FG001|Overall Study|Other Reason per Case Report Form|103|||
147479917|NCT01088412|531913627|FG002|Overall Study|Other Reason per Case Report Form|9|||
147479918|NCT01088412|531913625|FG000|Overall Study|Withdrawal by Subject|1761|||
147479919|NCT01088412|531913626|FG001|Overall Study|Withdrawal by Subject|25|||
147479920|NCT01088412|531913627|FG002|Overall Study|Withdrawal by Subject|1|||
147479921|NCT01088412|531913625|FG000|Overall Study|Received Another GH Product|79|||
147479922|NCT01088412|531913626|FG001|Overall Study|Received Another GH Product|0|||
147479923|NCT01088412|531913627|FG002|Overall Study|Received Another GH Product|0|||
147479924|NCT01088412|531913625|FG000|Overall Study|Participant Moved|601|||
147479925|NCT01088412|531913626|FG001|Overall Study|Participant Moved|21|||
147479926|NCT01088412|531913627|FG002|Overall Study|Participant Moved|2|||
147479927|NCT01088412|531913625|FG000|Overall Study|Physician Decision|1041|||
147479928|NCT01088412|531913626|FG001|Overall Study|Physician Decision|8|||
147479929|NCT01088412|531913627|FG002|Overall Study|Physician Decision|4|||
147479930|NCT01088412|531913625|FG000|Overall Study|Sponsor Decision|4467|||
147479931|NCT01088412|531913626|FG001|Overall Study|Sponsor Decision|79|||
147479932|NCT01088412|531913627|FG002|Overall Study|Sponsor Decision|23|||
147479933|NCT01088412|531913625|FG000|Overall Study|Third Party Required to Change Brand|487|||
147479934|NCT01088412|531913626|FG001|Overall Study|Third Party Required to Change Brand|0|||
147479935|NCT01088412|531913627|FG002|Overall Study|Third Party Required to Change Brand|0|||
147479936|NCT01088412|531913625|FG000|Overall Study|Lost to Follow-up|3052|||
147479937|NCT01088412|531913626|FG001|Overall Study|Lost to Follow-up|130|||
147479938|NCT01088412|531913627|FG002|Overall Study|Lost to Follow-up|11|||
147479939|NCT01088412|531913625|FG000|Overall Study|Study Summary Not Completed|4360|||
147479940|NCT01088412|531913626|FG001|Overall Study|Study Summary Not Completed|64|||
147479941|NCT01088412|531913627|FG002|Overall Study|Study Summary Not Completed|22|||
147479942|NCT00793104|531913628|FG000|Overall Study|Lost to Follow-up|1|||
147622650|NCT05207865|532436440|FG000|Open-Label Treatment Phase|Protocol Violation|1|||
147479943|NCT03494725|531913631|FG000|Overall Study|Withdrawal by Subject|0|||
147479944|NCT03494725|531913632|FG001|Overall Study|Withdrawal by Subject|2|||
147479945|NCT03494725|531913631|FG000|Overall Study|Antibiotic use|1|||
147479946|NCT03494725|531913632|FG001|Overall Study|Antibiotic use|0|||
147479947|NCT02619253|531913633|FG000|Overall Study|Adverse Event|0|||
147479948|NCT02619253|531913634|FG001|Overall Study|Adverse Event|0|||
147479949|NCT02619253|531913635|FG002|Overall Study|Adverse Event|1|||
147479950|NCT02619253|531913636|FG003|Overall Study|Adverse Event|1|||
147479951|NCT02619253|531913637|FG004|Overall Study|Adverse Event|3|||
147479952|NCT02619253|531913633|FG000|Overall Study|Alternative Therapy|0|||
147479953|NCT02619253|531913634|FG001|Overall Study|Alternative Therapy|0|||
147479954|NCT02619253|531913635|FG002|Overall Study|Alternative Therapy|1|||
147479955|NCT02619253|531913636|FG003|Overall Study|Alternative Therapy|0|||
147479956|NCT02619253|531913637|FG004|Overall Study|Alternative Therapy|0|||
147479957|NCT02619253|531913633|FG000|Overall Study|Death|0|||
147479958|NCT02619253|531913634|FG001|Overall Study|Death|0|||
147479959|NCT02619253|531913635|FG002|Overall Study|Death|0|||
147479960|NCT02619253|531913636|FG003|Overall Study|Death|1|||
147479961|NCT02619253|531913637|FG004|Overall Study|Death|0|||
147479962|NCT02619253|531913633|FG000|Overall Study|Disease Progression|4|||
147479963|NCT02619253|531913634|FG001|Overall Study|Disease Progression|2|||
147479964|NCT02619253|531913635|FG002|Overall Study|Disease Progression|8|||
147479965|NCT02619253|531913636|FG003|Overall Study|Disease Progression|9|||
147622651|NCT05207865|532436440|FG000|Open-Label Treatment Phase|Protocol-specified withdrawal criterion met|14|||
147622652|NCT05207865|532436440|FG000|Open-Label Treatment Phase|Withdrawal by Subject|10|||
147622653|NCT05207865|532436440|FG000|Follow-up Phase|Lost to Follow-up|1|||
147622654|NCT05207865|532436440|FG000|Follow-up Phase|Non-compliance|1|||
147622655|NCT05207865|532436440|FG000|Follow-up Phase|Not reported|2|||
147479966|NCT02619253|531913637|FG004|Overall Study|Disease Progression|10|||
147479967|NCT02619253|531913633|FG000|Overall Study|Needed a disqualifying therapy|0|||
147479968|NCT02619253|531913634|FG001|Overall Study|Needed a disqualifying therapy|0|||
147479969|NCT02619253|531913635|FG002|Overall Study|Needed a disqualifying therapy|1|||
147479970|NCT02619253|531913636|FG003|Overall Study|Needed a disqualifying therapy|0|||
147479971|NCT02619253|531913637|FG004|Overall Study|Needed a disqualifying therapy|0|||
147479972|NCT02619253|531913633|FG000|Overall Study|Transferred to hospice|0|||
147479973|NCT02619253|531913634|FG001|Overall Study|Transferred to hospice|0|||
147479974|NCT02619253|531913635|FG002|Overall Study|Transferred to hospice|1|||
147479975|NCT02619253|531913636|FG003|Overall Study|Transferred to hospice|0|||
147479976|NCT02619253|531913637|FG004|Overall Study|Transferred to hospice|0|||
147479977|NCT02619253|531913633|FG000|Overall Study|Physician Decision|0|||
147479978|NCT02619253|531913634|FG001|Overall Study|Physician Decision|1|||
147479979|NCT02619253|531913635|FG002|Overall Study|Physician Decision|2|||
147479980|NCT02619253|531913636|FG003|Overall Study|Physician Decision|3|||
147479981|NCT02619253|531913637|FG004|Overall Study|Physician Decision|0|||
147479982|NCT02619253|531913633|FG000|Overall Study|Withdrawal by Subject|0|||
147479983|NCT02619253|531913634|FG001|Overall Study|Withdrawal by Subject|1|||
147479984|NCT02619253|531913635|FG002|Overall Study|Withdrawal by Subject|0|||
147479985|NCT02619253|531913636|FG003|Overall Study|Withdrawal by Subject|0|||
147479986|NCT02619253|531913637|FG004|Overall Study|Withdrawal by Subject|2|||
147479987|NCT00514449|531913638|FG000|Overall Study|Withdrawal by Subject|1|||
147479988|NCT00514449|531913639|FG001|Overall Study|Withdrawal by Subject|2|||
147479989|NCT00514449|531913638|FG000|Overall Study|Protocol Violation|1|||
147479990|NCT00514449|531913639|FG001|Overall Study|Protocol Violation|2|||
147479991|NCT00514449|531913638|FG000|Overall Study|Lost to Follow-up|1|||
147479992|NCT00514449|531913639|FG001|Overall Study|Lost to Follow-up|0|||
147479993|NCT00206518|531913649|FG000|Overall Study|Lack of Efficacy|6|||
147479994|NCT00206518|531913650|FG001|Overall Study|Lack of Efficacy|4|||
147479995|NCT00206518|531913649|FG000|Overall Study|Adverse Event|2|||
147479996|NCT00206518|531913650|FG001|Overall Study|Adverse Event|1|||
147479997|NCT00206518|531913649|FG000|Overall Study|Physician Decision|1|||
147479998|NCT00206518|531913650|FG001|Overall Study|Physician Decision|0|||
147479999|NCT00206518|531913649|FG000|Overall Study|Protocol Violation|1|||
147622656|NCT05207865|532436440|FG000|Follow-up Phase|Not collected|11|||
147622657|NCT02546986|532436441|FG000|Treatment Period|Progressive Disease|20|||
147622658|NCT02546986|532436442|FG001|Treatment Period|Progressive Disease|22|||
147622659|NCT02546986|532436441|FG000|Treatment Period|Adverse Event|14|||
147622660|NCT02546986|532436442|FG001|Treatment Period|Adverse Event|6|||
147622661|NCT02546986|532436441|FG000|Treatment Period|Symptomatic Deterioration|4|||
147622662|NCT02546986|532436442|FG001|Treatment Period|Symptomatic Deterioration|3|||
147622663|NCT02546986|532436441|FG000|Treatment Period|Death|3|||
147622664|NCT02546986|532436442|FG001|Treatment Period|Death|4|||
147622665|NCT02546986|532436441|FG000|Treatment Period|Physician Decision|1|||
147622666|NCT02546986|532436442|FG001|Treatment Period|Physician Decision|2|||
147622667|NCT02546986|532436441|FG000|Treatment Period|Protocol Violation|1|||
147622668|NCT02546986|532436442|FG001|Treatment Period|Protocol Violation|0|||
147622669|NCT02546986|532436441|FG000|Treatment Period|Withdrawal by Subject|1|||
147622670|NCT02546986|532436442|FG001|Treatment Period|Withdrawal by Subject|1|||
147622671|NCT02546986|532436441|FG000|Treatment Period|Non-compliance with Study Drug|0|||
147622672|NCT02546986|532436442|FG001|Treatment Period|Non-compliance with Study Drug|1|||
147622673|NCT02546986|532436441|FG000|Treatment Period|Study Terminated by Sponsor|0|||
147622674|NCT02546986|532436442|FG001|Treatment Period|Study Terminated by Sponsor|1|||
147622675|NCT02546986|532436441|FG000|Treatment Period|Miscellaneous|7|||
147622676|NCT02546986|532436442|FG001|Treatment Period|Miscellaneous|9|||
147622677|NCT02546986|532436441|FG000|Survival Follow-Up Phase|Missing Status|3|||
147622678|NCT02546986|532436442|FG001|Survival Follow-Up Phase|Missing Status|5|||
147622679|NCT02546986|532436441|FG000|Survival Follow-Up Phase|Death|18|||
147622680|NCT02546986|532436442|FG001|Survival Follow-Up Phase|Death|12|||
147622681|NCT02546986|532436441|FG000|Survival Follow-Up Phase|Alive|13|||
147622682|NCT02546986|532436442|FG001|Survival Follow-Up Phase|Alive|16|||
147622683|NCT02546986|532436441|FG000|Survival Follow-Up Phase|Lost to Follow-up|2|||
147622684|NCT02546986|532436442|FG001|Survival Follow-Up Phase|Lost to Follow-up|2|||
147622685|NCT01415518|532436443|FG000|Overall Study|Withdrawal by Subject|2|||
147622686|NCT01415518|532436444|FG001|Overall Study|Withdrawal by Subject|12|||
147622687|NCT01415518|532436443|FG000|Overall Study|Protocol Violation|6|||
147622688|NCT01415518|532436444|FG001|Overall Study|Protocol Violation|8|||
147622689|NCT01415518|532436443|FG000|Overall Study|Lost to Follow-up|3|||
147622690|NCT01415518|532436444|FG001|Overall Study|Lost to Follow-up|5|||
147622691|NCT01415518|532436443|FG000|Overall Study|Adverse Event|3|||
147622692|NCT01415518|532436444|FG001|Overall Study|Adverse Event|4|||
147622693|NCT01415518|532436443|FG000|Overall Study|Death|1|||
147622694|NCT01415518|532436444|FG001|Overall Study|Death|1|||
147622695|NCT01415518|532436443|FG000|Overall Study|Condition under Investigation Worsened|1|||
147622696|NCT01415518|532436444|FG001|Overall Study|Condition under Investigation Worsened|1|||
147622697|NCT02445248|532436446|FG000|Overall Study|Death|45|||
147622698|NCT02445248|532436447|FG001|Overall Study|Death|12|||
147622699|NCT02445248|532436446|FG000|Overall Study|Progressive disease|13|||
147622700|NCT02445248|532436447|FG001|Overall Study|Progressive disease|1|||
147622701|NCT02445248|532436446|FG000|Overall Study|Subject decision|8|||
147480000|NCT00206518|531913650|FG001|Overall Study|Protocol Violation|1|||
147480001|NCT02335450|531913651|FG000|Overall Study|Pregnancy|1|||
147480002|NCT04538950|531913652|FG000|Overall Study|Pulmonary Issues|2|||
147622702|NCT02445248|532436447|FG001|Overall Study|Subject decision|0|||
147622703|NCT02445248|532436446|FG000|Overall Study|Physician Decision|5|||
147622704|NCT02445248|532436447|FG001|Overall Study|Physician Decision|0|||
147622705|NCT02445248|532436446|FG000|Overall Study|Adverse Event|1|||
147480003|NCT04538950|531913652|FG000|Overall Study|illness|2|||
147480004|NCT00847561|531913655|FG000|Overall Study|Withdrawal by Subject|4|||
147480005|NCT00847561|531913656|FG001|Overall Study|Withdrawal by Subject|3|||
147480006|NCT00847561|531913655|FG000|Overall Study|Unable to schedule|9|||
147480007|NCT00847561|531913656|FG001|Overall Study|Unable to schedule|1|||
147480008|NCT01707147|531913657|FG000|Overall Study|Administered Trajenta prior to contract|5|||
147480009|NCT01707147|531913657|FG000|Overall Study|Patients who have not taken Trajenta|1|||
147480010|NCT01707147|531913657|FG000|Overall Study|Follow-up failure|17|||
147480011|NCT01707147|531913657|FG000|Overall Study|Violated inclusion/exclusion criteria|77|||
147480012|NCT02489630|531913660|FG000|Overall Study|Oversedation|1|||
147480013|NCT02489630|531913661|FG001|Overall Study|Oversedation|1|||
147480014|NCT02489630|531913660|FG000|Overall Study|Time to med. admin. > protocol limit|1|||
147480015|NCT02489630|531913661|FG001|Overall Study|Time to med. admin. > protocol limit|1|||
147480016|NCT01056523|531913662|FG000|Overall Study|Death|1|||
147480017|NCT01056523|531913663|FG001|Overall Study|Death|0|||
147480018|NCT01056523|531913664|FG002|Overall Study|Death|2|||
147480019|NCT01056523|531913665|FG003|Overall Study|Death|3|||
147480020|NCT01056523|531913666|FG004|Overall Study|Death|0|||
147480021|NCT01056523|531913667|FG005|Overall Study|Death|0|||
147480022|NCT01056523|531913668|FG006|Overall Study|Death|1|||
147480023|NCT03429556|531913669|FG000|Overall Study|Lost to Follow-up|0|||
147480024|NCT03429556|531913670|FG001|Overall Study|Lost to Follow-up|1|||
147480025|NCT03429556|531913671|FG002|Overall Study|Lost to Follow-up|0|||
147480026|NCT03429556|531913672|FG003|Overall Study|Lost to Follow-up|0|||
147480027|NCT05243550|531915072|FG000|Overall Study|Ongoing in the Study|171|||
147480028|NCT05243550|531915072|FG000|Overall Study|Withdrawal by Subject|10|||
147480029|NCT05243550|531915072|FG000|Overall Study|Lost to Follow-up|7|||
147480030|NCT05243550|531915072|FG000|Overall Study|Adverse Event|3|||
147480031|NCT05243550|531915072|FG000|Overall Study|Noncompliance|1|||
147480032|NCT05243550|531915072|FG000|Overall Study|Physician Decision|1|||
147480033|NCT05243550|531915072|FG000|Overall Study|Other Reason|4|||
147480034|NCT01894516|531915073|FG000|Period 1 (Baseline up to Week 12)|Other|0|||
147480035|NCT01894516|531915074|FG001|Period 1 (Baseline up to Week 12)|Other|1|||
147480036|NCT01894516|531915075|FG002|Period 1 (Baseline up to Week 12)|Other|1|||
147480037|NCT01894516|531915076|FG003|Period 1 (Baseline up to Week 12)|Other|0|||
147480038|NCT01894516|531915073|FG000|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|2|||
147480039|NCT01894516|531915074|FG001|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
147480040|NCT01894516|531915075|FG002|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
147480041|NCT01894516|531915076|FG003|Period 1 (Baseline up to Week 12)|Adverse event and treatment failure|0|||
147480042|NCT01894516|531915073|FG000|Period 1 (Baseline up to Week 12)|Non compliance with the study medication|1|||
147480043|NCT01894516|531915074|FG001|Period 1 (Baseline up to Week 12)|Non compliance with the study medication|1|||
147480044|NCT01894516|531915075|FG002|Period 1 (Baseline up to Week 12)|Non compliance with the study medication|0|||
147480045|NCT01894516|531915076|FG003|Period 1 (Baseline up to Week 12)|Non compliance with the study medication|0|||
147480046|NCT01894516|531915073|FG000|Period 1 (Baseline up to Week 12)|Treatment failure|0|||
147480047|NCT01894516|531915074|FG001|Period 1 (Baseline up to Week 12)|Treatment failure|0|||
147480048|NCT01894516|531915075|FG002|Period 1 (Baseline up to Week 12)|Treatment failure|1|||
147480049|NCT01894516|531915076|FG003|Period 1 (Baseline up to Week 12)|Treatment failure|0|||
147480050|NCT01894516|531915073|FG000|Period 1 (Baseline up to Week 12)|Adverse Event|2|||
147480051|NCT01894516|531915074|FG001|Period 1 (Baseline up to Week 12)|Adverse Event|0|||
147480052|NCT01894516|531915075|FG002|Period 1 (Baseline up to Week 12)|Adverse Event|0|||
147480053|NCT01894516|531915076|FG003|Period 1 (Baseline up to Week 12)|Adverse Event|1|||
147480054|NCT01894516|531915073|FG000|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|2|||
147480055|NCT01894516|531915074|FG001|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|3|||
147480056|NCT01894516|531915075|FG002|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|1|||
147480057|NCT01894516|531915076|FG003|Period 1 (Baseline up to Week 12)|Withdrawal by Subject|2|||
147480058|NCT01894516|531915073|FG000|Period 2 (Week 13 to Week 24)|Adverse Event|0|||
147480059|NCT01894516|531915074|FG001|Period 2 (Week 13 to Week 24)|Adverse Event|2|||
147480060|NCT01894516|531915075|FG002|Period 2 (Week 13 to Week 24)|Adverse Event|3|||
147480061|NCT01894516|531915076|FG003|Period 2 (Week 13 to Week 24)|Adverse Event|1|||
147480062|NCT01894516|531915073|FG000|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
147480063|NCT01894516|531915074|FG001|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
147480064|NCT01894516|531915075|FG002|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|2|||
147480065|NCT01894516|531915076|FG003|Period 2 (Week 13 to Week 24)|Withdrawal by Subject|0|||
147480066|NCT01486316|531915080|FG000|Overall Study|Device explanted with/without re-implant|3|||
147480067|NCT01486316|531915081|FG001|Overall Study|Device explanted with/without re-implant|2|||
147480068|NCT01486316|531915082|FG002|Overall Study|Device explanted with/without re-implant|0|||
147480069|NCT01486316|531915083|FG003|Overall Study|Device explanted with/without re-implant|2|||
147480070|NCT01486316|531915080|FG000|Overall Study|Not meeting eligibility criteria|0|||
147480071|NCT01486316|531915081|FG001|Overall Study|Not meeting eligibility criteria|0|||
147480072|NCT01486316|531915082|FG002|Overall Study|Not meeting eligibility criteria|1|||
147480073|NCT01486316|531915083|FG003|Overall Study|Not meeting eligibility criteria|0|||
147480074|NCT01486316|531915080|FG000|Overall Study|Withdrawal by Subject|1|||
147480075|NCT01486316|531915081|FG001|Overall Study|Withdrawal by Subject|0|||
147480076|NCT01486316|531915082|FG002|Overall Study|Withdrawal by Subject|3|||
147480077|NCT01486316|531915083|FG003|Overall Study|Withdrawal by Subject|0|||
147480078|NCT01486316|531915080|FG000|Overall Study|Physician Decision|0|||
147480079|NCT01486316|531915081|FG001|Overall Study|Physician Decision|0|||
147480080|NCT01486316|531915082|FG002|Overall Study|Physician Decision|1|||
147480081|NCT01486316|531915083|FG003|Overall Study|Physician Decision|0|||
147480082|NCT01486316|531915080|FG000|Overall Study|Death|0|||
147480083|NCT01486316|531915081|FG001|Overall Study|Death|1|||
147480084|NCT01486316|531915082|FG002|Overall Study|Death|0|||
147480085|NCT01486316|531915083|FG003|Overall Study|Death|0|||
147480086|NCT00375934|531915093|FG000|Overall Study|Adverse Event|1|||
147480087|NCT00375934|531915094|FG001|Overall Study|Adverse Event|1|||
147480088|NCT00375934|531915093|FG000|Overall Study|Withdrawal by Subject|2|||
147480089|NCT00375934|531915094|FG001|Overall Study|Withdrawal by Subject|2|||
147480090|NCT00375934|531915093|FG000|Overall Study|Lack of Efficacy|0|||
147480091|NCT00375934|531915094|FG001|Overall Study|Lack of Efficacy|2|||
147480092|NCT00375934|531915093|FG000|Overall Study|Physician Decision|0|||
147480093|NCT00375934|531915094|FG001|Overall Study|Physician Decision|1|||
147480094|NCT03191396|531915095|FG000|Overall Study|Lost to Follow-up|0|||
147480095|NCT03191396|531915096|FG001|Overall Study|Lost to Follow-up|3|||
147480096|NCT03191396|531915095|FG000|Overall Study|Withdrawal by Subject|3|||
147480097|NCT03191396|531915096|FG001|Overall Study|Withdrawal by Subject|2|||
147480098|NCT00893113|531915099|FG000|Overall Study|Lost to Follow-up|4|||
147480099|NCT00893113|531915100|FG001|Overall Study|Lost to Follow-up|8|||
147480100|NCT00893113|531915099|FG000|Overall Study|Early Termination|1|||
147480101|NCT00893113|531915100|FG001|Overall Study|Early Termination|1|||
147480102|NCT00893113|531915099|FG000|Overall Study|Withdrew Consent|8|||
147480103|NCT00893113|531915100|FG001|Overall Study|Withdrew Consent|7|||
147480104|NCT03270085|531915103|FG000|Overall Study|Withdrawal by Subject|1|||
147480105|NCT03270085|531915104|FG001|Overall Study|Withdrawal by Subject|0|||
147480106|NCT02114203|531915105|FG000|Overall Study|Adverse Event|0|||
147480107|NCT02114203|531915106|FG001|Overall Study|Adverse Event|1|||
147480108|NCT02114203|531915107|FG002|Overall Study|Adverse Event|0|||
147480109|NCT02114203|531915105|FG000|Overall Study|Withdrawal by Subject|0|||
147480110|NCT02114203|531915106|FG001|Overall Study|Withdrawal by Subject|1|||
147480111|NCT02114203|531915107|FG002|Overall Study|Withdrawal by Subject|0|||
147480112|NCT01518699|531915108|FG000|Period 2|Protocol Violation|1|||
147480113|NCT01518699|531915109|FG001|Period 2|Protocol Violation|1|||
147480114|NCT01518699|531915110|FG002|Period 2|Protocol Violation|0|||
147480115|NCT01518699|531915111|FG003|Period 2|Protocol Violation|0|||
147480116|NCT01518699|531915112|FG004|Period 2|Protocol Violation|0|||
147480117|NCT01518699|531915113|FG005|Period 2|Protocol Violation|0|||
147480118|NCT01518699|531915108|FG000|Period 2|Lost to Follow-up|0|||
147480119|NCT01518699|531915109|FG001|Period 2|Lost to Follow-up|1|||
147480120|NCT01518699|531915110|FG002|Period 2|Lost to Follow-up|0|||
147480121|NCT01518699|531915111|FG003|Period 2|Lost to Follow-up|0|||
147480122|NCT01518699|531915112|FG004|Period 2|Lost to Follow-up|0|||
147480123|NCT01518699|531915113|FG005|Period 2|Lost to Follow-up|0|||
147480124|NCT01518699|531915108|FG000|Period 2|Adverse Event|1|||
147480125|NCT01518699|531915109|FG001|Period 2|Adverse Event|0|||
147480126|NCT01518699|531915110|FG002|Period 2|Adverse Event|0|||
147480127|NCT01518699|531915111|FG003|Period 2|Adverse Event|0|||
147480128|NCT01518699|531915112|FG004|Period 2|Adverse Event|0|||
147480129|NCT01518699|531915113|FG005|Period 2|Adverse Event|0|||
147480130|NCT00521339|531915122|FG000|Treatment Phase|Adverse Event|2|||
147480131|NCT00521339|531915123|FG001|Treatment Phase|Adverse Event|0|||
147480132|NCT00521339|531915124|FG002|Treatment Phase|Adverse Event|0|||
147480133|NCT00521339|531915122|FG000|Treatment Phase|Intolerability to study drug|2|||
147480134|NCT00521339|531915123|FG001|Treatment Phase|Intolerability to study drug|0|||
147480135|NCT00521339|531915124|FG002|Treatment Phase|Intolerability to study drug|0|||
147480136|NCT00521339|531915122|FG000|Treatment Phase|Lack of Efficacy|3|||
147622706|NCT02445248|532436447|FG001|Overall Study|Adverse Event|0|||
147622707|NCT02445248|532436446|FG000|Overall Study|Lost to Follow-up|1|||
147622708|NCT02445248|532436447|FG001|Overall Study|Lost to Follow-up|0|||
147622709|NCT00471822|532436452|FG000|Overall Study|Protocol Violation|2|||
147480137|NCT00521339|531915123|FG001|Treatment Phase|Lack of Efficacy|0|||
147480138|NCT00521339|531915124|FG002|Treatment Phase|Lack of Efficacy|0|||
147480139|NCT00521339|531915122|FG000|Treatment Phase|Withdrawal by Subject|3|||
147480140|NCT00521339|531915123|FG001|Treatment Phase|Withdrawal by Subject|0|||
147480141|NCT00521339|531915124|FG002|Treatment Phase|Withdrawal by Subject|0|||
147480142|NCT00521339|531915122|FG000|Treatment Phase|Lost to Follow-up|1|||
147480143|NCT00521339|531915123|FG001|Treatment Phase|Lost to Follow-up|0|||
147480144|NCT00521339|531915124|FG002|Treatment Phase|Lost to Follow-up|0|||
147480145|NCT00521339|531915122|FG000|Treatment Phase|Protocol Violation|1|||
147480146|NCT00521339|531915123|FG001|Treatment Phase|Protocol Violation|0|||
147622710|NCT04570670|532436453|FG000|Overall Study|Withdrawal by Subject|1|||
147480147|NCT00521339|531915124|FG002|Treatment Phase|Protocol Violation|0|||
147480148|NCT00521339|531915122|FG000|Treatment Extension Phase|Withdrawal by Subject|0|||
147480149|NCT00521339|531915123|FG001|Treatment Extension Phase|Withdrawal by Subject|0|||
147480150|NCT00521339|531915124|FG002|Treatment Extension Phase|Withdrawal by Subject|2|||
147480151|NCT00521339|531915122|FG000|Treatment Extension Phase|Death|0|||
147480152|NCT00521339|531915123|FG001|Treatment Extension Phase|Death|0|||
147480153|NCT00521339|531915124|FG002|Treatment Extension Phase|Death|1|||
147480154|NCT03060577|531915127|FG000|Overall Study|Withdrawal by Subject|25|||
147480155|NCT03060577|531915128|FG001|Overall Study|Withdrawal by Subject|5|||
147480156|NCT03060577|531915127|FG000|Overall Study|Physician Decision|4|||
147480157|NCT03060577|531915128|FG001|Overall Study|Physician Decision|3|||
147480158|NCT03060577|531915127|FG000|Overall Study|Lost to Follow-up|3|||
147480159|NCT03060577|531915128|FG001|Overall Study|Lost to Follow-up|0|||
147480160|NCT03060577|531915127|FG000|Overall Study|Death|7|||
147480161|NCT03060577|531915128|FG001|Overall Study|Death|1|||
147480162|NCT03060577|531915127|FG000|Overall Study|Adverse Event|9|||
147480163|NCT03060577|531915128|FG001|Overall Study|Adverse Event|1|||
147480164|NCT03060577|531915127|FG000|Overall Study|Inclusion/Exclusion|1|||
147480165|NCT03060577|531915128|FG001|Overall Study|Inclusion/Exclusion|0|||
147480166|NCT03060577|531915127|FG000|Overall Study|Other|8|||
147480167|NCT03060577|531915128|FG001|Overall Study|Other|2|||
147480168|NCT02940886|531915129|FG000|Overall Study|Adverse Event|7|||
147480169|NCT02940886|531915130|FG001|Overall Study|Adverse Event|3|||
147480170|NCT02940886|531915129|FG000|Overall Study|Protocol Violation|0|||
147480171|NCT02940886|531915130|FG001|Overall Study|Protocol Violation|2|||
147480172|NCT02940886|531915129|FG000|Overall Study|Withdrawal by Subject|28|||
147480173|NCT02940886|531915130|FG001|Overall Study|Withdrawal by Subject|20|||
147480174|NCT02940886|531915129|FG000|Overall Study|Death|1|||
147480175|NCT02940886|531915130|FG001|Overall Study|Death|0|||
147480176|NCT02940886|531915129|FG000|Overall Study|Lack of Efficacy|1|||
147480177|NCT02940886|531915130|FG001|Overall Study|Lack of Efficacy|0|||
147480178|NCT02940886|531915129|FG000|Overall Study|Lost to Follow-up|49|||
147480179|NCT02940886|531915130|FG001|Overall Study|Lost to Follow-up|21|||
147480180|NCT02940886|531915129|FG000|Overall Study|Physician Decision|9|||
147480181|NCT02940886|531915130|FG001|Overall Study|Physician Decision|4|||
147480182|NCT02940886|531915129|FG000|Overall Study|Sponsor decision|0|||
147480183|NCT02940886|531915130|FG001|Overall Study|Sponsor decision|1|||
147480184|NCT02940886|531915129|FG000|Overall Study|No treatment|7|||
147480185|NCT02940886|531915130|FG001|Overall Study|No treatment|2|||
147480186|NCT02940886|531915129|FG000|Overall Study|Enrolment error|0|||
147480187|NCT02940886|531915130|FG001|Overall Study|Enrolment error|1|||
147480188|NCT01650779|531915135|FG000|Overall Study|Withdrawal by Subject|1|||
147480189|NCT00915005|531915140|FG000|Overall Study|Withdrawal by Subject|4|||
147480190|NCT00915005|531915141|FG001|Overall Study|Withdrawal by Subject|4|||
147480191|NCT00915005|531915140|FG000|Overall Study|Patient preferred protons therapy|6|||
147480192|NCT00915005|531915141|FG001|Overall Study|Patient preferred protons therapy|0|||
147480193|NCT00915005|531915140|FG000|Overall Study|Insurance denial|3|||
147480194|NCT00915005|531915141|FG001|Overall Study|Insurance denial|15|||
147480195|NCT02397655|531915144|FG000|Overall Study|data not completed|1301|||
147480196|NCT02747043|531915145|FG000|Overall Study|Other|1|||
147480197|NCT02747043|531915146|FG001|Overall Study|Other|1|||
147480198|NCT02747043|531915145|FG000|Overall Study|Adverse Event|3|||
147480199|NCT02747043|531915146|FG001|Overall Study|Adverse Event|1|||
147480200|NCT02747043|531915145|FG000|Overall Study|Withdrawal by Subject|1|||
147480201|NCT02747043|531915146|FG001|Overall Study|Withdrawal by Subject|1|||
147480202|NCT02747043|531915145|FG000|Overall Study|Physician Decision|1|||
147480203|NCT02747043|531915146|FG001|Overall Study|Physician Decision|1|||
147480204|NCT02747043|531915145|FG000|Overall Study|Protocol Violation|0|||
147480205|NCT02747043|531915146|FG001|Overall Study|Protocol Violation|1|||
147480206|NCT02747043|531915145|FG000|Overall Study|Disease progression|4|||
147480207|NCT02747043|531915146|FG001|Overall Study|Disease progression|0|||
147480208|NCT02564120|531915151|FG000|Overall Study|Did not return release forms|160|||
147480209|NCT02564120|531915151|FG000|Overall Study|Death|58|||
147480210|NCT02564120|531915151|FG000|Overall Study|Withdrawal by Subject|204|||
147480211|NCT02564120|531915151|FG000|Overall Study|Other medical condition|24|||
147480212|NCT03952650|531915152|FG000|Overall Study|TRAVEL|0|||
147622711|NCT04570670|532436454|FG001|Overall Study|Withdrawal by Subject|0|||
147622712|NCT04335123|532436458|FG000|Overall Study|Withdrawal by Subject|2|||
147622713|NCT04335123|532436459|FG001|Overall Study|Withdrawal by Subject|0|||
147622714|NCT04335123|532436458|FG000|Overall Study|Physician Decision|2|||
147622715|NCT04335123|532436459|FG001|Overall Study|Physician Decision|0|||
147622716|NCT00957801|532436462|FG000|Overall Study|Withdrawal by Subject|0|||
147622717|NCT00957801|532436463|FG001|Overall Study|Withdrawal by Subject|0|||
147622718|NCT00957801|532436464|FG002|Overall Study|Withdrawal by Subject|0|||
147622719|NCT00957801|532436465|FG003|Overall Study|Withdrawal by Subject|1|||
147622720|NCT02626026|532436469|FG000|Overall Study|Randomized but Never Treated|0|||
147622721|NCT02626026|532436470|FG001|Overall Study|Randomized but Never Treated|0|||
147622722|NCT02626026|532436471|FG002|Overall Study|Randomized but Never Treated|0|||
147622723|NCT02626026|532436472|FG003|Overall Study|Randomized but Never Treated|0|||
147622724|NCT02626026|532436473|FG004|Overall Study|Randomized but Never Treated|1|||
147480213|NCT03952650|531915153|FG001|Overall Study|TRAVEL|4|||
147480214|NCT03952650|531915154|FG002|Overall Study|TRAVEL|0|||
147480215|NCT03952650|531915155|FG003|Overall Study|TRAVEL|4|||
147480216|NCT03952650|531915156|FG004|Overall Study|TRAVEL|0|||
147480217|NCT03952650|531915157|FG005|Overall Study|TRAVEL|3|||
147480218|NCT03952650|531915158|FG006|Overall Study|TRAVEL|2|||
147667256|NCT02265510|532608002|FG000|Overall Study|Death|2|||
147667257|NCT02265510|532608003|FG001|Overall Study|Death|0|||
147667258|NCT02265510|532608004|FG002|Overall Study|Death|2|||
147667259|NCT02265510|532608005|FG003|Overall Study|Death|2|||
147480219|NCT03952650|531915152|FG000|Overall Study|Withdrawal by Subject|0|||
147480220|NCT03952650|531915153|FG001|Overall Study|Withdrawal by Subject|2|||
147480221|NCT03952650|531915154|FG002|Overall Study|Withdrawal by Subject|0|||
147480222|NCT03952650|531915155|FG003|Overall Study|Withdrawal by Subject|3|||
147480223|NCT03952650|531915156|FG004|Overall Study|Withdrawal by Subject|0|||
147480224|NCT03952650|531915157|FG005|Overall Study|Withdrawal by Subject|1|||
147480225|NCT03952650|531915158|FG006|Overall Study|Withdrawal by Subject|1|||
147480226|NCT03952650|531915152|FG000|Overall Study|Lost to Follow-up|0|||
147480227|NCT03952650|531915153|FG001|Overall Study|Lost to Follow-up|1|||
147480228|NCT03952650|531915154|FG002|Overall Study|Lost to Follow-up|0|||
147480229|NCT03952650|531915155|FG003|Overall Study|Lost to Follow-up|0|||
147480230|NCT03952650|531915156|FG004|Overall Study|Lost to Follow-up|0|||
147480231|NCT03952650|531915157|FG005|Overall Study|Lost to Follow-up|1|||
147480232|NCT03952650|531915158|FG006|Overall Study|Lost to Follow-up|1|||
147622725|NCT02626026|532436474|FG005|Overall Study|Randomized but Never Treated|0|||
147622726|NCT01909934|532436475|FG000|Overall Study|Withdrawal by Subject|3|||
147622727|NCT01909934|532436475|FG000|Overall Study|Lost to Follow-up|1|||
147622728|NCT01909934|532436475|FG000|Overall Study|Death|25|||
147622729|NCT01909934|532436475|FG000|Overall Study|Withdrawal of Informed Consent|1|||
147622730|NCT01909934|532436475|FG000|Overall Study|Reason Not Specified|1|||
147622731|NCT00380874|532436478|FG000|Overall Study|Adverse Event|7|||
147622732|NCT00380874|532436479|FG001|Overall Study|Adverse Event|7|||
147622733|NCT00380874|532436478|FG000|Overall Study|Death|1|||
147622734|NCT00380874|532436479|FG001|Overall Study|Death|0|||
147622735|NCT00380874|532436478|FG000|Overall Study|Withdrawal by Subject|2|||
147622736|NCT00380874|532436479|FG001|Overall Study|Withdrawal by Subject|1|||
147622737|NCT00380874|532436478|FG000|Overall Study|Not related to study drug|3|||
147622738|NCT00380874|532436479|FG001|Overall Study|Not related to study drug|2|||
147622739|NCT03380429|532436480|FG000|Overall Study|Physician Decision|0|||
147622740|NCT03380429|532436481|FG001|Overall Study|Physician Decision|1|||
147622741|NCT03380429|532436482|FG002|Overall Study|Physician Decision|0|||
147622742|NCT03380429|532436483|FG003|Overall Study|Physician Decision|1|||
147622743|NCT03380429|532436484|FG004|Overall Study|Physician Decision|1|||
147622744|NCT03380429|532436480|FG000|Overall Study|Withdrawal by Subject|3|||
147622745|NCT03380429|532436481|FG001|Overall Study|Withdrawal by Subject|3|||
147622746|NCT03380429|532436482|FG002|Overall Study|Withdrawal by Subject|5|||
147622747|NCT03380429|532436483|FG003|Overall Study|Withdrawal by Subject|2|||
147622748|NCT03380429|532436484|FG004|Overall Study|Withdrawal by Subject|1|||
147622749|NCT03380429|532436480|FG000|Overall Study|Lost to Follow-up|0|||
147622750|NCT03380429|532436481|FG001|Overall Study|Lost to Follow-up|2|||
147622751|NCT03380429|532436482|FG002|Overall Study|Lost to Follow-up|4|||
147622752|NCT03380429|532436483|FG003|Overall Study|Lost to Follow-up|3|||
147622753|NCT03380429|532436484|FG004|Overall Study|Lost to Follow-up|1|||
147622754|NCT03380429|532436480|FG000|Overall Study|Protocol Violation|1|||
147622755|NCT03380429|532436481|FG001|Overall Study|Protocol Violation|0|||
147622756|NCT03380429|532436482|FG002|Overall Study|Protocol Violation|1|||
147622757|NCT03380429|532436483|FG003|Overall Study|Protocol Violation|0|||
147622758|NCT03380429|532436484|FG004|Overall Study|Protocol Violation|1|||
147622759|NCT03380429|532436480|FG000|Overall Study|Lack of Efficacy|0|||
147622760|NCT03380429|532436481|FG001|Overall Study|Lack of Efficacy|0|||
147622761|NCT03380429|532436482|FG002|Overall Study|Lack of Efficacy|0|||
147622762|NCT03380429|532436483|FG003|Overall Study|Lack of Efficacy|2|||
147622763|NCT03380429|532436484|FG004|Overall Study|Lack of Efficacy|1|||
147622764|NCT03380429|532436480|FG000|Overall Study|Adverse Event|1|||
147622765|NCT03380429|532436481|FG001|Overall Study|Adverse Event|1|||
147622766|NCT03380429|532436482|FG002|Overall Study|Adverse Event|1|||
147622767|NCT03380429|532436483|FG003|Overall Study|Adverse Event|2|||
147622768|NCT03380429|532436484|FG004|Overall Study|Adverse Event|0|||
147622769|NCT01707290|532436491|FG000|Overall Study|Adverse event (AE)|1|||
147622770|NCT01707290|532436492|FG001|Overall Study|Adverse event (AE)|0|||
147622771|NCT01707290|532436491|FG000|Overall Study|Physician Decision|1|||
147622772|NCT01707290|532436492|FG001|Overall Study|Physician Decision|0|||
147622773|NCT01707290|532436491|FG000|Overall Study|Lost to Follow-up|3|||
147622774|NCT01707290|532436492|FG001|Overall Study|Lost to Follow-up|0|||
147622775|NCT01707290|532436491|FG000|Overall Study|Withdrawal of Consent (Not Due to AE)|4|||
147622776|NCT01707290|532436492|FG001|Overall Study|Withdrawal of Consent (Not Due to AE)|0|||
147622777|NCT01707290|532436491|FG000|Overall Study|Commercial drug available|60|||
147622778|NCT01707290|532436492|FG001|Overall Study|Commercial drug available|1|||
147622779|NCT01707290|532436491|FG000|Overall Study|Other unspecified|17|||
147622780|NCT01707290|532436492|FG001|Overall Study|Other unspecified|0|||
147622781|NCT01198470|532436493|FG000|Overall Study|Adverse Event|2|||
147622782|NCT02949973|532436494|FG000|Overall Study|Physician Decision|1|||
147622783|NCT00586703|532436495|FG000|Overall Study|Death|12|||
147622784|NCT00806403|532436498|FG000|Overall Study|Death|4|||
147667260|NCT02265510|532608006|FG004|Overall Study|Death|1|||
147480233|NCT03952650|531915152|FG000|Overall Study|Received wrong vaccine and travelled|0|||
147480234|NCT03952650|531915153|FG001|Overall Study|Received wrong vaccine and travelled|0|||
147480235|NCT03952650|531915154|FG002|Overall Study|Received wrong vaccine and travelled|0|||
147480236|NCT03952650|531915155|FG003|Overall Study|Received wrong vaccine and travelled|0|||
147480237|NCT03952650|531915156|FG004|Overall Study|Received wrong vaccine and travelled|0|||
147480238|NCT03952650|531915157|FG005|Overall Study|Received wrong vaccine and travelled|1|||
147480239|NCT03952650|531915158|FG006|Overall Study|Received wrong vaccine and travelled|0|||
147480240|NCT03952650|531915152|FG000|Overall Study|Unable to make study visit|0|||
147480241|NCT03952650|531915153|FG001|Overall Study|Unable to make study visit|0|||
147480242|NCT03952650|531915154|FG002|Overall Study|Unable to make study visit|0|||
147480243|NCT03952650|531915155|FG003|Overall Study|Unable to make study visit|0|||
147480244|NCT03952650|531915156|FG004|Overall Study|Unable to make study visit|0|||
147480245|NCT03952650|531915157|FG005|Overall Study|Unable to make study visit|1|||
147480246|NCT03952650|531915158|FG006|Overall Study|Unable to make study visit|0|||
147480247|NCT00891657|531915161|FG000|Overall Study|Withdrawal by Subject|1|||
147480248|NCT00891657|531915162|FG001|Overall Study|Withdrawal by Subject|1|||
147480249|NCT03988751|531915165|FG000|Overall Study|Withdrawal by Subject|1|||
147480250|NCT03988751|531915166|FG001|Overall Study|Withdrawal by Subject|0|||
147480251|NCT03988751|531915165|FG000|Overall Study|Protocol Violation|0|||
147480252|NCT03988751|531915166|FG001|Overall Study|Protocol Violation|1|||
147480253|NCT02623361|531915167|FG000|Overall Study|Protocol Violation|0|||
147480254|NCT02623361|531915168|FG001|Overall Study|Protocol Violation|1|||
147480255|NCT02623361|531915167|FG000|Overall Study|Withdrawal by Subject|0|||
147480256|NCT02623361|531915168|FG001|Overall Study|Withdrawal by Subject|1|||
147480257|NCT02441803|531915170|FG000|Overall Study|Physician Decision|0|||
147480258|NCT02441803|531915171|FG001|Overall Study|Physician Decision|2|||
147480259|NCT02441803|531915172|FG002|Overall Study|Physician Decision|2|||
147480260|NCT03065530|531915173|FG000|Overall Study|Lack of Efficacy|1|||
147480261|NCT03065530|531915174|FG001|Overall Study|Lack of Efficacy|1|||
147480262|NCT03065530|531915175|FG002|Overall Study|Lack of Efficacy|0|||
147480263|NCT03065530|531915176|FG003|Overall Study|Lack of Efficacy|1|||
147480264|NCT03065530|531915173|FG000|Overall Study|Protocol Violation|1|||
147480265|NCT03065530|531915174|FG001|Overall Study|Protocol Violation|0|||
147480266|NCT03065530|531915175|FG002|Overall Study|Protocol Violation|1|||
147480267|NCT03065530|531915176|FG003|Overall Study|Protocol Violation|1|||
147480268|NCT00909090|531915177|FG000|Overall Study|Lost to Follow-up|17|||
147480269|NCT00909090|531915178|FG001|Overall Study|Lost to Follow-up|17|||
147480270|NCT01749735|531915180|FG000|Overall Study|Withdrawal by Subject|1|||
147480271|NCT01749735|531915181|FG001|Overall Study|Withdrawal by Subject|0|||
147480272|NCT02926573|531915182|FG000|Overall Study|Nausea|1|||
147480273|NCT02926573|531915183|FG001|Overall Study|Nausea|0|||
147480274|NCT02926573|531915182|FG000|Overall Study|Remain intubated|2|||
147480275|NCT02926573|531915183|FG001|Overall Study|Remain intubated|2|||
147480276|NCT02926573|531915182|FG000|Overall Study|Change in surgery plan|3|||
147480277|NCT02926573|531915183|FG001|Overall Study|Change in surgery plan|1|||
147480278|NCT02926573|531915182|FG000|Overall Study|Change to outpatient status|5|||
147480279|NCT02926573|531915183|FG001|Overall Study|Change to outpatient status|1|||
147480280|NCT02926573|531915182|FG000|Overall Study|Withdrawal by Subject|0|||
147480281|NCT02926573|531915183|FG001|Overall Study|Withdrawal by Subject|2|||
147480282|NCT02926573|531915182|FG000|Overall Study|Return to operating room|0|||
147480283|NCT02926573|531915183|FG001|Overall Study|Return to operating room|2|||
147480284|NCT02926573|531915182|FG000|Overall Study|Delirium|0|||
147480285|NCT02926573|531915183|FG001|Overall Study|Delirium|1|||
147480286|NCT00611455|531915186|FG000|DB Treatment Period (24 Weeks)|Adverse Event|2|||
147480287|NCT00611455|531915187|FG001|DB Treatment Period (24 Weeks)|Adverse Event|8|||
147480288|NCT00611455|531915188|FG002|DB Treatment Period (24 Weeks)|Adverse Event|0|||
147480289|NCT00611455|531915186|FG000|DB Treatment Period (24 Weeks)|Lack of Efficacy|2|||
147480290|NCT00611455|531915187|FG001|DB Treatment Period (24 Weeks)|Lack of Efficacy|0|||
147480291|NCT00611455|531915188|FG002|DB Treatment Period (24 Weeks)|Lack of Efficacy|0|||
147622785|NCT00806403|532436499|FG001|Overall Study|Death|3|||
147480292|NCT00611455|531915186|FG000|DB Treatment Period (24 Weeks)|Protocol Violation|4|||
147480293|NCT00611455|531915187|FG001|DB Treatment Period (24 Weeks)|Protocol Violation|1|||
147480294|NCT00611455|531915188|FG002|DB Treatment Period (24 Weeks)|Protocol Violation|0|||
147622786|NCT01882985|532436500|FG000|Overall Study|Lost to Follow-up|1|||
147480295|NCT00611455|531915186|FG000|DB Treatment Period (24 Weeks)|Withdrawal by Subject|2|||
147480296|NCT00611455|531915187|FG001|DB Treatment Period (24 Weeks)|Withdrawal by Subject|3|||
147480297|NCT00611455|531915188|FG002|DB Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
147480298|NCT00611455|531915186|FG000|DB Treatment Period (24 Weeks)|Randomized in Error; Not Treated|2|||
147480299|NCT00611455|531915187|FG001|DB Treatment Period (24 Weeks)|Randomized in Error; Not Treated|2|||
147480300|NCT00611455|531915188|FG002|DB Treatment Period (24 Weeks)|Randomized in Error; Not Treated|0|||
147480301|NCT00611455|531915186|FG000|DB Treatment Period (24 Weeks)|Randomized, but Not Treated|1|||
147480302|NCT00611455|531915187|FG001|DB Treatment Period (24 Weeks)|Randomized, but Not Treated|0|||
147622787|NCT01882985|532436500|FG000|Overall Study|Withdrawal by Subject|1|||
147622788|NCT00765102|532436501|FG000|Overall Study|Progressive disease|18|||
147480303|NCT00611455|531915188|FG002|DB Treatment Period (24 Weeks)|Randomized, but Not Treated|0|||
147480304|NCT00611455|531915186|FG000|OL Treatment Period (120 Weeks)|Adverse Event|0|||
147480305|NCT00611455|531915187|FG001|OL Treatment Period (120 Weeks)|Adverse Event|17|||
147480306|NCT00611455|531915188|FG002|OL Treatment Period (120 Weeks)|Adverse Event|0|||
147480307|NCT00611455|531915186|FG000|OL Treatment Period (120 Weeks)|Lack of Efficacy|0|||
147480308|NCT00611455|531915187|FG001|OL Treatment Period (120 Weeks)|Lack of Efficacy|9|||
147480309|NCT00611455|531915188|FG002|OL Treatment Period (120 Weeks)|Lack of Efficacy|0|||
147480310|NCT00611455|531915186|FG000|OL Treatment Period (120 Weeks)|Protocol Violation|0|||
147480311|NCT00611455|531915187|FG001|OL Treatment Period (120 Weeks)|Protocol Violation|3|||
147480312|NCT00611455|531915188|FG002|OL Treatment Period (120 Weeks)|Protocol Violation|0|||
147480313|NCT00611455|531915186|FG000|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0|||
147480314|NCT00611455|531915187|FG001|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|12|||
147480315|NCT00611455|531915188|FG002|OL Treatment Period (120 Weeks)|Protocol-defined Stopping Criteria Met|0|||
147480316|NCT00611455|531915186|FG000|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0|||
147480317|NCT00611455|531915187|FG001|OL Treatment Period (120 Weeks)|Study Closed/Terminated|110|||
147480318|NCT00611455|531915188|FG002|OL Treatment Period (120 Weeks)|Study Closed/Terminated|0|||
147480319|NCT00611455|531915186|FG000|OL Treatment Period (120 Weeks)|Lost to Follow-up|0|||
147480320|NCT00611455|531915187|FG001|OL Treatment Period (120 Weeks)|Lost to Follow-up|5|||
147480321|NCT00611455|531915188|FG002|OL Treatment Period (120 Weeks)|Lost to Follow-up|0|||
147480322|NCT00611455|531915186|FG000|OL Treatment Period (120 Weeks)|Physician Decision|0|||
147480323|NCT00611455|531915187|FG001|OL Treatment Period (120 Weeks)|Physician Decision|5|||
147480324|NCT00611455|531915188|FG002|OL Treatment Period (120 Weeks)|Physician Decision|0|||
147480325|NCT00611455|531915186|FG000|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0|||
147480326|NCT00611455|531915187|FG001|OL Treatment Period (120 Weeks)|Withdrawal by Subject|18|||
147480327|NCT00611455|531915188|FG002|OL Treatment Period (120 Weeks)|Withdrawal by Subject|0|||
147480328|NCT00611455|531915186|FG000|Follow-up Period (Approximately 2 Years)|Adverse Event|0|||
147480329|NCT00611455|531915187|FG001|Follow-up Period (Approximately 2 Years)|Adverse Event|0|||
147480330|NCT00611455|531915188|FG002|Follow-up Period (Approximately 2 Years)|Adverse Event|30|||
147480331|NCT00611455|531915186|FG000|Follow-up Period (Approximately 2 Years)|Lack of Efficacy|0|||
147480332|NCT00611455|531915187|FG001|Follow-up Period (Approximately 2 Years)|Lack of Efficacy|0|||
147480333|NCT00611455|531915188|FG002|Follow-up Period (Approximately 2 Years)|Lack of Efficacy|12|||
147480334|NCT00611455|531915186|FG000|Follow-up Period (Approximately 2 Years)|Protocol Violation|0|||
147480335|NCT00611455|531915187|FG001|Follow-up Period (Approximately 2 Years)|Protocol Violation|0|||
147480336|NCT00611455|531915188|FG002|Follow-up Period (Approximately 2 Years)|Protocol Violation|4|||
147480337|NCT00611455|531915186|FG000|Follow-up Period (Approximately 2 Years)|Protocol-defined Stopping Criteria Met|0|||
147480338|NCT00611455|531915187|FG001|Follow-up Period (Approximately 2 Years)|Protocol-defined Stopping Criteria Met|0|||
147480339|NCT00611455|531915188|FG002|Follow-up Period (Approximately 2 Years)|Protocol-defined Stopping Criteria Met|23|||
147480340|NCT00611455|531915186|FG000|Follow-up Period (Approximately 2 Years)|Study Closed/Terminated|0|||
147480341|NCT00611455|531915187|FG001|Follow-up Period (Approximately 2 Years)|Study Closed/Terminated|0|||
147480342|NCT00611455|531915188|FG002|Follow-up Period (Approximately 2 Years)|Study Closed/Terminated|80|||
147480343|NCT00611455|531915186|FG000|Follow-up Period (Approximately 2 Years)|Lost to Follow-up|0|||
147480344|NCT00611455|531915187|FG001|Follow-up Period (Approximately 2 Years)|Lost to Follow-up|0|||
147480345|NCT00611455|531915188|FG002|Follow-up Period (Approximately 2 Years)|Lost to Follow-up|13|||
147480346|NCT00611455|531915186|FG000|Follow-up Period (Approximately 2 Years)|Withdrawal by Subject|0|||
147480347|NCT00611455|531915187|FG001|Follow-up Period (Approximately 2 Years)|Withdrawal by Subject|0|||
147480348|NCT00611455|531915188|FG002|Follow-up Period (Approximately 2 Years)|Withdrawal by Subject|49|||
147480349|NCT04601272|531915191|FG000|Overall Study|did not have sufficient information to calculate the SDM Process score (primary outcome)|2|||
147480350|NCT04601272|531915192|FG001|Overall Study|did not have sufficient information to calculate the SDM Process score (primary outcome)|3|||
147480351|NCT04601272|531915193|FG002|Overall Study|did not have sufficient information to calculate the SDM Process score (primary outcome)|2|||
147480352|NCT00414440|531915194|FG000|Core Period|Withdrawal by Subject|70|||
147480353|NCT00414440|531915195|FG001|Core Period|Withdrawal by Subject|32|||
147480354|NCT00414440|531915194|FG000|Extension Period|Lost to Follow-up|44|||
147480355|NCT00414440|531915195|FG001|Extension Period|Lost to Follow-up|52|||
147480356|NCT00414440|531915194|FG000|Extension Period|Did not consent to continue follow up|61|||
147480357|NCT00414440|531915195|FG001|Extension Period|Did not consent to continue follow up|54|||
147480358|NCT00414440|531915194|FG000|Extension Period|Other|1|||
147480359|NCT00414440|531915195|FG001|Extension Period|Other|1|||
147480360|NCT00414440|531915194|FG000|Extension Period|Administrative|16|||
147480361|NCT00414440|531915195|FG001|Extension Period|Administrative|16|||
147480362|NCT00414440|531915194|FG000|Extension Period|Death|1|||
147480363|NCT00414440|531915195|FG001|Extension Period|Death|2|||
147480364|NCT00414440|531915194|FG000|Extension Period|Withdrawal by Subject|9|||
147480365|NCT00414440|531915195|FG001|Extension Period|Withdrawal by Subject|7|||
147480366|NCT00414440|531915194|FG000|Extension Period|Not included in follow up period|18|||
147480367|NCT00414440|531915195|FG001|Extension Period|Not included in follow up period|8|||
147480368|NCT02732912|531915196|FG000|Overall Study|Discharged before night|2|||
147667261|NCT02265510|532608007|FG005|Overall Study|Death|3|||
147667262|NCT02265510|532608008|FG006|Overall Study|Death|2|||
147667263|NCT02265510|532608009|FG007|Overall Study|Death|1|||
147667264|NCT02265510|532608010|FG008|Overall Study|Death|3|||
147480369|NCT02732912|531915197|FG001|Overall Study|Discharged before night|6|||
147622789|NCT00765102|532436501|FG000|Overall Study|Adverse Event|6|||
147622790|NCT00765102|532436501|FG000|Overall Study|Physician Decision|4|||
147622791|NCT00765102|532436501|FG000|Overall Study|Withdrawal by Subject|2|||
147622792|NCT00765102|532436501|FG000|Overall Study|Protocol Violation|1|||
147622793|NCT04129125|532436508|FG000|Overall Study|Participants did not meet eligibility criteria|65|||
147622794|NCT04129125|532436508|FG000|Overall Study|Study device was not used|3|||
147622795|NCT04383327|532436513|FG000|Overall Study|Lost to Follow-up|112|||
147622796|NCT04383327|532436514|FG001|Overall Study|Lost to Follow-up|14|||
147622797|NCT04383327|532436515|FG002|Overall Study|Lost to Follow-up|78|||
147622798|NCT04383327|532436516|FG003|Overall Study|Lost to Follow-up|13|||
147622799|NCT04383327|532436517|FG004|Overall Study|Lost to Follow-up|110|||
147622800|NCT04383327|532436518|FG005|Overall Study|Lost to Follow-up|13|||
147622801|NCT04383327|532436519|FG006|Overall Study|Lost to Follow-up|74|||
147622802|NCT04383327|532436520|FG007|Overall Study|Lost to Follow-up|13|||
147622803|NCT04383327|532436521|FG008|Overall Study|Lost to Follow-up|78|||
147622804|NCT04383327|532436522|FG009|Overall Study|Lost to Follow-up|10|||
147622805|NCT04383327|532436523|FG010|Overall Study|Lost to Follow-up|160|||
147622806|NCT04383327|532436524|FG011|Overall Study|Lost to Follow-up|13|||
147622807|NCT05271175|532436534|FG000|One Week Follow up|Lost to Follow-up|10|||
147622808|NCT05271175|532436535|FG001|One Week Follow up|Lost to Follow-up|7|||
147622809|NCT05271175|532436536|FG002|One Week Follow up|Lost to Follow-up|5|||
147622810|NCT05271175|532436534|FG000|One Month Follow up|Lost to Follow-up|12|||
147622811|NCT05271175|532436535|FG001|One Month Follow up|Lost to Follow-up|7|||
147622812|NCT05271175|532436536|FG002|One Month Follow up|Lost to Follow-up|9|||
147622813|NCT05271175|532436534|FG000|Six Months Follow up|Lost to Follow-up|8|||
147622814|NCT05271175|532436535|FG001|Six Months Follow up|Lost to Follow-up|2|||
147622815|NCT05271175|532436536|FG002|Six Months Follow up|Lost to Follow-up|2|||
147622816|NCT00991887|532436537|FG000|Overall Study|Lost to Follow-up|2|||
147622817|NCT00991887|532436538|FG001|Overall Study|Lost to Follow-up|1|||
147622818|NCT00226499|532436539|FG000|Overall Study|Adverse Event|10|||
147622819|NCT00226499|532436540|FG001|Overall Study|Adverse Event|6|||
147622820|NCT00226499|532436541|FG002|Overall Study|Adverse Event|3|||
147622821|NCT00226499|532436539|FG000|Overall Study|Others|1064|||
147622822|NCT00226499|532436540|FG001|Overall Study|Others|1066|||
147622823|NCT00226499|532436541|FG002|Overall Study|Others|356|||
147622824|NCT04564092|532436546|FG000|Overall Study|Withdrawal by Subject|1|||
147622825|NCT02859337|532436547|FG000|Overall Study|Study drug not dosed (no dominant follicle)|2|||
147622826|NCT02859337|532436548|FG001|Overall Study|Study drug not dosed (no dominant follicle)|2|||
147622827|NCT02859337|532436549|FG002|Overall Study|Study drug not dosed (no dominant follicle)|0|||
147622828|NCT02859337|532436547|FG000|Overall Study|Withdrawal by Subject|3|||
147622829|NCT02859337|532436548|FG001|Overall Study|Withdrawal by Subject|1|||
147622830|NCT02859337|532436549|FG002|Overall Study|Withdrawal by Subject|0|||
147622831|NCT02859337|532436547|FG000|Overall Study|Lost to Follow-up|1|||
147622832|NCT02859337|532436548|FG001|Overall Study|Lost to Follow-up|0|||
147622833|NCT02859337|532436549|FG002|Overall Study|Lost to Follow-up|0|||
147622834|NCT02362360|532436555|FG000|Period 1|Lack of Efficacy|1|||
147622835|NCT02362360|532436556|FG001|Period 1|Lack of Efficacy|0|||
147622836|NCT02362360|532436555|FG000|Period 1|Withdrawal by Subject|2|||
147622837|NCT02362360|532436556|FG001|Period 1|Withdrawal by Subject|1|||
147622838|NCT04146012|532436557|FG000|Overall Study|Study Terminated|30|||
147622839|NCT04146012|532436558|FG001|Overall Study|Study Terminated|15|||
147622840|NCT01546025|532436559|FG000|Overall Study|Lost to Follow-up|0|||
147622841|NCT01546025|532436560|FG001|Overall Study|Lost to Follow-up|1|||
147622842|NCT03349060|532438415|FG000|Overall Study|Adverse Event|9|||
147667265|NCT02265510|532608011|FG009|Overall Study|Death|3|||
147667266|NCT02265510|532608012|FG010|Overall Study|Death|4|||
147480370|NCT02732912|531915196|FG000|Overall Study|Incomplete completion of questionnaire|2|||
147480371|NCT02732912|531915197|FG001|Overall Study|Incomplete completion of questionnaire|3|||
147622843|NCT03349060|532438416|FG001|Overall Study|Adverse Event|9|||
147622844|NCT03349060|532438417|FG002|Overall Study|Adverse Event|7|||
147622845|NCT03349060|532438415|FG000|Overall Study|Lack of Efficacy|1|||
147622846|NCT03349060|532438416|FG001|Overall Study|Lack of Efficacy|0|||
147622847|NCT03349060|532438417|FG002|Overall Study|Lack of Efficacy|2|||
147622848|NCT03349060|532438415|FG000|Overall Study|Lost to Follow-up|2|||
147622849|NCT03349060|532438416|FG001|Overall Study|Lost to Follow-up|1|||
147622850|NCT03349060|532438417|FG002|Overall Study|Lost to Follow-up|1|||
147622851|NCT03349060|532438415|FG000|Overall Study|Protocol Violation|2|||
147622852|NCT03349060|532438416|FG001|Overall Study|Protocol Violation|2|||
147622853|NCT03349060|532438417|FG002|Overall Study|Protocol Violation|1|||
147622854|NCT03349060|532438415|FG000|Overall Study|Withdrawal by Subject|5|||
147622855|NCT03349060|532438416|FG001|Overall Study|Withdrawal by Subject|3|||
147622856|NCT03349060|532438417|FG002|Overall Study|Withdrawal by Subject|4|||
147622857|NCT03349060|532438415|FG000|Overall Study|Medication error,no linked adverse event|0|||
147667267|NCT02265510|532608013|FG011|Overall Study|Death|12|||
147480372|NCT02732912|531915196|FG000|Overall Study|No outcome; discharged or refused|6|||
147480373|NCT02732912|531915197|FG001|Overall Study|No outcome; discharged or refused|9|||
147480374|NCT04382651|531915198|FG000|Overall Study|Death|26|||
147480375|NCT04382651|531915199|FG001|Overall Study|Death|23|||
147480376|NCT04382651|531915198|FG000|Overall Study|Lost to Follow-up|3|||
147480377|NCT04382651|531915199|FG001|Overall Study|Lost to Follow-up|4|||
147480378|NCT04382651|531915198|FG000|Overall Study|Withdrawal by Subject|2|||
147667268|NCT02265510|532608014|FG012|Overall Study|Death|7|||
147667269|NCT02265510|532608015|FG013|Overall Study|Death|6|||
147667270|NCT02265510|532608002|FG000|Overall Study|Lost to Follow-up|0|||
147480379|NCT04382651|531915199|FG001|Overall Study|Withdrawal by Subject|0|||
147480380|NCT04382651|531915198|FG000|Overall Study|Physician Decision|0|||
147480381|NCT04382651|531915199|FG001|Overall Study|Physician Decision|1|||
147480382|NCT01507545|531915200|FG000|Overall Study|Withdrawal by Subject|6|||
147480383|NCT01507545|531915201|FG001|Overall Study|Withdrawal by Subject|2|||
147480384|NCT01507545|531915200|FG000|Overall Study|Lost to Follow-up|1|||
147480385|NCT01507545|531915201|FG001|Overall Study|Lost to Follow-up|0|||
147480386|NCT01507545|531915200|FG000|Overall Study|Discontinuation of the study by sponsor|11|||
147480387|NCT01507545|531915201|FG001|Overall Study|Discontinuation of the study by sponsor|9|||
147480388|NCT01507545|531915200|FG000|Overall Study|Progressive disease|60|||
147480389|NCT01507545|531915201|FG001|Overall Study|Progressive disease|27|||
147480390|NCT01507545|531915200|FG000|Overall Study|Other|6|||
147480391|NCT01507545|531915201|FG001|Overall Study|Other|4|||
147480392|NCT01873742|531915202|FG000|Overall Study|Lost to Follow-up|68|||
147480393|NCT01873742|531915203|FG001|Overall Study|Lost to Follow-up|76|||
147480394|NCT00790296|531915204|FG000|Overall Study|Did not meet study eligibility criteria|1|||
147480395|NCT00790296|531915205|FG001|Overall Study|Did not meet study eligibility criteria|1|||
147480396|NCT00790296|531915204|FG000|Overall Study|Adverse Event|0|||
147480397|NCT00790296|531915205|FG001|Overall Study|Adverse Event|1|||
147480398|NCT00853905|531915211|FG000|Overall Study|Lost to Follow-up|1|||
147480399|NCT00853905|531915212|FG001|Overall Study|Lost to Follow-up|3|||
147480400|NCT00853905|531915211|FG000|Overall Study|Withdrawal by Subject|0|||
147480401|NCT00853905|531915212|FG001|Overall Study|Withdrawal by Subject|1|||
147480402|NCT00853905|531915211|FG000|Overall Study|never had surgery|1|||
147480403|NCT00853905|531915212|FG001|Overall Study|never had surgery|0|||
147480404|NCT04799782|531915221|FG000|Washout|Physician Decision|2|||
147480405|NCT04799782|531915222|FG001|Washout|Physician Decision|0|||
147480406|NCT04799782|531915221|FG000|Washout|Withdrawal by Subject|0|||
147480407|NCT04799782|531915222|FG001|Washout|Withdrawal by Subject|2|||
147480408|NCT04799782|531915221|FG000|Washout|Lost to Follow-up|0|||
147480409|NCT04799782|531915222|FG001|Washout|Lost to Follow-up|1|||
147480410|NCT02050048|531915223|FG000|Overall Study|Lost to Follow-up|0|||
147480411|NCT02050048|531915224|FG001|Overall Study|Lost to Follow-up|1|||
147480412|NCT02050048|531915223|FG000|Overall Study|Death|1|||
147480413|NCT02050048|531915224|FG001|Overall Study|Death|0|||
147480414|NCT02050048|531915223|FG000|Overall Study|Ineligible after ERCP|4|||
147480415|NCT02050048|531915224|FG001|Overall Study|Ineligible after ERCP|1|||
147480416|NCT01589094|531915228|FG000|Overall Study|Did not receive treatment|2|||
147480417|NCT00969618|531915232|FG000|Overall Study|Adverse Event|29|||
147480418|NCT00969618|531915232|FG000|Overall Study|Entry Criteria Not Met|3|||
147480419|NCT00969618|531915232|FG000|Overall Study|Lack of Efficacy|2|||
147480420|NCT00969618|531915232|FG000|Overall Study|Lost to Follow-up|7|||
147480421|NCT00969618|531915232|FG000|Overall Study|Physician Decision|1|||
147480422|NCT00969618|531915232|FG000|Overall Study|Protocol Violation|9|||
147480423|NCT00969618|531915232|FG000|Overall Study|Withdrawal by Subject|27|||
147480424|NCT05094154|531917722|FG000|Overall Study|Participants experiencing incarceration or involuntary detainment.|3|||
147480425|NCT05094154|531917723|FG001|Overall Study|Participants experiencing incarceration or involuntary detainment.|1|||
147480426|NCT05094154|531917722|FG000|Overall Study|Did not receive appropriate drug in 7 days post-enrollment.|60|||
147480427|NCT05094154|531917723|FG001|Overall Study|Did not receive appropriate drug in 7 days post-enrollment.|59|||
147480428|NCT02100657|531917730|FG000|Cohort 1: Dose Level 1|Progressive disease|6|||
147480429|NCT02100657|531917731|FG001|Cohort 1: Dose Level 1|Progressive disease|0|||
147480430|NCT02100657|531917732|FG002|Cohort 1: Dose Level 1|Progressive disease|0|||
147480431|NCT02100657|531917730|FG000|Cohort 1: Dose Level 1|Treatment-related adverse event|1|||
147480432|NCT02100657|531917731|FG001|Cohort 1: Dose Level 1|Treatment-related adverse event|0|||
147480433|NCT02100657|531917732|FG002|Cohort 1: Dose Level 1|Treatment-related adverse event|0|||
147480434|NCT02100657|531917730|FG000|Cohort 1: Dose Level 1|Withdrawal by Subject|1|||
147480435|NCT02100657|531917731|FG001|Cohort 1: Dose Level 1|Withdrawal by Subject|0|||
147480436|NCT02100657|531917732|FG002|Cohort 1: Dose Level 1|Withdrawal by Subject|0|||
147480437|NCT02100657|531917730|FG000|Cohort 2: Dose Level 2|Progressive disease|0|||
147480438|NCT02100657|531917731|FG001|Cohort 2: Dose Level 2|Progressive disease|2|||
147480439|NCT02100657|531917732|FG002|Cohort 2: Dose Level 2|Progressive disease|0|||
147480440|NCT02100657|531917730|FG000|Cohort 2: Dose Level 2|Physician Decision|0|||
147480441|NCT02100657|531917731|FG001|Cohort 2: Dose Level 2|Physician Decision|1|||
147480442|NCT02100657|531917732|FG002|Cohort 2: Dose Level 2|Physician Decision|0|||
147480443|NCT02100657|531917730|FG000|Cohort 2: Dose Level 2|Treatment-related adverse event|0|||
147480444|NCT02100657|531917731|FG001|Cohort 2: Dose Level 2|Treatment-related adverse event|1|||
147480445|NCT02100657|531917732|FG002|Cohort 2: Dose Level 2|Treatment-related adverse event|0|||
147480446|NCT02100657|531917730|FG000|Cohort 3: Dose Level 3|Progressive disease|0|||
147480447|NCT02100657|531917731|FG001|Cohort 3: Dose Level 3|Progressive disease|0|||
147480448|NCT02100657|531917732|FG002|Cohort 3: Dose Level 3|Progressive disease|15|||
147480449|NCT02100657|531917730|FG000|Cohort 3: Dose Level 3|Death|0|||
147480450|NCT02100657|531917731|FG001|Cohort 3: Dose Level 3|Death|0|||
147480451|NCT02100657|531917732|FG002|Cohort 3: Dose Level 3|Death|1|||
147480452|NCT02100657|531917730|FG000|Cohort 3: Dose Level 3|Non-treatment related adverse event|0|||
147303206|NCT04382924|531276269|FG001|Overall Study|Withdrawal by Subject|3|||
147303207|NCT04382924|531276270|FG002|Overall Study|Withdrawal by Subject|6|||
147303208|NCT04207840|531276274|FG000|Washout Period 1 (2-7 Days)|Withdrawal by Subject|0|||
147303209|NCT04207840|531276275|FG001|Washout Period 1 (2-7 Days)|Withdrawal by Subject|0|||
147303210|NCT04207840|531276276|FG002|Washout Period 1 (2-7 Days)|Withdrawal by Subject|1|||
147303211|NCT04207840|531276274|FG000|Washout Period 2 (2-7 Days)|Withdrawal by Subject|0|||
147303212|NCT04207840|531276275|FG001|Washout Period 2 (2-7 Days)|Withdrawal by Subject|0|||
147303213|NCT04207840|531276276|FG002|Washout Period 2 (2-7 Days)|Withdrawal by Subject|1|||
147303214|NCT02173054|531276277|FG000|Overall Study|lack of compliance|1|||
147622858|NCT03349060|532438416|FG001|Overall Study|Medication error,no linked adverse event|0|||
147622859|NCT03349060|532438417|FG002|Overall Study|Medication error,no linked adverse event|1|||
147622860|NCT03349060|532438415|FG000|Overall Study|Withdrawal By Parent/Guardian|0|||
147622861|NCT03349060|532438416|FG001|Overall Study|Withdrawal By Parent/Guardian|1|||
147622862|NCT03349060|532438417|FG002|Overall Study|Withdrawal By Parent/Guardian|0|||
147622863|NCT03349060|532438415|FG000|Overall Study|Other|2|||
147622864|NCT03349060|532438416|FG001|Overall Study|Other|1|||
147480453|NCT02100657|531917731|FG001|Cohort 3: Dose Level 3|Non-treatment related adverse event|0|||
147480454|NCT02100657|531917732|FG002|Cohort 3: Dose Level 3|Non-treatment related adverse event|1|||
147480455|NCT02100657|531917730|FG000|Cohort 3: Dose Level 3|Physician Decision|0|||
147480456|NCT02100657|531917731|FG001|Cohort 3: Dose Level 3|Physician Decision|0|||
147480457|NCT02100657|531917732|FG002|Cohort 3: Dose Level 3|Physician Decision|1|||
147480458|NCT02100657|531917730|FG000|Cohort 3: Dose Level 3|Never were treated|0|||
147480459|NCT02100657|531917731|FG001|Cohort 3: Dose Level 3|Never were treated|0|||
147480460|NCT02100657|531917732|FG002|Cohort 3: Dose Level 3|Never were treated|3|||
147480461|NCT02100657|531917730|FG000|Cohort 3: Dose Level 3|Treatment-related adverse event|0|||
147480462|NCT02100657|531917731|FG001|Cohort 3: Dose Level 3|Treatment-related adverse event|0|||
147480463|NCT02100657|531917732|FG002|Cohort 3: Dose Level 3|Treatment-related adverse event|3|||
147480464|NCT02100657|531917730|FG000|Cohort 3: Dose Level 3|Withdrawal by Subject|0|||
147480465|NCT02100657|531917731|FG001|Cohort 3: Dose Level 3|Withdrawal by Subject|0|||
147480466|NCT02100657|531917732|FG002|Cohort 3: Dose Level 3|Withdrawal by Subject|3|||
147480467|NCT02531035|531917733|FG000|Overall Study|Death|0|||
147480468|NCT02531035|531917734|FG001|Overall Study|Death|1|||
147480469|NCT02531035|531917733|FG000|Overall Study|Protocol Violation|1|||
147480470|NCT02531035|531917734|FG001|Overall Study|Protocol Violation|1|||
147480471|NCT02531035|531917733|FG000|Overall Study|Noncompliance with study drug|8|||
147480472|NCT02531035|531917734|FG001|Overall Study|Noncompliance with study drug|3|||
147480473|NCT02531035|531917733|FG000|Overall Study|Physician Decision|1|||
147480474|NCT02531035|531917734|FG001|Overall Study|Physician Decision|0|||
147480475|NCT02531035|531917733|FG000|Overall Study|Adverse Event|16|||
147480476|NCT02531035|531917734|FG001|Overall Study|Adverse Event|45|||
147480477|NCT02531035|531917733|FG000|Overall Study|Other|3|||
147480478|NCT02531035|531917734|FG001|Overall Study|Other|2|||
147480479|NCT02531035|531917733|FG000|Overall Study|Withdrawal by Subject|42|||
147480480|NCT02531035|531917734|FG001|Overall Study|Withdrawal by Subject|32|||
147480481|NCT02531035|531917733|FG000|Overall Study|Lost to Follow-up|8|||
147480482|NCT02531035|531917734|FG001|Overall Study|Lost to Follow-up|10|||
147480483|NCT02531035|531917733|FG000|Overall Study|Randomized, not treated|2|||
147480484|NCT02531035|531917734|FG001|Overall Study|Randomized, not treated|1|||
147480485|NCT01543490|531917737|FG000|Overall Study|Adverse Event|4|||
147480486|NCT01543490|531917738|FG001|Overall Study|Adverse Event|0|||
147480487|NCT01543490|531917737|FG000|Overall Study|Physician Decision|1|||
147480488|NCT01543490|531917738|FG001|Overall Study|Physician Decision|0|||
147480489|NCT01543490|531917737|FG000|Overall Study|Lack of Efficacy|3|||
147480490|NCT01543490|531917738|FG001|Overall Study|Lack of Efficacy|3|||
147480491|NCT01543490|531917737|FG000|Overall Study|Lost to Follow-up|5|||
147480492|NCT01543490|531917738|FG001|Overall Study|Lost to Follow-up|0|||
147480493|NCT01543490|531917737|FG000|Overall Study|Withdrawal by Subject|2|||
147480494|NCT01543490|531917738|FG001|Overall Study|Withdrawal by Subject|0|||
147480495|NCT01543490|531917737|FG000|Overall Study|Other-Various Administrative Reasons|1|||
147480496|NCT01543490|531917738|FG001|Overall Study|Other-Various Administrative Reasons|2|||
147480497|NCT04168645|531917744|FG000|Overall Study|Lost to Follow-up|23|||
147480498|NCT04168645|531917745|FG001|Overall Study|Lost to Follow-up|28|||
147480499|NCT04168645|531917746|FG002|Overall Study|Lost to Follow-up|15|||
147480500|NCT04168645|531917747|FG003|Overall Study|Lost to Follow-up|12|||
147480501|NCT04168645|531917744|FG000|Overall Study|Death|1|||
147480502|NCT04168645|531917745|FG001|Overall Study|Death|1|||
147480503|NCT04168645|531917746|FG002|Overall Study|Death|0|||
147480504|NCT04168645|531917747|FG003|Overall Study|Death|0|||
147480505|NCT04168645|531917744|FG000|Overall Study|Withdrawal by Subject|5|||
147480506|NCT04168645|531917745|FG001|Overall Study|Withdrawal by Subject|2|||
147480507|NCT04168645|531917746|FG002|Overall Study|Withdrawal by Subject|2|||
147480508|NCT04168645|531917747|FG003|Overall Study|Withdrawal by Subject|2|||
147480509|NCT04168645|531917744|FG000|Overall Study|Administrative Withdrawal|3|||
147480510|NCT04168645|531917745|FG001|Overall Study|Administrative Withdrawal|1|||
147480511|NCT04168645|531917746|FG002|Overall Study|Administrative Withdrawal|1|||
147480512|NCT04168645|531917747|FG003|Overall Study|Administrative Withdrawal|3|||
147480513|NCT02400346|531917748|FG000|Overall Study|Adverse Event|24|||
147480514|NCT02400346|531917748|FG000|Overall Study|Lack of Efficacy|9|||
147480515|NCT02400346|531917748|FG000|Overall Study|Non-compliance with IMP|1|||
147480516|NCT02400346|531917748|FG000|Overall Study|Withdrawal by Subject|7|||
147480517|NCT02400346|531917748|FG000|Overall Study|Administrative or other reason(s)|2|||
147480518|NCT02400346|531917748|FG000|Overall Study|Lost to Follow-up|1|||
147480519|NCT00500149|531917749|FG000|Enrolled (Dose-optimization Phase)|Withdrawal by Subject|3|||
147480520|NCT00500149|531917750|FG001|Enrolled (Dose-optimization Phase)|Withdrawal by Subject|0|||
147480521|NCT00500149|531917749|FG000|Enrolled (Dose-optimization Phase)|Adverse Event|8|||
147480522|NCT00500149|531917750|FG001|Enrolled (Dose-optimization Phase)|Adverse Event|0|||
147480523|NCT00500149|531917749|FG000|Enrolled (Dose-optimization Phase)|Protocol Violation|1|||
147480524|NCT00500149|531917750|FG001|Enrolled (Dose-optimization Phase)|Protocol Violation|0|||
147480525|NCT00500149|531917749|FG000|First Intervention (Cross-over Phase)|Adverse Event|0|||
147480526|NCT00500149|531917750|FG001|First Intervention (Cross-over Phase)|Adverse Event|1|||
147480527|NCT00500149|531917749|FG000|First Intervention (Cross-over Phase)|Withdrawal by Subject|1|||
147480528|NCT00500149|531917750|FG001|First Intervention (Cross-over Phase)|Withdrawal by Subject|1|||
147480529|NCT00500149|531917749|FG000|First Intervention (Cross-over Phase)|Protocol Violation|1|||
147480530|NCT00500149|531917750|FG001|First Intervention (Cross-over Phase)|Protocol Violation|0|||
147480531|NCT00500149|531917749|FG000|Second Intervention (Cross-over Phase)|Lost to Follow-up|2|||
147480532|NCT00500149|531917750|FG001|Second Intervention (Cross-over Phase)|Lost to Follow-up|0|||
147480533|NCT00089843|531917751|FG000|Overall Study|Withdrawal by Subject|1|||
147480534|NCT00089843|531917752|FG001|Overall Study|Withdrawal by Subject|4|||
147480535|NCT00089843|531917753|FG002|Overall Study|Withdrawal by Subject|5|||
147480536|NCT00089843|531917754|FG003|Overall Study|Withdrawal by Subject|6|||
147480537|NCT00089843|531917751|FG000|Overall Study|Physician Decision|1|||
147480538|NCT00089843|531917752|FG001|Overall Study|Physician Decision|0|||
147480539|NCT00089843|531917753|FG002|Overall Study|Physician Decision|0|||
147480540|NCT00089843|531917754|FG003|Overall Study|Physician Decision|1|||
147480541|NCT01157169|531917755|FG000|First Intervention|Emesis Within 4 hrs of Administration|4|||
147480542|NCT01157169|531917756|FG001|First Intervention|Emesis Within 4 hrs of Administration|2|||
147480543|NCT01157169|531917755|FG000|Second Intervention|Emesis Within 4 hrs of Administration|0|||
147480544|NCT01157169|531917756|FG001|Second Intervention|Emesis Within 4 hrs of Administration|1|||
147480545|NCT00663858|531917757|FG000|Overall Study|Adverse Event|9|||
147480546|NCT00663858|531917758|FG001|Overall Study|Adverse Event|1|||
147480547|NCT00663858|531917759|FG002|Overall Study|Adverse Event|6|||
147480548|NCT00663858|531917757|FG000|Overall Study|Lack of Efficacy|5|||
147480549|NCT00663858|531917758|FG001|Overall Study|Lack of Efficacy|1|||
147480550|NCT00663858|531917759|FG002|Overall Study|Lack of Efficacy|3|||
147480551|NCT00663858|531917757|FG000|Overall Study|Withdrawal by Subject|7|||
147480552|NCT00663858|531917758|FG001|Overall Study|Withdrawal by Subject|3|||
147480553|NCT00663858|531917759|FG002|Overall Study|Withdrawal by Subject|3|||
147480554|NCT00663858|531917757|FG000|Overall Study|Protocol Violation|5|||
147480555|NCT00663858|531917758|FG001|Overall Study|Protocol Violation|3|||
147480556|NCT00663858|531917759|FG002|Overall Study|Protocol Violation|4|||
147480557|NCT00663858|531917757|FG000|Overall Study|Other|8|||
147480558|NCT00663858|531917758|FG001|Overall Study|Other|2|||
147480559|NCT00663858|531917759|FG002|Overall Study|Other|4|||
147480560|NCT01277289|531917763|FG000|Overall Study|fragile vein|1|||
147480561|NCT01277289|531917764|FG001|Overall Study|fragile vein|0|||
147480562|NCT01277289|531917763|FG000|Overall Study|Physician Decision|1|||
147480563|NCT01277289|531917764|FG001|Overall Study|Physician Decision|0|||
147480564|NCT01277289|531917763|FG000|Overall Study|therapy failure and/or Crohn's surgery|13|||
147480565|NCT01277289|531917764|FG001|Overall Study|therapy failure and/or Crohn's surgery|16|||
147480566|NCT01277289|531917763|FG000|Overall Study|Protocol Violation|1|||
147480567|NCT01277289|531917764|FG001|Overall Study|Protocol Violation|1|||
147480568|NCT01277289|531917763|FG000|Overall Study|Adverse Event|2|||
147480569|NCT01277289|531917764|FG001|Overall Study|Adverse Event|1|||
147480570|NCT01277289|531917763|FG000|Overall Study|consent withdrawn|1|||
147480571|NCT01277289|531917764|FG001|Overall Study|consent withdrawn|1|||
147480572|NCT01277289|531917763|FG000|Overall Study|premature closure of the study|4|||
147480573|NCT01277289|531917764|FG001|Overall Study|premature closure of the study|2|||
147480574|NCT02584634|531917774|FG000|Overall Study|Adverse Event|3|||
147622865|NCT03349060|532438417|FG002|Overall Study|Other|0|||
147622866|NCT00485732|532438418|FG000|Overall Study|Protocol Violation|1|||
147622867|NCT00485732|532438419|FG001|Overall Study|Protocol Violation|3|||
147667271|NCT02265510|532608003|FG001|Overall Study|Lost to Follow-up|0|||
147667272|NCT02265510|532608004|FG002|Overall Study|Lost to Follow-up|0|||
147667273|NCT02265510|532608005|FG003|Overall Study|Lost to Follow-up|0|||
147667274|NCT02265510|532608006|FG004|Overall Study|Lost to Follow-up|1|||
147667275|NCT02265510|532608007|FG005|Overall Study|Lost to Follow-up|0|||
147667276|NCT02265510|532608008|FG006|Overall Study|Lost to Follow-up|0|||
147667277|NCT02265510|532608009|FG007|Overall Study|Lost to Follow-up|0|||
147667278|NCT02265510|532608010|FG008|Overall Study|Lost to Follow-up|0|||
147667279|NCT02265510|532608011|FG009|Overall Study|Lost to Follow-up|2|||
147667280|NCT02265510|532608012|FG010|Overall Study|Lost to Follow-up|0|||
147667281|NCT02265510|532608013|FG011|Overall Study|Lost to Follow-up|0|||
147667282|NCT02265510|532608014|FG012|Overall Study|Lost to Follow-up|0|||
147667283|NCT02265510|532608015|FG013|Overall Study|Lost to Follow-up|2|||
147667284|NCT02265510|532608002|FG000|Overall Study|Other|0|||
147667285|NCT02265510|532608003|FG001|Overall Study|Other|1|||
147667286|NCT02265510|532608004|FG002|Overall Study|Other|0|||
147667287|NCT02265510|532608005|FG003|Overall Study|Other|0|||
147667288|NCT02265510|532608006|FG004|Overall Study|Other|0|||
147667289|NCT02265510|532608007|FG005|Overall Study|Other|0|||
147667290|NCT02265510|532608008|FG006|Overall Study|Other|0|||
147667291|NCT02265510|532608009|FG007|Overall Study|Other|0|||
147667292|NCT02265510|532608010|FG008|Overall Study|Other|0|||
147667293|NCT02265510|532608011|FG009|Overall Study|Other|0|||
147667294|NCT02265510|532608012|FG010|Overall Study|Other|0|||
147667295|NCT02265510|532608013|FG011|Overall Study|Other|0|||
147667296|NCT02265510|532608014|FG012|Overall Study|Other|0|||
147667297|NCT02265510|532608015|FG013|Overall Study|Other|0|||
147667298|NCT02265510|532608002|FG000|Overall Study|Study Terminated by Sponsor|0|||
147667299|NCT02265510|532608003|FG001|Overall Study|Study Terminated by Sponsor|0|||
147667300|NCT02265510|532608004|FG002|Overall Study|Study Terminated by Sponsor|0|||
147667301|NCT02265510|532608005|FG003|Overall Study|Study Terminated by Sponsor|0|||
147667302|NCT02265510|532608006|FG004|Overall Study|Study Terminated by Sponsor|0|||
147667303|NCT02265510|532608007|FG005|Overall Study|Study Terminated by Sponsor|1|||
147667304|NCT02265510|532608008|FG006|Overall Study|Study Terminated by Sponsor|1|||
147667305|NCT02265510|532608009|FG007|Overall Study|Study Terminated by Sponsor|1|||
147667306|NCT02265510|532608010|FG008|Overall Study|Study Terminated by Sponsor|1|||
147667307|NCT02265510|532608011|FG009|Overall Study|Study Terminated by Sponsor|2|||
147667308|NCT02265510|532608012|FG010|Overall Study|Study Terminated by Sponsor|1|||
147667309|NCT02265510|532608013|FG011|Overall Study|Study Terminated by Sponsor|4|||
147667310|NCT02265510|532608014|FG012|Overall Study|Study Terminated by Sponsor|1|||
147667311|NCT02265510|532608015|FG013|Overall Study|Study Terminated by Sponsor|2|||
147667312|NCT01004614|532608016|FG000|Washout|Withdrawal by Subject|0|||
147667313|NCT01004614|532608017|FG001|Washout|Withdrawal by Subject|1|||
147667314|NCT01004614|532608018|FG002|Washout|Withdrawal by Subject|0|||
147667315|NCT01004614|532608019|FG003|Washout|Withdrawal by Subject|0|||
147667316|NCT02530385|532608020|FG000|Overall Study|Withdrawal by Subject|0|||
147667317|NCT02530385|532608021|FG001|Overall Study|Withdrawal by Subject|1|||
147667318|NCT01569022|532608023|FG000|First Intervention|Lost to Follow-up|2|||
147667319|NCT01569022|532608024|FG001|First Intervention|Lost to Follow-up|1|||
147667320|NCT01569022|532608023|FG000|Second Intervention|Lost to Follow-up|2|||
147667321|NCT01569022|532608024|FG001|Second Intervention|Lost to Follow-up|2|||
147667322|NCT02111083|532608029|FG000|Interval Between Dosing (7-8 Days)|Adverse Event|1|||
147667323|NCT02111083|532608030|FG001|Interval Between Dosing (7-8 Days)|Adverse Event|1|||
147667324|NCT00116142|532608031|FG000|Overall Study|Adverse Event|8|||
147667325|NCT00116142|532608032|FG001|Overall Study|Adverse Event|7|||
147667326|NCT00116142|532608031|FG000|Overall Study|Protocol Violation|2|||
147667327|NCT00116142|532608032|FG001|Overall Study|Protocol Violation|1|||
147667328|NCT00116142|532608031|FG000|Overall Study|Withdrawal by Subject|5|||
147667329|NCT00116142|532608032|FG001|Overall Study|Withdrawal by Subject|5|||
147667330|NCT00116142|532608031|FG000|Overall Study|Physician Decision|3|||
147667331|NCT00116142|532608032|FG001|Overall Study|Physician Decision|1|||
147667332|NCT00116142|532608031|FG000|Overall Study|Delayed Radiation Therapy|1|||
147667333|NCT00116142|532608032|FG001|Overall Study|Delayed Radiation Therapy|0|||
147667334|NCT00116142|532608031|FG000|Overall Study|Patient could not tolerate docetaxel|0|||
147667335|NCT00116142|532608032|FG001|Overall Study|Patient could not tolerate docetaxel|2|||
147667336|NCT00116142|532608031|FG000|Overall Study|Patient stopped due to depression|0|||
147667337|NCT00116142|532608032|FG001|Overall Study|Patient stopped due to depression|1|||
147667338|NCT00116142|532608031|FG000|Overall Study|Patient stopped due to bilateral ruptured tendons|0|||
147667339|NCT00116142|532608032|FG001|Overall Study|Patient stopped due to bilateral ruptured tendons|1|||
147667340|NCT00116142|532608031|FG000|Overall Study|Patient didn't start due to diagnosis of colon cancer|0|||
147667341|NCT00116142|532608032|FG001|Overall Study|Patient didn't start due to diagnosis of colon cancer|1|||
147667342|NCT00116142|532608031|FG000|Overall Study|Patient didn't start due to low platelet counts|0|||
147667343|NCT00116142|532608032|FG001|Overall Study|Patient didn't start due to low platelet counts|1|||
147667344|NCT00644059|532608033|FG000|Overall Study|Lost to Follow-up|37|||
147667345|NCT00644059|532608034|FG001|Overall Study|Lost to Follow-up|34|||
147667346|NCT00644059|532608035|FG002|Overall Study|Lost to Follow-up|16|||
147667347|NCT00644059|532608033|FG000|Overall Study|Withdrawal by Subject|52|||
147667348|NCT00644059|532608034|FG001|Overall Study|Withdrawal by Subject|60|||
147667349|NCT00644059|532608035|FG002|Overall Study|Withdrawal by Subject|30|||
147667350|NCT00644059|532608033|FG000|Overall Study|Adverse Event|8|||
147667351|NCT00644059|532608034|FG001|Overall Study|Adverse Event|5|||
147667352|NCT00644059|532608035|FG002|Overall Study|Adverse Event|1|||
147667353|NCT00644059|532608033|FG000|Overall Study|Inappropriate Enrollment|1|||
147667354|NCT00644059|532608034|FG001|Overall Study|Inappropriate Enrollment|3|||
147667355|NCT00644059|532608035|FG002|Overall Study|Inappropriate Enrollment|0|||
147667356|NCT00644059|532608033|FG000|Overall Study|Protocol Deviation/violation|20|||
147667357|NCT00644059|532608034|FG001|Overall Study|Protocol Deviation/violation|19|||
147667358|NCT00644059|532608035|FG002|Overall Study|Protocol Deviation/violation|15|||
147667359|NCT00644059|532608033|FG000|Overall Study|Unable to classify|6|||
147667360|NCT00644059|532608034|FG001|Overall Study|Unable to classify|2|||
147667361|NCT00644059|532608035|FG002|Overall Study|Unable to classify|3|||
147667362|NCT02152007|532608036|FG000|Overall Study|Withdrawal by Subject|1|||
147667363|NCT01302899|532608041|FG000|Period 2 (Weeks 7 to 12)|Protocol Deviation|1|||
147667364|NCT01302899|532608042|FG001|Period 2 (Weeks 7 to 12)|Protocol Deviation|0|||
147667365|NCT01302899|532608041|FG000|Period 2 (Weeks 7 to 12)|Abnormal laboratory value(s)|0|||
147667366|NCT01302899|532608042|FG001|Period 2 (Weeks 7 to 12)|Abnormal laboratory value(s)|1|||
147667367|NCT02497469|532608043|FG000|Overall Study|Randomized but not Treated|0|||
147667368|NCT02497469|532608044|FG001|Overall Study|Randomized but not Treated|2|||
147667369|NCT02497469|532608043|FG000|Overall Study|Pretreatment Event/Adverse Event|18|||
147667370|NCT02497469|532608044|FG001|Overall Study|Pretreatment Event/Adverse Event|16|||
147667371|NCT02497469|532608043|FG000|Overall Study|Leukopenia or Lymphopenia|1|||
147667372|NCT02497469|532608044|FG001|Overall Study|Leukopenia or Lymphopenia|0|||
147667373|NCT02497469|532608043|FG000|Overall Study|Significant Protocol Deviation|4|||
147667374|NCT02497469|532608044|FG001|Overall Study|Significant Protocol Deviation|5|||
147667375|NCT02497469|532608043|FG000|Overall Study|Lost to Follow-up|14|||
147667376|NCT02497469|532608044|FG001|Overall Study|Lost to Follow-up|4|||
147667377|NCT02497469|532608043|FG000|Overall Study|Voluntary Withdrawal|39|||
147667378|NCT02497469|532608044|FG001|Overall Study|Voluntary Withdrawal|41|||
147667379|NCT02497469|532608043|FG000|Overall Study|Pregnancy|1|||
147667380|NCT02497469|532608044|FG001|Overall Study|Pregnancy|1|||
147667381|NCT02497469|532608043|FG000|Overall Study|Lack of Efficacy|86|||
147667382|NCT02497469|532608044|FG001|Overall Study|Lack of Efficacy|40|||
147667383|NCT02497469|532608043|FG000|Overall Study|Reason not Specified|6|||
147667384|NCT02497469|532608044|FG001|Overall Study|Reason not Specified|6|||
147667385|NCT03558516|532608045|FG000|Overall Study|Protocol Violation|2|||
147667386|NCT03558516|532608046|FG001|Overall Study|Protocol Violation|2|||
147667387|NCT00472420|532608047|FG000|Induction Treatment Period|Physician Decision|9|||
147667388|NCT00472420|532608047|FG000|Induction Treatment Period|Adverse Event|3|||
147667389|NCT00472420|532608047|FG000|Induction Treatment Period|Non-compliance|1|||
147667390|NCT00472420|532608047|FG000|Induction Treatment Period|Death|3|||
147667391|NCT00472420|532608047|FG000|Follow-up Period|Death|5|||
147667392|NCT00472420|532608047|FG000|Follow-up Period|Physician Decision|9|||
147667393|NCT00472420|532608047|FG000|Follow-up Period|Lost to Follow-up|2|||
147667394|NCT00472420|532608047|FG000|Follow-up Period|Protocol Violation|1|||
147667395|NCT01462942|532608052|FG000|Overall Study|Adverse Event|7|||
147667396|NCT01462942|532608053|FG001|Overall Study|Adverse Event|12|||
147667397|NCT01462942|532608054|FG002|Overall Study|Adverse Event|10|||
147667398|NCT01462942|532608055|FG003|Overall Study|Adverse Event|11|||
147667399|NCT01462942|532608056|FG004|Overall Study|Adverse Event|11|||
147480575|NCT02584634|531917775|FG001|Overall Study|Adverse Event|5|||
147480576|NCT02584634|531917774|FG000|Overall Study|Death|0|||
147480577|NCT02584634|531917775|FG001|Overall Study|Death|1|||
147480578|NCT02584634|531917774|FG000|Overall Study|Lost to Follow-up|0|||
147480579|NCT02584634|531917775|FG001|Overall Study|Lost to Follow-up|1|||
147480580|NCT02584634|531917774|FG000|Overall Study|Physician Decision|1|||
147480581|NCT02584634|531917775|FG001|Overall Study|Physician Decision|2|||
147480582|NCT02584634|531917774|FG000|Overall Study|Progressive disease|7|||
147480583|NCT02584634|531917775|FG001|Overall Study|Progressive disease|15|||
147480584|NCT02584634|531917774|FG000|Overall Study|Withdrawal by Subject|1|||
147480585|NCT02584634|531917775|FG001|Overall Study|Withdrawal by Subject|1|||
147480586|NCT02584634|531917774|FG000|Overall Study|Other|0|||
147480587|NCT02584634|531917775|FG001|Overall Study|Other|6|||
147480588|NCT00474630|531917776|FG000|Overall Study|Adverse Event|98|||
147480589|NCT00474630|531917777|FG001|Overall Study|Adverse Event|26|||
147480590|NCT00474630|531917776|FG000|Overall Study|Lost to Follow-up|22|||
147480591|NCT00474630|531917777|FG001|Overall Study|Lost to Follow-up|15|||
147480592|NCT00474630|531917776|FG000|Overall Study|Withdrawal by Subject|21|||
147480593|NCT00474630|531917777|FG001|Overall Study|Withdrawal by Subject|15|||
147480594|NCT00474630|531917776|FG000|Overall Study|Protocol Violation|3|||
147480595|NCT00474630|531917777|FG001|Overall Study|Protocol Violation|4|||
147667400|NCT01462942|532608052|FG000|Overall Study|Other, including COPD exacerbation|3|||
147667401|NCT01462942|532608053|FG001|Overall Study|Other, including COPD exacerbation|5|||
147480596|NCT00474630|531917776|FG000|Overall Study|Lack of Efficacy|5|||
147480597|NCT00474630|531917777|FG001|Overall Study|Lack of Efficacy|6|||
147480598|NCT00474630|531917776|FG000|Overall Study|Drug noncompliance, other|11|||
147480599|NCT00474630|531917777|FG001|Overall Study|Drug noncompliance, other|4|||
147480600|NCT03088605|531917778|FG000|Overall Study|Withdrawal by Subject|1|||
147480601|NCT03088605|531917779|FG001|Overall Study|Withdrawal by Subject|0|||
147480602|NCT02225223|531917781|FG000|Overall Study|Death|10|||
147480603|NCT02225223|531917782|FG001|Overall Study|Death|1|||
147480604|NCT02225223|531917781|FG000|Overall Study|Lost to Follow-up|5|||
147480605|NCT02225223|531917782|FG001|Overall Study|Lost to Follow-up|0|||
147480606|NCT02225223|531917781|FG000|Overall Study|Other|1|||
147480607|NCT02225223|531917782|FG001|Overall Study|Other|2|||
147480608|NCT02225223|531917781|FG000|Overall Study|Physician Decision|1|||
147480609|NCT02225223|531917782|FG001|Overall Study|Physician Decision|0|||
147480610|NCT02225223|531917781|FG000|Overall Study|Withdrawal by Subject|2|||
147480611|NCT02225223|531917782|FG001|Overall Study|Withdrawal by Subject|2|||
147480612|NCT03567291|531917783|FG000|Period I|Adverse Event|14|||
147480613|NCT03567291|531917784|FG001|Period I|Adverse Event|0|||
147480614|NCT03567291|531917785|FG002|Period I|Adverse Event|0|||
147480615|NCT03567291|531917786|FG003|Period I|Adverse Event|0|||
147480616|NCT03567291|531917783|FG000|Period I|Protocol Violation|1|||
147480617|NCT03567291|531917784|FG001|Period I|Protocol Violation|0|||
147480618|NCT03567291|531917785|FG002|Period I|Protocol Violation|0|||
147480619|NCT03567291|531917786|FG003|Period I|Protocol Violation|0|||
147480620|NCT03567291|531917783|FG000|Period I|Withdrawal by Subject|23|||
147480621|NCT03567291|531917784|FG001|Period I|Withdrawal by Subject|0|||
147480622|NCT03567291|531917785|FG002|Period I|Withdrawal by Subject|0|||
147480623|NCT03567291|531917786|FG003|Period I|Withdrawal by Subject|0|||
147480624|NCT03567291|531917783|FG000|Period I|Lost to Follow-up|2|||
147480625|NCT03567291|531917784|FG001|Period I|Lost to Follow-up|0|||
147480626|NCT03567291|531917785|FG002|Period I|Lost to Follow-up|0|||
147480627|NCT03567291|531917786|FG003|Period I|Lost to Follow-up|0|||
147480628|NCT03567291|531917783|FG000|Period I|Terminated by sponsor|44|||
147480629|NCT03567291|531917784|FG001|Period I|Terminated by sponsor|0|||
147480630|NCT03567291|531917785|FG002|Period I|Terminated by sponsor|0|||
147480631|NCT03567291|531917786|FG003|Period I|Terminated by sponsor|0|||
147480632|NCT03567291|531917783|FG000|Period I|Missing or unknown|7|||
147480633|NCT03567291|531917784|FG001|Period I|Missing or unknown|0|||
147480634|NCT03567291|531917785|FG002|Period I|Missing or unknown|0|||
147480635|NCT03567291|531917786|FG003|Period I|Missing or unknown|0|||
147480636|NCT03567291|531917783|FG000|Period II|Adverse Event|0|||
147480637|NCT03567291|531917784|FG001|Period II|Adverse Event|1|||
147480638|NCT03567291|531917785|FG002|Period II|Adverse Event|0|||
147480639|NCT03567291|531917786|FG003|Period II|Adverse Event|0|||
147480640|NCT03567291|531917783|FG000|Period II|Missing or unknown|0|||
147480641|NCT03567291|531917784|FG001|Period II|Missing or unknown|2|||
147480642|NCT03567291|531917785|FG002|Period II|Missing or unknown|1|||
147480643|NCT03567291|531917786|FG003|Period II|Missing or unknown|0|||
147480644|NCT03567291|531917783|FG000|Period III|Adverse Event|0|||
147480645|NCT03567291|531917784|FG001|Period III|Adverse Event|0|||
147480646|NCT03567291|531917785|FG002|Period III|Adverse Event|0|||
147480647|NCT03567291|531917786|FG003|Period III|Adverse Event|4|||
147480648|NCT03567291|531917783|FG000|Period III|Withdrawal by Subject|0|||
147480649|NCT03567291|531917784|FG001|Period III|Withdrawal by Subject|0|||
147480650|NCT03567291|531917785|FG002|Period III|Withdrawal by Subject|0|||
147480651|NCT03567291|531917786|FG003|Period III|Withdrawal by Subject|4|||
147480652|NCT03567291|531917783|FG000|Period III|Lost to Follow-up|0|||
147480653|NCT03567291|531917784|FG001|Period III|Lost to Follow-up|0|||
147480654|NCT03567291|531917785|FG002|Period III|Lost to Follow-up|0|||
147480655|NCT03567291|531917786|FG003|Period III|Lost to Follow-up|1|||
147480656|NCT03567291|531917783|FG000|Period III|Terminated by sponsor|0|||
147480657|NCT03567291|531917784|FG001|Period III|Terminated by sponsor|0|||
147480658|NCT03567291|531917785|FG002|Period III|Terminated by sponsor|0|||
147480659|NCT03567291|531917786|FG003|Period III|Terminated by sponsor|68|||
147480660|NCT03567291|531917783|FG000|Period III|Missing or unknown|0|||
147480661|NCT03567291|531917784|FG001|Period III|Missing or unknown|0|||
147480662|NCT03567291|531917785|FG002|Period III|Missing or unknown|0|||
147480663|NCT03567291|531917786|FG003|Period III|Missing or unknown|8|||
147480664|NCT03666143|531917787|FG000|Overall Study|Death|158|||
147480665|NCT03666143|531917787|FG000|Overall Study|Sponsor Decision|31|||
147480666|NCT03666143|531917787|FG000|Overall Study|Withdrawal by Subject|11|||
147480667|NCT03666143|531917787|FG000|Overall Study|Lost to Follow-up|5|||
147480668|NCT03666143|531917787|FG000|Overall Study|Physician Decision|1|||
147480669|NCT03666143|531917787|FG000|Overall Study|Rolled into extension study|9|||
147480670|NCT03666143|531917787|FG000|Overall Study|Progressive Disease|1|||
147480671|NCT01103349|531917788|FG000|Overall Study|Adverse Event|8|||
147480672|NCT01103349|531917789|FG001|Overall Study|Adverse Event|5|||
147480673|NCT01103349|531917790|FG002|Overall Study|Adverse Event|3|||
147480674|NCT01103349|531917788|FG000|Overall Study|Consent withdrawn|1|||
147480675|NCT01103349|531917789|FG001|Overall Study|Consent withdrawn|0|||
147480676|NCT01103349|531917790|FG002|Overall Study|Consent withdrawn|0|||
147480677|NCT01103349|531917788|FG000|Overall Study|Incorrectly included in the trial|1|||
147480678|NCT01103349|531917789|FG001|Overall Study|Incorrectly included in the trial|0|||
147480679|NCT01103349|531917790|FG002|Overall Study|Incorrectly included in the trial|0|||
147480680|NCT01103349|531917788|FG000|Overall Study|Withdrawal by Subject|1|||
147480681|NCT01103349|531917789|FG001|Overall Study|Withdrawal by Subject|1|||
147480682|NCT01103349|531917790|FG002|Overall Study|Withdrawal by Subject|0|||
147480683|NCT01103349|531917788|FG000|Overall Study|did not want to take trial medication|0|||
147480684|NCT01103349|531917789|FG001|Overall Study|did not want to take trial medication|1|||
147480685|NCT01103349|531917790|FG002|Overall Study|did not want to take trial medication|0|||
147480686|NCT01103349|531917788|FG000|Overall Study|forgot to take medication|0|||
147480687|NCT01103349|531917789|FG001|Overall Study|forgot to take medication|0|||
147480688|NCT01103349|531917790|FG002|Overall Study|forgot to take medication|1|||
147480689|NCT00958568|531917792|FG000|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|80|||
147480690|NCT00958568|531917793|FG001|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|0|||
147480691|NCT00958568|531917794|FG002|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|0|||
147480692|NCT00958568|531917795|FG003|SPII (Wk 0-8, Acute Open-label)|Response Criteria Not Met|0|||
147480693|NCT00958568|531917792|FG000|SPII (Wk 0-8, Acute Open-label)|Adverse Event|44|||
147480694|NCT00958568|531917793|FG001|SPII (Wk 0-8, Acute Open-label)|Adverse Event|0|||
147480695|NCT00958568|531917794|FG002|SPII (Wk 0-8, Acute Open-label)|Adverse Event|0|||
147480696|NCT00958568|531917795|FG003|SPII (Wk 0-8, Acute Open-label)|Adverse Event|0|||
147480697|NCT00958568|531917792|FG000|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|34|||
147480698|NCT00958568|531917793|FG001|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|0|||
147480699|NCT00958568|531917794|FG002|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|0|||
147480700|NCT00958568|531917795|FG003|SPII (Wk 0-8, Acute Open-label)|Entry Criteria Not Met|0|||
147480701|NCT00958568|531917792|FG000|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|39|||
147480702|NCT00958568|531917793|FG001|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|0|||
147480703|NCT00958568|531917794|FG002|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|0|||
147480704|NCT00958568|531917795|FG003|SPII (Wk 0-8, Acute Open-label)|Withdrawal by Subject|0|||
147480705|NCT00958568|531917792|FG000|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|14|||
147480706|NCT00958568|531917793|FG001|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|0|||
147480707|NCT00958568|531917794|FG002|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|0|||
147480708|NCT00958568|531917795|FG003|SPII (Wk 0-8, Acute Open-label)|Lost to Follow-up|0|||
147480709|NCT00958568|531917792|FG000|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|13|||
147480710|NCT00958568|531917793|FG001|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|0|||
147480711|NCT00958568|531917794|FG002|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|0|||
147480712|NCT00958568|531917795|FG003|SPII (Wk 0-8, Acute Open-label)|Protocol Violation|0|||
147480713|NCT00958568|531917792|FG000|SPII (Wk 0-8, Acute Open-label)|Physician Decision|4|||
147480714|NCT00958568|531917793|FG001|SPII (Wk 0-8, Acute Open-label)|Physician Decision|0|||
147480715|NCT00958568|531917794|FG002|SPII (Wk 0-8, Acute Open-label)|Physician Decision|0|||
147480716|NCT00958568|531917795|FG003|SPII (Wk 0-8, Acute Open-label)|Physician Decision|0|||
147480717|NCT00958568|531917792|FG000|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|8|||
147480718|NCT00958568|531917793|FG001|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|0|||
147480719|NCT00958568|531917794|FG002|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|0|||
147480720|NCT00958568|531917795|FG003|SPII (Wk 0-8, Acute Open-label)|Sponsor Decision|0|||
147480721|NCT00958568|531917792|FG000|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|1|||
147480722|NCT00958568|531917793|FG001|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|0|||
147480723|NCT00958568|531917794|FG002|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|0|||
147480724|NCT00958568|531917795|FG003|SPII (Wk 0-8, Acute Open-label)|Unknown, Not Otherwise Specified|0|||
147480725|NCT00958568|531917792|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|0|||
147480726|NCT00958568|531917793|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|62|||
147480727|NCT00958568|531917794|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|0|||
147480728|NCT00958568|531917795|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Stabilization Criteria Not Met|0|||
147480729|NCT00958568|531917792|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|0|||
147480730|NCT00958568|531917793|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|30|||
147480731|NCT00958568|531917794|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|0|||
147480732|NCT00958568|531917795|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Blinded Randomization Criteria Not Met|0|||
147480733|NCT00958568|531917792|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|0|||
147480734|NCT00958568|531917793|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|28|||
147480735|NCT00958568|531917794|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|0|||
147480736|NCT00958568|531917795|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Adverse Event|0|||
147480737|NCT00958568|531917792|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|0|||
147480738|NCT00958568|531917793|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|41|||
147480739|NCT00958568|531917794|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|0|||
147480740|NCT00958568|531917795|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Withdrawal by Subject|0|||
147480741|NCT00958568|531917792|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|0|||
147480742|NCT00958568|531917793|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|24|||
147480743|NCT00958568|531917794|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|0|||
147667402|NCT01462942|532608054|FG002|Overall Study|Other, including COPD exacerbation|2|||
147667403|NCT01462942|532608055|FG003|Overall Study|Other, including COPD exacerbation|8|||
147667404|NCT01462942|532608056|FG004|Overall Study|Other, including COPD exacerbation|5|||
147667405|NCT01462942|532608052|FG000|Overall Study|Withdrawal by Subject|14|||
147667406|NCT01462942|532608053|FG001|Overall Study|Withdrawal by Subject|10|||
147667407|NCT01462942|532608054|FG002|Overall Study|Withdrawal by Subject|14|||
147667408|NCT01462942|532608055|FG003|Overall Study|Withdrawal by Subject|16|||
147667409|NCT01462942|532608056|FG004|Overall Study|Withdrawal by Subject|19|||
147667410|NCT01462942|532608052|FG000|Overall Study|Lack of Efficacy|6|||
147667411|NCT01462942|532608053|FG001|Overall Study|Lack of Efficacy|0|||
147667412|NCT01462942|532608054|FG002|Overall Study|Lack of Efficacy|4|||
147667413|NCT01462942|532608055|FG003|Overall Study|Lack of Efficacy|5|||
147667414|NCT01462942|532608056|FG004|Overall Study|Lack of Efficacy|3|||
147667415|NCT01462942|532608052|FG000|Overall Study|Lost to Follow-up|0|||
147667416|NCT01462942|532608053|FG001|Overall Study|Lost to Follow-up|1|||
147667417|NCT01462942|532608054|FG002|Overall Study|Lost to Follow-up|1|||
147667418|NCT01462942|532608055|FG003|Overall Study|Lost to Follow-up|1|||
147667419|NCT01462942|532608056|FG004|Overall Study|Lost to Follow-up|1|||
147667420|NCT01462942|532608052|FG000|Overall Study|Protocol Violation|4|||
147667421|NCT01462942|532608053|FG001|Overall Study|Protocol Violation|6|||
147667422|NCT01462942|532608054|FG002|Overall Study|Protocol Violation|9|||
147667423|NCT01462942|532608055|FG003|Overall Study|Protocol Violation|9|||
147667424|NCT01462942|532608056|FG004|Overall Study|Protocol Violation|6|||
147667425|NCT02737722|532608059|FG000|Overall Study|Physician Decision|0|||
147667426|NCT02737722|532608060|FG001|Overall Study|Physician Decision|0|||
147667427|NCT02737722|532608061|FG002|Overall Study|Physician Decision|1|||
147667428|NCT02737722|532608062|FG003|Overall Study|Physician Decision|0|||
147667429|NCT02662569|532608063|FG000|Overall Study|Withdrawal by Subject|6|||
147667430|NCT02662569|532608064|FG001|Overall Study|Withdrawal by Subject|1|||
147667431|NCT02662569|532608065|FG002|Overall Study|Withdrawal by Subject|6|||
147667432|NCT02662569|532608066|FG003|Overall Study|Withdrawal by Subject|4|||
147667433|NCT02662569|532608063|FG000|Overall Study|Lost to Follow-up|1|||
147667434|NCT02662569|532608064|FG001|Overall Study|Lost to Follow-up|0|||
147667435|NCT02662569|532608065|FG002|Overall Study|Lost to Follow-up|0|||
147667436|NCT02662569|532608066|FG003|Overall Study|Lost to Follow-up|0|||
147667437|NCT02785939|532608074|FG000|Overall Study|Progression|25|||
147667438|NCT02785939|532608075|FG001|Overall Study|Progression|8|||
147667439|NCT02785939|532608074|FG000|Overall Study|Adverse Event|3|||
147667440|NCT02785939|532608075|FG001|Overall Study|Adverse Event|1|||
147667441|NCT02785939|532608074|FG000|Overall Study|Death|1|||
147667442|NCT02785939|532608075|FG001|Overall Study|Death|0|||
147667443|NCT02785939|532608074|FG000|Overall Study|Refusal|1|||
147480744|NCT00958568|531917795|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Protocol Violation|0|||
147480745|NCT00958568|531917792|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|0|||
147480746|NCT00958568|531917793|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|9|||
147480747|NCT00958568|531917794|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|0|||
147480748|NCT00958568|531917795|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Lost to Follow-up|0|||
147480749|NCT00958568|531917792|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|0|||
147480750|NCT00958568|531917793|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|6|||
147480751|NCT00958568|531917794|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|0|||
147480752|NCT00958568|531917795|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Entry Criteria Not Met|0|||
147480753|NCT00958568|531917792|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|0|||
147480754|NCT00958568|531917793|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|5|||
147480755|NCT00958568|531917794|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|0|||
147480756|NCT00958568|531917795|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Sponsor Decision|0|||
147480757|NCT00958568|531917792|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|0|||
147480758|NCT00958568|531917793|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|4|||
147480759|NCT00958568|531917794|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|0|||
147667444|NCT02785939|532608075|FG001|Overall Study|Refusal|0|||
147667445|NCT02785939|532608074|FG000|Overall Study|Deteriorating health|1|||
147667446|NCT02785939|532608075|FG001|Overall Study|Deteriorating health|0|||
147667447|NCT02785939|532608074|FG000|Overall Study|Not protocol specified|0|||
147667448|NCT02785939|532608075|FG001|Overall Study|Not protocol specified|1|||
147667449|NCT01787552|532608078|FG000|Overall Study|Withdrawal by Subject|2|||
147667450|NCT01787552|532608079|FG001|Overall Study|Withdrawal by Subject|0|||
147667451|NCT01787552|532608080|FG002|Overall Study|Withdrawal by Subject|0|||
147667452|NCT01787552|532608081|FG003|Overall Study|Withdrawal by Subject|4|||
147667453|NCT01787552|532608078|FG000|Overall Study|Physician Decision|2|||
147667454|NCT01787552|532608079|FG001|Overall Study|Physician Decision|2|||
147667455|NCT01787552|532608080|FG002|Overall Study|Physician Decision|1|||
147667456|NCT01787552|532608081|FG003|Overall Study|Physician Decision|2|||
147667457|NCT01787552|532608078|FG000|Overall Study|Death|0|||
147667458|NCT01787552|532608079|FG001|Overall Study|Death|0|||
147667459|NCT01787552|532608080|FG002|Overall Study|Death|0|||
147667460|NCT01787552|532608081|FG003|Overall Study|Death|1|||
147480760|NCT00958568|531917795|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Physician Decision|0|||
147480761|NCT00958568|531917792|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|0|||
147480762|NCT00958568|531917793|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|1|||
147480763|NCT00958568|531917794|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|0|||
147480764|NCT00958568|531917795|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Relapse Criteria Met|0|||
147480765|NCT00958568|531917792|FG000|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|0|||
147480766|NCT00958568|531917793|FG001|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|1|||
147480767|NCT00958568|531917794|FG002|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|0|||
147480768|NCT00958568|531917795|FG003|SPIII (Wk 9-20,Open-label Stabilization)|Unknown, Not Otherwise Specified|0|||
147480769|NCT00958568|531917792|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|0|||
147480770|NCT00958568|531917793|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|0|||
147480771|NCT00958568|531917794|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|24|||
147480772|NCT00958568|531917795|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Relapse Criteria Met|63|||
147480773|NCT00958568|531917792|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|0|||
147480774|NCT00958568|531917793|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|0|||
147480775|NCT00958568|531917794|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|19|||
147480776|NCT00958568|531917795|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Adverse Event|10|||
147480777|NCT00958568|531917792|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|0|||
147480778|NCT00958568|531917793|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|0|||
147480779|NCT00958568|531917794|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|16|||
147480780|NCT00958568|531917795|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Withdrawal by Subject|15|||
147480781|NCT00958568|531917792|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|0|||
147480782|NCT00958568|531917793|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|0|||
147480783|NCT00958568|531917794|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|11|||
147480784|NCT00958568|531917795|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Protocol Violation|5|||
147480785|NCT00958568|531917792|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|0|||
147480786|NCT00958568|531917793|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|0|||
147480787|NCT00958568|531917794|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|3|||
147480788|NCT00958568|531917795|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Lost to Follow-up|8|||
147480789|NCT00958568|531917792|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|0|||
147480790|NCT00958568|531917793|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|0|||
147480791|NCT00958568|531917794|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|5|||
147480792|NCT00958568|531917795|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Sponsor Decision|4|||
147480793|NCT00958568|531917792|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|0|||
147480794|NCT00958568|531917793|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|0|||
147480795|NCT00958568|531917794|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|2|||
147480796|NCT00958568|531917795|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Entry Criteria Not Met|1|||
147480797|NCT00958568|531917792|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Death|0|||
147480798|NCT00958568|531917793|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Death|0|||
147480799|NCT00958568|531917794|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Death|1|||
147480800|NCT00958568|531917795|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Death|0|||
147480801|NCT00958568|531917792|FG000|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|0|||
147480802|NCT00958568|531917793|FG001|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|0|||
147480803|NCT00958568|531917794|FG002|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|1|||
147480804|NCT00958568|531917795|FG003|SPIV (Wk 21-47, DB Relapse Prevention)|Physician Decision|0|||
147480805|NCT00283712|531917800|FG000|Overall Study|Death|0|||
147480806|NCT00283712|531917801|FG001|Overall Study|Death|1|||
147480807|NCT04655586|531917813|FG000|Overall Study|Physician Decision|1|||
147480808|NCT04655586|531917814|FG001|Overall Study|Physician Decision|3|||
147480809|NCT04655586|531917815|FG002|Overall Study|Physician Decision|4|||
147480810|NCT04655586|531917813|FG000|Overall Study|Withdrawal by Subject|1|||
147480811|NCT04655586|531917814|FG001|Overall Study|Withdrawal by Subject|3|||
147480812|NCT04655586|531917815|FG002|Overall Study|Withdrawal by Subject|1|||
147480813|NCT00553059|531917820|FG000|Overall Study|Deemed ineligible|1|||
147480814|NCT00553059|531917821|FG001|Overall Study|Deemed ineligible|1|||
147480815|NCT00553059|531917820|FG000|Overall Study|Drug supply not available|0|||
147480816|NCT00553059|531917821|FG001|Overall Study|Drug supply not available|1|||
147480817|NCT01966731|531917822|FG000|Overall Study|Death|2|||
147480818|NCT01966731|531917822|FG000|Overall Study|Lost to Follow-up|1|||
147303215|NCT02173054|531276278|FG001|Overall Study|lack of compliance|0|||
147480819|NCT01966731|531917822|FG000|Overall Study|Physician Decision|2|||
147480820|NCT01966731|531917822|FG000|Overall Study|Follow up is not complete|600|||
147480821|NCT01966731|531917822|FG000|Overall Study|Screening Failure|29|||
147480822|NCT01966731|531917822|FG000|Overall Study|Found to be ineligible|1|||
147480823|NCT01380093|531917823|FG000|Naloxone Challenge Phase|Screen failures|21|||
147480824|NCT01380093|531917824|FG001|Naloxone Challenge Phase|Screen failures|0|||
147480825|NCT01380093|531917825|FG002|Naloxone Challenge Phase|Screen failures|0|||
147480826|NCT01380093|531917826|FG003|Naloxone Challenge Phase|Screen failures|0|||
147480827|NCT01380093|531917827|FG004|Naloxone Challenge Phase|Screen failures|0|||
147480828|NCT01380093|531917828|FG005|Naloxone Challenge Phase|Screen failures|0|||
147480829|NCT01380093|531917829|FG006|Naloxone Challenge Phase|Screen failures|0|||
147480830|NCT01380093|531917830|FG007|Naloxone Challenge Phase|Screen failures|0|||
147480831|NCT01380093|531917831|FG008|Naloxone Challenge Phase|Screen failures|0|||
147480832|NCT01380093|531917823|FG000|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
147480833|NCT01380093|531917824|FG001|Drug Discrimination Phase: Day 1|Discrimination failure|1|||
147480834|NCT01380093|531917825|FG002|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
147480835|NCT01380093|531917826|FG003|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
147480836|NCT01380093|531917827|FG004|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
147480837|NCT01380093|531917828|FG005|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
147480838|NCT01380093|531917829|FG006|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
147480839|NCT01380093|531917830|FG007|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
147480840|NCT01380093|531917831|FG008|Drug Discrimination Phase: Day 1|Discrimination failure|0|||
147480841|NCT01380093|531917823|FG000|Drug Discrimination Phase: Day 2|Physician Decision|0|||
147480842|NCT01380093|531917824|FG001|Drug Discrimination Phase: Day 2|Physician Decision|3|||
147480843|NCT01380093|531917825|FG002|Drug Discrimination Phase: Day 2|Physician Decision|1|||
147480844|NCT01380093|531917826|FG003|Drug Discrimination Phase: Day 2|Physician Decision|0|||
147480845|NCT01380093|531917827|FG004|Drug Discrimination Phase: Day 2|Physician Decision|0|||
147480846|NCT01380093|531917828|FG005|Drug Discrimination Phase: Day 2|Physician Decision|0|||
147480847|NCT01380093|531917829|FG006|Drug Discrimination Phase: Day 2|Physician Decision|0|||
147480848|NCT01380093|531917830|FG007|Drug Discrimination Phase: Day 2|Physician Decision|0|||
147480849|NCT01380093|531917831|FG008|Drug Discrimination Phase: Day 2|Physician Decision|0|||
147480850|NCT01380093|531917823|FG000|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
147480851|NCT01380093|531917824|FG001|Drug Discrimination Phase: Day 2|Withdrawal by Subject|1|||
147480852|NCT01380093|531917825|FG002|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
147480853|NCT01380093|531917826|FG003|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
147480854|NCT01380093|531917827|FG004|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
147480855|NCT01380093|531917828|FG005|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
147480856|NCT01380093|531917829|FG006|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
147480857|NCT01380093|531917830|FG007|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
147480858|NCT01380093|531917831|FG008|Drug Discrimination Phase: Day 2|Withdrawal by Subject|0|||
147480859|NCT01380093|531917823|FG000|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
147480860|NCT01380093|531917824|FG001|Drug Discrimination Phase: Day 2|Discrimination failure|4|||
147480861|NCT01380093|531917825|FG002|Drug Discrimination Phase: Day 2|Discrimination failure|9|||
147480862|NCT01380093|531917826|FG003|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
147480863|NCT01380093|531917827|FG004|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
147480864|NCT01380093|531917828|FG005|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
147480865|NCT01380093|531917829|FG006|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
147480866|NCT01380093|531917830|FG007|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
147480867|NCT01380093|531917831|FG008|Drug Discrimination Phase: Day 2|Discrimination failure|0|||
147480868|NCT01380093|531917823|FG000|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
147480869|NCT01380093|531917824|FG001|Drug Discrimination Phase: Day 2|Positive urine drug screen|1|||
147480870|NCT01380093|531917825|FG002|Drug Discrimination Phase: Day 2|Positive urine drug screen|1|||
147480871|NCT01380093|531917826|FG003|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
147480872|NCT01380093|531917827|FG004|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
147480873|NCT01380093|531917828|FG005|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
147480874|NCT01380093|531917829|FG006|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
147480875|NCT01380093|531917830|FG007|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
147480876|NCT01380093|531917831|FG008|Drug Discrimination Phase: Day 2|Positive urine drug screen|0|||
147480877|NCT01380093|531917823|FG000|Drug Discrimination Phase: Day 2|Backup participant|0|||
147480878|NCT01380093|531917824|FG001|Drug Discrimination Phase: Day 2|Backup participant|0|||
147480879|NCT01380093|531917825|FG002|Drug Discrimination Phase: Day 2|Backup participant|1|||
147480880|NCT01380093|531917826|FG003|Drug Discrimination Phase: Day 2|Backup participant|0|||
147480881|NCT01380093|531917827|FG004|Drug Discrimination Phase: Day 2|Backup participant|0|||
147480882|NCT01380093|531917828|FG005|Drug Discrimination Phase: Day 2|Backup participant|0|||
147480883|NCT01380093|531917829|FG006|Drug Discrimination Phase: Day 2|Backup participant|0|||
147480884|NCT01380093|531917830|FG007|Drug Discrimination Phase: Day 2|Backup participant|0|||
147480885|NCT01380093|531917831|FG008|Drug Discrimination Phase: Day 2|Backup participant|0|||
147480886|NCT01380093|531917823|FG000|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
147480887|NCT01380093|531917824|FG001|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
147480888|NCT01380093|531917825|FG002|Drug Discrimination Phase: Day 2|Sponsor decision|1|||
147480889|NCT01380093|531917826|FG003|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
147480890|NCT01380093|531917827|FG004|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
147622868|NCT00485732|532438418|FG000|Overall Study|Withdrawal by Subject|5|||
147622869|NCT00485732|532438419|FG001|Overall Study|Withdrawal by Subject|4|||
147480891|NCT01380093|531917828|FG005|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
147480892|NCT01380093|531917829|FG006|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
147480893|NCT01380093|531917830|FG007|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
147480894|NCT01380093|531917831|FG008|Drug Discrimination Phase: Day 2|Sponsor decision|0|||
147480895|NCT01380093|531917823|FG000|Treatment Phase: Second Intervention|Other|0|||
147480896|NCT01380093|531917824|FG001|Treatment Phase: Second Intervention|Other|0|||
147480897|NCT01380093|531917825|FG002|Treatment Phase: Second Intervention|Other|0|||
147480898|NCT01380093|531917826|FG003|Treatment Phase: Second Intervention|Other|1|||
147480899|NCT01380093|531917827|FG004|Treatment Phase: Second Intervention|Other|0|||
147480900|NCT01380093|531917828|FG005|Treatment Phase: Second Intervention|Other|0|||
147480901|NCT01380093|531917829|FG006|Treatment Phase: Second Intervention|Other|0|||
147480902|NCT01380093|531917830|FG007|Treatment Phase: Second Intervention|Other|0|||
147480903|NCT01380093|531917831|FG008|Treatment Phase: Second Intervention|Other|0|||
147480904|NCT01380093|531917823|FG000|Treatment Phase: Third Intervention|Non-compliance|0|||
147480905|NCT01380093|531917824|FG001|Treatment Phase: Third Intervention|Non-compliance|0|||
147480906|NCT01380093|531917825|FG002|Treatment Phase: Third Intervention|Non-compliance|0|||
147480907|NCT01380093|531917826|FG003|Treatment Phase: Third Intervention|Non-compliance|0|||
147480908|NCT01380093|531917827|FG004|Treatment Phase: Third Intervention|Non-compliance|0|||
147480909|NCT01380093|531917828|FG005|Treatment Phase: Third Intervention|Non-compliance|0|||
147480910|NCT01380093|531917829|FG006|Treatment Phase: Third Intervention|Non-compliance|0|||
147480911|NCT01380093|531917830|FG007|Treatment Phase: Third Intervention|Non-compliance|0|||
147480912|NCT01380093|531917831|FG008|Treatment Phase: Third Intervention|Non-compliance|1|||
147480913|NCT01380093|531917823|FG000|Treatment Phase: Third Intervention|Other|0|||
147480914|NCT01380093|531917824|FG001|Treatment Phase: Third Intervention|Other|0|||
147480915|NCT01380093|531917825|FG002|Treatment Phase: Third Intervention|Other|0|||
147480916|NCT01380093|531917826|FG003|Treatment Phase: Third Intervention|Other|0|||
147480917|NCT01380093|531917827|FG004|Treatment Phase: Third Intervention|Other|0|||
147480918|NCT01380093|531917828|FG005|Treatment Phase: Third Intervention|Other|0|||
147480919|NCT01380093|531917829|FG006|Treatment Phase: Third Intervention|Other|0|||
147480920|NCT01380093|531917830|FG007|Treatment Phase: Third Intervention|Other|0|||
147480921|NCT01380093|531917831|FG008|Treatment Phase: Third Intervention|Other|1|||
147480922|NCT04734873|531917832|FG000|Overall Study|Lost to Follow-up|1|||
147480923|NCT04734873|531917833|FG001|Overall Study|Lost to Follow-up|3|||
147480924|NCT04734873|531917834|FG002|Overall Study|Lost to Follow-up|2|||
147480925|NCT04734873|531917832|FG000|Overall Study|Randomized but not dosed|1|||
147480926|NCT04734873|531917833|FG001|Overall Study|Randomized but not dosed|0|||
147480927|NCT04734873|531917834|FG002|Overall Study|Randomized but not dosed|1|||
147480928|NCT00592683|531917835|FG000|Overall Study|Found ineligible|0|||
147480929|NCT00592683|531917836|FG001|Overall Study|Found ineligible|1|||
147480930|NCT00592683|531917835|FG000|Overall Study|Withdrawal by Subject|1|||
147480931|NCT00592683|531917836|FG001|Overall Study|Withdrawal by Subject|0|||
147480932|NCT00592683|531917835|FG000|Overall Study|Adverse Event|0|||
147480933|NCT00592683|531917836|FG001|Overall Study|Adverse Event|2|||
147480934|NCT00592683|531917835|FG000|Overall Study|Protocol Violation|1|||
147480935|NCT00592683|531917836|FG001|Overall Study|Protocol Violation|0|||
147480936|NCT00592683|531917835|FG000|Overall Study|Study drug expired|1|||
147480937|NCT00592683|531917836|FG001|Overall Study|Study drug expired|0|||
147480938|NCT00592683|531917835|FG000|Overall Study|Other|1|||
147480939|NCT00592683|531917836|FG001|Overall Study|Other|0|||
147480940|NCT00592683|531917835|FG000|Overall Study|Lost to Follow-up|0|||
147480941|NCT00592683|531917836|FG001|Overall Study|Lost to Follow-up|1|||
147480942|NCT00201201|531917837|FG000|Overall Study|Death|0|||
147480943|NCT00201201|531917838|FG001|Overall Study|Death|2|||
147480944|NCT00201201|531917837|FG000|Overall Study|Withdrawal by Subject|5|||
147480945|NCT00201201|531917838|FG001|Overall Study|Withdrawal by Subject|5|||
147480946|NCT00545818|531917843|FG000|Overall Study|Protocol Violation|1|||
147480947|NCT00545818|531917844|FG001|Overall Study|Protocol Violation|0|||
147480948|NCT00545818|531917843|FG000|Overall Study|Adverse Event|1|||
147480949|NCT00545818|531917844|FG001|Overall Study|Adverse Event|1|||
147480950|NCT00545818|531917843|FG000|Overall Study|Lost to Follow-up|1|||
147480951|NCT00545818|531917844|FG001|Overall Study|Lost to Follow-up|6|||
147480952|NCT00609609|531917845|FG000|Overall Study|Withdrawal by Subject|2|||
147480953|NCT00609609|531917846|FG001|Overall Study|Withdrawal by Subject|0|||
147480954|NCT00609609|531917845|FG000|Overall Study|Progression|4|||
147480955|NCT00609609|531917846|FG001|Overall Study|Progression|2|||
147480956|NCT02240628|531917847|FG000|Overall Study|Physician Decision|6|||
147480957|NCT02240628|531917848|FG001|Overall Study|Physician Decision|5|||
147480958|NCT04530825|531917851|FG000|Overall Study|No longer eligible on the day of baseline visit|0|||
147480959|NCT04530825|531917852|FG001|Overall Study|No longer eligible on the day of baseline visit|1|||
147622870|NCT00485732|532438418|FG000|Overall Study|Lost to Follow-up|2|||
147622871|NCT00485732|532438419|FG001|Overall Study|Lost to Follow-up|2|||
147480960|NCT04530825|531917853|FG002|Overall Study|No longer eligible on the day of baseline visit|0|||
147480961|NCT04530825|531917854|FG003|Overall Study|No longer eligible on the day of baseline visit|1|||
147480962|NCT04530825|531917851|FG000|Overall Study|Did not complete follow-up|3|||
147622872|NCT02512302|532438422|FG000|Period 1|Adverse Event|0|||
147480963|NCT04530825|531917852|FG001|Overall Study|Did not complete follow-up|0|||
147480964|NCT04530825|531917853|FG002|Overall Study|Did not complete follow-up|0|||
147480965|NCT04530825|531917854|FG003|Overall Study|Did not complete follow-up|0|||
147480966|NCT04101422|531917856|FG000|Overall Study|Ineligible|1|||
147480967|NCT04101422|531917857|FG001|Overall Study|Ineligible|0|||
147480968|NCT04101422|531917858|FG002|Overall Study|Ineligible|9|||
147480969|NCT04101422|531917859|FG003|Overall Study|Ineligible|0|||
147480970|NCT04101422|531917856|FG000|Overall Study|Withdrawal by Subject|0|||
147480971|NCT04101422|531917857|FG001|Overall Study|Withdrawal by Subject|0|||
147480972|NCT04101422|531917858|FG002|Overall Study|Withdrawal by Subject|1|||
147480973|NCT04101422|531917859|FG003|Overall Study|Withdrawal by Subject|0|||
147480974|NCT04101422|531917856|FG000|Overall Study|Not attending to the stimuli|0|||
147480975|NCT04101422|531917857|FG001|Overall Study|Not attending to the stimuli|0|||
147480976|NCT04101422|531917858|FG002|Overall Study|Not attending to the stimuli|4|||
147480977|NCT04101422|531917859|FG003|Overall Study|Not attending to the stimuli|0|||
147480978|NCT04101422|531917856|FG000|Overall Study|Did not download app|0|||
147480979|NCT04101422|531917857|FG001|Overall Study|Did not download app|0|||
147480980|NCT04101422|531917858|FG002|Overall Study|Did not download app|0|||
147480981|NCT04101422|531917859|FG003|Overall Study|Did not download app|17|||
147480982|NCT04101422|531917856|FG000|Overall Study|Did not use app on 4 or more occasions per protocol|0|||
147480983|NCT04101422|531917857|FG001|Overall Study|Did not use app on 4 or more occasions per protocol|0|||
147480984|NCT04101422|531917858|FG002|Overall Study|Did not use app on 4 or more occasions per protocol|0|||
147480985|NCT04101422|531917859|FG003|Overall Study|Did not use app on 4 or more occasions per protocol|3|||
147480986|NCT00552305|531917860|FG000|Overall Study|Adverse Event|43|||
147480987|NCT00552305|531917860|FG000|Overall Study|Lack of Efficacy|120|||
147480988|NCT00552305|531917860|FG000|Overall Study|Lost to Follow-up|4|||
147480989|NCT00552305|531917860|FG000|Overall Study|Protocol Violation|3|||
147480990|NCT00552305|531917860|FG000|Overall Study|Withdrawal by Subject|44|||
147480991|NCT00552305|531917860|FG000|Overall Study|Lack of efficacy/withdrew consent|1|||
147480992|NCT00552305|531917860|FG000|Overall Study|Lack of efficacy (LoE)/adverse event|3|||
147480993|NCT00552305|531917860|FG000|Overall Study|Adverse event (AE)/withdrew (WD) consent|2|||
147480994|NCT00552305|531917860|FG000|Overall Study|Unsatisfactory compliance|11|||
147480995|NCT00552305|531917860|FG000|Overall Study|Poor compliance/lost to follow-up|1|||
147480996|NCT00552305|531917860|FG000|Overall Study|AE/Other: prohibited drug required|1|||
147480997|NCT00552305|531917860|FG000|Overall Study|LoE/WD consent/Other: cannot make visits|1|||
147480998|NCT00552305|531917860|FG000|Overall Study|Other: Site closed|4|||
147480999|NCT00552305|531917860|FG000|Overall Study|Other: Personal problems|1|||
147481000|NCT00552305|531917860|FG000|Overall Study|Other: Unable to attend visits|1|||
147481001|NCT00552305|531917860|FG000|Overall Study|Other: Subject underwent surgery|4|||
147481002|NCT00552305|531917860|FG000|Overall Study|Other: Subject became pregnant|1|||
147481003|NCT00552305|531917860|FG000|Overall Study|Other: Health problems, not drug related|1|||
147481004|NCT00552305|531917860|FG000|Overall Study|Other: Subject moved from area|2|||
147481005|NCT00552305|531917860|FG000|Overall Study|Other: Subject incarcerated|1|||
147481006|NCT00552305|531917860|FG000|Overall Study|Other: Subject went to rehab|1|||
147481007|NCT04983901|531917863|FG000|Overall Study|Death|1|||
147481008|NCT04983901|531917864|FG001|Overall Study|Death|4|||
147481009|NCT04983901|531917863|FG000|Overall Study|Lost to Follow-up|3|||
147481010|NCT04983901|531917864|FG001|Overall Study|Lost to Follow-up|0|||
147481011|NCT04983901|531917863|FG000|Overall Study|Protocol Violation|1|||
147481012|NCT04983901|531917864|FG001|Overall Study|Protocol Violation|0|||
147481013|NCT04983901|531917863|FG000|Overall Study|Withdrawal by Subject|1|||
147481014|NCT04983901|531917864|FG001|Overall Study|Withdrawal by Subject|2|||
147481015|NCT01174784|531917865|FG000|Overall Study|Screen fails|4|||
147481016|NCT01671488|531917866|FG000|Overall Study|Withdrawal by Subject|1|||
147481017|NCT01457339|531917871|FG000|Period 3 (100 mg)|Adverse Event|0|||
147481018|NCT01457339|531917872|FG001|Period 3 (100 mg)|Adverse Event|1|||
147481019|NCT01457339|531917871|FG000|Period 5 (200 mg)|Met stopping criteria for PANSS score|0|||
147622873|NCT02512302|532438423|FG001|Period 1|Adverse Event|1|||
147622874|NCT02512302|532438424|FG002|Period 1|Adverse Event|0|||
147622875|NCT02512302|532438425|FG003|Period 1|Adverse Event|0|||
147622876|NCT02512302|532438426|FG004|Period 1|Adverse Event|0|||
147481020|NCT01457339|531917872|FG001|Period 5 (200 mg)|Met stopping criteria for PANSS score|1|||
147481021|NCT01457339|531917871|FG000|Period 6 (250 mg)|Family Emergency|1|||
147481022|NCT01457339|531917872|FG001|Period 6 (250 mg)|Family Emergency|0|||
147481023|NCT01457339|531917871|FG000|Period 6 (250 mg)|Personal appointment|0|||
147481024|NCT01457339|531917872|FG001|Period 6 (250 mg)|Personal appointment|1|||
147481025|NCT01164501|531917875|FG000|Overall Study|Not treated|2|||
147481026|NCT01164501|531917876|FG001|Overall Study|Not treated|0|||
147622877|NCT02512302|532438427|FG005|Period 1|Adverse Event|0|||
147481027|NCT01164501|531917877|FG002|Overall Study|Not treated|1|||
147481028|NCT01164501|531917875|FG000|Overall Study|Adverse Event|18|||
147481029|NCT01164501|531917876|FG001|Overall Study|Adverse Event|4|||
147481030|NCT01164501|531917877|FG002|Overall Study|Adverse Event|21|||
147481031|NCT01164501|531917875|FG000|Overall Study|Lack of Efficacy|0|||
147622878|NCT02512302|532438428|FG006|Period 1|Adverse Event|0|||
147622879|NCT02512302|532438429|FG007|Period 1|Adverse Event|0|||
147622880|NCT02512302|532438430|FG008|Period 1|Adverse Event|0|||
147622881|NCT02512302|532438431|FG009|Period 1|Adverse Event|0|||
147622882|NCT02512302|532438422|FG000|Period 2|Adverse Event|0|||
147622883|NCT02512302|532438423|FG001|Period 2|Adverse Event|0|||
147622884|NCT02512302|532438424|FG002|Period 2|Adverse Event|0|||
147481032|NCT01164501|531917876|FG001|Overall Study|Lack of Efficacy|0|||
147481033|NCT01164501|531917877|FG002|Overall Study|Lack of Efficacy|1|||
147481034|NCT01164501|531917875|FG000|Overall Study|Non compliant with protocol|1|||
147481035|NCT01164501|531917876|FG001|Overall Study|Non compliant with protocol|1|||
147481036|NCT01164501|531917877|FG002|Overall Study|Non compliant with protocol|4|||
147481037|NCT01164501|531917875|FG000|Overall Study|Lost to Follow-up|3|||
147481038|NCT01164501|531917876|FG001|Overall Study|Lost to Follow-up|0|||
147481039|NCT01164501|531917877|FG002|Overall Study|Lost to Follow-up|3|||
147481040|NCT01164501|531917875|FG000|Overall Study|Patient refusal to continue,not due toAE|10|||
147481041|NCT01164501|531917876|FG001|Overall Study|Patient refusal to continue,not due toAE|4|||
147481042|NCT01164501|531917877|FG002|Overall Study|Patient refusal to continue,not due toAE|8|||
147481043|NCT01164501|531917875|FG000|Overall Study|Other reason not defined above|9|||
147481044|NCT01164501|531917876|FG001|Overall Study|Other reason not defined above|1|||
147481045|NCT01164501|531917877|FG002|Overall Study|Other reason not defined above|4|||
147481046|NCT01096667|531917879|FG000|Overall Study|Lost to Follow-up|1|||
147481047|NCT01096667|531917880|FG001|Overall Study|Lost to Follow-up|1|||
147481048|NCT01096667|531917881|FG002|Overall Study|Lost to Follow-up|1|||
147481049|NCT01096667|531917882|FG003|Overall Study|Lost to Follow-up|0|||
147481050|NCT01096667|531917883|FG004|Overall Study|Lost to Follow-up|0|||
147481051|NCT01096667|531917879|FG000|Overall Study|Withdrawal by Subject|1|||
147481052|NCT01096667|531917880|FG001|Overall Study|Withdrawal by Subject|0|||
147481053|NCT01096667|531917881|FG002|Overall Study|Withdrawal by Subject|0|||
147481054|NCT01096667|531917882|FG003|Overall Study|Withdrawal by Subject|1|||
147481055|NCT01096667|531917883|FG004|Overall Study|Withdrawal by Subject|0|||
147481056|NCT01096667|531917879|FG000|Overall Study|Reason not available|0|||
147481057|NCT01096667|531917880|FG001|Overall Study|Reason not available|1|||
147481058|NCT01096667|531917881|FG002|Overall Study|Reason not available|1|||
147481059|NCT01096667|531917882|FG003|Overall Study|Reason not available|1|||
147481060|NCT01096667|531917883|FG004|Overall Study|Reason not available|0|||
147481061|NCT01096667|531917879|FG000|Overall Study|Protocol Violation|0|||
147481062|NCT01096667|531917880|FG001|Overall Study|Protocol Violation|0|||
147481063|NCT01096667|531917881|FG002|Overall Study|Protocol Violation|0|||
147481064|NCT01096667|531917882|FG003|Overall Study|Protocol Violation|1|||
147481065|NCT01096667|531917883|FG004|Overall Study|Protocol Violation|0|||
147481066|NCT01096667|531917879|FG000|Overall Study|Not treated|1|||
147481067|NCT01096667|531917880|FG001|Overall Study|Not treated|0|||
147481068|NCT01096667|531917881|FG002|Overall Study|Not treated|0|||
147481069|NCT01096667|531917882|FG003|Overall Study|Not treated|0|||
147481070|NCT01096667|531917883|FG004|Overall Study|Not treated|0|||
147481071|NCT00408681|531917884|FG000|Overall Study|Lack of Efficacy|2|||
147481072|NCT00408681|531917884|FG000|Overall Study|Adverse Event|7|||
147481073|NCT00447421|531917891|FG000|Overall Study|Lack of Efficacy|1|||
147481074|NCT00447421|531917891|FG000|Overall Study|Adverse Event|3|||
147481075|NCT00447421|531917891|FG000|Overall Study|Sponsor Decision|2|||
147481076|NCT01787591|531917892|FG000|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|0|||
147481077|NCT01787591|531917893|FG001|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|0|||
147481078|NCT01787591|531917894|FG002|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|0|||
147481079|NCT01787591|531917895|FG003|Period 1 (Cross-over Arm 1)|Withdrawal by Subject|1|||
147481080|NCT02725177|531917898|FG000|Overall Study|Physician Decision|4|||
147481081|NCT02725177|531917898|FG000|Overall Study|Adverse Event|1|||
147481082|NCT00377299|531917899|FG000|Overall Study|Lost to Follow-up|14|||
147481083|NCT00377299|531917900|FG001|Overall Study|Lost to Follow-up|19|||
147481084|NCT00377299|531917899|FG000|Overall Study|Adverse Event|0|||
147481085|NCT00377299|531917900|FG001|Overall Study|Adverse Event|1|||
147481086|NCT00377299|531917899|FG000|Overall Study|Withdrawal by Subject|5|||
147481087|NCT00377299|531917900|FG001|Overall Study|Withdrawal by Subject|4|||
147481088|NCT00638846|531917901|FG000|Overall Study|Adverse Event|0|||
147481089|NCT00638846|531917902|FG001|Overall Study|Adverse Event|1|||
147481090|NCT00638846|531917901|FG000|Overall Study|Lost to Follow-up|3|||
147622885|NCT02512302|532438425|FG003|Period 2|Adverse Event|0|||
147481091|NCT00638846|531917902|FG001|Overall Study|Lost to Follow-up|2|||
147481092|NCT00638846|531917901|FG000|Overall Study|lens issue|1|||
147481093|NCT00638846|531917902|FG001|Overall Study|lens issue|3|||
147481094|NCT01507246|531917907|FG000|Overall Study|Required different surgical procedures|2|||
147481095|NCT01507246|531917908|FG001|Overall Study|Required different surgical procedures|1|||
147622886|NCT02512302|532438426|FG004|Period 2|Adverse Event|0|||
147481096|NCT02975349|531917911|FG000|Active Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
147481097|NCT02975349|531917912|FG001|Active Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
147481098|NCT02975349|531917913|FG002|Active Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
147622887|NCT02512302|532438427|FG005|Period 2|Adverse Event|0|||
147622888|NCT02512302|532438428|FG006|Period 2|Adverse Event|0|||
147481099|NCT02975349|531917914|FG003|Active Treatment Period (24 Weeks)|Withdrawal by Subject|3|||
147622889|NCT02512302|532438429|FG007|Period 2|Adverse Event|0|||
147667461|NCT01787552|532608078|FG000|Overall Study|Adverse Event|2|||
147667462|NCT01787552|532608079|FG001|Overall Study|Adverse Event|5|||
147667463|NCT01787552|532608080|FG002|Overall Study|Adverse Event|2|||
147667464|NCT01787552|532608081|FG003|Overall Study|Adverse Event|16|||
147667465|NCT01787552|532608078|FG000|Overall Study|Study terminated by Sponsor|0|||
147667466|NCT01787552|532608079|FG001|Overall Study|Study terminated by Sponsor|0|||
147667467|NCT01787552|532608080|FG002|Overall Study|Study terminated by Sponsor|1|||
147667468|NCT01787552|532608081|FG003|Overall Study|Study terminated by Sponsor|3|||
147667469|NCT01787552|532608078|FG000|Overall Study|Progressive Disease|2|||
147667470|NCT01787552|532608079|FG001|Overall Study|Progressive Disease|2|||
147667471|NCT01787552|532608080|FG002|Overall Study|Progressive Disease|1|||
147667472|NCT01787552|532608081|FG003|Overall Study|Progressive Disease|1|||
147667473|NCT03786380|532608084|FG000|Overall Study|Adverse Event|1|||
147667474|NCT03786380|532608085|FG001|Overall Study|Adverse Event|0|||
147667475|NCT03786380|532608086|FG002|Overall Study|Adverse Event|0|||
147667476|NCT03786380|532608087|FG003|Overall Study|Adverse Event|3|||
147667477|NCT03786380|532608088|FG004|Overall Study|Adverse Event|1|||
147667478|NCT03786380|532608084|FG000|Overall Study|Lack of Efficacy|0|||
147667479|NCT03786380|532608085|FG001|Overall Study|Lack of Efficacy|0|||
147667480|NCT03786380|532608086|FG002|Overall Study|Lack of Efficacy|0|||
147667481|NCT03786380|532608087|FG003|Overall Study|Lack of Efficacy|0|||
147667482|NCT03786380|532608088|FG004|Overall Study|Lack of Efficacy|1|||
147667483|NCT03786380|532608084|FG000|Overall Study|Withdrawal by Subject|1|||
147667484|NCT03786380|532608085|FG001|Overall Study|Withdrawal by Subject|2|||
147667485|NCT03786380|532608086|FG002|Overall Study|Withdrawal by Subject|2|||
147667486|NCT03786380|532608087|FG003|Overall Study|Withdrawal by Subject|1|||
147667487|NCT03786380|532608088|FG004|Overall Study|Withdrawal by Subject|2|||
147667488|NCT03786380|532608084|FG000|Overall Study|Lost to Follow-up|3|||
147667489|NCT03786380|532608085|FG001|Overall Study|Lost to Follow-up|0|||
147667490|NCT03786380|532608086|FG002|Overall Study|Lost to Follow-up|1|||
147667491|NCT03786380|532608087|FG003|Overall Study|Lost to Follow-up|2|||
147667492|NCT03786380|532608088|FG004|Overall Study|Lost to Follow-up|0|||
147667493|NCT03786380|532608084|FG000|Overall Study|Physician Decision|0|||
147667494|NCT03786380|532608085|FG001|Overall Study|Physician Decision|0|||
147667495|NCT03786380|532608086|FG002|Overall Study|Physician Decision|1|||
147667496|NCT03786380|532608087|FG003|Overall Study|Physician Decision|0|||
147667497|NCT03786380|532608088|FG004|Overall Study|Physician Decision|0|||
147667498|NCT03786380|532608084|FG000|Overall Study|Study Terminated by the Sponsor|30|||
147667499|NCT03786380|532608085|FG001|Overall Study|Study Terminated by the Sponsor|20|||
147667500|NCT03786380|532608086|FG002|Overall Study|Study Terminated by the Sponsor|50|||
147667501|NCT03786380|532608087|FG003|Overall Study|Study Terminated by the Sponsor|57|||
147667502|NCT03786380|532608088|FG004|Overall Study|Study Terminated by the Sponsor|23|||
147667503|NCT03786380|532608084|FG000|Overall Study|Reason Not Specified|0|||
147667504|NCT03786380|532608085|FG001|Overall Study|Reason Not Specified|0|||
147667505|NCT03786380|532608086|FG002|Overall Study|Reason Not Specified|0|||
147667506|NCT03786380|532608087|FG003|Overall Study|Reason Not Specified|0|||
147667507|NCT03786380|532608088|FG004|Overall Study|Reason Not Specified|1|||
147667508|NCT00423046|532608093|FG000|Overall Study|Other|340|||
147667509|NCT00423046|532608094|FG001|Overall Study|Other|345|||
147667510|NCT01791595|532608095|FG000|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|1|||
147481100|NCT02975349|531917915|FG004|Active Treatment Period (24 Weeks)|Withdrawal by Subject|3|||
147481101|NCT02975349|531917916|FG005|Active Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
147481102|NCT02975349|531917917|FG006|Active Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
147481103|NCT02975349|531917911|FG000|Active Treatment Period (24 Weeks)|Lost to Follow-up|1|||
147481104|NCT02975349|531917912|FG001|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
147481105|NCT02975349|531917913|FG002|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
147667511|NCT01791595|532608096|FG001|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
147667512|NCT01791595|532608097|FG002|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
147481106|NCT02975349|531917914|FG003|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
147481107|NCT02975349|531917915|FG004|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
147481108|NCT02975349|531917916|FG005|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
147667513|NCT01791595|532608098|FG003|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
147667514|NCT01791595|532608099|FG004|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
147667515|NCT01791595|532608100|FG005|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
147667516|NCT01791595|532608101|FG006|Part 1 AZD3965 Cohort 1 (5 mg OD)|Death|0|||
147667517|NCT01791595|532608095|FG000|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|2|||
147667518|NCT01791595|532608096|FG001|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
147667519|NCT01791595|532608097|FG002|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
147667520|NCT01791595|532608098|FG003|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
147667521|NCT01791595|532608099|FG004|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
147667522|NCT01791595|532608100|FG005|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
147667523|NCT01791595|532608101|FG006|Part 1 AZD3965 Cohort 1 (5 mg OD)|Evidence of disease progression|0|||
147667524|NCT01791595|532608095|FG000|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
147667525|NCT01791595|532608096|FG001|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|5|||
147622890|NCT02512302|532438430|FG008|Period 2|Adverse Event|0|||
147622891|NCT02512302|532438431|FG009|Period 2|Adverse Event|1|||
147622892|NCT02512302|532438422|FG000|Period 3|Lost to Follow-up|0|||
147622893|NCT02512302|532438423|FG001|Period 3|Lost to Follow-up|0|||
147622894|NCT02512302|532438424|FG002|Period 3|Lost to Follow-up|1|||
147622895|NCT02512302|532438425|FG003|Period 3|Lost to Follow-up|0|||
147622896|NCT02512302|532438426|FG004|Period 3|Lost to Follow-up|0|||
147622897|NCT02512302|532438427|FG005|Period 3|Lost to Follow-up|0|||
147622898|NCT02512302|532438428|FG006|Period 3|Lost to Follow-up|0|||
147622899|NCT02512302|532438429|FG007|Period 3|Lost to Follow-up|0|||
147622900|NCT02512302|532438430|FG008|Period 3|Lost to Follow-up|0|||
147622901|NCT02512302|532438431|FG009|Period 3|Lost to Follow-up|0|||
147622902|NCT02512302|532438422|FG000|Period 4|Adverse Event|0|||
147622903|NCT02512302|532438423|FG001|Period 4|Adverse Event|0|||
147622904|NCT02512302|532438424|FG002|Period 4|Adverse Event|0|||
147622905|NCT02512302|532438425|FG003|Period 4|Adverse Event|0|||
147622906|NCT02512302|532438426|FG004|Period 4|Adverse Event|0|||
147622907|NCT02512302|532438427|FG005|Period 4|Adverse Event|0|||
147622908|NCT02512302|532438428|FG006|Period 4|Adverse Event|1|||
147481109|NCT02975349|531917917|FG006|Active Treatment Period (24 Weeks)|Lost to Follow-up|0|||
147481110|NCT02975349|531917911|FG000|Active Treatment Period (24 Weeks)|Adverse Event|4|||
147481111|NCT02975349|531917912|FG001|Active Treatment Period (24 Weeks)|Adverse Event|0|||
147481112|NCT02975349|531917913|FG002|Active Treatment Period (24 Weeks)|Adverse Event|0|||
147481113|NCT02975349|531917914|FG003|Active Treatment Period (24 Weeks)|Adverse Event|2|||
147481114|NCT02975349|531917915|FG004|Active Treatment Period (24 Weeks)|Adverse Event|2|||
147481115|NCT02975349|531917916|FG005|Active Treatment Period (24 Weeks)|Adverse Event|6|||
147481116|NCT02975349|531917917|FG006|Active Treatment Period (24 Weeks)|Adverse Event|2|||
147481117|NCT02975349|531917911|FG000|Blinded Extension Period (24 Weeks)|Adverse Event|0|||
147481118|NCT02975349|531917912|FG001|Blinded Extension Period (24 Weeks)|Adverse Event|1|||
147481119|NCT02975349|531917913|FG002|Blinded Extension Period (24 Weeks)|Adverse Event|0|||
147481120|NCT02975349|531917914|FG003|Blinded Extension Period (24 Weeks)|Adverse Event|1|||
147481121|NCT02975349|531917915|FG004|Blinded Extension Period (24 Weeks)|Adverse Event|3|||
147481122|NCT02975349|531917916|FG005|Blinded Extension Period (24 Weeks)|Adverse Event|1|||
147481123|NCT02975349|531917917|FG006|Blinded Extension Period (24 Weeks)|Adverse Event|0|||
147481124|NCT02975349|531917911|FG000|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|0|||
147481125|NCT02975349|531917912|FG001|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|5|||
147481126|NCT02975349|531917913|FG002|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|0|||
147481127|NCT02975349|531917914|FG003|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|2|||
147481128|NCT02975349|531917915|FG004|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|1|||
147481129|NCT02975349|531917916|FG005|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|1|||
147481130|NCT02975349|531917917|FG006|Blinded Extension Period (24 Weeks)|Withdrawal by Subject|0|||
147481131|NCT02975349|531917911|FG000|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
147481132|NCT02975349|531917912|FG001|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
147481133|NCT02975349|531917913|FG002|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
147481134|NCT02975349|531917914|FG003|Blinded Extension Period (24 Weeks)|Lack of Efficacy|1|||
147481135|NCT02975349|531917915|FG004|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
147481136|NCT02975349|531917916|FG005|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
147481137|NCT02975349|531917917|FG006|Blinded Extension Period (24 Weeks)|Lack of Efficacy|0|||
147481138|NCT02975349|531917911|FG000|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
147481139|NCT02975349|531917912|FG001|Blinded Extension Period (24 Weeks)|Progressive Disease|1|||
147481140|NCT02975349|531917913|FG002|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
147481141|NCT02975349|531917914|FG003|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
147481142|NCT02975349|531917915|FG004|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
147481143|NCT02975349|531917916|FG005|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
147481144|NCT02975349|531917917|FG006|Blinded Extension Period (24 Weeks)|Progressive Disease|0|||
147481145|NCT02975349|531917911|FG000|Open-label Extension Period (336 Weeks)|Adverse Event|0|||
147481146|NCT02975349|531917912|FG001|Open-label Extension Period (336 Weeks)|Adverse Event|0|||
147481147|NCT02975349|531917913|FG002|Open-label Extension Period (336 Weeks)|Adverse Event|3|||
147481148|NCT02975349|531917914|FG003|Open-label Extension Period (336 Weeks)|Adverse Event|2|||
147481149|NCT02975349|531917915|FG004|Open-label Extension Period (336 Weeks)|Adverse Event|2|||
147481150|NCT02975349|531917916|FG005|Open-label Extension Period (336 Weeks)|Adverse Event|1|||
147481151|NCT02975349|531917917|FG006|Open-label Extension Period (336 Weeks)|Adverse Event|2|||
147481152|NCT02975349|531917911|FG000|Open-label Extension Period (336 Weeks)|Study reached its predefined end|0|||
147622909|NCT02512302|532438429|FG007|Period 4|Adverse Event|0|||
147622910|NCT02512302|532438430|FG008|Period 4|Adverse Event|0|||
147622911|NCT02512302|532438431|FG009|Period 4|Adverse Event|0|||
147622912|NCT04067050|532438432|FG000|One Month|Lost to Follow-up|4|||
147622913|NCT04067050|532438433|FG001|One Month|Lost to Follow-up|0|||
147622914|NCT04067050|532438432|FG000|Two Month|Lost to Follow-up|1|||
147622915|NCT04067050|532438433|FG001|Two Month|Lost to Follow-up|0|||
147622916|NCT04067050|532438432|FG000|Two Month|Adverse Event|1|||
147622917|NCT04067050|532438433|FG001|Two Month|Adverse Event|0|||
147622918|NCT02342678|532438441|FG000|Overall Study|Lost to Follow-up|0|||
147481153|NCT02975349|531917912|FG001|Open-label Extension Period (336 Weeks)|Study reached its predefined end|0|||
147481154|NCT02975349|531917913|FG002|Open-label Extension Period (336 Weeks)|Study reached its predefined end|0|||
147481155|NCT02975349|531917914|FG003|Open-label Extension Period (336 Weeks)|Study reached its predefined end|0|||
147481156|NCT02975349|531917915|FG004|Open-label Extension Period (336 Weeks)|Study reached its predefined end|1|||
147481157|NCT02975349|531917916|FG005|Open-label Extension Period (336 Weeks)|Study reached its predefined end|0|||
147481158|NCT02975349|531917917|FG006|Open-label Extension Period (336 Weeks)|Study reached its predefined end|0|||
147481159|NCT02975349|531917911|FG000|Open-label Extension Period (336 Weeks)|Lack of Efficacy|0|||
147481160|NCT02975349|531917912|FG001|Open-label Extension Period (336 Weeks)|Lack of Efficacy|0|||
147481161|NCT02975349|531917913|FG002|Open-label Extension Period (336 Weeks)|Lack of Efficacy|0|||
147481162|NCT02975349|531917914|FG003|Open-label Extension Period (336 Weeks)|Lack of Efficacy|0|||
147481163|NCT02975349|531917915|FG004|Open-label Extension Period (336 Weeks)|Lack of Efficacy|2|||
147481164|NCT02975349|531917916|FG005|Open-label Extension Period (336 Weeks)|Lack of Efficacy|0|||
147481165|NCT02975349|531917917|FG006|Open-label Extension Period (336 Weeks)|Lack of Efficacy|1|||
147481166|NCT02975349|531917911|FG000|Open-label Extension Period (336 Weeks)|Death|0|||
147481167|NCT02975349|531917912|FG001|Open-label Extension Period (336 Weeks)|Death|0|||
147481168|NCT02975349|531917913|FG002|Open-label Extension Period (336 Weeks)|Death|0|||
147481169|NCT02975349|531917914|FG003|Open-label Extension Period (336 Weeks)|Death|1|||
147481170|NCT02975349|531917915|FG004|Open-label Extension Period (336 Weeks)|Death|0|||
147481171|NCT02975349|531917916|FG005|Open-label Extension Period (336 Weeks)|Death|0|||
147481172|NCT02975349|531917917|FG006|Open-label Extension Period (336 Weeks)|Death|0|||
147481173|NCT02975349|531917911|FG000|Open-label Extension Period (336 Weeks)|COVID-19 Related|0|||
147481174|NCT02975349|531917912|FG001|Open-label Extension Period (336 Weeks)|COVID-19 Related|0|||
147481175|NCT02975349|531917913|FG002|Open-label Extension Period (336 Weeks)|COVID-19 Related|0|||
147481176|NCT02975349|531917914|FG003|Open-label Extension Period (336 Weeks)|COVID-19 Related|1|||
147481177|NCT02975349|531917915|FG004|Open-label Extension Period (336 Weeks)|COVID-19 Related|1|||
147481178|NCT02975349|531917916|FG005|Open-label Extension Period (336 Weeks)|COVID-19 Related|1|||
147481179|NCT02975349|531917917|FG006|Open-label Extension Period (336 Weeks)|COVID-19 Related|2|||
147481180|NCT02975349|531917911|FG000|Open-label Extension Period (336 Weeks)|Lost to Follow-up|0|||
147481181|NCT02975349|531917912|FG001|Open-label Extension Period (336 Weeks)|Lost to Follow-up|0|||
147481182|NCT02975349|531917913|FG002|Open-label Extension Period (336 Weeks)|Lost to Follow-up|1|||
147481183|NCT02975349|531917914|FG003|Open-label Extension Period (336 Weeks)|Lost to Follow-up|0|||
147481184|NCT02975349|531917915|FG004|Open-label Extension Period (336 Weeks)|Lost to Follow-up|0|||
147481185|NCT02975349|531917916|FG005|Open-label Extension Period (336 Weeks)|Lost to Follow-up|1|||
147481186|NCT02975349|531917917|FG006|Open-label Extension Period (336 Weeks)|Lost to Follow-up|0|||
147481187|NCT02975349|531917911|FG000|Open-label Extension Period (336 Weeks)|Other|0|||
147481188|NCT02975349|531917912|FG001|Open-label Extension Period (336 Weeks)|Other|0|||
147481189|NCT02975349|531917913|FG002|Open-label Extension Period (336 Weeks)|Other|3|||
147481190|NCT02975349|531917914|FG003|Open-label Extension Period (336 Weeks)|Other|3|||
147481191|NCT02975349|531917915|FG004|Open-label Extension Period (336 Weeks)|Other|1|||
147481192|NCT02975349|531917916|FG005|Open-label Extension Period (336 Weeks)|Other|2|||
147481193|NCT02975349|531917917|FG006|Open-label Extension Period (336 Weeks)|Other|3|||
147481194|NCT02975349|531917911|FG000|Open-label Extension Period (336 Weeks)|Withdrawal by Subject|0|||
147481195|NCT02975349|531917912|FG001|Open-label Extension Period (336 Weeks)|Withdrawal by Subject|0|||
147481196|NCT02975349|531917913|FG002|Open-label Extension Period (336 Weeks)|Withdrawal by Subject|4|||
147481197|NCT02975349|531917914|FG003|Open-label Extension Period (336 Weeks)|Withdrawal by Subject|7|||
147481198|NCT02975349|531917915|FG004|Open-label Extension Period (336 Weeks)|Withdrawal by Subject|2|||
147481199|NCT02975349|531917916|FG005|Open-label Extension Period (336 Weeks)|Withdrawal by Subject|4|||
147481200|NCT02975349|531917917|FG006|Open-label Extension Period (336 Weeks)|Withdrawal by Subject|2|||
147481201|NCT03825042|531919389|FG000|Overall Study|Adverse Event|1|||
147481202|NCT03825042|531919390|FG001|Overall Study|Adverse Event|0|||
147481203|NCT03825042|531919389|FG000|Overall Study|Withdrawal by Subject|1|||
147481204|NCT03825042|531919390|FG001|Overall Study|Withdrawal by Subject|0|||
147481205|NCT01158534|531919391|FG000|Overall Study|Withdrawal by Subject|1|||
147481206|NCT01158534|531919391|FG000|Overall Study|Death|1|||
147481207|NCT01158534|531919391|FG000|Overall Study|Other|1|||
147481208|NCT01058369|531919392|FG000|Overall Study|Adverse Event|1|||
147481209|NCT01058369|531919392|FG000|Overall Study|Early termination study|1|||
147481210|NCT04003155|531919393|FG000|Double-Blind (DB) Period (12 Weeks)|Adverse Event|9|||
147481211|NCT04003155|531919394|FG001|Double-Blind (DB) Period (12 Weeks)|Adverse Event|8|||
147481212|NCT04003155|531919395|FG002|Double-Blind (DB) Period (12 Weeks)|Adverse Event|5|||
147481213|NCT04003155|531919396|FG003|Double-Blind (DB) Period (12 Weeks)|Adverse Event|0|||
147481214|NCT04003155|531919397|FG004|Double-Blind (DB) Period (12 Weeks)|Adverse Event|0|||
147481215|NCT04003155|531919393|FG000|Double-Blind (DB) Period (12 Weeks)|Lost to Follow-up|3|||
147622919|NCT02342678|532438442|FG001|Overall Study|Lost to Follow-up|1|||
147622920|NCT02342678|532438441|FG000|Overall Study|Too busy to complete study|0|||
147622921|NCT02342678|532438442|FG001|Overall Study|Too busy to complete study|2|||
147622922|NCT02342678|532438441|FG000|Overall Study|Family illness/emergency|0|||
147622923|NCT02342678|532438442|FG001|Overall Study|Family illness/emergency|1|||
147481216|NCT04003155|531919394|FG001|Double-Blind (DB) Period (12 Weeks)|Lost to Follow-up|4|||
147481217|NCT04003155|531919395|FG002|Double-Blind (DB) Period (12 Weeks)|Lost to Follow-up|0|||
147481218|NCT04003155|531919396|FG003|Double-Blind (DB) Period (12 Weeks)|Lost to Follow-up|0|||
147481219|NCT04003155|531919397|FG004|Double-Blind (DB) Period (12 Weeks)|Lost to Follow-up|0|||
147481220|NCT04003155|531919393|FG000|Double-Blind (DB) Period (12 Weeks)|Protocol Violation|1|||
147481221|NCT04003155|531919394|FG001|Double-Blind (DB) Period (12 Weeks)|Protocol Violation|3|||
147481222|NCT04003155|531919395|FG002|Double-Blind (DB) Period (12 Weeks)|Protocol Violation|3|||
147481223|NCT04003155|531919396|FG003|Double-Blind (DB) Period (12 Weeks)|Protocol Violation|0|||
147481224|NCT04003155|531919397|FG004|Double-Blind (DB) Period (12 Weeks)|Protocol Violation|0|||
147481225|NCT04003155|531919393|FG000|Double-Blind (DB) Period (12 Weeks)|Withdrawal by Subject|9|||
147481226|NCT04003155|531919394|FG001|Double-Blind (DB) Period (12 Weeks)|Withdrawal by Subject|12|||
147481227|NCT04003155|531919395|FG002|Double-Blind (DB) Period (12 Weeks)|Withdrawal by Subject|4|||
147481228|NCT04003155|531919396|FG003|Double-Blind (DB) Period (12 Weeks)|Withdrawal by Subject|0|||
147481229|NCT04003155|531919397|FG004|Double-Blind (DB) Period (12 Weeks)|Withdrawal by Subject|0|||
147481230|NCT04003155|531919393|FG000|Double-Blind (DB) Period (12 Weeks)|Miscellaneous|1|||
147481231|NCT04003155|531919394|FG001|Double-Blind (DB) Period (12 Weeks)|Miscellaneous|7|||
147481232|NCT04003155|531919395|FG002|Double-Blind (DB) Period (12 Weeks)|Miscellaneous|3|||
147481233|NCT04003155|531919396|FG003|Double-Blind (DB) Period (12 Weeks)|Miscellaneous|0|||
147481234|NCT04003155|531919397|FG004|Double-Blind (DB) Period (12 Weeks)|Miscellaneous|0|||
147481235|NCT04003155|531919393|FG000|Extension Period (EP) (40 Weeks)|Adverse Event|0|||
147481236|NCT04003155|531919394|FG001|Extension Period (EP) (40 Weeks)|Adverse Event|5|||
147481237|NCT04003155|531919395|FG002|Extension Period (EP) (40 Weeks)|Adverse Event|4|||
147481238|NCT04003155|531919396|FG003|Extension Period (EP) (40 Weeks)|Adverse Event|2|||
147481239|NCT04003155|531919397|FG004|Extension Period (EP) (40 Weeks)|Adverse Event|2|||
147481240|NCT04003155|531919393|FG000|Extension Period (EP) (40 Weeks)|Lost to Follow-up|0|||
147481241|NCT04003155|531919394|FG001|Extension Period (EP) (40 Weeks)|Lost to Follow-up|1|||
147481242|NCT04003155|531919395|FG002|Extension Period (EP) (40 Weeks)|Lost to Follow-up|3|||
147481243|NCT04003155|531919396|FG003|Extension Period (EP) (40 Weeks)|Lost to Follow-up|1|||
147481244|NCT04003155|531919397|FG004|Extension Period (EP) (40 Weeks)|Lost to Follow-up|1|||
147481245|NCT04003155|531919393|FG000|Extension Period (EP) (40 Weeks)|Withdrawal by Subject|0|||
147481246|NCT04003155|531919394|FG001|Extension Period (EP) (40 Weeks)|Withdrawal by Subject|12|||
147481247|NCT04003155|531919395|FG002|Extension Period (EP) (40 Weeks)|Withdrawal by Subject|7|||
147481248|NCT04003155|531919396|FG003|Extension Period (EP) (40 Weeks)|Withdrawal by Subject|9|||
147481249|NCT04003155|531919397|FG004|Extension Period (EP) (40 Weeks)|Withdrawal by Subject|5|||
147481250|NCT04003155|531919393|FG000|Extension Period (EP) (40 Weeks)|Miscellaneous|0|||
147481251|NCT04003155|531919394|FG001|Extension Period (EP) (40 Weeks)|Miscellaneous|0|||
147481252|NCT04003155|531919395|FG002|Extension Period (EP) (40 Weeks)|Miscellaneous|1|||
147481253|NCT04003155|531919396|FG003|Extension Period (EP) (40 Weeks)|Miscellaneous|2|||
147481254|NCT04003155|531919397|FG004|Extension Period (EP) (40 Weeks)|Miscellaneous|1|||
147481255|NCT03042611|531919398|FG000|Core Phase|Withdrawal by Subject|13|||
147481256|NCT03042611|531919399|FG001|Core Phase|Withdrawal by Subject|4|||
147481257|NCT03042611|531919400|FG002|Core Phase|Withdrawal by Subject|0|||
147481258|NCT03042611|531919401|FG003|Core Phase|Withdrawal by Subject|0|||
147481259|NCT03042611|531919398|FG000|Core Phase|Death|232|||
147481260|NCT03042611|531919399|FG001|Core Phase|Death|110|||
147481261|NCT03042611|531919400|FG002|Core Phase|Death|0|||
147481262|NCT03042611|531919401|FG003|Core Phase|Death|0|||
147481263|NCT03042611|531919398|FG000|Core Phase|Lost to Follow-up|4|||
147481264|NCT03042611|531919399|FG001|Core Phase|Lost to Follow-up|7|||
147481265|NCT03042611|531919400|FG002|Core Phase|Lost to Follow-up|0|||
147481266|NCT03042611|531919401|FG003|Core Phase|Lost to Follow-up|0|||
147481267|NCT03042611|531919398|FG000|Core Phase|Physician Decision|7|||
147481268|NCT03042611|531919399|FG001|Core Phase|Physician Decision|2|||
147481269|NCT03042611|531919400|FG002|Core Phase|Physician Decision|0|||
147481270|NCT03042611|531919401|FG003|Core Phase|Physician Decision|0|||
147481271|NCT03042611|531919398|FG000|Core Phase|Study Closed|0|||
147481272|NCT03042611|531919399|FG001|Core Phase|Study Closed|1|||
147481273|NCT03042611|531919400|FG002|Core Phase|Study Closed|0|||
147481274|NCT03042611|531919401|FG003|Core Phase|Study Closed|0|||
147481275|NCT03042611|531919398|FG000|Extension Phase|Death|0|||
147481276|NCT03042611|531919399|FG001|Extension Phase|Death|0|||
147481277|NCT03042611|531919400|FG002|Extension Phase|Death|34|||
147481278|NCT03042611|531919401|FG003|Extension Phase|Death|16|||
147481279|NCT03042611|531919398|FG000|Extension Phase|Lost to Follow-up|0|||
147481280|NCT03042611|531919399|FG001|Extension Phase|Lost to Follow-up|0|||
147481281|NCT03042611|531919400|FG002|Extension Phase|Lost to Follow-up|1|||
147481282|NCT03042611|531919401|FG003|Extension Phase|Lost to Follow-up|1|||
147481283|NCT03042611|531919398|FG000|Extension Phase|Study Closed|0|||
147481284|NCT03042611|531919399|FG001|Extension Phase|Study Closed|0|||
147481285|NCT03042611|531919400|FG002|Extension Phase|Study Closed|17|||
147481286|NCT03042611|531919401|FG003|Extension Phase|Study Closed|11|||
147481287|NCT00950690|531919403|FG000|Overall Study|Death|4|||
147481288|NCT00950690|531919403|FG000|Overall Study|Adverse Event|15|||
147481289|NCT00950690|531919403|FG000|Overall Study|Lack of Efficacy|22|||
147481290|NCT00950690|531919403|FG000|Overall Study|Lost to Follow-up|40|||
147481291|NCT00950690|531919403|FG000|Overall Study|Other|163|||
147481292|NCT00092547|531919404|FG000|Base Vaccine Phase (Day 1 to Month 7)|Not Vaccinated|5|||
147481293|NCT00092547|531919405|FG001|Base Vaccine Phase (Day 1 to Month 7)|Not Vaccinated|1|||
147481294|NCT00092547|531919406|FG002|Base Vaccine Phase (Day 1 to Month 7)|Not Vaccinated|0|||
147481295|NCT00092547|531919404|FG000|Base Vaccine Phase (Day 1 to Month 7)|Adverse Event|4|||
147481296|NCT00092547|531919405|FG001|Base Vaccine Phase (Day 1 to Month 7)|Adverse Event|1|||
147481297|NCT00092547|531919406|FG002|Base Vaccine Phase (Day 1 to Month 7)|Adverse Event|0|||
147481298|NCT00092547|531919404|FG000|Base Vaccine Phase (Day 1 to Month 7)|Lost to Follow-up|18|||
147481299|NCT00092547|531919405|FG001|Base Vaccine Phase (Day 1 to Month 7)|Lost to Follow-up|7|||
147481300|NCT00092547|531919406|FG002|Base Vaccine Phase (Day 1 to Month 7)|Lost to Follow-up|0|||
147481301|NCT00092547|531919404|FG000|Base Vaccine Phase (Day 1 to Month 7)|Withdrawal by Subject|28|||
147481302|NCT00092547|531919405|FG001|Base Vaccine Phase (Day 1 to Month 7)|Withdrawal by Subject|21|||
147481303|NCT00092547|531919406|FG002|Base Vaccine Phase (Day 1 to Month 7)|Withdrawal by Subject|0|||
147622924|NCT02342678|532438441|FG000|Overall Study|Illness/medical reason|1|||
147622925|NCT02342678|532438442|FG001|Overall Study|Illness/medical reason|1|||
147622926|NCT00460603|532438443|FG000|Phase 1|Death|1|||
147622927|NCT00460603|532438444|FG001|Phase 1|Death|0|||
147622928|NCT00460603|532438445|FG002|Phase 1|Death|0|||
147622929|NCT00460603|532438446|FG003|Phase 1|Death|2|||
147622930|NCT00460603|532438447|FG004|Phase 1|Death|0|||
147622931|NCT00460603|532438448|FG005|Phase 1|Death|0|||
147622932|NCT00460603|532438449|FG006|Phase 1|Death|0|||
147622933|NCT00460603|532438450|FG007|Phase 1|Death|0|||
147622934|NCT00460603|532438451|FG008|Phase 1|Death|1|||
147622935|NCT00460603|532438452|FG009|Phase 1|Death|0|||
147622936|NCT00460603|532438453|FG010|Phase 1|Death|0|||
147622937|NCT00460603|532438454|FG011|Phase 1|Death|0|||
147622938|NCT00460603|532438443|FG000|Phase 1|Adverse Event|3|||
147622939|NCT00460603|532438444|FG001|Phase 1|Adverse Event|1|||
147622940|NCT00460603|532438445|FG002|Phase 1|Adverse Event|1|||
147622941|NCT00460603|532438446|FG003|Phase 1|Adverse Event|2|||
147622942|NCT00460603|532438447|FG004|Phase 1|Adverse Event|0|||
147622943|NCT00460603|532438448|FG005|Phase 1|Adverse Event|0|||
147622944|NCT00460603|532438449|FG006|Phase 1|Adverse Event|3|||
147622945|NCT00460603|532438450|FG007|Phase 1|Adverse Event|0|||
147622946|NCT00460603|532438451|FG008|Phase 1|Adverse Event|4|||
147622947|NCT00460603|532438452|FG009|Phase 1|Adverse Event|0|||
147622948|NCT00460603|532438453|FG010|Phase 1|Adverse Event|0|||
147622949|NCT00460603|532438454|FG011|Phase 1|Adverse Event|0|||
147622950|NCT00460603|532438443|FG000|Phase 1|Lack of Efficacy|1|||
147622951|NCT00460603|532438444|FG001|Phase 1|Lack of Efficacy|0|||
147622952|NCT00460603|532438445|FG002|Phase 1|Lack of Efficacy|1|||
147622953|NCT00460603|532438446|FG003|Phase 1|Lack of Efficacy|2|||
147622954|NCT00460603|532438447|FG004|Phase 1|Lack of Efficacy|2|||
147622955|NCT00460603|532438448|FG005|Phase 1|Lack of Efficacy|2|||
147622956|NCT00460603|532438449|FG006|Phase 1|Lack of Efficacy|2|||
147622957|NCT00460603|532438450|FG007|Phase 1|Lack of Efficacy|2|||
147622958|NCT00460603|532438451|FG008|Phase 1|Lack of Efficacy|11|||
147622959|NCT00460603|532438452|FG009|Phase 1|Lack of Efficacy|0|||
147622960|NCT00460603|532438453|FG010|Phase 1|Lack of Efficacy|0|||
147622961|NCT00460603|532438454|FG011|Phase 1|Lack of Efficacy|0|||
147622962|NCT00460603|532438443|FG000|Phase 1|Withdrawal by Subject|1|||
147622963|NCT00460603|532438444|FG001|Phase 1|Withdrawal by Subject|2|||
147622964|NCT00460603|532438445|FG002|Phase 1|Withdrawal by Subject|1|||
147622965|NCT00460603|532438446|FG003|Phase 1|Withdrawal by Subject|1|||
147622966|NCT00460603|532438447|FG004|Phase 1|Withdrawal by Subject|3|||
147622967|NCT00460603|532438448|FG005|Phase 1|Withdrawal by Subject|0|||
147481304|NCT00092547|531919404|FG000|Base Vaccine Phase (Day 1 to Month 7)|Moved|3|||
147481305|NCT00092547|531919405|FG001|Base Vaccine Phase (Day 1 to Month 7)|Moved|1|||
147481306|NCT00092547|531919406|FG002|Base Vaccine Phase (Day 1 to Month 7)|Moved|0|||
147481307|NCT00092547|531919404|FG000|Base Vaccine Phase (Day 1 to Month 7)|per sponsor request: (noncompliant)|0|||
147622968|NCT00460603|532438449|FG006|Phase 1|Withdrawal by Subject|1|||
147622969|NCT00460603|532438450|FG007|Phase 1|Withdrawal by Subject|0|||
147622970|NCT00460603|532438451|FG008|Phase 1|Withdrawal by Subject|2|||
147622971|NCT00460603|532438452|FG009|Phase 1|Withdrawal by Subject|0|||
147622972|NCT00460603|532438453|FG010|Phase 1|Withdrawal by Subject|0|||
147622973|NCT00460603|532438454|FG011|Phase 1|Withdrawal by Subject|0|||
147622974|NCT00460603|532438443|FG000|Phase 1|Other|0|||
147622975|NCT00460603|532438444|FG001|Phase 1|Other|3|||
147622976|NCT00460603|532438445|FG002|Phase 1|Other|1|||
147622977|NCT00460603|532438446|FG003|Phase 1|Other|1|||
147622978|NCT00460603|532438447|FG004|Phase 1|Other|1|||
147622979|NCT00460603|532438448|FG005|Phase 1|Other|2|||
147622980|NCT00460603|532438449|FG006|Phase 1|Other|0|||
147622981|NCT00460603|532438450|FG007|Phase 1|Other|1|||
147622982|NCT00460603|532438451|FG008|Phase 1|Other|0|||
147622983|NCT00460603|532438452|FG009|Phase 1|Other|0|||
147622984|NCT00460603|532438453|FG010|Phase 1|Other|0|||
147622985|NCT00460603|532438454|FG011|Phase 1|Other|0|||
147622986|NCT00460603|532438443|FG000|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
147622987|NCT00460603|532438444|FG001|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
147481308|NCT00092547|531919405|FG001|Base Vaccine Phase (Day 1 to Month 7)|per sponsor request: (noncompliant)|1|||
147481309|NCT00092547|531919406|FG002|Base Vaccine Phase (Day 1 to Month 7)|per sponsor request: (noncompliant)|0|||
147481310|NCT00092547|531919404|FG000|Base Vaccine Phase (Day 1 to Month 7)|Did not meet local regulations|0|||
147481311|NCT00092547|531919405|FG001|Base Vaccine Phase (Day 1 to Month 7)|Did not meet local regulations|1|||
147481312|NCT00092547|531919406|FG002|Base Vaccine Phase (Day 1 to Month 7)|Did not meet local regulations|0|||
147481313|NCT00092547|531919404|FG000|Base Vaccine Phase (Day 1 to Month 7)|Refused Vaccination|5|||
147481314|NCT00092547|531919405|FG001|Base Vaccine Phase (Day 1 to Month 7)|Refused Vaccination|3|||
147481315|NCT00092547|531919406|FG002|Base Vaccine Phase (Day 1 to Month 7)|Refused Vaccination|0|||
147481316|NCT00092547|531919404|FG000|Base Follow-up Phase (Month 7 to 18)|Subject moved|1|||
147481317|NCT00092547|531919405|FG001|Base Follow-up Phase (Month 7 to 18)|Subject moved|5|||
147481318|NCT00092547|531919406|FG002|Base Follow-up Phase (Month 7 to 18)|Subject moved|0|||
147481319|NCT00092547|531919404|FG000|Base Follow-up Phase (Month 7 to 18)|Withdrawal by Subject|4|||
147481320|NCT00092547|531919405|FG001|Base Follow-up Phase (Month 7 to 18)|Withdrawal by Subject|2|||
147481321|NCT00092547|531919406|FG002|Base Follow-up Phase (Month 7 to 18)|Withdrawal by Subject|0|||
147481322|NCT00092547|531919404|FG000|Base Follow-up Phase (Month 7 to 18)|Lost to Follow-up|13|||
147481323|NCT00092547|531919405|FG001|Base Follow-up Phase (Month 7 to 18)|Lost to Follow-up|7|||
147481324|NCT00092547|531919406|FG002|Base Follow-up Phase (Month 7 to 18)|Lost to Follow-up|0|||
147481325|NCT00092547|531919404|FG000|Base Follow-up Phase (Month 7 to 18)|Protocol Violation|1|||
147481326|NCT00092547|531919405|FG001|Base Follow-up Phase (Month 7 to 18)|Protocol Violation|0|||
147481327|NCT00092547|531919406|FG002|Base Follow-up Phase (Month 7 to 18)|Protocol Violation|0|||
147481328|NCT00092547|531919404|FG000|Base Follow-up Phase (Month 7 to 18)|Physician Decision|1|||
147481329|NCT00092547|531919405|FG001|Base Follow-up Phase (Month 7 to 18)|Physician Decision|0|||
147481330|NCT00092547|531919406|FG002|Base Follow-up Phase (Month 7 to 18)|Physician Decision|0|||
147481331|NCT00092547|531919404|FG000|Base Follow-up Phase (Month 18 to 30)|Subject moved|4|||
147481332|NCT00092547|531919405|FG001|Base Follow-up Phase (Month 18 to 30)|Subject moved|2|||
147481333|NCT00092547|531919406|FG002|Base Follow-up Phase (Month 18 to 30)|Subject moved|0|||
147481334|NCT00092547|531919404|FG000|Base Follow-up Phase (Month 18 to 30)|Withdrawal by Subject|1|||
147481335|NCT00092547|531919405|FG001|Base Follow-up Phase (Month 18 to 30)|Withdrawal by Subject|3|||
147481336|NCT00092547|531919406|FG002|Base Follow-up Phase (Month 18 to 30)|Withdrawal by Subject|0|||
147481337|NCT00092547|531919404|FG000|Base Follow-up Phase (Month 18 to 30)|Lost to Follow-up|2|||
147481338|NCT00092547|531919405|FG001|Base Follow-up Phase (Month 18 to 30)|Lost to Follow-up|0|||
147481339|NCT00092547|531919406|FG002|Base Follow-up Phase (Month 18 to 30)|Lost to Follow-up|0|||
147481340|NCT00092547|531919404|FG000|Base Follow-up Phase (Month 18 to 30)|Protocol Violation|1|||
147481341|NCT00092547|531919405|FG001|Base Follow-up Phase (Month 18 to 30)|Protocol Violation|0|||
147481342|NCT00092547|531919406|FG002|Base Follow-up Phase (Month 18 to 30)|Protocol Violation|0|||
147481343|NCT00092547|531919404|FG000|Extension Vaccine Phase (Month 30 to 37)|Subject moved|3|||
147481344|NCT00092547|531919405|FG001|Extension Vaccine Phase (Month 30 to 37)|Subject moved|0|||
147481345|NCT00092547|531919406|FG002|Extension Vaccine Phase (Month 30 to 37)|Subject moved|0|||
147481346|NCT00092547|531919404|FG000|Extension Vaccine Phase (Month 30 to 37)|Withdrawal by Subject|6|||
147481347|NCT00092547|531919405|FG001|Extension Vaccine Phase (Month 30 to 37)|Withdrawal by Subject|0|||
147481348|NCT00092547|531919406|FG002|Extension Vaccine Phase (Month 30 to 37)|Withdrawal by Subject|9|||
147481349|NCT00092547|531919404|FG000|Extension Vaccine Phase (Month 30 to 37)|Lost to Follow-up|14|||
147481350|NCT00092547|531919405|FG001|Extension Vaccine Phase (Month 30 to 37)|Lost to Follow-up|0|||
147481351|NCT00092547|531919406|FG002|Extension Vaccine Phase (Month 30 to 37)|Lost to Follow-up|7|||
147481352|NCT00092547|531919404|FG000|Long-term Follow-up (Month 42 Visit)|Adverse Event|1|||
147481353|NCT00092547|531919405|FG001|Long-term Follow-up (Month 42 Visit)|Adverse Event|0|||
147481354|NCT00092547|531919406|FG002|Long-term Follow-up (Month 42 Visit)|Adverse Event|0|||
147481355|NCT00084682|531919407|FG000|Overall Study|Withdrawal by Subject|1|||
147481356|NCT01013883|531919409|FG000|Overall Study|Lost to Follow-up|2|||
147481357|NCT01013883|531919410|FG001|Overall Study|Lost to Follow-up|2|||
147481358|NCT01371838|531919411|FG000|Overall Study|Withdrawal by Subject|27|||
147481359|NCT01371838|531919412|FG001|Overall Study|Withdrawal by Subject|33|||
147481360|NCT01371838|531919411|FG000|Overall Study|Lost to Follow-up|10|||
147481361|NCT01371838|531919412|FG001|Overall Study|Lost to Follow-up|20|||
147481362|NCT01371838|531919411|FG000|Overall Study|Death|3|||
147481363|NCT01371838|531919412|FG001|Overall Study|Death|4|||
147481364|NCT01371838|531919411|FG000|Overall Study|Protocol Violation|3|||
147481365|NCT01371838|531919412|FG001|Overall Study|Protocol Violation|0|||
147481366|NCT01371838|531919411|FG000|Overall Study|Investigator Decision|3|||
147481367|NCT01371838|531919412|FG001|Overall Study|Investigator Decision|8|||
147481368|NCT01371838|531919411|FG000|Overall Study|Last follow-up visit not conducted|2|||
147481369|NCT01371838|531919412|FG001|Overall Study|Last follow-up visit not conducted|0|||
147481370|NCT01371838|531919411|FG000|Overall Study|Lack of therapeutic response|0|||
147481371|NCT01371838|531919412|FG001|Overall Study|Lack of therapeutic response|1|||
147481372|NCT01371838|531919411|FG000|Overall Study|Surgery|1|||
147481373|NCT01371838|531919412|FG001|Overall Study|Surgery|0|||
147481374|NCT00641043|531919419|FG000|Overall Study|Adverse Event|6|||
147481375|NCT00641043|531919420|FG001|Overall Study|Adverse Event|4|||
147481376|NCT00641043|531919419|FG000|Overall Study|Protocol Violation|2|||
147481377|NCT00641043|531919420|FG001|Overall Study|Protocol Violation|3|||
147481378|NCT00641043|531919419|FG000|Overall Study|Lost to Follow-up|3|||
147481379|NCT00641043|531919420|FG001|Overall Study|Lost to Follow-up|2|||
147481380|NCT00641043|531919419|FG000|Overall Study|Withdrawal by Subject|4|||
147481381|NCT00641043|531919420|FG001|Overall Study|Withdrawal by Subject|4|||
147481382|NCT00641043|531919419|FG000|Overall Study|Other incl. lack of efficacy|4|||
147481383|NCT00641043|531919420|FG001|Overall Study|Other incl. lack of efficacy|2|||
147481384|NCT02805907|531919423|FG000|Overall Study|Lost to Follow-up|3|||
147481385|NCT02805907|531919424|FG001|Overall Study|Lost to Follow-up|3|||
147481386|NCT02416908|531919435|FG000|Dose Escalation Phase|Adverse Event|0|||
147481387|NCT02416908|531919436|FG001|Dose Escalation Phase|Adverse Event|0|||
147481388|NCT02416908|531919437|FG002|Dose Escalation Phase|Adverse Event|3|||
147481389|NCT02416908|531919438|FG003|Dose Escalation Phase|Adverse Event|0|||
147481390|NCT02416908|531919435|FG000|Dose Escalation Phase|Withdrawal by Subject|0|||
147481391|NCT02416908|531919436|FG001|Dose Escalation Phase|Withdrawal by Subject|0|||
147481392|NCT02416908|531919437|FG002|Dose Escalation Phase|Withdrawal by Subject|1|||
147481393|NCT02416908|531919438|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
147481394|NCT01214434|531919441|FG000|Overall Study|Withdrawal by Subject|1|||
147481395|NCT01214434|531919442|FG001|Overall Study|Withdrawal by Subject|0|||
147481396|NCT01214434|531919441|FG000|Overall Study|Lost to Follow-up|2|||
147481397|NCT01214434|531919442|FG001|Overall Study|Lost to Follow-up|2|||
147481398|NCT01214434|531919441|FG000|Overall Study|Site error|1|||
147481399|NCT01214434|531919442|FG001|Overall Study|Site error|0|||
147481400|NCT01651052|531919444|FG000|Overall Study|Death|21|||
147481401|NCT01651052|531919444|FG000|Overall Study|Explant|1|||
147481402|NCT01651052|531919444|FG000|Overall Study|Withdrawal by Subject|1|||
147481403|NCT01651052|531919444|FG000|Overall Study|Lost to Follow-up|3|||
147481404|NCT03503773|531919445|FG000|Overall Study|Not receiving bilateral treatment or an unsuccessful procedure|0|||
147481405|NCT03503773|531919446|FG001|Overall Study|Not receiving bilateral treatment or an unsuccessful procedure|2|||
147481406|NCT03503773|531919445|FG000|Overall Study|Receiving antihypertensive medications prior to evaluation of the primary ABPM|8|||
147481407|NCT03503773|531919446|FG001|Overall Study|Receiving antihypertensive medications prior to evaluation of the primary ABPM|4|||
147481408|NCT03503773|531919445|FG000|Overall Study|Not completing the primary ABPM|3|||
147481409|NCT03503773|531919446|FG001|Overall Study|Not completing the primary ABPM|1|||
147481410|NCT03503773|531919445|FG000|Overall Study|Not meeting inclusion/exclusion criteria|1|||
147481411|NCT03503773|531919446|FG001|Overall Study|Not meeting inclusion/exclusion criteria|0|||
147481412|NCT00425438|531919450|FG000|Overall Study|Termination by Sponsor|25|||
147481413|NCT00425438|531919451|FG001|Overall Study|Termination by Sponsor|27|||
147481414|NCT02285010|531919454|FG000|Overall Study|not abdominal hysterectomy|2|||
147481415|NCT02285010|531919455|FG001|Overall Study|not abdominal hysterectomy|0|||
147481416|NCT02285010|531919454|FG000|Overall Study|Not spinal anesthesia|3|||
147481417|NCT02285010|531919455|FG001|Overall Study|Not spinal anesthesia|1|||
147481418|NCT02902809|531919456|FG000|Overall Study|Discontinuation of asthma program|28|||
147481419|NCT00532259|531919457|FG000|Overall Study|Withdrawal by Subject|2|||
147481420|NCT00532259|531919457|FG000|Overall Study|Adverse Event|1|||
147481421|NCT00532259|531919457|FG000|Overall Study|Death|1|||
147481422|NCT00532259|531919457|FG000|Overall Study|Lack of Efficacy|21|||
147481423|NCT00532259|531919457|FG000|Overall Study|Lost to Follow-up|3|||
147481424|NCT00532259|531919457|FG000|Overall Study|Physician Decision|3|||
147481425|NCT00532259|531919457|FG000|Overall Study|Protocol Violation|1|||
147481426|NCT04983940|531919458|FG000|Overall Study|Lost to Follow-up|14|||
147481427|NCT04983940|531919458|FG000|Overall Study|Lack of Efficacy|2|||
147481428|NCT04156646|531919462|FG000|Treatment Period 3 (6 Days)|Withdrawal by Subject|0|||
147481429|NCT04156646|531919463|FG001|Treatment Period 3 (6 Days)|Withdrawal by Subject|1|||
147481430|NCT01208181|531919466|FG000|Part 1|Withdrawal by Subject|11|||
147481431|NCT01208181|531919467|FG001|Part 1|Withdrawal by Subject|10|||
147481432|NCT01208181|531919468|FG002|Part 1|Withdrawal by Subject|0|||
147481433|NCT01208181|531919469|FG003|Part 1|Withdrawal by Subject|0|||
147481434|NCT01208181|531919470|FG004|Part 1|Withdrawal by Subject|0|||
147481435|NCT01208181|531919466|FG000|Part 1|Technical problem|5|||
147481436|NCT01208181|531919467|FG001|Part 1|Technical problem|0|||
147481437|NCT01208181|531919468|FG002|Part 1|Technical problem|0|||
147481438|NCT01208181|531919469|FG003|Part 1|Technical problem|0|||
147481439|NCT01208181|531919470|FG004|Part 1|Technical problem|0|||
147481440|NCT01208181|531919466|FG000|Part 1|Protocol Violation|10|||
147481441|NCT01208181|531919467|FG001|Part 1|Protocol Violation|5|||
147481442|NCT01208181|531919468|FG002|Part 1|Protocol Violation|0|||
147481443|NCT01208181|531919469|FG003|Part 1|Protocol Violation|0|||
147481444|NCT01208181|531919470|FG004|Part 1|Protocol Violation|0|||
147481445|NCT01208181|531919466|FG000|Part 1|Physician Decision|4|||
147481446|NCT01208181|531919467|FG001|Part 1|Physician Decision|0|||
147481447|NCT01208181|531919468|FG002|Part 1|Physician Decision|0|||
147481448|NCT01208181|531919469|FG003|Part 1|Physician Decision|0|||
147481449|NCT01208181|531919470|FG004|Part 1|Physician Decision|0|||
147481450|NCT01208181|531919466|FG000|Part 1|Non-compliance with study drug|1|||
147481451|NCT01208181|531919467|FG001|Part 1|Non-compliance with study drug|1|||
147481452|NCT01208181|531919468|FG002|Part 1|Non-compliance with study drug|0|||
147481453|NCT01208181|531919469|FG003|Part 1|Non-compliance with study drug|0|||
147481454|NCT01208181|531919470|FG004|Part 1|Non-compliance with study drug|0|||
147481455|NCT01208181|531919466|FG000|Part 1|Lost to Follow-up|5|||
147481456|NCT01208181|531919467|FG001|Part 1|Lost to Follow-up|3|||
147481457|NCT01208181|531919468|FG002|Part 1|Lost to Follow-up|0|||
147481458|NCT01208181|531919469|FG003|Part 1|Lost to Follow-up|0|||
147481459|NCT01208181|531919470|FG004|Part 1|Lost to Follow-up|1|||
147481460|NCT01208181|531919466|FG000|Part 1|Lack of Efficacy|37|||
147481461|NCT01208181|531919467|FG001|Part 1|Lack of Efficacy|12|||
147481462|NCT01208181|531919468|FG002|Part 1|Lack of Efficacy|0|||
147481463|NCT01208181|531919469|FG003|Part 1|Lack of Efficacy|0|||
147481464|NCT01208181|531919470|FG004|Part 1|Lack of Efficacy|17|||
147481465|NCT01208181|531919466|FG000|Part 1|Adverse Event|26|||
147481466|NCT01208181|531919467|FG001|Part 1|Adverse Event|24|||
147481467|NCT01208181|531919468|FG002|Part 1|Adverse Event|0|||
147481468|NCT01208181|531919469|FG003|Part 1|Adverse Event|0|||
147481469|NCT01208181|531919470|FG004|Part 1|Adverse Event|4|||
147481470|NCT01208181|531919466|FG000|Part 2|Adverse Event|0|||
147481471|NCT01208181|531919467|FG001|Part 2|Adverse Event|0|||
147481472|NCT01208181|531919468|FG002|Part 2|Adverse Event|6|||
147481473|NCT01208181|531919469|FG003|Part 2|Adverse Event|7|||
147481474|NCT01208181|531919470|FG004|Part 2|Adverse Event|0|||
147481475|NCT01208181|531919466|FG000|Part 2|Withdrawal by Subject|0|||
147481476|NCT01208181|531919467|FG001|Part 2|Withdrawal by Subject|0|||
147481477|NCT01208181|531919468|FG002|Part 2|Withdrawal by Subject|1|||
147481478|NCT01208181|531919469|FG003|Part 2|Withdrawal by Subject|1|||
147481479|NCT01208181|531919470|FG004|Part 2|Withdrawal by Subject|0|||
147481480|NCT01208181|531919466|FG000|Part 2|Protocol Violation|0|||
147481481|NCT01208181|531919467|FG001|Part 2|Protocol Violation|0|||
147481482|NCT01208181|531919468|FG002|Part 2|Protocol Violation|1|||
147481483|NCT01208181|531919469|FG003|Part 2|Protocol Violation|0|||
147481484|NCT01208181|531919470|FG004|Part 2|Protocol Violation|0|||
147481485|NCT01208181|531919466|FG000|Part 2|Physician Decision|0|||
147481486|NCT01208181|531919467|FG001|Part 2|Physician Decision|0|||
147481487|NCT01208181|531919468|FG002|Part 2|Physician Decision|1|||
147481488|NCT01208181|531919469|FG003|Part 2|Physician Decision|2|||
147481489|NCT01208181|531919470|FG004|Part 2|Physician Decision|0|||
147481490|NCT01208181|531919466|FG000|Part 2|Non-compliance with study drug|0|||
147481491|NCT01208181|531919467|FG001|Part 2|Non-compliance with study drug|0|||
147481492|NCT01208181|531919468|FG002|Part 2|Non-compliance with study drug|1|||
147481493|NCT01208181|531919469|FG003|Part 2|Non-compliance with study drug|1|||
147481494|NCT01208181|531919470|FG004|Part 2|Non-compliance with study drug|0|||
147481495|NCT01208181|531919466|FG000|Part 2|Lost to Follow-up|0|||
147481496|NCT01208181|531919467|FG001|Part 2|Lost to Follow-up|0|||
147481497|NCT01208181|531919468|FG002|Part 2|Lost to Follow-up|1|||
147481498|NCT01208181|531919469|FG003|Part 2|Lost to Follow-up|2|||
147481499|NCT01208181|531919470|FG004|Part 2|Lost to Follow-up|0|||
147481500|NCT01208181|531919466|FG000|Part 2|Lack of Efficacy|0|||
147481501|NCT01208181|531919467|FG001|Part 2|Lack of Efficacy|0|||
147481502|NCT01208181|531919468|FG002|Part 2|Lack of Efficacy|5|||
147481503|NCT01208181|531919469|FG003|Part 2|Lack of Efficacy|7|||
147481504|NCT01208181|531919470|FG004|Part 2|Lack of Efficacy|0|||
147622988|NCT00460603|532438445|FG002|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
147622989|NCT00460603|532438446|FG003|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
147622990|NCT00460603|532438447|FG004|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
147622991|NCT00460603|532438448|FG005|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
147622992|NCT00460603|532438449|FG006|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
147622993|NCT00460603|532438450|FG007|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
147481505|NCT01478347|531919472|FG000|Visit 1-Visit 3 (Day 0-91) - Part I|Lost to Follow-up|1|||
147481506|NCT01478347|531919472|FG000|Visit 4-Visit 7 (Day 151-331) - Part II|Lost to Follow-up|4|||
147481507|NCT01478347|531919472|FG000|Visit 4-Visit 7 (Day 151-331) - Part II|Withdrawal by Subject|4|||
147481508|NCT01645930|531919473|FG000|Overall Study|Participants Ongoing on Study Treatment|22|||
147481509|NCT01645930|531919473|FG000|Overall Study|Progressive Disease|12|||
147481510|NCT01645930|531919473|FG000|Overall Study|Adverse Event|4|||
147481511|NCT01645930|531919473|FG000|Overall Study|Unsatisfactory Therapeutic Response|2|||
147481512|NCT01645930|531919473|FG000|Overall Study|Withdrawal by Participant|2|||
147481513|NCT01645930|531919473|FG000|Overall Study|Reason not Defined|1|||
147481514|NCT01845077|531919476|FG000|Washout Period|Lost to Follow-up|0|||
147481515|NCT01845077|531919477|FG001|Washout Period|Lost to Follow-up|1|||
147481516|NCT01845077|531919478|FG002|Washout Period|Lost to Follow-up|0|||
147481517|NCT01845077|531919479|FG003|Washout Period|Lost to Follow-up|1|||
147481518|NCT01845077|531919480|FG004|Washout Period|Lost to Follow-up|0|||
147481519|NCT01845077|531919481|FG005|Washout Period|Lost to Follow-up|1|||
147481520|NCT01845077|531919476|FG000|Washout Period|Adverse Event|1|||
147481521|NCT01845077|531919477|FG001|Washout Period|Adverse Event|0|||
147481522|NCT01845077|531919478|FG002|Washout Period|Adverse Event|0|||
147481523|NCT01845077|531919479|FG003|Washout Period|Adverse Event|0|||
147481524|NCT01845077|531919480|FG004|Washout Period|Adverse Event|0|||
147481525|NCT01845077|531919481|FG005|Washout Period|Adverse Event|0|||
147481526|NCT01845077|531919476|FG000|Washout Period|elevated lab values (not clinic. sign.)|0|||
147481527|NCT01845077|531919477|FG001|Washout Period|elevated lab values (not clinic. sign.)|0|||
147481528|NCT01845077|531919478|FG002|Washout Period|elevated lab values (not clinic. sign.)|1|||
147481529|NCT01845077|531919479|FG003|Washout Period|elevated lab values (not clinic. sign.)|0|||
147481530|NCT01845077|531919480|FG004|Washout Period|elevated lab values (not clinic. sign.)|0|||
147481531|NCT01845077|531919481|FG005|Washout Period|elevated lab values (not clinic. sign.)|0|||
147481532|NCT01845077|531919476|FG000|Washout Period|Protocol Violation|0|||
147481533|NCT01845077|531919477|FG001|Washout Period|Protocol Violation|0|||
147481534|NCT01845077|531919478|FG002|Washout Period|Protocol Violation|0|||
147481535|NCT01845077|531919479|FG003|Washout Period|Protocol Violation|1|||
147481536|NCT01845077|531919480|FG004|Washout Period|Protocol Violation|1|||
147481537|NCT01845077|531919481|FG005|Washout Period|Protocol Violation|0|||
147481538|NCT00394914|531919484|FG000|Treatment Period|Adverse Event|0|||
147481539|NCT00394914|531919485|FG001|Treatment Period|Adverse Event|3|||
147481540|NCT00394914|531919486|FG002|Treatment Period|Adverse Event|1|||
147481541|NCT00394914|531919484|FG000|Treatment Period|Lost to Follow-up|0|||
147481542|NCT00394914|531919485|FG001|Treatment Period|Lost to Follow-up|1|||
147481543|NCT00394914|531919486|FG002|Treatment Period|Lost to Follow-up|0|||
147481544|NCT00394914|531919484|FG000|Treatment Period|Withdrawal by Subject|0|||
147481545|NCT00394914|531919485|FG001|Treatment Period|Withdrawal by Subject|2|||
147481546|NCT00394914|531919486|FG002|Treatment Period|Withdrawal by Subject|2|||
147481547|NCT00394914|531919484|FG000|Treatment Period|Noncompliance with protocol|0|||
147481548|NCT00394914|531919485|FG001|Treatment Period|Noncompliance with protocol|3|||
147481549|NCT00394914|531919486|FG002|Treatment Period|Noncompliance with protocol|2|||
147481550|NCT00394914|531919484|FG000|Treatment Period|Did not meet protocol eligibility|0|||
147481551|NCT00394914|531919485|FG001|Treatment Period|Did not meet protocol eligibility|1|||
147481552|NCT00394914|531919486|FG002|Treatment Period|Did not meet protocol eligibility|1|||
147481553|NCT00312377|531919492|FG000|Overall Study|Death|403|||
147481554|NCT00312377|531919493|FG001|Overall Study|Death|418|||
147481555|NCT00312377|531919492|FG000|Overall Study|Withdrawal by Subject|23|||
147481556|NCT00312377|531919493|FG001|Overall Study|Withdrawal by Subject|30|||
147481557|NCT00312377|531919492|FG000|Overall Study|Lost to Follow-up|9|||
147481558|NCT00312377|531919493|FG001|Overall Study|Lost to Follow-up|12|||
147481559|NCT00312377|531919492|FG000|Overall Study|Non-compliance|0|||
147481560|NCT00312377|531919493|FG001|Overall Study|Non-compliance|2|||
147481561|NCT00312377|531919492|FG000|Overall Study|Randomised but never received treatment|6|||
147481562|NCT00312377|531919493|FG001|Overall Study|Randomised but never received treatment|6|||
147481563|NCT00312377|531919492|FG000|Overall Study|Discontinue treatment survival follow up|202|||
147481564|NCT00312377|531919493|FG001|Overall Study|Discontinue treatment survival follow up|200|||
147481565|NCT00312377|531919492|FG000|Overall Study|Site ended participation in study|1|||
147481566|NCT00312377|531919493|FG001|Overall Study|Site ended participation in study|0|||
147481567|NCT05258058|531919501|FG000|Overall Study|Withdrawal by Subject|2|||
147481568|NCT02179398|531919504|FG000|Overall Study|Lack of obligatory data|3|||
147481569|NCT02179398|531919505|FG001|Overall Study|Lack of obligatory data|3|||
147481570|NCT02179398|531919504|FG000|Overall Study|Lost to Follow-up|0|||
147481571|NCT02179398|531919505|FG001|Overall Study|Lost to Follow-up|1|||
147481572|NCT02519231|531919511|FG000|Overall Study|Lost to Follow-up|2|||
147481573|NCT02519231|531919512|FG001|Overall Study|Lost to Follow-up|5|||
147481574|NCT02519231|531919511|FG000|Overall Study|Withdrawal by Subject|0|||
147481575|NCT02519231|531919512|FG001|Overall Study|Withdrawal by Subject|1|||
147481576|NCT00465738|531919513|FG000|Overall Study|Lost to Follow-up|2|||
147481577|NCT00465738|531919514|FG001|Overall Study|Lost to Follow-up|0|||
147481578|NCT00465738|531919513|FG000|Overall Study|Adverse Event|0|||
147481579|NCT00465738|531919514|FG001|Overall Study|Adverse Event|1|||
147481580|NCT00465738|531919513|FG000|Overall Study|Withdrawal by Subject|2|||
147481581|NCT00465738|531919514|FG001|Overall Study|Withdrawal by Subject|0|||
147481582|NCT00465738|531919513|FG000|Overall Study|Other|2|||
147481583|NCT00465738|531919514|FG001|Overall Study|Other|5|||
147481584|NCT02707757|531919515|FG000|Overall Study|Protocol Violation|3|||
147481585|NCT02707757|531919516|FG001|Overall Study|Protocol Violation|2|||
147481586|NCT02707757|531919515|FG000|Overall Study|Withdrawal by Subject|2|||
147481587|NCT02707757|531919516|FG001|Overall Study|Withdrawal by Subject|0|||
147481588|NCT02707757|531919515|FG000|Overall Study|Death|0|||
147481589|NCT02707757|531919516|FG001|Overall Study|Death|1|||
147481590|NCT02707757|531919515|FG000|Overall Study|Adverse Event|6|||
147481591|NCT02707757|531919516|FG001|Overall Study|Adverse Event|4|||
147481592|NCT02707757|531919515|FG000|Overall Study|Renal transplant/elective operation|1|||
147481593|NCT02707757|531919516|FG001|Overall Study|Renal transplant/elective operation|5|||
147481594|NCT00815308|531919517|FG000|Overall Study|Adverse Event|4|||
147481595|NCT00815308|531919517|FG000|Overall Study|Withdrawal by Subject|0|||
147481596|NCT00815308|531919517|FG000|Overall Study|Protocol Violation|6|||
147481597|NCT00734929|531919518|FG000|Overall Study|Lost to Follow-up|1|||
147481598|NCT00734929|531919519|FG001|Overall Study|Lost to Follow-up|2|||
147481599|NCT00734929|531919518|FG000|Overall Study|No intervention/ screen fail|5|||
147481600|NCT00734929|531919519|FG001|Overall Study|No intervention/ screen fail|3|||
147481601|NCT01318902|531919524|FG000|Overall Study|Symptomatic Deterioration|0|||
147481602|NCT01318902|531919525|FG001|Overall Study|Symptomatic Deterioration|1|||
147481603|NCT01318902|531919526|FG002|Overall Study|Symptomatic Deterioration|1|||
147481604|NCT01318902|531919527|FG003|Overall Study|Symptomatic Deterioration|2|||
147481605|NCT01318902|531919524|FG000|Overall Study|Withdrawal by Patient|0|||
147481606|NCT01318902|531919525|FG001|Overall Study|Withdrawal by Patient|1|||
147481607|NCT01318902|531919526|FG002|Overall Study|Withdrawal by Patient|0|||
147481608|NCT01318902|531919527|FG003|Overall Study|Withdrawal by Patient|3|||
147481609|NCT01318902|531919524|FG000|Overall Study|Unsatisfactory Therapeutic Response|1|||
147481610|NCT01318902|531919525|FG001|Overall Study|Unsatisfactory Therapeutic Response|0|||
147481611|NCT01318902|531919526|FG002|Overall Study|Unsatisfactory Therapeutic Response|0|||
147481612|NCT01318902|531919527|FG003|Overall Study|Unsatisfactory Therapeutic Response|1|||
147481613|NCT01318902|531919524|FG000|Overall Study|Adverse Event|0|||
147481614|NCT01318902|531919525|FG001|Overall Study|Adverse Event|1|||
147481615|NCT01318902|531919526|FG002|Overall Study|Adverse Event|0|||
147481616|NCT01318902|531919527|FG003|Overall Study|Adverse Event|0|||
147481617|NCT01318902|531919524|FG000|Overall Study|Terminated by Sponsor|0|||
147481618|NCT01318902|531919525|FG001|Overall Study|Terminated by Sponsor|0|||
147481619|NCT01318902|531919526|FG002|Overall Study|Terminated by Sponsor|1|||
147481620|NCT01318902|531919527|FG003|Overall Study|Terminated by Sponsor|0|||
147481621|NCT03314519|531921243|FG000|Overall Study|Protocol Violation|3|||
147481622|NCT03314519|531921244|FG001|Overall Study|Protocol Violation|2|||
147481623|NCT01912872|531921245|FG000|Overall Study|Lost to Follow-up|2|||
147481624|NCT01912872|531921246|FG001|Overall Study|Lost to Follow-up|3|||
147481625|NCT01912872|531921247|FG002|Overall Study|Lost to Follow-up|5|||
147481626|NCT01912872|531921248|FG003|Overall Study|Lost to Follow-up|5|||
147481627|NCT01912872|531921245|FG000|Overall Study|Other unspecified|3|||
147481628|NCT01912872|531921246|FG001|Overall Study|Other unspecified|1|||
147481629|NCT01912872|531921247|FG002|Overall Study|Other unspecified|3|||
147481630|NCT01912872|531921248|FG003|Overall Study|Other unspecified|0|||
147481631|NCT01912872|531921245|FG000|Overall Study|Informed consent withdrawn|0|||
147481632|NCT01912872|531921246|FG001|Overall Study|Informed consent withdrawn|0|||
147481633|NCT01912872|531921247|FG002|Overall Study|Informed consent withdrawn|1|||
147481634|NCT01912872|531921248|FG003|Overall Study|Informed consent withdrawn|1|||
147481635|NCT01912872|531921245|FG000|Overall Study|Non-compliance with lab inc/exclusion|0|||
147481636|NCT01912872|531921246|FG001|Overall Study|Non-compliance with lab inc/exclusion|0|||
147481637|NCT01912872|531921247|FG002|Overall Study|Non-compliance with lab inc/exclusion|0|||
147481638|NCT01912872|531921248|FG003|Overall Study|Non-compliance with lab inc/exclusion|1|||
147481639|NCT01912872|531921245|FG000|Overall Study|Protocol Violation|0|||
147481640|NCT01912872|531921246|FG001|Overall Study|Protocol Violation|0|||
147481641|NCT01912872|531921247|FG002|Overall Study|Protocol Violation|1|||
147481642|NCT01912872|531921248|FG003|Overall Study|Protocol Violation|0|||
147481643|NCT01912872|531921245|FG000|Overall Study|Unsatisfactory therapeutic effect|0|||
147481644|NCT01912872|531921246|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
147481645|NCT01912872|531921247|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
147481646|NCT01912872|531921248|FG003|Overall Study|Unsatisfactory therapeutic effect|2|||
147481647|NCT01912872|531921245|FG000|Overall Study|Withdrawal of study medication|0|||
147481648|NCT01912872|531921246|FG001|Overall Study|Withdrawal of study medication|0|||
147481649|NCT01912872|531921247|FG002|Overall Study|Withdrawal of study medication|0|||
147481650|NCT01912872|531921248|FG003|Overall Study|Withdrawal of study medication|2|||
147481651|NCT01912872|531921245|FG000|Overall Study|Missing|0|||
147481652|NCT01912872|531921246|FG001|Overall Study|Missing|0|||
147481653|NCT01912872|531921247|FG002|Overall Study|Missing|0|||
147481654|NCT01912872|531921248|FG003|Overall Study|Missing|1|||
147481655|NCT01666444|531921251|FG000|Overall Study|Did not initiate treatment|2|||
147481656|NCT01666444|531921252|FG001|Overall Study|Did not initiate treatment|1|||
147481657|NCT01713036|531921255|FG000|Overall Study|Death|1|||
147481658|NCT00592358|531921256|FG000|Overall Study|Withdrawal by Subject|2|||
147481659|NCT00592358|531921256|FG000|Overall Study|Adverse Event|1|||
147481660|NCT00592358|531921256|FG000|Overall Study|Lack of Efficacy|2|||
147481661|NCT00592358|531921256|FG000|Overall Study|Inability to swallow pills|1|||
147481662|NCT01166659|531921257|FG000|Overall Study|Subject Decision|8|||
147481663|NCT01166659|531921257|FG000|Overall Study|Investigator Decision|2|||
147481664|NCT01166659|531921257|FG000|Overall Study|Death|1|||
147481665|NCT01166659|531921257|FG000|Overall Study|Lost to Follow-up|1|||
147481666|NCT01166659|531921257|FG000|Overall Study|Study Closed at Site|1|||
147481667|NCT04760314|531921260|FG000|Induction Period|Withdrawal by Subject|0|||
147481668|NCT04760314|531921261|FG001|Induction Period|Withdrawal by Subject|1|||
147481669|NCT04760314|531921262|FG002|Induction Period|Withdrawal by Subject|1|||
147481670|NCT04760314|531921263|FG003|Induction Period|Withdrawal by Subject|0|||
147481671|NCT04760314|531921264|FG004|Induction Period|Withdrawal by Subject|0|||
147481672|NCT04760314|531921265|FG005|Induction Period|Withdrawal by Subject|0|||
147481673|NCT04760314|531921266|FG006|Induction Period|Withdrawal by Subject|0|||
147481674|NCT04760314|531921267|FG007|Induction Period|Withdrawal by Subject|0|||
147481675|NCT04760314|531921268|FG008|Induction Period|Withdrawal by Subject|0|||
147481676|NCT04760314|531921269|FG009|Induction Period|Withdrawal by Subject|0|||
147667526|NCT01791595|532608097|FG002|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
147481677|NCT04760314|531921270|FG010|Induction Period|Withdrawal by Subject|0|||
147481678|NCT04760314|531921260|FG000|Induction Period|Adverse Event|0|||
147481679|NCT04760314|531921261|FG001|Induction Period|Adverse Event|0|||
147481680|NCT04760314|531921262|FG002|Induction Period|Adverse Event|2|||
147481681|NCT04760314|531921263|FG003|Induction Period|Adverse Event|0|||
147481682|NCT04760314|531921264|FG004|Induction Period|Adverse Event|0|||
147481683|NCT04760314|531921265|FG005|Induction Period|Adverse Event|0|||
147481684|NCT04760314|531921266|FG006|Induction Period|Adverse Event|0|||
147481685|NCT04760314|531921267|FG007|Induction Period|Adverse Event|0|||
147481686|NCT04760314|531921268|FG008|Induction Period|Adverse Event|0|||
147481687|NCT04760314|531921269|FG009|Induction Period|Adverse Event|0|||
147481688|NCT04760314|531921270|FG010|Induction Period|Adverse Event|0|||
147481689|NCT04760314|531921260|FG000|Maintenance Blinded Period|Withdrawal by Subject|0|||
147481690|NCT04760314|531921261|FG001|Maintenance Blinded Period|Withdrawal by Subject|0|||
147481691|NCT04760314|531921262|FG002|Maintenance Blinded Period|Withdrawal by Subject|0|||
147481692|NCT04760314|531921263|FG003|Maintenance Blinded Period|Withdrawal by Subject|1|||
147481693|NCT04760314|531921264|FG004|Maintenance Blinded Period|Withdrawal by Subject|2|||
147481694|NCT04760314|531921265|FG005|Maintenance Blinded Period|Withdrawal by Subject|1|||
147481695|NCT04760314|531921266|FG006|Maintenance Blinded Period|Withdrawal by Subject|2|||
147481696|NCT04760314|531921267|FG007|Maintenance Blinded Period|Withdrawal by Subject|0|||
147481697|NCT04760314|531921268|FG008|Maintenance Blinded Period|Withdrawal by Subject|0|||
147481698|NCT04760314|531921269|FG009|Maintenance Blinded Period|Withdrawal by Subject|0|||
147481699|NCT04760314|531921270|FG010|Maintenance Blinded Period|Withdrawal by Subject|0|||
147481700|NCT04760314|531921260|FG000|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
147481701|NCT04760314|531921261|FG001|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
147481702|NCT04760314|531921262|FG002|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
147481703|NCT04760314|531921263|FG003|Maintenance Blinded Period|Enrolled to Escape Arm|1|||
147481704|NCT04760314|531921264|FG004|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
147481705|NCT04760314|531921265|FG005|Maintenance Blinded Period|Enrolled to Escape Arm|4|||
147481706|NCT04760314|531921266|FG006|Maintenance Blinded Period|Enrolled to Escape Arm|3|||
147481707|NCT04760314|531921267|FG007|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
147481708|NCT04760314|531921268|FG008|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
147481709|NCT04760314|531921269|FG009|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
147481710|NCT04760314|531921270|FG010|Maintenance Blinded Period|Enrolled to Escape Arm|0|||
147481711|NCT04760314|531921260|FG000|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
147481712|NCT04760314|531921261|FG001|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
147481713|NCT04760314|531921262|FG002|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
147481714|NCT04760314|531921263|FG003|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
147481715|NCT04760314|531921264|FG004|Maintenance Blinded Period|Assigned Treatment by Mistake|1|||
147481716|NCT04760314|531921265|FG005|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
147481717|NCT04760314|531921266|FG006|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
147481718|NCT04760314|531921267|FG007|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
147481719|NCT04760314|531921268|FG008|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
147481720|NCT04760314|531921269|FG009|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
147481721|NCT04760314|531921270|FG010|Maintenance Blinded Period|Assigned Treatment by Mistake|0|||
147481722|NCT04760314|531921260|FG000|Maintenance Blinded Period|Protocol Deviation|0|||
147481723|NCT04760314|531921261|FG001|Maintenance Blinded Period|Protocol Deviation|0|||
147481724|NCT04760314|531921262|FG002|Maintenance Blinded Period|Protocol Deviation|0|||
147481725|NCT04760314|531921263|FG003|Maintenance Blinded Period|Protocol Deviation|0|||
147481726|NCT04760314|531921264|FG004|Maintenance Blinded Period|Protocol Deviation|0|||
147481727|NCT04760314|531921265|FG005|Maintenance Blinded Period|Protocol Deviation|1|||
147481728|NCT04760314|531921266|FG006|Maintenance Blinded Period|Protocol Deviation|0|||
147481729|NCT04760314|531921267|FG007|Maintenance Blinded Period|Protocol Deviation|0|||
147481730|NCT04760314|531921268|FG008|Maintenance Blinded Period|Protocol Deviation|0|||
147481731|NCT04760314|531921269|FG009|Maintenance Blinded Period|Protocol Deviation|0|||
147481732|NCT04760314|531921270|FG010|Maintenance Blinded Period|Protocol Deviation|0|||
147481733|NCT04760314|531921260|FG000|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
147481734|NCT04760314|531921261|FG001|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
147481735|NCT04760314|531921262|FG002|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
147481736|NCT04760314|531921263|FG003|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
147481737|NCT04760314|531921264|FG004|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
147481738|NCT04760314|531921265|FG005|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
147481739|NCT04760314|531921266|FG006|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
147481740|NCT04760314|531921267|FG007|Maintenance Open Label Escape Arm|Withdrawal by Subject|1|||
147481741|NCT04760314|531921268|FG008|Maintenance Open Label Escape Arm|Withdrawal by Subject|0|||
147481742|NCT04760314|531921269|FG009|Maintenance Open Label Escape Arm|Withdrawal by Subject|1|||
147481743|NCT04760314|531921270|FG010|Maintenance Open Label Escape Arm|Withdrawal by Subject|1|||
147481744|NCT04760314|531921260|FG000|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
147481745|NCT04760314|531921261|FG001|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
147481746|NCT04760314|531921262|FG002|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
147481747|NCT04760314|531921263|FG003|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
147667527|NCT01791595|532608098|FG003|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
147667528|NCT01791595|532608099|FG004|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
147481748|NCT04760314|531921264|FG004|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
147481749|NCT04760314|531921265|FG005|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
147481750|NCT04760314|531921266|FG006|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
147481751|NCT04760314|531921267|FG007|Maintenance Open Label Escape Arm|Lack of Efficacy|5|||
147481752|NCT04760314|531921268|FG008|Maintenance Open Label Escape Arm|Lack of Efficacy|1|||
147481753|NCT04760314|531921269|FG009|Maintenance Open Label Escape Arm|Lack of Efficacy|5|||
147481754|NCT04760314|531921270|FG010|Maintenance Open Label Escape Arm|Lack of Efficacy|0|||
147481755|NCT04760314|531921260|FG000|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
147481756|NCT04760314|531921261|FG001|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
147481757|NCT04760314|531921262|FG002|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
147481758|NCT04760314|531921263|FG003|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
147481759|NCT04760314|531921264|FG004|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
147481760|NCT04760314|531921265|FG005|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
147481761|NCT04760314|531921266|FG006|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
147481762|NCT04760314|531921267|FG007|Maintenance Open Label Escape Arm|Lost to Follow-up|2|||
147481763|NCT04760314|531921268|FG008|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
147481764|NCT04760314|531921269|FG009|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
147481765|NCT04760314|531921270|FG010|Maintenance Open Label Escape Arm|Lost to Follow-up|0|||
147481766|NCT04760314|531921260|FG000|Maintenance Open Label Escape Arm|Adverse Event|0|||
147481767|NCT04760314|531921261|FG001|Maintenance Open Label Escape Arm|Adverse Event|0|||
147481768|NCT04760314|531921262|FG002|Maintenance Open Label Escape Arm|Adverse Event|0|||
147481769|NCT04760314|531921263|FG003|Maintenance Open Label Escape Arm|Adverse Event|0|||
147481770|NCT04760314|531921264|FG004|Maintenance Open Label Escape Arm|Adverse Event|0|||
147481771|NCT04760314|531921265|FG005|Maintenance Open Label Escape Arm|Adverse Event|0|||
147481772|NCT04760314|531921266|FG006|Maintenance Open Label Escape Arm|Adverse Event|0|||
147481773|NCT04760314|531921267|FG007|Maintenance Open Label Escape Arm|Adverse Event|0|||
147481774|NCT04760314|531921268|FG008|Maintenance Open Label Escape Arm|Adverse Event|1|||
147481775|NCT04760314|531921269|FG009|Maintenance Open Label Escape Arm|Adverse Event|1|||
147481776|NCT04760314|531921270|FG010|Maintenance Open Label Escape Arm|Adverse Event|0|||
147481777|NCT04275310|531921271|FG000|Overall Study|Non-randomized due to running out of funding|4|||
147481778|NCT04275310|531921272|FG001|Overall Study|Non-randomized due to running out of funding|0|||
147481779|NCT00907478|531921274|FG000|Overall Study|Ineligibility determined|0|||
147481780|NCT00907478|531921275|FG001|Overall Study|Ineligibility determined|0|||
147481781|NCT00907478|531921276|FG002|Overall Study|Ineligibility determined|1|||
147481782|NCT00907478|531921274|FG000|Overall Study|Noncompliance|0|||
147481783|NCT00907478|531921275|FG001|Overall Study|Noncompliance|0|||
147481784|NCT00907478|531921276|FG002|Overall Study|Noncompliance|1|||
147481785|NCT00907478|531921274|FG000|Overall Study|Adverse Event|3|||
147481786|NCT00907478|531921275|FG001|Overall Study|Adverse Event|1|||
147481787|NCT00907478|531921276|FG002|Overall Study|Adverse Event|2|||
147481788|NCT00907478|531921274|FG000|Overall Study|Withdrawal by Subject|8|||
147481789|NCT00907478|531921275|FG001|Overall Study|Withdrawal by Subject|9|||
147481790|NCT00907478|531921276|FG002|Overall Study|Withdrawal by Subject|6|||
147481791|NCT00907478|531921274|FG000|Overall Study|Requirement for alternative therapy|1|||
147481792|NCT00907478|531921275|FG001|Overall Study|Requirement for alternative therapy|2|||
147481793|NCT00907478|531921276|FG002|Overall Study|Requirement for alternative therapy|3|||
147481794|NCT00907478|531921274|FG000|Overall Study|Physician Decision|2|||
147481795|NCT00907478|531921275|FG001|Overall Study|Physician Decision|0|||
147481796|NCT00907478|531921276|FG002|Overall Study|Physician Decision|3|||
147481797|NCT00907478|531921274|FG000|Overall Study|Death|4|||
147481798|NCT00907478|531921275|FG001|Overall Study|Death|2|||
147481799|NCT00907478|531921276|FG002|Overall Study|Death|1|||
147481800|NCT00907478|531921274|FG000|Overall Study|Protocol-specified criteria|5|||
147481801|NCT00907478|531921275|FG001|Overall Study|Protocol-specified criteria|2|||
147481802|NCT00907478|531921276|FG002|Overall Study|Protocol-specified criteria|3|||
147481803|NCT00907478|531921274|FG000|Overall Study|Pregnancy|0|||
147481804|NCT00907478|531921275|FG001|Overall Study|Pregnancy|1|||
147481805|NCT00907478|531921276|FG002|Overall Study|Pregnancy|1|||
147481806|NCT00907478|531921274|FG000|Overall Study|Lost to Follow-up|1|||
147481807|NCT00907478|531921275|FG001|Overall Study|Lost to Follow-up|0|||
147481808|NCT00907478|531921276|FG002|Overall Study|Lost to Follow-up|0|||
147481809|NCT00907478|531921274|FG000|Overall Study|Other|3|||
147481810|NCT00907478|531921275|FG001|Overall Study|Other|0|||
147667529|NCT01791595|532608100|FG005|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
147667530|NCT01791595|532608101|FG006|Part 1 AZD3965 Cohort 2 (10 mg OD)|Evidence of disease progression|0|||
147667531|NCT01791595|532608095|FG000|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
147481811|NCT00907478|531921276|FG002|Overall Study|Other|1|||
147481812|NCT01936649|531921281|FG000|Overall Study|Withdrawal by Subject|4|||
147481813|NCT01936649|531921281|FG000|Overall Study|Physician Decision|2|||
147481814|NCT01936649|531921281|FG000|Overall Study|Protocol Violation|2|||
147481815|NCT01936649|531921281|FG000|Overall Study|Other than specified above|5|||
147481816|NCT03554005|531921286|FG000|Overall Study|Not in participant's best interest|0|||
147481817|NCT03554005|531921287|FG001|Overall Study|Not in participant's best interest|0|||
147481818|NCT03554005|531921288|FG002|Overall Study|Not in participant's best interest|0|||
147481819|NCT03554005|531921289|FG003|Overall Study|Not in participant's best interest|0|||
147481820|NCT03554005|531921290|FG004|Overall Study|Not in participant's best interest|0|||
147481821|NCT03554005|531921291|FG005|Overall Study|Not in participant's best interest|1|||
147481822|NCT03554005|531921286|FG000|Overall Study|Disease Progression|1|||
147481823|NCT03554005|531921287|FG001|Overall Study|Disease Progression|1|||
147481824|NCT03554005|531921288|FG002|Overall Study|Disease Progression|1|||
147481825|NCT03554005|531921289|FG003|Overall Study|Disease Progression|1|||
147481826|NCT03554005|531921290|FG004|Overall Study|Disease Progression|5|||
147481827|NCT03554005|531921291|FG005|Overall Study|Disease Progression|6|||
147481828|NCT03554005|531921286|FG000|Overall Study|Adverse Event|0|||
147481829|NCT03554005|531921287|FG001|Overall Study|Adverse Event|0|||
147481830|NCT03554005|531921288|FG002|Overall Study|Adverse Event|0|||
147481831|NCT03554005|531921289|FG003|Overall Study|Adverse Event|0|||
147481832|NCT03554005|531921290|FG004|Overall Study|Adverse Event|0|||
147481833|NCT03554005|531921291|FG005|Overall Study|Adverse Event|3|||
147481834|NCT03554005|531921286|FG000|Overall Study|Physician Decision|0|||
147481835|NCT03554005|531921287|FG001|Overall Study|Physician Decision|0|||
147481836|NCT03554005|531921288|FG002|Overall Study|Physician Decision|0|||
147481837|NCT03554005|531921289|FG003|Overall Study|Physician Decision|0|||
147481838|NCT03554005|531921290|FG004|Overall Study|Physician Decision|1|||
147481839|NCT03554005|531921291|FG005|Overall Study|Physician Decision|0|||
147481840|NCT03554005|531921286|FG000|Overall Study|Other|0|||
147481841|NCT03554005|531921287|FG001|Overall Study|Other|0|||
147481842|NCT03554005|531921288|FG002|Overall Study|Other|0|||
147481843|NCT03554005|531921289|FG003|Overall Study|Other|0|||
147481844|NCT03554005|531921290|FG004|Overall Study|Other|0|||
147481845|NCT03554005|531921291|FG005|Overall Study|Other|1|||
147481846|NCT00631488|531921292|FG000|Overall Study|Adverse Event|1|||
147481847|NCT00631488|531921293|FG001|Overall Study|Adverse Event|0|||
147481848|NCT00631488|531921294|FG002|Overall Study|Adverse Event|0|||
147481849|NCT00631488|531921292|FG000|Overall Study|Lost to Follow-up|2|||
147481850|NCT00631488|531921293|FG001|Overall Study|Lost to Follow-up|2|||
147481851|NCT00631488|531921294|FG002|Overall Study|Lost to Follow-up|0|||
147481852|NCT00631488|531921292|FG000|Overall Study|Physician Decision|1|||
147481853|NCT00631488|531921293|FG001|Overall Study|Physician Decision|0|||
147481854|NCT00631488|531921294|FG002|Overall Study|Physician Decision|1|||
147481855|NCT00631488|531921292|FG000|Overall Study|Protocol Violation|0|||
147481856|NCT00631488|531921293|FG001|Overall Study|Protocol Violation|0|||
147481857|NCT00631488|531921294|FG002|Overall Study|Protocol Violation|1|||
147481858|NCT03648476|531921296|FG000|Overall Study|Withdrawal by Subject|2|||
147481859|NCT03648476|531921297|FG001|Overall Study|Withdrawal by Subject|1|||
147481860|NCT02639182|531921298|FG000|Overall Study|Disease Progression|50|||
147481861|NCT02639182|531921299|FG001|Overall Study|Disease Progression|49|||
147481862|NCT02639182|531921298|FG000|Overall Study|Adverse Event|7|||
147481863|NCT02639182|531921299|FG001|Overall Study|Adverse Event|5|||
147481864|NCT02639182|531921298|FG000|Overall Study|Physician Decision|3|||
147481865|NCT02639182|531921299|FG001|Overall Study|Physician Decision|3|||
147481866|NCT02639182|531921298|FG000|Overall Study|Withdrew Consent|5|||
147481867|NCT02639182|531921299|FG001|Overall Study|Withdrew Consent|4|||
147481868|NCT02639182|531921298|FG000|Overall Study|Lost to Follow-up|0|||
147481869|NCT02639182|531921299|FG001|Overall Study|Lost to Follow-up|1|||
147481870|NCT02639182|531921298|FG000|Overall Study|Study Closure|1|||
147481871|NCT02639182|531921299|FG001|Overall Study|Study Closure|2|||
147481872|NCT02639182|531921298|FG000|Overall Study|Sponsor Ended Study|0|||
147481873|NCT02639182|531921299|FG001|Overall Study|Sponsor Ended Study|1|||
147481874|NCT02639182|531921298|FG000|Overall Study|Randomized But Did Not Receive Study Drug|1|||
147481875|NCT02639182|531921299|FG001|Overall Study|Randomized But Did Not Receive Study Drug|1|||
147481876|NCT02546856|531921300|FG000|4 Months Evaluation|Death|2|||
147481877|NCT02546856|531921301|FG001|4 Months Evaluation|Death|3|||
147481878|NCT02546856|531921300|FG000|4 Months Evaluation|Withdrawal by Subject|2|||
147481879|NCT02546856|531921301|FG001|4 Months Evaluation|Withdrawal by Subject|3|||
147481880|NCT02546856|531921300|FG000|4 Months Evaluation|Lost to Follow-up|3|||
147481881|NCT02546856|531921301|FG001|4 Months Evaluation|Lost to Follow-up|3|||
147481882|NCT02546856|531921300|FG000|4 Months Evaluation|Physician Decision|3|||
147481883|NCT02546856|531921301|FG001|4 Months Evaluation|Physician Decision|0|||
147481884|NCT02546856|531921300|FG000|4 Months Evaluation|Working or living abroad|5|||
147481885|NCT02546856|531921301|FG001|4 Months Evaluation|Working or living abroad|1|||
147481886|NCT02546856|531921300|FG000|4 Months Evaluation|reasons not due to titration|4|||
147481887|NCT02546856|531921301|FG001|4 Months Evaluation|reasons not due to titration|1|||
147481888|NCT02546856|531921300|FG000|4 Months Evaluation|HF Unit not active in summer|1|||
147481889|NCT02546856|531921301|FG001|4 Months Evaluation|HF Unit not active in summer|0|||
147481890|NCT02546856|531921300|FG000|6 Months Evaluation|Death|1|||
147481891|NCT02546856|531921301|FG001|6 Months Evaluation|Death|1|||
147481892|NCT02546856|531921300|FG000|6 Months Evaluation|Lost to Follow-up|1|||
147481893|NCT02546856|531921301|FG001|6 Months Evaluation|Lost to Follow-up|1|||
147481894|NCT02546856|531921300|FG000|6 Months Evaluation|Working or living abroad|6|||
147481895|NCT02546856|531921301|FG001|6 Months Evaluation|Working or living abroad|4|||
147481896|NCT02546856|531921300|FG000|6 Months Evaluation|reasons not due to titration|0|||
147481897|NCT02546856|531921301|FG001|6 Months Evaluation|reasons not due to titration|1|||
147481898|NCT01097616|531921302|FG000|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|6|||
147481899|NCT01097616|531921303|FG001|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|15|||
147481900|NCT01097616|531921304|FG002|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|21|||
147481901|NCT01097616|531921305|FG003|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
147481902|NCT01097616|531921306|FG004|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
147481903|NCT01097616|531921307|FG005|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
147481904|NCT01097616|531921308|FG006|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
147481905|NCT01097616|531921309|FG007|Double-Blind (DB) Treatment (TRT) Phase|Adverse Event|0|||
147481906|NCT01097616|531921302|FG000|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|6|||
147481907|NCT01097616|531921303|FG001|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|8|||
147481908|NCT01097616|531921304|FG002|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|12|||
147481909|NCT01097616|531921305|FG003|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
147481910|NCT01097616|531921306|FG004|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
147481911|NCT01097616|531921307|FG005|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
147481912|NCT01097616|531921308|FG006|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
147481913|NCT01097616|531921309|FG007|Double-Blind (DB) Treatment (TRT) Phase|Withdrawal by Subject|0|||
147481914|NCT01097616|531921302|FG000|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|5|||
147481915|NCT01097616|531921303|FG001|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|3|||
147481916|NCT01097616|531921304|FG002|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|1|||
147481917|NCT01097616|531921305|FG003|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
147481918|NCT01097616|531921306|FG004|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
147481919|NCT01097616|531921307|FG005|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
147481920|NCT01097616|531921308|FG006|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
147481921|NCT01097616|531921309|FG007|Double-Blind (DB) Treatment (TRT) Phase|Protocol Violation|0|||
147481922|NCT01097616|531921302|FG000|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|1|||
147481923|NCT01097616|531921303|FG001|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|1|||
147481924|NCT01097616|531921304|FG002|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
147481925|NCT01097616|531921305|FG003|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
147481926|NCT01097616|531921306|FG004|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
147481927|NCT01097616|531921307|FG005|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
147481928|NCT01097616|531921308|FG006|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
147481929|NCT01097616|531921309|FG007|Double-Blind (DB) Treatment (TRT) Phase|Lost to Follow-up|0|||
147481930|NCT01097616|531921302|FG000|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|1|||
147481931|NCT01097616|531921303|FG001|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|7|||
147481932|NCT01097616|531921304|FG002|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|9|||
147481933|NCT01097616|531921305|FG003|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
147481934|NCT01097616|531921306|FG004|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
147481935|NCT01097616|531921307|FG005|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
147481936|NCT01097616|531921308|FG006|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
147481937|NCT01097616|531921309|FG007|Double-Blind (DB) Treatment (TRT) Phase|Lack of Efficacy|0|||
147481938|NCT01097616|531921302|FG000|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|1|||
147481939|NCT01097616|531921303|FG001|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|1|||
147481940|NCT01097616|531921304|FG002|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
147481941|NCT01097616|531921305|FG003|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
147481942|NCT01097616|531921306|FG004|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
147481943|NCT01097616|531921307|FG005|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
147481944|NCT01097616|531921308|FG006|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
147481945|NCT01097616|531921309|FG007|Double-Blind (DB) Treatment (TRT) Phase|Pregnancy|0|||
147481946|NCT01097616|531921302|FG000|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|4|||
147481947|NCT01097616|531921303|FG001|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|3|||
147481948|NCT01097616|531921304|FG002|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
147481949|NCT01097616|531921305|FG003|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
147481950|NCT01097616|531921306|FG004|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
147481951|NCT01097616|531921307|FG005|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
147481952|NCT01097616|531921308|FG006|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
147481953|NCT01097616|531921309|FG007|Double-Blind (DB) Treatment (TRT) Phase|Physician Decision|0|||
147481954|NCT01097616|531921302|FG000|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
147481955|NCT01097616|531921303|FG001|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
147481956|NCT01097616|531921304|FG002|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|1|||
147481957|NCT01097616|531921305|FG003|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
147481958|NCT01097616|531921306|FG004|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
147481959|NCT01097616|531921307|FG005|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
147622994|NCT00460603|532438451|FG008|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
147622995|NCT00460603|532438452|FG009|Phase 2|Ongoing in study A4061008 (NCT00828919)|1|||
147622996|NCT00460603|532438453|FG010|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
147622997|NCT00460603|532438454|FG011|Phase 2|Ongoing in study A4061008 (NCT00828919)|0|||
147622998|NCT00460603|532438443|FG000|Phase 2|Adverse Event|0|||
147622999|NCT00460603|532438444|FG001|Phase 2|Adverse Event|0|||
147623000|NCT00460603|532438445|FG002|Phase 2|Adverse Event|0|||
147623001|NCT00460603|532438446|FG003|Phase 2|Adverse Event|0|||
147623002|NCT00460603|532438447|FG004|Phase 2|Adverse Event|0|||
147623003|NCT00460603|532438448|FG005|Phase 2|Adverse Event|0|||
147623004|NCT00460603|532438449|FG006|Phase 2|Adverse Event|0|||
147623005|NCT00460603|532438450|FG007|Phase 2|Adverse Event|0|||
147623006|NCT00460603|532438451|FG008|Phase 2|Adverse Event|0|||
147623007|NCT00460603|532438452|FG009|Phase 2|Adverse Event|12|||
147623008|NCT00460603|532438453|FG010|Phase 2|Adverse Event|9|||
147623009|NCT00460603|532438454|FG011|Phase 2|Adverse Event|10|||
147623010|NCT00460603|532438443|FG000|Phase 2|Death|0|||
147623011|NCT00460603|532438444|FG001|Phase 2|Death|0|||
147623012|NCT00460603|532438445|FG002|Phase 2|Death|0|||
147623013|NCT00460603|532438446|FG003|Phase 2|Death|0|||
147623014|NCT00460603|532438447|FG004|Phase 2|Death|0|||
147623015|NCT00460603|532438448|FG005|Phase 2|Death|0|||
147623016|NCT00460603|532438449|FG006|Phase 2|Death|0|||
147623017|NCT00460603|532438450|FG007|Phase 2|Death|0|||
147623018|NCT00460603|532438451|FG008|Phase 2|Death|0|||
147623019|NCT00460603|532438452|FG009|Phase 2|Death|4|||
147623020|NCT00460603|532438453|FG010|Phase 2|Death|2|||
147623021|NCT00460603|532438454|FG011|Phase 2|Death|2|||
147623022|NCT00460603|532438443|FG000|Phase 2|Protocol Violation|0|||
147623023|NCT00460603|532438444|FG001|Phase 2|Protocol Violation|0|||
147623024|NCT00460603|532438445|FG002|Phase 2|Protocol Violation|0|||
147623025|NCT00460603|532438446|FG003|Phase 2|Protocol Violation|0|||
147623026|NCT00460603|532438447|FG004|Phase 2|Protocol Violation|0|||
147623027|NCT00460603|532438448|FG005|Phase 2|Protocol Violation|0|||
147623028|NCT00460603|532438449|FG006|Phase 2|Protocol Violation|0|||
147623029|NCT00460603|532438450|FG007|Phase 2|Protocol Violation|0|||
147623030|NCT00460603|532438451|FG008|Phase 2|Protocol Violation|0|||
147623031|NCT00460603|532438452|FG009|Phase 2|Protocol Violation|1|||
147623032|NCT00460603|532438453|FG010|Phase 2|Protocol Violation|1|||
147623033|NCT00460603|532438454|FG011|Phase 2|Protocol Violation|0|||
147623034|NCT00460603|532438443|FG000|Phase 2|Lost to Follow-up|0|||
147623035|NCT00460603|532438444|FG001|Phase 2|Lost to Follow-up|0|||
147623036|NCT00460603|532438445|FG002|Phase 2|Lost to Follow-up|0|||
147623037|NCT00460603|532438446|FG003|Phase 2|Lost to Follow-up|0|||
147623038|NCT00460603|532438447|FG004|Phase 2|Lost to Follow-up|0|||
147623039|NCT00460603|532438448|FG005|Phase 2|Lost to Follow-up|0|||
147623040|NCT00460603|532438449|FG006|Phase 2|Lost to Follow-up|0|||
147623041|NCT00460603|532438450|FG007|Phase 2|Lost to Follow-up|0|||
147623042|NCT00460603|532438451|FG008|Phase 2|Lost to Follow-up|0|||
147623043|NCT00460603|532438452|FG009|Phase 2|Lost to Follow-up|1|||
147623044|NCT00460603|532438453|FG010|Phase 2|Lost to Follow-up|0|||
147623045|NCT00460603|532438454|FG011|Phase 2|Lost to Follow-up|0|||
147623046|NCT00460603|532438443|FG000|Phase 2|Other|0|||
147623047|NCT00460603|532438444|FG001|Phase 2|Other|0|||
147623048|NCT00460603|532438445|FG002|Phase 2|Other|0|||
147623049|NCT00460603|532438446|FG003|Phase 2|Other|0|||
147623050|NCT00460603|532438447|FG004|Phase 2|Other|0|||
147623051|NCT00460603|532438448|FG005|Phase 2|Other|0|||
147623052|NCT00460603|532438449|FG006|Phase 2|Other|0|||
147623053|NCT00460603|532438450|FG007|Phase 2|Other|0|||
147623054|NCT00460603|532438451|FG008|Phase 2|Other|0|||
147623055|NCT00460603|532438452|FG009|Phase 2|Other|6|||
147623056|NCT00460603|532438453|FG010|Phase 2|Other|16|||
147623057|NCT00460603|532438454|FG011|Phase 2|Other|7|||
147623058|NCT00460603|532438443|FG000|Phase 2|Objective Progression or Relapse|0|||
147623059|NCT00460603|532438444|FG001|Phase 2|Objective Progression or Relapse|0|||
147623060|NCT00460603|532438445|FG002|Phase 2|Objective Progression or Relapse|0|||
147623061|NCT00460603|532438446|FG003|Phase 2|Objective Progression or Relapse|0|||
147623062|NCT00460603|532438447|FG004|Phase 2|Objective Progression or Relapse|0|||
147623063|NCT00460603|532438448|FG005|Phase 2|Objective Progression or Relapse|0|||
147623064|NCT00460603|532438449|FG006|Phase 2|Objective Progression or Relapse|0|||
147623065|NCT00460603|532438450|FG007|Phase 2|Objective Progression or Relapse|0|||
147623066|NCT00460603|532438451|FG008|Phase 2|Objective Progression or Relapse|0|||
147667532|NCT01791595|532608096|FG001|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
147623067|NCT00460603|532438452|FG009|Phase 2|Objective Progression or Relapse|9|||
147623068|NCT00460603|532438453|FG010|Phase 2|Objective Progression or Relapse|10|||
147623069|NCT00460603|532438454|FG011|Phase 2|Objective Progression or Relapse|17|||
147623070|NCT00460603|532438443|FG000|Phase 2|Global Deterioration of Health Status|0|||
147623071|NCT00460603|532438444|FG001|Phase 2|Global Deterioration of Health Status|0|||
147623072|NCT00460603|532438445|FG002|Phase 2|Global Deterioration of Health Status|0|||
147623073|NCT00460603|532438446|FG003|Phase 2|Global Deterioration of Health Status|0|||
147623074|NCT00460603|532438447|FG004|Phase 2|Global Deterioration of Health Status|0|||
147623075|NCT00460603|532438448|FG005|Phase 2|Global Deterioration of Health Status|0|||
147481960|NCT01097616|531921308|FG006|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
147481961|NCT01097616|531921309|FG007|Double-Blind (DB) Treatment (TRT) Phase|Not Treated|0|||
147481962|NCT01097616|531921302|FG000|Optional DB EXT Phase|Adverse Event|0|||
147481963|NCT01097616|531921303|FG001|Optional DB EXT Phase|Adverse Event|7|||
147481964|NCT01097616|531921304|FG002|Optional DB EXT Phase|Adverse Event|2|||
147481965|NCT01097616|531921305|FG003|Optional DB EXT Phase|Adverse Event|0|||
147481966|NCT01097616|531921306|FG004|Optional DB EXT Phase|Adverse Event|0|||
147481967|NCT01097616|531921307|FG005|Optional DB EXT Phase|Adverse Event|0|||
147481968|NCT01097616|531921308|FG006|Optional DB EXT Phase|Adverse Event|0|||
147481969|NCT01097616|531921309|FG007|Optional DB EXT Phase|Adverse Event|0|||
147481970|NCT01097616|531921302|FG000|Optional DB EXT Phase|Withdrawal by Subject|12|||
147481971|NCT01097616|531921303|FG001|Optional DB EXT Phase|Withdrawal by Subject|6|||
147481972|NCT01097616|531921304|FG002|Optional DB EXT Phase|Withdrawal by Subject|3|||
147481973|NCT01097616|531921305|FG003|Optional DB EXT Phase|Withdrawal by Subject|0|||
147481974|NCT01097616|531921306|FG004|Optional DB EXT Phase|Withdrawal by Subject|0|||
147481975|NCT01097616|531921307|FG005|Optional DB EXT Phase|Withdrawal by Subject|0|||
147481976|NCT01097616|531921308|FG006|Optional DB EXT Phase|Withdrawal by Subject|0|||
147481977|NCT01097616|531921309|FG007|Optional DB EXT Phase|Withdrawal by Subject|0|||
147481978|NCT01097616|531921302|FG000|Optional DB EXT Phase|Protocol Violation|0|||
147481979|NCT01097616|531921303|FG001|Optional DB EXT Phase|Protocol Violation|2|||
147481980|NCT01097616|531921304|FG002|Optional DB EXT Phase|Protocol Violation|3|||
147481981|NCT01097616|531921305|FG003|Optional DB EXT Phase|Protocol Violation|0|||
147481982|NCT01097616|531921306|FG004|Optional DB EXT Phase|Protocol Violation|0|||
147481983|NCT01097616|531921307|FG005|Optional DB EXT Phase|Protocol Violation|0|||
147481984|NCT01097616|531921308|FG006|Optional DB EXT Phase|Protocol Violation|0|||
147481985|NCT01097616|531921309|FG007|Optional DB EXT Phase|Protocol Violation|0|||
147481986|NCT01097616|531921302|FG000|Optional DB EXT Phase|Lost to Follow-up|1|||
147481987|NCT01097616|531921303|FG001|Optional DB EXT Phase|Lost to Follow-up|5|||
147481988|NCT01097616|531921304|FG002|Optional DB EXT Phase|Lost to Follow-up|1|||
147481989|NCT01097616|531921305|FG003|Optional DB EXT Phase|Lost to Follow-up|0|||
147481990|NCT01097616|531921306|FG004|Optional DB EXT Phase|Lost to Follow-up|0|||
147481991|NCT01097616|531921307|FG005|Optional DB EXT Phase|Lost to Follow-up|0|||
147481992|NCT01097616|531921308|FG006|Optional DB EXT Phase|Lost to Follow-up|0|||
147481993|NCT01097616|531921309|FG007|Optional DB EXT Phase|Lost to Follow-up|0|||
147481994|NCT01097616|531921302|FG000|Optional DB EXT Phase|Lack of Efficacy|1|||
147481995|NCT01097616|531921303|FG001|Optional DB EXT Phase|Lack of Efficacy|1|||
147481996|NCT01097616|531921304|FG002|Optional DB EXT Phase|Lack of Efficacy|1|||
147481997|NCT01097616|531921305|FG003|Optional DB EXT Phase|Lack of Efficacy|0|||
147481998|NCT01097616|531921306|FG004|Optional DB EXT Phase|Lack of Efficacy|0|||
147481999|NCT01097616|531921307|FG005|Optional DB EXT Phase|Lack of Efficacy|0|||
147482000|NCT01097616|531921308|FG006|Optional DB EXT Phase|Lack of Efficacy|0|||
147482001|NCT01097616|531921309|FG007|Optional DB EXT Phase|Lack of Efficacy|0|||
147482002|NCT01097616|531921302|FG000|Optional DB EXT Phase|Physician Decision|1|||
147482003|NCT01097616|531921303|FG001|Optional DB EXT Phase|Physician Decision|0|||
147482004|NCT01097616|531921304|FG002|Optional DB EXT Phase|Physician Decision|0|||
147482005|NCT01097616|531921305|FG003|Optional DB EXT Phase|Physician Decision|0|||
147482006|NCT01097616|531921306|FG004|Optional DB EXT Phase|Physician Decision|0|||
147482007|NCT01097616|531921307|FG005|Optional DB EXT Phase|Physician Decision|0|||
147482008|NCT01097616|531921308|FG006|Optional DB EXT Phase|Physician Decision|0|||
147482009|NCT01097616|531921309|FG007|Optional DB EXT Phase|Physician Decision|0|||
147482010|NCT01097616|531921302|FG000|DB RO Phase|Adverse Event|0|||
147482011|NCT01097616|531921303|FG001|DB RO Phase|Adverse Event|0|||
147482012|NCT01097616|531921304|FG002|DB RO Phase|Adverse Event|0|||
147482013|NCT01097616|531921305|FG003|DB RO Phase|Adverse Event|0|||
147482014|NCT01097616|531921306|FG004|DB RO Phase|Adverse Event|0|||
147482015|NCT01097616|531921307|FG005|DB RO Phase|Adverse Event|0|||
147482016|NCT01097616|531921308|FG006|DB RO Phase|Adverse Event|1|||
147482017|NCT01097616|531921309|FG007|DB RO Phase|Adverse Event|0|||
147482018|NCT01097616|531921302|FG000|DB RO Phase|Withdrawal by Subject|0|||
147482019|NCT01097616|531921303|FG001|DB RO Phase|Withdrawal by Subject|0|||
147482020|NCT01097616|531921304|FG002|DB RO Phase|Withdrawal by Subject|0|||
147482021|NCT01097616|531921305|FG003|DB RO Phase|Withdrawal by Subject|0|||
147482022|NCT01097616|531921306|FG004|DB RO Phase|Withdrawal by Subject|0|||
147482023|NCT01097616|531921307|FG005|DB RO Phase|Withdrawal by Subject|1|||
147667533|NCT01791595|532608097|FG002|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|1|||
147667534|NCT01791595|532608098|FG003|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
147667535|NCT01791595|532608099|FG004|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
147482024|NCT01097616|531921308|FG006|DB RO Phase|Withdrawal by Subject|0|||
147482025|NCT01097616|531921309|FG007|DB RO Phase|Withdrawal by Subject|0|||
147482026|NCT01097616|531921302|FG000|DB RO Phase|Lost to Follow-up|0|||
147482027|NCT01097616|531921303|FG001|DB RO Phase|Lost to Follow-up|0|||
147482028|NCT01097616|531921304|FG002|DB RO Phase|Lost to Follow-up|0|||
147482029|NCT01097616|531921305|FG003|DB RO Phase|Lost to Follow-up|1|||
147482030|NCT01097616|531921306|FG004|DB RO Phase|Lost to Follow-up|1|||
147482031|NCT01097616|531921307|FG005|DB RO Phase|Lost to Follow-up|0|||
147482032|NCT01097616|531921308|FG006|DB RO Phase|Lost to Follow-up|0|||
147482033|NCT01097616|531921309|FG007|DB RO Phase|Lost to Follow-up|1|||
147482034|NCT01097616|531921302|FG000|DB RO Phase|Not Treated in RO|0|||
147482035|NCT01097616|531921303|FG001|DB RO Phase|Not Treated in RO|0|||
147482036|NCT01097616|531921304|FG002|DB RO Phase|Not Treated in RO|0|||
147482037|NCT01097616|531921305|FG003|DB RO Phase|Not Treated in RO|0|||
147482038|NCT01097616|531921306|FG004|DB RO Phase|Not Treated in RO|0|||
147482039|NCT01097616|531921307|FG005|DB RO Phase|Not Treated in RO|1|||
147482040|NCT01097616|531921308|FG006|DB RO Phase|Not Treated in RO|0|||
147482041|NCT01097616|531921309|FG007|DB RO Phase|Not Treated in RO|0|||
147482042|NCT00130208|531921310|FG000|Maintenance Period (26 Weeks)|Adverse Event|10|||
147482043|NCT00130208|531921311|FG001|Maintenance Period (26 Weeks)|Adverse Event|12|||
147482044|NCT00130208|531921310|FG000|Maintenance Period (26 Weeks)|Physician Decision|0|||
147482045|NCT00130208|531921311|FG001|Maintenance Period (26 Weeks)|Physician Decision|2|||
147482046|NCT00130208|531921310|FG000|Maintenance Period (26 Weeks)|Withdrawal by Subject|8|||
147482047|NCT00130208|531921311|FG001|Maintenance Period (26 Weeks)|Withdrawal by Subject|11|||
147482048|NCT00130208|531921310|FG000|Maintenance Period (26 Weeks)|Lost to Follow-up|5|||
147482049|NCT00130208|531921311|FG001|Maintenance Period (26 Weeks)|Lost to Follow-up|4|||
147482050|NCT00130208|531921310|FG000|Maintenance Period (26 Weeks)|Other|1|||
147482051|NCT00130208|531921311|FG001|Maintenance Period (26 Weeks)|Other|1|||
147482052|NCT00130208|531921310|FG000|Washout Period (8 Weeks)|Adverse Event|3|||
147482053|NCT00130208|531921311|FG001|Washout Period (8 Weeks)|Adverse Event|6|||
147482054|NCT00130208|531921310|FG000|Washout Period (8 Weeks)|Withdrawal by Subject|2|||
147482055|NCT00130208|531921311|FG001|Washout Period (8 Weeks)|Withdrawal by Subject|4|||
147482056|NCT00130208|531921310|FG000|Washout Period (8 Weeks)|Lost to Follow-up|0|||
147482057|NCT00130208|531921311|FG001|Washout Period (8 Weeks)|Lost to Follow-up|1|||
147482058|NCT00130208|531921310|FG000|Washout Period (8 Weeks)|Other|1|||
147482059|NCT00130208|531921311|FG001|Washout Period (8 Weeks)|Other|1|||
147482060|NCT03268746|531921317|FG000|Overall Study|Withdrawal by Subject|1|||
147482061|NCT00589472|531921318|FG000|Overall Study|Adverse Event|1|||
147482062|NCT01372878|531921319|FG000|Overall Study|Withdrawal by Subject|63|||
147482063|NCT01372878|531921319|FG000|Overall Study|Protocol Violation|17|||
147482064|NCT01372878|531921319|FG000|Overall Study|incomplete study procedure|104|||
147482065|NCT00117338|531921320|FG000|Overall Study|Adverse Event|0|||
147482066|NCT00117338|531921321|FG001|Overall Study|Adverse Event|1|||
147482067|NCT00117338|531921320|FG000|Overall Study|Protocol Violation|3|||
147623076|NCT00460603|532438449|FG006|Phase 2|Global Deterioration of Health Status|0|||
147623077|NCT00460603|532438450|FG007|Phase 2|Global Deterioration of Health Status|0|||
147623078|NCT00460603|532438451|FG008|Phase 2|Global Deterioration of Health Status|0|||
147623079|NCT00460603|532438452|FG009|Phase 2|Global Deterioration of Health Status|0|||
147623080|NCT00460603|532438453|FG010|Phase 2|Global Deterioration of Health Status|1|||
147623081|NCT00460603|532438454|FG011|Phase 2|Global Deterioration of Health Status|0|||
147482068|NCT00117338|531921321|FG001|Overall Study|Protocol Violation|2|||
147482069|NCT00117338|531921320|FG000|Overall Study|Withdrawal by Subject|1|||
147482070|NCT00117338|531921321|FG001|Overall Study|Withdrawal by Subject|0|||
147482071|NCT00117338|531921320|FG000|Overall Study|Did not meet Inclusion Criteria|1|||
147482072|NCT00117338|531921321|FG001|Overall Study|Did not meet Inclusion Criteria|0|||
147482073|NCT00117338|531921320|FG000|Overall Study|Lack of Efficacy|0|||
147482074|NCT00117338|531921321|FG001|Overall Study|Lack of Efficacy|1|||
147482075|NCT00546351|531921322|FG000|Overall Study|Adverse Event|76|||
147482076|NCT00546351|531921322|FG000|Overall Study|Lack of Efficacy|15|||
147482077|NCT00546351|531921322|FG000|Overall Study|Withdrawal by Subject|109|||
147482078|NCT00546351|531921322|FG000|Overall Study|Lost to Follow-up|9|||
147482079|NCT00546351|531921322|FG000|Overall Study|Protocol Deviation|1|||
147482080|NCT00546351|531921322|FG000|Overall Study|Unsatisfactory compliance|9|||
147482081|NCT00546351|531921322|FG000|Overall Study|Other reasons for premature termination|17|||
147482082|NCT01342640|531921323|FG000|Overall Study|Adverse Event|3|||
147482083|NCT01342640|531921323|FG000|Overall Study|Protocol Violation|16|||
147482084|NCT01342640|531921323|FG000|Overall Study|Lost to Follow-up|21|||
147482085|NCT01342640|531921323|FG000|Overall Study|Other|1|||
147623082|NCT00460603|532438443|FG000|Phase 2|Withdrawal by Subject|0|||
147667536|NCT01791595|532608100|FG005|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
147482086|NCT02616029|531921324|FG000|Overall Study|Adverse Event|1|||
147482087|NCT02616029|531921325|FG001|Overall Study|Adverse Event|0|||
147623083|NCT00460603|532438444|FG001|Phase 2|Withdrawal by Subject|0|||
147667537|NCT01791595|532608101|FG006|Part 1 AZD3965 Cohort 3 (20 mg OD)|Adverse Event|0|||
147482088|NCT02616029|531921324|FG000|Overall Study|Death|0|||
147482089|NCT02616029|531921325|FG001|Overall Study|Death|1|||
147482090|NCT02616029|531921324|FG000|Overall Study|Protocol Violation|1|||
147482091|NCT02616029|531921325|FG001|Overall Study|Protocol Violation|0|||
147482092|NCT02616029|531921324|FG000|Overall Study|Withdrew Consent|1|||
147482093|NCT02616029|531921325|FG001|Overall Study|Withdrew Consent|0|||
147482094|NCT02616029|531921324|FG000|Overall Study|Enrolled and Never Treated|1|||
147482095|NCT02616029|531921325|FG001|Overall Study|Enrolled and Never Treated|1|||
147482096|NCT00479466|531921328|FG000|Overall Study|Adverse Event|5|||
147623084|NCT00460603|532438445|FG002|Phase 2|Withdrawal by Subject|0|||
147623085|NCT00460603|532438446|FG003|Phase 2|Withdrawal by Subject|0|||
147482097|NCT00479466|531921329|FG001|Overall Study|Adverse Event|1|||
147482098|NCT00479466|531921330|FG002|Overall Study|Adverse Event|0|||
147482099|NCT00479466|531921331|FG003|Overall Study|Adverse Event|1|||
147482100|NCT00479466|531921332|FG004|Overall Study|Adverse Event|2|||
147482101|NCT00479466|531921333|FG005|Overall Study|Adverse Event|0|||
147482102|NCT00479466|531921328|FG000|Overall Study|Hyperglycemia|0|||
147482103|NCT00479466|531921329|FG001|Overall Study|Hyperglycemia|0|||
147482104|NCT00479466|531921330|FG002|Overall Study|Hyperglycemia|0|||
147482105|NCT00479466|531921331|FG003|Overall Study|Hyperglycemia|0|||
147482106|NCT00479466|531921332|FG004|Overall Study|Hyperglycemia|0|||
147482107|NCT00479466|531921333|FG005|Overall Study|Hyperglycemia|1|||
147482108|NCT00479466|531921328|FG000|Overall Study|Lack of Efficacy|2|||
147482109|NCT00479466|531921329|FG001|Overall Study|Lack of Efficacy|0|||
147482110|NCT00479466|531921330|FG002|Overall Study|Lack of Efficacy|1|||
147482111|NCT00479466|531921331|FG003|Overall Study|Lack of Efficacy|0|||
147482112|NCT00479466|531921332|FG004|Overall Study|Lack of Efficacy|0|||
147482113|NCT00479466|531921333|FG005|Overall Study|Lack of Efficacy|0|||
147482114|NCT00479466|531921328|FG000|Overall Study|Lost to Follow-up|0|||
147482115|NCT00479466|531921329|FG001|Overall Study|Lost to Follow-up|1|||
147482116|NCT00479466|531921330|FG002|Overall Study|Lost to Follow-up|1|||
147482117|NCT00479466|531921331|FG003|Overall Study|Lost to Follow-up|0|||
147482118|NCT00479466|531921332|FG004|Overall Study|Lost to Follow-up|2|||
147482119|NCT00479466|531921333|FG005|Overall Study|Lost to Follow-up|2|||
147482120|NCT00479466|531921328|FG000|Overall Study|Physician Decision|2|||
147482121|NCT00479466|531921329|FG001|Overall Study|Physician Decision|1|||
147482122|NCT00479466|531921330|FG002|Overall Study|Physician Decision|1|||
147482123|NCT00479466|531921331|FG003|Overall Study|Physician Decision|0|||
147482124|NCT00479466|531921332|FG004|Overall Study|Physician Decision|0|||
147482125|NCT00479466|531921333|FG005|Overall Study|Physician Decision|0|||
147482126|NCT00479466|531921328|FG000|Overall Study|Pregnancy|0|||
147482127|NCT00479466|531921329|FG001|Overall Study|Pregnancy|0|||
147482128|NCT00479466|531921330|FG002|Overall Study|Pregnancy|0|||
147482129|NCT00479466|531921331|FG003|Overall Study|Pregnancy|0|||
147482130|NCT00479466|531921332|FG004|Overall Study|Pregnancy|1|||
147482131|NCT00479466|531921333|FG005|Overall Study|Pregnancy|0|||
147482132|NCT00479466|531921328|FG000|Overall Study|Protocol Violation|1|||
147482133|NCT00479466|531921329|FG001|Overall Study|Protocol Violation|0|||
147482134|NCT00479466|531921330|FG002|Overall Study|Protocol Violation|0|||
147482135|NCT00479466|531921331|FG003|Overall Study|Protocol Violation|0|||
147482136|NCT00479466|531921332|FG004|Overall Study|Protocol Violation|0|||
147482137|NCT00479466|531921333|FG005|Overall Study|Protocol Violation|0|||
147482138|NCT00479466|531921328|FG000|Overall Study|Withdrawal by Subject|3|||
147482139|NCT00479466|531921329|FG001|Overall Study|Withdrawal by Subject|5|||
147482140|NCT00479466|531921330|FG002|Overall Study|Withdrawal by Subject|0|||
147482141|NCT00479466|531921331|FG003|Overall Study|Withdrawal by Subject|2|||
147482142|NCT00479466|531921332|FG004|Overall Study|Withdrawal by Subject|3|||
147482143|NCT00479466|531921333|FG005|Overall Study|Withdrawal by Subject|1|||
147482144|NCT02927171|531921337|FG000|Overall Study|Lost to Follow-up|0|||
147482145|NCT02927171|531921338|FG001|Overall Study|Lost to Follow-up|1|||
147482146|NCT00718861|531921343|FG000|Overall Study|Withdrawal by Subject|15|||
147482147|NCT00718861|531921344|FG001|Overall Study|Withdrawal by Subject|10|||
147482148|NCT00718861|531921343|FG000|Overall Study|Adverse Event|2|||
147482149|NCT00718861|531921344|FG001|Overall Study|Adverse Event|1|||
147482150|NCT00718861|531921343|FG000|Overall Study|Lost to Follow-up|2|||
147482151|NCT00718861|531921344|FG001|Overall Study|Lost to Follow-up|1|||
147482152|NCT00718861|531921343|FG000|Overall Study|Administrative Problems|1|||
147482153|NCT00718861|531921344|FG001|Overall Study|Administrative Problems|1|||
147482154|NCT00718861|531921343|FG000|Overall Study|Death|1|||
147482155|NCT00718861|531921344|FG001|Overall Study|Death|5|||
147482156|NCT01703819|531921345|FG000|Overall Study|Adverse Event|0|||
147482157|NCT01703819|531921346|FG001|Overall Study|Adverse Event|1|||
147482158|NCT01703819|531921345|FG000|Overall Study|Withdrawal by Subject|0|||
147482159|NCT01703819|531921346|FG001|Overall Study|Withdrawal by Subject|1|||
147482160|NCT01302041|531921353|FG000|Overall Study|Death|5|||
147623086|NCT00460603|532438447|FG004|Phase 2|Withdrawal by Subject|0|||
147623087|NCT00460603|532438448|FG005|Phase 2|Withdrawal by Subject|0|||
147623088|NCT00460603|532438449|FG006|Phase 2|Withdrawal by Subject|0|||
147623089|NCT00460603|532438450|FG007|Phase 2|Withdrawal by Subject|0|||
147482161|NCT01302041|531921353|FG000|Overall Study|Withdrawal by Subject|4|||
147482162|NCT01302041|531921353|FG000|Overall Study|Other-Transitioned to 9785-CL-0123|29|||
147482163|NCT01302041|531921353|FG000|Overall Study|Other-Miscellaneous Reason|2|||
147482164|NCT02064439|531921354|FG000|Overall Study|Adverse Event|51|||
147482165|NCT02064439|531921355|FG001|Overall Study|Adverse Event|47|||
147482166|NCT02064439|531921356|FG002|Overall Study|Adverse Event|46|||
147482167|NCT02064439|531921354|FG000|Overall Study|Death|0|||
147482168|NCT02064439|531921355|FG001|Overall Study|Death|2|||
147482169|NCT02064439|531921356|FG002|Overall Study|Death|3|||
147482170|NCT02064439|531921354|FG000|Overall Study|Withdrawal by Subject|29|||
147482171|NCT02064439|531921355|FG001|Overall Study|Withdrawal by Subject|18|||
147482172|NCT02064439|531921356|FG002|Overall Study|Withdrawal by Subject|26|||
147623090|NCT00460603|532438451|FG008|Phase 2|Withdrawal by Subject|0|||
147482173|NCT02064439|531921354|FG000|Overall Study|Protocol Violation|3|||
147482174|NCT02064439|531921355|FG001|Overall Study|Protocol Violation|5|||
147482175|NCT02064439|531921356|FG002|Overall Study|Protocol Violation|3|||
147482176|NCT02064439|531921354|FG000|Overall Study|Lost to Follow-up|1|||
147482177|NCT02064439|531921355|FG001|Overall Study|Lost to Follow-up|3|||
147482178|NCT02064439|531921356|FG002|Overall Study|Lost to Follow-up|4|||
147482179|NCT02064439|531921354|FG000|Overall Study|Non-compliance with study medication|21|||
147482180|NCT02064439|531921355|FG001|Overall Study|Non-compliance with study medication|19|||
147482181|NCT02064439|531921356|FG002|Overall Study|Non-compliance with study medication|23|||
147482182|NCT02064439|531921354|FG000|Overall Study|Physician Decision|0|||
147482183|NCT02064439|531921355|FG001|Overall Study|Physician Decision|1|||
147482184|NCT02064439|531921356|FG002|Overall Study|Physician Decision|1|||
147482185|NCT02064439|531921354|FG000|Overall Study|Logistical difficulties|6|||
147482186|NCT02064439|531921355|FG001|Overall Study|Logistical difficulties|5|||
147482187|NCT02064439|531921356|FG002|Overall Study|Logistical difficulties|2|||
147623091|NCT00460603|532438452|FG009|Phase 2|Withdrawal by Subject|5|||
147623092|NCT00460603|532438453|FG010|Phase 2|Withdrawal by Subject|4|||
147623093|NCT00460603|532438454|FG011|Phase 2|Withdrawal by Subject|5|||
147623094|NCT00460603|532438443|FG000|Phase 2|Randomized, but not treated|0|||
147623095|NCT00460603|532438444|FG001|Phase 2|Randomized, but not treated|0|||
147623096|NCT00460603|532438445|FG002|Phase 2|Randomized, but not treated|0|||
147623097|NCT00460603|532438446|FG003|Phase 2|Randomized, but not treated|0|||
147623098|NCT00460603|532438447|FG004|Phase 2|Randomized, but not treated|0|||
147623099|NCT00460603|532438448|FG005|Phase 2|Randomized, but not treated|0|||
147623100|NCT00460603|532438449|FG006|Phase 2|Randomized, but not treated|0|||
147623101|NCT00460603|532438450|FG007|Phase 2|Randomized, but not treated|0|||
147623102|NCT00460603|532438451|FG008|Phase 2|Randomized, but not treated|0|||
147623103|NCT00460603|532438452|FG009|Phase 2|Randomized, but not treated|3|||
147623104|NCT00460603|532438453|FG010|Phase 2|Randomized, but not treated|0|||
147623105|NCT00460603|532438454|FG011|Phase 2|Randomized, but not treated|0|||
147623106|NCT03003962|532438455|FG000|Overall Study|Withdrawal by Subject|5|||
147623107|NCT03003962|532438456|FG001|Overall Study|Withdrawal by Subject|17|||
147623108|NCT03003962|532438455|FG000|Overall Study|Death|274|||
147623109|NCT03003962|532438456|FG001|Overall Study|Death|277|||
147623110|NCT03003962|532438455|FG000|Overall Study|Participants ongoing at DCO|55|||
147623111|NCT03003962|532438456|FG001|Overall Study|Participants ongoing at DCO|40|||
147623112|NCT03871543|532438457|FG000|Period 1|Unsatisfactory Lens Fitting due Test Article|10|||
147623113|NCT03871543|532438457|FG000|Period 1|Investigator Error|1|||
147623114|NCT03871543|532438457|FG000|Period 1|Protocol Violation|2|||
147623115|NCT03871543|532438457|FG000|Period 1|COVID-19 Related|1|||
147623116|NCT03871543|532438457|FG000|Period 1|Subject No Longer meets Eligibility Criteria|112|||
147623117|NCT03871543|532438457|FG000|Period 1|Withdrawal by Subject|10|||
147623118|NCT03871543|532438457|FG000|Period 2|Adverse Event|1|||
147623119|NCT03871543|532438457|FG000|Period 2|Withdrawal by Subject|1|||
147623120|NCT00350207|532438460|FG000|Overall Study|Adverse Event|5|||
147623121|NCT00350207|532438461|FG001|Overall Study|Adverse Event|2|||
147623122|NCT00350207|532438462|FG002|Overall Study|Adverse Event|2|||
147623123|NCT00350207|532438460|FG000|Overall Study|Lack of Efficacy|1|||
147623124|NCT00350207|532438461|FG001|Overall Study|Lack of Efficacy|0|||
147623125|NCT00350207|532438462|FG002|Overall Study|Lack of Efficacy|2|||
147623126|NCT00350207|532438460|FG000|Overall Study|Lost to Follow-up|1|||
147623127|NCT00350207|532438461|FG001|Overall Study|Lost to Follow-up|0|||
147623128|NCT00350207|532438462|FG002|Overall Study|Lost to Follow-up|1|||
147623129|NCT00350207|532438460|FG000|Overall Study|Withdrawal by Subject|0|||
147623130|NCT00350207|532438461|FG001|Overall Study|Withdrawal by Subject|1|||
147623131|NCT00350207|532438462|FG002|Overall Study|Withdrawal by Subject|1|||
147623132|NCT00350207|532438460|FG000|Overall Study|Other|1|||
147623133|NCT00350207|532438461|FG001|Overall Study|Other|3|||
147623134|NCT00350207|532438462|FG002|Overall Study|Other|1|||
147623135|NCT03214224|532438463|FG000|Overall Study|Protocol Violation|1|||
147623136|NCT03214224|532438463|FG000|Overall Study|Withdrawal by Subject|2|||
147482188|NCT02064439|531921354|FG000|Overall Study|Efficacy outcome reached|18|||
147482189|NCT02064439|531921355|FG001|Overall Study|Efficacy outcome reached|16|||
147482190|NCT02064439|531921356|FG002|Overall Study|Efficacy outcome reached|57|||
147482191|NCT02064439|531921354|FG000|Overall Study|Safety outcome reached|12|||
147482192|NCT02064439|531921355|FG001|Overall Study|Safety outcome reached|20|||
147482193|NCT02064439|531921356|FG002|Overall Study|Safety outcome reached|10|||
147482194|NCT02064439|531921354|FG000|Overall Study|Other|2|||
147482195|NCT02064439|531921355|FG001|Overall Study|Other|2|||
147623137|NCT03214224|532438463|FG000|Overall Study|Practice controls or therapists|6|||
147623138|NCT03802825|532438464|FG000|Overall Study|Lost to follow-up for intervention|12|||
147623139|NCT03802825|532438465|FG001|Overall Study|Lost to follow-up for intervention|3|||
147623140|NCT03802825|532438464|FG000|Overall Study|Received only 1 component of intervention|0|||
147623141|NCT03802825|532438465|FG001|Overall Study|Received only 1 component of intervention|13|||
147623142|NCT01051960|532438472|FG000|Overall Study|Adverse Event|1|||
147623143|NCT00360282|532438473|FG000|Washout 1-3 Weeks|Lost to Follow-up|0|||
147623144|NCT00360282|532438474|FG001|Washout 1-3 Weeks|Lost to Follow-up|0|||
147482196|NCT02064439|531921356|FG002|Overall Study|Other|7|||
147482197|NCT02433288|531921357|FG000|Overall Study|Severe non-compliance to protocol|13|||
147482198|NCT02433288|531921358|FG001|Overall Study|Severe non-compliance to protocol|7|||
147482199|NCT02433288|531921357|FG000|Overall Study|Eligibility criteria not fullfilled|7|||
147482200|NCT02433288|531921358|FG001|Overall Study|Eligibility criteria not fullfilled|3|||
147482201|NCT02433288|531921357|FG000|Overall Study|Withdrawal by Subject|101|||
147482202|NCT02433288|531921358|FG001|Overall Study|Withdrawal by Subject|99|||
147482203|NCT02433288|531921357|FG000|Overall Study|Lost to Follow-up|2|||
147482204|NCT02433288|531921358|FG001|Overall Study|Lost to Follow-up|14|||
147482205|NCT02433288|531921357|FG000|Overall Study|Death|0|||
147482206|NCT02433288|531921358|FG001|Overall Study|Death|3|||
147482207|NCT03350750|531921359|FG000|Overall Study|Death|1|||
147482208|NCT03350750|531921360|FG001|Overall Study|Death|1|||
147482209|NCT00858702|531921361|FG000|Overall Study|Lack of Efficacy|1|||
147482210|NCT00858702|531921362|FG001|Overall Study|Lack of Efficacy|0|||
147482211|NCT00858702|531921361|FG000|Overall Study|Protocol Violation|1|||
147482212|NCT00858702|531921362|FG001|Overall Study|Protocol Violation|1|||
147482213|NCT00858702|531921361|FG000|Overall Study|Other|2|||
147482214|NCT00858702|531921362|FG001|Overall Study|Other|1|||
147482215|NCT00858702|531921361|FG000|Overall Study|Withdrawal by Subject|1|||
147482216|NCT00858702|531921362|FG001|Overall Study|Withdrawal by Subject|0|||
147482217|NCT02234583|531921367|FG000|Overall Study|Adverse Event|172|||
147482218|NCT02234583|531921368|FG001|Overall Study|Adverse Event|156|||
147482219|NCT02234583|531921367|FG000|Overall Study|Withdrawal by Subject|109|||
147482220|NCT02234583|531921368|FG001|Overall Study|Withdrawal by Subject|157|||
147482221|NCT02234583|531921367|FG000|Overall Study|Lost to Follow-up|0|||
147482222|NCT02234583|531921368|FG001|Overall Study|Lost to Follow-up|1|||
147482223|NCT02234583|531921367|FG000|Overall Study|Lack of Efficacy|58|||
147482224|NCT02234583|531921368|FG001|Overall Study|Lack of Efficacy|103|||
147482225|NCT02234583|531921367|FG000|Overall Study|Protocol Violation|35|||
147482226|NCT02234583|531921368|FG001|Overall Study|Protocol Violation|42|||
147482227|NCT02234583|531921367|FG000|Overall Study|Other|39|||
147482228|NCT02234583|531921368|FG001|Overall Study|Other|97|||
147482229|NCT01849250|531921369|FG000|Overall Study|Withdrawal by Subject|1|||
147482230|NCT01849250|531921370|FG001|Overall Study|Withdrawal by Subject|0|||
147482231|NCT01849250|531921369|FG000|Overall Study|Not Evaluable|5|||
147482232|NCT01849250|531921370|FG001|Overall Study|Not Evaluable|3|||
147482233|NCT01849250|531921369|FG000|Overall Study|Screen Failure|1|||
147482234|NCT01849250|531921370|FG001|Overall Study|Screen Failure|0|||
147482235|NCT00367640|531921371|FG000|Overall Study|Adverse Event|3|||
147482236|NCT00367640|531921372|FG001|Overall Study|Adverse Event|6|||
147482237|NCT00367640|531921373|FG002|Overall Study|Adverse Event|8|||
147482238|NCT00367640|531921374|FG003|Overall Study|Adverse Event|0|||
147482239|NCT00367640|531921371|FG000|Overall Study|Withdrawal by Subject|8|||
147482240|NCT00367640|531921372|FG001|Overall Study|Withdrawal by Subject|11|||
147482241|NCT00367640|531921373|FG002|Overall Study|Withdrawal by Subject|8|||
147482242|NCT00367640|531921374|FG003|Overall Study|Withdrawal by Subject|6|||
147482243|NCT00367640|531921371|FG000|Overall Study|Any other reason not above-mentioned|7|||
147482244|NCT00367640|531921372|FG001|Overall Study|Any other reason not above-mentioned|5|||
147482245|NCT00367640|531921373|FG002|Overall Study|Any other reason not above-mentioned|3|||
147482246|NCT00367640|531921374|FG003|Overall Study|Any other reason not above-mentioned|4|||
147482247|NCT04504032|531921380|FG000|Overall Study|Adverse Event|1|||
147482248|NCT04504032|531921381|FG001|Overall Study|Adverse Event|2|||
147482249|NCT04504032|531921380|FG000|Overall Study|Lost to Follow-up|6|||
147482250|NCT04504032|531921381|FG001|Overall Study|Lost to Follow-up|9|||
147482251|NCT04504032|531921380|FG000|Overall Study|Protocol Violation|2|||
147482252|NCT04504032|531921381|FG001|Overall Study|Protocol Violation|0|||
147482253|NCT04504032|531921380|FG000|Overall Study|Study terminated by sponsor|1|||
147482254|NCT04504032|531921381|FG001|Overall Study|Study terminated by sponsor|2|||
147482255|NCT04504032|531921380|FG000|Overall Study|Withdrawal by Subject|9|||
147482256|NCT04504032|531921381|FG001|Overall Study|Withdrawal by Subject|11|||
147482257|NCT04504032|531921380|FG000|Overall Study|Disease progression prior to dosing|15|||
147482258|NCT04504032|531921381|FG001|Overall Study|Disease progression prior to dosing|3|||
147482259|NCT04504032|531921380|FG000|Overall Study|Drug supply issues|1|||
147482260|NCT04504032|531921381|FG001|Overall Study|Drug supply issues|1|||
147482261|NCT04504032|531921380|FG000|Overall Study|Progressed to moderate/severe COVID-19|1|||
147482262|NCT04504032|531921381|FG001|Overall Study|Progressed to moderate/severe COVID-19|0|||
147482263|NCT00771030|531921382|FG000|Overall Study|Adverse Event|0|||
147482264|NCT00771030|531921383|FG001|Overall Study|Adverse Event|1|||
147482265|NCT00771030|531921384|FG002|Overall Study|Adverse Event|0|||
147482266|NCT00771030|531921385|FG003|Overall Study|Adverse Event|0|||
147482267|NCT00771030|531921386|FG004|Overall Study|Adverse Event|0|||
147482268|NCT00771030|531921387|FG005|Overall Study|Adverse Event|0|||
147482269|NCT00771030|531921388|FG006|Overall Study|Adverse Event|0|||
147482270|NCT01839188|531921389|FG000|Overall Study|Withdrawal by Subject|1|||
147482271|NCT02075255|531921396|FG000|Overall Study|Study specific withdrawal criteria|0|||
147482272|NCT02075255|531921397|FG001|Overall Study|Study specific withdrawal criteria|1|||
147482273|NCT02075255|531921398|FG002|Overall Study|Study specific withdrawal criteria|1|||
147482274|NCT02075255|531921396|FG000|Overall Study|Withdrawal by Subject|4|||
147482275|NCT02075255|531921397|FG001|Overall Study|Withdrawal by Subject|1|||
147482276|NCT02075255|531921398|FG002|Overall Study|Withdrawal by Subject|0|||
147482277|NCT02075255|531921396|FG000|Overall Study|Lost to Follow-up|0|||
147482278|NCT02075255|531921397|FG001|Overall Study|Lost to Follow-up|0|||
147482279|NCT02075255|531921398|FG002|Overall Study|Lost to Follow-up|1|||
147482280|NCT02075255|531921396|FG000|Overall Study|Adverse Event|0|||
147482281|NCT02075255|531921397|FG001|Overall Study|Adverse Event|0|||
147482282|NCT02075255|531921398|FG002|Overall Study|Adverse Event|1|||
147482283|NCT02075255|531921396|FG000|Overall Study|Death|0|||
147482284|NCT02075255|531921397|FG001|Overall Study|Death|2|||
147482285|NCT02075255|531921398|FG002|Overall Study|Death|0|||
147482286|NCT03792750|531921399|FG000|Overall Study|Death|3|||
147482287|NCT01748760|531921400|FG000|Overall Study|Withdrawal by Subject|1|||
147482288|NCT01748760|531921401|FG001|Overall Study|Withdrawal by Subject|1|||
147482289|NCT01748760|531921400|FG000|Overall Study|Lost to Follow-up|5|||
147482290|NCT01748760|531921401|FG001|Overall Study|Lost to Follow-up|1|||
147482291|NCT00872898|531921402|FG000|Part Two - Double Blind|Adverse Event|4|||
147482292|NCT00872898|531921403|FG001|Part Two - Double Blind|Adverse Event|3|||
147482293|NCT00872898|531921402|FG000|Part Two - Double Blind|Lack of Efficacy|1|||
147482294|NCT00872898|531921403|FG001|Part Two - Double Blind|Lack of Efficacy|0|||
147482295|NCT00872898|531921402|FG000|Part Two - Double Blind|Protocol Violation|1|||
147482296|NCT00872898|531921403|FG001|Part Two - Double Blind|Protocol Violation|0|||
147482297|NCT00872898|531921402|FG000|Part Two - Double Blind|Withdrawal by Subject|3|||
147482298|NCT00872898|531921403|FG001|Part Two - Double Blind|Withdrawal by Subject|1|||
147482299|NCT00872898|531921402|FG000|Part Two - Double Blind|Lost to Follow-up|0|||
147482300|NCT00872898|531921403|FG001|Part Two - Double Blind|Lost to Follow-up|2|||
147482301|NCT00872898|531921402|FG000|Part Two - Double Blind|Other reasons|2|||
147482302|NCT00872898|531921403|FG001|Part Two - Double Blind|Other reasons|0|||
147482303|NCT03176966|531921409|FG000|Baseline to 3 Months (1st Intervention)|Death|2|||
147482304|NCT03176966|531921410|FG001|Baseline to 3 Months (1st Intervention)|Death|1|||
147482305|NCT03176966|531921409|FG000|Baseline to 3 Months (1st Intervention)|Withdrawal by Subject|1|||
147482306|NCT03176966|531921410|FG001|Baseline to 3 Months (1st Intervention)|Withdrawal by Subject|4|||
147482307|NCT03176966|531921409|FG000|Baseline to 3 Months (1st Intervention)|Lost to Follow-up|1|||
147482308|NCT03176966|531921410|FG001|Baseline to 3 Months (1st Intervention)|Lost to Follow-up|2|||
147482309|NCT03176966|531921409|FG000|3 Month to 6 Months (2nd Intervention)|Death|0|||
147482310|NCT03176966|531921410|FG001|3 Month to 6 Months (2nd Intervention)|Death|1|||
147482311|NCT03176966|531921409|FG000|3 Month to 6 Months (2nd Intervention)|Lost to Follow-up|3|||
147482312|NCT03176966|531921410|FG001|3 Month to 6 Months (2nd Intervention)|Lost to Follow-up|4|||
147482313|NCT03176966|531921409|FG000|3 Month to 6 Months (2nd Intervention)|Physician Decision|1|||
147482314|NCT03176966|531921410|FG001|3 Month to 6 Months (2nd Intervention)|Physician Decision|0|||
147482315|NCT03176966|531921409|FG000|3 Month to 6 Months (2nd Intervention)|Withdrawal by Subject|2|||
147482316|NCT03176966|531921410|FG001|3 Month to 6 Months (2nd Intervention)|Withdrawal by Subject|0|||
147482317|NCT01520922|531921411|FG000|Treatment Phase|Physician Decision|2|||
147482318|NCT01520922|531921412|FG001|Treatment Phase|Physician Decision|1|||
147482319|NCT01520922|531921411|FG000|Treatment Phase|Progression|0|||
147482320|NCT01520922|531921412|FG001|Treatment Phase|Progression|2|||
147482321|NCT01520922|531921411|FG000|Treatment Phase|Adverse Event|3|||
147482322|NCT01520922|531921412|FG001|Treatment Phase|Adverse Event|5|||
147482323|NCT01520922|531921411|FG000|Follow up|Lost to Follow-up|0|||
147482324|NCT01520922|531921412|FG001|Follow up|Lost to Follow-up|1|||
147482325|NCT01520922|531921411|FG000|Survival Follow-up|Withdrawal by Subject|1|||
147482326|NCT01520922|531921412|FG001|Survival Follow-up|Withdrawal by Subject|0|||
147482327|NCT02269319|531921415|FG000|Overall Study|Lost to Follow-up|4|||
147482328|NCT02269319|531921416|FG001|Overall Study|Lost to Follow-up|3|||
147482329|NCT02269319|531921415|FG000|Overall Study|Adverse Event|0|||
147482330|NCT02269319|531921416|FG001|Overall Study|Adverse Event|1|||
147482331|NCT02269319|531921415|FG000|Overall Study|Instructions not followed|1|||
147482332|NCT02269319|531921416|FG001|Overall Study|Instructions not followed|0|||
147667538|NCT01791595|532608095|FG000|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
147667539|NCT01791595|532608096|FG001|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
147667540|NCT01791595|532608097|FG002|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|6|||
147482333|NCT02699515|531923008|FG000|Overall Study|Death|3|||
147482334|NCT02699515|531923009|FG001|Overall Study|Death|3|||
147482335|NCT02699515|531923010|FG002|Overall Study|Death|3|||
147482336|NCT02699515|531923011|FG003|Overall Study|Death|23|||
147482337|NCT02699515|531923012|FG004|Overall Study|Death|22|||
147482338|NCT02699515|531923013|FG005|Overall Study|Death|23|||
147482339|NCT02699515|531923014|FG006|Overall Study|Death|3|||
147482340|NCT02699515|531923015|FG007|Overall Study|Death|5|||
147482341|NCT02699515|531923008|FG000|Overall Study|Withdrawal by Subject|0|||
147482342|NCT02699515|531923009|FG001|Overall Study|Withdrawal by Subject|0|||
147482343|NCT02699515|531923010|FG002|Overall Study|Withdrawal by Subject|3|||
147482344|NCT02699515|531923011|FG003|Overall Study|Withdrawal by Subject|1|||
147482345|NCT02699515|531923012|FG004|Overall Study|Withdrawal by Subject|5|||
147482346|NCT02699515|531923013|FG005|Overall Study|Withdrawal by Subject|3|||
147482347|NCT02699515|531923014|FG006|Overall Study|Withdrawal by Subject|0|||
147482348|NCT02699515|531923015|FG007|Overall Study|Withdrawal by Subject|1|||
147482349|NCT02699515|531923008|FG000|Overall Study|Other|1|||
147482350|NCT02699515|531923009|FG001|Overall Study|Other|0|||
147482351|NCT02699515|531923010|FG002|Overall Study|Other|1|||
147482352|NCT02699515|531923011|FG003|Overall Study|Other|6|||
147482353|NCT02699515|531923012|FG004|Overall Study|Other|4|||
147482354|NCT02699515|531923013|FG005|Overall Study|Other|3|||
147482355|NCT02699515|531923014|FG006|Overall Study|Other|0|||
147482356|NCT02699515|531923015|FG007|Overall Study|Other|0|||
147482357|NCT01240811|531923016|FG000|Overall Study|Physician Decision|0|||
147482358|NCT01240811|531923017|FG001|Overall Study|Physician Decision|1|||
147482359|NCT01240811|531923018|FG002|Overall Study|Physician Decision|0|||
147482360|NCT01240811|531923016|FG000|Overall Study|Withdrawal by Subject|0|||
147482361|NCT01240811|531923017|FG001|Overall Study|Withdrawal by Subject|0|||
147482362|NCT01240811|531923018|FG002|Overall Study|Withdrawal by Subject|1|||
147482363|NCT03032068|531923027|FG000|Overall Study|Adverse Event|1|||
147482364|NCT03918642|531923029|FG000|Overall Study|Lost to Follow-up|12|||
147482365|NCT03918642|531923030|FG001|Overall Study|Lost to Follow-up|10|||
147482366|NCT01988012|531923032|FG000|Overall Study|Adverse Event|5|||
147482367|NCT01988012|531923032|FG000|Overall Study|Insufficient Therapeutic Response|3|||
147482368|NCT01988012|531923032|FG000|Overall Study|Patient Withdrawal of Consent|4|||
147482369|NCT01988012|531923032|FG000|Overall Study|Lost to Follow-up|1|||
147482370|NCT01988012|531923032|FG000|Overall Study|Physician Decision|1|||
147482371|NCT01988012|531923032|FG000|Overall Study|Protocol Violation|1|||
147482372|NCT01228071|531923035|FG000|Overall Study|Protocol Violation|1|||
147482373|NCT01228071|531923035|FG000|Overall Study|Withdrawal by Subject|1|||
147482374|NCT03238248|531923041|FG000|Overall Study|Death|5|||
147482375|NCT03238248|531923041|FG000|Overall Study|Withdrawal by Subject|7|||
147482376|NCT03238248|531923041|FG000|Overall Study|Participant proceeding to transplant|10|||
147482377|NCT03238248|531923041|FG000|Overall Study|Lack of Efficacy|4|||
147482378|NCT03238248|531923041|FG000|Overall Study|Physician Decision|3|||
147482379|NCT03238248|531923041|FG000|Overall Study|Transitioning to another study|1|||
147482380|NCT03238248|531923041|FG000|Overall Study|No longer benefiting|1|||
147482381|NCT03238248|531923041|FG000|Overall Study|Other complicating disease|1|||
147482382|NCT03238248|531923041|FG000|Overall Study|Adverse Event|5|||
147482383|NCT03238248|531923041|FG000|Overall Study|Disease progression|26|||
147482384|NCT03238248|531923041|FG000|Overall Study|N/A participant is still on treatment|1|||
147482385|NCT03238248|531923041|FG000|Overall Study|Decline in condition|1|||
147482386|NCT03238248|531923041|FG000|Overall Study|Alternative therapy|2|||
147482387|NCT02241512|531923048|FG000|Overall Study|Pump malfunction, drug not delivered|1|||
147482388|NCT02241512|531923049|FG001|Overall Study|Pump malfunction, drug not delivered|0|||
147482389|NCT02345161|531923052|FG000|Overall Study|Withdrawal by Subject|25|||
147482390|NCT02345161|531923053|FG001|Overall Study|Withdrawal by Subject|33|||
147482391|NCT02345161|531923052|FG000|Overall Study|Adverse Event|16|||
147482392|NCT02345161|531923053|FG001|Overall Study|Adverse Event|19|||
147482393|NCT02345161|531923052|FG000|Overall Study|Physician Decision|4|||
147482394|NCT02345161|531923053|FG001|Overall Study|Physician Decision|4|||
147482395|NCT02345161|531923052|FG000|Overall Study|Lost to Follow-up|0|||
147482396|NCT02345161|531923053|FG001|Overall Study|Lost to Follow-up|1|||
147482397|NCT00972244|531923056|FG000|Overall Study|Incorrect Enrolment|1|||
147482398|NCT00972244|531923057|FG001|Overall Study|Incorrect Enrolment|0|||
147482399|NCT00972244|531923058|FG002|Overall Study|Incorrect Enrolment|0|||
147482400|NCT00972244|531923059|FG003|Overall Study|Incorrect Enrolment|0|||
147482401|NCT00972244|531923060|FG004|Overall Study|Incorrect Enrolment|0|||
147482402|NCT00972244|531923056|FG000|Overall Study|Adverse Event|0|||
147482403|NCT00972244|531923057|FG001|Overall Study|Adverse Event|1|||
147482404|NCT00972244|531923058|FG002|Overall Study|Adverse Event|1|||
147482405|NCT00972244|531923059|FG003|Overall Study|Adverse Event|0|||
147667541|NCT01791595|532608098|FG003|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
147667542|NCT01791595|532608099|FG004|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
147667543|NCT01791595|532608100|FG005|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
147482406|NCT00972244|531923060|FG004|Overall Study|Adverse Event|0|||
147482407|NCT00972244|531923056|FG000|Overall Study|Subject No Longer Meets Study Criteria|2|||
147482408|NCT00972244|531923057|FG001|Overall Study|Subject No Longer Meets Study Criteria|2|||
147482409|NCT00972244|531923058|FG002|Overall Study|Subject No Longer Meets Study Criteria|0|||
147482410|NCT00972244|531923059|FG003|Overall Study|Subject No Longer Meets Study Criteria|0|||
147667544|NCT01791595|532608101|FG006|Part 1 AZD3965 Cohort 3 (20 mg OD)|Evidence of disease progression|0|||
147482411|NCT00972244|531923060|FG004|Overall Study|Subject No Longer Meets Study Criteria|5|||
147482412|NCT00972244|531923056|FG000|Overall Study|Withdrawal by Subject|1|||
147482413|NCT00972244|531923057|FG001|Overall Study|Withdrawal by Subject|2|||
147482414|NCT00972244|531923058|FG002|Overall Study|Withdrawal by Subject|1|||
147482415|NCT00972244|531923059|FG003|Overall Study|Withdrawal by Subject|0|||
147482416|NCT00972244|531923060|FG004|Overall Study|Withdrawal by Subject|1|||
147482417|NCT00972244|531923056|FG000|Overall Study|Safety|0|||
147667545|NCT01791595|532608095|FG000|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
147667546|NCT01791595|532608096|FG001|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
147667547|NCT01791595|532608097|FG002|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|1|||
147667548|NCT01791595|532608098|FG003|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
147667549|NCT01791595|532608099|FG004|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
147667550|NCT01791595|532608100|FG005|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
147667551|NCT01791595|532608101|FG006|Part 1 AZD3965 Cohort 3 (20 mg OD)|Physician Decision|0|||
147667552|NCT01791595|532608095|FG000|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
147667553|NCT01791595|532608096|FG001|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
147667554|NCT01791595|532608097|FG002|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
147667555|NCT01791595|532608098|FG003|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|2|||
147667556|NCT01791595|532608099|FG004|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
147667557|NCT01791595|532608100|FG005|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
147667558|NCT01791595|532608101|FG006|Part 1 AZD3965 Cohort 4 (30 mg OD)|Adverse Event|0|||
147667559|NCT01791595|532608095|FG000|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
147667560|NCT01791595|532608096|FG001|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
147667561|NCT01791595|532608097|FG002|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
147667562|NCT01791595|532608098|FG003|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|2|||
147667563|NCT01791595|532608099|FG004|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
147482418|NCT00972244|531923057|FG001|Overall Study|Safety|0|||
147482419|NCT00972244|531923058|FG002|Overall Study|Safety|0|||
147482420|NCT00972244|531923059|FG003|Overall Study|Safety|0|||
147482421|NCT00972244|531923060|FG004|Overall Study|Safety|1|||
147482422|NCT00972244|531923056|FG000|Overall Study|Death|1|||
147482423|NCT00972244|531923057|FG001|Overall Study|Death|0|||
147482424|NCT00972244|531923058|FG002|Overall Study|Death|0|||
147482425|NCT00972244|531923059|FG003|Overall Study|Death|0|||
147482426|NCT00972244|531923060|FG004|Overall Study|Death|0|||
147482427|NCT00972244|531923056|FG000|Overall Study|Various|0|||
147482428|NCT00972244|531923057|FG001|Overall Study|Various|0|||
147482429|NCT00972244|531923058|FG002|Overall Study|Various|0|||
147482430|NCT00972244|531923059|FG003|Overall Study|Various|0|||
147482431|NCT00972244|531923060|FG004|Overall Study|Various|2|||
147482432|NCT00090285|531923061|FG000|Base Study Vaccination Period|Randomized Not Vaccinated|7|||
147482433|NCT00090285|531923062|FG001|Base Study Vaccination Period|Randomized Not Vaccinated|3|||
147482434|NCT00090285|531923063|FG002|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
147482435|NCT00090285|531923064|FG003|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
147482436|NCT00090285|531923065|FG004|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
147482437|NCT00090285|531923066|FG005|Base Study Vaccination Period|Randomized Not Vaccinated|0|||
147482438|NCT00090285|531923061|FG000|Base Study Vaccination Period|Adverse Event|2|||
147482439|NCT00090285|531923062|FG001|Base Study Vaccination Period|Adverse Event|4|||
147482440|NCT00090285|531923063|FG002|Base Study Vaccination Period|Adverse Event|0|||
147482441|NCT00090285|531923064|FG003|Base Study Vaccination Period|Adverse Event|0|||
147482442|NCT00090285|531923065|FG004|Base Study Vaccination Period|Adverse Event|0|||
147482443|NCT00090285|531923066|FG005|Base Study Vaccination Period|Adverse Event|0|||
147482444|NCT00090285|531923061|FG000|Base Study Vaccination Period|Lost to Follow-up|111|||
147482445|NCT00090285|531923062|FG001|Base Study Vaccination Period|Lost to Follow-up|112|||
147482446|NCT00090285|531923063|FG002|Base Study Vaccination Period|Lost to Follow-up|0|||
147482447|NCT00090285|531923064|FG003|Base Study Vaccination Period|Lost to Follow-up|0|||
147482448|NCT00090285|531923065|FG004|Base Study Vaccination Period|Lost to Follow-up|0|||
147482449|NCT00090285|531923066|FG005|Base Study Vaccination Period|Lost to Follow-up|0|||
147482450|NCT00090285|531923061|FG000|Base Study Vaccination Period|Protocol Violation|2|||
147482451|NCT00090285|531923062|FG001|Base Study Vaccination Period|Protocol Violation|3|||
147482452|NCT00090285|531923063|FG002|Base Study Vaccination Period|Protocol Violation|0|||
147482453|NCT00090285|531923064|FG003|Base Study Vaccination Period|Protocol Violation|0|||
147482454|NCT00090285|531923065|FG004|Base Study Vaccination Period|Protocol Violation|0|||
147482455|NCT00090285|531923066|FG005|Base Study Vaccination Period|Protocol Violation|0|||
147482456|NCT00090285|531923061|FG000|Base Study Vaccination Period|Withdrawal by Subject|64|||
147482457|NCT00090285|531923062|FG001|Base Study Vaccination Period|Withdrawal by Subject|69|||
147482458|NCT00090285|531923063|FG002|Base Study Vaccination Period|Withdrawal by Subject|0|||
147482459|NCT00090285|531923064|FG003|Base Study Vaccination Period|Withdrawal by Subject|0|||
147482460|NCT00090285|531923065|FG004|Base Study Vaccination Period|Withdrawal by Subject|0|||
147482461|NCT00090285|531923066|FG005|Base Study Vaccination Period|Withdrawal by Subject|0|||
147482462|NCT00090285|531923061|FG000|Base Study Vaccination Period|Uncooperative|2|||
147482463|NCT00090285|531923062|FG001|Base Study Vaccination Period|Uncooperative|2|||
147482464|NCT00090285|531923063|FG002|Base Study Vaccination Period|Uncooperative|0|||
147482465|NCT00090285|531923064|FG003|Base Study Vaccination Period|Uncooperative|0|||
147482466|NCT00090285|531923065|FG004|Base Study Vaccination Period|Uncooperative|0|||
147482467|NCT00090285|531923066|FG005|Base Study Vaccination Period|Uncooperative|0|||
147667564|NCT01791595|532608100|FG005|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
147482468|NCT00090285|531923061|FG000|Base Study Vaccination Period|Moved|20|||
147482469|NCT00090285|531923062|FG001|Base Study Vaccination Period|Moved|21|||
147482470|NCT00090285|531923063|FG002|Base Study Vaccination Period|Moved|0|||
147482471|NCT00090285|531923064|FG003|Base Study Vaccination Period|Moved|0|||
147482472|NCT00090285|531923065|FG004|Base Study Vaccination Period|Moved|0|||
147482473|NCT00090285|531923066|FG005|Base Study Vaccination Period|Moved|0|||
147482474|NCT00090285|531923061|FG000|Base Study Vaccination Period|Site Terminated|1|||
147482475|NCT00090285|531923062|FG001|Base Study Vaccination Period|Site Terminated|0|||
147482476|NCT00090285|531923063|FG002|Base Study Vaccination Period|Site Terminated|0|||
147482477|NCT00090285|531923064|FG003|Base Study Vaccination Period|Site Terminated|0|||
147482478|NCT00090285|531923065|FG004|Base Study Vaccination Period|Site Terminated|0|||
147482479|NCT00090285|531923066|FG005|Base Study Vaccination Period|Site Terminated|0|||
147482480|NCT00090285|531923061|FG000|Base Study Vaccination Period|Other|2|||
147482481|NCT00090285|531923062|FG001|Base Study Vaccination Period|Other|2|||
147482482|NCT00090285|531923063|FG002|Base Study Vaccination Period|Other|0|||
147482483|NCT00090285|531923064|FG003|Base Study Vaccination Period|Other|0|||
147482484|NCT00090285|531923065|FG004|Base Study Vaccination Period|Other|0|||
147482485|NCT00090285|531923066|FG005|Base Study Vaccination Period|Other|0|||
147482486|NCT00090285|531923061|FG000|Base Study Vaccination Period|Subject Incarcerated|2|||
147482487|NCT00090285|531923062|FG001|Base Study Vaccination Period|Subject Incarcerated|2|||
147482488|NCT00090285|531923063|FG002|Base Study Vaccination Period|Subject Incarcerated|0|||
147482489|NCT00090285|531923064|FG003|Base Study Vaccination Period|Subject Incarcerated|0|||
147482490|NCT00090285|531923065|FG004|Base Study Vaccination Period|Subject Incarcerated|0|||
147482491|NCT00090285|531923066|FG005|Base Study Vaccination Period|Subject Incarcerated|0|||
147482492|NCT00090285|531923061|FG000|Base Study Vaccination Period|HIV positive|1|||
147482493|NCT00090285|531923062|FG001|Base Study Vaccination Period|HIV positive|1|||
147482494|NCT00090285|531923063|FG002|Base Study Vaccination Period|HIV positive|0|||
147482495|NCT00090285|531923064|FG003|Base Study Vaccination Period|HIV positive|0|||
147482496|NCT00090285|531923065|FG004|Base Study Vaccination Period|HIV positive|0|||
147482497|NCT00090285|531923066|FG005|Base Study Vaccination Period|HIV positive|0|||
147482498|NCT00090285|531923061|FG000|Base Study Follow-up Period|Adverse Event|3|||
147482499|NCT00090285|531923062|FG001|Base Study Follow-up Period|Adverse Event|10|||
147482500|NCT00090285|531923063|FG002|Base Study Follow-up Period|Adverse Event|0|||
147482501|NCT00090285|531923064|FG003|Base Study Follow-up Period|Adverse Event|0|||
147482502|NCT00090285|531923065|FG004|Base Study Follow-up Period|Adverse Event|0|||
147482503|NCT00090285|531923066|FG005|Base Study Follow-up Period|Adverse Event|0|||
147482504|NCT00090285|531923061|FG000|Base Study Follow-up Period|Lost to Follow-up|232|||
147482505|NCT00090285|531923062|FG001|Base Study Follow-up Period|Lost to Follow-up|226|||
147482506|NCT00090285|531923063|FG002|Base Study Follow-up Period|Lost to Follow-up|0|||
147482507|NCT00090285|531923064|FG003|Base Study Follow-up Period|Lost to Follow-up|0|||
147482508|NCT00090285|531923065|FG004|Base Study Follow-up Period|Lost to Follow-up|0|||
147482509|NCT00090285|531923066|FG005|Base Study Follow-up Period|Lost to Follow-up|0|||
147482510|NCT00090285|531923061|FG000|Base Study Follow-up Period|Withdrawal by Subject|53|||
147482511|NCT00090285|531923062|FG001|Base Study Follow-up Period|Withdrawal by Subject|64|||
147482512|NCT00090285|531923063|FG002|Base Study Follow-up Period|Withdrawal by Subject|0|||
147482513|NCT00090285|531923064|FG003|Base Study Follow-up Period|Withdrawal by Subject|0|||
147482514|NCT00090285|531923065|FG004|Base Study Follow-up Period|Withdrawal by Subject|0|||
147482515|NCT00090285|531923066|FG005|Base Study Follow-up Period|Withdrawal by Subject|0|||
147482516|NCT00090285|531923061|FG000|Base Study Follow-up Period|Moved|41|||
147482517|NCT00090285|531923062|FG001|Base Study Follow-up Period|Moved|36|||
147482518|NCT00090285|531923063|FG002|Base Study Follow-up Period|Moved|0|||
147482519|NCT00090285|531923064|FG003|Base Study Follow-up Period|Moved|0|||
147482520|NCT00090285|531923065|FG004|Base Study Follow-up Period|Moved|0|||
147482521|NCT00090285|531923066|FG005|Base Study Follow-up Period|Moved|0|||
147482522|NCT00090285|531923061|FG000|Base Study Follow-up Period|Other|2|||
147482523|NCT00090285|531923062|FG001|Base Study Follow-up Period|Other|0|||
147482524|NCT00090285|531923063|FG002|Base Study Follow-up Period|Other|0|||
147482525|NCT00090285|531923064|FG003|Base Study Follow-up Period|Other|0|||
147482526|NCT00090285|531923065|FG004|Base Study Follow-up Period|Other|0|||
147623145|NCT00360282|532438475|FG002|Washout 1-3 Weeks|Lost to Follow-up|1|||
147623146|NCT00360282|532438476|FG003|Washout 1-3 Weeks|Lost to Follow-up|0|||
147623147|NCT00360282|532438473|FG000|Second Intervention|Adverse Event|0|||
147303216|NCT02173054|531276279|FG002|Overall Study|lack of compliance|0|||
147482527|NCT00090285|531923066|FG005|Base Study Follow-up Period|Other|0|||
147482528|NCT00090285|531923061|FG000|Base Study Follow-up Period|Protocol Violation|1|||
147482529|NCT00090285|531923062|FG001|Base Study Follow-up Period|Protocol Violation|0|||
147482530|NCT00090285|531923063|FG002|Base Study Follow-up Period|Protocol Violation|0|||
147482531|NCT00090285|531923064|FG003|Base Study Follow-up Period|Protocol Violation|0|||
147482532|NCT00090285|531923065|FG004|Base Study Follow-up Period|Protocol Violation|0|||
147482533|NCT00090285|531923066|FG005|Base Study Follow-up Period|Protocol Violation|0|||
147482534|NCT00090285|531923061|FG000|Base Study Follow-up Period|Uncooperative|3|||
147482535|NCT00090285|531923062|FG001|Base Study Follow-up Period|Uncooperative|4|||
147623148|NCT00360282|532438474|FG001|Second Intervention|Adverse Event|1|||
147482536|NCT00090285|531923063|FG002|Base Study Follow-up Period|Uncooperative|0|||
147482537|NCT00090285|531923064|FG003|Base Study Follow-up Period|Uncooperative|0|||
147482538|NCT00090285|531923065|FG004|Base Study Follow-up Period|Uncooperative|0|||
147482539|NCT00090285|531923066|FG005|Base Study Follow-up Period|Uncooperative|0|||
147482540|NCT00090285|531923061|FG000|Base Study Follow-up Period|Subject Incarcerated|0|||
147482541|NCT00090285|531923062|FG001|Base Study Follow-up Period|Subject Incarcerated|2|||
147482542|NCT00090285|531923063|FG002|Base Study Follow-up Period|Subject Incarcerated|0|||
147482543|NCT00090285|531923064|FG003|Base Study Follow-up Period|Subject Incarcerated|0|||
147482544|NCT00090285|531923065|FG004|Base Study Follow-up Period|Subject Incarcerated|0|||
147482545|NCT00090285|531923066|FG005|Base Study Follow-up Period|Subject Incarcerated|0|||
147482546|NCT00090285|531923061|FG000|Extension 1|Adverse Event|0|||
147482547|NCT00090285|531923062|FG001|Extension 1|Adverse Event|0|||
147482548|NCT00090285|531923063|FG002|Extension 1|Adverse Event|2|||
147482549|NCT00090285|531923064|FG003|Extension 1|Adverse Event|0|||
147482550|NCT00090285|531923065|FG004|Extension 1|Adverse Event|0|||
147482551|NCT00090285|531923066|FG005|Extension 1|Adverse Event|0|||
147482552|NCT00090285|531923061|FG000|Extension 1|Lost to Follow-up|0|||
147482553|NCT00090285|531923062|FG001|Extension 1|Lost to Follow-up|0|||
147482554|NCT00090285|531923063|FG002|Extension 1|Lost to Follow-up|35|||
147482555|NCT00090285|531923064|FG003|Extension 1|Lost to Follow-up|0|||
147482556|NCT00090285|531923065|FG004|Extension 1|Lost to Follow-up|0|||
147482557|NCT00090285|531923066|FG005|Extension 1|Lost to Follow-up|0|||
147482558|NCT00090285|531923061|FG000|Extension 1|Withdrawal by Subject|0|||
147482559|NCT00090285|531923062|FG001|Extension 1|Withdrawal by Subject|0|||
147482560|NCT00090285|531923063|FG002|Extension 1|Withdrawal by Subject|13|||
147482561|NCT00090285|531923064|FG003|Extension 1|Withdrawal by Subject|1|||
147482562|NCT00090285|531923065|FG004|Extension 1|Withdrawal by Subject|0|||
147482563|NCT00090285|531923066|FG005|Extension 1|Withdrawal by Subject|0|||
147482564|NCT00090285|531923061|FG000|Extension 1|Other|0|||
147623149|NCT00360282|532438475|FG002|Second Intervention|Adverse Event|0|||
147623150|NCT00360282|532438476|FG003|Second Intervention|Adverse Event|0|||
147623151|NCT01293695|532438482|FG000|Overall Study|Withdrawal by Subject|7|||
147623152|NCT01293695|532438483|FG001|Overall Study|Withdrawal by Subject|1|||
147623153|NCT01293695|532438482|FG000|Overall Study|Lost to Follow-up|8|||
147623154|NCT01293695|532438483|FG001|Overall Study|Lost to Follow-up|6|||
147623155|NCT01082328|532438486|FG000|Overall Study|Adverse Event|1|||
147623156|NCT00031590|532438487|FG000|Overall Study|Adverse Event|1|||
147623157|NCT00031590|532438487|FG000|Overall Study|Withdrawal by parents|2|||
147623158|NCT01568892|532438488|FG000|Open-label Phase|Adverse Event|2|||
147623159|NCT01568892|532438489|FG001|Open-label Phase|Adverse Event|0|||
147623160|NCT01568892|532438488|FG000|Open-label Phase|Lack of Efficacy|4|||
147623161|NCT01568892|532438489|FG001|Open-label Phase|Lack of Efficacy|2|||
147623162|NCT01568892|532438488|FG000|Open-label Phase|Lost to Follow-up|0|||
147623163|NCT01568892|532438489|FG001|Open-label Phase|Lost to Follow-up|1|||
147623164|NCT02375971|532438496|FG000|Treatment (Day 1 - Baseline)|Subj/Guardian Decision|0|||
147623165|NCT02375971|532438497|FG001|Treatment (Day 1 - Baseline)|Subj/Guardian Decision|0|||
147623166|NCT02375971|532438498|FG002|Treatment (Day 1 - Baseline)|Subj/Guardian Decision|2|||
147623167|NCT02375971|532438496|FG000|Treatment (Day 1 - Baseline)|Physician Decision|1|||
147623168|NCT02375971|532438497|FG001|Treatment (Day 1 - Baseline)|Physician Decision|1|||
147623169|NCT02375971|532438498|FG002|Treatment (Day 1 - Baseline)|Physician Decision|1|||
147623170|NCT02375971|532438496|FG000|Treatment (Day 1 - Baseline)|Lost to Follow-up|0|||
147623171|NCT02375971|532438497|FG001|Treatment (Day 1 - Baseline)|Lost to Follow-up|0|||
147623172|NCT02375971|532438498|FG002|Treatment (Day 1 - Baseline)|Lost to Follow-up|1|||
147623173|NCT02375971|532438496|FG000|Treatment (Day 1 - Baseline)|Adverse Event|0|||
147623174|NCT02375971|532438497|FG001|Treatment (Day 1 - Baseline)|Adverse Event|0|||
147623175|NCT02375971|532438498|FG002|Treatment (Day 1 - Baseline)|Adverse Event|1|||
147623176|NCT02375971|532438496|FG000|Follow-Up Phase (up to Day 169)|Adverse Event|1|||
147623177|NCT02375971|532438497|FG001|Follow-Up Phase (up to Day 169)|Adverse Event|0|||
147623178|NCT02375971|532438498|FG002|Follow-Up Phase (up to Day 169)|Adverse Event|0|||
147667565|NCT01791595|532608101|FG006|Part 1 AZD3965 Cohort 4 (30 mg OD)|Evidence of disease progression|0|||
147667566|NCT01791595|532608095|FG000|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
147623179|NCT02375971|532438496|FG000|Follow-Up Phase (up to Day 169)|Subject/Guardian Decision|1|||
147482565|NCT00090285|531923062|FG001|Extension 1|Other|0|||
147482566|NCT00090285|531923063|FG002|Extension 1|Other|4|||
147482567|NCT00090285|531923064|FG003|Extension 1|Other|0|||
147482568|NCT00090285|531923065|FG004|Extension 1|Other|0|||
147482569|NCT00090285|531923066|FG005|Extension 1|Other|0|||
147482570|NCT00090285|531923061|FG000|Extension 1|Moved|0|||
147482571|NCT00090285|531923062|FG001|Extension 1|Moved|0|||
147482572|NCT00090285|531923063|FG002|Extension 1|Moved|3|||
147482573|NCT00090285|531923064|FG003|Extension 1|Moved|0|||
147482574|NCT00090285|531923065|FG004|Extension 1|Moved|0|||
147482575|NCT00090285|531923066|FG005|Extension 1|Moved|0|||
147623180|NCT02375971|532438497|FG001|Follow-Up Phase (up to Day 169)|Subject/Guardian Decision|0|||
147623181|NCT02375971|532438498|FG002|Follow-Up Phase (up to Day 169)|Subject/Guardian Decision|1|||
147623182|NCT02375971|532438496|FG000|Follow-Up Phase (up to Day 169)|Death|4|||
147623183|NCT02375971|532438497|FG001|Follow-Up Phase (up to Day 169)|Death|4|||
147623184|NCT02375971|532438498|FG002|Follow-Up Phase (up to Day 169)|Death|4|||
147482576|NCT00090285|531923061|FG000|Long-term Follow-up (EXT2)|Adverse Event|0|||
147482577|NCT00090285|531923062|FG001|Long-term Follow-up (EXT2)|Adverse Event|0|||
147482578|NCT00090285|531923063|FG002|Long-term Follow-up (EXT2)|Adverse Event|0|||
147482579|NCT00090285|531923064|FG003|Long-term Follow-up (EXT2)|Adverse Event|0|||
147482580|NCT00090285|531923065|FG004|Long-term Follow-up (EXT2)|Adverse Event|5|||
147482581|NCT00090285|531923066|FG005|Long-term Follow-up (EXT2)|Adverse Event|2|||
147482582|NCT00090285|531923061|FG000|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
147482583|NCT00090285|531923062|FG001|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
147482584|NCT00090285|531923063|FG002|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
147482585|NCT00090285|531923064|FG003|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
147482586|NCT00090285|531923065|FG004|Long-term Follow-up (EXT2)|Lost to Follow-up|156|||
147482587|NCT00090285|531923066|FG005|Long-term Follow-up (EXT2)|Lost to Follow-up|143|||
147482588|NCT00090285|531923061|FG000|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
147482589|NCT00090285|531923062|FG001|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
147482590|NCT00090285|531923063|FG002|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
147482591|NCT00090285|531923064|FG003|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
147482592|NCT00090285|531923065|FG004|Long-term Follow-up (EXT2)|Withdrawal by Subject|60|||
147482593|NCT00090285|531923066|FG005|Long-term Follow-up (EXT2)|Withdrawal by Subject|53|||
147482594|NCT00090285|531923061|FG000|Long-term Follow-up (EXT2)|Physician Decision|0|||
147482595|NCT00090285|531923062|FG001|Long-term Follow-up (EXT2)|Physician Decision|0|||
147482596|NCT00090285|531923063|FG002|Long-term Follow-up (EXT2)|Physician Decision|0|||
147482597|NCT00090285|531923064|FG003|Long-term Follow-up (EXT2)|Physician Decision|0|||
147482598|NCT00090285|531923065|FG004|Long-term Follow-up (EXT2)|Physician Decision|6|||
147623185|NCT02375971|532438496|FG000|Follow-Up Phase (up to Day 169)|Withdrawal of Consent|1|||
147623186|NCT02375971|532438497|FG001|Follow-Up Phase (up to Day 169)|Withdrawal of Consent|1|||
147623187|NCT02375971|532438498|FG002|Follow-Up Phase (up to Day 169)|Withdrawal of Consent|0|||
147623188|NCT02755103|532438499|FG000|Overall Study|Lost to Follow-up|17|||
147623189|NCT02755103|532438500|FG001|Overall Study|Lost to Follow-up|15|||
147623190|NCT02755103|532438499|FG000|Overall Study|Death|0|||
147623191|NCT02755103|532438500|FG001|Overall Study|Death|1|||
147623192|NCT02755103|532438499|FG000|Overall Study|Physician Decision|0|||
147623193|NCT02755103|532438500|FG001|Overall Study|Physician Decision|1|||
147623194|NCT02755103|532438499|FG000|Overall Study|Pregnancy|0|||
147623195|NCT02755103|532438500|FG001|Overall Study|Pregnancy|1|||
147623196|NCT02755103|532438499|FG000|Overall Study|Withdrawal by Subject|3|||
147623197|NCT02755103|532438500|FG001|Overall Study|Withdrawal by Subject|0|||
147623198|NCT04177095|532438501|FG000|Overall Study|Withdrawal by Subject|3|||
147623199|NCT04177095|532438501|FG000|Overall Study|Screen Failure|3|||
147623200|NCT04177095|532438501|FG000|Overall Study|Problems with the Trugraf assay|1|||
147623201|NCT00777296|532438502|FG000|Overall Study|Adverse Event|0|||
147623202|NCT00777296|532438503|FG001|Overall Study|Adverse Event|1|||
147623203|NCT00777296|532438504|FG002|Overall Study|Adverse Event|0|||
147623204|NCT00777296|532438505|FG003|Overall Study|Adverse Event|1|||
147623205|NCT00777296|532438502|FG000|Overall Study|Withdrawal by Subject|1|||
147623206|NCT00777296|532438503|FG001|Overall Study|Withdrawal by Subject|0|||
147623207|NCT00777296|532438504|FG002|Overall Study|Withdrawal by Subject|0|||
147623208|NCT00777296|532438505|FG003|Overall Study|Withdrawal by Subject|0|||
147623209|NCT00777296|532438502|FG000|Overall Study|CRF form not completed|0|||
147623210|NCT00777296|532438503|FG001|Overall Study|CRF form not completed|0|||
147623211|NCT00777296|532438504|FG002|Overall Study|CRF form not completed|2|||
147623212|NCT00777296|532438505|FG003|Overall Study|CRF form not completed|0|||
147623213|NCT00658723|532438506|FG000|Overall Study|Lost to Follow-up|0|||
147623214|NCT00658723|532438507|FG001|Overall Study|Lost to Follow-up|2|||
147623215|NCT00658723|532438508|FG002|Overall Study|Lost to Follow-up|2|||
147623216|NCT00658723|532438506|FG000|Overall Study|Death|2|||
147623217|NCT00658723|532438507|FG001|Overall Study|Death|1|||
147623218|NCT00658723|532438508|FG002|Overall Study|Death|4|||
147623219|NCT00658723|532438506|FG000|Overall Study|Scheduling Issue|1|||
147623220|NCT00658723|532438507|FG001|Overall Study|Scheduling Issue|1|||
147623221|NCT00658723|532438508|FG002|Overall Study|Scheduling Issue|0|||
147623222|NCT00658723|532438506|FG000|Overall Study|Withdrawal by Subject|1|||
147623223|NCT00658723|532438507|FG001|Overall Study|Withdrawal by Subject|0|||
147623224|NCT00658723|532438508|FG002|Overall Study|Withdrawal by Subject|1|||
147623225|NCT01139125|532438510|FG000|Overall Study|Withdrawal by Subject|1|||
147623226|NCT02172664|532438518|FG000|Overall Study|Lost to Follow-up|4|||
147623227|NCT02172664|532438519|FG001|Overall Study|Lost to Follow-up|4|||
147623228|NCT02172664|532438518|FG000|Overall Study|Death|1|||
147623229|NCT02172664|532438519|FG001|Overall Study|Death|1|||
147623230|NCT02172664|532438518|FG000|Overall Study|Moved out of area|1|||
147623231|NCT02172664|532438519|FG001|Overall Study|Moved out of area|1|||
147623232|NCT04760626|532438522|FG000|Overall Study|Withdrawal by Subject|24|||
147623233|NCT04760626|532438523|FG001|Overall Study|Withdrawal by Subject|20|||
147482599|NCT00090285|531923066|FG005|Long-term Follow-up (EXT2)|Physician Decision|5|||
147482600|NCT02855411|531923074|FG000|Overall Study|Study terminated by sponsor|21|||
147623234|NCT04760626|532438522|FG000|Overall Study|Lost to Follow-up|14|||
147623235|NCT04760626|532438523|FG001|Overall Study|Lost to Follow-up|19|||
147482601|NCT02855411|531923074|FG000|Overall Study|Does not meet entrance criteria|14|||
147482602|NCT00907881|531923075|FG000|Overall Study|Lost to Follow-up|59|||
147482603|NCT00907881|531923075|FG000|Overall Study|Noncompliance|5|||
147482604|NCT00907881|531923075|FG000|Overall Study|Withdrawal by Subject|5|||
147482605|NCT00907881|531923075|FG000|Overall Study|Protocol Violation|1|||
147482606|NCT00907881|531923075|FG000|Overall Study|Missing discontinuation information|15|||
147482607|NCT00850499|531923085|FG000|Overall Study|Adverse Event|3|||
147482608|NCT00850499|531923086|FG001|Overall Study|Adverse Event|1|||
147482609|NCT00850499|531923085|FG000|Overall Study|Lack of Efficacy|0|||
147482610|NCT00850499|531923086|FG001|Overall Study|Lack of Efficacy|1|||
147482611|NCT02385123|531923087|FG000|Overall Study|15 participants were unable to complete study. Research was halted due to Coronavirus Disease 2019.|15|||
147482612|NCT04498910|531923091|FG000|Overall Study|Lost to Follow-up|0|||
147482613|NCT04498910|531923092|FG001|Overall Study|Lost to Follow-up|1|||
147482614|NCT04498910|531923091|FG000|Overall Study|Withdrawal by Subject|2|||
147482615|NCT04498910|531923092|FG001|Overall Study|Withdrawal by Subject|1|||
147482616|NCT04498910|531923091|FG000|Overall Study|Adverse Event|1|||
147482617|NCT04498910|531923092|FG001|Overall Study|Adverse Event|0|||
147482618|NCT02345434|531923095|FG000|Overall Study|Deceased (excluded from intervention and analysis)|5|||
147482619|NCT02345434|531923096|FG001|Overall Study|Deceased (excluded from intervention and analysis)|2|||
147482620|NCT01022853|531923098|FG000|Overall Study|Progressive disease|2|||
147482621|NCT01022853|531923099|FG001|Overall Study|Progressive disease|3|||
147482622|NCT01022853|531923100|FG002|Overall Study|Progressive disease|11|||
147482623|NCT01022853|531923101|FG003|Overall Study|Progressive disease|7|||
147482624|NCT01022853|531923102|FG004|Overall Study|Progressive disease|1|||
147482625|NCT01022853|531923098|FG000|Overall Study|Dose-limiting toxicity|0|||
147482626|NCT01022853|531923099|FG001|Overall Study|Dose-limiting toxicity|0|||
147482627|NCT01022853|531923100|FG002|Overall Study|Dose-limiting toxicity|0|||
147482628|NCT01022853|531923101|FG003|Overall Study|Dose-limiting toxicity|0|||
147482629|NCT01022853|531923102|FG004|Overall Study|Dose-limiting toxicity|1|||
147482630|NCT01022853|531923098|FG000|Overall Study|Withdrawal by Subject|0|||
147482631|NCT01022853|531923099|FG001|Overall Study|Withdrawal by Subject|1|||
147482632|NCT01022853|531923100|FG002|Overall Study|Withdrawal by Subject|1|||
147482633|NCT01022853|531923101|FG003|Overall Study|Withdrawal by Subject|1|||
147482634|NCT01022853|531923102|FG004|Overall Study|Withdrawal by Subject|0|||
147482635|NCT01022853|531923098|FG000|Overall Study|Other not stated above|1|||
147482636|NCT01022853|531923099|FG001|Overall Study|Other not stated above|0|||
147482637|NCT01022853|531923100|FG002|Overall Study|Other not stated above|1|||
147482638|NCT01022853|531923101|FG003|Overall Study|Other not stated above|0|||
147482639|NCT01022853|531923102|FG004|Overall Study|Other not stated above|0|||
147482640|NCT01327339|531923103|FG000|Overall Study|Protocol Violation|8|||
147482641|NCT03245814|531923104|FG000|Overall Study|Lost to Follow-up|5|||
147482642|NCT03245814|531923105|FG001|Overall Study|Lost to Follow-up|8|||
147482643|NCT03245814|531923104|FG000|Overall Study|Excluded (did not receive allocated condition)|10|||
147482644|NCT03245814|531923105|FG001|Overall Study|Excluded (did not receive allocated condition)|4|||
147482645|NCT02263365|531923109|FG000|Overall Study|Physician Decision|22|||
147482646|NCT02263365|531923110|FG001|Overall Study|Physician Decision|18|||
147482647|NCT00510692|531923111|FG000|Overall Study|Adverse Event|1|||
147482648|NCT00510692|531923112|FG001|Overall Study|Adverse Event|3|||
147482649|NCT00510692|531923111|FG000|Overall Study|Withdrawal by Subject|1|||
147482650|NCT00510692|531923112|FG001|Overall Study|Withdrawal by Subject|0|||
147482651|NCT00945191|531923113|FG000|Overall Study|Did not achieve a complete response|18|||
147482652|NCT00945191|531923113|FG000|Overall Study|Participant relocated to another state|1|||
147482653|NCT00945191|531923113|FG000|Overall Study|Disease progression|3|||
147482654|NCT00945191|531923113|FG000|Overall Study|Serious adverse event or adverse event|1|||
147482655|NCT00945191|531923113|FG000|Overall Study|Investigator's discretion|1|||
147482656|NCT00784784|531923114|FG000|Overall Study|Withdrawal by Subject|2|||
147482657|NCT00784784|531923115|FG001|Overall Study|Withdrawal by Subject|2|||
147482658|NCT01004146|531923116|FG000|Overall Study|Withdrawal by Subject|4|||
147482659|NCT01004146|531923117|FG001|Overall Study|Withdrawal by Subject|5|||
147623236|NCT04760626|532438522|FG000|Overall Study|Physician Decision|3|||
147623237|NCT04760626|532438523|FG001|Overall Study|Physician Decision|5|||
147623238|NCT04760626|532438522|FG000|Overall Study|Death|3|||
147623239|NCT04760626|532438523|FG001|Overall Study|Death|6|||
147623240|NCT04760626|532438522|FG000|Overall Study|Site closure|1|||
147623241|NCT04760626|532438523|FG001|Overall Study|Site closure|0|||
147623242|NCT03193853|532438526|FG000|Overall Study|Death|6|||
147482660|NCT03290300|531923124|FG000|Overall Study|Lost to Follow-up|3|||
147482661|NCT01001494|531923125|FG000|Overall Study|Adverse Event|8|||
147482662|NCT01001494|531923126|FG001|Overall Study|Adverse Event|4|||
147482663|NCT01001494|531923127|FG002|Overall Study|Adverse Event|6|||
147482664|NCT01001494|531923125|FG000|Overall Study|Protocol Violation|0|||
147482665|NCT01001494|531923126|FG001|Overall Study|Protocol Violation|1|||
147482666|NCT01001494|531923127|FG002|Overall Study|Protocol Violation|1|||
147482667|NCT01001494|531923125|FG000|Overall Study|Lost to Follow-up|2|||
147482668|NCT01001494|531923126|FG001|Overall Study|Lost to Follow-up|0|||
147482669|NCT01001494|531923127|FG002|Overall Study|Lost to Follow-up|1|||
147482670|NCT01001494|531923125|FG000|Overall Study|Withdrawal by Subject|9|||
147482671|NCT01001494|531923126|FG001|Overall Study|Withdrawal by Subject|7|||
147482672|NCT01001494|531923127|FG002|Overall Study|Withdrawal by Subject|17|||
147482673|NCT01001494|531923125|FG000|Overall Study|COPD exacerbation|3|||
147482674|NCT01001494|531923126|FG001|Overall Study|COPD exacerbation|4|||
147482675|NCT01001494|531923127|FG002|Overall Study|COPD exacerbation|5|||
147482676|NCT01001494|531923125|FG000|Overall Study|Lack of Efficacy|2|||
147482677|NCT01001494|531923126|FG001|Overall Study|Lack of Efficacy|0|||
147482678|NCT01001494|531923127|FG002|Overall Study|Lack of Efficacy|8|||
147482679|NCT01001494|531923125|FG000|Overall Study|Other|0|||
147482680|NCT01001494|531923126|FG001|Overall Study|Other|1|||
147482681|NCT01001494|531923127|FG002|Overall Study|Other|3|||
147482682|NCT01696877|531923134|FG000|Overall Study|Adverse Event|0|||
147482683|NCT01696877|531923135|FG001|Overall Study|Adverse Event|1|||
147482684|NCT00515463|531923136|FG000|Overall Study|Physician Decision|4|||
147482685|NCT00515463|531923137|FG001|Overall Study|Physician Decision|2|||
147482686|NCT00515463|531923136|FG000|Overall Study|Adverse Event|1|||
147482687|NCT00515463|531923137|FG001|Overall Study|Adverse Event|2|||
147482688|NCT00515463|531923136|FG000|Overall Study|Withdrawal by Subject|3|||
147482689|NCT00515463|531923137|FG001|Overall Study|Withdrawal by Subject|4|||
147482690|NCT00515463|531923136|FG000|Overall Study|Lost to Follow-up|6|||
147482691|NCT00515463|531923137|FG001|Overall Study|Lost to Follow-up|5|||
147482692|NCT00515463|531923136|FG000|Overall Study|Other|0|||
147482693|NCT00515463|531923137|FG001|Overall Study|Other|1|||
147482694|NCT00916721|531923138|FG000|Overall Study|Lost to Follow-up|0|||
147482695|NCT00916721|531923139|FG001|Overall Study|Lost to Follow-up|1|||
147482696|NCT00916721|531923138|FG000|Overall Study|Adverse Event|6|||
147482697|NCT00916721|531923139|FG001|Overall Study|Adverse Event|3|||
147482698|NCT00916721|531923138|FG000|Overall Study|Withdrawal by Subject|2|||
147482699|NCT00916721|531923139|FG001|Overall Study|Withdrawal by Subject|2|||
147482700|NCT00916721|531923138|FG000|Overall Study|Protocol Violation|2|||
147482701|NCT00916721|531923139|FG001|Overall Study|Protocol Violation|4|||
147482702|NCT01903434|531923143|FG000|Washout Period 1 (at Least 14 Days)|Adverse Event|1|||
147482703|NCT01903434|531923144|FG001|Washout Period 1 (at Least 14 Days)|Adverse Event|0|||
147482704|NCT01903434|531923143|FG000|Washout Period 1 (at Least 14 Days)|Withdrawal by Subject|0|||
147482705|NCT01903434|531923144|FG001|Washout Period 1 (at Least 14 Days)|Withdrawal by Subject|2|||
147482706|NCT01469052|531923145|FG000|Overall Study|Adverse Event|2|||
147482707|NCT01469052|531923146|FG001|Overall Study|Adverse Event|3|||
147482708|NCT01469052|531923147|FG002|Overall Study|Adverse Event|0|||
147482709|NCT01469052|531923148|FG003|Overall Study|Adverse Event|2|||
147482710|NCT01469052|531923149|FG004|Overall Study|Adverse Event|0|||
147482711|NCT01469052|531923150|FG005|Overall Study|Adverse Event|1|||
147482712|NCT01469052|531923145|FG000|Overall Study|Progressive disease|3|||
147482713|NCT01469052|531923146|FG001|Overall Study|Progressive disease|0|||
147482714|NCT01469052|531923147|FG002|Overall Study|Progressive disease|5|||
147482715|NCT01469052|531923148|FG003|Overall Study|Progressive disease|3|||
147482716|NCT01469052|531923149|FG004|Overall Study|Progressive disease|7|||
147482717|NCT01469052|531923150|FG005|Overall Study|Progressive disease|2|||
147482718|NCT01469052|531923145|FG000|Overall Study|Lack of Efficacy|0|||
147482719|NCT01469052|531923146|FG001|Overall Study|Lack of Efficacy|0|||
147482720|NCT01469052|531923147|FG002|Overall Study|Lack of Efficacy|0|||
147482721|NCT01469052|531923148|FG003|Overall Study|Lack of Efficacy|0|||
147482722|NCT01469052|531923149|FG004|Overall Study|Lack of Efficacy|0|||
147482723|NCT01469052|531923150|FG005|Overall Study|Lack of Efficacy|2|||
147482724|NCT01469052|531923145|FG000|Overall Study|Moved to rollover protocol|1|||
147482725|NCT01469052|531923146|FG001|Overall Study|Moved to rollover protocol|0|||
147482726|NCT01469052|531923147|FG002|Overall Study|Moved to rollover protocol|1|||
147482727|NCT01469052|531923148|FG003|Overall Study|Moved to rollover protocol|0|||
147482728|NCT01469052|531923149|FG004|Overall Study|Moved to rollover protocol|0|||
147482729|NCT01469052|531923150|FG005|Overall Study|Moved to rollover protocol|1|||
147482730|NCT01469052|531923145|FG000|Overall Study|Other|0|||
147482731|NCT01469052|531923146|FG001|Overall Study|Other|1|||
147482732|NCT01469052|531923147|FG002|Overall Study|Other|0|||
147482733|NCT01469052|531923148|FG003|Overall Study|Other|0|||
147482734|NCT01469052|531923149|FG004|Overall Study|Other|1|||
147482735|NCT01469052|531923150|FG005|Overall Study|Other|0|||
147482736|NCT00404768|531923153|FG000|Part A and B|Withdrawn due to labor progression|1|||
147482737|NCT00404768|531923154|FG001|Part A and B|Withdrawn due to labor progression|0|||
147482738|NCT00404768|531923155|FG002|Part A and B|Withdrawn due to labor progression|0|||
147482739|NCT00404768|531923156|FG003|Part A and B|Withdrawn due to labor progression|0|||
147482740|NCT00404768|531923153|FG000|Part A and B|Withdrawn as delivery imminemnt|0|||
147482741|NCT00404768|531923154|FG001|Part A and B|Withdrawn as delivery imminemnt|1|||
147482742|NCT00404768|531923155|FG002|Part A and B|Withdrawn as delivery imminemnt|0|||
147482743|NCT00404768|531923156|FG003|Part A and B|Withdrawn as delivery imminemnt|0|||
147482744|NCT00404768|531923153|FG000|Part C|Adverse Event|0|||
147482745|NCT00404768|531923154|FG001|Part C|Adverse Event|0|||
147482746|NCT00404768|531923155|FG002|Part C|Adverse Event|0|||
147482747|NCT00404768|531923156|FG003|Part C|Adverse Event|3|||
147482748|NCT00404768|531923153|FG000|Part C|Lost to Follow-up|0|||
147482749|NCT00404768|531923154|FG001|Part C|Lost to Follow-up|0|||
147482750|NCT00404768|531923155|FG002|Part C|Lost to Follow-up|3|||
147482751|NCT00404768|531923156|FG003|Part C|Lost to Follow-up|1|||
147482752|NCT00404768|531923153|FG000|Part C|Withdrawal by Subject|0|||
147482753|NCT00404768|531923154|FG001|Part C|Withdrawal by Subject|0|||
147482754|NCT00404768|531923155|FG002|Part C|Withdrawal by Subject|2|||
147482755|NCT00404768|531923156|FG003|Part C|Withdrawal by Subject|1|||
147482756|NCT00404768|531923153|FG000|Part C|Early withdrawal from study medication|0|||
147482757|NCT00404768|531923154|FG001|Part C|Early withdrawal from study medication|0|||
147482758|NCT00404768|531923155|FG002|Part C|Early withdrawal from study medication|1|||
147482759|NCT00404768|531923156|FG003|Part C|Early withdrawal from study medication|0|||
147482760|NCT00404768|531923153|FG000|Part C|Participant did not respond to therapy|0|||
147482761|NCT00404768|531923154|FG001|Part C|Participant did not respond to therapy|0|||
147482762|NCT00404768|531923155|FG002|Part C|Participant did not respond to therapy|1|||
147482763|NCT00404768|531923156|FG003|Part C|Participant did not respond to therapy|1|||
147482764|NCT00404768|531923153|FG000|Part C|Physician withdrew the study medication|0|||
147482765|NCT00404768|531923154|FG001|Part C|Physician withdrew the study medication|0|||
147482766|NCT00404768|531923155|FG002|Part C|Physician withdrew the study medication|1|||
147482767|NCT00404768|531923156|FG003|Part C|Physician withdrew the study medication|0|||
147482768|NCT00404768|531923153|FG000|Part C|Participant delivered baby|0|||
147482769|NCT00404768|531923154|FG001|Part C|Participant delivered baby|0|||
147482770|NCT00404768|531923155|FG002|Part C|Participant delivered baby|0|||
147482771|NCT00404768|531923156|FG003|Part C|Participant delivered baby|1|||
147482772|NCT00404768|531923153|FG000|Part C|Unsatisfactory uterine response to IP|0|||
147482773|NCT00404768|531923154|FG001|Part C|Unsatisfactory uterine response to IP|0|||
147482774|NCT00404768|531923155|FG002|Part C|Unsatisfactory uterine response to IP|0|||
147482775|NCT00404768|531923156|FG003|Part C|Unsatisfactory uterine response to IP|1|||
147482776|NCT00404768|531923153|FG000|Part C|Active labor|0|||
147482777|NCT00404768|531923154|FG001|Part C|Active labor|0|||
147482778|NCT00404768|531923155|FG002|Part C|Active labor|0|||
147482779|NCT00404768|531923156|FG003|Part C|Active labor|1|||
147482780|NCT00404768|531923153|FG000|Part C|Lack of Efficacy|0|||
147482781|NCT00404768|531923154|FG001|Part C|Lack of Efficacy|0|||
147482782|NCT00404768|531923155|FG002|Part C|Lack of Efficacy|0|||
147482783|NCT00404768|531923156|FG003|Part C|Lack of Efficacy|2|||
147482784|NCT00404768|531923153|FG000|Part C|Treatment failure|0|||
147482785|NCT00404768|531923154|FG001|Part C|Treatment failure|0|||
147482786|NCT00404768|531923155|FG002|Part C|Treatment failure|0|||
147482787|NCT00404768|531923156|FG003|Part C|Treatment failure|1|||
147482788|NCT00404768|531923153|FG000|Part C|Investigator discretion|0|||
147482789|NCT00404768|531923154|FG001|Part C|Investigator discretion|0|||
147482790|NCT00404768|531923155|FG002|Part C|Investigator discretion|0|||
147482791|NCT00404768|531923156|FG003|Part C|Investigator discretion|1|||
147482792|NCT00404768|531923153|FG000|Part C|Researcher suspended study medication|0|||
147482793|NCT00404768|531923154|FG001|Part C|Researcher suspended study medication|0|||
147482794|NCT00404768|531923155|FG002|Part C|Researcher suspended study medication|0|||
147482795|NCT00404768|531923156|FG003|Part C|Researcher suspended study medication|1|||
147482796|NCT03575468|531923157|FG000|Overall Study|Withdrawal by Subject|3|||
147482797|NCT03575468|531923158|FG001|Overall Study|Withdrawal by Subject|0|||
147482798|NCT03575468|531923157|FG000|Overall Study|Call 1 completion required to stay in study per consent process (not contacted for 3-month survey)|10|||
147482799|NCT03575468|531923158|FG001|Overall Study|Call 1 completion required to stay in study per consent process (not contacted for 3-month survey)|4|||
147482800|NCT03575468|531923157|FG000|Overall Study|Lost to Follow-up|13|||
147482801|NCT03575468|531923158|FG001|Overall Study|Lost to Follow-up|17|||
147482802|NCT04773041|531923161|FG000|Overall Study|Unable to data match|1|||
147482803|NCT04773041|531923162|FG001|Overall Study|Unable to data match|0|||
147482804|NCT04773041|531923163|FG002|Overall Study|Unable to data match|0|||
147482805|NCT00128206|531924797|FG000|Overall Study|Lost to Follow-up|137|||
147482806|NCT00128206|531924798|FG001|Overall Study|Lost to Follow-up|118|||
147482807|NCT00128206|531924797|FG000|Overall Study|Adverse Event|0|||
147482808|NCT00128206|531924798|FG001|Overall Study|Adverse Event|2|||
147482809|NCT01597622|531924801|FG000|Overall Study|Adverse Event|7|||
147623243|NCT01787292|532438530|FG000|Crossover Exercise Interventions|Withdrawal by Subject|2|||
147623244|NCT01787292|532438531|FG001|Crossover Exercise Interventions|Withdrawal by Subject|2|||
147482810|NCT01597622|531924801|FG000|Overall Study|Lack of Efficacy|3|||
147482811|NCT01597622|531924801|FG000|Overall Study|Protocol Violation|1|||
147482812|NCT01597622|531924801|FG000|Overall Study|Lost to Follow-up|1|||
147482813|NCT01597622|531924801|FG000|Overall Study|Investigator Discretion|5|||
147482814|NCT01597622|531924801|FG000|Overall Study|Withdrawal by Subject|20|||
147482815|NCT01597622|531924801|FG000|Overall Study|Death|1|||
147482816|NCT03132805|531924804|FG000|Overall Study|Lost to Follow-up|142|||
147482817|NCT03132805|531924805|FG001|Overall Study|Lost to Follow-up|141|||
147482818|NCT03132805|531924806|FG002|Overall Study|Lost to Follow-up|113|||
147482819|NCT03009539|531924807|FG000|Overall Study|Lost to Follow-up|132|||
147482820|NCT03009539|531924808|FG001|Overall Study|Lost to Follow-up|113|||
147482821|NCT03009539|531924809|FG002|Overall Study|Lost to Follow-up|132|||
147482822|NCT03009539|531924810|FG003|Overall Study|Lost to Follow-up|113|||
147482823|NCT03151148|531924811|FG000|Overall Study|Lost to Follow-up|1|||
147482824|NCT03151148|531924812|FG001|Overall Study|Lost to Follow-up|0|||
147482825|NCT03151148|531924811|FG000|Overall Study|Withdrawal by Subject|1|||
147482826|NCT03151148|531924812|FG001|Overall Study|Withdrawal by Subject|0|||
147482827|NCT00710034|531924813|FG000|Completed 6 Weeks of Treatment|Adverse Event|5|||
147482828|NCT00710034|531924814|FG001|Completed 6 Weeks of Treatment|Adverse Event|12|||
147482829|NCT00710034|531924813|FG000|Completed 6 Weeks of Treatment|Lack of Efficacy|12|||
147482830|NCT00710034|531924814|FG001|Completed 6 Weeks of Treatment|Lack of Efficacy|8|||
147482831|NCT00710034|531924813|FG000|Completed 6 Weeks of Treatment|Lost to Follow-up|15|||
147482832|NCT00710034|531924814|FG001|Completed 6 Weeks of Treatment|Lost to Follow-up|17|||
147482833|NCT00710034|531924813|FG000|Completed 6 Weeks of Treatment|Product dissatisfaction|2|||
147482834|NCT00710034|531924814|FG001|Completed 6 Weeks of Treatment|Product dissatisfaction|6|||
147482835|NCT00710034|531924813|FG000|Completed 6 Weeks of Treatment|Withdrawal by Subject|6|||
147482836|NCT00710034|531924814|FG001|Completed 6 Weeks of Treatment|Withdrawal by Subject|4|||
147482837|NCT00710034|531924813|FG000|Completed 6 Weeks of Treatment|Physician Decision|1|||
147482838|NCT00710034|531924814|FG001|Completed 6 Weeks of Treatment|Physician Decision|0|||
147482839|NCT00710034|531924813|FG000|Completed 12 Weeks of Treatment|Adverse Event|0|||
147482840|NCT00710034|531924814|FG001|Completed 12 Weeks of Treatment|Adverse Event|1|||
147482841|NCT00710034|531924813|FG000|Completed 12 Weeks of Treatment|Lack of Efficacy|0|||
147482842|NCT00710034|531924814|FG001|Completed 12 Weeks of Treatment|Lack of Efficacy|2|||
147482843|NCT00710034|531924813|FG000|Completed 12 Weeks of Treatment|Lost to Follow-up|5|||
147482844|NCT00710034|531924814|FG001|Completed 12 Weeks of Treatment|Lost to Follow-up|5|||
147482845|NCT00710034|531924813|FG000|Completed 12 Weeks of Treatment|Product Dissatisfaction|0|||
147482846|NCT00710034|531924814|FG001|Completed 12 Weeks of Treatment|Product Dissatisfaction|1|||
147482847|NCT00710034|531924813|FG000|Completed 12 Weeks of Treatment|Withdrawal by Subject|8|||
147482848|NCT00710034|531924814|FG001|Completed 12 Weeks of Treatment|Withdrawal by Subject|2|||
147482849|NCT00494871|531924815|FG000|Double-blind (DB) Treatment Period|Adverse Event|73|||
147482850|NCT00494871|531924816|FG001|Double-blind (DB) Treatment Period|Adverse Event|70|||
147482851|NCT00494871|531924815|FG000|Double-blind (DB) Treatment Period|Withdrawal by Subject|26|||
147482852|NCT00494871|531924816|FG001|Double-blind (DB) Treatment Period|Withdrawal by Subject|35|||
147482853|NCT00494871|531924815|FG000|Double-blind (DB) Treatment Period|Death|8|||
147482854|NCT00494871|531924816|FG001|Double-blind (DB) Treatment Period|Death|3|||
147482855|NCT00494871|531924815|FG000|Double-blind (DB) Treatment Period|Physician Decision|4|||
147623245|NCT01787292|532438530|FG000|Home Based Exercise Program|Withdrawal by Subject|3|||
147623246|NCT01787292|532438531|FG001|Home Based Exercise Program|Withdrawal by Subject|1|||
147623247|NCT01827111|532438532|FG000|Overall Study|Disease Progression|1|||
147623248|NCT02962648|532438533|FG000|Overall Study|Withdrawal by Subject|3|||
147623249|NCT02962648|532438533|FG000|Overall Study|Lost to Follow-up|3|||
147623250|NCT02962648|532438533|FG000|Overall Study|Physician Decision|1|||
147303217|NCT02173054|531276277|FG000|Overall Study|Withdrawal by Subject|0|||
147303218|NCT02173054|531276278|FG001|Overall Study|Withdrawal by Subject|0|||
147303219|NCT02173054|531276279|FG002|Overall Study|Withdrawal by Subject|1|||
147303220|NCT01114204|531276280|FG000|Overall Study|Adverse Event|3|||
147303221|NCT01114204|531276281|FG001|Overall Study|Adverse Event|2|||
147303222|NCT01114204|531276280|FG000|Overall Study|Lost to Follow-up|1|||
147303223|NCT01114204|531276281|FG001|Overall Study|Lost to Follow-up|0|||
147303224|NCT01114204|531276280|FG000|Overall Study|Withdrawal by Subject|10|||
147303225|NCT01114204|531276281|FG001|Overall Study|Withdrawal by Subject|6|||
147303226|NCT01114204|531276280|FG000|Overall Study|Death|1|||
147303227|NCT01114204|531276281|FG001|Overall Study|Death|0|||
147303228|NCT01114204|531276280|FG000|Overall Study|Other-Personal reasons|2|||
147303229|NCT01114204|531276281|FG001|Overall Study|Other-Personal reasons|0|||
147303230|NCT01114204|531276280|FG000|Overall Study|Other-Medical monitor request|1|||
147303231|NCT01114204|531276281|FG001|Overall Study|Other-Medical monitor request|0|||
147303232|NCT01114204|531276280|FG000|Overall Study|Other-Participant request|2|||
147303233|NCT01114204|531276281|FG001|Overall Study|Other-Participant request|0|||
147303234|NCT01114204|531276280|FG000|Overall Study|Other-Protocol Violation|1|||
147303235|NCT01114204|531276281|FG001|Overall Study|Other-Protocol Violation|0|||
147303236|NCT00991341|531276286|FG000|Overall Study|no surgery w/in 30 days of randomization|11|||
147303237|NCT00991341|531276287|FG001|Overall Study|no surgery w/in 30 days of randomization|18|||
147623251|NCT02962648|532438533|FG000|Overall Study|Subject had problems with transportation|2|||
147303238|NCT00991341|531276286|FG000|Overall Study|Death|3|||
147303239|NCT00991341|531276287|FG001|Overall Study|Death|0|||
147303240|NCT00991341|531276286|FG000|Overall Study|no RBCs received 96hrs after randomized|186|||
147303241|NCT00991341|531276287|FG001|Overall Study|no RBCs received 96hrs after randomized|155|||
147303242|NCT00991341|531276286|FG000|Overall Study|Physician Decision|1|||
147303243|NCT00991341|531276287|FG001|Overall Study|Physician Decision|2|||
147303244|NCT00991341|531276286|FG000|Overall Study|Withdrawal by Subject|3|||
147303245|NCT00991341|531276287|FG001|Overall Study|Withdrawal by Subject|4|||
147303246|NCT03010462|531276302|FG000|Overall Study|Withdrawal by Subject|3|||
147303247|NCT03010462|531276303|FG001|Overall Study|Withdrawal by Subject|1|||
147303248|NCT02799472|531276306|FG000|Overall Study|Withdrawal by Subject|2|||
147303249|NCT02799472|531276307|FG001|Overall Study|Withdrawal by Subject|4|||
147303250|NCT02799472|531276306|FG000|Overall Study|Lack of Efficacy|2|||
147303251|NCT02799472|531276307|FG001|Overall Study|Lack of Efficacy|0|||
147303252|NCT02799472|531276306|FG000|Overall Study|Lost to Follow-up|0|||
147303253|NCT02799472|531276307|FG001|Overall Study|Lost to Follow-up|1|||
147303254|NCT02007434|531276308|FG000|Overall Study|Lost to Follow-up|0|||
147303255|NCT02007434|531276309|FG001|Overall Study|Lost to Follow-up|1|||
147303256|NCT02007434|531276310|FG002|Overall Study|Lost to Follow-up|0|||
147303257|NCT02007434|531276311|FG003|Overall Study|Lost to Follow-up|0|||
147303258|NCT02007434|531276312|FG004|Overall Study|Lost to Follow-up|0|||
147303259|NCT02007434|531276313|FG005|Overall Study|Lost to Follow-up|0|||
147303260|NCT02007434|531276314|FG006|Overall Study|Lost to Follow-up|0|||
147303261|NCT02007434|531276315|FG007|Overall Study|Lost to Follow-up|0|||
147303262|NCT02007434|531276308|FG000|Overall Study|Non-compliance|1|||
147303263|NCT02007434|531276309|FG001|Overall Study|Non-compliance|0|||
147303264|NCT02007434|531276310|FG002|Overall Study|Non-compliance|1|||
147303265|NCT02007434|531276311|FG003|Overall Study|Non-compliance|0|||
147303266|NCT02007434|531276312|FG004|Overall Study|Non-compliance|0|||
147303267|NCT02007434|531276313|FG005|Overall Study|Non-compliance|0|||
147303268|NCT02007434|531276314|FG006|Overall Study|Non-compliance|0|||
147303269|NCT02007434|531276315|FG007|Overall Study|Non-compliance|0|||
147303270|NCT04074590|531276318|FG000|Overall Study|Adverse Event|1|||
147303271|NCT04074590|531276319|FG001|Overall Study|Adverse Event|0|||
147303272|NCT04074590|531276318|FG000|Overall Study|Physician Decision|1|||
147303273|NCT04074590|531276319|FG001|Overall Study|Physician Decision|0|||
147303274|NCT04074590|531276318|FG000|Overall Study|Withdrawal by Subject|2|||
147482856|NCT00494871|531924816|FG001|Double-blind (DB) Treatment Period|Physician Decision|13|||
147482857|NCT00494871|531924815|FG000|Double-blind (DB) Treatment Period|Lost to Follow-up|4|||
147482858|NCT00494871|531924816|FG001|Double-blind (DB) Treatment Period|Lost to Follow-up|1|||
147482859|NCT00494871|531924815|FG000|Double-blind (DB) Treatment Period|Protocol Violation|9|||
147482860|NCT00494871|531924816|FG001|Double-blind (DB) Treatment Period|Protocol Violation|9|||
147482861|NCT00494871|531924815|FG000|Double-blind (DB) Treatment Period|Clinical Endpoint Reached|18|||
147482862|NCT00494871|531924816|FG001|Double-blind (DB) Treatment Period|Clinical Endpoint Reached|28|||
147482863|NCT00494871|531924815|FG000|Double-blind (DB) Treatment Period|Non-compliant with Study Medication|3|||
147482864|NCT00494871|531924816|FG001|Double-blind (DB) Treatment Period|Non-compliant with Study Medication|1|||
147482865|NCT00494871|531924815|FG000|Double-blind (DB) Treatment Period|Protocol Driven Decision Point|12|||
147482866|NCT00494871|531924816|FG001|Double-blind (DB) Treatment Period|Protocol Driven Decision Point|8|||
147303275|NCT04074590|531276319|FG001|Overall Study|Withdrawal by Subject|0|||
147303276|NCT00792103|531276332|FG000|Overall Study|Enrolled, not treated|15|||
147303277|NCT00792103|531276332|FG000|Overall Study|Lost to Follow-up|17|||
147303278|NCT00792103|531276332|FG000|Overall Study|Adverse Event|25|||
147303279|NCT00792103|531276332|FG000|Overall Study|Withdrawal by Subject|52|||
147303280|NCT00792103|531276332|FG000|Overall Study|Protocol Violation|10|||
147303281|NCT00792103|531276332|FG000|Overall Study|Did not apply 6 patches in 1st 3 mths|14|||
147303282|NCT03745222|531276333|FG000|Overall Study|Withdrawal by Subject|0|||
147303283|NCT03745222|531276334|FG001|Overall Study|Withdrawal by Subject|1|||
147482867|NCT00494871|531924815|FG000|Double-blind (DB) Treatment Period|Site Closed by Investigator|1|||
147482868|NCT00494871|531924816|FG001|Double-blind (DB) Treatment Period|Site Closed by Investigator|2|||
147482869|NCT00494871|531924815|FG000|Double-blind (DB) Treatment Period|Site Closed by Sponsor|1|||
147482870|NCT00494871|531924816|FG001|Double-blind (DB) Treatment Period|Site Closed by Sponsor|1|||
147482871|NCT00494871|531924815|FG000|Double-blind (DB) Treatment Period|Drop out before Treatment Start|1|||
147482872|NCT00494871|531924816|FG001|Double-blind (DB) Treatment Period|Drop out before Treatment Start|1|||
147482873|NCT00494871|531924815|FG000|Follow-up (FU) Period|Adverse Event|1|||
147482874|NCT00494871|531924816|FG001|Follow-up (FU) Period|Adverse Event|1|||
147482875|NCT00494871|531924815|FG000|Follow-up (FU) Period|Death|13|||
147482876|NCT00494871|531924816|FG001|Follow-up (FU) Period|Death|12|||
147482877|NCT00494871|531924815|FG000|Follow-up (FU) Period|Lost to Follow-up|6|||
147482878|NCT00494871|531924816|FG001|Follow-up (FU) Period|Lost to Follow-up|2|||
147482879|NCT00494871|531924815|FG000|Follow-up (FU) Period|Physician Decision|0|||
147482880|NCT00494871|531924816|FG001|Follow-up (FU) Period|Physician Decision|1|||
147482881|NCT00494871|531924815|FG000|Follow-up (FU) Period|Protocol Violation|1|||
147303284|NCT03745222|531276335|FG002|Overall Study|Withdrawal by Subject|0|||
147482882|NCT00494871|531924816|FG001|Follow-up (FU) Period|Protocol Violation|0|||
147482883|NCT00494871|531924815|FG000|Follow-up (FU) Period|Withdrawal by Subject|5|||
147482884|NCT00494871|531924816|FG001|Follow-up (FU) Period|Withdrawal by Subject|5|||
147482885|NCT00494871|531924815|FG000|Follow-up (FU) Period|Clinical Endpoint Reached|3|||
147482886|NCT00494871|531924816|FG001|Follow-up (FU) Period|Clinical Endpoint Reached|2|||
147482887|NCT04543955|531924817|FG000|Overall Study|Company cancelled study|1|||
147623252|NCT03267212|532438534|FG000|First Intervention|Lost to Follow-up|0|||
147623253|NCT03267212|532438535|FG001|First Intervention|Lost to Follow-up|2|||
147303285|NCT02535364|531276336|FG000|Part A Screening Through Leukapheresis|Failure to meet criteria for Part A|22|||
147303286|NCT02535364|531276336|FG000|Part A Screening Through Leukapheresis|Study placed on clinical hold by FDA|2|||
147303287|NCT02535364|531276336|FG000|Part A Screening Through Leukapheresis|Disease progression|1|||
147482888|NCT04543955|531924818|FG001|Overall Study|Company cancelled study|0|||
147482889|NCT05232097|531924819|FG000|Overall Study|Physician Decision|1|||
147482890|NCT01172288|531924820|FG000|Overall Study|Adverse Event|1|||
147482891|NCT01172288|531924821|FG001|Overall Study|Adverse Event|0|||
147482892|NCT01172288|531924820|FG000|Overall Study|Protocol Violation|0|||
147482893|NCT01172288|531924821|FG001|Overall Study|Protocol Violation|1|||
147482894|NCT00871858|531924824|FG000|Overall Study|Protocol Violation|3|||
147482895|NCT00871858|531924825|FG001|Overall Study|Protocol Violation|4|||
147482896|NCT00871858|531924824|FG000|Overall Study|Adverse Event|1|||
147482897|NCT00871858|531924825|FG001|Overall Study|Adverse Event|1|||
147482898|NCT00871858|531924824|FG000|Overall Study|Withdrawal by Subject|1|||
147482899|NCT00871858|531924825|FG001|Overall Study|Withdrawal by Subject|1|||
147482900|NCT00871858|531924824|FG000|Overall Study|Lost to Follow-up|0|||
147482901|NCT00871858|531924825|FG001|Overall Study|Lost to Follow-up|1|||
147482902|NCT01188798|531924828|FG000|Overall Study|Death|0|||
147482903|NCT01188798|531924829|FG001|Overall Study|Death|1|||
147482904|NCT01188798|531924828|FG000|Overall Study|Required additional transplant|1|||
147482905|NCT01188798|531924829|FG001|Overall Study|Required additional transplant|1|||
147482906|NCT01188798|531924828|FG000|Overall Study|Protocol closure|1|||
147482907|NCT01188798|531924829|FG001|Overall Study|Protocol closure|1|||
147482908|NCT02795767|531924830|FG000|Overall Study|Received Commercial Emicizumab|1|||
147482909|NCT02795767|531924831|FG001|Overall Study|Received Commercial Emicizumab|0|||
147482910|NCT02795767|531924832|FG002|Overall Study|Received Commercial Emicizumab|0|||
147482911|NCT00700752|531924837|FG000|First Intervention|Withdrawal by Subject|0|||
147482912|NCT00700752|531924838|FG001|First Intervention|Withdrawal by Subject|2|||
147482913|NCT03964415|531924839|FG000|Overall Study|Sponsor's decision|1563|||
147482914|NCT03964415|531924840|FG001|Overall Study|Sponsor's decision|1528|||
147482915|NCT03964415|531924839|FG000|Overall Study|Lost to Follow-up|139|||
147482916|NCT03964415|531924840|FG001|Overall Study|Lost to Follow-up|146|||
147482917|NCT03964415|531924839|FG000|Overall Study|Withdrawal by Subject|68|||
147482918|NCT03964415|531924840|FG001|Overall Study|Withdrawal by Subject|72|||
147482919|NCT03964415|531924839|FG000|Overall Study|Physician Decision|34|||
147482920|NCT03964415|531924840|FG001|Overall Study|Physician Decision|48|||
147482921|NCT03964415|531924839|FG000|Overall Study|Adverse Event|3|||
147482922|NCT03964415|531924840|FG001|Overall Study|Adverse Event|0|||
147482923|NCT03964415|531924839|FG000|Overall Study|Death|4|||
147482924|NCT03964415|531924840|FG001|Overall Study|Death|6|||
147482925|NCT03964415|531924839|FG000|Overall Study|Protocol Violation|1|||
147482926|NCT03964415|531924840|FG001|Overall Study|Protocol Violation|4|||
147482927|NCT03964415|531924839|FG000|Overall Study|Other|35|||
147482928|NCT03964415|531924840|FG001|Overall Study|Other|38|||
147482929|NCT03964415|531924839|FG000|Overall Study|Randomized but not treated|6|||
147482930|NCT03964415|531924840|FG001|Overall Study|Randomized but not treated|7|||
147303288|NCT02535364|531276336|FG000|Part B Screening|Study placed on clinical hold by FDA|7|||
147303289|NCT02535364|531276336|FG000|Part B Screening|Unable to manufacture JCAR015|3|||
147303290|NCT02535364|531276336|FG000|Part B Screening|Death|2|||
147303291|NCT02535364|531276336|FG000|Part B Screening|Physician Decision|1|||
147303292|NCT02535364|531276336|FG000|Part B Screening|Withdrawal by Subject|1|||
147303293|NCT02535364|531276336|FG000|Part B Screening|Adverse Event|1|||
147303294|NCT02535364|531276336|FG000|Part B Screening|Change in diagnosis, no longer eligible|2|||
147303295|NCT02535364|531276336|FG000|Study Treatment|Death|1|||
147303296|NCT02535364|531276336|FG000|Study Treatment|Study placed on clinical hold by FDA|1|||
147303297|NCT02535364|531276336|FG000|12-Month Follow-up Period|Disease progression|22|||
147482931|NCT01302769|531924845|FG000|Overall Study|Lost to Follow-up|1|||
147482932|NCT01302769|531924846|FG001|Overall Study|Lost to Follow-up|1|||
147482933|NCT01097330|531924847|FG000|Overall Study|Study terminated early|7|||
147623254|NCT03267212|532438534|FG000|First Intervention|Withdrawal by Subject|1|||
147623255|NCT03267212|532438535|FG001|First Intervention|Withdrawal by Subject|1|||
147623256|NCT03267212|532438534|FG000|Washout (Min 2 Days / Max 7 Days)|Physician Decision|1|||
147303298|NCT02535364|531276336|FG000|12-Month Follow-up Period|Death|5|||
147303299|NCT02535364|531276336|FG000|12-Month Follow-up Period|Underwent stem cell transplant|5|||
147303300|NCT02535364|531276336|FG000|12-Month Follow-up Period|Subject received alternative therapy|2|||
147303301|NCT02535364|531276336|FG000|12-Month Follow-up Period|Subject transferred to hospice|1|||
147303302|NCT00571701|531276337|FG000|First Intervention 12 Months|Withdrawal by Subject|2|||
147303303|NCT00571701|531276338|FG001|First Intervention 12 Months|Withdrawal by Subject|1|||
147303304|NCT00571701|531276337|FG000|First Intervention 12 Months|Death|1|||
147303305|NCT00571701|531276338|FG001|First Intervention 12 Months|Death|0|||
147303306|NCT00571701|531276337|FG000|Second Intervention 12 Months|Adverse Event|0|||
147303307|NCT00571701|531276338|FG001|Second Intervention 12 Months|Adverse Event|1|||
147482934|NCT01097330|531924848|FG001|Overall Study|Study terminated early|5|||
147482935|NCT01426386|531924858|FG000|Overall Study|Adverse Event|0|||
147482936|NCT01426386|531924859|FG001|Overall Study|Adverse Event|1|||
147482937|NCT01426386|531924860|FG002|Overall Study|Adverse Event|0|||
147482938|NCT01426386|531924861|FG003|Overall Study|Adverse Event|0|||
147482939|NCT01426386|531924862|FG004|Overall Study|Adverse Event|0|||
147482940|NCT01426386|531924863|FG005|Overall Study|Adverse Event|0|||
147482941|NCT01426386|531924858|FG000|Overall Study|Did not attend scheduled visit|1|||
147482942|NCT01426386|531924859|FG001|Overall Study|Did not attend scheduled visit|4|||
147482943|NCT01426386|531924860|FG002|Overall Study|Did not attend scheduled visit|0|||
147482944|NCT01426386|531924861|FG003|Overall Study|Did not attend scheduled visit|0|||
147482945|NCT01426386|531924862|FG004|Overall Study|Did not attend scheduled visit|2|||
147482946|NCT01426386|531924863|FG005|Overall Study|Did not attend scheduled visit|1|||
147482947|NCT01426386|531924858|FG000|Overall Study|Poor response|2|||
147482948|NCT01426386|531924859|FG001|Overall Study|Poor response|1|||
147482949|NCT01426386|531924860|FG002|Overall Study|Poor response|2|||
147482950|NCT01426386|531924861|FG003|Overall Study|Poor response|0|||
147482951|NCT01426386|531924862|FG004|Overall Study|Poor response|1|||
147482952|NCT01426386|531924863|FG005|Overall Study|Poor response|0|||
147482953|NCT01426386|531924858|FG000|Overall Study|Personal reasons|0|||
147482954|NCT01426386|531924859|FG001|Overall Study|Personal reasons|0|||
147482955|NCT01426386|531924860|FG002|Overall Study|Personal reasons|0|||
147482956|NCT01426386|531924861|FG003|Overall Study|Personal reasons|0|||
147482957|NCT01426386|531924862|FG004|Overall Study|Personal reasons|1|||
147482958|NCT01426386|531924863|FG005|Overall Study|Personal reasons|0|||
147482959|NCT03694522|531924865|FG000|Overall Study|Withdrawal by Subject|8|||
147303308|NCT00571701|531276337|FG000|Second Intervention 12 Months|Withdrawal by Subject|3|||
147303309|NCT00571701|531276338|FG001|Second Intervention 12 Months|Withdrawal by Subject|0|||
147303310|NCT04766086|531276343|FG000|Overall Study|Lost to Follow-up|3|||
147303311|NCT04766086|531276344|FG001|Overall Study|Lost to Follow-up|5|||
147303312|NCT04766086|531276345|FG002|Overall Study|Lost to Follow-up|3|||
147303313|NCT04766086|531276343|FG000|Overall Study|Withdrawal by Subject|1|||
147303314|NCT04766086|531276344|FG001|Overall Study|Withdrawal by Subject|1|||
147303315|NCT04766086|531276345|FG002|Overall Study|Withdrawal by Subject|2|||
147303316|NCT04766086|531276343|FG000|Overall Study|Other|0|||
147303317|NCT04766086|531276344|FG001|Overall Study|Other|0|||
147303318|NCT04766086|531276345|FG002|Overall Study|Other|1|||
147303319|NCT01959347|531276346|FG000|Overall Study|Protocol Violation|9|||
147303320|NCT01959347|531276347|FG001|Overall Study|Protocol Violation|7|||
147303321|NCT03541044|531276348|FG000|Study Period 2: Up to Day 8|Protocol Violation|1|||
147303322|NCT03541044|531276349|FG001|Study Period 2: Up to Day 8|Protocol Violation|0|||
147303323|NCT03541044|531276348|FG000|Study Period 2: Up to Day 8|Withdrawal by Subject|1|||
147303324|NCT03541044|531276349|FG001|Study Period 2: Up to Day 8|Withdrawal by Subject|0|||
147303325|NCT04581200|531276352|FG000|Overall Study|Lost to Follow-up|6|||
147303326|NCT04581200|531276353|FG001|Overall Study|Lost to Follow-up|5|||
147303327|NCT03131960|531276354|FG000|Overall Study|Adverse Event|0|||
147303328|NCT03131960|531276355|FG001|Overall Study|Adverse Event|1|||
147303329|NCT04404478|531276359|FG000|Overall Study|Withdrawal by Subject|1|||
147303330|NCT04404478|531276360|FG001|Overall Study|Withdrawal by Subject|3|||
147303331|NCT01215357|531276361|FG000|Overall Study|Withdrawal by Subject|3|||
147303332|NCT01215357|531276361|FG000|Overall Study|Protocol Violation|9|||
147303333|NCT01859793|531276362|FG000|First Intervention (8 Weeks)|Protocol Violation|2|||
147303334|NCT01859793|531276363|FG001|First Intervention (8 Weeks)|Protocol Violation|0|||
147482960|NCT03694522|531924866|FG001|Overall Study|Withdrawal by Subject|10|||
147482961|NCT03694522|531924865|FG000|Overall Study|Physician Decision|53|||
147482962|NCT03694522|531924866|FG001|Overall Study|Physician Decision|54|||
147482963|NCT03694522|531924865|FG000|Overall Study|Other|1|||
147482964|NCT03694522|531924866|FG001|Overall Study|Other|1|||
147482965|NCT03694522|531924865|FG000|Overall Study|Lost to Follow-up|0|||
147482966|NCT03694522|531924866|FG001|Overall Study|Lost to Follow-up|1|||
147482967|NCT02760407|531924867|FG000|Overall Study|Death|2|||
147482968|NCT02760407|531924868|FG001|Overall Study|Death|3|||
147482969|NCT02760407|531924869|FG002|Overall Study|Death|1|||
147482970|NCT02760407|531924870|FG003|Overall Study|Death|1|||
147482971|NCT02760407|531924867|FG000|Overall Study|Lost to Follow-up|1|||
147482972|NCT02760407|531924868|FG001|Overall Study|Lost to Follow-up|7|||
147623257|NCT03267212|532438535|FG001|Washout (Min 2 Days / Max 7 Days)|Physician Decision|0|||
147623258|NCT05691712|532438537|FG000|Overall Study|Adverse Event|0|||
147623259|NCT05691712|532438538|FG001|Overall Study|Adverse Event|1|||
147482973|NCT02760407|531924869|FG002|Overall Study|Lost to Follow-up|4|||
147482974|NCT02760407|531924870|FG003|Overall Study|Lost to Follow-up|6|||
147482975|NCT02760407|531924867|FG000|Overall Study|Withdrawal by Subject|25|||
147623260|NCT05691712|532438539|FG002|Overall Study|Adverse Event|2|||
147623261|NCT05691712|532438540|FG003|Overall Study|Adverse Event|1|||
147623262|NCT05691712|532438537|FG000|Overall Study|Withdrawal by Subject|2|||
147303335|NCT01859793|531276362|FG000|First Intervention (8 Weeks)|Adverse Event|1|||
147303336|NCT01859793|531276363|FG001|First Intervention (8 Weeks)|Adverse Event|0|||
147303337|NCT01859793|531276362|FG000|First Intervention (8 Weeks)|Withdrawal by Subject|2|||
147303338|NCT01859793|531276363|FG001|First Intervention (8 Weeks)|Withdrawal by Subject|1|||
147303339|NCT01859793|531276362|FG000|Washout Period (4 Weeks)|Lost to Follow-up|1|||
147303340|NCT01859793|531276363|FG001|Washout Period (4 Weeks)|Lost to Follow-up|1|||
147482976|NCT02760407|531924868|FG001|Overall Study|Withdrawal by Subject|31|||
147482977|NCT02760407|531924869|FG002|Overall Study|Withdrawal by Subject|37|||
147482978|NCT02760407|531924870|FG003|Overall Study|Withdrawal by Subject|25|||
147482979|NCT02760407|531924867|FG000|Overall Study|Violation of Eligibility criteria|0|||
147482980|NCT02760407|531924868|FG001|Overall Study|Violation of Eligibility criteria|0|||
147482981|NCT02760407|531924869|FG002|Overall Study|Violation of Eligibility criteria|1|||
147482982|NCT02760407|531924870|FG003|Overall Study|Violation of Eligibility criteria|1|||
147482983|NCT02760407|531924867|FG000|Overall Study|Personal reasons|0|||
147482984|NCT02760407|531924868|FG001|Overall Study|Personal reasons|0|||
147482985|NCT02760407|531924869|FG002|Overall Study|Personal reasons|0|||
147482986|NCT02760407|531924870|FG003|Overall Study|Personal reasons|1|||
147482987|NCT02760407|531924867|FG000|Overall Study|The subject was early discontinued due to lab Adverse Event as per Investigator's decision|1|||
147482988|NCT02760407|531924868|FG001|Overall Study|The subject was early discontinued due to lab Adverse Event as per Investigator's decision|0|||
147482989|NCT02760407|531924869|FG002|Overall Study|The subject was early discontinued due to lab Adverse Event as per Investigator's decision|0|||
147482990|NCT02760407|531924870|FG003|Overall Study|The subject was early discontinued due to lab Adverse Event as per Investigator's decision|0|||
147482991|NCT02760407|531924867|FG000|Overall Study|Use of prohibited Medication|0|||
147482992|NCT02760407|531924868|FG001|Overall Study|Use of prohibited Medication|0|||
147303341|NCT03056534|531276371|FG000|Overall Study|Participant withdrew consent|8|||
147303342|NCT03056534|531276371|FG000|Overall Study|Participant not able to return|6|||
147303343|NCT03056534|531276371|FG000|Overall Study|Lost to Follow-up|37|||
147303344|NCT03056534|531276371|FG000|Overall Study|Investigator judgment|1|||
147303345|NCT03056534|531276371|FG000|Overall Study|Death|4|||
147303346|NCT03056534|531276371|FG000|Overall Study|Adverse Event|1|||
147303347|NCT03056534|531276371|FG000|Overall Study|Screen fail due to femoral stem implanted not being allowed per protocol|1|||
147303348|NCT02675465|531276374|FG000|Stage 3: 2 Year Treatment|Adverse Event|0|||
147303349|NCT02675465|531276375|FG001|Stage 3: 2 Year Treatment|Adverse Event|0|||
147303350|NCT02675465|531276376|FG002|Stage 3: 2 Year Treatment|Adverse Event|1|||
147303351|NCT02675465|531276377|FG003|Stage 3: 2 Year Treatment|Adverse Event|1|||
147303352|NCT02675465|531276378|FG004|Stage 3: 2 Year Treatment|Adverse Event|0|||
147303353|NCT02675465|531276379|FG005|Stage 3: 2 Year Treatment|Adverse Event|0|||
147303354|NCT02675465|531276374|FG000|Stage 3: 2 Year Treatment|Withdrawal by Subject|0|||
147303355|NCT02675465|531276375|FG001|Stage 3: 2 Year Treatment|Withdrawal by Subject|0|||
147303356|NCT02675465|531276376|FG002|Stage 3: 2 Year Treatment|Withdrawal by Subject|1|||
147303357|NCT02675465|531276377|FG003|Stage 3: 2 Year Treatment|Withdrawal by Subject|0|||
147303358|NCT02675465|531276378|FG004|Stage 3: 2 Year Treatment|Withdrawal by Subject|0|||
147303359|NCT02675465|531276379|FG005|Stage 3: 2 Year Treatment|Withdrawal by Subject|0|||
147303360|NCT02675465|531276374|FG000|Stage 4: Long Term Extension|Physician Decision|0|||
147303361|NCT02675465|531276375|FG001|Stage 4: Long Term Extension|Physician Decision|0|||
147303362|NCT02675465|531276376|FG002|Stage 4: Long Term Extension|Physician Decision|1|||
147303363|NCT02675465|531276377|FG003|Stage 4: Long Term Extension|Physician Decision|0|||
147303364|NCT02675465|531276378|FG004|Stage 4: Long Term Extension|Physician Decision|0|||
147303365|NCT02675465|531276379|FG005|Stage 4: Long Term Extension|Physician Decision|0|||
147303366|NCT02675465|531276374|FG000|Stage 4: Long Term Extension|Death|0|||
147303367|NCT02675465|531276375|FG001|Stage 4: Long Term Extension|Death|0|||
147303368|NCT02675465|531276376|FG002|Stage 4: Long Term Extension|Death|0|||
147482993|NCT02760407|531924869|FG002|Overall Study|Use of prohibited Medication|1|||
147482994|NCT02760407|531924870|FG003|Overall Study|Use of prohibited Medication|0|||
147482995|NCT02760407|531924867|FG000|Overall Study|Subject didn't Completed Visits Schedule After Serious Adverse Event|0|||
147482996|NCT02760407|531924868|FG001|Overall Study|Subject didn't Completed Visits Schedule After Serious Adverse Event|0|||
147482997|NCT02760407|531924869|FG002|Overall Study|Subject didn't Completed Visits Schedule After Serious Adverse Event|1|||
147482998|NCT02760407|531924870|FG003|Overall Study|Subject didn't Completed Visits Schedule After Serious Adverse Event|0|||
147482999|NCT02760407|531924867|FG000|Overall Study|Positive Quantiferon Testing, Patient Was Not Taken Prophylactic Medication|1|||
147483000|NCT02760407|531924868|FG001|Overall Study|Positive Quantiferon Testing, Patient Was Not Taken Prophylactic Medication|0|||
147483001|NCT02760407|531924869|FG002|Overall Study|Positive Quantiferon Testing, Patient Was Not Taken Prophylactic Medication|0|||
147483002|NCT02760407|531924870|FG003|Overall Study|Positive Quantiferon Testing, Patient Was Not Taken Prophylactic Medication|0|||
147483003|NCT02760407|531924867|FG000|Overall Study|Investigator's Decision (Adverse Event)|0|||
147483004|NCT02760407|531924868|FG001|Overall Study|Investigator's Decision (Adverse Event)|1|||
147483005|NCT02760407|531924869|FG002|Overall Study|Investigator's Decision (Adverse Event)|0|||
147483006|NCT02760407|531924870|FG003|Overall Study|Investigator's Decision (Adverse Event)|0|||
147483007|NCT02760407|531924867|FG000|Overall Study|Inadequately Enrolled|0|||
147483008|NCT02760407|531924868|FG001|Overall Study|Inadequately Enrolled|0|||
147483009|NCT02760407|531924869|FG002|Overall Study|Inadequately Enrolled|0|||
147483010|NCT02760407|531924870|FG003|Overall Study|Inadequately Enrolled|1|||
147623263|NCT05691712|532438538|FG001|Overall Study|Withdrawal by Subject|3|||
147623264|NCT05691712|532438539|FG002|Overall Study|Withdrawal by Subject|3|||
147623265|NCT05691712|532438540|FG003|Overall Study|Withdrawal by Subject|1|||
147303369|NCT02675465|531276377|FG003|Stage 4: Long Term Extension|Death|1|||
147303370|NCT02675465|531276378|FG004|Stage 4: Long Term Extension|Death|0|||
147303371|NCT02675465|531276379|FG005|Stage 4: Long Term Extension|Death|0|||
147303372|NCT00728962|531276382|FG000|Implant Placement Surgery|Adverse Event|8|||
147303373|NCT00728962|531276382|FG000|Implant Placement Surgery|Lost to Follow-up|1|||
147483011|NCT02760407|531924867|FG000|Overall Study|Withdrawal By PI's Decision|0|||
147483012|NCT02760407|531924868|FG001|Overall Study|Withdrawal By PI's Decision|1|||
147483013|NCT02760407|531924869|FG002|Overall Study|Withdrawal By PI's Decision|0|||
147483014|NCT02760407|531924870|FG003|Overall Study|Withdrawal By PI's Decision|0|||
147483015|NCT02760407|531924867|FG000|Overall Study|Subject Did not attend treatment period visits due to misunderstanding of protocol|1|||
147483016|NCT02760407|531924868|FG001|Overall Study|Subject Did not attend treatment period visits due to misunderstanding of protocol|0|||
147483017|NCT02760407|531924869|FG002|Overall Study|Subject Did not attend treatment period visits due to misunderstanding of protocol|1|||
147483018|NCT02760407|531924870|FG003|Overall Study|Subject Did not attend treatment period visits due to misunderstanding of protocol|0|||
147483019|NCT02760407|531924867|FG000|Overall Study|Subject met permanent IP discontinuation criteria, did not agree for treatment period visits|0|||
147483020|NCT02760407|531924868|FG001|Overall Study|Subject met permanent IP discontinuation criteria, did not agree for treatment period visits|0|||
147483021|NCT02760407|531924869|FG002|Overall Study|Subject met permanent IP discontinuation criteria, did not agree for treatment period visits|1|||
147483022|NCT02760407|531924870|FG003|Overall Study|Subject met permanent IP discontinuation criteria, did not agree for treatment period visits|0|||
147483023|NCT02760407|531924867|FG000|Overall Study|Investigator recorded as Sponsor's decision - decreased lymphocyte level|1|||
147667567|NCT01791595|532608096|FG001|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
147667568|NCT01791595|532608097|FG002|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
147667569|NCT01791595|532608098|FG003|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
147303374|NCT00728962|531276382|FG000|Implant Placement Surgery|Protocol Violation|1|||
147303375|NCT00728962|531276382|FG000|Permanent Prosthesis Placement|Adverse Event|3|||
147303376|NCT00728962|531276382|FG000|Two Year Post Placement Follow-up|Lost to Follow-up|3|||
147303377|NCT04954586|531276383|FG000|Overall Study|Withdrawal by Subject|5|||
147303378|NCT00532155|531276384|FG000|Overall Study|Adverse Event|66|||
147303379|NCT00532155|531276385|FG001|Overall Study|Adverse Event|123|||
147303380|NCT00532155|531276384|FG000|Overall Study|Lack of Efficacy|332|||
147303381|NCT00532155|531276385|FG001|Overall Study|Lack of Efficacy|255|||
147303382|NCT00532155|531276384|FG000|Overall Study|Protocol Violation|1|||
147303383|NCT00532155|531276385|FG001|Overall Study|Protocol Violation|3|||
147303384|NCT00532155|531276384|FG000|Overall Study|Lost to Follow-up|2|||
147303385|NCT00532155|531276385|FG001|Overall Study|Lost to Follow-up|0|||
147303386|NCT00532155|531276384|FG000|Overall Study|Physician Decision|16|||
147303387|NCT00532155|531276385|FG001|Overall Study|Physician Decision|15|||
147303388|NCT00532155|531276384|FG000|Overall Study|Withdrawal by Subject|23|||
147303389|NCT00532155|531276385|FG001|Overall Study|Withdrawal by Subject|44|||
147303390|NCT00532155|531276384|FG000|Overall Study|Consent withdrawn|5|||
147303391|NCT00532155|531276385|FG001|Overall Study|Consent withdrawn|7|||
147303392|NCT00532155|531276384|FG000|Overall Study|Moved|1|||
147303393|NCT00532155|531276385|FG001|Overall Study|Moved|0|||
147303394|NCT00532155|531276384|FG000|Overall Study|Pre-existing brain metastasis (by MRI)|1|||
147303395|NCT00532155|531276385|FG001|Overall Study|Pre-existing brain metastasis (by MRI)|0|||
147303396|NCT00532155|531276384|FG000|Overall Study|Occurence of a second cancer|0|||
147303397|NCT00532155|531276385|FG001|Overall Study|Occurence of a second cancer|1|||
147303398|NCT00532155|531276384|FG000|Overall Study|Occurence of a secondary cancer|0|||
147303399|NCT00532155|531276385|FG001|Overall Study|Occurence of a secondary cancer|1|||
147303400|NCT00532155|531276384|FG000|Overall Study|Promotor ended study|1|||
147303401|NCT00532155|531276385|FG001|Overall Study|Promotor ended study|0|||
147303402|NCT00532155|531276384|FG000|Overall Study|Progressive disease (by incorrect scan)|0|||
147303403|NCT00532155|531276385|FG001|Overall Study|Progressive disease (by incorrect scan)|1|||
147303404|NCT00532155|531276384|FG000|Overall Study|Had brain metastasis, was mis-randomized|1|||
147303405|NCT00532155|531276385|FG001|Overall Study|Had brain metastasis, was mis-randomized|0|||
147303406|NCT00532155|531276384|FG000|Overall Study|Study stopped|1|||
147303407|NCT00532155|531276385|FG001|Overall Study|Study stopped|0|||
147303408|NCT00532155|531276384|FG000|Overall Study|Study terminated by sponsor|1|||
147303409|NCT00532155|531276385|FG001|Overall Study|Study terminated by sponsor|0|||
147303410|NCT00532155|531276384|FG000|Overall Study|Study termination stop further treatment|4|||
147303411|NCT00532155|531276385|FG001|Overall Study|Study termination stop further treatment|0|||
147303412|NCT00532155|531276384|FG000|Overall Study|Did not receive study medication|2|||
147303413|NCT00532155|531276385|FG001|Overall Study|Did not receive study medication|6|||
147303414|NCT02134925|531276386|FG000|Overall Study|Withdrawal by Subject|1|||
147303415|NCT02134925|531276387|FG001|Overall Study|Withdrawal by Subject|0|||
147667570|NCT01791595|532608099|FG004|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|4|||
147667571|NCT01791595|532608100|FG005|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
147303416|NCT02134925|531276386|FG000|Overall Study|Cancel|1|||
147303417|NCT02134925|531276387|FG001|Overall Study|Cancel|6|||
147667572|NCT01791595|532608101|FG006|Part 1 AZD3965 Cohort 5 (15 mg BD)|Adverse Event|0|||
147303418|NCT04027348|531276388|FG000|Overall Study|Adverse Event|2|||
147303419|NCT02158884|531276389|FG000|Baseline Assessment|Missed performance assessment|3|||
147303420|NCT02158884|531276389|FG000|Baseline Assessment|Missed SMFA|1|||
147303421|NCT02158884|531276389|FG000|Intervention: IDEO and PT Program|Did not complete PT intervention|6|||
147303422|NCT02158884|531276389|FG000|Post Intervention (~4 Weeks)|Did not complete performance assessment|10|||
147303423|NCT02158884|531276389|FG000|6 Month Assessment|Missed SMFA|20|||
147303424|NCT02158884|531276389|FG000|12 Month Assessment|Missed SMFA|17|||
147303425|NCT02202434|531278671|FG000|Overall Study|Death|70|||
147303426|NCT02202434|531278672|FG001|Overall Study|Death|39|||
147303427|NCT02202434|531278673|FG002|Overall Study|Death|13|||
147303428|NCT02202434|531278674|FG003|Overall Study|Death|27|||
147303429|NCT02202434|531278671|FG000|Overall Study|Lost to Follow-up|1|||
147303430|NCT02202434|531278672|FG001|Overall Study|Lost to Follow-up|1|||
147303431|NCT02202434|531278673|FG002|Overall Study|Lost to Follow-up|1|||
147303432|NCT02202434|531278674|FG003|Overall Study|Lost to Follow-up|0|||
147303433|NCT02202434|531278671|FG000|Overall Study|Physician Decision|2|||
147303434|NCT02202434|531278672|FG001|Overall Study|Physician Decision|3|||
147303435|NCT02202434|531278673|FG002|Overall Study|Physician Decision|0|||
147303436|NCT02202434|531278674|FG003|Overall Study|Physician Decision|0|||
147303437|NCT02202434|531278671|FG000|Overall Study|Withdrawal by Subject|13|||
147303438|NCT02202434|531278672|FG001|Overall Study|Withdrawal by Subject|14|||
147303439|NCT02202434|531278673|FG002|Overall Study|Withdrawal by Subject|1|||
147303440|NCT02202434|531278674|FG003|Overall Study|Withdrawal by Subject|4|||
147303441|NCT02202434|531278671|FG000|Overall Study|Completed Study|1|||
147303442|NCT02202434|531278672|FG001|Overall Study|Completed Study|0|||
147303443|NCT02202434|531278673|FG002|Overall Study|Completed Study|0|||
147303444|NCT02202434|531278674|FG003|Overall Study|Completed Study|0|||
147303445|NCT02202434|531278671|FG000|Overall Study|Visit Missed|21|||
147303446|NCT02202434|531278672|FG001|Overall Study|Visit Missed|12|||
147303447|NCT02202434|531278673|FG002|Overall Study|Visit Missed|0|||
147303448|NCT02202434|531278674|FG003|Overall Study|Visit Missed|5|||
147303449|NCT02202434|531278671|FG000|Overall Study|Other|1|||
147303450|NCT02202434|531278672|FG001|Overall Study|Other|0|||
147303451|NCT02202434|531278673|FG002|Overall Study|Other|0|||
147303452|NCT02202434|531278674|FG003|Overall Study|Other|1|||
147303453|NCT03237858|531278675|FG000|Overall Study|Death|19|||
147303454|NCT03237858|531278675|FG000|Overall Study|Withdrawal by Subject|37|||
147303455|NCT04858802|531278678|FG000|Overall Study|Lost to Follow-up|1|||
147303456|NCT04858802|531278679|FG001|Overall Study|Lost to Follow-up|1|||
147303457|NCT04858802|531278678|FG000|Overall Study|Withdrawal by Subject|1|||
147303458|NCT04858802|531278679|FG001|Overall Study|Withdrawal by Subject|1|||
147303459|NCT03610737|531278682|FG000|Overall Study|Withdrawal by Subject|1|||
147303460|NCT03610737|531278683|FG001|Overall Study|Withdrawal by Subject|5|||
147303461|NCT03610737|531278682|FG000|Overall Study|Death|1|||
147303462|NCT03610737|531278683|FG001|Overall Study|Death|0|||
147303463|NCT03610737|531278682|FG000|Overall Study|Not treated|5|||
147303464|NCT03610737|531278683|FG001|Overall Study|Not treated|2|||
147303465|NCT03610737|531278682|FG000|Overall Study|Missed Visit|1|||
147303466|NCT03610737|531278683|FG001|Overall Study|Missed Visit|2|||
147303467|NCT02013388|531278686|FG000|Overall Study|work emergency|1|||
147303468|NCT02013388|531278687|FG001|Overall Study|work emergency|0|||
147303469|NCT02013388|531278688|FG002|Overall Study|work emergency|0|||
147303470|NCT02013388|531278689|FG003|Overall Study|work emergency|0|||
147303471|NCT02013388|531278690|FG004|Overall Study|work emergency|1|||
147303472|NCT02013388|531278691|FG005|Overall Study|work emergency|0|||
147303473|NCT02013388|531278692|FG006|Overall Study|work emergency|0|||
147303474|NCT02013388|531278693|FG007|Overall Study|work emergency|0|||
147303475|NCT03243422|531278694|FG000|Overall Study|Death|20|||
147303476|NCT03243422|531278695|FG001|Overall Study|Death|21|||
147303477|NCT03243422|531278694|FG000|Overall Study|Lost to Follow-up|9|||
147303478|NCT03243422|531278695|FG001|Overall Study|Lost to Follow-up|21|||
147303479|NCT03243422|531278694|FG000|Overall Study|Withdrawal by Subject|22|||
147303480|NCT03243422|531278695|FG001|Overall Study|Withdrawal by Subject|8|||
147303481|NCT00215540|531278699|FG000|Overall Study|Withdrew from study medication|1|||
147303482|NCT00215540|531278700|FG001|Overall Study|Withdrew from study medication|0|||
147303483|NCT00215540|531278701|FG002|Overall Study|Withdrew from study medication|0|||
147303484|NCT03145766|531278702|FG000|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|1|||
147303485|NCT03145766|531278703|FG001|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|1|||
147303486|NCT03145766|531278704|FG002|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|0|||
147303487|NCT03145766|531278705|FG003|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|1|||
147303488|NCT03145766|531278706|FG004|Active Vaccination Phase (Day 0-Day 56)|Other Adverse Event (AE)|2|||
147303489|NCT03145766|531278702|FG000|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|0|||
147303490|NCT03145766|531278703|FG001|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|0|||
147483024|NCT02760407|531924868|FG001|Overall Study|Investigator recorded as Sponsor's decision - decreased lymphocyte level|0|||
147483025|NCT02760407|531924869|FG002|Overall Study|Investigator recorded as Sponsor's decision - decreased lymphocyte level|0|||
147483026|NCT02760407|531924870|FG003|Overall Study|Investigator recorded as Sponsor's decision - decreased lymphocyte level|0|||
147483027|NCT02760407|531924867|FG000|Overall Study|Study Treatment Was Terminated At The Site|0|||
147483028|NCT02760407|531924868|FG001|Overall Study|Study Treatment Was Terminated At The Site|0|||
147303491|NCT03145766|531278704|FG002|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|1|||
147303492|NCT03145766|531278705|FG003|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|2|||
147303493|NCT03145766|531278706|FG004|Active Vaccination Phase (Day 0-Day 56)|Non-compliance with the Protocol|1|||
147483029|NCT02760407|531924869|FG002|Overall Study|Study Treatment Was Terminated At The Site|1|||
147483030|NCT02760407|531924870|FG003|Overall Study|Study Treatment Was Terminated At The Site|0|||
147483031|NCT02760407|531924867|FG000|Overall Study|Subject Taken Out Of Study Due To Sponsor Investigating Investigational Product.|1|||
147483032|NCT02760407|531924868|FG001|Overall Study|Subject Taken Out Of Study Due To Sponsor Investigating Investigational Product.|0|||
147483033|NCT02760407|531924869|FG002|Overall Study|Subject Taken Out Of Study Due To Sponsor Investigating Investigational Product.|0|||
147303494|NCT03145766|531278702|FG000|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|1|||
147303495|NCT03145766|531278703|FG001|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|1|||
147303496|NCT03145766|531278704|FG002|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|0|||
147303497|NCT03145766|531278705|FG003|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|3|||
147303498|NCT03145766|531278706|FG004|Active Vaccination Phase (Day 0-Day 56)|Lost to Follow-up|0|||
147303499|NCT03145766|531278702|FG000|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|4|||
147303500|NCT03145766|531278703|FG001|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|1|||
147303501|NCT03145766|531278704|FG002|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|1|||
147303502|NCT03145766|531278705|FG003|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|1|||
147303503|NCT03145766|531278706|FG004|Active Vaccination Phase (Day 0-Day 56)|Voluntary Withdrawal Not Due AE|0|||
147303504|NCT03145766|531278702|FG000|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|2|||
147483034|NCT02760407|531924870|FG003|Overall Study|Subject Taken Out Of Study Due To Sponsor Investigating Investigational Product.|0|||
147483035|NCT02760407|531924867|FG000|Overall Study|Inadequately enrolled patient refused to Follow-Up|1|||
147483036|NCT02760407|531924868|FG001|Overall Study|Inadequately enrolled patient refused to Follow-Up|0|||
147483037|NCT02760407|531924869|FG002|Overall Study|Inadequately enrolled patient refused to Follow-Up|0|||
147483038|NCT02760407|531924870|FG003|Overall Study|Inadequately enrolled patient refused to Follow-Up|0|||
147483039|NCT02760407|531924867|FG000|Overall Study|Lack Of Efficacy Per PI|0|||
147483040|NCT02760407|531924868|FG001|Overall Study|Lack Of Efficacy Per PI|0|||
147483041|NCT02760407|531924869|FG002|Overall Study|Lack Of Efficacy Per PI|0|||
147483042|NCT02760407|531924870|FG003|Overall Study|Lack Of Efficacy Per PI|1|||
147483043|NCT02760407|531924867|FG000|Overall Study|Patient had an upper respiratory infection and took medication that was not allowed|1|||
147483044|NCT02760407|531924868|FG001|Overall Study|Patient had an upper respiratory infection and took medication that was not allowed|0|||
147483045|NCT02760407|531924869|FG002|Overall Study|Patient had an upper respiratory infection and took medication that was not allowed|0|||
147483046|NCT02760407|531924870|FG003|Overall Study|Patient had an upper respiratory infection and took medication that was not allowed|0|||
147483047|NCT02760407|531924867|FG000|Overall Study|Investigator recorded as Adverse Event|1|||
147483048|NCT02760407|531924868|FG001|Overall Study|Investigator recorded as Adverse Event|0|||
147483049|NCT02760407|531924869|FG002|Overall Study|Investigator recorded as Adverse Event|2|||
147483050|NCT02760407|531924870|FG003|Overall Study|Investigator recorded as Adverse Event|0|||
147483051|NCT02522377|531924871|FG000|Overall Study|Withdrawal by Subject|1|||
147483052|NCT02522377|531924872|FG001|Overall Study|Withdrawal by Subject|0|||
147483053|NCT02522377|531924871|FG000|Overall Study|Remission Achieved|3|||
147483054|NCT02522377|531924872|FG001|Overall Study|Remission Achieved|0|||
147483055|NCT01158950|531924873|FG000|1st Intervention (1 Day)|Physician Decision|1|||
147483056|NCT01158950|531924874|FG001|1st Intervention (1 Day)|Physician Decision|2|||
147483057|NCT02116972|531924877|FG000|Overall Study|Adverse Event|4|||
147483058|NCT02116972|531924878|FG001|Overall Study|Adverse Event|4|||
147483059|NCT02116972|531924879|FG002|Overall Study|Adverse Event|1|||
147483060|NCT02116972|531924877|FG000|Overall Study|Withdrawal by Subject|1|||
147483061|NCT02116972|531924878|FG001|Overall Study|Withdrawal by Subject|1|||
147483062|NCT02116972|531924879|FG002|Overall Study|Withdrawal by Subject|5|||
147483063|NCT02116972|531924877|FG000|Overall Study|Protocol Violation|1|||
147483064|NCT02116972|531924878|FG001|Overall Study|Protocol Violation|0|||
147483065|NCT02116972|531924879|FG002|Overall Study|Protocol Violation|1|||
147483066|NCT02116972|531924877|FG000|Overall Study|Lost to Follow-up|4|||
147483067|NCT02116972|531924878|FG001|Overall Study|Lost to Follow-up|3|||
147483068|NCT02116972|531924879|FG002|Overall Study|Lost to Follow-up|1|||
147483069|NCT02116972|531924877|FG000|Overall Study|Lack of Efficacy|6|||
147483070|NCT02116972|531924878|FG001|Overall Study|Lack of Efficacy|6|||
147483071|NCT02116972|531924879|FG002|Overall Study|Lack of Efficacy|5|||
147483072|NCT02116972|531924877|FG000|Overall Study|scheduling conflicts and relocation|3|||
147483073|NCT02116972|531924878|FG001|Overall Study|scheduling conflicts and relocation|3|||
147483074|NCT02116972|531924879|FG002|Overall Study|scheduling conflicts and relocation|6|||
147483075|NCT00863928|531924880|FG000|Overall Study|Protocol Violation|26|||
147483076|NCT00863928|531924881|FG001|Overall Study|Protocol Violation|0|||
147483077|NCT00863928|531924880|FG000|Overall Study|Withdrawal by Subject|3|||
147483078|NCT00863928|531924881|FG001|Overall Study|Withdrawal by Subject|0|||
147483079|NCT00863928|531924880|FG000|Overall Study|surgery cancellation|4|||
147483080|NCT00863928|531924881|FG001|Overall Study|surgery cancellation|0|||
147483081|NCT00863928|531924880|FG000|Overall Study|medication allergy|3|||
147623266|NCT05691712|532438537|FG000|Overall Study|Death|1|||
147483082|NCT00863928|531924881|FG001|Overall Study|medication allergy|0|||
147483083|NCT02124798|531924882|FG000|Overall Study|Adverse Event|3|||
147623267|NCT05691712|532438538|FG001|Overall Study|Death|0|||
147483084|NCT02124798|531924882|FG000|Overall Study|Lost to Follow-up|1|||
147483085|NCT02792777|531924883|FG000|Overall Study|Withdrawal by Subject|2|||
147303505|NCT03145766|531278703|FG001|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|0|||
147303506|NCT03145766|531278704|FG002|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|0|||
147303507|NCT03145766|531278705|FG003|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|1|||
147303508|NCT03145766|531278706|FG004|Follow-up Phase (Day 56 Till Month 7)|Non-compliance with the Protocol|0|||
147303509|NCT03145766|531278702|FG000|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|4|||
147303510|NCT03145766|531278703|FG001|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|1|||
147303511|NCT03145766|531278704|FG002|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|4|||
147303512|NCT03145766|531278705|FG003|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|2|||
147303513|NCT03145766|531278706|FG004|Follow-up Phase (Day 56 Till Month 7)|Lost to Follow-up|3|||
147303514|NCT03145766|531278702|FG000|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|1|||
147303515|NCT03145766|531278703|FG001|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|1|||
147303516|NCT03145766|531278704|FG002|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|1|||
147303517|NCT03145766|531278705|FG003|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|0|||
147303518|NCT03145766|531278706|FG004|Follow-up Phase (Day 56 Till Month 7)|Voluntary Withdrawal not due to AE|0|||
147303519|NCT02801669|531278708|FG000|Overall Study|Death|66|||
147303520|NCT02801669|531278709|FG001|Overall Study|Death|69|||
147303521|NCT02801669|531278708|FG000|Overall Study|Withdrawal by Subject|81|||
147303522|NCT02801669|531278709|FG001|Overall Study|Withdrawal by Subject|77|||
147303523|NCT02801669|531278708|FG000|Overall Study|Other|4|||
147303524|NCT02801669|531278709|FG001|Overall Study|Other|6|||
147303525|NCT04461795|531278711|FG000|Overall Study|Lost to Follow-up|2|||
147303526|NCT04461795|531278711|FG000|Overall Study|Withdrawal by Subject|2|||
147303527|NCT04461795|531278711|FG000|Overall Study|Protocol Specified Withdrawal Criterion Met|1|||
147303528|NCT00615264|531278712|FG000|Overall Study|Withdrawal by Subject|17|||
147303529|NCT00615264|531278713|FG001|Overall Study|Withdrawal by Subject|19|||
147303530|NCT00615264|531278712|FG000|Overall Study|Lost to Follow-up|6|||
147303531|NCT00615264|531278713|FG001|Overall Study|Lost to Follow-up|13|||
147303532|NCT00615264|531278712|FG000|Overall Study|Adverse Event|8|||
147303533|NCT00615264|531278713|FG001|Overall Study|Adverse Event|5|||
147303534|NCT00615264|531278712|FG000|Overall Study|Death|1|||
147303535|NCT00615264|531278713|FG001|Overall Study|Death|1|||
147303536|NCT00615264|531278712|FG000|Overall Study|Protocol Violation|11|||
147303537|NCT00615264|531278713|FG001|Overall Study|Protocol Violation|7|||
147303538|NCT00615264|531278712|FG000|Overall Study|Not defined|7|||
147483086|NCT02792777|531924884|FG001|Overall Study|Withdrawal by Subject|0|||
147483087|NCT02792777|531924883|FG000|Overall Study|Recording malfunction|2|||
147483088|NCT02792777|531924884|FG001|Overall Study|Recording malfunction|0|||
147483089|NCT02792777|531924883|FG000|Overall Study|Later determined to be ineligible|2|||
147483090|NCT02792777|531924884|FG001|Overall Study|Later determined to be ineligible|0|||
147483091|NCT02792777|531924883|FG000|Overall Study|Participant interviewed twice|1|||
147483092|NCT02792777|531924884|FG001|Overall Study|Participant interviewed twice|0|||
147483093|NCT02795156|531924886|FG000|Overall Study|Progressive Disease|22|||
147483094|NCT02795156|531924887|FG001|Overall Study|Progressive Disease|7|||
147483095|NCT02795156|531924888|FG002|Overall Study|Progressive Disease|34|||
147623268|NCT05691712|532438539|FG002|Overall Study|Death|0|||
147303539|NCT00615264|531278713|FG001|Overall Study|Not defined|4|||
147303540|NCT00615264|531278712|FG000|Overall Study|Dermal Hypersensitivity|0|||
147303541|NCT00615264|531278713|FG001|Overall Study|Dermal Hypersensitivity|3|||
147303542|NCT00185640|531278714|FG000|Overall Study|Not Eligible|4|||
147303543|NCT00185640|531278714|FG000|Overall Study|Withdrawal by Subject|3|||
147303544|NCT00185640|531278714|FG000|Overall Study|Death|138|||
147303545|NCT00058422|531278715|FG000|Overall Study|Not treated|2|||
147303546|NCT02396537|531278724|FG000|Overall Study|Protocol Violation|0|||
147303547|NCT02396537|531278725|FG001|Overall Study|Protocol Violation|1|||
147303548|NCT01982435|531278726|FG000|Overall Study|Adverse Event|1|||
147303549|NCT01982435|531278727|FG001|Overall Study|Adverse Event|0|||
147623269|NCT05691712|532438540|FG003|Overall Study|Death|0|||
147623270|NCT05691712|532438537|FG000|Overall Study|Pregnancy|0|||
147623271|NCT05691712|532438538|FG001|Overall Study|Pregnancy|1|||
147623272|NCT05691712|532438539|FG002|Overall Study|Pregnancy|0|||
147303550|NCT00871403|531278728|FG000|Combination Treatment Phase|Randomized but Not Treated|1|||
147303551|NCT00871403|531278729|FG001|Combination Treatment Phase|Randomized but Not Treated|1|||
147303552|NCT00871403|531278730|FG002|Combination Treatment Phase|Randomized but Not Treated|1|||
147303553|NCT00871403|531278728|FG000|Combination Treatment Phase|Treatment Stopped; Protocol Amendment|8|||
147303554|NCT00871403|531278729|FG001|Combination Treatment Phase|Treatment Stopped; Protocol Amendment|19|||
147303555|NCT00871403|531278730|FG002|Combination Treatment Phase|Treatment Stopped; Protocol Amendment|0|||
147623273|NCT05691712|532438540|FG003|Overall Study|Pregnancy|0|||
147623274|NCT05691712|532438537|FG000|Overall Study|Assigned Treatment by Mistake|1|||
147303556|NCT00871403|531278728|FG000|Combination Treatment Phase|Adverse Event|0|||
147303557|NCT00871403|531278729|FG001|Combination Treatment Phase|Adverse Event|17|||
147303558|NCT00871403|531278730|FG002|Combination Treatment Phase|Adverse Event|2|||
147623275|NCT05691712|532438538|FG001|Overall Study|Assigned Treatment by Mistake|0|||
147303559|NCT00871403|531278728|FG000|Combination Treatment Phase|Disease Progression|0|||
147303560|NCT00871403|531278729|FG001|Combination Treatment Phase|Disease Progression|8|||
147303561|NCT00871403|531278730|FG002|Combination Treatment Phase|Disease Progression|5|||
147303562|NCT00871403|531278728|FG000|Combination Treatment Phase|Withdrawal by Subject|0|||
147303563|NCT00871403|531278729|FG001|Combination Treatment Phase|Withdrawal by Subject|3|||
147303564|NCT00871403|531278730|FG002|Combination Treatment Phase|Withdrawal by Subject|1|||
147303565|NCT00871403|531278728|FG000|Combination Treatment Phase|Physician Decision|0|||
147303566|NCT00871403|531278729|FG001|Combination Treatment Phase|Physician Decision|1|||
147303567|NCT00871403|531278730|FG002|Combination Treatment Phase|Physician Decision|3|||
147303568|NCT00871403|531278728|FG000|Monotherapy Treatment Phase|Disease Progression|0|||
147303569|NCT00871403|531278729|FG001|Monotherapy Treatment Phase|Disease Progression|9|||
147303570|NCT00871403|531278730|FG002|Monotherapy Treatment Phase|Disease Progression|1|||
147303571|NCT00871403|531278728|FG000|Monotherapy Treatment Phase|Adverse Event|0|||
147303572|NCT00871403|531278729|FG001|Monotherapy Treatment Phase|Adverse Event|4|||
147303573|NCT00871403|531278730|FG002|Monotherapy Treatment Phase|Adverse Event|0|||
147303574|NCT00985985|531278734|FG000|Overall Study|Adverse Event|4|||
147303575|NCT00985985|531278735|FG001|Overall Study|Adverse Event|2|||
147303576|NCT00985985|531278736|FG002|Overall Study|Adverse Event|2|||
147303577|NCT00985985|531278737|FG003|Overall Study|Adverse Event|2|||
147303578|NCT00985985|531278734|FG000|Overall Study|Lost to Follow-up|4|||
147303579|NCT00985985|531278735|FG001|Overall Study|Lost to Follow-up|11|||
147303580|NCT00985985|531278736|FG002|Overall Study|Lost to Follow-up|2|||
147303581|NCT00985985|531278737|FG003|Overall Study|Lost to Follow-up|3|||
147303582|NCT00985985|531278734|FG000|Overall Study|Protocol Violation|1|||
147303583|NCT00985985|531278735|FG001|Overall Study|Protocol Violation|2|||
147303584|NCT00985985|531278736|FG002|Overall Study|Protocol Violation|0|||
147303585|NCT00985985|531278737|FG003|Overall Study|Protocol Violation|1|||
147303586|NCT00985985|531278734|FG000|Overall Study|Lack of Efficacy|5|||
147303587|NCT00985985|531278735|FG001|Overall Study|Lack of Efficacy|6|||
147303588|NCT00985985|531278736|FG002|Overall Study|Lack of Efficacy|1|||
147303589|NCT00985985|531278737|FG003|Overall Study|Lack of Efficacy|3|||
147303590|NCT00985985|531278734|FG000|Overall Study|Withdrawal by Subject|4|||
147303591|NCT00985985|531278735|FG001|Overall Study|Withdrawal by Subject|2|||
147303592|NCT00985985|531278736|FG002|Overall Study|Withdrawal by Subject|2|||
147303593|NCT00985985|531278737|FG003|Overall Study|Withdrawal by Subject|2|||
147303594|NCT00985985|531278734|FG000|Overall Study|Other Reason|6|||
147303595|NCT00985985|531278735|FG001|Overall Study|Other Reason|1|||
147303596|NCT00985985|531278736|FG002|Overall Study|Other Reason|4|||
147303597|NCT00985985|531278737|FG003|Overall Study|Other Reason|2|||
147303598|NCT00927355|531278738|FG000|Overall Study|Adverse Event|1|||
147303599|NCT00927355|531278739|FG001|Overall Study|Adverse Event|1|||
147303600|NCT01572389|531278740|FG000|Overall Study|Death|1|||
147303601|NCT01572389|531278741|FG001|Overall Study|Death|3|||
147303602|NCT01572389|531278740|FG000|Overall Study|Withdrawal by Subject|14|||
147303603|NCT01572389|531278741|FG001|Overall Study|Withdrawal by Subject|2|||
147303604|NCT01572389|531278740|FG000|Overall Study|Lost to Follow-up|25|||
147303605|NCT01572389|531278741|FG001|Overall Study|Lost to Follow-up|14|||
147303606|NCT01572389|531278740|FG000|Overall Study|Only A1C or Assessment was Collected|6|||
147303607|NCT01572389|531278741|FG001|Overall Study|Only A1C or Assessment was Collected|2|||
147303608|NCT02914314|531278752|FG000|Core Phase (Up to 20 Weeks)|Lost to Follow-up|0|||
147303609|NCT02914314|531278753|FG001|Core Phase (Up to 20 Weeks)|Lost to Follow-up|0|||
147303610|NCT02914314|531278754|FG002|Core Phase (Up to 20 Weeks)|Lost to Follow-up|0|||
147303611|NCT02914314|531278755|FG003|Core Phase (Up to 20 Weeks)|Lost to Follow-up|1|||
147303612|NCT02914314|531278752|FG000|Core Phase (Up to 20 Weeks)|Withdrawal by Subject|0|||
147303613|NCT02914314|531278753|FG001|Core Phase (Up to 20 Weeks)|Withdrawal by Subject|0|||
147303614|NCT02914314|531278754|FG002|Core Phase (Up to 20 Weeks)|Withdrawal by Subject|0|||
147303615|NCT02914314|531278755|FG003|Core Phase (Up to 20 Weeks)|Withdrawal by Subject|1|||
147303616|NCT02914314|531278752|FG000|Core Phase (Up to 20 Weeks)|Inadequate Therapeutic Effect|0|||
147667573|NCT01791595|532608095|FG000|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
147667574|NCT01791595|532608096|FG001|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
147667575|NCT01791595|532608097|FG002|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
147303617|NCT02914314|531278753|FG001|Core Phase (Up to 20 Weeks)|Inadequate Therapeutic Effect|0|||
147667576|NCT01791595|532608098|FG003|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
147667577|NCT01791595|532608099|FG004|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|5|||
147303618|NCT02914314|531278754|FG002|Core Phase (Up to 20 Weeks)|Inadequate Therapeutic Effect|1|||
147303619|NCT02914314|531278755|FG003|Core Phase (Up to 20 Weeks)|Inadequate Therapeutic Effect|0|||
147303620|NCT02914314|531278752|FG000|Extension Phase (Up to 36 Weeks)|Withdrawal by Subject|0|||
147303621|NCT02914314|531278753|FG001|Extension Phase (Up to 36 Weeks)|Withdrawal by Subject|0|||
147303622|NCT02914314|531278754|FG002|Extension Phase (Up to 36 Weeks)|Withdrawal by Subject|1|||
147303623|NCT02914314|531278755|FG003|Extension Phase (Up to 36 Weeks)|Withdrawal by Subject|0|||
147303624|NCT02914314|531278752|FG000|Extension Phase (Up to 36 Weeks)|Participant choice|0|||
147303625|NCT02914314|531278753|FG001|Extension Phase (Up to 36 Weeks)|Participant choice|0|||
147483096|NCT02795156|531924889|FG003|Overall Study|Progressive Disease|7|||
147303626|NCT02914314|531278754|FG002|Extension Phase (Up to 36 Weeks)|Participant choice|1|||
147303627|NCT02914314|531278755|FG003|Extension Phase (Up to 36 Weeks)|Participant choice|0|||
147303628|NCT01597505|531278758|FG000|Overall Study|Physician Decision|5|||
147303629|NCT01597505|531278759|FG001|Overall Study|Physician Decision|0|||
147303630|NCT01597505|531278758|FG000|Overall Study|Adverse Event|19|||
147303631|NCT01597505|531278759|FG001|Overall Study|Adverse Event|7|||
147303632|NCT01597505|531278758|FG000|Overall Study|Lost to Follow-up|4|||
147303633|NCT01597505|531278759|FG001|Overall Study|Lost to Follow-up|2|||
147303634|NCT01597505|531278758|FG000|Overall Study|Withdrawal by Subject|10|||
147303635|NCT01597505|531278759|FG001|Overall Study|Withdrawal by Subject|18|||
147303636|NCT01597505|531278758|FG000|Overall Study|Other|5|||
147303637|NCT01597505|531278759|FG001|Overall Study|Other|6|||
147303638|NCT01597505|531278758|FG000|Overall Study|Missing|1|||
147303639|NCT01597505|531278759|FG001|Overall Study|Missing|0|||
147303640|NCT03728972|531278760|FG000|Overall Study|Death|1|||
147303641|NCT03728972|531278761|FG001|Overall Study|Death|0|||
147303642|NCT03728972|531278760|FG000|Overall Study|Lack of Efficacy|1|||
147303643|NCT03728972|531278761|FG001|Overall Study|Lack of Efficacy|0|||
147303644|NCT03728972|531278760|FG000|Overall Study|Physician Decision|3|||
147303645|NCT03728972|531278761|FG001|Overall Study|Physician Decision|0|||
147303646|NCT03728972|531278760|FG000|Overall Study|Disease progression|4|||
147303647|NCT03728972|531278761|FG001|Overall Study|Disease progression|3|||
147303648|NCT04543188|531278762|FG000|Phase 1a|Adverse Event|0|||
147303649|NCT04543188|531278763|FG001|Phase 1a|Adverse Event|0|||
147303650|NCT04543188|531278764|FG002|Phase 1a|Adverse Event|0|||
147303651|NCT04543188|531278765|FG003|Phase 1a|Adverse Event|1|||
147303652|NCT04543188|531278766|FG004|Phase 1a|Adverse Event|0|||
147303653|NCT04543188|531278767|FG005|Phase 1a|Adverse Event|0|||
147303654|NCT04543188|531278768|FG006|Phase 1a|Adverse Event|1|||
147303655|NCT04543188|531278769|FG007|Phase 1a|Adverse Event|0|||
147303656|NCT04543188|531278770|FG008|Phase 1a|Adverse Event|0|||
147303657|NCT04543188|531278771|FG009|Phase 1a|Adverse Event|0|||
147303658|NCT04543188|531278772|FG010|Phase 1a|Adverse Event|0|||
147303659|NCT04543188|531278773|FG011|Phase 1a|Adverse Event|0|||
147303660|NCT04543188|531278774|FG012|Phase 1a|Adverse Event|0|||
147303661|NCT04543188|531278775|FG013|Phase 1a|Adverse Event|0|||
147303662|NCT04543188|531278776|FG014|Phase 1a|Adverse Event|0|||
147303663|NCT04543188|531278762|FG000|Phase 1a|Other (Death)|0|||
147303664|NCT04543188|531278763|FG001|Phase 1a|Other (Death)|1|||
147303665|NCT04543188|531278764|FG002|Phase 1a|Other (Death)|0|||
147303666|NCT04543188|531278765|FG003|Phase 1a|Other (Death)|0|||
147303667|NCT04543188|531278766|FG004|Phase 1a|Other (Death)|1|||
147303668|NCT04543188|531278767|FG005|Phase 1a|Other (Death)|0|||
147303669|NCT04543188|531278768|FG006|Phase 1a|Other (Death)|0|||
147303670|NCT04543188|531278769|FG007|Phase 1a|Other (Death)|0|||
147303671|NCT04543188|531278770|FG008|Phase 1a|Other (Death)|0|||
147303672|NCT04543188|531278771|FG009|Phase 1a|Other (Death)|1|||
147303673|NCT04543188|531278772|FG010|Phase 1a|Other (Death)|0|||
147303674|NCT04543188|531278773|FG011|Phase 1a|Other (Death)|0|||
147303675|NCT04543188|531278774|FG012|Phase 1a|Other (Death)|0|||
147303676|NCT04543188|531278775|FG013|Phase 1a|Other (Death)|0|||
147303677|NCT04543188|531278776|FG014|Phase 1a|Other (Death)|0|||
147303678|NCT04543188|531278762|FG000|Phase 1a|Lost to Follow-up|0|||
147303679|NCT04543188|531278763|FG001|Phase 1a|Lost to Follow-up|0|||
147303680|NCT04543188|531278764|FG002|Phase 1a|Lost to Follow-up|0|||
147303681|NCT04543188|531278765|FG003|Phase 1a|Lost to Follow-up|0|||
147303682|NCT04543188|531278766|FG004|Phase 1a|Lost to Follow-up|0|||
147303683|NCT04543188|531278767|FG005|Phase 1a|Lost to Follow-up|0|||
147303684|NCT04543188|531278768|FG006|Phase 1a|Lost to Follow-up|0|||
147303685|NCT04543188|531278769|FG007|Phase 1a|Lost to Follow-up|0|||
147303686|NCT04543188|531278770|FG008|Phase 1a|Lost to Follow-up|0|||
147303687|NCT04543188|531278771|FG009|Phase 1a|Lost to Follow-up|0|||
147303688|NCT04543188|531278772|FG010|Phase 1a|Lost to Follow-up|1|||
147303689|NCT04543188|531278773|FG011|Phase 1a|Lost to Follow-up|0|||
147303690|NCT04543188|531278774|FG012|Phase 1a|Lost to Follow-up|0|||
147303691|NCT04543188|531278775|FG013|Phase 1a|Lost to Follow-up|0|||
147303692|NCT04543188|531278776|FG014|Phase 1a|Lost to Follow-up|0|||
147303693|NCT04543188|531278762|FG000|Phase 1a|Progressive Disease|2|||
147303694|NCT04543188|531278763|FG001|Phase 1a|Progressive Disease|2|||
147303695|NCT04543188|531278764|FG002|Phase 1a|Progressive Disease|3|||
147303696|NCT04543188|531278765|FG003|Phase 1a|Progressive Disease|1|||
147303697|NCT04543188|531278766|FG004|Phase 1a|Progressive Disease|4|||
147303698|NCT04543188|531278767|FG005|Phase 1a|Progressive Disease|2|||
147303699|NCT04543188|531278768|FG006|Phase 1a|Progressive Disease|3|||
147303700|NCT04543188|531278769|FG007|Phase 1a|Progressive Disease|4|||
147303701|NCT04543188|531278770|FG008|Phase 1a|Progressive Disease|1|||
147303702|NCT04543188|531278771|FG009|Phase 1a|Progressive Disease|0|||
147303703|NCT04543188|531278772|FG010|Phase 1a|Progressive Disease|4|||
147303704|NCT04543188|531278773|FG011|Phase 1a|Progressive Disease|0|||
147303705|NCT04543188|531278774|FG012|Phase 1a|Progressive Disease|0|||
147303706|NCT04543188|531278775|FG013|Phase 1a|Progressive Disease|0|||
147303707|NCT04543188|531278776|FG014|Phase 1a|Progressive Disease|0|||
147303708|NCT04543188|531278762|FG000|Phase 1a|Study terminated by sponsor|0|||
147303709|NCT04543188|531278763|FG001|Phase 1a|Study terminated by sponsor|0|||
147303710|NCT04543188|531278764|FG002|Phase 1a|Study terminated by sponsor|0|||
147303711|NCT04543188|531278765|FG003|Phase 1a|Study terminated by sponsor|0|||
147303712|NCT04543188|531278766|FG004|Phase 1a|Study terminated by sponsor|1|||
147303713|NCT04543188|531278767|FG005|Phase 1a|Study terminated by sponsor|0|||
147303714|NCT04543188|531278768|FG006|Phase 1a|Study terminated by sponsor|0|||
147303715|NCT04543188|531278769|FG007|Phase 1a|Study terminated by sponsor|0|||
147303716|NCT04543188|531278770|FG008|Phase 1a|Study terminated by sponsor|0|||
147303717|NCT04543188|531278771|FG009|Phase 1a|Study terminated by sponsor|0|||
147303718|NCT04543188|531278772|FG010|Phase 1a|Study terminated by sponsor|1|||
147303719|NCT04543188|531278773|FG011|Phase 1a|Study terminated by sponsor|0|||
147303720|NCT04543188|531278774|FG012|Phase 1a|Study terminated by sponsor|0|||
147303721|NCT04543188|531278775|FG013|Phase 1a|Study terminated by sponsor|0|||
147303722|NCT04543188|531278776|FG014|Phase 1a|Study terminated by sponsor|0|||
147303723|NCT04543188|531278762|FG000|Phase 1a|Withdrawal by Subject|0|||
147303724|NCT04543188|531278763|FG001|Phase 1a|Withdrawal by Subject|0|||
147303725|NCT04543188|531278764|FG002|Phase 1a|Withdrawal by Subject|0|||
147303726|NCT04543188|531278765|FG003|Phase 1a|Withdrawal by Subject|0|||
147303727|NCT04543188|531278766|FG004|Phase 1a|Withdrawal by Subject|3|||
147303728|NCT04543188|531278767|FG005|Phase 1a|Withdrawal by Subject|0|||
147303729|NCT04543188|531278768|FG006|Phase 1a|Withdrawal by Subject|0|||
147303730|NCT04543188|531278769|FG007|Phase 1a|Withdrawal by Subject|0|||
147303731|NCT04543188|531278770|FG008|Phase 1a|Withdrawal by Subject|1|||
147483097|NCT02795156|531924886|FG000|Overall Study|Adverse Event|13|||
147483098|NCT02795156|531924887|FG001|Overall Study|Adverse Event|2|||
147483099|NCT02795156|531924888|FG002|Overall Study|Adverse Event|3|||
147483100|NCT02795156|531924889|FG003|Overall Study|Adverse Event|2|||
147483101|NCT02795156|531924886|FG000|Overall Study|Death|1|||
147483102|NCT02795156|531924887|FG001|Overall Study|Death|1|||
147303732|NCT04543188|531278771|FG009|Phase 1a|Withdrawal by Subject|1|||
147303733|NCT04543188|531278772|FG010|Phase 1a|Withdrawal by Subject|2|||
147303734|NCT04543188|531278773|FG011|Phase 1a|Withdrawal by Subject|0|||
147303735|NCT04543188|531278774|FG012|Phase 1a|Withdrawal by Subject|0|||
147303736|NCT04543188|531278775|FG013|Phase 1a|Withdrawal by Subject|0|||
147303737|NCT04543188|531278776|FG014|Phase 1a|Withdrawal by Subject|0|||
147303738|NCT04543188|531278762|FG000|Phase 1a|Global Deterioration Of Health Status|0|||
147303739|NCT04543188|531278763|FG001|Phase 1a|Global Deterioration Of Health Status|1|||
147303740|NCT04543188|531278764|FG002|Phase 1a|Global Deterioration Of Health Status|0|||
147303741|NCT04543188|531278765|FG003|Phase 1a|Global Deterioration Of Health Status|1|||
147303742|NCT04543188|531278766|FG004|Phase 1a|Global Deterioration Of Health Status|1|||
147303743|NCT04543188|531278767|FG005|Phase 1a|Global Deterioration Of Health Status|1|||
147303744|NCT04543188|531278768|FG006|Phase 1a|Global Deterioration Of Health Status|0|||
147303745|NCT04543188|531278769|FG007|Phase 1a|Global Deterioration Of Health Status|0|||
147303746|NCT04543188|531278770|FG008|Phase 1a|Global Deterioration Of Health Status|0|||
147303747|NCT04543188|531278771|FG009|Phase 1a|Global Deterioration Of Health Status|2|||
147303748|NCT04543188|531278772|FG010|Phase 1a|Global Deterioration Of Health Status|0|||
147303749|NCT04543188|531278773|FG011|Phase 1a|Global Deterioration Of Health Status|0|||
147303750|NCT04543188|531278774|FG012|Phase 1a|Global Deterioration Of Health Status|0|||
147303751|NCT04543188|531278775|FG013|Phase 1a|Global Deterioration Of Health Status|0|||
147303752|NCT04543188|531278776|FG014|Phase 1a|Global Deterioration Of Health Status|0|||
147303753|NCT04543188|531278762|FG000|Phase 1a|Other|0|||
147303754|NCT04543188|531278763|FG001|Phase 1a|Other|0|||
147303755|NCT04543188|531278764|FG002|Phase 1a|Other|0|||
147303756|NCT04543188|531278765|FG003|Phase 1a|Other|0|||
147303757|NCT04543188|531278766|FG004|Phase 1a|Other|0|||
147303758|NCT04543188|531278767|FG005|Phase 1a|Other|0|||
147303759|NCT04543188|531278768|FG006|Phase 1a|Other|0|||
147303760|NCT04543188|531278769|FG007|Phase 1a|Other|0|||
147303761|NCT04543188|531278770|FG008|Phase 1a|Other|0|||
147303762|NCT04543188|531278771|FG009|Phase 1a|Other|1|||
147303763|NCT04543188|531278772|FG010|Phase 1a|Other|0|||
147303764|NCT04543188|531278773|FG011|Phase 1a|Other|0|||
147623276|NCT05691712|532438539|FG002|Overall Study|Assigned Treatment by Mistake|0|||
147303765|NCT04543188|531278774|FG012|Phase 1a|Other|0|||
147303766|NCT04543188|531278775|FG013|Phase 1a|Other|0|||
147303767|NCT04543188|531278776|FG014|Phase 1a|Other|0|||
147303768|NCT04543188|531278762|FG000|Phase 1b|Adverse Event|0|||
147623277|NCT05691712|532438540|FG003|Overall Study|Assigned Treatment by Mistake|1|||
147623278|NCT05303194|532438541|FG000|Overall Study|Lost to Follow-up|1|||
147303769|NCT04543188|531278763|FG001|Phase 1b|Adverse Event|0|||
147303770|NCT04543188|531278764|FG002|Phase 1b|Adverse Event|0|||
147483103|NCT02795156|531924888|FG002|Overall Study|Death|1|||
147623279|NCT05303194|532438542|FG001|Overall Study|Lost to Follow-up|1|||
147303771|NCT04543188|531278765|FG003|Phase 1b|Adverse Event|0|||
147303772|NCT04543188|531278766|FG004|Phase 1b|Adverse Event|0|||
147303773|NCT04543188|531278767|FG005|Phase 1b|Adverse Event|0|||
147303774|NCT04543188|531278768|FG006|Phase 1b|Adverse Event|0|||
147303775|NCT04543188|531278769|FG007|Phase 1b|Adverse Event|0|||
147303776|NCT04543188|531278770|FG008|Phase 1b|Adverse Event|0|||
147303777|NCT04543188|531278771|FG009|Phase 1b|Adverse Event|0|||
147483104|NCT02795156|531924889|FG003|Overall Study|Death|0|||
147303778|NCT04543188|531278772|FG010|Phase 1b|Adverse Event|0|||
147303779|NCT04543188|531278773|FG011|Phase 1b|Adverse Event|0|||
147303780|NCT04543188|531278774|FG012|Phase 1b|Adverse Event|0|||
147303781|NCT04543188|531278775|FG013|Phase 1b|Adverse Event|0|||
147303782|NCT04543188|531278776|FG014|Phase 1b|Adverse Event|2|||
147303783|NCT04543188|531278762|FG000|Phase 1b|Other (Death)|0|||
147303784|NCT04543188|531278763|FG001|Phase 1b|Other (Death)|0|||
147303785|NCT04543188|531278764|FG002|Phase 1b|Other (Death)|0|||
147303786|NCT04543188|531278765|FG003|Phase 1b|Other (Death)|0|||
147303787|NCT04543188|531278766|FG004|Phase 1b|Other (Death)|0|||
147303788|NCT04543188|531278767|FG005|Phase 1b|Other (Death)|0|||
147303789|NCT04543188|531278768|FG006|Phase 1b|Other (Death)|0|||
147303790|NCT04543188|531278769|FG007|Phase 1b|Other (Death)|0|||
147303791|NCT04543188|531278770|FG008|Phase 1b|Other (Death)|0|||
147303792|NCT04543188|531278771|FG009|Phase 1b|Other (Death)|0|||
147303793|NCT04543188|531278772|FG010|Phase 1b|Other (Death)|0|||
147303794|NCT04543188|531278773|FG011|Phase 1b|Other (Death)|0|||
147303795|NCT04543188|531278774|FG012|Phase 1b|Other (Death)|1|||
147303796|NCT04543188|531278775|FG013|Phase 1b|Other (Death)|0|||
147303797|NCT04543188|531278776|FG014|Phase 1b|Other (Death)|1|||
147303798|NCT04543188|531278762|FG000|Phase 1b|Progressive Disease|0|||
147303799|NCT04543188|531278763|FG001|Phase 1b|Progressive Disease|0|||
147303800|NCT04543188|531278764|FG002|Phase 1b|Progressive Disease|0|||
147303801|NCT04543188|531278765|FG003|Phase 1b|Progressive Disease|0|||
147303802|NCT04543188|531278766|FG004|Phase 1b|Progressive Disease|0|||
147303803|NCT04543188|531278767|FG005|Phase 1b|Progressive Disease|0|||
147303804|NCT04543188|531278768|FG006|Phase 1b|Progressive Disease|0|||
147303805|NCT04543188|531278769|FG007|Phase 1b|Progressive Disease|0|||
147303806|NCT04543188|531278770|FG008|Phase 1b|Progressive Disease|0|||
147303807|NCT04543188|531278771|FG009|Phase 1b|Progressive Disease|0|||
147303808|NCT04543188|531278772|FG010|Phase 1b|Progressive Disease|0|||
147303809|NCT04543188|531278773|FG011|Phase 1b|Progressive Disease|0|||
147303810|NCT04543188|531278774|FG012|Phase 1b|Progressive Disease|2|||
147303811|NCT04543188|531278775|FG013|Phase 1b|Progressive Disease|1|||
147303812|NCT04543188|531278776|FG014|Phase 1b|Progressive Disease|5|||
147303813|NCT04543188|531278762|FG000|Phase 1b|Study Terminated By Sponsor|0|||
147303814|NCT04543188|531278763|FG001|Phase 1b|Study Terminated By Sponsor|0|||
147303815|NCT04543188|531278764|FG002|Phase 1b|Study Terminated By Sponsor|0|||
147303816|NCT04543188|531278765|FG003|Phase 1b|Study Terminated By Sponsor|0|||
147303817|NCT04543188|531278766|FG004|Phase 1b|Study Terminated By Sponsor|0|||
147303818|NCT04543188|531278767|FG005|Phase 1b|Study Terminated By Sponsor|0|||
147303819|NCT04543188|531278768|FG006|Phase 1b|Study Terminated By Sponsor|0|||
147303820|NCT04543188|531278769|FG007|Phase 1b|Study Terminated By Sponsor|0|||
147303821|NCT04543188|531278770|FG008|Phase 1b|Study Terminated By Sponsor|0|||
147303822|NCT04543188|531278771|FG009|Phase 1b|Study Terminated By Sponsor|0|||
147303823|NCT04543188|531278772|FG010|Phase 1b|Study Terminated By Sponsor|0|||
147303824|NCT04543188|531278773|FG011|Phase 1b|Study Terminated By Sponsor|1|||
147303825|NCT04543188|531278774|FG012|Phase 1b|Study Terminated By Sponsor|1|||
147303826|NCT04543188|531278775|FG013|Phase 1b|Study Terminated By Sponsor|0|||
147303827|NCT04543188|531278776|FG014|Phase 1b|Study Terminated By Sponsor|1|||
147303828|NCT04543188|531278762|FG000|Phase 1b|Withdrawal by Subject|0|||
147303829|NCT04543188|531278763|FG001|Phase 1b|Withdrawal by Subject|0|||
147303830|NCT04543188|531278764|FG002|Phase 1b|Withdrawal by Subject|0|||
147303831|NCT04543188|531278765|FG003|Phase 1b|Withdrawal by Subject|0|||
147303832|NCT04543188|531278766|FG004|Phase 1b|Withdrawal by Subject|0|||
147303833|NCT04543188|531278767|FG005|Phase 1b|Withdrawal by Subject|0|||
147303834|NCT04543188|531278768|FG006|Phase 1b|Withdrawal by Subject|0|||
147303835|NCT04543188|531278769|FG007|Phase 1b|Withdrawal by Subject|0|||
147303836|NCT04543188|531278770|FG008|Phase 1b|Withdrawal by Subject|0|||
147303837|NCT04543188|531278771|FG009|Phase 1b|Withdrawal by Subject|0|||
147303838|NCT04543188|531278772|FG010|Phase 1b|Withdrawal by Subject|0|||
147303839|NCT04543188|531278773|FG011|Phase 1b|Withdrawal by Subject|0|||
147303840|NCT04543188|531278774|FG012|Phase 1b|Withdrawal by Subject|0|||
147303841|NCT04543188|531278775|FG013|Phase 1b|Withdrawal by Subject|0|||
147303842|NCT04543188|531278776|FG014|Phase 1b|Withdrawal by Subject|2|||
147303843|NCT02487472|531278777|FG000|Overall Study|Did not complete telephonic interviews|9|||
147303844|NCT02487472|531278777|FG000|Overall Study|Other|2|||
147303845|NCT01313286|531278782|FG000|Period 1|Withdrawal by Subject|2|||
147303846|NCT01313286|531278783|FG001|Period 1|Withdrawal by Subject|0|||
147303847|NCT04843930|531278784|FG000|Randomization|Withdrawal by Subject|6|||
147303848|NCT04843930|531278785|FG001|Randomization|Withdrawal by Subject|6|||
147303849|NCT04843930|531278786|FG002|Randomization|Withdrawal by Subject|0|||
147303850|NCT04843930|531278787|FG003|Randomization|Withdrawal by Subject|0|||
147303851|NCT04843930|531278784|FG000|Week 6 Assessment|Adverse Event|3|||
147303852|NCT04843930|531278785|FG001|Week 6 Assessment|Adverse Event|0|||
147303853|NCT04843930|531278786|FG002|Week 6 Assessment|Adverse Event|0|||
147303854|NCT04843930|531278787|FG003|Week 6 Assessment|Adverse Event|0|||
147303855|NCT04843930|531278784|FG000|Week 6 Assessment|Withdrawal by Subject|2|||
147303856|NCT04843930|531278785|FG001|Week 6 Assessment|Withdrawal by Subject|1|||
147303857|NCT04843930|531278786|FG002|Week 6 Assessment|Withdrawal by Subject|0|||
147303858|NCT04843930|531278787|FG003|Week 6 Assessment|Withdrawal by Subject|0|||
147303859|NCT04843930|531278784|FG000|Week 16 Follow-Up|Lost to Follow-up|0|||
147303860|NCT04843930|531278785|FG001|Week 16 Follow-Up|Lost to Follow-up|0|||
147303861|NCT04843930|531278786|FG002|Week 16 Follow-Up|Lost to Follow-up|2|||
147303862|NCT04843930|531278787|FG003|Week 16 Follow-Up|Lost to Follow-up|0|||
147303863|NCT02036645|531278790|FG000|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
147303864|NCT02036645|531278791|FG001|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
147303865|NCT02036645|531278792|FG002|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
147303866|NCT02036645|531278793|FG003|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
147303867|NCT02036645|531278794|FG004|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
147303868|NCT02036645|531278795|FG005|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
147303869|NCT02036645|531278796|FG006|SAD Cohorts : Study Part 1|Lost to Follow-up|1|||
147303870|NCT02036645|531278797|FG007|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
147303871|NCT02036645|531278798|FG008|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
147303872|NCT02036645|531278799|FG009|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
147303873|NCT02036645|531278800|FG010|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
147303874|NCT02036645|531278801|FG011|SAD Cohorts : Study Part 1|Lost to Follow-up|0|||
147303875|NCT02036645|531278790|FG000|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
147303876|NCT02036645|531278791|FG001|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
147303877|NCT02036645|531278792|FG002|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
147303878|NCT02036645|531278793|FG003|SAD Cohorts : Study Part 1|Withdrawal by Subject|1|||
147303879|NCT02036645|531278794|FG004|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
147303880|NCT02036645|531278795|FG005|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
147303881|NCT02036645|531278796|FG006|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
147303882|NCT02036645|531278797|FG007|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
147303883|NCT02036645|531278798|FG008|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
147303884|NCT02036645|531278799|FG009|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
147303885|NCT02036645|531278800|FG010|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
147303886|NCT02036645|531278801|FG011|SAD Cohorts : Study Part 1|Withdrawal by Subject|0|||
147303887|NCT02010632|531278802|FG000|Second Intervention (7 Days)|Withdrawal by Subject|1|||
147303888|NCT02010632|531278803|FG001|Second Intervention (7 Days)|Withdrawal by Subject|0|||
147303889|NCT04241094|531278804|FG000|Overall Study|Dropped out of treatment|4|||
147303890|NCT04241094|531278804|FG000|Overall Study|Ineligible after clinical assessment|2|||
147303891|NCT04241094|531278804|FG000|Overall Study|Lost to Follow-up|2|||
147303892|NCT01669798|531278805|FG000|Overall Study|Physician Decision|5|||
147303893|NCT05918978|531278809|FG000|Overall Study|Study Terminated by Sponsor|17|||
147303894|NCT05918978|531278810|FG001|Overall Study|Study Terminated by Sponsor|11|||
147303895|NCT05918978|531278809|FG000|Overall Study|Withdrawal by Subject|1|||
147303896|NCT05918978|531278810|FG001|Overall Study|Withdrawal by Subject|1|||
147303897|NCT05918978|531278809|FG000|Overall Study|Adverse Event|1|||
147303898|NCT05918978|531278810|FG001|Overall Study|Adverse Event|0|||
147303899|NCT05918978|531278809|FG000|Overall Study|Other|0|||
147303900|NCT05918978|531278810|FG001|Overall Study|Other|1|||
147303901|NCT00622180|531278811|FG000|Overall Study|Lost to Follow-up|1|||
147303902|NCT00622180|531278812|FG001|Overall Study|Lost to Follow-up|2|||
147303903|NCT06387472|531278815|FG000|Overall Study|Withdrawal by Subject|1|||
147303904|NCT06387472|531278815|FG000|Overall Study|Lost to Follow-up|2|||
147303905|NCT06387472|531278815|FG000|Overall Study|Physician Decision|1|||
147303906|NCT02332590|531278818|FG000|DB Period (up to 24 Weeks)|Adverse Event|15|||
147303907|NCT02332590|531278819|FG001|DB Period (up to 24 Weeks)|Adverse Event|11|||
147303908|NCT02332590|531278818|FG000|DB Period (up to 24 Weeks)|Lack of Efficacy|4|||
147303909|NCT02332590|531278819|FG001|DB Period (up to 24 Weeks)|Lack of Efficacy|2|||
147303910|NCT02332590|531278818|FG000|DB Period (up to 24 Weeks)|Poor compliance to protocol|3|||
147303911|NCT02332590|531278819|FG001|DB Period (up to 24 Weeks)|Poor compliance to protocol|1|||
147303912|NCT02332590|531278818|FG000|DB Period (up to 24 Weeks)|Randomized but not treated|1|||
147303913|NCT02332590|531278819|FG001|DB Period (up to 24 Weeks)|Randomized but not treated|0|||
147303914|NCT02332590|531278818|FG000|DB Period (up to 24 Weeks)|Other than specified above|6|||
147303915|NCT02332590|531278819|FG001|DB Period (up to 24 Weeks)|Other than specified above|5|||
147303916|NCT02332590|531278818|FG000|OLE Period (Week 24 up to Week 300)|Adverse Event|20|||
147303917|NCT02332590|531278819|FG001|OLE Period (Week 24 up to Week 300)|Adverse Event|23|||
147303918|NCT02332590|531278818|FG000|OLE Period (Week 24 up to Week 300)|Lack of Efficacy|2|||
147303919|NCT02332590|531278819|FG001|OLE Period (Week 24 up to Week 300)|Lack of Efficacy|6|||
147303920|NCT02332590|531278818|FG000|OLE Period (Week 24 up to Week 300)|Poor compliance to protocol|5|||
147303921|NCT02332590|531278819|FG001|OLE Period (Week 24 up to Week 300)|Poor compliance to protocol|1|||
147303922|NCT02332590|531278818|FG000|OLE Period (Week 24 up to Week 300)|Other Unspecified|20|||
147303923|NCT02332590|531278819|FG001|OLE Period (Week 24 up to Week 300)|Other Unspecified|15|||
147303924|NCT00279201|531278820|FG000|Initiation|Death|1|||
147303925|NCT00279201|531278821|FG001|Initiation|Death|5|||
147303926|NCT00279201|531278822|FG002|Initiation|Death|0|||
147667578|NCT01791595|532608100|FG005|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
147303927|NCT00279201|531278823|FG003|Initiation|Death|0|||
147303928|NCT00279201|531278824|FG004|Initiation|Death|0|||
147303929|NCT00279201|531278825|FG005|Initiation|Death|0|||
147303930|NCT00279201|531278820|FG000|Initiation|Adverse Event|6|||
147303931|NCT00279201|531278821|FG001|Initiation|Adverse Event|15|||
147303932|NCT00279201|531278822|FG002|Initiation|Adverse Event|0|||
147303933|NCT00279201|531278823|FG003|Initiation|Adverse Event|0|||
147303934|NCT00279201|531278824|FG004|Initiation|Adverse Event|0|||
147303935|NCT00279201|531278825|FG005|Initiation|Adverse Event|0|||
147303936|NCT00279201|531278820|FG000|Initiation|Lost to Follow-up|42|||
147303937|NCT00279201|531278821|FG001|Initiation|Lost to Follow-up|41|||
147303938|NCT00279201|531278822|FG002|Initiation|Lost to Follow-up|0|||
147303939|NCT00279201|531278823|FG003|Initiation|Lost to Follow-up|0|||
147303940|NCT00279201|531278824|FG004|Initiation|Lost to Follow-up|0|||
147303941|NCT00279201|531278825|FG005|Initiation|Lost to Follow-up|0|||
147303942|NCT00279201|531278820|FG000|Initiation|Entry Criteria Exclusion|7|||
147303943|NCT00279201|531278821|FG001|Initiation|Entry Criteria Exclusion|9|||
147303944|NCT00279201|531278822|FG002|Initiation|Entry Criteria Exclusion|0|||
147303945|NCT00279201|531278823|FG003|Initiation|Entry Criteria Exclusion|0|||
147303946|NCT00279201|531278824|FG004|Initiation|Entry Criteria Exclusion|0|||
147303947|NCT00279201|531278825|FG005|Initiation|Entry Criteria Exclusion|0|||
147303948|NCT00279201|531278820|FG000|Initiation|Protocol Violation|9|||
147303949|NCT00279201|531278821|FG001|Initiation|Protocol Violation|10|||
147303950|NCT00279201|531278822|FG002|Initiation|Protocol Violation|0|||
147303951|NCT00279201|531278823|FG003|Initiation|Protocol Violation|0|||
147303952|NCT00279201|531278824|FG004|Initiation|Protocol Violation|0|||
147303953|NCT00279201|531278825|FG005|Initiation|Protocol Violation|0|||
147303954|NCT00279201|531278820|FG000|Initiation|Withdrawal by Subject|35|||
147303955|NCT00279201|531278821|FG001|Initiation|Withdrawal by Subject|41|||
147303956|NCT00279201|531278822|FG002|Initiation|Withdrawal by Subject|0|||
147303957|NCT00279201|531278823|FG003|Initiation|Withdrawal by Subject|0|||
147303958|NCT00279201|531278824|FG004|Initiation|Withdrawal by Subject|0|||
147303959|NCT00279201|531278825|FG005|Initiation|Withdrawal by Subject|0|||
147303960|NCT00279201|531278820|FG000|Initiation|Physician Decision|15|||
147303961|NCT00279201|531278821|FG001|Initiation|Physician Decision|18|||
147303962|NCT00279201|531278822|FG002|Initiation|Physician Decision|0|||
147303963|NCT00279201|531278823|FG003|Initiation|Physician Decision|0|||
147303964|NCT00279201|531278824|FG004|Initiation|Physician Decision|0|||
147303965|NCT00279201|531278825|FG005|Initiation|Physician Decision|0|||
147303966|NCT00279201|531278820|FG000|Initiation|Sponsor Decision|13|||
147303967|NCT00279201|531278821|FG001|Initiation|Sponsor Decision|5|||
147303968|NCT00279201|531278822|FG002|Initiation|Sponsor Decision|0|||
147303969|NCT00279201|531278823|FG003|Initiation|Sponsor Decision|0|||
147303970|NCT00279201|531278824|FG004|Initiation|Sponsor Decision|0|||
147303971|NCT00279201|531278825|FG005|Initiation|Sponsor Decision|0|||
147303972|NCT00279201|531278820|FG000|Initiation|Discontinuation Oral Antihyperglycemics|0|||
147303973|NCT00279201|531278821|FG001|Initiation|Discontinuation Oral Antihyperglycemics|1|||
147303974|NCT00279201|531278822|FG002|Initiation|Discontinuation Oral Antihyperglycemics|0|||
147303975|NCT00279201|531278823|FG003|Initiation|Discontinuation Oral Antihyperglycemics|0|||
147303976|NCT00279201|531278824|FG004|Initiation|Discontinuation Oral Antihyperglycemics|0|||
147303977|NCT00279201|531278825|FG005|Initiation|Discontinuation Oral Antihyperglycemics|0|||
147303978|NCT00279201|531278820|FG000|Maintenance|Lack of Efficacy|32|||
147303979|NCT00279201|531278821|FG001|Maintenance|Lack of Efficacy|30|||
147303980|NCT00279201|531278822|FG002|Maintenance|Lack of Efficacy|0|||
147303981|NCT00279201|531278823|FG003|Maintenance|Lack of Efficacy|0|||
147303982|NCT00279201|531278824|FG004|Maintenance|Lack of Efficacy|0|||
147303983|NCT00279201|531278825|FG005|Maintenance|Lack of Efficacy|0|||
147623280|NCT05303194|532438541|FG000|Overall Study|Withdrawal by Subject|0|||
147623281|NCT05303194|532438542|FG001|Overall Study|Withdrawal by Subject|1|||
147623282|NCT04837196|532438543|FG000|Phase 1 Dose Escalation (Up to 817 Days)|Withdrawal by Subject|0|||
147623283|NCT04837196|532438544|FG001|Phase 1 Dose Escalation (Up to 817 Days)|Withdrawal by Subject|3|||
147623284|NCT04837196|532438545|FG002|Phase 1 Dose Escalation (Up to 817 Days)|Withdrawal by Subject|0|||
147303984|NCT00279201|531278820|FG000|Maintenance|Discontinuation Antihyperglycemic Drugs|3|||
147303985|NCT00279201|531278821|FG001|Maintenance|Discontinuation Antihyperglycemic Drugs|2|||
147303986|NCT00279201|531278822|FG002|Maintenance|Discontinuation Antihyperglycemic Drugs|0|||
147303987|NCT00279201|531278823|FG003|Maintenance|Discontinuation Antihyperglycemic Drugs|0|||
147303988|NCT00279201|531278824|FG004|Maintenance|Discontinuation Antihyperglycemic Drugs|0|||
147303989|NCT00279201|531278825|FG005|Maintenance|Discontinuation Antihyperglycemic Drugs|0|||
147303990|NCT00279201|531278820|FG000|Maintenance|Adverse Event|4|||
147303991|NCT00279201|531278821|FG001|Maintenance|Adverse Event|4|||
147623285|NCT04837196|532438546|FG003|Phase 1 Dose Escalation (Up to 817 Days)|Withdrawal by Subject|0|||
147303992|NCT00279201|531278822|FG002|Maintenance|Adverse Event|0|||
147303993|NCT00279201|531278823|FG003|Maintenance|Adverse Event|0|||
147303994|NCT00279201|531278824|FG004|Maintenance|Adverse Event|0|||
147623286|NCT04837196|532438547|FG004|Phase 1 Dose Escalation (Up to 817 Days)|Withdrawal by Subject|4|||
147303995|NCT00279201|531278825|FG005|Maintenance|Adverse Event|0|||
147303996|NCT00279201|531278820|FG000|Maintenance|Death|4|||
147303997|NCT00279201|531278821|FG001|Maintenance|Death|4|||
147303998|NCT00279201|531278822|FG002|Maintenance|Death|0|||
147303999|NCT00279201|531278823|FG003|Maintenance|Death|0|||
147304000|NCT00279201|531278824|FG004|Maintenance|Death|0|||
147304001|NCT00279201|531278825|FG005|Maintenance|Death|0|||
147304002|NCT00279201|531278820|FG000|Maintenance|Lost to Follow-up|17|||
147623287|NCT04837196|532438543|FG000|Phase 1 Dose Escalation (Up to 817 Days)|Progressive Disease|3|||
147623288|NCT04837196|532438544|FG001|Phase 1 Dose Escalation (Up to 817 Days)|Progressive Disease|4|||
147623289|NCT04837196|532438545|FG002|Phase 1 Dose Escalation (Up to 817 Days)|Progressive Disease|0|||
147623290|NCT04837196|532438546|FG003|Phase 1 Dose Escalation (Up to 817 Days)|Progressive Disease|3|||
147623291|NCT04837196|532438547|FG004|Phase 1 Dose Escalation (Up to 817 Days)|Progressive Disease|3|||
147623292|NCT04837196|532438543|FG000|Phase 1 Dose Escalation (Up to 817 Days)|Adverse Event|0|||
147623293|NCT04837196|532438544|FG001|Phase 1 Dose Escalation (Up to 817 Days)|Adverse Event|1|||
147623294|NCT04837196|532438545|FG002|Phase 1 Dose Escalation (Up to 817 Days)|Adverse Event|0|||
147623295|NCT04837196|532438546|FG003|Phase 1 Dose Escalation (Up to 817 Days)|Adverse Event|0|||
147623296|NCT04837196|532438547|FG004|Phase 1 Dose Escalation (Up to 817 Days)|Adverse Event|0|||
147623297|NCT04837196|532438543|FG000|Phase 2 Dose Expansion (Up to 504 Days)|Progressive Disease|0|||
147623298|NCT04837196|532438544|FG001|Phase 2 Dose Expansion (Up to 504 Days)|Progressive Disease|0|||
147623299|NCT04837196|532438545|FG002|Phase 2 Dose Expansion (Up to 504 Days)|Progressive Disease|1|||
147623300|NCT04837196|532438546|FG003|Phase 2 Dose Expansion (Up to 504 Days)|Progressive Disease|0|||
147623301|NCT04837196|532438547|FG004|Phase 2 Dose Expansion (Up to 504 Days)|Progressive Disease|0|||
147623302|NCT04837196|532438543|FG000|Phase 2 Dose Expansion (Up to 504 Days)|Lack of Efficacy|0|||
147623303|NCT04837196|532438544|FG001|Phase 2 Dose Expansion (Up to 504 Days)|Lack of Efficacy|0|||
147623304|NCT04837196|532438545|FG002|Phase 2 Dose Expansion (Up to 504 Days)|Lack of Efficacy|1|||
147623305|NCT04837196|532438546|FG003|Phase 2 Dose Expansion (Up to 504 Days)|Lack of Efficacy|0|||
147623306|NCT04837196|532438547|FG004|Phase 2 Dose Expansion (Up to 504 Days)|Lack of Efficacy|0|||
147623307|NCT01289678|532438548|FG000|Overall Study|Physician Decision|6|||
147623308|NCT02174627|532438549|FG000|Overall Study|Missing|0|||
147623309|NCT02174627|532438550|FG001|Overall Study|Missing|1|||
147623310|NCT02174627|532438549|FG000|Overall Study|Incorrect enrolment before randomization|0|||
147623311|NCT02174627|532438550|FG001|Overall Study|Incorrect enrolment before randomization|1|||
147623312|NCT02174627|532438549|FG000|Overall Study|Participant decision|84|||
147623313|NCT02174627|532438550|FG001|Overall Study|Participant decision|128|||
147623314|NCT02729025|532438554|FG000|Overall Study|Sponsor Decision|0|||
147623315|NCT02729025|532438555|FG001|Overall Study|Sponsor Decision|1|||
147623316|NCT05573464|532440135|FG000|12-week Treatment Period|Discontinued intervention - other reason|10|||
147623317|NCT05573464|532440136|FG001|12-week Treatment Period|Discontinued intervention - other reason|4|||
147623318|NCT05573464|532440135|FG000|12-week Treatment Period|Withdrawal by Subject|8|||
147623319|NCT05573464|532440136|FG001|12-week Treatment Period|Withdrawal by Subject|5|||
147304003|NCT00279201|531278821|FG001|Maintenance|Lost to Follow-up|13|||
147304004|NCT00279201|531278822|FG002|Maintenance|Lost to Follow-up|0|||
147304005|NCT00279201|531278823|FG003|Maintenance|Lost to Follow-up|0|||
147304006|NCT00279201|531278824|FG004|Maintenance|Lost to Follow-up|0|||
147304007|NCT00279201|531278825|FG005|Maintenance|Lost to Follow-up|0|||
147304008|NCT00279201|531278820|FG000|Maintenance|Entry Criteria Exclusion|1|||
147304009|NCT00279201|531278821|FG001|Maintenance|Entry Criteria Exclusion|4|||
147304010|NCT00279201|531278822|FG002|Maintenance|Entry Criteria Exclusion|0|||
147304011|NCT00279201|531278823|FG003|Maintenance|Entry Criteria Exclusion|0|||
147304012|NCT00279201|531278824|FG004|Maintenance|Entry Criteria Exclusion|0|||
147304013|NCT00279201|531278825|FG005|Maintenance|Entry Criteria Exclusion|0|||
147304014|NCT00279201|531278820|FG000|Maintenance|Protocol Violation|16|||
147304015|NCT00279201|531278821|FG001|Maintenance|Protocol Violation|24|||
147304016|NCT00279201|531278822|FG002|Maintenance|Protocol Violation|0|||
147623320|NCT05573464|532440135|FG000|12-week Treatment Period|Protocol Violation|3|||
147623321|NCT05573464|532440136|FG001|12-week Treatment Period|Protocol Violation|1|||
147304017|NCT00279201|531278823|FG003|Maintenance|Protocol Violation|0|||
147623322|NCT05573464|532440135|FG000|12-week Treatment Period|Physician Decision|1|||
147623323|NCT05573464|532440136|FG001|12-week Treatment Period|Physician Decision|2|||
147623324|NCT05573464|532440135|FG000|12-week Treatment Period|Lost to Follow-up|2|||
147304018|NCT00279201|531278824|FG004|Maintenance|Protocol Violation|0|||
147623325|NCT05573464|532440136|FG001|12-week Treatment Period|Lost to Follow-up|0|||
147623326|NCT05573464|532440135|FG000|12-week Treatment Period|Adverse Event|20|||
147304019|NCT00279201|531278825|FG005|Maintenance|Protocol Violation|0|||
147304020|NCT00279201|531278820|FG000|Maintenance|Withdrawal by Subject|18|||
147623327|NCT05573464|532440136|FG001|12-week Treatment Period|Adverse Event|9|||
147623328|NCT05573464|532440135|FG000|12-week Treatment Period|Protocol-specified withdrawal criterion met|1|||
147623329|NCT05573464|532440136|FG001|12-week Treatment Period|Protocol-specified withdrawal criterion met|0|||
147623330|NCT05573464|532440135|FG000|12-week Treatment Period|Randomised, not treated|0|||
147623331|NCT05573464|532440136|FG001|12-week Treatment Period|Randomised, not treated|1|||
147623332|NCT05573464|532440135|FG000|52-week Treatment Period|Discontinued intervention - other reason|9|||
147623333|NCT05573464|532440136|FG001|52-week Treatment Period|Discontinued intervention - other reason|8|||
147623334|NCT05573464|532440135|FG000|52-week Treatment Period|Withdrawal by Subject|9|||
147623335|NCT05573464|532440136|FG001|52-week Treatment Period|Withdrawal by Subject|5|||
147623336|NCT05573464|532440135|FG000|52-week Treatment Period|Protocol Violation|1|||
147623337|NCT05573464|532440136|FG001|52-week Treatment Period|Protocol Violation|1|||
147304021|NCT00279201|531278821|FG001|Maintenance|Withdrawal by Subject|18|||
147304022|NCT00279201|531278822|FG002|Maintenance|Withdrawal by Subject|0|||
147304023|NCT00279201|531278823|FG003|Maintenance|Withdrawal by Subject|0|||
147304024|NCT00279201|531278824|FG004|Maintenance|Withdrawal by Subject|0|||
147304025|NCT00279201|531278825|FG005|Maintenance|Withdrawal by Subject|0|||
147304026|NCT00279201|531278820|FG000|Maintenance|Physician Decision|9|||
147304027|NCT00279201|531278821|FG001|Maintenance|Physician Decision|9|||
147304028|NCT00279201|531278822|FG002|Maintenance|Physician Decision|0|||
147304029|NCT00279201|531278823|FG003|Maintenance|Physician Decision|0|||
147304030|NCT00279201|531278824|FG004|Maintenance|Physician Decision|0|||
147304031|NCT00279201|531278825|FG005|Maintenance|Physician Decision|0|||
147304032|NCT00279201|531278820|FG000|Maintenance|Sponsor Decision|4|||
147304033|NCT00279201|531278821|FG001|Maintenance|Sponsor Decision|0|||
147304034|NCT00279201|531278822|FG002|Maintenance|Sponsor Decision|0|||
147304035|NCT00279201|531278823|FG003|Maintenance|Sponsor Decision|0|||
147304036|NCT00279201|531278824|FG004|Maintenance|Sponsor Decision|0|||
147304037|NCT00279201|531278825|FG005|Maintenance|Sponsor Decision|0|||
147304038|NCT00279201|531278820|FG000|Maintenance|HbA1c>7.5%|123|||
147304039|NCT00279201|531278821|FG001|Maintenance|HbA1c>7.5%|126|||
147304040|NCT00279201|531278822|FG002|Maintenance|HbA1c>7.5%|0|||
147304041|NCT00279201|531278823|FG003|Maintenance|HbA1c>7.5%|0|||
147304042|NCT00279201|531278824|FG004|Maintenance|HbA1c>7.5%|0|||
147304043|NCT00279201|531278825|FG005|Maintenance|HbA1c>7.5%|0|||
147304044|NCT00279201|531278820|FG000|Intensification Addendum|Withdrawal by Subject|0|||
147304045|NCT00279201|531278821|FG001|Intensification Addendum|Withdrawal by Subject|0|||
147304046|NCT00279201|531278822|FG002|Intensification Addendum|Withdrawal by Subject|12|||
147304047|NCT00279201|531278823|FG003|Intensification Addendum|Withdrawal by Subject|14|||
147304048|NCT00279201|531278824|FG004|Intensification Addendum|Withdrawal by Subject|9|||
147304049|NCT00279201|531278825|FG005|Intensification Addendum|Withdrawal by Subject|18|||
147304050|NCT00279201|531278820|FG000|Intensification Addendum|Lost to Follow-up|0|||
147304051|NCT00279201|531278821|FG001|Intensification Addendum|Lost to Follow-up|0|||
147304052|NCT00279201|531278822|FG002|Intensification Addendum|Lost to Follow-up|4|||
147304053|NCT00279201|531278823|FG003|Intensification Addendum|Lost to Follow-up|6|||
147304054|NCT00279201|531278824|FG004|Intensification Addendum|Lost to Follow-up|7|||
147304055|NCT00279201|531278825|FG005|Intensification Addendum|Lost to Follow-up|7|||
147304056|NCT00279201|531278820|FG000|Intensification Addendum|Protocol Violation|0|||
147304057|NCT00279201|531278821|FG001|Intensification Addendum|Protocol Violation|0|||
147304058|NCT00279201|531278822|FG002|Intensification Addendum|Protocol Violation|2|||
147304059|NCT00279201|531278823|FG003|Intensification Addendum|Protocol Violation|2|||
147304060|NCT00279201|531278824|FG004|Intensification Addendum|Protocol Violation|6|||
147304061|NCT00279201|531278825|FG005|Intensification Addendum|Protocol Violation|6|||
147304062|NCT00279201|531278820|FG000|Intensification Addendum|Adverse Event|0|||
147304063|NCT00279201|531278821|FG001|Intensification Addendum|Adverse Event|0|||
147304064|NCT00279201|531278822|FG002|Intensification Addendum|Adverse Event|0|||
147304065|NCT00279201|531278823|FG003|Intensification Addendum|Adverse Event|4|||
147304066|NCT00279201|531278824|FG004|Intensification Addendum|Adverse Event|1|||
147304067|NCT00279201|531278825|FG005|Intensification Addendum|Adverse Event|3|||
147304068|NCT00279201|531278820|FG000|Intensification Addendum|Physician Decision|0|||
147304069|NCT00279201|531278821|FG001|Intensification Addendum|Physician Decision|0|||
147304070|NCT00279201|531278822|FG002|Intensification Addendum|Physician Decision|4|||
147304071|NCT00279201|531278823|FG003|Intensification Addendum|Physician Decision|1|||
147304072|NCT00279201|531278824|FG004|Intensification Addendum|Physician Decision|3|||
147304073|NCT00279201|531278825|FG005|Intensification Addendum|Physician Decision|2|||
147304074|NCT00279201|531278820|FG000|Intensification Addendum|Sponsor Decision|0|||
147304075|NCT00279201|531278821|FG001|Intensification Addendum|Sponsor Decision|0|||
147304076|NCT00279201|531278822|FG002|Intensification Addendum|Sponsor Decision|0|||
147304077|NCT00279201|531278823|FG003|Intensification Addendum|Sponsor Decision|0|||
147304078|NCT00279201|531278824|FG004|Intensification Addendum|Sponsor Decision|1|||
147304079|NCT00279201|531278825|FG005|Intensification Addendum|Sponsor Decision|1|||
147304080|NCT00279201|531278820|FG000|Intensification Addendum|Entry Criteria Exclusion|0|||
147304081|NCT00279201|531278821|FG001|Intensification Addendum|Entry Criteria Exclusion|0|||
147304082|NCT00279201|531278822|FG002|Intensification Addendum|Entry Criteria Exclusion|1|||
147304083|NCT00279201|531278823|FG003|Intensification Addendum|Entry Criteria Exclusion|0|||
147304084|NCT00279201|531278824|FG004|Intensification Addendum|Entry Criteria Exclusion|0|||
147304085|NCT00279201|531278825|FG005|Intensification Addendum|Entry Criteria Exclusion|0|||
147304086|NCT00279201|531278820|FG000|Intensification Addendum|Lack of Efficacy|0|||
147304087|NCT00279201|531278821|FG001|Intensification Addendum|Lack of Efficacy|0|||
147304088|NCT00279201|531278822|FG002|Intensification Addendum|Lack of Efficacy|0|||
147304089|NCT00279201|531278823|FG003|Intensification Addendum|Lack of Efficacy|1|||
147304090|NCT00279201|531278824|FG004|Intensification Addendum|Lack of Efficacy|1|||
147304091|NCT00279201|531278825|FG005|Intensification Addendum|Lack of Efficacy|0|||
147304092|NCT00279201|531278820|FG000|Intensification Addendum|Death|0|||
147304093|NCT00279201|531278821|FG001|Intensification Addendum|Death|0|||
147304094|NCT00279201|531278822|FG002|Intensification Addendum|Death|0|||
147304095|NCT00279201|531278823|FG003|Intensification Addendum|Death|0|||
147304096|NCT00279201|531278824|FG004|Intensification Addendum|Death|1|||
147304097|NCT00279201|531278825|FG005|Intensification Addendum|Death|0|||
147304098|NCT03881696|531278837|FG000|Overall Study|Adverse Event|2|||
147304099|NCT03881696|531278838|FG001|Overall Study|Adverse Event|0|||
147304100|NCT03881696|531278837|FG000|Overall Study|Withdrawal by Subject|2|||
147304101|NCT03881696|531278838|FG001|Overall Study|Withdrawal by Subject|0|||
147304102|NCT03881696|531278837|FG000|Overall Study|Subject withdrawal by parent or guardian|1|||
147304103|NCT03881696|531278838|FG001|Overall Study|Subject withdrawal by parent or guardian|0|||
147304104|NCT03881696|531278837|FG000|Overall Study|Failure to meet continuation criteria|1|||
147304105|NCT03881696|531278838|FG001|Overall Study|Failure to meet continuation criteria|0|||
147304106|NCT01061333|531278839|FG000|Period 4: 20-day Washout|Discontinued by Study Team|0|||
147304107|NCT01061333|531278840|FG001|Period 4: 20-day Washout|Discontinued by Study Team|1|||
147304108|NCT02228395|531280625|FG000|First Intervention Period|No longer willing to participate|1|||
147304109|NCT02228395|531280626|FG001|First Intervention Period|No longer willing to participate|0|||
147304110|NCT02228395|531280627|FG002|First Intervention Period|No longer willing to participate|0|||
147304111|NCT02228395|531280625|FG000|First Intervention Period|Unable to comply with study dates|0|||
147304112|NCT02228395|531280626|FG001|First Intervention Period|Unable to comply with study dates|1|||
147304113|NCT02228395|531280627|FG002|First Intervention Period|Unable to comply with study dates|1|||
147304114|NCT02569437|531280633|FG000|Overall Study|Lost to Follow-up|12|||
147304115|NCT02569437|531280634|FG001|Overall Study|Lost to Follow-up|14|||
147304116|NCT02255357|531280637|FG000|Overall Study|Physician Decision|10|||
147304117|NCT02255357|531280638|FG001|Overall Study|Physician Decision|24|||
147623338|NCT05573464|532440135|FG000|52-week Treatment Period|Physician Decision|2|||
147623339|NCT05573464|532440136|FG001|52-week Treatment Period|Physician Decision|2|||
147623340|NCT05573464|532440135|FG000|52-week Treatment Period|Lost to Follow-up|1|||
147623341|NCT05573464|532440136|FG001|52-week Treatment Period|Lost to Follow-up|1|||
147623342|NCT05573464|532440135|FG000|52-week Treatment Period|Adverse Event|11|||
147623343|NCT05573464|532440136|FG001|52-week Treatment Period|Adverse Event|8|||
147623344|NCT05573464|532440135|FG000|52-week Treatment Period|Death|1|||
147623345|NCT05573464|532440136|FG001|52-week Treatment Period|Death|1|||
147623346|NCT04632927|532440137|FG000|Overall Study|Adverse Event|0|||
147623347|NCT04632927|532440138|FG001|Overall Study|Adverse Event|1|||
147304118|NCT00509236|531280639|FG000|Overall Study|Adverse Event|7|||
147304119|NCT00509236|531280640|FG001|Overall Study|Adverse Event|9|||
147304120|NCT00509236|531280639|FG000|Overall Study|Withdrawal by Subject|5|||
147304121|NCT00509236|531280640|FG001|Overall Study|Withdrawal by Subject|10|||
147304122|NCT00509236|531280639|FG000|Overall Study|Protocol Violation|3|||
147304123|NCT00509236|531280640|FG001|Overall Study|Protocol Violation|0|||
147304124|NCT00509236|531280639|FG000|Overall Study|Excluded Medication|1|||
147304125|NCT00509236|531280640|FG001|Overall Study|Excluded Medication|1|||
147304126|NCT00509236|531280639|FG000|Overall Study|Scheduled Kidney Transplant|1|||
147304127|NCT00509236|531280640|FG001|Overall Study|Scheduled Kidney Transplant|0|||
147304128|NCT01641926|531280641|FG000|Overall Study|Adverse Event|5|||
147304129|NCT01641926|531280642|FG001|Overall Study|Adverse Event|2|||
147304130|NCT01641926|531280643|FG002|Overall Study|Adverse Event|3|||
147304131|NCT01641926|531280644|FG003|Overall Study|Adverse Event|1|||
147304132|NCT01641926|531280641|FG000|Overall Study|Lost to Follow-up|2|||
147304133|NCT01641926|531280642|FG001|Overall Study|Lost to Follow-up|2|||
147304134|NCT01641926|531280643|FG002|Overall Study|Lost to Follow-up|1|||
147304135|NCT01641926|531280644|FG003|Overall Study|Lost to Follow-up|0|||
147623348|NCT04632927|532440137|FG000|Overall Study|Lack of Efficacy|0|||
147623349|NCT04632927|532440138|FG001|Overall Study|Lack of Efficacy|4|||
147623350|NCT04632927|532440137|FG000|Overall Study|Loss of efficacy|0|||
147623351|NCT04632927|532440138|FG001|Overall Study|Loss of efficacy|1|||
147623352|NCT04632927|532440137|FG000|Overall Study|Non-compliance with study drug|0|||
147623353|NCT04632927|532440138|FG001|Overall Study|Non-compliance with study drug|1|||
147623354|NCT04632927|532440137|FG000|Overall Study|Physician Decision|0|||
147623355|NCT04632927|532440138|FG001|Overall Study|Physician Decision|1|||
147623356|NCT04632927|532440137|FG000|Overall Study|Subject decision|0|||
147623357|NCT04632927|532440138|FG001|Overall Study|Subject decision|1|||
147623358|NCT04632927|532440137|FG000|Overall Study|Withdrawal by Subject|0|||
147623359|NCT04632927|532440138|FG001|Overall Study|Withdrawal by Subject|1|||
147623360|NCT05734157|532440139|FG000|Overall Study|Death|3|||
147623361|NCT05734157|532440139|FG000|Overall Study|Withdrawal by Subject|2|||
147623362|NCT05734157|532440139|FG000|Overall Study|Lost to Follow-up|1|||
147623363|NCT05734157|532440139|FG000|Overall Study|Telephone call|3|||
147623364|NCT04846569|532440140|FG000|Overall Study|Withdrawal by Subject|3|||
147623365|NCT04846569|532440141|FG001|Overall Study|Withdrawal by Subject|1|||
147623366|NCT00838903|532440142|FG000|Treatment Period (156 Weeks)|Adverse Event|5|||
147304136|NCT01641926|531280641|FG000|Overall Study|Physician Decision|6|||
147623367|NCT00838903|532440143|FG001|Treatment Period (156 Weeks)|Adverse Event|13|||
147623368|NCT00838903|532440144|FG002|Treatment Period (156 Weeks)|Adverse Event|17|||
147623369|NCT00838903|532440145|FG003|Treatment Period (156 Weeks)|Adverse Event|25|||
147623370|NCT00838903|532440142|FG000|Treatment Period (156 Weeks)|Protocol Violation|1|||
147623371|NCT00838903|532440143|FG001|Treatment Period (156 Weeks)|Protocol Violation|6|||
147667579|NCT01791595|532608101|FG006|Part 1 AZD3965 Cohort 5 (15 mg BD)|Evidence of disease progression|0|||
147667580|NCT01791595|532608095|FG000|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
147667581|NCT01791595|532608096|FG001|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
147667582|NCT01791595|532608097|FG002|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
147667583|NCT01791595|532608098|FG003|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
147667584|NCT01791595|532608099|FG004|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|1|||
147667585|NCT01791595|532608100|FG005|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
147667586|NCT01791595|532608101|FG006|Part 1 AZD3965 Cohort 5 (15 mg BD)|Withdrawal by Subject|0|||
147667587|NCT01791595|532608095|FG000|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
147667588|NCT01791595|532608096|FG001|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
147667589|NCT01791595|532608097|FG002|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
147667590|NCT01791595|532608098|FG003|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
147667591|NCT01791595|532608099|FG004|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|1|||
147667592|NCT01791595|532608100|FG005|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
147667593|NCT01791595|532608101|FG006|Part 1 AZD3965 Cohort 5 (15 mg BD)|Physician Decision|0|||
147667594|NCT01791595|532608095|FG000|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
147667595|NCT01791595|532608096|FG001|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
147667596|NCT01791595|532608097|FG002|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
147667597|NCT01791595|532608098|FG003|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
147667598|NCT01791595|532608099|FG004|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
147667599|NCT01791595|532608100|FG005|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|5|||
147667600|NCT01791595|532608101|FG006|Part 1 AZD3965 Cohort 6 (10 mg BD)|Adverse Event|0|||
147667601|NCT01791595|532608095|FG000|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
147667602|NCT01791595|532608096|FG001|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
147667603|NCT01791595|532608097|FG002|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
147667604|NCT01791595|532608098|FG003|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
147667605|NCT01791595|532608099|FG004|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
147667606|NCT01791595|532608100|FG005|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|3|||
147667607|NCT01791595|532608101|FG006|Part 1 AZD3965 Cohort 6 (10 mg BD)|Evidence of disease progression|0|||
147667608|NCT01791595|532608095|FG000|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
147667609|NCT01791595|532608096|FG001|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
147667610|NCT01791595|532608097|FG002|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
147667611|NCT01791595|532608098|FG003|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
147667612|NCT01791595|532608099|FG004|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
147667613|NCT01791595|532608100|FG005|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|0|||
147667614|NCT01791595|532608101|FG006|Part 2 AZD3965 Expansion (10 mg BD)|Adverse Event|1|||
147667615|NCT01791595|532608095|FG000|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
147667616|NCT01791595|532608096|FG001|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
147667617|NCT01791595|532608097|FG002|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
147667618|NCT01791595|532608098|FG003|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
147667619|NCT01791595|532608099|FG004|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
147667620|NCT01791595|532608100|FG005|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|0|||
147667621|NCT01791595|532608101|FG006|Part 2 AZD3965 Expansion (10 mg BD)|Evidence of disease progression|6|||
147667622|NCT01791595|532608095|FG000|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
147667623|NCT01791595|532608096|FG001|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
147667624|NCT01791595|532608097|FG002|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
147667625|NCT01791595|532608098|FG003|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
147667626|NCT01791595|532608099|FG004|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
147667627|NCT01791595|532608100|FG005|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|0|||
147667628|NCT01791595|532608101|FG006|Part 2 AZD3965 Expansion (10 mg BD)|Withdrawal by Subject|2|||
147667629|NCT01791595|532608095|FG000|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
147667630|NCT01791595|532608096|FG001|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
147667631|NCT01791595|532608097|FG002|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
147304137|NCT01641926|531280642|FG001|Overall Study|Physician Decision|5|||
147304138|NCT01641926|531280643|FG002|Overall Study|Physician Decision|0|||
147304139|NCT01641926|531280644|FG003|Overall Study|Physician Decision|1|||
147304140|NCT01641926|531280641|FG000|Overall Study|Protocol Violation|1|||
147304141|NCT01641926|531280642|FG001|Overall Study|Protocol Violation|0|||
147304142|NCT01641926|531280643|FG002|Overall Study|Protocol Violation|0|||
147304143|NCT01641926|531280644|FG003|Overall Study|Protocol Violation|1|||
147304144|NCT01641926|531280641|FG000|Overall Study|Withdrawal by Subject|13|||
147304145|NCT01641926|531280642|FG001|Overall Study|Withdrawal by Subject|5|||
147667632|NCT01791595|532608098|FG003|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
147304146|NCT01641926|531280643|FG002|Overall Study|Withdrawal by Subject|6|||
147304147|NCT01641926|531280644|FG003|Overall Study|Withdrawal by Subject|1|||
147304148|NCT01641926|531280641|FG000|Overall Study|Not Treated|1|||
147667633|NCT01791595|532608099|FG004|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
147667634|NCT01791595|532608100|FG005|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|0|||
147667635|NCT01791595|532608101|FG006|Part 2 AZD3965 Expansion (10 mg BD)|Physician Decision|1|||
147667636|NCT02175121|532608102|FG000|Overall Study|Lack of Efficacy|1|||
147667637|NCT02175121|532608103|FG001|Overall Study|Lack of Efficacy|0|||
147667638|NCT02175121|532608104|FG002|Overall Study|Lack of Efficacy|0|||
147667639|NCT02175121|532608105|FG003|Overall Study|Lack of Efficacy|0|||
147667640|NCT02175121|532608106|FG004|Overall Study|Lack of Efficacy|0|||
147667641|NCT02175121|532608102|FG000|Overall Study|Lost to Follow-up|0|||
147667642|NCT02175121|532608103|FG001|Overall Study|Lost to Follow-up|1|||
147667643|NCT02175121|532608104|FG002|Overall Study|Lost to Follow-up|0|||
147667644|NCT02175121|532608105|FG003|Overall Study|Lost to Follow-up|1|||
147667645|NCT02175121|532608106|FG004|Overall Study|Lost to Follow-up|0|||
147667646|NCT02175121|532608102|FG000|Overall Study|Personal emergency|0|||
147667647|NCT02175121|532608103|FG001|Overall Study|Personal emergency|0|||
147667648|NCT02175121|532608104|FG002|Overall Study|Personal emergency|0|||
147667649|NCT02175121|532608105|FG003|Overall Study|Personal emergency|0|||
147667650|NCT02175121|532608106|FG004|Overall Study|Personal emergency|1|||
147667651|NCT02175121|532608102|FG000|Overall Study|Schedule conflict|0|||
147667652|NCT02175121|532608103|FG001|Overall Study|Schedule conflict|0|||
147667653|NCT02175121|532608104|FG002|Overall Study|Schedule conflict|1|||
147667654|NCT02175121|532608105|FG003|Overall Study|Schedule conflict|0|||
147667655|NCT02175121|532608106|FG004|Overall Study|Schedule conflict|0|||
147667656|NCT02175121|532608102|FG000|Overall Study|Time issues|0|||
147667657|NCT02175121|532608103|FG001|Overall Study|Time issues|0|||
147667658|NCT02175121|532608104|FG002|Overall Study|Time issues|1|||
147667659|NCT02175121|532608105|FG003|Overall Study|Time issues|0|||
147667660|NCT02175121|532608106|FG004|Overall Study|Time issues|0|||
147667661|NCT03329885|532608107|FG000|Overall Study|Sponsor discontinued the study early|0|||
147667662|NCT03329885|532608108|FG001|Overall Study|Sponsor discontinued the study early|0|||
147667663|NCT03329885|532608109|FG002|Overall Study|Sponsor discontinued the study early|0|||
147667664|NCT03329885|532608110|FG003|Overall Study|Sponsor discontinued the study early|0|||
147667665|NCT03329885|532608111|FG004|Overall Study|Sponsor discontinued the study early|0|||
147667666|NCT03329885|532608112|FG005|Overall Study|Sponsor discontinued the study early|0|||
147667667|NCT03329885|532608113|FG006|Overall Study|Sponsor discontinued the study early|1|||
147667668|NCT03329885|532608114|FG007|Overall Study|Sponsor discontinued the study early|1|||
147667669|NCT03329885|532608115|FG008|Overall Study|Sponsor discontinued the study early|0|||
147667670|NCT02027025|532608120|FG000|Overall Study|Adverse Event|0|||
147667671|NCT02027025|532608121|FG001|Overall Study|Adverse Event|1|||
147667672|NCT02027025|532608122|FG002|Overall Study|Adverse Event|1|||
147667673|NCT02027025|532608120|FG000|Overall Study|Protocol Violation|1|||
147667674|NCT02027025|532608121|FG001|Overall Study|Protocol Violation|0|||
147667675|NCT02027025|532608122|FG002|Overall Study|Protocol Violation|0|||
147667676|NCT02027025|532608120|FG000|Overall Study|Lost to Follow-up|0|||
147667677|NCT02027025|532608121|FG001|Overall Study|Lost to Follow-up|2|||
147667678|NCT02027025|532608122|FG002|Overall Study|Lost to Follow-up|0|||
147667679|NCT02027025|532608120|FG000|Overall Study|Withdrawal by Subject|0|||
147667680|NCT02027025|532608121|FG001|Overall Study|Withdrawal by Subject|1|||
147667681|NCT02027025|532608122|FG002|Overall Study|Withdrawal by Subject|0|||
147667682|NCT02027025|532608120|FG000|Overall Study|Sponsor's decision|0|||
147667683|NCT02027025|532608121|FG001|Overall Study|Sponsor's decision|1|||
147667684|NCT02027025|532608122|FG002|Overall Study|Sponsor's decision|0|||
147667685|NCT01118052|532608125|FG000|Overall Study|Never treated|2|||
147667686|NCT00843492|532608128|FG000|Overall Study|Adverse Event|0|||
147667687|NCT00843492|532608129|FG001|Overall Study|Adverse Event|3|||
147667688|NCT00843492|532608128|FG000|Overall Study|Lost to Follow-up|4|||
147667689|NCT00843492|532608129|FG001|Overall Study|Lost to Follow-up|4|||
147667690|NCT00843492|532608128|FG000|Overall Study|Withdrawal by Subject|0|||
147667691|NCT00843492|532608129|FG001|Overall Study|Withdrawal by Subject|4|||
147667692|NCT00843492|532608128|FG000|Overall Study|Immobilization Stopped|1|||
147667693|NCT00843492|532608129|FG001|Overall Study|Immobilization Stopped|0|||
147667694|NCT00843492|532608128|FG000|Overall Study|Investigator/Orthopedic Surgeon Decision|1|||
147667695|NCT00843492|532608129|FG001|Overall Study|Investigator/Orthopedic Surgeon Decision|1|||
147667696|NCT00843492|532608128|FG000|Overall Study|Orthopedic Surgery|0|||
147667697|NCT00843492|532608129|FG001|Overall Study|Orthopedic Surgery|2|||
147667698|NCT00843492|532608128|FG000|Overall Study|Visit Not Performed|1|||
147667699|NCT00843492|532608129|FG001|Overall Study|Visit Not Performed|0|||
147667700|NCT00843492|532608128|FG000|Overall Study|Deep-vein Thrombosis|1|||
147667701|NCT00843492|532608129|FG001|Overall Study|Deep-vein Thrombosis|0|||
147667702|NCT00369343|532608130|FG000|Double-blind Phase|Adverse Event|19|||
147667703|NCT00369343|532608131|FG001|Double-blind Phase|Adverse Event|4|||
147667704|NCT00369343|532608130|FG000|Double-blind Phase|Failed to return|2|||
147667705|NCT00369343|532608131|FG001|Double-blind Phase|Failed to return|0|||
147667706|NCT00369343|532608130|FG000|Double-blind Phase|Lost to Follow-up|9|||
147667707|NCT00369343|532608131|FG001|Double-blind Phase|Lost to Follow-up|2|||
147667708|NCT00369343|532608130|FG000|Double-blind Phase|Protocol Violation|2|||
147667709|NCT00369343|532608131|FG001|Double-blind Phase|Protocol Violation|0|||
147304149|NCT01641926|531280642|FG001|Overall Study|Not Treated|1|||
147304150|NCT01641926|531280643|FG002|Overall Study|Not Treated|1|||
147304151|NCT01641926|531280644|FG003|Overall Study|Not Treated|0|||
147304152|NCT01691521|531280645|FG000|Overall Study|Adverse Event|4|||
147304153|NCT01691521|531280646|FG001|Overall Study|Adverse Event|0|||
147304154|NCT01691521|531280647|FG002|Overall Study|Adverse Event|1|||
147304155|NCT01691521|531280645|FG000|Overall Study|Lack of Efficacy|1|||
147304156|NCT01691521|531280646|FG001|Overall Study|Lack of Efficacy|1|||
147304157|NCT01691521|531280647|FG002|Overall Study|Lack of Efficacy|2|||
147304158|NCT01691521|531280645|FG000|Overall Study|Protocol Violation|0|||
147304159|NCT01691521|531280646|FG001|Overall Study|Protocol Violation|3|||
147304160|NCT01691521|531280647|FG002|Overall Study|Protocol Violation|0|||
147304161|NCT01691521|531280645|FG000|Overall Study|Lost to Follow-up|0|||
147304162|NCT01691521|531280646|FG001|Overall Study|Lost to Follow-up|2|||
147304163|NCT01691521|531280647|FG002|Overall Study|Lost to Follow-up|2|||
147304164|NCT01691521|531280645|FG000|Overall Study|Physician Decision|2|||
147304165|NCT01691521|531280646|FG001|Overall Study|Physician Decision|1|||
147304166|NCT01691521|531280647|FG002|Overall Study|Physician Decision|0|||
147304167|NCT01691521|531280645|FG000|Overall Study|Withdrawal by Subject|5|||
147304168|NCT01691521|531280646|FG001|Overall Study|Withdrawal by Subject|9|||
147304169|NCT01691521|531280647|FG002|Overall Study|Withdrawal by Subject|4|||
147304170|NCT02343003|531280648|FG000|Overall Study|Withdrawal by Subject|9|||
147304171|NCT02343003|531280649|FG001|Overall Study|Withdrawal by Subject|4|||
147304172|NCT02343003|531280648|FG000|Overall Study|Lost to Follow-up|5|||
147304173|NCT02343003|531280649|FG001|Overall Study|Lost to Follow-up|1|||
147304174|NCT02343003|531280648|FG000|Overall Study|Protocol Violation|1|||
147304175|NCT02343003|531280649|FG001|Overall Study|Protocol Violation|0|||
147304176|NCT02343003|531280648|FG000|Overall Study|Death|0|||
147304177|NCT02343003|531280649|FG001|Overall Study|Death|1|||
147304178|NCT02343003|531280648|FG000|Overall Study|exclusion criteria met|1|||
147304179|NCT02343003|531280649|FG001|Overall Study|exclusion criteria met|1|||
147304180|NCT02343003|531280648|FG000|Overall Study|terminated by sponsor|2|||
147304181|NCT02343003|531280649|FG001|Overall Study|terminated by sponsor|0|||
147304182|NCT03954743|531280650|FG000|Overall Study|Adverse Event|1|||
147304183|NCT03954743|531280651|FG001|Overall Study|Adverse Event|0|||
147304184|NCT03954743|531280650|FG000|Overall Study|Lost to Follow-up|6|||
147304185|NCT03954743|531280651|FG001|Overall Study|Lost to Follow-up|4|||
147304186|NCT03954743|531280650|FG000|Overall Study|Protocol Violation|1|||
147304187|NCT03954743|531280651|FG001|Overall Study|Protocol Violation|0|||
147304188|NCT03954743|531280650|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|13|||
147304189|NCT03954743|531280651|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|12|||
147304190|NCT03954743|531280650|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|3|||
147304191|NCT03954743|531280651|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
147304192|NCT01153269|531280652|FG000|Overall Study|Withdrawal by Subject|1|||
147304193|NCT01153269|531280652|FG000|Overall Study|Antiretroviral therapy break|1|||
147304194|NCT02281760|531280653|FG000|Overall Study|Withdrawal by Subject|1|||
147304195|NCT02635724|531280654|FG000|Overall Study|Withdrawal by Subject|0|||
147304196|NCT02635724|531280655|FG001|Overall Study|Withdrawal by Subject|1|||
147304197|NCT02635724|531280656|FG002|Overall Study|Withdrawal by Subject|0|||
147304198|NCT00100932|531280661|FG000|Overall Study|Adverse Event|11|||
147304199|NCT00100932|531280662|FG001|Overall Study|Adverse Event|2|||
147304200|NCT00100932|531280661|FG000|Overall Study|Withdrawal by Subject|6|||
147304201|NCT00100932|531280662|FG001|Overall Study|Withdrawal by Subject|0|||
147304202|NCT00100932|531280661|FG000|Overall Study|Progressive Disease|44|||
147304203|NCT00100932|531280662|FG001|Overall Study|Progressive Disease|18|||
147304204|NCT00100932|531280661|FG000|Overall Study|Physician Decision|7|||
147304205|NCT00100932|531280662|FG001|Overall Study|Physician Decision|5|||
147304206|NCT00100932|531280661|FG000|Overall Study|Other|5|||
147304207|NCT00100932|531280662|FG001|Overall Study|Other|2|||
147304208|NCT02387996|531280667|FG000|Overall Study|Disease Progression|167|||
147304209|NCT02387996|531280667|FG000|Overall Study|Study Drug Toxicity|31|||
147304210|NCT02387996|531280667|FG000|Overall Study|Adverse Event Unrelated to Study Drug|39|||
147304211|NCT02387996|531280667|FG000|Overall Study|Participant Request to Discontinue Treatment|20|||
147304212|NCT02387996|531280667|FG000|Overall Study|Subject Withdrew Consent|5|||
147304213|NCT02387996|531280667|FG000|Overall Study|Lost to Follow-up|1|||
147304214|NCT02387996|531280667|FG000|Overall Study|Poor/Non-Compliance|1|||
147304215|NCT02387996|531280667|FG000|Overall Study|Other Reasons|5|||
147304216|NCT02387996|531280667|FG000|Overall Study|Death|1|||
147304217|NCT02424591|531280668|FG000|Overall Study|Protocol Violation|2|||
147304218|NCT02424591|531280669|FG001|Overall Study|Protocol Violation|3|||
147304219|NCT01446796|531280670|FG000|Overall Study|Withdrawal by Subject|1|||
147304220|NCT01446796|531280671|FG001|Overall Study|Withdrawal by Subject|0|||
147304221|NCT00312702|531280674|FG000|Immunization Phase|Lost to Follow-up|0|||
147304222|NCT00312702|531280675|FG001|Immunization Phase|Lost to Follow-up|1|||
147304223|NCT00312702|531280676|FG002|Immunization Phase|Lost to Follow-up|0|||
147304224|NCT00770432|531280677|FG000|Overall Study|Other|4|||
147304225|NCT00770432|531280678|FG001|Overall Study|Other|6|||
147304226|NCT00770432|531280677|FG000|Overall Study|Non-compliance|0|||
147304227|NCT00770432|531280678|FG001|Overall Study|Non-compliance|1|||
147304228|NCT01453348|531280679|FG000|Overall Study|Death|0|||
147304229|NCT01453348|531280680|FG001|Overall Study|Death|0|||
147304230|NCT01453348|531280681|FG002|Overall Study|Death|1|||
147304231|NCT01453348|531280679|FG000|Overall Study|Withdrawal by Subject|0|||
147304232|NCT01453348|531280680|FG001|Overall Study|Withdrawal by Subject|1|||
147304233|NCT01453348|531280681|FG002|Overall Study|Withdrawal by Subject|0|||
147304234|NCT01453348|531280679|FG000|Overall Study|Protocol Violation|1|||
147304235|NCT01453348|531280680|FG001|Overall Study|Protocol Violation|0|||
147304236|NCT01453348|531280681|FG002|Overall Study|Protocol Violation|0|||
147304237|NCT02756832|531280685|FG000|Overall Study|Lost for Observation after Baseline|6|||
147304238|NCT02756832|531280685|FG000|Overall Study|Lost for Observation|13|||
147304239|NCT02756832|531280685|FG000|Overall Study|Patient's Unwillingness|12|||
147304240|NCT02756832|531280685|FG000|Overall Study|Insufficient Efficacy|2|||
147304241|NCT02756832|531280685|FG000|Overall Study|Sponsor Decision/Regulatory Requirement|1|||
147304242|NCT02756832|531280685|FG000|Overall Study|Reason not Specified|9|||
147304243|NCT02756832|531280685|FG000|Overall Study|Protocol Deviation|10|||
147304244|NCT03579290|531280688|FG000|Overall Study|Lost to Follow-up|9|||
147304245|NCT01781390|531280691|FG000|Overall Study|Withdrawal of Consent|0|||
147304246|NCT01781390|531280692|FG001|Overall Study|Withdrawal of Consent|3|||
147304247|NCT01781390|531280693|FG002|Overall Study|Withdrawal of Consent|1|||
147304248|NCT01781390|531280691|FG000|Overall Study|Lost to Follow-up|1|||
147304249|NCT01781390|531280692|FG001|Overall Study|Lost to Follow-up|1|||
147304250|NCT01781390|531280693|FG002|Overall Study|Lost to Follow-up|1|||
147304251|NCT01781390|531280691|FG000|Overall Study|Adverse Event|1|||
147304252|NCT01781390|531280692|FG001|Overall Study|Adverse Event|2|||
147304253|NCT01781390|531280693|FG002|Overall Study|Adverse Event|1|||
147304254|NCT01781390|531280691|FG000|Overall Study|Participants who were Randomized and Not Treated|1|||
147304255|NCT01781390|531280692|FG001|Overall Study|Participants who were Randomized and Not Treated|1|||
147304256|NCT01781390|531280693|FG002|Overall Study|Participants who were Randomized and Not Treated|1|||
147304257|NCT00622713|531280696|FG000|Overall Study|Adverse Event|35|||
147304258|NCT00622713|531280696|FG000|Overall Study|Administrative problems|4|||
147304259|NCT00622713|531280696|FG000|Overall Study|Withdrawal by Subject|11|||
147304260|NCT00622713|531280696|FG000|Overall Study|Lost to Follow-up|5|||
147304261|NCT00622713|531280696|FG000|Overall Study|Death|2|||
147304262|NCT00622713|531280696|FG000|Overall Study|Subject no longer required study drug|1|||
147304263|NCT00622713|531280696|FG000|Overall Study|Did not meet eligibility criteria|1|||
147304264|NCT01719237|531280699|FG000|Overall Study|Physician Decision|0|||
147304265|NCT01719237|531280700|FG001|Overall Study|Physician Decision|1|||
147304266|NCT05375955|531280713|FG000|Treatment (12 Weeks)|Lost to Follow-up|0|||
147304267|NCT05375955|531280714|FG001|Treatment (12 Weeks)|Lost to Follow-up|2|||
147304268|NCT05375955|531280715|FG002|Treatment (12 Weeks)|Lost to Follow-up|2|||
147304269|NCT05375955|531280716|FG003|Treatment (12 Weeks)|Lost to Follow-up|1|||
147304270|NCT05375955|531280717|FG004|Treatment (12 Weeks)|Lost to Follow-up|1|||
147304271|NCT05375955|531280718|FG005|Treatment (12 Weeks)|Lost to Follow-up|1|||
147304272|NCT05375955|531280719|FG006|Treatment (12 Weeks)|Lost to Follow-up|0|||
147304273|NCT05375955|531280713|FG000|Treatment (12 Weeks)|Physician Decision|4|||
147304274|NCT05375955|531280714|FG001|Treatment (12 Weeks)|Physician Decision|1|||
147304275|NCT05375955|531280715|FG002|Treatment (12 Weeks)|Physician Decision|3|||
147304276|NCT05375955|531280716|FG003|Treatment (12 Weeks)|Physician Decision|0|||
147304277|NCT05375955|531280717|FG004|Treatment (12 Weeks)|Physician Decision|0|||
147304278|NCT05375955|531280718|FG005|Treatment (12 Weeks)|Physician Decision|1|||
147304279|NCT05375955|531280719|FG006|Treatment (12 Weeks)|Physician Decision|0|||
147304280|NCT05375955|531280713|FG000|Treatment (12 Weeks)|Other|0|||
147304281|NCT05375955|531280714|FG001|Treatment (12 Weeks)|Other|1|||
147304282|NCT05375955|531280715|FG002|Treatment (12 Weeks)|Other|0|||
147304283|NCT05375955|531280716|FG003|Treatment (12 Weeks)|Other|0|||
147304284|NCT05375955|531280717|FG004|Treatment (12 Weeks)|Other|0|||
147304285|NCT05375955|531280718|FG005|Treatment (12 Weeks)|Other|0|||
147304286|NCT05375955|531280719|FG006|Treatment (12 Weeks)|Other|0|||
147304287|NCT05375955|531280713|FG000|Treatment (12 Weeks)|Withdrawal by parent/guardian|0|||
147304288|NCT05375955|531280714|FG001|Treatment (12 Weeks)|Withdrawal by parent/guardian|0|||
147304289|NCT05375955|531280715|FG002|Treatment (12 Weeks)|Withdrawal by parent/guardian|0|||
147304290|NCT05375955|531280716|FG003|Treatment (12 Weeks)|Withdrawal by parent/guardian|0|||
147304291|NCT05375955|531280717|FG004|Treatment (12 Weeks)|Withdrawal by parent/guardian|0|||
147304292|NCT05375955|531280718|FG005|Treatment (12 Weeks)|Withdrawal by parent/guardian|0|||
147304293|NCT05375955|531280719|FG006|Treatment (12 Weeks)|Withdrawal by parent/guardian|1|||
147304294|NCT05375955|531280713|FG000|Treatment (12 Weeks)|Withdrawal by Subject|8|||
147304295|NCT05375955|531280714|FG001|Treatment (12 Weeks)|Withdrawal by Subject|4|||
147304296|NCT05375955|531280715|FG002|Treatment (12 Weeks)|Withdrawal by Subject|7|||
147304297|NCT05375955|531280716|FG003|Treatment (12 Weeks)|Withdrawal by Subject|8|||
147304298|NCT05375955|531280717|FG004|Treatment (12 Weeks)|Withdrawal by Subject|4|||
147304299|NCT05375955|531280718|FG005|Treatment (12 Weeks)|Withdrawal by Subject|3|||
147304300|NCT05375955|531280719|FG006|Treatment (12 Weeks)|Withdrawal by Subject|3|||
147304301|NCT05375955|531280713|FG000|Treatment (12 Weeks)|Pregnancy|0|||
147304302|NCT05375955|531280714|FG001|Treatment (12 Weeks)|Pregnancy|0|||
147483105|NCT02795156|531924886|FG000|Overall Study|Physician Decision|1|||
147483106|NCT02795156|531924887|FG001|Overall Study|Physician Decision|0|||
147483107|NCT02795156|531924888|FG002|Overall Study|Physician Decision|1|||
147304303|NCT05375955|531280715|FG002|Treatment (12 Weeks)|Pregnancy|1|||
147304304|NCT05375955|531280716|FG003|Treatment (12 Weeks)|Pregnancy|0|||
147304305|NCT05375955|531280717|FG004|Treatment (12 Weeks)|Pregnancy|0|||
147304306|NCT05375955|531280718|FG005|Treatment (12 Weeks)|Pregnancy|0|||
147304307|NCT05375955|531280719|FG006|Treatment (12 Weeks)|Pregnancy|0|||
147304308|NCT05375955|531280713|FG000|Follow-up (up to 5 Weeks)|Protocol Violation|0|||
147304309|NCT05375955|531280714|FG001|Follow-up (up to 5 Weeks)|Protocol Violation|0|||
147304310|NCT05375955|531280715|FG002|Follow-up (up to 5 Weeks)|Protocol Violation|1|||
147304311|NCT05375955|531280716|FG003|Follow-up (up to 5 Weeks)|Protocol Violation|0|||
147304312|NCT05375955|531280717|FG004|Follow-up (up to 5 Weeks)|Protocol Violation|0|||
147304313|NCT05375955|531280718|FG005|Follow-up (up to 5 Weeks)|Protocol Violation|0|||
147304314|NCT05375955|531280719|FG006|Follow-up (up to 5 Weeks)|Protocol Violation|0|||
147304315|NCT05375955|531280713|FG000|Follow-up (up to 5 Weeks)|Withdrawal by Subject|1|||
147304316|NCT05375955|531280714|FG001|Follow-up (up to 5 Weeks)|Withdrawal by Subject|0|||
147304317|NCT05375955|531280715|FG002|Follow-up (up to 5 Weeks)|Withdrawal by Subject|1|||
147304318|NCT05375955|531280716|FG003|Follow-up (up to 5 Weeks)|Withdrawal by Subject|0|||
147304319|NCT05375955|531280717|FG004|Follow-up (up to 5 Weeks)|Withdrawal by Subject|0|||
147304320|NCT05375955|531280718|FG005|Follow-up (up to 5 Weeks)|Withdrawal by Subject|1|||
147304321|NCT05375955|531280719|FG006|Follow-up (up to 5 Weeks)|Withdrawal by Subject|0|||
147304322|NCT05375955|531280713|FG000|Follow-up (up to 5 Weeks)|Other|0|||
147304323|NCT05375955|531280714|FG001|Follow-up (up to 5 Weeks)|Other|1|||
147304324|NCT05375955|531280715|FG002|Follow-up (up to 5 Weeks)|Other|0|||
147304325|NCT05375955|531280716|FG003|Follow-up (up to 5 Weeks)|Other|0|||
147304326|NCT05375955|531280717|FG004|Follow-up (up to 5 Weeks)|Other|0|||
147304327|NCT05375955|531280718|FG005|Follow-up (up to 5 Weeks)|Other|0|||
147304328|NCT05375955|531280719|FG006|Follow-up (up to 5 Weeks)|Other|0|||
147304329|NCT05375955|531280713|FG000|Follow-up (up to 5 Weeks)|Physician's decision|2|||
147304330|NCT05375955|531280714|FG001|Follow-up (up to 5 Weeks)|Physician's decision|0|||
147304331|NCT05375955|531280715|FG002|Follow-up (up to 5 Weeks)|Physician's decision|2|||
147304332|NCT05375955|531280716|FG003|Follow-up (up to 5 Weeks)|Physician's decision|0|||
147304333|NCT05375955|531280717|FG004|Follow-up (up to 5 Weeks)|Physician's decision|0|||
147304334|NCT05375955|531280718|FG005|Follow-up (up to 5 Weeks)|Physician's decision|0|||
147304335|NCT05375955|531280719|FG006|Follow-up (up to 5 Weeks)|Physician's decision|0|||
147304336|NCT05375955|531280713|FG000|Follow-up (up to 5 Weeks)|Lost to Follow-up|1|||
147304337|NCT05375955|531280714|FG001|Follow-up (up to 5 Weeks)|Lost to Follow-up|0|||
147304338|NCT05375955|531280715|FG002|Follow-up (up to 5 Weeks)|Lost to Follow-up|1|||
147304339|NCT05375955|531280716|FG003|Follow-up (up to 5 Weeks)|Lost to Follow-up|0|||
147304340|NCT05375955|531280717|FG004|Follow-up (up to 5 Weeks)|Lost to Follow-up|1|||
147304341|NCT05375955|531280718|FG005|Follow-up (up to 5 Weeks)|Lost to Follow-up|1|||
147304342|NCT05375955|531280719|FG006|Follow-up (up to 5 Weeks)|Lost to Follow-up|2|||
147304343|NCT05454410|531280720|FG000|Overall Study|Withdrawal by Subject|0|||
147304344|NCT05454410|531280721|FG001|Overall Study|Withdrawal by Subject|0|||
147304345|NCT05454410|531280722|FG002|Overall Study|Withdrawal by Subject|1|||
147304346|NCT05454410|531280723|FG003|Overall Study|Withdrawal by Subject|1|||
147304347|NCT05004688|531280733|FG000|Overall Study|Protocol Violation|7|||
147304348|NCT05004688|531280733|FG000|Overall Study|Physician Decision|2|||
147304349|NCT05004688|531280733|FG000|Overall Study|Withdrawal by Subject|2|||
147304350|NCT00895622|531280734|FG000|Overall Study|Protocol Violation|5|||
147304351|NCT00895622|531280735|FG001|Overall Study|Protocol Violation|4|||
147304352|NCT00895622|531280736|FG002|Overall Study|Protocol Violation|4|||
147304353|NCT03879408|531280737|FG000|Overall Study|Lost to Follow-up|0|||
147304354|NCT03879408|531280738|FG001|Overall Study|Lost to Follow-up|3|||
147304355|NCT03879408|531280739|FG002|Overall Study|Lost to Follow-up|2|||
147304356|NCT03879408|531280740|FG003|Overall Study|Lost to Follow-up|1|||
147304357|NCT03879408|531280741|FG004|Overall Study|Lost to Follow-up|0|||
147304358|NCT03879408|531280737|FG000|Overall Study|Withdrawal by Subject|2|||
147304359|NCT03879408|531280738|FG001|Overall Study|Withdrawal by Subject|1|||
147304360|NCT03879408|531280739|FG002|Overall Study|Withdrawal by Subject|1|||
147304361|NCT03879408|531280740|FG003|Overall Study|Withdrawal by Subject|0|||
147304362|NCT03879408|531280741|FG004|Overall Study|Withdrawal by Subject|1|||
147304363|NCT01320943|531280742|FG000|Overall Study|Lost to Follow-up|1|||
147304364|NCT01320943|531280743|FG001|Overall Study|Lost to Follow-up|0|||
147304365|NCT01320943|531280742|FG000|Overall Study|Physician Decision|0|||
147304366|NCT01320943|531280743|FG001|Overall Study|Physician Decision|1|||
147304367|NCT01320943|531280742|FG000|Overall Study|Randomized but not Treated|0|||
147304368|NCT01320943|531280743|FG001|Overall Study|Randomized but not Treated|1|||
147304369|NCT03489057|531280752|FG000|Overall Study|Lost to Follow-up|16|||
147483108|NCT02795156|531924889|FG003|Overall Study|Physician Decision|0|||
147483109|NCT02795156|531924886|FG000|Overall Study|Withdrawal by Subject|2|||
147483110|NCT02795156|531924887|FG001|Overall Study|Withdrawal by Subject|0|||
147483111|NCT02795156|531924888|FG002|Overall Study|Withdrawal by Subject|3|||
147483112|NCT02795156|531924889|FG003|Overall Study|Withdrawal by Subject|0|||
147483113|NCT01137435|531924890|FG000|Overall Study|Lost to Follow-up|24|||
147483114|NCT01137435|531924890|FG000|Overall Study|Off label usage|4|||
147483115|NCT02746679|531924898|FG000|Overall Study|Lost to Follow-up|4|||
147483116|NCT02746679|531924899|FG001|Overall Study|Lost to Follow-up|6|||
147483117|NCT01416610|531924900|FG000|Overall Study|Adverse Event|4|||
147483118|NCT01416610|531924900|FG000|Overall Study|Adverse Event -Patient decision|3|||
147483119|NCT01416610|531924900|FG000|Overall Study|Lack of Efficacy|4|||
147483120|NCT01416610|531924900|FG000|Overall Study|No reason given|5|||
147483121|NCT01416610|531924900|FG000|Overall Study|Withdrawal by Subject|13|||
147483122|NCT01416610|531924900|FG000|Overall Study|Lost to Follow-up|7|||
147483123|NCT01416610|531924900|FG000|Overall Study|Sufficient treatment duration (PCR neg.)|7|||
147483124|NCT02961764|531924901|FG000|Overall Study|Protocol Violation|0|||
147483125|NCT02961764|531924902|FG001|Overall Study|Protocol Violation|1|||
147483126|NCT02961764|531924901|FG000|Overall Study|Death|2|||
147483127|NCT02961764|531924902|FG001|Overall Study|Death|0|||
147483128|NCT02961764|531924901|FG000|Overall Study|Lost to Follow-up|35|||
147483129|NCT02961764|531924902|FG001|Overall Study|Lost to Follow-up|24|||
147623372|NCT00838903|532440144|FG002|Treatment Period (156 Weeks)|Protocol Violation|6|||
147623373|NCT00838903|532440145|FG003|Treatment Period (156 Weeks)|Protocol Violation|5|||
147483130|NCT02961764|531924901|FG000|Overall Study|Withdrawal by Subject|2|||
147483131|NCT02961764|531924902|FG001|Overall Study|Withdrawal by Subject|0|||
147483132|NCT03461289|531924903|FG000|Overall Study|Death|1|||
147483133|NCT02698423|531924904|FG000|Overall Study|Lost to Follow-up|19|||
147483134|NCT02698423|531924905|FG001|Overall Study|Lost to Follow-up|24|||
147483135|NCT02749370|531924907|FG000|Overall Study|Withdrawal by Subject|11|||
147483136|NCT02749370|531924907|FG000|Overall Study|Lost to Follow-up|3|||
147483137|NCT01519427|531924911|FG000|Overall Study|disease progression|2|||
147483138|NCT03894904|531924912|FG000|Randomized Dosing (Doses 1 and 2)|Did not receive intervention because peripheral arterial line (PAL) was replaced due to spasm|2|||
147483139|NCT03894904|531924913|FG001|Randomized Dosing (Doses 1 and 2)|Did not receive intervention because peripheral arterial line (PAL) was replaced due to spasm|3|||
147483140|NCT03894904|531924912|FG000|Randomized Dosing (Doses 1 and 2)|Did not receive second dose|2|||
147483141|NCT03894904|531924913|FG001|Randomized Dosing (Doses 1 and 2)|Did not receive second dose|1|||
147483142|NCT02190435|531924919|FG000|Overall Study|First 12 patients were lead-ins|12|||
147483143|NCT02190435|531924920|FG001|Overall Study|First 12 patients were lead-ins|0|||
147483144|NCT02190435|531924919|FG000|Overall Study|3 consented screen fails|3|||
147483145|NCT02190435|531924920|FG001|Overall Study|3 consented screen fails|0|||
147304370|NCT03489057|531280753|FG001|Overall Study|Lost to Follow-up|16|||
147304371|NCT03489057|531280754|FG002|Overall Study|Lost to Follow-up|14|||
147304372|NCT03489057|531280755|FG003|Overall Study|Lost to Follow-up|14|||
147304373|NCT03489057|531280752|FG000|Overall Study|Withdrawal by Subject|12|||
147304374|NCT03489057|531280753|FG001|Overall Study|Withdrawal by Subject|12|||
147304375|NCT03489057|531280754|FG002|Overall Study|Withdrawal by Subject|8|||
147304376|NCT03489057|531280755|FG003|Overall Study|Withdrawal by Subject|8|||
147483146|NCT02399475|531924927|FG000|Overall Study|Physician Decision|1|||
147483147|NCT02399475|531924928|FG001|Overall Study|Physician Decision|0|||
147483148|NCT02260193|531924929|FG000|Overall Study|Lack of Efficacy|0|||
147483149|NCT02260193|531924930|FG001|Overall Study|Lack of Efficacy|1|||
147483150|NCT02260193|531924931|FG002|Overall Study|Lack of Efficacy|6|||
147483151|NCT02260193|531924929|FG000|Overall Study|Adverse Event|3|||
147483152|NCT02260193|531924930|FG001|Overall Study|Adverse Event|4|||
147483153|NCT02260193|531924931|FG002|Overall Study|Adverse Event|1|||
147483154|NCT02260193|531924929|FG000|Overall Study|Protocol Violation|0|||
147483155|NCT02260193|531924930|FG001|Overall Study|Protocol Violation|4|||
147483156|NCT02260193|531924931|FG002|Overall Study|Protocol Violation|0|||
147483157|NCT02260193|531924929|FG000|Overall Study|Withdrawal by Subject|3|||
147483158|NCT02260193|531924930|FG001|Overall Study|Withdrawal by Subject|0|||
147483159|NCT02260193|531924931|FG002|Overall Study|Withdrawal by Subject|2|||
147483160|NCT02260193|531924929|FG000|Overall Study|Kidney Transplantation|0|||
147483161|NCT02260193|531924930|FG001|Overall Study|Kidney Transplantation|0|||
147483162|NCT02260193|531924931|FG002|Overall Study|Kidney Transplantation|1|||
147483163|NCT00935220|531924932|FG000|Overall Study|Adverse Event|1|||
147623374|NCT00838903|532440142|FG000|Treatment Period (156 Weeks)|Noncompliance|9|||
147623375|NCT00838903|532440143|FG001|Treatment Period (156 Weeks)|Noncompliance|13|||
147483164|NCT00935220|531924932|FG000|Overall Study|Other reason (not specified)|1|||
147483165|NCT01415440|531924935|FG000|Overall Study|Lost to Follow-up|0|||
147483166|NCT01415440|531924936|FG001|Overall Study|Lost to Follow-up|1|||
147483167|NCT01415440|531924937|FG002|Overall Study|Lost to Follow-up|2|||
147623376|NCT00838903|532440144|FG002|Treatment Period (156 Weeks)|Noncompliance|12|||
147623377|NCT00838903|532440145|FG003|Treatment Period (156 Weeks)|Noncompliance|6|||
147483168|NCT01415440|531924935|FG000|Overall Study|Physician Decision|3|||
147483169|NCT01415440|531924936|FG001|Overall Study|Physician Decision|0|||
147623378|NCT00838903|532440142|FG000|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0|||
147623379|NCT00838903|532440143|FG001|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0|||
147483170|NCT01415440|531924937|FG002|Overall Study|Physician Decision|0|||
147483171|NCT01415440|531924935|FG000|Overall Study|Withdrawal by Subject|1|||
147483172|NCT01415440|531924936|FG001|Overall Study|Withdrawal by Subject|0|||
147304377|NCT03489057|531280752|FG000|Overall Study|Protocol Violation|7|||
147304378|NCT03489057|531280753|FG001|Overall Study|Protocol Violation|7|||
147304379|NCT03489057|531280754|FG002|Overall Study|Protocol Violation|2|||
147304380|NCT03489057|531280755|FG003|Overall Study|Protocol Violation|2|||
147304381|NCT02034708|531280756|FG000|Wash-out (From 2 Days up to 14 Days)|Withdrawal by Subject|2|||
147304382|NCT02034708|531280757|FG001|Wash-out (From 2 Days up to 14 Days)|Withdrawal by Subject|5|||
147304383|NCT02034708|531280756|FG000|Wash-out (From 2 Days up to 14 Days)|Adverse Event|1|||
147304384|NCT02034708|531280757|FG001|Wash-out (From 2 Days up to 14 Days)|Adverse Event|0|||
147483173|NCT01415440|531924937|FG002|Overall Study|Withdrawal by Subject|0|||
147483174|NCT00336492|531924938|FG000|Overall Study|Adverse Event|4|||
147483175|NCT00336492|531924939|FG001|Overall Study|Adverse Event|3|||
147483176|NCT00336492|531924940|FG002|Overall Study|Adverse Event|6|||
147483177|NCT00336492|531924938|FG000|Overall Study|Lack of Efficacy|6|||
147483178|NCT00336492|531924939|FG001|Overall Study|Lack of Efficacy|1|||
147483179|NCT00336492|531924940|FG002|Overall Study|Lack of Efficacy|4|||
147483180|NCT00336492|531924938|FG000|Overall Study|Other|5|||
147483181|NCT00336492|531924939|FG001|Overall Study|Other|0|||
147483182|NCT00336492|531924940|FG002|Overall Study|Other|1|||
147483183|NCT01781026|531924941|FG000|Overall Study|Lack of Efficacy|2|||
147483184|NCT00633139|531924942|FG000|Overall Study|Non compliance|0|||
147483185|NCT00633139|531924943|FG001|Overall Study|Non compliance|0|||
147483186|NCT00633139|531924944|FG002|Overall Study|Non compliance|1|||
147483187|NCT00633139|531924942|FG000|Overall Study|Withdrawal by Subject|0|||
147483188|NCT00633139|531924943|FG001|Overall Study|Withdrawal by Subject|1|||
147483189|NCT00633139|531924944|FG002|Overall Study|Withdrawal by Subject|0|||
147483190|NCT02160977|531924945|FG000|Six Weeks After Surgery|Lost to Follow-up|1|||
147483191|NCT02160977|531924946|FG001|Six Weeks After Surgery|Lost to Follow-up|0|||
147483192|NCT02160977|531924945|FG000|Three Months After Surgery|Lost to Follow-up|0|||
147483193|NCT02160977|531924946|FG001|Three Months After Surgery|Lost to Follow-up|2|||
147304385|NCT02034708|531280756|FG000|Wash-out (From 2 Days up to 14 Days)|Protocol Violation|3|||
147304386|NCT02034708|531280757|FG001|Wash-out (From 2 Days up to 14 Days)|Protocol Violation|3|||
147304387|NCT02034708|531280756|FG000|Wash-out (From 2 Days up to 14 Days)|other reason|3|||
147304388|NCT02034708|531280757|FG001|Wash-out (From 2 Days up to 14 Days)|other reason|2|||
147304389|NCT00654901|531280758|FG000|Overall Study|Lost to Follow-up|1|||
147304390|NCT00654901|531280759|FG001|Overall Study|Lost to Follow-up|0|||
147304391|NCT00654901|531280760|FG002|Overall Study|Lost to Follow-up|1|||
147304392|NCT00654901|531280761|FG003|Overall Study|Lost to Follow-up|0|||
147483194|NCT02160977|531924945|FG000|Six Months After Surgery|Lost to Follow-up|2|||
147483195|NCT02160977|531924946|FG001|Six Months After Surgery|Lost to Follow-up|1|||
147483196|NCT02658656|531924952|FG000|Screening|Failed eligibility criteria|0|||
147483197|NCT02658656|531924953|FG001|Screening|Failed eligibility criteria|0|||
147483198|NCT02658656|531924954|FG002|Screening|Failed eligibility criteria|263|||
147483199|NCT02658656|531924952|FG000|Randomization|Withdrawal by Subject|8|||
147483200|NCT02658656|531924953|FG001|Randomization|Withdrawal by Subject|7|||
147483201|NCT02658656|531924954|FG002|Randomization|Withdrawal by Subject|0|||
147483202|NCT02658656|531924952|FG000|Randomization|Lost to Follow-up|1|||
147483203|NCT02658656|531924953|FG001|Randomization|Lost to Follow-up|3|||
147483204|NCT02658656|531924954|FG002|Randomization|Lost to Follow-up|0|||
147483205|NCT02658656|531924952|FG000|Randomization|Adverse Event|4|||
147483206|NCT02658656|531924953|FG001|Randomization|Adverse Event|0|||
147483207|NCT02658656|531924954|FG002|Randomization|Adverse Event|0|||
147483208|NCT02658656|531924952|FG000|Randomization|Administrative Termination|3|||
147483209|NCT02658656|531924953|FG001|Randomization|Administrative Termination|1|||
147304393|NCT00654901|531280758|FG000|Overall Study|Withdrawal by Subject|3|||
147304394|NCT00654901|531280759|FG001|Overall Study|Withdrawal by Subject|0|||
147304395|NCT00654901|531280760|FG002|Overall Study|Withdrawal by Subject|1|||
147304396|NCT00654901|531280761|FG003|Overall Study|Withdrawal by Subject|0|||
147304397|NCT02552238|531280762|FG000|Overall Study|Withdrawal by Subject|2|||
147304398|NCT02552238|531280762|FG000|Overall Study|Adverse Event|2|||
147304399|NCT05158296|531280763|FG000|Overall Study|Sponsor Decision|2|||
147304400|NCT05158296|531280764|FG001|Overall Study|Sponsor Decision|3|||
147483210|NCT02658656|531924954|FG002|Randomization|Administrative Termination|0|||
147483211|NCT02658656|531924952|FG000|Randomization|Administrative Termination due to COVID-19 Restrictions|13|||
147623380|NCT00838903|532440144|FG002|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|1|||
147623381|NCT00838903|532440145|FG003|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0|||
147623382|NCT00838903|532440142|FG000|Treatment Period (156 Weeks)|Lost to Follow-up|4|||
147623383|NCT00838903|532440143|FG001|Treatment Period (156 Weeks)|Lost to Follow-up|16|||
147623384|NCT00838903|532440144|FG002|Treatment Period (156 Weeks)|Lost to Follow-up|15|||
147623385|NCT00838903|532440145|FG003|Treatment Period (156 Weeks)|Lost to Follow-up|13|||
147623386|NCT00838903|532440142|FG000|Treatment Period (156 Weeks)|Withdrawal by Subject|20|||
147623387|NCT00838903|532440143|FG001|Treatment Period (156 Weeks)|Withdrawal by Subject|55|||
147623388|NCT00838903|532440144|FG002|Treatment Period (156 Weeks)|Withdrawal by Subject|56|||
147623389|NCT00838903|532440145|FG003|Treatment Period (156 Weeks)|Withdrawal by Subject|53|||
147623390|NCT00838903|532440142|FG000|Treatment Period (156 Weeks)|Physician Decision|1|||
147304401|NCT05158296|531280765|FG002|Overall Study|Sponsor Decision|2|||
147304402|NCT03324880|531280769|FG000|Overall Study|Adverse Event|0|||
147304403|NCT03324880|531280770|FG001|Overall Study|Adverse Event|2|||
147304404|NCT03324880|531280769|FG000|Overall Study|Withdrawal by Subject|2|||
147304405|NCT03324880|531280770|FG001|Overall Study|Withdrawal by Subject|2|||
147304406|NCT03324880|531280769|FG000|Overall Study|Lost to Follow-up|0|||
147304407|NCT03324880|531280770|FG001|Overall Study|Lost to Follow-up|1|||
147304408|NCT03324880|531280769|FG000|Overall Study|Product Recall|0|||
147304409|NCT03324880|531280770|FG001|Overall Study|Product Recall|1|||
147304410|NCT00652938|531280771|FG000|Overall Study|Adverse Event|1|||
147667710|NCT00369343|532608130|FG000|Double-blind Phase|Withdrawal by Subject|8|||
147667711|NCT00369343|532608131|FG001|Double-blind Phase|Withdrawal by Subject|6|||
147667712|NCT00369343|532608130|FG000|Double-blind Phase|Lack of Efficacy|0|||
147667713|NCT00369343|532608131|FG001|Double-blind Phase|Lack of Efficacy|4|||
147667714|NCT00369343|532608130|FG000|Double-blind Phase|Protocol deviation|4|||
147667715|NCT00369343|532608131|FG001|Double-blind Phase|Protocol deviation|0|||
147667716|NCT00369343|532608130|FG000|Open-label Phase|Adverse Event|19|||
147304411|NCT00652938|531280772|FG001|Overall Study|Adverse Event|0|||
147304412|NCT00652938|531280773|FG002|Overall Study|Adverse Event|2|||
147304413|NCT00652938|531280771|FG000|Overall Study|Withdrawal by Subject|0|||
147304414|NCT00652938|531280772|FG001|Overall Study|Withdrawal by Subject|6|||
147304415|NCT00652938|531280773|FG002|Overall Study|Withdrawal by Subject|1|||
147483212|NCT02658656|531924953|FG001|Randomization|Administrative Termination due to COVID-19 Restrictions|15|||
147483213|NCT02658656|531924954|FG002|Randomization|Administrative Termination due to COVID-19 Restrictions|0|||
147483214|NCT02658656|531924952|FG000|Randomization|Failed Exoskeletal-assisted walking (EAW) Advanced Skills Test|2|||
147483215|NCT02658656|531924953|FG001|Randomization|Failed Exoskeletal-assisted walking (EAW) Advanced Skills Test|0|||
147483216|NCT02658656|531924954|FG002|Randomization|Failed Exoskeletal-assisted walking (EAW) Advanced Skills Test|0|||
147483217|NCT02658656|531924952|FG000|Randomization|Not eligible for Randomization|1|||
147483218|NCT02658656|531924953|FG001|Randomization|Not eligible for Randomization|0|||
147483219|NCT02658656|531924954|FG002|Randomization|Not eligible for Randomization|0|||
147483220|NCT02658656|531924952|FG000|Randomization|Protocol Violation|1|||
147483221|NCT02658656|531924953|FG001|Randomization|Protocol Violation|0|||
147483222|NCT02658656|531924954|FG002|Randomization|Protocol Violation|0|||
147483223|NCT01118143|531924955|FG000|Overall Study|Withdrawal by Subject|2|||
147483224|NCT01118143|531924956|FG001|Overall Study|Withdrawal by Subject|5|||
147483225|NCT02112448|531924957|FG000|Overall Study|lab values precluding use of ketorolac|2|||
147483226|NCT02112448|531924958|FG001|Overall Study|lab values precluding use of ketorolac|2|||
147483227|NCT02112448|531924957|FG000|Overall Study|Protocol Violation|1|||
147483228|NCT02112448|531924958|FG001|Overall Study|Protocol Violation|2|||
147667717|NCT00369343|532608131|FG001|Open-label Phase|Adverse Event|7|||
147304416|NCT00652938|531280771|FG000|Overall Study|Lost to Follow-up|0|||
147304417|NCT00652938|531280772|FG001|Overall Study|Lost to Follow-up|0|||
147304418|NCT00652938|531280773|FG002|Overall Study|Lost to Follow-up|2|||
147304419|NCT00652938|531280771|FG000|Overall Study|fear of blood sampling|0|||
147304420|NCT00652938|531280772|FG001|Overall Study|fear of blood sampling|1|||
147304421|NCT00652938|531280773|FG002|Overall Study|fear of blood sampling|0|||
147304422|NCT01412801|531280777|FG000|Overall Study|Death|0|||
147304423|NCT01412801|531280778|FG001|Overall Study|Death|1|||
147304424|NCT01412801|531280779|FG002|Overall Study|Death|0|||
147304425|NCT01412801|531280780|FG003|Overall Study|Death|4|||
147304426|NCT01412801|531280781|FG004|Overall Study|Death|2|||
147304427|NCT01412801|531280782|FG005|Overall Study|Death|2|||
147304428|NCT01412801|531280777|FG000|Overall Study|Lost to Follow-up|1|||
147304429|NCT01412801|531280778|FG001|Overall Study|Lost to Follow-up|2|||
147304430|NCT01412801|531280779|FG002|Overall Study|Lost to Follow-up|4|||
147304431|NCT01412801|531280780|FG003|Overall Study|Lost to Follow-up|0|||
147304432|NCT01412801|531280781|FG004|Overall Study|Lost to Follow-up|1|||
147304433|NCT01412801|531280782|FG005|Overall Study|Lost to Follow-up|1|||
147304434|NCT01412801|531280777|FG000|Overall Study|Withdrawal by Subject|3|||
147304435|NCT01412801|531280778|FG001|Overall Study|Withdrawal by Subject|2|||
147304436|NCT01412801|531280779|FG002|Overall Study|Withdrawal by Subject|1|||
147304437|NCT01412801|531280780|FG003|Overall Study|Withdrawal by Subject|0|||
147304438|NCT01412801|531280781|FG004|Overall Study|Withdrawal by Subject|0|||
147304439|NCT01412801|531280782|FG005|Overall Study|Withdrawal by Subject|0|||
147304440|NCT01412801|531280777|FG000|Overall Study|Relocated to another area|0|||
147304441|NCT01412801|531280778|FG001|Overall Study|Relocated to another area|0|||
147667718|NCT00369343|532608130|FG000|Open-label Phase|Failed to return|4|||
147304442|NCT01412801|531280779|FG002|Overall Study|Relocated to another area|2|||
147304443|NCT01412801|531280780|FG003|Overall Study|Relocated to another area|0|||
147304444|NCT01412801|531280781|FG004|Overall Study|Relocated to another area|0|||
147667719|NCT00369343|532608131|FG001|Open-label Phase|Failed to return|0|||
147667720|NCT00369343|532608130|FG000|Open-label Phase|Physician Decision|2|||
147304445|NCT01412801|531280782|FG005|Overall Study|Relocated to another area|0|||
147304446|NCT01547299|531280783|FG000|Overall Study|Withdrawal by Subject|2|||
147304447|NCT01547299|531280784|FG001|Overall Study|Withdrawal by Subject|2|||
147304448|NCT02272725|531280789|FG000|Overall Study|equipment malfunction|2|||
147623391|NCT00838903|532440143|FG001|Treatment Period (156 Weeks)|Physician Decision|2|||
147623392|NCT00838903|532440144|FG002|Treatment Period (156 Weeks)|Physician Decision|1|||
147304449|NCT02272725|531280790|FG001|Overall Study|equipment malfunction|0|||
147304450|NCT04739761|531280791|FG000|Overall Study|Participant ongoing study at data cutoff date of 08Feb24|167|||
147304451|NCT04739761|531280792|FG001|Overall Study|Participant ongoing study at data cutoff date of 08Feb24|189|||
147304452|NCT04739761|531280791|FG000|Overall Study|By complete response from the participant|1|||
147304453|NCT04739761|531280792|FG001|Overall Study|By complete response from the participant|0|||
147304454|NCT04739761|531280791|FG000|Overall Study|Lost to Follow-up|3|||
147304455|NCT04739761|531280792|FG001|Overall Study|Lost to Follow-up|3|||
147304456|NCT04739761|531280791|FG000|Overall Study|Death|13|||
147304457|NCT04739761|531280792|FG001|Overall Study|Death|13|||
147304458|NCT04739761|531280791|FG000|Overall Study|Participant reports worsening of the general critical condition and will not continue|0|||
147304459|NCT04739761|531280792|FG001|Overall Study|Participant reports worsening of the general critical condition and will not continue|1|||
147304460|NCT04739761|531280791|FG000|Overall Study|Participant is in poor health and will not come to the study site|0|||
147304461|NCT04739761|531280792|FG001|Overall Study|Participant is in poor health and will not come to the study site|1|||
147304462|NCT04739761|531280791|FG000|Overall Study|Progression confirmed in magnetic resonance imaging|0|||
147304463|NCT04739761|531280792|FG001|Overall Study|Progression confirmed in magnetic resonance imaging|1|||
147304464|NCT04739761|531280791|FG000|Overall Study|Adverse Event|0|||
147304465|NCT04739761|531280792|FG001|Overall Study|Adverse Event|3|||
147304466|NCT04739761|531280791|FG000|Overall Study|Participant decision|1|||
147304467|NCT04739761|531280792|FG001|Overall Study|Participant decision|0|||
147304468|NCT04739761|531280791|FG000|Overall Study|Sub investigator decision approved by medical monitor|1|||
147304469|NCT04739761|531280792|FG001|Overall Study|Sub investigator decision approved by medical monitor|0|||
147304470|NCT04739761|531280791|FG000|Overall Study|Participant immediately started next line of treatment|1|||
147304471|NCT04739761|531280792|FG001|Overall Study|Participant immediately started next line of treatment|0|||
147304472|NCT04739761|531280791|FG000|Overall Study|Participant's decision because the treatment makes them anxious|1|||
147304473|NCT04739761|531280792|FG001|Overall Study|Participant's decision because the treatment makes them anxious|0|||
147304474|NCT04739761|531280791|FG000|Overall Study|Lack of clinical benefit|1|||
147304475|NCT04739761|531280792|FG001|Overall Study|Lack of clinical benefit|0|||
147304476|NCT04739761|531280791|FG000|Overall Study|Disease progression|5|||
147304477|NCT04739761|531280792|FG001|Overall Study|Disease progression|5|||
147304478|NCT04739761|531280791|FG000|Overall Study|Withdrawal by Subject|14|||
147304479|NCT04739761|531280792|FG001|Overall Study|Withdrawal by Subject|13|||
147304480|NCT04739761|531280791|FG000|Overall Study|Protocol Violation|1|||
147304481|NCT04739761|531280792|FG001|Overall Study|Protocol Violation|0|||
147304482|NCT04739761|531280791|FG000|Overall Study|Physician Decision|2|||
147304483|NCT04739761|531280792|FG001|Overall Study|Physician Decision|0|||
147416293|NCT03459443|531688368|FG000|Overall Study|Sponsor's decision to close the study|18|||
147416294|NCT03702231|531688369|FG000|Overall Study|Withdrawal by Subject|1|||
147416295|NCT03702231|531688370|FG001|Overall Study|Withdrawal by Subject|0|||
147416296|NCT03702231|531688371|FG002|Overall Study|Withdrawal by Subject|0|||
147416297|NCT03702231|531688369|FG000|Overall Study|Protocol Violation|0|||
147416298|NCT03702231|531688370|FG001|Overall Study|Protocol Violation|0|||
147416299|NCT03702231|531688371|FG002|Overall Study|Protocol Violation|1|||
147416300|NCT03702231|531688369|FG000|Overall Study|Change in CLL Treatment|0|||
147416301|NCT03702231|531688370|FG001|Overall Study|Change in CLL Treatment|0|||
147416302|NCT03702231|531688371|FG002|Overall Study|Change in CLL Treatment|1|||
147416303|NCT03702231|531688369|FG000|Overall Study|COVID Pandemic|1|||
147416304|NCT03702231|531688370|FG001|Overall Study|COVID Pandemic|4|||
147416305|NCT03702231|531688371|FG002|Overall Study|COVID Pandemic|1|||
147416306|NCT03702231|531688369|FG000|Overall Study|Non-compliance|0|||
147416307|NCT03702231|531688370|FG001|Overall Study|Non-compliance|0|||
147416308|NCT03702231|531688371|FG002|Overall Study|Non-compliance|1|||
147416309|NCT03592745|531688372|FG000|Overall Study|Adverse Event|0|||
147416310|NCT03592745|531688373|FG001|Overall Study|Adverse Event|2|||
147416311|NCT03592745|531688372|FG000|Overall Study|Lost to Follow-up|2|||
147416312|NCT03592745|531688373|FG001|Overall Study|Lost to Follow-up|0|||
147416313|NCT03592745|531688372|FG000|Overall Study|study temporary closure due to covid-19 pandemic|1|||
147416314|NCT03592745|531688373|FG001|Overall Study|study temporary closure due to covid-19 pandemic|1|||
147416315|NCT02729831|531688375|FG000|Baseline (Post Decision Aid, Pre-visit)|Ineligible post completion|38|||
147416316|NCT02729831|531688376|FG001|Baseline (Post Decision Aid, Pre-visit)|Ineligible post completion|23|||
147416317|NCT02729831|531688377|FG002|Baseline (Post Decision Aid, Pre-visit)|Ineligible post completion|18|||
147416318|NCT02729831|531688378|FG003|Baseline (Post Decision Aid, Pre-visit)|Ineligible post completion|17|||
147416319|NCT02729831|531688375|FG000|1 Week Post-visit|Lost to Follow-up|43|||
147416320|NCT02729831|531688376|FG001|1 Week Post-visit|Lost to Follow-up|40|||
147416321|NCT02729831|531688377|FG002|1 Week Post-visit|Lost to Follow-up|38|||
147416322|NCT02729831|531688378|FG003|1 Week Post-visit|Lost to Follow-up|36|||
147416323|NCT02729831|531688375|FG000|6 Month Follow-up|Lost to Follow-up|54|||
147416324|NCT02729831|531688376|FG001|6 Month Follow-up|Lost to Follow-up|51|||
147416325|NCT02729831|531688377|FG002|6 Month Follow-up|Lost to Follow-up|48|||
147416326|NCT02729831|531688378|FG003|6 Month Follow-up|Lost to Follow-up|42|||
147416327|NCT02729831|531688375|FG000|6 Month Follow-up|Death|1|||
147416328|NCT02729831|531688376|FG001|6 Month Follow-up|Death|3|||
147416329|NCT02729831|531688377|FG002|6 Month Follow-up|Death|0|||
147416330|NCT02729831|531688378|FG003|6 Month Follow-up|Death|1|||
147416331|NCT05260021|531688381|FG000|Double-blind Period (30 Weeks)|Adverse Event|2|||
147416332|NCT05260021|531688382|FG001|Double-blind Period (30 Weeks)|Adverse Event|0|||
147416333|NCT05260021|531688383|FG002|Double-blind Period (30 Weeks)|Adverse Event|0|||
147416334|NCT05260021|531688381|FG000|Double-blind Period (30 Weeks)|Withdrawal by Subject|1|||
147416335|NCT05260021|531688382|FG001|Double-blind Period (30 Weeks)|Withdrawal by Subject|2|||
147416336|NCT05260021|531688383|FG002|Double-blind Period (30 Weeks)|Withdrawal by Subject|1|||
147416337|NCT05260021|531688381|FG000|Double-blind Period (30 Weeks)|Lost to Follow-up|0|||
147416338|NCT05260021|531688382|FG001|Double-blind Period (30 Weeks)|Lost to Follow-up|0|||
147416339|NCT05260021|531688383|FG002|Double-blind Period (30 Weeks)|Lost to Follow-up|1|||
147416340|NCT05260021|531688381|FG000|Double-blind Period (30 Weeks)|Withdrawal due to Caregiver Circumstances|0|||
147483229|NCT02112448|531924957|FG000|Overall Study|Physician Decision|4|||
147483230|NCT02112448|531924958|FG001|Overall Study|Physician Decision|6|||
147483231|NCT02112448|531924957|FG000|Overall Study|required heparin so could not use ketoro|1|||
147483232|NCT02112448|531924958|FG001|Overall Study|required heparin so could not use ketoro|0|||
147483233|NCT05270694|531926562|FG000|Overall Study|Death|1|||
147483234|NCT05270694|531926562|FG000|Overall Study|Medical issues impacted ability to participate|2|||
147483235|NCT05270694|531926562|FG000|Overall Study|Lost to Follow-up|3|||
147483236|NCT05270694|531926562|FG000|Overall Study|Withdrawal by Subject|3|||
147483237|NCT01070303|531926563|FG000|Overall Study|Adverse Event|39|||
147483238|NCT01070303|531926563|FG000|Overall Study|Withdrawal by Subject|20|||
147483239|NCT01070303|531926563|FG000|Overall Study|Lost to Follow-up|9|||
147483240|NCT01070303|531926563|FG000|Overall Study|Protocol Violation|0|||
147483241|NCT01070303|531926563|FG000|Overall Study|Lack of Efficacy|2|||
147483242|NCT01070303|531926563|FG000|Overall Study|Administrative Reason|1|||
147483243|NCT01070303|531926563|FG000|Overall Study|Other|18|||
147483244|NCT00859898|531926565|FG000|Overall Study|Lack of Efficacy|0|||
147483245|NCT00859898|531926566|FG001|Overall Study|Lack of Efficacy|1|||
147483246|NCT00859898|531926567|FG002|Overall Study|Lack of Efficacy|1|||
147483247|NCT00859898|531926565|FG000|Overall Study|Adverse Event|4|||
147483248|NCT00859898|531926566|FG001|Overall Study|Adverse Event|9|||
147483249|NCT00859898|531926567|FG002|Overall Study|Adverse Event|8|||
147483250|NCT00859898|531926565|FG000|Overall Study|Withdrawal by Subject|11|||
147483251|NCT00859898|531926566|FG001|Overall Study|Withdrawal by Subject|8|||
147483252|NCT00859898|531926567|FG002|Overall Study|Withdrawal by Subject|11|||
147483253|NCT00859898|531926565|FG000|Overall Study|Death|0|||
147483254|NCT00859898|531926566|FG001|Overall Study|Death|0|||
147483255|NCT00859898|531926567|FG002|Overall Study|Death|1|||
147483256|NCT00859898|531926565|FG000|Overall Study|Lost to Follow-up|10|||
147483257|NCT00859898|531926566|FG001|Overall Study|Lost to Follow-up|11|||
147483258|NCT00859898|531926567|FG002|Overall Study|Lost to Follow-up|5|||
147483259|NCT00859898|531926565|FG000|Overall Study|poor/non-compliance|2|||
147483260|NCT00859898|531926566|FG001|Overall Study|poor/non-compliance|0|||
147483261|NCT00859898|531926567|FG002|Overall Study|poor/non-compliance|0|||
147483262|NCT00859898|531926565|FG000|Overall Study|No longer meets criteria|0|||
147483263|NCT00859898|531926566|FG001|Overall Study|No longer meets criteria|1|||
147483264|NCT00859898|531926567|FG002|Overall Study|No longer meets criteria|0|||
147483265|NCT00859898|531926565|FG000|Overall Study|non-specified|1|||
147483266|NCT00859898|531926566|FG001|Overall Study|non-specified|1|||
147483267|NCT00859898|531926567|FG002|Overall Study|non-specified|1|||
147483268|NCT04230486|531926568|FG000|Overall Study|Screen Failure|1|||
147483269|NCT03215264|531926569|FG000|Dose Level 2|Adverse Event|0|||
147483270|NCT03215264|531926570|FG001|Dose Level 2|Adverse Event|1|||
147483271|NCT03215264|531926571|FG002|Dose Level 2|Adverse Event|0|||
147483272|NCT03215264|531926569|FG000|Dose Level 3|Withdrawal by Subject|0|||
147483273|NCT03215264|531926570|FG001|Dose Level 3|Withdrawal by Subject|0|||
147483274|NCT03215264|531926571|FG002|Dose Level 3|Withdrawal by Subject|1|||
147483275|NCT02145156|531926573|FG000|Overall Study|No match to vaccination records|60|||
147483276|NCT02145156|531926574|FG001|Overall Study|No match to vaccination records|52|||
147483277|NCT02145156|531926575|FG002|Overall Study|No match to vaccination records|41|||
147483278|NCT02417233|531926578|FG000|Overall Study|Death|4|||
147483279|NCT02417233|531926579|FG001|Overall Study|Death|10|||
147483280|NCT02417233|531926580|FG002|Overall Study|Death|14|||
147483281|NCT02417233|531926578|FG000|Overall Study|Lost to Follow-up|27|||
147483282|NCT02417233|531926579|FG001|Overall Study|Lost to Follow-up|39|||
147483283|NCT02417233|531926580|FG002|Overall Study|Lost to Follow-up|34|||
147483284|NCT02417233|531926578|FG000|Overall Study|Protocol Violation|2|||
147483285|NCT02417233|531926579|FG001|Overall Study|Protocol Violation|0|||
147483286|NCT02417233|531926580|FG002|Overall Study|Protocol Violation|2|||
147483287|NCT02417233|531926578|FG000|Overall Study|Withdrawal by Subject|2|||
147483288|NCT02417233|531926579|FG001|Overall Study|Withdrawal by Subject|1|||
147483289|NCT02417233|531926580|FG002|Overall Study|Withdrawal by Subject|8|||
147483290|NCT02417233|531926578|FG000|Overall Study|Relocation out of study area|1|||
147483291|NCT02417233|531926579|FG001|Overall Study|Relocation out of study area|0|||
147483292|NCT02417233|531926580|FG002|Overall Study|Relocation out of study area|1|||
147483293|NCT02417233|531926578|FG000|Overall Study|Mentally unstable|0|||
147483294|NCT02417233|531926579|FG001|Overall Study|Mentally unstable|1|||
147483295|NCT02417233|531926580|FG002|Overall Study|Mentally unstable|0|||
147483296|NCT01264965|531926581|FG000|Overall Study|Withdrawal by Subject|10|||
147483297|NCT00532883|531926582|FG000|Overall Study|Adverse Event|1|||
147483298|NCT00532883|531926583|FG001|Overall Study|Adverse Event|0|||
147483299|NCT00532883|531926584|FG002|Overall Study|Adverse Event|0|||
147483300|NCT00532883|531926585|FG003|Overall Study|Adverse Event|1|||
147483301|NCT00532883|531926582|FG000|Overall Study|Lost to Follow-up|1|||
147483302|NCT00532883|531926583|FG001|Overall Study|Lost to Follow-up|1|||
147483303|NCT00532883|531926584|FG002|Overall Study|Lost to Follow-up|1|||
147483304|NCT00532883|531926585|FG003|Overall Study|Lost to Follow-up|0|||
147483305|NCT00532883|531926582|FG000|Overall Study|Withdrawal by Subject|0|||
147483306|NCT00532883|531926583|FG001|Overall Study|Withdrawal by Subject|1|||
147483307|NCT00532883|531926584|FG002|Overall Study|Withdrawal by Subject|1|||
147483308|NCT00532883|531926585|FG003|Overall Study|Withdrawal by Subject|0|||
147483309|NCT00532883|531926582|FG000|Overall Study|Subject was Nonadherent|0|||
147483310|NCT00532883|531926583|FG001|Overall Study|Subject was Nonadherent|1|||
147483311|NCT00532883|531926584|FG002|Overall Study|Subject was Nonadherent|1|||
147483312|NCT00532883|531926585|FG003|Overall Study|Subject was Nonadherent|0|||
147483313|NCT00532883|531926582|FG000|Overall Study|Early Study Termination|4|||
147483314|NCT00532883|531926583|FG001|Overall Study|Early Study Termination|4|||
147483315|NCT00532883|531926584|FG002|Overall Study|Early Study Termination|1|||
147483316|NCT00532883|531926585|FG003|Overall Study|Early Study Termination|4|||
147483317|NCT03799718|531926586|FG000|Overall Study|Adverse Event|2|||
147483318|NCT00321984|531926587|FG000|Overall Study|Adverse Event|9|||
147483319|NCT00321984|531926588|FG001|Overall Study|Adverse Event|6|||
147483320|NCT00321984|531926589|FG002|Overall Study|Adverse Event|8|||
147483321|NCT00321984|531926587|FG000|Overall Study|Protocol Violation|0|||
147483322|NCT00321984|531926588|FG001|Overall Study|Protocol Violation|1|||
147483323|NCT00321984|531926589|FG002|Overall Study|Protocol Violation|1|||
147483324|NCT00321984|531926587|FG000|Overall Study|Lost to Follow-up|2|||
147483325|NCT00321984|531926588|FG001|Overall Study|Lost to Follow-up|4|||
147483326|NCT00321984|531926589|FG002|Overall Study|Lost to Follow-up|2|||
147483327|NCT00321984|531926587|FG000|Overall Study|Withdrawal by Subject|8|||
147483328|NCT00321984|531926588|FG001|Overall Study|Withdrawal by Subject|6|||
147483329|NCT00321984|531926589|FG002|Overall Study|Withdrawal by Subject|5|||
147483330|NCT00321984|531926587|FG000|Overall Study|Unmet Inclusion/Exclusion Criteria|3|||
147483331|NCT00321984|531926588|FG001|Overall Study|Unmet Inclusion/Exclusion Criteria|1|||
147483332|NCT00321984|531926589|FG002|Overall Study|Unmet Inclusion/Exclusion Criteria|5|||
147483333|NCT00321984|531926587|FG000|Overall Study|Lack of Efficacy|3|||
147483334|NCT00321984|531926588|FG001|Overall Study|Lack of Efficacy|1|||
147483335|NCT00321984|531926589|FG002|Overall Study|Lack of Efficacy|3|||
147483336|NCT00321984|531926587|FG000|Overall Study|Noncompliant|0|||
147483337|NCT00321984|531926588|FG001|Overall Study|Noncompliant|0|||
147483338|NCT00321984|531926589|FG002|Overall Study|Noncompliant|2|||
147483339|NCT00321984|531926587|FG000|Overall Study|Pregnancy|0|||
147483340|NCT00321984|531926588|FG001|Overall Study|Pregnancy|1|||
147483341|NCT00321984|531926589|FG002|Overall Study|Pregnancy|0|||
147483342|NCT00321984|531926587|FG000|Overall Study|Per Subject Request|1|||
147483343|NCT00321984|531926588|FG001|Overall Study|Per Subject Request|0|||
147483344|NCT00321984|531926589|FG002|Overall Study|Per Subject Request|0|||
147483345|NCT00321984|531926587|FG000|Overall Study|Per Investigator Request|1|||
147483346|NCT00321984|531926588|FG001|Overall Study|Per Investigator Request|0|||
147483347|NCT00321984|531926589|FG002|Overall Study|Per Investigator Request|0|||
147483348|NCT00321984|531926587|FG000|Overall Study|Per Sponsor Due to High Baseline Gastrin|0|||
147483349|NCT00321984|531926588|FG001|Overall Study|Per Sponsor Due to High Baseline Gastrin|1|||
147483350|NCT00321984|531926589|FG002|Overall Study|Per Sponsor Due to High Baseline Gastrin|0|||
147483351|NCT01469013|531926590|FG000|Part A (Treatment Period)|Adverse Event|1|||
147483352|NCT01469013|531926591|FG001|Part A (Treatment Period)|Adverse Event|0|||
147483353|NCT01469013|531926592|FG002|Part A (Treatment Period)|Adverse Event|0|||
147483354|NCT01469013|531926593|FG003|Part A (Treatment Period)|Adverse Event|0|||
147483355|NCT01469013|531926594|FG004|Part A (Treatment Period)|Adverse Event|1|||
147483356|NCT01469013|531926595|FG005|Part A (Treatment Period)|Adverse Event|0|||
147483357|NCT01469013|531926596|FG006|Part A (Treatment Period)|Adverse Event|0|||
147483358|NCT01469013|531926597|FG007|Part A (Treatment Period)|Adverse Event|0|||
147483359|NCT01469013|531926598|FG008|Part A (Treatment Period)|Adverse Event|0|||
147483360|NCT01469013|531926599|FG009|Part A (Treatment Period)|Adverse Event|0|||
147483361|NCT01469013|531926600|FG010|Part A (Treatment Period)|Adverse Event|0|||
147483362|NCT01469013|531926601|FG011|Part A (Treatment Period)|Adverse Event|0|||
147483363|NCT01469013|531926602|FG012|Part A (Treatment Period)|Adverse Event|0|||
147483364|NCT01469013|531926590|FG000|Part A (Treatment Period)|Withdrawal by Subject|0|||
147483365|NCT01469013|531926591|FG001|Part A (Treatment Period)|Withdrawal by Subject|0|||
147483366|NCT01469013|531926592|FG002|Part A (Treatment Period)|Withdrawal by Subject|1|||
147483367|NCT01469013|531926593|FG003|Part A (Treatment Period)|Withdrawal by Subject|0|||
147483368|NCT01469013|531926594|FG004|Part A (Treatment Period)|Withdrawal by Subject|0|||
147483369|NCT01469013|531926595|FG005|Part A (Treatment Period)|Withdrawal by Subject|0|||
147483370|NCT01469013|531926596|FG006|Part A (Treatment Period)|Withdrawal by Subject|0|||
147483371|NCT01469013|531926597|FG007|Part A (Treatment Period)|Withdrawal by Subject|0|||
147416341|NCT05260021|531688382|FG001|Double-blind Period (30 Weeks)|Withdrawal due to Caregiver Circumstances|1|||
147416342|NCT05260021|531688383|FG002|Double-blind Period (30 Weeks)|Withdrawal due to Caregiver Circumstances|0|||
147416343|NCT05260021|531688381|FG000|Double-blind Period (30 Weeks)|Incorrectly Enrolled|0|||
147416344|NCT05260021|531688382|FG001|Double-blind Period (30 Weeks)|Incorrectly Enrolled|1|||
147416345|NCT05260021|531688383|FG002|Double-blind Period (30 Weeks)|Incorrectly Enrolled|0|||
147416346|NCT03842358|531688384|FG000|Overall Study|Poor DOT probe contact with breast|2|||
147416347|NCT03842358|531688384|FG000|Overall Study|DOT system problem|1|||
147416348|NCT03842358|531688384|FG000|Overall Study|Switched to x-ray guided biopsy|3|||
147416349|NCT03842358|531688384|FG000|Overall Study|No biopsy after physician review|4|||
147416350|NCT03842358|531688384|FG000|Overall Study|Patient withdrew|2|||
147483372|NCT01469013|531926598|FG008|Part A (Treatment Period)|Withdrawal by Subject|0|||
147483373|NCT01469013|531926599|FG009|Part A (Treatment Period)|Withdrawal by Subject|0|||
147623393|NCT00838903|532440145|FG003|Treatment Period (156 Weeks)|Physician Decision|2|||
147623394|NCT00838903|532440142|FG000|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|3|||
147623395|NCT00838903|532440143|FG001|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|5|||
147623396|NCT00838903|532440144|FG002|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|5|||
147483374|NCT01469013|531926600|FG010|Part A (Treatment Period)|Withdrawal by Subject|0|||
147483375|NCT01469013|531926601|FG011|Part A (Treatment Period)|Withdrawal by Subject|0|||
147483376|NCT01469013|531926602|FG012|Part A (Treatment Period)|Withdrawal by Subject|0|||
147483377|NCT01469013|531926590|FG000|Part B (Extension Period)|Adverse Event|0|||
147483378|NCT01469013|531926591|FG001|Part B (Extension Period)|Adverse Event|0|||
147483379|NCT01469013|531926592|FG002|Part B (Extension Period)|Adverse Event|0|||
147483380|NCT01469013|531926593|FG003|Part B (Extension Period)|Adverse Event|0|||
147483381|NCT01469013|531926594|FG004|Part B (Extension Period)|Adverse Event|0|||
147483382|NCT01469013|531926595|FG005|Part B (Extension Period)|Adverse Event|2|||
147483383|NCT01469013|531926596|FG006|Part B (Extension Period)|Adverse Event|5|||
147483384|NCT01469013|531926597|FG007|Part B (Extension Period)|Adverse Event|5|||
147483385|NCT01469013|531926598|FG008|Part B (Extension Period)|Adverse Event|3|||
147483386|NCT01469013|531926599|FG009|Part B (Extension Period)|Adverse Event|3|||
147483387|NCT01469013|531926600|FG010|Part B (Extension Period)|Adverse Event|1|||
147483388|NCT01469013|531926601|FG011|Part B (Extension Period)|Adverse Event|6|||
147483389|NCT01469013|531926602|FG012|Part B (Extension Period)|Adverse Event|3|||
147483390|NCT01469013|531926590|FG000|Part B (Extension Period)|Withdrawal by Subject|0|||
147483391|NCT01469013|531926591|FG001|Part B (Extension Period)|Withdrawal by Subject|0|||
147483392|NCT01469013|531926592|FG002|Part B (Extension Period)|Withdrawal by Subject|0|||
147483393|NCT01469013|531926593|FG003|Part B (Extension Period)|Withdrawal by Subject|0|||
147483394|NCT01469013|531926594|FG004|Part B (Extension Period)|Withdrawal by Subject|0|||
147483395|NCT01469013|531926595|FG005|Part B (Extension Period)|Withdrawal by Subject|0|||
147483396|NCT01469013|531926596|FG006|Part B (Extension Period)|Withdrawal by Subject|0|||
147483397|NCT01469013|531926597|FG007|Part B (Extension Period)|Withdrawal by Subject|0|||
147483398|NCT01469013|531926598|FG008|Part B (Extension Period)|Withdrawal by Subject|1|||
147483399|NCT01469013|531926599|FG009|Part B (Extension Period)|Withdrawal by Subject|0|||
147483400|NCT01469013|531926600|FG010|Part B (Extension Period)|Withdrawal by Subject|1|||
147483401|NCT01469013|531926601|FG011|Part B (Extension Period)|Withdrawal by Subject|0|||
147483402|NCT01469013|531926602|FG012|Part B (Extension Period)|Withdrawal by Subject|3|||
147483403|NCT01734993|531926605|FG000|Overall Study|Adverse Event|1|||
147483404|NCT01734993|531926605|FG000|Overall Study|Lack of Efficacy|1|||
147483405|NCT03303339|531926606|FG000|Overall Study|Death|2|||
147483406|NCT03303339|531926607|FG001|Overall Study|Death|2|||
147483407|NCT03303339|531926608|FG002|Overall Study|Death|2|||
147483408|NCT03303339|531926609|FG003|Overall Study|Death|1|||
147483409|NCT03303339|531926610|FG004|Overall Study|Death|4|||
147483410|NCT03303339|531926611|FG005|Overall Study|Death|2|||
147483411|NCT03303339|531926612|FG006|Overall Study|Death|2|||
147483412|NCT03303339|531926613|FG007|Overall Study|Death|2|||
147483413|NCT03303339|531926614|FG008|Overall Study|Death|3|||
147483414|NCT03303339|531926615|FG009|Overall Study|Death|3|||
147623397|NCT00838903|532440145|FG003|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|4|||
147623398|NCT00838903|532440142|FG000|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|0|||
147483415|NCT03303339|531926616|FG010|Overall Study|Death|4|||
147483416|NCT03303339|531926617|FG011|Overall Study|Death|24|||
147483417|NCT03303339|531926606|FG000|Overall Study|Study Terminated by Sponsor|0|||
147483418|NCT03303339|531926607|FG001|Overall Study|Study Terminated by Sponsor|0|||
147483419|NCT03303339|531926608|FG002|Overall Study|Study Terminated by Sponsor|0|||
147483420|NCT03303339|531926609|FG003|Overall Study|Study Terminated by Sponsor|0|||
147483421|NCT03303339|531926610|FG004|Overall Study|Study Terminated by Sponsor|0|||
147483422|NCT03303339|531926611|FG005|Overall Study|Study Terminated by Sponsor|0|||
147483423|NCT03303339|531926612|FG006|Overall Study|Study Terminated by Sponsor|0|||
147483424|NCT03303339|531926613|FG007|Overall Study|Study Terminated by Sponsor|0|||
147483425|NCT03303339|531926614|FG008|Overall Study|Study Terminated by Sponsor|1|||
147483426|NCT03303339|531926615|FG009|Overall Study|Study Terminated by Sponsor|0|||
147483427|NCT03303339|531926616|FG010|Overall Study|Study Terminated by Sponsor|1|||
147483428|NCT03303339|531926617|FG011|Overall Study|Study Terminated by Sponsor|1|||
147483429|NCT03303339|531926606|FG000|Overall Study|Withdrawal by Subject|1|||
147483430|NCT03303339|531926607|FG001|Overall Study|Withdrawal by Subject|0|||
147483431|NCT03303339|531926608|FG002|Overall Study|Withdrawal by Subject|0|||
147483432|NCT03303339|531926609|FG003|Overall Study|Withdrawal by Subject|0|||
147483433|NCT03303339|531926610|FG004|Overall Study|Withdrawal by Subject|0|||
147483434|NCT03303339|531926611|FG005|Overall Study|Withdrawal by Subject|1|||
147483435|NCT03303339|531926612|FG006|Overall Study|Withdrawal by Subject|1|||
147483436|NCT03303339|531926613|FG007|Overall Study|Withdrawal by Subject|0|||
147483437|NCT03303339|531926614|FG008|Overall Study|Withdrawal by Subject|0|||
147483438|NCT03303339|531926615|FG009|Overall Study|Withdrawal by Subject|0|||
147483439|NCT03303339|531926616|FG010|Overall Study|Withdrawal by Subject|0|||
147483440|NCT03303339|531926617|FG011|Overall Study|Withdrawal by Subject|2|||
147483441|NCT03303339|531926606|FG000|Overall Study|Physician Decision|0|||
147483442|NCT03303339|531926607|FG001|Overall Study|Physician Decision|0|||
147483443|NCT03303339|531926608|FG002|Overall Study|Physician Decision|0|||
147483444|NCT03303339|531926609|FG003|Overall Study|Physician Decision|0|||
147483445|NCT03303339|531926610|FG004|Overall Study|Physician Decision|1|||
147483446|NCT03303339|531926611|FG005|Overall Study|Physician Decision|0|||
147483447|NCT03303339|531926612|FG006|Overall Study|Physician Decision|0|||
147483448|NCT03303339|531926613|FG007|Overall Study|Physician Decision|0|||
147483449|NCT03303339|531926614|FG008|Overall Study|Physician Decision|0|||
147483450|NCT03303339|531926615|FG009|Overall Study|Physician Decision|0|||
147483451|NCT03303339|531926616|FG010|Overall Study|Physician Decision|0|||
147483452|NCT03303339|531926617|FG011|Overall Study|Physician Decision|0|||
147483453|NCT03303339|531926606|FG000|Overall Study|Safety/Non-compliance|0|||
147483454|NCT03303339|531926607|FG001|Overall Study|Safety/Non-compliance|0|||
147483455|NCT03303339|531926608|FG002|Overall Study|Safety/Non-compliance|0|||
147483456|NCT03303339|531926609|FG003|Overall Study|Safety/Non-compliance|0|||
147483457|NCT03303339|531926610|FG004|Overall Study|Safety/Non-compliance|0|||
147483458|NCT03303339|531926611|FG005|Overall Study|Safety/Non-compliance|0|||
147483459|NCT03303339|531926612|FG006|Overall Study|Safety/Non-compliance|0|||
147483460|NCT03303339|531926613|FG007|Overall Study|Safety/Non-compliance|0|||
147483461|NCT03303339|531926614|FG008|Overall Study|Safety/Non-compliance|0|||
147483462|NCT03303339|531926615|FG009|Overall Study|Safety/Non-compliance|0|||
147483463|NCT03303339|531926616|FG010|Overall Study|Safety/Non-compliance|0|||
147483464|NCT03303339|531926617|FG011|Overall Study|Safety/Non-compliance|1|||
147483465|NCT01879618|531926620|FG000|Overall Study|Does not meet entrance criteria|1|||
147483466|NCT01879618|531926620|FG000|Overall Study|Withdrawal by Subject|1|||
147483467|NCT01879618|531926620|FG000|Overall Study|Surgery;changed schedule; not available|8|||
147483468|NCT01879618|531926620|FG000|Overall Study|Protocol Violation|6|||
147483469|NCT01879618|531926620|FG000|Overall Study|Adverse Event|5|||
147483470|NCT01797432|531926621|FG000|Overall Study|Lost to Follow-up|1|||
147483471|NCT01797432|531926621|FG000|Overall Study|Adverse Event|1|||
147483472|NCT01797432|531926621|FG000|Overall Study|Withdrawal by Subject|1|||
147483473|NCT01797432|531926621|FG000|Overall Study|lived too far from study site|1|||
147483474|NCT00487279|531926625|FG000|Overall Study|Death|1|||
147483475|NCT00487279|531926626|FG001|Overall Study|Death|0|||
147483476|NCT00487279|531926625|FG000|Overall Study|Withdrawal by Subject|0|||
147483477|NCT00487279|531926626|FG001|Overall Study|Withdrawal by Subject|2|||
147483478|NCT00501852|531926627|FG000|Overall Study|Adverse Event|3|||
147483479|NCT00501852|531926627|FG000|Overall Study|Withdrawal by Subject|2|||
147483480|NCT01171521|531926630|FG000|Overall Study|Lost to Follow-up|5|||
147483481|NCT01171521|531926630|FG000|Overall Study|screen failure|1|||
147483482|NCT01927562|531926631|FG000|Overall Study|Lost to Follow-up|30|||
147483483|NCT01927562|531926631|FG000|Overall Study|Withdrawal by Subject|3|||
147483484|NCT01927562|531926631|FG000|Overall Study|Physician Decision|5|||
147483485|NCT00492921|531926632|FG000|Overall Study|Death|1|||
147483486|NCT00492921|531926633|FG001|Overall Study|Death|0|||
147483487|NCT00492921|531926634|FG002|Overall Study|Death|1|||
147483488|NCT00652093|531926635|FG000|Overall Study|Withdrawal by Subject|0|||
147483489|NCT00652093|531926636|FG001|Overall Study|Withdrawal by Subject|0|||
147483490|NCT00652093|531926637|FG002|Overall Study|Withdrawal by Subject|1|||
147483491|NCT00652093|531926638|FG003|Overall Study|Withdrawal by Subject|0|||
147483492|NCT00652093|531926639|FG004|Overall Study|Withdrawal by Subject|1|||
147483493|NCT00652093|531926640|FG005|Overall Study|Withdrawal by Subject|0|||
147483494|NCT00652093|531926635|FG000|Overall Study|Physician Decision|0|||
147483495|NCT00652093|531926636|FG001|Overall Study|Physician Decision|0|||
147483496|NCT00652093|531926637|FG002|Overall Study|Physician Decision|0|||
147483497|NCT00652093|531926638|FG003|Overall Study|Physician Decision|0|||
147483498|NCT00652093|531926639|FG004|Overall Study|Physician Decision|1|||
147483499|NCT00652093|531926640|FG005|Overall Study|Physician Decision|0|||
147483500|NCT01422304|531926643|FG000|Overall Study|Adverse Event|0|||
147483501|NCT01422304|531926644|FG001|Overall Study|Adverse Event|1|||
147483502|NCT01422304|531926643|FG000|Overall Study|Lost to Follow-up|14|||
147623399|NCT00838903|532440143|FG001|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|1|||
147623400|NCT00838903|532440144|FG002|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|0|||
147623401|NCT00838903|532440145|FG003|Treatment Period (156 Weeks)|Patient and PI Decision to Discontinue|0|||
147623402|NCT00838903|532440142|FG000|Treatment Period (156 Weeks)|Poor Glycemic Control|0|||
147623403|NCT00838903|532440143|FG001|Treatment Period (156 Weeks)|Poor Glycemic Control|0|||
147623404|NCT00838903|532440144|FG002|Treatment Period (156 Weeks)|Poor Glycemic Control|0|||
147623405|NCT00838903|532440145|FG003|Treatment Period (156 Weeks)|Poor Glycemic Control|1|||
147623406|NCT00838903|532440142|FG000|Treatment Period (156 Weeks)|Poor Therapeutic Response|1|||
147416351|NCT02626455|531688385|FG000|Overall Study|Other|1|||
147416352|NCT02626455|531688386|FG001|Overall Study|Other|1|||
147416353|NCT02626455|531688387|FG002|Overall Study|Other|0|||
147416354|NCT02626455|531688388|FG003|Overall Study|Other|0|||
147416355|NCT02626455|531688389|FG004|Overall Study|Other|0|||
147416356|NCT02626455|531688390|FG005|Overall Study|Other|17|||
147416357|NCT02626455|531688391|FG006|Overall Study|Other|23|||
147416358|NCT02626455|531688385|FG000|Overall Study|Withdrawal by Subject|1|||
147416359|NCT02626455|531688386|FG001|Overall Study|Withdrawal by Subject|0|||
147416360|NCT02626455|531688387|FG002|Overall Study|Withdrawal by Subject|0|||
147416361|NCT02626455|531688388|FG003|Overall Study|Withdrawal by Subject|0|||
147416362|NCT02626455|531688389|FG004|Overall Study|Withdrawal by Subject|0|||
147416363|NCT02626455|531688390|FG005|Overall Study|Withdrawal by Subject|10|||
147416364|NCT02626455|531688391|FG006|Overall Study|Withdrawal by Subject|6|||
147416365|NCT02626455|531688385|FG000|Overall Study|Physician Decision|0|||
147416366|NCT02626455|531688386|FG001|Overall Study|Physician Decision|2|||
147416367|NCT02626455|531688387|FG002|Overall Study|Physician Decision|2|||
147416368|NCT02626455|531688388|FG003|Overall Study|Physician Decision|2|||
147416369|NCT02626455|531688389|FG004|Overall Study|Physician Decision|1|||
147416370|NCT02626455|531688390|FG005|Overall Study|Physician Decision|10|||
147416371|NCT02626455|531688391|FG006|Overall Study|Physician Decision|3|||
147416372|NCT02626455|531688385|FG000|Overall Study|Patient decision: COVID-19 pandemic related|0|||
147416373|NCT02626455|531688386|FG001|Overall Study|Patient decision: COVID-19 pandemic related|0|||
147416374|NCT02626455|531688387|FG002|Overall Study|Patient decision: COVID-19 pandemic related|0|||
147416375|NCT02626455|531688388|FG003|Overall Study|Patient decision: COVID-19 pandemic related|0|||
147416376|NCT02626455|531688389|FG004|Overall Study|Patient decision: COVID-19 pandemic related|0|||
147416377|NCT02626455|531688390|FG005|Overall Study|Patient decision: COVID-19 pandemic related|0|||
147416378|NCT02626455|531688391|FG006|Overall Study|Patient decision: COVID-19 pandemic related|1|||
147416379|NCT02626455|531688385|FG000|Overall Study|Physician decision: COVID-19 pandemic related|0|||
147416380|NCT02626455|531688386|FG001|Overall Study|Physician decision: COVID-19 pandemic related|0|||
147416381|NCT02626455|531688387|FG002|Overall Study|Physician decision: COVID-19 pandemic related|0|||
147416382|NCT02626455|531688388|FG003|Overall Study|Physician decision: COVID-19 pandemic related|0|||
147416383|NCT02626455|531688389|FG004|Overall Study|Physician decision: COVID-19 pandemic related|0|||
147416384|NCT02626455|531688390|FG005|Overall Study|Physician decision: COVID-19 pandemic related|0|||
147416385|NCT02626455|531688391|FG006|Overall Study|Physician decision: COVID-19 pandemic related|2|||
147416386|NCT02626455|531688385|FG000|Overall Study|Logistical reason: COVID-19 pandemic related|0|||
147416387|NCT02626455|531688386|FG001|Overall Study|Logistical reason: COVID-19 pandemic related|0|||
147416388|NCT02626455|531688387|FG002|Overall Study|Logistical reason: COVID-19 pandemic related|0|||
147416389|NCT02626455|531688388|FG003|Overall Study|Logistical reason: COVID-19 pandemic related|0|||
147416390|NCT02626455|531688389|FG004|Overall Study|Logistical reason: COVID-19 pandemic related|0|||
147416391|NCT02626455|531688390|FG005|Overall Study|Logistical reason: COVID-19 pandemic related|1|||
147416392|NCT02626455|531688391|FG006|Overall Study|Logistical reason: COVID-19 pandemic related|1|||
147416393|NCT02626455|531688385|FG000|Overall Study|Patient decision|0|||
147416394|NCT02626455|531688386|FG001|Overall Study|Patient decision|1|||
147416395|NCT02626455|531688387|FG002|Overall Study|Patient decision|0|||
147416396|NCT02626455|531688388|FG003|Overall Study|Patient decision|0|||
147416397|NCT02626455|531688389|FG004|Overall Study|Patient decision|1|||
147416398|NCT02626455|531688390|FG005|Overall Study|Patient decision|36|||
147416399|NCT02626455|531688391|FG006|Overall Study|Patient decision|22|||
147416400|NCT02626455|531688385|FG000|Overall Study|Protocol Violation|0|||
147416401|NCT02626455|531688386|FG001|Overall Study|Protocol Violation|0|||
147416402|NCT02626455|531688387|FG002|Overall Study|Protocol Violation|0|||
147416403|NCT02626455|531688388|FG003|Overall Study|Protocol Violation|0|||
147416404|NCT02626455|531688389|FG004|Overall Study|Protocol Violation|0|||
147416405|NCT02626455|531688390|FG005|Overall Study|Protocol Violation|0|||
147416406|NCT02626455|531688391|FG006|Overall Study|Protocol Violation|1|||
147416407|NCT02626455|531688385|FG000|Overall Study|Progressive disease - radiological progression|0|||
147416408|NCT02626455|531688386|FG001|Overall Study|Progressive disease - radiological progression|0|||
147416409|NCT02626455|531688387|FG002|Overall Study|Progressive disease - radiological progression|0|||
147416410|NCT02626455|531688388|FG003|Overall Study|Progressive disease - radiological progression|0|||
147667721|NCT00369343|532608131|FG001|Open-label Phase|Physician Decision|0|||
147667722|NCT00369343|532608130|FG000|Open-label Phase|Lost to Follow-up|5|||
147667723|NCT00369343|532608131|FG001|Open-label Phase|Lost to Follow-up|3|||
147667724|NCT00369343|532608130|FG000|Open-label Phase|inadvertently reported study completers|3|||
147416411|NCT02626455|531688389|FG004|Overall Study|Progressive disease - radiological progression|0|||
147416412|NCT02626455|531688390|FG005|Overall Study|Progressive disease - radiological progression|11|||
147416413|NCT02626455|531688391|FG006|Overall Study|Progressive disease - radiological progression|22|||
147416414|NCT02626455|531688385|FG000|Overall Study|Progressive disease - clinical progression|0|||
147667725|NCT00369343|532608131|FG001|Open-label Phase|inadvertently reported study completers|2|||
147667726|NCT00369343|532608130|FG000|Open-label Phase|Protocol Violation|1|||
147667727|NCT00369343|532608131|FG001|Open-label Phase|Protocol Violation|3|||
147667728|NCT00369343|532608130|FG000|Open-label Phase|Withdrawal by Subject|15|||
147667729|NCT00369343|532608131|FG001|Open-label Phase|Withdrawal by Subject|6|||
147667730|NCT00369343|532608130|FG000|Open-label Phase|Lack of Efficacy|4|||
147667731|NCT00369343|532608131|FG001|Open-label Phase|Lack of Efficacy|3|||
147667732|NCT00369343|532608130|FG000|Open-label Phase|Lack of continuance tolerability|3|||
147667733|NCT00369343|532608131|FG001|Open-label Phase|Lack of continuance tolerability|4|||
147667734|NCT00369343|532608130|FG000|Open-label Phase|did not take study drug|1|||
147416415|NCT02626455|531688386|FG001|Overall Study|Progressive disease - clinical progression|0|||
147416416|NCT02626455|531688387|FG002|Overall Study|Progressive disease - clinical progression|0|||
147416417|NCT02626455|531688388|FG003|Overall Study|Progressive disease - clinical progression|0|||
147416418|NCT02626455|531688389|FG004|Overall Study|Progressive disease - clinical progression|0|||
147416419|NCT02626455|531688390|FG005|Overall Study|Progressive disease - clinical progression|1|||
147416420|NCT02626455|531688391|FG006|Overall Study|Progressive disease - clinical progression|2|||
147416421|NCT02626455|531688385|FG000|Overall Study|Lost to Follow-up|0|||
147416422|NCT02626455|531688386|FG001|Overall Study|Lost to Follow-up|0|||
147416423|NCT02626455|531688387|FG002|Overall Study|Lost to Follow-up|0|||
147416424|NCT02626455|531688388|FG003|Overall Study|Lost to Follow-up|0|||
147416425|NCT02626455|531688389|FG004|Overall Study|Lost to Follow-up|0|||
147416426|NCT02626455|531688390|FG005|Overall Study|Lost to Follow-up|1|||
147416427|NCT02626455|531688391|FG006|Overall Study|Lost to Follow-up|0|||
147416428|NCT02626455|531688385|FG000|Overall Study|AE not associated with clinical disease progression|1|||
147416429|NCT02626455|531688386|FG001|Overall Study|AE not associated with clinical disease progression|1|||
147416430|NCT02626455|531688387|FG002|Overall Study|AE not associated with clinical disease progression|0|||
147416431|NCT02626455|531688388|FG003|Overall Study|AE not associated with clinical disease progression|2|||
147416432|NCT02626455|531688389|FG004|Overall Study|AE not associated with clinical disease progression|1|||
147416433|NCT02626455|531688390|FG005|Overall Study|AE not associated with clinical disease progression|65|||
147416434|NCT02626455|531688391|FG006|Overall Study|AE not associated with clinical disease progression|21|||
147416435|NCT02626455|531688385|FG000|Overall Study|AE associated with clinical disease progression|0|||
147416436|NCT02626455|531688386|FG001|Overall Study|AE associated with clinical disease progression|0|||
147416437|NCT02626455|531688387|FG002|Overall Study|AE associated with clinical disease progression|0|||
147416438|NCT02626455|531688388|FG003|Overall Study|AE associated with clinical disease progression|0|||
147416439|NCT02626455|531688389|FG004|Overall Study|AE associated with clinical disease progression|0|||
147416440|NCT02626455|531688390|FG005|Overall Study|AE associated with clinical disease progression|1|||
147416441|NCT02626455|531688391|FG006|Overall Study|AE associated with clinical disease progression|2|||
147416442|NCT02626455|531688385|FG000|Overall Study|Study intervention never administered|0|||
147416443|NCT02626455|531688386|FG001|Overall Study|Study intervention never administered|0|||
147416444|NCT02626455|531688387|FG002|Overall Study|Study intervention never administered|0|||
147416445|NCT02626455|531688388|FG003|Overall Study|Study intervention never administered|0|||
147416446|NCT02626455|531688389|FG004|Overall Study|Study intervention never administered|0|||
147416447|NCT02626455|531688390|FG005|Overall Study|Study intervention never administered|1|||
147416448|NCT02626455|531688391|FG006|Overall Study|Study intervention never administered|3|||
147416449|NCT06665919|531688392|FG000|Overall Study|Withdrawal by Subject|4|||
147416450|NCT06665919|531688393|FG001|Overall Study|Withdrawal by Subject|4|||
147416451|NCT06665919|531688394|FG002|Overall Study|Withdrawal by Subject|4|||
147416452|NCT06665919|531688392|FG000|Overall Study|Non-compliance to Treatment|4|||
147416453|NCT06665919|531688393|FG001|Overall Study|Non-compliance to Treatment|1|||
147416454|NCT06665919|531688394|FG002|Overall Study|Non-compliance to Treatment|6|||
147416455|NCT06665919|531688392|FG000|Overall Study|Lost to Follow-up|3|||
147416456|NCT06665919|531688393|FG001|Overall Study|Lost to Follow-up|0|||
147667735|NCT00369343|532608131|FG001|Open-label Phase|did not take study drug|2|||
147667736|NCT00794664|532608132|FG000|Treatment Period|Withdrawal by Subject|0|||
147416457|NCT06665919|531688394|FG002|Overall Study|Lost to Follow-up|2|||
147416458|NCT06665919|531688392|FG000|Overall Study|Physician Decision|4|||
147667737|NCT00794664|532608133|FG001|Treatment Period|Withdrawal by Subject|2|||
147667738|NCT00794664|532608132|FG000|Treatment Period|Protocol non-compliance|0|||
147416459|NCT06665919|531688393|FG001|Overall Study|Physician Decision|0|||
147416460|NCT06665919|531688394|FG002|Overall Study|Physician Decision|1|||
147416461|NCT01200290|531688395|FG000|Treatment Period|Adverse Event|1|||
147483503|NCT01422304|531926644|FG001|Overall Study|Lost to Follow-up|20|||
147416462|NCT01200290|531688395|FG000|Post-Treatment Follow-Up Period|Death|2|||
147416463|NCT01144377|531688396|FG000|52 Week Treatment Period|Adverse Event|0|||
147416464|NCT01144377|531688397|FG001|52 Week Treatment Period|Adverse Event|0|||
147416465|NCT01144377|531688398|FG002|52 Week Treatment Period|Adverse Event|3|||
147416466|NCT01144377|531688399|FG003|52 Week Treatment Period|Adverse Event|2|||
147416467|NCT01144377|531688400|FG004|52 Week Treatment Period|Adverse Event|1|||
147416468|NCT01144377|531688396|FG000|52 Week Treatment Period|Entry Criteria Not Met|0|||
147416469|NCT01144377|531688397|FG001|52 Week Treatment Period|Entry Criteria Not Met|0|||
147416470|NCT01144377|531688398|FG002|52 Week Treatment Period|Entry Criteria Not Met|1|||
147416471|NCT01144377|531688399|FG003|52 Week Treatment Period|Entry Criteria Not Met|1|||
147416472|NCT01144377|531688400|FG004|52 Week Treatment Period|Entry Criteria Not Met|0|||
147416473|NCT01144377|531688396|FG000|52 Week Treatment Period|Protocol Violation|0|||
147416474|NCT01144377|531688397|FG001|52 Week Treatment Period|Protocol Violation|0|||
147416475|NCT01144377|531688398|FG002|52 Week Treatment Period|Protocol Violation|0|||
147416476|NCT01144377|531688399|FG003|52 Week Treatment Period|Protocol Violation|0|||
147416477|NCT01144377|531688400|FG004|52 Week Treatment Period|Protocol Violation|1|||
147416478|NCT01144377|531688396|FG000|52 Week Treatment Period|Lost to Follow-up|1|||
147416479|NCT01144377|531688397|FG001|52 Week Treatment Period|Lost to Follow-up|0|||
147416480|NCT01144377|531688398|FG002|52 Week Treatment Period|Lost to Follow-up|0|||
147416481|NCT01144377|531688399|FG003|52 Week Treatment Period|Lost to Follow-up|0|||
147416482|NCT01144377|531688400|FG004|52 Week Treatment Period|Lost to Follow-up|0|||
147416483|NCT01144377|531688396|FG000|52 Week Treatment Period|Withdrawal by Subject|4|||
147416484|NCT01144377|531688397|FG001|52 Week Treatment Period|Withdrawal by Subject|1|||
147483504|NCT01422304|531926643|FG000|Overall Study|Never Entered Follow-up|2|||
147483505|NCT01422304|531926644|FG001|Overall Study|Never Entered Follow-up|1|||
147483506|NCT01422304|531926643|FG000|Overall Study|Protocol Violation|1|||
147483507|NCT01422304|531926644|FG001|Overall Study|Protocol Violation|0|||
147416485|NCT01144377|531688398|FG002|52 Week Treatment Period|Withdrawal by Subject|1|||
147416486|NCT01144377|531688399|FG003|52 Week Treatment Period|Withdrawal by Subject|1|||
147416487|NCT01144377|531688400|FG004|52 Week Treatment Period|Withdrawal by Subject|0|||
147416488|NCT01144377|531688396|FG000|52 Week Treatment Period|Sponsor Decision|0|||
147416489|NCT01144377|531688397|FG001|52 Week Treatment Period|Sponsor Decision|0|||
147416490|NCT01144377|531688398|FG002|52 Week Treatment Period|Sponsor Decision|0|||
147416491|NCT01144377|531688399|FG003|52 Week Treatment Period|Sponsor Decision|0|||
147416492|NCT01144377|531688400|FG004|52 Week Treatment Period|Sponsor Decision|1|||
147416493|NCT01144377|531688396|FG000|Optional 40 Week Safety Follow-up Period|Adverse Event|0|||
147416494|NCT01144377|531688397|FG001|Optional 40 Week Safety Follow-up Period|Adverse Event|1|||
147416495|NCT01144377|531688398|FG002|Optional 40 Week Safety Follow-up Period|Adverse Event|0|||
147416496|NCT01144377|531688399|FG003|Optional 40 Week Safety Follow-up Period|Adverse Event|0|||
147416497|NCT01144377|531688400|FG004|Optional 40 Week Safety Follow-up Period|Adverse Event|1|||
147416498|NCT01144377|531688396|FG000|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0|||
147416499|NCT01144377|531688397|FG001|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0|||
147416500|NCT01144377|531688398|FG002|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0|||
147483508|NCT01422304|531926643|FG000|Overall Study|Withdrawal by Subject|4|||
147483509|NCT01422304|531926644|FG001|Overall Study|Withdrawal by Subject|2|||
147483510|NCT01422304|531926643|FG000|Overall Study|Did Not Meet Protocol Eligibility|0|||
147416501|NCT01144377|531688399|FG003|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|0|||
147416502|NCT01144377|531688400|FG004|Optional 40 Week Safety Follow-up Period|Lost to Follow-up|1|||
147416503|NCT01144377|531688396|FG000|Optional 40 Week Safety Follow-up Period|Sponsor Decision|1|||
147416504|NCT01144377|531688397|FG001|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0|||
147416505|NCT01144377|531688398|FG002|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0|||
147416506|NCT01144377|531688399|FG003|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0|||
147416507|NCT01144377|531688400|FG004|Optional 40 Week Safety Follow-up Period|Sponsor Decision|0|||
147416508|NCT00607724|531688401|FG000|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|7|||
147416509|NCT00607724|531688402|FG001|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|8|||
147416510|NCT00607724|531688403|FG002|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|4|||
147416511|NCT00607724|531688404|FG003|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|0|||
147416512|NCT00607724|531688405|FG004|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|0|||
147416513|NCT00607724|531688406|FG005|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|0|||
147416514|NCT00607724|531688407|FG006|Stage 1: Dose Escalation|Tumour Progression-Clinical/Radiographic|0|||
147416515|NCT00607724|531688401|FG000|Stage 2: Expanded Cohort|Adverse Event|0|||
147416516|NCT00607724|531688402|FG001|Stage 2: Expanded Cohort|Adverse Event|0|||
147416517|NCT00607724|531688403|FG002|Stage 2: Expanded Cohort|Adverse Event|0|||
147416518|NCT00607724|531688404|FG003|Stage 2: Expanded Cohort|Adverse Event|0|||
147416519|NCT00607724|531688405|FG004|Stage 2: Expanded Cohort|Adverse Event|0|||
147416520|NCT00607724|531688406|FG005|Stage 2: Expanded Cohort|Adverse Event|0|||
147416521|NCT00607724|531688407|FG006|Stage 2: Expanded Cohort|Adverse Event|1|||
147416522|NCT00607724|531688401|FG000|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|0|||
147416523|NCT00607724|531688402|FG001|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|0|||
147416524|NCT00607724|531688403|FG002|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|0|||
147416525|NCT00607724|531688404|FG003|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|4|||
147416526|NCT00607724|531688405|FG004|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|8|||
147416527|NCT00607724|531688406|FG005|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|11|||
147416528|NCT00607724|531688407|FG006|Stage 2: Expanded Cohort|Tumour Progression-Clinical/Radiographic|10|||
147416529|NCT00607724|531688401|FG000|Stage 2: Expanded Cohort|Physician Decision|0|||
147416530|NCT00607724|531688402|FG001|Stage 2: Expanded Cohort|Physician Decision|0|||
147416531|NCT00607724|531688403|FG002|Stage 2: Expanded Cohort|Physician Decision|0|||
147416532|NCT00607724|531688404|FG003|Stage 2: Expanded Cohort|Physician Decision|0|||
147416533|NCT00607724|531688405|FG004|Stage 2: Expanded Cohort|Physician Decision|1|||
147416534|NCT00607724|531688406|FG005|Stage 2: Expanded Cohort|Physician Decision|1|||
147416535|NCT00607724|531688407|FG006|Stage 2: Expanded Cohort|Physician Decision|0|||
147416536|NCT00607724|531688401|FG000|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
147416537|NCT00607724|531688402|FG001|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
147416538|NCT00607724|531688403|FG002|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
147416539|NCT00607724|531688404|FG003|Stage 2: Expanded Cohort|Withdrawal by Subject|1|||
147416540|NCT00607724|531688405|FG004|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
147416541|NCT00607724|531688406|FG005|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
147416542|NCT00607724|531688407|FG006|Stage 2: Expanded Cohort|Withdrawal by Subject|0|||
147416543|NCT00151281|531688408|FG000|Overall Study|Not evaluable|3|||
147416544|NCT01133418|531688411|FG000|Overall Study|Lost to Follow-up|5|||
147416545|NCT01133418|531688412|FG001|Overall Study|Lost to Follow-up|6|||
147416546|NCT04150068|531688413|FG000|Maintenance Period (Week 26 Analysis)|Still on study|24|||
147623407|NCT00838903|532440143|FG001|Treatment Period (156 Weeks)|Poor Therapeutic Response|0|||
147623408|NCT00838903|532440144|FG002|Treatment Period (156 Weeks)|Poor Therapeutic Response|0|||
147623409|NCT00838903|532440145|FG003|Treatment Period (156 Weeks)|Poor Therapeutic Response|0|||
147623410|NCT00838903|532440142|FG000|Treatment Period (156 Weeks)|Pregnancy|0|||
147416547|NCT04150068|531688414|FG001|Maintenance Period (Week 26 Analysis)|Still on study|12|||
147416548|NCT04150068|531688415|FG002|Maintenance Period (Week 26 Analysis)|Still on study|35|||
147416549|NCT04150068|531688413|FG000|Maintenance Period (Week 26 Analysis)|Death|0|||
147416550|NCT04150068|531688414|FG001|Maintenance Period (Week 26 Analysis)|Death|0|||
147416551|NCT04150068|531688415|FG002|Maintenance Period (Week 26 Analysis)|Death|1|||
147416552|NCT05316701|531688416|FG000|Overall Study|Adverse Event|0|||
147416553|NCT05316701|531688417|FG001|Overall Study|Adverse Event|1|||
147416554|NCT05316701|531688416|FG000|Overall Study|Death|3|||
147416555|NCT05316701|531688417|FG001|Overall Study|Death|9|||
147416556|NCT05316701|531688416|FG000|Overall Study|Lost to Follow-up|1|||
147416557|NCT05316701|531688417|FG001|Overall Study|Lost to Follow-up|0|||
147416558|NCT05316701|531688416|FG000|Overall Study|Physician Decision|1|||
147416559|NCT05316701|531688417|FG001|Overall Study|Physician Decision|4|||
147416560|NCT05316701|531688416|FG000|Overall Study|Withdrawal by Subject|3|||
147416561|NCT05316701|531688417|FG001|Overall Study|Withdrawal by Subject|5|||
147416562|NCT05316701|531688416|FG000|Overall Study|Progression/Relapse|14|||
147416563|NCT05316701|531688417|FG001|Overall Study|Progression/Relapse|9|||
147416564|NCT05316701|531688416|FG000|Overall Study|Received Standard of Care|1|||
147483511|NCT01422304|531926644|FG001|Overall Study|Did Not Meet Protocol Eligibility|2|||
147483512|NCT01422304|531926643|FG000|Overall Study|Not Treated|3|||
147483513|NCT01422304|531926644|FG001|Overall Study|Not Treated|11|||
147483514|NCT00469014|531926645|FG000|Initial Phase Randomization|Disease Progression|0|||
147483515|NCT00469014|531926646|FG001|Initial Phase Randomization|Disease Progression|1|||
147416565|NCT05316701|531688417|FG001|Overall Study|Received Standard of Care|0|||
147416566|NCT05316701|531688416|FG000|Overall Study|Ongoing|70|||
147416567|NCT05316701|531688417|FG001|Overall Study|Ongoing|64|||
147416568|NCT04679935|531688418|FG000|Overall Study|Death|0|||
147416569|NCT04679935|531688419|FG001|Overall Study|Death|1|||
147416570|NCT00775463|531689896|FG000|Overall Study|Withdrawal by Subject|0|||
147416571|NCT00775463|531689897|FG001|Overall Study|Withdrawal by Subject|1|||
147416572|NCT00775463|531689896|FG000|Overall Study|Adverse Event|7|||
147416573|NCT00775463|531689897|FG001|Overall Study|Adverse Event|9|||
147416574|NCT00775463|531689896|FG000|Overall Study|Protocol Violation|2|||
147416575|NCT00775463|531689897|FG001|Overall Study|Protocol Violation|2|||
147416576|NCT00775463|531689896|FG000|Overall Study|Lost to Follow-up|1|||
147416577|NCT00775463|531689897|FG001|Overall Study|Lost to Follow-up|0|||
147416578|NCT00775463|531689896|FG000|Overall Study|Lack of Efficacy|1|||
147416579|NCT00775463|531689897|FG001|Overall Study|Lack of Efficacy|1|||
147416580|NCT00969709|531689898|FG000|Overall Study|Adverse Event|3|||
147416581|NCT00969709|531689899|FG001|Overall Study|Adverse Event|13|||
147416582|NCT00969709|531689900|FG002|Overall Study|Adverse Event|26|||
147416583|NCT00969709|531689901|FG003|Overall Study|Adverse Event|12|||
147416584|NCT00969709|531689898|FG000|Overall Study|Lack of Efficacy|7|||
147416585|NCT00969709|531689899|FG001|Overall Study|Lack of Efficacy|4|||
147416586|NCT00969709|531689900|FG002|Overall Study|Lack of Efficacy|1|||
147416587|NCT00969709|531689901|FG003|Overall Study|Lack of Efficacy|3|||
147416588|NCT00969709|531689898|FG000|Overall Study|Protocol Violation|9|||
147416589|NCT00969709|531689899|FG001|Overall Study|Protocol Violation|5|||
147416590|NCT00969709|531689900|FG002|Overall Study|Protocol Violation|9|||
147416591|NCT00969709|531689901|FG003|Overall Study|Protocol Violation|10|||
147416592|NCT00969709|531689898|FG000|Overall Study|Withdrawal by Subject|9|||
147416593|NCT00969709|531689899|FG001|Overall Study|Withdrawal by Subject|12|||
147416594|NCT00969709|531689900|FG002|Overall Study|Withdrawal by Subject|11|||
147416595|NCT00969709|531689901|FG003|Overall Study|Withdrawal by Subject|23|||
147483516|NCT00469014|531926647|FG002|Initial Phase Randomization|Disease Progression|1|||
147483517|NCT00469014|531926648|FG003|Initial Phase Randomization|Disease Progression|0|||
147483518|NCT00469014|531926645|FG000|Initial Phase Randomization|No Response|1|||
147483519|NCT00469014|531926646|FG001|Initial Phase Randomization|No Response|0|||
147483520|NCT00469014|531926647|FG002|Initial Phase Randomization|No Response|0|||
147483521|NCT00469014|531926648|FG003|Initial Phase Randomization|No Response|1|||
147623411|NCT00838903|532440143|FG001|Treatment Period (156 Weeks)|Pregnancy|0|||
147623412|NCT00838903|532440144|FG002|Treatment Period (156 Weeks)|Pregnancy|1|||
147416596|NCT00969709|531689898|FG000|Overall Study|Lost to Follow-up|10|||
147416597|NCT00969709|531689899|FG001|Overall Study|Lost to Follow-up|14|||
147416598|NCT00969709|531689900|FG002|Overall Study|Lost to Follow-up|8|||
147416599|NCT00969709|531689901|FG003|Overall Study|Lost to Follow-up|15|||
147416600|NCT00969709|531689898|FG000|Overall Study|Other reasons|0|||
147416601|NCT00969709|531689899|FG001|Overall Study|Other reasons|0|||
147416602|NCT00969709|531689900|FG002|Overall Study|Other reasons|3|||
147416603|NCT00969709|531689901|FG003|Overall Study|Other reasons|0|||
147416604|NCT02980731|531689902|FG000|Overall Study|Death|63|||
147416605|NCT02980731|531689902|FG000|Overall Study|Withdrawal by Subject|6|||
147416606|NCT02980731|531689902|FG000|Overall Study|Lost to Follow-up|5|||
147416607|NCT02980731|531689902|FG000|Overall Study|Study terminated by Sponsor|4|||
147416608|NCT02980731|531689902|FG000|Overall Study|Completed survival follow-up period|65|||
147416609|NCT02980731|531689902|FG000|Overall Study|COVID-19 infection|1|||
147416610|NCT02980731|531689902|FG000|Overall Study|Other, not specified|66|||
147416611|NCT02075476|531689903|FG000|Overall Study|Death|2|||
147416612|NCT02075476|531689904|FG001|Overall Study|Death|2|||
147416613|NCT02075476|531689903|FG000|Overall Study|Lost to Follow-up|1|||
147416614|NCT02075476|531689904|FG001|Overall Study|Lost to Follow-up|3|||
147416615|NCT00091169|531689905|FG000|Overall Study|Disease progression|3|||
147416616|NCT00091169|531689906|FG001|Overall Study|Disease progression|1|||
147416617|NCT00091169|531689905|FG000|Overall Study|Adverse Event|11|||
147416618|NCT00091169|531689906|FG001|Overall Study|Adverse Event|17|||
147416619|NCT00091169|531689905|FG000|Overall Study|Death|4|||
147416620|NCT00091169|531689906|FG001|Overall Study|Death|1|||
147416621|NCT00091169|531689905|FG000|Overall Study|Withdrawal by Subject|10|||
147416622|NCT00091169|531689906|FG001|Overall Study|Withdrawal by Subject|13|||
147416623|NCT00091169|531689905|FG000|Overall Study|Other|3|||
147416624|NCT00091169|531689906|FG001|Overall Study|Other|4|||
147416625|NCT00091169|531689905|FG000|Overall Study|Not start protocol therapy|26|||
147416626|NCT00091169|531689906|FG001|Overall Study|Not start protocol therapy|17|||
147416627|NCT00836745|531689918|FG000|Overall Study|Death|2|||
147416628|NCT00836745|531689918|FG000|Overall Study|Lost to Follow-up|10|||
147623413|NCT00838903|532440145|FG003|Treatment Period (156 Weeks)|Pregnancy|0|||
147623414|NCT00838903|532440142|FG000|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|0|||
147623415|NCT00838903|532440143|FG001|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|0|||
147623416|NCT00838903|532440144|FG002|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|1|||
147623417|NCT00838903|532440145|FG003|Treatment Period (156 Weeks)|PI Decided for Safety Purpose|0|||
147623418|NCT00838903|532440142|FG000|Treatment Period (156 Weeks)|Site closed|0|||
147623419|NCT00838903|532440143|FG001|Treatment Period (156 Weeks)|Site closed|0|||
147623420|NCT00838903|532440144|FG002|Treatment Period (156 Weeks)|Site closed|1|||
147623421|NCT00838903|532440145|FG003|Treatment Period (156 Weeks)|Site closed|0|||
147623422|NCT00838903|532440142|FG000|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|1|||
147623423|NCT00838903|532440143|FG001|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|0|||
147623424|NCT00838903|532440144|FG002|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|0|||
147416629|NCT00836745|531689918|FG000|Overall Study|Adverse Event|3|||
147416630|NCT00836745|531689918|FG000|Overall Study|Objective progression or relapse|4|||
147416631|NCT00836745|531689918|FG000|Overall Study|Other|2|||
147416632|NCT02366468|531689919|FG000|Overall Study|Adverse Event|2|||
147416633|NCT02366468|531689920|FG001|Overall Study|Adverse Event|0|||
147416634|NCT02366468|531689919|FG000|Overall Study|Withdrawal by Subject|1|||
147416635|NCT02366468|531689920|FG001|Overall Study|Withdrawal by Subject|5|||
147416636|NCT02366468|531689919|FG000|Overall Study|Lost to Follow-up|2|||
147416637|NCT02366468|531689920|FG001|Overall Study|Lost to Follow-up|0|||
147416638|NCT02366468|531689919|FG000|Overall Study|Death|1|||
147416639|NCT02366468|531689920|FG001|Overall Study|Death|2|||
147416640|NCT02366468|531689919|FG000|Overall Study|Other|0|||
147416641|NCT02366468|531689920|FG001|Overall Study|Other|2|||
147623425|NCT00838903|532440145|FG003|Treatment Period (156 Weeks)|Site Closed and Subject Withdrew Consent|0|||
147416642|NCT05540717|531689921|FG000|Overall Study|Lost to Follow-up|2|||
147416643|NCT05540717|531689922|FG001|Overall Study|Lost to Follow-up|5|||
147416644|NCT05540717|531689921|FG000|Overall Study|Withdrawal by Subject|6|||
147483522|NCT00469014|531926645|FG000|Adaptive Randomization|Not Evaluable|1|||
147416645|NCT05540717|531689922|FG001|Overall Study|Withdrawal by Subject|6|||
147416646|NCT05540717|531689921|FG000|Overall Study|Sponsor request|1|||
147416647|NCT05540717|531689922|FG001|Overall Study|Sponsor request|0|||
147483523|NCT00469014|531926646|FG001|Adaptive Randomization|Not Evaluable|0|||
147483524|NCT00469014|531926647|FG002|Adaptive Randomization|Not Evaluable|0|||
147483525|NCT00469014|531926648|FG003|Adaptive Randomization|Not Evaluable|1|||
147483526|NCT00469014|531926645|FG000|Adaptive Randomization|No Response|0|||
147483527|NCT00469014|531926646|FG001|Adaptive Randomization|No Response|1|||
147483528|NCT00469014|531926647|FG002|Adaptive Randomization|No Response|0|||
147483529|NCT00469014|531926648|FG003|Adaptive Randomization|No Response|0|||
147483530|NCT00469014|531926645|FG000|Adaptive Randomization|Death|0|||
147483531|NCT00469014|531926646|FG001|Adaptive Randomization|Death|0|||
147483532|NCT00469014|531926647|FG002|Adaptive Randomization|Death|1|||
147483533|NCT00469014|531926648|FG003|Adaptive Randomization|Death|0|||
147483534|NCT00864227|531926651|FG000|Overall Study|Withdrawal by Subject|1|||
147483535|NCT00864227|531926651|FG000|Overall Study|Disease Relapse/Progression|3|||
147483536|NCT00866294|531926655|FG000|Overall Study|Adverse Event|12|||
147483537|NCT00866294|531926656|FG001|Overall Study|Adverse Event|13|||
147483538|NCT00866294|531926657|FG002|Overall Study|Adverse Event|9|||
147483539|NCT00866294|531926655|FG000|Overall Study|Lack of Efficacy|7|||
147483540|NCT00866294|531926656|FG001|Overall Study|Lack of Efficacy|1|||
147483541|NCT00866294|531926657|FG002|Overall Study|Lack of Efficacy|0|||
147483542|NCT00866294|531926655|FG000|Overall Study|Protocol Violation|2|||
147483543|NCT00866294|531926656|FG001|Overall Study|Protocol Violation|0|||
147483544|NCT00866294|531926657|FG002|Overall Study|Protocol Violation|0|||
147483545|NCT00866294|531926655|FG000|Overall Study|Met Protocol-defined Stopping Criteria|5|||
147483546|NCT00866294|531926656|FG001|Overall Study|Met Protocol-defined Stopping Criteria|1|||
147483547|NCT00866294|531926657|FG002|Overall Study|Met Protocol-defined Stopping Criteria|1|||
147483548|NCT00866294|531926655|FG000|Overall Study|Lost to Follow-up|1|||
147483549|NCT00866294|531926656|FG001|Overall Study|Lost to Follow-up|3|||
147483550|NCT00866294|531926657|FG002|Overall Study|Lost to Follow-up|0|||
147483551|NCT00866294|531926655|FG000|Overall Study|Physician Decision|6|||
147483552|NCT00866294|531926656|FG001|Overall Study|Physician Decision|2|||
147483553|NCT00866294|531926657|FG002|Overall Study|Physician Decision|1|||
147483554|NCT03241173|531926658|FG000|Overall Study|Death|3|||
147483555|NCT03241173|531926659|FG001|Overall Study|Death|2|||
147483556|NCT03241173|531926660|FG002|Overall Study|Death|4|||
147483557|NCT03241173|531926661|FG003|Overall Study|Death|4|||
147483558|NCT03241173|531926662|FG004|Overall Study|Death|2|||
147483559|NCT03241173|531926663|FG005|Overall Study|Death|2|||
147483560|NCT03241173|531926664|FG006|Overall Study|Death|3|||
147483561|NCT03241173|531926665|FG007|Overall Study|Death|1|||
147483562|NCT03241173|531926666|FG008|Overall Study|Death|0|||
147483563|NCT03241173|531926667|FG009|Overall Study|Death|5|||
147483564|NCT03241173|531926668|FG010|Overall Study|Death|4|||
147483565|NCT03241173|531926669|FG011|Overall Study|Death|3|||
147483566|NCT03241173|531926670|FG012|Overall Study|Death|0|||
147483567|NCT03241173|531926671|FG013|Overall Study|Death|0|||
147416648|NCT05540717|531689921|FG000|Overall Study|Study terminated by Sponsor for site 202 moving to a different location|3|||
147416649|NCT05540717|531689922|FG001|Overall Study|Study terminated by Sponsor for site 202 moving to a different location|3|||
147416650|NCT05540717|531689921|FG000|Overall Study|Other|0|||
147416651|NCT05540717|531689922|FG001|Overall Study|Other|1|||
147416652|NCT03651622|531689923|FG000|Diet Period 1 (Randomization 1)|Lost to Follow-up|0|||
147416653|NCT03651622|531689924|FG001|Diet Period 1 (Randomization 1)|Lost to Follow-up|6|||
147416654|NCT03651622|531689925|FG002|Diet Period 1 (Randomization 1)|Lost to Follow-up|2|||
147416655|NCT03651622|531689923|FG000|Diet Period 1 (Randomization 1)|Withdrawal by Subject|4|||
147416656|NCT03651622|531689924|FG001|Diet Period 1 (Randomization 1)|Withdrawal by Subject|1|||
147416657|NCT03651622|531689925|FG002|Diet Period 1 (Randomization 1)|Withdrawal by Subject|7|||
147416658|NCT03651622|531689923|FG000|Diet Period 2 (Randomization 2)|Lost to Follow-up|0|||
147416659|NCT03651622|531689924|FG001|Diet Period 2 (Randomization 2)|Lost to Follow-up|2|||
147416660|NCT03651622|531689925|FG002|Diet Period 2 (Randomization 2)|Lost to Follow-up|3|||
147416661|NCT03651622|531689923|FG000|Diet Period 2 (Randomization 2)|Withdrawal by Subject|2|||
147416662|NCT03651622|531689924|FG001|Diet Period 2 (Randomization 2)|Withdrawal by Subject|0|||
147416663|NCT03651622|531689925|FG002|Diet Period 2 (Randomization 2)|Withdrawal by Subject|0|||
147416664|NCT03651622|531689923|FG000|Diet Period 3 (Randomization 3)|Withdrawal by Subject|0|||
147483568|NCT03241173|531926672|FG014|Overall Study|Death|0|||
147483569|NCT03241173|531926658|FG000|Overall Study|Withdrawal by Subject|0|||
147483570|NCT03241173|531926659|FG001|Overall Study|Withdrawal by Subject|0|||
147483571|NCT03241173|531926660|FG002|Overall Study|Withdrawal by Subject|1|||
147483572|NCT03241173|531926661|FG003|Overall Study|Withdrawal by Subject|0|||
147483573|NCT03241173|531926662|FG004|Overall Study|Withdrawal by Subject|0|||
147483574|NCT03241173|531926663|FG005|Overall Study|Withdrawal by Subject|1|||
147623426|NCT00838903|532440142|FG000|Treatment Period (156 Weeks)|Subject Migrated to Other Country|0|||
147483575|NCT03241173|531926664|FG006|Overall Study|Withdrawal by Subject|0|||
147483576|NCT03241173|531926665|FG007|Overall Study|Withdrawal by Subject|0|||
147483577|NCT03241173|531926666|FG008|Overall Study|Withdrawal by Subject|0|||
147416665|NCT03651622|531689924|FG001|Diet Period 3 (Randomization 3)|Withdrawal by Subject|0|||
147416666|NCT03651622|531689925|FG002|Diet Period 3 (Randomization 3)|Withdrawal by Subject|1|||
147416667|NCT00307684|531689926|FG000|Open Label Phase|Lack of Efficacy|0|||
147416668|NCT00307684|531689927|FG001|Open Label Phase|Lack of Efficacy|0|||
147416669|NCT00307684|531689928|FG002|Open Label Phase|Lack of Efficacy|3|||
147416670|NCT00307684|531689926|FG000|Open Label Phase|Adverse Event|0|||
147416671|NCT00307684|531689927|FG001|Open Label Phase|Adverse Event|0|||
147416672|NCT00307684|531689928|FG002|Open Label Phase|Adverse Event|16|||
147416673|NCT00307684|531689926|FG000|Open Label Phase|Withdrawal by Subject|0|||
147416674|NCT00307684|531689927|FG001|Open Label Phase|Withdrawal by Subject|0|||
147416675|NCT00307684|531689928|FG002|Open Label Phase|Withdrawal by Subject|15|||
147416676|NCT00307684|531689926|FG000|Open Label Phase|Lost to Follow-up|0|||
147416677|NCT00307684|531689927|FG001|Open Label Phase|Lost to Follow-up|0|||
147416678|NCT00307684|531689928|FG002|Open Label Phase|Lost to Follow-up|11|||
147416679|NCT00307684|531689926|FG000|Open Label Phase|non compliance|0|||
147416680|NCT00307684|531689927|FG001|Open Label Phase|non compliance|0|||
147416681|NCT00307684|531689928|FG002|Open Label Phase|non compliance|5|||
147416682|NCT00307684|531689926|FG000|Open Label Phase|other|0|||
147416683|NCT00307684|531689927|FG001|Open Label Phase|other|0|||
147416684|NCT00307684|531689928|FG002|Open Label Phase|other|6|||
147416685|NCT00307684|531689926|FG000|Double Blind Phase|Lack of Efficacy|2|||
147416686|NCT00307684|531689927|FG001|Double Blind Phase|Lack of Efficacy|5|||
147416687|NCT00307684|531689928|FG002|Double Blind Phase|Lack of Efficacy|0|||
147416688|NCT02580305|531689932|FG000|Overall Study|Adverse Event|15|||
147416689|NCT02580305|531689933|FG001|Overall Study|Adverse Event|19|||
147483578|NCT03241173|531926667|FG009|Overall Study|Withdrawal by Subject|0|||
147483579|NCT03241173|531926668|FG010|Overall Study|Withdrawal by Subject|0|||
147483580|NCT03241173|531926669|FG011|Overall Study|Withdrawal by Subject|0|||
147483581|NCT03241173|531926670|FG012|Overall Study|Withdrawal by Subject|0|||
147483582|NCT03241173|531926671|FG013|Overall Study|Withdrawal by Subject|0|||
147483583|NCT03241173|531926672|FG014|Overall Study|Withdrawal by Subject|0|||
147483584|NCT03241173|531926658|FG000|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|1|||
147483585|NCT03241173|531926659|FG001|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|2|||
147483586|NCT03241173|531926660|FG002|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
147483587|NCT03241173|531926661|FG003|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|1|||
147483588|NCT03241173|531926662|FG004|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|1|||
147483589|NCT03241173|531926663|FG005|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|2|||
147483590|NCT03241173|531926664|FG006|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|1|||
147483591|NCT03241173|531926665|FG007|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|2|||
147483592|NCT03241173|531926666|FG008|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
147483593|NCT03241173|531926667|FG009|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
147483594|NCT03241173|531926668|FG010|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|2|||
147483595|NCT03241173|531926669|FG011|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|3|||
147483596|NCT03241173|531926670|FG012|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
147483597|NCT03241173|531926671|FG013|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
147483598|NCT03241173|531926672|FG014|Overall Study|Survival Follow-up No Longer Required per Protocol Amendment|0|||
147483599|NCT03241173|531926658|FG000|Overall Study|Lost to Follow-up|0|||
147483600|NCT03241173|531926659|FG001|Overall Study|Lost to Follow-up|0|||
147483601|NCT03241173|531926660|FG002|Overall Study|Lost to Follow-up|0|||
147483602|NCT03241173|531926661|FG003|Overall Study|Lost to Follow-up|0|||
147483603|NCT03241173|531926662|FG004|Overall Study|Lost to Follow-up|1|||
147483604|NCT03241173|531926663|FG005|Overall Study|Lost to Follow-up|0|||
147483605|NCT03241173|531926664|FG006|Overall Study|Lost to Follow-up|0|||
147483606|NCT03241173|531926665|FG007|Overall Study|Lost to Follow-up|0|||
147483607|NCT03241173|531926666|FG008|Overall Study|Lost to Follow-up|0|||
147483608|NCT03241173|531926667|FG009|Overall Study|Lost to Follow-up|1|||
147483609|NCT03241173|531926668|FG010|Overall Study|Lost to Follow-up|0|||
147483610|NCT03241173|531926669|FG011|Overall Study|Lost to Follow-up|0|||
147483611|NCT03241173|531926670|FG012|Overall Study|Lost to Follow-up|0|||
147483612|NCT03241173|531926671|FG013|Overall Study|Lost to Follow-up|0|||
147483613|NCT03241173|531926672|FG014|Overall Study|Lost to Follow-up|0|||
147483614|NCT00081289|531926676|FG000|Overall Study|Accrued prior to chemotherapy amendment|18|||
147483615|NCT00081289|531926677|FG001|Overall Study|Accrued prior to chemotherapy amendment|17|||
147483616|NCT00081289|531926676|FG000|Overall Study|Ineligible / no protocol treatment|3|||
147483617|NCT00081289|531926677|FG001|Overall Study|Ineligible / no protocol treatment|4|||
147483618|NCT02508701|531926680|FG000|Overall Study|Lost to Follow-up|9|||
147483619|NCT02508701|531926681|FG001|Overall Study|Lost to Follow-up|5|||
147483620|NCT02508701|531926682|FG002|Overall Study|Lost to Follow-up|5|||
147483621|NCT02508701|531926683|FG003|Overall Study|Lost to Follow-up|3|||
147483622|NCT00530712|531926686|FG000|30 Day Follow-up Visit|Withdrawal by Subject|2|||
147416690|NCT02580305|531689934|FG002|Overall Study|Adverse Event|10|||
147483623|NCT00530712|531926686|FG000|30 Day Follow-up Visit|Missed Visit|5|||
147483624|NCT00530712|531926686|FG000|6 Month Follow-up Visit|Withdrawal by Subject|4|||
147483625|NCT00530712|531926686|FG000|6 Month Follow-up Visit|Missed Visit|3|||
147483626|NCT00530712|531926686|FG000|6 Month Follow-up Visit|Lost to Follow-up|3|||
147483627|NCT00530712|531926686|FG000|6 Month Follow-up Visit|Death|2|||
147483628|NCT00530712|531926686|FG000|12 Month Follow-up Visit|Withdrawal by Subject|5|||
147483629|NCT00530712|531926686|FG000|12 Month Follow-up Visit|Missed Visit|3|||
147483630|NCT00530712|531926686|FG000|12 Month Follow-up Visit|Lost to Follow-up|7|||
147483631|NCT00530712|531926686|FG000|12 Month Follow-up Visit|Death|9|||
147483632|NCT00651118|531926693|FG000|Overall Study|Adverse Event|4|||
147483633|NCT00651118|531926694|FG001|Overall Study|Adverse Event|0|||
147483634|NCT00651118|531926695|FG002|Overall Study|Adverse Event|1|||
147483635|NCT00651118|531926696|FG003|Overall Study|Adverse Event|1|||
147483636|NCT00651118|531926693|FG000|Overall Study|Protocol Violation|2|||
147483637|NCT00651118|531926694|FG001|Overall Study|Protocol Violation|2|||
147483638|NCT00651118|531926695|FG002|Overall Study|Protocol Violation|6|||
147483639|NCT00651118|531926696|FG003|Overall Study|Protocol Violation|2|||
147483640|NCT00651118|531926693|FG000|Overall Study|Lost to Follow-up|2|||
147483641|NCT00651118|531926694|FG001|Overall Study|Lost to Follow-up|0|||
147483642|NCT00651118|531926695|FG002|Overall Study|Lost to Follow-up|1|||
147483643|NCT00651118|531926696|FG003|Overall Study|Lost to Follow-up|2|||
147483644|NCT00651118|531926693|FG000|Overall Study|administrative|1|||
147483645|NCT00651118|531926694|FG001|Overall Study|administrative|4|||
147483646|NCT00651118|531926695|FG002|Overall Study|administrative|2|||
147483647|NCT00651118|531926696|FG003|Overall Study|administrative|1|||
147483648|NCT00651118|531926693|FG000|Overall Study|Withdrawal by Subject|0|||
147483649|NCT00651118|531926694|FG001|Overall Study|Withdrawal by Subject|1|||
147483650|NCT00651118|531926695|FG002|Overall Study|Withdrawal by Subject|1|||
147483651|NCT00651118|531926696|FG003|Overall Study|Withdrawal by Subject|1|||
147483652|NCT03117049|531926697|FG000|Overall Study|Continued the follow-up period|109|||
147483653|NCT03117049|531926698|FG001|Overall Study|Continued the follow-up period|129|||
147483654|NCT03117049|531926697|FG000|Overall Study|Died|82|||
147483655|NCT03117049|531926698|FG001|Overall Study|Died|93|||
147483656|NCT03117049|531926697|FG000|Overall Study|Consent withdrawal|7|||
147483657|NCT03117049|531926698|FG001|Overall Study|Consent withdrawal|6|||
147483658|NCT03117049|531926697|FG000|Overall Study|Missing contact|3|||
147483659|NCT03117049|531926698|FG001|Overall Study|Missing contact|3|||
147483660|NCT00839098|531926699|FG000|Overall Study|Withdrawal by Subject|2|||
147483661|NCT00839098|531926700|FG001|Overall Study|Withdrawal by Subject|1|||
147483662|NCT00839098|531926701|FG002|Overall Study|Withdrawal by Subject|7|||
147483663|NCT00798967|531926702|FG000|Overall Study|Adverse Event|2|||
147483664|NCT00798967|531926703|FG001|Overall Study|Adverse Event|3|||
147483665|NCT00798967|531926702|FG000|Overall Study|Withdrawal by Subject|0|||
147483666|NCT00798967|531926703|FG001|Overall Study|Withdrawal by Subject|1|||
147483667|NCT00798967|531926702|FG000|Overall Study|Physician Decision|1|||
147483668|NCT00798967|531926703|FG001|Overall Study|Physician Decision|0|||
147483669|NCT00798967|531926702|FG000|Overall Study|Randomized in error by site|1|||
147483670|NCT00798967|531926703|FG001|Overall Study|Randomized in error by site|0|||
147483671|NCT03141307|531926706|FG000|In-Hospital|Withdrawal by Subject|0|||
147483672|NCT03141307|531926707|FG001|In-Hospital|Withdrawal by Subject|2|||
147483673|NCT03141307|531926706|FG000|In-Hospital|Protocol Violation|4|||
147483674|NCT03141307|531926707|FG001|In-Hospital|Protocol Violation|0|||
147483675|NCT03141307|531926706|FG000|Follow-Up|Lost to Follow-up|97|||
147483676|NCT03141307|531926707|FG001|Follow-Up|Lost to Follow-up|54|||
147483677|NCT03090737|531926708|FG000|Overall Study|Other reasons|1|||
147483678|NCT03090737|531926708|FG000|Overall Study|Completed treatment as per protocol|17|||
147483679|NCT03090737|531926708|FG000|Overall Study|Maximum clinical benefit|2|||
147483680|NCT03090737|531926708|FG000|Overall Study|Adverse event unrelated to study drug|7|||
147623427|NCT00838903|532440143|FG001|Treatment Period (156 Weeks)|Subject Migrated to Other Country|1|||
147623428|NCT00838903|532440144|FG002|Treatment Period (156 Weeks)|Subject Migrated to Other Country|0|||
147623429|NCT00838903|532440145|FG003|Treatment Period (156 Weeks)|Subject Migrated to Other Country|1|||
147623430|NCT00838903|532440142|FG000|Treatment Period (156 Weeks)|Missing Active Treatment Status|1|||
147623431|NCT00838903|532440143|FG001|Treatment Period (156 Weeks)|Missing Active Treatment Status|0|||
147483681|NCT03090737|531926708|FG000|Overall Study|Study drug toxicity|4|||
147483682|NCT03090737|531926708|FG000|Overall Study|Disease progression|98|||
147483683|NCT00227877|531926709|FG000|Pre-visit Assessment|Technical difficulties|7|||
147483684|NCT00227877|531926710|FG001|Pre-visit Assessment|Technical difficulties|3|||
147483685|NCT00227877|531926711|FG002|Pre-visit Assessment|Technical difficulties|0|||
147483686|NCT00227877|531926712|FG003|Pre-visit Assessment|Technical difficulties|0|||
147483687|NCT00227877|531926709|FG000|Post-visit Checklist|Lost to Follow-up|24|||
147483688|NCT00227877|531926710|FG001|Post-visit Checklist|Lost to Follow-up|13|||
147483689|NCT00227877|531926711|FG002|Post-visit Checklist|Lost to Follow-up|1|||
147483690|NCT00227877|531926712|FG003|Post-visit Checklist|Lost to Follow-up|0|||
147483691|NCT00227877|531926709|FG000|3-months Follow-up|Completed late|135|||
147483692|NCT00227877|531926710|FG001|3-months Follow-up|Completed late|128|||
147483693|NCT00227877|531926711|FG002|3-months Follow-up|Completed late|34|||
147483694|NCT00227877|531926712|FG003|3-months Follow-up|Completed late|8|||
147623432|NCT00838903|532440144|FG002|Treatment Period (156 Weeks)|Missing Active Treatment Status|0|||
147623433|NCT00838903|532440145|FG003|Treatment Period (156 Weeks)|Missing Active Treatment Status|0|||
147623434|NCT00838903|532440142|FG000|Follow-up Period (8 Weeks)|Adverse Event|0|||
147623435|NCT00838903|532440143|FG001|Follow-up Period (8 Weeks)|Adverse Event|0|||
147623436|NCT00838903|532440144|FG002|Follow-up Period (8 Weeks)|Adverse Event|3|||
147623437|NCT00838903|532440145|FG003|Follow-up Period (8 Weeks)|Adverse Event|1|||
147623438|NCT00838903|532440142|FG000|Follow-up Period (8 Weeks)|Noncompliance|2|||
147623439|NCT00838903|532440143|FG001|Follow-up Period (8 Weeks)|Noncompliance|8|||
147623440|NCT00838903|532440144|FG002|Follow-up Period (8 Weeks)|Noncompliance|5|||
147623441|NCT00838903|532440145|FG003|Follow-up Period (8 Weeks)|Noncompliance|5|||
147623442|NCT00838903|532440142|FG000|Follow-up Period (8 Weeks)|Lost to Follow-up|6|||
147623443|NCT00838903|532440143|FG001|Follow-up Period (8 Weeks)|Lost to Follow-up|28|||
147623444|NCT00838903|532440144|FG002|Follow-up Period (8 Weeks)|Lost to Follow-up|22|||
147623445|NCT00838903|532440145|FG003|Follow-up Period (8 Weeks)|Lost to Follow-up|24|||
147623446|NCT00838903|532440142|FG000|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|5|||
147623447|NCT00838903|532440143|FG001|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|7|||
147623448|NCT00838903|532440144|FG002|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|12|||
147623449|NCT00838903|532440145|FG003|Follow-up Period (8 Weeks)|Did Not Enter Follow-up Period|7|||
147623450|NCT00838903|532440142|FG000|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|8|||
147623451|NCT00838903|532440143|FG001|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|13|||
147623452|NCT00838903|532440144|FG002|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|14|||
147623453|NCT00838903|532440145|FG003|Follow-up Period (8 Weeks)|Subject Withdrawn from Follow-up|14|||
147623454|NCT00838903|532440142|FG000|Follow-up Period (8 Weeks)|Physician Decision|1|||
147623455|NCT00838903|532440143|FG001|Follow-up Period (8 Weeks)|Physician Decision|1|||
147623456|NCT00838903|532440144|FG002|Follow-up Period (8 Weeks)|Physician Decision|1|||
147667739|NCT00794664|532608133|FG001|Treatment Period|Protocol non-compliance|1|||
147667740|NCT00794664|532608132|FG000|Treatment Period|Other|0|||
147483695|NCT00227877|531926709|FG000|3-months Follow-up|Lost to Follow-up|178|||
147483696|NCT00227877|531926710|FG001|3-months Follow-up|Lost to Follow-up|139|||
147483697|NCT00227877|531926711|FG002|3-months Follow-up|Lost to Follow-up|18|||
147483698|NCT00227877|531926712|FG003|3-months Follow-up|Lost to Follow-up|13|||
147483699|NCT00227877|531926709|FG000|12-months Follow-up|Completed late|78|||
147483700|NCT00227877|531926710|FG001|12-months Follow-up|Completed late|74|||
147483701|NCT00227877|531926711|FG002|12-months Follow-up|Completed late|1|||
147483702|NCT00227877|531926712|FG003|12-months Follow-up|Completed late|0|||
147483703|NCT00227877|531926709|FG000|12-months Follow-up|Lost to Follow-up|232|||
147483704|NCT00227877|531926710|FG001|12-months Follow-up|Lost to Follow-up|189|||
147483705|NCT00227877|531926711|FG002|12-months Follow-up|Lost to Follow-up|30|||
147483706|NCT00227877|531926712|FG003|12-months Follow-up|Lost to Follow-up|26|||
147483707|NCT03103750|531926715|FG000|Overall Study|Adverse Event|1|||
147483708|NCT03103750|531926716|FG001|Overall Study|Adverse Event|0|||
147483709|NCT03103750|531926715|FG000|Overall Study|Lost to Follow-up|1|||
147483710|NCT03103750|531926716|FG001|Overall Study|Lost to Follow-up|0|||
147483711|NCT03103750|531926715|FG000|Overall Study|PET Equipment Related|2|||
147483712|NCT03103750|531926716|FG001|Overall Study|PET Equipment Related|2|||
147483713|NCT01663740|531926717|FG000|Overall Study|Lost to Follow-up|1|||
147483714|NCT01663740|531926718|FG001|Overall Study|Lost to Follow-up|4|||
147483715|NCT01663740|531926717|FG000|Overall Study|Other|9|||
147483716|NCT01663740|531926718|FG001|Overall Study|Other|2|||
147483717|NCT01663740|531926717|FG000|Overall Study|Inclusion/Exclusion not met|1|||
147483718|NCT01663740|531926718|FG001|Overall Study|Inclusion/Exclusion not met|0|||
147483719|NCT01663740|531926717|FG000|Overall Study|Death|0|||
147483720|NCT01663740|531926718|FG001|Overall Study|Death|1|||
147483721|NCT01663740|531926717|FG000|Overall Study|Withdrawal by Subject|2|||
147483722|NCT01663740|531926718|FG001|Overall Study|Withdrawal by Subject|1|||
147483723|NCT01663740|531926717|FG000|Overall Study|No end of study status|3|||
147483724|NCT01663740|531926718|FG001|Overall Study|No end of study status|0|||
147483725|NCT02522481|531926719|FG000|Overall Study|discontinued|1|||
147483726|NCT02522481|531926719|FG000|Overall Study|Not dosed|2|||
147483727|NCT03123939|531926722|FG000|Overall Study|Lack of Efficacy|6|||
147483728|NCT03123939|531926722|FG000|Overall Study|Death|5|||
147483729|NCT03123939|531926722|FG000|Overall Study|Physician Decision|2|||
147623457|NCT00838903|532440145|FG003|Follow-up Period (8 Weeks)|Physician Decision|1|||
147667741|NCT00794664|532608133|FG001|Treatment Period|Other|1|||
147483730|NCT03123939|531926722|FG000|Overall Study|Subject/guardian decision|2|||
147483731|NCT03123939|531926722|FG000|Overall Study|Lost to Follow-up|1|||
147483732|NCT03123939|531926722|FG000|Overall Study|New therapy for study indication|1|||
147483733|NCT03123939|531926722|FG000|Overall Study|Protocol deviation|1|||
147483734|NCT03123939|531926722|FG000|Overall Study|Progressive disease|18|||
147483735|NCT03123939|531926722|FG000|Overall Study|Discontinued prior to CTL019 infusion due to death|4|||
147483736|NCT03123939|531926722|FG000|Overall Study|Discontinued prior to CTL019 infusion due to technical problems|1|||
147483737|NCT01522651|531926723|FG000|Overall Study|Adverse Event|3|||
147483738|NCT01522651|531926724|FG001|Overall Study|Adverse Event|4|||
147483739|NCT01522651|531926725|FG002|Overall Study|Adverse Event|4|||
147483740|NCT01522651|531926726|FG003|Overall Study|Adverse Event|5|||
147483741|NCT01522651|531926727|FG004|Overall Study|Adverse Event|4|||
147483742|NCT01522651|531926723|FG000|Overall Study|Cardioversion|1|||
147483743|NCT01522651|531926724|FG001|Overall Study|Cardioversion|0|||
147483744|NCT01522651|531926725|FG002|Overall Study|Cardioversion|0|||
147483745|NCT01522651|531926726|FG003|Overall Study|Cardioversion|0|||
147483746|NCT01522651|531926727|FG004|Overall Study|Cardioversion|0|||
147483747|NCT01522651|531926723|FG000|Overall Study|Device Malfunction|0|||
147483748|NCT01522651|531926724|FG001|Overall Study|Device Malfunction|1|||
147483749|NCT01522651|531926725|FG002|Overall Study|Device Malfunction|0|||
147483750|NCT01522651|531926726|FG003|Overall Study|Device Malfunction|0|||
147483751|NCT01522651|531926727|FG004|Overall Study|Device Malfunction|0|||
147483752|NCT01522651|531926723|FG000|Overall Study|Investigator's Discretion|0|||
147483753|NCT01522651|531926724|FG001|Overall Study|Investigator's Discretion|1|||
147483754|NCT01522651|531926725|FG002|Overall Study|Investigator's Discretion|0|||
147483755|NCT01522651|531926726|FG003|Overall Study|Investigator's Discretion|0|||
147483756|NCT01522651|531926727|FG004|Overall Study|Investigator's Discretion|0|||
147483757|NCT01522651|531926723|FG000|Overall Study|Protocol Violation|3|||
147483758|NCT01522651|531926724|FG001|Overall Study|Protocol Violation|0|||
147483759|NCT01522651|531926725|FG002|Overall Study|Protocol Violation|0|||
147483760|NCT01522651|531926726|FG003|Overall Study|Protocol Violation|0|||
147483761|NCT01522651|531926727|FG004|Overall Study|Protocol Violation|0|||
147483762|NCT01522651|531926723|FG000|Overall Study|Reason Not Specified|0|||
147483763|NCT01522651|531926724|FG001|Overall Study|Reason Not Specified|0|||
147483764|NCT01522651|531926725|FG002|Overall Study|Reason Not Specified|0|||
147483765|NCT01522651|531926726|FG003|Overall Study|Reason Not Specified|1|||
147483766|NCT01522651|531926727|FG004|Overall Study|Reason Not Specified|0|||
147483767|NCT01522651|531926723|FG000|Overall Study|Participant Non-Compliance|1|||
147483768|NCT01522651|531926724|FG001|Overall Study|Participant Non-Compliance|0|||
147483769|NCT01522651|531926725|FG002|Overall Study|Participant Non-Compliance|0|||
147483770|NCT01522651|531926726|FG003|Overall Study|Participant Non-Compliance|0|||
147483771|NCT01522651|531926727|FG004|Overall Study|Participant Non-Compliance|0|||
147483772|NCT01522651|531926723|FG000|Overall Study|Withdrew Consent|1|||
147483773|NCT01522651|531926724|FG001|Overall Study|Withdrew Consent|1|||
147483774|NCT01522651|531926725|FG002|Overall Study|Withdrew Consent|0|||
147483775|NCT01522651|531926726|FG003|Overall Study|Withdrew Consent|1|||
147483776|NCT01522651|531926727|FG004|Overall Study|Withdrew Consent|1|||
147483777|NCT01522651|531926723|FG000|Overall Study|Randomized but Never Treated|0|||
147483778|NCT01522651|531926724|FG001|Overall Study|Randomized but Never Treated|1|||
147483779|NCT01522651|531926725|FG002|Overall Study|Randomized but Never Treated|0|||
147483780|NCT01522651|531926726|FG003|Overall Study|Randomized but Never Treated|1|||
147483781|NCT01522651|531926727|FG004|Overall Study|Randomized but Never Treated|1|||
147483782|NCT04267562|531928202|FG000|Assessed for Eligibility|Screen Failure|64|||
147483783|NCT04267562|531928202|FG000|Assessed for Eligibility|Trial enrollment reached|23|||
147483784|NCT04267562|531928202|FG000|Assessed for Eligibility|Withdrawal by Subject|9|||
147483785|NCT04267562|531928202|FG000|Assessed for Eligibility|Site closure|6|||
147483786|NCT04267562|531928202|FG000|Assessed for Eligibility|Lost to Follow-up|2|||
147483787|NCT04267562|531928202|FG000|Assessed for Eligibility|Physician Decision|1|||
147483788|NCT04267562|531928202|FG000|Month 24|Elective hysterectomy|1|||
147483789|NCT04267562|531928202|FG000|Month 24|Lost to Follow-up|1|||
147483790|NCT04267562|531928202|FG000|Month 36|Elective hysterectomy|2|||
147483791|NCT04267562|531928202|FG000|Month 36|Lost to Follow-up|3|||
147483792|NCT00408421|531928210|FG000|Treatment Initial Randomization|Adverse Event|5|||
147483793|NCT00408421|531928211|FG001|Treatment Initial Randomization|Adverse Event|9|||
147483794|NCT00408421|531928212|FG002|Treatment Initial Randomization|Adverse Event|0|||
147483795|NCT00408421|531928210|FG000|Treatment Initial Randomization|Lack of Efficacy|2|||
147483796|NCT00408421|531928211|FG001|Treatment Initial Randomization|Lack of Efficacy|2|||
147483797|NCT00408421|531928212|FG002|Treatment Initial Randomization|Lack of Efficacy|0|||
147483798|NCT00408421|531928210|FG000|Treatment Initial Randomization|Lost to Follow-up|0|||
147483799|NCT00408421|531928211|FG001|Treatment Initial Randomization|Lost to Follow-up|3|||
147483800|NCT00408421|531928212|FG002|Treatment Initial Randomization|Lost to Follow-up|0|||
147483801|NCT00408421|531928210|FG000|Treatment Initial Randomization|Physician Decision|1|||
147667742|NCT00794664|532608132|FG000|Treatment Period|Adverse Event|1|||
147483802|NCT00408421|531928211|FG001|Treatment Initial Randomization|Physician Decision|0|||
147483803|NCT00408421|531928212|FG002|Treatment Initial Randomization|Physician Decision|0|||
147483804|NCT00408421|531928210|FG000|Treatment Initial Randomization|Protocol Violation|0|||
147483805|NCT00408421|531928211|FG001|Treatment Initial Randomization|Protocol Violation|1|||
147483806|NCT00408421|531928212|FG002|Treatment Initial Randomization|Protocol Violation|0|||
147483807|NCT00408421|531928210|FG000|Treatment Initial Randomization|Withdrawal by Subject|7|||
147483808|NCT00408421|531928211|FG001|Treatment Initial Randomization|Withdrawal by Subject|7|||
147483809|NCT00408421|531928212|FG002|Treatment Initial Randomization|Withdrawal by Subject|0|||
147483810|NCT00408421|531928210|FG000|Treatment Initial Randomization|Entry Criteria Not Met|1|||
147483811|NCT00408421|531928211|FG001|Treatment Initial Randomization|Entry Criteria Not Met|0|||
147483812|NCT00408421|531928212|FG002|Treatment Initial Randomization|Entry Criteria Not Met|0|||
147483813|NCT00408421|531928210|FG000|Treatment Initial Randomization|Sponsor Decision|1|||
147483814|NCT00408421|531928211|FG001|Treatment Initial Randomization|Sponsor Decision|0|||
147483815|NCT00408421|531928212|FG002|Treatment Initial Randomization|Sponsor Decision|0|||
147483816|NCT00408421|531928210|FG000|Treatment Re-Randomization|Adverse Event|2|||
147483817|NCT00408421|531928211|FG001|Treatment Re-Randomization|Adverse Event|2|||
147483818|NCT00408421|531928212|FG002|Treatment Re-Randomization|Adverse Event|4|||
147483819|NCT00408421|531928210|FG000|Treatment Re-Randomization|Lack of Efficacy|1|||
147483820|NCT00408421|531928211|FG001|Treatment Re-Randomization|Lack of Efficacy|0|||
147483821|NCT00408421|531928212|FG002|Treatment Re-Randomization|Lack of Efficacy|0|||
147483822|NCT00408421|531928210|FG000|Treatment Re-Randomization|Lost to Follow-up|0|||
147483823|NCT00408421|531928211|FG001|Treatment Re-Randomization|Lost to Follow-up|0|||
147483824|NCT00408421|531928212|FG002|Treatment Re-Randomization|Lost to Follow-up|1|||
147483825|NCT00408421|531928210|FG000|Treatment Re-Randomization|Physician Decision|1|||
147483826|NCT00408421|531928211|FG001|Treatment Re-Randomization|Physician Decision|3|||
147483827|NCT00408421|531928212|FG002|Treatment Re-Randomization|Physician Decision|0|||
147483828|NCT00408421|531928210|FG000|Treatment Re-Randomization|Protocol Violation|1|||
147483829|NCT00408421|531928211|FG001|Treatment Re-Randomization|Protocol Violation|1|||
147483830|NCT00408421|531928212|FG002|Treatment Re-Randomization|Protocol Violation|0|||
147483831|NCT00408421|531928210|FG000|Treatment Re-Randomization|Withdrawal by Subject|2|||
147483832|NCT00408421|531928211|FG001|Treatment Re-Randomization|Withdrawal by Subject|1|||
147483833|NCT00408421|531928212|FG002|Treatment Re-Randomization|Withdrawal by Subject|0|||
147483834|NCT01614769|531928219|FG000|Period 1|Discontinued due to Hypoglycemia|0|||
147483835|NCT01614769|531928220|FG001|Period 1|Discontinued due to Hypoglycemia|0|||
147483836|NCT01614769|531928221|FG002|Period 1|Discontinued due to Hypoglycemia|0|||
147623458|NCT00838903|532440142|FG000|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|3|||
147623459|NCT00838903|532440143|FG001|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|4|||
147483837|NCT01614769|531928222|FG003|Period 1|Discontinued due to Hypoglycemia|1|||
147483838|NCT01614769|531928223|FG004|Period 1|Discontinued due to Hypoglycemia|0|||
147483839|NCT01614769|531928224|FG005|Period 1|Discontinued due to Hypoglycemia|1|||
147483840|NCT01614769|531928219|FG000|Period 1|Protocol Violation|0|||
147483841|NCT01614769|531928220|FG001|Period 1|Protocol Violation|0|||
147483842|NCT01614769|531928221|FG002|Period 1|Protocol Violation|0|||
147483843|NCT01614769|531928222|FG003|Period 1|Protocol Violation|1|||
147483844|NCT01614769|531928223|FG004|Period 1|Protocol Violation|0|||
147483845|NCT01614769|531928224|FG005|Period 1|Protocol Violation|0|||
147483846|NCT01614769|531928219|FG000|Period 1|Withdrawal by Subject|1|||
147483847|NCT01614769|531928220|FG001|Period 1|Withdrawal by Subject|0|||
147483848|NCT01614769|531928221|FG002|Period 1|Withdrawal by Subject|0|||
147483849|NCT01614769|531928222|FG003|Period 1|Withdrawal by Subject|0|||
147483850|NCT01614769|531928223|FG004|Period 1|Withdrawal by Subject|0|||
147483851|NCT01614769|531928224|FG005|Period 1|Withdrawal by Subject|0|||
147483852|NCT01614769|531928219|FG000|Period 3|Withdrawal by Subject|0|||
147483853|NCT01614769|531928220|FG001|Period 3|Withdrawal by Subject|0|||
147483854|NCT01614769|531928221|FG002|Period 3|Withdrawal by Subject|1|||
147483855|NCT01614769|531928222|FG003|Period 3|Withdrawal by Subject|0|||
147483856|NCT01614769|531928223|FG004|Period 3|Withdrawal by Subject|0|||
147483857|NCT01614769|531928224|FG005|Period 3|Withdrawal by Subject|0|||
147483858|NCT02115815|531928225|FG000|Overall Study|Withdrawal by Subject|2|||
147483859|NCT02115815|531928226|FG001|Overall Study|Withdrawal by Subject|0|||
147483860|NCT02115815|531928227|FG002|Overall Study|Withdrawal by Subject|0|||
147483861|NCT02115815|531928228|FG003|Overall Study|Withdrawal by Subject|0|||
147623460|NCT00838903|532440144|FG002|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|6|||
147623461|NCT00838903|532440145|FG003|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|4|||
147483862|NCT02115815|531928229|FG004|Overall Study|Withdrawal by Subject|0|||
147623462|NCT00838903|532440142|FG000|Follow-up Period (8 Weeks)|ICF Withdrawn|0|||
147623463|NCT00838903|532440143|FG001|Follow-up Period (8 Weeks)|ICF Withdrawn|1|||
147623464|NCT00838903|532440144|FG002|Follow-up Period (8 Weeks)|ICF Withdrawn|0|||
147623465|NCT00838903|532440145|FG003|Follow-up Period (8 Weeks)|ICF Withdrawn|0|||
147623466|NCT00838903|532440142|FG000|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|0|||
147623467|NCT00838903|532440143|FG001|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|1|||
147623468|NCT00838903|532440144|FG002|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|0|||
147623469|NCT00838903|532440145|FG003|Follow-up Period (8 Weeks)|Investigator Stopped Study at Site|0|||
147623470|NCT00838903|532440142|FG000|Follow-up Period (8 Weeks)|Subject Moved out of Town|0|||
147483863|NCT02115815|531928230|FG005|Overall Study|Withdrawal by Subject|0|||
147483864|NCT02115815|531928231|FG006|Overall Study|Withdrawal by Subject|0|||
147483865|NCT02115815|531928225|FG000|Overall Study|Not enough drug to dose participant|0|||
147483866|NCT02115815|531928226|FG001|Overall Study|Not enough drug to dose participant|0|||
147623471|NCT00838903|532440143|FG001|Follow-up Period (8 Weeks)|Subject Moved out of Town|0|||
147667743|NCT00794664|532608133|FG001|Treatment Period|Adverse Event|8|||
147483867|NCT02115815|531928227|FG002|Overall Study|Not enough drug to dose participant|0|||
147483868|NCT02115815|531928228|FG003|Overall Study|Not enough drug to dose participant|0|||
147483869|NCT02115815|531928229|FG004|Overall Study|Not enough drug to dose participant|0|||
147483870|NCT02115815|531928230|FG005|Overall Study|Not enough drug to dose participant|1|||
147483871|NCT02115815|531928231|FG006|Overall Study|Not enough drug to dose participant|0|||
147483872|NCT02115815|531928225|FG000|Overall Study|Missed appointment, randomized in error|0|||
147483873|NCT02115815|531928226|FG001|Overall Study|Missed appointment, randomized in error|0|||
147483874|NCT02115815|531928227|FG002|Overall Study|Missed appointment, randomized in error|0|||
147483875|NCT02115815|531928228|FG003|Overall Study|Missed appointment, randomized in error|0|||
147483876|NCT02115815|531928229|FG004|Overall Study|Missed appointment, randomized in error|0|||
147483877|NCT02115815|531928230|FG005|Overall Study|Missed appointment, randomized in error|1|||
147483878|NCT02115815|531928231|FG006|Overall Study|Missed appointment, randomized in error|0|||
147483879|NCT01989546|531928232|FG000|Overall Study|Clinical Progression|1|||
147483880|NCT01989546|531928232|FG000|Overall Study|Disease progression on study|8|||
147483881|NCT04439838|531928237|FG000|Overall Study|Withdrawal by Subject|0|||
147483882|NCT04439838|531928238|FG001|Overall Study|Withdrawal by Subject|0|||
147483883|NCT04439838|531928239|FG002|Overall Study|Withdrawal by Subject|0|||
147483884|NCT04439838|531928240|FG003|Overall Study|Withdrawal by Subject|0|||
147483885|NCT04439838|531928241|FG004|Overall Study|Withdrawal by Subject|0|||
147483886|NCT04439838|531928242|FG005|Overall Study|Withdrawal by Subject|0|||
147483887|NCT04439838|531928243|FG006|Overall Study|Withdrawal by Subject|0|||
147483888|NCT04439838|531928244|FG007|Overall Study|Withdrawal by Subject|0|||
147483889|NCT04439838|531928245|FG008|Overall Study|Withdrawal by Subject|1|||
147483890|NCT01958671|531928248|FG000|Overall Study|Adverse Event|1|||
147483891|NCT01958671|531928249|FG001|Overall Study|Adverse Event|1|||
147483892|NCT01958671|531928250|FG002|Overall Study|Adverse Event|5|||
147483893|NCT01958671|531928248|FG000|Overall Study|Death|1|||
147483894|NCT01958671|531928249|FG001|Overall Study|Death|0|||
147483895|NCT01958671|531928250|FG002|Overall Study|Death|0|||
147483896|NCT01958671|531928248|FG000|Overall Study|Excluded medication|0|||
147483897|NCT01958671|531928249|FG001|Overall Study|Excluded medication|0|||
147483898|NCT01958671|531928250|FG002|Overall Study|Excluded medication|1|||
147483899|NCT01958671|531928248|FG000|Overall Study|Hyperglycemia|0|||
147483900|NCT01958671|531928249|FG001|Overall Study|Hyperglycemia|0|||
147483901|NCT01958671|531928250|FG002|Overall Study|Hyperglycemia|2|||
147483902|NCT01958671|531928248|FG000|Overall Study|Lost to Follow-up|7|||
147483903|NCT01958671|531928249|FG001|Overall Study|Lost to Follow-up|11|||
147483904|NCT01958671|531928250|FG002|Overall Study|Lost to Follow-up|7|||
147483905|NCT01958671|531928248|FG000|Overall Study|Non-compliance with study drug|1|||
147483906|NCT01958671|531928249|FG001|Overall Study|Non-compliance with study drug|1|||
147483907|NCT01958671|531928250|FG002|Overall Study|Non-compliance with study drug|1|||
147483908|NCT01958671|531928248|FG000|Overall Study|Pregnancy|0|||
147483909|NCT01958671|531928249|FG001|Overall Study|Pregnancy|0|||
147483910|NCT01958671|531928250|FG002|Overall Study|Pregnancy|1|||
147483911|NCT01958671|531928248|FG000|Overall Study|Protocol Violation|0|||
147483912|NCT01958671|531928249|FG001|Overall Study|Protocol Violation|1|||
147483913|NCT01958671|531928250|FG002|Overall Study|Protocol Violation|0|||
147483914|NCT01958671|531928248|FG000|Overall Study|Study site terminated by sponsor|1|||
147483915|NCT01958671|531928249|FG001|Overall Study|Study site terminated by sponsor|0|||
147483916|NCT01958671|531928250|FG002|Overall Study|Study site terminated by sponsor|1|||
147483917|NCT01958671|531928248|FG000|Overall Study|Participant moved|0|||
147483918|NCT01958671|531928249|FG001|Overall Study|Participant moved|0|||
147483919|NCT01958671|531928250|FG002|Overall Study|Participant moved|1|||
147483920|NCT01958671|531928248|FG000|Overall Study|Withdrawal by Subject|8|||
147483921|NCT01958671|531928249|FG001|Overall Study|Withdrawal by Subject|10|||
147483922|NCT01958671|531928250|FG002|Overall Study|Withdrawal by Subject|13|||
147483923|NCT02778867|531928251|FG000|Phase 1|Withdrawal by Subject|2|||
147483924|NCT02778867|531928252|FG001|Phase 1|Withdrawal by Subject|3|||
147483925|NCT02778867|531928253|FG002|Phase 1|Withdrawal by Subject|0|||
147483926|NCT02778867|531928254|FG003|Phase 1|Withdrawal by Subject|0|||
147483927|NCT02778867|531928251|FG000|Phase 2|Withdrawal by Subject|0|||
147483928|NCT02778867|531928252|FG001|Phase 2|Withdrawal by Subject|0|||
147483929|NCT02778867|531928253|FG002|Phase 2|Withdrawal by Subject|1|||
147483930|NCT02778867|531928254|FG003|Phase 2|Withdrawal by Subject|0|||
147483931|NCT02778867|531928251|FG000|Phase 2|Physician Decision|0|||
147483932|NCT02778867|531928252|FG001|Phase 2|Physician Decision|0|||
147483933|NCT02778867|531928253|FG002|Phase 2|Physician Decision|0|||
147483934|NCT02778867|531928254|FG003|Phase 2|Physician Decision|1|||
147483935|NCT02778867|531928251|FG000|Phase 2|Adverse Event|0|||
147483936|NCT02778867|531928252|FG001|Phase 2|Adverse Event|0|||
147483937|NCT02778867|531928253|FG002|Phase 2|Adverse Event|0|||
147483938|NCT02778867|531928254|FG003|Phase 2|Adverse Event|1|||
147483939|NCT00960440|531928256|FG000|Overall Study|Death|0|||
147483940|NCT00960440|531928257|FG001|Overall Study|Death|0|||
147483941|NCT00960440|531928258|FG002|Overall Study|Death|0|||
147483942|NCT00960440|531928259|FG003|Overall Study|Death|1|||
147483943|NCT00960440|531928256|FG000|Overall Study|Adverse Event|12|||
147483944|NCT00960440|531928257|FG001|Overall Study|Adverse Event|12|||
147483945|NCT00960440|531928258|FG002|Overall Study|Adverse Event|4|||
147483946|NCT00960440|531928259|FG003|Overall Study|Adverse Event|4|||
147483947|NCT00960440|531928256|FG000|Overall Study|Lack of Efficacy|2|||
147483948|NCT00960440|531928257|FG001|Overall Study|Lack of Efficacy|5|||
147483949|NCT00960440|531928258|FG002|Overall Study|Lack of Efficacy|3|||
147483950|NCT00960440|531928259|FG003|Overall Study|Lack of Efficacy|8|||
147483951|NCT00960440|531928256|FG000|Overall Study|Protocol Violation|2|||
147483952|NCT00960440|531928257|FG001|Overall Study|Protocol Violation|8|||
147483953|NCT00960440|531928258|FG002|Overall Study|Protocol Violation|3|||
147483954|NCT00960440|531928259|FG003|Overall Study|Protocol Violation|4|||
147483955|NCT00960440|531928256|FG000|Overall Study|Withdrawal by Subject|9|||
147483956|NCT00960440|531928257|FG001|Overall Study|Withdrawal by Subject|5|||
147483957|NCT00960440|531928258|FG002|Overall Study|Withdrawal by Subject|2|||
147483958|NCT00960440|531928259|FG003|Overall Study|Withdrawal by Subject|1|||
147483959|NCT00960440|531928256|FG000|Overall Study|Other|1|||
147483960|NCT00960440|531928257|FG001|Overall Study|Other|1|||
147483961|NCT00960440|531928258|FG002|Overall Study|Other|1|||
147483962|NCT00960440|531928259|FG003|Overall Study|Other|0|||
147483963|NCT03504774|531928260|FG000|Overall Study|Adverse Event|2|||
147483964|NCT03504774|531928261|FG001|Overall Study|Adverse Event|0|||
147483965|NCT03504774|531928260|FG000|Overall Study|Lost to Follow-up|0|||
147483966|NCT03504774|531928261|FG001|Overall Study|Lost to Follow-up|1|||
147483967|NCT03504774|531928260|FG000|Overall Study|Protocol Violation|11|||
147483968|NCT03504774|531928261|FG001|Overall Study|Protocol Violation|3|||
147483969|NCT03504774|531928260|FG000|Overall Study|failed wk 52 DBPCFC|1|||
147483970|NCT03504774|531928261|FG001|Overall Study|failed wk 52 DBPCFC|0|||
147483971|NCT01781429|531928262|FG000|Overall Study|Death|0|||
147483972|NCT01781429|531928263|FG001|Overall Study|Death|0|||
147483973|NCT01781429|531928264|FG002|Overall Study|Death|0|||
147483974|NCT01781429|531928265|FG003|Overall Study|Death|0|||
147483975|NCT01781429|531928266|FG004|Overall Study|Death|0|||
147483976|NCT01781429|531928267|FG005|Overall Study|Death|0|||
147483977|NCT01781429|531928268|FG006|Overall Study|Death|0|||
147483978|NCT01781429|531928269|FG007|Overall Study|Death|0|||
147483979|NCT01781429|531928270|FG008|Overall Study|Death|0|||
147483980|NCT01781429|531928271|FG009|Overall Study|Death|1|||
147483981|NCT01781429|531928272|FG010|Overall Study|Death|0|||
147483982|NCT01781429|531928273|FG011|Overall Study|Death|0|||
147483983|NCT01781429|531928274|FG012|Overall Study|Death|1|||
147483984|NCT01781429|531928275|FG013|Overall Study|Death|0|||
147483985|NCT01781429|531928276|FG014|Overall Study|Death|1|||
147483986|NCT01781429|531928277|FG015|Overall Study|Death|0|||
147483987|NCT01781429|531928262|FG000|Overall Study|Withdrawal by Subject|0|||
147483988|NCT01781429|531928263|FG001|Overall Study|Withdrawal by Subject|0|||
147483989|NCT01781429|531928264|FG002|Overall Study|Withdrawal by Subject|0|||
147483990|NCT01781429|531928265|FG003|Overall Study|Withdrawal by Subject|0|||
147483991|NCT01781429|531928266|FG004|Overall Study|Withdrawal by Subject|0|||
147483992|NCT01781429|531928267|FG005|Overall Study|Withdrawal by Subject|0|||
147483993|NCT01781429|531928268|FG006|Overall Study|Withdrawal by Subject|0|||
147483994|NCT01781429|531928269|FG007|Overall Study|Withdrawal by Subject|0|||
147483995|NCT01781429|531928270|FG008|Overall Study|Withdrawal by Subject|1|||
147483996|NCT01781429|531928271|FG009|Overall Study|Withdrawal by Subject|3|||
147483997|NCT01781429|531928272|FG010|Overall Study|Withdrawal by Subject|1|||
147483998|NCT01781429|531928273|FG011|Overall Study|Withdrawal by Subject|1|||
147483999|NCT01781429|531928274|FG012|Overall Study|Withdrawal by Subject|5|||
147484000|NCT01781429|531928275|FG013|Overall Study|Withdrawal by Subject|2|||
147484001|NCT01781429|531928276|FG014|Overall Study|Withdrawal by Subject|3|||
147484002|NCT01781429|531928277|FG015|Overall Study|Withdrawal by Subject|0|||
147484003|NCT01781429|531928262|FG000|Overall Study|Disease Progression|1|||
147484004|NCT01781429|531928263|FG001|Overall Study|Disease Progression|0|||
147484005|NCT01781429|531928264|FG002|Overall Study|Disease Progression|1|||
147484006|NCT01781429|531928265|FG003|Overall Study|Disease Progression|1|||
147484007|NCT01781429|531928266|FG004|Overall Study|Disease Progression|1|||
147484008|NCT01781429|531928267|FG005|Overall Study|Disease Progression|4|||
147484009|NCT01781429|531928268|FG006|Overall Study|Disease Progression|7|||
147484010|NCT01781429|531928269|FG007|Overall Study|Disease Progression|4|||
147484011|NCT01781429|531928270|FG008|Overall Study|Disease Progression|6|||
147484012|NCT01781429|531928271|FG009|Overall Study|Disease Progression|15|||
147484013|NCT01781429|531928272|FG010|Overall Study|Disease Progression|15|||
147484014|NCT01781429|531928273|FG011|Overall Study|Disease Progression|15|||
147484015|NCT01781429|531928274|FG012|Overall Study|Disease Progression|15|||
147484016|NCT01781429|531928275|FG013|Overall Study|Disease Progression|4|||
147484017|NCT01781429|531928276|FG014|Overall Study|Disease Progression|11|||
147484018|NCT01781429|531928277|FG015|Overall Study|Disease Progression|0|||
147484019|NCT01781429|531928262|FG000|Overall Study|Unacceptable Toxicity|0|||
147484020|NCT01781429|531928263|FG001|Overall Study|Unacceptable Toxicity|0|||
147484021|NCT01781429|531928264|FG002|Overall Study|Unacceptable Toxicity|0|||
147484022|NCT01781429|531928265|FG003|Overall Study|Unacceptable Toxicity|0|||
147484023|NCT01781429|531928266|FG004|Overall Study|Unacceptable Toxicity|0|||
147484024|NCT01781429|531928267|FG005|Overall Study|Unacceptable Toxicity|0|||
147484025|NCT01781429|531928268|FG006|Overall Study|Unacceptable Toxicity|0|||
147484026|NCT01781429|531928269|FG007|Overall Study|Unacceptable Toxicity|0|||
147484027|NCT01781429|531928270|FG008|Overall Study|Unacceptable Toxicity|0|||
147484028|NCT01781429|531928271|FG009|Overall Study|Unacceptable Toxicity|0|||
147484029|NCT01781429|531928272|FG010|Overall Study|Unacceptable Toxicity|0|||
147484030|NCT01781429|531928273|FG011|Overall Study|Unacceptable Toxicity|2|||
147484031|NCT01781429|531928274|FG012|Overall Study|Unacceptable Toxicity|0|||
147484032|NCT01781429|531928275|FG013|Overall Study|Unacceptable Toxicity|0|||
147484033|NCT01781429|531928276|FG014|Overall Study|Unacceptable Toxicity|0|||
147484034|NCT01781429|531928277|FG015|Overall Study|Unacceptable Toxicity|0|||
147484035|NCT01781429|531928262|FG000|Overall Study|Patient Condition Changed|0|||
147484036|NCT01781429|531928263|FG001|Overall Study|Patient Condition Changed|0|||
147484037|NCT01781429|531928264|FG002|Overall Study|Patient Condition Changed|0|||
147484038|NCT01781429|531928265|FG003|Overall Study|Patient Condition Changed|0|||
147484039|NCT01781429|531928266|FG004|Overall Study|Patient Condition Changed|0|||
147484040|NCT01781429|531928267|FG005|Overall Study|Patient Condition Changed|0|||
147484041|NCT01781429|531928268|FG006|Overall Study|Patient Condition Changed|0|||
147484042|NCT01781429|531928269|FG007|Overall Study|Patient Condition Changed|0|||
147484043|NCT01781429|531928270|FG008|Overall Study|Patient Condition Changed|0|||
147484044|NCT01781429|531928271|FG009|Overall Study|Patient Condition Changed|4|||
147484045|NCT01781429|531928272|FG010|Overall Study|Patient Condition Changed|0|||
147484046|NCT01781429|531928273|FG011|Overall Study|Patient Condition Changed|1|||
147484047|NCT01781429|531928274|FG012|Overall Study|Patient Condition Changed|0|||
147484048|NCT01781429|531928275|FG013|Overall Study|Patient Condition Changed|1|||
147484049|NCT01781429|531928276|FG014|Overall Study|Patient Condition Changed|0|||
147484050|NCT01781429|531928277|FG015|Overall Study|Patient Condition Changed|0|||
147484051|NCT01781429|531928262|FG000|Overall Study|Other - as entered by PI in eCRF|0|||
147484052|NCT01781429|531928263|FG001|Overall Study|Other - as entered by PI in eCRF|1|||
147484053|NCT01781429|531928264|FG002|Overall Study|Other - as entered by PI in eCRF|0|||
147484054|NCT01781429|531928265|FG003|Overall Study|Other - as entered by PI in eCRF|0|||
147484055|NCT01781429|531928266|FG004|Overall Study|Other - as entered by PI in eCRF|0|||
147484056|NCT01781429|531928267|FG005|Overall Study|Other - as entered by PI in eCRF|0|||
147484057|NCT01781429|531928268|FG006|Overall Study|Other - as entered by PI in eCRF|0|||
147484058|NCT01781429|531928269|FG007|Overall Study|Other - as entered by PI in eCRF|0|||
147484059|NCT01781429|531928270|FG008|Overall Study|Other - as entered by PI in eCRF|0|||
147484060|NCT01781429|531928271|FG009|Overall Study|Other - as entered by PI in eCRF|1|||
147484061|NCT01781429|531928272|FG010|Overall Study|Other - as entered by PI in eCRF|1|||
147484062|NCT01781429|531928273|FG011|Overall Study|Other - as entered by PI in eCRF|2|||
147484063|NCT01781429|531928274|FG012|Overall Study|Other - as entered by PI in eCRF|1|||
147484064|NCT01781429|531928275|FG013|Overall Study|Other - as entered by PI in eCRF|1|||
147484065|NCT01781429|531928276|FG014|Overall Study|Other - as entered by PI in eCRF|1|||
147484066|NCT01781429|531928277|FG015|Overall Study|Other - as entered by PI in eCRF|0|||
147484067|NCT01781429|531928262|FG000|Overall Study|Enrolled, but not treated|0|||
147484068|NCT01781429|531928263|FG001|Overall Study|Enrolled, but not treated|0|||
147484069|NCT01781429|531928264|FG002|Overall Study|Enrolled, but not treated|0|||
147484070|NCT01781429|531928265|FG003|Overall Study|Enrolled, but not treated|0|||
147484071|NCT01781429|531928266|FG004|Overall Study|Enrolled, but not treated|0|||
147484072|NCT01781429|531928267|FG005|Overall Study|Enrolled, but not treated|0|||
147484073|NCT01781429|531928268|FG006|Overall Study|Enrolled, but not treated|0|||
147484074|NCT01781429|531928269|FG007|Overall Study|Enrolled, but not treated|0|||
147484075|NCT01781429|531928270|FG008|Overall Study|Enrolled, but not treated|0|||
147484076|NCT01781429|531928271|FG009|Overall Study|Enrolled, but not treated|0|||
147484077|NCT01781429|531928272|FG010|Overall Study|Enrolled, but not treated|1|||
147484078|NCT01781429|531928273|FG011|Overall Study|Enrolled, but not treated|0|||
147484079|NCT01781429|531928274|FG012|Overall Study|Enrolled, but not treated|0|||
147484080|NCT01781429|531928275|FG013|Overall Study|Enrolled, but not treated|0|||
147484081|NCT01781429|531928276|FG014|Overall Study|Enrolled, but not treated|0|||
147484082|NCT01781429|531928277|FG015|Overall Study|Enrolled, but not treated|0|||
147484083|NCT01035606|531928280|FG000|Overall Study|change in health, job demands,family|3|||
147484084|NCT01035606|531928281|FG001|Overall Study|change in health, job demands,family|3|||
147484085|NCT01035606|531928282|FG002|Overall Study|change in health, job demands,family|4|||
147484086|NCT01849848|531928283|FG000|Overall Study|Physician Decision|1|||
147484087|NCT01849848|531928283|FG000|Overall Study|Progression of the primary disease|3|||
147484088|NCT01809262|531928284|FG000|Period 1 (First Dose + Washout)|Adverse Event|0|||
147484089|NCT01809262|531928285|FG001|Period 1 (First Dose + Washout)|Adverse Event|0|||
147484090|NCT01809262|531928286|FG002|Period 1 (First Dose + Washout)|Adverse Event|0|||
147484091|NCT01809262|531928287|FG003|Period 1 (First Dose + Washout)|Adverse Event|0|||
147484092|NCT01809262|531928288|FG004|Period 1 (First Dose + Washout)|Adverse Event|1|||
147484093|NCT01809262|531928289|FG005|Period 1 (First Dose + Washout)|Adverse Event|0|||
147484094|NCT01809262|531928290|FG006|Period 1 (First Dose + Washout)|Adverse Event|0|||
147484095|NCT01809262|531928291|FG007|Period 1 (First Dose + Washout)|Adverse Event|0|||
147484096|NCT01809262|531928292|FG008|Period 1 (First Dose + Washout)|Adverse Event|0|||
147484097|NCT01809262|531928293|FG009|Period 1 (First Dose + Washout)|Adverse Event|0|||
147484098|NCT01809262|531928284|FG000|Period 3 (Third Dose + Washout)|Adverse Event|0|||
147484099|NCT01809262|531928285|FG001|Period 3 (Third Dose + Washout)|Adverse Event|1|||
147484100|NCT01809262|531928286|FG002|Period 3 (Third Dose + Washout)|Adverse Event|0|||
147667744|NCT00794664|532608132|FG000|Follow-up Period|Other|1|||
147484101|NCT01809262|531928287|FG003|Period 3 (Third Dose + Washout)|Adverse Event|0|||
147484102|NCT01809262|531928288|FG004|Period 3 (Third Dose + Washout)|Adverse Event|0|||
147484103|NCT01809262|531928289|FG005|Period 3 (Third Dose + Washout)|Adverse Event|0|||
147484104|NCT01809262|531928290|FG006|Period 3 (Third Dose + Washout)|Adverse Event|0|||
147484105|NCT01809262|531928291|FG007|Period 3 (Third Dose + Washout)|Adverse Event|0|||
147484106|NCT01809262|531928292|FG008|Period 3 (Third Dose + Washout)|Adverse Event|0|||
147484107|NCT01809262|531928293|FG009|Period 3 (Third Dose + Washout)|Adverse Event|0|||
147484108|NCT01505491|531928294|FG000|Overall Study|Other reason not listed|1|||
147484109|NCT01505491|531928295|FG001|Overall Study|Other reason not listed|0|||
147484110|NCT01505491|531928296|FG002|Overall Study|Other reason not listed|0|||
147484111|NCT01505491|531928294|FG000|Overall Study|Withdrawal by Subject|1|||
147484112|NCT01505491|531928295|FG001|Overall Study|Withdrawal by Subject|1|||
147484113|NCT01505491|531928296|FG002|Overall Study|Withdrawal by Subject|4|||
147484114|NCT01505491|531928294|FG000|Overall Study|Lost to Follow-up|0|||
147484115|NCT01505491|531928295|FG001|Overall Study|Lost to Follow-up|0|||
147484116|NCT01505491|531928296|FG002|Overall Study|Lost to Follow-up|1|||
147484117|NCT01740440|531928299|FG000|Overall Study|Lost to Follow-up|3|||
147484118|NCT01063751|531928301|FG000|Overall Study|Censored from analyses|42|||
147484119|NCT01063751|531928301|FG000|Overall Study|Withdrawal by Subject|34|||
147484120|NCT01063751|531928301|FG000|Overall Study|Lost to Follow-up|30|||
147484121|NCT01063751|531928301|FG000|Overall Study|Death|13|||
147484122|NCT01063751|531928301|FG000|Overall Study|Sponsored Terminated Study|60|||
147484123|NCT01063751|531928301|FG000|Overall Study|Cases terminated due to investigator leaving the site and site closure.|35|||
147484124|NCT01063751|531928301|FG000|Overall Study|Investigator site closed|10|||
147484125|NCT01063751|531928301|FG000|Overall Study|Revision|6|||
147484126|NCT01063751|531928301|FG000|Overall Study|Physician Decision|4|||
147484127|NCT03408873|531928307|FG000|Visit 1 Assessment (Baseline)|Lost to Follow-up|3|||
147484128|NCT03408873|531928307|FG000|Visit 2 Assessment|Lost to Follow-up|1|||
147484129|NCT03408873|531928307|FG000|Visit 3 Assessment|Withdrawal by Subject|1|||
147484130|NCT03408873|531928307|FG000|Visit 4 Assessment|Lost to Follow-up|2|||
147484131|NCT03408873|531928307|FG000|Visit 5 Assessment|Lost to Follow-up|1|||
147484132|NCT03408873|531928307|FG000|Visit 6 Assessment|Withdrawal by Subject|1|||
147484133|NCT00406315|531928313|FG000|Overall Study|Death|1|||
147484134|NCT00406315|531928313|FG000|Overall Study|Adverse Event|39|||
147484135|NCT00406315|531928313|FG000|Overall Study|Laboratory Abnormality|4|||
147484136|NCT00406315|531928313|FG000|Overall Study|Lack of Efficacy|13|||
147484137|NCT00406315|531928313|FG000|Overall Study|Other|33|||
147484138|NCT00406315|531928313|FG000|Overall Study|Lost to Follow-up|21|||
147484139|NCT00406315|531928313|FG000|Overall Study|Withdrawal by Subject|30|||
147484140|NCT01312428|531928314|FG000|Overall Study|Study Termination|3|||
147484141|NCT01312428|531928315|FG001|Overall Study|Study Termination|4|||
147484142|NCT01797783|531928319|FG000|Overall Study|Adverse Event|1|||
147484143|NCT01797783|531928320|FG001|Overall Study|Adverse Event|1|||
147484144|NCT01797783|531928319|FG000|Overall Study|Withdrawal by Subject|1|||
147484145|NCT01797783|531928320|FG001|Overall Study|Withdrawal by Subject|0|||
147484146|NCT02202031|531928322|FG000|Overall Study|Lost to Follow-up|1|||
147484147|NCT02202031|531928323|FG001|Overall Study|Lost to Follow-up|0|||
147484148|NCT02202031|531928322|FG000|Overall Study|Too Busy|1|||
147484149|NCT02202031|531928323|FG001|Overall Study|Too Busy|3|||
147484150|NCT02202031|531928322|FG000|Overall Study|Illness/Medical Reason|0|||
147484151|NCT02202031|531928323|FG001|Overall Study|Illness/Medical Reason|2|||
147484152|NCT02202031|531928322|FG000|Overall Study|Intolerance/Lack of Improvement|3|||
147484153|NCT02202031|531928323|FG001|Overall Study|Intolerance/Lack of Improvement|0|||
147484154|NCT02184143|531928324|FG000|Overall Study|Withdrawal by Subject|4|||
147484155|NCT02184143|531928325|FG001|Overall Study|Withdrawal by Subject|4|||
147484156|NCT02184143|531928324|FG000|Overall Study|Lost to Follow-up|5|||
147484157|NCT02184143|531928325|FG001|Overall Study|Lost to Follow-up|3|||
147484158|NCT02184143|531928324|FG000|Overall Study|Death|1|||
147484159|NCT02184143|531928325|FG001|Overall Study|Death|0|||
147484160|NCT02214186|531928331|FG000|Overall Study|Lost to Follow-up|1|||
147484161|NCT02214186|531928332|FG001|Overall Study|Lost to Follow-up|1|||
147484162|NCT02214186|531928331|FG000|Overall Study|Protocol Violation|1|||
147484163|NCT02214186|531928332|FG001|Overall Study|Protocol Violation|1|||
147484164|NCT01525849|531928333|FG000|Overall Study|Lost to Follow-up|3|||
147484165|NCT01525849|531928334|FG001|Overall Study|Lost to Follow-up|2|||
147484166|NCT01525849|531928333|FG000|Overall Study|Withdrawal by Subject|1|||
147484167|NCT01525849|531928334|FG001|Overall Study|Withdrawal by Subject|9|||
147484168|NCT01525849|531928333|FG000|Overall Study|Unrelated medical issue (not treated)|1|||
147484169|NCT01525849|531928334|FG001|Overall Study|Unrelated medical issue (not treated)|2|||
147484170|NCT01525849|531928333|FG000|Overall Study|Anatomic exclusion criteria identified|0|||
147484171|NCT01525849|531928334|FG001|Overall Study|Anatomic exclusion criteria identified|3|||
147484172|NCT00339183|531928335|FG000|Overall Study|Adverse Event|5|||
147484173|NCT00339183|531928336|FG001|Overall Study|Adverse Event|3|||
147484174|NCT00339183|531928335|FG000|Overall Study|Withdrawal by Subject|16|||
147484175|NCT00339183|531928336|FG001|Overall Study|Withdrawal by Subject|19|||
147484176|NCT00339183|531928335|FG000|Overall Study|Physician Decision|2|||
147484177|NCT00339183|531928336|FG001|Overall Study|Physician Decision|4|||
147484178|NCT00339183|531928335|FG000|Overall Study|Lost to Follow-up|17|||
147484179|NCT00339183|531928336|FG001|Overall Study|Lost to Follow-up|17|||
147484180|NCT00339183|531928335|FG000|Overall Study|Protocol-specified criteria|12|||
147484181|NCT00339183|531928336|FG001|Overall Study|Protocol-specified criteria|8|||
147484182|NCT00339183|531928335|FG000|Overall Study|Missing reason|3|||
147484183|NCT00339183|531928336|FG001|Overall Study|Missing reason|1|||
147484184|NCT00339183|531928335|FG000|Overall Study|Other|46|||
147484185|NCT00339183|531928336|FG001|Overall Study|Other|40|||
147484186|NCT00339183|531928335|FG000|Overall Study|Ongoing|20|||
147484187|NCT00339183|531928336|FG001|Overall Study|Ongoing|13|||
147484188|NCT00793819|531928337|FG000|Overall Study|Adverse Event|8|||
147484189|NCT00793819|531928338|FG001|Overall Study|Adverse Event|4|||
147484190|NCT00793819|531928337|FG000|Overall Study|Lack of Efficacy|1|||
147484191|NCT00793819|531928338|FG001|Overall Study|Lack of Efficacy|1|||
147484192|NCT00793819|531928337|FG000|Overall Study|Withdrawal by Subject|4|||
147484193|NCT00793819|531928338|FG001|Overall Study|Withdrawal by Subject|3|||
147484194|NCT00793819|531928337|FG000|Overall Study|Lost to Follow-up|1|||
147484195|NCT00793819|531928338|FG001|Overall Study|Lost to Follow-up|1|||
147484196|NCT00446446|531928339|FG000|Overall Study|Death|10|||
147484197|NCT00446446|531928339|FG000|Overall Study|Withdrawal by Subject|6|||
147484198|NCT00446446|531928339|FG000|Overall Study|Other|4|||
147484199|NCT00446446|531928339|FG000|Overall Study|Disease Progession|2|||
147484200|NCT00446446|531928339|FG000|Overall Study|Adverse Event|1|||
147484201|NCT00446446|531928339|FG000|Overall Study|On Treatment at Time of Data Cut-off|1|||
147484202|NCT00611130|531928346|FG000|Overall Study|Lost to Follow-up|25|||
147484203|NCT00611130|531928347|FG001|Overall Study|Lost to Follow-up|29|||
147484204|NCT00611130|531928346|FG000|Overall Study|Protocol noncompliance|7|||
147484205|NCT00611130|531928347|FG001|Overall Study|Protocol noncompliance|6|||
147484206|NCT00611130|531928346|FG000|Overall Study|Withdrawal by Subject|6|||
147484207|NCT00611130|531928347|FG001|Overall Study|Withdrawal by Subject|5|||
147484208|NCT00611130|531928346|FG000|Overall Study|Other|5|||
147484209|NCT00611130|531928347|FG001|Overall Study|Other|4|||
147484210|NCT00611130|531928346|FG000|Overall Study|Incarceration|3|||
147484211|NCT00611130|531928347|FG001|Overall Study|Incarceration|2|||
147484212|NCT00611130|531928346|FG000|Overall Study|Administrative|1|||
147484213|NCT00611130|531928347|FG001|Overall Study|Administrative|1|||
147484214|NCT00611130|531928346|FG000|Overall Study|Adverse Event|1|||
147484215|NCT00611130|531928347|FG001|Overall Study|Adverse Event|0|||
147484216|NCT00611130|531928346|FG000|Overall Study|Death|1|||
147484217|NCT00611130|531928347|FG001|Overall Study|Death|0|||
147484218|NCT03662334|531928349|FG000|Part 2: Treatment Period 2 (2 Days)|Intended Changes to Clamp Procedure|1|||
147484219|NCT03662334|531928350|FG001|Part 2: Treatment Period 2 (2 Days)|Intended Changes to Clamp Procedure|0|||
147484220|NCT02119104|531928355|FG000|Overall Study|Protocol Violation|16|||
147484221|NCT01632878|531928356|FG000|Screening|Physician Decision|268|||
147484222|NCT01632878|531928356|FG000|Treatment|Lost to Follow-up|41|||
147484223|NCT01632878|531928356|FG000|Treatment|Withdrawal by Subject|36|||
147484224|NCT01632878|531928356|FG000|Treatment|Physician Decision|34|||
147484225|NCT01632878|531928356|FG000|Treatment|missing information|4|||
147484226|NCT01632878|531928356|FG000|Treatment|no information on study completion|43|||
147484227|NCT01558089|531928357|FG000|Overall Study|Adverse Event|1|||
147484228|NCT01558089|531928357|FG000|Overall Study|Lack of Efficacy|1|||
147484229|NCT01558089|531928357|FG000|Overall Study|Lost to Follow-up|5|||
147484230|NCT01558089|531928357|FG000|Overall Study|Withdrawal by Subject|6|||
147484231|NCT02948777|531929661|FG000|Overall Study|worsening of asthma symptoms resulting in oral prednisolone use.|1|||
147484232|NCT03242928|531929662|FG000|Overall Study|Adverse Event|2|||
147484233|NCT03242928|531929663|FG001|Overall Study|Adverse Event|1|||
147484234|NCT03242928|531929662|FG000|Overall Study|Lost to Follow-up|2|||
147484235|NCT03242928|531929663|FG001|Overall Study|Lost to Follow-up|0|||
147484236|NCT03242928|531929662|FG000|Overall Study|Physician Decision|0|||
147484237|NCT03242928|531929663|FG001|Overall Study|Physician Decision|1|||
147484238|NCT03242928|531929662|FG000|Overall Study|Withdrawal by Subject|5|||
147484239|NCT03242928|531929663|FG001|Overall Study|Withdrawal by Subject|3|||
147484240|NCT00431847|531929668|FG000|Overall Study|completion of less than two study visits|6|||
147484241|NCT00431847|531929669|FG001|Overall Study|completion of less than two study visits|3|||
147623472|NCT00838903|532440144|FG002|Follow-up Period (8 Weeks)|Subject Moved out of Town|0|||
147623473|NCT00838903|532440145|FG003|Follow-up Period (8 Weeks)|Subject Moved out of Town|1|||
147484242|NCT00431847|531929670|FG002|Overall Study|completion of less than two study visits|4|||
147484243|NCT00431847|531929671|FG003|Overall Study|completion of less than two study visits|14|||
147484244|NCT00431847|531929672|FG004|Overall Study|completion of less than two study visits|0|||
147484245|NCT00431847|531929668|FG000|Overall Study|Protocol Violation|0|||
147484246|NCT00431847|531929669|FG001|Overall Study|Protocol Violation|0|||
147484247|NCT00431847|531929670|FG002|Overall Study|Protocol Violation|0|||
147484248|NCT00431847|531929671|FG003|Overall Study|Protocol Violation|0|||
147484249|NCT00431847|531929672|FG004|Overall Study|Protocol Violation|1|||
147484250|NCT02142894|531929675|FG000|Overall Study|Protocol Violation|8|||
147484251|NCT01024465|531929680|FG000|Overall Study|Adverse Event|2|||
147484252|NCT01024465|531929680|FG000|Overall Study|Physician Decision|1|||
147484253|NCT03078608|531929684|FG000|Overall Study|Death|1|||
147484254|NCT03078608|531929685|FG001|Overall Study|Death|2|||
147484255|NCT03078608|531929686|FG002|Overall Study|Death|0|||
147484256|NCT03078608|531929687|FG003|Overall Study|Death|0|||
147484257|NCT03078608|531929684|FG000|Overall Study|Withdrawal by Subject|8|||
147484258|NCT03078608|531929685|FG001|Overall Study|Withdrawal by Subject|1|||
147484259|NCT03078608|531929686|FG002|Overall Study|Withdrawal by Subject|0|||
147484260|NCT03078608|531929687|FG003|Overall Study|Withdrawal by Subject|0|||
147484261|NCT03078608|531929684|FG000|Overall Study|Lost to Follow-up|5|||
147484262|NCT03078608|531929685|FG001|Overall Study|Lost to Follow-up|8|||
147484263|NCT03078608|531929686|FG002|Overall Study|Lost to Follow-up|4|||
147484264|NCT03078608|531929687|FG003|Overall Study|Lost to Follow-up|1|||
147484265|NCT00723840|531929688|FG000|Overall Study|Lost to Follow-up|2|||
147484266|NCT00723840|531929688|FG000|Overall Study|Failure to return|18|||
147484267|NCT00723840|531929688|FG000|Overall Study|Withdrawal by Subject|55|||
147484268|NCT00723840|531929688|FG000|Overall Study|Serious Adverse Events|3|||
147484269|NCT00723840|531929688|FG000|Overall Study|Other Medical Event|2|||
147484270|NCT00723840|531929688|FG000|Overall Study|Unspecified reason|2|||
147484271|NCT01400971|531929692|FG000|Overall Study|Death|82|||
147484272|NCT01400971|531929692|FG000|Overall Study|Lost to Follow-up|196|||
147484273|NCT01400971|531929692|FG000|Overall Study|Lost to follow up + Subject Decision|2|||
147484274|NCT01400971|531929692|FG000|Overall Study|Physician Decision|57|||
147484275|NCT01400971|531929692|FG000|Overall Study|Withdrawal by Subject|158|||
147484276|NCT01400971|531929692|FG000|Overall Study|Other|422|||
147484277|NCT02137772|531929696|FG000|Overall Study|Adverse Event|6|||
147484278|NCT02137772|531929697|FG001|Overall Study|Adverse Event|3|||
147484279|NCT02137772|531929696|FG000|Overall Study|Death|71|||
147484280|NCT02137772|531929697|FG001|Overall Study|Death|44|||
147484281|NCT02137772|531929696|FG000|Overall Study|Lost to Follow-up|8|||
147484282|NCT02137772|531929697|FG001|Overall Study|Lost to Follow-up|4|||
147484283|NCT02137772|531929696|FG000|Overall Study|Physician Decision|15|||
147484284|NCT02137772|531929697|FG001|Overall Study|Physician Decision|5|||
147484285|NCT02137772|531929696|FG000|Overall Study|Withdrawal by Subject|28|||
147484286|NCT02137772|531929697|FG001|Overall Study|Withdrawal by Subject|17|||
147484287|NCT02137772|531929696|FG000|Overall Study|Non-compliance with study drug|1|||
147484288|NCT02137772|531929697|FG001|Overall Study|Non-compliance with study drug|0|||
147484289|NCT02137772|531929696|FG000|Overall Study|Not treated|3|||
147484290|NCT02137772|531929697|FG001|Overall Study|Not treated|2|||
147484291|NCT00455858|531929698|FG000|Overall Study|Lost to Follow-up|2|||
147484292|NCT00455858|531929698|FG000|Overall Study|Protocol Violation|1|||
147484293|NCT00455858|531929698|FG000|Overall Study|Lack of Efficacy|1|||
147484294|NCT00455858|531929698|FG000|Overall Study|Well controlled FPG without insulin|1|||
147484295|NCT00455858|531929698|FG000|Overall Study|Withdrawal|1|||
147484296|NCT02092389|531929699|FG000|Overall Study|Adverse Event|1|||
147484297|NCT02092389|531929699|FG000|Overall Study|Other|5|||
147484298|NCT01844700|531929700|FG000|Overall Study|Lack of Efficacy|1|||
147484299|NCT01844700|531929701|FG001|Overall Study|Lack of Efficacy|0|||
147484300|NCT01844700|531929700|FG000|Overall Study|refused medication switch|1|||
147484301|NCT01844700|531929701|FG001|Overall Study|refused medication switch|0|||
147484302|NCT01844700|531929700|FG000|Overall Study|Withdrawal by Subject|1|||
147484303|NCT01844700|531929701|FG001|Overall Study|Withdrawal by Subject|0|||
147484304|NCT01844700|531929700|FG000|Overall Study|stopped taking meds|0|||
147484305|NCT01844700|531929701|FG001|Overall Study|stopped taking meds|1|||
147484306|NCT01242020|531929702|FG000|Overall Study|Withdrawal by Subject|2|||
147484307|NCT01242020|531929703|FG001|Overall Study|Withdrawal by Subject|0|||
147484308|NCT01242020|531929702|FG000|Overall Study|Failed screening|1|||
147484309|NCT01242020|531929703|FG001|Overall Study|Failed screening|0|||
147484310|NCT01595646|531929709|FG000|Overall Study|Withdrawal by Subject|1|||
147484311|NCT01595646|531929710|FG001|Overall Study|Withdrawal by Subject|0|||
147484312|NCT01595646|531929711|FG002|Overall Study|Withdrawal by Subject|0|||
147484313|NCT01161524|531929714|FG000|Core Study (23 Weeks)|Adverse Event|3|||
147484314|NCT01161524|531929715|FG001|Core Study (23 Weeks)|Adverse Event|0|||
147484315|NCT01161524|531929716|FG002|Core Study (23 Weeks)|Adverse Event|0|||
147484316|NCT01161524|531929714|FG000|Core Study (23 Weeks)|Other|1|||
147484317|NCT01161524|531929715|FG001|Core Study (23 Weeks)|Other|0|||
147484318|NCT01161524|531929716|FG002|Core Study (23 Weeks)|Other|0|||
147484319|NCT01161524|531929714|FG000|Core Study (23 Weeks)|Withdrawal of Consent|1|||
147484320|NCT01161524|531929715|FG001|Core Study (23 Weeks)|Withdrawal of Consent|1|||
147484321|NCT01161524|531929716|FG002|Core Study (23 Weeks)|Withdrawal of Consent|0|||
147484322|NCT01161524|531929714|FG000|Core Study (23 Weeks)|Lost to Follow-up|1|||
147484323|NCT01161524|531929715|FG001|Core Study (23 Weeks)|Lost to Follow-up|2|||
147484324|NCT01161524|531929716|FG002|Core Study (23 Weeks)|Lost to Follow-up|0|||
147484325|NCT01161524|531929714|FG000|Core Study (23 Weeks)|Subject Choice|3|||
147484326|NCT01161524|531929715|FG001|Core Study (23 Weeks)|Subject Choice|2|||
147484327|NCT01161524|531929716|FG002|Core Study (23 Weeks)|Subject Choice|0|||
147484328|NCT01161524|531929714|FG000|Extension Phase (Approximately 83 Weeks)|Adverse Event|0|||
147484329|NCT01161524|531929715|FG001|Extension Phase (Approximately 83 Weeks)|Adverse Event|0|||
147484330|NCT01161524|531929716|FG002|Extension Phase (Approximately 83 Weeks)|Adverse Event|8|||
147484331|NCT01161524|531929714|FG000|Extension Phase (Approximately 83 Weeks)|Other|0|||
147484332|NCT01161524|531929715|FG001|Extension Phase (Approximately 83 Weeks)|Other|0|||
147484333|NCT01161524|531929716|FG002|Extension Phase (Approximately 83 Weeks)|Other|6|||
147484334|NCT01161524|531929714|FG000|Extension Phase (Approximately 83 Weeks)|Lost to Follow-up|0|||
147484335|NCT01161524|531929715|FG001|Extension Phase (Approximately 83 Weeks)|Lost to Follow-up|0|||
147484336|NCT01161524|531929716|FG002|Extension Phase (Approximately 83 Weeks)|Lost to Follow-up|1|||
147484337|NCT01161524|531929714|FG000|Extension Phase (Approximately 83 Weeks)|Subject Choice|0|||
147484338|NCT01161524|531929715|FG001|Extension Phase (Approximately 83 Weeks)|Subject Choice|0|||
147484339|NCT01161524|531929716|FG002|Extension Phase (Approximately 83 Weeks)|Subject Choice|5|||
147484340|NCT01161524|531929714|FG000|Extension Phase (Approximately 83 Weeks)|Inadequate Therapeutic Effect|0|||
147484341|NCT01161524|531929715|FG001|Extension Phase (Approximately 83 Weeks)|Inadequate Therapeutic Effect|0|||
147484342|NCT01161524|531929716|FG002|Extension Phase (Approximately 83 Weeks)|Inadequate Therapeutic Effect|4|||
147484343|NCT00642616|531929717|FG000|Overall Study|Adverse Event|2|||
147484344|NCT00642616|531929718|FG001|Overall Study|Adverse Event|0|||
147484345|NCT00642616|531929719|FG002|Overall Study|Adverse Event|1|||
147484346|NCT00642616|531929720|FG003|Overall Study|Adverse Event|0|||
147484347|NCT00642616|531929717|FG000|Overall Study|Study Terminated by Sponsor|7|||
147484348|NCT00642616|531929718|FG001|Overall Study|Study Terminated by Sponsor|6|||
147484349|NCT00642616|531929719|FG002|Overall Study|Study Terminated by Sponsor|4|||
147484350|NCT00642616|531929720|FG003|Overall Study|Study Terminated by Sponsor|5|||
147484351|NCT00642616|531929717|FG000|Overall Study|Withdrawal by Subject|0|||
147484352|NCT00642616|531929718|FG001|Overall Study|Withdrawal by Subject|1|||
147484353|NCT00642616|531929719|FG002|Overall Study|Withdrawal by Subject|1|||
147484354|NCT00642616|531929720|FG003|Overall Study|Withdrawal by Subject|1|||
147484355|NCT00642616|531929717|FG000|Overall Study|Protocol Violation|0|||
147484356|NCT00642616|531929718|FG001|Overall Study|Protocol Violation|0|||
147484357|NCT00642616|531929719|FG002|Overall Study|Protocol Violation|2|||
147484358|NCT00642616|531929720|FG003|Overall Study|Protocol Violation|0|||
147484359|NCT00642616|531929717|FG000|Overall Study|Physician Decision|0|||
147484360|NCT00642616|531929718|FG001|Overall Study|Physician Decision|0|||
147484361|NCT00642616|531929719|FG002|Overall Study|Physician Decision|1|||
147484362|NCT00642616|531929720|FG003|Overall Study|Physician Decision|1|||
147484363|NCT00399802|531929725|FG000|Overall Study|Adverse Event|0|||
147484364|NCT00399802|531929726|FG001|Overall Study|Adverse Event|2|||
147484365|NCT00399802|531929725|FG000|Overall Study|Participant discontinued by mistake|0|||
147484366|NCT00399802|531929726|FG001|Overall Study|Participant discontinued by mistake|1|||
147484367|NCT00542815|531929727|FG000|Overall Study|Adverse Event|19|||
147484368|NCT00542815|531929728|FG001|Overall Study|Adverse Event|6|||
147484369|NCT00542815|531929729|FG002|Overall Study|Adverse Event|9|||
147484370|NCT00542815|531929727|FG000|Overall Study|Death|10|||
147484371|NCT00542815|531929728|FG001|Overall Study|Death|7|||
147484372|NCT00542815|531929729|FG002|Overall Study|Death|3|||
147484373|NCT00542815|531929727|FG000|Overall Study|Lack of Efficacy|9|||
147484374|NCT00542815|531929728|FG001|Overall Study|Lack of Efficacy|2|||
147484375|NCT00542815|531929729|FG002|Overall Study|Lack of Efficacy|0|||
147484376|NCT00542815|531929727|FG000|Overall Study|Physician Decision|2|||
147484377|NCT00542815|531929728|FG001|Overall Study|Physician Decision|1|||
147484378|NCT00542815|531929729|FG002|Overall Study|Physician Decision|0|||
147484379|NCT00542815|531929727|FG000|Overall Study|Protocol Violation|1|||
147484380|NCT00542815|531929728|FG001|Overall Study|Protocol Violation|1|||
147484381|NCT00542815|531929729|FG002|Overall Study|Protocol Violation|2|||
147484382|NCT00542815|531929727|FG000|Overall Study|Withdrawal by Subject|41|||
147484383|NCT00542815|531929728|FG001|Overall Study|Withdrawal by Subject|5|||
147484384|NCT00542815|531929729|FG002|Overall Study|Withdrawal by Subject|8|||
147484385|NCT00542815|531929727|FG000|Overall Study|Other reasons|24|||
147484386|NCT00542815|531929728|FG001|Overall Study|Other reasons|10|||
147484387|NCT00542815|531929729|FG002|Overall Study|Other reasons|10|||
147484388|NCT04172831|531929732|FG000|Overall Study|Adverse Event|21|||
147484389|NCT04172831|531929733|FG001|Overall Study|Adverse Event|9|||
147484390|NCT04172831|531929732|FG000|Overall Study|Lack of Efficacy|2|||
147484391|NCT04172831|531929733|FG001|Overall Study|Lack of Efficacy|8|||
147484392|NCT04172831|531929732|FG000|Overall Study|Physician Decision|0|||
147484393|NCT04172831|531929733|FG001|Overall Study|Physician Decision|1|||
147484394|NCT04172831|531929732|FG000|Overall Study|Withdrawal by Subject|12|||
147484395|NCT04172831|531929733|FG001|Overall Study|Withdrawal by Subject|11|||
147484396|NCT04172831|531929732|FG000|Overall Study|Lost to Follow-up|4|||
147484397|NCT04172831|531929733|FG001|Overall Study|Lost to Follow-up|9|||
147484398|NCT04172831|531929732|FG000|Overall Study|COVID-19 related crisis|3|||
147484399|NCT04172831|531929733|FG001|Overall Study|COVID-19 related crisis|3|||
147484400|NCT04172831|531929732|FG000|Overall Study|Subject non-compliance|1|||
147484401|NCT04172831|531929733|FG001|Overall Study|Subject non-compliance|1|||
147484402|NCT04172831|531929732|FG000|Overall Study|Family emergency|1|||
147484403|NCT04172831|531929733|FG001|Overall Study|Family emergency|0|||
147484404|NCT01041573|531929734|FG000|Overall Study|Withdrawal by Subject|2|||
147484405|NCT01041573|531929735|FG001|Overall Study|Withdrawal by Subject|5|||
147484406|NCT01041573|531929736|FG002|Overall Study|Withdrawal by Subject|2|||
147484407|NCT01041573|531929737|FG003|Overall Study|Withdrawal by Subject|0|||
147484408|NCT01041573|531929734|FG000|Overall Study|Death|1|||
147484409|NCT01041573|531929735|FG001|Overall Study|Death|0|||
147484410|NCT01041573|531929736|FG002|Overall Study|Death|0|||
147484411|NCT01041573|531929737|FG003|Overall Study|Death|0|||
147484412|NCT01041573|531929734|FG000|Overall Study|Lost to Follow-up|0|||
147484413|NCT01041573|531929735|FG001|Overall Study|Lost to Follow-up|1|||
147484414|NCT01041573|531929736|FG002|Overall Study|Lost to Follow-up|2|||
147484415|NCT01041573|531929737|FG003|Overall Study|Lost to Follow-up|1|||
147484416|NCT01041573|531929734|FG000|Overall Study|Adverse Event|0|||
147484417|NCT01041573|531929735|FG001|Overall Study|Adverse Event|2|||
147484418|NCT01041573|531929736|FG002|Overall Study|Adverse Event|0|||
147484419|NCT01041573|531929737|FG003|Overall Study|Adverse Event|0|||
147484420|NCT01041573|531929734|FG000|Overall Study|relocation|1|||
147484421|NCT01041573|531929735|FG001|Overall Study|relocation|4|||
147484422|NCT01041573|531929736|FG002|Overall Study|relocation|3|||
147484423|NCT01041573|531929737|FG003|Overall Study|relocation|1|||
147484424|NCT01041573|531929734|FG000|Overall Study|further blood extraction|0|||
147484425|NCT01041573|531929735|FG001|Overall Study|further blood extraction|1|||
147484426|NCT01041573|531929736|FG002|Overall Study|further blood extraction|0|||
147484427|NCT01041573|531929737|FG003|Overall Study|further blood extraction|0|||
147484428|NCT01041573|531929734|FG000|Overall Study|positive to anti-HCV|1|||
147484429|NCT01041573|531929735|FG001|Overall Study|positive to anti-HCV|0|||
147484430|NCT01041573|531929736|FG002|Overall Study|positive to anti-HCV|0|||
147484431|NCT01041573|531929737|FG003|Overall Study|positive to anti-HCV|0|||
147484432|NCT02955186|531929738|FG000|Overall Study|Withdrawal by Subject|6|||
147484433|NCT02955186|531929739|FG001|Overall Study|Withdrawal by Subject|2|||
147484434|NCT02955186|531929738|FG000|Overall Study|Protocol Violation|1|||
147484435|NCT02955186|531929739|FG001|Overall Study|Protocol Violation|0|||
147484436|NCT01618656|531929742|FG000|Overall Study|Withdrawal by Subject|7|||
147484437|NCT01618656|531929743|FG001|Overall Study|Withdrawal by Subject|3|||
147484438|NCT01618656|531929742|FG000|Overall Study|Physician Decision|1|||
147484439|NCT01618656|531929743|FG001|Overall Study|Physician Decision|1|||
147484440|NCT01276847|531929744|FG000|Overall Study|Withdrawal by Subject|1|||
147484441|NCT01276847|531929745|FG001|Overall Study|Withdrawal by Subject|0|||
147484442|NCT01276847|531929746|FG002|Overall Study|Withdrawal by Subject|0|||
147484443|NCT01899144|531929747|FG000|Treatment Period 2|Other|1|||
147484444|NCT01899144|531929747|FG000|Treatment Period 3|Other|2|||
147484445|NCT01899144|531929747|FG000|Treatment Period 5|Other|1|||
147484446|NCT00751881|531929750|FG000|Core Treatment Period|Not treated|1|||
147484447|NCT00751881|531929751|FG001|Core Treatment Period|Not treated|1|||
147484448|NCT00751881|531929752|FG002|Core Treatment Period|Not treated|2|||
147484449|NCT00751881|531929750|FG000|Core Treatment Period|Adverse Event|26|||
147484450|NCT00751881|531929751|FG001|Core Treatment Period|Adverse Event|54|||
147484451|NCT00751881|531929752|FG002|Core Treatment Period|Adverse Event|58|||
147484452|NCT00751881|531929750|FG000|Core Treatment Period|Lack of Efficacy|37|||
147484453|NCT00751881|531929751|FG001|Core Treatment Period|Lack of Efficacy|30|||
147484454|NCT00751881|531929752|FG002|Core Treatment Period|Lack of Efficacy|20|||
147484455|NCT00751881|531929750|FG000|Core Treatment Period|Poor compliance to protocol|15|||
147484456|NCT00751881|531929751|FG001|Core Treatment Period|Poor compliance to protocol|3|||
147484457|NCT00751881|531929752|FG002|Core Treatment Period|Poor compliance to protocol|4|||
147484458|NCT00751881|531929750|FG000|Core Treatment Period|Lost to Follow-up|6|||
147484459|NCT00751881|531929751|FG001|Core Treatment Period|Lost to Follow-up|4|||
147484460|NCT00751881|531929752|FG002|Core Treatment Period|Lost to Follow-up|3|||
147484461|NCT00751881|531929750|FG000|Core Treatment Period|Other: protocol deviation|3|||
147484462|NCT00751881|531929751|FG001|Core Treatment Period|Other: protocol deviation|3|||
147484463|NCT00751881|531929752|FG002|Core Treatment Period|Other: protocol deviation|7|||
147484464|NCT00751881|531929750|FG000|Core Treatment Period|Other: wish to parent|5|||
147484465|NCT00751881|531929751|FG001|Core Treatment Period|Other: wish to parent|7|||
147484466|NCT00751881|531929752|FG002|Core Treatment Period|Other: wish to parent|4|||
147484467|NCT00751881|531929750|FG000|Core Treatment Period|Other: personal/family constraints|6|||
147484468|NCT00751881|531929751|FG001|Core Treatment Period|Other: personal/family constraints|7|||
147484469|NCT00751881|531929752|FG002|Core Treatment Period|Other: personal/family constraints|10|||
147623474|NCT00838903|532440142|FG000|Follow-up Period (8 Weeks)|Missing|1|||
147623475|NCT00838903|532440143|FG001|Follow-up Period (8 Weeks)|Missing|2|||
147484470|NCT00751881|531929750|FG000|Core Treatment Period|Other: MS treatment change|6|||
147484471|NCT00751881|531929751|FG001|Core Treatment Period|Other: MS treatment change|4|||
147484472|NCT00751881|531929752|FG002|Core Treatment Period|Other: MS treatment change|4|||
147484473|NCT00751881|531929750|FG000|Core Treatment Period|Other: tolerability complaints|2|||
147484474|NCT00751881|531929751|FG001|Core Treatment Period|Other: tolerability complaints|0|||
147623476|NCT00838903|532440144|FG002|Follow-up Period (8 Weeks)|Missing|1|||
147623477|NCT00838903|532440145|FG003|Follow-up Period (8 Weeks)|Missing|1|||
147484475|NCT00751881|531929752|FG002|Core Treatment Period|Other: tolerability complaints|0|||
147484476|NCT00751881|531929750|FG000|Core Treatment Period|Other:participant's decision/unspecified|19|||
147484477|NCT00751881|531929751|FG001|Core Treatment Period|Other:participant's decision/unspecified|22|||
147484478|NCT00751881|531929752|FG002|Core Treatment Period|Other:participant's decision/unspecified|16|||
147667745|NCT00794664|532608133|FG001|Follow-up Period|Other|2|||
147484479|NCT00751881|531929750|FG000|Extension Study Period|Adverse Event|18|||
147484480|NCT00751881|531929751|FG001|Extension Study Period|Adverse Event|20|||
147484481|NCT00751881|531929752|FG002|Extension Study Period|Adverse Event|21|||
147484482|NCT00751881|531929750|FG000|Extension Study Period|Lack of Efficacy|14|||
147484483|NCT00751881|531929751|FG001|Extension Study Period|Lack of Efficacy|10|||
147484484|NCT00751881|531929752|FG002|Extension Study Period|Lack of Efficacy|20|||
147484485|NCT00751881|531929750|FG000|Extension Study Period|Lost to Follow-up|4|||
147484486|NCT00751881|531929751|FG001|Extension Study Period|Lost to Follow-up|9|||
147484487|NCT00751881|531929752|FG002|Extension Study Period|Lost to Follow-up|6|||
147484488|NCT00751881|531929750|FG000|Extension Study Period|Poor Compliance to Protocol|3|||
147484489|NCT00751881|531929751|FG001|Extension Study Period|Poor Compliance to Protocol|2|||
147484490|NCT00751881|531929752|FG002|Extension Study Period|Poor Compliance to Protocol|1|||
147484491|NCT00751881|531929750|FG000|Extension Study Period|Other than specified above|26|||
147484492|NCT00751881|531929751|FG001|Extension Study Period|Other than specified above|30|||
147484493|NCT00751881|531929752|FG002|Extension Study Period|Other than specified above|18|||
147484494|NCT04770155|531929753|FG000|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
147484495|NCT04770155|531929754|FG001|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
147484496|NCT04770155|531929755|FG002|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
147484497|NCT04770155|531929756|FG003|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
147484498|NCT04770155|531929757|FG004|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
147484499|NCT04770155|531929758|FG005|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
147484500|NCT04770155|531929759|FG006|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
147484501|NCT04770155|531929760|FG007|Overall Study|Baseline measurements only. Investigator did not obtain treatments for the planned interventions.|1|||
147484502|NCT02021812|531929761|FG000|Overall Study|Death|8|||
147484503|NCT02021812|531929761|FG000|Overall Study|Withdrawal by Subject|3|||
147484504|NCT02021812|531929761|FG000|Overall Study|Lost to Follow-up|2|||
147484505|NCT02021812|531929761|FG000|Overall Study|Refuse to return, COVD 19|2|||
147484506|NCT00564629|531929762|FG000|Overall Study|Vomited within 2 hours of receiving drug|15|||
147484507|NCT00564629|531929763|FG001|Overall Study|Vomited within 2 hours of receiving drug|9|||
147484508|NCT03634072|531929764|FG000|Overall Study|Early termination of overall study|1|||
147484509|NCT03634072|531929765|FG001|Overall Study|Early termination of overall study|0|||
147484510|NCT01765764|531929766|FG000|Treatment Period|Adverse Event|1|||
147484511|NCT01765764|531929767|FG001|Treatment Period|Adverse Event|2|||
147484512|NCT01765764|531929768|FG002|Treatment Period|Adverse Event|1|||
147484513|NCT01765764|531929766|FG000|Treatment Period|Lost to Follow-up|0|||
147484514|NCT01765764|531929767|FG001|Treatment Period|Lost to Follow-up|3|||
147484515|NCT01765764|531929768|FG002|Treatment Period|Lost to Follow-up|2|||
147484516|NCT01765764|531929766|FG000|Treatment Period|Personal Reasons|1|||
147484517|NCT01765764|531929767|FG001|Treatment Period|Personal Reasons|2|||
147484518|NCT01765764|531929768|FG002|Treatment Period|Personal Reasons|1|||
147484519|NCT01765764|531929766|FG000|Treatment Period|Other Miscellaneous Reasons|1|||
147484520|NCT01765764|531929767|FG001|Treatment Period|Other Miscellaneous Reasons|2|||
147484521|NCT01765764|531929768|FG002|Treatment Period|Other Miscellaneous Reasons|2|||
147484522|NCT01651260|531929771|FG000|Overall Study|unable to apply product|3|||
147484523|NCT02144220|531929774|FG000|Overall Study|technology incompatibility|9|||
147484524|NCT02144220|531929774|FG000|Overall Study|Lack of Efficacy|4|||
147484525|NCT02144220|531929774|FG000|Overall Study|Physician Decision|3|||
147484526|NCT02144220|531929774|FG000|Overall Study|Withdrawal by Subject|2|||
147484527|NCT02144220|531929774|FG000|Overall Study|Protocol Violation|1|||
147484528|NCT01952015|531929777|FG000|Induction|Protocol Violation|1|||
147484529|NCT01952015|531929777|FG000|Maintenance|Adverse Event|2|||
147484530|NCT01952015|531929777|FG000|Treatment Period 3|Physician Decision|9|||
147484531|NCT02239094|531929778|FG000|Overall Study|Withdrawal by Subject|1|||
147484532|NCT02239094|531929778|FG000|Overall Study|Remitted before started|1|||
147484533|NCT01597193|531929779|FG000|Stage 1: Dose Escalation (141 Days)|Disease progression|7|||
147484534|NCT01597193|531929780|FG001|Stage 1: Dose Escalation (141 Days)|Disease progression|8|||
147484535|NCT01597193|531929781|FG002|Stage 1: Dose Escalation (141 Days)|Disease progression|0|||
147484536|NCT01597193|531929782|FG003|Stage 1: Dose Escalation (141 Days)|Disease progression|0|||
147484537|NCT01597193|531929783|FG004|Stage 1: Dose Escalation (141 Days)|Disease progression|0|||
147484538|NCT01597193|531929784|FG005|Stage 1: Dose Escalation (141 Days)|Disease progression|0|||
147623478|NCT04225715|532440146|FG000|Overall Study|Reason not Specified|1|||
147623479|NCT04225715|532440147|FG001|Overall Study|Reason not Specified|0|||
147484539|NCT01597193|531929785|FG006|Stage 1: Dose Escalation (141 Days)|Disease progression|0|||
147484540|NCT01597193|531929779|FG000|Stage 2: Dose Expansion (1067 Days)|Adverse Event|0|||
147484541|NCT01597193|531929780|FG001|Stage 2: Dose Expansion (1067 Days)|Adverse Event|0|||
147484542|NCT01597193|531929781|FG002|Stage 2: Dose Expansion (1067 Days)|Adverse Event|0|||
147484543|NCT01597193|531929782|FG003|Stage 2: Dose Expansion (1067 Days)|Adverse Event|1|||
147484544|NCT01597193|531929783|FG004|Stage 2: Dose Expansion (1067 Days)|Adverse Event|2|||
147484545|NCT01597193|531929784|FG005|Stage 2: Dose Expansion (1067 Days)|Adverse Event|3|||
147484546|NCT01597193|531929785|FG006|Stage 2: Dose Expansion (1067 Days)|Adverse Event|0|||
147484547|NCT01597193|531929779|FG000|Stage 2: Dose Expansion (1067 Days)|Disease progression|0|||
147484548|NCT01597193|531929780|FG001|Stage 2: Dose Expansion (1067 Days)|Disease progression|0|||
147484549|NCT01597193|531929781|FG002|Stage 2: Dose Expansion (1067 Days)|Disease progression|14|||
147484550|NCT01597193|531929782|FG003|Stage 2: Dose Expansion (1067 Days)|Disease progression|18|||
147484551|NCT01597193|531929783|FG004|Stage 2: Dose Expansion (1067 Days)|Disease progression|14|||
147484552|NCT01597193|531929784|FG005|Stage 2: Dose Expansion (1067 Days)|Disease progression|18|||
147484553|NCT01597193|531929785|FG006|Stage 2: Dose Expansion (1067 Days)|Disease progression|11|||
147484554|NCT01597193|531929779|FG000|Stage 2: Dose Expansion (1067 Days)|Other|0|||
147484555|NCT01597193|531929780|FG001|Stage 2: Dose Expansion (1067 Days)|Other|0|||
147484556|NCT01597193|531929781|FG002|Stage 2: Dose Expansion (1067 Days)|Other|0|||
147484557|NCT01597193|531929782|FG003|Stage 2: Dose Expansion (1067 Days)|Other|0|||
147484558|NCT01597193|531929783|FG004|Stage 2: Dose Expansion (1067 Days)|Other|0|||
147484559|NCT01597193|531929784|FG005|Stage 2: Dose Expansion (1067 Days)|Other|1|||
147484560|NCT01597193|531929785|FG006|Stage 2: Dose Expansion (1067 Days)|Other|0|||
147484561|NCT01597193|531929779|FG000|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0|||
147484562|NCT01597193|531929780|FG001|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0|||
147484563|NCT01597193|531929781|FG002|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0|||
147484564|NCT01597193|531929782|FG003|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|1|||
147484565|NCT01597193|531929783|FG004|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0|||
147484566|NCT01597193|531929784|FG005|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|1|||
147484567|NCT01597193|531929785|FG006|Stage 2: Dose Expansion (1067 Days)|Withdrawal by Subject|0|||
147484568|NCT03184701|531929787|FG000|Overall Study|Death|3|||
147484569|NCT03184701|531929787|FG000|Overall Study|Physician Decision|3|||
147484570|NCT03184701|531929787|FG000|Overall Study|Withdrawal by Subject|6|||
147484571|NCT03184701|531929787|FG000|Overall Study|Lost to Follow-up|5|||
147484572|NCT03648996|531929790|FG000|Overall Study|Withdrawal by Subject|0|||
147484573|NCT03648996|531929791|FG001|Overall Study|Withdrawal by Subject|2|||
147484574|NCT03648996|531929792|FG002|Overall Study|Withdrawal by Subject|2|||
147484575|NCT03648996|531929790|FG000|Overall Study|Physician Decision|2|||
147484576|NCT03648996|531929791|FG001|Overall Study|Physician Decision|0|||
147484577|NCT03648996|531929792|FG002|Overall Study|Physician Decision|0|||
147484578|NCT03242759|531929796|FG000|Overall Study|Adverse Event|5|||
147484579|NCT03242759|531929797|FG001|Overall Study|Adverse Event|1|||
147484580|NCT03242759|531929796|FG000|Overall Study|Withdrawal by Subject|4|||
147484581|NCT03242759|531929797|FG001|Overall Study|Withdrawal by Subject|3|||
147484582|NCT03242759|531929796|FG000|Overall Study|Lost to Follow-up|3|||
147484583|NCT03242759|531929797|FG001|Overall Study|Lost to Follow-up|1|||
147484584|NCT03242759|531929796|FG000|Overall Study|Administrative problems|1|||
147484585|NCT03242759|531929797|FG001|Overall Study|Administrative problems|1|||
147484586|NCT03242759|531929796|FG000|Overall Study|Death|22|||
147484587|NCT03242759|531929797|FG001|Overall Study|Death|0|||
147484588|NCT03242759|531929796|FG000|Overall Study|Change visit schedule|0|||
147484589|NCT03242759|531929797|FG001|Overall Study|Change visit schedule|1|||
147484590|NCT00064662|531929798|FG000|Overall Study|Death|1|||
147484591|NCT00064662|531929799|FG001|Overall Study|Death|1|||
147484592|NCT00064662|531929798|FG000|Overall Study|Lost to Follow-up|57|||
147484593|NCT00064662|531929799|FG001|Overall Study|Lost to Follow-up|44|||
147484594|NCT00064662|531929798|FG000|Overall Study|Withdrawal by Subject|14|||
147484595|NCT00064662|531929799|FG001|Overall Study|Withdrawal by Subject|14|||
147484596|NCT00064662|531929798|FG000|Overall Study|Administratively withdrawn|2|||
147484597|NCT00064662|531929799|FG001|Overall Study|Administratively withdrawn|2|||
147484598|NCT00365976|531929806|FG000|Overall Study|Withdrawal by Subject|1|||
147484599|NCT00365976|531929807|FG001|Overall Study|Withdrawal by Subject|5|||
147484600|NCT01963117|531929808|FG000|Overall Study|Death|1|||
147484601|NCT01780389|531929809|FG000|Overall Study|Adverse Event|1|||
147484602|NCT01095250|531929810|FG000|Overall Study|administrative reasons|8|||
147484603|NCT01095250|531929811|FG001|Overall Study|administrative reasons|10|||
147484604|NCT01095250|531929812|FG002|Overall Study|administrative reasons|7|||
147484605|NCT01095250|531929813|FG003|Overall Study|administrative reasons|5|||
147484606|NCT01095250|531929810|FG000|Overall Study|Withdrawal by Subject|0|||
147484607|NCT01095250|531929811|FG001|Overall Study|Withdrawal by Subject|0|||
147484608|NCT01095250|531929812|FG002|Overall Study|Withdrawal by Subject|1|||
147623480|NCT04225715|532440148|FG002|Overall Study|Reason not Specified|0|||
147623481|NCT04225715|532440149|FG003|Overall Study|Reason not Specified|0|||
147484609|NCT01095250|531929813|FG003|Overall Study|Withdrawal by Subject|0|||
147484610|NCT01000064|531929814|FG000|Overall Study|Withdrawal by Subject|1|||
147484611|NCT01000064|531929815|FG001|Overall Study|Withdrawal by Subject|1|||
147484612|NCT02518620|531929816|FG000|Overall Study|Adverse Event|23|||
147484613|NCT02518620|531929817|FG001|Overall Study|Adverse Event|11|||
147623482|NCT04225715|532440150|FG004|Overall Study|Reason not Specified|0|||
147484614|NCT02518620|531929816|FG000|Overall Study|Lack of Efficacy|2|||
147484615|NCT02518620|531929817|FG001|Overall Study|Lack of Efficacy|0|||
147484616|NCT02518620|531929816|FG000|Overall Study|Non-Compliance with Study Drug|1|||
147484617|NCT02518620|531929817|FG001|Overall Study|Non-Compliance with Study Drug|0|||
147484618|NCT02518620|531929816|FG000|Overall Study|Physician Decision|1|||
147484619|NCT02518620|531929817|FG001|Overall Study|Physician Decision|1|||
147484620|NCT02518620|531929816|FG000|Overall Study|Sponsor's Decision|0|||
147484621|NCT02518620|531929817|FG001|Overall Study|Sponsor's Decision|3|||
147484622|NCT02518620|531929816|FG000|Overall Study|Lost to Follow-up|1|||
147484623|NCT02518620|531929817|FG001|Overall Study|Lost to Follow-up|1|||
147484624|NCT02518620|531929816|FG000|Overall Study|Withdrawal by Subject|17|||
147484625|NCT02518620|531929817|FG001|Overall Study|Withdrawal by Subject|9|||
147484626|NCT02518620|531929816|FG000|Overall Study|Death|1|||
147484627|NCT02518620|531929817|FG001|Overall Study|Death|0|||
147484628|NCT02518620|531929816|FG000|Overall Study|Pregnancy Wish|3|||
147484629|NCT02518620|531929817|FG001|Overall Study|Pregnancy Wish|0|||
147484630|NCT02518620|531929816|FG000|Overall Study|Pregnancy|1|||
147484631|NCT02518620|531929817|FG001|Overall Study|Pregnancy|0|||
147484632|NCT02518620|531929816|FG000|Overall Study|Relocation|2|||
147484633|NCT02518620|531929817|FG001|Overall Study|Relocation|1|||
147484634|NCT02125331|531931728|FG000|Overall Study|Protocol Violation|1|||
147484635|NCT02125331|531931729|FG001|Overall Study|Protocol Violation|0|||
147484636|NCT02125331|531931728|FG000|Overall Study|technical problem|2|||
147484637|NCT02125331|531931729|FG001|Overall Study|technical problem|0|||
147484638|NCT02125331|531931728|FG000|Overall Study|screen failure|2|||
147484639|NCT02125331|531931729|FG001|Overall Study|screen failure|0|||
147484640|NCT02078713|531931730|FG000|Overall Study|Lost to Follow-up|49|||
147484641|NCT02078713|531931731|FG001|Overall Study|Lost to Follow-up|55|||
147484642|NCT02078713|531931732|FG002|Overall Study|Lost to Follow-up|0|||
147484643|NCT02078713|531931733|FG003|Overall Study|Lost to Follow-up|0|||
147484644|NCT02078713|531931730|FG000|Overall Study|Pregnant at baseline|3|||
147484645|NCT02078713|531931731|FG001|Overall Study|Pregnant at baseline|5|||
147484646|NCT02078713|531931732|FG002|Overall Study|Pregnant at baseline|0|||
147484647|NCT02078713|531931733|FG003|Overall Study|Pregnant at baseline|0|||
147484648|NCT02078713|531931730|FG000|Overall Study|Enrolled twice|0|||
147484649|NCT02078713|531931731|FG001|Overall Study|Enrolled twice|1|||
147484650|NCT02078713|531931732|FG002|Overall Study|Enrolled twice|0|||
147484651|NCT02078713|531931733|FG003|Overall Study|Enrolled twice|0|||
147484652|NCT00696657|531931738|FG000|Overall Study|Protocol Violation|0|||
147484653|NCT00696657|531931739|FG001|Overall Study|Protocol Violation|0|||
147484654|NCT00696657|531931740|FG002|Overall Study|Protocol Violation|0|||
147484655|NCT00696657|531931741|FG003|Overall Study|Protocol Violation|0|||
147484656|NCT00696657|531931742|FG004|Overall Study|Protocol Violation|0|||
147484657|NCT00696657|531931743|FG005|Overall Study|Protocol Violation|1|||
147484658|NCT00696657|531931744|FG006|Overall Study|Protocol Violation|0|||
147484659|NCT00696657|531931745|FG007|Overall Study|Protocol Violation|0|||
147484660|NCT00696657|531931746|FG008|Overall Study|Protocol Violation|1|||
147484661|NCT00696657|531931738|FG000|Overall Study|Lack of Efficacy|0|||
147484662|NCT00696657|531931739|FG001|Overall Study|Lack of Efficacy|1|||
147484663|NCT00696657|531931740|FG002|Overall Study|Lack of Efficacy|0|||
147484664|NCT00696657|531931741|FG003|Overall Study|Lack of Efficacy|0|||
147484665|NCT00696657|531931742|FG004|Overall Study|Lack of Efficacy|0|||
147623483|NCT04225715|532440151|FG005|Overall Study|Reason not Specified|0|||
147623484|NCT04225715|532440152|FG006|Overall Study|Reason not Specified|0|||
147484666|NCT00696657|531931743|FG005|Overall Study|Lack of Efficacy|0|||
147484667|NCT00696657|531931744|FG006|Overall Study|Lack of Efficacy|0|||
147484668|NCT00696657|531931745|FG007|Overall Study|Lack of Efficacy|0|||
147484669|NCT00696657|531931746|FG008|Overall Study|Lack of Efficacy|0|||
147484670|NCT00696657|531931738|FG000|Overall Study|Withdrawal criteria|1|||
147484671|NCT00696657|531931739|FG001|Overall Study|Withdrawal criteria|3|||
147484672|NCT00696657|531931740|FG002|Overall Study|Withdrawal criteria|2|||
147484673|NCT00696657|531931741|FG003|Overall Study|Withdrawal criteria|2|||
147484674|NCT00696657|531931742|FG004|Overall Study|Withdrawal criteria|0|||
147484675|NCT00696657|531931743|FG005|Overall Study|Withdrawal criteria|0|||
147484676|NCT00696657|531931744|FG006|Overall Study|Withdrawal criteria|1|||
147484677|NCT00696657|531931745|FG007|Overall Study|Withdrawal criteria|1|||
147484678|NCT00696657|531931746|FG008|Overall Study|Withdrawal criteria|2|||
147484679|NCT00696657|531931738|FG000|Overall Study|Unclassified|0|||
147484680|NCT00696657|531931739|FG001|Overall Study|Unclassified|1|||
147623485|NCT04225715|532440153|FG007|Overall Study|Reason not Specified|0|||
147623486|NCT04225715|532440154|FG008|Overall Study|Reason not Specified|0|||
147484681|NCT00696657|531931740|FG002|Overall Study|Unclassified|3|||
147484682|NCT00696657|531931741|FG003|Overall Study|Unclassified|2|||
147484683|NCT00696657|531931742|FG004|Overall Study|Unclassified|4|||
147484684|NCT00696657|531931743|FG005|Overall Study|Unclassified|2|||
147484685|NCT00696657|531931744|FG006|Overall Study|Unclassified|0|||
147484686|NCT00696657|531931745|FG007|Overall Study|Unclassified|0|||
147484687|NCT00696657|531931746|FG008|Overall Study|Unclassified|1|||
147484688|NCT00696657|531931738|FG000|Overall Study|Adverse Event|0|||
147484689|NCT00696657|531931739|FG001|Overall Study|Adverse Event|0|||
147484690|NCT00696657|531931740|FG002|Overall Study|Adverse Event|3|||
147484691|NCT00696657|531931741|FG003|Overall Study|Adverse Event|7|||
147484692|NCT00696657|531931742|FG004|Overall Study|Adverse Event|6|||
147623487|NCT04225715|532440146|FG000|Overall Study|Protocol Violation|1|||
147623488|NCT04225715|532440147|FG001|Overall Study|Protocol Violation|0|||
147623489|NCT04225715|532440148|FG002|Overall Study|Protocol Violation|0|||
147623490|NCT04225715|532440149|FG003|Overall Study|Protocol Violation|0|||
147484693|NCT00696657|531931743|FG005|Overall Study|Adverse Event|9|||
147484694|NCT00696657|531931744|FG006|Overall Study|Adverse Event|14|||
147484695|NCT00696657|531931745|FG007|Overall Study|Adverse Event|2|||
147484696|NCT00696657|531931746|FG008|Overall Study|Adverse Event|5|||
147484697|NCT02601001|531931747|FG000|Dosing Period 2|Adverse Event|0|||
147484698|NCT02601001|531931748|FG001|Dosing Period 2|Adverse Event|0|||
147484699|NCT02601001|531931749|FG002|Dosing Period 2|Adverse Event|0|||
147484700|NCT02601001|531931750|FG003|Dosing Period 2|Adverse Event|0|||
147484701|NCT02601001|531931751|FG004|Dosing Period 2|Adverse Event|0|||
147484702|NCT02601001|531931752|FG005|Dosing Period 2|Adverse Event|0|||
147484703|NCT02601001|531931753|FG006|Dosing Period 2|Adverse Event|1|||
147484704|NCT01790438|531931754|FG000|Overall Study|Adverse Event|3|||
147484705|NCT01790438|531931755|FG001|Overall Study|Adverse Event|2|||
147484706|NCT01790438|531931754|FG000|Overall Study|Death|4|||
147484707|NCT01790438|531931755|FG001|Overall Study|Death|0|||
147484708|NCT01790438|531931754|FG000|Overall Study|Lost to Follow-up|5|||
147484709|NCT01790438|531931755|FG001|Overall Study|Lost to Follow-up|2|||
147484710|NCT01790438|531931754|FG000|Overall Study|Withdrawal by Subject|13|||
147484711|NCT01790438|531931755|FG001|Overall Study|Withdrawal by Subject|2|||
147484712|NCT01790438|531931754|FG000|Overall Study|Physician Decision|3|||
147484713|NCT01790438|531931755|FG001|Overall Study|Physician Decision|1|||
147484714|NCT01790438|531931754|FG000|Overall Study|Sponsor Decision|0|||
147484715|NCT01790438|531931755|FG001|Overall Study|Sponsor Decision|3|||
147484716|NCT01790438|531931754|FG000|Overall Study|Protocol Required Discontinuation|7|||
147484717|NCT01790438|531931755|FG001|Overall Study|Protocol Required Discontinuation|1|||
147484718|NCT02433210|531931763|FG000|Overall Study|Physician Decision|1|||
147484719|NCT02433210|531931764|FG001|Overall Study|Physician Decision|0|||
147484720|NCT02433210|531931765|FG002|Overall Study|Physician Decision|0|||
147484721|NCT01115569|531931766|FG000|Conversion/Titration Phase|Adverse Event|59|||
147484722|NCT01115569|531931767|FG001|Conversion/Titration Phase|Adverse Event|0|||
147484723|NCT01115569|531931766|FG000|Conversion/Titration Phase|Lost to Follow-up|3|||
147484724|NCT01115569|531931767|FG001|Conversion/Titration Phase|Lost to Follow-up|0|||
147484725|NCT01115569|531931766|FG000|Conversion/Titration Phase|Physician Decision|5|||
147484726|NCT01115569|531931767|FG001|Conversion/Titration Phase|Physician Decision|0|||
147484727|NCT01115569|531931766|FG000|Conversion/Titration Phase|Protocol Violation|68|||
147484728|NCT01115569|531931767|FG001|Conversion/Titration Phase|Protocol Violation|0|||
147484729|NCT01115569|531931766|FG000|Conversion/Titration Phase|Withdrawal by Subject|26|||
147484730|NCT01115569|531931767|FG001|Conversion/Titration Phase|Withdrawal by Subject|0|||
147484731|NCT01115569|531931766|FG000|Conversion/Titration Phase|Non-Compliance with Study Drug|53|||
147484732|NCT01115569|531931767|FG001|Conversion/Titration Phase|Non-Compliance with Study Drug|0|||
147484733|NCT01115569|531931766|FG000|Maintenance Phase|Adverse Event|0|||
147484734|NCT01115569|531931767|FG001|Maintenance Phase|Adverse Event|43|||
147484735|NCT01115569|531931766|FG000|Maintenance Phase|Lost to Follow-up|0|||
147484736|NCT01115569|531931767|FG001|Maintenance Phase|Lost to Follow-up|8|||
147484737|NCT01115569|531931766|FG000|Maintenance Phase|Physician Decision|0|||
147484738|NCT01115569|531931767|FG001|Maintenance Phase|Physician Decision|3|||
147484739|NCT01115569|531931766|FG000|Maintenance Phase|Protocol Violation|0|||
147484740|NCT01115569|531931767|FG001|Maintenance Phase|Protocol Violation|9|||
147484741|NCT01115569|531931766|FG000|Maintenance Phase|Withdrawal by Subject|0|||
147484742|NCT01115569|531931767|FG001|Maintenance Phase|Withdrawal by Subject|27|||
147484743|NCT01115569|531931766|FG000|Maintenance Phase|Non-Compliance with Study Drug|0|||
147484744|NCT01115569|531931767|FG001|Maintenance Phase|Non-Compliance with Study Drug|48|||
147484745|NCT01115569|531931766|FG000|Maintenance Phase|Administrative|0|||
147484746|NCT01115569|531931767|FG001|Maintenance Phase|Administrative|1|||
147484747|NCT03123354|531931768|FG000|Overall Study|Physician Decision|6|||
147484748|NCT01254604|531931771|FG000|Overall Study|Lost to Follow-up|1|||
147484749|NCT01254604|531931772|FG001|Overall Study|Lost to Follow-up|1|||
147484750|NCT01254604|531931771|FG000|Overall Study|Protocol Violation|2|||
147484751|NCT01254604|531931772|FG001|Overall Study|Protocol Violation|2|||
147484752|NCT01254604|531931771|FG000|Overall Study|Withdrawal by Subject|2|||
147484753|NCT01254604|531931772|FG001|Overall Study|Withdrawal by Subject|4|||
147484754|NCT01254604|531931771|FG000|Overall Study|Adverse Event|3|||
147484755|NCT01254604|531931772|FG001|Overall Study|Adverse Event|2|||
147484756|NCT03074162|531931773|FG000|Period 1 Including Washout 1|Withdrawal by Subject|0|||
147484757|NCT03074162|531931774|FG001|Period 1 Including Washout 1|Withdrawal by Subject|0|||
147484758|NCT03074162|531931775|FG002|Period 1 Including Washout 1|Withdrawal by Subject|1|||
147484759|NCT03074162|531931776|FG003|Period 1 Including Washout 1|Withdrawal by Subject|0|||
147484760|NCT03074162|531931777|FG004|Period 1 Including Washout 1|Withdrawal by Subject|0|||
147484761|NCT03074162|531931778|FG005|Period 1 Including Washout 1|Withdrawal by Subject|0|||
147623491|NCT04225715|532440150|FG004|Overall Study|Protocol Violation|0|||
147484762|NCT03074162|531931773|FG000|Period 2 Including Washout 2|Withdrawal by Subject|0|||
147484763|NCT03074162|531931774|FG001|Period 2 Including Washout 2|Withdrawal by Subject|0|||
147623492|NCT04225715|532440151|FG005|Overall Study|Protocol Violation|9|||
147484764|NCT03074162|531931775|FG002|Period 2 Including Washout 2|Withdrawal by Subject|1|||
147484765|NCT03074162|531931776|FG003|Period 2 Including Washout 2|Withdrawal by Subject|0|||
147484766|NCT03074162|531931777|FG004|Period 2 Including Washout 2|Withdrawal by Subject|0|||
147484767|NCT03074162|531931778|FG005|Period 2 Including Washout 2|Withdrawal by Subject|1|||
147484768|NCT03074162|531931773|FG000|Period 3|Withdrawal by Subject|1|||
147484769|NCT03074162|531931774|FG001|Period 3|Withdrawal by Subject|0|||
147484770|NCT03074162|531931775|FG002|Period 3|Withdrawal by Subject|0|||
147484771|NCT03074162|531931776|FG003|Period 3|Withdrawal by Subject|0|||
147484772|NCT03074162|531931777|FG004|Period 3|Withdrawal by Subject|1|||
147484773|NCT03074162|531931778|FG005|Period 3|Withdrawal by Subject|0|||
147484774|NCT00625365|531931784|FG000|Overall Study|Withdrawal by Subject|1|||
147484775|NCT00625365|531931784|FG000|Overall Study|No IV access|5|||
147484776|NCT00625365|531931784|FG000|Overall Study|VSD|1|||
147484777|NCT01703286|531931793|FG000|Period 1 Including Washout|Withdrawal by Subject|0|||
147484778|NCT01703286|531931794|FG001|Period 1 Including Washout|Withdrawal by Subject|0|||
147484779|NCT01703286|531931795|FG002|Period 1 Including Washout|Withdrawal by Subject|0|||
147484780|NCT01703286|531931796|FG003|Period 1 Including Washout|Withdrawal by Subject|1|||
147484781|NCT01703286|531931797|FG004|Period 1 Including Washout|Withdrawal by Subject|0|||
147484782|NCT01703286|531931798|FG005|Period 1 Including Washout|Withdrawal by Subject|1|||
147484783|NCT01703286|531931793|FG000|Period 2 Including Washout|Adverse Event|0|||
147484784|NCT01703286|531931794|FG001|Period 2 Including Washout|Adverse Event|0|||
147484785|NCT01703286|531931795|FG002|Period 2 Including Washout|Adverse Event|0|||
147484786|NCT01703286|531931796|FG003|Period 2 Including Washout|Adverse Event|1|||
147484787|NCT01703286|531931797|FG004|Period 2 Including Washout|Adverse Event|0|||
147484788|NCT01703286|531931798|FG005|Period 2 Including Washout|Adverse Event|0|||
147484789|NCT02421120|531931799|FG000|Overall Study|Adverse Event|1|||
147484790|NCT00931892|531931800|FG000|Completed Endoscopies|Patient did not complete third endoscopy due to discomfort|0|||
147484791|NCT00931892|531931801|FG001|Completed Endoscopies|Patient did not complete third endoscopy due to discomfort|1|||
147484792|NCT01876732|531931802|FG000|Overall Study|MMA was not over 800mg/dL|75|||
147484793|NCT02531373|531931805|FG000|Overall Study|Lack of Efficacy|0|||
147484794|NCT02531373|531931806|FG001|Overall Study|Lack of Efficacy|0|||
147484795|NCT02531373|531931807|FG002|Overall Study|Lack of Efficacy|0|||
147484796|NCT02531373|531931808|FG003|Overall Study|Lack of Efficacy|0|||
147484797|NCT02531373|531931809|FG004|Overall Study|Lack of Efficacy|3|||
147484798|NCT02531373|531931810|FG005|Overall Study|Lack of Efficacy|2|||
147484799|NCT02531373|531931811|FG006|Overall Study|Lack of Efficacy|4|||
147484800|NCT02531373|531931812|FG007|Overall Study|Lack of Efficacy|8|||
147484801|NCT02531373|531931813|FG008|Overall Study|Lack of Efficacy|5|||
147484802|NCT02531373|531931805|FG000|Overall Study|Lost to Follow-up|0|||
147484803|NCT02531373|531931806|FG001|Overall Study|Lost to Follow-up|0|||
147484804|NCT02531373|531931807|FG002|Overall Study|Lost to Follow-up|0|||
147484805|NCT02531373|531931808|FG003|Overall Study|Lost to Follow-up|0|||
147484806|NCT02531373|531931809|FG004|Overall Study|Lost to Follow-up|0|||
147484807|NCT02531373|531931810|FG005|Overall Study|Lost to Follow-up|2|||
147484808|NCT02531373|531931811|FG006|Overall Study|Lost to Follow-up|2|||
147623493|NCT04225715|532440152|FG006|Overall Study|Protocol Violation|0|||
147623494|NCT04225715|532440153|FG007|Overall Study|Protocol Violation|0|||
147623495|NCT04225715|532440154|FG008|Overall Study|Protocol Violation|0|||
147623496|NCT04225715|532440146|FG000|Overall Study|Withdrawal by Subject|4|||
147623497|NCT04225715|532440147|FG001|Overall Study|Withdrawal by Subject|1|||
147623498|NCT04225715|532440148|FG002|Overall Study|Withdrawal by Subject|1|||
147623499|NCT04225715|532440149|FG003|Overall Study|Withdrawal by Subject|0|||
147484809|NCT02531373|531931812|FG007|Overall Study|Lost to Follow-up|0|||
147484810|NCT02531373|531931813|FG008|Overall Study|Lost to Follow-up|0|||
147484811|NCT02531373|531931805|FG000|Overall Study|Physician Decision|0|||
147484812|NCT02531373|531931806|FG001|Overall Study|Physician Decision|0|||
147484813|NCT02531373|531931807|FG002|Overall Study|Physician Decision|0|||
147484814|NCT02531373|531931808|FG003|Overall Study|Physician Decision|0|||
147484815|NCT02531373|531931809|FG004|Overall Study|Physician Decision|2|||
147484816|NCT02531373|531931810|FG005|Overall Study|Physician Decision|1|||
147484817|NCT02531373|531931811|FG006|Overall Study|Physician Decision|0|||
147484818|NCT02531373|531931812|FG007|Overall Study|Physician Decision|0|||
147484819|NCT02531373|531931813|FG008|Overall Study|Physician Decision|0|||
147484820|NCT02531373|531931805|FG000|Overall Study|Protocol Violation|0|||
147484821|NCT02531373|531931806|FG001|Overall Study|Protocol Violation|0|||
147484822|NCT02531373|531931807|FG002|Overall Study|Protocol Violation|0|||
147484823|NCT02531373|531931808|FG003|Overall Study|Protocol Violation|0|||
147484824|NCT02531373|531931809|FG004|Overall Study|Protocol Violation|0|||
147484825|NCT02531373|531931810|FG005|Overall Study|Protocol Violation|1|||
147484826|NCT02531373|531931811|FG006|Overall Study|Protocol Violation|1|||
147484827|NCT02531373|531931812|FG007|Overall Study|Protocol Violation|0|||
147484828|NCT02531373|531931813|FG008|Overall Study|Protocol Violation|1|||
147484829|NCT02531373|531931805|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
147484830|NCT02531373|531931806|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
147484831|NCT02531373|531931807|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
147484832|NCT02531373|531931808|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
147623500|NCT04225715|532440150|FG004|Overall Study|Withdrawal by Subject|3|||
147484833|NCT02531373|531931809|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
147484834|NCT02531373|531931810|FG005|Overall Study|Withdrawal by Parent/Guardian|3|||
147484835|NCT02531373|531931811|FG006|Overall Study|Withdrawal by Parent/Guardian|4|||
147484836|NCT02531373|531931812|FG007|Overall Study|Withdrawal by Parent/Guardian|1|||
147484837|NCT02531373|531931813|FG008|Overall Study|Withdrawal by Parent/Guardian|3|||
147484838|NCT02531373|531931805|FG000|Overall Study|Withdrawal by Subject|0|||
147484839|NCT02531373|531931806|FG001|Overall Study|Withdrawal by Subject|0|||
147484840|NCT02531373|531931807|FG002|Overall Study|Withdrawal by Subject|0|||
147484841|NCT02531373|531931808|FG003|Overall Study|Withdrawal by Subject|0|||
147484842|NCT02531373|531931809|FG004|Overall Study|Withdrawal by Subject|3|||
147484843|NCT02531373|531931810|FG005|Overall Study|Withdrawal by Subject|0|||
147484844|NCT02531373|531931811|FG006|Overall Study|Withdrawal by Subject|0|||
147484845|NCT02531373|531931812|FG007|Overall Study|Withdrawal by Subject|0|||
147484846|NCT02531373|531931813|FG008|Overall Study|Withdrawal by Subject|0|||
147484847|NCT02207530|531931814|FG000|Overall Study|Worsening condition under investigation|78|||
147484848|NCT02207530|531931814|FG000|Overall Study|Patient decision to stop study treatment|5|||
147484849|NCT02207530|531931814|FG000|Overall Study|Adverse Event|8|||
147484850|NCT00305006|531931815|FG000|Overall Study|Withdrawal by Subject|1|||
147484851|NCT00305006|531931816|FG001|Overall Study|Withdrawal by Subject|0|||
147484852|NCT00305006|531931815|FG000|Overall Study|Failure to complete pretest|0|||
147484853|NCT00305006|531931816|FG001|Overall Study|Failure to complete pretest|1|||
147484854|NCT01996319|531931817|FG000|Overall Study|Protocol Violation|1|||
147484855|NCT01996319|531931818|FG001|Overall Study|Protocol Violation|0|||
147484856|NCT01996319|531931817|FG000|Overall Study|Severe or moderate (COPD) Exacerbation|5|||
147484857|NCT01996319|531931818|FG001|Overall Study|Severe or moderate (COPD) Exacerbation|1|||
147484858|NCT01996319|531931817|FG000|Overall Study|Adverse Event|2|||
147484859|NCT01996319|531931818|FG001|Overall Study|Adverse Event|2|||
147484860|NCT06094296|531931819|FG000|Overall Study|Progressive Disease|1|||
147484861|NCT06094296|531931820|FG001|Overall Study|Progressive Disease|0|||
147484862|NCT06094296|531931821|FG002|Overall Study|Progressive Disease|0|||
147484863|NCT06094296|531931822|FG003|Overall Study|Progressive Disease|0|||
147484864|NCT00986258|531931823|FG000|Observation Period|Not eligible to be dosed|11|||
147484865|NCT00986258|531931823|FG000|Titration and Optimal Dose Period|Adverse Event|15|||
147484866|NCT00986258|531931823|FG000|Titration and Optimal Dose Period|Lack of Efficacy|3|||
147484867|NCT00986258|531931823|FG000|Titration and Optimal Dose Period|Withdrawal by Subject|3|||
147484868|NCT00986258|531931823|FG000|Titration and Optimal Dose Period|Non-Compliance|1|||
147484869|NCT00986258|531931823|FG000|Titration and Optimal Dose Period|Other|1|||
147484870|NCT00986258|531931823|FG000|Maintenance Period|Adverse Event|5|||
147484871|NCT00986258|531931823|FG000|Maintenance Period|Lack of Efficacy|2|||
147484872|NCT00986258|531931823|FG000|Maintenance Period|Withdrawal by Subject|2|||
147484873|NCT03332667|531931824|FG000|Overall Study|Adverse Event|0|||
147484874|NCT03332667|531931825|FG001|Overall Study|Adverse Event|0|||
147484875|NCT03332667|531931826|FG002|Overall Study|Adverse Event|2|||
147484876|NCT03332667|531931827|FG003|Overall Study|Adverse Event|1|||
147484877|NCT03332667|531931824|FG000|Overall Study|Withdrawal by Subject|2|||
147484878|NCT03332667|531931825|FG001|Overall Study|Withdrawal by Subject|1|||
147484879|NCT03332667|531931826|FG002|Overall Study|Withdrawal by Subject|5|||
147484880|NCT03332667|531931827|FG003|Overall Study|Withdrawal by Subject|1|||
147484881|NCT03332667|531931824|FG000|Overall Study|Disease Progression or Relapse|2|||
147484882|NCT03332667|531931825|FG001|Overall Study|Disease Progression or Relapse|1|||
147484883|NCT03332667|531931826|FG002|Overall Study|Disease Progression or Relapse|3|||
147484884|NCT03332667|531931827|FG003|Overall Study|Disease Progression or Relapse|0|||
147484885|NCT03332667|531931824|FG000|Overall Study|Initiation onto Another Anti-Cancer Therapy|1|||
147484886|NCT03332667|531931825|FG001|Overall Study|Initiation onto Another Anti-Cancer Therapy|1|||
147484887|NCT03332667|531931826|FG002|Overall Study|Initiation onto Another Anti-Cancer Therapy|3|||
147484888|NCT03332667|531931827|FG003|Overall Study|Initiation onto Another Anti-Cancer Therapy|1|||
147484889|NCT03332667|531931824|FG000|Overall Study|No Treatment Received|0|||
147484890|NCT03332667|531931825|FG001|Overall Study|No Treatment Received|0|||
147484891|NCT03332667|531931826|FG002|Overall Study|No Treatment Received|1|||
147484892|NCT03332667|531931827|FG003|Overall Study|No Treatment Received|0|||
147484893|NCT04964063|531931828|FG000|Overall Study|Adverse Event|4|||
147484894|NCT04964063|531931828|FG000|Overall Study|Lost to Follow-up|47|||
147484895|NCT04964063|531931828|FG000|Overall Study|Withdrawal by Subject|5|||
147484896|NCT04964063|531931828|FG000|Overall Study|Baseline Tasks Expired|41|||
147623501|NCT04225715|532440151|FG005|Overall Study|Withdrawal by Subject|1|||
147623502|NCT04225715|532440152|FG006|Overall Study|Withdrawal by Subject|1|||
147484897|NCT04964063|531931828|FG000|Overall Study|Participant withdrawn in error|1|||
147484898|NCT01120093|531931831|FG000|Treatment Period 1|Adverse Event|0|||
147484899|NCT01120093|531931832|FG001|Treatment Period 1|Adverse Event|0|||
147484900|NCT01120093|531931833|FG002|Treatment Period 1|Adverse Event|1|||
147484901|NCT01120093|531931834|FG003|Treatment Period 1|Adverse Event|0|||
147484902|NCT01120093|531931835|FG004|Treatment Period 1|Adverse Event|1|||
147484903|NCT01120093|531931831|FG000|Treatment Period 1|Withdrawal by Subject|0|||
147623503|NCT04225715|532440153|FG007|Overall Study|Withdrawal by Subject|1|||
147667746|NCT00794664|532608132|FG000|Follow-up Period|Withdrawal by Subject|0|||
147667747|NCT00794664|532608133|FG001|Follow-up Period|Withdrawal by Subject|2|||
147667748|NCT00794664|532608132|FG000|Follow-up Period|Protocol non-compliance|0|||
147667749|NCT00794664|532608133|FG001|Follow-up Period|Protocol non-compliance|1|||
147667750|NCT00828711|532608137|FG000|Overall Study|Lost to Follow-up|1|||
147667751|NCT00828711|532608138|FG001|Overall Study|Lost to Follow-up|0|||
147667752|NCT00828711|532608139|FG002|Overall Study|Lost to Follow-up|0|||
147667753|NCT03883386|532608140|FG000|First Assignment|Lost to Follow-up|1|||
147667754|NCT03883386|532608141|FG001|First Assignment|Lost to Follow-up|0|||
147667755|NCT03883386|532608140|FG000|First Assignment|Withdrawal by Subject|1|||
147484904|NCT01120093|531931832|FG001|Treatment Period 1|Withdrawal by Subject|1|||
147484905|NCT01120093|531931833|FG002|Treatment Period 1|Withdrawal by Subject|0|||
147484906|NCT01120093|531931834|FG003|Treatment Period 1|Withdrawal by Subject|0|||
147484907|NCT01120093|531931835|FG004|Treatment Period 1|Withdrawal by Subject|0|||
147484908|NCT01120093|531931831|FG000|Treatment Period 2|Adverse Event|0|||
147484909|NCT01120093|531931832|FG001|Treatment Period 2|Adverse Event|0|||
147484910|NCT01120093|531931833|FG002|Treatment Period 2|Adverse Event|0|||
147484911|NCT01120093|531931834|FG003|Treatment Period 2|Adverse Event|1|||
147484912|NCT01120093|531931835|FG004|Treatment Period 2|Adverse Event|0|||
147484913|NCT01120093|531931831|FG000|Treatment Period 2|Withdrawal by Subject|0|||
147484914|NCT01120093|531931832|FG001|Treatment Period 2|Withdrawal by Subject|0|||
147484915|NCT01120093|531931833|FG002|Treatment Period 2|Withdrawal by Subject|0|||
147484916|NCT01120093|531931834|FG003|Treatment Period 2|Withdrawal by Subject|0|||
147484917|NCT01120093|531931835|FG004|Treatment Period 2|Withdrawal by Subject|1|||
147484918|NCT01120093|531931831|FG000|Treatment Period 3|Lack of Efficacy|0|||
147623504|NCT04225715|532440154|FG008|Overall Study|Withdrawal by Subject|0|||
147623505|NCT04225715|532440146|FG000|Overall Study|Adverse Event|0|||
147623506|NCT04225715|532440147|FG001|Overall Study|Adverse Event|0|||
147623507|NCT04225715|532440148|FG002|Overall Study|Adverse Event|0|||
147623508|NCT04225715|532440149|FG003|Overall Study|Adverse Event|0|||
147623509|NCT04225715|532440150|FG004|Overall Study|Adverse Event|0|||
147623510|NCT04225715|532440151|FG005|Overall Study|Adverse Event|0|||
147623511|NCT04225715|532440152|FG006|Overall Study|Adverse Event|0|||
147623512|NCT04225715|532440153|FG007|Overall Study|Adverse Event|0|||
147623513|NCT04225715|532440154|FG008|Overall Study|Adverse Event|1|||
147623514|NCT04225715|532440146|FG000|Overall Study|Arm Terminated By Sponsor|0|||
147623515|NCT04225715|532440147|FG001|Overall Study|Arm Terminated By Sponsor|0|||
147623516|NCT04225715|532440148|FG002|Overall Study|Arm Terminated By Sponsor|0|||
147623517|NCT04225715|532440149|FG003|Overall Study|Arm Terminated By Sponsor|0|||
147623518|NCT04225715|532440150|FG004|Overall Study|Arm Terminated By Sponsor|0|||
147623519|NCT04225715|532440151|FG005|Overall Study|Arm Terminated By Sponsor|0|||
147623520|NCT04225715|532440152|FG006|Overall Study|Arm Terminated By Sponsor|0|||
147623521|NCT04225715|532440153|FG007|Overall Study|Arm Terminated By Sponsor|17|||
147623522|NCT04225715|532440154|FG008|Overall Study|Arm Terminated By Sponsor|18|||
147623523|NCT00683618|532440155|FG000|Randomised Treatment Period|Withdrawal by Subject|4|||
147623524|NCT00683618|532440156|FG001|Randomised Treatment Period|Withdrawal by Subject|1|||
147623525|NCT00683618|532440157|FG002|Randomised Treatment Period|Withdrawal by Subject|2|||
147623526|NCT00683618|532440155|FG000|Randomised Treatment Period|Protocol Violation|0|||
147623527|NCT00683618|532440156|FG001|Randomised Treatment Period|Protocol Violation|1|||
147623528|NCT00683618|532440157|FG002|Randomised Treatment Period|Protocol Violation|0|||
147623529|NCT00683618|532440155|FG000|Randomised Treatment Period|Adverse Event|2|||
147623530|NCT00683618|532440156|FG001|Randomised Treatment Period|Adverse Event|0|||
147623531|NCT00683618|532440157|FG002|Randomised Treatment Period|Adverse Event|2|||
147623532|NCT00683618|532440155|FG000|Randomised Treatment Period|Reason not provided|0|||
147623533|NCT00683618|532440156|FG001|Randomised Treatment Period|Reason not provided|0|||
147623534|NCT00683618|532440157|FG002|Randomised Treatment Period|Reason not provided|2|||
147623535|NCT00683618|532440155|FG000|Extension Treatment Period|Withdrawal by Subject|1|||
147484919|NCT01120093|531931832|FG001|Treatment Period 3|Lack of Efficacy|0|||
147623536|NCT00683618|532440156|FG001|Extension Treatment Period|Withdrawal by Subject|0|||
147623537|NCT00683618|532440157|FG002|Extension Treatment Period|Withdrawal by Subject|0|||
147623538|NCT00683618|532440155|FG000|Extension Treatment Period|Adverse Event|1|||
147623539|NCT00683618|532440156|FG001|Extension Treatment Period|Adverse Event|0|||
147623540|NCT00683618|532440157|FG002|Extension Treatment Period|Adverse Event|0|||
147623541|NCT00683618|532440155|FG000|Extension Treatment Period|Protocol Violation|1|||
147623542|NCT00683618|532440156|FG001|Extension Treatment Period|Protocol Violation|0|||
147623543|NCT00683618|532440157|FG002|Extension Treatment Period|Protocol Violation|0|||
147623544|NCT01002989|532440158|FG000|Overall Study|exclusion criteria, no consent|5|||
147623545|NCT01611935|532440159|FG000|Overall Study|Family Declined Participation|1|||
147623546|NCT01611935|532440160|FG001|Overall Study|Family Declined Participation|0|||
147623547|NCT05177484|532440161|FG000|Overall Study|Withdrawn as not anaemic post operatively|1|||
147623548|NCT05177484|532440162|FG001|Overall Study|Withdrawn as not anaemic post operatively|0|||
147667756|NCT03883386|532608141|FG001|First Assignment|Withdrawal by Subject|1|||
147667757|NCT01618968|532608142|FG000|Overall Study|Adverse Event|1|||
147667758|NCT01618968|532608143|FG001|Overall Study|Adverse Event|0|||
147623549|NCT05177484|532440161|FG000|Overall Study|Inadvertently withdrawn|3|||
147623550|NCT05177484|532440162|FG001|Overall Study|Inadvertently withdrawn|1|||
147623551|NCT05177484|532440161|FG000|Overall Study|Withdrawn as not given standard care, given IV iron|0|||
147623552|NCT05177484|532440162|FG001|Overall Study|Withdrawn as not given standard care, given IV iron|1|||
147623553|NCT02549859|532440163|FG000|Long-term 60 Hz DBS|Study Closed|1|||
147623554|NCT00729612|532440164|FG000|Overall Study|Non evaluable for response|10|||
147623555|NCT04537078|532440167|FG000|Overall Study|Protocol Violation|3|||
147623556|NCT04537078|532440168|FG001|Overall Study|Protocol Violation|2|||
147623557|NCT04537078|532440167|FG000|Overall Study|Lost to Follow-up|1|||
147623558|NCT04537078|532440168|FG001|Overall Study|Lost to Follow-up|0|||
147623559|NCT04537078|532440167|FG000|Overall Study|Withdrawal by Subject|0|||
147623560|NCT04537078|532440168|FG001|Overall Study|Withdrawal by Subject|1|||
147623561|NCT00444535|532440169|FG000|Overall Study|Withdrawal by Subject|5|||
147623562|NCT00444535|532440169|FG000|Overall Study|Physician Decision|5|||
147623563|NCT00444535|532440169|FG000|Overall Study|progressive disease|1|||
147623564|NCT00444535|532440169|FG000|Overall Study|Adverse Event|2|||
147623565|NCT03922308|532440170|FG000|Overall Study|Not Meeting Confirmatory Inclusion Criteria|0|||
147623566|NCT03922308|532440171|FG001|Overall Study|Not Meeting Confirmatory Inclusion Criteria|1|||
147623567|NCT03922308|532440172|FG002|Overall Study|Not Meeting Confirmatory Inclusion Criteria|0|||
147416691|NCT02580305|531689932|FG000|Overall Study|Lack of Efficacy|5|||
147416692|NCT02580305|531689933|FG001|Overall Study|Lack of Efficacy|0|||
147416693|NCT02580305|531689934|FG002|Overall Study|Lack of Efficacy|2|||
147416694|NCT02580305|531689932|FG000|Overall Study|Protocol Violation|4|||
147416695|NCT02580305|531689933|FG001|Overall Study|Protocol Violation|9|||
147416696|NCT02580305|531689934|FG002|Overall Study|Protocol Violation|6|||
147416697|NCT02580305|531689932|FG000|Overall Study|Lost to Follow-up|4|||
147416698|NCT02580305|531689933|FG001|Overall Study|Lost to Follow-up|4|||
147416699|NCT02580305|531689934|FG002|Overall Study|Lost to Follow-up|2|||
147416700|NCT02580305|531689932|FG000|Overall Study|Withdrawal by Subject|11|||
147416701|NCT02580305|531689933|FG001|Overall Study|Withdrawal by Subject|9|||
147416702|NCT02580305|531689934|FG002|Overall Study|Withdrawal by Subject|7|||
147416703|NCT02580305|531689932|FG000|Overall Study|Randomized in error and never treated|4|||
147416704|NCT02580305|531689933|FG001|Overall Study|Randomized in error and never treated|8|||
147416705|NCT02580305|531689934|FG002|Overall Study|Randomized in error and never treated|5|||
147416706|NCT00224887|531689935|FG000|Overall Study|Pregnancy|6|||
147416707|NCT00224887|531689936|FG001|Overall Study|Pregnancy|6|||
147416708|NCT04032613|531689937|FG000|Overall Study|Did not complete post-program assessment|5|||
147416709|NCT04032613|531689938|FG001|Overall Study|Did not complete post-program assessment|2|||
147416710|NCT00859222|531689944|FG000|Overall Study|Adverse Event|2|||
147416711|NCT00859222|531689945|FG001|Overall Study|Adverse Event|3|||
147416712|NCT00859222|531689946|FG002|Overall Study|Adverse Event|6|||
147416713|NCT00859222|531689947|FG003|Overall Study|Adverse Event|24|||
147416714|NCT00859222|531689948|FG004|Overall Study|Adverse Event|15|||
147416715|NCT00859222|531689944|FG000|Overall Study|DLT|1|||
147416716|NCT00859222|531689945|FG001|Overall Study|DLT|0|||
147416717|NCT00859222|531689946|FG002|Overall Study|DLT|0|||
147416718|NCT00859222|531689947|FG003|Overall Study|DLT|0|||
147416719|NCT00859222|531689948|FG004|Overall Study|DLT|0|||
147416720|NCT00488475|531689949|FG000|Overall Study|Other|1754|||
147416721|NCT00941070|531689950|FG000|Overall Study|Patient non-compliant|1|||
147416722|NCT03174431|531689961|FG000|Overall Study|Withdrawal by Subject|14|||
147416723|NCT03174431|531689962|FG001|Overall Study|Withdrawal by Subject|11|||
147416724|NCT03174431|531689961|FG000|Overall Study|alternative treatment|2|||
147416725|NCT03174431|531689962|FG001|Overall Study|alternative treatment|0|||
147416726|NCT03174431|531689961|FG000|Overall Study|Lost to Follow-up|1|||
147416727|NCT03174431|531689962|FG001|Overall Study|Lost to Follow-up|5|||
147416728|NCT04075994|531689965|FG000|Overall Study|Withdrawal by Subject|8|||
147416729|NCT04075994|531689966|FG001|Overall Study|Withdrawal by Subject|9|||
147416730|NCT04075994|531689965|FG000|Overall Study|Adverse Event|2|||
147416731|NCT04075994|531689966|FG001|Overall Study|Adverse Event|2|||
147416732|NCT04075994|531689965|FG000|Overall Study|Investigator withdrew|3|||
147416733|NCT04075994|531689966|FG001|Overall Study|Investigator withdrew|1|||
147416734|NCT01941719|531689972|FG000|Overall Study|Lost to Follow-up|20|||
147416735|NCT01941719|531689973|FG001|Overall Study|Lost to Follow-up|19|||
147416736|NCT00252577|531689974|FG000|Overall Study|Lost to Follow-up|20|||
147416737|NCT02797080|531689977|FG000|Overall Study|Lost to Follow-up|1|||
147416738|NCT02797080|531689977|FG000|Overall Study|Withdrawal by Subject|1|||
147416739|NCT00951015|531689980|FG000|Randomization Phase 96 Week|Adverse Event|1|||
147416740|NCT00951015|531689981|FG001|Randomization Phase 96 Week|Adverse Event|1|||
147416741|NCT00951015|531689982|FG002|Randomization Phase 96 Week|Adverse Event|2|||
147416742|NCT00951015|531689983|FG003|Randomization Phase 96 Week|Adverse Event|5|||
147416743|NCT00951015|531689984|FG004|Randomization Phase 96 Week|Adverse Event|0|||
147416744|NCT00951015|531689980|FG000|Randomization Phase 96 Week|Lack of Efficacy|1|||
147416745|NCT00951015|531689981|FG001|Randomization Phase 96 Week|Lack of Efficacy|1|||
147416746|NCT00951015|531689982|FG002|Randomization Phase 96 Week|Lack of Efficacy|0|||
147416747|NCT00951015|531689983|FG003|Randomization Phase 96 Week|Lack of Efficacy|0|||
147484920|NCT01120093|531931833|FG002|Treatment Period 3|Lack of Efficacy|0|||
147484921|NCT01120093|531931834|FG003|Treatment Period 3|Lack of Efficacy|1|||
147484922|NCT01120093|531931835|FG004|Treatment Period 3|Lack of Efficacy|0|||
147484923|NCT01120093|531931831|FG000|Treatment Period 3|Adverse Event|0|||
147484924|NCT01120093|531931832|FG001|Treatment Period 3|Adverse Event|0|||
147484925|NCT01120093|531931833|FG002|Treatment Period 3|Adverse Event|0|||
147484926|NCT01120093|531931834|FG003|Treatment Period 3|Adverse Event|0|||
147484927|NCT01120093|531931835|FG004|Treatment Period 3|Adverse Event|1|||
147484928|NCT01120093|531931831|FG000|Treatment Period 3|Withdrawal by Subject|0|||
147484929|NCT01120093|531931832|FG001|Treatment Period 3|Withdrawal by Subject|0|||
147484930|NCT01120093|531931833|FG002|Treatment Period 3|Withdrawal by Subject|1|||
147484931|NCT01120093|531931834|FG003|Treatment Period 3|Withdrawal by Subject|0|||
147484932|NCT01120093|531931835|FG004|Treatment Period 3|Withdrawal by Subject|0|||
147484933|NCT01120093|531931831|FG000|Treatment Period 4|Adverse Event|1|||
147484934|NCT01120093|531931832|FG001|Treatment Period 4|Adverse Event|0|||
147484935|NCT01120093|531931833|FG002|Treatment Period 4|Adverse Event|0|||
147484936|NCT01120093|531931834|FG003|Treatment Period 4|Adverse Event|0|||
147484937|NCT01120093|531931835|FG004|Treatment Period 4|Adverse Event|0|||
147484938|NCT01120093|531931831|FG000|Treatment Period 5|Adverse Event|0|||
147484939|NCT01120093|531931832|FG001|Treatment Period 5|Adverse Event|1|||
147484940|NCT01120093|531931833|FG002|Treatment Period 5|Adverse Event|0|||
147484941|NCT01120093|531931834|FG003|Treatment Period 5|Adverse Event|1|||
147484942|NCT01120093|531931835|FG004|Treatment Period 5|Adverse Event|0|||
147484943|NCT03649321|531931836|FG000|Overall Study|Withdrawal by Subject|1|||
147484944|NCT03649321|531931837|FG001|Overall Study|Withdrawal by Subject|0|||
147484945|NCT03649321|531931836|FG000|Overall Study|Death|1|||
147484946|NCT03649321|531931837|FG001|Overall Study|Death|0|||
147484947|NCT01455428|531931841|FG000|Overall Study|Protocol Violation|2|||
147484948|NCT01455428|531931842|FG001|Overall Study|Protocol Violation|1|||
147484949|NCT01455428|531931841|FG000|Overall Study|Adverse Event|6|||
147484950|NCT01455428|531931842|FG001|Overall Study|Adverse Event|2|||
147484951|NCT01455428|531931841|FG000|Overall Study|Lost to Follow-up|1|||
147484952|NCT01455428|531931842|FG001|Overall Study|Lost to Follow-up|1|||
147484953|NCT01455428|531931841|FG000|Overall Study|Withdrawal by Subject|2|||
147484954|NCT01455428|531931842|FG001|Overall Study|Withdrawal by Subject|5|||
147484955|NCT01455428|531931841|FG000|Overall Study|Did not meet entrance criteria|0|||
147484956|NCT01455428|531931842|FG001|Overall Study|Did not meet entrance criteria|2|||
147484957|NCT01455428|531931841|FG000|Overall Study|Insufficient clinical response|0|||
147484958|NCT01455428|531931842|FG001|Overall Study|Insufficient clinical response|2|||
147484959|NCT01455428|531931841|FG000|Overall Study|Did not receive treatment|1|||
147484960|NCT01455428|531931842|FG001|Overall Study|Did not receive treatment|1|||
147484961|NCT01455428|531931841|FG000|Overall Study|Other|2|||
147484962|NCT01455428|531931842|FG001|Overall Study|Other|4|||
147484963|NCT00751101|531931844|FG000|Overall Study|Withdrawal by Subject|1|||
147484964|NCT00751101|531931845|FG001|Overall Study|Withdrawal by Subject|0|||
147484965|NCT00751101|531931844|FG000|Overall Study|No HFS / Never Started Patch/|0|||
147484966|NCT00751101|531931845|FG001|Overall Study|No HFS / Never Started Patch/|4|||
147484967|NCT00751101|531931844|FG000|Overall Study|Never began capecitabine|1|||
147484968|NCT00751101|531931845|FG001|Overall Study|Never began capecitabine|0|||
147484969|NCT00751101|531931844|FG000|Overall Study|Physician Decision|0|||
147484970|NCT00751101|531931845|FG001|Overall Study|Physician Decision|1|||
147484971|NCT02086565|531931846|FG000|Overall Study|Lost to Follow-up|9|||
147484972|NCT02086565|531931847|FG001|Overall Study|Lost to Follow-up|7|||
147484973|NCT02086565|531931846|FG000|Overall Study|Withdrawal by Subject|2|||
147484974|NCT02086565|531931847|FG001|Overall Study|Withdrawal by Subject|1|||
147484975|NCT02086565|531931846|FG000|Overall Study|Death|3|||
147484976|NCT02086565|531931847|FG001|Overall Study|Death|2|||
147484977|NCT02086565|531931846|FG000|Overall Study|withdrawn by research team|2|||
147484978|NCT02086565|531931847|FG001|Overall Study|withdrawn by research team|2|||
147484979|NCT00739297|531931848|FG000|First Washout Period of 4-7 Days|Adverse Event|0|||
147484980|NCT00739297|531931849|FG001|First Washout Period of 4-7 Days|Adverse Event|0|||
147484981|NCT00739297|531931850|FG002|First Washout Period of 4-7 Days|Adverse Event|0|||
147484982|NCT00739297|531931851|FG003|First Washout Period of 4-7 Days|Adverse Event|2|||
147484983|NCT00739297|531931852|FG004|First Washout Period of 4-7 Days|Adverse Event|0|||
147484984|NCT00739297|531931853|FG005|First Washout Period of 4-7 Days|Adverse Event|0|||
147484985|NCT00739297|531931854|FG006|First Washout Period of 4-7 Days|Adverse Event|2|||
147484986|NCT00739297|531931848|FG000|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0|||
147484987|NCT00739297|531931849|FG001|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0|||
147484988|NCT00739297|531931850|FG002|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0|||
147484989|NCT00739297|531931851|FG003|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0|||
147484990|NCT00739297|531931852|FG004|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|0|||
147484991|NCT00739297|531931853|FG005|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|1|||
147484992|NCT00739297|531931854|FG006|Fourth Intervention(Visit 9 to Visit 10)|Patient unable to attend last visit|1|||
147667759|NCT01618968|532608144|FG002|Overall Study|Adverse Event|0|||
147623568|NCT03922308|532440170|FG000|Overall Study|Lost to Follow-up|1|||
147623569|NCT03922308|532440171|FG001|Overall Study|Lost to Follow-up|0|||
147623570|NCT03922308|532440172|FG002|Overall Study|Lost to Follow-up|0|||
147623571|NCT03922308|532440170|FG000|Overall Study|Reason not Specified|0|||
147623572|NCT03922308|532440171|FG001|Overall Study|Reason not Specified|2|||
147623573|NCT03922308|532440172|FG002|Overall Study|Reason not Specified|1|||
147623574|NCT01704495|532440176|FG000|Subjects Randomized|Other Reason|3|||
147623575|NCT01704495|532440177|FG001|Subjects Randomized|Other Reason|2|||
147623576|NCT01704495|532440178|FG002|Subjects Randomized|Other Reason|3|||
147623577|NCT01704495|532440179|FG003|Subjects Randomized|Other Reason|2|||
147623578|NCT01704495|532440176|FG000|Subjects Randomized|Discontinuation criteria met|4|||
147416748|NCT00951015|531689984|FG004|Randomization Phase 96 Week|Lack of Efficacy|0|||
147416749|NCT00951015|531689980|FG000|Randomization Phase 96 Week|Protocol Violation|1|||
147416750|NCT00951015|531689981|FG001|Randomization Phase 96 Week|Protocol Violation|1|||
147416751|NCT00951015|531689982|FG002|Randomization Phase 96 Week|Protocol Violation|1|||
147416752|NCT00951015|531689983|FG003|Randomization Phase 96 Week|Protocol Violation|0|||
147416753|NCT00951015|531689984|FG004|Randomization Phase 96 Week|Protocol Violation|0|||
147416754|NCT00951015|531689980|FG000|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0|||
147416755|NCT00951015|531689981|FG001|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0|||
147416756|NCT00951015|531689982|FG002|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0|||
147416757|NCT00951015|531689983|FG003|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|1|||
147416758|NCT00951015|531689984|FG004|Randomization Phase 96 Week|Protocol-Defined Stopping Criteria|0|||
147416759|NCT00951015|531689980|FG000|Randomization Phase 96 Week|Lost to Follow-up|0|||
147416760|NCT00951015|531689981|FG001|Randomization Phase 96 Week|Lost to Follow-up|3|||
147416761|NCT00951015|531689982|FG002|Randomization Phase 96 Week|Lost to Follow-up|1|||
147416762|NCT00951015|531689983|FG003|Randomization Phase 96 Week|Lost to Follow-up|2|||
147416763|NCT00951015|531689984|FG004|Randomization Phase 96 Week|Lost to Follow-up|0|||
147416764|NCT00951015|531689980|FG000|Randomization Phase 96 Week|Withdrawal by Subject|2|||
147416765|NCT00951015|531689981|FG001|Randomization Phase 96 Week|Withdrawal by Subject|1|||
147416766|NCT00951015|531689982|FG002|Randomization Phase 96 Week|Withdrawal by Subject|1|||
147416767|NCT00951015|531689983|FG003|Randomization Phase 96 Week|Withdrawal by Subject|2|||
147416768|NCT00951015|531689984|FG004|Randomization Phase 96 Week|Withdrawal by Subject|0|||
147416769|NCT00951015|531689980|FG000|Open-label Phase|Adverse Event|0|||
147416770|NCT00951015|531689981|FG001|Open-label Phase|Adverse Event|0|||
147416771|NCT00951015|531689982|FG002|Open-label Phase|Adverse Event|0|||
147416772|NCT00951015|531689983|FG003|Open-label Phase|Adverse Event|0|||
147416773|NCT00951015|531689984|FG004|Open-label Phase|Adverse Event|3|||
147416774|NCT00951015|531689980|FG000|Open-label Phase|Lack of Efficacy|0|||
147416775|NCT00951015|531689981|FG001|Open-label Phase|Lack of Efficacy|0|||
147416776|NCT00951015|531689982|FG002|Open-label Phase|Lack of Efficacy|0|||
147416777|NCT00951015|531689983|FG003|Open-label Phase|Lack of Efficacy|0|||
147416778|NCT00951015|531689984|FG004|Open-label Phase|Lack of Efficacy|1|||
147416779|NCT00951015|531689980|FG000|Open-label Phase|Protocol Violation|0|||
147416780|NCT00951015|531689981|FG001|Open-label Phase|Protocol Violation|0|||
147416781|NCT00951015|531689982|FG002|Open-label Phase|Protocol Violation|0|||
147416782|NCT00951015|531689983|FG003|Open-label Phase|Protocol Violation|0|||
147416783|NCT00951015|531689984|FG004|Open-label Phase|Protocol Violation|12|||
147416784|NCT00951015|531689980|FG000|Open-label Phase|Lost to Follow-up|0|||
147416785|NCT00951015|531689981|FG001|Open-label Phase|Lost to Follow-up|0|||
147416786|NCT00951015|531689982|FG002|Open-label Phase|Lost to Follow-up|0|||
147416787|NCT00951015|531689983|FG003|Open-label Phase|Lost to Follow-up|0|||
147416788|NCT00951015|531689984|FG004|Open-label Phase|Lost to Follow-up|12|||
147416789|NCT00951015|531689980|FG000|Open-label Phase|Withdrawal by Subject|0|||
147416790|NCT00951015|531689981|FG001|Open-label Phase|Withdrawal by Subject|0|||
147416791|NCT00951015|531689982|FG002|Open-label Phase|Withdrawal by Subject|0|||
147416792|NCT00951015|531689983|FG003|Open-label Phase|Withdrawal by Subject|0|||
147416793|NCT00951015|531689984|FG004|Open-label Phase|Withdrawal by Subject|14|||
147416794|NCT00951015|531689980|FG000|Open-label Phase|Physician Decision|0|||
147416795|NCT00951015|531689981|FG001|Open-label Phase|Physician Decision|0|||
147416796|NCT00951015|531689982|FG002|Open-label Phase|Physician Decision|0|||
147416797|NCT00951015|531689983|FG003|Open-label Phase|Physician Decision|0|||
147416798|NCT00951015|531689984|FG004|Open-label Phase|Physician Decision|8|||
147416799|NCT03819634|531689986|FG000|Overall Study|Physician Decision|2|||
147416800|NCT00299494|531689987|FG000|Overall Study|Withdrawal by Subject|0|||
147416801|NCT00299494|531689988|FG001|Overall Study|Withdrawal by Subject|0|||
147416802|NCT00299494|531689989|FG002|Overall Study|Withdrawal by Subject|0|||
147416803|NCT00299494|531689990|FG003|Overall Study|Withdrawal by Subject|3|||
147416804|NCT00299494|531689991|FG004|Overall Study|Withdrawal by Subject|1|||
147416805|NCT00299494|531689992|FG005|Overall Study|Withdrawal by Subject|4|||
147416806|NCT00299494|531689987|FG000|Overall Study|Physician Decision|0|||
147416807|NCT00299494|531689988|FG001|Overall Study|Physician Decision|0|||
147416808|NCT00299494|531689989|FG002|Overall Study|Physician Decision|0|||
147623579|NCT01704495|532440177|FG001|Subjects Randomized|Discontinuation criteria met|2|||
147623580|NCT01704495|532440178|FG002|Subjects Randomized|Discontinuation criteria met|2|||
147623581|NCT01704495|532440179|FG003|Subjects Randomized|Discontinuation criteria met|0|||
147623582|NCT01704495|532440176|FG000|Subjects Randomized|Adverse Event|8|||
147623583|NCT01704495|532440177|FG001|Subjects Randomized|Adverse Event|2|||
147623584|NCT01704495|532440178|FG002|Subjects Randomized|Adverse Event|0|||
147623585|NCT01704495|532440179|FG003|Subjects Randomized|Adverse Event|7|||
147623586|NCT01704495|532440176|FG000|Subjects Randomized|Withdrawal by Subject|5|||
147623587|NCT01704495|532440177|FG001|Subjects Randomized|Withdrawal by Subject|5|||
147623588|NCT01704495|532440178|FG002|Subjects Randomized|Withdrawal by Subject|5|||
147623589|NCT01704495|532440179|FG003|Subjects Randomized|Withdrawal by Subject|5|||
147623590|NCT01704495|532440176|FG000|Subjects Randomized|Protocol Violation|1|||
147623591|NCT01704495|532440177|FG001|Subjects Randomized|Protocol Violation|1|||
147623592|NCT01704495|532440178|FG002|Subjects Randomized|Protocol Violation|2|||
147623593|NCT01704495|532440179|FG003|Subjects Randomized|Protocol Violation|0|||
147623594|NCT01704495|532440176|FG000|Subjects Randomized|Eligibility criteria not fulfilled|1|||
147623595|NCT01704495|532440177|FG001|Subjects Randomized|Eligibility criteria not fulfilled|3|||
147484993|NCT00789477|531931855|FG000|Overall Study|Withdrawal by Subject|2|||
147484994|NCT00789477|531931856|FG001|Overall Study|Withdrawal by Subject|1|||
147484995|NCT00789477|531931857|FG002|Overall Study|Withdrawal by Subject|3|||
147484996|NCT00789477|531931858|FG003|Overall Study|Withdrawal by Subject|2|||
147484997|NCT00789477|531931859|FG004|Overall Study|Withdrawal by Subject|3|||
147484998|NCT00789477|531931855|FG000|Overall Study|Protocol Violation|1|||
147484999|NCT00789477|531931856|FG001|Overall Study|Protocol Violation|0|||
147485000|NCT00789477|531931857|FG002|Overall Study|Protocol Violation|0|||
147485001|NCT00789477|531931858|FG003|Overall Study|Protocol Violation|1|||
147485002|NCT00789477|531931859|FG004|Overall Study|Protocol Violation|0|||
147485003|NCT00789477|531931855|FG000|Overall Study|Adverse Event|3|||
147485004|NCT00789477|531931856|FG001|Overall Study|Adverse Event|3|||
147485005|NCT00789477|531931857|FG002|Overall Study|Adverse Event|1|||
147485006|NCT00789477|531931858|FG003|Overall Study|Adverse Event|0|||
147485007|NCT00789477|531931859|FG004|Overall Study|Adverse Event|0|||
147485008|NCT00789477|531931855|FG000|Overall Study|Death|1|||
147485009|NCT00789477|531931856|FG001|Overall Study|Death|1|||
147485010|NCT00789477|531931857|FG002|Overall Study|Death|2|||
147485011|NCT00789477|531931858|FG003|Overall Study|Death|2|||
147485012|NCT00789477|531931859|FG004|Overall Study|Death|0|||
147485013|NCT00789477|531931855|FG000|Overall Study|Lost to Follow-up|0|||
147485014|NCT00789477|531931856|FG001|Overall Study|Lost to Follow-up|1|||
147485015|NCT00789477|531931857|FG002|Overall Study|Lost to Follow-up|4|||
147485016|NCT00789477|531931858|FG003|Overall Study|Lost to Follow-up|2|||
147485017|NCT00789477|531931859|FG004|Overall Study|Lost to Follow-up|4|||
147485018|NCT00789477|531931855|FG000|Overall Study|Lack of Efficacy|2|||
147485019|NCT00789477|531931856|FG001|Overall Study|Lack of Efficacy|0|||
147485020|NCT00789477|531931857|FG002|Overall Study|Lack of Efficacy|0|||
147485021|NCT00789477|531931858|FG003|Overall Study|Lack of Efficacy|0|||
147485022|NCT00789477|531931859|FG004|Overall Study|Lack of Efficacy|0|||
147485023|NCT00789477|531931855|FG000|Overall Study|Other|2|||
147623596|NCT01704495|532440178|FG002|Subjects Randomized|Eligibility criteria not fulfilled|4|||
147623597|NCT01704495|532440179|FG003|Subjects Randomized|Eligibility criteria not fulfilled|3|||
147623598|NCT01704495|532440176|FG000|Optional Safety Extension|Adverse Event|0|||
147623599|NCT01704495|532440177|FG001|Optional Safety Extension|Adverse Event|4|||
147623600|NCT01704495|532440178|FG002|Optional Safety Extension|Adverse Event|0|||
147623601|NCT01704495|532440179|FG003|Optional Safety Extension|Adverse Event|1|||
147623602|NCT01704495|532440176|FG000|Optional Safety Extension|Other reason|27|||
147623603|NCT01704495|532440177|FG001|Optional Safety Extension|Other reason|29|||
147623604|NCT01704495|532440178|FG002|Optional Safety Extension|Other reason|30|||
147623605|NCT01704495|532440179|FG003|Optional Safety Extension|Other reason|28|||
147623606|NCT01704495|532440176|FG000|Optional Safety Extension|Withdrawal by Subject|2|||
147623607|NCT01704495|532440177|FG001|Optional Safety Extension|Withdrawal by Subject|0|||
147623608|NCT01704495|532440178|FG002|Optional Safety Extension|Withdrawal by Subject|1|||
147623609|NCT01704495|532440179|FG003|Optional Safety Extension|Withdrawal by Subject|2|||
147623610|NCT01256450|532440180|FG000|Open-label Titration|Adverse Event|39|||
147623611|NCT01256450|532440181|FG001|Open-label Titration|Adverse Event|0|||
147623612|NCT01256450|532440182|FG002|Open-label Titration|Adverse Event|0|||
147623613|NCT01256450|532440180|FG000|Open-label Titration|Lost to Follow-up|7|||
147623614|NCT01256450|532440181|FG001|Open-label Titration|Lost to Follow-up|0|||
147623615|NCT01256450|532440182|FG002|Open-label Titration|Lost to Follow-up|0|||
147623616|NCT01256450|532440180|FG000|Open-label Titration|Lack of analgesic effect|30|||
147623617|NCT01256450|532440181|FG001|Open-label Titration|Lack of analgesic effect|0|||
147623618|NCT01256450|532440182|FG002|Open-label Titration|Lack of analgesic effect|0|||
147485024|NCT00789477|531931856|FG001|Overall Study|Other|0|||
147485025|NCT00789477|531931857|FG002|Overall Study|Other|1|||
147485026|NCT00789477|531931858|FG003|Overall Study|Other|3|||
147485027|NCT00789477|531931859|FG004|Overall Study|Other|0|||
147485028|NCT02375698|531931860|FG000|Overall Study|Withdrawal by Subject|0|||
147485029|NCT02375698|531931861|FG001|Overall Study|Withdrawal by Subject|2|||
147485030|NCT02375698|531931860|FG000|Overall Study|Physician Decision|2|||
147485031|NCT02375698|531931861|FG001|Overall Study|Physician Decision|0|||
147485032|NCT02680847|531931862|FG000|Overall Study|Other|2|||
147485033|NCT02680847|531931863|FG001|Overall Study|Other|0|||
147485034|NCT02680847|531931864|FG002|Overall Study|Other|0|||
147485035|NCT02680847|531931862|FG000|Overall Study|No longer met eligibility criteria|2|||
147485036|NCT02680847|531931863|FG001|Overall Study|No longer met eligibility criteria|2|||
147485037|NCT02680847|531931864|FG002|Overall Study|No longer met eligibility criteria|0|||
147485038|NCT02680847|531931862|FG000|Overall Study|Unwilling to participate in study|1|||
147485039|NCT02680847|531931863|FG001|Overall Study|Unwilling to participate in study|1|||
147485040|NCT02680847|531931864|FG002|Overall Study|Unwilling to participate in study|0|||
147485041|NCT02680847|531931862|FG000|Overall Study|Lack of Efficacy|0|||
147485042|NCT02680847|531931863|FG001|Overall Study|Lack of Efficacy|0|||
147485043|NCT02680847|531931864|FG002|Overall Study|Lack of Efficacy|2|||
147485044|NCT02680847|531931862|FG000|Overall Study|Adverse Event|0|||
147485045|NCT02680847|531931863|FG001|Overall Study|Adverse Event|0|||
147485046|NCT02680847|531931864|FG002|Overall Study|Adverse Event|1|||
147485047|NCT01345786|531931870|FG000|Overall Study|Adverse Event|0|||
147485048|NCT01345786|531931871|FG001|Overall Study|Adverse Event|1|||
147485049|NCT01345786|531931872|FG002|Overall Study|Adverse Event|3|||
147485050|NCT01345786|531931873|FG003|Overall Study|Adverse Event|1|||
147485051|NCT01345786|531931870|FG000|Overall Study|Subject withdrew consent|2|||
147485052|NCT01345786|531931871|FG001|Overall Study|Subject withdrew consent|2|||
147485053|NCT01345786|531931872|FG002|Overall Study|Subject withdrew consent|1|||
147485054|NCT01345786|531931873|FG003|Overall Study|Subject withdrew consent|0|||
147485055|NCT01345786|531931870|FG000|Overall Study|Noncompliance with protocol|1|||
147485056|NCT01345786|531931871|FG001|Overall Study|Noncompliance with protocol|0|||
147485057|NCT01345786|531931872|FG002|Overall Study|Noncompliance with protocol|1|||
147485058|NCT01345786|531931873|FG003|Overall Study|Noncompliance with protocol|0|||
147485059|NCT01345786|531931870|FG000|Overall Study|Administrative|3|||
147485060|NCT01345786|531931871|FG001|Overall Study|Administrative|5|||
147485061|NCT01345786|531931872|FG002|Overall Study|Administrative|0|||
147485062|NCT01345786|531931873|FG003|Overall Study|Administrative|0|||
147485063|NCT01345786|531931870|FG000|Overall Study|Lost to Follow-up|0|||
147485064|NCT01345786|531931871|FG001|Overall Study|Lost to Follow-up|0|||
147485065|NCT01345786|531931872|FG002|Overall Study|Lost to Follow-up|0|||
147485066|NCT01345786|531931873|FG003|Overall Study|Lost to Follow-up|2|||
147485067|NCT01605396|531931880|FG000|Overall Study|Adverse Event|5|||
147485068|NCT01605396|531931881|FG001|Overall Study|Adverse Event|3|||
147485069|NCT01605396|531931880|FG000|Overall Study|Lost to Follow-up|1|||
147485070|NCT01605396|531931881|FG001|Overall Study|Lost to Follow-up|0|||
147485071|NCT01605396|531931880|FG000|Overall Study|Non-Compliance With Study Drug|1|||
147485072|NCT01605396|531931881|FG001|Overall Study|Non-Compliance With Study Drug|1|||
147485073|NCT01605396|531931880|FG000|Overall Study|Physician Decision|2|||
147485074|NCT01605396|531931881|FG001|Overall Study|Physician Decision|2|||
147485075|NCT01605396|531931880|FG000|Overall Study|Progressive Disease|23|||
147485076|NCT01605396|531931881|FG001|Overall Study|Progressive Disease|27|||
147485077|NCT01605396|531931880|FG000|Overall Study|Withdrawal by Subject|4|||
147485078|NCT01605396|531931881|FG001|Overall Study|Withdrawal by Subject|2|||
147485079|NCT01605396|531931880|FG000|Overall Study|Transfer Off Study|4|||
147485080|NCT01605396|531931881|FG001|Overall Study|Transfer Off Study|5|||
147485081|NCT04598165|531931883|FG000|Completed 6-week Follow-up|Withdrawal by Subject|6|||
147485082|NCT04598165|531931884|FG001|Completed 6-week Follow-up|Withdrawal by Subject|3|||
147485083|NCT04598165|531931883|FG000|Completed 6-week Follow-up|Death|2|||
147485084|NCT04598165|531931884|FG001|Completed 6-week Follow-up|Death|1|||
147485085|NCT04598165|531931883|FG000|Completed 6-week Follow-up|Lost to Follow-up|26|||
147485086|NCT04598165|531931884|FG001|Completed 6-week Follow-up|Lost to Follow-up|33|||
147485087|NCT04598165|531931883|FG000|Completed 6-week Follow-up|Ineligible|4|||
147485088|NCT04598165|531931884|FG001|Completed 6-week Follow-up|Ineligible|3|||
147485089|NCT04598165|531931883|FG000|Completed 6-week Follow-up|Partner refusal|0|||
147485090|NCT04598165|531931884|FG001|Completed 6-week Follow-up|Partner refusal|1|||
147623619|NCT01256450|532440180|FG000|Open-label Titration|Non-compliance|9|||
147485091|NCT04598165|531931883|FG000|Included in Intention to Treat Analysis|Ineligible for inclusion in analysis|67|||
147485092|NCT04598165|531931884|FG001|Included in Intention to Treat Analysis|Ineligible for inclusion in analysis|69|||
147485093|NCT01323673|531931885|FG000|Overall Study|Adverse Event|0|||
147485094|NCT01323673|531931886|FG001|Overall Study|Adverse Event|1|||
147485095|NCT01323673|531931885|FG000|Overall Study|Lost to Follow-up|0|||
147485096|NCT01323673|531931886|FG001|Overall Study|Lost to Follow-up|1|||
147623620|NCT01256450|532440181|FG001|Open-label Titration|Non-compliance|0|||
147485097|NCT01323673|531931885|FG000|Overall Study|Protocol Violation|1|||
147485098|NCT01323673|531931886|FG001|Overall Study|Protocol Violation|0|||
147485099|NCT01323673|531931885|FG000|Overall Study|Withdrawal by Subject|2|||
147485100|NCT01323673|531931886|FG001|Overall Study|Withdrawal by Subject|3|||
147485101|NCT03844633|531931887|FG000|1 Week FU|Lost to Follow-up|0|||
147623621|NCT01256450|532440182|FG002|Open-label Titration|Non-compliance|0|||
147485102|NCT03844633|531931888|FG001|1 Week FU|Lost to Follow-up|1|||
147485103|NCT03844633|531931889|FG002|1 Week FU|Lost to Follow-up|4|||
147485104|NCT03844633|531931887|FG000|12-month Follow-up|Lost to Follow-up|7|||
147485105|NCT03844633|531931888|FG001|12-month Follow-up|Lost to Follow-up|5|||
147485106|NCT03844633|531931889|FG002|12-month Follow-up|Lost to Follow-up|8|||
147485107|NCT03596177|531931892|FG000|Single Blind Period|Withdrawal by Subject|1|||
147485108|NCT03596177|531931893|FG001|Single Blind Period|Withdrawal by Subject|1|||
147485109|NCT03596177|531931892|FG000|Single Blind Period|Other|1|||
147485110|NCT03596177|531931893|FG001|Single Blind Period|Other|0|||
147485111|NCT03596177|531931892|FG000|Double Blind Period|Withdrawal by Subject|0|||
147667760|NCT01618968|532608145|FG003|Overall Study|Adverse Event|0|||
147485112|NCT03596177|531931893|FG001|Double Blind Period|Withdrawal by Subject|1|||
147485113|NCT03596177|531931892|FG000|Double Blind Period|Other|0|||
147485114|NCT03596177|531931893|FG001|Double Blind Period|Other|4|||
147485115|NCT03596177|531931892|FG000|Double Blind Period|Death during safety follow-up|0|||
147485116|NCT03596177|531931893|FG001|Double Blind Period|Death during safety follow-up|1|||
147485117|NCT04083222|531931897|FG000|Overall Study|Voluntary Withdrawal|0|||
147485118|NCT04083222|531931898|FG001|Overall Study|Voluntary Withdrawal|1|||
147485119|NCT04083222|531931897|FG000|Overall Study|Reason not Specified|0|||
147485120|NCT04083222|531931898|FG001|Overall Study|Reason not Specified|1|||
147485121|NCT03625986|531933887|FG000|Randomization Period|Lost to Follow-up|7|||
147485122|NCT03625986|531933888|FG001|Randomization Period|Lost to Follow-up|12|||
147485123|NCT03625986|531933887|FG000|Randomization Period|Withdrawal by Subject|10|||
147485124|NCT03625986|531933888|FG001|Randomization Period|Withdrawal by Subject|6|||
147485125|NCT01937130|531933889|FG000|Overall Study|Withdrawal by Subject|0|||
147485126|NCT01937130|531933890|FG001|Overall Study|Withdrawal by Subject|0|||
147485127|NCT01937130|531933891|FG002|Overall Study|Withdrawal by Subject|0|||
147485128|NCT01937130|531933892|FG003|Overall Study|Withdrawal by Subject|1|||
147485129|NCT01937130|531933889|FG000|Overall Study|Adverse Event|0|||
147485130|NCT01937130|531933890|FG001|Overall Study|Adverse Event|1|||
147485131|NCT01937130|531933891|FG002|Overall Study|Adverse Event|0|||
147485132|NCT01937130|531933892|FG003|Overall Study|Adverse Event|1|||
147485133|NCT01937130|531933889|FG000|Overall Study|Death|1|||
147485134|NCT01937130|531933890|FG001|Overall Study|Death|1|||
147485135|NCT01937130|531933891|FG002|Overall Study|Death|1|||
147485136|NCT01937130|531933892|FG003|Overall Study|Death|0|||
147485137|NCT01937130|531933889|FG000|Overall Study|Lost to Follow-up|2|||
147485138|NCT01937130|531933890|FG001|Overall Study|Lost to Follow-up|0|||
147485139|NCT01937130|531933891|FG002|Overall Study|Lost to Follow-up|2|||
147485140|NCT01937130|531933892|FG003|Overall Study|Lost to Follow-up|0|||
147485141|NCT01937130|531933889|FG000|Overall Study|Physician Decision|0|||
147485142|NCT01937130|531933890|FG001|Overall Study|Physician Decision|1|||
147485143|NCT01937130|531933891|FG002|Overall Study|Physician Decision|0|||
147485144|NCT01937130|531933892|FG003|Overall Study|Physician Decision|0|||
147485145|NCT01937130|531933889|FG000|Overall Study|Patients unable to swallow|0|||
147485146|NCT01937130|531933890|FG001|Overall Study|Patients unable to swallow|1|||
147485147|NCT01937130|531933891|FG002|Overall Study|Patients unable to swallow|0|||
147485148|NCT01937130|531933892|FG003|Overall Study|Patients unable to swallow|0|||
147485149|NCT01937130|531933889|FG000|Overall Study|Patient lost to FU due to death|2|||
147485150|NCT01937130|531933890|FG001|Overall Study|Patient lost to FU due to death|0|||
147485151|NCT01937130|531933891|FG002|Overall Study|Patient lost to FU due to death|0|||
147485152|NCT01937130|531933892|FG003|Overall Study|Patient lost to FU due to death|0|||
147485153|NCT01850563|531933893|FG000|Overall Study|Not eligible|3|||
147485154|NCT01850563|531933894|FG001|Overall Study|Not eligible|0|||
147485155|NCT04359823|531933895|FG000|Overall Study|Lost to Follow-up|0|||
147485156|NCT04359823|531933896|FG001|Overall Study|Lost to Follow-up|1|||
147485157|NCT04359823|531933895|FG000|Overall Study|Withdrawal by Subject|0|||
147485158|NCT04359823|531933896|FG001|Overall Study|Withdrawal by Subject|1|||
147485159|NCT04191967|531933897|FG000|Screening & Thermocoagulation (Ablation)|Not considered candidates for thermocoagulation|86|||
147485160|NCT04191967|531933897|FG000|12 Month Follow-up|Pathology results for 12 month treatment efficacy not available for these participants|4|||
147485161|NCT01431144|531933898|FG000|Overall Study|Implant mobility and removal|2|||
147485162|NCT01431144|531933899|FG001|Overall Study|Implant mobility and removal|0|||
147485163|NCT02322892|531933900|FG000|Overall Study|Surgery cancelled|1|||
147485164|NCT02322892|531933901|FG001|Overall Study|Surgery cancelled|2|||
147485165|NCT02322892|531933900|FG000|Overall Study|Met exclusion criteria|0|||
147485166|NCT02322892|531933901|FG001|Overall Study|Met exclusion criteria|1|||
147485167|NCT02322892|531933900|FG000|Overall Study|Protocol Violation|1|||
147485168|NCT02322892|531933901|FG001|Overall Study|Protocol Violation|0|||
147485169|NCT02819310|531933902|FG000|Overall Study|Withdrawal by Subject|37|||
147485170|NCT02819310|531933902|FG000|Overall Study|Lost to Follow-up|16|||
147485171|NCT02819310|531933902|FG000|Overall Study|Adverse Event|13|||
147485172|NCT02819310|531933902|FG000|Overall Study|Lack of Efficacy|5|||
147485173|NCT02819310|531933902|FG000|Overall Study|Physician Decision|8|||
147485174|NCT02819310|531933902|FG000|Overall Study|Protocol Violation|30|||
147485175|NCT01793051|531933907|FG000|Overall Study|Withdrawal by Subject|6|||
147667761|NCT01618968|532608142|FG000|Overall Study|Death|0|||
147485176|NCT01793051|531933908|FG001|Overall Study|Withdrawal by Subject|4|||
147485177|NCT01793051|531933907|FG000|Overall Study|Adverse Event|0|||
147485178|NCT01793051|531933908|FG001|Overall Study|Adverse Event|2|||
147623622|NCT01256450|532440180|FG000|Open-label Titration|Screen failure|1|||
147623623|NCT01256450|532440181|FG001|Open-label Titration|Screen failure|0|||
147623624|NCT01256450|532440182|FG002|Open-label Titration|Screen failure|0|||
147623625|NCT01256450|532440180|FG000|Open-label Titration|Other|13|||
147623626|NCT01256450|532440181|FG001|Open-label Titration|Other|0|||
147623627|NCT01256450|532440182|FG002|Open-label Titration|Other|0|||
147623628|NCT01256450|532440180|FG000|Double-blind Treatment|Adverse Event|0|||
147623629|NCT01256450|532440181|FG001|Double-blind Treatment|Adverse Event|8|||
147623630|NCT01256450|532440182|FG002|Double-blind Treatment|Adverse Event|6|||
147623631|NCT01256450|532440180|FG000|Double-blind Treatment|Lost to Follow-up|0|||
147623632|NCT01256450|532440181|FG001|Double-blind Treatment|Lost to Follow-up|1|||
147623633|NCT01256450|532440182|FG002|Double-blind Treatment|Lost to Follow-up|7|||
147623634|NCT01256450|532440180|FG000|Double-blind Treatment|Withdrawal by Subject|0|||
147623635|NCT01256450|532440181|FG001|Double-blind Treatment|Withdrawal by Subject|0|||
147485179|NCT01793051|531933907|FG000|Overall Study|Too ill to continue|1|||
147485180|NCT01793051|531933908|FG001|Overall Study|Too ill to continue|0|||
147485181|NCT01793051|531933907|FG000|Overall Study|Switched chemo|1|||
147485182|NCT01793051|531933908|FG001|Overall Study|Switched chemo|1|||
147485183|NCT01793051|531933907|FG000|Overall Study|Lack of compliance|1|||
147485184|NCT01793051|531933908|FG001|Overall Study|Lack of compliance|0|||
147485185|NCT01793051|531933907|FG000|Overall Study|Requested to be removed from the study|1|||
147485186|NCT01793051|531933908|FG001|Overall Study|Requested to be removed from the study|1|||
147485187|NCT00059215|531933909|FG000|Overall Study|Adverse Event|5|||
147485188|NCT00059215|531933910|FG001|Overall Study|Adverse Event|5|||
147485189|NCT00059215|531933911|FG002|Overall Study|Adverse Event|9|||
147485190|NCT00059215|531933912|FG003|Overall Study|Adverse Event|9|||
147485191|NCT00059215|531933909|FG000|Overall Study|Death|0|||
147485192|NCT00059215|531933910|FG001|Overall Study|Death|0|||
147485193|NCT00059215|531933911|FG002|Overall Study|Death|3|||
147485194|NCT00059215|531933912|FG003|Overall Study|Death|0|||
147485195|NCT00059215|531933909|FG000|Overall Study|Lost to Follow-up|1|||
147485196|NCT00059215|531933910|FG001|Overall Study|Lost to Follow-up|2|||
147485197|NCT00059215|531933911|FG002|Overall Study|Lost to Follow-up|0|||
147485198|NCT00059215|531933912|FG003|Overall Study|Lost to Follow-up|0|||
147485199|NCT00059215|531933909|FG000|Overall Study|Withdrawal by Subject|4|||
147485200|NCT00059215|531933910|FG001|Overall Study|Withdrawal by Subject|4|||
147485201|NCT00059215|531933911|FG002|Overall Study|Withdrawal by Subject|1|||
147485202|NCT00059215|531933912|FG003|Overall Study|Withdrawal by Subject|3|||
147485203|NCT00059215|531933909|FG000|Overall Study|Protocol Violation|1|||
147485204|NCT00059215|531933910|FG001|Overall Study|Protocol Violation|0|||
147485205|NCT00059215|531933911|FG002|Overall Study|Protocol Violation|1|||
147485206|NCT00059215|531933912|FG003|Overall Study|Protocol Violation|0|||
147485207|NCT00059215|531933909|FG000|Overall Study|Protocol entry criteria not met|1|||
147485208|NCT00059215|531933910|FG001|Overall Study|Protocol entry criteria not met|1|||
147485209|NCT00059215|531933911|FG002|Overall Study|Protocol entry criteria not met|0|||
147485210|NCT00059215|531933912|FG003|Overall Study|Protocol entry criteria not met|2|||
147485211|NCT00059215|531933909|FG000|Overall Study|Physician Decision|1|||
147485212|NCT00059215|531933910|FG001|Overall Study|Physician Decision|2|||
147485213|NCT00059215|531933911|FG002|Overall Study|Physician Decision|1|||
147485214|NCT00059215|531933912|FG003|Overall Study|Physician Decision|1|||
147485215|NCT04494633|531933918|FG000|Overall Study|Lost to Follow-up|5|||
147485216|NCT04494633|531933919|FG001|Overall Study|Lost to Follow-up|3|||
147485217|NCT04494633|531933918|FG000|Overall Study|Protocol Violation|1|||
147485218|NCT04494633|531933919|FG001|Overall Study|Protocol Violation|1|||
147485219|NCT04907539|531933920|FG000|Overall Study|Consent withdrawn|1|||
147485220|NCT04907539|531933921|FG001|Overall Study|Consent withdrawn|0|||
147623636|NCT01256450|532440182|FG002|Double-blind Treatment|Withdrawal by Subject|1|||
147623637|NCT01256450|532440180|FG000|Double-blind Treatment|Lack of analgesic effect|0|||
147623638|NCT01256450|532440181|FG001|Double-blind Treatment|Lack of analgesic effect|5|||
147623639|NCT01256450|532440182|FG002|Double-blind Treatment|Lack of analgesic effect|6|||
147485221|NCT04907539|531933920|FG000|Overall Study|Death|14|||
147485222|NCT04907539|531933921|FG001|Overall Study|Death|3|||
147485223|NCT02311478|531933922|FG000|Overall Study|Withdrawal by Subject|1|||
147485224|NCT02311478|531933922|FG000|Overall Study|Lost to Follow-up|5|||
147485225|NCT02311478|531933922|FG000|Overall Study|Failed IUD Insertion|1|||
147485226|NCT03276936|531933923|FG000|Overall Study|Adverse Event|4|||
147485227|NCT03276936|531933924|FG001|Overall Study|Adverse Event|2|||
147485228|NCT03276936|531933923|FG000|Overall Study|Lost to Follow-up|16|||
147485229|NCT03276936|531933924|FG001|Overall Study|Lost to Follow-up|13|||
147623640|NCT01256450|532440180|FG000|Double-blind Treatment|Non-compliance|0|||
147623641|NCT01256450|532440181|FG001|Double-blind Treatment|Non-compliance|5|||
147485230|NCT03276936|531933923|FG000|Overall Study|Withdrawal by Subject|30|||
147485231|NCT03276936|531933924|FG001|Overall Study|Withdrawal by Subject|20|||
147485232|NCT03276936|531933923|FG000|Overall Study|Not mentioned|6|||
147485233|NCT03276936|531933924|FG001|Overall Study|Not mentioned|3|||
147485234|NCT03041116|531933925|FG000|Double-blind|Death|0|||
147485235|NCT03041116|531933926|FG001|Double-blind|Death|2|||
147623642|NCT01256450|532440182|FG002|Double-blind Treatment|Non-compliance|4|||
147485236|NCT03041116|531933925|FG000|Double-blind|Withdrawal by Subject|0|||
147485237|NCT03041116|531933926|FG001|Double-blind|Withdrawal by Subject|4|||
147485238|NCT03041116|531933925|FG000|Open-label|Death|1|||
147485239|NCT03041116|531933926|FG001|Open-label|Death|0|||
147485240|NCT03041116|531933925|FG000|Open-label|Termination of the study by Sponsor|39|||
147485241|NCT03041116|531933926|FG001|Open-label|Termination of the study by Sponsor|37|||
147485242|NCT03041116|531933925|FG000|Open-label|Withdrawal by Subject|1|||
147485243|NCT03041116|531933926|FG001|Open-label|Withdrawal by Subject|0|||
147485244|NCT00943319|531933927|FG000|Overall Study|Death|1|||
147485245|NCT02043301|531933928|FG000|Overall Study|Discontinued|0|||
147485246|NCT02043301|531933929|FG001|Overall Study|Discontinued|1|||
147485247|NCT02043301|531933930|FG002|Overall Study|Discontinued|0|||
147485248|NCT03097328|531933931|FG000|Overall Study|Still on Therapy|2|||
147485249|NCT03097328|531933931|FG000|Overall Study|Progressive Disease|29|||
147485250|NCT03097328|531933931|FG000|Overall Study|Adverse Event|4|||
147485251|NCT03097328|531933931|FG000|Overall Study|Withdrawal by Subject|1|||
147485252|NCT03097328|531933931|FG000|Overall Study|Physician Decision|1|||
147485253|NCT03097328|531933931|FG000|Overall Study|Patient Decision|1|||
147485254|NCT03097328|531933931|FG000|Overall Study|Ineligible for Study Drug|1|||
147485255|NCT01798134|531933932|FG000|Overall Study|Lost to Follow-up|1|||
147485256|NCT01798134|531933932|FG000|Overall Study|Withdrawal by Subject|3|||
147485257|NCT01798134|531933932|FG000|Overall Study|Death|2|||
147485258|NCT01798134|531933932|FG000|Overall Study|Adverse Event|3|||
147485259|NCT01798134|531933932|FG000|Overall Study|Physician Decision|3|||
147485260|NCT01798134|531933932|FG000|Overall Study|Liver transplant/surgery|4|||
147485261|NCT02653976|531933933|FG000|Overall Study|Withdrawal by Subject|5|||
147485262|NCT02653976|531933933|FG000|Overall Study|Death|4|||
147485263|NCT02023164|531933934|FG000|24-Hour Follow-Up|Lost to Follow-up|0|||
147485264|NCT02023164|531933935|FG001|24-Hour Follow-Up|Lost to Follow-up|2|||
147485265|NCT02436577|531933936|FG000|Overall Study|Protocol Deviation|0|||
147485266|NCT02436577|531933937|FG001|Overall Study|Protocol Deviation|1|||
147485267|NCT02436577|531933938|FG002|Overall Study|Protocol Deviation|0|||
147485268|NCT02436577|531933939|FG003|Overall Study|Protocol Deviation|0|||
147485269|NCT02436577|531933940|FG004|Overall Study|Protocol Deviation|0|||
147485270|NCT02436577|531933941|FG005|Overall Study|Protocol Deviation|0|||
147485271|NCT03703375|531933942|FG000|Randomization Period|Withdrawal by Subject|0|||
147485272|NCT03703375|531933943|FG001|Randomization Period|Withdrawal by Subject|0|||
147485273|NCT03703375|531933944|FG002|Randomization Period|Withdrawal by Subject|0|||
147485274|NCT03703375|531933945|FG003|Randomization Period|Withdrawal by Subject|1|||
147485275|NCT03703375|531933942|FG000|Randomization Period|Completed safety run-in treatment|7|||
147485276|NCT03703375|531933943|FG001|Randomization Period|Completed safety run-in treatment|0|||
147485277|NCT03703375|531933944|FG002|Randomization Period|Completed safety run-in treatment|0|||
147485278|NCT03703375|531933945|FG003|Randomization Period|Completed safety run-in treatment|0|||
147485279|NCT03703375|531933942|FG000|Treatment Period|Other Reasons|0|||
147485280|NCT03703375|531933943|FG001|Treatment Period|Other Reasons|1|||
147485281|NCT03703375|531933944|FG002|Treatment Period|Other Reasons|0|||
147485282|NCT03703375|531933945|FG003|Treatment Period|Other Reasons|3|||
147485283|NCT03703375|531933942|FG000|Treatment Period|Consent Withdrawal|0|||
147485284|NCT03703375|531933943|FG001|Treatment Period|Consent Withdrawal|0|||
147485285|NCT03703375|531933944|FG002|Treatment Period|Consent Withdrawal|0|||
147485286|NCT03703375|531933945|FG003|Treatment Period|Consent Withdrawal|1|||
147485287|NCT03703375|531933942|FG000|Treatment Period|Death|1|||
147485288|NCT03703375|531933943|FG001|Treatment Period|Death|0|||
147485289|NCT03703375|531933944|FG002|Treatment Period|Death|1|||
147485290|NCT03703375|531933945|FG003|Treatment Period|Death|2|||
147485291|NCT03703375|531933942|FG000|Treatment Period|Toxicity of Study Treatment|2|||
147485292|NCT03703375|531933943|FG001|Treatment Period|Toxicity of Study Treatment|0|||
147485293|NCT03703375|531933944|FG002|Treatment Period|Toxicity of Study Treatment|4|||
147485294|NCT03703375|531933945|FG003|Treatment Period|Toxicity of Study Treatment|1|||
147485295|NCT03703375|531933942|FG000|Treatment Period|Progression|32|||
147623643|NCT01256450|532440180|FG000|Double-blind Treatment|Opioid withdrawal symptoms|0|||
147623644|NCT01256450|532440181|FG001|Double-blind Treatment|Opioid withdrawal symptoms|0|||
147667762|NCT01618968|532608143|FG001|Overall Study|Death|0|||
147485296|NCT03703375|531933943|FG001|Treatment Period|Progression|1|||
147485297|NCT03703375|531933944|FG002|Treatment Period|Progression|7|||
147485298|NCT03703375|531933945|FG003|Treatment Period|Progression|11|||
147485299|NCT03703375|531933942|FG000|Treatment Period|Completed treatment|7|||
147485300|NCT03703375|531933943|FG001|Treatment Period|Completed treatment|2|||
147485301|NCT03703375|531933944|FG002|Treatment Period|Completed treatment|0|||
147485302|NCT03703375|531933945|FG003|Treatment Period|Completed treatment|0|||
147485303|NCT01675011|531933946|FG000|Overall Study|Trial terminated by Sponsor|3|||
147485304|NCT01675011|531933947|FG001|Overall Study|Trial terminated by Sponsor|1|||
147485305|NCT00615290|531933948|FG000|Overall Study|Adverse Event|2|||
147485306|NCT00615290|531933948|FG000|Overall Study|Lost to Follow-up|3|||
147485307|NCT00615290|531933948|FG000|Overall Study|Withdrawal by Subject|1|||
147485308|NCT00615290|531933948|FG000|Overall Study|Other|2|||
147485309|NCT03650452|531933949|FG000|Overall Study|Physician Decision|1|||
147485310|NCT03650452|531933950|FG001|Overall Study|Physician Decision|0|||
147485311|NCT03650452|531933949|FG000|Overall Study|Withdrawal by Parent/Guardian|3|||
147485312|NCT03650452|531933950|FG001|Overall Study|Withdrawal by Parent/Guardian|1|||
147485313|NCT03650452|531933949|FG000|Overall Study|Adverse Event|3|||
147485314|NCT03650452|531933950|FG001|Overall Study|Adverse Event|4|||
147485315|NCT03650452|531933949|FG000|Overall Study|Early Withdrawal from Study Treatment|3|||
147485316|NCT03650452|531933950|FG001|Overall Study|Early Withdrawal from Study Treatment|0|||
147485317|NCT01623531|531933964|FG000|Overall Study|Death|1|||
147485318|NCT01623531|531933965|FG001|Overall Study|Death|0|||
147485319|NCT01623531|531933964|FG000|Overall Study|Protocol Violation|2|||
147485320|NCT01623531|531933965|FG001|Overall Study|Protocol Violation|1|||
147485321|NCT01623531|531933964|FG000|Overall Study|Missing data at primary outcome time poi|1|||
147485322|NCT01623531|531933965|FG001|Overall Study|Missing data at primary outcome time poi|1|||
147485323|NCT00623467|531933966|FG000|Overall Study|Lost to Follow-up|1|||
147485324|NCT00623467|531933966|FG000|Overall Study|Protocol Violation|4|||
147485325|NCT00623467|531933966|FG000|Overall Study|Withdrawal by Subject|2|||
147485326|NCT04184622|531933972|FG000|Primary Treatment Period|Adverse Event|6|||
147485327|NCT04184622|531933973|FG001|Primary Treatment Period|Adverse Event|4|||
147485328|NCT04184622|531933974|FG002|Primary Treatment Period|Adverse Event|8|||
147485329|NCT04184622|531933975|FG003|Primary Treatment Period|Adverse Event|6|||
147485330|NCT04184622|531933972|FG000|Primary Treatment Period|Death|4|||
147485331|NCT04184622|531933973|FG001|Primary Treatment Period|Death|4|||
147485332|NCT04184622|531933974|FG002|Primary Treatment Period|Death|2|||
147485333|NCT04184622|531933975|FG003|Primary Treatment Period|Death|1|||
147485334|NCT04184622|531933972|FG000|Primary Treatment Period|Lost to Follow-up|41|||
147485335|NCT04184622|531933973|FG001|Primary Treatment Period|Lost to Follow-up|17|||
147485336|NCT04184622|531933974|FG002|Primary Treatment Period|Lost to Follow-up|15|||
147485337|NCT04184622|531933975|FG003|Primary Treatment Period|Lost to Follow-up|13|||
147485338|NCT04184622|531933972|FG000|Primary Treatment Period|Other - as reported by the investigator|21|||
147485339|NCT04184622|531933973|FG001|Primary Treatment Period|Other - as reported by the investigator|7|||
147485340|NCT04184622|531933974|FG002|Primary Treatment Period|Other - as reported by the investigator|6|||
147485341|NCT04184622|531933975|FG003|Primary Treatment Period|Other - as reported by the investigator|12|||
147485342|NCT04184622|531933972|FG000|Primary Treatment Period|Physician Decision|0|||
147485343|NCT04184622|531933973|FG001|Primary Treatment Period|Physician Decision|0|||
147485344|NCT04184622|531933974|FG002|Primary Treatment Period|Physician Decision|3|||
147485345|NCT04184622|531933975|FG003|Primary Treatment Period|Physician Decision|1|||
147485346|NCT04184622|531933972|FG000|Primary Treatment Period|Pregnancy|4|||
147485347|NCT04184622|531933973|FG001|Primary Treatment Period|Pregnancy|3|||
147485348|NCT04184622|531933974|FG002|Primary Treatment Period|Pregnancy|4|||
147485349|NCT04184622|531933975|FG003|Primary Treatment Period|Pregnancy|1|||
147485350|NCT04184622|531933972|FG000|Primary Treatment Period|Withdrawal by Subject|58|||
147485351|NCT04184622|531933973|FG001|Primary Treatment Period|Withdrawal by Subject|26|||
147485352|NCT04184622|531933974|FG002|Primary Treatment Period|Withdrawal by Subject|32|||
147485353|NCT04184622|531933975|FG003|Primary Treatment Period|Withdrawal by Subject|21|||
147485354|NCT04184622|531933972|FG000|Additional Treatment Period|Adverse Event|1|||
147485355|NCT04184622|531933973|FG001|Additional Treatment Period|Adverse Event|2|||
147485356|NCT04184622|531933974|FG002|Additional Treatment Period|Adverse Event|1|||
147485357|NCT04184622|531933975|FG003|Additional Treatment Period|Adverse Event|0|||
147485358|NCT04184622|531933972|FG000|Additional Treatment Period|Death|0|||
147485359|NCT04184622|531933973|FG001|Additional Treatment Period|Death|0|||
147485360|NCT04184622|531933974|FG002|Additional Treatment Period|Death|1|||
147485361|NCT04184622|531933975|FG003|Additional Treatment Period|Death|1|||
147485362|NCT04184622|531933972|FG000|Additional Treatment Period|Lost to Follow-up|6|||
147485363|NCT04184622|531933973|FG001|Additional Treatment Period|Lost to Follow-up|4|||
147485364|NCT04184622|531933974|FG002|Additional Treatment Period|Lost to Follow-up|8|||
147485365|NCT04184622|531933975|FG003|Additional Treatment Period|Lost to Follow-up|6|||
147485366|NCT04184622|531933972|FG000|Additional Treatment Period|Other - as reported by the investigator|2|||
147485367|NCT04184622|531933973|FG001|Additional Treatment Period|Other - as reported by the investigator|5|||
147623645|NCT01256450|532440182|FG002|Double-blind Treatment|Opioid withdrawal symptoms|1|||
147623646|NCT01256450|532440180|FG000|Double-blind Treatment|Other|0|||
147623647|NCT01256450|532440181|FG001|Double-blind Treatment|Other|9|||
147623648|NCT01256450|532440182|FG002|Double-blind Treatment|Other|12|||
147623649|NCT03866512|532440183|FG000|Overall Study|Lost to Follow-up|1|||
147623650|NCT03866512|532440184|FG001|Overall Study|Lost to Follow-up|2|||
147485368|NCT04184622|531933974|FG002|Additional Treatment Period|Other - as reported by the investigator|2|||
147485369|NCT04184622|531933975|FG003|Additional Treatment Period|Other - as reported by the investigator|0|||
147485370|NCT04184622|531933972|FG000|Additional Treatment Period|Physician Decision|0|||
147485371|NCT04184622|531933973|FG001|Additional Treatment Period|Physician Decision|0|||
147485372|NCT04184622|531933974|FG002|Additional Treatment Period|Physician Decision|1|||
147485373|NCT04184622|531933975|FG003|Additional Treatment Period|Physician Decision|0|||
147623651|NCT03866512|532440185|FG002|Overall Study|Lost to Follow-up|1|||
147623652|NCT03866512|532440183|FG000|Overall Study|Cannulation issues|0|||
147623653|NCT03866512|532440184|FG001|Overall Study|Cannulation issues|1|||
147623654|NCT03866512|532440185|FG002|Overall Study|Cannulation issues|2|||
147485374|NCT04184622|531933972|FG000|Additional Treatment Period|Pregnancy|0|||
147485375|NCT04184622|531933973|FG001|Additional Treatment Period|Pregnancy|0|||
147485376|NCT04184622|531933974|FG002|Additional Treatment Period|Pregnancy|0|||
147485377|NCT04184622|531933975|FG003|Additional Treatment Period|Pregnancy|1|||
147485378|NCT04184622|531933972|FG000|Additional Treatment Period|Protocol deviation|0|||
147485379|NCT04184622|531933973|FG001|Additional Treatment Period|Protocol deviation|0|||
147485380|NCT04184622|531933974|FG002|Additional Treatment Period|Protocol deviation|1|||
147485381|NCT04184622|531933975|FG003|Additional Treatment Period|Protocol deviation|0|||
147485382|NCT04184622|531933972|FG000|Additional Treatment Period|Site closed|1|||
147485383|NCT04184622|531933973|FG001|Additional Treatment Period|Site closed|0|||
147485384|NCT04184622|531933974|FG002|Additional Treatment Period|Site closed|1|||
147485385|NCT04184622|531933975|FG003|Additional Treatment Period|Site closed|0|||
147485386|NCT04184622|531933972|FG000|Additional Treatment Period|Withdrawal by Subject|21|||
147485387|NCT04184622|531933973|FG001|Additional Treatment Period|Withdrawal by Subject|15|||
147485388|NCT04184622|531933974|FG002|Additional Treatment Period|Withdrawal by Subject|3|||
147485389|NCT04184622|531933975|FG003|Additional Treatment Period|Withdrawal by Subject|7|||
147485390|NCT04184622|531933972|FG000|Safety Follow-up Period|Adverse Event|6|||
147485391|NCT04184622|531933973|FG001|Safety Follow-up Period|Adverse Event|8|||
147485392|NCT04184622|531933974|FG002|Safety Follow-up Period|Adverse Event|9|||
147485393|NCT04184622|531933975|FG003|Safety Follow-up Period|Adverse Event|16|||
147485394|NCT04184622|531933972|FG000|Safety Follow-up Period|Lost to Follow-up|4|||
147485395|NCT04184622|531933973|FG001|Safety Follow-up Period|Lost to Follow-up|4|||
147485396|NCT04184622|531933974|FG002|Safety Follow-up Period|Lost to Follow-up|10|||
147485397|NCT04184622|531933975|FG003|Safety Follow-up Period|Lost to Follow-up|3|||
147485398|NCT04184622|531933972|FG000|Safety Follow-up Period|Missing Weight at Week 176|3|||
147485399|NCT04184622|531933973|FG001|Safety Follow-up Period|Missing Weight at Week 176|2|||
147485400|NCT04184622|531933974|FG002|Safety Follow-up Period|Missing Weight at Week 176|2|||
147485401|NCT04184622|531933975|FG003|Safety Follow-up Period|Missing Weight at Week 176|2|||
147485402|NCT04184622|531933972|FG000|Safety Follow-up Period|Other - as reported by the investigator|10|||
147485403|NCT04184622|531933973|FG001|Safety Follow-up Period|Other - as reported by the investigator|5|||
147485404|NCT04184622|531933974|FG002|Safety Follow-up Period|Other - as reported by the investigator|6|||
147485405|NCT04184622|531933975|FG003|Safety Follow-up Period|Other - as reported by the investigator|5|||
147485406|NCT04184622|531933972|FG000|Safety Follow-up Period|Physician Decision|1|||
147485407|NCT04184622|531933973|FG001|Safety Follow-up Period|Physician Decision|0|||
147485408|NCT04184622|531933974|FG002|Safety Follow-up Period|Physician Decision|0|||
147485409|NCT04184622|531933975|FG003|Safety Follow-up Period|Physician Decision|1|||
147485410|NCT04184622|531933972|FG000|Safety Follow-up Period|Pregnancy|1|||
147485411|NCT04184622|531933973|FG001|Safety Follow-up Period|Pregnancy|3|||
147485412|NCT04184622|531933974|FG002|Safety Follow-up Period|Pregnancy|0|||
147485413|NCT04184622|531933975|FG003|Safety Follow-up Period|Pregnancy|6|||
147485414|NCT04184622|531933972|FG000|Safety Follow-up Period|Protocol deviation|1|||
147485415|NCT04184622|531933973|FG001|Safety Follow-up Period|Protocol deviation|0|||
147485416|NCT04184622|531933974|FG002|Safety Follow-up Period|Protocol deviation|0|||
147485417|NCT04184622|531933975|FG003|Safety Follow-up Period|Protocol deviation|0|||
147485418|NCT04184622|531933972|FG000|Safety Follow-up Period|Withdrawal by Subject|31|||
147485419|NCT04184622|531933973|FG001|Safety Follow-up Period|Withdrawal by Subject|13|||
147485420|NCT04184622|531933974|FG002|Safety Follow-up Period|Withdrawal by Subject|7|||
147485421|NCT04184622|531933975|FG003|Safety Follow-up Period|Withdrawal by Subject|9|||
147485422|NCT02795988|531933980|FG000|Phase 1b|Withdrawal by Subject|0|||
147485423|NCT02795988|531933981|FG001|Phase 1b|Withdrawal by Subject|1|||
147485424|NCT02795988|531933982|FG002|Phase 1b|Withdrawal by Subject|0|||
147485425|NCT02795988|531933983|FG003|Phase 1b|Withdrawal by Subject|0|||
147485426|NCT02795988|531933984|FG004|Phase 1b|Withdrawal by Subject|0|||
147485427|NCT02795988|531933985|FG005|Phase 1b|Withdrawal by Subject|0|||
147485428|NCT02795988|531933986|FG006|Phase 1b|Withdrawal by Subject|0|||
147485429|NCT02795988|531933980|FG000|Phase 1b|Death|1|||
147485430|NCT02795988|531933981|FG001|Phase 1b|Death|2|||
147485431|NCT02795988|531933982|FG002|Phase 1b|Death|1|||
147485432|NCT02795988|531933983|FG003|Phase 1b|Death|0|||
147485433|NCT02795988|531933984|FG004|Phase 1b|Death|0|||
147485434|NCT02795988|531933985|FG005|Phase 1b|Death|0|||
147485435|NCT02795988|531933986|FG006|Phase 1b|Death|0|||
147485436|NCT02795988|531933980|FG000|Phase 1b|Physician Decision|0|||
147485437|NCT02795988|531933981|FG001|Phase 1b|Physician Decision|0|||
147485438|NCT02795988|531933982|FG002|Phase 1b|Physician Decision|1|||
147485439|NCT02795988|531933983|FG003|Phase 1b|Physician Decision|0|||
147485440|NCT02795988|531933984|FG004|Phase 1b|Physician Decision|0|||
147485441|NCT02795988|531933985|FG005|Phase 1b|Physician Decision|0|||
147485442|NCT02795988|531933986|FG006|Phase 1b|Physician Decision|0|||
147485443|NCT02795988|531933980|FG000|Phase 1b|Progressive Disease|2|||
147485444|NCT02795988|531933981|FG001|Phase 1b|Progressive Disease|2|||
147485445|NCT02795988|531933982|FG002|Phase 1b|Progressive Disease|0|||
147485446|NCT02795988|531933983|FG003|Phase 1b|Progressive Disease|0|||
147485447|NCT02795988|531933984|FG004|Phase 1b|Progressive Disease|0|||
147485448|NCT02795988|531933985|FG005|Phase 1b|Progressive Disease|0|||
147485449|NCT02795988|531933986|FG006|Phase 1b|Progressive Disease|0|||
147485450|NCT02795988|531933980|FG000|Phase 2|Withdrawal by Subject|0|||
147485451|NCT02795988|531933981|FG001|Phase 2|Withdrawal by Subject|0|||
147485452|NCT02795988|531933982|FG002|Phase 2|Withdrawal by Subject|0|||
147485453|NCT02795988|531933983|FG003|Phase 2|Withdrawal by Subject|1|||
147485454|NCT02795988|531933984|FG004|Phase 2|Withdrawal by Subject|0|||
147485455|NCT02795988|531933985|FG005|Phase 2|Withdrawal by Subject|0|||
147485456|NCT02795988|531933986|FG006|Phase 2|Withdrawal by Subject|0|||
147485457|NCT02795988|531933980|FG000|Phase 2|Death|0|||
147485458|NCT02795988|531933981|FG001|Phase 2|Death|0|||
147485459|NCT02795988|531933982|FG002|Phase 2|Death|0|||
147485460|NCT02795988|531933983|FG003|Phase 2|Death|17|||
147485461|NCT02795988|531933984|FG004|Phase 2|Death|17|||
147485462|NCT02795988|531933985|FG005|Phase 2|Death|0|||
147485463|NCT02795988|531933986|FG006|Phase 2|Death|0|||
147485464|NCT02795988|531933980|FG000|Phase 2|Other|0|||
147485465|NCT02795988|531933981|FG001|Phase 2|Other|0|||
147485466|NCT02795988|531933982|FG002|Phase 2|Other|0|||
147485467|NCT02795988|531933983|FG003|Phase 2|Other|1|||
147485468|NCT02795988|531933984|FG004|Phase 2|Other|0|||
147485469|NCT02795988|531933985|FG005|Phase 2|Other|0|||
147485470|NCT02795988|531933986|FG006|Phase 2|Other|0|||
147485471|NCT02795988|531933980|FG000|Phase 2 Extension|Death|0|||
147485472|NCT02795988|531933981|FG001|Phase 2 Extension|Death|0|||
147485473|NCT02795988|531933982|FG002|Phase 2 Extension|Death|0|||
147485474|NCT02795988|531933983|FG003|Phase 2 Extension|Death|0|||
147485475|NCT02795988|531933984|FG004|Phase 2 Extension|Death|0|||
147485476|NCT02795988|531933985|FG005|Phase 2 Extension|Death|5|||
147485477|NCT02795988|531933986|FG006|Phase 2 Extension|Death|6|||
147485478|NCT02795988|531933980|FG000|Phase 2 Extension|Other reasons|0|||
147485479|NCT02795988|531933981|FG001|Phase 2 Extension|Other reasons|0|||
147485480|NCT02795988|531933982|FG002|Phase 2 Extension|Other reasons|0|||
147485481|NCT02795988|531933983|FG003|Phase 2 Extension|Other reasons|0|||
147485482|NCT02795988|531933984|FG004|Phase 2 Extension|Other reasons|0|||
147485483|NCT02795988|531933985|FG005|Phase 2 Extension|Other reasons|2|||
147485484|NCT02795988|531933986|FG006|Phase 2 Extension|Other reasons|1|||
147485485|NCT02834403|531933987|FG000|Overall Study|Physician Decision|2|||
147485486|NCT02834403|531933988|FG001|Overall Study|Physician Decision|1|||
147485487|NCT02834403|531933989|FG002|Overall Study|Physician Decision|2|||
147485488|NCT02834403|531933990|FG003|Overall Study|Physician Decision|1|||
147485489|NCT02834403|531933991|FG004|Overall Study|Physician Decision|1|||
147485490|NCT02834403|531933992|FG005|Overall Study|Physician Decision|2|||
147485491|NCT02834403|531933993|FG006|Overall Study|Physician Decision|12|||
147485492|NCT02834403|531933987|FG000|Overall Study|Adverse Event|0|||
147485493|NCT02834403|531933988|FG001|Overall Study|Adverse Event|0|||
147485494|NCT02834403|531933989|FG002|Overall Study|Adverse Event|0|||
147485495|NCT02834403|531933990|FG003|Overall Study|Adverse Event|0|||
147485496|NCT02834403|531933991|FG004|Overall Study|Adverse Event|1|||
147485497|NCT02834403|531933992|FG005|Overall Study|Adverse Event|1|||
147485498|NCT02834403|531933993|FG006|Overall Study|Adverse Event|3|||
147485499|NCT02834403|531933987|FG000|Overall Study|Withdrawal by Subject|0|||
147485500|NCT02834403|531933988|FG001|Overall Study|Withdrawal by Subject|1|||
147485501|NCT02834403|531933989|FG002|Overall Study|Withdrawal by Subject|0|||
147485502|NCT02834403|531933990|FG003|Overall Study|Withdrawal by Subject|0|||
147485503|NCT02834403|531933991|FG004|Overall Study|Withdrawal by Subject|1|||
147485504|NCT02834403|531933992|FG005|Overall Study|Withdrawal by Subject|0|||
147485505|NCT02834403|531933993|FG006|Overall Study|Withdrawal by Subject|0|||
147485506|NCT02834403|531933987|FG000|Overall Study|Complete response before the end of 6 cycles|0|||
147485507|NCT02834403|531933988|FG001|Overall Study|Complete response before the end of 6 cycles|0|||
147485508|NCT02834403|531933989|FG002|Overall Study|Complete response before the end of 6 cycles|0|||
147485509|NCT02834403|531933990|FG003|Overall Study|Complete response before the end of 6 cycles|0|||
147485510|NCT02834403|531933991|FG004|Overall Study|Complete response before the end of 6 cycles|0|||
147485511|NCT02834403|531933992|FG005|Overall Study|Complete response before the end of 6 cycles|0|||
147485512|NCT02834403|531933993|FG006|Overall Study|Complete response before the end of 6 cycles|3|||
147485513|NCT02341014|531933994|FG000|Overall Study|Adverse Event|0|||
147485514|NCT02341014|531933995|FG001|Overall Study|Adverse Event|1|||
147485515|NCT02341014|531933996|FG002|Overall Study|Adverse Event|0|||
147485516|NCT02341014|531933997|FG003|Overall Study|Adverse Event|0|||
147485517|NCT02341014|531933998|FG004|Overall Study|Adverse Event|2|||
147485518|NCT00273858|531934005|FG000|Overall Study|Not completed 24 month observation time|334|||
147485519|NCT00273858|531934005|FG000|Overall Study|Lost to Follow-up|101|||
147485520|NCT00273858|531934005|FG000|Overall Study|Withdrawal by Subject|21|||
147485521|NCT00273858|531934005|FG000|Overall Study|Adverse Event|81|||
147485522|NCT02232516|531934010|FG000|Study Treatment Period: Cycles 1-3|Adverse Event|6|||
147485523|NCT02232516|531934010|FG000|Study Treatment Period: Cycles 1-3|Withdrawal by Subject|1|||
147485524|NCT02232516|531934010|FG000|Study Treatment Period: Cycles 1-3|No Response|1|||
147485525|NCT02232516|531934010|FG000|Study Treatment Period: Cycles 1-3|Screen failure|1|||
147485526|NCT02232516|531934010|FG000|Study Treatment Period: Cycles 1-3|Disease Progression|1|||
147623655|NCT00832455|532440190|FG000|Overall Study|Adverse Event|13|||
147623656|NCT00832455|532440190|FG000|Overall Study|Lost to Follow-up|26|||
147623657|NCT00832455|532440190|FG000|Overall Study|Protocol Violation|4|||
147485527|NCT02232516|531934010|FG000|Study Treatment Period: Cycles 4-6|Disease Progression|4|||
147485528|NCT02232516|531934010|FG000|Study Treatment Period: Cycles 4-6|Adverse Event|1|||
147485529|NCT02232516|531934010|FG000|Study Treatment Period: Cycles 4-6|Withdrawal by Subject|2|||
147485530|NCT02232516|531934010|FG000|Study Treatment Period: Cycles 7-9|Adverse Event|4|||
147485531|NCT02232516|531934010|FG000|Study Treatment Period: Cycles 7-9|Disease Progression|2|||
147485532|NCT02232516|531934010|FG000|Study Treatment Period: Cycles 7-9|Withdrawal by Subject|3|||
147485533|NCT02232516|531934010|FG000|Study Treatment Period: Cycles 7-9|Physician Decision|1|||
147485534|NCT02232516|531934010|FG000|Study Treatment Period: Cycles 10-12|Adverse Event|1|||
147485535|NCT02232516|531934010|FG000|Study Treatment Period: Cycles 10-12|Disease Progression|1|||
147485536|NCT02232516|531934010|FG000|Survival Follow-up|Death|15|||
147485537|NCT02232516|531934010|FG000|Survival Follow-up|Withdrawal by Subject|3|||
147485538|NCT02232516|531934010|FG000|Survival Follow-up|Lost to Follow-up|1|||
147485539|NCT02232516|531934010|FG000|Survival Follow-up|Still in follow-up|5|||
147485540|NCT05058664|531934011|FG000|Overall Study|No follow-up data provided|4|||
147485541|NCT05058664|531934012|FG001|Overall Study|No follow-up data provided|0|||
147485542|NCT05058664|531934013|FG002|Overall Study|No follow-up data provided|2|||
147485543|NCT05058664|531934011|FG000|Overall Study|Withdrawal by Subject|0|||
147485544|NCT05058664|531934012|FG001|Overall Study|Withdrawal by Subject|0|||
147485545|NCT05058664|531934013|FG002|Overall Study|Withdrawal by Subject|1|||
147485546|NCT02606045|531934014|FG000|Overall Study|Study closed before treament could begin|1|||
147485547|NCT02606045|531934015|FG001|Overall Study|Study closed before treament could begin|2|||
147485548|NCT01702363|531934016|FG000|Overall Study|Adverse Event|14|||
147485549|NCT01702363|531934016|FG000|Overall Study|Lack of Efficacy|4|||
147485550|NCT01702363|531934016|FG000|Overall Study|Withdrawal by Subject|2|||
147485551|NCT00002663|531934017|FG000|Overall Study|Death|4|||
147485552|NCT00002663|531934018|FG001|Overall Study|Death|1|||
147485553|NCT00002663|531934019|FG002|Overall Study|Death|1|||
147485554|NCT00002663|531934020|FG003|Overall Study|Death|0|||
147485555|NCT00002663|531934021|FG004|Overall Study|Death|0|||
147485556|NCT00002663|531934022|FG005|Overall Study|Death|13|||
147485557|NCT00002663|531934023|FG006|Overall Study|Death|0|||
147485558|NCT00002663|531934024|FG007|Overall Study|Death|1|||
147485559|NCT00002663|531934025|FG008|Overall Study|Death|1|||
147485560|NCT00002663|531934026|FG009|Overall Study|Death|1|||
147485561|NCT00002663|531934017|FG000|Overall Study|Lost to Follow-up|3|||
147485562|NCT00002663|531934018|FG001|Overall Study|Lost to Follow-up|0|||
147485563|NCT00002663|531934019|FG002|Overall Study|Lost to Follow-up|0|||
147485564|NCT00002663|531934020|FG003|Overall Study|Lost to Follow-up|1|||
147485565|NCT00002663|531934021|FG004|Overall Study|Lost to Follow-up|0|||
147485566|NCT00002663|531934022|FG005|Overall Study|Lost to Follow-up|1|||
147485567|NCT00002663|531934023|FG006|Overall Study|Lost to Follow-up|0|||
147485568|NCT00002663|531934024|FG007|Overall Study|Lost to Follow-up|0|||
147485569|NCT00002663|531934025|FG008|Overall Study|Lost to Follow-up|0|||
147485570|NCT00002663|531934026|FG009|Overall Study|Lost to Follow-up|0|||
147485571|NCT00002663|531934017|FG000|Overall Study|Other|0|||
147485572|NCT00002663|531934018|FG001|Overall Study|Other|1|||
147485573|NCT00002663|531934019|FG002|Overall Study|Other|0|||
147485574|NCT00002663|531934020|FG003|Overall Study|Other|0|||
147485575|NCT00002663|531934021|FG004|Overall Study|Other|0|||
147485576|NCT00002663|531934022|FG005|Overall Study|Other|1|||
147485577|NCT00002663|531934023|FG006|Overall Study|Other|1|||
147485578|NCT00002663|531934024|FG007|Overall Study|Other|0|||
147485579|NCT00002663|531934025|FG008|Overall Study|Other|0|||
147485580|NCT00002663|531934026|FG009|Overall Study|Other|0|||
147485581|NCT00002663|531934017|FG000|Overall Study|Physician Decision|0|||
147485582|NCT00002663|531934018|FG001|Overall Study|Physician Decision|0|||
147485583|NCT00002663|531934019|FG002|Overall Study|Physician Decision|0|||
147485584|NCT00002663|531934020|FG003|Overall Study|Physician Decision|0|||
147485585|NCT00002663|531934021|FG004|Overall Study|Physician Decision|1|||
147485586|NCT00002663|531934022|FG005|Overall Study|Physician Decision|0|||
147485587|NCT00002663|531934023|FG006|Overall Study|Physician Decision|0|||
147485588|NCT00002663|531934024|FG007|Overall Study|Physician Decision|0|||
147485589|NCT00002663|531934025|FG008|Overall Study|Physician Decision|1|||
147485590|NCT00002663|531934026|FG009|Overall Study|Physician Decision|1|||
147485591|NCT00002663|531934017|FG000|Overall Study|Adverse Event|0|||
147485592|NCT00002663|531934018|FG001|Overall Study|Adverse Event|0|||
147485593|NCT00002663|531934019|FG002|Overall Study|Adverse Event|0|||
147485594|NCT00002663|531934020|FG003|Overall Study|Adverse Event|1|||
147485595|NCT00002663|531934021|FG004|Overall Study|Adverse Event|0|||
147485596|NCT00002663|531934022|FG005|Overall Study|Adverse Event|0|||
147485597|NCT00002663|531934023|FG006|Overall Study|Adverse Event|0|||
147485598|NCT00002663|531934024|FG007|Overall Study|Adverse Event|1|||
147485599|NCT00002663|531934025|FG008|Overall Study|Adverse Event|0|||
147485600|NCT00002663|531934026|FG009|Overall Study|Adverse Event|0|||
147485601|NCT00525148|531934030|FG000|Overall Study|Other Adverse Event|3|||
147485602|NCT00525148|531934031|FG001|Overall Study|Other Adverse Event|5|||
147485603|NCT00525148|531934032|FG002|Overall Study|Other Adverse Event|1|||
147485604|NCT00525148|531934033|FG003|Overall Study|Other Adverse Event|8|||
147485605|NCT00525148|531934030|FG000|Overall Study|Progressive disease|18|||
147485606|NCT00525148|531934031|FG001|Overall Study|Progressive disease|30|||
147485607|NCT00525148|531934032|FG002|Overall Study|Progressive disease|6|||
147485608|NCT00525148|531934033|FG003|Overall Study|Progressive disease|49|||
147485609|NCT00525148|531934030|FG000|Overall Study|Refused continuation of study medication|0|||
147485610|NCT00525148|531934031|FG001|Overall Study|Refused continuation of study medication|2|||
147485611|NCT00525148|531934032|FG002|Overall Study|Refused continuation of study medication|0|||
147485612|NCT00525148|531934033|FG003|Overall Study|Refused continuation of study medication|1|||
147485613|NCT00525148|531934030|FG000|Overall Study|Other than stated|2|||
147485614|NCT00525148|531934031|FG001|Overall Study|Other than stated|1|||
147485615|NCT00525148|531934032|FG002|Overall Study|Other than stated|0|||
147485616|NCT00525148|531934033|FG003|Overall Study|Other than stated|3|||
147485617|NCT03015610|531934034|FG000|Overall Study|Lost to Follow-up|1|||
147485618|NCT03015610|531934035|FG001|Overall Study|Lost to Follow-up|5|||
147485619|NCT01603641|531934036|FG000|Overall Study|Did not Receive Treatment|3|||
147485620|NCT01603641|531934036|FG000|Overall Study|Adverse Event|1|||
147485621|NCT01603641|531934036|FG000|Overall Study|Lack of Efficacy|1|||
147485622|NCT01603641|531934036|FG000|Overall Study|Lost to Follow-up|6|||
147485623|NCT01603641|531934036|FG000|Overall Study|Personal Reasons|18|||
147485624|NCT01603641|531934036|FG000|Overall Study|Other Miscellaneous Reasons|6|||
147485625|NCT05100199|531934043|FG000|Overall Study|Lost to Follow-up|5|||
147485626|NCT05100199|531934044|FG001|Overall Study|Lost to Follow-up|8|||
147485627|NCT05100199|531934045|FG002|Overall Study|Lost to Follow-up|3|||
147485628|NCT05100199|531934046|FG003|Overall Study|Lost to Follow-up|6|||
147485629|NCT05100199|531934043|FG000|Overall Study|Withdrawal by Subject|3|||
147485630|NCT05100199|531934044|FG001|Overall Study|Withdrawal by Subject|3|||
147485631|NCT05100199|531934045|FG002|Overall Study|Withdrawal by Subject|9|||
147485632|NCT05100199|531934046|FG003|Overall Study|Withdrawal by Subject|7|||
147485633|NCT05100199|531934043|FG000|Overall Study|Other|0|||
147485634|NCT05100199|531934044|FG001|Overall Study|Other|0|||
147485635|NCT05100199|531934045|FG002|Overall Study|Other|1|||
147485636|NCT05100199|531934046|FG003|Overall Study|Other|1|||
147485637|NCT02853331|531934047|FG000|Overall Study|Death|59|||
147485638|NCT02853331|531934048|FG001|Overall Study|Death|95|||
147485639|NCT02853331|531934047|FG000|Overall Study|Withdrawal by Subject|5|||
147485640|NCT02853331|531934048|FG001|Overall Study|Withdrawal by Subject|9|||
147485641|NCT02853331|531934047|FG000|Overall Study|Ongoing in study|368|||
147485642|NCT02853331|531934048|FG001|Overall Study|Ongoing in study|325|||
147485643|NCT02062151|531934051|FG000|Overall Study|screen failure|1|||
147485644|NCT00257192|531934052|FG000|Overall Study|Adverse Event|21|||
147485645|NCT00257192|531934053|FG001|Overall Study|Adverse Event|10|||
147485646|NCT00257192|531934052|FG000|Overall Study|Laboratory abnormality|1|||
147485647|NCT00257192|531934053|FG001|Overall Study|Laboratory abnormality|1|||
147485648|NCT00257192|531934052|FG000|Overall Study|Lost to Follow-up|3|||
147485649|NCT00257192|531934053|FG001|Overall Study|Lost to Follow-up|3|||
147485650|NCT00257192|531934052|FG000|Overall Study|Insufficient clinical response|18|||
147485651|NCT00257192|531934053|FG001|Overall Study|Insufficient clinical response|18|||
147485652|NCT00257192|531934052|FG000|Overall Study|Withdrawal by Subject|14|||
147485653|NCT00257192|531934053|FG001|Overall Study|Withdrawal by Subject|2|||
147485654|NCT00257192|531934052|FG000|Overall Study|Randomized but not treated|0|||
147485655|NCT00257192|531934053|FG001|Overall Study|Randomized but not treated|1|||
147485656|NCT00257192|531934052|FG000|Overall Study|Study terminated by sponsor|1|||
147485657|NCT00257192|531934053|FG001|Overall Study|Study terminated by sponsor|0|||
147485658|NCT00257192|531934052|FG000|Overall Study|Miscellaneous|0|||
147485659|NCT00257192|531934053|FG001|Overall Study|Miscellaneous|4|||
147485660|NCT00570739|531934054|FG000|Overall Study|Adverse Event|8|||
147485661|NCT00570739|531934055|FG001|Overall Study|Adverse Event|6|||
147485662|NCT00570739|531934056|FG002|Overall Study|Adverse Event|2|||
147485663|NCT00570739|531934057|FG003|Overall Study|Adverse Event|2|||
147485664|NCT00570739|531934054|FG000|Overall Study|Lost to Follow-up|4|||
147485665|NCT00570739|531934055|FG001|Overall Study|Lost to Follow-up|5|||
147485666|NCT00570739|531934056|FG002|Overall Study|Lost to Follow-up|4|||
147485667|NCT00570739|531934057|FG003|Overall Study|Lost to Follow-up|1|||
147485668|NCT00570739|531934054|FG000|Overall Study|Physician Decision|1|||
147485669|NCT00570739|531934055|FG001|Overall Study|Physician Decision|1|||
147485670|NCT00570739|531934056|FG002|Overall Study|Physician Decision|0|||
147485671|NCT00570739|531934057|FG003|Overall Study|Physician Decision|0|||
147485672|NCT00570739|531934054|FG000|Overall Study|Withdrawal by Subject|7|||
147623658|NCT00832455|532440190|FG000|Overall Study|Withdrawal by Subject|17|||
147623659|NCT00832455|532440190|FG000|Overall Study|Screening Failure|2|||
147485673|NCT00570739|531934055|FG001|Overall Study|Withdrawal by Subject|7|||
147485674|NCT00570739|531934056|FG002|Overall Study|Withdrawal by Subject|3|||
147485675|NCT00570739|531934057|FG003|Overall Study|Withdrawal by Subject|5|||
147623660|NCT00832455|532440190|FG000|Overall Study|Stopped Medication|4|||
147485676|NCT00570739|531934054|FG000|Overall Study|Required restricted medication|0|||
147485677|NCT00570739|531934055|FG001|Overall Study|Required restricted medication|0|||
147485678|NCT00570739|531934056|FG002|Overall Study|Required restricted medication|1|||
147485679|NCT00570739|531934057|FG003|Overall Study|Required restricted medication|0|||
147485680|NCT00570739|531934054|FG000|Overall Study|Met discontinuation criteria|1|||
147623661|NCT00832455|532440190|FG000|Overall Study|Parent misunderstood study|1|||
147485681|NCT00570739|531934055|FG001|Overall Study|Met discontinuation criteria|0|||
147485682|NCT00570739|531934056|FG002|Overall Study|Met discontinuation criteria|1|||
147485683|NCT00570739|531934057|FG003|Overall Study|Met discontinuation criteria|1|||
147485684|NCT00570739|531934054|FG000|Overall Study|Other|0|||
147485685|NCT00570739|531934055|FG001|Overall Study|Other|2|||
147485686|NCT00570739|531934056|FG002|Overall Study|Other|5|||
147485687|NCT00570739|531934057|FG003|Overall Study|Other|3|||
147485688|NCT01905397|531934060|FG000|Overall Study|Death|0|||
147485689|NCT01905397|531934061|FG001|Overall Study|Death|1|||
147485690|NCT01905397|531934060|FG000|Overall Study|Withdrawal by Subject|2|||
147485691|NCT01905397|531934061|FG001|Overall Study|Withdrawal by Subject|0|||
147485692|NCT01905397|531934060|FG000|Overall Study|Surgery canceled/aborted|9|||
147485693|NCT01905397|531934061|FG001|Overall Study|Surgery canceled/aborted|5|||
147485694|NCT01905397|531934060|FG000|Overall Study|Incision < 7 cm|2|||
147485695|NCT01905397|531934061|FG001|Overall Study|Incision < 7 cm|0|||
147485696|NCT01905397|531934060|FG000|Overall Study|Wrong treatment|1|||
147485697|NCT01905397|531934061|FG001|Overall Study|Wrong treatment|1|||
147485698|NCT01905397|531934060|FG000|Overall Study|Device not applied|3|||
147485699|NCT01905397|531934061|FG001|Overall Study|Device not applied|0|||
147485700|NCT01905397|531934060|FG000|Overall Study|Dressing not applied in operating room|1|||
147485701|NCT01905397|531934061|FG001|Overall Study|Dressing not applied in operating room|0|||
147485702|NCT01905397|531934060|FG000|Overall Study|Wound vac turned off due to device alarm|1|||
147485703|NCT01905397|531934061|FG001|Overall Study|Wound vac turned off due to device alarm|0|||
147485704|NCT01921270|531934064|FG000|Overall Study|Withdrawal by Subject|1|||
147485705|NCT00844428|531934065|FG000|Screening Period|Screen Failure|3|||
147485706|NCT00844428|531934065|FG000|Extension Treatment Period|Death|1|||
147485707|NCT00844428|531934065|FG000|Post Treatment Period (Patients Who Disc|Death|1|||
147485708|NCT00772967|531934066|FG000|Crossover Treatment 1|Adverse Event (Pain)|0|||
147485709|NCT00772967|531934067|FG001|Crossover Treatment 1|Adverse Event (Pain)|0|||
147485710|NCT00772967|531934068|FG002|Crossover Treatment 1|Adverse Event (Pain)|0|||
147485711|NCT00772967|531934069|FG003|Crossover Treatment 1|Adverse Event (Pain)|1|||
147485712|NCT00772967|531934070|FG004|Crossover Treatment 1|Adverse Event (Pain)|0|||
147485713|NCT00772967|531934071|FG005|Crossover Treatment 1|Adverse Event (Pain)|0|||
147485714|NCT00772967|531934066|FG000|Break 1 (4-7 Days)|Withdrawal by Subject|0|||
147485715|NCT00772967|531934067|FG001|Break 1 (4-7 Days)|Withdrawal by Subject|1|||
147485716|NCT00772967|531934068|FG002|Break 1 (4-7 Days)|Withdrawal by Subject|0|||
147485717|NCT00772967|531934069|FG003|Break 1 (4-7 Days)|Withdrawal by Subject|0|||
147485718|NCT00772967|531934070|FG004|Break 1 (4-7 Days)|Withdrawal by Subject|0|||
147485719|NCT00772967|531934071|FG005|Break 1 (4-7 Days)|Withdrawal by Subject|0|||
147485720|NCT00772967|531934066|FG000|Crossover Treatment 3|Adverse Event|0|||
147485721|NCT00772967|531934067|FG001|Crossover Treatment 3|Adverse Event|0|||
147485722|NCT00772967|531934068|FG002|Crossover Treatment 3|Adverse Event|0|||
147623662|NCT00832455|532440190|FG000|Overall Study|Parent dissatisfied|1|||
147485723|NCT00772967|531934069|FG003|Crossover Treatment 3|Adverse Event|0|||
147485724|NCT00772967|531934070|FG004|Crossover Treatment 3|Adverse Event|1|||
147485725|NCT00772967|531934071|FG005|Crossover Treatment 3|Adverse Event|0|||
147485726|NCT01096550|531934072|FG000|Overall Study|discontinued site|10|||
147485727|NCT01096550|531934073|FG001|Overall Study|discontinued site|11|||
147485728|NCT01096550|531934072|FG000|Overall Study|non-regular treatment track at clinic|1|||
147485729|NCT01096550|531934073|FG001|Overall Study|non-regular treatment track at clinic|1|||
147485730|NCT01096550|531934072|FG000|Overall Study|clinic readmission|1|||
147485731|NCT01096550|531934073|FG001|Overall Study|clinic readmission|1|||
147485732|NCT01096550|531934072|FG000|Overall Study|Withdrawal by Subject|0|||
147485733|NCT01096550|531934073|FG001|Overall Study|Withdrawal by Subject|1|||
147485734|NCT01096550|531934072|FG000|Overall Study|non-African American participant|13|||
147485735|NCT01096550|531934073|FG001|Overall Study|non-African American participant|6|||
147485736|NCT01096550|531934072|FG000|Overall Study|Lost to Follow-up|12|||
147485737|NCT01096550|531934073|FG001|Overall Study|Lost to Follow-up|9|||
147485738|NCT02229864|531934074|FG000|Overall Study|Death|2|||
147485739|NCT02229864|531934074|FG000|Overall Study|Lost to Follow-up|1|||
147485740|NCT02588248|531934081|FG000|Overall Study|Physician Decision|4|||
147485741|NCT02588248|531934082|FG001|Overall Study|Physician Decision|3|||
147485742|NCT04229446|531934083|FG000|Overall Study|Death|12|||
147485743|NCT04229446|531934084|FG001|Overall Study|Death|10|||
147485744|NCT04229446|531934083|FG000|Overall Study|Lost to Follow-up|5|||
147485745|NCT04229446|531934084|FG001|Overall Study|Lost to Follow-up|8|||
147485746|NCT00705224|531934085|FG000|Overall Study|Adverse Event|1|||
147485747|NCT00705224|531934085|FG000|Overall Study|Lack of Efficacy|2|||
147485748|NCT00705224|531934085|FG000|Overall Study|Withdrawal by Subject|3|||
147485749|NCT00705224|531934085|FG000|Overall Study|Lost to Follow-up|5|||
147485750|NCT02566525|531934086|FG000|Overall Study|Protocol Violation|3|||
147485751|NCT02566525|531934087|FG001|Overall Study|Protocol Violation|5|||
147485752|NCT00337467|531934088|FG000|Overall Study|Adverse Event|3|||
147485753|NCT00337467|531934088|FG000|Overall Study|Subject Withdrew Consent|2|||
147485754|NCT00337467|531934088|FG000|Overall Study|Pregnancy|1|||
147485755|NCT00337467|531934088|FG000|Overall Study|Lost to Follow-up|2|||
147623663|NCT00832455|532440190|FG000|Overall Study|No improvement|3|||
147485756|NCT00337467|531934088|FG000|Overall Study|Subject No Longer Met Study Criteria|2|||
147485757|NCT03141086|531934089|FG000|Overall Study|Study Terminated By Sponsor|1|||
147485758|NCT03141086|531934090|FG001|Overall Study|Study Terminated By Sponsor|1|||
147485759|NCT03141086|531934089|FG000|Overall Study|Withdrawal by Subject|0|||
147485760|NCT03141086|531934090|FG001|Overall Study|Withdrawal by Subject|1|||
147485761|NCT03141086|531934089|FG000|Overall Study|Protocol Violation|0|||
147485762|NCT03141086|531934090|FG001|Overall Study|Protocol Violation|1|||
147485763|NCT03141086|531934089|FG000|Overall Study|Adverse Event|0|||
147485764|NCT03141086|531934090|FG001|Overall Study|Adverse Event|2|||
147485765|NCT04430582|531934092|FG000|Overall Study|Found to meet exclusionary criteria|1|||
147485766|NCT04430582|531934093|FG001|Overall Study|Found to meet exclusionary criteria|0|||
147485767|NCT04430582|531934092|FG000|Overall Study|Withdrawal by Subject|0|||
147485768|NCT04430582|531934093|FG001|Overall Study|Withdrawal by Subject|1|||
147485769|NCT03607682|531934094|FG000|Overall Study|Withdrawal by Subject|1|||
147485770|NCT03607682|531934094|FG000|Overall Study|Disease progression|1|||
147485771|NCT04400318|531936374|FG000|Overall Study|Adverse Event|1|||
147485772|NCT04400318|531936375|FG001|Overall Study|Adverse Event|0|||
147485773|NCT04400318|531936374|FG000|Overall Study|Withdrawal by Subject|1|||
147485774|NCT04400318|531936375|FG001|Overall Study|Withdrawal by Subject|1|||
147485775|NCT04400318|531936374|FG000|Overall Study|Not Related to Coronavirus Disease 2019 Pandemic|0|||
147485776|NCT04400318|531936375|FG001|Overall Study|Not Related to Coronavirus Disease 2019 Pandemic|3|||
147485777|NCT02410902|531936384|FG000|Overall Study|Adverse Event|2|||
147485778|NCT02410902|531936385|FG001|Overall Study|Adverse Event|3|||
147485779|NCT02410902|531936384|FG000|Overall Study|Lost to Follow-up|4|||
147485780|NCT02410902|531936385|FG001|Overall Study|Lost to Follow-up|1|||
147485781|NCT02410902|531936384|FG000|Overall Study|Protocol Violation|1|||
147485782|NCT02410902|531936385|FG001|Overall Study|Protocol Violation|4|||
147485783|NCT02410902|531936384|FG000|Overall Study|Withdrawal by Subject|6|||
147485784|NCT02410902|531936385|FG001|Overall Study|Withdrawal by Subject|8|||
147485785|NCT02410902|531936384|FG000|Overall Study|Non-Compliance|8|||
147485786|NCT02410902|531936385|FG001|Overall Study|Non-Compliance|2|||
147485787|NCT00953043|531936386|FG000|Overall Study|Withdrawal by Subject|4|||
147485788|NCT00953043|531936387|FG001|Overall Study|Withdrawal by Subject|0|||
147485789|NCT00953043|531936386|FG000|Overall Study|Physician Decision|0|||
147485790|NCT00953043|531936387|FG001|Overall Study|Physician Decision|2|||
147485791|NCT00747617|531936389|FG000|Overall Study|Lost to Follow-up|3|||
147485792|NCT00747617|531936390|FG001|Overall Study|Lost to Follow-up|1|||
147485793|NCT03509207|531936391|FG000|Overall Study|Death|2|||
147485794|NCT01043185|531936392|FG000|Period 6 - Third Washout Period|Protocol Violation|0|||
147485795|NCT01043185|531936393|FG001|Period 6 - Third Washout Period|Protocol Violation|0|||
147485796|NCT01043185|531936394|FG002|Period 6 - Third Washout Period|Protocol Violation|0|||
147485797|NCT01043185|531936395|FG003|Period 6 - Third Washout Period|Protocol Violation|0|||
147485798|NCT01043185|531936396|FG004|Period 6 - Third Washout Period|Protocol Violation|0|||
147485799|NCT01043185|531936397|FG005|Period 6 - Third Washout Period|Protocol Violation|0|||
147485800|NCT01043185|531936398|FG006|Period 6 - Third Washout Period|Protocol Violation|0|||
147485801|NCT01043185|531936399|FG007|Period 6 - Third Washout Period|Protocol Violation|0|||
147485802|NCT01043185|531936400|FG008|Period 6 - Third Washout Period|Protocol Violation|1|||
147485803|NCT01043185|531936401|FG009|Period 6 - Third Washout Period|Protocol Violation|0|||
147485804|NCT01432262|531936402|FG000|Overall Study|Withdrawal by Subject|2|||
147485805|NCT01432262|531936403|FG001|Overall Study|Withdrawal by Subject|1|||
147485806|NCT00165646|531936404|FG000|Overall Study|Adverse Event|1|||
147485807|NCT00165646|531936405|FG001|Overall Study|Adverse Event|1|||
147485808|NCT00165646|531936406|FG002|Overall Study|Adverse Event|1|||
147485809|NCT00165646|531936404|FG000|Overall Study|Lack of Efficacy|1|||
147485810|NCT00165646|531936405|FG001|Overall Study|Lack of Efficacy|2|||
147485811|NCT00165646|531936406|FG002|Overall Study|Lack of Efficacy|0|||
147485812|NCT00165646|531936404|FG000|Overall Study|Withdrawal by Subject|0|||
147485813|NCT00165646|531936405|FG001|Overall Study|Withdrawal by Subject|2|||
147485814|NCT00165646|531936406|FG002|Overall Study|Withdrawal by Subject|1|||
147485815|NCT00165646|531936404|FG000|Overall Study|Physician Decision|2|||
147485816|NCT00165646|531936405|FG001|Overall Study|Physician Decision|0|||
147485817|NCT00165646|531936406|FG002|Overall Study|Physician Decision|2|||
147485818|NCT00165646|531936404|FG000|Overall Study|Protocol Violation|1|||
147485819|NCT00165646|531936405|FG001|Overall Study|Protocol Violation|0|||
147485820|NCT00165646|531936406|FG002|Overall Study|Protocol Violation|0|||
147485821|NCT04657016|531936407|FG000|Overall Study|Adverse Event|2|||
147485822|NCT04657016|531936408|FG001|Overall Study|Adverse Event|4|||
147485823|NCT04657016|531936407|FG000|Overall Study|Death|1|||
147485824|NCT04657016|531936408|FG001|Overall Study|Death|1|||
147485825|NCT04657016|531936407|FG000|Overall Study|Lost to Follow-up|24|||
147485826|NCT04657016|531936408|FG001|Overall Study|Lost to Follow-up|12|||
147485827|NCT04657016|531936407|FG000|Overall Study|Physician Decision|1|||
147485828|NCT04657016|531936408|FG001|Overall Study|Physician Decision|2|||
147485829|NCT04657016|531936407|FG000|Overall Study|Pregnancy|2|||
147485830|NCT04657016|531936408|FG001|Overall Study|Pregnancy|2|||
147485831|NCT04657016|531936407|FG000|Overall Study|Protocol Deviation|1|||
147485832|NCT04657016|531936408|FG001|Overall Study|Protocol Deviation|0|||
147485833|NCT04657016|531936407|FG000|Overall Study|Withdrawal by Subject|28|||
147485834|NCT04657016|531936408|FG001|Overall Study|Withdrawal by Subject|14|||
147485835|NCT04657016|531936407|FG000|Overall Study|Other - as reported by the investigator|6|||
147485836|NCT04657016|531936408|FG001|Overall Study|Other - as reported by the investigator|0|||
147485837|NCT01104558|531936411|FG000|Overall Study|Protocol Violation|6|||
147485838|NCT01104558|531936411|FG000|Overall Study|Missing of primary efficacy assessment|10|||
147485839|NCT01104558|531936411|FG000|Overall Study|Missing of genetic analysis results|1|||
147485840|NCT00523341|531936415|FG000|Overall Study|Withdrawal by Subject|399|||
147485841|NCT00523341|531936416|FG001|Overall Study|Withdrawal by Subject|427|||
147485842|NCT00523341|531936415|FG000|Overall Study|Other|181|||
147485843|NCT00523341|531936416|FG001|Overall Study|Other|198|||
147485844|NCT00523341|531936415|FG000|Overall Study|Adverse Event|122|||
147485845|NCT00523341|531936416|FG001|Overall Study|Adverse Event|155|||
147485846|NCT00523341|531936415|FG000|Overall Study|Death|101|||
147485847|NCT00523341|531936416|FG001|Overall Study|Death|110|||
147485848|NCT00523341|531936415|FG000|Overall Study|Lost to Follow-up|73|||
147485849|NCT00523341|531936416|FG001|Overall Study|Lost to Follow-up|61|||
147485850|NCT00523341|531936415|FG000|Overall Study|Non-compliance|20|||
147485851|NCT00523341|531936416|FG001|Overall Study|Non-compliance|13|||
147485852|NCT00523341|531936415|FG000|Overall Study|Physician Decision|14|||
147485853|NCT00523341|531936416|FG001|Overall Study|Physician Decision|13|||
147485854|NCT00523341|531936415|FG000|Overall Study|Requirement for Alternative Therapy|4|||
147485855|NCT00523341|531936416|FG001|Overall Study|Requirement for Alternative Therapy|14|||
147485856|NCT00523341|531936415|FG000|Overall Study|Protocol Deviation|6|||
147485857|NCT00523341|531936416|FG001|Overall Study|Protocol Deviation|5|||
147485858|NCT00523341|531936415|FG000|Overall Study|Ineligibility Determined|3|||
147485859|NCT00523341|531936416|FG001|Overall Study|Ineligibility Determined|4|||
147485860|NCT00523341|531936415|FG000|Overall Study|Disease Progression|1|||
147485861|NCT00523341|531936416|FG001|Overall Study|Disease Progression|0|||
147485862|NCT00912015|531936419|FG000|Overall Study|Lack of Efficacy|1|||
147485863|NCT00912015|531936420|FG001|Overall Study|Lack of Efficacy|0|||
147485864|NCT00912015|531936421|FG002|Overall Study|Lack of Efficacy|0|||
147485865|NCT00912015|531936422|FG003|Overall Study|Lack of Efficacy|0|||
147485866|NCT00912015|531936419|FG000|Overall Study|Withdrawal by Subject|8|||
147485867|NCT00912015|531936420|FG001|Overall Study|Withdrawal by Subject|8|||
147485868|NCT00912015|531936421|FG002|Overall Study|Withdrawal by Subject|3|||
147485869|NCT00912015|531936422|FG003|Overall Study|Withdrawal by Subject|0|||
147485870|NCT00912015|531936419|FG000|Overall Study|Protocol Violation|1|||
147485871|NCT00912015|531936420|FG001|Overall Study|Protocol Violation|0|||
147485872|NCT00912015|531936421|FG002|Overall Study|Protocol Violation|0|||
147485873|NCT00912015|531936422|FG003|Overall Study|Protocol Violation|1|||
147485874|NCT00912015|531936419|FG000|Overall Study|Adverse Event|6|||
147485875|NCT00912015|531936420|FG001|Overall Study|Adverse Event|0|||
147485876|NCT00912015|531936421|FG002|Overall Study|Adverse Event|0|||
147485877|NCT00912015|531936422|FG003|Overall Study|Adverse Event|1|||
147485878|NCT05137041|531936423|FG000|Overall Study|Lost to Follow-up|1|||
147485879|NCT05137041|531936424|FG001|Overall Study|Lost to Follow-up|1|||
147485880|NCT05137041|531936423|FG000|Overall Study|Withdrawal by Subject|0|||
147485881|NCT05137041|531936424|FG001|Overall Study|Withdrawal by Subject|2|||
147485882|NCT05137041|531936423|FG000|Overall Study|Reason not Specified|0|||
147485883|NCT05137041|531936424|FG001|Overall Study|Reason not Specified|1|||
147485884|NCT02090114|531936425|FG000|Overall Study|Withdrawal by Subject|3|||
147485885|NCT02090114|531936426|FG001|Overall Study|Withdrawal by Subject|6|||
147485886|NCT02090114|531936427|FG002|Overall Study|Withdrawal by Subject|2|||
147485887|NCT02090114|531936428|FG003|Overall Study|Withdrawal by Subject|1|||
147485888|NCT02090114|531936425|FG000|Overall Study|Physician Decision|5|||
147485889|NCT02090114|531936426|FG001|Overall Study|Physician Decision|0|||
147485890|NCT02090114|531936427|FG002|Overall Study|Physician Decision|1|||
147485891|NCT02090114|531936428|FG003|Overall Study|Physician Decision|1|||
147485892|NCT02090114|531936425|FG000|Overall Study|Adverse Event|1|||
147485893|NCT02090114|531936426|FG001|Overall Study|Adverse Event|2|||
147485894|NCT02090114|531936427|FG002|Overall Study|Adverse Event|2|||
147485895|NCT02090114|531936428|FG003|Overall Study|Adverse Event|0|||
147485896|NCT02090114|531936425|FG000|Overall Study|Progressive Disease|20|||
147485897|NCT02090114|531936426|FG001|Overall Study|Progressive Disease|21|||
147485898|NCT02090114|531936427|FG002|Overall Study|Progressive Disease|23|||
147485899|NCT02090114|531936428|FG003|Overall Study|Progressive Disease|6|||
147485900|NCT02090114|531936425|FG000|Overall Study|Death|1|||
147485901|NCT02090114|531936426|FG001|Overall Study|Death|0|||
147485902|NCT02090114|531936427|FG002|Overall Study|Death|1|||
147623664|NCT00832455|532440190|FG000|Overall Study|Patient moved|1|||
147623665|NCT03876743|532440194|FG000|Overall Study|Lost to Follow-up|6|||
147485903|NCT02090114|531936428|FG003|Overall Study|Death|0|||
147485904|NCT01356602|531936429|FG000|Overall Study|Protocol Deviation|0|||
147485905|NCT01356602|531936430|FG001|Overall Study|Protocol Deviation|1|||
147485906|NCT01356602|531936431|FG002|Overall Study|Protocol Deviation|1|||
147485907|NCT01356602|531936429|FG000|Overall Study|Administrative Problems|1|||
147485908|NCT01356602|531936430|FG001|Overall Study|Administrative Problems|4|||
147623666|NCT03876743|532440195|FG001|Overall Study|Lost to Follow-up|4|||
147485909|NCT01356602|531936431|FG002|Overall Study|Administrative Problems|5|||
147485910|NCT01356602|531936429|FG000|Overall Study|Lost to Follow-up|4|||
147485911|NCT01356602|531936430|FG001|Overall Study|Lost to Follow-up|5|||
147485912|NCT01356602|531936431|FG002|Overall Study|Lost to Follow-up|6|||
147485913|NCT01356602|531936429|FG000|Overall Study|Withdrawal by Subject|4|||
147485914|NCT01356602|531936430|FG001|Overall Study|Withdrawal by Subject|3|||
147485915|NCT01356602|531936431|FG002|Overall Study|Withdrawal by Subject|7|||
147485916|NCT01356602|531936429|FG000|Overall Study|Lack of Efficacy|0|||
147485917|NCT01356602|531936430|FG001|Overall Study|Lack of Efficacy|1|||
147485918|NCT01356602|531936431|FG002|Overall Study|Lack of Efficacy|4|||
147485919|NCT01356602|531936429|FG000|Overall Study|Adverse Event|0|||
147485920|NCT01356602|531936430|FG001|Overall Study|Adverse Event|1|||
147485921|NCT01356602|531936431|FG002|Overall Study|Adverse Event|1|||
147485922|NCT00392171|531936432|FG000|Overall Study|Did not meet inclusion criteria|4|||
147485923|NCT00392171|531936432|FG000|Overall Study|Disease progression|101|||
147485924|NCT01605071|531936433|FG000|Overall Study|Withdrawal by Subject|3|||
147485925|NCT01605071|531936434|FG001|Overall Study|Withdrawal by Subject|2|||
147485926|NCT03470922|531936436|FG000|Overall Study|Death|107|||
147485927|NCT03470922|531936437|FG001|Overall Study|Death|118|||
147485928|NCT03470922|531936436|FG000|Overall Study|Lost to Follow-up|5|||
147485929|NCT03470922|531936437|FG001|Overall Study|Lost to Follow-up|5|||
147485930|NCT03470922|531936436|FG000|Overall Study|Participant Withdrew Consent|4|||
147485931|NCT03470922|531936437|FG001|Overall Study|Participant Withdrew Consent|9|||
147485932|NCT03470922|531936436|FG000|Overall Study|Other reasons|1|||
147485933|NCT03470922|531936437|FG001|Overall Study|Other reasons|0|||
147485934|NCT03470922|531936436|FG000|Overall Study|Not reported|1|||
147485935|NCT03470922|531936437|FG001|Overall Study|Not reported|0|||
147485936|NCT01931462|531936438|FG000|Overall Study|Withdrawal by Subject|1|||
147485937|NCT01881620|531936441|FG000|Overall Study|Protocol Violation|4|||
147485938|NCT01808118|531936444|FG000|Period 1|Adverse Event|15|||
147485939|NCT01808118|531936445|FG001|Period 1|Adverse Event|0|||
147485940|NCT01808118|531936446|FG002|Period 1|Adverse Event|0|||
147485941|NCT01808118|531936444|FG000|Period 1|Withdrew consent|24|||
147485942|NCT01808118|531936445|FG001|Period 1|Withdrew consent|0|||
147485943|NCT01808118|531936446|FG002|Period 1|Withdrew consent|0|||
147485944|NCT01808118|531936444|FG000|Period 1|Lost to Follow-up|9|||
147485945|NCT01808118|531936445|FG001|Period 1|Lost to Follow-up|0|||
147485946|NCT01808118|531936446|FG002|Period 1|Lost to Follow-up|0|||
147485947|NCT01808118|531936444|FG000|Period 1|Did not meet criteria for remission|303|||
147485948|NCT01808118|531936445|FG001|Period 1|Did not meet criteria for remission|0|||
147485949|NCT01808118|531936446|FG002|Period 1|Did not meet criteria for remission|0|||
147485950|NCT01808118|531936444|FG000|Period 1|Enrolled in error|7|||
147485951|NCT01808118|531936445|FG001|Period 1|Enrolled in error|0|||
147485952|NCT01808118|531936446|FG002|Period 1|Enrolled in error|0|||
147485953|NCT01808118|531936444|FG000|Period 1|Did not meet inclusion criteria|3|||
147485954|NCT01808118|531936445|FG001|Period 1|Did not meet inclusion criteria|0|||
147485955|NCT01808118|531936446|FG002|Period 1|Did not meet inclusion criteria|0|||
147485956|NCT01808118|531936444|FG000|Period 1|Non-conformance with inclusion criteria|3|||
147485957|NCT01808118|531936445|FG001|Period 1|Non-conformance with inclusion criteria|0|||
147485958|NCT01808118|531936446|FG002|Period 1|Non-conformance with inclusion criteria|0|||
147485959|NCT01808118|531936444|FG000|Period 1|Investigator decision: site closure|2|||
147485960|NCT01808118|531936445|FG001|Period 1|Investigator decision: site closure|0|||
147485961|NCT01808118|531936446|FG002|Period 1|Investigator decision: site closure|0|||
147485962|NCT01808118|531936444|FG000|Period 1|Non-compliance per sponsor|1|||
147485963|NCT01808118|531936445|FG001|Period 1|Non-compliance per sponsor|0|||
147485964|NCT01808118|531936446|FG002|Period 1|Non-compliance per sponsor|0|||
147485965|NCT01808118|531936444|FG000|Period 1|Lack of Efficacy|1|||
147485966|NCT01808118|531936445|FG001|Period 1|Lack of Efficacy|0|||
147485967|NCT01808118|531936446|FG002|Period 1|Lack of Efficacy|0|||
147485968|NCT01808118|531936444|FG000|Period 2|Adverse Event|0|||
147485969|NCT01808118|531936445|FG001|Period 2|Adverse Event|4|||
147485970|NCT01808118|531936446|FG002|Period 2|Adverse Event|0|||
147485971|NCT01808118|531936444|FG000|Period 2|Withdrew consent|0|||
147485972|NCT01808118|531936445|FG001|Period 2|Withdrew consent|7|||
147485973|NCT01808118|531936446|FG002|Period 2|Withdrew consent|6|||
147485974|NCT01808118|531936444|FG000|Period 2|Lost to Follow-up|0|||
147485975|NCT01808118|531936445|FG001|Period 2|Lost to Follow-up|0|||
147485976|NCT01808118|531936446|FG002|Period 2|Lost to Follow-up|2|||
147485977|NCT01808118|531936444|FG000|Period 2|Investigator no longer conducting trials|0|||
147485978|NCT01808118|531936445|FG001|Period 2|Investigator no longer conducting trials|1|||
147485979|NCT01808118|531936446|FG002|Period 2|Investigator no longer conducting trials|0|||
147485980|NCT01808118|531936444|FG000|Period 2|Switched to other therapy|0|||
147623667|NCT03876743|532440196|FG002|Overall Study|Lost to Follow-up|4|||
147485981|NCT01808118|531936445|FG001|Period 2|Switched to other therapy|1|||
147485982|NCT01808118|531936446|FG002|Period 2|Switched to other therapy|0|||
147485983|NCT00414310|531936447|FG000|Overall Study|Not treated|1|||
147485984|NCT00414310|531936448|FG001|Overall Study|Not treated|0|||
147485985|NCT01993329|531936452|FG000|Period 2|Adverse Event|0|||
147485986|NCT01993329|531936453|FG001|Period 2|Adverse Event|0|||
147485987|NCT01993329|531936454|FG002|Period 2|Adverse Event|0|||
147485988|NCT01993329|531936455|FG003|Period 2|Adverse Event|0|||
147485989|NCT01993329|531936456|FG004|Period 2|Adverse Event|0|||
147485990|NCT01993329|531936457|FG005|Period 2|Adverse Event|1|||
147485991|NCT01993329|531936452|FG000|Wash-out|Personal reasons|0|||
147485992|NCT01993329|531936453|FG001|Wash-out|Personal reasons|1|||
147485993|NCT01993329|531936454|FG002|Wash-out|Personal reasons|0|||
147485994|NCT01993329|531936455|FG003|Wash-out|Personal reasons|0|||
147485995|NCT01993329|531936456|FG004|Wash-out|Personal reasons|0|||
147485996|NCT01993329|531936457|FG005|Wash-out|Personal reasons|0|||
147485997|NCT05070429|531936458|FG000|Overall Study|Death|0|||
147485998|NCT05070429|531936459|FG001|Overall Study|Death|4|||
147485999|NCT05070429|531936458|FG000|Overall Study|Withdrawal by Subject|2|||
147486000|NCT05070429|531936459|FG001|Overall Study|Withdrawal by Subject|1|||
147486001|NCT05070429|531936458|FG000|Overall Study|Other|15|||
147486002|NCT05070429|531936459|FG001|Overall Study|Other|5|||
147486003|NCT02849990|531936460|FG000|Overall Study|Adverse Event|1|||
147486004|NCT02849990|531936460|FG000|Overall Study|Withdrawal by Subject|1|||
147486005|NCT02678741|531936461|FG000|Overall Study|Death|4|||
147486006|NCT02678741|531936461|FG000|Overall Study|Withdrawal by Subject|1|||
147486007|NCT02678741|531936461|FG000|Overall Study|ineligible|3|||
147486008|NCT02678741|531936461|FG000|Overall Study|Not RECIST Measurable|2|||
147486009|NCT02678741|531936461|FG000|Overall Study|Lack of Efficacy|10|||
147486010|NCT01795898|531936462|FG000|Overall Study|Adverse Event|27|||
147486011|NCT01795898|531936462|FG000|Overall Study|Lost to Follow-up|20|||
147486012|NCT01795898|531936462|FG000|Overall Study|Withdrawal of consent|6|||
147486013|NCT01795898|531936462|FG000|Overall Study|Diagnosed with metastasis|1|||
147486014|NCT01795898|531936462|FG000|Overall Study|No pain|1|||
147486015|NCT01795898|531936462|FG000|Overall Study|Death|1|||
147486016|NCT01795898|531936462|FG000|Overall Study|Withdrew consent & had adverse events|3|||
147486017|NCT01795898|531936462|FG000|Overall Study|Physician Decision|1|||
147486018|NCT00372190|531936463|FG000|Overall Study|Lost to Follow-up|3|||
147486019|NCT00372190|531936464|FG001|Overall Study|Lost to Follow-up|1|||
147486020|NCT04705597|531936465|FG000|Overall Study|Death|16|||
147486021|NCT04705597|531936466|FG001|Overall Study|Death|9|||
147486022|NCT04705597|531936465|FG000|Overall Study|Lost to Follow-up|1|||
147486023|NCT04705597|531936466|FG001|Overall Study|Lost to Follow-up|0|||
147486024|NCT04705597|531936465|FG000|Overall Study|Withdrawal by Subject|1|||
147486025|NCT04705597|531936466|FG001|Overall Study|Withdrawal by Subject|2|||
147486026|NCT00390780|531936470|FG000|Overall Study|Not completed|10|||
147486027|NCT00390780|531936471|FG001|Overall Study|Not completed|4|||
147486028|NCT00390780|531936470|FG000|Overall Study|Protocol Violation|6|||
147486029|NCT00390780|531936471|FG001|Overall Study|Protocol Violation|4|||
147486030|NCT00390780|531936470|FG000|Overall Study|Lost to Follow-up|3|||
147486031|NCT00390780|531936471|FG001|Overall Study|Lost to Follow-up|6|||
147486032|NCT00390780|531936470|FG000|Overall Study|Adverse Event|2|||
147486033|NCT00390780|531936471|FG001|Overall Study|Adverse Event|3|||
147486034|NCT00390780|531936470|FG000|Overall Study|Death|1|||
147486035|NCT00390780|531936471|FG001|Overall Study|Death|3|||
147486036|NCT00390780|531936470|FG000|Overall Study|Withdrawal by Subject|1|||
147486037|NCT00390780|531936471|FG001|Overall Study|Withdrawal by Subject|2|||
147486038|NCT00390780|531936470|FG000|Overall Study|Inclusion criteria not satisfied|0|||
147486039|NCT00390780|531936471|FG001|Overall Study|Inclusion criteria not satisfied|2|||
147486040|NCT00390780|531936470|FG000|Overall Study|Lost to follow up and other reasons|0|||
147486041|NCT00390780|531936471|FG001|Overall Study|Lost to follow up and other reasons|1|||
147486042|NCT00390780|531936470|FG000|Overall Study|Investigator decision, SAE, other reason|0|||
147486043|NCT00390780|531936471|FG001|Overall Study|Investigator decision, SAE, other reason|1|||
147486044|NCT00390780|531936470|FG000|Overall Study|SAE, death|0|||
147486045|NCT00390780|531936471|FG001|Overall Study|SAE, death|1|||
147486046|NCT01070550|531936473|FG000|Overall Study|Adverse Event|43|||
147486047|NCT01070550|531936474|FG001|Overall Study|Adverse Event|1|||
147486048|NCT01070550|531936475|FG002|Overall Study|Adverse Event|3|||
147623668|NCT03876743|532440197|FG003|Overall Study|Lost to Follow-up|7|||
147623669|NCT03889418|532440198|FG000|April-June 2019 (Months 0-3)|Protocol Violation|1|||
147486049|NCT01070550|531936476|FG003|Overall Study|Adverse Event|0|||
147486050|NCT01070550|531936477|FG004|Overall Study|Adverse Event|0|||
147623670|NCT03889418|532440199|FG001|April-June 2019 (Months 0-3)|Protocol Violation|0|||
147623671|NCT03889418|532440200|FG002|April-June 2019 (Months 0-3)|Protocol Violation|0|||
147486051|NCT01070550|531936478|FG005|Overall Study|Adverse Event|0|||
147486052|NCT01070550|531936473|FG000|Overall Study|Death|20|||
147486053|NCT01070550|531936474|FG001|Overall Study|Death|4|||
147486054|NCT01070550|531936475|FG002|Overall Study|Death|3|||
147623672|NCT03889418|532440201|FG003|April-June 2019 (Months 0-3)|Protocol Violation|0|||
147623673|NCT03889418|532440202|FG004|April-June 2019 (Months 0-3)|Protocol Violation|0|||
147486055|NCT01070550|531936476|FG003|Overall Study|Death|0|||
147486056|NCT01070550|531936477|FG004|Overall Study|Death|0|||
147486057|NCT01070550|531936478|FG005|Overall Study|Death|0|||
147486058|NCT01070550|531936473|FG000|Overall Study|Not meeting inclusion/exclusion criteria|2|||
147486059|NCT01070550|531936474|FG001|Overall Study|Not meeting inclusion/exclusion criteria|1|||
147486060|NCT01070550|531936475|FG002|Overall Study|Not meeting inclusion/exclusion criteria|1|||
147416809|NCT00299494|531689990|FG003|Overall Study|Physician Decision|0|||
147416810|NCT00299494|531689991|FG004|Overall Study|Physician Decision|1|||
147416811|NCT00299494|531689992|FG005|Overall Study|Physician Decision|0|||
147416812|NCT00299494|531689987|FG000|Overall Study|Death|3|||
147416813|NCT00299494|531689988|FG001|Overall Study|Death|1|||
147416814|NCT00299494|531689989|FG002|Overall Study|Death|4|||
147416815|NCT00299494|531689990|FG003|Overall Study|Death|6|||
147416816|NCT00299494|531689991|FG004|Overall Study|Death|18|||
147416817|NCT00299494|531689992|FG005|Overall Study|Death|19|||
147416818|NCT00299494|531689987|FG000|Overall Study|Lost to Follow-up|0|||
147416819|NCT00299494|531689988|FG001|Overall Study|Lost to Follow-up|0|||
147416820|NCT00299494|531689989|FG002|Overall Study|Lost to Follow-up|0|||
147416821|NCT00299494|531689990|FG003|Overall Study|Lost to Follow-up|0|||
147416822|NCT00299494|531689991|FG004|Overall Study|Lost to Follow-up|3|||
147416823|NCT00299494|531689992|FG005|Overall Study|Lost to Follow-up|1|||
147416824|NCT00299494|531689987|FG000|Overall Study|Other - Unspecified|0|||
147416825|NCT00299494|531689988|FG001|Overall Study|Other - Unspecified|0|||
147416826|NCT00299494|531689989|FG002|Overall Study|Other - Unspecified|0|||
147416827|NCT00299494|531689990|FG003|Overall Study|Other - Unspecified|0|||
147416828|NCT00299494|531689991|FG004|Overall Study|Other - Unspecified|3|||
147416829|NCT00299494|531689992|FG005|Overall Study|Other - Unspecified|1|||
147416830|NCT00299494|531689987|FG000|Overall Study|Other - site closure|0|||
147416831|NCT00299494|531689988|FG001|Overall Study|Other - site closure|0|||
147416832|NCT00299494|531689989|FG002|Overall Study|Other - site closure|0|||
147416833|NCT00299494|531689990|FG003|Overall Study|Other - site closure|1|||
147416834|NCT00299494|531689991|FG004|Overall Study|Other - site closure|1|||
147416835|NCT00299494|531689992|FG005|Overall Study|Other - site closure|1|||
147416836|NCT00757627|531689993|FG000|Overall Study|Adverse Event|15|||
147416837|NCT00757627|531689993|FG000|Overall Study|Lack of Efficacy|10|||
147416838|NCT00757627|531689993|FG000|Overall Study|Lost to Follow-up|28|||
147416839|NCT00757627|531689993|FG000|Overall Study|Withdrawal by Subject|27|||
147416840|NCT00757627|531689993|FG000|Overall Study|Other|1|||
147416841|NCT01696955|531689997|FG000|Main Study|Protocol Violation|1|||
147416842|NCT01696955|531689998|FG001|Main Study|Protocol Violation|0|||
147416843|NCT01696955|531689997|FG000|Main Study|Withdrawal by Subject|1|||
147416844|NCT01696955|531689998|FG001|Main Study|Withdrawal by Subject|1|||
147416845|NCT02416453|531689999|FG000|Overall Study|Adverse Event|0|||
147416846|NCT02416453|531690000|FG001|Overall Study|Adverse Event|0|||
147416847|NCT02416453|531690001|FG002|Overall Study|Adverse Event|0|||
147416848|NCT02416453|531690002|FG003|Overall Study|Adverse Event|2|||
147416849|NCT02416453|531690003|FG004|Overall Study|Adverse Event|0|||
147416850|NCT02416453|531690004|FG005|Overall Study|Adverse Event|1|||
147416851|NCT02416453|531690005|FG006|Overall Study|Adverse Event|0|||
147416852|NCT02416453|531690006|FG007|Overall Study|Adverse Event|0|||
147416853|NCT02416453|531690007|FG008|Overall Study|Adverse Event|0|||
147416854|NCT02416453|531690008|FG009|Overall Study|Adverse Event|0|||
147416855|NCT02416453|531690009|FG010|Overall Study|Adverse Event|0|||
147416856|NCT02416453|531689999|FG000|Overall Study|Lost to Follow-up|1|||
147416857|NCT02416453|531690000|FG001|Overall Study|Lost to Follow-up|3|||
147416858|NCT02416453|531690001|FG002|Overall Study|Lost to Follow-up|0|||
147416859|NCT02416453|531690002|FG003|Overall Study|Lost to Follow-up|8|||
147416860|NCT02416453|531690003|FG004|Overall Study|Lost to Follow-up|0|||
147416861|NCT02416453|531690004|FG005|Overall Study|Lost to Follow-up|5|||
147416862|NCT02416453|531690005|FG006|Overall Study|Lost to Follow-up|1|||
147416863|NCT02416453|531690006|FG007|Overall Study|Lost to Follow-up|3|||
147416864|NCT02416453|531690007|FG008|Overall Study|Lost to Follow-up|1|||
147416865|NCT02416453|531690008|FG009|Overall Study|Lost to Follow-up|0|||
147416866|NCT02416453|531690009|FG010|Overall Study|Lost to Follow-up|0|||
147416867|NCT02416453|531689999|FG000|Overall Study|Physician Decision|0|||
147416868|NCT02416453|531690000|FG001|Overall Study|Physician Decision|0|||
147416869|NCT02416453|531690001|FG002|Overall Study|Physician Decision|0|||
147416870|NCT02416453|531690002|FG003|Overall Study|Physician Decision|0|||
147416871|NCT02416453|531690003|FG004|Overall Study|Physician Decision|0|||
147416872|NCT02416453|531690004|FG005|Overall Study|Physician Decision|1|||
147416873|NCT02416453|531690005|FG006|Overall Study|Physician Decision|1|||
147416874|NCT02416453|531690006|FG007|Overall Study|Physician Decision|1|||
147416875|NCT02416453|531690007|FG008|Overall Study|Physician Decision|0|||
147416876|NCT02416453|531690008|FG009|Overall Study|Physician Decision|0|||
147416877|NCT02416453|531690009|FG010|Overall Study|Physician Decision|0|||
147416878|NCT02416453|531689999|FG000|Overall Study|Withdrawal by Subject|2|||
147416879|NCT02416453|531690000|FG001|Overall Study|Withdrawal by Subject|0|||
147416880|NCT02416453|531690001|FG002|Overall Study|Withdrawal by Subject|0|||
147416881|NCT02416453|531690002|FG003|Overall Study|Withdrawal by Subject|5|||
147416882|NCT02416453|531690003|FG004|Overall Study|Withdrawal by Subject|1|||
147416883|NCT02416453|531690004|FG005|Overall Study|Withdrawal by Subject|8|||
147416884|NCT02416453|531690005|FG006|Overall Study|Withdrawal by Subject|0|||
147416885|NCT02416453|531690006|FG007|Overall Study|Withdrawal by Subject|8|||
147416886|NCT02416453|531690007|FG008|Overall Study|Withdrawal by Subject|4|||
147486061|NCT01070550|531936476|FG003|Overall Study|Not meeting inclusion/exclusion criteria|0|||
147486062|NCT01070550|531936477|FG004|Overall Study|Not meeting inclusion/exclusion criteria|0|||
147486063|NCT01070550|531936478|FG005|Overall Study|Not meeting inclusion/exclusion criteria|0|||
147486064|NCT01070550|531936473|FG000|Overall Study|Early termination|3|||
147486065|NCT01070550|531936474|FG001|Overall Study|Early termination|0|||
147486066|NCT01070550|531936475|FG002|Overall Study|Early termination|0|||
147486067|NCT01070550|531936476|FG003|Overall Study|Early termination|0|||
147486068|NCT01070550|531936477|FG004|Overall Study|Early termination|0|||
147486069|NCT01070550|531936478|FG005|Overall Study|Early termination|0|||
147486070|NCT01070550|531936473|FG000|Overall Study|Failed to return|450|||
147486071|NCT01070550|531936474|FG001|Overall Study|Failed to return|33|||
147486072|NCT01070550|531936475|FG002|Overall Study|Failed to return|144|||
147486073|NCT01070550|531936476|FG003|Overall Study|Failed to return|40|||
147486074|NCT01070550|531936477|FG004|Overall Study|Failed to return|1|||
147486075|NCT01070550|531936478|FG005|Overall Study|Failed to return|2|||
147486076|NCT01070550|531936473|FG000|Overall Study|Incomplete treatment|2|||
147486077|NCT01070550|531936474|FG001|Overall Study|Incomplete treatment|0|||
147486078|NCT01070550|531936475|FG002|Overall Study|Incomplete treatment|0|||
147486079|NCT01070550|531936476|FG003|Overall Study|Incomplete treatment|0|||
147486080|NCT01070550|531936477|FG004|Overall Study|Incomplete treatment|0|||
147486081|NCT01070550|531936478|FG005|Overall Study|Incomplete treatment|0|||
147486082|NCT01070550|531936473|FG000|Overall Study|Lab test not done|22|||
147486083|NCT01070550|531936474|FG001|Overall Study|Lab test not done|3|||
147486084|NCT01070550|531936475|FG002|Overall Study|Lab test not done|4|||
147486085|NCT01070550|531936476|FG003|Overall Study|Lab test not done|1|||
147486086|NCT01070550|531936477|FG004|Overall Study|Lab test not done|0|||
147486087|NCT01070550|531936478|FG005|Overall Study|Lab test not done|1|||
147486088|NCT01070550|531936473|FG000|Overall Study|Lack of Efficacy|65|||
147486089|NCT01070550|531936474|FG001|Overall Study|Lack of Efficacy|1|||
147486090|NCT01070550|531936475|FG002|Overall Study|Lack of Efficacy|5|||
147486091|NCT01070550|531936476|FG003|Overall Study|Lack of Efficacy|5|||
147486092|NCT01070550|531936477|FG004|Overall Study|Lack of Efficacy|0|||
147486093|NCT01070550|531936478|FG005|Overall Study|Lack of Efficacy|1|||
147486094|NCT01070550|531936473|FG000|Overall Study|Miscellaneous|12|||
147486095|NCT01070550|531936474|FG001|Overall Study|Miscellaneous|2|||
147486096|NCT01070550|531936475|FG002|Overall Study|Miscellaneous|3|||
147486097|NCT01070550|531936476|FG003|Overall Study|Miscellaneous|1|||
147486098|NCT01070550|531936477|FG004|Overall Study|Miscellaneous|0|||
147486099|NCT01070550|531936478|FG005|Overall Study|Miscellaneous|0|||
147486100|NCT01070550|531936473|FG000|Overall Study|New treatment started|3|||
147486101|NCT01070550|531936474|FG001|Overall Study|New treatment started|1|||
147486102|NCT01070550|531936475|FG002|Overall Study|New treatment started|0|||
147486103|NCT01070550|531936476|FG003|Overall Study|New treatment started|2|||
147486104|NCT01070550|531936477|FG004|Overall Study|New treatment started|0|||
147486105|NCT01070550|531936478|FG005|Overall Study|New treatment started|0|||
147486106|NCT01070550|531936473|FG000|Overall Study|Non-responders|493|||
147486107|NCT01070550|531936474|FG001|Overall Study|Non-responders|4|||
147486108|NCT01070550|531936475|FG002|Overall Study|Non-responders|21|||
147486109|NCT01070550|531936476|FG003|Overall Study|Non-responders|20|||
147486110|NCT01070550|531936477|FG004|Overall Study|Non-responders|0|||
147486111|NCT01070550|531936478|FG005|Overall Study|Non-responders|2|||
147486112|NCT01070550|531936473|FG000|Overall Study|Not categorized|33|||
147486113|NCT01070550|531936474|FG001|Overall Study|Not categorized|2|||
147486114|NCT01070550|531936475|FG002|Overall Study|Not categorized|6|||
147486115|NCT01070550|531936476|FG003|Overall Study|Not categorized|1|||
147486116|NCT01070550|531936477|FG004|Overall Study|Not categorized|0|||
147486117|NCT01070550|531936478|FG005|Overall Study|Not categorized|1|||
147486118|NCT01070550|531936473|FG000|Overall Study|Protocol Violation|15|||
147486119|NCT01070550|531936474|FG001|Overall Study|Protocol Violation|1|||
147486120|NCT01070550|531936475|FG002|Overall Study|Protocol Violation|1|||
147486121|NCT01070550|531936476|FG003|Overall Study|Protocol Violation|1|||
147486122|NCT01070550|531936477|FG004|Overall Study|Protocol Violation|0|||
147486123|NCT01070550|531936478|FG005|Overall Study|Protocol Violation|0|||
147486124|NCT01070550|531936473|FG000|Overall Study|Relapse|44|||
147486125|NCT01070550|531936474|FG001|Overall Study|Relapse|5|||
147486126|NCT01070550|531936475|FG002|Overall Study|Relapse|14|||
147486127|NCT01070550|531936476|FG003|Overall Study|Relapse|4|||
147486128|NCT01070550|531936477|FG004|Overall Study|Relapse|0|||
147486129|NCT01070550|531936478|FG005|Overall Study|Relapse|0|||
147486130|NCT01070550|531936473|FG000|Overall Study|Result not available|3|||
147486131|NCT01070550|531936474|FG001|Overall Study|Result not available|1|||
147486132|NCT01070550|531936475|FG002|Overall Study|Result not available|3|||
147486133|NCT01070550|531936476|FG003|Overall Study|Result not available|0|||
147486134|NCT01070550|531936477|FG004|Overall Study|Result not available|0|||
147486135|NCT01070550|531936478|FG005|Overall Study|Result not available|0|||
147486136|NCT01070550|531936473|FG000|Overall Study|Screen failure|1|||
147486137|NCT01070550|531936474|FG001|Overall Study|Screen failure|0|||
147486138|NCT01070550|531936475|FG002|Overall Study|Screen failure|0|||
147486139|NCT01070550|531936476|FG003|Overall Study|Screen failure|0|||
147486140|NCT01070550|531936477|FG004|Overall Study|Screen failure|0|||
147486141|NCT01070550|531936478|FG005|Overall Study|Screen failure|0|||
147486142|NCT01070550|531936473|FG000|Overall Study|Sponsor decision|1|||
147486143|NCT01070550|531936474|FG001|Overall Study|Sponsor decision|0|||
147486144|NCT01070550|531936475|FG002|Overall Study|Sponsor decision|0|||
147486145|NCT01070550|531936476|FG003|Overall Study|Sponsor decision|0|||
147486146|NCT01070550|531936477|FG004|Overall Study|Sponsor decision|0|||
147486147|NCT01070550|531936478|FG005|Overall Study|Sponsor decision|0|||
147486148|NCT01070550|531936473|FG000|Overall Study|Treatment duration shortened|1|||
147486149|NCT01070550|531936474|FG001|Overall Study|Treatment duration shortened|0|||
147486150|NCT01070550|531936475|FG002|Overall Study|Treatment duration shortened|0|||
147486151|NCT01070550|531936476|FG003|Overall Study|Treatment duration shortened|0|||
147486152|NCT01070550|531936477|FG004|Overall Study|Treatment duration shortened|0|||
147486153|NCT01070550|531936478|FG005|Overall Study|Treatment duration shortened|0|||
147486154|NCT01070550|531936473|FG000|Overall Study|Treatment interrupted|7|||
147486155|NCT01070550|531936474|FG001|Overall Study|Treatment interrupted|0|||
147486156|NCT01070550|531936475|FG002|Overall Study|Treatment interrupted|1|||
147486157|NCT01070550|531936476|FG003|Overall Study|Treatment interrupted|1|||
147486158|NCT01070550|531936477|FG004|Overall Study|Treatment interrupted|0|||
147486159|NCT01070550|531936478|FG005|Overall Study|Treatment interrupted|0|||
147486160|NCT01070550|531936473|FG000|Overall Study|Treatment not started|14|||
147486161|NCT01070550|531936474|FG001|Overall Study|Treatment not started|2|||
147486162|NCT01070550|531936475|FG002|Overall Study|Treatment not started|4|||
147486163|NCT01070550|531936476|FG003|Overall Study|Treatment not started|0|||
147486164|NCT01070550|531936477|FG004|Overall Study|Treatment not started|0|||
147486165|NCT01070550|531936478|FG005|Overall Study|Treatment not started|0|||
147486166|NCT01070550|531936473|FG000|Overall Study|Treatment restarted|0|||
147486167|NCT01070550|531936474|FG001|Overall Study|Treatment restarted|1|||
147486168|NCT01070550|531936475|FG002|Overall Study|Treatment restarted|0|||
147486169|NCT01070550|531936476|FG003|Overall Study|Treatment restarted|0|||
147486170|NCT01070550|531936477|FG004|Overall Study|Treatment restarted|0|||
147486171|NCT01070550|531936478|FG005|Overall Study|Treatment restarted|0|||
147486172|NCT01070550|531936473|FG000|Overall Study|Treatment stopped|3|||
147486173|NCT01070550|531936474|FG001|Overall Study|Treatment stopped|0|||
147486174|NCT01070550|531936475|FG002|Overall Study|Treatment stopped|0|||
147486175|NCT01070550|531936476|FG003|Overall Study|Treatment stopped|0|||
147486176|NCT01070550|531936477|FG004|Overall Study|Treatment stopped|0|||
147486177|NCT01070550|531936478|FG005|Overall Study|Treatment stopped|0|||
147486178|NCT01070550|531936473|FG000|Overall Study|Treatment unavailable|1|||
147486179|NCT01070550|531936474|FG001|Overall Study|Treatment unavailable|0|||
147486180|NCT01070550|531936475|FG002|Overall Study|Treatment unavailable|0|||
147486181|NCT01070550|531936476|FG003|Overall Study|Treatment unavailable|0|||
147486182|NCT01070550|531936477|FG004|Overall Study|Treatment unavailable|0|||
147486183|NCT01070550|531936478|FG005|Overall Study|Treatment unavailable|0|||
147486184|NCT01070550|531936473|FG000|Overall Study|Treatment was stopped early|7|||
147486185|NCT01070550|531936474|FG001|Overall Study|Treatment was stopped early|0|||
147486186|NCT01070550|531936475|FG002|Overall Study|Treatment was stopped early|0|||
147486187|NCT01070550|531936476|FG003|Overall Study|Treatment was stopped early|0|||
147486188|NCT01070550|531936477|FG004|Overall Study|Treatment was stopped early|0|||
147486189|NCT01070550|531936478|FG005|Overall Study|Treatment was stopped early|0|||
147486190|NCT01070550|531936473|FG000|Overall Study|Other|5|||
147486191|NCT01070550|531936474|FG001|Overall Study|Other|0|||
147486192|NCT01070550|531936475|FG002|Overall Study|Other|0|||
147486193|NCT01070550|531936476|FG003|Overall Study|Other|1|||
147486194|NCT01070550|531936477|FG004|Overall Study|Other|0|||
147486195|NCT01070550|531936478|FG005|Overall Study|Other|0|||
147486196|NCT01070550|531936473|FG000|Overall Study|Withdrawal by Subject|35|||
147486197|NCT01070550|531936474|FG001|Overall Study|Withdrawal by Subject|0|||
147486198|NCT01070550|531936475|FG002|Overall Study|Withdrawal by Subject|3|||
147486199|NCT01070550|531936476|FG003|Overall Study|Withdrawal by Subject|0|||
147486200|NCT01070550|531936477|FG004|Overall Study|Withdrawal by Subject|0|||
147486201|NCT01070550|531936478|FG005|Overall Study|Withdrawal by Subject|0|||
147486202|NCT01585961|531936480|FG000|Overall Study|Death|6|||
147486203|NCT01585961|531936480|FG000|Overall Study|Physician Decision|1|||
147486204|NCT01585961|531936480|FG000|Overall Study|Decision to use non-study catheter|1|||
147486205|NCT01585961|531936480|FG000|Overall Study|Withdrawal by Subject|1|||
147486206|NCT01585961|531936480|FG000|Overall Study|Lost to Follow-up|23|||
147486207|NCT01585961|531936480|FG000|Overall Study|Ablation cancelled for slow-heal wound|1|||
147486208|NCT01258348|531936481|FG000|Overall Study|Adverse Event|1|||
147486209|NCT01258348|531936482|FG001|Overall Study|Adverse Event|1|||
147486210|NCT01258348|531936483|FG002|Overall Study|Adverse Event|3|||
147486211|NCT01258348|531936484|FG003|Overall Study|Adverse Event|2|||
147486212|NCT01258348|531936485|FG004|Overall Study|Adverse Event|4|||
147486213|NCT01258348|531936481|FG000|Overall Study|Progressive Disease|0|||
147486214|NCT01258348|531936482|FG001|Overall Study|Progressive Disease|3|||
147486215|NCT01258348|531936483|FG002|Overall Study|Progressive Disease|0|||
147486216|NCT01258348|531936484|FG003|Overall Study|Progressive Disease|2|||
147486217|NCT01258348|531936485|FG004|Overall Study|Progressive Disease|2|||
147486218|NCT01258348|531936481|FG000|Overall Study|Physician Decision|0|||
147486219|NCT01258348|531936482|FG001|Overall Study|Physician Decision|0|||
147623674|NCT03889418|532440203|FG005|April-June 2019 (Months 0-3)|Protocol Violation|0|||
147623675|NCT03889418|532440204|FG006|April-June 2019 (Months 0-3)|Protocol Violation|0|||
147623676|NCT03889418|532440205|FG007|April-June 2019 (Months 0-3)|Protocol Violation|0|||
147623677|NCT03889418|532440206|FG008|April-June 2019 (Months 0-3)|Protocol Violation|0|||
147623678|NCT03889418|532440207|FG009|April-June 2019 (Months 0-3)|Protocol Violation|0|||
147623679|NCT03889418|532440198|FG000|July-September 2019 (Months 4-6)|Protocol Violation|0|||
147623680|NCT03889418|532440199|FG001|July-September 2019 (Months 4-6)|Protocol Violation|1|||
147623681|NCT03889418|532440200|FG002|July-September 2019 (Months 4-6)|Protocol Violation|1|||
147623682|NCT03889418|532440201|FG003|July-September 2019 (Months 4-6)|Protocol Violation|0|||
147623683|NCT03889418|532440202|FG004|July-September 2019 (Months 4-6)|Protocol Violation|0|||
147623684|NCT03889418|532440203|FG005|July-September 2019 (Months 4-6)|Protocol Violation|0|||
147623685|NCT03889418|532440204|FG006|July-September 2019 (Months 4-6)|Protocol Violation|0|||
147623686|NCT03889418|532440205|FG007|July-September 2019 (Months 4-6)|Protocol Violation|0|||
147623687|NCT03889418|532440206|FG008|July-September 2019 (Months 4-6)|Protocol Violation|0|||
147623688|NCT03889418|532440207|FG009|July-September 2019 (Months 4-6)|Protocol Violation|0|||
147623689|NCT03889418|532440198|FG000|October-December 2019 (Month 7-9)|Death|0|||
147623690|NCT03889418|532440199|FG001|October-December 2019 (Month 7-9)|Death|0|||
147623691|NCT03889418|532440200|FG002|October-December 2019 (Month 7-9)|Death|0|||
147623692|NCT03889418|532440201|FG003|October-December 2019 (Month 7-9)|Death|0|||
147623693|NCT03889418|532440202|FG004|October-December 2019 (Month 7-9)|Death|0|||
147623694|NCT03889418|532440203|FG005|October-December 2019 (Month 7-9)|Death|0|||
147623695|NCT03889418|532440204|FG006|October-December 2019 (Month 7-9)|Death|0|||
147623696|NCT03889418|532440205|FG007|October-December 2019 (Month 7-9)|Death|0|||
147623697|NCT03889418|532440206|FG008|October-December 2019 (Month 7-9)|Death|1|||
147486220|NCT01258348|531936483|FG002|Overall Study|Physician Decision|0|||
147486221|NCT01258348|531936484|FG003|Overall Study|Physician Decision|2|||
147486222|NCT01258348|531936485|FG004|Overall Study|Physician Decision|0|||
147486223|NCT01258348|531936481|FG000|Overall Study|Withdrawal by Subject|0|||
147486224|NCT01258348|531936482|FG001|Overall Study|Withdrawal by Subject|1|||
147486225|NCT01258348|531936483|FG002|Overall Study|Withdrawal by Subject|0|||
147486226|NCT01258348|531936484|FG003|Overall Study|Withdrawal by Subject|0|||
147486227|NCT01258348|531936485|FG004|Overall Study|Withdrawal by Subject|0|||
147486228|NCT01671085|531936490|FG000|Overall Study|Withdrawal by Subject|1|||
147486229|NCT01671085|531936491|FG001|Overall Study|Withdrawal by Subject|0|||
147486230|NCT00637273|531936492|FG000|Overall Study|Adverse Event|11|||
147486231|NCT00637273|531936493|FG001|Overall Study|Adverse Event|5|||
147486232|NCT00637273|531936494|FG002|Overall Study|Adverse Event|7|||
147486233|NCT00637273|531936492|FG000|Overall Study|Lost to Follow-up|8|||
147486234|NCT00637273|531936493|FG001|Overall Study|Lost to Follow-up|9|||
147486235|NCT00637273|531936494|FG002|Overall Study|Lost to Follow-up|13|||
147486236|NCT00637273|531936492|FG000|Overall Study|Protocol Violation|2|||
147486237|NCT00637273|531936493|FG001|Overall Study|Protocol Violation|4|||
147486238|NCT00637273|531936494|FG002|Overall Study|Protocol Violation|1|||
147486239|NCT00637273|531936492|FG000|Overall Study|Withdrawal of Consent|18|||
147486240|NCT00637273|531936493|FG001|Overall Study|Withdrawal of Consent|6|||
147486241|NCT00637273|531936494|FG002|Overall Study|Withdrawal of Consent|18|||
147486242|NCT00637273|531936492|FG000|Overall Study|Investigator Decision|1|||
147486243|NCT00637273|531936493|FG001|Overall Study|Investigator Decision|3|||
147486244|NCT00637273|531936494|FG002|Overall Study|Investigator Decision|1|||
147486245|NCT00637273|531936492|FG000|Overall Study|Administrative|2|||
147486246|NCT00637273|531936493|FG001|Overall Study|Administrative|0|||
147486247|NCT00637273|531936494|FG002|Overall Study|Administrative|0|||
147486248|NCT00637273|531936492|FG000|Overall Study|Loss of Glucose Control|1|||
147486249|NCT00637273|531936493|FG001|Overall Study|Loss of Glucose Control|1|||
147486250|NCT00637273|531936494|FG002|Overall Study|Loss of Glucose Control|1|||
147486251|NCT00905307|531936496|FG000|Overall Study|Switched to Open Label Rescue|7|||
147486252|NCT00905307|531936497|FG001|Overall Study|Switched to Open Label Rescue|17|||
147486253|NCT00905307|531936498|FG002|Overall Study|Switched to Open Label Rescue|11|||
147623698|NCT03889418|532440207|FG009|October-December 2019 (Month 7-9)|Death|0|||
147623699|NCT03889418|532440198|FG000|January - March 2020 (Month 10-12)|Protocol Violation|0|||
147486254|NCT00905307|531936499|FG003|Overall Study|Switched to Open Label Rescue|11|||
147486255|NCT00905307|531936500|FG004|Overall Study|Switched to Open Label Rescue|4|||
147486256|NCT00905307|531936501|FG005|Overall Study|Switched to Open Label Rescue|15|||
147486257|NCT00905307|531936496|FG000|Overall Study|Lost to Follow-up|0|||
147623700|NCT03889418|532440199|FG001|January - March 2020 (Month 10-12)|Protocol Violation|0|||
147667763|NCT01618968|532608144|FG002|Overall Study|Death|0|||
147486258|NCT00905307|531936497|FG001|Overall Study|Lost to Follow-up|0|||
147486259|NCT00905307|531936498|FG002|Overall Study|Lost to Follow-up|0|||
147623701|NCT03889418|532440200|FG002|January - March 2020 (Month 10-12)|Protocol Violation|0|||
147623702|NCT03889418|532440201|FG003|January - March 2020 (Month 10-12)|Protocol Violation|1|||
147623703|NCT03889418|532440202|FG004|January - March 2020 (Month 10-12)|Protocol Violation|0|||
147623704|NCT03889418|532440203|FG005|January - March 2020 (Month 10-12)|Protocol Violation|0|||
147667764|NCT01618968|532608145|FG003|Overall Study|Death|1|||
147623705|NCT03889418|532440204|FG006|January - March 2020 (Month 10-12)|Protocol Violation|0|||
147623706|NCT03889418|532440205|FG007|January - March 2020 (Month 10-12)|Protocol Violation|2|||
147623707|NCT03889418|532440206|FG008|January - March 2020 (Month 10-12)|Protocol Violation|0|||
147623708|NCT03889418|532440207|FG009|January - March 2020 (Month 10-12)|Protocol Violation|0|||
147623709|NCT03889418|532440198|FG000|April - June 2020 (Month 13-15)|Death|0|||
147486260|NCT00905307|531936499|FG003|Overall Study|Lost to Follow-up|0|||
147486261|NCT00905307|531936500|FG004|Overall Study|Lost to Follow-up|1|||
147486262|NCT00905307|531936501|FG005|Overall Study|Lost to Follow-up|1|||
147486263|NCT00905307|531936496|FG000|Overall Study|Adverse Event|3|||
147486264|NCT00905307|531936497|FG001|Overall Study|Adverse Event|4|||
147486265|NCT00905307|531936498|FG002|Overall Study|Adverse Event|5|||
147486266|NCT00905307|531936499|FG003|Overall Study|Adverse Event|11|||
147486267|NCT00905307|531936500|FG004|Overall Study|Adverse Event|3|||
147486268|NCT00905307|531936501|FG005|Overall Study|Adverse Event|5|||
147486269|NCT00905307|531936496|FG000|Overall Study|Withdrawal by Subject|5|||
147486270|NCT00905307|531936497|FG001|Overall Study|Withdrawal by Subject|13|||
147486271|NCT00905307|531936498|FG002|Overall Study|Withdrawal by Subject|15|||
147486272|NCT00905307|531936499|FG003|Overall Study|Withdrawal by Subject|11|||
147486273|NCT00905307|531936500|FG004|Overall Study|Withdrawal by Subject|4|||
147623710|NCT03889418|532440199|FG001|April - June 2020 (Month 13-15)|Death|1|||
147486274|NCT00905307|531936501|FG005|Overall Study|Withdrawal by Subject|13|||
147486275|NCT00905307|531936496|FG000|Overall Study|Protocol Violation|1|||
147486276|NCT00905307|531936497|FG001|Overall Study|Protocol Violation|0|||
147486277|NCT00905307|531936498|FG002|Overall Study|Protocol Violation|1|||
147486278|NCT00905307|531936499|FG003|Overall Study|Protocol Violation|0|||
147486279|NCT00905307|531936500|FG004|Overall Study|Protocol Violation|0|||
147486280|NCT00905307|531936501|FG005|Overall Study|Protocol Violation|0|||
147486281|NCT00905307|531936496|FG000|Overall Study|Lack of Efficacy|6|||
147486282|NCT00905307|531936497|FG001|Overall Study|Lack of Efficacy|3|||
147486283|NCT00905307|531936498|FG002|Overall Study|Lack of Efficacy|5|||
147486284|NCT00905307|531936499|FG003|Overall Study|Lack of Efficacy|4|||
147486285|NCT00905307|531936500|FG004|Overall Study|Lack of Efficacy|4|||
147486286|NCT00905307|531936501|FG005|Overall Study|Lack of Efficacy|8|||
147486287|NCT03838367|531936502|FG000|Overall Study|Early termination of study|3|||
147486288|NCT03838367|531936503|FG001|Overall Study|Early termination of study|4|||
147486289|NCT03838367|531936504|FG002|Overall Study|Early termination of study|3|||
147486290|NCT03838367|531936505|FG003|Overall Study|Early termination of study|0|||
147486291|NCT03406104|531936506|FG000|Overall Study|Lost to Follow-up|2|||
147486292|NCT03406104|531936506|FG000|Overall Study|Withdrawal by Subject|2|||
147486293|NCT03406104|531936506|FG000|Overall Study|due to Covid patient did not want to travel|1|||
147486294|NCT03406104|531936506|FG000|Overall Study|Death|2|||
147486295|NCT00114972|531936507|FG000|Overall Study|Withdrawal by Subject|40|||
147486296|NCT00114972|531936508|FG001|Overall Study|Withdrawal by Subject|7|||
147486297|NCT00114972|531936507|FG000|Overall Study|Lost to Follow-up|8|||
147486298|NCT00114972|531936508|FG001|Overall Study|Lost to Follow-up|5|||
147486299|NCT02890329|531936509|FG000|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Withdrawal by Subject|0|||
147486300|NCT02890329|531936510|FG001|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Withdrawal by Subject|1|||
147486301|NCT02890329|531936511|FG002|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Withdrawal by Subject|0|||
147486302|NCT02890329|531936512|FG003|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Withdrawal by Subject|0|||
147486303|NCT02890329|531936513|FG004|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Withdrawal by Subject|0|||
147486304|NCT02890329|531936514|FG005|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Withdrawal by Subject|0|||
147486305|NCT02890329|531936509|FG000|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Progression during lead-in decitabine cycle|1|||
147486306|NCT02890329|531936510|FG001|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Progression during lead-in decitabine cycle|1|||
147486307|NCT02890329|531936511|FG002|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Progression during lead-in decitabine cycle|0|||
147486308|NCT02890329|531936512|FG003|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Progression during lead-in decitabine cycle|0|||
147486309|NCT02890329|531936513|FG004|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Progression during lead-in decitabine cycle|0|||
147486310|NCT02890329|531936514|FG005|Cohort 1: Dose Level 0 (3 mg/kg Ipi)|Progression during lead-in decitabine cycle|0|||
147486311|NCT02890329|531936509|FG000|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Withdrawal by Subject|0|||
147486312|NCT02890329|531936510|FG001|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Withdrawal by Subject|0|||
147486313|NCT02890329|531936511|FG002|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Withdrawal by Subject|0|||
147623711|NCT03889418|532440200|FG002|April - June 2020 (Month 13-15)|Death|0|||
147486314|NCT02890329|531936512|FG003|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Withdrawal by Subject|2|||
147486315|NCT02890329|531936513|FG004|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Withdrawal by Subject|0|||
147486316|NCT02890329|531936514|FG005|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Withdrawal by Subject|0|||
147486317|NCT02890329|531936509|FG000|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Adverse Event|0|||
147623712|NCT03889418|532440201|FG003|April - June 2020 (Month 13-15)|Death|0|||
147623713|NCT03889418|532440202|FG004|April - June 2020 (Month 13-15)|Death|0|||
147623714|NCT03889418|532440203|FG005|April - June 2020 (Month 13-15)|Death|0|||
147623715|NCT03889418|532440204|FG006|April - June 2020 (Month 13-15)|Death|0|||
147623716|NCT03889418|532440205|FG007|April - June 2020 (Month 13-15)|Death|0|||
147623717|NCT03889418|532440206|FG008|April - June 2020 (Month 13-15)|Death|0|||
147486318|NCT02890329|531936510|FG001|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Adverse Event|0|||
147486319|NCT02890329|531936511|FG002|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Adverse Event|1|||
147486320|NCT02890329|531936512|FG003|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Adverse Event|0|||
147486321|NCT02890329|531936513|FG004|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Adverse Event|0|||
147486322|NCT02890329|531936514|FG005|Cohort 2: Dose Level 1 (5 mg/kg Ipi)|Adverse Event|0|||
147486323|NCT00231062|531936517|FG000|Overall Study|Physician Decision|6|||
147486324|NCT00590681|531936521|FG000|Overall Study|Withdrawal by Subject|7|||
147486325|NCT00590681|531936521|FG000|Overall Study|Adverse Event|8|||
147486326|NCT00590681|531936521|FG000|Overall Study|Death|3|||
147486327|NCT00590681|531936521|FG000|Overall Study|Lost to Follow-up|1|||
147486328|NCT00590681|531936521|FG000|Overall Study|disease progression|1|||
147486329|NCT01259297|531936522|FG000|Double Blind Randomized Period|Death|1|||
147486330|NCT01259297|531936523|FG001|Double Blind Randomized Period|Death|1|||
147623718|NCT03889418|532440207|FG009|April - June 2020 (Month 13-15)|Death|0|||
147623719|NCT03889418|532440198|FG000|April - June 2020 (Month 13-15)|Protocol Violation|0|||
147623720|NCT03889418|532440199|FG001|April - June 2020 (Month 13-15)|Protocol Violation|0|||
147623721|NCT03889418|532440200|FG002|April - June 2020 (Month 13-15)|Protocol Violation|0|||
147623722|NCT03889418|532440201|FG003|April - June 2020 (Month 13-15)|Protocol Violation|1|||
147623723|NCT03889418|532440202|FG004|April - June 2020 (Month 13-15)|Protocol Violation|0|||
147623724|NCT03889418|532440203|FG005|April - June 2020 (Month 13-15)|Protocol Violation|0|||
147623725|NCT03889418|532440204|FG006|April - June 2020 (Month 13-15)|Protocol Violation|0|||
147667765|NCT01326871|532608146|FG000|Overall Study|Major surgery|0|||
147667766|NCT01326871|532608147|FG001|Overall Study|Major surgery|1|||
147667767|NCT01326871|532608148|FG002|Overall Study|Major surgery|0|||
147486331|NCT01259297|531936524|FG002|Double Blind Randomized Period|Death|1|||
147486332|NCT01259297|531936525|FG003|Double Blind Randomized Period|Death|2|||
147486333|NCT01259297|531936526|FG004|Double Blind Randomized Period|Death|1|||
147486334|NCT01259297|531936527|FG005|Double Blind Randomized Period|Death|5|||
147486335|NCT01259297|531936528|FG006|Double Blind Randomized Period|Death|2|||
147486336|NCT01259297|531936529|FG007|Double Blind Randomized Period|Death|1|||
147486337|NCT01259297|531936522|FG000|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1|||
147486338|NCT01259297|531936523|FG001|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1|||
147486339|NCT01259297|531936524|FG002|Double Blind Randomized Period|Withdrew informed consent/ refused visit|0|||
147486340|NCT01259297|531936525|FG003|Double Blind Randomized Period|Withdrew informed consent/ refused visit|2|||
147486341|NCT01259297|531936526|FG004|Double Blind Randomized Period|Withdrew informed consent/ refused visit|2|||
147486342|NCT01259297|531936527|FG005|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1|||
147486343|NCT01259297|531936528|FG006|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1|||
147486344|NCT01259297|531936529|FG007|Double Blind Randomized Period|Withdrew informed consent/ refused visit|1|||
147486345|NCT01259297|531936522|FG000|Double Blind Randomized Period|Other reasons|0|||
147486346|NCT01259297|531936523|FG001|Double Blind Randomized Period|Other reasons|1|||
147486347|NCT01259297|531936524|FG002|Double Blind Randomized Period|Other reasons|0|||
147486348|NCT01259297|531936525|FG003|Double Blind Randomized Period|Other reasons|0|||
147486349|NCT01259297|531936526|FG004|Double Blind Randomized Period|Other reasons|1|||
147486350|NCT01259297|531936527|FG005|Double Blind Randomized Period|Other reasons|2|||
147486351|NCT01259297|531936528|FG006|Double Blind Randomized Period|Other reasons|3|||
147486352|NCT01259297|531936529|FG007|Double Blind Randomized Period|Other reasons|1|||
147486353|NCT02084134|531936537|FG000|Overall Study|Protocol Violation|4|||
147486354|NCT02084134|531936538|FG001|Overall Study|Protocol Violation|2|||
147486355|NCT02084134|531936537|FG000|Overall Study|Death|0|||
147486356|NCT02084134|531936538|FG001|Overall Study|Death|1|||
147486357|NCT02807454|531936539|FG000|Overall Study|Adverse Event|1|||
147486358|NCT02807454|531936540|FG001|Overall Study|Adverse Event|0|||
147486359|NCT02807454|531936539|FG000|Overall Study|Withdrawal by Subject|0|||
147486360|NCT02807454|531936540|FG001|Overall Study|Withdrawal by Subject|1|||
147486361|NCT02807454|531936539|FG000|Overall Study|Progressive Disease|30|||
147486362|NCT02807454|531936540|FG001|Overall Study|Progressive Disease|3|||
147486363|NCT02807454|531936539|FG000|Overall Study|Other Reasons|1|||
147486364|NCT02807454|531936540|FG001|Overall Study|Other Reasons|1|||
147486365|NCT05468086|531936541|FG000|Overall Study|Withdrawal by Subject|3|||
147623726|NCT03889418|532440205|FG007|April - June 2020 (Month 13-15)|Protocol Violation|0|||
147623727|NCT03889418|532440206|FG008|April - June 2020 (Month 13-15)|Protocol Violation|0|||
147486366|NCT05468086|531936541|FG000|Overall Study|Subject was found ineligible after consent|1|||
147486367|NCT01165203|531936542|FG000|Active Phase|Serious Adverse Event|1|||
147486368|NCT01165203|531936543|FG001|Active Phase|Serious Adverse Event|0|||
147623728|NCT03889418|532440207|FG009|April - June 2020 (Month 13-15)|Protocol Violation|0|||
147623729|NCT03889418|532440198|FG000|July 2020 - January 2022 (Month 16-28)|Death|1|||
147623730|NCT03889418|532440199|FG001|July 2020 - January 2022 (Month 16-28)|Death|0|||
147486369|NCT01165203|531936542|FG000|Active Phase|Withdrawal by Subject|2|||
147486370|NCT01165203|531936543|FG001|Active Phase|Withdrawal by Subject|1|||
147623731|NCT03889418|532440200|FG002|July 2020 - January 2022 (Month 16-28)|Death|2|||
147623732|NCT03889418|532440201|FG003|July 2020 - January 2022 (Month 16-28)|Death|1|||
147623733|NCT03889418|532440202|FG004|July 2020 - January 2022 (Month 16-28)|Death|0|||
147623734|NCT03889418|532440203|FG005|July 2020 - January 2022 (Month 16-28)|Death|0|||
147486371|NCT01165203|531936542|FG000|Active Phase|Migrated/moved from study area|0|||
147486372|NCT01165203|531936543|FG001|Active Phase|Migrated/moved from study area|1|||
147486373|NCT01165203|531936542|FG000|Active Phase|Lost to Follow-up|2|||
147486374|NCT01165203|531936543|FG001|Active Phase|Lost to Follow-up|0|||
147486375|NCT01165203|531936542|FG000|Extended Safety Follow-up Phase|Serious Adverse Event|1|||
147486376|NCT01165203|531936543|FG001|Extended Safety Follow-up Phase|Serious Adverse Event|0|||
147486377|NCT01165203|531936542|FG000|Extended Safety Follow-up Phase|Withdrawal by Subject|2|||
147486378|NCT01165203|531936543|FG001|Extended Safety Follow-up Phase|Withdrawal by Subject|2|||
147486379|NCT01165203|531936542|FG000|Extended Safety Follow-up Phase|Migrated/moved from study area|2|||
147486380|NCT01165203|531936543|FG001|Extended Safety Follow-up Phase|Migrated/moved from study area|1|||
147486381|NCT01165203|531936542|FG000|Extended Safety Follow-up Phase|Lost to Follow-up|2|||
147486382|NCT01165203|531936543|FG001|Extended Safety Follow-up Phase|Lost to Follow-up|0|||
147486383|NCT01165203|531936542|FG000|Extended Safety Follow-up Phase|Other-subjects business reasons|0|||
147486384|NCT01165203|531936543|FG001|Extended Safety Follow-up Phase|Other-subjects business reasons|1|||
147486385|NCT01070784|531936544|FG000|Overall Study|Withdrawal by Subject|6|||
147486386|NCT01070784|531936545|FG001|Overall Study|Withdrawal by Subject|9|||
147486387|NCT01070784|531936544|FG000|Overall Study|Adverse Event|14|||
147486388|NCT01070784|531936545|FG001|Overall Study|Adverse Event|9|||
147486389|NCT02815397|531936547|FG000|Overall Study|Physician Decision|2|||
147486390|NCT00085540|531936548|FG000|Overall Study|Withdrawal by Subject|0|||
147486391|NCT00085540|531936549|FG001|Overall Study|Withdrawal by Subject|1|||
147486392|NCT00085540|531936548|FG000|Overall Study|Protocol Violation|0|||
147486393|NCT00085540|531936549|FG001|Overall Study|Protocol Violation|1|||
147486394|NCT01518192|531936550|FG000|Overall Study|Lost to Follow-up|29|||
147486395|NCT01518192|531936551|FG001|Overall Study|Lost to Follow-up|26|||
147486396|NCT01518192|531936552|FG002|Overall Study|Lost to Follow-up|35|||
147486397|NCT00783705|531936553|FG000|Overall Study|Adverse Event|2|||
147486398|NCT00783705|531936554|FG001|Overall Study|Adverse Event|0|||
147486399|NCT00783705|531936553|FG000|Overall Study|Withdrawal by Subject|3|||
147486400|NCT00783705|531936554|FG001|Overall Study|Withdrawal by Subject|2|||
147486401|NCT00783705|531936553|FG000|Overall Study|Lost to Follow-up|1|||
147486402|NCT00783705|531936554|FG001|Overall Study|Lost to Follow-up|3|||
147486403|NCT00426751|531936555|FG000|Overall Study|Adverse Event|8|||
147486404|NCT00426751|531936556|FG001|Overall Study|Adverse Event|1|||
147486405|NCT00426751|531936555|FG000|Overall Study|Lost to Follow-up|7|||
147486406|NCT00426751|531936556|FG001|Overall Study|Lost to Follow-up|6|||
147486407|NCT00426751|531936555|FG000|Overall Study|Consent Withdrawn|0|||
147486408|NCT00426751|531936556|FG001|Overall Study|Consent Withdrawn|1|||
147486409|NCT00426751|531936555|FG000|Overall Study|Other Reasons|7|||
147486410|NCT00426751|531936556|FG001|Overall Study|Other Reasons|12|||
147486411|NCT01200511|531936561|FG000|Overall Study|Lost to Follow-up|3|||
147486412|NCT01200511|531936561|FG000|Overall Study|Withdrawal by Subject|1|||
147486413|NCT01200511|531936561|FG000|Overall Study|Adverse Event|1|||
147486414|NCT03288779|531936562|FG000|Overall Study|Withdrawal by Subject|3|||
147486415|NCT01355068|531936565|FG000|First Intervention Period|Adverse Event|0|||
147486416|NCT01355068|531936566|FG001|First Intervention Period|Adverse Event|1|||
147486417|NCT01355068|531936565|FG000|First Intervention Period|Withdrawal by Subject|0|||
147486418|NCT01355068|531936566|FG001|First Intervention Period|Withdrawal by Subject|1|||
147486419|NCT00376688|531936568|FG000|Overall Study|Adverse Event|3|||
147486420|NCT00376688|531936568|FG000|Overall Study|Death|1|||
147486421|NCT01770353|531936569|FG000|Overall Study|Progressive disease|2|||
147486422|NCT01770353|531936570|FG001|Overall Study|Progressive disease|1|||
147486423|NCT01770353|531936569|FG000|Overall Study|Adverse Event|0|||
147486424|NCT01770353|531936570|FG001|Overall Study|Adverse Event|1|||
147486425|NCT01770353|531936569|FG000|Overall Study|Protocol Violation|1|||
147486426|NCT01770353|531936570|FG001|Overall Study|Protocol Violation|0|||
147486427|NCT01770353|531936569|FG000|Overall Study|Physician Decision|0|||
147486428|NCT01770353|531936570|FG001|Overall Study|Physician Decision|3|||
147486429|NCT01770353|531936569|FG000|Overall Study|Clinical deterioration|3|||
147486430|NCT01770353|531936570|FG001|Overall Study|Clinical deterioration|6|||
147486431|NCT01770353|531936569|FG000|Overall Study|Toxicity related diarrhoea + progression|0|||
147486432|NCT01770353|531936570|FG001|Overall Study|Toxicity related diarrhoea + progression|1|||
147486433|NCT02279524|531937781|FG000|Overall Study|Withdrawal by Subject|3|||
147486434|NCT02279524|531937782|FG001|Overall Study|Withdrawal by Subject|6|||
147486435|NCT02279524|531937783|FG002|Overall Study|Withdrawal by Subject|3|||
147623735|NCT03889418|532440204|FG006|July 2020 - January 2022 (Month 16-28)|Death|0|||
147486436|NCT02279524|531937781|FG000|Overall Study|Adverse Event|4|||
147486437|NCT02279524|531937782|FG001|Overall Study|Adverse Event|3|||
147486438|NCT02279524|531937783|FG002|Overall Study|Adverse Event|2|||
147486439|NCT02279524|531937781|FG000|Overall Study|Lost to Follow-up|1|||
147486440|NCT02279524|531937782|FG001|Overall Study|Lost to Follow-up|1|||
147486441|NCT02279524|531937783|FG002|Overall Study|Lost to Follow-up|0|||
147486442|NCT02279524|531937781|FG000|Overall Study|Disallowed medication|1|||
147623736|NCT03889418|532440205|FG007|July 2020 - January 2022 (Month 16-28)|Death|1|||
147486443|NCT02279524|531937782|FG001|Overall Study|Disallowed medication|1|||
147486444|NCT02279524|531937783|FG002|Overall Study|Disallowed medication|2|||
147486445|NCT02279524|531937781|FG000|Overall Study|Bariatric surgery|1|||
147486446|NCT02279524|531937782|FG001|Overall Study|Bariatric surgery|0|||
147486447|NCT02279524|531937783|FG002|Overall Study|Bariatric surgery|0|||
147486448|NCT01746732|531937784|FG000|Lead-In Period|Withdrawal by Subject|1|||
147486449|NCT01746732|531937785|FG001|Lead-In Period|Withdrawal by Subject|0|||
147486450|NCT01746732|531937786|FG002|Lead-In Period|Withdrawal by Subject|0|||
147486451|NCT01746732|531937784|FG000|Period 1|Physician Decision|0|||
147486452|NCT01746732|531937785|FG001|Period 1|Physician Decision|1|||
147486453|NCT01746732|531937786|FG002|Period 1|Physician Decision|0|||
147486454|NCT01746732|531937784|FG000|Period 2|Withdrawal by Subject|0|||
147486455|NCT01746732|531937785|FG001|Period 2|Withdrawal by Subject|0|||
147486456|NCT01746732|531937786|FG002|Period 2|Withdrawal by Subject|2|||
147486457|NCT01746732|531937784|FG000|Period 2|Adverse Event|0|||
147486458|NCT01746732|531937785|FG001|Period 2|Adverse Event|0|||
147486459|NCT01746732|531937786|FG002|Period 2|Adverse Event|1|||
147486460|NCT01746732|531937784|FG000|Period 2|Lost to Follow-up|0|||
147486461|NCT01746732|531937785|FG001|Period 2|Lost to Follow-up|0|||
147486462|NCT01746732|531937786|FG002|Period 2|Lost to Follow-up|1|||
147486463|NCT02817555|531937787|FG000|Overall Study|Death|1|||
147486464|NCT02817555|531937788|FG001|Overall Study|Death|3|||
147486465|NCT02817555|531937787|FG000|Overall Study|moved away|1|||
147486466|NCT02817555|531937788|FG001|Overall Study|moved away|0|||
147486467|NCT02817555|531937787|FG000|Overall Study|transplant|1|||
147486468|NCT02817555|531937788|FG001|Overall Study|transplant|1|||
147486469|NCT02817555|531937787|FG000|Overall Study|changed to Peritoneal Dialysis|0|||
147486470|NCT02817555|531937788|FG001|Overall Study|changed to Peritoneal Dialysis|1|||
147486471|NCT00137436|531937789|FG000|Overall Study|Adverse Event|13|||
147486472|NCT00137436|531937789|FG000|Overall Study|Death|2|||
147486473|NCT00137436|531937789|FG000|Overall Study|Lack of Efficacy|17|||
147486474|NCT00137436|531937789|FG000|Overall Study|Withdrawal by Subject|6|||
147486475|NCT00137436|531937789|FG000|Overall Study|Other|5|||
147486476|NCT00701727|531937790|FG000|First Treatment Period|Adverse Event|0|||
147486477|NCT00701727|531937791|FG001|First Treatment Period|Adverse Event|0|||
147486478|NCT00701727|531937790|FG000|First Treatment Period|Withdrawal by Subject|1|||
147486479|NCT00701727|531937791|FG001|First Treatment Period|Withdrawal by Subject|0|||
147486480|NCT00701727|531937790|FG000|First Treatment Period|sponsor decision|0|||
147486481|NCT00701727|531937791|FG001|First Treatment Period|sponsor decision|1|||
147486482|NCT00701727|531937790|FG000|First Treatment Period|Lost to Follow-up|0|||
147486483|NCT00701727|531937791|FG001|First Treatment Period|Lost to Follow-up|1|||
147486484|NCT00701727|531937790|FG000|Second Treatment Period|Withdrawal by Subject|2|||
147486485|NCT00701727|531937791|FG001|Second Treatment Period|Withdrawal by Subject|0|||
147486486|NCT00051558|531937792|FG000|Overall Study|Adverse Event|30|||
147486487|NCT00051558|531937793|FG001|Overall Study|Adverse Event|18|||
147486488|NCT00051558|531937792|FG000|Overall Study|Withdrawal by Subject|29|||
147486489|NCT00051558|531937793|FG001|Overall Study|Withdrawal by Subject|42|||
147486490|NCT00051558|531937792|FG000|Overall Study|Death|9|||
147486491|NCT00051558|531937793|FG001|Overall Study|Death|15|||
147486492|NCT00051558|531937792|FG000|Overall Study|Lost to Follow-up|4|||
147486493|NCT00051558|531937793|FG001|Overall Study|Lost to Follow-up|13|||
147486494|NCT00051558|531937792|FG000|Overall Study|Protocol Violation|3|||
147486495|NCT00051558|531937793|FG001|Overall Study|Protocol Violation|4|||
147486496|NCT00051558|531937792|FG000|Overall Study|Protocol Entry Criteria Unmet|1|||
147486497|NCT00051558|531937793|FG001|Overall Study|Protocol Entry Criteria Unmet|2|||
147486498|NCT00051558|531937792|FG000|Overall Study|Sponsor Decision|6|||
147486499|NCT00051558|531937793|FG001|Overall Study|Sponsor Decision|1|||
147486500|NCT00051558|531937792|FG000|Overall Study|Other|2|||
147486501|NCT00051558|531937793|FG001|Overall Study|Other|1|||
147486502|NCT00051558|531937792|FG000|Overall Study|Significant Lab Value|2|||
147486503|NCT00051558|531937793|FG001|Overall Study|Significant Lab Value|0|||
147486504|NCT00051558|531937792|FG000|Overall Study|Physician Decision|5|||
147486505|NCT00051558|531937793|FG001|Overall Study|Physician Decision|0|||
147486506|NCT01701583|531937797|FG000|Overall Study|Withdrawal by Subject|2|||
147486507|NCT01701583|531937798|FG001|Overall Study|Withdrawal by Subject|0|||
147486508|NCT01441440|531937799|FG000|Overall Study|Death|1|||
147486509|NCT01441440|531937800|FG001|Overall Study|Death|0|||
147486510|NCT01441440|531937801|FG002|Overall Study|Death|1|||
147486511|NCT01441440|531937799|FG000|Overall Study|Adverse Event|2|||
147486512|NCT01441440|531937800|FG001|Overall Study|Adverse Event|9|||
147486513|NCT01441440|531937801|FG002|Overall Study|Adverse Event|9|||
147486514|NCT01441440|531937799|FG000|Overall Study|Lost to Follow-up|0|||
147486515|NCT01441440|531937800|FG001|Overall Study|Lost to Follow-up|2|||
147486516|NCT01441440|531937801|FG002|Overall Study|Lost to Follow-up|1|||
147486517|NCT01441440|531937799|FG000|Overall Study|Withdrawal by Subject|11|||
147486518|NCT01441440|531937800|FG001|Overall Study|Withdrawal by Subject|9|||
147486519|NCT01441440|531937801|FG002|Overall Study|Withdrawal by Subject|9|||
147486520|NCT01441440|531937799|FG000|Overall Study|Pregnancy|1|||
147486521|NCT01441440|531937800|FG001|Overall Study|Pregnancy|0|||
147486522|NCT01441440|531937801|FG002|Overall Study|Pregnancy|0|||
147486523|NCT01441440|531937799|FG000|Overall Study|Lack of Efficacy|1|||
147486524|NCT01441440|531937800|FG001|Overall Study|Lack of Efficacy|0|||
147486525|NCT01441440|531937801|FG002|Overall Study|Lack of Efficacy|1|||
147486526|NCT01441440|531937799|FG000|Overall Study|Moving|0|||
147486527|NCT01441440|531937800|FG001|Overall Study|Moving|1|||
147486528|NCT01441440|531937801|FG002|Overall Study|Moving|1|||
147486529|NCT01441440|531937799|FG000|Overall Study|Work-related matter|0|||
147486530|NCT01441440|531937800|FG001|Overall Study|Work-related matter|1|||
147486531|NCT01441440|531937801|FG002|Overall Study|Work-related matter|0|||
147486532|NCT01441440|531937799|FG000|Overall Study|Difficllty in keeping the schedule|1|||
147486533|NCT01441440|531937800|FG001|Overall Study|Difficllty in keeping the schedule|1|||
147486534|NCT01441440|531937801|FG002|Overall Study|Difficllty in keeping the schedule|0|||
147486535|NCT01345123|531937802|FG000|Overall Study|participants no longer with health plan|79|||
147486536|NCT01345123|531937803|FG001|Overall Study|participants no longer with health plan|85|||
147486537|NCT01345123|531937804|FG002|Overall Study|participants no longer with health plan|88|||
147486538|NCT00883558|531937805|FG000|Titration Period (Weeks 0 to 4)|Withdrawal by Subject|2|||
147486539|NCT00883558|531937806|FG001|Titration Period (Weeks 0 to 4)|Withdrawal by Subject|0|||
147486540|NCT00883558|531937807|FG002|Titration Period (Weeks 0 to 4)|Withdrawal by Subject|0|||
147486541|NCT00883558|531937805|FG000|First Treatment Cycle (Weeks 4 to 16)|Adverse Event|0|||
147486542|NCT00883558|531937806|FG001|First Treatment Cycle (Weeks 4 to 16)|Adverse Event|1|||
147486543|NCT00883558|531937807|FG002|First Treatment Cycle (Weeks 4 to 16)|Adverse Event|0|||
147486544|NCT00883558|531937805|FG000|First Treatment Cycle (Weeks 4 to 16)|Withdrawal by Subject|0|||
147486545|NCT00883558|531937806|FG001|First Treatment Cycle (Weeks 4 to 16)|Withdrawal by Subject|1|||
147486546|NCT00883558|531937807|FG002|First Treatment Cycle (Weeks 4 to 16)|Withdrawal by Subject|1|||
147486547|NCT00883558|531937805|FG000|First Treatment Cycle (Weeks 4 to 16)|Protocol Violation|0|||
147486548|NCT00883558|531937806|FG001|First Treatment Cycle (Weeks 4 to 16)|Protocol Violation|1|||
147486549|NCT00883558|531937807|FG002|First Treatment Cycle (Weeks 4 to 16)|Protocol Violation|0|||
147486550|NCT00883558|531937805|FG000|Second Treatment Cycle (Weeks 16 to 28)|Withdrawal by Subject|0|||
147486551|NCT00883558|531937806|FG001|Second Treatment Cycle (Weeks 16 to 28)|Withdrawal by Subject|0|||
147486552|NCT00883558|531937807|FG002|Second Treatment Cycle (Weeks 16 to 28)|Withdrawal by Subject|1|||
147486553|NCT00366548|531937809|FG000|Infant Series|Adverse Event|1|||
147486554|NCT00366548|531937810|FG001|Infant Series|Adverse Event|3|||
147486555|NCT00366548|531937809|FG000|Infant Series|Protocol Violation|0|||
147486556|NCT00366548|531937810|FG001|Infant Series|Protocol Violation|1|||
147486557|NCT00366548|531937809|FG000|Infant Series|Withdrawal by Subject|3|||
147486558|NCT00366548|531937810|FG001|Infant Series|Withdrawal by Subject|1|||
147486559|NCT00366548|531937809|FG000|After Infant Series|Withdrawal by Subject|3|||
147486560|NCT00366548|531937810|FG001|After Infant Series|Withdrawal by Subject|1|||
147486561|NCT00366548|531937809|FG000|After Infant Series|Adverse Event|2|||
147486562|NCT00366548|531937810|FG001|After Infant Series|Adverse Event|0|||
147486563|NCT00366548|531937809|FG000|After Infant Series|Lost to Follow-up|1|||
147486564|NCT00366548|531937810|FG001|After Infant Series|Lost to Follow-up|0|||
147486565|NCT01984346|531937811|FG000|Overall Study|Physician Decision|4|||
147486566|NCT01984346|531937812|FG001|Overall Study|Physician Decision|2|||
147486567|NCT01984346|531937811|FG000|Overall Study|Withdrawal by Subject|2|||
147486568|NCT01984346|531937812|FG001|Overall Study|Withdrawal by Subject|2|||
147486569|NCT01984346|531937811|FG000|Overall Study|Enrollment Closed|8|||
147486570|NCT01984346|531937812|FG001|Overall Study|Enrollment Closed|1|||
147486571|NCT01984346|531937811|FG000|Overall Study|Insurance Coverage|1|||
147486572|NCT01984346|531937812|FG001|Overall Study|Insurance Coverage|0|||
147623737|NCT03889418|532440206|FG008|July 2020 - January 2022 (Month 16-28)|Death|0|||
147623738|NCT03889418|532440207|FG009|July 2020 - January 2022 (Month 16-28)|Death|0|||
147623739|NCT03889418|532440198|FG000|July 2020 - January 2022 (Month 16-28)|Protocol Violation|0|||
147623740|NCT03889418|532440199|FG001|July 2020 - January 2022 (Month 16-28)|Protocol Violation|4|||
147623741|NCT03889418|532440200|FG002|July 2020 - January 2022 (Month 16-28)|Protocol Violation|2|||
147623742|NCT03889418|532440201|FG003|July 2020 - January 2022 (Month 16-28)|Protocol Violation|1|||
147623743|NCT03889418|532440202|FG004|July 2020 - January 2022 (Month 16-28)|Protocol Violation|0|||
147623744|NCT03889418|532440203|FG005|July 2020 - January 2022 (Month 16-28)|Protocol Violation|0|||
147623745|NCT03889418|532440204|FG006|July 2020 - January 2022 (Month 16-28)|Protocol Violation|0|||
147623746|NCT03889418|532440205|FG007|July 2020 - January 2022 (Month 16-28)|Protocol Violation|1|||
147623747|NCT03889418|532440206|FG008|July 2020 - January 2022 (Month 16-28)|Protocol Violation|0|||
147623748|NCT03889418|532440207|FG009|July 2020 - January 2022 (Month 16-28)|Protocol Violation|4|||
147623749|NCT00092118|532440209|FG000|Overall Study|Adverse Event|35|||
147623750|NCT00092118|532440210|FG001|Overall Study|Adverse Event|32|||
147623751|NCT00092118|532440209|FG000|Overall Study|Lack of Efficacy|12|||
147623752|NCT00092118|532440210|FG001|Overall Study|Lack of Efficacy|14|||
147623753|NCT00092118|532440209|FG000|Overall Study|Lost to Follow-up|4|||
147486573|NCT01984346|531937811|FG000|Overall Study|Intra-operative Exclusion|2|||
147486574|NCT01984346|531937812|FG001|Overall Study|Intra-operative Exclusion|0|||
147623754|NCT00092118|532440210|FG001|Overall Study|Lost to Follow-up|3|||
147623755|NCT00092118|532440209|FG000|Overall Study|Protocol Violation|23|||
147623756|NCT00092118|532440210|FG001|Overall Study|Protocol Violation|25|||
147623757|NCT00092118|532440209|FG000|Overall Study|Withdrawal by Subject|4|||
147486575|NCT00536731|531937813|FG000|Overall Study|Adverse Event|3|||
147486576|NCT00536731|531937814|FG001|Overall Study|Adverse Event|2|||
147486577|NCT00536731|531937815|FG002|Overall Study|Adverse Event|3|||
147486578|NCT00536731|531937813|FG000|Overall Study|Withdrawal by Subject|0|||
147486579|NCT00536731|531937814|FG001|Overall Study|Withdrawal by Subject|2|||
147486580|NCT00536731|531937815|FG002|Overall Study|Withdrawal by Subject|0|||
147486581|NCT00536731|531937813|FG000|Overall Study|Intake of prohibited conc. medication|0|||
147486582|NCT00536731|531937814|FG001|Overall Study|Intake of prohibited conc. medication|0|||
147486583|NCT00536731|531937815|FG002|Overall Study|Intake of prohibited conc. medication|1|||
147486584|NCT00536731|531937813|FG000|Overall Study|Safety reasons|0|||
147486585|NCT00536731|531937814|FG001|Overall Study|Safety reasons|0|||
147486586|NCT00536731|531937815|FG002|Overall Study|Safety reasons|1|||
147486587|NCT00536731|531937813|FG000|Overall Study|Other|1|||
147486588|NCT00536731|531937814|FG001|Overall Study|Other|1|||
147486589|NCT00536731|531937815|FG002|Overall Study|Other|0|||
147486590|NCT00109733|531937817|FG000|Overall Study|Protocol Violation|0|||
147486591|NCT00109733|531937818|FG001|Overall Study|Protocol Violation|1|||
147486592|NCT00109733|531937817|FG000|Overall Study|Stopped taking study drug|1|||
147486593|NCT00109733|531937818|FG001|Overall Study|Stopped taking study drug|1|||
147486594|NCT00109733|531937817|FG000|Overall Study|Non-compliant|0|||
147486595|NCT00109733|531937818|FG001|Overall Study|Non-compliant|1|||
147486596|NCT00109733|531937817|FG000|Overall Study|Could not commit time for study|1|||
147486597|NCT00109733|531937818|FG001|Overall Study|Could not commit time for study|1|||
147486598|NCT03952468|531937819|FG000|Overall Study|Death|0|||
147486599|NCT03952468|531937820|FG001|Overall Study|Death|1|||
147486600|NCT03952468|531937819|FG000|Overall Study|Adverse Event|0|||
147486601|NCT03952468|531937820|FG001|Overall Study|Adverse Event|1|||
147486602|NCT03952468|531937819|FG000|Overall Study|Physician Decision|1|||
147486603|NCT03952468|531937820|FG001|Overall Study|Physician Decision|0|||
147486604|NCT03952468|531937819|FG000|Overall Study|Lost to Follow-up|3|||
147486605|NCT03952468|531937820|FG001|Overall Study|Lost to Follow-up|4|||
147486606|NCT03952468|531937819|FG000|Overall Study|Withdrawal by Subject|2|||
147486607|NCT03952468|531937820|FG001|Overall Study|Withdrawal by Subject|1|||
147486608|NCT00506077|531937829|FG000|Treatment Period 1|Adverse Event|2|||
147486609|NCT00506077|531937830|FG001|Treatment Period 1|Adverse Event|1|||
147486610|NCT00506077|531937829|FG000|Treatment Period 1|Lost to Follow-up|0|||
147486611|NCT00506077|531937830|FG001|Treatment Period 1|Lost to Follow-up|2|||
147486612|NCT00506077|531937829|FG000|Treatment Period 1|Withdrawal by Subject|2|||
147486613|NCT00506077|531937830|FG001|Treatment Period 1|Withdrawal by Subject|0|||
147486614|NCT00506077|531937829|FG000|Treatment Period 2|Adverse Event|0|||
147486615|NCT00506077|531937830|FG001|Treatment Period 2|Adverse Event|1|||
147486616|NCT00506077|531937829|FG000|Treatment Period 2|Withdrawal by Subject|1|||
147623758|NCT00092118|532440210|FG001|Overall Study|Withdrawal by Subject|10|||
147623759|NCT00092118|532440209|FG000|Overall Study|Other|6|||
147623760|NCT00092118|532440210|FG001|Overall Study|Other|5|||
147623761|NCT02314026|532440211|FG000|Overall Study|Protocol Violation|28|||
147623762|NCT01139775|532440212|FG000|Overall Study|Adverse Event|0|||
147623763|NCT01139775|532440213|FG001|Overall Study|Adverse Event|6|||
147623764|NCT01139775|532440214|FG002|Overall Study|Adverse Event|2|||
147623765|NCT01139775|532440212|FG000|Overall Study|Protocol Violation|0|||
147623766|NCT01139775|532440213|FG001|Overall Study|Protocol Violation|5|||
147623767|NCT01139775|532440214|FG002|Overall Study|Protocol Violation|0|||
147623768|NCT01139775|532440212|FG000|Overall Study|Withdrawal by Subject|1|||
147623769|NCT01139775|532440213|FG001|Overall Study|Withdrawal by Subject|0|||
147486617|NCT00506077|531937830|FG001|Treatment Period 2|Withdrawal by Subject|0|||
147486618|NCT00316303|531937832|FG000|Overall Study|Lost to Follow-up|11|||
147486619|NCT00316303|531937833|FG001|Overall Study|Lost to Follow-up|16|||
147486620|NCT01293032|531937836|FG000|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|0|||
147486621|NCT01293032|531937837|FG001|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|0|||
147486622|NCT01293032|531937838|FG002|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|5|||
147486623|NCT01293032|531937839|FG003|Recurrence Score(RS)Assigned/Randomized|Refused Assigned Arm|0|||
147486624|NCT01293032|531937836|FG000|Treatment|Adverse Event|0|||
147486625|NCT01293032|531937837|FG001|Treatment|Adverse Event|0|||
147623770|NCT01139775|532440214|FG002|Overall Study|Withdrawal by Subject|2|||
147623771|NCT01139775|532440212|FG000|Overall Study|Physician Decision|0|||
147623772|NCT01139775|532440213|FG001|Overall Study|Physician Decision|2|||
147623773|NCT01139775|532440214|FG002|Overall Study|Physician Decision|2|||
147623774|NCT03296527|532440217|FG000|Overall Study|Adverse Event|15|||
147623775|NCT03296527|532440218|FG001|Overall Study|Adverse Event|33|||
147623776|NCT03296527|532440217|FG000|Overall Study|Protocol Deviation|4|||
147623777|NCT03296527|532440218|FG001|Overall Study|Protocol Deviation|0|||
147623778|NCT03296527|532440217|FG000|Overall Study|Participant withdrew consent|3|||
147623779|NCT03296527|532440218|FG001|Overall Study|Participant withdrew consent|1|||
147644027|NCT01032070|532516701|FG001|Overall Study|Withdrawal by Subject|2|||
147486626|NCT01293032|531937838|FG002|Treatment|Adverse Event|1|||
147486627|NCT01293032|531937839|FG003|Treatment|Adverse Event|1|||
147486628|NCT01293032|531937836|FG000|Treatment|Withdrawal by Subject|2|||
147486629|NCT01293032|531937837|FG001|Treatment|Withdrawal by Subject|4|||
147486630|NCT01293032|531937838|FG002|Treatment|Withdrawal by Subject|0|||
147486631|NCT01293032|531937839|FG003|Treatment|Withdrawal by Subject|0|||
147486632|NCT01293032|531937836|FG000|Treatment|Disease Progression, relapse|0|||
147486633|NCT01293032|531937837|FG001|Treatment|Disease Progression, relapse|1|||
147486634|NCT01293032|531937838|FG002|Treatment|Disease Progression, relapse|0|||
147486635|NCT01293032|531937839|FG003|Treatment|Disease Progression, relapse|0|||
147486636|NCT01106534|531937842|FG000|Overall Study|Withdrawal by Subject|18|||
147486637|NCT01106534|531937842|FG000|Overall Study|Lost to Follow-up|2|||
147486638|NCT01106534|531937842|FG000|Overall Study|Death|16|||
147486639|NCT01106534|531937842|FG000|Overall Study|Physician Decision|1|||
147486640|NCT02985450|531937852|FG000|Overall Study|Lost to Follow-up|7|||
147486641|NCT00069576|531937853|FG000|Original Trial|Lost to Follow-up|25|||
147486642|NCT00069576|531937854|FG001|Original Trial|Lost to Follow-up|33|||
147486643|NCT00069576|531937853|FG000|Follow-up Study at 5-10 Years|Not eligible or did not consent|196|||
147486644|NCT00069576|531937854|FG001|Follow-up Study at 5-10 Years|Not eligible or did not consent|204|||
147486645|NCT05590793|531937855|FG000|Overall Study|Withdrawal by Subject|6|||
147486646|NCT05590793|531937855|FG000|Overall Study|Physician Decision|1|||
147486647|NCT04060667|531937856|FG000|Overall Study|Lost to Follow-up|75|||
147486648|NCT04060667|531937857|FG001|Overall Study|Lost to Follow-up|10|||
147486649|NCT04488822|531937858|FG000|Overall Study|Adverse Event|8|||
147486650|NCT04488822|531937858|FG000|Overall Study|Withdrawal by Subject|1|||
147486651|NCT00443430|531937869|FG000|Overall Study|Lack of Efficacy|3|||
147486652|NCT00443430|531937870|FG001|Overall Study|Lack of Efficacy|3|||
147486653|NCT00443430|531937869|FG000|Overall Study|Adverse Event|1|||
147486654|NCT00443430|531937870|FG001|Overall Study|Adverse Event|1|||
147486655|NCT00053846|531937871|FG000|Overall Study|Changed mind|8|||
147486656|NCT00053846|531937872|FG001|Overall Study|Changed mind|13|||
147486657|NCT00053846|531937871|FG000|Overall Study|Became too ill|8|||
147486658|NCT00053846|531937872|FG001|Overall Study|Became too ill|7|||
147486659|NCT00053846|531937871|FG000|Overall Study|Expired|5|||
147486660|NCT00053846|531937872|FG001|Overall Study|Expired|0|||
147486661|NCT00053846|531937871|FG000|Overall Study|Became ineligible|3|||
147486662|NCT00053846|531937872|FG001|Overall Study|Became ineligible|1|||
147486663|NCT00053846|531937871|FG000|Overall Study|Did not return data|1|||
147486664|NCT00053846|531937872|FG001|Overall Study|Did not return data|2|||
147486665|NCT00053846|531937871|FG000|Overall Study|Quit due to side effects|1|||
147486666|NCT00053846|531937872|FG001|Overall Study|Quit due to side effects|3|||
147486667|NCT00053846|531937871|FG000|Overall Study|Pills too large|0|||
147486668|NCT00053846|531937872|FG001|Overall Study|Pills too large|1|||
147486669|NCT00592501|531937873|FG000|Overall Study|Withdrawal by Subject|1|||
147486670|NCT00592501|531937873|FG000|Overall Study|Participant found to have metastatic disease after enrollment thus deemed ineligible|1|||
147486671|NCT00933335|531937875|FG000|Overall Study|Lost to Follow-up|1|||
147486672|NCT00933335|531937876|FG001|Overall Study|Lost to Follow-up|3|||
147486673|NCT00933335|531937875|FG000|Overall Study|Withdrawal by Subject|0|||
147486674|NCT00933335|531937876|FG001|Overall Study|Withdrawal by Subject|1|||
147486675|NCT00933335|531937875|FG000|Overall Study|Progressive Disease|0|||
147486676|NCT00933335|531937876|FG001|Overall Study|Progressive Disease|11|||
147486677|NCT00933335|531937875|FG000|Overall Study|Didn't Meet Criteria for TST/I 131 TST|0|||
147486678|NCT00933335|531937876|FG001|Overall Study|Didn't Meet Criteria for TST/I 131 TST|1|||
147486679|NCT00933335|531937875|FG000|Overall Study|Co-morbid Illness|1|||
147486680|NCT00933335|531937876|FG001|Overall Study|Co-morbid Illness|0|||
147486681|NCT03880227|531937877|FG000|First Visit|Withdrawal by Subject|1|||
147486682|NCT03880227|531937878|FG001|First Visit|Withdrawal by Subject|0|||
147486683|NCT03880227|531937879|FG002|First Visit|Withdrawal by Subject|0|||
147486684|NCT03880227|531937880|FG003|First Visit|Withdrawal by Subject|0|||
147486685|NCT03880227|531937877|FG000|1 Week Washout/ Delay|Lost to Follow-up|0|||
147486686|NCT03880227|531937878|FG001|1 Week Washout/ Delay|Lost to Follow-up|1|||
147486687|NCT03880227|531937879|FG002|1 Week Washout/ Delay|Lost to Follow-up|0|||
147486688|NCT03880227|531937880|FG003|1 Week Washout/ Delay|Lost to Follow-up|0|||
147486689|NCT03880227|531937877|FG000|1 Week Washout/ Delay|Withdrawal by Subject|0|||
147486690|NCT03880227|531937878|FG001|1 Week Washout/ Delay|Withdrawal by Subject|0|||
147486691|NCT03880227|531937879|FG002|1 Week Washout/ Delay|Withdrawal by Subject|2|||
147486692|NCT03880227|531937880|FG003|1 Week Washout/ Delay|Withdrawal by Subject|0|||
147486693|NCT03880227|531937877|FG000|1 Week Washout/ Delay|Incompatibility with technical component (eyetracking)|0|||
147486694|NCT03880227|531937878|FG001|1 Week Washout/ Delay|Incompatibility with technical component (eyetracking)|0|||
147486695|NCT03880227|531937879|FG002|1 Week Washout/ Delay|Incompatibility with technical component (eyetracking)|1|||
147486696|NCT03880227|531937880|FG003|1 Week Washout/ Delay|Incompatibility with technical component (eyetracking)|0|||
147486697|NCT00504166|531937881|FG000|Overall Study|Adverse Event|1|||
147486698|NCT00504166|531937882|FG001|Overall Study|Adverse Event|4|||
147486699|NCT00504166|531937881|FG000|Overall Study|Withdrawal by Subject|3|||
147486700|NCT00504166|531937882|FG001|Overall Study|Withdrawal by Subject|6|||
147486701|NCT00504166|531937881|FG000|Overall Study|Physician Decision|1|||
147486702|NCT00504166|531937882|FG001|Overall Study|Physician Decision|1|||
147486703|NCT00504166|531937881|FG000|Overall Study|Lost to Follow-up|1|||
147486704|NCT00504166|531937882|FG001|Overall Study|Lost to Follow-up|3|||
147486705|NCT02650284|531937885|FG000|Overall Study|Lost to Follow-up|3|||
147486706|NCT02650284|531937886|FG001|Overall Study|Lost to Follow-up|3|||
147486707|NCT02650284|531937885|FG000|Overall Study|Consent incorrectly taken|0|||
147486708|NCT02650284|531937886|FG001|Overall Study|Consent incorrectly taken|1|||
147486709|NCT04590937|531937887|FG000|Period 2 - BI 730357+Cocktail|COVID-19 related|1|||
147486710|NCT01929044|531937890|FG000|Overall Study|Adverse Event|1|||
147486711|NCT01929044|531937891|FG001|Overall Study|Adverse Event|0|||
147486712|NCT01929044|531937890|FG000|Overall Study|Protocol Violation|9|||
147486713|NCT01929044|531937891|FG001|Overall Study|Protocol Violation|14|||
147486714|NCT01929044|531937890|FG000|Overall Study|Not Treated|1|||
147486715|NCT01929044|531937891|FG001|Overall Study|Not Treated|3|||
147486716|NCT00001262|531937892|FG000|Overall Study|Death|10|||
147486717|NCT00001262|531937893|FG001|Overall Study|Death|11|||
147486718|NCT00001262|531937894|FG002|Overall Study|Death|0|||
147486719|NCT00001262|531937892|FG000|Overall Study|Withdrawal by Subject|0|||
147486720|NCT00001262|531937893|FG001|Overall Study|Withdrawal by Subject|3|||
147486721|NCT00001262|531937894|FG002|Overall Study|Withdrawal by Subject|0|||
147486722|NCT00524745|531937898|FG000|Overall Study|subject withdrawal or lost to follow up|34|||
147486723|NCT00524745|531937899|FG001|Overall Study|subject withdrawal or lost to follow up|13|||
147486724|NCT00524745|531937900|FG002|Overall Study|subject withdrawal or lost to follow up|29|||
147486725|NCT00524745|531937901|FG003|Overall Study|subject withdrawal or lost to follow up|22|||
147486726|NCT02504892|531937902|FG000|Overall Study|Adverse event-pneumonitis|2|||
147486727|NCT00576693|531937903|FG000|Overall Study|Lost to Follow-up|7|||
147486728|NCT00576693|531937904|FG001|Overall Study|Lost to Follow-up|11|||
147486729|NCT00576693|531937903|FG000|Overall Study|Withdrawal by Subject|3|||
147486730|NCT00576693|531937904|FG001|Overall Study|Withdrawal by Subject|13|||
147486731|NCT01413178|531937905|FG000|Overall Study|Toxicity|1|||
147486732|NCT01413178|531937906|FG001|Overall Study|Toxicity|0|||
147486733|NCT01413178|531937905|FG000|Overall Study|Ineligible|0|||
147486734|NCT01413178|531937906|FG001|Overall Study|Ineligible|2|||
147486735|NCT00540449|531937907|FG000|Overall Study|Adverse Event|12|||
147486736|NCT00540449|531937908|FG001|Overall Study|Adverse Event|32|||
147486737|NCT00540449|531937907|FG000|Overall Study|Sponsor's Decision|1|||
147486738|NCT00540449|531937908|FG001|Overall Study|Sponsor's Decision|1|||
147486739|NCT00540449|531937907|FG000|Overall Study|Subject Ineligible To Continue The Trial|2|||
147486740|NCT00540449|531937908|FG001|Overall Study|Subject Ineligible To Continue The Trial|1|||
147486741|NCT00540449|531937907|FG000|Overall Study|Lost to Follow-up|19|||
147486742|NCT00540449|531937908|FG001|Overall Study|Lost to Follow-up|17|||
147486743|NCT00540449|531937907|FG000|Overall Study|Subject Non-Compliant|7|||
147486744|NCT00540449|531937908|FG001|Overall Study|Subject Non-Compliant|5|||
147486745|NCT00540449|531937907|FG000|Overall Study|Subject Reached A Virologic Endpoint|32|||
147486746|NCT00540449|531937908|FG001|Overall Study|Subject Reached A Virologic Endpoint|8|||
147486747|NCT00540449|531937907|FG000|Overall Study|Withdrawal by Subject|10|||
147486748|NCT00540449|531937908|FG001|Overall Study|Withdrawal by Subject|10|||
147486749|NCT00540449|531937907|FG000|Overall Study|Other|1|||
147486750|NCT00540449|531937908|FG001|Overall Study|Other|4|||
147486751|NCT03643432|531937909|FG000|Overall Study|Lost to Follow-up|1|||
147486752|NCT03643432|531937910|FG001|Overall Study|Lost to Follow-up|0|||
147486753|NCT00237796|531937911|FG000|Overall Study|Baseline and one other ILSS required|10|||
147486754|NCT00237796|531937912|FG001|Overall Study|Baseline and one other ILSS required|5|||
147486755|NCT02574312|531937913|FG000|3 Months Follow-up|Withdrawal by Subject|1|||
147486756|NCT02574312|531937914|FG001|3 Months Follow-up|Withdrawal by Subject|0|||
147486757|NCT05128162|531937915|FG000|Overall Study|Concerns about participant ability to follow study procedures|1|||
147486758|NCT05128162|531937915|FG000|Overall Study|Physician Decision|1|||
147486759|NCT00370149|531937916|FG000|Overall Study|Physician Decision|16|||
147486760|NCT00370149|531937917|FG001|Overall Study|Physician Decision|16|||
147486761|NCT00370149|531937916|FG000|Overall Study|Protocol Violation|1|||
147486762|NCT00370149|531937917|FG001|Overall Study|Protocol Violation|0|||
147486763|NCT00370149|531937916|FG000|Overall Study|Catheter inserted in wrong vessel-|2|||
147486764|NCT00370149|531937917|FG001|Overall Study|Catheter inserted in wrong vessel-|1|||
147486765|NCT00370149|531937916|FG000|Overall Study|Pre-existing infection|0|||
147623780|NCT03296527|532440217|FG000|Overall Study|Discontinuations due to risk of ovarian hyperstimulation syndrome [OHSS]|9|||
147623781|NCT03296527|532440218|FG001|Overall Study|Discontinuations due to risk of ovarian hyperstimulation syndrome [OHSS]|14|||
147623782|NCT03296527|532440217|FG000|Overall Study|Discontinuations due to withdrawal from trial|2|||
147623783|NCT03296527|532440218|FG001|Overall Study|Discontinuations due to withdrawal from trial|3|||
147623784|NCT03296527|532440217|FG000|Overall Study|Discontinuations due to thin endometrium or poor endometrial receptivity|0|||
147486766|NCT00370149|531937917|FG001|Overall Study|Pre-existing infection|1|||
147486767|NCT00370149|531937916|FG000|Overall Study|Antibiotic coated dressing placed|0|||
147486768|NCT00370149|531937917|FG001|Overall Study|Antibiotic coated dressing placed|1|||
147486769|NCT00620321|531939184|FG000|Overall Study|Adverse Event|1|||
147486770|NCT00620321|531939185|FG001|Overall Study|Adverse Event|1|||
147486771|NCT00620321|531939184|FG000|Overall Study|Death|1|||
147486772|NCT00620321|531939185|FG001|Overall Study|Death|1|||
147486773|NCT00620321|531939184|FG000|Overall Study|Physician Decision|0|||
147486774|NCT00620321|531939185|FG001|Overall Study|Physician Decision|7|||
147486775|NCT00620321|531939184|FG000|Overall Study|Progressive Disease|5|||
147486776|NCT00620321|531939185|FG001|Overall Study|Progressive Disease|5|||
147486777|NCT00620321|531939184|FG000|Overall Study|Sponsor Decision|0|||
147486778|NCT00620321|531939185|FG001|Overall Study|Sponsor Decision|1|||
147486779|NCT00620321|531939184|FG000|Overall Study|Withdrawal by Subject|1|||
147486780|NCT00620321|531939185|FG001|Overall Study|Withdrawal by Subject|1|||
147486781|NCT01755195|531939186|FG000|Overall Study|Participant noncompliance|2|||
147486782|NCT01755195|531939186|FG000|Overall Study|Switched to alternative treatment|4|||
147486783|NCT01755195|531939186|FG000|Overall Study|Withdrawal by Subject|1|||
147486784|NCT01755195|531939186|FG000|Overall Study|Participant refused to start treatment|1|||
147486785|NCT01755195|531939186|FG000|Overall Study|Participant has been consented for another trial|1|||
147486786|NCT01755195|531939186|FG000|Overall Study|Refused further treatment|3|||
147486787|NCT01755195|531939186|FG000|Overall Study|Complicating disease/intercurrent illness|1|||
147486788|NCT02340819|531939187|FG000|Overall Study|Adverse Event|1|||
147486789|NCT02340819|531939187|FG000|Overall Study|Withdrawal by Subject|2|||
147486790|NCT02340819|531939187|FG000|Overall Study|Discontinued with other reason|1|||
147486791|NCT02163993|531939190|FG000|Treatment Period|Adverse Event|0|||
147486792|NCT02163993|531939191|FG001|Treatment Period|Adverse Event|1|||
147486793|NCT02163993|531939192|FG002|Treatment Period|Adverse Event|0|||
147486794|NCT02163993|531939193|FG003|Treatment Period|Adverse Event|0|||
147486795|NCT02163993|531939194|FG004|Treatment Period|Adverse Event|1|||
147486796|NCT02163993|531939190|FG000|Treatment Period|Lost to Follow-up|2|||
147486797|NCT02163993|531939191|FG001|Treatment Period|Lost to Follow-up|3|||
147486798|NCT02163993|531939192|FG002|Treatment Period|Lost to Follow-up|1|||
147486799|NCT02163993|531939193|FG003|Treatment Period|Lost to Follow-up|3|||
147486800|NCT02163993|531939194|FG004|Treatment Period|Lost to Follow-up|1|||
147486801|NCT02163993|531939190|FG000|Treatment Period|Physician Decision|1|||
147486802|NCT02163993|531939191|FG001|Treatment Period|Physician Decision|0|||
147486803|NCT02163993|531939192|FG002|Treatment Period|Physician Decision|0|||
147486804|NCT02163993|531939193|FG003|Treatment Period|Physician Decision|0|||
147486805|NCT02163993|531939194|FG004|Treatment Period|Physician Decision|0|||
147486806|NCT02163993|531939190|FG000|Treatment Period|Protocol Violation|2|||
147486807|NCT02163993|531939191|FG001|Treatment Period|Protocol Violation|1|||
147486808|NCT02163993|531939192|FG002|Treatment Period|Protocol Violation|0|||
147486809|NCT02163993|531939193|FG003|Treatment Period|Protocol Violation|1|||
147486810|NCT02163993|531939194|FG004|Treatment Period|Protocol Violation|2|||
147486811|NCT02163993|531939190|FG000|Treatment Period|Withdrawal by Subject|6|||
147486812|NCT02163993|531939191|FG001|Treatment Period|Withdrawal by Subject|4|||
147486813|NCT02163993|531939192|FG002|Treatment Period|Withdrawal by Subject|1|||
147486814|NCT02163993|531939193|FG003|Treatment Period|Withdrawal by Subject|4|||
147486815|NCT02163993|531939194|FG004|Treatment Period|Withdrawal by Subject|1|||
147486816|NCT02163993|531939190|FG000|Treatment Period|Not treated|1|||
147486817|NCT02163993|531939191|FG001|Treatment Period|Not treated|0|||
147486818|NCT02163993|531939192|FG002|Treatment Period|Not treated|0|||
147486819|NCT02163993|531939193|FG003|Treatment Period|Not treated|1|||
147486820|NCT02163993|531939194|FG004|Treatment Period|Not treated|2|||
147486821|NCT02163993|531939190|FG000|Post-treatment Period|Adverse Event|0|||
147486822|NCT02163993|531939191|FG001|Post-treatment Period|Adverse Event|0|||
147486823|NCT02163993|531939192|FG002|Post-treatment Period|Adverse Event|1|||
147486824|NCT02163993|531939193|FG003|Post-treatment Period|Adverse Event|0|||
147486825|NCT02163993|531939194|FG004|Post-treatment Period|Adverse Event|0|||
147486826|NCT02163993|531939190|FG000|Post-treatment Period|Lost to Follow-up|2|||
147486827|NCT02163993|531939191|FG001|Post-treatment Period|Lost to Follow-up|2|||
147486828|NCT02163993|531939192|FG002|Post-treatment Period|Lost to Follow-up|3|||
147486829|NCT02163993|531939193|FG003|Post-treatment Period|Lost to Follow-up|1|||
147486830|NCT02163993|531939194|FG004|Post-treatment Period|Lost to Follow-up|0|||
147486831|NCT02163993|531939190|FG000|Post-treatment Period|Protocol Violation|0|||
147486832|NCT02163993|531939191|FG001|Post-treatment Period|Protocol Violation|0|||
147486833|NCT02163993|531939192|FG002|Post-treatment Period|Protocol Violation|0|||
147486834|NCT02163993|531939193|FG003|Post-treatment Period|Protocol Violation|0|||
147486835|NCT02163993|531939194|FG004|Post-treatment Period|Protocol Violation|1|||
147486836|NCT02163993|531939190|FG000|Post-treatment Period|Withdrawal by Subject|2|||
147486837|NCT02163993|531939191|FG001|Post-treatment Period|Withdrawal by Subject|4|||
147486838|NCT02163993|531939192|FG002|Post-treatment Period|Withdrawal by Subject|0|||
147486839|NCT02163993|531939193|FG003|Post-treatment Period|Withdrawal by Subject|1|||
147486840|NCT02163993|531939194|FG004|Post-treatment Period|Withdrawal by Subject|2|||
147486841|NCT01252134|531939195|FG000|Period 1, 8 Hours|Personal Reasons|0|||
147486842|NCT01252134|531939196|FG001|Period 1, 8 Hours|Personal Reasons|1|||
147486843|NCT01252134|531939197|FG002|Period 1, 8 Hours|Personal Reasons|1|||
147486844|NCT01252134|531939198|FG003|Period 1, 8 Hours|Personal Reasons|0|||
147623785|NCT03296527|532440218|FG001|Overall Study|Discontinuations due to thin endometrium or poor endometrial receptivity|2|||
147623786|NCT03296527|532440217|FG000|Overall Study|Discontinuation due to liquid in uterus|1|||
147486845|NCT01252134|531939199|FG004|Period 1, 8 Hours|Personal Reasons|0|||
147486846|NCT01252134|531939200|FG005|Period 1, 8 Hours|Personal Reasons|0|||
147486847|NCT02273050|531939202|FG000|Overall Study|Adverse Event|4|||
147486848|NCT02273050|531939203|FG001|Overall Study|Adverse Event|3|||
147486849|NCT02273050|531939204|FG002|Overall Study|Adverse Event|3|||
147486850|NCT02273050|531939202|FG000|Overall Study|Death|0|||
147486851|NCT02273050|531939203|FG001|Overall Study|Death|0|||
147486852|NCT02273050|531939204|FG002|Overall Study|Death|1|||
147486853|NCT02273050|531939202|FG000|Overall Study|Dev. of study spec. withdrawal criteria|0|||
147486854|NCT02273050|531939203|FG001|Overall Study|Dev. of study spec. withdrawal criteria|1|||
147486855|NCT02273050|531939204|FG002|Overall Study|Dev. of study spec. withdrawal criteria|1|||
147486856|NCT02273050|531939202|FG000|Overall Study|Lack of Efficacy|0|||
147486857|NCT02273050|531939203|FG001|Overall Study|Lack of Efficacy|1|||
147486858|NCT02273050|531939204|FG002|Overall Study|Lack of Efficacy|1|||
147486859|NCT02273050|531939202|FG000|Overall Study|Withdrawal by Subject|17|||
147486860|NCT02273050|531939203|FG001|Overall Study|Withdrawal by Subject|14|||
147486861|NCT02273050|531939204|FG002|Overall Study|Withdrawal by Subject|16|||
147486862|NCT02273050|531939202|FG000|Overall Study|Lost to Follow-up|0|||
147486863|NCT02273050|531939203|FG001|Overall Study|Lost to Follow-up|2|||
147486864|NCT02273050|531939204|FG002|Overall Study|Lost to Follow-up|3|||
147486865|NCT02273050|531939202|FG000|Overall Study|Protocol Violation|3|||
147486866|NCT02273050|531939203|FG001|Overall Study|Protocol Violation|1|||
147486867|NCT02273050|531939204|FG002|Overall Study|Protocol Violation|4|||
147486868|NCT00718419|531939205|FG000|Overall Study|Adverse Event|2|||
147486869|NCT00718419|531939206|FG001|Overall Study|Adverse Event|1|||
147486870|NCT00718419|531939205|FG000|Overall Study|Physician Decision|1|||
147486871|NCT00718419|531939206|FG001|Overall Study|Physician Decision|6|||
147486872|NCT00718419|531939205|FG000|Overall Study|Sponsor decision|0|||
147486873|NCT00718419|531939206|FG001|Overall Study|Sponsor decision|1|||
147486874|NCT00718419|531939205|FG000|Overall Study|Withdrawal by Subject|0|||
147486875|NCT00718419|531939206|FG001|Overall Study|Withdrawal by Subject|5|||
147486876|NCT00718419|531939205|FG000|Overall Study|Progressive Disease|7|||
147486877|NCT00718419|531939206|FG001|Overall Study|Progressive Disease|25|||
147486878|NCT00718419|531939205|FG000|Overall Study|Death Due to Progressive Disease|2|||
147486879|NCT00718419|531939206|FG001|Overall Study|Death Due to Progressive Disease|0|||
147486880|NCT00718419|531939205|FG000|Overall Study|Death Due to Study Drug Related|0|||
147486881|NCT00718419|531939206|FG001|Overall Study|Death Due to Study Drug Related|1|||
147486882|NCT00718419|531939205|FG000|Overall Study|Death Due to Adverse Events|1|||
147486883|NCT00718419|531939206|FG001|Overall Study|Death Due to Adverse Events|0|||
147486884|NCT01675531|531939207|FG000|Overall Study|Adverse Event|9|||
147486885|NCT01675531|531939207|FG000|Overall Study|Withdrawal by Subject|7|||
147486886|NCT01675531|531939207|FG000|Overall Study|Lack of Efficacy|1|||
147486887|NCT01675531|531939207|FG000|Overall Study|Protocol Violation|8|||
147486888|NCT00726323|531939208|FG000|Overall Study|Withdrawal by Subject|3|||
147486889|NCT00726323|531939209|FG001|Overall Study|Withdrawal by Subject|1|||
147486890|NCT00726323|531939208|FG000|Overall Study|Physician Decision|1|||
147486891|NCT00726323|531939209|FG001|Overall Study|Physician Decision|0|||
147486892|NCT00726323|531939208|FG000|Overall Study|Progressive disease|23|||
147486893|NCT00726323|531939209|FG001|Overall Study|Progressive disease|16|||
147486894|NCT00726323|531939208|FG000|Overall Study|Clinical progression|0|||
147486895|NCT00726323|531939209|FG001|Overall Study|Clinical progression|3|||
147486896|NCT00726323|531939208|FG000|Overall Study|Adverse Event|9|||
147486897|NCT00726323|531939209|FG001|Overall Study|Adverse Event|9|||
147486898|NCT00726323|531939208|FG000|Overall Study|Death|1|||
147486899|NCT00726323|531939209|FG001|Overall Study|Death|0|||
147486900|NCT00726323|531939208|FG000|Overall Study|Participant wished to discontinue|0|||
147486901|NCT00726323|531939209|FG001|Overall Study|Participant wished to discontinue|1|||
147486902|NCT00726323|531939208|FG000|Overall Study|Metastatic lesions inferred cyst|0|||
147486903|NCT00726323|531939209|FG001|Overall Study|Metastatic lesions inferred cyst|1|||
147486904|NCT00972478|531939219|FG000|Overall Study|Adverse Event|3|||
147486905|NCT00972478|531939220|FG001|Overall Study|Adverse Event|16|||
147486906|NCT00972478|531939219|FG000|Overall Study|Withdrawal by Subject|1|||
147486907|NCT00972478|531939220|FG001|Overall Study|Withdrawal by Subject|8|||
147486908|NCT00972478|531939219|FG000|Overall Study|Progression/Relapse|0|||
147486909|NCT00972478|531939220|FG001|Overall Study|Progression/Relapse|2|||
147486910|NCT00972478|531939219|FG000|Overall Study|Death|0|||
147486911|NCT00972478|531939220|FG001|Overall Study|Death|2|||
147486912|NCT00972478|531939219|FG000|Overall Study|Not protocol specified|1|||
147486913|NCT00972478|531939220|FG001|Overall Study|Not protocol specified|1|||
147486914|NCT00972478|531939219|FG000|Overall Study|Ineligible|1|||
147486915|NCT00972478|531939220|FG001|Overall Study|Ineligible|7|||
147486916|NCT00972478|531939219|FG000|Overall Study|Not start protocol treatment|1|||
147623787|NCT03296527|532440218|FG001|Overall Study|Discontinuation due to liquid in uterus|0|||
147667768|NCT01326871|532608146|FG000|Overall Study|SAE and death|0|||
147486917|NCT00972478|531939220|FG001|Overall Study|Not start protocol treatment|2|||
147486918|NCT02561000|531939221|FG000|Overall Study|Withdrawal by Subject|2|||
147486919|NCT02561000|531939222|FG001|Overall Study|Withdrawal by Subject|3|||
147486920|NCT02561000|531939223|FG002|Overall Study|Withdrawal by Subject|0|||
147486921|NCT02561000|531939221|FG000|Overall Study|Adverse Event|0|||
147486922|NCT02561000|531939222|FG001|Overall Study|Adverse Event|1|||
147486923|NCT02561000|531939223|FG002|Overall Study|Adverse Event|0|||
147486924|NCT01234402|531939224|FG000|Overall Study|Lost to Follow-up|0|||
147667769|NCT01326871|532608147|FG001|Overall Study|SAE and death|2|||
147667770|NCT01326871|532608148|FG002|Overall Study|SAE and death|0|||
147667771|NCT01326871|532608146|FG000|Overall Study|Physician decision and decreased performance status|0|||
147667772|NCT01326871|532608147|FG001|Overall Study|Physician decision and decreased performance status|1|||
147667773|NCT01326871|532608148|FG002|Overall Study|Physician decision and decreased performance status|0|||
147486925|NCT01234402|531939225|FG001|Overall Study|Lost to Follow-up|1|||
147486926|NCT01234402|531939226|FG002|Overall Study|Lost to Follow-up|3|||
147486927|NCT01234402|531939224|FG000|Overall Study|Withdrawal by Subject|1|||
147486928|NCT01234402|531939225|FG001|Overall Study|Withdrawal by Subject|3|||
147486929|NCT01234402|531939226|FG002|Overall Study|Withdrawal by Subject|4|||
147486930|NCT01234402|531939224|FG000|Overall Study|Never treated: Death|0|||
147486931|NCT01234402|531939225|FG001|Overall Study|Never treated: Death|0|||
147486932|NCT01234402|531939226|FG002|Overall Study|Never treated: Death|1|||
147486933|NCT01234402|531939224|FG000|Overall Study|Never treated: Withdrawal By Subject|0|||
147486934|NCT01234402|531939225|FG001|Overall Study|Never treated: Withdrawal By Subject|1|||
147486935|NCT01234402|531939226|FG002|Overall Study|Never treated: Withdrawal By Subject|0|||
147486936|NCT01234402|531939224|FG000|Overall Study|Never treated: Insurance Denied Xeloda|0|||
147486937|NCT01234402|531939225|FG001|Overall Study|Never treated: Insurance Denied Xeloda|1|||
147486938|NCT01234402|531939226|FG002|Overall Study|Never treated: Insurance Denied Xeloda|0|||
147486939|NCT00365716|531939227|FG000|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|1|||
147486940|NCT00365716|531939228|FG001|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|2|||
147486941|NCT00365716|531939229|FG002|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
147486942|NCT00365716|531939230|FG003|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
147486943|NCT00365716|531939231|FG004|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
147486944|NCT00365716|531939232|FG005|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
147486945|NCT00365716|531939233|FG006|Base Study (Day 1 to Month 7)|Randomized Not Vaccinated|0|||
147486946|NCT00365716|531939227|FG000|Base Study (Day 1 to Month 7)|Adverse Event|0|||
147486947|NCT00365716|531939228|FG001|Base Study (Day 1 to Month 7)|Adverse Event|2|||
147486948|NCT00365716|531939229|FG002|Base Study (Day 1 to Month 7)|Adverse Event|0|||
147486949|NCT00365716|531939230|FG003|Base Study (Day 1 to Month 7)|Adverse Event|0|||
147486950|NCT00365716|531939231|FG004|Base Study (Day 1 to Month 7)|Adverse Event|1|||
147486951|NCT00365716|531939232|FG005|Base Study (Day 1 to Month 7)|Adverse Event|0|||
147486952|NCT00365716|531939233|FG006|Base Study (Day 1 to Month 7)|Adverse Event|0|||
147486953|NCT00365716|531939227|FG000|Base Study (Day 1 to Month 7)|Lost to Follow-up|4|||
147486954|NCT00365716|531939228|FG001|Base Study (Day 1 to Month 7)|Lost to Follow-up|6|||
147486955|NCT00365716|531939229|FG002|Base Study (Day 1 to Month 7)|Lost to Follow-up|6|||
147486956|NCT00365716|531939230|FG003|Base Study (Day 1 to Month 7)|Lost to Follow-up|4|||
147486957|NCT00365716|531939231|FG004|Base Study (Day 1 to Month 7)|Lost to Follow-up|0|||
147486958|NCT00365716|531939232|FG005|Base Study (Day 1 to Month 7)|Lost to Follow-up|0|||
147486959|NCT00365716|531939233|FG006|Base Study (Day 1 to Month 7)|Lost to Follow-up|0|||
147486960|NCT00365716|531939227|FG000|Base Study (Day 1 to Month 7)|Other|0|||
147486961|NCT00365716|531939228|FG001|Base Study (Day 1 to Month 7)|Other|1|||
147486962|NCT00365716|531939229|FG002|Base Study (Day 1 to Month 7)|Other|0|||
147486963|NCT00365716|531939230|FG003|Base Study (Day 1 to Month 7)|Other|0|||
147486964|NCT00365716|531939231|FG004|Base Study (Day 1 to Month 7)|Other|0|||
147486965|NCT00365716|531939232|FG005|Base Study (Day 1 to Month 7)|Other|0|||
147486966|NCT00365716|531939233|FG006|Base Study (Day 1 to Month 7)|Other|0|||
147486967|NCT00365716|531939227|FG000|Base Study (Day 1 to Month 7)|Pregnancy|3|||
147486968|NCT00365716|531939228|FG001|Base Study (Day 1 to Month 7)|Pregnancy|2|||
147486969|NCT00365716|531939229|FG002|Base Study (Day 1 to Month 7)|Pregnancy|3|||
147486970|NCT00365716|531939230|FG003|Base Study (Day 1 to Month 7)|Pregnancy|1|||
147486971|NCT00365716|531939231|FG004|Base Study (Day 1 to Month 7)|Pregnancy|1|||
147486972|NCT00365716|531939232|FG005|Base Study (Day 1 to Month 7)|Pregnancy|0|||
147486973|NCT00365716|531939233|FG006|Base Study (Day 1 to Month 7)|Pregnancy|0|||
147486974|NCT00365716|531939227|FG000|Base Study (Day 1 to Month 7)|Protocol Violation|1|||
147486975|NCT00365716|531939228|FG001|Base Study (Day 1 to Month 7)|Protocol Violation|2|||
147486976|NCT00365716|531939229|FG002|Base Study (Day 1 to Month 7)|Protocol Violation|0|||
147486977|NCT00365716|531939230|FG003|Base Study (Day 1 to Month 7)|Protocol Violation|1|||
147486978|NCT00365716|531939231|FG004|Base Study (Day 1 to Month 7)|Protocol Violation|2|||
147486979|NCT00365716|531939232|FG005|Base Study (Day 1 to Month 7)|Protocol Violation|0|||
147486980|NCT00365716|531939233|FG006|Base Study (Day 1 to Month 7)|Protocol Violation|0|||
147486981|NCT00365716|531939227|FG000|Base Study (Day 1 to Month 7)|Withdrawal by Subject|12|||
147486982|NCT00365716|531939228|FG001|Base Study (Day 1 to Month 7)|Withdrawal by Subject|9|||
147486983|NCT00365716|531939229|FG002|Base Study (Day 1 to Month 7)|Withdrawal by Subject|12|||
147486984|NCT00365716|531939230|FG003|Base Study (Day 1 to Month 7)|Withdrawal by Subject|4|||
147486985|NCT00365716|531939231|FG004|Base Study (Day 1 to Month 7)|Withdrawal by Subject|3|||
147486986|NCT00365716|531939232|FG005|Base Study (Day 1 to Month 7)|Withdrawal by Subject|0|||
147486987|NCT00365716|531939233|FG006|Base Study (Day 1 to Month 7)|Withdrawal by Subject|0|||
147486988|NCT00365716|531939227|FG000|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|114|||
147486989|NCT00365716|531939228|FG001|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0|||
147486990|NCT00365716|531939229|FG002|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0|||
147486991|NCT00365716|531939230|FG003|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|69|||
147486992|NCT00365716|531939231|FG004|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|75|||
147486993|NCT00365716|531939232|FG005|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0|||
147486994|NCT00365716|531939233|FG006|Long Term Follow-up (Month 7 toMonth 36)|Proceeded to Extension 1|0|||
147486995|NCT00365716|531939227|FG000|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|6|||
147486996|NCT00365716|531939228|FG001|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|8|||
147486997|NCT00365716|531939229|FG002|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|5|||
147486998|NCT00365716|531939230|FG003|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|4|||
147486999|NCT00365716|531939231|FG004|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|3|||
147487000|NCT00365716|531939232|FG005|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|0|||
147487001|NCT00365716|531939233|FG006|Long Term Follow-up (Month 7 toMonth 36)|Lost to Follow-up|0|||
147487002|NCT00365716|531939227|FG000|Long Term Follow-up (Month 7 toMonth 36)|Moved|3|||
147487003|NCT00365716|531939228|FG001|Long Term Follow-up (Month 7 toMonth 36)|Moved|2|||
147487004|NCT00365716|531939229|FG002|Long Term Follow-up (Month 7 toMonth 36)|Moved|1|||
147487005|NCT00365716|531939230|FG003|Long Term Follow-up (Month 7 toMonth 36)|Moved|2|||
147487006|NCT00365716|531939231|FG004|Long Term Follow-up (Month 7 toMonth 36)|Moved|0|||
147487007|NCT00365716|531939232|FG005|Long Term Follow-up (Month 7 toMonth 36)|Moved|0|||
147487008|NCT00365716|531939233|FG006|Long Term Follow-up (Month 7 toMonth 36)|Moved|0|||
147487009|NCT00365716|531939227|FG000|Long Term Follow-up (Month 7 toMonth 36)|Other|2|||
147487010|NCT00365716|531939228|FG001|Long Term Follow-up (Month 7 toMonth 36)|Other|0|||
147487011|NCT00365716|531939229|FG002|Long Term Follow-up (Month 7 toMonth 36)|Other|0|||
147487012|NCT00365716|531939230|FG003|Long Term Follow-up (Month 7 toMonth 36)|Other|0|||
147487013|NCT00365716|531939231|FG004|Long Term Follow-up (Month 7 toMonth 36)|Other|1|||
147487014|NCT00365716|531939232|FG005|Long Term Follow-up (Month 7 toMonth 36)|Other|0|||
147487015|NCT00365716|531939233|FG006|Long Term Follow-up (Month 7 toMonth 36)|Other|0|||
147487016|NCT00365716|531939227|FG000|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0|||
147487017|NCT00365716|531939228|FG001|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|1|||
147487018|NCT00365716|531939229|FG002|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|1|||
147487019|NCT00365716|531939230|FG003|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0|||
147487020|NCT00365716|531939231|FG004|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0|||
147487021|NCT00365716|531939232|FG005|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0|||
147487022|NCT00365716|531939233|FG006|Long Term Follow-up (Month 7 toMonth 36)|Protocol Violation|0|||
147487023|NCT00365716|531939227|FG000|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|7|||
147487024|NCT00365716|531939228|FG001|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|4|||
147487025|NCT00365716|531939229|FG002|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|13|||
147487026|NCT00365716|531939230|FG003|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|4|||
147487027|NCT00365716|531939231|FG004|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|3|||
147487028|NCT00365716|531939232|FG005|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|0|||
147487029|NCT00365716|531939233|FG006|Long Term Follow-up (Month 7 toMonth 36)|Withdrawal by Subject|0|||
147487030|NCT00365716|531939227|FG000|Extension 1|Lost to Follow-up|0|||
147487031|NCT00365716|531939228|FG001|Extension 1|Lost to Follow-up|0|||
147487032|NCT00365716|531939229|FG002|Extension 1|Lost to Follow-up|0|||
147487033|NCT00365716|531939230|FG003|Extension 1|Lost to Follow-up|0|||
147487034|NCT00365716|531939231|FG004|Extension 1|Lost to Follow-up|0|||
147487035|NCT00365716|531939232|FG005|Extension 1|Lost to Follow-up|1|||
147487036|NCT00365716|531939233|FG006|Extension 1|Lost to Follow-up|0|||
147487037|NCT00365716|531939227|FG000|Extension 1|Other|0|||
147487038|NCT00365716|531939228|FG001|Extension 1|Other|0|||
147487039|NCT00365716|531939229|FG002|Extension 1|Other|0|||
147487040|NCT00365716|531939230|FG003|Extension 1|Other|0|||
147487041|NCT00365716|531939231|FG004|Extension 1|Other|0|||
147487042|NCT00365716|531939232|FG005|Extension 1|Other|9|||
147487043|NCT00365716|531939233|FG006|Extension 1|Other|0|||
147487044|NCT00365716|531939227|FG000|Extension 1|Moved|0|||
147487045|NCT00365716|531939228|FG001|Extension 1|Moved|0|||
147487046|NCT00365716|531939229|FG002|Extension 1|Moved|0|||
147487047|NCT00365716|531939230|FG003|Extension 1|Moved|0|||
147487048|NCT00365716|531939231|FG004|Extension 1|Moved|0|||
147487049|NCT00365716|531939232|FG005|Extension 1|Moved|4|||
147487050|NCT00365716|531939233|FG006|Extension 1|Moved|0|||
147487051|NCT00365716|531939227|FG000|Extension 1|Withdrawal by Subject|0|||
147623788|NCT03296527|532440217|FG000|Overall Study|Discontinuation due to risk of Human Immunodeficiency Virus|1|||
147623789|NCT03296527|532440218|FG001|Overall Study|Discontinuation due to risk of Human Immunodeficiency Virus|0|||
147623790|NCT01597973|532440219|FG000|Overall Study|Found ineligible before study medication started|4|||
147623791|NCT01597973|532440220|FG001|Overall Study|Found ineligible before study medication started|2|||
147623792|NCT01597973|532440219|FG000|Overall Study|Eligible pathogen not confirmed|14|||
147623793|NCT01597973|532440220|FG001|Overall Study|Eligible pathogen not confirmed|15|||
147487052|NCT00365716|531939228|FG001|Extension 1|Withdrawal by Subject|0|||
147487053|NCT00365716|531939229|FG002|Extension 1|Withdrawal by Subject|0|||
147487054|NCT00365716|531939230|FG003|Extension 1|Withdrawal by Subject|0|||
147487055|NCT00365716|531939231|FG004|Extension 1|Withdrawal by Subject|0|||
147487056|NCT00365716|531939232|FG005|Extension 1|Withdrawal by Subject|3|||
147487057|NCT00365716|531939233|FG006|Extension 1|Withdrawal by Subject|0|||
147487058|NCT00365716|531939227|FG000|Extension 1|Pregnancy|0|||
147487059|NCT00365716|531939228|FG001|Extension 1|Pregnancy|0|||
147487060|NCT00365716|531939229|FG002|Extension 1|Pregnancy|0|||
147487061|NCT00365716|531939230|FG003|Extension 1|Pregnancy|0|||
147487062|NCT00365716|531939231|FG004|Extension 1|Pregnancy|0|||
147487063|NCT00365716|531939232|FG005|Extension 1|Pregnancy|4|||
147487064|NCT00365716|531939233|FG006|Extension 1|Pregnancy|0|||
147487065|NCT00365716|531939227|FG000|Extension 1|Protocol Violation|0|||
147487066|NCT00365716|531939228|FG001|Extension 1|Protocol Violation|0|||
147487067|NCT00365716|531939229|FG002|Extension 1|Protocol Violation|0|||
147487068|NCT00365716|531939230|FG003|Extension 1|Protocol Violation|0|||
147487069|NCT00365716|531939231|FG004|Extension 1|Protocol Violation|0|||
147487070|NCT00365716|531939232|FG005|Extension 1|Protocol Violation|1|||
147487071|NCT00365716|531939233|FG006|Extension 1|Protocol Violation|0|||
147487072|NCT00365716|531939227|FG000|Extension 2|Lost to Follow-up|0|||
147487073|NCT00365716|531939228|FG001|Extension 2|Lost to Follow-up|0|||
147487074|NCT00365716|531939229|FG002|Extension 2|Lost to Follow-up|0|||
147487075|NCT00365716|531939230|FG003|Extension 2|Lost to Follow-up|0|||
147487076|NCT00365716|531939231|FG004|Extension 2|Lost to Follow-up|0|||
147487077|NCT00365716|531939232|FG005|Extension 2|Lost to Follow-up|0|||
147487078|NCT00365716|531939233|FG006|Extension 2|Lost to Follow-up|2|||
147487079|NCT00365716|531939227|FG000|Extension 2|Other|0|||
147487080|NCT00365716|531939228|FG001|Extension 2|Other|0|||
147487081|NCT00365716|531939229|FG002|Extension 2|Other|0|||
147487082|NCT00365716|531939230|FG003|Extension 2|Other|0|||
147487083|NCT00365716|531939231|FG004|Extension 2|Other|0|||
147487084|NCT00365716|531939232|FG005|Extension 2|Other|0|||
147487085|NCT00365716|531939233|FG006|Extension 2|Other|3|||
147487086|NCT00365716|531939227|FG000|Extension 2|Withdrawal by Subject|0|||
147487087|NCT00365716|531939228|FG001|Extension 2|Withdrawal by Subject|0|||
147487088|NCT00365716|531939229|FG002|Extension 2|Withdrawal by Subject|0|||
147487089|NCT00365716|531939230|FG003|Extension 2|Withdrawal by Subject|0|||
147487090|NCT00365716|531939231|FG004|Extension 2|Withdrawal by Subject|0|||
147487091|NCT00365716|531939232|FG005|Extension 2|Withdrawal by Subject|0|||
147487092|NCT00365716|531939233|FG006|Extension 2|Withdrawal by Subject|5|||
147487093|NCT02280291|531939234|FG000|Overall Study|Lost to Follow-up|2|||
147487094|NCT02280291|531939235|FG001|Overall Study|Lost to Follow-up|1|||
147487095|NCT02280291|531939236|FG002|Overall Study|Lost to Follow-up|3|||
147487096|NCT02280291|531939237|FG003|Overall Study|Lost to Follow-up|8|||
147487097|NCT02280291|531939234|FG000|Overall Study|Protocol Violation|1|||
147487098|NCT02280291|531939235|FG001|Overall Study|Protocol Violation|0|||
147487099|NCT02280291|531939236|FG002|Overall Study|Protocol Violation|0|||
147487100|NCT02280291|531939237|FG003|Overall Study|Protocol Violation|0|||
147487101|NCT02280291|531939234|FG000|Overall Study|Other|1|||
147487102|NCT02280291|531939235|FG001|Overall Study|Other|1|||
147487103|NCT02280291|531939236|FG002|Overall Study|Other|0|||
147487104|NCT02280291|531939237|FG003|Overall Study|Other|0|||
147487105|NCT02918266|531939239|FG000|Part 2: Intervention Period 1 (2 Days)|Study termination|0|||
147487106|NCT02918266|531939240|FG001|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
147487107|NCT02918266|531939241|FG002|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
147487108|NCT02918266|531939242|FG003|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
147487109|NCT02918266|531939243|FG004|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
147487110|NCT02918266|531939244|FG005|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
147487111|NCT02918266|531939245|FG006|Part 2: Intervention Period 1 (2 Days)|Study termination|2|||
147487112|NCT02918266|531939246|FG007|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
147487113|NCT02918266|531939247|FG008|Part 2: Intervention Period 1 (2 Days)|Study termination|2|||
147487114|NCT02918266|531939248|FG009|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
147487115|NCT02918266|531939249|FG010|Part 2: Intervention Period 1 (2 Days)|Study termination|1|||
147487116|NCT00358917|531939252|FG000|Overall Study|Adverse Event|14|||
147487117|NCT00358917|531939253|FG001|Overall Study|Adverse Event|21|||
147487118|NCT00358917|531939252|FG000|Overall Study|Withdrawal by Subject|5|||
147487119|NCT00358917|531939253|FG001|Overall Study|Withdrawal by Subject|7|||
147487120|NCT00358917|531939252|FG000|Overall Study|Lost to Follow-up|20|||
147487121|NCT00358917|531939253|FG001|Overall Study|Lost to Follow-up|17|||
147487122|NCT00358917|531939252|FG000|Overall Study|Noncompliance|12|||
147487123|NCT00358917|531939253|FG001|Overall Study|Noncompliance|11|||
147487124|NCT00358917|531939252|FG000|Overall Study|Death|2|||
147487125|NCT00358917|531939253|FG001|Overall Study|Death|3|||
147487126|NCT00358917|531939252|FG000|Overall Study|Virologic failure|11|||
147487127|NCT00358917|531939253|FG001|Overall Study|Virologic failure|8|||
147487128|NCT00358917|531939252|FG000|Overall Study|Unable to Continue Participation|2|||
147487129|NCT00358917|531939253|FG001|Overall Study|Unable to Continue Participation|2|||
147487130|NCT01757704|531939259|FG000|Overall Study|Protocol Violation|1|||
147487131|NCT01757704|531939260|FG001|Overall Study|Protocol Violation|3|||
147487132|NCT02749721|531939261|FG000|Screening|Withdrawal by Subject|1|||
147487133|NCT02749721|531939261|FG000|Screening|Lost to Follow-up|2|||
147487134|NCT02749721|531939261|FG000|Screening|Protocol Violation|3|||
147487135|NCT02749721|531939261|FG000|8-week Open-Label Treatment Phase|Lost to Follow-up|2|||
147487136|NCT02749721|531939261|FG000|8-week Open-Label Treatment Phase|Withdrawal by Subject|1|||
147487137|NCT02691247|531939262|FG000|Overall Study|Withdrawal by Subject|1|||
147487138|NCT02691247|531939263|FG001|Overall Study|Withdrawal by Subject|2|||
147487139|NCT02691247|531939264|FG002|Overall Study|Withdrawal by Subject|2|||
147487140|NCT02691247|531939262|FG000|Overall Study|Lost to Follow-up|2|||
147487141|NCT02691247|531939263|FG001|Overall Study|Lost to Follow-up|0|||
147487142|NCT02691247|531939264|FG002|Overall Study|Lost to Follow-up|1|||
147487143|NCT02552355|531939265|FG000|Overall Study|Adverse Event|0|||
147487144|NCT02552355|531939266|FG001|Overall Study|Adverse Event|2|||
147487145|NCT02552355|531939267|FG002|Overall Study|Adverse Event|2|||
147487146|NCT02552355|531939268|FG003|Overall Study|Adverse Event|0|||
147487147|NCT02552355|531939265|FG000|Overall Study|Withdrawal by Subject|0|||
147487148|NCT02552355|531939266|FG001|Overall Study|Withdrawal by Subject|0|||
147487149|NCT02552355|531939267|FG002|Overall Study|Withdrawal by Subject|0|||
147487150|NCT02552355|531939268|FG003|Overall Study|Withdrawal by Subject|1|||
147487151|NCT01519245|531939269|FG000|Overall Study|Met exclusion criteria, not analysed|1|||
147487152|NCT01519245|531939270|FG001|Overall Study|Met exclusion criteria, not analysed|2|||
147487153|NCT00803244|531939273|FG000|Overall Study|Adverse Event|1|||
147487154|NCT00803244|531939274|FG001|Overall Study|Adverse Event|2|||
147487155|NCT00803244|531939273|FG000|Overall Study|Withdrawal by Subject|2|||
147487156|NCT00803244|531939274|FG001|Overall Study|Withdrawal by Subject|3|||
147487157|NCT00803244|531939273|FG000|Overall Study|Any other reason not above-mentioned|4|||
147487158|NCT00803244|531939274|FG001|Overall Study|Any other reason not above-mentioned|10|||
147487159|NCT03321929|531939275|FG000|Overall Study|Withdrawn prior to LUM Imaging Procedure completed|4|||
147487160|NCT00616239|531939277|FG000|Overall Study|Withdrawal by Subject|2|||
147487161|NCT01052012|531939278|FG000|Overall Study|Not treated|2|||
147487162|NCT01052012|531939279|FG001|Overall Study|Not treated|5|||
147487163|NCT01052012|531939280|FG002|Overall Study|Not treated|0|||
147487164|NCT01052012|531939281|FG003|Overall Study|Not treated|0|||
147487165|NCT01052012|531939282|FG004|Overall Study|Not treated|11|||
147487166|NCT01052012|531939283|FG005|Overall Study|Not treated|8|||
147487167|NCT01052012|531939278|FG000|Overall Study|Adverse Event|1|||
147487168|NCT01052012|531939279|FG001|Overall Study|Adverse Event|0|||
147487169|NCT01052012|531939280|FG002|Overall Study|Adverse Event|0|||
147487170|NCT01052012|531939281|FG003|Overall Study|Adverse Event|1|||
147487171|NCT01052012|531939282|FG004|Overall Study|Adverse Event|0|||
147487172|NCT01052012|531939283|FG005|Overall Study|Adverse Event|0|||
147487173|NCT01052012|531939278|FG000|Overall Study|Lost to Follow-up|0|||
147487174|NCT01052012|531939279|FG001|Overall Study|Lost to Follow-up|0|||
147487175|NCT01052012|531939280|FG002|Overall Study|Lost to Follow-up|0|||
147487176|NCT01052012|531939281|FG003|Overall Study|Lost to Follow-up|0|||
147487177|NCT01052012|531939282|FG004|Overall Study|Lost to Follow-up|1|||
147487178|NCT01052012|531939283|FG005|Overall Study|Lost to Follow-up|0|||
147487179|NCT01052012|531939278|FG000|Overall Study|Withdrawal by Subject|1|||
147487180|NCT01052012|531939279|FG001|Overall Study|Withdrawal by Subject|1|||
147487181|NCT01052012|531939280|FG002|Overall Study|Withdrawal by Subject|0|||
147487182|NCT01052012|531939281|FG003|Overall Study|Withdrawal by Subject|0|||
147487183|NCT01052012|531939282|FG004|Overall Study|Withdrawal by Subject|3|||
147487184|NCT01052012|531939283|FG005|Overall Study|Withdrawal by Subject|1|||
147487185|NCT01052012|531939278|FG000|Overall Study|Physician Decision|0|||
147487186|NCT01052012|531939279|FG001|Overall Study|Physician Decision|0|||
147487187|NCT01052012|531939280|FG002|Overall Study|Physician Decision|0|||
147487188|NCT01052012|531939281|FG003|Overall Study|Physician Decision|0|||
147487189|NCT01052012|531939282|FG004|Overall Study|Physician Decision|0|||
147487190|NCT01052012|531939283|FG005|Overall Study|Physician Decision|1|||
147487191|NCT01052012|531939278|FG000|Overall Study|Other|0|||
147487192|NCT01052012|531939279|FG001|Overall Study|Other|0|||
147487193|NCT01052012|531939280|FG002|Overall Study|Other|0|||
147487194|NCT01052012|531939281|FG003|Overall Study|Other|0|||
147487195|NCT01052012|531939282|FG004|Overall Study|Other|1|||
147487196|NCT01052012|531939283|FG005|Overall Study|Other|0|||
147487197|NCT02873715|531939284|FG000|Overall Study|Lost to Follow-up|84|||
147487198|NCT02873715|531939285|FG001|Overall Study|Lost to Follow-up|94|||
147487199|NCT02873715|531939284|FG000|Overall Study|Withdrawal by Subject|7|||
147487200|NCT02873715|531939285|FG001|Overall Study|Withdrawal by Subject|26|||
147487201|NCT01555463|531939292|FG000|Treatment|Adverse Event|6|||
147487202|NCT01555463|531939293|FG001|Treatment|Adverse Event|12|||
147487203|NCT01555463|531939292|FG000|Treatment|Withdrawal by Subject|24|||
147487204|NCT01555463|531939293|FG001|Treatment|Withdrawal by Subject|36|||
147487205|NCT01555463|531939292|FG000|Treatment|Lost to Follow-up|28|||
147487206|NCT01555463|531939293|FG001|Treatment|Lost to Follow-up|23|||
147487207|NCT01555463|531939292|FG000|Treatment|Protocol Violation|4|||
147487208|NCT01555463|531939293|FG001|Treatment|Protocol Violation|5|||
147487209|NCT01555463|531939292|FG000|Treatment|Other reason|2|||
147487210|NCT01555463|531939293|FG001|Treatment|Other reason|3|||
147487211|NCT01555463|531939292|FG000|Follow up|Adverse Event|2|||
147487212|NCT01555463|531939293|FG001|Follow up|Adverse Event|5|||
147487213|NCT01555463|531939292|FG000|Follow up|Death|0|||
147487214|NCT01555463|531939293|FG001|Follow up|Death|1|||
147623794|NCT01597973|532440219|FG000|Overall Study|LAR not authorized to consent|0|||
147487215|NCT01555463|531939292|FG000|Follow up|Withdrawal by Subject|22|||
147487216|NCT01555463|531939293|FG001|Follow up|Withdrawal by Subject|22|||
147487217|NCT01555463|531939292|FG000|Follow up|Lost to Follow-up|9|||
147487218|NCT01555463|531939293|FG001|Follow up|Lost to Follow-up|10|||
147487219|NCT01555463|531939292|FG000|Follow up|Protocol Violation|2|||
147487220|NCT01555463|531939293|FG001|Follow up|Protocol Violation|4|||
147487221|NCT01555463|531939292|FG000|Follow up|Other reason|3|||
147487222|NCT01555463|531939293|FG001|Follow up|Other reason|3|||
147487223|NCT04333433|531939294|FG000|Overall Study|Withdrawal by Subject|6|||
147487224|NCT04333433|531939295|FG001|Overall Study|Withdrawal by Subject|3|||
147487225|NCT04333433|531939294|FG000|Overall Study|Death|3|||
147487226|NCT04333433|531939295|FG001|Overall Study|Death|0|||
147487227|NCT04333433|531939294|FG000|Overall Study|Lost to Follow-up|6|||
147487228|NCT04333433|531939295|FG001|Overall Study|Lost to Follow-up|1|||
147487229|NCT04333433|531939294|FG000|Overall Study|2 PRESERFLO Early Exit 1 PRESERFLO PI decision 1 PRESERFLO Study Exit|4|||
147487230|NCT04333433|531939295|FG001|Overall Study|2 PRESERFLO Early Exit 1 PRESERFLO PI decision 1 PRESERFLO Study Exit|0|||
147487231|NCT02026271|531939296|FG000|Overall Study|Adverse Event|2|||
147487232|NCT02026271|531939297|FG001|Overall Study|Adverse Event|3|||
147487233|NCT02026271|531939298|FG002|Overall Study|Adverse Event|2|||
147487234|NCT02026271|531939299|FG003|Overall Study|Adverse Event|3|||
147487235|NCT02026271|531939300|FG004|Overall Study|Adverse Event|0|||
147487236|NCT02026271|531939296|FG000|Overall Study|Withdrawal by Subject|0|||
147487237|NCT02026271|531939297|FG001|Overall Study|Withdrawal by Subject|0|||
147487238|NCT02026271|531939298|FG002|Overall Study|Withdrawal by Subject|0|||
147487239|NCT02026271|531939299|FG003|Overall Study|Withdrawal by Subject|0|||
147487240|NCT02026271|531939300|FG004|Overall Study|Withdrawal by Subject|1|||
147487241|NCT02275026|531939301|FG000|Overall Study|Ineligible after cognitive baseline testing|11|||
147487242|NCT02275026|531939301|FG000|Overall Study|Withdrawal by Subject|4|||
147487243|NCT02275026|531939301|FG000|Overall Study|Ineligible due to medical history|13|||
147487244|NCT02275026|531939301|FG000|Overall Study|MRI malfunction precluded testing|1|||
147487245|NCT02275026|531939301|FG000|Overall Study|Ineligible after MRI findings|1|||
147487246|NCT02275026|531939301|FG000|Overall Study|Lost to Follow-up|2|||
147487247|NCT02275026|531939301|FG000|Overall Study|Scanner failure|1|||
147487248|NCT00374907|531939304|FG000|12-Week Short-term Period|Subject Withdrew Consent|3|||
147487249|NCT00374907|531939305|FG001|12-Week Short-term Period|Subject Withdrew Consent|1|||
147487250|NCT00374907|531939304|FG000|116-Week Short-term + Long-term Period|Subject Withdrew Consent|8|||
147487251|NCT00374907|531939305|FG001|116-Week Short-term + Long-term Period|Subject Withdrew Consent|9|||
147487252|NCT00374907|531939304|FG000|116-Week Short-term + Long-term Period|Lack of Efficacy|4|||
147487253|NCT00374907|531939305|FG001|116-Week Short-term + Long-term Period|Lack of Efficacy|2|||
147487254|NCT00374907|531939304|FG000|116-Week Short-term + Long-term Period|Adverse Event|0|||
147487255|NCT00374907|531939305|FG001|116-Week Short-term + Long-term Period|Adverse Event|2|||
147487256|NCT00374907|531939304|FG000|116-Week Short-term + Long-term Period|Lost to Follow-up|1|||
147487257|NCT00374907|531939305|FG001|116-Week Short-term + Long-term Period|Lost to Follow-up|1|||
147487258|NCT01108809|531939306|FG000|Overall Study|Adverse Event|3|||
147487259|NCT01108809|531939306|FG000|Overall Study|Lost to Follow-up|1|||
147487260|NCT02213198|531939311|FG000|Baseline|No show for intake|7|||
147487261|NCT02213198|531939312|FG001|Baseline|No show for intake|9|||
147487262|NCT02213198|531939311|FG000|Baseline|Withdrawal by Subject|34|||
147487263|NCT02213198|531939312|FG001|Baseline|Withdrawal by Subject|11|||
147487264|NCT02213198|531939311|FG000|Baseline|transferred out of clinic|7|||
147487265|NCT02213198|531939312|FG001|Baseline|transferred out of clinic|9|||
147487266|NCT02213198|531939311|FG000|Baseline|Lost to Follow-up|40|||
147487267|NCT02213198|531939312|FG001|Baseline|Lost to Follow-up|21|||
147487268|NCT02213198|531939311|FG000|Baseline|incarcerated,violent|0|||
147487269|NCT02213198|531939312|FG001|Baseline|incarcerated,violent|1|||
147487270|NCT02213198|531939311|FG000|Follow up 1 3 Mos Post BL End of TCC tx|Withdrawal by Subject|4|||
147487271|NCT02213198|531939312|FG001|Follow up 1 3 Mos Post BL End of TCC tx|Withdrawal by Subject|4|||
147487272|NCT02213198|531939311|FG000|Follow up 1 3 Mos Post BL End of TCC tx|rehab/incarceration/violence|3|||
147487273|NCT02213198|531939312|FG001|Follow up 1 3 Mos Post BL End of TCC tx|rehab/incarceration/violence|2|||
147487274|NCT02213198|531939311|FG000|Follow up 1 3 Mos Post BL End of TCC tx|Death|1|||
147623795|NCT01597973|532440220|FG001|Overall Study|LAR not authorized to consent|1|||
147487275|NCT02213198|531939312|FG001|Follow up 1 3 Mos Post BL End of TCC tx|Death|0|||
147487276|NCT02213198|531939311|FG000|Follow up 1 3 Mos Post BL End of TCC tx|Lost to Follow-up|68|||
147487277|NCT02213198|531939312|FG001|Follow up 1 3 Mos Post BL End of TCC tx|Lost to Follow-up|25|||
147623796|NCT01597973|532440219|FG000|Overall Study|Ineligible due to early seizures|1|||
147487278|NCT02213198|531939311|FG000|Follow up 1 3 Mos Post BL End of TCC tx|unable to contact at 3 but got 6 post DC|17|||
147487279|NCT02213198|531939312|FG001|Follow up 1 3 Mos Post BL End of TCC tx|unable to contact at 3 but got 6 post DC|10|||
147487280|NCT02213198|531939311|FG000|Follow up 2 6 Months Post TCC Treatment|Lost to Follow-up|23|||
147487281|NCT02213198|531939312|FG001|Follow up 2 6 Months Post TCC Treatment|Lost to Follow-up|7|||
147487282|NCT03283163|531939313|FG000|Overall Study|Lost to Follow-up|1|||
147487283|NCT03283163|531939313|FG000|Overall Study|other life commitments|6|||
147623797|NCT01597973|532440220|FG001|Overall Study|Ineligible due to early seizures|0|||
147623798|NCT01597973|532440219|FG000|Overall Study|Ineligible due to non-target infection|1|||
147623799|NCT01597973|532440220|FG001|Overall Study|Ineligible due to non-target infection|1|||
147487284|NCT03283163|531939313|FG000|Overall Study|COVID-19 institution wide halting|1|||
147487285|NCT03283163|531939313|FG000|Overall Study|Participants tested positive for illicit drugs on the day of the testing and/or training procedures|2|||
147487286|NCT03283163|531939313|FG000|Overall Study|Participant found to not be forthcoming with screening/baseline assessments|1|||
147487287|NCT04238663|531939314|FG000|Overall Study|Lost to Follow-up|0|||
147487288|NCT04238663|531939315|FG001|Overall Study|Lost to Follow-up|1|||
147487289|NCT04238663|531939316|FG002|Overall Study|Lost to Follow-up|0|||
147487290|NCT00968253|531939317|FG000|Overall Study|Death|0|||
147487291|NCT00968253|531939318|FG001|Overall Study|Death|0|||
147487292|NCT00968253|531939319|FG002|Overall Study|Death|2|||
147487293|NCT00968253|531939317|FG000|Overall Study|Withdrawal by Subject|0|||
147487294|NCT00968253|531939318|FG001|Overall Study|Withdrawal by Subject|0|||
147487295|NCT00968253|531939319|FG002|Overall Study|Withdrawal by Subject|1|||
147487296|NCT00968253|531939317|FG000|Overall Study|Disease Progression|0|||
147487297|NCT00968253|531939318|FG001|Overall Study|Disease Progression|3|||
147487298|NCT00968253|531939319|FG002|Overall Study|Disease Progression|3|||
147487299|NCT00968253|531939317|FG000|Overall Study|Adverse Event|0|||
147487300|NCT00968253|531939318|FG001|Overall Study|Adverse Event|0|||
147487301|NCT00968253|531939319|FG002|Overall Study|Adverse Event|1|||
147487302|NCT03987620|531939322|FG000|Overall Study|Lack of Efficacy or Use of antifungal therapy|43|||
147487303|NCT03987620|531939323|FG001|Overall Study|Lack of Efficacy or Use of antifungal therapy|41|||
147487304|NCT03987620|531939322|FG000|Overall Study|Adverse Event|3|||
147487305|NCT03987620|531939323|FG001|Overall Study|Adverse Event|0|||
147487306|NCT03987620|531939322|FG000|Overall Study|Lost to Follow-up|1|||
147487307|NCT03987620|531939323|FG001|Overall Study|Lost to Follow-up|2|||
147487308|NCT03987620|531939322|FG000|Overall Study|Physician Decision|0|||
147487309|NCT03987620|531939323|FG001|Overall Study|Physician Decision|1|||
147487310|NCT03987620|531939322|FG000|Overall Study|Pregnancy|1|||
147487311|NCT03987620|531939323|FG001|Overall Study|Pregnancy|0|||
147487312|NCT03987620|531939322|FG000|Overall Study|Withdrawal by Subject|7|||
147487313|NCT03987620|531939323|FG001|Overall Study|Withdrawal by Subject|1|||
147487314|NCT03987620|531939322|FG000|Overall Study|Other|2|||
147487315|NCT03987620|531939323|FG001|Overall Study|Other|5|||
147487316|NCT02149836|531939324|FG000|Overall Study|Withdrawal by Subject|1|||
147487317|NCT03860844|531939325|FG000|Overall Study|Adverse event, not related to Coronavirus Disease-2019 (COVID-19)|3|||
147487318|NCT03860844|531939326|FG001|Overall Study|Adverse event, not related to Coronavirus Disease-2019 (COVID-19)|2|||
147487319|NCT03860844|531939327|FG002|Overall Study|Adverse event, not related to Coronavirus Disease-2019 (COVID-19)|3|||
147487320|NCT03860844|531939325|FG000|Overall Study|Progressive disease|5|||
147487321|NCT03860844|531939326|FG001|Overall Study|Progressive disease|3|||
147487322|NCT03860844|531939327|FG002|Overall Study|Progressive disease|4|||
147487323|NCT03860844|531939325|FG000|Overall Study|Other, Not related to COVID-19|0|||
147487324|NCT03860844|531939326|FG001|Overall Study|Other, Not related to COVID-19|1|||
147487325|NCT03860844|531939327|FG002|Overall Study|Other, Not related to COVID-19|0|||
147487326|NCT01678807|531939335|FG000|Overall Study|Adverse Event|4|||
147487327|NCT01678807|531939336|FG001|Overall Study|Adverse Event|4|||
147487328|NCT01678807|531939337|FG002|Overall Study|Adverse Event|0|||
147487329|NCT01678807|531939335|FG000|Overall Study|Withdrawn by Parent/Guardian|0|||
147487330|NCT01678807|531939336|FG001|Overall Study|Withdrawn by Parent/Guardian|1|||
147487331|NCT01678807|531939337|FG002|Overall Study|Withdrawn by Parent/Guardian|0|||
147487332|NCT02429427|531939338|FG000|Overall Study|Adverse Event|220|||
147487333|NCT02429427|531939339|FG001|Overall Study|Adverse Event|92|||
147487334|NCT02429427|531939338|FG000|Overall Study|Protocol Violation|10|||
147487335|NCT02429427|531939339|FG001|Overall Study|Protocol Violation|6|||
147487336|NCT02429427|531939338|FG000|Overall Study|Lost to Follow-up|15|||
147487337|NCT02429427|531939339|FG001|Overall Study|Lost to Follow-up|6|||
147487338|NCT02429427|531939338|FG000|Overall Study|Withdrawal by Subject|64|||
147487339|NCT02429427|531939339|FG001|Overall Study|Withdrawal by Subject|34|||
147487340|NCT02429427|531939338|FG000|Overall Study|Other|62|||
147623800|NCT02723344|532440221|FG000|Overall Study|Lost to Follow-up|0|||
147623801|NCT02723344|532440222|FG001|Overall Study|Lost to Follow-up|4|||
147487341|NCT02429427|531939339|FG001|Overall Study|Other|41|||
147487342|NCT05306873|531940720|FG000|Stage 2|Study stopped|1|||
147487343|NCT05306873|531940721|FG001|Stage 2|Study stopped|1|||
147487344|NCT05306873|531940722|FG002|Stage 2|Study stopped|0|||
147487345|NCT05306873|531940723|FG003|Stage 2|Study stopped|0|||
147487346|NCT05306873|531940720|FG000|Stage 2|Stage 2 Treatment Failure|2|||
147487347|NCT05306873|531940721|FG001|Stage 2|Stage 2 Treatment Failure|3|||
147487348|NCT05306873|531940722|FG002|Stage 2|Stage 2 Treatment Failure|0|||
147487349|NCT05306873|531940723|FG003|Stage 2|Stage 2 Treatment Failure|0|||
147487350|NCT05306873|531940720|FG000|Stage 2|Logistical issues due to participant moving|1|||
147487351|NCT05306873|531940721|FG001|Stage 2|Logistical issues due to participant moving|0|||
147487352|NCT05306873|531940722|FG002|Stage 2|Logistical issues due to participant moving|0|||
147487353|NCT05306873|531940723|FG003|Stage 2|Logistical issues due to participant moving|0|||
147487354|NCT05306873|531940720|FG000|Stage 3|Stage 3 Treatment Failure|0|||
147487355|NCT05306873|531940721|FG001|Stage 3|Stage 3 Treatment Failure|0|||
147487356|NCT05306873|531940722|FG002|Stage 3|Stage 3 Treatment Failure|0|||
147487357|NCT05306873|531940723|FG003|Stage 3|Stage 3 Treatment Failure|1|||
147487358|NCT05306873|531940720|FG000|Stage 3|Study Stopped|0|||
147487359|NCT05306873|531940721|FG001|Stage 3|Study Stopped|0|||
147487360|NCT05306873|531940722|FG002|Stage 3|Study Stopped|1|||
147487361|NCT05306873|531940723|FG003|Stage 3|Study Stopped|0|||
147487362|NCT04920084|531940725|FG000|Overall Study|Adverse Event|1|||
147487363|NCT04920084|531940725|FG000|Overall Study|Lost to Follow-up|2|||
147487364|NCT04920084|531940725|FG000|Overall Study|Withdrawal by Subject|2|||
147487365|NCT00074412|531940727|FG000|Overall Study|Death|30|||
147487366|NCT00074412|531940728|FG001|Overall Study|Death|26|||
147487367|NCT00074412|531940727|FG000|Overall Study|Lost to Follow-up|52|||
147487368|NCT00074412|531940728|FG001|Overall Study|Lost to Follow-up|58|||
147487369|NCT02361762|531940729|FG000|Overall Study|Withdrawal by Subject|0|||
147487370|NCT02361762|531940730|FG001|Overall Study|Withdrawal by Subject|1|||
147487371|NCT02361762|531940729|FG000|Overall Study|Lost to Follow-up|0|||
147487372|NCT02361762|531940730|FG001|Overall Study|Lost to Follow-up|1|||
147487373|NCT03488472|531940731|FG000|Overall Study|disease progression additional mets|1|||
147487374|NCT00028002|531940732|FG000|Overall Study|Withdrawal by Subject|3|||
147487375|NCT00028002|531940732|FG000|Overall Study|Ineligible|8|||
147487376|NCT04467164|531940736|FG000|Washout (1 Week)|Lost to Follow-up|2|||
147487377|NCT04467164|531940737|FG001|Washout (1 Week)|Lost to Follow-up|0|||
147487378|NCT02750813|531940738|FG000|Period 1, First 14 Days of Wear|Withdrawal by Subject|1|||
147487379|NCT02750813|531940739|FG001|Period 1, First 14 Days of Wear|Withdrawal by Subject|0|||
147487380|NCT02750813|531940738|FG000|Period 1, First 14 Days of Wear|Reason not given|0|||
147487381|NCT02750813|531940739|FG001|Period 1, First 14 Days of Wear|Reason not given|1|||
147487382|NCT02273752|531940740|FG000|Overall Study|Trial was terminated early|2|||
147487383|NCT00903032|531940741|FG000|Overall Study|Withdrawal by Subject|5|||
147487384|NCT00903032|531940742|FG001|Overall Study|Withdrawal by Subject|3|||
147487385|NCT00903032|531940741|FG000|Overall Study|Lost to Follow-up|2|||
147487386|NCT00903032|531940742|FG001|Overall Study|Lost to Follow-up|2|||
147487387|NCT03539458|531940744|FG000|Overall Study|Death|1|||
147487388|NCT02042404|531940747|FG000|Overall Study|Death|1|||
147487389|NCT02042404|531940748|FG001|Overall Study|Death|0|||
147623802|NCT01326845|532440224|FG000|Overall Study|Administrative Problems|5|||
147623803|NCT01326845|532440225|FG001|Overall Study|Administrative Problems|2|||
147623804|NCT01326845|532440224|FG000|Overall Study|Adverse Event|1|||
147623805|NCT01326845|532440225|FG001|Overall Study|Adverse Event|0|||
147623806|NCT01326845|532440224|FG000|Overall Study|Misisng|1|||
147623807|NCT01326845|532440225|FG001|Overall Study|Misisng|3|||
147623808|NCT02524847|532440226|FG000|Overall Study|Adverse Event|4|||
147623809|NCT02524847|532440226|FG000|Overall Study|Unsatisfactory Therapeutic Effect|4|||
147623810|NCT02524847|532440226|FG000|Overall Study|Condition no Longer Requires Treatment|4|||
147623811|NCT02524847|532440226|FG000|Overall Study|Death|1|||
147623812|NCT02524847|532440226|FG000|Overall Study|Reason not Specified|1|||
147623813|NCT04352101|532440227|FG000|Overall Study|Physician Decision|2|||
147623814|NCT04352101|532440228|FG001|Overall Study|Physician Decision|1|||
147623815|NCT00908544|532440235|FG000|Overall Study|Withdrawal by Subject|2|||
147623816|NCT00908544|532440236|FG001|Overall Study|Withdrawal by Subject|4|||
147623817|NCT00908544|532440235|FG000|Overall Study|Lack of Efficacy|0|||
147623818|NCT00908544|532440236|FG001|Overall Study|Lack of Efficacy|1|||
147623819|NCT00908544|532440235|FG000|Overall Study|Pregnancy|1|||
147623820|NCT00908544|532440236|FG001|Overall Study|Pregnancy|0|||
147623821|NCT00908544|532440235|FG000|Overall Study|Relocation abroad|1|||
147623822|NCT00908544|532440236|FG001|Overall Study|Relocation abroad|1|||
147623823|NCT00908544|532440235|FG000|Overall Study|Unable to visit sutdy center|1|||
147623824|NCT00908544|532440236|FG001|Overall Study|Unable to visit sutdy center|0|||
147623825|NCT01213966|532440237|FG000|Overall Study|Protocol Violation|1|||
147623826|NCT01213966|532440238|FG001|Overall Study|Protocol Violation|0|||
147623827|NCT01213966|532440239|FG002|Overall Study|Protocol Violation|3|||
147623828|NCT01213966|532440240|FG003|Overall Study|Protocol Violation|1|||
147623829|NCT00740636|532440245|FG000|Overall Study|Adverse Event|0|||
147623830|NCT00740636|532440246|FG001|Overall Study|Adverse Event|2|||
147623831|NCT00740636|532440245|FG000|Overall Study|Patient Ineligible|0|||
147623832|NCT00740636|532440246|FG001|Overall Study|Patient Ineligible|1|||
147623833|NCT00740636|532440245|FG000|Overall Study|Patient Not Treated|0|||
147623834|NCT00740636|532440246|FG001|Overall Study|Patient Not Treated|1|||
147623835|NCT00740636|532440245|FG000|Overall Study|Progressive Disease|1|||
147623836|NCT00740636|532440246|FG001|Overall Study|Progressive Disease|0|||
147487390|NCT02042404|531940747|FG000|Overall Study|Unrelated Adverse Event|3|||
147487391|NCT02042404|531940748|FG001|Overall Study|Unrelated Adverse Event|0|||
147623837|NCT00740636|532440245|FG000|Overall Study|Death|1|||
147623838|NCT00740636|532440246|FG001|Overall Study|Death|0|||
147623839|NCT00682786|532440253|FG000|Overall Study|Withdrawal by Subject|2|||
147623840|NCT00682786|532440254|FG001|Overall Study|Withdrawal by Subject|2|||
147623841|NCT00682786|532440253|FG000|Overall Study|Did not receive irinotecan|0|||
147623842|NCT00682786|532440254|FG001|Overall Study|Did not receive irinotecan|1|||
147487392|NCT02042404|531940747|FG000|Overall Study|Inability to meet time requirements|1|||
147487393|NCT02042404|531940748|FG001|Overall Study|Inability to meet time requirements|0|||
147487394|NCT03100942|531940749|FG000|Randomized Treatment Period|Withdrew Consent|4|||
147487395|NCT03100942|531940750|FG001|Randomized Treatment Period|Withdrew Consent|5|||
147487396|NCT03100942|531940751|FG002|Randomized Treatment Period|Withdrew Consent|3|||
147487397|NCT03100942|531940752|FG003|Randomized Treatment Period|Withdrew Consent|3|||
147487398|NCT03100942|531940753|FG004|Randomized Treatment Period|Withdrew Consent|0|||
147487399|NCT03100942|531940754|FG005|Randomized Treatment Period|Withdrew Consent|0|||
147487400|NCT03100942|531940755|FG006|Randomized Treatment Period|Withdrew Consent|0|||
147487401|NCT03100942|531940749|FG000|Randomized Treatment Period|Adverse Event|5|||
147487402|NCT03100942|531940750|FG001|Randomized Treatment Period|Adverse Event|2|||
147487403|NCT03100942|531940751|FG002|Randomized Treatment Period|Adverse Event|1|||
147487404|NCT03100942|531940752|FG003|Randomized Treatment Period|Adverse Event|0|||
147487405|NCT03100942|531940753|FG004|Randomized Treatment Period|Adverse Event|0|||
147487406|NCT03100942|531940754|FG005|Randomized Treatment Period|Adverse Event|0|||
147487407|NCT03100942|531940755|FG006|Randomized Treatment Period|Adverse Event|0|||
147487408|NCT03100942|531940749|FG000|Randomized Treatment Period|Investigator's Discretion|2|||
147487409|NCT03100942|531940750|FG001|Randomized Treatment Period|Investigator's Discretion|1|||
147487410|NCT03100942|531940751|FG002|Randomized Treatment Period|Investigator's Discretion|0|||
147487411|NCT03100942|531940752|FG003|Randomized Treatment Period|Investigator's Discretion|0|||
147487412|NCT03100942|531940753|FG004|Randomized Treatment Period|Investigator's Discretion|0|||
147487413|NCT03100942|531940754|FG005|Randomized Treatment Period|Investigator's Discretion|0|||
147487414|NCT03100942|531940755|FG006|Randomized Treatment Period|Investigator's Discretion|0|||
147487415|NCT03100942|531940749|FG000|Randomized Treatment Period|Protocol Violation|0|||
147487416|NCT03100942|531940750|FG001|Randomized Treatment Period|Protocol Violation|1|||
147487417|NCT03100942|531940751|FG002|Randomized Treatment Period|Protocol Violation|1|||
147487418|NCT03100942|531940752|FG003|Randomized Treatment Period|Protocol Violation|1|||
147487419|NCT03100942|531940753|FG004|Randomized Treatment Period|Protocol Violation|0|||
147487420|NCT03100942|531940754|FG005|Randomized Treatment Period|Protocol Violation|0|||
147487421|NCT03100942|531940755|FG006|Randomized Treatment Period|Protocol Violation|0|||
147487422|NCT03100942|531940749|FG000|Randomized Treatment Period|Lost to Follow-up|0|||
147487423|NCT03100942|531940750|FG001|Randomized Treatment Period|Lost to Follow-up|0|||
147487424|NCT03100942|531940751|FG002|Randomized Treatment Period|Lost to Follow-up|1|||
147487425|NCT03100942|531940752|FG003|Randomized Treatment Period|Lost to Follow-up|0|||
147487426|NCT03100942|531940753|FG004|Randomized Treatment Period|Lost to Follow-up|0|||
147487427|NCT03100942|531940754|FG005|Randomized Treatment Period|Lost to Follow-up|0|||
147487428|NCT03100942|531940755|FG006|Randomized Treatment Period|Lost to Follow-up|0|||
147487429|NCT03100942|531940749|FG000|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|1|||
147487430|NCT03100942|531940750|FG001|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0|||
147487431|NCT03100942|531940751|FG002|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0|||
147487432|NCT03100942|531940752|FG003|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|1|||
147487433|NCT03100942|531940753|FG004|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0|||
147487434|NCT03100942|531940754|FG005|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0|||
147487435|NCT03100942|531940755|FG006|Randomized Treatment Period|Randomized but Didn't Receive Study Drug|0|||
147487436|NCT03100942|531940749|FG000|Placebo Arm Re-Randomized|Withdrew Consent|0|||
147487437|NCT03100942|531940750|FG001|Placebo Arm Re-Randomized|Withdrew Consent|0|||
147487438|NCT03100942|531940751|FG002|Placebo Arm Re-Randomized|Withdrew Consent|0|||
147487439|NCT03100942|531940752|FG003|Placebo Arm Re-Randomized|Withdrew Consent|0|||
147487440|NCT03100942|531940753|FG004|Placebo Arm Re-Randomized|Withdrew Consent|0|||
147487441|NCT03100942|531940754|FG005|Placebo Arm Re-Randomized|Withdrew Consent|0|||
147487442|NCT03100942|531940755|FG006|Placebo Arm Re-Randomized|Withdrew Consent|1|||
147487443|NCT01429792|531940756|FG000|Overall Study|Other Reasons|67|||
147487444|NCT01429792|531940756|FG000|Overall Study|Unknown Disposition|94|||
147487445|NCT01429792|531940756|FG000|Overall Study|Negative HCV-RNA at Week 4|1|||
147487446|NCT01429792|531940756|FG000|Overall Study|Negative HCV-RNA at Week 12|4|||
147487447|NCT01429792|531940756|FG000|Overall Study|Decrease of less than 2-log in HCV RNA|32|||
147487448|NCT01429792|531940756|FG000|Overall Study|Positive HCV-RNA at Week 24|50|||
147487449|NCT01429792|531940756|FG000|Overall Study|Withdrawal by Subject|70|||
147487450|NCT01429792|531940756|FG000|Overall Study|Lost to Follow-up|88|||
147487451|NCT01617681|531940758|FG000|Period 1 Double Blind|Adverse Event|2|||
147487452|NCT01617681|531940759|FG001|Period 1 Double Blind|Adverse Event|0|||
147487453|NCT01617681|531940760|FG002|Period 1 Double Blind|Adverse Event|0|||
147487454|NCT01617681|531940761|FG003|Period 1 Double Blind|Adverse Event|2|||
147487455|NCT01617681|531940762|FG004|Period 1 Double Blind|Adverse Event|0|||
147487456|NCT01617681|531940758|FG000|Period 1 Double Blind|Withdrawal by Subject|1|||
147487457|NCT01617681|531940759|FG001|Period 1 Double Blind|Withdrawal by Subject|1|||
147487458|NCT01617681|531940760|FG002|Period 1 Double Blind|Withdrawal by Subject|1|||
147487459|NCT01617681|531940761|FG003|Period 1 Double Blind|Withdrawal by Subject|0|||
147487460|NCT01617681|531940762|FG004|Period 1 Double Blind|Withdrawal by Subject|0|||
147487461|NCT01617681|531940758|FG000|Period 2 Open Label|Adverse Event|0|||
147487462|NCT01617681|531940759|FG001|Period 2 Open Label|Adverse Event|0|||
147487463|NCT01617681|531940760|FG002|Period 2 Open Label|Adverse Event|0|||
147487464|NCT01617681|531940761|FG003|Period 2 Open Label|Adverse Event|0|||
147487465|NCT01617681|531940762|FG004|Period 2 Open Label|Adverse Event|3|||
147487466|NCT01617681|531940758|FG000|Period 2 Open Label|Withdrawal by Subject|0|||
147487467|NCT01617681|531940759|FG001|Period 2 Open Label|Withdrawal by Subject|0|||
147487468|NCT01617681|531940760|FG002|Period 2 Open Label|Withdrawal by Subject|0|||
147487469|NCT01617681|531940761|FG003|Period 2 Open Label|Withdrawal by Subject|0|||
147487470|NCT01617681|531940762|FG004|Period 2 Open Label|Withdrawal by Subject|3|||
147487471|NCT00879814|531940767|FG000|Overall Study|Adverse Event|0|||
147487472|NCT00879814|531940768|FG001|Overall Study|Adverse Event|1|||
147487473|NCT00879814|531940769|FG002|Overall Study|Adverse Event|0|||
147487474|NCT00879814|531940770|FG003|Overall Study|Adverse Event|0|||
147487475|NCT00879814|531940767|FG000|Overall Study|Lost to Follow-up|1|||
147487476|NCT00879814|531940768|FG001|Overall Study|Lost to Follow-up|0|||
147487477|NCT00879814|531940769|FG002|Overall Study|Lost to Follow-up|0|||
147487478|NCT00879814|531940770|FG003|Overall Study|Lost to Follow-up|2|||
147487479|NCT00879814|531940767|FG000|Overall Study|Participant Failed to Return|0|||
147487480|NCT00879814|531940768|FG001|Overall Study|Participant Failed to Return|0|||
147487481|NCT00879814|531940769|FG002|Overall Study|Participant Failed to Return|0|||
147487482|NCT00879814|531940770|FG003|Overall Study|Participant Failed to Return|1|||
147487483|NCT00879814|531940767|FG000|Overall Study|Withdrawal by Subject|3|||
147623843|NCT04762160|532440257|FG000|Overall Study|Study terminated early due to business reasons|5|||
147623844|NCT05142722|532441661|FG000|Overall Study|Lost to Follow-up|16|||
147667774|NCT01326871|532608146|FG000|Overall Study|Disease progression|0|||
147667775|NCT01326871|532608147|FG001|Overall Study|Disease progression|11|||
147667776|NCT01326871|532608148|FG002|Overall Study|Disease progression|5|||
147667777|NCT01326871|532608146|FG000|Overall Study|Did not qualify or consent for repeat treatment|0|||
147667778|NCT01326871|532608147|FG001|Overall Study|Did not qualify or consent for repeat treatment|1|||
147667779|NCT01326871|532608148|FG002|Overall Study|Did not qualify or consent for repeat treatment|0|||
147667780|NCT01326871|532608146|FG000|Overall Study|Subject decision to continue survival follow-up only|0|||
147667781|NCT01326871|532608147|FG001|Overall Study|Subject decision to continue survival follow-up only|4|||
147667782|NCT01326871|532608148|FG002|Overall Study|Subject decision to continue survival follow-up only|1|||
147667783|NCT01326871|532608146|FG000|Overall Study|Withdrawal by Subject|0|||
147667784|NCT01326871|532608147|FG001|Overall Study|Withdrawal by Subject|1|||
147667785|NCT01326871|532608148|FG002|Overall Study|Withdrawal by Subject|0|||
147623845|NCT05142722|532441662|FG001|Overall Study|Lost to Follow-up|38|||
147667786|NCT01326871|532608146|FG000|Overall Study|DLT|0|||
147667787|NCT01326871|532608147|FG001|Overall Study|DLT|2|||
147667788|NCT01326871|532608148|FG002|Overall Study|DLT|0|||
147667789|NCT01326871|532608146|FG000|Overall Study|SAE, disease progression and subject decision|0|||
147623846|NCT05142722|532441661|FG000|Overall Study|Withdrawal by Subject|20|||
147623847|NCT05142722|532441662|FG001|Overall Study|Withdrawal by Subject|27|||
147623848|NCT05142722|532441661|FG000|Overall Study|Death|11|||
147623849|NCT05142722|532441662|FG001|Overall Study|Death|17|||
147623850|NCT05142722|532441661|FG000|Overall Study|Physician Decision|0|||
147623851|NCT05142722|532441662|FG001|Overall Study|Physician Decision|1|||
147623852|NCT05142722|532441661|FG000|Overall Study|Participant Moved Away|0|||
147623853|NCT05142722|532441662|FG001|Overall Study|Participant Moved Away|2|||
147623854|NCT05142722|532441661|FG000|Overall Study|Adverse Event|2|||
147623855|NCT05142722|532441662|FG001|Overall Study|Adverse Event|1|||
147623856|NCT02141438|532441663|FG000|Overall Study|Death|1308|||
147623857|NCT02141438|532441663|FG000|Overall Study|Lost to Follow-up|84|||
147623858|NCT02141438|532441663|FG000|Overall Study|Withdrawal by Subject|52|||
147623859|NCT02141438|532441663|FG000|Overall Study|Physician Decision|1|||
147623860|NCT02141438|532441663|FG000|Overall Study|Patients without documented end of observation due to premature site closure|5|||
147623861|NCT03896503|532441664|FG000|Initial Subgroup and Arm Enrollment|Disease progression before treatment|1|||
147623862|NCT03896503|532441665|FG001|Initial Subgroup and Arm Enrollment|Disease progression before treatment|0|||
147623863|NCT03896503|532441666|FG002|Initial Subgroup and Arm Enrollment|Disease progression before treatment|1|||
147623864|NCT03896503|532441667|FG003|Initial Subgroup and Arm Enrollment|Disease progression before treatment|0|||
147623865|NCT03896503|532441668|FG004|Initial Subgroup and Arm Enrollment|Disease progression before treatment|1|||
147623866|NCT03896503|532441669|FG005|Initial Subgroup and Arm Enrollment|Disease progression before treatment|0|||
147667790|NCT01326871|532608147|FG001|Overall Study|SAE, disease progression and subject decision|1|||
147667791|NCT01326871|532608148|FG002|Overall Study|SAE, disease progression and subject decision|0|||
147667792|NCT01326871|532608146|FG000|Overall Study|Death|0|||
147487484|NCT00879814|531940768|FG001|Overall Study|Withdrawal by Subject|1|||
147487485|NCT00879814|531940769|FG002|Overall Study|Withdrawal by Subject|1|||
147487486|NCT00879814|531940770|FG003|Overall Study|Withdrawal by Subject|2|||
147487487|NCT00879814|531940767|FG000|Overall Study|Physician Decision|0|||
147623867|NCT03896503|532441670|FG006|Initial Subgroup and Arm Enrollment|Disease progression before treatment|0|||
147623868|NCT03896503|532441671|FG007|Initial Subgroup and Arm Enrollment|Disease progression before treatment|0|||
147667793|NCT01326871|532608147|FG001|Overall Study|Death|1|||
147667794|NCT01326871|532608148|FG002|Overall Study|Death|0|||
147487488|NCT00879814|531940768|FG001|Overall Study|Physician Decision|0|||
147487489|NCT00879814|531940769|FG002|Overall Study|Physician Decision|1|||
147487490|NCT00879814|531940770|FG003|Overall Study|Physician Decision|0|||
147487491|NCT00879814|531940767|FG000|Overall Study|Other|0|||
147487492|NCT00879814|531940768|FG001|Overall Study|Other|0|||
147487493|NCT00879814|531940769|FG002|Overall Study|Other|1|||
147487494|NCT00879814|531940770|FG003|Overall Study|Other|0|||
147487495|NCT01428063|531940771|FG000|Overall Study|Lack of Efficacy|8|||
147487496|NCT01428063|531940772|FG001|Overall Study|Lack of Efficacy|4|||
147487497|NCT01428063|531940773|FG002|Overall Study|Lack of Efficacy|1|||
147487498|NCT01428063|531940771|FG000|Overall Study|Adverse Event|2|||
147487499|NCT01428063|531940772|FG001|Overall Study|Adverse Event|3|||
147487500|NCT01428063|531940773|FG002|Overall Study|Adverse Event|0|||
147487501|NCT01428063|531940771|FG000|Overall Study|Lost to Follow-up|0|||
147487502|NCT01428063|531940772|FG001|Overall Study|Lost to Follow-up|2|||
147487503|NCT01428063|531940773|FG002|Overall Study|Lost to Follow-up|0|||
147487504|NCT01428063|531940771|FG000|Overall Study|No longer meets study criteria|0|||
147487505|NCT01428063|531940772|FG001|Overall Study|No longer meets study criteria|1|||
147487506|NCT01428063|531940773|FG002|Overall Study|No longer meets study criteria|0|||
147487507|NCT05761444|531940774|FG000|Overall Study|Protocol Violation|2|||
147487508|NCT05761444|531940775|FG001|Overall Study|Protocol Violation|1|||
147487509|NCT05761444|531940774|FG000|Overall Study|Adverse Event|2|||
147487510|NCT05761444|531940775|FG001|Overall Study|Adverse Event|2|||
147487511|NCT05761444|531940774|FG000|Overall Study|Withdrawal by Subject|3|||
147487512|NCT05761444|531940775|FG001|Overall Study|Withdrawal by Subject|2|||
147487513|NCT05761444|531940774|FG000|Overall Study|Other|1|||
147487514|NCT05761444|531940775|FG001|Overall Study|Other|0|||
147487515|NCT03508622|531940776|FG000|Overall Study|Protocol Violation|1|||
147487516|NCT03508622|531940777|FG001|Overall Study|Protocol Violation|0|||
147487517|NCT03508622|531940776|FG000|Overall Study|Withdrawal by Subject|1|||
147487518|NCT03508622|531940777|FG001|Overall Study|Withdrawal by Subject|0|||
147487519|NCT03508622|531940776|FG000|Overall Study|Lost to Follow-up|16|||
147487520|NCT03508622|531940777|FG001|Overall Study|Lost to Follow-up|0|||
147487521|NCT03508622|531940776|FG000|Overall Study|Incomplete data|0|||
147487522|NCT03508622|531940777|FG001|Overall Study|Incomplete data|24|||
147487523|NCT01005719|531940778|FG000|Period 1|Adverse Event|0|||
147487524|NCT01005719|531940779|FG001|Period 1|Adverse Event|0|||
147487525|NCT01005719|531940780|FG002|Period 1|Adverse Event|0|||
147487526|NCT01005719|531940781|FG003|Period 1|Adverse Event|1|||
147487527|NCT01005719|531940782|FG004|Period 1|Adverse Event|0|||
147487528|NCT01005719|531940783|FG005|Period 1|Adverse Event|0|||
147487529|NCT01005719|531940778|FG000|Period 1|Delay in completing study procedures|0|||
147487530|NCT01005719|531940779|FG001|Period 1|Delay in completing study procedures|0|||
147487531|NCT01005719|531940780|FG002|Period 1|Delay in completing study procedures|0|||
147487532|NCT01005719|531940781|FG003|Period 1|Delay in completing study procedures|0|||
147487533|NCT01005719|531940782|FG004|Period 1|Delay in completing study procedures|0|||
147487534|NCT01005719|531940783|FG005|Period 1|Delay in completing study procedures|1|||
147487535|NCT01005719|531940778|FG000|Period 2|Adverse Event|0|||
147487536|NCT01005719|531940779|FG001|Period 2|Adverse Event|0|||
147487537|NCT01005719|531940780|FG002|Period 2|Adverse Event|0|||
147487538|NCT01005719|531940781|FG003|Period 2|Adverse Event|0|||
147487539|NCT01005719|531940782|FG004|Period 2|Adverse Event|1|||
147487540|NCT01005719|531940783|FG005|Period 2|Adverse Event|1|||
147487541|NCT02499146|531940784|FG000|Overall Study|Lost to Follow-up|1|||
147487542|NCT02499146|531940784|FG000|Overall Study|Withdrawal by Subject|1|||
147487543|NCT02499146|531940784|FG000|Overall Study|Other|2|||
147487544|NCT02499146|531940784|FG000|Overall Study|Ongoing at date of cut-off|9|||
147487545|NCT02499146|531940784|FG000|Overall Study|Began other treatment/therapy|13|||
147487546|NCT03161678|531940785|FG000|Intervention 1 (8 Days)|Withdrawal by Subject|1|||
147487547|NCT03161678|531940786|FG001|Intervention 1 (8 Days)|Withdrawal by Subject|1|||
147487548|NCT03161678|531940787|FG002|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
147487549|NCT03161678|531940788|FG003|Intervention 1 (8 Days)|Withdrawal by Subject|2|||
147487550|NCT03161678|531940789|FG004|Intervention 1 (8 Days)|Withdrawal by Subject|1|||
147623869|NCT03896503|532441664|FG000|Initial Subgroup and Arm Enrollment|No treatment per protocol|0|||
147487551|NCT03161678|531940790|FG005|Intervention 1 (8 Days)|Withdrawal by Subject|0|||
147487552|NCT03161678|531940785|FG000|Intervention 1 (8 Days)|Adverse Event|0|||
147487553|NCT03161678|531940786|FG001|Intervention 1 (8 Days)|Adverse Event|0|||
147487554|NCT03161678|531940787|FG002|Intervention 1 (8 Days)|Adverse Event|0|||
147487555|NCT03161678|531940788|FG003|Intervention 1 (8 Days)|Adverse Event|1|||
147487556|NCT03161678|531940789|FG004|Intervention 1 (8 Days)|Adverse Event|0|||
147487557|NCT03161678|531940790|FG005|Intervention 1 (8 Days)|Adverse Event|0|||
147487558|NCT03161678|531940785|FG000|Washout (14 Days)|Withdrawal by Subject|0|||
147623870|NCT03896503|532441665|FG001|Initial Subgroup and Arm Enrollment|No treatment per protocol|0|||
147623871|NCT03896503|532441666|FG002|Initial Subgroup and Arm Enrollment|No treatment per protocol|1|||
147487559|NCT03161678|531940786|FG001|Washout (14 Days)|Withdrawal by Subject|0|||
147487560|NCT03161678|531940787|FG002|Washout (14 Days)|Withdrawal by Subject|1|||
147487561|NCT03161678|531940788|FG003|Washout (14 Days)|Withdrawal by Subject|0|||
147487562|NCT03161678|531940789|FG004|Washout (14 Days)|Withdrawal by Subject|2|||
147487563|NCT03161678|531940790|FG005|Washout (14 Days)|Withdrawal by Subject|1|||
147487564|NCT03161678|531940785|FG000|Intervention 2 (8 Days)|Withdrawal by Subject|0|||
147487565|NCT03161678|531940786|FG001|Intervention 2 (8 Days)|Withdrawal by Subject|0|||
147487566|NCT03161678|531940787|FG002|Intervention 2 (8 Days)|Withdrawal by Subject|0|||
147487567|NCT03161678|531940788|FG003|Intervention 2 (8 Days)|Withdrawal by Subject|1|||
147487568|NCT03161678|531940789|FG004|Intervention 2 (8 Days)|Withdrawal by Subject|0|||
147487569|NCT03161678|531940790|FG005|Intervention 2 (8 Days)|Withdrawal by Subject|0|||
147487570|NCT00752609|531940791|FG000|Overall Study|Adverse Event|2|||
147487571|NCT00752609|531940792|FG001|Overall Study|Adverse Event|2|||
147487572|NCT00752609|531940791|FG000|Overall Study|Withdrawal by Subject|3|||
147487573|NCT00752609|531940792|FG001|Overall Study|Withdrawal by Subject|0|||
147487574|NCT00752609|531940791|FG000|Overall Study|Physician Decision|1|||
147487575|NCT00752609|531940792|FG001|Overall Study|Physician Decision|0|||
147487576|NCT00752609|531940791|FG000|Overall Study|Death|1|||
147487577|NCT00752609|531940792|FG001|Overall Study|Death|0|||
147487578|NCT00752609|531940791|FG000|Overall Study|Met exclusion criteria|1|||
147487579|NCT00752609|531940792|FG001|Overall Study|Met exclusion criteria|0|||
147487580|NCT00752609|531940791|FG000|Overall Study|Received Aranesp in error|1|||
147487581|NCT00752609|531940792|FG001|Overall Study|Received Aranesp in error|0|||
147487582|NCT05114590|531940793|FG000|Overall Study|Adverse Event|1|||
147487583|NCT05114590|531940793|FG000|Overall Study|Investigator decision|1|||
147487584|NCT05114590|531940793|FG000|Overall Study|Lost to Follow-up|5|||
147487585|NCT05114590|531940793|FG000|Overall Study|Withdrawal by Subject|5|||
147487586|NCT05114590|531940793|FG000|Overall Study|Other|2|||
147487587|NCT01425190|531940795|FG000|Overall Study|Full dose not consumed.|1|||
147487588|NCT01425190|531940796|FG001|Overall Study|Full dose not consumed.|0|||
147487589|NCT01425190|531940797|FG002|Overall Study|Full dose not consumed.|0|||
147487590|NCT01035255|531940799|FG000|Overall Study|Death|724|||
147487591|NCT01035255|531940800|FG001|Overall Study|Death|844|||
147487592|NCT01035255|531940799|FG000|Overall Study|Lost to Follow-up|2|||
147487593|NCT01035255|531940800|FG001|Overall Study|Lost to Follow-up|5|||
147487594|NCT01035255|531940799|FG000|Overall Study|patient's request|15|||
147487595|NCT01035255|531940800|FG001|Overall Study|patient's request|13|||
147487596|NCT00195260|531940803|FG000|Part 1: Dose Escalation|Adverse Event|0|||
147487597|NCT00195260|531940804|FG001|Part 1: Dose Escalation|Adverse Event|1|||
147487598|NCT00195260|531940805|FG002|Part 1: Dose Escalation|Adverse Event|0|||
147487599|NCT00195260|531940806|FG003|Part 1: Dose Escalation|Adverse Event|1|||
147487600|NCT00195260|531940807|FG004|Part 1: Dose Escalation|Adverse Event|1|||
147487601|NCT00195260|531940808|FG005|Part 1: Dose Escalation|Adverse Event|0|||
147487602|NCT00195260|531940809|FG006|Part 1: Dose Escalation|Adverse Event|3|||
147487603|NCT00195260|531940810|FG007|Part 1: Dose Escalation|Adverse Event|0|||
147487604|NCT00195260|531940811|FG008|Part 1: Dose Escalation|Adverse Event|0|||
147487605|NCT00195260|531940812|FG009|Part 1: Dose Escalation|Adverse Event|0|||
147487606|NCT00195260|531940813|FG010|Part 1: Dose Escalation|Adverse Event|0|||
147487607|NCT00195260|531940803|FG000|Part 1: Dose Escalation|Withdrawal by Subject|0|||
147487608|NCT00195260|531940804|FG001|Part 1: Dose Escalation|Withdrawal by Subject|0|||
147487609|NCT00195260|531940805|FG002|Part 1: Dose Escalation|Withdrawal by Subject|0|||
147487610|NCT00195260|531940806|FG003|Part 1: Dose Escalation|Withdrawal by Subject|0|||
147487611|NCT00195260|531940807|FG004|Part 1: Dose Escalation|Withdrawal by Subject|2|||
147487612|NCT00195260|531940808|FG005|Part 1: Dose Escalation|Withdrawal by Subject|0|||
147487613|NCT00195260|531940809|FG006|Part 1: Dose Escalation|Withdrawal by Subject|0|||
147487614|NCT00195260|531940810|FG007|Part 1: Dose Escalation|Withdrawal by Subject|1|||
147487615|NCT00195260|531940811|FG008|Part 1: Dose Escalation|Withdrawal by Subject|0|||
147487616|NCT00195260|531940812|FG009|Part 1: Dose Escalation|Withdrawal by Subject|0|||
147487617|NCT00195260|531940813|FG010|Part 1: Dose Escalation|Withdrawal by Subject|0|||
147487618|NCT00195260|531940803|FG000|Part 1: Dose Escalation|Death|0|||
147487619|NCT00195260|531940804|FG001|Part 1: Dose Escalation|Death|0|||
147487620|NCT00195260|531940805|FG002|Part 1: Dose Escalation|Death|0|||
147487621|NCT00195260|531940806|FG003|Part 1: Dose Escalation|Death|0|||
147487622|NCT00195260|531940807|FG004|Part 1: Dose Escalation|Death|0|||
147487623|NCT00195260|531940808|FG005|Part 1: Dose Escalation|Death|0|||
147487624|NCT00195260|531940809|FG006|Part 1: Dose Escalation|Death|0|||
147623872|NCT03896503|532441667|FG003|Initial Subgroup and Arm Enrollment|No treatment per protocol|0|||
147487625|NCT00195260|531940810|FG007|Part 1: Dose Escalation|Death|1|||
147487626|NCT00195260|531940811|FG008|Part 1: Dose Escalation|Death|0|||
147487627|NCT00195260|531940812|FG009|Part 1: Dose Escalation|Death|0|||
147487628|NCT00195260|531940813|FG010|Part 1: Dose Escalation|Death|0|||
147487629|NCT00195260|531940803|FG000|Part 1: Dose Escalation|Disease Progression|3|||
147487630|NCT00195260|531940804|FG001|Part 1: Dose Escalation|Disease Progression|2|||
147487631|NCT00195260|531940805|FG002|Part 1: Dose Escalation|Disease Progression|5|||
147487632|NCT00195260|531940806|FG003|Part 1: Dose Escalation|Disease Progression|6|||
147623873|NCT03896503|532441668|FG004|Initial Subgroup and Arm Enrollment|No treatment per protocol|0|||
147623874|NCT03896503|532441669|FG005|Initial Subgroup and Arm Enrollment|No treatment per protocol|1|||
147487633|NCT00195260|531940807|FG004|Part 1: Dose Escalation|Disease Progression|4|||
147487634|NCT00195260|531940808|FG005|Part 1: Dose Escalation|Disease Progression|6|||
147487635|NCT00195260|531940809|FG006|Part 1: Dose Escalation|Disease Progression|7|||
147487636|NCT00195260|531940810|FG007|Part 1: Dose Escalation|Disease Progression|4|||
147487637|NCT00195260|531940811|FG008|Part 1: Dose Escalation|Disease Progression|0|||
147667795|NCT01326871|532608146|FG000|Overall Study|Other|0|||
147667796|NCT01326871|532608147|FG001|Overall Study|Other|3|||
147667797|NCT01326871|532608148|FG002|Overall Study|Other|0|||
147667798|NCT01326871|532608146|FG000|Overall Study|SAE and disease progression|0|||
147667799|NCT01326871|532608147|FG001|Overall Study|SAE and disease progression|0|||
147667800|NCT01326871|532608148|FG002|Overall Study|SAE and disease progression|1|||
147667801|NCT01326871|532608146|FG000|Overall Study|SAE and physician decision|0|||
147667802|NCT01326871|532608147|FG001|Overall Study|SAE and physician decision|0|||
147667803|NCT01326871|532608148|FG002|Overall Study|SAE and physician decision|1|||
147667804|NCT01326871|532608146|FG000|Overall Study|Did not qualify/consent for repeat treatment, subject decision to continue survival follow-up only|0|||
147487638|NCT00195260|531940812|FG009|Part 1: Dose Escalation|Disease Progression|0|||
147487639|NCT00195260|531940813|FG010|Part 1: Dose Escalation|Disease Progression|0|||
147487640|NCT00195260|531940803|FG000|Part 1: Dose Escalation|Symptomatic Deterioration|1|||
147487641|NCT00195260|531940804|FG001|Part 1: Dose Escalation|Symptomatic Deterioration|1|||
147487642|NCT00195260|531940805|FG002|Part 1: Dose Escalation|Symptomatic Deterioration|1|||
147487643|NCT00195260|531940806|FG003|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
147487644|NCT00195260|531940807|FG004|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
147487645|NCT00195260|531940808|FG005|Part 1: Dose Escalation|Symptomatic Deterioration|1|||
147487646|NCT00195260|531940809|FG006|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
147487647|NCT00195260|531940810|FG007|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
147487648|NCT00195260|531940811|FG008|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
147487649|NCT00195260|531940812|FG009|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
147487650|NCT00195260|531940813|FG010|Part 1: Dose Escalation|Symptomatic Deterioration|0|||
147487651|NCT00195260|531940803|FG000|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
147487652|NCT00195260|531940804|FG001|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
147487653|NCT00195260|531940805|FG002|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
147487654|NCT00195260|531940806|FG003|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
147487655|NCT00195260|531940807|FG004|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
147487656|NCT00195260|531940808|FG005|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
147487657|NCT00195260|531940809|FG006|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
147487658|NCT00195260|531940810|FG007|Part 2: Recommended Phase 2 Dose (RP2D)|Death|0|||
147487659|NCT00195260|531940811|FG008|Part 2: Recommended Phase 2 Dose (RP2D)|Death|21|||
147487660|NCT00195260|531940812|FG009|Part 2: Recommended Phase 2 Dose (RP2D)|Death|29|||
147487661|NCT00195260|531940813|FG010|Part 2: Recommended Phase 2 Dose (RP2D)|Death|15|||
147487662|NCT00195260|531940803|FG000|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
147487663|NCT00195260|531940804|FG001|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
147487664|NCT00195260|531940805|FG002|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
147487665|NCT00195260|531940806|FG003|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
147487666|NCT00195260|531940807|FG004|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
147487667|NCT00195260|531940808|FG005|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
147487668|NCT00195260|531940809|FG006|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
147487669|NCT00195260|531940810|FG007|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|0|||
147487670|NCT00195260|531940811|FG008|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|5|||
147487671|NCT00195260|531940812|FG009|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|3|||
147487672|NCT00195260|531940813|FG010|Part 2: Recommended Phase 2 Dose (RP2D)|Withdrawal by Subject|2|||
147487673|NCT00195260|531940803|FG000|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
147487674|NCT00195260|531940804|FG001|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
147487675|NCT00195260|531940805|FG002|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
147487676|NCT00195260|531940806|FG003|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
147487677|NCT00195260|531940807|FG004|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
147487678|NCT00195260|531940808|FG005|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
147487679|NCT00195260|531940809|FG006|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
147487680|NCT00195260|531940810|FG007|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|0|||
147487681|NCT00195260|531940811|FG008|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|1|||
147487682|NCT00195260|531940812|FG009|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|2|||
147487683|NCT00195260|531940813|FG010|Part 2: Recommended Phase 2 Dose (RP2D)|Lost to Follow-up|3|||
147487684|NCT00195260|531940803|FG000|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
147487685|NCT00195260|531940804|FG001|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
147487686|NCT00195260|531940805|FG002|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
147487687|NCT00195260|531940806|FG003|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
147487688|NCT00195260|531940807|FG004|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
147667805|NCT01326871|532608147|FG001|Overall Study|Did not qualify/consent for repeat treatment, subject decision to continue survival follow-up only|0|||
147487689|NCT00195260|531940808|FG005|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
147487690|NCT00195260|531940809|FG006|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
147487691|NCT00195260|531940810|FG007|Part 2: Recommended Phase 2 Dose (RP2D)|Other|0|||
147487692|NCT00195260|531940811|FG008|Part 2: Recommended Phase 2 Dose (RP2D)|Other|6|||
147487693|NCT00195260|531940812|FG009|Part 2: Recommended Phase 2 Dose (RP2D)|Other|4|||
147487694|NCT00195260|531940813|FG010|Part 2: Recommended Phase 2 Dose (RP2D)|Other|3|||
147487695|NCT01379534|531940814|FG000|Treatment Phase|Withdrawal by Subject|2|||
147487696|NCT01379534|531940815|FG001|Treatment Phase|Withdrawal by Subject|2|||
147487697|NCT01379534|531940814|FG000|Treatment Phase|Progressive disease|13|||
147487698|NCT01379534|531940815|FG001|Treatment Phase|Progressive disease|22|||
147487699|NCT01379534|531940814|FG000|Treatment Phase|Adverse Event|7|||
147487700|NCT01379534|531940815|FG001|Treatment Phase|Adverse Event|7|||
147487701|NCT01379534|531940814|FG000|Tumor Assessment Follow-up (f/u) Phase|Death|0|||
147487702|NCT01379534|531940815|FG001|Tumor Assessment Follow-up (f/u) Phase|Death|1|||
147487703|NCT01379534|531940814|FG000|Tumor Assessment Follow-up (f/u) Phase|Progressive disease|3|||
147487704|NCT01379534|531940815|FG001|Tumor Assessment Follow-up (f/u) Phase|Progressive disease|0|||
147487705|NCT01379534|531940814|FG000|Tumor Assessment Follow-up (f/u) Phase|Lost to Follow-up|0|||
147487706|NCT01379534|531940815|FG001|Tumor Assessment Follow-up (f/u) Phase|Lost to Follow-up|1|||
147487707|NCT01379534|531940814|FG000|Tumor Assessment Follow-up (f/u) Phase|Adverse Event|1|||
147487708|NCT01379534|531940815|FG001|Tumor Assessment Follow-up (f/u) Phase|Adverse Event|0|||
147487709|NCT00829166|531940816|FG000|Overall Study|Death|305|||
147487710|NCT00829166|531940817|FG001|Overall Study|Death|333|||
147487711|NCT00829166|531940816|FG000|Overall Study|Lost to Follow-up|5|||
147487712|NCT00829166|531940817|FG001|Overall Study|Lost to Follow-up|4|||
147487713|NCT00829166|531940816|FG000|Overall Study|Physician's Decision|4|||
147487714|NCT00829166|531940817|FG001|Overall Study|Physician's Decision|3|||
147487715|NCT00829166|531940816|FG000|Overall Study|Subject's Decision|41|||
147487716|NCT00829166|531940817|FG001|Overall Study|Subject's Decision|55|||
147487717|NCT00829166|531940816|FG000|Overall Study|Sponsor's Decision|137|||
147487718|NCT00829166|531940817|FG001|Overall Study|Sponsor's Decision|98|||
147487719|NCT00829166|531940816|FG000|Overall Study|Reason Not Specified|3|||
147487720|NCT00829166|531940817|FG001|Overall Study|Reason Not Specified|3|||
147487721|NCT02582749|531940820|FG000|Overall Study|Study terminated by funder|5|||
147487722|NCT02582749|531940821|FG001|Overall Study|Study terminated by funder|10|||
147487723|NCT02582749|531940820|FG000|Overall Study|Withdrawal by Subject|0|||
147487724|NCT02582749|531940821|FG001|Overall Study|Withdrawal by Subject|1|||
147487725|NCT00878072|531940822|FG000|Overall Study|Withdrew consent|2|||
147487726|NCT02379923|531940828|FG000|Overall Study|Death|5|||
147487727|NCT00872170|531940829|FG000|Overall Study|Adverse Event|1|||
147487728|NCT00872170|531940830|FG001|Overall Study|Adverse Event|0|||
147487729|NCT00719732|531940833|FG000|Overall Study|Lost to Follow-up|20|||
147487730|NCT00719732|531940833|FG000|Overall Study|Unilateral (not bilateral) implantation|1|||
147487731|NCT00719732|531940833|FG000|Overall Study|Illness not associated with device|1|||
147487732|NCT05113953|531942565|FG000|Overall Study|Adverse Event|5|||
147487733|NCT05113953|531942566|FG001|Overall Study|Adverse Event|0|||
147487734|NCT05113953|531942567|FG002|Overall Study|Adverse Event|3|||
147487735|NCT05113953|531942565|FG000|Overall Study|Lost to Follow-up|3|||
147487736|NCT05113953|531942566|FG001|Overall Study|Lost to Follow-up|4|||
147487737|NCT05113953|531942567|FG002|Overall Study|Lost to Follow-up|2|||
147487738|NCT05113953|531942565|FG000|Overall Study|Non-compliance with Study Drug|1|||
147487739|NCT05113953|531942566|FG001|Overall Study|Non-compliance with Study Drug|0|||
147487740|NCT05113953|531942567|FG002|Overall Study|Non-compliance with Study Drug|0|||
147487741|NCT05113953|531942565|FG000|Overall Study|Withdrawal by Subject|2|||
147487742|NCT05113953|531942566|FG001|Overall Study|Withdrawal by Subject|6|||
147487743|NCT05113953|531942567|FG002|Overall Study|Withdrawal by Subject|4|||
147487744|NCT05113953|531942565|FG000|Overall Study|Reason not Specified|2|||
147487745|NCT05113953|531942566|FG001|Overall Study|Reason not Specified|0|||
147487746|NCT05113953|531942567|FG002|Overall Study|Reason not Specified|0|||
147487747|NCT02626819|531942568|FG000|Overall Study|Lost to Follow-up|3|||
147487748|NCT02626819|531942569|FG001|Overall Study|Lost to Follow-up|2|||
147487749|NCT02626819|531942568|FG000|Overall Study|Withdrawal by Subject|1|||
147667806|NCT01326871|532608148|FG002|Overall Study|Did not qualify/consent for repeat treatment, subject decision to continue survival follow-up only|1|||
147487750|NCT02626819|531942569|FG001|Overall Study|Withdrawal by Subject|0|||
147487751|NCT02626819|531942568|FG000|Overall Study|Diagnosed w/ catastrophic illness|0|||
147487752|NCT02626819|531942569|FG001|Overall Study|Diagnosed w/ catastrophic illness|1|||
147487753|NCT00502307|531942570|FG000|Open Label Period (16 Weeks)|Progressive disease|50|||
147487754|NCT00502307|531942571|FG001|Open Label Period (16 Weeks)|Progressive disease|0|||
147487755|NCT00502307|531942572|FG002|Open Label Period (16 Weeks)|Progressive disease|0|||
147487756|NCT00502307|531942570|FG000|Open Label Period (16 Weeks)|Discontinued due to other reasons|26|||
147487757|NCT00502307|531942571|FG001|Open Label Period (16 Weeks)|Discontinued due to other reasons|0|||
147487758|NCT00502307|531942572|FG002|Open Label Period (16 Weeks)|Discontinued due to other reasons|0|||
147487759|NCT00502307|531942570|FG000|Double-Blind Period (12 Weeks)|Progressive disease|0|||
147487760|NCT00502307|531942571|FG001|Double-Blind Period (12 Weeks)|Progressive disease|23|||
147487761|NCT00502307|531942572|FG002|Double-Blind Period (12 Weeks)|Progressive disease|2|||
147487762|NCT00502307|531942570|FG000|Double-Blind Period (12 Weeks)|Discontinued due to other reasons|0|||
147487763|NCT00502307|531942571|FG001|Double-Blind Period (12 Weeks)|Discontinued due to other reasons|3|||
147487764|NCT00502307|531942572|FG002|Double-Blind Period (12 Weeks)|Discontinued due to other reasons|7|||
147487765|NCT00502307|531942570|FG000|Maintenance Period|Progressive disease|80|||
147487766|NCT00502307|531942571|FG001|Maintenance Period|Progressive disease|0|||
147487767|NCT00502307|531942572|FG002|Maintenance Period|Progressive disease|0|||
147487768|NCT00502307|531942570|FG000|Maintenance Period|Discontinued due to other reasons|68|||
147487769|NCT00502307|531942571|FG001|Maintenance Period|Discontinued due to other reasons|0|||
147487770|NCT00502307|531942572|FG002|Maintenance Period|Discontinued due to other reasons|0|||
147487771|NCT01998581|531942574|FG000|Overall Study|Refused repeat treatment|20|||
147487772|NCT01998581|531942575|FG001|Overall Study|Refused repeat treatment|4|||
147487773|NCT01998581|531942574|FG000|Overall Study|Protocol Violation|1|||
147487774|NCT01998581|531942575|FG001|Overall Study|Protocol Violation|0|||
147487775|NCT01998581|531942574|FG000|Overall Study|Withdrawal by Subject|8|||
147487776|NCT01998581|531942575|FG001|Overall Study|Withdrawal by Subject|1|||
147487777|NCT01998581|531942574|FG000|Overall Study|Lost to Follow-up|12|||
147487778|NCT01998581|531942575|FG001|Overall Study|Lost to Follow-up|4|||
147487779|NCT01998581|531942574|FG000|Overall Study|Adverse Event|1|||
147487780|NCT01998581|531942575|FG001|Overall Study|Adverse Event|1|||
147487781|NCT01998581|531942574|FG000|Overall Study|Other reasons|3|||
147487782|NCT01998581|531942575|FG001|Overall Study|Other reasons|2|||
147487783|NCT01998581|531942574|FG000|Overall Study|Randomized but withdrew before treatment|1|||
147487784|NCT01998581|531942575|FG001|Overall Study|Randomized but withdrew before treatment|0|||
147487785|NCT04346628|531942579|FG000|Overall Study|Lost to Follow-up|4|||
147487786|NCT04346628|531942580|FG001|Overall Study|Lost to Follow-up|4|||
147487787|NCT04346628|531942579|FG000|Overall Study|Withdrew (had personal reasons)|2|||
147487788|NCT04346628|531942580|FG001|Overall Study|Withdrew (had personal reasons)|5|||
147487789|NCT04346628|531942579|FG000|Overall Study|Withdrew (medication intolerant)|0|||
147487790|NCT04346628|531942580|FG001|Overall Study|Withdrew (medication intolerant)|3|||
147487791|NCT04346628|531942579|FG000|Overall Study|Withdrew (declined intervention)|0|||
147487792|NCT04346628|531942580|FG001|Overall Study|Withdrew (declined intervention)|1|||
147487793|NCT01763905|531942581|FG000|Overall Study|Withdrawal by Subject|1|||
147623875|NCT03896503|532441670|FG006|Initial Subgroup and Arm Enrollment|No treatment per protocol|0|||
147623876|NCT03896503|532441671|FG007|Initial Subgroup and Arm Enrollment|No treatment per protocol|0|||
147623877|NCT03896503|532441664|FG000|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|0|||
147623878|NCT03896503|532441665|FG001|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|0|||
147623879|NCT03896503|532441666|FG002|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|1|||
147623880|NCT03896503|532441667|FG003|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|0|||
147487794|NCT01763905|531942582|FG001|Overall Study|Withdrawal by Subject|1|||
147487795|NCT01763905|531942583|FG002|Overall Study|Withdrawal by Subject|0|||
147487796|NCT01763905|531942584|FG003|Overall Study|Withdrawal by Subject|1|||
147487797|NCT01763905|531942581|FG000|Overall Study|Decision by sponsor|5|||
147487798|NCT01763905|531942582|FG001|Overall Study|Decision by sponsor|0|||
147487799|NCT01763905|531942583|FG002|Overall Study|Decision by sponsor|8|||
147487800|NCT01763905|531942584|FG003|Overall Study|Decision by sponsor|0|||
147487801|NCT01763905|531942581|FG000|Overall Study|Lost to Follow-up|0|||
147487802|NCT01763905|531942582|FG001|Overall Study|Lost to Follow-up|0|||
147487803|NCT01763905|531942583|FG002|Overall Study|Lost to Follow-up|1|||
147487804|NCT01763905|531942584|FG003|Overall Study|Lost to Follow-up|0|||
147487805|NCT01597557|531942585|FG000|Overall Study|Did not undergo cardioversion procedure|4|||
147487806|NCT01597557|531942586|FG001|Overall Study|Did not undergo cardioversion procedure|3|||
147487807|NCT03165721|531942596|FG000|Overall Study|Refused further treatment|3|||
147487808|NCT03165721|531942597|FG001|Overall Study|Refused further treatment|0|||
147487809|NCT03165721|531942598|FG002|Overall Study|Refused further treatment|0|||
147487810|NCT03165721|531942596|FG000|Overall Study|Physician Decision|1|||
147487811|NCT03165721|531942597|FG001|Overall Study|Physician Decision|0|||
147487812|NCT03165721|531942598|FG002|Overall Study|Physician Decision|0|||
147487813|NCT01863849|531942599|FG000|Overall Study|Lost to Follow-up|1|||
147487814|NCT01863849|531942600|FG001|Overall Study|Lost to Follow-up|0|||
147487815|NCT01457118|531942601|FG000|Overall Study|Adverse Event|1|||
147487816|NCT01457118|531942602|FG001|Overall Study|Adverse Event|0|||
147487817|NCT01457118|531942603|FG002|Overall Study|Adverse Event|0|||
147487818|NCT01457118|531942604|FG003|Overall Study|Adverse Event|1|||
147487819|NCT01457118|531942601|FG000|Overall Study|Clinical Progression|0|||
147487820|NCT01457118|531942602|FG001|Overall Study|Clinical Progression|1|||
147487821|NCT01457118|531942603|FG002|Overall Study|Clinical Progression|0|||
147487822|NCT01457118|531942604|FG003|Overall Study|Clinical Progression|1|||
147487823|NCT01457118|531942601|FG000|Overall Study|Physician Decision|2|||
147487824|NCT01457118|531942602|FG001|Overall Study|Physician Decision|0|||
147487825|NCT01457118|531942603|FG002|Overall Study|Physician Decision|0|||
147487826|NCT01457118|531942604|FG003|Overall Study|Physician Decision|0|||
147487827|NCT01457118|531942601|FG000|Overall Study|Progressive Disease by RECIST|12|||
147487828|NCT01457118|531942602|FG001|Overall Study|Progressive Disease by RECIST|3|||
147487829|NCT01457118|531942603|FG002|Overall Study|Progressive Disease by RECIST|1|||
147487830|NCT01457118|531942604|FG003|Overall Study|Progressive Disease by RECIST|0|||
147487831|NCT01457118|531942601|FG000|Overall Study|Withdrawal by Subject|5|||
147487832|NCT01457118|531942602|FG001|Overall Study|Withdrawal by Subject|0|||
147487833|NCT01457118|531942603|FG002|Overall Study|Withdrawal by Subject|0|||
147487834|NCT01457118|531942604|FG003|Overall Study|Withdrawal by Subject|0|||
147487835|NCT02324842|531942605|FG000|Overall Study|Lost to Follow-up|1|||
147487836|NCT02324842|531942606|FG001|Overall Study|Lost to Follow-up|1|||
147487837|NCT02324842|531942607|FG002|Overall Study|Lost to Follow-up|2|||
147487838|NCT02750800|531942611|FG000|Overall Study|Adverse Event|18|||
147487839|NCT02750800|531942611|FG000|Overall Study|Lost to Follow-up|12|||
147487840|NCT02750800|531942611|FG000|Overall Study|Investigator decision|53|||
147487841|NCT02750800|531942611|FG000|Overall Study|Patient request|12|||
147487842|NCT02750800|531942611|FG000|Overall Study|Other, not specified|3|||
147487843|NCT03456713|531942614|FG000|Overall Study|Lost to Follow-up|1|||
147487844|NCT03456713|531942615|FG001|Overall Study|Lost to Follow-up|0|||
147487845|NCT03456713|531942616|FG002|Overall Study|Lost to Follow-up|0|||
147487846|NCT03456713|531942617|FG003|Overall Study|Lost to Follow-up|0|||
147487847|NCT01263691|531942618|FG000|Overall Study|Lost to Follow-up|1|||
147487848|NCT01263691|531942619|FG001|Overall Study|Lost to Follow-up|0|||
147487849|NCT01263691|531942620|FG002|Overall Study|Lost to Follow-up|1|||
147487850|NCT01263691|531942621|FG003|Overall Study|Lost to Follow-up|1|||
147487851|NCT01263691|531942622|FG004|Overall Study|Lost to Follow-up|0|||
147487852|NCT01263691|531942623|FG005|Overall Study|Lost to Follow-up|0|||
147487853|NCT01263691|531942618|FG000|Overall Study|Withdrawal by Subject|1|||
147487854|NCT01263691|531942619|FG001|Overall Study|Withdrawal by Subject|0|||
147487855|NCT01263691|531942620|FG002|Overall Study|Withdrawal by Subject|0|||
147487856|NCT01263691|531942621|FG003|Overall Study|Withdrawal by Subject|0|||
147487857|NCT01263691|531942622|FG004|Overall Study|Withdrawal by Subject|0|||
147487858|NCT01263691|531942623|FG005|Overall Study|Withdrawal by Subject|0|||
147487859|NCT01263691|531942618|FG000|Overall Study|Adverse Event|1|||
147487860|NCT01263691|531942619|FG001|Overall Study|Adverse Event|0|||
147487861|NCT01263691|531942620|FG002|Overall Study|Adverse Event|0|||
147487862|NCT01263691|531942621|FG003|Overall Study|Adverse Event|0|||
147487863|NCT01263691|531942622|FG004|Overall Study|Adverse Event|0|||
147487864|NCT01263691|531942623|FG005|Overall Study|Adverse Event|0|||
147487865|NCT01202227|531942626|FG000|Overall Study|Adverse Event|16|||
147487866|NCT01202227|531942626|FG000|Overall Study|Withdrawal by Subject|2|||
147487867|NCT01202227|531942626|FG000|Overall Study|Lack of Efficacy|1|||
147487868|NCT00643487|531942627|FG000|Overall Study|Technical difficulty|3|||
147487869|NCT00630812|531942638|FG000|Randomisation to First Dose|Adverse Event|1|||
147487870|NCT00630812|531942639|FG001|Randomisation to First Dose|Adverse Event|1|||
147487871|NCT00630812|531942638|FG000|Randomisation to First Dose|Withdrawal by Subject|2|||
147487872|NCT00630812|531942639|FG001|Randomisation to First Dose|Withdrawal by Subject|3|||
147487873|NCT00630812|531942638|FG000|Randomisation to First Dose|Lost to Follow-up|1|||
147487874|NCT00630812|531942639|FG001|Randomisation to First Dose|Lost to Follow-up|0|||
147487875|NCT00630812|531942638|FG000|Randomisation to First Dose|Protocol Violation|4|||
147487876|NCT00630812|531942639|FG001|Randomisation to First Dose|Protocol Violation|1|||
147487877|NCT00630812|531942638|FG000|Double Blind Treatment Period|Adverse Event|13|||
147487878|NCT00630812|531942639|FG001|Double Blind Treatment Period|Adverse Event|5|||
147487879|NCT00630812|531942638|FG000|Double Blind Treatment Period|Lost to Follow-up|1|||
147487880|NCT00630812|531942639|FG001|Double Blind Treatment Period|Lost to Follow-up|0|||
147487881|NCT00630812|531942638|FG000|Double Blind Treatment Period|Physician Decision|2|||
147487882|NCT00630812|531942639|FG001|Double Blind Treatment Period|Physician Decision|1|||
147487883|NCT00630812|531942638|FG000|Double Blind Treatment Period|Protocol Violation|1|||
147487884|NCT00630812|531942639|FG001|Double Blind Treatment Period|Protocol Violation|0|||
147487885|NCT00630812|531942638|FG000|Double Blind Treatment Period|Withdrawal by Subject|13|||
147487886|NCT00630812|531942639|FG001|Double Blind Treatment Period|Withdrawal by Subject|7|||
147487887|NCT00630812|531942638|FG000|Double Blind Treatment Period|Wanted to take drug in non-protocol way|1|||
147487888|NCT00630812|531942639|FG001|Double Blind Treatment Period|Wanted to take drug in non-protocol way|0|||
147487889|NCT00630812|531942638|FG000|Double Blind Treatment Period|Non-compliance|0|||
147487890|NCT00630812|531942639|FG001|Double Blind Treatment Period|Non-compliance|1|||
147487891|NCT03430245|531942642|FG000|Overall Study|Withdrawal by Subject|6|||
147487892|NCT03430245|531942642|FG000|Overall Study|Lost to Follow-up|1|||
147487893|NCT05628181|531942643|FG000|Overall Study|Death|2|||
147487894|NCT05628181|531942644|FG001|Overall Study|Death|4|||
147487895|NCT05628181|531942645|FG002|Overall Study|Death|0|||
147487896|NCT04102098|531942646|FG000|Main Study Period|Ongoing in study|302|||
147487897|NCT04102098|531942647|FG001|Main Study Period|Ongoing in study|291|||
147487898|NCT04102098|531942646|FG000|Main Study Period|Death|20|||
147487899|NCT04102098|531942647|FG001|Main Study Period|Death|27|||
147487900|NCT04102098|531942646|FG000|Main Study Period|Lost to Follow-up|1|||
147487901|NCT04102098|531942647|FG001|Main Study Period|Lost to Follow-up|1|||
147487902|NCT04102098|531942646|FG000|Main Study Period|Physician Decision|0|||
147487903|NCT04102098|531942647|FG001|Main Study Period|Physician Decision|1|||
147487904|NCT04102098|531942646|FG000|Main Study Period|Withdrawal by Subject|11|||
147487905|NCT04102098|531942647|FG001|Main Study Period|Withdrawal by Subject|14|||
147487906|NCT04102098|531942646|FG000|Crossover: AS Who Crossed Over|Withdrawal by Subject|1|||
147623881|NCT03896503|532441668|FG004|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|0|||
147623882|NCT03896503|532441669|FG005|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|1|||
147623883|NCT03896503|532441670|FG006|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|0|||
147623884|NCT03896503|532441671|FG007|Initial Subgroup and Arm Enrollment|Late determination of ineligibility|1|||
147623885|NCT03896503|532441664|FG000|Initial Subgroup and Arm Enrollment|Declined to participate|0|||
147623886|NCT03896503|532441665|FG001|Initial Subgroup and Arm Enrollment|Declined to participate|0|||
147487907|NCT04102098|531942647|FG001|Crossover: AS Who Crossed Over|Withdrawal by Subject|0|||
147487908|NCT04102098|531942646|FG000|Crossover: AS Who Crossed Over|Death|11|||
147487909|NCT04102098|531942647|FG001|Crossover: AS Who Crossed Over|Death|0|||
147487910|NCT04102098|531942646|FG000|Crossover: AS Who Crossed Over|Ongoing in study|69|||
147487911|NCT04102098|531942647|FG001|Crossover: AS Who Crossed Over|Ongoing in study|0|||
147487912|NCT04742907|531942654|FG000|Overall Study|Adverse Event|1|||
147487913|NCT04742907|531942655|FG001|Overall Study|Adverse Event|0|||
147487914|NCT04742907|531942656|FG002|Overall Study|Adverse Event|1|||
147487915|NCT04742907|531942654|FG000|Overall Study|Lost to Follow-up|3|||
147487916|NCT04742907|531942655|FG001|Overall Study|Lost to Follow-up|3|||
147487917|NCT04742907|531942656|FG002|Overall Study|Lost to Follow-up|2|||
147487918|NCT04742907|531942654|FG000|Overall Study|Physician Decision|0|||
147487919|NCT04742907|531942655|FG001|Overall Study|Physician Decision|1|||
147487920|NCT04742907|531942656|FG002|Overall Study|Physician Decision|0|||
147487921|NCT04742907|531942654|FG000|Overall Study|Protocol Violation|1|||
147487922|NCT04742907|531942655|FG001|Overall Study|Protocol Violation|1|||
147487923|NCT04742907|531942656|FG002|Overall Study|Protocol Violation|1|||
147487924|NCT04742907|531942654|FG000|Overall Study|Withdrawal by Subject|5|||
147487925|NCT04742907|531942655|FG001|Overall Study|Withdrawal by Subject|6|||
147487926|NCT04742907|531942656|FG002|Overall Study|Withdrawal by Subject|4|||
147487927|NCT04742907|531942654|FG000|Overall Study|Subject Refusal of Study Procedures or Unable to Take the Study Drug|2|||
147487928|NCT04742907|531942655|FG001|Overall Study|Subject Refusal of Study Procedures or Unable to Take the Study Drug|5|||
147487929|NCT04742907|531942656|FG002|Overall Study|Subject Refusal of Study Procedures or Unable to Take the Study Drug|2|||
147487930|NCT04742907|531942654|FG000|Overall Study|Did Not Receive the Study Drug|2|||
147487931|NCT04742907|531942655|FG001|Overall Study|Did Not Receive the Study Drug|4|||
147487932|NCT04742907|531942656|FG002|Overall Study|Did Not Receive the Study Drug|4|||
147487933|NCT00850759|531942658|FG000|Overall Study|Lost to Follow-up|7|||
147487934|NCT00850759|531942659|FG001|Overall Study|Lost to Follow-up|5|||
147487935|NCT00850759|531942660|FG002|Overall Study|Lost to Follow-up|5|||
147487936|NCT00850759|531942661|FG003|Overall Study|Lost to Follow-up|3|||
147487937|NCT03196505|531942662|FG000|Overall Study|Physician Decision|26|||
147487938|NCT03196505|531942663|FG001|Overall Study|Physician Decision|26|||
147487939|NCT01753076|531942664|FG000|Overall Study|Adverse Event|17|||
147487940|NCT01753076|531942665|FG001|Overall Study|Adverse Event|18|||
147487941|NCT01753076|531942664|FG000|Overall Study|Lack of Efficacy|3|||
147487942|NCT01753076|531942665|FG001|Overall Study|Lack of Efficacy|1|||
147487943|NCT01753076|531942664|FG000|Overall Study|Lost to Follow-up|2|||
147487944|NCT01753076|531942665|FG001|Overall Study|Lost to Follow-up|1|||
147487945|NCT01753076|531942664|FG000|Overall Study|Physician Decision|4|||
147487946|NCT01753076|531942665|FG001|Overall Study|Physician Decision|2|||
147487947|NCT01753076|531942664|FG000|Overall Study|Withdrawal by Subject|14|||
147487948|NCT01753076|531942665|FG001|Overall Study|Withdrawal by Subject|24|||
147487949|NCT01753076|531942664|FG000|Overall Study|Other-Reached Protocol-defined Stopping|1|||
147487950|NCT01753076|531942665|FG001|Overall Study|Other-Reached Protocol-defined Stopping|0|||
147487951|NCT02389816|531942666|FG000|Overall Study|Randomized but Not Treated|1|||
147487952|NCT02389816|531942667|FG001|Overall Study|Randomized but Not Treated|0|||
147487953|NCT02389816|531942668|FG002|Overall Study|Randomized but Not Treated|0|||
147487954|NCT02389816|531942666|FG000|Overall Study|Pretreatment Event or Adverse Event (AE)|4|||
147487955|NCT02389816|531942667|FG001|Overall Study|Pretreatment Event or Adverse Event (AE)|6|||
147487956|NCT02389816|531942668|FG002|Overall Study|Pretreatment Event or Adverse Event (AE)|7|||
147487957|NCT02389816|531942666|FG000|Overall Study|Major Protocol Deviation|1|||
147487958|NCT02389816|531942667|FG001|Overall Study|Major Protocol Deviation|0|||
147487959|NCT02389816|531942668|FG002|Overall Study|Major Protocol Deviation|0|||
147487960|NCT02389816|531942666|FG000|Overall Study|Lost to Follow-up|1|||
147487961|NCT02389816|531942667|FG001|Overall Study|Lost to Follow-up|0|||
147487962|NCT02389816|531942668|FG002|Overall Study|Lost to Follow-up|0|||
147487963|NCT02389816|531942666|FG000|Overall Study|Withdrawal of Consent|6|||
147487964|NCT02389816|531942667|FG001|Overall Study|Withdrawal of Consent|4|||
147487965|NCT02389816|531942668|FG002|Overall Study|Withdrawal of Consent|4|||
147487966|NCT02389816|531942666|FG000|Overall Study|Lack of Efficacy|1|||
147487967|NCT02389816|531942667|FG001|Overall Study|Lack of Efficacy|0|||
147487968|NCT02389816|531942668|FG002|Overall Study|Lack of Efficacy|0|||
147487969|NCT02389816|531942666|FG000|Overall Study|Non Compliance with Study Drug|1|||
147487970|NCT02389816|531942667|FG001|Overall Study|Non Compliance with Study Drug|1|||
147487971|NCT02389816|531942668|FG002|Overall Study|Non Compliance with Study Drug|1|||
147487972|NCT02389816|531942666|FG000|Overall Study|Reason not Specified|0|||
147487973|NCT02389816|531942667|FG001|Overall Study|Reason not Specified|2|||
147487974|NCT02389816|531942668|FG002|Overall Study|Reason not Specified|0|||
147487975|NCT01259856|531942675|FG000|Overall Study|Adverse Event|12|||
147487976|NCT01259856|531942676|FG001|Overall Study|Adverse Event|9|||
147487977|NCT01259856|531942675|FG000|Overall Study|Death|0|||
147487978|NCT01259856|531942676|FG001|Overall Study|Death|1|||
147487979|NCT01259856|531942675|FG000|Overall Study|Lack of Efficacy|3|||
147487980|NCT01259856|531942676|FG001|Overall Study|Lack of Efficacy|1|||
147487981|NCT01259856|531942675|FG000|Overall Study|Lost to Follow-up|1|||
147487982|NCT01259856|531942676|FG001|Overall Study|Lost to Follow-up|1|||
147487983|NCT01259856|531942675|FG000|Overall Study|Physician Decision|2|||
147487984|NCT01259856|531942676|FG001|Overall Study|Physician Decision|1|||
147487985|NCT01259856|531942675|FG000|Overall Study|Withdrawal by Subject|9|||
147487986|NCT01259856|531942676|FG001|Overall Study|Withdrawal by Subject|10|||
147487987|NCT01259856|531942675|FG000|Overall Study|Treatment never started|0|||
147487988|NCT01259856|531942676|FG001|Overall Study|Treatment never started|6|||
147487989|NCT01259856|531942675|FG000|Overall Study|Study closure by sponsor|40|||
147487990|NCT01259856|531942676|FG001|Overall Study|Study closure by sponsor|41|||
147487991|NCT01259856|531942675|FG000|Overall Study|Patient developed other disease|0|||
147487992|NCT01259856|531942676|FG001|Overall Study|Patient developed other disease|1|||
147487993|NCT01259856|531942675|FG000|Overall Study|Transfer to another study|0|||
147487994|NCT01259856|531942676|FG001|Overall Study|Transfer to another study|1|||
147487995|NCT01259856|531942675|FG000|Overall Study|Unknown/missing|2|||
147487996|NCT01259856|531942676|FG001|Overall Study|Unknown/missing|2|||
147487997|NCT00788775|531942677|FG000|Overall Study|Progressive Disease|8|||
147487998|NCT00788775|531942678|FG001|Overall Study|Progressive Disease|6|||
147487999|NCT00788775|531942677|FG000|Overall Study|Withdrawal by Subject|0|||
147488000|NCT00788775|531942678|FG001|Overall Study|Withdrawal by Subject|2|||
147488001|NCT00788775|531942677|FG000|Overall Study|Patient Non-Compliance|1|||
147488002|NCT00788775|531942678|FG001|Overall Study|Patient Non-Compliance|0|||
147488003|NCT00788775|531942677|FG000|Overall Study|Patient's measurable disease resected.|1|||
147488004|NCT00788775|531942678|FG001|Overall Study|Patient's measurable disease resected.|0|||
147488005|NCT00578864|531942679|FG000|Overall Study|Death|1|||
147488006|NCT00578864|531942680|FG001|Overall Study|Death|0|||
147488007|NCT01217190|531942684|FG000|Second Dosing|Withdrawal by Subject|0|||
147488008|NCT01217190|531942685|FG001|Second Dosing|Withdrawal by Subject|2|||
147488009|NCT01594476|531942686|FG000|Overall Study|Protocol Violation|1|||
147488010|NCT01594476|531942687|FG001|Overall Study|Protocol Violation|3|||
147488011|NCT00938327|531942688|FG000|Overall Study|Adverse Event|2|||
147488012|NCT00938327|531942688|FG000|Overall Study|Protocol Violation|1|||
147488013|NCT00938327|531942688|FG000|Overall Study|Withdrawal by Subject|4|||
147488014|NCT00938327|531942688|FG000|Overall Study|Lost to Follow-up|37|||
147488015|NCT00938327|531942688|FG000|Overall Study|2nd dose received outside of the study|7|||
147488016|NCT00938327|531942688|FG000|Overall Study|Vaccine not received as out of stock|9|||
147488017|NCT03007953|531942691|FG000|Overall Study|Withdrawal by Subject|5|||
147488018|NCT03007953|531942692|FG001|Overall Study|Withdrawal by Subject|2|||
147488019|NCT03007953|531942691|FG000|Overall Study|Death|5|||
147488020|NCT03007953|531942692|FG001|Overall Study|Death|7|||
147488021|NCT03007953|531942691|FG000|Overall Study|Lost to Follow-up|3|||
147488022|NCT03007953|531942692|FG001|Overall Study|Lost to Follow-up|2|||
147488023|NCT03007953|531942691|FG000|Overall Study|Enrolled in Hospice|3|||
147488024|NCT03007953|531942692|FG001|Overall Study|Enrolled in Hospice|2|||
147488025|NCT01635933|531942696|FG000|Overall Study|Adverse Event|1|||
147488026|NCT01635933|531942697|FG001|Overall Study|Adverse Event|0|||
147488027|NCT01635933|531942696|FG000|Overall Study|Lost to Follow-up|0|||
147488028|NCT01635933|531942697|FG001|Overall Study|Lost to Follow-up|5|||
147488029|NCT01635933|531942696|FG000|Overall Study|Subject decision|1|||
147488030|NCT01635933|531942697|FG001|Overall Study|Subject decision|1|||
147488031|NCT01635933|531942696|FG000|Overall Study|Noncompliance|0|||
147488032|NCT01635933|531942697|FG001|Overall Study|Noncompliance|1|||
147488033|NCT01635933|531942696|FG000|Overall Study|No longer had transportation|0|||
147623887|NCT03896503|532441666|FG002|Initial Subgroup and Arm Enrollment|Declined to participate|1|||
147488034|NCT01635933|531942697|FG001|Overall Study|No longer had transportation|1|||
147488035|NCT01544595|531942698|FG000|Status at Week 68|Adverse Event|3|||
147623888|NCT03896503|532441667|FG003|Initial Subgroup and Arm Enrollment|Declined to participate|1|||
147488036|NCT01544595|531942699|FG001|Status at Week 68|Adverse Event|2|||
147488037|NCT01544595|531942700|FG002|Status at Week 68|Adverse Event|1|||
147488038|NCT01544595|531942701|FG003|Status at Week 68|Adverse Event|0|||
147488039|NCT01544595|531942702|FG004|Status at Week 68|Adverse Event|0|||
147488040|NCT01544595|531942703|FG005|Status at Week 68|Adverse Event|0|||
147488041|NCT01544595|531942698|FG000|Status at Week 68|Lack of Efficacy|1|||
147488042|NCT01544595|531942699|FG001|Status at Week 68|Lack of Efficacy|0|||
147488043|NCT01544595|531942700|FG002|Status at Week 68|Lack of Efficacy|0|||
147488044|NCT01544595|531942701|FG003|Status at Week 68|Lack of Efficacy|0|||
147488045|NCT01544595|531942702|FG004|Status at Week 68|Lack of Efficacy|0|||
147488046|NCT01544595|531942703|FG005|Status at Week 68|Lack of Efficacy|0|||
147488047|NCT01544595|531942698|FG000|Status at Week 68|Lost to Follow-up|1|||
147488048|NCT01544595|531942699|FG001|Status at Week 68|Lost to Follow-up|1|||
147488049|NCT01544595|531942700|FG002|Status at Week 68|Lost to Follow-up|0|||
147488050|NCT01544595|531942701|FG003|Status at Week 68|Lost to Follow-up|0|||
147488051|NCT01544595|531942702|FG004|Status at Week 68|Lost to Follow-up|0|||
147488052|NCT01544595|531942703|FG005|Status at Week 68|Lost to Follow-up|0|||
147488053|NCT01544595|531942698|FG000|Status at Week 68|Non-compliance with study treatment|1|||
147488054|NCT01544595|531942699|FG001|Status at Week 68|Non-compliance with study treatment|0|||
147488055|NCT01544595|531942700|FG002|Status at Week 68|Non-compliance with study treatment|0|||
147488056|NCT01544595|531942701|FG003|Status at Week 68|Non-compliance with study treatment|1|||
147488057|NCT01544595|531942702|FG004|Status at Week 68|Non-compliance with study treatment|0|||
147488058|NCT01544595|531942703|FG005|Status at Week 68|Non-compliance with study treatment|0|||
147488059|NCT01544595|531942698|FG000|Status at Week 68|Protocol Violation|2|||
147488060|NCT01544595|531942699|FG001|Status at Week 68|Protocol Violation|0|||
147488061|NCT01544595|531942700|FG002|Status at Week 68|Protocol Violation|1|||
147488062|NCT01544595|531942701|FG003|Status at Week 68|Protocol Violation|1|||
147488063|NCT01544595|531942702|FG004|Status at Week 68|Protocol Violation|0|||
147488064|NCT01544595|531942703|FG005|Status at Week 68|Protocol Violation|0|||
147488065|NCT01544595|531942698|FG000|Status at Week 68|Technical problems|1|||
147488066|NCT01544595|531942699|FG001|Status at Week 68|Technical problems|0|||
147488067|NCT01544595|531942700|FG002|Status at Week 68|Technical problems|0|||
147488068|NCT01544595|531942701|FG003|Status at Week 68|Technical problems|1|||
147488069|NCT01544595|531942702|FG004|Status at Week 68|Technical problems|0|||
147488070|NCT01544595|531942703|FG005|Status at Week 68|Technical problems|0|||
147667807|NCT01326871|532608146|FG000|Overall Study|Did not qualify or consent for repeat treatment and disease progression|0|||
147667808|NCT01326871|532608147|FG001|Overall Study|Did not qualify or consent for repeat treatment and disease progression|0|||
147667809|NCT01326871|532608148|FG002|Overall Study|Did not qualify or consent for repeat treatment and disease progression|1|||
147667810|NCT01326871|532608146|FG000|Overall Study|Physician decision, AEs and subject compliance|0|||
147667811|NCT01326871|532608147|FG001|Overall Study|Physician decision, AEs and subject compliance|0|||
147667812|NCT01326871|532608148|FG002|Overall Study|Physician decision, AEs and subject compliance|1|||
147667813|NCT01326871|532608146|FG000|Overall Study|Physician Decision|0|||
147667814|NCT01326871|532608147|FG001|Overall Study|Physician Decision|0|||
147667815|NCT01326871|532608148|FG002|Overall Study|Physician Decision|1|||
147667816|NCT01326871|532608146|FG000|Overall Study|SAE|0|||
147667817|NCT01326871|532608147|FG001|Overall Study|SAE|0|||
147667818|NCT01326871|532608148|FG002|Overall Study|SAE|1|||
147667819|NCT01326871|532608146|FG000|Overall Study|Disease progression and death|0|||
147667820|NCT01326871|532608147|FG001|Overall Study|Disease progression and death|0|||
147488071|NCT01544595|531942698|FG000|Status at Week 68|Withdrawal by Subject|0|||
147488072|NCT01544595|531942699|FG001|Status at Week 68|Withdrawal by Subject|1|||
147488073|NCT01544595|531942700|FG002|Status at Week 68|Withdrawal by Subject|1|||
147488074|NCT01544595|531942701|FG003|Status at Week 68|Withdrawal by Subject|2|||
147488075|NCT01544595|531942702|FG004|Status at Week 68|Withdrawal by Subject|0|||
147488076|NCT01544595|531942703|FG005|Status at Week 68|Withdrawal by Subject|0|||
147488077|NCT01544595|531942698|FG000|Status at Week 68|Moved to treatment period ≤ wk 68|30|||
147488078|NCT01544595|531942699|FG001|Status at Week 68|Moved to treatment period ≤ wk 68|13|||
147488079|NCT01544595|531942700|FG002|Status at Week 68|Moved to treatment period ≤ wk 68|60|||
147488080|NCT01544595|531942701|FG003|Status at Week 68|Moved to treatment period ≤ wk 68|46|||
147488081|NCT01544595|531942702|FG004|Status at Week 68|Moved to treatment period ≤ wk 68|0|||
147488082|NCT01544595|531942703|FG005|Status at Week 68|Moved to treatment period ≤ wk 68|0|||
147488083|NCT01544595|531942698|FG000|Status at Week 156|Withdrawal by Subject|9|||
147488084|NCT01544595|531942699|FG001|Status at Week 156|Withdrawal by Subject|10|||
147488085|NCT01544595|531942700|FG002|Status at Week 156|Withdrawal by Subject|4|||
147488086|NCT01544595|531942701|FG003|Status at Week 156|Withdrawal by Subject|9|||
147488087|NCT01544595|531942702|FG004|Status at Week 156|Withdrawal by Subject|20|||
147488088|NCT01544595|531942703|FG005|Status at Week 156|Withdrawal by Subject|6|||
147488089|NCT01544595|531942698|FG000|Status at Week 156|Adverse Event|9|||
147488090|NCT01544595|531942699|FG001|Status at Week 156|Adverse Event|11|||
147488091|NCT01544595|531942700|FG002|Status at Week 156|Adverse Event|1|||
147488092|NCT01544595|531942701|FG003|Status at Week 156|Adverse Event|3|||
147488093|NCT01544595|531942702|FG004|Status at Week 156|Adverse Event|4|||
147488094|NCT01544595|531942703|FG005|Status at Week 156|Adverse Event|2|||
147488095|NCT01544595|531942698|FG000|Status at Week 156|Lost to Follow-up|4|||
147488096|NCT01544595|531942699|FG001|Status at Week 156|Lost to Follow-up|4|||
147488097|NCT01544595|531942700|FG002|Status at Week 156|Lost to Follow-up|0|||
147488098|NCT01544595|531942701|FG003|Status at Week 156|Lost to Follow-up|1|||
147667821|NCT01326871|532608148|FG002|Overall Study|Disease progression and death|1|||
147667822|NCT01326871|532608146|FG000|Overall Study|Subject decision|0|||
147488099|NCT01544595|531942702|FG004|Status at Week 156|Lost to Follow-up|4|||
147488100|NCT01544595|531942703|FG005|Status at Week 156|Lost to Follow-up|1|||
147488101|NCT01544595|531942698|FG000|Status at Week 156|Non-compliance with study treatement|0|||
147488102|NCT01544595|531942699|FG001|Status at Week 156|Non-compliance with study treatement|1|||
147488103|NCT01544595|531942700|FG002|Status at Week 156|Non-compliance with study treatement|0|||
147488104|NCT01544595|531942701|FG003|Status at Week 156|Non-compliance with study treatement|1|||
147488105|NCT01544595|531942702|FG004|Status at Week 156|Non-compliance with study treatement|0|||
147488106|NCT01544595|531942703|FG005|Status at Week 156|Non-compliance with study treatement|1|||
147488107|NCT01544595|531942698|FG000|Status at Week 156|Physician Decision|0|||
147488108|NCT01544595|531942699|FG001|Status at Week 156|Physician Decision|3|||
147488109|NCT01544595|531942700|FG002|Status at Week 156|Physician Decision|1|||
147488110|NCT01544595|531942701|FG003|Status at Week 156|Physician Decision|0|||
147488111|NCT01544595|531942702|FG004|Status at Week 156|Physician Decision|0|||
147488112|NCT01544595|531942703|FG005|Status at Week 156|Physician Decision|0|||
147488113|NCT01544595|531942698|FG000|Status at Week 156|Pregnancy|2|||
147488114|NCT01544595|531942699|FG001|Status at Week 156|Pregnancy|3|||
147488115|NCT01544595|531942700|FG002|Status at Week 156|Pregnancy|0|||
147488116|NCT01544595|531942701|FG003|Status at Week 156|Pregnancy|0|||
147488117|NCT01544595|531942702|FG004|Status at Week 156|Pregnancy|0|||
147488118|NCT01544595|531942703|FG005|Status at Week 156|Pregnancy|0|||
147488119|NCT01544595|531942698|FG000|Status at Week 156|Protocol Violation|3|||
147488120|NCT01544595|531942699|FG001|Status at Week 156|Protocol Violation|1|||
147488121|NCT01544595|531942700|FG002|Status at Week 156|Protocol Violation|2|||
147488122|NCT01544595|531942701|FG003|Status at Week 156|Protocol Violation|2|||
147488123|NCT01544595|531942702|FG004|Status at Week 156|Protocol Violation|0|||
147488124|NCT01544595|531942703|FG005|Status at Week 156|Protocol Violation|0|||
147488125|NCT01544595|531942698|FG000|Status at Week 156|Technical problems|3|||
147488126|NCT01544595|531942699|FG001|Status at Week 156|Technical problems|1|||
147488127|NCT01544595|531942700|FG002|Status at Week 156|Technical problems|0|||
147488128|NCT01544595|531942701|FG003|Status at Week 156|Technical problems|1|||
147488129|NCT01544595|531942702|FG004|Status at Week 156|Technical problems|0|||
147488130|NCT01544595|531942703|FG005|Status at Week 156|Technical problems|0|||
147488131|NCT01544595|531942698|FG000|Status at Week 156|Moved to treatment period ≤ wk 156|86|||
147488132|NCT01544595|531942699|FG001|Status at Week 156|Moved to treatment period ≤ wk 156|44|||
147488133|NCT01544595|531942700|FG002|Status at Week 156|Moved to treatment period ≤ wk 156|131|||
147488134|NCT01544595|531942701|FG003|Status at Week 156|Moved to treatment period ≤ wk 156|145|||
147488135|NCT01544595|531942702|FG004|Status at Week 156|Moved to treatment period ≤ wk 156|0|||
147488136|NCT01544595|531942703|FG005|Status at Week 156|Moved to treatment period ≤ wk 156|0|||
147488137|NCT01544595|531942698|FG000|Status at Week 156|Lack of Efficacy|1|||
147488138|NCT01544595|531942699|FG001|Status at Week 156|Lack of Efficacy|0|||
147488139|NCT01544595|531942700|FG002|Status at Week 156|Lack of Efficacy|1|||
147488140|NCT01544595|531942701|FG003|Status at Week 156|Lack of Efficacy|4|||
147488141|NCT01544595|531942702|FG004|Status at Week 156|Lack of Efficacy|10|||
147488142|NCT01544595|531942703|FG005|Status at Week 156|Lack of Efficacy|5|||
147488143|NCT00601523|531942706|FG000|Overall Study|Adverse Event|42|||
147488144|NCT00601523|531942707|FG001|Overall Study|Adverse Event|14|||
147488145|NCT00601523|531942706|FG000|Overall Study|Lack of Efficacy|3|||
147488146|NCT00601523|531942707|FG001|Overall Study|Lack of Efficacy|0|||
147488147|NCT00601523|531942706|FG000|Overall Study|Protocol Violation|5|||
147488148|NCT00601523|531942707|FG001|Overall Study|Protocol Violation|1|||
147488149|NCT00601523|531942706|FG000|Overall Study|Lost to Follow-up|0|||
147488150|NCT00601523|531942707|FG001|Overall Study|Lost to Follow-up|1|||
147488151|NCT00601523|531942706|FG000|Overall Study|Withdrawal by Subject|18|||
147488152|NCT00601523|531942707|FG001|Overall Study|Withdrawal by Subject|9|||
147488153|NCT00601523|531942706|FG000|Overall Study|Other|9|||
147488154|NCT00601523|531942707|FG001|Overall Study|Other|1|||
147488155|NCT00804193|531942708|FG000|Overall Study|Lack of baseline fungus|32|||
147488156|NCT00804193|531942709|FG001|Overall Study|Lack of baseline fungus|31|||
147488157|NCT00804193|531942710|FG002|Overall Study|Lack of baseline fungus|19|||
147488158|NCT00804193|531942708|FG000|Overall Study|Adverse Event|0|||
147488159|NCT00804193|531942709|FG001|Overall Study|Adverse Event|0|||
147488160|NCT00804193|531942710|FG002|Overall Study|Adverse Event|2|||
147623889|NCT03896503|532441668|FG004|Initial Subgroup and Arm Enrollment|Declined to participate|1|||
147623890|NCT03896503|532441669|FG005|Initial Subgroup and Arm Enrollment|Declined to participate|1|||
147623891|NCT03896503|532441670|FG006|Initial Subgroup and Arm Enrollment|Declined to participate|0|||
147623892|NCT03896503|532441671|FG007|Initial Subgroup and Arm Enrollment|Declined to participate|0|||
147488161|NCT00804193|531942708|FG000|Overall Study|Lack of Efficacy|1|||
147488162|NCT00804193|531942709|FG001|Overall Study|Lack of Efficacy|1|||
147488163|NCT00804193|531942710|FG002|Overall Study|Lack of Efficacy|3|||
147488164|NCT00804193|531942708|FG000|Overall Study|Protocol Violation|0|||
147488165|NCT00804193|531942709|FG001|Overall Study|Protocol Violation|8|||
147488166|NCT00804193|531942710|FG002|Overall Study|Protocol Violation|2|||
147488167|NCT00804193|531942708|FG000|Overall Study|Lost to Follow-up|3|||
147488168|NCT00804193|531942709|FG001|Overall Study|Lost to Follow-up|3|||
147488169|NCT00804193|531942710|FG002|Overall Study|Lost to Follow-up|4|||
147488170|NCT00804193|531942708|FG000|Overall Study|Withdrawal by Subject|3|||
147488171|NCT00804193|531942709|FG001|Overall Study|Withdrawal by Subject|1|||
147488172|NCT00804193|531942710|FG002|Overall Study|Withdrawal by Subject|2|||
147488173|NCT04072146|531942711|FG000|Overall Study|Adverse Event|0|||
147488174|NCT04072146|531942712|FG001|Overall Study|Adverse Event|1|||
147488175|NCT01617434|531942713|FG000|Overall Study|Adverse Event|12|||
147488176|NCT01617434|531942714|FG001|Overall Study|Adverse Event|3|||
147488177|NCT01617434|531942713|FG000|Overall Study|Protocol Violation|8|||
147488178|NCT01617434|531942714|FG001|Overall Study|Protocol Violation|7|||
147488179|NCT01617434|531942713|FG000|Overall Study|Withdrawal Criteria|12|||
147488180|NCT01617434|531942714|FG001|Overall Study|Withdrawal Criteria|37|||
147488181|NCT01617434|531942713|FG000|Overall Study|Unclassified|3|||
147488182|NCT01617434|531942714|FG001|Overall Study|Unclassified|4|||
147488183|NCT01193348|531942715|FG000|Screening Period|Screen Failure|5|||
147488184|NCT01193348|531942715|FG000|Treatment Period (26 Weeks)|Positive Shiga-Toxin Result vial Local|1|||
147488185|NCT01193348|531942715|FG000|Treatment Period (26 Weeks)|Serious Adverse Event|1|||
147488186|NCT01193348|531942715|FG000|Treatment Period (26 Weeks)|Patient Requested to Withdraw|1|||
147488187|NCT01193348|531942715|FG000|Extension Treatment Period|Physician Decision|1|||
147488188|NCT01193348|531942715|FG000|Post Treatment Period (Patients Who Disc|Patient did not return for visit|2|||
147488189|NCT01721408|531942716|FG000|Overall Study|Adverse Event|6|||
147488190|NCT01721408|531942717|FG001|Overall Study|Adverse Event|1|||
147488191|NCT01721408|531942716|FG000|Overall Study|Death|1|||
147488192|NCT01721408|531942717|FG001|Overall Study|Death|0|||
147488193|NCT01721408|531942716|FG000|Overall Study|Insufficient clinical response|15|||
147488194|NCT01721408|531942717|FG001|Overall Study|Insufficient clinical response|6|||
147488195|NCT01721408|531942716|FG000|Overall Study|No longer willing to participate study|9|||
147488196|NCT01721408|531942717|FG001|Overall Study|No longer willing to participate study|10|||
147488197|NCT01721408|531942716|FG000|Overall Study|Protocol Violation|0|||
147488198|NCT01721408|531942717|FG001|Overall Study|Protocol Violation|2|||
147488199|NCT01721408|531942716|FG000|Overall Study|Other|3|||
147488200|NCT01721408|531942717|FG001|Overall Study|Other|3|||
147488201|NCT01721408|531942716|FG000|Overall Study|Lost to Follow-up|1|||
147488202|NCT01721408|531942717|FG001|Overall Study|Lost to Follow-up|2|||
147488203|NCT01721408|531942716|FG000|Overall Study|Does not meet entrance criteria|1|||
147488204|NCT01721408|531942717|FG001|Overall Study|Does not meet entrance criteria|0|||
147488205|NCT04160468|531942718|FG000|Overall Study|Lost to Follow-up|19|||
147488206|NCT04160468|531942719|FG001|Overall Study|Lost to Follow-up|4|||
147488207|NCT04160468|531942718|FG000|Overall Study|Randomized but not dosed|6|||
147488208|NCT04160468|531942719|FG001|Overall Study|Randomized but not dosed|0|||
147488209|NCT04160468|531942718|FG000|Overall Study|Withdrawal by Subject|4|||
147488210|NCT04160468|531942719|FG001|Overall Study|Withdrawal by Subject|1|||
147488211|NCT04160468|531942718|FG000|Overall Study|Participant unable/unwilling to adhere to protocol|1|||
147488212|NCT04160468|531942719|FG001|Overall Study|Participant unable/unwilling to adhere to protocol|0|||
147488213|NCT04160468|531942718|FG000|Overall Study|Participant incarcerated|1|||
147488214|NCT04160468|531942719|FG001|Overall Study|Participant incarcerated|0|||
147488215|NCT01187901|531942720|FG000|Overall Study|Protocol Violation|1|||
147488216|NCT01187901|531942721|FG001|Overall Study|Protocol Violation|0|||
147488217|NCT01187901|531942720|FG000|Overall Study|Lost to Follow-up|1|||
147488218|NCT01187901|531942721|FG001|Overall Study|Lost to Follow-up|2|||
147623893|NCT03896503|532441664|FG000|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
147623894|NCT03896503|532441665|FG001|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
147623895|NCT03896503|532441666|FG002|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|4|||
147623896|NCT03896503|532441667|FG003|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
147623897|NCT03896503|532441668|FG004|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
147623898|NCT03896503|532441669|FG005|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
147623899|NCT03896503|532441670|FG006|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|1|||
147623900|NCT03896503|532441671|FG007|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
147623901|NCT03896503|532441664|FG000|Initial Subgroup and Arm Enrollment|Not treated; screen failure|0|||
147623902|NCT03896503|532441665|FG001|Initial Subgroup and Arm Enrollment|Not treated; screen failure|0|||
147623903|NCT03896503|532441666|FG002|Initial Subgroup and Arm Enrollment|Not treated; screen failure|2|||
147623904|NCT03896503|532441667|FG003|Initial Subgroup and Arm Enrollment|Not treated; screen failure|0|||
147623905|NCT03896503|532441668|FG004|Initial Subgroup and Arm Enrollment|Not treated; screen failure|0|||
147623906|NCT03896503|532441669|FG005|Initial Subgroup and Arm Enrollment|Not treated; screen failure|3|||
147623907|NCT03896503|532441670|FG006|Initial Subgroup and Arm Enrollment|Not treated; screen failure|0|||
147623908|NCT03896503|532441671|FG007|Initial Subgroup and Arm Enrollment|Not treated; screen failure|2|||
147623909|NCT03896503|532441664|FG000|Initial Subgroup and Arm Enrollment|Refused further treatment|2|||
147488219|NCT01187901|531942720|FG000|Overall Study|Unrelated Health Reasons|1|||
147488220|NCT01187901|531942721|FG001|Overall Study|Unrelated Health Reasons|2|||
147488221|NCT01187901|531942720|FG000|Overall Study|Suspected Allergic Reaction|1|||
147488222|NCT01187901|531942721|FG001|Overall Study|Suspected Allergic Reaction|1|||
147488223|NCT01187901|531942720|FG000|Overall Study|Adverse Event|3|||
147488224|NCT01187901|531942721|FG001|Overall Study|Adverse Event|0|||
147488225|NCT01187901|531942720|FG000|Overall Study|No Endpoint due to Early Study Halt|2|||
147488226|NCT01187901|531942721|FG001|Overall Study|No Endpoint due to Early Study Halt|3|||
147488227|NCT01187901|531942720|FG000|Overall Study|Pregnancy|0|||
147488228|NCT01187901|531942721|FG001|Overall Study|Pregnancy|2|||
147667823|NCT01326871|532608147|FG001|Overall Study|Subject decision|0|||
147667824|NCT01326871|532608148|FG002|Overall Study|Subject decision|1|||
147667825|NCT02873689|532609740|FG000|Overall Study|Lack of Efficacy|1|||
147667826|NCT02873689|532609741|FG001|Overall Study|Lack of Efficacy|0|||
147667827|NCT02873689|532609740|FG000|Overall Study|Withdrawal by Subject|2|||
147667828|NCT02873689|532609741|FG001|Overall Study|Withdrawal by Subject|2|||
147667829|NCT02873689|532609740|FG000|Overall Study|Protocol Violation|1|||
147667830|NCT02873689|532609741|FG001|Overall Study|Protocol Violation|0|||
147667831|NCT02873689|532609740|FG000|Overall Study|Adverse Event|2|||
147667832|NCT02873689|532609741|FG001|Overall Study|Adverse Event|2|||
147667833|NCT02873689|532609740|FG000|Overall Study|Randomized but not Treated|1|||
147667834|NCT02873689|532609741|FG001|Overall Study|Randomized but not Treated|1|||
147667835|NCT00350545|532609742|FG000|Overall Study|Withdrawal by Subject|2|||
147667836|NCT00720278|532609765|FG000|Overall Study|Adverse Event|5|||
147667837|NCT00720278|532609766|FG001|Overall Study|Adverse Event|3|||
147667838|NCT00720278|532609767|FG002|Overall Study|Adverse Event|4|||
147667839|NCT00720278|532609765|FG000|Overall Study|Withdrawal by Subject|0|||
147667840|NCT00720278|532609766|FG001|Overall Study|Withdrawal by Subject|1|||
147667841|NCT00720278|532609767|FG002|Overall Study|Withdrawal by Subject|0|||
147667842|NCT00720278|532609765|FG000|Overall Study|Lost to Follow-up|0|||
147667843|NCT00720278|532609766|FG001|Overall Study|Lost to Follow-up|0|||
147667844|NCT00720278|532609767|FG002|Overall Study|Lost to Follow-up|1|||
147667845|NCT00720278|532609765|FG000|Overall Study|Non-compliance|1|||
147667846|NCT00720278|532609766|FG001|Overall Study|Non-compliance|0|||
147667847|NCT00720278|532609767|FG002|Overall Study|Non-compliance|0|||
147667848|NCT00720278|532609765|FG000|Overall Study|eligibility criteria violation|1|||
147667849|NCT00720278|532609766|FG001|Overall Study|eligibility criteria violation|0|||
147667850|NCT00720278|532609767|FG002|Overall Study|eligibility criteria violation|1|||
147667851|NCT03630393|532609771|FG000|Overall Study|Death|1|||
147667852|NCT03630393|532609772|FG001|Overall Study|Death|0|||
147667853|NCT00408499|532609773|FG000|Phase 1: Dose Levels 1-4|Adverse Event|0|||
147667854|NCT00408499|532609774|FG001|Phase 1: Dose Levels 1-4|Adverse Event|0|||
147667855|NCT00408499|532609775|FG002|Phase 1: Dose Levels 1-4|Adverse Event|1|||
147667856|NCT00408499|532609776|FG003|Phase 1: Dose Levels 1-4|Adverse Event|0|||
147667857|NCT00408499|532609777|FG004|Phase 1: Dose Levels 1-4|Adverse Event|0|||
147667858|NCT00408499|532609773|FG000|Phase 1: Dose Levels 1-4|Withdrawal by Subject|1|||
147667859|NCT00408499|532609774|FG001|Phase 1: Dose Levels 1-4|Withdrawal by Subject|1|||
147667860|NCT00408499|532609775|FG002|Phase 1: Dose Levels 1-4|Withdrawal by Subject|0|||
147667861|NCT00408499|532609776|FG003|Phase 1: Dose Levels 1-4|Withdrawal by Subject|0|||
147667862|NCT00408499|532609777|FG004|Phase 1: Dose Levels 1-4|Withdrawal by Subject|0|||
147667863|NCT00408499|532609773|FG000|Phase 1: Dose Levels 1-4|Physician Decision|1|||
147667864|NCT00408499|532609774|FG001|Phase 1: Dose Levels 1-4|Physician Decision|1|||
147667865|NCT00408499|532609775|FG002|Phase 1: Dose Levels 1-4|Physician Decision|0|||
147667866|NCT00408499|532609776|FG003|Phase 1: Dose Levels 1-4|Physician Decision|0|||
147667867|NCT00408499|532609777|FG004|Phase 1: Dose Levels 1-4|Physician Decision|0|||
147667868|NCT00408499|532609773|FG000|Phase II- MTD Expansion|Adverse Event|0|||
147667869|NCT00408499|532609774|FG001|Phase II- MTD Expansion|Adverse Event|0|||
147667870|NCT00408499|532609775|FG002|Phase II- MTD Expansion|Adverse Event|0|||
147667871|NCT00408499|532609776|FG003|Phase II- MTD Expansion|Adverse Event|0|||
147667872|NCT00408499|532609777|FG004|Phase II- MTD Expansion|Adverse Event|9|||
147667873|NCT00408499|532609773|FG000|Phase II- MTD Expansion|Death|0|||
147667874|NCT00408499|532609774|FG001|Phase II- MTD Expansion|Death|0|||
147667875|NCT00408499|532609775|FG002|Phase II- MTD Expansion|Death|0|||
147667876|NCT00408499|532609776|FG003|Phase II- MTD Expansion|Death|0|||
147667877|NCT00408499|532609777|FG004|Phase II- MTD Expansion|Death|2|||
147667878|NCT00408499|532609773|FG000|Phase II- MTD Expansion|Physician Decision|0|||
147667879|NCT00408499|532609774|FG001|Phase II- MTD Expansion|Physician Decision|0|||
147667880|NCT00408499|532609775|FG002|Phase II- MTD Expansion|Physician Decision|0|||
147667881|NCT00408499|532609776|FG003|Phase II- MTD Expansion|Physician Decision|0|||
147667882|NCT00408499|532609777|FG004|Phase II- MTD Expansion|Physician Decision|1|||
147667883|NCT00408499|532609773|FG000|Phase II- MTD Expansion|Withdrawal by Subject|0|||
147667884|NCT00408499|532609774|FG001|Phase II- MTD Expansion|Withdrawal by Subject|0|||
147667885|NCT00408499|532609775|FG002|Phase II- MTD Expansion|Withdrawal by Subject|0|||
147667886|NCT00408499|532609776|FG003|Phase II- MTD Expansion|Withdrawal by Subject|0|||
147667887|NCT00408499|532609777|FG004|Phase II- MTD Expansion|Withdrawal by Subject|5|||
147667888|NCT00408499|532609773|FG000|Phase II- MTD Expansion|treatment delay|0|||
147667889|NCT00408499|532609774|FG001|Phase II- MTD Expansion|treatment delay|0|||
147667890|NCT00408499|532609775|FG002|Phase II- MTD Expansion|treatment delay|0|||
147667891|NCT00408499|532609776|FG003|Phase II- MTD Expansion|treatment delay|0|||
147667892|NCT00408499|532609777|FG004|Phase II- MTD Expansion|treatment delay|3|||
147667893|NCT01586195|532609779|FG000|Overall Study|Death|11|||
147667894|NCT01586195|532609779|FG000|Overall Study|Withdrawal of Consent|5|||
147667895|NCT01586195|532609779|FG000|Overall Study|Started new anti-melanoma therapy|1|||
147667896|NCT01586195|532609779|FG000|Overall Study|Reason not specified|9|||
147667897|NCT00997334|532609780|FG000|Overall Study|still on therapy|12|||
147667898|NCT00997334|532609780|FG000|Overall Study|Adverse Event|3|||
147488229|NCT01402284|531942722|FG000|Overall Study|Withdrawal consent|2|||
147488230|NCT01402284|531942722|FG000|Overall Study|Follows up at Memorial Sloan Kettering|1|||
147488231|NCT01402284|531942722|FG000|Overall Study|Physician Decision|1|||
147488232|NCT01402284|531942722|FG000|Overall Study|Disease progression on study|10|||
147488233|NCT02928406|531942723|FG000|Overall Study|Death|780|||
147488234|NCT02928406|531942723|FG000|Overall Study|Progressive disease|3|||
147488235|NCT02928406|531942723|FG000|Overall Study|Lost to Follow-up|49|||
147488236|NCT02928406|531942723|FG000|Overall Study|Non-compliance|2|||
147488237|NCT02928406|531942723|FG000|Overall Study|Withdrawal by Subject|40|||
147488238|NCT02928406|531942723|FG000|Overall Study|Study terminated by sponsor|57|||
147488239|NCT02928406|531942723|FG000|Overall Study|Physician Decision|1|||
147488240|NCT02928406|531942723|FG000|Overall Study|Various reasons|72|||
147488241|NCT00540436|531942724|FG000|First 12-Week Treatment Period|Adverse Event|1|||
147488242|NCT00540436|531942724|FG000|First 12-Week Treatment Period|Withdrawal by Subject|1|||
147488243|NCT00540436|531942724|FG000|First 12-Week Treatment Period|Initiation of prohibited medication|1|||
147488244|NCT00540436|531942724|FG000|Second 12-Week Treatment Period|Adverse Event|1|||
147488245|NCT01745393|531942726|FG000|Treatment to End-of-treatment Assessment|Lost to Follow-up|20|||
147488246|NCT01745393|531942727|FG001|Treatment to End-of-treatment Assessment|Lost to Follow-up|8|||
147488247|NCT01745393|531942726|FG000|Treatment to End-of-treatment Assessment|Withdrawal by Subject|1|||
147488248|NCT01745393|531942727|FG001|Treatment to End-of-treatment Assessment|Withdrawal by Subject|0|||
147488249|NCT01745393|531942726|FG000|12-month Follow-up|Lost to Follow-up|6|||
147488250|NCT01745393|531942727|FG001|12-month Follow-up|Lost to Follow-up|5|||
147488251|NCT00905021|531942732|FG000|Overall Study|Adverse Event|2|||
147488252|NCT00786838|531942733|FG000|Overall Study|Physician Decision|4|||
147488253|NCT00786838|531942733|FG000|Overall Study|Death|4|||
147623910|NCT03896503|532441665|FG001|Initial Subgroup and Arm Enrollment|Refused further treatment|1|||
147623911|NCT03896503|532441666|FG002|Initial Subgroup and Arm Enrollment|Refused further treatment|0|||
147623912|NCT03896503|532441667|FG003|Initial Subgroup and Arm Enrollment|Refused further treatment|0|||
147623913|NCT03896503|532441668|FG004|Initial Subgroup and Arm Enrollment|Refused further treatment|0|||
147623914|NCT03896503|532441669|FG005|Initial Subgroup and Arm Enrollment|Refused further treatment|0|||
147623915|NCT03896503|532441670|FG006|Initial Subgroup and Arm Enrollment|Refused further treatment|0|||
147623916|NCT03896503|532441671|FG007|Initial Subgroup and Arm Enrollment|Refused further treatment|0|||
147623917|NCT03896503|532441664|FG000|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|0|||
147623918|NCT03896503|532441665|FG001|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|1|||
147623919|NCT03896503|532441666|FG002|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|0|||
147623920|NCT03896503|532441667|FG003|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|0|||
147623921|NCT03896503|532441668|FG004|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|0|||
147623922|NCT03896503|532441669|FG005|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|0|||
147623923|NCT03896503|532441670|FG006|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|0|||
147623924|NCT03896503|532441671|FG007|Initial Subgroup and Arm Enrollment|Off treatment? other reasons withdrew consent|0|||
147623925|NCT03896503|532441664|FG000|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|0|||
147623926|NCT03896503|532441665|FG001|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|0|||
147623927|NCT03896503|532441666|FG002|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|0|||
147623928|NCT03896503|532441667|FG003|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|0|||
147623929|NCT03896503|532441668|FG004|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|1|||
147623930|NCT03896503|532441669|FG005|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|0|||
147623931|NCT03896503|532441670|FG006|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|0|||
147623932|NCT03896503|532441671|FG007|Initial Subgroup and Arm Enrollment|Not treated; death before treatment|0|||
147623933|NCT03896503|532441664|FG000|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
147623934|NCT03896503|532441665|FG001|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
147623935|NCT03896503|532441666|FG002|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
147623936|NCT03896503|532441667|FG003|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
147623937|NCT03896503|532441668|FG004|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
147623938|NCT03896503|532441669|FG005|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|2|||
147623939|NCT03896503|532441670|FG006|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
147623940|NCT03896503|532441671|FG007|Initial Subgroup and Arm Enrollment|Not treated; participate found ineligible|0|||
147623941|NCT03896503|532441664|FG000|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|0|||
147623942|NCT03896503|532441665|FG001|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|0|||
147623943|NCT03896503|532441666|FG002|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|0|||
147488254|NCT00786838|531942733|FG000|Overall Study|Adverse Event|6|||
147488255|NCT00786838|531942733|FG000|Overall Study|Progressive disease|31|||
147488256|NCT00786838|531942733|FG000|Overall Study|Withdrawal by Subject|4|||
147488257|NCT02488759|531942735|FG000|Overall Study|Disease progression|73|||
147488258|NCT02488759|531942736|FG001|Overall Study|Disease progression|111|||
147488259|NCT02488759|531942737|FG002|Overall Study|Disease progression|62|||
147488260|NCT02488759|531942738|FG003|Overall Study|Disease progression|7|||
147488261|NCT02488759|531942739|FG004|Overall Study|Disease progression|4|||
147488262|NCT02488759|531942740|FG005|Overall Study|Disease progression|2|||
147488263|NCT02488759|531942735|FG000|Overall Study|Study drug toxicity|11|||
147488264|NCT02488759|531942736|FG001|Overall Study|Study drug toxicity|33|||
147488265|NCT02488759|531942737|FG002|Overall Study|Study drug toxicity|31|||
147488266|NCT02488759|531942738|FG003|Overall Study|Study drug toxicity|0|||
147488267|NCT02488759|531942739|FG004|Overall Study|Study drug toxicity|0|||
147488268|NCT02488759|531942740|FG005|Overall Study|Study drug toxicity|2|||
147488269|NCT02488759|531942735|FG000|Overall Study|Adverse event unrelated to study drug|9|||
147488270|NCT02488759|531942736|FG001|Overall Study|Adverse event unrelated to study drug|11|||
147488271|NCT02488759|531942737|FG002|Overall Study|Adverse event unrelated to study drug|7|||
147488272|NCT02488759|531942738|FG003|Overall Study|Adverse event unrelated to study drug|0|||
147488273|NCT02488759|531942739|FG004|Overall Study|Adverse event unrelated to study drug|1|||
147488274|NCT02488759|531942740|FG005|Overall Study|Adverse event unrelated to study drug|0|||
147488275|NCT02488759|531942735|FG000|Overall Study|Participant request to discontinue study treatment|6|||
147488276|NCT02488759|531942736|FG001|Overall Study|Participant request to discontinue study treatment|8|||
147488277|NCT02488759|531942737|FG002|Overall Study|Participant request to discontinue study treatment|4|||
147488278|NCT02488759|531942738|FG003|Overall Study|Participant request to discontinue study treatment|0|||
147488279|NCT02488759|531942739|FG004|Overall Study|Participant request to discontinue study treatment|0|||
147488280|NCT02488759|531942740|FG005|Overall Study|Participant request to discontinue study treatment|0|||
147488281|NCT02488759|531942735|FG000|Overall Study|Withdrawal by Subject|4|||
147488282|NCT02488759|531942736|FG001|Overall Study|Withdrawal by Subject|0|||
147488283|NCT02488759|531942737|FG002|Overall Study|Withdrawal by Subject|3|||
147488284|NCT02488759|531942738|FG003|Overall Study|Withdrawal by Subject|0|||
147488285|NCT02488759|531942739|FG004|Overall Study|Withdrawal by Subject|0|||
147488286|NCT02488759|531942740|FG005|Overall Study|Withdrawal by Subject|2|||
147488287|NCT02488759|531942735|FG000|Overall Study|Lost to Follow-up|0|||
147488288|NCT02488759|531942736|FG001|Overall Study|Lost to Follow-up|0|||
147488289|NCT02488759|531942737|FG002|Overall Study|Lost to Follow-up|2|||
147488290|NCT02488759|531942738|FG003|Overall Study|Lost to Follow-up|0|||
147488291|NCT02488759|531942739|FG004|Overall Study|Lost to Follow-up|0|||
147488292|NCT02488759|531942740|FG005|Overall Study|Lost to Follow-up|0|||
147488293|NCT02488759|531942735|FG000|Overall Study|Maximum clinical benefit|3|||
147488294|NCT02488759|531942736|FG001|Overall Study|Maximum clinical benefit|0|||
147488295|NCT02488759|531942737|FG002|Overall Study|Maximum clinical benefit|1|||
147488296|NCT02488759|531942738|FG003|Overall Study|Maximum clinical benefit|0|||
147488297|NCT02488759|531942739|FG004|Overall Study|Maximum clinical benefit|0|||
147488298|NCT02488759|531942740|FG005|Overall Study|Maximum clinical benefit|0|||
147488299|NCT02488759|531942735|FG000|Overall Study|Other reasons|7|||
147488300|NCT02488759|531942736|FG001|Overall Study|Other reasons|32|||
147488301|NCT02488759|531942737|FG002|Overall Study|Other reasons|23|||
147488302|NCT02488759|531942738|FG003|Overall Study|Other reasons|1|||
147488303|NCT02488759|531942739|FG004|Overall Study|Other reasons|1|||
147488304|NCT02488759|531942740|FG005|Overall Study|Other reasons|1|||
147488305|NCT04038255|531944089|FG000|Overall Study|Lost to Follow-up|0|||
147488306|NCT04038255|531944090|FG001|Overall Study|Lost to Follow-up|9|||
147488307|NCT04038255|531944091|FG002|Overall Study|Lost to Follow-up|5|||
147488308|NCT04038255|531944089|FG000|Overall Study|Withdrawal by Subject|0|||
147488309|NCT04038255|531944090|FG001|Overall Study|Withdrawal by Subject|0|||
147488310|NCT04038255|531944091|FG002|Overall Study|Withdrawal by Subject|1|||
147488311|NCT05183867|531944092|FG000|Overall Study|Withdrawal by Subject|3|||
147488312|NCT05183867|531944093|FG001|Overall Study|Withdrawal by Subject|2|||
147488313|NCT05183867|531944094|FG002|Overall Study|Withdrawal by Subject|0|||
147488314|NCT00418834|531944097|FG000|Overall Study|Adverse Event|16|||
147488315|NCT00418834|531944098|FG001|Overall Study|Adverse Event|9|||
147488316|NCT00418834|531944097|FG000|Overall Study|Lost to Follow-up|0|||
147488317|NCT00418834|531944098|FG001|Overall Study|Lost to Follow-up|1|||
147488318|NCT00418834|531944097|FG000|Overall Study|Protocol Violation|4|||
147488319|NCT00418834|531944098|FG001|Overall Study|Protocol Violation|3|||
147488320|NCT00418834|531944097|FG000|Overall Study|Withdrawal by Subject|3|||
147488321|NCT00418834|531944098|FG001|Overall Study|Withdrawal by Subject|7|||
147488322|NCT01953328|531944099|FG000|Overall Study|Withdrawal by Subject|0|||
147488323|NCT01953328|531944100|FG001|Overall Study|Withdrawal by Subject|0|||
147488324|NCT01953328|531944101|FG002|Overall Study|Withdrawal by Subject|0|||
147488325|NCT01953328|531944102|FG003|Overall Study|Withdrawal by Subject|0|||
147488326|NCT01953328|531944103|FG004|Overall Study|Withdrawal by Subject|1|||
147488327|NCT01953328|531944104|FG005|Overall Study|Withdrawal by Subject|0|||
147488328|NCT01953328|531944105|FG006|Overall Study|Withdrawal by Subject|0|||
147488329|NCT01953328|531944106|FG007|Overall Study|Withdrawal by Subject|0|||
147488330|NCT01953328|531944099|FG000|Overall Study|Lost to Follow-up|0|||
147488331|NCT01953328|531944100|FG001|Overall Study|Lost to Follow-up|0|||
147488332|NCT01953328|531944101|FG002|Overall Study|Lost to Follow-up|0|||
147488333|NCT01953328|531944102|FG003|Overall Study|Lost to Follow-up|0|||
147488334|NCT01953328|531944103|FG004|Overall Study|Lost to Follow-up|1|||
147488335|NCT01953328|531944104|FG005|Overall Study|Lost to Follow-up|0|||
147488336|NCT01953328|531944105|FG006|Overall Study|Lost to Follow-up|0|||
147488337|NCT01953328|531944106|FG007|Overall Study|Lost to Follow-up|0|||
147488338|NCT00492856|531944110|FG000|Induction|Adverse Event|2|||
147488339|NCT00492856|531944111|FG001|Induction|Adverse Event|0|||
147488340|NCT00492856|531944112|FG002|Induction|Adverse Event|0|||
147488341|NCT00492856|531944113|FG003|Induction|Adverse Event|0|||
147488342|NCT00492856|531944110|FG000|Induction|Withdrawal by Subject|1|||
147488343|NCT00492856|531944111|FG001|Induction|Withdrawal by Subject|0|||
147488344|NCT00492856|531944112|FG002|Induction|Withdrawal by Subject|0|||
147488345|NCT00492856|531944113|FG003|Induction|Withdrawal by Subject|0|||
147488346|NCT00492856|531944110|FG000|Induction|Death|3|||
147488347|NCT00492856|531944111|FG001|Induction|Death|0|||
147488348|NCT00492856|531944112|FG002|Induction|Death|0|||
147488349|NCT00492856|531944113|FG003|Induction|Death|0|||
147488350|NCT00492856|531944110|FG000|Consolidation|Adverse Event|6|||
147488351|NCT00492856|531944111|FG001|Consolidation|Adverse Event|0|||
147488352|NCT00492856|531944112|FG002|Consolidation|Adverse Event|0|||
147488353|NCT00492856|531944113|FG003|Consolidation|Adverse Event|0|||
147488354|NCT00492856|531944110|FG000|Consolidation|Not protocol specified|2|||
147488355|NCT00492856|531944111|FG001|Consolidation|Not protocol specified|0|||
147488356|NCT00492856|531944112|FG002|Consolidation|Not protocol specified|0|||
147488357|NCT00492856|531944113|FG003|Consolidation|Not protocol specified|0|||
147488358|NCT00492856|531944110|FG000|Consolidation|Lost to Follow-up|1|||
147488359|NCT00492856|531944111|FG001|Consolidation|Lost to Follow-up|0|||
147488360|NCT00492856|531944112|FG002|Consolidation|Lost to Follow-up|0|||
147488361|NCT00492856|531944113|FG003|Consolidation|Lost to Follow-up|0|||
147488362|NCT00492856|531944110|FG000|Post-consolidation|Adverse Event|0|||
147488363|NCT00492856|531944111|FG001|Post-consolidation|Adverse Event|4|||
147488364|NCT00492856|531944112|FG002|Post-consolidation|Adverse Event|0|||
147488365|NCT00492856|531944113|FG003|Post-consolidation|Adverse Event|1|||
147488366|NCT00492856|531944110|FG000|Post-consolidation|Withdrawal by Subject|0|||
147488367|NCT00492856|531944111|FG001|Post-consolidation|Withdrawal by Subject|4|||
147488368|NCT00492856|531944112|FG002|Post-consolidation|Withdrawal by Subject|0|||
147488369|NCT00492856|531944113|FG003|Post-consolidation|Withdrawal by Subject|0|||
147488370|NCT00492856|531944110|FG000|Post-consolidation|Death|0|||
147488371|NCT00492856|531944111|FG001|Post-consolidation|Death|1|||
147488372|NCT00492856|531944112|FG002|Post-consolidation|Death|0|||
147488373|NCT00492856|531944113|FG003|Post-consolidation|Death|0|||
147488374|NCT00492856|531944110|FG000|Post-consolidation|Not protocol specified|0|||
147488375|NCT00492856|531944111|FG001|Post-consolidation|Not protocol specified|1|||
147488376|NCT00492856|531944112|FG002|Post-consolidation|Not protocol specified|0|||
147488377|NCT00492856|531944113|FG003|Post-consolidation|Not protocol specified|0|||
147488378|NCT00492856|531944110|FG000|Post-consolidation|Lost to Follow-up|0|||
147488379|NCT00492856|531944111|FG001|Post-consolidation|Lost to Follow-up|2|||
147488380|NCT00492856|531944112|FG002|Post-consolidation|Lost to Follow-up|0|||
147488381|NCT00492856|531944113|FG003|Post-consolidation|Lost to Follow-up|0|||
147488382|NCT00492856|531944110|FG000|Post-consolidation|Observation Arm|0|||
147488383|NCT00492856|531944111|FG001|Post-consolidation|Observation Arm|0|||
147488384|NCT00492856|531944112|FG002|Post-consolidation|Observation Arm|27|||
147488385|NCT00492856|531944113|FG003|Post-consolidation|Observation Arm|0|||
147488386|NCT04426825|531944123|FG000|Overall Study|Death|17|||
147488387|NCT04426825|531944123|FG000|Overall Study|Lost to Follow-up|1|||
147488388|NCT04426825|531944123|FG000|Overall Study|Study terminated by sponsor|5|||
147488389|NCT06150573|531944129|FG000|Overall Study|Did not meet study criteria|1|||
147488390|NCT06150573|531944130|FG001|Overall Study|Did not meet study criteria|0|||
147488391|NCT06150573|531944129|FG000|Overall Study|Adverse Event|1|||
147488392|NCT06150573|531944130|FG001|Overall Study|Adverse Event|0|||
147488393|NCT06150573|531944129|FG000|Overall Study|Lost to Follow-up|0|||
147488394|NCT06150573|531944130|FG001|Overall Study|Lost to Follow-up|1|||
147488395|NCT06150573|531944129|FG000|Overall Study|Protocol Violation|0|||
147488396|NCT06150573|531944130|FG001|Overall Study|Protocol Violation|1|||
147488397|NCT06150573|531944129|FG000|Overall Study|Withdrawal by Subject|2|||
147488398|NCT06150573|531944130|FG001|Overall Study|Withdrawal by Subject|0|||
147488399|NCT02284906|531944135|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
147488400|NCT02284906|531944136|FG001|Overall Study|Pretreatment Event/Adverse Event|1|||
147488401|NCT02284906|531944137|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
147488402|NCT02284906|531944135|FG000|Overall Study|Major Protocol Deviation|0|||
147488403|NCT02284906|531944136|FG001|Overall Study|Major Protocol Deviation|1|||
147488404|NCT02284906|531944137|FG002|Overall Study|Major Protocol Deviation|0|||
147488405|NCT02284906|531944135|FG000|Overall Study|Voluntary Withdrawal|2|||
147488406|NCT02284906|531944136|FG001|Overall Study|Voluntary Withdrawal|4|||
147667899|NCT00997334|532609780|FG000|Overall Study|Patient non-compliance|1|||
147488407|NCT02284906|531944137|FG002|Overall Study|Voluntary Withdrawal|5|||
147488408|NCT02284906|531944135|FG000|Overall Study|Study Termination|0|||
147488409|NCT02284906|531944136|FG001|Overall Study|Study Termination|11|||
147488410|NCT02284906|531944137|FG002|Overall Study|Study Termination|14|||
147488411|NCT02284906|531944135|FG000|Overall Study|Reason not Specified|1|||
147488412|NCT02284906|531944136|FG001|Overall Study|Reason not Specified|1|||
147488413|NCT02284906|531944137|FG002|Overall Study|Reason not Specified|0|||
147488414|NCT02575079|531944139|FG000|Overall Study|Death|3|||
147488415|NCT02575079|531944140|FG001|Overall Study|Death|0|||
147488416|NCT02575079|531944139|FG000|Overall Study|Withdrawal by Subject|3|||
147488417|NCT02575079|531944140|FG001|Overall Study|Withdrawal by Subject|0|||
147488418|NCT01087528|531944141|FG000|Overall Study|Withdrawal by Subject|1|||
147488419|NCT01087528|531944141|FG000|Overall Study|Incomplete CE procedure|6|||
147623944|NCT03896503|532441667|FG003|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|0|||
147623945|NCT03896503|532441668|FG004|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|0|||
147623946|NCT03896503|532441669|FG005|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|1|||
147623947|NCT03896503|532441670|FG006|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|1|||
147623948|NCT03896503|532441671|FG007|Initial Subgroup and Arm Enrollment|Off treatment; screen failure|0|||
147623949|NCT00437021|532441672|FG000|Overall Study|Adverse Event|0|||
147623950|NCT00437021|532441673|FG001|Overall Study|Adverse Event|0|||
147623951|NCT00437021|532441674|FG002|Overall Study|Adverse Event|0|||
147623952|NCT00437021|532441675|FG003|Overall Study|Adverse Event|0|||
147623953|NCT00437021|532441676|FG004|Overall Study|Adverse Event|0|||
147623954|NCT00437021|532441677|FG005|Overall Study|Adverse Event|0|||
147623955|NCT00437021|532441678|FG006|Overall Study|Adverse Event|1|||
147623956|NCT00437021|532441679|FG007|Overall Study|Adverse Event|0|||
147488420|NCT03116399|531944144|FG000|Overall Study|Death|8|||
147488421|NCT03116399|531944145|FG001|Overall Study|Death|3|||
147488422|NCT03116399|531944144|FG000|Overall Study|Lost to Follow-up|7|||
147488423|NCT03116399|531944145|FG001|Overall Study|Lost to Follow-up|11|||
147488424|NCT03116399|531944144|FG000|Overall Study|Investigator Decision|1|||
147488425|NCT03116399|531944145|FG001|Overall Study|Investigator Decision|1|||
147488426|NCT03116399|531944144|FG000|Overall Study|Withdrawal by Subject|24|||
147488427|NCT03116399|531944145|FG001|Overall Study|Withdrawal by Subject|9|||
147488428|NCT03196297|531944147|FG000|Main Period|Withdrawal by Subject|4|||
147488429|NCT03196297|531944147|FG000|Extension Period|Withdrawal by Subject|1|||
147488430|NCT03196297|531944147|FG000|Extension Period|Lack of Efficacy|2|||
147488431|NCT02538666|531944148|FG000|Pre-Treatment|Disease progression|1|||
147488432|NCT02538666|531944149|FG001|Pre-Treatment|Disease progression|0|||
147488433|NCT02538666|531944150|FG002|Pre-Treatment|Disease progression|0|||
147488434|NCT02538666|531944148|FG000|Pre-Treatment|no longer meets study criteria|1|||
147488435|NCT02538666|531944149|FG001|Pre-Treatment|no longer meets study criteria|0|||
147488436|NCT02538666|531944150|FG002|Pre-Treatment|no longer meets study criteria|0|||
147488437|NCT02538666|531944148|FG000|Pre-Treatment|Withdrew Consent|0|||
147488438|NCT02538666|531944149|FG001|Pre-Treatment|Withdrew Consent|1|||
147488439|NCT02538666|531944150|FG002|Pre-Treatment|Withdrew Consent|1|||
147488440|NCT02538666|531944148|FG000|Treatment|Disease progression|270|||
147488441|NCT02538666|531944149|FG001|Treatment|Disease progression|227|||
147488442|NCT02538666|531944150|FG002|Treatment|Disease progression|165|||
147488443|NCT02538666|531944148|FG000|Treatment|Study drug toxicity|1|||
147488444|NCT02538666|531944149|FG001|Treatment|Study drug toxicity|29|||
147488445|NCT02538666|531944150|FG002|Treatment|Study drug toxicity|92|||
147488446|NCT02538666|531944148|FG000|Treatment|Death|0|||
147488447|NCT02538666|531944149|FG001|Treatment|Death|2|||
147488448|NCT02538666|531944150|FG002|Treatment|Death|3|||
147488449|NCT02538666|531944148|FG000|Treatment|Adverse event unrelated to study drug|8|||
147488450|NCT02538666|531944149|FG001|Treatment|Adverse event unrelated to study drug|10|||
147488451|NCT02538666|531944150|FG002|Treatment|Adverse event unrelated to study drug|15|||
147488452|NCT02538666|531944148|FG000|Treatment|Participant request to discontinue study treatment|3|||
147488453|NCT02538666|531944149|FG001|Treatment|Participant request to discontinue study treatment|6|||
147488454|NCT02538666|531944150|FG002|Treatment|Participant request to discontinue study treatment|11|||
147488455|NCT02538666|531944148|FG000|Treatment|Participant withdrew consent|2|||
147488456|NCT02538666|531944149|FG001|Treatment|Participant withdrew consent|5|||
147488457|NCT02538666|531944150|FG002|Treatment|Participant withdrew consent|3|||
147488458|NCT02538666|531944148|FG000|Treatment|Lost to Follow-up|0|||
147488459|NCT02538666|531944149|FG001|Treatment|Lost to Follow-up|1|||
147488460|NCT02538666|531944150|FG002|Treatment|Lost to Follow-up|1|||
147488461|NCT02538666|531944148|FG000|Treatment|Maximum clinical benefit|4|||
147623957|NCT00437021|532441680|FG008|Overall Study|Adverse Event|0|||
147488462|NCT02538666|531944149|FG001|Treatment|Maximum clinical benefit|3|||
147488463|NCT02538666|531944150|FG002|Treatment|Maximum clinical benefit|4|||
147623958|NCT00437021|532441681|FG009|Overall Study|Adverse Event|0|||
147623959|NCT00437021|532441682|FG010|Overall Study|Adverse Event|0|||
147488464|NCT02538666|531944148|FG000|Treatment|Poor/non-compliance|0|||
147488465|NCT02538666|531944149|FG001|Treatment|Poor/non-compliance|1|||
147488466|NCT02538666|531944150|FG002|Treatment|Poor/non-compliance|0|||
147488467|NCT02538666|531944148|FG000|Treatment|Participant no longer meets study criteria|0|||
147488468|NCT02538666|531944149|FG001|Treatment|Participant no longer meets study criteria|2|||
147623960|NCT00437021|532441683|FG011|Overall Study|Adverse Event|0|||
147623961|NCT00437021|532441672|FG000|Overall Study|Lost to Follow-up|0|||
147623962|NCT00437021|532441673|FG001|Overall Study|Lost to Follow-up|3|||
147623963|NCT00437021|532441674|FG002|Overall Study|Lost to Follow-up|0|||
147488469|NCT02538666|531944150|FG002|Treatment|Participant no longer meets study criteria|0|||
147488470|NCT02538666|531944148|FG000|Treatment|Administrative reason by sponsor|0|||
147488471|NCT02538666|531944149|FG001|Treatment|Administrative reason by sponsor|0|||
147488472|NCT02538666|531944150|FG002|Treatment|Administrative reason by sponsor|1|||
147488473|NCT02538666|531944148|FG000|Treatment|Other reasons|8|||
147488474|NCT02538666|531944149|FG001|Treatment|Other reasons|15|||
147488475|NCT02538666|531944150|FG002|Treatment|Other reasons|5|||
147488476|NCT02538666|531944148|FG000|Treatment|Not reported|2|||
147488477|NCT02538666|531944149|FG001|Treatment|Not reported|2|||
147488478|NCT02538666|531944150|FG002|Treatment|Not reported|2|||
147488479|NCT04370028|531944151|FG000|Overall Study|Withdrawal by Subject|695|||
147488480|NCT04370028|531944151|FG000|Overall Study|Protocol Violation|9|||
147488481|NCT04370028|531944151|FG000|Overall Study|Adverse Event|3|||
147488482|NCT03382899|531944153|FG000|Overall Study|Ineligibility Determined|0|||
147488483|NCT03382899|531944154|FG001|Overall Study|Ineligibility Determined|1|||
147488484|NCT03382899|531944153|FG000|Overall Study|Lost to Follow-up|0|||
147488485|NCT03382899|531944154|FG001|Overall Study|Lost to Follow-up|1|||
147488486|NCT03382899|531944153|FG000|Overall Study|Sponsor's decision|31|||
147488487|NCT03382899|531944154|FG001|Overall Study|Sponsor's decision|28|||
147488488|NCT03382899|531944153|FG000|Overall Study|Withdrawal by Subject|0|||
147488489|NCT03382899|531944154|FG001|Overall Study|Withdrawal by Subject|5|||
147488490|NCT01987986|531944155|FG000|Overall Study|Lost to Follow-up|1|||
147488491|NCT01987986|531944156|FG001|Overall Study|Lost to Follow-up|0|||
147488492|NCT01987986|531944157|FG002|Overall Study|Lost to Follow-up|0|||
147488493|NCT01987986|531944158|FG003|Overall Study|Lost to Follow-up|0|||
147488494|NCT01987986|531944155|FG000|Overall Study|Adverse Event|1|||
147488495|NCT01987986|531944156|FG001|Overall Study|Adverse Event|0|||
147488496|NCT01987986|531944157|FG002|Overall Study|Adverse Event|2|||
147488497|NCT01987986|531944158|FG003|Overall Study|Adverse Event|0|||
147488498|NCT03259334|531944159|FG000|Overall Study|Adverse Event|3|||
147488499|NCT03259334|531944160|FG001|Overall Study|Adverse Event|8|||
147488500|NCT03259334|531944161|FG002|Overall Study|Adverse Event|5|||
147488501|NCT03259334|531944159|FG000|Overall Study|Withdrawal by Subject|4|||
147488502|NCT03259334|531944160|FG001|Overall Study|Withdrawal by Subject|2|||
147488503|NCT03259334|531944161|FG002|Overall Study|Withdrawal by Subject|4|||
147488504|NCT03259334|531944159|FG000|Overall Study|Physician Decision|1|||
147488505|NCT03259334|531944160|FG001|Overall Study|Physician Decision|0|||
147488506|NCT03259334|531944161|FG002|Overall Study|Physician Decision|0|||
147488507|NCT03259334|531944159|FG000|Overall Study|Lost to Follow-up|0|||
147488508|NCT03259334|531944160|FG001|Overall Study|Lost to Follow-up|2|||
147488509|NCT03259334|531944161|FG002|Overall Study|Lost to Follow-up|1|||
147488510|NCT03259334|531944159|FG000|Overall Study|Protocol Deviation|0|||
147488511|NCT03259334|531944160|FG001|Overall Study|Protocol Deviation|3|||
147488512|NCT03259334|531944161|FG002|Overall Study|Protocol Deviation|2|||
147488513|NCT03259334|531944159|FG000|Overall Study|Lack of Efficacy|2|||
147488514|NCT03259334|531944160|FG001|Overall Study|Lack of Efficacy|0|||
147488515|NCT03259334|531944161|FG002|Overall Study|Lack of Efficacy|1|||
147488516|NCT03259334|531944159|FG000|Overall Study|Randomized but never treated|0|||
147488517|NCT03259334|531944160|FG001|Overall Study|Randomized but never treated|2|||
147488518|NCT03259334|531944161|FG002|Overall Study|Randomized but never treated|0|||
147488519|NCT04937816|531944164|FG000|Overall Study|Study drug stopped, reason missing|5|||
147488520|NCT04937816|531944165|FG001|Overall Study|Study drug stopped, reason missing|3|||
147488521|NCT04937816|531944166|FG002|Overall Study|Study drug stopped, reason missing|4|||
147488522|NCT04937816|531944167|FG003|Overall Study|Study drug stopped, reason missing|6|||
147488523|NCT04937816|531944168|FG004|Overall Study|Study drug stopped, reason missing|1|||
147488524|NCT04937816|531944169|FG005|Overall Study|Study drug stopped, reason missing|0|||
147488525|NCT04937816|531944170|FG006|Overall Study|Study drug stopped, reason missing|0|||
147623964|NCT00437021|532441675|FG003|Overall Study|Lost to Follow-up|0|||
147623965|NCT00437021|532441676|FG004|Overall Study|Lost to Follow-up|0|||
147623966|NCT00437021|532441677|FG005|Overall Study|Lost to Follow-up|2|||
147623967|NCT00437021|532441678|FG006|Overall Study|Lost to Follow-up|0|||
147488526|NCT04937816|531944164|FG000|Overall Study|Other than stated below|173|||
147488527|NCT04937816|531944165|FG001|Overall Study|Other than stated below|143|||
147488528|NCT04937816|531944166|FG002|Overall Study|Other than stated below|125|||
147488529|NCT04937816|531944167|FG003|Overall Study|Other than stated below|44|||
147488530|NCT04937816|531944168|FG004|Overall Study|Other than stated below|45|||
147488531|NCT04937816|531944169|FG005|Overall Study|Other than stated below|28|||
147488532|NCT04937816|531944170|FG006|Overall Study|Other than stated below|31|||
147488533|NCT04937816|531944164|FG000|Overall Study|Patient refusal to continue, not due to AE|172|||
147488534|NCT04937816|531944165|FG001|Overall Study|Patient refusal to continue, not due to AE|118|||
147623968|NCT00437021|532441679|FG007|Overall Study|Lost to Follow-up|1|||
147488535|NCT04937816|531944166|FG002|Overall Study|Patient refusal to continue, not due to AE|122|||
147488536|NCT04937816|531944167|FG003|Overall Study|Patient refusal to continue, not due to AE|304|||
147488537|NCT04937816|531944168|FG004|Overall Study|Patient refusal to continue, not due to AE|284|||
147488538|NCT04937816|531944169|FG005|Overall Study|Patient refusal to continue, not due to AE|124|||
147623969|NCT00437021|532441680|FG008|Overall Study|Lost to Follow-up|0|||
147623970|NCT00437021|532441681|FG009|Overall Study|Lost to Follow-up|0|||
147488539|NCT04937816|531944170|FG006|Overall Study|Patient refusal to continue, not due to AE|92|||
147488540|NCT04937816|531944164|FG000|Overall Study|Lost to Follow-up|15|||
147488541|NCT04937816|531944165|FG001|Overall Study|Lost to Follow-up|9|||
147488542|NCT04937816|531944166|FG002|Overall Study|Lost to Follow-up|6|||
147488543|NCT04937816|531944167|FG003|Overall Study|Lost to Follow-up|6|||
147488544|NCT04937816|531944168|FG004|Overall Study|Lost to Follow-up|16|||
147488545|NCT04937816|531944169|FG005|Overall Study|Lost to Follow-up|11|||
147488546|NCT04937816|531944170|FG006|Overall Study|Lost to Follow-up|17|||
147488547|NCT04937816|531944164|FG000|Overall Study|Protocol Violation|15|||
147488548|NCT04937816|531944165|FG001|Overall Study|Protocol Violation|15|||
147488549|NCT04937816|531944166|FG002|Overall Study|Protocol Violation|12|||
147488550|NCT04937816|531944167|FG003|Overall Study|Protocol Violation|30|||
147488551|NCT04937816|531944168|FG004|Overall Study|Protocol Violation|24|||
147488552|NCT04937816|531944169|FG005|Overall Study|Protocol Violation|5|||
147488553|NCT04937816|531944170|FG006|Overall Study|Protocol Violation|5|||
147488554|NCT04937816|531944164|FG000|Overall Study|Adverse Event|303|||
147488555|NCT04937816|531944165|FG001|Overall Study|Adverse Event|267|||
147488556|NCT04937816|531944166|FG002|Overall Study|Adverse Event|273|||
147488557|NCT04937816|531944167|FG003|Overall Study|Adverse Event|553|||
147488558|NCT04937816|531944168|FG004|Overall Study|Adverse Event|575|||
147488559|NCT04937816|531944169|FG005|Overall Study|Adverse Event|343|||
147488560|NCT04937816|531944170|FG006|Overall Study|Adverse Event|337|||
147488561|NCT04937816|531944164|FG000|Overall Study|Not treated|4|||
147488562|NCT04937816|531944165|FG001|Overall Study|Not treated|2|||
147488563|NCT04937816|531944166|FG002|Overall Study|Not treated|2|||
147488564|NCT04937816|531944167|FG003|Overall Study|Not treated|2|||
147488565|NCT04937816|531944168|FG004|Overall Study|Not treated|1|||
147488566|NCT04937816|531944169|FG005|Overall Study|Not treated|4|||
147488567|NCT04937816|531944170|FG006|Overall Study|Not treated|0|||
147488568|NCT01064648|531944171|FG000|Phase I Cohort1: Dose Level 1|Progression|5|||
147488569|NCT01064648|531944172|FG001|Phase I Cohort1: Dose Level 1|Progression|0|||
147488570|NCT01064648|531944173|FG002|Phase I Cohort1: Dose Level 1|Progression|0|||
147488571|NCT01064648|531944174|FG003|Phase I Cohort1: Dose Level 1|Progression|0|||
147488572|NCT01064648|531944171|FG000|Phase I Cohort1: Dose Level 1|Non-protocol specified|2|||
147488573|NCT01064648|531944172|FG001|Phase I Cohort1: Dose Level 1|Non-protocol specified|0|||
147488574|NCT01064648|531944173|FG002|Phase I Cohort1: Dose Level 1|Non-protocol specified|0|||
147488575|NCT01064648|531944174|FG003|Phase I Cohort1: Dose Level 1|Non-protocol specified|0|||
147488576|NCT01064648|531944171|FG000|Phase I Cohort 2: Dose Level 2|Adverse Event|0|||
147488577|NCT01064648|531944172|FG001|Phase I Cohort 2: Dose Level 2|Adverse Event|3|||
147488578|NCT01064648|531944173|FG002|Phase I Cohort 2: Dose Level 2|Adverse Event|0|||
147488579|NCT01064648|531944174|FG003|Phase I Cohort 2: Dose Level 2|Adverse Event|0|||
147488580|NCT01064648|531944171|FG000|Phase I Cohort 2: Dose Level 2|Withdrawal by Subject|0|||
147488581|NCT01064648|531944172|FG001|Phase I Cohort 2: Dose Level 2|Withdrawal by Subject|1|||
147488582|NCT01064648|531944173|FG002|Phase I Cohort 2: Dose Level 2|Withdrawal by Subject|0|||
147488583|NCT01064648|531944174|FG003|Phase I Cohort 2: Dose Level 2|Withdrawal by Subject|0|||
147488584|NCT01064648|531944171|FG000|Phase I Cohort 2: Dose Level 2|Progression|0|||
147488585|NCT01064648|531944172|FG001|Phase I Cohort 2: Dose Level 2|Progression|5|||
147488586|NCT01064648|531944173|FG002|Phase I Cohort 2: Dose Level 2|Progression|0|||
147488587|NCT01064648|531944174|FG003|Phase I Cohort 2: Dose Level 2|Progression|0|||
147488588|NCT01064648|531944171|FG000|Phase I Cohort 2: Dose Level 2|Non-protocol specified|0|||
147488589|NCT01064648|531944172|FG001|Phase I Cohort 2: Dose Level 2|Non-protocol specified|4|||
147488590|NCT01064648|531944173|FG002|Phase I Cohort 2: Dose Level 2|Non-protocol specified|0|||
147488591|NCT01064648|531944174|FG003|Phase I Cohort 2: Dose Level 2|Non-protocol specified|0|||
147488592|NCT01064648|531944171|FG000|Phase II|Adverse Event|0|||
147488593|NCT01064648|531944172|FG001|Phase II|Adverse Event|0|||
147488594|NCT01064648|531944173|FG002|Phase II|Adverse Event|15|||
147488595|NCT01064648|531944174|FG003|Phase II|Adverse Event|8|||
147488596|NCT01064648|531944171|FG000|Phase II|Death|0|||
147488597|NCT01064648|531944172|FG001|Phase II|Death|0|||
147488598|NCT01064648|531944173|FG002|Phase II|Death|4|||
147488599|NCT01064648|531944174|FG003|Phase II|Death|5|||
147488600|NCT01064648|531944171|FG000|Phase II|Withdrawal by Subject|0|||
147488601|NCT01064648|531944172|FG001|Phase II|Withdrawal by Subject|0|||
147488602|NCT01064648|531944173|FG002|Phase II|Withdrawal by Subject|2|||
147488603|NCT01064648|531944174|FG003|Phase II|Withdrawal by Subject|5|||
147488604|NCT01064648|531944171|FG000|Phase II|Progression|0|||
147488605|NCT01064648|531944172|FG001|Phase II|Progression|0|||
147488606|NCT01064648|531944173|FG002|Phase II|Progression|21|||
147488607|NCT01064648|531944174|FG003|Phase II|Progression|27|||
147488608|NCT01064648|531944171|FG000|Phase II|Non-protocol specified|0|||
147488609|NCT01064648|531944172|FG001|Phase II|Non-protocol specified|0|||
147488610|NCT01064648|531944173|FG002|Phase II|Non-protocol specified|5|||
147488611|NCT01064648|531944174|FG003|Phase II|Non-protocol specified|3|||
147488612|NCT01064648|531944171|FG000|Phase II|Under Review|0|||
147488613|NCT01064648|531944172|FG001|Phase II|Under Review|0|||
147488614|NCT01064648|531944173|FG002|Phase II|Under Review|2|||
147488615|NCT01064648|531944174|FG003|Phase II|Under Review|0|||
147488616|NCT05281523|531944175|FG000|Overall Study|Adverse Event|1|||
147488617|NCT05281523|531944176|FG001|Overall Study|Adverse Event|1|||
147488618|NCT05281523|531944175|FG000|Overall Study|Physician Decision|1|||
147488619|NCT05281523|531944176|FG001|Overall Study|Physician Decision|1|||
147488620|NCT05281523|531944175|FG000|Overall Study|Withdrawal by Subject|5|||
147488621|NCT05281523|531944176|FG001|Overall Study|Withdrawal by Subject|15|||
147488622|NCT05281523|531944175|FG000|Overall Study|GCP violations|3|||
147488623|NCT05281523|531944176|FG001|Overall Study|GCP violations|4|||
147488624|NCT05513391|531944177|FG000|Overall Study|Adverse Event|1|||
147488625|NCT05513391|531944178|FG001|Overall Study|Adverse Event|0|||
147488626|NCT05513391|531944177|FG000|Overall Study|Protocol Deviation|0|||
147488627|NCT05513391|531944178|FG001|Overall Study|Protocol Deviation|1|||
147488628|NCT05513391|531944177|FG000|Overall Study|Withdrawal by Subject|3|||
147488629|NCT05513391|531944178|FG001|Overall Study|Withdrawal by Subject|1|||
147488630|NCT05513391|531944177|FG000|Overall Study|Withdrawal by Parent/Guardian|2|||
147488631|NCT05513391|531944178|FG001|Overall Study|Withdrawal by Parent/Guardian|2|||
147488632|NCT05513391|531944177|FG000|Overall Study|Lost to Follow-up|0|||
147488633|NCT05513391|531944178|FG001|Overall Study|Lost to Follow-up|2|||
147488634|NCT05513053|531944179|FG000|Overall Study|Lost to Follow-up|9|||
147488635|NCT05513053|531944180|FG001|Overall Study|Lost to Follow-up|11|||
147488636|NCT05513053|531944179|FG000|Overall Study|Withdrawal by parent/guardian|2|||
147488637|NCT05513053|531944180|FG001|Overall Study|Withdrawal by parent/guardian|0|||
147488638|NCT05513053|531944179|FG000|Overall Study|Withdrawal by Subject|2|||
147488639|NCT05513053|531944180|FG001|Overall Study|Withdrawal by Subject|9|||
147488640|NCT05513053|531944179|FG000|Overall Study|Protocol Violation|6|||
147488641|NCT05513053|531944180|FG001|Overall Study|Protocol Violation|3|||
147488642|NCT05513053|531944179|FG000|Overall Study|Adverse Event|0|||
147488643|NCT05513053|531944180|FG001|Overall Study|Adverse Event|2|||
147488644|NCT04491877|531945400|FG000|Overall Study|Protocol Deviation|1|||
147488645|NCT04491877|531945401|FG001|Overall Study|Protocol Deviation|0|||
147488646|NCT04491877|531945402|FG002|Overall Study|Protocol Deviation|2|||
147488647|NCT04491877|531945403|FG003|Overall Study|Protocol Deviation|0|||
147488648|NCT04491877|531945404|FG004|Overall Study|Protocol Deviation|0|||
147488649|NCT04491877|531945405|FG005|Overall Study|Protocol Deviation|0|||
147488650|NCT04491877|531945406|FG006|Overall Study|Protocol Deviation|1|||
147488651|NCT04491877|531945407|FG007|Overall Study|Protocol Deviation|1|||
147488652|NCT04491877|531945408|FG008|Overall Study|Protocol Deviation|0|||
147488653|NCT04491877|531945400|FG000|Overall Study|Withdrawal by Parent/Guardian|0|||
147488654|NCT04491877|531945401|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
147488655|NCT04491877|531945402|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
147488656|NCT04491877|531945403|FG003|Overall Study|Withdrawal by Parent/Guardian|2|||
147488657|NCT04491877|531945404|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
147488658|NCT04491877|531945405|FG005|Overall Study|Withdrawal by Parent/Guardian|2|||
147488659|NCT04491877|531945406|FG006|Overall Study|Withdrawal by Parent/Guardian|2|||
147488660|NCT04491877|531945407|FG007|Overall Study|Withdrawal by Parent/Guardian|5|||
147488661|NCT04491877|531945408|FG008|Overall Study|Withdrawal by Parent/Guardian|3|||
147488662|NCT04491877|531945400|FG000|Overall Study|Lost to Follow-up|0|||
147488663|NCT04491877|531945401|FG001|Overall Study|Lost to Follow-up|2|||
147488664|NCT04491877|531945402|FG002|Overall Study|Lost to Follow-up|0|||
147488665|NCT04491877|531945403|FG003|Overall Study|Lost to Follow-up|0|||
147488666|NCT04491877|531945404|FG004|Overall Study|Lost to Follow-up|0|||
147488667|NCT04491877|531945405|FG005|Overall Study|Lost to Follow-up|0|||
147488668|NCT04491877|531945406|FG006|Overall Study|Lost to Follow-up|2|||
147488669|NCT04491877|531945407|FG007|Overall Study|Lost to Follow-up|1|||
147488670|NCT04491877|531945408|FG008|Overall Study|Lost to Follow-up|1|||
147488671|NCT01096446|531945414|FG000|Overall Study|Death|1|||
147488672|NCT01096446|531945415|FG001|Overall Study|Death|0|||
147488673|NCT01096446|531945414|FG000|Overall Study|Protocol Violation|2|||
147488674|NCT01096446|531945415|FG001|Overall Study|Protocol Violation|0|||
147488675|NCT01520324|531945416|FG000|Overall Study|Subject discontinued (moderate illness)|1|||
147488676|NCT01328249|531945417|FG000|Overall Study|Adverse Event|3|||
147488677|NCT01328249|531945418|FG001|Overall Study|Adverse Event|0|||
147488678|NCT01328249|531945417|FG000|Overall Study|Disease progression|1|||
147488679|NCT01328249|531945418|FG001|Overall Study|Disease progression|0|||
147488680|NCT01328249|531945417|FG000|Overall Study|Withdrawal by Subject|1|||
147488681|NCT01328249|531945418|FG001|Overall Study|Withdrawal by Subject|1|||
147488682|NCT01328249|531945417|FG000|Overall Study|Moved before end of treatment visit|1|||
147488683|NCT01328249|531945418|FG001|Overall Study|Moved before end of treatment visit|0|||
147488684|NCT01328249|531945417|FG000|Overall Study|Subject choice|1|||
147488685|NCT01328249|531945418|FG001|Overall Study|Subject choice|1|||
147488686|NCT01328249|531945417|FG000|Overall Study|Protocol Violation|0|||
147488687|NCT01328249|531945418|FG001|Overall Study|Protocol Violation|1|||
147488688|NCT00748553|531945419|FG000|Overall Study|Adverse Event|0|||
147488689|NCT00748553|531945420|FG001|Overall Study|Adverse Event|1|||
147488690|NCT00748553|531945419|FG000|Overall Study|disease progression|2|||
147488691|NCT00748553|531945420|FG001|Overall Study|disease progression|0|||
147488692|NCT00748553|531945419|FG000|Overall Study|noncompliance|1|||
147488693|NCT00748553|531945420|FG001|Overall Study|noncompliance|0|||
147488694|NCT00948818|531945421|FG000|Overall Study|Adverse Event|10|||
147488695|NCT00948818|531945422|FG001|Overall Study|Adverse Event|32|||
147488696|NCT00948818|531945421|FG000|Overall Study|Protocol Violation|9|||
147488697|NCT00948818|531945422|FG001|Overall Study|Protocol Violation|10|||
147488698|NCT00948818|531945421|FG000|Overall Study|Withdrawal by Subject|25|||
147488699|NCT00948818|531945422|FG001|Overall Study|Withdrawal by Subject|25|||
147488700|NCT00948818|531945421|FG000|Overall Study|Lost to Follow-up|10|||
147488701|NCT00948818|531945422|FG001|Overall Study|Lost to Follow-up|17|||
147488702|NCT00948818|531945421|FG000|Overall Study|Lack of Efficacy|4|||
147488703|NCT00948818|531945422|FG001|Overall Study|Lack of Efficacy|5|||
147488704|NCT00948818|531945421|FG000|Overall Study|Other Reason|4|||
147488705|NCT00948818|531945422|FG001|Overall Study|Other Reason|5|||
147488706|NCT01251276|531945425|FG000|Overall Study|Protocol Violation|1|||
147488707|NCT01251276|531945426|FG001|Overall Study|Protocol Violation|0|||
147488708|NCT01251276|531945425|FG000|Overall Study|Lost to Follow-up|0|||
147488709|NCT01251276|531945426|FG001|Overall Study|Lost to Follow-up|1|||
147488710|NCT02245568|531945427|FG000|Overall Study|Study terminated by Sponsor|346|||
147488711|NCT02245568|531945427|FG000|Overall Study|Adverse Event|144|||
147488712|NCT02245568|531945427|FG000|Overall Study|Lack of Efficacy|98|||
147488713|NCT02245568|531945427|FG000|Overall Study|Withdrawal by Caregiver|85|||
147488714|NCT02245568|531945427|FG000|Overall Study|Withdrawal by Subject|77|||
147488715|NCT02245568|531945427|FG000|Overall Study|Withdrawal by Legal Representative|31|||
147488716|NCT02245568|531945427|FG000|Overall Study|Missing (Site closure)|16|||
147488717|NCT02245568|531945427|FG000|Overall Study|Physician Decision|14|||
147488718|NCT02245568|531945427|FG000|Overall Study|Non-compliance with study drug|11|||
147488719|NCT02245568|531945427|FG000|Overall Study|Death|9|||
147488720|NCT02245568|531945427|FG000|Overall Study|Blue staining|6|||
147488721|NCT02245568|531945427|FG000|Overall Study|Worsening dementia/caregiver withdrawal|6|||
147488722|NCT02245568|531945427|FG000|Overall Study|Intolerance/dosing issues/interruption|5|||
147488723|NCT02245568|531945427|FG000|Overall Study|Lost to Follow-up|5|||
147488724|NCT02044159|531945428|FG000|Overall Study|Consent declined (deferred consent)|2|||
147488725|NCT02044159|531945429|FG001|Overall Study|Consent declined (deferred consent)|4|||
147488726|NCT02044159|531945428|FG000|Overall Study|No longer eligible, drug not given|1|||
147488727|NCT02044159|531945429|FG001|Overall Study|No longer eligible, drug not given|0|||
147488728|NCT02044159|531945428|FG000|Overall Study|Nurse declined to give study drug|1|||
147488729|NCT02044159|531945429|FG001|Overall Study|Nurse declined to give study drug|0|||
147488730|NCT01111539|531945430|FG000|Phase B (Day 1 to Week 8)|Lost to Follow-up|6|||
147488731|NCT01111539|531945431|FG001|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
147488732|NCT01111539|531945432|FG002|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
147488733|NCT01111539|531945433|FG003|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
147488734|NCT01111539|531945434|FG004|Phase B (Day 1 to Week 8)|Lost to Follow-up|0|||
147488735|NCT01111539|531945430|FG000|Phase B (Day 1 to Week 8)|Adverse Event|5|||
147488736|NCT01111539|531945431|FG001|Phase B (Day 1 to Week 8)|Adverse Event|0|||
147488737|NCT01111539|531945432|FG002|Phase B (Day 1 to Week 8)|Adverse Event|0|||
147488738|NCT01111539|531945433|FG003|Phase B (Day 1 to Week 8)|Adverse Event|0|||
147488739|NCT01111539|531945434|FG004|Phase B (Day 1 to Week 8)|Adverse Event|0|||
147488740|NCT01111539|531945430|FG000|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|60|||
147488741|NCT01111539|531945431|FG001|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
147488742|NCT01111539|531945432|FG002|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
147488743|NCT01111539|531945433|FG003|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
147488744|NCT01111539|531945434|FG004|Phase B (Day 1 to Week 8)|Sponsor Discontinued Study|0|||
147488745|NCT01111539|531945430|FG000|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|1|||
147488746|NCT01111539|531945431|FG001|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|0|||
147488747|NCT01111539|531945432|FG002|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|0|||
147488748|NCT01111539|531945433|FG003|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|0|||
147488749|NCT01111539|531945434|FG004|Phase B (Day 1 to Week 8)|Investigator Withdrew Subject|0|||
147488750|NCT01111539|531945430|FG000|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|7|||
147488751|NCT01111539|531945431|FG001|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|0|||
147488752|NCT01111539|531945432|FG002|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|0|||
147488753|NCT01111539|531945433|FG003|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|0|||
147623971|NCT00437021|532441682|FG010|Overall Study|Lost to Follow-up|0|||
147623972|NCT00437021|532441683|FG011|Overall Study|Lost to Follow-up|0|||
147623973|NCT00437021|532441672|FG000|Overall Study|Withdrawal by Subject|2|||
147488754|NCT01111539|531945434|FG004|Phase B (Day 1 to Week 8)|Subject Withdrew Consent|0|||
147488755|NCT01111539|531945430|FG000|Phase B (Day 1 to Week 8)|Protocol Deviation|2|||
147488756|NCT01111539|531945431|FG001|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
147488757|NCT01111539|531945432|FG002|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
147488758|NCT01111539|531945433|FG003|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
147488759|NCT01111539|531945434|FG004|Phase B (Day 1 to Week 8)|Protocol Deviation|0|||
147488760|NCT01111539|531945430|FG000|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|1|||
147488761|NCT01111539|531945431|FG001|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|0|||
147488762|NCT01111539|531945432|FG002|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|0|||
147623974|NCT00437021|532441673|FG001|Overall Study|Withdrawal by Subject|1|||
147623975|NCT00437021|532441674|FG002|Overall Study|Withdrawal by Subject|0|||
147488763|NCT01111539|531945433|FG003|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|0|||
147488764|NCT01111539|531945434|FG004|Phase B (Day 1 to Week 8)|Lack of Efficacy as Determined by the Investigator|0|||
147488765|NCT01111539|531945430|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
147488766|NCT01111539|531945431|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
147488767|NCT01111539|531945432|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|1|||
147488768|NCT01111539|531945433|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|0|||
147488769|NCT01111539|531945434|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Lost to Follow-up|1|||
147488770|NCT01111539|531945430|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
147488771|NCT01111539|531945431|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
147488772|NCT01111539|531945432|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|1|||
147488773|NCT01111539|531945433|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|0|||
147488774|NCT01111539|531945434|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Adverse Event|2|||
147488775|NCT01111539|531945430|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|0|||
147488776|NCT01111539|531945431|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|7|||
147488777|NCT01111539|531945432|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|4|||
147488778|NCT01111539|531945433|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|5|||
147488779|NCT01111539|531945434|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Sponsor Discontinued Study|5|||
147488780|NCT01111539|531945430|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|0|||
147488781|NCT01111539|531945431|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|0|||
147488782|NCT01111539|531945432|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|0|||
147488783|NCT01111539|531945433|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|0|||
147488784|NCT01111539|531945434|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Subject Met Withdrawal Criteria|1|||
147488785|NCT01111539|531945430|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|0|||
147488786|NCT01111539|531945431|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|0|||
147488787|NCT01111539|531945432|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|0|||
147488788|NCT01111539|531945433|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|1|||
147488789|NCT01111539|531945434|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Investigator Withdrew Subject|0|||
147488790|NCT01111539|531945430|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|0|||
147488791|NCT01111539|531945431|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|0|||
147488792|NCT01111539|531945432|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|0|||
147488793|NCT01111539|531945433|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|2|||
147488794|NCT01111539|531945434|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Subject Withdrew Consent|0|||
147488795|NCT01111539|531945430|FG000|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
147488796|NCT01111539|531945431|FG001|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
147488797|NCT01111539|531945432|FG002|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
147488798|NCT01111539|531945433|FG003|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|0|||
147488799|NCT01111539|531945434|FG004|Phase B+ and Phase C (Weeks 9 to 14)|Protocol Deviation|1|||
147488800|NCT03628417|531945435|FG000|Overall Study|Death|1|||
147488801|NCT03628417|531945436|FG001|Overall Study|Death|1|||
147488802|NCT05619172|531945440|FG000|Safety Cohort 1|Death|7|||
147488803|NCT05619172|531945441|FG001|Safety Cohort 1|Death|0|||
147488804|NCT05619172|531945440|FG000|Safety Cohort 1|Study terminated by sponsor|7|||
147488805|NCT05619172|531945441|FG001|Safety Cohort 1|Study terminated by sponsor|0|||
147488806|NCT05619172|531945440|FG000|Safety Cohort 2|Death|0|||
147488807|NCT05619172|531945441|FG001|Safety Cohort 2|Death|1|||
147488808|NCT05619172|531945440|FG000|Safety Cohort 2|Study terminated by sponsor|0|||
147488809|NCT05619172|531945441|FG001|Safety Cohort 2|Study terminated by sponsor|1|||
147488810|NCT00450372|531945443|FG000|Overall Study|Physician Decision|1|||
147488811|NCT00769704|531945444|FG000|Overall Study|Lost to Follow-up|3|||
147488812|NCT00769704|531945445|FG001|Overall Study|Lost to Follow-up|2|||
147488813|NCT00769704|531945444|FG000|Overall Study|Death|95|||
147488814|NCT00769704|531945445|FG001|Overall Study|Death|190|||
147488815|NCT00769704|531945444|FG000|Overall Study|Withdrawal by Subject|12|||
147488816|NCT00769704|531945445|FG001|Overall Study|Withdrawal by Subject|5|||
147488817|NCT00769704|531945444|FG000|Overall Study|Other|1|||
147488818|NCT00769704|531945445|FG001|Overall Study|Other|2|||
147488819|NCT05131451|531945446|FG000|Overall Study|Protocol Violation|1|||
147488820|NCT05131451|531945447|FG001|Overall Study|Protocol Violation|0|||
147488821|NCT01856595|531945453|FG000|Overall Study|Withdrawal by Subject|0|||
147488822|NCT01856595|531945454|FG001|Overall Study|Withdrawal by Subject|1|||
147488823|NCT01856595|531945455|FG002|Overall Study|Withdrawal by Subject|0|||
147488824|NCT01856595|531945456|FG003|Overall Study|Withdrawal by Subject|0|||
147488825|NCT01856595|531945457|FG004|Overall Study|Withdrawal by Subject|0|||
147488826|NCT01856595|531945458|FG005|Overall Study|Withdrawal by Subject|0|||
147488827|NCT01856595|531945459|FG006|Overall Study|Withdrawal by Subject|1|||
147488828|NCT01856595|531945460|FG007|Overall Study|Withdrawal by Subject|0|||
147488829|NCT01856595|531945461|FG008|Overall Study|Withdrawal by Subject|0|||
147488830|NCT01894477|531945465|FG000|Overall Study|Protocol Violation|0|||
147488831|NCT01894477|531945466|FG001|Overall Study|Protocol Violation|1|||
147488832|NCT01894477|531945465|FG000|Overall Study|protocol changed due SC changed to cord|0|||
147488833|NCT01894477|531945466|FG001|Overall Study|protocol changed due SC changed to cord|1|||
147488834|NCT03656926|531945470|FG000|Overall Study|Adverse Event|5|||
147488835|NCT03656926|531945471|FG001|Overall Study|Adverse Event|4|||
147488836|NCT03656926|531945470|FG000|Overall Study|Withdrawal by Subject|7|||
147488837|NCT03656926|531945471|FG001|Overall Study|Withdrawal by Subject|2|||
147488838|NCT03656926|531945470|FG000|Overall Study|Screen fail after randomization|1|||
147488839|NCT03656926|531945471|FG001|Overall Study|Screen fail after randomization|0|||
147488840|NCT03656926|531945470|FG000|Overall Study|PI decision due to patient condition|1|||
147488841|NCT03656926|531945471|FG001|Overall Study|PI decision due to patient condition|0|||
147488842|NCT03656926|531945470|FG000|Overall Study|Patient unresponsiveness|1|||
147488843|NCT03656926|531945471|FG001|Overall Study|Patient unresponsiveness|0|||
147488844|NCT00069095|531945472|FG000|Primary Treatment Phase|Ongoing|0|||
147488845|NCT00069095|531945473|FG001|Primary Treatment Phase|Ongoing|0|||
147488846|NCT00069095|531945474|FG002|Primary Treatment Phase|Ongoing|5|||
147488847|NCT00069095|531945475|FG003|Primary Treatment Phase|Ongoing|7|||
147488848|NCT00069095|531945476|FG004|Primary Treatment Phase|Ongoing|7|||
147488849|NCT00069095|531945477|FG005|Primary Treatment Phase|Ongoing|4|||
147488850|NCT00069095|531945472|FG000|Primary Treatment Phase|Admin/Other|29|||
147488851|NCT00069095|531945473|FG001|Primary Treatment Phase|Admin/Other|38|||
147488852|NCT00069095|531945474|FG002|Primary Treatment Phase|Admin/Other|31|||
147488853|NCT00069095|531945475|FG003|Primary Treatment Phase|Admin/Other|45|||
147488854|NCT00069095|531945476|FG004|Primary Treatment Phase|Admin/Other|48|||
147488855|NCT00069095|531945477|FG005|Primary Treatment Phase|Admin/Other|42|||
147488856|NCT00069095|531945472|FG000|Primary Treatment Phase|Adverse Event|99|||
147488857|NCT00069095|531945473|FG001|Primary Treatment Phase|Adverse Event|92|||
147488858|NCT00069095|531945474|FG002|Primary Treatment Phase|Adverse Event|71|||
147488859|NCT00069095|531945475|FG003|Primary Treatment Phase|Adverse Event|72|||
147488860|NCT00069095|531945476|FG004|Primary Treatment Phase|Adverse Event|109|||
147488861|NCT00069095|531945477|FG005|Primary Treatment Phase|Adverse Event|101|||
147488862|NCT00069095|531945472|FG000|Primary Treatment Phase|Death|14|||
147488863|NCT00069095|531945473|FG001|Primary Treatment Phase|Death|8|||
147488864|NCT00069095|531945474|FG002|Primary Treatment Phase|Death|2|||
147488865|NCT00069095|531945475|FG003|Primary Treatment Phase|Death|5|||
147488866|NCT00069095|531945476|FG004|Primary Treatment Phase|Death|8|||
147488867|NCT00069095|531945477|FG005|Primary Treatment Phase|Death|8|||
147488868|NCT00069095|531945472|FG000|Primary Treatment Phase|Failure to return|5|||
147488869|NCT00069095|531945473|FG001|Primary Treatment Phase|Failure to return|5|||
147667900|NCT00997334|532609780|FG000|Overall Study|Withdrawal by Subject|3|||
147667901|NCT00997334|532609780|FG000|Overall Study|Death|2|||
147667902|NCT00997334|532609780|FG000|Overall Study|Urgent Palliative Care|2|||
147667903|NCT00997334|532609780|FG000|Overall Study|No lesion amenable|1|||
147667904|NCT00997334|532609780|FG000|Overall Study|Ineligible|1|||
147667905|NCT01855958|532609783|FG000|Overall Study|Withdrawal by Subject|1|||
147667906|NCT01855958|532609784|FG001|Overall Study|Withdrawal by Subject|0|||
147667907|NCT00266708|532609790|FG000|Overall Study|No renal function|1|||
147667908|NCT00266708|532609791|FG001|Overall Study|No renal function|1|||
147667909|NCT00266708|532609790|FG000|Overall Study|Refused biopsy|3|||
147667910|NCT00266708|532609791|FG001|Overall Study|Refused biopsy|6|||
147667911|NCT00266708|532609790|FG000|Overall Study|Asthma|0|||
147667912|NCT00266708|532609791|FG001|Overall Study|Asthma|2|||
147667913|NCT02791269|532609792|FG000|Overall Study|Lost to Follow-up|0|||
147667914|NCT02791269|532609793|FG001|Overall Study|Lost to Follow-up|1|||
147488870|NCT00069095|531945474|FG002|Primary Treatment Phase|Failure to return|0|||
147488871|NCT00069095|531945475|FG003|Primary Treatment Phase|Failure to return|0|||
147488872|NCT00069095|531945476|FG004|Primary Treatment Phase|Failure to return|0|||
147488873|NCT00069095|531945477|FG005|Primary Treatment Phase|Failure to return|2|||
147488874|NCT00069095|531945472|FG000|Primary Treatment Phase|Insufficient Therapeutic Response|131|||
147488875|NCT00069095|531945473|FG001|Primary Treatment Phase|Insufficient Therapeutic Response|127|||
147488876|NCT00069095|531945474|FG002|Primary Treatment Phase|Insufficient Therapeutic Response|175|||
147488877|NCT00069095|531945475|FG003|Primary Treatment Phase|Insufficient Therapeutic Response|154|||
147488878|NCT00069095|531945476|FG004|Primary Treatment Phase|Insufficient Therapeutic Response|101|||
147488879|NCT00069095|531945477|FG005|Primary Treatment Phase|Insufficient Therapeutic Response|102|||
147488880|NCT00069095|531945472|FG000|Primary Treatment Phase|Refused treatment|15|||
147488881|NCT00069095|531945473|FG001|Primary Treatment Phase|Refused treatment|26|||
147488882|NCT00069095|531945474|FG002|Primary Treatment Phase|Refused treatment|17|||
147667915|NCT02351934|532609794|FG000|Allocation|POD weight<pre-op weight|3|||
147667916|NCT02351934|532609795|FG001|Allocation|POD weight<pre-op weight|0|||
147667917|NCT02351934|532609794|FG000|Allocation|Hypotension preventing administration|2|||
147667918|NCT02351934|532609795|FG001|Allocation|Hypotension preventing administration|0|||
147488883|NCT00069095|531945475|FG003|Primary Treatment Phase|Refused treatment|31|||
147488884|NCT00069095|531945476|FG004|Primary Treatment Phase|Refused treatment|24|||
147488885|NCT00069095|531945477|FG005|Primary Treatment Phase|Refused treatment|27|||
147488886|NCT00069095|531945472|FG000|Primary Treatment Phase|Withdrew|2|||
147488887|NCT00069095|531945473|FG001|Primary Treatment Phase|Withdrew|3|||
147667919|NCT02351934|532609794|FG000|Allocation|Acute Kidney Injury on Post Op Day 1|1|||
147488888|NCT00069095|531945474|FG002|Primary Treatment Phase|Withdrew|8|||
147488889|NCT00069095|531945475|FG003|Primary Treatment Phase|Withdrew|2|||
147488890|NCT00069095|531945476|FG004|Primary Treatment Phase|Withdrew|4|||
147488891|NCT00069095|531945477|FG005|Primary Treatment Phase|Withdrew|9|||
147488892|NCT00069095|531945472|FG000|Primary Treatment Phase|Other Violation|0|||
147488893|NCT00069095|531945473|FG001|Primary Treatment Phase|Other Violation|1|||
147488894|NCT00069095|531945474|FG002|Primary Treatment Phase|Other Violation|1|||
147488895|NCT00069095|531945475|FG003|Primary Treatment Phase|Other Violation|1|||
147488896|NCT00069095|531945476|FG004|Primary Treatment Phase|Other Violation|0|||
147488897|NCT00069095|531945477|FG005|Primary Treatment Phase|Other Violation|1|||
147488898|NCT00069095|531945472|FG000|Primary Treatment Phase|Violation criteria|0|||
147488899|NCT00069095|531945473|FG001|Primary Treatment Phase|Violation criteria|2|||
147488900|NCT00069095|531945474|FG002|Primary Treatment Phase|Violation criteria|4|||
147488901|NCT00069095|531945475|FG003|Primary Treatment Phase|Violation criteria|3|||
147488902|NCT00069095|531945476|FG004|Primary Treatment Phase|Violation criteria|1|||
147488903|NCT00069095|531945477|FG005|Primary Treatment Phase|Violation criteria|5|||
147488904|NCT00069095|531945472|FG000|Post-study Treatment Phase|Missing reason|1|||
147488905|NCT00069095|531945473|FG001|Post-study Treatment Phase|Missing reason|3|||
147488906|NCT00069095|531945474|FG002|Post-study Treatment Phase|Missing reason|12|||
147488907|NCT00069095|531945475|FG003|Post-study Treatment Phase|Missing reason|8|||
147488908|NCT00069095|531945476|FG004|Post-study Treatment Phase|Missing reason|18|||
147488909|NCT00069095|531945477|FG005|Post-study Treatment Phase|Missing reason|17|||
147488910|NCT00069095|531945472|FG000|Post-study Treatment Phase|Adverse Event|2|||
147488911|NCT00069095|531945473|FG001|Post-study Treatment Phase|Adverse Event|3|||
147488912|NCT00069095|531945474|FG002|Post-study Treatment Phase|Adverse Event|1|||
147488913|NCT00069095|531945475|FG003|Post-study Treatment Phase|Adverse Event|0|||
147488914|NCT00069095|531945476|FG004|Post-study Treatment Phase|Adverse Event|5|||
147488915|NCT00069095|531945477|FG005|Post-study Treatment Phase|Adverse Event|1|||
147488916|NCT00069095|531945472|FG000|Post-study Treatment Phase|Eligible for surgery|2|||
147488917|NCT00069095|531945473|FG001|Post-study Treatment Phase|Eligible for surgery|0|||
147488918|NCT00069095|531945474|FG002|Post-study Treatment Phase|Eligible for surgery|0|||
147488919|NCT00069095|531945475|FG003|Post-study Treatment Phase|Eligible for surgery|0|||
147488920|NCT00069095|531945476|FG004|Post-study Treatment Phase|Eligible for surgery|0|||
147488921|NCT00069095|531945477|FG005|Post-study Treatment Phase|Eligible for surgery|0|||
147488922|NCT00069095|531945472|FG000|Post-study Treatment Phase|Insufficient therapeutic response|1|||
147488923|NCT00069095|531945473|FG001|Post-study Treatment Phase|Insufficient therapeutic response|4|||
147488924|NCT00069095|531945474|FG002|Post-study Treatment Phase|Insufficient therapeutic response|5|||
147488925|NCT00069095|531945475|FG003|Post-study Treatment Phase|Insufficient therapeutic response|6|||
147488926|NCT00069095|531945476|FG004|Post-study Treatment Phase|Insufficient therapeutic response|7|||
147488927|NCT00069095|531945477|FG005|Post-study Treatment Phase|Insufficient therapeutic response|9|||
147488928|NCT00069095|531945472|FG000|Post-study Treatment Phase|Participant refusal/Admin reasons|1|||
147488929|NCT00069095|531945473|FG001|Post-study Treatment Phase|Participant refusal/Admin reasons|0|||
147488930|NCT00069095|531945474|FG002|Post-study Treatment Phase|Participant refusal/Admin reasons|0|||
147488931|NCT00069095|531945475|FG003|Post-study Treatment Phase|Participant refusal/Admin reasons|0|||
147488932|NCT00069095|531945476|FG004|Post-study Treatment Phase|Participant refusal/Admin reasons|0|||
147488933|NCT00069095|531945477|FG005|Post-study Treatment Phase|Participant refusal/Admin reasons|1|||
147488934|NCT00069095|531945472|FG000|Post-study Treatment Phase|Participant had complete response|1|||
147488935|NCT00069095|531945473|FG001|Post-study Treatment Phase|Participant had complete response|1|||
147488936|NCT00069095|531945474|FG002|Post-study Treatment Phase|Participant had complete response|0|||
147488937|NCT00069095|531945475|FG003|Post-study Treatment Phase|Participant had complete response|0|||
147488938|NCT00069095|531945476|FG004|Post-study Treatment Phase|Participant had complete response|0|||
147488939|NCT00069095|531945477|FG005|Post-study Treatment Phase|Participant had complete response|0|||
147488940|NCT00069095|531945472|FG000|Post-study Treatment Phase|More than 21 days delay between cycles|0|||
147488941|NCT00069095|531945473|FG001|Post-study Treatment Phase|More than 21 days delay between cycles|1|||
147488942|NCT00069095|531945474|FG002|Post-study Treatment Phase|More than 21 days delay between cycles|0|||
147488943|NCT00069095|531945475|FG003|Post-study Treatment Phase|More than 21 days delay between cycles|0|||
147488944|NCT00069095|531945476|FG004|Post-study Treatment Phase|More than 21 days delay between cycles|0|||
147488945|NCT00069095|531945477|FG005|Post-study Treatment Phase|More than 21 days delay between cycles|0|||
147488946|NCT00069095|531945472|FG000|Post-study Treatment Phase|Investigator decision (enough treatment)|0|||
147488947|NCT00069095|531945473|FG001|Post-study Treatment Phase|Investigator decision (enough treatment)|1|||
147488948|NCT00069095|531945474|FG002|Post-study Treatment Phase|Investigator decision (enough treatment)|1|||
147488949|NCT00069095|531945475|FG003|Post-study Treatment Phase|Investigator decision (enough treatment)|0|||
147488950|NCT00069095|531945476|FG004|Post-study Treatment Phase|Investigator decision (enough treatment)|1|||
147488951|NCT00069095|531945477|FG005|Post-study Treatment Phase|Investigator decision (enough treatment)|0|||
147488952|NCT00069095|531945472|FG000|Post-study Treatment Phase|Participant withdrew consent|0|||
147488953|NCT00069095|531945473|FG001|Post-study Treatment Phase|Participant withdrew consent|0|||
147488954|NCT00069095|531945474|FG002|Post-study Treatment Phase|Participant withdrew consent|1|||
147623976|NCT00437021|532441675|FG003|Overall Study|Withdrawal by Subject|0|||
147623977|NCT00437021|532441676|FG004|Overall Study|Withdrawal by Subject|0|||
147623978|NCT00437021|532441677|FG005|Overall Study|Withdrawal by Subject|0|||
147623979|NCT00437021|532441678|FG006|Overall Study|Withdrawal by Subject|0|||
147623980|NCT00437021|532441679|FG007|Overall Study|Withdrawal by Subject|0|||
147623981|NCT00437021|532441680|FG008|Overall Study|Withdrawal by Subject|0|||
147623982|NCT00437021|532441681|FG009|Overall Study|Withdrawal by Subject|0|||
147623983|NCT00437021|532441682|FG010|Overall Study|Withdrawal by Subject|0|||
147623984|NCT00437021|532441683|FG011|Overall Study|Withdrawal by Subject|0|||
147623985|NCT01880554|532441684|FG000|Overall Study|Protocol Violation|14|||
147623986|NCT01880554|532441684|FG000|Overall Study|Simon's design requirements|2|||
147623987|NCT05161481|532441685|FG000|Overall Study|Withdrawal of consent|0|||
147623988|NCT05161481|532441686|FG001|Overall Study|Withdrawal of consent|1|||
147623989|NCT05161481|532441687|FG002|Overall Study|Withdrawal of consent|1|||
147623990|NCT05161481|532441685|FG000|Overall Study|Study terminated by sponsor|3|||
147623991|NCT05161481|532441686|FG001|Overall Study|Study terminated by sponsor|3|||
147623992|NCT05161481|532441687|FG002|Overall Study|Study terminated by sponsor|2|||
147623993|NCT05161481|532441685|FG000|Overall Study|Adverse Event|3|||
147623994|NCT05161481|532441686|FG001|Overall Study|Adverse Event|0|||
147623995|NCT05161481|532441687|FG002|Overall Study|Adverse Event|6|||
147488955|NCT00069095|531945475|FG003|Post-study Treatment Phase|Participant withdrew consent|0|||
147488956|NCT00069095|531945476|FG004|Post-study Treatment Phase|Participant withdrew consent|0|||
147488957|NCT00069095|531945477|FG005|Post-study Treatment Phase|Participant withdrew consent|0|||
147488958|NCT00069095|531945472|FG000|Post-study Treatment Phase|Participant will start new treatment|0|||
147488959|NCT00069095|531945473|FG001|Post-study Treatment Phase|Participant will start new treatment|0|||
147488960|NCT00069095|531945474|FG002|Post-study Treatment Phase|Participant will start new treatment|1|||
147488961|NCT00069095|531945475|FG003|Post-study Treatment Phase|Participant will start new treatment|0|||
147488962|NCT00069095|531945476|FG004|Post-study Treatment Phase|Participant will start new treatment|0|||
147488963|NCT00069095|531945477|FG005|Post-study Treatment Phase|Participant will start new treatment|0|||
147488964|NCT00069095|531945472|FG000|Post-study Treatment Phase|Participant wanted break from treatment|0|||
147488965|NCT00069095|531945473|FG001|Post-study Treatment Phase|Participant wanted break from treatment|0|||
147488966|NCT00069095|531945474|FG002|Post-study Treatment Phase|Participant wanted break from treatment|0|||
147488967|NCT00069095|531945475|FG003|Post-study Treatment Phase|Participant wanted break from treatment|1|||
147488968|NCT00069095|531945476|FG004|Post-study Treatment Phase|Participant wanted break from treatment|0|||
147488969|NCT00069095|531945477|FG005|Post-study Treatment Phase|Participant wanted break from treatment|0|||
147488970|NCT00069095|531945472|FG000|Post-study Treatment Phase|Participant completed treatment|0|||
147488971|NCT00069095|531945473|FG001|Post-study Treatment Phase|Participant completed treatment|0|||
147488972|NCT00069095|531945474|FG002|Post-study Treatment Phase|Participant completed treatment|0|||
147488973|NCT00069095|531945475|FG003|Post-study Treatment Phase|Participant completed treatment|1|||
147488974|NCT00069095|531945476|FG004|Post-study Treatment Phase|Participant completed treatment|0|||
147488975|NCT00069095|531945477|FG005|Post-study Treatment Phase|Participant completed treatment|0|||
147488976|NCT00069095|531945472|FG000|Post-study Treatment Phase|Surgery|0|||
147488977|NCT00069095|531945473|FG001|Post-study Treatment Phase|Surgery|0|||
147488978|NCT00069095|531945474|FG002|Post-study Treatment Phase|Surgery|0|||
147488979|NCT00069095|531945475|FG003|Post-study Treatment Phase|Surgery|1|||
147488980|NCT00069095|531945476|FG004|Post-study Treatment Phase|Surgery|1|||
147488981|NCT00069095|531945477|FG005|Post-study Treatment Phase|Surgery|0|||
147488982|NCT00069095|531945472|FG000|Post-study Treatment Phase|Death|0|||
147488983|NCT00069095|531945473|FG001|Post-study Treatment Phase|Death|0|||
147488984|NCT00069095|531945474|FG002|Post-study Treatment Phase|Death|0|||
147488985|NCT00069095|531945475|FG003|Post-study Treatment Phase|Death|0|||
147488986|NCT00069095|531945476|FG004|Post-study Treatment Phase|Death|1|||
147488987|NCT00069095|531945477|FG005|Post-study Treatment Phase|Death|0|||
147488988|NCT00069095|531945472|FG000|Post-study Treatment Phase|Participant had progressive disease|0|||
147488989|NCT00069095|531945473|FG001|Post-study Treatment Phase|Participant had progressive disease|0|||
147488990|NCT00069095|531945474|FG002|Post-study Treatment Phase|Participant had progressive disease|0|||
147488991|NCT00069095|531945475|FG003|Post-study Treatment Phase|Participant had progressive disease|0|||
147488992|NCT00069095|531945476|FG004|Post-study Treatment Phase|Participant had progressive disease|1|||
147488993|NCT00069095|531945477|FG005|Post-study Treatment Phase|Participant had progressive disease|0|||
147488994|NCT00069095|531945472|FG000|Post-study Treatment Phase|Participant/Physician decision to stop|0|||
147623996|NCT05161481|532441685|FG000|Overall Study|Randomised in error and was not treated|1|||
147623997|NCT05161481|532441686|FG001|Overall Study|Randomised in error and was not treated|0|||
147623998|NCT05161481|532441687|FG002|Overall Study|Randomised in error and was not treated|0|||
147623999|NCT05161481|532441685|FG000|Overall Study|Subject decision|0|||
147624000|NCT05161481|532441686|FG001|Overall Study|Subject decision|0|||
147624001|NCT05161481|532441687|FG002|Overall Study|Subject decision|1|||
147624002|NCT00529087|532441690|FG000|Overall Study|Adverse Event|10|||
147624003|NCT00529087|532441691|FG001|Overall Study|Adverse Event|13|||
147624004|NCT00529087|532441692|FG002|Overall Study|Adverse Event|4|||
147624005|NCT00529087|532441690|FG000|Overall Study|Lost to Follow-up|6|||
147667920|NCT02351934|532609795|FG001|Allocation|Acute Kidney Injury on Post Op Day 1|0|||
147488995|NCT00069095|531945473|FG001|Post-study Treatment Phase|Participant/Physician decision to stop|0|||
147488996|NCT00069095|531945474|FG002|Post-study Treatment Phase|Participant/Physician decision to stop|0|||
147488997|NCT00069095|531945475|FG003|Post-study Treatment Phase|Participant/Physician decision to stop|0|||
147488998|NCT00069095|531945476|FG004|Post-study Treatment Phase|Participant/Physician decision to stop|1|||
147488999|NCT00069095|531945477|FG005|Post-study Treatment Phase|Participant/Physician decision to stop|0|||
147489000|NCT00069095|531945472|FG000|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0|||
147489001|NCT00069095|531945473|FG001|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0|||
147489002|NCT00069095|531945474|FG002|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0|||
147489003|NCT00069095|531945475|FG003|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0|||
147489004|NCT00069095|531945476|FG004|Post-study Treatment Phase|Preplanned 6 cycles after surgery|1|||
147489005|NCT00069095|531945477|FG005|Post-study Treatment Phase|Preplanned 6 cycles after surgery|0|||
147489006|NCT00069095|531945472|FG000|Post-study Treatment Phase|Investigator decision|0|||
147489007|NCT00069095|531945473|FG001|Post-study Treatment Phase|Investigator decision|0|||
147489008|NCT00069095|531945474|FG002|Post-study Treatment Phase|Investigator decision|0|||
147489009|NCT00069095|531945475|FG003|Post-study Treatment Phase|Investigator decision|0|||
147489010|NCT00069095|531945476|FG004|Post-study Treatment Phase|Investigator decision|0|||
147489011|NCT00069095|531945477|FG005|Post-study Treatment Phase|Investigator decision|1|||
147489012|NCT00069095|531945472|FG000|Follow-up Phase|Death|174|||
147489013|NCT00069095|531945473|FG001|Follow-up Phase|Death|206|||
147489014|NCT00069095|531945474|FG002|Follow-up Phase|Death|120|||
147489015|NCT00069095|531945475|FG003|Follow-up Phase|Death|112|||
147489016|NCT00069095|531945476|FG004|Follow-up Phase|Death|92|||
147489017|NCT00069095|531945477|FG005|Follow-up Phase|Death|101|||
147489018|NCT05610176|531945481|FG000|Overall Study|Death|6|||
147489019|NCT01727713|531945483|FG000|Overall Study|Lost to Follow-up|5|||
147489020|NCT01727713|531945483|FG000|Overall Study|Adverse Event|10|||
147489021|NCT01727713|531945483|FG000|Overall Study|Participant Met Withdrawal Criteria|5|||
147489022|NCT01727713|531945483|FG000|Overall Study|Withdrawal by Subject|13|||
147489023|NCT01727713|531945483|FG000|Overall Study|Protocol Deviation|2|||
147489024|NCT01253044|531945484|FG000|Overall Study|Lost to Follow-up|38|||
147489025|NCT01253044|531945485|FG001|Overall Study|Lost to Follow-up|29|||
147489026|NCT00987623|531945486|FG000|Overall Study|Lost to Follow-up|2|||
147489027|NCT00987623|531945487|FG001|Overall Study|Lost to Follow-up|1|||
147489028|NCT00987623|531945486|FG000|Overall Study|Time/job conflict|2|||
147489029|NCT00987623|531945487|FG001|Overall Study|Time/job conflict|0|||
147489030|NCT00987623|531945486|FG000|Overall Study|Discomfort|1|||
147489031|NCT00987623|531945487|FG001|Overall Study|Discomfort|0|||
147489032|NCT00987623|531945486|FG000|Overall Study|Biomicroscopy|0|||
147489033|NCT00987623|531945487|FG001|Overall Study|Biomicroscopy|1|||
147489034|NCT00987623|531945486|FG000|Overall Study|Influenza|0|||
147489035|NCT00987623|531945487|FG001|Overall Study|Influenza|1|||
147489036|NCT02702193|531945490|FG000|Baseline Assessment/Randomization|Withdrawal by Subject|1|||
147489037|NCT02702193|531945491|FG001|Baseline Assessment/Randomization|Withdrawal by Subject|0|||
147489038|NCT02702193|531945490|FG000|4 Month Follow up|Withdrawal by Subject|1|||
147489039|NCT02702193|531945491|FG001|4 Month Follow up|Withdrawal by Subject|0|||
147489040|NCT02702193|531945490|FG000|4 Month Follow up|Lost to Follow-up|17|||
147489041|NCT02702193|531945491|FG001|4 Month Follow up|Lost to Follow-up|18|||
147489042|NCT02702193|531945490|FG000|8 Month Follow up|Withdrawal by Subject|1|||
147489043|NCT02702193|531945491|FG001|8 Month Follow up|Withdrawal by Subject|0|||
147489044|NCT02702193|531945490|FG000|8 Month Follow up|Lost to Follow-up|14|||
147489045|NCT02702193|531945491|FG001|8 Month Follow up|Lost to Follow-up|18|||
147489046|NCT02702193|531945490|FG000|12 Month Follow up|Withdrawal by Subject|1|||
147489047|NCT02702193|531945491|FG001|12 Month Follow up|Withdrawal by Subject|0|||
147489048|NCT02702193|531945490|FG000|12 Month Follow up|Lost to Follow-up|16|||
147489049|NCT02702193|531945491|FG001|12 Month Follow up|Lost to Follow-up|18|||
147489050|NCT01201798|531945492|FG000|Overall Study|Adverse Event|2|||
147489051|NCT01201798|531945493|FG001|Overall Study|Adverse Event|0|||
147489052|NCT01201798|531945492|FG000|Overall Study|Lost to Follow-up|3|||
147667921|NCT02351934|532609794|FG000|Follow-Up|POD weight<pre-op weight|3|||
147667922|NCT02351934|532609795|FG001|Follow-Up|POD weight<pre-op weight|0|||
147667923|NCT02351934|532609794|FG000|Follow-Up|Acute Kidney Injury|1|||
147667924|NCT02351934|532609795|FG001|Follow-Up|Acute Kidney Injury|0|||
147489053|NCT01201798|531945493|FG001|Overall Study|Lost to Follow-up|5|||
147489054|NCT01201798|531945492|FG000|Overall Study|Decision Unrelated to an Adverse Event|1|||
147489055|NCT01201798|531945493|FG001|Overall Study|Decision Unrelated to an Adverse Event|1|||
147489056|NCT01201798|531945492|FG000|Overall Study|Noncompliance|1|||
147489057|NCT01201798|531945493|FG001|Overall Study|Noncompliance|0|||
147489058|NCT01201798|531945492|FG000|Overall Study|Protocol Violation|1|||
147489059|NCT01201798|531945493|FG001|Overall Study|Protocol Violation|1|||
147489060|NCT01201798|531945492|FG000|Overall Study|Treatment Failure|1|||
147489061|NCT01201798|531945493|FG001|Overall Study|Treatment Failure|8|||
147489062|NCT05692154|531945500|FG000|Overall Study|Adverse Event|0|||
147667925|NCT02351934|532609794|FG000|Follow-Up|Early dismissal|3|||
147489063|NCT05692154|531945501|FG001|Overall Study|Adverse Event|1|||
147489064|NCT01912729|531945504|FG000|Overall Study|Withdrawal by Subject|0|||
147489065|NCT01912729|531945505|FG001|Overall Study|Withdrawal by Subject|1|||
147489066|NCT04285346|531945513|FG000|Treatment Period (Up to 12 Weeks)|Adverse Event|4|||
147489067|NCT04285346|531945514|FG001|Treatment Period (Up to 12 Weeks)|Adverse Event|0|||
147489068|NCT04285346|531945513|FG000|Treatment Period (Up to 12 Weeks)|Lack of Efficacy|1|||
147489069|NCT04285346|531945514|FG001|Treatment Period (Up to 12 Weeks)|Lack of Efficacy|0|||
147489070|NCT04285346|531945513|FG000|Treatment Period (Up to 12 Weeks)|Withdrawal by Subject|1|||
147489071|NCT04285346|531945514|FG001|Treatment Period (Up to 12 Weeks)|Withdrawal by Subject|0|||
147489072|NCT01975272|531945517|FG000|Overall Study|Excluded after protocol amendment|1|||
147489073|NCT01975272|531945518|FG001|Overall Study|Excluded after protocol amendment|1|||
147489074|NCT01975272|531945519|FG002|Overall Study|Excluded after protocol amendment|2|||
147489075|NCT00850460|531945521|FG000|Overall Study|Lost to Follow-up|4|||
147489076|NCT00850460|531945522|FG001|Overall Study|Lost to Follow-up|4|||
147489077|NCT00988559|531945525|FG000|Overall Study|Withdrawal by Subject|1|||
147489078|NCT00988559|531945526|FG001|Overall Study|Withdrawal by Subject|1|||
147489079|NCT00988559|531945527|FG002|Overall Study|Withdrawal by Subject|0|||
147489080|NCT00988559|531945528|FG003|Overall Study|Withdrawal by Subject|1|||
147489081|NCT00988559|531945525|FG000|Overall Study|Pregnancy|0|||
147489082|NCT00988559|531945526|FG001|Overall Study|Pregnancy|1|||
147489083|NCT00988559|531945527|FG002|Overall Study|Pregnancy|1|||
147489084|NCT00988559|531945528|FG003|Overall Study|Pregnancy|0|||
147489085|NCT00988559|531945525|FG000|Overall Study|Lost to Follow-up|0|||
147489086|NCT00988559|531945526|FG001|Overall Study|Lost to Follow-up|0|||
147489087|NCT00988559|531945527|FG002|Overall Study|Lost to Follow-up|1|||
147489088|NCT00988559|531945528|FG003|Overall Study|Lost to Follow-up|0|||
147489089|NCT02224846|531945529|FG000|Period 1 (Month 3)|Adverse Event|2|||
147489090|NCT02224846|531945530|FG001|Period 1 (Month 3)|Adverse Event|1|||
147489091|NCT02224846|531945529|FG000|Period 1 (Month 3)|Lost to Follow-up|3|||
147489092|NCT02224846|531945530|FG001|Period 1 (Month 3)|Lost to Follow-up|8|||
147489093|NCT02224846|531945529|FG000|Period 1 (Month 3)|Protocol Violation|4|||
147489094|NCT02224846|531945530|FG001|Period 1 (Month 3)|Protocol Violation|8|||
147489095|NCT02224846|531945529|FG000|Period 1 (Month 3)|Withdrawal by Subject|8|||
147489096|NCT02224846|531945530|FG001|Period 1 (Month 3)|Withdrawal by Subject|18|||
147489097|NCT02224846|531945529|FG000|Period 1 (Month 3)|Sponsor Decision|2|||
147489098|NCT02224846|531945530|FG001|Period 1 (Month 3)|Sponsor Decision|1|||
147489099|NCT02224846|531945529|FG000|Period 2 (Month 3 to Month 12)|Adverse Event|1|||
147489100|NCT02224846|531945530|FG001|Period 2 (Month 3 to Month 12)|Adverse Event|2|||
147489101|NCT02224846|531945529|FG000|Period 2 (Month 3 to Month 12)|Lost to Follow-up|3|||
147489102|NCT02224846|531945530|FG001|Period 2 (Month 3 to Month 12)|Lost to Follow-up|5|||
147489103|NCT02224846|531945529|FG000|Period 2 (Month 3 to Month 12)|Protocol Violation|0|||
147489104|NCT02224846|531945530|FG001|Period 2 (Month 3 to Month 12)|Protocol Violation|3|||
147489105|NCT02224846|531945529|FG000|Period 2 (Month 3 to Month 12)|Withdrawal by Subject|15|||
147489106|NCT02224846|531945530|FG001|Period 2 (Month 3 to Month 12)|Withdrawal by Subject|19|||
147489107|NCT02224846|531945529|FG000|Period 2 (Month 3 to Month 12)|Physician Decision|0|||
147489108|NCT02224846|531945530|FG001|Period 2 (Month 3 to Month 12)|Physician Decision|2|||
147489109|NCT02224846|531945529|FG000|Period 2 (Month 12 to Month 24)|Adverse Event|3|||
147489110|NCT02224846|531945530|FG001|Period 2 (Month 12 to Month 24)|Adverse Event|4|||
147489111|NCT02224846|531945529|FG000|Period 2 (Month 12 to Month 24)|Death|1|||
147489112|NCT02224846|531945530|FG001|Period 2 (Month 12 to Month 24)|Death|0|||
147489113|NCT02224846|531945529|FG000|Period 2 (Month 12 to Month 24)|Lost to Follow-up|7|||
147489114|NCT02224846|531945530|FG001|Period 2 (Month 12 to Month 24)|Lost to Follow-up|13|||
147489115|NCT02224846|531945529|FG000|Period 2 (Month 12 to Month 24)|Protocol Violation|4|||
147489116|NCT02224846|531945530|FG001|Period 2 (Month 12 to Month 24)|Protocol Violation|11|||
147489117|NCT02224846|531945529|FG000|Period 2 (Month 12 to Month 24)|Withdrawal by Subject|25|||
147489118|NCT02224846|531945530|FG001|Period 2 (Month 12 to Month 24)|Withdrawal by Subject|43|||
147489119|NCT02224846|531945529|FG000|Period 2 (Month 12 to Month 24)|Physician Decision|0|||
147489120|NCT02224846|531945530|FG001|Period 2 (Month 12 to Month 24)|Physician Decision|2|||
147489121|NCT02224846|531945529|FG000|Period 2 (Month 12 to Month 24)|Sponsor Decision|2|||
147489122|NCT02224846|531945530|FG001|Period 2 (Month 12 to Month 24)|Sponsor Decision|1|||
147489123|NCT05372575|531945531|FG000|Overall Study|Protocol Violation|7|||
147489124|NCT05372575|531945532|FG001|Overall Study|Protocol Violation|16|||
147489125|NCT03510663|531945533|FG000|Overall Study|Withdrawal by Subject|0|||
147489126|NCT03510663|531945534|FG001|Overall Study|Withdrawal by Subject|1|||
147489127|NCT03510663|531945535|FG002|Overall Study|Withdrawal by Subject|0|||
147489128|NCT03510663|531945536|FG003|Overall Study|Withdrawal by Subject|0|||
147489129|NCT03510663|531945537|FG004|Overall Study|Withdrawal by Subject|0|||
147489130|NCT03510663|531945538|FG005|Overall Study|Withdrawal by Subject|0|||
147489131|NCT03510663|531945539|FG006|Overall Study|Withdrawal by Subject|0|||
147489132|NCT03510663|531945540|FG007|Overall Study|Withdrawal by Subject|0|||
147489133|NCT04743635|531945549|FG000|Overall Study|Lost to Follow-up|2|||
147489134|NCT04743635|531945550|FG001|Overall Study|Lost to Follow-up|0|||
147489135|NCT01954121|531945551|FG000|Overall Study|Lack of Efficacy|94|||
147489136|NCT01954121|531945552|FG001|Overall Study|Lack of Efficacy|41|||
147489137|NCT01954121|531945551|FG000|Overall Study|Protocol Violation|0|||
147489138|NCT01954121|531945552|FG001|Overall Study|Protocol Violation|2|||
147489139|NCT01954121|531945551|FG000|Overall Study|Lost to Follow-up|5|||
147489140|NCT01954121|531945552|FG001|Overall Study|Lost to Follow-up|6|||
147489141|NCT01954121|531945551|FG000|Overall Study|Withdrawal by Subject|18|||
147489142|NCT01954121|531945552|FG001|Overall Study|Withdrawal by Subject|12|||
147489143|NCT01954121|531945551|FG000|Overall Study|Pregnancy|1|||
147624006|NCT00529087|532441691|FG001|Overall Study|Lost to Follow-up|4|||
147624007|NCT00529087|532441692|FG002|Overall Study|Lost to Follow-up|1|||
147624008|NCT00529087|532441690|FG000|Overall Study|Protocol Violation|8|||
147624009|NCT00529087|532441691|FG001|Overall Study|Protocol Violation|7|||
147624010|NCT00529087|532441692|FG002|Overall Study|Protocol Violation|6|||
147624011|NCT00529087|532441690|FG000|Overall Study|Withdrawal by Subject|3|||
147624012|NCT00529087|532441691|FG001|Overall Study|Withdrawal by Subject|3|||
147624013|NCT00529087|532441692|FG002|Overall Study|Withdrawal by Subject|3|||
147624014|NCT00529087|532441690|FG000|Overall Study|Protocol deviation|1|||
147624015|NCT00529087|532441691|FG001|Overall Study|Protocol deviation|1|||
147624016|NCT00529087|532441692|FG002|Overall Study|Protocol deviation|2|||
147624017|NCT02954601|532441693|FG000|First Intervention (Five Days)|Withdrawal by Subject|0|||
147624018|NCT02954601|532441694|FG001|First Intervention (Five Days)|Withdrawal by Subject|0|||
147624019|NCT02954601|532441695|FG002|First Intervention (Five Days)|Withdrawal by Subject|1|||
147624020|NCT02954601|532441696|FG003|First Intervention (Five Days)|Withdrawal by Subject|0|||
147624021|NCT00318474|532441697|FG000|Overall Study|Adverse Event|1|||
147624022|NCT00318474|532441698|FG001|Overall Study|Adverse Event|1|||
147624023|NCT00318474|532441697|FG000|Overall Study|Lost to Follow-up|0|||
147624024|NCT00318474|532441698|FG001|Overall Study|Lost to Follow-up|1|||
147624025|NCT00318474|532441697|FG000|Overall Study|Pregnancy|0|||
147624026|NCT00318474|532441698|FG001|Overall Study|Pregnancy|2|||
147624027|NCT00318474|532441697|FG000|Overall Study|Protocol Violation|1|||
147624028|NCT00318474|532441698|FG001|Overall Study|Protocol Violation|0|||
147624029|NCT00318474|532441697|FG000|Overall Study|Withdrawal by Subject|3|||
147624030|NCT00318474|532441698|FG001|Overall Study|Withdrawal by Subject|2|||
147624031|NCT00318474|532441697|FG000|Overall Study|Fall in GFR|3|||
147624032|NCT00318474|532441698|FG001|Overall Study|Fall in GFR|3|||
147624033|NCT00318474|532441697|FG000|Overall Study|Post-therapy hyperflycemia|0|||
147624034|NCT00318474|532441698|FG001|Overall Study|Post-therapy hyperflycemia|1|||
147624035|NCT00318474|532441697|FG000|Overall Study|Trial terminated|10|||
147624036|NCT00318474|532441698|FG001|Overall Study|Trial terminated|7|||
147667926|NCT02351934|532609795|FG001|Follow-Up|Early dismissal|0|||
147667927|NCT02351934|532609794|FG000|Follow-Up|Hypotension|3|||
147667928|NCT02351934|532609795|FG001|Follow-Up|Hypotension|0|||
147489144|NCT01954121|531945552|FG001|Overall Study|Pregnancy|1|||
147489145|NCT01954121|531945551|FG000|Overall Study|AE, serious fatal|1|||
147489146|NCT01954121|531945552|FG001|Overall Study|AE, serious fatal|0|||
147489147|NCT01954121|531945551|FG000|Overall Study|AE, non-serious non-fatal|5|||
147489148|NCT01954121|531945552|FG001|Overall Study|AE, non-serious non-fatal|22|||
147489149|NCT01954121|531945551|FG000|Overall Study|SAE, non-fatal|1|||
147489150|NCT01954121|531945552|FG001|Overall Study|SAE, non-fatal|4|||
147489151|NCT01954121|531945551|FG000|Overall Study|Non-compliant with study procedures|1|||
147489152|NCT01954121|531945552|FG001|Overall Study|Non-compliant with study procedures|0|||
147489153|NCT01954121|531945551|FG000|Overall Study|Non-compliant patient|1|||
147489154|NCT01954121|531945552|FG001|Overall Study|Non-compliant patient|1|||
147489155|NCT01954121|531945551|FG000|Overall Study|Subject did not follow instructions|0|||
147489156|NCT01954121|531945552|FG001|Overall Study|Subject did not follow instructions|2|||
147489157|NCT01465178|531945554|FG000|Overall Study|Withdrawal by Subject|1|||
147489158|NCT01465178|531945555|FG001|Overall Study|Withdrawal by Subject|0|||
147489159|NCT00745368|531947536|FG000|Overall Study|Unable to provide sample|3|||
147489160|NCT02364947|531947537|FG000|Overall Study|Withdrawal by Subject|10|||
147489161|NCT02364947|531947538|FG001|Overall Study|Withdrawal by Subject|8|||
147489162|NCT02364947|531947539|FG002|Overall Study|Withdrawal by Subject|9|||
147489163|NCT02364947|531947537|FG000|Overall Study|Adverse Event|45|||
147489164|NCT02364947|531947538|FG001|Overall Study|Adverse Event|33|||
147489165|NCT02364947|531947539|FG002|Overall Study|Adverse Event|11|||
147489166|NCT02364947|531947537|FG000|Overall Study|Protocol Violation|1|||
147489167|NCT02364947|531947538|FG001|Overall Study|Protocol Violation|1|||
147489168|NCT02364947|531947539|FG002|Overall Study|Protocol Violation|1|||
147624037|NCT01735916|532441707|FG000|Overall Study|Subject not eligible to be randomized|11|||
147624038|NCT01735916|532441708|FG001|Overall Study|Subject not eligible to be randomized|0|||
147624039|NCT01735916|532441709|FG002|Overall Study|Subject not eligible to be randomized|0|||
147489169|NCT02364947|531947537|FG000|Overall Study|Physician Decision|3|||
147489170|NCT02364947|531947538|FG001|Overall Study|Physician Decision|2|||
147489171|NCT02364947|531947539|FG002|Overall Study|Physician Decision|5|||
147624040|NCT01735916|532441707|FG000|Overall Study|Early termination of study by sponsor|4|||
147624041|NCT01735916|532441708|FG001|Overall Study|Early termination of study by sponsor|19|||
147624042|NCT01735916|532441709|FG002|Overall Study|Early termination of study by sponsor|7|||
147624043|NCT01735916|532441707|FG000|Overall Study|Withdrawal by Subject|3|||
147624044|NCT01735916|532441708|FG001|Overall Study|Withdrawal by Subject|0|||
147667929|NCT02351934|532609794|FG000|Follow-Up|No documentation|2|||
147489172|NCT02364947|531947537|FG000|Overall Study|Death|0|||
147489173|NCT02364947|531947538|FG001|Overall Study|Death|1|||
147489174|NCT02364947|531947539|FG002|Overall Study|Death|0|||
147489175|NCT00423085|531947540|FG000|24-Week Double-Blind Treatment Phase|Adverse Event|21|||
147489176|NCT00423085|531947541|FG001|24-Week Double-Blind Treatment Phase|Adverse Event|38|||
147489177|NCT00423085|531947542|FG002|24-Week Double-Blind Treatment Phase|Adverse Event|34|||
147489178|NCT00423085|531947543|FG003|24-Week Double-Blind Treatment Phase|Adverse Event|0|||
147489179|NCT00423085|531947540|FG000|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|8|||
147489180|NCT00423085|531947541|FG001|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|16|||
147489181|NCT00423085|531947542|FG002|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|11|||
147489182|NCT00423085|531947543|FG003|24-Week Double-Blind Treatment Phase|Withdrawal by Subject|0|||
147489183|NCT00423085|531947540|FG000|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|7|||
147489184|NCT00423085|531947541|FG001|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|6|||
147489185|NCT00423085|531947542|FG002|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|7|||
147489186|NCT00423085|531947543|FG003|24-Week Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|0|||
147489187|NCT00423085|531947540|FG000|24-Week Double-Blind Treatment Phase|Protocol Violation|8|||
147489188|NCT00423085|531947541|FG001|24-Week Double-Blind Treatment Phase|Protocol Violation|3|||
147489189|NCT00423085|531947542|FG002|24-Week Double-Blind Treatment Phase|Protocol Violation|7|||
147489190|NCT00423085|531947543|FG003|24-Week Double-Blind Treatment Phase|Protocol Violation|0|||
147489191|NCT00423085|531947540|FG000|24-Week Double-Blind Treatment Phase|Death|1|||
147489192|NCT00423085|531947541|FG001|24-Week Double-Blind Treatment Phase|Death|1|||
147489193|NCT00423085|531947542|FG002|24-Week Double-Blind Treatment Phase|Death|0|||
147489194|NCT00423085|531947543|FG003|24-Week Double-Blind Treatment Phase|Death|0|||
147489195|NCT00423085|531947540|FG000|24-Week Double-Blind Treatment Phase|Lost to Follow-up|1|||
147489196|NCT00423085|531947541|FG001|24-Week Double-Blind Treatment Phase|Lost to Follow-up|0|||
147489197|NCT00423085|531947542|FG002|24-Week Double-Blind Treatment Phase|Lost to Follow-up|0|||
147489198|NCT00423085|531947543|FG003|24-Week Double-Blind Treatment Phase|Lost to Follow-up|0|||
147489199|NCT00423085|531947540|FG000|52-Week Open-Label Extension Phase|Adverse Event|0|||
147489200|NCT00423085|531947541|FG001|52-Week Open-Label Extension Phase|Adverse Event|0|||
147489201|NCT00423085|531947542|FG002|52-Week Open-Label Extension Phase|Adverse Event|0|||
147489202|NCT00423085|531947543|FG003|52-Week Open-Label Extension Phase|Adverse Event|97|||
147489203|NCT00423085|531947540|FG000|52-Week Open-Label Extension Phase|Withdrawal by Subject|0|||
147489204|NCT00423085|531947541|FG001|52-Week Open-Label Extension Phase|Withdrawal by Subject|0|||
147489205|NCT00423085|531947542|FG002|52-Week Open-Label Extension Phase|Withdrawal by Subject|0|||
147489206|NCT00423085|531947543|FG003|52-Week Open-Label Extension Phase|Withdrawal by Subject|37|||
147489207|NCT00423085|531947540|FG000|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|0|||
147489208|NCT00423085|531947541|FG001|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|0|||
147489209|NCT00423085|531947542|FG002|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|0|||
147489210|NCT00423085|531947543|FG003|52-Week Open-Label Extension Phase|Unsatisfactory therapeutic effect|18|||
147489211|NCT00423085|531947540|FG000|52-Week Open-Label Extension Phase|Protocol deviation|0|||
147489212|NCT00423085|531947541|FG001|52-Week Open-Label Extension Phase|Protocol deviation|0|||
147489213|NCT00423085|531947542|FG002|52-Week Open-Label Extension Phase|Protocol deviation|0|||
147489214|NCT00423085|531947543|FG003|52-Week Open-Label Extension Phase|Protocol deviation|9|||
147489215|NCT00423085|531947540|FG000|52-Week Open-Label Extension Phase|Death|0|||
147489216|NCT00423085|531947541|FG001|52-Week Open-Label Extension Phase|Death|0|||
147489217|NCT00423085|531947542|FG002|52-Week Open-Label Extension Phase|Death|0|||
147489218|NCT00423085|531947543|FG003|52-Week Open-Label Extension Phase|Death|2|||
147489219|NCT00853489|531947544|FG000|Overall Study|Lost to Follow-up|5|||
147489220|NCT00853489|531947545|FG001|Overall Study|Lost to Follow-up|2|||
147489221|NCT02326467|531947546|FG000|Overall Study|Withdrawal by Subject|1|||
147489222|NCT05525975|531947547|FG000|Overall Study|Surgery cancellation|4|||
147489223|NCT05525975|531947548|FG001|Overall Study|Surgery cancellation|5|||
147489224|NCT05525975|531947547|FG000|Overall Study|didn't fill prescription|1|||
147489225|NCT05525975|531947548|FG001|Overall Study|didn't fill prescription|0|||
147489226|NCT05525975|531947547|FG000|Overall Study|Withdrawal by Subject|0|||
147489227|NCT05525975|531947548|FG001|Overall Study|Withdrawal by Subject|3|||
147624045|NCT01735916|532441709|FG002|Overall Study|Withdrawal by Subject|0|||
147624046|NCT00708552|532441721|FG000|Overall Study|Adverse Event|10|||
147624047|NCT00708552|532441722|FG001|Overall Study|Adverse Event|3|||
147624048|NCT00708552|532441723|FG002|Overall Study|Adverse Event|4|||
147624049|NCT00708552|532441724|FG003|Overall Study|Adverse Event|6|||
147624050|NCT00708552|532441721|FG000|Overall Study|Lack of Efficacy|0|||
147489228|NCT00441441|531947551|FG000|Overall Study|Adverse Event|2|||
147489229|NCT00441441|531947552|FG001|Overall Study|Adverse Event|1|||
147489230|NCT00441441|531947551|FG000|Overall Study|Protocol Violation|4|||
147489231|NCT00441441|531947552|FG001|Overall Study|Protocol Violation|6|||
147489232|NCT00441441|531947551|FG000|Overall Study|Exacerbation of asthma|1|||
147489233|NCT00441441|531947552|FG001|Overall Study|Exacerbation of asthma|2|||
147489234|NCT00441441|531947551|FG000|Overall Study|Withdrawal by Subject|1|||
147624051|NCT00708552|532441722|FG001|Overall Study|Lack of Efficacy|4|||
147489235|NCT00441441|531947552|FG001|Overall Study|Withdrawal by Subject|2|||
147489236|NCT00441441|531947551|FG000|Overall Study|Other|3|||
147489237|NCT00441441|531947552|FG001|Overall Study|Other|3|||
147489238|NCT01051986|531947553|FG000|Overall Study|Death|1|||
147489239|NCT01051986|531947554|FG001|Overall Study|Death|0|||
147489240|NCT01051986|531947553|FG000|Overall Study|Withdrawal by Subject|2|||
147489241|NCT01051986|531947554|FG001|Overall Study|Withdrawal by Subject|1|||
147489242|NCT01051986|531947553|FG000|Overall Study|Protocol Violation|2|||
147489243|NCT01051986|531947554|FG001|Overall Study|Protocol Violation|3|||
147489244|NCT01725152|531947556|FG000|Treatment Period 1 (Week 1 to Week 6)|Adverse Event|3|||
147489245|NCT01725152|531947557|FG001|Treatment Period 1 (Week 1 to Week 6)|Adverse Event|0|||
147489246|NCT01725152|531947556|FG000|Treatment Period 1 (Week 1 to Week 6)|Consent Withdrawn|1|||
147489247|NCT01725152|531947557|FG001|Treatment Period 1 (Week 1 to Week 6)|Consent Withdrawn|0|||
147489248|NCT01725152|531947556|FG000|Treatment Period 2 (Week 8 to Week 14)|Adverse Event|1|||
147489249|NCT01725152|531947557|FG001|Treatment Period 2 (Week 8 to Week 14)|Adverse Event|1|||
147489250|NCT01725152|531947556|FG000|Treatment Period 2 (Week 8 to Week 14)|Other|0|||
147489251|NCT01725152|531947557|FG001|Treatment Period 2 (Week 8 to Week 14)|Other|2|||
147489252|NCT03580382|531947560|FG000|Overall Study|Early Termination of Study|0|||
147489253|NCT03580382|531947561|FG001|Overall Study|Early Termination of Study|3|||
147489254|NCT02808312|531947562|FG000|Overall Study|Enrolled but Never Treated|0|||
147489255|NCT02808312|531947563|FG001|Overall Study|Enrolled but Never Treated|0|||
147489256|NCT02808312|531947564|FG002|Overall Study|Enrolled but Never Treated|1|||
147489257|NCT02808312|531947565|FG003|Overall Study|Enrolled but Never Treated|0|||
147489258|NCT02808312|531947566|FG004|Overall Study|Enrolled but Never Treated|0|||
147489259|NCT05151471|531947567|FG000|Overall Study|Adverse Event|21|||
147489260|NCT05151471|531947568|FG001|Overall Study|Adverse Event|16|||
147489261|NCT05151471|531947567|FG000|Overall Study|Death|1|||
147489262|NCT05151471|531947568|FG001|Overall Study|Death|0|||
147489263|NCT05151471|531947567|FG000|Overall Study|Lost to Follow-up|0|||
147489264|NCT05151471|531947568|FG001|Overall Study|Lost to Follow-up|1|||
147489265|NCT05151471|531947567|FG000|Overall Study|Withdrawal by Subject|7|||
147489266|NCT05151471|531947568|FG001|Overall Study|Withdrawal by Subject|9|||
147489267|NCT05151471|531947567|FG000|Overall Study|Study terminated by sponsor|49|||
147489268|NCT05151471|531947568|FG001|Overall Study|Study terminated by sponsor|47|||
147489269|NCT05151471|531947567|FG000|Overall Study|Other|2|||
147489270|NCT05151471|531947568|FG001|Overall Study|Other|1|||
147489271|NCT04263142|531947569|FG000|Part 2 Period 1 (Day 1)|Adverse Event|0|||
147489272|NCT04263142|531947570|FG001|Part 2 Period 1 (Day 1)|Adverse Event|0|||
147489273|NCT04263142|531947571|FG002|Part 2 Period 1 (Day 1)|Adverse Event|0|||
147489274|NCT04263142|531947572|FG003|Part 2 Period 1 (Day 1)|Adverse Event|0|||
147489275|NCT04263142|531947573|FG004|Part 2 Period 1 (Day 1)|Adverse Event|1|||
147489276|NCT04263142|531947569|FG000|Part 2 Period 2 (Day 1)|Physician Decision|0|||
147489277|NCT04263142|531947570|FG001|Part 2 Period 2 (Day 1)|Physician Decision|0|||
147489278|NCT04263142|531947571|FG002|Part 2 Period 2 (Day 1)|Physician Decision|0|||
147489279|NCT04263142|531947572|FG003|Part 2 Period 2 (Day 1)|Physician Decision|0|||
147489280|NCT04263142|531947573|FG004|Part 2 Period 2 (Day 1)|Physician Decision|1|||
147489281|NCT03010423|531947576|FG000|Overall Study|Study termination|8|||
147489282|NCT00520676|531947578|FG000|Overall Study|Death|84|||
147489283|NCT00520676|531947579|FG001|Overall Study|Death|81|||
147489284|NCT00520676|531947578|FG000|Overall Study|Lost to Follow-up|6|||
147489285|NCT00520676|531947579|FG001|Overall Study|Lost to Follow-up|10|||
147489286|NCT00520676|531947578|FG000|Overall Study|Physician Decision|4|||
147489287|NCT00520676|531947579|FG001|Overall Study|Physician Decision|1|||
147489288|NCT00520676|531947578|FG000|Overall Study|Withdrawal by Subject|7|||
147489289|NCT00520676|531947579|FG001|Overall Study|Withdrawal by Subject|11|||
147489290|NCT03484923|531947582|FG000|Overall Study|Adverse Event|3|||
147489291|NCT03484923|531947583|FG001|Overall Study|Adverse Event|3|||
147489292|NCT03484923|531947584|FG002|Overall Study|Adverse Event|5|||
147489293|NCT03484923|531947585|FG003|Overall Study|Adverse Event|11|||
147489294|NCT03484923|531947586|FG004|Overall Study|Adverse Event|1|||
147489295|NCT03484923|531947582|FG000|Overall Study|Death|2|||
147667930|NCT02351934|532609795|FG001|Follow-Up|No documentation|0|||
147489296|NCT03484923|531947583|FG001|Overall Study|Death|2|||
147489297|NCT03484923|531947584|FG002|Overall Study|Death|3|||
147489298|NCT03484923|531947585|FG003|Overall Study|Death|0|||
147489299|NCT03484923|531947586|FG004|Overall Study|Death|1|||
147489300|NCT03484923|531947582|FG000|Overall Study|Physician Decision|6|||
147489301|NCT03484923|531947583|FG001|Overall Study|Physician Decision|7|||
147489302|NCT03484923|531947584|FG002|Overall Study|Physician Decision|6|||
147489303|NCT03484923|531947585|FG003|Overall Study|Physician Decision|3|||
147489304|NCT03484923|531947586|FG004|Overall Study|Physician Decision|2|||
147489305|NCT03484923|531947582|FG000|Overall Study|Progressive disease|33|||
147489306|NCT03484923|531947583|FG001|Overall Study|Progressive disease|28|||
147489307|NCT03484923|531947584|FG002|Overall Study|Progressive disease|26|||
147489308|NCT03484923|531947585|FG003|Overall Study|Progressive disease|30|||
147489309|NCT03484923|531947586|FG004|Overall Study|Progressive disease|16|||
147489310|NCT03484923|531947582|FG000|Overall Study|Subject Decision|1|||
147489311|NCT03484923|531947583|FG001|Overall Study|Subject Decision|3|||
147489312|NCT03484923|531947584|FG002|Overall Study|Subject Decision|3|||
147489313|NCT03484923|531947585|FG003|Overall Study|Subject Decision|0|||
147489314|NCT03484923|531947586|FG004|Overall Study|Subject Decision|1|||
147489315|NCT03439748|531947587|FG000|Overall Study|Withdrawal by Subject|11|||
147489316|NCT03439748|531947588|FG001|Overall Study|Withdrawal by Subject|17|||
147489317|NCT00115349|531947593|FG000|Overall Study|Study closed due to low enrollment.|11|||
147489318|NCT00115349|531947594|FG001|Overall Study|Study closed due to low enrollment.|9|||
147489319|NCT03298412|531947595|FG000|Run-in Period|Other, Not Specified|1|||
147489320|NCT03298412|531947595|FG000|Run-in Period|Disease Progression|1|||
147489321|NCT03298412|531947595|FG000|Run-in Period|Ineligibility Determined|1|||
147489322|NCT03298412|531947595|FG000|Run-in Period|Decision by Sponsor|6|||
147489323|NCT04402008|531947598|FG000|Overall Study|Adverse Event|0|||
147489324|NCT04402008|531947599|FG001|Overall Study|Adverse Event|0|||
147489325|NCT04402008|531947600|FG002|Overall Study|Adverse Event|0|||
147489326|NCT04402008|531947601|FG003|Overall Study|Adverse Event|1|||
147489327|NCT04402008|531947602|FG004|Overall Study|Adverse Event|0|||
147489328|NCT04402008|531947603|FG005|Overall Study|Adverse Event|0|||
147489329|NCT04402008|531947604|FG006|Overall Study|Adverse Event|0|||
147489330|NCT04402008|531947598|FG000|Overall Study|Disease Progression|3|||
147489331|NCT04402008|531947599|FG001|Overall Study|Disease Progression|2|||
147489332|NCT04402008|531947600|FG002|Overall Study|Disease Progression|3|||
147489333|NCT04402008|531947601|FG003|Overall Study|Disease Progression|3|||
147489334|NCT04402008|531947602|FG004|Overall Study|Disease Progression|4|||
147489335|NCT04402008|531947603|FG005|Overall Study|Disease Progression|3|||
147489336|NCT04402008|531947604|FG006|Overall Study|Disease Progression|10|||
147489337|NCT04402008|531947598|FG000|Overall Study|Withdrawal by Subject|0|||
147489338|NCT04402008|531947599|FG001|Overall Study|Withdrawal by Subject|1|||
147489339|NCT04402008|531947600|FG002|Overall Study|Withdrawal by Subject|0|||
147489340|NCT04402008|531947601|FG003|Overall Study|Withdrawal by Subject|0|||
147489341|NCT04402008|531947602|FG004|Overall Study|Withdrawal by Subject|1|||
147489342|NCT04402008|531947603|FG005|Overall Study|Withdrawal by Subject|0|||
147489343|NCT04402008|531947604|FG006|Overall Study|Withdrawal by Subject|0|||
147489344|NCT04402008|531947598|FG000|Overall Study|Sponsor Decision|0|||
147489345|NCT04402008|531947599|FG001|Overall Study|Sponsor Decision|0|||
147489346|NCT04402008|531947600|FG002|Overall Study|Sponsor Decision|0|||
147489347|NCT04402008|531947601|FG003|Overall Study|Sponsor Decision|0|||
147489348|NCT04402008|531947602|FG004|Overall Study|Sponsor Decision|0|||
147489349|NCT04402008|531947603|FG005|Overall Study|Sponsor Decision|0|||
147489350|NCT04402008|531947604|FG006|Overall Study|Sponsor Decision|3|||
147489351|NCT04402008|531947598|FG000|Overall Study|Death|0|||
147489352|NCT04402008|531947599|FG001|Overall Study|Death|0|||
147489353|NCT04402008|531947600|FG002|Overall Study|Death|0|||
147489354|NCT04402008|531947601|FG003|Overall Study|Death|0|||
147489355|NCT04402008|531947602|FG004|Overall Study|Death|1|||
147489356|NCT04402008|531947603|FG005|Overall Study|Death|0|||
147489357|NCT04402008|531947604|FG006|Overall Study|Death|2|||
147489358|NCT04402008|531947598|FG000|Overall Study|Other|0|||
147489359|NCT04402008|531947599|FG001|Overall Study|Other|0|||
147489360|NCT04402008|531947600|FG002|Overall Study|Other|0|||
147489361|NCT04402008|531947601|FG003|Overall Study|Other|0|||
147489362|NCT04402008|531947602|FG004|Overall Study|Other|0|||
147489363|NCT04402008|531947603|FG005|Overall Study|Other|0|||
147489364|NCT04402008|531947604|FG006|Overall Study|Other|5|||
147489365|NCT01028651|531947607|FG000|Overall Study|Death|2|||
147489366|NCT01028651|531947607|FG000|Overall Study|Adverse Event|1|||
147489367|NCT01533935|531947608|FG000|Overall Study|Adverse Event|5|||
147489368|NCT01533935|531947609|FG001|Overall Study|Adverse Event|7|||
147489369|NCT01533935|531947610|FG002|Overall Study|Adverse Event|1|||
147489370|NCT01533935|531947611|FG003|Overall Study|Adverse Event|5|||
147624052|NCT00708552|532441723|FG002|Overall Study|Lack of Efficacy|1|||
147624053|NCT00708552|532441724|FG003|Overall Study|Lack of Efficacy|0|||
147489371|NCT01533935|531947612|FG004|Overall Study|Adverse Event|3|||
147489372|NCT01533935|531947608|FG000|Overall Study|Protocol Violation|0|||
147489373|NCT01533935|531947609|FG001|Overall Study|Protocol Violation|2|||
147489374|NCT01533935|531947610|FG002|Overall Study|Protocol Violation|0|||
147489375|NCT01533935|531947611|FG003|Overall Study|Protocol Violation|0|||
147489376|NCT01533935|531947612|FG004|Overall Study|Protocol Violation|0|||
147489377|NCT01533935|531947608|FG000|Overall Study|Lost to Follow-up|0|||
147489378|NCT01533935|531947609|FG001|Overall Study|Lost to Follow-up|0|||
147489379|NCT01533935|531947610|FG002|Overall Study|Lost to Follow-up|1|||
147489380|NCT01533935|531947611|FG003|Overall Study|Lost to Follow-up|0|||
147489381|NCT01533935|531947612|FG004|Overall Study|Lost to Follow-up|0|||
147489382|NCT01533935|531947608|FG000|Overall Study|Withdrawal by Subject|0|||
147489383|NCT01533935|531947609|FG001|Overall Study|Withdrawal by Subject|4|||
147489384|NCT01533935|531947610|FG002|Overall Study|Withdrawal by Subject|5|||
147489385|NCT01533935|531947611|FG003|Overall Study|Withdrawal by Subject|2|||
147489386|NCT01533935|531947612|FG004|Overall Study|Withdrawal by Subject|4|||
147489387|NCT01533935|531947608|FG000|Overall Study|Other reason not defined above|1|||
147489388|NCT01533935|531947609|FG001|Overall Study|Other reason not defined above|0|||
147489389|NCT01533935|531947610|FG002|Overall Study|Other reason not defined above|1|||
147624054|NCT00708552|532441721|FG000|Overall Study|Protocol Violation|0|||
147489390|NCT01533935|531947611|FG003|Overall Study|Other reason not defined above|0|||
147489391|NCT01533935|531947612|FG004|Overall Study|Other reason not defined above|1|||
147489392|NCT05631548|531947613|FG000|First Intervention (2 Sessions)|excluded after randomization due to high blood pressure|0|||
147489393|NCT05631548|531947614|FG001|First Intervention (2 Sessions)|excluded after randomization due to high blood pressure|1|||
147489394|NCT04075266|531947615|FG000|OOE Period: 264 Week|Ongoing in Study|5|||
147489395|NCT04075266|531947616|FG001|OOE Period: 264 Week|Ongoing in Study|17|||
147489396|NCT04075266|531947615|FG000|OOE Period: 264 Week|Withdrawal by Subject|1|||
147489397|NCT04075266|531947616|FG001|OOE Period: 264 Week|Withdrawal by Subject|0|||
147489398|NCT05132569|531947617|FG000|DB Period: 26 Weeks|Withdrawal by Subject|0|||
147489399|NCT05132569|531947618|FG001|DB Period: 26 Weeks|Withdrawal by Subject|1|||
147489400|NCT05132569|531947617|FG000|DB Period: 26 Weeks|Study terminated by sponsor|1|||
147489401|NCT05132569|531947618|FG001|DB Period: 26 Weeks|Study terminated by sponsor|1|||
147489402|NCT05132569|531947617|FG000|OLE: Week 27 Till Termination (Week 61)|Study terminated by sponsor|2|||
147489403|NCT05132569|531947618|FG001|OLE: Week 27 Till Termination (Week 61)|Study terminated by sponsor|1|||
147489404|NCT01554956|531947619|FG000|Part 1 (Segment 1 and Segment 2)|Withdrawal by Subject|0|||
147489405|NCT01554956|531947620|FG001|Part 1 (Segment 1 and Segment 2)|Withdrawal by Subject|1|||
147489406|NCT01554956|531947621|FG002|Part 1 (Segment 1 and Segment 2)|Withdrawal by Subject|0|||
147489407|NCT01554956|531947619|FG000|Part 2 (Continuation Segment)|Withdrawal by Subject|0|||
147489408|NCT01554956|531947620|FG001|Part 2 (Continuation Segment)|Withdrawal by Subject|1|||
147489409|NCT01554956|531947621|FG002|Part 2 (Continuation Segment)|Withdrawal by Subject|1|||
147489410|NCT01554956|531947619|FG000|Part 2 (Continuation Segment)|SUBJECT WAS WITHDRAWN BY THE INVESTIGATOR AT THE SITE FOR NON-IMP RELATED REASON|2|||
147489411|NCT01554956|531947620|FG001|Part 2 (Continuation Segment)|SUBJECT WAS WITHDRAWN BY THE INVESTIGATOR AT THE SITE FOR NON-IMP RELATED REASON|4|||
147489412|NCT01554956|531947621|FG002|Part 2 (Continuation Segment)|SUBJECT WAS WITHDRAWN BY THE INVESTIGATOR AT THE SITE FOR NON-IMP RELATED REASON|0|||
147489413|NCT00913978|531947622|FG000|Overall Study|Surgeon choice|1|||
147489414|NCT00913978|531947623|FG001|Overall Study|Surgeon choice|3|||
147489415|NCT04716933|531947624|FG000|Overall Study|Sponsor Decision|36|||
147489416|NCT04716933|531947625|FG001|Overall Study|Sponsor Decision|33|||
147489417|NCT04716933|531947624|FG000|Overall Study|Death|65|||
147489418|NCT04716933|531947625|FG001|Overall Study|Death|67|||
147489419|NCT01327651|531947626|FG000|Self-administered Dosing Period|Lost to Follow-up|3|||
147489420|NCT01327651|531947627|FG001|Self-administered Dosing Period|Lost to Follow-up|2|||
147489421|NCT01327651|531947628|FG002|Self-administered Dosing Period|Lost to Follow-up|4|||
147489422|NCT01327651|531947629|FG003|Self-administered Dosing Period|Lost to Follow-up|2|||
147489423|NCT01327651|531947630|FG004|Self-administered Dosing Period|Lost to Follow-up|3|||
147489424|NCT01327651|531947631|FG005|Self-administered Dosing Period|Lost to Follow-up|0|||
147489425|NCT01327651|531947632|FG006|Self-administered Dosing Period|Lost to Follow-up|8|||
147489426|NCT01327651|531947633|FG007|Self-administered Dosing Period|Lost to Follow-up|9|||
147489427|NCT01327651|531947634|FG008|Self-administered Dosing Period|Lost to Follow-up|10|||
147489428|NCT01327651|531947626|FG000|Self-administered Dosing Period|Ineligible (retrospective result)|1|||
147489429|NCT01327651|531947627|FG001|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
147489430|NCT01327651|531947628|FG002|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
147489431|NCT01327651|531947629|FG003|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
147489432|NCT01327651|531947630|FG004|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
147489433|NCT01327651|531947631|FG005|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
147489434|NCT01327651|531947632|FG006|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
147489435|NCT01327651|531947633|FG007|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
147489436|NCT01327651|531947634|FG008|Self-administered Dosing Period|Ineligible (retrospective result)|0|||
147489437|NCT01327651|531947626|FG000|Self-administered Dosing Period|Withdrawal by Subject|0|||
147489438|NCT01327651|531947627|FG001|Self-administered Dosing Period|Withdrawal by Subject|1|||
147489439|NCT01327651|531947628|FG002|Self-administered Dosing Period|Withdrawal by Subject|0|||
147489440|NCT01327651|531947629|FG003|Self-administered Dosing Period|Withdrawal by Subject|1|||
147489441|NCT01327651|531947630|FG004|Self-administered Dosing Period|Withdrawal by Subject|0|||
147624055|NCT00708552|532441722|FG001|Overall Study|Protocol Violation|0|||
147624056|NCT00708552|532441723|FG002|Overall Study|Protocol Violation|2|||
147624057|NCT00708552|532441724|FG003|Overall Study|Protocol Violation|4|||
147624058|NCT00708552|532441721|FG000|Overall Study|Lost to Follow-up|4|||
147624059|NCT00708552|532441722|FG001|Overall Study|Lost to Follow-up|2|||
147624060|NCT00708552|532441723|FG002|Overall Study|Lost to Follow-up|0|||
147624061|NCT00708552|532441724|FG003|Overall Study|Lost to Follow-up|1|||
147624062|NCT00708552|532441721|FG000|Overall Study|Physician Decision|1|||
147624063|NCT00708552|532441722|FG001|Overall Study|Physician Decision|2|||
147624064|NCT00708552|532441723|FG002|Overall Study|Physician Decision|0|||
147624065|NCT00708552|532441724|FG003|Overall Study|Physician Decision|0|||
147489442|NCT01327651|531947631|FG005|Self-administered Dosing Period|Withdrawal by Subject|0|||
147489443|NCT01327651|531947632|FG006|Self-administered Dosing Period|Withdrawal by Subject|2|||
147624066|NCT00708552|532441721|FG000|Overall Study|Withdrawal by Subject|12|||
147624067|NCT00708552|532441722|FG001|Overall Study|Withdrawal by Subject|7|||
147624068|NCT00708552|532441723|FG002|Overall Study|Withdrawal by Subject|8|||
147624069|NCT00708552|532441724|FG003|Overall Study|Withdrawal by Subject|10|||
147624070|NCT04878432|532441726|FG000|Overall Study|Adverse Event|1|||
147624071|NCT04878432|532441726|FG000|Overall Study|Death|2|||
147624072|NCT04878432|532441726|FG000|Overall Study|Unsatisfactory Therapeutic Effect|3|||
147624073|NCT04878432|532441726|FG000|Overall Study|Withdrawal by Subject|6|||
147624074|NCT04878432|532441726|FG000|Overall Study|Progressive Disease|7|||
147624075|NCT04878432|532441726|FG000|Overall Study|New Therapy for Study Indication|7|||
147624076|NCT04878432|532441726|FG000|Overall Study|Physician Decision|11|||
147624077|NCT03971071|532441727|FG000|Double-blind Treatment Period (DBTP)|Sponsor decision|0|||
147624078|NCT03971071|532441728|FG001|Double-blind Treatment Period (DBTP)|Sponsor decision|1|||
147624079|NCT03971071|532441729|FG002|Double-blind Treatment Period (DBTP)|Sponsor decision|0|||
147624080|NCT03971071|532441730|FG003|Double-blind Treatment Period (DBTP)|Sponsor decision|0|||
147624081|NCT03971071|532441731|FG004|Double-blind Treatment Period (DBTP)|Sponsor decision|0|||
147624082|NCT03971071|532441727|FG000|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|7|||
147624083|NCT03971071|532441728|FG001|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|11|||
147624084|NCT03971071|532441729|FG002|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|6|||
147624085|NCT03971071|532441730|FG003|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
147624086|NCT03971071|532441731|FG004|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
147624087|NCT03971071|532441727|FG000|Double-blind Treatment Period (DBTP)|Other|2|||
147624088|NCT03971071|532441728|FG001|Double-blind Treatment Period (DBTP)|Other|2|||
147624089|NCT03971071|532441729|FG002|Double-blind Treatment Period (DBTP)|Other|0|||
147624090|NCT03971071|532441730|FG003|Double-blind Treatment Period (DBTP)|Other|0|||
147624091|NCT03971071|532441731|FG004|Double-blind Treatment Period (DBTP)|Other|0|||
147624092|NCT03971071|532441727|FG000|Open-label Treatment Period|Sponsor decision|0|||
147624093|NCT03971071|532441728|FG001|Open-label Treatment Period|Sponsor decision|0|||
147624094|NCT03971071|532441729|FG002|Open-label Treatment Period|Sponsor decision|0|||
147624095|NCT03971071|532441730|FG003|Open-label Treatment Period|Sponsor decision|0|||
147624096|NCT03971071|532441731|FG004|Open-label Treatment Period|Sponsor decision|1|||
147624097|NCT03971071|532441727|FG000|Open-label Treatment Period|Withdrawal by Subject|0|||
147624098|NCT03971071|532441728|FG001|Open-label Treatment Period|Withdrawal by Subject|0|||
147624099|NCT03971071|532441729|FG002|Open-label Treatment Period|Withdrawal by Subject|0|||
147624100|NCT03971071|532441730|FG003|Open-label Treatment Period|Withdrawal by Subject|10|||
147624101|NCT03971071|532441731|FG004|Open-label Treatment Period|Withdrawal by Subject|13|||
147624102|NCT03971071|532441727|FG000|Open-label Treatment Period|Lost to Follow-up|0|||
147624103|NCT03971071|532441728|FG001|Open-label Treatment Period|Lost to Follow-up|0|||
147624104|NCT03971071|532441729|FG002|Open-label Treatment Period|Lost to Follow-up|0|||
147624105|NCT03971071|532441730|FG003|Open-label Treatment Period|Lost to Follow-up|0|||
147624106|NCT03971071|532441731|FG004|Open-label Treatment Period|Lost to Follow-up|1|||
147624107|NCT03334435|532441732|FG000|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|70|||
147624108|NCT03334435|532441733|FG001|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|32|||
147624109|NCT03334435|532441734|FG002|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|379|||
147624110|NCT03334435|532441735|FG003|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|519|||
147624111|NCT03334435|532441736|FG004|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|146|||
147667931|NCT02351934|532609794|FG000|Follow-Up|1 ERAS Component Noncompliant|0|||
147667932|NCT02351934|532609795|FG001|Follow-Up|1 ERAS Component Noncompliant|6|||
147667933|NCT02351934|532609794|FG000|Follow-Up|2 ERAS Components Noncompliant|0|||
147667934|NCT02351934|532609795|FG001|Follow-Up|2 ERAS Components Noncompliant|4|||
147489444|NCT01327651|531947633|FG007|Self-administered Dosing Period|Withdrawal by Subject|1|||
147489445|NCT01327651|531947634|FG008|Self-administered Dosing Period|Withdrawal by Subject|1|||
147489446|NCT01327651|531947626|FG000|Post Study Follow-up|Lost to Follow-up|0|||
147489447|NCT01327651|531947627|FG001|Post Study Follow-up|Lost to Follow-up|1|||
147489448|NCT01327651|531947628|FG002|Post Study Follow-up|Lost to Follow-up|1|||
147489449|NCT01327651|531947629|FG003|Post Study Follow-up|Lost to Follow-up|0|||
147489450|NCT01327651|531947630|FG004|Post Study Follow-up|Lost to Follow-up|0|||
147489451|NCT01327651|531947631|FG005|Post Study Follow-up|Lost to Follow-up|0|||
147489452|NCT01327651|531947632|FG006|Post Study Follow-up|Lost to Follow-up|4|||
147489453|NCT01327651|531947633|FG007|Post Study Follow-up|Lost to Follow-up|1|||
147489454|NCT01327651|531947634|FG008|Post Study Follow-up|Lost to Follow-up|2|||
147489455|NCT03249792|531947639|FG000|Arms 1, 2, and 4|Death|1|||
147489456|NCT03249792|531947640|FG001|Arms 1, 2, and 4|Death|1|||
147489457|NCT03249792|531947641|FG002|Arms 1, 2, and 4|Death|0|||
147624112|NCT03334435|532441737|FG005|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
147489458|NCT03249792|531947642|FG003|Arms 1, 2, and 4|Death|2|||
147489459|NCT03249792|531947643|FG004|Arms 1, 2, and 4|Death|3|||
147489460|NCT03249792|531947644|FG005|Arms 1, 2, and 4|Death|2|||
147489461|NCT03249792|531947645|FG006|Arms 1, 2, and 4|Death|2|||
147489462|NCT03249792|531947646|FG007|Arms 1, 2, and 4|Death|4|||
147489463|NCT03249792|531947647|FG008|Arms 1, 2, and 4|Death|2|||
147489464|NCT03249792|531947648|FG009|Arms 1, 2, and 4|Death|1|||
147489465|NCT03249792|531947649|FG010|Arms 1, 2, and 4|Death|7|||
147489466|NCT03249792|531947650|FG011|Arms 1, 2, and 4|Death|7|||
147489467|NCT03249792|531947651|FG012|Arms 1, 2, and 4|Death|12|||
147489468|NCT03249792|531947652|FG013|Arms 1, 2, and 4|Death|7|||
147489469|NCT03249792|531947653|FG014|Arms 1, 2, and 4|Death|0|||
147489470|NCT03249792|531947654|FG015|Arms 1, 2, and 4|Death|4|||
147489471|NCT03249792|531947655|FG016|Arms 1, 2, and 4|Death|4|||
147489472|NCT03249792|531947656|FG017|Arms 1, 2, and 4|Death|12|||
147489473|NCT03249792|531947657|FG018|Arms 1, 2, and 4|Death|6|||
147489474|NCT03249792|531947658|FG019|Arms 1, 2, and 4|Death|4|||
147489475|NCT03249792|531947659|FG020|Arms 1, 2, and 4|Death|2|||
147489476|NCT03249792|531947660|FG021|Arms 1, 2, and 4|Death|3|||
147489477|NCT03249792|531947661|FG022|Arms 1, 2, and 4|Death|1|||
147489478|NCT03249792|531947662|FG023|Arms 1, 2, and 4|Death|1|||
147489479|NCT03249792|531947663|FG024|Arms 1, 2, and 4|Death|4|||
147489480|NCT03249792|531947664|FG025|Arms 1, 2, and 4|Death|0|||
147489481|NCT03249792|531947665|FG026|Arms 1, 2, and 4|Death|0|||
147489482|NCT03249792|531947666|FG027|Arms 1, 2, and 4|Death|0|||
147489483|NCT03249792|531947667|FG028|Arms 1, 2, and 4|Death|0|||
147489484|NCT03249792|531947668|FG029|Arms 1, 2, and 4|Death|0|||
147489485|NCT03249792|531947669|FG030|Arms 1, 2, and 4|Death|0|||
147489486|NCT03249792|531947670|FG031|Arms 1, 2, and 4|Death|0|||
147489487|NCT03249792|531947671|FG032|Arms 1, 2, and 4|Death|0|||
147489488|NCT03249792|531947639|FG000|Arms 1, 2, and 4|Withdrawal by Subject|0|||
147489489|NCT03249792|531947640|FG001|Arms 1, 2, and 4|Withdrawal by Subject|0|||
147489490|NCT03249792|531947641|FG002|Arms 1, 2, and 4|Withdrawal by Subject|1|||
147489491|NCT03249792|531947642|FG003|Arms 1, 2, and 4|Withdrawal by Subject|0|||
147489492|NCT03249792|531947643|FG004|Arms 1, 2, and 4|Withdrawal by Subject|0|||
147489493|NCT03249792|531947644|FG005|Arms 1, 2, and 4|Withdrawal by Subject|1|||
147489494|NCT03249792|531947645|FG006|Arms 1, 2, and 4|Withdrawal by Subject|4|||
147489495|NCT03249792|531947646|FG007|Arms 1, 2, and 4|Withdrawal by Subject|0|||
147489496|NCT03249792|531947647|FG008|Arms 1, 2, and 4|Withdrawal by Subject|2|||
147489497|NCT03249792|531947648|FG009|Arms 1, 2, and 4|Withdrawal by Subject|1|||
147489498|NCT03249792|531947649|FG010|Arms 1, 2, and 4|Withdrawal by Subject|4|||
147489499|NCT03249792|531947650|FG011|Arms 1, 2, and 4|Withdrawal by Subject|3|||
147489500|NCT03249792|531947651|FG012|Arms 1, 2, and 4|Withdrawal by Subject|5|||
147489501|NCT03249792|531947652|FG013|Arms 1, 2, and 4|Withdrawal by Subject|3|||
147489502|NCT03249792|531947653|FG014|Arms 1, 2, and 4|Withdrawal by Subject|0|||
147489503|NCT03249792|531947654|FG015|Arms 1, 2, and 4|Withdrawal by Subject|0|||
147489504|NCT03249792|531947655|FG016|Arms 1, 2, and 4|Withdrawal by Subject|3|||
147489505|NCT03249792|531947656|FG017|Arms 1, 2, and 4|Withdrawal by Subject|0|||
147489506|NCT03249792|531947657|FG018|Arms 1, 2, and 4|Withdrawal by Subject|1|||
147489507|NCT03249792|531947658|FG019|Arms 1, 2, and 4|Withdrawal by Subject|0|||
147489508|NCT03249792|531947659|FG020|Arms 1, 2, and 4|Withdrawal by Subject|0|||
147489509|NCT03249792|531947660|FG021|Arms 1, 2, and 4|Withdrawal by Subject|0|||
147489510|NCT03249792|531947661|FG022|Arms 1, 2, and 4|Withdrawal by Subject|1|||
147489511|NCT03249792|531947662|FG023|Arms 1, 2, and 4|Withdrawal by Subject|1|||
147489512|NCT03249792|531947663|FG024|Arms 1, 2, and 4|Withdrawal by Subject|0|||
147489513|NCT03249792|531947664|FG025|Arms 1, 2, and 4|Withdrawal by Subject|0|||
147489514|NCT03249792|531947665|FG026|Arms 1, 2, and 4|Withdrawal by Subject|0|||
147489515|NCT03249792|531947666|FG027|Arms 1, 2, and 4|Withdrawal by Subject|0|||
147489516|NCT03249792|531947667|FG028|Arms 1, 2, and 4|Withdrawal by Subject|0|||
147489517|NCT03249792|531947668|FG029|Arms 1, 2, and 4|Withdrawal by Subject|0|||
147489518|NCT03249792|531947669|FG030|Arms 1, 2, and 4|Withdrawal by Subject|0|||
147489519|NCT03249792|531947670|FG031|Arms 1, 2, and 4|Withdrawal by Subject|0|||
147489520|NCT03249792|531947671|FG032|Arms 1, 2, and 4|Withdrawal by Subject|0|||
147489521|NCT03249792|531947639|FG000|Arms 1, 2, and 4|Sponsor Decision|0|||
147489522|NCT03249792|531947640|FG001|Arms 1, 2, and 4|Sponsor Decision|0|||
147489523|NCT03249792|531947641|FG002|Arms 1, 2, and 4|Sponsor Decision|0|||
147489524|NCT03249792|531947642|FG003|Arms 1, 2, and 4|Sponsor Decision|0|||
147489525|NCT03249792|531947643|FG004|Arms 1, 2, and 4|Sponsor Decision|0|||
147489526|NCT03249792|531947644|FG005|Arms 1, 2, and 4|Sponsor Decision|0|||
147489527|NCT03249792|531947645|FG006|Arms 1, 2, and 4|Sponsor Decision|0|||
147489528|NCT03249792|531947646|FG007|Arms 1, 2, and 4|Sponsor Decision|0|||
147489529|NCT03249792|531947647|FG008|Arms 1, 2, and 4|Sponsor Decision|1|||
147489530|NCT03249792|531947648|FG009|Arms 1, 2, and 4|Sponsor Decision|0|||
147489531|NCT03249792|531947649|FG010|Arms 1, 2, and 4|Sponsor Decision|2|||
147489532|NCT03249792|531947650|FG011|Arms 1, 2, and 4|Sponsor Decision|1|||
147624113|NCT03334435|532441738|FG006|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
147667935|NCT02683109|532609796|FG000|Overall Study|Adverse Event|1|||
147489533|NCT03249792|531947651|FG012|Arms 1, 2, and 4|Sponsor Decision|1|||
147489534|NCT03249792|531947652|FG013|Arms 1, 2, and 4|Sponsor Decision|3|||
147489535|NCT03249792|531947653|FG014|Arms 1, 2, and 4|Sponsor Decision|0|||
147489536|NCT03249792|531947654|FG015|Arms 1, 2, and 4|Sponsor Decision|0|||
147489537|NCT03249792|531947655|FG016|Arms 1, 2, and 4|Sponsor Decision|0|||
147489538|NCT03249792|531947656|FG017|Arms 1, 2, and 4|Sponsor Decision|0|||
147489539|NCT03249792|531947657|FG018|Arms 1, 2, and 4|Sponsor Decision|0|||
147624114|NCT03334435|532441739|FG007|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
147624115|NCT03334435|532441740|FG008|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
147624116|NCT03334435|532441741|FG009|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
147624117|NCT03334435|532441742|FG010|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
147624118|NCT03334435|532441743|FG011|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
147624119|NCT03334435|532441744|FG012|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
147624120|NCT03334435|532441745|FG013|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
147489540|NCT03249792|531947658|FG019|Arms 1, 2, and 4|Sponsor Decision|1|||
147489541|NCT03249792|531947659|FG020|Arms 1, 2, and 4|Sponsor Decision|1|||
147489542|NCT03249792|531947660|FG021|Arms 1, 2, and 4|Sponsor Decision|0|||
147489543|NCT03249792|531947661|FG022|Arms 1, 2, and 4|Sponsor Decision|1|||
147489544|NCT03249792|531947662|FG023|Arms 1, 2, and 4|Sponsor Decision|2|||
147489545|NCT03249792|531947663|FG024|Arms 1, 2, and 4|Sponsor Decision|0|||
147489546|NCT03249792|531947664|FG025|Arms 1, 2, and 4|Sponsor Decision|0|||
147489547|NCT03249792|531947665|FG026|Arms 1, 2, and 4|Sponsor Decision|0|||
147489548|NCT03249792|531947666|FG027|Arms 1, 2, and 4|Sponsor Decision|0|||
147489549|NCT03249792|531947667|FG028|Arms 1, 2, and 4|Sponsor Decision|0|||
147489550|NCT03249792|531947668|FG029|Arms 1, 2, and 4|Sponsor Decision|0|||
147489551|NCT03249792|531947669|FG030|Arms 1, 2, and 4|Sponsor Decision|0|||
147489552|NCT03249792|531947670|FG031|Arms 1, 2, and 4|Sponsor Decision|0|||
147489553|NCT03249792|531947671|FG032|Arms 1, 2, and 4|Sponsor Decision|0|||
147489554|NCT03249792|531947639|FG000|Arms 1, 2, and 4|Lost to Follow-up|0|||
147489555|NCT03249792|531947640|FG001|Arms 1, 2, and 4|Lost to Follow-up|0|||
147489556|NCT03249792|531947641|FG002|Arms 1, 2, and 4|Lost to Follow-up|0|||
147489557|NCT03249792|531947642|FG003|Arms 1, 2, and 4|Lost to Follow-up|0|||
147489558|NCT03249792|531947643|FG004|Arms 1, 2, and 4|Lost to Follow-up|0|||
147489559|NCT03249792|531947644|FG005|Arms 1, 2, and 4|Lost to Follow-up|0|||
147489560|NCT03249792|531947645|FG006|Arms 1, 2, and 4|Lost to Follow-up|0|||
147489561|NCT03249792|531947646|FG007|Arms 1, 2, and 4|Lost to Follow-up|0|||
147489562|NCT03249792|531947647|FG008|Arms 1, 2, and 4|Lost to Follow-up|1|||
147489563|NCT03249792|531947648|FG009|Arms 1, 2, and 4|Lost to Follow-up|0|||
147489564|NCT03249792|531947649|FG010|Arms 1, 2, and 4|Lost to Follow-up|0|||
147489565|NCT03249792|531947650|FG011|Arms 1, 2, and 4|Lost to Follow-up|0|||
147489566|NCT03249792|531947651|FG012|Arms 1, 2, and 4|Lost to Follow-up|0|||
147489567|NCT03249792|531947652|FG013|Arms 1, 2, and 4|Lost to Follow-up|0|||
147489568|NCT03249792|531947653|FG014|Arms 1, 2, and 4|Lost to Follow-up|0|||
147489569|NCT03249792|531947654|FG015|Arms 1, 2, and 4|Lost to Follow-up|0|||
147489570|NCT03249792|531947655|FG016|Arms 1, 2, and 4|Lost to Follow-up|1|||
147489571|NCT03249792|531947656|FG017|Arms 1, 2, and 4|Lost to Follow-up|2|||
147489572|NCT03249792|531947657|FG018|Arms 1, 2, and 4|Lost to Follow-up|0|||
147489573|NCT03249792|531947658|FG019|Arms 1, 2, and 4|Lost to Follow-up|1|||
147489574|NCT03249792|531947659|FG020|Arms 1, 2, and 4|Lost to Follow-up|0|||
147489575|NCT03249792|531947660|FG021|Arms 1, 2, and 4|Lost to Follow-up|0|||
147489576|NCT03249792|531947661|FG022|Arms 1, 2, and 4|Lost to Follow-up|0|||
147624121|NCT03334435|532441746|FG014|Treatment Period 1: Week 0 to Week 52|Ongoing as of Week 52 (Later participants were moved to treatment period 2 [week 52 to 200])|0|||
147624122|NCT03334435|532441732|FG000|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|3|||
147624123|NCT03334435|532441733|FG001|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|5|||
147624124|NCT03334435|532441734|FG002|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|76|||
147624125|NCT03334435|532441735|FG003|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|140|||
147624126|NCT03334435|532441736|FG004|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|61|||
147624127|NCT03334435|532441737|FG005|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
147624128|NCT03334435|532441738|FG006|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
147624129|NCT03334435|532441739|FG007|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
147624130|NCT03334435|532441740|FG008|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
147624131|NCT03334435|532441741|FG009|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
147624132|NCT03334435|532441742|FG010|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
147624133|NCT03334435|532441743|FG011|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
147624134|NCT03334435|532441744|FG012|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
147624135|NCT03334435|532441745|FG013|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
147489577|NCT03249792|531947662|FG023|Arms 1, 2, and 4|Lost to Follow-up|0|||
147489578|NCT03249792|531947663|FG024|Arms 1, 2, and 4|Lost to Follow-up|0|||
147489579|NCT03249792|531947664|FG025|Arms 1, 2, and 4|Lost to Follow-up|0|||
147489580|NCT03249792|531947665|FG026|Arms 1, 2, and 4|Lost to Follow-up|0|||
147489581|NCT03249792|531947666|FG027|Arms 1, 2, and 4|Lost to Follow-up|0|||
147489582|NCT03249792|531947667|FG028|Arms 1, 2, and 4|Lost to Follow-up|0|||
147489583|NCT03249792|531947668|FG029|Arms 1, 2, and 4|Lost to Follow-up|0|||
147489584|NCT03249792|531947669|FG030|Arms 1, 2, and 4|Lost to Follow-up|0|||
147489585|NCT03249792|531947670|FG031|Arms 1, 2, and 4|Lost to Follow-up|0|||
147489586|NCT03249792|531947671|FG032|Arms 1, 2, and 4|Lost to Follow-up|0|||
147489587|NCT03249792|531947639|FG000|Switch Over Period|Withdrawal by Subject|0|||
147489588|NCT03249792|531947640|FG001|Switch Over Period|Withdrawal by Subject|0|||
147489589|NCT03249792|531947641|FG002|Switch Over Period|Withdrawal by Subject|0|||
147489590|NCT03249792|531947642|FG003|Switch Over Period|Withdrawal by Subject|0|||
147489591|NCT03249792|531947643|FG004|Switch Over Period|Withdrawal by Subject|0|||
147489592|NCT03249792|531947644|FG005|Switch Over Period|Withdrawal by Subject|0|||
147489593|NCT03249792|531947645|FG006|Switch Over Period|Withdrawal by Subject|0|||
147489594|NCT03249792|531947646|FG007|Switch Over Period|Withdrawal by Subject|0|||
147489595|NCT03249792|531947647|FG008|Switch Over Period|Withdrawal by Subject|0|||
147489596|NCT03249792|531947648|FG009|Switch Over Period|Withdrawal by Subject|0|||
147489597|NCT03249792|531947649|FG010|Switch Over Period|Withdrawal by Subject|0|||
147489598|NCT03249792|531947650|FG011|Switch Over Period|Withdrawal by Subject|0|||
147489599|NCT03249792|531947651|FG012|Switch Over Period|Withdrawal by Subject|0|||
147489600|NCT03249792|531947652|FG013|Switch Over Period|Withdrawal by Subject|0|||
147489601|NCT03249792|531947653|FG014|Switch Over Period|Withdrawal by Subject|0|||
147489602|NCT03249792|531947654|FG015|Switch Over Period|Withdrawal by Subject|0|||
147489603|NCT03249792|531947655|FG016|Switch Over Period|Withdrawal by Subject|0|||
147489604|NCT03249792|531947656|FG017|Switch Over Period|Withdrawal by Subject|0|||
147489605|NCT03249792|531947657|FG018|Switch Over Period|Withdrawal by Subject|0|||
147489606|NCT03249792|531947658|FG019|Switch Over Period|Withdrawal by Subject|0|||
147489607|NCT03249792|531947659|FG020|Switch Over Period|Withdrawal by Subject|0|||
147489608|NCT03249792|531947660|FG021|Switch Over Period|Withdrawal by Subject|0|||
147489609|NCT03249792|531947661|FG022|Switch Over Period|Withdrawal by Subject|0|||
147489610|NCT03249792|531947662|FG023|Switch Over Period|Withdrawal by Subject|0|||
147489611|NCT03249792|531947663|FG024|Switch Over Period|Withdrawal by Subject|0|||
147489612|NCT03249792|531947664|FG025|Switch Over Period|Withdrawal by Subject|0|||
147489613|NCT03249792|531947665|FG026|Switch Over Period|Withdrawal by Subject|0|||
147489614|NCT03249792|531947666|FG027|Switch Over Period|Withdrawal by Subject|0|||
147489615|NCT03249792|531947667|FG028|Switch Over Period|Withdrawal by Subject|0|||
147489616|NCT03249792|531947668|FG029|Switch Over Period|Withdrawal by Subject|0|||
147489617|NCT03249792|531947669|FG030|Switch Over Period|Withdrawal by Subject|0|||
147489618|NCT03249792|531947670|FG031|Switch Over Period|Withdrawal by Subject|1|||
147489619|NCT03249792|531947671|FG032|Switch Over Period|Withdrawal by Subject|0|||
147489620|NCT03249792|531947639|FG000|Switch Over Period|Progressive Disease|0|||
147489621|NCT03249792|531947640|FG001|Switch Over Period|Progressive Disease|0|||
147489622|NCT03249792|531947641|FG002|Switch Over Period|Progressive Disease|0|||
147489623|NCT03249792|531947642|FG003|Switch Over Period|Progressive Disease|0|||
147489624|NCT03249792|531947643|FG004|Switch Over Period|Progressive Disease|0|||
147489625|NCT03249792|531947644|FG005|Switch Over Period|Progressive Disease|0|||
147489626|NCT03249792|531947645|FG006|Switch Over Period|Progressive Disease|0|||
147489627|NCT03249792|531947646|FG007|Switch Over Period|Progressive Disease|0|||
147489628|NCT03249792|531947647|FG008|Switch Over Period|Progressive Disease|0|||
147489629|NCT03249792|531947648|FG009|Switch Over Period|Progressive Disease|0|||
147489630|NCT03249792|531947649|FG010|Switch Over Period|Progressive Disease|0|||
147489631|NCT03249792|531947650|FG011|Switch Over Period|Progressive Disease|0|||
147489632|NCT03249792|531947651|FG012|Switch Over Period|Progressive Disease|0|||
147489633|NCT03249792|531947652|FG013|Switch Over Period|Progressive Disease|0|||
147489634|NCT03249792|531947653|FG014|Switch Over Period|Progressive Disease|0|||
147489635|NCT03249792|531947654|FG015|Switch Over Period|Progressive Disease|0|||
147489636|NCT03249792|531947655|FG016|Switch Over Period|Progressive Disease|0|||
147489637|NCT03249792|531947656|FG017|Switch Over Period|Progressive Disease|0|||
147489638|NCT03249792|531947657|FG018|Switch Over Period|Progressive Disease|0|||
147489639|NCT03249792|531947658|FG019|Switch Over Period|Progressive Disease|0|||
147489640|NCT03249792|531947659|FG020|Switch Over Period|Progressive Disease|0|||
147489641|NCT03249792|531947660|FG021|Switch Over Period|Progressive Disease|0|||
147489642|NCT03249792|531947661|FG022|Switch Over Period|Progressive Disease|0|||
147489643|NCT03249792|531947662|FG023|Switch Over Period|Progressive Disease|0|||
147489644|NCT03249792|531947663|FG024|Switch Over Period|Progressive Disease|0|||
147489645|NCT03249792|531947664|FG025|Switch Over Period|Progressive Disease|0|||
147489646|NCT03249792|531947665|FG026|Switch Over Period|Progressive Disease|1|||
147489647|NCT03249792|531947666|FG027|Switch Over Period|Progressive Disease|0|||
147489648|NCT03249792|531947667|FG028|Switch Over Period|Progressive Disease|1|||
147489649|NCT03249792|531947668|FG029|Switch Over Period|Progressive Disease|2|||
147489650|NCT03249792|531947669|FG030|Switch Over Period|Progressive Disease|1|||
147489651|NCT03249792|531947670|FG031|Switch Over Period|Progressive Disease|0|||
147624136|NCT03334435|532441746|FG014|Treatment Period 1: Week 0 to Week 52|Lack of Efficacy|0|||
147624137|NCT03334435|532441732|FG000|Treatment Period 1: Week 0 to Week 52|Adverse Event|2|||
147624138|NCT03334435|532441733|FG001|Treatment Period 1: Week 0 to Week 52|Adverse Event|1|||
147489652|NCT03249792|531947671|FG032|Switch Over Period|Progressive Disease|1|||
147489653|NCT03249792|531947639|FG000|Switch Over Period|Adverse Event|0|||
147489654|NCT03249792|531947640|FG001|Switch Over Period|Adverse Event|0|||
147489655|NCT03249792|531947641|FG002|Switch Over Period|Adverse Event|0|||
147489656|NCT03249792|531947642|FG003|Switch Over Period|Adverse Event|0|||
147489657|NCT03249792|531947643|FG004|Switch Over Period|Adverse Event|0|||
147489658|NCT03249792|531947644|FG005|Switch Over Period|Adverse Event|0|||
147489659|NCT03249792|531947645|FG006|Switch Over Period|Adverse Event|0|||
147489660|NCT03249792|531947646|FG007|Switch Over Period|Adverse Event|0|||
147489661|NCT03249792|531947647|FG008|Switch Over Period|Adverse Event|0|||
147489662|NCT03249792|531947648|FG009|Switch Over Period|Adverse Event|0|||
147489663|NCT03249792|531947649|FG010|Switch Over Period|Adverse Event|0|||
147489664|NCT03249792|531947650|FG011|Switch Over Period|Adverse Event|0|||
147489665|NCT03249792|531947651|FG012|Switch Over Period|Adverse Event|0|||
147489666|NCT03249792|531947652|FG013|Switch Over Period|Adverse Event|0|||
147489667|NCT03249792|531947653|FG014|Switch Over Period|Adverse Event|0|||
147489668|NCT03249792|531947654|FG015|Switch Over Period|Adverse Event|0|||
147489669|NCT03249792|531947655|FG016|Switch Over Period|Adverse Event|0|||
147489670|NCT03249792|531947656|FG017|Switch Over Period|Adverse Event|0|||
147489671|NCT03249792|531947657|FG018|Switch Over Period|Adverse Event|0|||
147489672|NCT03249792|531947658|FG019|Switch Over Period|Adverse Event|0|||
147489673|NCT03249792|531947659|FG020|Switch Over Period|Adverse Event|0|||
147489674|NCT03249792|531947660|FG021|Switch Over Period|Adverse Event|0|||
147489675|NCT03249792|531947661|FG022|Switch Over Period|Adverse Event|0|||
147489676|NCT03249792|531947662|FG023|Switch Over Period|Adverse Event|0|||
147489677|NCT03249792|531947663|FG024|Switch Over Period|Adverse Event|0|||
147489678|NCT03249792|531947664|FG025|Switch Over Period|Adverse Event|1|||
147489679|NCT03249792|531947665|FG026|Switch Over Period|Adverse Event|0|||
147489680|NCT03249792|531947666|FG027|Switch Over Period|Adverse Event|1|||
147489681|NCT03249792|531947667|FG028|Switch Over Period|Adverse Event|0|||
147489682|NCT03249792|531947668|FG029|Switch Over Period|Adverse Event|0|||
147489683|NCT03249792|531947669|FG030|Switch Over Period|Adverse Event|0|||
147489684|NCT03249792|531947670|FG031|Switch Over Period|Adverse Event|0|||
147489685|NCT03249792|531947671|FG032|Switch Over Period|Adverse Event|0|||
147489686|NCT00532948|531947678|FG000|Overall Study|Protocol Violation|1|||
147489687|NCT00532948|531947679|FG001|Overall Study|Protocol Violation|0|||
147489688|NCT00532948|531947680|FG002|Overall Study|Protocol Violation|0|||
147489689|NCT00532948|531947678|FG000|Overall Study|Death|3|||
147489690|NCT00532948|531947679|FG001|Overall Study|Death|3|||
147489691|NCT00532948|531947680|FG002|Overall Study|Death|4|||
147489692|NCT00532948|531947678|FG000|Overall Study|Violation of selection criteria at entry|0|||
147489693|NCT00532948|531947679|FG001|Overall Study|Violation of selection criteria at entry|1|||
147489694|NCT00532948|531947680|FG002|Overall Study|Violation of selection criteria at entry|0|||
147489695|NCT00532948|531947678|FG000|Overall Study|Failure to return|0|||
147489696|NCT00532948|531947679|FG001|Overall Study|Failure to return|1|||
147489697|NCT00532948|531947680|FG002|Overall Study|Failure to return|0|||
147489698|NCT03885726|531947684|FG000|Overall Study|Staffing issues/lost interest|1|||
147489699|NCT03885726|531947684|FG000|Overall Study|Early discharge from hospital|3|||
147489700|NCT02868216|531947687|FG000|Overall Study|Death|0|||
147489701|NCT02868216|531947688|FG001|Overall Study|Death|1|||
147489702|NCT02868216|531947687|FG000|Overall Study|coronary artery bypass|1|||
147489703|NCT02868216|531947688|FG001|Overall Study|coronary artery bypass|0|||
147489704|NCT02868216|531947687|FG000|Overall Study|Withdrawal by Subject|7|||
147489705|NCT02868216|531947688|FG001|Overall Study|Withdrawal by Subject|5|||
147489706|NCT03609359|531947695|FG000|Overall Study|Progression of primary disease (PD)|25|||
147489707|NCT03609359|531947695|FG000|Overall Study|Patient's refusal|1|||
147489708|NCT03609359|531947695|FG000|Overall Study|Physician Decision|1|||
147489709|NCT03609359|531947695|FG000|Overall Study|The protocol treatment was discontinued for undergoing primary tumor resection.|1|||
147489710|NCT00610935|531947697|FG000|Overall Study|Lost to Follow-up|0|||
147489711|NCT00610935|531947698|FG001|Overall Study|Lost to Follow-up|1|||
147489712|NCT00610935|531947697|FG000|Overall Study|Withdrawal by Subject|0|||
147489713|NCT00610935|531947698|FG001|Overall Study|Withdrawal by Subject|2|||
147489714|NCT00610935|531947697|FG000|Overall Study|Sponsor Discontinuation|1|||
147489715|NCT00610935|531947698|FG001|Overall Study|Sponsor Discontinuation|0|||
147489716|NCT03345836|531947699|FG000|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|5|||
147489717|NCT03345836|531947700|FG001|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|17|||
147489718|NCT03345836|531947701|FG002|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|2|||
147624139|NCT03334435|532441734|FG002|Treatment Period 1: Week 0 to Week 52|Adverse Event|9|||
147489719|NCT03345836|531947702|FG003|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|0|||
147489720|NCT03345836|531947703|FG004|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|0|||
147489721|NCT03345836|531947704|FG005|Period 1: DB and OL Induction (12 Weeks)|Adverse Event|0|||
147489722|NCT03345836|531947699|FG000|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|8|||
147489723|NCT03345836|531947700|FG001|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|8|||
147489724|NCT03345836|531947701|FG002|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|3|||
147489725|NCT03345836|531947702|FG003|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|0|||
147489726|NCT03345836|531947703|FG004|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|0|||
147489727|NCT03345836|531947704|FG005|Period 1: DB and OL Induction (12 Weeks)|Withdrew Consent|0|||
147489728|NCT03345836|531947699|FG000|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|0|||
147489729|NCT03345836|531947700|FG001|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|1|||
147489730|NCT03345836|531947701|FG002|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|0|||
147489731|NCT03345836|531947702|FG003|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|0|||
147489732|NCT03345836|531947703|FG004|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|0|||
147489733|NCT03345836|531947704|FG005|Period 1: DB and OL Induction (12 Weeks)|Lost to Follow-up|0|||
147489734|NCT03345836|531947699|FG000|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|8|||
147489735|NCT03345836|531947700|FG001|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|4|||
147489736|NCT03345836|531947701|FG002|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|0|||
147489737|NCT03345836|531947702|FG003|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|0|||
147489738|NCT03345836|531947703|FG004|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|0|||
147489739|NCT03345836|531947704|FG005|Period 1: DB and OL Induction (12 Weeks)|Lack of Efficacy|0|||
147489740|NCT03345836|531947699|FG000|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|1|||
147489741|NCT03345836|531947700|FG001|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|3|||
147489742|NCT03345836|531947701|FG002|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|1|||
147489743|NCT03345836|531947702|FG003|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|0|||
147489744|NCT03345836|531947703|FG004|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|0|||
147489745|NCT03345836|531947704|FG005|Period 1: DB and OL Induction (12 Weeks)|Reason not Specified|0|||
147489746|NCT03345836|531947699|FG000|Period 2: 12-Week Extended Treatment|Adverse Event|0|||
147489747|NCT03345836|531947700|FG001|Period 2: 12-Week Extended Treatment|Adverse Event|0|||
147489748|NCT03345836|531947701|FG002|Period 2: 12-Week Extended Treatment|Adverse Event|0|||
147489749|NCT03345836|531947702|FG003|Period 2: 12-Week Extended Treatment|Adverse Event|8|||
147489750|NCT03345836|531947703|FG004|Period 2: 12-Week Extended Treatment|Adverse Event|5|||
147489751|NCT03345836|531947704|FG005|Period 2: 12-Week Extended Treatment|Adverse Event|0|||
147489752|NCT03345836|531947699|FG000|Period 2: 12-Week Extended Treatment|Withdrew Consent|0|||
147489753|NCT03345836|531947700|FG001|Period 2: 12-Week Extended Treatment|Withdrew Consent|0|||
147489754|NCT03345836|531947701|FG002|Period 2: 12-Week Extended Treatment|Withdrew Consent|0|||
147489755|NCT03345836|531947702|FG003|Period 2: 12-Week Extended Treatment|Withdrew Consent|0|||
147489756|NCT03345836|531947703|FG004|Period 2: 12-Week Extended Treatment|Withdrew Consent|5|||
147489757|NCT03345836|531947704|FG005|Period 2: 12-Week Extended Treatment|Withdrew Consent|1|||
147489758|NCT03345836|531947699|FG000|Period 2: 12-Week Extended Treatment|Lost to Follow-up|0|||
147489759|NCT03345836|531947700|FG001|Period 2: 12-Week Extended Treatment|Lost to Follow-up|0|||
147489760|NCT03345836|531947701|FG002|Period 2: 12-Week Extended Treatment|Lost to Follow-up|0|||
147489761|NCT03345836|531947702|FG003|Period 2: 12-Week Extended Treatment|Lost to Follow-up|0|||
147489762|NCT03345836|531947703|FG004|Period 2: 12-Week Extended Treatment|Lost to Follow-up|0|||
147489763|NCT03345836|531947704|FG005|Period 2: 12-Week Extended Treatment|Lost to Follow-up|1|||
147489764|NCT03345836|531947699|FG000|Period 2: 12-Week Extended Treatment|Lack of Efficacy|0|||
147489765|NCT03345836|531947700|FG001|Period 2: 12-Week Extended Treatment|Lack of Efficacy|0|||
147489766|NCT03345836|531947701|FG002|Period 2: 12-Week Extended Treatment|Lack of Efficacy|0|||
147489767|NCT03345836|531947702|FG003|Period 2: 12-Week Extended Treatment|Lack of Efficacy|2|||
147489768|NCT03345836|531947703|FG004|Period 2: 12-Week Extended Treatment|Lack of Efficacy|6|||
147489769|NCT03345836|531947704|FG005|Period 2: 12-Week Extended Treatment|Lack of Efficacy|3|||
147489770|NCT03345836|531947699|FG000|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|0|||
147489771|NCT03345836|531947700|FG001|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|0|||
147489772|NCT03345836|531947701|FG002|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|0|||
147489773|NCT03345836|531947702|FG003|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|0|||
147489774|NCT03345836|531947703|FG004|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|1|||
147489775|NCT03345836|531947704|FG005|Period 2: 12-Week Extended Treatment|Coronavirus Disease (COVID-19) Logistical Restrictions|0|||
147489776|NCT03345836|531947699|FG000|Period 2: 12-Week Extended Treatment|Reason not Specified|0|||
147489777|NCT03345836|531947700|FG001|Period 2: 12-Week Extended Treatment|Reason not Specified|0|||
147489778|NCT03345836|531947701|FG002|Period 2: 12-Week Extended Treatment|Reason not Specified|0|||
147489779|NCT03345836|531947702|FG003|Period 2: 12-Week Extended Treatment|Reason not Specified|1|||
147489780|NCT03345836|531947703|FG004|Period 2: 12-Week Extended Treatment|Reason not Specified|1|||
147489781|NCT03345836|531947704|FG005|Period 2: 12-Week Extended Treatment|Reason not Specified|1|||
147489782|NCT00320385|531947707|FG000|Overall Study|Lost to Follow-up|7|||
147489783|NCT00320385|531947708|FG001|Overall Study|Lost to Follow-up|10|||
147489784|NCT00320385|531947707|FG000|Overall Study|Withdrawal by Subject|6|||
147489785|NCT00320385|531947708|FG001|Overall Study|Withdrawal by Subject|7|||
147489786|NCT00320385|531947707|FG000|Overall Study|Sponsor Terminated Study|2|||
147489787|NCT00320385|531947708|FG001|Overall Study|Sponsor Terminated Study|1|||
147489788|NCT00320385|531947707|FG000|Overall Study|Investigator Decision|0|||
147489789|NCT00320385|531947708|FG001|Overall Study|Investigator Decision|1|||
147624140|NCT03334435|532441735|FG003|Treatment Period 1: Week 0 to Week 52|Adverse Event|23|||
147489790|NCT00320385|531947707|FG000|Overall Study|Death|1|||
147489791|NCT00320385|531947708|FG001|Overall Study|Death|2|||
147489792|NCT00320385|531947707|FG000|Overall Study|Serious Adverse Event|1|||
147624141|NCT03334435|532441736|FG004|Treatment Period 1: Week 0 to Week 52|Adverse Event|13|||
147624142|NCT03334435|532441737|FG005|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
147489793|NCT00320385|531947708|FG001|Overall Study|Serious Adverse Event|0|||
147489794|NCT00320385|531947707|FG000|Overall Study|Withdrew Consent|1|||
147489795|NCT00320385|531947708|FG001|Overall Study|Withdrew Consent|0|||
147489796|NCT00320385|531947707|FG000|Overall Study|Adverse Event|0|||
147489797|NCT00320385|531947708|FG001|Overall Study|Adverse Event|1|||
147489798|NCT00748540|531947714|FG000|Overall Study|Physician Decision|1|||
147489799|NCT00436215|531947718|FG000|Overall Study|Refused further treatment|3|||
147489800|NCT00436215|531947718|FG000|Overall Study|Small bowel obstruction|1|||
147489801|NCT00309777|531947719|FG000|Overall Study|Adverse Event|13|||
147489802|NCT00309777|531947720|FG001|Overall Study|Adverse Event|2|||
147489803|NCT00309777|531947721|FG002|Overall Study|Adverse Event|8|||
147489804|NCT00309777|531947722|FG003|Overall Study|Adverse Event|1|||
147489805|NCT00309777|531947719|FG000|Overall Study|Protocol Violation|4|||
147489806|NCT00309777|531947720|FG001|Overall Study|Protocol Violation|1|||
147489807|NCT00309777|531947721|FG002|Overall Study|Protocol Violation|3|||
147489808|NCT00309777|531947722|FG003|Overall Study|Protocol Violation|1|||
147489809|NCT00309777|531947719|FG000|Overall Study|Withdrawal by Subject|6|||
147489810|NCT00309777|531947720|FG001|Overall Study|Withdrawal by Subject|5|||
147489811|NCT00309777|531947721|FG002|Overall Study|Withdrawal by Subject|7|||
147489812|NCT00309777|531947722|FG003|Overall Study|Withdrawal by Subject|2|||
147489813|NCT00309777|531947719|FG000|Overall Study|Lost to Follow-up|0|||
147489814|NCT00309777|531947720|FG001|Overall Study|Lost to Follow-up|0|||
147489815|NCT00309777|531947721|FG002|Overall Study|Lost to Follow-up|1|||
147489816|NCT00309777|531947722|FG003|Overall Study|Lost to Follow-up|0|||
147489817|NCT00309777|531947719|FG000|Overall Study|Death|0|||
147489818|NCT00309777|531947720|FG001|Overall Study|Death|1|||
147489819|NCT00309777|531947721|FG002|Overall Study|Death|0|||
147489820|NCT00309777|531947722|FG003|Overall Study|Death|0|||
147489821|NCT03050359|531949283|FG000|Overall Study|Randomized But Not Treated|2|||
147489822|NCT03050359|531949284|FG001|Overall Study|Randomized But Not Treated|0|||
147489823|NCT03050359|531949283|FG000|Overall Study|Pretreatment Event/Adverse Event|5|||
147489824|NCT03050359|531949284|FG001|Overall Study|Pretreatment Event/Adverse Event|10|||
147489825|NCT03050359|531949283|FG000|Overall Study|Significant Protocol Deviation|2|||
147489826|NCT03050359|531949284|FG001|Overall Study|Significant Protocol Deviation|3|||
147489827|NCT03050359|531949283|FG000|Overall Study|Lost to Follow-up|2|||
147624143|NCT03334435|532441738|FG006|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
147624144|NCT03334435|532441739|FG007|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
147624145|NCT03334435|532441740|FG008|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
147624146|NCT03334435|532441741|FG009|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
147624147|NCT03334435|532441742|FG010|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
147624148|NCT03334435|532441743|FG011|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
147624149|NCT03334435|532441744|FG012|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
147624150|NCT03334435|532441745|FG013|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
147624151|NCT03334435|532441746|FG014|Treatment Period 1: Week 0 to Week 52|Adverse Event|0|||
147624152|NCT03334435|532441732|FG000|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|11|||
147624153|NCT03334435|532441733|FG001|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|4|||
147624154|NCT03334435|532441734|FG002|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|38|||
147624155|NCT03334435|532441735|FG003|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|42|||
147624156|NCT03334435|532441736|FG004|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|20|||
147624157|NCT03334435|532441737|FG005|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
147624158|NCT03334435|532441738|FG006|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
147624159|NCT03334435|532441739|FG007|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
147624160|NCT03334435|532441740|FG008|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
147624161|NCT03334435|532441741|FG009|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
147624162|NCT03334435|532441742|FG010|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
147624163|NCT03334435|532441743|FG011|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
147624164|NCT03334435|532441744|FG012|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
147624165|NCT03334435|532441745|FG013|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
147489828|NCT03050359|531949284|FG001|Overall Study|Lost to Follow-up|1|||
147624166|NCT03334435|532441746|FG014|Treatment Period 1: Week 0 to Week 52|Withdrawal by Subject|0|||
147624167|NCT03334435|532441732|FG000|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|3|||
147624168|NCT03334435|532441733|FG001|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
147624169|NCT03334435|532441734|FG002|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|2|||
147667936|NCT02683109|532609797|FG001|Overall Study|Adverse Event|0|||
147489829|NCT03050359|531949283|FG000|Overall Study|Voluntary Withdrawal|4|||
147489830|NCT03050359|531949284|FG001|Overall Study|Voluntary Withdrawal|6|||
147489831|NCT03050359|531949283|FG000|Overall Study|Pregnancy|1|||
147489832|NCT03050359|531949284|FG001|Overall Study|Pregnancy|0|||
147489833|NCT03050359|531949283|FG000|Overall Study|Reason Not Specified|1|||
147489834|NCT03050359|531949284|FG001|Overall Study|Reason Not Specified|0|||
147489835|NCT02614287|531949287|FG000|Open Label (OL) Treatment Phase|Adverse Event|7|||
147489836|NCT02614287|531949288|FG001|Open Label (OL) Treatment Phase|Adverse Event|6|||
147489837|NCT02614287|531949287|FG000|Open Label (OL) Treatment Phase|Lack of Efficacy|13|||
147489838|NCT02614287|531949288|FG001|Open Label (OL) Treatment Phase|Lack of Efficacy|5|||
147489839|NCT02614287|531949287|FG000|Open Label (OL) Treatment Phase|Lost to Follow-up|7|||
147489840|NCT02614287|531949288|FG001|Open Label (OL) Treatment Phase|Lost to Follow-up|4|||
147489841|NCT02614287|531949287|FG000|Open Label (OL) Treatment Phase|Physician Decision|1|||
147489842|NCT02614287|531949288|FG001|Open Label (OL) Treatment Phase|Physician Decision|0|||
147489843|NCT02614287|531949287|FG000|Open Label (OL) Treatment Phase|Withdrawal by Subject|10|||
147489844|NCT02614287|531949288|FG001|Open Label (OL) Treatment Phase|Withdrawal by Subject|7|||
147489845|NCT02614287|531949287|FG000|Post Treatment Follow-up Phase|Adverse Event|1|||
147489846|NCT02614287|531949288|FG001|Post Treatment Follow-up Phase|Adverse Event|0|||
147489847|NCT02614287|531949287|FG000|Post Treatment Follow-up Phase|Lost to Follow-up|2|||
147489848|NCT02614287|531949288|FG001|Post Treatment Follow-up Phase|Lost to Follow-up|2|||
147489849|NCT02614287|531949287|FG000|Post Treatment Follow-up Phase|Withdrawal by Subject|6|||
147489850|NCT02614287|531949288|FG001|Post Treatment Follow-up Phase|Withdrawal by Subject|3|||
147489851|NCT03364335|531949292|FG000|Overall Study|Adverse Event|3|||
147489852|NCT03364335|531949293|FG001|Overall Study|Adverse Event|4|||
147489853|NCT03364335|531949294|FG002|Overall Study|Adverse Event|1|||
147489854|NCT03364335|531949295|FG003|Overall Study|Adverse Event|2|||
147489855|NCT03364335|531949296|FG004|Overall Study|Adverse Event|0|||
147489856|NCT03364335|531949292|FG000|Overall Study|Lost to Follow-up|7|||
147489857|NCT03364335|531949293|FG001|Overall Study|Lost to Follow-up|7|||
147489858|NCT03364335|531949294|FG002|Overall Study|Lost to Follow-up|10|||
147489859|NCT03364335|531949295|FG003|Overall Study|Lost to Follow-up|11|||
147489860|NCT03364335|531949296|FG004|Overall Study|Lost to Follow-up|11|||
147489861|NCT03725202|531949297|FG000|Period 1 (Baseline - Week 52)|Adverse Event|13|||
147489862|NCT03725202|531949298|FG001|Period 1 (Baseline - Week 52)|Adverse Event|11|||
147489863|NCT03725202|531949299|FG002|Period 1 (Baseline - Week 52)|Adverse Event|17|||
147489864|NCT03725202|531949300|FG003|Period 1 (Baseline - Week 52)|Adverse Event|0|||
147489865|NCT03725202|531949301|FG004|Period 1 (Baseline - Week 52)|Adverse Event|0|||
147489866|NCT03725202|531949302|FG005|Period 1 (Baseline - Week 52)|Adverse Event|0|||
147489867|NCT03725202|531949303|FG006|Period 1 (Baseline - Week 52)|Adverse Event|0|||
147489868|NCT03725202|531949304|FG007|Period 1 (Baseline - Week 52)|Adverse Event|0|||
147489869|NCT03725202|531949297|FG000|Period 1 (Baseline - Week 52)|Withdrew consent|5|||
147624170|NCT03334435|532441735|FG003|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|1|||
147624171|NCT03334435|532441736|FG004|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|1|||
147624172|NCT03334435|532441737|FG005|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
147624173|NCT03334435|532441738|FG006|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
147624174|NCT03334435|532441739|FG007|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
147624175|NCT03334435|532441740|FG008|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
147624176|NCT03334435|532441741|FG009|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
147624177|NCT03334435|532441742|FG010|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
147624178|NCT03334435|532441743|FG011|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
147624179|NCT03334435|532441744|FG012|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
147624180|NCT03334435|532441745|FG013|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
147624181|NCT03334435|532441746|FG014|Treatment Period 1: Week 0 to Week 52|Lost to Follow-up|0|||
147624182|NCT03334435|532441732|FG000|Treatment Period 1: Week 0 to Week 52|Death|0|||
147624183|NCT03334435|532441733|FG001|Treatment Period 1: Week 0 to Week 52|Death|0|||
147624184|NCT03334435|532441734|FG002|Treatment Period 1: Week 0 to Week 52|Death|0|||
147624185|NCT03334435|532441735|FG003|Treatment Period 1: Week 0 to Week 52|Death|1|||
147624186|NCT03334435|532441736|FG004|Treatment Period 1: Week 0 to Week 52|Death|0|||
147624187|NCT03334435|532441737|FG005|Treatment Period 1: Week 0 to Week 52|Death|0|||
147624188|NCT03334435|532441738|FG006|Treatment Period 1: Week 0 to Week 52|Death|0|||
147624189|NCT03334435|532441739|FG007|Treatment Period 1: Week 0 to Week 52|Death|0|||
147624190|NCT03334435|532441740|FG008|Treatment Period 1: Week 0 to Week 52|Death|0|||
147624191|NCT03334435|532441741|FG009|Treatment Period 1: Week 0 to Week 52|Death|0|||
147624192|NCT03334435|532441742|FG010|Treatment Period 1: Week 0 to Week 52|Death|0|||
147624193|NCT03334435|532441743|FG011|Treatment Period 1: Week 0 to Week 52|Death|0|||
147624194|NCT03334435|532441744|FG012|Treatment Period 1: Week 0 to Week 52|Death|0|||
147624195|NCT03334435|532441745|FG013|Treatment Period 1: Week 0 to Week 52|Death|0|||
147624196|NCT03334435|532441746|FG014|Treatment Period 1: Week 0 to Week 52|Death|0|||
147624197|NCT03334435|532441732|FG000|Treatment Period 1: Week 0 to Week 52|Other|0|||
147624198|NCT03334435|532441733|FG001|Treatment Period 1: Week 0 to Week 52|Other|1|||
147624199|NCT03334435|532441734|FG002|Treatment Period 1: Week 0 to Week 52|Other|3|||
147624200|NCT03334435|532441735|FG003|Treatment Period 1: Week 0 to Week 52|Other|2|||
147624201|NCT03334435|532441736|FG004|Treatment Period 1: Week 0 to Week 52|Other|1|||
147624202|NCT03334435|532441737|FG005|Treatment Period 1: Week 0 to Week 52|Other|0|||
147667937|NCT00368251|532609798|FG000|Overall Study|SAE, non-fatal|1|||
147489870|NCT03725202|531949298|FG001|Period 1 (Baseline - Week 52)|Withdrew consent|6|||
147489871|NCT03725202|531949299|FG002|Period 1 (Baseline - Week 52)|Withdrew consent|10|||
147489872|NCT03725202|531949300|FG003|Period 1 (Baseline - Week 52)|Withdrew consent|0|||
147667938|NCT00368251|532609799|FG001|Overall Study|SAE, non-fatal|0|||
147667939|NCT00368251|532609800|FG002|Overall Study|SAE, non-fatal|0|||
147667940|NCT00368251|532609798|FG000|Overall Study|AE, non-serious non-fatal|0|||
147667941|NCT00368251|532609799|FG001|Overall Study|AE, non-serious non-fatal|0|||
147667942|NCT00368251|532609800|FG002|Overall Study|AE, non-serious non-fatal|1|||
147667943|NCT00499122|532609802|FG000|Overall Study|Withdrawal by Subject|2|||
147667944|NCT03312738|532609803|FG000|Overall Study|Progressive disease|58|||
147667945|NCT03312738|532609804|FG001|Overall Study|Progressive disease|67|||
147667946|NCT03312738|532609803|FG000|Overall Study|Patient/guardian decision|13|||
147667947|NCT03312738|532609804|FG001|Overall Study|Patient/guardian decision|5|||
147667948|NCT03312738|532609803|FG000|Overall Study|Adverse Event|5|||
147667949|NCT03312738|532609804|FG001|Overall Study|Adverse Event|3|||
147667950|NCT03312738|532609803|FG000|Overall Study|Protocol deviation|2|||
147667951|NCT03312738|532609804|FG001|Overall Study|Protocol deviation|0|||
147667952|NCT03312738|532609803|FG000|Overall Study|Technical problems|0|||
147667953|NCT03312738|532609804|FG001|Overall Study|Technical problems|1|||
147667954|NCT03312738|532609803|FG000|Overall Study|Physician Decision|2|||
147667955|NCT03312738|532609804|FG001|Overall Study|Physician Decision|3|||
147667956|NCT04539275|532609811|FG000|Overall Study|Death|2|||
147667957|NCT04539275|532609812|FG001|Overall Study|Death|4|||
147667958|NCT04539275|532609811|FG000|Overall Study|Lost to Follow-up|1|||
147667959|NCT04539275|532609812|FG001|Overall Study|Lost to Follow-up|1|||
147667960|NCT04539275|532609811|FG000|Overall Study|Withdrawal by Subject|3|||
147667961|NCT04539275|532609812|FG001|Overall Study|Withdrawal by Subject|0|||
147667962|NCT02466399|532609813|FG000|Overall Study|Adverse Event|1|||
147489873|NCT03725202|531949301|FG004|Period 1 (Baseline - Week 52)|Withdrew consent|0|||
147489874|NCT03725202|531949302|FG005|Period 1 (Baseline - Week 52)|Withdrew consent|0|||
147489875|NCT03725202|531949303|FG006|Period 1 (Baseline - Week 52)|Withdrew consent|0|||
147489876|NCT03725202|531949304|FG007|Period 1 (Baseline - Week 52)|Withdrew consent|0|||
147489877|NCT03725202|531949297|FG000|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|1|||
147489878|NCT03725202|531949298|FG001|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|0|||
147489879|NCT03725202|531949299|FG002|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|0|||
147489880|NCT03725202|531949300|FG003|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|0|||
147489881|NCT03725202|531949301|FG004|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|0|||
147489882|NCT03725202|531949302|FG005|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|0|||
147489883|NCT03725202|531949303|FG006|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|0|||
147489884|NCT03725202|531949304|FG007|Period 1 (Baseline - Week 52)|COVID-19 logistical restrictions|0|||
147489885|NCT03725202|531949297|FG000|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|2|||
147489886|NCT03725202|531949298|FG001|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|0|||
147489887|NCT03725202|531949299|FG002|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|0|||
147489888|NCT03725202|531949300|FG003|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|0|||
147489889|NCT03725202|531949301|FG004|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|0|||
147489890|NCT03725202|531949302|FG005|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|0|||
147489891|NCT03725202|531949303|FG006|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|0|||
147489892|NCT03725202|531949304|FG007|Period 1 (Baseline - Week 52)|Failure to meet continuation criteria|0|||
147489893|NCT03725202|531949297|FG000|Period 1 (Baseline - Week 52)|Other, not specified|5|||
147489894|NCT03725202|531949298|FG001|Period 1 (Baseline - Week 52)|Other, not specified|5|||
147489895|NCT03725202|531949299|FG002|Period 1 (Baseline - Week 52)|Other, not specified|5|||
147489896|NCT03725202|531949300|FG003|Period 1 (Baseline - Week 52)|Other, not specified|0|||
147489897|NCT03725202|531949301|FG004|Period 1 (Baseline - Week 52)|Other, not specified|0|||
147489898|NCT03725202|531949302|FG005|Period 1 (Baseline - Week 52)|Other, not specified|0|||
147489899|NCT03725202|531949303|FG006|Period 1 (Baseline - Week 52)|Other, not specified|0|||
147489900|NCT03725202|531949304|FG007|Period 1 (Baseline - Week 52)|Other, not specified|0|||
147489901|NCT03725202|531949297|FG000|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|0|||
147489902|NCT03725202|531949298|FG001|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|0|||
147489903|NCT03725202|531949299|FG002|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|1|||
147489904|NCT03725202|531949300|FG003|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|0|||
147489905|NCT03725202|531949301|FG004|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|0|||
147489906|NCT03725202|531949302|FG005|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|0|||
147489907|NCT03725202|531949303|FG006|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|0|||
147489908|NCT03725202|531949304|FG007|Period 1 (Baseline - Week 52)|Did not receive randomized study drug|0|||
147667963|NCT02466399|532609814|FG001|Overall Study|Adverse Event|0|||
147667964|NCT02466399|532609813|FG000|Overall Study|Early exit due to family emergency|1|||
147667965|NCT02466399|532609814|FG001|Overall Study|Early exit due to family emergency|0|||
147667966|NCT00607893|532609815|FG000|Overall Study|Lost to Follow-up|4|||
147667967|NCT00607893|532609816|FG001|Overall Study|Lost to Follow-up|0|||
147667968|NCT00607893|532609815|FG000|Overall Study|withdrew due to loss of interest|0|||
147667969|NCT00607893|532609816|FG001|Overall Study|withdrew due to loss of interest|1|||
147489909|NCT03725202|531949297|FG000|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|0|||
147489910|NCT03725202|531949298|FG001|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|0|||
147489911|NCT03725202|531949299|FG002|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|0|||
147489912|NCT03725202|531949300|FG003|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|19|||
147489913|NCT03725202|531949301|FG004|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|11|||
147489914|NCT03725202|531949302|FG005|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|2|||
147489915|NCT03725202|531949303|FG006|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|27|||
147489916|NCT03725202|531949304|FG007|Period 2 (Week 52 - Week 104)|Ongoing in Period 2|8|||
147489917|NCT03725202|531949297|FG000|Period 2 (Week 52 - Week 104)|Adverse Event|0|||
147489918|NCT03725202|531949298|FG001|Period 2 (Week 52 - Week 104)|Adverse Event|0|||
147489919|NCT03725202|531949299|FG002|Period 2 (Week 52 - Week 104)|Adverse Event|0|||
147489920|NCT03725202|531949300|FG003|Period 2 (Week 52 - Week 104)|Adverse Event|1|||
147489921|NCT03725202|531949301|FG004|Period 2 (Week 52 - Week 104)|Adverse Event|1|||
147489922|NCT03725202|531949302|FG005|Period 2 (Week 52 - Week 104)|Adverse Event|2|||
147489923|NCT03725202|531949303|FG006|Period 2 (Week 52 - Week 104)|Adverse Event|4|||
147489924|NCT03725202|531949304|FG007|Period 2 (Week 52 - Week 104)|Adverse Event|2|||
147489925|NCT03725202|531949297|FG000|Period 2 (Week 52 - Week 104)|Withdrew consent|0|||
147489926|NCT03725202|531949298|FG001|Period 2 (Week 52 - Week 104)|Withdrew consent|0|||
147489927|NCT03725202|531949299|FG002|Period 2 (Week 52 - Week 104)|Withdrew consent|0|||
147489928|NCT03725202|531949300|FG003|Period 2 (Week 52 - Week 104)|Withdrew consent|1|||
147489929|NCT03725202|531949301|FG004|Period 2 (Week 52 - Week 104)|Withdrew consent|0|||
147489930|NCT03725202|531949302|FG005|Period 2 (Week 52 - Week 104)|Withdrew consent|0|||
147489931|NCT03725202|531949303|FG006|Period 2 (Week 52 - Week 104)|Withdrew consent|1|||
147489932|NCT03725202|531949304|FG007|Period 2 (Week 52 - Week 104)|Withdrew consent|2|||
147489933|NCT03725202|531949297|FG000|Period 2 (Week 52 - Week 104)|Lost to Follow-up|0|||
147489934|NCT03725202|531949298|FG001|Period 2 (Week 52 - Week 104)|Lost to Follow-up|0|||
147489935|NCT03725202|531949299|FG002|Period 2 (Week 52 - Week 104)|Lost to Follow-up|0|||
147489936|NCT03725202|531949300|FG003|Period 2 (Week 52 - Week 104)|Lost to Follow-up|0|||
147489937|NCT03725202|531949301|FG004|Period 2 (Week 52 - Week 104)|Lost to Follow-up|0|||
147489938|NCT03725202|531949302|FG005|Period 2 (Week 52 - Week 104)|Lost to Follow-up|0|||
147489939|NCT03725202|531949303|FG006|Period 2 (Week 52 - Week 104)|Lost to Follow-up|1|||
147489940|NCT03725202|531949304|FG007|Period 2 (Week 52 - Week 104)|Lost to Follow-up|0|||
147489941|NCT03725202|531949297|FG000|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|0|||
147489942|NCT03725202|531949298|FG001|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|0|||
147489943|NCT03725202|531949299|FG002|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|0|||
147489944|NCT03725202|531949300|FG003|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|0|||
147489945|NCT03725202|531949301|FG004|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|0|||
147489946|NCT03725202|531949302|FG005|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|1|||
147489947|NCT03725202|531949303|FG006|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|0|||
147489948|NCT03725202|531949304|FG007|Period 2 (Week 52 - Week 104)|Failure to meet continuation criteria|0|||
147489949|NCT03725202|531949297|FG000|Period 2 (Week 52 - Week 104)|Other, not specified|0|||
147489950|NCT03725202|531949298|FG001|Period 2 (Week 52 - Week 104)|Other, not specified|0|||
147489951|NCT03725202|531949299|FG002|Period 2 (Week 52 - Week 104)|Other, not specified|0|||
147489952|NCT03725202|531949300|FG003|Period 2 (Week 52 - Week 104)|Other, not specified|2|||
147489953|NCT03725202|531949301|FG004|Period 2 (Week 52 - Week 104)|Other, not specified|0|||
147489954|NCT03725202|531949302|FG005|Period 2 (Week 52 - Week 104)|Other, not specified|0|||
147489955|NCT03725202|531949303|FG006|Period 2 (Week 52 - Week 104)|Other, not specified|1|||
147489956|NCT03725202|531949304|FG007|Period 2 (Week 52 - Week 104)|Other, not specified|1|||
147489957|NCT02330549|531949307|FG000|Overall Study|Adverse Event|1|||
147489958|NCT02330549|531949308|FG001|Overall Study|Adverse Event|0|||
147489959|NCT02330549|531949307|FG000|Overall Study|Subject withdrew consent|2|||
147489960|NCT02330549|531949308|FG001|Overall Study|Subject withdrew consent|1|||
147489961|NCT02330549|531949307|FG000|Overall Study|Failure to meet randomization criteria|1|||
147489962|NCT02330549|531949308|FG001|Overall Study|Failure to meet randomization criteria|0|||
147489963|NCT01575197|531949311|FG000|Overall Study|Migration out of study area|1|||
147489964|NCT01575197|531949312|FG001|Overall Study|Migration out of study area|5|||
147489965|NCT01575197|531949313|FG002|Overall Study|Migration out of study area|4|||
147489966|NCT01575197|531949311|FG000|Overall Study|SAE|0|||
147489967|NCT01575197|531949312|FG001|Overall Study|SAE|1|||
147489968|NCT01575197|531949313|FG002|Overall Study|SAE|0|||
147489969|NCT01575197|531949311|FG000|Overall Study|Lost to Follow-up|0|||
147489970|NCT01575197|531949312|FG001|Overall Study|Lost to Follow-up|1|||
147489971|NCT01575197|531949313|FG002|Overall Study|Lost to Follow-up|0|||
147489972|NCT01575197|531949311|FG000|Overall Study|Withdrawal by Subject|0|||
147624203|NCT03334435|532441738|FG006|Treatment Period 1: Week 0 to Week 52|Other|0|||
147489973|NCT01575197|531949312|FG001|Overall Study|Withdrawal by Subject|1|||
147489974|NCT01575197|531949313|FG002|Overall Study|Withdrawal by Subject|1|||
147489975|NCT01575197|531949311|FG000|Overall Study|Protocol Violation|2|||
147489976|NCT01575197|531949312|FG001|Overall Study|Protocol Violation|1|||
147624204|NCT03334435|532441739|FG007|Treatment Period 1: Week 0 to Week 52|Other|0|||
147489977|NCT01575197|531949313|FG002|Overall Study|Protocol Violation|1|||
147489978|NCT00833248|531949315|FG000|Overall Study|Adverse Event|3|||
147489979|NCT00833248|531949316|FG001|Overall Study|Adverse Event|0|||
147489980|NCT00833248|531949315|FG000|Overall Study|Protocol Violation|1|||
147489981|NCT00833248|531949316|FG001|Overall Study|Protocol Violation|2|||
147489982|NCT00833248|531949315|FG000|Overall Study|Withdrawal by Subject|0|||
147489983|NCT00833248|531949316|FG001|Overall Study|Withdrawal by Subject|1|||
147489984|NCT00262080|531949317|FG000|Double Blind Treatment Period|Lost to Follow-up|1|||
147489985|NCT00262080|531949318|FG001|Double Blind Treatment Period|Lost to Follow-up|0|||
147489986|NCT00262080|531949319|FG002|Double Blind Treatment Period|Lost to Follow-up|0|||
147489987|NCT00262080|531949317|FG000|Repeat Dose Treatment Period|Adverse Event|1|||
147489988|NCT00262080|531949318|FG001|Repeat Dose Treatment Period|Adverse Event|0|||
147489989|NCT00262080|531949319|FG002|Repeat Dose Treatment Period|Adverse Event|0|||
147489990|NCT00262080|531949317|FG000|Repeat Dose Treatment Period|Withdrawal by Subject|0|||
147489991|NCT00262080|531949318|FG001|Repeat Dose Treatment Period|Withdrawal by Subject|1|||
147489992|NCT00262080|531949319|FG002|Repeat Dose Treatment Period|Withdrawal by Subject|1|||
147489993|NCT00262080|531949317|FG000|Repeat Dose Treatment Period|Lost to Follow-up|2|||
147489994|NCT00262080|531949318|FG001|Repeat Dose Treatment Period|Lost to Follow-up|0|||
147489995|NCT00262080|531949319|FG002|Repeat Dose Treatment Period|Lost to Follow-up|2|||
147489996|NCT00262080|531949317|FG000|Repeat Dose Treatment Period|Decision to discontinue the study|0|||
147489997|NCT00262080|531949318|FG001|Repeat Dose Treatment Period|Decision to discontinue the study|0|||
147489998|NCT00262080|531949319|FG002|Repeat Dose Treatment Period|Decision to discontinue the study|2|||
147489999|NCT00262080|531949317|FG000|Repeat Dose Treatment Period|enrolled in EDEMA4|1|||
147490000|NCT00262080|531949318|FG001|Repeat Dose Treatment Period|enrolled in EDEMA4|0|||
147490001|NCT00262080|531949319|FG002|Repeat Dose Treatment Period|enrolled in EDEMA4|0|||
147490002|NCT01361009|531949320|FG000|Overall Study|Protocol Violation|116|||
147490003|NCT01826422|531949321|FG000|Overall Study|Withdrawal by Subject|1|||
147490004|NCT01826422|531949322|FG001|Overall Study|Withdrawal by Subject|3|||
147490005|NCT04009096|531949326|FG000|Overall Study|Withdrawal by Subject|0|||
147490006|NCT04009096|531949327|FG001|Overall Study|Withdrawal by Subject|7|||
147490007|NCT04009096|531949328|FG002|Overall Study|Withdrawal by Subject|0|||
147490008|NCT04009096|531949326|FG000|Overall Study|Physician Decision|0|||
147490009|NCT04009096|531949327|FG001|Overall Study|Physician Decision|1|||
147490010|NCT04009096|531949328|FG002|Overall Study|Physician Decision|0|||
147490011|NCT02935634|531949329|FG000|Randomization|Participant withdrew consent|0|||
147490012|NCT02935634|531949330|FG001|Randomization|Participant withdrew consent|1|||
147490013|NCT02935634|531949331|FG002|Randomization|Participant withdrew consent|0|||
147490014|NCT02935634|531949332|FG003|Randomization|Participant withdrew consent|0|||
147490015|NCT02935634|531949333|FG004|Randomization|Participant withdrew consent|0|||
147490016|NCT02935634|531949334|FG005|Randomization|Participant withdrew consent|0|||
147490017|NCT02935634|531949329|FG000|Randomization|Death|2|||
147490018|NCT02935634|531949330|FG001|Randomization|Death|1|||
147490019|NCT02935634|531949331|FG002|Randomization|Death|1|||
147490020|NCT02935634|531949332|FG003|Randomization|Death|0|||
147490021|NCT02935634|531949333|FG004|Randomization|Death|0|||
147490022|NCT02935634|531949334|FG005|Randomization|Death|0|||
147490023|NCT02935634|531949329|FG000|Randomization|Other reasons|0|||
147490024|NCT02935634|531949330|FG001|Randomization|Other reasons|2|||
147490025|NCT02935634|531949331|FG002|Randomization|Other reasons|2|||
147490026|NCT02935634|531949332|FG003|Randomization|Other reasons|0|||
147490027|NCT02935634|531949333|FG004|Randomization|Other reasons|0|||
147490028|NCT02935634|531949334|FG005|Randomization|Other reasons|0|||
147490029|NCT02935634|531949329|FG000|Treatment: Track 1|Disease progression|15|||
147490030|NCT02935634|531949330|FG001|Treatment: Track 1|Disease progression|17|||
147490031|NCT02935634|531949331|FG002|Treatment: Track 1|Disease progression|28|||
147416887|NCT02416453|531690008|FG009|Overall Study|Withdrawal by Subject|0|||
147416888|NCT02416453|531690009|FG010|Overall Study|Withdrawal by Subject|0|||
147416889|NCT02416453|531689999|FG000|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
147416890|NCT02416453|531690000|FG001|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
147416891|NCT02416453|531690001|FG002|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|1|||
147416892|NCT02416453|531690002|FG003|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
147416893|NCT02416453|531690003|FG004|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
147416894|NCT02416453|531690004|FG005|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
147416895|NCT02416453|531690005|FG006|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
147416896|NCT02416453|531690006|FG007|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
147416897|NCT02416453|531690007|FG008|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
147416898|NCT02416453|531690008|FG009|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
147416899|NCT02416453|531690009|FG010|Overall Study|PARTICIPANT UNABLE TO ATTEND ANY FURTHER|0|||
147416900|NCT02416453|531689999|FG000|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
147416901|NCT02416453|531690000|FG001|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
147416902|NCT02416453|531690001|FG002|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
147416903|NCT02416453|531690002|FG003|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
147490032|NCT02935634|531949332|FG003|Treatment: Track 1|Disease progression|4|||
147490033|NCT02935634|531949333|FG004|Treatment: Track 1|Disease progression|6|||
147490034|NCT02935634|531949334|FG005|Treatment: Track 1|Disease progression|2|||
147490035|NCT02935634|531949329|FG000|Treatment: Track 1|Adverse event unrelated to study drug|1|||
147624205|NCT03334435|532441740|FG008|Treatment Period 1: Week 0 to Week 52|Other|0|||
147624206|NCT03334435|532441741|FG009|Treatment Period 1: Week 0 to Week 52|Other|0|||
147624207|NCT03334435|532441742|FG010|Treatment Period 1: Week 0 to Week 52|Other|0|||
147624208|NCT03334435|532441743|FG011|Treatment Period 1: Week 0 to Week 52|Other|0|||
147624209|NCT03334435|532441744|FG012|Treatment Period 1: Week 0 to Week 52|Other|0|||
147624210|NCT03334435|532441745|FG013|Treatment Period 1: Week 0 to Week 52|Other|0|||
147624211|NCT03334435|532441746|FG014|Treatment Period 1: Week 0 to Week 52|Other|0|||
147624212|NCT03334435|532441732|FG000|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|0|||
147624213|NCT03334435|532441733|FG001|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|0|||
147624214|NCT03334435|532441734|FG002|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|0|||
147624215|NCT03334435|532441735|FG003|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|0|||
147624216|NCT03334435|532441736|FG004|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|0|||
147624217|NCT03334435|532441737|FG005|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|17|||
147624218|NCT03334435|532441738|FG006|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|21|||
147624219|NCT03334435|532441739|FG007|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|17|||
147624220|NCT03334435|532441740|FG008|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|19|||
147624221|NCT03334435|532441741|FG009|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|15|||
147624222|NCT03334435|532441742|FG010|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|17|||
147624223|NCT03334435|532441743|FG011|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|16|||
147624224|NCT03334435|532441744|FG012|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|3|||
147624225|NCT03334435|532441745|FG013|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|66|||
147624226|NCT03334435|532441746|FG014|Treatment Period 2: Week 52 to Week 200|Study Terminated by Sponsor|70|||
147624227|NCT03334435|532441732|FG000|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|0|||
147624228|NCT03334435|532441733|FG001|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|0|||
147624229|NCT03334435|532441734|FG002|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|0|||
147624230|NCT03334435|532441735|FG003|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|0|||
147624231|NCT03334435|532441736|FG004|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|0|||
147624232|NCT03334435|532441737|FG005|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|13|||
147624233|NCT03334435|532441738|FG006|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|10|||
147624234|NCT03334435|532441739|FG007|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|11|||
147624235|NCT03334435|532441740|FG008|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|7|||
147624236|NCT03334435|532441741|FG009|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|12|||
147490036|NCT02935634|531949330|FG001|Treatment: Track 1|Adverse event unrelated to study drug|1|||
147490037|NCT02935634|531949331|FG002|Treatment: Track 1|Adverse event unrelated to study drug|2|||
147490038|NCT02935634|531949332|FG003|Treatment: Track 1|Adverse event unrelated to study drug|3|||
147490039|NCT02935634|531949333|FG004|Treatment: Track 1|Adverse event unrelated to study drug|0|||
147490040|NCT02935634|531949334|FG005|Treatment: Track 1|Adverse event unrelated to study drug|3|||
147490041|NCT02935634|531949329|FG000|Treatment: Track 1|Lost to Follow-up|1|||
147490042|NCT02935634|531949330|FG001|Treatment: Track 1|Lost to Follow-up|0|||
147490043|NCT02935634|531949331|FG002|Treatment: Track 1|Lost to Follow-up|0|||
147490044|NCT02935634|531949332|FG003|Treatment: Track 1|Lost to Follow-up|0|||
147490045|NCT02935634|531949333|FG004|Treatment: Track 1|Lost to Follow-up|0|||
147490046|NCT02935634|531949334|FG005|Treatment: Track 1|Lost to Follow-up|0|||
147490047|NCT02935634|531949329|FG000|Treatment: Track 1|Study drug toxicity|2|||
147490048|NCT02935634|531949330|FG001|Treatment: Track 1|Study drug toxicity|1|||
147490049|NCT02935634|531949331|FG002|Treatment: Track 1|Study drug toxicity|3|||
147490050|NCT02935634|531949332|FG003|Treatment: Track 1|Study drug toxicity|0|||
147490051|NCT02935634|531949333|FG004|Treatment: Track 1|Study drug toxicity|0|||
147490052|NCT02935634|531949334|FG005|Treatment: Track 1|Study drug toxicity|1|||
147490053|NCT02935634|531949329|FG000|Treatment: Track 1|Participant request to discontinue treatment|1|||
147490054|NCT02935634|531949330|FG001|Treatment: Track 1|Participant request to discontinue treatment|0|||
147490055|NCT02935634|531949331|FG002|Treatment: Track 1|Participant request to discontinue treatment|1|||
147490056|NCT02935634|531949332|FG003|Treatment: Track 1|Participant request to discontinue treatment|0|||
147490057|NCT02935634|531949333|FG004|Treatment: Track 1|Participant request to discontinue treatment|1|||
147490058|NCT02935634|531949334|FG005|Treatment: Track 1|Participant request to discontinue treatment|0|||
147490059|NCT02935634|531949329|FG000|Treatment: Track 1|Participant withdrew consent|2|||
147490060|NCT02935634|531949330|FG001|Treatment: Track 1|Participant withdrew consent|0|||
147490061|NCT02935634|531949331|FG002|Treatment: Track 1|Participant withdrew consent|1|||
147490062|NCT02935634|531949332|FG003|Treatment: Track 1|Participant withdrew consent|0|||
147490063|NCT02935634|531949333|FG004|Treatment: Track 1|Participant withdrew consent|1|||
147490064|NCT02935634|531949334|FG005|Treatment: Track 1|Participant withdrew consent|0|||
147490065|NCT02935634|531949329|FG000|Treatment: Track 1|Other reasons|0|||
147490066|NCT02935634|531949330|FG001|Treatment: Track 1|Other reasons|0|||
147490067|NCT02935634|531949331|FG002|Treatment: Track 1|Other reasons|2|||
147490068|NCT02935634|531949332|FG003|Treatment: Track 1|Other reasons|0|||
147490069|NCT02935634|531949333|FG004|Treatment: Track 1|Other reasons|0|||
147490070|NCT02935634|531949334|FG005|Treatment: Track 1|Other reasons|0|||
147490071|NCT02935634|531949329|FG000|Treatment: Track 2|Disease progression|13|||
147490072|NCT02935634|531949330|FG001|Treatment: Track 2|Disease progression|26|||
147490073|NCT02935634|531949331|FG002|Treatment: Track 2|Disease progression|20|||
147490074|NCT02935634|531949332|FG003|Treatment: Track 2|Disease progression|5|||
147490075|NCT02935634|531949333|FG004|Treatment: Track 2|Disease progression|1|||
147490076|NCT02935634|531949334|FG005|Treatment: Track 2|Disease progression|4|||
147490077|NCT02935634|531949329|FG000|Treatment: Track 2|Adverse event unrelated to study drug|2|||
147490078|NCT02935634|531949330|FG001|Treatment: Track 2|Adverse event unrelated to study drug|2|||
147490079|NCT02935634|531949331|FG002|Treatment: Track 2|Adverse event unrelated to study drug|0|||
147490080|NCT02935634|531949332|FG003|Treatment: Track 2|Adverse event unrelated to study drug|0|||
147490081|NCT02935634|531949333|FG004|Treatment: Track 2|Adverse event unrelated to study drug|0|||
147490082|NCT02935634|531949334|FG005|Treatment: Track 2|Adverse event unrelated to study drug|0|||
147490083|NCT02935634|531949329|FG000|Treatment: Track 2|Study drug toxicity|7|||
147490084|NCT02935634|531949330|FG001|Treatment: Track 2|Study drug toxicity|3|||
147490085|NCT02935634|531949331|FG002|Treatment: Track 2|Study drug toxicity|0|||
147490086|NCT02935634|531949332|FG003|Treatment: Track 2|Study drug toxicity|0|||
147490087|NCT02935634|531949333|FG004|Treatment: Track 2|Study drug toxicity|0|||
147490088|NCT02935634|531949334|FG005|Treatment: Track 2|Study drug toxicity|0|||
147490089|NCT02935634|531949329|FG000|Treatment: Track 2|Participant request to discontinue treatment|0|||
147490090|NCT02935634|531949330|FG001|Treatment: Track 2|Participant request to discontinue treatment|2|||
147490091|NCT02935634|531949331|FG002|Treatment: Track 2|Participant request to discontinue treatment|1|||
147490092|NCT02935634|531949332|FG003|Treatment: Track 2|Participant request to discontinue treatment|0|||
147490093|NCT02935634|531949333|FG004|Treatment: Track 2|Participant request to discontinue treatment|0|||
147490094|NCT02935634|531949334|FG005|Treatment: Track 2|Participant request to discontinue treatment|0|||
147490095|NCT02935634|531949329|FG000|Treatment: Track 2|Participant withdrew consent|0|||
147490096|NCT02935634|531949330|FG001|Treatment: Track 2|Participant withdrew consent|1|||
147490097|NCT02935634|531949331|FG002|Treatment: Track 2|Participant withdrew consent|1|||
147490098|NCT02935634|531949332|FG003|Treatment: Track 2|Participant withdrew consent|0|||
147490099|NCT02935634|531949333|FG004|Treatment: Track 2|Participant withdrew consent|1|||
147490100|NCT02935634|531949334|FG005|Treatment: Track 2|Participant withdrew consent|0|||
147490101|NCT00210158|531949335|FG000|Overall Study|Protocol Violation|0|||
147490102|NCT00210158|531949336|FG001|Overall Study|Protocol Violation|2|||
147624237|NCT03334435|532441742|FG010|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|8|||
147624238|NCT03334435|532441743|FG011|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|7|||
147624239|NCT03334435|532441744|FG012|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|2|||
147624240|NCT03334435|532441745|FG013|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|63|||
147624241|NCT03334435|532441746|FG014|Treatment Period 2: Week 52 to Week 200|Lack of Efficacy|72|||
147624242|NCT03334435|532441732|FG000|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|0|||
147624243|NCT03334435|532441733|FG001|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|0|||
147624244|NCT03334435|532441734|FG002|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|0|||
147624245|NCT03334435|532441735|FG003|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|0|||
147624246|NCT03334435|532441736|FG004|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|0|||
147624247|NCT03334435|532441737|FG005|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|23|||
147624248|NCT03334435|532441738|FG006|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|15|||
147624249|NCT03334435|532441739|FG007|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|20|||
147624250|NCT03334435|532441740|FG008|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|17|||
147624251|NCT03334435|532441741|FG009|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|10|||
147624252|NCT03334435|532441742|FG010|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|11|||
147624253|NCT03334435|532441743|FG011|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|8|||
147624254|NCT03334435|532441744|FG012|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|0|||
147624255|NCT03334435|532441745|FG013|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|41|||
147667970|NCT00607893|532609815|FG000|Overall Study|Withdrew due to osteomyelitis surgery|0|||
147490103|NCT01842308|531949338|FG000|Overall Study|Withdrawal by Subject|0|||
147490104|NCT01842308|531949339|FG001|Overall Study|Withdrawal by Subject|0|||
147490105|NCT01842308|531949340|FG002|Overall Study|Withdrawal by Subject|0|||
147490106|NCT01842308|531949341|FG003|Overall Study|Withdrawal by Subject|0|||
147490107|NCT01842308|531949342|FG004|Overall Study|Withdrawal by Subject|1|||
147490108|NCT03521687|531949346|FG000|Overall Study|Adverse Event|4|||
147490109|NCT03521687|531949346|FG000|Overall Study|Physician Decision|1|||
147490110|NCT00830037|531949352|FG000|Overall Study|Withdrawal by Subject|2|||
147490111|NCT00830037|531949353|FG001|Overall Study|Withdrawal by Subject|3|||
147490112|NCT00830037|531949352|FG000|Overall Study|Lost to Follow-up|1|||
147490113|NCT00830037|531949353|FG001|Overall Study|Lost to Follow-up|2|||
147490114|NCT00830037|531949352|FG000|Overall Study|Active when terminated by DSMB|15|||
147490115|NCT00830037|531949353|FG001|Overall Study|Active when terminated by DSMB|14|||
147490116|NCT00740779|531949354|FG000|Overall Study|Adverse Event|4|||
147490117|NCT00740779|531949355|FG001|Overall Study|Adverse Event|6|||
147490118|NCT00740779|531949356|FG002|Overall Study|Adverse Event|3|||
147490119|NCT00740779|531949354|FG000|Overall Study|Protocol Violation|1|||
147490120|NCT00740779|531949355|FG001|Overall Study|Protocol Violation|1|||
147490121|NCT00740779|531949356|FG002|Overall Study|Protocol Violation|1|||
147490122|NCT00740779|531949354|FG000|Overall Study|Lack of Efficacy|0|||
147490123|NCT00740779|531949355|FG001|Overall Study|Lack of Efficacy|0|||
147490124|NCT00740779|531949356|FG002|Overall Study|Lack of Efficacy|2|||
147490125|NCT00740779|531949354|FG000|Overall Study|Withdrawal by Subject|2|||
147490126|NCT00740779|531949355|FG001|Overall Study|Withdrawal by Subject|4|||
147490127|NCT00740779|531949356|FG002|Overall Study|Withdrawal by Subject|2|||
147490128|NCT00740779|531949354|FG000|Overall Study|Lost to Follow-up|2|||
147490129|NCT00740779|531949355|FG001|Overall Study|Lost to Follow-up|3|||
147490130|NCT00740779|531949356|FG002|Overall Study|Lost to Follow-up|5|||
147490131|NCT02399813|531949362|FG000|Overall Study|Progressive Disease-Radiographic|2|||
147490132|NCT02399813|531949362|FG000|Overall Study|Death|20|||
147490133|NCT02399813|531949362|FG000|Overall Study|Withdrawal by Subject|3|||
147490134|NCT02399813|531949362|FG000|Overall Study|Initiating a Non-Study Cancer Treatment|4|||
147490135|NCT02399813|531949362|FG000|Overall Study|Lost to Follow-up|2|||
147490136|NCT02399813|531949362|FG000|Overall Study|Other than specified|5|||
147490137|NCT03280550|531949363|FG000|Overall Study|Withdrawal by Subject|2|||
147490138|NCT03280550|531949364|FG001|Overall Study|Withdrawal by Subject|2|||
147490139|NCT03280550|531949363|FG000|Overall Study|Physician Decision|0|||
147490140|NCT03280550|531949364|FG001|Overall Study|Physician Decision|1|||
147490141|NCT00222729|531949369|FG000|Overall Study|Adverse Event|3|||
147490142|NCT01915849|531949372|FG000|Treatment Period 1 (4 Days)|Protocol Violation|1|||
147490143|NCT01915849|531949373|FG001|Treatment Period 1 (4 Days)|Protocol Violation|0|||
147490144|NCT01915849|531949374|FG002|Treatment Period 1 (4 Days)|Protocol Violation|0|||
147490145|NCT01915849|531949375|FG003|Treatment Period 1 (4 Days)|Protocol Violation|0|||
147490146|NCT01915849|531949372|FG000|Treatment Period 1 (4 Days)|Withdrawal by Subject|1|||
147490147|NCT01915849|531949373|FG001|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
147490148|NCT01915849|531949374|FG002|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
147490149|NCT01915849|531949375|FG003|Treatment Period 1 (4 Days)|Withdrawal by Subject|0|||
147490150|NCT02775864|531949376|FG000|Overall Study|Data ended end of 2010|1764|||
147490151|NCT02775864|531949377|FG001|Overall Study|Data ended end of 2010|2880|||
147490152|NCT02775864|531949378|FG002|Overall Study|Data ended end of 2010|1140|||
147490153|NCT02775864|531949379|FG003|Overall Study|Data ended end of 2010|1194|||
147490154|NCT02775864|531949376|FG000|Overall Study|Medicaid eligibility discontinued|1478|||
147490155|NCT02775864|531949377|FG001|Overall Study|Medicaid eligibility discontinued|2019|||
147490156|NCT02775864|531949378|FG002|Overall Study|Medicaid eligibility discontinued|720|||
147490157|NCT02775864|531949379|FG003|Overall Study|Medicaid eligibility discontinued|890|||
147490158|NCT02028338|531949381|FG000|Overall Study|Withdrawal by Subject|3|||
147490159|NCT02028338|531949382|FG001|Overall Study|Withdrawal by Subject|1|||
147490160|NCT02028338|531949381|FG000|Overall Study|Unable to contact participant|1|||
147490161|NCT02028338|531949382|FG001|Overall Study|Unable to contact participant|0|||
147490162|NCT02761993|531949391|FG000|Overall Study|Adverse Event|0|||
147490163|NCT02761993|531949392|FG001|Overall Study|Adverse Event|2|||
147490164|NCT02761993|531949393|FG002|Overall Study|Adverse Event|0|||
147490165|NCT02761993|531949391|FG000|Overall Study|Lost to Follow-up|1|||
147490166|NCT02761993|531949392|FG001|Overall Study|Lost to Follow-up|3|||
147624256|NCT03334435|532441746|FG014|Treatment Period 2: Week 52 to Week 200|Withdrawal by Subject|32|||
147490167|NCT02761993|531949393|FG002|Overall Study|Lost to Follow-up|2|||
147490168|NCT02761993|531949391|FG000|Overall Study|Withdrawal by Subject|1|||
147490169|NCT02761993|531949392|FG001|Overall Study|Withdrawal by Subject|1|||
147490170|NCT02761993|531949393|FG002|Overall Study|Withdrawal by Subject|2|||
147490171|NCT01842620|531949394|FG000|Period 1|Withdrawal by Subject|1|||
147490172|NCT01842620|531949395|FG001|Period 1|Withdrawal by Subject|0|||
147490173|NCT00256867|531949396|FG000|Overall Study|Adverse Event|0|||
147490174|NCT00256867|531949397|FG001|Overall Study|Adverse Event|1|||
147624257|NCT03334435|532441732|FG000|Treatment Period 2: Week 52 to Week 200|Adverse Event|0|||
147490175|NCT00256867|531949398|FG002|Overall Study|Adverse Event|1|||
147490176|NCT00256867|531949399|FG003|Overall Study|Adverse Event|1|||
147490177|NCT00256867|531949400|FG004|Overall Study|Adverse Event|2|||
147490178|NCT00256867|531949401|FG005|Overall Study|Adverse Event|2|||
147490179|NCT00256867|531949402|FG006|Overall Study|Adverse Event|1|||
147490180|NCT00256867|531949403|FG007|Overall Study|Adverse Event|4|||
147490181|NCT00256867|531949396|FG000|Overall Study|Lost to Follow-up|2|||
147490182|NCT00256867|531949397|FG001|Overall Study|Lost to Follow-up|2|||
147490183|NCT00256867|531949398|FG002|Overall Study|Lost to Follow-up|2|||
147490184|NCT00256867|531949399|FG003|Overall Study|Lost to Follow-up|3|||
147490185|NCT00256867|531949400|FG004|Overall Study|Lost to Follow-up|2|||
147490186|NCT00256867|531949401|FG005|Overall Study|Lost to Follow-up|0|||
147490187|NCT00256867|531949402|FG006|Overall Study|Lost to Follow-up|1|||
147490188|NCT00256867|531949403|FG007|Overall Study|Lost to Follow-up|2|||
147490189|NCT00256867|531949396|FG000|Overall Study|Protocol Violation|0|||
147490190|NCT00256867|531949397|FG001|Overall Study|Protocol Violation|0|||
147490191|NCT00256867|531949398|FG002|Overall Study|Protocol Violation|0|||
147490192|NCT00256867|531949399|FG003|Overall Study|Protocol Violation|1|||
147490193|NCT00256867|531949400|FG004|Overall Study|Protocol Violation|0|||
147490194|NCT00256867|531949401|FG005|Overall Study|Protocol Violation|1|||
147490195|NCT00256867|531949402|FG006|Overall Study|Protocol Violation|0|||
147490196|NCT00256867|531949403|FG007|Overall Study|Protocol Violation|1|||
147490197|NCT00256867|531949396|FG000|Overall Study|Withdrawal by Subject|0|||
147490198|NCT00256867|531949397|FG001|Overall Study|Withdrawal by Subject|0|||
147490199|NCT00256867|531949398|FG002|Overall Study|Withdrawal by Subject|1|||
147490200|NCT00256867|531949399|FG003|Overall Study|Withdrawal by Subject|1|||
147490201|NCT00256867|531949400|FG004|Overall Study|Withdrawal by Subject|2|||
147490202|NCT00256867|531949401|FG005|Overall Study|Withdrawal by Subject|2|||
147490203|NCT00256867|531949402|FG006|Overall Study|Withdrawal by Subject|3|||
147490204|NCT00256867|531949403|FG007|Overall Study|Withdrawal by Subject|2|||
147490205|NCT00256867|531949396|FG000|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
147490206|NCT00256867|531949397|FG001|Overall Study|Fasting plasma glucose >240 mg/dL|1|||
147490207|NCT00256867|531949398|FG002|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
147490208|NCT00256867|531949399|FG003|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
147490209|NCT00256867|531949400|FG004|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
147490210|NCT00256867|531949401|FG005|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
147490211|NCT00256867|531949402|FG006|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
147490212|NCT00256867|531949403|FG007|Overall Study|Fasting plasma glucose >240 mg/dL|0|||
147490213|NCT00256867|531949396|FG000|Overall Study|Glycemia over 13.3 millimole per litre|0|||
147490214|NCT00256867|531949397|FG001|Overall Study|Glycemia over 13.3 millimole per litre|0|||
147490215|NCT00256867|531949398|FG002|Overall Study|Glycemia over 13.3 millimole per litre|0|||
147490216|NCT00256867|531949399|FG003|Overall Study|Glycemia over 13.3 millimole per litre|0|||
147490217|NCT00256867|531949400|FG004|Overall Study|Glycemia over 13.3 millimole per litre|0|||
147490218|NCT00256867|531949401|FG005|Overall Study|Glycemia over 13.3 millimole per litre|0|||
147490219|NCT00256867|531949402|FG006|Overall Study|Glycemia over 13.3 millimole per litre|0|||
147490220|NCT00256867|531949403|FG007|Overall Study|Glycemia over 13.3 millimole per litre|1|||
147490221|NCT00256867|531949396|FG000|Overall Study|Investigator's Decision|0|||
147490222|NCT00256867|531949397|FG001|Overall Study|Investigator's Decision|0|||
147490223|NCT00256867|531949398|FG002|Overall Study|Investigator's Decision|0|||
147490224|NCT00256867|531949399|FG003|Overall Study|Investigator's Decision|0|||
147490225|NCT00256867|531949400|FG004|Overall Study|Investigator's Decision|1|||
147490226|NCT00256867|531949401|FG005|Overall Study|Investigator's Decision|0|||
147490227|NCT00256867|531949402|FG006|Overall Study|Investigator's Decision|0|||
147490228|NCT00256867|531949403|FG007|Overall Study|Investigator's Decision|0|||
147490229|NCT00256867|531949396|FG000|Overall Study|Non-compliance with study medication|0|||
147490230|NCT00256867|531949397|FG001|Overall Study|Non-compliance with study medication|0|||
147490231|NCT00256867|531949398|FG002|Overall Study|Non-compliance with study medication|0|||
147490232|NCT00256867|531949399|FG003|Overall Study|Non-compliance with study medication|0|||
147490233|NCT00256867|531949400|FG004|Overall Study|Non-compliance with study medication|0|||
147490234|NCT00256867|531949401|FG005|Overall Study|Non-compliance with study medication|0|||
147490235|NCT00256867|531949402|FG006|Overall Study|Non-compliance with study medication|0|||
147490236|NCT00256867|531949403|FG007|Overall Study|Non-compliance with study medication|1|||
147490237|NCT00256867|531949396|FG000|Overall Study|Participant travelled Overseas|0|||
147490238|NCT00256867|531949397|FG001|Overall Study|Participant travelled Overseas|1|||
147490239|NCT00256867|531949398|FG002|Overall Study|Participant travelled Overseas|0|||
147490240|NCT00256867|531949399|FG003|Overall Study|Participant travelled Overseas|0|||
147490241|NCT00256867|531949400|FG004|Overall Study|Participant travelled Overseas|0|||
147490242|NCT00256867|531949401|FG005|Overall Study|Participant travelled Overseas|0|||
147490243|NCT00256867|531949402|FG006|Overall Study|Participant travelled Overseas|0|||
147490244|NCT00256867|531949403|FG007|Overall Study|Participant travelled Overseas|0|||
147490245|NCT00256867|531949396|FG000|Overall Study|Participant out of assessment window|0|||
147490246|NCT00256867|531949397|FG001|Overall Study|Participant out of assessment window|0|||
147490247|NCT00256867|531949398|FG002|Overall Study|Participant out of assessment window|1|||
147490248|NCT00256867|531949399|FG003|Overall Study|Participant out of assessment window|0|||
147490249|NCT00256867|531949400|FG004|Overall Study|Participant out of assessment window|0|||
147490250|NCT00256867|531949401|FG005|Overall Study|Participant out of assessment window|0|||
147490251|NCT00256867|531949402|FG006|Overall Study|Participant out of assessment window|0|||
147490252|NCT00256867|531949403|FG007|Overall Study|Participant out of assessment window|0|||
147490253|NCT00256867|531949396|FG000|Overall Study|Withdrawal by participant|0|||
147490254|NCT00256867|531949397|FG001|Overall Study|Withdrawal by participant|0|||
147490255|NCT00256867|531949398|FG002|Overall Study|Withdrawal by participant|0|||
147490256|NCT00256867|531949399|FG003|Overall Study|Withdrawal by participant|0|||
147490257|NCT00256867|531949400|FG004|Overall Study|Withdrawal by participant|0|||
147490258|NCT00256867|531949401|FG005|Overall Study|Withdrawal by participant|1|||
147667971|NCT00607893|532609816|FG001|Overall Study|Withdrew due to osteomyelitis surgery|1|||
147490259|NCT00256867|531949402|FG006|Overall Study|Withdrawal by participant|0|||
147490260|NCT00256867|531949403|FG007|Overall Study|Withdrawal by participant|0|||
147490261|NCT01930799|531949408|FG000|Overall Study|Withdrawal by Subject|3|||
147490262|NCT01930799|531949408|FG000|Overall Study|Lost to Follow-up|5|||
147490263|NCT00875017|531949411|FG000|First Intervention|Withdrawal by Subject|1|||
147490264|NCT00875017|531949412|FG001|First Intervention|Withdrawal by Subject|0|||
147490265|NCT00875017|531949413|FG002|First Intervention|Withdrawal by Subject|1|||
147490266|NCT00875017|531949414|FG003|First Intervention|Withdrawal by Subject|0|||
147490267|NCT00875017|531949415|FG004|First Intervention|Withdrawal by Subject|0|||
147490268|NCT00875017|531949416|FG005|First Intervention|Withdrawal by Subject|0|||
147490269|NCT00875017|531949411|FG000|First Intervention|Adverse Event|0|||
147490270|NCT00875017|531949412|FG001|First Intervention|Adverse Event|0|||
147490271|NCT00875017|531949413|FG002|First Intervention|Adverse Event|0|||
147490272|NCT00875017|531949414|FG003|First Intervention|Adverse Event|1|||
147490273|NCT00875017|531949415|FG004|First Intervention|Adverse Event|0|||
147490274|NCT00875017|531949416|FG005|First Intervention|Adverse Event|0|||
147490275|NCT00875017|531949411|FG000|First Intervention|Problems collecting rectal effluent|1|||
147490276|NCT00875017|531949412|FG001|First Intervention|Problems collecting rectal effluent|0|||
147490277|NCT00875017|531949413|FG002|First Intervention|Problems collecting rectal effluent|0|||
147490278|NCT00875017|531949414|FG003|First Intervention|Problems collecting rectal effluent|0|||
147490279|NCT00875017|531949415|FG004|First Intervention|Problems collecting rectal effluent|0|||
147490280|NCT00875017|531949416|FG005|First Intervention|Problems collecting rectal effluent|0|||
147490281|NCT00875017|531949411|FG000|First Intervention|Intolerance to nasogastric tube|0|||
147490282|NCT00875017|531949412|FG001|First Intervention|Intolerance to nasogastric tube|0|||
147490283|NCT00875017|531949413|FG002|First Intervention|Intolerance to nasogastric tube|0|||
147490284|NCT00875017|531949414|FG003|First Intervention|Intolerance to nasogastric tube|0|||
147490285|NCT00875017|531949415|FG004|First Intervention|Intolerance to nasogastric tube|1|||
147490286|NCT00875017|531949416|FG005|First Intervention|Intolerance to nasogastric tube|0|||
147490287|NCT00875017|531949411|FG000|Washout|Problem collecting rectal effluent|0|||
147490288|NCT00875017|531949412|FG001|Washout|Problem collecting rectal effluent|0|||
147490289|NCT00875017|531949413|FG002|Washout|Problem collecting rectal effluent|1|||
147490290|NCT00875017|531949414|FG003|Washout|Problem collecting rectal effluent|0|||
147490291|NCT00875017|531949415|FG004|Washout|Problem collecting rectal effluent|0|||
147490292|NCT00875017|531949416|FG005|Washout|Problem collecting rectal effluent|0|||
147490293|NCT00875017|531949411|FG000|Second Intervention|Adverse Event|0|||
147490294|NCT00875017|531949412|FG001|Second Intervention|Adverse Event|0|||
147490295|NCT00875017|531949413|FG002|Second Intervention|Adverse Event|0|||
147490296|NCT00875017|531949414|FG003|Second Intervention|Adverse Event|1|||
147490297|NCT00875017|531949415|FG004|Second Intervention|Adverse Event|0|||
147490298|NCT00875017|531949416|FG005|Second Intervention|Adverse Event|0|||
147490299|NCT00875017|531949411|FG000|Washout|Problems collecting rectal effluent|0|||
147490300|NCT00875017|531949412|FG001|Washout|Problems collecting rectal effluent|1|||
147490301|NCT00875017|531949413|FG002|Washout|Problems collecting rectal effluent|0|||
147490302|NCT00875017|531949414|FG003|Washout|Problems collecting rectal effluent|0|||
147490303|NCT00875017|531949415|FG004|Washout|Problems collecting rectal effluent|0|||
147490304|NCT00875017|531949416|FG005|Washout|Problems collecting rectal effluent|0|||
147490305|NCT00875017|531949411|FG000|Third Intervention|Adverse Event|0|||
147490306|NCT00875017|531949412|FG001|Third Intervention|Adverse Event|1|||
147490307|NCT00875017|531949413|FG002|Third Intervention|Adverse Event|1|||
147490308|NCT00875017|531949414|FG003|Third Intervention|Adverse Event|0|||
147490309|NCT00875017|531949415|FG004|Third Intervention|Adverse Event|0|||
147490310|NCT00875017|531949416|FG005|Third Intervention|Adverse Event|0|||
147490311|NCT00875017|531949411|FG000|Washout|Withdrawal by Subject|0|||
147490312|NCT00875017|531949412|FG001|Washout|Withdrawal by Subject|0|||
147490313|NCT00875017|531949413|FG002|Washout|Withdrawal by Subject|0|||
147490314|NCT00875017|531949414|FG003|Washout|Withdrawal by Subject|0|||
147490315|NCT00875017|531949415|FG004|Washout|Withdrawal by Subject|1|||
147490316|NCT00875017|531949416|FG005|Washout|Withdrawal by Subject|0|||
147490317|NCT00875017|531949411|FG000|Fourth Intervention|Inability to comply with fasting|0|||
147490318|NCT00875017|531949412|FG001|Fourth Intervention|Inability to comply with fasting|0|||
147490319|NCT00875017|531949413|FG002|Fourth Intervention|Inability to comply with fasting|0|||
147490320|NCT00875017|531949414|FG003|Fourth Intervention|Inability to comply with fasting|0|||
147490321|NCT00875017|531949415|FG004|Fourth Intervention|Inability to comply with fasting|0|||
147490322|NCT00875017|531949416|FG005|Fourth Intervention|Inability to comply with fasting|1|||
147490323|NCT02689219|531949417|FG000|Overall Study|Death|1|||
147490324|NCT02689219|531949418|FG001|Overall Study|Death|1|||
147490325|NCT02689219|531949417|FG000|Overall Study|Disease Progression|10|||
147490326|NCT02689219|531949418|FG001|Overall Study|Disease Progression|6|||
147490327|NCT03342469|531949419|FG000|Overall Study|Withdrawal by Subject|0|||
147490328|NCT03342469|531949420|FG001|Overall Study|Withdrawal by Subject|1|||
147490329|NCT03342469|531949421|FG002|Overall Study|Withdrawal by Subject|0|||
147490330|NCT03342469|531949422|FG003|Overall Study|Withdrawal by Subject|0|||
147490331|NCT01477892|531949423|FG000|Overall Study|Withdrawal by Subject|0|||
147490332|NCT01477892|531949424|FG001|Overall Study|Withdrawal by Subject|2|||
147490333|NCT01921257|531949426|FG000|Overall Study|Adverse Event|1|||
147490334|NCT01921257|531949426|FG000|Overall Study|Protocol Violation|1|||
147490335|NCT01921257|531949426|FG000|Overall Study|Withdrawal by Subject|1|||
147490336|NCT05515601|531949431|FG000|Overall Study|Withdrawal by Subject|1|||
147490337|NCT05515601|531949432|FG001|Overall Study|Withdrawal by Subject|3|||
147490338|NCT05515601|531949433|FG002|Overall Study|Withdrawal by Subject|2|||
147490339|NCT05515601|531949434|FG003|Overall Study|Withdrawal by Subject|1|||
147490340|NCT05515601|531949435|FG004|Overall Study|Withdrawal by Subject|1|||
147490341|NCT05515601|531949436|FG005|Overall Study|Withdrawal by Subject|1|||
147490342|NCT05515601|531949431|FG000|Overall Study|Lost to Follow-up|0|||
147490343|NCT05515601|531949432|FG001|Overall Study|Lost to Follow-up|0|||
147490344|NCT05515601|531949433|FG002|Overall Study|Lost to Follow-up|0|||
147490345|NCT05515601|531949434|FG003|Overall Study|Lost to Follow-up|0|||
147490346|NCT05515601|531949435|FG004|Overall Study|Lost to Follow-up|1|||
147490347|NCT05515601|531949436|FG005|Overall Study|Lost to Follow-up|0|||
147490348|NCT01689207|531949437|FG000|Overall Study|Adverse Event|0|||
147490349|NCT01689207|531949438|FG001|Overall Study|Adverse Event|1|||
147490350|NCT01689207|531949439|FG002|Overall Study|Adverse Event|0|||
147490351|NCT01689207|531949440|FG003|Overall Study|Adverse Event|0|||
147490352|NCT01689207|531949441|FG004|Overall Study|Adverse Event|2|||
147490353|NCT01689207|531949442|FG005|Overall Study|Adverse Event|1|||
147490354|NCT01689207|531949443|FG006|Overall Study|Adverse Event|0|||
147490355|NCT01689207|531949444|FG007|Overall Study|Adverse Event|0|||
147490356|NCT01689207|531949445|FG008|Overall Study|Adverse Event|1|||
147490357|NCT01689207|531949446|FG009|Overall Study|Adverse Event|0|||
147490358|NCT01689207|531949447|FG010|Overall Study|Adverse Event|0|||
147490359|NCT01912768|531949448|FG000|Overall Study|Adverse Event|2|||
147490360|NCT01912768|531949449|FG001|Overall Study|Adverse Event|0|||
147490361|NCT01912768|531949448|FG000|Overall Study|Lost to Follow-up|2|||
147490362|NCT01912768|531949449|FG001|Overall Study|Lost to Follow-up|1|||
147490363|NCT01912768|531949448|FG000|Overall Study|Withdrawal by Subject|5|||
147490364|NCT01912768|531949449|FG001|Overall Study|Withdrawal by Subject|3|||
147490365|NCT01912768|531949448|FG000|Overall Study|Randomized in error|1|||
147490366|NCT01912768|531949449|FG001|Overall Study|Randomized in error|0|||
147490367|NCT02426658|531949450|FG000|Overall Study|Withdrawal by Subject|1|||
147490368|NCT02426658|531949450|FG000|Overall Study|Patient expired before treatment|2|||
147490369|NCT00524316|531949451|FG000|Overall Study|Withdrawal by Subject|2|||
147490370|NCT00524316|531949451|FG000|Overall Study|Adverse Event|7|||
147490371|NCT00524316|531949451|FG000|Overall Study|Disease Progression|7|||
147490372|NCT01199263|531949454|FG000|Overall Study|Ineligible|0|||
147490373|NCT01199263|531949455|FG001|Overall Study|Ineligible|2|||
147490374|NCT01199263|531949454|FG000|Overall Study|Never Treated|6|||
147490375|NCT01199263|531949455|FG001|Overall Study|Never Treated|0|||
147490376|NCT00488033|531949456|FG000|Overall Study|Withdrawal by Subject|1|||
147490377|NCT00488033|531949457|FG001|Overall Study|Withdrawal by Subject|0|||
147490378|NCT01515306|531949458|FG000|Overall Study|Adverse Event|3|||
147490379|NCT01515306|531949459|FG001|Overall Study|Adverse Event|2|||
147490380|NCT01515306|531949458|FG000|Overall Study|Progressive Disease|19|||
147490381|NCT01515306|531949459|FG001|Overall Study|Progressive Disease|9|||
147490382|NCT01515306|531949458|FG000|Overall Study|Withdrawal by Subject|1|||
147490383|NCT01515306|531949459|FG001|Overall Study|Withdrawal by Subject|2|||
147490384|NCT01515306|531949458|FG000|Overall Study|Physician Decision|1|||
147624258|NCT03334435|532441733|FG001|Treatment Period 2: Week 52 to Week 200|Adverse Event|0|||
147624259|NCT03334435|532441734|FG002|Treatment Period 2: Week 52 to Week 200|Adverse Event|0|||
147624260|NCT03334435|532441735|FG003|Treatment Period 2: Week 52 to Week 200|Adverse Event|0|||
147624261|NCT03334435|532441736|FG004|Treatment Period 2: Week 52 to Week 200|Adverse Event|0|||
147624262|NCT03334435|532441737|FG005|Treatment Period 2: Week 52 to Week 200|Adverse Event|6|||
147624263|NCT03334435|532441738|FG006|Treatment Period 2: Week 52 to Week 200|Adverse Event|1|||
147624264|NCT03334435|532441739|FG007|Treatment Period 2: Week 52 to Week 200|Adverse Event|2|||
147490385|NCT01515306|531949459|FG001|Overall Study|Physician Decision|1|||
147490386|NCT04973228|531949460|FG000|Overall Study|Adverse Event|2|||
147490387|NCT04973228|531949461|FG001|Overall Study|Adverse Event|3|||
147624265|NCT03334435|532441740|FG008|Treatment Period 2: Week 52 to Week 200|Adverse Event|2|||
147624266|NCT03334435|532441741|FG009|Treatment Period 2: Week 52 to Week 200|Adverse Event|3|||
147624267|NCT03334435|532441742|FG010|Treatment Period 2: Week 52 to Week 200|Adverse Event|9|||
147490388|NCT04973228|531949460|FG000|Overall Study|Lack of Efficacy|1|||
147490389|NCT04973228|531949461|FG001|Overall Study|Lack of Efficacy|3|||
147490390|NCT04973228|531949460|FG000|Overall Study|Lost to Follow-up|12|||
147624268|NCT03334435|532441743|FG011|Treatment Period 2: Week 52 to Week 200|Adverse Event|3|||
147624269|NCT03334435|532441744|FG012|Treatment Period 2: Week 52 to Week 200|Adverse Event|2|||
147490391|NCT04973228|531949461|FG001|Overall Study|Lost to Follow-up|4|||
147490392|NCT04973228|531949460|FG000|Overall Study|Withdrawal by Subject|11|||
147490393|NCT04973228|531949461|FG001|Overall Study|Withdrawal by Subject|4|||
147490394|NCT04973228|531949460|FG000|Overall Study|Did not tolerate application|1|||
147490395|NCT04973228|531949461|FG001|Overall Study|Did not tolerate application|0|||
147490396|NCT04973228|531949460|FG000|Overall Study|Wanted to early terminate and use own product|0|||
147490397|NCT04973228|531949461|FG001|Overall Study|Wanted to early terminate and use own product|1|||
147490398|NCT04973228|531949460|FG000|Overall Study|Missed visits due to new work schedule|1|||
147490399|NCT04973228|531949461|FG001|Overall Study|Missed visits due to new work schedule|0|||
147490400|NCT00683475|531950980|FG000|Overall Study|Withdrawal by Subject|1|||
147490401|NCT00683475|531950981|FG001|Overall Study|Withdrawal by Subject|0|||
147490402|NCT00683475|531950980|FG000|Overall Study|Never Treated: Adverse Event|2|||
147490403|NCT00683475|531950981|FG001|Overall Study|Never Treated: Adverse Event|3|||
147490404|NCT00683475|531950980|FG000|Overall Study|Never Treated: Progressive Disease|1|||
147490405|NCT00683475|531950981|FG001|Overall Study|Never Treated: Progressive Disease|0|||
147490406|NCT02429258|531950982|FG000|Overall Study|Withdrawal by Subject|2|||
147490407|NCT02429258|531950983|FG001|Overall Study|Withdrawal by Subject|0|||
147490408|NCT02429258|531950982|FG000|Overall Study|Protocol Violation|0|||
147490409|NCT02429258|531950983|FG001|Overall Study|Protocol Violation|1|||
147490410|NCT01694420|531950984|FG000|Overall Study|Lost to Follow-up|3|||
147490411|NCT03987919|531950986|FG000|Overall Study|Adverse Event|1|||
147490412|NCT03987919|531950987|FG001|Overall Study|Adverse Event|4|||
147490413|NCT03987919|531950988|FG002|Overall Study|Adverse Event|1|||
147490414|NCT03987919|531950989|FG003|Overall Study|Adverse Event|3|||
147490415|NCT03987919|531950986|FG000|Overall Study|Death|4|||
147490416|NCT03987919|531950987|FG001|Overall Study|Death|4|||
147490417|NCT03987919|531950988|FG002|Overall Study|Death|4|||
147490418|NCT03987919|531950989|FG003|Overall Study|Death|1|||
147490419|NCT03987919|531950986|FG000|Overall Study|Lost to Follow-up|5|||
147490420|NCT03987919|531950987|FG001|Overall Study|Lost to Follow-up|6|||
147490421|NCT03987919|531950988|FG002|Overall Study|Lost to Follow-up|8|||
147490422|NCT03987919|531950989|FG003|Overall Study|Lost to Follow-up|12|||
147490423|NCT03987919|531950986|FG000|Overall Study|Physician Decision|0|||
147490424|NCT03987919|531950987|FG001|Overall Study|Physician Decision|2|||
147490425|NCT03987919|531950988|FG002|Overall Study|Physician Decision|0|||
147490426|NCT03987919|531950989|FG003|Overall Study|Physician Decision|4|||
147490427|NCT03987919|531950986|FG000|Overall Study|Pregnancy|1|||
147490428|NCT03987919|531950987|FG001|Overall Study|Pregnancy|0|||
147490429|NCT03987919|531950988|FG002|Overall Study|Pregnancy|1|||
147490430|NCT03987919|531950989|FG003|Overall Study|Pregnancy|1|||
147490431|NCT03987919|531950986|FG000|Overall Study|Protocol Violation|0|||
147490432|NCT03987919|531950987|FG001|Overall Study|Protocol Violation|1|||
147490433|NCT03987919|531950988|FG002|Overall Study|Protocol Violation|0|||
147490434|NCT03987919|531950989|FG003|Overall Study|Protocol Violation|0|||
147490435|NCT03987919|531950986|FG000|Overall Study|Site terminated by Sponsor|0|||
147490436|NCT03987919|531950987|FG001|Overall Study|Site terminated by Sponsor|0|||
147490437|NCT03987919|531950988|FG002|Overall Study|Site terminated by Sponsor|0|||
147490438|NCT03987919|531950989|FG003|Overall Study|Site terminated by Sponsor|1|||
147490439|NCT03987919|531950986|FG000|Overall Study|Withdrawal by Subject|7|||
147490440|NCT03987919|531950987|FG001|Overall Study|Withdrawal by Subject|7|||
147490441|NCT03987919|531950988|FG002|Overall Study|Withdrawal by Subject|8|||
147490442|NCT03987919|531950989|FG003|Overall Study|Withdrawal by Subject|4|||
147490443|NCT03987919|531950986|FG000|Overall Study|Other - as reported by the investigator|1|||
147490444|NCT03987919|531950987|FG001|Overall Study|Other - as reported by the investigator|3|||
147490445|NCT03987919|531950988|FG002|Overall Study|Other - as reported by the investigator|2|||
147490446|NCT03987919|531950989|FG003|Overall Study|Other - as reported by the investigator|0|||
147490447|NCT00434512|531950994|FG000|Overall Study|Migrated/moved from study area|0|||
147490448|NCT00434512|531950995|FG001|Overall Study|Migrated/moved from study area|0|||
147490449|NCT00434512|531950996|FG002|Overall Study|Migrated/moved from study area|0|||
147490450|NCT00434512|531950997|FG003|Overall Study|Migrated/moved from study area|1|||
147490451|NCT00434512|531950998|FG004|Overall Study|Migrated/moved from study area|1|||
147490452|NCT00434512|531950999|FG005|Overall Study|Migrated/moved from study area|1|||
147490453|NCT00434512|531950994|FG000|Overall Study|Other|0|||
147490454|NCT00434512|531950995|FG001|Overall Study|Other|1|||
147490455|NCT00434512|531950996|FG002|Overall Study|Other|0|||
147490456|NCT00434512|531950997|FG003|Overall Study|Other|0|||
147490457|NCT00434512|531950998|FG004|Overall Study|Other|0|||
147490458|NCT00434512|531950999|FG005|Overall Study|Other|0|||
147490459|NCT03303092|531951000|FG000|Overall Study|Adverse Event|1|||
147490460|NCT03303092|531951001|FG001|Overall Study|Adverse Event|0|||
147490461|NCT03303092|531951002|FG002|Overall Study|Adverse Event|1|||
147490462|NCT03303092|531951000|FG000|Overall Study|Protocol Violation|1|||
147490463|NCT03303092|531951001|FG001|Overall Study|Protocol Violation|5|||
147490464|NCT03303092|531951002|FG002|Overall Study|Protocol Violation|1|||
147490465|NCT03303092|531951000|FG000|Overall Study|Withdrawal by Subject|1|||
147490466|NCT03303092|531951001|FG001|Overall Study|Withdrawal by Subject|1|||
147490467|NCT03303092|531951002|FG002|Overall Study|Withdrawal by Subject|3|||
147490468|NCT01030458|531951013|FG000|Overall Study|Lost to Follow-up|9|||
147490469|NCT01030458|531951014|FG001|Overall Study|Lost to Follow-up|10|||
147490470|NCT01030458|531951013|FG000|Overall Study|Withdrawal by Subject|2|||
147490471|NCT01030458|531951014|FG001|Overall Study|Withdrawal by Subject|3|||
147490472|NCT01030458|531951013|FG000|Overall Study|Logistical reasons|9|||
147490473|NCT01030458|531951014|FG001|Overall Study|Logistical reasons|5|||
147490474|NCT01030458|531951013|FG000|Overall Study|Moved or changed job|6|||
147490475|NCT01030458|531951014|FG001|Overall Study|Moved or changed job|13|||
147490476|NCT01030458|531951013|FG000|Overall Study|Side effect of medication|1|||
147490477|NCT01030458|531951014|FG001|Overall Study|Side effect of medication|1|||
147490478|NCT02420223|531951015|FG000|Overall Study|Adverse Event|1|||
147490479|NCT02420223|531951016|FG001|Overall Study|Adverse Event|0|||
147490480|NCT02420223|531951015|FG000|Overall Study|Physician Decision|0|||
147490481|NCT02420223|531951016|FG001|Overall Study|Physician Decision|2|||
147490482|NCT00411788|531951019|FG000|Overall Study|Protocol Violation|1|||
147490483|NCT00411788|531951019|FG000|Overall Study|Adverse Event|1|||
147490484|NCT00390416|531951021|FG000|Overall Study|Withdrawal by Subject|1|||
147490485|NCT00390416|531951021|FG000|Overall Study|Not treated|3|||
147490486|NCT01592409|531951022|FG000|Overall Study|Withdrawal by Subject|0|||
147490487|NCT01592409|531951023|FG001|Overall Study|Withdrawal by Subject|1|||
147490488|NCT01219959|531951024|FG000|Overall Study|Adverse Event|6|||
147490489|NCT01219959|531951025|FG001|Overall Study|Adverse Event|14|||
147490490|NCT01219959|531951024|FG000|Overall Study|Physician Decision|0|||
147490491|NCT01219959|531951025|FG001|Overall Study|Physician Decision|4|||
147490492|NCT01219959|531951024|FG000|Overall Study|Withdrawal by Subject|0|||
147490493|NCT01219959|531951025|FG001|Overall Study|Withdrawal by Subject|2|||
147490494|NCT01219959|531951024|FG000|Overall Study|Renal Transplantation|0|||
147490495|NCT01219959|531951025|FG001|Overall Study|Renal Transplantation|3|||
147490496|NCT01219959|531951024|FG000|Overall Study|Other|1|||
147490497|NCT01219959|531951025|FG001|Overall Study|Other|0|||
147490498|NCT01728584|531951026|FG000|Overall Study|Adverse Event|1|||
147490499|NCT01728584|531951027|FG001|Overall Study|Adverse Event|0|||
147490500|NCT01728584|531951028|FG002|Overall Study|Adverse Event|0|||
147490501|NCT01728584|531951029|FG003|Overall Study|Adverse Event|0|||
147490502|NCT01728584|531951026|FG000|Overall Study|Physician Decision|4|||
147490503|NCT01728584|531951027|FG001|Overall Study|Physician Decision|0|||
147490504|NCT01728584|531951028|FG002|Overall Study|Physician Decision|1|||
147490505|NCT01728584|531951029|FG003|Overall Study|Physician Decision|0|||
147490506|NCT01728584|531951026|FG000|Overall Study|Withdrawal by Subject|1|||
147490507|NCT01728584|531951027|FG001|Overall Study|Withdrawal by Subject|0|||
147490508|NCT01728584|531951028|FG002|Overall Study|Withdrawal by Subject|0|||
147490509|NCT01728584|531951029|FG003|Overall Study|Withdrawal by Subject|0|||
147490510|NCT01728584|531951026|FG000|Overall Study|Screen failure|1|||
147490511|NCT01728584|531951027|FG001|Overall Study|Screen failure|0|||
147490512|NCT01728584|531951028|FG002|Overall Study|Screen failure|0|||
147490513|NCT01728584|531951029|FG003|Overall Study|Screen failure|0|||
147490514|NCT01728584|531951026|FG000|Overall Study|Other reason (not specified)|1|||
147490515|NCT01728584|531951027|FG001|Overall Study|Other reason (not specified)|0|||
147490516|NCT01728584|531951028|FG002|Overall Study|Other reason (not specified)|0|||
147490517|NCT01728584|531951029|FG003|Overall Study|Other reason (not specified)|1|||
147490518|NCT02345252|531951033|FG000|Double-Blind Phase|Adverse Event|2|||
147490519|NCT02345252|531951034|FG001|Double-Blind Phase|Adverse Event|3|||
147490520|NCT02345252|531951033|FG000|Double-Blind Phase|Death|1|||
147490521|NCT02345252|531951034|FG001|Double-Blind Phase|Death|2|||
147490522|NCT02345252|531951033|FG000|Double-Blind Phase|Lack of Efficacy|1|||
147490523|NCT02345252|531951034|FG001|Double-Blind Phase|Lack of Efficacy|0|||
147490524|NCT02345252|531951033|FG000|Double-Blind Phase|Investigator's Discretion|4|||
147490525|NCT02345252|531951034|FG001|Double-Blind Phase|Investigator's Discretion|6|||
147490526|NCT02345252|531951033|FG000|Double-Blind Phase|Non-Compliance with Study Drug|1|||
147490527|NCT02345252|531951034|FG001|Double-Blind Phase|Non-Compliance with Study Drug|2|||
147490528|NCT02345252|531951033|FG000|Double-Blind Phase|Protocol Violation|2|||
147490529|NCT02345252|531951034|FG001|Double-Blind Phase|Protocol Violation|1|||
147490530|NCT02345252|531951033|FG000|Double-Blind Phase|Withdrew Consent|21|||
147490531|NCT02345252|531951034|FG001|Double-Blind Phase|Withdrew Consent|23|||
147490532|NCT02345252|531951033|FG000|Double-Blind Phase|Lost to Follow-up|8|||
147490533|NCT02345252|531951034|FG001|Double-Blind Phase|Lost to Follow-up|10|||
147490534|NCT02345252|531951033|FG000|Double-Blind Phase|Randomized but Never Treated|0|||
147624270|NCT03334435|532441745|FG013|Treatment Period 2: Week 52 to Week 200|Adverse Event|11|||
147624271|NCT03334435|532441746|FG014|Treatment Period 2: Week 52 to Week 200|Adverse Event|13|||
147624272|NCT03334435|532441732|FG000|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
147624273|NCT03334435|532441733|FG001|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
147624274|NCT03334435|532441734|FG002|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
147490535|NCT02345252|531951034|FG001|Double-Blind Phase|Randomized but Never Treated|2|||
147490536|NCT00995345|531951035|FG000|Overall Study|Withdrawal by Subject|4|||
147490537|NCT00995345|531951036|FG001|Overall Study|Withdrawal by Subject|2|||
147490538|NCT00995345|531951037|FG002|Overall Study|Withdrawal by Subject|1|||
147490539|NCT00995345|531951038|FG003|Overall Study|Withdrawal by Subject|3|||
147490540|NCT00995345|531951039|FG004|Overall Study|Withdrawal by Subject|1|||
147490541|NCT00995345|531951035|FG000|Overall Study|Adverse Event|3|||
147490542|NCT00995345|531951036|FG001|Overall Study|Adverse Event|1|||
147490543|NCT00995345|531951037|FG002|Overall Study|Adverse Event|2|||
147490544|NCT00995345|531951038|FG003|Overall Study|Adverse Event|0|||
147490545|NCT00995345|531951039|FG004|Overall Study|Adverse Event|1|||
147624275|NCT03334435|532441735|FG003|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
147624276|NCT03334435|532441736|FG004|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
147624277|NCT03334435|532441737|FG005|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
147624278|NCT03334435|532441738|FG006|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|2|||
147624279|NCT03334435|532441739|FG007|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|2|||
147624280|NCT03334435|532441740|FG008|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|3|||
147624281|NCT03334435|532441741|FG009|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|1|||
147624282|NCT03334435|532441742|FG010|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|1|||
147624283|NCT03334435|532441743|FG011|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|1|||
147624284|NCT03334435|532441744|FG012|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|0|||
147624285|NCT03334435|532441745|FG013|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|4|||
147624286|NCT03334435|532441746|FG014|Treatment Period 2: Week 52 to Week 200|Lost to Follow-up|4|||
147624287|NCT03334435|532441732|FG000|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
147624288|NCT03334435|532441733|FG001|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
147624289|NCT03334435|532441734|FG002|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
147624290|NCT03334435|532441735|FG003|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
147624291|NCT03334435|532441736|FG004|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
147624292|NCT03334435|532441737|FG005|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
147624293|NCT03334435|532441738|FG006|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
147624294|NCT03334435|532441739|FG007|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
147624295|NCT03334435|532441740|FG008|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
147624296|NCT03334435|532441741|FG009|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
147624297|NCT03334435|532441742|FG010|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
147624298|NCT03334435|532441743|FG011|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|1|||
147624299|NCT03334435|532441744|FG012|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
147624300|NCT03334435|532441745|FG013|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|1|||
147624301|NCT03334435|532441746|FG014|Treatment Period 2: Week 52 to Week 200|Withdrawal due to Caregiver Circumstances|0|||
147624302|NCT03334435|532441732|FG000|Treatment Period 2: Week 52 to Week 200|Death|0|||
147624303|NCT03334435|532441733|FG001|Treatment Period 2: Week 52 to Week 200|Death|0|||
147624304|NCT03334435|532441734|FG002|Treatment Period 2: Week 52 to Week 200|Death|0|||
147624305|NCT03334435|532441735|FG003|Treatment Period 2: Week 52 to Week 200|Death|0|||
147624306|NCT03334435|532441736|FG004|Treatment Period 2: Week 52 to Week 200|Death|0|||
147624307|NCT03334435|532441737|FG005|Treatment Period 2: Week 52 to Week 200|Death|1|||
147624308|NCT03334435|532441738|FG006|Treatment Period 2: Week 52 to Week 200|Death|0|||
147624309|NCT03334435|532441739|FG007|Treatment Period 2: Week 52 to Week 200|Death|0|||
147624310|NCT03334435|532441740|FG008|Treatment Period 2: Week 52 to Week 200|Death|0|||
147624311|NCT03334435|532441741|FG009|Treatment Period 2: Week 52 to Week 200|Death|0|||
147624312|NCT03334435|532441742|FG010|Treatment Period 2: Week 52 to Week 200|Death|0|||
147624313|NCT03334435|532441743|FG011|Treatment Period 2: Week 52 to Week 200|Death|0|||
147624314|NCT03334435|532441744|FG012|Treatment Period 2: Week 52 to Week 200|Death|0|||
147624315|NCT03334435|532441745|FG013|Treatment Period 2: Week 52 to Week 200|Death|0|||
147624316|NCT03334435|532441746|FG014|Treatment Period 2: Week 52 to Week 200|Death|1|||
147624317|NCT03334435|532441732|FG000|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
147624318|NCT03334435|532441733|FG001|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
147624319|NCT03334435|532441734|FG002|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
147624320|NCT03334435|532441735|FG003|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
147624321|NCT03334435|532441736|FG004|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
147624322|NCT03334435|532441737|FG005|Treatment Period 2: Week 52 to Week 200|Physician is retiring|1|||
147624323|NCT03334435|532441738|FG006|Treatment Period 2: Week 52 to Week 200|Physician is retiring|1|||
147624324|NCT03334435|532441739|FG007|Treatment Period 2: Week 52 to Week 200|Physician is retiring|1|||
147624325|NCT03334435|532441740|FG008|Treatment Period 2: Week 52 to Week 200|Physician is retiring|1|||
147624326|NCT03334435|532441741|FG009|Treatment Period 2: Week 52 to Week 200|Physician is retiring|3|||
147624327|NCT03334435|532441742|FG010|Treatment Period 2: Week 52 to Week 200|Physician is retiring|1|||
147624328|NCT03334435|532441743|FG011|Treatment Period 2: Week 52 to Week 200|Physician is retiring|1|||
147624329|NCT03334435|532441744|FG012|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
147624330|NCT03334435|532441745|FG013|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
147624331|NCT03334435|532441746|FG014|Treatment Period 2: Week 52 to Week 200|Physician is retiring|0|||
147624332|NCT03334435|532441732|FG000|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
147624333|NCT03334435|532441733|FG001|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
147624334|NCT03334435|532441734|FG002|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
147624335|NCT03334435|532441735|FG003|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
147624336|NCT03334435|532441736|FG004|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
147624337|NCT03334435|532441737|FG005|Treatment Period 2: Week 52 to Week 200|Protocol deviation|1|||
147624338|NCT03334435|532441738|FG006|Treatment Period 2: Week 52 to Week 200|Protocol deviation|1|||
147624339|NCT03334435|532441739|FG007|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
147624340|NCT03334435|532441740|FG008|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
147624341|NCT03334435|532441741|FG009|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
147624342|NCT03334435|532441742|FG010|Treatment Period 2: Week 52 to Week 200|Protocol deviation|0|||
147624343|NCT03334435|532441743|FG011|Treatment Period 2: Week 52 to Week 200|Protocol deviation|1|||
147624344|NCT03334435|532441744|FG012|Treatment Period 2: Week 52 to Week 200|Protocol deviation|1|||
147624345|NCT03334435|532441745|FG013|Treatment Period 2: Week 52 to Week 200|Protocol deviation|2|||
147624346|NCT03334435|532441746|FG014|Treatment Period 2: Week 52 to Week 200|Protocol deviation|2|||
147624347|NCT03334435|532441732|FG000|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
147624348|NCT03334435|532441733|FG001|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
147624349|NCT03334435|532441734|FG002|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
147624350|NCT03334435|532441735|FG003|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
147624351|NCT03334435|532441736|FG004|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
147624352|NCT03334435|532441737|FG005|Treatment Period 2: Week 52 to Week 200|Physician Decision|1|||
147624353|NCT03334435|532441738|FG006|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
147624354|NCT03334435|532441739|FG007|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
147624355|NCT03334435|532441740|FG008|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
147624356|NCT03334435|532441741|FG009|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
147624357|NCT03334435|532441742|FG010|Treatment Period 2: Week 52 to Week 200|Physician Decision|1|||
147624358|NCT03334435|532441743|FG011|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
147624359|NCT03334435|532441744|FG012|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
147624360|NCT03334435|532441745|FG013|Treatment Period 2: Week 52 to Week 200|Physician Decision|0|||
147624361|NCT03334435|532441746|FG014|Treatment Period 2: Week 52 to Week 200|Physician Decision|1|||
147624362|NCT03334435|532441732|FG000|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
147624363|NCT03334435|532441733|FG001|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
147624364|NCT03334435|532441734|FG002|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
147624365|NCT03334435|532441735|FG003|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
147624366|NCT03334435|532441736|FG004|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
147624367|NCT03334435|532441737|FG005|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
147624368|NCT03334435|532441738|FG006|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
147624369|NCT03334435|532441739|FG007|Treatment Period 2: Week 52 to Week 200|Sponsor decision|1|||
147624370|NCT03334435|532441740|FG008|Treatment Period 2: Week 52 to Week 200|Sponsor decision|1|||
147624371|NCT03334435|532441741|FG009|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
147624372|NCT03334435|532441742|FG010|Treatment Period 2: Week 52 to Week 200|Sponsor decision|1|||
147624373|NCT03334435|532441743|FG011|Treatment Period 2: Week 52 to Week 200|Sponsor decision|3|||
147624374|NCT03334435|532441744|FG012|Treatment Period 2: Week 52 to Week 200|Sponsor decision|1|||
147624375|NCT03334435|532441745|FG013|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
147624376|NCT03334435|532441746|FG014|Treatment Period 2: Week 52 to Week 200|Sponsor decision|0|||
147624377|NCT03334435|532441732|FG000|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
147624378|NCT03334435|532441733|FG001|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
147624379|NCT03334435|532441734|FG002|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
147624380|NCT03334435|532441735|FG003|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
147624381|NCT03334435|532441736|FG004|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
147624382|NCT03334435|532441737|FG005|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
147624383|NCT03334435|532441738|FG006|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
147624384|NCT03334435|532441739|FG007|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
147624385|NCT03334435|532441740|FG008|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
147624386|NCT03334435|532441741|FG009|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
147624387|NCT03334435|532441742|FG010|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
147624388|NCT03334435|532441743|FG011|Treatment Period 2: Week 52 to Week 200|Pregnancy|1|||
147624389|NCT03334435|532441744|FG012|Treatment Period 2: Week 52 to Week 200|Pregnancy|0|||
147624390|NCT03334435|532441745|FG013|Treatment Period 2: Week 52 to Week 200|Pregnancy|1|||
147667972|NCT00607893|532609815|FG000|Overall Study|withdrew could not tolerate CPAP|0|||
147667973|NCT00607893|532609816|FG001|Overall Study|withdrew could not tolerate CPAP|1|||
147667974|NCT00607893|532609815|FG000|Overall Study|Declined to be treated|1|||
147667975|NCT00607893|532609816|FG001|Overall Study|Declined to be treated|0|||
147667976|NCT00607893|532609815|FG000|Overall Study|Withdrew due to hypertensive urgency|1|||
147667977|NCT00607893|532609816|FG001|Overall Study|Withdrew due to hypertensive urgency|1|||
147667978|NCT01373164|532609817|FG000|Overall Study|Lost to Follow-up|0|||
147624391|NCT03334435|532441746|FG014|Treatment Period 2: Week 52 to Week 200|Pregnancy|1|||
147667979|NCT01373164|532609818|FG001|Overall Study|Lost to Follow-up|0|||
147667980|NCT01373164|532609819|FG002|Overall Study|Lost to Follow-up|1|||
147667981|NCT01373164|532609820|FG003|Overall Study|Lost to Follow-up|2|||
147624392|NCT03922321|532441747|FG000|Overall Study|Participant Moved|1|||
147624393|NCT03922321|532441747|FG000|Overall Study|Unable to Come to Site Due to COVID 19|1|||
147624394|NCT00495391|532441748|FG000|Overall Study|Lack of Efficacy|34|||
147624395|NCT00495391|532441749|FG001|Overall Study|Lack of Efficacy|18|||
147624396|NCT00495391|532441748|FG000|Overall Study|Withdrawal by Subject|2|||
147624397|NCT00495391|532441749|FG001|Overall Study|Withdrawal by Subject|3|||
147624398|NCT02712320|532441750|FG000|Overall Study|Lost to Follow-up|1|||
147624399|NCT02712320|532441750|FG000|Overall Study|Withdrawal by Subject|1|||
147624400|NCT02712320|532441750|FG000|Overall Study|Transferred to another facility|1|||
147624401|NCT02712320|532441750|FG000|Overall Study|Treating with the prohibited medications|2|||
147624402|NCT03313180|532441751|FG000|Overall Study|Adverse Event|120|||
147624403|NCT03313180|532441751|FG000|Overall Study|Lost to Follow-up|3|||
147624404|NCT03313180|532441751|FG000|Overall Study|Withdrawal by Subject|39|||
147624405|NCT03313180|532441751|FG000|Overall Study|Other than listed above|15|||
147624406|NCT03313180|532441751|FG000|Overall Study|Covid-19 related|2|||
147624407|NCT01697748|532441752|FG000|Overall Study|ineligible skin incision|1|||
147624408|NCT01697748|532441753|FG001|Overall Study|ineligible skin incision|2|||
147624409|NCT01697748|532441752|FG000|Overall Study|ineligible uterine incision|4|||
147624410|NCT01697748|532441753|FG001|Overall Study|ineligible uterine incision|1|||
147624411|NCT01697748|532441752|FG000|Overall Study|Lost to Follow-up|53|||
147624412|NCT01697748|532441753|FG001|Overall Study|Lost to Follow-up|65|||
147624413|NCT03376789|532441755|FG000|Overall Study|Withdrawal by Subject|3|||
147624414|NCT03376789|532441756|FG001|Overall Study|Withdrawal by Subject|5|||
147624415|NCT03376789|532441755|FG000|Overall Study|Protocol Violation|0|||
147624416|NCT03376789|532441756|FG001|Overall Study|Protocol Violation|1|||
147624417|NCT03376789|532441755|FG000|Overall Study|Adverse Event|0|||
147624418|NCT03376789|532441756|FG001|Overall Study|Adverse Event|1|||
147624419|NCT03376789|532441755|FG000|Overall Study|Lost to Follow-up|1|||
147624420|NCT03376789|532441756|FG001|Overall Study|Lost to Follow-up|1|||
147624421|NCT03376789|532441755|FG000|Overall Study|Per sponsor due to noncompliance|1|||
147624422|NCT03376789|532441756|FG001|Overall Study|Per sponsor due to noncompliance|0|||
147624423|NCT03376789|532441755|FG000|Overall Study|Subject off study medication|0|||
147624424|NCT03376789|532441756|FG001|Overall Study|Subject off study medication|1|||
147624425|NCT02025725|532441764|FG000|Overall Study|Adverse Event|5|||
147624426|NCT02025725|532441765|FG001|Overall Study|Adverse Event|0|||
147624427|NCT02025725|532441764|FG000|Overall Study|Lost to Follow-up|2|||
147624428|NCT02025725|532441765|FG001|Overall Study|Lost to Follow-up|0|||
147624429|NCT02025725|532441764|FG000|Overall Study|Protocol Violation|1|||
147624430|NCT02025725|532441765|FG001|Overall Study|Protocol Violation|1|||
147624431|NCT02025725|532441764|FG000|Overall Study|Withdrawal by Subject|3|||
147624432|NCT02025725|532441765|FG001|Overall Study|Withdrawal by Subject|2|||
147624433|NCT02025725|532441764|FG000|Overall Study|Post-dose QTcB > 270 msec|0|||
147624434|NCT02025725|532441765|FG001|Overall Study|Post-dose QTcB > 270 msec|1|||
147624435|NCT02946463|532441766|FG000|Primary Evaluation Period|Physician Decision|0|||
147624436|NCT02946463|532441767|FG001|Primary Evaluation Period|Physician Decision|1|||
147624437|NCT02946463|532441768|FG002|Primary Evaluation Period|Physician Decision|0|||
147624438|NCT02946463|532441769|FG003|Primary Evaluation Period|Physician Decision|0|||
147624439|NCT02946463|532441766|FG000|Primary Evaluation Period|Withdrawal by Subject|0|||
147624440|NCT02946463|532441767|FG001|Primary Evaluation Period|Withdrawal by Subject|1|||
147490546|NCT00995345|531951035|FG000|Overall Study|Lost to Follow-up|2|||
147490547|NCT00995345|531951036|FG001|Overall Study|Lost to Follow-up|2|||
147490548|NCT00995345|531951037|FG002|Overall Study|Lost to Follow-up|2|||
147490549|NCT00995345|531951038|FG003|Overall Study|Lost to Follow-up|1|||
147490550|NCT00995345|531951039|FG004|Overall Study|Lost to Follow-up|0|||
147490551|NCT00995345|531951035|FG000|Overall Study|all other reasons combined|2|||
147490552|NCT00995345|531951036|FG001|Overall Study|all other reasons combined|2|||
147490553|NCT00995345|531951037|FG002|Overall Study|all other reasons combined|2|||
147490554|NCT00995345|531951038|FG003|Overall Study|all other reasons combined|1|||
147490555|NCT00995345|531951039|FG004|Overall Study|all other reasons combined|3|||
147490556|NCT00471536|531951044|FG000|Overall Study|Withdrawal by Subject|1|||
147490557|NCT02651194|531951045|FG000|Overall Study|Lost to Follow-up|3|||
147624441|NCT02946463|532441768|FG002|Primary Evaluation Period|Withdrawal by Subject|0|||
147624442|NCT02946463|532441769|FG003|Primary Evaluation Period|Withdrawal by Subject|0|||
147624443|NCT02946463|532441766|FG000|Extension Period|Death|4|||
147624444|NCT02946463|532441767|FG001|Extension Period|Death|4|||
147624445|NCT02946463|532441768|FG002|Extension Period|Death|0|||
147624446|NCT02946463|532441769|FG003|Extension Period|Death|0|||
147624447|NCT02946463|532441766|FG000|Extension Period|Withdrawal by Subject|4|||
147490558|NCT02651194|531951045|FG000|Overall Study|Other|2|||
147624448|NCT02946463|532441767|FG001|Extension Period|Withdrawal by Subject|3|||
147624449|NCT02946463|532441768|FG002|Extension Period|Withdrawal by Subject|0|||
147624450|NCT02946463|532441769|FG003|Extension Period|Withdrawal by Subject|0|||
147624451|NCT02946463|532441766|FG000|Extension Period|Other than specified|2|||
147624452|NCT02946463|532441767|FG001|Extension Period|Other than specified|3|||
147624453|NCT02946463|532441768|FG002|Extension Period|Other than specified|2|||
147624454|NCT02946463|532441769|FG003|Extension Period|Other than specified|0|||
147624455|NCT02946463|532441766|FG000|Extension Period|Physician Decision|1|||
147624456|NCT02946463|532441767|FG001|Extension Period|Physician Decision|4|||
147624457|NCT02946463|532441768|FG002|Extension Period|Physician Decision|0|||
147624458|NCT02946463|532441769|FG003|Extension Period|Physician Decision|0|||
147624459|NCT02946463|532441766|FG000|Extension Period|Pregnancy|3|||
147624460|NCT02946463|532441767|FG001|Extension Period|Pregnancy|1|||
147624461|NCT02946463|532441768|FG002|Extension Period|Pregnancy|0|||
147624462|NCT02946463|532441769|FG003|Extension Period|Pregnancy|0|||
147624463|NCT02946463|532441766|FG000|Extension Period|Adverse Event|1|||
147624464|NCT02946463|532441767|FG001|Extension Period|Adverse Event|2|||
147624465|NCT02946463|532441768|FG002|Extension Period|Adverse Event|0|||
147624466|NCT02946463|532441769|FG003|Extension Period|Adverse Event|0|||
147624467|NCT02946463|532441766|FG000|Extension Period|Lost to Follow-up|1|||
147624468|NCT02946463|532441767|FG001|Extension Period|Lost to Follow-up|0|||
147624469|NCT02946463|532441768|FG002|Extension Period|Lost to Follow-up|0|||
147624470|NCT02946463|532441769|FG003|Extension Period|Lost to Follow-up|0|||
147624471|NCT05581641|532441770|FG000|Overall Study|Withdrawal by Subject|0|||
147624472|NCT05581641|532441771|FG001|Overall Study|Withdrawal by Subject|1|||
147624473|NCT05581641|532441772|FG002|Overall Study|Withdrawal by Subject|3|||
147624474|NCT05581641|532441773|FG003|Overall Study|Withdrawal by Subject|1|||
147624475|NCT05581641|532441770|FG000|Overall Study|Lost to Follow-up|0|||
147624476|NCT05581641|532441771|FG001|Overall Study|Lost to Follow-up|1|||
147624477|NCT05581641|532441772|FG002|Overall Study|Lost to Follow-up|0|||
147624478|NCT05581641|532441773|FG003|Overall Study|Lost to Follow-up|1|||
147624479|NCT05581641|532441770|FG000|Overall Study|Protocol Violation|1|||
147624480|NCT05581641|532441771|FG001|Overall Study|Protocol Violation|0|||
147624481|NCT05581641|532441772|FG002|Overall Study|Protocol Violation|0|||
147624482|NCT05581641|532441773|FG003|Overall Study|Protocol Violation|0|||
147624483|NCT05581641|532441770|FG000|Overall Study|Other|1|||
147624484|NCT05581641|532441771|FG001|Overall Study|Other|0|||
147624485|NCT05581641|532441772|FG002|Overall Study|Other|2|||
147624486|NCT05581641|532441773|FG003|Overall Study|Other|1|||
147624487|NCT01924689|532441774|FG000|Overall Study|Death|0|||
147624488|NCT01924689|532441775|FG001|Overall Study|Death|1|||
147624489|NCT01924689|532441776|FG002|Overall Study|Death|0|||
147624490|NCT01924689|532441777|FG003|Overall Study|Death|1|||
147624491|NCT01924689|532441778|FG004|Overall Study|Death|0|||
147624492|NCT01924689|532441779|FG005|Overall Study|Death|0|||
147624493|NCT01924689|532441774|FG000|Overall Study|Disease progression|0|||
147624494|NCT01924689|532441775|FG001|Overall Study|Disease progression|0|||
147624495|NCT01924689|532441776|FG002|Overall Study|Disease progression|2|||
147624496|NCT01924689|532441777|FG003|Overall Study|Disease progression|0|||
147624497|NCT01924689|532441778|FG004|Overall Study|Disease progression|3|||
147624498|NCT01924689|532441779|FG005|Overall Study|Disease progression|2|||
147624499|NCT01924689|532441774|FG000|Overall Study|New therapy or study|3|||
147624500|NCT01924689|532441775|FG001|Overall Study|New therapy or study|2|||
147624501|NCT01924689|532441776|FG002|Overall Study|New therapy or study|1|||
147624502|NCT01924689|532441777|FG003|Overall Study|New therapy or study|4|||
147624503|NCT01924689|532441778|FG004|Overall Study|New therapy or study|2|||
147624504|NCT01924689|532441779|FG005|Overall Study|New therapy or study|0|||
147624505|NCT01924689|532441774|FG000|Overall Study|Withdrawal of consent|0|||
147624506|NCT01924689|532441775|FG001|Overall Study|Withdrawal of consent|0|||
147624507|NCT01924689|532441776|FG002|Overall Study|Withdrawal of consent|1|||
147624508|NCT01924689|532441777|FG003|Overall Study|Withdrawal of consent|1|||
147624509|NCT01924689|532441778|FG004|Overall Study|Withdrawal of consent|0|||
147624510|NCT01924689|532441779|FG005|Overall Study|Withdrawal of consent|0|||
147624511|NCT01924689|532441774|FG000|Overall Study|Other|0|||
147624512|NCT01924689|532441775|FG001|Overall Study|Other|0|||
147624513|NCT01924689|532441776|FG002|Overall Study|Other|0|||
147624514|NCT01924689|532441777|FG003|Overall Study|Other|0|||
147624515|NCT01924689|532441778|FG004|Overall Study|Other|1|||
147624516|NCT01924689|532441779|FG005|Overall Study|Other|0|||
147624517|NCT00468819|532441780|FG000|Overall Study|Withdrawal by Subject|4|||
147624518|NCT00468819|532441781|FG001|Overall Study|Withdrawal by Subject|0|||
147624519|NCT00468819|532441782|FG002|Overall Study|Withdrawal by Subject|1|||
147624520|NCT00468819|532441780|FG000|Overall Study|Lost to Follow-up|0|||
147624521|NCT00468819|532441781|FG001|Overall Study|Lost to Follow-up|0|||
147624522|NCT00468819|532441782|FG002|Overall Study|Lost to Follow-up|1|||
147624523|NCT00468819|532441780|FG000|Overall Study|Drop-outs (Treatment never received)|2|||
147624524|NCT00468819|532441781|FG001|Overall Study|Drop-outs (Treatment never received)|0|||
147624525|NCT00468819|532441782|FG002|Overall Study|Drop-outs (Treatment never received)|0|||
147624526|NCT02492867|532441783|FG000|Overall Study|Alternate therapy|1|||
147624527|NCT02492867|532441783|FG000|Overall Study|Withdrawal by Subject|2|||
147624528|NCT02492867|532441783|FG000|Overall Study|Disease progression after treatment started|1|||
147624529|NCT02492867|532441783|FG000|Overall Study|Death|1|||
147624530|NCT00122382|532441786|FG000|Double-Blind Study|Adverse Event|9|||
147624531|NCT00122382|532441787|FG001|Double-Blind Study|Adverse Event|11|||
147624532|NCT00122382|532441788|FG002|Double-Blind Study|Adverse Event|0|||
147624533|NCT00122382|532441786|FG000|Double-Blind Study|Death|2|||
147624534|NCT00122382|532441787|FG001|Double-Blind Study|Death|2|||
147624535|NCT00122382|532441788|FG002|Double-Blind Study|Death|0|||
147624536|NCT00122382|532441786|FG000|Double-Blind Study|Lack of Efficacy|0|||
147624537|NCT00122382|532441787|FG001|Double-Blind Study|Lack of Efficacy|8|||
147624538|NCT00122382|532441788|FG002|Double-Blind Study|Lack of Efficacy|0|||
147624539|NCT00122382|532441786|FG000|Double-Blind Study|Lost to Follow-up|2|||
147624540|NCT00122382|532441787|FG001|Double-Blind Study|Lost to Follow-up|1|||
147624541|NCT00122382|532441788|FG002|Double-Blind Study|Lost to Follow-up|0|||
147624542|NCT00122382|532441786|FG000|Double-Blind Study|Pregnancy|2|||
147624543|NCT00122382|532441787|FG001|Double-Blind Study|Pregnancy|0|||
147624544|NCT00122382|532441788|FG002|Double-Blind Study|Pregnancy|0|||
147624545|NCT00122382|532441786|FG000|Double-Blind Study|Subject No Longer Meets Study Criteria|1|||
147624546|NCT00122382|532441787|FG001|Double-Blind Study|Subject No Longer Meets Study Criteria|0|||
147624547|NCT00122382|532441788|FG002|Double-Blind Study|Subject No Longer Meets Study Criteria|0|||
147624548|NCT00122382|532441786|FG000|Double-Blind Study|Withdrawal of Consent|7|||
147624549|NCT00122382|532441787|FG001|Double-Blind Study|Withdrawal of Consent|3|||
147624550|NCT00122382|532441788|FG002|Double-Blind Study|Withdrawal of Consent|0|||
147624551|NCT00122382|532441786|FG000|Double-Blind Study|Protocol Violation|1|||
147624552|NCT00122382|532441787|FG001|Double-Blind Study|Protocol Violation|0|||
147624553|NCT00122382|532441788|FG002|Double-Blind Study|Protocol Violation|0|||
147624554|NCT00122382|532441786|FG000|Double-Blind Study|Methotrexate Discontinued|0|||
147624555|NCT00122382|532441787|FG001|Double-Blind Study|Methotrexate Discontinued|1|||
147624556|NCT00122382|532441788|FG002|Double-Blind Study|Methotrexate Discontinued|0|||
147624557|NCT00122382|532441786|FG000|Double-Blind Study|Randomized but not treated|0|||
147624558|NCT00122382|532441787|FG001|Double-Blind Study|Randomized but not treated|2|||
147624559|NCT00122382|532441788|FG002|Double-Blind Study|Randomized but not treated|0|||
147624560|NCT00122382|532441786|FG000|Open-Label Study|Adverse Event|0|||
147624561|NCT00122382|532441787|FG001|Open-Label Study|Adverse Event|0|||
147624562|NCT00122382|532441788|FG002|Open-Label Study|Adverse Event|11|||
147624563|NCT00122382|532441786|FG000|Open-Label Study|Death|0|||
147624564|NCT00122382|532441787|FG001|Open-Label Study|Death|0|||
147624565|NCT00122382|532441788|FG002|Open-Label Study|Death|2|||
147624566|NCT00122382|532441786|FG000|Open-Label Study|Lack of Efficacy|0|||
147624567|NCT00122382|532441787|FG001|Open-Label Study|Lack of Efficacy|0|||
147624568|NCT00122382|532441788|FG002|Open-Label Study|Lack of Efficacy|3|||
147624569|NCT00122382|532441786|FG000|Open-Label Study|Lost to Follow-up|0|||
147624570|NCT00122382|532441787|FG001|Open-Label Study|Lost to Follow-up|0|||
147624571|NCT00122382|532441788|FG002|Open-Label Study|Lost to Follow-up|3|||
147624572|NCT00122382|532441786|FG000|Open-Label Study|Pregnancy|0|||
147624573|NCT00122382|532441787|FG001|Open-Label Study|Pregnancy|0|||
147624574|NCT00122382|532441788|FG002|Open-Label Study|Pregnancy|2|||
147624575|NCT00122382|532441786|FG000|Open-Label Study|Poor/Non-Compliance|0|||
147624576|NCT00122382|532441787|FG001|Open-Label Study|Poor/Non-Compliance|0|||
147624577|NCT00122382|532441788|FG002|Open-Label Study|Poor/Non-Compliance|1|||
147624578|NCT00122382|532441786|FG000|Open-Label Study|Withdrawal of Consent|0|||
147624579|NCT00122382|532441787|FG001|Open-Label Study|Withdrawal of Consent|0|||
147624580|NCT00122382|532441788|FG002|Open-Label Study|Withdrawal of Consent|4|||
147624581|NCT01591096|532441789|FG000|Overall Study|Adverse Event|1|||
147624582|NCT01831635|532441790|FG000|Overall Study|Withdrawal by Subject|0|||
147624583|NCT01831635|532441791|FG001|Overall Study|Withdrawal by Subject|2|||
147624584|NCT01831635|532441792|FG002|Overall Study|Withdrawal by Subject|0|||
147624585|NCT05966584|532441795|FG000|Overall Study|Lost to Follow-up|1|||
147624586|NCT05086744|532443342|FG000|Part A|Adverse Event|0|||
147624587|NCT05086744|532443343|FG001|Part A|Adverse Event|1|||
147624588|NCT05086744|532443342|FG000|Part A|Lack of Efficacy|3|||
147624589|NCT05086744|532443343|FG001|Part A|Lack of Efficacy|0|||
147624590|NCT05086744|532443342|FG000|Part A|Protocol deviation|1|||
147624591|NCT05086744|532443343|FG001|Part A|Protocol deviation|0|||
147624592|NCT05086744|532443342|FG000|Part A|Subject decision|1|||
147624593|NCT05086744|532443343|FG001|Part A|Subject decision|0|||
147624594|NCT05086744|532443342|FG000|Part B|Adverse Event|0|||
147624595|NCT05086744|532443343|FG001|Part B|Adverse Event|1|||
147624596|NCT05086744|532443342|FG000|Part B|Lack of Efficacy|0|||
147490559|NCT01980706|531951048|FG000|Overall Study|Withdrawal by Subject|9|||
147624597|NCT05086744|532443343|FG001|Part B|Lack of Efficacy|1|||
147667982|NCT01373164|532609821|FG004|Overall Study|Lost to Follow-up|0|||
147490560|NCT01980706|531951049|FG001|Overall Study|Withdrawal by Subject|6|||
147490561|NCT01980706|531951050|FG002|Overall Study|Withdrawal by Subject|2|||
147624598|NCT05086744|532443342|FG000|Part B|Study terminated by sponsor|1|||
147624599|NCT05086744|532443343|FG001|Part B|Study terminated by sponsor|6|||
147624600|NCT01120184|532443352|FG000|Overall Study|Adverse Event|0|||
147624601|NCT01120184|532443353|FG001|Overall Study|Adverse Event|1|||
147624602|NCT01120184|532443354|FG002|Overall Study|Adverse Event|0|||
147624603|NCT01120184|532443352|FG000|Overall Study|Lost to Follow-up|13|||
147624604|NCT01120184|532443353|FG001|Overall Study|Lost to Follow-up|13|||
147624605|NCT01120184|532443354|FG002|Overall Study|Lost to Follow-up|11|||
147624606|NCT01120184|532443352|FG000|Overall Study|Physician Decision|9|||
147624607|NCT01120184|532443353|FG001|Overall Study|Physician Decision|1|||
147624608|NCT01120184|532443354|FG002|Overall Study|Physician Decision|3|||
147624609|NCT01120184|532443352|FG000|Overall Study|Reason not Specified|8|||
147624610|NCT01120184|532443353|FG001|Overall Study|Reason not Specified|3|||
147624611|NCT01120184|532443354|FG002|Overall Study|Reason not Specified|12|||
147624612|NCT01120184|532443352|FG000|Overall Study|Sponsor Decision to Terminate Study|133|||
147624613|NCT01120184|532443353|FG001|Overall Study|Sponsor Decision to Terminate Study|144|||
147624614|NCT01120184|532443354|FG002|Overall Study|Sponsor Decision to Terminate Study|143|||
147624615|NCT01120184|532443352|FG000|Overall Study|Subject/ Guardian Decision to Withdraw|32|||
147624616|NCT01120184|532443353|FG001|Overall Study|Subject/ Guardian Decision to Withdraw|29|||
147624617|NCT01120184|532443354|FG002|Overall Study|Subject/ Guardian Decision to Withdraw|25|||
147624618|NCT01120184|532443352|FG000|Overall Study|Death|170|||
147624619|NCT01120184|532443353|FG001|Overall Study|Death|176|||
147624620|NCT01120184|532443354|FG002|Overall Study|Death|169|||
147624621|NCT00536939|532443356|FG000|Overall Study|Withdrawal by Subject|1|||
147624622|NCT00536939|532443357|FG001|Overall Study|Withdrawal by Subject|0|||
147624623|NCT00536939|532443356|FG000|Overall Study|Other Complicating Disease|1|||
147624624|NCT00536939|532443357|FG001|Overall Study|Other Complicating Disease|0|||
147624625|NCT01894841|532443358|FG000|Overall Study|Withdrawal by Subject|9|||
147624626|NCT01894841|532443359|FG001|Overall Study|Withdrawal by Subject|4|||
147624627|NCT01894841|532443358|FG000|Overall Study|Withdrawn by investigator|2|||
147624628|NCT01894841|532443359|FG001|Overall Study|Withdrawn by investigator|2|||
147624629|NCT01894841|532443358|FG000|Overall Study|Lost to Follow-up|7|||
147624630|NCT01894841|532443359|FG001|Overall Study|Lost to Follow-up|3|||
147624631|NCT04227197|532443367|FG000|Randomization|Protocol Violation|1|||
147624632|NCT04227197|532443368|FG001|Randomization|Protocol Violation|0|||
147624633|NCT04227197|532443367|FG000|Randomization|Discontinued participation because uncomfortable sharing information|1|||
147624634|NCT04227197|532443368|FG001|Randomization|Discontinued participation because uncomfortable sharing information|0|||
147624635|NCT04227197|532443367|FG000|Primary Care Provider (PCP) Visit|Did not complete PCP visit|2|||
147624636|NCT04227197|532443368|FG001|Primary Care Provider (PCP) Visit|Did not complete PCP visit|0|||
147624637|NCT04227197|532443367|FG000|2-week Follow-up Survey for Caregivers|Not responsive|7|||
147624638|NCT04227197|532443368|FG001|2-week Follow-up Survey for Caregivers|Not responsive|5|||
147624639|NCT04227197|532443367|FG000|2-week Follow-up Survey for Caregivers|Lost to Follow-up|5|||
147624640|NCT04227197|532443368|FG001|2-week Follow-up Survey for Caregivers|Lost to Follow-up|0|||
147624641|NCT04227197|532443367|FG000|2-week Follow-up Survey for PCP's|Not responsive|20|||
147624642|NCT04227197|532443368|FG001|2-week Follow-up Survey for PCP's|Not responsive|25|||
147624643|NCT04227197|532443367|FG000|7-month Follow-up Survey for Caregivers|Lost to Follow-up|11|||
147624644|NCT04227197|532443368|FG001|7-month Follow-up Survey for Caregivers|Lost to Follow-up|3|||
147624645|NCT01379768|532443371|FG000|Overall Study|Adverse Event|1|||
147624646|NCT01379768|532443372|FG001|Overall Study|Adverse Event|1|||
147624647|NCT01379768|532443373|FG002|Overall Study|Adverse Event|0|||
147624648|NCT01379768|532443371|FG000|Overall Study|Lost to Follow-up|2|||
147624649|NCT01379768|532443372|FG001|Overall Study|Lost to Follow-up|0|||
147624650|NCT01379768|532443373|FG002|Overall Study|Lost to Follow-up|0|||
147624651|NCT01209949|532443381|FG000|Overall Study|Lost to Follow-up|3|||
147624652|NCT02075203|532443386|FG000|Overall Study|Withdrawal by Subject|1|||
147624653|NCT02075203|532443387|FG001|Overall Study|Withdrawal by Subject|0|||
147624654|NCT02075203|532443388|FG002|Overall Study|Withdrawal by Subject|1|||
147624655|NCT02075203|532443386|FG000|Overall Study|Adverse Event|1|||
147624656|NCT02075203|532443387|FG001|Overall Study|Adverse Event|0|||
147624657|NCT02075203|532443388|FG002|Overall Study|Adverse Event|0|||
147624658|NCT02075203|532443386|FG000|Overall Study|participant refused to use contraception|1|||
147624659|NCT02075203|532443387|FG001|Overall Study|participant refused to use contraception|0|||
147624660|NCT02075203|532443388|FG002|Overall Study|participant refused to use contraception|0|||
147624661|NCT00568451|532443397|FG000|Overall Study|Disease Progression|0|||
147667983|NCT01373164|532609817|FG000|Overall Study|Withdrawal by Subject|0|||
147667984|NCT01373164|532609818|FG001|Overall Study|Withdrawal by Subject|1|||
147667985|NCT01373164|532609819|FG002|Overall Study|Withdrawal by Subject|0|||
147490562|NCT01980706|531951048|FG000|Overall Study|Adverse Event|1|||
147490563|NCT01980706|531951049|FG001|Overall Study|Adverse Event|2|||
147490564|NCT01980706|531951050|FG002|Overall Study|Adverse Event|5|||
147490565|NCT01980706|531951048|FG000|Overall Study|Lost to Follow-up|3|||
147490566|NCT01980706|531951049|FG001|Overall Study|Lost to Follow-up|4|||
147490567|NCT01980706|531951050|FG002|Overall Study|Lost to Follow-up|3|||
147490568|NCT01980706|531951048|FG000|Overall Study|miscellaneous|4|||
147490569|NCT01980706|531951049|FG001|Overall Study|miscellaneous|5|||
147490570|NCT01980706|531951050|FG002|Overall Study|miscellaneous|3|||
147490571|NCT02546674|531951051|FG000|Overall Study|Adverse Event|19|||
147490572|NCT02546674|531951051|FG000|Overall Study|Death|1|||
147490573|NCT02546674|531951051|FG000|Overall Study|Lost to Follow-up|1|||
147624662|NCT00568451|532443398|FG001|Overall Study|Disease Progression|0|||
147490574|NCT02546674|531951051|FG000|Overall Study|Physician Decision|13|||
147624663|NCT00568451|532443399|FG002|Overall Study|Disease Progression|2|||
147624664|NCT00568451|532443400|FG003|Overall Study|Disease Progression|7|||
147624665|NCT05266053|532443401|FG000|Overall Study|Withdrawal by Subject|8|||
147624666|NCT05266053|532443402|FG001|Overall Study|Withdrawal by Subject|4|||
147624667|NCT05344560|532443403|FG000|Period 1|Subject out of visit window|1|||
147624668|NCT05344560|532443404|FG001|Period 1|Subject out of visit window|1|||
147624669|NCT05344560|532443403|FG000|Period 2|Covid-19 Related|1|||
147490575|NCT02546674|531951051|FG000|Overall Study|Pregnancy|1|||
147490576|NCT02546674|531951051|FG000|Overall Study|Progressive Disease|2|||
147490577|NCT02546674|531951051|FG000|Overall Study|Protocol Deviation|2|||
147490578|NCT02546674|531951051|FG000|Overall Study|Subject/Guardian Decision|6|||
147490579|NCT02546674|531951051|FG000|Overall Study|Withdrawal of Informed Consent|3|||
147490580|NCT01864018|531951055|FG000|Overall Study|Ineligible|3|||
147490581|NCT01864018|531951056|FG001|Overall Study|Ineligible|1|||
147490582|NCT05122650|531951058|FG000|Overall Study|Adverse Event|4|||
147490583|NCT05122650|531951059|FG001|Overall Study|Adverse Event|16|||
147490584|NCT05122650|531951060|FG002|Overall Study|Adverse Event|11|||
147490585|NCT05122650|531951061|FG003|Overall Study|Adverse Event|12|||
147490586|NCT05122650|531951058|FG000|Overall Study|Lack of Efficacy|0|||
147490587|NCT05122650|531951059|FG001|Overall Study|Lack of Efficacy|1|||
147490588|NCT05122650|531951060|FG002|Overall Study|Lack of Efficacy|1|||
147490589|NCT05122650|531951061|FG003|Overall Study|Lack of Efficacy|2|||
147490590|NCT05122650|531951058|FG000|Overall Study|Lost to Follow-up|1|||
147490591|NCT05122650|531951059|FG001|Overall Study|Lost to Follow-up|1|||
147490592|NCT05122650|531951060|FG002|Overall Study|Lost to Follow-up|3|||
147490593|NCT05122650|531951061|FG003|Overall Study|Lost to Follow-up|0|||
147490594|NCT05122650|531951058|FG000|Overall Study|Non-compliance with study intervention|0|||
147490595|NCT05122650|531951059|FG001|Overall Study|Non-compliance with study intervention|0|||
147490596|NCT05122650|531951060|FG002|Overall Study|Non-compliance with study intervention|0|||
147490597|NCT05122650|531951061|FG003|Overall Study|Non-compliance with study intervention|2|||
147490598|NCT05122650|531951058|FG000|Overall Study|Protocol Violation|0|||
147490599|NCT05122650|531951059|FG001|Overall Study|Protocol Violation|1|||
147490600|NCT05122650|531951060|FG002|Overall Study|Protocol Violation|0|||
147490601|NCT05122650|531951061|FG003|Overall Study|Protocol Violation|1|||
147490602|NCT05122650|531951058|FG000|Overall Study|Randomized by mistake|0|||
147490603|NCT05122650|531951059|FG001|Overall Study|Randomized by mistake|0|||
147490604|NCT05122650|531951060|FG002|Overall Study|Randomized by mistake|3|||
147490605|NCT05122650|531951061|FG003|Overall Study|Randomized by mistake|2|||
147490606|NCT05122650|531951058|FG000|Overall Study|Sponsor request|0|||
147490607|NCT05122650|531951059|FG001|Overall Study|Sponsor request|1|||
147490608|NCT05122650|531951060|FG002|Overall Study|Sponsor request|1|||
147490609|NCT05122650|531951061|FG003|Overall Study|Sponsor request|2|||
147490610|NCT05122650|531951058|FG000|Overall Study|Withdrawal by Subject|3|||
147490611|NCT05122650|531951059|FG001|Overall Study|Withdrawal by Subject|7|||
147490612|NCT05122650|531951060|FG002|Overall Study|Withdrawal by Subject|4|||
147490613|NCT05122650|531951061|FG003|Overall Study|Withdrawal by Subject|8|||
147490614|NCT05122650|531951058|FG000|Overall Study|Other|5|||
147490615|NCT05122650|531951059|FG001|Overall Study|Other|0|||
147490616|NCT05122650|531951060|FG002|Overall Study|Other|0|||
147490617|NCT05122650|531951061|FG003|Overall Study|Other|0|||
147490618|NCT01401010|531951065|FG000|Overall Study|Could not interpret assay results|1|||
147490619|NCT01401010|531951066|FG001|Overall Study|Could not interpret assay results|0|||
147490620|NCT03255291|531951069|FG000|Overall Study|Determined to be ineligible|10|||
147490621|NCT03255291|531951070|FG001|Overall Study|Determined to be ineligible|12|||
147490622|NCT03255291|531951071|FG002|Overall Study|Determined to be ineligible|6|||
147490623|NCT03255291|531951072|FG003|Overall Study|Determined to be ineligible|6|||
147490624|NCT03255291|531951073|FG004|Overall Study|Determined to be ineligible|5|||
147490625|NCT03255291|531951074|FG005|Overall Study|Determined to be ineligible|10|||
147490626|NCT03255291|531951069|FG000|Overall Study|Baseline data collection issues|3|||
147490627|NCT03255291|531951070|FG001|Overall Study|Baseline data collection issues|0|||
147490628|NCT03255291|531951071|FG002|Overall Study|Baseline data collection issues|0|||
147490629|NCT03255291|531951072|FG003|Overall Study|Baseline data collection issues|0|||
147490630|NCT03255291|531951073|FG004|Overall Study|Baseline data collection issues|2|||
147490631|NCT03255291|531951074|FG005|Overall Study|Baseline data collection issues|0|||
147490632|NCT00634244|531951075|FG000|Overall Study|Never started treatment|0|||
147490633|NCT00634244|531951076|FG001|Overall Study|Never started treatment|1|||
147490634|NCT00634244|531951077|FG002|Overall Study|Never started treatment|0|||
147624670|NCT05344560|532443404|FG001|Period 2|Covid-19 Related|0|||
147624671|NCT05344560|532443403|FG000|Period 2|Adverse Event|1|||
147624672|NCT05344560|532443404|FG001|Period 2|Adverse Event|0|||
147624673|NCT05344560|532443403|FG000|Period 2|Subject out of visit window|1|||
147624674|NCT05344560|532443404|FG001|Period 2|Subject out of visit window|1|||
147490635|NCT00634244|531951075|FG000|Overall Study|Death|1|||
147490636|NCT00634244|531951076|FG001|Overall Study|Death|6|||
147490637|NCT00634244|531951077|FG002|Overall Study|Death|0|||
147490638|NCT00634244|531951075|FG000|Overall Study|Adverse Event|0|||
147490639|NCT00634244|531951076|FG001|Overall Study|Adverse Event|2|||
147490640|NCT00634244|531951077|FG002|Overall Study|Adverse Event|0|||
147490641|NCT00634244|531951075|FG000|Overall Study|Withdrawal by Subject|0|||
147490642|NCT00634244|531951076|FG001|Overall Study|Withdrawal by Subject|1|||
147624675|NCT05344560|532443403|FG000|Period 3|Subject out of visit window|1|||
147490643|NCT00634244|531951077|FG002|Overall Study|Withdrawal by Subject|0|||
147490644|NCT00634244|531951075|FG000|Overall Study|Physician Decision|0|||
147624676|NCT05344560|532443404|FG001|Period 3|Subject out of visit window|0|||
147624677|NCT02996968|532443405|FG000|Overall Study|Withdrawal by Subject|1|||
147624678|NCT02996968|532443406|FG001|Overall Study|Withdrawal by Subject|0|||
147624679|NCT00391768|532443407|FG000|Overall Study|Withdrawal by Subject|0|||
147624680|NCT00391768|532443408|FG001|Overall Study|Withdrawal by Subject|0|||
147624681|NCT00391768|532443409|FG002|Overall Study|Withdrawal by Subject|1|||
147624682|NCT00391768|532443410|FG003|Overall Study|Withdrawal by Subject|0|||
147624683|NCT00391768|532443411|FG004|Overall Study|Withdrawal by Subject|0|||
147624684|NCT00391768|532443412|FG005|Overall Study|Withdrawal by Subject|1|||
147624685|NCT00391768|532443413|FG006|Overall Study|Withdrawal by Subject|1|||
147624686|NCT00391768|532443407|FG000|Overall Study|Lost to Follow-up|0|||
147624687|NCT00391768|532443408|FG001|Overall Study|Lost to Follow-up|0|||
147624688|NCT00391768|532443409|FG002|Overall Study|Lost to Follow-up|0|||
147624689|NCT00391768|532443410|FG003|Overall Study|Lost to Follow-up|1|||
147624690|NCT00391768|532443411|FG004|Overall Study|Lost to Follow-up|2|||
147624691|NCT00391768|532443412|FG005|Overall Study|Lost to Follow-up|2|||
147624692|NCT00391768|532443413|FG006|Overall Study|Lost to Follow-up|3|||
147624693|NCT01620138|532443414|FG000|Overall Study|Withdrawal by Subject|3|||
147624694|NCT01620138|532443415|FG001|Overall Study|Withdrawal by Subject|0|||
147624695|NCT01620138|532443414|FG000|Overall Study|Lack of Efficacy|1|||
147624696|NCT01620138|532443415|FG001|Overall Study|Lack of Efficacy|0|||
147624697|NCT01620138|532443414|FG000|Overall Study|Adverse Event|2|||
147624698|NCT01620138|532443415|FG001|Overall Study|Adverse Event|0|||
147624699|NCT05005507|532443416|FG000|Overall Study|Premature termination of study|1|||
147624700|NCT02556775|532443418|FG000|Overall Study|Withdrawal by Subject|1|||
147624701|NCT02556775|532443419|FG001|Overall Study|Withdrawal by Subject|0|||
147624702|NCT02556775|532443420|FG002|Overall Study|Withdrawal by Subject|1|||
147624703|NCT02556775|532443421|FG003|Overall Study|Withdrawal by Subject|0|||
147624704|NCT02556775|532443418|FG000|Overall Study|Lost to Follow-up|1|||
147624705|NCT02556775|532443419|FG001|Overall Study|Lost to Follow-up|0|||
147624706|NCT02556775|532443420|FG002|Overall Study|Lost to Follow-up|0|||
147624707|NCT02556775|532443421|FG003|Overall Study|Lost to Follow-up|0|||
147624708|NCT02792062|532443424|FG000|Washout Period (at Least 14 Days)|Voluntary Withdrawal|1|||
147624709|NCT02792062|532443425|FG001|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0|||
147624710|NCT02792062|532443426|FG002|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0|||
147624711|NCT02792062|532443427|FG003|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0|||
147624712|NCT02792062|532443428|FG004|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0|||
147624713|NCT02792062|532443429|FG005|Washout Period (at Least 14 Days)|Voluntary Withdrawal|0|||
147624714|NCT01565889|532443434|FG000|Part A|Withdrawal by Subject|1|||
147624715|NCT01565889|532443435|FG001|Part A|Withdrawal by Subject|0|||
147624716|NCT01565889|532443436|FG002|Part A|Withdrawal by Subject|0|||
147624717|NCT01565889|532443437|FG003|Part A|Withdrawal by Subject|0|||
147624718|NCT01565889|532443438|FG004|Part A|Withdrawal by Subject|0|||
147624719|NCT01565889|532443439|FG005|Part A|Withdrawal by Subject|0|||
147624720|NCT01565889|532443434|FG000|Part B|Withdrawal by Subject|0|||
147624721|NCT01565889|532443435|FG001|Part B|Withdrawal by Subject|0|||
147624722|NCT01565889|532443436|FG002|Part B|Withdrawal by Subject|0|||
147624723|NCT01565889|532443437|FG003|Part B|Withdrawal by Subject|0|||
147624724|NCT01565889|532443438|FG004|Part B|Withdrawal by Subject|0|||
147624725|NCT01565889|532443439|FG005|Part B|Withdrawal by Subject|1|||
147624726|NCT01565889|532443434|FG000|Part B|Lack of Efficacy|0|||
147490645|NCT00634244|531951076|FG001|Overall Study|Physician Decision|1|||
147490646|NCT00634244|531951077|FG002|Overall Study|Physician Decision|0|||
147490647|NCT00634244|531951075|FG000|Overall Study|Disease progression/relapse|0|||
147490648|NCT00634244|531951076|FG001|Overall Study|Disease progression/relapse|1|||
147490649|NCT00634244|531951077|FG002|Overall Study|Disease progression/relapse|0|||
147624727|NCT01565889|532443435|FG001|Part B|Lack of Efficacy|0|||
147624728|NCT01565889|532443436|FG002|Part B|Lack of Efficacy|0|||
147624729|NCT01565889|532443437|FG003|Part B|Lack of Efficacy|0|||
147624730|NCT01565889|532443438|FG004|Part B|Lack of Efficacy|0|||
147624731|NCT01565889|532443439|FG005|Part B|Lack of Efficacy|2|||
147624732|NCT01565889|532443434|FG000|Part B|Lost to Follow-up|0|||
147624733|NCT01565889|532443435|FG001|Part B|Lost to Follow-up|0|||
147624734|NCT01565889|532443436|FG002|Part B|Lost to Follow-up|0|||
147624735|NCT01565889|532443437|FG003|Part B|Lost to Follow-up|0|||
147490650|NCT00634244|531951075|FG000|Overall Study|Other complicating disease|0|||
147490651|NCT00634244|531951076|FG001|Overall Study|Other complicating disease|1|||
147624736|NCT01565889|532443438|FG004|Part B|Lost to Follow-up|0|||
147624737|NCT01565889|532443439|FG005|Part B|Lost to Follow-up|1|||
147624738|NCT02166333|532443440|FG000|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|4|||
147624739|NCT02166333|532443441|FG001|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|0|||
147644028|NCT00738062|532516704|FG000|Open Label Treatment|Lack of Efficacy|5|||
147644029|NCT00738062|532516705|FG001|Open Label Treatment|Lack of Efficacy|0|||
147644030|NCT00738062|532516706|FG002|Open Label Treatment|Lack of Efficacy|0|||
147644031|NCT00738062|532516704|FG000|Open Label Treatment|Adverse Event|11|||
147644032|NCT00738062|532516705|FG001|Open Label Treatment|Adverse Event|0|||
147644033|NCT00738062|532516706|FG002|Open Label Treatment|Adverse Event|0|||
147644034|NCT00738062|532516704|FG000|Open Label Treatment|Protocol Violation|2|||
147644035|NCT00738062|532516705|FG001|Open Label Treatment|Protocol Violation|0|||
147624740|NCT02166333|532443442|FG002|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|0|||
147624741|NCT02166333|532443443|FG003|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|0|||
147624742|NCT02166333|532443444|FG004|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|3|||
147624743|NCT02166333|532443445|FG005|Stage 1|Finished the trial (did the 2 year visit) during Stage 1 and did not advance to Stage 2|1|||
147624744|NCT02166333|532443440|FG000|Stage 1|Death|4|||
147624745|NCT02166333|532443441|FG001|Stage 1|Death|0|||
147624746|NCT02166333|532443442|FG002|Stage 1|Death|2|||
147624747|NCT02166333|532443443|FG003|Stage 1|Death|0|||
147624748|NCT02166333|532443444|FG004|Stage 1|Death|3|||
147624749|NCT02166333|532443445|FG005|Stage 1|Death|2|||
147624750|NCT02166333|532443440|FG000|Stage 1|Lost to Follow-up|12|||
147624751|NCT02166333|532443441|FG001|Stage 1|Lost to Follow-up|0|||
147624752|NCT02166333|532443442|FG002|Stage 1|Lost to Follow-up|6|||
147624753|NCT02166333|532443443|FG003|Stage 1|Lost to Follow-up|0|||
147624754|NCT02166333|532443444|FG004|Stage 1|Lost to Follow-up|3|||
147624755|NCT02166333|532443445|FG005|Stage 1|Lost to Follow-up|3|||
147624756|NCT02166333|532443440|FG000|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|180|||
147624757|NCT02166333|532443441|FG001|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|0|||
147624758|NCT02166333|532443442|FG002|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|63|||
147624759|NCT02166333|532443443|FG003|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|0|||
147624760|NCT02166333|532443444|FG004|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|54|||
147624761|NCT02166333|532443445|FG005|Stage 2|Finished the trial (did the 2 year visit) prior to or during trial closeout|52|||
147624762|NCT02166333|532443440|FG000|Stage 2|Death|4|||
147624763|NCT02166333|532443441|FG001|Stage 2|Death|2|||
147624764|NCT02166333|532443442|FG002|Stage 2|Death|1|||
147624765|NCT02166333|532443443|FG003|Stage 2|Death|0|||
147624766|NCT02166333|532443444|FG004|Stage 2|Death|0|||
147624767|NCT02166333|532443445|FG005|Stage 2|Death|1|||
147624768|NCT02166333|532443440|FG000|Stage 2|Lost to Follow-up|23|||
147624769|NCT02166333|532443441|FG001|Stage 2|Lost to Follow-up|4|||
147624770|NCT02166333|532443442|FG002|Stage 2|Lost to Follow-up|11|||
147624771|NCT02166333|532443443|FG003|Stage 2|Lost to Follow-up|9|||
147624772|NCT02166333|532443444|FG004|Stage 2|Lost to Follow-up|3|||
147624773|NCT02166333|532443445|FG005|Stage 2|Lost to Follow-up|6|||
147624774|NCT02269098|532443446|FG000|Overall Study|Lost to Follow-up|14|||
147624775|NCT02269098|532443447|FG001|Overall Study|Lost to Follow-up|9|||
147624776|NCT03644342|532443453|FG000|Overall Study|Adverse Event|2|||
147624777|NCT03644342|532443454|FG001|Overall Study|Adverse Event|0|||
147624778|NCT03644342|532443453|FG000|Overall Study|Protocol Violation|0|||
147624779|NCT03644342|532443454|FG001|Overall Study|Protocol Violation|1|||
147624780|NCT00359424|532443457|FG000|Overall Study|Death|99|||
147624781|NCT00359424|532443458|FG001|Overall Study|Death|58|||
147624782|NCT00359424|532443457|FG000|Overall Study|Lost to Follow-up|19|||
147624783|NCT00359424|532443458|FG001|Overall Study|Lost to Follow-up|7|||
147624784|NCT00359424|532443457|FG000|Overall Study|Withdrawal by Subject|10|||
147624785|NCT00359424|532443458|FG001|Overall Study|Withdrawal by Subject|2|||
147624786|NCT00359424|532443457|FG000|Overall Study|follow up not conducted|2|||
147624787|NCT00359424|532443458|FG001|Overall Study|follow up not conducted|0|||
147624788|NCT02259010|532443459|FG000|Overall Study|Didn't Completed Dosing; PK Assessment|5|||
147624789|NCT02462603|532443460|FG000|Overall Study|Investigator Decision|1|||
147624790|NCT02462603|532443460|FG000|Overall Study|Non-Compliance|1|||
147624791|NCT02462603|532443460|FG000|Overall Study|Withdrawal by Subject|2|||
147624792|NCT01445730|532443465|FG000|Overall Study|Adverse Event|1|||
147624793|NCT01445730|532443465|FG000|Overall Study|For the advice of a dentist|1|||
147624794|NCT01445730|532443465|FG000|Overall Study|The data from magnetic resonance examinations were not sufficient|9|||
147624795|NCT01167140|532443468|FG000|Overall Study|Withdrawal by Subject|1|||
147624796|NCT03805412|532443469|FG000|Overall Study|Lost to Follow-up|0|||
147624797|NCT03805412|532443470|FG001|Overall Study|Lost to Follow-up|1|||
147624798|NCT00848718|532443471|FG000|Overall Study|Adverse Event|2|||
147624799|NCT00848718|532443472|FG001|Overall Study|Adverse Event|2|||
147624800|NCT00848718|532443473|FG002|Overall Study|Adverse Event|1|||
147624801|NCT00848718|532443474|FG003|Overall Study|Adverse Event|1|||
147624802|NCT00848718|532443475|FG004|Overall Study|Adverse Event|1|||
147624803|NCT00848718|532443476|FG005|Overall Study|Adverse Event|0|||
147624804|NCT00848718|532443477|FG006|Overall Study|Adverse Event|0|||
147624805|NCT00848718|532443478|FG007|Overall Study|Adverse Event|1|||
147624806|NCT00848718|532443479|FG008|Overall Study|Adverse Event|1|||
147624807|NCT00848718|532443480|FG009|Overall Study|Adverse Event|0|||
147624808|NCT00848718|532443481|FG010|Overall Study|Adverse Event|0|||
147624809|NCT00848718|532443482|FG011|Overall Study|Adverse Event|0|||
147667986|NCT01373164|532609820|FG003|Overall Study|Withdrawal by Subject|10|||
147624810|NCT00848718|532443483|FG012|Overall Study|Adverse Event|2|||
147624811|NCT00848718|532443471|FG000|Overall Study|Lack of Efficacy|0|||
147624812|NCT00848718|532443472|FG001|Overall Study|Lack of Efficacy|0|||
147624813|NCT00848718|532443473|FG002|Overall Study|Lack of Efficacy|1|||
147624814|NCT00848718|532443474|FG003|Overall Study|Lack of Efficacy|0|||
147667987|NCT01373164|532609821|FG004|Overall Study|Withdrawal by Subject|2|||
147624815|NCT00848718|532443475|FG004|Overall Study|Lack of Efficacy|0|||
147624816|NCT00848718|532443476|FG005|Overall Study|Lack of Efficacy|0|||
147624817|NCT00848718|532443477|FG006|Overall Study|Lack of Efficacy|1|||
147624818|NCT00848718|532443478|FG007|Overall Study|Lack of Efficacy|0|||
147624819|NCT00848718|532443479|FG008|Overall Study|Lack of Efficacy|0|||
147624820|NCT00848718|532443480|FG009|Overall Study|Lack of Efficacy|0|||
147624821|NCT00848718|532443481|FG010|Overall Study|Lack of Efficacy|0|||
147624822|NCT00848718|532443482|FG011|Overall Study|Lack of Efficacy|0|||
147624823|NCT00848718|532443483|FG012|Overall Study|Lack of Efficacy|0|||
147624824|NCT00848718|532443471|FG000|Overall Study|Physician Decision|0|||
147624825|NCT00848718|532443472|FG001|Overall Study|Physician Decision|1|||
147624826|NCT00848718|532443473|FG002|Overall Study|Physician Decision|0|||
147624827|NCT00848718|532443474|FG003|Overall Study|Physician Decision|0|||
147624828|NCT00848718|532443475|FG004|Overall Study|Physician Decision|1|||
147624829|NCT00848718|532443476|FG005|Overall Study|Physician Decision|1|||
147624830|NCT00848718|532443477|FG006|Overall Study|Physician Decision|0|||
147624831|NCT00848718|532443478|FG007|Overall Study|Physician Decision|0|||
147624832|NCT00848718|532443479|FG008|Overall Study|Physician Decision|1|||
147624833|NCT00848718|532443480|FG009|Overall Study|Physician Decision|2|||
147624834|NCT00848718|532443481|FG010|Overall Study|Physician Decision|0|||
147624835|NCT00848718|532443482|FG011|Overall Study|Physician Decision|0|||
147624836|NCT00848718|532443483|FG012|Overall Study|Physician Decision|1|||
147624837|NCT00848718|532443471|FG000|Overall Study|Progressive disease before treatment|1|||
147624838|NCT00848718|532443472|FG001|Overall Study|Progressive disease before treatment|5|||
147624839|NCT00848718|532443473|FG002|Overall Study|Progressive disease before treatment|1|||
147624840|NCT00848718|532443474|FG003|Overall Study|Progressive disease before treatment|3|||
147624841|NCT00848718|532443475|FG004|Overall Study|Progressive disease before treatment|4|||
147624842|NCT00848718|532443476|FG005|Overall Study|Progressive disease before treatment|4|||
147624843|NCT00848718|532443477|FG006|Overall Study|Progressive disease before treatment|2|||
147624844|NCT00848718|532443478|FG007|Overall Study|Progressive disease before treatment|1|||
147624845|NCT00848718|532443479|FG008|Overall Study|Progressive disease before treatment|2|||
147624846|NCT00848718|532443480|FG009|Overall Study|Progressive disease before treatment|7|||
147624847|NCT00848718|532443481|FG010|Overall Study|Progressive disease before treatment|3|||
147624848|NCT00848718|532443482|FG011|Overall Study|Progressive disease before treatment|6|||
147624849|NCT00848718|532443483|FG012|Overall Study|Progressive disease before treatment|2|||
147624850|NCT00848718|532443471|FG000|Overall Study|Protocol Violation|0|||
147624851|NCT00848718|532443472|FG001|Overall Study|Protocol Violation|1|||
147624852|NCT00848718|532443473|FG002|Overall Study|Protocol Violation|0|||
147624853|NCT00848718|532443474|FG003|Overall Study|Protocol Violation|0|||
147624854|NCT00848718|532443475|FG004|Overall Study|Protocol Violation|0|||
147624855|NCT00848718|532443476|FG005|Overall Study|Protocol Violation|0|||
147624856|NCT00848718|532443477|FG006|Overall Study|Protocol Violation|0|||
147624857|NCT00848718|532443478|FG007|Overall Study|Protocol Violation|1|||
147624858|NCT00848718|532443479|FG008|Overall Study|Protocol Violation|0|||
147624859|NCT00848718|532443480|FG009|Overall Study|Protocol Violation|0|||
147624860|NCT00848718|532443481|FG010|Overall Study|Protocol Violation|0|||
147624861|NCT00848718|532443482|FG011|Overall Study|Protocol Violation|0|||
147624862|NCT00848718|532443483|FG012|Overall Study|Protocol Violation|1|||
147624863|NCT00848718|532443471|FG000|Overall Study|Withdrawal by Subject|1|||
147624864|NCT00848718|532443472|FG001|Overall Study|Withdrawal by Subject|0|||
147624865|NCT00848718|532443473|FG002|Overall Study|Withdrawal by Subject|0|||
147624866|NCT00848718|532443474|FG003|Overall Study|Withdrawal by Subject|1|||
147624867|NCT00848718|532443475|FG004|Overall Study|Withdrawal by Subject|0|||
147624868|NCT00848718|532443476|FG005|Overall Study|Withdrawal by Subject|0|||
147624869|NCT00848718|532443477|FG006|Overall Study|Withdrawal by Subject|0|||
147624870|NCT00848718|532443478|FG007|Overall Study|Withdrawal by Subject|0|||
147624871|NCT00848718|532443479|FG008|Overall Study|Withdrawal by Subject|0|||
147624872|NCT00848718|532443480|FG009|Overall Study|Withdrawal by Subject|0|||
147624873|NCT00848718|532443481|FG010|Overall Study|Withdrawal by Subject|1|||
147624874|NCT00848718|532443482|FG011|Overall Study|Withdrawal by Subject|0|||
147624875|NCT00848718|532443483|FG012|Overall Study|Withdrawal by Subject|0|||
147624876|NCT00848718|532443471|FG000|Overall Study|Progressive disease during treatment|3|||
147624877|NCT00848718|532443472|FG001|Overall Study|Progressive disease during treatment|0|||
147624878|NCT00848718|532443473|FG002|Overall Study|Progressive disease during treatment|3|||
147624879|NCT00848718|532443474|FG003|Overall Study|Progressive disease during treatment|0|||
147624880|NCT00848718|532443475|FG004|Overall Study|Progressive disease during treatment|0|||
147624881|NCT00848718|532443476|FG005|Overall Study|Progressive disease during treatment|0|||
147624882|NCT00848718|532443477|FG006|Overall Study|Progressive disease during treatment|0|||
147624883|NCT00848718|532443478|FG007|Overall Study|Progressive disease during treatment|2|||
147624884|NCT00848718|532443479|FG008|Overall Study|Progressive disease during treatment|0|||
147667988|NCT01799941|532609822|FG000|Overall Study|Adverse Event|34|||
147624885|NCT00848718|532443480|FG009|Overall Study|Progressive disease during treatment|0|||
147624886|NCT00848718|532443481|FG010|Overall Study|Progressive disease during treatment|0|||
147624887|NCT00848718|532443482|FG011|Overall Study|Progressive disease during treatment|0|||
147624888|NCT00848718|532443483|FG012|Overall Study|Progressive disease during treatment|2|||
147624889|NCT02389829|532443489|FG000|Overall Study|Lost to Follow-up|0|||
147624890|NCT02389829|532443490|FG001|Overall Study|Lost to Follow-up|1|||
147624891|NCT00571727|532443491|FG000|Overall Study|Did not enter in this study|1|||
147624892|NCT00571727|532443491|FG000|Overall Study|Non-compliance|4|||
147624893|NCT00571727|532443491|FG000|Overall Study|Lost to Follow-up|30|||
147624894|NCT00571727|532443491|FG000|Overall Study|Poor growth|1|||
147624895|NCT00571727|532443491|FG000|Overall Study|Parent/patient decision|2|||
147624896|NCT00571727|532443491|FG000|Overall Study|Participant transferred to commercial drug|14|||
147624897|NCT00571727|532443491|FG000|Overall Study|Unable to provide study drug|6|||
147624898|NCT00571727|532443491|FG000|Overall Study|On-treatment at end of study|8|||
147624899|NCT03817190|532443492|FG000|Overall Study|Early Termination|13|||
147624900|NCT03817190|532443493|FG001|Overall Study|Early Termination|20|||
147624901|NCT03817190|532443492|FG000|Overall Study|Adverse Event|10|||
147624902|NCT03817190|532443493|FG001|Overall Study|Adverse Event|17|||
147624903|NCT03817190|532443492|FG000|Overall Study|Withdrawal by Subject|12|||
147624904|NCT03817190|532443493|FG001|Overall Study|Withdrawal by Subject|8|||
147624905|NCT03817190|532443492|FG000|Overall Study|Lost to Follow-up|11|||
147624906|NCT03817190|532443493|FG001|Overall Study|Lost to Follow-up|7|||
147624907|NCT03817190|532443492|FG000|Overall Study|Lack of Efficacy|7|||
147624908|NCT03817190|532443493|FG001|Overall Study|Lack of Efficacy|5|||
147624909|NCT03817190|532443492|FG000|Overall Study|Investigator Decision|5|||
147624910|NCT03817190|532443493|FG001|Overall Study|Investigator Decision|1|||
147624911|NCT03817190|532443492|FG000|Overall Study|Due to Coronavirus, the patient did not want to continue the study.|0|||
147624912|NCT03817190|532443493|FG001|Overall Study|Due to Coronavirus, the patient did not want to continue the study.|1|||
147624913|NCT03817190|532443492|FG000|Overall Study|Lack of Contact|1|||
147624914|NCT03817190|532443493|FG001|Overall Study|Lack of Contact|0|||
147624915|NCT03817190|532443492|FG000|Overall Study|Due to worsening of atopic dermatitis and use of Con Med, patient was excluded|1|||
147624916|NCT03817190|532443493|FG001|Overall Study|Due to worsening of atopic dermatitis and use of Con Med, patient was excluded|0|||
147624917|NCT05514873|532443494|FG000|Main Treatment Period|Subject's lack of compliance with study procedures|1|||
147624918|NCT05514873|532443494|FG000|Main Treatment Period|Adverse Event|2|||
147624919|NCT05514873|532443494|FG000|Extension Treatment Period|Lost to Follow-up|3|||
147624920|NCT03525678|532443495|FG000|Main Study (Day 1 to 186 Weeks)|Withdrawal by Subject|8|||
147624921|NCT03525678|532443496|FG001|Main Study (Day 1 to 186 Weeks)|Withdrawal by Subject|2|||
147624922|NCT03525678|532443497|FG002|Main Study (Day 1 to 186 Weeks)|Withdrawal by Subject|2|||
147624923|NCT03525678|532443498|FG003|Main Study (Day 1 to 186 Weeks)|Withdrawal by Subject|0|||
147624924|NCT03525678|532443499|FG004|Main Study (Day 1 to 186 Weeks)|Withdrawal by Subject|0|||
147624925|NCT03525678|532443495|FG000|Main Study (Day 1 to 186 Weeks)|Physician Decision|2|||
147624926|NCT03525678|532443496|FG001|Main Study (Day 1 to 186 Weeks)|Physician Decision|4|||
147624927|NCT03525678|532443497|FG002|Main Study (Day 1 to 186 Weeks)|Physician Decision|0|||
147624928|NCT03525678|532443498|FG003|Main Study (Day 1 to 186 Weeks)|Physician Decision|0|||
147624929|NCT03525678|532443499|FG004|Main Study (Day 1 to 186 Weeks)|Physician Decision|0|||
147624930|NCT03525678|532443495|FG000|Main Study (Day 1 to 186 Weeks)|Lost to Follow-up|2|||
147624931|NCT03525678|532443496|FG001|Main Study (Day 1 to 186 Weeks)|Lost to Follow-up|1|||
147624932|NCT03525678|532443497|FG002|Main Study (Day 1 to 186 Weeks)|Lost to Follow-up|2|||
147624933|NCT03525678|532443498|FG003|Main Study (Day 1 to 186 Weeks)|Lost to Follow-up|0|||
147624934|NCT03525678|532443499|FG004|Main Study (Day 1 to 186 Weeks)|Lost to Follow-up|0|||
147624935|NCT03525678|532443495|FG000|Main Study (Day 1 to 186 Weeks)|Death|70|||
147624936|NCT03525678|532443496|FG001|Main Study (Day 1 to 186 Weeks)|Death|80|||
147624937|NCT03525678|532443497|FG002|Main Study (Day 1 to 186 Weeks)|Death|16|||
147624938|NCT03525678|532443498|FG003|Main Study (Day 1 to 186 Weeks)|Death|0|||
147624939|NCT03525678|532443499|FG004|Main Study (Day 1 to 186 Weeks)|Death|0|||
147624940|NCT03525678|532443495|FG000|Main Study (Day 1 to 186 Weeks)|other reasons|14|||
147624941|NCT03525678|532443496|FG001|Main Study (Day 1 to 186 Weeks)|other reasons|10|||
147624942|NCT03525678|532443497|FG002|Main Study (Day 1 to 186 Weeks)|other reasons|5|||
147624943|NCT03525678|532443498|FG003|Main Study (Day 1 to 186 Weeks)|other reasons|0|||
147624944|NCT03525678|532443499|FG004|Main Study (Day 1 to 186 Weeks)|other reasons|0|||
147624945|NCT03525678|532443495|FG000|Main Study (Day 1 to 186 Weeks)|Transitioned to PACT phase|1|||
147624946|NCT03525678|532443496|FG001|Main Study (Day 1 to 186 Weeks)|Transitioned to PACT phase|2|||
147624947|NCT03525678|532443497|FG002|Main Study (Day 1 to 186 Weeks)|Transitioned to PACT phase|0|||
147624948|NCT03525678|532443498|FG003|Main Study (Day 1 to 186 Weeks)|Transitioned to PACT phase|0|||
147624949|NCT03525678|532443499|FG004|Main Study (Day 1 to 186 Weeks)|Transitioned to PACT phase|0|||
147624950|NCT01068678|532444888|FG000|Overall Study|Lack of Efficacy|3|||
147624951|NCT01068678|532444889|FG001|Overall Study|Lack of Efficacy|2|||
147624952|NCT01068678|532444888|FG000|Overall Study|Protocol Violation|5|||
147624953|NCT01068678|532444889|FG001|Overall Study|Protocol Violation|1|||
147624954|NCT01068678|532444888|FG000|Overall Study|Withdrawal criteria|12|||
147624955|NCT01068678|532444889|FG001|Overall Study|Withdrawal criteria|6|||
147624956|NCT01068678|532444888|FG000|Overall Study|Unclassified|18|||
147624957|NCT01068678|532444889|FG001|Overall Study|Unclassified|15|||
147624958|NCT03055338|532444894|FG000|Overall Study|Lost to Follow-up|9|||
147624959|NCT03055338|532444895|FG001|Overall Study|Lost to Follow-up|2|||
147624960|NCT03055338|532444896|FG002|Overall Study|Lost to Follow-up|3|||
147624961|NCT03055338|532444894|FG000|Overall Study|No Post-treatment Protocol Contact|0|||
147624962|NCT03055338|532444895|FG001|Overall Study|No Post-treatment Protocol Contact|1|||
147624963|NCT03055338|532444896|FG002|Overall Study|No Post-treatment Protocol Contact|0|||
147624964|NCT03055338|532444894|FG000|Overall Study|Physician Decision|0|||
147624965|NCT03055338|532444895|FG001|Overall Study|Physician Decision|0|||
147624966|NCT03055338|532444896|FG002|Overall Study|Physician Decision|2|||
147624967|NCT03055338|532444894|FG000|Overall Study|Withdrawal by Subject|9|||
147624968|NCT03055338|532444895|FG001|Overall Study|Withdrawal by Subject|8|||
147624969|NCT03055338|532444896|FG002|Overall Study|Withdrawal by Subject|7|||
147624970|NCT03058705|532444897|FG000|Overall Study|Withdrawal by Subject|2|||
147624971|NCT03058705|532444897|FG000|Overall Study|Physician Decision|2|||
147624972|NCT03752970|532444898|FG000|Study Cohort Period 1 (Week 1 - <week12)|Lack of Efficacy|0|||
147624973|NCT03752970|532444899|FG001|Study Cohort Period 1 (Week 1 - <week12)|Lack of Efficacy|1|||
147624974|NCT03752970|532444900|FG002|Study Cohort Period 1 (Week 1 - <week12)|Lack of Efficacy|0|||
147624975|NCT03752970|532444898|FG000|Study Cohort Period 1 (Week 1 - <week12)|Lost to Follow-up|0|||
147624976|NCT03752970|532444899|FG001|Study Cohort Period 1 (Week 1 - <week12)|Lost to Follow-up|0|||
147624977|NCT03752970|532444900|FG002|Study Cohort Period 1 (Week 1 - <week12)|Lost to Follow-up|1|||
147624978|NCT03752970|532444898|FG000|Study Cohort Period 1 (Week 1 - <week12)|Withdrawal by Subject|0|||
147624979|NCT03752970|532444899|FG001|Study Cohort Period 1 (Week 1 - <week12)|Withdrawal by Subject|0|||
147624980|NCT03752970|532444900|FG002|Study Cohort Period 1 (Week 1 - <week12)|Withdrawal by Subject|1|||
147624981|NCT03752970|532444898|FG000|Study Cohort Week 12 Assignment|Switched to Spesolimab in period 2|0|||
147624982|NCT03752970|532444899|FG001|Study Cohort Week 12 Assignment|Switched to Spesolimab in period 2|4|||
147624983|NCT03752970|532444900|FG002|Study Cohort Week 12 Assignment|Switched to Spesolimab in period 2|0|||
147624984|NCT03752970|532444898|FG000|Study Cohort - Period 2 (>=Week 12 - 24)|Withdrawal by Subject|0|||
147624985|NCT03752970|532444899|FG001|Study Cohort - Period 2 (>=Week 12 - 24)|Withdrawal by Subject|0|||
147624986|NCT03752970|532444900|FG002|Study Cohort - Period 2 (>=Week 12 - 24)|Withdrawal by Subject|1|||
147624987|NCT03976362|532444901|FG000|Induction Phase|Failure to Meet Maintenance Randomization Criteria|198|||
147624988|NCT03976362|532444902|FG001|Induction Phase|Failure to Meet Maintenance Randomization Criteria|0|||
147624989|NCT03976362|532444903|FG002|Induction Phase|Failure to Meet Maintenance Randomization Criteria|0|||
147624990|NCT03976362|532444901|FG000|Induction Phase|Death|62|||
147624991|NCT03976362|532444902|FG001|Induction Phase|Death|0|||
147624992|NCT03976362|532444903|FG002|Induction Phase|Death|0|||
147624993|NCT03976362|532444901|FG000|Maintenance Phase|Participants Ongoing|0|||
147624994|NCT03976362|532444902|FG001|Maintenance Phase|Participants Ongoing|106|||
147624995|NCT03976362|532444903|FG002|Maintenance Phase|Participants Ongoing|103|||
147624996|NCT03976362|532444901|FG000|Maintenance Phase|Withdrawal by Subject|0|||
147624997|NCT03976362|532444902|FG001|Maintenance Phase|Withdrawal by Subject|4|||
147624998|NCT03976362|532444903|FG002|Maintenance Phase|Withdrawal by Subject|4|||
147624999|NCT03976362|532444901|FG000|Maintenance Phase|Failure To Meet Randomization Criteria|0|||
147625000|NCT03976362|532444902|FG001|Maintenance Phase|Failure To Meet Randomization Criteria|0|||
147625001|NCT03976362|532444903|FG002|Maintenance Phase|Failure To Meet Randomization Criteria|1|||
147625002|NCT03976362|532444901|FG000|Maintenance Phase|Death|0|||
147625003|NCT03976362|532444902|FG001|Maintenance Phase|Death|186|||
147625004|NCT03976362|532444903|FG002|Maintenance Phase|Death|187|||
147625005|NCT04767282|532444904|FG000|Overall Study|Refused or did not begin surveys|6|||
147625006|NCT04767282|532444905|FG001|Overall Study|Refused or did not begin surveys|2|||
147625007|NCT04767282|532444906|FG002|Overall Study|Refused or did not begin surveys|2|||
147625008|NCT04767282|532444904|FG000|Overall Study|Duplicate household previously enrolled|2|||
147625009|NCT04767282|532444905|FG001|Overall Study|Duplicate household previously enrolled|0|||
147625010|NCT04767282|532444906|FG002|Overall Study|Duplicate household previously enrolled|8|||
147625011|NCT04767282|532444904|FG000|Overall Study|Unable to confirm legal guardian|0|||
147625012|NCT04767282|532444905|FG001|Overall Study|Unable to confirm legal guardian|2|||
147625013|NCT04767282|532444906|FG002|Overall Study|Unable to confirm legal guardian|8|||
147625014|NCT04767282|532444904|FG000|Overall Study|Withdrawal by Subject|0|||
147625015|NCT04767282|532444905|FG001|Overall Study|Withdrawal by Subject|0|||
147625016|NCT04767282|532444906|FG002|Overall Study|Withdrawal by Subject|6|||
147625017|NCT04767282|532444904|FG000|Overall Study|Survey comprehension challenges|4|||
147625018|NCT04767282|532444905|FG001|Overall Study|Survey comprehension challenges|0|||
147625019|NCT04767282|532444906|FG002|Overall Study|Survey comprehension challenges|0|||
147625020|NCT00824772|532444907|FG000|Overall Study|Withdrawal by Subject|8|||
147625021|NCT02955355|532444911|FG000|Overall Study|Adverse Event|4|||
147625022|NCT02955355|532444911|FG000|Overall Study|Death|1|||
147625023|NCT02955355|532444911|FG000|Overall Study|Physician Decision|21|||
147625024|NCT02955355|532444911|FG000|Overall Study|Site Terminated by Sponsor|35|||
147490652|NCT00634244|531951077|FG002|Overall Study|Other complicating disease|0|||
147490653|NCT03591146|531951088|FG000|TLC590 190mg and Naropin 150mg|Lost to Follow-up|0|||
147490654|NCT03591146|531951089|FG001|TLC590 190mg and Naropin 150mg|Lost to Follow-up|0|||
147490655|NCT03591146|531951090|FG002|TLC590 190mg and Naropin 150mg|Lost to Follow-up|0|||
147490656|NCT03591146|531951091|FG003|TLC590 190mg and Naropin 150mg|Lost to Follow-up|0|||
147490657|NCT03591146|531951092|FG004|TLC590 190mg and Naropin 150mg|Lost to Follow-up|1|||
147490658|NCT03591146|531951088|FG000|TLC590 380mg and Naropin 150mg|Lost to Follow-up|0|||
147490659|NCT03591146|531951089|FG001|TLC590 380mg and Naropin 150mg|Lost to Follow-up|1|||
147490660|NCT03591146|531951090|FG002|TLC590 380mg and Naropin 150mg|Lost to Follow-up|0|||
147490661|NCT03591146|531951091|FG003|TLC590 380mg and Naropin 150mg|Lost to Follow-up|0|||
147490662|NCT03591146|531951092|FG004|TLC590 380mg and Naropin 150mg|Lost to Follow-up|0|||
147490663|NCT03591146|531951088|FG000|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|0|||
147490664|NCT03591146|531951089|FG001|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|0|||
147490665|NCT03591146|531951090|FG002|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|0|||
147490666|NCT03591146|531951091|FG003|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|0|||
147490667|NCT03591146|531951092|FG004|TLC590 380mg and Naropin 150mg|Withdrawal by Subject|1|||
147490668|NCT03591146|531951088|FG000|TLC590 570mg and Naropin 150mg|Lost to Follow-up|0|||
147490669|NCT03591146|531951089|FG001|TLC590 570mg and Naropin 150mg|Lost to Follow-up|0|||
147490670|NCT03591146|531951090|FG002|TLC590 570mg and Naropin 150mg|Lost to Follow-up|1|||
147490671|NCT03591146|531951091|FG003|TLC590 570mg and Naropin 150mg|Lost to Follow-up|0|||
147490672|NCT03591146|531951092|FG004|TLC590 570mg and Naropin 150mg|Lost to Follow-up|1|||
147490673|NCT04737031|531951095|FG000|Overall Study|Patients who did not have a treatment visit|0|||
147490674|NCT04737031|531951096|FG001|Overall Study|Patients who did not have a treatment visit|31|||
147490675|NCT04737031|531951097|FG002|Overall Study|Patients who did not have a treatment visit|93|||
147490676|NCT04737031|531951098|FG003|Overall Study|Patients who did not have a treatment visit|227|||
147490677|NCT04369430|531951099|FG000|Overall Study|Adverse Event|2|||
147490678|NCT04369430|531951100|FG001|Overall Study|Adverse Event|3|||
147490679|NCT04369430|531951099|FG000|Overall Study|Death|1|||
147490680|NCT04369430|531951100|FG001|Overall Study|Death|0|||
147490681|NCT04369430|531951099|FG000|Overall Study|Withdrawal by Subject|4|||
147490682|NCT04369430|531951100|FG001|Overall Study|Withdrawal by Subject|3|||
147490683|NCT04369430|531951099|FG000|Overall Study|COVID concern, Sponsor's decision|2|||
147490684|NCT04369430|531951100|FG001|Overall Study|COVID concern, Sponsor's decision|1|||
147490685|NCT04369430|531951099|FG000|Overall Study|Lost to Follow-up|0|||
147490686|NCT04369430|531951100|FG001|Overall Study|Lost to Follow-up|1|||
147490687|NCT00444626|531951103|FG000|Initial Treatment Period|Withdrawal by Subject|2|||
147490688|NCT00444626|531951103|FG000|Initial Treatment Period|Adverse Event|1|||
147490689|NCT00444626|531951103|FG000|Initial Treatment Period|Lost to Follow-up|9|||
147490690|NCT00008138|531951104|FG000|Neoadjuvant Chemotherapy|Adverse Event|3|||
147490691|NCT00008138|531951104|FG000|Neoadjuvant Chemotherapy|Withdrawal by Subject|3|||
147490692|NCT00008138|531951104|FG000|Neoadjuvant Chemotherapy|Lack of Efficacy|6|||
147490693|NCT00008138|531951104|FG000|Neoadjuvant Chemotherapy|not protocol specified|8|||
147490694|NCT00008138|531951104|FG000|Interval Debulking|Withdrawal by Subject|2|||
147490695|NCT00008138|531951104|FG000|Post-Cytoreduction Chemotherapy|Adverse Event|6|||
147490696|NCT00008138|531951104|FG000|Post-Cytoreduction Chemotherapy|Progression|1|||
147490697|NCT00008138|531951104|FG000|Post-Cytoreduction Chemotherapy|not protocol specified|1|||
147490698|NCT03453151|531951105|FG000|Overall Study|Withdrawal by Subject|1|||
147490699|NCT03453151|531951105|FG000|Overall Study|Physician Decision|3|||
147490700|NCT00142519|531951106|FG000|Overall Study|Not Treated|7|||
147490701|NCT00142519|531951107|FG001|Overall Study|Not Treated|9|||
147490702|NCT00142519|531951106|FG000|Overall Study|Protocol Violation|1|||
147490703|NCT00142519|531951107|FG001|Overall Study|Protocol Violation|0|||
147490704|NCT00142519|531951106|FG000|Overall Study|Withdrawal by Subject|10|||
147490705|NCT00142519|531951107|FG001|Overall Study|Withdrawal by Subject|7|||
147490706|NCT01204658|531951113|FG000|Primary Phase|Adverse Event|0|||
147490707|NCT01204658|531951114|FG001|Primary Phase|Adverse Event|0|||
147490708|NCT01204658|531951115|FG002|Primary Phase|Adverse Event|1|||
147490709|NCT01204658|531951116|FG003|Primary Phase|Adverse Event|0|||
147490710|NCT04594239|531951117|FG000|Overall Study|Withdrawal by Subject|3|||
147625025|NCT02955355|532444911|FG000|Overall Study|Withdrawal by Subject|19|||
147625026|NCT02955355|532444911|FG000|Overall Study|Reason Not Specified|5|||
147416904|NCT02416453|531690003|FG004|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
147416905|NCT02416453|531690004|FG005|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|1|||
147416906|NCT02416453|531690005|FG006|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
147416907|NCT02416453|531690006|FG007|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
147416908|NCT02416453|531690007|FG008|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
147416909|NCT02416453|531690008|FG009|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
147416910|NCT02416453|531690009|FG010|Overall Study|PARTICIPANT HAS MOVED TO SINGAPORE|0|||
147416911|NCT01036438|531690013|FG000|Overall Study|Adverse Event|7|||
147416912|NCT01036438|531690014|FG001|Overall Study|Adverse Event|8|||
147416913|NCT01036438|531690013|FG000|Overall Study|Death|0|||
147416914|NCT01036438|531690014|FG001|Overall Study|Death|1|||
147416915|NCT01036438|531690013|FG000|Overall Study|No effect of study treatment|3|||
147416916|NCT01036438|531690014|FG001|Overall Study|No effect of study treatment|1|||
147490711|NCT04594239|531951118|FG001|Overall Study|Withdrawal by Subject|4|||
147490712|NCT04594239|531951119|FG002|Overall Study|Withdrawal by Subject|2|||
147490713|NCT04594239|531951120|FG003|Overall Study|Withdrawal by Subject|4|||
147625027|NCT03817853|532444914|FG000|Induction Phase|Adverse Event|5|||
147625028|NCT03817853|532444915|FG001|Induction Phase|Adverse Event|0|||
147625029|NCT03817853|532444916|FG002|Induction Phase|Adverse Event|0|||
147625030|NCT03817853|532444914|FG000|Induction Phase|Measures due to covid19; transformation to double hit high-grade b lymphoma; discontinuation of trt.|3|||
147625031|NCT03817853|532444915|FG001|Induction Phase|Measures due to covid19; transformation to double hit high-grade b lymphoma; discontinuation of trt.|0|||
147625032|NCT03817853|532444916|FG002|Induction Phase|Measures due to covid19; transformation to double hit high-grade b lymphoma; discontinuation of trt.|0|||
147625033|NCT03817853|532444914|FG000|Induction Phase|Physician Decision|2|||
147625034|NCT03817853|532444915|FG001|Induction Phase|Physician Decision|0|||
147625035|NCT03817853|532444916|FG002|Induction Phase|Physician Decision|0|||
147625036|NCT03817853|532444914|FG000|Induction Phase|Progressive Disease|6|||
147625037|NCT03817853|532444915|FG001|Induction Phase|Progressive Disease|0|||
147625038|NCT03817853|532444916|FG002|Induction Phase|Progressive Disease|0|||
147625039|NCT03817853|532444914|FG000|Induction Phase|Withdrawal by Subject|4|||
147625040|NCT03817853|532444915|FG001|Induction Phase|Withdrawal by Subject|0|||
147625041|NCT03817853|532444916|FG002|Induction Phase|Withdrawal by Subject|0|||
147625042|NCT03817853|532444914|FG000|Maintenance Phase|Adverse Event|0|||
147625043|NCT03817853|532444915|FG001|Maintenance Phase|Adverse Event|8|||
147625044|NCT03817853|532444916|FG002|Maintenance Phase|Adverse Event|0|||
147625045|NCT03817853|532444914|FG000|Maintenance Phase|Death|0|||
147625046|NCT03817853|532444915|FG001|Maintenance Phase|Death|5|||
147625047|NCT03817853|532444916|FG002|Maintenance Phase|Death|0|||
147625048|NCT03817853|532444914|FG000|Maintenance Phase|Progressive Disease|0|||
147625049|NCT03817853|532444915|FG001|Maintenance Phase|Progressive Disease|7|||
147416917|NCT01413503|531690015|FG000|Overall Study|Lost to Follow-up|1|||
147416918|NCT02091206|531690016|FG000|Treatment Period|Adverse Event|0|||
147416919|NCT02091206|531690017|FG001|Treatment Period|Adverse Event|1|||
147416920|NCT02091206|531690018|FG002|Treatment Period|Adverse Event|0|||
147416921|NCT02091206|531690019|FG003|Treatment Period|Adverse Event|0|||
147416922|NCT02091206|531690016|FG000|Treatment Period|Met withdrawal criteria|0|||
147416923|NCT02091206|531690017|FG001|Treatment Period|Met withdrawal criteria|0|||
147416924|NCT02091206|531690018|FG002|Treatment Period|Met withdrawal criteria|1|||
147416925|NCT02091206|531690019|FG003|Treatment Period|Met withdrawal criteria|0|||
147416926|NCT02091206|531690016|FG000|Taper Period|Participant refused study drug|1|||
147416927|NCT02091206|531690017|FG001|Taper Period|Participant refused study drug|0|||
147416928|NCT02091206|531690018|FG002|Taper Period|Participant refused study drug|0|||
147416929|NCT02091206|531690019|FG003|Taper Period|Participant refused study drug|1|||
147416930|NCT02091206|531690016|FG000|Taper Period|Lost to Follow-up|0|||
147667989|NCT01799941|532609822|FG000|Overall Study|Withdrawal by Subject|21|||
147667990|NCT01799941|532609822|FG000|Overall Study|Death|2|||
147416931|NCT02091206|531690017|FG001|Taper Period|Lost to Follow-up|0|||
147416932|NCT02091206|531690018|FG002|Taper Period|Lost to Follow-up|0|||
147416933|NCT02091206|531690019|FG003|Taper Period|Lost to Follow-up|1|||
147416934|NCT05051462|531690026|FG000|Overall Study|Lost to Follow-up|1|||
147416935|NCT05051462|531690027|FG001|Overall Study|Lost to Follow-up|8|||
147416936|NCT05051462|531690026|FG000|Overall Study|Withdrawal by Subject|1|||
147416937|NCT05051462|531690027|FG001|Overall Study|Withdrawal by Subject|0|||
147416938|NCT05051462|531690026|FG000|Overall Study|Protocol Violation|0|||
147416939|NCT05051462|531690027|FG001|Overall Study|Protocol Violation|2|||
147416940|NCT05597787|531690033|FG000|Overall Study|Withdrawal by Subject|0|||
147416941|NCT05597787|531690034|FG001|Overall Study|Withdrawal by Subject|0|||
147416942|NCT05597787|531690035|FG002|Overall Study|Withdrawal by Subject|1|||
147416943|NCT01241604|531690036|FG000|Screening Period|Screen Failure|3|||
147416944|NCT01241604|531690037|FG001|Screening Period|Screen Failure|0|||
147416945|NCT01241604|531690038|FG002|Screening Period|Screen Failure|0|||
147416946|NCT04349631|531690040|FG000|Overall Study|Lost to Follow-up|3|||
147416947|NCT04349631|531690040|FG000|Overall Study|Withdrawal by Subject|7|||
147416948|NCT03037931|531691539|FG000|Overall Study|Death|354|||
147416949|NCT03037931|531691540|FG001|Overall Study|Death|367|||
147416950|NCT03037931|531691539|FG000|Overall Study|Lost to Follow-up|7|||
147416951|NCT03037931|531691540|FG001|Overall Study|Lost to Follow-up|4|||
147416952|NCT03037931|531691539|FG000|Overall Study|Withdrawal by Subject|48|||
147416953|NCT03037931|531691540|FG001|Overall Study|Withdrawal by Subject|41|||
147416954|NCT00872989|531691541|FG000|Overall Study|Adverse Event|7|||
147416955|NCT00872989|531691542|FG001|Overall Study|Adverse Event|15|||
147625050|NCT03817853|532444916|FG002|Maintenance Phase|Progressive Disease|0|||
147625051|NCT03817853|532444914|FG000|Maintenance Phase|Withdrawal by Subject|0|||
147667991|NCT01799941|532609822|FG000|Overall Study|Investigator Decision|4|||
147667992|NCT01799941|532609822|FG000|Overall Study|Lack of Efficacy|3|||
147416956|NCT00872989|531691541|FG000|Overall Study|Withdrawal by Subject|8|||
147416957|NCT00872989|531691542|FG001|Overall Study|Withdrawal by Subject|5|||
147416958|NCT00872989|531691541|FG000|Overall Study|Progression/relapse|47|||
147416959|NCT00872989|531691542|FG001|Overall Study|Progression/relapse|35|||
147416960|NCT00872989|531691541|FG000|Overall Study|Not protocol specified|3|||
147416961|NCT00872989|531691542|FG001|Overall Study|Not protocol specified|8|||
147416962|NCT02407990|531691543|FG000|Overall Study|Death|2|||
147667993|NCT01799941|532609822|FG000|Overall Study|Lost to Follow-up|17|||
147625052|NCT03817853|532444915|FG001|Maintenance Phase|Withdrawal by Subject|2|||
147625053|NCT03817853|532444916|FG002|Maintenance Phase|Withdrawal by Subject|0|||
147625054|NCT03817853|532444914|FG000|Maintenance Phase|Physician Decision|0|||
147625055|NCT03817853|532444915|FG001|Maintenance Phase|Physician Decision|1|||
147625056|NCT03817853|532444916|FG002|Maintenance Phase|Physician Decision|0|||
147625057|NCT03817853|532444914|FG000|Maintenance Phase|Various reasons|0|||
147625058|NCT03817853|532444915|FG001|Maintenance Phase|Various reasons|4|||
147625059|NCT03817853|532444916|FG002|Maintenance Phase|Various reasons|0|||
147625060|NCT03817853|532444914|FG000|Maintenance Phase|Protocol Deviation|0|||
147625061|NCT03817853|532444915|FG001|Maintenance Phase|Protocol Deviation|1|||
147625062|NCT03817853|532444916|FG002|Maintenance Phase|Protocol Deviation|0|||
147625063|NCT03817853|532444914|FG000|Follow-up Phase|Adverse Event|0|||
147625064|NCT03817853|532444915|FG001|Follow-up Phase|Adverse Event|0|||
147625065|NCT03817853|532444916|FG002|Follow-up Phase|Adverse Event|2|||
147625066|NCT03817853|532444914|FG000|Follow-up Phase|Death|0|||
147625067|NCT03817853|532444915|FG001|Follow-up Phase|Death|0|||
147625068|NCT03817853|532444916|FG002|Follow-up Phase|Death|1|||
147625069|NCT03817853|532444914|FG000|Follow-up Phase|Progressive Disease|0|||
147625070|NCT03817853|532444915|FG001|Follow-up Phase|Progressive Disease|0|||
147625071|NCT03817853|532444916|FG002|Follow-up Phase|Progressive Disease|3|||
147625072|NCT03817853|532444914|FG000|Follow-up Phase|Withdrawal by Subject|0|||
147625073|NCT03817853|532444915|FG001|Follow-up Phase|Withdrawal by Subject|0|||
147625074|NCT03817853|532444916|FG002|Follow-up Phase|Withdrawal by Subject|1|||
147625075|NCT02841995|532444919|FG000|Overall Study|Disease progression|5|||
147625076|NCT02841995|532444920|FG001|Overall Study|Disease progression|11|||
147625077|NCT02841995|532444921|FG002|Overall Study|Disease progression|8|||
147625078|NCT02841995|532444919|FG000|Overall Study|Withdrawal by Subject|2|||
147625079|NCT02841995|532444920|FG001|Overall Study|Withdrawal by Subject|4|||
147625080|NCT02841995|532444921|FG002|Overall Study|Withdrawal by Subject|4|||
147625081|NCT02841995|532444919|FG000|Overall Study|Adverse Event|2|||
147625082|NCT02841995|532444920|FG001|Overall Study|Adverse Event|0|||
147625083|NCT02841995|532444921|FG002|Overall Study|Adverse Event|1|||
147625084|NCT02841995|532444919|FG000|Overall Study|Investigator decision|2|||
147625085|NCT02841995|532444920|FG001|Overall Study|Investigator decision|0|||
147625086|NCT02841995|532444921|FG002|Overall Study|Investigator decision|1|||
147625087|NCT02841995|532444919|FG000|Overall Study|Death|0|||
147625088|NCT02841995|532444920|FG001|Overall Study|Death|0|||
147625089|NCT02841995|532444921|FG002|Overall Study|Death|2|||
147625090|NCT02841995|532444919|FG000|Overall Study|Noncompliance to protocol|1|||
147625091|NCT02841995|532444920|FG001|Overall Study|Noncompliance to protocol|0|||
147625092|NCT02841995|532444921|FG002|Overall Study|Noncompliance to protocol|0|||
147625093|NCT02841995|532444919|FG000|Overall Study|Sponsor decision|1|||
147625094|NCT02841995|532444920|FG001|Overall Study|Sponsor decision|0|||
147625095|NCT02841995|532444921|FG002|Overall Study|Sponsor decision|0|||
147625096|NCT02841995|532444919|FG000|Overall Study|Other|4|||
147625097|NCT02841995|532444920|FG001|Overall Study|Other|1|||
147625098|NCT02841995|532444921|FG002|Overall Study|Other|5|||
147625099|NCT03809663|532444929|FG000|Overall Study|Decision by sponsor|24|||
147625100|NCT03809663|532444930|FG001|Overall Study|Decision by sponsor|18|||
147625101|NCT03809663|532444931|FG002|Overall Study|Decision by sponsor|20|||
147625102|NCT03809663|532444932|FG003|Overall Study|Decision by sponsor|20|||
147625103|NCT03809663|532444933|FG004|Overall Study|Decision by sponsor|0|||
147625104|NCT03809663|532444934|FG005|Overall Study|Decision by sponsor|0|||
147625105|NCT03809663|532444929|FG000|Overall Study|Withdrawal by Subject|26|||
147625106|NCT03809663|532444930|FG001|Overall Study|Withdrawal by Subject|22|||
147625107|NCT03809663|532444931|FG002|Overall Study|Withdrawal by Subject|27|||
147625108|NCT03809663|532444932|FG003|Overall Study|Withdrawal by Subject|26|||
147625109|NCT03809663|532444933|FG004|Overall Study|Withdrawal by Subject|0|||
147625110|NCT03809663|532444934|FG005|Overall Study|Withdrawal by Subject|0|||
147625111|NCT03809663|532444929|FG000|Overall Study|Lost to Follow-up|1|||
147625112|NCT03809663|532444930|FG001|Overall Study|Lost to Follow-up|4|||
147625113|NCT03809663|532444931|FG002|Overall Study|Lost to Follow-up|1|||
147625114|NCT03809663|532444932|FG003|Overall Study|Lost to Follow-up|1|||
147625115|NCT03809663|532444933|FG004|Overall Study|Lost to Follow-up|0|||
147625116|NCT03809663|532444934|FG005|Overall Study|Lost to Follow-up|0|||
147625117|NCT01703260|532444935|FG000|Overall Study|Adverse Event|1|||
147625118|NCT01703260|532444936|FG001|Overall Study|Adverse Event|2|||
147625119|NCT01703260|532444937|FG002|Overall Study|Adverse Event|2|||
147416963|NCT02407990|531691544|FG001|Overall Study|Death|22|||
147625120|NCT01703260|532444935|FG000|Overall Study|Lost to Follow-up|1|||
147625121|NCT01703260|532444936|FG001|Overall Study|Lost to Follow-up|0|||
147625122|NCT01703260|532444937|FG002|Overall Study|Lost to Follow-up|0|||
147625123|NCT01703260|532444935|FG000|Overall Study|Withdrawal by Subject|0|||
147625124|NCT01703260|532444936|FG001|Overall Study|Withdrawal by Subject|0|||
147625125|NCT01703260|532444937|FG002|Overall Study|Withdrawal by Subject|1|||
147625126|NCT01703260|532444935|FG000|Overall Study|Study Termination|1|||
147625127|NCT01703260|532444936|FG001|Overall Study|Study Termination|2|||
147625128|NCT01703260|532444937|FG002|Overall Study|Study Termination|0|||
147625129|NCT00630825|532444940|FG000|Overall Study|Adverse Event|4|||
147625130|NCT00630825|532444941|FG001|Overall Study|Adverse Event|4|||
147625131|NCT00630825|532444942|FG002|Overall Study|Adverse Event|3|||
147625132|NCT00630825|532444943|FG003|Overall Study|Adverse Event|1|||
147625133|NCT00630825|532444940|FG000|Overall Study|Entry Criteria Not Met|1|||
147625134|NCT00630825|532444941|FG001|Overall Study|Entry Criteria Not Met|0|||
147625135|NCT00630825|532444942|FG002|Overall Study|Entry Criteria Not Met|2|||
147625136|NCT00630825|532444943|FG003|Overall Study|Entry Criteria Not Met|1|||
147625137|NCT00630825|532444940|FG000|Overall Study|Lost to Follow-up|1|||
147625138|NCT00630825|532444941|FG001|Overall Study|Lost to Follow-up|1|||
147625139|NCT00630825|532444942|FG002|Overall Study|Lost to Follow-up|1|||
147625140|NCT00630825|532444943|FG003|Overall Study|Lost to Follow-up|1|||
147625141|NCT00630825|532444940|FG000|Overall Study|Physician Decision|1|||
147625142|NCT00630825|532444941|FG001|Overall Study|Physician Decision|0|||
147625143|NCT00630825|532444942|FG002|Overall Study|Physician Decision|0|||
147625144|NCT00630825|532444943|FG003|Overall Study|Physician Decision|0|||
147625145|NCT00630825|532444940|FG000|Overall Study|Withdrawal by Subject|2|||
147625146|NCT00630825|532444941|FG001|Overall Study|Withdrawal by Subject|2|||
147625147|NCT00630825|532444942|FG002|Overall Study|Withdrawal by Subject|2|||
147625148|NCT00630825|532444943|FG003|Overall Study|Withdrawal by Subject|3|||
147625149|NCT02275819|532444944|FG000|Overall Study|Adverse Event|0|||
147625150|NCT02275819|532444945|FG001|Overall Study|Adverse Event|1|||
147625151|NCT01346059|532444946|FG000|Overall Study|Withdrawal by Subject|1|||
147625152|NCT01346059|532444947|FG001|Overall Study|Withdrawal by Subject|0|||
147625153|NCT02211209|532444951|FG000|Overall Study|Investigator judgment|0|||
147625154|NCT02211209|532444952|FG001|Overall Study|Investigator judgment|1|||
147625155|NCT02211209|532444951|FG000|Overall Study|Voluntary withdrawal|1|||
147625156|NCT02211209|532444952|FG001|Overall Study|Voluntary withdrawal|4|||
147625157|NCT02211209|532444951|FG000|Overall Study|Adverse Event or Serious Adverse Event|0|||
147625158|NCT02211209|532444952|FG001|Overall Study|Adverse Event or Serious Adverse Event|9|||
147625159|NCT02211209|532444951|FG000|Overall Study|Reason Not Specified|1|||
147625160|NCT02211209|532444952|FG001|Overall Study|Reason Not Specified|0|||
147625161|NCT00558701|532444954|FG000|Overall Study|Protocol Deviations|1|||
147625162|NCT00558701|532444955|FG001|Overall Study|Protocol Deviations|4|||
147625163|NCT01464424|532444956|FG000|Period 1, First 6 Weeks|Adverse Event|0|||
147625164|NCT01464424|532444957|FG001|Period 1, First 6 Weeks|Adverse Event|1|||
147625165|NCT01808066|532444958|FG000|Overall Study|Withdrawal by Subject|15|||
147625166|NCT00745901|532444959|FG000|Overall Study|Adverse Event|3|||
147625167|NCT00745901|532444960|FG001|Overall Study|Adverse Event|4|||
147625168|NCT00745901|532444959|FG000|Overall Study|Protocol Violation|0|||
147625169|NCT00745901|532444960|FG001|Overall Study|Protocol Violation|1|||
147625170|NCT00745901|532444959|FG000|Overall Study|Withdrawal by Subject|1|||
147625171|NCT00745901|532444960|FG001|Overall Study|Withdrawal by Subject|0|||
147625172|NCT00745901|532444959|FG000|Overall Study|Lost to Follow-up|7|||
147625173|NCT00745901|532444960|FG001|Overall Study|Lost to Follow-up|4|||
147625174|NCT00745901|532444959|FG000|Overall Study|Pregnancy|2|||
147625175|NCT00745901|532444960|FG001|Overall Study|Pregnancy|4|||
147625176|NCT00745901|532444959|FG000|Overall Study|Lack of compliance|2|||
147625177|NCT00745901|532444960|FG001|Overall Study|Lack of compliance|2|||
147625178|NCT00745901|532444959|FG000|Overall Study|Patient's next menses did not start with|1|||
147625179|NCT00745901|532444960|FG001|Overall Study|Patient's next menses did not start with|0|||
147625180|NCT00745901|532444959|FG000|Overall Study|Results of Pap smear at Vis 1 malignant|0|||
147625181|NCT00745901|532444960|FG001|Overall Study|Results of Pap smear at Vis 1 malignant|2|||
147625182|NCT00745901|532444959|FG000|Overall Study|Chlamydia test at Visit 1 was positive|1|||
147625183|NCT00745901|532444960|FG001|Overall Study|Chlamydia test at Visit 1 was positive|1|||
147625184|NCT00745901|532444959|FG000|Overall Study|Patient didn't take any study medication|7|||
147625185|NCT00745901|532444960|FG001|Overall Study|Patient didn't take any study medication|3|||
147625186|NCT00884117|532444963|FG000|Overall Study|Adverse Event|2|||
147625187|NCT00884117|532444963|FG000|Overall Study|Withdrawal by Subject|89|||
147625188|NCT00884117|532444963|FG000|Overall Study|Death|3|||
147625189|NCT00884117|532444963|FG000|Overall Study|Lost to Follow-up|143|||
147667994|NCT01799941|532609822|FG000|Overall Study|Other|15|||
147667995|NCT02669849|532609823|FG000|Overall Study|Withdrawal of Consent (not due to AE)|0|||
147625190|NCT00884117|532444963|FG000|Overall Study|Other|12|||
147625191|NCT00952068|532444965|FG000|Overall Study|Adverse Event|3|||
147625192|NCT00952068|532444965|FG000|Overall Study|Withdrawal by Subject|4|||
147625193|NCT02022202|532444966|FG000|Overall Study|Withdrawal by Subject|2|||
147625194|NCT02022202|532444966|FG000|Overall Study|Disease Progression|3|||
147625195|NCT02022202|532444966|FG000|Overall Study|Desire go to immediately to surgery|3|||
147625196|NCT04390763|532444968|FG000|Safety run-in Part|Adverse Event|4|||
147625197|NCT04390763|532444969|FG001|Safety run-in Part|Adverse Event|0|||
147625198|NCT04390763|532444970|FG002|Safety run-in Part|Adverse Event|0|||
147625199|NCT04390763|532444971|FG003|Safety run-in Part|Adverse Event|0|||
147625200|NCT04390763|532444968|FG000|Safety run-in Part|Physician Decision|1|||
147625201|NCT04390763|532444969|FG001|Safety run-in Part|Physician Decision|0|||
147625202|NCT04390763|532444970|FG002|Safety run-in Part|Physician Decision|0|||
147625203|NCT04390763|532444971|FG003|Safety run-in Part|Physician Decision|0|||
147416964|NCT02407990|531691545|FG002|Overall Study|Death|23|||
147416965|NCT02407990|531691546|FG003|Overall Study|Death|7|||
147416966|NCT02407990|531691547|FG004|Overall Study|Death|17|||
147416967|NCT02407990|531691548|FG005|Overall Study|Death|16|||
147416968|NCT02407990|531691549|FG006|Overall Study|Death|10|||
147416969|NCT02407990|531691550|FG007|Overall Study|Death|248|||
147416970|NCT02407990|531691543|FG000|Overall Study|Lost to Follow-up|0|||
147416971|NCT02407990|531691544|FG001|Overall Study|Lost to Follow-up|1|||
147416972|NCT02407990|531691545|FG002|Overall Study|Lost to Follow-up|0|||
147416973|NCT02407990|531691546|FG003|Overall Study|Lost to Follow-up|0|||
147416974|NCT02407990|531691547|FG004|Overall Study|Lost to Follow-up|0|||
147416975|NCT02407990|531691548|FG005|Overall Study|Lost to Follow-up|0|||
147416976|NCT02407990|531691549|FG006|Overall Study|Lost to Follow-up|0|||
147416977|NCT02407990|531691550|FG007|Overall Study|Lost to Follow-up|17|||
147416978|NCT02407990|531691543|FG000|Overall Study|Progressive Disease|0|||
147416979|NCT02407990|531691544|FG001|Overall Study|Progressive Disease|0|||
147416980|NCT02407990|531691545|FG002|Overall Study|Progressive Disease|0|||
147416981|NCT02407990|531691546|FG003|Overall Study|Progressive Disease|0|||
147416982|NCT02407990|531691547|FG004|Overall Study|Progressive Disease|0|||
147416983|NCT02407990|531691548|FG005|Overall Study|Progressive Disease|0|||
147416984|NCT02407990|531691549|FG006|Overall Study|Progressive Disease|0|||
147416985|NCT02407990|531691550|FG007|Overall Study|Progressive Disease|1|||
147416986|NCT02407990|531691543|FG000|Overall Study|Withdrawal by Subject|0|||
147416987|NCT02407990|531691544|FG001|Overall Study|Withdrawal by Subject|0|||
147416988|NCT02407990|531691545|FG002|Overall Study|Withdrawal by Subject|0|||
147416989|NCT02407990|531691546|FG003|Overall Study|Withdrawal by Subject|0|||
147416990|NCT02407990|531691547|FG004|Overall Study|Withdrawal by Subject|1|||
147416991|NCT02407990|531691548|FG005|Overall Study|Withdrawal by Subject|0|||
147416992|NCT02407990|531691549|FG006|Overall Study|Withdrawal by Subject|0|||
147416993|NCT02407990|531691550|FG007|Overall Study|Withdrawal by Subject|30|||
147416994|NCT02407990|531691543|FG000|Overall Study|Study Terminated by Sponsor|1|||
147416995|NCT02407990|531691544|FG001|Overall Study|Study Terminated by Sponsor|3|||
147416996|NCT02407990|531691545|FG002|Overall Study|Study Terminated by Sponsor|3|||
147416997|NCT02407990|531691546|FG003|Overall Study|Study Terminated by Sponsor|0|||
147416998|NCT02407990|531691547|FG004|Overall Study|Study Terminated by Sponsor|3|||
147416999|NCT02407990|531691548|FG005|Overall Study|Study Terminated by Sponsor|4|||
147417000|NCT02407990|531691549|FG006|Overall Study|Study Terminated by Sponsor|3|||
147417001|NCT02407990|531691550|FG007|Overall Study|Study Terminated by Sponsor|37|||
147417002|NCT02407990|531691543|FG000|Overall Study|Logistics|0|||
147417003|NCT02407990|531691544|FG001|Overall Study|Logistics|0|||
147417004|NCT02407990|531691545|FG002|Overall Study|Logistics|0|||
147417005|NCT02407990|531691546|FG003|Overall Study|Logistics|0|||
147417006|NCT02407990|531691547|FG004|Overall Study|Logistics|0|||
147417007|NCT02407990|531691548|FG005|Overall Study|Logistics|0|||
147417008|NCT02407990|531691549|FG006|Overall Study|Logistics|0|||
147417009|NCT02407990|531691550|FG007|Overall Study|Logistics|1|||
147417010|NCT02407990|531691543|FG000|Overall Study|Rolled into long-term extension study|0|||
147417011|NCT02407990|531691544|FG001|Overall Study|Rolled into long-term extension study|0|||
147417012|NCT02407990|531691545|FG002|Overall Study|Rolled into long-term extension study|0|||
147417013|NCT02407990|531691546|FG003|Overall Study|Rolled into long-term extension study|0|||
147417014|NCT02407990|531691547|FG004|Overall Study|Rolled into long-term extension study|0|||
147417015|NCT02407990|531691548|FG005|Overall Study|Rolled into long-term extension study|0|||
147417016|NCT02407990|531691549|FG006|Overall Study|Rolled into long-term extension study|0|||
147417017|NCT02407990|531691550|FG007|Overall Study|Rolled into long-term extension study|1|||
147417018|NCT00923260|531691551|FG000|Overall Study|Lost to Follow-up|1|||
147417019|NCT00923260|531691552|FG001|Overall Study|Lost to Follow-up|1|||
147625204|NCT04390763|532444968|FG000|Safety run-in Part|Progressive Disease|6|||
147625205|NCT04390763|532444969|FG001|Safety run-in Part|Progressive Disease|0|||
147625206|NCT04390763|532444970|FG002|Safety run-in Part|Progressive Disease|0|||
147625207|NCT04390763|532444971|FG003|Safety run-in Part|Progressive Disease|0|||
147625208|NCT04390763|532444968|FG000|Randomized Part|Adverse Event|0|||
147625209|NCT04390763|532444969|FG001|Randomized Part|Adverse Event|11|||
147625210|NCT04390763|532444970|FG002|Randomized Part|Adverse Event|5|||
147417020|NCT03809429|531691553|FG000|Overall Study|Withdrawal by Subject|7|||
147417021|NCT03809429|531691554|FG001|Overall Study|Withdrawal by Subject|3|||
147417022|NCT03809429|531691553|FG000|Overall Study|Adverse Event|6|||
147417023|NCT03809429|531691554|FG001|Overall Study|Adverse Event|9|||
147417024|NCT03809429|531691553|FG000|Overall Study|COVID-19|3|||
147417025|NCT03809429|531691554|FG001|Overall Study|COVID-19|1|||
147417026|NCT03809429|531691553|FG000|Overall Study|Participant was discontinued by investigator|12|||
147417027|NCT03809429|531691554|FG001|Overall Study|Participant was discontinued by investigator|7|||
147417028|NCT03377699|531691560|FG000|Overall Study|Withdrawal by Subject|2|||
147417029|NCT03377699|531691561|FG001|Overall Study|Withdrawal by Subject|9|||
147417030|NCT03377699|531691560|FG000|Overall Study|Lost to Follow-up|1|||
147417031|NCT03377699|531691561|FG001|Overall Study|Lost to Follow-up|1|||
147490714|NCT04594239|531951117|FG000|Overall Study|Lost to Follow-up|8|||
147625211|NCT04390763|532444971|FG003|Randomized Part|Adverse Event|5|||
147625212|NCT04390763|532444968|FG000|Randomized Part|Death|0|||
147625213|NCT04390763|532444969|FG001|Randomized Part|Death|3|||
147625214|NCT04390763|532444970|FG002|Randomized Part|Death|4|||
147625215|NCT04390763|532444971|FG003|Randomized Part|Death|2|||
147625216|NCT04390763|532444968|FG000|Randomized Part|Physician Decision|0|||
147625217|NCT04390763|532444969|FG001|Randomized Part|Physician Decision|2|||
147625218|NCT04390763|532444970|FG002|Randomized Part|Physician Decision|2|||
147625219|NCT04390763|532444971|FG003|Randomized Part|Physician Decision|9|||
147625220|NCT04390763|532444968|FG000|Randomized Part|Progressive Disease|0|||
147625221|NCT04390763|532444969|FG001|Randomized Part|Progressive Disease|24|||
147625222|NCT04390763|532444970|FG002|Randomized Part|Progressive Disease|31|||
147625223|NCT04390763|532444971|FG003|Randomized Part|Progressive Disease|23|||
147625224|NCT04390763|532444968|FG000|Randomized Part|Study terminated by sponsor|0|||
147625225|NCT04390763|532444969|FG001|Randomized Part|Study terminated by sponsor|1|||
147625226|NCT04390763|532444970|FG002|Randomized Part|Study terminated by sponsor|0|||
147625227|NCT04390763|532444971|FG003|Randomized Part|Study terminated by sponsor|0|||
147625228|NCT04390763|532444968|FG000|Randomized Part|Participant Decision|0|||
147625229|NCT04390763|532444969|FG001|Randomized Part|Participant Decision|5|||
147625230|NCT04390763|532444970|FG002|Randomized Part|Participant Decision|7|||
147625231|NCT04390763|532444971|FG003|Randomized Part|Participant Decision|6|||
147625232|NCT04390763|532444968|FG000|Randomized Part|Not treated|0|||
147625233|NCT04390763|532444969|FG001|Randomized Part|Not treated|4|||
147625234|NCT04390763|532444970|FG002|Randomized Part|Not treated|2|||
147625235|NCT04390763|532444971|FG003|Randomized Part|Not treated|7|||
147625236|NCT01956773|532444978|FG000|Overall Study|Lost to Follow-up|628|||
147625237|NCT01956773|532444979|FG001|Overall Study|Lost to Follow-up|1|||
147625238|NCT01383174|532444980|FG000|3 Month Assessment|Death|0|||
147625239|NCT01383174|532444981|FG001|3 Month Assessment|Death|1|||
147625240|NCT01383174|532444980|FG000|3 Month Assessment|Lost to Follow-up|2|||
147625241|NCT01383174|532444981|FG001|3 Month Assessment|Lost to Follow-up|0|||
147625242|NCT01383174|532444980|FG000|3 Month Assessment|Refused to complete|4|||
147625243|NCT01383174|532444981|FG001|3 Month Assessment|Refused to complete|0|||
147625244|NCT01383174|532444980|FG000|6 Month Assessment|Lost to Follow-up|1|||
147625245|NCT01383174|532444981|FG001|6 Month Assessment|Lost to Follow-up|1|||
147625246|NCT01383174|532444980|FG000|6 Month Assessment|Refused to complete|4|||
147625247|NCT01383174|532444981|FG001|6 Month Assessment|Refused to complete|0|||
147625248|NCT01153815|532444982|FG000|Overall Study|Adverse Event|3|||
147625249|NCT01153815|532444983|FG001|Overall Study|Adverse Event|1|||
147625250|NCT01153815|532444982|FG000|Overall Study|Withdrawal by Subject|6|||
147625251|NCT01153815|532444983|FG001|Overall Study|Withdrawal by Subject|4|||
147625252|NCT01786993|532444986|FG000|Overall Study|Death|6|||
147625253|NCT01786993|532444987|FG001|Overall Study|Death|7|||
147625254|NCT01786993|532444986|FG000|Overall Study|Withdrawal by Subject|3|||
147625255|NCT01786993|532444987|FG001|Overall Study|Withdrawal by Subject|2|||
147625256|NCT01786993|532444986|FG000|Overall Study|Lost to Follow-up|0|||
147625257|NCT01786993|532444987|FG001|Overall Study|Lost to Follow-up|1|||
147625258|NCT01786993|532444986|FG000|Overall Study|Subject Non-Compliance|1|||
147625259|NCT01786993|532444987|FG001|Overall Study|Subject Non-Compliance|0|||
147625260|NCT01786993|532444986|FG000|Overall Study|System Explant|1|||
147625261|NCT01786993|532444987|FG001|Overall Study|System Explant|0|||
147625262|NCT01786993|532444986|FG000|Overall Study|Hospice Admission|1|||
147625263|NCT01786993|532444987|FG001|Overall Study|Hospice Admission|0|||
147625264|NCT00450437|532444988|FG000|Overall Study|Withdrawal by Subject|10|||
147625265|NCT00450437|532444989|FG001|Overall Study|Withdrawal by Subject|2|||
147625266|NCT00450437|532444990|FG002|Overall Study|Withdrawal by Subject|0|||
147625267|NCT00450437|532444991|FG003|Overall Study|Withdrawal by Subject|1|||
147625268|NCT00450437|532444988|FG000|Overall Study|Lost to Follow-up|31|||
147625269|NCT00450437|532444989|FG001|Overall Study|Lost to Follow-up|12|||
147667996|NCT02669849|532609824|FG001|Overall Study|Withdrawal of Consent (not due to AE)|0|||
147667997|NCT02669849|532609825|FG002|Overall Study|Withdrawal of Consent (not due to AE)|3|||
147667998|NCT02669849|532609823|FG000|Overall Study|Lost to Follow-up|1|||
147625270|NCT00450437|532444990|FG002|Overall Study|Lost to Follow-up|19|||
147625271|NCT00450437|532444991|FG003|Overall Study|Lost to Follow-up|9|||
147625272|NCT00450437|532444988|FG000|Overall Study|Protocol Violation|0|||
147667999|NCT02669849|532609824|FG001|Overall Study|Lost to Follow-up|0|||
147625273|NCT00450437|532444989|FG001|Overall Study|Protocol Violation|1|||
147668000|NCT02669849|532609825|FG002|Overall Study|Lost to Follow-up|3|||
147668001|NCT02669849|532609823|FG000|Overall Study|Death|1|||
147668002|NCT02669849|532609824|FG001|Overall Study|Death|1|||
147668003|NCT02669849|532609825|FG002|Overall Study|Death|2|||
147668004|NCT02669849|532609823|FG000|Overall Study|Study terminated by sponsor|16|||
147625274|NCT00450437|532444990|FG002|Overall Study|Protocol Violation|0|||
147625275|NCT00450437|532444991|FG003|Overall Study|Protocol Violation|1|||
147625276|NCT00450437|532444988|FG000|Overall Study|Inappropriate enrollment|4|||
147625277|NCT00450437|532444989|FG001|Overall Study|Inappropriate enrollment|1|||
147625278|NCT00450437|532444990|FG002|Overall Study|Inappropriate enrollment|3|||
147625279|NCT00450437|532444991|FG003|Overall Study|Inappropriate enrollment|0|||
147625280|NCT00450437|532444988|FG000|Overall Study|Administrative reason|0|||
147625281|NCT00450437|532444989|FG001|Overall Study|Administrative reason|0|||
147625282|NCT00450437|532444990|FG002|Overall Study|Administrative reason|1|||
147625283|NCT00450437|532444991|FG003|Overall Study|Administrative reason|0|||
147625284|NCT00450437|532444988|FG000|Overall Study|Unable to Classify|1|||
147625285|NCT00450437|532444989|FG001|Overall Study|Unable to Classify|0|||
147625286|NCT00450437|532444990|FG002|Overall Study|Unable to Classify|1|||
147625287|NCT00450437|532444991|FG003|Overall Study|Unable to Classify|0|||
147625288|NCT01890122|532444992|FG000|Overall Study|Adverse Event|1|||
147625289|NCT01890122|532444993|FG001|Overall Study|Adverse Event|1|||
147625290|NCT01890122|532444994|FG002|Overall Study|Adverse Event|1|||
147625291|NCT01890122|532444995|FG003|Overall Study|Adverse Event|2|||
147625292|NCT01890122|532444992|FG000|Overall Study|Major Protocol Deviation|3|||
147625293|NCT01890122|532444993|FG001|Overall Study|Major Protocol Deviation|1|||
147625294|NCT01890122|532444994|FG002|Overall Study|Major Protocol Deviation|0|||
147625295|NCT01890122|532444995|FG003|Overall Study|Major Protocol Deviation|1|||
147625296|NCT01890122|532444992|FG000|Overall Study|Lost to Follow-up|0|||
147625297|NCT01890122|532444993|FG001|Overall Study|Lost to Follow-up|1|||
147625298|NCT01890122|532444994|FG002|Overall Study|Lost to Follow-up|2|||
147625299|NCT01890122|532444995|FG003|Overall Study|Lost to Follow-up|2|||
147625300|NCT01890122|532444992|FG000|Overall Study|Voluntary Withdrawal|8|||
147625301|NCT01890122|532444993|FG001|Overall Study|Voluntary Withdrawal|8|||
147625302|NCT01890122|532444994|FG002|Overall Study|Voluntary Withdrawal|2|||
147625303|NCT01890122|532444995|FG003|Overall Study|Voluntary Withdrawal|11|||
147625304|NCT01890122|532444992|FG000|Overall Study|Lack of Efficacy|14|||
147625305|NCT01890122|532444993|FG001|Overall Study|Lack of Efficacy|24|||
147625306|NCT01890122|532444994|FG002|Overall Study|Lack of Efficacy|7|||
147625307|NCT01890122|532444995|FG003|Overall Study|Lack of Efficacy|41|||
147625308|NCT01890122|532444992|FG000|Overall Study|Reason not Specified|0|||
147625309|NCT01890122|532444993|FG001|Overall Study|Reason not Specified|1|||
147625310|NCT01890122|532444994|FG002|Overall Study|Reason not Specified|1|||
147625311|NCT01890122|532444995|FG003|Overall Study|Reason not Specified|2|||
147625312|NCT01890122|532444992|FG000|Overall Study|Randomized but not Treated|1|||
147625313|NCT01890122|532444993|FG001|Overall Study|Randomized but not Treated|1|||
147625314|NCT01890122|532444994|FG002|Overall Study|Randomized but not Treated|0|||
147625315|NCT01890122|532444995|FG003|Overall Study|Randomized but not Treated|0|||
147625316|NCT02040805|532444996|FG000|Overall Study|Lost to Follow-up|14|||
147625317|NCT02040805|532444997|FG001|Overall Study|Lost to Follow-up|9|||
147625318|NCT02040805|532444996|FG000|Overall Study|Withdrawal by Subject|28|||
147625319|NCT02040805|532444997|FG001|Overall Study|Withdrawal by Subject|41|||
147625320|NCT03591874|532444998|FG000|Overall Study|Adverse Event|4|||
147625321|NCT03591874|532444999|FG001|Overall Study|Adverse Event|0|||
147625322|NCT03591874|532444998|FG000|Overall Study|Withdrawal by Subject|2|||
147625323|NCT03591874|532444999|FG001|Overall Study|Withdrawal by Subject|1|||
147625324|NCT03591874|532444998|FG000|Overall Study|Investigator Withdrawal of Subject|1|||
147625325|NCT03591874|532444999|FG001|Overall Study|Investigator Withdrawal of Subject|0|||
147625326|NCT03591874|532444998|FG000|Overall Study|On Study at Time of Study Termination|12|||
147625327|NCT03591874|532444999|FG001|Overall Study|On Study at Time of Study Termination|6|||
147625328|NCT00071110|532445002|FG000|Overall Study|Protocol Violation|0|||
147625329|NCT00071110|532445003|FG001|Overall Study|Protocol Violation|4|||
147625330|NCT00503698|532445005|FG000|Overall Study|Protocol Violation|5|||
147625331|NCT00503698|532445006|FG001|Overall Study|Protocol Violation|6|||
147625332|NCT00503698|532445005|FG000|Overall Study|Adverse Event|52|||
147625333|NCT00503698|532445006|FG001|Overall Study|Adverse Event|41|||
147625334|NCT00503698|532445005|FG000|Overall Study|Death|1|||
147625335|NCT00503698|532445006|FG001|Overall Study|Death|0|||
147625336|NCT00503698|532445005|FG000|Overall Study|Lack of Efficacy|3|||
147625337|NCT00503698|532445006|FG001|Overall Study|Lack of Efficacy|4|||
147625338|NCT00503698|532445005|FG000|Overall Study|Trial terminated|216|||
147625339|NCT00503698|532445006|FG001|Overall Study|Trial terminated|253|||
147625340|NCT00503698|532445005|FG000|Overall Study|End hemodialysis due to renal transplant|10|||
147625341|NCT00503698|532445006|FG001|Overall Study|End hemodialysis due to renal transplant|4|||
147625342|NCT00503698|532445005|FG000|Overall Study|Pregnancy/intention to become pregnant|1|||
147625343|NCT00503698|532445006|FG001|Overall Study|Pregnancy/intention to become pregnant|0|||
147625344|NCT00503698|532445005|FG000|Overall Study|Any condition in exclusion criteria|4|||
147625345|NCT00503698|532445006|FG001|Overall Study|Any condition in exclusion criteria|6|||
147625346|NCT00503698|532445005|FG000|Overall Study|Switch to peritoneal or home dialysis|2|||
147625347|NCT00503698|532445006|FG001|Overall Study|Switch to peritoneal or home dialysis|2|||
147625348|NCT00503698|532445005|FG000|Overall Study|Move to nonparticipating dialysis center|2|||
147625349|NCT00503698|532445006|FG001|Overall Study|Move to nonparticipating dialysis center|1|||
147625350|NCT00503698|532445005|FG000|Overall Study|Critically ill|2|||
147625351|NCT00503698|532445006|FG001|Overall Study|Critically ill|0|||
147625352|NCT00503698|532445005|FG000|Overall Study|Unclassified|48|||
147625353|NCT00503698|532445006|FG001|Overall Study|Unclassified|32|||
147625354|NCT00503698|532445005|FG000|Overall Study|Not exposed to trial drug|11|||
147625355|NCT00503698|532445006|FG001|Overall Study|Not exposed to trial drug|6|||
147625356|NCT03194542|532445008|FG000|Overall Study|Participant to Receive Bone Marrow Transplant|1|||
147625357|NCT03194542|532445009|FG001|Overall Study|Participant to Receive Bone Marrow Transplant|0|||
147625358|NCT03194542|532445010|FG002|Overall Study|Participant to Receive Bone Marrow Transplant|0|||
147625359|NCT03194542|532445011|FG003|Overall Study|Participant to Receive Bone Marrow Transplant|0|||
147625360|NCT03194542|532445008|FG000|Overall Study|Rollover to Long-term follow-up Protocol|1|||
147625361|NCT03194542|532445009|FG001|Overall Study|Rollover to Long-term follow-up Protocol|1|||
147625362|NCT03194542|532445010|FG002|Overall Study|Rollover to Long-term follow-up Protocol|0|||
147625363|NCT03194542|532445011|FG003|Overall Study|Rollover to Long-term follow-up Protocol|5|||
147625364|NCT03194542|532445008|FG000|Overall Study|Per Protocol Repeat Blasts of 10%|1|||
147625365|NCT03194542|532445009|FG001|Overall Study|Per Protocol Repeat Blasts of 10%|0|||
147625366|NCT03194542|532445010|FG002|Overall Study|Per Protocol Repeat Blasts of 10%|1|||
147625367|NCT03194542|532445011|FG003|Overall Study|Per Protocol Repeat Blasts of 10%|0|||
147625368|NCT03194542|532445008|FG000|Overall Study|Loss of Response|4|||
147625369|NCT03194542|532445009|FG001|Overall Study|Loss of Response|2|||
147625370|NCT03194542|532445010|FG002|Overall Study|Loss of Response|3|||
147625371|NCT03194542|532445011|FG003|Overall Study|Loss of Response|4|||
147625372|NCT03194542|532445008|FG000|Overall Study|Physician Decision|0|||
147625373|NCT03194542|532445009|FG001|Overall Study|Physician Decision|1|||
147625374|NCT03194542|532445010|FG002|Overall Study|Physician Decision|0|||
147625375|NCT03194542|532445011|FG003|Overall Study|Physician Decision|0|||
147625376|NCT03194542|532445008|FG000|Overall Study|Lack of Efficacy|2|||
147625377|NCT03194542|532445009|FG001|Overall Study|Lack of Efficacy|2|||
147625378|NCT03194542|532445010|FG002|Overall Study|Lack of Efficacy|2|||
147625379|NCT03194542|532445011|FG003|Overall Study|Lack of Efficacy|6|||
147625380|NCT03194542|532445008|FG000|Overall Study|Withdrawal by Subject|2|||
147625381|NCT03194542|532445009|FG001|Overall Study|Withdrawal by Subject|1|||
147625382|NCT03194542|532445010|FG002|Overall Study|Withdrawal by Subject|5|||
147625383|NCT03194542|532445011|FG003|Overall Study|Withdrawal by Subject|4|||
147625384|NCT03194542|532445008|FG000|Overall Study|Progressive Disease|1|||
147625385|NCT03194542|532445009|FG001|Overall Study|Progressive Disease|0|||
147625386|NCT03194542|532445010|FG002|Overall Study|Progressive Disease|1|||
147625387|NCT03194542|532445011|FG003|Overall Study|Progressive Disease|1|||
147625388|NCT03194542|532445008|FG000|Overall Study|Adverse Event|1|||
147625389|NCT03194542|532445009|FG001|Overall Study|Adverse Event|2|||
147625390|NCT03194542|532445010|FG002|Overall Study|Adverse Event|0|||
147625391|NCT03194542|532445011|FG003|Overall Study|Adverse Event|5|||
147625392|NCT03194542|532445008|FG000|Overall Study|Death|1|||
147625393|NCT03194542|532445009|FG001|Overall Study|Death|2|||
147625394|NCT03194542|532445010|FG002|Overall Study|Death|0|||
147625395|NCT03194542|532445011|FG003|Overall Study|Death|5|||
147625396|NCT03194542|532445008|FG000|Overall Study|Completed the primary treatment phase but did not meet clinical benefit criteria|8|||
147625397|NCT03194542|532445009|FG001|Overall Study|Completed the primary treatment phase but did not meet clinical benefit criteria|10|||
147625398|NCT03194542|532445010|FG002|Overall Study|Completed the primary treatment phase but did not meet clinical benefit criteria|2|||
147625399|NCT03194542|532445011|FG003|Overall Study|Completed the primary treatment phase but did not meet clinical benefit criteria|8|||
147625400|NCT03655405|532445012|FG000|Overall Study|Death after initial data collection|4|||
147625401|NCT03655405|532445013|FG001|Overall Study|Death after initial data collection|2|||
147625402|NCT03655405|532445012|FG000|Overall Study|Died before initial data collection|1|||
147625403|NCT03655405|532445013|FG001|Overall Study|Died before initial data collection|2|||
147625404|NCT03655405|532445012|FG000|Overall Study|Protocol Violation|0|||
147625405|NCT03655405|532445013|FG001|Overall Study|Protocol Violation|1|||
147625406|NCT00030901|532445014|FG000|Initial Registration|Ineligible|167|||
147625407|NCT00030901|532445015|FG001|Initial Registration|Ineligible|0|||
147625408|NCT00030901|532445016|FG002|Initial Registration|Ineligible|0|||
147625409|NCT00030901|532445014|FG000|Randomization|Adverse Event|0|||
147625410|NCT00030901|532445015|FG001|Randomization|Adverse Event|11|||
147625411|NCT00030901|532445016|FG002|Randomization|Adverse Event|7|||
147625412|NCT00030901|532445014|FG000|Randomization|Refusal Unrelated to Adverse Event|0|||
147490715|NCT04594239|531951118|FG001|Overall Study|Lost to Follow-up|5|||
147625413|NCT00030901|532445015|FG001|Randomization|Refusal Unrelated to Adverse Event|16|||
147625414|NCT00030901|532445016|FG002|Randomization|Refusal Unrelated to Adverse Event|10|||
147625415|NCT00030901|532445014|FG000|Randomization|Progression/Relapse|0|||
147625416|NCT00030901|532445015|FG001|Randomization|Progression/Relapse|22|||
147625417|NCT00030901|532445016|FG002|Randomization|Progression/Relapse|21|||
147625418|NCT00030901|532445014|FG000|Randomization|Death|0|||
147625419|NCT00030901|532445015|FG001|Randomization|Death|1|||
147625420|NCT00030901|532445016|FG002|Randomization|Death|3|||
147625421|NCT00030901|532445014|FG000|Randomization|Other|0|||
147625422|NCT00030901|532445015|FG001|Randomization|Other|36|||
147625423|NCT00030901|532445016|FG002|Randomization|Other|33|||
147625424|NCT00030901|532445014|FG000|Randomization|Ineligible|0|||
147625425|NCT00030901|532445015|FG001|Randomization|Ineligible|15|||
147625426|NCT00030901|532445016|FG002|Randomization|Ineligible|14|||
147625427|NCT01806051|532445017|FG000|Overall Study|Withdrawal by Subject|6|||
147625428|NCT02576847|532445018|FG000|Overall Study|Adverse Event|27|||
147625429|NCT02576847|532445018|FG000|Overall Study|Lost to Follow-up|22|||
147625430|NCT02576847|532445018|FG000|Overall Study|Physician Decision|1|||
147625431|NCT02576847|532445018|FG000|Overall Study|Pregnancy|1|||
147625432|NCT02576847|532445018|FG000|Overall Study|Protocol Violation|3|||
147625433|NCT02576847|532445018|FG000|Overall Study|Withdrawal by Subject|78|||
147625434|NCT02576847|532445018|FG000|Overall Study|Other|5|||
147625435|NCT04955691|532447017|FG000|Period 2|Discontinued intervention|1|||
147625436|NCT04955691|532447018|FG001|Period 2|Discontinued intervention|2|||
147625437|NCT05795153|532447019|FG000|Overall Study|Adverse Event|2|||
147625438|NCT05795153|532447019|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
147625439|NCT05795153|532447019|FG000|Overall Study|Lost to Follow-up|1|||
147625440|NCT05795153|532447019|FG000|Overall Study|Subject decision|2|||
147625441|NCT03760744|532447020|FG000|Overall Study|Lost to Follow-up|3|||
147625442|NCT03760744|532447021|FG001|Overall Study|Lost to Follow-up|0|||
147625443|NCT03668119|532447022|FG000|Pre-treatment|Disease Progression|1|||
147625444|NCT03668119|532447023|FG001|Pre-treatment|Disease Progression|0|||
147625445|NCT03668119|532447022|FG000|Treatment|Disease Progression|76|||
147625446|NCT03668119|532447023|FG001|Treatment|Disease Progression|57|||
147625447|NCT03668119|532447022|FG000|Treatment|Study drug toxicity|19|||
147625448|NCT03668119|532447023|FG001|Treatment|Study drug toxicity|1|||
147625449|NCT03668119|532447022|FG000|Treatment|Death|3|||
147625450|NCT03668119|532447023|FG001|Treatment|Death|0|||
147625451|NCT03668119|532447022|FG000|Treatment|Adverse Event unrelated to Study drug|4|||
147625452|NCT03668119|532447023|FG001|Treatment|Adverse Event unrelated to Study drug|3|||
147625453|NCT03668119|532447022|FG000|Treatment|Withdrawal by Subject|1|||
147625454|NCT03668119|532447023|FG001|Treatment|Withdrawal by Subject|1|||
147625455|NCT03668119|532447022|FG000|Treatment|Participant request to discontinue study treatment|3|||
147625456|NCT03668119|532447023|FG001|Treatment|Participant request to discontinue study treatment|1|||
147625457|NCT03668119|532447022|FG000|Treatment|Maximum Clinical Benefit|0|||
147625458|NCT03668119|532447023|FG001|Treatment|Maximum Clinical Benefit|1|||
147625459|NCT03668119|532447022|FG000|Treatment|Participants completed treatment|27|||
147625460|NCT03668119|532447023|FG001|Treatment|Participants completed treatment|11|||
147625461|NCT03668119|532447022|FG000|Treatment|Other reasons|2|||
147625462|NCT03668119|532447023|FG001|Treatment|Other reasons|1|||
147625463|NCT03769168|532447024|FG000|Overall Study|Adverse Event|0|||
147625464|NCT03769168|532447025|FG001|Overall Study|Adverse Event|1|||
147625465|NCT03769168|532447024|FG000|Overall Study|Lack of Efficacy|2|||
147625466|NCT03769168|532447025|FG001|Overall Study|Lack of Efficacy|4|||
147625467|NCT03769168|532447024|FG000|Overall Study|Post study access to treatment|3|||
147625468|NCT03769168|532447025|FG001|Overall Study|Post study access to treatment|11|||
147625469|NCT03769168|532447024|FG000|Overall Study|Physician Decision|1|||
147625470|NCT03769168|532447025|FG001|Overall Study|Physician Decision|4|||
147625471|NCT03769168|532447024|FG000|Overall Study|Subject Decision|2|||
147625472|NCT03769168|532447025|FG001|Overall Study|Subject Decision|4|||
147625473|NCT03769168|532447024|FG000|Overall Study|Guardian decision|1|||
147625474|NCT03769168|532447025|FG001|Overall Study|Guardian decision|0|||
147625475|NCT05336227|532447026|FG000|Overall Study|Adverse Event|1|||
147625476|NCT05336227|532447027|FG001|Overall Study|Adverse Event|0|||
147625477|NCT05336227|532447026|FG000|Overall Study|Lost to Follow-up|2|||
147625478|NCT05336227|532447027|FG001|Overall Study|Lost to Follow-up|0|||
147625479|NCT05336227|532447026|FG000|Overall Study|Withdrawal by Subject|1|||
147625480|NCT05336227|532447027|FG001|Overall Study|Withdrawal by Subject|0|||
147625481|NCT04050462|532447028|FG000|Overall Study|Withdrawal by Subject|1|||
147625482|NCT04050462|532447029|FG001|Overall Study|Withdrawal by Subject|0|||
147625483|NCT04050462|532447030|FG002|Overall Study|Withdrawal by Subject|0|||
147625484|NCT05468164|532447044|FG000|Treatment Period 4|Adverse Event|0|||
147625485|NCT05468164|532447045|FG001|Treatment Period 4|Adverse Event|0|||
147625486|NCT05468164|532447046|FG002|Treatment Period 4|Adverse Event|0|||
147625487|NCT05468164|532447047|FG003|Treatment Period 4|Adverse Event|1|||
147625488|NCT03827291|532447048|FG000|Overall Study|Intraoperative conversion of surgery from laparoscopic to open|5|||
147625489|NCT03827291|532447049|FG001|Overall Study|Intraoperative conversion of surgery from laparoscopic to open|0|||
147625490|NCT04795466|532447050|FG000|Overall Study|Adverse Event|3|||
147625491|NCT04795466|532447051|FG001|Overall Study|Adverse Event|1|||
147625492|NCT04795466|532447050|FG000|Overall Study|Physician Decision|1|||
147625493|NCT04795466|532447051|FG001|Overall Study|Physician Decision|0|||
147625494|NCT04795466|532447050|FG000|Overall Study|Withdrawal by Subject|2|||
147625495|NCT04795466|532447051|FG001|Overall Study|Withdrawal by Subject|1|||
147625496|NCT04652726|532447052|FG000|Part 1 (Double-blind Period)|Physician Decision|1|||
147625497|NCT04652726|532447053|FG001|Part 1 (Double-blind Period)|Physician Decision|0|||
147625498|NCT04652726|532447054|FG002|Part 1 (Double-blind Period)|Physician Decision|0|||
147625499|NCT04652726|532447052|FG000|Part 1 (Double-blind Period)|Participant/guardian decision|1|||
147625500|NCT04652726|532447053|FG001|Part 1 (Double-blind Period)|Participant/guardian decision|0|||
147625501|NCT04652726|532447054|FG002|Part 1 (Double-blind Period)|Participant/guardian decision|0|||
147625502|NCT01102257|532447061|FG000|Overall Study|Adverse Event|1|||
147625503|NCT01102257|532447062|FG001|Overall Study|Adverse Event|0|||
147625504|NCT01102257|532447061|FG000|Overall Study|Adverse Event|1|||
147625505|NCT01102257|532447062|FG001|Overall Study|Adverse Event|0|||
147625506|NCT04066244|532447063|FG000|Part 2 (Cohort 5)|Adverse Event|0|||
147625507|NCT04066244|532447064|FG001|Part 2 (Cohort 5)|Adverse Event|0|||
147625508|NCT04066244|532447065|FG002|Part 2 (Cohort 5)|Adverse Event|0|||
147625509|NCT04066244|532447066|FG003|Part 2 (Cohort 5)|Adverse Event|0|||
147625510|NCT04066244|532447067|FG004|Part 2 (Cohort 5)|Adverse Event|0|||
147625511|NCT04066244|532447068|FG005|Part 2 (Cohort 5)|Adverse Event|1|||
147625512|NCT04066244|532447063|FG000|Part 2 (Cohort 5)|Death|0|||
147625513|NCT04066244|532447064|FG001|Part 2 (Cohort 5)|Death|0|||
147625514|NCT04066244|532447065|FG002|Part 2 (Cohort 5)|Death|0|||
147625515|NCT04066244|532447066|FG003|Part 2 (Cohort 5)|Death|0|||
147625516|NCT04066244|532447067|FG004|Part 2 (Cohort 5)|Death|0|||
147625517|NCT04066244|532447068|FG005|Part 2 (Cohort 5)|Death|2|||
147625518|NCT04066244|532447063|FG000|Part 2 (Cohort 5)|Study terminated by sponsor|0|||
147625519|NCT04066244|532447064|FG001|Part 2 (Cohort 5)|Study terminated by sponsor|0|||
147625520|NCT04066244|532447065|FG002|Part 2 (Cohort 5)|Study terminated by sponsor|0|||
147625521|NCT04066244|532447066|FG003|Part 2 (Cohort 5)|Study terminated by sponsor|0|||
147625522|NCT04066244|532447067|FG004|Part 2 (Cohort 5)|Study terminated by sponsor|0|||
147625523|NCT04066244|532447068|FG005|Part 2 (Cohort 5)|Study terminated by sponsor|1|||
147625524|NCT04066244|532447063|FG000|Part 2 (Cohort 5)|Withdrawal by Subject|0|||
147625525|NCT04066244|532447064|FG001|Part 2 (Cohort 5)|Withdrawal by Subject|0|||
147625526|NCT04066244|532447065|FG002|Part 2 (Cohort 5)|Withdrawal by Subject|0|||
147625527|NCT04066244|532447066|FG003|Part 2 (Cohort 5)|Withdrawal by Subject|0|||
147625528|NCT04066244|532447067|FG004|Part 2 (Cohort 5)|Withdrawal by Subject|1|||
147625529|NCT04066244|532447068|FG005|Part 2 (Cohort 5)|Withdrawal by Subject|0|||
147625530|NCT01467713|532447070|FG000|Overall Study|Pretreatment Event or Adverse Event|9|||
147625531|NCT01467713|532447071|FG001|Overall Study|Pretreatment Event or Adverse Event|4|||
147625532|NCT01467713|532447072|FG002|Overall Study|Pretreatment Event or Adverse Event|6|||
147625533|NCT01467713|532447073|FG003|Overall Study|Pretreatment Event or Adverse Event|5|||
147625534|NCT01467713|532447070|FG000|Overall Study|Major Protocol Deviation|2|||
147625535|NCT01467713|532447071|FG001|Overall Study|Major Protocol Deviation|4|||
147625536|NCT01467713|532447072|FG002|Overall Study|Major Protocol Deviation|4|||
147625537|NCT01467713|532447073|FG003|Overall Study|Major Protocol Deviation|1|||
147625538|NCT01467713|532447070|FG000|Overall Study|Lost to Follow-up|9|||
147625539|NCT01467713|532447071|FG001|Overall Study|Lost to Follow-up|12|||
147625540|NCT01467713|532447072|FG002|Overall Study|Lost to Follow-up|6|||
147625541|NCT01467713|532447073|FG003|Overall Study|Lost to Follow-up|9|||
147625542|NCT01467713|532447070|FG000|Overall Study|Voluntary Withdrawal|18|||
147625543|NCT01467713|532447071|FG001|Overall Study|Voluntary Withdrawal|14|||
147625544|NCT01467713|532447072|FG002|Overall Study|Voluntary Withdrawal|21|||
147625545|NCT01467713|532447073|FG003|Overall Study|Voluntary Withdrawal|20|||
147625546|NCT01467713|532447070|FG000|Overall Study|Study Termination|23|||
147625547|NCT01467713|532447071|FG001|Overall Study|Study Termination|33|||
147625548|NCT01467713|532447072|FG002|Overall Study|Study Termination|28|||
147625549|NCT01467713|532447073|FG003|Overall Study|Study Termination|29|||
147625550|NCT01467713|532447070|FG000|Overall Study|Pregnancy|0|||
147625551|NCT01467713|532447071|FG001|Overall Study|Pregnancy|1|||
147625552|NCT01467713|532447072|FG002|Overall Study|Pregnancy|1|||
147625553|NCT01467713|532447073|FG003|Overall Study|Pregnancy|3|||
147625554|NCT01467713|532447070|FG000|Overall Study|Relapse|35|||
147625555|NCT01467713|532447071|FG001|Overall Study|Relapse|25|||
147625556|NCT01467713|532447072|FG002|Overall Study|Relapse|28|||
147625557|NCT01467713|532447073|FG003|Overall Study|Relapse|35|||
147625558|NCT01467713|532447070|FG000|Overall Study|Reason not Specified|6|||
147625559|NCT01467713|532447071|FG001|Overall Study|Reason not Specified|11|||
147625560|NCT01467713|532447072|FG002|Overall Study|Reason not Specified|8|||
147625561|NCT01467713|532447073|FG003|Overall Study|Reason not Specified|7|||
147625562|NCT02525783|532447074|FG000|Overall Study|Lost to Follow-up|10|||
147625563|NCT00866281|532447075|FG000|Overall Study|Adverse Event|1|||
147625564|NCT00866281|532447076|FG001|Overall Study|Adverse Event|0|||
147625565|NCT00866281|532447075|FG000|Overall Study|Withdrawal by participants|3|||
147625566|NCT00866281|532447076|FG001|Overall Study|Withdrawal by participants|0|||
147625567|NCT00866281|532447075|FG000|Overall Study|Disease progression|3|||
147625568|NCT00866281|532447076|FG001|Overall Study|Disease progression|11|||
147625569|NCT00866281|532447075|FG000|Overall Study|New cancer therapy|0|||
147625570|NCT00866281|532447076|FG001|Overall Study|New cancer therapy|4|||
147625571|NCT01100086|532447077|FG000|Period 1|Withdrawal by Subject|1|||
147625572|NCT01100086|532447078|FG001|Period 1|Withdrawal by Subject|0|||
147625573|NCT02275546|532447079|FG000|Treatment Period 2|Withdrawal by Subject|2|||
147625574|NCT02275546|532447080|FG001|Treatment Period 2|Withdrawal by Subject|1|||
147625575|NCT02275546|532447079|FG000|Treatment Period 2|Protocol Violation|0|||
147625576|NCT02275546|532447080|FG001|Treatment Period 2|Protocol Violation|1|||
147625577|NCT02612623|532447089|FG000|Overall Study|Withdrawal by Subject|0|||
147625578|NCT02612623|532447090|FG001|Overall Study|Withdrawal by Subject|1|||
147625579|NCT02612623|532447091|FG002|Overall Study|Withdrawal by Subject|0|||
147625580|NCT02612623|532447092|FG003|Overall Study|Withdrawal by Subject|0|||
147625581|NCT02612623|532447089|FG000|Overall Study|Adverse Event|1|||
147625582|NCT02612623|532447090|FG001|Overall Study|Adverse Event|0|||
147625583|NCT02612623|532447091|FG002|Overall Study|Adverse Event|1|||
147625584|NCT02612623|532447092|FG003|Overall Study|Adverse Event|0|||
147625585|NCT00333983|532447093|FG000|Overall Study|Lost to Follow-up|2|||
147625586|NCT00333983|532447094|FG001|Overall Study|Lost to Follow-up|1|||
147625587|NCT00333983|532447095|FG002|Overall Study|Lost to Follow-up|0|||
147625588|NCT00333983|532447093|FG000|Overall Study|Adverse Event|1|||
147625589|NCT00333983|532447094|FG001|Overall Study|Adverse Event|1|||
147417032|NCT03377699|531691560|FG000|Overall Study|Commencement of medical infertility treatment during the course of the trial|1|||
147417033|NCT03377699|531691561|FG001|Overall Study|Commencement of medical infertility treatment during the course of the trial|0|||
147625590|NCT00333983|532447095|FG002|Overall Study|Adverse Event|1|||
147625591|NCT00333983|532447093|FG000|Overall Study|Withdrawal by Subject|0|||
147625592|NCT00333983|532447094|FG001|Overall Study|Withdrawal by Subject|3|||
147625593|NCT00333983|532447095|FG002|Overall Study|Withdrawal by Subject|1|||
147417034|NCT03377699|531691560|FG000|Overall Study|Non-pregnant subject initiating medication contraindicated during pregnancy|1|||
147417035|NCT03377699|531691561|FG001|Overall Study|Non-pregnant subject initiating medication contraindicated during pregnancy|1|||
147417036|NCT03377699|531691560|FG000|Overall Study|Randomised non-pregnant did not become pregnant and withdrawn from trial|11|||
147417037|NCT03377699|531691561|FG001|Overall Study|Randomised non-pregnant did not become pregnant and withdrawn from trial|8|||
147417038|NCT03377699|531691560|FG000|Overall Study|Randomised non-pregnant did not become pregnant and NOT withdrawn from trial|6|||
147417039|NCT03377699|531691561|FG001|Overall Study|Randomised non-pregnant did not become pregnant and NOT withdrawn from trial|6|||
147417040|NCT00774930|531691564|FG000|DB Phase|Early Roll Over (ERO) to IOL phase|11|||
147417041|NCT00774930|531691565|FG001|DB Phase|Early Roll Over (ERO) to IOL phase|12|||
147417042|NCT00774930|531691564|FG000|DB Phase|Adverse Event|1|||
147417043|NCT00774930|531691565|FG001|DB Phase|Adverse Event|2|||
147417044|NCT00774930|531691564|FG000|DB Phase|Subject Decision|1|||
147417045|NCT00774930|531691565|FG001|DB Phase|Subject Decision|5|||
147417046|NCT00774930|531691564|FG000|DB Phase|Sponsor Decision|0|||
147417047|NCT00774930|531691565|FG001|DB Phase|Sponsor Decision|1|||
147417048|NCT00774930|531691564|FG000|DB Phase|Disease Progression|1|||
147417049|NCT00774930|531691565|FG001|DB Phase|Disease Progression|1|||
147417050|NCT00774930|531691564|FG000|DB Phase|Started Nonprotocol Radiation therapy|0|||
147417051|NCT00774930|531691565|FG001|DB Phase|Started Nonprotocol Radiation therapy|1|||
147417052|NCT00774930|531691564|FG000|IOL Phase|Adverse Event|1|||
147417053|NCT00774930|531691565|FG001|IOL Phase|Adverse Event|1|||
147417054|NCT00774930|531691564|FG000|IOL Phase|Subject Decision|4|||
147417055|NCT00774930|531691565|FG001|IOL Phase|Subject Decision|3|||
147417056|NCT00774930|531691564|FG000|IOL Phase|Physician Decision|3|||
147417057|NCT00774930|531691565|FG001|IOL Phase|Physician Decision|2|||
147417058|NCT00774930|531691564|FG000|IOL Phase|Sponsor Decision|1|||
147417059|NCT00774930|531691565|FG001|IOL Phase|Sponsor Decision|0|||
147417060|NCT00774930|531691564|FG000|IOL Phase|Disease Progression|2|||
147417061|NCT00774930|531691565|FG001|IOL Phase|Disease Progression|1|||
147417062|NCT00774930|531691564|FG000|IOL Phase|Subject Consumed Prohibited Medication|1|||
147417063|NCT00774930|531691565|FG001|IOL Phase|Subject Consumed Prohibited Medication|0|||
147417064|NCT00774930|531691564|FG000|IOL Phase|Peptide Receptor Radionuclide Therapy|0|||
147417065|NCT00774930|531691565|FG001|IOL Phase|Peptide Receptor Radionuclide Therapy|1|||
147417066|NCT00774930|531691564|FG000|IOL Phase|Other|1|||
147417067|NCT00774930|531691565|FG001|IOL Phase|Other|0|||
147417068|NCT00774930|531691564|FG000|IOL Phase|Brain radiation|0|||
147417069|NCT00774930|531691565|FG001|IOL Phase|Brain radiation|1|||
147417070|NCT00774930|531691564|FG000|LTOLE Phase|Adverse Event|7|||
147417071|NCT00774930|531691565|FG001|LTOLE Phase|Adverse Event|3|||
147417072|NCT00774930|531691564|FG000|LTOLE Phase|Subject decision|0|||
147417073|NCT00774930|531691565|FG001|LTOLE Phase|Subject decision|5|||
147417074|NCT00774930|531691564|FG000|LTOLE Phase|Physician Decision|4|||
147417075|NCT00774930|531691565|FG001|LTOLE Phase|Physician Decision|1|||
147417076|NCT00774930|531691564|FG000|LTOLE Phase|Sponsor decision|2|||
147417077|NCT00774930|531691565|FG001|LTOLE Phase|Sponsor decision|1|||
147417078|NCT00774930|531691564|FG000|LTOLE Phase|Disease Progression|2|||
147417079|NCT00774930|531691565|FG001|LTOLE Phase|Disease Progression|5|||
147417080|NCT00774930|531691564|FG000|LTOLE Phase|Tumour Progression of Hepatic Metastases|0|||
147417081|NCT00774930|531691565|FG001|LTOLE Phase|Tumour Progression of Hepatic Metastases|1|||
147417082|NCT00774930|531691564|FG000|LTOLE Phase|Proton Pump Inhibitor Dose Adjusted|0|||
147417083|NCT00774930|531691565|FG001|LTOLE Phase|Proton Pump Inhibitor Dose Adjusted|1|||
147417084|NCT01153321|531691566|FG000|Overall Study|Development of study withdrawal criteria|0|||
147417085|NCT01153321|531691567|FG001|Overall Study|Development of study withdrawal criteria|1|||
147417086|NCT01153321|531691566|FG000|Overall Study|Withdrawal by Subject|0|||
147417087|NCT01153321|531691567|FG001|Overall Study|Withdrawal by Subject|1|||
147417088|NCT01153321|531691566|FG000|Overall Study|Adverse Event|1|||
147417089|NCT01153321|531691567|FG001|Overall Study|Adverse Event|1|||
147417090|NCT01177800|531691568|FG000|Overall Study|Adverse Event|9|||
147417091|NCT01177800|531691569|FG001|Overall Study|Adverse Event|3|||
147417092|NCT01177800|531691568|FG000|Overall Study|Protocol Violation|0|||
147417093|NCT01177800|531691569|FG001|Overall Study|Protocol Violation|1|||
147417094|NCT01177800|531691568|FG000|Overall Study|Physician Decision|1|||
147417095|NCT01177800|531691569|FG001|Overall Study|Physician Decision|0|||
147417096|NCT01177800|531691568|FG000|Overall Study|Withdrawal of informed consent|0|||
147417097|NCT01177800|531691569|FG001|Overall Study|Withdrawal of informed consent|1|||
147417098|NCT00424385|531691570|FG000|Cohort 0|Withdrawal by Subject|5|||
147625594|NCT00449865|532447099|FG000|Overall Study|Withdrawal by Subject|110|||
147625595|NCT00449865|532447100|FG001|Overall Study|Withdrawal by Subject|110|||
147625596|NCT00449865|532447099|FG000|Overall Study|Lost to Follow-up|36|||
147625597|NCT00449865|532447100|FG001|Overall Study|Lost to Follow-up|37|||
147625598|NCT00449865|532447099|FG000|Overall Study|Physician Decision|13|||
147625599|NCT00449865|532447100|FG001|Overall Study|Physician Decision|12|||
147625600|NCT00449865|532447099|FG000|Overall Study|Death|31|||
147625601|NCT00449865|532447100|FG001|Overall Study|Death|40|||
147625602|NCT00449865|532447099|FG000|Overall Study|Protocol Violation|8|||
147625603|NCT00449865|532447100|FG001|Overall Study|Protocol Violation|7|||
147625604|NCT00449865|532447099|FG000|Overall Study|Study was stopped|324|||
147625605|NCT00449865|532447100|FG001|Overall Study|Study was stopped|328|||
147625606|NCT00406367|532447101|FG000|Main Period - 6 to 20 Weeks|Withdrawal Criteria Occurred|4|||
147625607|NCT00406367|532447102|FG001|Main Period - 6 to 20 Weeks|Withdrawal Criteria Occurred|0|||
147625608|NCT00406367|532447101|FG000|Main Period - 6 to 20 Weeks|Consent Withdrawn|1|||
147625609|NCT00406367|532447102|FG001|Main Period - 6 to 20 Weeks|Consent Withdrawn|0|||
147625610|NCT00406367|532447101|FG000|Main Period - 6 to 20 Weeks|Lost to Follow-up|0|||
147625611|NCT00406367|532447102|FG001|Main Period - 6 to 20 Weeks|Lost to Follow-up|1|||
147625612|NCT00406367|532447101|FG000|Main Period - 6 to 20 Weeks|Dosing Error At Visit 2 (Baseline)|0|||
147625613|NCT00406367|532447102|FG001|Main Period - 6 to 20 Weeks|Dosing Error At Visit 2 (Baseline)|1|||
147625614|NCT00406367|532447101|FG000|Open-Label Ext. Period - up to 68 Weeks|Lost to Follow-up|2|||
147625615|NCT00406367|532447102|FG001|Open-Label Ext. Period - up to 68 Weeks|Lost to Follow-up|0|||
147625616|NCT00406367|532447101|FG000|Open-Label Ext. Period - up to 68 Weeks|Consent Withdrawn|6|||
147625617|NCT00406367|532447102|FG001|Open-Label Ext. Period - up to 68 Weeks|Consent Withdrawn|0|||
147625618|NCT00406367|532447101|FG000|Open-Label Ext. Period - up to 68 Weeks|Withdrawal Criteria Occurred|4|||
147625619|NCT00406367|532447102|FG001|Open-Label Ext. Period - up to 68 Weeks|Withdrawal Criteria Occurred|0|||
147625620|NCT00406367|532447101|FG000|Open-Label Ext. Period - up to 68 Weeks|Lack of Efficacy|4|||
147625621|NCT00406367|532447102|FG001|Open-Label Ext. Period - up to 68 Weeks|Lack of Efficacy|0|||
147625622|NCT00406367|532447101|FG000|Open-Label Ext. Period - up to 68 Weeks|Subjects Needed Further Injection|1|||
147625623|NCT00406367|532447102|FG001|Open-Label Ext. Period - up to 68 Weeks|Subjects Needed Further Injection|0|||
147625624|NCT00406367|532447101|FG000|Open-Label Ext. Period - up to 68 Weeks|Subject Received Botox Injection|1|||
147625625|NCT00406367|532447102|FG001|Open-Label Ext. Period - up to 68 Weeks|Subject Received Botox Injection|0|||
147625626|NCT00406367|532447101|FG000|Open-Label Ext. Period - up to 68 Weeks|Injection in Wrong Muscle|1|||
147625627|NCT00406367|532447102|FG001|Open-Label Ext. Period - up to 68 Weeks|Injection in Wrong Muscle|0|||
147625628|NCT00406367|532447101|FG000|Open-Label Ext. Period - up to 68 Weeks|OLEX Drug Given at Baseline|1|||
147625629|NCT00406367|532447102|FG001|Open-Label Ext. Period - up to 68 Weeks|OLEX Drug Given at Baseline|0|||
147625630|NCT00171210|532447103|FG000|Overall Study|Adverse Event|16|||
147625631|NCT00171210|532447104|FG001|Overall Study|Adverse Event|27|||
147625632|NCT00171210|532447103|FG000|Overall Study|Abnormal laboratory value(s)|6|||
147625633|NCT00171210|532447104|FG001|Overall Study|Abnormal laboratory value(s)|3|||
147625634|NCT00171210|532447103|FG000|Overall Study|Abnormal test procedure result(s)|0|||
147625635|NCT00171210|532447104|FG001|Overall Study|Abnormal test procedure result(s)|1|||
147625636|NCT00171210|532447103|FG000|Overall Study|Unsatisfactory therapeutic effect|11|||
147625637|NCT00171210|532447104|FG001|Overall Study|Unsatisfactory therapeutic effect|15|||
147625638|NCT00171210|532447103|FG000|Overall Study|Protocol Violation|0|||
147625639|NCT00171210|532447104|FG001|Overall Study|Protocol Violation|2|||
147625640|NCT00171210|532447103|FG000|Overall Study|Withdrawal by Subject|32|||
147625641|NCT00171210|532447104|FG001|Overall Study|Withdrawal by Subject|30|||
147625642|NCT00171210|532447103|FG000|Overall Study|Lost to Follow-up|1|||
147625643|NCT00171210|532447104|FG001|Overall Study|Lost to Follow-up|0|||
147625644|NCT00171210|532447103|FG000|Overall Study|Administrative problems|1|||
147625645|NCT00171210|532447104|FG001|Overall Study|Administrative problems|1|||
147625646|NCT00171210|532447103|FG000|Overall Study|Death|2|||
147625647|NCT00171210|532447104|FG001|Overall Study|Death|3|||
147625648|NCT00171210|532447103|FG000|Overall Study|Stopped at end of core|0|||
147625649|NCT00171210|532447104|FG001|Overall Study|Stopped at end of core|32|||
147625650|NCT00171210|532447103|FG000|Overall Study|Stopped at end of extension 1|0|||
147625651|NCT00171210|532447104|FG001|Overall Study|Stopped at end of extension 1|1|||
147625652|NCT03187301|532447107|FG000|Titration Period|Adverse Event|0|||
147625653|NCT03187301|532447108|FG001|Titration Period|Adverse Event|0|||
147625654|NCT03187301|532447109|FG002|Titration Period|Adverse Event|0|||
147625655|NCT03187301|532447110|FG003|Titration Period|Adverse Event|0|||
147625656|NCT03187301|532447111|FG004|Titration Period|Adverse Event|0|||
147625657|NCT03187301|532447112|FG005|Titration Period|Adverse Event|0|||
147625658|NCT03187301|532447113|FG006|Titration Period|Adverse Event|5|||
147625659|NCT03187301|532447107|FG000|Titration Period|Withdrawal by Subject|0|||
147625660|NCT03187301|532447108|FG001|Titration Period|Withdrawal by Subject|0|||
147625661|NCT03187301|532447109|FG002|Titration Period|Withdrawal by Subject|0|||
147625662|NCT03187301|532447110|FG003|Titration Period|Withdrawal by Subject|0|||
147625663|NCT03187301|532447111|FG004|Titration Period|Withdrawal by Subject|0|||
147625664|NCT03187301|532447112|FG005|Titration Period|Withdrawal by Subject|0|||
147625665|NCT03187301|532447113|FG006|Titration Period|Withdrawal by Subject|1|||
147625666|NCT03187301|532447107|FG000|Titration Period|Exclusion Criteria Met|0|||
147625667|NCT03187301|532447108|FG001|Titration Period|Exclusion Criteria Met|0|||
147625668|NCT03187301|532447109|FG002|Titration Period|Exclusion Criteria Met|0|||
147625669|NCT03187301|532447110|FG003|Titration Period|Exclusion Criteria Met|0|||
147625670|NCT03187301|532447111|FG004|Titration Period|Exclusion Criteria Met|0|||
147625671|NCT03187301|532447112|FG005|Titration Period|Exclusion Criteria Met|0|||
147625672|NCT03187301|532447113|FG006|Titration Period|Exclusion Criteria Met|1|||
147625673|NCT03187301|532447107|FG000|Pre-Intervention|Withdrawal by Subject|1|||
147625674|NCT03187301|532447108|FG001|Pre-Intervention|Withdrawal by Subject|0|||
147625675|NCT03187301|532447109|FG002|Pre-Intervention|Withdrawal by Subject|0|||
147625676|NCT03187301|532447110|FG003|Pre-Intervention|Withdrawal by Subject|0|||
147625677|NCT03187301|532447111|FG004|Pre-Intervention|Withdrawal by Subject|0|||
147625678|NCT03187301|532447112|FG005|Pre-Intervention|Withdrawal by Subject|0|||
147625679|NCT03187301|532447113|FG006|Pre-Intervention|Withdrawal by Subject|0|||
147625680|NCT03252535|532447115|FG000|Overall Study|Withdrawal by Subject|1|||
147625681|NCT03252535|532447116|FG001|Overall Study|Withdrawal by Subject|0|||
147625682|NCT03252535|532447117|FG002|Overall Study|Withdrawal by Subject|0|||
147625683|NCT03252535|532447115|FG000|Overall Study|Physician Decision|0|||
147625684|NCT03252535|532447116|FG001|Overall Study|Physician Decision|1|||
147625685|NCT03252535|532447117|FG002|Overall Study|Physician Decision|0|||
147625686|NCT03252535|532447115|FG000|Overall Study|Met discontinuation criteria|0|||
147625687|NCT03252535|532447116|FG001|Overall Study|Met discontinuation criteria|1|||
147625688|NCT03252535|532447117|FG002|Overall Study|Met discontinuation criteria|0|||
147625689|NCT00461630|532447122|FG000|Overall Study|Death|798|||
147625690|NCT00461630|532447123|FG001|Overall Study|Death|732|||
147625691|NCT00461630|532447122|FG000|Overall Study|Lost to Follow-up|108|||
147625692|NCT00461630|532447123|FG001|Overall Study|Lost to Follow-up|95|||
147625693|NCT00442897|532447127|FG000|Base Study (12 Week Follow-up)|Adverse Event|1|||
147625694|NCT00442897|532447128|FG001|Base Study (12 Week Follow-up)|Adverse Event|0|||
147625695|NCT00442897|532447127|FG000|Base Study (12 Week Follow-up)|Death|0|||
147625696|NCT00442897|532447128|FG001|Base Study (12 Week Follow-up)|Death|1|||
147625697|NCT00442897|532447127|FG000|Base Study (12 Week Follow-up)|Protocol Violation|7|||
147625698|NCT00442897|532447128|FG001|Base Study (12 Week Follow-up)|Protocol Violation|3|||
147625699|NCT00442897|532447127|FG000|Base Study (12 Week Follow-up)|Withdrawal by Subject|9|||
147625700|NCT00442897|532447128|FG001|Base Study (12 Week Follow-up)|Withdrawal by Subject|8|||
147625701|NCT00442897|532447127|FG000|24 Weeks Follow-up (3 Centers)|Adverse Event|1|||
147625702|NCT00442897|532447128|FG001|24 Weeks Follow-up (3 Centers)|Adverse Event|0|||
147625703|NCT00442897|532447127|FG000|24 Weeks Follow-up (3 Centers)|Lost to Follow-up|2|||
147625704|NCT00442897|532447128|FG001|24 Weeks Follow-up (3 Centers)|Lost to Follow-up|2|||
147625705|NCT00442897|532447127|FG000|24 Weeks Follow-up (3 Centers)|Protocol Violation|2|||
147625706|NCT00442897|532447128|FG001|24 Weeks Follow-up (3 Centers)|Protocol Violation|1|||
147625707|NCT00442897|532447127|FG000|24 Weeks Follow-up (3 Centers)|Withdrawal by Subject|1|||
147625708|NCT00442897|532447128|FG001|24 Weeks Follow-up (3 Centers)|Withdrawal by Subject|3|||
147625709|NCT04498182|532447129|FG000|Overall Study|Adverse Event|2|||
147625710|NCT04498182|532447130|FG001|Overall Study|Adverse Event|3|||
147625711|NCT04498182|532447131|FG002|Overall Study|Adverse Event|2|||
147625712|NCT04498182|532447129|FG000|Overall Study|Withdrawal of Consent|3|||
147625713|NCT04498182|532447130|FG001|Overall Study|Withdrawal of Consent|4|||
147625714|NCT04498182|532447131|FG002|Overall Study|Withdrawal of Consent|3|||
147625715|NCT04498182|532447129|FG000|Overall Study|Non-Compliant|1|||
147625716|NCT04498182|532447130|FG001|Overall Study|Non-Compliant|0|||
147625717|NCT04498182|532447131|FG002|Overall Study|Non-Compliant|1|||
147625718|NCT04498182|532447129|FG000|Overall Study|Lost to Follow-up|0|||
147625719|NCT04498182|532447130|FG001|Overall Study|Lost to Follow-up|0|||
147625720|NCT04498182|532447131|FG002|Overall Study|Lost to Follow-up|1|||
147625721|NCT04498182|532447129|FG000|Overall Study|Investigator Decision|0|||
147625722|NCT04498182|532447130|FG001|Overall Study|Investigator Decision|0|||
147625723|NCT04498182|532447131|FG002|Overall Study|Investigator Decision|1|||
147625724|NCT04498182|532447129|FG000|Overall Study|Protocol Violation|1|||
147625725|NCT04498182|532447130|FG001|Overall Study|Protocol Violation|0|||
147625726|NCT04498182|532447131|FG002|Overall Study|Protocol Violation|2|||
147625727|NCT00891020|532447135|FG000|24 Week Treatment Period|Adverse event or intercurrent illness|11|||
147625728|NCT00891020|532447136|FG001|24 Week Treatment Period|Adverse event or intercurrent illness|32|||
147625729|NCT00891020|532447137|FG002|24 Week Treatment Period|Adverse event or intercurrent illness|17|||
147625730|NCT00891020|532447135|FG000|24 Week Treatment Period|Death|0|||
147625731|NCT00891020|532447136|FG001|24 Week Treatment Period|Death|2|||
147625732|NCT00891020|532447137|FG002|24 Week Treatment Period|Death|0|||
147625733|NCT00891020|532447135|FG000|24 Week Treatment Period|Insufficient therapeutic response|6|||
147625734|NCT00891020|532447136|FG001|24 Week Treatment Period|Insufficient therapeutic response|9|||
147625735|NCT00891020|532447137|FG002|24 Week Treatment Period|Insufficient therapeutic response|15|||
147625736|NCT00891020|532447135|FG000|24 Week Treatment Period|Failure to return|4|||
147625737|NCT00891020|532447136|FG001|24 Week Treatment Period|Failure to return|5|||
147625738|NCT00891020|532447137|FG002|24 Week Treatment Period|Failure to return|5|||
147625739|NCT00891020|532447135|FG000|24 Week Treatment Period|Violation of selection criteria at entry|1|||
147417099|NCT00424385|531691570|FG000|Cohort 0|Physician Decision|1|||
147417100|NCT00424385|531691570|FG000|Cohort 1|Withdrawal by Subject|1|||
147417101|NCT05560243|531691571|FG000|Overall Study|11 did not start the intervention, and 14 were lost to follow-up|25|||
147417102|NCT05870228|531691572|FG000|Overall Study|Lost to Follow-up|2|||
147417103|NCT05870228|531691573|FG001|Overall Study|Lost to Follow-up|0|||
147417104|NCT05870228|531691572|FG000|Overall Study|Withdrawal by Subject|1|||
147417105|NCT05870228|531691573|FG001|Overall Study|Withdrawal by Subject|0|||
147417106|NCT03231800|531691578|FG000|Overall Study|Lost to Follow-up|0|||
147417107|NCT03231800|531691579|FG001|Overall Study|Lost to Follow-up|2|||
147417108|NCT03231800|531691578|FG000|Overall Study|Protocol Violation|1|||
147417109|NCT03231800|531691579|FG001|Overall Study|Protocol Violation|1|||
147417110|NCT03231800|531691578|FG000|Overall Study|reason not provided|2|||
147417111|NCT03231800|531691579|FG001|Overall Study|reason not provided|0|||
147417112|NCT04035499|531691582|FG000|Overall Study|Death|2|||
147417113|NCT04035499|531691582|FG000|Overall Study|Withdrawal by Subject|1|||
147417114|NCT01417104|531691586|FG000|Overall Study|Withdrawal by Subject|5|||
147417115|NCT01417104|531691587|FG001|Overall Study|Withdrawal by Subject|1|||
147417116|NCT01417104|531691586|FG000|Overall Study|Failure to make contact|0|||
147417117|NCT01417104|531691587|FG001|Overall Study|Failure to make contact|1|||
147417118|NCT01417104|531691586|FG000|Overall Study|Adverse Event|1|||
147417119|NCT01417104|531691587|FG001|Overall Study|Adverse Event|0|||
147417120|NCT01416389|531691588|FG000|Overall Study|Lost to Follow-up|1|||
147417121|NCT01416389|531691589|FG001|Overall Study|Lost to Follow-up|0|||
147417122|NCT01416389|531691588|FG000|Overall Study|Started New Therapy|2|||
147417123|NCT01416389|531691589|FG001|Overall Study|Started New Therapy|0|||
147417124|NCT01125514|531691590|FG000|Treatment Period 1 (Day 1 - Day 7)|Adverse Event|1|||
147417125|NCT01125514|531691590|FG000|Treatment Period 1 (Day 1 - Day 7)|Administrative problems|1|||
147625740|NCT00891020|532447136|FG001|24 Week Treatment Period|Violation of selection criteria at entry|0|||
147417126|NCT01125514|531691590|FG000|Treatment Period 2 (Day 8 - Day 17)|Adverse Event|3|||
147417127|NCT01125514|531691590|FG000|Treatment Period2(Day9-Day27) and Day 28|Adverse Event|2|||
147417128|NCT01125514|531691590|FG000|Treatment Period2(Day9-Day27) and Day 28|Protocol Deviation|1|||
147417129|NCT01125514|531691590|FG000|Treatment Period2(Day9-Day27) and Day 28|Withdrawal by Subject|1|||
147417130|NCT00858364|531691591|FG000|Overall Study|Administrative Decision|3|||
147417131|NCT00858364|531691592|FG001|Overall Study|Administrative Decision|2|||
147417132|NCT00858364|531691591|FG000|Overall Study|Adverse Event|5|||
147417133|NCT00858364|531691592|FG001|Overall Study|Adverse Event|2|||
147417134|NCT00858364|531691591|FG000|Overall Study|Withdrawal by Subject|44|||
147417135|NCT00858364|531691592|FG001|Overall Study|Withdrawal by Subject|118|||
147417136|NCT00858364|531691591|FG000|Overall Study|Ineligibility Determined|1|||
147417137|NCT00858364|531691592|FG001|Overall Study|Ineligibility Determined|10|||
147417138|NCT00858364|531691591|FG000|Overall Study|Lost to Follow-up|24|||
147417139|NCT00858364|531691592|FG001|Overall Study|Lost to Follow-up|54|||
147417140|NCT00858364|531691591|FG000|Overall Study|Noncompliance|3|||
147417141|NCT00858364|531691592|FG001|Overall Study|Noncompliance|4|||
147417142|NCT00858364|531691591|FG000|Overall Study|Protocol Deviation|0|||
147417143|NCT00858364|531691592|FG001|Overall Study|Protocol Deviation|2|||
147417144|NCT00858364|531691591|FG000|Overall Study|Other|9|||
147417145|NCT00858364|531691592|FG001|Overall Study|Other|17|||
147417146|NCT00858364|531691591|FG000|Overall Study|Missing|1|||
147417147|NCT00858364|531691592|FG001|Overall Study|Missing|1|||
147417148|NCT00858364|531691591|FG000|Overall Study|Still on-study|114|||
147417149|NCT00858364|531691592|FG001|Overall Study|Still on-study|247|||
147417150|NCT03980808|531691593|FG000|Overall Study|Lost to Follow-up|2|||
147417151|NCT03980808|531691594|FG001|Overall Study|Lost to Follow-up|2|||
147417152|NCT01655693|531691595|FG000|Overall Study|Progression of Disease|92|||
147417153|NCT01655693|531691596|FG001|Overall Study|Progression of Disease|76|||
147417154|NCT01655693|531691597|FG002|Overall Study|Progression of Disease|58|||
147417155|NCT01655693|531691595|FG000|Overall Study|Death|8|||
147417156|NCT01655693|531691596|FG001|Overall Study|Death|9|||
147417157|NCT01655693|531691597|FG002|Overall Study|Death|12|||
147417158|NCT01655693|531691595|FG000|Overall Study|Serious Adverse Event|3|||
147625741|NCT00891020|532447137|FG002|24 Week Treatment Period|Violation of selection criteria at entry|2|||
147625742|NCT00891020|532447135|FG000|24 Week Treatment Period|Other protocol violation|1|||
147417159|NCT01655693|531691596|FG001|Overall Study|Serious Adverse Event|15|||
147417160|NCT01655693|531691597|FG002|Overall Study|Serious Adverse Event|11|||
147417161|NCT01655693|531691595|FG000|Overall Study|Withdrawal by Subject|3|||
147417162|NCT01655693|531691596|FG001|Overall Study|Withdrawal by Subject|2|||
147417163|NCT01655693|531691597|FG002|Overall Study|Withdrawal by Subject|20|||
147417164|NCT01655693|531691595|FG000|Overall Study|Adverse Event|3|||
147417165|NCT01655693|531691596|FG001|Overall Study|Adverse Event|11|||
147417166|NCT01655693|531691597|FG002|Overall Study|Adverse Event|3|||
147417167|NCT01655693|531691595|FG000|Overall Study|Aggravation of Liver Dysfunction|5|||
147417168|NCT01655693|531691596|FG001|Overall Study|Aggravation of Liver Dysfunction|4|||
147417169|NCT01655693|531691597|FG002|Overall Study|Aggravation of Liver Dysfunction|0|||
147417170|NCT01655693|531691595|FG000|Overall Study|Non-Compliance|0|||
147417171|NCT01655693|531691596|FG001|Overall Study|Non-Compliance|0|||
147417172|NCT01655693|531691597|FG002|Overall Study|Non-Compliance|7|||
147417173|NCT01655693|531691595|FG000|Overall Study|No Respect of Criteria for Continuing Treatment|1|||
147417174|NCT01655693|531691596|FG001|Overall Study|No Respect of Criteria for Continuing Treatment|3|||
147417175|NCT01655693|531691597|FG002|Overall Study|No Respect of Criteria for Continuing Treatment|0|||
147417176|NCT01655693|531691595|FG000|Overall Study|Protocol Violation|1|||
147417177|NCT01655693|531691596|FG001|Overall Study|Protocol Violation|0|||
147417178|NCT01655693|531691597|FG002|Overall Study|Protocol Violation|3|||
147417179|NCT01655693|531691595|FG000|Overall Study|Lost to Follow-up|1|||
147417180|NCT01655693|531691596|FG001|Overall Study|Lost to Follow-up|0|||
147417181|NCT01655693|531691597|FG002|Overall Study|Lost to Follow-up|1|||
147417182|NCT01655693|531691595|FG000|Overall Study|Screening Failure|1|||
147417183|NCT01655693|531691596|FG001|Overall Study|Screening Failure|0|||
147417184|NCT01655693|531691597|FG002|Overall Study|Screening Failure|0|||
147417185|NCT01655693|531691595|FG000|Overall Study|Other|8|||
147417186|NCT01655693|531691596|FG001|Overall Study|Other|6|||
147417187|NCT01655693|531691597|FG002|Overall Study|Other|15|||
147417188|NCT00929110|531691600|FG000|Overall Study|Adverse Event|40|||
147417189|NCT00929110|531691601|FG001|Overall Study|Adverse Event|29|||
147417190|NCT00929110|531691602|FG002|Overall Study|Adverse Event|18|||
147417191|NCT00929110|531691600|FG000|Overall Study|Subject withdrew consent|40|||
147417192|NCT00929110|531691601|FG001|Overall Study|Subject withdrew consent|23|||
147417193|NCT00929110|531691602|FG002|Overall Study|Subject withdrew consent|26|||
147417194|NCT00929110|531691600|FG000|Overall Study|Unsatisfactory therapeutic effect|20|||
147417195|NCT00929110|531691601|FG001|Overall Study|Unsatisfactory therapeutic effect|9|||
147417196|NCT00929110|531691602|FG002|Overall Study|Unsatisfactory therapeutic effect|6|||
147417197|NCT00929110|531691600|FG000|Overall Study|Lost to Follow-up|7|||
147417198|NCT00929110|531691601|FG001|Overall Study|Lost to Follow-up|7|||
147417199|NCT00929110|531691602|FG002|Overall Study|Lost to Follow-up|3|||
147417200|NCT00929110|531691600|FG000|Overall Study|Protocol deviation|5|||
147417201|NCT00929110|531691601|FG001|Overall Study|Protocol deviation|2|||
147417202|NCT00929110|531691602|FG002|Overall Study|Protocol deviation|4|||
147417203|NCT00929110|531691600|FG000|Overall Study|Administrative problems|4|||
147417204|NCT00929110|531691601|FG001|Overall Study|Administrative problems|1|||
147417205|NCT00929110|531691602|FG002|Overall Study|Administrative problems|2|||
147417206|NCT00929110|531691600|FG000|Overall Study|Death|2|||
147417207|NCT00929110|531691601|FG001|Overall Study|Death|2|||
147417208|NCT00929110|531691602|FG002|Overall Study|Death|2|||
147417209|NCT00929110|531691600|FG000|Overall Study|Abnormal laboratory value(s)|0|||
147417210|NCT00929110|531691601|FG001|Overall Study|Abnormal laboratory value(s)|1|||
147417211|NCT00929110|531691602|FG002|Overall Study|Abnormal laboratory value(s)|0|||
147417212|NCT00929110|531691600|FG000|Overall Study|Abnormal test procedure result(s)|0|||
147417213|NCT00929110|531691601|FG001|Overall Study|Abnormal test procedure result(s)|1|||
147417214|NCT00929110|531691602|FG002|Overall Study|Abnormal test procedure result(s)|1|||
147417215|NCT00929110|531691600|FG000|Overall Study|Patient inability to use the device|0|||
147417216|NCT00929110|531691601|FG001|Overall Study|Patient inability to use the device|1|||
147417217|NCT00929110|531691602|FG002|Overall Study|Patient inability to use the device|0|||
147417218|NCT01163292|531691606|FG000|Overall Study|Lack of Efficacy|9|||
147417219|NCT01163292|531691607|FG001|Overall Study|Lack of Efficacy|0|||
147417220|NCT01163292|531691606|FG000|Overall Study|Adverse Event|6|||
147417221|NCT01163292|531691607|FG001|Overall Study|Adverse Event|0|||
147417222|NCT01163292|531691606|FG000|Overall Study|Initiation of biological therapy|0|||
147417223|NCT01163292|531691607|FG001|Overall Study|Initiation of biological therapy|15|||
147417224|NCT01163292|531691606|FG000|Overall Study|Sufficient response to adalimumab|8|||
147417225|NCT01163292|531691607|FG001|Overall Study|Sufficient response to adalimumab|0|||
147417226|NCT01163292|531691606|FG000|Overall Study|Refusal to receive adalimumab|7|||
147417227|NCT01163292|531691607|FG001|Overall Study|Refusal to receive adalimumab|0|||
147417228|NCT01163292|531691606|FG000|Overall Study|Economic reasons|6|||
147417229|NCT01163292|531691607|FG001|Overall Study|Economic reasons|0|||
147417230|NCT01163292|531691606|FG000|Overall Study|No further visits|5|||
147417231|NCT01163292|531691607|FG001|Overall Study|No further visits|7|||
147417232|NCT02535091|531691608|FG000|Overall Study|Entered Expanded Access Program (EAP)/Navigator|34|||
147417233|NCT02535091|531691609|FG001|Overall Study|Entered Expanded Access Program (EAP)/Navigator|18|||
147417234|NCT02535091|531691610|FG002|Overall Study|Entered Expanded Access Program (EAP)/Navigator|575|||
147417235|NCT02535091|531691608|FG000|Overall Study|Withdrawal by Subject|14|||
147417236|NCT02535091|531691609|FG001|Overall Study|Withdrawal by Subject|5|||
147417237|NCT02535091|531691610|FG002|Overall Study|Withdrawal by Subject|121|||
147417238|NCT02535091|531691608|FG000|Overall Study|Adverse Event|9|||
147417239|NCT02535091|531691609|FG001|Overall Study|Adverse Event|4|||
147417240|NCT02535091|531691610|FG002|Overall Study|Adverse Event|170|||
147417241|NCT02535091|531691608|FG000|Overall Study|Other|4|||
147417242|NCT02535091|531691609|FG001|Overall Study|Other|3|||
147417243|NCT02535091|531691610|FG002|Overall Study|Other|81|||
147417244|NCT02535091|531691608|FG000|Overall Study|Lost to Follow-up|0|||
147417245|NCT02535091|531691609|FG001|Overall Study|Lost to Follow-up|1|||
147417246|NCT02535091|531691610|FG002|Overall Study|Lost to Follow-up|19|||
147417247|NCT02535091|531691608|FG000|Overall Study|Protocol Violation|0|||
147417248|NCT02535091|531691609|FG001|Overall Study|Protocol Violation|1|||
147625743|NCT00891020|532447136|FG001|24 Week Treatment Period|Other protocol violation|1|||
147625744|NCT00891020|532447137|FG002|24 Week Treatment Period|Other protocol violation|2|||
147625745|NCT00891020|532447135|FG000|24 Week Treatment Period|Refused treatment/did not cooperate|3|||
147625746|NCT00891020|532447136|FG001|24 Week Treatment Period|Refused treatment/did not cooperate|2|||
147625747|NCT00891020|532447137|FG002|24 Week Treatment Period|Refused treatment/did not cooperate|1|||
147625748|NCT00891020|532447135|FG000|24 Week Treatment Period|Withdrew consent|6|||
147625749|NCT00891020|532447136|FG001|24 Week Treatment Period|Withdrew consent|3|||
147625750|NCT00891020|532447137|FG002|24 Week Treatment Period|Withdrew consent|15|||
147625751|NCT00891020|532447135|FG000|24 Week Treatment Period|Administrative/Other|5|||
147625752|NCT00891020|532447136|FG001|24 Week Treatment Period|Administrative/Other|6|||
147625753|NCT00891020|532447137|FG002|24 Week Treatment Period|Administrative/Other|1|||
147625754|NCT00891020|532447135|FG000|Long-term Extension Period|Adverse Event|1|||
147625755|NCT00891020|532447136|FG001|Long-term Extension Period|Adverse Event|11|||
147625756|NCT00891020|532447137|FG002|Long-term Extension Period|Adverse Event|10|||
147625757|NCT00891020|532447135|FG000|Long-term Extension Period|Death|0|||
147625758|NCT00891020|532447136|FG001|Long-term Extension Period|Death|0|||
147625759|NCT00891020|532447137|FG002|Long-term Extension Period|Death|1|||
147625760|NCT00891020|532447135|FG000|Long-term Extension Period|Insufficient therapeutic response|3|||
147625761|NCT00891020|532447136|FG001|Long-term Extension Period|Insufficient therapeutic response|2|||
147625762|NCT00891020|532447137|FG002|Long-term Extension Period|Insufficient therapeutic response|2|||
147625763|NCT00891020|532447135|FG000|Long-term Extension Period|Protocol Violation|0|||
147625764|NCT00891020|532447136|FG001|Long-term Extension Period|Protocol Violation|1|||
147625765|NCT00891020|532447137|FG002|Long-term Extension Period|Protocol Violation|1|||
147625766|NCT00891020|532447135|FG000|Long-term Extension Period|Refused treatment/did not cooperate|1|||
147625767|NCT00891020|532447136|FG001|Long-term Extension Period|Refused treatment/did not cooperate|6|||
147625768|NCT00891020|532447137|FG002|Long-term Extension Period|Refused treatment/did not cooperate|4|||
147625769|NCT00891020|532447135|FG000|Long-term Extension Period|Failure to return|0|||
147625770|NCT00891020|532447136|FG001|Long-term Extension Period|Failure to return|2|||
147625771|NCT00891020|532447137|FG002|Long-term Extension Period|Failure to return|3|||
147625772|NCT00891020|532447135|FG000|Long-term Extension Period|Administrative|1|||
147625773|NCT00891020|532447136|FG001|Long-term Extension Period|Administrative|2|||
147625774|NCT00891020|532447137|FG002|Long-term Extension Period|Administrative|2|||
147625775|NCT00320710|532447145|FG000|Overall Study|Disease progression|24|||
147625776|NCT00320710|532447146|FG001|Overall Study|Disease progression|19|||
147625777|NCT00320710|532447147|FG002|Overall Study|Disease progression|2|||
147625778|NCT00320710|532447145|FG000|Overall Study|Death|10|||
147625779|NCT00320710|532447146|FG001|Overall Study|Death|7|||
147625780|NCT00320710|532447147|FG002|Overall Study|Death|1|||
147625781|NCT00320710|532447145|FG000|Overall Study|Administrative problems|1|||
147625782|NCT00320710|532447146|FG001|Overall Study|Administrative problems|2|||
147625783|NCT00320710|532447147|FG002|Overall Study|Administrative problems|0|||
147625784|NCT00320710|532447145|FG000|Overall Study|Withdrawal by Subject|20|||
147625785|NCT00320710|532447146|FG001|Overall Study|Withdrawal by Subject|26|||
147625786|NCT00320710|532447147|FG002|Overall Study|Withdrawal by Subject|1|||
147625787|NCT00320710|532447145|FG000|Overall Study|Protocol Violation|6|||
147625788|NCT00320710|532447146|FG001|Overall Study|Protocol Violation|5|||
147625789|NCT00320710|532447147|FG002|Overall Study|Protocol Violation|0|||
147625790|NCT00320710|532447145|FG000|Overall Study|Abnormal test procedure result(s)|2|||
147625791|NCT00320710|532447146|FG001|Overall Study|Abnormal test procedure result(s)|0|||
147625792|NCT00320710|532447147|FG002|Overall Study|Abnormal test procedure result(s)|0|||
147625793|NCT00320710|532447145|FG000|Overall Study|Abnormal laboratory value(s)|12|||
147625794|NCT00320710|532447146|FG001|Overall Study|Abnormal laboratory value(s)|3|||
147625795|NCT00320710|532447147|FG002|Overall Study|Abnormal laboratory value(s)|0|||
147625796|NCT00320710|532447145|FG000|Overall Study|Adverse Event|18|||
147625797|NCT00320710|532447146|FG001|Overall Study|Adverse Event|14|||
147625798|NCT00320710|532447147|FG002|Overall Study|Adverse Event|1|||
147625799|NCT00320710|532447145|FG000|Overall Study|Lost to Follow-up|1|||
147625800|NCT00320710|532447146|FG001|Overall Study|Lost to Follow-up|0|||
147625801|NCT00320710|532447147|FG002|Overall Study|Lost to Follow-up|0|||
147417249|NCT02535091|531691610|FG002|Overall Study|Protocol Violation|11|||
147625802|NCT00506415|532447149|FG000|Initial Open Label (Maximum 48 Weeks)|Adverse Event|272|||
147668005|NCT02669849|532609824|FG001|Overall Study|Study terminated by sponsor|1|||
147668006|NCT02669849|532609825|FG002|Overall Study|Study terminated by sponsor|14|||
147625803|NCT00506415|532447150|FG001|Initial Open Label (Maximum 48 Weeks)|Adverse Event|0|||
147625804|NCT00506415|532447151|FG002|Initial Open Label (Maximum 48 Weeks)|Adverse Event|0|||
147625805|NCT00506415|532447152|FG003|Initial Open Label (Maximum 48 Weeks)|Adverse Event|0|||
147625806|NCT00506415|532447149|FG000|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|1|||
147625807|NCT00506415|532447150|FG001|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|0|||
147625808|NCT00506415|532447151|FG002|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|0|||
147625809|NCT00506415|532447152|FG003|Initial Open Label (Maximum 48 Weeks)|Abnormal laboratory value|0|||
147625810|NCT00506415|532447149|FG000|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|1|||
147668007|NCT02669849|532609823|FG000|Overall Study|Other|0|||
147417250|NCT02535091|531691608|FG000|Overall Study|Pregnancy|0|||
147417251|NCT02535091|531691609|FG001|Overall Study|Pregnancy|0|||
147417252|NCT02535091|531691610|FG002|Overall Study|Pregnancy|7|||
147417253|NCT03223662|531691611|FG000|Overall Study|Physician Decision|1|||
147417254|NCT03223662|531691611|FG000|Overall Study|Study closure|1|||
147417255|NCT02643472|531691612|FG000|Overall Study|Death|2|||
147417256|NCT02643472|531691613|FG001|Overall Study|Death|5|||
147417257|NCT02643472|531691612|FG000|Overall Study|Withdrawal by Subject|3|||
147417258|NCT02643472|531691613|FG001|Overall Study|Withdrawal by Subject|2|||
147417259|NCT02643472|531691612|FG000|Overall Study|Protocol Violation|0|||
147417260|NCT02643472|531691613|FG001|Overall Study|Protocol Violation|1|||
147417261|NCT02643472|531691612|FG000|Overall Study|Lost to Follow-up|22|||
147417262|NCT02643472|531691613|FG001|Overall Study|Lost to Follow-up|26|||
147417263|NCT01258595|531691614|FG000|Overall Study|Lost to Follow-up|1|||
147417264|NCT01258595|531691615|FG001|Overall Study|Lost to Follow-up|0|||
147417265|NCT01258595|531691614|FG000|Overall Study|Withdrawal by Subject|0|||
147417266|NCT01258595|531691615|FG001|Overall Study|Withdrawal by Subject|1|||
147417267|NCT01012414|531691616|FG000|Overall Study|Withdrawal by Subject|2|||
147417268|NCT01012414|531691616|FG000|Overall Study|Lost to Follow-up|1|||
147417269|NCT01012414|531691616|FG000|Overall Study|Trial was stopped before completed|7|||
147417270|NCT01215188|531691617|FG000|Overall Study|Lost to Follow-up|22|||
147417271|NCT01215188|531691618|FG001|Overall Study|Lost to Follow-up|22|||
147417272|NCT01215188|531691619|FG002|Overall Study|Lost to Follow-up|16|||
147417273|NCT01215188|531691617|FG000|Overall Study|Adverse Event|1|||
147417274|NCT01215188|531691618|FG001|Overall Study|Adverse Event|1|||
147417275|NCT01215188|531691619|FG002|Overall Study|Adverse Event|3|||
147417276|NCT01215188|531691617|FG000|Overall Study|Physician Decision|2|||
147417277|NCT01215188|531691618|FG001|Overall Study|Physician Decision|1|||
147417278|NCT01215188|531691619|FG002|Overall Study|Physician Decision|0|||
147417279|NCT01215188|531691617|FG000|Overall Study|Lack of Efficacy|0|||
147417280|NCT01215188|531691618|FG001|Overall Study|Lack of Efficacy|0|||
147417281|NCT01215188|531691619|FG002|Overall Study|Lack of Efficacy|1|||
147417282|NCT01215188|531691617|FG000|Overall Study|Protocol Violation|1|||
147417283|NCT01215188|531691618|FG001|Overall Study|Protocol Violation|1|||
147417284|NCT01215188|531691619|FG002|Overall Study|Protocol Violation|1|||
147417285|NCT01215188|531691617|FG000|Overall Study|Withdrawal by Subject|32|||
147417286|NCT01215188|531691618|FG001|Overall Study|Withdrawal by Subject|34|||
147417287|NCT01215188|531691619|FG002|Overall Study|Withdrawal by Subject|31|||
147417288|NCT02601300|531691620|FG000|Induction Phase|Lack of Efficacy|2|||
147417289|NCT02601300|531691620|FG000|Induction Phase|Protocol Violation|1|||
147417290|NCT02601300|531691620|FG000|Extension Phase|Withdrawal by Subject|3|||
147417291|NCT02601300|531691620|FG000|Extension Phase|Adverse Event|4|||
147417292|NCT02601300|531691620|FG000|Extension Phase|Lack of Efficacy|10|||
147417293|NCT01127763|531691621|FG000|Overall Study|Adverse Event|2|||
147417294|NCT01127763|531691621|FG000|Overall Study|Withdrawal by Subject|1|||
147417295|NCT01127763|531691621|FG000|Overall Study|Physician Decision|2|||
147417296|NCT00528931|531691622|FG000|Overall Study|Lost to Follow-up|1|||
147417297|NCT02285153|531691628|FG000|Overall Study|Adverse Event|1|||
147417298|NCT02285153|531691629|FG001|Overall Study|Adverse Event|0|||
147417299|NCT01489891|531691633|FG000|Overall Study|Endoscopy failure|1|||
147417300|NCT01489891|531691634|FG001|Overall Study|Endoscopy failure|0|||
147417301|NCT00844532|531691636|FG000|Overall Study|Death|16|||
147417302|NCT00844532|531691636|FG000|Overall Study|Withdrawal by Subject|16|||
147417303|NCT00844532|531691636|FG000|Overall Study|Lost to Follow-up|7|||
147668008|NCT02669849|532609824|FG001|Overall Study|Other|0|||
147668009|NCT02669849|532609825|FG002|Overall Study|Other|2|||
147417304|NCT02576587|531691637|FG000|Baseline|Equipment failure|0|||
147417305|NCT02576587|531691638|FG001|Baseline|Equipment failure|1|||
147417306|NCT02576587|531691637|FG000|Follow up Period (Case Only)|Withdrawal by Subject|25|||
147417307|NCT02576587|531691638|FG001|Follow up Period (Case Only)|Withdrawal by Subject|0|||
147417308|NCT02576587|531691637|FG000|Follow up Period (Case Only)|Not selected for follow up (AHI<15)|92|||
147417309|NCT02576587|531691638|FG001|Follow up Period (Case Only)|Not selected for follow up (AHI<15)|0|||
147417310|NCT02576587|531691637|FG000|Follow up Period (Case Only)|Controls not eligible for followup|0|||
147417311|NCT02576587|531691638|FG001|Follow up Period (Case Only)|Controls not eligible for followup|155|||
147417312|NCT00948766|531691639|FG000|Core Study|Adverse Event|73|||
147417313|NCT00948766|531691640|FG001|Core Study|Adverse Event|51|||
147417314|NCT00948766|531691639|FG000|Core Study|Unsatisfactory Therapeutic Effect|13|||
147417315|NCT00948766|531691640|FG001|Core Study|Unsatisfactory Therapeutic Effect|14|||
147417316|NCT00948766|531691639|FG000|Core Study|Patient Withdrew Consent|27|||
147417317|NCT00948766|531691640|FG001|Core Study|Patient Withdrew Consent|46|||
147417318|NCT00948766|531691639|FG000|Core Study|Lost to Follow-up|3|||
147417319|NCT00948766|531691640|FG001|Core Study|Lost to Follow-up|2|||
147668010|NCT03408899|532609828|FG000|PC-1005 Gel: 4 mL Dose|Lost to Follow-up|1|||
147417320|NCT00948766|531691639|FG000|Core Study|Administrative Problems|2|||
147417321|NCT00948766|531691640|FG001|Core Study|Administrative Problems|2|||
147417322|NCT00948766|531691639|FG000|Core Study|Death|1|||
147417323|NCT00948766|531691640|FG001|Core Study|Death|1|||
147417324|NCT00948766|531691639|FG000|Core Study|Protocol Deviation|8|||
147417325|NCT00948766|531691640|FG001|Core Study|Protocol Deviation|10|||
147625811|NCT00506415|532447150|FG001|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|0|||
147625812|NCT00506415|532447151|FG002|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|0|||
147625813|NCT00506415|532447152|FG003|Initial Open Label (Maximum 48 Weeks)|Abnormal test procedure results|0|||
147625814|NCT00506415|532447149|FG000|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|58|||
147625815|NCT00506415|532447150|FG001|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
147625816|NCT00506415|532447151|FG002|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
147625817|NCT00506415|532447152|FG003|Initial Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
147625818|NCT00506415|532447149|FG000|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|88|||
147625819|NCT00506415|532447150|FG001|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
147625820|NCT00506415|532447151|FG002|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
147625821|NCT00506415|532447152|FG003|Initial Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
147625822|NCT00506415|532447149|FG000|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|22|||
147625823|NCT00506415|532447150|FG001|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
147625824|NCT00506415|532447151|FG002|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
147625825|NCT00506415|532447152|FG003|Initial Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
147625826|NCT00506415|532447149|FG000|Initial Open Label (Maximum 48 Weeks)|Administrative problem|7|||
147625827|NCT00506415|532447150|FG001|Initial Open Label (Maximum 48 Weeks)|Administrative problem|0|||
147625828|NCT00506415|532447151|FG002|Initial Open Label (Maximum 48 Weeks)|Administrative problem|0|||
147625829|NCT00506415|532447152|FG003|Initial Open Label (Maximum 48 Weeks)|Administrative problem|0|||
147625830|NCT00506415|532447149|FG000|Initial Open Label (Maximum 48 Weeks)|Death|22|||
147625831|NCT00506415|532447150|FG001|Initial Open Label (Maximum 48 Weeks)|Death|0|||
147625832|NCT00506415|532447151|FG002|Initial Open Label (Maximum 48 Weeks)|Death|0|||
147625833|NCT00506415|532447152|FG003|Initial Open Label (Maximum 48 Weeks)|Death|0|||
147625834|NCT00506415|532447149|FG000|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|28|||
147625835|NCT00506415|532447150|FG001|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
147625836|NCT00506415|532447151|FG002|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
147625837|NCT00506415|532447152|FG003|Initial Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
147625838|NCT00506415|532447149|FG000|Double Blind (Maximum 48 Weeks )|Adverse Event|0|||
147625839|NCT00506415|532447150|FG001|Double Blind (Maximum 48 Weeks )|Adverse Event|33|||
147625840|NCT00506415|532447151|FG002|Double Blind (Maximum 48 Weeks )|Adverse Event|28|||
147625841|NCT00506415|532447152|FG003|Double Blind (Maximum 48 Weeks )|Adverse Event|0|||
147625842|NCT00506415|532447149|FG000|Double Blind (Maximum 48 Weeks )|Death|0|||
147625843|NCT00506415|532447150|FG001|Double Blind (Maximum 48 Weeks )|Death|5|||
147625844|NCT00506415|532447151|FG002|Double Blind (Maximum 48 Weeks )|Death|3|||
147625845|NCT00506415|532447152|FG003|Double Blind (Maximum 48 Weeks )|Death|0|||
147625846|NCT00506415|532447149|FG000|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|0|||
147625847|NCT00506415|532447150|FG001|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|13|||
147625848|NCT00506415|532447151|FG002|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|13|||
147625849|NCT00506415|532447152|FG003|Double Blind (Maximum 48 Weeks )|Unsatisfactory therapeutic effect|0|||
147625850|NCT00506415|532447149|FG000|Double Blind (Maximum 48 Weeks )|Protocol Violation|0|||
147625851|NCT00506415|532447150|FG001|Double Blind (Maximum 48 Weeks )|Protocol Violation|5|||
147625852|NCT00506415|532447151|FG002|Double Blind (Maximum 48 Weeks )|Protocol Violation|3|||
147625853|NCT00506415|532447152|FG003|Double Blind (Maximum 48 Weeks )|Protocol Violation|0|||
147625854|NCT00506415|532447149|FG000|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|0|||
147625855|NCT00506415|532447150|FG001|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|4|||
147625856|NCT00506415|532447151|FG002|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|6|||
147625857|NCT00506415|532447152|FG003|Double Blind (Maximum 48 Weeks )|Lost to Follow-up|0|||
147625858|NCT00506415|532447149|FG000|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|0|||
147625859|NCT00506415|532447150|FG001|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|20|||
147625860|NCT00506415|532447151|FG002|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|17|||
147625861|NCT00506415|532447152|FG003|Double Blind (Maximum 48 Weeks )|Withdrawal by Subject|0|||
147625862|NCT00506415|532447149|FG000|Double Blind (Maximum 48 Weeks )|Administrative problems|0|||
147625863|NCT00506415|532447150|FG001|Double Blind (Maximum 48 Weeks )|Administrative problems|3|||
147625864|NCT00506415|532447151|FG002|Double Blind (Maximum 48 Weeks )|Administrative problems|2|||
147625865|NCT00506415|532447152|FG003|Double Blind (Maximum 48 Weeks )|Administrative problems|0|||
147625866|NCT00506415|532447149|FG000|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|0|||
147625867|NCT00506415|532447150|FG001|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|0|||
147625868|NCT00506415|532447151|FG002|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|1|||
147625869|NCT00506415|532447152|FG003|Double Blind (Maximum 48 Weeks )|Condition no longer requires study drug|0|||
147625870|NCT00506415|532447149|FG000|Extended Open Label (Maximum 48 Weeks)|Administrative problems|0|||
147625871|NCT00506415|532447150|FG001|Extended Open Label (Maximum 48 Weeks)|Administrative problems|0|||
147625872|NCT00506415|532447151|FG002|Extended Open Label (Maximum 48 Weeks)|Administrative problems|0|||
147625873|NCT00506415|532447152|FG003|Extended Open Label (Maximum 48 Weeks)|Administrative problems|4|||
147625874|NCT00506415|532447149|FG000|Extended Open Label (Maximum 48 Weeks)|Adverse Event|0|||
147417326|NCT00948766|531691639|FG000|Extension Study|Adverse Event|43|||
147417327|NCT00948766|531691640|FG001|Extension Study|Adverse Event|0|||
147417328|NCT00948766|531691639|FG000|Extension Study|Unsatisfactory Therapeutic Effect|2|||
147417329|NCT00948766|531691640|FG001|Extension Study|Unsatisfactory Therapeutic Effect|0|||
147417330|NCT00948766|531691639|FG000|Extension Study|Study Drug No Longer Required|1|||
147417331|NCT00948766|531691640|FG001|Extension Study|Study Drug No Longer Required|0|||
147417332|NCT00948766|531691639|FG000|Extension Study|Patient Withdrew Consent|32|||
147417333|NCT00948766|531691640|FG001|Extension Study|Patient Withdrew Consent|0|||
147417334|NCT00948766|531691639|FG000|Extension Study|Lost to Follow-up|8|||
147417335|NCT00948766|531691640|FG001|Extension Study|Lost to Follow-up|0|||
147417336|NCT00948766|531691639|FG000|Extension Study|Administrative Problems|1|||
147417337|NCT00948766|531691640|FG001|Extension Study|Administrative Problems|0|||
147417338|NCT00948766|531691639|FG000|Extension Study|Death|4|||
147417339|NCT00948766|531691640|FG001|Extension Study|Death|0|||
147417340|NCT00777088|531691641|FG000|Overall Study|PED Treatment not attempted|1|||
147417341|NCT01278173|531691642|FG000|Overall Study|Lack of Efficacy|13|||
147417342|NCT01278173|531691642|FG000|Overall Study|Adverse Event|8|||
147417343|NCT01278173|531691642|FG000|Overall Study|Administrative or other reason|4|||
147417344|NCT01278173|531691642|FG000|Overall Study|Protocol Violation|1|||
147417345|NCT01278173|531691642|FG000|Overall Study|Withdrawal by Subject|1|||
147417346|NCT02546921|531691643|FG000|Overall Study|Adverse Event|0|||
147417347|NCT02546921|531691644|FG001|Overall Study|Adverse Event|5|||
147417348|NCT02546921|531691645|FG002|Overall Study|Adverse Event|2|||
147417349|NCT02546921|531691646|FG003|Overall Study|Adverse Event|0|||
147417350|NCT02546921|531691647|FG004|Overall Study|Adverse Event|0|||
147417351|NCT02546921|531691648|FG005|Overall Study|Adverse Event|0|||
147417352|NCT02546921|531691649|FG006|Overall Study|Adverse Event|0|||
147417353|NCT02546921|531691643|FG000|Overall Study|Evidence of Disease Progression|1|||
147417354|NCT02546921|531691644|FG001|Overall Study|Evidence of Disease Progression|0|||
147417355|NCT02546921|531691645|FG002|Overall Study|Evidence of Disease Progression|0|||
147417356|NCT02546921|531691646|FG003|Overall Study|Evidence of Disease Progression|0|||
147417357|NCT02546921|531691647|FG004|Overall Study|Evidence of Disease Progression|1|||
147417358|NCT02546921|531691648|FG005|Overall Study|Evidence of Disease Progression|0|||
147417359|NCT02546921|531691649|FG006|Overall Study|Evidence of Disease Progression|0|||
147417360|NCT02546921|531691643|FG000|Overall Study|Patient Choice|0|||
147417361|NCT02546921|531691644|FG001|Overall Study|Patient Choice|1|||
147417362|NCT02546921|531691645|FG002|Overall Study|Patient Choice|0|||
147417363|NCT02546921|531691646|FG003|Overall Study|Patient Choice|0|||
147417364|NCT02546921|531691647|FG004|Overall Study|Patient Choice|0|||
147417365|NCT02546921|531691648|FG005|Overall Study|Patient Choice|1|||
147417366|NCT02546921|531691649|FG006|Overall Study|Patient Choice|0|||
147417367|NCT03381339|531691650|FG000|Overall Study|Protocol Violation|4|||
147417368|NCT03381339|531691651|FG001|Overall Study|Protocol Violation|3|||
147417369|NCT03381339|531691650|FG000|Overall Study|Lost to Follow-up|0|||
147417370|NCT03381339|531691651|FG001|Overall Study|Lost to Follow-up|1|||
147417371|NCT01593787|531691652|FG000|Overall Study|Adverse Event|1|||
147417372|NCT01593787|531691653|FG001|Overall Study|Adverse Event|0|||
147417373|NCT01593787|531691654|FG002|Overall Study|Adverse Event|0|||
147417374|NCT01022112|531691660|FG000|Overall Study|Adverse Event|1|||
147417375|NCT01022112|531691661|FG001|Overall Study|Adverse Event|2|||
147417376|NCT01022112|531691662|FG002|Overall Study|Adverse Event|0|||
147417377|NCT01022112|531691663|FG003|Overall Study|Adverse Event|1|||
147417378|NCT01022112|531691664|FG004|Overall Study|Adverse Event|0|||
147417379|NCT01022112|531691660|FG000|Overall Study|Lack of Efficacy|1|||
147417380|NCT01022112|531691661|FG001|Overall Study|Lack of Efficacy|0|||
147417381|NCT01022112|531691662|FG002|Overall Study|Lack of Efficacy|0|||
147417382|NCT01022112|531691663|FG003|Overall Study|Lack of Efficacy|0|||
147417383|NCT01022112|531691664|FG004|Overall Study|Lack of Efficacy|1|||
147417384|NCT01022112|531691660|FG000|Overall Study|Physician Decision|0|||
147417385|NCT01022112|531691661|FG001|Overall Study|Physician Decision|0|||
147625875|NCT00506415|532447150|FG001|Extended Open Label (Maximum 48 Weeks)|Adverse Event|0|||
147417386|NCT01022112|531691662|FG002|Overall Study|Physician Decision|1|||
147417387|NCT01022112|531691663|FG003|Overall Study|Physician Decision|0|||
147417388|NCT01022112|531691664|FG004|Overall Study|Physician Decision|1|||
147625876|NCT00506415|532447151|FG002|Extended Open Label (Maximum 48 Weeks)|Adverse Event|0|||
147417389|NCT01022112|531691660|FG000|Overall Study|Withdrawal by Subject|0|||
147417390|NCT01022112|531691661|FG001|Overall Study|Withdrawal by Subject|1|||
147417391|NCT01022112|531691662|FG002|Overall Study|Withdrawal by Subject|2|||
147417392|NCT01022112|531691663|FG003|Overall Study|Withdrawal by Subject|2|||
147417393|NCT01022112|531691664|FG004|Overall Study|Withdrawal by Subject|1|||
147417394|NCT01022112|531691660|FG000|Overall Study|Fasting plasma glucose level increased|1|||
147417395|NCT01022112|531691661|FG001|Overall Study|Fasting plasma glucose level increased|0|||
147417396|NCT01022112|531691662|FG002|Overall Study|Fasting plasma glucose level increased|0|||
147417397|NCT01022112|531691663|FG003|Overall Study|Fasting plasma glucose level increased|0|||
147417398|NCT01022112|531691664|FG004|Overall Study|Fasting plasma glucose level increased|7|||
147417399|NCT00591721|531693060|FG000|Overall Study|Withdrawal by Subject|10|||
147625877|NCT00506415|532447152|FG003|Extended Open Label (Maximum 48 Weeks)|Adverse Event|18|||
147417400|NCT00591721|531693061|FG001|Overall Study|Withdrawal by Subject|10|||
147417401|NCT00591721|531693060|FG000|Overall Study|Lost to Follow-up|1|||
147417402|NCT00591721|531693061|FG001|Overall Study|Lost to Follow-up|4|||
147417403|NCT00591721|531693060|FG000|Overall Study|Intervention not received|10|||
147417404|NCT00591721|531693061|FG001|Overall Study|Intervention not received|8|||
147417405|NCT00901186|531693062|FG000|Overall Study|Lack of Efficacy|0|||
147417406|NCT00901186|531693063|FG001|Overall Study|Lack of Efficacy|1|||
147417407|NCT00901186|531693062|FG000|Overall Study|Abnormal laboratory values|0|||
147417408|NCT00901186|531693063|FG001|Overall Study|Abnormal laboratory values|1|||
147417409|NCT00901186|531693062|FG000|Overall Study|Lost to Follow-up|2|||
147417410|NCT00901186|531693063|FG001|Overall Study|Lost to Follow-up|0|||
147417411|NCT00901186|531693062|FG000|Overall Study|Adverse Event|2|||
147417412|NCT00901186|531693063|FG001|Overall Study|Adverse Event|4|||
147417413|NCT00901186|531693062|FG000|Overall Study|Administration problems|0|||
147417414|NCT00901186|531693063|FG001|Overall Study|Administration problems|1|||
147417415|NCT00901186|531693062|FG000|Overall Study|Protocol deviations|5|||
147417416|NCT00901186|531693063|FG001|Overall Study|Protocol deviations|4|||
147417417|NCT02383056|531693066|FG000|Overall Study|Adverse Event|1|||
147417418|NCT02383056|531693067|FG001|Overall Study|Adverse Event|0|||
147417419|NCT02383056|531693066|FG000|Overall Study|Lost to Follow-up|0|||
147417420|NCT02383056|531693067|FG001|Overall Study|Lost to Follow-up|2|||
147417421|NCT03900416|531693068|FG000|Six Week Follow-up|Lost to Follow-up|1|||
147417422|NCT03900416|531693069|FG001|Six Week Follow-up|Lost to Follow-up|0|||
147417423|NCT03900416|531693068|FG000|Six Week Follow-up|Withdrawal by Subject|1|||
147417424|NCT03900416|531693069|FG001|Six Week Follow-up|Withdrawal by Subject|0|||
147417425|NCT03900416|531693068|FG000|Twelve Week Follow-up|Lost to Follow-up|0|||
147417426|NCT03900416|531693069|FG001|Twelve Week Follow-up|Lost to Follow-up|2|||
147417427|NCT03900416|531693068|FG000|Twelve Week Follow-up|Withdrawal by Subject|0|||
147417428|NCT03900416|531693069|FG001|Twelve Week Follow-up|Withdrawal by Subject|1|||
147417429|NCT03900416|531693068|FG000|Twelve Week Follow-up|Adverse Event|1|||
147417430|NCT03900416|531693069|FG001|Twelve Week Follow-up|Adverse Event|1|||
147417431|NCT03900416|531693068|FG000|Six Month Follow-up|Lost to Follow-up|4|||
147417432|NCT03900416|531693069|FG001|Six Month Follow-up|Lost to Follow-up|3|||
147417433|NCT03900416|531693068|FG000|Six Month Follow-up|Withdrawal by Subject|1|||
147417434|NCT03900416|531693069|FG001|Six Month Follow-up|Withdrawal by Subject|1|||
147417435|NCT03507777|531693070|FG000|Overall Study|Lost to Follow-up|5|||
147417436|NCT03507777|531693071|FG001|Overall Study|Lost to Follow-up|7|||
147417437|NCT03507777|531693070|FG000|Overall Study|Withdrawal by Subject|6|||
147417438|NCT03507777|531693071|FG001|Overall Study|Withdrawal by Subject|11|||
147417439|NCT03507777|531693070|FG000|Overall Study|Death|30|||
147417440|NCT03507777|531693071|FG001|Overall Study|Death|44|||
147417441|NCT03507777|531693070|FG000|Overall Study|Other Reasons|3|||
147417442|NCT03507777|531693071|FG001|Overall Study|Other Reasons|8|||
147417443|NCT02245737|531693072|FG000|Overall Study|Adverse Event|23|||
147417444|NCT02245737|531693073|FG001|Overall Study|Adverse Event|26|||
147417445|NCT02245737|531693074|FG002|Overall Study|Adverse Event|33|||
147417446|NCT02245737|531693072|FG000|Overall Study|Condition Worsened|9|||
147417447|NCT02245737|531693073|FG001|Overall Study|Condition Worsened|10|||
147417448|NCT02245737|531693074|FG002|Overall Study|Condition Worsened|9|||
147417449|NCT02245737|531693072|FG000|Overall Study|Death|2|||
147417450|NCT02245737|531693073|FG001|Overall Study|Death|4|||
147417451|NCT02245737|531693074|FG002|Overall Study|Death|4|||
147417452|NCT02245737|531693072|FG000|Overall Study|Eligibility Criteria No Longer Met|2|||
147417453|NCT02245737|531693073|FG001|Overall Study|Eligibility Criteria No Longer Met|4|||
147417454|NCT02245737|531693074|FG002|Overall Study|Eligibility Criteria No Longer Met|4|||
147417455|NCT02245737|531693072|FG000|Overall Study|Initiation of Symptomatic AD medication|2|||
147417456|NCT02245737|531693073|FG001|Overall Study|Initiation of Symptomatic AD medication|0|||
147417457|NCT02245737|531693074|FG002|Overall Study|Initiation of Symptomatic AD medication|0|||
147417458|NCT02245737|531693072|FG000|Overall Study|Lost to Follow-up|2|||
147417459|NCT02245737|531693073|FG001|Overall Study|Lost to Follow-up|5|||
147417460|NCT02245737|531693074|FG002|Overall Study|Lost to Follow-up|4|||
147417461|NCT02245737|531693072|FG000|Overall Study|Other-determined by Investigator|9|||
147417462|NCT02245737|531693073|FG001|Overall Study|Other-determined by Investigator|10|||
147417463|NCT02245737|531693074|FG002|Overall Study|Other-determined by Investigator|10|||
147417464|NCT02245737|531693072|FG000|Overall Study|Physician Decision|6|||
147417465|NCT02245737|531693073|FG001|Overall Study|Physician Decision|3|||
147417466|NCT02245737|531693074|FG002|Overall Study|Physician Decision|6|||
147417467|NCT02245737|531693072|FG000|Overall Study|Protocol Violation|3|||
147417468|NCT02245737|531693073|FG001|Overall Study|Protocol Violation|2|||
147417469|NCT02245737|531693074|FG002|Overall Study|Protocol Violation|3|||
147417470|NCT02245737|531693072|FG000|Overall Study|Withdrawal by Subject|40|||
147417471|NCT02245737|531693073|FG001|Overall Study|Withdrawal by Subject|41|||
147417472|NCT02245737|531693074|FG002|Overall Study|Withdrawal by Subject|44|||
147417473|NCT02245737|531693072|FG000|Overall Study|Withdrawal due to Caregiver Circumstance|10|||
147417474|NCT02245737|531693073|FG001|Overall Study|Withdrawal due to Caregiver Circumstance|20|||
147417475|NCT02245737|531693074|FG002|Overall Study|Withdrawal due to Caregiver Circumstance|22|||
147417476|NCT02245737|531693072|FG000|Overall Study|Sponsor Decision|445|||
147417477|NCT02245737|531693073|FG001|Overall Study|Sponsor Decision|430|||
147417478|NCT02245737|531693074|FG002|Overall Study|Sponsor Decision|432|||
147417479|NCT03122223|531693084|FG000|Overall Study|Withdrawal by Subject|2|||
147417480|NCT03122223|531693085|FG001|Overall Study|Withdrawal by Subject|2|||
147417481|NCT03122223|531693086|FG002|Overall Study|Withdrawal by Subject|1|||
147417482|NCT03122223|531693087|FG003|Overall Study|Withdrawal by Subject|0|||
147417483|NCT03122223|531693084|FG000|Overall Study|Lost to Follow-up|0|||
147417484|NCT03122223|531693085|FG001|Overall Study|Lost to Follow-up|2|||
147417485|NCT03122223|531693086|FG002|Overall Study|Lost to Follow-up|2|||
147417486|NCT03122223|531693087|FG003|Overall Study|Lost to Follow-up|0|||
147417487|NCT03122223|531693084|FG000|Overall Study|Participant unable to adhere|1|||
147417488|NCT03122223|531693085|FG001|Overall Study|Participant unable to adhere|1|||
147417489|NCT03122223|531693086|FG002|Overall Study|Participant unable to adhere|1|||
147417490|NCT03122223|531693087|FG003|Overall Study|Participant unable to adhere|0|||
147417491|NCT00291642|531693089|FG000|Overall Study|Adverse Event|1|||
147417492|NCT00291642|531693090|FG001|Overall Study|Adverse Event|0|||
147417493|NCT00291642|531693091|FG002|Overall Study|Adverse Event|1|||
147417494|NCT00291642|531693092|FG003|Overall Study|Adverse Event|0|||
147417495|NCT00291642|531693093|FG004|Overall Study|Adverse Event|1|||
147417496|NCT00291642|531693089|FG000|Overall Study|Patient missed visit|0|||
147417497|NCT00291642|531693090|FG001|Overall Study|Patient missed visit|0|||
147417498|NCT00291642|531693091|FG002|Overall Study|Patient missed visit|1|||
147417499|NCT00291642|531693092|FG003|Overall Study|Patient missed visit|0|||
147417500|NCT00291642|531693093|FG004|Overall Study|Patient missed visit|0|||
147417501|NCT00291642|531693089|FG000|Overall Study|Intake of prohibited medication|1|||
147417502|NCT00291642|531693090|FG001|Overall Study|Intake of prohibited medication|0|||
147417503|NCT00291642|531693091|FG002|Overall Study|Intake of prohibited medication|0|||
147417504|NCT00291642|531693092|FG003|Overall Study|Intake of prohibited medication|0|||
147417505|NCT00291642|531693093|FG004|Overall Study|Intake of prohibited medication|0|||
147417506|NCT00735475|531693094|FG000|Overall Study|Adverse Event|0|||
147417507|NCT00735475|531693095|FG001|Overall Study|Adverse Event|1|||
147417508|NCT00735475|531693094|FG000|Overall Study|Death|1|||
147417509|NCT00735475|531693095|FG001|Overall Study|Death|1|||
147417510|NCT00735475|531693094|FG000|Overall Study|Lost to Follow-up|3|||
147417511|NCT00735475|531693095|FG001|Overall Study|Lost to Follow-up|3|||
147417512|NCT00735475|531693094|FG000|Overall Study|Physician Decision|0|||
147417513|NCT00735475|531693095|FG001|Overall Study|Physician Decision|1|||
147417514|NCT00735475|531693094|FG000|Overall Study|Withdrawal by Subject|4|||
147417515|NCT00735475|531693095|FG001|Overall Study|Withdrawal by Subject|5|||
147417516|NCT01712659|531693096|FG000|Dose Escalation|Physician Decision|0|||
147417517|NCT01712659|531693097|FG001|Dose Escalation|Physician Decision|1|||
147417518|NCT01712659|531693098|FG002|Dose Escalation|Physician Decision|0|||
147417519|NCT01712659|531693099|FG003|Dose Escalation|Physician Decision|0|||
147417520|NCT01712659|531693100|FG004|Dose Escalation|Physician Decision|0|||
147417521|NCT01712659|531693096|FG000|Dose Escalation|Unable to take study drug|0|||
147417522|NCT01712659|531693097|FG001|Dose Escalation|Unable to take study drug|1|||
147417523|NCT01712659|531693098|FG002|Dose Escalation|Unable to take study drug|0|||
147417524|NCT01712659|531693099|FG003|Dose Escalation|Unable to take study drug|0|||
147417525|NCT01712659|531693100|FG004|Dose Escalation|Unable to take study drug|0|||
147417526|NCT01712659|531693096|FG000|Dose Expansion|Early disease progression|1|||
147417527|NCT01712659|531693097|FG001|Dose Expansion|Early disease progression|0|||
147417528|NCT01712659|531693098|FG002|Dose Expansion|Early disease progression|0|||
147417529|NCT01712659|531693099|FG003|Dose Expansion|Early disease progression|0|||
147417530|NCT01712659|531693100|FG004|Dose Expansion|Early disease progression|0|||
147417531|NCT01712659|531693096|FG000|Dose Expansion|Physician Decision|1|||
147417532|NCT01712659|531693097|FG001|Dose Expansion|Physician Decision|0|||
147417533|NCT01712659|531693098|FG002|Dose Expansion|Physician Decision|0|||
147417534|NCT01712659|531693099|FG003|Dose Expansion|Physician Decision|0|||
147417535|NCT01712659|531693100|FG004|Dose Expansion|Physician Decision|0|||
147417536|NCT00548262|531693103|FG000|Overall Study|Death|21|||
147417537|NCT00548262|531693103|FG000|Overall Study|Adverse Event|2|||
147417538|NCT00548262|531693103|FG000|Overall Study|Lack of Efficacy|4|||
147417539|NCT00548262|531693103|FG000|Overall Study|Lost to Follow-up|1|||
147417540|NCT00548262|531693103|FG000|Overall Study|Other|3|||
147417541|NCT00548262|531693103|FG000|Overall Study|Withdrawal by Subject|1|||
147417542|NCT03189745|531693109|FG000|Overall Study|Conflict in work schedule of participant|1|||
147417543|NCT03189745|531693110|FG001|Overall Study|Conflict in work schedule of participant|1|||
147417544|NCT05086276|531693111|FG000|Overall Study|Missed visit 5/Day 60 visit|1|||
147417545|NCT05086276|531693112|FG001|Overall Study|Missed visit 5/Day 60 visit|1|||
147417546|NCT03590366|531693113|FG000|Overall Study|Adverse Event|0|||
147417547|NCT03590366|531693114|FG001|Overall Study|Adverse Event|3|||
147417548|NCT03590366|531693113|FG000|Overall Study|Lost to Follow-up|3|||
147417549|NCT03590366|531693114|FG001|Overall Study|Lost to Follow-up|3|||
147668011|NCT00606008|532609829|FG000|Overall Study|Adverse Event|1|||
147417550|NCT03590366|531693113|FG000|Overall Study|Withdrawal by Subject|0|||
147417551|NCT03590366|531693114|FG001|Overall Study|Withdrawal by Subject|2|||
147668012|NCT00606008|532609829|FG000|Overall Study|Withdrawal by Subject|4|||
147625878|NCT00506415|532447149|FG000|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
147625879|NCT00506415|532447150|FG001|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
147625880|NCT00506415|532447151|FG002|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|0|||
147625881|NCT00506415|532447152|FG003|Extended Open Label (Maximum 48 Weeks)|Lost to Follow-up|8|||
147625882|NCT00506415|532447149|FG000|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
147625883|NCT00506415|532447150|FG001|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
147625884|NCT00506415|532447151|FG002|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|0|||
147625885|NCT00506415|532447152|FG003|Extended Open Label (Maximum 48 Weeks)|Withdrawal by Subject|14|||
147625886|NCT00506415|532447149|FG000|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
147625887|NCT00506415|532447150|FG001|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
147625888|NCT00506415|532447151|FG002|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|0|||
147625889|NCT00506415|532447152|FG003|Extended Open Label (Maximum 48 Weeks)|Protocol Violation|5|||
147625890|NCT00506415|532447149|FG000|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
147625891|NCT00506415|532447150|FG001|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
147625892|NCT00506415|532447151|FG002|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|0|||
147625893|NCT00506415|532447152|FG003|Extended Open Label (Maximum 48 Weeks)|Unsatisfactory therapeutic effect|6|||
147625894|NCT00506415|532447149|FG000|Extended Open Label (Maximum 48 Weeks)|Death|0|||
147625895|NCT00506415|532447150|FG001|Extended Open Label (Maximum 48 Weeks)|Death|0|||
147625896|NCT00506415|532447151|FG002|Extended Open Label (Maximum 48 Weeks)|Death|0|||
147625897|NCT00506415|532447152|FG003|Extended Open Label (Maximum 48 Weeks)|Death|7|||
147625898|NCT00997373|532447153|FG000|Overall Study|Withdrawal by Subject|5|||
147625899|NCT00997373|532447154|FG001|Overall Study|Withdrawal by Subject|0|||
147625900|NCT00997373|532447153|FG000|Overall Study|wrong tumor type|4|||
147625901|NCT00997373|532447154|FG001|Overall Study|wrong tumor type|0|||
147625902|NCT00997373|532447153|FG000|Overall Study|could not have hysterectomy|6|||
147625903|NCT00997373|532447154|FG001|Overall Study|could not have hysterectomy|0|||
147625904|NCT04578457|532447155|FG000|Hearing Aid Without NR Enabled (0)|Withdrawal by Subject|2|||
147625905|NCT04578457|532447155|FG000|Hearing Aid With NR (1)|Withdrawal by Subject|2|||
147625906|NCT04578457|532447155|FG000|Hearing Aid With NR (2)|Withdrawal by Subject|2|||
147625907|NCT04578457|532447155|FG000|Hearing Aid With NR (4)|Withdrawal by Subject|2|||
147625908|NCT03123393|532447156|FG000|Overall Study|Study Terminated by Sponsor|6|||
147625909|NCT03123393|532447157|FG001|Overall Study|Study Terminated by Sponsor|9|||
147417552|NCT00738894|531693115|FG000|Overall Study|Lost to Follow-up|23|||
147417553|NCT00738894|531693116|FG001|Overall Study|Lost to Follow-up|13|||
147417554|NCT00738894|531693115|FG000|Overall Study|Withdrawal by Subject|10|||
147417555|NCT00738894|531693116|FG001|Overall Study|Withdrawal by Subject|15|||
147417556|NCT00738894|531693115|FG000|Overall Study|Physician Decision|4|||
147417557|NCT00738894|531693116|FG001|Overall Study|Physician Decision|5|||
147417558|NCT00738894|531693115|FG000|Overall Study|Death|2|||
147417559|NCT00738894|531693116|FG001|Overall Study|Death|0|||
147417560|NCT05017103|531693117|FG000|Overall Study|Death|2|||
147417561|NCT01747551|531693131|FG000|Overall Study|Progressive Disease|24|||
147417562|NCT01747551|531693132|FG001|Overall Study|Progressive Disease|17|||
147417563|NCT01747551|531693131|FG000|Overall Study|Death|3|||
147417564|NCT01747551|531693132|FG001|Overall Study|Death|1|||
147417565|NCT01747551|531693131|FG000|Overall Study|Adverse Event|7|||
147417566|NCT01747551|531693132|FG001|Overall Study|Adverse Event|1|||
147417567|NCT01747551|531693131|FG000|Overall Study|Prolonged Treatment Delay|2|||
147417568|NCT01747551|531693132|FG001|Overall Study|Prolonged Treatment Delay|0|||
147417569|NCT01747551|531693131|FG000|Overall Study|Withdrawal by Subject|3|||
147417570|NCT01747551|531693132|FG001|Overall Study|Withdrawal by Subject|1|||
147417571|NCT01747551|531693131|FG000|Overall Study|Physician Decision|2|||
147417572|NCT01747551|531693132|FG001|Overall Study|Physician Decision|1|||
147417573|NCT01747551|531693131|FG000|Overall Study|Other|2|||
147417574|NCT01747551|531693132|FG001|Overall Study|Other|0|||
147417575|NCT01373151|531693134|FG000|Period 1|Lack of Efficacy|3|||
147417576|NCT01373151|531693135|FG001|Period 1|Lack of Efficacy|0|||
147417577|NCT01373151|531693136|FG002|Period 1|Lack of Efficacy|0|||
147417578|NCT01373151|531693137|FG003|Period 1|Lack of Efficacy|0|||
147417579|NCT01373151|531693138|FG004|Period 1|Lack of Efficacy|1|||
147417580|NCT01373151|531693139|FG005|Period 1|Lack of Efficacy|0|||
147417581|NCT01373151|531693140|FG006|Period 1|Lack of Efficacy|0|||
147417582|NCT01373151|531693134|FG000|Period 1|Adverse Event|0|||
147625910|NCT03123393|532447156|FG000|Overall Study|Withdrawal by Subject|2|||
147625911|NCT03123393|532447157|FG001|Overall Study|Withdrawal by Subject|1|||
147417583|NCT01373151|531693135|FG001|Period 1|Adverse Event|0|||
147417584|NCT01373151|531693136|FG002|Period 1|Adverse Event|1|||
147417585|NCT01373151|531693137|FG003|Period 1|Adverse Event|0|||
147417586|NCT01373151|531693138|FG004|Period 1|Adverse Event|4|||
147625912|NCT03123393|532447156|FG000|Overall Study|Reason not Specified|13|||
147417587|NCT01373151|531693139|FG005|Period 1|Adverse Event|3|||
147417588|NCT01373151|531693140|FG006|Period 1|Adverse Event|0|||
147417589|NCT01373151|531693134|FG000|Period 1|Withdrawal by Subject|2|||
147417590|NCT01373151|531693135|FG001|Period 1|Withdrawal by Subject|0|||
147417591|NCT01373151|531693136|FG002|Period 1|Withdrawal by Subject|3|||
147668013|NCT00547339|532609840|FG000|Overall Study|Physician Decision|0|||
147668014|NCT00547339|532609841|FG001|Overall Study|Physician Decision|0|||
147668015|NCT00547339|532609842|FG002|Overall Study|Physician Decision|1|||
147668016|NCT00547339|532609843|FG003|Overall Study|Physician Decision|0|||
147668017|NCT01603602|532609844|FG000|Overall Study|Adverse Event|1|||
147668018|NCT01603602|532609845|FG001|Overall Study|Adverse Event|0|||
147668019|NCT01603602|532609846|FG002|Overall Study|Adverse Event|0|||
147668020|NCT01603602|532609844|FG000|Overall Study|Personal Reasons|1|||
147668021|NCT01603602|532609845|FG001|Overall Study|Personal Reasons|0|||
147668022|NCT01603602|532609846|FG002|Overall Study|Personal Reasons|1|||
147668023|NCT03712280|532609849|FG000|Overall Study|Randomized, but not treated due to Adverse Event|0|||
147668024|NCT03712280|532609850|FG001|Overall Study|Randomized, but not treated due to Adverse Event|1|||
147668025|NCT03712280|532609851|FG002|Overall Study|Randomized, but not treated due to Adverse Event|0|||
147668026|NCT03712280|532609852|FG003|Overall Study|Randomized, but not treated due to Adverse Event|1|||
147668027|NCT03712280|532609849|FG000|Overall Study|Withdrawal by Participant or Caregiver|1|||
147668028|NCT03712280|532609850|FG001|Overall Study|Withdrawal by Participant or Caregiver|0|||
147668029|NCT03712280|532609851|FG002|Overall Study|Withdrawal by Participant or Caregiver|0|||
147668030|NCT03712280|532609852|FG003|Overall Study|Withdrawal by Participant or Caregiver|0|||
147668031|NCT03712280|532609849|FG000|Overall Study|Adverse Event|0|||
147668032|NCT03712280|532609850|FG001|Overall Study|Adverse Event|0|||
147668033|NCT03712280|532609851|FG002|Overall Study|Adverse Event|1|||
147668034|NCT03712280|532609852|FG003|Overall Study|Adverse Event|0|||
147668035|NCT01663623|532609853|FG000|Overall Study|Adverse Event|3|||
147668036|NCT01663623|532609854|FG001|Overall Study|Adverse Event|7|||
147668037|NCT01663623|532609853|FG000|Overall Study|Lack of Efficacy|5|||
147668038|NCT01663623|532609854|FG001|Overall Study|Lack of Efficacy|6|||
147668039|NCT01663623|532609853|FG000|Overall Study|Protocol Violation|0|||
147668040|NCT01663623|532609854|FG001|Overall Study|Protocol Violation|1|||
147668041|NCT01663623|532609853|FG000|Overall Study|Other-Study closed/terminated|1|||
147668042|NCT01663623|532609854|FG001|Overall Study|Other-Study closed/terminated|1|||
147668043|NCT01663623|532609853|FG000|Overall Study|Physician Decision|1|||
147668044|NCT01663623|532609854|FG001|Overall Study|Physician Decision|4|||
147668045|NCT01663623|532609853|FG000|Overall Study|Withdrawal by Subject|2|||
147668046|NCT01663623|532609854|FG001|Overall Study|Withdrawal by Subject|1|||
147668047|NCT00251758|532609856|FG000|Overall Study|Adverse Event|7|||
147668048|NCT00251758|532609857|FG001|Overall Study|Adverse Event|9|||
147668049|NCT00251758|532609858|FG002|Overall Study|Adverse Event|11|||
147417592|NCT01373151|531693137|FG003|Period 1|Withdrawal by Subject|1|||
147417593|NCT01373151|531693138|FG004|Period 1|Withdrawal by Subject|0|||
147417594|NCT01373151|531693139|FG005|Period 1|Withdrawal by Subject|1|||
147417595|NCT01373151|531693140|FG006|Period 1|Withdrawal by Subject|0|||
147417596|NCT01373151|531693134|FG000|Period 2|Lack of Efficacy|9|||
147417597|NCT01373151|531693135|FG001|Period 2|Lack of Efficacy|0|||
147417598|NCT01373151|531693136|FG002|Period 2|Lack of Efficacy|0|||
147417599|NCT01373151|531693137|FG003|Period 2|Lack of Efficacy|1|||
147417600|NCT01373151|531693138|FG004|Period 2|Lack of Efficacy|2|||
147417601|NCT01373151|531693139|FG005|Period 2|Lack of Efficacy|0|||
147417602|NCT01373151|531693140|FG006|Period 2|Lack of Efficacy|3|||
147417603|NCT01373151|531693134|FG000|Period 2|Adverse Event|0|||
147417604|NCT01373151|531693135|FG001|Period 2|Adverse Event|0|||
147417605|NCT01373151|531693136|FG002|Period 2|Adverse Event|3|||
147417606|NCT01373151|531693137|FG003|Period 2|Adverse Event|3|||
147417607|NCT01373151|531693138|FG004|Period 2|Adverse Event|0|||
147417608|NCT01373151|531693139|FG005|Period 2|Adverse Event|0|||
147417609|NCT01373151|531693140|FG006|Period 2|Adverse Event|1|||
147417610|NCT01373151|531693134|FG000|Period 2|subject request to discontinue|0|||
147417611|NCT01373151|531693135|FG001|Period 2|subject request to discontinue|1|||
147417612|NCT01373151|531693136|FG002|Period 2|subject request to discontinue|0|||
147417613|NCT01373151|531693137|FG003|Period 2|subject request to discontinue|0|||
147417614|NCT01373151|531693138|FG004|Period 2|subject request to discontinue|0|||
147417615|NCT01373151|531693139|FG005|Period 2|subject request to discontinue|0|||
147417616|NCT01373151|531693140|FG006|Period 2|subject request to discontinue|0|||
147417617|NCT01373151|531693134|FG000|Period 2|Withdrawal by Subject|0|||
147417618|NCT01373151|531693135|FG001|Period 2|Withdrawal by Subject|0|||
147417619|NCT01373151|531693136|FG002|Period 2|Withdrawal by Subject|0|||
147417620|NCT01373151|531693137|FG003|Period 2|Withdrawal by Subject|1|||
147417621|NCT01373151|531693138|FG004|Period 2|Withdrawal by Subject|0|||
147417622|NCT01373151|531693139|FG005|Period 2|Withdrawal by Subject|0|||
147417623|NCT01373151|531693140|FG006|Period 2|Withdrawal by Subject|0|||
147668050|NCT00251758|532609856|FG000|Overall Study|Lost to Follow-up|4|||
147668051|NCT00251758|532609857|FG001|Overall Study|Lost to Follow-up|2|||
147668052|NCT00251758|532609858|FG002|Overall Study|Lost to Follow-up|5|||
147668053|NCT00251758|532609856|FG000|Overall Study|Withdrawal by Subject|13|||
147668054|NCT00251758|532609857|FG001|Overall Study|Withdrawal by Subject|7|||
147668055|NCT00251758|532609858|FG002|Overall Study|Withdrawal by Subject|3|||
147417624|NCT01373151|531693134|FG000|Period 2|Other|0|||
147417625|NCT01373151|531693135|FG001|Period 2|Other|0|||
147417626|NCT01373151|531693136|FG002|Period 2|Other|1|||
147668056|NCT00251758|532609856|FG000|Overall Study|Unmet Inclusion/Exclusion Criteria|0|||
147417627|NCT01373151|531693137|FG003|Period 2|Other|0|||
147417628|NCT01373151|531693138|FG004|Period 2|Other|0|||
147417629|NCT01373151|531693139|FG005|Period 2|Other|0|||
147417630|NCT01373151|531693140|FG006|Period 2|Other|1|||
147417631|NCT03026075|531693145|FG000|Overall Study|Physician Decision|1|||
147417632|NCT04927247|531693149|FG000|Overall Study|Other|2|||
147417633|NCT04927247|531693150|FG001|Overall Study|Other|1|||
147417634|NCT04927247|531693149|FG000|Overall Study|Physician Decision|0|||
147417635|NCT04927247|531693150|FG001|Overall Study|Physician Decision|1|||
147417636|NCT04927247|531693149|FG000|Overall Study|Adverse Event|1|||
147417637|NCT04927247|531693150|FG001|Overall Study|Adverse Event|0|||
147417638|NCT04828837|531693152|FG000|Overall Study|Stay-at-home during a COVID-19 outbreak|1|||
147417639|NCT04828837|531693153|FG001|Overall Study|Stay-at-home during a COVID-19 outbreak|3|||
147417640|NCT04828837|531693152|FG000|Overall Study|Lost to Follow-up|2|||
147417641|NCT04828837|531693153|FG001|Overall Study|Lost to Follow-up|6|||
147417642|NCT04828837|531693152|FG000|Overall Study|Lack of Efficacy|1|||
147417643|NCT04828837|531693153|FG001|Overall Study|Lack of Efficacy|0|||
147417644|NCT04828837|531693152|FG000|Overall Study|Admitted due to pneumothorax.|1|||
147417645|NCT04828837|531693153|FG001|Overall Study|Admitted due to pneumothorax.|0|||
147417646|NCT04828837|531693152|FG000|Overall Study|Admitted due to HIVD for operation.|0|||
147417647|NCT04828837|531693153|FG001|Overall Study|Admitted due to HIVD for operation.|1|||
147417648|NCT01397422|531693154|FG000|Overall Study|Adverse Event|0|||
147417649|NCT01397422|531693155|FG001|Overall Study|Adverse Event|3|||
147417650|NCT01397422|531693156|FG002|Overall Study|Adverse Event|3|||
147417651|NCT01397422|531693157|FG003|Overall Study|Adverse Event|8|||
147417652|NCT01397422|531693154|FG000|Overall Study|Withdrawal by Subject|1|||
147417653|NCT01397422|531693155|FG001|Overall Study|Withdrawal by Subject|0|||
147417654|NCT01397422|531693156|FG002|Overall Study|Withdrawal by Subject|0|||
147417655|NCT01397422|531693157|FG003|Overall Study|Withdrawal by Subject|0|||
147417656|NCT01397422|531693154|FG000|Overall Study|Increased bradykinesia related to PD|1|||
147417657|NCT01397422|531693155|FG001|Overall Study|Increased bradykinesia related to PD|0|||
147417658|NCT01397422|531693156|FG002|Overall Study|Increased bradykinesia related to PD|0|||
147417659|NCT01397422|531693157|FG003|Overall Study|Increased bradykinesia related to PD|0|||
147417660|NCT00545753|531693158|FG000|Overall Study|Withdrawal by Subject|0|||
147417661|NCT00545753|531693159|FG001|Overall Study|Withdrawal by Subject|1|||
147417662|NCT00545753|531693160|FG002|Overall Study|Withdrawal by Subject|10|||
147417663|NCT00545753|531693158|FG000|Overall Study|Lost to Follow-up|13|||
147417664|NCT00545753|531693159|FG001|Overall Study|Lost to Follow-up|3|||
147417665|NCT00545753|531693160|FG002|Overall Study|Lost to Follow-up|12|||
147417666|NCT00545753|531693158|FG000|Overall Study|Protocol Violation|3|||
147417667|NCT00545753|531693159|FG001|Overall Study|Protocol Violation|1|||
147417668|NCT00545753|531693160|FG002|Overall Study|Protocol Violation|4|||
147417669|NCT02489968|531693170|FG000|Open-label Treatment Period|Adverse Event|14|||
147417670|NCT02489968|531693171|FG001|Open-label Treatment Period|Adverse Event|7|||
147417671|NCT02489968|531693172|FG002|Open-label Treatment Period|Adverse Event|0|||
147417672|NCT02489968|531693173|FG003|Open-label Treatment Period|Adverse Event|0|||
147417673|NCT02489968|531693174|FG004|Open-label Treatment Period|Adverse Event|0|||
147417674|NCT02489968|531693175|FG005|Open-label Treatment Period|Adverse Event|0|||
147417675|NCT02489968|531693170|FG000|Open-label Treatment Period|Protocol Violation|2|||
147417676|NCT02489968|531693171|FG001|Open-label Treatment Period|Protocol Violation|2|||
147417677|NCT02489968|531693172|FG002|Open-label Treatment Period|Protocol Violation|0|||
147417678|NCT02489968|531693173|FG003|Open-label Treatment Period|Protocol Violation|0|||
147417679|NCT02489968|531693174|FG004|Open-label Treatment Period|Protocol Violation|0|||
147417680|NCT02489968|531693175|FG005|Open-label Treatment Period|Protocol Violation|0|||
147417681|NCT02489968|531693170|FG000|Open-label Treatment Period|Lost to Follow-up|0|||
147417682|NCT02489968|531693171|FG001|Open-label Treatment Period|Lost to Follow-up|3|||
147417683|NCT02489968|531693172|FG002|Open-label Treatment Period|Lost to Follow-up|0|||
147417684|NCT02489968|531693173|FG003|Open-label Treatment Period|Lost to Follow-up|0|||
147417685|NCT02489968|531693174|FG004|Open-label Treatment Period|Lost to Follow-up|0|||
147417686|NCT02489968|531693175|FG005|Open-label Treatment Period|Lost to Follow-up|0|||
147417687|NCT02489968|531693170|FG000|Open-label Treatment Period|Withdrawal by Subject|4|||
147417688|NCT02489968|531693171|FG001|Open-label Treatment Period|Withdrawal by Subject|7|||
147417689|NCT02489968|531693172|FG002|Open-label Treatment Period|Withdrawal by Subject|0|||
147417690|NCT02489968|531693173|FG003|Open-label Treatment Period|Withdrawal by Subject|0|||
147417691|NCT02489968|531693174|FG004|Open-label Treatment Period|Withdrawal by Subject|0|||
147417692|NCT02489968|531693175|FG005|Open-label Treatment Period|Withdrawal by Subject|0|||
147417693|NCT02489968|531693170|FG000|Open-label Treatment Period|Other than specified above|204|||
147417694|NCT02489968|531693171|FG001|Open-label Treatment Period|Other than specified above|189|||
147417695|NCT02489968|531693172|FG002|Open-label Treatment Period|Other than specified above|0|||
147417696|NCT02489968|531693173|FG003|Open-label Treatment Period|Other than specified above|0|||
147417697|NCT02489968|531693174|FG004|Open-label Treatment Period|Other than specified above|0|||
147417698|NCT02489968|531693175|FG005|Open-label Treatment Period|Other than specified above|0|||
147417699|NCT02489968|531693170|FG000|Double-blind Treatment Period|Adverse Event|0|||
147417700|NCT02489968|531693171|FG001|Double-blind Treatment Period|Adverse Event|0|||
147417701|NCT02489968|531693172|FG002|Double-blind Treatment Period|Adverse Event|2|||
147417702|NCT02489968|531693173|FG003|Double-blind Treatment Period|Adverse Event|6|||
147417703|NCT02489968|531693174|FG004|Double-blind Treatment Period|Adverse Event|4|||
147417704|NCT02489968|531693175|FG005|Double-blind Treatment Period|Adverse Event|5|||
147417705|NCT02489968|531693170|FG000|Double-blind Treatment Period|Protocol Violation|0|||
147417706|NCT02489968|531693171|FG001|Double-blind Treatment Period|Protocol Violation|0|||
147417707|NCT02489968|531693172|FG002|Double-blind Treatment Period|Protocol Violation|0|||
147417708|NCT02489968|531693173|FG003|Double-blind Treatment Period|Protocol Violation|0|||
147417709|NCT02489968|531693174|FG004|Double-blind Treatment Period|Protocol Violation|1|||
147417710|NCT02489968|531693175|FG005|Double-blind Treatment Period|Protocol Violation|1|||
147417711|NCT02489968|531693170|FG000|Double-blind Treatment Period|Withdrawal by Subject|0|||
147417712|NCT02489968|531693171|FG001|Double-blind Treatment Period|Withdrawal by Subject|0|||
147417713|NCT02489968|531693172|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
147417714|NCT02489968|531693173|FG003|Double-blind Treatment Period|Withdrawal by Subject|2|||
147417715|NCT02489968|531693174|FG004|Double-blind Treatment Period|Withdrawal by Subject|0|||
147417716|NCT02489968|531693175|FG005|Double-blind Treatment Period|Withdrawal by Subject|2|||
147417717|NCT02489968|531693170|FG000|Double-blind Treatment Period|Other than specified above|0|||
147417718|NCT02489968|531693171|FG001|Double-blind Treatment Period|Other than specified above|0|||
147417719|NCT02489968|531693172|FG002|Double-blind Treatment Period|Other than specified above|0|||
147417720|NCT02489968|531693173|FG003|Double-blind Treatment Period|Other than specified above|0|||
147417721|NCT02489968|531693174|FG004|Double-blind Treatment Period|Other than specified above|1|||
147417722|NCT02489968|531693175|FG005|Double-blind Treatment Period|Other than specified above|0|||
147417723|NCT04577001|531693177|FG000|Overall Study|Subject became ineligible|0|||
147417724|NCT04577001|531693178|FG001|Overall Study|Subject became ineligible|1|||
147417725|NCT05618912|531693179|FG000|Overall Study|Lost to Follow-up|14|||
147417726|NCT05618912|531693180|FG001|Overall Study|Lost to Follow-up|19|||
147417727|NCT03973931|531693181|FG000|Overall Study|Lost to Follow-up|47|||
147417728|NCT03973931|531693182|FG001|Overall Study|Lost to Follow-up|63|||
147417729|NCT03973931|531693183|FG002|Overall Study|Lost to Follow-up|51|||
147417730|NCT03973931|531693184|FG003|Overall Study|Lost to Follow-up|54|||
147417731|NCT03973931|531693181|FG000|Overall Study|opted out|6|||
147417732|NCT03973931|531693182|FG001|Overall Study|opted out|5|||
147417733|NCT03973931|531693183|FG002|Overall Study|opted out|5|||
147417734|NCT03973931|531693184|FG003|Overall Study|opted out|1|||
147417735|NCT01982448|531693185|FG000|Preoperative Chemotherapy|Withdrawal by Subject|2|||
147417736|NCT01982448|531693186|FG001|Preoperative Chemotherapy|Withdrawal by Subject|2|||
147417737|NCT01982448|531693185|FG000|Preoperative Chemotherapy|Ineligible Prior to Starting Therapy|1|||
147417738|NCT01982448|531693186|FG001|Preoperative Chemotherapy|Ineligible Prior to Starting Therapy|0|||
147417739|NCT01982448|531693185|FG000|Preoperative Chemotherapy|Hypersensitivity during cycle 1 so therapy stopped|0|||
147417740|NCT01982448|531693186|FG001|Preoperative Chemotherapy|Hypersensitivity during cycle 1 so therapy stopped|2|||
147417741|NCT01982448|531693185|FG000|Preoperative Chemotherapy|Lost to Follow-up|0|||
147417742|NCT01982448|531693186|FG001|Preoperative Chemotherapy|Lost to Follow-up|1|||
147417743|NCT01789567|531694512|FG000|Overall Study|Death|6|||
147417744|NCT02914275|531694513|FG000|Overall Study|Lost to Follow-up|84|||
147417745|NCT02914275|531694514|FG001|Overall Study|Lost to Follow-up|29|||
147417746|NCT02914275|531694513|FG000|Overall Study|Withdrawal by Subject|26|||
147417747|NCT02914275|531694514|FG001|Overall Study|Withdrawal by Subject|10|||
147417748|NCT02914275|531694513|FG000|Overall Study|Protocol Violation|1|||
147417749|NCT02914275|531694514|FG001|Overall Study|Protocol Violation|1|||
147417750|NCT02914275|531694513|FG000|Overall Study|Physician Decision|3|||
147417751|NCT02914275|531694514|FG001|Overall Study|Physician Decision|1|||
147417752|NCT02914275|531694513|FG000|Overall Study|Other|4|||
147417753|NCT02914275|531694514|FG001|Overall Study|Other|1|||
147417754|NCT02914275|531694513|FG000|Overall Study|Excluded due to invalid informed consent|3|||
147417755|NCT02914275|531694514|FG001|Overall Study|Excluded due to invalid informed consent|0|||
147417756|NCT01238900|531694515|FG000|<12 Months Post Stent Removal|Lost to Follow-up|4|||
147417757|NCT01238900|531694515|FG000|<12 Months Post Stent Removal|persistent stricture after stenting|1|||
147417758|NCT02738203|531694519|FG000|Overall Study|Failed IUD Insertion|2|||
147417759|NCT02738203|531694520|FG001|Overall Study|Failed IUD Insertion|2|||
147417760|NCT02738203|531694519|FG000|Overall Study|Protocol Violation|0|||
147417761|NCT02738203|531694520|FG001|Overall Study|Protocol Violation|1|||
147417762|NCT03241927|531694521|FG000|Overall Study|study terminated|1|||
147417763|NCT03241927|531694522|FG001|Overall Study|study terminated|0|||
147417764|NCT01198756|531694523|FG000|Overall Study|Adverse Event|0|||
147417765|NCT01198756|531694524|FG001|Overall Study|Adverse Event|0|||
147417766|NCT01198756|531694525|FG002|Overall Study|Adverse Event|0|||
147417767|NCT01198756|531694526|FG003|Overall Study|Adverse Event|1|||
147417768|NCT01198756|531694523|FG000|Overall Study|Protocol Violation|0|||
147417769|NCT01198756|531694524|FG001|Overall Study|Protocol Violation|0|||
147417770|NCT01198756|531694525|FG002|Overall Study|Protocol Violation|0|||
147417771|NCT01198756|531694526|FG003|Overall Study|Protocol Violation|2|||
147417772|NCT01198756|531694523|FG000|Overall Study|Withdrawal by Subject|9|||
147417773|NCT01198756|531694524|FG001|Overall Study|Withdrawal by Subject|4|||
147668057|NCT00251758|532609857|FG001|Overall Study|Unmet Inclusion/Exclusion Criteria|6|||
147668058|NCT00251758|532609858|FG002|Overall Study|Unmet Inclusion/Exclusion Criteria|5|||
147668059|NCT00251758|532609856|FG000|Overall Study|Lack of Efficacy|3|||
147668060|NCT00251758|532609857|FG001|Overall Study|Lack of Efficacy|0|||
147668061|NCT00251758|532609858|FG002|Overall Study|Lack of Efficacy|0|||
147668062|NCT00251758|532609856|FG000|Overall Study|Noncompliant|0|||
147668063|NCT00251758|532609857|FG001|Overall Study|Noncompliant|2|||
147417774|NCT01198756|531694525|FG002|Overall Study|Withdrawal by Subject|7|||
147417775|NCT01198756|531694526|FG003|Overall Study|Withdrawal by Subject|5|||
147417776|NCT01198756|531694523|FG000|Overall Study|Lost to Follow-up|29|||
147417777|NCT01198756|531694524|FG001|Overall Study|Lost to Follow-up|36|||
147417778|NCT01198756|531694525|FG002|Overall Study|Lost to Follow-up|23|||
147417779|NCT01198756|531694526|FG003|Overall Study|Lost to Follow-up|18|||
147417780|NCT02915302|531694529|FG000|Overall Study|Adverse Event|3|||
147417781|NCT02915302|531694530|FG001|Overall Study|Adverse Event|0|||
147417782|NCT02915302|531694529|FG000|Overall Study|Protocol Violation|20|||
147417783|NCT02915302|531694530|FG001|Overall Study|Protocol Violation|27|||
147417784|NCT02915302|531694529|FG000|Overall Study|Lost to Follow-up|19|||
147417785|NCT02915302|531694530|FG001|Overall Study|Lost to Follow-up|22|||
147417786|NCT02915302|531694529|FG000|Overall Study|Withdrawal by Subject|22|||
147417787|NCT02915302|531694530|FG001|Overall Study|Withdrawal by Subject|29|||
147417788|NCT02915302|531694529|FG000|Overall Study|Other|1|||
147417789|NCT02915302|531694530|FG001|Overall Study|Other|0|||
147417790|NCT03725085|531694531|FG000|Overall Study|Lost to Follow-up|2|||
147417791|NCT02704754|531694532|FG000|Overall Study|Lost to Follow-up|1|||
147417792|NCT02704754|531694533|FG001|Overall Study|Lost to Follow-up|1|||
147417793|NCT02704754|531694532|FG000|Overall Study|Lack of Efficacy|1|||
147417794|NCT02704754|531694533|FG001|Overall Study|Lack of Efficacy|0|||
147417795|NCT02704754|531694532|FG000|Overall Study|Withdrawal by Subject|1|||
147417796|NCT02704754|531694533|FG001|Overall Study|Withdrawal by Subject|0|||
147417797|NCT00423943|531694534|FG000|Overall Study|Withdrawal by Subject|3|||
147417798|NCT00423943|531694535|FG001|Overall Study|Withdrawal by Subject|1|||
147417799|NCT02134977|531694536|FG000|Overall Study|Protocol Deviation|102|||
147417800|NCT04187989|531694543|FG000|Overall Study - 3-Month Follow-Up|Lost to Follow-up|6|||
147417801|NCT04187989|531694544|FG001|Overall Study - 3-Month Follow-Up|Lost to Follow-up|8|||
147417802|NCT04187989|531694543|FG000|Overall Study - 6-Month Follow-Up|Lost to Follow-up|8|||
147417803|NCT04187989|531694544|FG001|Overall Study - 6-Month Follow-Up|Lost to Follow-up|8|||
147417804|NCT03646656|531694545|FG000|Overall Study|Lost to Follow-up|1|||
147417805|NCT03646656|531694546|FG001|Overall Study|Lost to Follow-up|0|||
147417806|NCT03646656|531694545|FG000|Overall Study|Withdrawal by Subject|2|||
147417807|NCT03646656|531694546|FG001|Overall Study|Withdrawal by Subject|0|||
147417808|NCT04988867|531694550|FG000|Overall Study|Study terminated by Sponsor|12|||
147417809|NCT04988867|531694550|FG000|Overall Study|Adverse Event|2|||
147417810|NCT04988867|531694550|FG000|Overall Study|Study drug noncompliance|1|||
147417811|NCT01327495|531694551|FG000|Overall Study|Adverse Event|2|||
147417812|NCT01327495|531694552|FG001|Overall Study|Adverse Event|1|||
147417813|NCT01327495|531694553|FG002|Overall Study|Adverse Event|1|||
147417814|NCT01327495|531694554|FG003|Overall Study|Adverse Event|0|||
147417815|NCT01327495|531694555|FG004|Overall Study|Adverse Event|0|||
147417816|NCT01327495|531694556|FG005|Overall Study|Adverse Event|2|||
147417817|NCT01327495|531694551|FG000|Overall Study|Withdrawal by Subject|0|||
147417818|NCT01327495|531694552|FG001|Overall Study|Withdrawal by Subject|1|||
147417819|NCT01327495|531694553|FG002|Overall Study|Withdrawal by Subject|1|||
147417820|NCT01327495|531694554|FG003|Overall Study|Withdrawal by Subject|0|||
147417821|NCT01327495|531694555|FG004|Overall Study|Withdrawal by Subject|1|||
147417822|NCT01327495|531694556|FG005|Overall Study|Withdrawal by Subject|0|||
147417823|NCT01327495|531694551|FG000|Overall Study|Physician Decision|0|||
147417824|NCT01327495|531694552|FG001|Overall Study|Physician Decision|0|||
147417825|NCT01327495|531694553|FG002|Overall Study|Physician Decision|0|||
147417826|NCT01327495|531694554|FG003|Overall Study|Physician Decision|0|||
147417827|NCT01327495|531694555|FG004|Overall Study|Physician Decision|2|||
147417828|NCT01327495|531694556|FG005|Overall Study|Physician Decision|0|||
147417829|NCT03020576|531694559|FG000|Overall Study|Withdrawal by Subject|1|||
147417830|NCT03020576|531694560|FG001|Overall Study|Withdrawal by Subject|2|||
147417831|NCT00700427|531694563|FG000|Study Period 2 (Open-Label Acute Trx)|Adverse Event|298|||
147417832|NCT00700427|531694564|FG001|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0|||
147417833|NCT00700427|531694565|FG002|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0|||
147668064|NCT00251758|532609858|FG002|Overall Study|Noncompliant|2|||
147417834|NCT00700427|531694566|FG003|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0|||
147417835|NCT00700427|531694567|FG004|Study Period 2 (Open-Label Acute Trx)|Adverse Event|0|||
147417836|NCT00700427|531694563|FG000|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|173|||
147417837|NCT00700427|531694564|FG001|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0|||
147417838|NCT00700427|531694565|FG002|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0|||
147417839|NCT00700427|531694566|FG003|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0|||
147417840|NCT00700427|531694567|FG004|Study Period 2 (Open-Label Acute Trx)|Protocol Violation|0|||
147668065|NCT00251758|532609856|FG000|Overall Study|Pregnancy|0|||
147417841|NCT00700427|531694563|FG000|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|164|||
147417842|NCT00700427|531694564|FG001|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0|||
147417843|NCT00700427|531694565|FG002|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0|||
147417844|NCT00700427|531694566|FG003|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0|||
147417845|NCT00700427|531694567|FG004|Study Period 2 (Open-Label Acute Trx)|Withdrawal by Subject|0|||
147417846|NCT00700427|531694563|FG000|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|161|||
147417847|NCT00700427|531694564|FG001|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0|||
147417848|NCT00700427|531694565|FG002|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0|||
147417849|NCT00700427|531694566|FG003|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0|||
147417850|NCT00700427|531694567|FG004|Study Period 2 (Open-Label Acute Trx)|Protocol Interim Criteria Not Met|0|||
147417851|NCT00700427|531694563|FG000|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|108|||
147417852|NCT00700427|531694564|FG001|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0|||
147417853|NCT00700427|531694565|FG002|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0|||
147417854|NCT00700427|531694566|FG003|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0|||
147417855|NCT00700427|531694567|FG004|Study Period 2 (Open-Label Acute Trx)|Lost to Follow-up|0|||
147417856|NCT00700427|531694563|FG000|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|90|||
147417857|NCT00700427|531694564|FG001|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0|||
147417858|NCT00700427|531694565|FG002|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0|||
147417859|NCT00700427|531694566|FG003|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0|||
147417860|NCT00700427|531694567|FG004|Study Period 2 (Open-Label Acute Trx)|Lack of Efficacy|0|||
147417861|NCT00700427|531694563|FG000|Study Period 2 (Open-Label Acute Trx)|Physician Decision|8|||
147417862|NCT00700427|531694564|FG001|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0|||
147417863|NCT00700427|531694565|FG002|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0|||
147417864|NCT00700427|531694566|FG003|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0|||
147417865|NCT00700427|531694567|FG004|Study Period 2 (Open-Label Acute Trx)|Physician Decision|0|||
147417866|NCT00700427|531694563|FG000|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|7|||
147417867|NCT00700427|531694564|FG001|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0|||
147417868|NCT00700427|531694565|FG002|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0|||
147417869|NCT00700427|531694566|FG003|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0|||
147417870|NCT00700427|531694567|FG004|Study Period 2 (Open-Label Acute Trx)|Clinical Relapse|0|||
147417871|NCT00700427|531694563|FG000|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|2|||
147417872|NCT00700427|531694564|FG001|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0|||
147417873|NCT00700427|531694565|FG002|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0|||
147417874|NCT00700427|531694566|FG003|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0|||
147417875|NCT00700427|531694567|FG004|Study Period 2 (Open-Label Acute Trx)|Entry Criteria Not Met|0|||
147417876|NCT00700427|531694563|FG000|Study Period 3A (Blinded Maintenance)|Adverse Event|0|||
147417877|NCT00700427|531694564|FG001|Study Period 3A (Blinded Maintenance)|Adverse Event|50|||
147417878|NCT00700427|531694565|FG002|Study Period 3A (Blinded Maintenance)|Adverse Event|0|||
147417879|NCT00700427|531694566|FG003|Study Period 3A (Blinded Maintenance)|Adverse Event|0|||
147417880|NCT00700427|531694567|FG004|Study Period 3A (Blinded Maintenance)|Adverse Event|0|||
147417881|NCT00700427|531694563|FG000|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0|||
147417882|NCT00700427|531694564|FG001|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|162|||
147417883|NCT00700427|531694565|FG002|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0|||
147417884|NCT00700427|531694566|FG003|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0|||
147417885|NCT00700427|531694567|FG004|Study Period 3A (Blinded Maintenance)|Protocol Interim Criteria Not Met|0|||
147417886|NCT00700427|531694563|FG000|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0|||
147417887|NCT00700427|531694564|FG001|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|81|||
147417888|NCT00700427|531694565|FG002|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0|||
147417889|NCT00700427|531694566|FG003|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0|||
147417890|NCT00700427|531694567|FG004|Study Period 3A (Blinded Maintenance)|Withdrawal by Subject|0|||
147417891|NCT00700427|531694563|FG000|Study Period 3A (Blinded Maintenance)|Protocol Violation|0|||
147417892|NCT00700427|531694564|FG001|Study Period 3A (Blinded Maintenance)|Protocol Violation|56|||
147417893|NCT00700427|531694565|FG002|Study Period 3A (Blinded Maintenance)|Protocol Violation|0|||
147417894|NCT00700427|531694566|FG003|Study Period 3A (Blinded Maintenance)|Protocol Violation|0|||
147417895|NCT00700427|531694567|FG004|Study Period 3A (Blinded Maintenance)|Protocol Violation|0|||
147417896|NCT00700427|531694563|FG000|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0|||
147417897|NCT00700427|531694564|FG001|Study Period 3A (Blinded Maintenance)|Clinical Relapse|49|||
147417898|NCT00700427|531694565|FG002|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0|||
147417899|NCT00700427|531694566|FG003|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0|||
147417900|NCT00700427|531694567|FG004|Study Period 3A (Blinded Maintenance)|Clinical Relapse|0|||
147417901|NCT00700427|531694563|FG000|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0|||
147417902|NCT00700427|531694564|FG001|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|41|||
147625913|NCT03123393|532447157|FG001|Overall Study|Reason not Specified|13|||
147417903|NCT00700427|531694565|FG002|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0|||
147417904|NCT00700427|531694566|FG003|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0|||
147417905|NCT00700427|531694567|FG004|Study Period 3A (Blinded Maintenance)|Lost to Follow-up|0|||
147417906|NCT00700427|531694563|FG000|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0|||
147417907|NCT00700427|531694564|FG001|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|32|||
147417908|NCT00700427|531694565|FG002|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0|||
147417909|NCT00700427|531694566|FG003|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0|||
147417910|NCT00700427|531694567|FG004|Study Period 3A (Blinded Maintenance)|Lack of Efficacy|0|||
147417911|NCT00700427|531694563|FG000|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0|||
147417912|NCT00700427|531694564|FG001|Study Period 3A (Blinded Maintenance)|Sponsor Decision|3|||
147417913|NCT00700427|531694565|FG002|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0|||
147417914|NCT00700427|531694566|FG003|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0|||
147417915|NCT00700427|531694567|FG004|Study Period 3A (Blinded Maintenance)|Sponsor Decision|0|||
147417916|NCT00700427|531694563|FG000|Study Period 3A (Blinded Maintenance)|Physician Decision|0|||
147417917|NCT00700427|531694564|FG001|Study Period 3A (Blinded Maintenance)|Physician Decision|2|||
147417918|NCT00700427|531694565|FG002|Study Period 3A (Blinded Maintenance)|Physician Decision|0|||
147417919|NCT00700427|531694566|FG003|Study Period 3A (Blinded Maintenance)|Physician Decision|0|||
147417920|NCT00700427|531694567|FG004|Study Period 3A (Blinded Maintenance)|Physician Decision|0|||
147417921|NCT00700427|531694563|FG000|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0|||
147490716|NCT04594239|531951119|FG002|Overall Study|Lost to Follow-up|4|||
147490717|NCT04594239|531951120|FG003|Overall Study|Lost to Follow-up|6|||
147490718|NCT04594239|531951117|FG000|Overall Study|Subject relocated|0|||
147490719|NCT04594239|531951118|FG001|Overall Study|Subject relocated|0|||
147490720|NCT04594239|531951119|FG002|Overall Study|Subject relocated|0|||
147490721|NCT04594239|531951120|FG003|Overall Study|Subject relocated|1|||
147490722|NCT00091390|531951133|FG000|Overall Study|Protocol Violation|1|||
147490723|NCT00091390|531951133|FG000|Overall Study|No protocol treatment|3|||
147490724|NCT02020031|531952988|FG000|Overall Study|Physician Decision|1|||
147490725|NCT02020031|531952989|FG001|Overall Study|Physician Decision|1|||
147490726|NCT02669862|531952992|FG000|Overall Study|Lost to Follow-up|0|||
147490727|NCT02669862|531952993|FG001|Overall Study|Lost to Follow-up|2|||
147490728|NCT02669862|531952994|FG002|Overall Study|Lost to Follow-up|1|||
147490729|NCT02669862|531952992|FG000|Overall Study|Withdrawal by Subject|2|||
147490730|NCT02669862|531952993|FG001|Overall Study|Withdrawal by Subject|2|||
147490731|NCT02669862|531952994|FG002|Overall Study|Withdrawal by Subject|3|||
147490732|NCT02669862|531952992|FG000|Overall Study|moved|0|||
147490733|NCT02669862|531952993|FG001|Overall Study|moved|1|||
147490734|NCT02669862|531952994|FG002|Overall Study|moved|0|||
147490735|NCT02669862|531952992|FG000|Overall Study|Protocol Violation|0|||
147490736|NCT02669862|531952993|FG001|Overall Study|Protocol Violation|0|||
147490737|NCT02669862|531952994|FG002|Overall Study|Protocol Violation|1|||
147490738|NCT02294318|531952995|FG000|Overall Study|Worsening of drinking|3|||
147490739|NCT02294318|531952996|FG001|Overall Study|Worsening of drinking|0|||
147490740|NCT02294318|531952995|FG000|Overall Study|Not exposed to intervention|0|||
147490741|NCT02294318|531952996|FG001|Overall Study|Not exposed to intervention|2|||
147490742|NCT00762372|531952997|FG000|Overall Study|Adverse Event|1|||
147490743|NCT00762372|531952998|FG001|Overall Study|Adverse Event|0|||
147490744|NCT00762372|531952999|FG002|Overall Study|Adverse Event|0|||
147490745|NCT02670915|531953000|FG000|Overall Study|Withdrawal by Subject|0|||
147490746|NCT02670915|531953001|FG001|Overall Study|Withdrawal by Subject|1|||
147490747|NCT02670915|531953002|FG002|Overall Study|Withdrawal by Subject|4|||
147490748|NCT02670915|531953000|FG000|Overall Study|Withdrawal by parent/guardian|4|||
147490749|NCT02670915|531953001|FG001|Overall Study|Withdrawal by parent/guardian|4|||
147490750|NCT02670915|531953002|FG002|Overall Study|Withdrawal by parent/guardian|1|||
147490751|NCT02670915|531953000|FG000|Overall Study|Unclassified|0|||
147490752|NCT02670915|531953001|FG001|Overall Study|Unclassified|3|||
147490753|NCT02670915|531953002|FG002|Overall Study|Unclassified|0|||
147490754|NCT00495495|531953003|FG000|Overall Study|Protocol Violation|99|||
147490755|NCT02702518|531953004|FG000|Overall Study|Lost to Follow-up|3|||
147490756|NCT02702518|531953005|FG001|Overall Study|Lost to Follow-up|4|||
147490757|NCT03331666|531953006|FG000|Overall Study|Due to Covid-19 pandemic, the trial was prematurely terminated|2|||
147490758|NCT03331666|531953007|FG001|Overall Study|Due to Covid-19 pandemic, the trial was prematurely terminated|2|||
147490759|NCT01409031|531953010|FG000|Overall Study|transferred to other hosp|1|||
147490760|NCT01409031|531953011|FG001|Overall Study|transferred to other hosp|0|||
147490761|NCT01094730|531953014|FG000|Period 1 (14 Days)|Lost to Follow-up|0|||
147490762|NCT01094730|531953015|FG001|Period 1 (14 Days)|Lost to Follow-up|1|||
147490763|NCT01094730|531953014|FG000|Period 1 (14 Days)|Withdrawal by Subject|0|||
147490764|NCT01094730|531953015|FG001|Period 1 (14 Days)|Withdrawal by Subject|1|||
147490765|NCT01094730|531953014|FG000|Period 1 (14 Days)|No time for the follow-up visit|1|||
147490766|NCT01094730|531953015|FG001|Period 1 (14 Days)|No time for the follow-up visit|0|||
147490767|NCT01094730|531953014|FG000|Period 1 (14 Days)|Unsatisfactory visual response|1|||
147668066|NCT00251758|532609857|FG001|Overall Study|Pregnancy|1|||
147668067|NCT00251758|532609858|FG002|Overall Study|Pregnancy|0|||
147490768|NCT01094730|531953015|FG001|Period 1 (14 Days)|Unsatisfactory visual response|0|||
147490769|NCT01094730|531953014|FG000|Period 2 (14 Days)|Protocol Violation|2|||
147490770|NCT01094730|531953015|FG001|Period 2 (14 Days)|Protocol Violation|0|||
147490771|NCT01094730|531953014|FG000|Period 2 (14 Days)|No time for the follow-up visit|1|||
147490772|NCT01094730|531953015|FG001|Period 2 (14 Days)|No time for the follow-up visit|0|||
147490773|NCT01094730|531953014|FG000|Period 2 (14 Days)|Adverse Event|0|||
147490774|NCT01094730|531953015|FG001|Period 2 (14 Days)|Adverse Event|1|||
147490775|NCT01094730|531953014|FG000|Period 2 (14 Days)|Unsatisfactory lens fitting|0|||
147490776|NCT01094730|531953015|FG001|Period 2 (14 Days)|Unsatisfactory lens fitting|1|||
147490777|NCT02232087|531953016|FG000|Overall Study|Withdrawal by Subject|2|||
147490778|NCT02232087|531953017|FG001|Overall Study|Withdrawal by Subject|0|||
147490779|NCT02232087|531953018|FG002|Overall Study|Withdrawal by Subject|0|||
147490780|NCT02232087|531953019|FG003|Overall Study|Withdrawal by Subject|0|||
147490781|NCT02232087|531953020|FG004|Overall Study|Withdrawal by Subject|0|||
147490782|NCT02232087|531953021|FG005|Overall Study|Withdrawal by Subject|1|||
147490783|NCT02232087|531953016|FG000|Overall Study|poor inhalation technique|0|||
147490784|NCT02232087|531953017|FG001|Overall Study|poor inhalation technique|1|||
147490785|NCT02232087|531953018|FG002|Overall Study|poor inhalation technique|0|||
147490786|NCT02232087|531953019|FG003|Overall Study|poor inhalation technique|0|||
147490787|NCT02232087|531953020|FG004|Overall Study|poor inhalation technique|0|||
147490788|NCT02232087|531953021|FG005|Overall Study|poor inhalation technique|2|||
147490789|NCT02232087|531953016|FG000|Overall Study|protocol stop criteria|0|||
147490790|NCT02232087|531953017|FG001|Overall Study|protocol stop criteria|1|||
147490791|NCT02232087|531953018|FG002|Overall Study|protocol stop criteria|0|||
147490792|NCT02232087|531953019|FG003|Overall Study|protocol stop criteria|1|||
147490793|NCT02232087|531953020|FG004|Overall Study|protocol stop criteria|0|||
147490794|NCT02232087|531953021|FG005|Overall Study|protocol stop criteria|0|||
147490795|NCT02232087|531953016|FG000|Overall Study|Adverse Event|0|||
147490796|NCT02232087|531953017|FG001|Overall Study|Adverse Event|0|||
147490797|NCT02232087|531953018|FG002|Overall Study|Adverse Event|0|||
147490798|NCT02232087|531953019|FG003|Overall Study|Adverse Event|0|||
147490799|NCT02232087|531953020|FG004|Overall Study|Adverse Event|1|||
147490800|NCT02232087|531953021|FG005|Overall Study|Adverse Event|0|||
147490801|NCT01958125|531953022|FG000|Overall Study|Missing diary data|2|||
147490802|NCT01958125|531953023|FG001|Overall Study|Missing diary data|6|||
147490803|NCT01958125|531953022|FG000|Overall Study|No headache attacks|0|||
147490804|NCT01958125|531953023|FG001|Overall Study|No headache attacks|2|||
147490805|NCT04096326|531953024|FG000|Overall Study|Withdrawal by Subject|0|||
147490806|NCT04096326|531953025|FG001|Overall Study|Withdrawal by Subject|0|||
147490807|NCT04096326|531953026|FG002|Overall Study|Withdrawal by Subject|0|||
147490808|NCT04096326|531953027|FG003|Overall Study|Withdrawal by Subject|0|||
147490809|NCT04096326|531953028|FG004|Overall Study|Withdrawal by Subject|0|||
147490810|NCT04096326|531953029|FG005|Overall Study|Withdrawal by Subject|0|||
147490811|NCT04096326|531953030|FG006|Overall Study|Withdrawal by Subject|1|||
147490812|NCT04096326|531953031|FG007|Overall Study|Withdrawal by Subject|0|||
147490813|NCT04096326|531953032|FG008|Overall Study|Withdrawal by Subject|0|||
147490814|NCT04096326|531953033|FG009|Overall Study|Withdrawal by Subject|0|||
147490815|NCT04096326|531953024|FG000|Overall Study|Lost to Follow-up|0|||
147490816|NCT04096326|531953025|FG001|Overall Study|Lost to Follow-up|1|||
147490817|NCT04096326|531953026|FG002|Overall Study|Lost to Follow-up|0|||
147490818|NCT04096326|531953027|FG003|Overall Study|Lost to Follow-up|0|||
147490819|NCT04096326|531953028|FG004|Overall Study|Lost to Follow-up|0|||
147490820|NCT04096326|531953029|FG005|Overall Study|Lost to Follow-up|0|||
147490821|NCT04096326|531953030|FG006|Overall Study|Lost to Follow-up|0|||
147490822|NCT04096326|531953031|FG007|Overall Study|Lost to Follow-up|0|||
147490823|NCT04096326|531953032|FG008|Overall Study|Lost to Follow-up|0|||
147490824|NCT04096326|531953033|FG009|Overall Study|Lost to Follow-up|0|||
147490825|NCT04096326|531953024|FG000|Overall Study|COVID-19-related reasons|0|||
147490826|NCT04096326|531953025|FG001|Overall Study|COVID-19-related reasons|0|||
147490827|NCT04096326|531953026|FG002|Overall Study|COVID-19-related reasons|0|||
147490828|NCT04096326|531953027|FG003|Overall Study|COVID-19-related reasons|0|||
147490829|NCT04096326|531953028|FG004|Overall Study|COVID-19-related reasons|1|||
147490830|NCT04096326|531953029|FG005|Overall Study|COVID-19-related reasons|5|||
147490831|NCT04096326|531953030|FG006|Overall Study|COVID-19-related reasons|0|||
147490832|NCT04096326|531953031|FG007|Overall Study|COVID-19-related reasons|0|||
147490833|NCT04096326|531953032|FG008|Overall Study|COVID-19-related reasons|0|||
147490834|NCT04096326|531953033|FG009|Overall Study|COVID-19-related reasons|0|||
147490835|NCT02509598|531953034|FG000|Overall Study|Withdrawal by Subject|1|||
147490836|NCT04056455|531953035|FG000|Overall Study|Adverse Event|1|||
147490837|NCT04056455|531953036|FG001|Overall Study|Adverse Event|0|||
147490838|NCT02512068|531953037|FG000|Overall Study|Pretreatment Event/Adverse Event|8|||
147490839|NCT02512068|531953038|FG001|Overall Study|Pretreatment Event/Adverse Event|6|||
147490840|NCT02512068|531953037|FG000|Overall Study|Major Protocol Deviation|1|||
147490841|NCT02512068|531953038|FG001|Overall Study|Major Protocol Deviation|0|||
147625914|NCT00427648|532447159|FG000|Overall Study|Protocol Violation|1|||
147490842|NCT02512068|531953037|FG000|Overall Study|Voluntary Withdrawal|0|||
147490843|NCT02512068|531953038|FG001|Overall Study|Voluntary Withdrawal|1|||
147490844|NCT02512068|531953037|FG000|Overall Study|Lack of Efficacy|0|||
147490845|NCT02512068|531953038|FG001|Overall Study|Lack of Efficacy|1|||
147490846|NCT02512068|531953037|FG000|Overall Study|Reason Not Specified|3|||
147490847|NCT02512068|531953038|FG001|Overall Study|Reason Not Specified|5|||
147490848|NCT04891770|531953042|FG000|Overall Study|Withdrew consent|1|||
147490849|NCT04891770|531953043|FG001|Overall Study|Withdrew consent|3|||
147490850|NCT04891770|531953044|FG002|Overall Study|Withdrew consent|0|||
147490851|NCT04891770|531953042|FG000|Overall Study|Enrolled but never treated|0|||
147490852|NCT04891770|531953043|FG001|Overall Study|Enrolled but never treated|0|||
147490853|NCT04891770|531953044|FG002|Overall Study|Enrolled but never treated|1|||
147490854|NCT04891770|531953042|FG000|Overall Study|Investigator's discretion|0|||
147490855|NCT04891770|531953043|FG001|Overall Study|Investigator's discretion|1|||
147490856|NCT04891770|531953044|FG002|Overall Study|Investigator's discretion|0|||
147490857|NCT01952834|531953045|FG000|Overall Study|Adverse Event|1|||
147490858|NCT04360187|531953048|FG000|Double-Blind Treatment|Adverse Event|9|||
147490859|NCT04360187|531953049|FG001|Double-Blind Treatment|Adverse Event|11|||
147490860|NCT04360187|531953048|FG000|Double-Blind Treatment|Lack of Efficacy|7|||
147490861|NCT04360187|531953049|FG001|Double-Blind Treatment|Lack of Efficacy|2|||
147490862|NCT04360187|531953048|FG000|Double-Blind Treatment|Physician Decision|1|||
147490863|NCT04360187|531953049|FG001|Double-Blind Treatment|Physician Decision|0|||
147490864|NCT04360187|531953048|FG000|Double-Blind Treatment|Withdrawal by Subject|4|||
147490865|NCT04360187|531953049|FG001|Double-Blind Treatment|Withdrawal by Subject|2|||
147490866|NCT04360187|531953048|FG000|Double-Blind Treatment|Withdrawal By Parent/Guardian|2|||
147490867|NCT04360187|531953049|FG001|Double-Blind Treatment|Withdrawal By Parent/Guardian|0|||
147490868|NCT04360187|531953048|FG000|Follow-Up|Lost to Follow-up|1|||
147490869|NCT04360187|531953049|FG001|Follow-Up|Lost to Follow-up|0|||
147490870|NCT02203838|531953055|FG000|Overall Study|Lack of Efficacy|7|||
147490871|NCT02203838|531953056|FG001|Overall Study|Lack of Efficacy|0|||
147490872|NCT02203838|531953057|FG002|Overall Study|Lack of Efficacy|1|||
147490873|NCT02203838|531953058|FG003|Overall Study|Lack of Efficacy|1|||
147490874|NCT02203838|531953055|FG000|Overall Study|Adverse Event|46|||
147490875|NCT02203838|531953056|FG001|Overall Study|Adverse Event|6|||
147490876|NCT02203838|531953057|FG002|Overall Study|Adverse Event|3|||
147490877|NCT02203838|531953058|FG003|Overall Study|Adverse Event|2|||
147490878|NCT02203838|531953055|FG000|Overall Study|Lost to Follow-up|39|||
147490879|NCT02203838|531953056|FG001|Overall Study|Lost to Follow-up|3|||
147490880|NCT02203838|531953057|FG002|Overall Study|Lost to Follow-up|2|||
147490881|NCT02203838|531953058|FG003|Overall Study|Lost to Follow-up|1|||
147490882|NCT02203838|531953055|FG000|Overall Study|Protocol Violation|7|||
147490883|NCT02203838|531953056|FG001|Overall Study|Protocol Violation|3|||
147490884|NCT02203838|531953057|FG002|Overall Study|Protocol Violation|0|||
147490885|NCT02203838|531953058|FG003|Overall Study|Protocol Violation|0|||
147490886|NCT02203838|531953055|FG000|Overall Study|Withdrawal by Subject|83|||
147490887|NCT02203838|531953056|FG001|Overall Study|Withdrawal by Subject|10|||
147490888|NCT02203838|531953057|FG002|Overall Study|Withdrawal by Subject|8|||
147490889|NCT02203838|531953058|FG003|Overall Study|Withdrawal by Subject|11|||
147490890|NCT02203838|531953055|FG000|Overall Study|Physician Decision|27|||
147490891|NCT02203838|531953056|FG001|Overall Study|Physician Decision|0|||
147490892|NCT02203838|531953057|FG002|Overall Study|Physician Decision|2|||
147490893|NCT02203838|531953058|FG003|Overall Study|Physician Decision|3|||
147490894|NCT02203838|531953055|FG000|Overall Study|Other|1|||
147490895|NCT02203838|531953056|FG001|Overall Study|Other|0|||
147490896|NCT02203838|531953057|FG002|Overall Study|Other|0|||
147490897|NCT02203838|531953058|FG003|Overall Study|Other|0|||
147490898|NCT05091060|531953059|FG000|Overall Study|Lost to Follow-up|1|||
147490899|NCT01798706|531953060|FG000|Overall Study|Adverse Event|15|||
147490900|NCT01798706|531953061|FG001|Overall Study|Adverse Event|10|||
147490901|NCT01798706|531953060|FG000|Overall Study|Lack of Efficacy|0|||
147490902|NCT01798706|531953061|FG001|Overall Study|Lack of Efficacy|2|||
147490903|NCT01798706|531953060|FG000|Overall Study|Poor compliance to protocol|1|||
147490904|NCT01798706|531953061|FG001|Overall Study|Poor compliance to protocol|0|||
147490905|NCT01798706|531953060|FG000|Overall Study|Other than specified above|5|||
147490906|NCT01798706|531953061|FG001|Overall Study|Other than specified above|9|||
147490907|NCT00496873|531953062|FG000|Overall Study|Ineligible|2|||
147490908|NCT00496873|531953062|FG000|Overall Study|Death|2|||
147490909|NCT00496873|531953062|FG000|Overall Study|Withdrawal by Subject|3|||
147490910|NCT05896761|531953063|FG000|Thigh Injection Phase (Up to Week 16)|Adverse Event|1|||
147490911|NCT05896761|531953064|FG001|Thigh Injection Phase (Up to Week 16)|Adverse Event|0|||
147490912|NCT05896761|531953063|FG000|Thigh Injection Phase (Up to Week 16)|Withdrawal by Subject|2|||
147490913|NCT05896761|531953064|FG001|Thigh Injection Phase (Up to Week 16)|Withdrawal by Subject|3|||
147490914|NCT01318083|531953065|FG000|Overall Study|Adverse Event|4|||
147490915|NCT01318083|531953066|FG001|Overall Study|Adverse Event|1|||
147490916|NCT01318083|531953067|FG002|Overall Study|Adverse Event|2|||
147490917|NCT01318083|531953065|FG000|Overall Study|Withdrawal by Subject|1|||
147490918|NCT01318083|531953066|FG001|Overall Study|Withdrawal by Subject|0|||
147490919|NCT01318083|531953067|FG002|Overall Study|Withdrawal by Subject|2|||
147490920|NCT01318083|531953065|FG000|Overall Study|Lack of Efficacy|0|||
147490921|NCT01318083|531953066|FG001|Overall Study|Lack of Efficacy|0|||
147490922|NCT01318083|531953067|FG002|Overall Study|Lack of Efficacy|1|||
147490923|NCT01318083|531953065|FG000|Overall Study|Treatment Complications|1|||
147490924|NCT01318083|531953066|FG001|Overall Study|Treatment Complications|0|||
147490925|NCT01318083|531953067|FG002|Overall Study|Treatment Complications|0|||
147490926|NCT01318083|531953065|FG000|Overall Study|Lack of Study Medication Compliance|0|||
147490927|NCT01318083|531953066|FG001|Overall Study|Lack of Study Medication Compliance|1|||
147490928|NCT01318083|531953067|FG002|Overall Study|Lack of Study Medication Compliance|0|||
147490929|NCT03552549|531953070|FG000|Overall Study|Disease progression|25|||
147490930|NCT03552549|531953071|FG001|Overall Study|Disease progression|17|||
147490931|NCT03552549|531953070|FG000|Overall Study|Adverse event in first 12 months|12|||
147490932|NCT03552549|531953071|FG001|Overall Study|Adverse event in first 12 months|8|||
147490933|NCT03552549|531953070|FG000|Overall Study|Withdrawal by Subject|7|||
147490934|NCT03552549|531953071|FG001|Overall Study|Withdrawal by Subject|7|||
147490935|NCT03552549|531953070|FG000|Overall Study|Unknown (no reason provided)|4|||
147490936|NCT03552549|531953071|FG001|Overall Study|Unknown (no reason provided)|2|||
147490937|NCT03552549|531953070|FG000|Overall Study|Not in participant's best interest|2|||
147490938|NCT03552549|531953071|FG001|Overall Study|Not in participant's best interest|1|||
147490939|NCT03552549|531953070|FG000|Overall Study|Did not complete study treatment|2|||
147490940|NCT03552549|531953071|FG001|Overall Study|Did not complete study treatment|3|||
147490941|NCT03552549|531953070|FG000|Overall Study|Did not meet eligibility criteria|1|||
147490942|NCT03552549|531953071|FG001|Overall Study|Did not meet eligibility criteria|0|||
147490943|NCT03552549|531953070|FG000|Overall Study|Administrative|0|||
147490944|NCT03552549|531953071|FG001|Overall Study|Administrative|14|||
147490945|NCT02739594|531953072|FG000|Overall Study|Undesired Event|3|||
147490946|NCT02739594|531953073|FG001|Overall Study|Undesired Event|4|||
147490947|NCT02739594|531953072|FG000|Overall Study|Violation of Eligibility Criteria|1|||
147490948|NCT02739594|531953073|FG001|Overall Study|Violation of Eligibility Criteria|2|||
147490949|NCT02739594|531953072|FG000|Overall Study|Protocol Violation|5|||
147490950|NCT02739594|531953073|FG001|Overall Study|Protocol Violation|6|||
147490951|NCT02739594|531953072|FG000|Overall Study|Death|4|||
147490952|NCT02739594|531953073|FG001|Overall Study|Death|2|||
147490953|NCT02739594|531953072|FG000|Overall Study|Renal Insufficiency|4|||
147490954|NCT02739594|531953073|FG001|Overall Study|Renal Insufficiency|6|||
147490955|NCT02739594|531953072|FG000|Overall Study|Administrative Reasons|1|||
147490956|NCT02739594|531953073|FG001|Overall Study|Administrative Reasons|3|||
147490957|NCT02739594|531953072|FG000|Overall Study|Withdrawal by Subject|1|||
147490958|NCT02739594|531953073|FG001|Overall Study|Withdrawal by Subject|1|||
147490959|NCT02739594|531953072|FG000|Overall Study|Lost to Follow-up|0|||
147490960|NCT02739594|531953073|FG001|Overall Study|Lost to Follow-up|1|||
147490961|NCT02739594|531953072|FG000|Overall Study|Elevated Serum Creatinine|0|||
147490962|NCT02739594|531953073|FG001|Overall Study|Elevated Serum Creatinine|1|||
147490963|NCT02739594|531953072|FG000|Overall Study|Other|6|||
147490964|NCT02739594|531953073|FG001|Overall Study|Other|2|||
147490965|NCT00952289|531953078|FG000|All Participants|Death|9|||
147490966|NCT00952289|531953079|FG001|All Participants|Death|9|||
147490967|NCT00952289|531953078|FG000|All Participants|Adverse Event|8|||
147490968|NCT00952289|531953079|FG001|All Participants|Adverse Event|8|||
147490969|NCT00952289|531953078|FG000|All Participants|Disease progression|3|||
147490970|NCT00952289|531953079|FG001|All Participants|Disease progression|12|||
147490971|NCT00952289|531953078|FG000|All Participants|Withdrawal by Subject|1|||
147490972|NCT00952289|531953079|FG001|All Participants|Withdrawal by Subject|10|||
147490973|NCT00952289|531953078|FG000|All Participants|Data lost during site relocation|0|||
147490974|NCT00952289|531953079|FG001|All Participants|Data lost during site relocation|1|||
147490975|NCT00952289|531953078|FG000|Patients Who Crossed Over to Ruxolitinib|Adverse Event|0|||
147490976|NCT00952289|531953079|FG001|Patients Who Crossed Over to Ruxolitinib|Adverse Event|19|||
147490977|NCT00952289|531953078|FG000|Patients Who Crossed Over to Ruxolitinib|Disease progression|0|||
147490978|NCT00952289|531953079|FG001|Patients Who Crossed Over to Ruxolitinib|Disease progression|15|||
147490979|NCT00952289|531953078|FG000|Patients Who Crossed Over to Ruxolitinib|Withdrawal by Subject|0|||
147490980|NCT00952289|531953079|FG001|Patients Who Crossed Over to Ruxolitinib|Withdrawal by Subject|11|||
147490981|NCT00952289|531953078|FG000|Patients Who Crossed Over to Ruxolitinib|Non-compliance to study medication|0|||
147490982|NCT00952289|531953079|FG001|Patients Who Crossed Over to Ruxolitinib|Non-compliance to study medication|2|||
147490983|NCT00952289|531953078|FG000|Patients Who Crossed Over to Ruxolitinib|Other Unspecified|0|||
147490984|NCT00952289|531953079|FG001|Patients Who Crossed Over to Ruxolitinib|Other Unspecified|7|||
147490985|NCT00777491|531953084|FG000|Overall Study|Protocol Violation|0|||
147490986|NCT00777491|531953085|FG001|Overall Study|Protocol Violation|2|||
147490987|NCT00777491|531953084|FG000|Overall Study|Did not receive any protocol treatment|2|||
147490988|NCT00777491|531953085|FG001|Overall Study|Did not receive any protocol treatment|0|||
147490989|NCT00364845|531953086|FG000|Overall Study|Adverse Event|1|||
147490990|NCT00364845|531953087|FG001|Overall Study|Adverse Event|0|||
147490991|NCT00364845|531953086|FG000|Overall Study|Withdrawal by Subject|2|||
147490992|NCT00364845|531953087|FG001|Overall Study|Withdrawal by Subject|1|||
147490993|NCT00364845|531953086|FG000|Overall Study|Physician Decision|8|||
147490994|NCT00364845|531953087|FG001|Overall Study|Physician Decision|8|||
147490995|NCT00364845|531953086|FG000|Overall Study|Lost to Follow-up|0|||
147490996|NCT00364845|531953087|FG001|Overall Study|Lost to Follow-up|1|||
147490997|NCT00364845|531953086|FG000|Overall Study|Death|0|||
147490998|NCT00364845|531953087|FG001|Overall Study|Death|1|||
147490999|NCT03855137|531953092|FG000|DB Treatment Period (Day 1 to Week 12)|Adverse Event|10|||
147491000|NCT03855137|531953093|FG001|DB Treatment Period (Day 1 to Week 12)|Adverse Event|13|||
147491001|NCT03855137|531953094|FG002|DB Treatment Period (Day 1 to Week 12)|Adverse Event|9|||
147491002|NCT03855137|531953092|FG000|DB Treatment Period (Day 1 to Week 12)|Lack of Efficacy|5|||
147491003|NCT03855137|531953093|FG001|DB Treatment Period (Day 1 to Week 12)|Lack of Efficacy|2|||
147491004|NCT03855137|531953094|FG002|DB Treatment Period (Day 1 to Week 12)|Lack of Efficacy|1|||
147491005|NCT03855137|531953092|FG000|DB Treatment Period (Day 1 to Week 12)|Withdrawal by Subject|8|||
147491006|NCT03855137|531953093|FG001|DB Treatment Period (Day 1 to Week 12)|Withdrawal by Subject|7|||
147491007|NCT03855137|531953094|FG002|DB Treatment Period (Day 1 to Week 12)|Withdrawal by Subject|14|||
147491008|NCT03855137|531953092|FG000|DB Treatment Period (Day 1 to Week 12)|Lost to Follow-up|0|||
147491009|NCT03855137|531953093|FG001|DB Treatment Period (Day 1 to Week 12)|Lost to Follow-up|1|||
147491010|NCT03855137|531953094|FG002|DB Treatment Period (Day 1 to Week 12)|Lost to Follow-up|3|||
147491011|NCT03855137|531953092|FG000|DB Treatment Period (Day 1 to Week 12)|Protocol Deviation|5|||
147491012|NCT03855137|531953093|FG001|DB Treatment Period (Day 1 to Week 12)|Protocol Deviation|3|||
147491013|NCT03855137|531953094|FG002|DB Treatment Period (Day 1 to Week 12)|Protocol Deviation|2|||
147491014|NCT03855137|531953092|FG000|DB Treatment Period (Day 1 to Week 12)|Non-compliance With Study Drug|1|||
147491015|NCT03855137|531953093|FG001|DB Treatment Period (Day 1 to Week 12)|Non-compliance With Study Drug|0|||
147491016|NCT03855137|531953094|FG002|DB Treatment Period (Day 1 to Week 12)|Non-compliance With Study Drug|0|||
147491017|NCT03855137|531953092|FG000|FU Period (Week 12 to Week 16)|Withdrawal by Subject|5|||
147491018|NCT03855137|531953093|FG001|FU Period (Week 12 to Week 16)|Withdrawal by Subject|6|||
147491019|NCT03855137|531953094|FG002|FU Period (Week 12 to Week 16)|Withdrawal by Subject|3|||
147491020|NCT03855137|531953092|FG000|FU Period (Week 12 to Week 16)|Lost to Follow-up|0|||
147491021|NCT03855137|531953093|FG001|FU Period (Week 12 to Week 16)|Lost to Follow-up|3|||
147491022|NCT03855137|531953094|FG002|FU Period (Week 12 to Week 16)|Lost to Follow-up|1|||
147491023|NCT03855137|531953092|FG000|FU Period (Week 12 to Week 16)|Protocol Deviation|2|||
147491024|NCT03855137|531953093|FG001|FU Period (Week 12 to Week 16)|Protocol Deviation|0|||
147491025|NCT03855137|531953094|FG002|FU Period (Week 12 to Week 16)|Protocol Deviation|0|||
147491026|NCT03855137|531953092|FG000|FU Period (Week 12 to Week 16)|Reason not Specified|1|||
147491027|NCT03855137|531953093|FG001|FU Period (Week 12 to Week 16)|Reason not Specified|0|||
147491028|NCT03855137|531953094|FG002|FU Period (Week 12 to Week 16)|Reason not Specified|0|||
147491029|NCT02435277|531953095|FG000|Overall Study|Adverse Event|1|||
147491030|NCT02435277|531953096|FG001|Overall Study|Adverse Event|1|||
147491031|NCT02435277|531953097|FG002|Overall Study|Adverse Event|0|||
147491032|NCT02435277|531953098|FG003|Overall Study|Adverse Event|0|||
147491033|NCT02435277|531953095|FG000|Overall Study|Withdrawal by Subject|1|||
147491034|NCT02435277|531953096|FG001|Overall Study|Withdrawal by Subject|0|||
147491035|NCT02435277|531953097|FG002|Overall Study|Withdrawal by Subject|0|||
147491036|NCT02435277|531953098|FG003|Overall Study|Withdrawal by Subject|0|||
147491037|NCT01067508|531953099|FG000|Overall Study|Physician Decision|0|||
147491038|NCT01067508|531953100|FG001|Overall Study|Physician Decision|1|||
147491039|NCT01067508|531953099|FG000|Overall Study|Withdrawal by Subject|0|||
147491040|NCT01067508|531953100|FG001|Overall Study|Withdrawal by Subject|1|||
147491041|NCT02065622|531953103|FG000|Induction Study|Adverse Event|13|||
147491042|NCT02065622|531953104|FG001|Induction Study|Adverse Event|19|||
147491043|NCT02065622|531953105|FG002|Induction Study|Adverse Event|0|||
147491044|NCT02065622|531953106|FG003|Induction Study|Adverse Event|0|||
147491045|NCT02065622|531953107|FG004|Induction Study|Adverse Event|0|||
147491046|NCT02065622|531953103|FG000|Induction Study|Withdrawal by Subject|3|||
147491047|NCT02065622|531953104|FG001|Induction Study|Withdrawal by Subject|5|||
147491048|NCT02065622|531953105|FG002|Induction Study|Withdrawal by Subject|0|||
147491049|NCT02065622|531953106|FG003|Induction Study|Withdrawal by Subject|0|||
147491050|NCT02065622|531953107|FG004|Induction Study|Withdrawal by Subject|0|||
147491051|NCT02065622|531953103|FG000|Induction Study|Lost to Follow-up|1|||
147491052|NCT02065622|531953104|FG001|Induction Study|Lost to Follow-up|0|||
147491053|NCT02065622|531953105|FG002|Induction Study|Lost to Follow-up|0|||
147491054|NCT02065622|531953106|FG003|Induction Study|Lost to Follow-up|0|||
147491055|NCT02065622|531953107|FG004|Induction Study|Lost to Follow-up|0|||
147491056|NCT02065622|531953103|FG000|Induction Study|Lack of Efficacy|22|||
147491057|NCT02065622|531953104|FG001|Induction Study|Lack of Efficacy|27|||
147491058|NCT02065622|531953105|FG002|Induction Study|Lack of Efficacy|0|||
147491059|NCT02065622|531953106|FG003|Induction Study|Lack of Efficacy|0|||
147491060|NCT02065622|531953107|FG004|Induction Study|Lack of Efficacy|0|||
147491061|NCT02065622|531953103|FG000|Induction Study|Requires Alternative/Prohibited Therapy|4|||
147491062|NCT02065622|531953104|FG001|Induction Study|Requires Alternative/Prohibited Therapy|5|||
147491063|NCT02065622|531953105|FG002|Induction Study|Requires Alternative/Prohibited Therapy|0|||
147491064|NCT02065622|531953106|FG003|Induction Study|Requires Alternative/Prohibited Therapy|0|||
147491065|NCT02065622|531953107|FG004|Induction Study|Requires Alternative/Prohibited Therapy|0|||
147491066|NCT02065622|531953103|FG000|Induction Study|Subject Noncompliance|1|||
147491067|NCT02065622|531953104|FG001|Induction Study|Subject Noncompliance|1|||
147491068|NCT02065622|531953105|FG002|Induction Study|Subject Noncompliance|0|||
147491069|NCT02065622|531953106|FG003|Induction Study|Subject Noncompliance|0|||
147491070|NCT02065622|531953107|FG004|Induction Study|Subject Noncompliance|0|||
147491071|NCT02065622|531953103|FG000|Induction Study|Other, Not Specified|3|||
147491072|NCT02065622|531953104|FG001|Induction Study|Other, Not Specified|2|||
147491073|NCT02065622|531953105|FG002|Induction Study|Other, Not Specified|0|||
147491074|NCT02065622|531953106|FG003|Induction Study|Other, Not Specified|0|||
147491075|NCT02065622|531953107|FG004|Induction Study|Other, Not Specified|0|||
147491076|NCT02065622|531953103|FG000|Maintenance Study|Adverse Event|0|||
147491077|NCT02065622|531953104|FG001|Maintenance Study|Adverse Event|0|||
147491078|NCT02065622|531953105|FG002|Maintenance Study|Adverse Event|25|||
147491079|NCT02065622|531953106|FG003|Maintenance Study|Adverse Event|22|||
147491080|NCT02065622|531953107|FG004|Maintenance Study|Adverse Event|11|||
147491081|NCT02065622|531953103|FG000|Maintenance Study|Withdrawal by Subject|0|||
147491082|NCT02065622|531953104|FG001|Maintenance Study|Withdrawal by Subject|0|||
147491083|NCT02065622|531953105|FG002|Maintenance Study|Withdrawal by Subject|11|||
147491084|NCT02065622|531953106|FG003|Maintenance Study|Withdrawal by Subject|5|||
147491085|NCT02065622|531953107|FG004|Maintenance Study|Withdrawal by Subject|7|||
147491086|NCT02065622|531953103|FG000|Maintenance Study|Lost to Follow-up|0|||
147491087|NCT02065622|531953104|FG001|Maintenance Study|Lost to Follow-up|0|||
147491088|NCT02065622|531953105|FG002|Maintenance Study|Lost to Follow-up|4|||
147491089|NCT02065622|531953106|FG003|Maintenance Study|Lost to Follow-up|1|||
147491090|NCT02065622|531953107|FG004|Maintenance Study|Lost to Follow-up|1|||
147491091|NCT02065622|531953103|FG000|Maintenance Study|Lack of Efficacy|0|||
147491092|NCT02065622|531953104|FG001|Maintenance Study|Lack of Efficacy|0|||
147491093|NCT02065622|531953105|FG002|Maintenance Study|Lack of Efficacy|70|||
147491094|NCT02065622|531953106|FG003|Maintenance Study|Lack of Efficacy|55|||
147491095|NCT02065622|531953107|FG004|Maintenance Study|Lack of Efficacy|19|||
147491096|NCT02065622|531953103|FG000|Maintenance Study|Requires Alternative/Prohibited Therapy|0|||
147491097|NCT02065622|531953104|FG001|Maintenance Study|Requires Alternative/Prohibited Therapy|0|||
147491098|NCT02065622|531953105|FG002|Maintenance Study|Requires Alternative/Prohibited Therapy|7|||
147491099|NCT02065622|531953106|FG003|Maintenance Study|Requires Alternative/Prohibited Therapy|3|||
147491100|NCT02065622|531953107|FG004|Maintenance Study|Requires Alternative/Prohibited Therapy|4|||
147491101|NCT02065622|531953103|FG000|Maintenance Study|Subject Non-Compliance|0|||
147491102|NCT02065622|531953104|FG001|Maintenance Study|Subject Non-Compliance|0|||
147491103|NCT02065622|531953105|FG002|Maintenance Study|Subject Non-Compliance|1|||
147491104|NCT02065622|531953106|FG003|Maintenance Study|Subject Non-Compliance|3|||
147491105|NCT02065622|531953107|FG004|Maintenance Study|Subject Non-Compliance|2|||
147491106|NCT02065622|531953103|FG000|Maintenance Study|Other, Not Specified|0|||
147491107|NCT02065622|531953104|FG001|Maintenance Study|Other, Not Specified|0|||
147491108|NCT02065622|531953105|FG002|Maintenance Study|Other, Not Specified|6|||
147491109|NCT02065622|531953106|FG003|Maintenance Study|Other, Not Specified|14|||
147491110|NCT02065622|531953107|FG004|Maintenance Study|Other, Not Specified|2|||
147491111|NCT02065622|531953103|FG000|Maintenance Study|Unknown Reason|0|||
147491112|NCT02065622|531953104|FG001|Maintenance Study|Unknown Reason|0|||
147491113|NCT02065622|531953105|FG002|Maintenance Study|Unknown Reason|0|||
147491114|NCT02065622|531953106|FG003|Maintenance Study|Unknown Reason|1|||
147491115|NCT02065622|531953107|FG004|Maintenance Study|Unknown Reason|0|||
147491116|NCT01687413|531953120|FG000|Overall Study|Withdrawal by Subject|0|||
147491117|NCT01687413|531953121|FG001|Overall Study|Withdrawal by Subject|2|||
147491118|NCT01687413|531953120|FG000|Overall Study|Not eligible|0|||
147491119|NCT01687413|531953121|FG001|Overall Study|Not eligible|2|||
147491120|NCT01687413|531953120|FG000|Overall Study|Patient withdrew before completing all radiotherapy|1|||
147491121|NCT01687413|531953121|FG001|Overall Study|Patient withdrew before completing all radiotherapy|0|||
147491122|NCT02678780|531953128|FG000|Overall Study|Adverse Event|11|||
147491123|NCT02678780|531953129|FG001|Overall Study|Adverse Event|14|||
147491124|NCT02678780|531953128|FG000|Overall Study|Withdrawal by Subject|2|||
147491125|NCT02678780|531953129|FG001|Overall Study|Withdrawal by Subject|1|||
147491126|NCT02678780|531953128|FG000|Overall Study|Sponsor discontinuation|7|||
147491127|NCT02678780|531953129|FG001|Overall Study|Sponsor discontinuation|4|||
147491128|NCT02678780|531953128|FG000|Overall Study|Death|1|||
147491129|NCT02678780|531953129|FG001|Overall Study|Death|1|||
147491130|NCT02678780|531953128|FG000|Overall Study|Other|6|||
147491131|NCT02678780|531953129|FG001|Overall Study|Other|8|||
147491132|NCT00406640|531953137|FG000|Acute Phase|Adverse Event|18|||
147491133|NCT00406640|531953138|FG001|Acute Phase|Adverse Event|13|||
147491134|NCT00406640|531953137|FG000|Acute Phase|Failed to Return|5|||
147491135|NCT00406640|531953138|FG001|Acute Phase|Failed to Return|1|||
147625915|NCT00427648|532447160|FG001|Overall Study|Protocol Violation|2|||
147625916|NCT00427648|532447159|FG000|Overall Study|Adverse Event|0|||
147625917|NCT00427648|532447160|FG001|Overall Study|Adverse Event|1|||
147491136|NCT00406640|531953137|FG000|Acute Phase|Physician Decision|0|||
147491137|NCT00406640|531953138|FG001|Acute Phase|Physician Decision|1|||
147491138|NCT00406640|531953137|FG000|Acute Phase|Lost to Follow-up|7|||
147491139|NCT00406640|531953138|FG001|Acute Phase|Lost to Follow-up|4|||
147668068|NCT00251758|532609856|FG000|Overall Study|Per Subject Request|0|||
147491140|NCT00406640|531953137|FG000|Acute Phase|Protocol deviation|4|||
147491141|NCT00406640|531953138|FG001|Acute Phase|Protocol deviation|10|||
147491142|NCT00406640|531953137|FG000|Acute Phase|Protocol Violation|3|||
147491143|NCT00406640|531953138|FG001|Acute Phase|Protocol Violation|2|||
147491144|NCT00406640|531953137|FG000|Acute Phase|Withdrawal by Subject|11|||
147491145|NCT00406640|531953138|FG001|Acute Phase|Withdrawal by Subject|9|||
147491146|NCT00406640|531953137|FG000|Acute Phase|Lack of Efficacy|3|||
147491147|NCT00406640|531953138|FG001|Acute Phase|Lack of Efficacy|3|||
147491148|NCT00406640|531953137|FG000|DB Continuation Phase for Responders|Adverse Event|11|||
147491149|NCT00406640|531953138|FG001|DB Continuation Phase for Responders|Adverse Event|11|||
147491150|NCT00406640|531953137|FG000|DB Continuation Phase for Responders|Death|1|||
147491151|NCT00406640|531953138|FG001|DB Continuation Phase for Responders|Death|0|||
147491152|NCT00406640|531953137|FG000|DB Continuation Phase for Responders|Failed to Return|0|||
147491153|NCT00406640|531953138|FG001|DB Continuation Phase for Responders|Failed to Return|2|||
147491154|NCT00406640|531953137|FG000|DB Continuation Phase for Responders|Physician Decision|2|||
147491155|NCT00406640|531953138|FG001|DB Continuation Phase for Responders|Physician Decision|3|||
147491156|NCT00406640|531953137|FG000|DB Continuation Phase for Responders|Lost to Follow-up|1|||
147491157|NCT00406640|531953138|FG001|DB Continuation Phase for Responders|Lost to Follow-up|7|||
147491158|NCT00406640|531953137|FG000|DB Continuation Phase for Responders|non-compliance|7|||
147491159|NCT00406640|531953138|FG001|DB Continuation Phase for Responders|non-compliance|5|||
147491160|NCT00406640|531953137|FG000|DB Continuation Phase for Responders|Protocol Violation|2|||
147491161|NCT00406640|531953138|FG001|DB Continuation Phase for Responders|Protocol Violation|2|||
147491162|NCT00406640|531953137|FG000|DB Continuation Phase for Responders|Withdrawal by Subject|8|||
147491163|NCT00406640|531953138|FG001|DB Continuation Phase for Responders|Withdrawal by Subject|6|||
147491164|NCT00406640|531953137|FG000|DB Continuation Phase for Responders|Lack of Efficacy|1|||
147491165|NCT00406640|531953138|FG001|DB Continuation Phase for Responders|Lack of Efficacy|1|||
147491166|NCT00406640|531953137|FG000|OL Extension Phase for Non-Responders|Adverse Event|6|||
147491167|NCT00406640|531953138|FG001|OL Extension Phase for Non-Responders|Adverse Event|6|||
147491168|NCT00406640|531953137|FG000|OL Extension Phase for Non-Responders|Failed to Return|1|||
147491169|NCT00406640|531953138|FG001|OL Extension Phase for Non-Responders|Failed to Return|0|||
147491170|NCT00406640|531953137|FG000|OL Extension Phase for Non-Responders|Physician Decision|1|||
147491171|NCT00406640|531953138|FG001|OL Extension Phase for Non-Responders|Physician Decision|0|||
147491172|NCT00406640|531953137|FG000|OL Extension Phase for Non-Responders|Lost to Follow-up|2|||
147491173|NCT00406640|531953138|FG001|OL Extension Phase for Non-Responders|Lost to Follow-up|3|||
147491174|NCT00406640|531953137|FG000|OL Extension Phase for Non-Responders|non-compliance|3|||
147491175|NCT00406640|531953138|FG001|OL Extension Phase for Non-Responders|non-compliance|2|||
147491176|NCT00406640|531953137|FG000|OL Extension Phase for Non-Responders|Withdrawal by Subject|3|||
147491177|NCT00406640|531953138|FG001|OL Extension Phase for Non-Responders|Withdrawal by Subject|6|||
147491178|NCT00406640|531953137|FG000|OL Extension Phase for Non-Responders|Lack of Efficacy|6|||
147491179|NCT00406640|531953138|FG001|OL Extension Phase for Non-Responders|Lack of Efficacy|7|||
147491180|NCT03229759|531953144|FG000|Overall Study|Screen Failure|30|||
147491181|NCT00992446|531953146|FG000|Overall Study|Disease Progression|1|||
147491182|NCT00992446|531953146|FG000|Overall Study|Withdrawal by Subject|2|||
147491183|NCT00992446|531953146|FG000|Overall Study|Maintenance Therapy Screen Fail|5|||
147491184|NCT00755846|531955016|FG000|Overall Study|Adverse Event|0|||
147491185|NCT00755846|531955017|FG001|Overall Study|Adverse Event|0|||
147491186|NCT00755846|531955018|FG002|Overall Study|Adverse Event|0|||
147491187|NCT00755846|531955019|FG003|Overall Study|Adverse Event|1|||
147491188|NCT00755846|531955020|FG004|Overall Study|Adverse Event|3|||
147491189|NCT00755846|531955021|FG005|Overall Study|Adverse Event|2|||
147491190|NCT00755846|531955016|FG000|Overall Study|Protocol Violation|1|||
147491191|NCT00755846|531955017|FG001|Overall Study|Protocol Violation|1|||
147491192|NCT00755846|531955018|FG002|Overall Study|Protocol Violation|1|||
147491193|NCT00755846|531955019|FG003|Overall Study|Protocol Violation|1|||
147491194|NCT00755846|531955020|FG004|Overall Study|Protocol Violation|1|||
147491195|NCT00755846|531955021|FG005|Overall Study|Protocol Violation|1|||
147491196|NCT00755846|531955016|FG000|Overall Study|Lost to Follow-up|0|||
147491197|NCT00755846|531955017|FG001|Overall Study|Lost to Follow-up|2|||
147491198|NCT00755846|531955018|FG002|Overall Study|Lost to Follow-up|1|||
147491199|NCT00755846|531955019|FG003|Overall Study|Lost to Follow-up|0|||
147491200|NCT00755846|531955020|FG004|Overall Study|Lost to Follow-up|4|||
147491201|NCT00755846|531955021|FG005|Overall Study|Lost to Follow-up|2|||
147491202|NCT00755846|531955016|FG000|Overall Study|Withdrawal by Subject|2|||
147491203|NCT00755846|531955017|FG001|Overall Study|Withdrawal by Subject|3|||
147491204|NCT00755846|531955018|FG002|Overall Study|Withdrawal by Subject|5|||
147491205|NCT00755846|531955019|FG003|Overall Study|Withdrawal by Subject|2|||
147491206|NCT00755846|531955020|FG004|Overall Study|Withdrawal by Subject|0|||
147491207|NCT00755846|531955021|FG005|Overall Study|Withdrawal by Subject|1|||
147491208|NCT00755846|531955016|FG000|Overall Study|Hyperglycemic Rescue|21|||
147491209|NCT00755846|531955017|FG001|Overall Study|Hyperglycemic Rescue|7|||
147491210|NCT00755846|531955018|FG002|Overall Study|Hyperglycemic Rescue|5|||
147491211|NCT00755846|531955019|FG003|Overall Study|Hyperglycemic Rescue|8|||
147491212|NCT00755846|531955020|FG004|Overall Study|Hyperglycemic Rescue|8|||
147491213|NCT00755846|531955021|FG005|Overall Study|Hyperglycemic Rescue|7|||
147491214|NCT00755846|531955016|FG000|Overall Study|Physician Decision|1|||
147491215|NCT00755846|531955017|FG001|Overall Study|Physician Decision|3|||
147491216|NCT00755846|531955018|FG002|Overall Study|Physician Decision|0|||
147491217|NCT00755846|531955019|FG003|Overall Study|Physician Decision|1|||
147491218|NCT00755846|531955020|FG004|Overall Study|Physician Decision|0|||
147491219|NCT00755846|531955021|FG005|Overall Study|Physician Decision|1|||
147491220|NCT00755846|531955016|FG000|Overall Study|Administrative Error|0|||
147491221|NCT00755846|531955017|FG001|Overall Study|Administrative Error|1|||
147491222|NCT00755846|531955018|FG002|Overall Study|Administrative Error|0|||
147491223|NCT00755846|531955019|FG003|Overall Study|Administrative Error|0|||
147491224|NCT00755846|531955020|FG004|Overall Study|Administrative Error|0|||
147491225|NCT00755846|531955021|FG005|Overall Study|Administrative Error|0|||
147491226|NCT00755846|531955016|FG000|Overall Study|Participant Non-compliance|0|||
147491227|NCT00755846|531955017|FG001|Overall Study|Participant Non-compliance|0|||
147491228|NCT00755846|531955018|FG002|Overall Study|Participant Non-compliance|0|||
147491229|NCT00755846|531955019|FG003|Overall Study|Participant Non-compliance|0|||
147491230|NCT00755846|531955020|FG004|Overall Study|Participant Non-compliance|1|||
147491231|NCT00755846|531955021|FG005|Overall Study|Participant Non-compliance|0|||
147491232|NCT00818207|531955025|FG000|Overall Study|Adverse Event|6|||
147491233|NCT00818207|531955026|FG001|Overall Study|Adverse Event|0|||
147491234|NCT00818207|531955025|FG000|Overall Study|Lost to Follow-up|160|||
147491235|NCT00818207|531955026|FG001|Overall Study|Lost to Follow-up|146|||
147491236|NCT00818207|531955025|FG000|Overall Study|Multiple reasons|11|||
147491237|NCT00818207|531955026|FG001|Overall Study|Multiple reasons|12|||
147491238|NCT00818207|531955025|FG000|Overall Study|Withdrawal by Subject|42|||
147491239|NCT00818207|531955026|FG001|Overall Study|Withdrawal by Subject|104|||
147491240|NCT00818207|531955025|FG000|Overall Study|Death|3|||
147491241|NCT00818207|531955026|FG001|Overall Study|Death|5|||
147491242|NCT02616185|531955027|FG000|Overall Study|Death|0|||
147491243|NCT02616185|531955028|FG001|Overall Study|Death|0|||
147491244|NCT02616185|531955029|FG002|Overall Study|Death|0|||
147491245|NCT02616185|531955030|FG003|Overall Study|Death|1|||
147491246|NCT02616185|531955031|FG004|Overall Study|Death|2|||
147491247|NCT02616185|531955032|FG005|Overall Study|Death|0|||
147491248|NCT02616185|531955033|FG006|Overall Study|Death|0|||
147491249|NCT02616185|531955034|FG007|Overall Study|Death|2|||
147491250|NCT02616185|531955035|FG008|Overall Study|Death|1|||
147491251|NCT02616185|531955027|FG000|Overall Study|Study terminated by sponsor|0|||
147491252|NCT02616185|531955028|FG001|Overall Study|Study terminated by sponsor|0|||
147491253|NCT02616185|531955029|FG002|Overall Study|Study terminated by sponsor|1|||
147491254|NCT02616185|531955030|FG003|Overall Study|Study terminated by sponsor|0|||
147491255|NCT02616185|531955031|FG004|Overall Study|Study terminated by sponsor|0|||
147491256|NCT02616185|531955032|FG005|Overall Study|Study terminated by sponsor|0|||
147491257|NCT02616185|531955033|FG006|Overall Study|Study terminated by sponsor|5|||
147491258|NCT02616185|531955034|FG007|Overall Study|Study terminated by sponsor|2|||
147491259|NCT02616185|531955035|FG008|Overall Study|Study terminated by sponsor|0|||
147491260|NCT02616185|531955027|FG000|Overall Study|Participant refused further follow-up|1|||
147491261|NCT02616185|531955028|FG001|Overall Study|Participant refused further follow-up|1|||
147491262|NCT02616185|531955029|FG002|Overall Study|Participant refused further follow-up|2|||
147491263|NCT02616185|531955030|FG003|Overall Study|Participant refused further follow-up|3|||
147491264|NCT02616185|531955031|FG004|Overall Study|Participant refused further follow-up|4|||
147491265|NCT02616185|531955032|FG005|Overall Study|Participant refused further follow-up|0|||
147491266|NCT02616185|531955033|FG006|Overall Study|Participant refused further follow-up|3|||
147491267|NCT02616185|531955034|FG007|Overall Study|Participant refused further follow-up|4|||
147491268|NCT02616185|531955035|FG008|Overall Study|Participant refused further follow-up|3|||
147491269|NCT02616185|531955027|FG000|Overall Study|Not reported|0|||
147491270|NCT02616185|531955028|FG001|Overall Study|Not reported|0|||
147491271|NCT02616185|531955029|FG002|Overall Study|Not reported|0|||
147491272|NCT02616185|531955030|FG003|Overall Study|Not reported|1|||
147491273|NCT02616185|531955031|FG004|Overall Study|Not reported|3|||
147491274|NCT02616185|531955032|FG005|Overall Study|Not reported|1|||
147668069|NCT00251758|532609857|FG001|Overall Study|Per Subject Request|0|||
147491275|NCT02616185|531955033|FG006|Overall Study|Not reported|0|||
147491276|NCT02616185|531955034|FG007|Overall Study|Not reported|5|||
147491277|NCT02616185|531955035|FG008|Overall Study|Not reported|2|||
147491278|NCT03621943|531955036|FG000|First Randomized Intervention|Lost to Follow-up|51|||
147491279|NCT03621943|531955037|FG001|First Randomized Intervention|Lost to Follow-up|54|||
147491280|NCT03621943|531955036|FG000|First Randomized Intervention|Withdrawal by Subject|3|||
147491281|NCT03621943|531955037|FG001|First Randomized Intervention|Withdrawal by Subject|3|||
147491282|NCT03621943|531955036|FG000|Crossover Randomized Intervention|Lost to Follow-up|75|||
147491283|NCT03621943|531955037|FG001|Crossover Randomized Intervention|Lost to Follow-up|45|||
147491284|NCT03621943|531955036|FG000|Crossover Randomized Intervention|Withdrawal by Subject|0|||
147491285|NCT03621943|531955037|FG001|Crossover Randomized Intervention|Withdrawal by Subject|5|||
147491286|NCT01346371|531955038|FG000|Overall Study|Lost to Follow-up|2|||
147491287|NCT01346371|531955039|FG001|Overall Study|Lost to Follow-up|0|||
147491288|NCT01670656|531955043|FG000|Overall Study|Non-compliance with study drug|0|||
147491289|NCT01670656|531955044|FG001|Overall Study|Non-compliance with study drug|0|||
147491290|NCT01670656|531955045|FG002|Overall Study|Non-compliance with study drug|3|||
147491291|NCT01670656|531955046|FG003|Overall Study|Non-compliance with study drug|0|||
147491292|NCT01670656|531955047|FG004|Overall Study|Non-compliance with study drug|1|||
147491293|NCT01670656|531955043|FG000|Overall Study|Pregnancy|0|||
147491294|NCT01670656|531955044|FG001|Overall Study|Pregnancy|0|||
147491295|NCT01670656|531955045|FG002|Overall Study|Pregnancy|0|||
147491296|NCT01670656|531955046|FG003|Overall Study|Pregnancy|0|||
147491297|NCT01670656|531955047|FG004|Overall Study|Pregnancy|1|||
147491298|NCT01670656|531955043|FG000|Overall Study|Withdrawal by Subject|1|||
147491299|NCT01670656|531955044|FG001|Overall Study|Withdrawal by Subject|1|||
147491300|NCT01670656|531955045|FG002|Overall Study|Withdrawal by Subject|0|||
147491301|NCT01670656|531955046|FG003|Overall Study|Withdrawal by Subject|0|||
147491302|NCT01670656|531955047|FG004|Overall Study|Withdrawal by Subject|0|||
147491303|NCT01670656|531955043|FG000|Overall Study|Non-compliance with protocol|0|||
147491304|NCT01670656|531955044|FG001|Overall Study|Non-compliance with protocol|3|||
147491305|NCT01670656|531955045|FG002|Overall Study|Non-compliance with protocol|1|||
147491306|NCT01670656|531955046|FG003|Overall Study|Non-compliance with protocol|1|||
147491307|NCT01670656|531955047|FG004|Overall Study|Non-compliance with protocol|2|||
147491308|NCT01670656|531955043|FG000|Overall Study|Adverse Event|2|||
147491309|NCT01670656|531955044|FG001|Overall Study|Adverse Event|2|||
147491310|NCT01670656|531955045|FG002|Overall Study|Adverse Event|2|||
147491311|NCT01670656|531955046|FG003|Overall Study|Adverse Event|3|||
147491312|NCT01670656|531955047|FG004|Overall Study|Adverse Event|3|||
147491313|NCT01670656|531955043|FG000|Overall Study|Subject withdrew consent|0|||
147491314|NCT01670656|531955044|FG001|Overall Study|Subject withdrew consent|1|||
147491315|NCT01670656|531955045|FG002|Overall Study|Subject withdrew consent|2|||
147491316|NCT01670656|531955046|FG003|Overall Study|Subject withdrew consent|1|||
147491317|NCT01670656|531955047|FG004|Overall Study|Subject withdrew consent|1|||
147491318|NCT01670656|531955043|FG000|Overall Study|Lost to Follow-up|0|||
147491319|NCT01670656|531955044|FG001|Overall Study|Lost to Follow-up|0|||
147491320|NCT01670656|531955045|FG002|Overall Study|Lost to Follow-up|0|||
147491321|NCT01670656|531955046|FG003|Overall Study|Lost to Follow-up|0|||
147491322|NCT01670656|531955047|FG004|Overall Study|Lost to Follow-up|3|||
147491323|NCT01670656|531955043|FG000|Overall Study|Subject moved|0|||
147491324|NCT01670656|531955044|FG001|Overall Study|Subject moved|0|||
147491325|NCT01670656|531955045|FG002|Overall Study|Subject moved|0|||
147491326|NCT01670656|531955046|FG003|Overall Study|Subject moved|1|||
147491327|NCT01670656|531955047|FG004|Overall Study|Subject moved|0|||
147491328|NCT00111475|531955048|FG000|Overall Study|Lost to Follow-up|0|||
147491329|NCT00111475|531955049|FG001|Overall Study|Lost to Follow-up|0|||
147491330|NCT00111475|531955050|FG002|Overall Study|Lost to Follow-up|0|||
147491331|NCT00111475|531955051|FG003|Overall Study|Lost to Follow-up|0|||
147491332|NCT00111475|531955052|FG004|Overall Study|Lost to Follow-up|0|||
147491333|NCT00111475|531955053|FG005|Overall Study|Lost to Follow-up|1|||
147491334|NCT00111475|531955054|FG006|Overall Study|Lost to Follow-up|0|||
147491335|NCT00111475|531955055|FG007|Overall Study|Lost to Follow-up|0|||
147491336|NCT00111475|531955056|FG008|Overall Study|Lost to Follow-up|0|||
147491337|NCT00111475|531955057|FG009|Overall Study|Lost to Follow-up|0|||
147491338|NCT01026389|531955062|FG000|Overall Study|Withdrawal by Subject|1|||
147491339|NCT01026389|531955063|FG001|Overall Study|Withdrawal by Subject|3|||
147491340|NCT01026389|531955062|FG000|Overall Study|change of treatment, patient moved|4|||
147491341|NCT01026389|531955063|FG001|Overall Study|change of treatment, patient moved|2|||
147491342|NCT01995136|531955064|FG000|Overall Study|Change in residence|1|||
147491343|NCT03544268|531955065|FG000|Overall Study|Did not meet full criteria for inclusion after enrollment|2|||
147491344|NCT03544268|531955066|FG001|Overall Study|Did not meet full criteria for inclusion after enrollment|0|||
147491345|NCT01830543|531955070|FG000|Overall Study|Subject Decision|19|||
147491346|NCT01830543|531955071|FG001|Overall Study|Subject Decision|21|||
147491347|NCT01830543|531955072|FG002|Overall Study|Subject Decision|57|||
147491348|NCT01830543|531955070|FG000|Overall Study|Adverse Event|91|||
147491349|NCT01830543|531955071|FG001|Overall Study|Adverse Event|77|||
147491350|NCT01830543|531955072|FG002|Overall Study|Adverse Event|76|||
147491351|NCT01830543|531955070|FG000|Overall Study|Death|20|||
147491352|NCT01830543|531955071|FG001|Overall Study|Death|22|||
147491353|NCT01830543|531955072|FG002|Overall Study|Death|22|||
147491354|NCT01830543|531955070|FG000|Overall Study|Protocol Violation|3|||
147491355|NCT01830543|531955071|FG001|Overall Study|Protocol Violation|7|||
147491356|NCT01830543|531955072|FG002|Overall Study|Protocol Violation|7|||
147491357|NCT01830543|531955070|FG000|Overall Study|Physician Decision|11|||
147491358|NCT01830543|531955071|FG001|Overall Study|Physician Decision|5|||
147491359|NCT01830543|531955072|FG002|Overall Study|Physician Decision|12|||
147491360|NCT01830543|531955070|FG000|Overall Study|Withdrawal by consent|3|||
147491361|NCT01830543|531955071|FG001|Overall Study|Withdrawal by consent|3|||
147491362|NCT01830543|531955072|FG002|Overall Study|Withdrawal by consent|3|||
147491363|NCT01830543|531955070|FG000|Overall Study|Other|12|||
147491364|NCT01830543|531955071|FG001|Overall Study|Other|17|||
147491365|NCT01830543|531955072|FG002|Overall Study|Other|37|||
147491366|NCT02695524|531955077|FG000|Overall Study|Lost to Follow-up|3|||
147491367|NCT02695524|531955078|FG001|Overall Study|Lost to Follow-up|2|||
147491368|NCT02695524|531955077|FG000|Overall Study|Death|0|||
147491369|NCT02695524|531955078|FG001|Overall Study|Death|1|||
147491370|NCT03446651|531955088|FG000|Overall Study|Lost to Follow-up|4|||
147491371|NCT03446651|531955089|FG001|Overall Study|Lost to Follow-up|0|||
147491372|NCT03446651|531955088|FG000|Overall Study|Open Label Participants|5|||
147491373|NCT03446651|531955089|FG001|Overall Study|Open Label Participants|0|||
147491374|NCT00798655|531955090|FG000|Overall Study|Did not receive at least one dose of pan|2|||
147491375|NCT00343291|531955091|FG000|Overall Study|Adverse Event|13|||
147491376|NCT00343291|531955092|FG001|Overall Study|Adverse Event|13|||
147491377|NCT00343291|531955091|FG000|Overall Study|Death|3|||
147491378|NCT00343291|531955092|FG001|Overall Study|Death|2|||
147491379|NCT00343291|531955091|FG000|Overall Study|Progressive disease|33|||
147491380|NCT00343291|531955092|FG001|Overall Study|Progressive disease|34|||
147491381|NCT00343291|531955091|FG000|Overall Study|Withdrawal by Subject|0|||
147491382|NCT00343291|531955092|FG001|Overall Study|Withdrawal by Subject|2|||
147491383|NCT00343291|531955091|FG000|Overall Study|Other|8|||
147491384|NCT00343291|531955092|FG001|Overall Study|Other|5|||
147491385|NCT00960934|531955093|FG000|Overall Study|Adverse Event|2|||
147491386|NCT00960934|531955094|FG001|Overall Study|Adverse Event|3|||
147491387|NCT00960934|531955095|FG002|Overall Study|Adverse Event|3|||
147491388|NCT00960934|531955096|FG003|Overall Study|Adverse Event|2|||
147491389|NCT00960934|531955097|FG004|Overall Study|Adverse Event|4|||
147491390|NCT00960934|531955098|FG005|Overall Study|Adverse Event|3|||
147491391|NCT00960934|531955093|FG000|Overall Study|Lack of Efficacy|1|||
147491392|NCT00960934|531955094|FG001|Overall Study|Lack of Efficacy|0|||
147491393|NCT00960934|531955095|FG002|Overall Study|Lack of Efficacy|0|||
147491394|NCT00960934|531955096|FG003|Overall Study|Lack of Efficacy|0|||
147491395|NCT00960934|531955097|FG004|Overall Study|Lack of Efficacy|0|||
147491396|NCT00960934|531955098|FG005|Overall Study|Lack of Efficacy|0|||
147491397|NCT00960934|531955093|FG000|Overall Study|Lost to Follow-up|0|||
147491398|NCT00960934|531955094|FG001|Overall Study|Lost to Follow-up|1|||
147491399|NCT00960934|531955095|FG002|Overall Study|Lost to Follow-up|0|||
147491400|NCT00960934|531955096|FG003|Overall Study|Lost to Follow-up|0|||
147491401|NCT00960934|531955097|FG004|Overall Study|Lost to Follow-up|0|||
147491402|NCT00960934|531955098|FG005|Overall Study|Lost to Follow-up|0|||
147491403|NCT00960934|531955093|FG000|Overall Study|Other|2|||
147491404|NCT00960934|531955094|FG001|Overall Study|Other|1|||
147491405|NCT00960934|531955095|FG002|Overall Study|Other|5|||
147491406|NCT00960934|531955096|FG003|Overall Study|Other|4|||
147491407|NCT00960934|531955097|FG004|Overall Study|Other|2|||
147491408|NCT00960934|531955098|FG005|Overall Study|Other|2|||
147491409|NCT00960934|531955093|FG000|Overall Study|Physician Decision|0|||
147491410|NCT00960934|531955094|FG001|Overall Study|Physician Decision|1|||
147491411|NCT00960934|531955095|FG002|Overall Study|Physician Decision|0|||
147491412|NCT00960934|531955096|FG003|Overall Study|Physician Decision|0|||
147491413|NCT00960934|531955097|FG004|Overall Study|Physician Decision|0|||
147491414|NCT00960934|531955098|FG005|Overall Study|Physician Decision|0|||
147491415|NCT00960934|531955093|FG000|Overall Study|Progressive Disease|1|||
147491416|NCT00960934|531955094|FG001|Overall Study|Progressive Disease|1|||
147491417|NCT00960934|531955095|FG002|Overall Study|Progressive Disease|0|||
147491418|NCT00960934|531955096|FG003|Overall Study|Progressive Disease|0|||
147491419|NCT00960934|531955097|FG004|Overall Study|Progressive Disease|1|||
147491420|NCT00960934|531955098|FG005|Overall Study|Progressive Disease|1|||
147491421|NCT00960934|531955093|FG000|Overall Study|Protocol Violation|3|||
147491422|NCT00960934|531955094|FG001|Overall Study|Protocol Violation|4|||
147491423|NCT00960934|531955095|FG002|Overall Study|Protocol Violation|0|||
147491424|NCT00960934|531955096|FG003|Overall Study|Protocol Violation|3|||
147491425|NCT00960934|531955097|FG004|Overall Study|Protocol Violation|3|||
147491426|NCT00960934|531955098|FG005|Overall Study|Protocol Violation|2|||
147491427|NCT00960934|531955093|FG000|Overall Study|Withdrawal by Subject|5|||
147491428|NCT00960934|531955094|FG001|Overall Study|Withdrawal by Subject|6|||
147491429|NCT00960934|531955095|FG002|Overall Study|Withdrawal by Subject|4|||
147491430|NCT00960934|531955096|FG003|Overall Study|Withdrawal by Subject|5|||
147491431|NCT00960934|531955097|FG004|Overall Study|Withdrawal by Subject|5|||
147491432|NCT00960934|531955098|FG005|Overall Study|Withdrawal by Subject|7|||
147491433|NCT00960934|531955093|FG000|Overall Study|Study Terminated by Sponsor|50|||
147491434|NCT00960934|531955094|FG001|Overall Study|Study Terminated by Sponsor|46|||
147491435|NCT00960934|531955095|FG002|Overall Study|Study Terminated by Sponsor|52|||
147491436|NCT00960934|531955096|FG003|Overall Study|Study Terminated by Sponsor|50|||
147491437|NCT00960934|531955097|FG004|Overall Study|Study Terminated by Sponsor|49|||
147491438|NCT00960934|531955098|FG005|Overall Study|Study Terminated by Sponsor|49|||
147491439|NCT04281030|531955103|FG000|Overall Study|Technology issues prevented participant from receiving intervention|2|||
147491440|NCT04281030|531955104|FG001|Overall Study|Technology issues prevented participant from receiving intervention|2|||
147491441|NCT04281030|531955103|FG000|Overall Study|Participant excluded from analysis as they did not meet criteria of MIDAS score > 5|8|||
147491442|NCT04281030|531955104|FG001|Overall Study|Participant excluded from analysis as they did not meet criteria of MIDAS score > 5|6|||
147491443|NCT01395368|531955105|FG000|Overall Study|Physician Decision|14|||
147491444|NCT01395368|531955105|FG000|Overall Study|Withdrawal by Subject|2|||
147491445|NCT00288860|531955110|FG000|Overall Study|Did not complete intake|4|||
147491446|NCT00288860|531955111|FG001|Overall Study|Did not complete intake|8|||
147491447|NCT00288860|531955110|FG000|Overall Study|Death|4|||
147491448|NCT00288860|531955111|FG001|Overall Study|Death|3|||
147491449|NCT00288860|531955110|FG000|Overall Study|Withdrawal by Subject|20|||
147491450|NCT00288860|531955111|FG001|Overall Study|Withdrawal by Subject|15|||
147491451|NCT00288860|531955110|FG000|Overall Study|Lost to Follow-up|74|||
147491452|NCT00288860|531955111|FG001|Overall Study|Lost to Follow-up|71|||
147491453|NCT05142332|531955112|FG000|Overall Study|Withdrawal by Subject|0|||
147491454|NCT05142332|531955113|FG001|Overall Study|Withdrawal by Subject|1|||
147491455|NCT05142332|531955114|FG002|Overall Study|Withdrawal by Subject|2|||
147491456|NCT05142332|531955115|FG003|Overall Study|Withdrawal by Subject|0|||
147491457|NCT05142332|531955116|FG004|Overall Study|Withdrawal by Subject|0|||
147491458|NCT05142332|531955117|FG005|Overall Study|Withdrawal by Subject|2|||
147491459|NCT05142332|531955118|FG006|Overall Study|Withdrawal by Subject|6|||
147491460|NCT05142332|531955112|FG000|Overall Study|Left ED|3|||
147491461|NCT05142332|531955113|FG001|Overall Study|Left ED|0|||
147491462|NCT05142332|531955114|FG002|Overall Study|Left ED|4|||
147491463|NCT05142332|531955115|FG003|Overall Study|Left ED|6|||
147491464|NCT05142332|531955116|FG004|Overall Study|Left ED|1|||
147491465|NCT05142332|531955117|FG005|Overall Study|Left ED|2|||
147491466|NCT05142332|531955118|FG006|Overall Study|Left ED|6|||
147491467|NCT05142332|531955112|FG000|Overall Study|Physician Decision|0|||
147491468|NCT05142332|531955113|FG001|Overall Study|Physician Decision|0|||
147491469|NCT05142332|531955114|FG002|Overall Study|Physician Decision|2|||
147491470|NCT05142332|531955115|FG003|Overall Study|Physician Decision|1|||
147491471|NCT05142332|531955116|FG004|Overall Study|Physician Decision|0|||
147491472|NCT05142332|531955117|FG005|Overall Study|Physician Decision|0|||
147491473|NCT05142332|531955118|FG006|Overall Study|Physician Decision|3|||
147491474|NCT05142332|531955112|FG000|Overall Study|Became ineligible (e.g. developed altered mental status)|2|||
147491475|NCT05142332|531955113|FG001|Overall Study|Became ineligible (e.g. developed altered mental status)|0|||
147491476|NCT05142332|531955114|FG002|Overall Study|Became ineligible (e.g. developed altered mental status)|1|||
147491477|NCT05142332|531955115|FG003|Overall Study|Became ineligible (e.g. developed altered mental status)|2|||
147491478|NCT05142332|531955116|FG004|Overall Study|Became ineligible (e.g. developed altered mental status)|0|||
147491479|NCT05142332|531955117|FG005|Overall Study|Became ineligible (e.g. developed altered mental status)|1|||
147491480|NCT05142332|531955118|FG006|Overall Study|Became ineligible (e.g. developed altered mental status)|0|||
147491481|NCT01718509|531955119|FG000|Overall Study|Lost to Follow-up|18|||
147491482|NCT01718509|531955120|FG001|Overall Study|Lost to Follow-up|15|||
147491483|NCT01718509|531955119|FG000|Overall Study|Withdrawal by Subject|7|||
147491484|NCT01718509|531955120|FG001|Overall Study|Withdrawal by Subject|13|||
147491485|NCT01718509|531955119|FG000|Overall Study|Adverse Event|5|||
147491486|NCT01718509|531955120|FG001|Overall Study|Adverse Event|7|||
147491487|NCT01718509|531955119|FG000|Overall Study|Other|13|||
147491488|NCT01718509|531955120|FG001|Overall Study|Other|11|||
147491489|NCT01718509|531955119|FG000|Overall Study|Protocol Violation|4|||
147491490|NCT01718509|531955120|FG001|Overall Study|Protocol Violation|2|||
147491491|NCT01718509|531955119|FG000|Overall Study|Lack of Efficacy|1|||
147491492|NCT01718509|531955120|FG001|Overall Study|Lack of Efficacy|0|||
147491493|NCT05906732|531955121|FG000|Overall Study|Withdrawal by Subject|1|||
147491494|NCT05906732|531955122|FG001|Overall Study|Withdrawal by Subject|0|||
147491495|NCT05906732|531955123|FG002|Overall Study|Withdrawal by Subject|0|||
147491496|NCT05906732|531955124|FG003|Overall Study|Withdrawal by Subject|0|||
147491497|NCT05906732|531955121|FG000|Overall Study|Physician Decision|2|||
147491498|NCT05906732|531955122|FG001|Overall Study|Physician Decision|4|||
147491499|NCT05906732|531955123|FG002|Overall Study|Physician Decision|0|||
147491500|NCT05906732|531955124|FG003|Overall Study|Physician Decision|0|||
147491501|NCT02052778|531955125|FG000|Dose Escalation(Approximately 60 Months)|Radiographic progression|4|||
147491502|NCT02052778|531955126|FG001|Dose Escalation(Approximately 60 Months)|Radiographic progression|2|||
147491503|NCT02052778|531955127|FG002|Dose Escalation(Approximately 60 Months)|Radiographic progression|2|||
147491504|NCT02052778|531955128|FG003|Dose Escalation(Approximately 60 Months)|Radiographic progression|1|||
147491505|NCT02052778|531955129|FG004|Dose Escalation(Approximately 60 Months)|Radiographic progression|2|||
147491506|NCT02052778|531955130|FG005|Dose Escalation(Approximately 60 Months)|Radiographic progression|3|||
147491507|NCT02052778|531955131|FG006|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
147491508|NCT02052778|531955132|FG007|Dose Escalation(Approximately 60 Months)|Radiographic progression|6|||
147491509|NCT02052778|531955133|FG008|Dose Escalation(Approximately 60 Months)|Radiographic progression|5|||
147491510|NCT02052778|531955134|FG009|Dose Escalation(Approximately 60 Months)|Radiographic progression|4|||
147491511|NCT02052778|531955135|FG010|Dose Escalation(Approximately 60 Months)|Radiographic progression|5|||
147668070|NCT00251758|532609858|FG002|Overall Study|Per Subject Request|1|||
147491512|NCT02052778|531955136|FG011|Dose Escalation(Approximately 60 Months)|Radiographic progression|11|||
147491513|NCT02052778|531955137|FG012|Dose Escalation(Approximately 60 Months)|Radiographic progression|4|||
147491514|NCT02052778|531955138|FG013|Dose Escalation(Approximately 60 Months)|Radiographic progression|7|||
147491515|NCT02052778|531955139|FG014|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
147491516|NCT02052778|531955140|FG015|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
147491517|NCT02052778|531955141|FG016|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
147491518|NCT02052778|531955142|FG017|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
147491519|NCT02052778|531955143|FG018|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
147491520|NCT02052778|531955144|FG019|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
147491521|NCT02052778|531955145|FG020|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
147491522|NCT02052778|531955146|FG021|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
147491523|NCT02052778|531955147|FG022|Dose Escalation(Approximately 60 Months)|Radiographic progression|0|||
147491524|NCT02052778|531955125|FG000|Dose Escalation(Approximately 60 Months)|Clinical disease progression|2|||
147491525|NCT02052778|531955126|FG001|Dose Escalation(Approximately 60 Months)|Clinical disease progression|1|||
147491526|NCT02052778|531955127|FG002|Dose Escalation(Approximately 60 Months)|Clinical disease progression|1|||
147491527|NCT02052778|531955128|FG003|Dose Escalation(Approximately 60 Months)|Clinical disease progression|2|||
147491528|NCT02052778|531955129|FG004|Dose Escalation(Approximately 60 Months)|Clinical disease progression|1|||
147491529|NCT02052778|531955130|FG005|Dose Escalation(Approximately 60 Months)|Clinical disease progression|1|||
147491530|NCT02052778|531955131|FG006|Dose Escalation(Approximately 60 Months)|Clinical disease progression|3|||
147491531|NCT02052778|531955132|FG007|Dose Escalation(Approximately 60 Months)|Clinical disease progression|2|||
147491532|NCT02052778|531955133|FG008|Dose Escalation(Approximately 60 Months)|Clinical disease progression|1|||
147491533|NCT02052778|531955134|FG009|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
147491534|NCT02052778|531955135|FG010|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
147491535|NCT02052778|531955136|FG011|Dose Escalation(Approximately 60 Months)|Clinical disease progression|2|||
147491536|NCT02052778|531955137|FG012|Dose Escalation(Approximately 60 Months)|Clinical disease progression|2|||
147491537|NCT02052778|531955138|FG013|Dose Escalation(Approximately 60 Months)|Clinical disease progression|3|||
147491538|NCT02052778|531955139|FG014|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
147491539|NCT02052778|531955140|FG015|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
147491540|NCT02052778|531955141|FG016|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
147491541|NCT02052778|531955142|FG017|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
147491542|NCT02052778|531955143|FG018|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
147491543|NCT02052778|531955144|FG019|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
147491544|NCT02052778|531955145|FG020|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
147491545|NCT02052778|531955146|FG021|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
147491546|NCT02052778|531955147|FG022|Dose Escalation(Approximately 60 Months)|Clinical disease progression|0|||
147491547|NCT02052778|531955125|FG000|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
147491548|NCT02052778|531955126|FG001|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
147491549|NCT02052778|531955127|FG002|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
147491550|NCT02052778|531955128|FG003|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
147491551|NCT02052778|531955129|FG004|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
147491552|NCT02052778|531955130|FG005|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
147491553|NCT02052778|531955131|FG006|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
147491554|NCT02052778|531955132|FG007|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
147491555|NCT02052778|531955133|FG008|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
147491556|NCT02052778|531955134|FG009|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
147491557|NCT02052778|531955135|FG010|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
147491558|NCT02052778|531955136|FG011|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
147491559|NCT02052778|531955137|FG012|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
147491560|NCT02052778|531955138|FG013|Dose Escalation(Approximately 60 Months)|Adverse Event|1|||
147491561|NCT02052778|531955139|FG014|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
147491562|NCT02052778|531955140|FG015|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
147491563|NCT02052778|531955141|FG016|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
147491564|NCT02052778|531955142|FG017|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
147491565|NCT02052778|531955143|FG018|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
147491566|NCT02052778|531955144|FG019|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
147491567|NCT02052778|531955145|FG020|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
147491568|NCT02052778|531955146|FG021|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
147491569|NCT02052778|531955147|FG022|Dose Escalation(Approximately 60 Months)|Adverse Event|0|||
147491570|NCT02052778|531955125|FG000|Dose Escalation(Approximately 60 Months)|Death|0|||
147491571|NCT02052778|531955126|FG001|Dose Escalation(Approximately 60 Months)|Death|0|||
147491572|NCT02052778|531955127|FG002|Dose Escalation(Approximately 60 Months)|Death|0|||
147491573|NCT02052778|531955128|FG003|Dose Escalation(Approximately 60 Months)|Death|0|||
147491574|NCT02052778|531955129|FG004|Dose Escalation(Approximately 60 Months)|Death|0|||
147491575|NCT02052778|531955130|FG005|Dose Escalation(Approximately 60 Months)|Death|0|||
147491576|NCT02052778|531955131|FG006|Dose Escalation(Approximately 60 Months)|Death|1|||
147491577|NCT02052778|531955132|FG007|Dose Escalation(Approximately 60 Months)|Death|0|||
147491578|NCT02052778|531955133|FG008|Dose Escalation(Approximately 60 Months)|Death|0|||
147491579|NCT02052778|531955134|FG009|Dose Escalation(Approximately 60 Months)|Death|0|||
147491580|NCT02052778|531955135|FG010|Dose Escalation(Approximately 60 Months)|Death|0|||
147491581|NCT02052778|531955136|FG011|Dose Escalation(Approximately 60 Months)|Death|1|||
147491582|NCT02052778|531955137|FG012|Dose Escalation(Approximately 60 Months)|Death|0|||
147491583|NCT02052778|531955138|FG013|Dose Escalation(Approximately 60 Months)|Death|0|||
147491584|NCT02052778|531955139|FG014|Dose Escalation(Approximately 60 Months)|Death|0|||
147491585|NCT02052778|531955140|FG015|Dose Escalation(Approximately 60 Months)|Death|0|||
147491586|NCT02052778|531955141|FG016|Dose Escalation(Approximately 60 Months)|Death|0|||
147491587|NCT02052778|531955142|FG017|Dose Escalation(Approximately 60 Months)|Death|0|||
147491588|NCT02052778|531955143|FG018|Dose Escalation(Approximately 60 Months)|Death|0|||
147491589|NCT02052778|531955144|FG019|Dose Escalation(Approximately 60 Months)|Death|0|||
147491590|NCT02052778|531955145|FG020|Dose Escalation(Approximately 60 Months)|Death|0|||
147491591|NCT02052778|531955146|FG021|Dose Escalation(Approximately 60 Months)|Death|0|||
147491592|NCT02052778|531955147|FG022|Dose Escalation(Approximately 60 Months)|Death|0|||
147491593|NCT02052778|531955125|FG000|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
147491594|NCT02052778|531955126|FG001|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
147491595|NCT02052778|531955127|FG002|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
147491596|NCT02052778|531955128|FG003|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
147491597|NCT02052778|531955129|FG004|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
147491598|NCT02052778|531955130|FG005|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
147491599|NCT02052778|531955131|FG006|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
147491600|NCT02052778|531955132|FG007|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
147491601|NCT02052778|531955133|FG008|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|1|||
147491602|NCT02052778|531955134|FG009|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
147491603|NCT02052778|531955135|FG010|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
147491604|NCT02052778|531955136|FG011|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
147491605|NCT02052778|531955137|FG012|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
147491606|NCT02052778|531955138|FG013|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|3|||
147491607|NCT02052778|531955139|FG014|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
147491608|NCT02052778|531955140|FG015|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
147491609|NCT02052778|531955141|FG016|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
147491610|NCT02052778|531955142|FG017|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
147491611|NCT02052778|531955143|FG018|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
147491612|NCT02052778|531955144|FG019|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
147491613|NCT02052778|531955145|FG020|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
147491614|NCT02052778|531955146|FG021|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
147491615|NCT02052778|531955147|FG022|Dose Escalation(Approximately 60 Months)|Withdrawal by participant|0|||
147491616|NCT02052778|531955125|FG000|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
147491617|NCT02052778|531955126|FG001|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
147491618|NCT02052778|531955127|FG002|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
147491619|NCT02052778|531955128|FG003|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
147491620|NCT02052778|531955129|FG004|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
147491621|NCT02052778|531955130|FG005|Dose Escalation(Approximately 60 Months)|Investigator decision|1|||
147491622|NCT02052778|531955131|FG006|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
147491623|NCT02052778|531955132|FG007|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
147491624|NCT02052778|531955133|FG008|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
147491625|NCT02052778|531955134|FG009|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
147491626|NCT02052778|531955135|FG010|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
147491627|NCT02052778|531955136|FG011|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
147491628|NCT02052778|531955137|FG012|Dose Escalation(Approximately 60 Months)|Investigator decision|1|||
147491629|NCT02052778|531955138|FG013|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
147491630|NCT02052778|531955139|FG014|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
147491631|NCT02052778|531955140|FG015|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
147491632|NCT02052778|531955141|FG016|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
147491633|NCT02052778|531955142|FG017|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
147491634|NCT02052778|531955143|FG018|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
147491635|NCT02052778|531955144|FG019|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
147668071|NCT00251758|532609856|FG000|Overall Study|Per Investigator Request|1|||
147668072|NCT00251758|532609857|FG001|Overall Study|Per Investigator Request|0|||
147668073|NCT00251758|532609858|FG002|Overall Study|Per Investigator Request|0|||
147668074|NCT01387269|532609862|FG000|Overall Study|Death|38|||
147491636|NCT02052778|531955145|FG020|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
147491637|NCT02052778|531955146|FG021|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
147491638|NCT02052778|531955147|FG022|Dose Escalation(Approximately 60 Months)|Investigator decision|0|||
147491639|NCT02052778|531955125|FG000|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
147491640|NCT02052778|531955126|FG001|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
147491641|NCT02052778|531955127|FG002|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
147491642|NCT02052778|531955128|FG003|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
147491643|NCT02052778|531955129|FG004|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
147491644|NCT02052778|531955130|FG005|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
147491645|NCT02052778|531955131|FG006|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
147491646|NCT02052778|531955132|FG007|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
147491647|NCT02052778|531955133|FG008|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
147491648|NCT02052778|531955134|FG009|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
147491649|NCT02052778|531955135|FG010|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
147491650|NCT02052778|531955136|FG011|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
147491651|NCT02052778|531955137|FG012|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
147491652|NCT02052778|531955138|FG013|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
147491653|NCT02052778|531955139|FG014|Dose Expansion (Approximately 59 Months)|Radiographic progression|38|||
147491654|NCT02052778|531955140|FG015|Dose Expansion (Approximately 59 Months)|Radiographic progression|23|||
147491655|NCT02052778|531955141|FG016|Dose Expansion (Approximately 59 Months)|Radiographic progression|12|||
147491656|NCT02052778|531955142|FG017|Dose Expansion (Approximately 59 Months)|Radiographic progression|11|||
147491657|NCT02052778|531955143|FG018|Dose Expansion (Approximately 59 Months)|Radiographic progression|17|||
147491658|NCT02052778|531955144|FG019|Dose Expansion (Approximately 59 Months)|Radiographic progression|21|||
147491659|NCT02052778|531955145|FG020|Dose Expansion (Approximately 59 Months)|Radiographic progression|14|||
147491660|NCT02052778|531955146|FG021|Dose Expansion (Approximately 59 Months)|Radiographic progression|6|||
147491661|NCT02052778|531955147|FG022|Dose Expansion (Approximately 59 Months)|Radiographic progression|0|||
147491662|NCT02052778|531955125|FG000|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
147491663|NCT02052778|531955126|FG001|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
147491664|NCT02052778|531955127|FG002|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
147491665|NCT02052778|531955128|FG003|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
147491666|NCT02052778|531955129|FG004|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
147491667|NCT02052778|531955130|FG005|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
147491668|NCT02052778|531955131|FG006|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
147491669|NCT02052778|531955132|FG007|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
147491670|NCT02052778|531955133|FG008|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
147491671|NCT02052778|531955134|FG009|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
147491672|NCT02052778|531955135|FG010|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
147491673|NCT02052778|531955136|FG011|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
147491674|NCT02052778|531955137|FG012|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
147491675|NCT02052778|531955138|FG013|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
147491676|NCT02052778|531955139|FG014|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|6|||
147491677|NCT02052778|531955140|FG015|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|3|||
147491678|NCT02052778|531955141|FG016|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
147491679|NCT02052778|531955142|FG017|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|2|||
147625918|NCT02230904|532447161|FG000|Overall Study|Safety follow up could not take place|0|||
147625919|NCT02230904|532447162|FG001|Overall Study|Safety follow up could not take place|1|||
147625920|NCT01464333|532447164|FG000|Overall Study|Adverse Event|34|||
147625921|NCT01464333|532447164|FG000|Overall Study|Lack of Efficacy|72|||
147625922|NCT01464333|532447164|FG000|Overall Study|Withdrawal by Subject|11|||
147625923|NCT01464333|532447164|FG000|Overall Study|Other|4|||
147625924|NCT01464333|532447164|FG000|Overall Study|No Hospital Visit|42|||
147625925|NCT00463047|532447168|FG000|Titration Period 1|Adverse Event|10|||
147625926|NCT00463047|532447169|FG001|Titration Period 1|Adverse Event|8|||
147625927|NCT00463047|532447168|FG000|Titration Period 1|Lack of Efficacy|10|||
147625928|NCT00463047|532447169|FG001|Titration Period 1|Lack of Efficacy|4|||
147625929|NCT00463047|532447168|FG000|Titration Period 1|Lost to Follow-up|2|||
147625930|NCT00463047|532447169|FG001|Titration Period 1|Lost to Follow-up|0|||
147625931|NCT00463047|532447168|FG000|Titration Period 1|Non-compliance with study medication|3|||
147625932|NCT00463047|532447169|FG001|Titration Period 1|Non-compliance with study medication|5|||
147625933|NCT00463047|532447168|FG000|Titration Period 1|Protocol Violation|5|||
147625934|NCT00463047|532447169|FG001|Titration Period 1|Protocol Violation|5|||
147625935|NCT00463047|532447168|FG000|Titration Period 1|Withdrawal by Subject|3|||
147625936|NCT00463047|532447169|FG001|Titration Period 1|Withdrawal by Subject|5|||
147625937|NCT00463047|532447168|FG000|Titration Period 1|Non-compliance procedures|4|||
147491680|NCT02052778|531955143|FG018|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|3|||
147491681|NCT02052778|531955144|FG019|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|4|||
147491682|NCT02052778|531955145|FG020|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|5|||
147491683|NCT02052778|531955146|FG021|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|1|||
147491684|NCT02052778|531955147|FG022|Dose Expansion (Approximately 59 Months)|Clinical Disease Progression|0|||
147491685|NCT02052778|531955125|FG000|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
147491686|NCT02052778|531955126|FG001|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
147491687|NCT02052778|531955127|FG002|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
147491688|NCT02052778|531955128|FG003|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
147491689|NCT02052778|531955129|FG004|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
147491690|NCT02052778|531955130|FG005|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
147491691|NCT02052778|531955131|FG006|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
147491692|NCT02052778|531955132|FG007|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
147491693|NCT02052778|531955133|FG008|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
147491694|NCT02052778|531955134|FG009|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
147491695|NCT02052778|531955135|FG010|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
147491696|NCT02052778|531955136|FG011|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
147491697|NCT02052778|531955137|FG012|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
147491698|NCT02052778|531955138|FG013|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
147491699|NCT02052778|531955139|FG014|Dose Expansion (Approximately 59 Months)|Adverse Event|5|||
147491700|NCT02052778|531955140|FG015|Dose Expansion (Approximately 59 Months)|Adverse Event|1|||
147491701|NCT02052778|531955141|FG016|Dose Expansion (Approximately 59 Months)|Adverse Event|3|||
147491702|NCT02052778|531955142|FG017|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
147491703|NCT02052778|531955143|FG018|Dose Expansion (Approximately 59 Months)|Adverse Event|3|||
147491704|NCT02052778|531955144|FG019|Dose Expansion (Approximately 59 Months)|Adverse Event|1|||
147491705|NCT02052778|531955145|FG020|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
147491706|NCT02052778|531955146|FG021|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
147491707|NCT02052778|531955147|FG022|Dose Expansion (Approximately 59 Months)|Adverse Event|0|||
147491708|NCT02052778|531955125|FG000|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
147491709|NCT02052778|531955126|FG001|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
147491710|NCT02052778|531955127|FG002|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
147491711|NCT02052778|531955128|FG003|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
147491712|NCT02052778|531955129|FG004|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
147491713|NCT02052778|531955130|FG005|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
147491714|NCT02052778|531955131|FG006|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
147491715|NCT02052778|531955132|FG007|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
147491716|NCT02052778|531955133|FG008|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
147491717|NCT02052778|531955134|FG009|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
147491718|NCT02052778|531955135|FG010|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
147491719|NCT02052778|531955136|FG011|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
147491720|NCT02052778|531955137|FG012|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
147491721|NCT02052778|531955138|FG013|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
147491722|NCT02052778|531955139|FG014|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|2|||
147491723|NCT02052778|531955140|FG015|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|3|||
147491724|NCT02052778|531955141|FG016|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
147491725|NCT02052778|531955142|FG017|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
147491726|NCT02052778|531955143|FG018|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
147491727|NCT02052778|531955144|FG019|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
147491728|NCT02052778|531955145|FG020|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
147491729|NCT02052778|531955146|FG021|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
147491730|NCT02052778|531955147|FG022|Dose Expansion (Approximately 59 Months)|Withdrawal by Subject|0|||
147491731|NCT02052778|531955125|FG000|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
147491732|NCT02052778|531955126|FG001|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
147491733|NCT02052778|531955127|FG002|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
147491734|NCT02052778|531955128|FG003|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
147491735|NCT02052778|531955129|FG004|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
147491736|NCT02052778|531955130|FG005|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
147491737|NCT02052778|531955131|FG006|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
147491738|NCT02052778|531955132|FG007|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
147491739|NCT02052778|531955133|FG008|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
147625938|NCT00463047|532447169|FG001|Titration Period 1|Non-compliance procedures|10|||
147625939|NCT00463047|532447168|FG000|Titration Period 1|Other|0|||
147625940|NCT00463047|532447169|FG001|Titration Period 1|Other|2|||
147491740|NCT02052778|531955134|FG009|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
147491741|NCT02052778|531955135|FG010|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
147491742|NCT02052778|531955136|FG011|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
147491743|NCT02052778|531955137|FG012|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
147491744|NCT02052778|531955138|FG013|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
147491745|NCT02052778|531955139|FG014|Dose Expansion (Approximately 59 Months)|Investigator decision|5|||
147491746|NCT02052778|531955140|FG015|Dose Expansion (Approximately 59 Months)|Investigator decision|3|||
147491747|NCT02052778|531955141|FG016|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
147491748|NCT02052778|531955142|FG017|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
147491749|NCT02052778|531955143|FG018|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
147491750|NCT02052778|531955144|FG019|Dose Expansion (Approximately 59 Months)|Investigator decision|1|||
147491751|NCT02052778|531955145|FG020|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
147491752|NCT02052778|531955146|FG021|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
147491753|NCT02052778|531955147|FG022|Dose Expansion (Approximately 59 Months)|Investigator decision|0|||
147491754|NCT02052778|531955125|FG000|Dose Expansion (Approximately 59 Months)|Other|0|||
147491755|NCT02052778|531955126|FG001|Dose Expansion (Approximately 59 Months)|Other|0|||
147491756|NCT02052778|531955127|FG002|Dose Expansion (Approximately 59 Months)|Other|0|||
147491757|NCT02052778|531955128|FG003|Dose Expansion (Approximately 59 Months)|Other|0|||
147491758|NCT02052778|531955129|FG004|Dose Expansion (Approximately 59 Months)|Other|0|||
147491759|NCT02052778|531955130|FG005|Dose Expansion (Approximately 59 Months)|Other|0|||
147491760|NCT02052778|531955131|FG006|Dose Expansion (Approximately 59 Months)|Other|0|||
147491761|NCT02052778|531955132|FG007|Dose Expansion (Approximately 59 Months)|Other|0|||
147491762|NCT02052778|531955133|FG008|Dose Expansion (Approximately 59 Months)|Other|0|||
147491763|NCT02052778|531955134|FG009|Dose Expansion (Approximately 59 Months)|Other|0|||
147491764|NCT02052778|531955135|FG010|Dose Expansion (Approximately 59 Months)|Other|0|||
147491765|NCT02052778|531955136|FG011|Dose Expansion (Approximately 59 Months)|Other|0|||
147491766|NCT02052778|531955137|FG012|Dose Expansion (Approximately 59 Months)|Other|0|||
147491767|NCT02052778|531955138|FG013|Dose Expansion (Approximately 59 Months)|Other|0|||
147491768|NCT02052778|531955139|FG014|Dose Expansion (Approximately 59 Months)|Other|1|||
147491769|NCT02052778|531955140|FG015|Dose Expansion (Approximately 59 Months)|Other|1|||
147491770|NCT02052778|531955141|FG016|Dose Expansion (Approximately 59 Months)|Other|0|||
147491771|NCT02052778|531955142|FG017|Dose Expansion (Approximately 59 Months)|Other|0|||
147491772|NCT02052778|531955143|FG018|Dose Expansion (Approximately 59 Months)|Other|1|||
147491773|NCT02052778|531955144|FG019|Dose Expansion (Approximately 59 Months)|Other|0|||
147491774|NCT02052778|531955145|FG020|Dose Expansion (Approximately 59 Months)|Other|0|||
147491775|NCT02052778|531955146|FG021|Dose Expansion (Approximately 59 Months)|Other|1|||
147491776|NCT02052778|531955147|FG022|Dose Expansion (Approximately 59 Months)|Other|0|||
147491777|NCT02052778|531955125|FG000|Dose Expansion (Approximately 59 Months)|Untreated|0|||
147491778|NCT02052778|531955126|FG001|Dose Expansion (Approximately 59 Months)|Untreated|0|||
147491779|NCT02052778|531955127|FG002|Dose Expansion (Approximately 59 Months)|Untreated|0|||
147491780|NCT02052778|531955128|FG003|Dose Expansion (Approximately 59 Months)|Untreated|0|||
147491781|NCT02052778|531955129|FG004|Dose Expansion (Approximately 59 Months)|Untreated|0|||
147491782|NCT02052778|531955130|FG005|Dose Expansion (Approximately 59 Months)|Untreated|0|||
147491783|NCT02052778|531955131|FG006|Dose Expansion (Approximately 59 Months)|Untreated|0|||
147491784|NCT02052778|531955132|FG007|Dose Expansion (Approximately 59 Months)|Untreated|0|||
147491785|NCT02052778|531955133|FG008|Dose Expansion (Approximately 59 Months)|Untreated|0|||
147491786|NCT02052778|531955134|FG009|Dose Expansion (Approximately 59 Months)|Untreated|0|||
147491787|NCT02052778|531955135|FG010|Dose Expansion (Approximately 59 Months)|Untreated|0|||
147491788|NCT02052778|531955136|FG011|Dose Expansion (Approximately 59 Months)|Untreated|0|||
147491789|NCT02052778|531955137|FG012|Dose Expansion (Approximately 59 Months)|Untreated|0|||
147491790|NCT02052778|531955138|FG013|Dose Expansion (Approximately 59 Months)|Untreated|0|||
147491791|NCT02052778|531955139|FG014|Dose Expansion (Approximately 59 Months)|Untreated|1|||
147491792|NCT02052778|531955140|FG015|Dose Expansion (Approximately 59 Months)|Untreated|1|||
147491793|NCT02052778|531955141|FG016|Dose Expansion (Approximately 59 Months)|Untreated|1|||
147491794|NCT02052778|531955142|FG017|Dose Expansion (Approximately 59 Months)|Untreated|0|||
147491795|NCT02052778|531955143|FG018|Dose Expansion (Approximately 59 Months)|Untreated|1|||
147491796|NCT02052778|531955144|FG019|Dose Expansion (Approximately 59 Months)|Untreated|0|||
147491797|NCT02052778|531955145|FG020|Dose Expansion (Approximately 59 Months)|Untreated|0|||
147491798|NCT02052778|531955146|FG021|Dose Expansion (Approximately 59 Months)|Untreated|0|||
147491799|NCT02052778|531955147|FG022|Dose Expansion (Approximately 59 Months)|Untreated|0|||
147491800|NCT02052778|531955125|FG000|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
147491801|NCT02052778|531955126|FG001|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
147491802|NCT02052778|531955127|FG002|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
147491803|NCT02052778|531955128|FG003|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
147491804|NCT02052778|531955129|FG004|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
147625941|NCT00463047|532447168|FG000|Titration Period 2|Adverse Event|9|||
147625942|NCT00463047|532447169|FG001|Titration Period 2|Adverse Event|9|||
147491805|NCT02052778|531955130|FG005|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
147491806|NCT02052778|531955131|FG006|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
147491807|NCT02052778|531955132|FG007|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
147491808|NCT02052778|531955133|FG008|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
147491809|NCT02052778|531955134|FG009|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
147491810|NCT02052778|531955135|FG010|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
147491811|NCT02052778|531955136|FG011|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
147491812|NCT02052778|531955137|FG012|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
147491813|NCT02052778|531955138|FG013|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
147491814|NCT02052778|531955139|FG014|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
147491815|NCT02052778|531955140|FG015|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
147491816|NCT02052778|531955141|FG016|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
147491817|NCT02052778|531955142|FG017|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
147491818|NCT02052778|531955143|FG018|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
147491819|NCT02052778|531955144|FG019|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
147491820|NCT02052778|531955145|FG020|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
147491821|NCT02052778|531955146|FG021|Phase 2 (Approximately 63 Months)|Adverse Event|0|||
147491822|NCT02052778|531955147|FG022|Phase 2 (Approximately 63 Months)|Adverse Event|7|||
147491823|NCT02052778|531955125|FG000|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
147491824|NCT02052778|531955126|FG001|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
147491825|NCT02052778|531955127|FG002|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
147491826|NCT02052778|531955128|FG003|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
147491827|NCT02052778|531955129|FG004|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
147491828|NCT02052778|531955130|FG005|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
147491829|NCT02052778|531955131|FG006|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
147491830|NCT02052778|531955132|FG007|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
147491831|NCT02052778|531955133|FG008|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
147491832|NCT02052778|531955134|FG009|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
147491833|NCT02052778|531955135|FG010|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
147491834|NCT02052778|531955136|FG011|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
147491835|NCT02052778|531955137|FG012|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
147491836|NCT02052778|531955138|FG013|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
147491837|NCT02052778|531955139|FG014|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
147491838|NCT02052778|531955140|FG015|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
147491839|NCT02052778|531955141|FG016|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
147491840|NCT02052778|531955142|FG017|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
147491841|NCT02052778|531955143|FG018|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
147491842|NCT02052778|531955144|FG019|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
147491843|NCT02052778|531955145|FG020|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
147491844|NCT02052778|531955146|FG021|Phase 2 (Approximately 63 Months)|Radiologic Progression|0|||
147491845|NCT02052778|531955147|FG022|Phase 2 (Approximately 63 Months)|Radiologic Progression|78|||
147491846|NCT02052778|531955125|FG000|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
147491847|NCT02052778|531955126|FG001|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
147491848|NCT02052778|531955127|FG002|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
147491849|NCT02052778|531955128|FG003|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
147491850|NCT02052778|531955129|FG004|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
147491851|NCT02052778|531955130|FG005|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
147491852|NCT02052778|531955131|FG006|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
147491853|NCT02052778|531955132|FG007|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
147491854|NCT02052778|531955133|FG008|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
147491855|NCT02052778|531955134|FG009|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
147491856|NCT02052778|531955135|FG010|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
147491857|NCT02052778|531955136|FG011|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
147491858|NCT02052778|531955137|FG012|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
147491859|NCT02052778|531955138|FG013|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
147491860|NCT02052778|531955139|FG014|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
147491861|NCT02052778|531955140|FG015|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
147491862|NCT02052778|531955141|FG016|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
147491863|NCT02052778|531955142|FG017|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
147491864|NCT02052778|531955143|FG018|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
147668075|NCT01387269|532609863|FG001|Overall Study|Death|20|||
147668076|NCT01387269|532609862|FG000|Overall Study|Other|8|||
147491865|NCT02052778|531955144|FG019|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
147668077|NCT01387269|532609863|FG001|Overall Study|Other|7|||
147668078|NCT01387269|532609862|FG000|Overall Study|Unrelated AE|12|||
147668079|NCT01387269|532609863|FG001|Overall Study|Unrelated AE|3|||
147668080|NCT01387269|532609862|FG000|Overall Study|Withdrawal by patient|32|||
147491866|NCT02052778|531955145|FG020|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
147491867|NCT02052778|531955146|FG021|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|0|||
147491868|NCT02052778|531955147|FG022|Phase 2 (Approximately 63 Months)|Clinical Disease Progression|6|||
147491869|NCT02052778|531955125|FG000|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
147491870|NCT02052778|531955126|FG001|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
147491871|NCT02052778|531955127|FG002|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
147491872|NCT02052778|531955128|FG003|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
147491873|NCT02052778|531955129|FG004|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
147491874|NCT02052778|531955130|FG005|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
147491875|NCT02052778|531955131|FG006|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
147491876|NCT02052778|531955132|FG007|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
147491877|NCT02052778|531955133|FG008|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
147491878|NCT02052778|531955134|FG009|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
147491879|NCT02052778|531955135|FG010|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
147491880|NCT02052778|531955136|FG011|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
147491881|NCT02052778|531955137|FG012|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
147491882|NCT02052778|531955138|FG013|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
147491883|NCT02052778|531955139|FG014|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
147491884|NCT02052778|531955140|FG015|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
147491885|NCT02052778|531955141|FG016|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
147491886|NCT02052778|531955142|FG017|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
147491887|NCT02052778|531955143|FG018|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
147491888|NCT02052778|531955144|FG019|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
147491889|NCT02052778|531955145|FG020|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
147491890|NCT02052778|531955146|FG021|Phase 2 (Approximately 63 Months)|Withdrawal by participant|0|||
147491891|NCT02052778|531955147|FG022|Phase 2 (Approximately 63 Months)|Withdrawal by participant|2|||
147491892|NCT02052778|531955125|FG000|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
147491893|NCT02052778|531955126|FG001|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
147491894|NCT02052778|531955127|FG002|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
147491895|NCT02052778|531955128|FG003|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
147491896|NCT02052778|531955129|FG004|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
147491897|NCT02052778|531955130|FG005|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
147491898|NCT02052778|531955131|FG006|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
147491899|NCT02052778|531955132|FG007|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
147491900|NCT02052778|531955133|FG008|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
147491901|NCT02052778|531955134|FG009|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
147491902|NCT02052778|531955135|FG010|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
147491903|NCT02052778|531955136|FG011|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
147491904|NCT02052778|531955137|FG012|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
147491905|NCT02052778|531955138|FG013|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
147491906|NCT02052778|531955139|FG014|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
147491907|NCT02052778|531955140|FG015|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
147491908|NCT02052778|531955141|FG016|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
147491909|NCT02052778|531955142|FG017|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
147491910|NCT02052778|531955143|FG018|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
147491911|NCT02052778|531955144|FG019|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
147491912|NCT02052778|531955145|FG020|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
147491913|NCT02052778|531955146|FG021|Phase 2 (Approximately 63 Months)|Investigator Decision|0|||
147491914|NCT02052778|531955147|FG022|Phase 2 (Approximately 63 Months)|Investigator Decision|3|||
147491915|NCT02052778|531955125|FG000|Phase 2 (Approximately 63 Months)|Other|0|||
147491916|NCT02052778|531955126|FG001|Phase 2 (Approximately 63 Months)|Other|0|||
147491917|NCT02052778|531955127|FG002|Phase 2 (Approximately 63 Months)|Other|0|||
147491918|NCT02052778|531955128|FG003|Phase 2 (Approximately 63 Months)|Other|0|||
147491919|NCT02052778|531955129|FG004|Phase 2 (Approximately 63 Months)|Other|0|||
147491920|NCT02052778|531955130|FG005|Phase 2 (Approximately 63 Months)|Other|0|||
147491921|NCT02052778|531955131|FG006|Phase 2 (Approximately 63 Months)|Other|0|||
147491922|NCT02052778|531955132|FG007|Phase 2 (Approximately 63 Months)|Other|0|||
147491923|NCT02052778|531955133|FG008|Phase 2 (Approximately 63 Months)|Other|0|||
147491924|NCT02052778|531955134|FG009|Phase 2 (Approximately 63 Months)|Other|0|||
147491925|NCT02052778|531955135|FG010|Phase 2 (Approximately 63 Months)|Other|0|||
147491926|NCT02052778|531955136|FG011|Phase 2 (Approximately 63 Months)|Other|0|||
147491927|NCT02052778|531955137|FG012|Phase 2 (Approximately 63 Months)|Other|0|||
147491928|NCT02052778|531955138|FG013|Phase 2 (Approximately 63 Months)|Other|0|||
147491929|NCT02052778|531955139|FG014|Phase 2 (Approximately 63 Months)|Other|0|||
147491930|NCT02052778|531955140|FG015|Phase 2 (Approximately 63 Months)|Other|0|||
147491931|NCT02052778|531955141|FG016|Phase 2 (Approximately 63 Months)|Other|0|||
147491932|NCT02052778|531955142|FG017|Phase 2 (Approximately 63 Months)|Other|0|||
147491933|NCT02052778|531955143|FG018|Phase 2 (Approximately 63 Months)|Other|0|||
147491934|NCT02052778|531955144|FG019|Phase 2 (Approximately 63 Months)|Other|0|||
147491935|NCT02052778|531955145|FG020|Phase 2 (Approximately 63 Months)|Other|0|||
147491936|NCT02052778|531955146|FG021|Phase 2 (Approximately 63 Months)|Other|0|||
147491937|NCT02052778|531955147|FG022|Phase 2 (Approximately 63 Months)|Other|7|||
147491938|NCT02052778|531955125|FG000|Phase 2 (Approximately 63 Months)|Untreated|0|||
147491939|NCT02052778|531955126|FG001|Phase 2 (Approximately 63 Months)|Untreated|0|||
147491940|NCT02052778|531955127|FG002|Phase 2 (Approximately 63 Months)|Untreated|0|||
147491941|NCT02052778|531955128|FG003|Phase 2 (Approximately 63 Months)|Untreated|0|||
147491942|NCT02052778|531955129|FG004|Phase 2 (Approximately 63 Months)|Untreated|0|||
147491943|NCT02052778|531955130|FG005|Phase 2 (Approximately 63 Months)|Untreated|0|||
147491944|NCT02052778|531955131|FG006|Phase 2 (Approximately 63 Months)|Untreated|0|||
147491945|NCT02052778|531955132|FG007|Phase 2 (Approximately 63 Months)|Untreated|0|||
147491946|NCT02052778|531955133|FG008|Phase 2 (Approximately 63 Months)|Untreated|0|||
147491947|NCT02052778|531955134|FG009|Phase 2 (Approximately 63 Months)|Untreated|0|||
147491948|NCT02052778|531955135|FG010|Phase 2 (Approximately 63 Months)|Untreated|0|||
147491949|NCT02052778|531955136|FG011|Phase 2 (Approximately 63 Months)|Untreated|0|||
147491950|NCT02052778|531955137|FG012|Phase 2 (Approximately 63 Months)|Untreated|0|||
147491951|NCT02052778|531955138|FG013|Phase 2 (Approximately 63 Months)|Untreated|0|||
147491952|NCT02052778|531955139|FG014|Phase 2 (Approximately 63 Months)|Untreated|0|||
147491953|NCT02052778|531955140|FG015|Phase 2 (Approximately 63 Months)|Untreated|0|||
147491954|NCT02052778|531955141|FG016|Phase 2 (Approximately 63 Months)|Untreated|0|||
147491955|NCT02052778|531955142|FG017|Phase 2 (Approximately 63 Months)|Untreated|0|||
147491956|NCT02052778|531955143|FG018|Phase 2 (Approximately 63 Months)|Untreated|0|||
147491957|NCT02052778|531955144|FG019|Phase 2 (Approximately 63 Months)|Untreated|0|||
147491958|NCT02052778|531955145|FG020|Phase 2 (Approximately 63 Months)|Untreated|0|||
147491959|NCT02052778|531955146|FG021|Phase 2 (Approximately 63 Months)|Untreated|0|||
147491960|NCT02052778|531955147|FG022|Phase 2 (Approximately 63 Months)|Untreated|17|||
147491961|NCT02864940|531955148|FG000|Overall Study|Never took part in intervention or control arm activities or completed post assessments|13|||
147491962|NCT02864940|531955149|FG001|Overall Study|Never took part in intervention or control arm activities or completed post assessments|11|||
147491963|NCT04804033|531955151|FG000|Period 1: DBT Phase|Adverse Event|1|||
147491964|NCT04804033|531955152|FG001|Period 1: DBT Phase|Adverse Event|5|||
147491965|NCT04804033|531955153|FG002|Period 1: DBT Phase|Adverse Event|3|||
147491966|NCT04804033|531955154|FG003|Period 1: DBT Phase|Adverse Event|4|||
147491967|NCT04804033|531955151|FG000|Period 1: DBT Phase|Death|1|||
147491968|NCT04804033|531955152|FG001|Period 1: DBT Phase|Death|0|||
147491969|NCT04804033|531955153|FG002|Period 1: DBT Phase|Death|0|||
147491970|NCT04804033|531955154|FG003|Period 1: DBT Phase|Death|0|||
147491971|NCT04804033|531955151|FG000|Period 1: DBT Phase|Lost to Follow-up|3|||
147491972|NCT04804033|531955152|FG001|Period 1: DBT Phase|Lost to Follow-up|7|||
147491973|NCT04804033|531955153|FG002|Period 1: DBT Phase|Lost to Follow-up|1|||
147491974|NCT04804033|531955154|FG003|Period 1: DBT Phase|Lost to Follow-up|3|||
147491975|NCT04804033|531955151|FG000|Period 1: DBT Phase|Non-compliance|1|||
147491976|NCT04804033|531955152|FG001|Period 1: DBT Phase|Non-compliance|0|||
147491977|NCT04804033|531955153|FG002|Period 1: DBT Phase|Non-compliance|1|||
147491978|NCT04804033|531955154|FG003|Period 1: DBT Phase|Non-compliance|2|||
147491979|NCT04804033|531955151|FG000|Period 1: DBT Phase|Other|0|||
147491980|NCT04804033|531955152|FG001|Period 1: DBT Phase|Other|1|||
147491981|NCT04804033|531955153|FG002|Period 1: DBT Phase|Other|0|||
147491982|NCT04804033|531955154|FG003|Period 1: DBT Phase|Other|0|||
147491983|NCT04804033|531955151|FG000|Period 1: DBT Phase|Pregnancy|2|||
147491984|NCT04804033|531955152|FG001|Period 1: DBT Phase|Pregnancy|0|||
147491985|NCT04804033|531955153|FG002|Period 1: DBT Phase|Pregnancy|0|||
147491986|NCT04804033|531955154|FG003|Period 1: DBT Phase|Pregnancy|0|||
147491987|NCT04804033|531955151|FG000|Period 1: DBT Phase|Study terminated by sponsor|15|||
147491988|NCT04804033|531955152|FG001|Period 1: DBT Phase|Study terminated by sponsor|16|||
147491989|NCT04804033|531955153|FG002|Period 1: DBT Phase|Study terminated by sponsor|5|||
147491990|NCT04804033|531955154|FG003|Period 1: DBT Phase|Study terminated by sponsor|9|||
147491991|NCT04804033|531955151|FG000|Period 1: DBT Phase|Withdrawal by Subject|6|||
147491992|NCT04804033|531955152|FG001|Period 1: DBT Phase|Withdrawal by Subject|12|||
147491993|NCT04804033|531955153|FG002|Period 1: DBT Phase|Withdrawal by Subject|7|||
147491994|NCT04804033|531955154|FG003|Period 1: DBT Phase|Withdrawal by Subject|6|||
147491995|NCT04804033|531955151|FG000|Period 1: DBT Phase|Randomized but not treated|5|||
147491996|NCT04804033|531955152|FG001|Period 1: DBT Phase|Randomized but not treated|5|||
147491997|NCT04804033|531955153|FG002|Period 1: DBT Phase|Randomized but not treated|2|||
147491998|NCT04804033|531955154|FG003|Period 1: DBT Phase|Randomized but not treated|0|||
147491999|NCT04804033|531955151|FG000|Period 2: OLE Phase|Adverse Event|3|||
147492000|NCT04804033|531955152|FG001|Period 2: OLE Phase|Adverse Event|4|||
147492001|NCT04804033|531955153|FG002|Period 2: OLE Phase|Adverse Event|2|||
147492002|NCT04804033|531955154|FG003|Period 2: OLE Phase|Adverse Event|0|||
147492003|NCT04804033|531955151|FG000|Period 2: OLE Phase|Lost to Follow-up|8|||
147492004|NCT04804033|531955152|FG001|Period 2: OLE Phase|Lost to Follow-up|4|||
147492005|NCT04804033|531955153|FG002|Period 2: OLE Phase|Lost to Follow-up|3|||
147492006|NCT04804033|531955154|FG003|Period 2: OLE Phase|Lost to Follow-up|4|||
147492007|NCT04804033|531955151|FG000|Period 2: OLE Phase|Non-compliance|2|||
147492008|NCT04804033|531955152|FG001|Period 2: OLE Phase|Non-compliance|2|||
147492009|NCT04804033|531955153|FG002|Period 2: OLE Phase|Non-compliance|0|||
147492010|NCT04804033|531955154|FG003|Period 2: OLE Phase|Non-compliance|1|||
147492011|NCT04804033|531955151|FG000|Period 2: OLE Phase|Other|0|||
147492012|NCT04804033|531955152|FG001|Period 2: OLE Phase|Other|2|||
147492013|NCT04804033|531955153|FG002|Period 2: OLE Phase|Other|0|||
147492014|NCT04804033|531955154|FG003|Period 2: OLE Phase|Other|0|||
147492015|NCT04804033|531955151|FG000|Period 2: OLE Phase|Physician Decision|1|||
147492016|NCT04804033|531955152|FG001|Period 2: OLE Phase|Physician Decision|1|||
147492017|NCT04804033|531955153|FG002|Period 2: OLE Phase|Physician Decision|0|||
147492018|NCT04804033|531955154|FG003|Period 2: OLE Phase|Physician Decision|0|||
147492019|NCT04804033|531955151|FG000|Period 2: OLE Phase|Pregnancy|0|||
147492020|NCT04804033|531955152|FG001|Period 2: OLE Phase|Pregnancy|0|||
147492021|NCT04804033|531955153|FG002|Period 2: OLE Phase|Pregnancy|2|||
147492022|NCT04804033|531955154|FG003|Period 2: OLE Phase|Pregnancy|0|||
147492023|NCT04804033|531955151|FG000|Period 2: OLE Phase|Study terminated by sponsor|41|||
147492024|NCT04804033|531955152|FG001|Period 2: OLE Phase|Study terminated by sponsor|37|||
147492025|NCT04804033|531955153|FG002|Period 2: OLE Phase|Study terminated by sponsor|17|||
147492026|NCT04804033|531955154|FG003|Period 2: OLE Phase|Study terminated by sponsor|19|||
147492027|NCT04804033|531955151|FG000|Period 2: OLE Phase|Withdrawal by Subject|16|||
147492028|NCT04804033|531955152|FG001|Period 2: OLE Phase|Withdrawal by Subject|8|||
147492029|NCT04804033|531955153|FG002|Period 2: OLE Phase|Withdrawal by Subject|3|||
147492030|NCT04804033|531955154|FG003|Period 2: OLE Phase|Withdrawal by Subject|7|||
147492031|NCT04804033|531955151|FG000|Period 2: OLE Phase|Not reported|0|||
147492032|NCT04804033|531955152|FG001|Period 2: OLE Phase|Not reported|2|||
147492033|NCT04804033|531955153|FG002|Period 2: OLE Phase|Not reported|0|||
147492034|NCT04804033|531955154|FG003|Period 2: OLE Phase|Not reported|0|||
147492035|NCT04804033|531955151|FG000|Period 2: OLE Phase|Failure to meet continuation criteria|0|||
147492036|NCT04804033|531955152|FG001|Period 2: OLE Phase|Failure to meet continuation criteria|0|||
147492037|NCT04804033|531955153|FG002|Period 2: OLE Phase|Failure to meet continuation criteria|1|||
147492038|NCT04804033|531955154|FG003|Period 2: OLE Phase|Failure to meet continuation criteria|1|||
147492039|NCT04804033|531955151|FG000|Period 3: Follow-up Phase|Lost to Follow-up|5|||
147492040|NCT04804033|531955152|FG001|Period 3: Follow-up Phase|Lost to Follow-up|9|||
147492041|NCT04804033|531955153|FG002|Period 3: Follow-up Phase|Lost to Follow-up|0|||
147492042|NCT04804033|531955154|FG003|Period 3: Follow-up Phase|Lost to Follow-up|1|||
147492043|NCT04804033|531955151|FG000|Period 3: Follow-up Phase|Other|0|||
147492044|NCT04804033|531955152|FG001|Period 3: Follow-up Phase|Other|1|||
147492045|NCT04804033|531955153|FG002|Period 3: Follow-up Phase|Other|2|||
147492046|NCT04804033|531955154|FG003|Period 3: Follow-up Phase|Other|1|||
147492047|NCT04804033|531955151|FG000|Period 3: Follow-up Phase|Withdrawal by Subject|7|||
147492048|NCT04804033|531955152|FG001|Period 3: Follow-up Phase|Withdrawal by Subject|6|||
147492049|NCT04804033|531955153|FG002|Period 3: Follow-up Phase|Withdrawal by Subject|3|||
147492050|NCT04804033|531955154|FG003|Period 3: Follow-up Phase|Withdrawal by Subject|4|||
147492051|NCT04804033|531955151|FG000|Period 3: Follow-up Phase|Not reported|18|||
147492052|NCT04804033|531955152|FG001|Period 3: Follow-up Phase|Not reported|15|||
147492053|NCT04804033|531955153|FG002|Period 3: Follow-up Phase|Not reported|1|||
147492054|NCT04804033|531955154|FG003|Period 3: Follow-up Phase|Not reported|4|||
147492055|NCT01106625|531955165|FG000|Core Period: Baseline to Week 26|Adverse Event|6|||
147492056|NCT01106625|531955166|FG001|Core Period: Baseline to Week 26|Adverse Event|8|||
147492057|NCT01106625|531955167|FG002|Core Period: Baseline to Week 26|Adverse Event|8|||
147492058|NCT01106625|531955165|FG000|Core Period: Baseline to Week 26|Lost to Follow-up|5|||
147492059|NCT01106625|531955166|FG001|Core Period: Baseline to Week 26|Lost to Follow-up|0|||
147492060|NCT01106625|531955167|FG002|Core Period: Baseline to Week 26|Lost to Follow-up|4|||
147492061|NCT01106625|531955165|FG000|Core Period: Baseline to Week 26|Physician Decision|1|||
147492062|NCT01106625|531955166|FG001|Core Period: Baseline to Week 26|Physician Decision|0|||
147492063|NCT01106625|531955167|FG002|Core Period: Baseline to Week 26|Physician Decision|0|||
147492064|NCT01106625|531955165|FG000|Core Period: Baseline to Week 26|Protocol Violation|2|||
147492065|NCT01106625|531955166|FG001|Core Period: Baseline to Week 26|Protocol Violation|1|||
147492066|NCT01106625|531955167|FG002|Core Period: Baseline to Week 26|Protocol Violation|3|||
147492067|NCT01106625|531955165|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|6|||
147492068|NCT01106625|531955166|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|9|||
147492069|NCT01106625|531955167|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|7|||
147492070|NCT01106625|531955165|FG000|Core Period: Baseline to Week 26|Unable to take rescue therapy|4|||
147492071|NCT01106625|531955166|FG001|Core Period: Baseline to Week 26|Unable to take rescue therapy|1|||
147492072|NCT01106625|531955167|FG002|Core Period: Baseline to Week 26|Unable to take rescue therapy|0|||
147492073|NCT01106625|531955165|FG000|Core Period: Baseline to Week 26|Creatinine, or eGFR withdrawal criteria|0|||
147492074|NCT01106625|531955166|FG001|Core Period: Baseline to Week 26|Creatinine, or eGFR withdrawal criteria|1|||
147492075|NCT01106625|531955167|FG002|Core Period: Baseline to Week 26|Creatinine, or eGFR withdrawal criteria|1|||
147492076|NCT01106625|531955165|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|1|||
147492077|NCT01106625|531955166|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|1|||
147492078|NCT01106625|531955167|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
147492079|NCT01106625|531955165|FG000|Core Period: Baseline to Week 26|Other|8|||
147492080|NCT01106625|531955166|FG001|Core Period: Baseline to Week 26|Other|7|||
147492081|NCT01106625|531955167|FG002|Core Period: Baseline to Week 26|Other|4|||
147492082|NCT01106625|531955165|FG000|Extension Period: Week 26 to Week 52|Adverse Event|2|||
147492083|NCT01106625|531955166|FG001|Extension Period: Week 26 to Week 52|Adverse Event|2|||
147492084|NCT01106625|531955167|FG002|Extension Period: Week 26 to Week 52|Adverse Event|3|||
147492085|NCT01106625|531955165|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|1|||
147492086|NCT01106625|531955166|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|3|||
147492087|NCT01106625|531955167|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|2|||
147492088|NCT01106625|531955165|FG000|Extension Period: Week 26 to Week 52|Physician Decision|2|||
147492089|NCT01106625|531955166|FG001|Extension Period: Week 26 to Week 52|Physician Decision|0|||
147492090|NCT01106625|531955167|FG002|Extension Period: Week 26 to Week 52|Physician Decision|1|||
147492091|NCT01106625|531955165|FG000|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
147492092|NCT01106625|531955166|FG001|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
147492093|NCT01106625|531955167|FG002|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
147492094|NCT01106625|531955165|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|4|||
147492095|NCT01106625|531955166|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
147492096|NCT01106625|531955167|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
147492097|NCT01106625|531955165|FG000|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|14|||
147492098|NCT01106625|531955166|FG001|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|5|||
147492099|NCT01106625|531955167|FG002|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|4|||
147492100|NCT01106625|531955165|FG000|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|1|||
147492101|NCT01106625|531955166|FG001|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|1|||
147492102|NCT01106625|531955167|FG002|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|2|||
147492103|NCT01106625|531955165|FG000|Extension Period: Week 26 to Week 52|Other|5|||
147492104|NCT01106625|531955166|FG001|Extension Period: Week 26 to Week 52|Other|5|||
147492105|NCT01106625|531955167|FG002|Extension Period: Week 26 to Week 52|Other|4|||
147492106|NCT02496585|531955168|FG000|Overall Study|Death|3|||
147492107|NCT02496585|531955169|FG001|Overall Study|Death|0|||
147492108|NCT02496585|531955168|FG000|Overall Study|Lost to Follow-up|2|||
147492109|NCT02496585|531955169|FG001|Overall Study|Lost to Follow-up|0|||
147492110|NCT02496585|531955168|FG000|Overall Study|Withdrawal by Subject|1|||
147492111|NCT02496585|531955169|FG001|Overall Study|Withdrawal by Subject|2|||
147492112|NCT02496585|531955168|FG000|Overall Study|Progression of Malignancy|4|||
147492113|NCT02496585|531955169|FG001|Overall Study|Progression of Malignancy|1|||
147492114|NCT01100307|531955170|FG000|Double Masked Phase (Up to Week 24)|Lack of Efficacy|1|||
147492115|NCT01100307|531955171|FG001|Double Masked Phase (Up to Week 24)|Lack of Efficacy|1|||
147492116|NCT01100307|531955170|FG000|Double Masked Phase (Up to Week 24)|Withdrawal by Subject|0|||
147492117|NCT01100307|531955171|FG001|Double Masked Phase (Up to Week 24)|Withdrawal by Subject|1|||
147492118|NCT01100307|531955170|FG000|Double Masked Phase (Up to Week 24)|Adverse Event|5|||
147492119|NCT01100307|531955171|FG001|Double Masked Phase (Up to Week 24)|Adverse Event|2|||
147492120|NCT01100307|531955170|FG000|Open Phase (Week 24 up to Week 54)|Lack of Efficacy|1|||
147492121|NCT01100307|531955171|FG001|Open Phase (Week 24 up to Week 54)|Lack of Efficacy|2|||
147492122|NCT01100307|531955170|FG000|Open Phase (Week 24 up to Week 54)|Withdrawal by Subject|2|||
147492123|NCT01100307|531955171|FG001|Open Phase (Week 24 up to Week 54)|Withdrawal by Subject|3|||
147492124|NCT01100307|531955170|FG000|Open Phase (Week 24 up to Week 54)|Adverse Event|3|||
147492125|NCT01100307|531955171|FG001|Open Phase (Week 24 up to Week 54)|Adverse Event|8|||
147492126|NCT00997321|531955172|FG000|Overall Study|did not undergo sedation after enrollmen|0|||
147492127|NCT00997321|531955173|FG001|Overall Study|did not undergo sedation after enrollmen|3|||
147492128|NCT01276457|531955176|FG000|Core Study|Adverse Event|6|||
147492129|NCT01276457|531955177|FG001|Core Study|Adverse Event|3|||
147492130|NCT01276457|531955176|FG000|Core Study|Lost to Follow-up|1|||
147492131|NCT01276457|531955177|FG001|Core Study|Lost to Follow-up|2|||
147492132|NCT01276457|531955176|FG000|Core Study|Administrative problems|1|||
147492133|NCT01276457|531955177|FG001|Core Study|Administrative problems|1|||
147492134|NCT01276457|531955176|FG000|Core Study|Death|2|||
147492135|NCT01276457|531955177|FG001|Core Study|Death|2|||
147492136|NCT01276457|531955176|FG000|Core Study|Lack of Efficacy|3|||
147492137|NCT01276457|531955177|FG001|Core Study|Lack of Efficacy|12|||
147492138|NCT01276457|531955176|FG000|Extension Study|Lost to Follow-up|3|||
147492139|NCT01276457|531955177|FG001|Extension Study|Lost to Follow-up|0|||
147492140|NCT01276457|531955176|FG000|Extension Study|Death|0|||
147492141|NCT01276457|531955177|FG001|Extension Study|Death|1|||
147492142|NCT01276457|531955176|FG000|Extension Study|Lack of Efficacy|3|||
147492143|NCT01276457|531955177|FG001|Extension Study|Lack of Efficacy|1|||
147492144|NCT02065869|531955178|FG000|Overall Study|Death|7|||
147492145|NCT02065869|531955178|FG000|Overall Study|Disease relapse|16|||
147668081|NCT01387269|532609863|FG001|Overall Study|Withdrawal by patient|10|||
147668082|NCT01387269|532609862|FG000|Overall Study|Study drug-related AE|1|||
147492146|NCT02065869|531955178|FG000|Overall Study|Lost to Follow-up|4|||
147492147|NCT02065869|531955178|FG000|Overall Study|No rivogenlecleucel cells infused (non-evaluable)|7|||
147492148|NCT02065869|531955178|FG000|Overall Study|Withdrawal by Subject|1|||
147492149|NCT00527111|531955179|FG000|Overall Study|Adverse Event|14|||
147492150|NCT00527111|531955180|FG001|Overall Study|Adverse Event|13|||
147492151|NCT00527111|531955179|FG000|Overall Study|Death|0|||
147492152|NCT00527111|531955180|FG001|Overall Study|Death|1|||
147492153|NCT00527111|531955179|FG000|Overall Study|Investigator Request|2|||
147492154|NCT00527111|531955180|FG001|Overall Study|Investigator Request|1|||
147492155|NCT00527111|531955179|FG000|Overall Study|Patient Request|2|||
147492156|NCT00527111|531955180|FG001|Overall Study|Patient Request|5|||
147492157|NCT00527111|531955179|FG000|Overall Study|Other|2|||
147492158|NCT00527111|531955180|FG001|Overall Study|Other|2|||
147492159|NCT02993224|531955181|FG000|Core Phase - Period 1|Adverse Event|4|||
147492160|NCT02993224|531955181|FG000|Core Phase - Period 1|Withdrawal by Subject|1|||
147492161|NCT02993224|531955181|FG000|Core Phase - Period 1|Lost to Follow-up|3|||
147492162|NCT02993224|531955181|FG000|Core Phase- Period 2|Adverse Event|1|||
147492163|NCT02993224|531955181|FG000|Core Phase- Period 2|Unwillingness To Comply With Protocol Procedures And Prescribed Study Treatment|2|||
147492164|NCT02993224|531955181|FG000|Core Phase- Period 2|Allogenic stem cell transplantation|1|||
147492165|NCT02993224|531955181|FG000|Extension Phase|Unwillingness To Comply With Protocol Procedures And Prescribed Study Treatment|1|||
147492166|NCT02993224|531955181|FG000|Extension Phase|Adverse Event|3|||
147492167|NCT02993224|531955181|FG000|Extension Phase|Withdrawal by Subject|3|||
147492168|NCT02993224|531955181|FG000|Extension Phase|Lost to Follow-up|2|||
147492169|NCT02993224|531955181|FG000|Extension Phase|Deferasirox FCT locally reimbursed|27|||
147492170|NCT03827473|531955183|FG000|Overall Study|Withdrawal by Subject|1|||
147492171|NCT03827473|531955184|FG001|Overall Study|Withdrawal by Subject|0|||
147492172|NCT01423617|531955185|FG000|Overall Study|Lost to Follow-up|0|||
147492173|NCT01423617|531955186|FG001|Overall Study|Lost to Follow-up|1|||
147492174|NCT02635737|531955187|FG000|Overall Study|Protocol Violation|1|||
147492175|NCT01552928|531955188|FG000|Period 3|Adverse Event|0|||
147492176|NCT01552928|531955189|FG001|Period 3|Adverse Event|0|||
147492177|NCT01552928|531955190|FG002|Period 3|Adverse Event|1|||
147492178|NCT01552928|531955191|FG003|Period 3|Adverse Event|0|||
147492179|NCT01511419|531955192|FG000|Dose 2|Physician Decision|1|||
147492180|NCT01511419|531955193|FG001|Dose 2|Physician Decision|0|||
147492181|NCT00937768|531955194|FG000|Overall Study|Refused Further Treatment|3|||
147492182|NCT00937768|531955195|FG001|Overall Study|Refused Further Treatment|2|||
147492183|NCT00937768|531955194|FG000|Overall Study|Disease Progression|1|||
147492184|NCT00937768|531955195|FG001|Overall Study|Disease Progression|1|||
147492185|NCT00937768|531955194|FG000|Overall Study|Alternate Treatment|0|||
147492186|NCT00937768|531955195|FG001|Overall Study|Alternate Treatment|1|||
147492187|NCT00937768|531955194|FG000|Overall Study|No Further Funding|4|||
147492188|NCT00937768|531955195|FG001|Overall Study|No Further Funding|4|||
147492189|NCT00488618|531955197|FG000|Overall Study|Adverse Event|13|||
147492190|NCT00488618|531955198|FG001|Overall Study|Adverse Event|17|||
147492191|NCT00488618|531955197|FG000|Overall Study|Insufficient Therapeutic Response|18|||
147492192|NCT00488618|531955198|FG001|Overall Study|Insufficient Therapeutic Response|11|||
147492193|NCT00488618|531955197|FG000|Overall Study|Protocol Violation|0|||
147492194|NCT00488618|531955198|FG001|Overall Study|Protocol Violation|2|||
147492195|NCT00488618|531955197|FG000|Overall Study|Withdrawal of Consent|15|||
147492196|NCT00488618|531955198|FG001|Overall Study|Withdrawal of Consent|13|||
147492197|NCT00488618|531955197|FG000|Overall Study|Lost to Follow-up|1|||
147492198|NCT00488618|531955198|FG001|Overall Study|Lost to Follow-up|0|||
147492199|NCT00786032|531956787|FG000|Overall Study|Death|4|||
147492200|NCT00786032|531956787|FG000|Overall Study|Withdrawal by Subject|14|||
147492201|NCT00786032|531956787|FG000|Overall Study|Did not complete in the timeframe|6|||
147492202|NCT02922634|531956788|FG000|Overall Study|Withdrawal by Subject|5|||
147492203|NCT02922634|531956788|FG000|Overall Study|Did not have their surgery|5|||
147492204|NCT02723604|531956789|FG000|Overall Study|ineligible|1|||
147492205|NCT02723604|531956789|FG000|Overall Study|never received treatment|1|||
147492206|NCT01194804|531956790|FG000|Overall Study|Withdrawal by Subject|1|||
147492207|NCT02494778|531956791|FG000|Overall Study|Death|3|||
147492208|NCT02494778|531956791|FG000|Overall Study|Other|173|||
147492209|NCT02494778|531956791|FG000|Overall Study|Lack of Efficacy|4|||
147492210|NCT02494778|531956791|FG000|Overall Study|Adverse Event|18|||
147492211|NCT02494778|531956791|FG000|Overall Study|Withdrawal by Subject|20|||
147492212|NCT02494778|531956791|FG000|Overall Study|Lost to Follow-up|2|||
147492213|NCT02494778|531956791|FG000|Overall Study|Noncompliant with study drug admin.|1|||
147492214|NCT01303380|531956792|FG000|Overall Study|Lack of compliance to study procedures|1|||
147492215|NCT02174861|531956793|FG000|Overall Study|Decision by sponsor|8|||
147492216|NCT02174861|531956793|FG000|Overall Study|Withdrawal by Subject|124|||
147492217|NCT02174861|531956793|FG000|Overall Study|Lost to Follow-up|26|||
147492218|NCT01215734|531956794|FG000|Overall Study|Death|0|||
147492219|NCT01215734|531956795|FG001|Overall Study|Death|1|||
147492220|NCT00315705|531956796|FG000|Phase 1|Refused further treatment|1|||
147492221|NCT00315705|531956796|FG000|Phase 1|Failure to achieve response|8|||
147492222|NCT00315705|531956796|FG000|Phase 1|Disease relapse|4|||
147492223|NCT00315705|531956796|FG000|Phase 1|Scheduled for transplant|9|||
147492224|NCT00315705|531956796|FG000|Phase 1|Death|3|||
147492225|NCT00315705|531956796|FG000|Phase 2|Physician Decision|4|||
147492226|NCT00315705|531956796|FG000|Phase 2|Adverse Event|1|||
147492227|NCT00315705|531956796|FG000|Phase 2|Failure to achieve response|3|||
147492228|NCT00315705|531956796|FG000|Phase 2|Disease relapse|1|||
147492229|NCT00315705|531956796|FG000|Phase 2|Scheduled for transplant|8|||
147492230|NCT00315705|531956796|FG000|Phase 2|Other|1|||
147492231|NCT00315705|531956796|FG000|Phase 2|Death|7|||
147492232|NCT01716533|531956797|FG000|Overall Study|Failure of antibiotic treatment to treat|0|||
147492233|NCT01716533|531956798|FG001|Overall Study|Failure of antibiotic treatment to treat|0|||
147492234|NCT01716533|531956799|FG002|Overall Study|Failure of antibiotic treatment to treat|5|||
147492235|NCT01716533|531956800|FG003|Overall Study|Failure of antibiotic treatment to treat|0|||
147492236|NCT01716533|531956797|FG000|Overall Study|Withdrawal by Subject|0|||
147492237|NCT01716533|531956798|FG001|Overall Study|Withdrawal by Subject|0|||
147492238|NCT01716533|531956799|FG002|Overall Study|Withdrawal by Subject|0|||
147492239|NCT01716533|531956800|FG003|Overall Study|Withdrawal by Subject|5|||
147492240|NCT01716533|531956797|FG000|Overall Study|Death|0|||
147492241|NCT01716533|531956798|FG001|Overall Study|Death|0|||
147492242|NCT01716533|531956799|FG002|Overall Study|Death|0|||
147492243|NCT01716533|531956800|FG003|Overall Study|Death|2|||
147492244|NCT01716533|531956797|FG000|Overall Study|Immunosuppressants>14days past 6months|0|||
147492245|NCT01716533|531956798|FG001|Overall Study|Immunosuppressants>14days past 6months|0|||
147492246|NCT01716533|531956799|FG002|Overall Study|Immunosuppressants>14days past 6months|0|||
147492247|NCT01716533|531956800|FG003|Overall Study|Immunosuppressants>14days past 6months|1|||
147492248|NCT00165841|531956807|FG000|Overall Study|Adverse Event|2|||
147492249|NCT00165841|531956808|FG001|Overall Study|Adverse Event|3|||
147492250|NCT00165841|531956807|FG000|Overall Study|Lack of Efficacy|6|||
147492251|NCT00165841|531956808|FG001|Overall Study|Lack of Efficacy|33|||
147492252|NCT00165841|531956807|FG000|Overall Study|Lost to Follow-up|4|||
147492253|NCT00165841|531956808|FG001|Overall Study|Lost to Follow-up|4|||
147492254|NCT00165841|531956807|FG000|Overall Study|Withdrawal by Subject|7|||
147492255|NCT00165841|531956808|FG001|Overall Study|Withdrawal by Subject|8|||
147492256|NCT00165841|531956807|FG000|Overall Study|Physician Decision|1|||
147492257|NCT00165841|531956808|FG001|Overall Study|Physician Decision|0|||
147492258|NCT00165841|531956807|FG000|Overall Study|Protocol Violation|6|||
147492259|NCT00165841|531956808|FG001|Overall Study|Protocol Violation|8|||
147492260|NCT00165841|531956807|FG000|Overall Study|Other|3|||
147492261|NCT00165841|531956808|FG001|Overall Study|Other|5|||
147492262|NCT00165841|531956807|FG000|Overall Study|Medication Noncompliance|1|||
147492263|NCT00165841|531956808|FG001|Overall Study|Medication Noncompliance|1|||
147492264|NCT02006667|531956811|FG000|Overall Study|Adverse Event|3|||
147492265|NCT02006667|531956811|FG000|Overall Study|Death|2|||
147492266|NCT02006667|531956811|FG000|Overall Study|Withdrawal by Subject|1|||
147492267|NCT01626352|531956812|FG000|Overall Study|Disease Progression|3|||
147492268|NCT01626352|531956812|FG000|Overall Study|Intercurrent Illness|2|||
147492269|NCT01626352|531956812|FG000|Overall Study|Death|2|||
147492270|NCT01626352|531956812|FG000|Overall Study|Withdrawal by Subject|1|||
147492271|NCT01626352|531956812|FG000|Overall Study|Non-Compliance|1|||
147492272|NCT01626352|531956812|FG000|Overall Study|Never Treated|1|||
147492273|NCT02681055|531956816|FG000|Weeks 5-12|Adverse Event|1|||
147492274|NCT03712345|531956819|FG000|Overall Study|Failure to meet randomization criteria|0|||
147492275|NCT03712345|531956820|FG001|Overall Study|Failure to meet randomization criteria|0|||
147492276|NCT03712345|531956821|FG002|Overall Study|Failure to meet randomization criteria|1|||
147492277|NCT00839423|531956828|FG000|Overall Study|Adverse Event|4|||
147492278|NCT00839423|531956829|FG001|Overall Study|Adverse Event|3|||
147492279|NCT00839423|531956830|FG002|Overall Study|Adverse Event|7|||
147492280|NCT00839423|531956831|FG003|Overall Study|Adverse Event|16|||
147492281|NCT00839423|531956828|FG000|Overall Study|Lack of Efficacy|6|||
147492282|NCT00839423|531956829|FG001|Overall Study|Lack of Efficacy|6|||
147492283|NCT00839423|531956830|FG002|Overall Study|Lack of Efficacy|3|||
147492284|NCT00839423|531956831|FG003|Overall Study|Lack of Efficacy|2|||
147492285|NCT00839423|531956828|FG000|Overall Study|Non-compliance|0|||
147625943|NCT00463047|532447168|FG000|Titration Period 2|Lack of Efficacy|6|||
147625944|NCT00463047|532447169|FG001|Titration Period 2|Lack of Efficacy|4|||
147625945|NCT00463047|532447168|FG000|Titration Period 2|Withdrawal by Subject|1|||
147492286|NCT00839423|531956829|FG001|Overall Study|Non-compliance|0|||
147492287|NCT00839423|531956830|FG002|Overall Study|Non-compliance|0|||
147492288|NCT00839423|531956831|FG003|Overall Study|Non-compliance|1|||
147492289|NCT00839423|531956828|FG000|Overall Study|Protocol Violation|0|||
147492290|NCT00839423|531956829|FG001|Overall Study|Protocol Violation|1|||
147492291|NCT00839423|531956830|FG002|Overall Study|Protocol Violation|2|||
147492292|NCT00839423|531956831|FG003|Overall Study|Protocol Violation|0|||
147492293|NCT00839423|531956828|FG000|Overall Study|Withdrawal of consent|4|||
147492294|NCT00839423|531956829|FG001|Overall Study|Withdrawal of consent|0|||
147492295|NCT00839423|531956830|FG002|Overall Study|Withdrawal of consent|4|||
147492296|NCT00839423|531956831|FG003|Overall Study|Withdrawal of consent|1|||
147492297|NCT00839423|531956828|FG000|Overall Study|Lost to Follow-up|1|||
147625946|NCT00463047|532447169|FG001|Titration Period 2|Withdrawal by Subject|0|||
147492298|NCT00839423|531956829|FG001|Overall Study|Lost to Follow-up|0|||
147492299|NCT00839423|531956830|FG002|Overall Study|Lost to Follow-up|1|||
147492300|NCT00839423|531956831|FG003|Overall Study|Lost to Follow-up|0|||
147492301|NCT00839423|531956828|FG000|Overall Study|Administrative or other reasons|3|||
147492302|NCT00839423|531956829|FG001|Overall Study|Administrative or other reasons|0|||
147492303|NCT00839423|531956830|FG002|Overall Study|Administrative or other reasons|1|||
147492304|NCT00839423|531956831|FG003|Overall Study|Administrative or other reasons|0|||
147492305|NCT01071096|531956832|FG000|First Intervention (90 Days)|Lost to Follow-up|1|||
147492306|NCT01071096|531956833|FG001|First Intervention (90 Days)|Lost to Follow-up|0|||
147492307|NCT02585999|531956834|FG000|Overall Study|Lost to Follow-up|1|||
147492308|NCT02585999|531956834|FG000|Overall Study|Protocol Violation|1|||
147492309|NCT01332019|531956835|FG000|Overall Study|Was Not Dosed|1|||
147492310|NCT01332019|531956836|FG001|Overall Study|Was Not Dosed|0|||
147492311|NCT01332019|531956835|FG000|Overall Study|Other|16|||
147492312|NCT01332019|531956836|FG001|Overall Study|Other|18|||
147492313|NCT01332019|531956835|FG000|Overall Study|Death|2|||
147492314|NCT01332019|531956836|FG001|Overall Study|Death|1|||
147492315|NCT01332019|531956835|FG000|Overall Study|Physician Decision|4|||
147492316|NCT01332019|531956836|FG001|Overall Study|Physician Decision|3|||
147492317|NCT01332019|531956835|FG000|Overall Study|Withdrawal by Subject|73|||
147492318|NCT01332019|531956836|FG001|Overall Study|Withdrawal by Subject|71|||
147492319|NCT01332019|531956835|FG000|Overall Study|Lost to Follow-up|4|||
147492320|NCT01332019|531956836|FG001|Overall Study|Lost to Follow-up|7|||
147492321|NCT01332019|531956835|FG000|Overall Study|Adverse Event|13|||
147492322|NCT01332019|531956836|FG001|Overall Study|Adverse Event|22|||
147492323|NCT01369849|531956837|FG000|Overall Study|Ineligible prior to treatment|0|||
147492324|NCT01369849|531956838|FG001|Overall Study|Ineligible prior to treatment|0|||
147492325|NCT01369849|531956839|FG002|Overall Study|Ineligible prior to treatment|1|||
147492326|NCT01369849|531956837|FG000|Overall Study|Ineligible after receiving treatment|0|||
147492327|NCT01369849|531956838|FG001|Overall Study|Ineligible after receiving treatment|1|||
147492328|NCT01369849|531956839|FG002|Overall Study|Ineligible after receiving treatment|0|||
147492329|NCT00871377|531956840|FG000|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
147492330|NCT00871377|531956841|FG001|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
147492331|NCT00871377|531956842|FG002|First Intervention (10 Weeks)|Withdrawal by Subject|1|||
147492332|NCT00871377|531956843|FG003|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
147492333|NCT00871377|531956844|FG004|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
147492334|NCT00871377|531956845|FG005|First Intervention (10 Weeks)|Withdrawal by Subject|0|||
147492335|NCT00871377|531956840|FG000|First Intervention (10 Weeks)|Lost to Follow-up|0|||
147492336|NCT00871377|531956841|FG001|First Intervention (10 Weeks)|Lost to Follow-up|0|||
147492337|NCT00871377|531956842|FG002|First Intervention (10 Weeks)|Lost to Follow-up|0|||
147492338|NCT00871377|531956843|FG003|First Intervention (10 Weeks)|Lost to Follow-up|0|||
147492339|NCT00871377|531956844|FG004|First Intervention (10 Weeks)|Lost to Follow-up|0|||
147492340|NCT00871377|531956845|FG005|First Intervention (10 Weeks)|Lost to Follow-up|1|||
147492341|NCT00871377|531956840|FG000|Washout (6 Weeks)|Withdrawal by Subject|1|||
147492342|NCT00871377|531956841|FG001|Washout (6 Weeks)|Withdrawal by Subject|0|||
147492343|NCT00871377|531956842|FG002|Washout (6 Weeks)|Withdrawal by Subject|0|||
147492344|NCT00871377|531956843|FG003|Washout (6 Weeks)|Withdrawal by Subject|0|||
147492345|NCT00871377|531956844|FG004|Washout (6 Weeks)|Withdrawal by Subject|0|||
147492346|NCT00871377|531956845|FG005|Washout (6 Weeks)|Withdrawal by Subject|0|||
147492347|NCT00871377|531956840|FG000|Washout (6 Weeks)|Withdrawal by Subject|0|||
147492348|NCT00871377|531956841|FG001|Washout (6 Weeks)|Withdrawal by Subject|0|||
147492349|NCT00871377|531956842|FG002|Washout (6 Weeks)|Withdrawal by Subject|0|||
147492350|NCT00871377|531956843|FG003|Washout (6 Weeks)|Withdrawal by Subject|0|||
147492351|NCT00871377|531956844|FG004|Washout (6 Weeks)|Withdrawal by Subject|0|||
147492352|NCT00871377|531956845|FG005|Washout (6 Weeks)|Withdrawal by Subject|1|||
147492353|NCT00871377|531956840|FG000|Third Intervention (10 Weeks)|Death|0|||
147492354|NCT00871377|531956841|FG001|Third Intervention (10 Weeks)|Death|0|||
147492355|NCT00871377|531956842|FG002|Third Intervention (10 Weeks)|Death|0|||
147492356|NCT00871377|531956843|FG003|Third Intervention (10 Weeks)|Death|1|||
147668083|NCT01387269|532609863|FG001|Overall Study|Study drug-related AE|0|||
147668084|NCT01387269|532609862|FG000|Overall Study|Lost to Follow-up|1|||
147668085|NCT01387269|532609863|FG001|Overall Study|Lost to Follow-up|0|||
147492357|NCT00871377|531956844|FG004|Third Intervention (10 Weeks)|Death|0|||
147492358|NCT00871377|531956845|FG005|Third Intervention (10 Weeks)|Death|0|||
147492359|NCT02179515|531956850|FG000|Overall Study|switched to alternative treatment|0|||
147492360|NCT02179515|531956851|FG001|Overall Study|switched to alternative treatment|1|||
147492361|NCT02179515|531956852|FG002|Overall Study|switched to alternative treatment|1|||
147492362|NCT02179515|531956850|FG000|Overall Study|Death|0|||
147492363|NCT02179515|531956851|FG001|Overall Study|Death|1|||
147492364|NCT02179515|531956852|FG002|Overall Study|Death|1|||
147492365|NCT02179515|531956850|FG000|Overall Study|refused further treatment|0|||
147492366|NCT02179515|531956851|FG001|Overall Study|refused further treatment|3|||
147492367|NCT02179515|531956852|FG002|Overall Study|refused further treatment|4|||
147492368|NCT02179515|531956850|FG000|Overall Study|Disease progression on study|2|||
147668086|NCT01200329|532609865|FG000|Overall Study|Lack of financial coverage|2|||
147492369|NCT02179515|531956851|FG001|Overall Study|Disease progression on study|11|||
147492370|NCT02179515|531956852|FG002|Overall Study|Disease progression on study|8|||
147492371|NCT02116660|531956853|FG000|Overall Study|Deteriorating renal function|0|||
147492372|NCT02116660|531956854|FG001|Overall Study|Deteriorating renal function|1|||
147492373|NCT02116660|531956853|FG000|Overall Study|Adverse Event|1|||
147492374|NCT02116660|531956854|FG001|Overall Study|Adverse Event|1|||
147492375|NCT02116660|531956853|FG000|Overall Study|Withdrawal by Subject|0|||
147492376|NCT02116660|531956854|FG001|Overall Study|Withdrawal by Subject|2|||
147492377|NCT02116660|531956853|FG000|Overall Study|Organization reason|1|||
147492378|NCT02116660|531956854|FG001|Overall Study|Organization reason|0|||
147492379|NCT00848549|531956855|FG000|E2090-E044-310 (Base Study) Disposition|Adverse Event|31|||
147492380|NCT00848549|531956856|FG001|E2090-E044-310 (Base Study) Disposition|Adverse Event|35|||
147492381|NCT00848549|531956855|FG000|E2090-E044-310 (Base Study) Disposition|Withdrawal by Subject|35|||
147492382|NCT00848549|531956856|FG001|E2090-E044-310 (Base Study) Disposition|Withdrawal by Subject|24|||
147492383|NCT00848549|531956855|FG000|E2090-E044-310 (Base Study) Disposition|Lack of Efficacy|23|||
147492384|NCT00848549|531956856|FG001|E2090-E044-310 (Base Study) Disposition|Lack of Efficacy|23|||
147492385|NCT00848549|531956855|FG000|E2090-E044-310 (Base Study) Disposition|Protocol Violation|3|||
147492386|NCT00848549|531956856|FG001|E2090-E044-310 (Base Study) Disposition|Protocol Violation|8|||
147492387|NCT00848549|531956855|FG000|E2090-E044-310 (Base Study) Disposition|Physician Decision|4|||
147492388|NCT00848549|531956856|FG001|E2090-E044-310 (Base Study) Disposition|Physician Decision|5|||
147492389|NCT00848549|531956855|FG000|E2090-E044-310 (Base Study) Disposition|Lost to Follow-up|21|||
147492390|NCT00848549|531956856|FG001|E2090-E044-310 (Base Study) Disposition|Lost to Follow-up|11|||
147492391|NCT00848549|531956855|FG000|E2090-E044-310 (Base Study) Disposition|Other|4|||
147492392|NCT00848549|531956856|FG001|E2090-E044-310 (Base Study) Disposition|Other|3|||
147492393|NCT00848549|531956855|FG000|E2090-E044-310 (Base Study) Transition|Chose not to enter 314 Extension study|24|||
147492394|NCT00848549|531956856|FG001|E2090-E044-310 (Base Study) Transition|Chose not to enter 314 Extension study|34|||
147492395|NCT00848549|531956855|FG000|E2090-E044-314 (Extension Study)|Adverse Event|2|||
147492396|NCT00848549|531956856|FG001|E2090-E044-314 (Extension Study)|Adverse Event|1|||
147492397|NCT00848549|531956855|FG000|E2090-E044-314 (Extension Study)|Protocol Violation|1|||
147492398|NCT00848549|531956856|FG001|E2090-E044-314 (Extension Study)|Protocol Violation|2|||
147492399|NCT00848549|531956855|FG000|E2090-E044-314 (Extension Study)|Withdrawal by Subject|8|||
147492400|NCT00848549|531956856|FG001|E2090-E044-314 (Extension Study)|Withdrawal by Subject|12|||
147492401|NCT00848549|531956855|FG000|E2090-E044-314 (Extension Study)|Lack of Efficacy|1|||
147492402|NCT00848549|531956856|FG001|E2090-E044-314 (Extension Study)|Lack of Efficacy|1|||
147492403|NCT00848549|531956855|FG000|E2090-E044-314 (Extension Study)|Physician Decision|0|||
147492404|NCT00848549|531956856|FG001|E2090-E044-314 (Extension Study)|Physician Decision|2|||
147492405|NCT00848549|531956855|FG000|E2090-E044-314 (Extension Study)|Other|5|||
147492406|NCT00848549|531956856|FG001|E2090-E044-314 (Extension Study)|Other|6|||
147492407|NCT02561299|531956857|FG000|Overall Study|Death|2|||
147492408|NCT02561299|531956858|FG001|Overall Study|Death|4|||
147492409|NCT02561299|531956857|FG000|Overall Study|Lost to Follow-up|1|||
147492410|NCT02561299|531956858|FG001|Overall Study|Lost to Follow-up|0|||
147492411|NCT02561299|531956857|FG000|Overall Study|Withdrawal by Subject|2|||
147492412|NCT02561299|531956858|FG001|Overall Study|Withdrawal by Subject|2|||
147492413|NCT01248130|531956859|FG000|Overall Study|Protocol Violation|1|||
147492414|NCT01248130|531956860|FG001|Overall Study|Protocol Violation|0|||
147492415|NCT01248130|531956859|FG000|Overall Study|Ineligible|1|||
147492416|NCT01248130|531956860|FG001|Overall Study|Ineligible|0|||
147492417|NCT01911845|531956869|FG000|Overall Study|Adverse Event|2|||
147492418|NCT01911845|531956869|FG000|Overall Study|Lost to Follow-up|1|||
147492419|NCT01911845|531956869|FG000|Overall Study|Other (not specified)|3|||
147492420|NCT01994226|531956870|FG000|Overall Study|Protocol Violation|13|||
147492421|NCT01994226|531956871|FG001|Overall Study|Protocol Violation|10|||
147492422|NCT01994226|531956870|FG000|Overall Study|Early Cessation of treatment|6|||
147492423|NCT01994226|531956871|FG001|Overall Study|Early Cessation of treatment|11|||
147492424|NCT02488551|531956874|FG000|Overall Study|Lost to Follow-up|4|||
147492425|NCT02488551|531956875|FG001|Overall Study|Lost to Follow-up|7|||
147492426|NCT02488551|531956876|FG002|Overall Study|Lost to Follow-up|0|||
147492427|NCT02488551|531956877|FG003|Overall Study|Lost to Follow-up|0|||
147492428|NCT02488551|531956874|FG000|Overall Study|Military Deployment|1|||
147492429|NCT02488551|531956875|FG001|Overall Study|Military Deployment|1|||
147492430|NCT02488551|531956876|FG002|Overall Study|Military Deployment|0|||
147492431|NCT02488551|531956877|FG003|Overall Study|Military Deployment|0|||
147492432|NCT01188564|531956886|FG000|Double-blind Phase|randomized not treated|1|||
147492433|NCT01188564|531956887|FG001|Double-blind Phase|randomized not treated|0|||
147492434|NCT04171037|531956888|FG000|Overall Study|Lost to Follow-up|1|||
147492435|NCT04171037|531956889|FG001|Overall Study|Lost to Follow-up|0|||
147492436|NCT04171037|531956888|FG000|Overall Study|Physician Decision|3|||
147492437|NCT04171037|531956889|FG001|Overall Study|Physician Decision|3|||
147492438|NCT01934894|531956890|FG000|Overall Study|Adverse Event|1|||
147492439|NCT01934894|531956891|FG001|Overall Study|Adverse Event|2|||
147492440|NCT01934894|531956890|FG000|Overall Study|Death|2|||
147492441|NCT01934894|531956891|FG001|Overall Study|Death|0|||
147492442|NCT01934894|531956890|FG000|Overall Study|Withdrawal by Subject|0|||
147492443|NCT01934894|531956891|FG001|Overall Study|Withdrawal by Subject|1|||
147492444|NCT01934894|531956890|FG000|Overall Study|Progressive Disease|3|||
147492445|NCT01934894|531956891|FG001|Overall Study|Progressive Disease|2|||
147492446|NCT04436822|531956893|FG000|Overall Study|Physician Decision|2|||
147492447|NCT04436822|531956894|FG001|Overall Study|Physician Decision|0|||
147492448|NCT04436822|531956893|FG000|Overall Study|Sponsor request|1|||
147492449|NCT04436822|531956894|FG001|Overall Study|Sponsor request|0|||
147492450|NCT04436822|531956893|FG000|Overall Study|Withdrawal by parent/guardian|0|||
147492451|NCT04436822|531956894|FG001|Overall Study|Withdrawal by parent/guardian|3|||
147492452|NCT04436822|531956893|FG000|Overall Study|Unsuccessful procedure|0|||
147492453|NCT04436822|531956894|FG001|Overall Study|Unsuccessful procedure|1|||
147492454|NCT04436822|531956893|FG000|Overall Study|Withdrawal due to Covid-19|8|||
147492455|NCT04436822|531956894|FG001|Overall Study|Withdrawal due to Covid-19|1|||
147492456|NCT04436822|531956893|FG000|Overall Study|Withdrawal by Subject|1|||
147492457|NCT04436822|531956894|FG001|Overall Study|Withdrawal by Subject|0|||
147492458|NCT04436822|531956893|FG000|Overall Study|The sponsor was not able to provide the investigational product|0|||
147492459|NCT04436822|531956894|FG001|Overall Study|The sponsor was not able to provide the investigational product|1|||
147492460|NCT05118386|531956895|FG000|Dose Escalation Phase (Day 1 to Day 151)|Lost to Follow-up|0|||
147492461|NCT05118386|531956896|FG001|Dose Escalation Phase (Day 1 to Day 151)|Lost to Follow-up|0|||
147492462|NCT05118386|531956897|FG002|Dose Escalation Phase (Day 1 to Day 151)|Lost to Follow-up|0|||
147492463|NCT05118386|531956898|FG003|Dose Escalation Phase (Day 1 to Day 151)|Lost to Follow-up|2|||
147492464|NCT05118386|531956899|FG004|Dose Escalation Phase (Day 1 to Day 151)|Lost to Follow-up|0|||
147492465|NCT05118386|531956900|FG005|Dose Escalation Phase (Day 1 to Day 151)|Lost to Follow-up|0|||
147492466|NCT05118386|531956895|FG000|Dose Expansion Phase (Day 1 to Day 151)|Unspecified Reason Not Completed|0|||
147492467|NCT05118386|531956896|FG001|Dose Expansion Phase (Day 1 to Day 151)|Unspecified Reason Not Completed|0|||
147492468|NCT05118386|531956897|FG002|Dose Expansion Phase (Day 1 to Day 151)|Unspecified Reason Not Completed|0|||
147492469|NCT05118386|531956898|FG003|Dose Expansion Phase (Day 1 to Day 151)|Unspecified Reason Not Completed|0|||
147492470|NCT05118386|531956899|FG004|Dose Expansion Phase (Day 1 to Day 151)|Unspecified Reason Not Completed|1|||
147492471|NCT05118386|531956900|FG005|Dose Expansion Phase (Day 1 to Day 151)|Unspecified Reason Not Completed|0|||
147492472|NCT00369668|531956901|FG000|Overall Study|Lack of Efficacy|4|||
147492473|NCT00369668|531956902|FG001|Overall Study|Lack of Efficacy|5|||
147492474|NCT00369668|531956903|FG002|Overall Study|Lack of Efficacy|7|||
147492475|NCT00303108|531956904|FG000|Overall Study|Adverse Event|5|||
147492476|NCT00303108|531956905|FG001|Overall Study|Adverse Event|6|||
147492477|NCT00303108|531956906|FG002|Overall Study|Adverse Event|7|||
147492478|NCT00303108|531956904|FG000|Overall Study|Patient Request|4|||
147492479|NCT00303108|531956905|FG001|Overall Study|Patient Request|2|||
147492480|NCT00303108|531956906|FG002|Overall Study|Patient Request|8|||
147492481|NCT00303108|531956904|FG000|Overall Study|Failed Entry|1|||
147492482|NCT00303108|531956905|FG001|Overall Study|Failed Entry|0|||
147492483|NCT00303108|531956906|FG002|Overall Study|Failed Entry|1|||
147492484|NCT00303108|531956904|FG000|Overall Study|ineligible|2|||
147492485|NCT00303108|531956905|FG001|Overall Study|ineligible|1|||
147492486|NCT00303108|531956906|FG002|Overall Study|ineligible|0|||
147492487|NCT00894413|531956909|FG000|Overall Study|Physician Decision|0|||
147492488|NCT00894413|531956910|FG001|Overall Study|Physician Decision|2|||
147492489|NCT00894413|531956909|FG000|Overall Study|Adverse Event|0|||
147492490|NCT00894413|531956910|FG001|Overall Study|Adverse Event|2|||
147492491|NCT00894413|531956909|FG000|Overall Study|Withdrawal by Subject|0|||
147492492|NCT00894413|531956910|FG001|Overall Study|Withdrawal by Subject|4|||
147492493|NCT00471445|531956914|FG000|Overall Study|Withdrawal by Subject|1|||
147492494|NCT00471445|531956915|FG001|Overall Study|Withdrawal by Subject|1|||
147492495|NCT00471445|531956914|FG000|Overall Study|Ineligible|1|||
147492496|NCT00471445|531956915|FG001|Overall Study|Ineligible|0|||
147492497|NCT00471445|531956914|FG000|Overall Study|Protocol Violation|0|||
147492498|NCT00471445|531956915|FG001|Overall Study|Protocol Violation|1|||
147492499|NCT02427477|531956916|FG000|Period 1|Adverse Event|1|||
147492500|NCT02427477|531956917|FG001|Period 1|Adverse Event|0|||
147492501|NCT04715230|531956918|FG000|Overall Study|Withdrawal by Subject|1|||
147492502|NCT04715230|531956919|FG001|Overall Study|Withdrawal by Subject|0|||
147492503|NCT04715230|531956920|FG002|Overall Study|Withdrawal by Subject|0|||
147492504|NCT04715230|531956918|FG000|Overall Study|Lost to Follow-up|0|||
147492505|NCT04715230|531956919|FG001|Overall Study|Lost to Follow-up|5|||
147492506|NCT04715230|531956920|FG002|Overall Study|Lost to Follow-up|1|||
147492507|NCT01468909|531956928|FG000|Overall Study|Never Treated|2|||
147492508|NCT01468909|531956929|FG001|Overall Study|Never Treated|2|||
147492509|NCT00311181|531958873|FG000|Overall Study|Final DFTs were not obtained|96|||
147492510|NCT00506948|531958879|FG000|Overall Study|Death|4|||
147492511|NCT00506948|531958879|FG000|Overall Study|Adverse Event|5|||
147492512|NCT00506948|531958879|FG000|Overall Study|Physician Decision|1|||
147492513|NCT02395653|531958880|FG000|Overall Study|Exclusion Criteria Met at Screening|4|||
147492514|NCT02395653|531958880|FG000|Overall Study|Consent Withdrawn at Screening|1|||
147492515|NCT02395653|531958880|FG000|Overall Study|SSEC Application But With 0 Dose|1|||
147492516|NCT02395653|531958880|FG000|Overall Study|Investigator Decision at Screening|1|||
147492517|NCT02395653|531958880|FG000|Overall Study|Inclusion Criteria Not Met at Screening|3|||
147492518|NCT02395653|531958880|FG000|Overall Study|Withdrawal by Subject|1|||
147492519|NCT02395653|531958880|FG000|Overall Study|Lost to Follow-up|1|||
147492520|NCT00789958|531958883|FG000|Overall Study|Adverse Event|3|||
147492521|NCT00789958|531958883|FG000|Overall Study|Withdrawal by Subject|4|||
147492522|NCT00789958|531958883|FG000|Overall Study|Progression|3|||
147492523|NCT00789958|531958883|FG000|Overall Study|not protocol specified|1|||
147492524|NCT00789958|531958883|FG000|Overall Study|Not eligible/not analyzable|26|||
147492525|NCT02622724|531958886|FG000|Overall Study|Death|51|||
147492526|NCT02622724|531958887|FG001|Overall Study|Death|53|||
147492527|NCT02622724|531958886|FG000|Overall Study|Lost to Follow-UP, withdrawal of consent|4|||
147492528|NCT02622724|531958887|FG001|Overall Study|Lost to Follow-UP, withdrawal of consent|7|||
147492529|NCT02622724|531958886|FG000|Overall Study|Early termination of study|38|||
147492530|NCT02622724|531958887|FG001|Overall Study|Early termination of study|43|||
147492531|NCT00296725|531958888|FG000|Phase 1: Fluoxetine (1-12 Weeks)|Lost to Follow-up|1|||
147492532|NCT00296725|531958888|FG000|Phase 1: Fluoxetine (1-12 Weeks)|Adverse Event|4|||
147492533|NCT00296725|531958888|FG000|Phase 2: Imipramine (1-6 Weeks)|Lost to Follow-up|1|||
147492534|NCT00487084|531958889|FG000|Overall Study|Did not receive intervention|4|||
147492535|NCT00487084|531958890|FG001|Overall Study|Did not receive intervention|3|||
147492536|NCT00487084|531958891|FG002|Overall Study|Did not receive intervention|5|||
147492537|NCT00254293|531958892|FG000|Short Term (12 Week) Randomized Dosing|Adverse Event|0|||
147492538|NCT00254293|531958893|FG001|Short Term (12 Week) Randomized Dosing|Adverse Event|1|||
147492539|NCT00254293|531958894|FG002|Short Term (12 Week) Randomized Dosing|Adverse Event|0|||
147492540|NCT00254293|531958895|FG003|Short Term (12 Week) Randomized Dosing|Adverse Event|1|||
147492541|NCT00254293|531958896|FG004|Short Term (12 Week) Randomized Dosing|Adverse Event|0|||
147492542|NCT00254293|531958897|FG005|Short Term (12 Week) Randomized Dosing|Adverse Event|0|||
147492543|NCT00254293|531958898|FG006|Short Term (12 Week) Randomized Dosing|Adverse Event|0|||
147492544|NCT00254293|531958892|FG000|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
147492545|NCT00254293|531958893|FG001|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
147492546|NCT00254293|531958894|FG002|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|1|||
147492547|NCT00254293|531958895|FG003|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
147492548|NCT00254293|531958896|FG004|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
147492549|NCT00254293|531958897|FG005|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
147492550|NCT00254293|531958898|FG006|Short Term (12 Week) Randomized Dosing|Lost to Follow-up|0|||
147492551|NCT00254293|531958892|FG000|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
147492552|NCT00254293|531958893|FG001|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
147492553|NCT00254293|531958894|FG002|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|2|||
147492554|NCT00254293|531958895|FG003|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
147492555|NCT00254293|531958896|FG004|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
147492556|NCT00254293|531958897|FG005|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
147492557|NCT00254293|531958898|FG006|Short Term (12 Week) Randomized Dosing|poor/non-compliance by participant|0|||
147492558|NCT00254293|531958892|FG000|LTE Open Label Variable SC Dosing|Death|0|||
147492559|NCT00254293|531958893|FG001|LTE Open Label Variable SC Dosing|Death|0|||
147492560|NCT00254293|531958894|FG002|LTE Open Label Variable SC Dosing|Death|1|||
147492561|NCT00254293|531958895|FG003|LTE Open Label Variable SC Dosing|Death|0|||
147492562|NCT00254293|531958896|FG004|LTE Open Label Variable SC Dosing|Death|0|||
147492563|NCT00254293|531958897|FG005|LTE Open Label Variable SC Dosing|Death|0|||
147492564|NCT00254293|531958898|FG006|LTE Open Label Variable SC Dosing|Death|0|||
147492565|NCT00254293|531958892|FG000|LTE Open Label Variable SC Dosing|Adverse Event|1|||
147492566|NCT00254293|531958893|FG001|LTE Open Label Variable SC Dosing|Adverse Event|0|||
147492567|NCT00254293|531958894|FG002|LTE Open Label Variable SC Dosing|Adverse Event|2|||
147492568|NCT00254293|531958895|FG003|LTE Open Label Variable SC Dosing|Adverse Event|0|||
147492569|NCT00254293|531958896|FG004|LTE Open Label Variable SC Dosing|Adverse Event|1|||
147492570|NCT00254293|531958897|FG005|LTE Open Label Variable SC Dosing|Adverse Event|0|||
147492571|NCT00254293|531958898|FG006|LTE Open Label Variable SC Dosing|Adverse Event|0|||
147492572|NCT00254293|531958892|FG000|LTE Open Label Variable SC Dosing|Lack of Efficacy|2|||
147492573|NCT00254293|531958893|FG001|LTE Open Label Variable SC Dosing|Lack of Efficacy|0|||
147492574|NCT00254293|531958894|FG002|LTE Open Label Variable SC Dosing|Lack of Efficacy|2|||
147625947|NCT00463047|532447168|FG000|Titration Period 2|Protocol Violation|2|||
147625948|NCT00463047|532447169|FG001|Titration Period 2|Protocol Violation|3|||
147625949|NCT00463047|532447168|FG000|Titration Period 2|Lost to Follow-up|1|||
147625950|NCT00463047|532447169|FG001|Titration Period 2|Lost to Follow-up|2|||
147625951|NCT00463047|532447168|FG000|Titration Period 2|Non-compliance study medication|4|||
147625952|NCT00463047|532447169|FG001|Titration Period 2|Non-compliance study medication|2|||
147625953|NCT00463047|532447168|FG000|Titration Period 2|Non-compliance procedures|4|||
147625954|NCT00463047|532447169|FG001|Titration Period 2|Non-compliance procedures|1|||
147625955|NCT00463047|532447168|FG000|Titration Period 2|Other|3|||
147492575|NCT00254293|531958895|FG003|LTE Open Label Variable SC Dosing|Lack of Efficacy|0|||
147492576|NCT00254293|531958896|FG004|LTE Open Label Variable SC Dosing|Lack of Efficacy|1|||
147492577|NCT00254293|531958897|FG005|LTE Open Label Variable SC Dosing|Lack of Efficacy|0|||
147492578|NCT00254293|531958898|FG006|LTE Open Label Variable SC Dosing|Lack of Efficacy|0|||
147492579|NCT00254293|531958892|FG000|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
147492580|NCT00254293|531958893|FG001|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
147492581|NCT00254293|531958894|FG002|LTE Open Label Variable SC Dosing|Lost to Follow-up|1|||
147492582|NCT00254293|531958895|FG003|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
147492583|NCT00254293|531958896|FG004|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
147492584|NCT00254293|531958897|FG005|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
147492585|NCT00254293|531958898|FG006|LTE Open Label Variable SC Dosing|Lost to Follow-up|0|||
147492586|NCT00254293|531958892|FG000|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
147492587|NCT00254293|531958893|FG001|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
147492588|NCT00254293|531958894|FG002|LTE Open Label Variable SC Dosing|Withdrawal by Subject|1|||
147492589|NCT00254293|531958895|FG003|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
147492590|NCT00254293|531958896|FG004|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
147492591|NCT00254293|531958897|FG005|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
147492592|NCT00254293|531958898|FG006|LTE Open Label Variable SC Dosing|Withdrawal by Subject|0|||
147492593|NCT00254293|531958892|FG000|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
147492594|NCT00254293|531958893|FG001|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
147492595|NCT00254293|531958894|FG002|LTE Open Label Variable SC Dosing|Poor or non-compliance|1|||
147492596|NCT00254293|531958895|FG003|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
147492597|NCT00254293|531958896|FG004|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
147492598|NCT00254293|531958897|FG005|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
147492599|NCT00254293|531958898|FG006|LTE Open Label Variable SC Dosing|Poor or non-compliance|0|||
147492600|NCT00254293|531958892|FG000|LTE Open Label Variable SC Dosing|Other|0|||
147492601|NCT00254293|531958893|FG001|LTE Open Label Variable SC Dosing|Other|0|||
147492602|NCT00254293|531958894|FG002|LTE Open Label Variable SC Dosing|Other|2|||
147492603|NCT00254293|531958895|FG003|LTE Open Label Variable SC Dosing|Other|0|||
147492604|NCT00254293|531958896|FG004|LTE Open Label Variable SC Dosing|Other|0|||
147492605|NCT00254293|531958897|FG005|LTE Open Label Variable SC Dosing|Other|0|||
147492606|NCT00254293|531958898|FG006|LTE Open Label Variable SC Dosing|Other|0|||
147492607|NCT00254293|531958892|FG000|LTE Open Label Fixed Dosing|Death|0|||
147492608|NCT00254293|531958893|FG001|LTE Open Label Fixed Dosing|Death|0|||
147492609|NCT00254293|531958894|FG002|LTE Open Label Fixed Dosing|Death|0|||
147492610|NCT00254293|531958895|FG003|LTE Open Label Fixed Dosing|Death|0|||
147492611|NCT00254293|531958896|FG004|LTE Open Label Fixed Dosing|Death|0|||
147492612|NCT00254293|531958897|FG005|LTE Open Label Fixed Dosing|Death|0|||
147492613|NCT00254293|531958898|FG006|LTE Open Label Fixed Dosing|Death|3|||
147492614|NCT00254293|531958892|FG000|LTE Open Label Fixed Dosing|Adverse Event|0|||
147492615|NCT00254293|531958893|FG001|LTE Open Label Fixed Dosing|Adverse Event|0|||
147492616|NCT00254293|531958894|FG002|LTE Open Label Fixed Dosing|Adverse Event|0|||
147492617|NCT00254293|531958895|FG003|LTE Open Label Fixed Dosing|Adverse Event|0|||
147492618|NCT00254293|531958896|FG004|LTE Open Label Fixed Dosing|Adverse Event|0|||
147492619|NCT00254293|531958897|FG005|LTE Open Label Fixed Dosing|Adverse Event|0|||
147492620|NCT00254293|531958898|FG006|LTE Open Label Fixed Dosing|Adverse Event|1|||
147492621|NCT00254293|531958892|FG000|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
147492622|NCT00254293|531958893|FG001|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
147492623|NCT00254293|531958894|FG002|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
147492624|NCT00254293|531958895|FG003|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
147492625|NCT00254293|531958896|FG004|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
147492626|NCT00254293|531958897|FG005|LTE Open Label Fixed Dosing|Lack of Efficacy|0|||
147492627|NCT00254293|531958898|FG006|LTE Open Label Fixed Dosing|Lack of Efficacy|3|||
147492628|NCT00254293|531958892|FG000|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
147492629|NCT00254293|531958893|FG001|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
147492630|NCT00254293|531958894|FG002|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
147492631|NCT00254293|531958895|FG003|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
147492632|NCT00254293|531958896|FG004|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
147492633|NCT00254293|531958897|FG005|LTE Open Label Fixed Dosing|Lost to Follow-up|0|||
147492634|NCT00254293|531958898|FG006|LTE Open Label Fixed Dosing|Lost to Follow-up|1|||
147492635|NCT00254293|531958892|FG000|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
147492636|NCT00254293|531958893|FG001|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
147492637|NCT00254293|531958894|FG002|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
147492638|NCT00254293|531958895|FG003|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
147492639|NCT00254293|531958896|FG004|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
147492640|NCT00254293|531958897|FG005|LTE Open Label Fixed Dosing|Withdrawal by Subject|0|||
147492641|NCT00254293|531958898|FG006|LTE Open Label Fixed Dosing|Withdrawal by Subject|3|||
147492642|NCT00254293|531958892|FG000|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
147492643|NCT00254293|531958893|FG001|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
147492644|NCT00254293|531958894|FG002|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
147492645|NCT00254293|531958895|FG003|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
147492646|NCT00254293|531958896|FG004|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
147492647|NCT00254293|531958897|FG005|LTE Open Label Fixed Dosing|Poor or non-compliance|0|||
147492648|NCT00254293|531958898|FG006|LTE Open Label Fixed Dosing|Poor or non-compliance|1|||
147492649|NCT00254293|531958892|FG000|LTE Open Label Fixed Dosing|Other|0|||
147492650|NCT00254293|531958893|FG001|LTE Open Label Fixed Dosing|Other|0|||
147492651|NCT00254293|531958894|FG002|LTE Open Label Fixed Dosing|Other|0|||
147492652|NCT00254293|531958895|FG003|LTE Open Label Fixed Dosing|Other|0|||
147492653|NCT00254293|531958896|FG004|LTE Open Label Fixed Dosing|Other|0|||
147492654|NCT00254293|531958897|FG005|LTE Open Label Fixed Dosing|Other|0|||
147492655|NCT00254293|531958898|FG006|LTE Open Label Fixed Dosing|Other|1|||
147492656|NCT01000727|531958904|FG000|Overall Study|Lost to Follow-up|41|||
147492657|NCT01000727|531958905|FG001|Overall Study|Lost to Follow-up|43|||
147492658|NCT01000727|531958904|FG000|Overall Study|Withdrawal by Subject|111|||
147492659|NCT01000727|531958905|FG001|Overall Study|Withdrawal by Subject|109|||
147492660|NCT01000727|531958904|FG000|Overall Study|Study closed/terminated|23|||
147492661|NCT01000727|531958905|FG001|Overall Study|Study closed/terminated|24|||
147492662|NCT03137121|531958906|FG000|Overall Study|Withdrawal by Subject|0|||
147492663|NCT03137121|531958907|FG001|Overall Study|Withdrawal by Subject|1|||
147492664|NCT03196193|531958908|FG000|Overall Study|Adverse Event|1|||
147492665|NCT03196193|531958909|FG001|Overall Study|Adverse Event|0|||
147492666|NCT03196193|531958908|FG000|Overall Study|Computed Tomography (CT) data missing|2|||
147492667|NCT03196193|531958909|FG001|Overall Study|Computed Tomography (CT) data missing|0|||
147492668|NCT02709083|531958912|FG000|Overall Study|Original PI left institution|7|||
147492669|NCT01697267|531958917|FG000|Overall Study|Death|3|||
147492670|NCT01697267|531958918|FG001|Overall Study|Death|1|||
147492671|NCT01697267|531958917|FG000|Overall Study|Withdrawal by Subject|5|||
147492672|NCT01697267|531958918|FG001|Overall Study|Withdrawal by Subject|5|||
147492673|NCT01697267|531958917|FG000|Overall Study|Adverse Event|2|||
147492674|NCT01697267|531958918|FG001|Overall Study|Adverse Event|1|||
147492675|NCT01697267|531958917|FG000|Overall Study|Lost to Follow-up|2|||
147492676|NCT01697267|531958918|FG001|Overall Study|Lost to Follow-up|4|||
147492677|NCT01697267|531958917|FG000|Overall Study|Physician Decision|2|||
147492678|NCT01697267|531958918|FG001|Overall Study|Physician Decision|4|||
147492679|NCT04410198|531958919|FG000|Overall Study|Death|10|||
147492680|NCT04410198|531958919|FG000|Overall Study|Withdrawal by Subject|7|||
147492681|NCT04410198|531958919|FG000|Overall Study|Transferred/Relocation|4|||
147492682|NCT04410198|531958919|FG000|Overall Study|Kidney Transplant|9|||
147492683|NCT04410198|531958919|FG000|Overall Study|Adverse Event|4|||
147492684|NCT04410198|531958919|FG000|Overall Study|Physician Decision|2|||
147492685|NCT04410198|531958919|FG000|Overall Study|Other than specified|1|||
147492686|NCT02939937|531958920|FG000|Overall Study|Adverse Event|5|||
147492687|NCT02939937|531958921|FG001|Overall Study|Adverse Event|0|||
147492688|NCT02939937|531958920|FG000|Overall Study|Lost to Follow-up|1|||
147492689|NCT02939937|531958921|FG001|Overall Study|Lost to Follow-up|3|||
147492690|NCT00120289|531958931|FG000|Overall Study|Death|96|||
147492691|NCT00120289|531958932|FG001|Overall Study|Death|82|||
147492692|NCT00120289|531958931|FG000|Overall Study|Lost to Follow-up|11|||
147492693|NCT00120289|531958932|FG001|Overall Study|Lost to Follow-up|14|||
147492694|NCT00120289|531958931|FG000|Overall Study|Withdrawal by Subject|14|||
147492695|NCT00120289|531958932|FG001|Overall Study|Withdrawal by Subject|13|||
147492696|NCT00782418|531958934|FG000|Period 1 Procedure/Treatment Groups|Adverse Event|1|||
147492697|NCT00782418|531958935|FG001|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
147492698|NCT00782418|531958936|FG002|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
147492699|NCT00782418|531958937|FG003|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
147492700|NCT00782418|531958938|FG004|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
147492701|NCT00782418|531958939|FG005|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
147492702|NCT00782418|531958940|FG006|Period 1 Procedure/Treatment Groups|Adverse Event|0|||
147492703|NCT00782418|531958934|FG000|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|1|||
147492704|NCT00782418|531958935|FG001|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0|||
147492705|NCT00782418|531958936|FG002|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0|||
147492706|NCT00782418|531958937|FG003|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0|||
147492707|NCT00782418|531958938|FG004|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|1|||
147492708|NCT00782418|531958939|FG005|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|1|||
147492709|NCT00782418|531958940|FG006|Period 1 Procedure/Treatment Groups|Study placed on temporary hold|0|||
147492710|NCT00882999|531958941|FG000|Overall Study|Adverse Event|0|||
147492711|NCT00882999|531958942|FG001|Overall Study|Adverse Event|0|||
147492712|NCT00882999|531958943|FG002|Overall Study|Adverse Event|0|||
147492713|NCT00882999|531958944|FG003|Overall Study|Adverse Event|0|||
147492714|NCT00882999|531958945|FG004|Overall Study|Adverse Event|1|||
147492715|NCT00882999|531958946|FG005|Overall Study|Adverse Event|0|||
147492716|NCT00882999|531958947|FG006|Overall Study|Adverse Event|0|||
147492717|NCT00882999|531958941|FG000|Overall Study|Death|0|||
147492718|NCT00882999|531958942|FG001|Overall Study|Death|1|||
147492719|NCT00882999|531958943|FG002|Overall Study|Death|0|||
147492720|NCT00882999|531958944|FG003|Overall Study|Death|0|||
147492721|NCT00882999|531958945|FG004|Overall Study|Death|0|||
147492722|NCT00882999|531958946|FG005|Overall Study|Death|0|||
147492723|NCT00882999|531958947|FG006|Overall Study|Death|0|||
147492724|NCT00882999|531958941|FG000|Overall Study|Withdrawal by Subject|7|||
147492725|NCT00882999|531958942|FG001|Overall Study|Withdrawal by Subject|6|||
147492726|NCT00882999|531958943|FG002|Overall Study|Withdrawal by Subject|3|||
147492727|NCT00882999|531958944|FG003|Overall Study|Withdrawal by Subject|3|||
147492728|NCT00882999|531958945|FG004|Overall Study|Withdrawal by Subject|6|||
147492729|NCT00882999|531958946|FG005|Overall Study|Withdrawal by Subject|5|||
147492730|NCT00882999|531958947|FG006|Overall Study|Withdrawal by Subject|5|||
147492731|NCT00882999|531958941|FG000|Overall Study|Lost to Follow-up|0|||
147492732|NCT00882999|531958942|FG001|Overall Study|Lost to Follow-up|1|||
147492733|NCT00882999|531958943|FG002|Overall Study|Lost to Follow-up|1|||
147492734|NCT00882999|531958944|FG003|Overall Study|Lost to Follow-up|2|||
147492735|NCT00882999|531958945|FG004|Overall Study|Lost to Follow-up|1|||
147492736|NCT00882999|531958946|FG005|Overall Study|Lost to Follow-up|1|||
147492737|NCT00882999|531958947|FG006|Overall Study|Lost to Follow-up|2|||
147492738|NCT00882999|531958941|FG000|Overall Study|Physician Decision|1|||
147492739|NCT00882999|531958942|FG001|Overall Study|Physician Decision|0|||
147492740|NCT00882999|531958943|FG002|Overall Study|Physician Decision|0|||
147492741|NCT00882999|531958944|FG003|Overall Study|Physician Decision|0|||
147492742|NCT00882999|531958945|FG004|Overall Study|Physician Decision|0|||
147492743|NCT00882999|531958946|FG005|Overall Study|Physician Decision|1|||
147492744|NCT00882999|531958947|FG006|Overall Study|Physician Decision|1|||
147492745|NCT01757405|531958948|FG000|Overall Study|Lost to Follow-up|1|||
147492746|NCT01757405|531958949|FG001|Overall Study|Lost to Follow-up|1|||
147492747|NCT01757405|531958948|FG000|Overall Study|Withdrawal by Subject|0|||
147492748|NCT01757405|531958949|FG001|Overall Study|Withdrawal by Subject|1|||
147492749|NCT00082758|531958951|FG000|Overall Study|Adverse Event|0|||
147492750|NCT00082758|531958952|FG001|Overall Study|Adverse Event|2|||
147492751|NCT00082758|531958953|FG002|Overall Study|Adverse Event|0|||
147492752|NCT00082758|531958951|FG000|Overall Study|Lack of Efficacy|12|||
147492753|NCT00082758|531958952|FG001|Overall Study|Lack of Efficacy|13|||
147492754|NCT00082758|531958953|FG002|Overall Study|Lack of Efficacy|0|||
147492755|NCT00082758|531958951|FG000|Overall Study|Physician Decision|0|||
147492756|NCT00082758|531958952|FG001|Overall Study|Physician Decision|1|||
147492757|NCT00082758|531958953|FG002|Overall Study|Physician Decision|0|||
147492758|NCT00082758|531958951|FG000|Overall Study|Withdrawal by Subject|3|||
147492759|NCT00082758|531958952|FG001|Overall Study|Withdrawal by Subject|0|||
147492760|NCT00082758|531958953|FG002|Overall Study|Withdrawal by Subject|0|||
147492761|NCT00082758|531958951|FG000|Overall Study|Protocol Violation|0|||
147492762|NCT00082758|531958952|FG001|Overall Study|Protocol Violation|1|||
147492763|NCT00082758|531958953|FG002|Overall Study|Protocol Violation|0|||
147492764|NCT00238303|531958954|FG000|Overall Study|Withdrawal by Subject|11|||
147492765|NCT00238303|531958955|FG001|Overall Study|Withdrawal by Subject|1|||
147492766|NCT00238303|531958956|FG002|Overall Study|Withdrawal by Subject|2|||
147492767|NCT00238303|531958954|FG000|Overall Study|Death|1|||
147492768|NCT00238303|531958955|FG001|Overall Study|Death|0|||
147492769|NCT00238303|531958956|FG002|Overall Study|Death|1|||
147492770|NCT00238303|531958954|FG000|Overall Study|Other Medical Problems|2|||
147492771|NCT00238303|531958955|FG001|Overall Study|Other Medical Problems|0|||
147492772|NCT00238303|531958956|FG002|Overall Study|Other Medical Problems|2|||
147492773|NCT00238303|531958954|FG000|Overall Study|Poor tolerance of study treatment|1|||
147492774|NCT00238303|531958955|FG001|Overall Study|Poor tolerance of study treatment|0|||
147492775|NCT00238303|531958956|FG002|Overall Study|Poor tolerance of study treatment|1|||
147492776|NCT00238303|531958954|FG000|Overall Study|Adverse Event|0|||
147492777|NCT00238303|531958955|FG001|Overall Study|Adverse Event|1|||
147492778|NCT00238303|531958956|FG002|Overall Study|Adverse Event|3|||
147492779|NCT00937560|531958958|FG000|Initial Treatment|Death|6|||
147492780|NCT00937560|531958958|FG000|Initial Treatment|Withdraw consent|3|||
147492781|NCT00937560|531958958|FG000|Initial Treatment|Adverse Event|1|||
147492782|NCT00937560|531958958|FG000|Initial Treatment|Lost to Follow-up|1|||
147492783|NCT00937560|531958958|FG000|Initial Treatment|No end of study page|10|||
147492784|NCT00937560|531958958|FG000|Maintenance Treatment|Death|12|||
147492785|NCT00937560|531958958|FG000|Maintenance Treatment|Withdraw consent|5|||
147492786|NCT00937560|531958958|FG000|Maintenance Treatment|According to protocol|1|||
147625956|NCT00463047|532447169|FG001|Titration Period 2|Other|2|||
147668087|NCT01200329|532609865|FG000|Overall Study|Progressive disease|1|||
147492787|NCT00501046|531958963|FG000|Overall Study|Adverse Event|21|||
147492788|NCT00501046|531958964|FG001|Overall Study|Adverse Event|25|||
147492789|NCT00501046|531958963|FG000|Overall Study|Death|23|||
147492790|NCT00501046|531958964|FG001|Overall Study|Death|30|||
147492791|NCT00501046|531958963|FG000|Overall Study|Lost to Follow-up|14|||
147492792|NCT00501046|531958964|FG001|Overall Study|Lost to Follow-up|13|||
147492793|NCT00501046|531958963|FG000|Overall Study|Physician Decision|7|||
147492794|NCT00501046|531958964|FG001|Overall Study|Physician Decision|2|||
147492795|NCT00501046|531958963|FG000|Overall Study|Pregnancy|0|||
147492796|NCT00501046|531958964|FG001|Overall Study|Pregnancy|3|||
147492797|NCT00501046|531958963|FG000|Overall Study|Protocol Violation|2|||
147492798|NCT00501046|531958964|FG001|Overall Study|Protocol Violation|1|||
147492799|NCT00501046|531958963|FG000|Overall Study|Withdrawal by Subject|84|||
147492800|NCT00501046|531958964|FG001|Overall Study|Withdrawal by Subject|83|||
147492801|NCT00501046|531958963|FG000|Overall Study|Reaching endpoints,Noncompliance,etc|119|||
147492802|NCT00501046|531958964|FG001|Overall Study|Reaching endpoints,Noncompliance,etc|137|||
147492803|NCT01576016|531958968|FG000|Lead Safety|Death|132|||
147492804|NCT01576016|531958969|FG001|Lead Safety|Death|0|||
147492805|NCT01576016|531958968|FG000|Lead Safety|Withdrawal by Subject|81|||
147492806|NCT01576016|531958969|FG001|Lead Safety|Withdrawal by Subject|0|||
147492807|NCT01576016|531958968|FG000|Lead Safety|System Explanted without Replacement|24|||
147492808|NCT01576016|531958969|FG001|Lead Safety|System Explanted without Replacement|0|||
147492809|NCT01576016|531958968|FG000|Lead Safety|Physician Decision|14|||
147492810|NCT01576016|531958969|FG001|Lead Safety|Physician Decision|0|||
147492811|NCT01576016|531958968|FG000|Lead Safety|Lost to Follow-up|13|||
147492812|NCT01576016|531958969|FG001|Lead Safety|Lost to Follow-up|0|||
147492813|NCT01576016|531958968|FG000|Lead Safety|Unsuccessful implant|2|||
147492814|NCT01576016|531958969|FG001|Lead Safety|Unsuccessful implant|0|||
147492815|NCT01576016|531958968|FG000|Lead Safety|Sponsor request|1|||
147492816|NCT01576016|531958969|FG001|Lead Safety|Sponsor request|0|||
147492817|NCT01576016|531958968|FG000|Lead Safety|Device replaced with CRT-D|1|||
147492818|NCT01576016|531958969|FG001|Lead Safety|Device replaced with CRT-D|0|||
147492819|NCT01576016|531958968|FG000|Lead Safety|Patient on Palliative Care|1|||
147492820|NCT01576016|531958969|FG001|Lead Safety|Patient on Palliative Care|0|||
147492821|NCT01576016|531958968|FG000|Lead Safety|Patient noncompliance|1|||
147492822|NCT01576016|531958969|FG001|Lead Safety|Patient noncompliance|0|||
147492823|NCT01576016|531958968|FG000|Lead Safety|Too far from study site|1|||
147492824|NCT01576016|531958969|FG001|Lead Safety|Too far from study site|0|||
147492825|NCT01576016|531958968|FG000|Lead Safety|System deactivated|1|||
147492826|NCT01576016|531958969|FG001|Lead Safety|System deactivated|0|||
147492827|NCT01576016|531958968|FG000|Lead Safety|Patient no longer followed by study PI|1|||
147492828|NCT01576016|531958969|FG001|Lead Safety|Patient no longer followed by study PI|0|||
147492829|NCT01576016|531958968|FG000|MRI Safety|Withdrawal by Subject|0|||
147492830|NCT01576016|531958969|FG001|MRI Safety|Withdrawal by Subject|10|||
147492831|NCT01576016|531958968|FG000|MRI Safety|Non-MRI Compatible Device or Material|0|||
147492832|NCT01576016|531958969|FG001|MRI Safety|Non-MRI Compatible Device or Material|5|||
147492833|NCT01576016|531958968|FG000|MRI Safety|Has not yet completed MRI scan|0|||
147492834|NCT01576016|531958969|FG001|MRI Safety|Has not yet completed MRI scan|56|||
147492835|NCT01576016|531958968|FG000|MRI Safety|MRI scan not performed at MRI visit|0|||
147492836|NCT01576016|531958969|FG001|MRI Safety|MRI scan not performed at MRI visit|3|||
147492837|NCT04507867|531958973|FG000|Overall Study|Death|7|||
147492838|NCT04507867|531958974|FG001|Overall Study|Death|1|||
147492839|NCT01860534|531958975|FG000|ROP #1|Needed treatment for ROP|0|||
147492840|NCT01860534|531958976|FG001|ROP #1|Needed treatment for ROP|1|||
147492841|NCT01860534|531958975|FG000|ROP #2|discharged prior to ROP #2|1|||
147492842|NCT01860534|531958976|FG001|ROP #2|discharged prior to ROP #2|0|||
147492843|NCT02175771|531958982|FG000|Run-In Period (Pre-assignment)|Randomization criteria not met|23|||
147492844|NCT02175771|531958983|FG001|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
147492845|NCT02175771|531958984|FG002|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
147492846|NCT02175771|531958985|FG003|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
147492847|NCT02175771|531958986|FG004|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
147492848|NCT02175771|531958987|FG005|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
147492849|NCT02175771|531958988|FG006|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
147492850|NCT02175771|531958989|FG007|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
147492851|NCT02175771|531958990|FG008|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
147492852|NCT02175771|531958982|FG000|Run-In Period (Pre-assignment)|Exclusion criteria met|20|||
147492853|NCT02175771|531958983|FG001|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
147492854|NCT02175771|531958984|FG002|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
147492855|NCT02175771|531958985|FG003|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
147492856|NCT02175771|531958986|FG004|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
147492857|NCT02175771|531958987|FG005|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
147492858|NCT02175771|531958988|FG006|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
147492859|NCT02175771|531958989|FG007|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
147492860|NCT02175771|531958990|FG008|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
147492861|NCT02175771|531958982|FG000|Run-In Period (Pre-assignment)|Withdrawal by Subject|11|||
147492862|NCT02175771|531958983|FG001|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
147492863|NCT02175771|531958984|FG002|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
147492864|NCT02175771|531958985|FG003|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
147492865|NCT02175771|531958986|FG004|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
147492866|NCT02175771|531958987|FG005|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
147492867|NCT02175771|531958988|FG006|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
147668088|NCT02404545|532609868|FG000|Overall Study|Sponsor Termination|6|||
147492868|NCT02175771|531958989|FG007|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
147492869|NCT02175771|531958990|FG008|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
147492870|NCT02175771|531958982|FG000|Run-In Period (Pre-assignment)|Adverse Event|9|||
147492871|NCT02175771|531958983|FG001|Run-In Period (Pre-assignment)|Adverse Event|0|||
147492872|NCT02175771|531958984|FG002|Run-In Period (Pre-assignment)|Adverse Event|0|||
147492873|NCT02175771|531958985|FG003|Run-In Period (Pre-assignment)|Adverse Event|0|||
147492874|NCT02175771|531958986|FG004|Run-In Period (Pre-assignment)|Adverse Event|0|||
147492875|NCT02175771|531958987|FG005|Run-In Period (Pre-assignment)|Adverse Event|0|||
147492876|NCT02175771|531958988|FG006|Run-In Period (Pre-assignment)|Adverse Event|0|||
147492877|NCT02175771|531958989|FG007|Run-In Period (Pre-assignment)|Adverse Event|0|||
147492878|NCT02175771|531958990|FG008|Run-In Period (Pre-assignment)|Adverse Event|0|||
147492879|NCT02175771|531958982|FG000|Run-In Period (Pre-assignment)|Inclusion criteria not met|7|||
147492880|NCT02175771|531958983|FG001|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
147492881|NCT02175771|531958984|FG002|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
147492882|NCT02175771|531958985|FG003|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
147492883|NCT02175771|531958986|FG004|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
147492884|NCT02175771|531958987|FG005|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
147492885|NCT02175771|531958988|FG006|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
147492886|NCT02175771|531958989|FG007|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
147492887|NCT02175771|531958990|FG008|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
147492888|NCT02175771|531958982|FG000|Run-In Period (Pre-assignment)|Lost to Follow-up|6|||
147492889|NCT02175771|531958983|FG001|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
147492890|NCT02175771|531958984|FG002|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
147492891|NCT02175771|531958985|FG003|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
147492892|NCT02175771|531958986|FG004|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
147492893|NCT02175771|531958987|FG005|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
147492894|NCT02175771|531958988|FG006|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
147492895|NCT02175771|531958989|FG007|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
147492896|NCT02175771|531958990|FG008|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
147492897|NCT02175771|531958982|FG000|Run-In Period (Pre-assignment)|Other|8|||
147492898|NCT02175771|531958983|FG001|Run-In Period (Pre-assignment)|Other|0|||
147492899|NCT02175771|531958984|FG002|Run-In Period (Pre-assignment)|Other|0|||
147492900|NCT02175771|531958985|FG003|Run-In Period (Pre-assignment)|Other|0|||
147492901|NCT02175771|531958986|FG004|Run-In Period (Pre-assignment)|Other|0|||
147492902|NCT02175771|531958987|FG005|Run-In Period (Pre-assignment)|Other|0|||
147492903|NCT02175771|531958988|FG006|Run-In Period (Pre-assignment)|Other|0|||
147492904|NCT02175771|531958989|FG007|Run-In Period (Pre-assignment)|Other|0|||
147492905|NCT02175771|531958990|FG008|Run-In Period (Pre-assignment)|Other|0|||
147492906|NCT02175771|531958982|FG000|Treatment Period|Adverse Event|0|||
147492907|NCT02175771|531958983|FG001|Treatment Period|Adverse Event|2|||
147492908|NCT02175771|531958984|FG002|Treatment Period|Adverse Event|1|||
147492909|NCT02175771|531958985|FG003|Treatment Period|Adverse Event|1|||
147492910|NCT02175771|531958986|FG004|Treatment Period|Adverse Event|1|||
147492911|NCT02175771|531958987|FG005|Treatment Period|Adverse Event|3|||
147492912|NCT02175771|531958988|FG006|Treatment Period|Adverse Event|2|||
147492913|NCT02175771|531958989|FG007|Treatment Period|Adverse Event|0|||
147492914|NCT02175771|531958990|FG008|Treatment Period|Adverse Event|1|||
147492915|NCT02175771|531958982|FG000|Treatment Period|Withdrawal by Subject|0|||
147492916|NCT02175771|531958983|FG001|Treatment Period|Withdrawal by Subject|9|||
147492917|NCT02175771|531958984|FG002|Treatment Period|Withdrawal by Subject|3|||
147492918|NCT02175771|531958985|FG003|Treatment Period|Withdrawal by Subject|6|||
147492919|NCT02175771|531958986|FG004|Treatment Period|Withdrawal by Subject|2|||
147492920|NCT02175771|531958987|FG005|Treatment Period|Withdrawal by Subject|4|||
147492921|NCT02175771|531958988|FG006|Treatment Period|Withdrawal by Subject|2|||
147492922|NCT02175771|531958989|FG007|Treatment Period|Withdrawal by Subject|9|||
147492923|NCT02175771|531958990|FG008|Treatment Period|Withdrawal by Subject|2|||
147492924|NCT02175771|531958982|FG000|Treatment Period|Noncompliance|0|||
147492925|NCT02175771|531958983|FG001|Treatment Period|Noncompliance|1|||
147492926|NCT02175771|531958984|FG002|Treatment Period|Noncompliance|2|||
147492927|NCT02175771|531958985|FG003|Treatment Period|Noncompliance|0|||
147492928|NCT02175771|531958986|FG004|Treatment Period|Noncompliance|0|||
147492929|NCT02175771|531958987|FG005|Treatment Period|Noncompliance|0|||
147492930|NCT02175771|531958988|FG006|Treatment Period|Noncompliance|0|||
147492931|NCT02175771|531958989|FG007|Treatment Period|Noncompliance|0|||
147492932|NCT02175771|531958990|FG008|Treatment Period|Noncompliance|1|||
147492933|NCT02175771|531958982|FG000|Treatment Period|Protocol Violation|0|||
147492934|NCT02175771|531958983|FG001|Treatment Period|Protocol Violation|0|||
147492935|NCT02175771|531958984|FG002|Treatment Period|Protocol Violation|0|||
147492936|NCT02175771|531958985|FG003|Treatment Period|Protocol Violation|0|||
147492937|NCT02175771|531958986|FG004|Treatment Period|Protocol Violation|0|||
147492938|NCT02175771|531958987|FG005|Treatment Period|Protocol Violation|0|||
147492939|NCT02175771|531958988|FG006|Treatment Period|Protocol Violation|0|||
147492940|NCT02175771|531958989|FG007|Treatment Period|Protocol Violation|1|||
147492941|NCT02175771|531958990|FG008|Treatment Period|Protocol Violation|0|||
147492942|NCT02175771|531958982|FG000|Treatment Period|Disease progression|0|||
147492943|NCT02175771|531958983|FG001|Treatment Period|Disease progression|0|||
147492944|NCT02175771|531958984|FG002|Treatment Period|Disease progression|0|||
147492945|NCT02175771|531958985|FG003|Treatment Period|Disease progression|0|||
147492946|NCT02175771|531958986|FG004|Treatment Period|Disease progression|0|||
147492947|NCT02175771|531958987|FG005|Treatment Period|Disease progression|0|||
147492948|NCT02175771|531958988|FG006|Treatment Period|Disease progression|0|||
147492949|NCT02175771|531958989|FG007|Treatment Period|Disease progression|2|||
147492950|NCT02175771|531958990|FG008|Treatment Period|Disease progression|0|||
147492951|NCT02175771|531958982|FG000|Treatment Period|Lost to Follow-up|0|||
147492952|NCT02175771|531958983|FG001|Treatment Period|Lost to Follow-up|3|||
147492953|NCT02175771|531958984|FG002|Treatment Period|Lost to Follow-up|1|||
147492954|NCT02175771|531958985|FG003|Treatment Period|Lost to Follow-up|3|||
147492955|NCT02175771|531958986|FG004|Treatment Period|Lost to Follow-up|1|||
147492956|NCT02175771|531958987|FG005|Treatment Period|Lost to Follow-up|2|||
147492957|NCT02175771|531958988|FG006|Treatment Period|Lost to Follow-up|1|||
147492958|NCT02175771|531958989|FG007|Treatment Period|Lost to Follow-up|2|||
147492959|NCT02175771|531958990|FG008|Treatment Period|Lost to Follow-up|2|||
147492960|NCT02175771|531958982|FG000|Treatment Period|Lack of Efficacy|0|||
147492961|NCT02175771|531958983|FG001|Treatment Period|Lack of Efficacy|0|||
147492962|NCT02175771|531958984|FG002|Treatment Period|Lack of Efficacy|0|||
147492963|NCT02175771|531958985|FG003|Treatment Period|Lack of Efficacy|0|||
147492964|NCT02175771|531958986|FG004|Treatment Period|Lack of Efficacy|0|||
147492965|NCT02175771|531958987|FG005|Treatment Period|Lack of Efficacy|1|||
147492966|NCT02175771|531958988|FG006|Treatment Period|Lack of Efficacy|0|||
147492967|NCT02175771|531958989|FG007|Treatment Period|Lack of Efficacy|1|||
147492968|NCT02175771|531958990|FG008|Treatment Period|Lack of Efficacy|0|||
147492969|NCT02175771|531958982|FG000|Treatment Period|Other|0|||
147492970|NCT02175771|531958983|FG001|Treatment Period|Other|1|||
147492971|NCT02175771|531958984|FG002|Treatment Period|Other|0|||
147492972|NCT02175771|531958985|FG003|Treatment Period|Other|3|||
147492973|NCT02175771|531958986|FG004|Treatment Period|Other|1|||
147492974|NCT02175771|531958987|FG005|Treatment Period|Other|0|||
147492975|NCT02175771|531958988|FG006|Treatment Period|Other|0|||
147492976|NCT02175771|531958989|FG007|Treatment Period|Other|2|||
147492977|NCT02175771|531958990|FG008|Treatment Period|Other|0|||
147492978|NCT03364673|531958991|FG000|Overall Study|Withdrawal by Subject|2|||
147492979|NCT03364673|531958991|FG000|Overall Study|Injury unrelated to study|3|||
147492980|NCT02208024|531958992|FG000|Overall Study|Withdrawal by Subject|1|||
147492981|NCT00779324|531958993|FG000|Overall Study|Lost to Follow-up|2|||
147492982|NCT00779324|531958994|FG001|Overall Study|Lost to Follow-up|1|||
147492983|NCT00779324|531958993|FG000|Overall Study|Withdrawal by Subject|4|||
147492984|NCT00779324|531958994|FG001|Overall Study|Withdrawal by Subject|2|||
147492985|NCT00779324|531958993|FG000|Overall Study|Missed visit|1|||
147492986|NCT00779324|531958994|FG001|Overall Study|Missed visit|1|||
147492987|NCT02207556|531958995|FG000|Overall Study|Physician Decision|1|||
147492988|NCT02207556|531958996|FG001|Overall Study|Physician Decision|0|||
147492989|NCT02207556|531958995|FG000|Overall Study|Withdrawal by Subject|1|||
147492990|NCT02207556|531958996|FG001|Overall Study|Withdrawal by Subject|0|||
147492991|NCT02207556|531958995|FG000|Overall Study|Death|0|||
147492992|NCT02207556|531958996|FG001|Overall Study|Death|5|||
147492993|NCT03558555|531958997|FG000|Overall Study|Lost to Follow-up|2|||
147492994|NCT03558555|531958998|FG001|Overall Study|Lost to Follow-up|1|||
147492995|NCT00194025|531958999|FG000|Overall Study|Adverse Event|1|||
147492996|NCT00194025|531958999|FG000|Overall Study|non-adherence with study medication|4|||
147492997|NCT00543569|531959000|FG000|Overall Study|Death|2|||
147492998|NCT00543569|531959001|FG001|Overall Study|Death|2|||
147492999|NCT00543569|531959002|FG002|Overall Study|Death|3|||
147493000|NCT00543569|531959003|FG003|Overall Study|Death|1|||
147493001|NCT00543569|531959000|FG000|Overall Study|Lost to Follow-up|0|||
147493002|NCT00543569|531959001|FG001|Overall Study|Lost to Follow-up|0|||
147493003|NCT00543569|531959002|FG002|Overall Study|Lost to Follow-up|1|||
147493004|NCT00543569|531959003|FG003|Overall Study|Lost to Follow-up|1|||
147493005|NCT00543569|531959000|FG000|Overall Study|Miscellaneous Reasons|7|||
147493006|NCT00543569|531959001|FG001|Overall Study|Miscellaneous Reasons|3|||
147493007|NCT00543569|531959002|FG002|Overall Study|Miscellaneous Reasons|11|||
147493008|NCT00543569|531959003|FG003|Overall Study|Miscellaneous Reasons|4|||
147493009|NCT00543569|531959000|FG000|Overall Study|Randomized but never received study drug|3|||
147493010|NCT00543569|531959001|FG001|Overall Study|Randomized but never received study drug|3|||
147493011|NCT00543569|531959002|FG002|Overall Study|Randomized but never received study drug|5|||
147493012|NCT00543569|531959003|FG003|Overall Study|Randomized but never received study drug|3|||
147493013|NCT00862849|531959004|FG000|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0|||
147493014|NCT00862849|531959005|FG001|Washout 1 (3 to 14 Days)|Withdrawal by Subject|1|||
147493015|NCT00862849|531959006|FG002|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0|||
147493016|NCT00862849|531959007|FG003|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0|||
147493017|NCT00862849|531959008|FG004|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0|||
147493018|NCT00862849|531959009|FG005|Washout 1 (3 to 14 Days)|Withdrawal by Subject|0|||
147493019|NCT00862849|531959004|FG000|Washout 2 (3 to 14 Days)|Protocol Violation|0|||
147493020|NCT00862849|531959005|FG001|Washout 2 (3 to 14 Days)|Protocol Violation|1|||
147493021|NCT00862849|531959006|FG002|Washout 2 (3 to 14 Days)|Protocol Violation|0|||
147493022|NCT00862849|531959007|FG003|Washout 2 (3 to 14 Days)|Protocol Violation|0|||
147493023|NCT00862849|531959008|FG004|Washout 2 (3 to 14 Days)|Protocol Violation|0|||
147493024|NCT00862849|531959009|FG005|Washout 2 (3 to 14 Days)|Protocol Violation|0|||
147493025|NCT00617409|531959010|FG000|Overall Study|Withdrawal by Subject|4|||
147493026|NCT00617409|531959011|FG001|Overall Study|Withdrawal by Subject|1|||
147493027|NCT00617409|531959012|FG002|Overall Study|Withdrawal by Subject|2|||
147493028|NCT00617409|531959010|FG000|Overall Study|Adverse Event|0|||
147493029|NCT00617409|531959011|FG001|Overall Study|Adverse Event|2|||
147493030|NCT00617409|531959012|FG002|Overall Study|Adverse Event|3|||
147493031|NCT00617409|531959010|FG000|Overall Study|Disease Progression|8|||
147493032|NCT00617409|531959011|FG001|Overall Study|Disease Progression|8|||
147493033|NCT00617409|531959012|FG002|Overall Study|Disease Progression|18|||
147493034|NCT00617409|531959010|FG000|Overall Study|Death|3|||
147493035|NCT00617409|531959011|FG001|Overall Study|Death|5|||
147493036|NCT00617409|531959012|FG002|Overall Study|Death|4|||
147493037|NCT00617409|531959010|FG000|Overall Study|Alternative Therapy|1|||
147493038|NCT00617409|531959011|FG001|Overall Study|Alternative Therapy|2|||
147493039|NCT00617409|531959012|FG002|Overall Study|Alternative Therapy|0|||
147493040|NCT01153763|531959015|FG000|Overall Study|Study Closed|16|||
147493041|NCT01153763|531959015|FG000|Overall Study|Lost to Follow-up|1|||
147493042|NCT01153763|531959015|FG000|Overall Study|Physician Decision|2|||
147493043|NCT01153763|531959015|FG000|Overall Study|Withdrawal by Subject|2|||
147493044|NCT01474746|531959018|FG000|Overall Study|Lost to Follow-up|1|||
147493045|NCT01474746|531959019|FG001|Overall Study|Lost to Follow-up|1|||
147493046|NCT01474746|531959018|FG000|Overall Study|Withdrawal by Subject|2|||
147493047|NCT01474746|531959019|FG001|Overall Study|Withdrawal by Subject|1|||
147493048|NCT01606761|531959023|FG000|Prior to Week 24|Lost to Follow-up|0|||
147493049|NCT01606761|531959024|FG001|Prior to Week 24|Lost to Follow-up|3|||
147493050|NCT01606761|531959025|FG002|Prior to Week 24|Lost to Follow-up|2|||
147493051|NCT01606761|531959026|FG003|Prior to Week 24|Lost to Follow-up|0|||
147493052|NCT01606761|531959027|FG004|Prior to Week 24|Lost to Follow-up|0|||
147493053|NCT01606761|531959023|FG000|Prior to Week 24|Withdrawal by Subject|12|||
147493054|NCT01606761|531959024|FG001|Prior to Week 24|Withdrawal by Subject|10|||
147493055|NCT01606761|531959025|FG002|Prior to Week 24|Withdrawal by Subject|9|||
147493056|NCT01606761|531959026|FG003|Prior to Week 24|Withdrawal by Subject|0|||
147493057|NCT01606761|531959027|FG004|Prior to Week 24|Withdrawal by Subject|0|||
147493058|NCT01606761|531959023|FG000|Prior to Week 24|Adverse Event|11|||
147493059|NCT01606761|531959024|FG001|Prior to Week 24|Adverse Event|18|||
147493060|NCT01606761|531959025|FG002|Prior to Week 24|Adverse Event|22|||
147493061|NCT01606761|531959026|FG003|Prior to Week 24|Adverse Event|0|||
147493062|NCT01606761|531959027|FG004|Prior to Week 24|Adverse Event|0|||
147493063|NCT01606761|531959023|FG000|Prior to Week 24|Lack of Efficacy|15|||
147493064|NCT01606761|531959024|FG001|Prior to Week 24|Lack of Efficacy|14|||
147493065|NCT01606761|531959025|FG002|Prior to Week 24|Lack of Efficacy|8|||
147493066|NCT01606761|531959026|FG003|Prior to Week 24|Lack of Efficacy|0|||
147493067|NCT01606761|531959027|FG004|Prior to Week 24|Lack of Efficacy|0|||
147493068|NCT01606761|531959023|FG000|Prior to Week 24|Physician Decision|0|||
147493069|NCT01606761|531959024|FG001|Prior to Week 24|Physician Decision|3|||
147493070|NCT01606761|531959025|FG002|Prior to Week 24|Physician Decision|1|||
147493071|NCT01606761|531959026|FG003|Prior to Week 24|Physician Decision|0|||
147493072|NCT01606761|531959027|FG004|Prior to Week 24|Physician Decision|0|||
147493073|NCT01606761|531959023|FG000|Prior to Week 24|Other|4|||
147493074|NCT01606761|531959024|FG001|Prior to Week 24|Other|7|||
147493075|NCT01606761|531959025|FG002|Prior to Week 24|Other|5|||
147493076|NCT01606761|531959026|FG003|Prior to Week 24|Other|0|||
147493077|NCT01606761|531959027|FG004|Prior to Week 24|Other|0|||
147493078|NCT01606761|531959023|FG000|Week 24 to Week 52|Lost to Follow-up|0|||
147493079|NCT01606761|531959024|FG001|Week 24 to Week 52|Lost to Follow-up|1|||
147493080|NCT01606761|531959025|FG002|Week 24 to Week 52|Lost to Follow-up|1|||
147493081|NCT01606761|531959026|FG003|Week 24 to Week 52|Lost to Follow-up|1|||
147493082|NCT01606761|531959027|FG004|Week 24 to Week 52|Lost to Follow-up|0|||
147493083|NCT01606761|531959023|FG000|Week 24 to Week 52|Withdrawal by Subject|0|||
147493084|NCT01606761|531959024|FG001|Week 24 to Week 52|Withdrawal by Subject|6|||
147493085|NCT01606761|531959025|FG002|Week 24 to Week 52|Withdrawal by Subject|3|||
147668089|NCT02404545|532609869|FG001|Overall Study|Sponsor Termination|6|||
147668090|NCT03641508|532609870|FG000|First Injection|Lost to Follow-up|2|||
147668091|NCT03641508|532609871|FG001|First Injection|Lost to Follow-up|0|||
147493086|NCT01606761|531959026|FG003|Week 24 to Week 52|Withdrawal by Subject|0|||
147493087|NCT01606761|531959027|FG004|Week 24 to Week 52|Withdrawal by Subject|0|||
147493088|NCT01606761|531959023|FG000|Week 24 to Week 52|Adverse Event|0|||
147493089|NCT01606761|531959024|FG001|Week 24 to Week 52|Adverse Event|11|||
147493090|NCT01606761|531959025|FG002|Week 24 to Week 52|Adverse Event|14|||
147493091|NCT01606761|531959026|FG003|Week 24 to Week 52|Adverse Event|3|||
147493092|NCT01606761|531959027|FG004|Week 24 to Week 52|Adverse Event|15|||
147493093|NCT01606761|531959023|FG000|Week 24 to Week 52|Death|0|||
147493094|NCT01606761|531959024|FG001|Week 24 to Week 52|Death|0|||
147493095|NCT01606761|531959025|FG002|Week 24 to Week 52|Death|2|||
147493096|NCT01606761|531959026|FG003|Week 24 to Week 52|Death|1|||
147493097|NCT01606761|531959027|FG004|Week 24 to Week 52|Death|0|||
147493098|NCT01606761|531959023|FG000|Week 24 to Week 52|Lack of Efficacy|0|||
147493099|NCT01606761|531959024|FG001|Week 24 to Week 52|Lack of Efficacy|13|||
147493100|NCT01606761|531959025|FG002|Week 24 to Week 52|Lack of Efficacy|7|||
147493101|NCT01606761|531959026|FG003|Week 24 to Week 52|Lack of Efficacy|10|||
147493102|NCT01606761|531959027|FG004|Week 24 to Week 52|Lack of Efficacy|3|||
147493103|NCT01606761|531959023|FG000|Week 24 to Week 52|Physician Decision|0|||
147493104|NCT01606761|531959024|FG001|Week 24 to Week 52|Physician Decision|1|||
147493105|NCT01606761|531959025|FG002|Week 24 to Week 52|Physician Decision|1|||
147493106|NCT01606761|531959026|FG003|Week 24 to Week 52|Physician Decision|0|||
147493107|NCT01606761|531959027|FG004|Week 24 to Week 52|Physician Decision|0|||
147493108|NCT01606761|531959023|FG000|Week 24 to Week 52|Other|0|||
147493109|NCT01606761|531959024|FG001|Week 24 to Week 52|Other|1|||
147493110|NCT01606761|531959025|FG002|Week 24 to Week 52|Other|5|||
147493111|NCT01606761|531959026|FG003|Week 24 to Week 52|Other|2|||
147493112|NCT01606761|531959027|FG004|Week 24 to Week 52|Other|2|||
147493113|NCT01606761|531959023|FG000|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|0|||
147493114|NCT01606761|531959024|FG001|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|1|||
147493115|NCT01606761|531959025|FG002|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|2|||
147493116|NCT01606761|531959026|FG003|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|0|||
147493117|NCT01606761|531959027|FG004|Safety Follow-up Period (Week 52-68)|Lost to Follow-up|1|||
147493118|NCT01606761|531959023|FG000|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|4|||
147493119|NCT01606761|531959024|FG001|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|6|||
147493120|NCT01606761|531959025|FG002|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|6|||
147493121|NCT01606761|531959026|FG003|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|1|||
147493122|NCT01606761|531959027|FG004|Safety Follow-up Period (Week 52-68)|Withdrawal by Subject|3|||
147493123|NCT01606761|531959023|FG000|Safety Follow-up Period (Week 52-68)|Death|0|||
147493124|NCT01606761|531959024|FG001|Safety Follow-up Period (Week 52-68)|Death|0|||
147493125|NCT01606761|531959025|FG002|Safety Follow-up Period (Week 52-68)|Death|0|||
147493126|NCT01606761|531959026|FG003|Safety Follow-up Period (Week 52-68)|Death|0|||
147493127|NCT01606761|531959027|FG004|Safety Follow-up Period (Week 52-68)|Death|1|||
147493128|NCT01606761|531959023|FG000|Safety Follow-up Period (Week 52-68)|Other|0|||
147493129|NCT01606761|531959024|FG001|Safety Follow-up Period (Week 52-68)|Other|3|||
147493130|NCT01606761|531959025|FG002|Safety Follow-up Period (Week 52-68)|Other|9|||
147493131|NCT01606761|531959026|FG003|Safety Follow-up Period (Week 52-68)|Other|1|||
147493132|NCT01606761|531959027|FG004|Safety Follow-up Period (Week 52-68)|Other|3|||
147493133|NCT05086289|531959028|FG000|Overall Study|Adverse Event|4|||
147493134|NCT05086289|531959029|FG001|Overall Study|Adverse Event|2|||
147493135|NCT05086289|531959028|FG000|Overall Study|Lost to Follow-up|2|||
147493136|NCT05086289|531959029|FG001|Overall Study|Lost to Follow-up|0|||
147493137|NCT05086289|531959028|FG000|Overall Study|Non-compliance with study drug|2|||
147493138|NCT05086289|531959029|FG001|Overall Study|Non-compliance with study drug|1|||
147493139|NCT05086289|531959028|FG000|Overall Study|Physician Decision|2|||
147493140|NCT05086289|531959029|FG001|Overall Study|Physician Decision|0|||
147493141|NCT05086289|531959028|FG000|Overall Study|Withdrawal by Subject|5|||
147493142|NCT05086289|531959029|FG001|Overall Study|Withdrawal by Subject|2|||
147493143|NCT04544709|531959030|FG000|Overall Study|The study was discontinued due to low enrollment.|3|||
147493144|NCT03238235|531959031|FG000|Overall Study|Adverse Event|2|||
147493145|NCT03238235|531959032|FG001|Overall Study|Adverse Event|0|||
147493146|NCT03238235|531959031|FG000|Overall Study|patients unable to travel to the site due to the COVID-19 pandemic|2|||
147493147|NCT03238235|531959032|FG001|Overall Study|patients unable to travel to the site due to the COVID-19 pandemic|0|||
147493148|NCT01814800|531959033|FG000|Overall Study|Adverse Event|2|||
147493149|NCT01814800|531959033|FG000|Overall Study|Pregnancy|1|||
147493150|NCT01814800|531959033|FG000|Overall Study|Sponsor decision|1|||
147493151|NCT01814800|531959033|FG000|Overall Study|Subject relocation|1|||
147493152|NCT03807739|531959034|FG000|Overall Study|Adverse Event|1|||
147493153|NCT03807739|531959035|FG001|Overall Study|Adverse Event|0|||
147493154|NCT03807739|531959036|FG002|Overall Study|Adverse Event|0|||
147493155|NCT03807739|531959037|FG003|Overall Study|Adverse Event|0|||
147493156|NCT03807739|531959034|FG000|Overall Study|Withdrawal by Subject|1|||
147493157|NCT03807739|531959035|FG001|Overall Study|Withdrawal by Subject|0|||
147493158|NCT03807739|531959036|FG002|Overall Study|Withdrawal by Subject|0|||
147493159|NCT03807739|531959037|FG003|Overall Study|Withdrawal by Subject|0|||
147625957|NCT00463047|532447168|FG000|Double-Blind Treatment Period 1|Adverse Event|0|||
147625958|NCT00463047|532447169|FG001|Double-Blind Treatment Period 1|Adverse Event|2|||
147625959|NCT00463047|532447168|FG000|Double-Blind Treatment Period 1|Protocol Violation|1|||
147625960|NCT00463047|532447169|FG001|Double-Blind Treatment Period 1|Protocol Violation|2|||
147625961|NCT00463047|532447168|FG000|Double-Blind Treatment Period 1|Non-compliance with procedures|1|||
147493160|NCT02371759|531959038|FG000|Overall Study|Protocol Violation|3|||
147493161|NCT02371759|531959039|FG001|Overall Study|Protocol Violation|1|||
147493162|NCT02371759|531959040|FG002|Overall Study|Protocol Violation|1|||
147493163|NCT02371759|531959041|FG003|Overall Study|Protocol Violation|0|||
147493164|NCT02371759|531959042|FG004|Overall Study|Protocol Violation|3|||
147493165|NCT02371759|531959043|FG005|Overall Study|Protocol Violation|1|||
147493166|NCT02371759|531959044|FG006|Overall Study|Protocol Violation|0|||
147493167|NCT02371759|531959045|FG007|Overall Study|Protocol Violation|3|||
147493168|NCT02371759|531959038|FG000|Overall Study|Withdrawal by Subject|0|||
147493169|NCT02371759|531959039|FG001|Overall Study|Withdrawal by Subject|0|||
147493170|NCT02371759|531959040|FG002|Overall Study|Withdrawal by Subject|0|||
147493171|NCT02371759|531959041|FG003|Overall Study|Withdrawal by Subject|0|||
147493172|NCT02371759|531959042|FG004|Overall Study|Withdrawal by Subject|0|||
147493173|NCT02371759|531959043|FG005|Overall Study|Withdrawal by Subject|0|||
147493174|NCT02371759|531959044|FG006|Overall Study|Withdrawal by Subject|0|||
147493175|NCT02371759|531959045|FG007|Overall Study|Withdrawal by Subject|1|||
147493176|NCT03201198|531959059|FG000|Overall Study|Did not complete f reasons; lost to follow-up, subject withdrew, family illnesses, moving, etc.|35|||
147493177|NCT03201198|531959060|FG001|Overall Study|Did not complete f reasons; lost to follow-up, subject withdrew, family illnesses, moving, etc.|37|||
147493178|NCT03201198|531959059|FG000|Overall Study|Withdrawal by Subject|2|||
147493179|NCT03201198|531959060|FG001|Overall Study|Withdrawal by Subject|3|||
147493180|NCT03213626|531959061|FG000|Overall Study|Adverse Event|1|||
147493181|NCT03213626|531959061|FG000|Overall Study|Progressive Disease|6|||
147493182|NCT01767194|531959062|FG000|Overall Study|Adverse Event|1|||
147493183|NCT01767194|531959063|FG001|Overall Study|Adverse Event|1|||
147493184|NCT01767194|531959062|FG000|Overall Study|Death|0|||
147493185|NCT01767194|531959063|FG001|Overall Study|Death|1|||
147493186|NCT01767194|531959062|FG000|Overall Study|Lack of Efficacy|12|||
147493187|NCT01767194|531959063|FG001|Overall Study|Lack of Efficacy|11|||
147493188|NCT01767194|531959062|FG000|Overall Study|Physician Decision|2|||
147493189|NCT01767194|531959063|FG001|Overall Study|Physician Decision|23|||
147493190|NCT01767194|531959062|FG000|Overall Study|Withdrawal by Subject|0|||
147493191|NCT01767194|531959063|FG001|Overall Study|Withdrawal by Subject|1|||
147493192|NCT01767194|531959062|FG000|Overall Study|Ineligible|1|||
147493193|NCT01767194|531959063|FG001|Overall Study|Ineligible|1|||
147493194|NCT01767194|531959062|FG000|Overall Study|Refusal by patient/parent|2|||
147493195|NCT01767194|531959063|FG001|Overall Study|Refusal by patient/parent|4|||
147493196|NCT01767194|531959062|FG000|Overall Study|Criteria not met on time for next cycle|0|||
147493197|NCT01767194|531959063|FG001|Overall Study|Criteria not met on time for next cycle|1|||
147493198|NCT02625324|531960988|FG000|30-Day Follow-up for Primary Endpoint|Death|1|||
147493199|NCT02625324|531960988|FG000|30-Day Follow-up for Secondary Endpoint|Death|1|||
147493200|NCT02625324|531960988|FG000|6-Month Follow-up Subject Accountability|Death|5|||
147493201|NCT02625324|531960988|FG000|6-Month Follow-up Subject Accountability|Withdrawal by Subject|2|||
147493202|NCT02625324|531960988|FG000|6-Month Follow-up Subject Accountability|Lost to Follow-up|1|||
147493203|NCT02625324|531960988|FG000|12-Month Follow-up Secondary Endpoint|Death|4|||
147493204|NCT02625324|531960988|FG000|24-Month Follow-up Secondary Endpoint|Death|2|||
147493205|NCT02625324|531960988|FG000|24-Month Follow-up Secondary Endpoint|Withdrawal by Subject|3|||
147493206|NCT02625324|531960988|FG000|24-Month Follow-up Secondary Endpoint|Lost to Follow-up|2|||
147493207|NCT02625324|531960988|FG000|24-Month Follow-up Secondary Endpoint|Subject declined reconsenting to extended follow-up out to 5 years|28|||
147493208|NCT02625324|531960988|FG000|36-Month Follow-up Secondary Endpoint|Death|2|||
147493209|NCT02625324|531960988|FG000|36-Month Follow-up Secondary Endpoint|Withdrawal by Subject|2|||
147493210|NCT02625324|531960988|FG000|48-Month Follow-up Secondary Endpoint|Death|4|||
147493211|NCT02625324|531960988|FG000|48-Month Follow-up Secondary Endpoint|Lost to Follow-up|1|||
147493212|NCT02625324|531960988|FG000|48-Month Follow-up Secondary Endpoint|Withdrawal by Subject|1|||
147493213|NCT02625324|531960988|FG000|60-Month Follow-up Secondary Endpoint|Death|5|||
147493214|NCT02625324|531960988|FG000|60-Month Follow-up Secondary Endpoint|Withdrawal by Subject|1|||
147493215|NCT02457182|531960989|FG000|Overall Study|Lost to Follow-up|1|||
147493216|NCT02457182|531960990|FG001|Overall Study|Lost to Follow-up|0|||
147493217|NCT00352755|531960991|FG000|Overall Study|Physician Decision|1|||
147493218|NCT00352755|531960991|FG000|Overall Study|Adverse Event|1|||
147493219|NCT02397694|531960992|FG000|Double-Blinded Phase|Adverse Event|1|||
147493220|NCT02397694|531960993|FG001|Double-Blinded Phase|Adverse Event|0|||
147493221|NCT02397694|531960992|FG000|Double-Blinded Phase|Non-compliance with study drug|0|||
147493222|NCT02397694|531960993|FG001|Double-Blinded Phase|Non-compliance with study drug|2|||
147493223|NCT02397694|531960992|FG000|Double-Blinded Phase|Withdrawal by Subject|1|||
147493224|NCT02397694|531960993|FG001|Double-Blinded Phase|Withdrawal by Subject|0|||
147493225|NCT02397694|531960992|FG000|Double-Blinded Phase|Lost to Follow-up|1|||
147625962|NCT00463047|532447169|FG001|Double-Blind Treatment Period 1|Non-compliance with procedures|0|||
147625963|NCT00463047|532447168|FG000|Double-Blind Treatment Period 1|Other|1|||
147625964|NCT00463047|532447169|FG001|Double-Blind Treatment Period 1|Other|0|||
147625965|NCT00463047|532447168|FG000|Double-Blind Treatment Period 2|Adverse Event|0|||
147625966|NCT00463047|532447169|FG001|Double-Blind Treatment Period 2|Adverse Event|1|||
147625967|NCT00463047|532447168|FG000|Double-Blind Treatment Period 2|Withdrawal by Subject|0|||
147625968|NCT00463047|532447169|FG001|Double-Blind Treatment Period 2|Withdrawal by Subject|1|||
147625969|NCT00463047|532447168|FG000|Double-Blind Treatment Period 2|Non-compliance with procedures|1|||
147625970|NCT00463047|532447169|FG001|Double-Blind Treatment Period 2|Non-compliance with procedures|0|||
147625971|NCT00739661|532447175|FG000|Overall Study|Adverse Event|2|||
147625972|NCT00739661|532447176|FG001|Overall Study|Adverse Event|0|||
147493226|NCT02397694|531960993|FG001|Double-Blinded Phase|Lost to Follow-up|1|||
147493227|NCT02397694|531960992|FG000|Open Label Extension Phase|Protocol Violation|1|||
147493228|NCT02397694|531960993|FG001|Open Label Extension Phase|Protocol Violation|0|||
147493229|NCT02397694|531960992|FG000|Open Label Extension Phase|Withdrew Consent|3|||
147493230|NCT02397694|531960993|FG001|Open Label Extension Phase|Withdrew Consent|1|||
147493231|NCT02397694|531960992|FG000|Open Label Extension Phase|Lost to Follow-up|4|||
147493232|NCT02397694|531960993|FG001|Open Label Extension Phase|Lost to Follow-up|0|||
147493233|NCT01116687|531960994|FG000|Overall Study|Withdrawal by Subject|4|||
147493234|NCT00424528|531960995|FG000|Overall Study|Adverse Event|2|||
147493235|NCT00424528|531960996|FG001|Overall Study|Adverse Event|1|||
147493236|NCT00424528|531960997|FG002|Overall Study|Adverse Event|2|||
147493237|NCT00424528|531960995|FG000|Overall Study|Protocol Violation|1|||
147493238|NCT00424528|531960996|FG001|Overall Study|Protocol Violation|1|||
147493239|NCT00424528|531960997|FG002|Overall Study|Protocol Violation|0|||
147493240|NCT00424528|531960995|FG000|Overall Study|Lost to Follow-up|0|||
147493241|NCT00424528|531960996|FG001|Overall Study|Lost to Follow-up|1|||
147493242|NCT00424528|531960997|FG002|Overall Study|Lost to Follow-up|0|||
147493243|NCT00424528|531960995|FG000|Overall Study|noncompliance with study requirements|2|||
147493244|NCT00424528|531960996|FG001|Overall Study|noncompliance with study requirements|1|||
147493245|NCT00424528|531960997|FG002|Overall Study|noncompliance with study requirements|2|||
147493246|NCT02115113|531960998|FG000|Participants in Run-in Period|Death|0|||
147493247|NCT02115113|531960999|FG001|Participants in Run-in Period|Death|0|||
147493248|NCT02115113|531961000|FG002|Participants in Run-in Period|Death|1|||
147493249|NCT02115113|531960998|FG000|Participants in Run-in Period|Administrative problems|0|||
147493250|NCT02115113|531960999|FG001|Participants in Run-in Period|Administrative problems|0|||
147493251|NCT02115113|531961000|FG002|Participants in Run-in Period|Administrative problems|1|||
147493252|NCT02115113|531960998|FG000|Participants in Run-in Period|Lost to Follow-up|0|||
147493253|NCT02115113|531960999|FG001|Participants in Run-in Period|Lost to Follow-up|0|||
147493254|NCT02115113|531961000|FG002|Participants in Run-in Period|Lost to Follow-up|5|||
147493255|NCT02115113|531960998|FG000|Participants in Run-in Period|Withdrawal by Subject|0|||
147493256|NCT02115113|531960999|FG001|Participants in Run-in Period|Withdrawal by Subject|0|||
147493257|NCT02115113|531961000|FG002|Participants in Run-in Period|Withdrawal by Subject|3|||
147493258|NCT02115113|531960998|FG000|Participants Randomized|Lost to Follow-up|1|||
147493259|NCT02115113|531960999|FG001|Participants Randomized|Lost to Follow-up|0|||
147493260|NCT02115113|531961000|FG002|Participants Randomized|Lost to Follow-up|0|||
147493261|NCT02115113|531960998|FG000|Participants Randomized|Death|1|||
147493262|NCT02115113|531960999|FG001|Participants Randomized|Death|0|||
147493263|NCT02115113|531961000|FG002|Participants Randomized|Death|0|||
147493264|NCT00789191|531961002|FG000|Overall Study|Adverse Event|2|||
147493265|NCT00789191|531961003|FG001|Overall Study|Adverse Event|4|||
147493266|NCT00789191|531961002|FG000|Overall Study|Lack of Efficacy|0|||
147493267|NCT00789191|531961003|FG001|Overall Study|Lack of Efficacy|5|||
147493268|NCT00789191|531961002|FG000|Overall Study|Protocol Violation|5|||
147493269|NCT00789191|531961003|FG001|Overall Study|Protocol Violation|3|||
147493270|NCT00789191|531961002|FG000|Overall Study|Withdrawal Criteria|2|||
147493271|NCT00789191|531961003|FG001|Overall Study|Withdrawal Criteria|4|||
147493272|NCT00789191|531961002|FG000|Overall Study|Unclassified|5|||
147493273|NCT00789191|531961003|FG001|Overall Study|Unclassified|3|||
147493274|NCT03497429|531961005|FG000|Overall Study|Progressive disease|3|||
147668092|NCT03087058|532609873|FG000|Overall Study|Withdrawal by Subject|2|||
147668093|NCT03087058|532609874|FG001|Overall Study|Withdrawal by Subject|0|||
147668094|NCT03087058|532609875|FG002|Overall Study|Withdrawal by Subject|0|||
147668095|NCT02577029|532609878|FG000|Overall Study|Adverse Event|1|||
147668096|NCT02577029|532609879|FG001|Overall Study|Adverse Event|0|||
147668097|NCT02577029|532609880|FG002|Overall Study|Adverse Event|2|||
147668098|NCT02577029|532609881|FG003|Overall Study|Adverse Event|0|||
147668099|NCT02577029|532609882|FG004|Overall Study|Adverse Event|1|||
147493275|NCT03497429|531961006|FG001|Overall Study|Progressive disease|4|||
147493276|NCT03497429|531961005|FG000|Overall Study|Adverse Event|0|||
147493277|NCT03497429|531961006|FG001|Overall Study|Adverse Event|2|||
147493278|NCT01009983|531961007|FG000|Overall Study|necessary scans not completed|1|||
147493279|NCT00967226|531961011|FG000|Overall Study|Adverse Event|0|||
147493280|NCT00967226|531961012|FG001|Overall Study|Adverse Event|5|||
147493281|NCT00967226|531961011|FG000|Overall Study|Protocol Violation|2|||
147493282|NCT00967226|531961012|FG001|Overall Study|Protocol Violation|0|||
147493283|NCT00967226|531961011|FG000|Overall Study|Physician Decision|0|||
147493284|NCT00967226|531961012|FG001|Overall Study|Physician Decision|1|||
147668100|NCT02577029|532609883|FG005|Overall Study|Adverse Event|0|||
147493285|NCT05254613|531961013|FG000|Overall Study|Lost to Follow-up|0|||
147493286|NCT05254613|531961014|FG001|Overall Study|Lost to Follow-up|0|||
147493287|NCT05254613|531961015|FG002|Overall Study|Lost to Follow-up|1|||
147668101|NCT02577029|532609884|FG006|Overall Study|Adverse Event|0|||
147493288|NCT02338492|531961016|FG000|Overall Study|Death|32|||
147493289|NCT02338492|531961016|FG000|Overall Study|Adverse Event|3|||
147493290|NCT02338492|531961016|FG000|Overall Study|Lost to Follow-up|4|||
147493291|NCT02338492|531961016|FG000|Overall Study|Reason not captured above|6|||
147493292|NCT00756886|531961020|FG000|Overall Study|Lost to Follow-up|1|||
147668102|NCT02577029|532609885|FG007|Overall Study|Adverse Event|0|||
147493293|NCT00756886|531961021|FG001|Overall Study|Lost to Follow-up|0|||
147493294|NCT00756886|531961020|FG000|Overall Study|Adverse Event|0|||
147493295|NCT00756886|531961021|FG001|Overall Study|Adverse Event|3|||
147493296|NCT00756886|531961020|FG000|Overall Study|Lack of Efficacy|1|||
147493297|NCT00756886|531961021|FG001|Overall Study|Lack of Efficacy|0|||
147493298|NCT00756886|531961020|FG000|Overall Study|Ineligible|9|||
147493299|NCT00756886|531961021|FG001|Overall Study|Ineligible|4|||
147493300|NCT00174785|531961022|FG000|Overall Study|Adverse Event|293|||
147493301|NCT00174785|531961023|FG001|Overall Study|Adverse Event|191|||
147493302|NCT00174785|531961022|FG000|Overall Study|Protocol Violation|14|||
147493303|NCT00174785|531961023|FG001|Overall Study|Protocol Violation|14|||
147493304|NCT00174785|531961022|FG000|Overall Study|Withdrawal by Subject|173|||
147493305|NCT00174785|531961023|FG001|Overall Study|Withdrawal by Subject|175|||
147493306|NCT00174785|531961022|FG000|Overall Study|Atrial Fibrillation/Flutter recurrence|110|||
147493307|NCT00174785|531961023|FG001|Overall Study|Atrial Fibrillation/Flutter recurrence|167|||
147493308|NCT00174785|531961022|FG000|Overall Study|Prohibited antiarrhythmic medication|39|||
147493309|NCT00174785|531961023|FG001|Overall Study|Prohibited antiarrhythmic medication|88|||
147493310|NCT00174785|531961022|FG000|Overall Study|Other prohibited medication|5|||
147493311|NCT00174785|531961023|FG001|Overall Study|Other prohibited medication|3|||
147493312|NCT00174785|531961022|FG000|Overall Study|Family request|6|||
147493313|NCT00174785|531961023|FG001|Overall Study|Family request|8|||
147493314|NCT00174785|531961022|FG000|Overall Study|Not pre-specified/Not coded|56|||
147493315|NCT00174785|531961023|FG001|Overall Study|Not pre-specified/Not coded|70|||
147493316|NCT00310388|531961025|FG000|Primary Reporting Phase|Adverse Event|101|||
147493317|NCT00310388|531961026|FG001|Primary Reporting Phase|Adverse Event|0|||
147493318|NCT00310388|531961025|FG000|Primary Reporting Phase|Lack of Efficacy|56|||
147493319|NCT00310388|531961026|FG001|Primary Reporting Phase|Lack of Efficacy|0|||
147493320|NCT00310388|531961025|FG000|Primary Reporting Phase|Withdrawal by Subject|97|||
147493321|NCT00310388|531961026|FG001|Primary Reporting Phase|Withdrawal by Subject|0|||
147493322|NCT00310388|531961025|FG000|Primary Reporting Phase|Protocol Violation|10|||
147493323|NCT00310388|531961026|FG001|Primary Reporting Phase|Protocol Violation|0|||
147493324|NCT00310388|531961025|FG000|Primary Reporting Phase|Pregnancy|3|||
147493325|NCT00310388|531961026|FG001|Primary Reporting Phase|Pregnancy|0|||
147493326|NCT00310388|531961025|FG000|Primary Reporting Phase|Change in participant medical condition|3|||
147493327|NCT00310388|531961026|FG001|Primary Reporting Phase|Change in participant medical condition|0|||
147493328|NCT00310388|531961025|FG000|Primary Reporting Phase|Persistent ALT/AST above 3 times the ULN|3|||
147493329|NCT00310388|531961026|FG001|Primary Reporting Phase|Persistent ALT/AST above 3 times the ULN|0|||
147493330|NCT00310388|531961025|FG000|Primary Reporting Phase|ALT/AST levels above 5 times the ULN|3|||
147493331|NCT00310388|531961026|FG001|Primary Reporting Phase|ALT/AST levels above 5 times the ULN|0|||
147493332|NCT00310388|531961025|FG000|Primary Reporting Phase|Physician Decision|2|||
147493333|NCT00310388|531961026|FG001|Primary Reporting Phase|Physician Decision|0|||
147493334|NCT00310388|531961025|FG000|Primary Reporting Phase|Request of the sponsor|19|||
147493335|NCT00310388|531961026|FG001|Primary Reporting Phase|Request of the sponsor|0|||
147493336|NCT00310388|531961025|FG000|Primary Reporting Phase|Failed to return|8|||
147493337|NCT00310388|531961026|FG001|Primary Reporting Phase|Failed to return|0|||
147493338|NCT00310388|531961025|FG000|Primary Reporting Phase|Participant request unrelated to study|2|||
147493339|NCT00310388|531961026|FG001|Primary Reporting Phase|Participant request unrelated to study|0|||
147493340|NCT00310388|531961025|FG000|Primary Reporting Phase|Participant request|2|||
147493341|NCT00310388|531961026|FG001|Primary Reporting Phase|Participant request|0|||
147493342|NCT00310388|531961025|FG000|Primary Reporting Phase|Ministry of Health decision|25|||
147493343|NCT00310388|531961026|FG001|Primary Reporting Phase|Ministry of Health decision|0|||
147493344|NCT00310388|531961025|FG000|Primary Reporting Phase|Discontinuation of study|1|||
147493345|NCT00310388|531961026|FG001|Primary Reporting Phase|Discontinuation of study|0|||
147493346|NCT00310388|531961025|FG000|Primary Reporting Phase|Participant Immigrated to New Zealand|1|||
147493347|NCT00310388|531961026|FG001|Primary Reporting Phase|Participant Immigrated to New Zealand|0|||
147493348|NCT00310388|531961025|FG000|Primary Reporting Phase|Termination of study at sponsor request|3|||
147493349|NCT00310388|531961026|FG001|Primary Reporting Phase|Termination of study at sponsor request|0|||
147493350|NCT00310388|531961025|FG000|Primary Reporting Phase|Ongoing SAE from parent study|1|||
147493351|NCT00310388|531961026|FG001|Primary Reporting Phase|Ongoing SAE from parent study|0|||
147493352|NCT00310388|531961025|FG000|Primary Reporting Phase|Due to pigmentation risk concerns|2|||
147493353|NCT00310388|531961026|FG001|Primary Reporting Phase|Due to pigmentation risk concerns|0|||
147493354|NCT00310388|531961025|FG000|Primary Reporting Phase|Participant passed away|1|||
147493355|NCT00310388|531961026|FG001|Primary Reporting Phase|Participant passed away|0|||
147493356|NCT00310388|531961025|FG000|Primary Reporting Phase|Participant retired the informed consent|1|||
147493357|NCT00310388|531961026|FG001|Primary Reporting Phase|Participant retired the informed consent|0|||
147493358|NCT00310388|531961025|FG000|Primary Reporting Phase|Missing|1|||
147493359|NCT00310388|531961026|FG001|Primary Reporting Phase|Missing|0|||
147493360|NCT00310388|531961025|FG000|Primary Reporting Phase|Other|1|||
147493361|NCT00310388|531961026|FG001|Primary Reporting Phase|Other|0|||
147493362|NCT00310388|531961025|FG000|Safety Follow-up Continuation Phase|Missing SFUCP disposition information|0|||
147527306|NCT00594958|532084213|FG001|Overall Study|Withdrawal by Subject|0|||
147493363|NCT00310388|531961026|FG001|Safety Follow-up Continuation Phase|Missing SFUCP disposition information|5|||
147493364|NCT00310388|531961025|FG000|Safety Follow-up Continuation Phase|Adverse Event|0|||
147493365|NCT00310388|531961026|FG001|Safety Follow-up Continuation Phase|Adverse Event|1|||
147493366|NCT00310388|531961025|FG000|Safety Follow-up Continuation Phase|Withdrawal by Subject|0|||
147493367|NCT00310388|531961026|FG001|Safety Follow-up Continuation Phase|Withdrawal by Subject|5|||
147493368|NCT00310388|531961025|FG000|Safety Follow-up Continuation Phase|Study Closed/Terminated|0|||
147493369|NCT00310388|531961026|FG001|Safety Follow-up Continuation Phase|Study Closed/Terminated|2|||
147493370|NCT03198754|531961051|FG000|Overall Study|Withdrawal by Subject|5|||
147493371|NCT03198754|531961052|FG001|Overall Study|Withdrawal by Subject|4|||
147493372|NCT03198754|531961051|FG000|Overall Study|Lost to Follow-up|4|||
147493373|NCT03198754|531961052|FG001|Overall Study|Lost to Follow-up|3|||
147493374|NCT03198754|531961051|FG000|Overall Study|Ineligible|2|||
147493375|NCT03198754|531961052|FG001|Overall Study|Ineligible|1|||
147493376|NCT00668200|531961053|FG000|Overall Study|Withdrawal by Subject|2|||
147493377|NCT00668200|531961053|FG000|Overall Study|Lost to Follow-up|1|||
147493378|NCT01496430|531961057|FG000|Overall Study|Adverse Event|0|||
147493379|NCT01496430|531961058|FG001|Overall Study|Adverse Event|0|||
147493380|NCT01496430|531961059|FG002|Overall Study|Adverse Event|1|||
147493381|NCT01496430|531961057|FG000|Overall Study|Major Protocol Deviation|0|||
147493382|NCT01496430|531961058|FG001|Overall Study|Major Protocol Deviation|0|||
147493383|NCT01496430|531961059|FG002|Overall Study|Major Protocol Deviation|1|||
147493384|NCT01496430|531961057|FG000|Overall Study|Lost to Follow-up|2|||
147493385|NCT01496430|531961058|FG001|Overall Study|Lost to Follow-up|3|||
147493386|NCT01496430|531961059|FG002|Overall Study|Lost to Follow-up|1|||
147493387|NCT01496430|531961057|FG000|Overall Study|Voluntary Withdrawal|2|||
147493388|NCT01496430|531961058|FG001|Overall Study|Voluntary Withdrawal|1|||
147493389|NCT01496430|531961059|FG002|Overall Study|Voluntary Withdrawal|6|||
147493390|NCT01496430|531961057|FG000|Overall Study|Principal Investigator Discretion|0|||
147493391|NCT01496430|531961058|FG001|Overall Study|Principal Investigator Discretion|1|||
147493392|NCT01496430|531961059|FG002|Overall Study|Principal Investigator Discretion|1|||
147493393|NCT01496430|531961057|FG000|Overall Study|Other|2|||
147493394|NCT01496430|531961058|FG001|Overall Study|Other|0|||
147493395|NCT01496430|531961059|FG002|Overall Study|Other|0|||
147493396|NCT02108951|531961060|FG000|Overall Study|Lost to Follow-up|1|||
147493397|NCT02108951|531961060|FG000|Overall Study|Patient's/guardian's decision|1|||
147493398|NCT02108951|531961060|FG000|Overall Study|Study Terminated by Sponsor|14|||
147493399|NCT01151579|531961065|FG000|Overall Study|Physician Decision|3|||
147493400|NCT01151579|531961066|FG001|Overall Study|Physician Decision|1|||
147493401|NCT01151579|531961065|FG000|Overall Study|Withdrawal by Subject|3|||
147493402|NCT01151579|531961066|FG001|Overall Study|Withdrawal by Subject|2|||
147493403|NCT01151579|531961065|FG000|Overall Study|Not meet inclusion criteria|6|||
147493404|NCT01151579|531961066|FG001|Overall Study|Not meet inclusion criteria|4|||
147493405|NCT03633227|531961069|FG000|Double Blind (DB), up to Week 48|Withdrawal by Subject|1|||
147493406|NCT03633227|531961070|FG001|Double Blind (DB), up to Week 48|Withdrawal by Subject|1|||
147493407|NCT03633227|531961069|FG000|Double Blind (DB), up to Week 48|Death|2|||
147493408|NCT03633227|531961070|FG001|Double Blind (DB), up to Week 48|Death|1|||
147493409|NCT03633227|531961069|FG000|Double Blind (DB), up to Week 48|Adverse Event|0|||
147493410|NCT03633227|531961070|FG001|Double Blind (DB), up to Week 48|Adverse Event|1|||
147493411|NCT03633227|531961069|FG000|Double Blind (DB), up to Week 48|Study Terminated by Sponsor|2|||
147493412|NCT03633227|531961070|FG001|Double Blind (DB), up to Week 48|Study Terminated by Sponsor|1|||
147493413|NCT03633227|531961069|FG000|Double Blind (DB), up to Week 48|Physician Decision|1|||
147493414|NCT03633227|531961070|FG001|Double Blind (DB), up to Week 48|Physician Decision|0|||
147493415|NCT03633227|531961069|FG000|Double Blind (DB), up to Week 48|Liver Transplant During the Course of the Study|1|||
147493416|NCT03633227|531961070|FG001|Double Blind (DB), up to Week 48|Liver Transplant During the Course of the Study|0|||
147493417|NCT03633227|531961069|FG000|Double Blind (DB), up to Week 48|Multiple Serious Adverse Events and Drug Interruptions|1|||
147493418|NCT03633227|531961070|FG001|Double Blind (DB), up to Week 48|Multiple Serious Adverse Events and Drug Interruptions|0|||
147668103|NCT02577029|532609878|FG000|Overall Study|Withdrawal by Subject|0|||
147668104|NCT02577029|532609879|FG001|Overall Study|Withdrawal by Subject|0|||
147668105|NCT02577029|532609880|FG002|Overall Study|Withdrawal by Subject|0|||
147493419|NCT03633227|531961069|FG000|DB Extension, Week 48 up to 3 Years|Withdrawal by Subject|0|||
147493420|NCT03633227|531961070|FG001|DB Extension, Week 48 up to 3 Years|Withdrawal by Subject|2|||
147493421|NCT03633227|531961069|FG000|DB Extension, Week 48 up to 3 Years|Death|0|||
147493422|NCT03633227|531961070|FG001|DB Extension, Week 48 up to 3 Years|Death|1|||
147493423|NCT03633227|531961069|FG000|DB Extension, Week 48 up to 3 Years|Study Terminated by Sponsor|3|||
147493424|NCT03633227|531961070|FG001|DB Extension, Week 48 up to 3 Years|Study Terminated by Sponsor|2|||
147493425|NCT03633227|531961069|FG000|DB Extension, Week 48 up to 3 Years|Lost to Follow-up|1|||
147668106|NCT02577029|532609881|FG003|Overall Study|Withdrawal by Subject|0|||
147668107|NCT02577029|532609882|FG004|Overall Study|Withdrawal by Subject|0|||
147668108|NCT02577029|532609883|FG005|Overall Study|Withdrawal by Subject|1|||
147668109|NCT02577029|532609884|FG006|Overall Study|Withdrawal by Subject|0|||
147668110|NCT02577029|532609885|FG007|Overall Study|Withdrawal by Subject|0|||
147668111|NCT02577029|532609878|FG000|Overall Study|Sponsor Termination of the Study|9|||
147493426|NCT03633227|531961070|FG001|DB Extension, Week 48 up to 3 Years|Lost to Follow-up|0|||
147493427|NCT03633227|531961069|FG000|DB Extension, Week 48 up to 3 Years|Physician Decision|0|||
147493428|NCT03633227|531961070|FG001|DB Extension, Week 48 up to 3 Years|Physician Decision|1|||
147493429|NCT01766336|531961076|FG000|Overall Study|Adverse Event|11|||
147493430|NCT01766336|531961077|FG001|Overall Study|Adverse Event|8|||
147493431|NCT01766336|531961076|FG000|Overall Study|Death|4|||
147493432|NCT01766336|531961077|FG001|Overall Study|Death|3|||
147493433|NCT01766336|531961076|FG000|Overall Study|Lost to Follow-up|1|||
147493434|NCT01766336|531961077|FG001|Overall Study|Lost to Follow-up|3|||
147493435|NCT01766336|531961076|FG000|Overall Study|Physician Decision|4|||
147493436|NCT01766336|531961077|FG001|Overall Study|Physician Decision|2|||
147493437|NCT01766336|531961076|FG000|Overall Study|Protocol Violation|0|||
147493438|NCT01766336|531961077|FG001|Overall Study|Protocol Violation|1|||
147493439|NCT01766336|531961076|FG000|Overall Study|Sponsor Decision|52|||
147493440|NCT01766336|531961077|FG001|Overall Study|Sponsor Decision|43|||
147493441|NCT01766336|531961076|FG000|Overall Study|Withdrawal by Subject|18|||
147493442|NCT01766336|531961077|FG001|Overall Study|Withdrawal by Subject|15|||
147493443|NCT02605447|531961079|FG000|Overall Study|Death|66|||
147493444|NCT02605447|531961079|FG000|Overall Study|Physician Decision|1|||
147493445|NCT02605447|531961079|FG000|Overall Study|Lost to Follow-up|24|||
147493446|NCT02605447|531961079|FG000|Overall Study|Withdrawal by Subject|10|||
147493447|NCT02605447|531961079|FG000|Overall Study|Not disclosed|1|||
147493448|NCT01479374|531961080|FG000|Overall Study|Adverse Event|2|||
147493449|NCT01479374|531961081|FG001|Overall Study|Adverse Event|1|||
147493450|NCT01479374|531961082|FG002|Overall Study|Adverse Event|0|||
147493451|NCT01479374|531961080|FG000|Overall Study|Lost to Follow-up|1|||
147493452|NCT01479374|531961081|FG001|Overall Study|Lost to Follow-up|2|||
147493453|NCT01479374|531961082|FG002|Overall Study|Lost to Follow-up|0|||
147493454|NCT01479374|531961080|FG000|Overall Study|Decision Unrelated to Adverse Event|0|||
147493455|NCT01479374|531961081|FG001|Overall Study|Decision Unrelated to Adverse Event|1|||
147493456|NCT01479374|531961082|FG002|Overall Study|Decision Unrelated to Adverse Event|0|||
147493457|NCT01479374|531961080|FG000|Overall Study|Other|0|||
147493458|NCT01479374|531961081|FG001|Overall Study|Other|4|||
147493459|NCT01479374|531961082|FG002|Overall Study|Other|5|||
147493460|NCT02045212|531961084|FG000|Overall Study|Adverse Event|0|||
147493461|NCT02045212|531961085|FG001|Overall Study|Adverse Event|1|||
147493462|NCT02045212|531961084|FG000|Overall Study|Withdrawal by Subject|1|||
147493463|NCT02045212|531961085|FG001|Overall Study|Withdrawal by Subject|0|||
147493464|NCT02045212|531961084|FG000|Overall Study|Finished 13 weeks, chose not to extend|1|||
147493465|NCT02045212|531961085|FG001|Overall Study|Finished 13 weeks, chose not to extend|0|||
147493466|NCT00515008|531961091|FG000|Overall Study|Lost to Follow-up|1|||
147493467|NCT00515008|531961092|FG001|Overall Study|Lost to Follow-up|0|||
147493468|NCT00515008|531961091|FG000|Overall Study|Declined|0|||
147493469|NCT00515008|531961092|FG001|Overall Study|Declined|3|||
147493470|NCT00515008|531961091|FG000|Overall Study|Left the Boston Area|1|||
147493471|NCT00515008|531961092|FG001|Overall Study|Left the Boston Area|1|||
147493472|NCT00515008|531961091|FG000|Overall Study|Scheduling conflict|1|||
147493473|NCT00515008|531961092|FG001|Overall Study|Scheduling conflict|0|||
147493474|NCT03135028|531961093|FG000|Overall Study|Death|6|||
147493475|NCT03135028|531961093|FG000|Overall Study|Study Terminated by Sponsor|2|||
147493476|NCT03135028|531961093|FG000|Overall Study|Withdrew Consent|1|||
147493477|NCT03126539|531961103|FG000|Overall Study|Lost to Follow-up|1|||
147493478|NCT03126539|531961104|FG001|Overall Study|Lost to Follow-up|1|||
147493479|NCT03126539|531961105|FG002|Overall Study|Lost to Follow-up|1|||
147493480|NCT03126539|531961106|FG003|Overall Study|Lost to Follow-up|0|||
147493481|NCT03126539|531961107|FG004|Overall Study|Lost to Follow-up|0|||
147493482|NCT02596711|531961110|FG000|Overall Study|Lost to Follow-up|1|||
147493483|NCT02596711|531961111|FG001|Overall Study|Lost to Follow-up|2|||
147493484|NCT02596711|531961112|FG002|Overall Study|Lost to Follow-up|3|||
147493485|NCT01005732|531961113|FG000|Overall Study|Lost to Follow-up|10|||
147493486|NCT01005732|531961113|FG000|Overall Study|Death|1|||
147493487|NCT00632463|531961115|FG000|Overall Study|Adverse Event|0|||
147493488|NCT00632463|531961116|FG001|Overall Study|Adverse Event|1|||
147493489|NCT00632463|531961117|FG002|Overall Study|Adverse Event|0|||
147493490|NCT02998554|531961121|FG000|Overall Study|Adverse Event|8|||
147493491|NCT02998554|531961122|FG001|Overall Study|Adverse Event|3|||
147493492|NCT02998554|531961121|FG000|Overall Study|Protocol deviation|1|||
147493493|NCT02998554|531961122|FG001|Overall Study|Protocol deviation|0|||
147493494|NCT02998554|531961121|FG000|Overall Study|Withdrawal by Subject|2|||
147493495|NCT02998554|531961122|FG001|Overall Study|Withdrawal by Subject|6|||
147493496|NCT02998554|531961121|FG000|Overall Study|Lost to Follow-up|0|||
147493497|NCT02998554|531961122|FG001|Overall Study|Lost to Follow-up|1|||
147493498|NCT02998554|531961121|FG000|Overall Study|Lack of Efficacy|0|||
147493499|NCT02998554|531961122|FG001|Overall Study|Lack of Efficacy|1|||
147493500|NCT02112994|531961125|FG000|Overall Study|Progressive Disease|0|||
147493501|NCT02112994|531961126|FG001|Overall Study|Progressive Disease|0|||
147493502|NCT02112994|531961127|FG002|Overall Study|Progressive Disease|1|||
147493503|NCT02112994|531961125|FG000|Overall Study|Pregnancy|0|||
147493504|NCT02112994|531961126|FG001|Overall Study|Pregnancy|1|||
147493505|NCT02112994|531961127|FG002|Overall Study|Pregnancy|1|||
147493506|NCT02112994|531961125|FG000|Overall Study|Liver Transplant|0|||
147493507|NCT02112994|531961126|FG001|Overall Study|Liver Transplant|1|||
147493508|NCT02112994|531961127|FG002|Overall Study|Liver Transplant|0|||
147493509|NCT02112994|531961125|FG000|Overall Study|Withdrawal by Subject|0|||
147493510|NCT02112994|531961126|FG001|Overall Study|Withdrawal by Subject|0|||
147493511|NCT02112994|531961127|FG002|Overall Study|Withdrawal by Subject|1|||
147493512|NCT01683071|531961131|FG000|Part 1|Lack of Efficacy|1|||
147493513|NCT01683071|531961132|FG001|Part 1|Lack of Efficacy|0|||
147493514|NCT01683071|531961133|FG002|Part 1|Lack of Efficacy|0|||
147493515|NCT01683071|531961134|FG003|Part 1|Lack of Efficacy|3|||
147493516|NCT01683071|531961135|FG004|Part 1|Lack of Efficacy|0|||
147493517|NCT01683071|531961136|FG005|Part 1|Lack of Efficacy|0|||
147493518|NCT01683071|531961131|FG000|Part 1|Withdrawal by Subject|1|||
147493519|NCT01683071|531961132|FG001|Part 1|Withdrawal by Subject|2|||
147493520|NCT01683071|531961133|FG002|Part 1|Withdrawal by Subject|2|||
147493521|NCT01683071|531961134|FG003|Part 1|Withdrawal by Subject|1|||
147493522|NCT01683071|531961135|FG004|Part 1|Withdrawal by Subject|0|||
147493523|NCT01683071|531961136|FG005|Part 1|Withdrawal by Subject|0|||
147493524|NCT01683071|531961131|FG000|Part 1|Surgery Cancelled|1|||
147493525|NCT01683071|531961132|FG001|Part 1|Surgery Cancelled|0|||
147493526|NCT01683071|531961133|FG002|Part 1|Surgery Cancelled|0|||
147493527|NCT01683071|531961134|FG003|Part 1|Surgery Cancelled|0|||
147493528|NCT01683071|531961135|FG004|Part 1|Surgery Cancelled|0|||
147493529|NCT01683071|531961136|FG005|Part 1|Surgery Cancelled|0|||
147493530|NCT01683071|531961131|FG000|Part 1|Did not receive study drug|1|||
147493531|NCT01683071|531961132|FG001|Part 1|Did not receive study drug|0|||
147493532|NCT01683071|531961133|FG002|Part 1|Did not receive study drug|0|||
147493533|NCT01683071|531961134|FG003|Part 1|Did not receive study drug|1|||
147493534|NCT01683071|531961135|FG004|Part 1|Did not receive study drug|0|||
147493535|NCT01683071|531961136|FG005|Part 1|Did not receive study drug|0|||
147493536|NCT01683071|531961131|FG000|Part 1|Early termination; met exclusion criteria|0|||
147493537|NCT01683071|531961132|FG001|Part 1|Early termination; met exclusion criteria|2|||
147493538|NCT01683071|531961133|FG002|Part 1|Early termination; met exclusion criteria|1|||
147493539|NCT01683071|531961134|FG003|Part 1|Early termination; met exclusion criteria|0|||
147493540|NCT01683071|531961135|FG004|Part 1|Early termination; met exclusion criteria|0|||
147493541|NCT01683071|531961136|FG005|Part 1|Early termination; met exclusion criteria|0|||
147493542|NCT01683071|531961131|FG000|Part 2|Lack of Efficacy|0|||
147493543|NCT01683071|531961132|FG001|Part 2|Lack of Efficacy|0|||
147493544|NCT01683071|531961133|FG002|Part 2|Lack of Efficacy|0|||
147493545|NCT01683071|531961134|FG003|Part 2|Lack of Efficacy|0|||
147493546|NCT01683071|531961135|FG004|Part 2|Lack of Efficacy|3|||
147493547|NCT01683071|531961136|FG005|Part 2|Lack of Efficacy|4|||
147493548|NCT01683071|531961131|FG000|Part 2|Lost to Follow-up|0|||
147493549|NCT01683071|531961132|FG001|Part 2|Lost to Follow-up|0|||
147493550|NCT01683071|531961133|FG002|Part 2|Lost to Follow-up|0|||
147493551|NCT01683071|531961134|FG003|Part 2|Lost to Follow-up|0|||
147493552|NCT01683071|531961135|FG004|Part 2|Lost to Follow-up|2|||
147493553|NCT01683071|531961136|FG005|Part 2|Lost to Follow-up|0|||
147493554|NCT01683071|531961131|FG000|Part 2|Withdrawal by Subject|0|||
147493555|NCT01683071|531961132|FG001|Part 2|Withdrawal by Subject|0|||
147493556|NCT01683071|531961133|FG002|Part 2|Withdrawal by Subject|0|||
147493557|NCT01683071|531961134|FG003|Part 2|Withdrawal by Subject|0|||
147668112|NCT02577029|532609879|FG001|Overall Study|Sponsor Termination of the Study|2|||
147668113|NCT02577029|532609880|FG002|Overall Study|Sponsor Termination of the Study|5|||
147668114|NCT02577029|532609881|FG003|Overall Study|Sponsor Termination of the Study|12|||
147493558|NCT01683071|531961135|FG004|Part 2|Withdrawal by Subject|3|||
147493559|NCT01683071|531961136|FG005|Part 2|Withdrawal by Subject|3|||
147493560|NCT01683071|531961131|FG000|Part 2|Surgery cancelled|0|||
147493561|NCT01683071|531961132|FG001|Part 2|Surgery cancelled|0|||
147493562|NCT01683071|531961133|FG002|Part 2|Surgery cancelled|0|||
147493563|NCT01683071|531961134|FG003|Part 2|Surgery cancelled|0|||
147493564|NCT01683071|531961135|FG004|Part 2|Surgery cancelled|4|||
147493565|NCT01683071|531961136|FG005|Part 2|Surgery cancelled|2|||
147668115|NCT02577029|532609882|FG004|Overall Study|Sponsor Termination of the Study|10|||
147668116|NCT02577029|532609883|FG005|Overall Study|Sponsor Termination of the Study|12|||
147668117|NCT02577029|532609884|FG006|Overall Study|Sponsor Termination of the Study|12|||
147493566|NCT01683071|531961131|FG000|Part 2|Did not receive study drug|0|||
147493567|NCT01683071|531961132|FG001|Part 2|Did not receive study drug|0|||
147493568|NCT01683071|531961133|FG002|Part 2|Did not receive study drug|0|||
147493569|NCT01683071|531961134|FG003|Part 2|Did not receive study drug|0|||
147493570|NCT01683071|531961135|FG004|Part 2|Did not receive study drug|2|||
147493571|NCT01683071|531961136|FG005|Part 2|Did not receive study drug|1|||
147493572|NCT01683071|531961131|FG000|Part 2|Met exclusion criterion|0|||
147493573|NCT01683071|531961132|FG001|Part 2|Met exclusion criterion|0|||
147493574|NCT01683071|531961133|FG002|Part 2|Met exclusion criterion|0|||
147493575|NCT01683071|531961134|FG003|Part 2|Met exclusion criterion|0|||
147493576|NCT01683071|531961135|FG004|Part 2|Met exclusion criterion|1|||
147493577|NCT01683071|531961136|FG005|Part 2|Met exclusion criterion|1|||
147493578|NCT01683071|531961131|FG000|Part 2|Protocol deviation|0|||
147493579|NCT01683071|531961132|FG001|Part 2|Protocol deviation|0|||
147493580|NCT01683071|531961133|FG002|Part 2|Protocol deviation|0|||
147493581|NCT01683071|531961134|FG003|Part 2|Protocol deviation|0|||
147493582|NCT01683071|531961135|FG004|Part 2|Protocol deviation|1|||
147493583|NCT01683071|531961136|FG005|Part 2|Protocol deviation|2|||
147493584|NCT01683071|531961131|FG000|Part 2|Withdrawal by investigator decision|0|||
147493585|NCT01683071|531961132|FG001|Part 2|Withdrawal by investigator decision|0|||
147493586|NCT01683071|531961133|FG002|Part 2|Withdrawal by investigator decision|0|||
147493587|NCT01683071|531961134|FG003|Part 2|Withdrawal by investigator decision|0|||
147493588|NCT01683071|531961135|FG004|Part 2|Withdrawal by investigator decision|1|||
147493589|NCT01683071|531961136|FG005|Part 2|Withdrawal by investigator decision|2|||
147493590|NCT03675737|531961140|FG000|Overall Study|Death|593|||
147493591|NCT03675737|531961141|FG001|Overall Study|Death|660|||
147493592|NCT03675737|531961140|FG000|Overall Study|Lost to Follow-up|1|||
147493593|NCT03675737|531961141|FG001|Overall Study|Lost to Follow-up|5|||
147493594|NCT03675737|531961140|FG000|Overall Study|Physician Decision|1|||
147493595|NCT03675737|531961141|FG001|Overall Study|Physician Decision|0|||
147493596|NCT03675737|531961140|FG000|Overall Study|Withdrawal by Subject|14|||
147493597|NCT03675737|531961141|FG001|Overall Study|Withdrawal by Subject|12|||
147493598|NCT03675737|531961140|FG000|Overall Study|Ongoing in Study|181|||
147493599|NCT03675737|531961141|FG001|Overall Study|Ongoing in Study|112|||
147493600|NCT02349789|531962420|FG000|Overall Study|Withdrawal by Subject|2|||
147493601|NCT00280150|531962423|FG000|Overall Study|Adverse Event|0|||
147493602|NCT00280150|531962424|FG001|Overall Study|Adverse Event|1|||
147493603|NCT00280150|531962425|FG002|Overall Study|Adverse Event|2|||
147493604|NCT00280150|531962426|FG003|Overall Study|Adverse Event|3|||
147493605|NCT00280150|531962423|FG000|Overall Study|Lack of Efficacy|0|||
147493606|NCT00280150|531962424|FG001|Overall Study|Lack of Efficacy|0|||
147493607|NCT00280150|531962425|FG002|Overall Study|Lack of Efficacy|0|||
147493608|NCT00280150|531962426|FG003|Overall Study|Lack of Efficacy|3|||
147493609|NCT00280150|531962423|FG000|Overall Study|Physician Decision|0|||
147493610|NCT00280150|531962424|FG001|Overall Study|Physician Decision|0|||
147493611|NCT00280150|531962425|FG002|Overall Study|Physician Decision|0|||
147493612|NCT00280150|531962426|FG003|Overall Study|Physician Decision|1|||
147493613|NCT00280150|531962423|FG000|Overall Study|Protocol Violation|0|||
147493614|NCT00280150|531962424|FG001|Overall Study|Protocol Violation|0|||
147493615|NCT00280150|531962425|FG002|Overall Study|Protocol Violation|0|||
147493616|NCT00280150|531962426|FG003|Overall Study|Protocol Violation|1|||
147493617|NCT00280150|531962423|FG000|Overall Study|Withdrawal by Subject|0|||
147493618|NCT00280150|531962424|FG001|Overall Study|Withdrawal by Subject|0|||
147493619|NCT00280150|531962425|FG002|Overall Study|Withdrawal by Subject|0|||
147493620|NCT00280150|531962426|FG003|Overall Study|Withdrawal by Subject|1|||
147493621|NCT00280150|531962423|FG000|Overall Study|Did not get consolidation therapy|3|||
147493622|NCT00280150|531962424|FG001|Overall Study|Did not get consolidation therapy|0|||
147493623|NCT00280150|531962425|FG002|Overall Study|Did not get consolidation therapy|3|||
147493624|NCT00280150|531962426|FG003|Overall Study|Did not get consolidation therapy|0|||
147493625|NCT00280150|531962423|FG000|Overall Study|Declining Performance Status|0|||
147493626|NCT00280150|531962424|FG001|Overall Study|Declining Performance Status|0|||
147493627|NCT00280150|531962425|FG002|Overall Study|Declining Performance Status|0|||
147493628|NCT00280150|531962426|FG003|Overall Study|Declining Performance Status|1|||
147493629|NCT00568958|531962427|FG000|Allocation|Withdrawal by Subject|7|||
147493630|NCT00568958|531962428|FG001|Allocation|Withdrawal by Subject|3|||
147493631|NCT00568958|531962427|FG000|Allocation|Physician Decision|2|||
147493632|NCT00568958|531962428|FG001|Allocation|Physician Decision|0|||
147493633|NCT00568958|531962427|FG000|Follow-Up|Withdrawal by Subject|6|||
147493634|NCT00568958|531962428|FG001|Follow-Up|Withdrawal by Subject|6|||
147493635|NCT00568958|531962427|FG000|Follow-Up|Physician Decision|1|||
147493636|NCT00568958|531962428|FG001|Follow-Up|Physician Decision|1|||
147493637|NCT00568958|531962427|FG000|Follow-Up|Family Emergency|1|||
147493638|NCT00568958|531962428|FG001|Follow-Up|Family Emergency|0|||
147493639|NCT00568958|531962427|FG000|Follow-Up|Adverse Event|1|||
147493640|NCT00568958|531962428|FG001|Follow-Up|Adverse Event|0|||
147493641|NCT03583372|531962430|FG000|Overall Study|Withdrawal by Subject|6|||
147493642|NCT03583372|531962431|FG001|Overall Study|Withdrawal by Subject|11|||
147493643|NCT03583372|531962432|FG002|Overall Study|Withdrawal by Subject|7|||
147493644|NCT03583372|531962433|FG003|Overall Study|Withdrawal by Subject|8|||
147493645|NCT03583372|531962430|FG000|Overall Study|Lost to Follow-up|4|||
147493646|NCT03583372|531962431|FG001|Overall Study|Lost to Follow-up|6|||
147493647|NCT03583372|531962432|FG002|Overall Study|Lost to Follow-up|3|||
147493648|NCT03583372|531962433|FG003|Overall Study|Lost to Follow-up|2|||
147493649|NCT03583372|531962430|FG000|Overall Study|Adverse Event|1|||
147493650|NCT03583372|531962431|FG001|Overall Study|Adverse Event|3|||
147493651|NCT03583372|531962432|FG002|Overall Study|Adverse Event|4|||
147493652|NCT03583372|531962433|FG003|Overall Study|Adverse Event|4|||
147493653|NCT03583372|531962430|FG000|Overall Study|Physician Decision|0|||
147493654|NCT03583372|531962431|FG001|Overall Study|Physician Decision|1|||
147493655|NCT03583372|531962432|FG002|Overall Study|Physician Decision|1|||
147493656|NCT03583372|531962433|FG003|Overall Study|Physician Decision|1|||
147493657|NCT03583372|531962430|FG000|Overall Study|Lack of Efficacy|0|||
147493658|NCT03583372|531962431|FG001|Overall Study|Lack of Efficacy|1|||
147493659|NCT03583372|531962432|FG002|Overall Study|Lack of Efficacy|0|||
147493660|NCT03583372|531962433|FG003|Overall Study|Lack of Efficacy|1|||
147493661|NCT03583372|531962430|FG000|Overall Study|Death|1|||
147493662|NCT03583372|531962431|FG001|Overall Study|Death|0|||
147493663|NCT03583372|531962432|FG002|Overall Study|Death|0|||
147493664|NCT03583372|531962433|FG003|Overall Study|Death|0|||
147493665|NCT03583372|531962430|FG000|Overall Study|Protocol Violation|0|||
147493666|NCT03583372|531962431|FG001|Overall Study|Protocol Violation|1|||
147493667|NCT03583372|531962432|FG002|Overall Study|Protocol Violation|0|||
147493668|NCT03583372|531962433|FG003|Overall Study|Protocol Violation|0|||
147493669|NCT03583372|531962430|FG000|Overall Study|Subject Withdrawn due to Sponsor|0|||
147493670|NCT03583372|531962431|FG001|Overall Study|Subject Withdrawn due to Sponsor|0|||
147493671|NCT03583372|531962432|FG002|Overall Study|Subject Withdrawn due to Sponsor|0|||
147493672|NCT03583372|531962433|FG003|Overall Study|Subject Withdrawn due to Sponsor|1|||
147493673|NCT03583372|531962430|FG000|Overall Study|Did Not Receive Study Drug|0|||
147493674|NCT03583372|531962431|FG001|Overall Study|Did Not Receive Study Drug|1|||
147493675|NCT03583372|531962432|FG002|Overall Study|Did Not Receive Study Drug|0|||
147493676|NCT03583372|531962433|FG003|Overall Study|Did Not Receive Study Drug|0|||
147493677|NCT03583372|531962430|FG000|Overall Study|Captured as Other in the Database|1|||
147493678|NCT03583372|531962431|FG001|Overall Study|Captured as Other in the Database|2|||
147493679|NCT03583372|531962432|FG002|Overall Study|Captured as Other in the Database|4|||
147493680|NCT03583372|531962433|FG003|Overall Study|Captured as Other in the Database|1|||
147493681|NCT02796391|531962434|FG000|Overall Study|Lost to Follow-up|2|||
147493682|NCT02796391|531962435|FG001|Overall Study|Lost to Follow-up|2|||
147493683|NCT02796391|531962436|FG002|Overall Study|Lost to Follow-up|13|||
147493684|NCT02796391|531962437|FG003|Overall Study|Lost to Follow-up|8|||
147493685|NCT02796391|531962438|FG004|Overall Study|Lost to Follow-up|14|||
147493686|NCT02796391|531962439|FG005|Overall Study|Lost to Follow-up|13|||
147493687|NCT02796391|531962434|FG000|Overall Study|COVID|0|||
147493688|NCT02796391|531962435|FG001|Overall Study|COVID|0|||
147493689|NCT02796391|531962436|FG002|Overall Study|COVID|5|||
147493690|NCT02796391|531962437|FG003|Overall Study|COVID|5|||
147493691|NCT02796391|531962438|FG004|Overall Study|COVID|2|||
147493692|NCT02796391|531962439|FG005|Overall Study|COVID|4|||
147493693|NCT02796391|531962434|FG000|Overall Study|Participant did not like study cigarettes|0|||
147493694|NCT02796391|531962435|FG001|Overall Study|Participant did not like study cigarettes|0|||
147493695|NCT02796391|531962436|FG002|Overall Study|Participant did not like study cigarettes|3|||
147493696|NCT02796391|531962437|FG003|Overall Study|Participant did not like study cigarettes|0|||
147493697|NCT02796391|531962438|FG004|Overall Study|Participant did not like study cigarettes|0|||
147493698|NCT02796391|531962439|FG005|Overall Study|Participant did not like study cigarettes|0|||
147493699|NCT02796391|531962434|FG000|Overall Study|Withdrawal by Subject|1|||
147493700|NCT02796391|531962435|FG001|Overall Study|Withdrawal by Subject|1|||
147493701|NCT02796391|531962436|FG002|Overall Study|Withdrawal by Subject|4|||
147493702|NCT02796391|531962437|FG003|Overall Study|Withdrawal by Subject|3|||
147493703|NCT02796391|531962438|FG004|Overall Study|Withdrawal by Subject|4|||
147493704|NCT02796391|531962439|FG005|Overall Study|Withdrawal by Subject|3|||
147493705|NCT02796391|531962434|FG000|Overall Study|Adverse Event|0|||
147493706|NCT02796391|531962435|FG001|Overall Study|Adverse Event|0|||
147493707|NCT02796391|531962436|FG002|Overall Study|Adverse Event|0|||
147493708|NCT02796391|531962437|FG003|Overall Study|Adverse Event|1|||
147493709|NCT02796391|531962438|FG004|Overall Study|Adverse Event|0|||
147493710|NCT02796391|531962439|FG005|Overall Study|Adverse Event|0|||
147493711|NCT02796391|531962434|FG000|Overall Study|Protocol Violation|0|||
147493712|NCT02796391|531962435|FG001|Overall Study|Protocol Violation|0|||
147493713|NCT02796391|531962436|FG002|Overall Study|Protocol Violation|0|||
147493714|NCT02796391|531962437|FG003|Overall Study|Protocol Violation|1|||
147493715|NCT02796391|531962438|FG004|Overall Study|Protocol Violation|0|||
147493716|NCT02796391|531962439|FG005|Overall Study|Protocol Violation|0|||
147493717|NCT00831441|531962440|FG000|Randomized|Death|82|||
147493718|NCT00831441|531962441|FG001|Randomized|Death|81|||
147493719|NCT00831441|531962440|FG000|Randomized|Adverse Event|248|||
147493720|NCT00831441|531962441|FG001|Randomized|Adverse Event|321|||
147493721|NCT00831441|531962440|FG000|Randomized|Emergency procedure|2|||
147493722|NCT00831441|531962441|FG001|Randomized|Emergency procedure|2|||
147493723|NCT00831441|531962440|FG000|Randomized|Elective procedure|26|||
147493724|NCT00831441|531962441|FG001|Randomized|Elective procedure|25|||
147493725|NCT00831441|531962440|FG000|Randomized|Physician Decision|26|||
147493726|NCT00831441|531962441|FG001|Randomized|Physician Decision|35|||
147493727|NCT00831441|531962440|FG000|Randomized|No longer met criteria|13|||
147493728|NCT00831441|531962441|FG001|Randomized|No longer met criteria|19|||
147493729|NCT00831441|531962440|FG000|Randomized|Withdrawal by Subject|178|||
147493730|NCT00831441|531962441|FG001|Randomized|Withdrawal by Subject|212|||
147493731|NCT00831441|531962440|FG000|Randomized|Lost to Follow-up|26|||
147493732|NCT00831441|531962441|FG001|Randomized|Lost to Follow-up|35|||
147493733|NCT00831441|531962440|FG000|Randomized|Administrative reason by sponsor|2780|||
147493734|NCT00831441|531962441|FG001|Randomized|Administrative reason by sponsor|2671|||
147493735|NCT00831441|531962440|FG000|Randomized|poor/non-compliance|30|||
147493736|NCT00831441|531962441|FG001|Randomized|poor/non-compliance|38|||
147493737|NCT00831441|531962440|FG000|Randomized|non-specified|276|||
147493738|NCT00831441|531962441|FG001|Randomized|non-specified|266|||
147493739|NCT00831441|531962440|FG000|Follow Up (30 Days)|Withdrawal by Subject|41|||
147493740|NCT00831441|531962441|FG001|Follow Up (30 Days)|Withdrawal by Subject|34|||
147493741|NCT00831441|531962440|FG000|Follow Up (30 Days)|Lost to Follow-up|13|||
147493742|NCT00831441|531962441|FG001|Follow Up (30 Days)|Lost to Follow-up|27|||
147493743|NCT00831441|531962440|FG000|Follow Up (30 Days)|Death|63|||
147493744|NCT00831441|531962441|FG001|Follow Up (30 Days)|Death|86|||
147493745|NCT00831441|531962440|FG000|Follow Up (30 Days)|non-specified|16|||
147493746|NCT00831441|531962441|FG001|Follow Up (30 Days)|non-specified|26|||
147493747|NCT00831441|531962440|FG000|Follow Up (30 Days)|missing end of study status|0|||
147493748|NCT00831441|531962441|FG001|Follow Up (30 Days)|missing end of study status|1|||
147493749|NCT00377611|531962442|FG000|Overall Study|Adverse Event|2|||
147493750|NCT00377611|531962443|FG001|Overall Study|Adverse Event|9|||
147493751|NCT00377611|531962442|FG000|Overall Study|Protocol Violation|2|||
147493752|NCT00377611|531962443|FG001|Overall Study|Protocol Violation|0|||
147493753|NCT00377611|531962442|FG000|Overall Study|Withdrawal by Subject|0|||
147493754|NCT00377611|531962443|FG001|Overall Study|Withdrawal by Subject|5|||
147493755|NCT00377611|531962442|FG000|Overall Study|Lost to Follow-up|18|||
147493756|NCT00377611|531962443|FG001|Overall Study|Lost to Follow-up|16|||
147493757|NCT00377611|531962442|FG000|Overall Study|Other|0|||
147493758|NCT00377611|531962443|FG001|Overall Study|Other|3|||
147493759|NCT05674344|531962444|FG000|Overall Study|Screen Fail|21|||
147493760|NCT05674344|531962444|FG000|Overall Study|Incomplete study procedures|3|||
147493761|NCT00111917|531962445|FG000|Overall Study|Withdrawal by Subject|1|||
147493762|NCT00111917|531962446|FG001|Overall Study|Withdrawal by Subject|1|||
147493763|NCT04831515|531962447|FG000|First Intervention|Adverse Event|0|||
147493764|NCT04831515|531962448|FG001|First Intervention|Adverse Event|1|||
147493765|NCT01640925|531962449|FG000|Overall Study|Withdrawal by Subject|1|||
147493766|NCT01640925|531962450|FG001|Overall Study|Withdrawal by Subject|0|||
147493767|NCT01640925|531962449|FG000|Overall Study|Previously enrolled in this trial|13|||
147493768|NCT01640925|531962450|FG001|Overall Study|Previously enrolled in this trial|11|||
147493769|NCT02156492|531962451|FG000|Period 1|No Reason Given|0|||
147493770|NCT02156492|531962452|FG001|Period 1|No Reason Given|1|||
147493771|NCT02156492|531962453|FG002|Period 1|No Reason Given|0|||
147493772|NCT02156492|531962451|FG000|Period 3|Adverse Event|0|||
147493773|NCT02156492|531962452|FG001|Period 3|Adverse Event|1|||
147493774|NCT02156492|531962453|FG002|Period 3|Adverse Event|0|||
147493775|NCT00485589|531962471|FG000|Overall Study|Death|2|||
147493776|NCT00485589|531962472|FG001|Overall Study|Death|2|||
147493777|NCT00485589|531962473|FG002|Overall Study|Death|0|||
147493778|NCT00485589|531962471|FG000|Overall Study|Failure to return|6|||
147493779|NCT00485589|531962472|FG001|Overall Study|Failure to return|5|||
147493780|NCT00485589|531962473|FG002|Overall Study|Failure to return|1|||
147493781|NCT00485589|531962471|FG000|Overall Study|Protocol Violation|1|||
147493782|NCT00485589|531962472|FG001|Overall Study|Protocol Violation|0|||
147493783|NCT00485589|531962473|FG002|Overall Study|Protocol Violation|0|||
147493784|NCT00485589|531962471|FG000|Overall Study|Violation of selection criteria at entry|0|||
147493785|NCT00485589|531962472|FG001|Overall Study|Violation of selection criteria at entry|3|||
147493786|NCT00485589|531962473|FG002|Overall Study|Violation of selection criteria at entry|1|||
147493787|NCT00485589|531962471|FG000|Overall Study|Administrative/Other|1|||
147493788|NCT00485589|531962472|FG001|Overall Study|Administrative/Other|2|||
147493789|NCT00485589|531962473|FG002|Overall Study|Administrative/Other|1|||
147493790|NCT00485589|531962471|FG000|Overall Study|Insufficient therapeutic response|10|||
147493791|NCT00485589|531962472|FG001|Overall Study|Insufficient therapeutic response|3|||
147493792|NCT00485589|531962473|FG002|Overall Study|Insufficient therapeutic response|1|||
147493793|NCT00485589|531962471|FG000|Overall Study|Refused treatment/did not cooperate|1|||
147493794|NCT00485589|531962472|FG001|Overall Study|Refused treatment/did not cooperate|0|||
147493795|NCT00485589|531962473|FG002|Overall Study|Refused treatment/did not cooperate|2|||
147493796|NCT00485589|531962471|FG000|Overall Study|Withdrawal by Subject|3|||
147493797|NCT00485589|531962472|FG001|Overall Study|Withdrawal by Subject|2|||
147493798|NCT00485589|531962473|FG002|Overall Study|Withdrawal by Subject|2|||
147493799|NCT00485589|531962471|FG000|Overall Study|Adverse Event|3|||
147493800|NCT00485589|531962472|FG001|Overall Study|Adverse Event|3|||
147493801|NCT00485589|531962473|FG002|Overall Study|Adverse Event|10|||
147493802|NCT04348656|531962474|FG000|Overall Study|Withdrawal by Subject|2|||
147493803|NCT04348656|531962475|FG001|Overall Study|Withdrawal by Subject|0|||
147493804|NCT04348656|531962474|FG000|Overall Study|Lost to Follow-up|11|||
147493805|NCT04348656|531962475|FG001|Overall Study|Lost to Follow-up|6|||
147493806|NCT01944969|531962476|FG000|Overall Study|Adverse Event|1|||
147493807|NCT01944969|531962476|FG000|Overall Study|Lack of Efficacy|1|||
147493808|NCT01944969|531962476|FG000|Overall Study|Non-compliance with IMP|1|||
147493809|NCT01944969|531962476|FG000|Overall Study|Administrative or other reasons|23|||
147493810|NCT03072719|531962477|FG000|Overall Study|Adverse Event|1|||
147493811|NCT03072719|531962478|FG001|Overall Study|Adverse Event|1|||
147493812|NCT02387372|531962479|FG000|Overall Study|Not Treated|1|||
147493813|NCT02387372|531962480|FG001|Overall Study|Not Treated|0|||
147493814|NCT00436566|531962484|FG000|Overall Study|Withdrawal by Subject|2|||
147493815|NCT00436566|531962484|FG000|Overall Study|Protocol Violation|1|||
147493816|NCT01954251|531962487|FG000|Overall Study|Adverse Event|5|||
147493817|NCT01954251|531962488|FG001|Overall Study|Adverse Event|7|||
147493818|NCT01954251|531962487|FG000|Overall Study|Lost to Follow-up|6|||
147493819|NCT01954251|531962488|FG001|Overall Study|Lost to Follow-up|6|||
147493820|NCT01954251|531962487|FG000|Overall Study|Withdrawal by Subject|2|||
147493821|NCT01954251|531962488|FG001|Overall Study|Withdrawal by Subject|6|||
147493822|NCT02504268|531962491|FG000|Overall Study|Adverse Event|18|||
147493823|NCT02504268|531962492|FG001|Overall Study|Adverse Event|8|||
147493824|NCT02504268|531962493|FG002|Overall Study|Adverse Event|14|||
147493825|NCT02504268|531962494|FG003|Overall Study|Adverse Event|0|||
147493826|NCT02504268|531962495|FG004|Overall Study|Adverse Event|0|||
147493827|NCT02504268|531962496|FG005|Overall Study|Adverse Event|0|||
147493828|NCT02504268|531962497|FG006|Overall Study|Adverse Event|0|||
147493829|NCT02504268|531962498|FG007|Overall Study|Adverse Event|0|||
147493830|NCT02504268|531962499|FG008|Overall Study|Adverse Event|0|||
147493831|NCT02504268|531962491|FG000|Overall Study|Withdrawal of Consent|11|||
147493832|NCT02504268|531962492|FG001|Overall Study|Withdrawal of Consent|10|||
147493833|NCT02504268|531962493|FG002|Overall Study|Withdrawal of Consent|3|||
147493834|NCT02504268|531962494|FG003|Overall Study|Withdrawal of Consent|0|||
147493835|NCT02504268|531962495|FG004|Overall Study|Withdrawal of Consent|0|||
147493836|NCT02504268|531962496|FG005|Overall Study|Withdrawal of Consent|0|||
147493837|NCT02504268|531962497|FG006|Overall Study|Withdrawal of Consent|0|||
147493838|NCT02504268|531962498|FG007|Overall Study|Withdrawal of Consent|0|||
147493839|NCT02504268|531962499|FG008|Overall Study|Withdrawal of Consent|0|||
147493840|NCT02504268|531962491|FG000|Overall Study|Pregnancy|2|||
147493841|NCT02504268|531962492|FG001|Overall Study|Pregnancy|0|||
147493842|NCT02504268|531962493|FG002|Overall Study|Pregnancy|0|||
147493843|NCT02504268|531962494|FG003|Overall Study|Pregnancy|0|||
147493844|NCT02504268|531962495|FG004|Overall Study|Pregnancy|0|||
147493845|NCT02504268|531962496|FG005|Overall Study|Pregnancy|0|||
147493846|NCT02504268|531962497|FG006|Overall Study|Pregnancy|0|||
147493847|NCT02504268|531962498|FG007|Overall Study|Pregnancy|0|||
147493848|NCT02504268|531962499|FG008|Overall Study|Pregnancy|0|||
147493849|NCT02504268|531962491|FG000|Overall Study|Lost to Follow-up|3|||
147493850|NCT02504268|531962492|FG001|Overall Study|Lost to Follow-up|6|||
147493851|NCT02504268|531962493|FG002|Overall Study|Lost to Follow-up|4|||
147493852|NCT02504268|531962494|FG003|Overall Study|Lost to Follow-up|0|||
147493853|NCT02504268|531962495|FG004|Overall Study|Lost to Follow-up|0|||
147493854|NCT02504268|531962496|FG005|Overall Study|Lost to Follow-up|0|||
147493855|NCT02504268|531962497|FG006|Overall Study|Lost to Follow-up|0|||
147493856|NCT02504268|531962498|FG007|Overall Study|Lost to Follow-up|0|||
147493857|NCT02504268|531962499|FG008|Overall Study|Lost to Follow-up|0|||
147493858|NCT02504268|531962491|FG000|Overall Study|Death|1|||
147493859|NCT02504268|531962492|FG001|Overall Study|Death|1|||
147493860|NCT02504268|531962493|FG002|Overall Study|Death|0|||
147493861|NCT02504268|531962494|FG003|Overall Study|Death|0|||
147493862|NCT02504268|531962495|FG004|Overall Study|Death|0|||
147493863|NCT02504268|531962496|FG005|Overall Study|Death|0|||
147493864|NCT02504268|531962497|FG006|Overall Study|Death|0|||
147493865|NCT02504268|531962498|FG007|Overall Study|Death|0|||
147493866|NCT02504268|531962499|FG008|Overall Study|Death|0|||
147493867|NCT02504268|531962491|FG000|Overall Study|Subject Request to Discontinue|11|||
147493868|NCT02504268|531962492|FG001|Overall Study|Subject Request to Discontinue|3|||
147493869|NCT02504268|531962493|FG002|Overall Study|Subject Request to Discontinue|6|||
147493870|NCT02504268|531962494|FG003|Overall Study|Subject Request to Discontinue|0|||
147493871|NCT02504268|531962495|FG004|Overall Study|Subject Request to Discontinue|0|||
147493872|NCT02504268|531962496|FG005|Overall Study|Subject Request to Discontinue|0|||
147493873|NCT02504268|531962497|FG006|Overall Study|Subject Request to Discontinue|0|||
147493874|NCT02504268|531962498|FG007|Overall Study|Subject Request to Discontinue|0|||
147493875|NCT02504268|531962499|FG008|Overall Study|Subject Request to Discontinue|0|||
147493876|NCT02504268|531962491|FG000|Overall Study|No Longer Meets Study Criteria|2|||
147493877|NCT02504268|531962492|FG001|Overall Study|No Longer Meets Study Criteria|3|||
147493878|NCT02504268|531962493|FG002|Overall Study|No Longer Meets Study Criteria|0|||
147493879|NCT02504268|531962494|FG003|Overall Study|No Longer Meets Study Criteria|0|||
147493880|NCT02504268|531962495|FG004|Overall Study|No Longer Meets Study Criteria|0|||
147493881|NCT02504268|531962496|FG005|Overall Study|No Longer Meets Study Criteria|0|||
147493882|NCT02504268|531962497|FG006|Overall Study|No Longer Meets Study Criteria|0|||
147493883|NCT02504268|531962498|FG007|Overall Study|No Longer Meets Study Criteria|0|||
147493884|NCT02504268|531962499|FG008|Overall Study|No Longer Meets Study Criteria|0|||
147493885|NCT02504268|531962491|FG000|Overall Study|Lack of Efficacy|11|||
147493886|NCT02504268|531962492|FG001|Overall Study|Lack of Efficacy|35|||
147493887|NCT02504268|531962493|FG002|Overall Study|Lack of Efficacy|9|||
147493888|NCT02504268|531962494|FG003|Overall Study|Lack of Efficacy|0|||
147493889|NCT02504268|531962495|FG004|Overall Study|Lack of Efficacy|0|||
147493890|NCT02504268|531962496|FG005|Overall Study|Lack of Efficacy|0|||
147493891|NCT02504268|531962497|FG006|Overall Study|Lack of Efficacy|0|||
147493892|NCT02504268|531962498|FG007|Overall Study|Lack of Efficacy|0|||
147493893|NCT02504268|531962499|FG008|Overall Study|Lack of Efficacy|0|||
147493894|NCT02504268|531962491|FG000|Overall Study|Poor/Non-Compliance|3|||
147493895|NCT02504268|531962492|FG001|Overall Study|Poor/Non-Compliance|2|||
147493896|NCT02504268|531962493|FG002|Overall Study|Poor/Non-Compliance|3|||
147493897|NCT02504268|531962494|FG003|Overall Study|Poor/Non-Compliance|0|||
147493898|NCT02504268|531962495|FG004|Overall Study|Poor/Non-Compliance|0|||
147493899|NCT02504268|531962496|FG005|Overall Study|Poor/Non-Compliance|0|||
147493900|NCT02504268|531962497|FG006|Overall Study|Poor/Non-Compliance|0|||
147493901|NCT02504268|531962498|FG007|Overall Study|Poor/Non-Compliance|0|||
147493902|NCT02504268|531962499|FG008|Overall Study|Poor/Non-Compliance|0|||
147493903|NCT02504268|531962491|FG000|Overall Study|Not Disclosed|1|||
147493904|NCT02504268|531962492|FG001|Overall Study|Not Disclosed|0|||
147493905|NCT02504268|531962493|FG002|Overall Study|Not Disclosed|2|||
147493906|NCT02504268|531962494|FG003|Overall Study|Not Disclosed|0|||
147493907|NCT02504268|531962495|FG004|Overall Study|Not Disclosed|0|||
147493908|NCT02504268|531962496|FG005|Overall Study|Not Disclosed|0|||
147493909|NCT02504268|531962497|FG006|Overall Study|Not Disclosed|0|||
147493910|NCT02504268|531962498|FG007|Overall Study|Not Disclosed|0|||
147493911|NCT02504268|531962499|FG008|Overall Study|Not Disclosed|0|||
147493912|NCT03025217|531962500|FG000|Overall Study|Pregnancy|1|||
147493913|NCT03025217|531962500|FG000|Overall Study|Lost to Follow-up|1|||
147493914|NCT03025217|531962500|FG000|Overall Study|Not eligible, poor English|2|||
147493915|NCT00511342|531962501|FG000|Overall Study|Unacceptable vaginal bleeding|2|||
147493916|NCT00511342|531962502|FG001|Overall Study|Unacceptable vaginal bleeding|1|||
147493917|NCT00511342|531962501|FG000|Overall Study|Other Adverse Event (AE)/ Serious AE|8|||
147493918|NCT00511342|531962502|FG001|Overall Study|Other Adverse Event (AE)/ Serious AE|12|||
147493919|NCT00511342|531962501|FG000|Overall Study|Pregnancy|0|||
147493920|NCT00511342|531962502|FG001|Overall Study|Pregnancy|1|||
147493921|NCT00511342|531962501|FG000|Overall Study|Pregnancy wish|0|||
147493922|NCT00511342|531962502|FG001|Overall Study|Pregnancy wish|1|||
147493923|NCT00511342|531962501|FG000|Overall Study|Lost to Follow-up|1|||
147493924|NCT00511342|531962502|FG001|Overall Study|Lost to Follow-up|5|||
147493925|NCT00511342|531962501|FG000|Overall Study|Other Reason|2|||
147493926|NCT00511342|531962502|FG001|Overall Study|Other Reason|2|||
147493927|NCT02432040|531962503|FG000|Overall Study|Lack of Efficacy|3|||
147493928|NCT02432040|531962504|FG001|Overall Study|Lack of Efficacy|0|||
147493929|NCT02432040|531962503|FG000|Overall Study|Lost to Follow-up|4|||
147493930|NCT02432040|531962504|FG001|Overall Study|Lost to Follow-up|5|||
147493931|NCT02432040|531962503|FG000|Overall Study|Physician Decision|1|||
147493932|NCT02432040|531962504|FG001|Overall Study|Physician Decision|1|||
147493933|NCT00718666|531962506|FG000|Booster Phase Year 5|No active participation request|0|||
147493934|NCT00718666|531962507|FG001|Booster Phase Year 5|No active participation request|0|||
147493935|NCT00718666|531962508|FG002|Booster Phase Year 5|No active participation request|1|||
147493936|NCT00718666|531962506|FG000|Booster Phase Year 5|Declined v-4 serology|1|||
147493937|NCT00718666|531962507|FG001|Booster Phase Year 5|Declined v-4 serology|0|||
147493938|NCT00718666|531962508|FG002|Booster Phase Year 5|Declined v-4 serology|0|||
147493939|NCT00718666|531962506|FG000|Booster Phase Year 5|Withdrawal by Subject|0|||
147493940|NCT00718666|531962507|FG001|Booster Phase Year 5|Withdrawal by Subject|0|||
147493941|NCT00718666|531962508|FG002|Booster Phase Year 5|Withdrawal by Subject|1|||
147493942|NCT00718666|531962506|FG000|Booster Phase Year 5|Lost to Follow-up|1|||
147493943|NCT00718666|531962507|FG001|Booster Phase Year 5|Lost to Follow-up|0|||
147493944|NCT00718666|531962508|FG002|Booster Phase Year 5|Lost to Follow-up|4|||
147493945|NCT02196038|531962509|FG000|Overall Study|Death|16|||
147493946|NCT02196038|531962510|FG001|Overall Study|Death|21|||
147493947|NCT02196038|531962509|FG000|Overall Study|Withdrawal by Subject|0|||
147493948|NCT02196038|531962510|FG001|Overall Study|Withdrawal by Subject|1|||
147493949|NCT02196038|531962509|FG000|Overall Study|Lost to Follow-up|1|||
147493950|NCT02196038|531962510|FG001|Overall Study|Lost to Follow-up|0|||
147493951|NCT00421343|531962514|FG000|Overall Study|Death|1|||
147493952|NCT00421343|531962514|FG000|Overall Study|Withdrawal by Subject|2|||
147493953|NCT00421343|531962514|FG000|Overall Study|Lost to Follow-up|3|||
147493954|NCT03471767|531962523|FG000|Overall Study|Withdrawal by Subject|3|||
147493955|NCT03471767|531962524|FG001|Overall Study|Withdrawal by Subject|1|||
147493956|NCT03471767|531962523|FG000|Overall Study|Adverse Event|1|||
147493957|NCT03471767|531962524|FG001|Overall Study|Adverse Event|0|||
147493958|NCT03471767|531962523|FG000|Overall Study|Lost to Follow-up|1|||
147493959|NCT03471767|531962524|FG001|Overall Study|Lost to Follow-up|0|||
147493960|NCT03471767|531962523|FG000|Overall Study|PI Withdrawal|1|||
147625973|NCT00739661|532447175|FG000|Overall Study|Physician decision to withdraw patient|1|||
147493961|NCT03471767|531962524|FG001|Overall Study|PI Withdrawal|3|||
147493962|NCT00608530|531962527|FG000|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|11|||
147493963|NCT00608530|531962528|FG001|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|5|||
147493964|NCT00608530|531962529|FG002|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|0|||
147493965|NCT00608530|531962530|FG003|Study 1 Psychologist-delivered Treatment|Withdrawal by Subject|0|||
147493966|NCT00608530|531962527|FG000|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|0|||
147493967|NCT00608530|531962528|FG001|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|0|||
147493968|NCT00608530|531962529|FG002|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|3|||
147493969|NCT00608530|531962530|FG003|Study 2 Nurse-delivered Treatments|Withdrawal by Subject|3|||
147493970|NCT00608530|531962527|FG000|Study 2 Nurse-delivered Treatments|Lack of Efficacy|0|||
147493971|NCT00608530|531962528|FG001|Study 2 Nurse-delivered Treatments|Lack of Efficacy|0|||
147493972|NCT00608530|531962529|FG002|Study 2 Nurse-delivered Treatments|Lack of Efficacy|2|||
147493973|NCT00608530|531962530|FG003|Study 2 Nurse-delivered Treatments|Lack of Efficacy|3|||
147493974|NCT00608530|531962527|FG000|Study 2 Nurse-delivered Treatments|Protocol Violation|0|||
147493975|NCT00608530|531962528|FG001|Study 2 Nurse-delivered Treatments|Protocol Violation|0|||
147493976|NCT00608530|531962529|FG002|Study 2 Nurse-delivered Treatments|Protocol Violation|2|||
147493977|NCT00608530|531962530|FG003|Study 2 Nurse-delivered Treatments|Protocol Violation|0|||
147493978|NCT00608530|531962527|FG000|Study 2 Nurse-delivered Treatments|Time demands of study|0|||
147493979|NCT00608530|531962528|FG001|Study 2 Nurse-delivered Treatments|Time demands of study|0|||
147493980|NCT00608530|531962529|FG002|Study 2 Nurse-delivered Treatments|Time demands of study|4|||
147493981|NCT00608530|531962530|FG003|Study 2 Nurse-delivered Treatments|Time demands of study|1|||
147493982|NCT00608530|531962527|FG000|Study 2 Nurse-delivered Treatments|Lost to Follow-up|0|||
147493983|NCT00608530|531962528|FG001|Study 2 Nurse-delivered Treatments|Lost to Follow-up|0|||
147493984|NCT00608530|531962529|FG002|Study 2 Nurse-delivered Treatments|Lost to Follow-up|1|||
147493985|NCT00608530|531962530|FG003|Study 2 Nurse-delivered Treatments|Lost to Follow-up|0|||
147493986|NCT01952730|531962531|FG000|Overall Study|FDA shut down core lab used by study|1|||
147493987|NCT01098461|531962532|FG000|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|10|||
147493988|NCT01098461|531962533|FG001|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|2|||
147493989|NCT01098461|531962534|FG002|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|0|||
147493990|NCT01098461|531962535|FG003|Treatment Period (TP) (16 Weeks)|Persistent Hypoglycemia|0|||
147493991|NCT01098461|531962532|FG000|Treatment Period (TP) (16 Weeks)|Adverse Event|1|||
147493992|NCT01098461|531962533|FG001|Treatment Period (TP) (16 Weeks)|Adverse Event|2|||
147493993|NCT01098461|531962534|FG002|Treatment Period (TP) (16 Weeks)|Adverse Event|1|||
147493994|NCT01098461|531962535|FG003|Treatment Period (TP) (16 Weeks)|Adverse Event|3|||
147493995|NCT01098461|531962532|FG000|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|1|||
147493996|NCT01098461|531962533|FG001|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|2|||
147493997|NCT01098461|531962534|FG002|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|0|||
147493998|NCT01098461|531962535|FG003|Treatment Period (TP) (16 Weeks)|Withdrawal by Subject|0|||
147493999|NCT01098461|531962532|FG000|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|0|||
147494000|NCT01098461|531962533|FG001|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|1|||
147494001|NCT01098461|531962534|FG002|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|0|||
147494002|NCT01098461|531962535|FG003|Treatment Period (TP) (16 Weeks)|Transferred to Oita (Japan)|0|||
147494003|NCT01098461|531962532|FG000|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|0|||
147494004|NCT01098461|531962533|FG001|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|1|||
147494005|NCT01098461|531962534|FG002|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|0|||
147494006|NCT01098461|531962535|FG003|Follow-up (FU) Period (8 Weeks)|Withdrawal by Subject|0|||
147494007|NCT01098461|531962532|FG000|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|0|||
147494008|NCT01098461|531962533|FG001|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|1|||
147494009|NCT01098461|531962534|FG002|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|0|||
147494010|NCT01098461|531962535|FG003|Follow-up (FU) Period (8 Weeks)|Transferred to Oita (Japan)|0|||
147494011|NCT01098461|531962532|FG000|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|0|||
147494012|NCT01098461|531962533|FG001|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|1|||
147494013|NCT01098461|531962534|FG002|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|1|||
147494014|NCT01098461|531962535|FG003|Follow-up (FU) Period (8 Weeks)|Follow-up Not Conducted Due to Earthquak|0|||
147494015|NCT01514188|531962536|FG000|Overall Study|Adverse Event|3|||
147494016|NCT01514188|531962537|FG001|Overall Study|Adverse Event|5|||
147494017|NCT01514188|531962536|FG000|Overall Study|Withdrawal by Subject|2|||
147494018|NCT01514188|531962537|FG001|Overall Study|Withdrawal by Subject|4|||
147494019|NCT01514188|531962536|FG000|Overall Study|Protocol Violation|2|||
147494020|NCT01514188|531962537|FG001|Overall Study|Protocol Violation|4|||
147494021|NCT01514188|531962536|FG000|Overall Study|Physician Decision|0|||
147494022|NCT01514188|531962537|FG001|Overall Study|Physician Decision|2|||
147494023|NCT01514188|531962536|FG000|Overall Study|Disease Progression|13|||
147494024|NCT01514188|531962537|FG001|Overall Study|Disease Progression|14|||
147494025|NCT01514188|531962536|FG000|Overall Study|Death|1|||
147494026|NCT01514188|531962537|FG001|Overall Study|Death|3|||
147494027|NCT01514188|531962536|FG000|Overall Study|Other|2|||
147494028|NCT01514188|531962537|FG001|Overall Study|Other|1|||
147494029|NCT01019486|531962538|FG000|Overall Study|Withdrawal by Subject|1|||
147494030|NCT01019486|531962539|FG001|Overall Study|Withdrawal by Subject|1|||
147494031|NCT01019486|531962540|FG002|Overall Study|Withdrawal by Subject|1|||
147494032|NCT05373706|531962546|FG000|Overall Study|Lost to Follow-up|2|||
147494033|NCT05373706|531962547|FG001|Overall Study|Lost to Follow-up|2|||
147494034|NCT02402218|531962552|FG000|Overall Study|Did not pickup study medication|12|||
147494035|NCT02402218|531962553|FG001|Overall Study|Did not pickup study medication|9|||
147494036|NCT02402218|531962554|FG002|Overall Study|Did not pickup study medication|13|||
147494037|NCT02402218|531962552|FG000|Overall Study|Lack of Efficacy|0|||
147494038|NCT02402218|531962553|FG001|Overall Study|Lack of Efficacy|1|||
147494039|NCT02402218|531962554|FG002|Overall Study|Lack of Efficacy|1|||
147494040|NCT02402218|531962552|FG000|Overall Study|Death|1|||
147494041|NCT02402218|531962553|FG001|Overall Study|Death|0|||
147494042|NCT02402218|531962554|FG002|Overall Study|Death|0|||
147494043|NCT02402218|531962552|FG000|Overall Study|Reinfection|0|||
147494044|NCT02402218|531962553|FG001|Overall Study|Reinfection|0|||
147494045|NCT02402218|531962554|FG002|Overall Study|Reinfection|1|||
147494046|NCT02402218|531962552|FG000|Overall Study|Adverse Event|0|||
147494047|NCT02402218|531962553|FG001|Overall Study|Adverse Event|2|||
147494048|NCT02402218|531962554|FG002|Overall Study|Adverse Event|1|||
147494049|NCT02402218|531962552|FG000|Overall Study|Withdrawal by Subject|1|||
147494050|NCT02402218|531962553|FG001|Overall Study|Withdrawal by Subject|1|||
147494051|NCT02402218|531962554|FG002|Overall Study|Withdrawal by Subject|1|||
147494052|NCT03375112|531962557|FG000|Overall Study|Withdrawal by Subject|3|||
147494053|NCT03375112|531962558|FG001|Overall Study|Withdrawal by Subject|0|||
147494054|NCT00243230|531962560|FG000|Double-Blind Period|Adverse Event|0|||
147494055|NCT00243230|531962561|FG001|Double-Blind Period|Adverse Event|2|||
147494056|NCT00243230|531962562|FG002|Double-Blind Period|Adverse Event|2|||
147494057|NCT00243230|531962563|FG003|Double-Blind Period|Adverse Event|0|||
147494058|NCT00243230|531962560|FG000|Double-Blind Period|Withdrawal by Subject|1|||
147494059|NCT00243230|531962561|FG001|Double-Blind Period|Withdrawal by Subject|0|||
147494060|NCT00243230|531962562|FG002|Double-Blind Period|Withdrawal by Subject|0|||
147494061|NCT00243230|531962563|FG003|Double-Blind Period|Withdrawal by Subject|0|||
147494062|NCT00243230|531962560|FG000|Double-Blind Period|Protocol Violation|0|||
147494063|NCT00243230|531962561|FG001|Double-Blind Period|Protocol Violation|0|||
147494064|NCT00243230|531962562|FG002|Double-Blind Period|Protocol Violation|1|||
147494065|NCT00243230|531962563|FG003|Double-Blind Period|Protocol Violation|0|||
147494066|NCT00243230|531962560|FG000|Double-Blind Period|Randomized but Not Treated|0|||
147494067|NCT00243230|531962561|FG001|Double-Blind Period|Randomized but Not Treated|0|||
147494068|NCT00243230|531962562|FG002|Double-Blind Period|Randomized but Not Treated|2|||
147494069|NCT00243230|531962563|FG003|Double-Blind Period|Randomized but Not Treated|0|||
147494070|NCT00243230|531962560|FG000|Double-Blind Period|Treatment Failure - Virologic Failure defined by investigator|5|||
147494071|NCT00243230|531962561|FG001|Double-Blind Period|Treatment Failure - Virologic Failure defined by investigator|3|||
147494072|NCT00243230|531962562|FG002|Double-Blind Period|Treatment Failure - Virologic Failure defined by investigator|14|||
147494073|NCT00243230|531962563|FG003|Double-Blind Period|Treatment Failure - Virologic Failure defined by investigator|0|||
147494074|NCT00243230|531962560|FG000|Open Label Period|Adverse Event|0|||
147494075|NCT00243230|531962561|FG001|Open Label Period|Adverse Event|0|||
147494076|NCT00243230|531962562|FG002|Open Label Period|Adverse Event|0|||
147494077|NCT00243230|531962563|FG003|Open Label Period|Adverse Event|2|||
147494078|NCT00243230|531962560|FG000|Open Label Period|Treatment Failure - Virologic Failure|0|||
147494079|NCT00243230|531962561|FG001|Open Label Period|Treatment Failure - Virologic Failure|0|||
147494080|NCT00243230|531962562|FG002|Open Label Period|Treatment Failure - Virologic Failure|0|||
147494081|NCT00243230|531962563|FG003|Open Label Period|Treatment Failure - Virologic Failure|13|||
147494082|NCT00243230|531962560|FG000|Open Label Period|Progressive Disease (AIDS-Event)|0|||
147494083|NCT00243230|531962561|FG001|Open Label Period|Progressive Disease (AIDS-Event)|0|||
147494084|NCT00243230|531962562|FG002|Open Label Period|Progressive Disease (AIDS-Event)|0|||
147494085|NCT00243230|531962563|FG003|Open Label Period|Progressive Disease (AIDS-Event)|1|||
147494086|NCT00243230|531962560|FG000|Open Label Period|Lost to Follow-up|0|||
147494087|NCT00243230|531962561|FG001|Open Label Period|Lost to Follow-up|0|||
147494088|NCT00243230|531962562|FG002|Open Label Period|Lost to Follow-up|0|||
147494089|NCT00243230|531962563|FG003|Open Label Period|Lost to Follow-up|2|||
147494090|NCT00243230|531962560|FG000|Open Label Period|Withdrawal by Subject|0|||
147625974|NCT00739661|532447176|FG001|Overall Study|Physician decision to withdraw patient|0|||
147625975|NCT00739661|532447175|FG000|Overall Study|Patient decision to withdraw|9|||
147625976|NCT00739661|532447176|FG001|Overall Study|Patient decision to withdraw|4|||
147625977|NCT00739661|532447175|FG000|Overall Study|Disease progression, radiographic|33|||
147625978|NCT00739661|532447176|FG001|Overall Study|Disease progression, radiographic|37|||
147625979|NCT00739661|532447175|FG000|Overall Study|Reason for discontinuation not available|1|||
147625980|NCT00739661|532447176|FG001|Overall Study|Reason for discontinuation not available|1|||
147625981|NCT02198664|532447177|FG000|Overall Study|Adverse Event|2|||
147625982|NCT02198664|532447178|FG001|Overall Study|Adverse Event|0|||
147625983|NCT02198664|532447177|FG000|Overall Study|Withdrawal by Subject|11|||
147625984|NCT02198664|532447178|FG001|Overall Study|Withdrawal by Subject|8|||
147625985|NCT02198664|532447177|FG000|Overall Study|Failure to tolerate|2|||
147625986|NCT02198664|532447178|FG001|Overall Study|Failure to tolerate|0|||
147494091|NCT00243230|531962561|FG001|Open Label Period|Withdrawal by Subject|0|||
147494092|NCT00243230|531962562|FG002|Open Label Period|Withdrawal by Subject|0|||
147494093|NCT00243230|531962563|FG003|Open Label Period|Withdrawal by Subject|2|||
147494094|NCT00243230|531962560|FG000|Open Label Period|Protocol Violation|0|||
147494095|NCT00243230|531962561|FG001|Open Label Period|Protocol Violation|0|||
147494096|NCT00243230|531962562|FG002|Open Label Period|Protocol Violation|0|||
147625987|NCT02198664|532447177|FG000|Overall Study|Not stated|1|||
147494097|NCT00243230|531962563|FG003|Open Label Period|Protocol Violation|2|||
147668118|NCT02577029|532609885|FG007|Overall Study|Sponsor Termination of the Study|12|||
147668119|NCT02078817|532609886|FG000|Overall Study|Withdrawal by Subject|1|||
147668120|NCT01441973|532609892|FG000|Overall Study|Disease progression|8|||
147668121|NCT01441973|532609893|FG001|Overall Study|Disease progression|6|||
147668122|NCT01441973|532609892|FG000|Overall Study|Adverse event unrelated to study drug|3|||
147668123|NCT01441973|532609893|FG001|Overall Study|Adverse event unrelated to study drug|2|||
147668124|NCT01441973|532609892|FG000|Overall Study|Participant request to discontinue|1|||
147668125|NCT01441973|532609893|FG001|Overall Study|Participant request to discontinue|1|||
147668126|NCT01441973|532609892|FG000|Overall Study|Poor compliance/noncompliance|0|||
147668127|NCT01441973|532609893|FG001|Overall Study|Poor compliance/noncompliance|1|||
147668128|NCT01441973|532609892|FG000|Overall Study|Administrative reason by sponsor|3|||
147668129|NCT01441973|532609893|FG001|Overall Study|Administrative reason by sponsor|5|||
147668130|NCT01441973|532609892|FG000|Overall Study|Participant withdrew consent|0|||
147668131|NCT01441973|532609893|FG001|Overall Study|Participant withdrew consent|1|||
147668132|NCT01149655|532609894|FG000|Period 1 - Conversion Phase|Lost to Follow-up|1|||
147668133|NCT01149655|532609895|FG001|Period 1 - Conversion Phase|Lost to Follow-up|0|||
147625988|NCT02198664|532447178|FG001|Overall Study|Not stated|0|||
147625989|NCT02632409|532447179|FG000|Randomized|AE unrelated to study Drug|0|||
147625990|NCT02632409|532447180|FG001|Randomized|AE unrelated to study Drug|1|||
147625991|NCT02632409|532447179|FG000|Randomized|Participant withdrew consent|2|||
147625992|NCT02632409|532447180|FG001|Randomized|Participant withdrew consent|1|||
147625993|NCT02632409|532447179|FG000|Randomized|No Longer meets study criteria|5|||
147625994|NCT02632409|532447180|FG001|Randomized|No Longer meets study criteria|0|||
147625995|NCT02632409|532447179|FG000|Randomized|other reasons|1|||
147625996|NCT02632409|532447180|FG001|Randomized|other reasons|0|||
147625997|NCT02632409|532447179|FG000|Treatment Period|Ongoing Treatment|20|||
147625998|NCT02632409|532447180|FG001|Treatment Period|Ongoing Treatment|21|||
147625999|NCT02632409|532447179|FG000|Treatment Period|Disease Recurrence|147|||
147626000|NCT02632409|532447180|FG001|Treatment Period|Disease Recurrence|90|||
147626001|NCT02632409|532447179|FG000|Treatment Period|Study Drug Toxicity|8|||
147626002|NCT02632409|532447180|FG001|Treatment Period|Study Drug Toxicity|49|||
147626003|NCT02632409|532447179|FG000|Treatment Period|Death|1|||
147626004|NCT02632409|532447180|FG001|Treatment Period|Death|0|||
147626005|NCT02632409|532447179|FG000|Treatment Period|AE unrelated to study drug|15|||
147626006|NCT02632409|532447180|FG001|Treatment Period|AE unrelated to study drug|16|||
147626007|NCT02632409|532447179|FG000|Treatment Period|Request to discontinue treatment|4|||
147626008|NCT02632409|532447180|FG001|Treatment Period|Request to discontinue treatment|19|||
147626009|NCT02632409|532447179|FG000|Treatment Period|Participant withdrew consent|7|||
147626010|NCT02632409|532447180|FG001|Treatment Period|Participant withdrew consent|5|||
147626011|NCT02632409|532447179|FG000|Treatment Period|Lost to Follow-up|0|||
147626012|NCT02632409|532447180|FG001|Treatment Period|Lost to Follow-up|1|||
147626013|NCT02632409|532447179|FG000|Treatment Period|Maximum clinical benefit|1|||
147626014|NCT02632409|532447180|FG001|Treatment Period|Maximum clinical benefit|0|||
147626015|NCT02632409|532447179|FG000|Treatment Period|No longer meets study criteria|3|||
147626016|NCT02632409|532447180|FG001|Treatment Period|No longer meets study criteria|0|||
147626017|NCT02632409|532447179|FG000|Treatment Period|Administrative Reason by sponsor|0|||
147626018|NCT02632409|532447180|FG001|Treatment Period|Administrative Reason by sponsor|1|||
147626019|NCT02632409|532447179|FG000|Treatment Period|Other Reasons|10|||
147626020|NCT02632409|532447180|FG001|Treatment Period|Other Reasons|6|||
147626021|NCT05600283|532447181|FG000|Overall Study|Withdrawal by Subject|3|||
147626022|NCT05600283|532447182|FG001|Overall Study|Withdrawal by Subject|8|||
147626023|NCT05600283|532447181|FG000|Overall Study|invalid individual swab|1|||
147626024|NCT05600283|532447182|FG001|Overall Study|invalid individual swab|0|||
147626025|NCT05600283|532447181|FG000|Overall Study|missing clinician collection|3|||
147626026|NCT05600283|532447182|FG001|Overall Study|missing clinician collection|0|||
147626027|NCT05600283|532447181|FG000|Overall Study|screening failure|0|||
147626028|NCT05600283|532447182|FG001|Overall Study|screening failure|2|||
147668134|NCT01149655|532609896|FG002|Period 1 - Conversion Phase|Lost to Follow-up|0|||
147626029|NCT02883062|532447183|FG000|Overall Study|Withdrawal by Subject|6|||
147626030|NCT02883062|532447184|FG001|Overall Study|Withdrawal by Subject|0|||
147626031|NCT04426006|532447185|FG000|Inclusion|Protocol Violation|1|||
147626032|NCT04426006|532447185|FG000|Inclusion|Self-administered questionnaire at inclusion not completed|7|||
147626033|NCT04426006|532447185|FG000|Inclusion|Blood sample at inclusion not done|1|||
147626034|NCT04426006|532447185|FG000|3 Months|Lost to Follow-up|17|||
147626035|NCT04426006|532447185|FG000|12 Months|Lost to Follow-up|38|||
147626036|NCT00720213|532447188|FG000|Screening Phase With Diagnostic PSG|Screen Failure|7|||
147626037|NCT00720213|532447189|FG001|Screening Phase With Diagnostic PSG|Screen Failure|0|||
147626038|NCT00720213|532447190|FG002|Screening Phase With Diagnostic PSG|Screen Failure|0|||
147668135|NCT01149655|532609897|FG003|Period 1 - Conversion Phase|Lost to Follow-up|0|||
147668136|NCT01149655|532609894|FG000|Period 1 - Conversion Phase|Sponsor Discontinued Trial|4|||
147626039|NCT01252095|532447195|FG000|Overall Study|Disease progression|1|||
147626040|NCT01252095|532447196|FG001|Overall Study|Disease progression|0|||
147626041|NCT01420068|532447197|FG000|Overall Study|Administrative problems|1|||
147626042|NCT01420068|532447198|FG001|Overall Study|Administrative problems|3|||
147626043|NCT01420068|532447197|FG000|Overall Study|Withdrawal by Subject|1|||
147626044|NCT01420068|532447198|FG001|Overall Study|Withdrawal by Subject|2|||
147626045|NCT01753310|532447199|FG000|Overall Study|Entered into open label extension study|25|||
147626046|NCT01753310|532447200|FG001|Overall Study|Entered into open label extension study|22|||
147626047|NCT01753310|532447199|FG000|Overall Study|Adverse Event|1|||
147626048|NCT01753310|532447200|FG001|Overall Study|Adverse Event|0|||
147626049|NCT01753310|532447199|FG000|Overall Study|Lost to Follow-up|2|||
147626050|NCT01753310|532447200|FG001|Overall Study|Lost to Follow-up|0|||
147626051|NCT01753310|532447199|FG000|Overall Study|Subject decision|2|||
147626052|NCT01753310|532447200|FG001|Overall Study|Subject decision|2|||
147626053|NCT01753310|532447199|FG000|Overall Study|Sponsor decision|1|||
147626054|NCT01753310|532447200|FG001|Overall Study|Sponsor decision|0|||
147626055|NCT01753310|532447199|FG000|Overall Study|Withdrawal by Subject|1|||
147626056|NCT01753310|532447200|FG001|Overall Study|Withdrawal by Subject|0|||
147626057|NCT04495829|532447202|FG000|Overall Study|Lost to Follow-up|2|||
147626058|NCT04495829|532447202|FG000|Overall Study|Inclusion criterion not met|3|||
147626059|NCT02712554|532447205|FG000|Part B: Qualification Phase|Drug Discrimination Failure|0|||
147626060|NCT02712554|532447206|FG001|Part B: Qualification Phase|Drug Discrimination Failure|13|||
147626061|NCT02712554|532447205|FG000|Part B: Qualification Phase|Sponsor Decision|0|||
147626062|NCT02712554|532447206|FG001|Part B: Qualification Phase|Sponsor Decision|4|||
147626063|NCT02712554|532447205|FG000|Part B: Qualification Phase|Withdrawal by Subject|0|||
147626064|NCT02712554|532447206|FG001|Part B: Qualification Phase|Withdrawal by Subject|3|||
147626065|NCT02712554|532447205|FG000|Part B: Qualification Phase|Adverse Event|0|||
147626066|NCT02712554|532447206|FG001|Part B: Qualification Phase|Adverse Event|1|||
147626067|NCT02712554|532447205|FG000|Part B: Treatment Phase|Adverse Event|0|||
147626068|NCT02712554|532447206|FG001|Part B: Treatment Phase|Adverse Event|1|||
147626069|NCT02712554|532447205|FG000|Part B: Treatment Phase|Withdrawal by Subject|0|||
147626070|NCT02712554|532447206|FG001|Part B: Treatment Phase|Withdrawal by Subject|1|||
147626071|NCT02712554|532447205|FG000|Part B: Treatment Phase|Other|0|||
147626072|NCT02712554|532447206|FG001|Part B: Treatment Phase|Other|1|||
147626073|NCT02503540|532447208|FG000|Overall Study|Death|2|||
147626074|NCT02503540|532447208|FG000|Overall Study|Withdrawal by Subject|1|||
147626075|NCT01662492|532447209|FG000|Overall Study|Other miscellaneous reasons.|1|||
147626076|NCT01662492|532447210|FG001|Overall Study|Other miscellaneous reasons.|0|||
147626077|NCT01662492|532447211|FG002|Overall Study|Other miscellaneous reasons.|1|||
147626078|NCT01662492|532447209|FG000|Overall Study|Withdrawal by Subject|0|||
147626079|NCT01662492|532447210|FG001|Overall Study|Withdrawal by Subject|0|||
147626080|NCT01662492|532447211|FG002|Overall Study|Withdrawal by Subject|1|||
147626081|NCT01662492|532447209|FG000|Overall Study|Protocol Violation|1|||
147626082|NCT01662492|532447210|FG001|Overall Study|Protocol Violation|0|||
147626083|NCT01662492|532447211|FG002|Overall Study|Protocol Violation|0|||
147626084|NCT01662492|532447209|FG000|Overall Study|Lost to Follow-up|0|||
147626085|NCT01662492|532447210|FG001|Overall Study|Lost to Follow-up|0|||
147626086|NCT01662492|532447211|FG002|Overall Study|Lost to Follow-up|2|||
147626087|NCT01662492|532447209|FG000|Overall Study|Lack of Efficacy|1|||
147626088|NCT01662492|532447210|FG001|Overall Study|Lack of Efficacy|1|||
147626089|NCT01662492|532447211|FG002|Overall Study|Lack of Efficacy|2|||
147626090|NCT02747108|532447213|FG000|Overall Study|Death|2|||
147626091|NCT02747108|532447214|FG001|Overall Study|Death|2|||
147626092|NCT02747108|532447213|FG000|Overall Study|Withdrawal by Subject|1|||
147626093|NCT02747108|532447214|FG001|Overall Study|Withdrawal by Subject|0|||
147626094|NCT02747108|532447213|FG000|Overall Study|Protocol Violation|2|||
147626095|NCT02747108|532447214|FG001|Overall Study|Protocol Violation|0|||
147626096|NCT05151744|532449266|FG000|Overall Study|Adverse Event|6|||
147626097|NCT05151744|532449267|FG001|Overall Study|Adverse Event|2|||
147626098|NCT05151744|532449266|FG000|Overall Study|Death|1|||
147626099|NCT05151744|532449267|FG001|Overall Study|Death|2|||
147626100|NCT05151744|532449266|FG000|Overall Study|Lack of Efficacy|1|||
147626101|NCT05151744|532449267|FG001|Overall Study|Lack of Efficacy|1|||
147626102|NCT05151744|532449266|FG000|Overall Study|Lost to Follow-up|2|||
147626103|NCT05151744|532449267|FG001|Overall Study|Lost to Follow-up|2|||
147626104|NCT05151744|532449266|FG000|Overall Study|Need for Rescue Treatment|0|||
147626105|NCT05151744|532449267|FG001|Overall Study|Need for Rescue Treatment|1|||
147626106|NCT05151744|532449266|FG000|Overall Study|Non-compliance with Study Drug|0|||
147668137|NCT01149655|532609895|FG001|Period 1 - Conversion Phase|Sponsor Discontinued Trial|0|||
147626107|NCT05151744|532449267|FG001|Overall Study|Non-compliance with Study Drug|1|||
147668138|NCT01149655|532609896|FG002|Period 1 - Conversion Phase|Sponsor Discontinued Trial|0|||
147626108|NCT05151744|532449266|FG000|Overall Study|Reason not Specified|10|||
147626109|NCT05151744|532449267|FG001|Overall Study|Reason not Specified|0|||
147626110|NCT05151744|532449266|FG000|Overall Study|Physician Decision|2|||
147626111|NCT05151744|532449267|FG001|Overall Study|Physician Decision|1|||
147626112|NCT05151744|532449266|FG000|Overall Study|Protocol Violation|1|||
147626113|NCT05151744|532449267|FG001|Overall Study|Protocol Violation|0|||
147626114|NCT05151744|532449266|FG000|Overall Study|Withdrawal by Subject|6|||
147626115|NCT05151744|532449267|FG001|Overall Study|Withdrawal by Subject|3|||
147626116|NCT05228470|532449268|FG000|Overall Study|Death|6|||
147668139|NCT01149655|532609897|FG003|Period 1 - Conversion Phase|Sponsor Discontinued Trial|0|||
147668140|NCT01149655|532609894|FG000|Period 1 - Conversion Phase|Met Withdrawal Criteria|1|||
147668141|NCT01149655|532609895|FG001|Period 1 - Conversion Phase|Met Withdrawal Criteria|0|||
147668142|NCT01149655|532609896|FG002|Period 1 - Conversion Phase|Met Withdrawal Criteria|0|||
147668143|NCT01149655|532609897|FG003|Period 1 - Conversion Phase|Met Withdrawal Criteria|0|||
147668144|NCT01149655|532609894|FG000|Period 1 - Conversion Phase|Physician Decision|2|||
147668145|NCT01149655|532609895|FG001|Period 1 - Conversion Phase|Physician Decision|0|||
147668146|NCT01149655|532609896|FG002|Period 1 - Conversion Phase|Physician Decision|0|||
147668147|NCT01149655|532609897|FG003|Period 1 - Conversion Phase|Physician Decision|0|||
147668148|NCT01149655|532609894|FG000|Period 1 - Conversion Phase|Withdrawal by Subject|7|||
147668149|NCT01149655|532609895|FG001|Period 1 - Conversion Phase|Withdrawal by Subject|0|||
147668150|NCT01149655|532609896|FG002|Period 1 - Conversion Phase|Withdrawal by Subject|0|||
147668151|NCT01149655|532609897|FG003|Period 1 - Conversion Phase|Withdrawal by Subject|0|||
147668152|NCT01149655|532609894|FG000|Period 1 - Conversion Phase|Adverse Event Without Relapse|3|||
147668153|NCT01149655|532609895|FG001|Period 1 - Conversion Phase|Adverse Event Without Relapse|0|||
147668154|NCT01149655|532609896|FG002|Period 1 - Conversion Phase|Adverse Event Without Relapse|0|||
147668155|NCT01149655|532609897|FG003|Period 1 - Conversion Phase|Adverse Event Without Relapse|0|||
147668156|NCT01149655|532609894|FG000|Period 2-Stabilization Phase|Sponsor Discontinued Trial|0|||
147668157|NCT01149655|532609895|FG001|Period 2-Stabilization Phase|Sponsor Discontinued Trial|16|||
147668158|NCT01149655|532609896|FG002|Period 2-Stabilization Phase|Sponsor Discontinued Trial|0|||
147668159|NCT01149655|532609897|FG003|Period 2-Stabilization Phase|Sponsor Discontinued Trial|0|||
147668160|NCT01149655|532609894|FG000|Period 2-Stabilization Phase|Met Withdrawal Criteria|0|||
147668161|NCT01149655|532609895|FG001|Period 2-Stabilization Phase|Met Withdrawal Criteria|7|||
147668162|NCT01149655|532609896|FG002|Period 2-Stabilization Phase|Met Withdrawal Criteria|0|||
147668163|NCT01149655|532609897|FG003|Period 2-Stabilization Phase|Met Withdrawal Criteria|0|||
147668164|NCT01149655|532609894|FG000|Period 2-Stabilization Phase|Physician Decision|0|||
147668165|NCT01149655|532609895|FG001|Period 2-Stabilization Phase|Physician Decision|3|||
147668166|NCT01149655|532609896|FG002|Period 2-Stabilization Phase|Physician Decision|0|||
147668167|NCT01149655|532609897|FG003|Period 2-Stabilization Phase|Physician Decision|0|||
147668168|NCT01149655|532609894|FG000|Period 2-Stabilization Phase|Withdrawal by Subject|0|||
147668169|NCT01149655|532609895|FG001|Period 2-Stabilization Phase|Withdrawal by Subject|5|||
147668170|NCT01149655|532609896|FG002|Period 2-Stabilization Phase|Withdrawal by Subject|0|||
147668171|NCT01149655|532609897|FG003|Period 2-Stabilization Phase|Withdrawal by Subject|0|||
147668172|NCT01149655|532609894|FG000|Period 2-Stabilization Phase|Adverse Event Without Relapse|0|||
147668173|NCT01149655|532609895|FG001|Period 2-Stabilization Phase|Adverse Event Without Relapse|6|||
147668174|NCT01149655|532609896|FG002|Period 2-Stabilization Phase|Adverse Event Without Relapse|0|||
147668175|NCT01149655|532609897|FG003|Period 2-Stabilization Phase|Adverse Event Without Relapse|0|||
147668176|NCT01149655|532609894|FG000|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|0|||
147668177|NCT01149655|532609895|FG001|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|0|||
147668178|NCT01149655|532609896|FG002|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|58|||
147668179|NCT01149655|532609897|FG003|Period 3-DB Maintenance Phase|Sponsor Discontinued Trial|19|||
147668180|NCT01149655|532609894|FG000|Period 3-DB Maintenance Phase|Physician Decision|0|||
147668181|NCT01149655|532609895|FG001|Period 3-DB Maintenance Phase|Physician Decision|0|||
147668182|NCT01149655|532609896|FG002|Period 3-DB Maintenance Phase|Physician Decision|1|||
147494098|NCT00243230|531962560|FG000|Open Label Period|Administrative Reason|0|||
147494099|NCT00243230|531962561|FG001|Open Label Period|Administrative Reason|0|||
147494100|NCT00243230|531962562|FG002|Open Label Period|Administrative Reason|0|||
147494101|NCT00243230|531962563|FG003|Open Label Period|Administrative Reason|63|||
147494102|NCT03599141|531962564|FG000|Overall Study|Lost to Follow-up|3|||
147494103|NCT03599141|531962565|FG001|Overall Study|Lost to Follow-up|1|||
147494104|NCT03136185|531962566|FG000|Overall Study|Adverse Event|0|||
147494105|NCT03136185|531962567|FG001|Overall Study|Adverse Event|1|||
147494106|NCT03136185|531962568|FG002|Overall Study|Adverse Event|3|||
147494107|NCT03136185|531962569|FG003|Overall Study|Adverse Event|1|||
147494108|NCT03136185|531962570|FG004|Overall Study|Adverse Event|2|||
147494109|NCT03136185|531962571|FG005|Overall Study|Adverse Event|2|||
147494110|NCT03136185|531962572|FG006|Overall Study|Adverse Event|5|||
147494111|NCT03136185|531962573|FG007|Overall Study|Adverse Event|1|||
147494112|NCT03136185|531962574|FG008|Overall Study|Adverse Event|1|||
147494113|NCT03136185|531962566|FG000|Overall Study|Death|0|||
147494114|NCT03136185|531962567|FG001|Overall Study|Death|0|||
147494115|NCT03136185|531962568|FG002|Overall Study|Death|0|||
147494116|NCT03136185|531962569|FG003|Overall Study|Death|1|||
147494117|NCT03136185|531962570|FG004|Overall Study|Death|1|||
147494118|NCT03136185|531962571|FG005|Overall Study|Death|0|||
147494119|NCT03136185|531962572|FG006|Overall Study|Death|1|||
147494120|NCT03136185|531962573|FG007|Overall Study|Death|0|||
147494121|NCT03136185|531962574|FG008|Overall Study|Death|0|||
147494122|NCT03136185|531962566|FG000|Overall Study|Physician Decision|3|||
147494123|NCT03136185|531962567|FG001|Overall Study|Physician Decision|1|||
147494124|NCT03136185|531962568|FG002|Overall Study|Physician Decision|1|||
147494125|NCT03136185|531962569|FG003|Overall Study|Physician Decision|2|||
147494126|NCT03136185|531962570|FG004|Overall Study|Physician Decision|1|||
147494127|NCT03136185|531962571|FG005|Overall Study|Physician Decision|2|||
147494128|NCT03136185|531962572|FG006|Overall Study|Physician Decision|1|||
147494129|NCT03136185|531962573|FG007|Overall Study|Physician Decision|0|||
147494130|NCT03136185|531962574|FG008|Overall Study|Physician Decision|1|||
147494131|NCT03136185|531962566|FG000|Overall Study|Protocol Defined Disease Progression|0|||
147494132|NCT03136185|531962567|FG001|Overall Study|Protocol Defined Disease Progression|0|||
147494133|NCT03136185|531962568|FG002|Overall Study|Protocol Defined Disease Progression|1|||
147494134|NCT03136185|531962569|FG003|Overall Study|Protocol Defined Disease Progression|0|||
147494135|NCT03136185|531962570|FG004|Overall Study|Protocol Defined Disease Progression|0|||
147494136|NCT03136185|531962571|FG005|Overall Study|Protocol Defined Disease Progression|1|||
147494137|NCT03136185|531962572|FG006|Overall Study|Protocol Defined Disease Progression|0|||
147494138|NCT03136185|531962573|FG007|Overall Study|Protocol Defined Disease Progression|1|||
147494139|NCT03136185|531962574|FG008|Overall Study|Protocol Defined Disease Progression|1|||
147494140|NCT03136185|531962566|FG000|Overall Study|Withdrawal by Subject|1|||
147494141|NCT03136185|531962567|FG001|Overall Study|Withdrawal by Subject|0|||
147494142|NCT03136185|531962568|FG002|Overall Study|Withdrawal by Subject|1|||
147494143|NCT03136185|531962569|FG003|Overall Study|Withdrawal by Subject|1|||
147494144|NCT03136185|531962570|FG004|Overall Study|Withdrawal by Subject|1|||
147494145|NCT03136185|531962571|FG005|Overall Study|Withdrawal by Subject|1|||
147494146|NCT03136185|531962572|FG006|Overall Study|Withdrawal by Subject|2|||
147494147|NCT03136185|531962573|FG007|Overall Study|Withdrawal by Subject|3|||
147494148|NCT03136185|531962574|FG008|Overall Study|Withdrawal by Subject|3|||
147494149|NCT03136185|531962566|FG000|Overall Study|Not Reported|4|||
147494150|NCT03136185|531962567|FG001|Overall Study|Not Reported|1|||
147494151|NCT03136185|531962568|FG002|Overall Study|Not Reported|0|||
147494152|NCT03136185|531962569|FG003|Overall Study|Not Reported|1|||
147494153|NCT03136185|531962570|FG004|Overall Study|Not Reported|0|||
147494154|NCT03136185|531962571|FG005|Overall Study|Not Reported|2|||
147494155|NCT03136185|531962572|FG006|Overall Study|Not Reported|1|||
147668183|NCT01149655|532609897|FG003|Period 3-DB Maintenance Phase|Physician Decision|0|||
147668184|NCT01149655|532609894|FG000|Period 3-DB Maintenance Phase|Withdrawal by Subject|0|||
147668185|NCT01149655|532609895|FG001|Period 3-DB Maintenance Phase|Withdrawal by Subject|0|||
147668186|NCT01149655|532609896|FG002|Period 3-DB Maintenance Phase|Withdrawal by Subject|4|||
147668187|NCT01149655|532609897|FG003|Period 3-DB Maintenance Phase|Withdrawal by Subject|4|||
147668188|NCT01149655|532609894|FG000|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|0|||
147668189|NCT01149655|532609895|FG001|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|0|||
147668190|NCT01149655|532609896|FG002|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|1|||
147668191|NCT01149655|532609897|FG003|Period 3-DB Maintenance Phase|Adverse Event Without Relapse|1|||
147668192|NCT01149655|532609894|FG000|Period 3-DB Maintenance Phase|Relapse With AE|0|||
147668193|NCT01149655|532609895|FG001|Period 3-DB Maintenance Phase|Relapse With AE|0|||
147668194|NCT01149655|532609896|FG002|Period 3-DB Maintenance Phase|Relapse With AE|19|||
147668195|NCT01149655|532609897|FG003|Period 3-DB Maintenance Phase|Relapse With AE|18|||
147668196|NCT01265498|532609898|FG000|Overall Study|Protocol modified to eliminate wk72 bx|31|||
147668197|NCT01265498|532609899|FG001|Overall Study|Protocol modified to eliminate wk72 bx|33|||
147668198|NCT00617279|532609906|FG000|Overall Study|Study terminated by Sponsor|10|||
147668199|NCT00617279|532609907|FG001|Overall Study|Study terminated by Sponsor|15|||
147668200|NCT00617279|532609906|FG000|Overall Study|Graft abandonment|2|||
147668201|NCT00617279|532609907|FG001|Overall Study|Graft abandonment|0|||
147668202|NCT00617279|532609906|FG000|Overall Study|Lost to Follow-up|1|||
147668203|NCT00617279|532609907|FG001|Overall Study|Lost to Follow-up|0|||
147668204|NCT00617279|532609906|FG000|Overall Study|Death|1|||
147668205|NCT00617279|532609907|FG001|Overall Study|Death|2|||
147668206|NCT00921024|532609908|FG000|Overall Study|Lost to Follow-up|2|||
147668207|NCT00921024|532609909|FG001|Overall Study|Lost to Follow-up|0|||
147668208|NCT00921024|532609908|FG000|Overall Study|Received concomittant therapy|2|||
147668209|NCT00921024|532609909|FG001|Overall Study|Received concomittant therapy|0|||
147668210|NCT00921024|532609908|FG000|Overall Study|Withdrawal by Subject|0|||
147668211|NCT00921024|532609909|FG001|Overall Study|Withdrawal by Subject|3|||
147668212|NCT02014272|532611684|FG000|Intervention Period 1|Withdrawal by Subject|1|||
147668213|NCT02014272|532611685|FG001|Intervention Period 1|Withdrawal by Subject|0|||
147668214|NCT02014272|532611684|FG000|Intervention Period 1|Adverse Event|0|||
147668215|NCT02014272|532611685|FG001|Intervention Period 1|Adverse Event|1|||
147668216|NCT01516216|532611686|FG000|Overall Study|Adverse Event|2|||
147668217|NCT01516216|532611687|FG001|Overall Study|Adverse Event|4|||
147668218|NCT01516216|532611686|FG000|Overall Study|Disease Progression|38|||
147668219|NCT01516216|532611687|FG001|Overall Study|Disease Progression|34|||
147494156|NCT03136185|531962573|FG007|Overall Study|Not Reported|1|||
147494157|NCT03136185|531962574|FG008|Overall Study|Not Reported|0|||
147494158|NCT03011840|531962575|FG000|Overall Study|Not received PIL in post PIL phase|0|||
147494159|NCT03011840|531962576|FG001|Overall Study|Not received PIL in post PIL phase|21|||
147494160|NCT03738566|531962577|FG000|Initial Study Phase|Withdrawal by Subject|1|||
147668220|NCT01516216|532611686|FG000|Overall Study|Withdrawal by Subject|9|||
147494161|NCT03738566|531962578|FG001|Initial Study Phase|Withdrawal by Subject|1|||
147494162|NCT03738566|531962579|FG002|Initial Study Phase|Withdrawal by Subject|2|||
147494163|NCT03738566|531962580|FG003|Initial Study Phase|Withdrawal by Subject|0|||
147494164|NCT03738566|531962577|FG000|Initial Study Phase|Death|0|||
147494165|NCT03738566|531962578|FG001|Initial Study Phase|Death|1|||
147494166|NCT03738566|531962579|FG002|Initial Study Phase|Death|0|||
147494167|NCT03738566|531962580|FG003|Initial Study Phase|Death|0|||
147494168|NCT03738566|531962577|FG000|Initial Study Phase|Treatment failure|5|||
147494169|NCT03738566|531962578|FG001|Initial Study Phase|Treatment failure|0|||
147494170|NCT03738566|531962579|FG002|Initial Study Phase|Treatment failure|0|||
147494171|NCT03738566|531962580|FG003|Initial Study Phase|Treatment failure|0|||
147494172|NCT03738566|531962577|FG000|Cross-over for Treatment Failure|Withdrawal by Subject|0|||
147494173|NCT03738566|531962578|FG001|Cross-over for Treatment Failure|Withdrawal by Subject|0|||
147494174|NCT03738566|531962579|FG002|Cross-over for Treatment Failure|Withdrawal by Subject|0|||
147494175|NCT03738566|531962580|FG003|Cross-over for Treatment Failure|Withdrawal by Subject|1|||
147494176|NCT00605722|531964356|FG000|Overall Study|Adverse Event|6|||
147494177|NCT00605722|531964356|FG000|Overall Study|Insufficient therapeutic response|44|||
147494178|NCT00605722|531964356|FG000|Overall Study|Failure to return|1|||
147494179|NCT00356863|531964362|FG000|Overall Study|Death|16|||
147494180|NCT00356863|531964363|FG001|Overall Study|Death|32|||
147494181|NCT00356863|531964362|FG000|Overall Study|Lost to Follow-up|76|||
147494182|NCT00356863|531964363|FG001|Overall Study|Lost to Follow-up|43|||
147494183|NCT00836277|531964366|FG000|Overall Study|Not evaluable for response|6|||
147494184|NCT00333619|531964367|FG000|Overall Study|Death|12|||
147494185|NCT00333619|531964368|FG001|Overall Study|Death|6|||
147494186|NCT00333619|531964367|FG000|Overall Study|Withdrawal by Subject|6|||
147494187|NCT00333619|531964368|FG001|Overall Study|Withdrawal by Subject|1|||
147494188|NCT00333619|531964367|FG000|Overall Study|Lost to Follow-up|3|||
147494189|NCT00333619|531964368|FG001|Overall Study|Lost to Follow-up|3|||
147494190|NCT02871401|531964375|FG000|Overall Study|Adverse Event|1|||
147494191|NCT02871401|531964376|FG001|Overall Study|Adverse Event|0|||
147494192|NCT01120379|531964379|FG000|One Year Timepoint|Withdrawal by Subject|41|||
147494193|NCT01120379|531964379|FG000|One Year Timepoint|Lost to Follow-up|115|||
147494194|NCT01120379|531964379|FG000|One Year Timepoint|Death|108|||
147494195|NCT01120379|531964379|FG000|One Year Timepoint|Physician Decision|9|||
147494196|NCT01120379|531964379|FG000|One Year Timepoint|Any other reason for early termination|5|||
147494197|NCT01120379|531964379|FG000|Two Year Timepoint|Withdrawal by Subject|11|||
147494198|NCT01120379|531964379|FG000|Two Year Timepoint|Lost to Follow-up|87|||
147494199|NCT01120379|531964379|FG000|Two Year Timepoint|Death|123|||
147494200|NCT01120379|531964379|FG000|Two Year Timepoint|Physician Decision|12|||
147494201|NCT01120379|531964379|FG000|Two Year Timepoint|Any other reason for early termination|4|||
147494202|NCT01120379|531964379|FG000|Three Year Timepoint|Withdrawal by Subject|25|||
147494203|NCT01120379|531964379|FG000|Three Year Timepoint|Lost to Follow-up|43|||
147494204|NCT01120379|531964379|FG000|Three Year Timepoint|Death|120|||
147494205|NCT01120379|531964379|FG000|Three Year Timepoint|Physician Decision|9|||
147494206|NCT01120379|531964379|FG000|Three Year Timepoint|Any other reason for early termination|17|||
147494207|NCT01120379|531964379|FG000|Four Year Timepoint|Withdrawal by Subject|5|||
147494208|NCT01120379|531964379|FG000|Four Year Timepoint|Lost to Follow-up|10|||
147494209|NCT01120379|531964379|FG000|Four Year Timepoint|Death|131|||
147494210|NCT01120379|531964379|FG000|Four Year Timepoint|Physician Decision|5|||
147494211|NCT01120379|531964379|FG000|Four Year Timepoint|Any other reason for early termination|217|||
147494212|NCT04031404|531964380|FG000|Baseline|Lost to Follow-up|0|||
147494213|NCT04031404|531964381|FG001|Baseline|Lost to Follow-up|1|||
147494214|NCT04031404|531964380|FG000|Baseline|Did not meet full inclusion/exclusion.|2|||
147668221|NCT01516216|532611687|FG001|Overall Study|Withdrawal by Subject|11|||
147494215|NCT04031404|531964381|FG001|Baseline|Did not meet full inclusion/exclusion.|4|||
147494216|NCT04031404|531964380|FG000|Pre-randomization|Withdrawn for COVID19 precautions|1|||
147494217|NCT04031404|531964381|FG001|Pre-randomization|Withdrawn for COVID19 precautions|3|||
147494218|NCT04031404|531964380|FG000|Pre-randomization|Disqualified by TMS safety screening|1|||
147494219|NCT04031404|531964381|FG001|Pre-randomization|Disqualified by TMS safety screening|0|||
147494220|NCT04031404|531964380|FG000|Washout (5 Day Min)|Lost to Follow-up|1|||
147494221|NCT04031404|531964381|FG001|Washout (5 Day Min)|Lost to Follow-up|0|||
147494222|NCT01354353|531964384|FG000|Overall Study|Adverse Event|1|||
147494223|NCT01354353|531964385|FG001|Overall Study|Adverse Event|0|||
147494224|NCT01354353|531964386|FG002|Overall Study|Adverse Event|0|||
147494225|NCT01354353|531964387|FG003|Overall Study|Adverse Event|4|||
147494226|NCT01354353|531964388|FG004|Overall Study|Adverse Event|0|||
147494227|NCT01354353|531964389|FG005|Overall Study|Adverse Event|5|||
147494228|NCT01354353|531964384|FG000|Overall Study|Entry Criteria Not Met|0|||
147494229|NCT01354353|531964385|FG001|Overall Study|Entry Criteria Not Met|0|||
147494230|NCT01354353|531964386|FG002|Overall Study|Entry Criteria Not Met|0|||
147494231|NCT01354353|531964387|FG003|Overall Study|Entry Criteria Not Met|1|||
147494232|NCT01354353|531964388|FG004|Overall Study|Entry Criteria Not Met|1|||
147494233|NCT01354353|531964389|FG005|Overall Study|Entry Criteria Not Met|0|||
147494234|NCT01354353|531964384|FG000|Overall Study|Physician Decision|0|||
147494235|NCT01354353|531964385|FG001|Overall Study|Physician Decision|1|||
147494236|NCT01354353|531964386|FG002|Overall Study|Physician Decision|1|||
147494237|NCT01354353|531964387|FG003|Overall Study|Physician Decision|0|||
147494238|NCT01354353|531964388|FG004|Overall Study|Physician Decision|0|||
147494239|NCT01354353|531964389|FG005|Overall Study|Physician Decision|0|||
147494240|NCT01354353|531964384|FG000|Overall Study|Withdrawal by Subject|2|||
147494241|NCT01354353|531964385|FG001|Overall Study|Withdrawal by Subject|0|||
147494242|NCT01354353|531964386|FG002|Overall Study|Withdrawal by Subject|1|||
147494243|NCT01354353|531964387|FG003|Overall Study|Withdrawal by Subject|0|||
147494244|NCT01354353|531964388|FG004|Overall Study|Withdrawal by Subject|0|||
147494245|NCT01354353|531964389|FG005|Overall Study|Withdrawal by Subject|1|||
147494246|NCT01104584|531964390|FG000|Overall Study|Study drug never administered|21|||
147494247|NCT01104584|531964390|FG000|Overall Study|Study prematurely discontinued|2|||
147494248|NCT04017442|531964391|FG000|Overall Study|Withdrawal by Subject|0|||
147494249|NCT04017442|531964392|FG001|Overall Study|Withdrawal by Subject|3|||
147494250|NCT04017442|531964391|FG000|Overall Study|Lost to Follow-up|21|||
147494251|NCT04017442|531964392|FG001|Overall Study|Lost to Follow-up|19|||
147494252|NCT02586233|531964393|FG000|Overall Study|Randomized but did not receive treatment|0|||
147494253|NCT02586233|531964394|FG001|Overall Study|Randomized but did not receive treatment|1|||
147494254|NCT02586233|531964395|FG002|Overall Study|Randomized but did not receive treatment|0|||
147494255|NCT02586233|531964396|FG003|Overall Study|Randomized but did not receive treatment|0|||
147494256|NCT02586233|531964397|FG004|Overall Study|Randomized but did not receive treatment|0|||
147494257|NCT02586233|531964398|FG005|Overall Study|Randomized but did not receive treatment|2|||
147494258|NCT02586233|531964399|FG006|Overall Study|Randomized but did not receive treatment|2|||
147494259|NCT02586233|531964393|FG000|Overall Study|Death|0|||
147494260|NCT02586233|531964394|FG001|Overall Study|Death|1|||
147494261|NCT02586233|531964395|FG002|Overall Study|Death|0|||
147494262|NCT02586233|531964396|FG003|Overall Study|Death|0|||
147494263|NCT02586233|531964397|FG004|Overall Study|Death|2|||
147494264|NCT02586233|531964398|FG005|Overall Study|Death|0|||
147494265|NCT02586233|531964399|FG006|Overall Study|Death|0|||
147494266|NCT03421964|531964407|FG000|Overall Study|Lost to Follow-up|11|||
147494267|NCT03421964|531964408|FG001|Overall Study|Lost to Follow-up|21|||
147494268|NCT03421964|531964407|FG000|Overall Study|Withdrawal by Subject|9|||
147494269|NCT03421964|531964408|FG001|Overall Study|Withdrawal by Subject|3|||
147494270|NCT03421964|531964407|FG000|Overall Study|Incarcerated|1|||
147494271|NCT03421964|531964408|FG001|Overall Study|Incarcerated|0|||
147494272|NCT03421964|531964407|FG000|Overall Study|Inpt Treatment Facility|1|||
147494273|NCT03421964|531964408|FG001|Overall Study|Inpt Treatment Facility|1|||
147494274|NCT03421964|531964407|FG000|Overall Study|Virtual Platform Issues|1|||
147494275|NCT03421964|531964408|FG001|Overall Study|Virtual Platform Issues|1|||
147494276|NCT02938585|531964409|FG000|Overall Study|Withdrawal by parent or guardian|0|||
147494277|NCT02938585|531964410|FG001|Overall Study|Withdrawal by parent or guardian|1|||
147494278|NCT02938585|531964411|FG002|Overall Study|Withdrawal by parent or guardian|0|||
147494279|NCT02938585|531964412|FG003|Overall Study|Withdrawal by parent or guardian|0|||
147494280|NCT02938585|531964409|FG000|Overall Study|Withdrawal by Subject|0|||
147494281|NCT02938585|531964410|FG001|Overall Study|Withdrawal by Subject|0|||
147494282|NCT02938585|531964411|FG002|Overall Study|Withdrawal by Subject|0|||
147494283|NCT02938585|531964412|FG003|Overall Study|Withdrawal by Subject|5|||
147494284|NCT02106455|531964413|FG000|Overall Study|Case Report Form Uncollected|6|||
147494285|NCT02106455|531964413|FG000|Overall Study|Protocol Deviation|2|||
147494286|NCT01260467|531964414|FG000|Overall Study|Withdrawal by Subject|2|||
147494287|NCT03888391|531964419|FG000|Overall Study|Lost to Follow-up|15|||
147494288|NCT00502320|531964420|FG000|Overall Study|Lost to Follow-up|1|||
147494289|NCT00502320|531964421|FG001|Overall Study|Lost to Follow-up|1|||
147494290|NCT00502320|531964420|FG000|Overall Study|Withdrew Consent|1|||
147494291|NCT00502320|531964421|FG001|Overall Study|Withdrew Consent|0|||
147494292|NCT00502320|531964420|FG000|Overall Study|No longer met criteria|1|||
147494293|NCT00502320|531964421|FG001|Overall Study|No longer met criteria|0|||
147494294|NCT00502320|531964420|FG000|Overall Study|Screen Failure|0|||
147494295|NCT00502320|531964421|FG001|Overall Study|Screen Failure|1|||
147494296|NCT00502320|531964420|FG000|Overall Study|Adverse Event|3|||
147494297|NCT00502320|531964421|FG001|Overall Study|Adverse Event|5|||
147494298|NCT03654755|531964427|FG000|Overall Study|Early Termination of study due to COVID-19|42|||
147494299|NCT03654755|531964428|FG001|Overall Study|Early Termination of study due to COVID-19|33|||
147494300|NCT03654755|531964429|FG002|Overall Study|Early Termination of study due to COVID-19|56|||
147494301|NCT03654755|531964427|FG000|Overall Study|Withdrawal by Subject|2|||
147494302|NCT03654755|531964428|FG001|Overall Study|Withdrawal by Subject|4|||
147494303|NCT03654755|531964429|FG002|Overall Study|Withdrawal by Subject|8|||
147494304|NCT03654755|531964427|FG000|Overall Study|Lost to Follow-up|1|||
147494305|NCT03654755|531964428|FG001|Overall Study|Lost to Follow-up|3|||
147494306|NCT03654755|531964429|FG002|Overall Study|Lost to Follow-up|7|||
147494307|NCT03654755|531964427|FG000|Overall Study|Physician Decision|0|||
147494308|NCT03654755|531964428|FG001|Overall Study|Physician Decision|1|||
147494309|NCT03654755|531964429|FG002|Overall Study|Physician Decision|0|||
147494310|NCT03654755|531964427|FG000|Overall Study|Adverse Event|0|||
147494311|NCT03654755|531964428|FG001|Overall Study|Adverse Event|0|||
147494312|NCT03654755|531964429|FG002|Overall Study|Adverse Event|4|||
147494313|NCT03654755|531964427|FG000|Overall Study|Lack of Efficacy|0|||
147494314|NCT03654755|531964428|FG001|Overall Study|Lack of Efficacy|0|||
147494315|NCT03654755|531964429|FG002|Overall Study|Lack of Efficacy|1|||
147494316|NCT02124707|531964431|FG000|Overall Study|Adverse Event|5|||
147494317|NCT02124707|531964431|FG000|Overall Study|Physician Decision|1|||
147494318|NCT02124707|531964431|FG000|Overall Study|Death|1|||
147494319|NCT00781599|531964432|FG000|Overall Study|Lost to Follow-up|7|||
147494320|NCT00781599|531964433|FG001|Overall Study|Lost to Follow-up|4|||
147494321|NCT01088438|531964442|FG000|Overall Study|Withdrawal by Subject|11|||
147494322|NCT01088438|531964443|FG001|Overall Study|Withdrawal by Subject|6|||
147494323|NCT01088438|531964442|FG000|Overall Study|Lost to Follow-up|18|||
147494324|NCT01088438|531964443|FG001|Overall Study|Lost to Follow-up|30|||
147494325|NCT01363713|531964444|FG000|Overall Study|Adverse Event|1|||
147494326|NCT01363713|531964444|FG000|Overall Study|Protocol Violation|3|||
147494327|NCT01363713|531964444|FG000|Overall Study|Withdrawal by Subject|2|||
147494328|NCT01199055|531964445|FG000|Overall Study|Death|0|||
147494329|NCT01199055|531964446|FG001|Overall Study|Death|1|||
147494330|NCT01199055|531964447|FG002|Overall Study|Death|0|||
147494331|NCT01199055|531964445|FG000|Overall Study|Physician Decision|0|||
147494332|NCT01199055|531964446|FG001|Overall Study|Physician Decision|1|||
147494333|NCT01199055|531964447|FG002|Overall Study|Physician Decision|1|||
147494334|NCT01199055|531964445|FG000|Overall Study|Progressive disease|2|||
147494335|NCT01199055|531964446|FG001|Overall Study|Progressive disease|1|||
147494336|NCT01199055|531964447|FG002|Overall Study|Progressive disease|2|||
147494337|NCT01199055|531964445|FG000|Overall Study|Withdrawal by Subject|0|||
147494338|NCT01199055|531964446|FG001|Overall Study|Withdrawal by Subject|0|||
147494339|NCT01199055|531964447|FG002|Overall Study|Withdrawal by Subject|1|||
147494340|NCT00678587|531964449|FG000|Overall Study|Adverse Event|3|||
147494341|NCT00678587|531964450|FG001|Overall Study|Adverse Event|3|||
147494342|NCT00678587|531964449|FG000|Overall Study|Lack of Efficacy|1|||
147494343|NCT00678587|531964450|FG001|Overall Study|Lack of Efficacy|0|||
147494344|NCT00678587|531964449|FG000|Overall Study|Protocol Violation|2|||
147494345|NCT00678587|531964450|FG001|Overall Study|Protocol Violation|1|||
147494346|NCT00678587|531964449|FG000|Overall Study|Study Closed/Terminated|1|||
147494347|NCT00678587|531964450|FG001|Overall Study|Study Closed/Terminated|0|||
147494348|NCT00678587|531964449|FG000|Overall Study|Lost to Follow-up|3|||
147494349|NCT00678587|531964450|FG001|Overall Study|Lost to Follow-up|5|||
147494350|NCT00678587|531964449|FG000|Overall Study|Investigator Discretion|2|||
147494351|NCT00678587|531964450|FG001|Overall Study|Investigator Discretion|6|||
147494352|NCT00678587|531964449|FG000|Overall Study|Withdrew Consent|8|||
147494353|NCT00678587|531964450|FG001|Overall Study|Withdrew Consent|3|||
147494354|NCT03806179|531964451|FG000|Overall Study|Progressive disease|0|||
147494355|NCT03806179|531964452|FG001|Overall Study|Progressive disease|2|||
147494356|NCT00077610|531964455|FG000|Overall Study|Adverse Event|9|||
147494357|NCT00077610|531964456|FG001|Overall Study|Adverse Event|7|||
147494358|NCT00077610|531964457|FG002|Overall Study|Adverse Event|1|||
147494359|NCT00077610|531964455|FG000|Overall Study|Lost to Follow-up|0|||
147494360|NCT00077610|531964456|FG001|Overall Study|Lost to Follow-up|1|||
147494361|NCT00077610|531964457|FG002|Overall Study|Lost to Follow-up|2|||
147494362|NCT00077610|531964455|FG000|Overall Study|Withdrawal by Subject|4|||
147494363|NCT00077610|531964456|FG001|Overall Study|Withdrawal by Subject|10|||
147494364|NCT00077610|531964457|FG002|Overall Study|Withdrawal by Subject|6|||
147494365|NCT00077610|531964455|FG000|Overall Study|Death|17|||
147494366|NCT00077610|531964456|FG001|Overall Study|Death|13|||
147494367|NCT00077610|531964457|FG002|Overall Study|Death|13|||
147494368|NCT00077610|531964455|FG000|Overall Study|Renal transplant|12|||
147494369|NCT00077610|531964456|FG001|Overall Study|Renal transplant|15|||
147494370|NCT00077610|531964457|FG002|Overall Study|Renal transplant|11|||
147494371|NCT00077610|531964455|FG000|Overall Study|Withdrew from dialysis care|5|||
147494372|NCT00077610|531964456|FG001|Overall Study|Withdrew from dialysis care|0|||
147668222|NCT01516216|532611686|FG000|Overall Study|Potentially Curative Resection|6|||
147668223|NCT01516216|532611687|FG001|Overall Study|Potentially Curative Resection|12|||
147668224|NCT01516216|532611686|FG000|Overall Study|Nonadherence|2|||
147494373|NCT00077610|531964457|FG002|Overall Study|Withdrew from dialysis care|3|||
147494374|NCT00077610|531964455|FG000|Overall Study|Insufficient Therapeutic Response|1|||
147494375|NCT00077610|531964456|FG001|Overall Study|Insufficient Therapeutic Response|0|||
147494376|NCT00077610|531964457|FG002|Overall Study|Insufficient Therapeutic Response|0|||
147494377|NCT00077610|531964455|FG000|Overall Study|Multiple blood transfusions|0|||
147494378|NCT00077610|531964456|FG001|Overall Study|Multiple blood transfusions|0|||
147494379|NCT00077610|531964457|FG002|Overall Study|Multiple blood transfusions|1|||
147494380|NCT00077610|531964455|FG000|Overall Study|Principal Investigator's decision|1|||
147668225|NCT01516216|532611687|FG001|Overall Study|Nonadherence|3|||
147494381|NCT00077610|531964456|FG001|Overall Study|Principal Investigator's decision|0|||
147668226|NCT01516216|532611686|FG000|Overall Study|Physician Decision|6|||
147668227|NCT01516216|532611687|FG001|Overall Study|Physician Decision|3|||
147494382|NCT00077610|531964457|FG002|Overall Study|Principal Investigator's decision|1|||
147494383|NCT00077610|531964455|FG000|Overall Study|Worsening of health condition|1|||
147494384|NCT00077610|531964456|FG001|Overall Study|Worsening of health condition|1|||
147494385|NCT00077610|531964457|FG002|Overall Study|Worsening of health condition|0|||
147494386|NCT00077610|531964455|FG000|Overall Study|Given Epogen in hospital|1|||
147494387|NCT00077610|531964456|FG001|Overall Study|Given Epogen in hospital|0|||
147494388|NCT00077610|531964457|FG002|Overall Study|Given Epogen in hospital|0|||
147494389|NCT00077610|531964455|FG000|Overall Study|Transferred to other unit|0|||
147494390|NCT00077610|531964456|FG001|Overall Study|Transferred to other unit|0|||
147494391|NCT00077610|531964457|FG002|Overall Study|Transferred to other unit|1|||
147494392|NCT00077610|531964455|FG000|Overall Study|Transferred to nursing home|0|||
147494393|NCT00077610|531964456|FG001|Overall Study|Transferred to nursing home|0|||
147494394|NCT00077610|531964457|FG002|Overall Study|Transferred to nursing home|1|||
147494395|NCT00077610|531964455|FG000|Overall Study|Transfer to satellite unit|1|||
147494396|NCT00077610|531964456|FG001|Overall Study|Transfer to satellite unit|0|||
147494397|NCT00077610|531964457|FG002|Overall Study|Transfer to satellite unit|0|||
147494398|NCT00077610|531964455|FG000|Overall Study|Transfer to other center for surgery|1|||
147494399|NCT00077610|531964456|FG001|Overall Study|Transfer to other center for surgery|0|||
147494400|NCT00077610|531964457|FG002|Overall Study|Transfer to other center for surgery|0|||
147494401|NCT00077610|531964455|FG000|Overall Study|Change in dialysis modality|1|||
147494402|NCT00077610|531964456|FG001|Overall Study|Change in dialysis modality|0|||
147494403|NCT00077610|531964457|FG002|Overall Study|Change in dialysis modality|0|||
147494404|NCT00077610|531964455|FG000|Overall Study|Relocation|0|||
147494405|NCT00077610|531964456|FG001|Overall Study|Relocation|8|||
147668228|NCT01516216|532611686|FG000|Overall Study|Prolonged Treatment Delay|5|||
147668229|NCT01516216|532611687|FG001|Overall Study|Prolonged Treatment Delay|1|||
147668230|NCT01516216|532611686|FG000|Overall Study|Intercurrent Illness|1|||
147668231|NCT01516216|532611687|FG001|Overall Study|Intercurrent Illness|0|||
147668232|NCT01516216|532611686|FG000|Overall Study|Death|1|||
147668233|NCT01516216|532611687|FG001|Overall Study|Death|1|||
147668234|NCT03736967|532611688|FG000|Overall Study|Withdrawal by Subject|26|||
147668235|NCT03736967|532611689|FG001|Overall Study|Withdrawal by Subject|25|||
147668236|NCT03736967|532611690|FG002|Overall Study|Withdrawal by Subject|23|||
147668237|NCT03736967|532611691|FG003|Overall Study|Withdrawal by Subject|26|||
147668238|NCT03736967|532611688|FG000|Overall Study|Lost to Follow-up|3|||
147668239|NCT03736967|532611689|FG001|Overall Study|Lost to Follow-up|2|||
147668240|NCT03736967|532611690|FG002|Overall Study|Lost to Follow-up|1|||
147668241|NCT03736967|532611691|FG003|Overall Study|Lost to Follow-up|1|||
147668242|NCT03736967|532611688|FG000|Overall Study|Physician Decision|1|||
147668243|NCT03736967|532611689|FG001|Overall Study|Physician Decision|0|||
147494406|NCT00077610|531964457|FG002|Overall Study|Relocation|5|||
147494407|NCT00077610|531964455|FG000|Overall Study|Financial issues|0|||
147494408|NCT00077610|531964456|FG001|Overall Study|Financial issues|1|||
147626117|NCT05228470|532449269|FG001|Overall Study|Death|11|||
147626118|NCT05228470|532449268|FG000|Overall Study|Withdrawal by Subject|1|||
147626119|NCT05228470|532449269|FG001|Overall Study|Withdrawal by Subject|8|||
147626120|NCT05228470|532449268|FG000|Overall Study|Ongoing|1|||
147626121|NCT05228470|532449269|FG001|Overall Study|Ongoing|11|||
147626122|NCT04053868|532449270|FG000|Overall Study|Withdrawal by Subject|1|||
147626123|NCT04053868|532449271|FG001|Overall Study|Withdrawal by Subject|0|||
147626124|NCT05731700|532449272|FG000|Overall Study|Death|1|||
147626125|NCT05400655|532449275|FG000|Part 1A: Period 2|Withdrawal by Subject|0|||
147626126|NCT05400655|532449276|FG001|Part 1A: Period 2|Withdrawal by Subject|0|||
147626127|NCT05400655|532449277|FG002|Part 1A: Period 2|Withdrawal by Subject|0|||
147626128|NCT05400655|532449278|FG003|Part 1A: Period 2|Withdrawal by Subject|1|||
147626129|NCT05400655|532449279|FG004|Part 1A: Period 2|Withdrawal by Subject|0|||
147626130|NCT05400655|532449280|FG005|Part 1A: Period 2|Withdrawal by Subject|0|||
147626131|NCT05400655|532449281|FG006|Part 1A: Period 2|Withdrawal by Subject|0|||
147668244|NCT03736967|532611690|FG002|Overall Study|Physician Decision|0|||
147668245|NCT03736967|532611691|FG003|Overall Study|Physician Decision|1|||
147668246|NCT03736967|532611688|FG000|Overall Study|Adverse Event|0|||
147668247|NCT03736967|532611689|FG001|Overall Study|Adverse Event|1|||
147668248|NCT03736967|532611690|FG002|Overall Study|Adverse Event|0|||
147668249|NCT03736967|532611691|FG003|Overall Study|Adverse Event|1|||
147668250|NCT03736967|532611688|FG000|Overall Study|Death|0|||
147668251|NCT03736967|532611689|FG001|Overall Study|Death|0|||
147668252|NCT03736967|532611690|FG002|Overall Study|Death|0|||
147626132|NCT05400655|532449282|FG007|Part 1A: Period 2|Withdrawal by Subject|0|||
147668253|NCT03736967|532611691|FG003|Overall Study|Death|1|||
147626133|NCT05400655|532449283|FG008|Part 1A: Period 2|Withdrawal by Subject|0|||
147668254|NCT03736967|532611688|FG000|Overall Study|Randomized but never treated|1|||
147626134|NCT05400655|532449284|FG009|Part 1A: Period 2|Withdrawal by Subject|0|||
147626135|NCT05400655|532449285|FG010|Part 1A: Period 2|Withdrawal by Subject|0|||
147668255|NCT03736967|532611689|FG001|Overall Study|Randomized but never treated|0|||
147668256|NCT03736967|532611690|FG002|Overall Study|Randomized but never treated|0|||
147668257|NCT03736967|532611691|FG003|Overall Study|Randomized but never treated|0|||
147668258|NCT02369653|532611692|FG000|Overall Study|Lost to Follow-up|0|||
147494409|NCT00077610|531964457|FG002|Overall Study|Financial issues|0|||
147626136|NCT05400655|532449286|FG011|Part 1A: Period 2|Withdrawal by Subject|0|||
147626137|NCT05400655|532449287|FG012|Part 1A: Period 2|Withdrawal by Subject|0|||
147626138|NCT05400655|532449288|FG013|Part 1A: Period 2|Withdrawal by Subject|0|||
147626139|NCT05400655|532449289|FG014|Part 1A: Period 2|Withdrawal by Subject|0|||
147626140|NCT05400655|532449290|FG015|Part 1A: Period 2|Withdrawal by Subject|0|||
147626141|NCT05400655|532449291|FG016|Part 1A: Period 2|Withdrawal by Subject|0|||
147626142|NCT05400655|532449292|FG017|Part 1A: Period 2|Withdrawal by Subject|0|||
147626143|NCT05400655|532449293|FG018|Part 1A: Period 2|Withdrawal by Subject|0|||
147626144|NCT05400655|532449294|FG019|Part 1A: Period 2|Withdrawal by Subject|0|||
147626145|NCT05400655|532449295|FG020|Part 1A: Period 2|Withdrawal by Subject|0|||
147626146|NCT05400655|532449296|FG021|Part 1A: Period 2|Withdrawal by Subject|0|||
147626147|NCT05400655|532449275|FG000|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
147626148|NCT05400655|532449276|FG001|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
147626149|NCT05400655|532449277|FG002|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
147626150|NCT05400655|532449278|FG003|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
147626151|NCT05400655|532449279|FG004|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
147626152|NCT05400655|532449280|FG005|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
147626153|NCT05400655|532449281|FG006|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
147626154|NCT05400655|532449282|FG007|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
147626155|NCT05400655|532449283|FG008|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
147626156|NCT05400655|532449284|FG009|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
147626157|NCT05400655|532449285|FG010|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
147626158|NCT05400655|532449286|FG011|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
147626159|NCT05400655|532449287|FG012|Part 1B/Part 2 - Period 1|Withdrawal by Subject|1|||
147626160|NCT05400655|532449288|FG013|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
147668259|NCT02369653|532611693|FG001|Overall Study|Lost to Follow-up|1|||
147668260|NCT02369653|532611692|FG000|Overall Study|Administrative reason by sponsor|0|||
147668261|NCT02369653|532611693|FG001|Overall Study|Administrative reason by sponsor|1|||
147668262|NCT02369653|532611692|FG000|Overall Study|Death|1|||
147668263|NCT02369653|532611693|FG001|Overall Study|Death|2|||
147668264|NCT02369653|532611692|FG000|Overall Study|Participant withdrew consent|13|||
147668265|NCT02369653|532611693|FG001|Overall Study|Participant withdrew consent|3|||
147668266|NCT03587636|532611694|FG000|Overall Study|Lost to Follow-up|2|||
147668267|NCT03587636|532611695|FG001|Overall Study|Lost to Follow-up|5|||
147668268|NCT01458587|532611696|FG000|Overall Study|Withdrawal by Subject|1|||
147668269|NCT01458587|532611697|FG001|Overall Study|Withdrawal by Subject|0|||
147668270|NCT01006629|532611698|FG000|Overall Study|Adverse Event|1|||
147668271|NCT01006629|532611698|FG000|Overall Study|Parent refused to continue participation|1|||
147668272|NCT01006629|532611698|FG000|Overall Study|Parent unable to perform site visit|4|||
147668273|NCT00316004|532611699|FG000|Overall Study|Subject was not given study fluid.|14|||
147668274|NCT00316004|532611700|FG001|Overall Study|Subject was not given study fluid.|14|||
147668275|NCT00316004|532611701|FG002|Overall Study|Subject was not given study fluid.|21|||
147668276|NCT02665117|532611704|FG000|Overall Study|Physician Decision|1|||
147668277|NCT02665117|532611705|FG001|Overall Study|Physician Decision|0|||
147668278|NCT00977197|532611708|FG000|Overall Study|Withdrawal by Subject|3|||
147668279|NCT00977197|532611709|FG001|Overall Study|Withdrawal by Subject|4|||
147668280|NCT00977197|532611708|FG000|Overall Study|Adverse Event|3|||
147668281|NCT00977197|532611709|FG001|Overall Study|Adverse Event|1|||
147668282|NCT00977197|532611708|FG000|Overall Study|Lack of Efficacy|1|||
147668283|NCT00977197|532611709|FG001|Overall Study|Lack of Efficacy|0|||
147668284|NCT00977197|532611708|FG000|Overall Study|Lost to Follow-up|1|||
147668285|NCT00977197|532611709|FG001|Overall Study|Lost to Follow-up|3|||
147668286|NCT00977197|532611708|FG000|Overall Study|Nonadherence|1|||
147668287|NCT00977197|532611709|FG001|Overall Study|Nonadherence|1|||
147668288|NCT00958074|532611710|FG000|Overall Study|Withdrawal by Subject|0|||
147668289|NCT00958074|532611711|FG001|Overall Study|Withdrawal by Subject|1|||
147668290|NCT01432951|532611712|FG000|Treatment Phase (Day 1 to 30)|Never Treated|1|||
147668291|NCT00095979|532611715|FG000|Overall Study|Ineligible: Second primary cancer site|2|||
147668292|NCT01829347|532611716|FG000|VTI-210|Death|5|||
147668293|NCT01829347|532611717|FG001|VTI-210|Death|3|||
147668294|NCT01829347|532611716|FG000|VTI-210|Withdrawal by Subject|1|||
147668295|NCT01829347|532611717|FG001|VTI-210|Withdrawal by Subject|0|||
147668296|NCT01829347|532611716|FG000|VTI-210E|Death|2|||
147668297|NCT01829347|532611717|FG001|VTI-210E|Death|1|||
147668298|NCT01829347|532611716|FG000|VTI-210E|Study terminated prematurely|1|||
147668299|NCT01829347|532611717|FG001|VTI-210E|Study terminated prematurely|5|||
147668300|NCT03530293|532611721|FG000|Pre-randomization|Adverse Event|12|||
147494410|NCT00077610|531964455|FG000|Overall Study|Sponsors decision to withdraw|0|||
147626161|NCT05400655|532449289|FG014|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
147626162|NCT05400655|532449290|FG015|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
147626163|NCT05400655|532449291|FG016|Part 1B/Part 2 - Period 1|Withdrawal by Subject|1|||
147626164|NCT05400655|532449292|FG017|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
147626165|NCT05400655|532449293|FG018|Part 1B/Part 2 - Period 1|Withdrawal by Subject|1|||
147668301|NCT03530293|532611722|FG001|Pre-randomization|Adverse Event|0|||
147668302|NCT03530293|532611723|FG002|Pre-randomization|Adverse Event|0|||
147668303|NCT03530293|532611721|FG000|Pre-randomization|Protocol Violation|2|||
147626166|NCT05400655|532449294|FG019|Part 1B/Part 2 - Period 1|Withdrawal by Subject|2|||
147626167|NCT05400655|532449295|FG020|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
147626168|NCT05400655|532449296|FG021|Part 1B/Part 2 - Period 1|Withdrawal by Subject|0|||
147626169|NCT05400655|532449275|FG000|Part 1B/Part 2 - Period 1|Adverse Event|0|||
147626170|NCT05400655|532449276|FG001|Part 1B/Part 2 - Period 1|Adverse Event|0|||
147626171|NCT05400655|532449277|FG002|Part 1B/Part 2 - Period 1|Adverse Event|0|||
147626172|NCT05400655|532449278|FG003|Part 1B/Part 2 - Period 1|Adverse Event|0|||
147626173|NCT05400655|532449279|FG004|Part 1B/Part 2 - Period 1|Adverse Event|0|||
147626174|NCT05400655|532449280|FG005|Part 1B/Part 2 - Period 1|Adverse Event|0|||
147626175|NCT05400655|532449281|FG006|Part 1B/Part 2 - Period 1|Adverse Event|0|||
147626176|NCT05400655|532449282|FG007|Part 1B/Part 2 - Period 1|Adverse Event|0|||
147626177|NCT05400655|532449283|FG008|Part 1B/Part 2 - Period 1|Adverse Event|0|||
147626178|NCT05400655|532449284|FG009|Part 1B/Part 2 - Period 1|Adverse Event|0|||
147626179|NCT05400655|532449285|FG010|Part 1B/Part 2 - Period 1|Adverse Event|0|||
147626180|NCT05400655|532449286|FG011|Part 1B/Part 2 - Period 1|Adverse Event|0|||
147626181|NCT05400655|532449287|FG012|Part 1B/Part 2 - Period 1|Adverse Event|0|||
147626182|NCT05400655|532449288|FG013|Part 1B/Part 2 - Period 1|Adverse Event|1|||
147626183|NCT05400655|532449289|FG014|Part 1B/Part 2 - Period 1|Adverse Event|0|||
147626184|NCT05400655|532449290|FG015|Part 1B/Part 2 - Period 1|Adverse Event|0|||
147626185|NCT05400655|532449291|FG016|Part 1B/Part 2 - Period 1|Adverse Event|2|||
147626186|NCT05400655|532449292|FG017|Part 1B/Part 2 - Period 1|Adverse Event|0|||
147626187|NCT05400655|532449293|FG018|Part 1B/Part 2 - Period 1|Adverse Event|1|||
147626188|NCT05400655|532449294|FG019|Part 1B/Part 2 - Period 1|Adverse Event|0|||
147626189|NCT05400655|532449295|FG020|Part 1B/Part 2 - Period 1|Adverse Event|0|||
147626190|NCT05400655|532449296|FG021|Part 1B/Part 2 - Period 1|Adverse Event|0|||
147626191|NCT05400655|532449275|FG000|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
147626192|NCT05400655|532449276|FG001|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
147626193|NCT05400655|532449277|FG002|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
147626194|NCT05400655|532449278|FG003|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
147626195|NCT05400655|532449279|FG004|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
147626196|NCT05400655|532449280|FG005|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
147626197|NCT05400655|532449281|FG006|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
147626198|NCT05400655|532449282|FG007|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
147626199|NCT05400655|532449283|FG008|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
147626200|NCT05400655|532449284|FG009|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
147626201|NCT05400655|532449285|FG010|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
147626202|NCT05400655|532449286|FG011|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
147626203|NCT05400655|532449287|FG012|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
147626204|NCT05400655|532449288|FG013|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
147626205|NCT05400655|532449289|FG014|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
147626206|NCT05400655|532449290|FG015|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
147626207|NCT05400655|532449291|FG016|Part 1B/Part 2 - Period 1|Lost to Follow-up|2|||
147626208|NCT05400655|532449292|FG017|Part 1B/Part 2 - Period 1|Lost to Follow-up|2|||
147626209|NCT05400655|532449293|FG018|Part 1B/Part 2 - Period 1|Lost to Follow-up|3|||
147626210|NCT05400655|532449294|FG019|Part 1B/Part 2 - Period 1|Lost to Follow-up|0|||
147626211|NCT05400655|532449295|FG020|Part 1B/Part 2 - Period 1|Lost to Follow-up|7|||
147626212|NCT05400655|532449296|FG021|Part 1B/Part 2 - Period 1|Lost to Follow-up|2|||
147626213|NCT05400655|532449275|FG000|Part 1B/Part 2 - Period 1|Physician Decision|0|||
147626214|NCT05400655|532449276|FG001|Part 1B/Part 2 - Period 1|Physician Decision|0|||
147626215|NCT05400655|532449277|FG002|Part 1B/Part 2 - Period 1|Physician Decision|0|||
147626216|NCT05400655|532449278|FG003|Part 1B/Part 2 - Period 1|Physician Decision|0|||
147626217|NCT05400655|532449279|FG004|Part 1B/Part 2 - Period 1|Physician Decision|0|||
147626218|NCT05400655|532449280|FG005|Part 1B/Part 2 - Period 1|Physician Decision|0|||
147626219|NCT05400655|532449281|FG006|Part 1B/Part 2 - Period 1|Physician Decision|0|||
147626220|NCT05400655|532449282|FG007|Part 1B/Part 2 - Period 1|Physician Decision|0|||
147626221|NCT05400655|532449283|FG008|Part 1B/Part 2 - Period 1|Physician Decision|0|||
147626222|NCT05400655|532449284|FG009|Part 1B/Part 2 - Period 1|Physician Decision|0|||
147626223|NCT05400655|532449285|FG010|Part 1B/Part 2 - Period 1|Physician Decision|0|||
147626224|NCT05400655|532449286|FG011|Part 1B/Part 2 - Period 1|Physician Decision|0|||
147626225|NCT05400655|532449287|FG012|Part 1B/Part 2 - Period 1|Physician Decision|0|||
147626226|NCT05400655|532449288|FG013|Part 1B/Part 2 - Period 1|Physician Decision|0|||
147626227|NCT05400655|532449289|FG014|Part 1B/Part 2 - Period 1|Physician Decision|0|||
147626228|NCT05400655|532449290|FG015|Part 1B/Part 2 - Period 1|Physician Decision|0|||
147626229|NCT05400655|532449291|FG016|Part 1B/Part 2 - Period 1|Physician Decision|0|||
147626230|NCT05400655|532449292|FG017|Part 1B/Part 2 - Period 1|Physician Decision|3|||
147626231|NCT05400655|532449293|FG018|Part 1B/Part 2 - Period 1|Physician Decision|2|||
147626232|NCT05400655|532449294|FG019|Part 1B/Part 2 - Period 1|Physician Decision|0|||
147626233|NCT05400655|532449295|FG020|Part 1B/Part 2 - Period 1|Physician Decision|0|||
147626234|NCT05400655|532449296|FG021|Part 1B/Part 2 - Period 1|Physician Decision|0|||
147626235|NCT05400655|532449275|FG000|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
147626236|NCT05400655|532449276|FG001|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
147626237|NCT05400655|532449277|FG002|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
147626238|NCT05400655|532449278|FG003|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
147626239|NCT05400655|532449279|FG004|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
147626240|NCT05400655|532449280|FG005|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
147626241|NCT05400655|532449281|FG006|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
147626242|NCT05400655|532449282|FG007|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
147626243|NCT05400655|532449283|FG008|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
147626244|NCT05400655|532449284|FG009|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
147626245|NCT05400655|532449285|FG010|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
147626246|NCT05400655|532449286|FG011|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
147626247|NCT05400655|532449287|FG012|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
147626248|NCT05400655|532449288|FG013|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
147626249|NCT05400655|532449289|FG014|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
147626250|NCT05400655|532449290|FG015|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
147626251|NCT05400655|532449291|FG016|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|1|||
147626252|NCT05400655|532449292|FG017|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|0|||
147626253|NCT05400655|532449293|FG018|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|1|||
147626254|NCT05400655|532449294|FG019|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|3|||
147626255|NCT05400655|532449295|FG020|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|1|||
147626256|NCT05400655|532449296|FG021|Part 1B/Part 2 - Period 1|Missed multiple clinic visits|3|||
147626257|NCT02088554|532449297|FG000|Overall Study|Exited before procedure|130|||
147626258|NCT02088554|532449297|FG000|Overall Study|Attempted but not implanted|31|||
147626259|NCT02088554|532449297|FG000|Overall Study|Implant not attempted|19|||
147626260|NCT02088554|532449297|FG000|Overall Study|Pending next visit|532|||
147626261|NCT02088554|532449297|FG000|Overall Study|Death|170|||
147626262|NCT02088554|532449297|FG000|Overall Study|Subject Withdrew + Physician Withdrew + Subject Not Implanted With Study Valve|96|||
147626263|NCT02088554|532449297|FG000|Overall Study|Lost to Follow-up|23|||
147626264|NCT02088554|532449297|FG000|Overall Study|Explanted|32|||
147626265|NCT02088554|532449297|FG000|Overall Study|Any other reason not covered by previous categories|11|||
147626266|NCT02283268|532449304|FG000|Overall Study|Withdrawal by Subject|1|||
147626267|NCT00570141|532449309|FG000|Overall Study|Adverse Event|1|||
147626268|NCT00570141|532449309|FG000|Overall Study|Missed visits|1|||
147626269|NCT00570141|532449309|FG000|Overall Study|Lost to Follow-up|1|||
147626270|NCT02309411|532449312|FG000|Overall Study|Physician Decision|1|||
147626271|NCT02309411|532449313|FG001|Overall Study|Physician Decision|0|||
147626272|NCT02309411|532449314|FG002|Overall Study|Physician Decision|0|||
147626273|NCT02309411|532449312|FG000|Overall Study|Withdrawal by Subject|1|||
147626274|NCT02309411|532449313|FG001|Overall Study|Withdrawal by Subject|1|||
147626275|NCT02309411|532449314|FG002|Overall Study|Withdrawal by Subject|0|||
147626276|NCT03270657|532449315|FG000|Overall Study|Withdrawal by Subject|1|||
147626277|NCT00455403|532449316|FG000|Overall Study|Lost to Follow-up|2|||
147626278|NCT00455403|532449317|FG001|Overall Study|Lost to Follow-up|1|||
147626279|NCT00455403|532449316|FG000|Overall Study|Withdrawal by Subject|1|||
147626280|NCT00455403|532449317|FG001|Overall Study|Withdrawal by Subject|3|||
147626281|NCT00455403|532449316|FG000|Overall Study|Protocol Violation|0|||
147626282|NCT00455403|532449317|FG001|Overall Study|Protocol Violation|2|||
147626283|NCT01343043|532449320|FG000|Overall Study|Disease progression before treatment|1|||
147626284|NCT01343043|532449321|FG001|Overall Study|Disease progression before treatment|0|||
147626285|NCT01343043|532449322|FG002|Overall Study|Disease progression before treatment|0|||
147626286|NCT01343043|532449323|FG003|Overall Study|Disease progression before treatment|0|||
147626287|NCT01343043|532449320|FG000|Overall Study|Withdrawal by Subject|1|||
147626288|NCT01343043|532449321|FG001|Overall Study|Withdrawal by Subject|0|||
147626289|NCT01343043|532449322|FG002|Overall Study|Withdrawal by Subject|0|||
147626290|NCT01343043|532449323|FG003|Overall Study|Withdrawal by Subject|0|||
147626291|NCT01343043|532449320|FG000|Overall Study|Death|1|||
147626292|NCT01343043|532449321|FG001|Overall Study|Death|1|||
147626293|NCT01343043|532449322|FG002|Overall Study|Death|0|||
147626294|NCT01343043|532449323|FG003|Overall Study|Death|1|||
147626295|NCT00925704|532449324|FG000|First Intervention|Withdrew consent|0|||
147626296|NCT00925704|532449325|FG001|First Intervention|Withdrew consent|0|||
147626297|NCT00925704|532449326|FG002|First Intervention|Withdrew consent|0|||
147626298|NCT00925704|532449327|FG003|First Intervention|Withdrew consent|1|||
147626299|NCT00925704|532449328|FG004|First Intervention|Withdrew consent|1|||
147626300|NCT00925704|532449329|FG005|First Intervention|Withdrew consent|0|||
147626301|NCT00925704|532449324|FG000|Second Intervention|Withdrawal by Subject|1|||
147626302|NCT00925704|532449325|FG001|Second Intervention|Withdrawal by Subject|0|||
147626303|NCT00925704|532449326|FG002|Second Intervention|Withdrawal by Subject|0|||
147626304|NCT00925704|532449327|FG003|Second Intervention|Withdrawal by Subject|0|||
147626305|NCT00925704|532449328|FG004|Second Intervention|Withdrawal by Subject|1|||
147626306|NCT00925704|532449329|FG005|Second Intervention|Withdrawal by Subject|0|||
147626307|NCT00925704|532449324|FG000|Third Intervention|Withdrew consent|0|||
147626308|NCT00925704|532449325|FG001|Third Intervention|Withdrew consent|0|||
147626309|NCT00925704|532449326|FG002|Third Intervention|Withdrew consent|0|||
147494411|NCT00077610|531964456|FG001|Overall Study|Sponsors decision to withdraw|0|||
147494412|NCT00077610|531964457|FG002|Overall Study|Sponsors decision to withdraw|1|||
147494413|NCT01357915|531964461|FG000|Overall Study|Lost to Follow-up|3|||
147494414|NCT01357915|531964462|FG001|Overall Study|Lost to Follow-up|0|||
147494415|NCT00305253|531964463|FG000|Overall Study|Withdrawal by Subject|0|||
147494416|NCT00305253|531964464|FG001|Overall Study|Withdrawal by Subject|1|||
147494417|NCT02662985|531964466|FG000|Treatment Period 1|Adverse Event|0|||
147494418|NCT02662985|531964467|FG001|Treatment Period 1|Adverse Event|2|||
147494419|NCT02662985|531964466|FG000|Treatment Period 1|Protocol Violation|0|||
147494420|NCT02662985|531964467|FG001|Treatment Period 1|Protocol Violation|1|||
147494421|NCT02662985|531964466|FG000|Treatment Period 1|Physician Decision|1|||
147494422|NCT02662985|531964467|FG001|Treatment Period 1|Physician Decision|0|||
147494423|NCT02662985|531964466|FG000|Treatment Period 1|Withdrawal by Subject|0|||
147494424|NCT02662985|531964467|FG001|Treatment Period 1|Withdrawal by Subject|1|||
147494425|NCT02662985|531964466|FG000|Treatment Period 2|Lack of Efficacy|0|||
147494426|NCT02662985|531964467|FG001|Treatment Period 2|Lack of Efficacy|1|||
147494427|NCT02662985|531964466|FG000|Treatment Period 2|Lost to Follow-up|1|||
147494428|NCT02662985|531964467|FG001|Treatment Period 2|Lost to Follow-up|0|||
147494429|NCT02662985|531964466|FG000|Treatment Period 3 (Extension Period)|Withdrew before entering period|4|||
147494430|NCT02662985|531964467|FG001|Treatment Period 3 (Extension Period)|Withdrew before entering period|4|||
147494431|NCT02662985|531964466|FG000|Treatment Period 3 (Extension Period)|Adverse Event|1|||
147494432|NCT02662985|531964467|FG001|Treatment Period 3 (Extension Period)|Adverse Event|1|||
147494433|NCT02662985|531964466|FG000|Treatment Period 3 (Extension Period)|Lack of Efficacy|0|||
147494434|NCT02662985|531964467|FG001|Treatment Period 3 (Extension Period)|Lack of Efficacy|1|||
147494435|NCT02662985|531964466|FG000|Treatment Period 3 (Extension Period)|Withdrawal by Subject|1|||
147494436|NCT02662985|531964467|FG001|Treatment Period 3 (Extension Period)|Withdrawal by Subject|2|||
147494437|NCT02662985|531964466|FG000|Treatment Period 3 (Extension Period)|Death|0|||
147494438|NCT02662985|531964467|FG001|Treatment Period 3 (Extension Period)|Death|1|||
147494439|NCT03442829|531964468|FG000|Overall Study|Scheduling clash|3|||
147494440|NCT03442829|531964469|FG001|Overall Study|Scheduling clash|1|||
147494441|NCT03442829|531964468|FG000|Overall Study|Illness unrelated to study|1|||
147494442|NCT03442829|531964469|FG001|Overall Study|Illness unrelated to study|1|||
147494443|NCT01486784|531964470|FG000|Overall Study|Withdrawal by Subject|0|||
147494444|NCT01486784|531964471|FG001|Overall Study|Withdrawal by Subject|0|||
147494445|NCT01486784|531964472|FG002|Overall Study|Withdrawal by Subject|1|||
147494446|NCT01486784|531964473|FG003|Overall Study|Withdrawal by Subject|0|||
147494447|NCT01486784|531964474|FG004|Overall Study|Withdrawal by Subject|1|||
147494448|NCT01486784|531964475|FG005|Overall Study|Withdrawal by Subject|2|||
147494449|NCT01486784|531964470|FG000|Overall Study|Subject did not meet entry criteria|0|||
147494450|NCT01486784|531964471|FG001|Overall Study|Subject did not meet entry criteria|0|||
147494451|NCT01486784|531964472|FG002|Overall Study|Subject did not meet entry criteria|0|||
147494452|NCT01486784|531964473|FG003|Overall Study|Subject did not meet entry criteria|0|||
147494453|NCT01486784|531964474|FG004|Overall Study|Subject did not meet entry criteria|1|||
147494454|NCT01486784|531964475|FG005|Overall Study|Subject did not meet entry criteria|0|||
147494455|NCT01486784|531964470|FG000|Overall Study|Death|0|||
147494456|NCT01486784|531964471|FG001|Overall Study|Death|0|||
147494457|NCT01486784|531964472|FG002|Overall Study|Death|0|||
147494458|NCT01486784|531964473|FG003|Overall Study|Death|0|||
147494459|NCT01486784|531964474|FG004|Overall Study|Death|0|||
147494460|NCT01486784|531964475|FG005|Overall Study|Death|1|||
147494461|NCT02841787|531964476|FG000|Overall Study|Lost to Follow-up|1|||
147494462|NCT02841787|531964477|FG001|Overall Study|Lost to Follow-up|0|||
147494463|NCT02841787|531964478|FG002|Overall Study|Lost to Follow-up|0|||
147494464|NCT02841787|531964476|FG000|Overall Study|Symptoms dropped below threshold|1|||
147494465|NCT02841787|531964477|FG001|Overall Study|Symptoms dropped below threshold|0|||
147494466|NCT02841787|531964478|FG002|Overall Study|Symptoms dropped below threshold|0|||
147494467|NCT02841787|531964476|FG000|Overall Study|Withdrawal by Subject|1|||
147494468|NCT02841787|531964477|FG001|Overall Study|Withdrawal by Subject|4|||
147494469|NCT02841787|531964478|FG002|Overall Study|Withdrawal by Subject|0|||
147494470|NCT03491553|531964479|FG000|Main Study (Up to Week 48)|Adverse Event|0|||
147626310|NCT00925704|532449327|FG003|Third Intervention|Withdrew consent|0|||
147626311|NCT00925704|532449328|FG004|Third Intervention|Withdrew consent|0|||
147626312|NCT00925704|532449329|FG005|Third Intervention|Withdrew consent|1|||
147626313|NCT00502242|532449335|FG000|Overall Study|Lack of Efficacy|1|||
147494471|NCT03491553|531964480|FG001|Main Study (Up to Week 48)|Adverse Event|0|||
147494472|NCT03491553|531964481|FG002|Main Study (Up to Week 48)|Adverse Event|0|||
147494473|NCT03491553|531964482|FG003|Main Study (Up to Week 48)|Adverse Event|1|||
147494474|NCT03491553|531964483|FG004|Main Study (Up to Week 48)|Adverse Event|0|||
147494475|NCT03491553|531964484|FG005|Main Study (Up to Week 48)|Adverse Event|0|||
147494476|NCT03491553|531964479|FG000|Main Study (Up to Week 48)|Withdrew Consent|1|||
147494477|NCT03491553|531964480|FG001|Main Study (Up to Week 48)|Withdrew Consent|1|||
147494478|NCT03491553|531964481|FG002|Main Study (Up to Week 48)|Withdrew Consent|0|||
147494479|NCT03491553|531964482|FG003|Main Study (Up to Week 48)|Withdrew Consent|0|||
147626314|NCT00502242|532449336|FG001|Overall Study|Lack of Efficacy|11|||
147626315|NCT00502242|532449335|FG000|Overall Study|Adverse Event|31|||
147626316|NCT00502242|532449336|FG001|Overall Study|Adverse Event|20|||
147626317|NCT00502242|532449335|FG000|Overall Study|Physician Decision|2|||
147626318|NCT00502242|532449336|FG001|Overall Study|Physician Decision|3|||
147626319|NCT00502242|532449335|FG000|Overall Study|Other - Unspecified|8|||
147626320|NCT00502242|532449336|FG001|Overall Study|Other - Unspecified|14|||
147626321|NCT00502242|532449335|FG000|Overall Study|Protocol Violation|3|||
147626322|NCT00502242|532449336|FG001|Overall Study|Protocol Violation|1|||
147626323|NCT00502242|532449335|FG000|Overall Study|Withdrawal by Subject|6|||
147626324|NCT00502242|532449336|FG001|Overall Study|Withdrawal by Subject|7|||
147626325|NCT03207815|532449337|FG000|Overall Study|Protocol Violation|3|||
147626326|NCT03207815|532449338|FG001|Overall Study|Protocol Violation|1|||
147626327|NCT03207815|532449337|FG000|Overall Study|Adverse Event|1|||
147626328|NCT03207815|532449338|FG001|Overall Study|Adverse Event|2|||
147626329|NCT03207815|532449337|FG000|Overall Study|Lost to Follow-up|1|||
147626330|NCT03207815|532449338|FG001|Overall Study|Lost to Follow-up|2|||
147626331|NCT03207815|532449337|FG000|Overall Study|Investigator's Discretion|1|||
147626332|NCT03207815|532449338|FG001|Overall Study|Investigator's Discretion|1|||
147626333|NCT03207815|532449337|FG000|Overall Study|Lack of Efficacy|0|||
147626334|NCT03207815|532449338|FG001|Overall Study|Lack of Efficacy|1|||
147626335|NCT03207815|532449337|FG000|Overall Study|Pregnancy/Partner Pregnancy|1|||
147626336|NCT03207815|532449338|FG001|Overall Study|Pregnancy/Partner Pregnancy|0|||
147626337|NCT03207815|532449337|FG000|Overall Study|Withdrew Consent|1|||
147626338|NCT03207815|532449338|FG001|Overall Study|Withdrew Consent|0|||
147626339|NCT01671007|532449339|FG000|Overall Study|Other reasons than listed|166|||
147626340|NCT01671007|532449340|FG001|Overall Study|Other reasons than listed|373|||
147626341|NCT01671007|532449341|FG002|Overall Study|Other reasons than listed|197|||
147626342|NCT01671007|532449342|FG003|Overall Study|Other reasons than listed|228|||
147626343|NCT01671007|532449343|FG004|Overall Study|Other reasons than listed|14|||
147626344|NCT01671007|532449344|FG005|Overall Study|Other reasons than listed|71|||
147626345|NCT01671007|532449345|FG006|Overall Study|Other reasons than listed|17|||
147626346|NCT01671007|532449346|FG007|Overall Study|Other reasons than listed|66|||
147626347|NCT01671007|532449347|FG008|Overall Study|Other reasons than listed|0|||
147626348|NCT01671007|532449339|FG000|Overall Study|Withdrawal by Subject|36|||
147626349|NCT01671007|532449340|FG001|Overall Study|Withdrawal by Subject|59|||
147626350|NCT01671007|532449341|FG002|Overall Study|Withdrawal by Subject|53|||
147626351|NCT01671007|532449342|FG003|Overall Study|Withdrawal by Subject|58|||
147626352|NCT01671007|532449343|FG004|Overall Study|Withdrawal by Subject|4|||
147626353|NCT01671007|532449344|FG005|Overall Study|Withdrawal by Subject|15|||
147626354|NCT01671007|532449345|FG006|Overall Study|Withdrawal by Subject|1|||
147626355|NCT01671007|532449346|FG007|Overall Study|Withdrawal by Subject|19|||
147626356|NCT01671007|532449347|FG008|Overall Study|Withdrawal by Subject|0|||
147626357|NCT01671007|532449339|FG000|Overall Study|Lost to Follow-up|93|||
147626358|NCT01671007|532449340|FG001|Overall Study|Lost to Follow-up|142|||
147626359|NCT01671007|532449341|FG002|Overall Study|Lost to Follow-up|91|||
147626360|NCT01671007|532449342|FG003|Overall Study|Lost to Follow-up|63|||
147626361|NCT01671007|532449343|FG004|Overall Study|Lost to Follow-up|7|||
147626362|NCT01671007|532449344|FG005|Overall Study|Lost to Follow-up|20|||
147626363|NCT01671007|532449345|FG006|Overall Study|Lost to Follow-up|2|||
147626364|NCT01671007|532449346|FG007|Overall Study|Lost to Follow-up|28|||
147626365|NCT01671007|532449347|FG008|Overall Study|Lost to Follow-up|0|||
147626366|NCT01671007|532449339|FG000|Overall Study|No end of study case report form|3|||
147626367|NCT01671007|532449340|FG001|Overall Study|No end of study case report form|1|||
147626368|NCT01671007|532449341|FG002|Overall Study|No end of study case report form|0|||
147626369|NCT01671007|532449342|FG003|Overall Study|No end of study case report form|2|||
147626370|NCT01671007|532449343|FG004|Overall Study|No end of study case report form|0|||
147626371|NCT01671007|532449344|FG005|Overall Study|No end of study case report form|0|||
147626372|NCT01671007|532449345|FG006|Overall Study|No end of study case report form|0|||
147626373|NCT01671007|532449346|FG007|Overall Study|No end of study case report form|0|||
147626374|NCT01671007|532449347|FG008|Overall Study|No end of study case report form|0|||
147626375|NCT01671007|532449339|FG000|Overall Study|Not eligible|23|||
147626376|NCT01671007|532449340|FG001|Overall Study|Not eligible|76|||
147626377|NCT01671007|532449341|FG002|Overall Study|Not eligible|25|||
147626378|NCT01671007|532449342|FG003|Overall Study|Not eligible|17|||
147626379|NCT01671007|532449343|FG004|Overall Study|Not eligible|0|||
147626380|NCT01671007|532449344|FG005|Overall Study|Not eligible|6|||
147626381|NCT01671007|532449345|FG006|Overall Study|Not eligible|1|||
147626382|NCT01671007|532449346|FG007|Overall Study|Not eligible|19|||
147626383|NCT01671007|532449347|FG008|Overall Study|Not eligible|0|||
147626384|NCT03877068|532449348|FG000|Overall Study|Physician Decision|9|||
147626385|NCT03877068|532449349|FG001|Overall Study|Physician Decision|3|||
147417922|NCT00700427|531694564|FG001|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|5|||
147626386|NCT01812109|532449350|FG000|Overall Study|research personnel delay|16|||
147626387|NCT01812109|532449350|FG000|Overall Study|NIRS Unattainable|17|||
147626388|NCT01966120|532449351|FG000|Overall Study|Withdrawal by Subject|0|||
147626389|NCT01966120|532449352|FG001|Overall Study|Withdrawal by Subject|5|||
147626390|NCT01966120|532449351|FG000|Overall Study|Lost to Follow-up|1|||
147494480|NCT03491553|531964483|FG004|Main Study (Up to Week 48)|Withdrew Consent|0|||
147494481|NCT03491553|531964484|FG005|Main Study (Up to Week 48)|Withdrew Consent|0|||
147494482|NCT03029650|531964487|FG000|Washout (1 Week)|Withdrawal by Subject|1|||
147494483|NCT03029650|531964488|FG001|Washout (1 Week)|Withdrawal by Subject|1|||
147494484|NCT03029650|531964487|FG000|Washout (1 Week)|Physician Decision|0|||
147494485|NCT03029650|531964488|FG001|Washout (1 Week)|Physician Decision|1|||
147494486|NCT01875367|531964489|FG000|Overall Study|Not complete at least 2 questionaries|4|||
147494487|NCT01875367|531964490|FG001|Overall Study|Not complete at least 2 questionaries|2|||
147494488|NCT01875367|531964489|FG000|Overall Study|Not receive study treatment|1|||
147494489|NCT01875367|531964490|FG001|Overall Study|Not receive study treatment|0|||
147494490|NCT02237157|531964491|FG000|Gemcitabine, Local Delivery (Dose 1)|Adverse Event|3|||
147494491|NCT02237157|531964492|FG001|Gemcitabine, Local Delivery (Dose 1)|Adverse Event|0|||
147494492|NCT02237157|531964493|FG002|Gemcitabine, Local Delivery (Dose 1)|Adverse Event|0|||
147494493|NCT02237157|531964494|FG003|Gemcitabine, Local Delivery (Dose 1)|Adverse Event|0|||
147494494|NCT02237157|531964491|FG000|Gemcitabine, Local Delivery (Dose 1)|Withdrawal by Subject|1|||
147494495|NCT02237157|531964492|FG001|Gemcitabine, Local Delivery (Dose 1)|Withdrawal by Subject|0|||
147494496|NCT02237157|531964493|FG002|Gemcitabine, Local Delivery (Dose 1)|Withdrawal by Subject|0|||
147494497|NCT02237157|531964494|FG003|Gemcitabine, Local Delivery (Dose 1)|Withdrawal by Subject|0|||
147494498|NCT03628508|531964495|FG000|Overall Study|Lost to Follow-up|1|||
147494499|NCT01996748|531964496|FG000|Overall Study|Personal reason|1|||
147494500|NCT01996748|531964497|FG001|Overall Study|Personal reason|0|||
147494501|NCT01996748|531964496|FG000|Overall Study|Physician Decision|2|||
147494502|NCT01996748|531964497|FG001|Overall Study|Physician Decision|0|||
147494503|NCT01996748|531964496|FG000|Overall Study|Adverse Event|1|||
147494504|NCT01996748|531964497|FG001|Overall Study|Adverse Event|4|||
147494505|NCT01996748|531964496|FG000|Overall Study|Withdrawal by Subject|0|||
147494506|NCT01996748|531964497|FG001|Overall Study|Withdrawal by Subject|1|||
147494507|NCT01996748|531964496|FG000|Overall Study|Lost to Follow-up|4|||
147494508|NCT01996748|531964497|FG001|Overall Study|Lost to Follow-up|1|||
147494509|NCT00586924|531964503|FG000|Overall Study|Adverse event/serious adverse event|0|||
147494510|NCT00586924|531964504|FG001|Overall Study|Adverse event/serious adverse event|0|||
147494511|NCT00586924|531964505|FG002|Overall Study|Adverse event/serious adverse event|0|||
147494512|NCT00586924|531964506|FG003|Overall Study|Adverse event/serious adverse event|1|||
147494513|NCT00586924|531964507|FG004|Overall Study|Adverse event/serious adverse event|0|||
147494514|NCT00586924|531964508|FG005|Overall Study|Adverse event/serious adverse event|2|||
147494515|NCT00586924|531964503|FG000|Overall Study|Initiation of alternative cancer therapy|0|||
147494516|NCT00586924|531964504|FG001|Overall Study|Initiation of alternative cancer therapy|0|||
147494517|NCT00586924|531964505|FG002|Overall Study|Initiation of alternative cancer therapy|0|||
147494518|NCT00586924|531964506|FG003|Overall Study|Initiation of alternative cancer therapy|0|||
147494519|NCT00586924|531964507|FG004|Overall Study|Initiation of alternative cancer therapy|0|||
147494520|NCT00586924|531964508|FG005|Overall Study|Initiation of alternative cancer therapy|1|||
147494521|NCT00586924|531964503|FG000|Overall Study|Disease progression|0|||
147494522|NCT00586924|531964504|FG001|Overall Study|Disease progression|0|||
147494523|NCT00586924|531964505|FG002|Overall Study|Disease progression|0|||
147494524|NCT00586924|531964506|FG003|Overall Study|Disease progression|1|||
147494525|NCT00586924|531964507|FG004|Overall Study|Disease progression|1|||
147494526|NCT00586924|531964508|FG005|Overall Study|Disease progression|0|||
147494527|NCT00586924|531964503|FG000|Overall Study|Development of neutralizing antibodies|2|||
147494528|NCT00586924|531964504|FG001|Overall Study|Development of neutralizing antibodies|2|||
147494529|NCT00586924|531964505|FG002|Overall Study|Development of neutralizing antibodies|2|||
147494530|NCT00586924|531964506|FG003|Overall Study|Development of neutralizing antibodies|0|||
147494531|NCT00586924|531964507|FG004|Overall Study|Development of neutralizing antibodies|0|||
147494532|NCT00586924|531964508|FG005|Overall Study|Development of neutralizing antibodies|22|||
147494533|NCT00586924|531964503|FG000|Overall Study|Complete response|0|||
147494534|NCT00586924|531964504|FG001|Overall Study|Complete response|1|||
147494535|NCT00586924|531964505|FG002|Overall Study|Complete response|0|||
147494536|NCT00586924|531964506|FG003|Overall Study|Complete response|0|||
147494537|NCT00586924|531964507|FG004|Overall Study|Complete response|2|||
147494538|NCT00586924|531964508|FG005|Overall Study|Complete response|2|||
147494539|NCT00586924|531964503|FG000|Overall Study|Other|1|||
147494540|NCT00586924|531964504|FG001|Overall Study|Other|0|||
147494541|NCT00586924|531964505|FG002|Overall Study|Other|1|||
147494542|NCT00586924|531964506|FG003|Overall Study|Other|1|||
147494543|NCT00586924|531964507|FG004|Overall Study|Other|1|||
147494544|NCT00586924|531964508|FG005|Overall Study|Other|6|||
147494545|NCT04570657|531964511|FG000|Overall Study|Adverse Event|0|||
147626391|NCT01966120|532449352|FG001|Overall Study|Lost to Follow-up|1|||
147626392|NCT01346696|532449353|FG000|Overall Study|Death|1|||
147626393|NCT04630002|532449354|FG000|Cohort1:Treatment Period2(Days 12 to 21)|Physician Decision|2|||
147626394|NCT04630002|532449355|FG001|Cohort1:Treatment Period2(Days 12 to 21)|Physician Decision|0|||
147494546|NCT04570657|531964512|FG001|Overall Study|Adverse Event|0|||
147494547|NCT04570657|531964513|FG002|Overall Study|Adverse Event|1|||
147494548|NCT04570657|531964511|FG000|Overall Study|Lost to Follow-up|0|||
147668304|NCT03530293|532611722|FG001|Pre-randomization|Protocol Violation|0|||
147668305|NCT03530293|532611723|FG002|Pre-randomization|Protocol Violation|0|||
147668306|NCT03530293|532611721|FG000|Pre-randomization|Study Terminated by Sponsor|5|||
147668307|NCT03530293|532611722|FG001|Pre-randomization|Study Terminated by Sponsor|0|||
147668308|NCT03530293|532611723|FG002|Pre-randomization|Study Terminated by Sponsor|0|||
147668309|NCT03530293|532611721|FG000|Pre-randomization|Withdrawal by Subject|5|||
147668310|NCT03530293|532611722|FG001|Pre-randomization|Withdrawal by Subject|0|||
147668311|NCT03530293|532611723|FG002|Pre-randomization|Withdrawal by Subject|0|||
147668312|NCT03530293|532611721|FG000|Randomized Withdrawal Period / Follow-up|Adverse Event|0|||
147668313|NCT03530293|532611722|FG001|Randomized Withdrawal Period / Follow-up|Adverse Event|2|||
147668314|NCT03530293|532611723|FG002|Randomized Withdrawal Period / Follow-up|Adverse Event|4|||
147668315|NCT03530293|532611721|FG000|Randomized Withdrawal Period / Follow-up|Protocol Violation|0|||
147668316|NCT03530293|532611722|FG001|Randomized Withdrawal Period / Follow-up|Protocol Violation|0|||
147668317|NCT03530293|532611723|FG002|Randomized Withdrawal Period / Follow-up|Protocol Violation|1|||
147668318|NCT03530293|532611721|FG000|Randomized Withdrawal Period / Follow-up|Withdrawal by Subject|0|||
147668319|NCT03530293|532611722|FG001|Randomized Withdrawal Period / Follow-up|Withdrawal by Subject|3|||
147668320|NCT03530293|532611723|FG002|Randomized Withdrawal Period / Follow-up|Withdrawal by Subject|2|||
147668321|NCT03530293|532611721|FG000|Randomized Withdrawal Period / Follow-up|Lack of Efficacy|0|||
147668322|NCT03530293|532611722|FG001|Randomized Withdrawal Period / Follow-up|Lack of Efficacy|2|||
147668323|NCT03530293|532611723|FG002|Randomized Withdrawal Period / Follow-up|Lack of Efficacy|0|||
147668324|NCT03530293|532611721|FG000|Randomized Withdrawal Period / Follow-up|Study Terminated by Sponsor|0|||
147626395|NCT04630002|532449356|FG002|Cohort1:Treatment Period2(Days 12 to 21)|Physician Decision|0|||
147626396|NCT04630002|532449354|FG000|Cohort1:Treatment Period3(Days 22 to 31)|Physician Decision|1|||
147626397|NCT04630002|532449355|FG001|Cohort1:Treatment Period3(Days 22 to 31)|Physician Decision|0|||
147626398|NCT04630002|532449356|FG002|Cohort1:Treatment Period3(Days 22 to 31)|Physician Decision|0|||
147626399|NCT04630002|532449354|FG000|Cohort1:Treatment Period3(Days 22 to 31)|Adverse Event|1|||
147626400|NCT04630002|532449355|FG001|Cohort1:Treatment Period3(Days 22 to 31)|Adverse Event|0|||
147626401|NCT04630002|532449356|FG002|Cohort1:Treatment Period3(Days 22 to 31)|Adverse Event|0|||
147626402|NCT04630002|532449354|FG000|Cohort2:Treatment Period2(Days 12 to 21)|Physician Decision|0|||
147626403|NCT04630002|532449355|FG001|Cohort2:Treatment Period2(Days 12 to 21)|Physician Decision|2|||
147626404|NCT04630002|532449356|FG002|Cohort2:Treatment Period2(Days 12 to 21)|Physician Decision|0|||
147626405|NCT04630002|532449354|FG000|Cohort2:Treatment Period3(Days 22 to 31)|Physician Decision|0|||
147626406|NCT04630002|532449355|FG001|Cohort2:Treatment Period3(Days 22 to 31)|Physician Decision|2|||
147626407|NCT04630002|532449356|FG002|Cohort2:Treatment Period3(Days 22 to 31)|Physician Decision|0|||
147626408|NCT04630002|532449354|FG000|Cohort2:Treatment Period3(Days 22 to 31)|Adverse Event|0|||
147626409|NCT04630002|532449355|FG001|Cohort2:Treatment Period3(Days 22 to 31)|Adverse Event|1|||
147626410|NCT04630002|532449356|FG002|Cohort2:Treatment Period3(Days 22 to 31)|Adverse Event|0|||
147626411|NCT04630002|532449354|FG000|Cohort 3:Treatment Period2(Days 8 to 21)|Physician Decision|0|||
147417923|NCT00700427|531694565|FG002|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0|||
147417924|NCT00700427|531694566|FG003|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0|||
147417925|NCT00700427|531694567|FG004|Study Period 3A (Blinded Maintenance)|Missing - Not Otherwise Defined|0|||
147417926|NCT00700427|531694563|FG000|Study Period 3B (Randomized Withdrawal)|Adverse Event|0|||
147417927|NCT00700427|531694564|FG001|Study Period 3B (Randomized Withdrawal)|Adverse Event|0|||
147417928|NCT00700427|531694565|FG002|Study Period 3B (Randomized Withdrawal)|Adverse Event|8|||
147417929|NCT00700427|531694566|FG003|Study Period 3B (Randomized Withdrawal)|Adverse Event|5|||
147417930|NCT00700427|531694567|FG004|Study Period 3B (Randomized Withdrawal)|Adverse Event|0|||
147417931|NCT00700427|531694563|FG000|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|0|||
147417932|NCT00700427|531694564|FG001|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|0|||
147417933|NCT00700427|531694565|FG002|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|25|||
147417934|NCT00700427|531694566|FG003|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|34|||
147417935|NCT00700427|531694567|FG004|Study Period 3B (Randomized Withdrawal)|Withdrawal by Subject|0|||
147417936|NCT00700427|531694563|FG000|Study Period 3B (Randomized Withdrawal)|Protocol Violation|0|||
147417937|NCT00700427|531694564|FG001|Study Period 3B (Randomized Withdrawal)|Protocol Violation|0|||
147417938|NCT00700427|531694565|FG002|Study Period 3B (Randomized Withdrawal)|Protocol Violation|23|||
147417939|NCT00700427|531694566|FG003|Study Period 3B (Randomized Withdrawal)|Protocol Violation|25|||
147417940|NCT00700427|531694567|FG004|Study Period 3B (Randomized Withdrawal)|Protocol Violation|0|||
147417941|NCT00700427|531694563|FG000|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|0|||
147417942|NCT00700427|531694564|FG001|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|0|||
147417943|NCT00700427|531694565|FG002|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|19|||
147417944|NCT00700427|531694566|FG003|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|9|||
147417945|NCT00700427|531694567|FG004|Study Period 3B (Randomized Withdrawal)|Lost to Follow-up|0|||
147417946|NCT00700427|531694563|FG000|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|0|||
147417947|NCT00700427|531694564|FG001|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|0|||
147417948|NCT00700427|531694565|FG002|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|3|||
147626412|NCT04630002|532449355|FG001|Cohort 3:Treatment Period2(Days 8 to 21)|Physician Decision|0|||
147626413|NCT04630002|532449356|FG002|Cohort 3:Treatment Period2(Days 8 to 21)|Physician Decision|1|||
147626414|NCT04630002|532449354|FG000|Cohort 3:Treatment Period2(Days 8 to 21)|Adverse Event|0|||
147626415|NCT04630002|532449355|FG001|Cohort 3:Treatment Period2(Days 8 to 21)|Adverse Event|0|||
147626416|NCT04630002|532449356|FG002|Cohort 3:Treatment Period2(Days 8 to 21)|Adverse Event|1|||
147626417|NCT02182843|532449358|FG000|Overall Study|Withdrawal by Subject|7|||
147626418|NCT02182843|532449358|FG000|Overall Study|Lost to Follow-up|2|||
147626419|NCT02182843|532449358|FG000|Overall Study|Adverse Event|1|||
147626420|NCT04548193|532449363|FG000|Overall Study|Lost to Follow-up|0|||
147626421|NCT04548193|532449364|FG001|Overall Study|Lost to Follow-up|1|||
147626422|NCT04548193|532449363|FG000|Overall Study|Death|0|||
147626423|NCT04548193|532449364|FG001|Overall Study|Death|1|||
147626424|NCT04548193|532449363|FG000|Overall Study|Not eligible. Participant underwent cystectomy in August|1|||
147626425|NCT04548193|532449364|FG001|Overall Study|Not eligible. Participant underwent cystectomy in August|0|||
147626426|NCT04548193|532449363|FG000|Overall Study|Withdrawal by Subject|2|||
147626427|NCT04548193|532449364|FG001|Overall Study|Withdrawal by Subject|2|||
147626428|NCT02042014|532449365|FG000|Overall Study|Adverse Event|1|||
147626429|NCT02042014|532449365|FG000|Overall Study|Physician Decision|7|||
147626430|NCT01681212|532449372|FG000|Overall Study|No longer met study criteria|5|||
147626431|NCT01681212|532449372|FG000|Overall Study|Administrative reason by sponsor|1|||
147626432|NCT05047211|532449374|FG000|Overall Study|Lost to Follow-up|8|||
147626433|NCT05047211|532449375|FG001|Overall Study|Lost to Follow-up|5|||
147626434|NCT02187198|532449378|FG000|Overall Study|did not show up for appointment and did not return calls after week 9|1|||
147626435|NCT02187198|532449379|FG001|Overall Study|did not show up for appointment and did not return calls after week 9|0|||
147626436|NCT02187198|532449378|FG000|Overall Study|did not show up for appointment and did not return calls after week 11|0|||
147626437|NCT02187198|532449379|FG001|Overall Study|did not show up for appointment and did not return calls after week 11|1|||
147626438|NCT00561392|532449380|FG000|Overall Study|Adverse Event|38|||
147626439|NCT00561392|532449380|FG000|Overall Study|Lack of Efficacy|2|||
147626440|NCT00561392|532449380|FG000|Overall Study|Protocol Violation|1|||
147626441|NCT00561392|532449380|FG000|Overall Study|Withdrawal by Subject|8|||
147626442|NCT00561392|532449380|FG000|Overall Study|Administrative problems|4|||
147626443|NCT03321968|532449381|FG000|Overall Study|Withdrawal by Subject|1|||
147626444|NCT03321968|532449382|FG001|Overall Study|Withdrawal by Subject|2|||
147626445|NCT03321968|532449383|FG002|Overall Study|Withdrawal by Subject|1|||
147626446|NCT03321968|532449381|FG000|Overall Study|Lost to Follow-up|2|||
147626447|NCT03321968|532449382|FG001|Overall Study|Lost to Follow-up|0|||
147626448|NCT03321968|532449383|FG002|Overall Study|Lost to Follow-up|1|||
147626449|NCT03321968|532449381|FG000|Overall Study|Other than specified|0|||
147626450|NCT03321968|532449382|FG001|Overall Study|Other than specified|0|||
147626451|NCT03321968|532449383|FG002|Overall Study|Other than specified|1|||
147626452|NCT03822468|532449384|FG000|Treatment Period|Progressive disease|98|||
147626453|NCT03822468|532449385|FG001|Treatment Period|Progressive disease|94|||
147626454|NCT03822468|532449384|FG000|Treatment Period|Adverse Event|21|||
147626455|NCT03822468|532449385|FG001|Treatment Period|Adverse Event|24|||
147626456|NCT03822468|532449384|FG000|Treatment Period|Withdrawal by Subject|9|||
147626457|NCT03822468|532449385|FG001|Treatment Period|Withdrawal by Subject|5|||
147626458|NCT03822468|532449384|FG000|Treatment Period|Physician Decision|9|||
147626459|NCT03822468|532449385|FG001|Treatment Period|Physician Decision|7|||
147626460|NCT03822468|532449384|FG000|Treatment Period|Protocol Violation|2|||
147626461|NCT03822468|532449385|FG001|Treatment Period|Protocol Violation|1|||
147626462|NCT03822468|532449384|FG000|Treatment Period|Death|2|||
147626463|NCT03822468|532449385|FG001|Treatment Period|Death|3|||
147626464|NCT03822468|532449384|FG000|Treatment Period|Lost to Follow-up|1|||
147626465|NCT03822468|532449385|FG001|Treatment Period|Lost to Follow-up|1|||
147626466|NCT03822468|532449384|FG000|Treatment Period|Sponsor decision|46|||
147626467|NCT03822468|532449385|FG001|Treatment Period|Sponsor decision|53|||
147626468|NCT03822468|532449384|FG000|Post-treatment Efficacy Follow-up|Progressive disease|11|||
147626469|NCT03822468|532449385|FG001|Post-treatment Efficacy Follow-up|Progressive disease|14|||
147626470|NCT03822468|532449384|FG000|Post-treatment Efficacy Follow-up|Withdrawal by Subject|4|||
147626471|NCT03822468|532449385|FG001|Post-treatment Efficacy Follow-up|Withdrawal by Subject|3|||
147494549|NCT04570657|531964512|FG001|Overall Study|Lost to Follow-up|0|||
147494550|NCT04570657|531964513|FG002|Overall Study|Lost to Follow-up|1|||
147494551|NCT04570657|531964511|FG000|Overall Study|Physician Decision|0|||
147494552|NCT04570657|531964512|FG001|Overall Study|Physician Decision|1|||
147494553|NCT04570657|531964513|FG002|Overall Study|Physician Decision|0|||
147626472|NCT03822468|532449384|FG000|Post-treatment Efficacy Follow-up|Death|1|||
147626473|NCT03822468|532449385|FG001|Post-treatment Efficacy Follow-up|Death|0|||
147626474|NCT03822468|532449384|FG000|Post-treatment Efficacy Follow-up|Physician Decision|1|||
147626475|NCT03822468|532449385|FG001|Post-treatment Efficacy Follow-up|Physician Decision|2|||
147626476|NCT03822468|532449384|FG000|Post-treatment Efficacy Follow-up|Adverse Event|1|||
147626477|NCT03822468|532449385|FG001|Post-treatment Efficacy Follow-up|Adverse Event|0|||
147626478|NCT03822468|532449384|FG000|Post-treatment Efficacy Follow-up|Lost to Follow-up|1|||
147626479|NCT03822468|532449385|FG001|Post-treatment Efficacy Follow-up|Lost to Follow-up|0|||
147626480|NCT03822468|532449384|FG000|Post-treatment Efficacy Follow-up|Sponsor decision|3|||
147626481|NCT03822468|532449385|FG001|Post-treatment Efficacy Follow-up|Sponsor decision|7|||
147626482|NCT01532518|532449386|FG000|Overall Study|Withdrawal by Subject|0|||
147626483|NCT01532518|532449387|FG001|Overall Study|Withdrawal by Subject|0|||
147626484|NCT01532518|532449388|FG002|Overall Study|Withdrawal by Subject|1|||
147626485|NCT01575834|532449389|FG000|Overall Study|Withdrawal by Subject|352|||
147626486|NCT01575834|532449390|FG001|Overall Study|Withdrawal by Subject|390|||
147626487|NCT01575834|532449389|FG000|Overall Study|Death|81|||
147626488|NCT01575834|532449390|FG001|Overall Study|Death|74|||
147626489|NCT01575834|532449389|FG000|Overall Study|Other|70|||
147626490|NCT01575834|532449390|FG001|Overall Study|Other|70|||
147626491|NCT01575834|532449389|FG000|Overall Study|Adverse Event|63|||
147626492|NCT01575834|532449390|FG001|Overall Study|Adverse Event|61|||
147626493|NCT01575834|532449389|FG000|Overall Study|Lost to Follow-up|55|||
147626494|NCT01575834|532449390|FG001|Overall Study|Lost to Follow-up|68|||
147626495|NCT01575834|532449389|FG000|Overall Study|Noncompliance|52|||
147626496|NCT01575834|532449390|FG001|Overall Study|Noncompliance|27|||
147626497|NCT01575834|532449389|FG000|Overall Study|Administrative decision|15|||
147626498|NCT01575834|532449390|FG001|Overall Study|Administrative decision|33|||
147626499|NCT01575834|532449389|FG000|Overall Study|Ineligibility Determined|5|||
147626500|NCT01575834|532449390|FG001|Overall Study|Ineligibility Determined|8|||
147626501|NCT01575834|532449389|FG000|Overall Study|Protocol Deviation|4|||
147626502|NCT01575834|532449390|FG001|Overall Study|Protocol Deviation|3|||
147626503|NCT01575834|532449389|FG000|Overall Study|Requirement for Alternative Therapy|2|||
147626504|NCT01575834|532449390|FG001|Overall Study|Requirement for Alternative Therapy|4|||
147626505|NCT02155283|532449391|FG000|Overall Study|Lost to Follow-up|3|||
147626506|NCT02155283|532449391|FG000|Overall Study|Withdrawal by Subject|1|||
147626507|NCT02155283|532449391|FG000|Overall Study|Protocol Violation|3|||
147626508|NCT01741688|532449394|FG000|Overall Study|Lack of insurance coverage|2|||
147626509|NCT01741688|532449394|FG000|Overall Study|Withdrawal by Subject|1|||
147626510|NCT02282813|532449397|FG000|Overall Study|Withdrawal by Subject|4|||
147626511|NCT02282813|532449398|FG001|Overall Study|Withdrawal by Subject|5|||
147626512|NCT02282813|532449399|FG002|Overall Study|Withdrawal by Subject|0|||
147626513|NCT02282813|532449397|FG000|Overall Study|Adverse Event|3|||
147626514|NCT02282813|532449398|FG001|Overall Study|Adverse Event|10|||
147626515|NCT02282813|532449399|FG002|Overall Study|Adverse Event|1|||
147626516|NCT02282813|532449397|FG000|Overall Study|Subject non-compliance|1|||
147626517|NCT02282813|532449398|FG001|Overall Study|Subject non-compliance|4|||
147626518|NCT02282813|532449399|FG002|Overall Study|Subject non-compliance|0|||
147626519|NCT02282813|532449397|FG000|Overall Study|Physician Decision|0|||
147626520|NCT02282813|532449398|FG001|Overall Study|Physician Decision|3|||
147626521|NCT02282813|532449399|FG002|Overall Study|Physician Decision|1|||
147626522|NCT02282813|532449397|FG000|Overall Study|Lost to Follow-up|2|||
147626523|NCT02282813|532449398|FG001|Overall Study|Lost to Follow-up|0|||
147626524|NCT02282813|532449399|FG002|Overall Study|Lost to Follow-up|1|||
147626525|NCT02282813|532449397|FG000|Overall Study|Serum Ca >/=11.0mg/dL|1|||
147626526|NCT02282813|532449398|FG001|Overall Study|Serum Ca >/=11.0mg/dL|0|||
147626527|NCT02282813|532449399|FG002|Overall Study|Serum Ca >/=11.0mg/dL|0|||
147626528|NCT02282813|532449397|FG000|Overall Study|Lack of Efficacy|1|||
147626529|NCT02282813|532449398|FG001|Overall Study|Lack of Efficacy|0|||
147626530|NCT02282813|532449399|FG002|Overall Study|Lack of Efficacy|0|||
147626531|NCT02282813|532449397|FG000|Overall Study|Administrative reasons|0|||
147626532|NCT02282813|532449398|FG001|Overall Study|Administrative reasons|1|||
147626533|NCT02282813|532449399|FG002|Overall Study|Administrative reasons|0|||
147626534|NCT00410813|532449400|FG000|Overall Study|Adverse Event|6|||
147626535|NCT00410813|532449401|FG001|Overall Study|Adverse Event|11|||
147626536|NCT00410813|532449400|FG000|Overall Study|Progression|32|||
147626537|NCT00410813|532449401|FG001|Overall Study|Progression|21|||
147626538|NCT00410813|532449400|FG000|Overall Study|Not protocol specified|3|||
147626539|NCT00410813|532449401|FG001|Overall Study|Not protocol specified|4|||
147626540|NCT00410813|532449400|FG000|Overall Study|Ineligible|2|||
147626541|NCT00410813|532449401|FG001|Overall Study|Ineligible|4|||
147626542|NCT00410813|532449400|FG000|Overall Study|Death|0|||
147626543|NCT00410813|532449401|FG001|Overall Study|Death|2|||
147626544|NCT04278417|532449402|FG000|Overall Study|Withdrawal by Subject|20|||
147626545|NCT04278417|532449403|FG001|Overall Study|Withdrawal by Subject|20|||
147626546|NCT04278417|532449402|FG000|Overall Study|Progressive disease|0|||
147626547|NCT04278417|532449403|FG001|Overall Study|Progressive disease|2|||
147626548|NCT04278417|532449402|FG000|Overall Study|Physician Decision|4|||
147626549|NCT04278417|532449403|FG001|Overall Study|Physician Decision|6|||
147626550|NCT04278417|532449402|FG000|Overall Study|Lost to Follow-up|11|||
147626551|NCT04278417|532449403|FG001|Overall Study|Lost to Follow-up|13|||
147626552|NCT04278417|532449402|FG000|Overall Study|Death|8|||
147626553|NCT04278417|532449403|FG001|Overall Study|Death|9|||
147626554|NCT04278417|532449402|FG000|Overall Study|Adverse Event|3|||
147626555|NCT04278417|532449403|FG001|Overall Study|Adverse Event|5|||
147626556|NCT06509438|532449404|FG000|Overall Study|Adverse Event|1|||
147626557|NCT06509438|532449404|FG000|Overall Study|Lost to Follow-up|3|||
147626558|NCT01262872|532449405|FG000|Step 2|Death|0|||
147626559|NCT01262872|532449406|FG001|Step 2|Death|0|||
147626560|NCT01262872|532449407|FG002|Step 2|Death|0|||
147626561|NCT01262872|532449408|FG003|Step 2|Death|1|||
147626562|NCT01262872|532449409|FG004|Step 2|Death|0|||
147626563|NCT01262872|532449410|FG005|Step 2|Death|2|||
147626564|NCT01262872|532449411|FG006|Step 2|Death|2|||
147626565|NCT01262872|532449412|FG007|Step 2|Death|1|||
147626566|NCT01262872|532449405|FG000|Step 2|Protocol Violation|0|||
147626567|NCT01262872|532449406|FG001|Step 2|Protocol Violation|0|||
147626568|NCT01262872|532449407|FG002|Step 2|Protocol Violation|1|||
147626569|NCT01262872|532449408|FG003|Step 2|Protocol Violation|0|||
147626570|NCT01262872|532449409|FG004|Step 2|Protocol Violation|0|||
147626571|NCT01262872|532449410|FG005|Step 2|Protocol Violation|0|||
147626572|NCT01262872|532449411|FG006|Step 2|Protocol Violation|3|||
147626573|NCT01262872|532449412|FG007|Step 2|Protocol Violation|1|||
147626574|NCT01262872|532449405|FG000|Step 2|Withdrawal by Subject|0|||
147626575|NCT01262872|532449406|FG001|Step 2|Withdrawal by Subject|0|||
147626576|NCT01262872|532449407|FG002|Step 2|Withdrawal by Subject|4|||
147626577|NCT01262872|532449408|FG003|Step 2|Withdrawal by Subject|6|||
147626578|NCT01262872|532449409|FG004|Step 2|Withdrawal by Subject|3|||
147626579|NCT01262872|532449410|FG005|Step 2|Withdrawal by Subject|1|||
147626580|NCT01262872|532449411|FG006|Step 2|Withdrawal by Subject|2|||
147626581|NCT01262872|532449412|FG007|Step 2|Withdrawal by Subject|1|||
147626582|NCT01262872|532449405|FG000|Step 2|Migrated/moved from study area|0|||
147626583|NCT01262872|532449406|FG001|Step 2|Migrated/moved from study area|0|||
147626584|NCT01262872|532449407|FG002|Step 2|Migrated/moved from study area|4|||
147626585|NCT01262872|532449408|FG003|Step 2|Migrated/moved from study area|3|||
147626586|NCT01262872|532449409|FG004|Step 2|Migrated/moved from study area|2|||
147626587|NCT01262872|532449410|FG005|Step 2|Migrated/moved from study area|6|||
147626588|NCT01262872|532449411|FG006|Step 2|Migrated/moved from study area|2|||
147626589|NCT01262872|532449412|FG007|Step 2|Migrated/moved from study area|3|||
147626590|NCT01000155|532449413|FG000|Overall Study|Withdrawal by Subject|1|||
147626591|NCT01000155|532449413|FG000|Overall Study|Adverse Event|1|||
147494554|NCT04570657|531964511|FG000|Overall Study|Withdrawal by Subject|1|||
147494555|NCT04570657|531964512|FG001|Overall Study|Withdrawal by Subject|2|||
147494556|NCT04570657|531964513|FG002|Overall Study|Withdrawal by Subject|2|||
147494557|NCT01079962|531964514|FG000|Overall Study|Adverse Event|2|||
147494558|NCT01079962|531964515|FG001|Overall Study|Adverse Event|2|||
147494559|NCT01079962|531964514|FG000|Overall Study|Withdrawal by Subject|5|||
147494560|NCT01079962|531964515|FG001|Overall Study|Withdrawal by Subject|7|||
147494561|NCT01079962|531964514|FG000|Overall Study|Protocol Violation|2|||
147494562|NCT01079962|531964515|FG001|Overall Study|Protocol Violation|2|||
147494563|NCT01079962|531964514|FG000|Overall Study|No blood pressure (BP) control|3|||
147494564|NCT01079962|531964515|FG001|Overall Study|No blood pressure (BP) control|0|||
147494565|NCT01079962|531964514|FG000|Overall Study|Inclusion/exclusion criteria|1|||
147494566|NCT01079962|531964515|FG001|Overall Study|Inclusion/exclusion criteria|3|||
147494567|NCT01079962|531964514|FG000|Overall Study|Participant not returning for next visit|1|||
147494568|NCT01079962|531964515|FG001|Overall Study|Participant not returning for next visit|0|||
147494569|NCT01079962|531964514|FG000|Overall Study|Due to arrhythmia/bradycardia|1|||
147494570|NCT01079962|531964515|FG001|Overall Study|Due to arrhythmia/bradycardia|1|||
147494571|NCT01331239|531964516|FG000|Part II: Core Study|Adverse Event|0|||
147494572|NCT01331239|531964517|FG001|Part II: Core Study|Adverse Event|3|||
147494573|NCT01331239|531964518|FG002|Part II: Core Study|Adverse Event|0|||
147494574|NCT01331239|531964516|FG000|Part II: Core Study|Subj's cond. no longer require treatment|0|||
147494575|NCT01331239|531964517|FG001|Part II: Core Study|Subj's cond. no longer require treatment|2|||
147494576|NCT01331239|531964518|FG002|Part II: Core Study|Subj's cond. no longer require treatment|1|||
147494577|NCT01331239|531964516|FG000|Part II: Core Study|Withdrawal by Subject|0|||
147494578|NCT01331239|531964517|FG001|Part II: Core Study|Withdrawal by Subject|2|||
147494579|NCT01331239|531964518|FG002|Part II: Core Study|Withdrawal by Subject|0|||
147626592|NCT00365794|532449415|FG000|Overall Study|Withdrawal by Subject|2|||
147626593|NCT02554682|532449416|FG000|Overall Study|Lost to Follow-up|11|||
147626594|NCT02554682|532449417|FG001|Overall Study|Lost to Follow-up|9|||
147626595|NCT02554682|532449418|FG002|Overall Study|Lost to Follow-up|4|||
147626596|NCT02554682|532449419|FG003|Overall Study|Lost to Follow-up|3|||
147626597|NCT02554682|532449420|FG004|Overall Study|Lost to Follow-up|2|||
147626598|NCT02554682|532449421|FG005|Overall Study|Lost to Follow-up|1|||
147626599|NCT02554682|532449422|FG006|Overall Study|Lost to Follow-up|6|||
147626600|NCT02554682|532449423|FG007|Overall Study|Lost to Follow-up|6|||
147626601|NCT02554682|532449424|FG008|Overall Study|Lost to Follow-up|2|||
147626602|NCT02554682|532449425|FG009|Overall Study|Lost to Follow-up|2|||
147626603|NCT02554682|532449416|FG000|Overall Study|Withdrawal by Subject|2|||
147626604|NCT02554682|532449417|FG001|Overall Study|Withdrawal by Subject|1|||
147626605|NCT02554682|532449418|FG002|Overall Study|Withdrawal by Subject|0|||
147626606|NCT02554682|532449419|FG003|Overall Study|Withdrawal by Subject|0|||
147626607|NCT02554682|532449420|FG004|Overall Study|Withdrawal by Subject|0|||
147626608|NCT02554682|532449421|FG005|Overall Study|Withdrawal by Subject|0|||
147626609|NCT02554682|532449422|FG006|Overall Study|Withdrawal by Subject|0|||
147626610|NCT02554682|532449423|FG007|Overall Study|Withdrawal by Subject|0|||
147494580|NCT01331239|531964516|FG000|Part II: Core Study|Administrative problems|0|||
147494581|NCT01331239|531964517|FG001|Part II: Core Study|Administrative problems|1|||
147494582|NCT01331239|531964518|FG002|Part II: Core Study|Administrative problems|0|||
147494583|NCT01072539|531964519|FG000|Overall Study|Treated prior to the Site Initiation|1|||
147494584|NCT01072539|531964519|FG000|Overall Study|Protocol Violation|2|||
147494585|NCT00946530|531964520|FG000|Overall Study|Withdrawal by Subject|0|||
147494586|NCT00946530|531964521|FG001|Overall Study|Withdrawal by Subject|3|||
147494587|NCT00946530|531964522|FG002|Overall Study|Withdrawal by Subject|0|||
147494588|NCT00946530|531964523|FG003|Overall Study|Withdrawal by Subject|3|||
147494589|NCT00946530|531964520|FG000|Overall Study|Physician Decision|1|||
147494590|NCT00946530|531964521|FG001|Overall Study|Physician Decision|1|||
147494591|NCT00946530|531964522|FG002|Overall Study|Physician Decision|1|||
147494592|NCT00946530|531964523|FG003|Overall Study|Physician Decision|1|||
147494593|NCT03105700|531964524|FG000|Overall Study|screen fail|3|||
147494594|NCT03105700|531964524|FG000|Overall Study|Lost to Follow-up|4|||
147494595|NCT02768194|531964525|FG000|Period 1|Adverse Event|0|||
147494596|NCT02768194|531964526|FG001|Period 1|Adverse Event|0|||
147494597|NCT02768194|531964527|FG002|Period 1|Adverse Event|0|||
147494598|NCT02768194|531964528|FG003|Period 1|Adverse Event|1|||
147494599|NCT02768194|531964529|FG004|Period 1|Adverse Event|0|||
147494600|NCT02768194|531964530|FG005|Period 1|Adverse Event|0|||
147494601|NCT02768194|531964525|FG000|Period 2|Other (Reason not specified)|1|||
147494602|NCT02768194|531964526|FG001|Period 2|Other (Reason not specified)|0|||
147494603|NCT02768194|531964527|FG002|Period 2|Other (Reason not specified)|0|||
147494604|NCT02768194|531964528|FG003|Period 2|Other (Reason not specified)|0|||
147494605|NCT02768194|531964529|FG004|Period 2|Other (Reason not specified)|0|||
147494606|NCT02768194|531964530|FG005|Period 2|Other (Reason not specified)|0|||
147494607|NCT02768194|531964525|FG000|Period 3|Other (Reason not specified)|0|||
147494608|NCT02768194|531964526|FG001|Period 3|Other (Reason not specified)|1|||
147494609|NCT02768194|531964527|FG002|Period 3|Other (Reason not specified)|0|||
147494610|NCT02768194|531964528|FG003|Period 3|Other (Reason not specified)|0|||
147494611|NCT02768194|531964529|FG004|Period 3|Other (Reason not specified)|0|||
147494612|NCT02768194|531964530|FG005|Period 3|Other (Reason not specified)|0|||
147494613|NCT03095521|531964531|FG000|Overall Study|Withdrawal by Subject|0|||
147494614|NCT03095521|531964532|FG001|Overall Study|Withdrawal by Subject|1|||
147494615|NCT03095521|531964531|FG000|Overall Study|Lost to Follow-up|0|||
147494616|NCT03095521|531964532|FG001|Overall Study|Lost to Follow-up|1|||
147494617|NCT01536119|531964533|FG000|Overall Study|Lost to Follow-up|17|||
147494618|NCT01536119|531964534|FG001|Overall Study|Lost to Follow-up|14|||
147494619|NCT03521193|531964535|FG000|Overall Study|Withdrawal by Subject|8|||
147494620|NCT03521193|531964536|FG001|Overall Study|Withdrawal by Subject|0|||
147494621|NCT03521193|531964535|FG000|Overall Study|non compliant to ASA treatment|8|||
147494622|NCT03521193|531964536|FG001|Overall Study|non compliant to ASA treatment|0|||
147494623|NCT01810042|531964537|FG000|Overall Study|Lost to Follow-up|10|||
147494624|NCT01454401|531964540|FG000|Overall Study|Death|1|||
147494625|NCT01454401|531964540|FG000|Overall Study|hospitalised|1|||
147494626|NCT01454401|531964540|FG000|Overall Study|osteomyelitis|2|||
147494627|NCT01454401|531964540|FG000|Overall Study|non-adherence|1|||
147494628|NCT03162055|531966594|FG000|Overall Study|Adverse Event|6|||
147494629|NCT03162055|531966595|FG001|Overall Study|Adverse Event|5|||
147494630|NCT03162055|531966594|FG000|Overall Study|Death|3|||
147494631|NCT03162055|531966595|FG001|Overall Study|Death|3|||
147494632|NCT03162055|531966594|FG000|Overall Study|Lost to Follow-up|0|||
147494633|NCT03162055|531966595|FG001|Overall Study|Lost to Follow-up|1|||
147494634|NCT03162055|531966594|FG000|Overall Study|Study-specific withdrawal criteria|22|||
147494635|NCT03162055|531966595|FG001|Overall Study|Study-specific withdrawal criteria|14|||
147494636|NCT03162055|531966594|FG000|Overall Study|Withdrawal by Subject|17|||
147494637|NCT03162055|531966595|FG001|Overall Study|Withdrawal by Subject|2|||
147494638|NCT03162055|531966594|FG000|Overall Study|Did not receive treatment|2|||
147494639|NCT03162055|531966595|FG001|Overall Study|Did not receive treatment|0|||
147494640|NCT03162055|531966594|FG000|Overall Study|Incorrect randomization|4|||
147494641|NCT03162055|531966595|FG001|Overall Study|Incorrect randomization|3|||
147494642|NCT03162055|531966594|FG000|Overall Study|Other|8|||
147494643|NCT03162055|531966595|FG001|Overall Study|Other|15|||
147494644|NCT01993615|531966596|FG000|Overall Study|Death|1|||
147494645|NCT01993615|531966597|FG001|Overall Study|Death|0|||
147494646|NCT02370498|531966598|FG000|Overall Study|Adverse Event|10|||
147494647|NCT02370498|531966599|FG001|Overall Study|Adverse Event|8|||
147494648|NCT02370498|531966598|FG000|Overall Study|Death|263|||
147494649|NCT02370498|531966599|FG001|Overall Study|Death|265|||
147494650|NCT02370498|531966598|FG000|Overall Study|Protocol Violation|1|||
147494651|NCT02370498|531966599|FG001|Overall Study|Protocol Violation|2|||
147494652|NCT02370498|531966598|FG000|Overall Study|Withdrawal by Subject|7|||
147494653|NCT02370498|531966599|FG001|Overall Study|Withdrawal by Subject|12|||
147626611|NCT02554682|532449424|FG008|Overall Study|Withdrawal by Subject|0|||
147626612|NCT02554682|532449425|FG009|Overall Study|Withdrawal by Subject|0|||
147494654|NCT02370498|531966598|FG000|Overall Study|Sponsor's decision|15|||
147494655|NCT02370498|531966599|FG001|Overall Study|Sponsor's decision|9|||
147494656|NCT03225716|531966603|FG000|Overall Study|Withdrawal by Subject|2|||
147494657|NCT03225716|531966604|FG001|Overall Study|Withdrawal by Subject|2|||
147494658|NCT03225716|531966605|FG002|Overall Study|Withdrawal by Subject|0|||
147494659|NCT03225716|531966603|FG000|Overall Study|Lack of Efficacy|1|||
147494660|NCT03225716|531966604|FG001|Overall Study|Lack of Efficacy|0|||
147494661|NCT03225716|531966605|FG002|Overall Study|Lack of Efficacy|0|||
147494662|NCT03225716|531966603|FG000|Overall Study|Adverse Event|2|||
147494663|NCT03225716|531966604|FG001|Overall Study|Adverse Event|0|||
147494664|NCT03225716|531966605|FG002|Overall Study|Adverse Event|1|||
147494665|NCT03225716|531966603|FG000|Overall Study|Study early termination by Sponsor|0|||
147494666|NCT03225716|531966604|FG001|Overall Study|Study early termination by Sponsor|0|||
147494667|NCT03225716|531966605|FG002|Overall Study|Study early termination by Sponsor|2|||
147494668|NCT00848250|531966606|FG000|Overall Study|surgery was completed without cardiopulm|0|||
147494669|NCT00848250|531966607|FG001|Overall Study|surgery was completed without cardiopulm|1|||
147494670|NCT00213980|531966615|FG000|Overall Study|Withdrawal by Subject|3|||
147494671|NCT00213980|531966616|FG001|Overall Study|Withdrawal by Subject|1|||
147494672|NCT00213980|531966615|FG000|Overall Study|Adverse Event|1|||
147494673|NCT00213980|531966616|FG001|Overall Study|Adverse Event|1|||
147494674|NCT00213980|531966615|FG000|Overall Study|Disease progression|0|||
147494675|NCT00213980|531966616|FG001|Overall Study|Disease progression|2|||
147494676|NCT00213980|531966615|FG000|Overall Study|Developed ovarian cancer|1|||
147494677|NCT00213980|531966616|FG001|Overall Study|Developed ovarian cancer|0|||
147494678|NCT00213980|531966615|FG000|Overall Study|Failed to obtain all 3 DXAs|1|||
147494679|NCT00213980|531966616|FG001|Overall Study|Failed to obtain all 3 DXAs|3|||
147494680|NCT03607838|531966617|FG000|Overall Study|Lack of Efficacy|14|||
147494681|NCT03607838|531966618|FG001|Overall Study|Lack of Efficacy|20|||
147494682|NCT03607838|531966617|FG000|Overall Study|Withdrawal by Subject|13|||
147494683|NCT03607838|531966618|FG001|Overall Study|Withdrawal by Subject|8|||
147494684|NCT03607838|531966617|FG000|Overall Study|Lost to Follow-up|6|||
147494685|NCT03607838|531966618|FG001|Overall Study|Lost to Follow-up|11|||
147494686|NCT03607838|531966617|FG000|Overall Study|Adverse Event|2|||
147494687|NCT03607838|531966618|FG001|Overall Study|Adverse Event|2|||
147494688|NCT03607838|531966617|FG000|Overall Study|Physician Decision|2|||
147494689|NCT03607838|531966618|FG001|Overall Study|Physician Decision|0|||
147494690|NCT03607838|531966617|FG000|Overall Study|Failure to meet randomization criteria|1|||
147494691|NCT03607838|531966618|FG001|Overall Study|Failure to meet randomization criteria|2|||
147494692|NCT03607838|531966617|FG000|Overall Study|Pregnancy|1|||
147494693|NCT03607838|531966618|FG001|Overall Study|Pregnancy|0|||
147494694|NCT03607838|531966617|FG000|Overall Study|Protocol Violation|1|||
147494695|NCT03607838|531966618|FG001|Overall Study|Protocol Violation|0|||
147494696|NCT03607838|531966617|FG000|Overall Study|Due to work|1|||
147494697|NCT03607838|531966618|FG001|Overall Study|Due to work|0|||
147494698|NCT03607838|531966617|FG000|Overall Study|Litigation|0|||
147494699|NCT03607838|531966618|FG001|Overall Study|Litigation|1|||
147494700|NCT03607838|531966617|FG000|Overall Study|Temperature excursion for study drug|0|||
147494701|NCT03607838|531966618|FG001|Overall Study|Temperature excursion for study drug|1|||
147494702|NCT03607838|531966617|FG000|Overall Study|Change of mind|0|||
147494703|NCT03607838|531966618|FG001|Overall Study|Change of mind|1|||
147494704|NCT02411201|531966619|FG000|Overall Study|Adverse Event|2|||
147494705|NCT02411201|531966619|FG000|Overall Study|Withdrawal by Subject|2|||
147494706|NCT02411201|531966619|FG000|Overall Study|Age group completed|2|||
147626613|NCT02554682|532449416|FG000|Overall Study|Physician Decision|2|||
147626614|NCT02554682|532449417|FG001|Overall Study|Physician Decision|2|||
147626615|NCT02554682|532449418|FG002|Overall Study|Physician Decision|0|||
147626616|NCT02554682|532449419|FG003|Overall Study|Physician Decision|0|||
147626617|NCT02554682|532449420|FG004|Overall Study|Physician Decision|0|||
147626618|NCT02554682|532449421|FG005|Overall Study|Physician Decision|0|||
147626619|NCT02554682|532449422|FG006|Overall Study|Physician Decision|0|||
147626620|NCT02554682|532449423|FG007|Overall Study|Physician Decision|0|||
147494707|NCT00798694|531966620|FG000|Overall Study|Lost to Follow-up|1|||
147494708|NCT00798694|531966621|FG001|Overall Study|Lost to Follow-up|1|||
147494709|NCT00798694|531966620|FG000|Overall Study|Physician Decision|1|||
147494710|NCT00798694|531966621|FG001|Overall Study|Physician Decision|0|||
147494711|NCT01774344|531966623|FG000|Overall Study|Withdrawal by Subject|3|||
147494712|NCT01774344|531966624|FG001|Overall Study|Withdrawal by Subject|10|||
147494713|NCT01774344|531966623|FG000|Overall Study|Protocol Violation|0|||
147494714|NCT01774344|531966624|FG001|Overall Study|Protocol Violation|1|||
147626621|NCT02554682|532449424|FG008|Overall Study|Physician Decision|0|||
147494715|NCT01774344|531966623|FG000|Overall Study|Lost to Follow-up|4|||
147494716|NCT01774344|531966624|FG001|Overall Study|Lost to Follow-up|10|||
147494717|NCT01774344|531966623|FG000|Overall Study|End of survival follow-up not available|2|||
147494718|NCT01774344|531966624|FG001|Overall Study|End of survival follow-up not available|2|||
147494719|NCT01774344|531966623|FG000|Overall Study|Data collection finished|4|||
147494720|NCT01774344|531966624|FG001|Overall Study|Data collection finished|14|||
147626622|NCT02554682|532449425|FG009|Overall Study|Physician Decision|0|||
147626623|NCT02169271|532449426|FG000|Overall Study|Protocol Violation|1|||
147494721|NCT01774344|531966623|FG000|Overall Study|Other|0|||
147494722|NCT01774344|531966624|FG001|Overall Study|Other|1|||
147494723|NCT01774344|531966623|FG000|Overall Study|Did not enter Survival Follow up|49|||
147494724|NCT01774344|531966624|FG001|Overall Study|Did not enter Survival Follow up|83|||
147494725|NCT03364608|531966633|FG000|Overall Study|Withdrawal by Subject|4|||
147494726|NCT03364608|531966633|FG000|Overall Study|Protocol Violation|2|||
147494727|NCT03364608|531966633|FG000|Overall Study|Lost to Follow-up|2|||
147494728|NCT02951988|531966634|FG000|Open-Label Treatment Period|Miscellaneous Reasons|8|||
147494729|NCT02951988|531966635|FG001|Open-Label Treatment Period|Miscellaneous Reasons|0|||
147494730|NCT02951988|531966636|FG002|Open-Label Treatment Period|Miscellaneous Reasons|0|||
147494731|NCT02951988|531966637|FG003|Open-Label Treatment Period|Miscellaneous Reasons|0|||
147494732|NCT02951988|531966634|FG000|Open-Label Treatment Period|Study terminated by sponsor|9|||
147494733|NCT02951988|531966635|FG001|Open-Label Treatment Period|Study terminated by sponsor|0|||
147494734|NCT02951988|531966636|FG002|Open-Label Treatment Period|Study terminated by sponsor|0|||
147494735|NCT02951988|531966637|FG003|Open-Label Treatment Period|Study terminated by sponsor|0|||
147494736|NCT02951988|531966634|FG000|Open-Label Treatment Period|Non-compliance with background ADT|2|||
147494737|NCT02951988|531966635|FG001|Open-Label Treatment Period|Non-compliance with background ADT|0|||
147494738|NCT02951988|531966636|FG002|Open-Label Treatment Period|Non-compliance with background ADT|0|||
147494739|NCT02951988|531966637|FG003|Open-Label Treatment Period|Non-compliance with background ADT|0|||
147494740|NCT02951988|531966634|FG000|Open-Label Treatment Period|Non-compliance with study drug|5|||
147494741|NCT02951988|531966635|FG001|Open-Label Treatment Period|Non-compliance with study drug|0|||
147494742|NCT02951988|531966636|FG002|Open-Label Treatment Period|Non-compliance with study drug|0|||
147494743|NCT02951988|531966637|FG003|Open-Label Treatment Period|Non-compliance with study drug|0|||
147494744|NCT02951988|531966634|FG000|Open-Label Treatment Period|Protocol Violation|22|||
147494745|NCT02951988|531966635|FG001|Open-Label Treatment Period|Protocol Violation|0|||
147494746|NCT02951988|531966636|FG002|Open-Label Treatment Period|Protocol Violation|0|||
147494747|NCT02951988|531966637|FG003|Open-Label Treatment Period|Protocol Violation|0|||
147494748|NCT02951988|531966634|FG000|Open-Label Treatment Period|Pregnancy|2|||
147494749|NCT02951988|531966635|FG001|Open-Label Treatment Period|Pregnancy|0|||
147494750|NCT02951988|531966636|FG002|Open-Label Treatment Period|Pregnancy|0|||
147494751|NCT02951988|531966637|FG003|Open-Label Treatment Period|Pregnancy|0|||
147494752|NCT02951988|531966634|FG000|Open-Label Treatment Period|Lost to Follow-up|28|||
147494753|NCT02951988|531966635|FG001|Open-Label Treatment Period|Lost to Follow-up|0|||
147494754|NCT02951988|531966636|FG002|Open-Label Treatment Period|Lost to Follow-up|0|||
147494755|NCT02951988|531966637|FG003|Open-Label Treatment Period|Lost to Follow-up|0|||
147494756|NCT02951988|531966634|FG000|Open-Label Treatment Period|Withdrawal by Subject|78|||
147494757|NCT02951988|531966635|FG001|Open-Label Treatment Period|Withdrawal by Subject|0|||
147494758|NCT02951988|531966636|FG002|Open-Label Treatment Period|Withdrawal by Subject|0|||
147494759|NCT02951988|531966637|FG003|Open-Label Treatment Period|Withdrawal by Subject|0|||
147494760|NCT02951988|531966634|FG000|Open-Label Treatment Period|Lack of Efficacy|49|||
147494761|NCT02951988|531966635|FG001|Open-Label Treatment Period|Lack of Efficacy|0|||
147494762|NCT02951988|531966636|FG002|Open-Label Treatment Period|Lack of Efficacy|0|||
147494763|NCT02951988|531966637|FG003|Open-Label Treatment Period|Lack of Efficacy|0|||
147494764|NCT02951988|531966634|FG000|Open-Label Treatment Period|Adverse Event|45|||
147494765|NCT02951988|531966635|FG001|Open-Label Treatment Period|Adverse Event|0|||
147494766|NCT02951988|531966636|FG002|Open-Label Treatment Period|Adverse Event|0|||
147494767|NCT02951988|531966637|FG003|Open-Label Treatment Period|Adverse Event|0|||
147494768|NCT02951988|531966634|FG000|Double-Blind Treatment Period|Site terminated by sponsor|0|||
147494769|NCT02951988|531966635|FG001|Double-Blind Treatment Period|Site terminated by sponsor|0|||
147494770|NCT02951988|531966636|FG002|Double-Blind Treatment Period|Site terminated by sponsor|1|||
147494771|NCT02951988|531966637|FG003|Double-Blind Treatment Period|Site terminated by sponsor|1|||
147494772|NCT02951988|531966634|FG000|Double-Blind Treatment Period|Study terminated by sponsor|0|||
147494773|NCT02951988|531966635|FG001|Double-Blind Treatment Period|Study terminated by sponsor|58|||
147494774|NCT02951988|531966636|FG002|Double-Blind Treatment Period|Study terminated by sponsor|54|||
147494775|NCT02951988|531966637|FG003|Double-Blind Treatment Period|Study terminated by sponsor|69|||
147494776|NCT02951988|531966634|FG000|Double-Blind Treatment Period|Non-compliance with study drug|0|||
147494777|NCT02951988|531966635|FG001|Double-Blind Treatment Period|Non-compliance with study drug|1|||
147494778|NCT02951988|531966636|FG002|Double-Blind Treatment Period|Non-compliance with study drug|3|||
147494779|NCT02951988|531966637|FG003|Double-Blind Treatment Period|Non-compliance with study drug|0|||
147494780|NCT02951988|531966634|FG000|Double-Blind Treatment Period|Protocol Violation|0|||
147494781|NCT02951988|531966635|FG001|Double-Blind Treatment Period|Protocol Violation|4|||
147494782|NCT02951988|531966636|FG002|Double-Blind Treatment Period|Protocol Violation|4|||
147494783|NCT02951988|531966637|FG003|Double-Blind Treatment Period|Protocol Violation|8|||
147494784|NCT02951988|531966634|FG000|Double-Blind Treatment Period|Pregnancy|0|||
147494785|NCT02951988|531966635|FG001|Double-Blind Treatment Period|Pregnancy|1|||
147494786|NCT02951988|531966636|FG002|Double-Blind Treatment Period|Pregnancy|1|||
147494787|NCT02951988|531966637|FG003|Double-Blind Treatment Period|Pregnancy|0|||
147494788|NCT02951988|531966634|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
147494789|NCT02951988|531966635|FG001|Double-Blind Treatment Period|Lost to Follow-up|4|||
147494790|NCT02951988|531966636|FG002|Double-Blind Treatment Period|Lost to Follow-up|12|||
147494791|NCT02951988|531966637|FG003|Double-Blind Treatment Period|Lost to Follow-up|3|||
147494792|NCT02951988|531966634|FG000|Double-Blind Treatment Period|Withdrawal by Subject|0|||
147494793|NCT02951988|531966635|FG001|Double-Blind Treatment Period|Withdrawal by Subject|23|||
147494794|NCT02951988|531966636|FG002|Double-Blind Treatment Period|Withdrawal by Subject|22|||
147494795|NCT02951988|531966637|FG003|Double-Blind Treatment Period|Withdrawal by Subject|28|||
147494796|NCT02951988|531966634|FG000|Double-Blind Treatment Period|Adverse Event|0|||
147494797|NCT02951988|531966635|FG001|Double-Blind Treatment Period|Adverse Event|8|||
147494798|NCT02951988|531966636|FG002|Double-Blind Treatment Period|Adverse Event|3|||
147494799|NCT02951988|531966637|FG003|Double-Blind Treatment Period|Adverse Event|6|||
147626624|NCT02169271|532449427|FG001|Overall Study|Protocol Violation|2|||
147626625|NCT01991743|532449432|FG000|Overall Study|external cephalic version not performed|0|||
147626626|NCT01991743|532449433|FG001|Overall Study|external cephalic version not performed|0|||
147626627|NCT01991743|532449434|FG002|Overall Study|external cephalic version not performed|1|||
147626628|NCT01991743|532449435|FG003|Overall Study|external cephalic version not performed|0|||
147626629|NCT04010240|532450968|FG000|Overall Study|IHC not performed|2299|||
147626630|NCT00570687|532450969|FG000|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
147626631|NCT00570687|532450970|FG001|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
147626632|NCT00570687|532450971|FG002|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
147626633|NCT00570687|532450972|FG003|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
147626634|NCT00570687|532450973|FG004|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3|||
147626635|NCT00570687|532450974|FG005|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3|||
147626636|NCT00570687|532450975|FG006|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|2|||
147626637|NCT00570687|532450976|FG007|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3|||
147626638|NCT00570687|532450977|FG008|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|2|||
147626639|NCT00570687|532450978|FG009|Washout 3 (7-21 Days) - Orig Protocol|Sponsor Decision|3|||
147626640|NCT00570687|532450969|FG000|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
147626641|NCT00570687|532450970|FG001|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
147626642|NCT00570687|532450971|FG002|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
147626643|NCT00570687|532450972|FG003|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
147626644|NCT00570687|532450973|FG004|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
147626645|NCT00570687|532450974|FG005|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
147626646|NCT00570687|532450975|FG006|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
147626647|NCT00570687|532450976|FG007|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
147626648|NCT00570687|532450977|FG008|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|1|||
147626649|NCT00570687|532450978|FG009|Washout 4 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
147626650|NCT00570687|532450969|FG000|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
147626651|NCT00570687|532450970|FG001|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
147626652|NCT00570687|532450971|FG002|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
147626653|NCT00570687|532450972|FG003|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
147626654|NCT00570687|532450973|FG004|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
147626655|NCT00570687|532450974|FG005|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
147626656|NCT00570687|532450975|FG006|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|1|||
147626657|NCT00570687|532450976|FG007|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
147626658|NCT00570687|532450977|FG008|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
147626659|NCT00570687|532450978|FG009|Washout 5 (7-21 Days) - Orig Protocol|Sponsor Decision|0|||
147626660|NCT00975611|532450979|FG000|Overall Study|Screen Fail|16|||
147626661|NCT00975611|532450979|FG000|Overall Study|Physician Decision|1|||
147626662|NCT01682226|532450980|FG000|Overall Study|Participants were pediatric subjects and not adults subjects|3|||
147626663|NCT01682226|532450980|FG000|Overall Study|Participants did not receive treatment|2|||
147626664|NCT01682226|532450980|FG000|Overall Study|Participants received a transplant under a different protocol|1|||
147626665|NCT03771898|532450981|FG000|Overall Study|Adverse Event|1|||
147626666|NCT03771898|532450982|FG001|Overall Study|Adverse Event|0|||
147626667|NCT03771898|532450983|FG002|Overall Study|Adverse Event|0|||
147626668|NCT03771898|532450984|FG003|Overall Study|Adverse Event|0|||
147626669|NCT03771898|532450985|FG004|Overall Study|Adverse Event|0|||
147626670|NCT03771898|532450981|FG000|Overall Study|Lost to Follow-up|1|||
147626671|NCT03771898|532450982|FG001|Overall Study|Lost to Follow-up|1|||
147626672|NCT03771898|532450983|FG002|Overall Study|Lost to Follow-up|1|||
147494800|NCT02951988|531966634|FG000|Double-Blind Treatment Period|Miscellaneous Reasons|0|||
147494801|NCT02951988|531966635|FG001|Double-Blind Treatment Period|Miscellaneous Reasons|2|||
147494802|NCT02951988|531966636|FG002|Double-Blind Treatment Period|Miscellaneous Reasons|1|||
147494803|NCT02951988|531966637|FG003|Double-Blind Treatment Period|Miscellaneous Reasons|0|||
147494804|NCT05836818|531966638|FG000|Overall Study|Physician Decision|1|||
147494805|NCT05836818|531966639|FG001|Overall Study|Physician Decision|1|||
147494806|NCT05836818|531966640|FG002|Overall Study|Physician Decision|0|||
147626673|NCT03771898|532450984|FG003|Overall Study|Lost to Follow-up|0|||
147626674|NCT03771898|532450985|FG004|Overall Study|Lost to Follow-up|0|||
147626675|NCT03771898|532450981|FG000|Overall Study|Withdrawal by parent/guardian|1|||
147626676|NCT03771898|532450982|FG001|Overall Study|Withdrawal by parent/guardian|1|||
147626677|NCT03771898|532450983|FG002|Overall Study|Withdrawal by parent/guardian|0|||
147626678|NCT03771898|532450984|FG003|Overall Study|Withdrawal by parent/guardian|0|||
147494807|NCT05836818|531966638|FG000|Overall Study|Withdrawal by Subject|0|||
147494808|NCT05836818|531966639|FG001|Overall Study|Withdrawal by Subject|0|||
147494809|NCT05836818|531966640|FG002|Overall Study|Withdrawal by Subject|1|||
147494810|NCT05836818|531966638|FG000|Overall Study|Later found to be previously vaccinated|0|||
147494811|NCT05836818|531966639|FG001|Overall Study|Later found to be previously vaccinated|1|||
147494812|NCT05836818|531966640|FG002|Overall Study|Later found to be previously vaccinated|3|||
147494813|NCT05836818|531966638|FG000|Overall Study|Pregnancy|0|||
147494814|NCT05836818|531966639|FG001|Overall Study|Pregnancy|1|||
147494815|NCT05836818|531966640|FG002|Overall Study|Pregnancy|0|||
147494816|NCT05836818|531966638|FG000|Overall Study|Allergic to vaccines|0|||
147494817|NCT05836818|531966639|FG001|Overall Study|Allergic to vaccines|1|||
147494818|NCT05836818|531966640|FG002|Overall Study|Allergic to vaccines|0|||
147494819|NCT02491073|531966641|FG000|Overall Study|screen failure|1|||
147494820|NCT02491073|531966642|FG001|Overall Study|screen failure|0|||
147494821|NCT01165021|531966643|FG000|Overall Study|Death|1|||
147494822|NCT01419665|531966644|FG000|Combination Treatment|Adverse Event|7|||
147494823|NCT01419665|531966645|FG001|Combination Treatment|Adverse Event|10|||
147494824|NCT01419665|531966644|FG000|Combination Treatment|Physician Decision|5|||
147494825|NCT01419665|531966645|FG001|Combination Treatment|Physician Decision|8|||
147494826|NCT01419665|531966644|FG000|Combination Treatment|Protocol Violation|6|||
147494827|NCT01419665|531966645|FG001|Combination Treatment|Protocol Violation|2|||
147494828|NCT01419665|531966644|FG000|Combination Treatment|disease progression|10|||
147494829|NCT01419665|531966645|FG001|Combination Treatment|disease progression|9|||
147494830|NCT01419665|531966644|FG000|Combination Treatment|Death|5|||
147494831|NCT01419665|531966645|FG001|Combination Treatment|Death|7|||
147494832|NCT01419665|531966644|FG000|Combination Treatment|administrative problems|0|||
147494833|NCT01419665|531966645|FG001|Combination Treatment|administrative problems|1|||
147494834|NCT01419665|531966644|FG000|Combination Treatment|Withdrawal by Subject|5|||
147494835|NCT01419665|531966645|FG001|Combination Treatment|Withdrawal by Subject|4|||
147494836|NCT01419665|531966644|FG000|Maintenance Treatment and/or Follow up|switch to open label|44|||
147494837|NCT01419665|531966645|FG001|Maintenance Treatment and/or Follow up|switch to open label|39|||
147494838|NCT01419665|531966644|FG000|Maintenance Treatment and/or Follow up|administrative problems|0|||
147494839|NCT01419665|531966645|FG001|Maintenance Treatment and/or Follow up|administrative problems|6|||
147494840|NCT01419665|531966644|FG000|Maintenance Treatment and/or Follow up|Withdrawal by Subject|6|||
147494841|NCT01419665|531966645|FG001|Maintenance Treatment and/or Follow up|Withdrawal by Subject|6|||
147494842|NCT01419665|531966644|FG000|Maintenance Treatment and/or Follow up|Protocol Violation|1|||
147494843|NCT01419665|531966645|FG001|Maintenance Treatment and/or Follow up|Protocol Violation|1|||
147494844|NCT01419665|531966644|FG000|Maintenance Treatment and/or Follow up|Physician Decision|5|||
147494845|NCT01419665|531966645|FG001|Maintenance Treatment and/or Follow up|Physician Decision|2|||
147494846|NCT01419665|531966644|FG000|Maintenance Treatment and/or Follow up|disease progression|53|||
147494847|NCT01419665|531966645|FG001|Maintenance Treatment and/or Follow up|disease progression|37|||
147494848|NCT01419665|531966644|FG000|Maintenance Treatment and/or Follow up|Death|1|||
147494849|NCT01419665|531966645|FG001|Maintenance Treatment and/or Follow up|Death|2|||
147494850|NCT01419665|531966644|FG000|Maintenance Treatment and/or Follow up|Adverse Event|11|||
147494851|NCT01419665|531966645|FG001|Maintenance Treatment and/or Follow up|Adverse Event|7|||
147494852|NCT01419665|531966644|FG000|Maintenance Treatment and/or Follow up|Lost to Follow-up|1|||
147494853|NCT01419665|531966645|FG001|Maintenance Treatment and/or Follow up|Lost to Follow-up|2|||
147494854|NCT01419665|531966644|FG000|Open Label Phase|Death|1|||
147494855|NCT01419665|531966645|FG001|Open Label Phase|Death|0|||
147494856|NCT01419665|531966644|FG000|Open Label Phase|disease progression|0|||
147494857|NCT01419665|531966645|FG001|Open Label Phase|disease progression|1|||
147494858|NCT03977727|531966646|FG000|Second Treatment|Lost to Follow-up|0|||
147494859|NCT03977727|531966647|FG001|Second Treatment|Lost to Follow-up|3|||
147494860|NCT00516269|531966649|FG000|Overall Study|Adverse Event|2|||
147494861|NCT00516269|531966650|FG001|Overall Study|Adverse Event|1|||
147494862|NCT00516269|531966649|FG000|Overall Study|Lost to Follow-up|0|||
147494863|NCT00516269|531966650|FG001|Overall Study|Lost to Follow-up|1|||
147494864|NCT00516269|531966649|FG000|Overall Study|Protocol Violation|0|||
147494865|NCT00516269|531966650|FG001|Overall Study|Protocol Violation|1|||
147494866|NCT00926796|531966651|FG000|Overall Study|Did not receive randomized treatment|4|||
147494867|NCT00926796|531966652|FG001|Overall Study|Did not receive randomized treatment|7|||
147494868|NCT00926796|531966651|FG000|Overall Study|Ineligible, negative for gonorrhea|57|||
147494869|NCT00926796|531966652|FG001|Overall Study|Ineligible, negative for gonorrhea|60|||
147494870|NCT00926796|531966651|FG000|Overall Study|Ineligible, but positive for gonorrhea|1|||
147494871|NCT00926796|531966652|FG001|Overall Study|Ineligible, but positive for gonorrhea|1|||
147494872|NCT00926796|531966651|FG000|Overall Study|Adverse Event|7|||
147494873|NCT00926796|531966652|FG001|Overall Study|Adverse Event|14|||
147494874|NCT00926796|531966651|FG000|Overall Study|Lost to Follow-up|22|||
147494875|NCT00926796|531966652|FG001|Overall Study|Lost to Follow-up|13|||
147494876|NCT00926796|531966651|FG000|Overall Study|Protocol Violation|15|||
147494877|NCT00926796|531966652|FG001|Overall Study|Protocol Violation|11|||
147494878|NCT00926796|531966651|FG000|Overall Study|Withdrawal by Subject|1|||
147494879|NCT00926796|531966652|FG001|Overall Study|Withdrawal by Subject|0|||
147626679|NCT03771898|532450985|FG004|Overall Study|Withdrawal by parent/guardian|0|||
147626680|NCT03771898|532450981|FG000|Overall Study|Ongoing (Participants in GLIA-MLD, [part of GLIA-CTN study])|0|||
147626681|NCT03771898|532450982|FG001|Overall Study|Ongoing (Participants in GLIA-MLD, [part of GLIA-CTN study])|0|||
147626682|NCT03771898|532450983|FG002|Overall Study|Ongoing (Participants in GLIA-MLD, [part of GLIA-CTN study])|0|||
147626683|NCT03771898|532450984|FG003|Overall Study|Ongoing (Participants in GLIA-MLD, [part of GLIA-CTN study])|0|||
147626684|NCT03771898|532450985|FG004|Overall Study|Ongoing (Participants in GLIA-MLD, [part of GLIA-CTN study])|33|||
147626685|NCT03263936|532450986|FG000|Overall Study|Adverse Event|0|||
147626686|NCT03263936|532450987|FG001|Overall Study|Adverse Event|1|||
147626687|NCT03263936|532450988|FG002|Overall Study|Adverse Event|0|||
147626688|NCT03263936|532450986|FG000|Overall Study|Death|0|||
147626689|NCT03263936|532450987|FG001|Overall Study|Death|1|||
147626690|NCT03263936|532450988|FG002|Overall Study|Death|0|||
147626691|NCT05343000|532450989|FG000|Overall Study|Physician Decision|2|||
147494880|NCT01341652|531966653|FG000|Overall Study|Incorrect Random Assignment|0|||
147494881|NCT01341652|531966654|FG001|Overall Study|Incorrect Random Assignment|1|||
147626692|NCT03123120|532450990|FG000|Overall Study|Lost to Follow-up|0|||
147626693|NCT03123120|532450991|FG001|Overall Study|Lost to Follow-up|1|||
147626694|NCT03123120|532450990|FG000|Overall Study|Withdrawal by Subject|0|||
147626695|NCT03123120|532450991|FG001|Overall Study|Withdrawal by Subject|1|||
147626696|NCT03135548|532450992|FG000|Overall Study|Lost to Follow-up|3|||
147626697|NCT03135548|532450993|FG001|Overall Study|Lost to Follow-up|0|||
147626698|NCT03135548|532450994|FG002|Overall Study|Lost to Follow-up|0|||
147626699|NCT03135548|532450992|FG000|Overall Study|Withdrawal by Subject|2|||
147626700|NCT03135548|532450993|FG001|Overall Study|Withdrawal by Subject|2|||
147626701|NCT03135548|532450994|FG002|Overall Study|Withdrawal by Subject|1|||
147626702|NCT03135548|532450992|FG000|Overall Study|Other than listed|0|||
147626703|NCT03135548|532450993|FG001|Overall Study|Other than listed|2|||
147626704|NCT03135548|532450994|FG002|Overall Study|Other than listed|2|||
147626705|NCT02632175|532450995|FG000|Overall Study|Withdrawal by Subject|6|||
147626706|NCT02632175|532450995|FG000|Overall Study|Lost to Follow-up|1|||
147626707|NCT02632175|532450995|FG000|Overall Study|Lack of Efficacy|18|||
147668325|NCT03530293|532611722|FG001|Randomized Withdrawal Period / Follow-up|Study Terminated by Sponsor|10|||
147668326|NCT03530293|532611723|FG002|Randomized Withdrawal Period / Follow-up|Study Terminated by Sponsor|10|||
147668327|NCT00686972|532611724|FG000|Overall Study|P.I, Left institution. Study terminated|51|||
147668328|NCT04465422|532611737|FG000|Overall Study|Lost to Follow-up|0|||
147668329|NCT04465422|532611738|FG001|Overall Study|Lost to Follow-up|2|||
147668330|NCT05412134|532611743|FG000|Overall Study|Lost to Follow-up|2|||
147668331|NCT05412134|532611744|FG001|Overall Study|Lost to Follow-up|0|||
147668332|NCT03307174|532611746|FG000|Overall Study|Unplanned ICU Administrion|5|||
147668333|NCT03307174|532611747|FG001|Overall Study|Unplanned ICU Administrion|3|||
147668334|NCT03307174|532611746|FG000|Overall Study|Aborted Surgery|1|||
147668335|NCT03307174|532611747|FG001|Overall Study|Aborted Surgery|2|||
147668336|NCT03307174|532611746|FG000|Overall Study|Hypotension|6|||
147668337|NCT03307174|532611747|FG001|Overall Study|Hypotension|0|||
147668338|NCT03307174|532611746|FG000|Overall Study|Nonfunctional epidural|1|||
147668339|NCT03307174|532611747|FG001|Overall Study|Nonfunctional epidural|1|||
147668340|NCT03307174|532611746|FG000|Overall Study|Planned epidural removal|1|||
147668341|NCT03307174|532611747|FG001|Overall Study|Planned epidural removal|0|||
147668342|NCT03307174|532611746|FG000|Overall Study|Intrathecal catheter placement|0|||
147668343|NCT03307174|532611747|FG001|Overall Study|Intrathecal catheter placement|1|||
147668344|NCT01192815|532611748|FG000|Overall Study|Withdrawal by Subject|1|||
147668345|NCT01192815|532611748|FG000|Overall Study|Lack of Efficacy|1|||
147668346|NCT03444584|532611749|FG000|Overall Study|Withdrawal by Subject|0|||
147668347|NCT03444584|532611750|FG001|Overall Study|Withdrawal by Subject|1|||
147668348|NCT03444584|532611749|FG000|Overall Study|Other|0|||
147668349|NCT03444584|532611750|FG001|Overall Study|Other|1|||
147668350|NCT00863707|532611751|FG000|Overall Study|Randomized, but drug not received|4|||
147668351|NCT00863707|532611752|FG001|Overall Study|Randomized, but drug not received|3|||
147668352|NCT01142336|532611753|FG000|Overall Study|Adverse Event|1|||
147668353|NCT01142336|532611754|FG001|Overall Study|Adverse Event|1|||
147668354|NCT01142336|532611753|FG000|Overall Study|Lost to Follow-up|0|||
147668355|NCT01142336|532611754|FG001|Overall Study|Lost to Follow-up|1|||
147668356|NCT01704261|532611755|FG000|Overall Study|Withdrawal by Subject|12|||
147668357|NCT01704261|532611756|FG001|Overall Study|Withdrawal by Subject|15|||
147626708|NCT02632175|532450995|FG000|Overall Study|Required alternative (or prohibited) therapy|1|||
147626709|NCT02632175|532450995|FG000|Overall Study|Subject noncompliance|3|||
147626710|NCT02632175|532450995|FG000|Overall Study|other|2|||
147668358|NCT01704261|532611755|FG000|Overall Study|Lost to Follow-up|1|||
147626711|NCT04623216|532450996|FG000|Overall Study|Death|5|||
147626712|NCT04623216|532450997|FG001|Overall Study|Death|2|||
147668359|NCT01704261|532611756|FG001|Overall Study|Lost to Follow-up|0|||
147668360|NCT02722967|532611757|FG000|Overall Study|Adverse Event|1|||
147668361|NCT02722967|532611758|FG001|Overall Study|Adverse Event|0|||
147668362|NCT02722967|532611759|FG002|Overall Study|Adverse Event|0|||
147668363|NCT02722967|532611757|FG000|Overall Study|Lost to Follow-up|0|||
147668364|NCT02722967|532611758|FG001|Overall Study|Lost to Follow-up|1|||
147626713|NCT04623216|532450998|FG002|Overall Study|Death|0|||
147626714|NCT04623216|532450999|FG003|Overall Study|Death|0|||
147626715|NCT04623216|532450996|FG000|Overall Study|Terminated by Sponsor|3|||
147626716|NCT04623216|532450997|FG001|Overall Study|Terminated by Sponsor|2|||
147626717|NCT04623216|532450998|FG002|Overall Study|Terminated by Sponsor|2|||
147626718|NCT04623216|532450999|FG003|Overall Study|Terminated by Sponsor|0|||
147626719|NCT04623216|532450996|FG000|Overall Study|Physician Decision|1|||
147626720|NCT04623216|532450997|FG001|Overall Study|Physician Decision|0|||
147626721|NCT04623216|532450998|FG002|Overall Study|Physician Decision|0|||
147626722|NCT04623216|532450999|FG003|Overall Study|Physician Decision|0|||
147626723|NCT03521154|532451002|FG000|Overall Study|Ongoing study at data cut-off|111|||
147626724|NCT03521154|532451003|FG001|Overall Study|Ongoing study at data cut-off|52|||
147626725|NCT05386680|532451004|FG000|Overall Study|Guardian decision|2|||
147626726|NCT00298272|532451018|FG000|Double-blind Phase|Adverse Event|2|||
147626727|NCT00298272|532451019|FG001|Double-blind Phase|Adverse Event|0|||
147626728|NCT00298272|532451018|FG000|Double-blind Phase|Failure to Return|2|||
147626729|NCT00298272|532451019|FG001|Double-blind Phase|Failure to Return|0|||
147626730|NCT00298272|532451018|FG000|Double-blind Phase|Protocol Violation|2|||
147626731|NCT00298272|532451019|FG001|Double-blind Phase|Protocol Violation|0|||
147626732|NCT00298272|532451018|FG000|Double-blind Phase|Withdrawal by Subject|2|||
147626733|NCT00298272|532451019|FG001|Double-blind Phase|Withdrawal by Subject|0|||
147626734|NCT00298272|532451018|FG000|Open Label Retreatment Phase|Adverse Event|1|||
147626735|NCT00298272|532451019|FG001|Open Label Retreatment Phase|Adverse Event|2|||
147626736|NCT00298272|532451018|FG000|Open Label Retreatment Phase|Insufficient Therapeutic Response|2|||
147626737|NCT00298272|532451019|FG001|Open Label Retreatment Phase|Insufficient Therapeutic Response|1|||
147626738|NCT00298272|532451018|FG000|Open Label Retreatment Phase|Failure to Return|1|||
147626739|NCT00298272|532451019|FG001|Open Label Retreatment Phase|Failure to Return|0|||
147626740|NCT00298272|532451018|FG000|Open Label Retreatment Phase|Protocol Violation|2|||
147626741|NCT00298272|532451019|FG001|Open Label Retreatment Phase|Protocol Violation|1|||
147626742|NCT00298272|532451018|FG000|Open Label Retreatment Phase|Withdrawal by Subject|1|||
147626743|NCT00298272|532451019|FG001|Open Label Retreatment Phase|Withdrawal by Subject|0|||
147626744|NCT00298272|532451018|FG000|Open Label Retreatment Phase|Administrative/Other Reason|2|||
147626745|NCT00298272|532451019|FG001|Open Label Retreatment Phase|Administrative/Other Reason|0|||
147626746|NCT00298272|532451018|FG000|Safety Follow-up Phase|Failure to Return|1|||
147626747|NCT00298272|532451019|FG001|Safety Follow-up Phase|Failure to Return|1|||
147626748|NCT00298272|532451018|FG000|Safety Follow-up Phase|Withdrawal by Subject|2|||
147626749|NCT00298272|532451019|FG001|Safety Follow-up Phase|Withdrawal by Subject|2|||
147626750|NCT00298272|532451018|FG000|Safety Follow-up Phase|Administrative/Other Reason|1|||
147626751|NCT00298272|532451019|FG001|Safety Follow-up Phase|Administrative/Other Reason|1|||
147626752|NCT00915018|532451020|FG000|Overall Study|Death|75|||
147626753|NCT00915018|532451021|FG001|Overall Study|Death|70|||
147626754|NCT00915018|532451020|FG000|Overall Study|Lost to Follow-up|10|||
147626755|NCT00915018|532451021|FG001|Overall Study|Lost to Follow-up|5|||
147626756|NCT00915018|532451020|FG000|Overall Study|Withdrawal by Subject|38|||
147626757|NCT00915018|532451021|FG001|Overall Study|Withdrawal by Subject|27|||
147494882|NCT01341652|531966653|FG000|Overall Study|ineligible; presence metastatic disease|0|||
147494883|NCT01341652|531966654|FG001|Overall Study|ineligible; presence metastatic disease|1|||
147494884|NCT01008995|531966657|FG000|Controlled Period|Adverse Event|1|||
147494885|NCT01008995|531966658|FG001|Controlled Period|Adverse Event|2|||
147494886|NCT01008995|531966659|FG002|Controlled Period|Adverse Event|0|||
147494887|NCT01008995|531966660|FG003|Controlled Period|Adverse Event|0|||
147494888|NCT01008995|531966657|FG000|Controlled Period|Other|2|||
147494889|NCT01008995|531966658|FG001|Controlled Period|Other|1|||
147494890|NCT01008995|531966659|FG002|Controlled Period|Other|0|||
147494891|NCT01008995|531966660|FG003|Controlled Period|Other|0|||
147494892|NCT01008995|531966657|FG000|After Controlled Period|Adverse Event|0|||
147494893|NCT01008995|531966658|FG001|After Controlled Period|Adverse Event|0|||
147494894|NCT01008995|531966659|FG002|After Controlled Period|Adverse Event|1|||
147494895|NCT01008995|531966660|FG003|After Controlled Period|Adverse Event|1|||
147494896|NCT01008995|531966657|FG000|After Controlled Period|Other|0|||
147494897|NCT01008995|531966658|FG001|After Controlled Period|Other|0|||
147494898|NCT01008995|531966659|FG002|After Controlled Period|Other|1|||
147626758|NCT00915018|532451020|FG000|Overall Study|By Sponsor due to Protocol Amendment|92|||
147626759|NCT00915018|532451021|FG001|Overall Study|By Sponsor due to Protocol Amendment|105|||
147626760|NCT00457002|532451022|FG000|Overall Study|Death|40|||
147668365|NCT02722967|532611759|FG002|Overall Study|Lost to Follow-up|0|||
147494899|NCT01008995|531966660|FG003|After Controlled Period|Other|0|||
147494900|NCT00115804|531966661|FG000|Overall Study|Adverse Event|2|||
147494901|NCT00621855|531966664|FG000|Overall Study|Adverse Event|32|||
147494902|NCT00621855|531966665|FG001|Overall Study|Adverse Event|31|||
147626761|NCT00457002|532451023|FG001|Overall Study|Death|47|||
147626762|NCT00457002|532451022|FG000|Overall Study|Adverse Event|284|||
147626763|NCT00457002|532451023|FG001|Overall Study|Adverse Event|260|||
147626764|NCT00457002|532451022|FG000|Overall Study|Withdrawal by Subject|299|||
147626765|NCT00457002|532451023|FG001|Overall Study|Withdrawal by Subject|271|||
147626766|NCT00457002|532451022|FG000|Overall Study|Lost to Follow-up|72|||
147626767|NCT00457002|532451023|FG001|Overall Study|Lost to Follow-up|71|||
147626768|NCT00457002|532451022|FG000|Overall Study|Poor/Non-compliance|46|||
147626769|NCT00457002|532451023|FG001|Overall Study|Poor/Non-compliance|33|||
147626770|NCT00457002|532451022|FG000|Overall Study|No longer met criteria|41|||
147626771|NCT00457002|532451023|FG001|Overall Study|No longer met criteria|37|||
147626772|NCT00457002|532451022|FG000|Overall Study|Administrative reason by Sponsor|1|||
147626773|NCT00457002|532451023|FG001|Overall Study|Administrative reason by Sponsor|0|||
147626774|NCT00457002|532451022|FG000|Overall Study|non-specified|29|||
147626775|NCT00457002|532451023|FG001|Overall Study|non-specified|38|||
147626776|NCT00457002|532451022|FG000|Overall Study|treated for 1 day; missing status/reason|1|||
147626777|NCT00457002|532451023|FG001|Overall Study|treated for 1 day; missing status/reason|0|||
147626778|NCT04168112|532451024|FG000|Overall Study|Lost to Follow-up|1|||
147626779|NCT04168112|532451025|FG001|Overall Study|Lost to Follow-up|0|||
147626780|NCT04168112|532451024|FG000|Overall Study|Withdrawal by Subject|1|||
147626781|NCT04168112|532451025|FG001|Overall Study|Withdrawal by Subject|0|||
147626782|NCT00454246|532451028|FG000|Overall Study|Adverse Event|2|||
147626783|NCT00454246|532451029|FG001|Overall Study|Adverse Event|2|||
147626784|NCT00454246|532451030|FG002|Overall Study|Adverse Event|0|||
147626785|NCT00454246|532451028|FG000|Overall Study|Violation of selection criteria at entry|6|||
147626786|NCT00454246|532451029|FG001|Overall Study|Violation of selection criteria at entry|0|||
147626787|NCT00454246|532451030|FG002|Overall Study|Violation of selection criteria at entry|0|||
147626788|NCT00454246|532451028|FG000|Overall Study|Protocol Violation|1|||
147626789|NCT00454246|532451029|FG001|Overall Study|Protocol Violation|0|||
147626790|NCT00454246|532451030|FG002|Overall Study|Protocol Violation|0|||
147626791|NCT00454246|532451028|FG000|Overall Study|Refused Treatment|1|||
147626792|NCT00454246|532451029|FG001|Overall Study|Refused Treatment|1|||
147626793|NCT00454246|532451030|FG002|Overall Study|Refused Treatment|0|||
147626794|NCT00454246|532451028|FG000|Overall Study|Failure to return|1|||
147626795|NCT00454246|532451029|FG001|Overall Study|Failure to return|0|||
147626796|NCT00454246|532451030|FG002|Overall Study|Failure to return|0|||
147626797|NCT00454246|532451028|FG000|Overall Study|Early termination of study|62|||
147626798|NCT00454246|532451029|FG001|Overall Study|Early termination of study|26|||
147626799|NCT00454246|532451030|FG002|Overall Study|Early termination of study|9|||
147626800|NCT02898597|532451031|FG000|Overall Study|Protocol Violation|4|||
147626801|NCT02898597|532451032|FG001|Overall Study|Protocol Violation|2|||
147626802|NCT02898597|532451031|FG000|Overall Study|Lost to Follow-up|0|||
147626803|NCT02898597|532451032|FG001|Overall Study|Lost to Follow-up|9|||
147626804|NCT02898597|532451031|FG000|Overall Study|Death|0|||
147626805|NCT02898597|532451032|FG001|Overall Study|Death|1|||
147626806|NCT05326529|532451033|FG000|Overall Study|Lack of Efficacy|0|||
147626807|NCT05326529|532451034|FG001|Overall Study|Lack of Efficacy|1|||
147626808|NCT05326529|532451035|FG002|Overall Study|Lack of Efficacy|0|||
147626809|NCT05326529|532451033|FG000|Overall Study|Physician Decision|0|||
147626810|NCT05326529|532451034|FG001|Overall Study|Physician Decision|0|||
147626811|NCT05326529|532451035|FG002|Overall Study|Physician Decision|2|||
147626812|NCT00154284|532451036|FG000|Overall Study|Adverse Event|6|||
147626813|NCT00154284|532451037|FG001|Overall Study|Adverse Event|9|||
147626814|NCT00154284|532451036|FG000|Overall Study|Abnormal laboratory value(s)|0|||
147626815|NCT00154284|532451037|FG001|Overall Study|Abnormal laboratory value(s)|1|||
147626816|NCT00154284|532451036|FG000|Overall Study|Lack of Efficacy|1|||
147626817|NCT00154284|532451037|FG001|Overall Study|Lack of Efficacy|2|||
147626818|NCT00154284|532451036|FG000|Overall Study|Protocol Violation|0|||
147626819|NCT00154284|532451037|FG001|Overall Study|Protocol Violation|1|||
147626820|NCT00326716|532451038|FG000|Pre-Natal Mothers|Discontinued ATV Before Delivery|1|||
147626821|NCT00326716|532451039|FG001|Pre-Natal Mothers|Discontinued ATV Before Delivery|2|||
147626822|NCT00326716|532451040|FG002|Pre-Natal Mothers|Discontinued ATV Before Delivery|0|||
147626823|NCT00326716|532451041|FG003|Pre-Natal Mothers|Discontinued ATV Before Delivery|0|||
147626824|NCT00684411|532451042|FG000|Overall Study|New Primary Cancer|1|||
147626825|NCT00684411|532451042|FG000|Overall Study|Disease Progression|10|||
147626826|NCT00684411|532451042|FG000|Overall Study|Adverse Event|1|||
147668366|NCT02722967|532611757|FG000|Overall Study|Non-compliance with patch wearing|2|||
147668367|NCT02722967|532611758|FG001|Overall Study|Non-compliance with patch wearing|1|||
147626827|NCT02126579|532451043|FG000|Overall Study|disease progression|0|||
147626828|NCT02126579|532451044|FG001|Overall Study|disease progression|0|||
147626829|NCT02126579|532451045|FG002|Overall Study|disease progression|0|||
147626830|NCT02126579|532451046|FG003|Overall Study|disease progression|1|||
147626831|NCT02126579|532451047|FG004|Overall Study|disease progression|0|||
147626832|NCT02126579|532451048|FG005|Overall Study|disease progression|0|||
147626833|NCT02126579|532451049|FG006|Overall Study|disease progression|1|||
147626834|NCT01780038|532451050|FG000|Overall Study|Lost to Follow-up|4|||
147626835|NCT01780038|532451051|FG001|Overall Study|Lost to Follow-up|1|||
147626836|NCT03168711|532451054|FG000|Overall Study|Adverse Event|2|||
147626837|NCT03168711|532451055|FG001|Overall Study|Adverse Event|0|||
147626838|NCT03168711|532451054|FG000|Overall Study|Withdrawal by Subject|0|||
147626839|NCT03168711|532451055|FG001|Overall Study|Withdrawal by Subject|1|||
147626840|NCT03168711|532451054|FG000|Overall Study|Death|0|||
147626841|NCT03168711|532451055|FG001|Overall Study|Death|1|||
147626842|NCT04509076|532451056|FG000|Overall Study|Withdrawal by Subject|1|||
147626843|NCT04509076|532451057|FG001|Overall Study|Withdrawal by Subject|2|||
147626844|NCT04509076|532451056|FG000|Overall Study|Lost to Follow-up|1|||
147626845|NCT04509076|532451057|FG001|Overall Study|Lost to Follow-up|2|||
147626846|NCT02588612|532451062|FG000|Overall Study|Physician Decision|1|||
147626847|NCT02588612|532451062|FG000|Overall Study|Leukapheresis did not yield enough cells|1|||
147626848|NCT02588612|532451062|FG000|Overall Study|Failed eligibility prior to chemotherapy|2|||
147626849|NCT02588612|532451062|FG000|Overall Study|Death prior to T-cell infusion|1|||
147626850|NCT03448419|532451072|FG000|Overall Study|Adverse Event|10|||
147626851|NCT03448419|532451073|FG001|Overall Study|Adverse Event|9|||
147626852|NCT03448419|532451072|FG000|Overall Study|Lost to Follow-up|0|||
147626853|NCT03448419|532451073|FG001|Overall Study|Lost to Follow-up|2|||
147626854|NCT03448419|532451072|FG000|Overall Study|Withdrawal by Subject|3|||
147626855|NCT03448419|532451073|FG001|Overall Study|Withdrawal by Subject|1|||
147626856|NCT03448419|532451072|FG000|Overall Study|Not treated|0|||
147626857|NCT03448419|532451073|FG001|Overall Study|Not treated|1|||
147626858|NCT03448419|532451072|FG000|Overall Study|Patient did not attend all visits|0|||
147626859|NCT03448419|532451073|FG001|Overall Study|Patient did not attend all visits|2|||
147626860|NCT03448419|532451072|FG000|Overall Study|Withdrawn by Sponsor|0|||
147626861|NCT03448419|532451073|FG001|Overall Study|Withdrawn by Sponsor|1|||
147626862|NCT04025879|532451076|FG000|Randomization|Participant withdrew consent|0|||
147626863|NCT04025879|532451077|FG001|Randomization|Participant withdrew consent|1|||
147626864|NCT04025879|532451076|FG000|Randomization|Participant no longer met study criteria|1|||
147626865|NCT04025879|532451077|FG001|Randomization|Participant no longer met study criteria|1|||
147626866|NCT04025879|532451076|FG000|Treatment|Ongoing treatment|10|||
147626867|NCT04025879|532451077|FG001|Treatment|Ongoing treatment|8|||
147626868|NCT04025879|532451076|FG000|Treatment|Disease progression/recurrence|36|||
147626869|NCT04025879|532451077|FG001|Treatment|Disease progression/recurrence|72|||
147626870|NCT04025879|532451076|FG000|Treatment|Study drug toxicity|36|||
147626871|NCT04025879|532451077|FG001|Treatment|Study drug toxicity|13|||
147626872|NCT04025879|532451076|FG000|Treatment|Death|2|||
147626873|NCT04025879|532451077|FG001|Treatment|Death|0|||
147626874|NCT04025879|532451076|FG000|Treatment|Adverse event unrelated to study drug|21|||
147626875|NCT04025879|532451077|FG001|Treatment|Adverse event unrelated to study drug|14|||
147626876|NCT04025879|532451076|FG000|Treatment|Participant request to discontinue study treatment|16|||
147626877|NCT04025879|532451077|FG001|Treatment|Participant request to discontinue study treatment|8|||
147626878|NCT04025879|532451076|FG000|Treatment|Participant withdrew consent|1|||
147626879|NCT04025879|532451077|FG001|Treatment|Participant withdrew consent|3|||
147626880|NCT04025879|532451076|FG000|Treatment|Participant no longer meets study criteria|3|||
147626881|NCT04025879|532451077|FG001|Treatment|Participant no longer meets study criteria|2|||
147626882|NCT04025879|532451076|FG000|Treatment|Lost to Follow-up|1|||
147626883|NCT04025879|532451077|FG001|Treatment|Lost to Follow-up|0|||
147626884|NCT04025879|532451076|FG000|Treatment|Other reasons|15|||
147626885|NCT04025879|532451077|FG001|Treatment|Other reasons|17|||
147626886|NCT04025879|532451076|FG000|Treatment|Administrative reason by sponsor|0|||
147626887|NCT04025879|532451077|FG001|Treatment|Administrative reason by sponsor|1|||
147626888|NCT04025879|532451076|FG000|Treatment|Not reported|2|||
147626889|NCT04025879|532451077|FG001|Treatment|Not reported|0|||
147626890|NCT03482635|532451078|FG000|Overall Study|Lack of Efficacy|0|||
147626891|NCT03482635|532451079|FG001|Overall Study|Lack of Efficacy|0|||
147626892|NCT03482635|532451080|FG002|Overall Study|Lack of Efficacy|1|||
147668368|NCT02722967|532611759|FG002|Overall Study|Non-compliance with patch wearing|1|||
147668369|NCT02722967|532611757|FG000|Overall Study|Withdrawal by Subject|1|||
147668370|NCT02722967|532611758|FG001|Overall Study|Withdrawal by Subject|0|||
147626893|NCT03482635|532451081|FG003|Overall Study|Lack of Efficacy|3|||
147626894|NCT03482635|532451078|FG000|Overall Study|Adverse Event|2|||
147626895|NCT03482635|532451079|FG001|Overall Study|Adverse Event|2|||
147626896|NCT03482635|532451080|FG002|Overall Study|Adverse Event|0|||
147626897|NCT03482635|532451081|FG003|Overall Study|Adverse Event|3|||
147626898|NCT03482635|532451078|FG000|Overall Study|Withdrawal by Subject|2|||
147626899|NCT03482635|532451079|FG001|Overall Study|Withdrawal by Subject|1|||
147626900|NCT03482635|532451080|FG002|Overall Study|Withdrawal by Subject|0|||
147626901|NCT03482635|532451081|FG003|Overall Study|Withdrawal by Subject|1|||
147626902|NCT03482635|532451078|FG000|Overall Study|Withdrawn by Principle Investigator|1|||
147626903|NCT03482635|532451079|FG001|Overall Study|Withdrawn by Principle Investigator|0|||
147668371|NCT02722967|532611759|FG002|Overall Study|Withdrawal by Subject|1|||
147626904|NCT03482635|532451080|FG002|Overall Study|Withdrawn by Principle Investigator|0|||
147626905|NCT03482635|532451081|FG003|Overall Study|Withdrawn by Principle Investigator|0|||
147626906|NCT03482635|532451078|FG000|Overall Study|Not treated|0|||
147626907|NCT03482635|532451079|FG001|Overall Study|Not treated|0|||
147626908|NCT03482635|532451080|FG002|Overall Study|Not treated|0|||
147626909|NCT03482635|532451081|FG003|Overall Study|Not treated|1|||
147626910|NCT00979654|532451088|FG000|Overall Study|Lost to Follow-up|1|||
147626911|NCT00979654|532451088|FG000|Overall Study|Withdrawal by Subject|22|||
147626912|NCT00979654|532451088|FG000|Overall Study|Death|1|||
147626913|NCT00979654|532451088|FG000|Overall Study|Lack of Efficacy|6|||
147626914|NCT00979654|532451088|FG000|Overall Study|Adverse Event|1|||
147626915|NCT00979654|532451088|FG000|Overall Study|Adverse Event of Diverticulitis|1|||
147626916|NCT00979654|532451088|FG000|Overall Study|Per Principal Investigator's Discretion|1|||
147626917|NCT00979654|532451088|FG000|Overall Study|Patient Wanted to Pursue Other Treatment|1|||
147626918|NCT00979654|532451088|FG000|Overall Study|Serious Adverse Event|1|||
147626919|NCT00979654|532451088|FG000|Overall Study|Unfavorable Risk-Benefit Analysis|1|||
147626920|NCT03830333|532451091|FG000|Overall Study|Death|0|||
147626921|NCT03830333|532451092|FG001|Overall Study|Death|1|||
147626922|NCT03830333|532451091|FG000|Overall Study|Withdrawal by Subject|5|||
147626923|NCT03830333|532451092|FG001|Overall Study|Withdrawal by Subject|1|||
147626924|NCT03830333|532451091|FG000|Overall Study|Discontinuations associated with failure to return for follow-up assessments due to COVID-19|3|||
147626925|NCT03830333|532451092|FG001|Overall Study|Discontinuations associated with failure to return for follow-up assessments due to COVID-19|2|||
147626926|NCT00722137|532451093|FG000|Overall Study|Overt Disease Progression|5|||
147626927|NCT00722137|532451094|FG001|Overall Study|Overt Disease Progression|4|||
147626928|NCT00722137|532451093|FG000|Overall Study|Adverse Event|17|||
147626929|NCT00722137|532451094|FG001|Overall Study|Adverse Event|21|||
147626930|NCT00722137|532451093|FG000|Overall Study|Death|12|||
147626931|NCT00722137|532451094|FG001|Overall Study|Death|7|||
147626932|NCT00722137|532451093|FG000|Overall Study|Withdrawal by Subject|6|||
147626933|NCT00722137|532451094|FG001|Overall Study|Withdrawal by Subject|9|||
147626934|NCT00722137|532451093|FG000|Overall Study|Other Reason Unknown|3|||
147626935|NCT00722137|532451094|FG001|Overall Study|Other Reason Unknown|4|||
147626936|NCT00722137|532451093|FG000|Overall Study|Randomized But Not Treated|2|||
147626937|NCT00722137|532451094|FG001|Overall Study|Randomized But Not Treated|3|||
147626938|NCT01129557|532451095|FG000|Overall Study|Adverse Event|1|||
147626939|NCT01129557|532451096|FG001|Overall Study|Adverse Event|2|||
147626940|NCT01129557|532451097|FG002|Overall Study|Adverse Event|2|||
147626941|NCT01129557|532451095|FG000|Overall Study|Novartis terminated study early|3|||
147626942|NCT01129557|532451096|FG001|Overall Study|Novartis terminated study early|3|||
147626943|NCT01129557|532451097|FG002|Overall Study|Novartis terminated study early|2|||
147626944|NCT01486446|532451098|FG000|Overall Study|Adverse Event|1|||
147626945|NCT01486446|532451099|FG001|Overall Study|Adverse Event|0|||
147626946|NCT01367886|532451100|FG000|Overall Study|Lost to Follow-up|4|||
147626947|NCT01367886|532451100|FG000|Overall Study|Lack of Efficacy|2|||
147626948|NCT01367886|532451100|FG000|Overall Study|Death|1|||
147626949|NCT00985504|532451103|FG000|Acute Treatment Period|Adverse Event|3|||
147626950|NCT00985504|532451104|FG001|Acute Treatment Period|Adverse Event|4|||
147626951|NCT00985504|532451103|FG000|Acute Treatment Period|Entry Criteria Not Met|1|||
147626952|NCT00985504|532451104|FG001|Acute Treatment Period|Entry Criteria Not Met|2|||
147626953|NCT00985504|532451103|FG000|Acute Treatment Period|Protocol Violation|2|||
147626954|NCT00985504|532451104|FG001|Acute Treatment Period|Protocol Violation|0|||
147626955|NCT00985504|532451103|FG000|Acute Treatment Period|Sponsor Decision|0|||
147626956|NCT00985504|532451104|FG001|Acute Treatment Period|Sponsor Decision|1|||
147626957|NCT00985504|532451103|FG000|Acute Treatment Period|Withdrawal by Subject|9|||
147626958|NCT00985504|532451104|FG001|Acute Treatment Period|Withdrawal by Subject|5|||
147626959|NCT00985504|532451103|FG000|Optimization Period|Adverse Event|7|||
147626960|NCT00985504|532451104|FG001|Optimization Period|Adverse Event|9|||
147626961|NCT00985504|532451103|FG000|Optimization Period|Death|0|||
147626962|NCT00985504|532451104|FG001|Optimization Period|Death|1|||
147626963|NCT00985504|532451103|FG000|Optimization Period|Lack of Efficacy|5|||
147626964|NCT00985504|532451104|FG001|Optimization Period|Lack of Efficacy|3|||
147626965|NCT00985504|532451103|FG000|Optimization Period|Lost to Follow-up|0|||
147626966|NCT00985504|532451104|FG001|Optimization Period|Lost to Follow-up|1|||
147626967|NCT00985504|532451103|FG000|Optimization Period|Physician Decision|1|||
147626968|NCT00985504|532451104|FG001|Optimization Period|Physician Decision|0|||
147626969|NCT00985504|532451103|FG000|Optimization Period|Protocol Violation|3|||
147626970|NCT00985504|532451104|FG001|Optimization Period|Protocol Violation|1|||
147626971|NCT00985504|532451103|FG000|Optimization Period|Withdrawal by Subject|10|||
147626972|NCT00985504|532451104|FG001|Optimization Period|Withdrawal by Subject|8|||
147626973|NCT03711786|532451113|FG000|Period 1: Recruited in Study Months 1-5|Lost to Follow-up|13|||
147626974|NCT03711786|532451114|FG001|Period 1: Recruited in Study Months 1-5|Lost to Follow-up|4|||
147626975|NCT03711786|532451113|FG000|Period 1: Recruited in Study Months 1-5|Withdrawal by Subject|0|||
147626976|NCT03711786|532451114|FG001|Period 1: Recruited in Study Months 1-5|Withdrawal by Subject|1|||
147626977|NCT03711786|532451113|FG000|Period 1: Recruited in Study Months 1-5|Death|7|||
147626978|NCT03711786|532451114|FG001|Period 1: Recruited in Study Months 1-5|Death|1|||
147626979|NCT03711786|532451113|FG000|Period 1: Recruited in Study Months 6-32|Lost to Follow-up|17|||
147626980|NCT03711786|532451114|FG001|Period 1: Recruited in Study Months 6-32|Lost to Follow-up|21|||
147626981|NCT03711786|532451113|FG000|Period 1: Recruited in Study Months 6-32|Withdrawal by Subject|0|||
147626982|NCT03711786|532451114|FG001|Period 1: Recruited in Study Months 6-32|Withdrawal by Subject|5|||
147626983|NCT03711786|532451113|FG000|Period 1: Recruited in Study Months 6-32|Death|5|||
147626984|NCT03711786|532451114|FG001|Period 1: Recruited in Study Months 6-32|Death|4|||
147626985|NCT04390113|532451115|FG000|Overall Study|Not Treated|0|||
147626986|NCT04390113|532451116|FG001|Overall Study|Not Treated|1|||
147626987|NCT04390113|532451115|FG000|Overall Study|Adverse Event|1|||
147626988|NCT04390113|532451116|FG001|Overall Study|Adverse Event|0|||
147626989|NCT04390113|532451115|FG000|Overall Study|Death|2|||
147626990|NCT04390113|532451116|FG001|Overall Study|Death|1|||
147626991|NCT04390113|532451115|FG000|Overall Study|Physician Decision|1|||
147626992|NCT04390113|532451116|FG001|Overall Study|Physician Decision|3|||
147626993|NCT04390113|532451115|FG000|Overall Study|Study Terminated by Sponsor|5|||
147626994|NCT04390113|532451116|FG001|Overall Study|Study Terminated by Sponsor|3|||
147626995|NCT04390113|532451115|FG000|Overall Study|Withdrawal by Subject|10|||
147626996|NCT04390113|532451116|FG001|Overall Study|Withdrawal by Subject|5|||
147626997|NCT04390113|532451115|FG000|Overall Study|Other|1|||
147626998|NCT04390113|532451116|FG001|Overall Study|Other|0|||
147626999|NCT04390113|532451115|FG000|Overall Study|Missing|0|||
147627000|NCT04390113|532451116|FG001|Overall Study|Missing|1|||
147627001|NCT01611883|532451117|FG000|Overall Study|Adverse Event|1|||
147627002|NCT01611883|532451118|FG001|Overall Study|Adverse Event|1|||
147627003|NCT03379727|532451120|FG000|Overall Study|Lack of Efficacy|73|||
147627004|NCT03379727|532451120|FG000|Overall Study|Adverse Event|32|||
147627005|NCT03379727|532451120|FG000|Overall Study|Death|18|||
147627006|NCT03379727|532451120|FG000|Overall Study|Patient/guardian decision|17|||
147627007|NCT03379727|532451120|FG000|Overall Study|Physician Decision|104|||
147627008|NCT03379727|532451120|FG000|Overall Study|Protocol Violation|4|||
147627009|NCT03379727|532451120|FG000|Overall Study|Lost to Follow-up|1|||
147627010|NCT02418182|532451123|FG000|Overall Study|Unable to re-consent|18|||
147627011|NCT02418182|532451124|FG001|Overall Study|Unable to re-consent|15|||
147627012|NCT02418182|532451123|FG000|Overall Study|Lost to Follow-up|0|||
147627013|NCT02418182|532451124|FG001|Overall Study|Lost to Follow-up|2|||
147627014|NCT00734994|532451125|FG000|Overall Study|Withdrawal by Subject|1|||
147627015|NCT02431676|532451126|FG000|Overall Study|no lab obtained|0|||
147627016|NCT02431676|532451127|FG001|Overall Study|no lab obtained|1|||
147627017|NCT02431676|532451128|FG002|Overall Study|no lab obtained|2|||
147627018|NCT01622673|532451129|FG000|Treatment Period 1|Withdrawal by Subject|0|||
147627019|NCT01622673|532451130|FG001|Treatment Period 1|Withdrawal by Subject|0|||
147627020|NCT01622673|532451131|FG002|Treatment Period 1|Withdrawal by Subject|0|||
147627021|NCT01622673|532451132|FG003|Treatment Period 1|Withdrawal by Subject|1|||
147627022|NCT01622673|532451133|FG004|Treatment Period 1|Withdrawal by Subject|0|||
147627023|NCT01622673|532451134|FG005|Treatment Period 1|Withdrawal by Subject|0|||
147627024|NCT01622673|532451129|FG000|Treatment Period 1|Protocol Violation|0|||
147627025|NCT01622673|532451130|FG001|Treatment Period 1|Protocol Violation|1|||
147627026|NCT01622673|532451131|FG002|Treatment Period 1|Protocol Violation|0|||
147627027|NCT01622673|532451132|FG003|Treatment Period 1|Protocol Violation|0|||
147627028|NCT01622673|532451133|FG004|Treatment Period 1|Protocol Violation|0|||
147627029|NCT01622673|532451134|FG005|Treatment Period 1|Protocol Violation|0|||
147627030|NCT01622673|532451129|FG000|Treatment Period 2|Withdrawal by Subject|0|||
147627031|NCT01622673|532451130|FG001|Treatment Period 2|Withdrawal by Subject|0|||
147627032|NCT01622673|532451131|FG002|Treatment Period 2|Withdrawal by Subject|0|||
147627033|NCT01622673|532451132|FG003|Treatment Period 2|Withdrawal by Subject|1|||
147627034|NCT01622673|532451133|FG004|Treatment Period 2|Withdrawal by Subject|0|||
147627035|NCT01622673|532451134|FG005|Treatment Period 2|Withdrawal by Subject|0|||
147627036|NCT01622673|532451129|FG000|Treatment Period 3|Protocol Violation|0|||
147627037|NCT01622673|532451130|FG001|Treatment Period 3|Protocol Violation|1|||
147627038|NCT01622673|532451131|FG002|Treatment Period 3|Protocol Violation|0|||
147627039|NCT01622673|532451132|FG003|Treatment Period 3|Protocol Violation|0|||
147627040|NCT01622673|532451133|FG004|Treatment Period 3|Protocol Violation|0|||
147627041|NCT01622673|532451134|FG005|Treatment Period 3|Protocol Violation|0|||
147627042|NCT03782792|532453041|FG000|Overall Study|Patient left the country|0|||
147627043|NCT03782792|532453042|FG001|Overall Study|Patient left the country|1|||
147627044|NCT03782792|532453041|FG000|Overall Study|Withdrawal by Subject|1|||
147627045|NCT03782792|532453042|FG001|Overall Study|Withdrawal by Subject|2|||
147627046|NCT05271370|532453043|FG000|Overall Study|Study early termination|8|||
147627047|NCT05271370|532453044|FG001|Overall Study|Study early termination|16|||
147627048|NCT05271370|532453045|FG002|Overall Study|Study early termination|29|||
147627049|NCT03048747|532453047|FG000|Overall Study|Adverse Event|2|||
147627050|NCT03048747|532453047|FG000|Overall Study|Participant Met Withdrawal Criteria|2|||
147627051|NCT03048747|532453047|FG000|Overall Study|Physician Decision|1|||
147627052|NCT00833105|532453048|FG000|Overall Study|Withdrawal by Subject|1|||
147627053|NCT00833105|532453048|FG000|Overall Study|Adverse Event|2|||
147627054|NCT03656068|532453049|FG000|Overall Study|Withdrawal by Subject|4|||
147627055|NCT03656068|532453049|FG000|Overall Study|Adverse Event|1|||
147627056|NCT05253573|532453050|FG000|Overall Study|Death|1|||
147627057|NCT05253573|532453051|FG001|Overall Study|Death|0|||
147627058|NCT01344824|532453052|FG000|Overall Study|Adverse Event|15|||
147627059|NCT01344824|532453052|FG000|Overall Study|Withdrawal by Subject|6|||
147627060|NCT01344824|532453052|FG000|Overall Study|Other complicating disease|1|||
147627061|NCT01344824|532453052|FG000|Overall Study|Progression|15|||
147627062|NCT01085630|532453063|FG000|Overall Study|Insufficient data|1|||
147627063|NCT01085630|532453064|FG001|Overall Study|Insufficient data|0|||
147627064|NCT01085630|532453063|FG000|Overall Study|Ineligible|3|||
147627065|NCT01085630|532453064|FG001|Overall Study|Ineligible|0|||
147668372|NCT02722967|532611757|FG000|Overall Study|Physician Decision|1|||
147627066|NCT02366637|532453070|FG000|First Intervention Period|Adverse Event|0|||
147627067|NCT02366637|532453071|FG001|First Intervention Period|Adverse Event|1|||
147627068|NCT02366637|532453070|FG000|First Intervention Period|Study Terminated by Sponsor|6|||
147627069|NCT02366637|532453071|FG001|First Intervention Period|Study Terminated by Sponsor|4|||
147627070|NCT02366637|532453070|FG000|Second Intervention Period|Study Terminated by Sponsor|1|||
147627071|NCT02366637|532453071|FG001|Second Intervention Period|Study Terminated by Sponsor|1|||
147627072|NCT01609010|532453072|FG000|Overall Study|Stable disease (SD)|22|||
147627073|NCT01609010|532453073|FG001|Overall Study|Stable disease (SD)|16|||
147627074|NCT01609010|532453072|FG000|Overall Study|Progressive disease (PD)|8|||
147627075|NCT01609010|532453073|FG001|Overall Study|Progressive disease (PD)|10|||
147627076|NCT01609010|532453072|FG000|Overall Study|Adverse Event|3|||
147627077|NCT01609010|532453073|FG001|Overall Study|Adverse Event|6|||
147627078|NCT01609010|532453072|FG000|Overall Study|Withdrawal by Subject|2|||
147627079|NCT01609010|532453073|FG001|Overall Study|Withdrawal by Subject|2|||
147627080|NCT01609010|532453072|FG000|Overall Study|Other|2|||
147627081|NCT01609010|532453073|FG001|Overall Study|Other|0|||
147627082|NCT01609010|532453072|FG000|Overall Study|Other malignancy|1|||
147627083|NCT01609010|532453073|FG001|Overall Study|Other malignancy|0|||
147627084|NCT01609010|532453072|FG000|Overall Study|Pathology review|2|||
147627085|NCT01609010|532453073|FG001|Overall Study|Pathology review|1|||
147627086|NCT01609010|532453072|FG000|Overall Study|Protocol Violation|1|||
147627087|NCT01609010|532453073|FG001|Overall Study|Protocol Violation|1|||
147627088|NCT01609010|532453072|FG000|Overall Study|New cancer|1|||
147627089|NCT01609010|532453073|FG001|Overall Study|New cancer|0|||
147627090|NCT01609010|532453072|FG000|Overall Study|Lost to Follow-up|1|||
147627091|NCT01609010|532453073|FG001|Overall Study|Lost to Follow-up|1|||
147627092|NCT02770170|532453077|FG000|Overall Study|Withdrawal by Subject|0|||
147627093|NCT02770170|532453078|FG001|Overall Study|Withdrawal by Subject|0|||
147627094|NCT02770170|532453079|FG002|Overall Study|Withdrawal by Subject|0|||
147627095|NCT02770170|532453080|FG003|Overall Study|Withdrawal by Subject|2|||
147627096|NCT02770170|532453077|FG000|Overall Study|due to pregnancy|1|||
147627097|NCT02770170|532453078|FG001|Overall Study|due to pregnancy|0|||
147627098|NCT02770170|532453079|FG002|Overall Study|due to pregnancy|0|||
147627099|NCT02770170|532453080|FG003|Overall Study|due to pregnancy|0|||
147627100|NCT02770170|532453077|FG000|Overall Study|Lack of Efficacy|2|||
147627101|NCT02770170|532453078|FG001|Overall Study|Lack of Efficacy|0|||
147627102|NCT02770170|532453079|FG002|Overall Study|Lack of Efficacy|0|||
147627103|NCT02770170|532453080|FG003|Overall Study|Lack of Efficacy|1|||
147627104|NCT02770170|532453077|FG000|Overall Study|Adverse Event|4|||
147627105|NCT02770170|532453078|FG001|Overall Study|Adverse Event|3|||
147627106|NCT02770170|532453079|FG002|Overall Study|Adverse Event|5|||
147627107|NCT02770170|532453080|FG003|Overall Study|Adverse Event|3|||
147627108|NCT02770170|532453077|FG000|Overall Study|due to disease worsening|0|||
147627109|NCT02770170|532453078|FG001|Overall Study|due to disease worsening|0|||
147627110|NCT02770170|532453079|FG002|Overall Study|due to disease worsening|0|||
147627111|NCT02770170|532453080|FG003|Overall Study|due to disease worsening|1|||
147627112|NCT03581123|532453083|FG000|2-month Follow-up|Withdrawal by Subject|5|||
147627113|NCT03581123|532453084|FG001|2-month Follow-up|Withdrawal by Subject|4|||
147627114|NCT03581123|532453085|FG002|2-month Follow-up|Withdrawal by Subject|6|||
147627115|NCT03581123|532453086|FG003|2-month Follow-up|Withdrawal by Subject|4|||
147627116|NCT03581123|532453083|FG000|2-month Follow-up|Lost to Follow-up|8|||
147627117|NCT03581123|532453084|FG001|2-month Follow-up|Lost to Follow-up|1|||
147627118|NCT03581123|532453085|FG002|2-month Follow-up|Lost to Follow-up|2|||
147627119|NCT03581123|532453086|FG003|2-month Follow-up|Lost to Follow-up|2|||
147627120|NCT03581123|532453083|FG000|6-Month Follow-up|Withdrawal by Subject|2|||
147627121|NCT03581123|532453084|FG001|6-Month Follow-up|Withdrawal by Subject|0|||
147627122|NCT03581123|532453085|FG002|6-Month Follow-up|Withdrawal by Subject|1|||
147627123|NCT03581123|532453086|FG003|6-Month Follow-up|Withdrawal by Subject|2|||
147627124|NCT03581123|532453083|FG000|6-Month Follow-up|Lost to Follow-up|3|||
147627125|NCT03581123|532453084|FG001|6-Month Follow-up|Lost to Follow-up|3|||
147627126|NCT03581123|532453085|FG002|6-Month Follow-up|Lost to Follow-up|1|||
147494903|NCT00621855|531966666|FG002|Overall Study|Adverse Event|48|||
147494904|NCT00621855|531966667|FG003|Overall Study|Adverse Event|34|||
147494905|NCT00621855|531966668|FG004|Overall Study|Adverse Event|31|||
147494906|NCT00621855|531966664|FG000|Overall Study|Lost to Follow-up|0|||
147494907|NCT00621855|531966665|FG001|Overall Study|Lost to Follow-up|1|||
147627127|NCT03581123|532453086|FG003|6-Month Follow-up|Lost to Follow-up|1|||
147627128|NCT03581123|532453083|FG000|12-Month Follow-up|Lost to Follow-up|4|||
147627129|NCT03581123|532453084|FG001|12-Month Follow-up|Lost to Follow-up|3|||
147627130|NCT03581123|532453085|FG002|12-Month Follow-up|Lost to Follow-up|4|||
147627131|NCT03581123|532453086|FG003|12-Month Follow-up|Lost to Follow-up|5|||
147627132|NCT04195685|532453087|FG000|Overall Study|Withdrawal by Subject|6|||
147627133|NCT04195685|532453088|FG001|Overall Study|Withdrawal by Subject|2|||
147627134|NCT04195685|532453087|FG000|Overall Study|Lost to Follow-up|1|||
147627135|NCT04195685|532453088|FG001|Overall Study|Lost to Follow-up|4|||
147627136|NCT00162981|532453089|FG000|Overall Study|Adverse Event|2|||
147627137|NCT00162981|532453090|FG001|Overall Study|Adverse Event|5|||
147494908|NCT00621855|531966666|FG002|Overall Study|Lost to Follow-up|3|||
147627138|NCT00162981|532453089|FG000|Overall Study|Withdrawal by Subject|1|||
147627139|NCT00162981|532453090|FG001|Overall Study|Withdrawal by Subject|1|||
147627140|NCT00162981|532453089|FG000|Overall Study|Physician Decision|1|||
147627141|NCT00162981|532453090|FG001|Overall Study|Physician Decision|0|||
147627142|NCT03351608|532453097|FG000|Overall Study|Lost to Follow-up|0|||
147627143|NCT03351608|532453098|FG001|Overall Study|Lost to Follow-up|1|||
147627144|NCT03351608|532453099|FG002|Overall Study|Lost to Follow-up|1|||
147627145|NCT03351608|532453100|FG003|Overall Study|Lost to Follow-up|1|||
147627146|NCT03351608|532453101|FG004|Overall Study|Lost to Follow-up|1|||
147627147|NCT03351608|532453097|FG000|Overall Study|Physician Decision|1|||
147627148|NCT03351608|532453098|FG001|Overall Study|Physician Decision|0|||
147627149|NCT03351608|532453099|FG002|Overall Study|Physician Decision|0|||
147627150|NCT03351608|532453100|FG003|Overall Study|Physician Decision|2|||
147627151|NCT03351608|532453101|FG004|Overall Study|Physician Decision|1|||
147627152|NCT03351608|532453097|FG000|Overall Study|Randomized by mistake, no treatment given|0|||
147627153|NCT03351608|532453098|FG001|Overall Study|Randomized by mistake, no treatment given|0|||
147627154|NCT03351608|532453099|FG002|Overall Study|Randomized by mistake, no treatment given|0|||
147627155|NCT03351608|532453100|FG003|Overall Study|Randomized by mistake, no treatment given|1|||
147627156|NCT03351608|532453101|FG004|Overall Study|Randomized by mistake, no treatment given|0|||
147627157|NCT03351608|532453097|FG000|Overall Study|Withdrawal by parent/guardian|0|||
147627158|NCT03351608|532453098|FG001|Overall Study|Withdrawal by parent/guardian|0|||
147627159|NCT03351608|532453099|FG002|Overall Study|Withdrawal by parent/guardian|1|||
147627160|NCT03351608|532453100|FG003|Overall Study|Withdrawal by parent/guardian|1|||
147627161|NCT03351608|532453101|FG004|Overall Study|Withdrawal by parent/guardian|0|||
147627162|NCT03351608|532453097|FG000|Overall Study|Other|0|||
147627163|NCT03351608|532453098|FG001|Overall Study|Other|1|||
147627164|NCT03351608|532453099|FG002|Overall Study|Other|1|||
147627165|NCT03351608|532453100|FG003|Overall Study|Other|3|||
147627166|NCT03351608|532453101|FG004|Overall Study|Other|0|||
147627167|NCT02877004|532453102|FG000|Overall Study|Pregnancy|0|||
147627168|NCT02877004|532453103|FG001|Overall Study|Pregnancy|0|||
147627169|NCT02877004|532453104|FG002|Overall Study|Pregnancy|1|||
147627170|NCT02044302|532453106|FG000|Overall Study|study terminated|2|||
147627171|NCT02044302|532453107|FG001|Overall Study|study terminated|0|||
147627172|NCT01684423|532453116|FG000|Overall Study|Withdrawal by Subject|0|||
147627173|NCT01684423|532453117|FG001|Overall Study|Withdrawal by Subject|0|||
147627174|NCT01684423|532453118|FG002|Overall Study|Withdrawal by Subject|1|||
147627175|NCT01684423|532453119|FG003|Overall Study|Withdrawal by Subject|0|||
147627176|NCT01684423|532453120|FG004|Overall Study|Withdrawal by Subject|0|||
147627177|NCT02220764|532453123|FG000|Overall Study|Lost to Follow-up|3|||
147627178|NCT02220764|532453124|FG001|Overall Study|Lost to Follow-up|1|||
147627179|NCT02220764|532453123|FG000|Overall Study|Death|1|||
147627180|NCT02220764|532453124|FG001|Overall Study|Death|0|||
147627181|NCT05000164|532453125|FG000|Overall Study|Adverse Event|1|||
147627182|NCT05000164|532453125|FG000|Overall Study|Unsatisfactory Visual Response due to Test Article|1|||
147627183|NCT05000164|532453125|FG000|Overall Study|Lens Discomfort|3|||
147494909|NCT00621855|531966667|FG003|Overall Study|Lost to Follow-up|4|||
147494910|NCT00621855|531966668|FG004|Overall Study|Lost to Follow-up|1|||
147494911|NCT00621855|531966664|FG000|Overall Study|Protocol Violation|16|||
147494912|NCT00621855|531966665|FG001|Overall Study|Protocol Violation|8|||
147494913|NCT00621855|531966666|FG002|Overall Study|Protocol Violation|6|||
147627184|NCT05000164|532453125|FG000|Overall Study|Withdrew Consent during Study|2|||
147627185|NCT05000164|532453125|FG000|Overall Study|Subject Withdrawn by PI|2|||
147627186|NCT05000164|532453125|FG000|Overall Study|Other Fractured Test Article|1|||
147627187|NCT03020992|532453126|FG000|Overall Study|Adverse Event|5|||
147627188|NCT03020992|532453126|FG000|Overall Study|Withdrawal by Subject|1|||
147627189|NCT02861807|532453127|FG000|Overall Study|Lost to Follow-up|7|||
147627190|NCT02861807|532453128|FG001|Overall Study|Lost to Follow-up|6|||
147627191|NCT02861807|532453127|FG000|Overall Study|Withdrawal by Subject|5|||
147627192|NCT02861807|532453128|FG001|Overall Study|Withdrawal by Subject|8|||
147627193|NCT01006122|532453129|FG000|First Double-blind Intervention Period|Lost to Follow-up|0|||
147627194|NCT01006122|532453130|FG001|First Double-blind Intervention Period|Lost to Follow-up|2|||
147627195|NCT01006122|532453129|FG000|First Double-blind Intervention Period|Protocol Violation|1|||
147627196|NCT01006122|532453130|FG001|First Double-blind Intervention Period|Protocol Violation|1|||
147627197|NCT01006122|532453129|FG000|First Double-blind Intervention Period|Pregnancy|0|||
147627198|NCT01006122|532453130|FG001|First Double-blind Intervention Period|Pregnancy|1|||
147627199|NCT01006122|532453129|FG000|First Double-blind Intervention Period|Withdrawal by Subject|9|||
147627200|NCT01006122|532453130|FG001|First Double-blind Intervention Period|Withdrawal by Subject|8|||
147627201|NCT01006122|532453129|FG000|First Double-blind Intervention Period|Does not meet entrance criteria|1|||
147627202|NCT01006122|532453130|FG001|First Double-blind Intervention Period|Does not meet entrance criteria|0|||
147627203|NCT01006122|532453129|FG000|First Double-blind Intervention Period|Lack of Efficacy|2|||
147627204|NCT01006122|532453130|FG001|First Double-blind Intervention Period|Lack of Efficacy|1|||
147627205|NCT01006122|532453129|FG000|First Double-blind Intervention Period|Other|3|||
147627206|NCT01006122|532453130|FG001|First Double-blind Intervention Period|Other|0|||
147627207|NCT01006122|532453129|FG000|First Double-blind Intervention Period|Adverse Event|0|||
147494914|NCT00621855|531966667|FG003|Overall Study|Protocol Violation|7|||
147494915|NCT00621855|531966668|FG004|Overall Study|Protocol Violation|8|||
147494916|NCT00621855|531966664|FG000|Overall Study|Withdrawal by Subject|16|||
147494917|NCT00621855|531966665|FG001|Overall Study|Withdrawal by Subject|11|||
147494918|NCT00621855|531966666|FG002|Overall Study|Withdrawal by Subject|13|||
147668373|NCT02722967|532611758|FG001|Overall Study|Physician Decision|0|||
147494919|NCT00621855|531966667|FG003|Overall Study|Withdrawal by Subject|13|||
147494920|NCT00621855|531966668|FG004|Overall Study|Withdrawal by Subject|9|||
147494921|NCT00621855|531966664|FG000|Overall Study|Other|9|||
147494922|NCT00621855|531966665|FG001|Overall Study|Other|7|||
147494923|NCT00621855|531966666|FG002|Overall Study|Other|6|||
147494924|NCT00621855|531966667|FG003|Overall Study|Other|5|||
147494925|NCT00621855|531966668|FG004|Overall Study|Other|4|||
147494926|NCT00621855|531966664|FG000|Overall Study|Patients did not receive study drug|3|||
147494927|NCT00621855|531966665|FG001|Overall Study|Patients did not receive study drug|3|||
147494928|NCT00621855|531966666|FG002|Overall Study|Patients did not receive study drug|5|||
147494929|NCT00621855|531966667|FG003|Overall Study|Patients did not receive study drug|4|||
147494930|NCT00621855|531966668|FG004|Overall Study|Patients did not receive study drug|2|||
147494931|NCT03731364|531966669|FG000|Overall Study|Adverse Event|0|||
147494932|NCT03731364|531966670|FG001|Overall Study|Adverse Event|0|||
147494933|NCT03731364|531966671|FG002|Overall Study|Adverse Event|1|||
147494934|NCT03731364|531966672|FG003|Overall Study|Adverse Event|2|||
147494935|NCT03731364|531966673|FG004|Overall Study|Adverse Event|1|||
147494936|NCT02953782|531966674|FG000|Phase 1b (Maximum Duration: 14.3 Months)|Death|5|||
147494937|NCT02953782|531966675|FG001|Phase 1b (Maximum Duration: 14.3 Months)|Death|2|||
147494938|NCT02953782|531966676|FG002|Phase 1b (Maximum Duration: 14.3 Months)|Death|6|||
147494939|NCT02953782|531966677|FG003|Phase 1b (Maximum Duration: 14.3 Months)|Death|6|||
147494940|NCT02953782|531966678|FG004|Phase 1b (Maximum Duration: 14.3 Months)|Death|4|||
147494941|NCT02953782|531966679|FG005|Phase 1b (Maximum Duration: 14.3 Months)|Death|0|||
147494942|NCT02953782|531966680|FG006|Phase 1b (Maximum Duration: 14.3 Months)|Death|0|||
147494943|NCT02953782|531966681|FG007|Phase 1b (Maximum Duration: 14.3 Months)|Death|0|||
147494944|NCT02953782|531966674|FG000|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|1|||
147494945|NCT02953782|531966675|FG001|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0|||
147494946|NCT02953782|531966676|FG002|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|2|||
147494947|NCT02953782|531966677|FG003|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0|||
147494948|NCT02953782|531966678|FG004|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|1|||
147494949|NCT02953782|531966679|FG005|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0|||
147494950|NCT02953782|531966680|FG006|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0|||
147494951|NCT02953782|531966681|FG007|Phase 1b (Maximum Duration: 14.3 Months)|Withdrawal by Subject|0|||
147494952|NCT02953782|531966674|FG000|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0|||
147494953|NCT02953782|531966675|FG001|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|1|||
147494954|NCT02953782|531966676|FG002|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0|||
147494955|NCT02953782|531966677|FG003|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|1|||
147494956|NCT02953782|531966678|FG004|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|1|||
147494957|NCT02953782|531966679|FG005|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0|||
147494958|NCT02953782|531966680|FG006|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0|||
147494959|NCT02953782|531966681|FG007|Phase 1b (Maximum Duration: 14.3 Months)|Discontinued by Sponsor|0|||
147494960|NCT02953782|531966674|FG000|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
147494961|NCT02953782|531966675|FG001|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
147494962|NCT02953782|531966676|FG002|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|1|||
147494963|NCT02953782|531966677|FG003|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|1|||
147494964|NCT02953782|531966678|FG004|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
147494965|NCT02953782|531966679|FG005|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
147494966|NCT02953782|531966680|FG006|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
147494967|NCT02953782|531966681|FG007|Phase 1b (Maximum Duration: 14.3 Months)|Participant placed in hospice care|0|||
147494968|NCT02953782|531966674|FG000|Phase 2 (Maximum Duration: 11.1 Months)|Death|0|||
147494969|NCT02953782|531966675|FG001|Phase 2 (Maximum Duration: 11.1 Months)|Death|0|||
147494970|NCT02953782|531966676|FG002|Phase 2 (Maximum Duration: 11.1 Months)|Death|0|||
147494971|NCT02953782|531966677|FG003|Phase 2 (Maximum Duration: 11.1 Months)|Death|0|||
147494972|NCT02953782|531966678|FG004|Phase 2 (Maximum Duration: 11.1 Months)|Death|0|||
147494973|NCT02953782|531966679|FG005|Phase 2 (Maximum Duration: 11.1 Months)|Death|14|||
147494974|NCT02953782|531966680|FG006|Phase 2 (Maximum Duration: 11.1 Months)|Death|11|||
147494975|NCT02953782|531966681|FG007|Phase 2 (Maximum Duration: 11.1 Months)|Death|8|||
147494976|NCT02953782|531966674|FG000|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0|||
147494977|NCT02953782|531966675|FG001|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0|||
147494978|NCT02953782|531966676|FG002|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0|||
147494979|NCT02953782|531966677|FG003|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0|||
147668374|NCT02722967|532611759|FG002|Overall Study|Physician Decision|0|||
147494980|NCT02953782|531966678|FG004|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|0|||
147494981|NCT02953782|531966679|FG005|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|1|||
147494982|NCT02953782|531966680|FG006|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|2|||
147494983|NCT02953782|531966681|FG007|Phase 2 (Maximum Duration: 11.1 Months)|Withdrawal by Subject|3|||
147494984|NCT02953782|531966674|FG000|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0|||
147494985|NCT02953782|531966675|FG001|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0|||
147494986|NCT02953782|531966676|FG002|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0|||
147494987|NCT02953782|531966677|FG003|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0|||
147494988|NCT02953782|531966678|FG004|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|0|||
147494989|NCT02953782|531966679|FG005|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|1|||
147494990|NCT02953782|531966680|FG006|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|1|||
147494991|NCT02953782|531966681|FG007|Phase 2 (Maximum Duration: 11.1 Months)|Discontinued by Sponsor|4|||
147494992|NCT02953782|531966674|FG000|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
147494993|NCT02953782|531966675|FG001|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
147494994|NCT02953782|531966676|FG002|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
147494995|NCT02953782|531966677|FG003|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
147494996|NCT02953782|531966678|FG004|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
147494997|NCT02953782|531966679|FG005|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
147494998|NCT02953782|531966680|FG006|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|1|||
147494999|NCT02953782|531966681|FG007|Phase 2 (Maximum Duration: 11.1 Months)|Lost to Follow-up|0|||
147495000|NCT01934192|531966684|FG000|Overall Study|Protocol Violation|0|||
147495001|NCT01934192|531966685|FG001|Overall Study|Protocol Violation|0|||
147495002|NCT01934192|531966686|FG002|Overall Study|Protocol Violation|0|||
147495003|NCT01934192|531966687|FG003|Overall Study|Protocol Violation|1|||
147495004|NCT01934192|531966684|FG000|Overall Study|Other: reached stopping criteria|6|||
147495005|NCT01934192|531966685|FG001|Overall Study|Other: reached stopping criteria|5|||
147495006|NCT01934192|531966686|FG002|Overall Study|Other: reached stopping criteria|1|||
147495007|NCT01934192|531966687|FG003|Overall Study|Other: reached stopping criteria|0|||
147495008|NCT01934192|531966684|FG000|Overall Study|Physician Decision|3|||
147495009|NCT01934192|531966685|FG001|Overall Study|Physician Decision|2|||
147495010|NCT01934192|531966686|FG002|Overall Study|Physician Decision|0|||
147495011|NCT01934192|531966687|FG003|Overall Study|Physician Decision|0|||
147495012|NCT01737840|531966688|FG000|Overall Study|Diagnosed with an other pathology|2|||
147495013|NCT01737840|531966689|FG001|Overall Study|Diagnosed with an other pathology|2|||
147495014|NCT02357849|531966692|FG000|Overall Study|Withdrawal by Subject|2|||
147495015|NCT02357849|531966693|FG001|Overall Study|Withdrawal by Subject|3|||
147495016|NCT00403559|531966694|FG000|Overall Study|Adverse Event|0|||
147495017|NCT00403559|531966695|FG001|Overall Study|Adverse Event|1|||
147495018|NCT00403559|531966694|FG000|Overall Study|Lost to Follow-up|3|||
147495019|NCT00403559|531966695|FG001|Overall Study|Lost to Follow-up|3|||
147495020|NCT00403559|531966694|FG000|Overall Study|Withdrawal by Subject|1|||
147495021|NCT00403559|531966695|FG001|Overall Study|Withdrawal by Subject|0|||
147495022|NCT04105244|531966698|FG000|Overall Study|Withdrawal by Subject|10|||
147495023|NCT04105244|531966699|FG001|Overall Study|Withdrawal by Subject|12|||
147495024|NCT04105244|531966698|FG000|Overall Study|Lost to Follow-up|20|||
147495025|NCT04105244|531966699|FG001|Overall Study|Lost to Follow-up|15|||
147495026|NCT04105244|531966698|FG000|Overall Study|Parent no longer eligible- child not living at home|0|||
147495027|NCT04105244|531966699|FG001|Overall Study|Parent no longer eligible- child not living at home|2|||
147495028|NCT04105244|531966698|FG000|Overall Study|Unable to contact to complete the intervention.|0|||
147495029|NCT04105244|531966699|FG001|Overall Study|Unable to contact to complete the intervention.|9|||
147495030|NCT04633473|531966700|FG000|Overall Study|Withdrawal by Subject|6|||
147495031|NCT04387136|531966701|FG000|Overall Study|Protocol Deviation by SOC staff|1|||
147495032|NCT04387136|531966702|FG001|Overall Study|Protocol Deviation by SOC staff|2|||
147495033|NCT01982773|531966703|FG000|Overall Study|Withdrawal by Subject|1|||
147495034|NCT01982773|531966704|FG001|Overall Study|Withdrawal by Subject|3|||
147495035|NCT01982773|531966703|FG000|Overall Study|Lost to Follow-up|7|||
147495036|NCT01982773|531966704|FG001|Overall Study|Lost to Follow-up|1|||
147495037|NCT01029886|531966707|FG000|Overall Study|Adverse Event|12|||
147495038|NCT01029886|531966708|FG001|Overall Study|Adverse Event|25|||
147495039|NCT01029886|531966707|FG000|Overall Study|Lost to Follow-up|1|||
147495040|NCT01029886|531966708|FG001|Overall Study|Lost to Follow-up|0|||
147495041|NCT01029886|531966707|FG000|Overall Study|Physician Decision|2|||
147495042|NCT01029886|531966708|FG001|Overall Study|Physician Decision|6|||
147495043|NCT01029886|531966707|FG000|Overall Study|Protocol Violation|17|||
147495044|NCT01029886|531966708|FG001|Overall Study|Protocol Violation|5|||
147495045|NCT01029886|531966707|FG000|Overall Study|Withdrawal by Subject|8|||
147495046|NCT01029886|531966708|FG001|Overall Study|Withdrawal by Subject|18|||
147495047|NCT01029886|531966707|FG000|Overall Study|Entry Criteria Not Met|13|||
147495048|NCT01029886|531966708|FG001|Overall Study|Entry Criteria Not Met|5|||
147627208|NCT01006122|532453130|FG001|First Double-blind Intervention Period|Adverse Event|4|||
147495049|NCT01029886|531966707|FG000|Overall Study|Sponsor Decision|1|||
147627209|NCT01006122|532453129|FG000|Second Double-blind Intervention Period|Adverse Event|1|||
147627210|NCT01006122|532453130|FG001|Second Double-blind Intervention Period|Adverse Event|1|||
147627211|NCT01006122|532453129|FG000|Second Double-blind Intervention Period|Protocol Violation|1|||
147627212|NCT01006122|532453130|FG001|Second Double-blind Intervention Period|Protocol Violation|0|||
147627213|NCT01006122|532453129|FG000|Second Double-blind Intervention Period|Lost to Follow-up|0|||
147627214|NCT01006122|532453130|FG001|Second Double-blind Intervention Period|Lost to Follow-up|3|||
147627215|NCT01006122|532453129|FG000|Second Double-blind Intervention Period|Withdrawal by Subject|0|||
147627216|NCT01006122|532453130|FG001|Second Double-blind Intervention Period|Withdrawal by Subject|2|||
147627217|NCT01006122|532453129|FG000|Second Double-blind Intervention Period|Death|0|||
147627218|NCT01006122|532453130|FG001|Second Double-blind Intervention Period|Death|1|||
147627219|NCT03493854|532453131|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Adverse Event|3|||
147627220|NCT03493854|532453132|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Adverse Event|5|||
147627221|NCT03493854|532453131|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Death|1|||
147627222|NCT03493854|532453132|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Death|1|||
147627223|NCT03493854|532453131|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Protocol Violation|0|||
147627224|NCT03493854|532453132|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Protocol Violation|1|||
147627225|NCT03493854|532453131|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Withdrawal by Subject|1|||
147627226|NCT03493854|532453132|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Withdrawal by Subject|2|||
147627227|NCT03493854|532453131|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Progressive Disease|3|||
147627228|NCT03493854|532453132|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Progressive Disease|3|||
147627229|NCT03493854|532453131|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Other|1|||
147627230|NCT03493854|532453132|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Other|2|||
147627231|NCT03493854|532453131|FG000|Neoadjuvant Treatment Phase (24 Weeks)|Other|1|||
147627232|NCT03493854|532453132|FG001|Neoadjuvant Treatment Phase (24 Weeks)|Other|0|||
147627233|NCT03493854|532453131|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Adverse Event|12|||
147627234|NCT03493854|532453132|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Adverse Event|7|||
147627235|NCT03493854|532453131|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Lack of Efficacy|0|||
147627236|NCT03493854|532453132|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Lack of Efficacy|2|||
147627237|NCT03493854|532453131|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Progressive Disease|4|||
147627238|NCT03493854|532453132|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Progressive Disease|0|||
147627239|NCT03493854|532453131|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Withdrawal by Subject|2|||
147627240|NCT03493854|532453132|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Withdrawal by Subject|2|||
147627241|NCT03493854|532453131|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Other|7|||
147627242|NCT03493854|532453132|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Other|2|||
147627243|NCT03493854|532453131|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Death|1|||
147627244|NCT03493854|532453132|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Death|1|||
147627245|NCT03493854|532453131|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Physician Decision|3|||
147627246|NCT03493854|532453132|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Physician Decision|2|||
147627247|NCT03493854|532453131|FG000|Surgery & Adjuvant Treatment (42 Weeks)|Disease Relapse|4|||
147627248|NCT03493854|532453132|FG001|Surgery & Adjuvant Treatment (42 Weeks)|Disease Relapse|1|||
147627249|NCT03493854|532453131|FG000|Treatment-Free Follow-Up (up to 3 Years)|Death|10|||
147627250|NCT03493854|532453132|FG001|Treatment-Free Follow-Up (up to 3 Years)|Death|11|||
147627251|NCT03493854|532453131|FG000|Treatment-Free Follow-Up (up to 3 Years)|Withdrawal by Subject|10|||
147627252|NCT03493854|532453132|FG001|Treatment-Free Follow-Up (up to 3 Years)|Withdrawal by Subject|10|||
147627253|NCT03493854|532453131|FG000|Treatment-Free Follow-Up (up to 3 Years)|Lost to Follow-up|4|||
147495050|NCT01029886|531966708|FG001|Overall Study|Sponsor Decision|0|||
147495051|NCT01029886|531966707|FG000|Overall Study|Loss Glucose Control|7|||
147495052|NCT01029886|531966708|FG001|Overall Study|Loss Glucose Control|1|||
147495053|NCT03294681|531966709|FG000|Overall Study|Withdrawal by Subject|1|||
147495054|NCT03089216|531966712|FG000|Overall Study|Adverse Event|0|||
147495055|NCT03089216|531966713|FG001|Overall Study|Adverse Event|0|||
147495056|NCT03089216|531966714|FG002|Overall Study|Adverse Event|0|||
147495057|NCT03089216|531966715|FG003|Overall Study|Adverse Event|1|||
147495058|NCT00417976|531966716|FG000|Overall Study|Non compliance unrelated to toxicity|1|||
147495059|NCT00417976|531966716|FG000|Overall Study|Treatment -related toxicity|2|||
147495060|NCT01778127|531966719|FG000|Overall Study|Lost to Follow-up|5|||
147495061|NCT01778127|531966720|FG001|Overall Study|Lost to Follow-up|1|||
147627254|NCT03493854|532453132|FG001|Treatment-Free Follow-Up (up to 3 Years)|Lost to Follow-up|1|||
147627255|NCT00529308|532453137|FG000|Overall Study|Withdrawal by Subject|1|||
147627256|NCT00529308|532453138|FG001|Overall Study|Withdrawal by Subject|1|||
147627257|NCT05343364|532453155|FG000|Overall Study|Miscellaneous|0|||
147627258|NCT05343364|532453156|FG001|Overall Study|Miscellaneous|1|||
147627259|NCT03331796|532453157|FG000|Allocation and Primary Endpoint|Pandemic Disruption|0|||
147627260|NCT03331796|532453158|FG001|Allocation and Primary Endpoint|Pandemic Disruption|1|||
147668375|NCT02722967|532611757|FG000|Overall Study|Non-adherence of the patch to the skin|0|||
147495062|NCT01778127|531966721|FG002|Overall Study|Lost to Follow-up|2|||
147495063|NCT01778127|531966719|FG000|Overall Study|Withdrawal by Subject|3|||
147495064|NCT01778127|531966720|FG001|Overall Study|Withdrawal by Subject|1|||
147495065|NCT01778127|531966721|FG002|Overall Study|Withdrawal by Subject|4|||
147495066|NCT02720016|531966724|FG000|Overall Study|Separation of couple|6|||
147495067|NCT02720016|531966725|FG001|Overall Study|Separation of couple|8|||
147495068|NCT02720016|531966726|FG002|Overall Study|Separation of couple|2|||
147495069|NCT02720016|531966724|FG000|Overall Study|Withdrawal by Subject|6|||
147495070|NCT02720016|531966725|FG001|Overall Study|Withdrawal by Subject|6|||
147495071|NCT02720016|531966726|FG002|Overall Study|Withdrawal by Subject|4|||
147495072|NCT02720016|531966724|FG000|Overall Study|Scheduling issues|2|||
147495073|NCT02720016|531966725|FG001|Overall Study|Scheduling issues|4|||
147495074|NCT02720016|531966726|FG002|Overall Study|Scheduling issues|7|||
147495075|NCT02720016|531966724|FG000|Overall Study|Childcare|2|||
147495076|NCT02720016|531966725|FG001|Overall Study|Childcare|0|||
147495077|NCT02720016|531966726|FG002|Overall Study|Childcare|2|||
147495078|NCT02720016|531966724|FG000|Overall Study|Withdrawal by PI|2|||
147495079|NCT02720016|531966725|FG001|Overall Study|Withdrawal by PI|2|||
147495080|NCT02720016|531966726|FG002|Overall Study|Withdrawal by PI|0|||
147495081|NCT02720016|531966724|FG000|Overall Study|Moved away|2|||
147495082|NCT02720016|531966725|FG001|Overall Study|Moved away|0|||
147495083|NCT02720016|531966726|FG002|Overall Study|Moved away|0|||
147495084|NCT02720016|531966724|FG000|Overall Study|Not Primary Health Concern|0|||
147627261|NCT03331796|532453159|FG002|Allocation and Primary Endpoint|Pandemic Disruption|1|||
147627262|NCT03331796|532453157|FG000|Allocation and Primary Endpoint|Withdrawal by Subject|0|||
147627263|NCT03331796|532453158|FG001|Allocation and Primary Endpoint|Withdrawal by Subject|0|||
147627264|NCT03331796|532453159|FG002|Allocation and Primary Endpoint|Withdrawal by Subject|1|||
147627265|NCT03331796|532453157|FG000|Extended Follow-up|Adverse Event|1|||
147627266|NCT03331796|532453158|FG001|Extended Follow-up|Adverse Event|0|||
147627267|NCT03331796|532453159|FG002|Extended Follow-up|Adverse Event|1|||
147627268|NCT03331796|532453157|FG000|Extended Follow-up|Lost to Follow-up|0|||
147627269|NCT03331796|532453158|FG001|Extended Follow-up|Lost to Follow-up|0|||
147627270|NCT03331796|532453159|FG002|Extended Follow-up|Lost to Follow-up|1|||
147627271|NCT03331796|532453157|FG000|Extended Follow-up|Withdrawal by Subject|1|||
147627272|NCT03331796|532453158|FG001|Extended Follow-up|Withdrawal by Subject|0|||
147627273|NCT03331796|532453159|FG002|Extended Follow-up|Withdrawal by Subject|0|||
147627274|NCT03331796|532453157|FG000|Extended Follow-up|Termination of Funding|0|||
147627275|NCT03331796|532453158|FG001|Extended Follow-up|Termination of Funding|1|||
147627276|NCT03331796|532453159|FG002|Extended Follow-up|Termination of Funding|0|||
147627277|NCT01791894|532453166|FG000|Overall Study|Adverse Event|1|||
147627278|NCT02268916|532453169|FG000|Overall Study|Lost to Follow-up|1|||
147627279|NCT02268916|532453170|FG001|Overall Study|Lost to Follow-up|1|||
147627280|NCT02268916|532453169|FG000|Overall Study|Withdrawal by Subject|6|||
147627281|NCT02268916|532453170|FG001|Overall Study|Withdrawal by Subject|5|||
147627282|NCT02268916|532453169|FG000|Overall Study|Participant did not have diabetes|1|||
147627283|NCT02268916|532453170|FG001|Overall Study|Participant did not have diabetes|0|||
147627284|NCT02268916|532453169|FG000|Overall Study|Did not complete home monitoring activities after baseline visit|9|||
147627285|NCT02268916|532453170|FG001|Overall Study|Did not complete home monitoring activities after baseline visit|4|||
147627286|NCT04526288|532453176|FG000|Overall Study|Disease Progression|1|||
147627287|NCT04526288|532453177|FG001|Overall Study|Disease Progression|0|||
147627288|NCT00594165|532453178|FG000|Overall Study|Major protocol violation|1|||
147627289|NCT00594165|532453178|FG000|Overall Study|Lack of Efficacy|12|||
147627290|NCT00594165|532453178|FG000|Overall Study|Adverse Event|52|||
147627291|NCT00594165|532453178|FG000|Overall Study|Unsatisfactory compliance of subject|6|||
147627292|NCT00594165|532453178|FG000|Overall Study|Subject withdrew consent|27|||
147627293|NCT00594165|532453178|FG000|Overall Study|Study ended per sponsor|102|||
147627294|NCT00594165|532453178|FG000|Overall Study|Lost to Follow-up|4|||
147627295|NCT00594165|532453178|FG000|Overall Study|Other: PI discretion|5|||
147627296|NCT00594165|532453178|FG000|Overall Study|Other: Subject moving|3|||
147627297|NCT00594165|532453178|FG000|Overall Study|Other: Brain surgery controlled symptoms|1|||
147627298|NCT00594165|532453178|FG000|Overall Study|Other: House bound; can't get to clinic|1|||
147627299|NCT00594165|532453178|FG000|Overall Study|Other: Subject enrolled in other trial|1|||
147627300|NCT00594165|532453178|FG000|Overall Study|Other: Site terminated participation|2|||
147495085|NCT02720016|531966725|FG001|Overall Study|Not Primary Health Concern|0|||
147495086|NCT02720016|531966726|FG002|Overall Study|Not Primary Health Concern|2|||
147495087|NCT02720016|531966724|FG000|Overall Study|Transportation issues|0|||
147495088|NCT02720016|531966725|FG001|Overall Study|Transportation issues|0|||
147627301|NCT04830969|532453179|FG000|Overall Study|Withdrawal by Subject|6|||
147627302|NCT04830969|532453180|FG001|Overall Study|Withdrawal by Subject|2|||
147668376|NCT02722967|532611758|FG001|Overall Study|Non-adherence of the patch to the skin|0|||
147627303|NCT04830969|532453179|FG000|Overall Study|Protocol Violation|3|||
147627304|NCT04830969|532453180|FG001|Overall Study|Protocol Violation|9|||
147627305|NCT04830969|532453179|FG000|Overall Study|Lost to Follow-up|4|||
147627306|NCT04830969|532453180|FG001|Overall Study|Lost to Follow-up|4|||
147495089|NCT02720016|531966726|FG002|Overall Study|Transportation issues|1|||
147495090|NCT02720016|531966724|FG000|Overall Study|Other|0|||
147495091|NCT02720016|531966725|FG001|Overall Study|Other|0|||
147495092|NCT02720016|531966726|FG002|Overall Study|Other|2|||
147495093|NCT00751114|531966729|FG000|Overall Study|Adverse Event|2|||
147627307|NCT01422889|532453181|FG000|Overall Study|No Data Entered for Study Stent|9|||
147627308|NCT01580670|532453182|FG000|Maintenance Period (Week 14 to 54)|Adverse Event|1|||
147627309|NCT01580670|532453182|FG000|Maintenance Period (Week 14 to 54)|Lack of Efficacy|1|||
147627310|NCT00996125|532453183|FG000|Overall Study|Adverse Event|0|||
147627311|NCT00996125|532453184|FG001|Overall Study|Adverse Event|2|||
147627312|NCT00996125|532453183|FG000|Overall Study|Lost to Follow-up|1|||
147627313|NCT00996125|532453184|FG001|Overall Study|Lost to Follow-up|6|||
147627314|NCT00996125|532453183|FG000|Overall Study|Withdrawal by Subject|4|||
147627315|NCT00996125|532453184|FG001|Overall Study|Withdrawal by Subject|3|||
147627316|NCT00488644|532453185|FG000|Overall Study|Not Eligible|1|||
147627317|NCT00488644|532453185|FG000|Overall Study|Not Evaluable|1|||
147627318|NCT04331067|532453186|FG000|Overall Study|Adverse Event|1|||
147627319|NCT04331067|532453187|FG001|Overall Study|Adverse Event|3|||
147627320|NCT04331067|532453188|FG002|Overall Study|Adverse Event|1|||
147627321|NCT04331067|532453186|FG000|Overall Study|Physician decision - patient not compliant with visits|1|||
147627322|NCT04331067|532453187|FG001|Overall Study|Physician decision - patient not compliant with visits|0|||
147627323|NCT04331067|532453188|FG002|Overall Study|Physician decision - patient not compliant with visits|0|||
147627324|NCT04926831|532453189|FG000|Overall Study|Withdrawal by Subject|2|||
147495094|NCT00751114|531966730|FG001|Overall Study|Adverse Event|4|||
147495095|NCT00751114|531966729|FG000|Overall Study|Protocol Violation|8|||
147495096|NCT00751114|531966730|FG001|Overall Study|Protocol Violation|9|||
147495097|NCT00751114|531966729|FG000|Overall Study|Withdrawal by Subject|9|||
147495098|NCT00751114|531966730|FG001|Overall Study|Withdrawal by Subject|4|||
147495099|NCT00751114|531966729|FG000|Overall Study|Lost to Follow-up|4|||
147495100|NCT00751114|531966730|FG001|Overall Study|Lost to Follow-up|7|||
147495101|NCT00751114|531966729|FG000|Overall Study|Lack of Efficacy|0|||
147495102|NCT00751114|531966730|FG001|Overall Study|Lack of Efficacy|7|||
147495103|NCT00751114|531966729|FG000|Overall Study|Not Treated|13|||
147495104|NCT00751114|531966730|FG001|Overall Study|Not Treated|1|||
147495105|NCT00751114|531966729|FG000|Overall Study|Out of country for 2 months|1|||
147495106|NCT00751114|531966730|FG001|Overall Study|Out of country for 2 months|0|||
147495107|NCT00751114|531966729|FG000|Overall Study|Move to another city|1|||
147495108|NCT00751114|531966730|FG001|Overall Study|Move to another city|0|||
147495109|NCT05319080|531966731|FG000|Overall Study|Withdrawal by Subject|2|||
147495110|NCT05319080|531966731|FG000|Overall Study|Physician Decision|4|||
147495111|NCT02358369|531966732|FG000|Pre-Randomization Washout Period|Not Qualified for Randomization|35|||
147495112|NCT02358369|531966733|FG001|Pre-Randomization Washout Period|Not Qualified for Randomization|0|||
147495113|NCT02358369|531966734|FG002|Pre-Randomization Washout Period|Not Qualified for Randomization|0|||
147495114|NCT02358369|531966735|FG003|Pre-Randomization Washout Period|Not Qualified for Randomization|0|||
147495115|NCT02358369|531966736|FG004|Pre-Randomization Washout Period|Not Qualified for Randomization|0|||
147495116|NCT02358369|531966732|FG000|Treatment Period A/B|Adverse Event|0|||
147495117|NCT02358369|531966733|FG001|Treatment Period A/B|Adverse Event|0|||
147495118|NCT02358369|531966734|FG002|Treatment Period A/B|Adverse Event|1|||
147495119|NCT02358369|531966735|FG003|Treatment Period A/B|Adverse Event|2|||
147495120|NCT02358369|531966736|FG004|Treatment Period A/B|Adverse Event|0|||
147495121|NCT02358369|531966732|FG000|Treatment Period A/B|Death|0|||
147495122|NCT02358369|531966733|FG001|Treatment Period A/B|Death|0|||
147495123|NCT02358369|531966734|FG002|Treatment Period A/B|Death|1|||
147495124|NCT02358369|531966735|FG003|Treatment Period A/B|Death|0|||
147495125|NCT02358369|531966736|FG004|Treatment Period A/B|Death|0|||
147495126|NCT02358369|531966732|FG000|Treatment Period A/B|Withdrawal by Subject|0|||
147495127|NCT02358369|531966733|FG001|Treatment Period A/B|Withdrawal by Subject|2|||
147495128|NCT02358369|531966734|FG002|Treatment Period A/B|Withdrawal by Subject|0|||
147495129|NCT02358369|531966735|FG003|Treatment Period A/B|Withdrawal by Subject|2|||
147495130|NCT02358369|531966736|FG004|Treatment Period A/B|Withdrawal by Subject|0|||
147495131|NCT02358369|531966732|FG000|Treatment Period C|Adverse Event|0|||
147495132|NCT02358369|531966733|FG001|Treatment Period C|Adverse Event|0|||
147495133|NCT02358369|531966734|FG002|Treatment Period C|Adverse Event|0|||
147495134|NCT02358369|531966735|FG003|Treatment Period C|Adverse Event|0|||
147495135|NCT02358369|531966736|FG004|Treatment Period C|Adverse Event|7|||
147495136|NCT00448916|531966737|FG000|Overall Study|Adverse Event|2|||
147495137|NCT00448916|531966738|FG001|Overall Study|Adverse Event|2|||
147668377|NCT02722967|532611759|FG002|Overall Study|Non-adherence of the patch to the skin|2|||
147495138|NCT00448916|531966739|FG002|Overall Study|Adverse Event|3|||
147495139|NCT00448916|531966740|FG003|Overall Study|Adverse Event|2|||
147495140|NCT00448916|531966737|FG000|Overall Study|Lack of Efficacy|1|||
147627325|NCT04926831|532453189|FG000|Overall Study|Adverse Event|2|||
147627326|NCT03859427|532453191|FG000|Overall Study|Withdrawal by Subject|4|||
147495141|NCT00448916|531966738|FG001|Overall Study|Lack of Efficacy|0|||
147495142|NCT00448916|531966739|FG002|Overall Study|Lack of Efficacy|2|||
147495143|NCT00448916|531966740|FG003|Overall Study|Lack of Efficacy|1|||
147495144|NCT00448916|531966737|FG000|Overall Study|Withdrawal by Subject|3|||
147495145|NCT00448916|531966738|FG001|Overall Study|Withdrawal by Subject|3|||
147627327|NCT03859427|532453192|FG001|Overall Study|Withdrawal by Subject|7|||
147627328|NCT03859427|532453191|FG000|Overall Study|Decision by sponsor|0|||
147627329|NCT03859427|532453192|FG001|Overall Study|Decision by sponsor|3|||
147627330|NCT03859427|532453191|FG000|Overall Study|Lost to Follow-up|3|||
147627331|NCT03859427|532453192|FG001|Overall Study|Lost to Follow-up|2|||
147627332|NCT03859427|532453191|FG000|Overall Study|Death|22|||
147627333|NCT03859427|532453192|FG001|Overall Study|Death|25|||
147627334|NCT01804946|532453194|FG000|Overall Study|Protocol Violation|1|||
147627335|NCT01804946|532453195|FG001|Overall Study|Protocol Violation|0|||
147627336|NCT01804946|532453194|FG000|Overall Study|Adverse Event|0|||
147627337|NCT01804946|532453195|FG001|Overall Study|Adverse Event|1|||
147627338|NCT01804946|532453194|FG000|Overall Study|Insufficient data available|0|||
147627339|NCT01804946|532453195|FG001|Overall Study|Insufficient data available|1|||
147627340|NCT01804946|532453194|FG000|Overall Study|Do not meet inclusion criteria|1|||
147627341|NCT01804946|532453195|FG001|Overall Study|Do not meet inclusion criteria|2|||
147627342|NCT03103152|532453196|FG000|Overall Study|Physician Decision|5|||
147627343|NCT03103152|532453197|FG001|Overall Study|Physician Decision|2|||
147627344|NCT03103152|532453198|FG002|Overall Study|Physician Decision|6|||
147627345|NCT03103152|532453199|FG003|Overall Study|Physician Decision|3|||
147627346|NCT03103152|532453200|FG004|Overall Study|Physician Decision|3|||
147627347|NCT03103152|532453201|FG005|Overall Study|Physician Decision|1|||
147627348|NCT03103152|532453196|FG000|Overall Study|Protocol Violation|2|||
147627349|NCT03103152|532453197|FG001|Overall Study|Protocol Violation|2|||
147627350|NCT03103152|532453198|FG002|Overall Study|Protocol Violation|1|||
147627351|NCT03103152|532453199|FG003|Overall Study|Protocol Violation|2|||
147627352|NCT03103152|532453200|FG004|Overall Study|Protocol Violation|1|||
147627353|NCT03103152|532453201|FG005|Overall Study|Protocol Violation|1|||
147627354|NCT03103152|532453196|FG000|Overall Study|Inter-current illness|0|||
147627355|NCT03103152|532453197|FG001|Overall Study|Inter-current illness|0|||
147627356|NCT03103152|532453198|FG002|Overall Study|Inter-current illness|1|||
147627357|NCT03103152|532453199|FG003|Overall Study|Inter-current illness|0|||
147627358|NCT03103152|532453200|FG004|Overall Study|Inter-current illness|0|||
147627359|NCT03103152|532453201|FG005|Overall Study|Inter-current illness|0|||
147627360|NCT03103152|532453196|FG000|Overall Study|Death|0|||
147627361|NCT03103152|532453197|FG001|Overall Study|Death|1|||
147627362|NCT03103152|532453198|FG002|Overall Study|Death|0|||
147627363|NCT03103152|532453199|FG003|Overall Study|Death|0|||
147627364|NCT03103152|532453200|FG004|Overall Study|Death|0|||
147627365|NCT03103152|532453201|FG005|Overall Study|Death|0|||
147627366|NCT03103152|532453196|FG000|Overall Study|Adverse Event|0|||
147627367|NCT03103152|532453197|FG001|Overall Study|Adverse Event|0|||
147627368|NCT03103152|532453198|FG002|Overall Study|Adverse Event|1|||
147627369|NCT03103152|532453199|FG003|Overall Study|Adverse Event|0|||
147627370|NCT03103152|532453200|FG004|Overall Study|Adverse Event|0|||
147627371|NCT03103152|532453201|FG005|Overall Study|Adverse Event|1|||
147627372|NCT03103152|532453196|FG000|Overall Study|Withdrawal by Subject|1|||
147627373|NCT03103152|532453197|FG001|Overall Study|Withdrawal by Subject|0|||
147627374|NCT03103152|532453198|FG002|Overall Study|Withdrawal by Subject|1|||
147627375|NCT03103152|532453199|FG003|Overall Study|Withdrawal by Subject|1|||
147627376|NCT03103152|532453200|FG004|Overall Study|Withdrawal by Subject|1|||
147627377|NCT03103152|532453201|FG005|Overall Study|Withdrawal by Subject|1|||
147627378|NCT03103152|532453196|FG000|Overall Study|Patient wishes to come off active surveillance|2|||
147627379|NCT03103152|532453197|FG001|Overall Study|Patient wishes to come off active surveillance|0|||
147627380|NCT03103152|532453198|FG002|Overall Study|Patient wishes to come off active surveillance|1|||
147627381|NCT03103152|532453199|FG003|Overall Study|Patient wishes to come off active surveillance|1|||
147627382|NCT03103152|532453200|FG004|Overall Study|Patient wishes to come off active surveillance|1|||
147627383|NCT03103152|532453201|FG005|Overall Study|Patient wishes to come off active surveillance|3|||
147627384|NCT03103152|532453196|FG000|Overall Study|Unacceptable side effects|0|||
147627385|NCT03103152|532453197|FG001|Overall Study|Unacceptable side effects|0|||
147627386|NCT03103152|532453198|FG002|Overall Study|Unacceptable side effects|0|||
147627387|NCT03103152|532453199|FG003|Overall Study|Unacceptable side effects|0|||
147627388|NCT03103152|532453200|FG004|Overall Study|Unacceptable side effects|0|||
147627389|NCT03103152|532453201|FG005|Overall Study|Unacceptable side effects|1|||
147627390|NCT03103152|532453196|FG000|Overall Study|Lost to Follow-up|0|||
147627391|NCT03103152|532453197|FG001|Overall Study|Lost to Follow-up|1|||
147627392|NCT03103152|532453198|FG002|Overall Study|Lost to Follow-up|0|||
147495146|NCT00448916|531966739|FG002|Overall Study|Withdrawal by Subject|1|||
147627393|NCT03103152|532453199|FG003|Overall Study|Lost to Follow-up|1|||
147627394|NCT03103152|532453200|FG004|Overall Study|Lost to Follow-up|0|||
147627395|NCT03103152|532453201|FG005|Overall Study|Lost to Follow-up|1|||
147627396|NCT03103152|532453196|FG000|Overall Study|Testicular pain|0|||
147627397|NCT03103152|532453197|FG001|Overall Study|Testicular pain|0|||
147627398|NCT03103152|532453198|FG002|Overall Study|Testicular pain|0|||
147627399|NCT03103152|532453199|FG003|Overall Study|Testicular pain|1|||
147627400|NCT03103152|532453200|FG004|Overall Study|Testicular pain|0|||
147627401|NCT03103152|532453201|FG005|Overall Study|Testicular pain|0|||
147627402|NCT03474965|532453202|FG000|Overall Study|Pregnancy|1|||
147627403|NCT03474965|532453203|FG001|Overall Study|Pregnancy|0|||
147627404|NCT03474965|532453204|FG002|Overall Study|Pregnancy|0|||
147627405|NCT03474965|532453205|FG003|Overall Study|Pregnancy|0|||
147627406|NCT03474965|532453202|FG000|Overall Study|Lost to Follow-up|0|||
147627407|NCT03474965|532453203|FG001|Overall Study|Lost to Follow-up|0|||
147627408|NCT03474965|532453204|FG002|Overall Study|Lost to Follow-up|1|||
147627409|NCT03474965|532453205|FG003|Overall Study|Lost to Follow-up|0|||
147627410|NCT03474965|532453202|FG000|Overall Study|Death|1|||
147627411|NCT03474965|532453203|FG001|Overall Study|Death|0|||
147627412|NCT03474965|532453204|FG002|Overall Study|Death|0|||
147627413|NCT03474965|532453205|FG003|Overall Study|Death|0|||
147627414|NCT03474965|532453202|FG000|Overall Study|Adverse Event|1|||
147627415|NCT03474965|532453203|FG001|Overall Study|Adverse Event|0|||
147627416|NCT03474965|532453204|FG002|Overall Study|Adverse Event|0|||
147627417|NCT03474965|532453205|FG003|Overall Study|Adverse Event|1|||
147627418|NCT03474965|532453202|FG000|Overall Study|Physician Decision|3|||
147627419|NCT03474965|532453203|FG001|Overall Study|Physician Decision|1|||
147627420|NCT03474965|532453204|FG002|Overall Study|Physician Decision|2|||
147627421|NCT03474965|532453205|FG003|Overall Study|Physician Decision|0|||
147627422|NCT03474965|532453202|FG000|Overall Study|Participant Decision|7|||
147627423|NCT03474965|532453203|FG001|Overall Study|Participant Decision|0|||
147627424|NCT03474965|532453204|FG002|Overall Study|Participant Decision|1|||
147627425|NCT03474965|532453205|FG003|Overall Study|Participant Decision|0|||
147627426|NCT03474965|532453202|FG000|Overall Study|Guardian Decision|4|||
147627427|NCT03474965|532453203|FG001|Overall Study|Guardian Decision|2|||
147627428|NCT03474965|532453204|FG002|Overall Study|Guardian Decision|7|||
147627429|NCT03474965|532453205|FG003|Overall Study|Guardian Decision|2|||
147627430|NCT03100903|532454908|FG000|Overall Study|Withdrawal by Subject|0|||
147627431|NCT03100903|532454909|FG001|Overall Study|Withdrawal by Subject|0|||
147627432|NCT03100903|532454910|FG002|Overall Study|Withdrawal by Subject|1|||
147627433|NCT04659993|532454911|FG000|Overall Study|Withdrawal by Subject|2|||
147627434|NCT04659993|532454911|FG000|Overall Study|Lost to Follow-up|2|||
147627435|NCT01295671|532454912|FG000|Overall Study|Lost to Follow-up|4|||
147627436|NCT01295671|532454913|FG001|Overall Study|Lost to Follow-up|6|||
147627437|NCT01295671|532454914|FG002|Overall Study|Lost to Follow-up|3|||
147627438|NCT01295671|532454912|FG000|Overall Study|Withdrawal by Subject|3|||
147627439|NCT01295671|532454913|FG001|Overall Study|Withdrawal by Subject|1|||
147627440|NCT01295671|532454914|FG002|Overall Study|Withdrawal by Subject|0|||
147627441|NCT01436370|532454917|FG000|Overall Study|Lost to Follow-up|0|||
147627442|NCT01436370|532454918|FG001|Overall Study|Lost to Follow-up|0|||
147627443|NCT01436370|532454919|FG002|Overall Study|Lost to Follow-up|0|||
147627444|NCT01436370|532454920|FG003|Overall Study|Lost to Follow-up|0|||
147627445|NCT01436370|532454921|FG004|Overall Study|Lost to Follow-up|1|||
147627446|NCT01436370|532454922|FG005|Overall Study|Lost to Follow-up|0|||
147627447|NCT01436370|532454923|FG006|Overall Study|Lost to Follow-up|0|||
147627448|NCT01436370|532454924|FG007|Overall Study|Lost to Follow-up|0|||
147627449|NCT02395848|532454925|FG000|Overall Study|Lost to Follow-up|2|||
147627450|NCT01754129|532454926|FG000|Overall Study|Death|13|||
147627451|NCT01754129|532454926|FG000|Overall Study|Duodopa discontinuation|9|||
147627452|NCT01754129|532454926|FG000|Overall Study|Lost to Follow-up|7|||
147627453|NCT01754129|532454926|FG000|Overall Study|Withdrew consent|1|||
147627454|NCT01754129|532454926|FG000|Overall Study|Inclusion/exclusion criteria violation|3|||
147627455|NCT02276560|532454927|FG000|Overall Study|Adverse Event|1|||
147627456|NCT02276560|532454928|FG001|Overall Study|Adverse Event|0|||
147627457|NCT02276560|532454929|FG002|Overall Study|Adverse Event|0|||
147627458|NCT02609607|532454936|FG000|Overall Study|Lost to Follow-up|0|||
147627459|NCT02609607|532454937|FG001|Overall Study|Lost to Follow-up|1|||
147627460|NCT00651261|532454938|FG000|Overall Study|Adverse Event|32|||
147627461|NCT00651261|532454939|FG001|Overall Study|Adverse Event|22|||
147627462|NCT00651261|532454938|FG000|Overall Study|Death|18|||
147627463|NCT00651261|532454939|FG001|Overall Study|Death|18|||
147627464|NCT00651261|532454938|FG000|Overall Study|Withdrawal by Subject|22|||
147627465|NCT00651261|532454939|FG001|Overall Study|Withdrawal by Subject|40|||
147627466|NCT00651261|532454938|FG000|Overall Study|Induction failure|24|||
147627467|NCT00651261|532454939|FG001|Overall Study|Induction failure|35|||
147627468|NCT00651261|532454938|FG000|Overall Study|Disease progression|58|||
147627469|NCT00651261|532454939|FG001|Overall Study|Disease progression|58|||
147627470|NCT00651261|532454938|FG000|Overall Study|Alternative therapy|109|||
147627471|NCT00651261|532454939|FG001|Overall Study|Alternative therapy|107|||
147627472|NCT00651261|532454938|FG000|Overall Study|Other disease or participant decisions|23|||
147627473|NCT00651261|532454939|FG001|Overall Study|Other disease or participant decisions|23|||
147627474|NCT00651261|532454938|FG000|Overall Study|Never treated|5|||
147627475|NCT00651261|532454939|FG001|Overall Study|Never treated|3|||
147627476|NCT02027545|532454941|FG000|Overall Study|Failed to sign HIPAA|0|||
147417949|NCT00700427|531694566|FG003|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|11|||
147627477|NCT02027545|532454942|FG001|Overall Study|Failed to sign HIPAA|2|||
147627478|NCT02027545|532454941|FG000|Overall Study|Failed to attend study visit|2|||
147627479|NCT02027545|532454942|FG001|Overall Study|Failed to attend study visit|0|||
147627480|NCT02027545|532454941|FG000|Overall Study|Protocol Violation|1|||
147627481|NCT02027545|532454942|FG001|Overall Study|Protocol Violation|0|||
147627482|NCT04610346|532454943|FG000|Overall Study|Withdrawal by Subject|1|||
147627483|NCT04610346|532454944|FG001|Overall Study|Withdrawal by Subject|1|||
147627484|NCT04610346|532454943|FG000|Overall Study|did not complete shelter onboarding|2|||
147627485|NCT04610346|532454944|FG001|Overall Study|did not complete shelter onboarding|1|||
147627486|NCT03309943|532454946|FG000|Overall Study|Withdrawal by Subject|0|||
147627487|NCT03309943|532454947|FG001|Overall Study|Withdrawal by Subject|1|||
147627488|NCT03309943|532454946|FG000|Overall Study|Inappropriate behavior towards staff|0|||
147495147|NCT00448916|531966740|FG003|Overall Study|Withdrawal by Subject|1|||
147495148|NCT00448916|531966737|FG000|Overall Study|Other|1|||
147495149|NCT00448916|531966738|FG001|Overall Study|Other|0|||
147495150|NCT00448916|531966739|FG002|Overall Study|Other|0|||
147495151|NCT00448916|531966740|FG003|Overall Study|Other|0|||
147495152|NCT00448916|531966737|FG000|Overall Study|Lost to Follow-up|0|||
147495153|NCT00448916|531966738|FG001|Overall Study|Lost to Follow-up|1|||
147495154|NCT00448916|531966739|FG002|Overall Study|Lost to Follow-up|0|||
147495155|NCT00448916|531966740|FG003|Overall Study|Lost to Follow-up|1|||
147495156|NCT00448916|531966737|FG000|Overall Study|Protocol Violation|0|||
147495157|NCT00448916|531966738|FG001|Overall Study|Protocol Violation|0|||
147495158|NCT00448916|531966739|FG002|Overall Study|Protocol Violation|0|||
147495159|NCT00448916|531966740|FG003|Overall Study|Protocol Violation|1|||
147495160|NCT03655717|531966741|FG000|Overall Study|Withdrawal by Subject|4|||
147495161|NCT03655717|531966742|FG001|Overall Study|Withdrawal by Subject|8|||
147495162|NCT03655717|531966743|FG002|Overall Study|Withdrawal by Subject|1|||
147495163|NCT03655717|531966744|FG003|Overall Study|Withdrawal by Subject|0|||
147495164|NCT03655717|531966745|FG004|Overall Study|Withdrawal by Subject|0|||
147495165|NCT03655717|531966746|FG005|Overall Study|Withdrawal by Subject|1|||
147495166|NCT03655717|531966747|FG006|Overall Study|Withdrawal by Subject|3|||
147495167|NCT03655717|531966748|FG007|Overall Study|Withdrawal by Subject|1|||
147495168|NCT03655717|531966749|FG008|Overall Study|Withdrawal by Subject|2|||
147495169|NCT03655717|531966750|FG009|Overall Study|Withdrawal by Subject|0|||
147495170|NCT03655717|531966751|FG010|Overall Study|Withdrawal by Subject|0|||
147495171|NCT03655717|531966752|FG011|Overall Study|Withdrawal by Subject|1|||
147495172|NCT03655717|531966753|FG012|Overall Study|Withdrawal by Subject|0|||
147495173|NCT03655717|531966754|FG013|Overall Study|Withdrawal by Subject|3|||
147495174|NCT03655717|531966755|FG014|Overall Study|Withdrawal by Subject|0|||
147495175|NCT03655717|531966756|FG015|Overall Study|Withdrawal by Subject|1|||
147495176|NCT03655717|531966757|FG016|Overall Study|Withdrawal by Subject|0|||
147495177|NCT03655717|531966758|FG017|Overall Study|Withdrawal by Subject|0|||
147495178|NCT03655717|531966759|FG018|Overall Study|Withdrawal by Subject|1|||
147495179|NCT03655717|531966760|FG019|Overall Study|Withdrawal by Subject|0|||
147495180|NCT03655717|531966761|FG020|Overall Study|Withdrawal by Subject|0|||
147495181|NCT03655717|531966762|FG021|Overall Study|Withdrawal by Subject|1|||
147495182|NCT03655717|531966763|FG022|Overall Study|Withdrawal by Subject|2|||
147495183|NCT03655717|531966764|FG023|Overall Study|Withdrawal by Subject|1|||
147495184|NCT03655717|531966765|FG024|Overall Study|Withdrawal by Subject|1|||
147495185|NCT03655717|531966766|FG025|Overall Study|Withdrawal by Subject|0|||
147495186|NCT03655717|531966741|FG000|Overall Study|Physician Decision|3|||
147495187|NCT03655717|531966742|FG001|Overall Study|Physician Decision|3|||
147495188|NCT03655717|531966743|FG002|Overall Study|Physician Decision|0|||
147495189|NCT03655717|531966744|FG003|Overall Study|Physician Decision|0|||
147495190|NCT03655717|531966745|FG004|Overall Study|Physician Decision|0|||
147495191|NCT03655717|531966746|FG005|Overall Study|Physician Decision|0|||
147495192|NCT03655717|531966747|FG006|Overall Study|Physician Decision|0|||
147495193|NCT03655717|531966748|FG007|Overall Study|Physician Decision|0|||
147495194|NCT03655717|531966749|FG008|Overall Study|Physician Decision|0|||
147495195|NCT03655717|531966750|FG009|Overall Study|Physician Decision|1|||
147495196|NCT03655717|531966751|FG010|Overall Study|Physician Decision|0|||
147495197|NCT03655717|531966752|FG011|Overall Study|Physician Decision|0|||
147495198|NCT03655717|531966753|FG012|Overall Study|Physician Decision|0|||
147495199|NCT03655717|531966754|FG013|Overall Study|Physician Decision|0|||
147495200|NCT03655717|531966755|FG014|Overall Study|Physician Decision|0|||
147495201|NCT03655717|531966756|FG015|Overall Study|Physician Decision|0|||
147627489|NCT03309943|532454947|FG001|Overall Study|Inappropriate behavior towards staff|1|||
147627490|NCT02019264|532454958|FG000|Overall Study|Not treated|6|||
147627491|NCT02019264|532454959|FG001|Overall Study|Not treated|4|||
147627492|NCT02019264|532454958|FG000|Overall Study|Lost to Follow-up|50|||
147627493|NCT02019264|532454959|FG001|Overall Study|Lost to Follow-up|47|||
147495202|NCT03655717|531966757|FG016|Overall Study|Physician Decision|0|||
147495203|NCT03655717|531966758|FG017|Overall Study|Physician Decision|0|||
147495204|NCT03655717|531966759|FG018|Overall Study|Physician Decision|0|||
147495205|NCT03655717|531966760|FG019|Overall Study|Physician Decision|1|||
147495206|NCT03655717|531966761|FG020|Overall Study|Physician Decision|0|||
147495207|NCT03655717|531966762|FG021|Overall Study|Physician Decision|0|||
147495208|NCT03655717|531966763|FG022|Overall Study|Physician Decision|0|||
147495209|NCT03655717|531966764|FG023|Overall Study|Physician Decision|1|||
147495210|NCT03655717|531966765|FG024|Overall Study|Physician Decision|0|||
147495211|NCT03655717|531966766|FG025|Overall Study|Physician Decision|0|||
147495212|NCT03655717|531966741|FG000|Overall Study|Lost to Follow-up|3|||
147495213|NCT03655717|531966742|FG001|Overall Study|Lost to Follow-up|1|||
147495214|NCT03655717|531966743|FG002|Overall Study|Lost to Follow-up|0|||
147495215|NCT03655717|531966744|FG003|Overall Study|Lost to Follow-up|1|||
147627494|NCT02019264|532454958|FG000|Overall Study|Withdrawal by Subject|142|||
147627495|NCT02019264|532454959|FG001|Overall Study|Withdrawal by Subject|117|||
147627496|NCT02019264|532454958|FG000|Overall Study|Administrative reason|36|||
147627497|NCT02019264|532454959|FG001|Overall Study|Administrative reason|28|||
147627498|NCT02019264|532454958|FG000|Overall Study|Missing|14|||
147627499|NCT02019264|532454959|FG001|Overall Study|Missing|11|||
147627500|NCT01297517|532454962|FG000|Overall Study|Adverse Event|21|||
147627501|NCT01297517|532454963|FG001|Overall Study|Adverse Event|7|||
147627502|NCT01297517|532454964|FG002|Overall Study|Adverse Event|16|||
147627503|NCT01297517|532454962|FG000|Overall Study|Lost to Follow-up|1|||
147627504|NCT01297517|532454963|FG001|Overall Study|Lost to Follow-up|0|||
147627505|NCT01297517|532454964|FG002|Overall Study|Lost to Follow-up|1|||
147627506|NCT01297517|532454962|FG000|Overall Study|Patient Decision Unrelated to AE|2|||
147627507|NCT01297517|532454963|FG001|Overall Study|Patient Decision Unrelated to AE|3|||
147627508|NCT01297517|532454964|FG002|Overall Study|Patient Decision Unrelated to AE|7|||
147627509|NCT01297517|532454962|FG000|Overall Study|Noncompliance|1|||
147627510|NCT01297517|532454963|FG001|Overall Study|Noncompliance|0|||
147627511|NCT01297517|532454964|FG002|Overall Study|Noncompliance|0|||
147627512|NCT01297517|532454962|FG000|Overall Study|Protocol Violation|1|||
147627513|NCT01297517|532454963|FG001|Overall Study|Protocol Violation|1|||
147627514|NCT01297517|532454964|FG002|Overall Study|Protocol Violation|1|||
147627515|NCT01297517|532454962|FG000|Overall Study|Inadequate Control of IOP|1|||
147627516|NCT01297517|532454963|FG001|Overall Study|Inadequate Control of IOP|1|||
147627517|NCT01297517|532454964|FG002|Overall Study|Inadequate Control of IOP|2|||
147627518|NCT01609296|532454965|FG000|Overall Study|Death|253|||
147627519|NCT01609296|532454965|FG000|Overall Study|Withdrawal by Subject|151|||
147627520|NCT01609296|532454965|FG000|Overall Study|Lost to Follow-up|21|||
147627521|NCT01609296|532454965|FG000|Overall Study|Exit reason other than withdrawal, death or lost to follow up|35|||
147627522|NCT01609296|532454965|FG000|Overall Study|missed visit but known to be alive|28|||
147627523|NCT00386360|532454966|FG000|Overall Study|Adverse Event|4|||
147627524|NCT00386360|532454967|FG001|Overall Study|Adverse Event|2|||
147627525|NCT00386360|532454966|FG000|Overall Study|Physician Decision|2|||
147627526|NCT00386360|532454967|FG001|Overall Study|Physician Decision|2|||
147627527|NCT00386360|532454966|FG000|Overall Study|Lost to Follow-up|0|||
147627528|NCT00386360|532454967|FG001|Overall Study|Lost to Follow-up|2|||
147627529|NCT00386360|532454966|FG000|Overall Study|Protocol Violation|0|||
147627530|NCT00386360|532454967|FG001|Overall Study|Protocol Violation|3|||
147627531|NCT00386360|532454966|FG000|Overall Study|Withdrawal by Subject|3|||
147627532|NCT00386360|532454967|FG001|Overall Study|Withdrawal by Subject|6|||
147627533|NCT00386360|532454966|FG000|Overall Study|Did not take any study medication|0|||
147627534|NCT00386360|532454967|FG001|Overall Study|Did not take any study medication|2|||
147627535|NCT00628212|532454968|FG000|Overall Study|Adverse Event|2|||
147627536|NCT00628212|532454969|FG001|Overall Study|Adverse Event|0|||
147627537|NCT00628212|532454970|FG002|Overall Study|Adverse Event|1|||
147627538|NCT00628212|532454971|FG003|Overall Study|Adverse Event|2|||
147627539|NCT00628212|532454968|FG000|Overall Study|Physician Decision|1|||
147627540|NCT00628212|532454969|FG001|Overall Study|Physician Decision|1|||
147627541|NCT00628212|532454970|FG002|Overall Study|Physician Decision|2|||
147627542|NCT00628212|532454971|FG003|Overall Study|Physician Decision|3|||
147627543|NCT02914613|532454972|FG000|Overall Study|Withdrawal by Subject|1|||
147627544|NCT02914613|532454973|FG001|Overall Study|Withdrawal by Subject|2|||
147627545|NCT02914613|532454972|FG000|Overall Study|Adverse Event|1|||
147627546|NCT02914613|532454973|FG001|Overall Study|Adverse Event|0|||
147627547|NCT00546377|532454974|FG000|Overall Study|Deemed ineligible|1|||
147627548|NCT00546377|532454974|FG000|Overall Study|Adverse Event|6|||
147627549|NCT03850496|532454979|FG000|Overall Study|Withdrawal by Subject|1|||
147627550|NCT03850496|532454980|FG001|Overall Study|Withdrawal by Subject|0|||
147627551|NCT03850496|532454981|FG002|Overall Study|Withdrawal by Subject|0|||
147627552|NCT03850496|532454979|FG000|Overall Study|Lost to Follow-up|0|||
147627553|NCT03850496|532454980|FG001|Overall Study|Lost to Follow-up|1|||
147627554|NCT03850496|532454981|FG002|Overall Study|Lost to Follow-up|4|||
147627555|NCT00869999|532454989|FG000|Overall Study|Withdrawal by Subject|1|||
147627556|NCT00869999|532454989|FG000|Overall Study|removed prior to starting therapy|1|||
147627557|NCT03363776|532454992|FG000|Overall Study|Progressive disease|2|||
147627558|NCT03363776|532454993|FG001|Overall Study|Progressive disease|3|||
147627559|NCT03363776|532454994|FG002|Overall Study|Progressive disease|1|||
147627560|NCT03363776|532454992|FG000|Overall Study|Study drug toxicity|0|||
147627561|NCT03363776|532454993|FG001|Overall Study|Study drug toxicity|0|||
147627562|NCT03363776|532454994|FG002|Overall Study|Study drug toxicity|1|||
147627563|NCT03363776|532454992|FG000|Overall Study|Death|1|||
147627564|NCT03363776|532454993|FG001|Overall Study|Death|0|||
147627565|NCT03363776|532454994|FG002|Overall Study|Death|0|||
147627566|NCT04157348|532454995|FG000|Double-blind Treatment Period|other reasons or due to COVID-19|1|||
147627567|NCT04157348|532454996|FG001|Double-blind Treatment Period|other reasons or due to COVID-19|1|||
147627568|NCT04157348|532454995|FG000|Double-blind Treatment Period|Withdrawal by Subject|0|||
147627569|NCT04157348|532454996|FG001|Double-blind Treatment Period|Withdrawal by Subject|1|||
147627570|NCT04157348|532454995|FG000|Double-blind Treatment Period|Adverse Event|0|||
147627571|NCT04157348|532454996|FG001|Double-blind Treatment Period|Adverse Event|1|||
147627572|NCT04157348|532454995|FG000|Open-label Extension Period|Adverse Event|1|||
147627573|NCT04157348|532454996|FG001|Open-label Extension Period|Adverse Event|1|||
147627574|NCT04157348|532454995|FG000|Open-label Extension Period|Death|0|||
147627575|NCT04157348|532454996|FG001|Open-label Extension Period|Death|1|||
147627576|NCT04157348|532454995|FG000|Open-label Extension Period|Lack of Efficacy|2|||
147627577|NCT04157348|532454996|FG001|Open-label Extension Period|Lack of Efficacy|2|||
147627578|NCT04157348|532454995|FG000|Open-label Extension Period|Withdrawal by Subject|2|||
147627579|NCT04157348|532454996|FG001|Open-label Extension Period|Withdrawal by Subject|0|||
147627580|NCT04157348|532454995|FG000|Open-label Extension Period|Ongoing|60|||
147627581|NCT04157348|532454996|FG001|Open-label Extension Period|Ongoing|57|||
147627582|NCT04157348|532454995|FG000|Open-label Extension Period|other reasons|1|||
147627583|NCT04157348|532454996|FG001|Open-label Extension Period|other reasons|1|||
147627584|NCT02527434|532454997|FG000|Overall Study|Lost to Follow-up|2|||
147627585|NCT02527434|532454998|FG001|Overall Study|Lost to Follow-up|2|||
147627586|NCT02527434|532454999|FG002|Overall Study|Lost to Follow-up|0|||
147627587|NCT02527434|532454997|FG000|Overall Study|Death|19|||
147627588|NCT02527434|532454998|FG001|Overall Study|Death|6|||
147627589|NCT02527434|532454999|FG002|Overall Study|Death|17|||
147627590|NCT02527434|532454997|FG000|Overall Study|Withdrawal by Subject|5|||
147627591|NCT02527434|532454998|FG001|Overall Study|Withdrawal by Subject|3|||
147627592|NCT02527434|532454999|FG002|Overall Study|Withdrawal by Subject|3|||
147627593|NCT02527434|532454997|FG000|Overall Study|Reason Not Specified|1|||
147627594|NCT02527434|532454998|FG001|Overall Study|Reason Not Specified|0|||
147627595|NCT02527434|532454999|FG002|Overall Study|Reason Not Specified|0|||
147627596|NCT02527434|532454997|FG000|Overall Study|Site closure|1|||
147627597|NCT02527434|532454998|FG001|Overall Study|Site closure|0|||
147627598|NCT02527434|532454999|FG002|Overall Study|Site closure|0|||
147627599|NCT00568061|532455000|FG000|Overall Study|Inclusion / exclusion criteria|5|||
147627600|NCT00568061|532455001|FG001|Overall Study|Inclusion / exclusion criteria|1|||
147627601|NCT00568061|532455000|FG000|Overall Study|Adverse Event|0|||
147627602|NCT00568061|532455001|FG001|Overall Study|Adverse Event|1|||
147627603|NCT05027451|532455002|FG000|Overall Study|Lost to Follow-up|1|||
147627604|NCT05027451|532455003|FG001|Overall Study|Lost to Follow-up|1|||
147627605|NCT02693002|532455005|FG000|Overall Study|Withdrawal by Subject|1|||
147627606|NCT02693002|532455006|FG001|Overall Study|Withdrawal by Subject|0|||
147627607|NCT01753570|532455009|FG000|Overall Study|Adverse Event|1|||
147627608|NCT01753570|532455010|FG001|Overall Study|Adverse Event|0|||
147627609|NCT01753570|532455011|FG002|Overall Study|Adverse Event|1|||
147627610|NCT01753570|532455009|FG000|Overall Study|Physician Decision|0|||
147627611|NCT01753570|532455010|FG001|Overall Study|Physician Decision|1|||
147627612|NCT01753570|532455011|FG002|Overall Study|Physician Decision|0|||
147627613|NCT01753570|532455009|FG000|Overall Study|Withdrawal by Subject|1|||
147627614|NCT01753570|532455010|FG001|Overall Study|Withdrawal by Subject|4|||
147627615|NCT01753570|532455011|FG002|Overall Study|Withdrawal by Subject|0|||
147627616|NCT02062450|532455013|FG000|Overall Study|No follow-up visit|124|||
147627617|NCT02203721|532455016|FG000|Overall Study|Lost to Follow-up|1|||
147627618|NCT02203721|532455017|FG001|Overall Study|Lost to Follow-up|0|||
147627619|NCT02203721|532455016|FG000|Overall Study|Death|0|||
147627620|NCT02203721|532455017|FG001|Overall Study|Death|2|||
147627621|NCT02203721|532455016|FG000|Overall Study|Illness|0|||
147627622|NCT02203721|532455017|FG001|Overall Study|Illness|1|||
147627623|NCT04745689|532455018|FG000|Overall Study|Death|9|||
147627624|NCT04745689|532455019|FG001|Overall Study|Death|6|||
147627625|NCT04745689|532455018|FG000|Overall Study|Lost to Follow-up|1|||
147627626|NCT04745689|532455019|FG001|Overall Study|Lost to Follow-up|0|||
147627627|NCT04745689|532455018|FG000|Overall Study|Withdrawal by Subject|2|||
147627628|NCT04745689|532455019|FG001|Overall Study|Withdrawal by Subject|0|||
147627629|NCT04745689|532455018|FG000|Overall Study|Study terminated by sponsor|10|||
147627630|NCT04745689|532455019|FG001|Overall Study|Study terminated by sponsor|3|||
147627631|NCT00153179|532455020|FG000|Study Visit Day 2|Withdrawal by Subject|1|||
147627632|NCT00153179|532455021|FG001|Study Visit Day 2|Withdrawal by Subject|0|||
147627633|NCT00153179|532455022|FG002|Study Visit Day 2|Withdrawal by Subject|2|||
147627634|NCT00153179|532455023|FG003|Study Visit Day 2|Withdrawal by Subject|2|||
147627635|NCT02640664|532455028|FG000|Epoch 1|Withdrawal of informed consent|1|||
147627636|NCT02640664|532455029|FG001|Epoch 1|Withdrawal of informed consent|0|||
147627637|NCT02640664|532455030|FG002|Epoch 1|Withdrawal of informed consent|0|||
147627638|NCT02640664|532455028|FG000|Epoch 1|Death|0|||
147627639|NCT02640664|532455029|FG001|Epoch 1|Death|0|||
147627640|NCT02640664|532455030|FG002|Epoch 1|Death|1|||
147627641|NCT02640664|532455028|FG000|Epoch 2|Withdrawal of informed consent|3|||
147627642|NCT02640664|532455029|FG001|Epoch 2|Withdrawal of informed consent|4|||
147627643|NCT02640664|532455030|FG002|Epoch 2|Withdrawal of informed consent|2|||
147627644|NCT02640664|532455028|FG000|Epoch 2|Subject/guardian decision|0|||
147627645|NCT02640664|532455029|FG001|Epoch 2|Subject/guardian decision|2|||
147627646|NCT02640664|532455030|FG002|Epoch 2|Subject/guardian decision|2|||
147627647|NCT02640664|532455028|FG000|Epoch 2|Lost to Follow-up|3|||
147627648|NCT02640664|532455029|FG001|Epoch 2|Lost to Follow-up|4|||
147627649|NCT02640664|532455030|FG002|Epoch 2|Lost to Follow-up|1|||
147627650|NCT02640664|532455028|FG000|Epoch 2|Death|0|||
147627651|NCT02640664|532455029|FG001|Epoch 2|Death|0|||
147627652|NCT02640664|532455030|FG002|Epoch 2|Death|1|||
147627653|NCT00314327|532455031|FG000|Overall Study|Withdrawal by Subject|1|||
147627654|NCT01408303|532455032|FG000|Overall Study|Adverse Event|3|||
147627655|NCT01408303|532455033|FG001|Overall Study|Adverse Event|7|||
147627656|NCT01408303|532455034|FG002|Overall Study|Adverse Event|2|||
147627657|NCT01408303|532455032|FG000|Overall Study|Lost to Follow-up|0|||
147627658|NCT01408303|532455033|FG001|Overall Study|Lost to Follow-up|1|||
147627659|NCT01408303|532455034|FG002|Overall Study|Lost to Follow-up|2|||
147627660|NCT01408303|532455032|FG000|Overall Study|Withdrawal by Subject|2|||
147627661|NCT01408303|532455033|FG001|Overall Study|Withdrawal by Subject|3|||
147627662|NCT01408303|532455034|FG002|Overall Study|Withdrawal by Subject|1|||
147627663|NCT01408303|532455032|FG000|Overall Study|Protocol Violation|0|||
147627664|NCT01408303|532455033|FG001|Overall Study|Protocol Violation|1|||
147627665|NCT01408303|532455034|FG002|Overall Study|Protocol Violation|0|||
147627666|NCT01408303|532455032|FG000|Overall Study|Noncompliance|1|||
147627667|NCT01408303|532455033|FG001|Overall Study|Noncompliance|0|||
147627668|NCT01408303|532455034|FG002|Overall Study|Noncompliance|1|||
147627669|NCT00669669|532455036|FG000|Overall Study|To late to start treatment|1|||
147627670|NCT01205776|532455040|FG000|Overall Study|Lost to Follow-up|53|||
147627671|NCT01205776|532455041|FG001|Overall Study|Lost to Follow-up|61|||
147627672|NCT01205776|532455040|FG000|Overall Study|Withdrawal by Subject|11|||
147627673|NCT01205776|532455041|FG001|Overall Study|Withdrawal by Subject|34|||
147627674|NCT04031846|532455044|FG000|Overall Study|Lost to Follow-up|4|||
147627675|NCT04031846|532455045|FG001|Overall Study|Lost to Follow-up|4|||
147627676|NCT04031846|532455044|FG000|Overall Study|Physician Decision|0|||
147627677|NCT04031846|532455045|FG001|Overall Study|Physician Decision|1|||
147627678|NCT04031846|532455044|FG000|Overall Study|Protocol Violation|1|||
147627679|NCT04031846|532455045|FG001|Overall Study|Protocol Violation|1|||
147627680|NCT04031846|532455044|FG000|Overall Study|Withdrawal By Parent/Guardian|17|||
147627681|NCT04031846|532455045|FG001|Overall Study|Withdrawal By Parent/Guardian|17|||
147627682|NCT04541589|532456826|FG000|Treatment Period|Adverse Event|8|||
147627683|NCT04541589|532456827|FG001|Treatment Period|Adverse Event|2|||
147627684|NCT04541589|532456826|FG000|Treatment Period|Physician Decision|3|||
147627685|NCT04541589|532456827|FG001|Treatment Period|Physician Decision|1|||
147627686|NCT04541589|532456826|FG000|Treatment Period|Subject decision|7|||
147627687|NCT04541589|532456827|FG001|Treatment Period|Subject decision|4|||
147627688|NCT04541589|532456826|FG000|Treatment Period|Withdrawal by Subject|1|||
147627689|NCT04541589|532456827|FG001|Treatment Period|Withdrawal by Subject|0|||
147627690|NCT04541589|532456826|FG000|Safety Follow-up Period|Adverse Event|2|||
147627691|NCT04541589|532456827|FG001|Safety Follow-up Period|Adverse Event|1|||
147627692|NCT04541589|532456826|FG000|Safety Follow-up Period|Physician Decision|1|||
147627693|NCT04541589|532456827|FG001|Safety Follow-up Period|Physician Decision|0|||
147627694|NCT04541589|532456826|FG000|Safety Follow-up Period|Subject decision|5|||
147627695|NCT04541589|532456827|FG001|Safety Follow-up Period|Subject decision|3|||
147627696|NCT04541589|532456826|FG000|Safety Follow-up Period|Withdrawal by Subject|1|||
147627697|NCT04541589|532456827|FG001|Safety Follow-up Period|Withdrawal by Subject|1|||
147627698|NCT02727478|532456828|FG000|Overall Study|Withdrawal by Subject|8|||
147627699|NCT02727478|532456829|FG001|Overall Study|Withdrawal by Subject|10|||
147627700|NCT02633293|532456830|FG000|Overall Study|Death|56|||
147627701|NCT02633293|532456830|FG000|Overall Study|Progressive Disease|12|||
147627702|NCT02633293|532456830|FG000|Overall Study|Adverse Event|29|||
147627703|NCT02633293|532456830|FG000|Overall Study|Withdrawal by Subject|41|||
147627704|NCT02633293|532456830|FG000|Overall Study|Protocol Violation|1|||
147627705|NCT02633293|532456830|FG000|Overall Study|Lost to Follow-up|1|||
147627706|NCT02633293|532456830|FG000|Overall Study|Study Terminated by Sponsor|24|||
147627707|NCT02633293|532456830|FG000|Overall Study|Withdrawal by Sponsor Prior to Dose Administration|1|||
147627708|NCT02633293|532456830|FG000|Overall Study|Lung Transplant|5|||
147627709|NCT02633293|532456830|FG000|Overall Study|Lack of Efficacy|2|||
147627710|NCT02633293|532456830|FG000|Overall Study|Principal Investigator Terminated Study Site|1|||
147627711|NCT01017874|532456831|FG000|Overall Study|Withdrawal by Subject|23|||
147627712|NCT01017874|532456832|FG001|Overall Study|Withdrawal by Subject|20|||
147495216|NCT03655717|531966745|FG004|Overall Study|Lost to Follow-up|0|||
147495217|NCT03655717|531966746|FG005|Overall Study|Lost to Follow-up|1|||
147627713|NCT01017874|532456831|FG000|Overall Study|Sponsor decision|3|||
147627714|NCT01017874|532456832|FG001|Overall Study|Sponsor decision|1|||
147627715|NCT01017874|532456831|FG000|Overall Study|Lost to Follow-up|3|||
147627716|NCT01017874|532456832|FG001|Overall Study|Lost to Follow-up|2|||
147627717|NCT01017874|532456831|FG000|Overall Study|Physician Decision|1|||
147627718|NCT01017874|532456832|FG001|Overall Study|Physician Decision|3|||
147627719|NCT00808210|532456833|FG000|Study Period + 48 Weeks of Follow-up|Sponsor decision to terminate study|3|||
147627720|NCT00808210|532456834|FG001|Study Period + 48 Weeks of Follow-up|Sponsor decision to terminate study|7|||
147495218|NCT03655717|531966747|FG006|Overall Study|Lost to Follow-up|0|||
147627721|NCT00808210|532456833|FG000|Study Period + 48 Weeks of Follow-up|Other reasons outside Sponsor decision|6|||
147627722|NCT00808210|532456834|FG001|Study Period + 48 Weeks of Follow-up|Other reasons outside Sponsor decision|2|||
147627723|NCT00808210|532456833|FG000|Double-Blind TX Period|Adverse Event|0|||
147495219|NCT03655717|531966748|FG007|Overall Study|Lost to Follow-up|0|||
147495220|NCT03655717|531966749|FG008|Overall Study|Lost to Follow-up|0|||
147627724|NCT00808210|532456834|FG001|Double-Blind TX Period|Adverse Event|1|||
147627725|NCT00808210|532456833|FG000|Double-Blind TX Period|Sponsor decision to terminate study|1|||
147627726|NCT00808210|532456834|FG001|Double-Blind TX Period|Sponsor decision to terminate study|1|||
147627727|NCT00808210|532456833|FG000|Double-Blind TX Period|Other reasons outside Sponsor decision|1|||
147627728|NCT00808210|532456834|FG001|Double-Blind TX Period|Other reasons outside Sponsor decision|1|||
147627729|NCT00808210|532456833|FG000|Open Label Ocrelizumab Treatment Period|Sponsor decision to terminate study|9|||
147627730|NCT00808210|532456834|FG001|Open Label Ocrelizumab Treatment Period|Sponsor decision to terminate study|4|||
147627731|NCT00778817|532456839|FG000|Overall Study|Adverse Event|2|||
147627732|NCT00778817|532456839|FG000|Overall Study|Withdrawal by Subject|2|||
147627733|NCT02356588|532456840|FG000|Overall Study|Lack of Efficacy|4|||
147627734|NCT02356588|532456841|FG001|Overall Study|Lack of Efficacy|10|||
147627735|NCT02356588|532456840|FG000|Overall Study|Adverse Event|0|||
147627736|NCT02356588|532456841|FG001|Overall Study|Adverse Event|2|||
147627737|NCT02356588|532456840|FG000|Overall Study|Withdrawal by Subject|1|||
147627738|NCT02356588|532456841|FG001|Overall Study|Withdrawal by Subject|0|||
147627739|NCT02356588|532456840|FG000|Overall Study|Protocol Violation|0|||
147627740|NCT02356588|532456841|FG001|Overall Study|Protocol Violation|1|||
147627741|NCT01418378|532456842|FG000|Overall Study|Death|1|||
147627742|NCT01418378|532456843|FG001|Overall Study|Death|2|||
147627743|NCT01418378|532456842|FG000|Overall Study|Physician Decision|0|||
147627744|NCT01418378|532456843|FG001|Overall Study|Physician Decision|1|||
147627745|NCT01418378|532456842|FG000|Overall Study|ligament imbalance|0|||
147627746|NCT01418378|532456843|FG001|Overall Study|ligament imbalance|1|||
147627747|NCT01418378|532456842|FG000|Overall Study|developed chronic myopathy|0|||
147627748|NCT01418378|532456843|FG001|Overall Study|developed chronic myopathy|1|||
147627749|NCT03150719|532456844|FG000|Overall Study|Adverse Event|0|||
147627750|NCT03150719|532456845|FG001|Overall Study|Adverse Event|1|||
147627751|NCT03150719|532456844|FG000|Overall Study|Death|0|||
147627752|NCT03150719|532456845|FG001|Overall Study|Death|1|||
147627753|NCT03150719|532456844|FG000|Overall Study|Other|1|||
147627754|NCT03150719|532456845|FG001|Overall Study|Other|0|||
147627755|NCT01790984|532456846|FG000|First Dietary Intervention (12 Weeks)|Withdrawal by Subject|1|||
147495221|NCT03655717|531966750|FG009|Overall Study|Lost to Follow-up|0|||
147495222|NCT03655717|531966751|FG010|Overall Study|Lost to Follow-up|0|||
147627756|NCT01790984|532456847|FG001|First Dietary Intervention (12 Weeks)|Withdrawal by Subject|1|||
147627757|NCT01790984|532456848|FG002|First Dietary Intervention (12 Weeks)|Withdrawal by Subject|0|||
147627758|NCT01790984|532456849|FG003|First Dietary Intervention (12 Weeks)|Withdrawal by Subject|0|||
147627759|NCT01051791|532456857|FG000|Overall Study|Failed screening|3|||
147627760|NCT01051791|532456857|FG000|Overall Study|Withdrawal by Subject|1|||
147627761|NCT00288626|532456858|FG000|Overall Study|Death|3|||
147627762|NCT00288626|532456858|FG000|Overall Study|Withdrawal by Subject|4|||
147627763|NCT01372618|532456861|FG000|Overall Study|PI Died. Study Terminated|9|||
147627764|NCT01081769|532456863|FG000|Whole Intent-to-Treat|Missing Responder Assessment|10|||
147627765|NCT01081769|532456864|FG001|Whole Intent-to-Treat|Missing Responder Assessment|12|||
147627766|NCT01081769|532456863|FG000|Whole Intent-to-Treat|Stopped; non-responder after 2 weeks|6|||
147627767|NCT01081769|532456864|FG001|Whole Intent-to-Treat|Stopped; non-responder after 2 weeks|6|||
147627768|NCT01081769|532456863|FG000|Whole Intent-to-Treat|Deviation; non-responder after 2 weeks|6|||
147627769|NCT01081769|532456864|FG001|Whole Intent-to-Treat|Deviation; non-responder after 2 weeks|7|||
147627770|NCT01081769|532456863|FG000|Whole Intent-to-Treat|Responder after 2 weeks, but stopped|2|||
147627771|NCT01081769|532456864|FG001|Whole Intent-to-Treat|Responder after 2 weeks, but stopped|0|||
147627772|NCT01081769|532456863|FG000|CORE Intent-To-Treat|Adverse Event|14|||
147627773|NCT01081769|532456864|FG001|CORE Intent-To-Treat|Adverse Event|11|||
147627774|NCT01081769|532456863|FG000|CORE Intent-To-Treat|Death|1|||
147627775|NCT01081769|532456864|FG001|CORE Intent-To-Treat|Death|1|||
147627776|NCT01081769|532456863|FG000|CORE Intent-To-Treat|Lack of Efficacy|2|||
147495223|NCT03655717|531966752|FG011|Overall Study|Lost to Follow-up|1|||
147495224|NCT03655717|531966753|FG012|Overall Study|Lost to Follow-up|0|||
147495225|NCT03655717|531966754|FG013|Overall Study|Lost to Follow-up|0|||
147627777|NCT01081769|532456864|FG001|CORE Intent-To-Treat|Lack of Efficacy|6|||
147627778|NCT01081769|532456863|FG000|CORE Intent-To-Treat|Lost to Follow-up|4|||
147627779|NCT01081769|532456864|FG001|CORE Intent-To-Treat|Lost to Follow-up|5|||
147627780|NCT01081769|532456863|FG000|CORE Intent-To-Treat|Pregnancy|1|||
147627781|NCT01081769|532456864|FG001|CORE Intent-To-Treat|Pregnancy|0|||
147668378|NCT02783911|532611766|FG000|Overall Study|Lost to Follow-up|3|||
147668379|NCT02783911|532611767|FG001|Overall Study|Lost to Follow-up|32|||
147495226|NCT03655717|531966755|FG014|Overall Study|Lost to Follow-up|0|||
147495227|NCT03655717|531966756|FG015|Overall Study|Lost to Follow-up|0|||
147627782|NCT01081769|532456863|FG000|CORE Intent-To-Treat|Withdrawal by Subject|52|||
147627783|NCT01081769|532456864|FG001|CORE Intent-To-Treat|Withdrawal by Subject|60|||
147627784|NCT01081769|532456863|FG000|CORE Intent-To-Treat|Noncompliance With Study Drug|0|||
147627785|NCT01081769|532456864|FG001|CORE Intent-To-Treat|Noncompliance With Study Drug|5|||
147627786|NCT01081769|532456863|FG000|CORE Intent-To-Treat|Other|0|||
147627787|NCT01081769|532456864|FG001|CORE Intent-To-Treat|Other|1|||
147627788|NCT01081769|532456863|FG000|CORE Intent-To-Treat|Ineligibility|3|||
147627789|NCT01081769|532456864|FG001|CORE Intent-To-Treat|Ineligibility|4|||
147627790|NCT01081769|532456863|FG000|CORE Intent-To-Treat|Visit Schedule Issues|1|||
147627791|NCT01081769|532456864|FG001|CORE Intent-To-Treat|Visit Schedule Issues|2|||
147627792|NCT01081769|532456863|FG000|CORE Intent-To-Treat|Patient Moved|2|||
147627793|NCT01081769|532456864|FG001|CORE Intent-To-Treat|Patient Moved|2|||
147627794|NCT00558467|532456868|FG000|Overall Study|Adverse Event|1|||
147627795|NCT00558467|532456869|FG001|Overall Study|Adverse Event|2|||
147627796|NCT00558467|532456868|FG000|Overall Study|Lack of Efficacy|0|||
147627797|NCT00558467|532456869|FG001|Overall Study|Lack of Efficacy|1|||
147627798|NCT00558467|532456868|FG000|Overall Study|Patient moving out of state|0|||
147627799|NCT00558467|532456869|FG001|Overall Study|Patient moving out of state|1|||
147627800|NCT00507455|532456870|FG000|Overall Study|Adverse Event|3|||
147627801|NCT00507455|532456871|FG001|Overall Study|Adverse Event|3|||
147627802|NCT00507455|532456872|FG002|Overall Study|Adverse Event|6|||
147627803|NCT00507455|532456870|FG000|Overall Study|Withdrawal by Subject|2|||
147627804|NCT00507455|532456871|FG001|Overall Study|Withdrawal by Subject|1|||
147627805|NCT00507455|532456872|FG002|Overall Study|Withdrawal by Subject|2|||
147627806|NCT00507455|532456870|FG000|Overall Study|Protocol Violation|4|||
147627807|NCT00507455|532456871|FG001|Overall Study|Protocol Violation|1|||
147627808|NCT00507455|532456872|FG002|Overall Study|Protocol Violation|1|||
147627809|NCT00507455|532456870|FG000|Overall Study|Lost to Follow-up|2|||
147627810|NCT00507455|532456871|FG001|Overall Study|Lost to Follow-up|0|||
147627811|NCT00507455|532456872|FG002|Overall Study|Lost to Follow-up|2|||
147627812|NCT00507455|532456870|FG000|Overall Study|Lack of Efficacy|0|||
147627813|NCT00507455|532456871|FG001|Overall Study|Lack of Efficacy|1|||
147627814|NCT00507455|532456872|FG002|Overall Study|Lack of Efficacy|0|||
147627815|NCT00507455|532456870|FG000|Overall Study|Other - miscellaneous reason|1|||
147627816|NCT00507455|532456871|FG001|Overall Study|Other - miscellaneous reason|0|||
147627817|NCT00507455|532456872|FG002|Overall Study|Other - miscellaneous reason|1|||
147627818|NCT00931255|532456873|FG000|Overall Study|Follow up biopsy not done|2|||
147627819|NCT00931255|532456874|FG001|Overall Study|Follow up biopsy not done|3|||
147627820|NCT01372995|532456875|FG000|Overall Study|Spouse withdrew participant from study|0|||
147627821|NCT01372995|532456876|FG001|Overall Study|Spouse withdrew participant from study|1|||
147627822|NCT01372995|532456877|FG002|Overall Study|Spouse withdrew participant from study|0|||
147627823|NCT01372995|532456875|FG000|Overall Study|Physician Decision|0|||
147627824|NCT01372995|532456876|FG001|Overall Study|Physician Decision|0|||
147627825|NCT01372995|532456877|FG002|Overall Study|Physician Decision|1|||
147627826|NCT00789373|532456884|FG000|Induction|Adverse Event|64|||
147627827|NCT00789373|532456885|FG001|Induction|Adverse Event|0|||
147627828|NCT00789373|532456886|FG002|Induction|Adverse Event|0|||
147627829|NCT00789373|532456884|FG000|Induction|Death Due to study disease|24|||
147627830|NCT00789373|532456885|FG001|Induction|Death Due to study disease|0|||
147627831|NCT00789373|532456886|FG002|Induction|Death Due to study disease|0|||
147627832|NCT00789373|532456884|FG000|Induction|Death due to adverse event|19|||
147627833|NCT00789373|532456885|FG001|Induction|Death due to adverse event|0|||
147627834|NCT00789373|532456886|FG002|Induction|Death due to adverse event|0|||
147627835|NCT00789373|532456884|FG000|Induction|Death due to toxicity|11|||
147627836|NCT00789373|532456885|FG001|Induction|Death due to toxicity|0|||
147627837|NCT00789373|532456886|FG002|Induction|Death due to toxicity|0|||
147627838|NCT00789373|532456884|FG000|Induction|Death due to procedure|1|||
147627839|NCT00789373|532456885|FG001|Induction|Death due to procedure|0|||
147627840|NCT00789373|532456886|FG002|Induction|Death due to procedure|0|||
147627841|NCT00789373|532456884|FG000|Induction|Investigator decision|7|||
147627842|NCT00789373|532456885|FG001|Induction|Investigator decision|0|||
147627843|NCT00789373|532456886|FG002|Induction|Investigator decision|0|||
147627844|NCT00789373|532456884|FG000|Induction|Protocol entry criteria not met|9|||
147627845|NCT00789373|532456885|FG001|Induction|Protocol entry criteria not met|0|||
147627846|NCT00789373|532456886|FG002|Induction|Protocol entry criteria not met|0|||
147627847|NCT00789373|532456884|FG000|Induction|Lost to Follow-up|6|||
147627848|NCT00789373|532456885|FG001|Induction|Lost to Follow-up|0|||
147627849|NCT00789373|532456886|FG002|Induction|Lost to Follow-up|0|||
147668380|NCT00467519|532611770|FG000|Overall Study|Protocol Violation|8|||
147627850|NCT00789373|532456884|FG000|Induction|Protocol Violation|1|||
147627851|NCT00789373|532456885|FG001|Induction|Protocol Violation|0|||
147627852|NCT00789373|532456886|FG002|Induction|Protocol Violation|0|||
147627853|NCT00789373|532456884|FG000|Induction|Progressive Disease|220|||
147627854|NCT00789373|532456885|FG001|Induction|Progressive Disease|0|||
147627855|NCT00789373|532456886|FG002|Induction|Progressive Disease|0|||
147627856|NCT00789373|532456884|FG000|Induction|Withdrawal by Subject|37|||
147627857|NCT00789373|532456885|FG001|Induction|Withdrawal by Subject|0|||
147627858|NCT00789373|532456886|FG002|Induction|Withdrawal by Subject|0|||
147627859|NCT00789373|532456884|FG000|Maintenance|Adverse Event|0|||
147627860|NCT00789373|532456885|FG001|Maintenance|Adverse Event|65|||
147627861|NCT00789373|532456886|FG002|Maintenance|Adverse Event|12|||
147627862|NCT00789373|532456884|FG000|Maintenance|Death due to study disease|0|||
147627863|NCT00789373|532456885|FG001|Maintenance|Death due to study disease|3|||
147627864|NCT00789373|532456886|FG002|Maintenance|Death due to study disease|1|||
147627865|NCT00789373|532456884|FG000|Maintenance|Death due to adverse event|0|||
147627866|NCT00789373|532456885|FG001|Maintenance|Death due to adverse event|4|||
147627867|NCT00789373|532456886|FG002|Maintenance|Death due to adverse event|1|||
147627868|NCT00789373|532456884|FG000|Maintenance|Death due to toxicity|0|||
147627869|NCT00789373|532456885|FG001|Maintenance|Death due to toxicity|1|||
147627870|NCT00789373|532456886|FG002|Maintenance|Death due to toxicity|2|||
147627871|NCT00789373|532456884|FG000|Maintenance|Investigator Decision|0|||
147627872|NCT00789373|532456885|FG001|Maintenance|Investigator Decision|4|||
147627873|NCT00789373|532456886|FG002|Maintenance|Investigator Decision|2|||
147627874|NCT00789373|532456884|FG000|Maintenance|Protocol entry criteria not met|0|||
147627875|NCT00789373|532456885|FG001|Maintenance|Protocol entry criteria not met|2|||
147627876|NCT00789373|532456886|FG002|Maintenance|Protocol entry criteria not met|0|||
147627877|NCT00789373|532456884|FG000|Maintenance|Lost to Follow-up|0|||
147627878|NCT00789373|532456885|FG001|Maintenance|Lost to Follow-up|2|||
147627879|NCT00789373|532456886|FG002|Maintenance|Lost to Follow-up|0|||
147627880|NCT00789373|532456884|FG000|Maintenance|Progressive Disease|0|||
147627881|NCT00789373|532456885|FG001|Maintenance|Progressive Disease|253|||
147627882|NCT00789373|532456886|FG002|Maintenance|Progressive Disease|152|||
147627883|NCT00789373|532456884|FG000|Maintenance|Withdrawal by Subject|0|||
147627884|NCT00789373|532456885|FG001|Maintenance|Withdrawal by Subject|21|||
147627885|NCT00789373|532456886|FG002|Maintenance|Withdrawal by Subject|8|||
147627886|NCT00789373|532456884|FG000|Maintenance|Sponsor Decision|0|||
147627887|NCT00789373|532456885|FG001|Maintenance|Sponsor Decision|0|||
147627888|NCT00789373|532456886|FG002|Maintenance|Sponsor Decision|2|||
147627889|NCT00789373|532456884|FG000|Maintenance|Participants On-Going at Data Cut-Off|0|||
147627890|NCT00789373|532456885|FG001|Maintenance|Participants On-Going at Data Cut-Off|4|||
147627891|NCT00789373|532456886|FG002|Maintenance|Participants On-Going at Data Cut-Off|0|||
147627892|NCT01964222|532456892|FG000|Overall Study|Lost to Follow-up|7|||
147627893|NCT01964222|532456893|FG001|Overall Study|Lost to Follow-up|5|||
147627894|NCT01964222|532456892|FG000|Overall Study|Withdrawal by Subject|6|||
147627895|NCT01964222|532456893|FG001|Overall Study|Withdrawal by Subject|6|||
147627896|NCT01964222|532456892|FG000|Overall Study|Screening Failure|2|||
147627897|NCT01964222|532456893|FG001|Overall Study|Screening Failure|0|||
147627898|NCT01019694|532456896|FG000|Overall Study|Adverse Event|12|||
147627899|NCT01019694|532456897|FG001|Overall Study|Adverse Event|16|||
147627900|NCT01019694|532456898|FG002|Overall Study|Adverse Event|19|||
147627901|NCT01019694|532456896|FG000|Overall Study|Protocol Violation|2|||
147627902|NCT01019694|532456897|FG001|Overall Study|Protocol Violation|6|||
147627903|NCT01019694|532456898|FG002|Overall Study|Protocol Violation|4|||
147627904|NCT01019694|532456896|FG000|Overall Study|Lost to Follow-up|5|||
147627905|NCT01019694|532456897|FG001|Overall Study|Lost to Follow-up|3|||
147627906|NCT01019694|532456898|FG002|Overall Study|Lost to Follow-up|3|||
147627907|NCT01019694|532456896|FG000|Overall Study|Withdrawal by Subject|4|||
147627908|NCT01019694|532456897|FG001|Overall Study|Withdrawal by Subject|6|||
147627909|NCT01019694|532456898|FG002|Overall Study|Withdrawal by Subject|12|||
147627910|NCT01019694|532456896|FG000|Overall Study|Not treated|0|||
147627911|NCT01019694|532456897|FG001|Overall Study|Not treated|2|||
147627912|NCT01019694|532456898|FG002|Overall Study|Not treated|3|||
147627913|NCT01019694|532456896|FG000|Overall Study|Other reason (not specified)|1|||
147627914|NCT01019694|532456897|FG001|Overall Study|Other reason (not specified)|5|||
147627915|NCT01019694|532456898|FG002|Overall Study|Other reason (not specified)|6|||
147627916|NCT00026494|532456907|FG000|Overall Study|Withdrawal by Subject|1|||
147627917|NCT00026494|532456908|FG001|Overall Study|Withdrawal by Subject|0|||
147627918|NCT00026494|532456909|FG002|Overall Study|Withdrawal by Subject|1|||
147627919|NCT00026494|532456910|FG003|Overall Study|Withdrawal by Subject|0|||
147627920|NCT00026494|532456907|FG000|Overall Study|Patient non-compliance|1|||
147627921|NCT00026494|532456908|FG001|Overall Study|Patient non-compliance|0|||
147627922|NCT00026494|532456909|FG002|Overall Study|Patient non-compliance|0|||
147627923|NCT00026494|532456910|FG003|Overall Study|Patient non-compliance|0|||
147627924|NCT00026494|532456907|FG000|Overall Study|Patient not treated|0|||
147627925|NCT00026494|532456908|FG001|Overall Study|Patient not treated|0|||
147627926|NCT00026494|532456909|FG002|Overall Study|Patient not treated|2|||
147627927|NCT00026494|532456910|FG003|Overall Study|Patient not treated|0|||
147627928|NCT00026494|532456907|FG000|Overall Study|Clinical progression|0|||
147627929|NCT00026494|532456908|FG001|Overall Study|Clinical progression|0|||
147627930|NCT00026494|532456909|FG002|Overall Study|Clinical progression|3|||
147627931|NCT00026494|532456910|FG003|Overall Study|Clinical progression|0|||
147627932|NCT01455597|532456911|FG000|Overall Study|Adverse Event|7|||
147627933|NCT01455597|532456912|FG001|Overall Study|Adverse Event|0|||
147627934|NCT01455597|532456913|FG002|Overall Study|Adverse Event|5|||
147627935|NCT01455597|532456914|FG003|Overall Study|Adverse Event|1|||
147627936|NCT01455597|532456911|FG000|Overall Study|Lack of Efficacy|0|||
147627937|NCT01455597|532456912|FG001|Overall Study|Lack of Efficacy|1|||
147627938|NCT01455597|532456913|FG002|Overall Study|Lack of Efficacy|2|||
147627939|NCT01455597|532456914|FG003|Overall Study|Lack of Efficacy|0|||
147627940|NCT01455597|532456911|FG000|Overall Study|Lost to Follow-up|3|||
147627941|NCT01455597|532456912|FG001|Overall Study|Lost to Follow-up|0|||
147627942|NCT01455597|532456913|FG002|Overall Study|Lost to Follow-up|2|||
147627943|NCT01455597|532456914|FG003|Overall Study|Lost to Follow-up|1|||
147627944|NCT01455597|532456911|FG000|Overall Study|Withdrew Consent|6|||
147627945|NCT01455597|532456912|FG001|Overall Study|Withdrew Consent|5|||
147627946|NCT01455597|532456913|FG002|Overall Study|Withdrew Consent|8|||
147627947|NCT01455597|532456914|FG003|Overall Study|Withdrew Consent|5|||
147627948|NCT01455597|532456911|FG000|Overall Study|Reason not Specified|1|||
147627949|NCT01455597|532456912|FG001|Overall Study|Reason not Specified|2|||
147627950|NCT01455597|532456913|FG002|Overall Study|Reason not Specified|3|||
147627951|NCT01455597|532456914|FG003|Overall Study|Reason not Specified|3|||
147627952|NCT00441129|532456915|FG000|Overall Study|Withdrawal by Subject|6|||
147627953|NCT00441129|532456916|FG001|Overall Study|Withdrawal by Subject|14|||
147627954|NCT01737710|532456917|FG000|Overall Study|Lost to Follow-up|0|||
147627955|NCT01737710|532456918|FG001|Overall Study|Lost to Follow-up|2|||
147627956|NCT01737710|532456919|FG002|Overall Study|Lost to Follow-up|2|||
147627957|NCT01737710|532456920|FG003|Overall Study|Lost to Follow-up|0|||
147627958|NCT01737710|532456921|FG004|Overall Study|Lost to Follow-up|0|||
147627959|NCT01737710|532456917|FG000|Overall Study|Withdrawal by Subject|1|||
147627960|NCT01737710|532456918|FG001|Overall Study|Withdrawal by Subject|1|||
147627961|NCT01737710|532456919|FG002|Overall Study|Withdrawal by Subject|1|||
147627962|NCT01737710|532456920|FG003|Overall Study|Withdrawal by Subject|0|||
147627963|NCT01737710|532456921|FG004|Overall Study|Withdrawal by Subject|0|||
147627964|NCT01737710|532456917|FG000|Overall Study|Vaccinated in Error/Ineligible|1|||
147627965|NCT01737710|532456918|FG001|Overall Study|Vaccinated in Error/Ineligible|1|||
147627966|NCT01737710|532456919|FG002|Overall Study|Vaccinated in Error/Ineligible|0|||
147627967|NCT01737710|532456920|FG003|Overall Study|Vaccinated in Error/Ineligible|0|||
147627968|NCT01737710|532456921|FG004|Overall Study|Vaccinated in Error/Ineligible|0|||
147627969|NCT00812981|532456922|FG000|Overall Study|Other|0|||
147627970|NCT00812981|532456923|FG001|Overall Study|Other|1|||
147627971|NCT04666259|532456928|FG000|Treatment Phase|Physician Decision|9|||
147627972|NCT04666259|532456929|FG001|Treatment Phase|Physician Decision|3|||
147627973|NCT04666259|532456930|FG002|Treatment Phase|Physician Decision|3|||
147627974|NCT04666259|532456928|FG000|Treatment Phase|Adverse Event|3|||
147627975|NCT04666259|532456929|FG001|Treatment Phase|Adverse Event|1|||
147627976|NCT04666259|532456930|FG002|Treatment Phase|Adverse Event|0|||
147627977|NCT04666259|532456928|FG000|Treatment Phase|Subject decision|1|||
147627978|NCT04666259|532456929|FG001|Treatment Phase|Subject decision|2|||
147627979|NCT04666259|532456930|FG002|Treatment Phase|Subject decision|0|||
147627980|NCT04666259|532456928|FG000|Treatment Phase|Progressive disease|0|||
147627981|NCT04666259|532456929|FG001|Treatment Phase|Progressive disease|1|||
147627982|NCT04666259|532456930|FG002|Treatment Phase|Progressive disease|0|||
147627983|NCT04666259|532456928|FG000|Treatment Phase|Enrolled but not treated and discontinued|1|||
147627984|NCT04666259|532456929|FG001|Treatment Phase|Enrolled but not treated and discontinued|0|||
147627985|NCT04666259|532456930|FG002|Treatment Phase|Enrolled but not treated and discontinued|0|||
147627986|NCT04666259|532456928|FG000|Safety Follow-up Phase|Physician Decision|2|||
147627987|NCT04666259|532456929|FG001|Safety Follow-up Phase|Physician Decision|0|||
147627988|NCT04666259|532456930|FG002|Safety Follow-up Phase|Physician Decision|0|||
147627989|NCT04666259|532456928|FG000|Safety Follow-up Phase|Subject decision|1|||
147627990|NCT04666259|532456929|FG001|Safety Follow-up Phase|Subject decision|0|||
147627991|NCT04666259|532456930|FG002|Safety Follow-up Phase|Subject decision|0|||
147627992|NCT04666259|532456928|FG000|Safety Follow-up Phase|Death|0|||
147627993|NCT04666259|532456929|FG001|Safety Follow-up Phase|Death|1|||
147627994|NCT04666259|532456930|FG002|Safety Follow-up Phase|Death|0|||
147627995|NCT04178122|532456931|FG000|Overall Study|Withdrawal by Subject|1|||
147627996|NCT04178122|532456932|FG001|Overall Study|Withdrawal by Subject|1|||
147627997|NCT04178122|532456931|FG000|Overall Study|Death|2|||
147627998|NCT04178122|532456932|FG001|Overall Study|Death|0|||
147627999|NCT04178122|532456931|FG000|Overall Study|Did not complete testing|3|||
147628000|NCT04178122|532456932|FG001|Overall Study|Did not complete testing|13|||
147628001|NCT02677922|532456933|FG000|Pre-Treatment Period|Withdrawal by Subject|0|||
147668381|NCT00467519|532611771|FG001|Overall Study|Protocol Violation|4|||
147668382|NCT00467519|532611770|FG000|Overall Study|Lost to Follow-up|2|||
147628002|NCT02677922|532456934|FG001|Pre-Treatment Period|Withdrawal by Subject|0|||
147628003|NCT02677922|532456935|FG002|Pre-Treatment Period|Withdrawal by Subject|0|||
147628004|NCT02677922|532456936|FG003|Pre-Treatment Period|Withdrawal by Subject|0|||
147668383|NCT00467519|532611771|FG001|Overall Study|Lost to Follow-up|9|||
147668384|NCT00467519|532611770|FG000|Overall Study|Withdrawal by Subject|4|||
147628005|NCT02677922|532456937|FG004|Pre-Treatment Period|Withdrawal by Subject|0|||
147628006|NCT02677922|532456938|FG005|Pre-Treatment Period|Withdrawal by Subject|1|||
147628007|NCT02677922|532456933|FG000|Treatment Period|Adverse Event|0|||
147628008|NCT02677922|532456934|FG001|Treatment Period|Adverse Event|0|||
147628009|NCT02677922|532456935|FG002|Treatment Period|Adverse Event|1|||
147628010|NCT02677922|532456936|FG003|Treatment Period|Adverse Event|3|||
147628011|NCT02677922|532456937|FG004|Treatment Period|Adverse Event|5|||
147628012|NCT02677922|532456938|FG005|Treatment Period|Adverse Event|2|||
147628013|NCT02677922|532456933|FG000|Treatment Period|Progressive Disease|1|||
147628014|NCT02677922|532456934|FG001|Treatment Period|Progressive Disease|1|||
147628015|NCT02677922|532456935|FG002|Treatment Period|Progressive Disease|0|||
147628016|NCT02677922|532456936|FG003|Treatment Period|Progressive Disease|0|||
147628017|NCT02677922|532456937|FG004|Treatment Period|Progressive Disease|8|||
147628018|NCT02677922|532456938|FG005|Treatment Period|Progressive Disease|7|||
147628019|NCT02677922|532456933|FG000|Treatment Period|Lack of Efficacy|0|||
147628020|NCT02677922|532456934|FG001|Treatment Period|Lack of Efficacy|0|||
147628021|NCT02677922|532456935|FG002|Treatment Period|Lack of Efficacy|0|||
147628022|NCT02677922|532456936|FG003|Treatment Period|Lack of Efficacy|1|||
147628023|NCT02677922|532456937|FG004|Treatment Period|Lack of Efficacy|1|||
147628024|NCT02677922|532456938|FG005|Treatment Period|Lack of Efficacy|6|||
147628025|NCT02677922|532456933|FG000|Treatment Period|Withdrawal by Subject|0|||
147628026|NCT02677922|532456934|FG001|Treatment Period|Withdrawal by Subject|0|||
147628027|NCT02677922|532456935|FG002|Treatment Period|Withdrawal by Subject|1|||
147628028|NCT02677922|532456936|FG003|Treatment Period|Withdrawal by Subject|3|||
147628029|NCT02677922|532456937|FG004|Treatment Period|Withdrawal by Subject|5|||
147628030|NCT02677922|532456938|FG005|Treatment Period|Withdrawal by Subject|5|||
147628031|NCT02677922|532456933|FG000|Treatment Period|Transition to Commercially Available Treatment|0|||
147628032|NCT02677922|532456934|FG001|Treatment Period|Transition to Commercially Available Treatment|1|||
147628033|NCT02677922|532456935|FG002|Treatment Period|Transition to Commercially Available Treatment|1|||
147628034|NCT02677922|532456936|FG003|Treatment Period|Transition to Commercially Available Treatment|1|||
147628035|NCT02677922|532456937|FG004|Treatment Period|Transition to Commercially Available Treatment|1|||
147628036|NCT02677922|532456938|FG005|Treatment Period|Transition to Commercially Available Treatment|2|||
147628037|NCT02677922|532456933|FG000|Treatment Period|Disease Relapse|0|||
147628038|NCT02677922|532456934|FG001|Treatment Period|Disease Relapse|0|||
147628039|NCT02677922|532456935|FG002|Treatment Period|Disease Relapse|0|||
147628040|NCT02677922|532456936|FG003|Treatment Period|Disease Relapse|3|||
147628041|NCT02677922|532456937|FG004|Treatment Period|Disease Relapse|6|||
147628042|NCT02677922|532456938|FG005|Treatment Period|Disease Relapse|1|||
147628043|NCT02677922|532456933|FG000|Treatment Period|Allogeneic HSCT|1|||
147628044|NCT02677922|532456934|FG001|Treatment Period|Allogeneic HSCT|0|||
147628045|NCT02677922|532456935|FG002|Treatment Period|Allogeneic HSCT|0|||
147628046|NCT02677922|532456936|FG003|Treatment Period|Allogeneic HSCT|1|||
147628047|NCT02677922|532456937|FG004|Treatment Period|Allogeneic HSCT|4|||
147628048|NCT02677922|532456938|FG005|Treatment Period|Allogeneic HSCT|1|||
147628049|NCT02677922|532456933|FG000|Treatment Period|Other Reasons|0|||
147628050|NCT02677922|532456934|FG001|Treatment Period|Other Reasons|0|||
147628051|NCT02677922|532456935|FG002|Treatment Period|Other Reasons|0|||
147628052|NCT02677922|532456936|FG003|Treatment Period|Other Reasons|1|||
147628053|NCT02677922|532456937|FG004|Treatment Period|Other Reasons|3|||
147628054|NCT02677922|532456938|FG005|Treatment Period|Other Reasons|5|||
147628055|NCT02677922|532456933|FG000|Treatment Period|Death|0|||
147628056|NCT02677922|532456934|FG001|Treatment Period|Death|0|||
147628057|NCT02677922|532456935|FG002|Treatment Period|Death|0|||
147628058|NCT02677922|532456936|FG003|Treatment Period|Death|0|||
147628059|NCT02677922|532456937|FG004|Treatment Period|Death|12|||
147628060|NCT02677922|532456938|FG005|Treatment Period|Death|1|||
147628061|NCT02677922|532456933|FG000|Treatment Period|Non-compliance with Study Drug|0|||
147628062|NCT02677922|532456934|FG001|Treatment Period|Non-compliance with Study Drug|0|||
147628063|NCT02677922|532456935|FG002|Treatment Period|Non-compliance with Study Drug|0|||
147628064|NCT02677922|532456936|FG003|Treatment Period|Non-compliance with Study Drug|0|||
147628065|NCT02677922|532456937|FG004|Treatment Period|Non-compliance with Study Drug|1|||
147628066|NCT02677922|532456938|FG005|Treatment Period|Non-compliance with Study Drug|0|||
147628067|NCT02677922|532456933|FG000|Treatment Period|Physician Decision|0|||
147628068|NCT02677922|532456934|FG001|Treatment Period|Physician Decision|0|||
147628069|NCT02677922|532456935|FG002|Treatment Period|Physician Decision|0|||
147628070|NCT02677922|532456936|FG003|Treatment Period|Physician Decision|0|||
147628071|NCT02677922|532456937|FG004|Treatment Period|Physician Decision|0|||
147628072|NCT02677922|532456938|FG005|Treatment Period|Physician Decision|1|||
147495228|NCT03655717|531966757|FG016|Overall Study|Lost to Follow-up|0|||
147495229|NCT03655717|531966758|FG017|Overall Study|Lost to Follow-up|0|||
147628073|NCT02677922|532456933|FG000|Treatment Period|Symptomatic Deterioration|0|||
147628074|NCT02677922|532456934|FG001|Treatment Period|Symptomatic Deterioration|0|||
147628075|NCT02677922|532456935|FG002|Treatment Period|Symptomatic Deterioration|0|||
147628076|NCT02677922|532456936|FG003|Treatment Period|Symptomatic Deterioration|0|||
147628077|NCT02677922|532456937|FG004|Treatment Period|Symptomatic Deterioration|1|||
147628078|NCT02677922|532456938|FG005|Treatment Period|Symptomatic Deterioration|0|||
147628079|NCT02105987|532456940|FG000|Early Switch Phase (24 Weeks)|Adverse Event|10|||
147628080|NCT02105987|532456941|FG001|Early Switch Phase (24 Weeks)|Adverse Event|0|||
147628081|NCT02105987|532456942|FG002|Early Switch Phase (24 Weeks)|Adverse Event|0|||
147628082|NCT02105987|532456943|FG003|Early Switch Phase (24 Weeks)|Adverse Event|0|||
147628083|NCT02105987|532456944|FG004|Early Switch Phase (24 Weeks)|Adverse Event|0|||
147628084|NCT02105987|532456945|FG005|Early Switch Phase (24 Weeks)|Adverse Event|0|||
147628085|NCT02105987|532456940|FG000|Early Switch Phase (24 Weeks)|Protocol Violation|15|||
147628086|NCT02105987|532456941|FG001|Early Switch Phase (24 Weeks)|Protocol Violation|17|||
147628087|NCT02105987|532456942|FG002|Early Switch Phase (24 Weeks)|Protocol Violation|0|||
147668385|NCT00467519|532611771|FG001|Overall Study|Withdrawal by Subject|10|||
147668386|NCT01218802|532611775|FG000|Overall Study|Lost to Follow-up|5|||
147668387|NCT01218802|532611776|FG001|Overall Study|Lost to Follow-up|6|||
147668388|NCT01218802|532611775|FG000|Overall Study|Withdrawal by Subject|3|||
147668389|NCT01218802|532611776|FG001|Overall Study|Withdrawal by Subject|10|||
147668390|NCT01218802|532611775|FG000|Overall Study|Adverse Event|0|||
147668391|NCT01218802|532611776|FG001|Overall Study|Adverse Event|2|||
147668392|NCT01218802|532611775|FG000|Overall Study|Incarcerated|2|||
147668393|NCT01218802|532611776|FG001|Overall Study|Incarcerated|0|||
147668394|NCT01776554|532611780|FG000|Overall Study|Adverse Event|1|||
147668395|NCT01776554|532611781|FG001|Overall Study|Adverse Event|0|||
147668396|NCT01776554|532611780|FG000|Overall Study|Withdrawal by Subject|3|||
147668397|NCT01776554|532611781|FG001|Overall Study|Withdrawal by Subject|8|||
147668398|NCT01776554|532611780|FG000|Overall Study|Lost to Follow-up|6|||
147668399|NCT01776554|532611781|FG001|Overall Study|Lost to Follow-up|9|||
147668400|NCT01776554|532611780|FG000|Overall Study|Administrative Reason|2|||
147495230|NCT03655717|531966759|FG018|Overall Study|Lost to Follow-up|0|||
147495231|NCT03655717|531966760|FG019|Overall Study|Lost to Follow-up|0|||
147495232|NCT03655717|531966761|FG020|Overall Study|Lost to Follow-up|0|||
147495233|NCT03655717|531966762|FG021|Overall Study|Lost to Follow-up|0|||
147495234|NCT03655717|531966763|FG022|Overall Study|Lost to Follow-up|0|||
147495235|NCT03655717|531966764|FG023|Overall Study|Lost to Follow-up|0|||
147495236|NCT03655717|531966765|FG024|Overall Study|Lost to Follow-up|0|||
147495237|NCT03655717|531966766|FG025|Overall Study|Lost to Follow-up|0|||
147495238|NCT01208038|531966770|FG000|Overall Study|Withdrawal by Subject|1|||
147495239|NCT00430521|531966771|FG000|Overall Study|Adverse Event|0|||
147495240|NCT00430521|531966772|FG001|Overall Study|Adverse Event|0|||
147495241|NCT00430521|531966773|FG002|Overall Study|Adverse Event|0|||
147495242|NCT00430521|531966774|FG003|Overall Study|Adverse Event|0|||
147495243|NCT00430521|531966775|FG004|Overall Study|Adverse Event|0|||
147495244|NCT00430521|531966776|FG005|Overall Study|Adverse Event|2|||
147495245|NCT00430521|531966777|FG006|Overall Study|Adverse Event|1|||
147495246|NCT00430521|531966778|FG007|Overall Study|Adverse Event|0|||
147495247|NCT00430521|531966771|FG000|Overall Study|Lost to Follow-up|7|||
147495248|NCT00430521|531966772|FG001|Overall Study|Lost to Follow-up|8|||
147495249|NCT00430521|531966773|FG002|Overall Study|Lost to Follow-up|3|||
147495250|NCT00430521|531966774|FG003|Overall Study|Lost to Follow-up|5|||
147495251|NCT00430521|531966775|FG004|Overall Study|Lost to Follow-up|5|||
147495252|NCT00430521|531966776|FG005|Overall Study|Lost to Follow-up|2|||
147495253|NCT00430521|531966777|FG006|Overall Study|Lost to Follow-up|8|||
147495254|NCT00430521|531966778|FG007|Overall Study|Lost to Follow-up|10|||
147495255|NCT00430521|531966771|FG000|Overall Study|Pregnancy|0|||
147495256|NCT00430521|531966772|FG001|Overall Study|Pregnancy|0|||
147495257|NCT00430521|531966773|FG002|Overall Study|Pregnancy|0|||
147495258|NCT00430521|531966774|FG003|Overall Study|Pregnancy|0|||
147495259|NCT00430521|531966775|FG004|Overall Study|Pregnancy|0|||
147495260|NCT00430521|531966776|FG005|Overall Study|Pregnancy|0|||
147495261|NCT00430521|531966777|FG006|Overall Study|Pregnancy|1|||
147495262|NCT00430521|531966778|FG007|Overall Study|Pregnancy|0|||
147495263|NCT00430521|531966771|FG000|Overall Study|Vaccine Expired|0|||
147495264|NCT00430521|531966772|FG001|Overall Study|Vaccine Expired|0|||
147495265|NCT00430521|531966773|FG002|Overall Study|Vaccine Expired|0|||
147495266|NCT00430521|531966774|FG003|Overall Study|Vaccine Expired|0|||
147495267|NCT00430521|531966775|FG004|Overall Study|Vaccine Expired|0|||
147495268|NCT00430521|531966776|FG005|Overall Study|Vaccine Expired|1|||
147495269|NCT00430521|531966777|FG006|Overall Study|Vaccine Expired|0|||
147495270|NCT00430521|531966778|FG007|Overall Study|Vaccine Expired|0|||
147495271|NCT00430521|531966771|FG000|Overall Study|Protocol Violation|1|||
147495272|NCT00430521|531966772|FG001|Overall Study|Protocol Violation|0|||
147495273|NCT00430521|531966773|FG002|Overall Study|Protocol Violation|0|||
147495274|NCT00430521|531966774|FG003|Overall Study|Protocol Violation|0|||
147495275|NCT00430521|531966775|FG004|Overall Study|Protocol Violation|0|||
147495276|NCT00430521|531966776|FG005|Overall Study|Protocol Violation|0|||
147495277|NCT00430521|531966777|FG006|Overall Study|Protocol Violation|0|||
147495278|NCT00430521|531966778|FG007|Overall Study|Protocol Violation|0|||
147668401|NCT01776554|532611781|FG001|Overall Study|Administrative Reason|5|||
147668402|NCT01776554|532611780|FG000|Overall Study|Protocol Violation|1|||
147668403|NCT01776554|532611781|FG001|Overall Study|Protocol Violation|0|||
147668404|NCT01776554|532611780|FG000|Overall Study|Unclassified|4|||
147495279|NCT00430521|531966771|FG000|Overall Study|Withdrawal by Subject|3|||
147495280|NCT00430521|531966772|FG001|Overall Study|Withdrawal by Subject|1|||
147495281|NCT00430521|531966773|FG002|Overall Study|Withdrawal by Subject|0|||
147495282|NCT00430521|531966774|FG003|Overall Study|Withdrawal by Subject|3|||
147495283|NCT00430521|531966775|FG004|Overall Study|Withdrawal by Subject|0|||
147495284|NCT00430521|531966776|FG005|Overall Study|Withdrawal by Subject|0|||
147495285|NCT00430521|531966777|FG006|Overall Study|Withdrawal by Subject|0|||
147495286|NCT00430521|531966778|FG007|Overall Study|Withdrawal by Subject|2|||
147495287|NCT05108805|531966781|FG000|Overall Study|T-cell expansion was not successful.|5|||
147495288|NCT00369967|531968821|FG000|Overall Study|Lost to Follow-up|23|||
147495289|NCT00369967|531968822|FG001|Overall Study|Lost to Follow-up|12|||
147628088|NCT02105987|532456943|FG003|Early Switch Phase (24 Weeks)|Protocol Violation|0|||
147628089|NCT02105987|532456944|FG004|Early Switch Phase (24 Weeks)|Protocol Violation|0|||
147628090|NCT02105987|532456945|FG005|Early Switch Phase (24 Weeks)|Protocol Violation|0|||
147628091|NCT02105987|532456940|FG000|Early Switch Phase (24 Weeks)|Withdrawal by Subject|4|||
147628092|NCT02105987|532456941|FG001|Early Switch Phase (24 Weeks)|Withdrawal by Subject|10|||
147628093|NCT02105987|532456942|FG002|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
147628094|NCT02105987|532456943|FG003|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
147628095|NCT02105987|532456944|FG004|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
147628096|NCT02105987|532456945|FG005|Early Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
147628097|NCT02105987|532456940|FG000|Early Switch Phase (24 Weeks)|Lost to Follow-up|3|||
147628098|NCT02105987|532456941|FG001|Early Switch Phase (24 Weeks)|Lost to Follow-up|3|||
147628099|NCT02105987|532456942|FG002|Early Switch Phase (24 Weeks)|Lost to Follow-up|0|||
147628100|NCT02105987|532456943|FG003|Early Switch Phase (24 Weeks)|Lost to Follow-up|0|||
147628101|NCT02105987|532456944|FG004|Early Switch Phase (24 Weeks)|Lost to Follow-up|0|||
147628102|NCT02105987|532456945|FG005|Early Switch Phase (24 Weeks)|Lost to Follow-up|0|||
147628103|NCT02105987|532456940|FG000|Early Switch Phase (24 Weeks)|Physician Decision|4|||
147628104|NCT02105987|532456941|FG001|Early Switch Phase (24 Weeks)|Physician Decision|3|||
147628105|NCT02105987|532456942|FG002|Early Switch Phase (24 Weeks)|Physician Decision|0|||
147628106|NCT02105987|532456943|FG003|Early Switch Phase (24 Weeks)|Physician Decision|0|||
147628107|NCT02105987|532456944|FG004|Early Switch Phase (24 Weeks)|Physician Decision|0|||
147628108|NCT02105987|532456945|FG005|Early Switch Phase (24 Weeks)|Physician Decision|0|||
147628109|NCT02105987|532456940|FG000|Early Switch Phase (24 Weeks)|Missing Disposition Data|0|||
147628110|NCT02105987|532456941|FG001|Early Switch Phase (24 Weeks)|Missing Disposition Data|1|||
147628111|NCT02105987|532456942|FG002|Early Switch Phase (24 Weeks)|Missing Disposition Data|0|||
147628112|NCT02105987|532456943|FG003|Early Switch Phase (24 Weeks)|Missing Disposition Data|0|||
147628113|NCT02105987|532456944|FG004|Early Switch Phase (24 Weeks)|Missing Disposition Data|0|||
147628114|NCT02105987|532456945|FG005|Early Switch Phase (24 Weeks)|Missing Disposition Data|0|||
147628115|NCT02105987|532456940|FG000|Late Switch Phase (24 Weeks)|Adverse Event|0|||
147628116|NCT02105987|532456941|FG001|Late Switch Phase (24 Weeks)|Adverse Event|0|||
147628117|NCT02105987|532456942|FG002|Late Switch Phase (24 Weeks)|Adverse Event|10|||
147628118|NCT02105987|532456943|FG003|Late Switch Phase (24 Weeks)|Adverse Event|4|||
147628119|NCT02105987|532456944|FG004|Late Switch Phase (24 Weeks)|Adverse Event|0|||
147628120|NCT02105987|532456945|FG005|Late Switch Phase (24 Weeks)|Adverse Event|0|||
147628121|NCT02105987|532456940|FG000|Late Switch Phase (24 Weeks)|Protocol Violation|0|||
147628122|NCT02105987|532456941|FG001|Late Switch Phase (24 Weeks)|Protocol Violation|0|||
147628123|NCT02105987|532456942|FG002|Late Switch Phase (24 Weeks)|Protocol Violation|15|||
147628124|NCT02105987|532456943|FG003|Late Switch Phase (24 Weeks)|Protocol Violation|1|||
147628125|NCT02105987|532456944|FG004|Late Switch Phase (24 Weeks)|Protocol Violation|0|||
147628126|NCT02105987|532456945|FG005|Late Switch Phase (24 Weeks)|Protocol Violation|0|||
147628127|NCT02105987|532456940|FG000|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
147628128|NCT02105987|532456941|FG001|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
147628129|NCT02105987|532456942|FG002|Late Switch Phase (24 Weeks)|Withdrawal by Subject|6|||
147628130|NCT02105987|532456943|FG003|Late Switch Phase (24 Weeks)|Withdrawal by Subject|5|||
147628131|NCT02105987|532456944|FG004|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
147628132|NCT02105987|532456945|FG005|Late Switch Phase (24 Weeks)|Withdrawal by Subject|0|||
147628133|NCT02105987|532456940|FG000|Late Switch Phase (24 Weeks)|Lost to Follow-up|0|||
147628134|NCT02105987|532456941|FG001|Late Switch Phase (24 Weeks)|Lost to Follow-up|0|||
147628135|NCT02105987|532456942|FG002|Late Switch Phase (24 Weeks)|Lost to Follow-up|8|||
147628136|NCT02105987|532456943|FG003|Late Switch Phase (24 Weeks)|Lost to Follow-up|3|||
147628137|NCT02105987|532456944|FG004|Late Switch Phase (24 Weeks)|Lost to Follow-up|0|||
147628138|NCT02105987|532456945|FG005|Late Switch Phase (24 Weeks)|Lost to Follow-up|0|||
147628139|NCT02105987|532456940|FG000|Late Switch Phase (24 Weeks)|Physician Decision|0|||
147628140|NCT02105987|532456941|FG001|Late Switch Phase (24 Weeks)|Physician Decision|0|||
147628141|NCT02105987|532456942|FG002|Late Switch Phase (24 Weeks)|Physician Decision|5|||
147628142|NCT02105987|532456943|FG003|Late Switch Phase (24 Weeks)|Physician Decision|0|||
147628143|NCT02105987|532456944|FG004|Late Switch Phase (24 Weeks)|Physician Decision|0|||
147628144|NCT02105987|532456945|FG005|Late Switch Phase (24 Weeks)|Physician Decision|0|||
147495290|NCT02282982|531968833|FG000|Overall Study|Lost to Follow-up|15|||
147495291|NCT02282982|531968833|FG000|Overall Study|Withdrew consent|2|||
147495292|NCT02282982|531968833|FG000|Overall Study|Death|4|||
147495293|NCT02282982|531968833|FG000|Overall Study|Lack of product|156|||
147495294|NCT02282982|531968833|FG000|Overall Study|Palivizumab is ended|11|||
147628145|NCT02105987|532456940|FG000|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0|||
147628146|NCT02105987|532456941|FG001|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0|||
147628147|NCT02105987|532456942|FG002|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0|||
147628148|NCT02105987|532456943|FG003|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|1|||
147628149|NCT02105987|532456944|FG004|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0|||
147495295|NCT02282982|531968833|FG000|Overall Study|Other, not specified|18|||
147495296|NCT02924688|531968836|FG000|Overall Study|Adverse Event|9|||
147495297|NCT02924688|531968837|FG001|Overall Study|Adverse Event|3|||
147495298|NCT02924688|531968838|FG002|Overall Study|Adverse Event|2|||
147495299|NCT02924688|531968839|FG003|Overall Study|Adverse Event|2|||
147495300|NCT02924688|531968840|FG004|Overall Study|Adverse Event|3|||
147495301|NCT02924688|531968841|FG005|Overall Study|Adverse Event|2|||
147495302|NCT02924688|531968836|FG000|Overall Study|Lack of Efficacy|2|||
147495303|NCT02924688|531968837|FG001|Overall Study|Lack of Efficacy|3|||
147495304|NCT02924688|531968838|FG002|Overall Study|Lack of Efficacy|4|||
147495305|NCT02924688|531968839|FG003|Overall Study|Lack of Efficacy|2|||
147495306|NCT02924688|531968840|FG004|Overall Study|Lack of Efficacy|1|||
147495307|NCT02924688|531968841|FG005|Overall Study|Lack of Efficacy|1|||
147495308|NCT02924688|531968836|FG000|Overall Study|Protocol Violation|3|||
147495309|NCT02924688|531968837|FG001|Overall Study|Protocol Violation|7|||
147495310|NCT02924688|531968838|FG002|Overall Study|Protocol Violation|5|||
147495311|NCT02924688|531968839|FG003|Overall Study|Protocol Violation|6|||
147495312|NCT02924688|531968840|FG004|Overall Study|Protocol Violation|2|||
147495313|NCT02924688|531968841|FG005|Overall Study|Protocol Violation|2|||
147495314|NCT02924688|531968836|FG000|Overall Study|Protocol defined withdrawal criteria met|1|||
147495315|NCT02924688|531968837|FG001|Overall Study|Protocol defined withdrawal criteria met|0|||
147495316|NCT02924688|531968838|FG002|Overall Study|Protocol defined withdrawal criteria met|1|||
147495317|NCT02924688|531968839|FG003|Overall Study|Protocol defined withdrawal criteria met|1|||
147495318|NCT02924688|531968840|FG004|Overall Study|Protocol defined withdrawal criteria met|1|||
147495319|NCT02924688|531968841|FG005|Overall Study|Protocol defined withdrawal criteria met|0|||
147495320|NCT02924688|531968836|FG000|Overall Study|Lost to Follow-up|2|||
147495321|NCT02924688|531968837|FG001|Overall Study|Lost to Follow-up|4|||
147495322|NCT02924688|531968838|FG002|Overall Study|Lost to Follow-up|2|||
147495323|NCT02924688|531968839|FG003|Overall Study|Lost to Follow-up|4|||
147495324|NCT02924688|531968840|FG004|Overall Study|Lost to Follow-up|2|||
147495325|NCT02924688|531968841|FG005|Overall Study|Lost to Follow-up|4|||
147495326|NCT02924688|531968836|FG000|Overall Study|Physician Decision|2|||
147495327|NCT02924688|531968837|FG001|Overall Study|Physician Decision|1|||
147495328|NCT02924688|531968838|FG002|Overall Study|Physician Decision|0|||
147495329|NCT02924688|531968839|FG003|Overall Study|Physician Decision|1|||
147495330|NCT02924688|531968840|FG004|Overall Study|Physician Decision|1|||
147495331|NCT02924688|531968841|FG005|Overall Study|Physician Decision|1|||
147495332|NCT02924688|531968836|FG000|Overall Study|Withdrawal by Subject|14|||
147495333|NCT02924688|531968837|FG001|Overall Study|Withdrawal by Subject|13|||
147495334|NCT02924688|531968838|FG002|Overall Study|Withdrawal by Subject|9|||
147495335|NCT02924688|531968839|FG003|Overall Study|Withdrawal by Subject|12|||
147495336|NCT02924688|531968840|FG004|Overall Study|Withdrawal by Subject|13|||
147495337|NCT02924688|531968841|FG005|Overall Study|Withdrawal by Subject|14|||
147495338|NCT01205451|531968853|FG000|Overall Study|Lost to Follow-up|1|||
147495339|NCT01205451|531968854|FG001|Overall Study|Lost to Follow-up|1|||
147495340|NCT01205451|531968853|FG000|Overall Study|Withdrawal by Subject|5|||
147668405|NCT01776554|532611781|FG001|Overall Study|Unclassified|1|||
147668406|NCT01041859|532611782|FG000|Open-Label Titration|Adverse Event|69|||
147668407|NCT01041859|532611783|FG001|Open-Label Titration|Adverse Event|0|||
147668408|NCT01041859|532611784|FG002|Open-Label Titration|Adverse Event|0|||
147668409|NCT01041859|532611782|FG000|Open-Label Titration|Lack of Efficacy|3|||
147668410|NCT01041859|532611783|FG001|Open-Label Titration|Lack of Efficacy|0|||
147668411|NCT01041859|532611784|FG002|Open-Label Titration|Lack of Efficacy|0|||
147668412|NCT01041859|532611782|FG000|Open-Label Titration|Lost to Follow-up|1|||
147495341|NCT01205451|531968854|FG001|Overall Study|Withdrawal by Subject|9|||
147495342|NCT00423735|531968857|FG000|Overall Study|Ineligible / No protocol treatment|8|||
147495343|NCT00423735|531968858|FG001|Overall Study|Ineligible / No protocol treatment|6|||
147495344|NCT00423735|531968859|FG002|Overall Study|Ineligible / No protocol treatment|0|||
147495345|NCT00579501|531968860|FG000|Overall Study|Death|1|||
147495346|NCT00579501|531968860|FG000|Overall Study|End of neoadjuvant therapy|25|||
147495347|NCT00579501|531968860|FG000|Overall Study|toxicity|1|||
147495348|NCT00579501|531968860|FG000|Overall Study|Secondary lesion|1|||
147495349|NCT00579501|531968860|FG000|Overall Study|Radiation therapy before surgery|1|||
147495350|NCT01089582|531968861|FG000|Overall Study|Death|2|||
147495351|NCT01089582|531968861|FG000|Overall Study|Adverse Event|15|||
147495352|NCT01089582|531968861|FG000|Overall Study|Lost to Follow-up|8|||
147495353|NCT01089582|531968861|FG000|Overall Study|Other|4|||
147668413|NCT01041859|532611783|FG001|Open-Label Titration|Lost to Follow-up|0|||
147668414|NCT01041859|532611784|FG002|Open-Label Titration|Lost to Follow-up|0|||
147668415|NCT01041859|532611782|FG000|Open-Label Titration|Physician Decision|1|||
147495354|NCT01089582|531968861|FG000|Overall Study|Withdrawal by Subject|1|||
147495355|NCT02287402|531968862|FG000|Treatment Period|Adverse Event|17|||
147495356|NCT02287402|531968862|FG000|Treatment Period|Voluntary Withdrawal|10|||
147495357|NCT02287402|531968862|FG000|Follow-up|Lost to Follow-up|1|||
147495358|NCT02287402|531968862|FG000|Follow-up|Voluntary Withdrawal|2|||
147495359|NCT02394808|531968863|FG000|Period 1|Unsatisfactory lens fitting|0|||
147495360|NCT02394808|531968864|FG001|Period 1|Unsatisfactory lens fitting|1|||
147495361|NCT02394808|531968863|FG000|Period 2|Lost to Follow-up|1|||
147628150|NCT02105987|532456945|FG005|Late Switch Phase (24 Weeks)|met protocol defined stopping criteria|0|||
147628151|NCT02105987|532456940|FG000|Late Switch Phase (24 Weeks)|Per sponsor request|0|||
147628152|NCT02105987|532456941|FG001|Late Switch Phase (24 Weeks)|Per sponsor request|0|||
147628153|NCT02105987|532456942|FG002|Late Switch Phase (24 Weeks)|Per sponsor request|1|||
147628154|NCT02105987|532456943|FG003|Late Switch Phase (24 Weeks)|Per sponsor request|0|||
147628155|NCT02105987|532456944|FG004|Late Switch Phase (24 Weeks)|Per sponsor request|0|||
147628156|NCT02105987|532456945|FG005|Late Switch Phase (24 Weeks)|Per sponsor request|0|||
147628157|NCT02105987|532456940|FG000|Continuation Phase|Protocol Violation|0|||
147628158|NCT02105987|532456941|FG001|Continuation Phase|Protocol Violation|0|||
147628159|NCT02105987|532456942|FG002|Continuation Phase|Protocol Violation|0|||
147628160|NCT02105987|532456943|FG003|Continuation Phase|Protocol Violation|0|||
147628161|NCT02105987|532456944|FG004|Continuation Phase|Protocol Violation|1|||
147628162|NCT02105987|532456945|FG005|Continuation Phase|Protocol Violation|0|||
147628163|NCT03926117|532456952|FG000|Overall Study|Unclassified|1|||
147628164|NCT03926117|532456953|FG001|Overall Study|Unclassified|4|||
147628165|NCT03926117|532456954|FG002|Overall Study|Unclassified|1|||
147628166|NCT03926117|532456955|FG003|Overall Study|Unclassified|4|||
147628167|NCT03926117|532456952|FG000|Overall Study|Withdrawal by Subject|3|||
147628168|NCT03926117|532456953|FG001|Overall Study|Withdrawal by Subject|0|||
147628169|NCT03926117|532456954|FG002|Overall Study|Withdrawal by Subject|1|||
147628170|NCT03926117|532456955|FG003|Overall Study|Withdrawal by Subject|1|||
147628171|NCT03926117|532456952|FG000|Overall Study|Lost to Follow-up|0|||
147495362|NCT02394808|531968864|FG001|Period 2|Lost to Follow-up|0|||
147495363|NCT00209170|531968865|FG000|Overall Study|Adverse Event|0|||
147495364|NCT00209170|531968866|FG001|Overall Study|Adverse Event|1|||
147495365|NCT00209170|531968865|FG000|Overall Study|Withdrawal by Subject|2|||
147495366|NCT00209170|531968866|FG001|Overall Study|Withdrawal by Subject|1|||
147495367|NCT00209170|531968865|FG000|Overall Study|Lack of Efficacy|0|||
147495368|NCT00209170|531968866|FG001|Overall Study|Lack of Efficacy|1|||
147495369|NCT02130427|531968867|FG000|Overall Study|Imaging results not interpretable|30|||
147495370|NCT02108600|531968872|FG000|Overall Study|Withdrawal by Subject|2|||
147495371|NCT02108600|531968873|FG001|Overall Study|Withdrawal by Subject|0|||
147495372|NCT02108600|531968872|FG000|Overall Study|Lost to Follow-up|1|||
147495373|NCT02108600|531968873|FG001|Overall Study|Lost to Follow-up|1|||
147495374|NCT01295580|531968875|FG000|Overall Study|Protocol Violation|4|||
147495375|NCT01295580|531968876|FG001|Overall Study|Protocol Violation|2|||
147495376|NCT01295580|531968875|FG000|Overall Study|Withdrawal by Subject|1|||
147495377|NCT01295580|531968876|FG001|Overall Study|Withdrawal by Subject|4|||
147495378|NCT01295580|531968875|FG000|Overall Study|Adverse Event|2|||
147495379|NCT01295580|531968876|FG001|Overall Study|Adverse Event|1|||
147628172|NCT03926117|532456953|FG001|Overall Study|Lost to Follow-up|2|||
147628173|NCT03926117|532456954|FG002|Overall Study|Lost to Follow-up|1|||
147628174|NCT03926117|532456955|FG003|Overall Study|Lost to Follow-up|0|||
147628175|NCT03926117|532456952|FG000|Overall Study|Adverse Event|1|||
147628176|NCT03926117|532456953|FG001|Overall Study|Adverse Event|2|||
147628177|NCT03926117|532456954|FG002|Overall Study|Adverse Event|3|||
147628178|NCT03926117|532456955|FG003|Overall Study|Adverse Event|1|||
147628179|NCT03926117|532456952|FG000|Overall Study|Randomized but not treated|1|||
147628180|NCT03926117|532456953|FG001|Overall Study|Randomized but not treated|1|||
147628181|NCT03926117|532456954|FG002|Overall Study|Randomized but not treated|0|||
147628182|NCT03926117|532456955|FG003|Overall Study|Randomized but not treated|1|||
147628183|NCT02748356|532456964|FG000|Overall Study|Withdrawal by Subject|1|||
147628184|NCT05107492|532456965|FG000|Overall Study|Lost to Follow-up|1|||
147628185|NCT05107492|532456966|FG001|Overall Study|Lost to Follow-up|0|||
147628186|NCT05236764|532456967|FG000|Overall Study|In follow up (ongoing)|1|||
147628187|NCT05236764|532456967|FG000|Overall Study|Taken off study - secondary graft failure|1|||
147628188|NCT05236764|532456967|FG000|Overall Study|Death|1|||
147628189|NCT05870371|532456968|FG000|Overall Study|Nonadherence (missed appointmetns).|24|||
147628190|NCT05870371|532456969|FG001|Overall Study|Nonadherence (missed appointmetns).|24|||
147628191|NCT00564850|532456976|FG000|Overall Study|Protocol Violation|2|||
147628192|NCT00652626|532458650|FG000|Initial Treatment Phase|Adverse Event|0|||
147628193|NCT00652626|532458651|FG001|Initial Treatment Phase|Adverse Event|0|||
147628194|NCT00652626|532458652|FG002|Initial Treatment Phase|Adverse Event|0|||
147628195|NCT00652626|532458653|FG003|Initial Treatment Phase|Adverse Event|0|||
147628196|NCT00652626|532458654|FG004|Initial Treatment Phase|Adverse Event|1|||
147495380|NCT01295580|531968875|FG000|Overall Study|Lost to Follow-up|1|||
147495381|NCT01295580|531968876|FG001|Overall Study|Lost to Follow-up|0|||
147495382|NCT01295580|531968875|FG000|Overall Study|Lack of Efficacy|1|||
147495383|NCT01295580|531968876|FG001|Overall Study|Lack of Efficacy|0|||
147628197|NCT00652626|532458655|FG005|Initial Treatment Phase|Adverse Event|0|||
147628198|NCT00652626|532458656|FG006|Initial Treatment Phase|Adverse Event|0|||
147628199|NCT00652626|532458650|FG000|Initial Treatment Phase|Protocol Violation|0|||
147628200|NCT00652626|532458651|FG001|Initial Treatment Phase|Protocol Violation|0|||
147495384|NCT01295580|531968875|FG000|Overall Study|Other: inconvenience|1|||
147495385|NCT01295580|531968876|FG001|Overall Study|Other: inconvenience|0|||
147628201|NCT00652626|532458652|FG002|Initial Treatment Phase|Protocol Violation|0|||
147495386|NCT01295580|531968875|FG000|Overall Study|Other: family objection|0|||
147495387|NCT01295580|531968876|FG001|Overall Study|Other: family objection|1|||
147495388|NCT04032171|531968877|FG000|Overall Study|Study Termination|1|||
147495389|NCT04032171|531968878|FG001|Overall Study|Study Termination|0|||
147495390|NCT00992784|531968879|FG000|Overall Study|Adverse Event|2|||
147495391|NCT00992784|531968880|FG001|Overall Study|Adverse Event|1|||
147495392|NCT00992784|531968881|FG002|Overall Study|Adverse Event|0|||
147495393|NCT00992784|531968879|FG000|Overall Study|Withdrawal by Subject|1|||
147668416|NCT01041859|532611783|FG001|Open-Label Titration|Physician Decision|0|||
147668417|NCT01041859|532611784|FG002|Open-Label Titration|Physician Decision|0|||
147668418|NCT01041859|532611782|FG000|Open-Label Titration|Protocol Violation|1|||
147668419|NCT01041859|532611783|FG001|Open-Label Titration|Protocol Violation|0|||
147668420|NCT01041859|532611784|FG002|Open-Label Titration|Protocol Violation|0|||
147668421|NCT01041859|532611782|FG000|Open-Label Titration|Other|7|||
147668422|NCT01041859|532611783|FG001|Open-Label Titration|Other|0|||
147495394|NCT00992784|531968880|FG001|Overall Study|Withdrawal by Subject|1|||
147495395|NCT00992784|531968881|FG002|Overall Study|Withdrawal by Subject|1|||
147495396|NCT00642746|531968882|FG000|Overall Study|Patient unevaluable|1|||
147495397|NCT00642746|531968883|FG001|Overall Study|Patient unevaluable|0|||
147495398|NCT00424294|531968884|FG000|Overall Study|Adverse Event|4|||
147495399|NCT00424294|531968885|FG001|Overall Study|Adverse Event|10|||
147495400|NCT00424294|531968884|FG000|Overall Study|Lack of Efficacy|2|||
147495401|NCT00424294|531968885|FG001|Overall Study|Lack of Efficacy|1|||
147495402|NCT00424294|531968884|FG000|Overall Study|Withdrawal by Subject|1|||
147495403|NCT00424294|531968885|FG001|Overall Study|Withdrawal by Subject|2|||
147495404|NCT00424294|531968884|FG000|Overall Study|Other|0|||
147495405|NCT00424294|531968885|FG001|Overall Study|Other|2|||
147495406|NCT00424294|531968884|FG000|Overall Study|Randomized but not Treated|1|||
147495407|NCT00424294|531968885|FG001|Overall Study|Randomized but not Treated|0|||
147495408|NCT00976950|531968889|FG000|Overall Study|Adverse Event|3|||
147495409|NCT00976950|531968889|FG000|Overall Study|Events with no relationship to Aptivus|3|||
147495410|NCT02932332|531968898|FG000|Overall Study|Withdrawal by Subject|1|||
147495411|NCT02932332|531968899|FG001|Overall Study|Withdrawal by Subject|1|||
147495412|NCT02932332|531968900|FG002|Overall Study|Withdrawal by Subject|0|||
147495413|NCT02932332|531968901|FG003|Overall Study|Withdrawal by Subject|1|||
147495414|NCT02932332|531968898|FG000|Overall Study|Chest pain|0|||
147495415|NCT02932332|531968899|FG001|Overall Study|Chest pain|0|||
147495416|NCT02932332|531968900|FG002|Overall Study|Chest pain|0|||
147495417|NCT02932332|531968901|FG003|Overall Study|Chest pain|1|||
147495418|NCT02932332|531968898|FG000|Overall Study|Not Dyspneic cough|1|||
147495419|NCT02932332|531968899|FG001|Overall Study|Not Dyspneic cough|2|||
147495420|NCT02932332|531968900|FG002|Overall Study|Not Dyspneic cough|1|||
147495421|NCT02932332|531968901|FG003|Overall Study|Not Dyspneic cough|0|||
147495422|NCT01069523|531968902|FG000|Overall Study|Withdrawal by Subject|4|||
147668423|NCT01041859|532611784|FG002|Open-Label Titration|Other|0|||
147668424|NCT01041859|532611782|FG000|Open-Label Titration|Noncompliance With Study Drug|8|||
147668425|NCT01041859|532611783|FG001|Open-Label Titration|Noncompliance With Study Drug|0|||
147668426|NCT01041859|532611784|FG002|Open-Label Titration|Noncompliance With Study Drug|0|||
147495423|NCT01069523|531968903|FG001|Overall Study|Withdrawal by Subject|7|||
147495424|NCT01025817|531968906|FG000|Completed Study Medication|Adverse Event|66|||
147495425|NCT01025817|531968907|FG001|Completed Study Medication|Adverse Event|39|||
147495426|NCT01025817|531968906|FG000|Completed Study Medication|Protocol Deviation|9|||
147495427|NCT01025817|531968907|FG001|Completed Study Medication|Protocol Deviation|8|||
147495428|NCT01025817|531968906|FG000|Completed Study Medication|Withdrawal by Subject|8|||
147495429|NCT01025817|531968907|FG001|Completed Study Medication|Withdrawal by Subject|9|||
147495430|NCT01025817|531968906|FG000|Completed Study Medication|Administrative problems|7|||
147495431|NCT01025817|531968907|FG001|Completed Study Medication|Administrative problems|5|||
147495432|NCT01025817|531968906|FG000|Completed Study Medication|Unsatisfactory therapeutic effect|7|||
147495433|NCT01025817|531968907|FG001|Completed Study Medication|Unsatisfactory therapeutic effect|0|||
147495434|NCT01025817|531968906|FG000|Completed Study Medication|Abnormal test procedure|4|||
147495435|NCT01025817|531968907|FG001|Completed Study Medication|Abnormal test procedure|0|||
147495436|NCT01025817|531968906|FG000|Completed Study Medication|Graft loss|2|||
147495437|NCT01025817|531968907|FG001|Completed Study Medication|Graft loss|5|||
147495438|NCT01025817|531968906|FG000|Completed Study Medication|Death|2|||
147495439|NCT01025817|531968907|FG001|Completed Study Medication|Death|2|||
147495440|NCT01025817|531968906|FG000|Completed Study Medication|Abnormal lab values|0|||
147495441|NCT01025817|531968907|FG001|Completed Study Medication|Abnormal lab values|2|||
147495442|NCT01025817|531968906|FG000|Completed Study Medication|Subject no longer required study drug|0|||
147495443|NCT01025817|531968907|FG001|Completed Study Medication|Subject no longer required study drug|1|||
147495444|NCT01025817|531968906|FG000|Completed Study Medication|Lost to Follow-up|0|||
147495445|NCT01025817|531968907|FG001|Completed Study Medication|Lost to Follow-up|1|||
147495446|NCT01025817|531968906|FG000|Completed Study|Withdrawal by Subject|8|||
147668427|NCT01041859|532611782|FG000|Open-Label Titration|Withdrawal by Subject|11|||
147495447|NCT01025817|531968907|FG001|Completed Study|Withdrawal by Subject|16|||
147495448|NCT01025817|531968906|FG000|Completed Study|Death|6|||
147628202|NCT00652626|532458653|FG003|Initial Treatment Phase|Protocol Violation|1|||
147628203|NCT00652626|532458654|FG004|Initial Treatment Phase|Protocol Violation|0|||
147628204|NCT00652626|532458655|FG005|Initial Treatment Phase|Protocol Violation|0|||
147628205|NCT00652626|532458656|FG006|Initial Treatment Phase|Protocol Violation|0|||
147628206|NCT00652626|532458650|FG000|Initial Treatment Phase|Physician Decision|0|||
147628207|NCT00652626|532458651|FG001|Initial Treatment Phase|Physician Decision|0|||
147628208|NCT00652626|532458652|FG002|Initial Treatment Phase|Physician Decision|0|||
147628209|NCT00652626|532458653|FG003|Initial Treatment Phase|Physician Decision|0|||
147628210|NCT00652626|532458654|FG004|Initial Treatment Phase|Physician Decision|1|||
147628211|NCT00652626|532458655|FG005|Initial Treatment Phase|Physician Decision|0|||
147628212|NCT00652626|532458656|FG006|Initial Treatment Phase|Physician Decision|0|||
147628213|NCT00652626|532458650|FG000|Initial Treatment Phase|Sponsor Request|0|||
147628214|NCT00652626|532458651|FG001|Initial Treatment Phase|Sponsor Request|0|||
147628215|NCT00652626|532458652|FG002|Initial Treatment Phase|Sponsor Request|1|||
147628216|NCT00652626|532458653|FG003|Initial Treatment Phase|Sponsor Request|0|||
147628217|NCT00652626|532458654|FG004|Initial Treatment Phase|Sponsor Request|0|||
147628218|NCT00652626|532458655|FG005|Initial Treatment Phase|Sponsor Request|0|||
147628219|NCT00652626|532458656|FG006|Initial Treatment Phase|Sponsor Request|0|||
147628220|NCT00652626|532458650|FG000|Initial Treatment Phase|Lost to Follow-up|0|||
147628221|NCT00652626|532458651|FG001|Initial Treatment Phase|Lost to Follow-up|0|||
147628222|NCT00652626|532458652|FG002|Initial Treatment Phase|Lost to Follow-up|0|||
147628223|NCT00652626|532458653|FG003|Initial Treatment Phase|Lost to Follow-up|0|||
147628224|NCT00652626|532458654|FG004|Initial Treatment Phase|Lost to Follow-up|1|||
147628225|NCT00652626|532458655|FG005|Initial Treatment Phase|Lost to Follow-up|0|||
147628226|NCT00652626|532458656|FG006|Initial Treatment Phase|Lost to Follow-up|0|||
147628227|NCT00652626|532458650|FG000|Extension Phase|Withdrawal by Subject|0|||
147628228|NCT00652626|532458651|FG001|Extension Phase|Withdrawal by Subject|0|||
147628229|NCT00652626|532458652|FG002|Extension Phase|Withdrawal by Subject|0|||
147628230|NCT00652626|532458653|FG003|Extension Phase|Withdrawal by Subject|0|||
147628231|NCT00652626|532458654|FG004|Extension Phase|Withdrawal by Subject|0|||
147628232|NCT00652626|532458655|FG005|Extension Phase|Withdrawal by Subject|2|||
147628233|NCT00652626|532458656|FG006|Extension Phase|Withdrawal by Subject|0|||
147628234|NCT00652626|532458650|FG000|Extension Phase|Adverse Event|0|||
147628235|NCT00652626|532458651|FG001|Extension Phase|Adverse Event|0|||
147628236|NCT00652626|532458652|FG002|Extension Phase|Adverse Event|0|||
147628237|NCT00652626|532458653|FG003|Extension Phase|Adverse Event|0|||
147628238|NCT00652626|532458654|FG004|Extension Phase|Adverse Event|0|||
147628239|NCT00652626|532458655|FG005|Extension Phase|Adverse Event|2|||
147628240|NCT00652626|532458656|FG006|Extension Phase|Adverse Event|1|||
147628241|NCT00652626|532458650|FG000|Extension Phase|No Longer Receiving Clinical Benefit|0|||
147628242|NCT00652626|532458651|FG001|Extension Phase|No Longer Receiving Clinical Benefit|0|||
147628243|NCT00652626|532458652|FG002|Extension Phase|No Longer Receiving Clinical Benefit|0|||
147628244|NCT00652626|532458653|FG003|Extension Phase|No Longer Receiving Clinical Benefit|0|||
147628245|NCT00652626|532458654|FG004|Extension Phase|No Longer Receiving Clinical Benefit|0|||
147628246|NCT00652626|532458655|FG005|Extension Phase|No Longer Receiving Clinical Benefit|6|||
147628247|NCT00652626|532458656|FG006|Extension Phase|No Longer Receiving Clinical Benefit|0|||
147628248|NCT00652626|532458650|FG000|Extension Phase|Physician Decision|0|||
147628249|NCT00652626|532458651|FG001|Extension Phase|Physician Decision|0|||
147628250|NCT00652626|532458652|FG002|Extension Phase|Physician Decision|0|||
147628251|NCT00652626|532458653|FG003|Extension Phase|Physician Decision|0|||
147628252|NCT00652626|532458654|FG004|Extension Phase|Physician Decision|0|||
147628253|NCT00652626|532458655|FG005|Extension Phase|Physician Decision|1|||
147628254|NCT00652626|532458656|FG006|Extension Phase|Physician Decision|1|||
147628255|NCT00652626|532458650|FG000|Extension Phase|Death|0|||
147628256|NCT00652626|532458651|FG001|Extension Phase|Death|0|||
147628257|NCT00652626|532458652|FG002|Extension Phase|Death|0|||
147628258|NCT00652626|532458653|FG003|Extension Phase|Death|0|||
147628259|NCT00652626|532458654|FG004|Extension Phase|Death|0|||
147628260|NCT00652626|532458655|FG005|Extension Phase|Death|1|||
147628261|NCT00652626|532458656|FG006|Extension Phase|Death|1|||
147628262|NCT04003636|532458657|FG000|Overall Study|Death|409|||
147628263|NCT04003636|532458658|FG001|Overall Study|Death|443|||
147628264|NCT04003636|532458657|FG000|Overall Study|Lost to Follow-up|0|||
147628265|NCT04003636|532458658|FG001|Overall Study|Lost to Follow-up|1|||
147628266|NCT04003636|532458657|FG000|Overall Study|Withdrawal by Subject|5|||
147495449|NCT01025817|531968907|FG001|Completed Study|Death|5|||
147628267|NCT04003636|532458658|FG001|Overall Study|Withdrawal by Subject|2|||
147628268|NCT04003636|532458657|FG000|Overall Study|Participant On-going|119|||
147628269|NCT04003636|532458658|FG001|Overall Study|Participant On-going|90|||
147495450|NCT01025817|531968906|FG000|Completed Study|Missing|2|||
147628270|NCT02058537|532458659|FG000|Overall Study|Withdrawal by Subject|1|||
147628271|NCT02582242|532458660|FG000|Overall Study|Adverse Event|4|||
147628272|NCT02582242|532458661|FG001|Overall Study|Adverse Event|3|||
147628273|NCT02582242|532458660|FG000|Overall Study|Protocol Violation|3|||
147628274|NCT02582242|532458661|FG001|Overall Study|Protocol Violation|1|||
147495451|NCT01025817|531968907|FG001|Completed Study|Missing|0|||
147495452|NCT01025817|531968906|FG000|Completed Study|Lost to Follow-up|0|||
147495453|NCT01025817|531968907|FG001|Completed Study|Lost to Follow-up|1|||
147495454|NCT04533815|531968911|FG000|Overall Study|Adverse Event|2|||
147495455|NCT04533815|531968911|FG000|Overall Study|Site withdrew|5|||
147495456|NCT00488592|531968914|FG000|Overall Study|Withdrawal by Subject|1|||
147495457|NCT00488592|531968914|FG000|Overall Study|Disease progression|1|||
147495458|NCT00488592|531968914|FG000|Overall Study|Enrolled but not treated|1|||
147495459|NCT00441103|531968915|FG000|Overall Study|Adverse Event|2|||
147495460|NCT00441103|531968916|FG001|Overall Study|Adverse Event|1|||
147495461|NCT00441103|531968915|FG000|Overall Study|Death|1|||
147495462|NCT00441103|531968916|FG001|Overall Study|Death|0|||
147495463|NCT00441103|531968915|FG000|Overall Study|Disease Progression|2|||
147495464|NCT00441103|531968916|FG001|Overall Study|Disease Progression|0|||
147495465|NCT00441103|531968915|FG000|Overall Study|Lost to Follow-up|1|||
147495466|NCT00441103|531968916|FG001|Overall Study|Lost to Follow-up|0|||
147495467|NCT00441103|531968915|FG000|Overall Study|Protocol Violation|1|||
147495468|NCT00441103|531968916|FG001|Overall Study|Protocol Violation|0|||
147495469|NCT00441103|531968915|FG000|Overall Study|Participant unable to use Rebiject II|1|||
147495470|NCT00441103|531968916|FG001|Overall Study|Participant unable to use Rebiject II|0|||
147495471|NCT00441103|531968915|FG000|Overall Study|Participant refused MRI|1|||
147495472|NCT00441103|531968916|FG001|Overall Study|Participant refused MRI|0|||
147495473|NCT00441103|531968915|FG000|Overall Study|Inclusion criteria absent|1|||
147495474|NCT00441103|531968916|FG001|Overall Study|Inclusion criteria absent|0|||
147495475|NCT00441103|531968915|FG000|Overall Study|Non-compliant|0|||
147495476|NCT00441103|531968916|FG001|Overall Study|Non-compliant|1|||
147495477|NCT00441103|531968915|FG000|Overall Study|Participant decided to withdraw|1|||
147495478|NCT00441103|531968916|FG001|Overall Study|Participant decided to withdraw|0|||
147495479|NCT00441103|531968915|FG000|Overall Study|Participant's reason|0|||
147495480|NCT00441103|531968916|FG001|Overall Study|Participant's reason|1|||
147495481|NCT00441103|531968915|FG000|Overall Study|Participant decided to stop|0|||
147495482|NCT00441103|531968916|FG001|Overall Study|Participant decided to stop|1|||
147495483|NCT01655823|531968917|FG000|Overall Study|Lost to Follow-up|0|||
147495484|NCT01655823|531968918|FG001|Overall Study|Lost to Follow-up|1|||
147495485|NCT01655823|531968919|FG002|Overall Study|Lost to Follow-up|0|||
147495486|NCT01655823|531968920|FG003|Overall Study|Lost to Follow-up|0|||
147495487|NCT01655823|531968921|FG004|Overall Study|Lost to Follow-up|1|||
147495488|NCT01655823|531968917|FG000|Overall Study|Withdrawal by Subject|0|||
147495489|NCT01655823|531968918|FG001|Overall Study|Withdrawal by Subject|1|||
147495490|NCT01655823|531968919|FG002|Overall Study|Withdrawal by Subject|0|||
147495491|NCT01655823|531968920|FG003|Overall Study|Withdrawal by Subject|1|||
147495492|NCT01655823|531968921|FG004|Overall Study|Withdrawal by Subject|0|||
147495493|NCT01627067|531968922|FG000|Overall Study|Screen Failure|1|||
147495494|NCT02632110|531968926|FG000|Overall Study|Withdrawal by Subject|1|||
147495495|NCT02632110|531968927|FG001|Overall Study|Withdrawal by Subject|1|||
147495496|NCT02632110|531968928|FG002|Overall Study|Withdrawal by Subject|0|||
147495497|NCT02632110|531968929|FG003|Overall Study|Withdrawal by Subject|0|||
147495498|NCT02632110|531968930|FG004|Overall Study|Withdrawal by Subject|1|||
147495499|NCT02632110|531968931|FG005|Overall Study|Withdrawal by Subject|1|||
147495500|NCT02632110|531968932|FG006|Overall Study|Withdrawal by Subject|3|||
147495501|NCT02632110|531968933|FG007|Overall Study|Withdrawal by Subject|3|||
147495502|NCT02632110|531968934|FG008|Overall Study|Withdrawal by Subject|1|||
147495503|NCT02632110|531968935|FG009|Overall Study|Withdrawal by Subject|1|||
147495504|NCT03352414|531968936|FG000|Overall Study|Ineligible by operative criteria|12|||
147628275|NCT02582242|532458660|FG000|Overall Study|Lost to Follow-up|0|||
147628276|NCT02582242|532458661|FG001|Overall Study|Lost to Follow-up|1|||
147628277|NCT02582242|532458660|FG000|Overall Study|Withdrawal by Subject|11|||
147628278|NCT02582242|532458661|FG001|Overall Study|Withdrawal by Subject|11|||
147628279|NCT02582242|532458660|FG000|Overall Study|Unclassified|2|||
147628280|NCT02582242|532458661|FG001|Overall Study|Unclassified|1|||
147628281|NCT00300885|532458662|FG000|Treatment|Adverse Event|134|||
147628282|NCT00300885|532458663|FG001|Treatment|Adverse Event|82|||
147628283|NCT00300885|532458662|FG000|Treatment|Death|20|||
147628284|NCT00300885|532458663|FG001|Treatment|Death|7|||
147628285|NCT00300885|532458662|FG000|Treatment|Lack of Efficacy|1|||
147495505|NCT03352414|531968937|FG001|Overall Study|Ineligible by operative criteria|10|||
147495506|NCT01348425|531968938|FG000|Overall Study|Imaging was not taken.|1|||
147495507|NCT01348425|531968939|FG001|Overall Study|Imaging was not taken.|1|||
147495508|NCT01968954|531968945|FG000|Overall Study|Adverse Event|6|||
147495509|NCT01968954|531968946|FG001|Overall Study|Adverse Event|3|||
147495510|NCT01968954|531968945|FG000|Overall Study|Death|1|||
147628286|NCT00300885|532458663|FG001|Treatment|Lack of Efficacy|1|||
147628287|NCT00300885|532458662|FG000|Treatment|Lost to Follow-up|3|||
147628288|NCT00300885|532458663|FG001|Treatment|Lost to Follow-up|2|||
147628289|NCT00300885|532458662|FG000|Treatment|Physician Decision|4|||
147495511|NCT01968954|531968946|FG001|Overall Study|Death|2|||
147495512|NCT01968954|531968945|FG000|Overall Study|Lost to Follow-up|6|||
147495513|NCT01968954|531968946|FG001|Overall Study|Lost to Follow-up|4|||
147628290|NCT00300885|532458663|FG001|Treatment|Physician Decision|5|||
147628291|NCT00300885|532458662|FG000|Treatment|Protocol Violation|11|||
147628292|NCT00300885|532458663|FG001|Treatment|Protocol Violation|11|||
147628293|NCT00300885|532458662|FG000|Treatment|Withdrawal by Subject|26|||
147628294|NCT00300885|532458663|FG001|Treatment|Withdrawal by Subject|23|||
147628295|NCT00300885|532458662|FG000|Treatment|Disease progression|171|||
147628296|NCT00300885|532458663|FG001|Treatment|Disease progression|238|||
147628297|NCT00300885|532458662|FG000|Treatment|Random code broken (subject died)|0|||
147628298|NCT00300885|532458663|FG001|Treatment|Random code broken (subject died)|1|||
147628299|NCT00300885|532458662|FG000|Treatment|Non-compliant with study medication|3|||
147628300|NCT00300885|532458663|FG001|Treatment|Non-compliant with study medication|4|||
147628301|NCT00300885|532458662|FG000|Follow-up|Death|141|||
147628302|NCT00300885|532458663|FG001|Follow-up|Death|163|||
147628303|NCT00300885|532458662|FG000|Follow-up|Lost to Follow-up|11|||
147628304|NCT00300885|532458663|FG001|Follow-up|Lost to Follow-up|7|||
147628305|NCT00300885|532458662|FG000|Follow-up|Withdrawal by Subject|26|||
147628306|NCT00300885|532458663|FG001|Follow-up|Withdrawal by Subject|25|||
147628307|NCT02101736|532458667|FG000|Overall Study|Protocol Violation|3|||
147628308|NCT02101736|532458668|FG001|Overall Study|Protocol Violation|0|||
147628309|NCT02101736|532458667|FG000|Overall Study|Withdrawal by Subject|1|||
147628310|NCT02101736|532458668|FG001|Overall Study|Withdrawal by Subject|1|||
147628311|NCT00459290|532458669|FG000|Overall Study|Adverse Event|3|||
147628312|NCT00459290|532458669|FG000|Overall Study|Ineligible|2|||
147628313|NCT03691207|532458670|FG000|Overall Study|Death|41|||
147628314|NCT03691207|532458671|FG001|Overall Study|Death|26|||
147628315|NCT03691207|532458670|FG000|Overall Study|Lost to Follow-up|1|||
147628316|NCT03691207|532458671|FG001|Overall Study|Lost to Follow-up|1|||
147628317|NCT03691207|532458670|FG000|Overall Study|Withdrawal by Subject|2|||
147628318|NCT03691207|532458671|FG001|Overall Study|Withdrawal by Subject|8|||
147628319|NCT03691207|532458670|FG000|Overall Study|Sponsor decision|1|||
147628320|NCT03691207|532458671|FG001|Overall Study|Sponsor decision|7|||
147628321|NCT01134107|532458673|FG000|Period 1-First Treatment Intervention|Adverse Event|1|||
147628322|NCT01134107|532458674|FG001|Period 1-First Treatment Intervention|Adverse Event|0|||
147628323|NCT01134107|532458673|FG000|Period 1-First Treatment Intervention|Entry Criteria Not Met|1|||
147628324|NCT01134107|532458674|FG001|Period 1-First Treatment Intervention|Entry Criteria Not Met|1|||
147628325|NCT01134107|532458673|FG000|Period 1-First Treatment Intervention|Withdrawal by Subject|3|||
147628326|NCT01134107|532458674|FG001|Period 1-First Treatment Intervention|Withdrawal by Subject|4|||
147628327|NCT01134107|532458673|FG000|Period 1-First Treatment Intervention|Physician Decision|1|||
147628328|NCT01134107|532458674|FG001|Period 1-First Treatment Intervention|Physician Decision|0|||
147628329|NCT01134107|532458673|FG000|Period 2-Second Treatment Intervention|Withdrawal by Subject|2|||
147628330|NCT01134107|532458674|FG001|Period 2-Second Treatment Intervention|Withdrawal by Subject|0|||
147628331|NCT01134107|532458673|FG000|Period 2-Second Treatment Intervention|Physician Decision|1|||
147628332|NCT01134107|532458674|FG001|Period 2-Second Treatment Intervention|Physician Decision|0|||
147628333|NCT01134107|532458673|FG000|Period 2-Second Treatment Intervention|Sponsor Decision|1|||
147628334|NCT01134107|532458674|FG001|Period 2-Second Treatment Intervention|Sponsor Decision|0|||
147628335|NCT00687271|532458675|FG000|Overall Study|Adverse Event|1|||
147628336|NCT00687271|532458676|FG001|Overall Study|Adverse Event|3|||
147628337|NCT00687271|532458677|FG002|Overall Study|Adverse Event|1|||
147628338|NCT00687271|532458678|FG003|Overall Study|Adverse Event|0|||
147628339|NCT00687271|532458675|FG000|Overall Study|Lost to Follow-up|0|||
147628340|NCT00687271|532458676|FG001|Overall Study|Lost to Follow-up|1|||
147628341|NCT00687271|532458677|FG002|Overall Study|Lost to Follow-up|0|||
147628342|NCT00687271|532458678|FG003|Overall Study|Lost to Follow-up|0|||
147628343|NCT00687271|532458675|FG000|Overall Study|Protocol Violation|2|||
147628344|NCT00687271|532458676|FG001|Overall Study|Protocol Violation|1|||
147628345|NCT00687271|532458677|FG002|Overall Study|Protocol Violation|1|||
147628346|NCT00687271|532458678|FG003|Overall Study|Protocol Violation|0|||
147628347|NCT00687271|532458675|FG000|Overall Study|Withdrawal by Subject|0|||
147628348|NCT00687271|532458676|FG001|Overall Study|Withdrawal by Subject|1|||
147628349|NCT00687271|532458677|FG002|Overall Study|Withdrawal by Subject|3|||
147628350|NCT00687271|532458678|FG003|Overall Study|Withdrawal by Subject|0|||
147628351|NCT05483686|532458679|FG000|Overall Study|Lost to Follow-up|5|||
147628352|NCT05483686|532458680|FG001|Overall Study|Lost to Follow-up|7|||
147628353|NCT05780983|532458681|FG000|Overall Study|Withdrawal by Subject|1|||
147628354|NCT04747886|532458682|FG000|Overall Study|Withdrawal by Subject|1|||
147628355|NCT04747886|532458683|FG001|Overall Study|Withdrawal by Subject|4|||
147628356|NCT03777436|532458684|FG000|Placebo-controlled Phase|Adverse Event|8|||
147628357|NCT03777436|532458685|FG001|Placebo-controlled Phase|Adverse Event|10|||
147628358|NCT03777436|532458686|FG002|Placebo-controlled Phase|Adverse Event|0|||
147628359|NCT03777436|532458684|FG000|Placebo-controlled Phase|Lack of Efficacy|0|||
147628360|NCT03777436|532458685|FG001|Placebo-controlled Phase|Lack of Efficacy|1|||
147628361|NCT03777436|532458686|FG002|Placebo-controlled Phase|Lack of Efficacy|0|||
147628362|NCT03777436|532458684|FG000|Placebo-controlled Phase|Withdrawal by Subject|19|||
147628363|NCT03777436|532458685|FG001|Placebo-controlled Phase|Withdrawal by Subject|3|||
147628364|NCT03777436|532458686|FG002|Placebo-controlled Phase|Withdrawal by Subject|0|||
147628365|NCT03777436|532458684|FG000|Placebo-controlled Phase|Non-compliance with study drug|0|||
147628366|NCT03777436|532458685|FG001|Placebo-controlled Phase|Non-compliance with study drug|2|||
147495514|NCT01968954|531968945|FG000|Overall Study|Withdrawal by Subject|20|||
147495515|NCT01968954|531968946|FG001|Overall Study|Withdrawal by Subject|23|||
147495516|NCT01968954|531968945|FG000|Overall Study|Other|7|||
147495517|NCT01968954|531968946|FG001|Overall Study|Other|8|||
147495518|NCT01968954|531968945|FG000|Overall Study|Protocol Violation|0|||
147495519|NCT01968954|531968946|FG001|Overall Study|Protocol Violation|1|||
147495520|NCT01968954|531968945|FG000|Overall Study|Did not met inclusion criteria|0|||
147495521|NCT01968954|531968946|FG001|Overall Study|Did not met inclusion criteria|2|||
147495522|NCT00064350|531968947|FG000|Induction Treatment|Disease Progression|5|||
147495523|NCT00064350|531968948|FG001|Induction Treatment|Disease Progression|1|||
147495524|NCT00064350|531968949|FG002|Induction Treatment|Disease Progression|110|||
147495525|NCT00064350|531968947|FG000|Induction Treatment|Adverse Event|0|||
147495526|NCT00064350|531968948|FG001|Induction Treatment|Adverse Event|2|||
147495527|NCT00064350|531968949|FG002|Induction Treatment|Adverse Event|49|||
147495528|NCT00064350|531968947|FG000|Induction Treatment|Death|0|||
147495529|NCT00064350|531968948|FG001|Induction Treatment|Death|0|||
147495530|NCT00064350|531968949|FG002|Induction Treatment|Death|9|||
147495531|NCT00064350|531968947|FG000|Induction Treatment|Withdrawal by Subject|0|||
147495532|NCT00064350|531968948|FG001|Induction Treatment|Withdrawal by Subject|0|||
147495533|NCT00064350|531968949|FG002|Induction Treatment|Withdrawal by Subject|21|||
147495534|NCT00064350|531968947|FG000|Induction Treatment|Ineligible or never started treatment|3|||
147495535|NCT00064350|531968948|FG001|Induction Treatment|Ineligible or never started treatment|6|||
147495536|NCT00064350|531968949|FG002|Induction Treatment|Ineligible or never started treatment|34|||
147495537|NCT00064350|531968947|FG000|Induction Treatment|Other|0|||
147495538|NCT00064350|531968948|FG001|Induction Treatment|Other|0|||
147495539|NCT00064350|531968949|FG002|Induction Treatment|Other|13|||
147495540|NCT00064350|531968947|FG000|Randomization|Adverse Event|8|||
147495541|NCT00064350|531968948|FG001|Randomization|Adverse Event|3|||
147495542|NCT00064350|531968949|FG002|Randomization|Adverse Event|0|||
147495543|NCT00064350|531968947|FG000|Randomization|Death|3|||
147495544|NCT00064350|531968948|FG001|Randomization|Death|0|||
147495545|NCT00064350|531968949|FG002|Randomization|Death|0|||
147495546|NCT00064350|531968947|FG000|Randomization|Withdrawal by Subject|1|||
147495547|NCT00064350|531968948|FG001|Randomization|Withdrawal by Subject|0|||
147495548|NCT00064350|531968949|FG002|Randomization|Withdrawal by Subject|0|||
147495549|NCT00064350|531968947|FG000|Randomization|Ineligible or never started treatment|9|||
147495550|NCT00064350|531968948|FG001|Randomization|Ineligible or never started treatment|15|||
147495551|NCT00064350|531968949|FG002|Randomization|Ineligible or never started treatment|0|||
147495552|NCT00064350|531968947|FG000|Randomization|Other|5|||
147495553|NCT00064350|531968948|FG001|Randomization|Other|0|||
147495554|NCT00064350|531968949|FG002|Randomization|Other|0|||
147495555|NCT00064350|531968947|FG000|Cross-Over|Adverse Event|0|||
147495556|NCT00064350|531968948|FG001|Cross-Over|Adverse Event|1|||
147495557|NCT00064350|531968949|FG002|Cross-Over|Adverse Event|0|||
147495558|NCT00064350|531968947|FG000|Cross-Over|Death|1|||
147495559|NCT00064350|531968948|FG001|Cross-Over|Death|3|||
147495560|NCT00064350|531968949|FG002|Cross-Over|Death|0|||
147495561|NCT00064350|531968947|FG000|Cross-Over|Withdrawal by Subject|2|||
147495562|NCT00064350|531968948|FG001|Cross-Over|Withdrawal by Subject|2|||
147495563|NCT00064350|531968949|FG002|Cross-Over|Withdrawal by Subject|0|||
147495564|NCT00064350|531968947|FG000|Cross-Over|Ineligible or never started treatment|3|||
147495565|NCT00064350|531968948|FG001|Cross-Over|Ineligible or never started treatment|6|||
147495566|NCT00064350|531968949|FG002|Cross-Over|Ineligible or never started treatment|0|||
147495567|NCT00064350|531968947|FG000|Cross-Over|Other|0|||
147495568|NCT00064350|531968948|FG001|Cross-Over|Other|2|||
147495569|NCT00064350|531968949|FG002|Cross-Over|Other|0|||
147495570|NCT03600714|531968950|FG000|Overall Study|Out of country and could not return for post-treatment visits|1|||
147495571|NCT01935336|531968953|FG000|Overall Study|Adverse Event|1|||
147495572|NCT01935336|531968954|FG001|Overall Study|Adverse Event|0|||
147495573|NCT01935336|531968955|FG002|Overall Study|Adverse Event|0|||
147495574|NCT01935336|531968956|FG003|Overall Study|Adverse Event|0|||
147495575|NCT01935336|531968953|FG000|Overall Study|Progressive disease|5|||
147495576|NCT01935336|531968954|FG001|Overall Study|Progressive disease|3|||
147495577|NCT01935336|531968955|FG002|Overall Study|Progressive disease|47|||
147495578|NCT01935336|531968956|FG003|Overall Study|Progressive disease|66|||
147628367|NCT03777436|532458686|FG002|Placebo-controlled Phase|Non-compliance with study drug|0|||
147628368|NCT03777436|532458684|FG000|Placebo-controlled Phase|Lost to Follow-up|7|||
147628369|NCT03777436|532458685|FG001|Placebo-controlled Phase|Lost to Follow-up|7|||
147628370|NCT03777436|532458686|FG002|Placebo-controlled Phase|Lost to Follow-up|0|||
147628371|NCT03777436|532458684|FG000|Placebo-controlled Phase|Physician Decision|0|||
147495579|NCT00592553|531968957|FG000|Overall Study|Protocol Noncompliance|1|||
147495580|NCT00592553|531968958|FG001|Overall Study|Protocol Noncompliance|0|||
147495581|NCT00592553|531968959|FG002|Overall Study|Protocol Noncompliance|0|||
147495582|NCT01752842|531968960|FG000|Overall Study|Adverse Event|3|||
147495583|NCT01752842|531968961|FG001|Overall Study|Adverse Event|0|||
147495584|NCT01752842|531968960|FG000|Overall Study|Withdrawal by Subject|0|||
147495585|NCT01752842|531968961|FG001|Overall Study|Withdrawal by Subject|2|||
147495586|NCT03260205|531968962|FG000|Overall Study|Adverse Event|2|||
147628372|NCT03777436|532458685|FG001|Placebo-controlled Phase|Physician Decision|1|||
147628373|NCT03777436|532458686|FG002|Placebo-controlled Phase|Physician Decision|0|||
147628374|NCT03777436|532458684|FG000|Placebo-controlled Phase|Due to COVID-19 control measures|1|||
147628375|NCT03777436|532458685|FG001|Placebo-controlled Phase|Due to COVID-19 control measures|0|||
147628376|NCT03777436|532458686|FG002|Placebo-controlled Phase|Due to COVID-19 control measures|0|||
147628377|NCT03777436|532458684|FG000|Apremilast Extension Phase|Adverse Event|0|||
147628378|NCT03777436|532458685|FG001|Apremilast Extension Phase|Adverse Event|0|||
147628379|NCT03777436|532458686|FG002|Apremilast Extension Phase|Adverse Event|6|||
147628380|NCT03777436|532458684|FG000|Apremilast Extension Phase|Lack of Efficacy|0|||
147628381|NCT03777436|532458685|FG001|Apremilast Extension Phase|Lack of Efficacy|0|||
147628382|NCT03777436|532458686|FG002|Apremilast Extension Phase|Lack of Efficacy|1|||
147628383|NCT03777436|532458684|FG000|Apremilast Extension Phase|Withdrawal by Subject|0|||
147628384|NCT03777436|532458685|FG001|Apremilast Extension Phase|Withdrawal by Subject|0|||
147628385|NCT03777436|532458686|FG002|Apremilast Extension Phase|Withdrawal by Subject|13|||
147628386|NCT03777436|532458684|FG000|Apremilast Extension Phase|Lost to Follow-up|0|||
147628387|NCT03777436|532458685|FG001|Apremilast Extension Phase|Lost to Follow-up|0|||
147628388|NCT03777436|532458686|FG002|Apremilast Extension Phase|Lost to Follow-up|7|||
147628389|NCT03777436|532458684|FG000|Apremilast Extension Phase|Miscellaneous|0|||
147628390|NCT03777436|532458685|FG001|Apremilast Extension Phase|Miscellaneous|0|||
147628391|NCT03777436|532458686|FG002|Apremilast Extension Phase|Miscellaneous|1|||
147628392|NCT00685399|532458687|FG000|Treatment Period 1|Withdrawal by Subject|2|||
147628393|NCT00685399|532458688|FG001|Treatment Period 1|Withdrawal by Subject|0|||
147628394|NCT00685399|532458689|FG002|Treatment Period 1|Withdrawal by Subject|0|||
147628395|NCT00685399|532458690|FG003|Treatment Period 1|Withdrawal by Subject|0|||
147628396|NCT00685399|532458691|FG004|Treatment Period 1|Withdrawal by Subject|0|||
147628397|NCT00685399|532458692|FG005|Treatment Period 1|Withdrawal by Subject|0|||
147628398|NCT00685399|532458693|FG006|Treatment Period 1|Withdrawal by Subject|0|||
147628399|NCT00685399|532458694|FG007|Treatment Period 1|Withdrawal by Subject|0|||
147628400|NCT00685399|532458687|FG000|Treatment Period 1|Protocol Violation|1|||
147628401|NCT00685399|532458688|FG001|Treatment Period 1|Protocol Violation|0|||
147628402|NCT00685399|532458689|FG002|Treatment Period 1|Protocol Violation|0|||
147628403|NCT00685399|532458690|FG003|Treatment Period 1|Protocol Violation|0|||
147628404|NCT00685399|532458691|FG004|Treatment Period 1|Protocol Violation|0|||
147628405|NCT00685399|532458692|FG005|Treatment Period 1|Protocol Violation|0|||
147628406|NCT00685399|532458693|FG006|Treatment Period 1|Protocol Violation|0|||
147628407|NCT00685399|532458694|FG007|Treatment Period 1|Protocol Violation|0|||
147628408|NCT00685399|532458687|FG000|Treatment Period 1|Administrative|2|||
147628409|NCT00685399|532458688|FG001|Treatment Period 1|Administrative|0|||
147628410|NCT00685399|532458689|FG002|Treatment Period 1|Administrative|0|||
147628411|NCT00685399|532458690|FG003|Treatment Period 1|Administrative|0|||
147628412|NCT00685399|532458691|FG004|Treatment Period 1|Administrative|0|||
147628413|NCT00685399|532458692|FG005|Treatment Period 1|Administrative|0|||
147628414|NCT00685399|532458693|FG006|Treatment Period 1|Administrative|0|||
147628415|NCT00685399|532458694|FG007|Treatment Period 1|Administrative|0|||
147628416|NCT00685399|532458687|FG000|Treatment Period 1|Lack of Efficacy|1|||
147628417|NCT00685399|532458688|FG001|Treatment Period 1|Lack of Efficacy|0|||
147628418|NCT00685399|532458689|FG002|Treatment Period 1|Lack of Efficacy|0|||
147628419|NCT00685399|532458690|FG003|Treatment Period 1|Lack of Efficacy|0|||
147628420|NCT00685399|532458691|FG004|Treatment Period 1|Lack of Efficacy|0|||
147628421|NCT00685399|532458692|FG005|Treatment Period 1|Lack of Efficacy|0|||
147628422|NCT00685399|532458693|FG006|Treatment Period 1|Lack of Efficacy|0|||
147628423|NCT00685399|532458694|FG007|Treatment Period 1|Lack of Efficacy|0|||
147628424|NCT00685399|532458687|FG000|Treatment Period 2|Administrative Problems|0|||
147628425|NCT00685399|532458688|FG001|Treatment Period 2|Administrative Problems|2|||
147628426|NCT00685399|532458689|FG002|Treatment Period 2|Administrative Problems|1|||
147628427|NCT00685399|532458690|FG003|Treatment Period 2|Administrative Problems|0|||
147628428|NCT00685399|532458691|FG004|Treatment Period 2|Administrative Problems|0|||
147628429|NCT00685399|532458692|FG005|Treatment Period 2|Administrative Problems|0|||
147628430|NCT00685399|532458693|FG006|Treatment Period 2|Administrative Problems|0|||
147628431|NCT00685399|532458694|FG007|Treatment Period 2|Administrative Problems|0|||
147628432|NCT00685399|532458687|FG000|Treatment Period 2|Withdrawal by Subject|0|||
147628433|NCT00685399|532458688|FG001|Treatment Period 2|Withdrawal by Subject|0|||
147628434|NCT00685399|532458689|FG002|Treatment Period 2|Withdrawal by Subject|0|||
147628435|NCT00685399|532458690|FG003|Treatment Period 2|Withdrawal by Subject|0|||
147628436|NCT00685399|532458691|FG004|Treatment Period 2|Withdrawal by Subject|0|||
147628437|NCT00685399|532458692|FG005|Treatment Period 2|Withdrawal by Subject|0|||
147628438|NCT00685399|532458693|FG006|Treatment Period 2|Withdrawal by Subject|0|||
147628439|NCT00685399|532458694|FG007|Treatment Period 2|Withdrawal by Subject|2|||
147628440|NCT00685399|532458687|FG000|Treatment Period 2|Adverse Event|0|||
147628441|NCT00685399|532458688|FG001|Treatment Period 2|Adverse Event|0|||
147628442|NCT00685399|532458689|FG002|Treatment Period 2|Adverse Event|0|||
147628443|NCT00685399|532458690|FG003|Treatment Period 2|Adverse Event|0|||
147628444|NCT00685399|532458691|FG004|Treatment Period 2|Adverse Event|0|||
147628445|NCT00685399|532458692|FG005|Treatment Period 2|Adverse Event|1|||
147495587|NCT03260205|531968963|FG001|Overall Study|Adverse Event|0|||
147495588|NCT03260205|531968964|FG002|Overall Study|Adverse Event|2|||
147495589|NCT03260205|531968965|FG003|Overall Study|Adverse Event|2|||
147495590|NCT03260205|531968966|FG004|Overall Study|Adverse Event|4|||
147495591|NCT03260205|531968962|FG000|Overall Study|Lost to Follow-up|2|||
147495592|NCT03260205|531968963|FG001|Overall Study|Lost to Follow-up|2|||
147495593|NCT03260205|531968964|FG002|Overall Study|Lost to Follow-up|1|||
147495594|NCT03260205|531968965|FG003|Overall Study|Lost to Follow-up|1|||
147495595|NCT03260205|531968966|FG004|Overall Study|Lost to Follow-up|5|||
147495596|NCT03260205|531968962|FG000|Overall Study|Protocol Violation|0|||
147495597|NCT03260205|531968963|FG001|Overall Study|Protocol Violation|0|||
147495598|NCT03260205|531968964|FG002|Overall Study|Protocol Violation|2|||
147495599|NCT03260205|531968965|FG003|Overall Study|Protocol Violation|0|||
147495600|NCT03260205|531968966|FG004|Overall Study|Protocol Violation|1|||
147495601|NCT03260205|531968962|FG000|Overall Study|Withdrawal by Participant or Parent/LAR|4|||
147495602|NCT03260205|531968963|FG001|Overall Study|Withdrawal by Participant or Parent/LAR|5|||
147495603|NCT03260205|531968964|FG002|Overall Study|Withdrawal by Participant or Parent/LAR|1|||
147495604|NCT03260205|531968965|FG003|Overall Study|Withdrawal by Participant or Parent/LAR|0|||
147495605|NCT03260205|531968966|FG004|Overall Study|Withdrawal by Participant or Parent/LAR|2|||
147495606|NCT03260205|531968962|FG000|Overall Study|Other: Unspecified|0|||
147495607|NCT03260205|531968963|FG001|Overall Study|Other: Unspecified|0|||
147495608|NCT03260205|531968964|FG002|Overall Study|Other: Unspecified|3|||
147495609|NCT03260205|531968965|FG003|Overall Study|Other: Unspecified|1|||
147495610|NCT03260205|531968966|FG004|Overall Study|Other: Unspecified|1|||
147495611|NCT03260205|531968962|FG000|Overall Study|Participant Who Did Not Received AnyDose|1|||
147495612|NCT03260205|531968963|FG001|Overall Study|Participant Who Did Not Received AnyDose|1|||
147495613|NCT03260205|531968964|FG002|Overall Study|Participant Who Did Not Received AnyDose|2|||
147495614|NCT03260205|531968965|FG003|Overall Study|Participant Who Did Not Received AnyDose|3|||
147495615|NCT03260205|531968966|FG004|Overall Study|Participant Who Did Not Received AnyDose|1|||
147495616|NCT01968187|531968969|FG000|Overall Study|Adverse Event|0|||
147495617|NCT01968187|531968970|FG001|Overall Study|Adverse Event|1|||
147495618|NCT01968187|531968969|FG000|Overall Study|Randomized but not treated|1|||
147495619|NCT01968187|531968970|FG001|Overall Study|Randomized but not treated|0|||
147495620|NCT01877382|531968971|FG000|Dose Escalation|Progressive disease|2|||
147495621|NCT01877382|531968972|FG001|Dose Escalation|Progressive disease|0|||
147495622|NCT01877382|531968973|FG002|Dose Escalation|Progressive disease|1|||
147495623|NCT01877382|531968974|FG003|Dose Escalation|Progressive disease|6|||
147495624|NCT01877382|531968975|FG004|Dose Escalation|Progressive disease|1|||
147495625|NCT01877382|531968976|FG005|Dose Escalation|Progressive disease|0|||
147495626|NCT01877382|531968977|FG006|Dose Escalation|Progressive disease|3|||
147495627|NCT01877382|531968978|FG007|Dose Escalation|Progressive disease|10|||
147495628|NCT01877382|531968979|FG008|Dose Escalation|Progressive disease|4|||
147495629|NCT01877382|531968980|FG009|Dose Escalation|Progressive disease|2|||
147495630|NCT01877382|531968981|FG010|Dose Escalation|Progressive disease|3|||
147495631|NCT01877382|531968982|FG011|Dose Escalation|Progressive disease|3|||
147495632|NCT01877382|531968983|FG012|Dose Escalation|Progressive disease|13|||
147495633|NCT01877382|531968984|FG013|Dose Escalation|Progressive disease|1|||
147495634|NCT01877382|531968985|FG014|Dose Escalation|Progressive disease|0|||
147495635|NCT01877382|531968971|FG000|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|1|||
147495636|NCT01877382|531968972|FG001|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
147495637|NCT01877382|531968973|FG002|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
147495638|NCT01877382|531968974|FG003|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|1|||
147495639|NCT01877382|531968975|FG004|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
147495640|NCT01877382|531968976|FG005|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
147495641|NCT01877382|531968977|FG006|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|1|||
147495642|NCT01877382|531968978|FG007|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
147495643|NCT01877382|531968979|FG008|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
147495644|NCT01877382|531968980|FG009|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
147495645|NCT01877382|531968981|FG010|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
147495646|NCT01877382|531968982|FG011|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
147495647|NCT01877382|531968983|FG012|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
147628446|NCT00685399|532458693|FG006|Treatment Period 2|Adverse Event|0|||
147628447|NCT00685399|532458694|FG007|Treatment Period 2|Adverse Event|0|||
147628448|NCT00685399|532458687|FG000|Treatment Period 2|Lack of Efficacy|0|||
147628449|NCT00685399|532458688|FG001|Treatment Period 2|Lack of Efficacy|10|||
147628450|NCT00685399|532458689|FG002|Treatment Period 2|Lack of Efficacy|2|||
147495648|NCT01877382|531968984|FG013|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
147495649|NCT01877382|531968985|FG014|Dose Escalation|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
147495650|NCT01877382|531968971|FG000|Dose Escalation|Clinical progression|0|||
147628451|NCT00685399|532458690|FG003|Treatment Period 2|Lack of Efficacy|0|||
147628452|NCT00685399|532458691|FG004|Treatment Period 2|Lack of Efficacy|0|||
147628453|NCT00685399|532458692|FG005|Treatment Period 2|Lack of Efficacy|1|||
147628454|NCT00685399|532458693|FG006|Treatment Period 2|Lack of Efficacy|0|||
147628455|NCT00685399|532458694|FG007|Treatment Period 2|Lack of Efficacy|0|||
147628456|NCT00685399|532458687|FG000|Extension|Administrative Issues|0|||
147628457|NCT00685399|532458688|FG001|Extension|Administrative Issues|0|||
147628458|NCT00685399|532458689|FG002|Extension|Administrative Issues|0|||
147628459|NCT00685399|532458690|FG003|Extension|Administrative Issues|1|||
147628460|NCT00685399|532458691|FG004|Extension|Administrative Issues|0|||
147628461|NCT00685399|532458692|FG005|Extension|Administrative Issues|0|||
147628462|NCT00685399|532458693|FG006|Extension|Administrative Issues|0|||
147628463|NCT00685399|532458694|FG007|Extension|Administrative Issues|0|||
147628464|NCT00685399|532458687|FG000|Extension|Withdrawal by Subject|0|||
147628465|NCT00685399|532458688|FG001|Extension|Withdrawal by Subject|0|||
147628466|NCT00685399|532458689|FG002|Extension|Withdrawal by Subject|0|||
147628467|NCT00685399|532458690|FG003|Extension|Withdrawal by Subject|1|||
147628468|NCT00685399|532458691|FG004|Extension|Withdrawal by Subject|0|||
147628469|NCT00685399|532458692|FG005|Extension|Withdrawal by Subject|0|||
147628470|NCT00685399|532458693|FG006|Extension|Withdrawal by Subject|0|||
147628471|NCT00685399|532458694|FG007|Extension|Withdrawal by Subject|0|||
147628472|NCT00685399|532458687|FG000|Extension|Protocol Violation|0|||
147628473|NCT00685399|532458688|FG001|Extension|Protocol Violation|0|||
147628474|NCT00685399|532458689|FG002|Extension|Protocol Violation|0|||
147628475|NCT00685399|532458690|FG003|Extension|Protocol Violation|1|||
147628476|NCT00685399|532458691|FG004|Extension|Protocol Violation|0|||
147628477|NCT00685399|532458692|FG005|Extension|Protocol Violation|0|||
147628478|NCT00685399|532458693|FG006|Extension|Protocol Violation|0|||
147628479|NCT00685399|532458694|FG007|Extension|Protocol Violation|0|||
147628480|NCT00685399|532458687|FG000|Extension|Lack of Efficacy|0|||
147628481|NCT00685399|532458688|FG001|Extension|Lack of Efficacy|0|||
147628482|NCT00685399|532458689|FG002|Extension|Lack of Efficacy|0|||
147628483|NCT00685399|532458690|FG003|Extension|Lack of Efficacy|2|||
147628484|NCT00685399|532458691|FG004|Extension|Lack of Efficacy|0|||
147628485|NCT00685399|532458692|FG005|Extension|Lack of Efficacy|0|||
147628486|NCT00685399|532458693|FG006|Extension|Lack of Efficacy|0|||
147628487|NCT00685399|532458694|FG007|Extension|Lack of Efficacy|0|||
147628488|NCT00685399|532458687|FG000|Extension|Adverse Event|0|||
147628489|NCT00685399|532458688|FG001|Extension|Adverse Event|0|||
147628490|NCT00685399|532458689|FG002|Extension|Adverse Event|0|||
147628491|NCT00685399|532458690|FG003|Extension|Adverse Event|2|||
147628492|NCT00685399|532458691|FG004|Extension|Adverse Event|0|||
147628493|NCT00685399|532458692|FG005|Extension|Adverse Event|0|||
147628494|NCT00685399|532458693|FG006|Extension|Adverse Event|0|||
147628495|NCT00685399|532458694|FG007|Extension|Adverse Event|0|||
147628496|NCT00656292|532458696|FG000|Overall Study|Withdrawal by Subject|2|||
147628497|NCT00656292|532458697|FG001|Overall Study|Withdrawal by Subject|3|||
147628498|NCT00656292|532458696|FG000|Overall Study|Screen failure|1|||
147628499|NCT00656292|532458697|FG001|Overall Study|Screen failure|2|||
147628500|NCT03674112|532458698|FG000|Treatment Cross-Over (Cycles 1 to 6)|Adverse Event|1|||
147628501|NCT03674112|532458699|FG001|Treatment Cross-Over (Cycles 1 to 6)|Adverse Event|0|||
147628502|NCT03674112|532458698|FG000|Treatment Continuation (Cycles 7 to ≤18)|Reason Not Specified|0|||
147628503|NCT03674112|532458699|FG001|Treatment Continuation (Cycles 7 to ≤18)|Reason Not Specified|2|||
147628504|NCT03674112|532458698|FG000|Treatment Continuation (Cycles 7 to ≤18)|Withdrawal by Subject|0|||
147628505|NCT03674112|532458699|FG001|Treatment Continuation (Cycles 7 to ≤18)|Withdrawal by Subject|1|||
147628506|NCT03674112|532458698|FG000|Treatment Continuation (Cycles 7 to ≤18)|Disease Relapse|1|||
147628507|NCT03674112|532458699|FG001|Treatment Continuation (Cycles 7 to ≤18)|Disease Relapse|0|||
147628508|NCT03674112|532458698|FG000|Follow-Up Period (≥3 Years)|Withdrawal by Subject|2|||
147628509|NCT03674112|532458699|FG001|Follow-Up Period (≥3 Years)|Withdrawal by Subject|2|||
147628510|NCT03674112|532458698|FG000|Follow-Up Period (≥3 Years)|Lost to Follow-up|2|||
147628511|NCT03674112|532458699|FG001|Follow-Up Period (≥3 Years)|Lost to Follow-up|1|||
147628512|NCT03674112|532458698|FG000|Follow-Up Period (≥3 Years)|Death|2|||
147628513|NCT03674112|532458699|FG001|Follow-Up Period (≥3 Years)|Death|0|||
147628514|NCT03674112|532458698|FG000|Follow-Up Period (≥3 Years)|Reason Not Specified|1|||
147628515|NCT03674112|532458699|FG001|Follow-Up Period (≥3 Years)|Reason Not Specified|1|||
147628516|NCT02684097|532458707|FG000|Overall Study|Lack of Efficacy|13|||
147628517|NCT02684097|532458708|FG001|Overall Study|Lack of Efficacy|6|||
147628518|NCT00462709|532458709|FG000|Overall Study|Transitioned to commercial C1INH-nf|40|||
147628519|NCT00462709|532458709|FG000|Overall Study|Lost to Follow-up|10|||
147628520|NCT00462709|532458709|FG000|Overall Study|Withdrawal by Subject|8|||
147628521|NCT00462709|532458709|FG000|Overall Study|Transferred to LEVP2006-1 (NCT00438815)|3|||
147628522|NCT00462709|532458709|FG000|Overall Study|Death|2|||
147628523|NCT00462709|532458709|FG000|Overall Study|Logistical reasons|2|||
147628524|NCT00462709|532458709|FG000|Overall Study|Physician Decision|1|||
147628525|NCT00462709|532458709|FG000|Overall Study|Withdrew to start treatment with Cetor|1|||
147628526|NCT02064816|532458710|FG000|Overall Study|Adverse Event|3|||
147628527|NCT02064816|532458711|FG001|Overall Study|Adverse Event|2|||
147628528|NCT02064816|532458710|FG000|Overall Study|Withdrawal by Subject|2|||
147495651|NCT01877382|531968972|FG001|Dose Escalation|Clinical progression|1|||
147495652|NCT01877382|531968973|FG002|Dose Escalation|Clinical progression|0|||
147495653|NCT01877382|531968974|FG003|Dose Escalation|Clinical progression|2|||
147628529|NCT02064816|532458711|FG001|Overall Study|Withdrawal by Subject|1|||
147628530|NCT02064816|532458710|FG000|Overall Study|Lost to Follow-up|2|||
147628531|NCT02064816|532458711|FG001|Overall Study|Lost to Follow-up|1|||
147628532|NCT02064816|532458710|FG000|Overall Study|Therapeutic failure|0|||
147628533|NCT02064816|532458711|FG001|Overall Study|Therapeutic failure|1|||
147628534|NCT02064816|532458710|FG000|Overall Study|Other|1|||
147628535|NCT02064816|532458711|FG001|Overall Study|Other|3|||
147628536|NCT04468347|532458712|FG000|Overall Study|Withdrawal by Subject|0|||
147628537|NCT04468347|532458713|FG001|Overall Study|Withdrawal by Subject|1|||
147628538|NCT04468347|532458714|FG002|Overall Study|Withdrawal by Subject|3|||
147628539|NCT04468347|532458715|FG003|Overall Study|Withdrawal by Subject|3|||
147628540|NCT04468347|532458712|FG000|Overall Study|Lost to Follow-up|0|||
147628541|NCT04468347|532458713|FG001|Overall Study|Lost to Follow-up|0|||
147628542|NCT04468347|532458714|FG002|Overall Study|Lost to Follow-up|1|||
147628543|NCT04468347|532458715|FG003|Overall Study|Lost to Follow-up|1|||
147628544|NCT04468347|532458712|FG000|Overall Study|Physician Decision|1|||
147628545|NCT04468347|532458713|FG001|Overall Study|Physician Decision|0|||
147628546|NCT04468347|532458714|FG002|Overall Study|Physician Decision|2|||
147628547|NCT04468347|532458715|FG003|Overall Study|Physician Decision|0|||
147628548|NCT04468347|532458712|FG000|Overall Study|Protocol Violation|1|||
147628549|NCT04468347|532458713|FG001|Overall Study|Protocol Violation|0|||
147628550|NCT04468347|532458714|FG002|Overall Study|Protocol Violation|0|||
147628551|NCT04468347|532458715|FG003|Overall Study|Protocol Violation|0|||
147628552|NCT01732458|532458716|FG000|Overall Study|Lost to Follow-up|0|||
147628553|NCT01732458|532458717|FG001|Overall Study|Lost to Follow-up|2|||
147628554|NCT01732458|532458718|FG002|Overall Study|Lost to Follow-up|0|||
147628555|NCT01732458|532458719|FG003|Overall Study|Lost to Follow-up|0|||
147628556|NCT01732458|532458716|FG000|Overall Study|Non-Compliance With Study Drug|0|||
147628557|NCT01732458|532458717|FG001|Overall Study|Non-Compliance With Study Drug|0|||
147628558|NCT01732458|532458718|FG002|Overall Study|Non-Compliance With Study Drug|1|||
147628559|NCT01732458|532458719|FG003|Overall Study|Non-Compliance With Study Drug|0|||
147628560|NCT01732458|532458716|FG000|Overall Study|Physician Decision|1|||
147628561|NCT01732458|532458717|FG001|Overall Study|Physician Decision|2|||
147628562|NCT01732458|532458718|FG002|Overall Study|Physician Decision|2|||
147628563|NCT01732458|532458719|FG003|Overall Study|Physician Decision|0|||
147628564|NCT01732458|532458716|FG000|Overall Study|Protocol Violation|2|||
147628565|NCT01732458|532458717|FG001|Overall Study|Protocol Violation|0|||
147628566|NCT01732458|532458718|FG002|Overall Study|Protocol Violation|0|||
147628567|NCT01732458|532458719|FG003|Overall Study|Protocol Violation|2|||
147628568|NCT01732458|532458716|FG000|Overall Study|Screen Failure|0|||
147628569|NCT01732458|532458717|FG001|Overall Study|Screen Failure|1|||
147628570|NCT01732458|532458718|FG002|Overall Study|Screen Failure|0|||
147628571|NCT01732458|532458719|FG003|Overall Study|Screen Failure|0|||
147628572|NCT04339062|532458720|FG000|Overall Study|Death|0|||
147628573|NCT04339062|532458721|FG001|Overall Study|Death|1|||
147628574|NCT03218826|532458722|FG000|Overall Study|Non-compliance with protocol|1|||
147628575|NCT03218826|532458723|FG001|Overall Study|Non-compliance with protocol|0|||
147628576|NCT03218826|532458724|FG002|Overall Study|Non-compliance with protocol|2|||
147628577|NCT03218826|532458725|FG003|Overall Study|Non-compliance with protocol|1|||
147628578|NCT03218826|532458726|FG004|Overall Study|Non-compliance with protocol|1|||
147628579|NCT01197534|532458727|FG000|Overall Study|Not reported|16|||
147628580|NCT01197534|532458728|FG001|Overall Study|Not reported|10|||
147628581|NCT01197534|532458729|FG002|Overall Study|Not reported|16|||
147495654|NCT01877382|531968975|FG004|Dose Escalation|Clinical progression|0|||
147628582|NCT01197534|532458727|FG000|Overall Study|Enrolment in long term extension|57|||
147628583|NCT01197534|532458728|FG001|Overall Study|Enrolment in long term extension|66|||
147628584|NCT01197534|532458729|FG002|Overall Study|Enrolment in long term extension|119|||
147628585|NCT01197534|532458727|FG000|Overall Study|Severe non-compliance to protocol|3|||
147628586|NCT01197534|532458728|FG001|Overall Study|Severe non-compliance to protocol|4|||
147628587|NCT01197534|532458729|FG002|Overall Study|Severe non-compliance to protocol|1|||
147628588|NCT01197534|532458727|FG000|Overall Study|Lack of therapeutic response|9|||
147628589|NCT01197534|532458728|FG001|Overall Study|Lack of therapeutic response|4|||
147628590|NCT01197534|532458729|FG002|Overall Study|Lack of therapeutic response|9|||
147495655|NCT01877382|531968976|FG005|Dose Escalation|Clinical progression|0|||
147628591|NCT01197534|532458727|FG000|Overall Study|Dev. of study specific discont. criteria|13|||
147628592|NCT01197534|532458728|FG001|Overall Study|Dev. of study specific discont. criteria|6|||
147628593|NCT01197534|532458729|FG002|Overall Study|Dev. of study specific discont. criteria|2|||
147628594|NCT01197534|532458727|FG000|Overall Study|Lost to Follow-up|1|||
147628595|NCT01197534|532458728|FG001|Overall Study|Lost to Follow-up|4|||
147628596|NCT01197534|532458729|FG002|Overall Study|Lost to Follow-up|2|||
147628597|NCT01197534|532458727|FG000|Overall Study|Adverse Event|35|||
147628598|NCT01197534|532458728|FG001|Overall Study|Adverse Event|36|||
147495656|NCT01877382|531968977|FG006|Dose Escalation|Clinical progression|1|||
147628599|NCT01197534|532458729|FG002|Overall Study|Adverse Event|24|||
147495657|NCT01877382|531968978|FG007|Dose Escalation|Clinical progression|0|||
147495658|NCT01877382|531968979|FG008|Dose Escalation|Clinical progression|0|||
147495659|NCT01877382|531968980|FG009|Dose Escalation|Clinical progression|1|||
147495660|NCT01877382|531968981|FG010|Dose Escalation|Clinical progression|0|||
147495661|NCT01877382|531968982|FG011|Dose Escalation|Clinical progression|0|||
147495662|NCT01877382|531968983|FG012|Dose Escalation|Clinical progression|2|||
147495663|NCT01877382|531968984|FG013|Dose Escalation|Clinical progression|1|||
147495664|NCT01877382|531968985|FG014|Dose Escalation|Clinical progression|0|||
147495665|NCT01877382|531968971|FG000|Dose Escalation|Adverse Event|0|||
147495666|NCT01877382|531968972|FG001|Dose Escalation|Adverse Event|0|||
147495667|NCT01877382|531968973|FG002|Dose Escalation|Adverse Event|0|||
147495668|NCT01877382|531968974|FG003|Dose Escalation|Adverse Event|4|||
147495669|NCT01877382|531968975|FG004|Dose Escalation|Adverse Event|1|||
147495670|NCT01877382|531968976|FG005|Dose Escalation|Adverse Event|2|||
147495671|NCT01877382|531968977|FG006|Dose Escalation|Adverse Event|1|||
147495672|NCT01877382|531968978|FG007|Dose Escalation|Adverse Event|2|||
147495673|NCT01877382|531968979|FG008|Dose Escalation|Adverse Event|0|||
147495674|NCT01877382|531968980|FG009|Dose Escalation|Adverse Event|0|||
147495675|NCT01877382|531968981|FG010|Dose Escalation|Adverse Event|0|||
147495676|NCT01877382|531968982|FG011|Dose Escalation|Adverse Event|0|||
147495677|NCT01877382|531968983|FG012|Dose Escalation|Adverse Event|1|||
147495678|NCT01877382|531968984|FG013|Dose Escalation|Adverse Event|0|||
147495679|NCT01877382|531968985|FG014|Dose Escalation|Adverse Event|0|||
147495680|NCT01877382|531968971|FG000|Dose Escalation|Withdrawal by Subject|0|||
147495681|NCT01877382|531968972|FG001|Dose Escalation|Withdrawal by Subject|0|||
147495682|NCT01877382|531968973|FG002|Dose Escalation|Withdrawal by Subject|0|||
147495683|NCT01877382|531968974|FG003|Dose Escalation|Withdrawal by Subject|0|||
147495684|NCT01877382|531968975|FG004|Dose Escalation|Withdrawal by Subject|0|||
147495685|NCT01877382|531968976|FG005|Dose Escalation|Withdrawal by Subject|3|||
147495686|NCT01877382|531968977|FG006|Dose Escalation|Withdrawal by Subject|2|||
147495687|NCT01877382|531968978|FG007|Dose Escalation|Withdrawal by Subject|1|||
147495688|NCT01877382|531968979|FG008|Dose Escalation|Withdrawal by Subject|1|||
147495689|NCT01877382|531968980|FG009|Dose Escalation|Withdrawal by Subject|0|||
147495690|NCT01877382|531968981|FG010|Dose Escalation|Withdrawal by Subject|0|||
147495691|NCT01877382|531968982|FG011|Dose Escalation|Withdrawal by Subject|0|||
147495692|NCT01877382|531968983|FG012|Dose Escalation|Withdrawal by Subject|0|||
147495693|NCT01877382|531968984|FG013|Dose Escalation|Withdrawal by Subject|0|||
147495694|NCT01877382|531968985|FG014|Dose Escalation|Withdrawal by Subject|0|||
147495695|NCT01877382|531968971|FG000|Dose Escalation|Protocol Violation|0|||
147495696|NCT01877382|531968972|FG001|Dose Escalation|Protocol Violation|0|||
147495697|NCT01877382|531968973|FG002|Dose Escalation|Protocol Violation|0|||
147495698|NCT01877382|531968974|FG003|Dose Escalation|Protocol Violation|0|||
147495699|NCT01877382|531968975|FG004|Dose Escalation|Protocol Violation|0|||
147495700|NCT01877382|531968976|FG005|Dose Escalation|Protocol Violation|0|||
147495701|NCT01877382|531968977|FG006|Dose Escalation|Protocol Violation|1|||
147495702|NCT01877382|531968978|FG007|Dose Escalation|Protocol Violation|0|||
147495703|NCT01877382|531968979|FG008|Dose Escalation|Protocol Violation|0|||
147495704|NCT01877382|531968980|FG009|Dose Escalation|Protocol Violation|0|||
147495705|NCT01877382|531968981|FG010|Dose Escalation|Protocol Violation|0|||
147495706|NCT01877382|531968982|FG011|Dose Escalation|Protocol Violation|0|||
147495707|NCT01877382|531968983|FG012|Dose Escalation|Protocol Violation|0|||
147495708|NCT01877382|531968984|FG013|Dose Escalation|Protocol Violation|0|||
147495709|NCT01877382|531968985|FG014|Dose Escalation|Protocol Violation|0|||
147495710|NCT01877382|531968971|FG000|Dose Escalation|Study terminated by sponsor|0|||
147495711|NCT01877382|531968972|FG001|Dose Escalation|Study terminated by sponsor|0|||
147495712|NCT01877382|531968973|FG002|Dose Escalation|Study terminated by sponsor|0|||
147495713|NCT01877382|531968974|FG003|Dose Escalation|Study terminated by sponsor|0|||
147495714|NCT01877382|531968975|FG004|Dose Escalation|Study terminated by sponsor|0|||
147495715|NCT01877382|531968976|FG005|Dose Escalation|Study terminated by sponsor|0|||
147495716|NCT01877382|531968977|FG006|Dose Escalation|Study terminated by sponsor|0|||
147495717|NCT01877382|531968978|FG007|Dose Escalation|Study terminated by sponsor|1|||
147495718|NCT01877382|531968979|FG008|Dose Escalation|Study terminated by sponsor|1|||
147495719|NCT01877382|531968980|FG009|Dose Escalation|Study terminated by sponsor|0|||
147495720|NCT01877382|531968981|FG010|Dose Escalation|Study terminated by sponsor|0|||
147628600|NCT02589639|532458734|FG000|Overall Study|Lost to Follow-up|1|||
147628601|NCT02589639|532458735|FG001|Overall Study|Lost to Follow-up|0|||
147628602|NCT02589639|532458736|FG002|Overall Study|Lost to Follow-up|0|||
147628603|NCT02589639|532458734|FG000|Overall Study|Protocol Violation|1|||
147628604|NCT02589639|532458735|FG001|Overall Study|Protocol Violation|0|||
147628605|NCT02589639|532458736|FG002|Overall Study|Protocol Violation|0|||
147628606|NCT02589639|532458734|FG000|Overall Study|Patient withdrawal, not due to AE|3|||
147628607|NCT02589639|532458735|FG001|Overall Study|Patient withdrawal, not due to AE|0|||
147628608|NCT02589639|532458736|FG002|Overall Study|Patient withdrawal, not due to AE|0|||
147628609|NCT02589639|532458734|FG000|Overall Study|Adverse Event|4|||
147628610|NCT02589639|532458735|FG001|Overall Study|Adverse Event|5|||
147628611|NCT02589639|532458736|FG002|Overall Study|Adverse Event|3|||
147495721|NCT01877382|531968982|FG011|Dose Escalation|Study terminated by sponsor|0|||
147495722|NCT01877382|531968983|FG012|Dose Escalation|Study terminated by sponsor|3|||
147495723|NCT01877382|531968984|FG013|Dose Escalation|Study terminated by sponsor|0|||
147495724|NCT01877382|531968985|FG014|Dose Escalation|Study terminated by sponsor|0|||
147495725|NCT01877382|531968971|FG000|Dose Escalation|Death|0|||
147495726|NCT01877382|531968972|FG001|Dose Escalation|Death|0|||
147495727|NCT01877382|531968973|FG002|Dose Escalation|Death|0|||
147495728|NCT01877382|531968974|FG003|Dose Escalation|Death|0|||
147495729|NCT01877382|531968975|FG004|Dose Escalation|Death|0|||
147495730|NCT01877382|531968976|FG005|Dose Escalation|Death|0|||
147495731|NCT01877382|531968977|FG006|Dose Escalation|Death|0|||
147495732|NCT01877382|531968978|FG007|Dose Escalation|Death|1|||
147495733|NCT01877382|531968979|FG008|Dose Escalation|Death|0|||
147495734|NCT01877382|531968980|FG009|Dose Escalation|Death|0|||
147495735|NCT01877382|531968981|FG010|Dose Escalation|Death|0|||
147495736|NCT01877382|531968982|FG011|Dose Escalation|Death|0|||
147495737|NCT01877382|531968983|FG012|Dose Escalation|Death|1|||
147495738|NCT01877382|531968984|FG013|Dose Escalation|Death|1|||
147495739|NCT01877382|531968985|FG014|Dose Escalation|Death|0|||
147495740|NCT01877382|531968971|FG000|Dose Expansion|Progressive disease|0|||
147495741|NCT01877382|531968972|FG001|Dose Expansion|Progressive disease|0|||
147495742|NCT01877382|531968973|FG002|Dose Expansion|Progressive disease|0|||
147495743|NCT01877382|531968974|FG003|Dose Expansion|Progressive disease|0|||
147495744|NCT01877382|531968975|FG004|Dose Expansion|Progressive disease|0|||
147495745|NCT01877382|531968976|FG005|Dose Expansion|Progressive disease|0|||
147495746|NCT01877382|531968977|FG006|Dose Expansion|Progressive disease|0|||
147495747|NCT01877382|531968978|FG007|Dose Expansion|Progressive disease|0|||
147495748|NCT01877382|531968979|FG008|Dose Expansion|Progressive disease|0|||
147495749|NCT01877382|531968980|FG009|Dose Expansion|Progressive disease|0|||
147495750|NCT01877382|531968981|FG010|Dose Expansion|Progressive disease|0|||
147495751|NCT01877382|531968982|FG011|Dose Expansion|Progressive disease|0|||
147495752|NCT01877382|531968983|FG012|Dose Expansion|Progressive disease|0|||
147495753|NCT01877382|531968984|FG013|Dose Expansion|Progressive disease|0|||
147495754|NCT01877382|531968985|FG014|Dose Expansion|Progressive disease|11|||
147495755|NCT01877382|531968971|FG000|Dose Expansion|Clinical progression|0|||
147495756|NCT01877382|531968972|FG001|Dose Expansion|Clinical progression|0|||
147495757|NCT01877382|531968973|FG002|Dose Expansion|Clinical progression|0|||
147495758|NCT01877382|531968974|FG003|Dose Expansion|Clinical progression|0|||
147495759|NCT01877382|531968975|FG004|Dose Expansion|Clinical progression|0|||
147495760|NCT01877382|531968976|FG005|Dose Expansion|Clinical progression|0|||
147495761|NCT01877382|531968977|FG006|Dose Expansion|Clinical progression|0|||
147495762|NCT01877382|531968978|FG007|Dose Expansion|Clinical progression|0|||
147495763|NCT01877382|531968979|FG008|Dose Expansion|Clinical progression|0|||
147495764|NCT01877382|531968980|FG009|Dose Expansion|Clinical progression|0|||
147495765|NCT01877382|531968981|FG010|Dose Expansion|Clinical progression|0|||
147495766|NCT01877382|531968982|FG011|Dose Expansion|Clinical progression|0|||
147495767|NCT01877382|531968983|FG012|Dose Expansion|Clinical progression|0|||
147495768|NCT01877382|531968984|FG013|Dose Expansion|Clinical progression|0|||
147495769|NCT01877382|531968985|FG014|Dose Expansion|Clinical progression|6|||
147495770|NCT01877382|531968971|FG000|Dose Expansion|Adverse Event|0|||
147495771|NCT01877382|531968972|FG001|Dose Expansion|Adverse Event|0|||
147495772|NCT01877382|531968973|FG002|Dose Expansion|Adverse Event|0|||
147495773|NCT01877382|531968974|FG003|Dose Expansion|Adverse Event|0|||
147495774|NCT01877382|531968975|FG004|Dose Expansion|Adverse Event|0|||
147495775|NCT01877382|531968976|FG005|Dose Expansion|Adverse Event|0|||
147495776|NCT01877382|531968977|FG006|Dose Expansion|Adverse Event|0|||
147495777|NCT01877382|531968978|FG007|Dose Expansion|Adverse Event|0|||
147495778|NCT01877382|531968979|FG008|Dose Expansion|Adverse Event|0|||
147495779|NCT01877382|531968980|FG009|Dose Expansion|Adverse Event|0|||
147495780|NCT01877382|531968981|FG010|Dose Expansion|Adverse Event|0|||
147628612|NCT02589639|532458734|FG000|Overall Study|Other reason than specified above|1|||
147628613|NCT02589639|532458735|FG001|Overall Study|Other reason than specified above|2|||
147628614|NCT02589639|532458736|FG002|Overall Study|Other reason than specified above|1|||
147628615|NCT02589639|532458734|FG000|Overall Study|Not Treated|0|||
147628616|NCT02589639|532458735|FG001|Overall Study|Not Treated|3|||
147495781|NCT01877382|531968982|FG011|Dose Expansion|Adverse Event|0|||
147495782|NCT01877382|531968983|FG012|Dose Expansion|Adverse Event|0|||
147628617|NCT02589639|532458736|FG002|Overall Study|Not Treated|0|||
147628618|NCT00703157|532458737|FG000|Overall Study|Lost to Follow-up|0|||
147495783|NCT01877382|531968984|FG013|Dose Expansion|Adverse Event|0|||
147495784|NCT01877382|531968985|FG014|Dose Expansion|Adverse Event|1|||
147495785|NCT01877382|531968971|FG000|Dose Expansion|Death|0|||
147495786|NCT01877382|531968972|FG001|Dose Expansion|Death|0|||
147495787|NCT01877382|531968973|FG002|Dose Expansion|Death|0|||
147495788|NCT01877382|531968974|FG003|Dose Expansion|Death|0|||
147495789|NCT01877382|531968975|FG004|Dose Expansion|Death|0|||
147495790|NCT01877382|531968976|FG005|Dose Expansion|Death|0|||
147495791|NCT01877382|531968977|FG006|Dose Expansion|Death|0|||
147495792|NCT01877382|531968978|FG007|Dose Expansion|Death|0|||
147495793|NCT01877382|531968979|FG008|Dose Expansion|Death|0|||
147628619|NCT00703157|532458738|FG001|Overall Study|Lost to Follow-up|1|||
147628620|NCT00703157|532458737|FG000|Overall Study|source data permanently lost/ other|4|||
147628621|NCT00703157|532458738|FG001|Overall Study|source data permanently lost/ other|1|||
147628622|NCT00347009|532458739|FG000|Overall Study|Death|1|||
147628623|NCT00347009|532458739|FG000|Overall Study|Adverse Event|6|||
147628624|NCT00347009|532458739|FG000|Overall Study|Withdrawal by Subject|3|||
147628625|NCT00347009|532458739|FG000|Overall Study|Physician Decision|5|||
147628626|NCT00347009|532458739|FG000|Overall Study|Lost to Follow-up|4|||
147628627|NCT00347009|532458739|FG000|Overall Study|Protocol Violation|2|||
147628628|NCT00347009|532458739|FG000|Overall Study|Adverse Laboratory Experience|1|||
147628629|NCT00347009|532458739|FG000|Overall Study|Insufficient Viral Suppression|3|||
147628630|NCT00347009|532458739|FG000|Overall Study|Increased ALT/HBV DNA|1|||
147628631|NCT00347009|532458739|FG000|Overall Study|Serious Adverse Event|1|||
147628632|NCT02522884|532458740|FG000|Overall Study|Withdrawal by Subject|6|||
147628633|NCT02522884|532458740|FG000|Overall Study|Death|3|||
147628634|NCT02522884|532458740|FG000|Overall Study|Missed 12-month Follow-up|9|||
147628635|NCT04495751|532458741|FG000|Overall Study|Withdrawal by Subject|1|||
147628636|NCT04495751|532458742|FG001|Overall Study|Withdrawal by Subject|0|||
147628637|NCT04495751|532458741|FG000|Overall Study|Lost to Follow-up|1|||
147628638|NCT04495751|532458742|FG001|Overall Study|Lost to Follow-up|0|||
147628639|NCT03289754|532458743|FG000|Overall Study|Screen Failure or Failure to Meet Follow-up|3|||
147628640|NCT04873934|532458744|FG000|Overall Study|Adverse Event|0|||
147628641|NCT04873934|532458745|FG001|Overall Study|Adverse Event|1|||
147628642|NCT04873934|532458744|FG000|Overall Study|Death|0|||
147628643|NCT04873934|532458745|FG001|Overall Study|Death|2|||
147628644|NCT04873934|532458744|FG000|Overall Study|Lost to Follow-up|13|||
147628645|NCT04873934|532458745|FG001|Overall Study|Lost to Follow-up|9|||
147628646|NCT04873934|532458744|FG000|Overall Study|Physician Decision|1|||
147628647|NCT04873934|532458745|FG001|Overall Study|Physician Decision|1|||
147628648|NCT04873934|532458744|FG000|Overall Study|Protocol deviation|2|||
147628649|NCT04873934|532458745|FG001|Overall Study|Protocol deviation|1|||
147628650|NCT04873934|532458744|FG000|Overall Study|Subject decision|1|||
147628651|NCT04873934|532458745|FG001|Overall Study|Subject decision|8|||
147628652|NCT04873934|532458744|FG000|Overall Study|Withdrew consent|0|||
147628653|NCT04873934|532458745|FG001|Overall Study|Withdrew consent|4|||
147628654|NCT04873934|532458744|FG000|Overall Study|Missing|1|||
147628655|NCT04873934|532458745|FG001|Overall Study|Missing|0|||
147628656|NCT00708461|532458746|FG000|Overall Study|Lost to Follow-up|18|||
147628657|NCT00708461|532458747|FG001|Overall Study|Lost to Follow-up|11|||
147628658|NCT00708461|532458746|FG000|Overall Study|Withdrawal by Subject|8|||
147628659|NCT00708461|532458747|FG001|Overall Study|Withdrawal by Subject|9|||
147628660|NCT00708461|532458746|FG000|Overall Study|left workforce|115|||
147628661|NCT00708461|532458747|FG001|Overall Study|left workforce|180|||
147628662|NCT03584854|532458753|FG000|Overall Study|Primary outcome not measured|1|||
147628663|NCT03584854|532458754|FG001|Overall Study|Primary outcome not measured|2|||
147628664|NCT02907177|532458755|FG000|Overall Study|Death|0|||
147628665|NCT02907177|532458756|FG001|Overall Study|Death|1|||
147628666|NCT02907177|532458755|FG000|Overall Study|Physician Decision|3|||
147628667|NCT02907177|532458756|FG001|Overall Study|Physician Decision|3|||
147628668|NCT02907177|532458755|FG000|Overall Study|Withdrawal by Subject|15|||
147628669|NCT02907177|532458756|FG001|Overall Study|Withdrawal by Subject|7|||
147628670|NCT02907177|532458755|FG000|Overall Study|Sponsor's Decision|50|||
147628671|NCT02907177|532458756|FG001|Overall Study|Sponsor's Decision|57|||
147628672|NCT02968173|532458759|FG000|Overall Study|Withdrawal by Subject|1|||
147628673|NCT02670525|532458760|FG000|Overall Study|Death|94|||
147628674|NCT02670525|532458761|FG001|Overall Study|Death|14|||
147628675|NCT02670525|532458760|FG000|Overall Study|Lost to Follow-up|4|||
147628676|NCT02670525|532458761|FG001|Overall Study|Lost to Follow-up|1|||
147628677|NCT02670525|532458760|FG000|Overall Study|Subject withdrew consent|1|||
147628678|NCT02670525|532458761|FG001|Overall Study|Subject withdrew consent|0|||
147628679|NCT02670525|532458760|FG000|Overall Study|Unknown, data entry delayed|123|||
147628680|NCT02670525|532458761|FG001|Overall Study|Unknown, data entry delayed|78|||
147668428|NCT01041859|532611783|FG001|Open-Label Titration|Withdrawal by Subject|0|||
147668429|NCT01041859|532611784|FG002|Open-Label Titration|Withdrawal by Subject|0|||
147628681|NCT01796392|532458762|FG000|Overall Study|Withdrawal by Subject|2|||
147628682|NCT01796392|532458763|FG001|Overall Study|Withdrawal by Subject|0|||
147628683|NCT01796392|532458762|FG000|Overall Study|Death|5|||
147628684|NCT01796392|532458763|FG001|Overall Study|Death|1|||
147628685|NCT01796392|532458762|FG000|Overall Study|Excluded for medical reasons|1|||
147628686|NCT01796392|532458763|FG001|Overall Study|Excluded for medical reasons|2|||
147628687|NCT01796392|532458762|FG000|Overall Study|Lost to Follow-up|1|||
147628688|NCT01796392|532458763|FG001|Overall Study|Lost to Follow-up|0|||
147628689|NCT02505217|532458764|FG000|Overall Study|Withdrawal by Subject|1|||
147628690|NCT02505217|532458765|FG001|Overall Study|Withdrawal by Subject|2|||
147628691|NCT04639219|532458766|FG000|Overall Study|Withdrawal by Subject|8|||
147628692|NCT04639219|532458766|FG000|Overall Study|Lost to Follow-up|6|||
147628693|NCT04639219|532458766|FG000|Overall Study|Death|55|||
147628694|NCT04681066|532458767|FG000|Overall Study|Lost to Follow-up|3|||
147628695|NCT04681066|532458768|FG001|Overall Study|Lost to Follow-up|1|||
147495794|NCT01877382|531968980|FG009|Dose Expansion|Death|0|||
147495795|NCT01877382|531968981|FG010|Dose Expansion|Death|0|||
147495796|NCT01877382|531968982|FG011|Dose Expansion|Death|0|||
147495797|NCT01877382|531968983|FG012|Dose Expansion|Death|0|||
147495798|NCT01877382|531968984|FG013|Dose Expansion|Death|0|||
147495799|NCT01877382|531968985|FG014|Dose Expansion|Death|1|||
147495800|NCT01877382|531968971|FG000|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
147495801|NCT01877382|531968972|FG001|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
147495802|NCT01877382|531968973|FG002|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
147495803|NCT01877382|531968974|FG003|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
147495804|NCT01877382|531968975|FG004|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
147495805|NCT01877382|531968976|FG005|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
147495806|NCT01877382|531968977|FG006|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
147495807|NCT01877382|531968978|FG007|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
147495808|NCT01877382|531968979|FG008|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
147495809|NCT01877382|531968980|FG009|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
147495810|NCT01877382|531968981|FG010|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
147495811|NCT01877382|531968982|FG011|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
147495812|NCT01877382|531968983|FG012|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
147495813|NCT01877382|531968984|FG013|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|0|||
147495814|NCT01877382|531968985|FG014|Dose Expansion|TP53 gene nonsynonymous mutation, insertion, or deletion detected|1|||
147495815|NCT01617655|531970758|FG000|Overall Study|Adverse Event|2|||
147495816|NCT01617655|531970759|FG001|Overall Study|Adverse Event|3|||
147495817|NCT01617655|531970758|FG000|Overall Study|Poor compliance to protocol|1|||
147495818|NCT01617655|531970759|FG001|Overall Study|Poor compliance to protocol|4|||
147495819|NCT01617655|531970758|FG000|Overall Study|Participants moved|0|||
147495820|NCT01617655|531970759|FG001|Overall Study|Participants moved|4|||
147495821|NCT01617655|531970758|FG000|Overall Study|Consent withdrawn by participant|1|||
147495822|NCT01617655|531970759|FG001|Overall Study|Consent withdrawn by participant|1|||
147495823|NCT01617655|531970758|FG000|Overall Study|Last visit outside protocol visit window|1|||
147495824|NCT01617655|531970759|FG001|Overall Study|Last visit outside protocol visit window|10|||
147495825|NCT01617655|531970758|FG000|Overall Study|Site closure|3|||
147495826|NCT01617655|531970759|FG001|Overall Study|Site closure|5|||
147495827|NCT01617655|531970758|FG000|Overall Study|Other than specified above|1|||
147495828|NCT01617655|531970759|FG001|Overall Study|Other than specified above|2|||
147495829|NCT00229203|531970764|FG000|Overall Study|Progressive disease|18|||
147495830|NCT00229203|531970765|FG001|Overall Study|Progressive disease|9|||
147495831|NCT00229203|531970764|FG000|Overall Study|Toxicity|6|||
147495832|NCT00229203|531970765|FG001|Overall Study|Toxicity|1|||
147495833|NCT00229203|531970764|FG000|Overall Study|Death|4|||
147495834|NCT00229203|531970765|FG001|Overall Study|Death|2|||
147495835|NCT00229203|531970764|FG000|Overall Study|Other|3|||
147495836|NCT00229203|531970765|FG001|Overall Study|Other|3|||
147495837|NCT00229203|531970764|FG000|Overall Study|Withdrawal by Subject|1|||
147495838|NCT00229203|531970765|FG001|Overall Study|Withdrawal by Subject|4|||
147495839|NCT03457103|531970766|FG000|Overall Study|illness/hospitalization|4|||
147495840|NCT03457103|531970767|FG001|Overall Study|illness/hospitalization|2|||
147495841|NCT03457103|531970766|FG000|Overall Study|Lost to Follow-up|2|||
147495842|NCT03457103|531970767|FG001|Overall Study|Lost to Follow-up|1|||
147495843|NCT03457103|531970766|FG000|Overall Study|Withdrawal by Subject|1|||
147495844|NCT03457103|531970767|FG001|Overall Study|Withdrawal by Subject|2|||
147495845|NCT03457103|531970766|FG000|Overall Study|financial/ insurance issues|1|||
147628696|NCT04681066|532458769|FG002|Overall Study|Lost to Follow-up|2|||
147628697|NCT04681066|532458770|FG003|Overall Study|Lost to Follow-up|1|||
147628698|NCT04681066|532458767|FG000|Overall Study|Withdrawal by Subject|2|||
147628699|NCT04681066|532458768|FG001|Overall Study|Withdrawal by Subject|1|||
147628700|NCT04681066|532458769|FG002|Overall Study|Withdrawal by Subject|0|||
147628701|NCT04681066|532458770|FG003|Overall Study|Withdrawal by Subject|3|||
147628702|NCT04681066|532458767|FG000|Overall Study|Death|0|||
147628703|NCT04681066|532458768|FG001|Overall Study|Death|1|||
147628704|NCT04681066|532458769|FG002|Overall Study|Death|0|||
147628705|NCT04681066|532458770|FG003|Overall Study|Death|0|||
147628706|NCT03517540|532458776|FG000|Overall Study|Protocol Violation|2|||
147628707|NCT03517540|532458777|FG001|Overall Study|Protocol Violation|0|||
147628708|NCT03517540|532458778|FG002|Overall Study|Protocol Violation|0|||
147628709|NCT03517540|532458779|FG003|Overall Study|Protocol Violation|1|||
147628710|NCT03517540|532458776|FG000|Overall Study|Adverse Event|9|||
147628711|NCT03517540|532458777|FG001|Overall Study|Adverse Event|3|||
147495846|NCT03457103|531970767|FG001|Overall Study|financial/ insurance issues|1|||
147628712|NCT03517540|532458778|FG002|Overall Study|Adverse Event|8|||
147628713|NCT03517540|532458779|FG003|Overall Study|Adverse Event|1|||
147628714|NCT03517540|532458776|FG000|Overall Study|Withdrawal by Subject|3|||
147628715|NCT03517540|532458777|FG001|Overall Study|Withdrawal by Subject|4|||
147628716|NCT03517540|532458778|FG002|Overall Study|Withdrawal by Subject|1|||
147628717|NCT03517540|532458779|FG003|Overall Study|Withdrawal by Subject|3|||
147628718|NCT01205269|532458780|FG000|Period 4 - Washout|Eligibility criteria not fulfilled|0|||
147628719|NCT01205269|532458781|FG001|Period 4 - Washout|Eligibility criteria not fulfilled|0|||
147628720|NCT01205269|532458782|FG002|Period 4 - Washout|Eligibility criteria not fulfilled|0|||
147628721|NCT01205269|532458783|FG003|Period 4 - Washout|Eligibility criteria not fulfilled|1|||
147628722|NCT01205269|532458784|FG004|Period 4 - Washout|Eligibility criteria not fulfilled|0|||
147628723|NCT01205269|532458785|FG005|Period 4 - Washout|Eligibility criteria not fulfilled|0|||
147628724|NCT01207687|532458786|FG000|Overall Study|Adverse Event|1|||
147628725|NCT01207687|532458786|FG000|Overall Study|Withdrawal by Subject|1|||
147628726|NCT00987337|532458787|FG000|Overall Study|Adverse Event|10|||
147628727|NCT00987337|532458788|FG001|Overall Study|Adverse Event|9|||
147628728|NCT00987337|532458789|FG002|Overall Study|Adverse Event|8|||
147628729|NCT00987337|532458787|FG000|Overall Study|Insufficient Virologic Response|10|||
147628730|NCT00987337|532458788|FG001|Overall Study|Insufficient Virologic Response|7|||
147628731|NCT00987337|532458789|FG002|Overall Study|Insufficient Virologic Response|12|||
147628732|NCT00987337|532458787|FG000|Overall Study|Virologic Breakthrough|2|||
147628733|NCT00987337|532458788|FG001|Overall Study|Virologic Breakthrough|2|||
147628734|NCT00987337|532458789|FG002|Overall Study|Virologic Breakthrough|8|||
147628735|NCT00987337|532458787|FG000|Overall Study|Lost to Follow-up|10|||
147628736|NCT00987337|532458788|FG001|Overall Study|Lost to Follow-up|6|||
147628737|NCT00987337|532458789|FG002|Overall Study|Lost to Follow-up|2|||
147628738|NCT00987337|532458787|FG000|Overall Study|Withdrawal by Subject|6|||
147628739|NCT00987337|532458788|FG001|Overall Study|Withdrawal by Subject|9|||
147628740|NCT00987337|532458789|FG002|Overall Study|Withdrawal by Subject|9|||
147628741|NCT00987337|532458787|FG000|Overall Study|Other|0|||
147628742|NCT00987337|532458788|FG001|Overall Study|Other|2|||
147628743|NCT00987337|532458789|FG002|Overall Study|Other|5|||
147628744|NCT00987337|532458787|FG000|Overall Study|Protocol Violation|1|||
147628745|NCT00987337|532458788|FG001|Overall Study|Protocol Violation|0|||
147628746|NCT00987337|532458789|FG002|Overall Study|Protocol Violation|2|||
147628747|NCT00987337|532458787|FG000|Overall Study|Participant Relapsed|18|||
147628748|NCT00987337|532458788|FG001|Overall Study|Participant Relapsed|20|||
147495847|NCT03004469|531970768|FG000|Overall Study|Adverse Event|6|||
147495848|NCT03004469|531970769|FG001|Overall Study|Adverse Event|4|||
147495849|NCT03004469|531970770|FG002|Overall Study|Adverse Event|6|||
147495850|NCT03004469|531970768|FG000|Overall Study|Lack of Efficacy|1|||
147495851|NCT03004469|531970769|FG001|Overall Study|Lack of Efficacy|0|||
147495852|NCT03004469|531970770|FG002|Overall Study|Lack of Efficacy|1|||
147495853|NCT03004469|531970768|FG000|Overall Study|Lost to Follow-up|23|||
147495854|NCT03004469|531970769|FG001|Overall Study|Lost to Follow-up|14|||
147495855|NCT03004469|531970770|FG002|Overall Study|Lost to Follow-up|6|||
147495856|NCT03004469|531970768|FG000|Overall Study|Non-Compliance with Study Drug|2|||
147495857|NCT03004469|531970769|FG001|Overall Study|Non-Compliance with Study Drug|0|||
147495858|NCT03004469|531970770|FG002|Overall Study|Non-Compliance with Study Drug|0|||
147495859|NCT03004469|531970768|FG000|Overall Study|Protocol Violation|0|||
147495860|NCT03004469|531970769|FG001|Overall Study|Protocol Violation|0|||
147495861|NCT03004469|531970770|FG002|Overall Study|Protocol Violation|1|||
147495862|NCT03004469|531970768|FG000|Overall Study|Withdrawal by Subject|29|||
147495863|NCT03004469|531970769|FG001|Overall Study|Withdrawal by Subject|27|||
147495864|NCT03004469|531970770|FG002|Overall Study|Withdrawal by Subject|10|||
147495865|NCT03004469|531970768|FG000|Overall Study|Other unspecified reason|0|||
147495866|NCT03004469|531970769|FG001|Overall Study|Other unspecified reason|4|||
147495867|NCT03004469|531970770|FG002|Overall Study|Other unspecified reason|1|||
147495868|NCT01163253|531970771|FG000|Overall Study|Withdrawn Due to Pregnancy|12|||
147495869|NCT01163253|531970772|FG001|Overall Study|Withdrawn Due to Pregnancy|2|||
147495870|NCT01163253|531970771|FG000|Overall Study|Study Terminated by Sponsor|978|||
147495871|NCT01163253|531970772|FG001|Overall Study|Study Terminated by Sponsor|349|||
147495872|NCT01163253|531970771|FG000|Overall Study|Protocol Violation|43|||
147495873|NCT01163253|531970772|FG001|Overall Study|Protocol Violation|12|||
147495874|NCT01163253|531970771|FG000|Overall Study|Withdrawal by Subject|199|||
147628749|NCT00987337|532458789|FG002|Overall Study|Participant Relapsed|5|||
147495875|NCT01163253|531970772|FG001|Overall Study|Withdrawal by Subject|50|||
147495876|NCT01163253|531970771|FG000|Overall Study|Medication Error|1|||
147495877|NCT01163253|531970772|FG001|Overall Study|Medication Error|0|||
147495878|NCT01163253|531970771|FG000|Overall Study|Lost to Follow-up|125|||
147495879|NCT01163253|531970772|FG001|Overall Study|Lost to Follow-up|23|||
147628750|NCT01801865|532458790|FG000|Overall Study|Patients scanned on another MRI scanner|35|||
147628751|NCT01801865|532458790|FG000|Overall Study|Physician Decision|7|||
147628752|NCT02134015|532458791|FG000|Overall Study|Protocol Violation|0|||
147495880|NCT01163253|531970771|FG000|Overall Study|Insufficient Clinical Response|423|||
147628753|NCT02134015|532458792|FG001|Overall Study|Protocol Violation|1|||
147628754|NCT02134015|532458791|FG000|Overall Study|Death|2|||
147628755|NCT02134015|532458792|FG001|Overall Study|Death|1|||
147628756|NCT02134015|532458791|FG000|Overall Study|Reason not provided|1|||
147628757|NCT02134015|532458792|FG001|Overall Study|Reason not provided|2|||
147628758|NCT02134015|532458791|FG000|Overall Study|Clinical progression|14|||
147495881|NCT01163253|531970772|FG001|Overall Study|Insufficient Clinical Response|29|||
147495882|NCT01163253|531970771|FG000|Overall Study|Adverse Event|300|||
147495883|NCT01163253|531970772|FG001|Overall Study|Adverse Event|78|||
147495884|NCT01163253|531970771|FG000|Overall Study|Death|17|||
147495885|NCT01163253|531970772|FG001|Overall Study|Death|5|||
147495886|NCT01163253|531970771|FG000|Overall Study|Ongoing|13|||
147495887|NCT01163253|531970772|FG001|Overall Study|Ongoing|4|||
147495888|NCT01163253|531970771|FG000|Overall Study|Other Unspecified|170|||
147495889|NCT01163253|531970772|FG001|Overall Study|Other Unspecified|34|||
147495890|NCT02492997|531970773|FG000|Overall Study|Withdrawal by Subject|1|||
147495891|NCT02492997|531970774|FG001|Overall Study|Withdrawal by Subject|0|||
147495892|NCT02492997|531970773|FG000|Overall Study|Gained Weight|1|||
147495893|NCT02492997|531970774|FG001|Overall Study|Gained Weight|0|||
147495894|NCT02492997|531970773|FG000|Overall Study|Lost to Follow-up|0|||
147495895|NCT02492997|531970774|FG001|Overall Study|Lost to Follow-up|1|||
147495896|NCT01397552|531970775|FG000|Overall Study|Adverse Event|1|||
147628759|NCT02134015|532458792|FG001|Overall Study|Clinical progression|7|||
147628760|NCT02134015|532458791|FG000|Overall Study|Progressive disease (per RECIST 1.1)|40|||
147628761|NCT02134015|532458792|FG001|Overall Study|Progressive disease (per RECIST 1.1)|43|||
147628762|NCT02134015|532458791|FG000|Overall Study|Study terminated by sponsor|2|||
147628763|NCT02134015|532458792|FG001|Overall Study|Study terminated by sponsor|3|||
147628764|NCT02134015|532458791|FG000|Overall Study|Adverse Event|9|||
147628765|NCT02134015|532458792|FG001|Overall Study|Adverse Event|10|||
147628766|NCT02134015|532458791|FG000|Overall Study|Withdrawal by Subject|3|||
147628767|NCT02134015|532458792|FG001|Overall Study|Withdrawal by Subject|7|||
147628768|NCT03867201|532458795|FG000|Double-Blind Period Until Week 12|Lack of Efficacy|1|||
147628769|NCT03867201|532458796|FG001|Double-Blind Period Until Week 12|Lack of Efficacy|0|||
147628770|NCT03867201|532458795|FG000|Double-Blind Period Until Week 12|Withdrawal by Subject|1|||
147628771|NCT03867201|532458796|FG001|Double-Blind Period Until Week 12|Withdrawal by Subject|2|||
147628772|NCT03867201|532458795|FG000|Double-Blind Period Until Week 12|Protocol Violation|1|||
147628773|NCT03867201|532458796|FG001|Double-Blind Period Until Week 12|Protocol Violation|2|||
147628774|NCT03867201|532458795|FG000|Double-Blind Period Until Week 12|Pregnancy|1|||
147628775|NCT03867201|532458796|FG001|Double-Blind Period Until Week 12|Pregnancy|1|||
147628776|NCT03867201|532458795|FG000|Double-Blind Period Until Week 12|Adverse Event|2|||
147628777|NCT03867201|532458796|FG001|Double-Blind Period Until Week 12|Adverse Event|1|||
147628778|NCT03867201|532458795|FG000|Open-Label Period From Week 12|Adverse Event|5|||
147628779|NCT03867201|532458796|FG001|Open-Label Period From Week 12|Adverse Event|11|||
147628780|NCT03867201|532458795|FG000|Open-Label Period From Week 12|Lost to Follow-up|1|||
147628781|NCT03867201|532458796|FG001|Open-Label Period From Week 12|Lost to Follow-up|0|||
147628782|NCT03867201|532458795|FG000|Open-Label Period From Week 12|Physician Decision|6|||
147628783|NCT03867201|532458796|FG001|Open-Label Period From Week 12|Physician Decision|3|||
147628784|NCT03867201|532458795|FG000|Open-Label Period From Week 12|Pregnancy|2|||
147495897|NCT01397552|531970776|FG001|Overall Study|Adverse Event|0|||
147495898|NCT01397552|531970775|FG000|Overall Study|Withdrawal by Subject|2|||
147495899|NCT01397552|531970776|FG001|Overall Study|Withdrawal by Subject|1|||
147495900|NCT00190983|531970782|FG000|Overall Study|Inevaluable (never treated)|2|||
147495901|NCT04069156|531970783|FG000|Modified Intent-to-Treat (mITT)|Death|1|||
147495902|NCT04069156|531970784|FG001|Modified Intent-to-Treat (mITT)|Death|2|||
147495903|NCT04069156|531970783|FG000|Modified Intent-to-Treat (mITT)|Withdrawal by Subject|9|||
147495904|NCT04069156|531970784|FG001|Modified Intent-to-Treat (mITT)|Withdrawal by Subject|7|||
147495905|NCT04069156|531970783|FG000|Modified Intent-to-Treat (mITT)|Transitioned to open label|8|||
147495906|NCT04069156|531970784|FG001|Modified Intent-to-Treat (mITT)|Transitioned to open label|12|||
147495907|NCT04069156|531970783|FG000|Principal Analysis|Withdrawn without primary end point event|25|||
147495908|NCT04069156|531970784|FG001|Principal Analysis|Withdrawn without primary end point event|20|||
147495909|NCT04247815|531970785|FG000|Overall Study|Adverse Event|1|||
147495910|NCT04247815|531970786|FG001|Overall Study|Adverse Event|0|||
147495911|NCT04247815|531970785|FG000|Overall Study|Withdrawal by Subject|1|||
147495912|NCT04247815|531970786|FG001|Overall Study|Withdrawal by Subject|0|||
147495913|NCT04247815|531970785|FG000|Overall Study|Protocol Violation|0|||
147495914|NCT04247815|531970786|FG001|Overall Study|Protocol Violation|1|||
147668430|NCT01041859|532611782|FG000|Double-Blind Maintenance|Adverse Event|0|||
147668431|NCT01041859|532611783|FG001|Double-Blind Maintenance|Adverse Event|23|||
147495915|NCT00089479|531970795|FG000|Overall Study|Death|108|||
147495916|NCT00089479|531970796|FG001|Overall Study|Death|75|||
147628785|NCT03867201|532458796|FG001|Open-Label Period From Week 12|Pregnancy|2|||
147628786|NCT03867201|532458795|FG000|Open-Label Period From Week 12|Protocol Violation|2|||
147495917|NCT00089479|531970795|FG000|Overall Study|Withdrawal by Subject|86|||
147495918|NCT00089479|531970796|FG001|Overall Study|Withdrawal by Subject|107|||
147495919|NCT00089479|531970795|FG000|Overall Study|Lost to Follow-up|137|||
147495920|NCT00089479|531970796|FG001|Overall Study|Lost to Follow-up|107|||
147495921|NCT03943953|531970797|FG000|Trial of ITG 1|Lost to Follow-up|19|||
147668432|NCT01041859|532611784|FG002|Double-Blind Maintenance|Adverse Event|13|||
147495922|NCT03943953|531970798|FG001|Trial of ITG 1|Lost to Follow-up|1|||
147495923|NCT03943953|531970797|FG000|Trial of ITG 2|Lost to Follow-up|8|||
147628787|NCT03867201|532458796|FG001|Open-Label Period From Week 12|Protocol Violation|0|||
147628788|NCT03867201|532458795|FG000|Open-Label Period From Week 12|Withdrawal by Subject|90|||
147628789|NCT03867201|532458796|FG001|Open-Label Period From Week 12|Withdrawal by Subject|85|||
147628790|NCT03867201|532458795|FG000|Open-Label Period From Week 12|No longer clinically benefiting|12|||
147628791|NCT03867201|532458796|FG001|Open-Label Period From Week 12|No longer clinically benefiting|10|||
147628792|NCT03867201|532458795|FG000|Open-Label Period From Week 12|New Therapy for Study Indication|1|||
147628793|NCT03867201|532458796|FG001|Open-Label Period From Week 12|New Therapy for Study Indication|0|||
147628794|NCT05763875|532458801|FG000|Overall Study|Subject decision|5|||
147628795|NCT05763875|532458802|FG001|Overall Study|Subject decision|2|||
147628796|NCT05763875|532458803|FG002|Overall Study|Subject decision|1|||
147628797|NCT05763875|532458801|FG000|Overall Study|Lost to Follow-up|4|||
147628798|NCT05763875|532458802|FG001|Overall Study|Lost to Follow-up|1|||
147628799|NCT05763875|532458803|FG002|Overall Study|Lost to Follow-up|2|||
147628800|NCT05763875|532458801|FG000|Overall Study|Adverse Event|1|||
147628801|NCT05763875|532458802|FG001|Overall Study|Adverse Event|0|||
147628802|NCT05763875|532458803|FG002|Overall Study|Adverse Event|0|||
147628803|NCT01777282|532458804|FG000|Overall Study|Persistent Hyperglycemia|0|||
147628804|NCT01777282|532458805|FG001|Overall Study|Persistent Hyperglycemia|0|||
147628805|NCT01777282|532458806|FG002|Overall Study|Persistent Hyperglycemia|1|||
147628806|NCT01777282|532458807|FG003|Overall Study|Persistent Hyperglycemia|0|||
147628807|NCT01777282|532458808|FG004|Overall Study|Persistent Hyperglycemia|0|||
147628808|NCT01777282|532458804|FG000|Overall Study|New Antidiabetic Medication|0|||
147628809|NCT01777282|532458805|FG001|Overall Study|New Antidiabetic Medication|0|||
147628810|NCT01777282|532458806|FG002|Overall Study|New Antidiabetic Medication|1|||
147628811|NCT01777282|532458807|FG003|Overall Study|New Antidiabetic Medication|0|||
147628812|NCT01777282|532458808|FG004|Overall Study|New Antidiabetic Medication|0|||
147628813|NCT01777282|532458804|FG000|Overall Study|Adverse Event|4|||
147628814|NCT01777282|532458805|FG001|Overall Study|Adverse Event|4|||
147628815|NCT01777282|532458806|FG002|Overall Study|Adverse Event|2|||
147628816|NCT01777282|532458807|FG003|Overall Study|Adverse Event|1|||
147628817|NCT01777282|532458808|FG004|Overall Study|Adverse Event|3|||
147628818|NCT01777282|532458804|FG000|Overall Study|Withdrawal by Subject|4|||
147628819|NCT01777282|532458805|FG001|Overall Study|Withdrawal by Subject|0|||
147628820|NCT01777282|532458806|FG002|Overall Study|Withdrawal by Subject|0|||
147628821|NCT01777282|532458807|FG003|Overall Study|Withdrawal by Subject|1|||
147628822|NCT01777282|532458808|FG004|Overall Study|Withdrawal by Subject|2|||
147628823|NCT01777282|532458804|FG000|Overall Study|Protocol Violation|2|||
147628824|NCT01777282|532458805|FG001|Overall Study|Protocol Violation|0|||
147628825|NCT01777282|532458806|FG002|Overall Study|Protocol Violation|1|||
147628826|NCT01777282|532458807|FG003|Overall Study|Protocol Violation|0|||
147628827|NCT01777282|532458808|FG004|Overall Study|Protocol Violation|2|||
147628828|NCT01777282|532458804|FG000|Overall Study|Moved, transfer abroad, did not enter FU|1|||
147628829|NCT01777282|532458805|FG001|Overall Study|Moved, transfer abroad, did not enter FU|0|||
147628830|NCT01777282|532458806|FG002|Overall Study|Moved, transfer abroad, did not enter FU|1|||
147628831|NCT01777282|532458807|FG003|Overall Study|Moved, transfer abroad, did not enter FU|0|||
147628832|NCT01777282|532458808|FG004|Overall Study|Moved, transfer abroad, did not enter FU|0|||
147628833|NCT02186873|532460482|FG000|Overall Study|Adverse Event|1|||
147628834|NCT02186873|532460483|FG001|Overall Study|Adverse Event|3|||
147628835|NCT02186873|532460482|FG000|Overall Study|Lack of Efficacy|0|||
147628836|NCT02186873|532460483|FG001|Overall Study|Lack of Efficacy|1|||
147628837|NCT02186873|532460482|FG000|Overall Study|Lost to Follow-up|1|||
147628838|NCT02186873|532460483|FG001|Overall Study|Lost to Follow-up|2|||
147628839|NCT02186873|532460482|FG000|Overall Study|Withdrawal by Subject|7|||
147628840|NCT02186873|532460483|FG001|Overall Study|Withdrawal by Subject|2|||
147628841|NCT03694002|532460484|FG000|Overall Study|Progression|4|||
147628842|NCT03694002|532460485|FG001|Overall Study|Progression|2|||
147628843|NCT03694002|532460484|FG000|Overall Study|Adverse Event|2|||
147628844|NCT03694002|532460485|FG001|Overall Study|Adverse Event|0|||
147628845|NCT03694002|532460484|FG000|Overall Study|Other not protocol specified|1|||
147628846|NCT03694002|532460485|FG001|Overall Study|Other not protocol specified|0|||
147628847|NCT03694002|532460484|FG000|Overall Study|Ineligible|0|||
147628848|NCT03694002|532460485|FG001|Overall Study|Ineligible|1|||
147628849|NCT03694002|532460484|FG000|Overall Study|Withdrew consent before starting treatment|0|||
147628850|NCT03694002|532460485|FG001|Overall Study|Withdrew consent before starting treatment|3|||
147628851|NCT05678959|532460486|FG000|Overall Study|Study Terminated by Sponsor|76|||
147628852|NCT05678959|532460487|FG001|Overall Study|Study Terminated by Sponsor|76|||
147668433|NCT01041859|532611782|FG000|Double-Blind Maintenance|Lack of Efficacy|0|||
147668434|NCT01041859|532611783|FG001|Double-Blind Maintenance|Lack of Efficacy|3|||
147668435|NCT01041859|532611784|FG002|Double-Blind Maintenance|Lack of Efficacy|11|||
147668436|NCT01041859|532611782|FG000|Double-Blind Maintenance|Lost to Follow-up|0|||
147668437|NCT01041859|532611783|FG001|Double-Blind Maintenance|Lost to Follow-up|1|||
147668438|NCT01041859|532611784|FG002|Double-Blind Maintenance|Lost to Follow-up|0|||
147628853|NCT05678959|532460486|FG000|Overall Study|Physician Decision|2|||
147628854|NCT05678959|532460487|FG001|Overall Study|Physician Decision|3|||
147668439|NCT01041859|532611782|FG000|Double-Blind Maintenance|Physician Decision|0|||
147628855|NCT05678959|532460486|FG000|Overall Study|Adverse Event|1|||
147628856|NCT05678959|532460487|FG001|Overall Study|Adverse Event|1|||
147628857|NCT05678959|532460486|FG000|Overall Study|Guardian Decision|1|||
147628858|NCT05678959|532460487|FG001|Overall Study|Guardian Decision|0|||
147628859|NCT05678959|532460486|FG000|Overall Study|Protocol Deviation|0|||
147628860|NCT05678959|532460487|FG001|Overall Study|Protocol Deviation|1|||
147628861|NCT05678959|532460486|FG000|Overall Study|Subject Decision|1|||
147628862|NCT05678959|532460487|FG001|Overall Study|Subject Decision|0|||
147628863|NCT05678959|532460486|FG000|Overall Study|Technical Problem|0|||
147628864|NCT05678959|532460487|FG001|Overall Study|Technical Problem|1|||
147628865|NCT01481766|532460491|FG000|4 months|Lost to Follow-up|3|||
147628866|NCT01481766|532460492|FG001|4 months|Lost to Follow-up|2|||
147628867|NCT01481766|532460493|FG002|4 months|Lost to Follow-up|1|||
147628868|NCT01481766|532460494|FG003|4 months|Lost to Follow-up|5|||
147628869|NCT01481766|532460491|FG000|12 months|Lost to Follow-up|7|||
147628870|NCT01481766|532460492|FG001|12 months|Lost to Follow-up|8|||
147628871|NCT01481766|532460493|FG002|12 months|Lost to Follow-up|5|||
147628872|NCT01481766|532460494|FG003|12 months|Lost to Follow-up|3|||
147628873|NCT00347958|532460495|FG000|Overall Study|Adverse Event|1|||
147628874|NCT00347958|532460495|FG000|Overall Study|Protocol Violation|2|||
147628875|NCT00347958|532460495|FG000|Overall Study|Withdrawal by Subject|1|||
147628876|NCT03868930|532460496|FG000|Intervention & Post-Treatment Assessment|Lost to Follow-up|3|||
147628877|NCT03868930|532460497|FG001|Intervention & Post-Treatment Assessment|Lost to Follow-up|1|||
147628878|NCT03868930|532460496|FG000|Intervention & Post-Treatment Assessment|Physician Decision|1|||
147628879|NCT03868930|532460497|FG001|Intervention & Post-Treatment Assessment|Physician Decision|4|||
147628880|NCT03868930|532460496|FG000|Intervention & Post-Treatment Assessment|Did not start treatment|18|||
147628881|NCT03868930|532460497|FG001|Intervention & Post-Treatment Assessment|Did not start treatment|16|||
147628882|NCT03868930|532460496|FG000|Intervention & Post-Treatment Assessment|Withdrawal by Subject|25|||
147628883|NCT03868930|532460497|FG001|Intervention & Post-Treatment Assessment|Withdrawal by Subject|17|||
147628884|NCT03868930|532460496|FG000|Follow-Up Assessment|Lost to Follow-up|9|||
147628885|NCT03868930|532460497|FG001|Follow-Up Assessment|Lost to Follow-up|12|||
147628886|NCT02151851|532460504|FG000|Overall Study|Lack of Efficacy|67|||
147628887|NCT02151851|532460505|FG001|Overall Study|Lack of Efficacy|94|||
147628888|NCT02151851|532460504|FG000|Overall Study|Protocol Violation|0|||
147628889|NCT02151851|532460505|FG001|Overall Study|Protocol Violation|1|||
147628890|NCT02151851|532460504|FG000|Overall Study|Withdrawal by Subject|2|||
147628891|NCT02151851|532460505|FG001|Overall Study|Withdrawal by Subject|5|||
147628892|NCT02151851|532460504|FG000|Overall Study|Medical impairment|1|||
147628893|NCT02151851|532460505|FG001|Overall Study|Medical impairment|0|||
147628894|NCT02151851|532460504|FG000|Overall Study|Low compliance to study visits|0|||
147628895|NCT02151851|532460505|FG001|Overall Study|Low compliance to study visits|1|||
147628896|NCT02151851|532460504|FG000|Overall Study|Subject entered into study in error|0|||
147628897|NCT02151851|532460505|FG001|Overall Study|Subject entered into study in error|1|||
147628898|NCT02151851|532460504|FG000|Overall Study|Adverse Event|6|||
147628899|NCT02151851|532460505|FG001|Overall Study|Adverse Event|28|||
147628900|NCT02159053|532460506|FG000|Overall Study|Death|2|||
147628901|NCT02159053|532460507|FG001|Overall Study|Death|0|||
147628902|NCT02159053|532460508|FG002|Overall Study|Death|1|||
147628903|NCT02159053|532460506|FG000|Overall Study|Physician Decision|0|||
147628904|NCT02159053|532460507|FG001|Overall Study|Physician Decision|1|||
147628905|NCT02159053|532460508|FG002|Overall Study|Physician Decision|1|||
147628906|NCT02159053|532460506|FG000|Overall Study|Lack of Efficacy|3|||
147628907|NCT02159053|532460507|FG001|Overall Study|Lack of Efficacy|4|||
147628908|NCT02159053|532460508|FG002|Overall Study|Lack of Efficacy|7|||
147628909|NCT02159053|532460506|FG000|Overall Study|Adverse Event|7|||
147628910|NCT02159053|532460507|FG001|Overall Study|Adverse Event|6|||
147628911|NCT02159053|532460508|FG002|Overall Study|Adverse Event|5|||
147628912|NCT02159053|532460506|FG000|Overall Study|Participants/guardian decision|8|||
147628913|NCT02159053|532460507|FG001|Overall Study|Participants/guardian decision|10|||
147628914|NCT02159053|532460508|FG002|Overall Study|Participants/guardian decision|6|||
147628915|NCT01540487|532460509|FG000|Overall Study|Protocol Violation|1|||
147628916|NCT01540487|532460510|FG001|Overall Study|Protocol Violation|0|||
147628917|NCT00617890|532460511|FG000|Overall Study|Treatment ongoing at data cut-off|0|||
147668440|NCT01041859|532611783|FG001|Double-Blind Maintenance|Physician Decision|2|||
147668441|NCT01041859|532611784|FG002|Double-Blind Maintenance|Physician Decision|1|||
147628918|NCT00617890|532460512|FG001|Overall Study|Treatment ongoing at data cut-off|0|||
147628919|NCT00617890|532460513|FG002|Overall Study|Treatment ongoing at data cut-off|0|||
147628920|NCT00617890|532460514|FG003|Overall Study|Treatment ongoing at data cut-off|5|||
147628921|NCT00617890|532460511|FG000|Overall Study|Lack of Efficacy|23|||
147628922|NCT00617890|532460512|FG001|Overall Study|Lack of Efficacy|26|||
147628923|NCT00617890|532460513|FG002|Overall Study|Lack of Efficacy|30|||
147628924|NCT00617890|532460514|FG003|Overall Study|Lack of Efficacy|97|||
147628925|NCT00617890|532460511|FG000|Overall Study|Lost to Follow-up|0|||
147628926|NCT00617890|532460512|FG001|Overall Study|Lost to Follow-up|0|||
147628927|NCT00617890|532460513|FG002|Overall Study|Lost to Follow-up|1|||
147628928|NCT00617890|532460514|FG003|Overall Study|Lost to Follow-up|2|||
147628929|NCT00617890|532460511|FG000|Overall Study|Withdrawal by Subject|4|||
147628930|NCT00617890|532460512|FG001|Overall Study|Withdrawal by Subject|1|||
147628931|NCT00617890|532460513|FG002|Overall Study|Withdrawal by Subject|0|||
147628932|NCT00617890|532460514|FG003|Overall Study|Withdrawal by Subject|2|||
147628933|NCT00617890|532460511|FG000|Overall Study|Protocol Violation|2|||
147628934|NCT00617890|532460512|FG001|Overall Study|Protocol Violation|1|||
147628935|NCT00617890|532460513|FG002|Overall Study|Protocol Violation|0|||
147628936|NCT00617890|532460514|FG003|Overall Study|Protocol Violation|0|||
147628937|NCT00617890|532460511|FG000|Overall Study|Adverse Event|1|||
147628938|NCT00617890|532460512|FG001|Overall Study|Adverse Event|0|||
147628939|NCT00617890|532460513|FG002|Overall Study|Adverse Event|3|||
147628940|NCT00617890|532460514|FG003|Overall Study|Adverse Event|8|||
147628941|NCT00617890|532460511|FG000|Overall Study|Not treated|1|||
147628942|NCT00617890|532460512|FG001|Overall Study|Not treated|0|||
147628943|NCT00617890|532460513|FG002|Overall Study|Not treated|1|||
147628944|NCT00617890|532460514|FG003|Overall Study|Not treated|1|||
147628945|NCT03503370|532460515|FG000|Overall Study|Death|3|||
147628946|NCT03503370|532460516|FG001|Overall Study|Death|1|||
147628947|NCT03483961|532460517|FG000|Overall Study|Lost to Follow-up|7|||
147628948|NCT03483961|532460518|FG001|Overall Study|Lost to Follow-up|6|||
147628949|NCT03483961|532460519|FG002|Overall Study|Lost to Follow-up|6|||
147628950|NCT03483961|532460520|FG003|Overall Study|Lost to Follow-up|6|||
147628951|NCT03483961|532460521|FG004|Overall Study|Lost to Follow-up|6|||
147628952|NCT03483961|532460522|FG005|Overall Study|Lost to Follow-up|4|||
147628953|NCT03483961|532460523|FG006|Overall Study|Lost to Follow-up|4|||
147628954|NCT03483961|532460524|FG007|Overall Study|Lost to Follow-up|11|||
147628955|NCT03483961|532460525|FG008|Overall Study|Lost to Follow-up|1|||
147628956|NCT03483961|532460526|FG009|Overall Study|Lost to Follow-up|0|||
147628957|NCT03483961|532460517|FG000|Overall Study|Withdrawal by Subject|3|||
147628958|NCT03483961|532460518|FG001|Overall Study|Withdrawal by Subject|4|||
147628959|NCT03483961|532460519|FG002|Overall Study|Withdrawal by Subject|5|||
147628960|NCT03483961|532460520|FG003|Overall Study|Withdrawal by Subject|3|||
147628961|NCT03483961|532460521|FG004|Overall Study|Withdrawal by Subject|4|||
147628962|NCT03483961|532460522|FG005|Overall Study|Withdrawal by Subject|2|||
147628963|NCT03483961|532460523|FG006|Overall Study|Withdrawal by Subject|1|||
147628964|NCT03483961|532460524|FG007|Overall Study|Withdrawal by Subject|2|||
147495924|NCT03943953|531970798|FG001|Trial of ITG 2|Lost to Follow-up|0|||
147495925|NCT03943953|531970797|FG000|Trial of ITG 3|Lost to Follow-up|2|||
147495926|NCT03943953|531970798|FG001|Trial of ITG 3|Lost to Follow-up|0|||
147495927|NCT03943953|531970797|FG000|Trial of ITG 4|Lost to Follow-up|2|||
147495928|NCT03943953|531970798|FG001|Trial of ITG 4|Lost to Follow-up|0|||
147495929|NCT00289185|531970801|FG000|Overall Study|Withdrawal by Subject|4|||
147495930|NCT00289185|531970802|FG001|Overall Study|Withdrawal by Subject|8|||
147495931|NCT00289185|531970801|FG000|Overall Study|Lost to Follow-up|23|||
147495932|NCT00289185|531970802|FG001|Overall Study|Lost to Follow-up|17|||
147495933|NCT00289185|531970801|FG000|Overall Study|Death|1|||
147495934|NCT00289185|531970802|FG001|Overall Study|Death|1|||
147495935|NCT01742078|531970803|FG000|Overall Study|Withdrawal by Subject|0|||
147495936|NCT01742078|531970804|FG001|Overall Study|Withdrawal by Subject|0|||
147495937|NCT01742078|531970805|FG002|Overall Study|Withdrawal by Subject|0|||
147495938|NCT01742078|531970806|FG003|Overall Study|Withdrawal by Subject|1|||
147495939|NCT01742078|531970807|FG004|Overall Study|Withdrawal by Subject|0|||
147495940|NCT01742078|531970808|FG005|Overall Study|Withdrawal by Subject|0|||
147495941|NCT01742078|531970809|FG006|Overall Study|Withdrawal by Subject|0|||
147495942|NCT01742078|531970810|FG007|Overall Study|Withdrawal by Subject|0|||
147495943|NCT01742078|531970811|FG008|Overall Study|Withdrawal by Subject|0|||
147495944|NCT01124448|531970816|FG000|Overall Study|Lost to Follow-up|0|||
147495945|NCT01124448|531970817|FG001|Overall Study|Lost to Follow-up|3|||
147495946|NCT01124448|531970816|FG000|Overall Study|Protocol Violation|2|||
147495947|NCT01124448|531970817|FG001|Overall Study|Protocol Violation|0|||
147495948|NCT03247413|531970821|FG000|Overall Study|Lost to Follow-up|28|||
147495949|NCT03337152|531970822|FG000|Overall Study|Physician Decision|1|||
147495950|NCT03337152|531970823|FG001|Overall Study|Physician Decision|0|||
147495951|NCT03337152|531970822|FG000|Overall Study|Lost to Follow-up|1|||
147495952|NCT03337152|531970823|FG001|Overall Study|Lost to Follow-up|3|||
147495953|NCT03337152|531970822|FG000|Overall Study|Adverse Event|3|||
147495954|NCT03337152|531970823|FG001|Overall Study|Adverse Event|1|||
147495955|NCT03337152|531970822|FG000|Overall Study|Stopped drug dosing due to study halt|6|||
147495956|NCT03337152|531970823|FG001|Overall Study|Stopped drug dosing due to study halt|7|||
147495957|NCT01021852|531970824|FG000|Treatment Period 1|Adverse Event|3|||
147628965|NCT03483961|532460525|FG008|Overall Study|Withdrawal by Subject|1|||
147628966|NCT03483961|532460526|FG009|Overall Study|Withdrawal by Subject|0|||
147628967|NCT03483961|532460517|FG000|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|1|||
147628968|NCT03483961|532460518|FG001|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
147628969|NCT03483961|532460519|FG002|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
147628970|NCT03483961|532460520|FG003|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
147495958|NCT01021852|531970825|FG001|Treatment Period 1|Adverse Event|1|||
147628971|NCT03483961|532460521|FG004|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
147628972|NCT03483961|532460522|FG005|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
147628973|NCT03483961|532460523|FG006|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
147628974|NCT03483961|532460524|FG007|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
147628975|NCT03483961|532460525|FG008|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
147628976|NCT03483961|532460526|FG009|Overall Study|Other than AE, death, PI decision, LTFU, noncompliance, study terminated, or withdrawal of consent|0|||
147628977|NCT03483961|532460517|FG000|Overall Study|Adverse Event|0|||
147628978|NCT03483961|532460518|FG001|Overall Study|Adverse Event|0|||
147628979|NCT03483961|532460519|FG002|Overall Study|Adverse Event|1|||
147628980|NCT03483961|532460520|FG003|Overall Study|Adverse Event|0|||
147628981|NCT03483961|532460521|FG004|Overall Study|Adverse Event|0|||
147628982|NCT03483961|532460522|FG005|Overall Study|Adverse Event|0|||
147628983|NCT03483961|532460523|FG006|Overall Study|Adverse Event|0|||
147628984|NCT03483961|532460524|FG007|Overall Study|Adverse Event|0|||
147628985|NCT03483961|532460525|FG008|Overall Study|Adverse Event|0|||
147628986|NCT03483961|532460526|FG009|Overall Study|Adverse Event|0|||
147628987|NCT02640950|532460527|FG000|Overall Study|Adverse Event|1|||
147628988|NCT02640950|532460527|FG000|Overall Study|Withdrawal by Subject|1|||
147628989|NCT04545489|532460528|FG000|Overall Study|Withdrawal by Subject|12|||
147628990|NCT04545489|532460529|FG001|Overall Study|Withdrawal by Subject|4|||
147628991|NCT04545489|532460528|FG000|Overall Study|Lost to Follow-up|17|||
147628992|NCT04545489|532460529|FG001|Overall Study|Lost to Follow-up|18|||
147628993|NCT04545489|532460528|FG000|Overall Study|12month BP not collected|4|||
147628994|NCT04545489|532460529|FG001|Overall Study|12month BP not collected|4|||
147628995|NCT04134767|532460531|FG000|Overall Study|Death|0|||
147628996|NCT04134767|532460532|FG001|Overall Study|Death|1|||
147628997|NCT04134767|532460531|FG000|Overall Study|Removed for harassing staff|0|||
147628998|NCT04134767|532460532|FG001|Overall Study|Removed for harassing staff|1|||
147628999|NCT04134767|532460531|FG000|Overall Study|Lost to Follow-up|44|||
147629000|NCT04134767|532460532|FG001|Overall Study|Lost to Follow-up|40|||
147629001|NCT00638404|532460533|FG000|Overall Study|Physician Decision|8|||
147629002|NCT00638404|532460534|FG001|Overall Study|Physician Decision|0|||
147629003|NCT02453334|532460535|FG000|Overall Study|Death|15|||
147629004|NCT02453334|532460536|FG001|Overall Study|Death|13|||
147629005|NCT02453334|532460535|FG000|Overall Study|Adverse Event|2|||
147629006|NCT02453334|532460536|FG001|Overall Study|Adverse Event|1|||
147629007|NCT02453334|532460535|FG000|Overall Study|Lost to Follow-up|5|||
147629008|NCT02453334|532460536|FG001|Overall Study|Lost to Follow-up|9|||
147629009|NCT02453334|532460535|FG000|Overall Study|Physician Decision|1|||
147629010|NCT02453334|532460536|FG001|Overall Study|Physician Decision|0|||
147629011|NCT02453334|532460535|FG000|Overall Study|Withdrawal by Subject|17|||
147629012|NCT02453334|532460536|FG001|Overall Study|Withdrawal by Subject|13|||
147629013|NCT02453334|532460535|FG000|Overall Study|Other reason|1|||
147629014|NCT02453334|532460536|FG001|Overall Study|Other reason|4|||
147629015|NCT02693106|532460540|FG000|Overall Study|No time|3|||
147629016|NCT06028438|532460549|FG000|Overall Study|Adverse Event|3|||
147629017|NCT06028438|532460550|FG001|Overall Study|Adverse Event|9|||
147629018|NCT06028438|532460549|FG000|Overall Study|Lack of Efficacy|1|||
147629019|NCT06028438|532460550|FG001|Overall Study|Lack of Efficacy|1|||
147629020|NCT06028438|532460549|FG000|Overall Study|Lost to Follow-up|1|||
147629021|NCT06028438|532460550|FG001|Overall Study|Lost to Follow-up|0|||
147629022|NCT06028438|532460549|FG000|Overall Study|Withdrawal by Subject|1|||
147629023|NCT06028438|532460550|FG001|Overall Study|Withdrawal by Subject|0|||
147629024|NCT06028438|532460549|FG000|Overall Study|Other|3|||
147629025|NCT06028438|532460550|FG001|Overall Study|Other|3|||
147629026|NCT05625802|532460551|FG000|Overall Study|Lost to Follow-up|1|||
147629027|NCT05625802|532460552|FG001|Overall Study|Lost to Follow-up|0|||
147629028|NCT01954056|532460554|FG000|Birth to 22-26 Mos. Corrected GA|Lost to Follow-up|1|||
147629029|NCT01954056|532460555|FG001|Birth to 22-26 Mos. Corrected GA|Lost to Follow-up|0|||
147629030|NCT00105079|532460558|FG000|Overall Study|Adverse Event|5|||
147629031|NCT00105079|532460559|FG001|Overall Study|Adverse Event|12|||
147629032|NCT00105079|532460558|FG000|Overall Study|Death|3|||
147495959|NCT01021852|531970826|FG002|Treatment Period 1|Adverse Event|1|||
147495960|NCT01021852|531970827|FG003|Treatment Period 1|Adverse Event|0|||
147495961|NCT01021852|531970828|FG004|Treatment Period 1|Adverse Event|2|||
147495962|NCT01021852|531970829|FG005|Treatment Period 1|Adverse Event|2|||
147629033|NCT00105079|532460559|FG001|Overall Study|Death|1|||
147495963|NCT01021852|531970830|FG006|Treatment Period 1|Adverse Event|0|||
147495964|NCT01021852|531970831|FG007|Treatment Period 1|Adverse Event|0|||
147629034|NCT00105079|532460558|FG000|Overall Study|Lost to Follow-up|12|||
147629035|NCT00105079|532460559|FG001|Overall Study|Lost to Follow-up|12|||
147629036|NCT00105079|532460558|FG000|Overall Study|Lack of Efficacy|9|||
147629037|NCT00105079|532460559|FG001|Overall Study|Lack of Efficacy|3|||
147629038|NCT00105079|532460558|FG000|Overall Study|Refused treatment|6|||
147629039|NCT00105079|532460559|FG001|Overall Study|Refused treatment|4|||
147668442|NCT01041859|532611782|FG000|Double-Blind Maintenance|Protocol Violation|0|||
147668443|NCT01041859|532611783|FG001|Double-Blind Maintenance|Protocol Violation|1|||
147668444|NCT01041859|532611784|FG002|Double-Blind Maintenance|Protocol Violation|3|||
147668445|NCT01041859|532611782|FG000|Double-Blind Maintenance|Other|0|||
147668446|NCT01041859|532611783|FG001|Double-Blind Maintenance|Other|6|||
147668447|NCT01041859|532611784|FG002|Double-Blind Maintenance|Other|2|||
147668448|NCT01041859|532611782|FG000|Double-Blind Maintenance|Noncompliance With Study Drug|0|||
147668449|NCT01041859|532611783|FG001|Double-Blind Maintenance|Noncompliance With Study Drug|2|||
147668450|NCT01041859|532611784|FG002|Double-Blind Maintenance|Noncompliance With Study Drug|6|||
147668451|NCT01041859|532611782|FG000|Double-Blind Maintenance|Withdrawal by Subject|0|||
147668452|NCT01041859|532611783|FG001|Double-Blind Maintenance|Withdrawal by Subject|8|||
147668453|NCT01041859|532611784|FG002|Double-Blind Maintenance|Withdrawal by Subject|9|||
147668454|NCT02475369|532611785|FG000|Run-in Washout Period #1 (7 Days)|Sponsor terminated study prematurely|7|||
147668455|NCT02475369|532611786|FG001|Run-in Washout Period #1 (7 Days)|Sponsor terminated study prematurely|2|||
147668456|NCT01991795|532611791|FG000|Overall Study|Lost to Follow-up|6|||
147668457|NCT01991795|532611792|FG001|Overall Study|Lost to Follow-up|4|||
147668458|NCT01991795|532611791|FG000|Overall Study|Withdrawal by Subject|117|||
147668459|NCT01991795|532611792|FG001|Overall Study|Withdrawal by Subject|94|||
147668460|NCT01991795|532611791|FG000|Overall Study|Site prematurely closed by sponsor|26|||
147668461|NCT01991795|532611792|FG001|Overall Study|Site prematurely closed by sponsor|25|||
147668462|NCT00885118|532611796|FG000|Overall Study|Adverse Event|1|||
147495965|NCT01021852|531970824|FG000|Treatment Period 1|Pregnancy|0|||
147495966|NCT01021852|531970825|FG001|Treatment Period 1|Pregnancy|0|||
147495967|NCT01021852|531970826|FG002|Treatment Period 1|Pregnancy|1|||
147495968|NCT01021852|531970827|FG003|Treatment Period 1|Pregnancy|0|||
147495969|NCT01021852|531970828|FG004|Treatment Period 1|Pregnancy|0|||
147495970|NCT01021852|531970829|FG005|Treatment Period 1|Pregnancy|0|||
147495971|NCT01021852|531970830|FG006|Treatment Period 1|Pregnancy|0|||
147629040|NCT00105079|532460558|FG000|Overall Study|Violation of selection criteria at entry|0|||
147629041|NCT00105079|532460559|FG001|Overall Study|Violation of selection criteria at entry|2|||
147629042|NCT00105079|532460558|FG000|Overall Study|Protocol Violation|1|||
147629043|NCT00105079|532460559|FG001|Overall Study|Protocol Violation|0|||
147629044|NCT00105079|532460558|FG000|Overall Study|Other|3|||
147629045|NCT00105079|532460559|FG001|Overall Study|Other|1|||
147629046|NCT01464593|532460562|FG000|Overall Study|Study terminated early due to lack of enrollment|1|||
147629047|NCT02476578|532460572|FG000|Overall Study|Died before Email was sent (<9.11.2015)|35|||
147629048|NCT02476578|532460573|FG001|Overall Study|Died before Email was sent (<9.11.2015)|43|||
147629049|NCT02476578|532460572|FG000|Overall Study|Lost to Follow-up|6|||
147629050|NCT02476578|532460573|FG001|Overall Study|Lost to Follow-up|13|||
147629051|NCT03491462|532460574|FG000|Overall Study|Lost to Follow-up|2|||
147629052|NCT03491462|532460575|FG001|Overall Study|Lost to Follow-up|0|||
147629053|NCT03491462|532460574|FG000|Overall Study|Adverse Event|11|||
147629054|NCT03491462|532460575|FG001|Overall Study|Adverse Event|1|||
147629055|NCT03491462|532460574|FG000|Overall Study|Physician Decision|3|||
147629056|NCT03491462|532460575|FG001|Overall Study|Physician Decision|0|||
147629057|NCT03491462|532460574|FG000|Overall Study|Withdrawal by Subject|22|||
147629058|NCT03491462|532460575|FG001|Overall Study|Withdrawal by Subject|15|||
147629059|NCT04938180|532460576|FG000|Overall Study|Adverse Event|1|||
147629060|NCT00423332|532460577|FG000|Overall Study|Adverse Event|6|||
147629061|NCT00423332|532460578|FG001|Overall Study|Adverse Event|2|||
147629062|NCT00423332|532460577|FG000|Overall Study|Withdrawal by Subject|1|||
147629063|NCT00423332|532460578|FG001|Overall Study|Withdrawal by Subject|0|||
147629064|NCT00423332|532460577|FG000|Overall Study|Condition under investigation worsened|1|||
147629065|NCT00423332|532460578|FG001|Overall Study|Condition under investigation worsened|1|||
147629066|NCT00423332|532460577|FG000|Overall Study|Progressive at Week 6|0|||
147629067|NCT00423332|532460578|FG001|Overall Study|Progressive at Week 6|1|||
147629068|NCT00423332|532460577|FG000|Overall Study|Unblinded before 12 weeks|1|||
147629069|NCT00423332|532460578|FG001|Overall Study|Unblinded before 12 weeks|3|||
147629070|NCT02035202|532460580|FG000|Overall Study|Lost to Follow-up|8|||
147629071|NCT02035202|532460581|FG001|Overall Study|Lost to Follow-up|16|||
147629072|NCT02035202|532460582|FG002|Overall Study|Lost to Follow-up|2|||
147629073|NCT02097238|532460590|FG000|Overall Study|Death|1|||
147668463|NCT00885118|532611797|FG001|Overall Study|Adverse Event|0|||
147668464|NCT00885118|532611798|FG002|Overall Study|Adverse Event|0|||
147668465|NCT00885118|532611799|FG003|Overall Study|Adverse Event|0|||
147668466|NCT00885118|532611800|FG004|Overall Study|Adverse Event|0|||
147668467|NCT00885118|532611796|FG000|Overall Study|Withdrawal by Subject|0|||
147668468|NCT00885118|532611797|FG001|Overall Study|Withdrawal by Subject|0|||
147495972|NCT01021852|531970831|FG007|Treatment Period 1|Pregnancy|0|||
147629074|NCT02097238|532460590|FG000|Overall Study|Physician Decision|1|||
147629075|NCT02097238|532460590|FG000|Overall Study|Progressive Disease|17|||
147629076|NCT01106911|532460591|FG000|Overall Study|Physician Decision|2|||
147629077|NCT01106911|532460591|FG000|Overall Study|deemed ineligible after screening|3|||
147668469|NCT00885118|532611798|FG002|Overall Study|Withdrawal by Subject|0|||
147495973|NCT01021852|531970824|FG000|Treatment Period 1|Withdrawal by Subject|0|||
147629078|NCT01814696|532460593|FG000|Overall Study|Withdrawal by Subject|1|||
147629079|NCT01814696|532460594|FG001|Overall Study|Withdrawal by Subject|0|||
147629080|NCT01814696|532460593|FG000|Overall Study|Randomized to wrong group|1|||
147629081|NCT01814696|532460594|FG001|Overall Study|Randomized to wrong group|0|||
147629082|NCT00984542|532460599|FG000|Overall Study|disease progression|19|||
147629083|NCT00984542|532460599|FG000|Overall Study|toxicity|7|||
147629084|NCT00984542|532460599|FG000|Overall Study|Death|7|||
147629085|NCT00984542|532460599|FG000|Overall Study|complicating disease|3|||
147629086|NCT00984542|532460599|FG000|Overall Study|Withdrawal by Subject|3|||
147629087|NCT00984542|532460599|FG000|Overall Study|clinical deterioration|2|||
147629088|NCT00425750|532460600|FG000|Overall Study|Death|1|||
147629089|NCT00425750|532460600|FG000|Overall Study|Withdrawal by Subject|3|||
147629090|NCT00425750|532460600|FG000|Overall Study|Adverse Event|3|||
147629091|NCT00425750|532460600|FG000|Overall Study|Progression of disease|18|||
147629092|NCT01757184|532460605|FG000|Double-blind Period|Adverse Event|1|||
147629093|NCT01757184|532460606|FG001|Double-blind Period|Adverse Event|0|||
147629094|NCT01757184|532460607|FG002|Double-blind Period|Adverse Event|0|||
147629095|NCT01757184|532460608|FG003|Double-blind Period|Adverse Event|0|||
147629096|NCT01757184|532460605|FG000|Open-label Period|Lost to Follow-up|0|||
147629097|NCT01757184|532460606|FG001|Open-label Period|Lost to Follow-up|0|||
147629098|NCT01757184|532460607|FG002|Open-label Period|Lost to Follow-up|2|||
147629099|NCT01757184|532460608|FG003|Open-label Period|Lost to Follow-up|0|||
147629100|NCT01757184|532460605|FG000|Open-label Period|Withdrawal by Subject|0|||
147629101|NCT01757184|532460606|FG001|Open-label Period|Withdrawal by Subject|0|||
147629102|NCT01757184|532460607|FG002|Open-label Period|Withdrawal by Subject|1|||
147629103|NCT01757184|532460608|FG003|Open-label Period|Withdrawal by Subject|1|||
147629104|NCT01757184|532460605|FG000|Open-label Period|Discontinued by Sponsor|0|||
147629105|NCT01757184|532460606|FG001|Open-label Period|Discontinued by Sponsor|0|||
147629106|NCT01757184|532460607|FG002|Open-label Period|Discontinued by Sponsor|1|||
147629107|NCT01757184|532460608|FG003|Open-label Period|Discontinued by Sponsor|2|||
147629108|NCT03515811|532460611|FG000|Overall Study|Lost to Follow-up|2|||
147629109|NCT03515811|532460612|FG001|Overall Study|Lost to Follow-up|1|||
147629110|NCT03515811|532460611|FG000|Overall Study|Protocol Violation|1|||
147629111|NCT03515811|532460612|FG001|Overall Study|Protocol Violation|1|||
147629112|NCT03515811|532460611|FG000|Overall Study|Death|1|||
147629113|NCT03515811|532460612|FG001|Overall Study|Death|1|||
147629114|NCT03515811|532460611|FG000|Overall Study|Withdrawal by Subject|0|||
147629115|NCT03515811|532460612|FG001|Overall Study|Withdrawal by Subject|2|||
147629116|NCT03515811|532460611|FG000|Overall Study|Technical Problems|1|||
147629117|NCT03515811|532460612|FG001|Overall Study|Technical Problems|0|||
147629118|NCT03515811|532460611|FG000|Overall Study|Subject Unable to Return for Follow-Up|0|||
147629119|NCT03515811|532460612|FG001|Overall Study|Subject Unable to Return for Follow-Up|2|||
147629120|NCT03515811|532460611|FG000|Overall Study|COVID-19|0|||
147629121|NCT03515811|532460612|FG001|Overall Study|COVID-19|1|||
147629122|NCT00237458|532460613|FG000|Overall Study|Lack of Efficacy|1|||
147629123|NCT00237458|532460613|FG000|Overall Study|Adverse Event|1|||
147629124|NCT00237458|532460613|FG000|Overall Study|Withdrawal by Subject|1|||
147629125|NCT01276756|532460614|FG000|Overall Study|Lost to Follow-up|2|||
147629126|NCT01276756|532460615|FG001|Overall Study|Lost to Follow-up|0|||
147629127|NCT01276756|532460614|FG000|Overall Study|Adverse Event|3|||
147629128|NCT01276756|532460615|FG001|Overall Study|Adverse Event|2|||
147629129|NCT05868577|532460616|FG000|Overall Study|Lost to Follow-up|5|||
147629130|NCT05868577|532460617|FG001|Overall Study|Lost to Follow-up|5|||
147629131|NCT02630251|532460618|FG000|Overall Study|Physician Decision|0|||
147629132|NCT02630251|532460619|FG001|Overall Study|Physician Decision|0|||
147629133|NCT02630251|532460620|FG002|Overall Study|Physician Decision|1|||
147629134|NCT02630251|532460621|FG003|Overall Study|Physician Decision|0|||
147629135|NCT04586244|532460622|FG000|Overall Study|Lost to Follow-up|1|||
147629136|NCT04586244|532460623|FG001|Overall Study|Lost to Follow-up|0|||
147629137|NCT04586244|532460624|FG002|Overall Study|Lost to Follow-up|0|||
147629138|NCT04586244|532460625|FG003|Overall Study|Lost to Follow-up|1|||
147629139|NCT04586244|532460626|FG004|Overall Study|Lost to Follow-up|0|||
147629140|NCT04586244|532460622|FG000|Overall Study|Surgery Delayed 140 Days Post-Last Dose Due to AE; Follow-up Data Not Collected|0|||
147629141|NCT04586244|532460623|FG001|Overall Study|Surgery Delayed 140 Days Post-Last Dose Due to AE; Follow-up Data Not Collected|1|||
147629142|NCT04586244|532460624|FG002|Overall Study|Surgery Delayed 140 Days Post-Last Dose Due to AE; Follow-up Data Not Collected|0|||
147629143|NCT04586244|532460625|FG003|Overall Study|Surgery Delayed 140 Days Post-Last Dose Due to AE; Follow-up Data Not Collected|0|||
147668470|NCT00885118|532611799|FG003|Overall Study|Withdrawal by Subject|0|||
147495974|NCT01021852|531970825|FG001|Treatment Period 1|Withdrawal by Subject|0|||
147629144|NCT04586244|532460626|FG004|Overall Study|Surgery Delayed 140 Days Post-Last Dose Due to AE; Follow-up Data Not Collected|0|||
147629145|NCT03564119|532460629|FG000|Overall Study|Adverse Event|4|||
147629146|NCT03564119|532460630|FG001|Overall Study|Adverse Event|0|||
147629147|NCT03564119|532460629|FG000|Overall Study|Lost to Follow-up|1|||
147629148|NCT03564119|532460630|FG001|Overall Study|Lost to Follow-up|4|||
147629149|NCT03564119|532460629|FG000|Overall Study|Protocol Violation|1|||
147629150|NCT03564119|532460630|FG001|Overall Study|Protocol Violation|0|||
147629151|NCT03564119|532460629|FG000|Overall Study|Withdrawal by Subject|9|||
147629152|NCT03564119|532460630|FG001|Overall Study|Withdrawal by Subject|4|||
147629153|NCT03564119|532460629|FG000|Overall Study|Other Than Specified|0|||
147629154|NCT03564119|532460630|FG001|Overall Study|Other Than Specified|1|||
147629155|NCT00634036|532460631|FG000|Overall Study|Lost to Follow-up|1|||
147629156|NCT00634036|532460632|FG001|Overall Study|Lost to Follow-up|1|||
147629157|NCT00634036|532460631|FG000|Overall Study|Withdrawal by Subject|1|||
147495975|NCT01021852|531970826|FG002|Treatment Period 1|Withdrawal by Subject|0|||
147495976|NCT01021852|531970827|FG003|Treatment Period 1|Withdrawal by Subject|0|||
147629158|NCT00634036|532460632|FG001|Overall Study|Withdrawal by Subject|1|||
147629159|NCT03896022|532460633|FG000|Overall Study|Withdrawal by Subject|1|||
147629160|NCT03896022|532460634|FG001|Overall Study|Withdrawal by Subject|0|||
147629161|NCT03896022|532460635|FG002|Overall Study|Withdrawal by Subject|0|||
147629162|NCT03896022|532460633|FG000|Overall Study|Did not have procedure|3|||
147629163|NCT03896022|532460634|FG001|Overall Study|Did not have procedure|0|||
147629164|NCT03896022|532460635|FG002|Overall Study|Did not have procedure|0|||
147629165|NCT01500382|532460642|FG000|Washout Period|Study site went out of business|0|||
147629166|NCT01500382|532460643|FG001|Washout Period|Study site went out of business|0|||
147629167|NCT01500382|532460644|FG002|Washout Period|Study site went out of business|1|||
147629168|NCT01500382|532460645|FG003|Washout Period|Study site went out of business|0|||
147629169|NCT06868654|532460646|FG000|Overall Study|Death|4|||
147629170|NCT06868654|532460647|FG001|Overall Study|Death|14|||
147629171|NCT06868654|532460646|FG000|Overall Study|Lost to Follow-up|0|||
147629172|NCT06868654|532460647|FG001|Overall Study|Lost to Follow-up|1|||
147629173|NCT06868654|532460646|FG000|Overall Study|Withdrawal by Subject|5|||
147629174|NCT06868654|532460647|FG001|Overall Study|Withdrawal by Subject|3|||
147629175|NCT06868654|532460646|FG000|Overall Study|Physician Decision|0|||
147629176|NCT06868654|532460647|FG001|Overall Study|Physician Decision|1|||
147629177|NCT06868654|532460646|FG000|Overall Study|Ongoing|23|||
147629178|NCT06868654|532460647|FG001|Overall Study|Ongoing|21|||
147629179|NCT04015518|532460648|FG000|Overall Study|Adverse Event|6|||
147629180|NCT04015518|532460649|FG001|Overall Study|Adverse Event|1|||
147629181|NCT04015518|532460650|FG002|Overall Study|Adverse Event|1|||
147629182|NCT04015518|532460651|FG003|Overall Study|Adverse Event|3|||
147629183|NCT04015518|532460652|FG004|Overall Study|Adverse Event|3|||
147629184|NCT04015518|532460648|FG000|Overall Study|Lack of Efficacy|1|||
147629185|NCT04015518|532460649|FG001|Overall Study|Lack of Efficacy|0|||
147629186|NCT04015518|532460650|FG002|Overall Study|Lack of Efficacy|1|||
147629187|NCT04015518|532460651|FG003|Overall Study|Lack of Efficacy|0|||
147629188|NCT04015518|532460652|FG004|Overall Study|Lack of Efficacy|4|||
147629189|NCT04015518|532460648|FG000|Overall Study|Lost to Follow-up|0|||
147629190|NCT04015518|532460649|FG001|Overall Study|Lost to Follow-up|0|||
147629191|NCT04015518|532460650|FG002|Overall Study|Lost to Follow-up|0|||
147629192|NCT04015518|532460651|FG003|Overall Study|Lost to Follow-up|0|||
147629193|NCT04015518|532460652|FG004|Overall Study|Lost to Follow-up|1|||
147629194|NCT04015518|532460648|FG000|Overall Study|Withdrawal by Subject|0|||
147629195|NCT04015518|532460649|FG001|Overall Study|Withdrawal by Subject|1|||
147629196|NCT04015518|532460650|FG002|Overall Study|Withdrawal by Subject|0|||
147629197|NCT04015518|532460651|FG003|Overall Study|Withdrawal by Subject|1|||
147629198|NCT04015518|532460652|FG004|Overall Study|Withdrawal by Subject|1|||
147629199|NCT04015518|532460648|FG000|Overall Study|Patient did not come for consecutive visits|0|||
147629200|NCT04015518|532460649|FG001|Overall Study|Patient did not come for consecutive visits|1|||
147495977|NCT01021852|531970828|FG004|Treatment Period 1|Withdrawal by Subject|1|||
147495978|NCT01021852|531970829|FG005|Treatment Period 1|Withdrawal by Subject|0|||
147495979|NCT01021852|531970830|FG006|Treatment Period 1|Withdrawal by Subject|0|||
147495980|NCT01021852|531970831|FG007|Treatment Period 1|Withdrawal by Subject|1|||
147495981|NCT01021852|531970824|FG000|Treatment Period 1|Not Treated|0|||
147495982|NCT01021852|531970825|FG001|Treatment Period 1|Not Treated|0|||
147495983|NCT01021852|531970826|FG002|Treatment Period 1|Not Treated|0|||
147495984|NCT01021852|531970827|FG003|Treatment Period 1|Not Treated|2|||
147495985|NCT01021852|531970828|FG004|Treatment Period 1|Not Treated|0|||
147495986|NCT01021852|531970829|FG005|Treatment Period 1|Not Treated|0|||
147495987|NCT01021852|531970830|FG006|Treatment Period 1|Not Treated|0|||
147629201|NCT04015518|532460650|FG002|Overall Study|Patient did not come for consecutive visits|0|||
147668471|NCT00885118|532611800|FG004|Overall Study|Withdrawal by Subject|1|||
147495988|NCT01021852|531970831|FG007|Treatment Period 1|Not Treated|0|||
147495989|NCT01021852|531970824|FG000|Washout Period-Placebo|Adverse Event|0|||
147629202|NCT04015518|532460651|FG003|Overall Study|Patient did not come for consecutive visits|0|||
147629203|NCT04015518|532460652|FG004|Overall Study|Patient did not come for consecutive visits|0|||
147629204|NCT04015518|532460648|FG000|Overall Study|not willing to travel due to Covid-19|0|||
147629205|NCT04015518|532460649|FG001|Overall Study|not willing to travel due to Covid-19|0|||
147629206|NCT04015518|532460650|FG002|Overall Study|not willing to travel due to Covid-19|1|||
147629207|NCT04015518|532460651|FG003|Overall Study|not willing to travel due to Covid-19|0|||
147629208|NCT04015518|532460652|FG004|Overall Study|not willing to travel due to Covid-19|0|||
147629209|NCT04015518|532460648|FG000|Overall Study|Patient wants to discontinue treatment|0|||
147495990|NCT01021852|531970825|FG001|Washout Period-Placebo|Adverse Event|0|||
147495991|NCT01021852|531970826|FG002|Washout Period-Placebo|Adverse Event|0|||
147629210|NCT04015518|532460649|FG001|Overall Study|Patient wants to discontinue treatment|0|||
147629211|NCT04015518|532460650|FG002|Overall Study|Patient wants to discontinue treatment|0|||
147629212|NCT04015518|532460651|FG003|Overall Study|Patient wants to discontinue treatment|1|||
147629213|NCT04015518|532460652|FG004|Overall Study|Patient wants to discontinue treatment|0|||
147629214|NCT04015518|532460648|FG000|Overall Study|Difficult for patient to come to the hospital|0|||
147629215|NCT04015518|532460649|FG001|Overall Study|Difficult for patient to come to the hospital|0|||
147629216|NCT04015518|532460650|FG002|Overall Study|Difficult for patient to come to the hospital|0|||
147629217|NCT04015518|532460651|FG003|Overall Study|Difficult for patient to come to the hospital|0|||
147629218|NCT04015518|532460652|FG004|Overall Study|Difficult for patient to come to the hospital|1|||
147629219|NCT04015518|532460648|FG000|Overall Study|Pregnancy|0|||
147629220|NCT04015518|532460649|FG001|Overall Study|Pregnancy|0|||
147629221|NCT04015518|532460650|FG002|Overall Study|Pregnancy|0|||
147629222|NCT04015518|532460651|FG003|Overall Study|Pregnancy|0|||
147629223|NCT04015518|532460652|FG004|Overall Study|Pregnancy|1|||
147629224|NCT04015518|532460648|FG000|Overall Study|Personal reasons|1|||
147629225|NCT04015518|532460649|FG001|Overall Study|Personal reasons|0|||
147629226|NCT04015518|532460650|FG002|Overall Study|Personal reasons|0|||
147629227|NCT04015518|532460651|FG003|Overall Study|Personal reasons|0|||
147629228|NCT04015518|532460652|FG004|Overall Study|Personal reasons|1|||
147629229|NCT04015518|532460648|FG000|Overall Study|Withdrew consent|1|||
147629230|NCT04015518|532460649|FG001|Overall Study|Withdrew consent|0|||
147629231|NCT04015518|532460650|FG002|Overall Study|Withdrew consent|0|||
147629232|NCT04015518|532460651|FG003|Overall Study|Withdrew consent|0|||
147629233|NCT04015518|532460652|FG004|Overall Study|Withdrew consent|0|||
147629234|NCT04015518|532460648|FG000|Overall Study|Prostate carcinoma|1|||
147629235|NCT04015518|532460649|FG001|Overall Study|Prostate carcinoma|0|||
147629236|NCT04015518|532460650|FG002|Overall Study|Prostate carcinoma|0|||
147629237|NCT04015518|532460651|FG003|Overall Study|Prostate carcinoma|0|||
147629238|NCT04015518|532460652|FG004|Overall Study|Prostate carcinoma|0|||
147629239|NCT04015518|532460648|FG000|Overall Study|Could not keep appointments due to work|1|||
147629240|NCT04015518|532460649|FG001|Overall Study|Could not keep appointments due to work|0|||
147629241|NCT04015518|532460650|FG002|Overall Study|Could not keep appointments due to work|0|||
147629242|NCT04015518|532460651|FG003|Overall Study|Could not keep appointments due to work|0|||
147629243|NCT04015518|532460652|FG004|Overall Study|Could not keep appointments due to work|0|||
147629244|NCT00550745|532460653|FG000|Overall Study|Death|20|||
147629245|NCT00550745|532460654|FG001|Overall Study|Death|16|||
147629246|NCT00550745|532460653|FG000|Overall Study|Lost to Follow-up|45|||
147629247|NCT00550745|532460654|FG001|Overall Study|Lost to Follow-up|30|||
147629248|NCT00550745|532460653|FG000|Overall Study|Physician Decision|0|||
147629249|NCT00550745|532460654|FG001|Overall Study|Physician Decision|2|||
147629250|NCT00550745|532460653|FG000|Overall Study|Protocol Violation|4|||
147629251|NCT00550745|532460654|FG001|Overall Study|Protocol Violation|2|||
147629252|NCT00550745|532460653|FG000|Overall Study|Withdrawal by Subject|17|||
147629253|NCT00550745|532460654|FG001|Overall Study|Withdrawal by Subject|10|||
147629254|NCT00550745|532460653|FG000|Overall Study|Screen failure|1|||
147629255|NCT00550745|532460654|FG001|Overall Study|Screen failure|0|||
147629256|NCT00764660|532460655|FG000|Overall Study|Adverse Event|6|||
147629257|NCT00764660|532460656|FG001|Overall Study|Adverse Event|3|||
147629258|NCT00764660|532460655|FG000|Overall Study|Lost to Follow-up|3|||
147629259|NCT00764660|532460656|FG001|Overall Study|Lost to Follow-up|4|||
147629260|NCT00764660|532460655|FG000|Overall Study|Withdrawal by Subject|7|||
147629261|NCT00764660|532460656|FG001|Overall Study|Withdrawal by Subject|3|||
147629262|NCT00764660|532460655|FG000|Overall Study|Noncompliance With Protocol|5|||
147629263|NCT00764660|532460656|FG001|Overall Study|Noncompliance With Protocol|1|||
147629264|NCT00764660|532460655|FG000|Overall Study|Did Not Meet Protocol Eligibility|1|||
147629265|NCT00764660|532460656|FG001|Overall Study|Did Not Meet Protocol Eligibility|0|||
147629266|NCT01131455|532460657|FG000|Overall Study|Death of PI|6|||
147629267|NCT01131455|532460658|FG001|Overall Study|Death of PI|4|||
147629268|NCT01131455|532460659|FG002|Overall Study|Death of PI|0|||
147629269|NCT06360588|532462644|FG000|Overall Study|Adverse Event|3|||
147629270|NCT06360588|532462644|FG000|Overall Study|Death|2|||
147629271|NCT06360588|532462644|FG000|Overall Study|Disease Progression|14|||
147629272|NCT06360588|532462644|FG000|Overall Study|Withdrawal by Subject|1|||
147629273|NCT06360588|532462644|FG000|Overall Study|Lack of Efficacy|1|||
147629274|NCT06360588|532462644|FG000|Overall Study|Ineligible|1|||
147495992|NCT01021852|531970827|FG003|Washout Period-Placebo|Adverse Event|1|||
147495993|NCT01021852|531970828|FG004|Washout Period-Placebo|Adverse Event|0|||
147495994|NCT01021852|531970829|FG005|Washout Period-Placebo|Adverse Event|1|||
147629275|NCT00754234|532462645|FG000|Overall Study|Withdrawal by Subject|3|||
147629276|NCT04432831|532462646|FG000|Overall Study|Withdrawal by Subject|24|||
147629277|NCT04432831|532462647|FG001|Overall Study|Withdrawal by Subject|28|||
147629278|NCT04432831|532462648|FG002|Overall Study|Withdrawal by Subject|21|||
147629279|NCT04432831|532462646|FG000|Overall Study|Death|23|||
147629280|NCT04432831|532462647|FG001|Overall Study|Death|23|||
147629281|NCT04432831|532462648|FG002|Overall Study|Death|17|||
147629282|NCT04432831|532462646|FG000|Overall Study|Lost to Follow-up|15|||
147629283|NCT04432831|532462647|FG001|Overall Study|Lost to Follow-up|15|||
147629284|NCT04432831|532462648|FG002|Overall Study|Lost to Follow-up|12|||
147629285|NCT04432831|532462646|FG000|Overall Study|Final End of Study Visit Not Completed|10|||
147629286|NCT04432831|532462647|FG001|Overall Study|Final End of Study Visit Not Completed|11|||
147629287|NCT04432831|532462648|FG002|Overall Study|Final End of Study Visit Not Completed|7|||
147629288|NCT04432831|532462646|FG000|Overall Study|Reason Not Specified|7|||
147629289|NCT04432831|532462647|FG001|Overall Study|Reason Not Specified|11|||
147629290|NCT04432831|532462648|FG002|Overall Study|Reason Not Specified|9|||
147629291|NCT04432831|532462646|FG000|Overall Study|Adverse Event|7|||
147629292|NCT04432831|532462647|FG001|Overall Study|Adverse Event|7|||
147629293|NCT04432831|532462648|FG002|Overall Study|Adverse Event|7|||
147629294|NCT04432831|532462646|FG000|Overall Study|Physician Decision|1|||
147629295|NCT04432831|532462647|FG001|Overall Study|Physician Decision|3|||
147629296|NCT04432831|532462648|FG002|Overall Study|Physician Decision|6|||
147629297|NCT04432831|532462646|FG000|Overall Study|Protocol Violation|1|||
147629298|NCT04432831|532462647|FG001|Overall Study|Protocol Violation|0|||
147629299|NCT04432831|532462648|FG002|Overall Study|Protocol Violation|2|||
147629300|NCT04432831|532462646|FG000|Overall Study|Pregnancy|0|||
147629301|NCT04432831|532462647|FG001|Overall Study|Pregnancy|1|||
147629302|NCT04432831|532462648|FG002|Overall Study|Pregnancy|0|||
147629303|NCT04432831|532462646|FG000|Overall Study|Lack of Efficacy|0|||
147629304|NCT04432831|532462647|FG001|Overall Study|Lack of Efficacy|0|||
147629305|NCT04432831|532462648|FG002|Overall Study|Lack of Efficacy|2|||
147629306|NCT01623310|532462651|FG000|Overall Study|Adverse Event|21|||
147629307|NCT01623310|532462651|FG000|Overall Study|Lost to Follow-up|18|||
147629308|NCT01623310|532462651|FG000|Overall Study|Lack of Efficacy|6|||
147629309|NCT01623310|532462651|FG000|Overall Study|Protocol Violation|6|||
147629310|NCT01623310|532462651|FG000|Overall Study|Withdrawal by Subject|25|||
147629311|NCT01623310|532462651|FG000|Overall Study|Became potentially child-bearing|1|||
147629312|NCT01623310|532462651|FG000|Overall Study|Diagnoses of bilateral cateracts|1|||
147629313|NCT01623310|532462651|FG000|Overall Study|Investigators Discretion-Noncompliant|1|||
147629314|NCT00356603|532462652|FG000|Overall Study|Other|6|||
147629315|NCT00356603|532462653|FG001|Overall Study|Other|3|||
147629316|NCT00734162|532462654|FG000|Randomized Phase (Through Week 72)|Investigator's Discretion|0|||
147629317|NCT00734162|532462655|FG001|Randomized Phase (Through Week 72)|Investigator's Discretion|1|||
147629318|NCT00734162|532462656|FG002|Randomized Phase (Through Week 72)|Investigator's Discretion|0|||
147629319|NCT00734162|532462657|FG003|Randomized Phase (Through Week 72)|Investigator's Discretion|2|||
147629320|NCT00734162|532462654|FG000|Randomized Phase (Through Week 72)|Per protocol ALT elevation|0|||
147629321|NCT00734162|532462655|FG001|Randomized Phase (Through Week 72)|Per protocol ALT elevation|0|||
147629322|NCT00734162|532462656|FG002|Randomized Phase (Through Week 72)|Per protocol ALT elevation|0|||
147629323|NCT00734162|532462657|FG003|Randomized Phase (Through Week 72)|Per protocol ALT elevation|2|||
147629324|NCT00734162|532462654|FG000|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|1|||
147629325|NCT00734162|532462655|FG001|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|0|||
147629326|NCT00734162|532462656|FG002|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|0|||
147629327|NCT00734162|532462657|FG003|Open-Label Phase|Safety, Tolerability or Efficacy Reasons|0|||
147629328|NCT00734162|532462654|FG000|Open-Label Phase|Withdrew Consent|1|||
147629329|NCT00734162|532462655|FG001|Open-Label Phase|Withdrew Consent|0|||
147629330|NCT00734162|532462656|FG002|Open-Label Phase|Withdrew Consent|1|||
147629331|NCT00734162|532462657|FG003|Open-Label Phase|Withdrew Consent|1|||
147629332|NCT00734162|532462654|FG000|Open-Label Phase|Lost to Follow-up|1|||
147629333|NCT00734162|532462655|FG001|Open-Label Phase|Lost to Follow-up|2|||
147629334|NCT00734162|532462656|FG002|Open-Label Phase|Lost to Follow-up|0|||
147629335|NCT00734162|532462657|FG003|Open-Label Phase|Lost to Follow-up|1|||
147629336|NCT00734162|532462654|FG000|Open-Label Phase|Did Not Meet Entrance Criteria|0|||
147629337|NCT00734162|532462655|FG001|Open-Label Phase|Did Not Meet Entrance Criteria|0|||
147629338|NCT00734162|532462656|FG002|Open-Label Phase|Did Not Meet Entrance Criteria|0|||
147629339|NCT00734162|532462657|FG003|Open-Label Phase|Did Not Meet Entrance Criteria|1|||
147629340|NCT00566020|532462658|FG000|6-week Dosage Adjustment Phase|Adverse Event|5|||
147629341|NCT00566020|532462659|FG001|6-week Dosage Adjustment Phase|Adverse Event|0|||
147629342|NCT00566020|532462658|FG000|6-week Dosage Adjustment Phase|Lack of Efficacy|2|||
147629343|NCT00566020|532462659|FG001|6-week Dosage Adjustment Phase|Lack of Efficacy|0|||
147629344|NCT00566020|532462658|FG000|46-week Long-term Administration Phase|Adverse Event|0|||
147668472|NCT00885118|532611796|FG000|Overall Study|Other reason not defined above|0|||
147495995|NCT01021852|531970830|FG006|Washout Period-Placebo|Adverse Event|0|||
147495996|NCT01021852|531970831|FG007|Washout Period-Placebo|Adverse Event|0|||
147495997|NCT01021852|531970824|FG000|Washout Period-Placebo|Lost to Follow-up|0|||
147495998|NCT01021852|531970825|FG001|Washout Period-Placebo|Lost to Follow-up|0|||
147629345|NCT00566020|532462659|FG001|46-week Long-term Administration Phase|Adverse Event|7|||
147629346|NCT00566020|532462658|FG000|46-week Long-term Administration Phase|Physician Decision|0|||
147629347|NCT00566020|532462659|FG001|46-week Long-term Administration Phase|Physician Decision|7|||
147629348|NCT00566020|532462658|FG000|46-week Long-term Administration Phase|Lost to Follow-up|0|||
147629349|NCT00566020|532462659|FG001|46-week Long-term Administration Phase|Lost to Follow-up|2|||
147629350|NCT00566020|532462658|FG000|46-week Long-term Administration Phase|Protocol-defined Stopping Criteria|0|||
147629351|NCT00566020|532462659|FG001|46-week Long-term Administration Phase|Protocol-defined Stopping Criteria|1|||
147629352|NCT00596687|532462660|FG000|Overall Study|< 24 hours of insulin treatment|8|||
147629353|NCT00596687|532462661|FG001|Overall Study|< 24 hours of insulin treatment|6|||
147629354|NCT00596687|532462660|FG000|Overall Study|continuous insulin infusion during TPN|2|||
147629355|NCT00596687|532462661|FG001|Overall Study|continuous insulin infusion during TPN|1|||
147629356|NCT00596687|532462660|FG000|Overall Study|Withdrawal by Subject|3|||
147629357|NCT00596687|532462661|FG001|Overall Study|Withdrawal by Subject|1|||
147629358|NCT00596687|532462660|FG000|Overall Study|cancelled surgery|1|||
147629359|NCT00596687|532462661|FG001|Overall Study|cancelled surgery|1|||
147629360|NCT01262287|532462662|FG000|Overall Study|Lost to Follow-up|2|||
147629361|NCT01262287|532462663|FG001|Overall Study|Lost to Follow-up|1|||
147629362|NCT00932373|532462664|FG000|Overall Study|Progressive disease|3|||
147629363|NCT00932373|532462665|FG001|Overall Study|Progressive disease|1|||
147629364|NCT00932373|532462666|FG002|Overall Study|Progressive disease|0|||
147629365|NCT00932373|532462667|FG003|Overall Study|Progressive disease|0|||
147629366|NCT00932373|532462668|FG004|Overall Study|Progressive disease|10|||
147629367|NCT00932373|532462669|FG005|Overall Study|Progressive disease|1|||
147629368|NCT00932373|532462670|FG006|Overall Study|Progressive disease|0|||
147629369|NCT00932373|532462671|FG007|Overall Study|Progressive disease|2|||
147629370|NCT00932373|532462672|FG008|Overall Study|Progressive disease|1|||
147629371|NCT00932373|532462673|FG009|Overall Study|Progressive disease|9|||
147629372|NCT00932373|532462674|FG010|Overall Study|Progressive disease|2|||
147629373|NCT00932373|532462664|FG000|Overall Study|Adverse Event|0|||
147629374|NCT00932373|532462665|FG001|Overall Study|Adverse Event|0|||
147629375|NCT00932373|532462666|FG002|Overall Study|Adverse Event|0|||
147629376|NCT00932373|532462667|FG003|Overall Study|Adverse Event|0|||
147629377|NCT00932373|532462668|FG004|Overall Study|Adverse Event|2|||
147629378|NCT00932373|532462669|FG005|Overall Study|Adverse Event|1|||
147629379|NCT00932373|532462670|FG006|Overall Study|Adverse Event|0|||
147629380|NCT00932373|532462671|FG007|Overall Study|Adverse Event|1|||
147629381|NCT00932373|532462672|FG008|Overall Study|Adverse Event|0|||
147629382|NCT00932373|532462673|FG009|Overall Study|Adverse Event|2|||
147629383|NCT00932373|532462674|FG010|Overall Study|Adverse Event|1|||
147629384|NCT00932373|532462664|FG000|Overall Study|Physician Decision|0|||
147629385|NCT00932373|532462665|FG001|Overall Study|Physician Decision|0|||
147629386|NCT00932373|532462666|FG002|Overall Study|Physician Decision|1|||
147629387|NCT00932373|532462667|FG003|Overall Study|Physician Decision|0|||
147629388|NCT00932373|532462668|FG004|Overall Study|Physician Decision|2|||
147629389|NCT00932373|532462669|FG005|Overall Study|Physician Decision|0|||
147629390|NCT00932373|532462670|FG006|Overall Study|Physician Decision|0|||
147629391|NCT00932373|532462671|FG007|Overall Study|Physician Decision|0|||
147629392|NCT00932373|532462672|FG008|Overall Study|Physician Decision|0|||
147629393|NCT00932373|532462673|FG009|Overall Study|Physician Decision|1|||
147629394|NCT00932373|532462674|FG010|Overall Study|Physician Decision|0|||
147629395|NCT00932373|532462664|FG000|Overall Study|Dose limiting toxicity|0|||
147629396|NCT00932373|532462665|FG001|Overall Study|Dose limiting toxicity|0|||
147629397|NCT00932373|532462666|FG002|Overall Study|Dose limiting toxicity|0|||
147629398|NCT00932373|532462667|FG003|Overall Study|Dose limiting toxicity|0|||
147629399|NCT00932373|532462668|FG004|Overall Study|Dose limiting toxicity|0|||
147629400|NCT00932373|532462669|FG005|Overall Study|Dose limiting toxicity|1|||
147629401|NCT00932373|532462670|FG006|Overall Study|Dose limiting toxicity|0|||
147629402|NCT00932373|532462671|FG007|Overall Study|Dose limiting toxicity|0|||
147629403|NCT00932373|532462672|FG008|Overall Study|Dose limiting toxicity|0|||
147629404|NCT00932373|532462673|FG009|Overall Study|Dose limiting toxicity|0|||
147629405|NCT00932373|532462674|FG010|Overall Study|Dose limiting toxicity|0|||
147629406|NCT00932373|532462664|FG000|Overall Study|Withdrawal by Subject|0|||
147629407|NCT00932373|532462665|FG001|Overall Study|Withdrawal by Subject|0|||
147629408|NCT00932373|532462666|FG002|Overall Study|Withdrawal by Subject|0|||
147629409|NCT00932373|532462667|FG003|Overall Study|Withdrawal by Subject|0|||
147629410|NCT00932373|532462668|FG004|Overall Study|Withdrawal by Subject|0|||
147629411|NCT00932373|532462669|FG005|Overall Study|Withdrawal by Subject|0|||
147668473|NCT00885118|532611797|FG001|Overall Study|Other reason not defined above|0|||
147668474|NCT00885118|532611798|FG002|Overall Study|Other reason not defined above|1|||
147629412|NCT00932373|532462670|FG006|Overall Study|Withdrawal by Subject|0|||
147629413|NCT00932373|532462671|FG007|Overall Study|Withdrawal by Subject|0|||
147629414|NCT00932373|532462672|FG008|Overall Study|Withdrawal by Subject|1|||
147629415|NCT00932373|532462673|FG009|Overall Study|Withdrawal by Subject|0|||
147629416|NCT00932373|532462674|FG010|Overall Study|Withdrawal by Subject|0|||
147629417|NCT00932373|532462664|FG000|Overall Study|Clinical progression|0|||
147629418|NCT00932373|532462665|FG001|Overall Study|Clinical progression|0|||
147629419|NCT00932373|532462666|FG002|Overall Study|Clinical progression|0|||
147629420|NCT00932373|532462667|FG003|Overall Study|Clinical progression|0|||
147629421|NCT00932373|532462668|FG004|Overall Study|Clinical progression|0|||
147629422|NCT00932373|532462669|FG005|Overall Study|Clinical progression|0|||
147629423|NCT00932373|532462670|FG006|Overall Study|Clinical progression|1|||
147629424|NCT00932373|532462671|FG007|Overall Study|Clinical progression|0|||
147629425|NCT00932373|532462672|FG008|Overall Study|Clinical progression|0|||
147629426|NCT00932373|532462673|FG009|Overall Study|Clinical progression|0|||
147629427|NCT00932373|532462674|FG010|Overall Study|Clinical progression|0|||
147629428|NCT00932373|532462664|FG000|Overall Study|Lack of Efficacy|0|||
147629429|NCT00932373|532462665|FG001|Overall Study|Lack of Efficacy|0|||
147629430|NCT00932373|532462666|FG002|Overall Study|Lack of Efficacy|0|||
147629431|NCT00932373|532462667|FG003|Overall Study|Lack of Efficacy|0|||
147629432|NCT00932373|532462668|FG004|Overall Study|Lack of Efficacy|0|||
147629433|NCT00932373|532462669|FG005|Overall Study|Lack of Efficacy|0|||
147629434|NCT00932373|532462670|FG006|Overall Study|Lack of Efficacy|0|||
147629435|NCT00932373|532462671|FG007|Overall Study|Lack of Efficacy|0|||
147629436|NCT00932373|532462672|FG008|Overall Study|Lack of Efficacy|0|||
147629437|NCT00932373|532462673|FG009|Overall Study|Lack of Efficacy|1|||
147629438|NCT00932373|532462674|FG010|Overall Study|Lack of Efficacy|0|||
147629439|NCT06098339|532462675|FG000|Period 1: First Intervention 28-32 Days|Lost to Follow-up|0|||
147629440|NCT06098339|532462676|FG001|Period 1: First Intervention 28-32 Days|Lost to Follow-up|1|||
147629441|NCT06098339|532462675|FG000|Period 1: First Intervention 28-32 Days|Enrolled outside the study inclusion/exclusion criteria and was discontinued early|1|||
147629442|NCT06098339|532462676|FG001|Period 1: First Intervention 28-32 Days|Enrolled outside the study inclusion/exclusion criteria and was discontinued early|1|||
147629443|NCT03831113|532462679|FG000|Overall Study|Withdrawal by Subject|0|||
147629444|NCT03831113|532462680|FG001|Overall Study|Withdrawal by Subject|2|||
147629445|NCT03831113|532462679|FG000|Overall Study|Protocol Violation|0|||
147629446|NCT03831113|532462680|FG001|Overall Study|Protocol Violation|9|||
147629447|NCT02492984|532462681|FG000|Overall Study|Adverse Event|1|||
147629448|NCT02492984|532462682|FG001|Overall Study|Adverse Event|0|||
147668475|NCT00885118|532611799|FG003|Overall Study|Other reason not defined above|0|||
147668476|NCT00885118|532611800|FG004|Overall Study|Other reason not defined above|0|||
147495999|NCT01021852|531970826|FG002|Washout Period-Placebo|Lost to Follow-up|0|||
147496000|NCT01021852|531970827|FG003|Washout Period-Placebo|Lost to Follow-up|0|||
147496001|NCT01021852|531970828|FG004|Washout Period-Placebo|Lost to Follow-up|1|||
147496002|NCT01021852|531970829|FG005|Washout Period-Placebo|Lost to Follow-up|0|||
147496003|NCT01021852|531970830|FG006|Washout Period-Placebo|Lost to Follow-up|0|||
147496004|NCT01021852|531970831|FG007|Washout Period-Placebo|Lost to Follow-up|0|||
147496005|NCT01021852|531970824|FG000|Washout Period-Placebo|Protocol Violation|0|||
147496006|NCT01021852|531970825|FG001|Washout Period-Placebo|Protocol Violation|0|||
147496007|NCT01021852|531970826|FG002|Washout Period-Placebo|Protocol Violation|0|||
147496008|NCT01021852|531970827|FG003|Washout Period-Placebo|Protocol Violation|0|||
147496009|NCT01021852|531970828|FG004|Washout Period-Placebo|Protocol Violation|0|||
147496010|NCT01021852|531970829|FG005|Washout Period-Placebo|Protocol Violation|0|||
147496011|NCT01021852|531970830|FG006|Washout Period-Placebo|Protocol Violation|1|||
147496012|NCT01021852|531970831|FG007|Washout Period-Placebo|Protocol Violation|0|||
147496013|NCT01021852|531970824|FG000|Washout Period-No Drug|Adverse Event|1|||
147496014|NCT01021852|531970825|FG001|Washout Period-No Drug|Adverse Event|0|||
147496015|NCT01021852|531970826|FG002|Washout Period-No Drug|Adverse Event|0|||
147496016|NCT01021852|531970827|FG003|Washout Period-No Drug|Adverse Event|0|||
147496017|NCT01021852|531970828|FG004|Washout Period-No Drug|Adverse Event|0|||
147496018|NCT01021852|531970829|FG005|Washout Period-No Drug|Adverse Event|1|||
147496019|NCT01021852|531970830|FG006|Washout Period-No Drug|Adverse Event|0|||
147496020|NCT01021852|531970831|FG007|Washout Period-No Drug|Adverse Event|0|||
147496021|NCT01021852|531970824|FG000|Treatment Period 2|Adverse Event|0|||
147496022|NCT01021852|531970825|FG001|Treatment Period 2|Adverse Event|1|||
147496023|NCT01021852|531970826|FG002|Treatment Period 2|Adverse Event|0|||
147496024|NCT01021852|531970827|FG003|Treatment Period 2|Adverse Event|0|||
147496025|NCT01021852|531970828|FG004|Treatment Period 2|Adverse Event|1|||
147496026|NCT01021852|531970829|FG005|Treatment Period 2|Adverse Event|0|||
147496027|NCT01021852|531970830|FG006|Treatment Period 2|Adverse Event|1|||
147496028|NCT01021852|531970831|FG007|Treatment Period 2|Adverse Event|0|||
147496029|NCT01021852|531970824|FG000|Treatment Period 2|Lack of Efficacy|0|||
147496030|NCT01021852|531970825|FG001|Treatment Period 2|Lack of Efficacy|0|||
147496031|NCT01021852|531970826|FG002|Treatment Period 2|Lack of Efficacy|0|||
147496032|NCT01021852|531970827|FG003|Treatment Period 2|Lack of Efficacy|0|||
147496033|NCT01021852|531970828|FG004|Treatment Period 2|Lack of Efficacy|0|||
147496034|NCT01021852|531970829|FG005|Treatment Period 2|Lack of Efficacy|1|||
147496035|NCT01021852|531970830|FG006|Treatment Period 2|Lack of Efficacy|0|||
147629449|NCT02492984|532462681|FG000|Overall Study|Protocol Violation|1|||
147629450|NCT02492984|532462682|FG001|Overall Study|Protocol Violation|0|||
147629451|NCT02492984|532462681|FG000|Overall Study|Withdrawal by Subject|1|||
147496036|NCT01021852|531970831|FG007|Treatment Period 2|Lack of Efficacy|0|||
147629452|NCT02492984|532462682|FG001|Overall Study|Withdrawal by Subject|0|||
147629453|NCT02282631|532462683|FG000|Overall Study|Lost to Follow-up|2|||
147668477|NCT00094445|532611801|FG000|Overall Study|Withdrawal by Subject|3|||
147496037|NCT01021852|531970824|FG000|Treatment Period 2|Physician Decision|0|||
147496038|NCT01021852|531970825|FG001|Treatment Period 2|Physician Decision|0|||
147496039|NCT01021852|531970826|FG002|Treatment Period 2|Physician Decision|1|||
147496040|NCT01021852|531970827|FG003|Treatment Period 2|Physician Decision|0|||
147496041|NCT01021852|531970828|FG004|Treatment Period 2|Physician Decision|0|||
147496042|NCT01021852|531970829|FG005|Treatment Period 2|Physician Decision|0|||
147629454|NCT02282631|532462684|FG001|Overall Study|Lost to Follow-up|0|||
147629455|NCT03981900|532462687|FG000|Overall Study|Participant decision - Without withdrawal of consent|17|||
147629456|NCT03981900|532462687|FG000|Overall Study|Adverse Event|5|||
147629457|NCT03981900|532462687|FG000|Overall Study|Protocol Violation|1|||
147629458|NCT03981900|532462687|FG000|Overall Study|Withdrawal by Subject|7|||
147629459|NCT03981900|532462687|FG000|Overall Study|Lost to Follow-up|46|||
147629460|NCT03981900|532462687|FG000|Overall Study|Decision of the researcher|3|||
147629461|NCT03981900|532462687|FG000|Overall Study|Death|3|||
147629462|NCT03981900|532462687|FG000|Overall Study|Other|5|||
147629463|NCT06152224|532462691|FG000|Overall Study|Withdrawal by Subject|1|||
147629464|NCT06152224|532462692|FG001|Overall Study|Withdrawal by Subject|0|||
147629465|NCT06152224|532462691|FG000|Overall Study|Lost to Follow-up|0|||
147629466|NCT06152224|532462692|FG001|Overall Study|Lost to Follow-up|1|||
147629467|NCT06152224|532462691|FG000|Overall Study|On Follow Up|18|||
147629468|NCT06152224|532462692|FG001|Overall Study|On Follow Up|18|||
147629469|NCT02509507|532462695|FG000|Overall Study|Death|21|||
147629470|NCT02509507|532462696|FG001|Overall Study|Death|3|||
147629471|NCT02509507|532462697|FG002|Overall Study|Death|22|||
147629472|NCT02509507|532462698|FG003|Overall Study|Death|14|||
147629473|NCT02509507|532462699|FG004|Overall Study|Death|8|||
147629474|NCT02509507|532462700|FG005|Overall Study|Death|12|||
147629475|NCT02509507|532462701|FG006|Overall Study|Death|5|||
147629476|NCT02509507|532462702|FG007|Overall Study|Death|4|||
147629477|NCT02509507|532462703|FG008|Overall Study|Death|8|||
147629478|NCT02509507|532462695|FG000|Overall Study|Lost to Follow-up|0|||
147629479|NCT02509507|532462696|FG001|Overall Study|Lost to Follow-up|1|||
147629480|NCT02509507|532462697|FG002|Overall Study|Lost to Follow-up|0|||
147629481|NCT02509507|532462698|FG003|Overall Study|Lost to Follow-up|0|||
147629482|NCT02509507|532462699|FG004|Overall Study|Lost to Follow-up|0|||
147629483|NCT02509507|532462700|FG005|Overall Study|Lost to Follow-up|2|||
147629484|NCT02509507|532462701|FG006|Overall Study|Lost to Follow-up|0|||
147629485|NCT02509507|532462702|FG007|Overall Study|Lost to Follow-up|0|||
147629486|NCT02509507|532462703|FG008|Overall Study|Lost to Follow-up|0|||
147629487|NCT02509507|532462695|FG000|Overall Study|Withdrawal by Subject|2|||
147629488|NCT02509507|532462696|FG001|Overall Study|Withdrawal by Subject|0|||
147629489|NCT02509507|532462697|FG002|Overall Study|Withdrawal by Subject|1|||
147629490|NCT02509507|532462698|FG003|Overall Study|Withdrawal by Subject|4|||
147629491|NCT02509507|532462699|FG004|Overall Study|Withdrawal by Subject|1|||
147629492|NCT02509507|532462700|FG005|Overall Study|Withdrawal by Subject|3|||
147629493|NCT02509507|532462701|FG006|Overall Study|Withdrawal by Subject|4|||
147629494|NCT02509507|532462702|FG007|Overall Study|Withdrawal by Subject|0|||
147629495|NCT02509507|532462703|FG008|Overall Study|Withdrawal by Subject|1|||
147629496|NCT03337113|532462713|FG000|Overall Study|Adverse Event|1|||
147629497|NCT03337113|532462714|FG001|Overall Study|Adverse Event|1|||
147629498|NCT03337113|532462715|FG002|Overall Study|Adverse Event|0|||
147629499|NCT03337113|532462716|FG003|Overall Study|Adverse Event|1|||
147629500|NCT03337113|532462713|FG000|Overall Study|Physician Decision|0|||
147629501|NCT03337113|532462714|FG001|Overall Study|Physician Decision|2|||
147629502|NCT03337113|532462715|FG002|Overall Study|Physician Decision|0|||
147629503|NCT03337113|532462716|FG003|Overall Study|Physician Decision|1|||
147629504|NCT03337113|532462713|FG000|Overall Study|Withdrawal by Subject|0|||
147629505|NCT03337113|532462714|FG001|Overall Study|Withdrawal by Subject|0|||
147629506|NCT03337113|532462715|FG002|Overall Study|Withdrawal by Subject|1|||
147629507|NCT03337113|532462716|FG003|Overall Study|Withdrawal by Subject|0|||
147629508|NCT00644917|532462719|FG000|Overall Study|Withdrawal by Subject|2|||
147629509|NCT00758485|532462720|FG000|Overall Study|Lost to Follow-up|0|||
147629510|NCT00758485|532462721|FG001|Overall Study|Lost to Follow-up|1|||
147629511|NCT00758485|532462720|FG000|Overall Study|Not Treated|1|||
147629512|NCT00758485|532462721|FG001|Overall Study|Not Treated|2|||
147629513|NCT00921557|532462722|FG000|Weeks 0-48 (on Study Treatment)|Baseline lumbar spine > -1.5|2|||
147629514|NCT00921557|532462723|FG001|Weeks 0-48 (on Study Treatment)|Baseline lumbar spine > -1.5|0|||
147629515|NCT00921557|532462724|FG002|Weeks 0-48 (on Study Treatment)|Baseline lumbar spine > -1.5|0|||
147629516|NCT00921557|532462722|FG000|Weeks 48-96 (on Study Treatment)|Site Closure|0|||
147629517|NCT00921557|532462723|FG001|Weeks 48-96 (on Study Treatment)|Site Closure|1|||
147629518|NCT00921557|532462724|FG002|Weeks 48-96 (on Study Treatment)|Site Closure|0|||
147629519|NCT00921557|532462722|FG000|Weeks 48-96 (on Study Treatment)|Became a ward of the state|0|||
147629520|NCT00921557|532462723|FG001|Weeks 48-96 (on Study Treatment)|Became a ward of the state|0|||
147629521|NCT00921557|532462724|FG002|Weeks 48-96 (on Study Treatment)|Became a ward of the state|1|||
147629522|NCT00921557|532462722|FG000|Weeks 96-144 (Off Study Treatment)|Site closure|1|||
147629523|NCT00921557|532462723|FG001|Weeks 96-144 (Off Study Treatment)|Site closure|0|||
147629524|NCT00921557|532462724|FG002|Weeks 96-144 (Off Study Treatment)|Site closure|0|||
147496043|NCT01021852|531970830|FG006|Treatment Period 2|Physician Decision|0|||
147629525|NCT00921557|532462722|FG000|Weeks 96-144 (Off Study Treatment)|Not able to attend clinic|2|||
147629526|NCT00921557|532462723|FG001|Weeks 96-144 (Off Study Treatment)|Not able to attend clinic|1|||
147629527|NCT00921557|532462724|FG002|Weeks 96-144 (Off Study Treatment)|Not able to attend clinic|1|||
147629528|NCT03259425|532462734|FG000|Overall Study|Disease progression to an extent that didn't allow surgery|1|||
147629529|NCT01282372|532462737|FG000|Overall Study|Lack of Efficacy / Exacerbation|25|||
147629530|NCT01282372|532462737|FG000|Overall Study|Lost to Follow-up|23|||
147629531|NCT01282372|532462737|FG000|Overall Study|Withdrawal by Subject|11|||
147629532|NCT01282372|532462737|FG000|Overall Study|Refer Pre-Assignment Detail for Reason 1|4|||
147629533|NCT01282372|532462737|FG000|Overall Study|Death|1|||
147629534|NCT01282372|532462737|FG000|Overall Study|Presence of AE, Lack of Efficacy|1|||
147629535|NCT01282372|532462737|FG000|Overall Study|Presence of AE, Regression of Symptoms|1|||
147629536|NCT01282372|532462737|FG000|Overall Study|Refer Pre-Assignment Detail for Reason 2|1|||
147629537|NCT01282372|532462737|FG000|Overall Study|Adverse Event|12|||
147629538|NCT00713258|532462738|FG000|Overall Study|Adverse Event|2|||
147629539|NCT00713258|532462739|FG001|Overall Study|Adverse Event|4|||
147629540|NCT00713258|532462738|FG000|Overall Study|Non-Compliance|2|||
147629541|NCT00713258|532462739|FG001|Overall Study|Non-Compliance|1|||
147629542|NCT00713258|532462738|FG000|Overall Study|Other|1|||
147629543|NCT00713258|532462739|FG001|Overall Study|Other|1|||
147629544|NCT01322490|532462740|FG000|Treatment Period|Adverse Event|12|||
147629545|NCT01322490|532462741|FG001|Treatment Period|Adverse Event|18|||
147629546|NCT01322490|532462742|FG002|Treatment Period|Adverse Event|15|||
147629547|NCT01322490|532462740|FG000|Treatment Period|Death|5|||
147629548|NCT01322490|532462741|FG001|Treatment Period|Death|7|||
147629549|NCT01322490|532462742|FG002|Treatment Period|Death|3|||
147629550|NCT01322490|532462740|FG000|Treatment Period|Lack of Efficacy|89|||
147629551|NCT01322490|532462741|FG001|Treatment Period|Lack of Efficacy|100|||
147629552|NCT01322490|532462742|FG002|Treatment Period|Lack of Efficacy|112|||
147629553|NCT01322490|532462740|FG000|Treatment Period|Physician Decision|0|||
147629554|NCT01322490|532462741|FG001|Treatment Period|Physician Decision|2|||
147629555|NCT01322490|532462742|FG002|Treatment Period|Physician Decision|1|||
147629556|NCT01322490|532462740|FG000|Treatment Period|Protocol Violation|7|||
147629557|NCT01322490|532462741|FG001|Treatment Period|Protocol Violation|5|||
147629558|NCT01322490|532462742|FG002|Treatment Period|Protocol Violation|4|||
147629559|NCT01322490|532462740|FG000|Treatment Period|Withdrawal by Subject|14|||
147629560|NCT01322490|532462741|FG001|Treatment Period|Withdrawal by Subject|16|||
147629561|NCT01322490|532462742|FG002|Treatment Period|Withdrawal by Subject|11|||
147629562|NCT01322490|532462740|FG000|Treatment Period|Non-compliance with study drug|0|||
147629563|NCT01322490|532462741|FG001|Treatment Period|Non-compliance with study drug|0|||
147629564|NCT01322490|532462742|FG002|Treatment Period|Non-compliance with study drug|1|||
147629565|NCT01322490|532462740|FG000|Treatment Period|Other per report|2|||
147629566|NCT01322490|532462741|FG001|Treatment Period|Other per report|2|||
147629567|NCT01322490|532462742|FG002|Treatment Period|Other per report|1|||
147629568|NCT01322490|532462740|FG000|Treatment Period|Randomized but Not Treated|3|||
147629569|NCT01322490|532462741|FG001|Treatment Period|Randomized but Not Treated|3|||
147629570|NCT01322490|532462742|FG002|Treatment Period|Randomized but Not Treated|5|||
147629571|NCT01322490|532462740|FG000|Long Term Follow-up Period|Death|235|||
147629572|NCT01322490|532462741|FG001|Long Term Follow-up Period|Death|239|||
147629573|NCT01322490|532462742|FG002|Long Term Follow-up Period|Death|236|||
147629574|NCT01322490|532462740|FG000|Long Term Follow-up Period|Lost to Follow-up|2|||
147629575|NCT01322490|532462741|FG001|Long Term Follow-up Period|Lost to Follow-up|2|||
147629576|NCT01322490|532462742|FG002|Long Term Follow-up Period|Lost to Follow-up|3|||
147629577|NCT01322490|532462740|FG000|Long Term Follow-up Period|Withdrawal by Subject|9|||
147629578|NCT01322490|532462741|FG001|Long Term Follow-up Period|Withdrawal by Subject|6|||
147629579|NCT01322490|532462742|FG002|Long Term Follow-up Period|Withdrawal by Subject|6|||
147629580|NCT01322490|532462740|FG000|Long Term Follow-up Period|Study Terminated by Sponsor|160|||
147629581|NCT01322490|532462741|FG001|Long Term Follow-up Period|Study Terminated by Sponsor|158|||
147629582|NCT01322490|532462742|FG002|Long Term Follow-up Period|Study Terminated by Sponsor|165|||
147629583|NCT01322490|532462740|FG000|Long Term Follow-up Period|Other per report|3|||
147629584|NCT01322490|532462741|FG001|Long Term Follow-up Period|Other per report|2|||
147629585|NCT01322490|532462742|FG002|Long Term Follow-up Period|Other per report|2|||
147629586|NCT01322490|532462740|FG000|Long Term Follow-up Period|Unknown/Missing|0|||
147629587|NCT01322490|532462741|FG001|Long Term Follow-up Period|Unknown/Missing|1|||
147629588|NCT01322490|532462742|FG002|Long Term Follow-up Period|Unknown/Missing|1|||
147629589|NCT01431716|532462743|FG000|Overall Study|Withdrawal of consent|1|||
147629590|NCT02199795|532462744|FG000|Overall Study|no longer met inclusion criteria|1|||
147629591|NCT02199795|532462745|FG001|Overall Study|no longer met inclusion criteria|0|||
147629592|NCT02199795|532462744|FG000|Overall Study|withdrew due to shoulder pain|1|||
147629593|NCT02199795|532462745|FG001|Overall Study|withdrew due to shoulder pain|0|||
147629594|NCT05310071|532462759|FG000|Overall Study|Death|0|||
147629595|NCT05310071|532462760|FG001|Overall Study|Death|3|||
147629596|NCT05310071|532462759|FG000|Overall Study|Adverse Event|4|||
147629597|NCT05310071|532462760|FG001|Overall Study|Adverse Event|31|||
147629598|NCT05310071|532462759|FG000|Overall Study|Lack of Efficacy - Based on Participant Perception|0|||
147629599|NCT05310071|532462760|FG001|Overall Study|Lack of Efficacy - Based on Participant Perception|2|||
147629600|NCT05310071|532462759|FG000|Overall Study|Protocol Deviation|2|||
147629601|NCT05310071|532462760|FG001|Overall Study|Protocol Deviation|0|||
147629602|NCT05310071|532462759|FG000|Overall Study|Randomized by Mistake|0|||
147629603|NCT05310071|532462760|FG001|Overall Study|Randomized by Mistake|1|||
147496044|NCT01021852|531970831|FG007|Treatment Period 2|Physician Decision|0|||
147496045|NCT01021852|531970824|FG000|Treatment Period 2|Protocol Violation|0|||
147496046|NCT01021852|531970825|FG001|Treatment Period 2|Protocol Violation|0|||
147496047|NCT01021852|531970826|FG002|Treatment Period 2|Protocol Violation|0|||
147496048|NCT01021852|531970827|FG003|Treatment Period 2|Protocol Violation|0|||
147496049|NCT01021852|531970828|FG004|Treatment Period 2|Protocol Violation|1|||
147496050|NCT01021852|531970829|FG005|Treatment Period 2|Protocol Violation|0|||
147496051|NCT01021852|531970830|FG006|Treatment Period 2|Protocol Violation|1|||
147496052|NCT01021852|531970831|FG007|Treatment Period 2|Protocol Violation|0|||
147496053|NCT01021852|531970824|FG000|Treatment Period 2|Withdrawal by Subject|0|||
147496054|NCT01021852|531970825|FG001|Treatment Period 2|Withdrawal by Subject|0|||
147496055|NCT01021852|531970826|FG002|Treatment Period 2|Withdrawal by Subject|0|||
147496056|NCT01021852|531970827|FG003|Treatment Period 2|Withdrawal by Subject|0|||
147496057|NCT01021852|531970828|FG004|Treatment Period 2|Withdrawal by Subject|0|||
147496058|NCT01021852|531970829|FG005|Treatment Period 2|Withdrawal by Subject|0|||
147496059|NCT01021852|531970830|FG006|Treatment Period 2|Withdrawal by Subject|1|||
147496060|NCT01021852|531970831|FG007|Treatment Period 2|Withdrawal by Subject|2|||
147496061|NCT02493426|531970832|FG000|Overall Study|Withdrawal by Subject|0|||
147496062|NCT02493426|531970833|FG001|Overall Study|Withdrawal by Subject|1|||
147496063|NCT00807846|531970835|FG000|Overall Study|Adverse Event|5|||
147496064|NCT00807846|531970836|FG001|Overall Study|Adverse Event|0|||
147496065|NCT00807846|531970835|FG000|Overall Study|Lack of Efficacy|2|||
147496066|NCT00807846|531970836|FG001|Overall Study|Lack of Efficacy|0|||
147496067|NCT00807846|531970835|FG000|Overall Study|Protocol Violation|2|||
147496068|NCT00807846|531970836|FG001|Overall Study|Protocol Violation|1|||
147496069|NCT00807846|531970835|FG000|Overall Study|Withdrawal by Subject|2|||
147496070|NCT00807846|531970836|FG001|Overall Study|Withdrawal by Subject|1|||
147496071|NCT00807846|531970835|FG000|Overall Study|Other|1|||
147496072|NCT00807846|531970836|FG001|Overall Study|Other|2|||
147496073|NCT01081873|531970837|FG000|Overall Study|Death|86|||
147496074|NCT01081873|531970837|FG000|Overall Study|Withdrawal by Subject|10|||
147496075|NCT01081873|531970837|FG000|Overall Study|Lost to Follow-up|142|||
147496076|NCT01081873|531970837|FG000|Overall Study|Progression of prostate cancer|13|||
147496077|NCT01081873|531970837|FG000|Overall Study|Other|47|||
147496078|NCT04799405|531970839|FG000|Phase 1 - Acute Stimulation, Daily tDCS|Withdrawal by Subject|2|||
147496079|NCT00603980|531970840|FG000|Study Qualification|Protocol Violation|3|||
147496080|NCT00603980|531970840|FG000|Study Qualification|Inconsistent data reporting|13|||
147496081|NCT00603980|531970840|FG000|Main Study|14th subject completed trial|1|||
147496082|NCT01029002|531970841|FG000|Overall Study|Lost to Follow-up|2|||
147496083|NCT01029002|531970842|FG001|Overall Study|Lost to Follow-up|4|||
147496084|NCT02683525|531970843|FG000|Overall Study|Lost to Follow-up|1|||
147496085|NCT02683525|531970843|FG000|Overall Study|Physician Decision|1|||
147496086|NCT02683525|531970843|FG000|Overall Study|Disease Progression|6|||
147496087|NCT02618928|531970850|FG000|Overall Study|Failure to Return|28|||
147496088|NCT02618928|531970850|FG000|Overall Study|Insufficient Virological Response|1|||
147496089|NCT02618928|531970850|FG000|Overall Study|Withdrawal by Subject|2|||
147496090|NCT02618928|531970850|FG000|Overall Study|Death|3|||
147496091|NCT02618928|531970850|FG000|Overall Study|Other|11|||
147496092|NCT02618928|531970850|FG000|Overall Study|Missing|6|||
147496093|NCT02618928|531970850|FG000|Overall Study|Treatment Never Started|7|||
147496094|NCT04167306|531970856|FG000|Overall Study|Lost to Follow-up|2|||
147496095|NCT04167306|531970857|FG001|Overall Study|Lost to Follow-up|2|||
147496096|NCT04167306|531970858|FG002|Overall Study|Lost to Follow-up|5|||
147496097|NCT04167306|531970859|FG003|Overall Study|Lost to Follow-up|5|||
147496098|NCT04167306|531970856|FG000|Overall Study|Adverse Event|13|||
147496099|NCT04167306|531970857|FG001|Overall Study|Adverse Event|14|||
147496100|NCT04167306|531970858|FG002|Overall Study|Adverse Event|5|||
147496101|NCT04167306|531970859|FG003|Overall Study|Adverse Event|4|||
147496102|NCT04167306|531970856|FG000|Overall Study|Withdrawal by Subject|4|||
147496103|NCT04167306|531970857|FG001|Overall Study|Withdrawal by Subject|6|||
147496104|NCT04167306|531970858|FG002|Overall Study|Withdrawal by Subject|8|||
147629604|NCT05310071|532462759|FG000|Overall Study|Failure to Meet Continuation Criteria|2|||
147629605|NCT05310071|532462760|FG001|Overall Study|Failure to Meet Continuation Criteria|0|||
147629606|NCT05310071|532462759|FG000|Overall Study|Failure to Meet Randomization Criteria|1|||
147496105|NCT04167306|531970859|FG003|Overall Study|Withdrawal by Subject|3|||
147629607|NCT05310071|532462760|FG001|Overall Study|Failure to Meet Randomization Criteria|2|||
147496106|NCT04167306|531970856|FG000|Overall Study|covid|1|||
147496107|NCT04167306|531970857|FG001|Overall Study|covid|1|||
147496108|NCT04167306|531970858|FG002|Overall Study|covid|2|||
147496109|NCT04167306|531970859|FG003|Overall Study|covid|1|||
147496110|NCT04167306|531970856|FG000|Overall Study|concomitant medication|0|||
147496111|NCT04167306|531970857|FG001|Overall Study|concomitant medication|0|||
147496112|NCT04167306|531970858|FG002|Overall Study|concomitant medication|0|||
147496113|NCT04167306|531970859|FG003|Overall Study|concomitant medication|1|||
147496114|NCT04167306|531970856|FG000|Overall Study|Alcohol treatment|0|||
147496115|NCT04167306|531970857|FG001|Overall Study|Alcohol treatment|4|||
147496116|NCT04167306|531970858|FG002|Overall Study|Alcohol treatment|3|||
147496117|NCT04167306|531970859|FG003|Overall Study|Alcohol treatment|2|||
147629608|NCT05310071|532462759|FG000|Overall Study|Site Terminated by Sponsor|0|||
147629609|NCT05310071|532462760|FG001|Overall Study|Site Terminated by Sponsor|2|||
147629610|NCT05310071|532462759|FG000|Overall Study|Study Terminated by Sponsor|282|||
147629611|NCT05310071|532462760|FG001|Overall Study|Study Terminated by Sponsor|559|||
147629612|NCT05310071|532462759|FG000|Overall Study|Withdrawal by Participant - Study Visit Burden/Scheduling Conflicts|14|||
147629613|NCT05310071|532462760|FG001|Overall Study|Withdrawal by Participant - Study Visit Burden/Scheduling Conflicts|17|||
147629614|NCT05310071|532462759|FG000|Overall Study|Withdrawal by Participant - Concern About Study Procedures/Perceived Risks|2|||
147629615|NCT05310071|532462760|FG001|Overall Study|Withdrawal by Participant - Concern About Study Procedures/Perceived Risks|6|||
147629616|NCT05310071|532462759|FG000|Overall Study|Withdrawal by Participant Relocation (Moving or Has Moved)|1|||
147629617|NCT05310071|532462760|FG001|Overall Study|Withdrawal by Participant Relocation (Moving or Has Moved)|3|||
147629618|NCT05310071|532462759|FG000|Overall Study|Withdrawal by Participant - Desire for Change in Treatment (Unrelated to Safety/Efficacy)|8|||
147629619|NCT05310071|532462760|FG001|Overall Study|Withdrawal by Participant - Desire for Change in Treatment (Unrelated to Safety/Efficacy)|17|||
147629620|NCT05310071|532462759|FG000|Overall Study|Withdrawal by Participant - Other|25|||
147629621|NCT05310071|532462760|FG001|Overall Study|Withdrawal by Participant - Other|30|||
147629622|NCT05310071|532462759|FG000|Overall Study|Lost to Follow-up|2|||
147629623|NCT05310071|532462760|FG001|Overall Study|Lost to Follow-up|4|||
147629624|NCT05310071|532462759|FG000|Overall Study|Reason Not Specified|1|||
147629625|NCT05310071|532462760|FG001|Overall Study|Reason Not Specified|3|||
147629626|NCT02418949|532462761|FG000|Overall Study|Withdrawal by Subject|1|||
147629627|NCT02418949|532462762|FG001|Overall Study|Withdrawal by Subject|0|||
147629628|NCT02418949|532462763|FG002|Overall Study|Withdrawal by Subject|1|||
147629629|NCT02418949|532462764|FG003|Overall Study|Withdrawal by Subject|1|||
147629630|NCT02418949|532462761|FG000|Overall Study|Lost to Follow-up|1|||
147629631|NCT02418949|532462762|FG001|Overall Study|Lost to Follow-up|0|||
147629632|NCT02418949|532462763|FG002|Overall Study|Lost to Follow-up|1|||
147629633|NCT02418949|532462764|FG003|Overall Study|Lost to Follow-up|0|||
147629634|NCT02418949|532462761|FG000|Overall Study|Physician Decision|1|||
147629635|NCT02418949|532462762|FG001|Overall Study|Physician Decision|1|||
147629636|NCT02418949|532462763|FG002|Overall Study|Physician Decision|1|||
147629637|NCT02418949|532462764|FG003|Overall Study|Physician Decision|0|||
147629638|NCT02343939|532462765|FG000|Overall Study|Death|0|||
147629639|NCT02343939|532462766|FG001|Overall Study|Death|15|||
147629640|NCT02343939|532462767|FG002|Overall Study|Death|4|||
147629641|NCT02343939|532462768|FG003|Overall Study|Death|2|||
147629642|NCT02343939|532462769|FG004|Overall Study|Death|5|||
147629643|NCT02343939|532462770|FG005|Overall Study|Death|11|||
147629644|NCT02343939|532462771|FG006|Overall Study|Death|8|||
147629645|NCT02343939|532462772|FG007|Overall Study|Death|22|||
147629646|NCT02343939|532462773|FG008|Overall Study|Death|1|||
147629647|NCT02343939|532462765|FG000|Overall Study|Study terminated by sponsor|0|||
147629648|NCT02343939|532462766|FG001|Overall Study|Study terminated by sponsor|27|||
147629649|NCT02343939|532462767|FG002|Overall Study|Study terminated by sponsor|0|||
147629650|NCT02343939|532462768|FG003|Overall Study|Study terminated by sponsor|1|||
147629651|NCT02343939|532462769|FG004|Overall Study|Study terminated by sponsor|1|||
147629652|NCT02343939|532462770|FG005|Overall Study|Study terminated by sponsor|5|||
147629653|NCT02343939|532462771|FG006|Overall Study|Study terminated by sponsor|3|||
147629654|NCT02343939|532462772|FG007|Overall Study|Study terminated by sponsor|4|||
147629655|NCT02343939|532462773|FG008|Overall Study|Study terminated by sponsor|0|||
147629656|NCT02343939|532462765|FG000|Overall Study|Withdrew consent|3|||
147629657|NCT02343939|532462766|FG001|Overall Study|Withdrew consent|6|||
147629658|NCT02343939|532462767|FG002|Overall Study|Withdrew consent|1|||
147629659|NCT02343939|532462768|FG003|Overall Study|Withdrew consent|2|||
147629660|NCT02343939|532462769|FG004|Overall Study|Withdrew consent|2|||
147629661|NCT02343939|532462770|FG005|Overall Study|Withdrew consent|0|||
147629662|NCT02343939|532462771|FG006|Overall Study|Withdrew consent|0|||
147629663|NCT02343939|532462772|FG007|Overall Study|Withdrew consent|8|||
147629664|NCT02343939|532462773|FG008|Overall Study|Withdrew consent|6|||
147629665|NCT02343939|532462765|FG000|Overall Study|Treatment failure|0|||
147629666|NCT02343939|532462766|FG001|Overall Study|Treatment failure|0|||
147629667|NCT02343939|532462767|FG002|Overall Study|Treatment failure|0|||
147629668|NCT02343939|532462768|FG003|Overall Study|Treatment failure|0|||
147629669|NCT02343939|532462769|FG004|Overall Study|Treatment failure|0|||
147629670|NCT02343939|532462770|FG005|Overall Study|Treatment failure|0|||
147629671|NCT02343939|532462771|FG006|Overall Study|Treatment failure|2|||
147629672|NCT02343939|532462772|FG007|Overall Study|Treatment failure|1|||
147629673|NCT02343939|532462773|FG008|Overall Study|Treatment failure|0|||
147668478|NCT00094445|532611801|FG000|Overall Study|Lost to Follow-up|1|||
147629674|NCT02343939|532462765|FG000|Overall Study|Investigator's discretion|0|||
147629675|NCT02343939|532462766|FG001|Overall Study|Investigator's discretion|0|||
147629676|NCT02343939|532462767|FG002|Overall Study|Investigator's discretion|0|||
147629677|NCT02343939|532462768|FG003|Overall Study|Investigator's discretion|1|||
147629678|NCT02343939|532462769|FG004|Overall Study|Investigator's discretion|0|||
147629679|NCT02343939|532462770|FG005|Overall Study|Investigator's discretion|0|||
147629680|NCT02343939|532462771|FG006|Overall Study|Investigator's discretion|1|||
147629681|NCT02343939|532462772|FG007|Overall Study|Investigator's discretion|0|||
147496118|NCT04167306|531970856|FG000|Overall Study|non-compliance|0|||
147496119|NCT04167306|531970857|FG001|Overall Study|non-compliance|0|||
147496120|NCT04167306|531970858|FG002|Overall Study|non-compliance|1|||
147496121|NCT04167306|531970859|FG003|Overall Study|non-compliance|0|||
147496122|NCT04167306|531970856|FG000|Overall Study|incorrectly randomized or did not commence study drug|1|||
147496123|NCT04167306|531970857|FG001|Overall Study|incorrectly randomized or did not commence study drug|1|||
147496124|NCT04167306|531970858|FG002|Overall Study|incorrectly randomized or did not commence study drug|2|||
147496125|NCT04167306|531970859|FG003|Overall Study|incorrectly randomized or did not commence study drug|0|||
147496126|NCT01253421|531970865|FG000|Assessment and Scheduling|Found to be Ineligible|74|||
147496127|NCT01253421|531970866|FG001|Assessment and Scheduling|Found to be Ineligible|0|||
147496128|NCT01253421|531970867|FG002|Assessment and Scheduling|Found to be Ineligible|0|||
147496129|NCT01253421|531970868|FG003|Assessment and Scheduling|Found to be Ineligible|0|||
147496130|NCT01253421|531970869|FG004|Assessment and Scheduling|Found to be Ineligible|0|||
147496131|NCT01253421|531970865|FG000|Assessment and Scheduling|Lost to Follow-up|17|||
147496132|NCT01253421|531970866|FG001|Assessment and Scheduling|Lost to Follow-up|0|||
147496133|NCT01253421|531970867|FG002|Assessment and Scheduling|Lost to Follow-up|0|||
147496134|NCT01253421|531970868|FG003|Assessment and Scheduling|Lost to Follow-up|0|||
147496135|NCT01253421|531970869|FG004|Assessment and Scheduling|Lost to Follow-up|0|||
147496136|NCT01253421|531970865|FG000|Assessment and Scheduling|Withdrawal by Subject|7|||
147496137|NCT01253421|531970866|FG001|Assessment and Scheduling|Withdrawal by Subject|0|||
147496138|NCT01253421|531970867|FG002|Assessment and Scheduling|Withdrawal by Subject|0|||
147496139|NCT01253421|531970868|FG003|Assessment and Scheduling|Withdrawal by Subject|0|||
147496140|NCT01253421|531970869|FG004|Assessment and Scheduling|Withdrawal by Subject|0|||
147496141|NCT01253421|531970865|FG000|Assessment and Scheduling|Physician Decision|1|||
147496142|NCT01253421|531970866|FG001|Assessment and Scheduling|Physician Decision|0|||
147496143|NCT01253421|531970867|FG002|Assessment and Scheduling|Physician Decision|0|||
147496144|NCT01253421|531970868|FG003|Assessment and Scheduling|Physician Decision|0|||
147496145|NCT01253421|531970869|FG004|Assessment and Scheduling|Physician Decision|0|||
147496146|NCT01253421|531970865|FG000|Drug+Scanning Visit|Physician Decision|0|||
147496147|NCT01253421|531970866|FG001|Drug+Scanning Visit|Physician Decision|0|||
147496148|NCT01253421|531970867|FG002|Drug+Scanning Visit|Physician Decision|0|||
147496149|NCT01253421|531970868|FG003|Drug+Scanning Visit|Physician Decision|0|||
147496150|NCT01253421|531970869|FG004|Drug+Scanning Visit|Physician Decision|1|||
147496151|NCT00547378|531970870|FG000|Randomized Cohort|Withdrawal by Subject|7|||
147496152|NCT00547378|531970871|FG001|Randomized Cohort|Withdrawal by Subject|5|||
147496153|NCT00547378|531970872|FG002|Randomized Cohort|Withdrawal by Subject|0|||
147496154|NCT00547378|531970870|FG000|Randomized Cohort|Death|0|||
147496155|NCT00547378|531970871|FG001|Randomized Cohort|Death|1|||
147496156|NCT00547378|531970872|FG002|Randomized Cohort|Death|0|||
147496157|NCT00547378|531970870|FG000|Randomized Cohort|Lost to Follow-up|1|||
147496158|NCT00547378|531970871|FG001|Randomized Cohort|Lost to Follow-up|0|||
147496159|NCT00547378|531970872|FG002|Randomized Cohort|Lost to Follow-up|0|||
147496160|NCT00547378|531970870|FG000|Randomized Cohort|Adverse Event|1|||
147496161|NCT00547378|531970871|FG001|Randomized Cohort|Adverse Event|0|||
147496162|NCT00547378|531970872|FG002|Randomized Cohort|Adverse Event|0|||
147496163|NCT00547378|531970870|FG000|Randomized Cohort|Other reasons|2|||
147496164|NCT00547378|531970871|FG001|Randomized Cohort|Other reasons|0|||
147496165|NCT00547378|531970872|FG002|Randomized Cohort|Other reasons|0|||
147496166|NCT00547378|531970870|FG000|All Implanted Cohort|Withdrawal by Subject|5|||
147496167|NCT00547378|531970871|FG001|All Implanted Cohort|Withdrawal by Subject|4|||
147496168|NCT00547378|531970872|FG002|All Implanted Cohort|Withdrawal by Subject|27|||
147496169|NCT00547378|531970870|FG000|All Implanted Cohort|Adverse Event|4|||
147496170|NCT00547378|531970871|FG001|All Implanted Cohort|Adverse Event|10|||
147496171|NCT00547378|531970872|FG002|All Implanted Cohort|Adverse Event|17|||
147496172|NCT00547378|531970870|FG000|All Implanted Cohort|Lost to Follow-up|0|||
147496173|NCT00547378|531970871|FG001|All Implanted Cohort|Lost to Follow-up|1|||
147496174|NCT00547378|531970872|FG002|All Implanted Cohort|Lost to Follow-up|14|||
147496175|NCT00547378|531970870|FG000|All Implanted Cohort|Death|3|||
147496176|NCT00547378|531970871|FG001|All Implanted Cohort|Death|1|||
147496177|NCT00547378|531970872|FG002|All Implanted Cohort|Death|4|||
147629682|NCT02343939|532462773|FG008|Overall Study|Investigator's discretion|0|||
147496178|NCT00547378|531970870|FG000|All Implanted Cohort|Physician Decision|0|||
147496179|NCT00547378|531970871|FG001|All Implanted Cohort|Physician Decision|2|||
147496180|NCT00547378|531970872|FG002|All Implanted Cohort|Physician Decision|6|||
147496181|NCT00547378|531970870|FG000|All Implanted Cohort|Site closure|2|||
147496182|NCT00547378|531970871|FG001|All Implanted Cohort|Site closure|0|||
147496183|NCT00547378|531970872|FG002|All Implanted Cohort|Site closure|1|||
147496184|NCT00547378|531970870|FG000|All Implanted Cohort|Other reasons|1|||
147496185|NCT00547378|531970871|FG001|All Implanted Cohort|Other reasons|0|||
147496186|NCT00547378|531970872|FG002|All Implanted Cohort|Other reasons|1|||
147629683|NCT02343939|532462765|FG000|Overall Study|Adverse Event|0|||
147496187|NCT04863014|531970874|FG000|Overall Study|Lost to Follow-up|3|||
147496188|NCT04863014|531970875|FG001|Overall Study|Lost to Follow-up|2|||
147629684|NCT02343939|532462766|FG001|Overall Study|Adverse Event|0|||
147629685|NCT02343939|532462767|FG002|Overall Study|Adverse Event|0|||
147629686|NCT02343939|532462768|FG003|Overall Study|Adverse Event|0|||
147629687|NCT02343939|532462769|FG004|Overall Study|Adverse Event|0|||
147629688|NCT02343939|532462770|FG005|Overall Study|Adverse Event|1|||
147629689|NCT02343939|532462771|FG006|Overall Study|Adverse Event|0|||
147629690|NCT02343939|532462772|FG007|Overall Study|Adverse Event|0|||
147629691|NCT02343939|532462773|FG008|Overall Study|Adverse Event|0|||
147629692|NCT02343939|532462765|FG000|Overall Study|Never Treated With ENTO|0|||
147629693|NCT02343939|532462766|FG001|Overall Study|Never Treated With ENTO|0|||
147629694|NCT02343939|532462767|FG002|Overall Study|Never Treated With ENTO|0|||
147629695|NCT02343939|532462768|FG003|Overall Study|Never Treated With ENTO|0|||
147629696|NCT02343939|532462769|FG004|Overall Study|Never Treated With ENTO|0|||
147629697|NCT02343939|532462770|FG005|Overall Study|Never Treated With ENTO|0|||
147629698|NCT02343939|532462771|FG006|Overall Study|Never Treated With ENTO|1|||
147629699|NCT02343939|532462772|FG007|Overall Study|Never Treated With ENTO|2|||
147629700|NCT02343939|532462773|FG008|Overall Study|Never Treated With ENTO|0|||
147629701|NCT00460811|532462774|FG000|Overall Study|Adverse Event|4|||
147629702|NCT00460811|532462775|FG001|Overall Study|Adverse Event|6|||
147629703|NCT00460811|532462776|FG002|Overall Study|Adverse Event|3|||
147629704|NCT00460811|532462777|FG003|Overall Study|Adverse Event|10|||
147629705|NCT00460811|532462778|FG004|Overall Study|Adverse Event|2|||
147629706|NCT00460811|532462774|FG000|Overall Study|Noncompliance|1|||
147629707|NCT00460811|532462775|FG001|Overall Study|Noncompliance|0|||
147629708|NCT00460811|532462776|FG002|Overall Study|Noncompliance|0|||
147629709|NCT00460811|532462777|FG003|Overall Study|Noncompliance|2|||
147629710|NCT00460811|532462778|FG004|Overall Study|Noncompliance|1|||
147629711|NCT00460811|532462774|FG000|Overall Study|Withdrawal by Subject|7|||
147629712|NCT00460811|532462775|FG001|Overall Study|Withdrawal by Subject|7|||
147629713|NCT00460811|532462776|FG002|Overall Study|Withdrawal by Subject|6|||
147629714|NCT00460811|532462777|FG003|Overall Study|Withdrawal by Subject|3|||
147629715|NCT00460811|532462778|FG004|Overall Study|Withdrawal by Subject|11|||
147629716|NCT00460811|532462774|FG000|Overall Study|Physician Decision|1|||
147629717|NCT00460811|532462775|FG001|Overall Study|Physician Decision|0|||
147629718|NCT00460811|532462776|FG002|Overall Study|Physician Decision|0|||
147629719|NCT00460811|532462777|FG003|Overall Study|Physician Decision|0|||
147629720|NCT00460811|532462778|FG004|Overall Study|Physician Decision|0|||
147629721|NCT00460811|532462774|FG000|Overall Study|Lost to Follow-up|3|||
147629722|NCT00460811|532462775|FG001|Overall Study|Lost to Follow-up|2|||
147629723|NCT00460811|532462776|FG002|Overall Study|Lost to Follow-up|5|||
147629724|NCT00460811|532462777|FG003|Overall Study|Lost to Follow-up|3|||
147629725|NCT00460811|532462778|FG004|Overall Study|Lost to Follow-up|6|||
147629726|NCT02097745|532462779|FG000|Overall Study|Adverse Event|25|||
147629727|NCT02097745|532462779|FG000|Overall Study|Death|16|||
147629728|NCT02097745|532462779|FG000|Overall Study|Failure to Return|14|||
147629729|NCT02097745|532462779|FG000|Overall Study|Administrative/Other|27|||
147629730|NCT02097745|532462779|FG000|Overall Study|Reason Not Specified|96|||
147629731|NCT02099110|532462785|FG000|Overall Study|Protocol Violation|2|||
147629732|NCT02099110|532462786|FG001|Overall Study|Protocol Violation|1|||
147629733|NCT02099110|532462787|FG002|Overall Study|Protocol Violation|0|||
147629734|NCT02099110|532462788|FG003|Overall Study|Protocol Violation|3|||
147629735|NCT02099110|532462789|FG004|Overall Study|Protocol Violation|1|||
147629736|NCT02099110|532462785|FG000|Overall Study|Participant moved|1|||
147629737|NCT02099110|532462786|FG001|Overall Study|Participant moved|1|||
147629738|NCT02099110|532462787|FG002|Overall Study|Participant moved|1|||
147629739|NCT02099110|532462788|FG003|Overall Study|Participant moved|0|||
147629740|NCT02099110|532462789|FG004|Overall Study|Participant moved|2|||
147629741|NCT02099110|532462785|FG000|Overall Study|Withdrawal by Subject|7|||
147629742|NCT02099110|532462786|FG001|Overall Study|Withdrawal by Subject|11|||
147629743|NCT02099110|532462787|FG002|Overall Study|Withdrawal by Subject|13|||
147629744|NCT02099110|532462788|FG003|Overall Study|Withdrawal by Subject|9|||
147629745|NCT02099110|532462789|FG004|Overall Study|Withdrawal by Subject|13|||
147629746|NCT02099110|532462785|FG000|Overall Study|Adverse Event|3|||
147629747|NCT02099110|532462786|FG001|Overall Study|Adverse Event|5|||
147629748|NCT02099110|532462787|FG002|Overall Study|Adverse Event|2|||
147629749|NCT02099110|532462788|FG003|Overall Study|Adverse Event|3|||
147629750|NCT02099110|532462789|FG004|Overall Study|Adverse Event|2|||
147629751|NCT02099110|532462785|FG000|Overall Study|Lost to Follow-up|6|||
147629752|NCT02099110|532462786|FG001|Overall Study|Lost to Follow-up|12|||
147629753|NCT02099110|532462787|FG002|Overall Study|Lost to Follow-up|11|||
147629754|NCT02099110|532462788|FG003|Overall Study|Lost to Follow-up|5|||
147629755|NCT02099110|532462789|FG004|Overall Study|Lost to Follow-up|6|||
147629756|NCT02099110|532462785|FG000|Overall Study|Death|0|||
147629757|NCT02099110|532462786|FG001|Overall Study|Death|1|||
147629758|NCT02099110|532462787|FG002|Overall Study|Death|0|||
147629759|NCT02099110|532462788|FG003|Overall Study|Death|0|||
147629760|NCT02099110|532462789|FG004|Overall Study|Death|0|||
147629761|NCT02099110|532462785|FG000|Overall Study|Screen failure|0|||
147629762|NCT02099110|532462786|FG001|Overall Study|Screen failure|0|||
147629763|NCT02099110|532462787|FG002|Overall Study|Screen failure|0|||
147629764|NCT02099110|532462788|FG003|Overall Study|Screen failure|0|||
147629765|NCT02099110|532462789|FG004|Overall Study|Screen failure|1|||
147629766|NCT02099110|532462785|FG000|Overall Study|Non-compliance with study drug|2|||
147629767|NCT02099110|532462786|FG001|Overall Study|Non-compliance with study drug|0|||
147629768|NCT02099110|532462787|FG002|Overall Study|Non-compliance with study drug|0|||
147629769|NCT02099110|532462788|FG003|Overall Study|Non-compliance with study drug|0|||
147629770|NCT02099110|532462789|FG004|Overall Study|Non-compliance with study drug|1|||
147629771|NCT02099110|532462785|FG000|Overall Study|Physician Decision|3|||
147629772|NCT02099110|532462786|FG001|Overall Study|Physician Decision|0|||
147629773|NCT02099110|532462787|FG002|Overall Study|Physician Decision|1|||
147629774|NCT02099110|532462788|FG003|Overall Study|Physician Decision|2|||
147629775|NCT02099110|532462789|FG004|Overall Study|Physician Decision|1|||
147629776|NCT02977572|532462792|FG000|Overall Study|Exclusion criterion|2|||
147629777|NCT02977572|532462793|FG001|Overall Study|Exclusion criterion|2|||
147629778|NCT00523848|532462799|FG000|Overall Study|Adverse Event|11|||
147629779|NCT00523848|532462799|FG000|Overall Study|Withdrawal by Subject|2|||
147496189|NCT04863014|531970874|FG000|Overall Study|Subject Decision|0|||
147496190|NCT04863014|531970875|FG001|Overall Study|Subject Decision|4|||
147496191|NCT02104804|531970880|FG000|Overall Study|Did not take study medication|0|||
147496192|NCT02104804|531970881|FG001|Overall Study|Did not take study medication|1|||
147496193|NCT02104804|531970880|FG000|Overall Study|Study specific discontinuation criteria|6|||
147496194|NCT02104804|531970881|FG001|Overall Study|Study specific discontinuation criteria|1|||
147496195|NCT02104804|531970880|FG000|Overall Study|Other listed|2|||
147496196|NCT02104804|531970881|FG001|Overall Study|Other listed|1|||
147496197|NCT02104804|531970880|FG000|Overall Study|Protocol Violation|0|||
147496198|NCT02104804|531970881|FG001|Overall Study|Protocol Violation|1|||
147496199|NCT02104804|531970880|FG000|Overall Study|Adverse Event|4|||
147496200|NCT02104804|531970881|FG001|Overall Study|Adverse Event|3|||
147496201|NCT02104804|531970880|FG000|Overall Study|Withdrawal by Subject|4|||
147496202|NCT02104804|531970881|FG001|Overall Study|Withdrawal by Subject|12|||
147496203|NCT04501679|531970882|FG000|Overall Study|Pregnancy|0|||
147496204|NCT04501679|531970883|FG001|Overall Study|Pregnancy|1|||
147496205|NCT04501679|531970882|FG000|Overall Study|Adverse Event|4|||
147496206|NCT04501679|531970883|FG001|Overall Study|Adverse Event|2|||
147496207|NCT04501679|531970882|FG000|Overall Study|Withdrawal by Subject|2|||
147496208|NCT04501679|531970883|FG001|Overall Study|Withdrawal by Subject|0|||
147496209|NCT04501679|531970882|FG000|Overall Study|Physician Decision|1|||
147496210|NCT04501679|531970883|FG001|Overall Study|Physician Decision|0|||
147496211|NCT04501679|531970882|FG000|Overall Study|Lost to Follow-up|2|||
147496212|NCT04501679|531970883|FG001|Overall Study|Lost to Follow-up|0|||
147496213|NCT02121756|531970888|FG000|Overall Study|Adverse Event|3|||
147496214|NCT02121756|531970889|FG001|Overall Study|Adverse Event|0|||
147496215|NCT02121756|531970888|FG000|Overall Study|Protocol Violation|1|||
147496216|NCT02121756|531970889|FG001|Overall Study|Protocol Violation|1|||
147496217|NCT02121756|531970888|FG000|Overall Study|Physician Decision|2|||
147496218|NCT02121756|531970889|FG001|Overall Study|Physician Decision|1|||
147496219|NCT04191577|531970893|FG000|Overall Study|Withdrawal by Subject|2|||
147496220|NCT04191577|531970894|FG001|Overall Study|Withdrawal by Subject|2|||
147496221|NCT04191577|531970895|FG002|Overall Study|Withdrawal by Subject|1|||
147496222|NCT04191577|531970893|FG000|Overall Study|Physician Decision|1|||
147496223|NCT04191577|531970894|FG001|Overall Study|Physician Decision|1|||
147496224|NCT04191577|531970895|FG002|Overall Study|Physician Decision|0|||
147496225|NCT04191577|531970893|FG000|Overall Study|Adverse Event|0|||
147496226|NCT04191577|531970894|FG001|Overall Study|Adverse Event|0|||
147496227|NCT04191577|531970895|FG002|Overall Study|Adverse Event|1|||
147496228|NCT04191577|531970893|FG000|Overall Study|Death|0|||
147496229|NCT04191577|531970894|FG001|Overall Study|Death|0|||
147496230|NCT04191577|531970895|FG002|Overall Study|Death|1|||
147629780|NCT00523848|532462799|FG000|Overall Study|NOT TREATED (Became ineligible)|2|||
147629781|NCT00523848|532462799|FG000|Overall Study|Disease Progression|5|||
147629782|NCT00523848|532462799|FG000|Overall Study|Other, unspecified|4|||
147496231|NCT01185249|531970896|FG000|Overall Study|Patients discharged or change in status|42|||
147496232|NCT02365584|531970897|FG000|Overall Study|Adverse Event|2|||
147496233|NCT02365584|531970898|FG001|Overall Study|Adverse Event|2|||
147496234|NCT02365584|531970897|FG000|Overall Study|Withdrawal by Subject|1|||
147496235|NCT02365584|531970898|FG001|Overall Study|Withdrawal by Subject|0|||
147496236|NCT02365584|531970897|FG000|Overall Study|Disease Progression|9|||
147496237|NCT02365584|531970898|FG001|Overall Study|Disease Progression|12|||
147496238|NCT01973452|531970899|FG000|Overall Study|Lack of Efficacy|0|||
147496239|NCT01973452|531970900|FG001|Overall Study|Lack of Efficacy|1|||
147629783|NCT00086619|532462800|FG000|Overall Study|Withdrawal by Subject|6|||
147629784|NCT00086619|532462801|FG001|Overall Study|Withdrawal by Subject|6|||
147629785|NCT00086619|532462800|FG000|Overall Study|Adverse Event|8|||
147496240|NCT01973452|531970899|FG000|Overall Study|Lost to Follow-up|1|||
147496241|NCT01973452|531970900|FG001|Overall Study|Lost to Follow-up|0|||
147496242|NCT01973452|531970899|FG000|Overall Study|Withdrawal by Subject|10|||
147496243|NCT01973452|531970900|FG001|Overall Study|Withdrawal by Subject|9|||
147496244|NCT01973452|531970899|FG000|Overall Study|Ineligible|1|||
147629786|NCT00086619|532462801|FG001|Overall Study|Adverse Event|10|||
147496245|NCT01973452|531970900|FG001|Overall Study|Ineligible|1|||
147629787|NCT00086619|532462800|FG000|Overall Study|Protocol Violation|1|||
147629788|NCT00086619|532462801|FG001|Overall Study|Protocol Violation|1|||
147629789|NCT00489918|532462802|FG000|Overall Study|Withdrawal by Subject|2|||
147629790|NCT00489918|532462803|FG001|Overall Study|Withdrawal by Subject|1|||
147629791|NCT00489918|532462804|FG002|Overall Study|Withdrawal by Subject|1|||
147629792|NCT00489918|532462805|FG003|Overall Study|Withdrawal by Subject|0|||
147629793|NCT00489918|532462806|FG004|Overall Study|Withdrawal by Subject|1|||
147629794|NCT00489918|532462802|FG000|Overall Study|Adverse Event|0|||
147629795|NCT00489918|532462803|FG001|Overall Study|Adverse Event|1|||
147629796|NCT00489918|532462804|FG002|Overall Study|Adverse Event|1|||
147629797|NCT00489918|532462805|FG003|Overall Study|Adverse Event|0|||
147629798|NCT00489918|532462806|FG004|Overall Study|Adverse Event|0|||
147629799|NCT00489918|532462802|FG000|Overall Study|Lost to Follow-up|0|||
147629800|NCT00489918|532462803|FG001|Overall Study|Lost to Follow-up|0|||
147629801|NCT00489918|532462804|FG002|Overall Study|Lost to Follow-up|1|||
147629802|NCT00489918|532462805|FG003|Overall Study|Lost to Follow-up|1|||
147629803|NCT00489918|532462806|FG004|Overall Study|Lost to Follow-up|0|||
147629804|NCT00489918|532462802|FG000|Overall Study|Physician Decision|0|||
147629805|NCT00489918|532462803|FG001|Overall Study|Physician Decision|0|||
147629806|NCT00489918|532462804|FG002|Overall Study|Physician Decision|1|||
147629807|NCT00489918|532462805|FG003|Overall Study|Physician Decision|0|||
147629808|NCT00489918|532462806|FG004|Overall Study|Physician Decision|0|||
147629809|NCT02748213|532462807|FG000|Overall Study|Withdrawal Prior to Treatment|1|||
147629810|NCT02748213|532462808|FG001|Overall Study|Withdrawal Prior to Treatment|2|||
147629811|NCT02748213|532462807|FG000|Overall Study|Abnormal Laboratory Test|1|||
147629812|NCT02748213|532462808|FG001|Overall Study|Abnormal Laboratory Test|0|||
147629813|NCT02748213|532462807|FG000|Overall Study|Adverse Event or Intercurrent Illness|5|||
147629814|NCT02748213|532462808|FG001|Overall Study|Adverse Event or Intercurrent Illness|11|||
147629815|NCT02748213|532462807|FG000|Overall Study|Death|5|||
147629816|NCT02748213|532462808|FG001|Overall Study|Death|3|||
147629817|NCT02748213|532462807|FG000|Overall Study|Insufficient Therapeutic Response|56|||
147629818|NCT02748213|532462808|FG001|Overall Study|Insufficient Therapeutic Response|57|||
147629819|NCT02748213|532462807|FG000|Overall Study|Violation of Selection Criteria|2|||
147629820|NCT02748213|532462808|FG001|Overall Study|Violation of Selection Criteria|0|||
147629821|NCT02748213|532462807|FG000|Overall Study|Protocol Violation|6|||
147629822|NCT02748213|532462808|FG001|Overall Study|Protocol Violation|4|||
147629823|NCT02748213|532462807|FG000|Overall Study|Refused Treatment*|6|||
147629824|NCT02748213|532462808|FG001|Overall Study|Refused Treatment*|6|||
147629825|NCT02748213|532462807|FG000|Overall Study|Failure to Return|1|||
147629826|NCT02748213|532462808|FG001|Overall Study|Failure to Return|0|||
147629827|NCT02748213|532462807|FG000|Overall Study|Other|30|||
147629828|NCT02748213|532462808|FG001|Overall Study|Other|29|||
147629829|NCT00961350|532462810|FG000|Overall Study|Adverse Event|18|||
147629830|NCT00961350|532462811|FG001|Overall Study|Adverse Event|33|||
147629831|NCT00961350|532462810|FG000|Overall Study|Withdrawal by Subject|10|||
147629832|NCT00961350|532462811|FG001|Overall Study|Withdrawal by Subject|10|||
147629833|NCT00961350|532462810|FG000|Overall Study|Lost to Follow-up|3|||
147629834|NCT00961350|532462811|FG001|Overall Study|Lost to Follow-up|3|||
147629835|NCT00961350|532462810|FG000|Overall Study|Misc|16|||
147629836|NCT00961350|532462811|FG001|Overall Study|Misc|21|||
147629837|NCT01760655|532464017|FG000|Overall Study|Death|18|||
147629838|NCT01760655|532464017|FG000|Overall Study|Physician Decision|1|||
147629839|NCT01515865|532464024|FG000|Part A (Open-label)|Other|3|||
147629840|NCT01515865|532464025|FG001|Part A (Open-label)|Other|0|||
147629841|NCT01515865|532464026|FG002|Part A (Open-label)|Other|0|||
147629842|NCT01515865|532464024|FG000|Part B (Open-label)|Withdrawal by Subject|1|||
147629843|NCT01515865|532464025|FG001|Part B (Open-label)|Withdrawal by Subject|0|||
147629844|NCT01515865|532464026|FG002|Part B (Open-label)|Withdrawal by Subject|0|||
147629845|NCT01515865|532464024|FG000|Part B (Open-label)|Other|1|||
147629846|NCT01515865|532464025|FG001|Part B (Open-label)|Other|0|||
147629847|NCT01515865|532464026|FG002|Part B (Open-label)|Other|0|||
147629848|NCT02510664|532464031|FG000|Overall Study|Transferred Care|9|||
147629849|NCT02510664|532464032|FG001|Overall Study|Transferred Care|9|||
147629850|NCT02510664|532464033|FG002|Overall Study|Transferred Care|0|||
147629851|NCT02510664|532464031|FG000|Overall Study|Provider Retired/No Time to Reschedule|10|||
147629852|NCT02510664|532464032|FG001|Overall Study|Provider Retired/No Time to Reschedule|10|||
147629853|NCT02510664|532464033|FG002|Overall Study|Provider Retired/No Time to Reschedule|0|||
147629854|NCT02510664|532464031|FG000|Overall Study|Time Constraints|1|||
147629855|NCT02510664|532464032|FG001|Overall Study|Time Constraints|1|||
147629856|NCT02510664|532464033|FG002|Overall Study|Time Constraints|0|||
147629857|NCT02801617|532464035|FG000|Overall Study|Protocol Violation|2|||
147629858|NCT02801617|532464036|FG001|Overall Study|Protocol Violation|6|||
147629859|NCT04090060|532464042|FG000|Overall Study|Lost to Follow-up|76|||
147629860|NCT04090060|532464043|FG001|Overall Study|Lost to Follow-up|77|||
147629861|NCT02176655|532464044|FG000|Overall Study|Subjects did not treat|6|||
147629862|NCT06110494|532464045|FG000|Overall Study|Protocol Violation|2|||
147629863|NCT06110494|532464046|FG001|Overall Study|Protocol Violation|0|||
147629864|NCT06110494|532464047|FG002|Overall Study|Protocol Violation|1|||
147629865|NCT06110494|532464045|FG000|Overall Study|Dixon's test for outlier analysis|1|||
147629866|NCT06110494|532464046|FG001|Overall Study|Dixon's test for outlier analysis|1|||
147629867|NCT06110494|532464047|FG002|Overall Study|Dixon's test for outlier analysis|0|||
147629868|NCT02490371|532464050|FG000|Overall Study|Lost to Follow-up|1|||
147629869|NCT02490371|532464051|FG001|Overall Study|Lost to Follow-up|1|||
147629870|NCT01718535|532464054|FG000|Overall Study|Bidirectional Sequencing not possible|1|||
147629871|NCT01718535|532464055|FG001|Overall Study|Bidirectional Sequencing not possible|0|||
147629872|NCT01718535|532464056|FG002|Overall Study|Bidirectional Sequencing not possible|0|||
147629873|NCT01718535|532464057|FG003|Overall Study|Bidirectional Sequencing not possible|1|||
147629874|NCT01718535|532464058|FG004|Overall Study|Bidirectional Sequencing not possible|0|||
147629875|NCT01718535|532464059|FG005|Overall Study|Bidirectional Sequencing not possible|0|||
147629876|NCT01718535|532464060|FG006|Overall Study|Bidirectional Sequencing not possible|0|||
147629877|NCT01718535|532464061|FG007|Overall Study|Bidirectional Sequencing not possible|0|||
147629878|NCT01718535|532464062|FG008|Overall Study|Bidirectional Sequencing not possible|0|||
147629879|NCT01718535|532464063|FG009|Overall Study|Bidirectional Sequencing not possible|0|||
147629880|NCT01163851|532464066|FG000|Overall Study|Site Closure|0|||
147629881|NCT01163851|532464067|FG001|Overall Study|Site Closure|1|||
147629882|NCT01163851|532464066|FG000|Overall Study|Enrolled but not treated|1|||
147629883|NCT01163851|532464067|FG001|Overall Study|Enrolled but not treated|0|||
147629884|NCT01073605|532464071|FG000|Overall Study|Ongoing at Cutoff Date|1|||
147629885|NCT01073605|532464072|FG001|Overall Study|Ongoing at Cutoff Date|1|||
147629886|NCT01073605|532464073|FG002|Overall Study|Ongoing at Cutoff Date|0|||
147629887|NCT01073605|532464071|FG000|Overall Study|Adverse Event|2|||
147629888|NCT01073605|532464072|FG001|Overall Study|Adverse Event|1|||
147629889|NCT01073605|532464073|FG002|Overall Study|Adverse Event|0|||
147629890|NCT01073605|532464071|FG000|Overall Study|Lost to Follow-up|3|||
147629891|NCT01073605|532464072|FG001|Overall Study|Lost to Follow-up|4|||
147629892|NCT01073605|532464073|FG002|Overall Study|Lost to Follow-up|9|||
147629893|NCT01073605|532464071|FG000|Overall Study|Other|25|||
147629894|NCT01073605|532464072|FG001|Overall Study|Other|21|||
147629895|NCT01073605|532464073|FG002|Overall Study|Other|29|||
147629896|NCT01073605|532464071|FG000|Overall Study|Withdrawal by Subject|31|||
147629897|NCT01073605|532464072|FG001|Overall Study|Withdrawal by Subject|39|||
147629898|NCT01073605|532464073|FG002|Overall Study|Withdrawal by Subject|22|||
147629899|NCT01073605|532464071|FG000|Overall Study|Randomized But Not Treated|0|||
147629900|NCT01073605|532464072|FG001|Overall Study|Randomized But Not Treated|1|||
147629901|NCT01073605|532464073|FG002|Overall Study|Randomized But Not Treated|1|||
147629902|NCT03018080|532464074|FG000|Overall Study|Death|12|||
147629903|NCT03018080|532464075|FG001|Overall Study|Death|19|||
147629904|NCT00740792|532464076|FG000|Overall Study|Adverse Event|3|||
147629905|NCT00740792|532464077|FG001|Overall Study|Adverse Event|1|||
147629906|NCT00740792|532464078|FG002|Overall Study|Adverse Event|1|||
147629907|NCT00740792|532464079|FG003|Overall Study|Adverse Event|3|||
147629908|NCT00740792|532464076|FG000|Overall Study|Lack of Efficacy|1|||
147629909|NCT00740792|532464077|FG001|Overall Study|Lack of Efficacy|1|||
147629910|NCT00740792|532464078|FG002|Overall Study|Lack of Efficacy|0|||
147629911|NCT00740792|532464079|FG003|Overall Study|Lack of Efficacy|3|||
147629912|NCT00740792|532464076|FG000|Overall Study|Lost to Follow-up|2|||
147629913|NCT00740792|532464077|FG001|Overall Study|Lost to Follow-up|1|||
147629914|NCT00740792|532464078|FG002|Overall Study|Lost to Follow-up|0|||
147629915|NCT00740792|532464079|FG003|Overall Study|Lost to Follow-up|0|||
147629916|NCT00740792|532464076|FG000|Overall Study|Protocol Violation|0|||
147629917|NCT00740792|532464077|FG001|Overall Study|Protocol Violation|1|||
147629918|NCT00740792|532464078|FG002|Overall Study|Protocol Violation|0|||
147629919|NCT00740792|532464079|FG003|Overall Study|Protocol Violation|2|||
147629920|NCT00740792|532464076|FG000|Overall Study|Withdrawal by Subject|1|||
147629921|NCT00740792|532464077|FG001|Overall Study|Withdrawal by Subject|1|||
147629922|NCT00740792|532464078|FG002|Overall Study|Withdrawal by Subject|0|||
147629923|NCT00740792|532464079|FG003|Overall Study|Withdrawal by Subject|0|||
147629924|NCT00740792|532464076|FG000|Overall Study|administrative|3|||
147629925|NCT00740792|532464077|FG001|Overall Study|administrative|3|||
147629926|NCT00740792|532464078|FG002|Overall Study|administrative|8|||
147629927|NCT00740792|532464079|FG003|Overall Study|administrative|2|||
147629928|NCT03412734|532464088|FG000|Overall Study|Incorrect labeling of samples|2|||
147629929|NCT03412734|532464089|FG001|Overall Study|Incorrect labeling of samples|0|||
147629930|NCT03412734|532464088|FG000|Overall Study|Exclusion criteria - patient receiving Flagyl for treatment|1|||
147629931|NCT03412734|532464089|FG001|Overall Study|Exclusion criteria - patient receiving Flagyl for treatment|0|||
147629932|NCT00179660|532464099|FG000|Overall Study|Adverse Event|7|||
147629933|NCT00179660|532464099|FG000|Overall Study|Lack of therapeutic effect|28|||
147629934|NCT00179660|532464099|FG000|Overall Study|Withdrawal by Subject|2|||
147629935|NCT00179660|532464099|FG000|Overall Study|Lost to Follow-up|1|||
147629936|NCT00179660|532464099|FG000|Overall Study|Death|3|||
147629937|NCT00179660|532464099|FG000|Overall Study|Other - Unspecified|9|||
147629938|NCT00402688|532464102|FG000|Overall Study|Adverse Event|12|||
147629939|NCT00402688|532464103|FG001|Overall Study|Adverse Event|9|||
147629940|NCT00402688|532464104|FG002|Overall Study|Adverse Event|3|||
147629941|NCT00402688|532464102|FG000|Overall Study|Withdrawal by Subject|3|||
147629942|NCT00402688|532464103|FG001|Overall Study|Withdrawal by Subject|1|||
147629943|NCT00402688|532464104|FG002|Overall Study|Withdrawal by Subject|1|||
147629944|NCT00402688|532464102|FG000|Overall Study|Physician Decision|0|||
147629945|NCT00402688|532464103|FG001|Overall Study|Physician Decision|0|||
147629946|NCT00402688|532464104|FG002|Overall Study|Physician Decision|1|||
147629947|NCT00402688|532464102|FG000|Overall Study|Lack of Efficacy|4|||
147629948|NCT00402688|532464103|FG001|Overall Study|Lack of Efficacy|4|||
147629949|NCT00402688|532464104|FG002|Overall Study|Lack of Efficacy|5|||
147629950|NCT00402688|532464102|FG000|Overall Study|Protocol Violation|1|||
147629951|NCT00402688|532464103|FG001|Overall Study|Protocol Violation|1|||
147629952|NCT00402688|532464104|FG002|Overall Study|Protocol Violation|1|||
147629953|NCT00402688|532464102|FG000|Overall Study|Lost to Follow-up|1|||
147629954|NCT00402688|532464103|FG001|Overall Study|Lost to Follow-up|0|||
147629955|NCT00402688|532464104|FG002|Overall Study|Lost to Follow-up|2|||
147629956|NCT00402688|532464102|FG000|Overall Study|Culture Show Fluoroquinolone Resistance|0|||
147629957|NCT00402688|532464103|FG001|Overall Study|Culture Show Fluoroquinolone Resistance|1|||
147629958|NCT00402688|532464104|FG002|Overall Study|Culture Show Fluoroquinolone Resistance|0|||
147629959|NCT00402688|532464102|FG000|Overall Study|Urine Cult. Yield Resistant to Levaquin|0|||
147629960|NCT00402688|532464103|FG001|Overall Study|Urine Cult. Yield Resistant to Levaquin|0|||
147629961|NCT00402688|532464104|FG002|Overall Study|Urine Cult. Yield Resistant to Levaquin|1|||
147629962|NCT00402688|532464102|FG000|Overall Study|Patient Left Town and Forgot Medication|0|||
147629963|NCT00402688|532464103|FG001|Overall Study|Patient Left Town and Forgot Medication|0|||
147629964|NCT00402688|532464104|FG002|Overall Study|Patient Left Town and Forgot Medication|1|||
147629965|NCT00014495|532464121|FG000|Overall Study|Death|0|||
147629966|NCT00014495|532464122|FG001|Overall Study|Death|0|||
147629967|NCT00014495|532464123|FG002|Overall Study|Death|1|||
147629968|NCT00014495|532464124|FG003|Overall Study|Death|0|||
147629969|NCT00014495|532464121|FG000|Overall Study|Clinical deterioration|0|||
147629970|NCT00014495|532464122|FG001|Overall Study|Clinical deterioration|0|||
147629971|NCT00014495|532464123|FG002|Overall Study|Clinical deterioration|0|||
147629972|NCT00014495|532464124|FG003|Overall Study|Clinical deterioration|1|||
147629973|NCT02929589|532464158|FG000|Overall Study|Withdrawal by Subject|1|||
147629974|NCT02929589|532464159|FG001|Overall Study|Withdrawal by Subject|0|||
147629975|NCT02929589|532464160|FG002|Overall Study|Withdrawal by Subject|0|||
147629976|NCT02929589|532464161|FG003|Overall Study|Withdrawal by Subject|0|||
147629977|NCT02929589|532464158|FG000|Overall Study|Physician Decision|2|||
147629978|NCT02929589|532464159|FG001|Overall Study|Physician Decision|0|||
147629979|NCT02929589|532464160|FG002|Overall Study|Physician Decision|0|||
147629980|NCT02929589|532464161|FG003|Overall Study|Physician Decision|0|||
147629981|NCT02091089|532464163|FG000|Overall Study|Lost to Follow-up|2|||
147629982|NCT00994461|532464168|FG000|Overall Study|Adverse Event|2|||
147629983|NCT00994461|532464169|FG001|Overall Study|Adverse Event|1|||
147629984|NCT00994461|532464170|FG002|Overall Study|Adverse Event|0|||
147629985|NCT00591565|532464181|FG000|Overall Study|lost follow up, withdrawn|5|||
147629986|NCT01863667|532464183|FG000|Overall Study|Adverse Event|1|||
147629987|NCT01863667|532464184|FG001|Overall Study|Adverse Event|0|||
147629988|NCT01863667|532464183|FG000|Overall Study|Study terminated by Sponsor|30|||
147629989|NCT01863667|532464184|FG001|Overall Study|Study terminated by Sponsor|30|||
147629990|NCT01863667|532464183|FG000|Overall Study|Withdrawal by Subject|2|||
147629991|NCT01863667|532464184|FG001|Overall Study|Withdrawal by Subject|2|||
147629992|NCT03627546|532464185|FG000|Overall Study|Deemed ineligible after ransdomization|1|||
147629993|NCT03627546|532464186|FG001|Overall Study|Deemed ineligible after ransdomization|0|||
147629994|NCT03627546|532464187|FG002|Overall Study|Deemed ineligible after ransdomization|0|||
147629995|NCT03627546|532464185|FG000|Overall Study|HCV RNA Negative (protocol pre-specified)|0|||
147629996|NCT03627546|532464186|FG001|Overall Study|HCV RNA Negative (protocol pre-specified)|0|||
147629997|NCT03627546|532464187|FG002|Overall Study|HCV RNA Negative (protocol pre-specified)|13|||
147629998|NCT00615550|532464190|FG000|Overall Study|Lost to Follow-up|6|||
147629999|NCT00615550|532464191|FG001|Overall Study|Lost to Follow-up|1|||
147630000|NCT01537042|532464192|FG000|Overall Study|Adverse Event|0|||
147630001|NCT01537042|532464193|FG001|Overall Study|Adverse Event|2|||
147630002|NCT01537042|532464192|FG000|Overall Study|Lack of Efficacy|0|||
147630003|NCT01537042|532464193|FG001|Overall Study|Lack of Efficacy|1|||
147630004|NCT01537042|532464192|FG000|Overall Study|Protocol Violation|0|||
147630005|NCT01537042|532464193|FG001|Overall Study|Protocol Violation|1|||
147630006|NCT01537042|532464192|FG000|Overall Study|Other|0|||
147630007|NCT01537042|532464193|FG001|Overall Study|Other|1|||
147630008|NCT02741076|532464194|FG000|Overall Study|Adverse Event|0|||
147630009|NCT02741076|532464195|FG001|Overall Study|Adverse Event|1|||
147630010|NCT02741076|532464196|FG002|Overall Study|Adverse Event|1|||
147630011|NCT02741076|532464197|FG003|Overall Study|Adverse Event|0|||
147630012|NCT02741076|532464194|FG000|Overall Study|Lack of Efficacy|1|||
147630013|NCT02741076|532464195|FG001|Overall Study|Lack of Efficacy|0|||
147630014|NCT02741076|532464196|FG002|Overall Study|Lack of Efficacy|0|||
147630015|NCT02741076|532464197|FG003|Overall Study|Lack of Efficacy|0|||
147630016|NCT02741076|532464194|FG000|Overall Study|Withdrawal by Subject|0|||
147630017|NCT02741076|532464195|FG001|Overall Study|Withdrawal by Subject|1|||
147630018|NCT02741076|532464196|FG002|Overall Study|Withdrawal by Subject|0|||
147496246|NCT01973452|531970899|FG000|Overall Study|Surgery canceled by participant|5|||
147496247|NCT01973452|531970900|FG001|Overall Study|Surgery canceled by participant|3|||
147496248|NCT00406783|531970904|FG000|Overall Study|Adverse Event|4|||
147496249|NCT00406783|531970905|FG001|Overall Study|Adverse Event|4|||
147496250|NCT00406783|531970904|FG000|Overall Study|Treatment Failure|2|||
147496251|NCT00406783|531970905|FG001|Overall Study|Treatment Failure|3|||
147496252|NCT00406783|531970904|FG000|Overall Study|Lost to Follow-up|3|||
147496253|NCT00406783|531970905|FG001|Overall Study|Lost to Follow-up|0|||
147496254|NCT00406783|531970904|FG000|Overall Study|Withdrawal by Subject|1|||
147496255|NCT00406783|531970905|FG001|Overall Study|Withdrawal by Subject|4|||
147496256|NCT00406783|531970904|FG000|Overall Study|Protocol Violation|4|||
147496257|NCT00406783|531970905|FG001|Overall Study|Protocol Violation|4|||
147496258|NCT05294211|531970906|FG000|Overall Study|Withdrawal by Subject|3|||
147496259|NCT05294211|531970906|FG000|Overall Study|Physician Decision|2|||
147496260|NCT05294211|531970906|FG000|Overall Study|Progressed to active labor|1|||
147496261|NCT05294211|531970906|FG000|Overall Study|Did not complete 5-minute monitoring session|15|||
147496262|NCT05294211|531970906|FG000|Overall Study|Did not have ≥ 1 minute of concurrent data|19|||
147496263|NCT03707158|531970907|FG000|Midtreatment|Lost to Follow-up|16|||
147496264|NCT03707158|531970908|FG001|Midtreatment|Lost to Follow-up|7|||
147496265|NCT03707158|531970907|FG000|Midtreatment|Withdrawal by Subject|28|||
147496266|NCT03707158|531970908|FG001|Midtreatment|Withdrawal by Subject|19|||
147496267|NCT03707158|531970907|FG000|Posttreatment|Lost to Follow-up|0|||
147496268|NCT03707158|531970908|FG001|Posttreatment|Lost to Follow-up|5|||
147496269|NCT03707158|531970907|FG000|Follow-up|Lost to Follow-up|19|||
147496270|NCT03707158|531970908|FG001|Follow-up|Lost to Follow-up|18|||
147496271|NCT03707158|531970907|FG000|Follow-up|Withdrawal by Subject|13|||
147496272|NCT03707158|531970908|FG001|Follow-up|Withdrawal by Subject|6|||
147496273|NCT01274338|531972348|FG000|Overall Study|Lack of Efficacy|72|||
147496274|NCT01274338|531972349|FG001|Overall Study|Lack of Efficacy|108|||
147496275|NCT01274338|531972350|FG002|Overall Study|Lack of Efficacy|116|||
147496276|NCT01274338|531972351|FG003|Overall Study|Lack of Efficacy|0|||
147496277|NCT01274338|531972352|FG004|Overall Study|Lack of Efficacy|0|||
147496278|NCT01274338|531972353|FG005|Overall Study|Lack of Efficacy|0|||
147496279|NCT01274338|531972348|FG000|Overall Study|Adverse Event|272|||
147496280|NCT01274338|531972349|FG001|Overall Study|Adverse Event|105|||
147496281|NCT01274338|531972350|FG002|Overall Study|Adverse Event|180|||
147496282|NCT01274338|531972351|FG003|Overall Study|Adverse Event|1|||
147496283|NCT01274338|531972352|FG004|Overall Study|Adverse Event|0|||
147496284|NCT01274338|531972353|FG005|Overall Study|Adverse Event|0|||
147496285|NCT01274338|531972348|FG000|Overall Study|Death|8|||
147496286|NCT01274338|531972349|FG001|Overall Study|Death|1|||
147496287|NCT01274338|531972350|FG002|Overall Study|Death|0|||
147496288|NCT01274338|531972351|FG003|Overall Study|Death|0|||
147496289|NCT01274338|531972352|FG004|Overall Study|Death|0|||
147496290|NCT01274338|531972353|FG005|Overall Study|Death|0|||
147496291|NCT01274338|531972348|FG000|Overall Study|Withdrawal by Subject|27|||
147496292|NCT01274338|531972349|FG001|Overall Study|Withdrawal by Subject|99|||
147496293|NCT01274338|531972350|FG002|Overall Study|Withdrawal by Subject|17|||
147496294|NCT01274338|531972351|FG003|Overall Study|Withdrawal by Subject|0|||
147496295|NCT01274338|531972352|FG004|Overall Study|Withdrawal by Subject|0|||
147496296|NCT01274338|531972353|FG005|Overall Study|Withdrawal by Subject|0|||
147496297|NCT01274338|531972348|FG000|Overall Study|Did not start treatment|8|||
147496298|NCT01274338|531972349|FG001|Overall Study|Did not start treatment|116|||
147496299|NCT01274338|531972350|FG002|Overall Study|Did not start treatment|7|||
147496300|NCT01274338|531972351|FG003|Overall Study|Did not start treatment|0|||
147496301|NCT01274338|531972352|FG004|Overall Study|Did not start treatment|0|||
147496302|NCT01274338|531972353|FG005|Overall Study|Did not start treatment|0|||
147496303|NCT01274338|531972348|FG000|Overall Study|Alternative therapy|0|||
147496304|NCT01274338|531972349|FG001|Overall Study|Alternative therapy|1|||
147496305|NCT01274338|531972350|FG002|Overall Study|Alternative therapy|0|||
147496306|NCT01274338|531972351|FG003|Overall Study|Alternative therapy|0|||
147496307|NCT01274338|531972352|FG004|Overall Study|Alternative therapy|0|||
147496308|NCT01274338|531972353|FG005|Overall Study|Alternative therapy|0|||
147496309|NCT01274338|531972348|FG000|Overall Study|Other complicating diseases|0|||
147496310|NCT01274338|531972349|FG001|Overall Study|Other complicating diseases|3|||
147496311|NCT01274338|531972350|FG002|Overall Study|Other complicating diseases|1|||
147496312|NCT01274338|531972351|FG003|Overall Study|Other complicating diseases|0|||
147496313|NCT01274338|531972352|FG004|Overall Study|Other complicating diseases|0|||
147496314|NCT01274338|531972353|FG005|Overall Study|Other complicating diseases|0|||
147496315|NCT01274338|531972348|FG000|Overall Study|Treatment arm was suspended due to toxicity|4|||
147496316|NCT01274338|531972349|FG001|Overall Study|Treatment arm was suspended due to toxicity|0|||
147496317|NCT01274338|531972350|FG002|Overall Study|Treatment arm was suspended due to toxicity|0|||
147496318|NCT01274338|531972351|FG003|Overall Study|Treatment arm was suspended due to toxicity|0|||
147496319|NCT01274338|531972352|FG004|Overall Study|Treatment arm was suspended due to toxicity|0|||
147496320|NCT01274338|531972353|FG005|Overall Study|Treatment arm was suspended due to toxicity|0|||
147496321|NCT01274338|531972348|FG000|Overall Study|Pregnancy|0|||
147496322|NCT01274338|531972349|FG001|Overall Study|Pregnancy|0|||
147496323|NCT01274338|531972350|FG002|Overall Study|Pregnancy|1|||
147496324|NCT01274338|531972351|FG003|Overall Study|Pregnancy|0|||
147496325|NCT01274338|531972352|FG004|Overall Study|Pregnancy|0|||
147496326|NCT01274338|531972353|FG005|Overall Study|Pregnancy|0|||
147496327|NCT01274338|531972348|FG000|Overall Study|Reason not reported|12|||
147496328|NCT01274338|531972349|FG001|Overall Study|Reason not reported|21|||
147496329|NCT01274338|531972350|FG002|Overall Study|Reason not reported|3|||
147496330|NCT01274338|531972351|FG003|Overall Study|Reason not reported|0|||
147496331|NCT01274338|531972352|FG004|Overall Study|Reason not reported|1|||
147496332|NCT01274338|531972353|FG005|Overall Study|Reason not reported|0|||
147496333|NCT01927744|531972354|FG000|Overall Study|Death|2|||
147496334|NCT01927744|531972355|FG001|Overall Study|Death|9|||
147496335|NCT02198651|531972359|FG000|Lead-in Period|Withdrew consent|13|||
147496336|NCT02198651|531972360|FG001|Lead-in Period|Withdrew consent|0|||
147496337|NCT02198651|531972361|FG002|Lead-in Period|Withdrew consent|0|||
147496338|NCT02198651|531972362|FG003|Lead-in Period|Withdrew consent|0|||
147496339|NCT02198651|531972363|FG004|Lead-in Period|Withdrew consent|0|||
147496340|NCT02198651|531972359|FG000|Lead-in Period|Adverse Event|2|||
147496341|NCT02198651|531972360|FG001|Lead-in Period|Adverse Event|0|||
147496342|NCT02198651|531972361|FG002|Lead-in Period|Adverse Event|0|||
147496343|NCT02198651|531972362|FG003|Lead-in Period|Adverse Event|0|||
147496344|NCT02198651|531972363|FG004|Lead-in Period|Adverse Event|0|||
147496345|NCT02198651|531972359|FG000|Lead-in Period|Other, not specified|22|||
147496346|NCT02198651|531972360|FG001|Lead-in Period|Other, not specified|0|||
147496347|NCT02198651|531972361|FG002|Lead-in Period|Other, not specified|0|||
147496348|NCT02198651|531972362|FG003|Lead-in Period|Other, not specified|0|||
147496349|NCT02198651|531972363|FG004|Lead-in Period|Other, not specified|0|||
147496350|NCT02198651|531972359|FG000|Double-blind Period|Withdrew consent|0|||
147496351|NCT02198651|531972360|FG001|Double-blind Period|Withdrew consent|4|||
147496352|NCT02198651|531972361|FG002|Double-blind Period|Withdrew consent|0|||
147496353|NCT02198651|531972362|FG003|Double-blind Period|Withdrew consent|0|||
147496354|NCT02198651|531972363|FG004|Double-blind Period|Withdrew consent|0|||
147496355|NCT02198651|531972359|FG000|Double-blind Period|Adverse Event|0|||
147496356|NCT02198651|531972360|FG001|Double-blind Period|Adverse Event|1|||
147496357|NCT02198651|531972361|FG002|Double-blind Period|Adverse Event|0|||
147496358|NCT02198651|531972362|FG003|Double-blind Period|Adverse Event|0|||
147496359|NCT02198651|531972363|FG004|Double-blind Period|Adverse Event|0|||
147496360|NCT02198651|531972359|FG000|Double-blind Period|Other, not specified|0|||
147496361|NCT02198651|531972360|FG001|Double-blind Period|Other, not specified|4|||
147496362|NCT02198651|531972361|FG002|Double-blind Period|Other, not specified|1|||
147496363|NCT02198651|531972362|FG003|Double-blind Period|Other, not specified|0|||
147496364|NCT02198651|531972363|FG004|Double-blind Period|Other, not specified|0|||
147496365|NCT02198651|531972359|FG000|Open-label Rescue Period|Withdrew consent|0|||
147496366|NCT02198651|531972360|FG001|Open-label Rescue Period|Withdrew consent|0|||
147496367|NCT02198651|531972361|FG002|Open-label Rescue Period|Withdrew consent|0|||
147496368|NCT02198651|531972362|FG003|Open-label Rescue Period|Withdrew consent|2|||
147496369|NCT02198651|531972363|FG004|Open-label Rescue Period|Withdrew consent|0|||
147496370|NCT02198651|531972359|FG000|Open-label Rescue Period|Incorrectly entered Open-label Rescue|0|||
147496371|NCT02198651|531972360|FG001|Open-label Rescue Period|Incorrectly entered Open-label Rescue|0|||
147496372|NCT02198651|531972361|FG002|Open-label Rescue Period|Incorrectly entered Open-label Rescue|0|||
147496373|NCT02198651|531972362|FG003|Open-label Rescue Period|Incorrectly entered Open-label Rescue|1|||
147496374|NCT02198651|531972363|FG004|Open-label Rescue Period|Incorrectly entered Open-label Rescue|0|||
147496375|NCT01146951|531972364|FG000|Overall Study|Adverse Event|4|||
147496376|NCT01146951|531972365|FG001|Overall Study|Adverse Event|1|||
147496377|NCT04092816|531972369|FG000|Overall Study|Lost to Follow-up|1|||
147496378|NCT04092816|531972370|FG001|Overall Study|Lost to Follow-up|2|||
147496379|NCT01747811|531972371|FG000|Overall Study|Lack of Efficacy|2|||
147496380|NCT01747811|531972372|FG001|Overall Study|Lack of Efficacy|4|||
147496381|NCT03073213|531972373|FG000|Multiple Dose Period|Protocol Violation|0|||
147496382|NCT03073213|531972374|FG001|Multiple Dose Period|Protocol Violation|0|||
147496383|NCT03073213|531972375|FG002|Multiple Dose Period|Protocol Violation|1|||
147496384|NCT05458011|531972377|FG000|DB Period (12 Weeks)|Adverse Event|2|||
147496385|NCT05458011|531972378|FG001|DB Period (12 Weeks)|Adverse Event|1|||
147496386|NCT05458011|531972379|FG002|DB Period (12 Weeks)|Adverse Event|1|||
147496387|NCT05458011|531972377|FG000|DB Period (12 Weeks)|Withdrawal by Subject|4|||
147496388|NCT05458011|531972378|FG001|DB Period (12 Weeks)|Withdrawal by Subject|1|||
147496389|NCT05458011|531972379|FG002|DB Period (12 Weeks)|Withdrawal by Subject|1|||
147496390|NCT05458011|531972377|FG000|DB Period (12 Weeks)|Non-compliance with trial drug|0|||
147496391|NCT05458011|531972378|FG001|DB Period (12 Weeks)|Non-compliance with trial drug|0|||
147496392|NCT05458011|531972379|FG002|DB Period (12 Weeks)|Non-compliance with trial drug|1|||
147496393|NCT05458011|531972377|FG000|DB Period (12 Weeks)|Protocol deviation|0|||
147496394|NCT05458011|531972378|FG001|DB Period (12 Weeks)|Protocol deviation|2|||
147496395|NCT05458011|531972379|FG002|DB Period (12 Weeks)|Protocol deviation|2|||
147496396|NCT05458011|531972377|FG000|OL Period (12 Weeks)|Adverse Event|1|||
147496397|NCT05458011|531972378|FG001|OL Period (12 Weeks)|Adverse Event|2|||
147496398|NCT05458011|531972379|FG002|OL Period (12 Weeks)|Adverse Event|1|||
147630019|NCT02741076|532464197|FG003|Overall Study|Withdrawal by Subject|0|||
147630020|NCT02741076|532464194|FG000|Overall Study|Sponsor Request|2|||
147630021|NCT02741076|532464195|FG001|Overall Study|Sponsor Request|3|||
147630022|NCT02741076|532464196|FG002|Overall Study|Sponsor Request|0|||
147630023|NCT02741076|532464197|FG003|Overall Study|Sponsor Request|1|||
147630024|NCT02741076|532464194|FG000|Overall Study|No additional information available|0|||
147630025|NCT02741076|532464195|FG001|Overall Study|No additional information available|0|||
147630026|NCT02741076|532464196|FG002|Overall Study|No additional information available|1|||
147630027|NCT02741076|532464197|FG003|Overall Study|No additional information available|1|||
147630028|NCT01779440|532464198|FG000|Overall Study|Withdrawal by Subject|3|||
147630029|NCT01779440|532464199|FG001|Overall Study|Withdrawal by Subject|5|||
147630030|NCT02965573|532464203|FG000|Overall Study|Lack of Efficacy|1|||
147630031|NCT02965573|532464204|FG001|Overall Study|Lack of Efficacy|0|||
147630032|NCT00315458|532464205|FG000|Overall Study|Administrative|0|||
147630033|NCT00315458|532464206|FG001|Overall Study|Administrative|3|||
147630034|NCT00315458|532464207|FG002|Overall Study|Administrative|8|||
147630035|NCT00315458|532464208|FG003|Overall Study|Administrative|21|||
147630036|NCT00315458|532464205|FG000|Overall Study|Adverse Event|2|||
147630037|NCT00315458|532464206|FG001|Overall Study|Adverse Event|4|||
147630038|NCT00315458|532464207|FG002|Overall Study|Adverse Event|23|||
147630039|NCT00315458|532464208|FG003|Overall Study|Adverse Event|3|||
147630040|NCT00315458|532464205|FG000|Overall Study|Lost to Follow-up|1|||
147630041|NCT00315458|532464206|FG001|Overall Study|Lost to Follow-up|2|||
147630042|NCT00315458|532464207|FG002|Overall Study|Lost to Follow-up|0|||
147630043|NCT00315458|532464208|FG003|Overall Study|Lost to Follow-up|2|||
147630044|NCT00315458|532464205|FG000|Overall Study|Withdrawal by Subject|0|||
147630045|NCT00315458|532464206|FG001|Overall Study|Withdrawal by Subject|3|||
147630046|NCT00315458|532464207|FG002|Overall Study|Withdrawal by Subject|0|||
147630047|NCT00315458|532464208|FG003|Overall Study|Withdrawal by Subject|2|||
147630048|NCT00315458|532464205|FG000|Overall Study|Lack of Efficacy|0|||
147630049|NCT00315458|532464206|FG001|Overall Study|Lack of Efficacy|0|||
147630050|NCT00315458|532464207|FG002|Overall Study|Lack of Efficacy|20|||
147630051|NCT00315458|532464208|FG003|Overall Study|Lack of Efficacy|1|||
147630052|NCT00315458|532464205|FG000|Overall Study|Did not qualify|0|||
147630053|NCT00315458|532464206|FG001|Overall Study|Did not qualify|0|||
147630054|NCT00315458|532464207|FG002|Overall Study|Did not qualify|1|||
147630055|NCT00315458|532464208|FG003|Overall Study|Did not qualify|0|||
147630056|NCT01209520|532464209|FG000|Overall Study|Withdrawal by Subject|3|||
147630057|NCT03056638|532465849|FG000|Overall Study|Death|1|||
147630058|NCT03056638|532465850|FG001|Overall Study|Death|0|||
147630059|NCT02530125|532465851|FG000|Completed Treatment|Early termination of study|1|||
147630060|NCT02530125|532465851|FG000|Followed for Survival for 2 Years|Early termination of study|3|||
147630061|NCT00468481|532465852|FG000|Overall Study|Adverse Event|13|||
147630062|NCT00468481|532465853|FG001|Overall Study|Adverse Event|3|||
147630063|NCT00468481|532465852|FG000|Overall Study|Lost to Follow-up|25|||
147630064|NCT00468481|532465853|FG001|Overall Study|Lost to Follow-up|8|||
147630065|NCT00468481|532465852|FG000|Overall Study|Pregnancy|2|||
147630066|NCT00468481|532465853|FG001|Overall Study|Pregnancy|0|||
147630067|NCT00468481|532465852|FG000|Overall Study|Protocol Violation|18|||
147630068|NCT00468481|532465853|FG001|Overall Study|Protocol Violation|8|||
147630069|NCT00468481|532465852|FG000|Overall Study|Withdrawal by Subject|12|||
147630070|NCT00468481|532465853|FG001|Overall Study|Withdrawal by Subject|3|||
147630071|NCT00468481|532465852|FG000|Overall Study|susp/diag malignant/premalignant disease|1|||
147630072|NCT00468481|532465853|FG001|Overall Study|susp/diag malignant/premalignant disease|0|||
147630073|NCT00468481|532465852|FG000|Overall Study|Prohibited Medication|1|||
147630074|NCT00468481|532465853|FG001|Overall Study|Prohibited Medication|1|||
147630075|NCT00468481|532465852|FG000|Overall Study|Egg Donor|1|||
147630076|NCT00468481|532465853|FG001|Overall Study|Egg Donor|0|||
147630077|NCT00468481|532465852|FG000|Overall Study|Moved out of area|4|||
147630078|NCT00468481|532465853|FG001|Overall Study|Moved out of area|1|||
147630079|NCT00468481|532465852|FG000|Overall Study|Non-Compliance|5|||
147630080|NCT00468481|532465853|FG001|Overall Study|Non-Compliance|0|||
147630081|NCT00468481|532465852|FG000|Overall Study|Other|6|||
147630082|NCT00468481|532465853|FG001|Overall Study|Other|0|||
147630083|NCT00728468|532465855|FG000|Overall Study|Enrolled but not treated|1|||
147630084|NCT00728468|532465855|FG000|Overall Study|Death|1|||
147630085|NCT00728468|532465855|FG000|Overall Study|Protocol Violation|4|||
147630086|NCT00728468|532465855|FG000|Overall Study|Objective progression or relapse|9|||
147630087|NCT00728468|532465855|FG000|Overall Study|Study terminated by sponsor|1|||
147630088|NCT01568034|532465856|FG000|Overall Study|Withdrawal by Subject|1|||
147630089|NCT01568034|532465857|FG001|Overall Study|Withdrawal by Subject|0|||
147630090|NCT01568034|532465858|FG002|Overall Study|Withdrawal by Subject|0|||
147630091|NCT01568034|532465859|FG003|Overall Study|Withdrawal by Subject|0|||
147630092|NCT01637922|532465860|FG000|Overall Study|Adverse Event|0|||
147630093|NCT01637922|532465861|FG001|Overall Study|Adverse Event|1|||
147630094|NCT01637922|532465860|FG000|Overall Study|Protocol Violation|0|||
147630095|NCT01637922|532465861|FG001|Overall Study|Protocol Violation|1|||
147630096|NCT01637922|532465860|FG000|Overall Study|Withdrawal by Subject|0|||
147630097|NCT01637922|532465861|FG001|Overall Study|Withdrawal by Subject|3|||
147496399|NCT05458011|531972377|FG000|OL Period (12 Weeks)|Withdrawal by Subject|0|||
147496400|NCT05458011|531972378|FG001|OL Period (12 Weeks)|Withdrawal by Subject|3|||
147496401|NCT05458011|531972379|FG002|OL Period (12 Weeks)|Withdrawal by Subject|0|||
147496402|NCT02690207|531972380|FG000|Overall Study|Lost to Follow-up|48|||
147496403|NCT02690207|531972380|FG000|Overall Study|Withdrawal by Subject|46|||
147496404|NCT02690207|531972380|FG000|Overall Study|Protocol Violation|2|||
147496405|NCT02690207|531972380|FG000|Overall Study|Serious adverse event|110|||
147496406|NCT02690207|531972380|FG000|Overall Study|Non-serious Adverse Event|18|||
147496407|NCT02690207|531972380|FG000|Overall Study|Migrated/moved from study area|5|||
147496408|NCT02690207|531972380|FG000|Overall Study|Suspected HZ Episode|1|||
147496409|NCT02690207|531972380|FG000|Overall Study|Other reasons for withdrawal|23|||
147496410|NCT01175213|531972385|FG000|IGSC, 10%/rHuPH20|Withdrawal by Subject|4|||
147496411|NCT01175213|531972386|FG001|IGSC, 10%/rHuPH20|Withdrawal by Subject|0|||
147496412|NCT01175213|531972385|FG000|IGSC, 10%/rHuPH20|Death|1|||
147496413|NCT01175213|531972386|FG001|IGSC, 10%/rHuPH20|Death|0|||
147496414|NCT01175213|531972385|FG000|IGSC, 10%/rHuPH20|bone marrow transplant|1|||
147496415|NCT01175213|531972386|FG001|IGSC, 10%/rHuPH20|bone marrow transplant|0|||
147496416|NCT01175213|531972385|FG000|IGSC, 10%/rHuPH20|clinical site closed by sponsor|6|||
147496417|NCT01175213|531972386|FG001|IGSC, 10%/rHuPH20|clinical site closed by sponsor|0|||
147496418|NCT01175213|531972385|FG000|IGSC, 10%/rHuPH20|site elected to exit study|3|||
147496419|NCT01175213|531972386|FG001|IGSC, 10%/rHuPH20|site elected to exit study|0|||
147496420|NCT01175213|531972385|FG000|Safety Follow-up|Adverse Event|1|||
147630098|NCT01637922|532465860|FG000|Overall Study|Lost to Follow-up|2|||
147668479|NCT00094445|532611801|FG000|Overall Study|Progressive Disease|2|||
147668480|NCT00855218|532611802|FG000|Overall Study|Adverse Event|43|||
147668481|NCT00855218|532611803|FG001|Overall Study|Adverse Event|27|||
147668482|NCT00855218|532611802|FG000|Overall Study|Withdrawal by Subject|10|||
147668483|NCT00855218|532611803|FG001|Overall Study|Withdrawal by Subject|6|||
147630099|NCT01637922|532465861|FG001|Overall Study|Lost to Follow-up|0|||
147630100|NCT02498444|532465864|FG000|Overall Study|Withdrawal by Subject|3|||
147630101|NCT02498444|532465865|FG001|Overall Study|Withdrawal by Subject|0|||
147630102|NCT02498444|532465864|FG000|Overall Study|Physician Decision|1|||
147630103|NCT02498444|532465865|FG001|Overall Study|Physician Decision|0|||
147630104|NCT03656692|532465866|FG000|Overall Study|Worsening of disease activity|2|||
147630105|NCT03656692|532465866|FG000|Overall Study|Physician Decision|1|||
147630106|NCT01841762|532465867|FG000|Screening Period|Other, 2 PAH-SYMPACT cycles not complete|51|||
147630107|NCT01841762|532465867|FG000|Treatment Period|Adverse Event|16|||
147630108|NCT01841762|532465867|FG000|Treatment Period|Death|1|||
147630109|NCT01841762|532465867|FG000|Treatment Period|Withdrawal by Subject|7|||
147630110|NCT01841762|532465867|FG000|Treatment Period|Lost to Follow-up|1|||
147630111|NCT01841762|532465867|FG000|Treatment Period|Physician Decision|2|||
147630112|NCT01841762|532465867|FG000|Treatment Period|Other, including non-compliance|5|||
147630113|NCT01841762|532465867|FG000|Post-Treatment Safety Follow-Up Period|Death|1|||
147630114|NCT01841762|532465867|FG000|Post-Treatment Safety Follow-Up Period|Withdrawal by Subject|7|||
147630115|NCT01841762|532465867|FG000|Post-Treatment Safety Follow-Up Period|Lost to Follow-up|6|||
147630116|NCT01841762|532465867|FG000|Post-Treatment Safety Follow-Up Period|Other, administrative error|1|||
147630117|NCT01270464|532465868|FG000|Overall Study|Protocol Violation|4|||
147630118|NCT01270464|532465869|FG001|Overall Study|Protocol Violation|3|||
147630119|NCT01270464|532465870|FG002|Overall Study|Protocol Violation|2|||
147630120|NCT01270464|532465868|FG000|Overall Study|Lack of Efficacy|2|||
147630121|NCT01270464|532465869|FG001|Overall Study|Lack of Efficacy|3|||
147630122|NCT01270464|532465870|FG002|Overall Study|Lack of Efficacy|1|||
147496421|NCT01175213|531972386|FG001|Safety Follow-up|Adverse Event|0|||
147496422|NCT02064205|531972388|FG000|Overall Study|Withdrawal by Subject|1|||
147630123|NCT01270464|532465868|FG000|Overall Study|Adverse Event|9|||
147630124|NCT01270464|532465869|FG001|Overall Study|Adverse Event|1|||
147630125|NCT01270464|532465870|FG002|Overall Study|Adverse Event|7|||
147630126|NCT01270464|532465868|FG000|Overall Study|Withdrawal by Subject|2|||
147630127|NCT01270464|532465869|FG001|Overall Study|Withdrawal by Subject|1|||
147630128|NCT01270464|532465870|FG002|Overall Study|Withdrawal by Subject|4|||
147496423|NCT03057951|531972389|FG000|Overall Study|Adverse Event|553|||
147496424|NCT03057951|531972390|FG001|Overall Study|Adverse Event|575|||
147496425|NCT03057951|531972389|FG000|Overall Study|Protocol Violation|30|||
147630129|NCT01270464|532465868|FG000|Overall Study|Lost to Follow-up|2|||
147630130|NCT01270464|532465869|FG001|Overall Study|Lost to Follow-up|3|||
147630131|NCT01270464|532465870|FG002|Overall Study|Lost to Follow-up|1|||
147630132|NCT01270464|532465868|FG000|Overall Study|Other|1|||
147630133|NCT01270464|532465869|FG001|Overall Study|Other|1|||
147668484|NCT00855218|532611802|FG000|Overall Study|Physician Decision|18|||
147668485|NCT00855218|532611803|FG001|Overall Study|Physician Decision|11|||
147496426|NCT03057951|531972390|FG001|Overall Study|Protocol Violation|24|||
147496427|NCT03057951|531972389|FG000|Overall Study|Lost to Follow-up|6|||
147496428|NCT03057951|531972390|FG001|Overall Study|Lost to Follow-up|16|||
147630134|NCT01270464|532465870|FG002|Overall Study|Other|3|||
147630135|NCT02448537|532465871|FG000|Overall Study|Withdrawal by Subject|1|||
147630136|NCT02448537|532465872|FG001|Overall Study|Withdrawal by Subject|1|||
147630137|NCT02448537|532465873|FG002|Overall Study|Withdrawal by Subject|1|||
147630138|NCT04725812|532465874|FG000|Overall Study|Withdrawal by Subject|1|||
147630139|NCT05656534|532465876|FG000|Overall Study|Withdrawal by Subject|1|||
147630140|NCT05656534|532465877|FG001|Overall Study|Withdrawal by Subject|1|||
147630141|NCT05656534|532465878|FG002|Overall Study|Withdrawal by Subject|0|||
147630142|NCT05656534|532465879|FG003|Overall Study|Withdrawal by Subject|0|||
147630143|NCT05656534|532465876|FG000|Overall Study|Physician Decision|1|||
147630144|NCT05656534|532465877|FG001|Overall Study|Physician Decision|1|||
147630145|NCT05656534|532465878|FG002|Overall Study|Physician Decision|0|||
147630146|NCT05656534|532465879|FG003|Overall Study|Physician Decision|0|||
147496429|NCT03057951|531972389|FG000|Overall Study|Patient refusal to continue, not due to AE|304|||
147496430|NCT03057951|531972390|FG001|Overall Study|Patient refusal to continue, not due to AE|284|||
147630147|NCT00839800|532465881|FG000|Overall Study|Adverse Event|8|||
147630148|NCT00839800|532465882|FG001|Overall Study|Adverse Event|12|||
147630149|NCT00839800|532465881|FG000|Overall Study|Lost to Follow-up|31|||
147630150|NCT00839800|532465882|FG001|Overall Study|Lost to Follow-up|26|||
147630151|NCT00839800|532465881|FG000|Overall Study|Withdrawal by Subject|28|||
147630152|NCT00839800|532465882|FG001|Overall Study|Withdrawal by Subject|34|||
147630153|NCT00839800|532465881|FG000|Overall Study|Incorrect Enrolment|3|||
147630154|NCT00839800|532465882|FG001|Overall Study|Incorrect Enrolment|3|||
147630155|NCT00839800|532465881|FG000|Overall Study|Study-Specific Discontinuation Criteria|6|||
147630156|NCT00839800|532465882|FG001|Overall Study|Study-Specific Discontinuation Criteria|13|||
147496431|NCT03057951|531972389|FG000|Overall Study|Study drug stopped, reason missing|6|||
147496432|NCT03057951|531972390|FG001|Overall Study|Study drug stopped, reason missing|1|||
147496433|NCT03057951|531972389|FG000|Overall Study|Medical advice|6|||
147496434|NCT03057951|531972390|FG001|Overall Study|Medical advice|2|||
147496435|NCT03057951|531972389|FG000|Overall Study|Due to Covid-19 Pandemic|2|||
147496436|NCT03057951|531972390|FG001|Overall Study|Due to Covid-19 Pandemic|8|||
147496437|NCT03057951|531972389|FG000|Overall Study|Investigator decision|2|||
147496438|NCT03057951|531972390|FG001|Overall Study|Investigator decision|0|||
147496439|NCT03057951|531972389|FG000|Overall Study|Patient decision|5|||
147496440|NCT03057951|531972390|FG001|Overall Study|Patient decision|2|||
147496441|NCT03057951|531972389|FG000|Overall Study|Not attending study visits|3|||
147496442|NCT03057951|531972390|FG001|Overall Study|Not attending study visits|0|||
147496443|NCT03057951|531972389|FG000|Overall Study|Patient moved away|3|||
147496444|NCT03057951|531972390|FG001|Overall Study|Patient moved away|4|||
147496445|NCT03057951|531972389|FG000|Overall Study|Other reason than stated above|23|||
147496446|NCT03057951|531972390|FG001|Overall Study|Other reason than stated above|29|||
147496447|NCT03057951|531972389|FG000|Overall Study|Not treated|2|||
147496448|NCT03057951|531972390|FG001|Overall Study|Not treated|1|||
147496449|NCT05136170|531972391|FG000|Overall Study|Withdrawal by Subject|2|||
147496450|NCT05136170|531972392|FG001|Overall Study|Withdrawal by Subject|2|||
147496451|NCT05136170|531972391|FG000|Overall Study|Can no longer make office visits|1|||
147496452|NCT05136170|531972392|FG001|Overall Study|Can no longer make office visits|0|||
147496453|NCT02680587|531972396|FG000|Overall Study|Withdrawal by Subject|1|||
147496454|NCT02680587|531972397|FG001|Overall Study|Withdrawal by Subject|0|||
147496455|NCT01194869|531972399|FG000|Overall Study|Disease Progression|2|||
147496456|NCT01194869|531972399|FG000|Overall Study|Toxicity|2|||
147496457|NCT01708941|531972400|FG000|Overall Study|Adverse Event|4|||
147496458|NCT01708941|531972401|FG001|Overall Study|Adverse Event|6|||
147496459|NCT01708941|531972402|FG002|Overall Study|Adverse Event|1|||
147496460|NCT01708941|531972403|FG003|Overall Study|Adverse Event|0|||
147496461|NCT01708941|531972400|FG000|Overall Study|Death|1|||
147496462|NCT01708941|531972401|FG001|Overall Study|Death|1|||
147630157|NCT00839800|532465881|FG000|Overall Study|Safety Reasons|2|||
147630158|NCT00839800|532465882|FG001|Overall Study|Safety Reasons|1|||
147630159|NCT00839800|532465881|FG000|Overall Study|Other|8|||
147630160|NCT00839800|532465882|FG001|Overall Study|Other|14|||
147630161|NCT00839800|532465881|FG000|Overall Study|Severe Non-Compliance to Protocol|7|||
147630162|NCT00839800|532465882|FG001|Overall Study|Severe Non-Compliance to Protocol|7|||
147630163|NCT04478695|532465885|FG000|Overall Study|Death|1|||
147630164|NCT04478695|532465886|FG001|Overall Study|Death|0|||
147630165|NCT02875613|532465887|FG000|Overall Study|Withdrawal by Subject|1|||
147630166|NCT02875613|532465887|FG000|Overall Study|Screen Failure|1|||
147496463|NCT01708941|531972402|FG002|Overall Study|Death|2|||
147496464|NCT01708941|531972403|FG003|Overall Study|Death|14|||
147496465|NCT01708941|531972400|FG000|Overall Study|Withdrawal by Subject|1|||
147496466|NCT01708941|531972401|FG001|Overall Study|Withdrawal by Subject|0|||
147496467|NCT01708941|531972402|FG002|Overall Study|Withdrawal by Subject|3|||
147496468|NCT01708941|531972403|FG003|Overall Study|Withdrawal by Subject|4|||
147496469|NCT01708941|531972400|FG000|Overall Study|Disease progression|9|||
147496470|NCT01708941|531972401|FG001|Overall Study|Disease progression|10|||
147496471|NCT01708941|531972402|FG002|Overall Study|Disease progression|8|||
147496472|NCT01708941|531972403|FG003|Overall Study|Disease progression|0|||
147630167|NCT01136356|532465888|FG000|First 18-day Withdrawal|Withdrawal by Subject|3|||
147630168|NCT01136356|532465889|FG001|First 18-day Withdrawal|Withdrawal by Subject|0|||
147630169|NCT01136356|532465888|FG000|First 18-day Withdrawal|Physician Decision|1|||
147668486|NCT00855218|532611802|FG000|Overall Study|Lost to Follow-up|0|||
147496473|NCT01708941|531972400|FG000|Overall Study|Alternative therapy|0|||
147630170|NCT01136356|532465889|FG001|First 18-day Withdrawal|Physician Decision|0|||
147630171|NCT01136356|532465888|FG000|Second 18-day Withdrawal|Withdrawal by Subject|0|||
147630172|NCT01136356|532465889|FG001|Second 18-day Withdrawal|Withdrawal by Subject|1|||
147630173|NCT02347774|532465890|FG000|Study Participation|Lost to Follow-up|3|||
147630174|NCT02347774|532465891|FG001|Study Participation|Lost to Follow-up|6|||
147630175|NCT02347774|532465892|FG002|Study Participation|Lost to Follow-up|2|||
147630176|NCT02347774|532465890|FG000|Study Participation|Withdrawal by Subject|8|||
147630177|NCT02347774|532465891|FG001|Study Participation|Withdrawal by Subject|9|||
147630178|NCT02347774|532465892|FG002|Study Participation|Withdrawal by Subject|15|||
147630179|NCT02347774|532465890|FG000|Study Participation|Adverse Event|1|||
147630180|NCT02347774|532465891|FG001|Study Participation|Adverse Event|4|||
147630181|NCT02347774|532465892|FG002|Study Participation|Adverse Event|6|||
147630182|NCT02347774|532465890|FG000|Study Participation|withdrew consent|1|||
147630183|NCT02347774|532465891|FG001|Study Participation|withdrew consent|1|||
147630184|NCT02347774|532465892|FG002|Study Participation|withdrew consent|1|||
147630185|NCT02347774|532465890|FG000|Study Participation|Met Prolonged QT criteria|1|||
147630186|NCT02347774|532465891|FG001|Study Participation|Met Prolonged QT criteria|0|||
147630187|NCT02347774|532465892|FG002|Study Participation|Met Prolonged QT criteria|0|||
147630188|NCT02347774|532465890|FG000|Study Participation|non-compliance with study drug|0|||
147630189|NCT02347774|532465891|FG001|Study Participation|non-compliance with study drug|1|||
147630190|NCT02347774|532465892|FG002|Study Participation|non-compliance with study drug|0|||
147630191|NCT02347774|532465890|FG000|Study Participation|incarceration|1|||
147630192|NCT02347774|532465891|FG001|Study Participation|incarceration|0|||
147630193|NCT02347774|532465892|FG002|Study Participation|incarceration|0|||
147630194|NCT02347774|532465890|FG000|Study Participation|randomized in error|0|||
147630195|NCT02347774|532465891|FG001|Study Participation|randomized in error|0|||
147630196|NCT02347774|532465892|FG002|Study Participation|randomized in error|1|||
147630197|NCT02347774|532465890|FG000|On Study Treatment|Adverse Event|9|||
147630198|NCT02347774|532465891|FG001|On Study Treatment|Adverse Event|15|||
147630199|NCT02347774|532465892|FG002|On Study Treatment|Adverse Event|19|||
147630200|NCT02347774|532465890|FG000|On Study Treatment|Lack of Efficacy|3|||
147630201|NCT02347774|532465891|FG001|On Study Treatment|Lack of Efficacy|0|||
147630202|NCT02347774|532465892|FG002|On Study Treatment|Lack of Efficacy|2|||
147630203|NCT02347774|532465890|FG000|On Study Treatment|non-complicance with study medication|0|||
147630204|NCT02347774|532465891|FG001|On Study Treatment|non-complicance with study medication|2|||
147630205|NCT02347774|532465892|FG002|On Study Treatment|non-complicance with study medication|0|||
147630206|NCT02347774|532465890|FG000|On Study Treatment|Protocol Violation|0|||
147630207|NCT02347774|532465891|FG001|On Study Treatment|Protocol Violation|0|||
147630208|NCT02347774|532465892|FG002|On Study Treatment|Protocol Violation|1|||
147630209|NCT02347774|532465890|FG000|On Study Treatment|withdrew consent|9|||
147630210|NCT02347774|532465891|FG001|On Study Treatment|withdrew consent|8|||
147630211|NCT02347774|532465892|FG002|On Study Treatment|withdrew consent|12|||
147630212|NCT02347774|532465890|FG000|On Study Treatment|Lost to Follow-up|2|||
147630213|NCT02347774|532465891|FG001|On Study Treatment|Lost to Follow-up|6|||
147630214|NCT02347774|532465892|FG002|On Study Treatment|Lost to Follow-up|1|||
147630215|NCT02347774|532465890|FG000|On Study Treatment|Met Prolonged QT criteria|1|||
147630216|NCT02347774|532465891|FG001|On Study Treatment|Met Prolonged QT criteria|0|||
147630217|NCT02347774|532465892|FG002|On Study Treatment|Met Prolonged QT criteria|0|||
147630218|NCT02347774|532465890|FG000|On Study Treatment|ranomized in error|0|||
147630219|NCT02347774|532465891|FG001|On Study Treatment|ranomized in error|0|||
147630220|NCT02347774|532465892|FG002|On Study Treatment|ranomized in error|1|||
147630221|NCT00927862|532465893|FG000|Overall Study|Missing data needed for endpt analyses|27|||
147630222|NCT00927862|532465894|FG001|Overall Study|Missing data needed for endpt analyses|45|||
147630223|NCT00820248|532465896|FG000|Overall Study|No treated|4|||
147630224|NCT00820248|532465897|FG001|Overall Study|No treated|1|||
147630225|NCT01562782|532465903|FG000|Overall Study|Withdrawal by Subject|3|||
147630226|NCT01562782|532465904|FG001|Overall Study|Withdrawal by Subject|3|||
147630227|NCT01562782|532465903|FG000|Overall Study|screen failure|1|||
147630228|NCT01562782|532465904|FG001|Overall Study|screen failure|2|||
147630229|NCT02993250|532465905|FG000|Overall Study|Lost to Follow-up|0|||
147630230|NCT02993250|532465906|FG001|Overall Study|Lost to Follow-up|1|||
147630231|NCT00356148|532465910|FG000|Overall Study|Reoperation within 30 days|2|||
147630232|NCT00356148|532465911|FG001|Overall Study|Reoperation within 30 days|1|||
147630233|NCT02484456|532465912|FG000|Washout Period|Withdrawal by Subject|0|||
147630234|NCT02484456|532465913|FG001|Washout Period|Withdrawal by Subject|1|||
147630235|NCT02484456|532465912|FG000|Second Treatment Period: Week 1|Adverse Event|1|||
147630236|NCT02484456|532465913|FG001|Second Treatment Period: Week 1|Adverse Event|0|||
147630237|NCT02484456|532465912|FG000|Second Treatment Period: Week 1|Withdrawal by Subject|0|||
147630238|NCT02484456|532465913|FG001|Second Treatment Period: Week 1|Withdrawal by Subject|1|||
147630239|NCT02484456|532465912|FG000|Second Treatment Period: Week 2|Adverse Event|0|||
147630240|NCT02484456|532465913|FG001|Second Treatment Period: Week 2|Adverse Event|1|||
147630241|NCT01053663|532465914|FG000|Overall Study|Death|2|||
147630242|NCT01053663|532465914|FG000|Overall Study|Lost to Follow-up|1|||
147630243|NCT01053663|532465914|FG000|Overall Study|Poor IV Access|1|||
147630244|NCT01053663|532465914|FG000|Overall Study|Transferred to Another Hospital|1|||
147630245|NCT01053663|532465914|FG000|Overall Study|Negative Influenza Diagnosis|1|||
147630246|NCT02737930|532465915|FG000|Overall Study|Withdrawal by Subject|0|||
147630247|NCT02737930|532465916|FG001|Overall Study|Withdrawal by Subject|1|||
147630248|NCT00708214|532465919|FG000|Overall Study|Other Adverse Event|3|||
147630249|NCT00708214|532465920|FG001|Overall Study|Other Adverse Event|6|||
147630250|NCT00708214|532465921|FG002|Overall Study|Other Adverse Event|2|||
147630251|NCT00708214|532465919|FG000|Overall Study|Other|0|||
147630252|NCT00708214|532465920|FG001|Overall Study|Other|1|||
147630253|NCT00708214|532465921|FG002|Overall Study|Other|1|||
147630254|NCT00708214|532465919|FG000|Overall Study|Progressive Disease|4|||
147630255|NCT00708214|532465920|FG001|Overall Study|Progressive Disease|6|||
147630256|NCT00708214|532465921|FG002|Overall Study|Progressive Disease|5|||
147630257|NCT03852264|532465922|FG000|Third Research Visit|Lost to Follow-up|1|||
147630258|NCT03852264|532465923|FG001|Third Research Visit|Lost to Follow-up|0|||
147630259|NCT03124407|532465931|FG000|Overall Study|Lost to Follow-up|1|||
147630260|NCT03124407|532465932|FG001|Overall Study|Lost to Follow-up|0|||
147630261|NCT03124407|532465933|FG002|Overall Study|Lost to Follow-up|0|||
147630262|NCT03124407|532465934|FG003|Overall Study|Lost to Follow-up|0|||
147630263|NCT03124407|532465931|FG000|Overall Study|Adverse Event|0|||
147630264|NCT03124407|532465932|FG001|Overall Study|Adverse Event|0|||
147630265|NCT03124407|532465933|FG002|Overall Study|Adverse Event|1|||
147496474|NCT01708941|531972401|FG001|Overall Study|Alternative therapy|0|||
147496475|NCT01708941|531972402|FG002|Overall Study|Alternative therapy|2|||
147496476|NCT01708941|531972403|FG003|Overall Study|Alternative therapy|0|||
147496477|NCT01708941|531972400|FG000|Overall Study|Ineligible and never started treatment|1|||
147496478|NCT01708941|531972401|FG001|Overall Study|Ineligible and never started treatment|0|||
147496479|NCT01708941|531972402|FG002|Overall Study|Ineligible and never started treatment|1|||
147496480|NCT01708941|531972403|FG003|Overall Study|Ineligible and never started treatment|0|||
147496481|NCT01708941|531972400|FG000|Overall Study|Never started treatment|2|||
147496482|NCT01708941|531972401|FG001|Overall Study|Never started treatment|1|||
147496483|NCT01708941|531972402|FG002|Overall Study|Never started treatment|0|||
147496484|NCT01708941|531972403|FG003|Overall Study|Never started treatment|0|||
147496485|NCT01708941|531972400|FG000|Overall Study|Ineligible|0|||
147496486|NCT01708941|531972401|FG001|Overall Study|Ineligible|0|||
147496487|NCT01708941|531972402|FG002|Overall Study|Ineligible|2|||
147496488|NCT01708941|531972403|FG003|Overall Study|Ineligible|0|||
147496489|NCT02226146|531972404|FG000|Overall Study|Received rescue therapy|1|||
147496490|NCT02226146|531972404|FG000|Overall Study|Withdrawal by Subject|2|||
147496491|NCT05464836|531972405|FG000|Overall Study|Progression of Disease|1|||
147496492|NCT05464836|531972405|FG000|Overall Study|Physician Decision|1|||
147496493|NCT01522976|531972406|FG000|Overall Study|Ineligible|4|||
147496494|NCT01522976|531972407|FG001|Overall Study|Ineligible|0|||
147496495|NCT01522976|531972408|FG002|Overall Study|Ineligible|1|||
147496496|NCT01522976|531972406|FG000|Overall Study|Death|7|||
147496497|NCT01522976|531972407|FG001|Overall Study|Death|6|||
147496498|NCT01522976|531972408|FG002|Overall Study|Death|2|||
147496499|NCT01522976|531972406|FG000|Overall Study|Still on treatment|9|||
147496500|NCT01522976|531972407|FG001|Overall Study|Still on treatment|9|||
147496501|NCT01522976|531972408|FG002|Overall Study|Still on treatment|6|||
147496502|NCT01522976|531972406|FG000|Overall Study|Disease progression|28|||
147496503|NCT01522976|531972407|FG001|Overall Study|Disease progression|30|||
147496504|NCT01522976|531972408|FG002|Overall Study|Disease progression|25|||
147496505|NCT01522976|531972406|FG000|Overall Study|Adverse Event|17|||
147496506|NCT01522976|531972407|FG001|Overall Study|Adverse Event|7|||
147496507|NCT01522976|531972408|FG002|Overall Study|Adverse Event|18|||
147496508|NCT01522976|531972406|FG000|Overall Study|Refusal unrelated to adverse event|10|||
147496509|NCT01522976|531972407|FG001|Overall Study|Refusal unrelated to adverse event|13|||
147496510|NCT01522976|531972408|FG002|Overall Study|Refusal unrelated to adverse event|14|||
147496511|NCT01522976|531972406|FG000|Overall Study|Not protocol specified|22|||
147630266|NCT03124407|532465934|FG003|Overall Study|Adverse Event|0|||
147496512|NCT01522976|531972407|FG001|Overall Study|Not protocol specified|27|||
147496513|NCT01522976|531972408|FG002|Overall Study|Not protocol specified|27|||
147496514|NCT02883049|531972409|FG000|Induction|Adverse Event|52|||
147496515|NCT02883049|531972410|FG001|Induction|Adverse Event|2|||
147496516|NCT02883049|531972411|FG002|Induction|Adverse Event|0|||
147496517|NCT02883049|531972412|FG003|Induction|Adverse Event|0|||
147496518|NCT02883049|531972413|FG004|Induction|Adverse Event|0|||
147496519|NCT02883049|531972414|FG005|Induction|Adverse Event|0|||
147496520|NCT02883049|531972415|FG006|Induction|Adverse Event|0|||
147630267|NCT05708976|532465939|FG000|Overall Study|Withdrawal by Subject|0|||
147630268|NCT05708976|532465940|FG001|Overall Study|Withdrawal by Subject|1|||
147630269|NCT00183885|532465943|FG000|Overall Study|Adverse Event|11|||
147496521|NCT02883049|531972416|FG007|Induction|Adverse Event|0|||
147496522|NCT02883049|531972417|FG008|Induction|Adverse Event|0|||
147496523|NCT02883049|531972418|FG009|Induction|Adverse Event|0|||
147496524|NCT02883049|531972419|FG010|Induction|Adverse Event|0|||
147630270|NCT00183885|532465943|FG000|Overall Study|Death|1|||
147630271|NCT00183885|532465943|FG000|Overall Study|Lost to Follow-up|3|||
147630272|NCT00183885|532465943|FG000|Overall Study|Physician Decision|6|||
147630273|NCT00183885|532465943|FG000|Overall Study|Withdrawal by Subject|5|||
147630274|NCT00183885|532465943|FG000|Overall Study|Switched to alternative treatment|8|||
147630275|NCT00183885|532465943|FG000|Overall Study|Treatment delayed too long|4|||
147630276|NCT00183885|532465943|FG000|Overall Study|Developed second malignancy|1|||
147630277|NCT00396656|532465946|FG000|First Treatment Period|Withdrawal by Subject|0|||
147630278|NCT00396656|532465947|FG001|First Treatment Period|Withdrawal by Subject|2|||
147630279|NCT00396656|532465946|FG000|Second Treatment Period|Adverse Event|0|||
147630280|NCT00396656|532465947|FG001|Second Treatment Period|Adverse Event|1|||
147630281|NCT01303172|532465952|FG000|Overall Study|Physician Decision|9|||
147630282|NCT01303172|532465953|FG001|Overall Study|Physician Decision|6|||
147630283|NCT01303172|532465952|FG000|Overall Study|Adverse Event|5|||
147630284|NCT01303172|532465953|FG001|Overall Study|Adverse Event|2|||
147630285|NCT01303172|532465952|FG000|Overall Study|Withdrawal by Subject|4|||
147630286|NCT01303172|532465953|FG001|Overall Study|Withdrawal by Subject|2|||
147630287|NCT01303172|532465952|FG000|Overall Study|Death|20|||
147630288|NCT01303172|532465953|FG001|Overall Study|Death|7|||
147630289|NCT01303172|532465952|FG000|Overall Study|Lack of Efficacy|25|||
147630290|NCT01303172|532465953|FG001|Overall Study|Lack of Efficacy|17|||
147630291|NCT02821754|532465954|FG000|Overall Study|Procedure not required prior to amendment change|13|||
147630292|NCT02821754|532465955|FG001|Overall Study|Procedure not required prior to amendment change|11|||
147630293|NCT02821754|532465956|FG002|Overall Study|Procedure not required prior to amendment change|0|||
147630294|NCT02821754|532465954|FG000|Overall Study|Participant's Clinical status|2|||
147630295|NCT02821754|532465955|FG001|Overall Study|Participant's Clinical status|0|||
147630296|NCT02821754|532465956|FG002|Overall Study|Participant's Clinical status|0|||
147630297|NCT02821754|532465954|FG000|Overall Study|Participant removed for noncompliance|1|||
147630298|NCT02821754|532465955|FG001|Overall Study|Participant removed for noncompliance|0|||
147630299|NCT02821754|532465956|FG002|Overall Study|Participant removed for noncompliance|0|||
147630300|NCT02821754|532465954|FG000|Overall Study|Drug not available.|0|||
147630301|NCT02821754|532465955|FG001|Overall Study|Drug not available.|0|||
147630302|NCT02821754|532465956|FG002|Overall Study|Drug not available.|1|||
147630303|NCT02821754|532465954|FG000|Overall Study|Participant declined to participate (before treatment started.)|0|||
147630304|NCT02821754|532465955|FG001|Overall Study|Participant declined to participate (before treatment started.)|1|||
147630305|NCT02821754|532465956|FG002|Overall Study|Participant declined to participate (before treatment started.)|1|||
147630306|NCT00554515|532465960|FG000|Overall Study|Withdrawal by Subject|3|||
147630307|NCT00554515|532465960|FG000|Overall Study|Disease progression|52|||
147630308|NCT00554515|532465960|FG000|Overall Study|Physician Decision|18|||
147630309|NCT00554515|532465960|FG000|Overall Study|Withdrawal by Subject|11|||
147630310|NCT00554515|532465960|FG000|Overall Study|Adverse Event|9|||
147630311|NCT00554515|532465960|FG000|Overall Study|Death|2|||
147630312|NCT00554515|532465960|FG000|Overall Study|Achieved Stable Disease|7|||
147630313|NCT00554515|532465960|FG000|Overall Study|Other|1|||
147630314|NCT00554515|532465960|FG000|Overall Study|Misc|15|||
147630315|NCT00766636|532465961|FG000|Overall Study|Withdrawal by Subject|1|||
147630316|NCT00766636|532465962|FG001|Overall Study|Withdrawal by Subject|1|||
147630317|NCT00766636|532465961|FG000|Overall Study|Incomplete Treatment|0|||
147630318|NCT00766636|532465962|FG001|Overall Study|Incomplete Treatment|1|||
147630319|NCT00766636|532465961|FG000|Overall Study|Adverse Event|1|||
147630320|NCT00766636|532465962|FG001|Overall Study|Adverse Event|0|||
147630321|NCT00766636|532465961|FG000|Overall Study|Disease Progression|1|||
147630322|NCT00766636|532465962|FG001|Overall Study|Disease Progression|0|||
147630323|NCT02837731|532465970|FG000|Allocation|Admitted to General Floor|3|||
147630324|NCT02837731|532465971|FG001|Allocation|Admitted to General Floor|4|||
147630325|NCT02837731|532465970|FG000|Allocation|Immediate surgery/withdrew|2|||
147668487|NCT00855218|532611803|FG001|Overall Study|Lost to Follow-up|1|||
147630326|NCT02837731|532465971|FG001|Allocation|Immediate surgery/withdrew|0|||
147630327|NCT02837731|532465970|FG000|Allocation|Diabetic Ketoacidosis/withdrew|1|||
147630328|NCT02837731|532465971|FG001|Allocation|Diabetic Ketoacidosis/withdrew|0|||
147630329|NCT02837731|532465970|FG000|Allocation|Withdrawal by Subject|2|||
147630330|NCT02837731|532465971|FG001|Allocation|Withdrawal by Subject|0|||
147668488|NCT00855218|532611802|FG000|Overall Study|Protocol Violation|5|||
147668489|NCT00855218|532611803|FG001|Overall Study|Protocol Violation|9|||
147630331|NCT02837731|532465970|FG000|Allocation|Device not available|1|||
147630332|NCT02837731|532465971|FG001|Allocation|Device not available|0|||
147630333|NCT02837731|532465970|FG000|Allocation|Protocol not implemented|7|||
147668490|NCT00855218|532611802|FG000|Overall Study|non-compliant with study drug|3|||
147630334|NCT02837731|532465971|FG001|Allocation|Protocol not implemented|0|||
147630335|NCT02837731|532465970|FG000|Allocation|Moribund/Do not resuscitate|2|||
147630336|NCT02837731|532465971|FG001|Allocation|Moribund/Do not resuscitate|0|||
147630337|NCT02837731|532465970|FG000|Allocation|Did not meet sepsis criteria|1|||
147630338|NCT02837731|532465971|FG001|Allocation|Did not meet sepsis criteria|2|||
147630339|NCT02837731|532465970|FG000|Allocation|Known aortic abnormalities|0|||
147630340|NCT02837731|532465971|FG001|Allocation|Known aortic abnormalities|1|||
147630341|NCT01119859|532465972|FG000|Overall Study|Adverse Event|9|||
147668491|NCT00855218|532611803|FG001|Overall Study|non-compliant with study drug|1|||
147668492|NCT00855218|532611802|FG000|Overall Study|patient convenience|2|||
147630342|NCT01119859|532465973|FG001|Overall Study|Adverse Event|10|||
147630343|NCT01119859|532465972|FG000|Overall Study|Death|2|||
147630344|NCT01119859|532465973|FG001|Overall Study|Death|0|||
147630345|NCT01119859|532465972|FG000|Overall Study|Insufficient therapeutic response|7|||
147630346|NCT01119859|532465973|FG001|Overall Study|Insufficient therapeutic response|14|||
147630347|NCT01119859|532465972|FG000|Overall Study|Refused treatment|3|||
147630348|NCT01119859|532465973|FG001|Overall Study|Refused treatment|6|||
147630349|NCT01119859|532465972|FG000|Overall Study|Failure to return|3|||
147630350|NCT01119859|532465973|FG001|Overall Study|Failure to return|0|||
147630351|NCT02644668|532465975|FG000|Overall Study|Adverse Event|2|||
147630352|NCT02644668|532465976|FG001|Overall Study|Adverse Event|0|||
147630353|NCT02644668|532465977|FG002|Overall Study|Adverse Event|1|||
147630354|NCT02644668|532465975|FG000|Overall Study|Protocol Violation|0|||
147630355|NCT02644668|532465976|FG001|Overall Study|Protocol Violation|0|||
147630356|NCT02644668|532465977|FG002|Overall Study|Protocol Violation|1|||
147630357|NCT02644668|532465975|FG000|Overall Study|Withdrawal by Subject|0|||
147630358|NCT02644668|532465976|FG001|Overall Study|Withdrawal by Subject|0|||
147630359|NCT02644668|532465977|FG002|Overall Study|Withdrawal by Subject|1|||
147630360|NCT03850483|532465980|FG000|Treatment for Stage 1|Adverse Event|1|||
147630361|NCT03850483|532465981|FG001|Treatment for Stage 1|Adverse Event|1|||
147630362|NCT03850483|532465982|FG002|Treatment for Stage 1|Adverse Event|3|||
147630363|NCT03850483|532465983|FG003|Treatment for Stage 1|Adverse Event|0|||
147630364|NCT03850483|532465984|FG004|Treatment for Stage 1|Adverse Event|2|||
147630365|NCT03850483|532465985|FG005|Treatment for Stage 1|Adverse Event|0|||
147630366|NCT03850483|532465986|FG006|Treatment for Stage 1|Adverse Event|2|||
147630367|NCT03850483|532465987|FG007|Treatment for Stage 1|Adverse Event|2|||
147630368|NCT03850483|532465988|FG008|Treatment for Stage 1|Adverse Event|0|||
147630369|NCT03850483|532465989|FG009|Treatment for Stage 1|Adverse Event|0|||
147630370|NCT03850483|532465980|FG000|Treatment for Stage 1|Withdrawal by Subject|4|||
147630371|NCT03850483|532465981|FG001|Treatment for Stage 1|Withdrawal by Subject|4|||
147630372|NCT03850483|532465982|FG002|Treatment for Stage 1|Withdrawal by Subject|2|||
147630373|NCT03850483|532465983|FG003|Treatment for Stage 1|Withdrawal by Subject|2|||
147630374|NCT03850483|532465984|FG004|Treatment for Stage 1|Withdrawal by Subject|2|||
147630375|NCT03850483|532465985|FG005|Treatment for Stage 1|Withdrawal by Subject|1|||
147630376|NCT03850483|532465986|FG006|Treatment for Stage 1|Withdrawal by Subject|2|||
147630377|NCT03850483|532465987|FG007|Treatment for Stage 1|Withdrawal by Subject|3|||
147630378|NCT03850483|532465988|FG008|Treatment for Stage 1|Withdrawal by Subject|0|||
147630379|NCT03850483|532465989|FG009|Treatment for Stage 1|Withdrawal by Subject|0|||
147630380|NCT03850483|532465980|FG000|Treatment for Stage 1|Protocol Violation|1|||
147630381|NCT03850483|532465981|FG001|Treatment for Stage 1|Protocol Violation|0|||
147630382|NCT03850483|532465982|FG002|Treatment for Stage 1|Protocol Violation|0|||
147630383|NCT03850483|532465983|FG003|Treatment for Stage 1|Protocol Violation|0|||
147630384|NCT03850483|532465984|FG004|Treatment for Stage 1|Protocol Violation|0|||
147630385|NCT03850483|532465985|FG005|Treatment for Stage 1|Protocol Violation|0|||
147630386|NCT03850483|532465986|FG006|Treatment for Stage 1|Protocol Violation|1|||
147630387|NCT03850483|532465987|FG007|Treatment for Stage 1|Protocol Violation|0|||
147630388|NCT03850483|532465988|FG008|Treatment for Stage 1|Protocol Violation|0|||
147630389|NCT03850483|532465989|FG009|Treatment for Stage 1|Protocol Violation|0|||
147630390|NCT03850483|532465980|FG000|Treatment for Stage 1|Physician Decision|0|||
147630391|NCT03850483|532465981|FG001|Treatment for Stage 1|Physician Decision|0|||
147630392|NCT03850483|532465982|FG002|Treatment for Stage 1|Physician Decision|0|||
147630393|NCT03850483|532465983|FG003|Treatment for Stage 1|Physician Decision|0|||
147630394|NCT03850483|532465984|FG004|Treatment for Stage 1|Physician Decision|0|||
147630395|NCT03850483|532465985|FG005|Treatment for Stage 1|Physician Decision|1|||
147630396|NCT03850483|532465986|FG006|Treatment for Stage 1|Physician Decision|0|||
147630397|NCT03850483|532465987|FG007|Treatment for Stage 1|Physician Decision|0|||
147630398|NCT03850483|532465988|FG008|Treatment for Stage 1|Physician Decision|0|||
147630399|NCT03850483|532465989|FG009|Treatment for Stage 1|Physician Decision|0|||
147630400|NCT03850483|532465980|FG000|Treatment for Stage 1|Other|0|||
147630401|NCT03850483|532465981|FG001|Treatment for Stage 1|Other|0|||
147496525|NCT02883049|531972420|FG011|Induction|Adverse Event|0|||
147496526|NCT02883049|531972421|FG012|Induction|Adverse Event|0|||
147630402|NCT03850483|532465982|FG002|Treatment for Stage 1|Other|0|||
147630403|NCT03850483|532465983|FG003|Treatment for Stage 1|Other|0|||
147496527|NCT02883049|531972422|FG013|Induction|Adverse Event|0|||
147630404|NCT03850483|532465984|FG004|Treatment for Stage 1|Other|2|||
147630405|NCT03850483|532465985|FG005|Treatment for Stage 1|Other|1|||
147630406|NCT03850483|532465986|FG006|Treatment for Stage 1|Other|0|||
147496528|NCT02883049|531972423|FG014|Induction|Adverse Event|0|||
147496529|NCT02883049|531972424|FG015|Induction|Adverse Event|0|||
147630407|NCT03850483|532465987|FG007|Treatment for Stage 1|Other|0|||
147630408|NCT03850483|532465988|FG008|Treatment for Stage 1|Other|0|||
147630409|NCT03850483|532465989|FG009|Treatment for Stage 1|Other|0|||
147630410|NCT03850483|532465980|FG000|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
147630411|NCT03850483|532465981|FG001|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
147630412|NCT03850483|532465982|FG002|Treatment for Stage 1|Non-Compliance With Study Drug|1|||
147496530|NCT02883049|531972409|FG000|Induction|Death|76|||
147496531|NCT02883049|531972410|FG001|Induction|Death|8|||
147496532|NCT02883049|531972411|FG002|Induction|Death|0|||
147496533|NCT02883049|531972412|FG003|Induction|Death|0|||
147496534|NCT02883049|531972413|FG004|Induction|Death|0|||
147496535|NCT02883049|531972414|FG005|Induction|Death|0|||
147496536|NCT02883049|531972415|FG006|Induction|Death|0|||
147496537|NCT02883049|531972416|FG007|Induction|Death|0|||
147496538|NCT02883049|531972417|FG008|Induction|Death|0|||
147496539|NCT02883049|531972418|FG009|Induction|Death|0|||
147496540|NCT02883049|531972419|FG010|Induction|Death|0|||
147496541|NCT02883049|531972420|FG011|Induction|Death|0|||
147496542|NCT02883049|531972421|FG012|Induction|Death|0|||
147496543|NCT02883049|531972422|FG013|Induction|Death|0|||
147496544|NCT02883049|531972423|FG014|Induction|Death|0|||
147496545|NCT02883049|531972424|FG015|Induction|Death|0|||
147496546|NCT02883049|531972409|FG000|Induction|Lost to Follow-up|2|||
147496547|NCT02883049|531972410|FG001|Induction|Lost to Follow-up|0|||
147496548|NCT02883049|531972411|FG002|Induction|Lost to Follow-up|0|||
147496549|NCT02883049|531972412|FG003|Induction|Lost to Follow-up|0|||
147496550|NCT02883049|531972413|FG004|Induction|Lost to Follow-up|0|||
147496551|NCT02883049|531972414|FG005|Induction|Lost to Follow-up|0|||
147496552|NCT02883049|531972415|FG006|Induction|Lost to Follow-up|0|||
147496553|NCT02883049|531972416|FG007|Induction|Lost to Follow-up|0|||
147496554|NCT02883049|531972417|FG008|Induction|Lost to Follow-up|0|||
147496555|NCT02883049|531972418|FG009|Induction|Lost to Follow-up|0|||
147496556|NCT02883049|531972419|FG010|Induction|Lost to Follow-up|0|||
147496557|NCT02883049|531972420|FG011|Induction|Lost to Follow-up|0|||
147496558|NCT02883049|531972421|FG012|Induction|Lost to Follow-up|0|||
147496559|NCT02883049|531972422|FG013|Induction|Lost to Follow-up|0|||
147496560|NCT02883049|531972423|FG014|Induction|Lost to Follow-up|0|||
147496561|NCT02883049|531972424|FG015|Induction|Lost to Follow-up|0|||
147496562|NCT02883049|531972409|FG000|Induction|Physician Decision|1407|||
147496563|NCT02883049|531972410|FG001|Induction|Physician Decision|8|||
147496564|NCT02883049|531972411|FG002|Induction|Physician Decision|0|||
147496565|NCT02883049|531972412|FG003|Induction|Physician Decision|0|||
147496566|NCT02883049|531972413|FG004|Induction|Physician Decision|0|||
147496567|NCT02883049|531972414|FG005|Induction|Physician Decision|0|||
147496568|NCT02883049|531972415|FG006|Induction|Physician Decision|0|||
147496569|NCT02883049|531972416|FG007|Induction|Physician Decision|0|||
147496570|NCT02883049|531972417|FG008|Induction|Physician Decision|0|||
147496571|NCT02883049|531972418|FG009|Induction|Physician Decision|0|||
147496572|NCT02883049|531972419|FG010|Induction|Physician Decision|0|||
147496573|NCT02883049|531972420|FG011|Induction|Physician Decision|0|||
147496574|NCT02883049|531972421|FG012|Induction|Physician Decision|0|||
147496575|NCT02883049|531972422|FG013|Induction|Physician Decision|0|||
147496576|NCT02883049|531972423|FG014|Induction|Physician Decision|0|||
147496577|NCT02883049|531972424|FG015|Induction|Physician Decision|0|||
147496578|NCT02883049|531972409|FG000|Induction|Protocol Violation|6|||
147496579|NCT02883049|531972410|FG001|Induction|Protocol Violation|0|||
147496580|NCT02883049|531972411|FG002|Induction|Protocol Violation|0|||
147496581|NCT02883049|531972412|FG003|Induction|Protocol Violation|0|||
147496582|NCT02883049|531972413|FG004|Induction|Protocol Violation|0|||
147496583|NCT02883049|531972414|FG005|Induction|Protocol Violation|0|||
147496584|NCT02883049|531972415|FG006|Induction|Protocol Violation|0|||
147496585|NCT02883049|531972416|FG007|Induction|Protocol Violation|0|||
147496586|NCT02883049|531972417|FG008|Induction|Protocol Violation|0|||
147496587|NCT02883049|531972418|FG009|Induction|Protocol Violation|0|||
147496588|NCT02883049|531972419|FG010|Induction|Protocol Violation|0|||
147496589|NCT02883049|531972420|FG011|Induction|Protocol Violation|0|||
147496590|NCT02883049|531972421|FG012|Induction|Protocol Violation|0|||
147496591|NCT02883049|531972422|FG013|Induction|Protocol Violation|0|||
147496592|NCT02883049|531972423|FG014|Induction|Protocol Violation|0|||
147496593|NCT02883049|531972424|FG015|Induction|Protocol Violation|0|||
147496594|NCT02883049|531972409|FG000|Induction|Withdrawal by Subject|6|||
147496595|NCT02883049|531972410|FG001|Induction|Withdrawal by Subject|0|||
147496596|NCT02883049|531972411|FG002|Induction|Withdrawal by Subject|0|||
147496597|NCT02883049|531972412|FG003|Induction|Withdrawal by Subject|0|||
147496598|NCT02883049|531972413|FG004|Induction|Withdrawal by Subject|0|||
147496599|NCT02883049|531972414|FG005|Induction|Withdrawal by Subject|0|||
147496600|NCT02883049|531972415|FG006|Induction|Withdrawal by Subject|0|||
147496601|NCT02883049|531972416|FG007|Induction|Withdrawal by Subject|0|||
147496602|NCT02883049|531972417|FG008|Induction|Withdrawal by Subject|0|||
147496603|NCT02883049|531972418|FG009|Induction|Withdrawal by Subject|0|||
147496604|NCT02883049|531972419|FG010|Induction|Withdrawal by Subject|0|||
147496605|NCT02883049|531972420|FG011|Induction|Withdrawal by Subject|0|||
147496606|NCT02883049|531972421|FG012|Induction|Withdrawal by Subject|0|||
147496607|NCT02883049|531972422|FG013|Induction|Withdrawal by Subject|0|||
147496608|NCT02883049|531972423|FG014|Induction|Withdrawal by Subject|0|||
147496609|NCT02883049|531972424|FG015|Induction|Withdrawal by Subject|0|||
147496610|NCT02883049|531972409|FG000|Induction|Ineligible|35|||
147496611|NCT02883049|531972410|FG001|Induction|Ineligible|1|||
147496612|NCT02883049|531972411|FG002|Induction|Ineligible|0|||
147496613|NCT02883049|531972412|FG003|Induction|Ineligible|0|||
147630413|NCT03850483|532465983|FG003|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
147630414|NCT03850483|532465984|FG004|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
147630415|NCT03850483|532465985|FG005|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
147630416|NCT03850483|532465986|FG006|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
147630417|NCT03850483|532465987|FG007|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
147630418|NCT03850483|532465988|FG008|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
147630419|NCT03850483|532465989|FG009|Treatment for Stage 1|Non-Compliance With Study Drug|0|||
147630420|NCT03850483|532465980|FG000|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
147630421|NCT03850483|532465981|FG001|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
147630422|NCT03850483|532465982|FG002|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
147630423|NCT03850483|532465983|FG003|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
147630424|NCT03850483|532465984|FG004|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
147630425|NCT03850483|532465985|FG005|Treatment for Stage 1|No Longer Met Eligibility Criteria|1|||
147630426|NCT03850483|532465986|FG006|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
147630427|NCT03850483|532465987|FG007|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
147630428|NCT03850483|532465988|FG008|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
147630429|NCT03850483|532465989|FG009|Treatment for Stage 1|No Longer Met Eligibility Criteria|0|||
147630430|NCT03850483|532465980|FG000|Treatment for Stage 1|Lost to Follow-up|0|||
147630431|NCT03850483|532465981|FG001|Treatment for Stage 1|Lost to Follow-up|1|||
147630432|NCT03850483|532465982|FG002|Treatment for Stage 1|Lost to Follow-up|1|||
147630433|NCT03850483|532465983|FG003|Treatment for Stage 1|Lost to Follow-up|1|||
147630434|NCT03850483|532465984|FG004|Treatment for Stage 1|Lost to Follow-up|0|||
147630435|NCT03850483|532465985|FG005|Treatment for Stage 1|Lost to Follow-up|1|||
147630436|NCT03850483|532465986|FG006|Treatment for Stage 1|Lost to Follow-up|2|||
147630437|NCT03850483|532465987|FG007|Treatment for Stage 1|Lost to Follow-up|0|||
147630438|NCT03850483|532465988|FG008|Treatment for Stage 1|Lost to Follow-up|0|||
147630439|NCT03850483|532465989|FG009|Treatment for Stage 1|Lost to Follow-up|0|||
147630440|NCT03850483|532465980|FG000|Treatment for Stage 1|Lack of Efficacy|1|||
147630441|NCT03850483|532465981|FG001|Treatment for Stage 1|Lack of Efficacy|2|||
147630442|NCT03850483|532465982|FG002|Treatment for Stage 1|Lack of Efficacy|2|||
147630443|NCT03850483|532465983|FG003|Treatment for Stage 1|Lack of Efficacy|3|||
147630444|NCT03850483|532465984|FG004|Treatment for Stage 1|Lack of Efficacy|2|||
147630445|NCT03850483|532465985|FG005|Treatment for Stage 1|Lack of Efficacy|4|||
147630446|NCT03850483|532465986|FG006|Treatment for Stage 1|Lack of Efficacy|3|||
147630447|NCT03850483|532465987|FG007|Treatment for Stage 1|Lack of Efficacy|1|||
147630448|NCT03850483|532465988|FG008|Treatment for Stage 1|Lack of Efficacy|0|||
147630449|NCT03850483|532465989|FG009|Treatment for Stage 1|Lack of Efficacy|0|||
147630450|NCT03850483|532465980|FG000|Treatment for Stage 1|Death|0|||
147630451|NCT03850483|532465981|FG001|Treatment for Stage 1|Death|0|||
147630452|NCT03850483|532465982|FG002|Treatment for Stage 1|Death|0|||
147630453|NCT03850483|532465983|FG003|Treatment for Stage 1|Death|0|||
147630454|NCT03850483|532465984|FG004|Treatment for Stage 1|Death|0|||
147630455|NCT03850483|532465985|FG005|Treatment for Stage 1|Death|1|||
147630456|NCT03850483|532465986|FG006|Treatment for Stage 1|Death|0|||
147630457|NCT03850483|532465987|FG007|Treatment for Stage 1|Death|0|||
147630458|NCT03850483|532465988|FG008|Treatment for Stage 1|Death|0|||
147630459|NCT03850483|532465989|FG009|Treatment for Stage 1|Death|0|||
147630460|NCT03850483|532465980|FG000|Treatment for Stage 1|Refused Further Treatment|1|||
147630461|NCT03850483|532465981|FG001|Treatment for Stage 1|Refused Further Treatment|0|||
147630462|NCT03850483|532465982|FG002|Treatment for Stage 1|Refused Further Treatment|2|||
147630463|NCT03850483|532465983|FG003|Treatment for Stage 1|Refused Further Treatment|0|||
147630464|NCT03850483|532465984|FG004|Treatment for Stage 1|Refused Further Treatment|1|||
147630465|NCT03850483|532465985|FG005|Treatment for Stage 1|Refused Further Treatment|0|||
147630466|NCT03850483|532465986|FG006|Treatment for Stage 1|Refused Further Treatment|1|||
147630467|NCT03850483|532465987|FG007|Treatment for Stage 1|Refused Further Treatment|0|||
147630468|NCT03850483|532465988|FG008|Treatment for Stage 1|Refused Further Treatment|0|||
147630469|NCT03850483|532465989|FG009|Treatment for Stage 1|Refused Further Treatment|0|||
147630470|NCT03850483|532465980|FG000|Treatment for Stage 1|Randomized but not Treated|0|||
147630471|NCT03850483|532465981|FG001|Treatment for Stage 1|Randomized but not Treated|0|||
147630472|NCT03850483|532465982|FG002|Treatment for Stage 1|Randomized but not Treated|0|||
147630473|NCT03850483|532465983|FG003|Treatment for Stage 1|Randomized but not Treated|0|||
147630474|NCT03850483|532465984|FG004|Treatment for Stage 1|Randomized but not Treated|0|||
147630475|NCT03850483|532465985|FG005|Treatment for Stage 1|Randomized but not Treated|1|||
147630476|NCT03850483|532465986|FG006|Treatment for Stage 1|Randomized but not Treated|0|||
147630477|NCT03850483|532465987|FG007|Treatment for Stage 1|Randomized but not Treated|0|||
147630478|NCT03850483|532465988|FG008|Treatment for Stage 1|Randomized but not Treated|0|||
147630479|NCT03850483|532465989|FG009|Treatment for Stage 1|Randomized but not Treated|0|||
147630480|NCT03850483|532465980|FG000|Follow-up for Stage 1|Withdrawal by Subject|0|||
147630481|NCT03850483|532465981|FG001|Follow-up for Stage 1|Withdrawal by Subject|0|||
147630482|NCT03850483|532465982|FG002|Follow-up for Stage 1|Withdrawal by Subject|0|||
147630483|NCT03850483|532465983|FG003|Follow-up for Stage 1|Withdrawal by Subject|0|||
147630484|NCT03850483|532465984|FG004|Follow-up for Stage 1|Withdrawal by Subject|0|||
147496614|NCT02883049|531972413|FG004|Induction|Ineligible|0|||
147496615|NCT02883049|531972414|FG005|Induction|Ineligible|0|||
147496616|NCT02883049|531972415|FG006|Induction|Ineligible|0|||
147496617|NCT02883049|531972416|FG007|Induction|Ineligible|0|||
147496618|NCT02883049|531972417|FG008|Induction|Ineligible|0|||
147496619|NCT02883049|531972418|FG009|Induction|Ineligible|0|||
147496620|NCT02883049|531972419|FG010|Induction|Ineligible|0|||
147496621|NCT02883049|531972420|FG011|Induction|Ineligible|0|||
147496622|NCT02883049|531972421|FG012|Induction|Ineligible|0|||
147496623|NCT02883049|531972422|FG013|Induction|Ineligible|0|||
147496624|NCT02883049|531972423|FG014|Induction|Ineligible|0|||
147496625|NCT02883049|531972424|FG015|Induction|Ineligible|0|||
147496626|NCT02883049|531972409|FG000|Induction|Refusal of further protocol therapy|466|||
147496627|NCT02883049|531972410|FG001|Induction|Refusal of further protocol therapy|2|||
147496628|NCT02883049|531972411|FG002|Induction|Refusal of further protocol therapy|0|||
147496629|NCT02883049|531972412|FG003|Induction|Refusal of further protocol therapy|0|||
147496630|NCT02883049|531972413|FG004|Induction|Refusal of further protocol therapy|0|||
147496631|NCT02883049|531972414|FG005|Induction|Refusal of further protocol therapy|0|||
147496632|NCT02883049|531972415|FG006|Induction|Refusal of further protocol therapy|0|||
147496633|NCT02883049|531972416|FG007|Induction|Refusal of further protocol therapy|0|||
147496634|NCT02883049|531972417|FG008|Induction|Refusal of further protocol therapy|0|||
147496635|NCT02883049|531972418|FG009|Induction|Refusal of further protocol therapy|0|||
147496636|NCT02883049|531972419|FG010|Induction|Refusal of further protocol therapy|0|||
147496637|NCT02883049|531972420|FG011|Induction|Refusal of further protocol therapy|0|||
147496638|NCT02883049|531972421|FG012|Induction|Refusal of further protocol therapy|0|||
147496639|NCT02883049|531972422|FG013|Induction|Refusal of further protocol therapy|0|||
147496640|NCT02883049|531972423|FG014|Induction|Refusal of further protocol therapy|0|||
147496641|NCT02883049|531972424|FG015|Induction|Refusal of further protocol therapy|0|||
147496642|NCT02883049|531972409|FG000|Induction|Identified as Ph+ patients|279|||
147496643|NCT02883049|531972410|FG001|Induction|Identified as Ph+ patients|1|||
147496644|NCT02883049|531972411|FG002|Induction|Identified as Ph+ patients|0|||
147496645|NCT02883049|531972412|FG003|Induction|Identified as Ph+ patients|0|||
147496646|NCT02883049|531972413|FG004|Induction|Identified as Ph+ patients|0|||
147496647|NCT02883049|531972414|FG005|Induction|Identified as Ph+ patients|0|||
147496648|NCT02883049|531972415|FG006|Induction|Identified as Ph+ patients|0|||
147496649|NCT02883049|531972416|FG007|Induction|Identified as Ph+ patients|0|||
147496650|NCT02883049|531972417|FG008|Induction|Identified as Ph+ patients|0|||
147496651|NCT02883049|531972418|FG009|Induction|Identified as Ph+ patients|0|||
147496652|NCT02883049|531972419|FG010|Induction|Identified as Ph+ patients|0|||
147496653|NCT02883049|531972420|FG011|Induction|Identified as Ph+ patients|0|||
147496654|NCT02883049|531972421|FG012|Induction|Identified as Ph+ patients|0|||
147496655|NCT02883049|531972422|FG013|Induction|Identified as Ph+ patients|0|||
147496656|NCT02883049|531972423|FG014|Induction|Identified as Ph+ patients|0|||
147496657|NCT02883049|531972424|FG015|Induction|Identified as Ph+ patients|0|||
147496658|NCT02883049|531972409|FG000|Induction|M3 Marrow at Day29|8|||
147496659|NCT02883049|531972410|FG001|Induction|M3 Marrow at Day29|1|||
147496660|NCT02883049|531972411|FG002|Induction|M3 Marrow at Day29|0|||
147496661|NCT02883049|531972412|FG003|Induction|M3 Marrow at Day29|0|||
147496662|NCT02883049|531972413|FG004|Induction|M3 Marrow at Day29|0|||
147496663|NCT02883049|531972414|FG005|Induction|M3 Marrow at Day29|0|||
147496664|NCT02883049|531972415|FG006|Induction|M3 Marrow at Day29|0|||
147496665|NCT02883049|531972416|FG007|Induction|M3 Marrow at Day29|0|||
147496666|NCT02883049|531972417|FG008|Induction|M3 Marrow at Day29|0|||
147496667|NCT02883049|531972418|FG009|Induction|M3 Marrow at Day29|0|||
147496668|NCT02883049|531972419|FG010|Induction|M3 Marrow at Day29|0|||
147496669|NCT02883049|531972420|FG011|Induction|M3 Marrow at Day29|0|||
147496670|NCT02883049|531972421|FG012|Induction|M3 Marrow at Day29|0|||
147496671|NCT02883049|531972422|FG013|Induction|M3 Marrow at Day29|0|||
147496672|NCT02883049|531972423|FG014|Induction|M3 Marrow at Day29|0|||
147496673|NCT02883049|531972424|FG015|Induction|M3 Marrow at Day29|0|||
147496674|NCT02883049|531972409|FG000|Induction|Inevaluable|33|||
147630485|NCT03850483|532465985|FG005|Follow-up for Stage 1|Withdrawal by Subject|0|||
147630486|NCT03850483|532465986|FG006|Follow-up for Stage 1|Withdrawal by Subject|1|||
147630487|NCT03850483|532465987|FG007|Follow-up for Stage 1|Withdrawal by Subject|2|||
147496675|NCT02883049|531972410|FG001|Induction|Inevaluable|1|||
147496676|NCT02883049|531972411|FG002|Induction|Inevaluable|0|||
147630488|NCT03850483|532465988|FG008|Follow-up for Stage 1|Withdrawal by Subject|0|||
147630489|NCT03850483|532465989|FG009|Follow-up for Stage 1|Withdrawal by Subject|0|||
147668493|NCT00855218|532611803|FG001|Overall Study|patient convenience|0|||
147496677|NCT02883049|531972412|FG003|Induction|Inevaluable|0|||
147496678|NCT02883049|531972413|FG004|Induction|Inevaluable|0|||
147496679|NCT02883049|531972414|FG005|Induction|Inevaluable|0|||
147496680|NCT02883049|531972415|FG006|Induction|Inevaluable|0|||
147496681|NCT02883049|531972416|FG007|Induction|Inevaluable|0|||
147496682|NCT02883049|531972417|FG008|Induction|Inevaluable|0|||
147496683|NCT02883049|531972418|FG009|Induction|Inevaluable|0|||
147496684|NCT02883049|531972419|FG010|Induction|Inevaluable|0|||
147496685|NCT02883049|531972420|FG011|Induction|Inevaluable|0|||
147496686|NCT02883049|531972421|FG012|Induction|Inevaluable|0|||
147496687|NCT02883049|531972422|FG013|Induction|Inevaluable|0|||
147496688|NCT02883049|531972423|FG014|Induction|Inevaluable|0|||
147496689|NCT02883049|531972424|FG015|Induction|Inevaluable|0|||
147496690|NCT02883049|531972409|FG000|Induction|Identified as VHR at end of Induction|244|||
147496691|NCT02883049|531972410|FG001|Induction|Identified as VHR at end of Induction|0|||
147496692|NCT02883049|531972411|FG002|Induction|Identified as VHR at end of Induction|0|||
147496693|NCT02883049|531972412|FG003|Induction|Identified as VHR at end of Induction|0|||
147496694|NCT02883049|531972413|FG004|Induction|Identified as VHR at end of Induction|0|||
147496695|NCT02883049|531972414|FG005|Induction|Identified as VHR at end of Induction|0|||
147496696|NCT02883049|531972415|FG006|Induction|Identified as VHR at end of Induction|0|||
147496697|NCT02883049|531972416|FG007|Induction|Identified as VHR at end of Induction|0|||
147496698|NCT02883049|531972417|FG008|Induction|Identified as VHR at end of Induction|0|||
147496699|NCT02883049|531972418|FG009|Induction|Identified as VHR at end of Induction|0|||
147496700|NCT02883049|531972419|FG010|Induction|Identified as VHR at end of Induction|0|||
147496701|NCT02883049|531972420|FG011|Induction|Identified as VHR at end of Induction|0|||
147496702|NCT02883049|531972421|FG012|Induction|Identified as VHR at end of Induction|0|||
147496703|NCT02883049|531972422|FG013|Induction|Identified as VHR at end of Induction|0|||
147496704|NCT02883049|531972423|FG014|Induction|Identified as VHR at end of Induction|0|||
147496705|NCT02883049|531972424|FG015|Induction|Identified as VHR at end of Induction|0|||
147496706|NCT02883049|531972409|FG000|Induction|Moved to another non-COG institution|3|||
147496707|NCT02883049|531972410|FG001|Induction|Moved to another non-COG institution|0|||
147496708|NCT02883049|531972411|FG002|Induction|Moved to another non-COG institution|0|||
147496709|NCT02883049|531972412|FG003|Induction|Moved to another non-COG institution|0|||
147496710|NCT02883049|531972413|FG004|Induction|Moved to another non-COG institution|0|||
147496711|NCT02883049|531972414|FG005|Induction|Moved to another non-COG institution|0|||
147496712|NCT02883049|531972415|FG006|Induction|Moved to another non-COG institution|0|||
147496713|NCT02883049|531972416|FG007|Induction|Moved to another non-COG institution|0|||
147496714|NCT02883049|531972417|FG008|Induction|Moved to another non-COG institution|0|||
147496715|NCT02883049|531972418|FG009|Induction|Moved to another non-COG institution|0|||
147496716|NCT02883049|531972419|FG010|Induction|Moved to another non-COG institution|0|||
147496717|NCT02883049|531972420|FG011|Induction|Moved to another non-COG institution|0|||
147496718|NCT02883049|531972421|FG012|Induction|Moved to another non-COG institution|0|||
147496719|NCT02883049|531972422|FG013|Induction|Moved to another non-COG institution|0|||
147496720|NCT02883049|531972423|FG014|Induction|Moved to another non-COG institution|0|||
147496721|NCT02883049|531972424|FG015|Induction|Moved to another non-COG institution|0|||
147496722|NCT02883049|531972409|FG000|Induction|Randomization closed|41|||
147496723|NCT02883049|531972410|FG001|Induction|Randomization closed|0|||
147496724|NCT02883049|531972411|FG002|Induction|Randomization closed|0|||
147496725|NCT02883049|531972412|FG003|Induction|Randomization closed|0|||
147496726|NCT02883049|531972413|FG004|Induction|Randomization closed|0|||
147496727|NCT02883049|531972414|FG005|Induction|Randomization closed|0|||
147496728|NCT02883049|531972415|FG006|Induction|Randomization closed|0|||
147496729|NCT02883049|531972416|FG007|Induction|Randomization closed|0|||
147496730|NCT02883049|531972417|FG008|Induction|Randomization closed|0|||
147496731|NCT02883049|531972418|FG009|Induction|Randomization closed|0|||
147496732|NCT02883049|531972419|FG010|Induction|Randomization closed|0|||
147496733|NCT02883049|531972420|FG011|Induction|Randomization closed|0|||
147496734|NCT02883049|531972421|FG012|Induction|Randomization closed|0|||
147496735|NCT02883049|531972422|FG013|Induction|Randomization closed|0|||
147496736|NCT02883049|531972423|FG014|Induction|Randomization closed|0|||
147496737|NCT02883049|531972424|FG015|Induction|Randomization closed|0|||
147496738|NCT02883049|531972409|FG000|Induction|MRD negative|36|||
147496739|NCT02883049|531972410|FG001|Induction|MRD negative|0|||
147496740|NCT02883049|531972411|FG002|Induction|MRD negative|0|||
147496741|NCT02883049|531972412|FG003|Induction|MRD negative|0|||
147496742|NCT02883049|531972413|FG004|Induction|MRD negative|0|||
147496743|NCT02883049|531972414|FG005|Induction|MRD negative|0|||
147496744|NCT02883049|531972415|FG006|Induction|MRD negative|0|||
147496745|NCT02883049|531972416|FG007|Induction|MRD negative|0|||
147496746|NCT02883049|531972417|FG008|Induction|MRD negative|0|||
147496747|NCT02883049|531972418|FG009|Induction|MRD negative|0|||
147496748|NCT02883049|531972419|FG010|Induction|MRD negative|0|||
147496749|NCT02883049|531972420|FG011|Induction|MRD negative|0|||
147496750|NCT02883049|531972421|FG012|Induction|MRD negative|0|||
147496751|NCT02883049|531972422|FG013|Induction|MRD negative|0|||
147496752|NCT02883049|531972423|FG014|Induction|MRD negative|0|||
147496753|NCT02883049|531972424|FG015|Induction|MRD negative|0|||
147496754|NCT02883049|531972409|FG000|Induction|Identified as HR patients|165|||
147496755|NCT02883049|531972410|FG001|Induction|Identified as HR patients|0|||
147496756|NCT02883049|531972411|FG002|Induction|Identified as HR patients|0|||
147496757|NCT02883049|531972412|FG003|Induction|Identified as HR patients|0|||
147496758|NCT02883049|531972413|FG004|Induction|Identified as HR patients|0|||
147496759|NCT02883049|531972414|FG005|Induction|Identified as HR patients|0|||
147496760|NCT02883049|531972415|FG006|Induction|Identified as HR patients|0|||
147496761|NCT02883049|531972416|FG007|Induction|Identified as HR patients|0|||
147496762|NCT02883049|531972417|FG008|Induction|Identified as HR patients|0|||
147496763|NCT02883049|531972418|FG009|Induction|Identified as HR patients|0|||
147630490|NCT03850483|532465980|FG000|Follow-up for Stage 1|Physician Decision|0|||
147630491|NCT03850483|532465981|FG001|Follow-up for Stage 1|Physician Decision|0|||
147630492|NCT03850483|532465982|FG002|Follow-up for Stage 1|Physician Decision|0|||
147630493|NCT03850483|532465983|FG003|Follow-up for Stage 1|Physician Decision|0|||
147630494|NCT03850483|532465984|FG004|Follow-up for Stage 1|Physician Decision|1|||
147630495|NCT03850483|532465985|FG005|Follow-up for Stage 1|Physician Decision|0|||
147630496|NCT03850483|532465986|FG006|Follow-up for Stage 1|Physician Decision|1|||
147630497|NCT03850483|532465987|FG007|Follow-up for Stage 1|Physician Decision|0|||
147630498|NCT03850483|532465988|FG008|Follow-up for Stage 1|Physician Decision|0|||
147630499|NCT03850483|532465989|FG009|Follow-up for Stage 1|Physician Decision|0|||
147630500|NCT03850483|532465980|FG000|Follow-up for Stage 1|Lack of Efficacy|0|||
147630501|NCT03850483|532465981|FG001|Follow-up for Stage 1|Lack of Efficacy|0|||
147630502|NCT03850483|532465982|FG002|Follow-up for Stage 1|Lack of Efficacy|1|||
147630503|NCT03850483|532465983|FG003|Follow-up for Stage 1|Lack of Efficacy|0|||
147630504|NCT03850483|532465984|FG004|Follow-up for Stage 1|Lack of Efficacy|0|||
147630505|NCT03850483|532465985|FG005|Follow-up for Stage 1|Lack of Efficacy|0|||
147630506|NCT03850483|532465986|FG006|Follow-up for Stage 1|Lack of Efficacy|0|||
147630507|NCT03850483|532465987|FG007|Follow-up for Stage 1|Lack of Efficacy|1|||
147630508|NCT03850483|532465988|FG008|Follow-up for Stage 1|Lack of Efficacy|0|||
147630509|NCT03850483|532465989|FG009|Follow-up for Stage 1|Lack of Efficacy|0|||
147630510|NCT03850483|532465980|FG000|Follow-up for Stage 1|Adverse Event|0|||
147630511|NCT03850483|532465981|FG001|Follow-up for Stage 1|Adverse Event|0|||
147630512|NCT03850483|532465982|FG002|Follow-up for Stage 1|Adverse Event|1|||
147630513|NCT03850483|532465983|FG003|Follow-up for Stage 1|Adverse Event|0|||
147630514|NCT03850483|532465984|FG004|Follow-up for Stage 1|Adverse Event|0|||
147630515|NCT03850483|532465985|FG005|Follow-up for Stage 1|Adverse Event|1|||
147630516|NCT03850483|532465986|FG006|Follow-up for Stage 1|Adverse Event|0|||
147630517|NCT03850483|532465987|FG007|Follow-up for Stage 1|Adverse Event|0|||
147630518|NCT03850483|532465988|FG008|Follow-up for Stage 1|Adverse Event|0|||
147630519|NCT03850483|532465989|FG009|Follow-up for Stage 1|Adverse Event|0|||
147630520|NCT03850483|532465980|FG000|Follow-up for Stage 1|Refused Further Study Procedures|0|||
147630521|NCT03850483|532465981|FG001|Follow-up for Stage 1|Refused Further Study Procedures|1|||
147630522|NCT03850483|532465982|FG002|Follow-up for Stage 1|Refused Further Study Procedures|0|||
147630523|NCT03850483|532465983|FG003|Follow-up for Stage 1|Refused Further Study Procedures|0|||
147630524|NCT03850483|532465984|FG004|Follow-up for Stage 1|Refused Further Study Procedures|2|||
147630525|NCT03850483|532465985|FG005|Follow-up for Stage 1|Refused Further Study Procedures|2|||
147630526|NCT03850483|532465986|FG006|Follow-up for Stage 1|Refused Further Study Procedures|0|||
147630527|NCT03850483|532465987|FG007|Follow-up for Stage 1|Refused Further Study Procedures|0|||
147630528|NCT03850483|532465988|FG008|Follow-up for Stage 1|Refused Further Study Procedures|0|||
147630529|NCT03850483|532465989|FG009|Follow-up for Stage 1|Refused Further Study Procedures|0|||
147630530|NCT03850483|532465980|FG000|Follow-up for Stage 1|Other|0|||
147630531|NCT03850483|532465981|FG001|Follow-up for Stage 1|Other|2|||
147630532|NCT03850483|532465982|FG002|Follow-up for Stage 1|Other|0|||
147630533|NCT03850483|532465983|FG003|Follow-up for Stage 1|Other|2|||
147630534|NCT03850483|532465984|FG004|Follow-up for Stage 1|Other|0|||
147630535|NCT03850483|532465985|FG005|Follow-up for Stage 1|Other|1|||
147630536|NCT03850483|532465986|FG006|Follow-up for Stage 1|Other|0|||
147630537|NCT03850483|532465987|FG007|Follow-up for Stage 1|Other|0|||
147630538|NCT03850483|532465988|FG008|Follow-up for Stage 1|Other|0|||
147630539|NCT03850483|532465989|FG009|Follow-up for Stage 1|Other|0|||
147630540|NCT03850483|532465980|FG000|Treatment for Stage 2|Adverse Event|0|||
147630541|NCT03850483|532465981|FG001|Treatment for Stage 2|Adverse Event|0|||
147630542|NCT03850483|532465982|FG002|Treatment for Stage 2|Adverse Event|0|||
147630543|NCT03850483|532465983|FG003|Treatment for Stage 2|Adverse Event|0|||
147630544|NCT03850483|532465984|FG004|Treatment for Stage 2|Adverse Event|0|||
147630545|NCT03850483|532465985|FG005|Treatment for Stage 2|Adverse Event|0|||
147630546|NCT03850483|532465986|FG006|Treatment for Stage 2|Adverse Event|0|||
147630547|NCT03850483|532465987|FG007|Treatment for Stage 2|Adverse Event|0|||
147630548|NCT03850483|532465988|FG008|Treatment for Stage 2|Adverse Event|0|||
147630549|NCT03850483|532465989|FG009|Treatment for Stage 2|Adverse Event|1|||
147630550|NCT03850483|532465980|FG000|Treatment for Stage 2|Lack of Efficacy|0|||
147630551|NCT03850483|532465981|FG001|Treatment for Stage 2|Lack of Efficacy|0|||
147630552|NCT03850483|532465982|FG002|Treatment for Stage 2|Lack of Efficacy|0|||
147496764|NCT02883049|531972419|FG010|Induction|Identified as HR patients|0|||
147630553|NCT03850483|532465983|FG003|Treatment for Stage 2|Lack of Efficacy|0|||
147496765|NCT02883049|531972420|FG011|Induction|Identified as HR patients|0|||
147496766|NCT02883049|531972421|FG012|Induction|Identified as HR patients|0|||
147496767|NCT02883049|531972422|FG013|Induction|Identified as HR patients|0|||
147630554|NCT03850483|532465984|FG004|Treatment for Stage 2|Lack of Efficacy|0|||
147630555|NCT03850483|532465985|FG005|Treatment for Stage 2|Lack of Efficacy|0|||
147630556|NCT03850483|532465986|FG006|Treatment for Stage 2|Lack of Efficacy|0|||
147630557|NCT03850483|532465987|FG007|Treatment for Stage 2|Lack of Efficacy|0|||
147668494|NCT00855218|532611802|FG000|Overall Study|technical problems|2|||
147630558|NCT03850483|532465988|FG008|Treatment for Stage 2|Lack of Efficacy|1|||
147668495|NCT00855218|532611803|FG001|Overall Study|technical problems|1|||
147496768|NCT02883049|531972423|FG014|Induction|Identified as HR patients|0|||
147496769|NCT02883049|531972424|FG015|Induction|Identified as HR patients|0|||
147496770|NCT02883049|531972409|FG000|Induction|Developed SMN|0|||
147496771|NCT02883049|531972410|FG001|Induction|Developed SMN|1|||
147496772|NCT02883049|531972411|FG002|Induction|Developed SMN|0|||
147496773|NCT02883049|531972412|FG003|Induction|Developed SMN|0|||
147496774|NCT02883049|531972413|FG004|Induction|Developed SMN|0|||
147496775|NCT02883049|531972414|FG005|Induction|Developed SMN|0|||
147496776|NCT02883049|531972415|FG006|Induction|Developed SMN|0|||
147496777|NCT02883049|531972416|FG007|Induction|Developed SMN|0|||
147496778|NCT02883049|531972417|FG008|Induction|Developed SMN|0|||
147496779|NCT02883049|531972418|FG009|Induction|Developed SMN|0|||
147496780|NCT02883049|531972419|FG010|Induction|Developed SMN|0|||
147496781|NCT02883049|531972420|FG011|Induction|Developed SMN|0|||
147496782|NCT02883049|531972421|FG012|Induction|Developed SMN|0|||
147496783|NCT02883049|531972422|FG013|Induction|Developed SMN|0|||
147496784|NCT02883049|531972423|FG014|Induction|Developed SMN|0|||
147496785|NCT02883049|531972424|FG015|Induction|Developed SMN|0|||
147496786|NCT02883049|531972409|FG000|Induction|Enrolled onto another COG study|72|||
147496787|NCT02883049|531972410|FG001|Induction|Enrolled onto another COG study|0|||
147496788|NCT02883049|531972411|FG002|Induction|Enrolled onto another COG study|0|||
147496789|NCT02883049|531972412|FG003|Induction|Enrolled onto another COG study|0|||
147496790|NCT02883049|531972413|FG004|Induction|Enrolled onto another COG study|0|||
147496791|NCT02883049|531972414|FG005|Induction|Enrolled onto another COG study|0|||
147496792|NCT02883049|531972415|FG006|Induction|Enrolled onto another COG study|0|||
147496793|NCT02883049|531972416|FG007|Induction|Enrolled onto another COG study|0|||
147496794|NCT02883049|531972417|FG008|Induction|Enrolled onto another COG study|0|||
147496795|NCT02883049|531972418|FG009|Induction|Enrolled onto another COG study|0|||
147496796|NCT02883049|531972419|FG010|Induction|Enrolled onto another COG study|0|||
147496797|NCT02883049|531972420|FG011|Induction|Enrolled onto another COG study|0|||
147496798|NCT02883049|531972421|FG012|Induction|Enrolled onto another COG study|0|||
147496799|NCT02883049|531972422|FG013|Induction|Enrolled onto another COG study|0|||
147496800|NCT02883049|531972423|FG014|Induction|Enrolled onto another COG study|0|||
147496801|NCT02883049|531972424|FG015|Induction|Enrolled onto another COG study|0|||
147496802|NCT02883049|531972409|FG000|Induction|Incomplete induction data|17|||
147496803|NCT02883049|531972410|FG001|Induction|Incomplete induction data|0|||
147496804|NCT02883049|531972411|FG002|Induction|Incomplete induction data|0|||
147496805|NCT02883049|531972412|FG003|Induction|Incomplete induction data|0|||
147496806|NCT02883049|531972413|FG004|Induction|Incomplete induction data|0|||
147496807|NCT02883049|531972414|FG005|Induction|Incomplete induction data|0|||
147496808|NCT02883049|531972415|FG006|Induction|Incomplete induction data|0|||
147496809|NCT02883049|531972416|FG007|Induction|Incomplete induction data|0|||
147496810|NCT02883049|531972417|FG008|Induction|Incomplete induction data|0|||
147496811|NCT02883049|531972418|FG009|Induction|Incomplete induction data|0|||
147496812|NCT02883049|531972419|FG010|Induction|Incomplete induction data|0|||
147496813|NCT02883049|531972420|FG011|Induction|Incomplete induction data|0|||
147496814|NCT02883049|531972421|FG012|Induction|Incomplete induction data|0|||
147496815|NCT02883049|531972422|FG013|Induction|Incomplete induction data|0|||
147496816|NCT02883049|531972423|FG014|Induction|Incomplete induction data|0|||
147496817|NCT02883049|531972424|FG015|Induction|Incomplete induction data|0|||
147496818|NCT02883049|531972409|FG000|Post Induction|Adverse Event|0|||
147496819|NCT02883049|531972410|FG001|Post Induction|Adverse Event|0|||
147496820|NCT02883049|531972411|FG002|Post Induction|Adverse Event|0|||
147496821|NCT02883049|531972412|FG003|Post Induction|Adverse Event|7|||
147496822|NCT02883049|531972413|FG004|Post Induction|Adverse Event|8|||
147496823|NCT02883049|531972414|FG005|Post Induction|Adverse Event|3|||
147496824|NCT02883049|531972415|FG006|Post Induction|Adverse Event|4|||
147496825|NCT02883049|531972416|FG007|Post Induction|Adverse Event|5|||
147496826|NCT02883049|531972417|FG008|Post Induction|Adverse Event|6|||
147496827|NCT02883049|531972418|FG009|Post Induction|Adverse Event|7|||
147496828|NCT02883049|531972419|FG010|Post Induction|Adverse Event|2|||
147496829|NCT02883049|531972420|FG011|Post Induction|Adverse Event|2|||
147668496|NCT00855218|532611802|FG000|Overall Study|Still treated with study medication|0|||
147496830|NCT02883049|531972421|FG012|Post Induction|Adverse Event|0|||
147496831|NCT02883049|531972422|FG013|Post Induction|Adverse Event|0|||
147496832|NCT02883049|531972423|FG014|Post Induction|Adverse Event|5|||
147496833|NCT02883049|531972424|FG015|Post Induction|Adverse Event|2|||
147496834|NCT02883049|531972409|FG000|Post Induction|Death|0|||
147496835|NCT02883049|531972410|FG001|Post Induction|Death|0|||
147496836|NCT02883049|531972411|FG002|Post Induction|Death|0|||
147496837|NCT02883049|531972412|FG003|Post Induction|Death|9|||
147496838|NCT02883049|531972413|FG004|Post Induction|Death|9|||
147496839|NCT02883049|531972414|FG005|Post Induction|Death|0|||
147496840|NCT02883049|531972415|FG006|Post Induction|Death|1|||
147496841|NCT02883049|531972416|FG007|Post Induction|Death|6|||
147496842|NCT02883049|531972417|FG008|Post Induction|Death|5|||
147496843|NCT02883049|531972418|FG009|Post Induction|Death|3|||
147496844|NCT02883049|531972419|FG010|Post Induction|Death|1|||
147496845|NCT02883049|531972420|FG011|Post Induction|Death|0|||
147496846|NCT02883049|531972421|FG012|Post Induction|Death|1|||
147630559|NCT03850483|532465989|FG009|Treatment for Stage 2|Lack of Efficacy|0|||
147630560|NCT03850483|532465980|FG000|Treatment for Stage 2|Lost to Follow-up|0|||
147630561|NCT03850483|532465981|FG001|Treatment for Stage 2|Lost to Follow-up|0|||
147630562|NCT03850483|532465982|FG002|Treatment for Stage 2|Lost to Follow-up|0|||
147630563|NCT03850483|532465983|FG003|Treatment for Stage 2|Lost to Follow-up|0|||
147630564|NCT03850483|532465984|FG004|Treatment for Stage 2|Lost to Follow-up|0|||
147630565|NCT03850483|532465985|FG005|Treatment for Stage 2|Lost to Follow-up|0|||
147630566|NCT03850483|532465986|FG006|Treatment for Stage 2|Lost to Follow-up|0|||
147630567|NCT03850483|532465987|FG007|Treatment for Stage 2|Lost to Follow-up|0|||
147630568|NCT03850483|532465988|FG008|Treatment for Stage 2|Lost to Follow-up|0|||
147630569|NCT03850483|532465989|FG009|Treatment for Stage 2|Lost to Follow-up|3|||
147630570|NCT03850483|532465980|FG000|Treatment for Stage 2|Physician Decision|0|||
147630571|NCT03850483|532465981|FG001|Treatment for Stage 2|Physician Decision|0|||
147630572|NCT03850483|532465982|FG002|Treatment for Stage 2|Physician Decision|0|||
147630573|NCT03850483|532465983|FG003|Treatment for Stage 2|Physician Decision|0|||
147630574|NCT03850483|532465984|FG004|Treatment for Stage 2|Physician Decision|0|||
147630575|NCT03850483|532465985|FG005|Treatment for Stage 2|Physician Decision|0|||
147630576|NCT03850483|532465986|FG006|Treatment for Stage 2|Physician Decision|0|||
147630577|NCT03850483|532465987|FG007|Treatment for Stage 2|Physician Decision|0|||
147630578|NCT03850483|532465988|FG008|Treatment for Stage 2|Physician Decision|0|||
147630579|NCT03850483|532465989|FG009|Treatment for Stage 2|Physician Decision|1|||
147630580|NCT03850483|532465980|FG000|Treatment for Stage 2|Protocol Violation|0|||
147630581|NCT03850483|532465981|FG001|Treatment for Stage 2|Protocol Violation|0|||
147630582|NCT03850483|532465982|FG002|Treatment for Stage 2|Protocol Violation|0|||
147630583|NCT03850483|532465983|FG003|Treatment for Stage 2|Protocol Violation|0|||
147630584|NCT03850483|532465984|FG004|Treatment for Stage 2|Protocol Violation|0|||
147630585|NCT03850483|532465985|FG005|Treatment for Stage 2|Protocol Violation|0|||
147630586|NCT03850483|532465986|FG006|Treatment for Stage 2|Protocol Violation|0|||
147630587|NCT03850483|532465987|FG007|Treatment for Stage 2|Protocol Violation|0|||
147630588|NCT03850483|532465988|FG008|Treatment for Stage 2|Protocol Violation|1|||
147630589|NCT03850483|532465989|FG009|Treatment for Stage 2|Protocol Violation|0|||
147630590|NCT03850483|532465980|FG000|Treatment for Stage 2|Withdrawal by Subject|0|||
147630591|NCT03850483|532465981|FG001|Treatment for Stage 2|Withdrawal by Subject|0|||
147630592|NCT03850483|532465982|FG002|Treatment for Stage 2|Withdrawal by Subject|0|||
147630593|NCT03850483|532465983|FG003|Treatment for Stage 2|Withdrawal by Subject|0|||
147630594|NCT03850483|532465984|FG004|Treatment for Stage 2|Withdrawal by Subject|0|||
147630595|NCT03850483|532465985|FG005|Treatment for Stage 2|Withdrawal by Subject|0|||
147630596|NCT03850483|532465986|FG006|Treatment for Stage 2|Withdrawal by Subject|0|||
147630597|NCT03850483|532465987|FG007|Treatment for Stage 2|Withdrawal by Subject|0|||
147630598|NCT03850483|532465988|FG008|Treatment for Stage 2|Withdrawal by Subject|2|||
147630599|NCT03850483|532465989|FG009|Treatment for Stage 2|Withdrawal by Subject|5|||
147630600|NCT03850483|532465980|FG000|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
147630601|NCT03850483|532465981|FG001|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
147630602|NCT03850483|532465982|FG002|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
147630603|NCT03850483|532465983|FG003|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
147630604|NCT03850483|532465984|FG004|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
147630605|NCT03850483|532465985|FG005|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
147630606|NCT03850483|532465986|FG006|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
147630607|NCT03850483|532465987|FG007|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
147630608|NCT03850483|532465988|FG008|Treatment for Stage 2|No Longer Meets Eligibility Criteria|0|||
147630609|NCT03850483|532465989|FG009|Treatment for Stage 2|No Longer Meets Eligibility Criteria|1|||
147630610|NCT03850483|532465980|FG000|Treatment for Stage 2|Refused Further Treatment|0|||
147630611|NCT03850483|532465981|FG001|Treatment for Stage 2|Refused Further Treatment|0|||
147630612|NCT03850483|532465982|FG002|Treatment for Stage 2|Refused Further Treatment|0|||
147630613|NCT03850483|532465983|FG003|Treatment for Stage 2|Refused Further Treatment|0|||
147630614|NCT03850483|532465984|FG004|Treatment for Stage 2|Refused Further Treatment|0|||
147630615|NCT03850483|532465985|FG005|Treatment for Stage 2|Refused Further Treatment|0|||
147630616|NCT03850483|532465986|FG006|Treatment for Stage 2|Refused Further Treatment|0|||
147630617|NCT03850483|532465987|FG007|Treatment for Stage 2|Refused Further Treatment|0|||
147496847|NCT02883049|531972422|FG013|Post Induction|Death|1|||
147496848|NCT02883049|531972423|FG014|Post Induction|Death|10|||
147496849|NCT02883049|531972424|FG015|Post Induction|Death|2|||
147496850|NCT02883049|531972409|FG000|Post Induction|Lost to Follow-up|0|||
147496851|NCT02883049|531972410|FG001|Post Induction|Lost to Follow-up|0|||
147496852|NCT02883049|531972411|FG002|Post Induction|Lost to Follow-up|0|||
147496853|NCT02883049|531972412|FG003|Post Induction|Lost to Follow-up|0|||
147630618|NCT03850483|532465988|FG008|Treatment for Stage 2|Refused Further Treatment|1|||
147630619|NCT03850483|532465989|FG009|Treatment for Stage 2|Refused Further Treatment|0|||
147630620|NCT03850483|532465980|FG000|Follow-up For Stage 2|Lost to Follow-up|0|||
147630621|NCT03850483|532465981|FG001|Follow-up For Stage 2|Lost to Follow-up|0|||
147630622|NCT03850483|532465982|FG002|Follow-up For Stage 2|Lost to Follow-up|0|||
147496854|NCT02883049|531972413|FG004|Post Induction|Lost to Follow-up|1|||
147630623|NCT03850483|532465983|FG003|Follow-up For Stage 2|Lost to Follow-up|0|||
147630624|NCT03850483|532465984|FG004|Follow-up For Stage 2|Lost to Follow-up|0|||
147630625|NCT03850483|532465985|FG005|Follow-up For Stage 2|Lost to Follow-up|0|||
147630626|NCT03850483|532465986|FG006|Follow-up For Stage 2|Lost to Follow-up|0|||
147630627|NCT03850483|532465987|FG007|Follow-up For Stage 2|Lost to Follow-up|0|||
147630628|NCT03850483|532465988|FG008|Follow-up For Stage 2|Lost to Follow-up|0|||
147630629|NCT03850483|532465989|FG009|Follow-up For Stage 2|Lost to Follow-up|1|||
147630630|NCT03850483|532465980|FG000|Follow-up For Stage 2|Other|0|||
147630631|NCT03850483|532465981|FG001|Follow-up For Stage 2|Other|0|||
147630632|NCT03850483|532465982|FG002|Follow-up For Stage 2|Other|0|||
147630633|NCT03850483|532465983|FG003|Follow-up For Stage 2|Other|0|||
147630634|NCT03850483|532465984|FG004|Follow-up For Stage 2|Other|0|||
147630635|NCT03850483|532465985|FG005|Follow-up For Stage 2|Other|0|||
147630636|NCT03850483|532465986|FG006|Follow-up For Stage 2|Other|0|||
147630637|NCT03850483|532465987|FG007|Follow-up For Stage 2|Other|0|||
147630638|NCT03850483|532465988|FG008|Follow-up For Stage 2|Other|0|||
147630639|NCT03850483|532465989|FG009|Follow-up For Stage 2|Other|1|||
147630640|NCT01164579|532467564|FG000|Overall Study|Lack of Efficacy|0|||
147630641|NCT01164579|532467565|FG001|Overall Study|Lack of Efficacy|0|||
147630642|NCT01164579|532467566|FG002|Overall Study|Lack of Efficacy|6|||
147630643|NCT01164579|532467564|FG000|Overall Study|Lost to Follow-up|1|||
147630644|NCT01164579|532467565|FG001|Overall Study|Lost to Follow-up|1|||
147630645|NCT01164579|532467566|FG002|Overall Study|Lost to Follow-up|0|||
147630646|NCT01164579|532467564|FG000|Overall Study|Withdrawal by Subject|2|||
147630647|NCT01164579|532467565|FG001|Overall Study|Withdrawal by Subject|5|||
147630648|NCT01164579|532467566|FG002|Overall Study|Withdrawal by Subject|3|||
147630649|NCT01164579|532467564|FG000|Overall Study|Protocol Violation|0|||
147630650|NCT01164579|532467565|FG001|Overall Study|Protocol Violation|1|||
147630651|NCT01164579|532467566|FG002|Overall Study|Protocol Violation|2|||
147630652|NCT01164579|532467564|FG000|Overall Study|Adverse Event|4|||
147630653|NCT01164579|532467565|FG001|Overall Study|Adverse Event|2|||
147630654|NCT01164579|532467566|FG002|Overall Study|Adverse Event|5|||
147630655|NCT01164579|532467564|FG000|Overall Study|Reason not specified|1|||
147630656|NCT01164579|532467565|FG001|Overall Study|Reason not specified|0|||
147630657|NCT01164579|532467566|FG002|Overall Study|Reason not specified|0|||
147630658|NCT00302328|532467570|FG000|Overall Study|Physician Decision|0|||
147630659|NCT00302328|532467571|FG001|Overall Study|Physician Decision|1|||
147630660|NCT00302328|532467572|FG002|Overall Study|Physician Decision|0|||
147630661|NCT01288937|532467573|FG000|Overall Study|Adverse Event|1|||
147630662|NCT01288937|532467574|FG001|Overall Study|Adverse Event|0|||
147496855|NCT02883049|531972414|FG005|Post Induction|Lost to Follow-up|1|||
147496856|NCT02883049|531972415|FG006|Post Induction|Lost to Follow-up|0|||
147496857|NCT02883049|531972416|FG007|Post Induction|Lost to Follow-up|0|||
147496858|NCT02883049|531972417|FG008|Post Induction|Lost to Follow-up|3|||
147496859|NCT02883049|531972418|FG009|Post Induction|Lost to Follow-up|0|||
147496860|NCT02883049|531972419|FG010|Post Induction|Lost to Follow-up|1|||
147496861|NCT02883049|531972420|FG011|Post Induction|Lost to Follow-up|0|||
147496862|NCT02883049|531972421|FG012|Post Induction|Lost to Follow-up|0|||
147496863|NCT02883049|531972422|FG013|Post Induction|Lost to Follow-up|0|||
147496864|NCT02883049|531972423|FG014|Post Induction|Lost to Follow-up|0|||
147496865|NCT02883049|531972424|FG015|Post Induction|Lost to Follow-up|0|||
147496866|NCT02883049|531972409|FG000|Post Induction|Physician Decision|0|||
147496867|NCT02883049|531972410|FG001|Post Induction|Physician Decision|0|||
147496868|NCT02883049|531972411|FG002|Post Induction|Physician Decision|0|||
147496869|NCT02883049|531972412|FG003|Post Induction|Physician Decision|27|||
147496870|NCT02883049|531972413|FG004|Post Induction|Physician Decision|27|||
147496871|NCT02883049|531972414|FG005|Post Induction|Physician Decision|23|||
147496872|NCT02883049|531972415|FG006|Post Induction|Physician Decision|30|||
147496873|NCT02883049|531972416|FG007|Post Induction|Physician Decision|56|||
147496874|NCT02883049|531972417|FG008|Post Induction|Physician Decision|85|||
147496875|NCT02883049|531972418|FG009|Post Induction|Physician Decision|12|||
147496876|NCT02883049|531972419|FG010|Post Induction|Physician Decision|5|||
147496877|NCT02883049|531972420|FG011|Post Induction|Physician Decision|14|||
147496878|NCT02883049|531972421|FG012|Post Induction|Physician Decision|1|||
147496879|NCT02883049|531972422|FG013|Post Induction|Physician Decision|11|||
147496880|NCT02883049|531972423|FG014|Post Induction|Physician Decision|19|||
147496881|NCT02883049|531972424|FG015|Post Induction|Physician Decision|5|||
147496882|NCT02883049|531972409|FG000|Post Induction|Protocol Violation|0|||
147496883|NCT02883049|531972410|FG001|Post Induction|Protocol Violation|0|||
147496884|NCT02883049|531972411|FG002|Post Induction|Protocol Violation|0|||
147496885|NCT02883049|531972412|FG003|Post Induction|Protocol Violation|0|||
147630663|NCT00912743|532467578|FG000|Overall Study|Adverse Event|3|||
147630664|NCT00912743|532467579|FG001|Overall Study|Adverse Event|1|||
147630665|NCT00912743|532467578|FG000|Overall Study|Lack of Efficacy|9|||
147630666|NCT00912743|532467579|FG001|Overall Study|Lack of Efficacy|18|||
147630667|NCT00912743|532467578|FG000|Overall Study|Toxicity|0|||
147630668|NCT00912743|532467579|FG001|Overall Study|Toxicity|1|||
147630669|NCT00912743|532467578|FG000|Overall Study|End of treatment form was not collected|1|||
147630670|NCT00912743|532467579|FG001|Overall Study|End of treatment form was not collected|0|||
147630671|NCT04157296|532467580|FG000|Overall Study|Withdrawal by Subject|0|||
147496886|NCT02883049|531972413|FG004|Post Induction|Protocol Violation|0|||
147496887|NCT02883049|531972414|FG005|Post Induction|Protocol Violation|0|||
147496888|NCT02883049|531972415|FG006|Post Induction|Protocol Violation|0|||
147496889|NCT02883049|531972416|FG007|Post Induction|Protocol Violation|1|||
147496890|NCT02883049|531972417|FG008|Post Induction|Protocol Violation|0|||
147496891|NCT02883049|531972418|FG009|Post Induction|Protocol Violation|0|||
147496892|NCT02883049|531972419|FG010|Post Induction|Protocol Violation|0|||
147496893|NCT02883049|531972420|FG011|Post Induction|Protocol Violation|0|||
147496894|NCT02883049|531972421|FG012|Post Induction|Protocol Violation|0|||
147496895|NCT02883049|531972422|FG013|Post Induction|Protocol Violation|0|||
147496896|NCT02883049|531972423|FG014|Post Induction|Protocol Violation|0|||
147496897|NCT02883049|531972424|FG015|Post Induction|Protocol Violation|0|||
147496898|NCT02883049|531972409|FG000|Post Induction|Withdrawal by Subject|0|||
147496899|NCT02883049|531972410|FG001|Post Induction|Withdrawal by Subject|0|||
147496900|NCT02883049|531972411|FG002|Post Induction|Withdrawal by Subject|0|||
147496901|NCT02883049|531972412|FG003|Post Induction|Withdrawal by Subject|5|||
147496902|NCT02883049|531972413|FG004|Post Induction|Withdrawal by Subject|2|||
147496903|NCT02883049|531972414|FG005|Post Induction|Withdrawal by Subject|1|||
147496904|NCT02883049|531972415|FG006|Post Induction|Withdrawal by Subject|0|||
147496905|NCT02883049|531972416|FG007|Post Induction|Withdrawal by Subject|0|||
147496906|NCT02883049|531972417|FG008|Post Induction|Withdrawal by Subject|2|||
147496907|NCT02883049|531972418|FG009|Post Induction|Withdrawal by Subject|0|||
147496908|NCT02883049|531972419|FG010|Post Induction|Withdrawal by Subject|1|||
147496909|NCT02883049|531972420|FG011|Post Induction|Withdrawal by Subject|1|||
147496910|NCT02883049|531972421|FG012|Post Induction|Withdrawal by Subject|0|||
147496911|NCT02883049|531972422|FG013|Post Induction|Withdrawal by Subject|0|||
147496912|NCT02883049|531972423|FG014|Post Induction|Withdrawal by Subject|1|||
147496913|NCT02883049|531972424|FG015|Post Induction|Withdrawal by Subject|0|||
147496914|NCT02883049|531972409|FG000|Post Induction|Ineligible|0|||
147496915|NCT02883049|531972410|FG001|Post Induction|Ineligible|0|||
147496916|NCT02883049|531972411|FG002|Post Induction|Ineligible|2|||
147496917|NCT02883049|531972412|FG003|Post Induction|Ineligible|0|||
147496918|NCT02883049|531972413|FG004|Post Induction|Ineligible|0|||
147496919|NCT02883049|531972414|FG005|Post Induction|Ineligible|0|||
147496920|NCT02883049|531972415|FG006|Post Induction|Ineligible|1|||
147496921|NCT02883049|531972416|FG007|Post Induction|Ineligible|0|||
147496922|NCT02883049|531972417|FG008|Post Induction|Ineligible|0|||
147496923|NCT02883049|531972418|FG009|Post Induction|Ineligible|0|||
147496924|NCT02883049|531972419|FG010|Post Induction|Ineligible|1|||
147496925|NCT02883049|531972420|FG011|Post Induction|Ineligible|0|||
147496926|NCT02883049|531972421|FG012|Post Induction|Ineligible|0|||
147496927|NCT02883049|531972422|FG013|Post Induction|Ineligible|0|||
147496928|NCT02883049|531972423|FG014|Post Induction|Ineligible|0|||
147496929|NCT02883049|531972424|FG015|Post Induction|Ineligible|1|||
147496930|NCT02883049|531972409|FG000|Post Induction|Refusal of further protocol therapy|0|||
147496931|NCT02883049|531972410|FG001|Post Induction|Refusal of further protocol therapy|0|||
147496932|NCT02883049|531972411|FG002|Post Induction|Refusal of further protocol therapy|0|||
147496933|NCT02883049|531972412|FG003|Post Induction|Refusal of further protocol therapy|11|||
147496934|NCT02883049|531972413|FG004|Post Induction|Refusal of further protocol therapy|15|||
147496935|NCT02883049|531972414|FG005|Post Induction|Refusal of further protocol therapy|9|||
147496936|NCT02883049|531972415|FG006|Post Induction|Refusal of further protocol therapy|13|||
147496937|NCT02883049|531972416|FG007|Post Induction|Refusal of further protocol therapy|5|||
147496938|NCT02883049|531972417|FG008|Post Induction|Refusal of further protocol therapy|21|||
147496939|NCT02883049|531972418|FG009|Post Induction|Refusal of further protocol therapy|7|||
147496940|NCT02883049|531972419|FG010|Post Induction|Refusal of further protocol therapy|0|||
147496941|NCT02883049|531972420|FG011|Post Induction|Refusal of further protocol therapy|7|||
147496942|NCT02883049|531972421|FG012|Post Induction|Refusal of further protocol therapy|3|||
147496943|NCT02883049|531972422|FG013|Post Induction|Refusal of further protocol therapy|0|||
147496944|NCT02883049|531972423|FG014|Post Induction|Refusal of further protocol therapy|4|||
147496945|NCT02883049|531972424|FG015|Post Induction|Refusal of further protocol therapy|1|||
147496946|NCT02883049|531972409|FG000|Post Induction|Inevaluable|0|||
147496947|NCT02883049|531972410|FG001|Post Induction|Inevaluable|0|||
147496948|NCT02883049|531972411|FG002|Post Induction|Inevaluable|0|||
147496949|NCT02883049|531972412|FG003|Post Induction|Inevaluable|1|||
147496950|NCT02883049|531972413|FG004|Post Induction|Inevaluable|1|||
147496951|NCT02883049|531972414|FG005|Post Induction|Inevaluable|2|||
147496952|NCT02883049|531972415|FG006|Post Induction|Inevaluable|7|||
147496953|NCT02883049|531972416|FG007|Post Induction|Inevaluable|6|||
147496954|NCT02883049|531972417|FG008|Post Induction|Inevaluable|4|||
147496955|NCT02883049|531972418|FG009|Post Induction|Inevaluable|4|||
147496956|NCT02883049|531972419|FG010|Post Induction|Inevaluable|1|||
147496957|NCT02883049|531972420|FG011|Post Induction|Inevaluable|1|||
147496958|NCT02883049|531972421|FG012|Post Induction|Inevaluable|2|||
147496959|NCT02883049|531972422|FG013|Post Induction|Inevaluable|0|||
147496960|NCT02883049|531972423|FG014|Post Induction|Inevaluable|0|||
147496961|NCT02883049|531972424|FG015|Post Induction|Inevaluable|1|||
147496962|NCT02883049|531972409|FG000|Post Induction|Moved to another non-COG institution|0|||
147630672|NCT04157296|532467581|FG001|Overall Study|Withdrawal by Subject|1|||
147630673|NCT04157296|532467580|FG000|Overall Study|Did not obtain second fMRI.|0|||
147630674|NCT04157296|532467581|FG001|Overall Study|Did not obtain second fMRI.|1|||
147630675|NCT04157296|532467580|FG000|Overall Study|MRI failed/no second fMRI|0|||
147630676|NCT04157296|532467581|FG001|Overall Study|MRI failed/no second fMRI|1|||
147630677|NCT02237196|532467582|FG000|Overall Study|Adverse Event|0|||
147630678|NCT02237196|532467583|FG001|Overall Study|Adverse Event|1|||
147630679|NCT02237196|532467584|FG002|Overall Study|Adverse Event|1|||
147630680|NCT02237196|532467585|FG003|Overall Study|Adverse Event|0|||
147630681|NCT02237196|532467582|FG000|Overall Study|Lost to Follow-up|4|||
147630682|NCT02237196|532467583|FG001|Overall Study|Lost to Follow-up|2|||
147630683|NCT02237196|532467584|FG002|Overall Study|Lost to Follow-up|4|||
147630684|NCT02237196|532467585|FG003|Overall Study|Lost to Follow-up|6|||
147630685|NCT02237196|532467582|FG000|Overall Study|Physician Decision|2|||
147630686|NCT02237196|532467583|FG001|Overall Study|Physician Decision|0|||
147630687|NCT02237196|532467584|FG002|Overall Study|Physician Decision|0|||
147630688|NCT02237196|532467585|FG003|Overall Study|Physician Decision|1|||
147630689|NCT02237196|532467582|FG000|Overall Study|Pregnancy|0|||
147630690|NCT02237196|532467583|FG001|Overall Study|Pregnancy|0|||
147630691|NCT02237196|532467584|FG002|Overall Study|Pregnancy|1|||
147630692|NCT02237196|532467585|FG003|Overall Study|Pregnancy|1|||
147630693|NCT02237196|532467582|FG000|Overall Study|Withdrawal by Subject|1|||
147630694|NCT02237196|532467583|FG001|Overall Study|Withdrawal by Subject|1|||
147630695|NCT02237196|532467584|FG002|Overall Study|Withdrawal by Subject|4|||
147630696|NCT02237196|532467585|FG003|Overall Study|Withdrawal by Subject|1|||
147630697|NCT02237196|532467582|FG000|Overall Study|Site Error|1|||
147630698|NCT02237196|532467583|FG001|Overall Study|Site Error|2|||
147630699|NCT02237196|532467584|FG002|Overall Study|Site Error|0|||
147630700|NCT02237196|532467585|FG003|Overall Study|Site Error|2|||
147630701|NCT00862823|532467588|FG000|First Intervention|Withdrawal by Subject|1|||
147630702|NCT00862823|532467589|FG001|First Intervention|Withdrawal by Subject|1|||
147630703|NCT00619892|532467590|FG000|Overall Study|Adverse Event|3|||
147630704|NCT00619892|532467591|FG001|Overall Study|Adverse Event|0|||
147630705|NCT00619892|532467590|FG000|Overall Study|Lost to Follow-up|0|||
147630706|NCT00619892|532467591|FG001|Overall Study|Lost to Follow-up|1|||
147630707|NCT00619892|532467590|FG000|Overall Study|Intercurrent illness|0|||
147630708|NCT00619892|532467591|FG001|Overall Study|Intercurrent illness|1|||
147630709|NCT00857896|532467595|FG000|Baseline to Week 4|Withdrawal by Subject|1|||
147630710|NCT02308540|532467597|FG000|Overall Study|Lost to Follow-up|0|||
147630711|NCT02308540|532467598|FG001|Overall Study|Lost to Follow-up|0|||
147630712|NCT02308540|532467599|FG002|Overall Study|Lost to Follow-up|0|||
147630713|NCT02308540|532467600|FG003|Overall Study|Lost to Follow-up|0|||
147630714|NCT02308540|532467601|FG004|Overall Study|Lost to Follow-up|0|||
147630715|NCT02308540|532467602|FG005|Overall Study|Lost to Follow-up|1|||
147630716|NCT01091662|532467603|FG000|Overall Study|Adverse Event|1|||
147630717|NCT01091662|532467604|FG001|Overall Study|Adverse Event|9|||
147630718|NCT01091662|532467603|FG000|Overall Study|Physician Decision|1|||
147630719|NCT01091662|532467604|FG001|Overall Study|Physician Decision|1|||
147630720|NCT01091662|532467603|FG000|Overall Study|Withdrawal by Subject|7|||
147630721|NCT01091662|532467604|FG001|Overall Study|Withdrawal by Subject|6|||
147630722|NCT01091662|532467603|FG000|Overall Study|met exit criteria|7|||
147630723|NCT01091662|532467604|FG001|Overall Study|met exit criteria|13|||
147630724|NCT01091662|532467603|FG000|Overall Study|met exclusion criteria|1|||
147630725|NCT01091662|532467604|FG001|Overall Study|met exclusion criteria|0|||
147630726|NCT01091662|532467603|FG000|Overall Study|Lost to Follow-up|0|||
147630727|NCT01091662|532467604|FG001|Overall Study|Lost to Follow-up|1|||
147630728|NCT01091662|532467603|FG000|Overall Study|Pregnancy|0|||
147630729|NCT01091662|532467604|FG001|Overall Study|Pregnancy|1|||
147630730|NCT01091662|532467603|FG000|Overall Study|Protocol Violation|0|||
147630731|NCT01091662|532467604|FG001|Overall Study|Protocol Violation|2|||
147630732|NCT01091662|532467603|FG000|Overall Study|unable to swallow capsule|0|||
147630733|NCT01091662|532467604|FG001|Overall Study|unable to swallow capsule|1|||
147630734|NCT04109391|532467605|FG000|Overall Study|Adverse Event|2|||
147630735|NCT04109391|532467606|FG001|Overall Study|Adverse Event|2|||
147630736|NCT04109391|532467607|FG002|Overall Study|Adverse Event|0|||
147630737|NCT04109391|532467605|FG000|Overall Study|Withdrawal by Subject|2|||
147630738|NCT04109391|532467606|FG001|Overall Study|Withdrawal by Subject|0|||
147630739|NCT04109391|532467607|FG002|Overall Study|Withdrawal by Subject|0|||
147630740|NCT04109391|532467605|FG000|Overall Study|Pregnancy|1|||
147630741|NCT04109391|532467606|FG001|Overall Study|Pregnancy|0|||
147630742|NCT04109391|532467607|FG002|Overall Study|Pregnancy|0|||
147630743|NCT04109391|532467605|FG000|Overall Study|Subject refused to continue, AE and 2 patients only received 10 of 13 cycles|3|||
147630744|NCT04109391|532467606|FG001|Overall Study|Subject refused to continue, AE and 2 patients only received 10 of 13 cycles|1|||
147630745|NCT04109391|532467607|FG002|Overall Study|Subject refused to continue, AE and 2 patients only received 10 of 13 cycles|0|||
147630746|NCT04109391|532467605|FG000|Overall Study|Lost to Follow-up|0|||
147630747|NCT04109391|532467606|FG001|Overall Study|Lost to Follow-up|0|||
147630748|NCT04109391|532467607|FG002|Overall Study|Lost to Follow-up|1|||
147630749|NCT04109391|532467605|FG000|Overall Study|Lack of Efficacy|2|||
147630750|NCT04109391|532467606|FG001|Overall Study|Lack of Efficacy|2|||
147630751|NCT04109391|532467607|FG002|Overall Study|Lack of Efficacy|3|||
147630752|NCT02049814|532467614|FG000|Overall Study|Reason not Specified|4|||
147630753|NCT02049814|532467615|FG001|Overall Study|Reason not Specified|3|||
147630754|NCT02049814|532467614|FG000|Overall Study|Pregnancy|1|||
147630755|NCT02049814|532467615|FG001|Overall Study|Pregnancy|0|||
147630756|NCT02049814|532467614|FG000|Overall Study|Lost to Follow-up|2|||
147630757|NCT02049814|532467615|FG001|Overall Study|Lost to Follow-up|3|||
147630758|NCT02049814|532467614|FG000|Overall Study|Serious Protocol Violation|5|||
147630759|NCT02049814|532467615|FG001|Overall Study|Serious Protocol Violation|7|||
147630760|NCT02049814|532467614|FG000|Overall Study|Study Termination|0|||
147668497|NCT00855218|532611803|FG001|Overall Study|Still treated with study medication|1|||
147668498|NCT00855218|532611802|FG000|Overall Study|Untreatable disease progression|54|||
147668499|NCT00855218|532611803|FG001|Overall Study|Untreatable disease progression|67|||
147668500|NCT00855218|532611802|FG000|Overall Study|Second malignancy|0|||
147668501|NCT00855218|532611803|FG001|Overall Study|Second malignancy|1|||
147668502|NCT00855218|532611802|FG000|Overall Study|Progression measurement proven|7|||
147496963|NCT02883049|531972410|FG001|Post Induction|Moved to another non-COG institution|0|||
147496964|NCT02883049|531972411|FG002|Post Induction|Moved to another non-COG institution|0|||
147496965|NCT02883049|531972412|FG003|Post Induction|Moved to another non-COG institution|0|||
147496966|NCT02883049|531972413|FG004|Post Induction|Moved to another non-COG institution|0|||
147496967|NCT02883049|531972414|FG005|Post Induction|Moved to another non-COG institution|0|||
147496968|NCT02883049|531972415|FG006|Post Induction|Moved to another non-COG institution|0|||
147496969|NCT02883049|531972416|FG007|Post Induction|Moved to another non-COG institution|2|||
147496970|NCT02883049|531972417|FG008|Post Induction|Moved to another non-COG institution|2|||
147496971|NCT02883049|531972418|FG009|Post Induction|Moved to another non-COG institution|0|||
147496972|NCT02883049|531972419|FG010|Post Induction|Moved to another non-COG institution|0|||
147496973|NCT02883049|531972420|FG011|Post Induction|Moved to another non-COG institution|1|||
147496974|NCT02883049|531972421|FG012|Post Induction|Moved to another non-COG institution|0|||
147496975|NCT02883049|531972422|FG013|Post Induction|Moved to another non-COG institution|0|||
147496976|NCT02883049|531972423|FG014|Post Induction|Moved to another non-COG institution|0|||
147496977|NCT02883049|531972424|FG015|Post Induction|Moved to another non-COG institution|0|||
147496978|NCT02883049|531972409|FG000|Post Induction|Randomization closed|0|||
147496979|NCT02883049|531972410|FG001|Post Induction|Randomization closed|0|||
147496980|NCT02883049|531972411|FG002|Post Induction|Randomization closed|0|||
147496981|NCT02883049|531972412|FG003|Post Induction|Randomization closed|0|||
147496982|NCT02883049|531972413|FG004|Post Induction|Randomization closed|0|||
147496983|NCT02883049|531972414|FG005|Post Induction|Randomization closed|0|||
147496984|NCT02883049|531972415|FG006|Post Induction|Randomization closed|0|||
147496985|NCT02883049|531972416|FG007|Post Induction|Randomization closed|20|||
147496986|NCT02883049|531972417|FG008|Post Induction|Randomization closed|0|||
147496987|NCT02883049|531972418|FG009|Post Induction|Randomization closed|0|||
147496988|NCT02883049|531972419|FG010|Post Induction|Randomization closed|0|||
147496989|NCT02883049|531972420|FG011|Post Induction|Randomization closed|0|||
147496990|NCT02883049|531972421|FG012|Post Induction|Randomization closed|0|||
147496991|NCT02883049|531972422|FG013|Post Induction|Randomization closed|0|||
147496992|NCT02883049|531972423|FG014|Post Induction|Randomization closed|0|||
147496993|NCT02883049|531972424|FG015|Post Induction|Randomization closed|0|||
147496994|NCT02883049|531972409|FG000|Post Induction|MRD negative|0|||
147496995|NCT02883049|531972410|FG001|Post Induction|MRD negative|0|||
147496996|NCT02883049|531972411|FG002|Post Induction|MRD negative|0|||
147496997|NCT02883049|531972412|FG003|Post Induction|MRD negative|0|||
147496998|NCT02883049|531972413|FG004|Post Induction|MRD negative|0|||
147496999|NCT02883049|531972414|FG005|Post Induction|MRD negative|0|||
147497000|NCT02883049|531972415|FG006|Post Induction|MRD negative|0|||
147630761|NCT02049814|532467615|FG001|Overall Study|Study Termination|1|||
147668503|NCT00855218|532611803|FG001|Overall Study|Progression measurement proven|15|||
147497001|NCT02883049|531972416|FG007|Post Induction|MRD negative|11|||
147497002|NCT02883049|531972417|FG008|Post Induction|MRD negative|0|||
147497003|NCT02883049|531972418|FG009|Post Induction|MRD negative|0|||
147497004|NCT02883049|531972419|FG010|Post Induction|MRD negative|0|||
147497005|NCT02883049|531972420|FG011|Post Induction|MRD negative|0|||
147497006|NCT02883049|531972421|FG012|Post Induction|MRD negative|0|||
147497007|NCT02883049|531972422|FG013|Post Induction|MRD negative|0|||
147497008|NCT02883049|531972423|FG014|Post Induction|MRD negative|0|||
147630762|NCT02049814|532467614|FG000|Overall Study|Pretreatment event/Adverse Event (AE)|8|||
147630763|NCT02049814|532467615|FG001|Overall Study|Pretreatment event/Adverse Event (AE)|5|||
147668504|NCT00855218|532611802|FG000|Overall Study|Clinical endpoint reached|10|||
147497009|NCT02883049|531972424|FG015|Post Induction|MRD negative|0|||
147497010|NCT02883049|531972409|FG000|Post Induction|Developed SMN|0|||
147497011|NCT02883049|531972410|FG001|Post Induction|Developed SMN|0|||
147497012|NCT02883049|531972411|FG002|Post Induction|Developed SMN|0|||
147497013|NCT02883049|531972412|FG003|Post Induction|Developed SMN|0|||
147497014|NCT02883049|531972413|FG004|Post Induction|Developed SMN|1|||
147668505|NCT00855218|532611803|FG001|Overall Study|Clinical endpoint reached|13|||
147630764|NCT02049814|532467614|FG000|Overall Study|Voluntary withdrawal|9|||
147630765|NCT02049814|532467615|FG001|Overall Study|Voluntary withdrawal|8|||
147630766|NCT00954941|532467616|FG000|Overall Study|Received treatment at home|1|||
147630767|NCT00954941|532467617|FG001|Overall Study|Received treatment at home|0|||
147630768|NCT00954941|532467616|FG000|Overall Study|Withdrawal by Subject|1|||
147630769|NCT00954941|532467617|FG001|Overall Study|Withdrawal by Subject|0|||
147630770|NCT00954941|532467616|FG000|Overall Study|Insurance Denial|2|||
147630771|NCT00954941|532467617|FG001|Overall Study|Insurance Denial|2|||
147630772|NCT00954941|532467616|FG000|Overall Study|Physician Decision|2|||
147630773|NCT00954941|532467617|FG001|Overall Study|Physician Decision|2|||
147630774|NCT00954941|532467616|FG000|Overall Study|Ineligible|2|||
147630775|NCT00954941|532467617|FG001|Overall Study|Ineligible|2|||
147630776|NCT00954941|532467616|FG000|Overall Study|Adverse Event|0|||
147630777|NCT00954941|532467617|FG001|Overall Study|Adverse Event|1|||
147630778|NCT03533114|532467620|FG000|Overall|Adverse Event|16|||
147630779|NCT03533114|532467621|FG001|Overall|Adverse Event|11|||
147630780|NCT03533114|532467620|FG000|Overall|Consent Withdrawal by Participant|7|||
147630781|NCT03533114|532467621|FG001|Overall|Consent Withdrawal by Participant|6|||
147630782|NCT03533114|532467620|FG000|Overall|Lack of Efficacy|5|||
147630783|NCT03533114|532467621|FG001|Overall|Lack of Efficacy|3|||
147630784|NCT03533114|532467620|FG000|Overall|Lost to Follow-up|1|||
147630785|NCT03533114|532467621|FG001|Overall|Lost to Follow-up|1|||
147630786|NCT03533114|532467620|FG000|Overall|Physician Decision|0|||
147630787|NCT03533114|532467621|FG001|Overall|Physician Decision|2|||
147630788|NCT03533114|532467620|FG000|Overall|Protocol deviation|1|||
147630789|NCT03533114|532467621|FG001|Overall|Protocol deviation|1|||
147630790|NCT03533114|532467620|FG000|Overall|Failure to meet randomization criteria|1|||
147630791|NCT03533114|532467621|FG001|Overall|Failure to meet randomization criteria|2|||
147630792|NCT03533114|532467620|FG000|Overall|Non-Compliance with study drug|0|||
147630793|NCT03533114|532467621|FG001|Overall|Non-Compliance with study drug|1|||
147630794|NCT03533114|532467620|FG000|Overall|Other|0|||
147630795|NCT03533114|532467621|FG001|Overall|Other|1|||
147630796|NCT03533114|532467620|FG000|Open Label Titration and Optimization|Adverse Event|11|||
147630797|NCT03533114|532467621|FG001|Open Label Titration and Optimization|Adverse Event|8|||
147497015|NCT02883049|531972414|FG005|Post Induction|Developed SMN|0|||
147497016|NCT02883049|531972415|FG006|Post Induction|Developed SMN|1|||
147497017|NCT02883049|531972416|FG007|Post Induction|Developed SMN|0|||
147497018|NCT02883049|531972417|FG008|Post Induction|Developed SMN|0|||
147497019|NCT02883049|531972418|FG009|Post Induction|Developed SMN|0|||
147497020|NCT02883049|531972419|FG010|Post Induction|Developed SMN|1|||
147497021|NCT02883049|531972420|FG011|Post Induction|Developed SMN|1|||
147497022|NCT02883049|531972421|FG012|Post Induction|Developed SMN|0|||
147497023|NCT02883049|531972422|FG013|Post Induction|Developed SMN|0|||
147497024|NCT02883049|531972423|FG014|Post Induction|Developed SMN|1|||
147497025|NCT02883049|531972424|FG015|Post Induction|Developed SMN|0|||
147497026|NCT02883049|531972409|FG000|Post Induction|Enrolled onto another COG study|0|||
147497027|NCT02883049|531972410|FG001|Post Induction|Enrolled onto another COG study|0|||
147497028|NCT02883049|531972411|FG002|Post Induction|Enrolled onto another COG study|0|||
147497029|NCT02883049|531972412|FG003|Post Induction|Enrolled onto another COG study|1|||
147497030|NCT02883049|531972413|FG004|Post Induction|Enrolled onto another COG study|1|||
147630798|NCT03533114|532467620|FG000|Open Label Titration and Optimization|Consent Withdrawal by Participant|2|||
147630799|NCT03533114|532467621|FG001|Open Label Titration and Optimization|Consent Withdrawal by Participant|1|||
147630800|NCT03533114|532467620|FG000|Open Label Titration and Optimization|Lack of Efficacy|3|||
147630801|NCT03533114|532467621|FG001|Open Label Titration and Optimization|Lack of Efficacy|1|||
147630802|NCT03533114|532467620|FG000|Open Label Titration and Optimization|Lost to Follow-up|0|||
147630803|NCT03533114|532467621|FG001|Open Label Titration and Optimization|Lost to Follow-up|1|||
147630804|NCT03533114|532467620|FG000|Open Label Titration and Optimization|Protocol Deviation|0|||
147630805|NCT03533114|532467621|FG001|Open Label Titration and Optimization|Protocol Deviation|1|||
147630806|NCT03533114|532467620|FG000|Open Label Titration and Optimization|Non-Compliance with Study Drug|0|||
147630807|NCT03533114|532467621|FG001|Open Label Titration and Optimization|Non-Compliance with Study Drug|1|||
147630808|NCT03533114|532467620|FG000|Stable Dose|Adverse Event|0|||
147630809|NCT03533114|532467621|FG001|Stable Dose|Adverse Event|2|||
147630810|NCT03533114|532467620|FG000|Stable Dose|Consent Withdrawal by Participant|1|||
147630811|NCT03533114|532467621|FG001|Stable Dose|Consent Withdrawal by Participant|0|||
147630812|NCT03533114|532467620|FG000|Stable Dose|Lack of Efficacy|1|||
147630813|NCT03533114|532467621|FG001|Stable Dose|Lack of Efficacy|0|||
147630814|NCT03533114|532467620|FG000|Double Blind Randomized-Withdrawal|Adverse Event|1|||
147497031|NCT02883049|531972414|FG005|Post Induction|Enrolled onto another COG study|0|||
147630815|NCT03533114|532467621|FG001|Double Blind Randomized-Withdrawal|Adverse Event|1|||
147630816|NCT03533114|532467620|FG000|Double Blind Randomized-Withdrawal|Failure to Meet Randomization Criteria|1|||
147497032|NCT02883049|531972415|FG006|Post Induction|Enrolled onto another COG study|0|||
147497033|NCT02883049|531972416|FG007|Post Induction|Enrolled onto another COG study|4|||
147497034|NCT02883049|531972417|FG008|Post Induction|Enrolled onto another COG study|0|||
147497035|NCT02883049|531972418|FG009|Post Induction|Enrolled onto another COG study|0|||
147630817|NCT03533114|532467621|FG001|Double Blind Randomized-Withdrawal|Failure to Meet Randomization Criteria|0|||
147630818|NCT03533114|532467620|FG000|Open-Label Safety Extension|Adverse Event|3|||
147630819|NCT03533114|532467621|FG001|Open-Label Safety Extension|Adverse Event|0|||
147630820|NCT03533114|532467620|FG000|Open-Label Safety Extension|Consent Withdrawal by Participant|2|||
147630821|NCT03533114|532467621|FG001|Open-Label Safety Extension|Consent Withdrawal by Participant|3|||
147630822|NCT03533114|532467620|FG000|Open-Label Safety Extension|Lack of Efficacy|1|||
147630823|NCT03533114|532467621|FG001|Open-Label Safety Extension|Lack of Efficacy|0|||
147630824|NCT03533114|532467620|FG000|Open-Label Safety Extension|Lost to Follow-up|1|||
147630825|NCT03533114|532467621|FG001|Open-Label Safety Extension|Lost to Follow-up|0|||
147630826|NCT03533114|532467620|FG000|Open-Label Safety Extension|Protocol Deviation|1|||
147630827|NCT03533114|532467621|FG001|Open-Label Safety Extension|Protocol Deviation|0|||
147630828|NCT01028014|532467625|FG000|Overall Study|Lost to Follow-up|1|||
147630829|NCT01028014|532467626|FG001|Overall Study|Lost to Follow-up|2|||
147630830|NCT01028014|532467627|FG002|Overall Study|Lost to Follow-up|0|||
147630831|NCT01028014|532467628|FG003|Overall Study|Lost to Follow-up|1|||
147630832|NCT01028014|532467629|FG004|Overall Study|Lost to Follow-up|1|||
147630833|NCT01028014|532467630|FG005|Overall Study|Lost to Follow-up|2|||
147630834|NCT02411396|532467631|FG000|Overall Study|Lost to Follow-up|31|||
147630835|NCT02411396|532467631|FG000|Overall Study|Death|10|||
147630836|NCT02016105|532467638|FG000|TREATMENT PERIOD 1|Protocol Violation|2|||
147630837|NCT02016105|532467639|FG001|TREATMENT PERIOD 1|Protocol Violation|8|||
147630838|NCT02016105|532467640|FG002|TREATMENT PERIOD 1|Protocol Violation|0|||
147630839|NCT02016105|532467641|FG003|TREATMENT PERIOD 1|Protocol Violation|0|||
147630840|NCT02016105|532467642|FG004|TREATMENT PERIOD 1|Protocol Violation|0|||
147630841|NCT02016105|532467643|FG005|TREATMENT PERIOD 1|Protocol Violation|0|||
147630842|NCT02016105|532467638|FG000|TREATMENT PERIOD 1|Physician Decision|0|||
147630843|NCT02016105|532467639|FG001|TREATMENT PERIOD 1|Physician Decision|2|||
147630844|NCT02016105|532467640|FG002|TREATMENT PERIOD 1|Physician Decision|0|||
147630845|NCT02016105|532467641|FG003|TREATMENT PERIOD 1|Physician Decision|0|||
147630846|NCT02016105|532467642|FG004|TREATMENT PERIOD 1|Physician Decision|0|||
147630847|NCT02016105|532467643|FG005|TREATMENT PERIOD 1|Physician Decision|0|||
147630848|NCT02016105|532467638|FG000|TREATMENT PERIOD 1|Lack of Efficacy|4|||
147630849|NCT02016105|532467639|FG001|TREATMENT PERIOD 1|Lack of Efficacy|2|||
147630850|NCT02016105|532467640|FG002|TREATMENT PERIOD 1|Lack of Efficacy|0|||
147630851|NCT02016105|532467641|FG003|TREATMENT PERIOD 1|Lack of Efficacy|0|||
147630852|NCT02016105|532467642|FG004|TREATMENT PERIOD 1|Lack of Efficacy|0|||
147497036|NCT02883049|531972419|FG010|Post Induction|Enrolled onto another COG study|0|||
147497037|NCT02883049|531972420|FG011|Post Induction|Enrolled onto another COG study|2|||
147497038|NCT02883049|531972421|FG012|Post Induction|Enrolled onto another COG study|0|||
147497039|NCT02883049|531972422|FG013|Post Induction|Enrolled onto another COG study|1|||
147497040|NCT02883049|531972423|FG014|Post Induction|Enrolled onto another COG study|0|||
147497041|NCT02883049|531972424|FG015|Post Induction|Enrolled onto another COG study|0|||
147497042|NCT02883049|531972409|FG000|Post Induction|Recurrent leukemia|0|||
147497043|NCT02883049|531972410|FG001|Post Induction|Recurrent leukemia|0|||
147630853|NCT02016105|532467643|FG005|TREATMENT PERIOD 1|Lack of Efficacy|0|||
147630854|NCT02016105|532467638|FG000|TREATMENT PERIOD 1|Pregnancy|0|||
147630855|NCT02016105|532467639|FG001|TREATMENT PERIOD 1|Pregnancy|1|||
147630856|NCT02016105|532467640|FG002|TREATMENT PERIOD 1|Pregnancy|0|||
147630857|NCT02016105|532467641|FG003|TREATMENT PERIOD 1|Pregnancy|0|||
147630858|NCT02016105|532467642|FG004|TREATMENT PERIOD 1|Pregnancy|0|||
147630859|NCT02016105|532467643|FG005|TREATMENT PERIOD 1|Pregnancy|0|||
147630860|NCT02016105|532467638|FG000|TREATMENT PERIOD 1|Adverse Event|3|||
147630861|NCT02016105|532467639|FG001|TREATMENT PERIOD 1|Adverse Event|5|||
147630862|NCT02016105|532467640|FG002|TREATMENT PERIOD 1|Adverse Event|0|||
147630863|NCT02016105|532467641|FG003|TREATMENT PERIOD 1|Adverse Event|0|||
147630864|NCT02016105|532467642|FG004|TREATMENT PERIOD 1|Adverse Event|0|||
147630865|NCT02016105|532467643|FG005|TREATMENT PERIOD 1|Adverse Event|0|||
147497044|NCT02883049|531972411|FG002|Post Induction|Recurrent leukemia|0|||
147630866|NCT02016105|532467638|FG000|TREATMENT PERIOD 1|Withdrawal by Subject|15|||
147630867|NCT02016105|532467639|FG001|TREATMENT PERIOD 1|Withdrawal by Subject|11|||
147630868|NCT02016105|532467640|FG002|TREATMENT PERIOD 1|Withdrawal by Subject|0|||
147630869|NCT02016105|532467641|FG003|TREATMENT PERIOD 1|Withdrawal by Subject|0|||
147630870|NCT02016105|532467642|FG004|TREATMENT PERIOD 1|Withdrawal by Subject|0|||
147630871|NCT02016105|532467643|FG005|TREATMENT PERIOD 1|Withdrawal by Subject|0|||
147630872|NCT02016105|532467638|FG000|TREATMENT PERIOD 1|Lost to Follow-up|6|||
147497045|NCT02883049|531972412|FG003|Post Induction|Recurrent leukemia|17|||
147497046|NCT02883049|531972413|FG004|Post Induction|Recurrent leukemia|12|||
147497047|NCT02883049|531972414|FG005|Post Induction|Recurrent leukemia|4|||
147497048|NCT02883049|531972415|FG006|Post Induction|Recurrent leukemia|1|||
147497049|NCT02883049|531972416|FG007|Post Induction|Recurrent leukemia|13|||
147497050|NCT02883049|531972417|FG008|Post Induction|Recurrent leukemia|27|||
147630873|NCT02016105|532467639|FG001|TREATMENT PERIOD 1|Lost to Follow-up|4|||
147630874|NCT02016105|532467640|FG002|TREATMENT PERIOD 1|Lost to Follow-up|0|||
147630875|NCT02016105|532467641|FG003|TREATMENT PERIOD 1|Lost to Follow-up|0|||
147630876|NCT02016105|532467642|FG004|TREATMENT PERIOD 1|Lost to Follow-up|0|||
147630877|NCT02016105|532467643|FG005|TREATMENT PERIOD 1|Lost to Follow-up|0|||
147630878|NCT02016105|532467638|FG000|TREATMENT PERIOD 2|Non compliance study medication|0|||
147497051|NCT02883049|531972418|FG009|Post Induction|Recurrent leukemia|5|||
147497052|NCT02883049|531972419|FG010|Post Induction|Recurrent leukemia|3|||
147497053|NCT02883049|531972420|FG011|Post Induction|Recurrent leukemia|12|||
147497054|NCT02883049|531972421|FG012|Post Induction|Recurrent leukemia|1|||
147497055|NCT02883049|531972422|FG013|Post Induction|Recurrent leukemia|1|||
147497056|NCT02883049|531972423|FG014|Post Induction|Recurrent leukemia|9|||
147497057|NCT02883049|531972424|FG015|Post Induction|Recurrent leukemia|3|||
147497058|NCT02883049|531972409|FG000|Post Induction|Induction Failure|0|||
147497059|NCT02883049|531972410|FG001|Post Induction|Induction Failure|0|||
147497060|NCT02883049|531972411|FG002|Post Induction|Induction Failure|0|||
147497061|NCT02883049|531972412|FG003|Post Induction|Induction Failure|0|||
147497062|NCT02883049|531972413|FG004|Post Induction|Induction Failure|0|||
147497063|NCT02883049|531972414|FG005|Post Induction|Induction Failure|0|||
147497064|NCT02883049|531972415|FG006|Post Induction|Induction Failure|0|||
147497065|NCT02883049|531972416|FG007|Post Induction|Induction Failure|2|||
147497066|NCT02883049|531972417|FG008|Post Induction|Induction Failure|2|||
147497067|NCT02883049|531972418|FG009|Post Induction|Induction Failure|0|||
147497068|NCT02883049|531972419|FG010|Post Induction|Induction Failure|0|||
147497069|NCT02883049|531972420|FG011|Post Induction|Induction Failure|0|||
147497070|NCT02883049|531972421|FG012|Post Induction|Induction Failure|0|||
147497071|NCT02883049|531972422|FG013|Post Induction|Induction Failure|2|||
147497072|NCT02883049|531972423|FG014|Post Induction|Induction Failure|0|||
147497073|NCT02883049|531972424|FG015|Post Induction|Induction Failure|0|||
147497074|NCT01096849|531972425|FG000|Overall Study|Consent Withdrawn|1|||
147497075|NCT01096849|531972426|FG001|Overall Study|Consent Withdrawn|4|||
147497076|NCT01096849|531972427|FG002|Overall Study|Consent Withdrawn|2|||
147497077|NCT01096849|531972425|FG000|Overall Study|Lack of Efficacy|0|||
147497078|NCT01096849|531972426|FG001|Overall Study|Lack of Efficacy|2|||
147497079|NCT01096849|531972427|FG002|Overall Study|Lack of Efficacy|0|||
147497080|NCT01096849|531972425|FG000|Overall Study|Unacceptable/ Intolerable AE(s)|0|||
147497081|NCT01096849|531972426|FG001|Overall Study|Unacceptable/ Intolerable AE(s)|1|||
147497082|NCT01096849|531972427|FG002|Overall Study|Unacceptable/ Intolerable AE(s)|1|||
147497083|NCT01096849|531972425|FG000|Overall Study|Investigator or Medical Monitor Decision|0|||
147497084|NCT01096849|531972426|FG001|Overall Study|Investigator or Medical Monitor Decision|1|||
147497085|NCT01096849|531972427|FG002|Overall Study|Investigator or Medical Monitor Decision|0|||
147497086|NCT01096849|531972425|FG000|Overall Study|Administrative Reasons|0|||
147497087|NCT01096849|531972426|FG001|Overall Study|Administrative Reasons|1|||
147497088|NCT01096849|531972427|FG002|Overall Study|Administrative Reasons|2|||
147497089|NCT01096849|531972425|FG000|Overall Study|Lost to Follow-up|1|||
147497090|NCT01096849|531972426|FG001|Overall Study|Lost to Follow-up|3|||
147497091|NCT01096849|531972427|FG002|Overall Study|Lost to Follow-up|1|||
147497092|NCT04146467|531972428|FG000|Overall Study|Adverse Event|0|||
147497093|NCT04146467|531972429|FG001|Overall Study|Adverse Event|1|||
147497094|NCT04146467|531972428|FG000|Overall Study|Lost to Follow-up|0|||
147497095|NCT04146467|531972429|FG001|Overall Study|Lost to Follow-up|2|||
147497096|NCT01189435|531972431|FG000|Overall Study|Withdrawal by Subject|1|||
147497097|NCT01189435|531972431|FG000|Overall Study|Physician Decision|1|||
147497098|NCT00414960|531972432|FG000|Overall Study|Adverse Event|4|||
147497099|NCT00414960|531972433|FG001|Overall Study|Adverse Event|0|||
147497100|NCT00414960|531972432|FG000|Overall Study|Withdrawal by Subject|3|||
147497101|NCT00414960|531972433|FG001|Overall Study|Withdrawal by Subject|0|||
147497102|NCT00414960|531972432|FG000|Overall Study|Physician Decision|0|||
147497103|NCT00414960|531972433|FG001|Overall Study|Physician Decision|1|||
147497104|NCT01449682|531972434|FG000|Overall Study|Death|0|||
147497105|NCT01449682|531972435|FG001|Overall Study|Death|1|||
147497106|NCT01449682|531972434|FG000|Overall Study|Adverse Event|1|||
147497107|NCT01449682|531972435|FG001|Overall Study|Adverse Event|0|||
147497108|NCT00264849|531972436|FG000|Overall Study|Adverse Event|7|||
147497109|NCT00264849|531972437|FG001|Overall Study|Adverse Event|2|||
147497110|NCT00264849|531972436|FG000|Overall Study|Withdrawal by Subject|7|||
147497111|NCT00264849|531972437|FG001|Overall Study|Withdrawal by Subject|11|||
147497112|NCT00264849|531972436|FG000|Overall Study|Protocol Violation|5|||
147497113|NCT00264849|531972437|FG001|Overall Study|Protocol Violation|3|||
147497114|NCT00264849|531972436|FG000|Overall Study|Lack of Efficacy|1|||
147497115|NCT00264849|531972437|FG001|Overall Study|Lack of Efficacy|6|||
147497116|NCT00264849|531972436|FG000|Overall Study|Lost to Follow-up|0|||
147497117|NCT00264849|531972437|FG001|Overall Study|Lost to Follow-up|2|||
147497118|NCT00264849|531972436|FG000|Overall Study|Death|0|||
147497119|NCT00264849|531972437|FG001|Overall Study|Death|1|||
147497120|NCT00264849|531972436|FG000|Overall Study|Administrative Problems|2|||
147497121|NCT00264849|531972437|FG001|Overall Study|Administrative Problems|0|||
147497122|NCT00099359|531972439|FG000|Overall Study|Death|11|||
147497123|NCT00099359|531972440|FG001|Overall Study|Death|15|||
147497124|NCT00099359|531972441|FG002|Overall Study|Death|17|||
147497125|NCT00099359|531972439|FG000|Overall Study|Withdrawal by Subject|19|||
147497126|NCT00099359|531972440|FG001|Overall Study|Withdrawal by Subject|19|||
147497127|NCT00099359|531972441|FG002|Overall Study|Withdrawal by Subject|23|||
147497128|NCT00099359|531972439|FG000|Overall Study|Lost to Follow-up|15|||
147497129|NCT00099359|531972440|FG001|Overall Study|Lost to Follow-up|24|||
147497130|NCT00099359|531972441|FG002|Overall Study|Lost to Follow-up|24|||
147497131|NCT00099359|531972439|FG000|Overall Study|moved out of area|9|||
147630879|NCT02016105|532467639|FG001|TREATMENT PERIOD 2|Non compliance study medication|0|||
147630880|NCT02016105|532467640|FG002|TREATMENT PERIOD 2|Non compliance study medication|0|||
147630881|NCT02016105|532467641|FG003|TREATMENT PERIOD 2|Non compliance study medication|0|||
147630882|NCT02016105|532467642|FG004|TREATMENT PERIOD 2|Non compliance study medication|0|||
147630883|NCT02016105|532467643|FG005|TREATMENT PERIOD 2|Non compliance study medication|1|||
147630884|NCT02016105|532467638|FG000|TREATMENT PERIOD 2|Lack of Efficacy|0|||
147630885|NCT02016105|532467639|FG001|TREATMENT PERIOD 2|Lack of Efficacy|0|||
147630886|NCT02016105|532467640|FG002|TREATMENT PERIOD 2|Lack of Efficacy|2|||
147630887|NCT02016105|532467641|FG003|TREATMENT PERIOD 2|Lack of Efficacy|6|||
147630888|NCT02016105|532467642|FG004|TREATMENT PERIOD 2|Lack of Efficacy|3|||
147630889|NCT02016105|532467643|FG005|TREATMENT PERIOD 2|Lack of Efficacy|2|||
147630890|NCT02016105|532467638|FG000|TREATMENT PERIOD 2|Pregnancy|0|||
147630891|NCT02016105|532467639|FG001|TREATMENT PERIOD 2|Pregnancy|0|||
147630892|NCT02016105|532467640|FG002|TREATMENT PERIOD 2|Pregnancy|0|||
147630893|NCT02016105|532467641|FG003|TREATMENT PERIOD 2|Pregnancy|0|||
147630894|NCT02016105|532467642|FG004|TREATMENT PERIOD 2|Pregnancy|0|||
147630895|NCT02016105|532467643|FG005|TREATMENT PERIOD 2|Pregnancy|1|||
147630896|NCT02016105|532467638|FG000|TREATMENT PERIOD 2|Death|0|||
147630897|NCT02016105|532467639|FG001|TREATMENT PERIOD 2|Death|0|||
147630898|NCT02016105|532467640|FG002|TREATMENT PERIOD 2|Death|0|||
147630899|NCT02016105|532467641|FG003|TREATMENT PERIOD 2|Death|0|||
147630900|NCT02016105|532467642|FG004|TREATMENT PERIOD 2|Death|0|||
147630901|NCT02016105|532467643|FG005|TREATMENT PERIOD 2|Death|1|||
147630902|NCT02016105|532467638|FG000|TREATMENT PERIOD 2|Adverse Event|0|||
147630903|NCT02016105|532467639|FG001|TREATMENT PERIOD 2|Adverse Event|0|||
147630904|NCT02016105|532467640|FG002|TREATMENT PERIOD 2|Adverse Event|0|||
147630905|NCT02016105|532467641|FG003|TREATMENT PERIOD 2|Adverse Event|4|||
147630906|NCT02016105|532467642|FG004|TREATMENT PERIOD 2|Adverse Event|0|||
147630907|NCT02016105|532467643|FG005|TREATMENT PERIOD 2|Adverse Event|1|||
147630908|NCT02016105|532467638|FG000|TREATMENT PERIOD 2|Withdrawal by Subject|0|||
147630909|NCT02016105|532467639|FG001|TREATMENT PERIOD 2|Withdrawal by Subject|0|||
147630910|NCT02016105|532467640|FG002|TREATMENT PERIOD 2|Withdrawal by Subject|3|||
147630911|NCT02016105|532467641|FG003|TREATMENT PERIOD 2|Withdrawal by Subject|1|||
147630912|NCT02016105|532467642|FG004|TREATMENT PERIOD 2|Withdrawal by Subject|1|||
147630913|NCT02016105|532467643|FG005|TREATMENT PERIOD 2|Withdrawal by Subject|7|||
147630914|NCT02016105|532467638|FG000|TREATMENT PERIOD 2|Lost to Follow-up|0|||
147630915|NCT02016105|532467639|FG001|TREATMENT PERIOD 2|Lost to Follow-up|0|||
147630916|NCT02016105|532467640|FG002|TREATMENT PERIOD 2|Lost to Follow-up|1|||
147630917|NCT02016105|532467641|FG003|TREATMENT PERIOD 2|Lost to Follow-up|0|||
147630918|NCT02016105|532467642|FG004|TREATMENT PERIOD 2|Lost to Follow-up|0|||
147630919|NCT02016105|532467643|FG005|TREATMENT PERIOD 2|Lost to Follow-up|1|||
147630920|NCT02016105|532467638|FG000|EXTENSION PERIOD|New therapy for study indication|0|||
147630921|NCT02016105|532467639|FG001|EXTENSION PERIOD|New therapy for study indication|0|||
147630922|NCT02016105|532467640|FG002|EXTENSION PERIOD|New therapy for study indication|0|||
147630923|NCT02016105|532467641|FG003|EXTENSION PERIOD|New therapy for study indication|0|||
147630924|NCT02016105|532467642|FG004|EXTENSION PERIOD|New therapy for study indication|1|||
147630925|NCT02016105|532467643|FG005|EXTENSION PERIOD|New therapy for study indication|1|||
147630926|NCT02016105|532467638|FG000|EXTENSION PERIOD|Lack of Efficacy|0|||
147630927|NCT02016105|532467639|FG001|EXTENSION PERIOD|Lack of Efficacy|0|||
147630928|NCT02016105|532467640|FG002|EXTENSION PERIOD|Lack of Efficacy|1|||
147630929|NCT02016105|532467641|FG003|EXTENSION PERIOD|Lack of Efficacy|3|||
147630930|NCT02016105|532467642|FG004|EXTENSION PERIOD|Lack of Efficacy|1|||
147630931|NCT02016105|532467643|FG005|EXTENSION PERIOD|Lack of Efficacy|1|||
147630932|NCT02016105|532467638|FG000|EXTENSION PERIOD|Adverse Event|0|||
147630933|NCT02016105|532467639|FG001|EXTENSION PERIOD|Adverse Event|0|||
147630934|NCT02016105|532467640|FG002|EXTENSION PERIOD|Adverse Event|2|||
147630935|NCT02016105|532467641|FG003|EXTENSION PERIOD|Adverse Event|0|||
147630936|NCT02016105|532467642|FG004|EXTENSION PERIOD|Adverse Event|1|||
147630937|NCT02016105|532467643|FG005|EXTENSION PERIOD|Adverse Event|0|||
147630938|NCT02016105|532467638|FG000|EXTENSION PERIOD|Withdrawal by Subject|0|||
147630939|NCT02016105|532467639|FG001|EXTENSION PERIOD|Withdrawal by Subject|0|||
147630940|NCT02016105|532467640|FG002|EXTENSION PERIOD|Withdrawal by Subject|2|||
147630941|NCT02016105|532467641|FG003|EXTENSION PERIOD|Withdrawal by Subject|2|||
147497132|NCT00099359|531972440|FG001|Overall Study|moved out of area|7|||
147630942|NCT02016105|532467642|FG004|EXTENSION PERIOD|Withdrawal by Subject|2|||
147630943|NCT02016105|532467643|FG005|EXTENSION PERIOD|Withdrawal by Subject|2|||
147497133|NCT00099359|531972441|FG002|Overall Study|moved out of area|4|||
147668506|NCT00769561|532611809|FG000|Overall Study|Withdrawal by Subject|2|||
147630944|NCT02016105|532467638|FG000|EXTENSION PERIOD|Non-compliance with study indication|0|||
147630945|NCT02016105|532467639|FG001|EXTENSION PERIOD|Non-compliance with study indication|0|||
147630946|NCT02016105|532467640|FG002|EXTENSION PERIOD|Non-compliance with study indication|0|||
147630947|NCT02016105|532467641|FG003|EXTENSION PERIOD|Non-compliance with study indication|0|||
147497134|NCT00717366|531972442|FG000|Core Study Period (20 Weeks)|Renal transplant|4|||
147630948|NCT02016105|532467642|FG004|EXTENSION PERIOD|Non-compliance with study indication|1|||
147630949|NCT02016105|532467643|FG005|EXTENSION PERIOD|Non-compliance with study indication|0|||
147497135|NCT00717366|531972443|FG001|Core Study Period (20 Weeks)|Renal transplant|9|||
147497136|NCT00717366|531972442|FG000|Core Study Period (20 Weeks)|Admin/Other than specified|0|||
147497137|NCT00717366|531972443|FG001|Core Study Period (20 Weeks)|Admin/Other than specified|2|||
147497138|NCT00717366|531972442|FG000|Core Study Period (20 Weeks)|Death|0|||
147497139|NCT00717366|531972443|FG001|Core Study Period (20 Weeks)|Death|1|||
147497140|NCT00717366|531972442|FG000|Core Study Period (20 Weeks)|Refused treatment/Did not cooperate|0|||
147497141|NCT00717366|531972443|FG001|Core Study Period (20 Weeks)|Refused treatment/Did not cooperate|1|||
147497142|NCT00717366|531972442|FG000|Extension Period (52 Weeks)|Renal transplant|3|||
147497143|NCT00717366|531972443|FG001|Extension Period (52 Weeks)|Renal transplant|13|||
147497144|NCT00717366|531972442|FG000|Extension Period (52 Weeks)|Admin/Other than specified|0|||
147497145|NCT00717366|531972443|FG001|Extension Period (52 Weeks)|Admin/Other than specified|2|||
147497146|NCT00717366|531972442|FG000|Extension Period (52 Weeks)|Withdrew consent|1|||
147497147|NCT00717366|531972443|FG001|Extension Period (52 Weeks)|Withdrew consent|1|||
147497148|NCT00838916|531972444|FG000|Treatment Period (156 Weeks)|Adverse Event|50|||
147497149|NCT00838916|531972445|FG001|Treatment Period (156 Weeks)|Adverse Event|11|||
147497150|NCT00838916|531972444|FG000|Treatment Period (156 Weeks)|Protocol Violation|12|||
147497151|NCT00838916|531972445|FG001|Treatment Period (156 Weeks)|Protocol Violation|3|||
147497152|NCT00838916|531972444|FG000|Treatment Period (156 Weeks)|Noncompliance|21|||
147497153|NCT00838916|531972445|FG001|Treatment Period (156 Weeks)|Noncompliance|14|||
147497154|NCT00838916|531972444|FG000|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|1|||
147497155|NCT00838916|531972445|FG001|Treatment Period (156 Weeks)|Severe or Repeated Hypoglycaemia|0|||
147497156|NCT00838916|531972444|FG000|Treatment Period (156 Weeks)|Lost to Follow-up|19|||
147497157|NCT00838916|531972445|FG001|Treatment Period (156 Weeks)|Lost to Follow-up|18|||
147497158|NCT00838916|531972444|FG000|Treatment Period (156 Weeks)|Withdrawal by Subject|81|||
147497159|NCT00838916|531972445|FG001|Treatment Period (156 Weeks)|Withdrawal by Subject|29|||
147497160|NCT00838916|531972444|FG000|Treatment Period (156 Weeks)|Physician Decision|6|||
147497161|NCT00838916|531972445|FG001|Treatment Period (156 Weeks)|Physician Decision|1|||
147497162|NCT00838916|531972444|FG000|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|1|||
147497163|NCT00838916|531972445|FG001|Treatment Period (156 Weeks)|Termination of Study/Site by GSK|0|||
147497164|NCT00838916|531972444|FG000|Treatment Period (156 Weeks)|Missing|3|||
147497165|NCT00838916|531972445|FG001|Treatment Period (156 Weeks)|Missing|1|||
147497166|NCT00838916|531972444|FG000|Treatment Period (156 Weeks)|Pregnancy|2|||
147497167|NCT00838916|531972445|FG001|Treatment Period (156 Weeks)|Pregnancy|0|||
147497168|NCT00838916|531972444|FG000|Follow-up Period (8 Weeks)|Adverse Event|10|||
147497169|NCT00838916|531972445|FG001|Follow-up Period (8 Weeks)|Adverse Event|5|||
147497170|NCT00838916|531972444|FG000|Follow-up Period (8 Weeks)|Noncompliance|6|||
147497171|NCT00838916|531972445|FG001|Follow-up Period (8 Weeks)|Noncompliance|5|||
147497172|NCT00838916|531972444|FG000|Follow-up Period (8 Weeks)|Lost to Follow-up|38|||
147497173|NCT00838916|531972445|FG001|Follow-up Period (8 Weeks)|Lost to Follow-up|22|||
147497174|NCT00838916|531972444|FG000|Follow-up Period (8 Weeks)|Did not Enter Follow-up Period|7|||
147497175|NCT00838916|531972445|FG001|Follow-up Period (8 Weeks)|Did not Enter Follow-up Period|7|||
147497176|NCT00838916|531972444|FG000|Follow-up Period (8 Weeks)|Withdrawn from Follow-up Participation|26|||
147497177|NCT00838916|531972445|FG001|Follow-up Period (8 Weeks)|Withdrawn from Follow-up Participation|12|||
147497178|NCT00838916|531972444|FG000|Follow-up Period (8 Weeks)|Physician Decision|2|||
147497179|NCT00838916|531972445|FG001|Follow-up Period (8 Weeks)|Physician Decision|0|||
147497180|NCT00838916|531972444|FG000|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|2|||
147497181|NCT00838916|531972445|FG001|Follow-up Period (8 Weeks)|Termination of Study/Site by GSK|0|||
147497182|NCT00838916|531972444|FG000|Follow-up Period (8 Weeks)|Withdrawal by Subject|2|||
147497183|NCT00838916|531972445|FG001|Follow-up Period (8 Weeks)|Withdrawal by Subject|0|||
147497184|NCT00838916|531972444|FG000|Follow-up Period (8 Weeks)|Missing|3|||
147497185|NCT00838916|531972445|FG001|Follow-up Period (8 Weeks)|Missing|0|||
147497186|NCT01927419|531972446|FG000|Pre-Treatment Period|Adverse event unrelated to study drug|0|||
147497187|NCT01927419|531972447|FG001|Pre-Treatment Period|Adverse event unrelated to study drug|1|||
147497188|NCT01927419|531972446|FG000|Pre-Treatment Period|Participants no longer meeting study criteria|1|||
147668507|NCT00769561|532611810|FG001|Overall Study|Withdrawal by Subject|2|||
147497189|NCT01927419|531972447|FG001|Pre-Treatment Period|Participants no longer meeting study criteria|0|||
147497190|NCT01927419|531972446|FG000|Treatment Period|Disease progression|17|||
147497191|NCT01927419|531972447|FG001|Treatment Period|Disease progression|20|||
147497192|NCT01927419|531972446|FG000|Treatment Period|Study drug toxicity|48|||
147497193|NCT01927419|531972447|FG001|Treatment Period|Study drug toxicity|10|||
147497194|NCT01927419|531972446|FG000|Treatment Period|Death|0|||
147497195|NCT01927419|531972447|FG001|Treatment Period|Death|1|||
147497196|NCT01927419|531972446|FG000|Treatment Period|Adverse event unrelated to study drug|6|||
147497197|NCT01927419|531972447|FG001|Treatment Period|Adverse event unrelated to study drug|3|||
147497198|NCT01927419|531972446|FG000|Treatment Period|Participant request to discontinue|12|||
147497199|NCT01927419|531972447|FG001|Treatment Period|Participant request to discontinue|4|||
147497200|NCT01927419|531972446|FG000|Treatment Period|Withdrawal by Subject|1|||
147497201|NCT01927419|531972447|FG001|Treatment Period|Withdrawal by Subject|1|||
147497202|NCT01927419|531972446|FG000|Treatment Period|Maximum Clinical Benefit|6|||
147630950|NCT02016105|532467638|FG000|EXTENSION PERIOD|Lost to Follow-up|0|||
147630951|NCT02016105|532467639|FG001|EXTENSION PERIOD|Lost to Follow-up|0|||
147630952|NCT02016105|532467640|FG002|EXTENSION PERIOD|Lost to Follow-up|0|||
147630953|NCT02016105|532467641|FG003|EXTENSION PERIOD|Lost to Follow-up|0|||
147630954|NCT02016105|532467642|FG004|EXTENSION PERIOD|Lost to Follow-up|0|||
147630955|NCT02016105|532467643|FG005|EXTENSION PERIOD|Lost to Follow-up|2|||
147630956|NCT00090493|532467644|FG000|Overall Study|Physician Decision|2|||
147630957|NCT02071706|532467645|FG000|Overall Study|Adverse Event|1|||
147630958|NCT02071706|532467645|FG000|Overall Study|Withdrawal by Subject|2|||
147630959|NCT01908829|532467649|FG000|Overall Study|Adverse Event|13|||
147630960|NCT01908829|532467650|FG001|Overall Study|Adverse Event|11|||
147630961|NCT01908829|532467651|FG002|Overall Study|Adverse Event|13|||
147497203|NCT01927419|531972447|FG001|Treatment Period|Maximum Clinical Benefit|2|||
147497204|NCT01927419|531972446|FG000|Treatment Period|Other reasons|3|||
147497205|NCT01927419|531972447|FG001|Treatment Period|Other reasons|4|||
147497206|NCT01927419|531972446|FG000|Treatment Period|Not Reported|1|||
147497207|NCT01927419|531972447|FG001|Treatment Period|Not Reported|1|||
147497208|NCT03488251|531972448|FG000|Part 1:Dose Escalation (Up to 168 Days)|Adverse Event|1|||
147497209|NCT03488251|531972449|FG001|Part 1:Dose Escalation (Up to 168 Days)|Adverse Event|0|||
147497210|NCT03488251|531972450|FG002|Part 1:Dose Escalation (Up to 168 Days)|Adverse Event|0|||
147497211|NCT03488251|531972451|FG003|Part 1:Dose Escalation (Up to 168 Days)|Adverse Event|0|||
147497212|NCT03488251|531972448|FG000|Part 1:Dose Escalation (Up to 168 Days)|Physician Decision|1|||
147497213|NCT03488251|531972449|FG001|Part 1:Dose Escalation (Up to 168 Days)|Physician Decision|0|||
147497214|NCT03488251|531972450|FG002|Part 1:Dose Escalation (Up to 168 Days)|Physician Decision|0|||
147497215|NCT03488251|531972451|FG003|Part 1:Dose Escalation (Up to 168 Days)|Physician Decision|0|||
147497216|NCT03488251|531972448|FG000|Part 1:Dose Escalation (Up to 168 Days)|Progressive disease|4|||
147497217|NCT03488251|531972449|FG001|Part 1:Dose Escalation (Up to 168 Days)|Progressive disease|0|||
147497218|NCT03488251|531972450|FG002|Part 1:Dose Escalation (Up to 168 Days)|Progressive disease|0|||
147497219|NCT03488251|531972451|FG003|Part 1:Dose Escalation (Up to 168 Days)|Progressive disease|0|||
147497220|NCT03488251|531972448|FG000|Part 1:Dose Escalation (Up to 168 Days)|Protocol deviation|1|||
147497221|NCT03488251|531972449|FG001|Part 1:Dose Escalation (Up to 168 Days)|Protocol deviation|0|||
147497222|NCT03488251|531972450|FG002|Part 1:Dose Escalation (Up to 168 Days)|Protocol deviation|0|||
147497223|NCT03488251|531972451|FG003|Part 1:Dose Escalation (Up to 168 Days)|Protocol deviation|0|||
147497224|NCT03488251|531972448|FG000|Part 1:Dose Escalation (Up to 168 Days)|Study terminated by sponsor|1|||
147497225|NCT03488251|531972449|FG001|Part 1:Dose Escalation (Up to 168 Days)|Study terminated by sponsor|0|||
147497226|NCT03488251|531972450|FG002|Part 1:Dose Escalation (Up to 168 Days)|Study terminated by sponsor|0|||
147497227|NCT03488251|531972451|FG003|Part 1:Dose Escalation (Up to 168 Days)|Study terminated by sponsor|0|||
147497228|NCT00115765|531972454|FG000|Overall Study|Withdrawal by Subject|22|||
147497229|NCT00115765|531972455|FG001|Overall Study|Withdrawal by Subject|53|||
147497230|NCT00115765|531972456|FG002|Overall Study|Withdrawal by Subject|76|||
147497231|NCT00115765|531972457|FG003|Overall Study|Withdrawal by Subject|15|||
147630962|NCT01908829|532467649|FG000|Overall Study|Lost to Follow-up|4|||
147630963|NCT01908829|532467650|FG001|Overall Study|Lost to Follow-up|2|||
147630964|NCT01908829|532467651|FG002|Overall Study|Lost to Follow-up|1|||
147630965|NCT01908829|532467649|FG000|Overall Study|Randomized no double-blind drug received|1|||
147630966|NCT01908829|532467650|FG001|Overall Study|Randomized no double-blind drug received|0|||
147630967|NCT01908829|532467651|FG002|Overall Study|Randomized no double-blind drug received|1|||
147630968|NCT01908829|532467649|FG000|Overall Study|Discontinued (no EoT page)|2|||
147497232|NCT00115765|531972454|FG000|Overall Study|Physician Decision|4|||
147497233|NCT00115765|531972455|FG001|Overall Study|Physician Decision|15|||
147497234|NCT00115765|531972456|FG002|Overall Study|Physician Decision|18|||
147497235|NCT00115765|531972457|FG003|Overall Study|Physician Decision|13|||
147497236|NCT00115765|531972454|FG000|Overall Study|Lost to Follow-up|3|||
147497237|NCT00115765|531972455|FG001|Overall Study|Lost to Follow-up|20|||
147497238|NCT00115765|531972456|FG002|Overall Study|Lost to Follow-up|18|||
147497239|NCT00115765|531972457|FG003|Overall Study|Lost to Follow-up|1|||
147497240|NCT00115765|531972454|FG000|Overall Study|Other|6|||
147497241|NCT00115765|531972455|FG001|Overall Study|Other|12|||
147497242|NCT00115765|531972456|FG002|Overall Study|Other|9|||
147497243|NCT00115765|531972457|FG003|Overall Study|Other|2|||
147630969|NCT01908829|532467650|FG001|Overall Study|Discontinued (no EoT page)|0|||
147630970|NCT01908829|532467651|FG002|Overall Study|Discontinued (no EoT page)|0|||
147630971|NCT01908829|532467649|FG000|Overall Study|Miscellaneous|0|||
147630972|NCT01908829|532467650|FG001|Overall Study|Miscellaneous|2|||
147630973|NCT01908829|532467651|FG002|Overall Study|Miscellaneous|0|||
147497244|NCT00995670|531972458|FG000|Overall Study|Failed arterial cannulation|1|||
147497245|NCT00995670|531972459|FG001|Overall Study|Failed arterial cannulation|0|||
147497246|NCT00995670|531972460|FG002|Overall Study|Failed arterial cannulation|3|||
147497247|NCT00675103|531972461|FG000|Overall Study|Lack of Efficacy|2|||
147630974|NCT01908829|532467649|FG000|Overall Study|Protocol Violation|2|||
147630975|NCT01908829|532467650|FG001|Overall Study|Protocol Violation|2|||
147630976|NCT01908829|532467651|FG002|Overall Study|Protocol Violation|0|||
147630977|NCT01908829|532467649|FG000|Overall Study|Lack of Efficacy|1|||
147630978|NCT01908829|532467650|FG001|Overall Study|Lack of Efficacy|3|||
147630979|NCT01908829|532467651|FG002|Overall Study|Lack of Efficacy|2|||
147630980|NCT01908829|532467649|FG000|Overall Study|Withdrawal by Subject|26|||
147630981|NCT01908829|532467650|FG001|Overall Study|Withdrawal by Subject|29|||
147630982|NCT01908829|532467651|FG002|Overall Study|Withdrawal by Subject|22|||
147630983|NCT02865499|532467652|FG000|Baseline|Adverse Event|1|||
147630984|NCT02865499|532467652|FG000|Baseline|Withdrawal by Subject|1|||
147630985|NCT02247440|532467653|FG000|Overall Study|Withdrawal by Subject|1|||
147630986|NCT02247440|532467653|FG000|Overall Study|Lack of Efficacy|3|||
147630987|NCT02792192|532467654|FG000|Overall Study|Death|1|||
147630988|NCT02792192|532467655|FG001|Overall Study|Death|0|||
147630989|NCT02792192|532467656|FG002|Overall Study|Death|0|||
147630990|NCT02792192|532467657|FG003|Overall Study|Death|0|||
147630991|NCT02792192|532467654|FG000|Overall Study|Informed Consent Withdrawn|4|||
147630992|NCT02792192|532467655|FG001|Overall Study|Informed Consent Withdrawn|0|||
147630993|NCT02792192|532467656|FG002|Overall Study|Informed Consent Withdrawn|0|||
147630994|NCT02792192|532467657|FG003|Overall Study|Informed Consent Withdrawn|0|||
147630995|NCT02792192|532467654|FG000|Overall Study|Physician Decision|1|||
147630996|NCT02792192|532467655|FG001|Overall Study|Physician Decision|0|||
147630997|NCT02792192|532467656|FG002|Overall Study|Physician Decision|0|||
147630998|NCT02792192|532467657|FG003|Overall Study|Physician Decision|0|||
147630999|NCT02792192|532467654|FG000|Overall Study|Progressive Disease|0|||
147631000|NCT02792192|532467655|FG001|Overall Study|Progressive Disease|1|||
147631001|NCT02792192|532467656|FG002|Overall Study|Progressive Disease|0|||
147631002|NCT02792192|532467657|FG003|Overall Study|Progressive Disease|0|||
147631003|NCT02792192|532467654|FG000|Overall Study|Study Terminated By Sponsor|6|||
147631004|NCT02792192|532467655|FG001|Overall Study|Study Terminated By Sponsor|10|||
147631005|NCT02792192|532467656|FG002|Overall Study|Study Terminated By Sponsor|0|||
147631006|NCT02792192|532467657|FG003|Overall Study|Study Terminated By Sponsor|0|||
147631007|NCT02320058|532467658|FG000|Overall Study|Death|25|||
147631008|NCT02320058|532467659|FG001|Overall Study|Death|10|||
147631009|NCT02320058|532467658|FG000|Overall Study|Lost to Follow-up|4|||
147631010|NCT02320058|532467659|FG001|Overall Study|Lost to Follow-up|0|||
147631011|NCT02320058|532467658|FG000|Overall Study|Other reasons|4|||
147631012|NCT02320058|532467659|FG001|Overall Study|Other reasons|1|||
147631013|NCT02320058|532467658|FG000|Overall Study|Withdrawal by Subject|8|||
147631014|NCT02320058|532467659|FG001|Overall Study|Withdrawal by Subject|2|||
147631015|NCT02320058|532467658|FG000|Overall Study|Not reported|1|||
147631016|NCT02320058|532467659|FG001|Overall Study|Not reported|0|||
147631017|NCT00661609|532467660|FG000|Overall Study|Adverse Event|4|||
147631018|NCT00661609|532467660|FG000|Overall Study|Death|20|||
147631019|NCT00661609|532467660|FG000|Overall Study|Withdrawal by Subject|2|||
147631020|NCT00661609|532467660|FG000|Overall Study|PI Decision|1|||
147631021|NCT00661609|532467660|FG000|Overall Study|Survival follow up stage discontinued|11|||
147631022|NCT00661609|532467660|FG000|Overall Study|Disease progression|3|||
147631023|NCT01430403|532467661|FG000|Overall Study|Lost to Follow-up|5|||
147631024|NCT01430403|532467662|FG001|Overall Study|Lost to Follow-up|5|||
147631025|NCT01430403|532467663|FG002|Overall Study|Lost to Follow-up|3|||
147631026|NCT01430403|532467661|FG000|Overall Study|Physician Decision|1|||
147631027|NCT01430403|532467662|FG001|Overall Study|Physician Decision|0|||
147631028|NCT01430403|532467663|FG002|Overall Study|Physician Decision|0|||
147631029|NCT01430403|532467661|FG000|Overall Study|Protocol Violation|2|||
147631030|NCT01430403|532467662|FG001|Overall Study|Protocol Violation|3|||
147631031|NCT01430403|532467663|FG002|Overall Study|Protocol Violation|2|||
147631032|NCT01430403|532467661|FG000|Overall Study|Withdrawal by Subject|9|||
147631033|NCT01430403|532467662|FG001|Overall Study|Withdrawal by Subject|1|||
147631034|NCT01430403|532467663|FG002|Overall Study|Withdrawal by Subject|3|||
147631035|NCT04481789|532467666|FG000|Period 1|Withdrawal by Subject|1|||
147631036|NCT04481789|532467667|FG001|Period 1|Withdrawal by Subject|0|||
147631037|NCT04481789|532467668|FG002|Period 1|Withdrawal by Subject|0|||
147631038|NCT04481789|532467669|FG003|Period 1|Withdrawal by Subject|0|||
147631039|NCT04481789|532467670|FG004|Period 1|Withdrawal by Subject|0|||
147631040|NCT04481789|532467671|FG005|Period 1|Withdrawal by Subject|0|||
147631041|NCT02477332|532467672|FG000|Overall Study|Adverse Event|0|||
147631042|NCT02477332|532467673|FG001|Overall Study|Adverse Event|1|||
147631043|NCT02477332|532467674|FG002|Overall Study|Adverse Event|1|||
147631044|NCT02477332|532467675|FG003|Overall Study|Adverse Event|2|||
147631045|NCT02477332|532467676|FG004|Overall Study|Adverse Event|1|||
147631046|NCT02477332|532467677|FG005|Overall Study|Adverse Event|2|||
147631047|NCT02477332|532467672|FG000|Overall Study|Lack of Efficacy|1|||
147631048|NCT02477332|532467673|FG001|Overall Study|Lack of Efficacy|2|||
147631049|NCT02477332|532467674|FG002|Overall Study|Lack of Efficacy|1|||
147631050|NCT02477332|532467675|FG003|Overall Study|Lack of Efficacy|2|||
147631051|NCT02477332|532467676|FG004|Overall Study|Lack of Efficacy|1|||
147631052|NCT02477332|532467677|FG005|Overall Study|Lack of Efficacy|1|||
147631053|NCT02477332|532467672|FG000|Overall Study|Non-compliance with study treatment|0|||
147631054|NCT02477332|532467673|FG001|Overall Study|Non-compliance with study treatment|1|||
147631055|NCT02477332|532467674|FG002|Overall Study|Non-compliance with study treatment|2|||
147631056|NCT02477332|532467675|FG003|Overall Study|Non-compliance with study treatment|0|||
147668508|NCT00769561|532611809|FG000|Overall Study|Lost to Follow-up|1|||
147631057|NCT02477332|532467676|FG004|Overall Study|Non-compliance with study treatment|0|||
147631058|NCT02477332|532467677|FG005|Overall Study|Non-compliance with study treatment|0|||
147631059|NCT02477332|532467672|FG000|Overall Study|Pregnancy|0|||
147631060|NCT02477332|532467673|FG001|Overall Study|Pregnancy|0|||
147631061|NCT02477332|532467674|FG002|Overall Study|Pregnancy|0|||
147631062|NCT02477332|532467675|FG003|Overall Study|Pregnancy|1|||
147631063|NCT02477332|532467676|FG004|Overall Study|Pregnancy|0|||
147631064|NCT02477332|532467677|FG005|Overall Study|Pregnancy|0|||
147631065|NCT02477332|532467672|FG000|Overall Study|Protocol Violation|2|||
147631066|NCT02477332|532467673|FG001|Overall Study|Protocol Violation|0|||
147631067|NCT02477332|532467674|FG002|Overall Study|Protocol Violation|3|||
147631068|NCT02477332|532467675|FG003|Overall Study|Protocol Violation|3|||
147631069|NCT02477332|532467676|FG004|Overall Study|Protocol Violation|1|||
147631070|NCT02477332|532467677|FG005|Overall Study|Protocol Violation|1|||
147631071|NCT02477332|532467672|FG000|Overall Study|Technical problems|0|||
147631072|NCT02477332|532467673|FG001|Overall Study|Technical problems|0|||
147631073|NCT02477332|532467674|FG002|Overall Study|Technical problems|1|||
147631074|NCT02477332|532467675|FG003|Overall Study|Technical problems|0|||
147631075|NCT02477332|532467676|FG004|Overall Study|Technical problems|0|||
147631076|NCT02477332|532467677|FG005|Overall Study|Technical problems|0|||
147631077|NCT02477332|532467672|FG000|Overall Study|Lost to Follow-up|0|||
147631078|NCT02477332|532467673|FG001|Overall Study|Lost to Follow-up|0|||
147631079|NCT02477332|532467674|FG002|Overall Study|Lost to Follow-up|2|||
147631080|NCT02477332|532467675|FG003|Overall Study|Lost to Follow-up|0|||
147631081|NCT02477332|532467676|FG004|Overall Study|Lost to Follow-up|0|||
147631082|NCT02477332|532467677|FG005|Overall Study|Lost to Follow-up|0|||
147631083|NCT02477332|532467672|FG000|Overall Study|Physician Decision|0|||
147631084|NCT02477332|532467673|FG001|Overall Study|Physician Decision|0|||
147631085|NCT02477332|532467674|FG002|Overall Study|Physician Decision|1|||
147631086|NCT02477332|532467675|FG003|Overall Study|Physician Decision|3|||
147631087|NCT02477332|532467676|FG004|Overall Study|Physician Decision|0|||
147631088|NCT02477332|532467677|FG005|Overall Study|Physician Decision|1|||
147631089|NCT02477332|532467672|FG000|Overall Study|Withdrawal by Subject|0|||
147631090|NCT02477332|532467673|FG001|Overall Study|Withdrawal by Subject|3|||
147631091|NCT02477332|532467674|FG002|Overall Study|Withdrawal by Subject|1|||
147631092|NCT02477332|532467675|FG003|Overall Study|Withdrawal by Subject|2|||
147631093|NCT02477332|532467676|FG004|Overall Study|Withdrawal by Subject|1|||
147631094|NCT02477332|532467677|FG005|Overall Study|Withdrawal by Subject|0|||
147631095|NCT00900159|532467682|FG000|Second Intervention|disempanelled for inappropriate behavior|1|||
147631096|NCT00900159|532467683|FG001|Second Intervention|disempanelled for inappropriate behavior|0|||
147631097|NCT01075256|532467684|FG000|Overall Study|Withdrawal by Subject|1|||
147631098|NCT01075256|532467685|FG001|Overall Study|Withdrawal by Subject|0|||
147631099|NCT01075256|532467686|FG002|Overall Study|Withdrawal by Subject|0|||
147631100|NCT02593097|532467700|FG000|First Intervention (12 Weeks)|Lost to Follow-up|1|||
147631101|NCT02593097|532467701|FG001|First Intervention (12 Weeks)|Lost to Follow-up|2|||
147631102|NCT02593097|532467700|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
147631103|NCT02593097|532467701|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|2|||
147631104|NCT02593097|532467700|FG000|Second Intervention (12 Weeks)|Lost to Follow-up|1|||
147631105|NCT02593097|532467701|FG001|Second Intervention (12 Weeks)|Lost to Follow-up|1|||
147631106|NCT02593097|532467700|FG000|Second Intervention (12 Weeks)|Lack of Efficacy|1|||
147631107|NCT02593097|532467701|FG001|Second Intervention (12 Weeks)|Lack of Efficacy|0|||
147631108|NCT02593097|532467700|FG000|Second Intervention (12 Weeks)|Withdrawal by Subject|1|||
147631109|NCT02593097|532467701|FG001|Second Intervention (12 Weeks)|Withdrawal by Subject|0|||
147631110|NCT03759587|532467702|FG000|Overall Study|Adverse Event|5|||
147631111|NCT03759587|532467702|FG000|Overall Study|Progressive Disease|10|||
147631112|NCT03759587|532467702|FG000|Overall Study|Site Terminated by Sponsor|3|||
147631113|NCT03759587|532467702|FG000|Overall Study|Withdrawal by Subject|1|||
147631114|NCT00665431|532467704|FG000|Overall Study|Adverse Event|16|||
147631115|NCT00665431|532467705|FG001|Overall Study|Adverse Event|22|||
147631116|NCT00665431|532467706|FG002|Overall Study|Adverse Event|6|||
147631117|NCT00665431|532467704|FG000|Overall Study|Withdrawal by Subject|17|||
147631118|NCT00665431|532467705|FG001|Overall Study|Withdrawal by Subject|25|||
147631119|NCT00665431|532467706|FG002|Overall Study|Withdrawal by Subject|15|||
147631120|NCT00665431|532467704|FG000|Overall Study|Lost to Follow-up|3|||
147631121|NCT00665431|532467705|FG001|Overall Study|Lost to Follow-up|3|||
147631122|NCT00665431|532467706|FG002|Overall Study|Lost to Follow-up|1|||
147631123|NCT00665431|532467704|FG000|Overall Study|Other|4|||
147631124|NCT00665431|532467705|FG001|Overall Study|Other|7|||
147631125|NCT00665431|532467706|FG002|Overall Study|Other|2|||
147631126|NCT00454363|532467707|FG000|Overall Study|Adverse Event|1|||
147631127|NCT00454363|532467708|FG001|Overall Study|Adverse Event|2|||
147631128|NCT00454363|532467707|FG000|Overall Study|Withdrawal prior to 12 weeks treatment|4|||
147631129|NCT00454363|532467708|FG001|Overall Study|Withdrawal prior to 12 weeks treatment|0|||
147631130|NCT01578239|532467709|FG000|Treatment Period|Progressive Disease|19|||
147631131|NCT01578239|532467710|FG001|Treatment Period|Progressive Disease|64|||
147631132|NCT01578239|532467709|FG000|Treatment Period|Physician Decision|17|||
147631133|NCT01578239|532467710|FG001|Treatment Period|Physician Decision|17|||
147497248|NCT00675103|531972461|FG000|Overall Study|Adverse Event|1|||
147497249|NCT02164513|531972465|FG000|Overall Study|Adverse Event|162|||
147497250|NCT02164513|531972466|FG001|Overall Study|Adverse Event|180|||
147497251|NCT02164513|531972467|FG002|Overall Study|Adverse Event|111|||
147497252|NCT02164513|531972465|FG000|Overall Study|Other: Study Closed or terminated|5|||
147497253|NCT02164513|531972466|FG001|Overall Study|Other: Study Closed or terminated|2|||
147497254|NCT02164513|531972467|FG002|Overall Study|Other: Study Closed or terminated|4|||
147497255|NCT02164513|531972465|FG000|Overall Study|Lost to Follow-up|30|||
147497256|NCT02164513|531972466|FG001|Overall Study|Lost to Follow-up|36|||
147497257|NCT02164513|531972467|FG002|Overall Study|Lost to Follow-up|22|||
147497258|NCT02164513|531972465|FG000|Overall Study|Physician Decision|47|||
147497259|NCT02164513|531972466|FG001|Overall Study|Physician Decision|57|||
147497260|NCT02164513|531972467|FG002|Overall Study|Physician Decision|28|||
147497261|NCT02164513|531972465|FG000|Overall Study|Withdrawal by Subject|192|||
147497262|NCT02164513|531972466|FG001|Overall Study|Withdrawal by Subject|261|||
147497263|NCT02164513|531972467|FG002|Overall Study|Withdrawal by Subject|130|||
147497264|NCT02164513|531972465|FG000|Overall Study|Other: Reason not provided by site|1|||
147497265|NCT02164513|531972466|FG001|Overall Study|Other: Reason not provided by site|0|||
147497266|NCT02164513|531972467|FG002|Overall Study|Other: Reason not provided by site|0|||
147497267|NCT02773238|531972469|FG000|Overall Study|Lack of Efficacy|4|||
147497268|NCT04095286|531972470|FG000|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
147497269|NCT04095286|531972471|FG001|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|1|||
147497270|NCT04095286|531972472|FG002|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
147497271|NCT04095286|531972473|FG003|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
147497272|NCT04095286|531972474|FG004|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
147497273|NCT04095286|531972475|FG005|Period 1 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
147497274|NCT04095286|531972470|FG000|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|1|||
147497275|NCT04095286|531972471|FG001|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0|||
147497276|NCT04095286|531972472|FG002|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0|||
147497277|NCT04095286|531972473|FG003|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0|||
147497278|NCT04095286|531972474|FG004|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0|||
147497279|NCT04095286|531972475|FG005|Period 1 (4 Days) + Washout (7days)|Withdrawal by Subject|0|||
147497280|NCT04095286|531972470|FG000|Period 1 (4 Days) + Washout (7days)|Adverse Event|0|||
147497281|NCT04095286|531972471|FG001|Period 1 (4 Days) + Washout (7days)|Adverse Event|0|||
147497282|NCT04095286|531972472|FG002|Period 1 (4 Days) + Washout (7days)|Adverse Event|1|||
147497283|NCT04095286|531972473|FG003|Period 1 (4 Days) + Washout (7days)|Adverse Event|0|||
147497284|NCT04095286|531972474|FG004|Period 1 (4 Days) + Washout (7days)|Adverse Event|0|||
147497285|NCT04095286|531972475|FG005|Period 1 (4 Days) + Washout (7days)|Adverse Event|0|||
147497286|NCT04095286|531972470|FG000|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
147497287|NCT04095286|531972471|FG001|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
147497288|NCT04095286|531972472|FG002|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|2|||
147497289|NCT04095286|531972473|FG003|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
147497290|NCT04095286|531972474|FG004|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
147497291|NCT04095286|531972475|FG005|Period 2 (4 Days) + Washout (7days)|Met Protocol-defined Stopping Criteria|0|||
147497292|NCT04095286|531972470|FG000|Period 2 (4 Days) + Washout (7days)|Adverse Event|0|||
147497293|NCT04095286|531972471|FG001|Period 2 (4 Days) + Washout (7days)|Adverse Event|0|||
147497294|NCT04095286|531972472|FG002|Period 2 (4 Days) + Washout (7days)|Adverse Event|0|||
147497295|NCT04095286|531972473|FG003|Period 2 (4 Days) + Washout (7days)|Adverse Event|0|||
147497296|NCT04095286|531972474|FG004|Period 2 (4 Days) + Washout (7days)|Adverse Event|1|||
147497297|NCT04095286|531972475|FG005|Period 2 (4 Days) + Washout (7days)|Adverse Event|0|||
147497298|NCT00479557|531972476|FG000|Overall Study|Death|0|||
147497299|NCT00479557|531972477|FG001|Overall Study|Death|0|||
147497300|NCT00479557|531972478|FG002|Overall Study|Death|0|||
147497301|NCT00479557|531972479|FG003|Overall Study|Death|0|||
147497302|NCT00479557|531972480|FG004|Overall Study|Death|0|||
147497303|NCT00479557|531972481|FG005|Overall Study|Death|1|||
147497304|NCT00479557|531972482|FG006|Overall Study|Death|0|||
147497305|NCT00479557|531972476|FG000|Overall Study|Lack of Efficacy|1|||
147497306|NCT00479557|531972477|FG001|Overall Study|Lack of Efficacy|0|||
147497307|NCT00479557|531972478|FG002|Overall Study|Lack of Efficacy|0|||
147631134|NCT01578239|532467709|FG000|Treatment Period|Adverse Event|13|||
147631135|NCT01578239|532467710|FG001|Treatment Period|Adverse Event|10|||
147497308|NCT00479557|531972479|FG003|Overall Study|Lack of Efficacy|0|||
147497309|NCT00479557|531972480|FG004|Overall Study|Lack of Efficacy|0|||
147497310|NCT00479557|531972481|FG005|Overall Study|Lack of Efficacy|0|||
147497311|NCT00479557|531972482|FG006|Overall Study|Lack of Efficacy|0|||
147497312|NCT00479557|531972476|FG000|Overall Study|Lost to Follow-up|0|||
147497313|NCT00479557|531972477|FG001|Overall Study|Lost to Follow-up|2|||
147497314|NCT00479557|531972478|FG002|Overall Study|Lost to Follow-up|0|||
147497315|NCT00479557|531972479|FG003|Overall Study|Lost to Follow-up|2|||
147497316|NCT00479557|531972480|FG004|Overall Study|Lost to Follow-up|0|||
147497317|NCT00479557|531972481|FG005|Overall Study|Lost to Follow-up|0|||
147497318|NCT00479557|531972482|FG006|Overall Study|Lost to Follow-up|0|||
147497319|NCT00479557|531972476|FG000|Overall Study|Adverse Event (AE) related to Study Drug|1|||
147631136|NCT01578239|532467709|FG000|Treatment Period|Non-compliance|2|||
147631137|NCT01578239|532467710|FG001|Treatment Period|Non-compliance|0|||
147631138|NCT01578239|532467709|FG000|Treatment Period|Withdrawal by Subject|10|||
147631139|NCT01578239|532467710|FG001|Treatment Period|Withdrawal by Subject|9|||
147631140|NCT01578239|532467709|FG000|Treatment Period|Other|6|||
147631141|NCT01578239|532467710|FG001|Treatment Period|Other|1|||
147631142|NCT01578239|532467709|FG000|Long-term Follow-Up Period|Death|69|||
147631143|NCT01578239|532467710|FG001|Long-term Follow-Up Period|Death|64|||
147631144|NCT01578239|532467709|FG000|Long-term Follow-Up Period|Consent withdrawal|4|||
147631145|NCT01578239|532467710|FG001|Long-term Follow-Up Period|Consent withdrawal|10|||
147631146|NCT01578239|532467709|FG000|Long-term Follow-Up Period|Lost to Follow-up|2|||
147631147|NCT01578239|532467710|FG001|Long-term Follow-Up Period|Lost to Follow-up|4|||
147631148|NCT01578239|532467709|FG000|Long-term Follow-Up Period|Other|2|||
147631149|NCT01578239|532467710|FG001|Long-term Follow-Up Period|Other|2|||
147631150|NCT02654977|532467719|FG000|Overall Study|Death|1|||
147631151|NCT02654977|532467719|FG000|Overall Study|Lost to Follow-up|1|||
147631152|NCT02654977|532467719|FG000|Overall Study|Adverse Event|1|||
147631153|NCT02654977|532467719|FG000|Overall Study|Withdrawal by Subject|1|||
147631154|NCT02654977|532467719|FG000|Overall Study|Lack of Efficacy|3|||
147631155|NCT01266291|532467721|FG000|Overall Study|Adverse Event|1|||
147631156|NCT03291431|532467722|FG000|Overall Study|Protocol Violation|2|||
147631157|NCT03291431|532467723|FG001|Overall Study|Protocol Violation|1|||
147631158|NCT03291431|532467722|FG000|Overall Study|Participant self-discharged against medical advice from treatment program during active study phase|1|||
147631159|NCT03291431|532467723|FG001|Overall Study|Participant self-discharged against medical advice from treatment program during active study phase|0|||
147631160|NCT03291431|532467722|FG000|Overall Study|Residential treatment team requested participant withdraw due to multiple conflicting appointments.|0|||
147631161|NCT03291431|532467723|FG001|Overall Study|Residential treatment team requested participant withdraw due to multiple conflicting appointments.|1|||
147631162|NCT03508726|532469387|FG000|Overall Study|Withdrawal by Subject|0|||
147631163|NCT03508726|532469388|FG001|Overall Study|Withdrawal by Subject|1|||
147631164|NCT00178685|532469393|FG000|Overall Study|Death|3|||
147631165|NCT00178685|532469394|FG001|Overall Study|Death|3|||
147631166|NCT00178685|532469395|FG002|Overall Study|Death|6|||
147631167|NCT00178685|532469393|FG000|Overall Study|Lost to Follow-up|100|||
147631168|NCT00178685|532469394|FG001|Overall Study|Lost to Follow-up|187|||
147631169|NCT00178685|532469395|FG002|Overall Study|Lost to Follow-up|183|||
147631170|NCT00178685|532469393|FG000|Overall Study|Withdrawal by Subject|8|||
147631171|NCT00178685|532469394|FG001|Overall Study|Withdrawal by Subject|14|||
147631172|NCT00178685|532469395|FG002|Overall Study|Withdrawal by Subject|7|||
147631173|NCT04112043|532469396|FG000|Overall Study|Withdrawal by Subject|1|||
147631174|NCT04112043|532469397|FG001|Overall Study|Withdrawal by Subject|1|||
147631175|NCT04112043|532469398|FG002|Overall Study|Withdrawal by Subject|1|||
147631176|NCT04112043|532469396|FG000|Overall Study|Taking NR supplement|1|||
147631177|NCT04112043|532469397|FG001|Overall Study|Taking NR supplement|0|||
147631178|NCT04112043|532469398|FG002|Overall Study|Taking NR supplement|0|||
147631179|NCT04112043|532469396|FG000|Overall Study|Adverse Event|0|||
147631180|NCT04112043|532469397|FG001|Overall Study|Adverse Event|1|||
147631181|NCT04112043|532469398|FG002|Overall Study|Adverse Event|0|||
147631182|NCT01750697|532469401|FG000|Overall Study|Transferred Back to Local Hospital|1|||
147631183|NCT01750697|532469401|FG000|Overall Study|Physician and Family Decision|1|||
147631184|NCT01750697|532469401|FG000|Overall Study|Transferred to Adult Services|5|||
147631185|NCT01750697|532469401|FG000|Overall Study|Physician Decision|1|||
147631186|NCT01750697|532469401|FG000|Overall Study|Withdrawal by Subject|1|||
147631187|NCT01057810|532469402|FG000|Overall Study|Disease progression|156|||
147631188|NCT01057810|532469403|FG001|Overall Study|Disease progression|197|||
147631189|NCT01057810|532469402|FG000|Overall Study|Study drug toxicity|5|||
147631190|NCT01057810|532469403|FG001|Overall Study|Study drug toxicity|114|||
147631191|NCT01057810|532469402|FG000|Overall Study|Adverse event unrelated to study drug|13|||
147631192|NCT01057810|532469403|FG001|Overall Study|Adverse event unrelated to study drug|29|||
147631193|NCT01057810|532469402|FG000|Overall Study|Withdrawal by Subject|10|||
147631194|NCT01057810|532469403|FG001|Overall Study|Withdrawal by Subject|25|||
147631195|NCT01057810|532469402|FG000|Overall Study|Death|2|||
147631196|NCT01057810|532469403|FG001|Overall Study|Death|12|||
147631197|NCT01057810|532469402|FG000|Overall Study|Maximum clinical benefit|5|||
147497320|NCT00479557|531972477|FG001|Overall Study|Adverse Event (AE) related to Study Drug|0|||
147497321|NCT00479557|531972478|FG002|Overall Study|Adverse Event (AE) related to Study Drug|3|||
147497322|NCT00479557|531972479|FG003|Overall Study|Adverse Event (AE) related to Study Drug|2|||
147631198|NCT01057810|532469403|FG001|Overall Study|Maximum clinical benefit|5|||
147631199|NCT01057810|532469402|FG000|Overall Study|Poor/non-compliance|0|||
147631200|NCT01057810|532469403|FG001|Overall Study|Poor/non-compliance|1|||
147631201|NCT01057810|532469402|FG000|Overall Study|No longer met study criteria|0|||
147631202|NCT01057810|532469403|FG001|Overall Study|No longer met study criteria|1|||
147631203|NCT01057810|532469402|FG000|Overall Study|Other|7|||
147631204|NCT01057810|532469403|FG001|Overall Study|Other|14|||
147631205|NCT02088905|532469404|FG000|Overall Study|Withdrawal by Subject|5|||
147631206|NCT02088905|532469405|FG001|Overall Study|Withdrawal by Subject|1|||
147631207|NCT00267969|532469406|FG000|Controlled Period|Adverse Event|6|||
147631208|NCT00267969|532469407|FG001|Controlled Period|Adverse Event|0|||
147631209|NCT00267969|532469408|FG002|Controlled Period|Adverse Event|2|||
147631210|NCT00267969|532469409|FG003|Controlled Period|Adverse Event|0|||
147631211|NCT00267969|532469410|FG004|Controlled Period|Adverse Event|0|||
147631212|NCT00267969|532469411|FG005|Controlled Period|Adverse Event|0|||
147631213|NCT00267969|532469412|FG006|Controlled Period|Adverse Event|0|||
147631214|NCT00267969|532469406|FG000|Controlled Period|Lack of Efficacy|3|||
147631215|NCT00267969|532469407|FG001|Controlled Period|Lack of Efficacy|0|||
147631216|NCT00267969|532469408|FG002|Controlled Period|Lack of Efficacy|1|||
147631217|NCT00267969|532469409|FG003|Controlled Period|Lack of Efficacy|0|||
147631218|NCT00267969|532469410|FG004|Controlled Period|Lack of Efficacy|0|||
147631219|NCT00267969|532469411|FG005|Controlled Period|Lack of Efficacy|0|||
147631220|NCT00267969|532469412|FG006|Controlled Period|Lack of Efficacy|0|||
147631221|NCT00267969|532469406|FG000|Controlled Period|Lost to Follow-up|1|||
147631222|NCT00267969|532469407|FG001|Controlled Period|Lost to Follow-up|0|||
147631223|NCT00267969|532469408|FG002|Controlled Period|Lost to Follow-up|1|||
147631224|NCT00267969|532469409|FG003|Controlled Period|Lost to Follow-up|0|||
147631225|NCT00267969|532469410|FG004|Controlled Period|Lost to Follow-up|0|||
147631226|NCT00267969|532469411|FG005|Controlled Period|Lost to Follow-up|0|||
147631227|NCT00267969|532469412|FG006|Controlled Period|Lost to Follow-up|0|||
147631228|NCT00267969|532469406|FG000|Controlled Period|Randomized but not treated|0|||
147631229|NCT00267969|532469407|FG001|Controlled Period|Randomized but not treated|0|||
147631230|NCT00267969|532469408|FG002|Controlled Period|Randomized but not treated|1|||
147631231|NCT00267969|532469409|FG003|Controlled Period|Randomized but not treated|0|||
147631232|NCT00267969|532469410|FG004|Controlled Period|Randomized but not treated|0|||
147631233|NCT00267969|532469411|FG005|Controlled Period|Randomized but not treated|0|||
147631234|NCT00267969|532469412|FG006|Controlled Period|Randomized but not treated|0|||
147631235|NCT00267969|532469406|FG000|Controlled Period|Other|2|||
147631236|NCT00267969|532469407|FG001|Controlled Period|Other|1|||
147631237|NCT00267969|532469408|FG002|Controlled Period|Other|6|||
147631238|NCT00267969|532469409|FG003|Controlled Period|Other|0|||
147631239|NCT00267969|532469410|FG004|Controlled Period|Other|0|||
147631240|NCT00267969|532469411|FG005|Controlled Period|Other|0|||
147631241|NCT00267969|532469412|FG006|Controlled Period|Other|0|||
147631242|NCT00267969|532469406|FG000|After Controlled Period|Adverse Event|0|||
147631243|NCT00267969|532469407|FG001|After Controlled Period|Adverse Event|0|||
147631244|NCT00267969|532469408|FG002|After Controlled Period|Adverse Event|0|||
147631245|NCT00267969|532469409|FG003|After Controlled Period|Adverse Event|7|||
147631246|NCT00267969|532469410|FG004|After Controlled Period|Adverse Event|8|||
147631247|NCT00267969|532469411|FG005|After Controlled Period|Adverse Event|23|||
147631248|NCT00267969|532469412|FG006|After Controlled Period|Adverse Event|21|||
147631249|NCT00267969|532469406|FG000|After Controlled Period|Death|0|||
147631250|NCT00267969|532469407|FG001|After Controlled Period|Death|0|||
147631251|NCT00267969|532469408|FG002|After Controlled Period|Death|0|||
147631252|NCT00267969|532469409|FG003|After Controlled Period|Death|1|||
147631253|NCT00267969|532469410|FG004|After Controlled Period|Death|2|||
147631254|NCT00267969|532469411|FG005|After Controlled Period|Death|0|||
147631255|NCT00267969|532469412|FG006|After Controlled Period|Death|1|||
147631256|NCT00267969|532469406|FG000|After Controlled Period|Lack of Efficacy|0|||
147631257|NCT00267969|532469407|FG001|After Controlled Period|Lack of Efficacy|0|||
147631258|NCT00267969|532469408|FG002|After Controlled Period|Lack of Efficacy|0|||
147631259|NCT00267969|532469409|FG003|After Controlled Period|Lack of Efficacy|10|||
147631260|NCT00267969|532469410|FG004|After Controlled Period|Lack of Efficacy|6|||
147631261|NCT00267969|532469411|FG005|After Controlled Period|Lack of Efficacy|28|||
147497323|NCT00479557|531972480|FG004|Overall Study|Adverse Event (AE) related to Study Drug|0|||
147631262|NCT00267969|532469412|FG006|After Controlled Period|Lack of Efficacy|15|||
147631263|NCT00267969|532469406|FG000|After Controlled Period|Lost to Follow-up|0|||
147497324|NCT00479557|531972481|FG005|Overall Study|Adverse Event (AE) related to Study Drug|1|||
147497325|NCT00479557|531972482|FG006|Overall Study|Adverse Event (AE) related to Study Drug|0|||
147631264|NCT00267969|532469407|FG001|After Controlled Period|Lost to Follow-up|0|||
147497326|NCT00479557|531972476|FG000|Overall Study|AE not related to Study Drug|1|||
147631265|NCT00267969|532469408|FG002|After Controlled Period|Lost to Follow-up|0|||
147631266|NCT00267969|532469409|FG003|After Controlled Period|Lost to Follow-up|5|||
147631267|NCT00267969|532469410|FG004|After Controlled Period|Lost to Follow-up|8|||
147631268|NCT00267969|532469411|FG005|After Controlled Period|Lost to Follow-up|9|||
147631269|NCT00267969|532469412|FG006|After Controlled Period|Lost to Follow-up|10|||
147497327|NCT00479557|531972477|FG001|Overall Study|AE not related to Study Drug|3|||
147631270|NCT00267969|532469406|FG000|After Controlled Period|Other|0|||
147631271|NCT00267969|532469407|FG001|After Controlled Period|Other|0|||
147631272|NCT00267969|532469408|FG002|After Controlled Period|Other|0|||
147631273|NCT00267969|532469409|FG003|After Controlled Period|Other|13|||
147631274|NCT00267969|532469410|FG004|After Controlled Period|Other|11|||
147631275|NCT00267969|532469411|FG005|After Controlled Period|Other|22|||
147497328|NCT00479557|531972478|FG002|Overall Study|AE not related to Study Drug|0|||
147497329|NCT00479557|531972479|FG003|Overall Study|AE not related to Study Drug|0|||
147497330|NCT00479557|531972480|FG004|Overall Study|AE not related to Study Drug|2|||
147497331|NCT00479557|531972481|FG005|Overall Study|AE not related to Study Drug|2|||
147497332|NCT00479557|531972482|FG006|Overall Study|AE not related to Study Drug|1|||
147497333|NCT00479557|531972476|FG000|Overall Study|Caregiver Request|2|||
147497334|NCT00479557|531972477|FG001|Overall Study|Caregiver Request|2|||
147497335|NCT00479557|531972478|FG002|Overall Study|Caregiver Request|2|||
147497336|NCT00479557|531972479|FG003|Overall Study|Caregiver Request|0|||
147497337|NCT00479557|531972480|FG004|Overall Study|Caregiver Request|1|||
147497338|NCT00479557|531972481|FG005|Overall Study|Caregiver Request|2|||
147497339|NCT00479557|531972482|FG006|Overall Study|Caregiver Request|0|||
147497340|NCT00479557|531972476|FG000|Overall Study|Investigator Request|0|||
147497341|NCT00479557|531972477|FG001|Overall Study|Investigator Request|0|||
147497342|NCT00479557|531972478|FG002|Overall Study|Investigator Request|1|||
147497343|NCT00479557|531972479|FG003|Overall Study|Investigator Request|0|||
147497344|NCT00479557|531972480|FG004|Overall Study|Investigator Request|0|||
147497345|NCT00479557|531972481|FG005|Overall Study|Investigator Request|0|||
147497346|NCT00479557|531972482|FG006|Overall Study|Investigator Request|0|||
147497347|NCT00479557|531972476|FG000|Overall Study|Subject Request|3|||
147497348|NCT00479557|531972477|FG001|Overall Study|Subject Request|0|||
147497349|NCT00479557|531972478|FG002|Overall Study|Subject Request|1|||
147497350|NCT00479557|531972479|FG003|Overall Study|Subject Request|1|||
147497351|NCT00479557|531972480|FG004|Overall Study|Subject Request|1|||
147497352|NCT00479557|531972481|FG005|Overall Study|Subject Request|4|||
147497353|NCT00479557|531972482|FG006|Overall Study|Subject Request|1|||
147497354|NCT00479557|531972476|FG000|Overall Study|Other|2|||
147497355|NCT00479557|531972477|FG001|Overall Study|Other|3|||
147497356|NCT00479557|531972478|FG002|Overall Study|Other|1|||
147497357|NCT00479557|531972479|FG003|Overall Study|Other|0|||
147497358|NCT00479557|531972480|FG004|Overall Study|Other|0|||
147497359|NCT00479557|531972481|FG005|Overall Study|Other|3|||
147497360|NCT00479557|531972482|FG006|Overall Study|Other|0|||
147497361|NCT02509494|531972483|FG000|Overall Study|Lost to Follow-up|8|||
147497362|NCT02509494|531972484|FG001|Overall Study|Lost to Follow-up|47|||
147497363|NCT02509494|531972485|FG002|Overall Study|Lost to Follow-up|19|||
147497364|NCT02509494|531972486|FG003|Overall Study|Lost to Follow-up|6|||
147497365|NCT02509494|531972487|FG004|Overall Study|Lost to Follow-up|3|||
147497366|NCT02509494|531972488|FG005|Overall Study|Lost to Follow-up|3|||
147497367|NCT02509494|531972489|FG006|Overall Study|Lost to Follow-up|1|||
147497368|NCT02509494|531972490|FG007|Overall Study|Lost to Follow-up|3|||
147497369|NCT02509494|531972491|FG008|Overall Study|Lost to Follow-up|1|||
147497370|NCT02509494|531972483|FG000|Overall Study|Physician Decision|2|||
147497371|NCT02509494|531972484|FG001|Overall Study|Physician Decision|1|||
147497372|NCT02509494|531972485|FG002|Overall Study|Physician Decision|0|||
147497373|NCT02509494|531972486|FG003|Overall Study|Physician Decision|0|||
147497374|NCT02509494|531972487|FG004|Overall Study|Physician Decision|0|||
147497375|NCT02509494|531972488|FG005|Overall Study|Physician Decision|0|||
147497376|NCT02509494|531972489|FG006|Overall Study|Physician Decision|0|||
147497377|NCT02509494|531972490|FG007|Overall Study|Physician Decision|0|||
147497378|NCT02509494|531972491|FG008|Overall Study|Physician Decision|0|||
147497379|NCT02509494|531972483|FG000|Overall Study|Withdrawal by Subject|4|||
147497380|NCT02509494|531972484|FG001|Overall Study|Withdrawal by Subject|17|||
147497381|NCT02509494|531972485|FG002|Overall Study|Withdrawal by Subject|7|||
147631276|NCT00267969|532469412|FG006|After Controlled Period|Other|25|||
147631277|NCT04075682|532469413|FG000|Overall Study|Lost to Follow-up|5|||
147631278|NCT04075682|532469414|FG001|Overall Study|Lost to Follow-up|5|||
147497382|NCT02509494|531972486|FG003|Overall Study|Withdrawal by Subject|5|||
147497383|NCT02509494|531972487|FG004|Overall Study|Withdrawal by Subject|0|||
147497384|NCT02509494|531972488|FG005|Overall Study|Withdrawal by Subject|6|||
147497385|NCT02509494|531972489|FG006|Overall Study|Withdrawal by Subject|1|||
147497386|NCT02509494|531972490|FG007|Overall Study|Withdrawal by Subject|2|||
147497387|NCT02509494|531972491|FG008|Overall Study|Withdrawal by Subject|1|||
147497388|NCT02509494|531972483|FG000|Overall Study|Death|0|||
147497389|NCT02509494|531972484|FG001|Overall Study|Death|1|||
147497390|NCT02509494|531972485|FG002|Overall Study|Death|0|||
147497391|NCT02509494|531972486|FG003|Overall Study|Death|0|||
147497392|NCT02509494|531972487|FG004|Overall Study|Death|1|||
147497393|NCT02509494|531972488|FG005|Overall Study|Death|0|||
147497394|NCT02509494|531972489|FG006|Overall Study|Death|0|||
147497395|NCT02509494|531972490|FG007|Overall Study|Death|1|||
147497396|NCT02509494|531972491|FG008|Overall Study|Death|0|||
147497397|NCT02509494|531972483|FG000|Overall Study|Other|0|||
147497398|NCT02509494|531972484|FG001|Overall Study|Other|4|||
147497399|NCT02509494|531972485|FG002|Overall Study|Other|5|||
147497400|NCT02509494|531972486|FG003|Overall Study|Other|0|||
147497401|NCT02509494|531972487|FG004|Overall Study|Other|0|||
147497402|NCT02509494|531972488|FG005|Overall Study|Other|0|||
147497403|NCT02509494|531972489|FG006|Overall Study|Other|0|||
147497404|NCT02509494|531972490|FG007|Overall Study|Other|0|||
147497405|NCT02509494|531972491|FG008|Overall Study|Other|0|||
147631279|NCT04075682|532469415|FG002|Overall Study|Lost to Follow-up|2|||
147631280|NCT04075682|532469416|FG003|Overall Study|Lost to Follow-up|2|||
147631281|NCT04075682|532469413|FG000|Overall Study|Withdrawal by Subject|1|||
147631282|NCT04075682|532469414|FG001|Overall Study|Withdrawal by Subject|0|||
147631283|NCT04075682|532469415|FG002|Overall Study|Withdrawal by Subject|1|||
147631284|NCT04075682|532469416|FG003|Overall Study|Withdrawal by Subject|0|||
147631285|NCT04075682|532469413|FG000|Overall Study|Protocol Violation|0|||
147631286|NCT04075682|532469414|FG001|Overall Study|Protocol Violation|1|||
147631287|NCT04075682|532469415|FG002|Overall Study|Protocol Violation|1|||
147631288|NCT04075682|532469416|FG003|Overall Study|Protocol Violation|0|||
147631289|NCT04075682|532469413|FG000|Overall Study|Not literate enough to self-administer study surveys|1|||
147631290|NCT04075682|532469414|FG001|Overall Study|Not literate enough to self-administer study surveys|0|||
147631291|NCT04075682|532469415|FG002|Overall Study|Not literate enough to self-administer study surveys|0|||
147631292|NCT04075682|532469416|FG003|Overall Study|Not literate enough to self-administer study surveys|0|||
147631293|NCT04075682|532469413|FG000|Overall Study|Lost study phone the first day of study participation|0|||
147631294|NCT04075682|532469414|FG001|Overall Study|Lost study phone the first day of study participation|1|||
147631295|NCT04075682|532469415|FG002|Overall Study|Lost study phone the first day of study participation|0|||
147631296|NCT04075682|532469416|FG003|Overall Study|Lost study phone the first day of study participation|0|||
147631297|NCT00887315|532469419|FG000|Overall Study|Study termination|7|||
147631298|NCT00887315|532469420|FG001|Overall Study|Study termination|4|||
147631299|NCT00384839|532469424|FG000|Overall Study|Adverse Event|4|||
147631300|NCT00384839|532469424|FG000|Overall Study|Investigator Request|1|||
147631301|NCT00384839|532469424|FG000|Overall Study|Patient Request|1|||
147631302|NCT00384839|532469424|FG000|Overall Study|Ineligible|2|||
147631303|NCT00443079|532469425|FG000|Overall Study|Lost to Follow-up|0|||
147631304|NCT00443079|532469426|FG001|Overall Study|Lost to Follow-up|1|||
147631305|NCT01421225|532469429|FG000|Overall Study|Withdrawal by Subject|0|||
147631306|NCT01421225|532469430|FG001|Overall Study|Withdrawal by Subject|1|||
147631307|NCT02649439|532469431|FG000|Overall Study|Switched to alternative treatment|6|||
147631308|NCT02649439|532469432|FG001|Overall Study|Switched to alternative treatment|4|||
147631309|NCT02649439|532469431|FG000|Overall Study|Patient decision|1|||
147631310|NCT02649439|532469432|FG001|Overall Study|Patient decision|0|||
147631311|NCT02649439|532469431|FG000|Overall Study|Patient going out of country|1|||
147631312|NCT02649439|532469432|FG001|Overall Study|Patient going out of country|0|||
147631313|NCT02649439|532469431|FG000|Overall Study|To start finasteride|1|||
147631314|NCT02649439|532469432|FG001|Overall Study|To start finasteride|0|||
147631315|NCT02649439|532469431|FG000|Overall Study|Physician Decision|1|||
147631316|NCT02649439|532469432|FG001|Overall Study|Physician Decision|0|||
147631317|NCT02649439|532469431|FG000|Overall Study|Disease progression on study|12|||
147631318|NCT02649439|532469432|FG001|Overall Study|Disease progression on study|13|||
147631319|NCT02649439|532469431|FG000|Overall Study|Refused further treatment|1|||
147631320|NCT02649439|532469432|FG001|Overall Study|Refused further treatment|0|||
147631321|NCT02649439|532469431|FG000|Overall Study|Refused further follow up|2|||
147631322|NCT02649439|532469432|FG001|Overall Study|Refused further follow up|7|||
147631323|NCT02649439|532469431|FG000|Overall Study|Completed treatment phase but refused the protocol specified follow up|1|||
147631324|NCT02649439|532469432|FG001|Overall Study|Completed treatment phase but refused the protocol specified follow up|0|||
147631325|NCT02649439|532469431|FG000|Overall Study|No treatment, per protocol|1|||
147631326|NCT02649439|532469432|FG001|Overall Study|No treatment, per protocol|0|||
147631327|NCT02649439|532469431|FG000|Overall Study|PSA DT makes ineligible|0|||
147631328|NCT02649439|532469432|FG001|Overall Study|PSA DT makes ineligible|1|||
147631329|NCT02649439|532469431|FG000|Overall Study|Rising PSA No Mets|0|||
147631330|NCT02649439|532469432|FG001|Overall Study|Rising PSA No Mets|1|||
147631331|NCT02649439|532469431|FG000|Overall Study|Rising PSA|0|||
147631332|NCT02649439|532469432|FG001|Overall Study|Rising PSA|1|||
147631333|NCT02649439|532469431|FG000|Overall Study|Signed follow up protocol|0|||
147631334|NCT02649439|532469432|FG001|Overall Study|Signed follow up protocol|1|||
147631335|NCT02714595|532469435|FG000|Overall Study|Lost to Follow-up|1|||
147631336|NCT02714595|532469436|FG001|Overall Study|Lost to Follow-up|0|||
147631337|NCT02714595|532469435|FG000|Overall Study|Withdrawal by Subject|1|||
147631338|NCT02714595|532469436|FG001|Overall Study|Withdrawal by Subject|2|||
147631339|NCT02714595|532469435|FG000|Overall Study|Lack of Efficacy|0|||
147631340|NCT02714595|532469436|FG001|Overall Study|Lack of Efficacy|1|||
147631341|NCT02714595|532469435|FG000|Overall Study|Death|30|||
147631342|NCT02714595|532469436|FG001|Overall Study|Death|9|||
147631343|NCT02714595|532469435|FG000|Overall Study|Other-Miscellaneous|0|||
147631344|NCT02714595|532469436|FG001|Overall Study|Other-Miscellaneous|1|||
147631345|NCT02257489|532469439|FG000|Overall Study|Withdrawal by Subject|0|||
147631346|NCT02257489|532469440|FG001|Overall Study|Withdrawal by Subject|0|||
147631347|NCT02257489|532469441|FG002|Overall Study|Withdrawal by Subject|0|||
147631348|NCT02257489|532469442|FG003|Overall Study|Withdrawal by Subject|1|||
147631349|NCT02257489|532469443|FG004|Overall Study|Withdrawal by Subject|0|||
147631350|NCT02257489|532469444|FG005|Overall Study|Withdrawal by Subject|0|||
147631351|NCT02257489|532469445|FG006|Overall Study|Withdrawal by Subject|0|||
147631352|NCT02257489|532469446|FG007|Overall Study|Withdrawal by Subject|0|||
147631353|NCT02257489|532469447|FG008|Overall Study|Withdrawal by Subject|0|||
147631354|NCT04606394|532469448|FG000|Overall Study|Withdrawal by Subject|3|||
147631355|NCT04606394|532469448|FG000|Overall Study|Exclusion criteria screen failure|12|||
147631356|NCT01896128|532469449|FG000|Overall Study|Withdrawal by Subject|3|||
147631357|NCT01896128|532469450|FG001|Overall Study|Withdrawal by Subject|3|||
147631358|NCT00955955|532469451|FG000|Overall Study|Lost to Follow-up|2|||
147631359|NCT00955955|532469452|FG001|Overall Study|Lost to Follow-up|0|||
147631360|NCT00955955|532469453|FG002|Overall Study|Lost to Follow-up|0|||
147631361|NCT01996254|532469455|FG000|Overall Study|Change in Eligibility|0|||
147631362|NCT01996254|532469456|FG001|Overall Study|Change in Eligibility|2|||
147631363|NCT01996254|532469457|FG002|Overall Study|Change in Eligibility|0|||
147631364|NCT01996254|532469455|FG000|Overall Study|Withdrawal by Subject|0|||
147631365|NCT01996254|532469456|FG001|Overall Study|Withdrawal by Subject|3|||
147631366|NCT01996254|532469457|FG002|Overall Study|Withdrawal by Subject|4|||
147631367|NCT01996254|532469455|FG000|Overall Study|Lost to Follow-up|1|||
147631368|NCT01996254|532469456|FG001|Overall Study|Lost to Follow-up|0|||
147631369|NCT01996254|532469457|FG002|Overall Study|Lost to Follow-up|4|||
147631370|NCT01339923|532469458|FG000|Overall Study|Adverse Event|1|||
147631371|NCT01339923|532469459|FG001|Overall Study|Adverse Event|1|||
147631372|NCT01339923|532469460|FG002|Overall Study|Adverse Event|1|||
147631373|NCT01339923|532469461|FG003|Overall Study|Adverse Event|0|||
147631374|NCT01339923|532469462|FG004|Overall Study|Adverse Event|0|||
147631375|NCT01339923|532469463|FG005|Overall Study|Adverse Event|0|||
147631376|NCT01339923|532469464|FG006|Overall Study|Adverse Event|1|||
147631377|NCT01339923|532469458|FG000|Overall Study|Inappropriate Enrollment|1|||
147631378|NCT01339923|532469459|FG001|Overall Study|Inappropriate Enrollment|0|||
147631379|NCT01339923|532469460|FG002|Overall Study|Inappropriate Enrollment|0|||
147631380|NCT01339923|532469461|FG003|Overall Study|Inappropriate Enrollment|0|||
147631381|NCT01339923|532469462|FG004|Overall Study|Inappropriate Enrollment|0|||
147631382|NCT01339923|532469463|FG005|Overall Study|Inappropriate Enrollment|1|||
147631383|NCT01339923|532469464|FG006|Overall Study|Inappropriate Enrollment|0|||
147631384|NCT01339923|532469458|FG000|Overall Study|Lost to Follow-up|4|||
147631385|NCT01339923|532469459|FG001|Overall Study|Lost to Follow-up|4|||
147631386|NCT01339923|532469460|FG002|Overall Study|Lost to Follow-up|0|||
147631387|NCT01339923|532469461|FG003|Overall Study|Lost to Follow-up|3|||
147631388|NCT01339923|532469462|FG004|Overall Study|Lost to Follow-up|1|||
147631389|NCT01339923|532469463|FG005|Overall Study|Lost to Follow-up|1|||
147631390|NCT01339923|532469464|FG006|Overall Study|Lost to Follow-up|5|||
147631391|NCT01339923|532469458|FG000|Overall Study|Protocol Violation|0|||
147631392|NCT01339923|532469459|FG001|Overall Study|Protocol Violation|0|||
147631393|NCT01339923|532469460|FG002|Overall Study|Protocol Violation|0|||
147631394|NCT01339923|532469461|FG003|Overall Study|Protocol Violation|0|||
147631395|NCT01339923|532469462|FG004|Overall Study|Protocol Violation|0|||
147631396|NCT01339923|532469463|FG005|Overall Study|Protocol Violation|3|||
147631397|NCT01339923|532469464|FG006|Overall Study|Protocol Violation|1|||
147631398|NCT01339923|532469458|FG000|Overall Study|Unable to Classify|1|||
147631399|NCT01339923|532469459|FG001|Overall Study|Unable to Classify|0|||
147631400|NCT01339923|532469460|FG002|Overall Study|Unable to Classify|1|||
147631401|NCT01339923|532469461|FG003|Overall Study|Unable to Classify|0|||
147631402|NCT01339923|532469462|FG004|Overall Study|Unable to Classify|0|||
147631403|NCT01339923|532469463|FG005|Overall Study|Unable to Classify|1|||
147631404|NCT01339923|532469464|FG006|Overall Study|Unable to Classify|5|||
147631405|NCT01339923|532469458|FG000|Overall Study|Withdrawal by Subject|7|||
147631406|NCT01339923|532469459|FG001|Overall Study|Withdrawal by Subject|11|||
147631407|NCT01339923|532469460|FG002|Overall Study|Withdrawal by Subject|6|||
147631408|NCT01339923|532469461|FG003|Overall Study|Withdrawal by Subject|1|||
147631409|NCT01339923|532469462|FG004|Overall Study|Withdrawal by Subject|4|||
147631410|NCT01339923|532469463|FG005|Overall Study|Withdrawal by Subject|3|||
147631411|NCT01339923|532469464|FG006|Overall Study|Withdrawal by Subject|2|||
147631412|NCT00637000|532469465|FG000|Overall Study|Withdrawal by Subject|4|||
147631413|NCT00637000|532469466|FG001|Overall Study|Withdrawal by Subject|3|||
147631414|NCT01855243|532469467|FG000|Overall Study|develpoed diabetic ketoacidosis|1|||
147631415|NCT01855243|532469468|FG001|Overall Study|develpoed diabetic ketoacidosis|0|||
147631416|NCT01855243|532469469|FG002|Overall Study|develpoed diabetic ketoacidosis|0|||
147631417|NCT01860040|532469472|FG000|Overall Study|Withdrawal by Subject|1|||
147497406|NCT02509494|531972483|FG000|Overall Study|Non-Compliance With Study Drug|1|||
147631418|NCT01860040|532469473|FG001|Overall Study|Withdrawal by Subject|0|||
147497407|NCT02509494|531972484|FG001|Overall Study|Non-Compliance With Study Drug|11|||
147631419|NCT01931995|532469474|FG000|First Intervention (1 Day)|Withdrawal by Subject|2|||
147631420|NCT01931995|532469475|FG001|First Intervention (1 Day)|Withdrawal by Subject|2|||
147631421|NCT01931995|532469474|FG000|First Intervention (1 Day)|Physician Decision|1|||
147497408|NCT02509494|531972485|FG002|Overall Study|Non-Compliance With Study Drug|7|||
147631422|NCT01931995|532469475|FG001|First Intervention (1 Day)|Physician Decision|1|||
147631423|NCT01931995|532469474|FG000|First Intervention (1 Day)|Lost to Follow-up|1|||
147631424|NCT01931995|532469475|FG001|First Intervention (1 Day)|Lost to Follow-up|1|||
147631425|NCT02477826|532469494|FG000|Pre-Treatment|Adverse events unrelated to study drug|0|||
147668509|NCT00769561|532611810|FG001|Overall Study|Lost to Follow-up|3|||
147631426|NCT02477826|532469495|FG001|Pre-Treatment|Adverse events unrelated to study drug|1|||
147631427|NCT02477826|532469496|FG002|Pre-Treatment|Adverse events unrelated to study drug|2|||
147631428|NCT02477826|532469497|FG003|Pre-Treatment|Adverse events unrelated to study drug|1|||
147631429|NCT02477826|532469498|FG004|Pre-Treatment|Adverse events unrelated to study drug|0|||
147631430|NCT02477826|532469499|FG005|Pre-Treatment|Adverse events unrelated to study drug|0|||
147631431|NCT02477826|532469500|FG006|Pre-Treatment|Adverse events unrelated to study drug|1|||
147631432|NCT02477826|532469501|FG007|Pre-Treatment|Adverse events unrelated to study drug|5|||
147631433|NCT02477826|532469502|FG008|Pre-Treatment|Adverse events unrelated to study drug|0|||
147631434|NCT02477826|532469503|FG009|Pre-Treatment|Adverse events unrelated to study drug|0|||
147631435|NCT02477826|532469494|FG000|Pre-Treatment|Other reasons|4|||
147631436|NCT02477826|532469495|FG001|Pre-Treatment|Other reasons|1|||
147631437|NCT02477826|532469496|FG002|Pre-Treatment|Other reasons|4|||
147631438|NCT02477826|532469497|FG003|Pre-Treatment|Other reasons|1|||
147631439|NCT02477826|532469498|FG004|Pre-Treatment|Other reasons|4|||
147631440|NCT02477826|532469499|FG005|Pre-Treatment|Other reasons|2|||
147631441|NCT02477826|532469500|FG006|Pre-Treatment|Other reasons|0|||
147631442|NCT02477826|532469501|FG007|Pre-Treatment|Other reasons|0|||
147631443|NCT02477826|532469502|FG008|Pre-Treatment|Other reasons|0|||
147631444|NCT02477826|532469503|FG009|Pre-Treatment|Other reasons|0|||
147631445|NCT02477826|532469494|FG000|Pre-Treatment|Subject no longer meets study criteria|1|||
147631446|NCT02477826|532469495|FG001|Pre-Treatment|Subject no longer meets study criteria|2|||
147631447|NCT02477826|532469496|FG002|Pre-Treatment|Subject no longer meets study criteria|1|||
147631448|NCT02477826|532469497|FG003|Pre-Treatment|Subject no longer meets study criteria|0|||
147631449|NCT02477826|532469498|FG004|Pre-Treatment|Subject no longer meets study criteria|1|||
147631450|NCT02477826|532469499|FG005|Pre-Treatment|Subject no longer meets study criteria|0|||
147631451|NCT02477826|532469500|FG006|Pre-Treatment|Subject no longer meets study criteria|0|||
147631452|NCT02477826|532469501|FG007|Pre-Treatment|Subject no longer meets study criteria|1|||
147631453|NCT02477826|532469502|FG008|Pre-Treatment|Subject no longer meets study criteria|0|||
147631454|NCT02477826|532469503|FG009|Pre-Treatment|Subject no longer meets study criteria|0|||
147631455|NCT02477826|532469494|FG000|Pre-Treatment|Subject withdrew consent|0|||
147631456|NCT02477826|532469495|FG001|Pre-Treatment|Subject withdrew consent|0|||
147631457|NCT02477826|532469496|FG002|Pre-Treatment|Subject withdrew consent|3|||
147631458|NCT02477826|532469497|FG003|Pre-Treatment|Subject withdrew consent|0|||
147631459|NCT02477826|532469498|FG004|Pre-Treatment|Subject withdrew consent|0|||
147631460|NCT02477826|532469499|FG005|Pre-Treatment|Subject withdrew consent|1|||
147631461|NCT02477826|532469500|FG006|Pre-Treatment|Subject withdrew consent|0|||
147631462|NCT02477826|532469501|FG007|Pre-Treatment|Subject withdrew consent|1|||
147631463|NCT02477826|532469502|FG008|Pre-Treatment|Subject withdrew consent|0|||
147631464|NCT02477826|532469503|FG009|Pre-Treatment|Subject withdrew consent|3|||
147631465|NCT02477826|532469494|FG000|Pre-Treatment|Subject request to discontinue study treatment|0|||
147631466|NCT02477826|532469495|FG001|Pre-Treatment|Subject request to discontinue study treatment|1|||
147631467|NCT02477826|532469496|FG002|Pre-Treatment|Subject request to discontinue study treatment|0|||
147631468|NCT02477826|532469497|FG003|Pre-Treatment|Subject request to discontinue study treatment|0|||
147631469|NCT02477826|532469498|FG004|Pre-Treatment|Subject request to discontinue study treatment|0|||
147631470|NCT02477826|532469499|FG005|Pre-Treatment|Subject request to discontinue study treatment|0|||
147631471|NCT02477826|532469500|FG006|Pre-Treatment|Subject request to discontinue study treatment|0|||
147631472|NCT02477826|532469501|FG007|Pre-Treatment|Subject request to discontinue study treatment|0|||
147631473|NCT02477826|532469502|FG008|Pre-Treatment|Subject request to discontinue study treatment|0|||
147631474|NCT02477826|532469503|FG009|Pre-Treatment|Subject request to discontinue study treatment|1|||
147631475|NCT02477826|532469494|FG000|Pre-Treatment|Death|0|||
147631476|NCT02477826|532469495|FG001|Pre-Treatment|Death|0|||
147631477|NCT02477826|532469496|FG002|Pre-Treatment|Death|0|||
147631478|NCT02477826|532469497|FG003|Pre-Treatment|Death|0|||
147631479|NCT02477826|532469498|FG004|Pre-Treatment|Death|0|||
147497409|NCT02509494|531972486|FG003|Overall Study|Non-Compliance With Study Drug|0|||
147497410|NCT02509494|531972487|FG004|Overall Study|Non-Compliance With Study Drug|1|||
147497411|NCT02509494|531972488|FG005|Overall Study|Non-Compliance With Study Drug|2|||
147497412|NCT02509494|531972489|FG006|Overall Study|Non-Compliance With Study Drug|1|||
147497413|NCT02509494|531972490|FG007|Overall Study|Non-Compliance With Study Drug|1|||
147497414|NCT02509494|531972491|FG008|Overall Study|Non-Compliance With Study Drug|0|||
147497415|NCT01511107|531972492|FG000|Overall Study|Ineligible|3|||
147497416|NCT01511107|531972493|FG001|Overall Study|Ineligible|2|||
147497417|NCT01511107|531972492|FG000|Overall Study|Lost to Follow-up|10|||
147631480|NCT02477826|532469499|FG005|Pre-Treatment|Death|0|||
147631481|NCT02477826|532469500|FG006|Pre-Treatment|Death|1|||
147497418|NCT01511107|531972493|FG001|Overall Study|Lost to Follow-up|19|||
147497419|NCT01511107|531972492|FG000|Overall Study|Withdrawal by Subject|9|||
147631482|NCT02477826|532469501|FG007|Pre-Treatment|Death|0|||
147631483|NCT02477826|532469502|FG008|Pre-Treatment|Death|0|||
147631484|NCT02477826|532469503|FG009|Pre-Treatment|Death|0|||
147631485|NCT02477826|532469494|FG000|Treatment Period|Not reported|8|||
147497420|NCT01511107|531972493|FG001|Overall Study|Withdrawal by Subject|20|||
147497421|NCT04752189|531972494|FG000|Overall Study|Withdrawal by Subject|0|||
147497422|NCT04752189|531972495|FG001|Overall Study|Withdrawal by Subject|150|||
147497423|NCT04752189|531972494|FG000|Overall Study|Lost to Follow-up|261|||
147497424|NCT04752189|531972495|FG001|Overall Study|Lost to Follow-up|126|||
147497425|NCT00975195|531972496|FG000|Overall Study|Adverse Event|108|||
147497426|NCT00975195|531972497|FG001|Overall Study|Adverse Event|101|||
147497427|NCT00975195|531972496|FG000|Overall Study|Lack of Efficacy|6|||
147497428|NCT00975195|531972497|FG001|Overall Study|Lack of Efficacy|6|||
147497429|NCT00975195|531972496|FG000|Overall Study|Protocol Violation|27|||
147497430|NCT00975195|531972497|FG001|Overall Study|Protocol Violation|23|||
147497431|NCT00975195|531972496|FG000|Overall Study|Lost to Follow-up|9|||
147497432|NCT00975195|531972497|FG001|Overall Study|Lost to Follow-up|7|||
147497433|NCT00975195|531972496|FG000|Overall Study|Withdrawal by Subject|48|||
147497434|NCT00975195|531972497|FG001|Overall Study|Withdrawal by Subject|61|||
147497435|NCT00975195|531972496|FG000|Overall Study|Other reason not defined above|29|||
147497436|NCT00975195|531972497|FG001|Overall Study|Other reason not defined above|33|||
147497437|NCT00975195|531972496|FG000|Overall Study|Not treated|1|||
147497438|NCT00975195|531972497|FG001|Overall Study|Not treated|2|||
147497439|NCT03422133|531972502|FG000|Overall Study|Ineligible procedure, data error, patient declined because of timing, MD not consented|14|||
147497440|NCT03422133|531972503|FG001|Overall Study|Ineligible procedure, data error, patient declined because of timing, MD not consented|4|||
147497441|NCT03003403|531972504|FG000|Overall Study|Ineligible|8|||
147497442|NCT03003403|531972505|FG001|Overall Study|Ineligible|7|||
147497443|NCT03003403|531972504|FG000|Overall Study|Withdrawal by Subject|3|||
147497444|NCT03003403|531972505|FG001|Overall Study|Withdrawal by Subject|1|||
147497445|NCT05084053|531973928|FG000|Epoch 1: Up to 6 months|Withdrawal by Subject|1|||
147497446|NCT05084053|531973929|FG001|Epoch 1: Up to 6 months|Withdrawal by Subject|0|||
147497447|NCT05084053|531973930|FG002|Epoch 1: Up to 6 months|Withdrawal by Subject|0|||
147497448|NCT05084053|531973931|FG003|Epoch 1: Up to 6 months|Withdrawal by Subject|0|||
147497449|NCT05084053|531973928|FG000|Epoch 1: Up to 6 months|Physician Decision|1|||
147497450|NCT05084053|531973929|FG001|Epoch 1: Up to 6 months|Physician Decision|0|||
147497451|NCT05084053|531973930|FG002|Epoch 1: Up to 6 months|Physician Decision|0|||
147497452|NCT05084053|531973931|FG003|Epoch 1: Up to 6 months|Physician Decision|0|||
147497453|NCT05084053|531973928|FG000|Epoch 2: Up to 6 months|Physician Decision|0|||
147497454|NCT05084053|531973929|FG001|Epoch 2: Up to 6 months|Physician Decision|0|||
147497455|NCT05084053|531973930|FG002|Epoch 2: Up to 6 months|Physician Decision|1|||
147497456|NCT05084053|531973931|FG003|Epoch 2: Up to 6 months|Physician Decision|0|||
147497457|NCT02180724|531973932|FG000|Overall Study|Death|26|||
147497458|NCT02180724|531973933|FG001|Overall Study|Death|1|||
147497459|NCT02180724|531973932|FG000|Overall Study|Lost to Follow-up|3|||
147497460|NCT02180724|531973933|FG001|Overall Study|Lost to Follow-up|1|||
147497461|NCT02180724|531973932|FG000|Overall Study|Withdrawal by Subject|4|||
147497462|NCT02180724|531973933|FG001|Overall Study|Withdrawal by Subject|2|||
147497463|NCT02180724|531973932|FG000|Overall Study|PI Decision|5|||
147497464|NCT02180724|531973933|FG001|Overall Study|PI Decision|2|||
147497465|NCT02180724|531973932|FG000|Overall Study|Study terminated by sponsor|54|||
147497466|NCT02180724|531973933|FG001|Overall Study|Study terminated by sponsor|8|||
147497467|NCT05195359|531973934|FG000|Overall Study|Lost to Follow-up|124|||
147497468|NCT05195359|531973935|FG001|Overall Study|Lost to Follow-up|34|||
147497469|NCT02700919|531973941|FG000|Overall Study|Physician Decision|1|||
147497470|NCT02700919|531973942|FG001|Overall Study|Physician Decision|0|||
147497471|NCT02700919|531973943|FG002|Overall Study|Physician Decision|0|||
147497472|NCT02700919|531973941|FG000|Overall Study|Protocol Violation|1|||
147497473|NCT02700919|531973942|FG001|Overall Study|Protocol Violation|0|||
147497474|NCT02700919|531973943|FG002|Overall Study|Protocol Violation|0|||
147497475|NCT02700919|531973941|FG000|Overall Study|Adverse Event|1|||
147497476|NCT02700919|531973942|FG001|Overall Study|Adverse Event|3|||
147668510|NCT03824561|532611813|FG000|Overall Study|Protocol Violation|19|||
147668511|NCT03191552|532611814|FG000|Overall Study|Lost to Follow-up|1|||
147497477|NCT02700919|531973943|FG002|Overall Study|Adverse Event|1|||
147497478|NCT02700919|531973941|FG000|Overall Study|Withdrawal by Subject|5|||
147497479|NCT02700919|531973942|FG001|Overall Study|Withdrawal by Subject|8|||
147497480|NCT02700919|531973943|FG002|Overall Study|Withdrawal by Subject|2|||
147497481|NCT02700919|531973941|FG000|Overall Study|Lost to Follow-up|2|||
147497482|NCT02700919|531973942|FG001|Overall Study|Lost to Follow-up|0|||
147497483|NCT02700919|531973943|FG002|Overall Study|Lost to Follow-up|0|||
147497484|NCT02700919|531973941|FG000|Overall Study|Other|2|||
147497485|NCT02700919|531973942|FG001|Overall Study|Other|1|||
147497486|NCT02700919|531973943|FG002|Overall Study|Other|1|||
147497487|NCT03569449|531973945|FG000|Overall Study|Lost to Follow-up|0|||
147497488|NCT03569449|531973946|FG001|Overall Study|Lost to Follow-up|1|||
147497489|NCT03569449|531973947|FG002|Overall Study|Lost to Follow-up|0|||
147497490|NCT03569449|531973948|FG003|Overall Study|Lost to Follow-up|2|||
147497491|NCT03569449|531973949|FG004|Overall Study|Lost to Follow-up|0|||
147497492|NCT03569449|531973950|FG005|Overall Study|Lost to Follow-up|0|||
147497493|NCT03569449|531973951|FG006|Overall Study|Lost to Follow-up|0|||
147497494|NCT03569449|531973952|FG007|Overall Study|Lost to Follow-up|0|||
147497495|NCT03569449|531973953|FG008|Overall Study|Lost to Follow-up|0|||
147497496|NCT03569449|531973954|FG009|Overall Study|Lost to Follow-up|0|||
147497497|NCT03569449|531973955|FG010|Overall Study|Lost to Follow-up|0|||
147497498|NCT03569449|531973956|FG011|Overall Study|Lost to Follow-up|0|||
147497499|NCT03569449|531973957|FG012|Overall Study|Lost to Follow-up|0|||
147497500|NCT03569449|531973958|FG013|Overall Study|Lost to Follow-up|0|||
147497501|NCT03569449|531973959|FG014|Overall Study|Lost to Follow-up|1|||
147497502|NCT03569449|531973960|FG015|Overall Study|Lost to Follow-up|0|||
147497503|NCT03569449|531973945|FG000|Overall Study|Withdrawal by Subject|0|||
147497504|NCT03569449|531973946|FG001|Overall Study|Withdrawal by Subject|1|||
147497505|NCT03569449|531973947|FG002|Overall Study|Withdrawal by Subject|0|||
147497506|NCT03569449|531973948|FG003|Overall Study|Withdrawal by Subject|0|||
147497507|NCT03569449|531973949|FG004|Overall Study|Withdrawal by Subject|1|||
147497508|NCT03569449|531973950|FG005|Overall Study|Withdrawal by Subject|0|||
147497509|NCT03569449|531973951|FG006|Overall Study|Withdrawal by Subject|0|||
147497510|NCT03569449|531973952|FG007|Overall Study|Withdrawal by Subject|0|||
147497511|NCT03569449|531973953|FG008|Overall Study|Withdrawal by Subject|0|||
147497512|NCT03569449|531973954|FG009|Overall Study|Withdrawal by Subject|0|||
147497513|NCT03569449|531973955|FG010|Overall Study|Withdrawal by Subject|0|||
147497514|NCT03569449|531973956|FG011|Overall Study|Withdrawal by Subject|0|||
147497515|NCT03569449|531973957|FG012|Overall Study|Withdrawal by Subject|0|||
147497516|NCT03569449|531973958|FG013|Overall Study|Withdrawal by Subject|0|||
147497517|NCT03569449|531973959|FG014|Overall Study|Withdrawal by Subject|0|||
147497518|NCT03569449|531973960|FG015|Overall Study|Withdrawal by Subject|0|||
147497519|NCT05279898|531973963|FG000|Overall Study|Withdrawal by Subject|1|||
147497520|NCT05279898|531973964|FG001|Overall Study|Withdrawal by Subject|0|||
147497521|NCT05279898|531973963|FG000|Overall Study|Physician Decision|1|||
147497522|NCT05279898|531973964|FG001|Overall Study|Physician Decision|1|||
147497523|NCT04393038|531973965|FG000|Overall Study|Adverse Event|11|||
147497524|NCT04393038|531973966|FG001|Overall Study|Adverse Event|2|||
147497525|NCT04393038|531973965|FG000|Overall Study|Protocol Violation|1|||
147497526|NCT04393038|531973966|FG001|Overall Study|Protocol Violation|0|||
147497527|NCT04393038|531973965|FG000|Overall Study|Death|6|||
147497528|NCT04393038|531973966|FG001|Overall Study|Death|4|||
147497529|NCT04393038|531973965|FG000|Overall Study|Withdrawal by Subject|24|||
147497530|NCT04393038|531973966|FG001|Overall Study|Withdrawal by Subject|8|||
147497531|NCT04393038|531973965|FG000|Overall Study|Lost to Follow-up|5|||
147497532|NCT04393038|531973966|FG001|Overall Study|Lost to Follow-up|4|||
147497533|NCT04393038|531973965|FG000|Overall Study|Other reasons+ trial site terminated by sponsor + Study terminated by sponsor|94|||
147497534|NCT04393038|531973966|FG001|Overall Study|Other reasons+ trial site terminated by sponsor + Study terminated by sponsor|49|||
147497535|NCT04393038|531973965|FG000|Overall Study|End of Study date not collected in the eCRF|10|||
147497536|NCT04393038|531973966|FG001|Overall Study|End of Study date not collected in the eCRF|4|||
147497537|NCT05168813|531973967|FG000|Part A (Open-label)|Lost to Follow-up|21|||
147497538|NCT05168813|531973968|FG001|Part A (Open-label)|Lost to Follow-up|39|||
147497539|NCT05168813|531973969|FG002|Part A (Open-label)|Lost to Follow-up|8|||
147497540|NCT05168813|531973970|FG003|Part A (Open-label)|Lost to Follow-up|26|||
147497541|NCT05168813|531973971|FG004|Part A (Open-label)|Lost to Follow-up|0|||
147497542|NCT05168813|531973972|FG005|Part A (Open-label)|Lost to Follow-up|0|||
147497543|NCT05168813|531973967|FG000|Part A (Open-label)|Withdrawal by Subject|35|||
147497544|NCT05168813|531973968|FG001|Part A (Open-label)|Withdrawal by Subject|30|||
147497545|NCT05168813|531973969|FG002|Part A (Open-label)|Withdrawal by Subject|14|||
147497546|NCT05168813|531973970|FG003|Part A (Open-label)|Withdrawal by Subject|17|||
147497547|NCT05168813|531973971|FG004|Part A (Open-label)|Withdrawal by Subject|0|||
147497548|NCT05168813|531973972|FG005|Part A (Open-label)|Withdrawal by Subject|0|||
147497549|NCT05168813|531973967|FG000|Part A (Open-label)|Death|23|||
147497550|NCT05168813|531973968|FG001|Part A (Open-label)|Death|28|||
147497551|NCT05168813|531973969|FG002|Part A (Open-label)|Death|1|||
147497552|NCT05168813|531973970|FG003|Part A (Open-label)|Death|9|||
147497553|NCT05168813|531973971|FG004|Part A (Open-label)|Death|0|||
147497554|NCT05168813|531973972|FG005|Part A (Open-label)|Death|0|||
147497555|NCT05168813|531973967|FG000|Part A (Open-label)|Physician Decision|0|||
147497556|NCT05168813|531973968|FG001|Part A (Open-label)|Physician Decision|1|||
147497557|NCT05168813|531973969|FG002|Part A (Open-label)|Physician Decision|0|||
147497558|NCT05168813|531973970|FG003|Part A (Open-label)|Physician Decision|2|||
147497559|NCT05168813|531973971|FG004|Part A (Open-label)|Physician Decision|0|||
147497560|NCT05168813|531973972|FG005|Part A (Open-label)|Physician Decision|0|||
147497561|NCT05168813|531973967|FG000|Part A (Open-label)|Participant Unable to Adhere to Visit Schedule|10|||
147497562|NCT05168813|531973968|FG001|Part A (Open-label)|Participant Unable to Adhere to Visit Schedule|18|||
147497563|NCT05168813|531973969|FG002|Part A (Open-label)|Participant Unable to Adhere to Visit Schedule|0|||
147497564|NCT05168813|531973970|FG003|Part A (Open-label)|Participant Unable to Adhere to Visit Schedule|7|||
147497565|NCT05168813|531973971|FG004|Part A (Open-label)|Participant Unable to Adhere to Visit Schedule|0|||
147497566|NCT05168813|531973972|FG005|Part A (Open-label)|Participant Unable to Adhere to Visit Schedule|0|||
147497567|NCT05168813|531973967|FG000|Part A (Open-label)|Protocol Violation|0|||
147497568|NCT05168813|531973968|FG001|Part A (Open-label)|Protocol Violation|1|||
147497569|NCT05168813|531973969|FG002|Part A (Open-label)|Protocol Violation|0|||
147631486|NCT02477826|532469495|FG001|Treatment Period|Not reported|6|||
147631487|NCT02477826|532469496|FG002|Treatment Period|Not reported|4|||
147631488|NCT02477826|532469497|FG003|Treatment Period|Not reported|4|||
147631489|NCT02477826|532469498|FG004|Treatment Period|Not reported|2|||
147631490|NCT02477826|532469499|FG005|Treatment Period|Not reported|1|||
147631491|NCT02477826|532469500|FG006|Treatment Period|Not reported|14|||
147631492|NCT02477826|532469501|FG007|Treatment Period|Not reported|8|||
147631493|NCT02477826|532469502|FG008|Treatment Period|Not reported|5|||
147631494|NCT02477826|532469503|FG009|Treatment Period|Not reported|2|||
147631495|NCT02477826|532469494|FG000|Treatment Period|Other reasons|5|||
147631496|NCT02477826|532469495|FG001|Treatment Period|Other reasons|6|||
147631497|NCT02477826|532469496|FG002|Treatment Period|Other reasons|12|||
147631498|NCT02477826|532469497|FG003|Treatment Period|Other reasons|7|||
147631499|NCT02477826|532469498|FG004|Treatment Period|Other reasons|5|||
147631500|NCT02477826|532469499|FG005|Treatment Period|Other reasons|1|||
147631501|NCT02477826|532469500|FG006|Treatment Period|Other reasons|8|||
147631502|NCT02477826|532469501|FG007|Treatment Period|Other reasons|8|||
147631503|NCT02477826|532469502|FG008|Treatment Period|Other reasons|21|||
147631504|NCT02477826|532469503|FG009|Treatment Period|Other reasons|1|||
147631505|NCT02477826|532469494|FG000|Treatment Period|Administrative reason by sponsor|0|||
147631506|NCT02477826|532469495|FG001|Treatment Period|Administrative reason by sponsor|3|||
147631507|NCT02477826|532469496|FG002|Treatment Period|Administrative reason by sponsor|0|||
147631508|NCT02477826|532469497|FG003|Treatment Period|Administrative reason by sponsor|0|||
147631509|NCT02477826|532469498|FG004|Treatment Period|Administrative reason by sponsor|0|||
147631510|NCT02477826|532469499|FG005|Treatment Period|Administrative reason by sponsor|0|||
147631511|NCT02477826|532469500|FG006|Treatment Period|Administrative reason by sponsor|0|||
147631512|NCT02477826|532469501|FG007|Treatment Period|Administrative reason by sponsor|0|||
147631513|NCT02477826|532469502|FG008|Treatment Period|Administrative reason by sponsor|0|||
147631514|NCT02477826|532469503|FG009|Treatment Period|Administrative reason by sponsor|0|||
147631515|NCT02477826|532469494|FG000|Treatment Period|Participant meet no longer study criteria|1|||
147631516|NCT02477826|532469495|FG001|Treatment Period|Participant meet no longer study criteria|1|||
147631517|NCT02477826|532469496|FG002|Treatment Period|Participant meet no longer study criteria|0|||
147631518|NCT02477826|532469497|FG003|Treatment Period|Participant meet no longer study criteria|0|||
147631519|NCT02477826|532469498|FG004|Treatment Period|Participant meet no longer study criteria|1|||
147631520|NCT02477826|532469499|FG005|Treatment Period|Participant meet no longer study criteria|1|||
147631521|NCT02477826|532469500|FG006|Treatment Period|Participant meet no longer study criteria|0|||
147631522|NCT02477826|532469501|FG007|Treatment Period|Participant meet no longer study criteria|1|||
147631523|NCT02477826|532469502|FG008|Treatment Period|Participant meet no longer study criteria|0|||
147631524|NCT02477826|532469503|FG009|Treatment Period|Participant meet no longer study criteria|0|||
147631525|NCT02477826|532469494|FG000|Treatment Period|Poor/Non Compliance|1|||
147631526|NCT02477826|532469495|FG001|Treatment Period|Poor/Non Compliance|0|||
147631527|NCT02477826|532469496|FG002|Treatment Period|Poor/Non Compliance|2|||
147631528|NCT02477826|532469497|FG003|Treatment Period|Poor/Non Compliance|0|||
147631529|NCT02477826|532469498|FG004|Treatment Period|Poor/Non Compliance|0|||
147631530|NCT02477826|532469499|FG005|Treatment Period|Poor/Non Compliance|1|||
147631531|NCT02477826|532469500|FG006|Treatment Period|Poor/Non Compliance|1|||
147631532|NCT02477826|532469501|FG007|Treatment Period|Poor/Non Compliance|0|||
147631533|NCT02477826|532469502|FG008|Treatment Period|Poor/Non Compliance|0|||
147631534|NCT02477826|532469503|FG009|Treatment Period|Poor/Non Compliance|1|||
147631535|NCT02477826|532469494|FG000|Treatment Period|Maximum Clinical Benefit|3|||
147631536|NCT02477826|532469495|FG001|Treatment Period|Maximum Clinical Benefit|3|||
147631537|NCT02477826|532469496|FG002|Treatment Period|Maximum Clinical Benefit|1|||
147631538|NCT02477826|532469497|FG003|Treatment Period|Maximum Clinical Benefit|1|||
147631539|NCT02477826|532469498|FG004|Treatment Period|Maximum Clinical Benefit|3|||
147497570|NCT05168813|531973970|FG003|Part A (Open-label)|Protocol Violation|0|||
147631540|NCT02477826|532469499|FG005|Treatment Period|Maximum Clinical Benefit|0|||
147631541|NCT02477826|532469500|FG006|Treatment Period|Maximum Clinical Benefit|3|||
147631542|NCT02477826|532469501|FG007|Treatment Period|Maximum Clinical Benefit|2|||
147631543|NCT02477826|532469502|FG008|Treatment Period|Maximum Clinical Benefit|2|||
147631544|NCT02477826|532469503|FG009|Treatment Period|Maximum Clinical Benefit|2|||
147631545|NCT02477826|532469494|FG000|Treatment Period|Lost to Follow-up|0|||
147631546|NCT02477826|532469495|FG001|Treatment Period|Lost to Follow-up|0|||
147631547|NCT02477826|532469496|FG002|Treatment Period|Lost to Follow-up|1|||
147631548|NCT02477826|532469497|FG003|Treatment Period|Lost to Follow-up|1|||
147631549|NCT02477826|532469498|FG004|Treatment Period|Lost to Follow-up|0|||
147631550|NCT02477826|532469499|FG005|Treatment Period|Lost to Follow-up|0|||
147631551|NCT02477826|532469500|FG006|Treatment Period|Lost to Follow-up|2|||
147631552|NCT02477826|532469501|FG007|Treatment Period|Lost to Follow-up|2|||
147497571|NCT05168813|531973971|FG004|Part A (Open-label)|Protocol Violation|0|||
147631553|NCT02477826|532469502|FG008|Treatment Period|Lost to Follow-up|0|||
147631554|NCT02477826|532469503|FG009|Treatment Period|Lost to Follow-up|0|||
147631555|NCT02477826|532469494|FG000|Treatment Period|Participant withdrew Consent|5|||
147631556|NCT02477826|532469495|FG001|Treatment Period|Participant withdrew Consent|5|||
147668512|NCT03191552|532611815|FG001|Overall Study|Lost to Follow-up|0|||
147631557|NCT02477826|532469496|FG002|Treatment Period|Participant withdrew Consent|3|||
147631558|NCT02477826|532469497|FG003|Treatment Period|Participant withdrew Consent|3|||
147631559|NCT02477826|532469498|FG004|Treatment Period|Participant withdrew Consent|1|||
147631560|NCT02477826|532469499|FG005|Treatment Period|Participant withdrew Consent|3|||
147631561|NCT02477826|532469500|FG006|Treatment Period|Participant withdrew Consent|3|||
147631562|NCT02477826|532469501|FG007|Treatment Period|Participant withdrew Consent|3|||
147631563|NCT02477826|532469502|FG008|Treatment Period|Participant withdrew Consent|2|||
147631564|NCT02477826|532469503|FG009|Treatment Period|Participant withdrew Consent|3|||
147631565|NCT02477826|532469494|FG000|Treatment Period|Participant request to discontinue treatment|5|||
147631566|NCT02477826|532469495|FG001|Treatment Period|Participant request to discontinue treatment|3|||
147631567|NCT02477826|532469496|FG002|Treatment Period|Participant request to discontinue treatment|15|||
147631568|NCT02477826|532469497|FG003|Treatment Period|Participant request to discontinue treatment|5|||
147631569|NCT02477826|532469498|FG004|Treatment Period|Participant request to discontinue treatment|3|||
147631570|NCT02477826|532469499|FG005|Treatment Period|Participant request to discontinue treatment|6|||
147631571|NCT02477826|532469500|FG006|Treatment Period|Participant request to discontinue treatment|13|||
147631572|NCT02477826|532469501|FG007|Treatment Period|Participant request to discontinue treatment|15|||
147631573|NCT02477826|532469502|FG008|Treatment Period|Participant request to discontinue treatment|4|||
147631574|NCT02477826|532469503|FG009|Treatment Period|Participant request to discontinue treatment|18|||
147631575|NCT02477826|532469494|FG000|Treatment Period|Adverse event unrelated to study drug|23|||
147631576|NCT02477826|532469495|FG001|Treatment Period|Adverse event unrelated to study drug|29|||
147631577|NCT02477826|532469496|FG002|Treatment Period|Adverse event unrelated to study drug|22|||
147631578|NCT02477826|532469497|FG003|Treatment Period|Adverse event unrelated to study drug|18|||
147631579|NCT02477826|532469498|FG004|Treatment Period|Adverse event unrelated to study drug|11|||
147631580|NCT02477826|532469499|FG005|Treatment Period|Adverse event unrelated to study drug|15|||
147631581|NCT02477826|532469500|FG006|Treatment Period|Adverse event unrelated to study drug|25|||
147631582|NCT02477826|532469501|FG007|Treatment Period|Adverse event unrelated to study drug|19|||
147631583|NCT02477826|532469502|FG008|Treatment Period|Adverse event unrelated to study drug|4|||
147631584|NCT02477826|532469503|FG009|Treatment Period|Adverse event unrelated to study drug|2|||
147631585|NCT02477826|532469494|FG000|Treatment Period|Death|4|||
147631586|NCT02477826|532469495|FG001|Treatment Period|Death|7|||
147631587|NCT02477826|532469496|FG002|Treatment Period|Death|0|||
147631588|NCT02477826|532469497|FG003|Treatment Period|Death|0|||
147631589|NCT02477826|532469498|FG004|Treatment Period|Death|1|||
147631590|NCT02477826|532469499|FG005|Treatment Period|Death|2|||
147631591|NCT02477826|532469500|FG006|Treatment Period|Death|6|||
147631592|NCT02477826|532469501|FG007|Treatment Period|Death|5|||
147631593|NCT02477826|532469502|FG008|Treatment Period|Death|9|||
147631594|NCT02477826|532469503|FG009|Treatment Period|Death|0|||
147631595|NCT02477826|532469494|FG000|Treatment Period|Study Drug Toxicity|79|||
147631596|NCT02477826|532469495|FG001|Treatment Period|Study Drug Toxicity|51|||
147631597|NCT02477826|532469496|FG002|Treatment Period|Study Drug Toxicity|31|||
147631598|NCT02477826|532469497|FG003|Treatment Period|Study Drug Toxicity|39|||
147631599|NCT02477826|532469498|FG004|Treatment Period|Study Drug Toxicity|12|||
147631600|NCT02477826|532469499|FG005|Treatment Period|Study Drug Toxicity|25|||
147497572|NCT05168813|531973972|FG005|Part A (Open-label)|Protocol Violation|0|||
147497573|NCT05168813|531973967|FG000|Part A (Open-label)|Study Terminated by Sponsor|3|||
147497574|NCT05168813|531973968|FG001|Part A (Open-label)|Study Terminated by Sponsor|4|||
147497575|NCT05168813|531973969|FG002|Part A (Open-label)|Study Terminated by Sponsor|1|||
147497576|NCT05168813|531973970|FG003|Part A (Open-label)|Study Terminated by Sponsor|5|||
147497577|NCT05168813|531973971|FG004|Part A (Open-label)|Study Terminated by Sponsor|0|||
147497578|NCT05168813|531973972|FG005|Part A (Open-label)|Study Terminated by Sponsor|0|||
147497579|NCT05168813|531973967|FG000|Part A (Open-label)|Other|0|||
147497580|NCT05168813|531973968|FG001|Part A (Open-label)|Other|1|||
147497581|NCT05168813|531973969|FG002|Part A (Open-label)|Other|0|||
147497582|NCT05168813|531973970|FG003|Part A (Open-label)|Other|0|||
147497583|NCT05168813|531973971|FG004|Part A (Open-label)|Other|0|||
147497584|NCT05168813|531973972|FG005|Part A (Open-label)|Other|0|||
147497585|NCT05168813|531973967|FG000|Part B (Blinded)|Lost to Follow-up|0|||
147497586|NCT05168813|531973968|FG001|Part B (Blinded)|Lost to Follow-up|0|||
147497587|NCT05168813|531973969|FG002|Part B (Blinded)|Lost to Follow-up|0|||
147497588|NCT05168813|531973970|FG003|Part B (Blinded)|Lost to Follow-up|0|||
147497589|NCT05168813|531973971|FG004|Part B (Blinded)|Lost to Follow-up|219|||
147497590|NCT05168813|531973972|FG005|Part B (Blinded)|Lost to Follow-up|88|||
147497591|NCT05168813|531973967|FG000|Part B (Blinded)|Withdrawal by Subject|0|||
147497592|NCT05168813|531973968|FG001|Part B (Blinded)|Withdrawal by Subject|0|||
147497593|NCT05168813|531973969|FG002|Part B (Blinded)|Withdrawal by Subject|0|||
147497594|NCT05168813|531973970|FG003|Part B (Blinded)|Withdrawal by Subject|0|||
147631601|NCT02477826|532469500|FG006|Treatment Period|Study Drug Toxicity|52|||
147497595|NCT05168813|531973971|FG004|Part B (Blinded)|Withdrawal by Subject|91|||
147497596|NCT05168813|531973972|FG005|Part B (Blinded)|Withdrawal by Subject|55|||
147497597|NCT05168813|531973967|FG000|Part B (Blinded)|Death|0|||
147497598|NCT05168813|531973968|FG001|Part B (Blinded)|Death|0|||
147497599|NCT05168813|531973969|FG002|Part B (Blinded)|Death|0|||
147497600|NCT05168813|531973970|FG003|Part B (Blinded)|Death|0|||
147497601|NCT05168813|531973971|FG004|Part B (Blinded)|Death|63|||
147497602|NCT05168813|531973972|FG005|Part B (Blinded)|Death|19|||
147497603|NCT05168813|531973967|FG000|Part B (Blinded)|Physician Decision|0|||
147497604|NCT05168813|531973968|FG001|Part B (Blinded)|Physician Decision|0|||
147497605|NCT05168813|531973969|FG002|Part B (Blinded)|Physician Decision|0|||
147497606|NCT05168813|531973970|FG003|Part B (Blinded)|Physician Decision|0|||
147497607|NCT05168813|531973971|FG004|Part B (Blinded)|Physician Decision|6|||
147497608|NCT05168813|531973972|FG005|Part B (Blinded)|Physician Decision|1|||
147497609|NCT05168813|531973967|FG000|Part B (Blinded)|Participant Unable to Adhere to Visit Schedule|0|||
147497610|NCT05168813|531973968|FG001|Part B (Blinded)|Participant Unable to Adhere to Visit Schedule|0|||
147497611|NCT05168813|531973969|FG002|Part B (Blinded)|Participant Unable to Adhere to Visit Schedule|0|||
147497612|NCT05168813|531973970|FG003|Part B (Blinded)|Participant Unable to Adhere to Visit Schedule|0|||
147497613|NCT05168813|531973971|FG004|Part B (Blinded)|Participant Unable to Adhere to Visit Schedule|54|||
147497614|NCT05168813|531973972|FG005|Part B (Blinded)|Participant Unable to Adhere to Visit Schedule|21|||
147668513|NCT03191552|532611816|FG002|Overall Study|Lost to Follow-up|0|||
147668514|NCT03191552|532611814|FG000|Overall Study|Undergone surgery (Progressive hip dyspl|0|||
147497615|NCT05168813|531973967|FG000|Part B (Blinded)|Pregnancy|0|||
147497616|NCT05168813|531973968|FG001|Part B (Blinded)|Pregnancy|0|||
147497617|NCT05168813|531973969|FG002|Part B (Blinded)|Pregnancy|0|||
147497618|NCT05168813|531973970|FG003|Part B (Blinded)|Pregnancy|0|||
147497619|NCT05168813|531973971|FG004|Part B (Blinded)|Pregnancy|1|||
147497620|NCT05168813|531973972|FG005|Part B (Blinded)|Pregnancy|0|||
147497621|NCT05168813|531973967|FG000|Part B (Blinded)|Study Terminated by Sponsor|0|||
147497622|NCT05168813|531973968|FG001|Part B (Blinded)|Study Terminated by Sponsor|0|||
147497623|NCT05168813|531973969|FG002|Part B (Blinded)|Study Terminated by Sponsor|0|||
147497624|NCT05168813|531973970|FG003|Part B (Blinded)|Study Terminated by Sponsor|0|||
147497625|NCT05168813|531973971|FG004|Part B (Blinded)|Study Terminated by Sponsor|8682|||
147497626|NCT05168813|531973972|FG005|Part B (Blinded)|Study Terminated by Sponsor|125|||
147497627|NCT05168813|531973967|FG000|Part B (Blinded)|Other|0|||
147497628|NCT05168813|531973968|FG001|Part B (Blinded)|Other|0|||
147497629|NCT05168813|531973969|FG002|Part B (Blinded)|Other|0|||
147497630|NCT05168813|531973970|FG003|Part B (Blinded)|Other|0|||
147497631|NCT05168813|531973971|FG004|Part B (Blinded)|Other|41|||
147497632|NCT05168813|531973972|FG005|Part B (Blinded)|Other|27|||
147497633|NCT00571688|531973978|FG000|Overall Study|Lost to Follow-up|3|||
147497634|NCT00571688|531973979|FG001|Overall Study|Lost to Follow-up|6|||
147497635|NCT00571688|531973978|FG000|Overall Study|subject did not tolerate Consta|1|||
147497636|NCT00571688|531973979|FG001|Overall Study|subject did not tolerate Consta|0|||
147497637|NCT00571688|531973978|FG000|Overall Study|subject moved out of the area|1|||
147497638|NCT00571688|531973979|FG001|Overall Study|subject moved out of the area|0|||
147497639|NCT01048853|531973980|FG000|Overall Study|Death|1|||
147497640|NCT01048853|531973981|FG001|Overall Study|Death|0|||
147497641|NCT01048853|531973982|FG002|Overall Study|Death|0|||
147497642|NCT01048853|531973980|FG000|Overall Study|Lost to Follow-up|1|||
147497643|NCT01048853|531973981|FG001|Overall Study|Lost to Follow-up|4|||
147497644|NCT01048853|531973982|FG002|Overall Study|Lost to Follow-up|0|||
147497645|NCT04999969|531973983|FG000|Overall Study|Death|76|||
147497646|NCT04999969|531973983|FG000|Overall Study|Progressive Disease|1|||
147497647|NCT04999969|531973983|FG000|Overall Study|Withdrawal by Subject|8|||
147497648|NCT03779334|531973988|FG000|Overall Study|Withdrawal by Subject|3|||
147497649|NCT03779334|531973989|FG001|Overall Study|Withdrawal by Subject|0|||
147497650|NCT03779334|531973990|FG002|Overall Study|Withdrawal by Subject|0|||
147497651|NCT03779334|531973988|FG000|Overall Study|Ongoing in Study|5|||
147497652|NCT03779334|531973989|FG001|Overall Study|Ongoing in Study|13|||
147497653|NCT03779334|531973990|FG002|Overall Study|Ongoing in Study|5|||
147497654|NCT06964165|531973997|FG000|Overall Study|Death|4|||
147497655|NCT06964165|531973998|FG001|Overall Study|Death|4|||
147497656|NCT06964165|531973997|FG000|Overall Study|Physician Decision|1|||
147497657|NCT06964165|531973998|FG001|Overall Study|Physician Decision|1|||
147497658|NCT06964165|531973997|FG000|Overall Study|Withdrawal by Subject|0|||
147497659|NCT06964165|531973998|FG001|Overall Study|Withdrawal by Subject|2|||
147668515|NCT03191552|532611815|FG001|Overall Study|Undergone surgery (Progressive hip dyspl|1|||
147497660|NCT06964165|531973997|FG000|Overall Study|Study terminated by sponsor|12|||
147497661|NCT06964165|531973998|FG001|Overall Study|Study terminated by sponsor|10|||
147497662|NCT06964165|531973997|FG000|Overall Study|Participant discontinued due to relocation to a long-term care facility|0|||
147497663|NCT06964165|531973998|FG001|Overall Study|Participant discontinued due to relocation to a long-term care facility|1|||
147497664|NCT06964165|531973997|FG000|Overall Study|Participant removed due to non-compliance|0|||
147497665|NCT06964165|531973998|FG001|Overall Study|Participant removed due to non-compliance|1|||
147497666|NCT06245044|531973999|FG000|No MI help|Technical issues|18|||
147497667|NCT04735393|531974003|FG000|Overall Study|Lost to Follow-up|46|||
147497668|NCT04735393|531974004|FG001|Overall Study|Lost to Follow-up|24|||
147497669|NCT04735393|531974003|FG000|Overall Study|Physician Decision|2|||
147497670|NCT04735393|531974004|FG001|Overall Study|Physician Decision|1|||
147497671|NCT04735393|531974003|FG000|Overall Study|Not Detailed|1|||
147497672|NCT04735393|531974004|FG001|Overall Study|Not Detailed|2|||
147497673|NCT04735393|531974003|FG000|Overall Study|Withdrawal by Subject|71|||
147497674|NCT04735393|531974004|FG001|Overall Study|Withdrawal by Subject|28|||
147497675|NCT04735393|531974003|FG000|Overall Study|Adverse Event|56|||
147497676|NCT04735393|531974004|FG001|Overall Study|Adverse Event|7|||
147497677|NCT04735393|531974003|FG000|Overall Study|Protocol Violation|6|||
147497678|NCT04735393|531974004|FG001|Overall Study|Protocol Violation|1|||
147497679|NCT04735393|531974003|FG000|Overall Study|Trial terminated by Sponsor|49|||
147497680|NCT04735393|531974004|FG001|Overall Study|Trial terminated by Sponsor|29|||
147497681|NCT03224104|531974009|FG000|Overall Study|Lack of Efficacy|2|||
147497682|NCT03224104|531974010|FG001|Overall Study|Lack of Efficacy|6|||
147497683|NCT03224104|531974011|FG002|Overall Study|Lack of Efficacy|3|||
147497684|NCT03224104|531974012|FG003|Overall Study|Lack of Efficacy|4|||
147497685|NCT03224104|531974013|FG004|Overall Study|Lack of Efficacy|42|||
147497686|NCT03224104|531974009|FG000|Overall Study|Withdrawal by Subject|0|||
147497687|NCT03224104|531974010|FG001|Overall Study|Withdrawal by Subject|2|||
147497688|NCT03224104|531974011|FG002|Overall Study|Withdrawal by Subject|0|||
147497689|NCT03224104|531974012|FG003|Overall Study|Withdrawal by Subject|1|||
147497690|NCT03224104|531974013|FG004|Overall Study|Withdrawal by Subject|3|||
147497691|NCT03224104|531974009|FG000|Overall Study|Death|0|||
147497692|NCT03224104|531974010|FG001|Overall Study|Death|1|||
147497693|NCT03224104|531974011|FG002|Overall Study|Death|0|||
147497694|NCT03224104|531974012|FG003|Overall Study|Death|0|||
147497695|NCT03224104|531974013|FG004|Overall Study|Death|0|||
147497696|NCT03224104|531974009|FG000|Overall Study|Adverse Event|1|||
147497697|NCT03224104|531974010|FG001|Overall Study|Adverse Event|0|||
147497698|NCT03224104|531974011|FG002|Overall Study|Adverse Event|0|||
147497699|NCT03224104|531974012|FG003|Overall Study|Adverse Event|1|||
147497700|NCT03224104|531974013|FG004|Overall Study|Adverse Event|3|||
147497701|NCT03224104|531974009|FG000|Overall Study|Start of a new anti-cancer treatment|0|||
147497702|NCT03224104|531974010|FG001|Overall Study|Start of a new anti-cancer treatment|0|||
147497703|NCT03224104|531974011|FG002|Overall Study|Start of a new anti-cancer treatment|0|||
147497704|NCT03224104|531974012|FG003|Overall Study|Start of a new anti-cancer treatment|0|||
147497705|NCT03224104|531974013|FG004|Overall Study|Start of a new anti-cancer treatment|1|||
147497706|NCT03224104|531974009|FG000|Overall Study|Treatment ongoing|0|||
147497707|NCT03224104|531974010|FG001|Overall Study|Treatment ongoing|0|||
147497708|NCT03224104|531974011|FG002|Overall Study|Treatment ongoing|0|||
147497709|NCT03224104|531974012|FG003|Overall Study|Treatment ongoing|0|||
147497710|NCT03224104|531974013|FG004|Overall Study|Treatment ongoing|1|||
147497711|NCT05600309|531974014|FG000|Overall Study|Death|41|||
147497712|NCT05600309|531974015|FG001|Overall Study|Death|38|||
147497713|NCT05600309|531974014|FG000|Overall Study|Sponsor Decision|9|||
147497714|NCT05600309|531974015|FG001|Overall Study|Sponsor Decision|6|||
147497715|NCT06087328|531974016|FG000|28-Day Treatment|Lost to Follow-up|7|||
147497716|NCT06087328|531974017|FG001|28-Day Treatment|Lost to Follow-up|3|||
147497717|NCT06087328|531974018|FG002|28-Day Treatment|Lost to Follow-up|4|||
147497718|NCT06087328|531974016|FG000|1-month Follow-up|Lost to Follow-up|0|||
147497719|NCT06087328|531974017|FG001|1-month Follow-up|Lost to Follow-up|1|||
147497720|NCT06087328|531974018|FG002|1-month Follow-up|Lost to Follow-up|1|||
147497721|NCT05822830|531974019|FG000|Overall Study|Adverse Event|6|||
147497722|NCT05822830|531974020|FG001|Overall Study|Adverse Event|6|||
147497723|NCT05822830|531974019|FG000|Overall Study|Assigned Treatment by Mistake|5|||
147497724|NCT05822830|531974020|FG001|Overall Study|Assigned Treatment by Mistake|3|||
147497725|NCT05822830|531974019|FG000|Overall Study|Lost to Follow-up|16|||
147497726|NCT05822830|531974020|FG001|Overall Study|Lost to Follow-up|18|||
147497727|NCT05822830|531974019|FG000|Overall Study|Non-Compliance With Study Drug|1|||
147497728|NCT05822830|531974020|FG001|Overall Study|Non-Compliance With Study Drug|1|||
147497729|NCT05822830|531974019|FG000|Overall Study|Participant was Out of the Country|0|||
147497730|NCT05822830|531974020|FG001|Overall Study|Participant was Out of the Country|1|||
147497731|NCT05822830|531974019|FG000|Overall Study|Pregnancy|1|||
147631602|NCT02477826|532469501|FG007|Treatment Period|Study Drug Toxicity|30|||
147631603|NCT02477826|532469502|FG008|Treatment Period|Study Drug Toxicity|20|||
147497732|NCT05822830|531974020|FG001|Overall Study|Pregnancy|2|||
147497733|NCT05822830|531974019|FG000|Overall Study|Withdrawal by Subject|27|||
147497734|NCT05822830|531974020|FG001|Overall Study|Withdrawal by Subject|26|||
147497735|NCT03201965|531974024|FG000|Overall Study|Death|5|||
147497736|NCT03201965|531974025|FG001|Overall Study|Death|65|||
147497737|NCT03201965|531974026|FG002|Overall Study|Death|47|||
147497738|NCT03201965|531974024|FG000|Overall Study|Lost to Follow-up|0|||
147497739|NCT03201965|531974025|FG001|Overall Study|Lost to Follow-up|6|||
147497740|NCT03201965|531974026|FG002|Overall Study|Lost to Follow-up|0|||
147497741|NCT03201965|531974024|FG000|Overall Study|Withdrawal by Subject|3|||
147497742|NCT03201965|531974025|FG001|Overall Study|Withdrawal by Subject|23|||
147497743|NCT03201965|531974026|FG002|Overall Study|Withdrawal by Subject|8|||
147497744|NCT03201965|531974024|FG000|Overall Study|Sponsor's Decision|20|||
147497745|NCT03201965|531974025|FG001|Overall Study|Sponsor's Decision|99|||
147497746|NCT03201965|531974026|FG002|Overall Study|Sponsor's Decision|140|||
147497747|NCT03368664|531974027|FG000|Phase1: Prior DMT:Month -4 to Month 0|Physician Decision|1|||
147497748|NCT03368664|531974027|FG000|Phase1: Prior DMT:Month -4 to Month 0|Participant was withdrawn from study|1|||
147497749|NCT03368664|531974027|FG000|Phase1: Prior DMT:Month -4 to Month 0|Principal Investigator and Parents Decision|1|||
147497750|NCT03368664|531974027|FG000|Phase1: Prior DMT:Month -4 to Month 0|Still on Prior DMT Phase or missing Completion|1|||
147497751|NCT03589326|531974035|FG000|IP (Cycles 1-3) (Cycle Length=28 Days)|Participants Ongoing on Study|135|||
147497752|NCT03589326|531974036|FG001|IP (Cycles 1-3) (Cycle Length=28 Days)|Participants Ongoing on Study|63|||
147497753|NCT03589326|531974035|FG000|IP (Cycles 1-3) (Cycle Length=28 Days)|Death|21|||
147497754|NCT03589326|531974036|FG001|IP (Cycles 1-3) (Cycle Length=28 Days)|Death|13|||
147497755|NCT03589326|531974035|FG000|IP (Cycles 1-3) (Cycle Length=28 Days)|Lost to Follow-up|0|||
147497756|NCT03589326|531974036|FG001|IP (Cycles 1-3) (Cycle Length=28 Days)|Lost to Follow-up|1|||
147497757|NCT03589326|531974035|FG000|IP (Cycles 1-3) (Cycle Length=28 Days)|Withdrawal by Subject|6|||
147497758|NCT03589326|531974036|FG001|IP (Cycles 1-3) (Cycle Length=28 Days)|Withdrawal by Subject|4|||
147497759|NCT03589326|531974035|FG000|IP (Cycles 1-3) (Cycle Length=28 Days)|Reason not Specified|2|||
147631604|NCT02477826|532469503|FG009|Treatment Period|Study Drug Toxicity|9|||
147631605|NCT02477826|532469494|FG000|Treatment Period|Disease progression|212|||
147631606|NCT02477826|532469495|FG001|Treatment Period|Disease progression|240|||
147631607|NCT02477826|532469496|FG002|Treatment Period|Disease progression|202|||
147631608|NCT02477826|532469497|FG003|Treatment Period|Disease progression|93|||
147631609|NCT02477826|532469498|FG004|Treatment Period|Disease progression|113|||
147631610|NCT02477826|532469499|FG005|Treatment Period|Disease progression|96|||
147631611|NCT02477826|532469500|FG006|Treatment Period|Disease progression|208|||
147631612|NCT02477826|532469501|FG007|Treatment Period|Disease progression|195|||
147631613|NCT02477826|532469502|FG008|Treatment Period|Disease progression|59|||
147631614|NCT02477826|532469503|FG009|Treatment Period|Disease progression|46|||
147631615|NCT02477826|532469494|FG000|Treatment Period|Pregnancy|0|||
147631616|NCT02477826|532469495|FG001|Treatment Period|Pregnancy|0|||
147631617|NCT02477826|532469496|FG002|Treatment Period|Pregnancy|0|||
147631618|NCT02477826|532469497|FG003|Treatment Period|Pregnancy|0|||
147631619|NCT02477826|532469498|FG004|Treatment Period|Pregnancy|0|||
147631620|NCT02477826|532469499|FG005|Treatment Period|Pregnancy|0|||
147631621|NCT02477826|532469500|FG006|Treatment Period|Pregnancy|0|||
147631622|NCT02477826|532469501|FG007|Treatment Period|Pregnancy|0|||
147631623|NCT02477826|532469502|FG008|Treatment Period|Pregnancy|0|||
147631624|NCT02477826|532469503|FG009|Treatment Period|Pregnancy|1|||
147631625|NCT02477826|532469494|FG000|Treatment Period|Other|0|||
147631626|NCT02477826|532469495|FG001|Treatment Period|Other|0|||
147631627|NCT02477826|532469496|FG002|Treatment Period|Other|0|||
147631628|NCT02477826|532469497|FG003|Treatment Period|Other|0|||
147631629|NCT02477826|532469498|FG004|Treatment Period|Other|0|||
147631630|NCT02477826|532469499|FG005|Treatment Period|Other|0|||
147631631|NCT02477826|532469500|FG006|Treatment Period|Other|0|||
147631632|NCT02477826|532469501|FG007|Treatment Period|Other|0|||
147631633|NCT02477826|532469502|FG008|Treatment Period|Other|0|||
147631634|NCT02477826|532469503|FG009|Treatment Period|Other|1|||
147631635|NCT00828568|532469504|FG000|Randomized|Withdrawal by Subject|1|||
147631636|NCT00828568|532469505|FG001|Randomized|Withdrawal by Subject|0|||
147631637|NCT00828568|532469506|FG002|Randomized|Withdrawal by Subject|2|||
147631638|NCT00828568|532469504|FG000|Treated - Received at Least One Dose|Adverse Event|11|||
147631639|NCT00828568|532469505|FG001|Treated - Received at Least One Dose|Adverse Event|8|||
147631640|NCT00828568|532469506|FG002|Treated - Received at Least One Dose|Adverse Event|1|||
147631641|NCT00828568|532469504|FG000|Treated - Received at Least One Dose|Withdrawal by Subject|9|||
147631642|NCT00828568|532469505|FG001|Treated - Received at Least One Dose|Withdrawal by Subject|11|||
147631643|NCT00828568|532469506|FG002|Treated - Received at Least One Dose|Withdrawal by Subject|0|||
147631644|NCT00828568|532469504|FG000|Treated - Received at Least One Dose|Lost to Follow-up|1|||
147631645|NCT00828568|532469505|FG001|Treated - Received at Least One Dose|Lost to Follow-up|5|||
147631646|NCT00828568|532469506|FG002|Treated - Received at Least One Dose|Lost to Follow-up|1|||
147631647|NCT00828568|532469504|FG000|Treated - Received at Least One Dose|Protocol Violation|9|||
147631648|NCT00828568|532469505|FG001|Treated - Received at Least One Dose|Protocol Violation|5|||
147631649|NCT00828568|532469506|FG002|Treated - Received at Least One Dose|Protocol Violation|3|||
147631650|NCT00403481|532469507|FG000|Olmesartan Medoxomil (Olm) 20 mg|Adverse Event|1|||
147631651|NCT00403481|532469507|FG000|Olmesartan Medoxomil (Olm) 20 mg|Physician Decision|1|||
147631652|NCT00403481|532469507|FG000|Olmesartan Medoxomil (Olm) 20 mg|Protocol Violation|3|||
147631653|NCT00403481|532469507|FG000|Olmesartan Medoxomil (Olm) 20 mg|Withdrawal by Subject|1|||
147497760|NCT03589326|531974036|FG001|IP (Cycles 1-3) (Cycle Length=28 Days)|Reason not Specified|0|||
147497761|NCT05441592|531974037|FG000|Overall Study|Lost to Follow-up|1|||
147631654|NCT00403481|532469507|FG000|Olm 40 mg|Adverse Event|2|||
147631655|NCT00403481|532469507|FG000|Olm 40 mg|Protocol Violation|1|||
147631656|NCT00403481|532469507|FG000|Olm 40 mg|Withdrawal by Subject|1|||
147631657|NCT00403481|532469507|FG000|Olm 40 mg|Other|1|||
147631658|NCT00403481|532469507|FG000|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Adverse Event|2|||
147631659|NCT00403481|532469507|FG000|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Protocol Violation|1|||
147631660|NCT00403481|532469507|FG000|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Withdrawal by Subject|1|||
147631661|NCT00403481|532469507|FG000|Olm 40 mg + Hydrochlorothiazide 12.5 mg|Other|1|||
147668516|NCT03191552|532611816|FG002|Overall Study|Undergone surgery (Progressive hip dyspl|0|||
147668517|NCT02370511|532611819|FG000|Overall Study|Death|10|||
147668518|NCT02370511|532611820|FG001|Overall Study|Death|7|||
147668519|NCT02370511|532611821|FG002|Overall Study|Death|1|||
147497762|NCT05441592|531974038|FG001|Overall Study|Lost to Follow-up|5|||
147497763|NCT01371981|531974039|FG000|Overall Study|Adverse Event|12|||
147497764|NCT01371981|531974040|FG001|Overall Study|Adverse Event|17|||
147497765|NCT01371981|531974041|FG002|Overall Study|Adverse Event|0|||
147497766|NCT01371981|531974042|FG003|Overall Study|Adverse Event|4|||
147497767|NCT01371981|531974043|FG004|Overall Study|Adverse Event|1|||
147497768|NCT01371981|531974044|FG005|Overall Study|Adverse Event|0|||
147497769|NCT01371981|531974039|FG000|Overall Study|Death|22|||
147497770|NCT01371981|531974040|FG001|Overall Study|Death|16|||
147497771|NCT01371981|531974041|FG002|Overall Study|Death|0|||
147497772|NCT01371981|531974042|FG003|Overall Study|Death|0|||
147497773|NCT01371981|531974043|FG004|Overall Study|Death|2|||
147497774|NCT01371981|531974044|FG005|Overall Study|Death|2|||
147497775|NCT01371981|531974039|FG000|Overall Study|Lack of Efficacy|69|||
147497776|NCT01371981|531974040|FG001|Overall Study|Lack of Efficacy|61|||
147497777|NCT01371981|531974041|FG002|Overall Study|Lack of Efficacy|4|||
147497778|NCT01371981|531974042|FG003|Overall Study|Lack of Efficacy|8|||
147497779|NCT01371981|531974043|FG004|Overall Study|Lack of Efficacy|5|||
147497780|NCT01371981|531974044|FG005|Overall Study|Lack of Efficacy|0|||
147497781|NCT01371981|531974039|FG000|Overall Study|Physician Decision|48|||
147497782|NCT01371981|531974040|FG001|Overall Study|Physician Decision|63|||
147497783|NCT01371981|531974041|FG002|Overall Study|Physician Decision|1|||
147497784|NCT01371981|531974042|FG003|Overall Study|Physician Decision|7|||
147497785|NCT01371981|531974043|FG004|Overall Study|Physician Decision|14|||
147497786|NCT01371981|531974044|FG005|Overall Study|Physician Decision|3|||
147497787|NCT01371981|531974039|FG000|Overall Study|Withdrawal by Subject|12|||
147497788|NCT01371981|531974040|FG001|Overall Study|Withdrawal by Subject|19|||
147497789|NCT01371981|531974041|FG002|Overall Study|Withdrawal by Subject|1|||
147497790|NCT01371981|531974042|FG003|Overall Study|Withdrawal by Subject|2|||
147497791|NCT01371981|531974043|FG004|Overall Study|Withdrawal by Subject|10|||
147497792|NCT01371981|531974044|FG005|Overall Study|Withdrawal by Subject|3|||
147497793|NCT01371981|531974039|FG000|Overall Study|Ineligible|19|||
147497794|NCT01371981|531974040|FG001|Overall Study|Ineligible|13|||
147497795|NCT01371981|531974041|FG002|Overall Study|Ineligible|0|||
147497796|NCT01371981|531974042|FG003|Overall Study|Ineligible|0|||
147497797|NCT01371981|531974043|FG004|Overall Study|Ineligible|0|||
147497798|NCT01371981|531974044|FG005|Overall Study|Ineligible|4|||
147497799|NCT01371981|531974039|FG000|Overall Study|Did not start treatment|2|||
147497800|NCT01371981|531974040|FG001|Overall Study|Did not start treatment|3|||
147497801|NCT01371981|531974041|FG002|Overall Study|Did not start treatment|0|||
147497802|NCT01371981|531974042|FG003|Overall Study|Did not start treatment|0|||
147497803|NCT01371981|531974043|FG004|Overall Study|Did not start treatment|0|||
147497804|NCT01371981|531974044|FG005|Overall Study|Did not start treatment|2|||
147497805|NCT00118482|531974045|FG000|Overall Study|Lost to Follow-up|7|||
147497806|NCT00118482|531974046|FG001|Overall Study|Lost to Follow-up|7|||
147497807|NCT00118482|531974045|FG000|Overall Study|Withdrawal by Subject|23|||
147497808|NCT00118482|531974046|FG001|Overall Study|Withdrawal by Subject|22|||
147497809|NCT00125190|531974047|FG000|Overall Study|Subject/Parent Decision|7|||
147497810|NCT00125190|531974047|FG000|Overall Study|Non-compliance|2|||
147497811|NCT00125190|531974047|FG000|Overall Study|Adverse Event|1|||
147497812|NCT00125190|531974047|FG000|Overall Study|Other|1|||
147497813|NCT00125190|531974047|FG000|Overall Study|Lost to Follow-up|4|||
147497814|NCT01586156|531974048|FG000|Overall Study|Pregnancy|0|||
147497815|NCT01586156|531974049|FG001|Overall Study|Pregnancy|1|||
147497816|NCT01586156|531974050|FG002|Overall Study|Pregnancy|0|||
147668520|NCT02370511|532611819|FG000|Overall Study|Withdrawal by Subject|2|||
147497817|NCT03259490|531974055|FG000|Period 1|Withdrawal by Subject|0|||
147497818|NCT03259490|531974056|FG001|Period 1|Withdrawal by Subject|1|||
147497819|NCT03259490|531974055|FG000|Period 2|Protocol Violation|1|||
147497820|NCT03259490|531974056|FG001|Period 2|Protocol Violation|0|||
147497821|NCT00255086|531974057|FG000|Overall Study|Adverse Event|1|||
147497822|NCT00255086|531974058|FG001|Overall Study|Adverse Event|1|||
147497823|NCT00255086|531974057|FG000|Overall Study|Protocol Violation|1|||
147497824|NCT00255086|531974058|FG001|Overall Study|Protocol Violation|1|||
147668521|NCT02370511|532611820|FG001|Overall Study|Withdrawal by Subject|0|||
147668522|NCT02370511|532611821|FG002|Overall Study|Withdrawal by Subject|0|||
147497825|NCT00434122|531974060|FG000|Overall Study|Non-compliance with protocol|0|||
147497826|NCT00434122|531974061|FG001|Overall Study|Non-compliance with protocol|1|||
147497827|NCT00434122|531974060|FG000|Overall Study|loss of subject contact|1|||
147497828|NCT00434122|531974061|FG001|Overall Study|loss of subject contact|1|||
147497829|NCT00434122|531974060|FG000|Overall Study|Personal reasons|1|||
147497830|NCT00434122|531974061|FG001|Overall Study|Personal reasons|1|||
147497831|NCT00434122|531974060|FG000|Overall Study|Large follicle size|2|||
147497832|NCT00434122|531974061|FG001|Overall Study|Large follicle size|2|||
147497833|NCT00434122|531974060|FG000|Overall Study|Low follicular response.|1|||
147497834|NCT00434122|531974061|FG001|Overall Study|Low follicular response.|2|||
147631662|NCT00403481|532469507|FG000|Olm 40 mg + Hydrochlorothiazide 25 mg|Withdrawal by Subject|1|||
147631663|NCT00403481|532469507|FG000|Olm 40 mg + Hydrochlorothiazide 25 mg|Lost to Follow-up|1|||
147631664|NCT04657198|532469513|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO A (S)AE|1|||
147631665|NCT04657198|532469514|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO A (S)AE|0|||
147631666|NCT04657198|532469515|FG002|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO A (S)AE|0|||
147631667|NCT03793842|532469516|FG000|Randomization-Intervention 1 (~6 Hrs)|Physician Decision|0|||
147631668|NCT03793842|532469517|FG001|Randomization-Intervention 1 (~6 Hrs)|Physician Decision|1|||
147631669|NCT03793842|532469516|FG000|Randomization-Intervention 1 (~6 Hrs)|Prone positioning after baseline data collection|2|||
147631670|NCT03793842|532469517|FG001|Randomization-Intervention 1 (~6 Hrs)|Prone positioning after baseline data collection|1|||
147631671|NCT04087720|532469518|FG000|Overall Study|Withdrawal by Subject|2|||
147631672|NCT04087720|532469518|FG000|Overall Study|Withdrawal by Subject - COVID-19 Concerns|3|||
147631673|NCT01166438|532469519|FG000|Double-blind Phase: 1st 6 Months|Withdrawal by Subject|8|||
147631674|NCT01166438|532469520|FG001|Double-blind Phase: 1st 6 Months|Withdrawal by Subject|4|||
147631675|NCT01166438|532469519|FG000|Double-blind Phase: 1st 6 Months|Lost to Follow-up|0|||
147631676|NCT01166438|532469520|FG001|Double-blind Phase: 1st 6 Months|Lost to Follow-up|4|||
147631677|NCT01166438|532469519|FG000|Double-blind Phase: 1st 6 Months|Not treated|1|||
147631678|NCT01166438|532469520|FG001|Double-blind Phase: 1st 6 Months|Not treated|1|||
147631679|NCT01166438|532469519|FG000|Off Treatment Follow-up Phase|Withdrawal by Subject|1|||
147631680|NCT01166438|532469520|FG001|Off Treatment Follow-up Phase|Withdrawal by Subject|2|||
147631681|NCT01166438|532469519|FG000|Off Treatment Follow-up Phase|Lost to Follow-up|4|||
147631682|NCT01166438|532469520|FG001|Off Treatment Follow-up Phase|Lost to Follow-up|2|||
147631683|NCT01166438|532469519|FG000|Off Treatment Follow-up Phase|Lack of Efficacy|29|||
147631684|NCT01166438|532469520|FG001|Off Treatment Follow-up Phase|Lack of Efficacy|52|||
147631685|NCT03340454|532469521|FG000|Overall Study|Lost to Follow-up|0|||
147631686|NCT03340454|532469522|FG001|Overall Study|Lost to Follow-up|4|||
147631687|NCT01464164|532469523|FG000|Overall Study|Screen failure|0|||
147631688|NCT01464164|532469524|FG001|Overall Study|Screen failure|1|||
147631689|NCT01464164|532469525|FG002|Overall Study|Screen failure|2|||
147631690|NCT01464164|532469526|FG003|Overall Study|Screen failure|0|||
147631691|NCT01464164|532469527|FG004|Overall Study|Screen failure|0|||
147631692|NCT01464164|532469528|FG005|Overall Study|Screen failure|0|||
147631693|NCT01464164|532469529|FG006|Overall Study|Screen failure|0|||
147631694|NCT01464164|532469523|FG000|Overall Study|Physician Decision|0|||
147631695|NCT01464164|532469524|FG001|Overall Study|Physician Decision|1|||
147631696|NCT01464164|532469525|FG002|Overall Study|Physician Decision|0|||
147631697|NCT01464164|532469526|FG003|Overall Study|Physician Decision|0|||
147631698|NCT01464164|532469527|FG004|Overall Study|Physician Decision|0|||
147631699|NCT01464164|532469528|FG005|Overall Study|Physician Decision|0|||
147631700|NCT01464164|532469529|FG006|Overall Study|Physician Decision|2|||
147631701|NCT03682848|532469530|FG000|Overall Study|Withdrawal by Subject|2|||
147631702|NCT03682848|532469530|FG000|Overall Study|Site closed|5|||
147631703|NCT03682848|532469530|FG000|Overall Study|Protocol Deviation|1|||
147631704|NCT03682848|532469530|FG000|Overall Study|Adverse Event|1|||
147631705|NCT02347813|532469533|FG000|First Intervention, 24 Weeks|Withdrawal by Subject|1|||
147631706|NCT02347813|532469534|FG001|First Intervention, 24 Weeks|Withdrawal by Subject|1|||
147631707|NCT02347813|532469533|FG000|First Intervention, 24 Weeks|Adverse Event|1|||
147631708|NCT02347813|532469534|FG001|First Intervention, 24 Weeks|Adverse Event|1|||
147631709|NCT01134939|532469535|FG000|Overall Study|Adverse Event|9|||
147631710|NCT01134939|532469536|FG001|Overall Study|Adverse Event|3|||
147631711|NCT01134939|532469537|FG002|Overall Study|Adverse Event|4|||
147631712|NCT01134939|532469538|FG003|Overall Study|Adverse Event|5|||
147631713|NCT01134939|532469539|FG004|Overall Study|Adverse Event|5|||
147631714|NCT01134939|532469540|FG005|Overall Study|Adverse Event|5|||
147631715|NCT01134939|532469541|FG006|Overall Study|Adverse Event|1|||
147631716|NCT01134939|532469542|FG007|Overall Study|Adverse Event|0|||
147631717|NCT01134939|532469535|FG000|Overall Study|Lack of Efficacy|2|||
147631718|NCT01134939|532469536|FG001|Overall Study|Lack of Efficacy|5|||
147631719|NCT01134939|532469537|FG002|Overall Study|Lack of Efficacy|1|||
147631720|NCT01134939|532469538|FG003|Overall Study|Lack of Efficacy|0|||
147631721|NCT01134939|532469539|FG004|Overall Study|Lack of Efficacy|3|||
147631722|NCT01134939|532469540|FG005|Overall Study|Lack of Efficacy|0|||
147631723|NCT01134939|532469541|FG006|Overall Study|Lack of Efficacy|1|||
147631724|NCT01134939|532469542|FG007|Overall Study|Lack of Efficacy|0|||
147631725|NCT01134939|532469535|FG000|Overall Study|Lost to Follow-up|2|||
147668523|NCT02370511|532611819|FG000|Overall Study|Lost to Follow-up|0|||
147668524|NCT02370511|532611820|FG001|Overall Study|Lost to Follow-up|4|||
147631726|NCT01134939|532469536|FG001|Overall Study|Lost to Follow-up|3|||
147631727|NCT01134939|532469537|FG002|Overall Study|Lost to Follow-up|0|||
147631728|NCT01134939|532469538|FG003|Overall Study|Lost to Follow-up|1|||
147631729|NCT01134939|532469539|FG004|Overall Study|Lost to Follow-up|2|||
147631730|NCT01134939|532469540|FG005|Overall Study|Lost to Follow-up|1|||
147631731|NCT01134939|532469541|FG006|Overall Study|Lost to Follow-up|0|||
147631732|NCT01134939|532469542|FG007|Overall Study|Lost to Follow-up|0|||
147631733|NCT01134939|532469535|FG000|Overall Study|Death|0|||
147631734|NCT01134939|532469536|FG001|Overall Study|Death|1|||
147631735|NCT01134939|532469537|FG002|Overall Study|Death|0|||
147631736|NCT01134939|532469538|FG003|Overall Study|Death|0|||
147631737|NCT01134939|532469539|FG004|Overall Study|Death|0|||
147631738|NCT01134939|532469540|FG005|Overall Study|Death|0|||
147631739|NCT01134939|532469541|FG006|Overall Study|Death|0|||
147631740|NCT01134939|532469542|FG007|Overall Study|Death|0|||
147631741|NCT01134939|532469535|FG000|Overall Study|Termination page not available|4|||
147631742|NCT01134939|532469536|FG001|Overall Study|Termination page not available|6|||
147631743|NCT01134939|532469537|FG002|Overall Study|Termination page not available|5|||
147631744|NCT01134939|532469538|FG003|Overall Study|Termination page not available|8|||
147631745|NCT01134939|532469539|FG004|Overall Study|Termination page not available|0|||
147631746|NCT01134939|532469540|FG005|Overall Study|Termination page not available|3|||
147631747|NCT01134939|532469541|FG006|Overall Study|Termination page not available|7|||
147631748|NCT01134939|532469542|FG007|Overall Study|Termination page not available|0|||
147631749|NCT03817229|532469543|FG000|Intervention Period-Stage 1|Withdrawal by Subject|6|||
147631750|NCT03817229|532469544|FG001|Intervention Period-Stage 1|Withdrawal by Subject|8|||
147631751|NCT03817229|532469545|FG002|Intervention Period-Stage 1|Withdrawal by Subject|0|||
147631752|NCT03817229|532469546|FG003|Intervention Period-Stage 1|Withdrawal by Subject|0|||
147631753|NCT03817229|532469543|FG000|Intervention Period-Stage 1|Withdrawn by Study Team|0|||
147631754|NCT03817229|532469544|FG001|Intervention Period-Stage 1|Withdrawn by Study Team|1|||
147631755|NCT03817229|532469545|FG002|Intervention Period-Stage 1|Withdrawn by Study Team|0|||
147631756|NCT03817229|532469546|FG003|Intervention Period-Stage 1|Withdrawn by Study Team|0|||
147631757|NCT03817229|532469543|FG000|Intervention Period-Stage 1|Weaned from medication|0|||
147631758|NCT03817229|532469544|FG001|Intervention Period-Stage 1|Weaned from medication|3|||
147631759|NCT03817229|532469545|FG002|Intervention Period-Stage 1|Weaned from medication|0|||
147631760|NCT03817229|532469546|FG003|Intervention Period-Stage 1|Weaned from medication|0|||
147631761|NCT03817229|532469543|FG000|Intervention Period-Stage 2|Withdrawal by Subject|1|||
147631762|NCT03817229|532469544|FG001|Intervention Period-Stage 2|Withdrawal by Subject|0|||
147631763|NCT03817229|532469545|FG002|Intervention Period-Stage 2|Withdrawal by Subject|1|||
147631764|NCT03817229|532469546|FG003|Intervention Period-Stage 2|Withdrawal by Subject|10|||
147631765|NCT03817229|532469543|FG000|Intervention Period-Stage 2|Withdrawal by Study Team|0|||
147631766|NCT03817229|532469544|FG001|Intervention Period-Stage 2|Withdrawal by Study Team|0|||
147631767|NCT03817229|532469545|FG002|Intervention Period-Stage 2|Withdrawal by Study Team|0|||
147631768|NCT03817229|532469546|FG003|Intervention Period-Stage 2|Withdrawal by Study Team|3|||
147631769|NCT03817229|532469543|FG000|Intervention Period-Stage 2|Weaned from medication|0|||
147631770|NCT03817229|532469544|FG001|Intervention Period-Stage 2|Weaned from medication|0|||
147631771|NCT03817229|532469545|FG002|Intervention Period-Stage 2|Weaned from medication|0|||
147631772|NCT03817229|532469546|FG003|Intervention Period-Stage 2|Weaned from medication|1|||
147631773|NCT03817229|532469543|FG000|Post-Intervention|Withdrawal by Subject|6|||
147631774|NCT03817229|532469544|FG001|Post-Intervention|Withdrawal by Subject|0|||
147631775|NCT03817229|532469545|FG002|Post-Intervention|Withdrawal by Subject|2|||
147631776|NCT03817229|532469546|FG003|Post-Intervention|Withdrawal by Subject|2|||
147631777|NCT03817229|532469543|FG000|Post-Intervention|Withdrawal by Study Team|3|||
147631778|NCT03817229|532469544|FG001|Post-Intervention|Withdrawal by Study Team|1|||
147631779|NCT03817229|532469545|FG002|Post-Intervention|Withdrawal by Study Team|1|||
147631780|NCT03817229|532469546|FG003|Post-Intervention|Withdrawal by Study Team|4|||
147631781|NCT03817229|532469543|FG000|Post-Intervention|Weaned from medication|3|||
147631782|NCT03817229|532469544|FG001|Post-Intervention|Weaned from medication|0|||
147631783|NCT03817229|532469545|FG002|Post-Intervention|Weaned from medication|2|||
147631784|NCT03817229|532469546|FG003|Post-Intervention|Weaned from medication|1|||
147631785|NCT03817229|532469543|FG000|Post-Intervention|Transferred care to another institution|1|||
147631786|NCT03817229|532469544|FG001|Post-Intervention|Transferred care to another institution|0|||
147631787|NCT03817229|532469545|FG002|Post-Intervention|Transferred care to another institution|0|||
147631788|NCT03817229|532469546|FG003|Post-Intervention|Transferred care to another institution|0|||
147631789|NCT03817229|532469543|FG000|Post-Intervention|Change in parental guardianship|0|||
147631790|NCT03817229|532469544|FG001|Post-Intervention|Change in parental guardianship|0|||
147631791|NCT03817229|532469545|FG002|Post-Intervention|Change in parental guardianship|1|||
147631792|NCT03817229|532469546|FG003|Post-Intervention|Change in parental guardianship|0|||
147631793|NCT03817229|532469543|FG000|Follow-up 1|Ineligible for this follow-up visit due to study timing|7|||
147631794|NCT03817229|532469544|FG001|Follow-up 1|Ineligible for this follow-up visit due to study timing|4|||
147631795|NCT03817229|532469545|FG002|Follow-up 1|Ineligible for this follow-up visit due to study timing|4|||
147631796|NCT03817229|532469546|FG003|Follow-up 1|Ineligible for this follow-up visit due to study timing|3|||
147631797|NCT03817229|532469543|FG000|Follow-up 1|Withdrawal by Subject|1|||
147631798|NCT03817229|532469544|FG001|Follow-up 1|Withdrawal by Subject|2|||
147631799|NCT03817229|532469545|FG002|Follow-up 1|Withdrawal by Subject|0|||
147631800|NCT03817229|532469546|FG003|Follow-up 1|Withdrawal by Subject|0|||
147631801|NCT03817229|532469543|FG000|Follow-up 1|Withdrawal by Study Team|3|||
147631802|NCT03817229|532469544|FG001|Follow-up 1|Withdrawal by Study Team|1|||
147631803|NCT03817229|532469545|FG002|Follow-up 1|Withdrawal by Study Team|0|||
147497835|NCT00434122|531974060|FG000|Overall Study|Travelling of subject.|1|||
147631804|NCT03817229|532469546|FG003|Follow-up 1|Withdrawal by Study Team|0|||
147631805|NCT03817229|532469543|FG000|Follow-up 1|Wean from medication|3|||
147631806|NCT03817229|532469544|FG001|Follow-up 1|Wean from medication|4|||
147631807|NCT03817229|532469545|FG002|Follow-up 1|Wean from medication|0|||
147631808|NCT03817229|532469546|FG003|Follow-up 1|Wean from medication|1|||
147631809|NCT03817229|532469543|FG000|Follow-up 1|Transferred care to another hospital|1|||
147631810|NCT03817229|532469544|FG001|Follow-up 1|Transferred care to another hospital|0|||
147631811|NCT03817229|532469545|FG002|Follow-up 1|Transferred care to another hospital|0|||
147631812|NCT03817229|532469546|FG003|Follow-up 1|Transferred care to another hospital|0|||
147631813|NCT03817229|532469543|FG000|Follow-up 2|Ineligible for this follow-up visit due to study timing|4|||
147631814|NCT03817229|532469544|FG001|Follow-up 2|Ineligible for this follow-up visit due to study timing|3|||
147631815|NCT03817229|532469545|FG002|Follow-up 2|Ineligible for this follow-up visit due to study timing|1|||
147631816|NCT03817229|532469546|FG003|Follow-up 2|Ineligible for this follow-up visit due to study timing|4|||
147631817|NCT03817229|532469543|FG000|Follow-up 2|Withdrawal by Subject|2|||
147631818|NCT03817229|532469544|FG001|Follow-up 2|Withdrawal by Subject|0|||
147631819|NCT03817229|532469545|FG002|Follow-up 2|Withdrawal by Subject|1|||
147631820|NCT03817229|532469546|FG003|Follow-up 2|Withdrawal by Subject|1|||
147631821|NCT03817229|532469543|FG000|Follow-up 2|Withdrawal by Study Team|2|||
147631822|NCT03817229|532469544|FG001|Follow-up 2|Withdrawal by Study Team|0|||
147631823|NCT03817229|532469545|FG002|Follow-up 2|Withdrawal by Study Team|1|||
147631824|NCT03817229|532469546|FG003|Follow-up 2|Withdrawal by Study Team|0|||
147631825|NCT03817229|532469543|FG000|Follow-up 2|Wean from medication|1|||
147631826|NCT03817229|532469544|FG001|Follow-up 2|Wean from medication|0|||
147631827|NCT03817229|532469545|FG002|Follow-up 2|Wean from medication|0|||
147631828|NCT03817229|532469546|FG003|Follow-up 2|Wean from medication|0|||
147631829|NCT03817229|532469543|FG000|Follow-up 2|Transferred care|0|||
147631830|NCT03817229|532469544|FG001|Follow-up 2|Transferred care|0|||
147631831|NCT03817229|532469545|FG002|Follow-up 2|Transferred care|1|||
147631832|NCT03817229|532469546|FG003|Follow-up 2|Transferred care|0|||
147631833|NCT01186692|532469549|FG000|Overall Study|Not Catheterized|11|||
147631834|NCT01186692|532469549|FG000|Overall Study|Futher testing contraindicated implant|19|||
147631835|NCT01186692|532469549|FG000|Overall Study|Adverse Event|2|||
147631836|NCT00757042|532469550|FG000|Overall Study|Lost to Follow-up|0|||
147631837|NCT00757042|532469551|FG001|Overall Study|Lost to Follow-up|0|||
147631838|NCT00757042|532469552|FG002|Overall Study|Lost to Follow-up|0|||
147631839|NCT00757042|532469553|FG003|Overall Study|Lost to Follow-up|0|||
147631840|NCT00757042|532469554|FG004|Overall Study|Lost to Follow-up|0|||
147631841|NCT00757042|532469555|FG005|Overall Study|Lost to Follow-up|0|||
147631842|NCT00757042|532469556|FG006|Overall Study|Lost to Follow-up|0|||
147631843|NCT00757042|532469557|FG007|Overall Study|Lost to Follow-up|0|||
147631844|NCT00757042|532469558|FG008|Overall Study|Lost to Follow-up|1|||
147631845|NCT00757042|532469559|FG009|Overall Study|Lost to Follow-up|0|||
147631846|NCT00757042|532469560|FG010|Overall Study|Lost to Follow-up|0|||
147631847|NCT00757042|532469550|FG000|Overall Study|Ineligibility Determined|0|||
147631848|NCT00757042|532469551|FG001|Overall Study|Ineligibility Determined|0|||
147631849|NCT00757042|532469552|FG002|Overall Study|Ineligibility Determined|0|||
147631850|NCT00757042|532469553|FG003|Overall Study|Ineligibility Determined|0|||
147631851|NCT00757042|532469554|FG004|Overall Study|Ineligibility Determined|0|||
147631852|NCT00757042|532469555|FG005|Overall Study|Ineligibility Determined|0|||
147631853|NCT00757042|532469556|FG006|Overall Study|Ineligibility Determined|0|||
147631854|NCT00757042|532469557|FG007|Overall Study|Ineligibility Determined|0|||
147631855|NCT00757042|532469558|FG008|Overall Study|Ineligibility Determined|0|||
147631856|NCT00757042|532469559|FG009|Overall Study|Ineligibility Determined|0|||
147631857|NCT00757042|532469560|FG010|Overall Study|Ineligibility Determined|1|||
147631858|NCT00757042|532469550|FG000|Overall Study|Withdrawal by Subject|0|||
147631859|NCT00757042|532469551|FG001|Overall Study|Withdrawal by Subject|0|||
147631860|NCT00757042|532469552|FG002|Overall Study|Withdrawal by Subject|0|||
147631861|NCT00757042|532469553|FG003|Overall Study|Withdrawal by Subject|0|||
147631862|NCT00757042|532469554|FG004|Overall Study|Withdrawal by Subject|0|||
147631863|NCT00757042|532469555|FG005|Overall Study|Withdrawal by Subject|0|||
147631864|NCT00757042|532469556|FG006|Overall Study|Withdrawal by Subject|0|||
147631865|NCT00757042|532469557|FG007|Overall Study|Withdrawal by Subject|0|||
147631866|NCT00757042|532469558|FG008|Overall Study|Withdrawal by Subject|0|||
147631867|NCT00757042|532469559|FG009|Overall Study|Withdrawal by Subject|1|||
147631868|NCT00757042|532469560|FG010|Overall Study|Withdrawal by Subject|0|||
147631869|NCT03319732|532469561|FG000|Overall Study|Adverse Event|40|||
147631870|NCT03319732|532469561|FG000|Overall Study|Withdrawal by Subject|50|||
147631871|NCT03319732|532469561|FG000|Overall Study|MS relapse|10|||
147631872|NCT03319732|532469561|FG000|Overall Study|reason not specified|5|||
147631873|NCT03232931|532470819|FG000|Overall Study|Physician Decision|1|||
147631874|NCT03232931|532470820|FG001|Overall Study|Physician Decision|1|||
147631875|NCT03232931|532470819|FG000|Overall Study|Withdrawal by Subject|6|||
147631876|NCT03232931|532470820|FG001|Overall Study|Withdrawal by Subject|0|||
147631877|NCT03232931|532470819|FG000|Overall Study|Discharged before completing study activities per protocol|4|||
147631878|NCT03232931|532470820|FG001|Overall Study|Discharged before completing study activities per protocol|2|||
147631879|NCT03232931|532470819|FG000|Overall Study|Parent did not record voice|1|||
147631880|NCT03232931|532470820|FG001|Overall Study|Parent did not record voice|2|||
147631881|NCT03232931|532470819|FG000|Overall Study|Research and staffing limitations during the Coronavirus Disease 2019 (COVID-19) pandemic|2|||
147631882|NCT03232931|532470820|FG001|Overall Study|Research and staffing limitations during the Coronavirus Disease 2019 (COVID-19) pandemic|1|||
147631883|NCT04925557|532470821|FG000|Overall Study|Study closed|5|||
147631884|NCT04925557|532470822|FG001|Overall Study|Study closed|3|||
147631885|NCT05488470|532470823|FG000|Overall Study|Physician Decision|2|||
147631886|NCT05488470|532470823|FG000|Overall Study|Withdrawal by Subject|1|||
147631887|NCT05488470|532470823|FG000|Overall Study|Death|1|||
147631888|NCT00068393|532470828|FG000|Overall Study|Adverse Event|2|||
147631889|NCT00068393|532470828|FG000|Overall Study|Death|3|||
147631890|NCT00068393|532470828|FG000|Overall Study|Withdrawal by Subject|3|||
147631891|NCT00068393|532470828|FG000|Overall Study|Alternative treatment|1|||
147631892|NCT00068393|532470828|FG000|Overall Study|Quality of life worsening|1|||
147631893|NCT01190410|532470829|FG000|Overall Study|Adverse Event|0|||
147631894|NCT01190410|532470830|FG001|Overall Study|Adverse Event|3|||
147631895|NCT01190410|532470829|FG000|Overall Study|Lack of Efficacy|0|||
147631896|NCT01190410|532470830|FG001|Overall Study|Lack of Efficacy|2|||
147631897|NCT01190410|532470829|FG000|Overall Study|Withdrawal by Subject|0|||
147631898|NCT01190410|532470830|FG001|Overall Study|Withdrawal by Subject|2|||
147631899|NCT01190410|532470829|FG000|Overall Study|Administrative decision|1|||
147631900|NCT01190410|532470830|FG001|Overall Study|Administrative decision|0|||
147631901|NCT01190410|532470829|FG000|Overall Study|PI discretion|0|||
147631902|NCT01190410|532470830|FG001|Overall Study|PI discretion|2|||
147631903|NCT03300505|532470839|FG000|Overall Study|Death|0|||
147631904|NCT03300505|532470840|FG001|Overall Study|Death|1|||
147631905|NCT03300505|532470841|FG002|Overall Study|Death|0|||
147631906|NCT03300505|532470839|FG000|Overall Study|Withdrawal by Subject|0|||
147631907|NCT03300505|532470840|FG001|Overall Study|Withdrawal by Subject|1|||
147631908|NCT03300505|532470841|FG002|Overall Study|Withdrawal by Subject|1|||
147631909|NCT03300505|532470839|FG000|Overall Study|Sponsor Termination|0|||
147497836|NCT00434122|531974061|FG001|Overall Study|Travelling of subject.|0|||
147497837|NCT01963208|531974062|FG000|Treatment Phase 1 (Up to Week 14)|Adverse Event|1|||
147497838|NCT01963208|531974063|FG001|Treatment Phase 1 (Up to Week 14)|Adverse Event|0|||
147497839|NCT01963208|531974064|FG002|Treatment Phase 1 (Up to Week 14)|Adverse Event|30|||
147497840|NCT01963208|531974065|FG003|Treatment Phase 1 (Up to Week 14)|Adverse Event|11|||
147497841|NCT01963208|531974066|FG004|Treatment Phase 1 (Up to Week 14)|Adverse Event|0|||
147497842|NCT01963208|531974067|FG005|Treatment Phase 1 (Up to Week 14)|Adverse Event|0|||
147497843|NCT01963208|531974062|FG000|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|0|||
147497844|NCT01963208|531974063|FG001|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|2|||
147497845|NCT01963208|531974064|FG002|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|8|||
147497846|NCT01963208|531974065|FG003|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|9|||
147497847|NCT01963208|531974066|FG004|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|0|||
147497848|NCT01963208|531974067|FG005|Treatment Phase 1 (Up to Week 14)|Withdrawal by Subject|0|||
147497849|NCT01963208|531974062|FG000|Treatment Phase 1 (Up to Week 14)|Non-compliance|0|||
147497850|NCT01963208|531974063|FG001|Treatment Phase 1 (Up to Week 14)|Non-compliance|0|||
147497851|NCT01963208|531974064|FG002|Treatment Phase 1 (Up to Week 14)|Non-compliance|4|||
147497852|NCT01963208|531974065|FG003|Treatment Phase 1 (Up to Week 14)|Non-compliance|0|||
147497853|NCT01963208|531974066|FG004|Treatment Phase 1 (Up to Week 14)|Non-compliance|0|||
147497854|NCT01963208|531974067|FG005|Treatment Phase 1 (Up to Week 14)|Non-compliance|0|||
147497855|NCT01963208|531974062|FG000|Treatment Phase 1 (Up to Week 14)|Protocol Violation|0|||
147497856|NCT01963208|531974063|FG001|Treatment Phase 1 (Up to Week 14)|Protocol Violation|0|||
147497857|NCT01963208|531974064|FG002|Treatment Phase 1 (Up to Week 14)|Protocol Violation|1|||
147497858|NCT01963208|531974065|FG003|Treatment Phase 1 (Up to Week 14)|Protocol Violation|3|||
147497859|NCT01963208|531974066|FG004|Treatment Phase 1 (Up to Week 14)|Protocol Violation|0|||
147497860|NCT01963208|531974067|FG005|Treatment Phase 1 (Up to Week 14)|Protocol Violation|0|||
147497861|NCT01963208|531974062|FG000|Treatment Phase 1 (Up to Week 14)|Other|0|||
147497862|NCT01963208|531974063|FG001|Treatment Phase 1 (Up to Week 14)|Other|1|||
147497863|NCT01963208|531974064|FG002|Treatment Phase 1 (Up to Week 14)|Other|1|||
147497864|NCT01963208|531974065|FG003|Treatment Phase 1 (Up to Week 14)|Other|1|||
147497865|NCT01963208|531974066|FG004|Treatment Phase 1 (Up to Week 14)|Other|0|||
147497866|NCT01963208|531974067|FG005|Treatment Phase 1 (Up to Week 14)|Other|0|||
147497867|NCT01963208|531974062|FG000|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|0|||
147497868|NCT01963208|531974063|FG001|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|0|||
147631910|NCT03300505|532470840|FG001|Overall Study|Sponsor Termination|1|||
147631911|NCT03300505|532470841|FG002|Overall Study|Sponsor Termination|0|||
147497869|NCT01963208|531974064|FG002|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|0|||
147631912|NCT03300505|532470839|FG000|Overall Study|Adverse Event|0|||
147631913|NCT03300505|532470840|FG001|Overall Study|Adverse Event|0|||
147631914|NCT03300505|532470841|FG002|Overall Study|Adverse Event|2|||
147631915|NCT05119595|532470842|FG000|Overall Study|Death|1|||
147497870|NCT01963208|531974065|FG003|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|1|||
147631916|NCT05119595|532470842|FG000|Overall Study|Lost to Follow-up|7|||
147497871|NCT01963208|531974066|FG004|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|0|||
147497872|NCT01963208|531974067|FG005|Treatment Phase 1 (Up to Week 14)|Insufficient Clinical Response|0|||
147497873|NCT01963208|531974062|FG000|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|0|||
147497874|NCT01963208|531974063|FG001|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|0|||
147497875|NCT01963208|531974064|FG002|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|0|||
147497876|NCT01963208|531974065|FG003|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|1|||
147497877|NCT01963208|531974066|FG004|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|0|||
147497878|NCT01963208|531974067|FG005|Treatment Phase 1 (Up to Week 14)|Lost to Follow-up|0|||
147497879|NCT01963208|531974062|FG000|Treatment Phase 2 (Up to Week 68)|Adverse Event|0|||
147497880|NCT01963208|531974063|FG001|Treatment Phase 2 (Up to Week 68)|Adverse Event|0|||
147497881|NCT01963208|531974064|FG002|Treatment Phase 2 (Up to Week 68)|Adverse Event|0|||
147497882|NCT01963208|531974065|FG003|Treatment Phase 2 (Up to Week 68)|Adverse Event|0|||
147497883|NCT01963208|531974066|FG004|Treatment Phase 2 (Up to Week 68)|Adverse Event|16|||
147497884|NCT01963208|531974067|FG005|Treatment Phase 2 (Up to Week 68)|Adverse Event|15|||
147497885|NCT01963208|531974062|FG000|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|0|||
147497886|NCT01963208|531974063|FG001|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|0|||
147497887|NCT01963208|531974064|FG002|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|0|||
147497888|NCT01963208|531974065|FG003|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|0|||
147497889|NCT01963208|531974066|FG004|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|7|||
147497890|NCT01963208|531974067|FG005|Treatment Phase 2 (Up to Week 68)|Withdrawal by Subject|19|||
147497891|NCT01963208|531974062|FG000|Treatment Phase 2 (Up to Week 68)|Non-Compliance|0|||
147497892|NCT01963208|531974063|FG001|Treatment Phase 2 (Up to Week 68)|Non-Compliance|0|||
147497893|NCT01963208|531974064|FG002|Treatment Phase 2 (Up to Week 68)|Non-Compliance|0|||
147497894|NCT01963208|531974065|FG003|Treatment Phase 2 (Up to Week 68)|Non-Compliance|0|||
147497895|NCT01963208|531974066|FG004|Treatment Phase 2 (Up to Week 68)|Non-Compliance|0|||
147497896|NCT01963208|531974067|FG005|Treatment Phase 2 (Up to Week 68)|Non-Compliance|1|||
147497897|NCT01963208|531974062|FG000|Treatment Phase 2 (Up to Week 68)|Protocol Violation|0|||
147497898|NCT01963208|531974063|FG001|Treatment Phase 2 (Up to Week 68)|Protocol Violation|0|||
147497899|NCT01963208|531974064|FG002|Treatment Phase 2 (Up to Week 68)|Protocol Violation|0|||
147497900|NCT01963208|531974065|FG003|Treatment Phase 2 (Up to Week 68)|Protocol Violation|0|||
147497901|NCT01963208|531974066|FG004|Treatment Phase 2 (Up to Week 68)|Protocol Violation|0|||
147497902|NCT01963208|531974067|FG005|Treatment Phase 2 (Up to Week 68)|Protocol Violation|1|||
147497903|NCT01963208|531974062|FG000|Treatment Phase 2 (Up to Week 68)|Other|0|||
147497904|NCT01963208|531974063|FG001|Treatment Phase 2 (Up to Week 68)|Other|0|||
147497905|NCT01963208|531974064|FG002|Treatment Phase 2 (Up to Week 68)|Other|0|||
147497906|NCT01963208|531974065|FG003|Treatment Phase 2 (Up to Week 68)|Other|0|||
147497907|NCT01963208|531974066|FG004|Treatment Phase 2 (Up to Week 68)|Other|58|||
147497908|NCT01963208|531974067|FG005|Treatment Phase 2 (Up to Week 68)|Other|75|||
147497909|NCT01963208|531974062|FG000|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|0|||
147497910|NCT01963208|531974063|FG001|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|0|||
147497911|NCT01963208|531974064|FG002|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|0|||
147497912|NCT01963208|531974065|FG003|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|0|||
147497913|NCT01963208|531974066|FG004|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|20|||
147497914|NCT01963208|531974067|FG005|Treatment Phase 2 (Up to Week 68)|Insufficient Clinical Response|17|||
147497915|NCT01963208|531974062|FG000|Treatment Phase 2 (Up to Week 68)|Death|0|||
147497916|NCT01963208|531974063|FG001|Treatment Phase 2 (Up to Week 68)|Death|0|||
147497917|NCT01963208|531974064|FG002|Treatment Phase 2 (Up to Week 68)|Death|0|||
147497918|NCT01963208|531974065|FG003|Treatment Phase 2 (Up to Week 68)|Death|0|||
147497919|NCT01963208|531974066|FG004|Treatment Phase 2 (Up to Week 68)|Death|0|||
147497920|NCT01963208|531974067|FG005|Treatment Phase 2 (Up to Week 68)|Death|1|||
147497921|NCT01842607|531974068|FG000|Overall Study|Adverse Event|11|||
147497922|NCT01842607|531974068|FG000|Overall Study|Lack of Efficacy|19|||
147497923|NCT01842607|531974068|FG000|Overall Study|Protocol Violation|8|||
147497924|NCT01842607|531974068|FG000|Overall Study|Protocol defined stopping criteria|2|||
147497925|NCT01842607|531974068|FG000|Overall Study|Lost to Follow-up|3|||
147497926|NCT01842607|531974068|FG000|Overall Study|Physician Decision|9|||
147497927|NCT01842607|531974068|FG000|Overall Study|Withdrawal by Subject|14|||
147497928|NCT00012012|531974069|FG000|Overall Study|Protocol Violation|1|||
147497929|NCT00012012|531974070|FG001|Overall Study|Protocol Violation|1|||
147497930|NCT00012012|531974069|FG000|Overall Study|Withdrawal by Subject|0|||
147497931|NCT00012012|531974070|FG001|Overall Study|Withdrawal by Subject|2|||
147497932|NCT02159469|531974071|FG000|Overall Study|Missing Completion status|1|||
147497933|NCT02159469|531974071|FG000|Overall Study|Adverse Event|5|||
147497934|NCT02159469|531974071|FG000|Overall Study|Non-compliance|2|||
147497935|NCT02159469|531974071|FG000|Overall Study|Withdrawal by Subject|9|||
147497936|NCT02159469|531974071|FG000|Overall Study|Lost to Follow-up|1|||
147497937|NCT02159469|531974071|FG000|Overall Study|Sponsor's request|2|||
147497938|NCT02159469|531974071|FG000|Overall Study|Met Stopping Criteria|3|||
147497939|NCT02159469|531974071|FG000|Overall Study|Other|1|||
147497940|NCT02159469|531974071|FG000|Overall Study|Multiple|29|||
147497941|NCT02034474|531974072|FG000|Overall Study|Adverse Event|3|||
147631917|NCT01108341|532470845|FG000|Overall Study|Death|2|||
147631918|NCT01108341|532470845|FG000|Overall Study|Withdrawal by Subject|1|||
147631919|NCT01108341|532470845|FG000|Overall Study|Lost to Follow-up|1|||
147631920|NCT01108341|532470845|FG000|Overall Study|Other|1|||
147631921|NCT04402138|532470846|FG000|Overall Study|Progressive Disease|2|||
147631922|NCT04402138|532470846|FG000|Overall Study|Adverse Event|1|||
147631923|NCT04390503|532470847|FG000|Overall Study|Physician Decision|2|||
147631924|NCT04390503|532470848|FG001|Overall Study|Physician Decision|1|||
147631925|NCT04390503|532470847|FG000|Overall Study|Adverse Event|1|||
147631926|NCT04390503|532470848|FG001|Overall Study|Adverse Event|0|||
147631927|NCT01068730|532470849|FG000|Period 3|Personal reason|1|||
147631928|NCT01068730|532470850|FG001|Period 3|Personal reason|0|||
147631929|NCT01068730|532470851|FG002|Period 3|Personal reason|0|||
147631930|NCT01068730|532470852|FG003|Period 3|Personal reason|0|||
147631931|NCT01068730|532470849|FG000|Period 4|Family emergency|0|||
147631932|NCT01068730|532470850|FG001|Period 4|Family emergency|1|||
147631933|NCT01068730|532470851|FG002|Period 4|Family emergency|0|||
147631934|NCT01068730|532470852|FG003|Period 4|Family emergency|0|||
147631935|NCT00379080|532470855|FG000|Overall Study|Withdrawal by Subject|0|||
147631936|NCT00379080|532470856|FG001|Overall Study|Withdrawal by Subject|4|||
147631937|NCT00379080|532470857|FG002|Overall Study|Withdrawal by Subject|0|||
147631938|NCT01222520|532470858|FG000|Open-label run-in Period|Withdrawal by Subject|0|||
147631939|NCT01222520|532470859|FG001|Open-label run-in Period|Withdrawal by Subject|2|||
147631940|NCT01222520|532470858|FG000|Open-label run-in Period|Blood pressure criteria not met|0|||
147631941|NCT01222520|532470859|FG001|Open-label run-in Period|Blood pressure criteria not met|18|||
147631942|NCT01222520|532470858|FG000|Open-label run-in Period|Number of patients fulfilled|0|||
147631943|NCT01222520|532470859|FG001|Open-label run-in Period|Number of patients fulfilled|3|||
147631944|NCT01222520|532470858|FG000|Double-blind Period|Adverse Event|0|||
147631945|NCT01222520|532470859|FG001|Double-blind Period|Adverse Event|1|||
147631946|NCT01222520|532470858|FG000|Double-blind Period|Lack of Efficacy|0|||
147631947|NCT01222520|532470859|FG001|Double-blind Period|Lack of Efficacy|1|||
147631948|NCT01222520|532470858|FG000|Double-blind Period|Study medication stolen|1|||
147631949|NCT01222520|532470859|FG001|Double-blind Period|Study medication stolen|0|||
147631950|NCT02285166|532470860|FG000|Overall Study|Case Report Forms Uncollected|564|||
147631951|NCT02285166|532470860|FG000|Overall Study|Protocol Deviation|402|||
147631952|NCT03423173|532470863|FG000|Overall Study|Randomized but not vaccinated|1|||
147631953|NCT03423173|532470864|FG001|Overall Study|Randomized but not vaccinated|0|||
147631954|NCT03423173|532470865|FG002|Overall Study|Randomized but not vaccinated|2|||
147631955|NCT03423173|532470866|FG003|Overall Study|Randomized but not vaccinated|1|||
147631956|NCT03423173|532470863|FG000|Overall Study|Adverse Event|1|||
147631957|NCT03423173|532470864|FG001|Overall Study|Adverse Event|1|||
147631958|NCT03423173|532470865|FG002|Overall Study|Adverse Event|1|||
147631959|NCT03423173|532470866|FG003|Overall Study|Adverse Event|1|||
147631960|NCT03423173|532470863|FG000|Overall Study|Lost to Follow-up|10|||
147631961|NCT03423173|532470864|FG001|Overall Study|Lost to Follow-up|19|||
147631962|NCT03423173|532470865|FG002|Overall Study|Lost to Follow-up|17|||
147631963|NCT03423173|532470866|FG003|Overall Study|Lost to Follow-up|22|||
147631964|NCT03423173|532470863|FG000|Overall Study|Withdrawal of consent|4|||
147631965|NCT03423173|532470864|FG001|Overall Study|Withdrawal of consent|10|||
147631966|NCT03423173|532470865|FG002|Overall Study|Withdrawal of consent|4|||
147631967|NCT03423173|532470866|FG003|Overall Study|Withdrawal of consent|5|||
147631968|NCT03423173|532470863|FG000|Overall Study|Death|1|||
147631969|NCT03423173|532470864|FG001|Overall Study|Death|0|||
147631970|NCT03423173|532470865|FG002|Overall Study|Death|0|||
147631971|NCT03423173|532470866|FG003|Overall Study|Death|0|||
147631972|NCT03423173|532470863|FG000|Overall Study|Reason not Specified|2|||
147631973|NCT03423173|532470864|FG001|Overall Study|Reason not Specified|5|||
147631974|NCT03423173|532470865|FG002|Overall Study|Reason not Specified|3|||
147497942|NCT02034474|531974073|FG001|Overall Study|Adverse Event|2|||
147497943|NCT02034474|531974072|FG000|Overall Study|Withdrawal by Subject|1|||
147497944|NCT02034474|531974073|FG001|Overall Study|Withdrawal by Subject|2|||
147497945|NCT03629041|531974074|FG000|Visit 2 (2 Weeks ± 3 Days From Visit 1)|Withdrawal by Subject|0|||
147497946|NCT03629041|531974075|FG001|Visit 2 (2 Weeks ± 3 Days From Visit 1)|Withdrawal by Subject|1|||
147631975|NCT03423173|532470866|FG003|Overall Study|Reason not Specified|1|||
147631976|NCT03348930|532470867|FG000|Washout (1 Week)|Lost to Follow-up|1|||
147631977|NCT03348930|532470868|FG001|Washout (1 Week)|Lost to Follow-up|1|||
147631978|NCT02920008|532470869|FG000|Overall Study|Death|117|||
147631979|NCT02920008|532470870|FG001|Overall Study|Death|127|||
147631980|NCT02920008|532470869|FG000|Overall Study|Withdrawal by Subject|3|||
147631981|NCT02920008|532470870|FG001|Overall Study|Withdrawal by Subject|6|||
147631982|NCT02920008|532470869|FG000|Overall Study|Lost to Follow-up|0|||
147631983|NCT02920008|532470870|FG001|Overall Study|Lost to Follow-up|1|||
147497947|NCT03629041|531974076|FG002|Visit 2 (2 Weeks ± 3 Days From Visit 1)|Withdrawal by Subject|0|||
147631984|NCT01862250|532470871|FG000|Overall Study|Adverse Event|4|||
147631985|NCT00839527|532470876|FG000|Treatment Period (TP) (156 Weeks)|Adverse Event|11|||
147631986|NCT00839527|532470877|FG001|Treatment Period (TP) (156 Weeks)|Adverse Event|29|||
147631987|NCT00839527|532470878|FG002|Treatment Period (TP) (156 Weeks)|Adverse Event|22|||
147497948|NCT03629041|531974077|FG003|Visit 2 (2 Weeks ± 3 Days From Visit 1)|Withdrawal by Subject|0|||
147497949|NCT01391819|531974083|FG000|Overall Study|Withdrawal by Subject|56|||
147497950|NCT01391819|531974083|FG000|Overall Study|Migrated/moved from study area|82|||
147497951|NCT01391819|531974083|FG000|Overall Study|Lost to Follow-up|252|||
147497952|NCT01391819|531974083|FG000|Overall Study|Death|3|||
147497953|NCT01391819|531974083|FG000|Overall Study|Other|9|||
147497954|NCT01244191|531974085|FG000|Overall Study|Progressive disease|295|||
147497955|NCT01244191|531974086|FG001|Overall Study|Progressive disease|350|||
147497956|NCT01244191|531974085|FG000|Overall Study|Clinical disease progression|54|||
147497957|NCT01244191|531974086|FG001|Overall Study|Clinical disease progression|36|||
147497958|NCT01244191|531974085|FG000|Overall Study|Adverse Event|65|||
147497959|NCT01244191|531974086|FG001|Overall Study|Adverse Event|48|||
147497960|NCT01244191|531974085|FG000|Overall Study|Death|22|||
147497961|NCT01244191|531974086|FG001|Overall Study|Death|29|||
147497962|NCT01244191|531974085|FG000|Overall Study|Lost to Follow-up|0|||
147497963|NCT01244191|531974086|FG001|Overall Study|Lost to Follow-up|2|||
147497964|NCT01244191|531974085|FG000|Overall Study|Protocol Violation|1|||
147497965|NCT01244191|531974086|FG001|Overall Study|Protocol Violation|2|||
147497966|NCT01244191|531974085|FG000|Overall Study|Withdrawal by Subject|31|||
147497967|NCT01244191|531974086|FG001|Overall Study|Withdrawal by Subject|23|||
147497968|NCT01244191|531974085|FG000|Overall Study|'Missing' or 'Terminated by sponsor'|12|||
147497969|NCT01244191|531974086|FG001|Overall Study|'Missing' or 'Terminated by sponsor'|8|||
147497970|NCT05584202|531974087|FG000|Overall Study|Withdrawal of Consent|3|||
147497971|NCT05584202|531974088|FG001|Overall Study|Withdrawal of Consent|2|||
147497972|NCT05584202|531974087|FG000|Overall Study|Lost to Follow-up|2|||
147497973|NCT05584202|531974088|FG001|Overall Study|Lost to Follow-up|1|||
147497974|NCT05584202|531974087|FG000|Overall Study|Death|0|||
147497975|NCT05584202|531974088|FG001|Overall Study|Death|1|||
147497976|NCT03297216|531975590|FG000|Overall Study|Death|0|||
147497977|NCT03297216|531975591|FG001|Overall Study|Death|1|||
147497978|NCT03297216|531975590|FG000|Overall Study|Miscarriage|0|||
147497979|NCT03297216|531975591|FG001|Overall Study|Miscarriage|2|||
147497980|NCT03297216|531975590|FG000|Overall Study|Lost to Follow-up|3|||
147497981|NCT03297216|531975591|FG001|Overall Study|Lost to Follow-up|2|||
147497982|NCT00781963|531975592|FG000|Overall Study|Death|3|||
147497983|NCT00781963|531975593|FG001|Overall Study|Death|0|||
147497984|NCT00781963|531975592|FG000|Overall Study|Lost to Follow-up|2|||
147497985|NCT00781963|531975593|FG001|Overall Study|Lost to Follow-up|1|||
147497986|NCT00781963|531975592|FG000|Overall Study|Withdrawal by Subject|3|||
147497987|NCT00781963|531975593|FG001|Overall Study|Withdrawal by Subject|1|||
147497988|NCT00781963|531975592|FG000|Overall Study|Refused follow-up|9|||
147497989|NCT00781963|531975593|FG001|Overall Study|Refused follow-up|0|||
147497990|NCT01830816|531975596|FG000|Overall Study|Progressive Disease|12|||
147497991|NCT01830816|531975597|FG001|Overall Study|Progressive Disease|7|||
147497992|NCT01830816|531975598|FG002|Overall Study|Progressive Disease|7|||
147497993|NCT01830816|531975596|FG000|Overall Study|Adverse Event|3|||
147497994|NCT01830816|531975597|FG001|Overall Study|Adverse Event|4|||
147497995|NCT01830816|531975598|FG002|Overall Study|Adverse Event|0|||
147497996|NCT01830816|531975596|FG000|Overall Study|Study Terminated by Sponsor|1|||
147497997|NCT01830816|531975597|FG001|Overall Study|Study Terminated by Sponsor|1|||
147497998|NCT01830816|531975598|FG002|Overall Study|Study Terminated by Sponsor|0|||
147497999|NCT01830816|531975596|FG000|Overall Study|Withdrawal by Subject|1|||
147498000|NCT01830816|531975597|FG001|Overall Study|Withdrawal by Subject|1|||
147498001|NCT01830816|531975598|FG002|Overall Study|Withdrawal by Subject|0|||
147498002|NCT01830816|531975596|FG000|Overall Study|Lost to Follow-up|0|||
147498003|NCT01830816|531975597|FG001|Overall Study|Lost to Follow-up|1|||
147498004|NCT01830816|531975598|FG002|Overall Study|Lost to Follow-up|0|||
147498005|NCT01830816|531975596|FG000|Overall Study|Symptomatic Deterioration|1|||
147498006|NCT01830816|531975597|FG001|Overall Study|Symptomatic Deterioration|0|||
147498007|NCT01830816|531975598|FG002|Overall Study|Symptomatic Deterioration|0|||
147498008|NCT01830816|531975596|FG000|Overall Study|Reason not Specified|2|||
147498009|NCT01830816|531975597|FG001|Overall Study|Reason not Specified|0|||
147498010|NCT01830816|531975598|FG002|Overall Study|Reason not Specified|0|||
147498011|NCT04124692|531975599|FG000|Overall Study|Medical reason|0|||
147498012|NCT04124692|531975600|FG001|Overall Study|Medical reason|1|||
147498013|NCT04124692|531975599|FG000|Overall Study|Withdrawal of informed consent (not due to coronavirus disease-19 concerns)|2|||
147498014|NCT04124692|531975600|FG001|Overall Study|Withdrawal of informed consent (not due to coronavirus disease-19 concerns)|1|||
147498015|NCT04124692|531975599|FG000|Overall Study|Withdrawal of informed consent (due to coronavirus disease-19 concerns)|1|||
147498016|NCT04124692|531975600|FG001|Overall Study|Withdrawal of informed consent (due to coronavirus disease-19 concerns)|3|||
147498017|NCT04124692|531975599|FG000|Overall Study|Lost to Follow-up|2|||
147498018|NCT04124692|531975600|FG001|Overall Study|Lost to Follow-up|4|||
147498019|NCT04124692|531975599|FG000|Overall Study|Screen failure due to previous use of Radiesse|1|||
147498020|NCT04124692|531975600|FG001|Overall Study|Screen failure due to previous use of Radiesse|0|||
147498021|NCT00205699|531975604|FG000|Overall Study|Lost to Follow-up|1|||
147498022|NCT00205699|531975605|FG001|Overall Study|Lost to Follow-up|3|||
147498023|NCT00205699|531975606|FG002|Overall Study|Lost to Follow-up|5|||
147498024|NCT00205699|531975604|FG000|Overall Study|Adverse Event|1|||
147498025|NCT00205699|531975605|FG001|Overall Study|Adverse Event|0|||
147498026|NCT00205699|531975606|FG002|Overall Study|Adverse Event|0|||
147498027|NCT00205699|531975604|FG000|Overall Study|Withdrawal by Subject|1|||
147498028|NCT00205699|531975605|FG001|Overall Study|Withdrawal by Subject|2|||
147498029|NCT00205699|531975606|FG002|Overall Study|Withdrawal by Subject|1|||
147498030|NCT00205699|531975604|FG000|Overall Study|Lack of Efficacy|0|||
147631988|NCT00839527|532470876|FG000|Treatment Period (TP) (156 Weeks)|Protocol Violation|4|||
147631989|NCT00839527|532470877|FG001|Treatment Period (TP) (156 Weeks)|Protocol Violation|7|||
147631990|NCT00839527|532470878|FG002|Treatment Period (TP) (156 Weeks)|Protocol Violation|1|||
147631991|NCT00839527|532470876|FG000|Treatment Period (TP) (156 Weeks)|Noncompliance|5|||
147631992|NCT00839527|532470877|FG001|Treatment Period (TP) (156 Weeks)|Noncompliance|6|||
147631993|NCT00839527|532470878|FG002|Treatment Period (TP) (156 Weeks)|Noncompliance|16|||
147631994|NCT00839527|532470876|FG000|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|3|||
147631995|NCT00839527|532470877|FG001|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|12|||
147631996|NCT00839527|532470878|FG002|Treatment Period (TP) (156 Weeks)|Lost to Follow-up|7|||
147631997|NCT00839527|532470876|FG000|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|32|||
147631998|NCT00839527|532470877|FG001|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|46|||
147631999|NCT00839527|532470878|FG002|Treatment Period (TP) (156 Weeks)|Withdrawal by Subject|64|||
147632000|NCT00839527|532470876|FG000|Treatment Period (TP) (156 Weeks)|Physician Decision|1|||
147632001|NCT00839527|532470877|FG001|Treatment Period (TP) (156 Weeks)|Physician Decision|6|||
147632002|NCT00839527|532470878|FG002|Treatment Period (TP) (156 Weeks)|Physician Decision|1|||
147632003|NCT00839527|532470876|FG000|Treatment Period (TP) (156 Weeks)|Termination of Site by Sponsor|3|||
147632004|NCT00839527|532470877|FG001|Treatment Period (TP) (156 Weeks)|Termination of Site by Sponsor|8|||
147632005|NCT00839527|532470878|FG002|Treatment Period (TP) (156 Weeks)|Termination of Site by Sponsor|5|||
147632006|NCT00839527|532470876|FG000|Treatment Period (TP) (156 Weeks)|Missing|0|||
147632007|NCT00839527|532470877|FG001|Treatment Period (TP) (156 Weeks)|Missing|1|||
147632008|NCT00839527|532470878|FG002|Treatment Period (TP) (156 Weeks)|Missing|0|||
147632009|NCT00839527|532470876|FG000|Treatment Period (TP) (156 Weeks)|Persistant Elevated HbA1c Results|0|||
147632010|NCT00839527|532470877|FG001|Treatment Period (TP) (156 Weeks)|Persistant Elevated HbA1c Results|0|||
147632011|NCT00839527|532470878|FG002|Treatment Period (TP) (156 Weeks)|Persistant Elevated HbA1c Results|1|||
147632012|NCT00839527|532470876|FG000|Treatment Period (TP) (156 Weeks)|Pregnancy|0|||
147632013|NCT00839527|532470877|FG001|Treatment Period (TP) (156 Weeks)|Pregnancy|1|||
147632014|NCT00839527|532470878|FG002|Treatment Period (TP) (156 Weeks)|Pregnancy|1|||
147632015|NCT00839527|532470876|FG000|Treatment Period (TP) (156 Weeks)|Site Closed|1|||
147632016|NCT00839527|532470877|FG001|Treatment Period (TP) (156 Weeks)|Site Closed|2|||
147632017|NCT00839527|532470878|FG002|Treatment Period (TP) (156 Weeks)|Site Closed|0|||
147632018|NCT00839527|532470876|FG000|Treatment Period (TP) (156 Weeks)|Sponsor Decision on Blinding|0|||
147668525|NCT02370511|532611821|FG002|Overall Study|Lost to Follow-up|0|||
147668526|NCT03141359|532611824|FG000|Overall Study|Death|32|||
147498031|NCT00205699|531975605|FG001|Overall Study|Lack of Efficacy|1|||
147498032|NCT00205699|531975606|FG002|Overall Study|Lack of Efficacy|0|||
147498033|NCT01754922|531975613|FG000|Overall Study|Adverse Event|0|||
147498034|NCT01754922|531975614|FG001|Overall Study|Adverse Event|1|||
147498035|NCT01207388|531975615|FG000|Overall Study|Death|67|||
147498036|NCT01207388|531975615|FG000|Overall Study|Withdrawal by Subject|1|||
147498037|NCT01885078|531975616|FG000|Treatment Period|Adverse Event|52|||
147498038|NCT01885078|531975617|FG001|Treatment Period|Adverse Event|136|||
147498039|NCT01885078|531975618|FG002|Treatment Period|Adverse Event|30|||
147498040|NCT01885078|531975619|FG003|Treatment Period|Adverse Event|73|||
147498041|NCT01885078|531975620|FG004|Treatment Period|Adverse Event|17|||
147498042|NCT01885078|531975621|FG005|Treatment Period|Adverse Event|72|||
147498043|NCT01885078|531975622|FG006|Treatment Period|Adverse Event|24|||
147498044|NCT01885078|531975623|FG007|Treatment Period|Adverse Event|5|||
147498045|NCT01885078|531975624|FG008|Treatment Period|Adverse Event|0|||
147498046|NCT01885078|531975625|FG009|Treatment Period|Adverse Event|0|||
147498047|NCT01885078|531975616|FG000|Treatment Period|Death|13|||
147498048|NCT01885078|531975617|FG001|Treatment Period|Death|33|||
147498049|NCT01885078|531975618|FG002|Treatment Period|Death|5|||
147498050|NCT01885078|531975619|FG003|Treatment Period|Death|9|||
147498051|NCT01885078|531975620|FG004|Treatment Period|Death|2|||
147498052|NCT01885078|531975621|FG005|Treatment Period|Death|10|||
147632019|NCT00839527|532470877|FG001|Treatment Period (TP) (156 Weeks)|Sponsor Decision on Blinding|0|||
147668527|NCT03141359|532611824|FG000|Overall Study|Still On Study (in follow up)|29|||
147498053|NCT01885078|531975622|FG006|Treatment Period|Death|3|||
147498054|NCT01885078|531975623|FG007|Treatment Period|Death|2|||
147498055|NCT01885078|531975624|FG008|Treatment Period|Death|0|||
147498056|NCT01885078|531975625|FG009|Treatment Period|Death|0|||
147498057|NCT01885078|531975616|FG000|Treatment Period|Lack of Efficacy|12|||
147498058|NCT01885078|531975617|FG001|Treatment Period|Lack of Efficacy|33|||
147498059|NCT01885078|531975618|FG002|Treatment Period|Lack of Efficacy|10|||
147498060|NCT01885078|531975619|FG003|Treatment Period|Lack of Efficacy|23|||
147498061|NCT01885078|531975620|FG004|Treatment Period|Lack of Efficacy|24|||
147498062|NCT01885078|531975621|FG005|Treatment Period|Lack of Efficacy|58|||
147632020|NCT00839527|532470878|FG002|Treatment Period (TP) (156 Weeks)|Sponsor Decision on Blinding|1|||
147632021|NCT00839527|532470876|FG000|Follow-up Period (FUP) (8 Weeks)|Adverse Event|1|||
147632022|NCT00839527|532470877|FG001|Follow-up Period (FUP) (8 Weeks)|Adverse Event|2|||
147632023|NCT00839527|532470878|FG002|Follow-up Period (FUP) (8 Weeks)|Adverse Event|1|||
147632024|NCT00839527|532470876|FG000|Follow-up Period (FUP) (8 Weeks)|Noncompliance|1|||
147632025|NCT00839527|532470877|FG001|Follow-up Period (FUP) (8 Weeks)|Noncompliance|0|||
147632026|NCT00839527|532470878|FG002|Follow-up Period (FUP) (8 Weeks)|Noncompliance|5|||
147632027|NCT00839527|532470876|FG000|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|8|||
147632028|NCT00839527|532470877|FG001|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|20|||
147632029|NCT00839527|532470878|FG002|Follow-up Period (FUP) (8 Weeks)|Lost to Follow-up|29|||
147632030|NCT00839527|532470876|FG000|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|12|||
147632031|NCT00839527|532470877|FG001|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|21|||
147632032|NCT00839527|532470878|FG002|Follow-up Period (FUP) (8 Weeks)|Withdrawal by Subject|19|||
147632033|NCT00839527|532470876|FG000|Follow-up Period (FUP) (8 Weeks)|Physician Decision|0|||
147632034|NCT00839527|532470877|FG001|Follow-up Period (FUP) (8 Weeks)|Physician Decision|0|||
147632035|NCT00839527|532470878|FG002|Follow-up Period (FUP) (8 Weeks)|Physician Decision|1|||
147632036|NCT00839527|532470876|FG000|Follow-up Period (FUP) (8 Weeks)|Termination of Study by Sponsor|3|||
147632037|NCT00839527|532470877|FG001|Follow-up Period (FUP) (8 Weeks)|Termination of Study by Sponsor|10|||
147632038|NCT00839527|532470878|FG002|Follow-up Period (FUP) (8 Weeks)|Termination of Study by Sponsor|5|||
147632039|NCT00839527|532470876|FG000|Follow-up Period (FUP) (8 Weeks)|Informed Consent Recalled by Participant|1|||
147632040|NCT00839527|532470877|FG001|Follow-up Period (FUP) (8 Weeks)|Informed Consent Recalled by Participant|0|||
147632041|NCT00839527|532470878|FG002|Follow-up Period (FUP) (8 Weeks)|Informed Consent Recalled by Participant|0|||
147632042|NCT00839527|532470876|FG000|Follow-up Period (FUP) (8 Weeks)|Investigator Closed Study at Site|1|||
147632043|NCT00839527|532470877|FG001|Follow-up Period (FUP) (8 Weeks)|Investigator Closed Study at Site|0|||
147632044|NCT00839527|532470878|FG002|Follow-up Period (FUP) (8 Weeks)|Investigator Closed Study at Site|0|||
147632045|NCT00839527|532470876|FG000|Follow-up Period (FUP) (8 Weeks)|Site Closed|0|||
147632046|NCT00839527|532470877|FG001|Follow-up Period (FUP) (8 Weeks)|Site Closed|1|||
147632047|NCT00839527|532470878|FG002|Follow-up Period (FUP) (8 Weeks)|Site Closed|0|||
147632048|NCT00839527|532470876|FG000|Follow-up Period (FUP) (8 Weeks)|Site Closing and Withdrew Consent|1|||
147632049|NCT00839527|532470877|FG001|Follow-up Period (FUP) (8 Weeks)|Site Closing and Withdrew Consent|0|||
147632050|NCT00839527|532470878|FG002|Follow-up Period (FUP) (8 Weeks)|Site Closing and Withdrew Consent|1|||
147632051|NCT00839527|532470876|FG000|Follow-up Period (FUP) (8 Weeks)|Unable to Complete Follow-up|0|||
147632052|NCT00839527|532470877|FG001|Follow-up Period (FUP) (8 Weeks)|Unable to Complete Follow-up|1|||
147632053|NCT00839527|532470878|FG002|Follow-up Period (FUP) (8 Weeks)|Unable to Complete Follow-up|0|||
147632054|NCT00839527|532470876|FG000|Follow-up Period (FUP) (8 Weeks)|Missing Follow-up Status|0|||
147632055|NCT00839527|532470877|FG001|Follow-up Period (FUP) (8 Weeks)|Missing Follow-up Status|1|||
147632056|NCT00839527|532470878|FG002|Follow-up Period (FUP) (8 Weeks)|Missing Follow-up Status|1|||
147632057|NCT02549287|532470879|FG000|Overall Study|Lost to Follow-up|65|||
147632058|NCT02549287|532470880|FG001|Overall Study|Lost to Follow-up|26|||
147632059|NCT02549287|532470879|FG000|Overall Study|Withdrawal by Subject|15|||
147632060|NCT02549287|532470880|FG001|Overall Study|Withdrawal by Subject|6|||
147632061|NCT00427921|532470884|FG000|Overall Study|Adverse Event|26|||
147632062|NCT00427921|532470884|FG000|Overall Study|Withdrawal by Subject|4|||
147632063|NCT00427921|532470884|FG000|Overall Study|Lost to Follow-up|2|||
147632064|NCT00427921|532470884|FG000|Overall Study|Other reason not specified|10|||
147632065|NCT00427921|532470884|FG000|Overall Study|Adverse Event + Hospitalization|1|||
147632066|NCT00427921|532470884|FG000|Overall Study|Adverse Event + Withdrew Consent|1|||
147632067|NCT00427921|532470884|FG000|Overall Study|Adverse Event + No Response|1|||
147632068|NCT00427921|532470884|FG000|Overall Study|Adverse Event + Worsening of CD|1|||
147632069|NCT00427921|532470884|FG000|Overall Study|Adverse Event + No Therapeutic Benefit|1|||
147632070|NCT00427921|532470884|FG000|Overall Study|Adverse Event + Lost Response|1|||
147632071|NCT00427921|532470884|FG000|Overall Study|Adverse Event + Withdrawn from Study|1|||
147632072|NCT00427921|532470884|FG000|Overall Study|Withdrew Consent + Lack of Efficacy|1|||
147632073|NCT00520533|532470885|FG000|Overall Study|Death|1|||
147632074|NCT00520533|532470885|FG000|Overall Study|Suspension of the study for safety reasons|1|||
147632075|NCT00520533|532470885|FG000|Overall Study|Withdrawal by Subject|1|||
147632076|NCT00520533|532470885|FG000|Overall Study|Physician Decision|1|||
147632077|NCT03502070|532470886|FG000|Overall Study|Withdrawal by Subject|1|||
147632078|NCT03502070|532470886|FG000|Overall Study|Screen Failure|1|||
147632079|NCT01218087|532470887|FG000|Overall Study|Death|2|||
147668528|NCT02003144|532611825|FG000|Open Label Maintenance Phase|Other than specified|2|||
147668529|NCT02003144|532611826|FG001|Open Label Maintenance Phase|Other than specified|4|||
147668530|NCT02003144|532611825|FG000|Open Label Maintenance Phase|Withdrawal by Subject|4|||
147632080|NCT01218087|532470888|FG001|Overall Study|Death|1|||
147498063|NCT01885078|531975622|FG006|Treatment Period|Lack of Efficacy|9|||
147632081|NCT01218087|532470887|FG000|Overall Study|Withdrawal by Subject|5|||
147632082|NCT01218087|532470888|FG001|Overall Study|Withdrawal by Subject|0|||
147632083|NCT01218087|532470887|FG000|Overall Study|Transferred|8|||
147632084|NCT01218087|532470888|FG001|Overall Study|Transferred|5|||
147632085|NCT02568189|532470889|FG000|Overall Study|Protocol Violation|0|||
147632086|NCT02568189|532470890|FG001|Overall Study|Protocol Violation|0|||
147632087|NCT02568189|532470891|FG002|Overall Study|Protocol Violation|19|||
147632088|NCT02568189|532470892|FG003|Overall Study|Protocol Violation|18|||
147632089|NCT04200651|532470893|FG000|Overall Study|Moved to another country during follow-up|2|||
147632090|NCT04200651|532470894|FG001|Overall Study|Moved to another country during follow-up|2|||
147632091|NCT04200651|532470893|FG000|Overall Study|Lost to Follow-up|1|||
147632092|NCT04200651|532470894|FG001|Overall Study|Lost to Follow-up|3|||
147632093|NCT02547220|532470898|FG000|Overall Study|Withdrawal by Subject|1|||
147632094|NCT02547220|532470899|FG001|Overall Study|Withdrawal by Subject|0|||
147632095|NCT02547220|532470898|FG000|Overall Study|Study terminated by sponsor|18|||
147632096|NCT02547220|532470899|FG001|Overall Study|Study terminated by sponsor|20|||
147632097|NCT02887183|532470903|FG000|Overall Study|Adverse Event|44|||
147632098|NCT02887183|532470903|FG000|Overall Study|Death|30|||
147632099|NCT02887183|532470903|FG000|Overall Study|Pregnancy|1|||
147632100|NCT02887183|532470903|FG000|Overall Study|Protocol Violation|6|||
147632101|NCT02887183|532470903|FG000|Overall Study|Technical Problems|2|||
147632102|NCT02887183|532470903|FG000|Overall Study|Lost to Follow-up|13|||
147632103|NCT02887183|532470903|FG000|Overall Study|Physician Decision|10|||
147632104|NCT02887183|532470903|FG000|Overall Study|Withdrawal by Subject|35|||
147632105|NCT01031680|532470904|FG000|Overall Study|Adverse Event|8|||
147632106|NCT01031680|532470905|FG001|Overall Study|Adverse Event|3|||
147632107|NCT01031680|532470904|FG000|Overall Study|Lost to Follow-up|2|||
147632108|NCT01031680|532470905|FG001|Overall Study|Lost to Follow-up|10|||
147632109|NCT01031680|532470904|FG000|Overall Study|Withdrawal by Subject|12|||
147632110|NCT01031680|532470905|FG001|Overall Study|Withdrawal by Subject|16|||
147632111|NCT01031680|532470904|FG000|Overall Study|Death|2|||
147632112|NCT01031680|532470905|FG001|Overall Study|Death|1|||
147632113|NCT01031680|532470904|FG000|Overall Study|Subject No Longer Meets Study Criteria|26|||
147632114|NCT01031680|532470905|FG001|Overall Study|Subject No Longer Meets Study Criteria|17|||
147632115|NCT01031680|532470904|FG000|Overall Study|Poor/Non-compliance|5|||
147632116|NCT01031680|532470905|FG001|Overall Study|Poor/Non-compliance|6|||
147632117|NCT01031680|532470904|FG000|Overall Study|Safety|1|||
147632118|NCT01031680|532470905|FG001|Overall Study|Safety|0|||
147632119|NCT01031680|532470904|FG000|Overall Study|Incorrect Enrolment|1|||
147632120|NCT01031680|532470905|FG001|Overall Study|Incorrect Enrolment|2|||
147632121|NCT01031680|532470904|FG000|Overall Study|Administrative Reason by Sponsor|0|||
147632122|NCT01031680|532470905|FG001|Overall Study|Administrative Reason by Sponsor|1|||
147632123|NCT01031680|532470904|FG000|Overall Study|Various|0|||
147632124|NCT01031680|532470905|FG001|Overall Study|Various|2|||
147632125|NCT01029782|532470908|FG000|Overall Study|Lost to Follow-up|2|||
147632126|NCT01029782|532470909|FG001|Overall Study|Lost to Follow-up|2|||
147632127|NCT01029782|532470908|FG000|Overall Study|Diagnosis changed|1|||
147632128|NCT01029782|532470909|FG001|Overall Study|Diagnosis changed|1|||
147632129|NCT01029782|532470908|FG000|Overall Study|Adverse Event|0|||
147632130|NCT01029782|532470909|FG001|Overall Study|Adverse Event|1|||
147632131|NCT01029782|532470908|FG000|Overall Study|Physician Decision|0|||
147632132|NCT01029782|532470909|FG001|Overall Study|Physician Decision|1|||
147632133|NCT01029782|532470908|FG000|Overall Study|Protocol Violation|0|||
147632134|NCT01029782|532470909|FG001|Overall Study|Protocol Violation|2|||
147632135|NCT01029782|532470908|FG000|Overall Study|Withdrawal by Subject|0|||
147632136|NCT01029782|532470909|FG001|Overall Study|Withdrawal by Subject|1|||
147632137|NCT02195869|532470913|FG000|Overall Study|cGVHD Progression|5|||
147632138|NCT02195869|532470913|FG000|Overall Study|Malignancy Progression/relapse|2|||
147632139|NCT02195869|532470913|FG000|Overall Study|Adverse Event|15|||
147632140|NCT02195869|532470913|FG000|Overall Study|Withdrawal by Subject|7|||
147632141|NCT02195869|532470913|FG000|Overall Study|Physician Decision|4|||
147632142|NCT02195869|532470913|FG000|Overall Study|Study Terminated by Sponsor|7|||
147632143|NCT02195869|532470913|FG000|Overall Study|Noncompliance with study drug|2|||
147632144|NCT00767455|532470914|FG000|Overall Study|Investigator error|19|||
147632145|NCT01921101|532470915|FG000|Overall Study|Death|16|||
147632146|NCT01921101|532470916|FG001|Overall Study|Death|6|||
147632147|NCT02729051|532470918|FG000|Overall Study|Adverse Event|21|||
147632148|NCT02729051|532470919|FG001|Overall Study|Adverse Event|11|||
147632149|NCT02729051|532470918|FG000|Overall Study|Lack of Efficacy|1|||
147632150|NCT02729051|532470919|FG001|Overall Study|Lack of Efficacy|1|||
147632151|NCT02729051|532470918|FG000|Overall Study|Lost to Follow-up|1|||
147632152|NCT02729051|532470919|FG001|Overall Study|Lost to Follow-up|2|||
147668531|NCT02003144|532611826|FG001|Open Label Maintenance Phase|Withdrawal by Subject|5|||
147632153|NCT02729051|532470918|FG000|Overall Study|Physician Decision|1|||
147632154|NCT02729051|532470919|FG001|Overall Study|Physician Decision|1|||
147632155|NCT02729051|532470918|FG000|Overall Study|Withdrawal by Subject|6|||
147632156|NCT02729051|532470919|FG001|Overall Study|Withdrawal by Subject|17|||
147632157|NCT00596817|532470920|FG000|Open-label Period|Adverse Event|0|||
147632158|NCT00596817|532470921|FG001|Open-label Period|Adverse Event|49|||
147632159|NCT00596817|532470920|FG000|Open-label Period|Lack of Efficacy|0|||
147632160|NCT00596817|532470921|FG001|Open-label Period|Lack of Efficacy|33|||
147632161|NCT00596817|532470920|FG000|Open-label Period|Other Reasons|0|||
147632162|NCT00596817|532470921|FG001|Open-label Period|Other Reasons|65|||
147632163|NCT00596817|532470920|FG000|Open-label Period to Double-blind Period|Adverse Event|0|||
147632164|NCT00596817|532470921|FG001|Open-label Period to Double-blind Period|Adverse Event|5|||
147632165|NCT00596817|532470920|FG000|Open-label Period to Double-blind Period|Lack of Efficacy|0|||
147632166|NCT00596817|532470921|FG001|Open-label Period to Double-blind Period|Lack of Efficacy|24|||
147632167|NCT00596817|532470920|FG000|Open-label Period to Double-blind Period|Not Eligible|0|||
147632168|NCT00596817|532470921|FG001|Open-label Period to Double-blind Period|Not Eligible|49|||
147632169|NCT00596817|532470920|FG000|Open-label Period to Double-blind Period|Other Reasons|0|||
147632170|NCT00596817|532470921|FG001|Open-label Period to Double-blind Period|Other Reasons|14|||
147632171|NCT00596817|532470920|FG000|Double-blind Period|Adverse Event|5|||
147632172|NCT00596817|532470921|FG001|Double-blind Period|Adverse Event|16|||
147632173|NCT00596817|532470920|FG000|Double-blind Period|Lack of Efficacy|52|||
147632174|NCT00596817|532470921|FG001|Double-blind Period|Lack of Efficacy|28|||
147632175|NCT00596817|532470920|FG000|Double-blind Period|Non-compliance With Study Product|3|||
147632176|NCT00596817|532470921|FG001|Double-blind Period|Non-compliance With Study Product|4|||
147632177|NCT00596817|532470920|FG000|Double-blind Period|Protocol Violation|11|||
147632178|NCT00596817|532470921|FG001|Double-blind Period|Protocol Violation|8|||
147632179|NCT00596817|532470920|FG000|Double-blind Period|Withdrawal of Consent|7|||
147632180|NCT00596817|532470921|FG001|Double-blind Period|Withdrawal of Consent|3|||
147632181|NCT00596817|532470920|FG000|Double-blind Period|Lost to Follow-up|0|||
147632182|NCT00596817|532470921|FG001|Double-blind Period|Lost to Follow-up|2|||
147632183|NCT00596817|532470920|FG000|Double-blind Period|Other Reasons|10|||
147632184|NCT00596817|532470921|FG001|Double-blind Period|Other Reasons|18|||
147632185|NCT03225105|532470927|FG000|Overall Study|Withdrawal by Subject|1|||
147632186|NCT03225105|532470928|FG001|Overall Study|Withdrawal by Subject|0|||
147632187|NCT03225105|532470929|FG002|Overall Study|Withdrawal by Subject|0|||
147632188|NCT03225105|532470930|FG003|Overall Study|Withdrawal by Subject|0|||
147632189|NCT03225105|532470927|FG000|Overall Study|Death|0|||
147632190|NCT03225105|532470928|FG001|Overall Study|Death|4|||
147632191|NCT03225105|532470929|FG002|Overall Study|Death|2|||
147632192|NCT03225105|532470930|FG003|Overall Study|Death|0|||
147632193|NCT03225105|532470927|FG000|Overall Study|Study termination per Sponsor Decision|2|||
147632194|NCT03225105|532470928|FG001|Overall Study|Study termination per Sponsor Decision|0|||
147632195|NCT03225105|532470929|FG002|Overall Study|Study termination per Sponsor Decision|3|||
147632196|NCT03225105|532470930|FG003|Overall Study|Study termination per Sponsor Decision|3|||
147632197|NCT01399047|532472335|FG000|Overall Study|Withdrawal by Subject|0|||
147632198|NCT01399047|532472336|FG001|Overall Study|Withdrawal by Subject|1|||
147632199|NCT03652636|532472344|FG000|Overall Study|Withdrawal by Subject|7|||
147632200|NCT01283334|532472347|FG000|Overall Study|Withdrawal by Subject|1|||
147632201|NCT01283334|532472347|FG000|Overall Study|Inability to Swallow Everolimus Pills|1|||
147632202|NCT01283334|532472347|FG000|Overall Study|Adverse Event|4|||
147632203|NCT01283334|532472347|FG000|Overall Study|Physician Decision|1|||
147632204|NCT03467217|532472348|FG000|Overall Study|Trial stopped early|5|||
147632205|NCT03467217|532472349|FG001|Overall Study|Trial stopped early|2|||
147632206|NCT03467217|532472348|FG000|Overall Study|Clinic closed due to COVID-19 pandemic|5|||
147632207|NCT03467217|532472349|FG001|Overall Study|Clinic closed due to COVID-19 pandemic|2|||
147632208|NCT03467217|532472348|FG000|Overall Study|Lost to Follow-up|0|||
147632209|NCT03467217|532472349|FG001|Overall Study|Lost to Follow-up|2|||
147632210|NCT00784238|532472350|FG000|Overall Study|Adverse Event|14|||
147632211|NCT00784238|532472350|FG000|Overall Study|Death|2|||
147632212|NCT00784238|532472350|FG000|Overall Study|Lack of Efficacy|33|||
147632213|NCT00784238|532472350|FG000|Overall Study|Lost to Follow-up|29|||
147632214|NCT00784238|532472350|FG000|Overall Study|Pregnancy|1|||
147632215|NCT00784238|532472350|FG000|Overall Study|Withdrawal by Subject|26|||
147632216|NCT00784238|532472350|FG000|Overall Study|Other|14|||
147498064|NCT01885078|531975623|FG007|Treatment Period|Lack of Efficacy|5|||
147498065|NCT01885078|531975624|FG008|Treatment Period|Lack of Efficacy|0|||
147668532|NCT02003144|532611825|FG000|Open Label Maintenance Phase|Pregnancy|0|||
147498066|NCT01885078|531975625|FG009|Treatment Period|Lack of Efficacy|0|||
147632217|NCT03806933|532472351|FG000|Main Period|Physician Decision|0|||
147632218|NCT03806933|532472352|FG001|Main Period|Physician Decision|0|||
147632219|NCT03806933|532472353|FG002|Main Period|Physician Decision|0|||
147632220|NCT03806933|532472354|FG003|Main Period|Physician Decision|1|||
147632221|NCT03806933|532472351|FG000|Main Period|Pregnancy|0|||
147632222|NCT03806933|532472352|FG001|Main Period|Pregnancy|0|||
147632223|NCT03806933|532472353|FG002|Main Period|Pregnancy|1|||
147632224|NCT03806933|532472354|FG003|Main Period|Pregnancy|0|||
147632225|NCT03806933|532472351|FG000|Main Period|Withdrawal by Subject|2|||
147668533|NCT02003144|532611826|FG001|Open Label Maintenance Phase|Pregnancy|2|||
147632226|NCT03806933|532472352|FG001|Main Period|Withdrawal by Subject|1|||
147632227|NCT03806933|532472353|FG002|Main Period|Withdrawal by Subject|1|||
147632228|NCT03806933|532472354|FG003|Main Period|Withdrawal by Subject|2|||
147632229|NCT03806933|532472351|FG000|Main Period|Lost to Follow-up|2|||
147632230|NCT03806933|532472352|FG001|Main Period|Lost to Follow-up|2|||
147632231|NCT03806933|532472353|FG002|Main Period|Lost to Follow-up|0|||
147632232|NCT03806933|532472354|FG003|Main Period|Lost to Follow-up|0|||
147632233|NCT03806933|532472351|FG000|OLEX Period|Due to coronavirus disease (COVID) 19 pandemic|0|||
147632234|NCT03806933|532472352|FG001|OLEX Period|Due to coronavirus disease (COVID) 19 pandemic|0|||
147632235|NCT03806933|532472353|FG002|OLEX Period|Due to coronavirus disease (COVID) 19 pandemic|0|||
147632236|NCT03806933|532472354|FG003|OLEX Period|Due to coronavirus disease (COVID) 19 pandemic|1|||
147632237|NCT01736397|532472357|FG000|Overall Study|Lack of Efficacy|1|||
147632238|NCT01736397|532472358|FG001|Overall Study|Lack of Efficacy|11|||
147632239|NCT01736397|532472357|FG000|Overall Study|Withdrawal by Subject|6|||
147632240|NCT01736397|532472358|FG001|Overall Study|Withdrawal by Subject|5|||
147632241|NCT01736397|532472357|FG000|Overall Study|Lost to Follow-up|0|||
147632242|NCT01736397|532472358|FG001|Overall Study|Lost to Follow-up|1|||
147632243|NCT01736397|532472357|FG000|Overall Study|Adverse Event|6|||
147632244|NCT01736397|532472358|FG001|Overall Study|Adverse Event|3|||
147632245|NCT01736397|532472357|FG000|Overall Study|Not stated|1|||
147632246|NCT01736397|532472358|FG001|Overall Study|Not stated|4|||
147632247|NCT05088603|532472359|FG000|Overall Study|Protocol Violation|6|||
147632248|NCT05088603|532472360|FG001|Overall Study|Protocol Violation|1|||
147632249|NCT01868438|532472363|FG000|First Intervention|Withdrawal by Subject|5|||
147632250|NCT01868438|532472364|FG001|First Intervention|Withdrawal by Subject|1|||
147632251|NCT01868438|532472363|FG000|First Intervention|Lost to Follow-up|2|||
147632252|NCT01868438|532472364|FG001|First Intervention|Lost to Follow-up|3|||
147632253|NCT01868438|532472363|FG000|First Intervention|Meeting the non-redosing criteria|0|||
147632254|NCT01868438|532472364|FG001|First Intervention|Meeting the non-redosing criteria|1|||
147632255|NCT01868438|532472363|FG000|Second Intervention|Adverse Event|3|||
147632256|NCT01868438|532472364|FG001|Second Intervention|Adverse Event|3|||
147632257|NCT03260244|532472368|FG000|Overall Study|Death|19|||
147632258|NCT03260244|532472368|FG000|Overall Study|Lost to Follow-up|60|||
147632259|NCT03260244|532472368|FG000|Overall Study|Withdrawal by Subject|48|||
147632260|NCT03260244|532472368|FG000|Overall Study|Procedure Not Performed|21|||
147632261|NCT03260244|532472368|FG000|Overall Study|Enrollment Criteria Not Met|31|||
147632262|NCT03260244|532472368|FG000|Overall Study|Procedure Not Performed Per Protocol|12|||
147632263|NCT03260244|532472368|FG000|Overall Study|Subject Noncompliance|6|||
147632264|NCT03260244|532472368|FG000|Overall Study|No inducible Arrhythmia|2|||
147632265|NCT03260244|532472368|FG000|Overall Study|Procedure Not Performed by Trained Physician on Study|2|||
147632266|NCT03260244|532472368|FG000|Overall Study|Screen Failure|2|||
147632267|NCT03260244|532472368|FG000|Overall Study|Treated Off Label|69|||
147632268|NCT03260244|532472368|FG000|Overall Study|No Radiofrequency Ablation|14|||
147632269|NCT01177293|532472369|FG000|Washout Period (of 14 Days)|Lost to Follow-up|0|||
147632270|NCT01177293|532472370|FG001|Washout Period (of 14 Days)|Lost to Follow-up|1|||
147632271|NCT00956592|532472371|FG000|Overall Study|Protocol Violation|1|||
147632272|NCT00956592|532472372|FG001|Overall Study|Protocol Violation|3|||
147632273|NCT03528369|532472373|FG000|Overall Study|Withdrawal by Subject|2|||
147632274|NCT03528369|532472374|FG001|Overall Study|Withdrawal by Subject|0|||
147632275|NCT03528369|532472375|FG002|Overall Study|Withdrawal by Subject|0|||
147632276|NCT03528369|532472373|FG000|Overall Study|Lost to Follow-up|1|||
147632277|NCT03528369|532472374|FG001|Overall Study|Lost to Follow-up|0|||
147632278|NCT03528369|532472375|FG002|Overall Study|Lost to Follow-up|0|||
147632279|NCT03528369|532472373|FG000|Overall Study|Adverse Event|0|||
147632280|NCT03528369|532472374|FG001|Overall Study|Adverse Event|1|||
147632281|NCT03528369|532472375|FG002|Overall Study|Adverse Event|0|||
147632282|NCT02162719|532472376|FG000|Overall Study|Death|41|||
147632283|NCT02162719|532472377|FG001|Overall Study|Death|46|||
147632284|NCT02162719|532472376|FG000|Overall Study|Lost to Follow-up|1|||
147632285|NCT02162719|532472377|FG001|Overall Study|Lost to Follow-up|3|||
147632286|NCT02162719|532472376|FG000|Overall Study|Disease Progression|2|||
147632287|NCT02162719|532472377|FG001|Overall Study|Disease Progression|1|||
147632288|NCT02162719|532472376|FG000|Overall Study|Withdrawal by Subject|8|||
147632289|NCT02162719|532472377|FG001|Overall Study|Withdrawal by Subject|2|||
147632290|NCT02162719|532472376|FG000|Overall Study|Discontinuation of Overall Survival Follow-up|10|||
147632291|NCT02162719|532472377|FG001|Overall Study|Discontinuation of Overall Survival Follow-up|10|||
147632292|NCT03555565|532472378|FG000|Overall Study|Case Report Forms Uncollected|2|||
147632293|NCT03555565|532472378|FG000|Overall Study|Protocol Deviation|13|||
147632294|NCT00076752|532472384|FG000|Overall Study|Death|2|||
147632295|NCT00076752|532472384|FG000|Overall Study|Withdrawal per PI, PI put study on hold|1|||
147632296|NCT00394836|532472385|FG000|Teatment or Follow-up Phase|Adverse Event|0|||
147632297|NCT00394836|532472386|FG001|Teatment or Follow-up Phase|Adverse Event|2|||
147632298|NCT00394836|532472385|FG000|Teatment or Follow-up Phase|Protocol Violation|0|||
147632299|NCT00394836|532472386|FG001|Teatment or Follow-up Phase|Protocol Violation|2|||
147632300|NCT00394836|532472385|FG000|Teatment or Follow-up Phase|Disease Progression|27|||
147632301|NCT00394836|532472386|FG001|Teatment or Follow-up Phase|Disease Progression|60|||
147632302|NCT00394836|532472385|FG000|Teatment or Follow-up Phase|Patient Refusal|1|||
147632303|NCT00394836|532472386|FG001|Teatment or Follow-up Phase|Patient Refusal|2|||
147632304|NCT00394836|532472385|FG000|Teatment or Follow-up Phase|Death|0|||
147632305|NCT00394836|532472386|FG001|Teatment or Follow-up Phase|Death|1|||
147632306|NCT00394836|532472385|FG000|Teatment or Follow-up Phase|Patient refuses to continue with CT scan|0|||
147632307|NCT00394836|532472386|FG001|Teatment or Follow-up Phase|Patient refuses to continue with CT scan|1|||
147668534|NCT02003144|532611825|FG000|Open Label Maintenance Phase|Physician Decision|1|||
147498067|NCT01885078|531975616|FG000|Treatment Period|Lost to Follow-up|16|||
147498068|NCT01885078|531975617|FG001|Treatment Period|Lost to Follow-up|19|||
147498069|NCT01885078|531975618|FG002|Treatment Period|Lost to Follow-up|7|||
147498070|NCT01885078|531975619|FG003|Treatment Period|Lost to Follow-up|9|||
147498071|NCT01885078|531975620|FG004|Treatment Period|Lost to Follow-up|2|||
147498072|NCT01885078|531975621|FG005|Treatment Period|Lost to Follow-up|8|||
147498073|NCT01885078|531975622|FG006|Treatment Period|Lost to Follow-up|2|||
147498074|NCT01885078|531975623|FG007|Treatment Period|Lost to Follow-up|0|||
147498075|NCT01885078|531975624|FG008|Treatment Period|Lost to Follow-up|0|||
147498076|NCT01885078|531975625|FG009|Treatment Period|Lost to Follow-up|0|||
147498077|NCT01885078|531975616|FG000|Treatment Period|Physician Decision|19|||
147498078|NCT01885078|531975617|FG001|Treatment Period|Physician Decision|21|||
147498079|NCT01885078|531975618|FG002|Treatment Period|Physician Decision|5|||
147498080|NCT01885078|531975619|FG003|Treatment Period|Physician Decision|12|||
147498081|NCT01885078|531975620|FG004|Treatment Period|Physician Decision|9|||
147498082|NCT01885078|531975621|FG005|Treatment Period|Physician Decision|24|||
147498083|NCT01885078|531975622|FG006|Treatment Period|Physician Decision|4|||
147498084|NCT01885078|531975623|FG007|Treatment Period|Physician Decision|3|||
147498085|NCT01885078|531975624|FG008|Treatment Period|Physician Decision|0|||
147498086|NCT01885078|531975625|FG009|Treatment Period|Physician Decision|0|||
147498087|NCT01885078|531975616|FG000|Treatment Period|Protocol Violation|3|||
147498088|NCT01885078|531975617|FG001|Treatment Period|Protocol Violation|5|||
147498089|NCT01885078|531975618|FG002|Treatment Period|Protocol Violation|0|||
147498090|NCT01885078|531975619|FG003|Treatment Period|Protocol Violation|3|||
147498091|NCT01885078|531975620|FG004|Treatment Period|Protocol Violation|1|||
147498092|NCT01885078|531975621|FG005|Treatment Period|Protocol Violation|6|||
147498093|NCT01885078|531975622|FG006|Treatment Period|Protocol Violation|0|||
147498094|NCT01885078|531975623|FG007|Treatment Period|Protocol Violation|0|||
147498095|NCT01885078|531975624|FG008|Treatment Period|Protocol Violation|0|||
147498096|NCT01885078|531975625|FG009|Treatment Period|Protocol Violation|0|||
147498097|NCT01885078|531975616|FG000|Treatment Period|Sponsor Decision|245|||
147498098|NCT01885078|531975617|FG001|Treatment Period|Sponsor Decision|648|||
147498099|NCT01885078|531975618|FG002|Treatment Period|Sponsor Decision|49|||
147498100|NCT01885078|531975619|FG003|Treatment Period|Sponsor Decision|90|||
147498101|NCT01885078|531975620|FG004|Treatment Period|Sponsor Decision|20|||
147498102|NCT01885078|531975621|FG005|Treatment Period|Sponsor Decision|38|||
147498103|NCT01885078|531975622|FG006|Treatment Period|Sponsor Decision|162|||
147498104|NCT01885078|531975623|FG007|Treatment Period|Sponsor Decision|3|||
147498105|NCT01885078|531975624|FG008|Treatment Period|Sponsor Decision|0|||
147498106|NCT01885078|531975625|FG009|Treatment Period|Sponsor Decision|0|||
147498107|NCT01885078|531975616|FG000|Treatment Period|Withdrawal by Subject|72|||
147498108|NCT01885078|531975617|FG001|Treatment Period|Withdrawal by Subject|132|||
147498109|NCT01885078|531975618|FG002|Treatment Period|Withdrawal by Subject|25|||
147498110|NCT01885078|531975619|FG003|Treatment Period|Withdrawal by Subject|63|||
147498111|NCT01885078|531975620|FG004|Treatment Period|Withdrawal by Subject|15|||
147498112|NCT01885078|531975621|FG005|Treatment Period|Withdrawal by Subject|34|||
147498113|NCT01885078|531975622|FG006|Treatment Period|Withdrawal by Subject|17|||
147498114|NCT01885078|531975623|FG007|Treatment Period|Withdrawal by Subject|10|||
147498115|NCT01885078|531975624|FG008|Treatment Period|Withdrawal by Subject|0|||
147498116|NCT01885078|531975625|FG009|Treatment Period|Withdrawal by Subject|0|||
147498117|NCT01885078|531975616|FG000|Treatment Period|Other|0|||
147498118|NCT01885078|531975617|FG001|Treatment Period|Other|0|||
147498119|NCT01885078|531975618|FG002|Treatment Period|Other|0|||
147498120|NCT01885078|531975619|FG003|Treatment Period|Other|1|||
147498121|NCT01885078|531975620|FG004|Treatment Period|Other|0|||
147498122|NCT01885078|531975621|FG005|Treatment Period|Other|0|||
147498123|NCT01885078|531975622|FG006|Treatment Period|Other|0|||
147498124|NCT01885078|531975623|FG007|Treatment Period|Other|0|||
147498125|NCT01885078|531975624|FG008|Treatment Period|Other|0|||
147498126|NCT01885078|531975625|FG009|Treatment Period|Other|0|||
147498127|NCT01885078|531975616|FG000|Step-down Period|Sponsor Decision|0|||
147498128|NCT01885078|531975617|FG001|Step-down Period|Sponsor Decision|0|||
147498129|NCT01885078|531975618|FG002|Step-down Period|Sponsor Decision|0|||
147498130|NCT01885078|531975619|FG003|Step-down Period|Sponsor Decision|0|||
147498131|NCT01885078|531975620|FG004|Step-down Period|Sponsor Decision|0|||
147498132|NCT01885078|531975621|FG005|Step-down Period|Sponsor Decision|0|||
147498133|NCT01885078|531975622|FG006|Step-down Period|Sponsor Decision|0|||
147498134|NCT01885078|531975623|FG007|Step-down Period|Sponsor Decision|0|||
147498135|NCT01885078|531975624|FG008|Step-down Period|Sponsor Decision|1|||
147498136|NCT01885078|531975625|FG009|Step-down Period|Sponsor Decision|1|||
147498137|NCT01885078|531975616|FG000|Step-down Period|Adverse Event|0|||
147498138|NCT01885078|531975617|FG001|Step-down Period|Adverse Event|0|||
147498139|NCT01885078|531975618|FG002|Step-down Period|Adverse Event|0|||
147498140|NCT01885078|531975619|FG003|Step-down Period|Adverse Event|0|||
147498141|NCT01885078|531975620|FG004|Step-down Period|Adverse Event|0|||
147498142|NCT01885078|531975621|FG005|Step-down Period|Adverse Event|0|||
147498143|NCT01885078|531975622|FG006|Step-down Period|Adverse Event|0|||
147632308|NCT00394836|532472385|FG000|Teatment or Follow-up Phase|Started alternative treatment|0|||
147632309|NCT00394836|532472386|FG001|Teatment or Follow-up Phase|Started alternative treatment|6|||
147632310|NCT00394836|532472385|FG000|Teatment or Follow-up Phase|Suspicion of cholangiocarcinoma|0|||
147632311|NCT00394836|532472386|FG001|Teatment or Follow-up Phase|Suspicion of cholangiocarcinoma|1|||
147632312|NCT00394836|532472385|FG000|Teatment or Follow-up Phase|Physician Decision|0|||
147632313|NCT00394836|532472386|FG001|Teatment or Follow-up Phase|Physician Decision|1|||
147632314|NCT00394836|532472385|FG000|Teatment or Follow-up Phase|Patient progressed, return to Pakistan|0|||
147632315|NCT00394836|532472386|FG001|Teatment or Follow-up Phase|Patient progressed, return to Pakistan|1|||
147632316|NCT00394836|532472385|FG000|Teatment or Follow-up Phase|Non compliance|0|||
147632317|NCT00394836|532472386|FG001|Teatment or Follow-up Phase|Non compliance|1|||
147632318|NCT00394836|532472385|FG000|Extended Follow-up Phase (2-5 Years)|Lost to Follow-up|0|||
147632319|NCT00394836|532472386|FG001|Extended Follow-up Phase (2-5 Years)|Lost to Follow-up|1|||
147632320|NCT00394836|532472385|FG000|Extended Follow-up Phase (2-5 Years)|Death|0|||
147632321|NCT00394836|532472386|FG001|Extended Follow-up Phase (2-5 Years)|Death|1|||
147632322|NCT00394836|532472385|FG000|Extended Follow-up Phase (2-5 Years)|Alternative treatment|13|||
147632323|NCT00394836|532472386|FG001|Extended Follow-up Phase (2-5 Years)|Alternative treatment|41|||
147498144|NCT01885078|531975623|FG007|Step-down Period|Adverse Event|0|||
147498145|NCT01885078|531975624|FG008|Step-down Period|Adverse Event|29|||
147498146|NCT01885078|531975625|FG009|Step-down Period|Adverse Event|38|||
147498147|NCT01885078|531975616|FG000|Step-down Period|Withdrawal by Subject|0|||
147498148|NCT01885078|531975617|FG001|Step-down Period|Withdrawal by Subject|0|||
147498149|NCT01885078|531975618|FG002|Step-down Period|Withdrawal by Subject|0|||
147498150|NCT01885078|531975619|FG003|Step-down Period|Withdrawal by Subject|0|||
147498151|NCT01885078|531975620|FG004|Step-down Period|Withdrawal by Subject|0|||
147498152|NCT01885078|531975621|FG005|Step-down Period|Withdrawal by Subject|0|||
147498153|NCT01885078|531975622|FG006|Step-down Period|Withdrawal by Subject|0|||
147498154|NCT01885078|531975623|FG007|Step-down Period|Withdrawal by Subject|0|||
147498155|NCT01885078|531975624|FG008|Step-down Period|Withdrawal by Subject|25|||
147498156|NCT01885078|531975625|FG009|Step-down Period|Withdrawal by Subject|15|||
147498157|NCT01885078|531975616|FG000|Step-down Period|Physician Decision|0|||
147498158|NCT01885078|531975617|FG001|Step-down Period|Physician Decision|0|||
147498159|NCT01885078|531975618|FG002|Step-down Period|Physician Decision|0|||
147498160|NCT01885078|531975619|FG003|Step-down Period|Physician Decision|0|||
147498161|NCT01885078|531975620|FG004|Step-down Period|Physician Decision|0|||
147498162|NCT01885078|531975621|FG005|Step-down Period|Physician Decision|0|||
147498163|NCT01885078|531975622|FG006|Step-down Period|Physician Decision|0|||
147498164|NCT01885078|531975623|FG007|Step-down Period|Physician Decision|0|||
147498165|NCT01885078|531975624|FG008|Step-down Period|Physician Decision|7|||
147498166|NCT01885078|531975625|FG009|Step-down Period|Physician Decision|2|||
147498167|NCT01885078|531975616|FG000|Step-down Period|Death|0|||
147498168|NCT01885078|531975617|FG001|Step-down Period|Death|0|||
147498169|NCT01885078|531975618|FG002|Step-down Period|Death|0|||
147498170|NCT01885078|531975619|FG003|Step-down Period|Death|0|||
147498171|NCT01885078|531975620|FG004|Step-down Period|Death|0|||
147498172|NCT01885078|531975621|FG005|Step-down Period|Death|0|||
147498173|NCT01885078|531975622|FG006|Step-down Period|Death|0|||
147498174|NCT01885078|531975623|FG007|Step-down Period|Death|0|||
147498175|NCT01885078|531975624|FG008|Step-down Period|Death|4|||
147498176|NCT01885078|531975625|FG009|Step-down Period|Death|3|||
147498177|NCT01885078|531975616|FG000|Step-down Period|Lost to Follow-up|0|||
147498178|NCT01885078|531975617|FG001|Step-down Period|Lost to Follow-up|0|||
147498179|NCT01885078|531975618|FG002|Step-down Period|Lost to Follow-up|0|||
147498180|NCT01885078|531975619|FG003|Step-down Period|Lost to Follow-up|0|||
147498181|NCT01885078|531975620|FG004|Step-down Period|Lost to Follow-up|0|||
147498182|NCT01885078|531975621|FG005|Step-down Period|Lost to Follow-up|0|||
147498183|NCT01885078|531975622|FG006|Step-down Period|Lost to Follow-up|0|||
147498184|NCT01885078|531975623|FG007|Step-down Period|Lost to Follow-up|0|||
147498185|NCT01885078|531975624|FG008|Step-down Period|Lost to Follow-up|1|||
147632324|NCT00394836|532472385|FG000|Extended Follow-up Phase (2-5 Years)|Medical Reasons|7|||
147632325|NCT00394836|532472386|FG001|Extended Follow-up Phase (2-5 Years)|Medical Reasons|10|||
147632326|NCT00610155|532472393|FG000|Period 1|Withdrawal by Subject|0|||
147632327|NCT00610155|532472394|FG001|Period 1|Withdrawal by Subject|0|||
147632328|NCT00610155|532472395|FG002|Period 1|Withdrawal by Subject|1|||
147498186|NCT01885078|531975625|FG009|Step-down Period|Lost to Follow-up|1|||
147498187|NCT01885078|531975616|FG000|Step-down Period|Lack of Efficacy|0|||
147498188|NCT01885078|531975617|FG001|Step-down Period|Lack of Efficacy|0|||
147498189|NCT01885078|531975618|FG002|Step-down Period|Lack of Efficacy|0|||
147498190|NCT01885078|531975619|FG003|Step-down Period|Lack of Efficacy|0|||
147498191|NCT01885078|531975620|FG004|Step-down Period|Lack of Efficacy|0|||
147498192|NCT01885078|531975621|FG005|Step-down Period|Lack of Efficacy|0|||
147498193|NCT01885078|531975622|FG006|Step-down Period|Lack of Efficacy|0|||
147498194|NCT01885078|531975623|FG007|Step-down Period|Lack of Efficacy|0|||
147498195|NCT01885078|531975624|FG008|Step-down Period|Lack of Efficacy|1|||
147498196|NCT01885078|531975625|FG009|Step-down Period|Lack of Efficacy|0|||
147498197|NCT01885078|531975616|FG000|Step-down Period|Protocol Violation|0|||
147632329|NCT00610155|532472396|FG003|Period 1|Withdrawal by Subject|0|||
147632330|NCT00610155|532472397|FG004|Period 1|Withdrawal by Subject|0|||
147632331|NCT00610155|532472398|FG005|Period 1|Withdrawal by Subject|0|||
147632332|NCT00610155|532472393|FG000|Period 3|Adverse Event|1|||
147632333|NCT00610155|532472394|FG001|Period 3|Adverse Event|0|||
147632334|NCT00610155|532472395|FG002|Period 3|Adverse Event|0|||
147632335|NCT00610155|532472396|FG003|Period 3|Adverse Event|0|||
147632336|NCT00610155|532472397|FG004|Period 3|Adverse Event|0|||
147632337|NCT00610155|532472398|FG005|Period 3|Adverse Event|0|||
147632338|NCT03192306|532472401|FG000|Overall Study|Did not treat cold sore during study|149|||
147632339|NCT03192306|532472402|FG001|Overall Study|Did not treat cold sore during study|143|||
147632340|NCT03192306|532472401|FG000|Overall Study|Withdrawal by Subject|1|||
147632341|NCT03192306|532472402|FG001|Overall Study|Withdrawal by Subject|1|||
147632342|NCT03192306|532472401|FG000|Overall Study|Lost to Follow-up|1|||
147632343|NCT03192306|532472402|FG001|Overall Study|Lost to Follow-up|0|||
147632344|NCT03192306|532472401|FG000|Overall Study|Protocol Violation|1|||
147632345|NCT03192306|532472402|FG001|Overall Study|Protocol Violation|1|||
147632346|NCT00083759|532472407|FG000|Overall Study|Adverse Event|5|||
147632347|NCT00083759|532472408|FG001|Overall Study|Adverse Event|3|||
147632348|NCT00083759|532472407|FG000|Overall Study|Lost to Follow-up|1|||
147632349|NCT00083759|532472408|FG001|Overall Study|Lost to Follow-up|0|||
147632350|NCT00083759|532472407|FG000|Overall Study|Death|1|||
147632351|NCT00083759|532472408|FG001|Overall Study|Death|1|||
147632352|NCT00083759|532472407|FG000|Overall Study|Inadequate Therapeutic Response|32|||
147632353|NCT00083759|532472408|FG001|Overall Study|Inadequate Therapeutic Response|35|||
147632354|NCT00083759|532472407|FG000|Overall Study|Subject Withdrew Consent|2|||
147632355|NCT00083759|532472408|FG001|Overall Study|Subject Withdrew Consent|2|||
147632356|NCT00083759|532472407|FG000|Overall Study|Non-Compliance|1|||
147632357|NCT00083759|532472408|FG001|Overall Study|Non-Compliance|0|||
147632358|NCT00083759|532472407|FG000|Overall Study|Sponsor's Discretion|28|||
147632359|NCT00083759|532472408|FG001|Overall Study|Sponsor's Discretion|29|||
147632360|NCT00083759|532472407|FG000|Overall Study|Other|14|||
147632361|NCT00083759|532472408|FG001|Overall Study|Other|13|||
147632362|NCT03645395|532472409|FG000|Part 1 (Up to 6 Months)|Adverse Event|1|||
147632363|NCT03645395|532472410|FG001|Part 1 (Up to 6 Months)|Adverse Event|0|||
147632364|NCT03645395|532472411|FG002|Part 1 (Up to 6 Months)|Adverse Event|0|||
147632365|NCT03645395|532472412|FG003|Part 1 (Up to 6 Months)|Adverse Event|0|||
147632366|NCT03645395|532472409|FG000|Part 1 (Up to 6 Months)|Disease Progression|0|||
147632367|NCT03645395|532472410|FG001|Part 1 (Up to 6 Months)|Disease Progression|1|||
147632368|NCT03645395|532472411|FG002|Part 1 (Up to 6 Months)|Disease Progression|0|||
147632369|NCT03645395|532472412|FG003|Part 1 (Up to 6 Months)|Disease Progression|0|||
147632370|NCT03645395|532472409|FG000|Part 1 (Up to 6 Months)|Withdrawal by Subject|0|||
147632371|NCT03645395|532472410|FG001|Part 1 (Up to 6 Months)|Withdrawal by Subject|0|||
147632372|NCT03645395|532472411|FG002|Part 1 (Up to 6 Months)|Withdrawal by Subject|1|||
147632373|NCT03645395|532472412|FG003|Part 1 (Up to 6 Months)|Withdrawal by Subject|0|||
147632374|NCT03645395|532472409|FG000|Part 1 (Up to 6 Months)|Sponsor's decision to close the trial|1|||
147632375|NCT03645395|532472410|FG001|Part 1 (Up to 6 Months)|Sponsor's decision to close the trial|2|||
147632376|NCT03645395|532472411|FG002|Part 1 (Up to 6 Months)|Sponsor's decision to close the trial|2|||
147632377|NCT03645395|532472412|FG003|Part 1 (Up to 6 Months)|Sponsor's decision to close the trial|0|||
147632378|NCT00892151|532472413|FG000|Overall Study|Protocol Violation|1|||
147632379|NCT02429778|532472414|FG000|Overall Study|Lost to Follow-up|2|||
147632380|NCT02429778|532472415|FG001|Overall Study|Lost to Follow-up|0|||
147632381|NCT02429778|532472414|FG000|Overall Study|Withdrawal by Subject|5|||
147632382|NCT02429778|532472415|FG001|Overall Study|Withdrawal by Subject|0|||
147632383|NCT02475265|532472416|FG000|Overall Study|Physician Decision|1|||
147632384|NCT02475265|532472416|FG000|Overall Study|Withdrawal by Subject|2|||
147632385|NCT02751450|532472417|FG000|Overall Study|Adverse Event|1|||
147632386|NCT02751450|532472418|FG001|Overall Study|Adverse Event|0|||
147632387|NCT01598090|532472419|FG000|Treatment Period|Poor/non-compliance|0|||
147632388|NCT01598090|532472420|FG001|Treatment Period|Poor/non-compliance|2|||
147632389|NCT01598090|532472421|FG002|Treatment Period|Poor/non-compliance|0|||
147632390|NCT01598090|532472419|FG000|Treatment Period|No longer meet study criteria|0|||
147632391|NCT01598090|532472420|FG001|Treatment Period|No longer meet study criteria|1|||
147632392|NCT01598090|532472421|FG002|Treatment Period|No longer meet study criteria|0|||
147632393|NCT01598090|532472419|FG000|Treatment Period|Lack of Efficacy|5|||
147632394|NCT01598090|532472420|FG001|Treatment Period|Lack of Efficacy|14|||
147632395|NCT01598090|532472421|FG002|Treatment Period|Lack of Efficacy|6|||
147632396|NCT01598090|532472419|FG000|Treatment Period|Adverse Event|2|||
147632397|NCT01598090|532472420|FG001|Treatment Period|Adverse Event|33|||
147632398|NCT01598090|532472421|FG002|Treatment Period|Adverse Event|17|||
147632399|NCT01598090|532472419|FG000|Treatment Period|Other reasons|0|||
147632400|NCT01598090|532472420|FG001|Treatment Period|Other reasons|4|||
147632401|NCT01598090|532472421|FG002|Treatment Period|Other reasons|1|||
147632402|NCT01598090|532472419|FG000|Treatment Period|Withdrawal by Subject|3|||
147632403|NCT01598090|532472420|FG001|Treatment Period|Withdrawal by Subject|13|||
147632404|NCT01598090|532472421|FG002|Treatment Period|Withdrawal by Subject|10|||
147632405|NCT01598090|532472419|FG000|Treatment Period|Lost to Follow-up|1|||
147632406|NCT01598090|532472420|FG001|Treatment Period|Lost to Follow-up|5|||
147632407|NCT01598090|532472421|FG002|Treatment Period|Lost to Follow-up|1|||
147632408|NCT01598090|532472419|FG000|Follow-up Period|Death|0|||
147632409|NCT01598090|532472420|FG001|Follow-up Period|Death|1|||
147498198|NCT01885078|531975617|FG001|Step-down Period|Protocol Violation|0|||
147498199|NCT01885078|531975618|FG002|Step-down Period|Protocol Violation|0|||
147498200|NCT01885078|531975619|FG003|Step-down Period|Protocol Violation|0|||
147498201|NCT01885078|531975620|FG004|Step-down Period|Protocol Violation|0|||
147498202|NCT01885078|531975621|FG005|Step-down Period|Protocol Violation|0|||
147498203|NCT01885078|531975622|FG006|Step-down Period|Protocol Violation|0|||
147498204|NCT01885078|531975623|FG007|Step-down Period|Protocol Violation|0|||
147498205|NCT01885078|531975624|FG008|Step-down Period|Protocol Violation|1|||
147498206|NCT01885078|531975625|FG009|Step-down Period|Protocol Violation|1|||
147498207|NCT02899377|531975629|FG000|Overall Study|Adverse Event|1|||
147498208|NCT02899377|531975630|FG001|Overall Study|Adverse Event|0|||
147498209|NCT04321252|531975631|FG000|Overall Study|Withdrawal by Subject|0|||
147498210|NCT04321252|531975632|FG001|Overall Study|Withdrawal by Subject|0|||
147498211|NCT04321252|531975633|FG002|Overall Study|Withdrawal by Subject|0|||
147498212|NCT04321252|531975634|FG003|Overall Study|Withdrawal by Subject|0|||
147498213|NCT04321252|531975635|FG004|Overall Study|Withdrawal by Subject|0|||
147498214|NCT04321252|531975636|FG005|Overall Study|Withdrawal by Subject|1|||
147498215|NCT04321252|531975637|FG006|Overall Study|Withdrawal by Subject|0|||
147498216|NCT04321252|531975638|FG007|Overall Study|Withdrawal by Subject|0|||
147498217|NCT04321252|531975639|FG008|Overall Study|Withdrawal by Subject|0|||
147498218|NCT00259740|531975642|FG000|Overall Study|Physician Decision|1|||
147498219|NCT00259740|531975643|FG001|Overall Study|Physician Decision|1|||
147498220|NCT00259740|531975642|FG000|Overall Study|Adverse Event|0|||
147498221|NCT00259740|531975643|FG001|Overall Study|Adverse Event|2|||
147498222|NCT00259740|531975642|FG000|Overall Study|Withdrawal by Subject|2|||
147498223|NCT00259740|531975643|FG001|Overall Study|Withdrawal by Subject|6|||
147498224|NCT00259740|531975642|FG000|Overall Study|Death|1|||
147498225|NCT00259740|531975643|FG001|Overall Study|Death|1|||
147498226|NCT00259740|531975642|FG000|Overall Study|Disease progression|19|||
147498227|NCT00259740|531975643|FG001|Overall Study|Disease progression|36|||
147498228|NCT00259740|531975642|FG000|Overall Study|Ongoing|17|||
147498229|NCT00259740|531975643|FG001|Overall Study|Ongoing|3|||
147498230|NCT00259740|531975642|FG000|Overall Study|Other|3|||
147498231|NCT00259740|531975643|FG001|Overall Study|Other|0|||
147498232|NCT00259740|531975642|FG000|Overall Study|Requirement for alternative therapy|0|||
147498233|NCT00259740|531975643|FG001|Overall Study|Requirement for alternative therapy|4|||
147498234|NCT01844830|531975645|FG000|Overall Study|Withdrawal by Subject|1|||
147498235|NCT01844830|531975646|FG001|Overall Study|Withdrawal by Subject|0|||
147498236|NCT03150095|531975652|FG000|Overall Study|Death|0|||
147498237|NCT03150095|531975653|FG001|Overall Study|Death|1|||
147498238|NCT03150095|531975652|FG000|Overall Study|Lost to Follow-up|1|||
147498239|NCT03150095|531975653|FG001|Overall Study|Lost to Follow-up|1|||
147498240|NCT03150095|531975652|FG000|Overall Study|Withdrawal by Subject|4|||
147498241|NCT03150095|531975653|FG001|Overall Study|Withdrawal by Subject|0|||
147498242|NCT03150095|531975652|FG000|Overall Study|unable or unwilling to continue health coaching|4|||
147498243|NCT03150095|531975653|FG001|Overall Study|unable or unwilling to continue health coaching|0|||
147498244|NCT05025787|531975655|FG000|Overall Study|Lack of Efficacy|0|||
147498245|NCT05025787|531975656|FG001|Overall Study|Lack of Efficacy|1|||
147498246|NCT05025787|531975655|FG000|Overall Study|Adverse Event|2|||
147498247|NCT05025787|531975656|FG001|Overall Study|Adverse Event|4|||
147498248|NCT05025787|531975655|FG000|Overall Study|Non compliance|0|||
147498249|NCT05025787|531975656|FG001|Overall Study|Non compliance|1|||
147498250|NCT05025787|531975655|FG000|Overall Study|Protocol Violation|3|||
147632410|NCT01598090|532472421|FG002|Follow-up Period|Death|0|||
147632411|NCT01598090|532472419|FG000|Follow-up Period|No longer required per protocol|1|||
147632412|NCT01598090|532472420|FG001|Follow-up Period|No longer required per protocol|3|||
147632413|NCT01598090|532472421|FG002|Follow-up Period|No longer required per protocol|2|||
147632414|NCT01598090|532472419|FG000|Follow-up Period|Not reported|0|||
147498251|NCT05025787|531975656|FG001|Overall Study|Protocol Violation|1|||
147498252|NCT05025787|531975655|FG000|Overall Study|Stopping criteria met|1|||
147498253|NCT05025787|531975656|FG001|Overall Study|Stopping criteria met|1|||
147498254|NCT05025787|531975655|FG000|Overall Study|Withdrawal by Subject|3|||
147498255|NCT05025787|531975656|FG001|Overall Study|Withdrawal by Subject|1|||
147498256|NCT05301322|531975660|FG000|Overall Study|Adverse Event|7|||
147498257|NCT05301322|531975661|FG001|Overall Study|Adverse Event|3|||
147498258|NCT05301322|531975660|FG000|Overall Study|Death|0|||
147498259|NCT05301322|531975661|FG001|Overall Study|Death|1|||
147498260|NCT05301322|531975660|FG000|Overall Study|Lost to Follow-up|2|||
147498261|NCT05301322|531975661|FG001|Overall Study|Lost to Follow-up|1|||
147498262|NCT05301322|531975660|FG000|Overall Study|Protocol Violation|3|||
147498263|NCT05301322|531975661|FG001|Overall Study|Protocol Violation|1|||
147632415|NCT01598090|532472420|FG001|Follow-up Period|Not reported|10|||
147498264|NCT05301322|531975660|FG000|Overall Study|Withdrawal by Subject|3|||
147498265|NCT05301322|531975661|FG001|Overall Study|Withdrawal by Subject|0|||
147498266|NCT05301322|531975660|FG000|Overall Study|Other|4|||
147498267|NCT05301322|531975661|FG001|Overall Study|Other|0|||
147498268|NCT05757427|531975662|FG000|Overall Study|Adverse Event|1|||
147498269|NCT05757427|531975662|FG000|Overall Study|Device deficiency|1|||
147498270|NCT05757427|531975662|FG000|Overall Study|All cysts aspirated before Wavelia scan|1|||
147498271|NCT05757427|531975662|FG000|Overall Study|MWBI scan of only 1 breast|3|||
147498272|NCT05757427|531975662|FG000|Overall Study|Invalid MWBI scan - various reasons - positioning, breast too large, patient movement|5|||
147498273|NCT03423979|531975663|FG000|Overall Study|Death|5|||
147498274|NCT03423979|531975663|FG000|Overall Study|Adverse Event|4|||
147498275|NCT03423979|531975663|FG000|Overall Study|Withdrawal by Subject|3|||
147498276|NCT03423979|531975663|FG000|Overall Study|Lost to Follow-up|16|||
147498277|NCT04971785|531975664|FG000|Overall Study|Withdrew Consent|5|||
147498278|NCT04971785|531975665|FG001|Overall Study|Withdrew Consent|5|||
147498279|NCT04971785|531975666|FG002|Overall Study|Withdrew Consent|17|||
147498280|NCT04971785|531975667|FG003|Overall Study|Withdrew Consent|7|||
147498281|NCT04971785|531975664|FG000|Overall Study|Adverse Event|7|||
147498282|NCT04971785|531975665|FG001|Overall Study|Adverse Event|8|||
147498283|NCT04971785|531975666|FG002|Overall Study|Adverse Event|6|||
147498284|NCT04971785|531975667|FG003|Overall Study|Adverse Event|3|||
147498285|NCT04971785|531975664|FG000|Overall Study|Lost to Follow-up|2|||
147498286|NCT04971785|531975665|FG001|Overall Study|Lost to Follow-up|1|||
147498287|NCT04971785|531975666|FG002|Overall Study|Lost to Follow-up|6|||
147498288|NCT04971785|531975667|FG003|Overall Study|Lost to Follow-up|7|||
147498289|NCT04971785|531975664|FG000|Overall Study|Protocol Violation|3|||
147498290|NCT04971785|531975665|FG001|Overall Study|Protocol Violation|1|||
147498291|NCT04971785|531975666|FG002|Overall Study|Protocol Violation|1|||
147498292|NCT04971785|531975667|FG003|Overall Study|Protocol Violation|2|||
147498293|NCT04971785|531975664|FG000|Overall Study|Investigator's Discretion|3|||
147498294|NCT04971785|531975665|FG001|Overall Study|Investigator's Discretion|1|||
147498295|NCT04971785|531975666|FG002|Overall Study|Investigator's Discretion|1|||
147498296|NCT04971785|531975667|FG003|Overall Study|Investigator's Discretion|0|||
147498297|NCT04971785|531975664|FG000|Overall Study|Randomized but Never Treated|1|||
147498298|NCT04971785|531975665|FG001|Overall Study|Randomized but Never Treated|2|||
147498299|NCT04971785|531975666|FG002|Overall Study|Randomized but Never Treated|0|||
147498300|NCT04971785|531975667|FG003|Overall Study|Randomized but Never Treated|1|||
147498301|NCT04971785|531975664|FG000|Overall Study|Death|0|||
147498302|NCT04971785|531975665|FG001|Overall Study|Death|1|||
147498303|NCT04971785|531975666|FG002|Overall Study|Death|1|||
147498304|NCT04971785|531975667|FG003|Overall Study|Death|0|||
147498305|NCT04971785|531975664|FG000|Overall Study|Site Terminated by Sponsor|1|||
147498306|NCT04971785|531975665|FG001|Overall Study|Site Terminated by Sponsor|1|||
147498307|NCT04971785|531975666|FG002|Overall Study|Site Terminated by Sponsor|0|||
147498308|NCT04971785|531975667|FG003|Overall Study|Site Terminated by Sponsor|0|||
147498309|NCT00808249|531975668|FG000|Overall Study|Adverse Event|4|||
147498310|NCT00808249|531975669|FG001|Overall Study|Adverse Event|7|||
147498311|NCT00808249|531975670|FG002|Overall Study|Adverse Event|10|||
147498312|NCT00808249|531975671|FG003|Overall Study|Adverse Event|6|||
147498313|NCT00808249|531975668|FG000|Overall Study|Lost to Follow-up|2|||
147498314|NCT00808249|531975669|FG001|Overall Study|Lost to Follow-up|3|||
147498315|NCT00808249|531975670|FG002|Overall Study|Lost to Follow-up|3|||
147498316|NCT00808249|531975671|FG003|Overall Study|Lost to Follow-up|5|||
147498317|NCT00808249|531975668|FG000|Overall Study|Withdrawal by Subject|4|||
147498318|NCT00808249|531975669|FG001|Overall Study|Withdrawal by Subject|0|||
147498319|NCT00808249|531975670|FG002|Overall Study|Withdrawal by Subject|2|||
147498320|NCT00808249|531975671|FG003|Overall Study|Withdrawal by Subject|4|||
147498321|NCT00808249|531975668|FG000|Overall Study|Protocol Violation|3|||
147498322|NCT00808249|531975669|FG001|Overall Study|Protocol Violation|3|||
147498323|NCT00808249|531975670|FG002|Overall Study|Protocol Violation|3|||
147498324|NCT00808249|531975671|FG003|Overall Study|Protocol Violation|0|||
147498325|NCT00808249|531975668|FG000|Overall Study|Lack of Efficacy|1|||
147498326|NCT00808249|531975669|FG001|Overall Study|Lack of Efficacy|1|||
147498327|NCT00808249|531975670|FG002|Overall Study|Lack of Efficacy|0|||
147498328|NCT00808249|531975671|FG003|Overall Study|Lack of Efficacy|0|||
147498329|NCT00808249|531975668|FG000|Overall Study|study specific discontinuation criteria|1|||
147498330|NCT00808249|531975669|FG001|Overall Study|study specific discontinuation criteria|0|||
147498331|NCT00808249|531975670|FG002|Overall Study|study specific discontinuation criteria|1|||
147498332|NCT00808249|531975671|FG003|Overall Study|study specific discontinuation criteria|0|||
147498333|NCT00808249|531975668|FG000|Overall Study|All other reasons|2|||
147498334|NCT00808249|531975669|FG001|Overall Study|All other reasons|1|||
147498335|NCT00808249|531975670|FG002|Overall Study|All other reasons|3|||
147498336|NCT00808249|531975671|FG003|Overall Study|All other reasons|1|||
147498337|NCT01251861|531975672|FG000|Overall Study|Disease progression|6|||
147498338|NCT01251861|531975673|FG001|Overall Study|Disease progression|6|||
147498339|NCT01251861|531975672|FG000|Overall Study|Adverse Event|2|||
147498340|NCT01251861|531975673|FG001|Overall Study|Adverse Event|17|||
147498341|NCT01251861|531975672|FG000|Overall Study|Withdrawal by Subject|2|||
147498342|NCT01251861|531975673|FG001|Overall Study|Withdrawal by Subject|2|||
147498343|NCT01251861|531975672|FG000|Overall Study|Alternative therapy|1|||
147498344|NCT01251861|531975673|FG001|Overall Study|Alternative therapy|0|||
147498345|NCT01251861|531975672|FG000|Overall Study|Other complicating disease|0|||
147498346|NCT01251861|531975673|FG001|Overall Study|Other complicating disease|1|||
147498347|NCT01251861|531975672|FG000|Overall Study|Physician Decision|1|||
147498348|NCT01251861|531975673|FG001|Overall Study|Physician Decision|0|||
147498349|NCT01251861|531975672|FG000|Overall Study|Continued treatment beyond 18 cycles|1|||
147498350|NCT01251861|531975673|FG001|Overall Study|Continued treatment beyond 18 cycles|0|||
147498351|NCT01251861|531975672|FG000|Overall Study|Other|1|||
147498352|NCT01251861|531975673|FG001|Overall Study|Other|0|||
147498353|NCT01251861|531975672|FG000|Overall Study|Never started therapy|4|||
147498354|NCT01251861|531975673|FG001|Overall Study|Never started therapy|1|||
147498355|NCT01251861|531975672|FG000|Overall Study|Potential interaction of drugs|0|||
147498356|NCT01251861|531975673|FG001|Overall Study|Potential interaction of drugs|1|||
147498357|NCT03829332|531975674|FG000|Overall Study|Death|225|||
147498358|NCT03829332|531975675|FG001|Overall Study|Death|230|||
147498359|NCT03829332|531975674|FG000|Overall Study|Lost to Follow-up|1|||
147498360|NCT03829332|531975675|FG001|Overall Study|Lost to Follow-up|3|||
147498361|NCT03829332|531975674|FG000|Overall Study|Physician Decision|1|||
147498362|NCT03829332|531975675|FG001|Overall Study|Physician Decision|0|||
147498363|NCT03829332|531975674|FG000|Overall Study|Sponsor Decision|71|||
147498364|NCT03829332|531975675|FG001|Overall Study|Sponsor Decision|72|||
147498365|NCT03829332|531975674|FG000|Overall Study|Withdrawal by Subject|11|||
147498366|NCT03829332|531975675|FG001|Overall Study|Withdrawal by Subject|9|||
147498367|NCT05371912|531975676|FG000|Overall Study|Lost to Follow-up|3|||
147498368|NCT05371912|531975677|FG001|Overall Study|Lost to Follow-up|2|||
147498369|NCT02598661|531975678|FG000|Overall Study|Death|27|||
147498370|NCT02598661|531975679|FG001|Overall Study|Death|34|||
147498371|NCT02598661|531975680|FG002|Overall Study|Death|14|||
147498372|NCT02598661|531975681|FG003|Overall Study|Death|1|||
147498373|NCT02598661|531975682|FG004|Overall Study|Death|0|||
147498374|NCT02598661|531975678|FG000|Overall Study|Lost to Follow-up|2|||
147498375|NCT02598661|531975679|FG001|Overall Study|Lost to Follow-up|3|||
147498376|NCT02598661|531975680|FG002|Overall Study|Lost to Follow-up|2|||
147498377|NCT02598661|531975681|FG003|Overall Study|Lost to Follow-up|0|||
147498378|NCT02598661|531975682|FG004|Overall Study|Lost to Follow-up|0|||
147498379|NCT02598661|531975678|FG000|Overall Study|Withdrawal by Subject|13|||
147498380|NCT02598661|531975679|FG001|Overall Study|Withdrawal by Subject|24|||
147498381|NCT02598661|531975680|FG002|Overall Study|Withdrawal by Subject|14|||
147498382|NCT02598661|531975681|FG003|Overall Study|Withdrawal by Subject|1|||
147498383|NCT02598661|531975682|FG004|Overall Study|Withdrawal by Subject|1|||
147498384|NCT02598661|531975678|FG000|Overall Study|Adverse Event|0|||
147498385|NCT02598661|531975679|FG001|Overall Study|Adverse Event|0|||
147498386|NCT02598661|531975680|FG002|Overall Study|Adverse Event|1|||
147498387|NCT02598661|531975681|FG003|Overall Study|Adverse Event|0|||
147498388|NCT02598661|531975682|FG004|Overall Study|Adverse Event|0|||
147498389|NCT02598661|531975678|FG000|Overall Study|Randomized, Never Treated|0|||
147498390|NCT02598661|531975679|FG001|Overall Study|Randomized, Never Treated|0|||
147498391|NCT02598661|531975680|FG002|Overall Study|Randomized, Never Treated|0|||
147498392|NCT02598661|531975681|FG003|Overall Study|Randomized, Never Treated|0|||
147498393|NCT02598661|531975682|FG004|Overall Study|Randomized, Never Treated|1|||
147498394|NCT01646398|531977279|FG000|Overall Study|Withdrawal by Subject|1|||
147498395|NCT01646398|531977280|FG001|Overall Study|Withdrawal by Subject|0|||
147498396|NCT00571519|531977281|FG000|Overall Study|Subject withdrew consent|0|||
147498397|NCT00571519|531977282|FG001|Overall Study|Subject withdrew consent|1|||
147498398|NCT00571519|531977283|FG002|Overall Study|Subject withdrew consent|0|||
147498399|NCT00571519|531977284|FG003|Overall Study|Subject withdrew consent|2|||
147498400|NCT00571519|531977285|FG004|Overall Study|Subject withdrew consent|1|||
147498401|NCT00571519|531977286|FG005|Overall Study|Subject withdrew consent|1|||
147498402|NCT00571519|531977287|FG006|Overall Study|Subject withdrew consent|2|||
147498403|NCT00571519|531977281|FG000|Overall Study|Hyperglycemia meeting discontinuation criteria|1|||
147498404|NCT00571519|531977282|FG001|Overall Study|Hyperglycemia meeting discontinuation criteria|0|||
147498405|NCT00571519|531977283|FG002|Overall Study|Hyperglycemia meeting discontinuation criteria|1|||
147498406|NCT00571519|531977284|FG003|Overall Study|Hyperglycemia meeting discontinuation criteria|1|||
147498407|NCT00571519|531977285|FG004|Overall Study|Hyperglycemia meeting discontinuation criteria|0|||
147498408|NCT00571519|531977286|FG005|Overall Study|Hyperglycemia meeting discontinuation criteria|0|||
147498409|NCT00571519|531977287|FG006|Overall Study|Hyperglycemia meeting discontinuation criteria|0|||
147498410|NCT00571519|531977281|FG000|Overall Study|Therapeutic failure/lack of efficacy|0|||
147498411|NCT00571519|531977282|FG001|Overall Study|Therapeutic failure/lack of efficacy|1|||
147498412|NCT00571519|531977283|FG002|Overall Study|Therapeutic failure/lack of efficacy|0|||
147668535|NCT02003144|532611826|FG001|Open Label Maintenance Phase|Physician Decision|1|||
147498413|NCT00571519|531977284|FG003|Overall Study|Therapeutic failure/lack of efficacy|0|||
147498414|NCT00571519|531977285|FG004|Overall Study|Therapeutic failure/lack of efficacy|0|||
147498415|NCT00571519|531977286|FG005|Overall Study|Therapeutic failure/lack of efficacy|0|||
147498416|NCT00571519|531977287|FG006|Overall Study|Therapeutic failure/lack of efficacy|0|||
147498417|NCT00571519|531977281|FG000|Overall Study|Termination of study by Sponsor|2|||
147498418|NCT00571519|531977282|FG001|Overall Study|Termination of study by Sponsor|7|||
147498419|NCT00571519|531977283|FG002|Overall Study|Termination of study by Sponsor|10|||
147498420|NCT00571519|531977284|FG003|Overall Study|Termination of study by Sponsor|24|||
147498421|NCT00571519|531977285|FG004|Overall Study|Termination of study by Sponsor|8|||
147498422|NCT00571519|531977286|FG005|Overall Study|Termination of study by Sponsor|9|||
147498423|NCT00571519|531977287|FG006|Overall Study|Termination of study by Sponsor|22|||
147498424|NCT00571519|531977281|FG000|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
147498425|NCT00571519|531977282|FG001|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
147498426|NCT00571519|531977283|FG002|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|1|||
147498427|NCT00571519|531977284|FG003|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
147498428|NCT00571519|531977285|FG004|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
147498429|NCT00571519|531977286|FG005|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
147498430|NCT00571519|531977287|FG006|Overall Study|Per medical monitor regarding thyroid-stimulating hormone level|0|||
147498431|NCT02475850|531977288|FG000|Overall Study|Death|155|||
147498432|NCT02475850|531977289|FG001|Overall Study|Death|141|||
147498433|NCT02475850|531977288|FG000|Overall Study|Lost to Follow-up|217|||
147498434|NCT02475850|531977289|FG001|Overall Study|Lost to Follow-up|188|||
147498435|NCT02475850|531977288|FG000|Overall Study|Withdrawal by Subject|221|||
147498436|NCT02475850|531977289|FG001|Overall Study|Withdrawal by Subject|155|||
147498437|NCT03434418|531977290|FG000|Overall Study|Disease Progression|11|||
147498438|NCT03434418|531977290|FG000|Overall Study|Adverse Event|2|||
147498439|NCT03434418|531977290|FG000|Overall Study|Physician Decision|1|||
147498440|NCT03434418|531977290|FG000|Overall Study|Decline in Performance Status (PS)|1|||
147498441|NCT00696436|531977291|FG000|Overall Study|Adverse Event|7|||
147498442|NCT00696436|531977292|FG001|Overall Study|Adverse Event|9|||
147498443|NCT00696436|531977293|FG002|Overall Study|Adverse Event|8|||
147498444|NCT00696436|531977294|FG003|Overall Study|Adverse Event|6|||
147498445|NCT00696436|531977295|FG004|Overall Study|Adverse Event|4|||
147498446|NCT00696436|531977291|FG000|Overall Study|Protocol Violation|3|||
147498447|NCT00696436|531977292|FG001|Overall Study|Protocol Violation|2|||
147498448|NCT00696436|531977293|FG002|Overall Study|Protocol Violation|2|||
147498449|NCT00696436|531977294|FG003|Overall Study|Protocol Violation|0|||
147498450|NCT00696436|531977295|FG004|Overall Study|Protocol Violation|1|||
147498451|NCT00696436|531977291|FG000|Overall Study|Lost to Follow-up|1|||
147498452|NCT00696436|531977292|FG001|Overall Study|Lost to Follow-up|6|||
147498453|NCT00696436|531977293|FG002|Overall Study|Lost to Follow-up|2|||
147498454|NCT00696436|531977294|FG003|Overall Study|Lost to Follow-up|4|||
147498455|NCT00696436|531977295|FG004|Overall Study|Lost to Follow-up|3|||
147498456|NCT00696436|531977291|FG000|Overall Study|Withdrawal by Subject|4|||
147498457|NCT00696436|531977292|FG001|Overall Study|Withdrawal by Subject|11|||
147498458|NCT00696436|531977293|FG002|Overall Study|Withdrawal by Subject|5|||
147498459|NCT00696436|531977294|FG003|Overall Study|Withdrawal by Subject|7|||
147498460|NCT00696436|531977295|FG004|Overall Study|Withdrawal by Subject|1|||
147498461|NCT00696436|531977291|FG000|Overall Study|Lack of Efficacy|3|||
147498462|NCT00696436|531977292|FG001|Overall Study|Lack of Efficacy|1|||
147498463|NCT00696436|531977293|FG002|Overall Study|Lack of Efficacy|5|||
147498464|NCT00696436|531977294|FG003|Overall Study|Lack of Efficacy|2|||
147498465|NCT00696436|531977295|FG004|Overall Study|Lack of Efficacy|4|||
147498466|NCT00696436|531977291|FG000|Overall Study|Participant Unavailability|2|||
147498467|NCT00696436|531977292|FG001|Overall Study|Participant Unavailability|0|||
147498468|NCT00696436|531977293|FG002|Overall Study|Participant Unavailability|2|||
147498469|NCT00696436|531977294|FG003|Overall Study|Participant Unavailability|1|||
147498470|NCT00696436|531977295|FG004|Overall Study|Participant Unavailability|0|||
147498471|NCT00696436|531977291|FG000|Overall Study|Administrative Error|2|||
147498472|NCT00696436|531977292|FG001|Overall Study|Administrative Error|0|||
147498473|NCT00696436|531977293|FG002|Overall Study|Administrative Error|2|||
147632416|NCT01598090|532472421|FG002|Follow-up Period|Not reported|4|||
147632417|NCT01598090|532472419|FG000|Follow-up Period|Withdrawal by Subject|0|||
147632418|NCT01598090|532472420|FG001|Follow-up Period|Withdrawal by Subject|3|||
147632419|NCT01598090|532472421|FG002|Follow-up Period|Withdrawal by Subject|2|||
147632420|NCT01598090|532472419|FG000|Follow-up Period|Other reasons|2|||
147632421|NCT01598090|532472420|FG001|Follow-up Period|Other reasons|8|||
147632422|NCT01598090|532472421|FG002|Follow-up Period|Other reasons|8|||
147498474|NCT00696436|531977294|FG003|Overall Study|Administrative Error|0|||
147498475|NCT00696436|531977295|FG004|Overall Study|Administrative Error|0|||
147498476|NCT00696436|531977291|FG000|Overall Study|Participant Non-compliance|0|||
147498477|NCT00696436|531977292|FG001|Overall Study|Participant Non-compliance|0|||
147498478|NCT00696436|531977293|FG002|Overall Study|Participant Non-compliance|1|||
147498479|NCT00696436|531977294|FG003|Overall Study|Participant Non-compliance|2|||
147498480|NCT00696436|531977295|FG004|Overall Study|Participant Non-compliance|0|||
147498481|NCT00696436|531977291|FG000|Overall Study|Administrative Decision|1|||
147498482|NCT00696436|531977292|FG001|Overall Study|Administrative Decision|0|||
147498483|NCT00696436|531977293|FG002|Overall Study|Administrative Decision|0|||
147632423|NCT01598090|532472419|FG000|Follow-up Period|Lost to Follow-up|2|||
147498484|NCT00696436|531977294|FG003|Overall Study|Administrative Decision|0|||
147498485|NCT00696436|531977295|FG004|Overall Study|Administrative Decision|0|||
147498486|NCT00696436|531977291|FG000|Overall Study|Missing|0|||
147498487|NCT00696436|531977292|FG001|Overall Study|Missing|1|||
147498488|NCT00696436|531977293|FG002|Overall Study|Missing|1|||
147498489|NCT00696436|531977294|FG003|Overall Study|Missing|0|||
147498490|NCT00696436|531977295|FG004|Overall Study|Missing|0|||
147498491|NCT01517412|531977298|FG000|Overall Study|Adverse Event|10|||
147498492|NCT01517412|531977299|FG001|Overall Study|Adverse Event|11|||
147498493|NCT01517412|531977298|FG000|Overall Study|Lack of Efficacy|10|||
147498494|NCT01517412|531977299|FG001|Overall Study|Lack of Efficacy|5|||
147498495|NCT01517412|531977298|FG000|Overall Study|Poor compliance to protocol|8|||
147498496|NCT01517412|531977299|FG001|Overall Study|Poor compliance to protocol|3|||
147498497|NCT01517412|531977298|FG000|Overall Study|Other than specified above|8|||
147498498|NCT01517412|531977299|FG001|Overall Study|Other than specified above|5|||
147498499|NCT02716194|531977303|FG000|Period 1 - ADVATE|Withdrawal by Subject|1|||
147498500|NCT02716194|531977304|FG001|Period 1 - ADVATE|Withdrawal by Subject|1|||
147498501|NCT02716194|531977305|FG002|Period 1 - ADVATE|Withdrawal by Subject|0|||
147498502|NCT00363051|531977306|FG000|Overall Study|Adminstrative problems|1|||
147498503|NCT00363051|531977307|FG001|Overall Study|Adminstrative problems|1|||
147498504|NCT00363051|531977306|FG000|Overall Study|Adverse Event|21|||
147498505|NCT00363051|531977307|FG001|Overall Study|Adverse Event|12|||
147498506|NCT00363051|531977306|FG000|Overall Study|New Cancer Therapy|2|||
147498507|NCT00363051|531977307|FG001|Overall Study|New Cancer Therapy|1|||
147498508|NCT00363051|531977306|FG000|Overall Study|Withdrawal by Subject|11|||
147498509|NCT00363051|531977307|FG001|Overall Study|Withdrawal by Subject|3|||
147498510|NCT00363051|531977306|FG000|Overall Study|Lost to Follow-up|0|||
147498511|NCT00363051|531977307|FG001|Overall Study|Lost to Follow-up|1|||
147498512|NCT00363051|531977306|FG000|Overall Study|Protocol Violation|0|||
147498513|NCT00363051|531977307|FG001|Overall Study|Protocol Violation|2|||
147498514|NCT00363051|531977306|FG000|Overall Study|Death|3|||
147498515|NCT00363051|531977307|FG001|Overall Study|Death|2|||
147498516|NCT01610076|531977317|FG000|Overall Study|Technical issue with video|0|||
147498517|NCT01610076|531977318|FG001|Overall Study|Technical issue with video|1|||
147498518|NCT01610076|531977317|FG000|Overall Study|Lost to Follow-up|3|||
147498519|NCT01610076|531977318|FG001|Overall Study|Lost to Follow-up|4|||
147498520|NCT01895452|531977322|FG000|Overall Study|Adverse Event|1|||
147498521|NCT01895452|531977323|FG001|Overall Study|Adverse Event|4|||
147498522|NCT01895452|531977322|FG000|Overall Study|Lost to Follow-up|1|||
147498523|NCT01895452|531977323|FG001|Overall Study|Lost to Follow-up|5|||
147498524|NCT01895452|531977322|FG000|Overall Study|Pregnancy|0|||
147498525|NCT01895452|531977323|FG001|Overall Study|Pregnancy|1|||
147498526|NCT01895452|531977322|FG000|Overall Study|Withdrawal by Subject|2|||
147498527|NCT01895452|531977323|FG001|Overall Study|Withdrawal by Subject|14|||
147498528|NCT01895452|531977322|FG000|Overall Study|Underlying disease|0|||
147498529|NCT01895452|531977323|FG001|Overall Study|Underlying disease|3|||
147498530|NCT01895452|531977322|FG000|Overall Study|Noncompliance with study drug|0|||
147498531|NCT01895452|531977323|FG001|Overall Study|Noncompliance with study drug|1|||
147498532|NCT01653158|531977324|FG000|Overall Study|Death|0|||
147498533|NCT01653158|531977325|FG001|Overall Study|Death|0|||
147498534|NCT01653158|531977326|FG002|Overall Study|Death|0|||
147498535|NCT01653158|531977327|FG003|Overall Study|Death|1|||
147498536|NCT01653158|531977328|FG004|Overall Study|Death|0|||
147498537|NCT01653158|531977329|FG005|Overall Study|Death|0|||
147498538|NCT01653158|531977330|FG006|Overall Study|Death|0|||
147498539|NCT01653158|531977331|FG007|Overall Study|Death|2|||
147498540|NCT01653158|531977324|FG000|Overall Study|Adverse Event|0|||
147498541|NCT01653158|531977325|FG001|Overall Study|Adverse Event|0|||
147498542|NCT01653158|531977326|FG002|Overall Study|Adverse Event|0|||
147498543|NCT01653158|531977327|FG003|Overall Study|Adverse Event|1|||
147498544|NCT01653158|531977328|FG004|Overall Study|Adverse Event|0|||
147498545|NCT01653158|531977329|FG005|Overall Study|Adverse Event|0|||
147498546|NCT01653158|531977330|FG006|Overall Study|Adverse Event|0|||
147498547|NCT01653158|531977331|FG007|Overall Study|Adverse Event|3|||
147498548|NCT01653158|531977324|FG000|Overall Study|Other|0|||
147498549|NCT01653158|531977325|FG001|Overall Study|Other|0|||
147498550|NCT01653158|531977326|FG002|Overall Study|Other|0|||
147498551|NCT01653158|531977327|FG003|Overall Study|Other|0|||
147498552|NCT01653158|531977328|FG004|Overall Study|Other|0|||
147498553|NCT01653158|531977329|FG005|Overall Study|Other|0|||
147498554|NCT01653158|531977330|FG006|Overall Study|Other|0|||
147498555|NCT01653158|531977331|FG007|Overall Study|Other|1|||
147498556|NCT01653158|531977324|FG000|Overall Study|Progressive disease|0|||
147632424|NCT01598090|532472420|FG001|Follow-up Period|Lost to Follow-up|10|||
147498557|NCT01653158|531977325|FG001|Overall Study|Progressive disease|0|||
147498558|NCT01653158|531977326|FG002|Overall Study|Progressive disease|0|||
147498559|NCT01653158|531977327|FG003|Overall Study|Progressive disease|0|||
147498560|NCT01653158|531977328|FG004|Overall Study|Progressive disease|1|||
147498561|NCT01653158|531977329|FG005|Overall Study|Progressive disease|1|||
147498562|NCT01653158|531977330|FG006|Overall Study|Progressive disease|2|||
147498563|NCT01653158|531977331|FG007|Overall Study|Progressive disease|9|||
147498564|NCT01653158|531977324|FG000|Overall Study|Withdrawal by Subject|1|||
147498565|NCT01653158|531977325|FG001|Overall Study|Withdrawal by Subject|0|||
147498566|NCT01653158|531977326|FG002|Overall Study|Withdrawal by Subject|0|||
147498567|NCT01653158|531977327|FG003|Overall Study|Withdrawal by Subject|0|||
147498568|NCT01653158|531977328|FG004|Overall Study|Withdrawal by Subject|0|||
147498569|NCT01653158|531977329|FG005|Overall Study|Withdrawal by Subject|0|||
147498570|NCT01653158|531977330|FG006|Overall Study|Withdrawal by Subject|0|||
147498571|NCT01653158|531977331|FG007|Overall Study|Withdrawal by Subject|0|||
147498572|NCT00980343|531977332|FG000|Overall Study|no tumor at surgery - treatment effect|1|||
147498573|NCT00980343|531977333|FG001|Overall Study|no tumor at surgery - treatment effect|3|||
147498574|NCT01231607|531977342|FG000|Overall Study|Adverse Event|0|||
147498575|NCT01231607|531977343|FG001|Overall Study|Adverse Event|8|||
147498576|NCT01231607|531977344|FG002|Overall Study|Adverse Event|4|||
147498577|NCT01231607|531977345|FG003|Overall Study|Adverse Event|4|||
147498578|NCT01231607|531977346|FG004|Overall Study|Adverse Event|5|||
147498579|NCT01231607|531977342|FG000|Overall Study|Lost to Follow-up|13|||
147498580|NCT01231607|531977343|FG001|Overall Study|Lost to Follow-up|11|||
147498581|NCT01231607|531977344|FG002|Overall Study|Lost to Follow-up|10|||
147498582|NCT01231607|531977345|FG003|Overall Study|Lost to Follow-up|10|||
147498583|NCT01231607|531977346|FG004|Overall Study|Lost to Follow-up|4|||
147498584|NCT01231607|531977342|FG000|Overall Study|Physician Decision|4|||
147498585|NCT01231607|531977343|FG001|Overall Study|Physician Decision|4|||
147498586|NCT01231607|531977344|FG002|Overall Study|Physician Decision|3|||
147498587|NCT01231607|531977345|FG003|Overall Study|Physician Decision|5|||
147498588|NCT01231607|531977346|FG004|Overall Study|Physician Decision|4|||
147498589|NCT01231607|531977342|FG000|Overall Study|Protocol Violation|3|||
147498590|NCT01231607|531977343|FG001|Overall Study|Protocol Violation|2|||
147498591|NCT01231607|531977344|FG002|Overall Study|Protocol Violation|0|||
147498592|NCT01231607|531977345|FG003|Overall Study|Protocol Violation|2|||
147498593|NCT01231607|531977346|FG004|Overall Study|Protocol Violation|2|||
147498594|NCT01231607|531977342|FG000|Overall Study|Withdrawal by Subject|9|||
147498595|NCT01231607|531977343|FG001|Overall Study|Withdrawal by Subject|9|||
147498596|NCT01231607|531977344|FG002|Overall Study|Withdrawal by Subject|14|||
147498597|NCT01231607|531977345|FG003|Overall Study|Withdrawal by Subject|17|||
147498598|NCT01231607|531977346|FG004|Overall Study|Withdrawal by Subject|9|||
147498599|NCT01677507|531977347|FG000|Initial Assignment|Adverse Event|0|||
147498600|NCT01677507|531977348|FG001|Initial Assignment|Adverse Event|1|||
147498601|NCT01677507|531977347|FG000|Initial Assignment|Protocol Violation|0|||
147498602|NCT01677507|531977348|FG001|Initial Assignment|Protocol Violation|1|||
147498603|NCT01677507|531977347|FG000|Second Assigment|Withdrawal by Subject|2|||
147498604|NCT01677507|531977348|FG001|Second Assigment|Withdrawal by Subject|2|||
147498605|NCT01677507|531977347|FG000|Second Assigment|Adverse Event|1|||
147498606|NCT01677507|531977348|FG001|Second Assigment|Adverse Event|3|||
147498607|NCT01840228|531977359|FG000|Overall Study|Lost to Follow-up|1|||
147498608|NCT01840228|531977360|FG001|Overall Study|Lost to Follow-up|1|||
147498609|NCT01103778|531977365|FG000|Overall Study|Lost to Follow-up|1|||
147498610|NCT01103778|531977365|FG000|Overall Study|Proteinuria improved prior to enrollment|1|||
147498611|NCT01103778|531977365|FG000|Overall Study|Screen failure|1|||
147498612|NCT01658579|531977366|FG000|Treatment Period A|Other|0|||
147498613|NCT01658579|531977367|FG001|Treatment Period A|Other|0|||
147498614|NCT01658579|531977368|FG002|Treatment Period A|Other|1|||
147498615|NCT01658579|531977369|FG003|Treatment Period A|Other|1|||
147498616|NCT01658579|531977366|FG000|Treatment Period A|Adverse Event|1|||
147498617|NCT01658579|531977367|FG001|Treatment Period A|Adverse Event|0|||
147498618|NCT01658579|531977368|FG002|Treatment Period A|Adverse Event|0|||
147498619|NCT01658579|531977369|FG003|Treatment Period A|Adverse Event|0|||
147498620|NCT01658579|531977366|FG000|Treatment Period B|Other|0|||
147498621|NCT01658579|531977367|FG001|Treatment Period B|Other|0|||
147498622|NCT01658579|531977368|FG002|Treatment Period B|Other|0|||
147498623|NCT01658579|531977369|FG003|Treatment Period B|Other|1|||
147498624|NCT04580394|531977370|FG000|First Intervention|Incorrectly Randomized|1|||
147498625|NCT04580394|531977370|FG000|First Intervention|Physician Decision|1|||
147498626|NCT04580394|531977370|FG000|First Intervention|Lost to Follow-up|1|||
147498627|NCT04580394|531977370|FG000|Washout (One Week)|Withdrawal by Subject|1|||
147498628|NCT04580394|531977370|FG000|Washout (One Week)|Adverse Event|1|||
147498629|NCT04580394|531977370|FG000|Washout (One Week)|Withdrawal by Subject|2|||
147498630|NCT04580394|531977370|FG000|Third Intervention|Adverse Event|1|||
147498631|NCT04580394|531977370|FG000|Third Intervention|Withdrawal by Subject|1|||
147498632|NCT04580394|531977370|FG000|Washout (One Week)|Withdrawal by Subject|2|||
147498633|NCT01464788|531977371|FG000|Overall Study|Lost to Follow-up|0|||
147498634|NCT01464788|531977372|FG001|Overall Study|Lost to Follow-up|1|||
147498635|NCT01464788|531977373|FG002|Overall Study|Lost to Follow-up|0|||
147498636|NCT01464788|531977371|FG000|Overall Study|Patient had hemorrhage after tPA started|0|||
147498637|NCT01464788|531977372|FG001|Overall Study|Patient had hemorrhage after tPA started|1|||
147498638|NCT01464788|531977373|FG002|Overall Study|Patient had hemorrhage after tPA started|0|||
147498639|NCT04397718|531977376|FG000|Overall Study|Death|7|||
147498640|NCT04397718|531977377|FG001|Overall Study|Death|11|||
147498641|NCT04397718|531977376|FG000|Overall Study|Lost to Follow-up|0|||
147498642|NCT04397718|531977377|FG001|Overall Study|Lost to Follow-up|4|||
147498643|NCT01153893|531977378|FG000|Overall Study|Adverse Event|1|||
147498644|NCT01153893|531977379|FG001|Overall Study|Adverse Event|0|||
147498645|NCT01551758|531977384|FG000|Overall Study|Adverse Event|29|||
147498646|NCT01551758|531977385|FG001|Overall Study|Adverse Event|43|||
147498647|NCT01551758|531977384|FG000|Overall Study|Lack of Efficacy|0|||
147498648|NCT01551758|531977385|FG001|Overall Study|Lack of Efficacy|1|||
147498649|NCT01551758|531977384|FG000|Overall Study|Protocol Violation|5|||
147498650|NCT01551758|531977385|FG001|Overall Study|Protocol Violation|6|||
147498651|NCT01551758|531977384|FG000|Overall Study|Met Protocol-defined stopping criteria|8|||
147498652|NCT01551758|531977385|FG001|Overall Study|Met Protocol-defined stopping criteria|10|||
147498653|NCT01551758|531977384|FG000|Overall Study|Lost to Follow-up|29|||
147498654|NCT01551758|531977385|FG001|Overall Study|Lost to Follow-up|25|||
147498655|NCT01551758|531977384|FG000|Overall Study|Physician Decision|9|||
147498656|NCT01551758|531977385|FG001|Overall Study|Physician Decision|3|||
147498657|NCT01551758|531977384|FG000|Overall Study|Withdrawal by Subject|14|||
147498658|NCT01551758|531977385|FG001|Overall Study|Withdrawal by Subject|17|||
147498659|NCT02128763|531977386|FG000|Overall Study|Death|1|||
147498660|NCT02128763|531977387|FG001|Overall Study|Death|0|||
147498661|NCT02128763|531977386|FG000|Overall Study|Lost to Follow-up|19|||
147498662|NCT02128763|531977387|FG001|Overall Study|Lost to Follow-up|16|||
147498663|NCT03666858|531977388|FG000|Cohort 1|Adverse Event|1|||
147498664|NCT03666858|531977389|FG001|Cohort 1|Adverse Event|0|||
147498665|NCT03666858|531977388|FG000|Cohort 2|Adverse Event|0|||
147498666|NCT03666858|531977389|FG001|Cohort 2|Adverse Event|1|||
147498667|NCT00121992|531977390|FG000|Overall Study|Treatment not received|2|||
147498668|NCT00121992|531977391|FG001|Overall Study|Treatment not received|11|||
147498669|NCT00363246|531977392|FG000|Overall Study|Death|40|||
147498670|NCT00363246|531977392|FG000|Overall Study|Withdrawal by Subject|19|||
147498671|NCT00363246|531977392|FG000|Overall Study|Lost to Follow-up|14|||
147498672|NCT00363246|531977392|FG000|Overall Study|Bad health|6|||
147498673|NCT00363246|531977392|FG000|Overall Study|Stopped using wheelchair|11|||
147498674|NCT00363246|531977392|FG000|Overall Study|Subject expressed security concerns|2|||
147632425|NCT01598090|532472421|FG002|Follow-up Period|Lost to Follow-up|12|||
147632426|NCT01377922|532472424|FG000|Overall Study|rescue tx after part 2, entered part 4|1|||
147632427|NCT01377922|532472425|FG001|Overall Study|rescue tx after part 2, entered part 4|0|||
147632428|NCT02858583|532472426|FG000|Overall Study|Declined consent|1|||
147632429|NCT02858583|532472427|FG001|Overall Study|Declined consent|1|||
147632430|NCT04615403|532472431|FG000|Overall Study|Death|1|||
147632431|NCT03170362|532472432|FG000|Overall Study|Death|2|||
147632432|NCT03170362|532472433|FG001|Overall Study|Death|2|||
147632433|NCT03170362|532472432|FG000|Overall Study|Withdrawal by Subject|23|||
147632434|NCT03170362|532472433|FG001|Overall Study|Withdrawal by Subject|22|||
147632435|NCT03170362|532472432|FG000|Overall Study|Lost to Follow-up|187|||
147632436|NCT03170362|532472433|FG001|Overall Study|Lost to Follow-up|167|||
147632437|NCT01972438|532472436|FG000|Baseline-Month 3 Crossover Period|Death|1|||
147632438|NCT01972438|532472437|FG001|Baseline-Month 3 Crossover Period|Death|0|||
147632439|NCT01972438|532472436|FG000|Baseline-Month 3 Crossover Period|Did not meet inclusion criteria|1|||
147632440|NCT01972438|532472437|FG001|Baseline-Month 3 Crossover Period|Did not meet inclusion criteria|0|||
147632441|NCT01972438|532472436|FG000|Baseline-Month 3 Crossover Period|Unable to donate blood|0|||
147632442|NCT01972438|532472437|FG001|Baseline-Month 3 Crossover Period|Unable to donate blood|1|||
147632443|NCT01972438|532472436|FG000|Baseline-Month 3 Crossover Period|Scheduling difficulties (Missed Month 3)|1|||
147632444|NCT01972438|532472437|FG001|Baseline-Month 3 Crossover Period|Scheduling difficulties (Missed Month 3)|2|||
147632445|NCT01972438|532472436|FG000|Months 3-6 Crossover Period|Early Study Closure|0|||
147632446|NCT01972438|532472437|FG001|Months 3-6 Crossover Period|Early Study Closure|1|||
147632447|NCT01972438|532472436|FG000|Months 6-12 Study Period|Death|1|||
147668536|NCT02003144|532611825|FG000|Open Label Maintenance Phase|Lost to Follow-up|0|||
147668537|NCT02003144|532611826|FG001|Open Label Maintenance Phase|Lost to Follow-up|1|||
147498675|NCT00363246|531977392|FG000|Overall Study|Eligibility changed due to Hospice move|5|||
147498676|NCT01608724|531977393|FG000|Overall Study|Withdrawal by Subject|131|||
147498677|NCT01608724|531977393|FG000|Overall Study|Lost to Follow-up|41|||
147498678|NCT01608724|531977393|FG000|Overall Study|Study-specific discontinuation criteria|32|||
147498679|NCT01608724|531977393|FG000|Overall Study|Adverse Event|29|||
147498680|NCT01608724|531977393|FG000|Overall Study|Protocol Violation|6|||
147632448|NCT01972438|532472437|FG001|Months 6-12 Study Period|Death|0|||
147632449|NCT01972438|532472436|FG000|Months 6-12 Study Period|Early Study Closure|2|||
147632450|NCT01972438|532472437|FG001|Months 6-12 Study Period|Early Study Closure|2|||
147632451|NCT01972438|532472436|FG000|Post Month 12 Study Period|Early Study Closure|3|||
147668538|NCT02003144|532611825|FG000|Open Label Maintenance Phase|Adverse Event|2|||
147498681|NCT01608724|531977393|FG000|Overall Study|bood sugar too high, etc.|3|||
147498682|NCT01608724|531977393|FG000|Overall Study|Safety reasons|1|||
147498683|NCT03722784|531977396|FG000|Overall Study|Withdrawal by Subject|1|||
147498684|NCT03722784|531977397|FG001|Overall Study|Withdrawal by Subject|0|||
147498685|NCT03722784|531977396|FG000|Overall Study|Physician Decision|1|||
147498686|NCT03722784|531977397|FG001|Overall Study|Physician Decision|1|||
147498687|NCT03722784|531977396|FG000|Overall Study|Protocol Violation|0|||
147498688|NCT03722784|531977397|FG001|Overall Study|Protocol Violation|1|||
147498689|NCT00910429|531977400|FG000|Overall Study|Death|18|||
147498690|NCT00910429|531977401|FG001|Overall Study|Death|12|||
147498691|NCT00910429|531977400|FG000|Overall Study|Withdrawal by Subject|3|||
147498692|NCT00910429|531977401|FG001|Overall Study|Withdrawal by Subject|2|||
147498693|NCT00910429|531977400|FG000|Overall Study|Protocol Violation|1|||
147498694|NCT00910429|531977401|FG001|Overall Study|Protocol Violation|0|||
147498695|NCT00910429|531977400|FG000|Overall Study|Lost to Follow-up|2|||
147668539|NCT02003144|532611826|FG001|Open Label Maintenance Phase|Adverse Event|1|||
147498696|NCT00910429|531977401|FG001|Overall Study|Lost to Follow-up|1|||
147498697|NCT00910429|531977400|FG000|Overall Study|Adverse Event|10|||
147498698|NCT00910429|531977401|FG001|Overall Study|Adverse Event|5|||
147498699|NCT00910429|531977400|FG000|Overall Study|Drug non-compliance|1|||
147498700|NCT00910429|531977401|FG001|Overall Study|Drug non-compliance|0|||
147498701|NCT00910429|531977400|FG000|Overall Study|Lack of Efficacy|4|||
147498702|NCT00910429|531977401|FG001|Overall Study|Lack of Efficacy|1|||
147498703|NCT01317615|531977402|FG000|Overall Study|Disease progression|25|||
147498704|NCT01317615|531977402|FG000|Overall Study|New cancer therapy|5|||
147498705|NCT01317615|531977402|FG000|Overall Study|Death|6|||
147498706|NCT01317615|531977402|FG000|Overall Study|Withdrawal by Subject|5|||
147498707|NCT01317615|531977402|FG000|Overall Study|Abnormal laboratory value(s)|1|||
147498708|NCT01317615|531977402|FG000|Overall Study|Adverse Event|7|||
147498709|NCT04465396|531977405|FG000|Treatment Period 2 (Day 1)|Lost to Follow-up|0|||
147498710|NCT04465396|531977406|FG001|Treatment Period 2 (Day 1)|Lost to Follow-up|1|||
147498711|NCT04465396|531977407|FG002|Treatment Period 2 (Day 1)|Lost to Follow-up|1|||
147498712|NCT04465396|531977408|FG003|Treatment Period 2 (Day 1)|Lost to Follow-up|0|||
147498713|NCT03730194|531977409|FG000|First Stage Treatment|Withdrawal by Subject|1|||
147498714|NCT03730194|531977410|FG001|First Stage Treatment|Withdrawal by Subject|1|||
147498715|NCT03730194|531977411|FG002|First Stage Treatment|Withdrawal by Subject|0|||
147498716|NCT03730194|531977412|FG003|First Stage Treatment|Withdrawal by Subject|0|||
147498717|NCT03730194|531977413|FG004|First Stage Treatment|Withdrawal by Subject|0|||
147498718|NCT03730194|531977414|FG005|First Stage Treatment|Withdrawal by Subject|0|||
147498719|NCT03730194|531977409|FG000|First Stage Treatment|Protocol Violation|3|||
147498720|NCT03730194|531977410|FG001|First Stage Treatment|Protocol Violation|3|||
147498721|NCT03730194|531977411|FG002|First Stage Treatment|Protocol Violation|0|||
147498722|NCT03730194|531977412|FG003|First Stage Treatment|Protocol Violation|0|||
147668540|NCT01296412|532611831|FG000|Overall Study|Adverse Event|8|||
147668541|NCT01296412|532611832|FG001|Overall Study|Adverse Event|29|||
147668542|NCT01296412|532611831|FG000|Overall Study|Lack of Efficacy|1|||
147668543|NCT01296412|532611832|FG001|Overall Study|Lack of Efficacy|0|||
147668544|NCT01296412|532611831|FG000|Overall Study|Lost to Follow-up|10|||
147668545|NCT01296412|532611832|FG001|Overall Study|Lost to Follow-up|7|||
147498723|NCT03730194|531977413|FG004|First Stage Treatment|Protocol Violation|0|||
147498724|NCT03730194|531977414|FG005|First Stage Treatment|Protocol Violation|0|||
147498725|NCT01255306|531979951|FG000|Overall Study|Physician Decision|1|||
147498726|NCT01255306|531979952|FG001|Overall Study|Physician Decision|1|||
147498727|NCT01179347|531979953|FG000|Double-blind Period (12 Weeks)|Adverse Event|2|||
147498728|NCT01179347|531979954|FG001|Double-blind Period (12 Weeks)|Adverse Event|6|||
147498729|NCT01179347|531979953|FG000|Double-blind Period (12 Weeks)|Protocol Violation|2|||
147498730|NCT01179347|531979954|FG001|Double-blind Period (12 Weeks)|Protocol Violation|0|||
147498731|NCT01179347|531979953|FG000|Double-blind Period (12 Weeks)|Lost to Follow-up|1|||
147632452|NCT01972438|532472437|FG001|Post Month 12 Study Period|Early Study Closure|4|||
147632453|NCT02157376|532472443|FG000|Overall Study|Death|10|||
147632454|NCT02157376|532472444|FG001|Overall Study|Death|4|||
147632455|NCT02157376|532472443|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
147632456|NCT02157376|532472444|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
147632457|NCT02157376|532472443|FG000|Overall Study|Withdrawal by Subject|3|||
147632458|NCT02157376|532472444|FG001|Overall Study|Withdrawal by Subject|8|||
147498732|NCT01179347|531979954|FG001|Double-blind Period (12 Weeks)|Lost to Follow-up|2|||
147498733|NCT01179347|531979953|FG000|Double-blind Period (12 Weeks)|Withdrawal by Subject|1|||
147498734|NCT01179347|531979954|FG001|Double-blind Period (12 Weeks)|Withdrawal by Subject|2|||
147498735|NCT01179347|531979953|FG000|Double-blind Period (12 Weeks)|Other|2|||
147498736|NCT01179347|531979954|FG001|Double-blind Period (12 Weeks)|Other|4|||
147498737|NCT01179347|531979953|FG000|Open-label Period (12 Weeks)|Adverse Event|5|||
147498738|NCT01179347|531979954|FG001|Open-label Period (12 Weeks)|Adverse Event|9|||
147498739|NCT01179347|531979953|FG000|Open-label Period (12 Weeks)|Lack of Efficacy|0|||
147498740|NCT01179347|531979954|FG001|Open-label Period (12 Weeks)|Lack of Efficacy|2|||
147498741|NCT01179347|531979953|FG000|Open-label Period (12 Weeks)|Lost to Follow-up|1|||
147498742|NCT01179347|531979954|FG001|Open-label Period (12 Weeks)|Lost to Follow-up|0|||
147632459|NCT02157376|532472443|FG000|Overall Study|Not treated|8|||
147632460|NCT02157376|532472444|FG001|Overall Study|Not treated|3|||
147632461|NCT02157376|532472443|FG000|Overall Study|Investigator's misjudgement|1|||
147632462|NCT02157376|532472444|FG001|Overall Study|Investigator's misjudgement|2|||
147632463|NCT01052480|532472445|FG000|Overall Study|Lost to Follow-up|3|||
147632464|NCT01052480|532472446|FG001|Overall Study|Lost to Follow-up|3|||
147668546|NCT01296412|532611831|FG000|Overall Study|Non-compliance with study drug|1|||
147498743|NCT01179347|531979953|FG000|Open-label Period (12 Weeks)|Withdrawal by Subject|1|||
147498744|NCT01179347|531979954|FG001|Open-label Period (12 Weeks)|Withdrawal by Subject|1|||
147498745|NCT01179347|531979953|FG000|Open-label Period (12 Weeks)|Protocol Violation|1|||
147498746|NCT01179347|531979954|FG001|Open-label Period (12 Weeks)|Protocol Violation|0|||
147498747|NCT01179347|531979953|FG000|Open-label Period (12 Weeks)|Other|7|||
147498748|NCT01179347|531979954|FG001|Open-label Period (12 Weeks)|Other|4|||
147498749|NCT01337167|531979961|FG000|Infant Series|Adverse Event|1|||
147498750|NCT01337167|531979962|FG001|Infant Series|Adverse Event|1|||
147498751|NCT01337167|531979961|FG000|Infant Series|Death|1|||
147498752|NCT01337167|531979962|FG001|Infant Series|Death|1|||
147498753|NCT01337167|531979961|FG000|Infant Series|Lost to Follow-up|13|||
147498754|NCT01337167|531979962|FG001|Infant Series|Lost to Follow-up|7|||
147498755|NCT01337167|531979961|FG000|Infant Series|Non-compliance with study drug|2|||
147498756|NCT01337167|531979962|FG001|Infant Series|Non-compliance with study drug|1|||
147498757|NCT01337167|531979961|FG000|Infant Series|Physician Decision|3|||
147498758|NCT01337167|531979962|FG001|Infant Series|Physician Decision|1|||
147498759|NCT01337167|531979961|FG000|Infant Series|Protocol Violation|22|||
147498760|NCT01337167|531979962|FG001|Infant Series|Protocol Violation|9|||
147498761|NCT01337167|531979961|FG000|Infant Series|Withdrawal by Subject|15|||
147498762|NCT01337167|531979962|FG001|Infant Series|Withdrawal by Subject|4|||
147498763|NCT01337167|531979961|FG000|Infant Series|Randomized but not vaccinated|5|||
147498764|NCT01337167|531979962|FG001|Infant Series|Randomized but not vaccinated|3|||
147498765|NCT01337167|531979961|FG000|Interim Period|Lost to Follow-up|51|||
147498766|NCT01337167|531979962|FG001|Interim Period|Lost to Follow-up|23|||
147498767|NCT01337167|531979961|FG000|Interim Period|Non-compliance with study drug|1|||
147498768|NCT01337167|531979962|FG001|Interim Period|Non-compliance with study drug|0|||
147498769|NCT01337167|531979961|FG000|Interim Period|Physician Decision|6|||
147498770|NCT01337167|531979962|FG001|Interim Period|Physician Decision|3|||
147498771|NCT01337167|531979961|FG000|Interim Period|Protocol Violation|5|||
147498772|NCT01337167|531979962|FG001|Interim Period|Protocol Violation|3|||
147498773|NCT01337167|531979961|FG000|Interim Period|Withdrawal by Subject|18|||
147498774|NCT01337167|531979962|FG001|Interim Period|Withdrawal by Subject|10|||
147498775|NCT01337167|531979961|FG000|Interim Period|Other protocol criterion not met|0|||
147498776|NCT01337167|531979962|FG001|Interim Period|Other protocol criterion not met|1|||
147498777|NCT01337167|531979961|FG000|Toddler Vaccinations|Lost to Follow-up|11|||
147498778|NCT01337167|531979962|FG001|Toddler Vaccinations|Lost to Follow-up|12|||
147498779|NCT01337167|531979961|FG000|Toddler Vaccinations|Protocol Violation|0|||
147498780|NCT01337167|531979962|FG001|Toddler Vaccinations|Protocol Violation|1|||
147498781|NCT01337167|531979961|FG000|Toddler Vaccinations|Withdrawal by Subject|3|||
147498782|NCT01337167|531979962|FG001|Toddler Vaccinations|Withdrawal by Subject|0|||
147498783|NCT03833817|531979967|FG000|Overall Study|Withdrawal by Subject|3|||
147498784|NCT03833817|531979968|FG001|Overall Study|Withdrawal by Subject|3|||
147498785|NCT03833817|531979967|FG000|Overall Study|Lost to Follow-up|3|||
147498786|NCT03833817|531979968|FG001|Overall Study|Lost to Follow-up|3|||
147498787|NCT00884221|531979969|FG000|Overall Study|Withdrawal by Subject|0|||
147498788|NCT00884221|531979970|FG001|Overall Study|Withdrawal by Subject|3|||
147498789|NCT00884221|531979969|FG000|Overall Study|Adverse Event|6|||
147498790|NCT00884221|531979970|FG001|Overall Study|Adverse Event|3|||
147498791|NCT00884221|531979969|FG000|Overall Study|Protocol Violation|16|||
147498792|NCT00884221|531979970|FG001|Overall Study|Protocol Violation|13|||
147498793|NCT00884221|531979969|FG000|Overall Study|Cancellation of Cycle and Other Reason|12|||
147498794|NCT00884221|531979970|FG001|Overall Study|Cancellation of Cycle and Other Reason|13|||
147498795|NCT02126670|531979975|FG000|Overall Study|Withdrawal by Subject|1|||
147498796|NCT02126670|531979976|FG001|Overall Study|Withdrawal by Subject|0|||
147498797|NCT02126670|531979977|FG002|Overall Study|Withdrawal by Subject|0|||
147498798|NCT02126670|531979978|FG003|Overall Study|Withdrawal by Subject|1|||
147498799|NCT03363919|531979981|FG000|Overall Study|Withdrawal by subject - did not receive allocated intervention|0|||
147498800|NCT03363919|531979982|FG001|Overall Study|Withdrawal by subject - did not receive allocated intervention|1|||
147498801|NCT03363919|531979981|FG000|Overall Study|Withdrawal by subject - discontinued intervention prior to week 1|1|||
147498802|NCT03363919|531979982|FG001|Overall Study|Withdrawal by subject - discontinued intervention prior to week 1|4|||
147498803|NCT01827319|531979983|FG000|Overall Study|Lost to Follow-up|3|||
147498804|NCT03947255|531979985|FG000|Overall Study|Study Closure by Sponsor|2|||
147498805|NCT03947255|531979986|FG001|Overall Study|Study Closure by Sponsor|2|||
147498806|NCT03947255|531979985|FG000|Overall Study|Withdrawal by Subject|2|||
147498807|NCT03947255|531979986|FG001|Overall Study|Withdrawal by Subject|2|||
147498808|NCT03947255|531979985|FG000|Overall Study|Lost to Follow-up|2|||
147498809|NCT03947255|531979986|FG001|Overall Study|Lost to Follow-up|0|||
147498810|NCT03947255|531979985|FG000|Overall Study|Death|0|||
147498811|NCT03947255|531979986|FG001|Overall Study|Death|2|||
147498812|NCT02499575|531979987|FG000|Overall Study|Protocol Violation|0|||
147498813|NCT02499575|531979988|FG001|Overall Study|Protocol Violation|1|||
147498814|NCT00574119|531979989|FG000|Overall Study|Adverse Event|1|||
147498815|NCT00574119|531979989|FG000|Overall Study|Protocol Violation|1|||
147498816|NCT00574119|531979989|FG000|Overall Study|Withdrawal by Subject|1|||
147498817|NCT00574119|531979989|FG000|Overall Study|Physician Decision|1|||
147498818|NCT04656418|531979995|FG000|Overall Study|Withdrawal by Subject|1|||
147498819|NCT04656418|531979996|FG001|Overall Study|Withdrawal by Subject|3|||
147498820|NCT02586077|531979997|FG000|Overall Study|Withdrawal by Subject|1|||
147498821|NCT02586077|531979997|FG000|Overall Study|Physician Decision|4|||
147498822|NCT02586077|531979997|FG000|Overall Study|Lost to Follow-up|3|||
147498823|NCT01245764|531979998|FG000|Study Phase A|Other|3|||
147498824|NCT01245764|531979999|FG001|Study Phase A|Other|2|||
147498825|NCT01245764|531980000|FG002|Study Phase A|Other|3|||
147498826|NCT01245764|531980001|FG003|Study Phase A|Other|1|||
147498827|NCT01245764|531979998|FG000|Study Phase A|Protocol Violation|6|||
147498828|NCT01245764|531979999|FG001|Study Phase A|Protocol Violation|3|||
147498829|NCT01245764|531980000|FG002|Study Phase A|Protocol Violation|2|||
147498830|NCT01245764|531980001|FG003|Study Phase A|Protocol Violation|2|||
147498831|NCT01245764|531979998|FG000|Study Phase A|Lost to Follow-up|0|||
147498832|NCT01245764|531979999|FG001|Study Phase A|Lost to Follow-up|0|||
147498833|NCT01245764|531980000|FG002|Study Phase A|Lost to Follow-up|5|||
147498834|NCT01245764|531980001|FG003|Study Phase A|Lost to Follow-up|0|||
147498835|NCT00003476|531980002|FG000|Overall Study|Not evaluable|1|||
147498836|NCT03039738|531980009|FG000|Overall Study|Incomplete data sets|54|||
147498837|NCT03039738|531980010|FG001|Overall Study|Incomplete data sets|0|||
147498838|NCT00912340|531980011|FG000|Overall Study|Adverse Event|2|||
147498839|NCT00912340|531980012|FG001|Overall Study|Adverse Event|4|||
147498840|NCT00912340|531980013|FG002|Overall Study|Adverse Event|0|||
147498841|NCT00912340|531980011|FG000|Overall Study|Protocol revised to remove arm|0|||
147498842|NCT00912340|531980012|FG001|Overall Study|Protocol revised to remove arm|0|||
147498843|NCT00912340|531980013|FG002|Overall Study|Protocol revised to remove arm|4|||
147498844|NCT02062463|531980014|FG000|Crossover Stage 1|Withdrawals during stage 1 were not captured|3|||
147498845|NCT02062463|531980015|FG001|Crossover Stage 1|Withdrawals during stage 1 were not captured|1|||
147498846|NCT02062463|531980016|FG002|Crossover Stage 1|Withdrawals during stage 1 were not captured|0|||
147498847|NCT02062463|531980017|FG003|Crossover Stage 1|Withdrawals during stage 1 were not captured|0|||
147498848|NCT02062463|531980014|FG000|Stage 2|Adverse Event|0|||
147498849|NCT02062463|531980015|FG001|Stage 2|Adverse Event|0|||
147498850|NCT02062463|531980016|FG002|Stage 2|Adverse Event|12|||
147498851|NCT02062463|531980017|FG003|Stage 2|Adverse Event|20|||
147498852|NCT02062463|531980014|FG000|Stage 2|Lack of Efficacy|0|||
147498853|NCT02062463|531980015|FG001|Stage 2|Lack of Efficacy|0|||
147498854|NCT02062463|531980016|FG002|Stage 2|Lack of Efficacy|3|||
147498855|NCT02062463|531980017|FG003|Stage 2|Lack of Efficacy|4|||
147498856|NCT02062463|531980014|FG000|Stage 2|Lost to Follow-up|0|||
147498857|NCT02062463|531980015|FG001|Stage 2|Lost to Follow-up|0|||
147498858|NCT02062463|531980016|FG002|Stage 2|Lost to Follow-up|20|||
147498859|NCT02062463|531980017|FG003|Stage 2|Lost to Follow-up|20|||
147498860|NCT02062463|531980014|FG000|Stage 2|Non-Compliance|0|||
147498861|NCT02062463|531980015|FG001|Stage 2|Non-Compliance|0|||
147498862|NCT02062463|531980016|FG002|Stage 2|Non-Compliance|0|||
147498863|NCT02062463|531980017|FG003|Stage 2|Non-Compliance|1|||
147498864|NCT02062463|531980014|FG000|Stage 2|Other than specified|0|||
147498865|NCT02062463|531980015|FG001|Stage 2|Other than specified|0|||
147498866|NCT02062463|531980016|FG002|Stage 2|Other than specified|3|||
147498867|NCT02062463|531980017|FG003|Stage 2|Other than specified|1|||
147498868|NCT02062463|531980014|FG000|Stage 2|Withdrawal by Subject|0|||
147498869|NCT02062463|531980015|FG001|Stage 2|Withdrawal by Subject|0|||
147498870|NCT02062463|531980016|FG002|Stage 2|Withdrawal by Subject|15|||
147498871|NCT02062463|531980017|FG003|Stage 2|Withdrawal by Subject|10|||
147498872|NCT00600028|531980028|FG000|First Intervention (12 Weeks)|Withdrawal by Subject|1|||
147498873|NCT00600028|531980029|FG001|First Intervention (12 Weeks)|Withdrawal by Subject|0|||
147498874|NCT00600028|531980028|FG000|First Intervention (12 Weeks)|Adverse Event|0|||
147498875|NCT00600028|531980029|FG001|First Intervention (12 Weeks)|Adverse Event|1|||
147498876|NCT00600028|531980028|FG000|Second Intervention (12 Weeks)|Adverse Event|0|||
147498877|NCT00600028|531980029|FG001|Second Intervention (12 Weeks)|Adverse Event|2|||
147498878|NCT03172481|531980030|FG000|Double-blind|Withdrawal by Subject|1|||
147498879|NCT03172481|531980031|FG001|Double-blind|Withdrawal by Subject|0|||
147498880|NCT00830115|531980032|FG000|Overall Study|Adverse Event|2|||
147498881|NCT00830115|531980032|FG000|Overall Study|Improvement/recovery|1|||
147498882|NCT01925612|531980033|FG000|Overall Study|Progressive Disease|1|||
147498883|NCT01925612|531980034|FG001|Overall Study|Progressive Disease|1|||
147498884|NCT01925612|531980035|FG002|Overall Study|Progressive Disease|1|||
147498885|NCT01925612|531980036|FG003|Overall Study|Progressive Disease|0|||
147498886|NCT01925612|531980037|FG004|Overall Study|Progressive Disease|0|||
147498887|NCT01925612|531980033|FG000|Overall Study|Adverse Event|3|||
147498888|NCT01925612|531980034|FG001|Overall Study|Adverse Event|3|||
147498889|NCT01925612|531980035|FG002|Overall Study|Adverse Event|0|||
147498890|NCT01925612|531980036|FG003|Overall Study|Adverse Event|1|||
147498891|NCT01925612|531980037|FG004|Overall Study|Adverse Event|2|||
147498892|NCT01107405|531980042|FG000|Overall Study|Adverse Event|1|||
147498893|NCT01107405|531980043|FG001|Overall Study|Adverse Event|1|||
147498894|NCT01107405|531980044|FG002|Overall Study|Adverse Event|0|||
147498895|NCT01107405|531980045|FG003|Overall Study|Adverse Event|0|||
147498896|NCT01107405|531980046|FG004|Overall Study|Adverse Event|2|||
147498897|NCT01107405|531980042|FG000|Overall Study|Withdrawal by Subject|1|||
147498898|NCT01107405|531980043|FG001|Overall Study|Withdrawal by Subject|0|||
147498899|NCT01107405|531980044|FG002|Overall Study|Withdrawal by Subject|1|||
147498900|NCT01107405|531980045|FG003|Overall Study|Withdrawal by Subject|2|||
147498901|NCT01107405|531980046|FG004|Overall Study|Withdrawal by Subject|1|||
147498902|NCT01107405|531980042|FG000|Overall Study|Protocol Violation|0|||
147498903|NCT01107405|531980043|FG001|Overall Study|Protocol Violation|0|||
147498904|NCT01107405|531980044|FG002|Overall Study|Protocol Violation|1|||
147498905|NCT01107405|531980045|FG003|Overall Study|Protocol Violation|1|||
147498906|NCT01107405|531980046|FG004|Overall Study|Protocol Violation|0|||
147498907|NCT03495453|531980047|FG000|Overall Study|Withdrawal by Subject|0|||
147498908|NCT03495453|531980048|FG001|Overall Study|Withdrawal by Subject|1|||
147498909|NCT00085917|531980049|FG000|Overall Study|Adverse Event|4|||
147498910|NCT00085917|531980050|FG001|Overall Study|Adverse Event|3|||
147498911|NCT01360762|531980053|FG000|Main Study Period (12-month Treatment)|Lost to Follow-up|7|||
147498912|NCT01360762|531980053|FG000|Main Study Period (12-month Treatment)|Death|5|||
147498913|NCT01360762|531980053|FG000|Main Study Period (12-month Treatment)|Discontinuation of study drug for safety|1|||
147498914|NCT01360762|531980053|FG000|Main Study Period (12-month Treatment)|Patient relapsed|15|||
147498915|NCT01360762|531980053|FG000|Main Study Period (12-month Treatment)|Discontinuation|1|||
147498916|NCT01360762|531980053|FG000|Whole Study Period|Lost to Follow-up|10|||
147498917|NCT01360762|531980053|FG000|Whole Study Period|Death|7|||
147498918|NCT01360762|531980053|FG000|Whole Study Period|Patient relapsed|18|||
147498919|NCT01360762|531980053|FG000|Whole Study Period|Discontinuation of study drug for safety|1|||
147498920|NCT05590767|531980054|FG000|Overall Study|Protocol Violation|1|||
147498921|NCT05590767|531980054|FG000|Overall Study|surgery canceled|1|||
147498922|NCT05590767|531980054|FG000|Overall Study|interscalene brachial block not performed|1|||
147498923|NCT02802878|531980055|FG000|Overall Study|Withdrawal by Subject|3|||
147498924|NCT02802878|531980056|FG001|Overall Study|Withdrawal by Subject|3|||
147498925|NCT02802878|531980055|FG000|Overall Study|Protocol Violation|1|||
147498926|NCT02802878|531980056|FG001|Overall Study|Protocol Violation|0|||
147498927|NCT01232894|531980057|FG000|Overall Study|Lost to Follow-up|0|||
147498928|NCT01232894|531980058|FG001|Overall Study|Lost to Follow-up|1|||
147498929|NCT01232894|531980057|FG000|Overall Study|Death|1|||
147498930|NCT01232894|531980058|FG001|Overall Study|Death|0|||
147498931|NCT01232894|531980057|FG000|Overall Study|Protocol Violation|1|||
147498932|NCT01232894|531980058|FG001|Overall Study|Protocol Violation|1|||
147498933|NCT01232894|531980057|FG000|Overall Study|Withdrawal by Subject|8|||
147498934|NCT01232894|531980058|FG001|Overall Study|Withdrawal by Subject|5|||
147498935|NCT01232894|531980057|FG000|Overall Study|Physician Decision|2|||
147498936|NCT01232894|531980058|FG001|Overall Study|Physician Decision|1|||
147498937|NCT03970395|531980063|FG000|Overall Study|Withdrawal by Subject|3|||
147498938|NCT03970395|531980064|FG001|Overall Study|Withdrawal by Subject|4|||
147498939|NCT03970395|531980063|FG000|Overall Study|Lost to Follow-up|4|||
147498940|NCT03970395|531980064|FG001|Overall Study|Lost to Follow-up|8|||
147498941|NCT00916370|531980065|FG000|Overall Study|Death|3|||
147498942|NCT00916370|531980066|FG001|Overall Study|Death|1|||
147498943|NCT00916370|531980065|FG000|Overall Study|Withdrawal by Subject|2|||
147498944|NCT00916370|531980066|FG001|Overall Study|Withdrawal by Subject|0|||
147498945|NCT00916370|531980065|FG000|Overall Study|Physician Decision|0|||
147417950|NCT00700427|531694567|FG004|Study Period 3B (Randomized Withdrawal)|Lack of Efficacy|0|||
147417951|NCT00700427|531694563|FG000|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0|||
147417952|NCT00700427|531694564|FG001|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0|||
147417953|NCT00700427|531694565|FG002|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0|||
147417954|NCT00700427|531694566|FG003|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|5|||
147417955|NCT00700427|531694567|FG004|Study Period 3B (Randomized Withdrawal)|Protocol Interim Criteria Not Met|0|||
147417956|NCT00700427|531694563|FG000|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0|||
147417957|NCT00700427|531694564|FG001|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0|||
147417958|NCT00700427|531694565|FG002|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0|||
147417959|NCT00700427|531694566|FG003|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|3|||
147417960|NCT00700427|531694567|FG004|Study Period 3B (Randomized Withdrawal)|Clinical Relapse|0|||
147417961|NCT00700427|531694563|FG000|Study Period 3B (Randomized Withdrawal)|Missing|0|||
147417962|NCT00700427|531694564|FG001|Study Period 3B (Randomized Withdrawal)|Missing|0|||
147417963|NCT00700427|531694565|FG002|Study Period 3B (Randomized Withdrawal)|Missing|1|||
147417964|NCT00700427|531694566|FG003|Study Period 3B (Randomized Withdrawal)|Missing|1|||
147417965|NCT00700427|531694567|FG004|Study Period 3B (Randomized Withdrawal)|Missing|0|||
147417966|NCT00700427|531694563|FG000|Study Period 3B (Randomized Withdrawal)|Physician Decision|0|||
147417967|NCT00700427|531694564|FG001|Study Period 3B (Randomized Withdrawal)|Physician Decision|0|||
147417968|NCT00700427|531694565|FG002|Study Period 3B (Randomized Withdrawal)|Physician Decision|2|||
147417969|NCT00700427|531694566|FG003|Study Period 3B (Randomized Withdrawal)|Physician Decision|0|||
147417970|NCT00700427|531694567|FG004|Study Period 3B (Randomized Withdrawal)|Physician Decision|0|||
147417971|NCT00700427|531694563|FG000|Study Period 3B (Randomized Withdrawal)|Death|0|||
147498946|NCT00916370|531980066|FG001|Overall Study|Physician Decision|1|||
147498947|NCT00929734|531980067|FG000|Overall Study|Lost to Follow-up|2|||
147498948|NCT00929734|531980068|FG001|Overall Study|Lost to Follow-up|1|||
147498949|NCT00929734|531980067|FG000|Overall Study|Withdrawal by Subject|0|||
147498950|NCT00929734|531980068|FG001|Overall Study|Withdrawal by Subject|2|||
147498951|NCT00980980|531980070|FG000|Overall Study|Withdrawal by Hospital|0|||
147498952|NCT00980980|531980071|FG001|Overall Study|Withdrawal by Hospital|1|||
147498953|NCT00980980|531980072|FG002|Overall Study|Withdrawal by Hospital|0|||
147632465|NCT01052480|532472445|FG000|Overall Study|Protocol Violation|1|||
147632466|NCT01052480|532472446|FG001|Overall Study|Protocol Violation|0|||
147632467|NCT01052480|532472445|FG000|Overall Study|Withdrawal by Subject|3|||
147632468|NCT01052480|532472446|FG001|Overall Study|Withdrawal by Subject|7|||
147632469|NCT01052480|532472445|FG000|Overall Study|Physician Decision|0|||
147632470|NCT01052480|532472446|FG001|Overall Study|Physician Decision|2|||
147632471|NCT01052480|532472445|FG000|Overall Study|Death|1|||
147632472|NCT01052480|532472446|FG001|Overall Study|Death|5|||
147632473|NCT00529373|532472447|FG000|Base Study|Adverse Event|525|||
147632474|NCT00529373|532472448|FG001|Base Study|Adverse Event|470|||
147632475|NCT00529373|532472447|FG000|Base Study|Lack of Efficacy|16|||
147632476|NCT00529373|532472448|FG001|Base Study|Lack of Efficacy|75|||
147632477|NCT00529373|532472447|FG000|Base Study|Lost to Follow-up|221|||
147632478|NCT00529373|532472448|FG001|Base Study|Lost to Follow-up|208|||
147632479|NCT00529373|532472447|FG000|Base Study|Other Protocol Specified Criteria|19|||
147632480|NCT00529373|532472448|FG001|Base Study|Other Protocol Specified Criteria|20|||
147632481|NCT00529373|532472447|FG000|Base Study|Physician Decision|60|||
147632482|NCT00529373|532472448|FG001|Base Study|Physician Decision|52|||
147632483|NCT00529373|532472447|FG000|Base Study|Protocol Violation|48|||
147498954|NCT02921919|531980073|FG000|Overall Study|Other|5|||
147498955|NCT02921919|531980074|FG001|Overall Study|Other|6|||
147498956|NCT02921919|531980073|FG000|Overall Study|Lost to Follow-up|0|||
147498957|NCT02921919|531980074|FG001|Overall Study|Lost to Follow-up|1|||
147498958|NCT02921919|531980073|FG000|Overall Study|Withdrawal by Subject|5|||
147498959|NCT02921919|531980074|FG001|Overall Study|Withdrawal by Subject|1|||
147498960|NCT02921919|531980073|FG000|Overall Study|Disease Progression|47|||
147498961|NCT02921919|531980074|FG001|Overall Study|Disease Progression|38|||
147498962|NCT02921919|531980073|FG000|Overall Study|Physician Decision|3|||
147498963|NCT02921919|531980074|FG001|Overall Study|Physician Decision|2|||
147498964|NCT02921919|531980073|FG000|Overall Study|Adverse Event|6|||
147498965|NCT02921919|531980074|FG001|Overall Study|Adverse Event|4|||
147498966|NCT02756650|531980075|FG000|Overall Study|Physician Decision|1|||
147498967|NCT02756650|531980075|FG000|Overall Study|Adverse Event|1|||
147498968|NCT01553916|531980076|FG000|Overall Study|Withdrawal by Subject|2|||
147498969|NCT01553916|531980076|FG000|Overall Study|Pre-treatment MRI metastatic disease|1|||
147498970|NCT04348591|531980080|FG000|Imaging Session (120 Min)|Lost to Follow-up|0|||
147498971|NCT04348591|531980081|FG001|Imaging Session (120 Min)|Lost to Follow-up|2|||
147498972|NCT04348591|531980080|FG000|Imaging Session (120 Min)|Physician Decision|0|||
147498973|NCT04348591|531980081|FG001|Imaging Session (120 Min)|Physician Decision|1|||
147498974|NCT04348591|531980080|FG000|Imaging Session (120 Min)|Withdrawal by Subject|2|||
147498975|NCT04348591|531980081|FG001|Imaging Session (120 Min)|Withdrawal by Subject|0|||
147498976|NCT00645567|531980084|FG000|Overall Study|Adverse Event|1|||
147498977|NCT02648724|531980085|FG000|Overall Study|Withdrawal by Subject|0|||
147498978|NCT02648724|531980086|FG001|Overall Study|Withdrawal by Subject|1|||
147498979|NCT02648724|531980087|FG002|Overall Study|Withdrawal by Subject|1|||
147498980|NCT02648724|531980088|FG003|Overall Study|Withdrawal by Subject|0|||
147498981|NCT02648724|531980089|FG004|Overall Study|Withdrawal by Subject|1|||
147498982|NCT02648724|531980090|FG005|Overall Study|Withdrawal by Subject|0|||
147498983|NCT02648724|531980091|FG006|Overall Study|Withdrawal by Subject|0|||
147498984|NCT02648724|531980085|FG000|Overall Study|Progressive disease|2|||
147498985|NCT02648724|531980086|FG001|Overall Study|Progressive disease|2|||
147632484|NCT00529373|532472448|FG001|Base Study|Protocol Violation|38|||
147632485|NCT00529373|532472447|FG000|Base Study|Withdrawal by Subject|1062|||
147632486|NCT00529373|532472448|FG001|Base Study|Withdrawal by Subject|967|||
147632487|NCT00529373|532472447|FG000|Base Study|Did not continue into Extension|1795|||
147632488|NCT00529373|532472448|FG001|Base Study|Did not continue into Extension|2238|||
147498986|NCT02648724|531980087|FG002|Overall Study|Progressive disease|2|||
147632489|NCT00529373|532472447|FG000|First Extension Study|Adverse Event|162|||
147632490|NCT00529373|532472448|FG001|First Extension Study|Adverse Event|142|||
147632491|NCT00529373|532472447|FG000|First Extension Study|Lack of Efficacy|65|||
147632492|NCT00529373|532472448|FG001|First Extension Study|Lack of Efficacy|427|||
147632493|NCT00529373|532472447|FG000|First Extension Study|Lost to Follow-up|41|||
147498987|NCT02648724|531980088|FG003|Overall Study|Progressive disease|3|||
147498988|NCT02648724|531980089|FG004|Overall Study|Progressive disease|22|||
147498989|NCT02648724|531980090|FG005|Overall Study|Progressive disease|7|||
147498990|NCT02648724|531980091|FG006|Overall Study|Progressive disease|8|||
147498991|NCT02648724|531980085|FG000|Overall Study|Other reason (unknown)|1|||
147632494|NCT00529373|532472448|FG001|First Extension Study|Lost to Follow-up|37|||
147632495|NCT00529373|532472447|FG000|First Extension Study|Other|27|||
147632496|NCT00529373|532472448|FG001|First Extension Study|Other|47|||
147498992|NCT02648724|531980086|FG001|Overall Study|Other reason (unknown)|0|||
147498993|NCT02648724|531980087|FG002|Overall Study|Other reason (unknown)|0|||
147498994|NCT02648724|531980088|FG003|Overall Study|Other reason (unknown)|0|||
147498995|NCT02648724|531980089|FG004|Overall Study|Other reason (unknown)|0|||
147498996|NCT02648724|531980090|FG005|Overall Study|Other reason (unknown)|0|||
147498997|NCT02648724|531980091|FG006|Overall Study|Other reason (unknown)|0|||
147498998|NCT02648724|531980085|FG000|Overall Study|Protocol Violation|0|||
147498999|NCT02648724|531980086|FG001|Overall Study|Protocol Violation|0|||
147499000|NCT02648724|531980087|FG002|Overall Study|Protocol Violation|0|||
147499001|NCT02648724|531980088|FG003|Overall Study|Protocol Violation|0|||
147499002|NCT02648724|531980089|FG004|Overall Study|Protocol Violation|1|||
147499003|NCT02648724|531980090|FG005|Overall Study|Protocol Violation|0|||
147499004|NCT02648724|531980091|FG006|Overall Study|Protocol Violation|0|||
147499005|NCT02648724|531980085|FG000|Overall Study|Death|0|||
147499006|NCT02648724|531980086|FG001|Overall Study|Death|0|||
147499007|NCT02648724|531980087|FG002|Overall Study|Death|0|||
147499008|NCT02648724|531980088|FG003|Overall Study|Death|0|||
147499009|NCT02648724|531980089|FG004|Overall Study|Death|0|||
147499010|NCT02648724|531980090|FG005|Overall Study|Death|0|||
147499011|NCT02648724|531980091|FG006|Overall Study|Death|3|||
147499012|NCT02648724|531980085|FG000|Overall Study|Physician Decision|0|||
147499013|NCT02648724|531980086|FG001|Overall Study|Physician Decision|0|||
147499014|NCT02648724|531980087|FG002|Overall Study|Physician Decision|0|||
147499015|NCT02648724|531980088|FG003|Overall Study|Physician Decision|0|||
147499016|NCT02648724|531980089|FG004|Overall Study|Physician Decision|1|||
147499017|NCT02648724|531980090|FG005|Overall Study|Physician Decision|0|||
147499018|NCT02648724|531980091|FG006|Overall Study|Physician Decision|1|||
147499019|NCT02648724|531980085|FG000|Overall Study|Transferred to named patient program|0|||
147499020|NCT02648724|531980086|FG001|Overall Study|Transferred to named patient program|0|||
147499021|NCT02648724|531980087|FG002|Overall Study|Transferred to named patient program|0|||
147499022|NCT02648724|531980088|FG003|Overall Study|Transferred to named patient program|0|||
147499023|NCT02648724|531980089|FG004|Overall Study|Transferred to named patient program|0|||
147499024|NCT02648724|531980090|FG005|Overall Study|Transferred to named patient program|1|||
147499025|NCT02648724|531980091|FG006|Overall Study|Transferred to named patient program|0|||
147499026|NCT01364233|531980092|FG000|Overall Study|Lost to Follow-up|1|||
147499027|NCT00438399|531980093|FG000|Overall Study|Lost to Follow-up|2|||
147499028|NCT00438399|531980094|FG001|Overall Study|Lost to Follow-up|2|||
147499029|NCT00438399|531980095|FG002|Overall Study|Lost to Follow-up|1|||
147499030|NCT00438399|531980096|FG003|Overall Study|Lost to Follow-up|1|||
147499031|NCT00438399|531980097|FG004|Overall Study|Lost to Follow-up|1|||
147499032|NCT00438399|531980098|FG005|Overall Study|Lost to Follow-up|1|||
147499033|NCT00438399|531980093|FG000|Overall Study|Adverse Event|0|||
147499034|NCT00438399|531980094|FG001|Overall Study|Adverse Event|0|||
147499035|NCT00438399|531980095|FG002|Overall Study|Adverse Event|1|||
147499036|NCT00438399|531980096|FG003|Overall Study|Adverse Event|1|||
147499037|NCT00438399|531980097|FG004|Overall Study|Adverse Event|0|||
147499038|NCT00438399|531980098|FG005|Overall Study|Adverse Event|1|||
147499039|NCT00438399|531980093|FG000|Overall Study|Withdrawal by Subject|5|||
147499040|NCT00438399|531980094|FG001|Overall Study|Withdrawal by Subject|6|||
147499041|NCT00438399|531980095|FG002|Overall Study|Withdrawal by Subject|3|||
147499042|NCT00438399|531980096|FG003|Overall Study|Withdrawal by Subject|2|||
147499043|NCT00438399|531980097|FG004|Overall Study|Withdrawal by Subject|2|||
147499044|NCT00438399|531980098|FG005|Overall Study|Withdrawal by Subject|2|||
147499045|NCT00438399|531980093|FG000|Overall Study|Protocol Violation|0|||
147499046|NCT00438399|531980094|FG001|Overall Study|Protocol Violation|0|||
147499047|NCT00438399|531980095|FG002|Overall Study|Protocol Violation|1|||
147499048|NCT00438399|531980096|FG003|Overall Study|Protocol Violation|0|||
147499049|NCT00438399|531980097|FG004|Overall Study|Protocol Violation|0|||
147499050|NCT00438399|531980098|FG005|Overall Study|Protocol Violation|1|||
147499051|NCT00438399|531980093|FG000|Overall Study|Subje stopped study|0|||
147499052|NCT00438399|531980094|FG001|Overall Study|Subje stopped study|0|||
147499053|NCT00438399|531980095|FG002|Overall Study|Subje stopped study|1|||
147499054|NCT00438399|531980096|FG003|Overall Study|Subje stopped study|0|||
147499055|NCT00438399|531980097|FG004|Overall Study|Subje stopped study|0|||
147499056|NCT00438399|531980098|FG005|Overall Study|Subje stopped study|0|||
147499057|NCT00438399|531980093|FG000|Overall Study|Pregnancy|0|||
147499058|NCT00438399|531980094|FG001|Overall Study|Pregnancy|0|||
147499059|NCT00438399|531980095|FG002|Overall Study|Pregnancy|0|||
147499060|NCT00438399|531980096|FG003|Overall Study|Pregnancy|0|||
147499061|NCT00438399|531980097|FG004|Overall Study|Pregnancy|0|||
147499062|NCT00438399|531980098|FG005|Overall Study|Pregnancy|1|||
147499063|NCT00438399|531980093|FG000|Overall Study|Patien stopped study at visit 4 by error|1|||
147499064|NCT00438399|531980094|FG001|Overall Study|Patien stopped study at visit 4 by error|0|||
147499065|NCT00438399|531980095|FG002|Overall Study|Patien stopped study at visit 4 by error|0|||
147499066|NCT00438399|531980096|FG003|Overall Study|Patien stopped study at visit 4 by error|0|||
147499067|NCT00438399|531980097|FG004|Overall Study|Patien stopped study at visit 4 by error|0|||
147499068|NCT00438399|531980098|FG005|Overall Study|Patien stopped study at visit 4 by error|0|||
147499069|NCT00302718|531980102|FG000|Overall Study|Participant left the hospital|1|||
147499070|NCT00302718|531980103|FG001|Overall Study|Participant left the hospital|0|||
147499071|NCT00302718|531980104|FG002|Overall Study|Participant left the hospital|0|||
147499072|NCT00302718|531980105|FG003|Overall Study|Participant left the hospital|1|||
147499073|NCT00302718|531980102|FG000|Overall Study|Withdrawal by Subject|0|||
147499074|NCT00302718|531980103|FG001|Overall Study|Withdrawal by Subject|1|||
147499075|NCT00302718|531980104|FG002|Overall Study|Withdrawal by Subject|0|||
147499076|NCT00302718|531980105|FG003|Overall Study|Withdrawal by Subject|0|||
147499077|NCT00302718|531980102|FG000|Overall Study|Participant left primary care setting|0|||
147499078|NCT00302718|531980103|FG001|Overall Study|Participant left primary care setting|0|||
147499079|NCT00302718|531980104|FG002|Overall Study|Participant left primary care setting|2|||
147499080|NCT00302718|531980105|FG003|Overall Study|Participant left primary care setting|1|||
147499081|NCT00349752|531980106|FG000|Overall Study|Adverse Event|8|||
147499082|NCT00349752|531980107|FG001|Overall Study|Adverse Event|12|||
147499083|NCT00349752|531980106|FG000|Overall Study|Lack of Efficacy|37|||
147499084|NCT00349752|531980107|FG001|Overall Study|Lack of Efficacy|42|||
147499085|NCT00349752|531980106|FG000|Overall Study|Lost to Follow-up|4|||
147499086|NCT00349752|531980107|FG001|Overall Study|Lost to Follow-up|2|||
147499087|NCT00349752|531980106|FG000|Overall Study|Personal reasons|6|||
147499088|NCT00349752|531980107|FG001|Overall Study|Personal reasons|5|||
147499089|NCT00349752|531980106|FG000|Overall Study|Other: Required exclusionary medication|0|||
147499090|NCT00349752|531980107|FG001|Overall Study|Other: Required exclusionary medication|1|||
147499091|NCT00349752|531980106|FG000|Overall Study|Other: Non compliance|0|||
147499092|NCT00349752|531980107|FG001|Overall Study|Other: Non compliance|1|||
147499093|NCT00349752|531980106|FG000|Overall Study|Other: Patient stopped steroids|0|||
147499094|NCT00349752|531980107|FG001|Overall Study|Other: Patient stopped steroids|1|||
147499095|NCT00349752|531980106|FG000|Overall Study|Other: Patient's steroid use|1|||
147499096|NCT00349752|531980107|FG001|Overall Study|Other: Patient's steroid use|0|||
147499097|NCT00349752|531980106|FG000|Overall Study|Other: Ineligible|1|||
147499098|NCT00349752|531980107|FG001|Overall Study|Other: Ineligible|0|||
147499099|NCT00349752|531980106|FG000|Overall Study|Other: Inadvertently unblinded|1|||
147499100|NCT00349752|531980107|FG001|Overall Study|Other: Inadvertently unblinded|0|||
147499101|NCT00349752|531980106|FG000|Overall Study|Other:History of squamous cell carcinoma|1|||
147499102|NCT00349752|531980107|FG001|Overall Study|Other:History of squamous cell carcinoma|0|||
147499103|NCT00819585|531980108|FG000|Core Study|Adverse Event|2|||
147499104|NCT00819585|531980109|FG001|Core Study|Adverse Event|1|||
147499105|NCT00819585|531980110|FG002|Core Study|Adverse Event|1|||
147499106|NCT00819585|531980111|FG003|Core Study|Adverse Event|4|||
147499107|NCT00819585|531980112|FG004|Core Study|Adverse Event|1|||
147499108|NCT00819585|531980113|FG005|Core Study|Adverse Event|0|||
147499109|NCT00819585|531980114|FG006|Core Study|Adverse Event|2|||
147499110|NCT00819585|531980115|FG007|Core Study|Adverse Event|0|||
147499111|NCT00819585|531980116|FG008|Core Study|Adverse Event|0|||
147499112|NCT00819585|531980117|FG009|Core Study|Adverse Event|0|||
147499113|NCT00819585|531980118|FG010|Core Study|Adverse Event|0|||
147499114|NCT00819585|531980108|FG000|Core Study|Abnormal Laboratory Value(s)|2|||
147499115|NCT00819585|531980109|FG001|Core Study|Abnormal Laboratory Value(s)|0|||
147499116|NCT00819585|531980110|FG002|Core Study|Abnormal Laboratory Value(s)|0|||
147499117|NCT00819585|531980111|FG003|Core Study|Abnormal Laboratory Value(s)|0|||
147499118|NCT00819585|531980112|FG004|Core Study|Abnormal Laboratory Value(s)|0|||
147499119|NCT00819585|531980113|FG005|Core Study|Abnormal Laboratory Value(s)|0|||
147499120|NCT00819585|531980114|FG006|Core Study|Abnormal Laboratory Value(s)|0|||
147499121|NCT00819585|531980115|FG007|Core Study|Abnormal Laboratory Value(s)|0|||
147499122|NCT00819585|531980116|FG008|Core Study|Abnormal Laboratory Value(s)|0|||
147499123|NCT00819585|531980117|FG009|Core Study|Abnormal Laboratory Value(s)|0|||
147499124|NCT00819585|531980118|FG010|Core Study|Abnormal Laboratory Value(s)|0|||
147499125|NCT00819585|531980108|FG000|Core Study|Unsatisfactory Therapeutic Effect|0|||
147499126|NCT00819585|531980109|FG001|Core Study|Unsatisfactory Therapeutic Effect|1|||
147499127|NCT00819585|531980110|FG002|Core Study|Unsatisfactory Therapeutic Effect|0|||
147499128|NCT00819585|531980111|FG003|Core Study|Unsatisfactory Therapeutic Effect|0|||
147499129|NCT00819585|531980112|FG004|Core Study|Unsatisfactory Therapeutic Effect|0|||
147499130|NCT00819585|531980113|FG005|Core Study|Unsatisfactory Therapeutic Effect|0|||
147499131|NCT00819585|531980114|FG006|Core Study|Unsatisfactory Therapeutic Effect|1|||
147499132|NCT00819585|531980115|FG007|Core Study|Unsatisfactory Therapeutic Effect|0|||
147499133|NCT00819585|531980116|FG008|Core Study|Unsatisfactory Therapeutic Effect|0|||
147499134|NCT00819585|531980117|FG009|Core Study|Unsatisfactory Therapeutic Effect|0|||
147499135|NCT00819585|531980118|FG010|Core Study|Unsatisfactory Therapeutic Effect|0|||
147499136|NCT00819585|531980108|FG000|Core Study|Subject No Longer Requires Study Drug|0|||
147499137|NCT00819585|531980109|FG001|Core Study|Subject No Longer Requires Study Drug|0|||
147499138|NCT00819585|531980110|FG002|Core Study|Subject No Longer Requires Study Drug|0|||
147499139|NCT00819585|531980111|FG003|Core Study|Subject No Longer Requires Study Drug|0|||
147499140|NCT00819585|531980112|FG004|Core Study|Subject No Longer Requires Study Drug|1|||
147499141|NCT00819585|531980113|FG005|Core Study|Subject No Longer Requires Study Drug|0|||
147499142|NCT00819585|531980114|FG006|Core Study|Subject No Longer Requires Study Drug|0|||
147499143|NCT00819585|531980115|FG007|Core Study|Subject No Longer Requires Study Drug|0|||
147499144|NCT00819585|531980116|FG008|Core Study|Subject No Longer Requires Study Drug|0|||
147499145|NCT00819585|531980117|FG009|Core Study|Subject No Longer Requires Study Drug|0|||
147499146|NCT00819585|531980118|FG010|Core Study|Subject No Longer Requires Study Drug|0|||
147499147|NCT00819585|531980108|FG000|Core Study|Subject Withdrew Consent|0|||
147499148|NCT00819585|531980109|FG001|Core Study|Subject Withdrew Consent|3|||
147499149|NCT00819585|531980110|FG002|Core Study|Subject Withdrew Consent|2|||
147499150|NCT00819585|531980111|FG003|Core Study|Subject Withdrew Consent|1|||
147499151|NCT00819585|531980112|FG004|Core Study|Subject Withdrew Consent|0|||
147499152|NCT00819585|531980113|FG005|Core Study|Subject Withdrew Consent|0|||
147499153|NCT00819585|531980114|FG006|Core Study|Subject Withdrew Consent|3|||
147499154|NCT00819585|531980115|FG007|Core Study|Subject Withdrew Consent|0|||
147499155|NCT00819585|531980116|FG008|Core Study|Subject Withdrew Consent|0|||
147499156|NCT00819585|531980117|FG009|Core Study|Subject Withdrew Consent|0|||
147499157|NCT00819585|531980118|FG010|Core Study|Subject Withdrew Consent|0|||
147499158|NCT00819585|531980108|FG000|Core Study|Lost to Follow-up|2|||
147499159|NCT00819585|531980109|FG001|Core Study|Lost to Follow-up|1|||
147499160|NCT00819585|531980110|FG002|Core Study|Lost to Follow-up|2|||
147499161|NCT00819585|531980111|FG003|Core Study|Lost to Follow-up|0|||
147499162|NCT00819585|531980112|FG004|Core Study|Lost to Follow-up|1|||
147499163|NCT00819585|531980113|FG005|Core Study|Lost to Follow-up|1|||
147499164|NCT00819585|531980114|FG006|Core Study|Lost to Follow-up|1|||
147499165|NCT00819585|531980115|FG007|Core Study|Lost to Follow-up|0|||
147499166|NCT00819585|531980116|FG008|Core Study|Lost to Follow-up|0|||
147499167|NCT00819585|531980117|FG009|Core Study|Lost to Follow-up|0|||
147499168|NCT00819585|531980118|FG010|Core Study|Lost to Follow-up|0|||
147499169|NCT00819585|531980108|FG000|Core Study|Administrative Problems|0|||
147499170|NCT00819585|531980109|FG001|Core Study|Administrative Problems|0|||
147499171|NCT00819585|531980110|FG002|Core Study|Administrative Problems|0|||
147499172|NCT00819585|531980111|FG003|Core Study|Administrative Problems|0|||
147499173|NCT00819585|531980112|FG004|Core Study|Administrative Problems|0|||
147499174|NCT00819585|531980113|FG005|Core Study|Administrative Problems|0|||
147499175|NCT00819585|531980114|FG006|Core Study|Administrative Problems|2|||
147499176|NCT00819585|531980115|FG007|Core Study|Administrative Problems|0|||
147499177|NCT00819585|531980116|FG008|Core Study|Administrative Problems|0|||
147499178|NCT00819585|531980117|FG009|Core Study|Administrative Problems|0|||
147499179|NCT00819585|531980118|FG010|Core Study|Administrative Problems|0|||
147499180|NCT00819585|531980108|FG000|Core Study|Death|0|||
147499181|NCT00819585|531980109|FG001|Core Study|Death|0|||
147499182|NCT00819585|531980110|FG002|Core Study|Death|0|||
147499183|NCT00819585|531980111|FG003|Core Study|Death|0|||
147499184|NCT00819585|531980112|FG004|Core Study|Death|0|||
147499185|NCT00819585|531980113|FG005|Core Study|Death|0|||
147499186|NCT00819585|531980114|FG006|Core Study|Death|1|||
147499187|NCT00819585|531980115|FG007|Core Study|Death|0|||
147499188|NCT00819585|531980116|FG008|Core Study|Death|0|||
147499189|NCT00819585|531980117|FG009|Core Study|Death|0|||
147499190|NCT00819585|531980118|FG010|Core Study|Death|0|||
147499191|NCT00819585|531980108|FG000|Core Study|Protocol Violation|0|||
147499192|NCT00819585|531980109|FG001|Core Study|Protocol Violation|0|||
147499193|NCT00819585|531980110|FG002|Core Study|Protocol Violation|1|||
147499194|NCT00819585|531980111|FG003|Core Study|Protocol Violation|0|||
147499195|NCT00819585|531980112|FG004|Core Study|Protocol Violation|0|||
147499196|NCT00819585|531980113|FG005|Core Study|Protocol Violation|1|||
147499197|NCT00819585|531980114|FG006|Core Study|Protocol Violation|3|||
147499198|NCT00819585|531980115|FG007|Core Study|Protocol Violation|0|||
147499199|NCT00819585|531980116|FG008|Core Study|Protocol Violation|0|||
147499200|NCT00819585|531980117|FG009|Core Study|Protocol Violation|0|||
147499201|NCT00819585|531980118|FG010|Core Study|Protocol Violation|0|||
147499202|NCT00819585|531980108|FG000|Extension Study|Abnormal Laboratory Value(s)|0|||
147499203|NCT00819585|531980109|FG001|Extension Study|Abnormal Laboratory Value(s)|0|||
147499204|NCT00819585|531980110|FG002|Extension Study|Abnormal Laboratory Value(s)|0|||
147499205|NCT00819585|531980111|FG003|Extension Study|Abnormal Laboratory Value(s)|0|||
147499206|NCT00819585|531980112|FG004|Extension Study|Abnormal Laboratory Value(s)|0|||
147499207|NCT00819585|531980113|FG005|Extension Study|Abnormal Laboratory Value(s)|0|||
147499208|NCT00819585|531980114|FG006|Extension Study|Abnormal Laboratory Value(s)|0|||
147499209|NCT00819585|531980115|FG007|Extension Study|Abnormal Laboratory Value(s)|0|||
147499210|NCT00819585|531980116|FG008|Extension Study|Abnormal Laboratory Value(s)|1|||
147499211|NCT00819585|531980117|FG009|Extension Study|Abnormal Laboratory Value(s)|0|||
147499212|NCT00819585|531980118|FG010|Extension Study|Abnormal Laboratory Value(s)|0|||
147499213|NCT00819585|531980108|FG000|Extension Study|Subject Withdrew Consent|0|||
147499214|NCT00819585|531980109|FG001|Extension Study|Subject Withdrew Consent|0|||
147499215|NCT00819585|531980110|FG002|Extension Study|Subject Withdrew Consent|0|||
147499216|NCT00819585|531980111|FG003|Extension Study|Subject Withdrew Consent|0|||
147499217|NCT00819585|531980112|FG004|Extension Study|Subject Withdrew Consent|0|||
147499218|NCT00819585|531980113|FG005|Extension Study|Subject Withdrew Consent|0|||
147499219|NCT00819585|531980114|FG006|Extension Study|Subject Withdrew Consent|0|||
147499220|NCT00819585|531980115|FG007|Extension Study|Subject Withdrew Consent|0|||
147499221|NCT00819585|531980116|FG008|Extension Study|Subject Withdrew Consent|3|||
147499222|NCT00819585|531980117|FG009|Extension Study|Subject Withdrew Consent|0|||
147499223|NCT00819585|531980118|FG010|Extension Study|Subject Withdrew Consent|1|||
147499224|NCT00819585|531980108|FG000|Extension Study|Lost to Follow-up|0|||
147499225|NCT00819585|531980109|FG001|Extension Study|Lost to Follow-up|0|||
147499226|NCT00819585|531980110|FG002|Extension Study|Lost to Follow-up|0|||
147499227|NCT00819585|531980111|FG003|Extension Study|Lost to Follow-up|0|||
147499228|NCT00819585|531980112|FG004|Extension Study|Lost to Follow-up|0|||
147499229|NCT00819585|531980113|FG005|Extension Study|Lost to Follow-up|0|||
147499230|NCT00819585|531980114|FG006|Extension Study|Lost to Follow-up|0|||
147499231|NCT00819585|531980115|FG007|Extension Study|Lost to Follow-up|0|||
147499232|NCT00819585|531980116|FG008|Extension Study|Lost to Follow-up|2|||
147499233|NCT00819585|531980117|FG009|Extension Study|Lost to Follow-up|1|||
147499234|NCT00819585|531980118|FG010|Extension Study|Lost to Follow-up|1|||
147499235|NCT00819585|531980108|FG000|Extension Study|Death|0|||
147499236|NCT00819585|531980109|FG001|Extension Study|Death|0|||
147499237|NCT00819585|531980110|FG002|Extension Study|Death|0|||
147499238|NCT00819585|531980111|FG003|Extension Study|Death|0|||
147499239|NCT00819585|531980112|FG004|Extension Study|Death|0|||
147499240|NCT00819585|531980113|FG005|Extension Study|Death|0|||
147499241|NCT00819585|531980114|FG006|Extension Study|Death|0|||
147499242|NCT00819585|531980115|FG007|Extension Study|Death|0|||
147499243|NCT00819585|531980116|FG008|Extension Study|Death|2|||
147499244|NCT00819585|531980117|FG009|Extension Study|Death|0|||
147499245|NCT00819585|531980118|FG010|Extension Study|Death|0|||
147499246|NCT00738374|531980119|FG000|Induction Treatment Phase|Adverse Event|14|||
147499247|NCT00738374|531980120|FG001|Induction Treatment Phase|Adverse Event|0|||
147499248|NCT00738374|531980121|FG002|Induction Treatment Phase|Adverse Event|0|||
147499249|NCT00738374|531980122|FG003|Induction Treatment Phase|Adverse Event|0|||
147499250|NCT00738374|531980119|FG000|Induction Treatment Phase|Disease progression/relapse/stable|4|||
147499251|NCT00738374|531980120|FG001|Induction Treatment Phase|Disease progression/relapse/stable|0|||
147499252|NCT00738374|531980121|FG002|Induction Treatment Phase|Disease progression/relapse/stable|0|||
147499253|NCT00738374|531980122|FG003|Induction Treatment Phase|Disease progression/relapse/stable|0|||
147499254|NCT00738374|531980119|FG000|Induction Treatment Phase|Physician Decision|2|||
147499255|NCT00738374|531980120|FG001|Induction Treatment Phase|Physician Decision|0|||
147499256|NCT00738374|531980121|FG002|Induction Treatment Phase|Physician Decision|0|||
147499257|NCT00738374|531980122|FG003|Induction Treatment Phase|Physician Decision|0|||
147499258|NCT00738374|531980119|FG000|Induction Treatment Phase|Protocol Violation|2|||
147499259|NCT00738374|531980120|FG001|Induction Treatment Phase|Protocol Violation|0|||
147499260|NCT00738374|531980121|FG002|Induction Treatment Phase|Protocol Violation|0|||
147499261|NCT00738374|531980122|FG003|Induction Treatment Phase|Protocol Violation|0|||
147499262|NCT00738374|531980119|FG000|Induction Treatment Phase|Non-compliance|1|||
147499263|NCT00738374|531980120|FG001|Induction Treatment Phase|Non-compliance|0|||
147499264|NCT00738374|531980121|FG002|Induction Treatment Phase|Non-compliance|0|||
147499265|NCT00738374|531980122|FG003|Induction Treatment Phase|Non-compliance|0|||
147499266|NCT00738374|531980119|FG000|Induction Treatment Phase|Withdrawal by Subject|1|||
147499267|NCT00738374|531980120|FG001|Induction Treatment Phase|Withdrawal by Subject|0|||
147499268|NCT00738374|531980121|FG002|Induction Treatment Phase|Withdrawal by Subject|0|||
147499269|NCT00738374|531980122|FG003|Induction Treatment Phase|Withdrawal by Subject|0|||
147499270|NCT00738374|531980119|FG000|Maintenance Treatment/Observation Phase|Adverse Event|0|||
147499271|NCT00738374|531980120|FG001|Maintenance Treatment/Observation Phase|Adverse Event|1|||
147499272|NCT00738374|531980121|FG002|Maintenance Treatment/Observation Phase|Adverse Event|2|||
147499273|NCT00738374|531980122|FG003|Maintenance Treatment/Observation Phase|Adverse Event|0|||
147499274|NCT00738374|531980119|FG000|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|0|||
147499275|NCT00738374|531980120|FG001|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|4|||
147499276|NCT00738374|531980121|FG002|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|5|||
147499277|NCT00738374|531980122|FG003|Maintenance Treatment/Observation Phase|Disease progression/relapse/stable|11|||
147499278|NCT00738374|531980119|FG000|Maintenance Treatment/Observation Phase|Withdrawal by Subject|0|||
147499279|NCT00738374|531980120|FG001|Maintenance Treatment/Observation Phase|Withdrawal by Subject|0|||
147499280|NCT00738374|531980121|FG002|Maintenance Treatment/Observation Phase|Withdrawal by Subject|0|||
147499281|NCT00738374|531980122|FG003|Maintenance Treatment/Observation Phase|Withdrawal by Subject|1|||
147499282|NCT00738374|531980119|FG000|Maintenance Treatment/Observation Phase|Protocol Violation|0|||
147499283|NCT00738374|531980120|FG001|Maintenance Treatment/Observation Phase|Protocol Violation|1|||
147499284|NCT00738374|531980121|FG002|Maintenance Treatment/Observation Phase|Protocol Violation|0|||
147499285|NCT00738374|531980122|FG003|Maintenance Treatment/Observation Phase|Protocol Violation|0|||
147499286|NCT00738374|531980119|FG000|Maintenance Treatment/Observation Phase|Other|0|||
147499287|NCT00738374|531980120|FG001|Maintenance Treatment/Observation Phase|Other|1|||
147499288|NCT00738374|531980121|FG002|Maintenance Treatment/Observation Phase|Other|0|||
147499289|NCT00738374|531980122|FG003|Maintenance Treatment/Observation Phase|Other|0|||
147499290|NCT00632541|531980123|FG000|Overall Study|Adverse Event|7|||
147499291|NCT03334396|531980124|FG000|Overall Study|Adverse Event|1|||
147499292|NCT03334396|531980125|FG001|Overall Study|Adverse Event|0|||
147499293|NCT03334396|531980126|FG002|Overall Study|Adverse Event|1|||
147499294|NCT03334396|531980127|FG003|Overall Study|Adverse Event|0|||
147499295|NCT03334396|531980128|FG004|Overall Study|Adverse Event|0|||
147499296|NCT03334396|531980129|FG005|Overall Study|Adverse Event|0|||
147499297|NCT03334396|531980130|FG006|Overall Study|Adverse Event|0|||
147499298|NCT03334396|531980131|FG007|Overall Study|Adverse Event|0|||
147499299|NCT03334396|531980124|FG000|Overall Study|Lack of Efficacy|10|||
147499300|NCT03334396|531980125|FG001|Overall Study|Lack of Efficacy|4|||
147499301|NCT03334396|531980126|FG002|Overall Study|Lack of Efficacy|1|||
147499302|NCT03334396|531980127|FG003|Overall Study|Lack of Efficacy|3|||
147499303|NCT03334396|531980128|FG004|Overall Study|Lack of Efficacy|1|||
147499304|NCT03334396|531980129|FG005|Overall Study|Lack of Efficacy|0|||
147499305|NCT03334396|531980130|FG006|Overall Study|Lack of Efficacy|0|||
147499306|NCT03334396|531980131|FG007|Overall Study|Lack of Efficacy|1|||
147499307|NCT03334396|531980124|FG000|Overall Study|Lost to Follow-up|0|||
147499308|NCT03334396|531980125|FG001|Overall Study|Lost to Follow-up|0|||
147499309|NCT03334396|531980126|FG002|Overall Study|Lost to Follow-up|1|||
147499310|NCT03334396|531980127|FG003|Overall Study|Lost to Follow-up|0|||
147499311|NCT03334396|531980128|FG004|Overall Study|Lost to Follow-up|0|||
147499312|NCT03334396|531980129|FG005|Overall Study|Lost to Follow-up|0|||
147499313|NCT03334396|531980130|FG006|Overall Study|Lost to Follow-up|1|||
147499314|NCT03334396|531980131|FG007|Overall Study|Lost to Follow-up|0|||
147499315|NCT03334396|531980124|FG000|Overall Study|Physician Decision|1|||
147499316|NCT03334396|531980125|FG001|Overall Study|Physician Decision|0|||
147499317|NCT03334396|531980126|FG002|Overall Study|Physician Decision|0|||
147499318|NCT03334396|531980127|FG003|Overall Study|Physician Decision|0|||
147499319|NCT03334396|531980128|FG004|Overall Study|Physician Decision|0|||
147499320|NCT03334396|531980129|FG005|Overall Study|Physician Decision|0|||
147499321|NCT03334396|531980130|FG006|Overall Study|Physician Decision|0|||
147499322|NCT03334396|531980131|FG007|Overall Study|Physician Decision|0|||
147499323|NCT03334396|531980124|FG000|Overall Study|Withdrawal by Subject|10|||
147499324|NCT03334396|531980125|FG001|Overall Study|Withdrawal by Subject|5|||
147499325|NCT03334396|531980126|FG002|Overall Study|Withdrawal by Subject|7|||
147632497|NCT00529373|532472447|FG000|First Extension Study|Physician Decision|50|||
147632498|NCT00529373|532472448|FG001|First Extension Study|Physician Decision|45|||
147632499|NCT00529373|532472447|FG000|First Extension Study|Protocol Violation|16|||
147632500|NCT00529373|532472448|FG001|First Extension Study|Protocol Violation|13|||
147632501|NCT00529373|532472447|FG000|First Extension Study|Withdrawal by Subject|296|||
147632502|NCT00529373|532472448|FG001|First Extension Study|Withdrawal by Subject|287|||
147632503|NCT00529373|532472447|FG000|First Extension Study|Disposition record non-existing|0|||
147632504|NCT00529373|532472448|FG001|First Extension Study|Disposition record non-existing|1|||
147632505|NCT00529373|532472447|FG000|First Extension Study|Discontinued after 5 years completion|208|||
147632506|NCT00529373|532472448|FG001|First Extension Study|Discontinued after 5 years completion|346|||
147632507|NCT00529373|532472447|FG000|First Extension Study|Did not cont. into 2nd Ext (verified)|256|||
147499326|NCT03334396|531980127|FG003|Overall Study|Withdrawal by Subject|2|||
147499327|NCT03334396|531980128|FG004|Overall Study|Withdrawal by Subject|2|||
147499328|NCT03334396|531980129|FG005|Overall Study|Withdrawal by Subject|1|||
147499329|NCT03334396|531980130|FG006|Overall Study|Withdrawal by Subject|2|||
147499330|NCT03334396|531980131|FG007|Overall Study|Withdrawal by Subject|0|||
147499331|NCT03334396|531980124|FG000|Overall Study|Pregnancy|0|||
147499332|NCT03334396|531980125|FG001|Overall Study|Pregnancy|1|||
147499333|NCT03334396|531980126|FG002|Overall Study|Pregnancy|0|||
147499334|NCT03334396|531980127|FG003|Overall Study|Pregnancy|0|||
147499335|NCT03334396|531980128|FG004|Overall Study|Pregnancy|0|||
147499336|NCT03334396|531980129|FG005|Overall Study|Pregnancy|0|||
147499337|NCT03334396|531980130|FG006|Overall Study|Pregnancy|0|||
147499338|NCT03334396|531980131|FG007|Overall Study|Pregnancy|0|||
147499339|NCT03334396|531980124|FG000|Overall Study|Ineligible|0|||
147499340|NCT03334396|531980125|FG001|Overall Study|Ineligible|1|||
147499341|NCT03334396|531980126|FG002|Overall Study|Ineligible|0|||
147499342|NCT03334396|531980127|FG003|Overall Study|Ineligible|0|||
147499343|NCT03334396|531980128|FG004|Overall Study|Ineligible|0|||
147499344|NCT03334396|531980129|FG005|Overall Study|Ineligible|0|||
147499345|NCT03334396|531980130|FG006|Overall Study|Ineligible|0|||
147499346|NCT03334396|531980131|FG007|Overall Study|Ineligible|0|||
147499347|NCT03334396|531980124|FG000|Overall Study|Started New Job|1|||
147499348|NCT03334396|531980125|FG001|Overall Study|Started New Job|0|||
147499349|NCT03334396|531980126|FG002|Overall Study|Started New Job|0|||
147499350|NCT03334396|531980127|FG003|Overall Study|Started New Job|0|||
147499351|NCT03334396|531980128|FG004|Overall Study|Started New Job|0|||
147632508|NCT00529373|532472448|FG001|First Extension Study|Did not cont. into 2nd Ext (verified)|281|||
147499352|NCT03334396|531980129|FG005|Overall Study|Started New Job|0|||
147499353|NCT03334396|531980130|FG006|Overall Study|Started New Job|0|||
147499354|NCT03334396|531980131|FG007|Overall Study|Started New Job|0|||
147499355|NCT02927873|531980135|FG000|Overall Study|Lost to Follow-up|0|||
147499356|NCT02927873|531980136|FG001|Overall Study|Lost to Follow-up|1|||
147499357|NCT02927873|531980137|FG002|Overall Study|Lost to Follow-up|0|||
147499358|NCT02927873|531980138|FG003|Overall Study|Lost to Follow-up|0|||
147499359|NCT02927873|531980139|FG004|Overall Study|Lost to Follow-up|0|||
147499360|NCT02927873|531980140|FG005|Overall Study|Lost to Follow-up|0|||
147499361|NCT02927873|531980135|FG000|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
147499362|NCT02927873|531980136|FG001|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|1|||
147499363|NCT02927873|531980137|FG002|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
147499364|NCT02927873|531980138|FG003|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
147499365|NCT02927873|531980139|FG004|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
147499366|NCT02927873|531980140|FG005|Overall Study|CONSENT WITHDRAWAL NOT DUE TO ADV. EVENT|0|||
147499367|NCT02927873|531980135|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
147499368|NCT02927873|531980136|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
147499369|NCT02927873|531980137|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
147499370|NCT02927873|531980138|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
147499371|NCT02927873|531980139|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
147499372|NCT02927873|531980140|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
147499373|NCT02927873|531980135|FG000|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0|||
147499374|NCT02927873|531980136|FG001|Overall Study|PARENTS NOT ABLE TO COME TO SITE|1|||
147499375|NCT02927873|531980137|FG002|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0|||
147499376|NCT02927873|531980138|FG003|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0|||
147499377|NCT02927873|531980139|FG004|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0|||
147499378|NCT02927873|531980140|FG005|Overall Study|PARENTS NOT ABLE TO COME TO SITE|0|||
147499379|NCT02927873|531980135|FG000|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|1|||
147499380|NCT02927873|531980136|FG001|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0|||
147499381|NCT02927873|531980137|FG002|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0|||
147499382|NCT02927873|531980138|FG003|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0|||
147499383|NCT02927873|531980139|FG004|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0|||
147499384|NCT02927873|531980140|FG005|Overall Study|SUBJECT WITHDRAWN AT AN INTERIM TIMEPOINT, BUT ACCEPTED CALLS FOR SAFETY SURVEILLANCE|0|||
147499385|NCT02927873|531980135|FG000|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|1|||
147499386|NCT02927873|531980136|FG001|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0|||
147499387|NCT02927873|531980137|FG002|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0|||
147499388|NCT02927873|531980138|FG003|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0|||
147499389|NCT02927873|531980139|FG004|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0|||
147499390|NCT02927873|531980140|FG005|Overall Study|PARENTS REFUSED SAFETY FOLLOW-UP|0|||
147499391|NCT01766817|531980141|FG000|Overall Study|Drug-related adverse event|1|||
147499392|NCT01766817|531980142|FG001|Overall Study|Drug-related adverse event|2|||
147499393|NCT01766817|531980143|FG002|Overall Study|Drug-related adverse event|1|||
147499394|NCT01766817|531980141|FG000|Overall Study|Drug-unrelated adverse event|3|||
147499395|NCT01766817|531980142|FG001|Overall Study|Drug-unrelated adverse event|3|||
147499396|NCT01766817|531980143|FG002|Overall Study|Drug-unrelated adverse event|3|||
147499397|NCT01766817|531980141|FG000|Overall Study|Death|1|||
147499398|NCT01766817|531980142|FG001|Overall Study|Death|1|||
147499399|NCT01766817|531980143|FG002|Overall Study|Death|0|||
147499400|NCT01766817|531980141|FG000|Overall Study|Unable to take study drug|0|||
147499401|NCT01766817|531980142|FG001|Overall Study|Unable to take study drug|1|||
147499402|NCT01766817|531980143|FG002|Overall Study|Unable to take study drug|0|||
147499403|NCT01766817|531980141|FG000|Overall Study|Withdrawal by Subject|2|||
147499404|NCT01766817|531980142|FG001|Overall Study|Withdrawal by Subject|0|||
147499405|NCT01766817|531980143|FG002|Overall Study|Withdrawal by Subject|3|||
147499406|NCT01766817|531980141|FG000|Overall Study|Subject non-compliance|0|||
147499407|NCT01766817|531980142|FG001|Overall Study|Subject non-compliance|1|||
147499408|NCT01766817|531980143|FG002|Overall Study|Subject non-compliance|2|||
147499409|NCT01766817|531980141|FG000|Overall Study|Physician Decision|3|||
147499410|NCT01766817|531980142|FG001|Overall Study|Physician Decision|3|||
147499411|NCT01766817|531980143|FG002|Overall Study|Physician Decision|4|||
147499412|NCT01766817|531980141|FG000|Overall Study|Other|1|||
147499413|NCT01766817|531980142|FG001|Overall Study|Other|0|||
147499414|NCT01766817|531980143|FG002|Overall Study|Other|0|||
147499415|NCT00383721|531980147|FG000|26-Week Double-Blind Treatment Period|Adverse Event|11|||
147499416|NCT00383721|531980148|FG001|26-Week Double-Blind Treatment Period|Adverse Event|5|||
147499417|NCT00383721|531980149|FG002|26-Week Double-Blind Treatment Period|Adverse Event|7|||
147499418|NCT00383721|531980150|FG003|26-Week Double-Blind Treatment Period|Adverse Event|14|||
147499419|NCT00383721|531980151|FG004|26-Week Double-Blind Treatment Period|Adverse Event|13|||
147499420|NCT00383721|531980147|FG000|26-Week Double-Blind Treatment Period|Lack of Efficacy|1|||
147499421|NCT00383721|531980148|FG001|26-Week Double-Blind Treatment Period|Lack of Efficacy|3|||
147499422|NCT00383721|531980149|FG002|26-Week Double-Blind Treatment Period|Lack of Efficacy|3|||
147499423|NCT00383721|531980150|FG003|26-Week Double-Blind Treatment Period|Lack of Efficacy|4|||
147499424|NCT00383721|531980151|FG004|26-Week Double-Blind Treatment Period|Lack of Efficacy|8|||
147499425|NCT00383721|531980147|FG000|26-Week Double-Blind Treatment Period|Lost to Follow-up|0|||
147499426|NCT00383721|531980148|FG001|26-Week Double-Blind Treatment Period|Lost to Follow-up|0|||
147499427|NCT00383721|531980149|FG002|26-Week Double-Blind Treatment Period|Lost to Follow-up|2|||
147499428|NCT00383721|531980150|FG003|26-Week Double-Blind Treatment Period|Lost to Follow-up|1|||
147499429|NCT00383721|531980151|FG004|26-Week Double-Blind Treatment Period|Lost to Follow-up|4|||
147499430|NCT00383721|531980147|FG000|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|4|||
147499431|NCT00383721|531980148|FG001|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|12|||
147499432|NCT00383721|531980149|FG002|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|15|||
147499433|NCT00383721|531980150|FG003|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|10|||
147499434|NCT00383721|531980151|FG004|26-Week Double-Blind Treatment Period|Participant withdrawal unrelated|11|||
147499435|NCT00383721|531980147|FG000|26-Week Double-Blind Treatment Period|Participant withdrawal related|5|||
147499436|NCT00383721|531980148|FG001|26-Week Double-Blind Treatment Period|Participant withdrawal related|3|||
147499437|NCT00383721|531980149|FG002|26-Week Double-Blind Treatment Period|Participant withdrawal related|6|||
147499438|NCT00383721|531980150|FG003|26-Week Double-Blind Treatment Period|Participant withdrawal related|8|||
147499439|NCT00383721|531980151|FG004|26-Week Double-Blind Treatment Period|Participant withdrawal related|9|||
147499440|NCT00383721|531980147|FG000|26-Week Double-Blind Treatment Period|Non-compliance with protocol|7|||
147499441|NCT00383721|531980148|FG001|26-Week Double-Blind Treatment Period|Non-compliance with protocol|5|||
147499442|NCT00383721|531980149|FG002|26-Week Double-Blind Treatment Period|Non-compliance with protocol|4|||
147499443|NCT00383721|531980150|FG003|26-Week Double-Blind Treatment Period|Non-compliance with protocol|6|||
147499444|NCT00383721|531980151|FG004|26-Week Double-Blind Treatment Period|Non-compliance with protocol|6|||
147499445|NCT00383721|531980147|FG000|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|5|||
147499446|NCT00383721|531980148|FG001|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|6|||
147499447|NCT00383721|531980149|FG002|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|11|||
147499448|NCT00383721|531980150|FG003|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|4|||
147499449|NCT00383721|531980151|FG004|26-Week Double-Blind Treatment Period|Did not meet protocol eligibility|13|||
147499450|NCT00383721|531980147|FG000|26-Week Double-Blind Treatment Period|Administrative|1|||
147499451|NCT00383721|531980148|FG001|26-Week Double-Blind Treatment Period|Administrative|3|||
147499452|NCT00383721|531980149|FG002|26-Week Double-Blind Treatment Period|Administrative|3|||
147499453|NCT00383721|531980150|FG003|26-Week Double-Blind Treatment Period|Administrative|3|||
147499454|NCT00383721|531980151|FG004|26-Week Double-Blind Treatment Period|Administrative|3|||
147499455|NCT00383721|531980147|FG000|26-Week Double-Blind Treatment Period|Ongoing|1|||
147499456|NCT00383721|531980148|FG001|26-Week Double-Blind Treatment Period|Ongoing|0|||
147499457|NCT00383721|531980149|FG002|26-Week Double-Blind Treatment Period|Ongoing|0|||
147499458|NCT00383721|531980150|FG003|26-Week Double-Blind Treatment Period|Ongoing|0|||
147499459|NCT00383721|531980151|FG004|26-Week Double-Blind Treatment Period|Ongoing|0|||
147499460|NCT00383721|531980147|FG000|26-Week Treatment Safety Extension|Adverse Event|6|||
147499461|NCT00383721|531980148|FG001|26-Week Treatment Safety Extension|Adverse Event|7|||
147499462|NCT00383721|531980149|FG002|26-Week Treatment Safety Extension|Adverse Event|10|||
147499463|NCT00383721|531980150|FG003|26-Week Treatment Safety Extension|Adverse Event|1|||
147499464|NCT00383721|531980151|FG004|26-Week Treatment Safety Extension|Adverse Event|0|||
147499465|NCT00383721|531980147|FG000|26-Week Treatment Safety Extension|Lack of Efficacy|0|||
147499466|NCT00383721|531980148|FG001|26-Week Treatment Safety Extension|Lack of Efficacy|2|||
147499467|NCT00383721|531980149|FG002|26-Week Treatment Safety Extension|Lack of Efficacy|4|||
147499468|NCT00383721|531980150|FG003|26-Week Treatment Safety Extension|Lack of Efficacy|1|||
147499469|NCT00383721|531980151|FG004|26-Week Treatment Safety Extension|Lack of Efficacy|0|||
147499470|NCT00383721|531980147|FG000|26-Week Treatment Safety Extension|Lost to Follow-up|2|||
147499471|NCT00383721|531980148|FG001|26-Week Treatment Safety Extension|Lost to Follow-up|0|||
147499472|NCT00383721|531980149|FG002|26-Week Treatment Safety Extension|Lost to Follow-up|1|||
147499473|NCT00383721|531980150|FG003|26-Week Treatment Safety Extension|Lost to Follow-up|1|||
147499474|NCT00383721|531980151|FG004|26-Week Treatment Safety Extension|Lost to Follow-up|0|||
147499475|NCT00383721|531980147|FG000|26-Week Treatment Safety Extension|Participant withdrawal unrelated|6|||
147499476|NCT00383721|531980148|FG001|26-Week Treatment Safety Extension|Participant withdrawal unrelated|4|||
147499477|NCT00383721|531980149|FG002|26-Week Treatment Safety Extension|Participant withdrawal unrelated|2|||
147499478|NCT00383721|531980150|FG003|26-Week Treatment Safety Extension|Participant withdrawal unrelated|7|||
147499479|NCT00383721|531980151|FG004|26-Week Treatment Safety Extension|Participant withdrawal unrelated|0|||
147499480|NCT00383721|531980147|FG000|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
147499481|NCT00383721|531980148|FG001|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
147499482|NCT00383721|531980149|FG002|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
147499483|NCT00383721|531980150|FG003|26-Week Treatment Safety Extension|Participant withdrawal related|1|||
147499484|NCT00383721|531980151|FG004|26-Week Treatment Safety Extension|Participant withdrawal related|0|||
147499485|NCT00383721|531980147|FG000|26-Week Treatment Safety Extension|Non-compliance with protocol|2|||
147499486|NCT00383721|531980148|FG001|26-Week Treatment Safety Extension|Non-compliance with protocol|1|||
147499487|NCT00383721|531980149|FG002|26-Week Treatment Safety Extension|Non-compliance with protocol|1|||
147499488|NCT00383721|531980150|FG003|26-Week Treatment Safety Extension|Non-compliance with protocol|4|||
147499489|NCT00383721|531980151|FG004|26-Week Treatment Safety Extension|Non-compliance with protocol|0|||
147499490|NCT00383721|531980147|FG000|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1|||
147499491|NCT00383721|531980148|FG001|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0|||
147499492|NCT00383721|531980149|FG002|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1|||
147499493|NCT00383721|531980150|FG003|26-Week Treatment Safety Extension|Did not meet protocol eligibility|1|||
147499494|NCT00383721|531980151|FG004|26-Week Treatment Safety Extension|Did not meet protocol eligibility|0|||
147499495|NCT00383721|531980147|FG000|26-Week Treatment Safety Extension|Administrative|1|||
147499496|NCT00383721|531980148|FG001|26-Week Treatment Safety Extension|Administrative|2|||
147499497|NCT00383721|531980149|FG002|26-Week Treatment Safety Extension|Administrative|3|||
147499498|NCT00383721|531980150|FG003|26-Week Treatment Safety Extension|Administrative|1|||
147499499|NCT00383721|531980151|FG004|26-Week Treatment Safety Extension|Administrative|0|||
147499500|NCT03814590|531980152|FG000|Overall Study|Adverse Event|0|||
147499501|NCT03814590|531980153|FG001|Overall Study|Adverse Event|0|||
147499502|NCT03814590|531980154|FG002|Overall Study|Adverse Event|0|||
147499503|NCT03814590|531980155|FG003|Overall Study|Adverse Event|0|||
147499504|NCT03814590|531980156|FG004|Overall Study|Adverse Event|0|||
147499505|NCT03814590|531980157|FG005|Overall Study|Adverse Event|1|||
147499506|NCT03814590|531980158|FG006|Overall Study|Adverse Event|1|||
147499507|NCT03814590|531980159|FG007|Overall Study|Adverse Event|1|||
147499508|NCT03814590|531980160|FG008|Overall Study|Adverse Event|0|||
147499509|NCT03814590|531980161|FG009|Overall Study|Adverse Event|0|||
147499510|NCT03814590|531980162|FG010|Overall Study|Adverse Event|1|||
147499511|NCT03814590|531980163|FG011|Overall Study|Adverse Event|0|||
147499512|NCT03814590|531980164|FG012|Overall Study|Adverse Event|3|||
147499513|NCT03814590|531980165|FG013|Overall Study|Adverse Event|0|||
147499514|NCT03814590|531980152|FG000|Overall Study|Lost to Follow-up|0|||
147499515|NCT03814590|531980153|FG001|Overall Study|Lost to Follow-up|2|||
147499516|NCT03814590|531980154|FG002|Overall Study|Lost to Follow-up|1|||
147499517|NCT03814590|531980155|FG003|Overall Study|Lost to Follow-up|0|||
147499518|NCT03814590|531980156|FG004|Overall Study|Lost to Follow-up|1|||
147499519|NCT03814590|531980157|FG005|Overall Study|Lost to Follow-up|1|||
147499520|NCT03814590|531980158|FG006|Overall Study|Lost to Follow-up|1|||
147499521|NCT03814590|531980159|FG007|Overall Study|Lost to Follow-up|1|||
147499522|NCT03814590|531980160|FG008|Overall Study|Lost to Follow-up|0|||
147499523|NCT03814590|531980161|FG009|Overall Study|Lost to Follow-up|0|||
147499524|NCT03814590|531980162|FG010|Overall Study|Lost to Follow-up|1|||
147499525|NCT03814590|531980163|FG011|Overall Study|Lost to Follow-up|0|||
147499526|NCT03814590|531980164|FG012|Overall Study|Lost to Follow-up|0|||
147499527|NCT03814590|531980165|FG013|Overall Study|Lost to Follow-up|1|||
147499528|NCT03814590|531980152|FG000|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
147499529|NCT03814590|531980153|FG001|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
147499530|NCT03814590|531980154|FG002|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
147499531|NCT03814590|531980155|FG003|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
147499532|NCT03814590|531980156|FG004|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
147499533|NCT03814590|531980157|FG005|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
147499534|NCT03814590|531980158|FG006|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
147499535|NCT03814590|531980159|FG007|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
147499536|NCT03814590|531980160|FG008|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
147499537|NCT03814590|531980161|FG009|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|1|||
147499538|NCT03814590|531980162|FG010|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
147499539|NCT03814590|531980163|FG011|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
147499540|NCT03814590|531980164|FG012|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
147499541|NCT03814590|531980165|FG013|Overall Study|CONSENT WITHDRAWAL, DUE TO COVID-19 BUT NOT DUE TO AN ADVERSE EVENT|0|||
147499542|NCT03814590|531980152|FG000|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
147499543|NCT03814590|531980153|FG001|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
147499544|NCT03814590|531980154|FG002|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
147499545|NCT03814590|531980155|FG003|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
147499546|NCT03814590|531980156|FG004|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
147499547|NCT03814590|531980157|FG005|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|3|||
147499548|NCT03814590|531980158|FG006|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|1|||
147499549|NCT03814590|531980159|FG007|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|2|||
147499550|NCT03814590|531980160|FG008|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
147499551|NCT03814590|531980161|FG009|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|3|||
147499552|NCT03814590|531980162|FG010|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|1|||
147499553|NCT03814590|531980163|FG011|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|0|||
147499554|NCT03814590|531980164|FG012|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|1|||
147499555|NCT03814590|531980165|FG013|Overall Study|CONSENT WITHDRAWAL, NOT DUE TO COVID-19 AND NOT DUE TO AN ADVERSE EVENT|2|||
147499556|NCT03814590|531980152|FG000|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
147499557|NCT03814590|531980153|FG001|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
147499558|NCT03814590|531980154|FG002|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
147499559|NCT03814590|531980155|FG003|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
147499560|NCT03814590|531980156|FG004|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
147499561|NCT03814590|531980157|FG005|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
147499562|NCT03814590|531980158|FG006|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
147499563|NCT03814590|531980159|FG007|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
147499564|NCT03814590|531980160|FG008|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
147499565|NCT03814590|531980161|FG009|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|1|||
147499566|NCT03814590|531980162|FG010|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
147499567|NCT03814590|531980163|FG011|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
147499568|NCT03814590|531980164|FG012|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
147499569|NCT03814590|531980165|FG013|Overall Study|MIGRATED / MOVED FROM THE STUDY AREA|0|||
147499570|NCT03814590|531980152|FG000|Overall Study|UNKNOWN REASON|0|||
147499571|NCT03814590|531980153|FG001|Overall Study|UNKNOWN REASON|0|||
147499572|NCT03814590|531980154|FG002|Overall Study|UNKNOWN REASON|0|||
147499573|NCT03814590|531980155|FG003|Overall Study|UNKNOWN REASON|0|||
147499574|NCT03814590|531980156|FG004|Overall Study|UNKNOWN REASON|0|||
147499575|NCT03814590|531980157|FG005|Overall Study|UNKNOWN REASON|0|||
147499576|NCT03814590|531980158|FG006|Overall Study|UNKNOWN REASON|0|||
147499577|NCT03814590|531980159|FG007|Overall Study|UNKNOWN REASON|1|||
147499578|NCT03814590|531980160|FG008|Overall Study|UNKNOWN REASON|0|||
147499579|NCT03814590|531980161|FG009|Overall Study|UNKNOWN REASON|0|||
147499580|NCT03814590|531980162|FG010|Overall Study|UNKNOWN REASON|0|||
147499581|NCT03814590|531980163|FG011|Overall Study|UNKNOWN REASON|0|||
147499582|NCT03814590|531980164|FG012|Overall Study|UNKNOWN REASON|0|||
147499583|NCT03814590|531980165|FG013|Overall Study|UNKNOWN REASON|0|||
147499584|NCT03519516|531980169|FG000|Overall Study|Adverse Event|0|||
147499585|NCT03519516|531980170|FG001|Overall Study|Adverse Event|1|||
147499586|NCT03287245|531981797|FG000|Overall Study|Study terminated by sponsor|3|||
147499587|NCT03287245|531981798|FG001|Overall Study|Study terminated by sponsor|0|||
147499588|NCT03287245|531981799|FG002|Overall Study|Study terminated by sponsor|3|||
147499589|NCT03287245|531981800|FG003|Overall Study|Study terminated by sponsor|1|||
147499590|NCT03287245|531981797|FG000|Overall Study|Adverse Event|1|||
147499591|NCT03287245|531981798|FG001|Overall Study|Adverse Event|0|||
147499592|NCT03287245|531981799|FG002|Overall Study|Adverse Event|0|||
147499593|NCT03287245|531981800|FG003|Overall Study|Adverse Event|0|||
147499594|NCT03287245|531981797|FG000|Overall Study|Withdrawal by Subject|8|||
147499595|NCT03287245|531981798|FG001|Overall Study|Withdrawal by Subject|3|||
147499596|NCT03287245|531981799|FG002|Overall Study|Withdrawal by Subject|3|||
147499597|NCT03287245|531981800|FG003|Overall Study|Withdrawal by Subject|0|||
147499598|NCT03287245|531981797|FG000|Overall Study|Physician Decision|3|||
147499599|NCT03287245|531981798|FG001|Overall Study|Physician Decision|2|||
147499600|NCT03287245|531981799|FG002|Overall Study|Physician Decision|0|||
147499601|NCT03287245|531981800|FG003|Overall Study|Physician Decision|0|||
147499602|NCT02701192|531981801|FG000|Overall Study|Protocol Violation|2|||
147499603|NCT02701192|531981801|FG000|Overall Study|Lost to Follow-up|4|||
147499604|NCT02862548|531981802|FG000|Randomized Phase (Up to Week 48)|Death|0|||
147499605|NCT02862548|531981803|FG001|Randomized Phase (Up to Week 48)|Death|1|||
147499606|NCT02862548|531981802|FG000|OLE Phase (Week 49 to Week 192)|Death|2|||
147499607|NCT02862548|531981803|FG001|OLE Phase (Week 49 to Week 192)|Death|0|||
147499608|NCT02862548|531981802|FG000|OLE Phase (Week 49 to Week 192)|Adverse Event|1|||
147499609|NCT02862548|531981803|FG001|OLE Phase (Week 49 to Week 192)|Adverse Event|0|||
147632509|NCT00529373|532472447|FG000|First Extension Study|Did not cont. into 2nd Ext (unknown)|32|||
147499610|NCT02862548|531981802|FG000|OLE Phase (Week 49 to Week 192)|Withdrew Consent|0|||
147499611|NCT02862548|531981803|FG001|OLE Phase (Week 49 to Week 192)|Withdrew Consent|1|||
147499612|NCT00880763|531981804|FG000|Extension Period (Part 2)|Adverse Event|0|||
147499613|NCT00880763|531981805|FG001|Extension Period (Part 2)|Adverse Event|0|||
147499614|NCT00880763|531981806|FG002|Extension Period (Part 2)|Adverse Event|1|||
147499615|NCT00880763|531981807|FG003|Extension Period (Part 2)|Adverse Event|1|||
147499616|NCT00880763|531981804|FG000|Extension Period (Part 2)|Withdrawal by Subject|0|||
147499617|NCT00880763|531981805|FG001|Extension Period (Part 2)|Withdrawal by Subject|2|||
147499618|NCT00880763|531981806|FG002|Extension Period (Part 2)|Withdrawal by Subject|1|||
147499619|NCT00880763|531981807|FG003|Extension Period (Part 2)|Withdrawal by Subject|1|||
147499620|NCT00880763|531981804|FG000|Extension Period (Part 2)|Physician Decision|0|||
147499621|NCT00880763|531981805|FG001|Extension Period (Part 2)|Physician Decision|1|||
147499622|NCT00880763|531981806|FG002|Extension Period (Part 2)|Physician Decision|1|||
147499623|NCT00880763|531981807|FG003|Extension Period (Part 2)|Physician Decision|0|||
147499624|NCT00880763|531981804|FG000|Extension Period (Part 2)|Lack of Efficacy|0|||
147499625|NCT00880763|531981805|FG001|Extension Period (Part 2)|Lack of Efficacy|0|||
147499626|NCT00880763|531981806|FG002|Extension Period (Part 2)|Lack of Efficacy|0|||
147499627|NCT00880763|531981807|FG003|Extension Period (Part 2)|Lack of Efficacy|1|||
147499628|NCT02667457|531981809|FG000|Overall Study|Withdrawal by Subject|1|||
147499629|NCT02667457|531981810|FG001|Overall Study|Withdrawal by Subject|0|||
147499630|NCT02667457|531981809|FG000|Overall Study|Other Reason|0|||
147499631|NCT02667457|531981810|FG001|Overall Study|Other Reason|2|||
147499632|NCT00603733|531981813|FG000|Active Phase ITT|Adverse Event|8|||
147499633|NCT00603733|531981814|FG001|Active Phase ITT|Adverse Event|7|||
147499634|NCT00603733|531981813|FG000|Active Phase ITT|Withdrawal by Subject|0|||
147499635|NCT00603733|531981814|FG001|Active Phase ITT|Withdrawal by Subject|3|||
147499636|NCT00603733|531981813|FG000|Active Phase ITT|Lost to Follow-up|0|||
147499637|NCT00603733|531981814|FG001|Active Phase ITT|Lost to Follow-up|1|||
147499638|NCT00603733|531981813|FG000|Active Phase ITT|Did not meet inclusion/exclusion|1|||
147499639|NCT00603733|531981814|FG001|Active Phase ITT|Did not meet inclusion/exclusion|3|||
147499640|NCT00603733|531981813|FG000|Active Phase ITT|Lack of Efficacy|1|||
147499641|NCT00603733|531981814|FG001|Active Phase ITT|Lack of Efficacy|2|||
147499642|NCT00603733|531981813|FG000|Active Phase ITT|Subject moved, site closed|1|||
147499643|NCT00603733|531981814|FG001|Active Phase ITT|Subject moved, site closed|1|||
147499644|NCT00603733|531981813|FG000|Run-In Phase - 4 Weeks|Adverse Event|2|||
147499645|NCT00603733|531981814|FG001|Run-In Phase - 4 Weeks|Adverse Event|1|||
147499646|NCT00603733|531981813|FG000|Run-In Phase - 4 Weeks|Withdrawal by Subject|4|||
147499647|NCT00603733|531981814|FG001|Run-In Phase - 4 Weeks|Withdrawal by Subject|1|||
147499648|NCT00603733|531981813|FG000|Run-In Phase - 4 Weeks|Lost to Follow-up|1|||
147499649|NCT00603733|531981814|FG001|Run-In Phase - 4 Weeks|Lost to Follow-up|0|||
147499650|NCT00603733|531981813|FG000|Run-In Phase - 4 Weeks|Did not meet incl/excl criteria|5|||
147499651|NCT00603733|531981814|FG001|Run-In Phase - 4 Weeks|Did not meet incl/excl criteria|10|||
147499652|NCT00603733|531981813|FG000|Run-In Phase - 4 Weeks|Lack of Efficacy|2|||
147499653|NCT00603733|531981814|FG001|Run-In Phase - 4 Weeks|Lack of Efficacy|1|||
147499654|NCT00603733|531981813|FG000|Maintenance Phase ITT|Adverse Event|3|||
147499655|NCT00603733|531981814|FG001|Maintenance Phase ITT|Adverse Event|6|||
147499656|NCT00603733|531981813|FG000|Maintenance Phase ITT|Withdrawal by Subject|1|||
147499657|NCT00603733|531981814|FG001|Maintenance Phase ITT|Withdrawal by Subject|0|||
147499658|NCT00603733|531981813|FG000|Maintenance Phase ITT|Protocol Violation|1|||
147499659|NCT00603733|531981814|FG001|Maintenance Phase ITT|Protocol Violation|1|||
147499660|NCT00603733|531981813|FG000|Maintenance Phase ITT|Lost to Follow-up|0|||
147499661|NCT00603733|531981814|FG001|Maintenance Phase ITT|Lost to Follow-up|1|||
147499662|NCT00603733|531981813|FG000|Maintenance Phase ITT|Lack of Efficacy|2|||
147499663|NCT00603733|531981814|FG001|Maintenance Phase ITT|Lack of Efficacy|2|||
147499664|NCT00603733|531981813|FG000|Maintenance Phase ITT|Physician Decision|0|||
147499665|NCT00603733|531981814|FG001|Maintenance Phase ITT|Physician Decision|1|||
147499666|NCT00603733|531981813|FG000|Maintenance Phase ITT|Site withdrew, subject away, lost IMP|3|||
147499667|NCT00603733|531981814|FG001|Maintenance Phase ITT|Site withdrew, subject away, lost IMP|5|||
147499668|NCT01253187|531981823|FG000|Period 2|Withdrawal by Subject|0|||
147499669|NCT01253187|531981824|FG001|Period 2|Withdrawal by Subject|0|||
147499670|NCT01253187|531981825|FG002|Period 2|Withdrawal by Subject|0|||
147499671|NCT01253187|531981826|FG003|Period 2|Withdrawal by Subject|0|||
147499672|NCT01253187|531981827|FG004|Period 2|Withdrawal by Subject|1|||
147499673|NCT01253187|531981828|FG005|Period 2|Withdrawal by Subject|0|||
147499674|NCT01253187|531981823|FG000|Period 3|Pregnancy|1|||
147499675|NCT01253187|531981824|FG001|Period 3|Pregnancy|0|||
147499676|NCT01253187|531981825|FG002|Period 3|Pregnancy|0|||
147499677|NCT01253187|531981826|FG003|Period 3|Pregnancy|0|||
147499678|NCT01253187|531981827|FG004|Period 3|Pregnancy|0|||
147499679|NCT01253187|531981828|FG005|Period 3|Pregnancy|0|||
147499680|NCT01253187|531981823|FG000|Period 3|difficulty with blood sampling|0|||
147499681|NCT01253187|531981824|FG001|Period 3|difficulty with blood sampling|1|||
147499682|NCT01253187|531981825|FG002|Period 3|difficulty with blood sampling|0|||
147499683|NCT01253187|531981826|FG003|Period 3|difficulty with blood sampling|0|||
147499684|NCT01253187|531981827|FG004|Period 3|difficulty with blood sampling|0|||
147499685|NCT01253187|531981828|FG005|Period 3|difficulty with blood sampling|0|||
147499686|NCT01253187|531981823|FG000|Period 3|non-compliance|0|||
147499687|NCT01253187|531981824|FG001|Period 3|non-compliance|0|||
147499688|NCT01253187|531981825|FG002|Period 3|non-compliance|0|||
147499689|NCT01253187|531981826|FG003|Period 3|non-compliance|0|||
147499690|NCT01253187|531981827|FG004|Period 3|non-compliance|1|||
147499691|NCT01253187|531981828|FG005|Period 3|non-compliance|0|||
147499692|NCT01293006|531981832|FG000|Period 2|Lost to Follow-up|1|||
147499693|NCT01293006|531981833|FG001|Period 2|Lost to Follow-up|0|||
147499694|NCT01293006|531981834|FG002|Period 2|Lost to Follow-up|0|||
147499695|NCT01293006|531981835|FG003|Period 2|Lost to Follow-up|0|||
147499696|NCT03084718|531981836|FG000|Overall Study|Withdrawal by Subject|4|||
147499697|NCT03084718|531981837|FG001|Overall Study|Withdrawal by Subject|3|||
147499698|NCT03084718|531981838|FG002|Overall Study|Withdrawal by Subject|4|||
147499699|NCT03084718|531981839|FG003|Overall Study|Withdrawal by Subject|0|||
147499700|NCT03084718|531981840|FG004|Overall Study|Withdrawal by Subject|0|||
147499701|NCT03084718|531981836|FG000|Overall Study|Physician Decision|1|||
147499702|NCT03084718|531981837|FG001|Overall Study|Physician Decision|0|||
147499703|NCT03084718|531981838|FG002|Overall Study|Physician Decision|0|||
147499704|NCT03084718|531981839|FG003|Overall Study|Physician Decision|0|||
147499705|NCT03084718|531981840|FG004|Overall Study|Physician Decision|0|||
147499706|NCT03084718|531981836|FG000|Overall Study|Adverse Event|3|||
147499707|NCT03084718|531981837|FG001|Overall Study|Adverse Event|5|||
147499708|NCT03084718|531981838|FG002|Overall Study|Adverse Event|5|||
147499709|NCT03084718|531981839|FG003|Overall Study|Adverse Event|8|||
147499710|NCT03084718|531981840|FG004|Overall Study|Adverse Event|2|||
147499711|NCT03084718|531981836|FG000|Overall Study|Lack of Efficacy|2|||
147499712|NCT03084718|531981837|FG001|Overall Study|Lack of Efficacy|0|||
147499713|NCT03084718|531981838|FG002|Overall Study|Lack of Efficacy|1|||
147499714|NCT03084718|531981839|FG003|Overall Study|Lack of Efficacy|4|||
147499715|NCT03084718|531981840|FG004|Overall Study|Lack of Efficacy|0|||
147499716|NCT03084718|531981836|FG000|Overall Study|Lost to Follow-up|0|||
147499717|NCT03084718|531981837|FG001|Overall Study|Lost to Follow-up|1|||
147499718|NCT03084718|531981838|FG002|Overall Study|Lost to Follow-up|0|||
147499719|NCT03084718|531981839|FG003|Overall Study|Lost to Follow-up|0|||
147499720|NCT03084718|531981840|FG004|Overall Study|Lost to Follow-up|2|||
147499721|NCT03084718|531981836|FG000|Overall Study|Protocol Violation|0|||
147499722|NCT03084718|531981837|FG001|Overall Study|Protocol Violation|0|||
147499723|NCT03084718|531981838|FG002|Overall Study|Protocol Violation|1|||
147499724|NCT03084718|531981839|FG003|Overall Study|Protocol Violation|0|||
147499725|NCT03084718|531981840|FG004|Overall Study|Protocol Violation|0|||
147499726|NCT03084718|531981836|FG000|Overall Study|Death|0|||
147499727|NCT03084718|531981837|FG001|Overall Study|Death|1|||
147499728|NCT03084718|531981838|FG002|Overall Study|Death|0|||
147499729|NCT03084718|531981839|FG003|Overall Study|Death|0|||
147499730|NCT03084718|531981840|FG004|Overall Study|Death|0|||
147499731|NCT03084718|531981836|FG000|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|1|||
147499732|NCT03084718|531981837|FG001|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|0|||
147499733|NCT03084718|531981838|FG002|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|1|||
147499734|NCT03084718|531981839|FG003|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|2|||
147499735|NCT03084718|531981840|FG004|Overall Study|Randomization error; E-diary non-compliance; Complications with device use|0|||
147499736|NCT02806947|531981841|FG000|Overall Study|Withdrawal by Subject|5|||
147499737|NCT02806947|531981842|FG001|Overall Study|Withdrawal by Subject|1|||
147499738|NCT00865189|531981843|FG000|Overall Study|Other|1|||
147499739|NCT00865189|531981844|FG001|Overall Study|Other|2|||
147499740|NCT00865189|531981843|FG000|Overall Study|Death|4|||
147499741|NCT00865189|531981844|FG001|Overall Study|Death|11|||
147499742|NCT00865189|531981843|FG000|Overall Study|Lost to Follow-up|6|||
147499743|NCT00865189|531981844|FG001|Overall Study|Lost to Follow-up|6|||
147499744|NCT00865189|531981843|FG000|Overall Study|Withdrawal by Subject|1|||
147499745|NCT00865189|531981844|FG001|Overall Study|Withdrawal by Subject|0|||
147499746|NCT00084929|531981850|FG000|Overall Study|ineligible - medical contraindication|1|||
147499747|NCT00084929|531981850|FG000|Overall Study|ineligible - Pre-scheduled procedure not|1|||
147499748|NCT00084929|531981850|FG000|Overall Study|Ineligible - Medical history|6|||
147499749|NCT00084929|531981850|FG000|Overall Study|Withdrawal by Subject|10|||
147499750|NCT00084929|531981850|FG000|Overall Study|Missing/incomplete CTC exam|9|||
147499751|NCT00084929|531981850|FG000|Overall Study|Missing Reference Standard (Colonoscopy)|42|||
147499752|NCT00091026|531981863|FG000|Overall Study|Patient deemed non eligible-never receiv|1|||
147499753|NCT00091026|531981864|FG001|Overall Study|Patient deemed non eligible-never receiv|0|||
147499754|NCT00091026|531981863|FG000|Overall Study|Patient withdrew and never received trea|0|||
147499755|NCT00091026|531981864|FG001|Overall Study|Patient withdrew and never received trea|2|||
147499756|NCT00091026|531981863|FG000|Overall Study|Unknown-never received treatment|0|||
147499757|NCT00091026|531981864|FG001|Overall Study|Unknown-never received treatment|1|||
147499758|NCT00065442|531981867|FG000|Overall Study|Lost to Follow-up|1|||
147499759|NCT00065442|531981868|FG001|Overall Study|Lost to Follow-up|1|||
147499760|NCT00065442|531981867|FG000|Overall Study|Death|121|||
147499761|NCT00065442|531981868|FG001|Overall Study|Death|210|||
147499762|NCT00065442|531981867|FG000|Overall Study|Withdrawal by Subject|3|||
147499763|NCT00065442|531981868|FG001|Overall Study|Withdrawal by Subject|9|||
147499764|NCT01594333|531981869|FG000|Overall Study|Death|96|||
147499765|NCT01594333|531981870|FG001|Overall Study|Death|83|||
147499766|NCT01594333|531981869|FG000|Overall Study|Lost to Follow-up|5|||
147499767|NCT01594333|531981870|FG001|Overall Study|Lost to Follow-up|5|||
147499768|NCT01594333|531981869|FG000|Overall Study|Withdrawal by Subject|60|||
147499769|NCT01594333|531981870|FG001|Overall Study|Withdrawal by Subject|63|||
147499770|NCT01797965|531981871|FG000|Overall Study|Adverse Event|104|||
147499771|NCT01797965|531981872|FG001|Overall Study|Adverse Event|129|||
147499772|NCT01797965|531981873|FG002|Overall Study|Adverse Event|4|||
147499773|NCT01797965|531981874|FG003|Overall Study|Adverse Event|21|||
147499774|NCT01797965|531981871|FG000|Overall Study|Lost to Follow-up|9|||
147499775|NCT01797965|531981872|FG001|Overall Study|Lost to Follow-up|8|||
147499776|NCT01797965|531981873|FG002|Overall Study|Lost to Follow-up|1|||
147499777|NCT01797965|531981874|FG003|Overall Study|Lost to Follow-up|2|||
147499778|NCT01797965|531981871|FG000|Overall Study|Consent withdrawn|130|||
147499779|NCT01797965|531981872|FG001|Overall Study|Consent withdrawn|117|||
147499780|NCT01797965|531981873|FG002|Overall Study|Consent withdrawn|3|||
147499781|NCT01797965|531981874|FG003|Overall Study|Consent withdrawn|35|||
147499782|NCT01797965|531981871|FG000|Overall Study|Investigator decision|21|||
147499783|NCT01797965|531981872|FG001|Overall Study|Investigator decision|15|||
147499784|NCT01797965|531981873|FG002|Overall Study|Investigator decision|0|||
147499785|NCT01797965|531981874|FG003|Overall Study|Investigator decision|0|||
147499786|NCT01797965|531981871|FG000|Overall Study|Death|2|||
147499787|NCT01797965|531981872|FG001|Overall Study|Death|4|||
147499788|NCT01797965|531981873|FG002|Overall Study|Death|0|||
147499789|NCT01797965|531981874|FG003|Overall Study|Death|0|||
147499790|NCT01797965|531981871|FG000|Overall Study|Disease progression, defined by protocol|3|||
147499791|NCT01797965|531981872|FG001|Overall Study|Disease progression, defined by protocol|1|||
147499792|NCT01797965|531981873|FG002|Overall Study|Disease progression, defined by protocol|0|||
147499793|NCT01797965|531981874|FG003|Overall Study|Disease progression, defined by protocol|0|||
147499794|NCT01797965|531981871|FG000|Overall Study|Reason Not Specified|280|||
147499795|NCT01797965|531981872|FG001|Overall Study|Reason Not Specified|295|||
147499796|NCT01797965|531981873|FG002|Overall Study|Reason Not Specified|0|||
147499797|NCT01797965|531981874|FG003|Overall Study|Reason Not Specified|15|||
147499798|NCT00304915|531981875|FG000|Overall Study|Lost to Follow-up|11|||
147499799|NCT00304915|531981876|FG001|Overall Study|Lost to Follow-up|11|||
147499800|NCT00304915|531981875|FG000|Overall Study|Death|4|||
147499801|NCT00304915|531981876|FG001|Overall Study|Death|5|||
147499802|NCT00304915|531981875|FG000|Overall Study|Withdrawal by Subject|3|||
147499803|NCT00304915|531981876|FG001|Overall Study|Withdrawal by Subject|0|||
147499804|NCT00712322|531981877|FG000|Overall Study|Protocol deviation|0|||
147499805|NCT00712322|531981878|FG001|Overall Study|Protocol deviation|1|||
147499806|NCT00712322|531981879|FG002|Overall Study|Protocol deviation|0|||
147499807|NCT00973921|531981882|FG000|Overall Study|IVUS results were not available|9|||
147499808|NCT02670330|531981893|FG000|Overall Study|Protocol Deviation|1|||
147499809|NCT02670330|531981894|FG001|Overall Study|Protocol Deviation|0|||
147499810|NCT02670330|531981893|FG000|Overall Study|Study Terminated By Sponsor|36|||
147499811|NCT02670330|531981894|FG001|Overall Study|Study Terminated By Sponsor|43|||
147499812|NCT02670330|531981893|FG000|Overall Study|Adverse Event|1|||
147499813|NCT02670330|531981894|FG001|Overall Study|Adverse Event|3|||
147499814|NCT02670330|531981893|FG000|Overall Study|Withdrawal by Subject|34|||
147499815|NCT02670330|531981894|FG001|Overall Study|Withdrawal by Subject|29|||
147499816|NCT02670330|531981893|FG000|Overall Study|Lost to Follow-up|3|||
147499817|NCT02670330|531981894|FG001|Overall Study|Lost to Follow-up|2|||
147499818|NCT04404010|531981895|FG000|Overall Study|Mistakenly enrolled, withdrawn after randomization (did not meet eligibility criteria)|1|||
147499819|NCT04404010|531981896|FG001|Overall Study|Mistakenly enrolled, withdrawn after randomization (did not meet eligibility criteria)|0|||
147499820|NCT02120157|531981897|FG000|Overall Study|Death|8|||
147499821|NCT01354431|531981903|FG000|Pre-Treatment Period|Not reported|1|||
147499822|NCT01354431|531981904|FG001|Pre-Treatment Period|Not reported|0|||
147499823|NCT01354431|531981905|FG002|Pre-Treatment Period|Not reported|0|||
147499824|NCT01354431|531981903|FG000|Treatment Period|Disease Progression|50|||
147499825|NCT01354431|531981904|FG001|Treatment Period|Disease Progression|40|||
147499826|NCT01354431|531981905|FG002|Treatment Period|Disease Progression|44|||
147499827|NCT01354431|531981903|FG000|Treatment Period|Study Drug Toxicity|5|||
147499828|NCT01354431|531981904|FG001|Treatment Period|Study Drug Toxicity|8|||
147499829|NCT01354431|531981905|FG002|Treatment Period|Study Drug Toxicity|4|||
147499830|NCT01354431|531981903|FG000|Treatment Period|Death|0|||
147499831|NCT01354431|531981904|FG001|Treatment Period|Death|1|||
147499832|NCT01354431|531981905|FG002|Treatment Period|Death|0|||
147499833|NCT01354431|531981903|FG000|Treatment Period|AE unrelated to study drug|1|||
147499834|NCT01354431|531981904|FG001|Treatment Period|AE unrelated to study drug|2|||
147499835|NCT01354431|531981905|FG002|Treatment Period|AE unrelated to study drug|5|||
147499836|NCT01354431|531981903|FG000|Treatment Period|Participant request to discontinue|2|||
147499837|NCT01354431|531981904|FG001|Treatment Period|Participant request to discontinue|2|||
147499838|NCT01354431|531981905|FG002|Treatment Period|Participant request to discontinue|1|||
147499839|NCT01354431|531981903|FG000|Treatment Period|Participant withdrew consent|0|||
147499840|NCT01354431|531981904|FG001|Treatment Period|Participant withdrew consent|1|||
147499841|NCT01354431|531981905|FG002|Treatment Period|Participant withdrew consent|0|||
147499842|NCT01354431|531981903|FG000|Treatment Period|Participant no longer meeting study criteria|1|||
147499843|NCT01354431|531981904|FG001|Treatment Period|Participant no longer meeting study criteria|0|||
147499844|NCT01354431|531981905|FG002|Treatment Period|Participant no longer meeting study criteria|0|||
147499845|NCT04685499|531981906|FG000|Overall Study|Study Terminated Early|1|||
147499846|NCT03176277|531981907|FG000|Part A Dose Escalation Study|Adverse Event|1|||
147499847|NCT03176277|531981908|FG001|Part A Dose Escalation Study|Adverse Event|0|||
147499848|NCT03176277|531981909|FG002|Part A Dose Escalation Study|Adverse Event|1|||
147499849|NCT03176277|531981910|FG003|Part A Dose Escalation Study|Adverse Event|0|||
147499850|NCT03176277|531981907|FG000|Part A Dose Escalation Study|Physician Decision|1|||
147499851|NCT03176277|531981908|FG001|Part A Dose Escalation Study|Physician Decision|1|||
147499852|NCT03176277|531981909|FG002|Part A Dose Escalation Study|Physician Decision|2|||
147499853|NCT03176277|531981910|FG003|Part A Dose Escalation Study|Physician Decision|0|||
147499854|NCT03176277|531981907|FG000|Part A Dose Escalation Study|Withdrawal by Subject|5|||
147499855|NCT03176277|531981908|FG001|Part A Dose Escalation Study|Withdrawal by Subject|1|||
147499856|NCT03176277|531981909|FG002|Part A Dose Escalation Study|Withdrawal by Subject|1|||
147499857|NCT03176277|531981910|FG003|Part A Dose Escalation Study|Withdrawal by Subject|0|||
147499858|NCT03176277|531981907|FG000|Part A Dose Escalation Study|Progressive disease|3|||
147499859|NCT03176277|531981908|FG001|Part A Dose Escalation Study|Progressive disease|1|||
147499860|NCT03176277|531981909|FG002|Part A Dose Escalation Study|Progressive disease|3|||
147499861|NCT03176277|531981910|FG003|Part A Dose Escalation Study|Progressive disease|0|||
147499862|NCT00634114|531981911|FG000|Overall Study|Adverse Event|6|||
147499863|NCT00634114|531981912|FG001|Overall Study|Adverse Event|8|||
147499864|NCT00634114|531981913|FG002|Overall Study|Adverse Event|3|||
147499865|NCT00634114|531981911|FG000|Overall Study|Withdrawal by Subject|9|||
147499866|NCT00634114|531981912|FG001|Overall Study|Withdrawal by Subject|6|||
147499867|NCT00634114|531981913|FG002|Overall Study|Withdrawal by Subject|11|||
147499868|NCT00634114|531981911|FG000|Overall Study|Lost to Follow-up|0|||
147499869|NCT00634114|531981912|FG001|Overall Study|Lost to Follow-up|0|||
147499870|NCT00634114|531981913|FG002|Overall Study|Lost to Follow-up|1|||
147499871|NCT00634114|531981911|FG000|Overall Study|Protocol Violation|3|||
147499872|NCT00634114|531981912|FG001|Overall Study|Protocol Violation|3|||
147499873|NCT00634114|531981913|FG002|Overall Study|Protocol Violation|1|||
147499874|NCT00634114|531981911|FG000|Overall Study|Pregnancy|1|||
147499875|NCT00634114|531981912|FG001|Overall Study|Pregnancy|0|||
147499876|NCT00634114|531981913|FG002|Overall Study|Pregnancy|0|||
147499877|NCT00634114|531981911|FG000|Overall Study|Incorrect enrolment|0|||
147499878|NCT00634114|531981912|FG001|Overall Study|Incorrect enrolment|1|||
147499879|NCT00634114|531981913|FG002|Overall Study|Incorrect enrolment|0|||
147499880|NCT00634114|531981911|FG000|Overall Study|Recurrence of reflux esophagitis|5|||
147499881|NCT00634114|531981912|FG001|Overall Study|Recurrence of reflux esophagitis|15|||
147499882|NCT00634114|531981913|FG002|Overall Study|Recurrence of reflux esophagitis|21|||
147499883|NCT00634114|531981911|FG000|Overall Study|Difficult to continue|3|||
147499884|NCT00634114|531981912|FG001|Overall Study|Difficult to continue|1|||
147499885|NCT00634114|531981913|FG002|Overall Study|Difficult to continue|1|||
147499886|NCT00634114|531981911|FG000|Overall Study|Other reason|1|||
147499887|NCT00634114|531981912|FG001|Overall Study|Other reason|1|||
147499888|NCT00634114|531981913|FG002|Overall Study|Other reason|1|||
147499889|NCT01599754|531981914|FG000|Overall Study|Anticancer therapy need not in protocol|5|||
147499890|NCT01599754|531981915|FG001|Overall Study|Anticancer therapy need not in protocol|2|||
147499891|NCT01599754|531981914|FG000|Overall Study|Participant noncompliance|4|||
147499892|NCT01599754|531981915|FG001|Overall Study|Participant noncompliance|4|||
147499893|NCT01599754|531981914|FG000|Overall Study|Lost to Follow-up|13|||
147499894|NCT01599754|531981915|FG001|Overall Study|Lost to Follow-up|6|||
147499895|NCT01599754|531981914|FG000|Overall Study|Death|31|||
147499896|NCT01599754|531981915|FG001|Overall Study|Death|33|||
147499897|NCT01599754|531981914|FG000|Overall Study|Adverse Event|3|||
147499898|NCT01599754|531981915|FG001|Overall Study|Adverse Event|2|||
147499899|NCT01599754|531981914|FG000|Overall Study|Investigator decision|1|||
147499900|NCT01599754|531981915|FG001|Overall Study|Investigator decision|3|||
147499901|NCT01599754|531981914|FG000|Overall Study|Withdrawal by Subject|24|||
147499902|NCT01599754|531981915|FG001|Overall Study|Withdrawal by Subject|25|||
147499903|NCT01599754|531981914|FG000|Overall Study|Study terminated by sponsor|282|||
147499904|NCT01599754|531981915|FG001|Overall Study|Study terminated by sponsor|285|||
147499905|NCT00702052|531981916|FG000|Overall Study|Adverse Event|23|||
147499906|NCT00702052|531981916|FG000|Overall Study|Disease Progression|30|||
147499907|NCT00702052|531981916|FG000|Overall Study|Withdrawal by Subject|5|||
147499908|NCT01577160|531981917|FG000|Overall Study|Adverse Event|9|||
147499909|NCT01577160|531981917|FG000|Overall Study|Lack of Efficacy|15|||
147499910|NCT01577160|531981917|FG000|Overall Study|Lost to Follow-up|40|||
147499911|NCT01577160|531981917|FG000|Overall Study|Withdrawal by Subject|18|||
147499912|NCT01577160|531981917|FG000|Overall Study|Subject Uncooperative|7|||
147499913|NCT01577160|531981917|FG000|Overall Study|Other|9|||
147499914|NCT00101192|531981918|FG000|Overall Study|Ineligible|6|||
147499915|NCT00101192|531981918|FG000|Overall Study|Inevaluable|1|||
147499916|NCT03670641|531981919|FG000|Overall Study|Lost to Follow-up|3|||
147632510|NCT00529373|532472448|FG001|First Extension Study|Did not cont. into 2nd Ext (unknown)|25|||
147632511|NCT00529373|532472447|FG000|Second Extension Study|Adverse Event|101|||
147632512|NCT00529373|532472448|FG001|Second Extension Study|Adverse Event|51|||
147499917|NCT03691610|531981920|FG000|Overall Study|Adverse Event|0|||
147499918|NCT03691610|531981921|FG001|Overall Study|Adverse Event|1|||
147499919|NCT03691610|531981922|FG002|Overall Study|Adverse Event|0|||
147499920|NCT03691610|531981923|FG003|Overall Study|Adverse Event|0|||
147499921|NCT03691610|531981920|FG000|Overall Study|Protocol Deviation|15|||
147499922|NCT03691610|531981921|FG001|Overall Study|Protocol Deviation|8|||
147499923|NCT03691610|531981922|FG002|Overall Study|Protocol Deviation|1|||
147499924|NCT03691610|531981923|FG003|Overall Study|Protocol Deviation|2|||
147499925|NCT03691610|531981920|FG000|Overall Study|Withdrawal by Parent/Guardian|47|||
147499926|NCT03691610|531981921|FG001|Overall Study|Withdrawal by Parent/Guardian|60|||
147499927|NCT03691610|531981922|FG002|Overall Study|Withdrawal by Parent/Guardian|7|||
147668547|NCT01296412|532611832|FG001|Overall Study|Non-compliance with study drug|2|||
147668548|NCT01296412|532611831|FG000|Overall Study|Other reason not specified|20|||
147668549|NCT01296412|532611832|FG001|Overall Study|Other reason not specified|15|||
147668550|NCT01296412|532611831|FG000|Overall Study|Physician Decision|1|||
147668551|NCT01296412|532611832|FG001|Overall Study|Physician Decision|3|||
147668552|NCT01296412|532611831|FG000|Overall Study|Pregnancy|0|||
147668553|NCT01296412|532611832|FG001|Overall Study|Pregnancy|1|||
147668554|NCT01296412|532611831|FG000|Overall Study|Withdrawal by Subject|10|||
147668555|NCT01296412|532611832|FG001|Overall Study|Withdrawal by Subject|13|||
147668556|NCT02160626|532611833|FG000|Overall Study|Adverse Event|1|||
147668557|NCT02160626|532611834|FG001|Overall Study|Adverse Event|0|||
147668558|NCT02160626|532611835|FG002|Overall Study|Adverse Event|0|||
147499928|NCT03691610|531981923|FG003|Overall Study|Withdrawal by Parent/Guardian|6|||
147499929|NCT03691610|531981920|FG000|Overall Study|Lost to Follow-up|20|||
147499930|NCT03691610|531981921|FG001|Overall Study|Lost to Follow-up|11|||
147499931|NCT03691610|531981922|FG002|Overall Study|Lost to Follow-up|5|||
147499932|NCT03691610|531981923|FG003|Overall Study|Lost to Follow-up|2|||
147499933|NCT00242580|531981926|FG000|Overall Study|Adverse Event|3|||
147499934|NCT00242580|531981927|FG001|Overall Study|Adverse Event|0|||
147499935|NCT00242580|531981928|FG002|Overall Study|Adverse Event|2|||
147499936|NCT00242580|531981926|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
147499937|NCT00242580|531981927|FG001|Overall Study|Unsatisfactory therapeutic effect|5|||
147499938|NCT00242580|531981928|FG002|Overall Study|Unsatisfactory therapeutic effect|5|||
147499939|NCT00242580|531981926|FG000|Overall Study|Protocol Violation|0|||
147499940|NCT00242580|531981927|FG001|Overall Study|Protocol Violation|0|||
147499941|NCT00242580|531981928|FG002|Overall Study|Protocol Violation|1|||
147499942|NCT00242580|531981926|FG000|Overall Study|Subject withdrew consent|2|||
147499943|NCT00242580|531981927|FG001|Overall Study|Subject withdrew consent|2|||
147499944|NCT00242580|531981928|FG002|Overall Study|Subject withdrew consent|5|||
147499945|NCT00242580|531981926|FG000|Overall Study|Lost to Follow-up|0|||
147499946|NCT00242580|531981927|FG001|Overall Study|Lost to Follow-up|3|||
147499947|NCT00242580|531981928|FG002|Overall Study|Lost to Follow-up|0|||
147499948|NCT00242580|531981926|FG000|Overall Study|Death|1|||
147499949|NCT00242580|531981927|FG001|Overall Study|Death|2|||
147499950|NCT00242580|531981928|FG002|Overall Study|Death|1|||
147499951|NCT03282357|531981930|FG000|Overall Study|Lost to Follow-up|3|||
147499952|NCT03282357|531981930|FG000|Overall Study|Withdrawal by Subject|4|||
147632513|NCT00529373|532472447|FG000|Second Extension Study|Lack of Efficacy|7|||
147632514|NCT00529373|532472448|FG001|Second Extension Study|Lack of Efficacy|15|||
147632515|NCT00529373|532472447|FG000|Second Extension Study|Lost to Follow-up|18|||
147632516|NCT00529373|532472448|FG001|Second Extension Study|Lost to Follow-up|12|||
147632517|NCT00529373|532472447|FG000|Second Extension Study|Other|7|||
147632518|NCT00529373|532472448|FG001|Second Extension Study|Other|12|||
147632519|NCT00529373|532472447|FG000|Second Extension Study|Physician Decision|63|||
147632520|NCT00529373|532472448|FG001|Second Extension Study|Physician Decision|26|||
147632521|NCT00529373|532472447|FG000|Second Extension Study|Protocol Violation|2|||
147632522|NCT00529373|532472448|FG001|Second Extension Study|Protocol Violation|1|||
147632523|NCT00529373|532472447|FG000|Second Extension Study|Withdrawal by Subject|97|||
147632524|NCT00529373|532472448|FG001|Second Extension Study|Withdrawal by Subject|75|||
147632525|NCT00529373|532472447|FG000|Second Extension Study|Status Missing|5|||
147632526|NCT00529373|532472448|FG001|Second Extension Study|Status Missing|5|||
147632527|NCT01074268|532472455|FG000|Main: Week 0 to 26 (NN1250-3585)|Adverse Event|3|||
147632528|NCT01074268|532472456|FG001|Main: Week 0 to 26 (NN1250-3585)|Adverse Event|1|||
147632529|NCT01074268|532472455|FG000|Main: Week 0 to 26 (NN1250-3585)|Lack of Efficacy|0|||
147632530|NCT01074268|532472456|FG001|Main: Week 0 to 26 (NN1250-3585)|Lack of Efficacy|2|||
147632531|NCT01074268|532472455|FG000|Main: Week 0 to 26 (NN1250-3585)|Protocol Violation|3|||
147632532|NCT01074268|532472456|FG001|Main: Week 0 to 26 (NN1250-3585)|Protocol Violation|4|||
147632533|NCT01074268|532472455|FG000|Main: Week 0 to 26 (NN1250-3585)|Withdrawal criteria|6|||
147632534|NCT01074268|532472456|FG001|Main: Week 0 to 26 (NN1250-3585)|Withdrawal criteria|3|||
147632535|NCT01074268|532472455|FG000|Main: Week 0 to 26 (NN1250-3585)|Unclassified|8|||
147632536|NCT01074268|532472456|FG001|Main: Week 0 to 26 (NN1250-3585)|Unclassified|5|||
147632537|NCT01074268|532472455|FG000|Extension: Week 27 to 52 (NN1250-3725)|Adverse Event|1|||
147632538|NCT01074268|532472456|FG001|Extension: Week 27 to 52 (NN1250-3725)|Adverse Event|1|||
147632539|NCT01074268|532472455|FG000|Extension: Week 27 to 52 (NN1250-3725)|Protocol Violation|0|||
147499953|NCT03282357|531981930|FG000|Overall Study|Adverse Event|1|||
147499954|NCT03282357|531981930|FG000|Overall Study|Other|9|||
147499955|NCT03550131|531981931|FG000|Overall Study|Lost to Follow-up|16|||
147499956|NCT03550131|531981932|FG001|Overall Study|Lost to Follow-up|24|||
147632540|NCT01074268|532472456|FG001|Extension: Week 27 to 52 (NN1250-3725)|Protocol Violation|2|||
147632541|NCT01074268|532472455|FG000|Extension: Week 27 to 52 (NN1250-3725)|Withdrawal criteria|2|||
147632542|NCT01074268|532472456|FG001|Extension: Week 27 to 52 (NN1250-3725)|Withdrawal criteria|2|||
147499957|NCT03550131|531981931|FG000|Overall Study|Withdrawal by Subject|36|||
147668559|NCT02160626|532611833|FG000|Overall Study|Schedule not conducive to study visits|0|||
147668560|NCT02160626|532611834|FG001|Overall Study|Schedule not conducive to study visits|0|||
147499958|NCT03550131|531981932|FG001|Overall Study|Withdrawal by Subject|28|||
147499959|NCT03550131|531981931|FG000|Overall Study|Illness of dyad member|10|||
147499960|NCT03550131|531981932|FG001|Overall Study|Illness of dyad member|2|||
147499961|NCT03550131|531981931|FG000|Overall Study|Death of person with dementia|4|||
147499962|NCT03550131|531981932|FG001|Overall Study|Death of person with dementia|8|||
147499963|NCT01318512|531981933|FG000|Maintenance Period (6 Months)|Death|2|||
147499964|NCT01318512|531981933|FG000|Maintenance Period (6 Months)|Protocol Violation|9|||
147499965|NCT01822691|531981936|FG000|Overall Study|Withdrawal by Subject|2|||
147499966|NCT02379390|531981937|FG000|Overall Study|Adverse Event|1|||
147499967|NCT02379390|531981938|FG001|Overall Study|Adverse Event|1|||
147499968|NCT02379390|531981937|FG000|Overall Study|Investigator's decision|1|||
147499969|NCT02379390|531981938|FG001|Overall Study|Investigator's decision|0|||
147499970|NCT02379390|531981937|FG000|Overall Study|Study Termination|0|||
147499971|NCT02379390|531981938|FG001|Overall Study|Study Termination|1|||
147499972|NCT03245723|531981947|FG000|Overall Study|Bigeminy precluding hypoxia exposure|1|||
147499973|NCT03245723|531981948|FG001|Overall Study|Bigeminy precluding hypoxia exposure|0|||
147499974|NCT03245723|531981947|FG000|Overall Study|Claustrophobia from wearing the mask|1|||
147499975|NCT03245723|531981948|FG001|Overall Study|Claustrophobia from wearing the mask|0|||
147499976|NCT03245723|531981947|FG000|Overall Study|Having to abruptly stop the scan to use the restroom|2|||
147499977|NCT03245723|531981948|FG001|Overall Study|Having to abruptly stop the scan to use the restroom|0|||
147499978|NCT03245723|531981947|FG000|Overall Study|Image acquisition/reconstruction failure|1|||
147499979|NCT03245723|531981948|FG001|Overall Study|Image acquisition/reconstruction failure|1|||
147499980|NCT00077376|531981949|FG000|Overall Study|Adverse Event|8|||
147499981|NCT00077376|531981949|FG000|Overall Study|Withdrawal by Subject|2|||
147499982|NCT00077376|531981949|FG000|Overall Study|Death|1|||
147499983|NCT00077376|531981949|FG000|Overall Study|Physician Decision|1|||
147499984|NCT00077376|531981949|FG000|Overall Study|Alternative therapy|5|||
147499985|NCT00077376|531981949|FG000|Overall Study|Complicating disease|1|||
147499986|NCT00077376|531981949|FG000|Overall Study|Still on treatment|1|||
147499987|NCT00077376|531981949|FG000|Overall Study|Symptomatic deterioration|1|||
147499988|NCT00077376|531981949|FG000|Overall Study|Surgery|1|||
147499989|NCT00077376|531981949|FG000|Overall Study|Insurance ran out|1|||
147499990|NCT01283997|531982980|FG000|Overall Study|Physician Decision|8|||
147499991|NCT01283997|531982981|FG001|Overall Study|Physician Decision|10|||
147499992|NCT01283997|531982980|FG000|Overall Study|Withdrawal by Subject|3|||
147499993|NCT01283997|531982981|FG001|Overall Study|Withdrawal by Subject|2|||
147499994|NCT01283997|531982980|FG000|Overall Study|Physically unable to continue|0|||
147499995|NCT01283997|531982981|FG001|Overall Study|Physically unable to continue|1|||
147499996|NCT01283997|531982980|FG000|Overall Study|Progressive disease|1|||
147499997|NCT01283997|531982981|FG001|Overall Study|Progressive disease|0|||
147499998|NCT01283997|531982980|FG000|Overall Study|Other|4|||
147499999|NCT01283997|531982981|FG001|Overall Study|Other|4|||
147500000|NCT01975246|531982982|FG000|Overall Study|Adverse Event|2|||
147500001|NCT01975246|531982983|FG001|Overall Study|Adverse Event|1|||
147500002|NCT01975246|531982982|FG000|Overall Study|Lack of Efficacy|1|||
147500003|NCT01975246|531982983|FG001|Overall Study|Lack of Efficacy|0|||
147500004|NCT01975246|531982982|FG000|Overall Study|Protocol Violation|1|||
147500005|NCT01975246|531982983|FG001|Overall Study|Protocol Violation|0|||
147500006|NCT01975246|531982982|FG000|Overall Study|Other than stated|0|||
147500007|NCT01975246|531982983|FG001|Overall Study|Other than stated|1|||
147500008|NCT00255034|531982984|FG000|Overall Study|Withdrawal by Subject|15|||
147500009|NCT00255034|531982985|FG001|Overall Study|Withdrawal by Subject|38|||
147500010|NCT01263093|531982986|FG000|Washout|Physician Decision|1|||
147500011|NCT01263093|531982987|FG001|Washout|Physician Decision|0|||
147500012|NCT01263093|531982986|FG000|Period 2|Adverse Event|1|||
147500013|NCT01263093|531982987|FG001|Period 2|Adverse Event|0|||
147500014|NCT00424346|531982988|FG000|Core Study|Adverse Event|5|||
147500015|NCT00424346|531982989|FG001|Core Study|Adverse Event|3|||
147500016|NCT00424346|531982990|FG002|Core Study|Adverse Event|1|||
147500017|NCT00424346|531982991|FG003|Core Study|Adverse Event|1|||
147500018|NCT00424346|531982988|FG000|Core Study|Abnormal Laboratory Values|0|||
147500019|NCT00424346|531982989|FG001|Core Study|Abnormal Laboratory Values|1|||
147500020|NCT00424346|531982990|FG002|Core Study|Abnormal Laboratory Values|0|||
147500021|NCT00424346|531982991|FG003|Core Study|Abnormal Laboratory Values|0|||
147500022|NCT00424346|531982988|FG000|Core Study|Lack of Efficacy|1|||
147500023|NCT00424346|531982989|FG001|Core Study|Lack of Efficacy|3|||
147500024|NCT00424346|531982990|FG002|Core Study|Lack of Efficacy|0|||
147500025|NCT00424346|531982991|FG003|Core Study|Lack of Efficacy|4|||
147500026|NCT00424346|531982988|FG000|Core Study|Withdrawal by Subject|1|||
147500027|NCT00424346|531982989|FG001|Core Study|Withdrawal by Subject|0|||
147500028|NCT00424346|531982990|FG002|Core Study|Withdrawal by Subject|0|||
147500029|NCT00424346|531982991|FG003|Core Study|Withdrawal by Subject|2|||
147500030|NCT00424346|531982988|FG000|Core Study|Lost to Follow-up|1|||
147500031|NCT00424346|531982989|FG001|Core Study|Lost to Follow-up|1|||
147500032|NCT00424346|531982990|FG002|Core Study|Lost to Follow-up|0|||
147500033|NCT00424346|531982991|FG003|Core Study|Lost to Follow-up|0|||
147500034|NCT00424346|531982988|FG000|Core Study|Administrative Problems|1|||
147500035|NCT00424346|531982989|FG001|Core Study|Administrative Problems|0|||
147500036|NCT00424346|531982990|FG002|Core Study|Administrative Problems|1|||
147500037|NCT00424346|531982991|FG003|Core Study|Administrative Problems|0|||
147500038|NCT00424346|531982988|FG000|Core Study|Protocol Violation|0|||
147500039|NCT00424346|531982989|FG001|Core Study|Protocol Violation|0|||
147500040|NCT00424346|531982990|FG002|Core Study|Protocol Violation|2|||
147500041|NCT00424346|531982991|FG003|Core Study|Protocol Violation|0|||
147500042|NCT00424346|531982988|FG000|Extension Phase|Adverse Event|0|||
147500043|NCT00424346|531982989|FG001|Extension Phase|Adverse Event|9|||
147500044|NCT00424346|531982990|FG002|Extension Phase|Adverse Event|5|||
147500045|NCT00424346|531982991|FG003|Extension Phase|Adverse Event|4|||
147500046|NCT00424346|531982988|FG000|Extension Phase|Lack of Efficacy|0|||
147500047|NCT00424346|531982989|FG001|Extension Phase|Lack of Efficacy|16|||
147500048|NCT00424346|531982990|FG002|Extension Phase|Lack of Efficacy|14|||
147500049|NCT00424346|531982991|FG003|Extension Phase|Lack of Efficacy|11|||
147500050|NCT00424346|531982988|FG000|Extension Phase|Withdrawal by Subject|0|||
147500051|NCT00424346|531982989|FG001|Extension Phase|Withdrawal by Subject|5|||
147500052|NCT00424346|531982990|FG002|Extension Phase|Withdrawal by Subject|3|||
147500053|NCT00424346|531982991|FG003|Extension Phase|Withdrawal by Subject|4|||
147500054|NCT00424346|531982988|FG000|Extension Phase|Lost to Follow-up|0|||
147500055|NCT00424346|531982989|FG001|Extension Phase|Lost to Follow-up|2|||
147500056|NCT00424346|531982990|FG002|Extension Phase|Lost to Follow-up|0|||
147500057|NCT00424346|531982991|FG003|Extension Phase|Lost to Follow-up|0|||
147500058|NCT00424346|531982988|FG000|Extension Phase|Administrative Problems|0|||
147500059|NCT00424346|531982989|FG001|Extension Phase|Administrative Problems|69|||
147500060|NCT00424346|531982990|FG002|Extension Phase|Administrative Problems|32|||
147500061|NCT00424346|531982991|FG003|Extension Phase|Administrative Problems|35|||
147500062|NCT00424346|531982988|FG000|Extension Phase|Death|0|||
147500063|NCT00424346|531982989|FG001|Extension Phase|Death|0|||
147500064|NCT00424346|531982990|FG002|Extension Phase|Death|0|||
147500065|NCT00424346|531982991|FG003|Extension Phase|Death|1|||
147500066|NCT00424346|531982988|FG000|Extension Phase|Protocol Violation|0|||
147500067|NCT00424346|531982989|FG001|Extension Phase|Protocol Violation|1|||
147500068|NCT00424346|531982990|FG002|Extension Phase|Protocol Violation|1|||
147500069|NCT00424346|531982991|FG003|Extension Phase|Protocol Violation|0|||
147500070|NCT01494987|531982992|FG000|Overall Study|Adverse Event|6|||
147500071|NCT01494987|531982993|FG001|Overall Study|Adverse Event|5|||
147500072|NCT01494987|531982992|FG000|Overall Study|Hyperglycemia|6|||
147500073|NCT01494987|531982993|FG001|Overall Study|Hyperglycemia|4|||
147500074|NCT01494987|531982992|FG000|Overall Study|Investigator's Discretion|1|||
147500075|NCT01494987|531982993|FG001|Overall Study|Investigator's Discretion|2|||
147500076|NCT01494987|531982992|FG000|Overall Study|Lost to Follow-up|1|||
147500077|NCT01494987|531982993|FG001|Overall Study|Lost to Follow-up|1|||
147500078|NCT01494987|531982992|FG000|Overall Study|Protocol Violation|3|||
147500079|NCT01494987|531982993|FG001|Overall Study|Protocol Violation|3|||
147500080|NCT01494987|531982992|FG000|Overall Study|Subject Non-Compliance|9|||
147500081|NCT01494987|531982993|FG001|Overall Study|Subject Non-Compliance|10|||
147500082|NCT01494987|531982992|FG000|Overall Study|Subject Withdrew Consent|2|||
147500083|NCT01494987|531982993|FG001|Overall Study|Subject Withdrew Consent|3|||
147500084|NCT02254551|531982996|FG000|Dose Escalation|Physician Decision|1|||
147500085|NCT02254551|531982996|FG000|Dose Escalation|Dose-limiting toxicity|2|||
147500086|NCT02759562|531982997|FG000|Open-Label Treatment Period|Withdrew Consent|1|||
147500087|NCT02759562|531982998|FG001|Open-Label Treatment Period|Withdrew Consent|0|||
147500088|NCT02759562|531982997|FG000|Open-Label Treatment Period|Study Terminated by Sponsor|1|||
147500089|NCT02759562|531982998|FG001|Open-Label Treatment Period|Study Terminated by Sponsor|2|||
147500090|NCT02293993|531982999|FG000|Course 1 (DLT Evaluation Period)|Clear progression of the primary disease including relapses|1|||
147500091|NCT02293993|531983000|FG001|Course 1 (DLT Evaluation Period)|Clear progression of the primary disease including relapses|0|||
147632543|NCT01074268|532472455|FG000|Extension: Week 27 to 52 (NN1250-3725)|Unclassified|3|||
147632544|NCT01074268|532472456|FG001|Extension: Week 27 to 52 (NN1250-3725)|Unclassified|2|||
147632545|NCT00603473|532472459|FG000|Overall Study|Adverse Event|4|||
147500092|NCT02293993|531983001|FG002|Course 1 (DLT Evaluation Period)|Clear progression of the primary disease including relapses|0|||
147500093|NCT02293993|531983002|FG003|Course 1 (DLT Evaluation Period)|Clear progression of the primary disease including relapses|1|||
147500094|NCT02293993|531982999|FG000|Course ≥2 (Extended Treatment Period)|Physician Decision|0|||
147500095|NCT02293993|531983000|FG001|Course ≥2 (Extended Treatment Period)|Physician Decision|2|||
147500096|NCT02293993|531983001|FG002|Course ≥2 (Extended Treatment Period)|Physician Decision|1|||
147500097|NCT02293993|531983002|FG003|Course ≥2 (Extended Treatment Period)|Physician Decision|0|||
147500098|NCT02293993|531982999|FG000|Course ≥2 (Extended Treatment Period)|Withdrawal by Subject|0|||
147500099|NCT02293993|531983000|FG001|Course ≥2 (Extended Treatment Period)|Withdrawal by Subject|0|||
147500100|NCT02293993|531983001|FG002|Course ≥2 (Extended Treatment Period)|Withdrawal by Subject|1|||
147500101|NCT02293993|531983002|FG003|Course ≥2 (Extended Treatment Period)|Withdrawal by Subject|0|||
147500102|NCT02293993|531982999|FG000|Course ≥2 (Extended Treatment Period)|Clear progression of the primary disease including relapses|2|||
147500103|NCT02293993|531983000|FG001|Course ≥2 (Extended Treatment Period)|Clear progression of the primary disease including relapses|2|||
147632546|NCT00603473|532472459|FG000|Overall Study|Lack of Efficacy|4|||
147500104|NCT02293993|531983001|FG002|Course ≥2 (Extended Treatment Period)|Clear progression of the primary disease including relapses|3|||
147500105|NCT02293993|531983002|FG003|Course ≥2 (Extended Treatment Period)|Clear progression of the primary disease including relapses|1|||
147500106|NCT02293993|531982999|FG000|Course ≥2 (Extended Treatment Period)|Delay in commencement of the next course by more than 4 weeks|0|||
147500107|NCT02293993|531983000|FG001|Course ≥2 (Extended Treatment Period)|Delay in commencement of the next course by more than 4 weeks|1|||
147500108|NCT02293993|531983001|FG002|Course ≥2 (Extended Treatment Period)|Delay in commencement of the next course by more than 4 weeks|0|||
147500109|NCT02293993|531983002|FG003|Course ≥2 (Extended Treatment Period)|Delay in commencement of the next course by more than 4 weeks|0|||
147500110|NCT01957709|531983003|FG000|Overall Study|Patient refused to complete post-tx bx|1|||
147500111|NCT03587584|531983004|FG000|Overall Study|SOC deviations|4|||
147500112|NCT03587584|531983005|FG001|Overall Study|SOC deviations|6|||
147500113|NCT03587584|531983004|FG000|Overall Study|Incomplete data|0|||
147500114|NCT03587584|531983005|FG001|Overall Study|Incomplete data|3|||
147500115|NCT01061736|531983008|FG000|Overall Study|Dose regimen not selected|0|||
147500116|NCT01061736|531983009|FG001|Overall Study|Dose regimen not selected|0|||
147500117|NCT01061736|531983010|FG002|Overall Study|Dose regimen not selected|0|||
147500118|NCT01061736|531983011|FG003|Overall Study|Dose regimen not selected|0|||
147500119|NCT01061736|531983012|FG004|Overall Study|Dose regimen not selected|0|||
147500120|NCT01061736|531983013|FG005|Overall Study|Dose regimen not selected|0|||
147500121|NCT01061736|531983014|FG006|Overall Study|Dose regimen not selected|79|||
147500122|NCT01061736|531983015|FG007|Overall Study|Dose regimen not selected|0|||
147500123|NCT01061736|531983016|FG008|Overall Study|Dose regimen not selected|0|||
147500124|NCT01061736|531983017|FG009|Overall Study|Dose regimen not selected|0|||
147500125|NCT01061736|531983008|FG000|Overall Study|Adverse Event|13|||
147500126|NCT01061736|531983009|FG001|Overall Study|Adverse Event|1|||
147500127|NCT01061736|531983010|FG002|Overall Study|Adverse Event|3|||
147632547|NCT00603473|532472459|FG000|Overall Study|Protocol Violation|1|||
147632548|NCT00733421|532472460|FG000|Overall Study|Withdrawal by Subject|1|||
147632549|NCT00733421|532472461|FG001|Overall Study|Withdrawal by Subject|1|||
147632550|NCT04185220|532472465|FG000|Dose Escalation|Stopped treatment early due to progressive disease, dose limiting toxicity and acute renal failure|0|||
147632551|NCT04185220|532472466|FG001|Dose Escalation|Stopped treatment early due to progressive disease, dose limiting toxicity and acute renal failure|1|||
147632552|NCT04185220|532472465|FG000|Dose Escalation|Stopped treatment early on cycle 1/day 2 due to Gr 2 infusion reaction & resulting Gr 3 hip fracture|0|||
147632553|NCT04185220|532472466|FG001|Dose Escalation|Stopped treatment early on cycle 1/day 2 due to Gr 2 infusion reaction & resulting Gr 3 hip fracture|1|||
147632554|NCT00789698|532472469|FG000|Overall Study|Lack of Efficacy|10|||
147632555|NCT00789698|532472470|FG001|Overall Study|Lack of Efficacy|4|||
147632556|NCT00789698|532472471|FG002|Overall Study|Lack of Efficacy|5|||
147632557|NCT00789698|532472472|FG003|Overall Study|Lack of Efficacy|18|||
147632558|NCT00789698|532472469|FG000|Overall Study|Adverse Event|5|||
147632559|NCT00789698|532472470|FG001|Overall Study|Adverse Event|5|||
147632560|NCT00789698|532472471|FG002|Overall Study|Adverse Event|3|||
147632561|NCT00789698|532472472|FG003|Overall Study|Adverse Event|4|||
147632562|NCT00789698|532472469|FG000|Overall Study|Lost to Follow-up|5|||
147632563|NCT00789698|532472470|FG001|Overall Study|Lost to Follow-up|5|||
147632564|NCT00789698|532472471|FG002|Overall Study|Lost to Follow-up|2|||
147632565|NCT00789698|532472472|FG003|Overall Study|Lost to Follow-up|9|||
147632566|NCT00789698|532472469|FG000|Overall Study|Protocol Violation|6|||
147632567|NCT00789698|532472470|FG001|Overall Study|Protocol Violation|1|||
147632568|NCT00789698|532472471|FG002|Overall Study|Protocol Violation|2|||
147632569|NCT00789698|532472472|FG003|Overall Study|Protocol Violation|1|||
147632570|NCT00789698|532472469|FG000|Overall Study|Withdrawal by Subject|14|||
147632571|NCT00789698|532472470|FG001|Overall Study|Withdrawal by Subject|15|||
147632572|NCT00789698|532472471|FG002|Overall Study|Withdrawal by Subject|12|||
147632573|NCT00789698|532472472|FG003|Overall Study|Withdrawal by Subject|19|||
147632574|NCT00789698|532472469|FG000|Overall Study|Administrative|0|||
147632575|NCT00789698|532472470|FG001|Overall Study|Administrative|3|||
147632576|NCT00789698|532472471|FG002|Overall Study|Administrative|3|||
147632577|NCT00789698|532472472|FG003|Overall Study|Administrative|1|||
147632578|NCT01870973|532472473|FG000|Overall Study|Lost to Follow-up|10|||
147632579|NCT01870973|532472474|FG001|Overall Study|Lost to Follow-up|3|||
147632580|NCT02702388|532472477|FG000|Overall Study|Disease Progression|18|||
147632581|NCT02702388|532472478|FG001|Overall Study|Disease Progression|25|||
147632582|NCT02702388|532472477|FG000|Overall Study|Withdrawal by Subject|9|||
147632583|NCT02702388|532472478|FG001|Overall Study|Withdrawal by Subject|7|||
147632584|NCT02702388|532472477|FG000|Overall Study|Adverse Event|11|||
147632585|NCT02702388|532472478|FG001|Overall Study|Adverse Event|15|||
147632586|NCT02702388|532472477|FG000|Overall Study|Other|2|||
147500128|NCT01061736|531983011|FG003|Overall Study|Adverse Event|2|||
147500129|NCT01061736|531983012|FG004|Overall Study|Adverse Event|4|||
147632587|NCT02702388|532472478|FG001|Overall Study|Other|4|||
147632588|NCT01806961|532474413|FG000|Overall Study|sponsor decision|16|||
147632589|NCT00679029|532474416|FG000|Overall Study|Adverse Event|3|||
147632590|NCT00679029|532474416|FG000|Overall Study|Withdrawal by Subject|1|||
147632591|NCT00679029|532474416|FG000|Overall Study|Lost to Follow-up|1|||
147632592|NCT00769067|532474420|FG000|Overall Study|Death|89|||
147668561|NCT02160626|532611835|FG002|Overall Study|Schedule not conducive to study visits|1|||
147668562|NCT02160626|532611833|FG000|Overall Study|Withdrawal by Subject|0|||
147668563|NCT02160626|532611834|FG001|Overall Study|Withdrawal by Subject|1|||
147668564|NCT02160626|532611835|FG002|Overall Study|Withdrawal by Subject|0|||
147500130|NCT01061736|531983013|FG005|Overall Study|Adverse Event|1|||
147500131|NCT01061736|531983014|FG006|Overall Study|Adverse Event|4|||
147500132|NCT01061736|531983015|FG007|Overall Study|Adverse Event|63|||
147500133|NCT01061736|531983016|FG008|Overall Study|Adverse Event|67|||
147500134|NCT01061736|531983017|FG009|Overall Study|Adverse Event|34|||
147500135|NCT01061736|531983008|FG000|Overall Study|Lack of Efficacy|0|||
147500136|NCT01061736|531983009|FG001|Overall Study|Lack of Efficacy|2|||
147500137|NCT01061736|531983010|FG002|Overall Study|Lack of Efficacy|1|||
147500138|NCT01061736|531983011|FG003|Overall Study|Lack of Efficacy|1|||
147500139|NCT01061736|531983012|FG004|Overall Study|Lack of Efficacy|1|||
147500140|NCT01061736|531983013|FG005|Overall Study|Lack of Efficacy|2|||
147500141|NCT01061736|531983014|FG006|Overall Study|Lack of Efficacy|1|||
147500142|NCT01061736|531983015|FG007|Overall Study|Lack of Efficacy|9|||
147500143|NCT01061736|531983016|FG008|Overall Study|Lack of Efficacy|9|||
147500144|NCT01061736|531983017|FG009|Overall Study|Lack of Efficacy|10|||
147500145|NCT01061736|531983008|FG000|Overall Study|Poor compliance to protocol|0|||
147500146|NCT01061736|531983009|FG001|Overall Study|Poor compliance to protocol|0|||
147500147|NCT01061736|531983010|FG002|Overall Study|Poor compliance to protocol|0|||
147500148|NCT01061736|531983011|FG003|Overall Study|Poor compliance to protocol|0|||
147500149|NCT01061736|531983012|FG004|Overall Study|Poor compliance to protocol|0|||
147500150|NCT01061736|531983013|FG005|Overall Study|Poor compliance to protocol|0|||
147500151|NCT01061736|531983014|FG006|Overall Study|Poor compliance to protocol|0|||
147500152|NCT01061736|531983015|FG007|Overall Study|Poor compliance to protocol|2|||
147500153|NCT01061736|531983016|FG008|Overall Study|Poor compliance to protocol|5|||
147500154|NCT01061736|531983017|FG009|Overall Study|Poor compliance to protocol|9|||
147500155|NCT01061736|531983008|FG000|Overall Study|Not treated|0|||
147500156|NCT01061736|531983009|FG001|Overall Study|Not treated|0|||
147500157|NCT01061736|531983010|FG002|Overall Study|Not treated|0|||
147500158|NCT01061736|531983011|FG003|Overall Study|Not treated|0|||
147500159|NCT01061736|531983012|FG004|Overall Study|Not treated|1|||
147500160|NCT01061736|531983013|FG005|Overall Study|Not treated|0|||
147500161|NCT01061736|531983014|FG006|Overall Study|Not treated|0|||
147500162|NCT01061736|531983015|FG007|Overall Study|Not treated|2|||
147500163|NCT01061736|531983016|FG008|Overall Study|Not treated|1|||
147500164|NCT01061736|531983017|FG009|Overall Study|Not treated|0|||
147500165|NCT01061736|531983008|FG000|Overall Study|Other than specified above|0|||
147500166|NCT01061736|531983009|FG001|Overall Study|Other than specified above|1|||
147500167|NCT01061736|531983010|FG002|Overall Study|Other than specified above|2|||
147500168|NCT01061736|531983011|FG003|Overall Study|Other than specified above|0|||
147500169|NCT01061736|531983012|FG004|Overall Study|Other than specified above|1|||
147500170|NCT01061736|531983013|FG005|Overall Study|Other than specified above|0|||
147500171|NCT01061736|531983014|FG006|Overall Study|Other than specified above|0|||
147500172|NCT01061736|531983015|FG007|Overall Study|Other than specified above|18|||
147500173|NCT01061736|531983016|FG008|Overall Study|Other than specified above|15|||
147500174|NCT01061736|531983017|FG009|Overall Study|Other than specified above|21|||
147500175|NCT01093755|531983019|FG000|Overall Study|Withdrawal by Subject|3|||
147668565|NCT00750269|532613319|FG000|Overall Study|Protocol Violation|0|||
147500176|NCT01093755|531983020|FG001|Overall Study|Withdrawal by Subject|4|||
147500177|NCT03115112|531983021|FG000|Overall Study|Adverse Event|5|||
147500178|NCT03115112|531983022|FG001|Overall Study|Adverse Event|1|||
147500179|NCT03115112|531983021|FG000|Overall Study|Withdrawal by Subject|4|||
147500180|NCT03115112|531983022|FG001|Overall Study|Withdrawal by Subject|2|||
147500181|NCT03115112|531983021|FG000|Overall Study|Lost to Follow-up|0|||
147500182|NCT03115112|531983022|FG001|Overall Study|Lost to Follow-up|1|||
147500183|NCT03115112|531983021|FG000|Overall Study|Death|1|||
147500184|NCT03115112|531983022|FG001|Overall Study|Death|0|||
147500185|NCT03115112|531983021|FG000|Overall Study|Pregnancy|1|||
147500186|NCT03115112|531983022|FG001|Overall Study|Pregnancy|0|||
147500187|NCT03115112|531983021|FG000|Overall Study|Site closure|1|||
147500188|NCT03115112|531983022|FG001|Overall Study|Site closure|1|||
147500189|NCT04019795|531983024|FG000|Overall Study|Withdrawal by Subject|1|||
147500190|NCT04019795|531983025|FG001|Overall Study|Withdrawal by Subject|2|||
147500191|NCT04019795|531983026|FG002|Overall Study|Withdrawal by Subject|2|||
147500192|NCT04019795|531983027|FG003|Overall Study|Withdrawal by Subject|1|||
147500193|NCT04019795|531983024|FG000|Overall Study|Lost to Follow-up|0|||
147500194|NCT04019795|531983025|FG001|Overall Study|Lost to Follow-up|1|||
147500195|NCT04019795|531983026|FG002|Overall Study|Lost to Follow-up|1|||
147500196|NCT04019795|531983027|FG003|Overall Study|Lost to Follow-up|2|||
147500197|NCT04019795|531983024|FG000|Overall Study|Treatment non-compliance|3|||
147500198|NCT04019795|531983025|FG001|Overall Study|Treatment non-compliance|1|||
147500199|NCT04019795|531983026|FG002|Overall Study|Treatment non-compliance|2|||
147500200|NCT04019795|531983027|FG003|Overall Study|Treatment non-compliance|0|||
147500201|NCT04019795|531983024|FG000|Overall Study|Physician Decision|0|||
147668566|NCT00750269|532613320|FG001|Overall Study|Protocol Violation|1|||
147500202|NCT04019795|531983025|FG001|Overall Study|Physician Decision|0|||
147500203|NCT04019795|531983026|FG002|Overall Study|Physician Decision|1|||
147500204|NCT04019795|531983027|FG003|Overall Study|Physician Decision|0|||
147500205|NCT04019795|531983024|FG000|Overall Study|Adverse Event|1|||
147500206|NCT04019795|531983025|FG001|Overall Study|Adverse Event|0|||
147500207|NCT04019795|531983026|FG002|Overall Study|Adverse Event|0|||
147500208|NCT04019795|531983027|FG003|Overall Study|Adverse Event|0|||
147500209|NCT01170702|531983034|FG000|Overall Study|Exclusion criteria met after consent|1|||
147500210|NCT01170702|531983035|FG001|Overall Study|Exclusion criteria met after consent|2|||
147500211|NCT01170702|531983036|FG002|Overall Study|Exclusion criteria met after consent|0|||
147500212|NCT01170702|531983037|FG003|Overall Study|Exclusion criteria met after consent|2|||
147500213|NCT00098020|531983040|FG000|Overall Study|Adverse Event|2|||
147500214|NCT00098020|531983040|FG000|Overall Study|Lost to Follow-up|1|||
147500215|NCT00098020|531983040|FG000|Overall Study|elevated liver enzymes|1|||
147500216|NCT00098020|531983040|FG000|Overall Study|Low urine PCR|1|||
147500217|NCT00098020|531983040|FG000|Overall Study|Low epidermal growth factor receptor|1|||
147500218|NCT02022033|531983046|FG000|Overall Study|Physician Decision|1|||
147500219|NCT01429077|531983047|FG000|Overall Study|Lost to Follow-up|0|||
147500220|NCT01429077|531983048|FG001|Overall Study|Lost to Follow-up|3|||
147500221|NCT01413542|531983050|FG000|Overall Study|Physician Decision|1|||
147500222|NCT01413542|531983051|FG001|Overall Study|Physician Decision|0|||
147500223|NCT01413542|531983052|FG002|Overall Study|Physician Decision|3|||
147500224|NCT01413542|531983053|FG003|Overall Study|Physician Decision|0|||
147500225|NCT01413542|531983050|FG000|Overall Study|Adverse Event|0|||
147500226|NCT01413542|531983051|FG001|Overall Study|Adverse Event|0|||
147500227|NCT01413542|531983052|FG002|Overall Study|Adverse Event|0|||
147500228|NCT01413542|531983053|FG003|Overall Study|Adverse Event|1|||
147500229|NCT03341923|531983054|FG000|Period 2, Second 14 Days of Wear|Adverse Event|0|||
147500230|NCT03341923|531983055|FG001|Period 2, Second 14 Days of Wear|Adverse Event|1|||
147500231|NCT03986190|531983056|FG000|Overall Study|Withdrawal by Subject|12|||
147500232|NCT03986190|531983057|FG001|Overall Study|Withdrawal by Subject|0|||
147500233|NCT04511819|531983058|FG000|Overall Study|Non-compliance with study drug|5|||
147500234|NCT04511819|531983059|FG001|Overall Study|Non-compliance with study drug|1|||
147500235|NCT04511819|531983058|FG000|Overall Study|Withdrawal by Subject|0|||
147500236|NCT04511819|531983059|FG001|Overall Study|Withdrawal by Subject|3|||
147500237|NCT04511819|531983058|FG000|Overall Study|Adverse Event|0|||
147500238|NCT04511819|531983059|FG001|Overall Study|Adverse Event|1|||
147500239|NCT04511819|531983058|FG000|Overall Study|Protocol deviation|1|||
147500240|NCT04511819|531983059|FG001|Overall Study|Protocol deviation|0|||
147500241|NCT00844649|531983060|FG000|Overall Study|Progressive Disease|196|||
147500242|NCT00844649|531983061|FG001|Overall Study|Progressive Disease|245|||
147500243|NCT00844649|531983060|FG000|Overall Study|Adverse Event|128|||
147500244|NCT00844649|531983061|FG001|Overall Study|Adverse Event|73|||
147500245|NCT00844649|531983060|FG000|Overall Study|Physician Decision|25|||
147500246|NCT00844649|531983061|FG001|Overall Study|Physician Decision|18|||
147500247|NCT00844649|531983060|FG000|Overall Study|Protocol Violation|10|||
147500248|NCT00844649|531983061|FG001|Overall Study|Protocol Violation|6|||
147500249|NCT00844649|531983060|FG000|Overall Study|Withdrawal by Subject|28|||
147500250|NCT00844649|531983061|FG001|Overall Study|Withdrawal by Subject|39|||
147632593|NCT00769067|532474421|FG001|Overall Study|Death|86|||
147632594|NCT00769067|532474420|FG000|Overall Study|Lost to Follow-up|3|||
147632595|NCT00769067|532474421|FG001|Overall Study|Lost to Follow-up|1|||
147632596|NCT00769067|532474420|FG000|Overall Study|Study terminated by sponsor|1|||
147632597|NCT00769067|532474421|FG001|Overall Study|Study terminated by sponsor|3|||
147500251|NCT00844649|531983060|FG000|Overall Study|Other|7|||
147500252|NCT00844649|531983061|FG001|Overall Study|Other|10|||
147500253|NCT00844649|531983060|FG000|Overall Study|Withdrew prior to starting treatment|11|||
147500254|NCT00844649|531983061|FG001|Overall Study|Withdrew prior to starting treatment|27|||
147500255|NCT02767856|531983062|FG000|Overall Study|Lost to Follow-up|9|||
147500256|NCT02767856|531983063|FG001|Overall Study|Lost to Follow-up|1|||
147500257|NCT02767856|531983062|FG000|Overall Study|Withdrawal by Subject|2|||
147500258|NCT02767856|531983063|FG001|Overall Study|Withdrawal by Subject|1|||
147500259|NCT00239837|531983064|FG000|Overall Study|Lost to Follow-up|3|||
147500260|NCT00239837|531983065|FG001|Overall Study|Lost to Follow-up|7|||
147500261|NCT00536978|531983066|FG000|Overall Study|Not eligible for Adback Infusion|22|||
147500262|NCT00622869|531983072|FG000|Overall Study|Subject Withdrew Consent|13|||
147500263|NCT00622869|531983073|FG001|Overall Study|Subject Withdrew Consent|17|||
147500264|NCT00622869|531983074|FG002|Overall Study|Subject Withdrew Consent|11|||
147500265|NCT00622869|531983072|FG000|Overall Study|Administrative Problems|11|||
147632598|NCT00769067|532474420|FG000|Overall Study|Other|1|||
147632599|NCT00769067|532474421|FG001|Overall Study|Other|3|||
147632600|NCT00769067|532474420|FG000|Overall Study|Withdrawal by Subject|0|||
147632601|NCT00769067|532474421|FG001|Overall Study|Withdrawal by Subject|1|||
147500266|NCT00622869|531983073|FG001|Overall Study|Administrative Problems|17|||
147500267|NCT00622869|531983074|FG002|Overall Study|Administrative Problems|13|||
147632602|NCT04981470|532474424|FG000|Overall Study|Device failure in all 4 patients|4|||
147500268|NCT00622869|531983072|FG000|Overall Study|Death|12|||
147500269|NCT00622869|531983073|FG001|Overall Study|Death|15|||
147632603|NCT00078767|532474425|FG000|Overall Study|Withdrawal by Subject|1|||
147500270|NCT00622869|531983074|FG002|Overall Study|Death|10|||
147500271|NCT00622869|531983072|FG000|Overall Study|Lost to Follow-up|2|||
147500272|NCT00622869|531983073|FG001|Overall Study|Lost to Follow-up|4|||
147500273|NCT00622869|531983074|FG002|Overall Study|Lost to Follow-up|2|||
147668567|NCT00750269|532613321|FG002|Overall Study|Protocol Violation|1|||
147668568|NCT00750269|532613322|FG003|Overall Study|Protocol Violation|2|||
147668569|NCT00750269|532613323|FG004|Overall Study|Protocol Violation|4|||
147668570|NCT00750269|532613319|FG000|Overall Study|Withdrawal by Subject|0|||
147668571|NCT00750269|532613320|FG001|Overall Study|Withdrawal by Subject|0|||
147668572|NCT00750269|532613321|FG002|Overall Study|Withdrawal by Subject|2|||
147668573|NCT00750269|532613322|FG003|Overall Study|Withdrawal by Subject|2|||
147668574|NCT00750269|532613323|FG004|Overall Study|Withdrawal by Subject|2|||
147668575|NCT00750269|532613319|FG000|Overall Study|Physician Decision|0|||
147668576|NCT00750269|532613320|FG001|Overall Study|Physician Decision|0|||
147500274|NCT00622869|531983072|FG000|Overall Study|Graft Loss|5|||
147500275|NCT00622869|531983073|FG001|Overall Study|Graft Loss|3|||
147500276|NCT00622869|531983074|FG002|Overall Study|Graft Loss|2|||
147500277|NCT00622869|531983072|FG000|Overall Study|Missing|0|||
147500278|NCT00622869|531983073|FG001|Overall Study|Missing|1|||
147500279|NCT00622869|531983074|FG002|Overall Study|Missing|1|||
147500280|NCT04664855|531983076|FG000|Overall Study|Withdrawal by Subject|0|||
147500281|NCT04664855|531983077|FG001|Overall Study|Withdrawal by Subject|2|||
147500282|NCT03076190|531983078|FG000|Overall Study|Lost to Follow-up|9|||
147500283|NCT03076190|531983079|FG001|Overall Study|Lost to Follow-up|34|||
147500284|NCT03076190|531983078|FG000|Overall Study|Excluded from Analysis (zero duration ev|9|||
147500285|NCT03076190|531983079|FG001|Overall Study|Excluded from Analysis (zero duration ev|7|||
147500286|NCT00393913|531983081|FG000|Initial Assessment|diagnosed with other sleep disorder|21|||
147500287|NCT00393913|531983081|FG000|Initial Assessment|Withdrawal by Subject|16|||
147500288|NCT00393913|531983081|FG000|CPAP|Withdrawal by Subject|3|||
147500289|NCT00393913|531983081|FG000|CPAP|Physician Decision|1|||
147500290|NCT00393913|531983081|FG000|CPAP|TEchnical problem with CPAP|3|||
147500291|NCT01518244|531983082|FG000|Overall Study|Adverse Event|3|||
147500292|NCT00870818|531983083|FG000|Overall Study|Lost to Follow-up|3|||
147500293|NCT00870818|531983084|FG001|Overall Study|Lost to Follow-up|2|||
147500294|NCT00870818|531983085|FG002|Overall Study|Lost to Follow-up|1|||
147500295|NCT00870818|531983086|FG003|Overall Study|Lost to Follow-up|0|||
147500296|NCT00870818|531983087|FG004|Overall Study|Lost to Follow-up|0|||
147500297|NCT00870818|531983083|FG000|Overall Study|Withdrawal by Subject|0|||
147500298|NCT00870818|531983084|FG001|Overall Study|Withdrawal by Subject|0|||
147500299|NCT00870818|531983085|FG002|Overall Study|Withdrawal by Subject|1|||
147500300|NCT00870818|531983086|FG003|Overall Study|Withdrawal by Subject|2|||
147500301|NCT00870818|531983087|FG004|Overall Study|Withdrawal by Subject|0|||
147500302|NCT00870818|531983083|FG000|Overall Study|Terminated by sponsor|29|||
147500303|NCT00870818|531983084|FG001|Overall Study|Terminated by sponsor|70|||
147500304|NCT00870818|531983085|FG002|Overall Study|Terminated by sponsor|36|||
147500305|NCT00870818|531983086|FG003|Overall Study|Terminated by sponsor|36|||
147500306|NCT00870818|531983087|FG004|Overall Study|Terminated by sponsor|38|||
147500307|NCT00870818|531983083|FG000|Overall Study|Other|0|||
147500308|NCT00870818|531983084|FG001|Overall Study|Other|1|||
147500309|NCT00870818|531983085|FG002|Overall Study|Other|0|||
147632604|NCT00078767|532474426|FG001|Overall Study|Withdrawal by Subject|1|||
147632605|NCT03233529|532474427|FG000|Double-Blind Period (Day 1 to Day 15)|Adverse Event|1|||
147632606|NCT03233529|532474427|FG000|Open-Label Period (Day 15 to Day 71)|Adverse Event|1|||
147632607|NCT00594100|532474434|FG000|Procedure|Technical Failure|9|||
147632608|NCT00594100|532474434|FG000|Follow-up Through 30 Days Post Procedure|Death / Reintervention / Medical Reasons|2|||
147632609|NCT00594100|532474434|FG000|Follow-up Through 30 Days Post Procedure|Discontinued Prior to Visit|6|||
147632610|NCT00594100|532474434|FG000|Follow-up Through 30 Days Post Procedure|Missed Visit - Phone Contact Follow-up|4|||
147632611|NCT00160706|532474437|FG000|Overall Study|Adverse Event|53|||
147632612|NCT00160706|532474437|FG000|Overall Study|Adverse Event and Other Reason|105|||
147632613|NCT00160706|532474437|FG000|Overall Study|Protocol Violation|3|||
147632614|NCT00160706|532474437|FG000|Overall Study|Withdrawal by Subject|41|||
147632615|NCT00160706|532474437|FG000|Overall Study|Withdrawal by Subject and Other|12|||
147632616|NCT00160706|532474437|FG000|Overall Study|Physician Decision|10|||
147632617|NCT00160706|532474437|FG000|Overall Study|Physician Decision and Other|3|||
147632618|NCT00160706|532474437|FG000|Overall Study|Lost to Follow-up|4|||
147668577|NCT00750269|532613321|FG002|Overall Study|Physician Decision|0|||
147500310|NCT00870818|531983086|FG003|Overall Study|Other|0|||
147500311|NCT00870818|531983087|FG004|Overall Study|Other|0|||
147500312|NCT04900038|531983090|FG000|Overall Study|Adverse Event|1|||
147500313|NCT04900038|531983091|FG001|Overall Study|Adverse Event|0|||
147500314|NCT04900038|531983092|FG002|Overall Study|Adverse Event|1|||
147500315|NCT04900038|531983093|FG003|Overall Study|Adverse Event|1|||
147500316|NCT04900038|531983090|FG000|Overall Study|Withdrawal by Subject|0|||
147632619|NCT00160706|532474437|FG000|Overall Study|Lost to Follow-up and Other|1|||
147632620|NCT00160706|532474437|FG000|Overall Study|Lack of Efficacy|42|||
147632621|NCT00160706|532474437|FG000|Overall Study|Lack of Efficacy and Other|1|||
147632622|NCT00160706|532474437|FG000|Overall Study|Other Reason|11|||
147500317|NCT04900038|531983091|FG001|Overall Study|Withdrawal by Subject|1|||
147500318|NCT04900038|531983092|FG002|Overall Study|Withdrawal by Subject|0|||
147500319|NCT04900038|531983093|FG003|Overall Study|Withdrawal by Subject|0|||
147500320|NCT04900038|531983090|FG000|Overall Study|Study terminated by sponsor|18|||
147500321|NCT04900038|531983091|FG001|Overall Study|Study terminated by sponsor|15|||
147500322|NCT04900038|531983092|FG002|Overall Study|Study terminated by sponsor|17|||
147500323|NCT04900038|531983093|FG003|Overall Study|Study terminated by sponsor|14|||
147500324|NCT04900038|531983090|FG000|Overall Study|Protocol Deviation|1|||
147500325|NCT04900038|531983091|FG001|Overall Study|Protocol Deviation|1|||
147500326|NCT04900038|531983092|FG002|Overall Study|Protocol Deviation|0|||
147500327|NCT04900038|531983093|FG003|Overall Study|Protocol Deviation|0|||
147500328|NCT04900038|531983090|FG000|Overall Study|Participant reached protocol-defined stoping criteria|0|||
147500329|NCT04900038|531983091|FG001|Overall Study|Participant reached protocol-defined stoping criteria|0|||
147500330|NCT04900038|531983092|FG002|Overall Study|Participant reached protocol-defined stoping criteria|2|||
147500331|NCT04900038|531983093|FG003|Overall Study|Participant reached protocol-defined stoping criteria|2|||
147500332|NCT04900038|531983090|FG000|Overall Study|Lost to Follow-up|0|||
147500333|NCT04900038|531983091|FG001|Overall Study|Lost to Follow-up|0|||
147500334|NCT04900038|531983092|FG002|Overall Study|Lost to Follow-up|0|||
147500335|NCT04900038|531983093|FG003|Overall Study|Lost to Follow-up|1|||
147500336|NCT04093258|531983095|FG000|Period 2|Subject no longer meets the eligibility criteria|1|||
147500337|NCT04093258|531983096|FG001|Period 2|Subject no longer meets the eligibility criteria|0|||
147500338|NCT00986427|531983097|FG000|Overall Study|Lost to Follow-up|2|||
147500339|NCT00986427|531983098|FG001|Overall Study|Lost to Follow-up|0|||
147500340|NCT00986427|531983097|FG000|Overall Study|Lack of Efficacy|1|||
147500341|NCT00986427|531983098|FG001|Overall Study|Lack of Efficacy|0|||
147500342|NCT00986427|531983097|FG000|Overall Study|Withdrawal by Subject|1|||
147500343|NCT00986427|531983098|FG001|Overall Study|Withdrawal by Subject|0|||
147500344|NCT03784027|531983099|FG000|Period 1|Withdrawal by Subject|0|||
147500345|NCT03784027|531983100|FG001|Period 1|Withdrawal by Subject|1|||
147500346|NCT02109744|531984690|FG000|Overall Study|Death|1|||
147500347|NCT02109744|531984691|FG001|Overall Study|Death|1|||
147500348|NCT02109744|531984690|FG000|Overall Study|no marrow exam|1|||
147500349|NCT02109744|531984691|FG001|Overall Study|no marrow exam|0|||
147500350|NCT04095442|531984692|FG000|Overall Study|Lost to Follow-up|0|||
147500351|NCT04095442|531984693|FG001|Overall Study|Lost to Follow-up|1|||
147500352|NCT04095442|531984692|FG000|Overall Study|Screen failure|1|||
147500353|NCT04095442|531984693|FG001|Overall Study|Screen failure|0|||
147500354|NCT01677624|531984694|FG000|Overall Study|Insuf Resp: intra-articular hemorrhage|1|||
147500355|NCT02658968|531984695|FG000|Received Rituximab|Adverse Event|0|||
147500356|NCT02658968|531984696|FG001|Received Rituximab|Adverse Event|0|||
147500357|NCT02658968|531984697|FG002|Received Rituximab|Adverse Event|0|||
147500358|NCT02658968|531984698|FG003|Received Rituximab|Adverse Event|0|||
147500359|NCT02658968|531984699|FG004|Received Rituximab|Adverse Event|1|||
147500360|NCT02658968|531984695|FG000|Received Rituximab|Progressive disease|0|||
147500361|NCT02658968|531984696|FG001|Received Rituximab|Progressive disease|0|||
147500362|NCT02658968|531984697|FG002|Received Rituximab|Progressive disease|0|||
147500363|NCT02658968|531984698|FG003|Received Rituximab|Progressive disease|0|||
147500364|NCT02658968|531984699|FG004|Received Rituximab|Progressive disease|1|||
147500365|NCT02658968|531984695|FG000|Received Lilotomab and Betalutin|Disease progression (including death due to disease progression)|2|||
147500366|NCT02658968|531984696|FG001|Received Lilotomab and Betalutin|Disease progression (including death due to disease progression)|0|||
147500367|NCT02658968|531984697|FG002|Received Lilotomab and Betalutin|Disease progression (including death due to disease progression)|3|||
147500368|NCT02658968|531984698|FG003|Received Lilotomab and Betalutin|Disease progression (including death due to disease progression)|3|||
147500369|NCT02658968|531984699|FG004|Received Lilotomab and Betalutin|Disease progression (including death due to disease progression)|0|||
147500370|NCT02658968|531984695|FG000|Received Lilotomab and Betalutin|Progressive disease|1|||
147500371|NCT02658968|531984696|FG001|Received Lilotomab and Betalutin|Progressive disease|0|||
147500372|NCT02658968|531984697|FG002|Received Lilotomab and Betalutin|Progressive disease|0|||
147500373|NCT02658968|531984698|FG003|Received Lilotomab and Betalutin|Progressive disease|0|||
147500374|NCT02658968|531984699|FG004|Received Lilotomab and Betalutin|Progressive disease|0|||
147500375|NCT02658968|531984695|FG000|Received Lilotomab and Betalutin|Start of further anticancer therapy|0|||
147500376|NCT02658968|531984696|FG001|Received Lilotomab and Betalutin|Start of further anticancer therapy|2|||
147500377|NCT02658968|531984697|FG002|Received Lilotomab and Betalutin|Start of further anticancer therapy|0|||
147500378|NCT02658968|531984698|FG003|Received Lilotomab and Betalutin|Start of further anticancer therapy|2|||
147500379|NCT02658968|531984699|FG004|Received Lilotomab and Betalutin|Start of further anticancer therapy|0|||
147500380|NCT02658968|531984695|FG000|Received Lilotomab and Betalutin|Lost to Follow-up|0|||
147500381|NCT02658968|531984696|FG001|Received Lilotomab and Betalutin|Lost to Follow-up|1|||
147500382|NCT02658968|531984697|FG002|Received Lilotomab and Betalutin|Lost to Follow-up|0|||
147500383|NCT02658968|531984698|FG003|Received Lilotomab and Betalutin|Lost to Follow-up|0|||
147500384|NCT02658968|531984699|FG004|Received Lilotomab and Betalutin|Lost to Follow-up|0|||
147500385|NCT02658968|531984695|FG000|Received Lilotomab and Betalutin|Adverse Event|0|||
147500386|NCT02658968|531984696|FG001|Received Lilotomab and Betalutin|Adverse Event|0|||
147500387|NCT02658968|531984697|FG002|Received Lilotomab and Betalutin|Adverse Event|0|||
147500388|NCT02658968|531984698|FG003|Received Lilotomab and Betalutin|Adverse Event|1|||
147500389|NCT02658968|531984699|FG004|Received Lilotomab and Betalutin|Adverse Event|0|||
147500390|NCT03097614|531984703|FG000|Overall Study|Adverse Event|3|||
147500391|NCT00436982|531984704|FG000|Overall Study|Withdrawal by Subject|3|||
147500392|NCT00436982|531984705|FG001|Overall Study|Withdrawal by Subject|1|||
147500393|NCT00436982|531984704|FG000|Overall Study|Did not receive allocated intervention|0|||
147500394|NCT00436982|531984705|FG001|Overall Study|Did not receive allocated intervention|1|||
147500395|NCT00436982|531984704|FG000|Overall Study|no RSA data|1|||
147500396|NCT00436982|531984705|FG001|Overall Study|no RSA data|2|||
147500397|NCT00953225|531984706|FG000|Overall Study|Withdrawal by Subject|2|||
147500398|NCT00953225|531984707|FG001|Overall Study|Withdrawal by Subject|0|||
147500399|NCT02215616|531984711|FG000|Overall Study|Sponsor requested to stop study drug|0|||
147500400|NCT02215616|531984712|FG001|Overall Study|Sponsor requested to stop study drug|0|||
147500401|NCT02215616|531984713|FG002|Overall Study|Sponsor requested to stop study drug|1|||
147500402|NCT02215616|531984714|FG003|Overall Study|Sponsor requested to stop study drug|4|||
147500403|NCT02215616|531984711|FG000|Overall Study|Death|1|||
147500404|NCT02215616|531984712|FG001|Overall Study|Death|0|||
147500405|NCT02215616|531984713|FG002|Overall Study|Death|0|||
147500406|NCT02215616|531984714|FG003|Overall Study|Death|0|||
147500407|NCT02215616|531984711|FG000|Overall Study|Adverse Event|7|||
147500408|NCT02215616|531984712|FG001|Overall Study|Adverse Event|4|||
147500409|NCT02215616|531984713|FG002|Overall Study|Adverse Event|9|||
147500410|NCT02215616|531984714|FG003|Overall Study|Adverse Event|2|||
147500411|NCT02215616|531984711|FG000|Overall Study|Withdrawal by Subject|1|||
147500412|NCT02215616|531984712|FG001|Overall Study|Withdrawal by Subject|8|||
147500413|NCT02215616|531984713|FG002|Overall Study|Withdrawal by Subject|2|||
147500414|NCT02215616|531984714|FG003|Overall Study|Withdrawal by Subject|5|||
147500415|NCT02215616|531984711|FG000|Overall Study|Non-compliance|0|||
147500416|NCT02215616|531984712|FG001|Overall Study|Non-compliance|2|||
147500417|NCT02215616|531984713|FG002|Overall Study|Non-compliance|1|||
147500418|NCT02215616|531984714|FG003|Overall Study|Non-compliance|0|||
147500419|NCT02215616|531984711|FG000|Overall Study|Protocol Violation|0|||
147500420|NCT02215616|531984712|FG001|Overall Study|Protocol Violation|2|||
147500421|NCT02215616|531984713|FG002|Overall Study|Protocol Violation|0|||
147500422|NCT02215616|531984714|FG003|Overall Study|Protocol Violation|0|||
147500423|NCT02215616|531984711|FG000|Overall Study|Lost to Follow-up|1|||
147500424|NCT02215616|531984712|FG001|Overall Study|Lost to Follow-up|1|||
147500425|NCT02215616|531984713|FG002|Overall Study|Lost to Follow-up|0|||
147500426|NCT02215616|531984714|FG003|Overall Study|Lost to Follow-up|1|||
147500427|NCT02215616|531984711|FG000|Overall Study|Other than specified|1|||
147500428|NCT02215616|531984712|FG001|Overall Study|Other than specified|0|||
147500429|NCT02215616|531984713|FG002|Overall Study|Other than specified|1|||
147500430|NCT02215616|531984714|FG003|Overall Study|Other than specified|1|||
147500431|NCT04058158|531984715|FG000|Period 1|Death|1|||
147500432|NCT04058158|531984716|FG001|Period 1|Death|0|||
147500433|NCT04058158|531984715|FG000|Period 1|Adverse Event|1|||
147500434|NCT04058158|531984716|FG001|Period 1|Adverse Event|1|||
147500435|NCT04058158|531984715|FG000|Period 1|Pregnancy|0|||
147500436|NCT04058158|531984716|FG001|Period 1|Pregnancy|1|||
147500437|NCT01634113|531984717|FG000|Overall Study|Not treated|0|||
147500438|NCT01634113|531984718|FG001|Overall Study|Not treated|0|||
147500439|NCT01634113|531984719|FG002|Overall Study|Not treated|1|||
147500440|NCT00520299|531984722|FG000|Overall Study|Withdrawal by Subject|0|||
147500441|NCT00520299|531984723|FG001|Overall Study|Withdrawal by Subject|0|||
147500442|NCT00520299|531984724|FG002|Overall Study|Withdrawal by Subject|2|||
147500443|NCT00520299|531984722|FG000|Overall Study|Progressive disease|0|||
147500444|NCT00520299|531984723|FG001|Overall Study|Progressive disease|3|||
147500445|NCT00520299|531984724|FG002|Overall Study|Progressive disease|4|||
147500446|NCT01352845|531984725|FG000|Overall Study|Lost to Follow-up|313|||
147500447|NCT01352845|531984726|FG001|Overall Study|Lost to Follow-up|92|||
147500448|NCT01352845|531984725|FG000|Overall Study|No Longer Willing to Participate|205|||
147632623|NCT00748189|532474438|FG000|Overall Study|Death|99|||
147632624|NCT00748189|532474439|FG001|Overall Study|Death|84|||
147500449|NCT01352845|531984726|FG001|Overall Study|No Longer Willing to Participate|58|||
147500450|NCT01352845|531984725|FG000|Overall Study|Withdrawal by Subject|48|||
147500451|NCT01352845|531984726|FG001|Overall Study|Withdrawal by Subject|16|||
147500452|NCT01352845|531984725|FG000|Overall Study|No Longer Meets Eligibility Criteria|24|||
147632625|NCT00748189|532474438|FG000|Overall Study|Withdrawal by Subject|23|||
147500453|NCT01352845|531984726|FG001|Overall Study|No Longer Meets Eligibility Criteria|11|||
147500454|NCT01352845|531984725|FG000|Overall Study|Pregnancy|27|||
147500455|NCT01352845|531984726|FG001|Overall Study|Pregnancy|7|||
147500456|NCT01352845|531984725|FG000|Overall Study|Adverse Event|22|||
147500457|NCT01352845|531984726|FG001|Overall Study|Adverse Event|6|||
147500458|NCT01352845|531984725|FG000|Overall Study|Other|17|||
147500459|NCT01352845|531984726|FG001|Overall Study|Other|7|||
147500460|NCT01352845|531984725|FG000|Overall Study|Protocol Violation|12|||
147632626|NCT00748189|532474439|FG001|Overall Study|Withdrawal by Subject|29|||
147632627|NCT00748189|532474438|FG000|Overall Study|Physician Decision|16|||
147500461|NCT01352845|531984726|FG001|Overall Study|Protocol Violation|6|||
147500462|NCT01352845|531984725|FG000|Overall Study|Death|3|||
147500463|NCT01352845|531984726|FG001|Overall Study|Death|0|||
147500464|NCT01956240|531984727|FG000|Overall Study|Lost to Follow-up|6|||
147500465|NCT01956240|531984728|FG001|Overall Study|Lost to Follow-up|20|||
147500466|NCT01956240|531984727|FG000|Overall Study|Adverse Event|17|||
147500467|NCT01956240|531984728|FG001|Overall Study|Adverse Event|4|||
147500468|NCT02310906|531984737|FG000|Part 2: Open Label Phase (168 Weeks)|Enrollment in other therapeutic study|0|||
147500469|NCT02310906|531984738|FG001|Part 2: Open Label Phase (168 Weeks)|Enrollment in other therapeutic study|0|||
147500470|NCT02310906|531984739|FG002|Part 2: Open Label Phase (168 Weeks)|Enrollment in other therapeutic study|0|||
147500471|NCT02310906|531984740|FG003|Part 2: Open Label Phase (168 Weeks)|Enrollment in other therapeutic study|2|||
147500472|NCT02310906|531984737|FG000|Part 2: Open Label Phase (168 Weeks)|Withdrawal by Subject|0|||
147500473|NCT02310906|531984738|FG001|Part 2: Open Label Phase (168 Weeks)|Withdrawal by Subject|0|||
147500474|NCT02310906|531984739|FG002|Part 2: Open Label Phase (168 Weeks)|Withdrawal by Subject|2|||
147500475|NCT02310906|531984740|FG003|Part 2: Open Label Phase (168 Weeks)|Withdrawal by Subject|4|||
147500476|NCT02310906|531984737|FG000|Part 2: Open Label Phase (168 Weeks)|Personal reasons|0|||
147500477|NCT02310906|531984738|FG001|Part 2: Open Label Phase (168 Weeks)|Personal reasons|0|||
147500478|NCT02310906|531984739|FG002|Part 2: Open Label Phase (168 Weeks)|Personal reasons|0|||
147500479|NCT02310906|531984740|FG003|Part 2: Open Label Phase (168 Weeks)|Personal reasons|1|||
147500480|NCT02310906|531984737|FG000|Part 2: Open Label Phase (168 Weeks)|Lost to Follow-up|0|||
147500481|NCT02310906|531984738|FG001|Part 2: Open Label Phase (168 Weeks)|Lost to Follow-up|0|||
147500482|NCT02310906|531984739|FG002|Part 2: Open Label Phase (168 Weeks)|Lost to Follow-up|0|||
147500483|NCT02310906|531984740|FG003|Part 2: Open Label Phase (168 Weeks)|Lost to Follow-up|1|||
147500484|NCT03819218|531984743|FG000|Overall Study|Protocol Violation|1|||
147500485|NCT00433446|531984744|FG000|Overall Study|Adverse Event|4|||
147500486|NCT00433446|531984744|FG000|Overall Study|Refusal Unrelated to Adverse Event|1|||
147500487|NCT00433446|531984744|FG000|Overall Study|Progression|44|||
147500488|NCT00433446|531984744|FG000|Overall Study|Other - Not Protocol specified|3|||
147500489|NCT00433446|531984744|FG000|Overall Study|Ineligible|9|||
147500490|NCT01188538|531984745|FG000|Overall Study|Lost to Follow-up|0|||
147500491|NCT01188538|531984746|FG001|Overall Study|Lost to Follow-up|1|||
147500492|NCT02267278|531984747|FG000|Overall Study|Proceeded to transplantation (allo-HCT)|1|||
147500493|NCT02267278|531984747|FG000|Overall Study|transformation to acute leukemia (AML)|1|||
147500494|NCT02267278|531984747|FG000|Overall Study|Developed new cancer diagnoses|2|||
147500495|NCT02267278|531984747|FG000|Overall Study|prescribed prohibited medication|1|||
147500496|NCT02513771|531984748|FG000|Overall Study|Lost to Follow-up|1|||
147500497|NCT02513771|531984749|FG001|Overall Study|Lost to Follow-up|1|||
147500498|NCT02513771|531984748|FG000|Overall Study|Not being able to get to clinic|1|||
147500499|NCT02513771|531984749|FG001|Overall Study|Not being able to get to clinic|0|||
147500500|NCT01797445|531984750|FG000|Double-Blind Phase|Randomized but Not Treated|4|||
147500501|NCT01797445|531984751|FG001|Double-Blind Phase|Randomized but Not Treated|2|||
147500502|NCT01797445|531984750|FG000|Double-Blind Phase|Adverse Event|3|||
147500503|NCT01797445|531984751|FG001|Double-Blind Phase|Adverse Event|0|||
147500504|NCT01797445|531984750|FG000|Double-Blind Phase|Death|5|||
147500505|NCT01797445|531984751|FG001|Double-Blind Phase|Death|4|||
147500506|NCT01797445|531984750|FG000|Double-Blind Phase|Pregnancy|0|||
147500507|NCT01797445|531984751|FG001|Double-Blind Phase|Pregnancy|1|||
147500508|NCT01797445|531984750|FG000|Double-Blind Phase|Lack of Efficacy|1|||
147500509|NCT01797445|531984751|FG001|Double-Blind Phase|Lack of Efficacy|2|||
147500510|NCT01797445|531984750|FG000|Double-Blind Phase|Investigator's Discretion|15|||
147500511|NCT01797445|531984751|FG001|Double-Blind Phase|Investigator's Discretion|17|||
147500512|NCT01797445|531984750|FG000|Double-Blind Phase|Noncompliance with Study Drug|5|||
147500513|NCT01797445|531984751|FG001|Double-Blind Phase|Noncompliance with Study Drug|1|||
147500514|NCT01797445|531984750|FG000|Double-Blind Phase|Protocol Violation|0|||
147500515|NCT01797445|531984751|FG001|Double-Blind Phase|Protocol Violation|1|||
147500516|NCT01797445|531984750|FG000|Double-Blind Phase|Withdrew Consent|20|||
147500517|NCT01797445|531984751|FG001|Double-Blind Phase|Withdrew Consent|35|||
147500518|NCT01797445|531984750|FG000|Double-Blind Phase|Lost to Follow-up|34|||
147500519|NCT01797445|531984751|FG001|Double-Blind Phase|Lost to Follow-up|26|||
147500520|NCT01797445|531984750|FG000|Open-Label Extension Phase|Investigator's Discretion|1|||
147500521|NCT01797445|531984751|FG001|Open-Label Extension Phase|Investigator's Discretion|0|||
147500522|NCT01595438|531984752|FG000|Overall Study|Lost to Follow-up|20|||
147500523|NCT01595438|531984753|FG001|Overall Study|Lost to Follow-up|20|||
147500524|NCT01595438|531984752|FG000|Overall Study|Withdrawal by Subject|12|||
147500525|NCT01595438|531984753|FG001|Overall Study|Withdrawal by Subject|12|||
147500526|NCT01595438|531984752|FG000|Overall Study|Other Eligibility criteria|11|||
147500527|NCT01595438|531984753|FG001|Overall Study|Other Eligibility criteria|9|||
147500528|NCT00650091|531984755|FG000|Amended Study Design|Withdrawal by Subject|12|||
147500529|NCT00650091|531984756|FG001|Amended Study Design|Withdrawal by Subject|11|||
147500530|NCT00650091|531984757|FG002|Amended Study Design|Withdrawal by Subject|0|||
147500531|NCT00650091|531984755|FG000|Amended Study Design|Physician Decision|5|||
147500532|NCT00650091|531984756|FG001|Amended Study Design|Physician Decision|0|||
147500533|NCT00650091|531984757|FG002|Amended Study Design|Physician Decision|0|||
147500534|NCT00650091|531984755|FG000|Amended Study Design|Adverse Event|1|||
147500535|NCT00650091|531984756|FG001|Amended Study Design|Adverse Event|4|||
147500536|NCT00650091|531984757|FG002|Amended Study Design|Adverse Event|0|||
147500537|NCT00650091|531984755|FG000|Amended Study Design|Lung transplantation|4|||
147500538|NCT00650091|531984756|FG001|Amended Study Design|Lung transplantation|2|||
147500539|NCT00650091|531984757|FG002|Amended Study Design|Lung transplantation|0|||
147500540|NCT00650091|531984755|FG000|Amended Study Design|Other|1|||
147500541|NCT00650091|531984756|FG001|Amended Study Design|Other|3|||
147500542|NCT00650091|531984757|FG002|Amended Study Design|Other|0|||
147500543|NCT01204697|531984758|FG000|Overall Study|Death|26|||
147500544|NCT01204697|531984759|FG001|Overall Study|Death|27|||
147500545|NCT01204697|531984758|FG000|Overall Study|Lost to Follow-up|3|||
147500546|NCT01204697|531984759|FG001|Overall Study|Lost to Follow-up|4|||
147500547|NCT01204697|531984758|FG000|Overall Study|Withdrawal by Subject|2|||
147500548|NCT01204697|531984759|FG001|Overall Study|Withdrawal by Subject|4|||
147500549|NCT01204697|531984758|FG000|Overall Study|Randomized, but not treated|0|||
147500550|NCT01204697|531984759|FG001|Overall Study|Randomized, but not treated|1|||
147500551|NCT01280266|531984766|FG000|First Intervention (Week 1-4)|Adverse Event|1|||
147500552|NCT01280266|531984767|FG001|First Intervention (Week 1-4)|Adverse Event|0|||
147500553|NCT01280266|531984766|FG000|First Intervention (Week 1-4)|Withdrawal by Subject|0|||
147500554|NCT01280266|531984767|FG001|First Intervention (Week 1-4)|Withdrawal by Subject|2|||
147500555|NCT00469209|531984774|FG000|Overall Study|Adverse Event|1|||
147500556|NCT00469209|531984775|FG001|Overall Study|Adverse Event|0|||
147500557|NCT00469209|531984776|FG002|Overall Study|Adverse Event|1|||
147500558|NCT04268004|531984779|FG000|Overall Study|Excluded from analyses|0|||
147500559|NCT04268004|531984780|FG001|Overall Study|Excluded from analyses|1|||
147500560|NCT01082367|531984781|FG000|Double-blind Period|Administrative problems|0|||
147500561|NCT01082367|531984782|FG001|Double-blind Period|Administrative problems|1|||
147500562|NCT01082367|531984781|FG000|Double-blind Period|Lack of Efficacy|5|||
147500563|NCT01082367|531984782|FG001|Double-blind Period|Lack of Efficacy|11|||
147500564|NCT01082367|531984781|FG000|Double-blind Period|Adverse Event|0|||
147500565|NCT01082367|531984782|FG001|Double-blind Period|Adverse Event|1|||
147500566|NCT01082367|531984781|FG000|Follow-up (F-U) Period|Administrative problems|1|||
147500567|NCT01082367|531984782|FG001|Follow-up (F-U) Period|Administrative problems|0|||
147500568|NCT01082367|531984781|FG000|Follow-up (F-U) Period|Abnormal lab values|1|||
147500569|NCT01082367|531984782|FG001|Follow-up (F-U) Period|Abnormal lab values|0|||
147500570|NCT01082367|531984781|FG000|Follow-up (F-U) Period|Adverse Event|0|||
147500571|NCT01082367|531984782|FG001|Follow-up (F-U) Period|Adverse Event|1|||
147500572|NCT01453998|531984783|FG000|After Protocol Amendment 2.|Withdrawal by Subject|1|||
147500573|NCT01453998|531984784|FG001|After Protocol Amendment 2.|Withdrawal by Subject|0|||
147500574|NCT01453998|531984785|FG002|After Protocol Amendment 2.|Withdrawal by Subject|0|||
147500575|NCT00712933|531984789|FG000|Overall Study|Adverse Event|69|||
147500576|NCT00712933|531984789|FG000|Overall Study|Lack of Efficacy|6|||
147500577|NCT00712933|531984789|FG000|Overall Study|Lost to Follow-up|22|||
147500578|NCT00712933|531984789|FG000|Overall Study|Non-compliance with study drug|13|||
147500579|NCT00712933|531984789|FG000|Overall Study|Other Pregnancy|37|||
147500580|NCT00712933|531984789|FG000|Overall Study|Sponsor decision|14|||
147500581|NCT00712933|531984789|FG000|Overall Study|Withdrew consent|4|||
147500582|NCT00712933|531984789|FG000|Overall Study|Hip replacement surgery|1|||
147500583|NCT00712933|531984789|FG000|Overall Study|Involved in Clinical research|3|||
147500584|NCT00712933|531984789|FG000|Overall Study|Participant hospitalized|1|||
147500585|NCT00712933|531984789|FG000|Overall Study|Participant travelled overseas|2|||
147500586|NCT00712933|531984789|FG000|Overall Study|Death of patient|1|||
147500587|NCT00712933|531984789|FG000|Overall Study|Other Physician decision|1|||
147500588|NCT00712933|531984789|FG000|Overall Study|Not committed to contraception|1|||
147500589|NCT00712933|531984789|FG000|Overall Study|Participant received medication|1|||
147632628|NCT00748189|532474439|FG001|Overall Study|Physician Decision|5|||
147632629|NCT00748189|532474438|FG000|Overall Study|Lost to Follow-up|8|||
147632630|NCT00748189|532474439|FG001|Overall Study|Lost to Follow-up|15|||
147632631|NCT00748189|532474438|FG000|Overall Study|Study terminated by Sponsor|70|||
147632632|NCT00748189|532474439|FG001|Overall Study|Study terminated by Sponsor|79|||
147632633|NCT04696055|532474440|FG000|Overall Study|Adverse Event|10|||
147632634|NCT04696055|532474441|FG001|Overall Study|Adverse Event|2|||
147632635|NCT04696055|532474440|FG000|Overall Study|Death|4|||
147500590|NCT00712933|531984789|FG000|Overall Study|Physician Decision|36|||
147500591|NCT00712933|531984789|FG000|Overall Study|Protocol Violation|4|||
147500592|NCT00712933|531984789|FG000|Overall Study|Withdrawal by Subject|151|||
147500593|NCT01879319|531984792|FG000|Overall Study|Withdrawal by Subject|1|||
147500594|NCT01879319|531984793|FG001|Overall Study|Withdrawal by Subject|0|||
147500595|NCT01879319|531984792|FG000|Overall Study|Lost to Follow-up|1|||
147500596|NCT01879319|531984793|FG001|Overall Study|Lost to Follow-up|5|||
147500597|NCT04724733|531984796|FG000|Overall Study|Lost to Follow-up|1|||
147500598|NCT04724733|531984797|FG001|Overall Study|Lost to Follow-up|1|||
147500599|NCT04724733|531984798|FG002|Overall Study|Lost to Follow-up|1|||
147632636|NCT04696055|532474441|FG001|Overall Study|Death|0|||
147632637|NCT04696055|532474440|FG000|Overall Study|Other|7|||
147500600|NCT03067129|531984799|FG000|Overall Study|Partially Dosed; Refused to Swallow Entire Dose|0|||
147500601|NCT03067129|531984800|FG001|Overall Study|Partially Dosed; Refused to Swallow Entire Dose|0|||
147500602|NCT03067129|531984801|FG002|Overall Study|Partially Dosed; Refused to Swallow Entire Dose|0|||
147500603|NCT03067129|531984802|FG003|Overall Study|Partially Dosed; Refused to Swallow Entire Dose|1|||
147500604|NCT03067129|531984799|FG000|Overall Study|Withdrawal by Subject|0|||
147500605|NCT03067129|531984800|FG001|Overall Study|Withdrawal by Subject|0|||
147500606|NCT03067129|531984801|FG002|Overall Study|Withdrawal by Subject|1|||
147500607|NCT03067129|531984802|FG003|Overall Study|Withdrawal by Subject|2|||
147500608|NCT03067129|531984799|FG000|Overall Study|Lost to Follow-up|5|||
147500609|NCT03067129|531984800|FG001|Overall Study|Lost to Follow-up|5|||
147500610|NCT03067129|531984801|FG002|Overall Study|Lost to Follow-up|4|||
147500611|NCT03067129|531984802|FG003|Overall Study|Lost to Follow-up|3|||
147500612|NCT03372603|531984803|FG000|Wash-out Period (14-21 Days)|Sponsor terminated study treatment|1|||
147500613|NCT03372603|531984804|FG001|Wash-out Period (14-21 Days)|Sponsor terminated study treatment|0|||
147500614|NCT03372603|531984803|FG000|Treatment Period 2 (Up to 7 Days)|Study closed/Terminated|1|||
147500615|NCT03372603|531984804|FG001|Treatment Period 2 (Up to 7 Days)|Study closed/Terminated|0|||
147500616|NCT04929613|531984805|FG000|Overall Study|Withdrawal by Subject|12|||
147500617|NCT00664209|531984811|FG000|Motor Fluctuations Screen|Negative for motor fluctuation|7|||
147500618|NCT00664209|531984811|FG000|Study Treatment Period|Physician Decision|4|||
147500619|NCT00664209|531984811|FG000|Study Treatment Period|Withdrawal by Subject|2|||
147500620|NCT00843843|531984812|FG000|Overall Study|Physician Decision|1|||
147500621|NCT00843843|531984813|FG001|Overall Study|Physician Decision|1|||
147500622|NCT00843843|531984812|FG000|Overall Study|Protocol Violation|1|||
147500623|NCT00843843|531984813|FG001|Overall Study|Protocol Violation|1|||
147500624|NCT00418379|531984814|FG000|Year 1|Adverse Event|9|||
147500625|NCT00418379|531984815|FG001|Year 1|Adverse Event|15|||
147500626|NCT00418379|531984816|FG002|Year 1|Adverse Event|3|||
147500627|NCT00418379|531984814|FG000|Year 1|Withdrawal by Subject|7|||
147500628|NCT00418379|531984815|FG001|Year 1|Withdrawal by Subject|8|||
147500629|NCT00418379|531984816|FG002|Year 1|Withdrawal by Subject|5|||
147500630|NCT00418379|531984814|FG000|Year 1|Any other reason not above-mentioned|2|||
147500631|NCT00418379|531984815|FG001|Year 1|Any other reason not above-mentioned|5|||
147500632|NCT00418379|531984816|FG002|Year 1|Any other reason not above-mentioned|7|||
147500633|NCT00418379|531984814|FG000|Year 2|Adverse Event|5|||
147500634|NCT00418379|531984815|FG001|Year 2|Adverse Event|2|||
147500635|NCT00418379|531984816|FG002|Year 2|Adverse Event|1|||
147500636|NCT00418379|531984814|FG000|Year 2|Withdrawal by Subject|1|||
147500637|NCT00418379|531984815|FG001|Year 2|Withdrawal by Subject|1|||
147500638|NCT00418379|531984816|FG002|Year 2|Withdrawal by Subject|3|||
147500639|NCT00418379|531984814|FG000|Year 2|Any other reason not above-mentioned|2|||
147500640|NCT00418379|531984815|FG001|Year 2|Any other reason not above-mentioned|1|||
147500641|NCT00418379|531984816|FG002|Year 2|Any other reason not above-mentioned|6|||
147500642|NCT00418379|531984814|FG000|Year 3|Withdrawal by Subject|1|||
147500643|NCT00418379|531984815|FG001|Year 3|Withdrawal by Subject|1|||
147500644|NCT00418379|531984816|FG002|Year 3|Withdrawal by Subject|2|||
147500645|NCT00418379|531984814|FG000|Year 3|Any other reason not above-mentioned|2|||
147500646|NCT00418379|531984815|FG001|Year 3|Any other reason not above-mentioned|1|||
147500647|NCT00418379|531984816|FG002|Year 3|Any other reason not above-mentioned|1|||
147500648|NCT00418379|531984814|FG000|Year 4|Adverse Event|0|||
147500649|NCT00418379|531984815|FG001|Year 4|Adverse Event|1|||
147500650|NCT00418379|531984816|FG002|Year 4|Adverse Event|0|||
147500651|NCT00418379|531984814|FG000|Year 4|Withdrawal by Subject|2|||
147500652|NCT00418379|531984815|FG001|Year 4|Withdrawal by Subject|3|||
147500653|NCT00418379|531984816|FG002|Year 4|Withdrawal by Subject|2|||
147500654|NCT00418379|531984814|FG000|Year 4|Any other reason not above-mentioned|1|||
147500655|NCT00418379|531984815|FG001|Year 4|Any other reason not above-mentioned|1|||
147500656|NCT00418379|531984816|FG002|Year 4|Any other reason not above-mentioned|0|||
147500657|NCT00418379|531984814|FG000|Year 5|Adverse Event|0|||
147500658|NCT00418379|531984815|FG001|Year 5|Adverse Event|1|||
147500659|NCT00418379|531984816|FG002|Year 5|Adverse Event|0|||
147500660|NCT00418379|531984814|FG000|Year 5|Any other reason not above-mentioned|2|||
147500661|NCT00418379|531984815|FG001|Year 5|Any other reason not above-mentioned|4|||
147500662|NCT00418379|531984816|FG002|Year 5|Any other reason not above-mentioned|3|||
147500663|NCT01764256|531984818|FG000|Received All Vaccinations|Adverse Event|1|||
147500664|NCT01764256|531984819|FG001|Received All Vaccinations|Adverse Event|1|||
147500665|NCT01764256|531984820|FG002|Received All Vaccinations|Adverse Event|0|||
147500666|NCT01764256|531984821|FG003|Received All Vaccinations|Adverse Event|0|||
147500667|NCT01764256|531984818|FG000|Received All Vaccinations|Did not meet inclusion criteria|0|||
147500668|NCT01764256|531984819|FG001|Received All Vaccinations|Did not meet inclusion criteria|0|||
147500669|NCT01764256|531984820|FG002|Received All Vaccinations|Did not meet inclusion criteria|1|||
147500670|NCT01764256|531984821|FG003|Received All Vaccinations|Did not meet inclusion criteria|0|||
147500671|NCT01764256|531984818|FG000|Received All Vaccinations|Lost to Follow-up|1|||
147500672|NCT01764256|531984819|FG001|Received All Vaccinations|Lost to Follow-up|0|||
147500673|NCT01764256|531984820|FG002|Received All Vaccinations|Lost to Follow-up|0|||
147500674|NCT01764256|531984821|FG003|Received All Vaccinations|Lost to Follow-up|0|||
147500675|NCT01764256|531984818|FG000|Completed Study|Lost to Follow-up|0|||
147500676|NCT01764256|531984819|FG001|Completed Study|Lost to Follow-up|0|||
147500677|NCT01764256|531984820|FG002|Completed Study|Lost to Follow-up|0|||
147500678|NCT01764256|531984821|FG003|Completed Study|Lost to Follow-up|1|||
147500679|NCT00589979|531984822|FG000|Run-In Period|Adverse Event|5|||
147500680|NCT00589979|531984823|FG001|Run-In Period|Adverse Event|0|||
147500681|NCT00589979|531984824|FG002|Run-In Period|Adverse Event|0|||
147500682|NCT00589979|531984822|FG000|Run-In Period|Protocol Violation|3|||
147500683|NCT00589979|531984823|FG001|Run-In Period|Protocol Violation|0|||
147500684|NCT00589979|531984824|FG002|Run-In Period|Protocol Violation|0|||
147500685|NCT00589979|531984822|FG000|Run-In Period|Did not qualify for randomization|54|||
147500686|NCT00589979|531984823|FG001|Run-In Period|Did not qualify for randomization|0|||
147500687|NCT00589979|531984824|FG002|Run-In Period|Did not qualify for randomization|0|||
147500688|NCT00589979|531984822|FG000|Run-In Period|Withdrawal by Subject|10|||
147500689|NCT00589979|531984823|FG001|Run-In Period|Withdrawal by Subject|0|||
147500690|NCT00589979|531984824|FG002|Run-In Period|Withdrawal by Subject|0|||
147500691|NCT00589979|531984822|FG000|Run-In Period|Informed Consent Withdrawn|4|||
147500692|NCT00589979|531984823|FG001|Run-In Period|Informed Consent Withdrawn|0|||
147500693|NCT00589979|531984824|FG002|Run-In Period|Informed Consent Withdrawn|0|||
147500694|NCT00589979|531984822|FG000|Double-Blind Treatment Period 1|Adverse Event|0|||
147500695|NCT00589979|531984823|FG001|Double-Blind Treatment Period 1|Adverse Event|1|||
147500696|NCT00589979|531984824|FG002|Double-Blind Treatment Period 1|Adverse Event|0|||
147500697|NCT00589979|531984822|FG000|Double-Blind Treatment Period 1|Protocol Violation|0|||
147500698|NCT00589979|531984823|FG001|Double-Blind Treatment Period 1|Protocol Violation|1|||
147500699|NCT00589979|531984824|FG002|Double-Blind Treatment Period 1|Protocol Violation|1|||
147500700|NCT00589979|531984822|FG000|Double-Blind Treatment Period 1|Withdrawal by Subject|0|||
147500701|NCT00589979|531984823|FG001|Double-Blind Treatment Period 1|Withdrawal by Subject|0|||
147500702|NCT00589979|531984824|FG002|Double-Blind Treatment Period 1|Withdrawal by Subject|1|||
147500703|NCT00589979|531984822|FG000|Double-Blind Treatment Period 2|Adverse Event|0|||
147500704|NCT00589979|531984823|FG001|Double-Blind Treatment Period 2|Adverse Event|1|||
147500705|NCT00589979|531984824|FG002|Double-Blind Treatment Period 2|Adverse Event|0|||
147500706|NCT00589979|531984822|FG000|Double-Blind Treatment Period 2|Withdrawal by Subject|0|||
147500707|NCT00589979|531984823|FG001|Double-Blind Treatment Period 2|Withdrawal by Subject|0|||
147500708|NCT00589979|531984824|FG002|Double-Blind Treatment Period 2|Withdrawal by Subject|1|||
147500709|NCT00589979|531984822|FG000|Double-Blind Treatment Period 2|Other|0|||
147500710|NCT00589979|531984823|FG001|Double-Blind Treatment Period 2|Other|0|||
147500711|NCT00589979|531984824|FG002|Double-Blind Treatment Period 2|Other|1|||
147500712|NCT00589979|531984822|FG000|Double-Blind Treatment Period 3|Protocol Violation|0|||
147500713|NCT00589979|531984823|FG001|Double-Blind Treatment Period 3|Protocol Violation|1|||
147500714|NCT00589979|531984824|FG002|Double-Blind Treatment Period 3|Protocol Violation|0|||
147500715|NCT00589979|531984822|FG000|Double-Blind Treatment Period 3|Withdrawal by Subject|0|||
147500716|NCT00589979|531984823|FG001|Double-Blind Treatment Period 3|Withdrawal by Subject|0|||
147500717|NCT00589979|531984824|FG002|Double-Blind Treatment Period 3|Withdrawal by Subject|1|||
147500718|NCT02029638|531984825|FG000|Overall Study|Death|0|||
147500719|NCT02029638|531984826|FG001|Overall Study|Death|0|||
147500720|NCT02029638|531984827|FG002|Overall Study|Death|1|||
147500721|NCT02029638|531984825|FG000|Overall Study|Decision by Study Sponsor or Regulatory|2|||
147500722|NCT02029638|531984826|FG001|Overall Study|Decision by Study Sponsor or Regulatory|0|||
147500723|NCT02029638|531984827|FG002|Overall Study|Decision by Study Sponsor or Regulatory|0|||
147500724|NCT01153841|531984830|FG000|Overall Study|Adverse Event|1|||
147500725|NCT01153841|531984831|FG001|Overall Study|Adverse Event|0|||
147500726|NCT01153841|531984830|FG000|Overall Study|Withdrawal by Subject|1|||
147500727|NCT01153841|531984831|FG001|Overall Study|Withdrawal by Subject|0|||
147500728|NCT01153841|531984830|FG000|Overall Study|Protocol Violation|2|||
147500729|NCT01153841|531984831|FG001|Overall Study|Protocol Violation|0|||
147500730|NCT01153841|531984830|FG000|Overall Study|Lost to Follow-up|2|||
147500731|NCT01153841|531984831|FG001|Overall Study|Lost to Follow-up|0|||
147500732|NCT00830804|531984832|FG000|Overall Study|Lost to Follow-up|4|||
147500733|NCT00830804|531984832|FG000|Overall Study|Death|1|||
147500734|NCT00830804|531984832|FG000|Overall Study|Unable to get to clinic|7|||
147500735|NCT00830804|531984832|FG000|Overall Study|Consent withdrawn|2|||
147500736|NCT00830804|531984832|FG000|Overall Study|Unwilling to adhere to study requirement|1|||
147500737|NCT03428997|531984840|FG000|Overall Study|Sponsor decision.|1|||
147500738|NCT03428997|531984840|FG000|Overall Study|Withdrawal by Subject|3|||
147500739|NCT03428997|531984840|FG000|Overall Study|Lost to Follow-up|4|||
147500740|NCT01838590|531984842|FG000|Overall Study|Lack of Efficacy|12|||
147500741|NCT01838590|531984843|FG001|Overall Study|Lack of Efficacy|4|||
147500742|NCT01838590|531984842|FG000|Overall Study|Lost to Follow-up|0|||
147500743|NCT01838590|531984843|FG001|Overall Study|Lost to Follow-up|1|||
147500744|NCT02843178|531987662|FG000|Overall Study|Lost to Follow-up|8|||
147500745|NCT02843178|531987663|FG001|Overall Study|Lost to Follow-up|8|||
147500746|NCT02843178|531987664|FG002|Overall Study|Lost to Follow-up|6|||
147500747|NCT02843178|531987665|FG003|Overall Study|Lost to Follow-up|3|||
147632638|NCT04696055|532474441|FG001|Overall Study|Other|2|||
147632639|NCT04696055|532474440|FG000|Overall Study|Physician Decision|3|||
147500748|NCT02843178|531987662|FG000|Overall Study|Withdrawal by Subject|0|||
147500749|NCT02843178|531987663|FG001|Overall Study|Withdrawal by Subject|0|||
147500750|NCT02843178|531987664|FG002|Overall Study|Withdrawal by Subject|1|||
147500751|NCT02843178|531987665|FG003|Overall Study|Withdrawal by Subject|1|||
147500752|NCT02420795|531987674|FG000|Overall Study|Withdrawal by Subject|1|||
147500753|NCT02420795|531987675|FG001|Overall Study|Withdrawal by Subject|0|||
147500754|NCT02420795|531987676|FG002|Overall Study|Withdrawal by Subject|0|||
147500755|NCT02420795|531987674|FG000|Overall Study|Adverse Event|1|||
147500756|NCT02420795|531987675|FG001|Overall Study|Adverse Event|0|||
147500757|NCT02420795|531987676|FG002|Overall Study|Adverse Event|0|||
147500758|NCT02420795|531987674|FG000|Overall Study|Progressive disease|2|||
147500759|NCT02420795|531987675|FG001|Overall Study|Progressive disease|2|||
147500760|NCT02420795|531987676|FG002|Overall Study|Progressive disease|4|||
147500761|NCT02420795|531987674|FG000|Overall Study|Death|0|||
147500762|NCT02420795|531987675|FG001|Overall Study|Death|0|||
147500763|NCT02420795|531987676|FG002|Overall Study|Death|1|||
147500764|NCT00949910|531987677|FG000|Overall Study|Progressive Disease|3750|||
147500765|NCT00949910|531987677|FG000|Overall Study|Symptomatic Deterioration|1088|||
147500766|NCT00949910|531987677|FG000|Overall Study|Lost to Follow-up|100|||
147500767|NCT00949910|531987677|FG000|Overall Study|Study Drug-Related Adverse Event|315|||
147500768|NCT00949910|531987677|FG000|Overall Study|Participant Refusal|390|||
147500769|NCT00949910|531987677|FG000|Overall Study|Death Due to Malignant Disease|456|||
147500770|NCT00949910|531987677|FG000|Overall Study|Death Due to Progression/Deterioration|4|||
147500771|NCT00949910|531987677|FG000|Overall Study|Death Due to Adverse Event|115|||
147500772|NCT00949910|531987677|FG000|Overall Study|Death Due to Toxicity|3|||
147500773|NCT00949910|531987677|FG000|Overall Study|Death from Unknown Cause|5|||
147500774|NCT00949910|531987677|FG000|Overall Study|Unspecified Progression/Deterioration|13|||
147500775|NCT00949910|531987677|FG000|Overall Study|Switched to Compassionate/Other Use|174|||
147500776|NCT00949910|531987677|FG000|Overall Study|Switched to Commercial Treatment|4|||
147500777|NCT00949910|531987677|FG000|Overall Study|Violation of Eligibility|23|||
147500778|NCT00949910|531987677|FG000|Overall Study|Logistical Reasons|13|||
147500779|NCT00949910|531987677|FG000|Overall Study|Non-Compliance|10|||
147500780|NCT00949910|531987677|FG000|Overall Study|Prolonged Dosing Interruption|4|||
147500781|NCT00949910|531987677|FG000|Overall Study|Adverse Event|83|||
147500782|NCT00949910|531987677|FG000|Overall Study|Serious Adverse Event|6|||
147500783|NCT00949910|531987677|FG000|Overall Study|Physician/Participant Decision|7|||
147500784|NCT00949910|531987677|FG000|Overall Study|Other|4|||
147500785|NCT00949910|531987677|FG000|Overall Study|No Data|9|||
147500786|NCT03287869|531987678|FG000|Overall Study|Adverse Event|14|||
147500787|NCT03287869|531987679|FG001|Overall Study|Adverse Event|12|||
147500788|NCT03287869|531987678|FG000|Overall Study|Lack of Efficacy|1|||
147500789|NCT03287869|531987679|FG001|Overall Study|Lack of Efficacy|0|||
147500790|NCT03287869|531987678|FG000|Overall Study|Lost to Follow-up|13|||
147500791|NCT03287869|531987679|FG001|Overall Study|Lost to Follow-up|19|||
147500792|NCT03287869|531987678|FG000|Overall Study|Non-Compliance With Study Drug|5|||
147500793|NCT03287869|531987679|FG001|Overall Study|Non-Compliance With Study Drug|9|||
147500794|NCT03287869|531987678|FG000|Overall Study|Progressive Disease|1|||
147500795|NCT03287869|531987679|FG001|Overall Study|Progressive Disease|0|||
147500796|NCT03287869|531987678|FG000|Overall Study|Protocol Deviation|2|||
147500797|NCT03287869|531987679|FG001|Overall Study|Protocol Deviation|1|||
147500798|NCT03287869|531987678|FG000|Overall Study|Withdrawal by Subject|36|||
147500799|NCT03287869|531987679|FG001|Overall Study|Withdrawal by Subject|43|||
147500800|NCT03287869|531987678|FG000|Overall Study|Early Closure of the Site|0|||
147500801|NCT03287869|531987679|FG001|Overall Study|Early Closure of the Site|1|||
147500802|NCT03287869|531987678|FG000|Overall Study|Physician Decision|5|||
147500803|NCT03287869|531987679|FG001|Overall Study|Physician Decision|5|||
147500804|NCT03287869|531987678|FG000|Overall Study|Reason not Specified|6|||
147500805|NCT03287869|531987679|FG001|Overall Study|Reason not Specified|3|||
147500806|NCT02455388|531987680|FG000|Overall Study|Protocol Violation|1|||
147500807|NCT02455388|531987681|FG001|Overall Study|Protocol Violation|0|||
147500808|NCT02455388|531987682|FG002|Overall Study|Protocol Violation|4|||
147500809|NCT02455388|531987680|FG000|Overall Study|Withdrawal by Subject|0|||
147500810|NCT02455388|531987681|FG001|Overall Study|Withdrawal by Subject|0|||
147500811|NCT02455388|531987682|FG002|Overall Study|Withdrawal by Subject|7|||
147500812|NCT04847141|531987683|FG000|Overall Study|Adverse Event|1|||
147500813|NCT04847141|531987684|FG001|Overall Study|Adverse Event|0|||
147500814|NCT04847141|531987685|FG002|Overall Study|Adverse Event|1|||
147500815|NCT04847141|531987683|FG000|Overall Study|Withdrawal by Subject|2|||
147500816|NCT04847141|531987684|FG001|Overall Study|Withdrawal by Subject|4|||
147500817|NCT04847141|531987685|FG002|Overall Study|Withdrawal by Subject|3|||
147500818|NCT04847141|531987683|FG000|Overall Study|Lost to Follow-up|7|||
147500819|NCT04847141|531987684|FG001|Overall Study|Lost to Follow-up|5|||
147500820|NCT04847141|531987685|FG002|Overall Study|Lost to Follow-up|7|||
147500821|NCT04847141|531987683|FG000|Overall Study|Reason not Specified|0|||
147500822|NCT04847141|531987684|FG001|Overall Study|Reason not Specified|1|||
147500823|NCT04847141|531987685|FG002|Overall Study|Reason not Specified|0|||
147500824|NCT00324740|531987686|FG000|Overall Study|Withdrawal by Subject|1|||
147632640|NCT04696055|532474441|FG001|Overall Study|Physician Decision|0|||
147668578|NCT00750269|532613322|FG003|Overall Study|Physician Decision|0|||
147668579|NCT00750269|532613323|FG004|Overall Study|Physician Decision|2|||
147500825|NCT00324740|531987687|FG001|Overall Study|Withdrawal by Subject|0|||
147500826|NCT00324740|531987688|FG002|Overall Study|Withdrawal by Subject|1|||
147500827|NCT00971425|531987693|FG000|Overall Study|Adverse Event|1|||
147668580|NCT00750269|532613319|FG000|Overall Study|Patient too large for positioning|0|||
147668581|NCT00750269|532613320|FG001|Overall Study|Patient too large for positioning|0|||
147668582|NCT00750269|532613321|FG002|Overall Study|Patient too large for positioning|1|||
147668583|NCT00750269|532613322|FG003|Overall Study|Patient too large for positioning|0|||
147668584|NCT00750269|532613323|FG004|Overall Study|Patient too large for positioning|0|||
147668585|NCT00750269|532613319|FG000|Overall Study|Site error|0|||
147668586|NCT00750269|532613320|FG001|Overall Study|Site error|0|||
147500828|NCT00971425|531987694|FG001|Overall Study|Adverse Event|1|||
147500829|NCT00971425|531987693|FG000|Overall Study|Withdrawal by Subject|0|||
147500830|NCT00971425|531987694|FG001|Overall Study|Withdrawal by Subject|1|||
147500831|NCT01357980|531987695|FG000|Overall Study|Lack of Efficacy|0|||
147500832|NCT01357980|531987696|FG001|Overall Study|Lack of Efficacy|1|||
147500833|NCT01357980|531987697|FG002|Overall Study|Lack of Efficacy|0|||
147500834|NCT01357980|531987698|FG003|Overall Study|Lack of Efficacy|0|||
147500835|NCT01357980|531987695|FG000|Overall Study|Consent withdrawn|0|||
147500836|NCT01357980|531987696|FG001|Overall Study|Consent withdrawn|0|||
147500837|NCT01357980|531987697|FG002|Overall Study|Consent withdrawn|1|||
147500838|NCT01357980|531987698|FG003|Overall Study|Consent withdrawn|0|||
147500839|NCT02528253|531987699|FG000|Overall Study|Adverse Event|3|||
147500840|NCT02528253|531987700|FG001|Overall Study|Adverse Event|4|||
147500841|NCT02528253|531987701|FG002|Overall Study|Adverse Event|4|||
147500842|NCT02528253|531987702|FG003|Overall Study|Adverse Event|8|||
147500843|NCT02528253|531987703|FG004|Overall Study|Adverse Event|18|||
147500844|NCT02528253|531987699|FG000|Overall Study|Death|2|||
147500845|NCT02528253|531987700|FG001|Overall Study|Death|2|||
147500846|NCT02528253|531987701|FG002|Overall Study|Death|1|||
147500847|NCT02528253|531987702|FG003|Overall Study|Death|0|||
147500848|NCT02528253|531987703|FG004|Overall Study|Death|1|||
147500849|NCT02528253|531987699|FG000|Overall Study|Insufficient clinical response|7|||
147500850|NCT02528253|531987700|FG001|Overall Study|Insufficient clinical response|10|||
147500851|NCT02528253|531987701|FG002|Overall Study|Insufficient clinical response|13|||
147500852|NCT02528253|531987702|FG003|Overall Study|Insufficient clinical response|12|||
147500853|NCT02528253|531987703|FG004|Overall Study|Insufficient clinical response|16|||
147500854|NCT02528253|531987699|FG000|Overall Study|Lost to Follow-up|16|||
147500855|NCT02528253|531987700|FG001|Overall Study|Lost to Follow-up|9|||
147500856|NCT02528253|531987701|FG002|Overall Study|Lost to Follow-up|31|||
147500857|NCT02528253|531987702|FG003|Overall Study|Lost to Follow-up|16|||
147500858|NCT02528253|531987703|FG004|Overall Study|Lost to Follow-up|34|||
147500859|NCT02528253|531987699|FG000|Overall Study|Other|21|||
147500860|NCT02528253|531987700|FG001|Overall Study|Other|22|||
147500861|NCT02528253|531987701|FG002|Overall Study|Other|58|||
147500862|NCT02528253|531987702|FG003|Overall Study|Other|52|||
147500863|NCT02528253|531987703|FG004|Overall Study|Other|76|||
147500864|NCT02528253|531987699|FG000|Overall Study|Withdrawal by Subject|25|||
147632641|NCT04696055|532474440|FG000|Overall Study|Progressive Disease - Clinical Progression|1|||
147632642|NCT04696055|532474441|FG001|Overall Study|Progressive Disease - Clinical Progression|1|||
147632643|NCT04696055|532474440|FG000|Overall Study|Progressive Disease - Radiological Progression|42|||
147632644|NCT04696055|532474441|FG001|Overall Study|Progressive Disease - Radiological Progression|20|||
147632645|NCT04696055|532474440|FG000|Overall Study|Subject Decision|1|||
147632646|NCT04696055|532474441|FG001|Overall Study|Subject Decision|2|||
147632647|NCT03969901|532474442|FG000|Overall Study|Withdrawal by parent/guardian|0|||
147632648|NCT03969901|532474443|FG001|Overall Study|Withdrawal by parent/guardian|0|||
147632649|NCT03969901|532474444|FG002|Overall Study|Withdrawal by parent/guardian|0|||
147632650|NCT03969901|532474445|FG003|Overall Study|Withdrawal by parent/guardian|0|||
147632651|NCT03969901|532474446|FG004|Overall Study|Withdrawal by parent/guardian|1|||
147632652|NCT03969901|532474447|FG005|Overall Study|Withdrawal by parent/guardian|0|||
147668587|NCT00750269|532613321|FG002|Overall Study|Site error|0|||
147668588|NCT00750269|532613322|FG003|Overall Study|Site error|1|||
147500865|NCT02528253|531987700|FG001|Overall Study|Withdrawal by Subject|20|||
147500866|NCT02528253|531987701|FG002|Overall Study|Withdrawal by Subject|29|||
147632653|NCT03969901|532474448|FG006|Overall Study|Withdrawal by parent/guardian|0|||
147668589|NCT00750269|532613323|FG004|Overall Study|Site error|0|||
147500867|NCT02528253|531987702|FG003|Overall Study|Withdrawal by Subject|48|||
147668590|NCT00750269|532613319|FG000|Overall Study|SBRT plan could not be drawn|0|||
147500868|NCT02528253|531987703|FG004|Overall Study|Withdrawal by Subject|73|||
147500869|NCT02528253|531987699|FG000|Overall Study|Protocol Violation|1|||
147500870|NCT02528253|531987700|FG001|Overall Study|Protocol Violation|2|||
147500871|NCT02528253|531987701|FG002|Overall Study|Protocol Violation|4|||
147500872|NCT02528253|531987702|FG003|Overall Study|Protocol Violation|0|||
147500873|NCT02528253|531987703|FG004|Overall Study|Protocol Violation|4|||
147500874|NCT02528253|531987699|FG000|Overall Study|Withdrawn Due to Pregnancy|0|||
147500875|NCT02528253|531987700|FG001|Overall Study|Withdrawn Due to Pregnancy|1|||
147500876|NCT02528253|531987701|FG002|Overall Study|Withdrawn Due to Pregnancy|0|||
147500877|NCT02528253|531987702|FG003|Overall Study|Withdrawn Due to Pregnancy|0|||
147500878|NCT02528253|531987703|FG004|Overall Study|Withdrawn Due to Pregnancy|1|||
147500879|NCT00094835|531987706|FG000|Overall Study|Physician Decision|1|||
147500880|NCT00094835|531987707|FG001|Overall Study|Physician Decision|0|||
147500881|NCT00094835|531987708|FG002|Overall Study|Physician Decision|0|||
147500882|NCT00094835|531987709|FG003|Overall Study|Physician Decision|0|||
147500883|NCT00094835|531987710|FG004|Overall Study|Physician Decision|0|||
147500884|NCT00094835|531987711|FG005|Overall Study|Physician Decision|1|||
147500885|NCT00094835|531987712|FG006|Overall Study|Physician Decision|0|||
147500886|NCT00094835|531987706|FG000|Overall Study|Withdrawal by Subject|0|||
147500887|NCT00094835|531987707|FG001|Overall Study|Withdrawal by Subject|0|||
147500888|NCT00094835|531987708|FG002|Overall Study|Withdrawal by Subject|0|||
147500889|NCT00094835|531987709|FG003|Overall Study|Withdrawal by Subject|0|||
147500890|NCT00094835|531987710|FG004|Overall Study|Withdrawal by Subject|0|||
147500891|NCT00094835|531987711|FG005|Overall Study|Withdrawal by Subject|0|||
147500892|NCT00094835|531987712|FG006|Overall Study|Withdrawal by Subject|1|||
147500893|NCT00094835|531987706|FG000|Overall Study|Lost to Follow-up|0|||
147500894|NCT00094835|531987707|FG001|Overall Study|Lost to Follow-up|0|||
147500895|NCT00094835|531987708|FG002|Overall Study|Lost to Follow-up|0|||
147500896|NCT00094835|531987709|FG003|Overall Study|Lost to Follow-up|0|||
147500897|NCT00094835|531987710|FG004|Overall Study|Lost to Follow-up|1|||
147500898|NCT00094835|531987711|FG005|Overall Study|Lost to Follow-up|0|||
147500899|NCT00094835|531987712|FG006|Overall Study|Lost to Follow-up|0|||
147500900|NCT00094835|531987706|FG000|Overall Study|Death|1|||
147500901|NCT00094835|531987707|FG001|Overall Study|Death|0|||
147500902|NCT00094835|531987708|FG002|Overall Study|Death|0|||
147500903|NCT00094835|531987709|FG003|Overall Study|Death|0|||
147500904|NCT00094835|531987710|FG004|Overall Study|Death|1|||
147500905|NCT00094835|531987711|FG005|Overall Study|Death|0|||
147500906|NCT00094835|531987712|FG006|Overall Study|Death|0|||
147500907|NCT00094835|531987706|FG000|Overall Study|Non-compliance|1|||
147500908|NCT00094835|531987707|FG001|Overall Study|Non-compliance|2|||
147500909|NCT00094835|531987708|FG002|Overall Study|Non-compliance|2|||
147500910|NCT00094835|531987709|FG003|Overall Study|Non-compliance|0|||
147500911|NCT00094835|531987710|FG004|Overall Study|Non-compliance|2|||
147500912|NCT00094835|531987711|FG005|Overall Study|Non-compliance|2|||
147500913|NCT00094835|531987712|FG006|Overall Study|Non-compliance|1|||
147500914|NCT00094835|531987706|FG000|Overall Study|Other|1|||
147500915|NCT00094835|531987707|FG001|Overall Study|Other|1|||
147500916|NCT00094835|531987708|FG002|Overall Study|Other|1|||
147500917|NCT00094835|531987709|FG003|Overall Study|Other|1|||
147500918|NCT00094835|531987710|FG004|Overall Study|Other|0|||
147500919|NCT00094835|531987711|FG005|Overall Study|Other|0|||
147500920|NCT00094835|531987712|FG006|Overall Study|Other|0|||
147500921|NCT00387348|531987713|FG000|Overall Study|Death|1|||
147500922|NCT00387348|531987714|FG001|Overall Study|Death|1|||
147500923|NCT00387348|531987715|FG002|Overall Study|Death|0|||
147500924|NCT00387348|531987713|FG000|Overall Study|Physician Decision|1|||
147500925|NCT00387348|531987714|FG001|Overall Study|Physician Decision|0|||
147500926|NCT00387348|531987715|FG002|Overall Study|Physician Decision|1|||
147500927|NCT00387348|531987713|FG000|Overall Study|Withdrawal by Subject|0|||
147500928|NCT00387348|531987714|FG001|Overall Study|Withdrawal by Subject|2|||
147500929|NCT00387348|531987715|FG002|Overall Study|Withdrawal by Subject|2|||
147500930|NCT00387348|531987713|FG000|Overall Study|Adverse Event|1|||
147500931|NCT00387348|531987714|FG001|Overall Study|Adverse Event|0|||
147500932|NCT00387348|531987715|FG002|Overall Study|Adverse Event|1|||
147500933|NCT00505752|531987716|FG000|Overall Study|Adverse Event|1|||
147500934|NCT00505752|531987717|FG001|Overall Study|Adverse Event|0|||
147500935|NCT00505752|531987718|FG002|Overall Study|Adverse Event|1|||
147500936|NCT00505752|531987719|FG003|Overall Study|Adverse Event|0|||
147500937|NCT00505752|531987716|FG000|Overall Study|Lost to Follow-up|1|||
147500938|NCT00505752|531987717|FG001|Overall Study|Lost to Follow-up|0|||
147500939|NCT00505752|531987718|FG002|Overall Study|Lost to Follow-up|0|||
147500940|NCT00505752|531987719|FG003|Overall Study|Lost to Follow-up|0|||
147500941|NCT00505752|531987716|FG000|Overall Study|Lack of ovarian response|1|||
147500942|NCT00505752|531987717|FG001|Overall Study|Lack of ovarian response|3|||
147500943|NCT00505752|531987718|FG002|Overall Study|Lack of ovarian response|0|||
147500944|NCT00505752|531987719|FG003|Overall Study|Lack of ovarian response|0|||
147500945|NCT00505752|531987716|FG000|Overall Study|Ovarian hyperstimulation syndrome risk|1|||
147500946|NCT00505752|531987717|FG001|Overall Study|Ovarian hyperstimulation syndrome risk|1|||
147500947|NCT00505752|531987718|FG002|Overall Study|Ovarian hyperstimulation syndrome risk|3|||
147500948|NCT00505752|531987719|FG003|Overall Study|Ovarian hyperstimulation syndrome risk|1|||
147500949|NCT00505752|531987716|FG000|Overall Study|No oocytes retrieved|0|||
147500950|NCT00505752|531987717|FG001|Overall Study|No oocytes retrieved|2|||
147500951|NCT00505752|531987718|FG002|Overall Study|No oocytes retrieved|0|||
147500952|NCT00505752|531987719|FG003|Overall Study|No oocytes retrieved|1|||
147500953|NCT00505752|531987716|FG000|Overall Study|No Fertilization|1|||
147500954|NCT00505752|531987717|FG001|Overall Study|No Fertilization|1|||
147500955|NCT00505752|531987718|FG002|Overall Study|No Fertilization|2|||
147500956|NCT00505752|531987719|FG003|Overall Study|No Fertilization|1|||
147500957|NCT00505752|531987716|FG000|Overall Study|All embryos/blastocysts discarded|0|||
147500958|NCT00505752|531987717|FG001|Overall Study|All embryos/blastocysts discarded|0|||
147500959|NCT00505752|531987718|FG002|Overall Study|All embryos/blastocysts discarded|1|||
147500960|NCT00505752|531987719|FG003|Overall Study|All embryos/blastocysts discarded|1|||
147500961|NCT00505752|531987716|FG000|Overall Study|Other|1|||
147500962|NCT00505752|531987717|FG001|Overall Study|Other|2|||
147500963|NCT00505752|531987718|FG002|Overall Study|Other|1|||
147500964|NCT00505752|531987719|FG003|Overall Study|Other|2|||
147500965|NCT01149343|531987720|FG000|Overall Study|Withdrawal by Subject|1|||
147500966|NCT01149343|531987721|FG001|Overall Study|Withdrawal by Subject|1|||
147500967|NCT01149343|531987722|FG002|Overall Study|Withdrawal by Subject|1|||
147500968|NCT01149343|531987723|FG003|Overall Study|Withdrawal by Subject|5|||
147500969|NCT01149343|531987720|FG000|Overall Study|Death|10|||
147500970|NCT01149343|531987721|FG001|Overall Study|Death|13|||
147500971|NCT01149343|531987722|FG002|Overall Study|Death|18|||
147500972|NCT01149343|531987723|FG003|Overall Study|Death|18|||
147500973|NCT01149343|531987720|FG000|Overall Study|Lost to Follow-up|1|||
147500974|NCT01149343|531987721|FG001|Overall Study|Lost to Follow-up|0|||
147500975|NCT01149343|531987722|FG002|Overall Study|Lost to Follow-up|0|||
147500976|NCT01149343|531987723|FG003|Overall Study|Lost to Follow-up|1|||
147500977|NCT01149343|531987720|FG000|Overall Study|Other|8|||
147500978|NCT01149343|531987721|FG001|Overall Study|Other|10|||
147500979|NCT01149343|531987722|FG002|Overall Study|Other|2|||
147500980|NCT01149343|531987723|FG003|Overall Study|Other|14|||
147500981|NCT01149343|531987720|FG000|Overall Study|Sponsor study termination|0|||
147500982|NCT01149343|531987721|FG001|Overall Study|Sponsor study termination|0|||
147500983|NCT01149343|531987722|FG002|Overall Study|Sponsor study termination|0|||
147500984|NCT01149343|531987723|FG003|Overall Study|Sponsor study termination|2|||
147500985|NCT01149343|531987720|FG000|Overall Study|Recurrence / Progressive disease|0|||
147500986|NCT01149343|531987721|FG001|Overall Study|Recurrence / Progressive disease|0|||
147500987|NCT01149343|531987722|FG002|Overall Study|Recurrence / Progressive disease|1|||
147500988|NCT01149343|531987723|FG003|Overall Study|Recurrence / Progressive disease|0|||
147500989|NCT04624672|531987727|FG000|Overall Study|Early Study Closure|2|||
147500990|NCT04624672|531987728|FG001|Overall Study|Early Study Closure|1|||
147500991|NCT03472040|531987729|FG000|Overall Study|Physician Decision|0|||
147500992|NCT03472040|531987730|FG001|Overall Study|Physician Decision|3|||
147500993|NCT03472040|531987729|FG000|Overall Study|Withdrawal by Subject|10|||
147500994|NCT03472040|531987730|FG001|Overall Study|Withdrawal by Subject|23|||
147500995|NCT03472040|531987729|FG000|Overall Study|Perceived Lack of Efficacy|29|||
147500996|NCT03472040|531987730|FG001|Overall Study|Perceived Lack of Efficacy|30|||
147500997|NCT03472040|531987729|FG000|Overall Study|Lab Abnormality or Adverse Event (AE)|7|||
147500998|NCT03472040|531987730|FG001|Overall Study|Lab Abnormality or Adverse Event (AE)|25|||
147500999|NCT03472040|531987729|FG000|Overall Study|Intercurrent Illness/Medical Condition|2|||
147501000|NCT03472040|531987730|FG001|Overall Study|Intercurrent Illness/Medical Condition|3|||
147501001|NCT03472040|531987729|FG000|Overall Study|Other - Not Otherwise Specified (NOS)|4|||
147501002|NCT03472040|531987730|FG001|Overall Study|Other - Not Otherwise Specified (NOS)|19|||
147501003|NCT03472040|531987729|FG000|Overall Study|Subject Non-compliance|2|||
147501004|NCT03472040|531987730|FG001|Overall Study|Subject Non-compliance|5|||
147501005|NCT03472040|531987729|FG000|Overall Study|Discontinuation due to Rash|0|||
147501006|NCT03472040|531987730|FG001|Overall Study|Discontinuation due to Rash|1|||
147501007|NCT03472040|531987729|FG000|Overall Study|Subsequent Ineligibility|0|||
147501008|NCT03472040|531987730|FG001|Overall Study|Subsequent Ineligibility|2|||
147501009|NCT03472040|531987729|FG000|Overall Study|Berotralstat Provided by alternative Means (i.e., Early Access Program or Commercially Available)|46|||
147501010|NCT03472040|531987730|FG001|Overall Study|Berotralstat Provided by alternative Means (i.e., Early Access Program or Commercially Available)|175|||
147501011|NCT02769832|531987731|FG000|Overall Study|Death|30|||
147501012|NCT00225147|531987740|FG000|Open-label Phase|Lost to Follow-up|0|||
147632654|NCT03969901|532474449|FG007|Overall Study|Withdrawal by parent/guardian|1|||
147501013|NCT00225147|531987741|FG001|Open-label Phase|Lost to Follow-up|0|||
147501014|NCT00225147|531987742|FG002|Open-label Phase|Lost to Follow-up|0|||
147501015|NCT00225147|531987743|FG003|Open-label Phase|Lost to Follow-up|4|||
147501016|NCT00225147|531987740|FG000|Open-label Phase|Withdrawal by Subject|0|||
147501017|NCT00225147|531987741|FG001|Open-label Phase|Withdrawal by Subject|0|||
147501018|NCT00225147|531987742|FG002|Open-label Phase|Withdrawal by Subject|0|||
147501019|NCT00225147|531987743|FG003|Open-label Phase|Withdrawal by Subject|6|||
147501020|NCT03625141|531987749|FG000|Overall Study|Adverse Event|0|||
147501021|NCT03625141|531987750|FG001|Overall Study|Adverse Event|2|||
147501022|NCT03625141|531987749|FG000|Overall Study|Study Terminated By Sponsor|1|||
147501023|NCT03625141|531987750|FG001|Overall Study|Study Terminated By Sponsor|13|||
147501024|NCT03625141|531987749|FG000|Overall Study|Withdrawal by Subject|3|||
147501025|NCT03625141|531987750|FG001|Overall Study|Withdrawal by Subject|0|||
147632655|NCT03969901|532474450|FG008|Overall Study|Withdrawal by parent/guardian|1|||
147632656|NCT03969901|532474451|FG009|Overall Study|Withdrawal by parent/guardian|0|||
147501026|NCT03625141|531987749|FG000|Overall Study|Withdrawal Of Consent|0|||
147501027|NCT03625141|531987750|FG001|Overall Study|Withdrawal Of Consent|1|||
147501028|NCT03625141|531987749|FG000|Overall Study|Death|11|||
147501029|NCT03625141|531987750|FG001|Overall Study|Death|47|||
147501030|NCT03625141|531987749|FG000|Overall Study|Progressive Disease|0|||
147501031|NCT03625141|531987750|FG001|Overall Study|Progressive Disease|2|||
147501032|NCT03250377|531987751|FG000|Overall Study|Adverse Event|2|||
147501033|NCT03250377|531987752|FG001|Overall Study|Adverse Event|4|||
147501034|NCT03250377|531987753|FG002|Overall Study|Adverse Event|0|||
147501035|NCT03250377|531987754|FG003|Overall Study|Adverse Event|4|||
147501036|NCT03250377|531987751|FG000|Overall Study|Lack of Efficacy|5|||
147501037|NCT03250377|531987752|FG001|Overall Study|Lack of Efficacy|14|||
147501038|NCT03250377|531987753|FG002|Overall Study|Lack of Efficacy|1|||
147501039|NCT03250377|531987754|FG003|Overall Study|Lack of Efficacy|3|||
147501040|NCT03250377|531987751|FG000|Overall Study|Protocol Violation|0|||
147501041|NCT03250377|531987752|FG001|Overall Study|Protocol Violation|2|||
147501042|NCT03250377|531987753|FG002|Overall Study|Protocol Violation|0|||
147501043|NCT03250377|531987754|FG003|Overall Study|Protocol Violation|1|||
147501044|NCT03250377|531987751|FG000|Overall Study|Lost to Follow-up|0|||
147501045|NCT03250377|531987752|FG001|Overall Study|Lost to Follow-up|1|||
147501046|NCT03250377|531987753|FG002|Overall Study|Lost to Follow-up|0|||
147501047|NCT03250377|531987754|FG003|Overall Study|Lost to Follow-up|0|||
147501048|NCT03250377|531987751|FG000|Overall Study|Withdrawal by Subject|7|||
147501049|NCT03250377|531987752|FG001|Overall Study|Withdrawal by Subject|7|||
147501050|NCT03250377|531987753|FG002|Overall Study|Withdrawal by Subject|0|||
147501051|NCT03250377|531987754|FG003|Overall Study|Withdrawal by Subject|4|||
147501052|NCT03250377|531987751|FG000|Overall Study|Investigator's Judgment|1|||
147501053|NCT03250377|531987752|FG001|Overall Study|Investigator's Judgment|0|||
147501054|NCT03250377|531987753|FG002|Overall Study|Investigator's Judgment|0|||
147501055|NCT03250377|531987754|FG003|Overall Study|Investigator's Judgment|0|||
147501056|NCT03250377|531987751|FG000|Overall Study|She wanted to change other therapeutic medication|1|||
147501057|NCT03250377|531987752|FG001|Overall Study|She wanted to change other therapeutic medication|0|||
147501058|NCT03250377|531987753|FG002|Overall Study|She wanted to change other therapeutic medication|0|||
147501059|NCT03250377|531987754|FG003|Overall Study|She wanted to change other therapeutic medication|0|||
147501060|NCT03250377|531987751|FG000|Overall Study|The Subject Go Abroad and Not Return|1|||
147501061|NCT03250377|531987752|FG001|Overall Study|The Subject Go Abroad and Not Return|0|||
147501062|NCT03250377|531987753|FG002|Overall Study|The Subject Go Abroad and Not Return|0|||
147501063|NCT03250377|531987754|FG003|Overall Study|The Subject Go Abroad and Not Return|0|||
147501064|NCT03250377|531987751|FG000|Overall Study|Epilepsy Surgery|0|||
147501065|NCT03250377|531987752|FG001|Overall Study|Epilepsy Surgery|1|||
147501066|NCT03250377|531987753|FG002|Overall Study|Epilepsy Surgery|2|||
147501067|NCT03250377|531987754|FG003|Overall Study|Epilepsy Surgery|0|||
147501068|NCT03250377|531987751|FG000|Overall Study|Subject moved to kanagawa (faraway from clinic)|0|||
147501069|NCT03250377|531987752|FG001|Overall Study|Subject moved to kanagawa (faraway from clinic)|1|||
147501070|NCT03250377|531987753|FG002|Overall Study|Subject moved to kanagawa (faraway from clinic)|0|||
147501071|NCT03250377|531987754|FG003|Overall Study|Subject moved to kanagawa (faraway from clinic)|0|||
147501072|NCT03250377|531987751|FG000|Overall Study|Request From The Sponsor|0|||
147501073|NCT03250377|531987752|FG001|Overall Study|Request From The Sponsor|1|||
147501074|NCT03250377|531987753|FG002|Overall Study|Request From The Sponsor|0|||
147501075|NCT03250377|531987754|FG003|Overall Study|Request From The Sponsor|0|||
147501076|NCT03250377|531987751|FG000|Overall Study|Subject did not follow procedure or study drug|0|||
147501077|NCT03250377|531987752|FG001|Overall Study|Subject did not follow procedure or study drug|1|||
147501078|NCT03250377|531987753|FG002|Overall Study|Subject did not follow procedure or study drug|0|||
147501079|NCT03250377|531987754|FG003|Overall Study|Subject did not follow procedure or study drug|0|||
147501080|NCT03250377|531987751|FG000|Overall Study|Subject stopped drug; did not wish to continue|0|||
147501081|NCT03250377|531987752|FG001|Overall Study|Subject stopped drug; did not wish to continue|1|||
147501082|NCT03250377|531987753|FG002|Overall Study|Subject stopped drug; did not wish to continue|0|||
147501083|NCT03250377|531987754|FG003|Overall Study|Subject stopped drug; did not wish to continue|0|||
147501084|NCT03250377|531987751|FG000|Overall Study|Subjects did not follow procedures or medication|0|||
147501085|NCT03250377|531987752|FG001|Overall Study|Subjects did not follow procedures or medication|1|||
147501086|NCT03250377|531987753|FG002|Overall Study|Subjects did not follow procedures or medication|0|||
147501087|NCT03250377|531987754|FG003|Overall Study|Subjects did not follow procedures or medication|0|||
147501088|NCT03250377|531987751|FG000|Overall Study|Pregnancy Event|0|||
147501089|NCT03250377|531987752|FG001|Overall Study|Pregnancy Event|1|||
147501090|NCT03250377|531987753|FG002|Overall Study|Pregnancy Event|0|||
147501091|NCT03250377|531987754|FG003|Overall Study|Pregnancy Event|0|||
147501092|NCT03250377|531987751|FG000|Overall Study|PI's opinion:Subject noncompliant with medication|0|||
147501093|NCT03250377|531987752|FG001|Overall Study|PI's opinion:Subject noncompliant with medication|1|||
147501094|NCT03250377|531987753|FG002|Overall Study|PI's opinion:Subject noncompliant with medication|0|||
147668591|NCT00750269|532613320|FG001|Overall Study|SBRT plan could not be drawn|0|||
147501095|NCT03250377|531987754|FG003|Overall Study|PI's opinion:Subject noncompliant with medication|0|||
147501096|NCT03250377|531987751|FG000|Overall Study|Subjects felt no effect;want to discontinue study|0|||
147501097|NCT03250377|531987752|FG001|Overall Study|Subjects felt no effect;want to discontinue study|1|||
147668592|NCT00750269|532613321|FG002|Overall Study|SBRT plan could not be drawn|0|||
147668593|NCT00750269|532613322|FG003|Overall Study|SBRT plan could not be drawn|0|||
147668594|NCT00750269|532613323|FG004|Overall Study|SBRT plan could not be drawn|1|||
147668595|NCT00750269|532613319|FG000|Overall Study|Fiducials could not be placed|0|||
147668596|NCT00750269|532613320|FG001|Overall Study|Fiducials could not be placed|0|||
147668597|NCT00750269|532613321|FG002|Overall Study|Fiducials could not be placed|0|||
147668598|NCT00750269|532613322|FG003|Overall Study|Fiducials could not be placed|0|||
147668599|NCT00750269|532613323|FG004|Overall Study|Fiducials could not be placed|1|||
147668600|NCT01898078|532613325|FG000|Overall Study|Progressive Disease|1|||
147668601|NCT01898078|532613326|FG001|Overall Study|Progressive Disease|5|||
147668602|NCT01898078|532613325|FG000|Overall Study|Adverse Event|2|||
147668603|NCT01898078|532613326|FG001|Overall Study|Adverse Event|1|||
147668604|NCT01898078|532613325|FG000|Overall Study|Withdrawal by Subject|1|||
147668605|NCT01898078|532613326|FG001|Overall Study|Withdrawal by Subject|1|||
147668606|NCT01898078|532613325|FG000|Overall Study|Symptomatic Deterioration|2|||
147668607|NCT01898078|532613326|FG001|Overall Study|Symptomatic Deterioration|0|||
147668608|NCT01898078|532613325|FG000|Overall Study|Reason not Specified|0|||
147668609|NCT01898078|532613326|FG001|Overall Study|Reason not Specified|1|||
147668610|NCT01075048|532613327|FG000|Overall Study|Death|4|||
147668611|NCT01075048|532613328|FG001|Overall Study|Death|17|||
147668612|NCT01075048|532613329|FG002|Overall Study|Death|12|||
147668613|NCT01075048|532613327|FG000|Overall Study|Start of other or new therapy|4|||
147668614|NCT01075048|532613328|FG001|Overall Study|Start of other or new therapy|36|||
147668615|NCT01075048|532613329|FG002|Overall Study|Start of other or new therapy|46|||
147668616|NCT01075048|532613327|FG000|Overall Study|Withdrawal by Subject|1|||
147668617|NCT01075048|532613328|FG001|Overall Study|Withdrawal by Subject|6|||
147668618|NCT01075048|532613329|FG002|Overall Study|Withdrawal by Subject|3|||
147668619|NCT01075048|532613327|FG000|Overall Study|Lost to Follow-up|0|||
147668620|NCT01075048|532613328|FG001|Overall Study|Lost to Follow-up|1|||
147668621|NCT01075048|532613329|FG002|Overall Study|Lost to Follow-up|1|||
147668622|NCT00761319|532613336|FG000|Overall Study|Protocol Violation|21|||
147668623|NCT00761319|532613337|FG001|Overall Study|Protocol Violation|14|||
147668624|NCT00761319|532613336|FG000|Overall Study|Adverse Event|11|||
147668625|NCT00761319|532613337|FG001|Overall Study|Adverse Event|7|||
147668626|NCT00761319|532613336|FG000|Overall Study|Withdrawal by Subject|8|||
147668627|NCT00761319|532613337|FG001|Overall Study|Withdrawal by Subject|7|||
147668628|NCT00761319|532613336|FG000|Overall Study|Noncompliance|4|||
147668629|NCT00761319|532613337|FG001|Overall Study|Noncompliance|3|||
147668630|NCT00761319|532613336|FG000|Overall Study|Lost to Follow-up|1|||
147668631|NCT00761319|532613337|FG001|Overall Study|Lost to Follow-up|1|||
147668632|NCT00761319|532613336|FG000|Overall Study|Nonspecified|2|||
147668633|NCT00761319|532613337|FG001|Overall Study|Nonspecified|2|||
147668634|NCT00761319|532613336|FG000|Overall Study|Missing|1|||
147668635|NCT00761319|532613337|FG001|Overall Study|Missing|0|||
147668636|NCT01715831|532613342|FG000|Overall Study|Adverse Event|1|||
147668637|NCT00900562|532613343|FG000|Overall Study|Progressive disease|9|||
147668638|NCT00900562|532613344|FG001|Overall Study|Progressive disease|5|||
147668639|NCT00900562|532613343|FG000|Overall Study|Toxicity|1|||
147668640|NCT00900562|532613344|FG001|Overall Study|Toxicity|0|||
147668641|NCT00900562|532613343|FG000|Overall Study|Death|1|||
147668642|NCT00900562|532613344|FG001|Overall Study|Death|1|||
147668643|NCT00900562|532613343|FG000|Overall Study|Withdrawal by Subject|0|||
147668644|NCT00900562|532613344|FG001|Overall Study|Withdrawal by Subject|1|||
147668645|NCT00900562|532613343|FG000|Overall Study|Unrelated adverse event|1|||
147668646|NCT00900562|532613344|FG001|Overall Study|Unrelated adverse event|0|||
147668647|NCT03098979|532613347|FG000|Overall Study|Adverse Event|1|||
147668648|NCT03098979|532613348|FG001|Overall Study|Adverse Event|0|||
147668649|NCT03098979|532613349|FG002|Overall Study|Adverse Event|1|||
147668650|NCT03098979|532613350|FG003|Overall Study|Adverse Event|4|||
147668651|NCT03098979|532613351|FG004|Overall Study|Adverse Event|6|||
147668652|NCT03098979|532613352|FG005|Overall Study|Adverse Event|1|||
147668653|NCT03098979|532613347|FG000|Overall Study|Withdrawal by Subject|2|||
147668654|NCT03098979|532613348|FG001|Overall Study|Withdrawal by Subject|1|||
147668655|NCT03098979|532613349|FG002|Overall Study|Withdrawal by Subject|1|||
147668656|NCT03098979|532613350|FG003|Overall Study|Withdrawal by Subject|1|||
147501098|NCT03250377|531987753|FG002|Overall Study|Subjects felt no effect;want to discontinue study|0|||
147501099|NCT03250377|531987754|FG003|Overall Study|Subjects felt no effect;want to discontinue study|0|||
147668657|NCT03098979|532613351|FG004|Overall Study|Withdrawal by Subject|2|||
147668658|NCT03098979|532613352|FG005|Overall Study|Withdrawal by Subject|1|||
147668659|NCT03098979|532613347|FG000|Overall Study|Death|1|||
147668660|NCT03098979|532613348|FG001|Overall Study|Death|0|||
147668661|NCT03098979|532613349|FG002|Overall Study|Death|2|||
147668662|NCT03098979|532613350|FG003|Overall Study|Death|0|||
147668663|NCT03098979|532613351|FG004|Overall Study|Death|1|||
147668664|NCT03098979|532613352|FG005|Overall Study|Death|0|||
147668665|NCT03098979|532613347|FG000|Overall Study|Physician Decision|2|||
147668666|NCT03098979|532613348|FG001|Overall Study|Physician Decision|1|||
147668667|NCT03098979|532613349|FG002|Overall Study|Physician Decision|0|||
147501100|NCT03250377|531987751|FG000|Overall Study|Subjects underweight; intolerant to study drugs|0|||
147501101|NCT03250377|531987752|FG001|Overall Study|Subjects underweight; intolerant to study drugs|1|||
147501102|NCT03250377|531987753|FG002|Overall Study|Subjects underweight; intolerant to study drugs|0|||
147501103|NCT03250377|531987754|FG003|Overall Study|Subjects underweight; intolerant to study drugs|0|||
147501104|NCT03250377|531987751|FG000|Overall Study|Patient requested to change hospital|0|||
147501105|NCT03250377|531987752|FG001|Overall Study|Patient requested to change hospital|0|||
147501106|NCT03250377|531987753|FG002|Overall Study|Patient requested to change hospital|0|||
147501107|NCT03250377|531987754|FG003|Overall Study|Patient requested to change hospital|1|||
147501108|NCT03250377|531987751|FG000|Overall Study|Admission To Geriatric Health Facility|0|||
147501109|NCT03250377|531987752|FG001|Overall Study|Admission To Geriatric Health Facility|0|||
147501110|NCT03250377|531987753|FG002|Overall Study|Admission To Geriatric Health Facility|0|||
147501111|NCT03250377|531987754|FG003|Overall Study|Admission To Geriatric Health Facility|1|||
147501112|NCT03444870|531987755|FG000|Double-Blind Treatment (DBT) Period|Study Terminated By Sponsor|0|||
147501113|NCT03444870|531987756|FG001|Double-Blind Treatment (DBT) Period|Study Terminated By Sponsor|0|||
147501114|NCT03444870|531987757|FG002|Double-Blind Treatment (DBT) Period|Study Terminated By Sponsor|30|||
147501115|NCT03444870|531987758|FG003|Double-Blind Treatment (DBT) Period|Study Terminated By Sponsor|35|||
147501116|NCT03444870|531987759|FG004|Double-Blind Treatment (DBT) Period|Study Terminated By Sponsor|0|||
147501117|NCT03444870|531987760|FG005|Double-Blind Treatment (DBT) Period|Study Terminated By Sponsor|0|||
147501118|NCT03444870|531987755|FG000|Double-Blind Treatment (DBT) Period|Reason not Specified|17|||
147501119|NCT03444870|531987756|FG001|Double-Blind Treatment (DBT) Period|Reason not Specified|16|||
147501120|NCT03444870|531987757|FG002|Double-Blind Treatment (DBT) Period|Reason not Specified|1|||
147501121|NCT03444870|531987758|FG003|Double-Blind Treatment (DBT) Period|Reason not Specified|0|||
147501122|NCT03444870|531987759|FG004|Double-Blind Treatment (DBT) Period|Reason not Specified|0|||
147501123|NCT03444870|531987760|FG005|Double-Blind Treatment (DBT) Period|Reason not Specified|0|||
147501124|NCT03444870|531987755|FG000|Double-Blind Treatment (DBT) Period|Withdrawal by Subject|56|||
147501125|NCT03444870|531987756|FG001|Double-Blind Treatment (DBT) Period|Withdrawal by Subject|63|||
147501126|NCT03444870|531987757|FG002|Double-Blind Treatment (DBT) Period|Withdrawal by Subject|2|||
147501127|NCT03444870|531987758|FG003|Double-Blind Treatment (DBT) Period|Withdrawal by Subject|0|||
147501128|NCT03444870|531987759|FG004|Double-Blind Treatment (DBT) Period|Withdrawal by Subject|0|||
147501129|NCT03444870|531987760|FG005|Double-Blind Treatment (DBT) Period|Withdrawal by Subject|0|||
147668668|NCT03098979|532613350|FG003|Overall Study|Physician Decision|0|||
147668669|NCT03098979|532613351|FG004|Overall Study|Physician Decision|0|||
147501130|NCT03444870|531987755|FG000|Double-Blind Treatment (DBT) Period|Protocol Deviation|4|||
147501131|NCT03444870|531987756|FG001|Double-Blind Treatment (DBT) Period|Protocol Deviation|3|||
147501132|NCT03444870|531987757|FG002|Double-Blind Treatment (DBT) Period|Protocol Deviation|0|||
147501133|NCT03444870|531987758|FG003|Double-Blind Treatment (DBT) Period|Protocol Deviation|0|||
147501134|NCT03444870|531987759|FG004|Double-Blind Treatment (DBT) Period|Protocol Deviation|0|||
147501135|NCT03444870|531987760|FG005|Double-Blind Treatment (DBT) Period|Protocol Deviation|0|||
147501136|NCT03444870|531987755|FG000|Double-Blind Treatment (DBT) Period|Physician Decision|3|||
147501137|NCT03444870|531987756|FG001|Double-Blind Treatment (DBT) Period|Physician Decision|11|||
147501138|NCT03444870|531987757|FG002|Double-Blind Treatment (DBT) Period|Physician Decision|0|||
147501139|NCT03444870|531987758|FG003|Double-Blind Treatment (DBT) Period|Physician Decision|0|||
147501140|NCT03444870|531987759|FG004|Double-Blind Treatment (DBT) Period|Physician Decision|0|||
147501141|NCT03444870|531987760|FG005|Double-Blind Treatment (DBT) Period|Physician Decision|0|||
147501142|NCT03444870|531987755|FG000|Double-Blind Treatment (DBT) Period|Lost to Follow-up|1|||
147501143|NCT03444870|531987756|FG001|Double-Blind Treatment (DBT) Period|Lost to Follow-up|0|||
147501144|NCT03444870|531987757|FG002|Double-Blind Treatment (DBT) Period|Lost to Follow-up|0|||
147501145|NCT03444870|531987758|FG003|Double-Blind Treatment (DBT) Period|Lost to Follow-up|0|||
147501146|NCT03444870|531987759|FG004|Double-Blind Treatment (DBT) Period|Lost to Follow-up|0|||
147501147|NCT03444870|531987760|FG005|Double-Blind Treatment (DBT) Period|Lost to Follow-up|0|||
147501148|NCT03444870|531987755|FG000|Double-Blind Treatment (DBT) Period|Death|10|||
147501149|NCT03444870|531987756|FG001|Double-Blind Treatment (DBT) Period|Death|2|||
147501150|NCT03444870|531987757|FG002|Double-Blind Treatment (DBT) Period|Death|0|||
147501151|NCT03444870|531987758|FG003|Double-Blind Treatment (DBT) Period|Death|0|||
147501152|NCT03444870|531987759|FG004|Double-Blind Treatment (DBT) Period|Death|0|||
147501153|NCT03444870|531987760|FG005|Double-Blind Treatment (DBT) Period|Death|0|||
147501154|NCT03444870|531987755|FG000|Double-Blind Treatment (DBT) Period|Adverse Event|7|||
147501155|NCT03444870|531987756|FG001|Double-Blind Treatment (DBT) Period|Adverse Event|29|||
147501156|NCT03444870|531987757|FG002|Double-Blind Treatment (DBT) Period|Adverse Event|0|||
147501157|NCT03444870|531987758|FG003|Double-Blind Treatment (DBT) Period|Adverse Event|0|||
147501158|NCT03444870|531987759|FG004|Double-Blind Treatment (DBT) Period|Adverse Event|0|||
147501159|NCT03444870|531987760|FG005|Double-Blind Treatment (DBT) Period|Adverse Event|0|||
147501160|NCT03444870|531987755|FG000|Double-Blind Treatment (DBT) Period|Randomized, but not Treated|1|||
147501161|NCT03444870|531987756|FG001|Double-Blind Treatment (DBT) Period|Randomized, but not Treated|0|||
147501162|NCT03444870|531987757|FG002|Double-Blind Treatment (DBT) Period|Randomized, but not Treated|0|||
147501163|NCT03444870|531987758|FG003|Double-Blind Treatment (DBT) Period|Randomized, but not Treated|0|||
147501164|NCT03444870|531987759|FG004|Double-Blind Treatment (DBT) Period|Randomized, but not Treated|0|||
147501165|NCT03444870|531987760|FG005|Double-Blind Treatment (DBT) Period|Randomized, but not Treated|0|||
147501166|NCT03444870|531987755|FG000|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
147501167|NCT03444870|531987756|FG001|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
147501168|NCT03444870|531987757|FG002|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
147501169|NCT03444870|531987758|FG003|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
147501170|NCT03444870|531987759|FG004|Open-Label Extension (OLE) Period|Withdrawal by Subject|1|||
147501171|NCT03444870|531987760|FG005|Open-Label Extension (OLE) Period|Withdrawal by Subject|2|||
147501172|NCT03444870|531987755|FG000|Open-Label Extension (OLE) Period|Physician Decision|0|||
147501173|NCT03444870|531987756|FG001|Open-Label Extension (OLE) Period|Physician Decision|0|||
147501174|NCT03444870|531987757|FG002|Open-Label Extension (OLE) Period|Physician Decision|0|||
147501175|NCT03444870|531987758|FG003|Open-Label Extension (OLE) Period|Physician Decision|0|||
147501176|NCT03444870|531987759|FG004|Open-Label Extension (OLE) Period|Physician Decision|1|||
147501177|NCT03444870|531987760|FG005|Open-Label Extension (OLE) Period|Physician Decision|0|||
147501178|NCT03444870|531987755|FG000|Open-Label Extension (OLE) Period|Death|0|||
147501179|NCT03444870|531987756|FG001|Open-Label Extension (OLE) Period|Death|0|||
147501180|NCT03444870|531987757|FG002|Open-Label Extension (OLE) Period|Death|0|||
147501181|NCT03444870|531987758|FG003|Open-Label Extension (OLE) Period|Death|0|||
147501182|NCT03444870|531987759|FG004|Open-Label Extension (OLE) Period|Death|1|||
147501183|NCT03444870|531987760|FG005|Open-Label Extension (OLE) Period|Death|0|||
147501184|NCT02501902|531987764|FG000|Overall Study|Subject Refused Further Follow-up|0|||
147501185|NCT02501902|531987765|FG001|Overall Study|Subject Refused Further Follow-up|0|||
147501186|NCT02501902|531987766|FG002|Overall Study|Subject Refused Further Follow-up|0|||
147501187|NCT02501902|531987767|FG003|Overall Study|Subject Refused Further Follow-up|0|||
147501188|NCT02501902|531987768|FG004|Overall Study|Subject Refused Further Follow-up|0|||
147501189|NCT02501902|531987769|FG005|Overall Study|Subject Refused Further Follow-up|0|||
147501190|NCT02501902|531987770|FG006|Overall Study|Subject Refused Further Follow-up|0|||
147501191|NCT02501902|531987771|FG007|Overall Study|Subject Refused Further Follow-up|1|||
147501192|NCT02501902|531987764|FG000|Overall Study|Study Terminated by Sponsor|0|||
147501193|NCT02501902|531987765|FG001|Overall Study|Study Terminated by Sponsor|3|||
147501194|NCT02501902|531987766|FG002|Overall Study|Study Terminated by Sponsor|0|||
147501195|NCT02501902|531987767|FG003|Overall Study|Study Terminated by Sponsor|1|||
147501196|NCT02501902|531987768|FG004|Overall Study|Study Terminated by Sponsor|1|||
147501197|NCT02501902|531987769|FG005|Overall Study|Study Terminated by Sponsor|0|||
147501198|NCT02501902|531987770|FG006|Overall Study|Study Terminated by Sponsor|2|||
147501199|NCT02501902|531987771|FG007|Overall Study|Study Terminated by Sponsor|4|||
147501200|NCT02501902|531987764|FG000|Overall Study|Death|3|||
147501201|NCT02501902|531987765|FG001|Overall Study|Death|4|||
147501202|NCT02501902|531987766|FG002|Overall Study|Death|4|||
147501203|NCT02501902|531987767|FG003|Overall Study|Death|10|||
147501204|NCT02501902|531987768|FG004|Overall Study|Death|10|||
147501205|NCT02501902|531987769|FG005|Overall Study|Death|11|||
147501206|NCT02501902|531987770|FG006|Overall Study|Death|7|||
147501207|NCT02501902|531987771|FG007|Overall Study|Death|15|||
147501208|NCT00565058|531987772|FG000|Overall Study|Adverse Event|1|||
147501209|NCT00565058|531987773|FG001|Overall Study|Adverse Event|0|||
147501210|NCT00510068|531987780|FG000|Double-blind Period|Disease progression|98|||
147501211|NCT00510068|531987781|FG001|Double-blind Period|Disease progression|169|||
147501212|NCT00510068|531987780|FG000|Double-blind Period|Final primary analysis|52|||
147501213|NCT00510068|531987781|FG001|Double-blind Period|Final primary analysis|18|||
147501214|NCT00510068|531987780|FG000|Double-blind Period|Adverse Event|37|||
147501215|NCT00510068|531987781|FG001|Double-blind Period|Adverse Event|7|||
147632657|NCT04411810|532474452|FG000|Overall Study|Screen failure|1|||
147632658|NCT04411810|532474452|FG000|Overall Study|Withdrawal by Subject|1|||
147632659|NCT01920958|532474453|FG000|Overall Study|Did Not Fulfill Inclusion Criteria|5|||
147632660|NCT02028767|532474456|FG000|Treatment Period 2|Non compliant with protocol|1|||
147632661|NCT02028767|532474457|FG001|Treatment Period 2|Non compliant with protocol|0|||
147632662|NCT02028767|532474456|FG000|Treatment Period 2|Reason other than those specified above|1|||
147632663|NCT02028767|532474457|FG001|Treatment Period 2|Reason other than those specified above|0|||
147632664|NCT01284348|532474458|FG000|Overall Study|Death|1|||
147632665|NCT01284348|532474459|FG001|Overall Study|Death|1|||
147632666|NCT01284348|532474458|FG000|Overall Study|Withdrew consent|0|||
147632667|NCT01284348|532474459|FG001|Overall Study|Withdrew consent|1|||
147632668|NCT01284348|532474458|FG000|Overall Study|Status not recorded|9|||
147632669|NCT01284348|532474459|FG001|Overall Study|Status not recorded|10|||
147632670|NCT02589626|532474467|FG000|Overall Study|Other than the reason specified|1|||
147632671|NCT02589626|532474468|FG001|Overall Study|Other than the reason specified|0|||
147632672|NCT02589626|532474467|FG000|Overall Study|Withdrawal by Subject|1|||
147632673|NCT02589626|532474468|FG001|Overall Study|Withdrawal by Subject|1|||
147632674|NCT02589626|532474467|FG000|Overall Study|Adverse Event|1|||
147632675|NCT02589626|532474468|FG001|Overall Study|Adverse Event|1|||
147632676|NCT02564900|532474469|FG000|Dose Escalation|Progressive disease per RECIST|2|||
147632677|NCT02564900|532474470|FG001|Dose Escalation|Progressive disease per RECIST|3|||
147668670|NCT03098979|532613352|FG005|Overall Study|Physician Decision|0|||
147501216|NCT00510068|531987780|FG000|Double-blind Period|Withdrawal by Subject|8|||
147501217|NCT00510068|531987781|FG001|Double-blind Period|Withdrawal by Subject|6|||
147501218|NCT00510068|531987780|FG000|Double-blind Period|Death|4|||
147501219|NCT00510068|531987781|FG001|Double-blind Period|Death|3|||
147501220|NCT00510068|531987780|FG000|Double-blind Period|Abnormal test result (s)|1|||
147501221|NCT00510068|531987781|FG001|Double-blind Period|Abnormal test result (s)|0|||
147501222|NCT00510068|531987780|FG000|Double-blind Period|Lost to Follow-up|1|||
147501223|NCT00510068|531987781|FG001|Double-blind Period|Lost to Follow-up|0|||
147501224|NCT00510068|531987780|FG000|Double-blind Period|Protocol Violation|6|||
147501225|NCT00510068|531987781|FG001|Double-blind Period|Protocol Violation|0|||
147501226|NCT00510068|531987780|FG000|Open-label Period|Disease Progression|124|||
147501227|NCT00510068|531987781|FG001|Open-label Period|Disease Progression|0|||
147501228|NCT00510068|531987780|FG000|Open-label Period|Adverse Event|46|||
147501229|NCT00510068|531987781|FG001|Open-label Period|Adverse Event|0|||
147501230|NCT00510068|531987780|FG000|Open-label Period|Withdrawal by Subject|21|||
147501231|NCT00510068|531987781|FG001|Open-label Period|Withdrawal by Subject|0|||
147501232|NCT00510068|531987780|FG000|Open-label Period|Administrative problems|17|||
147501233|NCT00510068|531987781|FG001|Open-label Period|Administrative problems|0|||
147501234|NCT00510068|531987780|FG000|Open-label Period|Death|7|||
147501235|NCT00510068|531987781|FG001|Open-label Period|Death|0|||
147632678|NCT02564900|532474471|FG002|Dose Escalation|Progressive disease per RECIST|3|||
147632679|NCT02564900|532474472|FG003|Dose Escalation|Progressive disease per RECIST|3|||
147632680|NCT02564900|532474473|FG004|Dose Escalation|Progressive disease per RECIST|3|||
147632681|NCT02564900|532474474|FG005|Dose Escalation|Progressive disease per RECIST|1|||
147632682|NCT02564900|532474475|FG006|Dose Escalation|Progressive disease per RECIST|0|||
147632683|NCT02564900|532474476|FG007|Dose Escalation|Progressive disease per RECIST|0|||
147632684|NCT02564900|532474477|FG008|Dose Escalation|Progressive disease per RECIST|0|||
147632685|NCT02564900|532474478|FG009|Dose Escalation|Progressive disease per RECIST|0|||
147632686|NCT02564900|532474479|FG010|Dose Escalation|Progressive disease per RECIST|0|||
147632687|NCT02564900|532474480|FG011|Dose Escalation|Progressive disease per RECIST|0|||
147632688|NCT02564900|532474481|FG012|Dose Escalation|Progressive disease per RECIST|0|||
147632689|NCT02564900|532474482|FG013|Dose Escalation|Progressive disease per RECIST|0|||
147632690|NCT02564900|532474483|FG014|Dose Escalation|Progressive disease per RECIST|0|||
147632691|NCT02564900|532474469|FG000|Dose Escalation|Ongoing|1|||
147632692|NCT02564900|532474470|FG001|Dose Escalation|Ongoing|0|||
147632693|NCT02564900|532474471|FG002|Dose Escalation|Ongoing|0|||
147632694|NCT02564900|532474472|FG003|Dose Escalation|Ongoing|2|||
147632695|NCT02564900|532474473|FG004|Dose Escalation|Ongoing|2|||
147632696|NCT02564900|532474474|FG005|Dose Escalation|Ongoing|2|||
147632697|NCT02564900|532474475|FG006|Dose Escalation|Ongoing|0|||
147632698|NCT02564900|532474476|FG007|Dose Escalation|Ongoing|0|||
147632699|NCT02564900|532474477|FG008|Dose Escalation|Ongoing|0|||
147632700|NCT02564900|532474478|FG009|Dose Escalation|Ongoing|0|||
147632701|NCT02564900|532474479|FG010|Dose Escalation|Ongoing|0|||
147632702|NCT02564900|532474480|FG011|Dose Escalation|Ongoing|0|||
147632703|NCT02564900|532474481|FG012|Dose Escalation|Ongoing|0|||
147632704|NCT02564900|532474482|FG013|Dose Escalation|Ongoing|0|||
147632705|NCT02564900|532474483|FG014|Dose Escalation|Ongoing|0|||
147632706|NCT02564900|532474469|FG000|Dose Escalation|Adverse Event|0|||
147632707|NCT02564900|532474470|FG001|Dose Escalation|Adverse Event|0|||
147632708|NCT02564900|532474471|FG002|Dose Escalation|Adverse Event|0|||
147632709|NCT02564900|532474472|FG003|Dose Escalation|Adverse Event|1|||
147632710|NCT02564900|532474473|FG004|Dose Escalation|Adverse Event|1|||
147632711|NCT02564900|532474474|FG005|Dose Escalation|Adverse Event|3|||
147632712|NCT02564900|532474475|FG006|Dose Escalation|Adverse Event|0|||
147632713|NCT02564900|532474476|FG007|Dose Escalation|Adverse Event|0|||
147632714|NCT02564900|532474477|FG008|Dose Escalation|Adverse Event|0|||
147632715|NCT02564900|532474478|FG009|Dose Escalation|Adverse Event|0|||
147632716|NCT02564900|532474479|FG010|Dose Escalation|Adverse Event|0|||
147632717|NCT02564900|532474480|FG011|Dose Escalation|Adverse Event|0|||
147632718|NCT02564900|532474481|FG012|Dose Escalation|Adverse Event|0|||
147632719|NCT02564900|532474482|FG013|Dose Escalation|Adverse Event|0|||
147501236|NCT00510068|531987780|FG000|Open-label Period|New cancer therapy|7|||
147501237|NCT00510068|531987781|FG001|Open-label Period|New cancer therapy|0|||
147501238|NCT00510068|531987780|FG000|Open-label Period|Protocol Violation|2|||
147501239|NCT00510068|531987781|FG001|Open-label Period|Protocol Violation|0|||
147501240|NCT00510068|531987780|FG000|Open-label Period|Abnormal laboratory value (s)|1|||
147632720|NCT02564900|532474483|FG014|Dose Escalation|Adverse Event|0|||
147632721|NCT02564900|532474469|FG000|Dose Expansion|Progressive disease per RECIST|0|||
147632722|NCT02564900|532474470|FG001|Dose Expansion|Progressive disease per RECIST|0|||
147632723|NCT02564900|532474471|FG002|Dose Expansion|Progressive disease per RECIST|0|||
147632724|NCT02564900|532474472|FG003|Dose Expansion|Progressive disease per RECIST|0|||
147632725|NCT02564900|532474473|FG004|Dose Expansion|Progressive disease per RECIST|0|||
147632726|NCT02564900|532474474|FG005|Dose Expansion|Progressive disease per RECIST|0|||
147632727|NCT02564900|532474475|FG006|Dose Expansion|Progressive disease per RECIST|19|||
147632728|NCT02564900|532474476|FG007|Dose Expansion|Progressive disease per RECIST|17|||
147632729|NCT02564900|532474477|FG008|Dose Expansion|Progressive disease per RECIST|8|||
147501241|NCT00510068|531987781|FG001|Open-label Period|Abnormal laboratory value (s)|0|||
147501242|NCT01397448|531987783|FG000|Overall Study|Adverse Event|4|||
147501243|NCT01397448|531987784|FG001|Overall Study|Adverse Event|4|||
147632730|NCT02564900|532474478|FG009|Dose Expansion|Progressive disease per RECIST|16|||
147632731|NCT02564900|532474479|FG010|Dose Expansion|Progressive disease per RECIST|13|||
147632732|NCT02564900|532474480|FG011|Dose Expansion|Progressive disease per RECIST|19|||
147632733|NCT02564900|532474481|FG012|Dose Expansion|Progressive disease per RECIST|10|||
147501244|NCT01397448|531987785|FG002|Overall Study|Adverse Event|6|||
147501245|NCT01397448|531987783|FG000|Overall Study|Withdrawal by Subject|4|||
147501246|NCT01397448|531987784|FG001|Overall Study|Withdrawal by Subject|4|||
147501247|NCT01397448|531987785|FG002|Overall Study|Withdrawal by Subject|3|||
147501248|NCT01397448|531987783|FG000|Overall Study|Lack of Efficacy|2|||
147501249|NCT01397448|531987784|FG001|Overall Study|Lack of Efficacy|0|||
147501250|NCT01397448|531987785|FG002|Overall Study|Lack of Efficacy|5|||
147501251|NCT01397448|531987783|FG000|Overall Study|Other|8|||
147501252|NCT01397448|531987784|FG001|Overall Study|Other|7|||
147501253|NCT01397448|531987785|FG002|Overall Study|Other|4|||
147501254|NCT02180217|531987792|FG000|Overall Study|Adverse Event|3|||
147501255|NCT02180217|531987793|FG001|Overall Study|Adverse Event|2|||
147501256|NCT02180217|531987794|FG002|Overall Study|Adverse Event|22|||
147501257|NCT02180217|531987792|FG000|Overall Study|Death|1|||
147501258|NCT02180217|531987793|FG001|Overall Study|Death|1|||
147501259|NCT02180217|531987794|FG002|Overall Study|Death|0|||
147501260|NCT02180217|531987792|FG000|Overall Study|Withdrawal by Subject|1|||
147501261|NCT02180217|531987793|FG001|Overall Study|Withdrawal by Subject|1|||
147501262|NCT02180217|531987794|FG002|Overall Study|Withdrawal by Subject|4|||
147501263|NCT02180217|531987792|FG000|Overall Study|Subject/Guardian decision|5|||
147501264|NCT02180217|531987793|FG001|Overall Study|Subject/Guardian decision|3|||
147501265|NCT02180217|531987794|FG002|Overall Study|Subject/Guardian decision|6|||
147501266|NCT02180217|531987792|FG000|Overall Study|Physician Decision|1|||
147501267|NCT02180217|531987793|FG001|Overall Study|Physician Decision|1|||
147501268|NCT02180217|531987794|FG002|Overall Study|Physician Decision|6|||
147501269|NCT02180217|531987792|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
147501270|NCT02180217|531987793|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
147501271|NCT02180217|531987794|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
147501272|NCT00776555|531987795|FG000|Overall Study|Study terminated|3|||
147501273|NCT00776555|531987796|FG001|Overall Study|Study terminated|0|||
147501274|NCT02553317|531987797|FG000|Overall Treatment Period + Follow-up|Withdrawn by legal representative|0|||
147501275|NCT02553317|531987798|FG001|Overall Treatment Period + Follow-up|Withdrawn by legal representative|1|||
147501276|NCT02553317|531987797|FG000|Overall Treatment Period + Follow-up|Physician Decision|2|||
147501277|NCT02553317|531987798|FG001|Overall Treatment Period + Follow-up|Physician Decision|4|||
147501278|NCT02553317|531987797|FG000|Overall Treatment Period + Follow-up|Non-compliance with study drug|0|||
147501279|NCT02553317|531987798|FG001|Overall Treatment Period + Follow-up|Non-compliance with study drug|1|||
147501280|NCT02553317|531987797|FG000|Overall Treatment Period + Follow-up|Death|1|||
147501281|NCT02553317|531987798|FG001|Overall Treatment Period + Follow-up|Death|3|||
147501282|NCT02553317|531987797|FG000|Overall Treatment Period + Follow-up|Adverse Event|6|||
147501283|NCT02553317|531987798|FG001|Overall Treatment Period + Follow-up|Adverse Event|5|||
147501284|NCT02553317|531987797|FG000|Overall Treatment Period + Follow-up|Withdrawal by Subject|4|||
147501285|NCT02553317|531987798|FG001|Overall Treatment Period + Follow-up|Withdrawal by Subject|5|||
147501286|NCT02553317|531987797|FG000|Overall Treatment Period + Follow-up|Lost to Follow-up|0|||
147501287|NCT02553317|531987798|FG001|Overall Treatment Period + Follow-up|Lost to Follow-up|1|||
147501288|NCT02553317|531987797|FG000|Overall Treatment Period + Follow-up|Diagnosed as non-TTP patient|1|||
147501289|NCT02553317|531987798|FG001|Overall Treatment Period + Follow-up|Diagnosed as non-TTP patient|1|||
147501290|NCT02553317|531987797|FG000|Overall Treatment Period + Follow-up|Protocol Violation|0|||
147501291|NCT02553317|531987798|FG001|Overall Treatment Period + Follow-up|Protocol Violation|1|||
147501292|NCT02553317|531987797|FG000|Overall Treatment Period + Follow-up|Withdrew treatment, agreed for ET visit|0|||
147501293|NCT02553317|531987798|FG001|Overall Treatment Period + Follow-up|Withdrew treatment, agreed for ET visit|1|||
147501294|NCT03483116|531987800|FG000|Overall Study|Adverse Event|0|||
147632734|NCT02564900|532474482|FG013|Dose Expansion|Progressive disease per RECIST|13|||
147632735|NCT02564900|532474483|FG014|Dose Expansion|Progressive disease per RECIST|11|||
147632736|NCT02564900|532474469|FG000|Dose Expansion|Clinical progression|0|||
147501295|NCT03483116|531987801|FG001|Overall Study|Adverse Event|1|||
147501296|NCT03483116|531987802|FG002|Overall Study|Adverse Event|0|||
147501297|NCT03483116|531987803|FG003|Overall Study|Adverse Event|1|||
147501298|NCT03483116|531987800|FG000|Overall Study|Protocol Violation|1|||
147632737|NCT02564900|532474470|FG001|Dose Expansion|Clinical progression|0|||
147501299|NCT03483116|531987801|FG001|Overall Study|Protocol Violation|0|||
147501300|NCT03483116|531987802|FG002|Overall Study|Protocol Violation|0|||
147632738|NCT02564900|532474471|FG002|Dose Expansion|Clinical progression|0|||
147501301|NCT03483116|531987803|FG003|Overall Study|Protocol Violation|7|||
147501302|NCT03483116|531987800|FG000|Overall Study|Lost to Follow-up|9|||
147501303|NCT03483116|531987801|FG001|Overall Study|Lost to Follow-up|4|||
147501304|NCT03483116|531987802|FG002|Overall Study|Lost to Follow-up|9|||
147501305|NCT03483116|531987803|FG003|Overall Study|Lost to Follow-up|5|||
147501306|NCT03483116|531987800|FG000|Overall Study|Death|1|||
147501307|NCT03483116|531987801|FG001|Overall Study|Death|0|||
147501308|NCT03483116|531987802|FG002|Overall Study|Death|2|||
147501309|NCT03483116|531987803|FG003|Overall Study|Death|1|||
147501310|NCT03483116|531987800|FG000|Overall Study|Withdrawal by Subject|14|||
147501311|NCT03483116|531987801|FG001|Overall Study|Withdrawal by Subject|16|||
147501312|NCT03483116|531987802|FG002|Overall Study|Withdrawal by Subject|14|||
147501313|NCT03483116|531987803|FG003|Overall Study|Withdrawal by Subject|16|||
147501314|NCT03483116|531987800|FG000|Overall Study|Unknown other reason|3|||
147501315|NCT03483116|531987801|FG001|Overall Study|Unknown other reason|2|||
147501316|NCT03483116|531987802|FG002|Overall Study|Unknown other reason|1|||
147501317|NCT03483116|531987803|FG003|Overall Study|Unknown other reason|1|||
147501318|NCT02475395|531987806|FG000|Overall Study|Protocol Violation|30|||
147501319|NCT02475395|531987807|FG001|Overall Study|Protocol Violation|3|||
147501320|NCT02227108|531987808|FG000|Overall Study|Did not receive treatment|2|||
147501321|NCT02227108|531987808|FG000|Overall Study|Other|3|||
147501322|NCT02227108|531987808|FG000|Overall Study|Progressive disease|17|||
147501323|NCT02227108|531987808|FG000|Overall Study|Initiation of alternative therapy|2|||
147501324|NCT02227108|531987808|FG000|Overall Study|Investigator discretion|1|||
147501325|NCT02227108|531987808|FG000|Overall Study|Adverse Event|6|||
147501326|NCT02486952|531987809|FG000|Overall Study|Not Started Induction Therapy|3|||
147501327|NCT02486952|531987809|FG000|Overall Study|Adverse Event|1|||
147501328|NCT02486952|531987809|FG000|Overall Study|Death|15|||
147501329|NCT02486952|531987809|FG000|Overall Study|Lack of Efficacy|3|||
147501330|NCT02486952|531987809|FG000|Overall Study|Lost to Follow-up|26|||
147501331|NCT02486952|531987809|FG000|Overall Study|Other|2|||
147501332|NCT00594204|531987810|FG000|Overall Study|Adverse Event|15|||
147501333|NCT00594204|531987811|FG001|Overall Study|Adverse Event|3|||
147501334|NCT00594204|531987810|FG000|Overall Study|Lost to Follow-up|9|||
147501335|NCT00594204|531987811|FG001|Overall Study|Lost to Follow-up|5|||
147501336|NCT00594204|531987810|FG000|Overall Study|Withdrawal by Subject|23|||
147501337|NCT00594204|531987811|FG001|Overall Study|Withdrawal by Subject|29|||
147501338|NCT00594204|531987810|FG000|Overall Study|Other|4|||
147501339|NCT00594204|531987811|FG001|Overall Study|Other|3|||
147501340|NCT00594204|531987810|FG000|Overall Study|Lack of Efficacy|3|||
147501341|NCT00594204|531987811|FG001|Overall Study|Lack of Efficacy|4|||
147501342|NCT00594204|531987810|FG000|Overall Study|Randomized but not treated|4|||
147501343|NCT00594204|531987811|FG001|Overall Study|Randomized but not treated|1|||
147501344|NCT00567541|531987812|FG000|Overall Study|Adverse Event|0|||
147501345|NCT00567541|531987813|FG001|Overall Study|Adverse Event|1|||
147501346|NCT01890512|531987816|FG000|Overall Study|Physician Decision|1|||
147501347|NCT01890512|531987816|FG000|Overall Study|Withdrawal by Subject|1|||
147501348|NCT01890512|531987816|FG000|Overall Study|Protocol Violation|1|||
147501349|NCT01529385|531987817|FG000|Overall Study|Lost to Follow-up|2|||
147501350|NCT01529385|531987818|FG001|Overall Study|Lost to Follow-up|1|||
147501351|NCT01401465|531987819|FG000|Treatment Period 1|Adverse Event|4|||
147501352|NCT01401465|531987820|FG001|Treatment Period 1|Adverse Event|1|||
147501353|NCT01401465|531987819|FG000|Treatment Period 1|Pregnancy|0|||
147501354|NCT01401465|531987820|FG001|Treatment Period 1|Pregnancy|1|||
147501355|NCT01401465|531987819|FG000|Treatment Period 1|Protocol Violation|5|||
147501356|NCT01401465|531987820|FG001|Treatment Period 1|Protocol Violation|0|||
147501357|NCT01401465|531987819|FG000|Treatment Period 1|Withdrawal by Subject|1|||
147501358|NCT01401465|531987820|FG001|Treatment Period 1|Withdrawal by Subject|4|||
147501359|NCT01401465|531987819|FG000|Treatment Period 1|Non-Compliance to Study Drug|1|||
147501360|NCT01401465|531987820|FG001|Treatment Period 1|Non-Compliance to Study Drug|0|||
147501361|NCT01401465|531987819|FG000|Treatment Period 1|Inability to Meet Continuation Criteria|3|||
147501362|NCT01401465|531987820|FG001|Treatment Period 1|Inability to Meet Continuation Criteria|9|||
147501363|NCT01401465|531987819|FG000|Treatment Period 1|Scheduling Difficulties|1|||
147501364|NCT01401465|531987820|FG001|Treatment Period 1|Scheduling Difficulties|1|||
147501365|NCT01401465|531987819|FG000|Treatment Period 2|Lost to Follow-up|0|||
147501366|NCT01401465|531987820|FG001|Treatment Period 2|Lost to Follow-up|1|||
147501367|NCT01401465|531987819|FG000|Treatment Period 2|Withdrawal by Subject|0|||
147501368|NCT01401465|531987820|FG001|Treatment Period 2|Withdrawal by Subject|1|||
147501369|NCT01115738|531987821|FG000|Overall Study|Death|1|||
147501370|NCT01115738|531987822|FG001|Overall Study|Death|0|||
147501371|NCT01115738|531987823|FG002|Overall Study|Death|0|||
147501372|NCT01115738|531987821|FG000|Overall Study|Lost to Follow-up|0|||
147501373|NCT01115738|531987822|FG001|Overall Study|Lost to Follow-up|0|||
147501374|NCT01115738|531987823|FG002|Overall Study|Lost to Follow-up|1|||
147501375|NCT01115738|531987821|FG000|Overall Study|Physician Decision|18|||
147501376|NCT01115738|531987822|FG001|Overall Study|Physician Decision|15|||
147501377|NCT01115738|531987823|FG002|Overall Study|Physician Decision|17|||
147501378|NCT01115738|531987821|FG000|Overall Study|Withdrawal by Subject|6|||
147501379|NCT01115738|531987822|FG001|Overall Study|Withdrawal by Subject|6|||
147501380|NCT01115738|531987823|FG002|Overall Study|Withdrawal by Subject|9|||
147501381|NCT00575094|531987826|FG000|Overall Study|Adverse Event|2|||
147501382|NCT00575094|531987826|FG000|Overall Study|Withdrawal by Subject|1|||
147501383|NCT00772382|531987827|FG000|Overall Study|Adverse Event|19|||
147501384|NCT00772382|531987827|FG000|Overall Study|Death|6|||
147501385|NCT00772382|531987827|FG000|Overall Study|Lack of Efficacy|4|||
147501386|NCT00772382|531987827|FG000|Overall Study|Physician Decision|5|||
147501387|NCT00772382|531987827|FG000|Overall Study|Protocol Violation|1|||
147501388|NCT00772382|531987827|FG000|Overall Study|Withdrawal by Subject|10|||
147501389|NCT00772382|531987827|FG000|Overall Study|Other Reasons|10|||
147501390|NCT02721251|531987828|FG000|Overall Study|Withdrawal by Subject|8|||
147501391|NCT02721251|531987829|FG001|Overall Study|Withdrawal by Subject|7|||
147501392|NCT02721251|531987830|FG002|Overall Study|Withdrawal by Subject|9|||
147501393|NCT02721251|531987828|FG000|Overall Study|poor adherence|2|||
147501394|NCT02721251|531987829|FG001|Overall Study|poor adherence|2|||
147501395|NCT02721251|531987830|FG002|Overall Study|poor adherence|2|||
147501396|NCT02921763|531987831|FG000|Overall Study|Adverse Event|4|||
147501397|NCT02921763|531987831|FG000|Overall Study|Lost to Follow-up|4|||
147501398|NCT02921763|531987831|FG000|Overall Study|Lack of Efficacy|3|||
147501399|NCT02921763|531987831|FG000|Overall Study|Protocol Violation|2|||
147501400|NCT02921763|531987831|FG000|Overall Study|Withdrawal by Subject|2|||
147501401|NCT02921763|531987831|FG000|Overall Study|Physician Decision|1|||
147501402|NCT02921763|531987831|FG000|Overall Study|No data obtained|2|||
147501403|NCT00862121|531987836|FG000|Overall Study|Adverse Event|1|||
147501404|NCT00862121|531987837|FG001|Overall Study|Adverse Event|2|||
147501405|NCT00862121|531987836|FG000|Overall Study|Lack of Efficacy|0|||
147501406|NCT00862121|531987837|FG001|Overall Study|Lack of Efficacy|3|||
147501407|NCT00862121|531987836|FG000|Overall Study|Protocol Violation|0|||
147501408|NCT00862121|531987837|FG001|Overall Study|Protocol Violation|1|||
147501409|NCT00862121|531987836|FG000|Overall Study|Exclusion criterion violation|0|||
147501410|NCT00862121|531987837|FG001|Overall Study|Exclusion criterion violation|1|||
147501411|NCT00862121|531987836|FG000|Overall Study|Incorrect randomisation|0|||
147501412|NCT00862121|531987837|FG001|Overall Study|Incorrect randomisation|1|||
147501413|NCT01582971|531987838|FG000|Overall Study|Death|2|||
147501414|NCT01582971|531987839|FG001|Overall Study|Death|1|||
147501415|NCT01582971|531987838|FG000|Overall Study|Lost to Follow-up|18|||
147501416|NCT01582971|531987839|FG001|Overall Study|Lost to Follow-up|21|||
147501417|NCT01582971|531987838|FG000|Overall Study|Withdrawal by Subject|4|||
147501418|NCT01582971|531987839|FG001|Overall Study|Withdrawal by Subject|2|||
147501419|NCT01582971|531987838|FG000|Overall Study|Other|15|||
147501420|NCT01582971|531987839|FG001|Overall Study|Other|13|||
147501421|NCT02007954|531987840|FG000|Overall Study|Received liver transplant|3|||
147501422|NCT02007954|531987840|FG000|Overall Study|Switch in treatment modality|2|||
147501423|NCT02007954|531987840|FG000|Overall Study|Disease progression and unrelated AE|1|||
147501424|NCT02007954|531987840|FG000|Overall Study|Death|1|||
147501425|NCT01763866|531987842|FG000|Overall Study|Withdrawal by Subject|2|||
147501426|NCT01763866|531987843|FG001|Overall Study|Withdrawal by Subject|1|||
147501427|NCT01763866|531987844|FG002|Overall Study|Withdrawal by Subject|4|||
147501428|NCT01763866|531987845|FG003|Overall Study|Withdrawal by Subject|0|||
147501429|NCT01763866|531987846|FG004|Overall Study|Withdrawal by Subject|0|||
147501430|NCT01763866|531987847|FG005|Overall Study|Withdrawal by Subject|3|||
147501431|NCT01763866|531987848|FG006|Overall Study|Withdrawal by Subject|4|||
147501432|NCT01763866|531987849|FG007|Overall Study|Withdrawal by Subject|0|||
147501433|NCT01763866|531987850|FG008|Overall Study|Withdrawal by Subject|1|||
147501434|NCT01763866|531987851|FG009|Overall Study|Withdrawal by Subject|1|||
147501435|NCT01763866|531987852|FG010|Overall Study|Withdrawal by Subject|2|||
147501436|NCT01763866|531987853|FG011|Overall Study|Withdrawal by Subject|2|||
147501437|NCT01763866|531987854|FG012|Overall Study|Withdrawal by Subject|2|||
147501438|NCT01763866|531987855|FG013|Overall Study|Withdrawal by Subject|0|||
147501439|NCT01763866|531987856|FG014|Overall Study|Withdrawal by Subject|6|||
147501440|NCT01763866|531987857|FG015|Overall Study|Withdrawal by Subject|3|||
147501441|NCT01763866|531987858|FG016|Overall Study|Withdrawal by Subject|0|||
147501442|NCT01763866|531987859|FG017|Overall Study|Withdrawal by Subject|1|||
147501443|NCT01763866|531987860|FG018|Overall Study|Withdrawal by Subject|1|||
147501444|NCT01763866|531987861|FG019|Overall Study|Withdrawal by Subject|1|||
147501445|NCT01763866|531987862|FG020|Overall Study|Withdrawal by Subject|2|||
147501446|NCT01763866|531987863|FG021|Overall Study|Withdrawal by Subject|1|||
147501447|NCT01763866|531987864|FG022|Overall Study|Withdrawal by Subject|2|||
147501448|NCT01763866|531987865|FG023|Overall Study|Withdrawal by Subject|1|||
147501449|NCT01763866|531987842|FG000|Overall Study|Decision by sponsor|0|||
147501450|NCT01763866|531987843|FG001|Overall Study|Decision by sponsor|0|||
147501451|NCT01763866|531987844|FG002|Overall Study|Decision by sponsor|1|||
147501452|NCT01763866|531987845|FG003|Overall Study|Decision by sponsor|0|||
147501453|NCT01763866|531987846|FG004|Overall Study|Decision by sponsor|2|||
147501454|NCT01763866|531987847|FG005|Overall Study|Decision by sponsor|0|||
147501455|NCT01763866|531987848|FG006|Overall Study|Decision by sponsor|2|||
147501456|NCT01763866|531987849|FG007|Overall Study|Decision by sponsor|0|||
147501457|NCT01763866|531987850|FG008|Overall Study|Decision by sponsor|2|||
147501458|NCT01763866|531987851|FG009|Overall Study|Decision by sponsor|0|||
147501459|NCT01763866|531987852|FG010|Overall Study|Decision by sponsor|6|||
147501460|NCT01763866|531987853|FG011|Overall Study|Decision by sponsor|0|||
147501461|NCT01763866|531987854|FG012|Overall Study|Decision by sponsor|1|||
147501462|NCT01763866|531987855|FG013|Overall Study|Decision by sponsor|0|||
147501463|NCT01763866|531987856|FG014|Overall Study|Decision by sponsor|5|||
147501464|NCT01763866|531987857|FG015|Overall Study|Decision by sponsor|0|||
147501465|NCT01763866|531987858|FG016|Overall Study|Decision by sponsor|0|||
147501466|NCT01763866|531987859|FG017|Overall Study|Decision by sponsor|0|||
147501467|NCT01763866|531987860|FG018|Overall Study|Decision by sponsor|4|||
147501468|NCT01763866|531987861|FG019|Overall Study|Decision by sponsor|0|||
147501469|NCT01763866|531987862|FG020|Overall Study|Decision by sponsor|2|||
147501470|NCT01763866|531987863|FG021|Overall Study|Decision by sponsor|0|||
147501471|NCT01763866|531987864|FG022|Overall Study|Decision by sponsor|1|||
147501472|NCT01763866|531987865|FG023|Overall Study|Decision by sponsor|0|||
147501473|NCT01763866|531987842|FG000|Overall Study|Lost to Follow-up|0|||
147501474|NCT01763866|531987843|FG001|Overall Study|Lost to Follow-up|0|||
147501475|NCT01763866|531987844|FG002|Overall Study|Lost to Follow-up|0|||
147501476|NCT01763866|531987845|FG003|Overall Study|Lost to Follow-up|0|||
147501477|NCT01763866|531987846|FG004|Overall Study|Lost to Follow-up|0|||
147501478|NCT01763866|531987847|FG005|Overall Study|Lost to Follow-up|0|||
147501479|NCT01763866|531987848|FG006|Overall Study|Lost to Follow-up|1|||
147501480|NCT01763866|531987849|FG007|Overall Study|Lost to Follow-up|0|||
147501481|NCT01763866|531987850|FG008|Overall Study|Lost to Follow-up|0|||
147501482|NCT01763866|531987851|FG009|Overall Study|Lost to Follow-up|0|||
147501483|NCT01763866|531987852|FG010|Overall Study|Lost to Follow-up|0|||
147501484|NCT01763866|531987853|FG011|Overall Study|Lost to Follow-up|0|||
147501485|NCT01763866|531987854|FG012|Overall Study|Lost to Follow-up|1|||
147501486|NCT01763866|531987855|FG013|Overall Study|Lost to Follow-up|0|||
147501487|NCT01763866|531987856|FG014|Overall Study|Lost to Follow-up|1|||
147501488|NCT01763866|531987857|FG015|Overall Study|Lost to Follow-up|0|||
147501489|NCT01763866|531987858|FG016|Overall Study|Lost to Follow-up|0|||
147501490|NCT01763866|531987859|FG017|Overall Study|Lost to Follow-up|0|||
147501491|NCT01763866|531987860|FG018|Overall Study|Lost to Follow-up|1|||
147501492|NCT01763866|531987861|FG019|Overall Study|Lost to Follow-up|1|||
147501493|NCT01763866|531987862|FG020|Overall Study|Lost to Follow-up|0|||
147501494|NCT01763866|531987863|FG021|Overall Study|Lost to Follow-up|0|||
147501495|NCT01763866|531987864|FG022|Overall Study|Lost to Follow-up|0|||
147501496|NCT01763866|531987865|FG023|Overall Study|Lost to Follow-up|1|||
147501497|NCT01763866|531987842|FG000|Overall Study|Death|0|||
147501498|NCT01763866|531987843|FG001|Overall Study|Death|0|||
147501499|NCT01763866|531987844|FG002|Overall Study|Death|0|||
147501500|NCT01763866|531987845|FG003|Overall Study|Death|0|||
147501501|NCT01763866|531987846|FG004|Overall Study|Death|0|||
147501502|NCT01763866|531987847|FG005|Overall Study|Death|0|||
147501503|NCT01763866|531987848|FG006|Overall Study|Death|0|||
147501504|NCT01763866|531987849|FG007|Overall Study|Death|0|||
147501505|NCT01763866|531987850|FG008|Overall Study|Death|0|||
147501506|NCT01763866|531987851|FG009|Overall Study|Death|0|||
147501507|NCT01763866|531987852|FG010|Overall Study|Death|0|||
147501508|NCT01763866|531987853|FG011|Overall Study|Death|0|||
147501509|NCT01763866|531987854|FG012|Overall Study|Death|0|||
147501510|NCT01763866|531987855|FG013|Overall Study|Death|0|||
147668671|NCT03098979|532613347|FG000|Overall Study|Non-compliance|0|||
147501511|NCT01763866|531987856|FG014|Overall Study|Death|0|||
147501512|NCT01763866|531987857|FG015|Overall Study|Death|0|||
147501513|NCT01763866|531987858|FG016|Overall Study|Death|1|||
147501514|NCT01763866|531987859|FG017|Overall Study|Death|0|||
147501515|NCT01763866|531987860|FG018|Overall Study|Death|0|||
147501516|NCT01763866|531987861|FG019|Overall Study|Death|0|||
147632739|NCT02564900|532474472|FG003|Dose Expansion|Clinical progression|0|||
147632740|NCT02564900|532474473|FG004|Dose Expansion|Clinical progression|0|||
147632741|NCT02564900|532474474|FG005|Dose Expansion|Clinical progression|0|||
147632742|NCT02564900|532474475|FG006|Dose Expansion|Clinical progression|5|||
147632743|NCT02564900|532474476|FG007|Dose Expansion|Clinical progression|12|||
147632744|NCT02564900|532474477|FG008|Dose Expansion|Clinical progression|0|||
147501517|NCT01763866|531987862|FG020|Overall Study|Death|0|||
147501518|NCT01763866|531987863|FG021|Overall Study|Death|0|||
147501519|NCT01763866|531987864|FG022|Overall Study|Death|0|||
147501520|NCT01763866|531987865|FG023|Overall Study|Death|0|||
147501521|NCT03288493|531987868|FG000|Overall Study|Withdrawal by Subject|4|||
147501522|NCT03288493|531987869|FG001|Overall Study|Withdrawal by Subject|0|||
147501523|NCT03288493|531987870|FG002|Overall Study|Withdrawal by Subject|0|||
147632745|NCT02564900|532474478|FG009|Dose Expansion|Clinical progression|3|||
147632746|NCT02564900|532474479|FG010|Dose Expansion|Clinical progression|2|||
147632747|NCT02564900|532474480|FG011|Dose Expansion|Clinical progression|0|||
147632748|NCT02564900|532474481|FG012|Dose Expansion|Clinical progression|1|||
147632749|NCT02564900|532474482|FG013|Dose Expansion|Clinical progression|3|||
147632750|NCT02564900|532474483|FG014|Dose Expansion|Clinical progression|1|||
147632751|NCT02564900|532474469|FG000|Dose Expansion|Adverse Event|0|||
147632752|NCT02564900|532474470|FG001|Dose Expansion|Adverse Event|0|||
147501524|NCT03288493|531987871|FG003|Overall Study|Withdrawal by Subject|0|||
147501525|NCT03288493|531987872|FG004|Overall Study|Withdrawal by Subject|0|||
147501526|NCT03288493|531987873|FG005|Overall Study|Withdrawal by Subject|2|||
147501527|NCT03288493|531987874|FG006|Overall Study|Withdrawal by Subject|0|||
147501528|NCT03288493|531987868|FG000|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|52|||
147501529|NCT03288493|531987869|FG001|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|3|||
147501530|NCT03288493|531987870|FG002|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|1|||
147501531|NCT03288493|531987871|FG003|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|6|||
147501532|NCT03288493|531987872|FG004|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|5|||
147501533|NCT03288493|531987873|FG005|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|10|||
147501534|NCT03288493|531987874|FG006|Overall Study|Significant progression of malignancy requiring alternative, medical, radiation or surgical interven|3|||
147501535|NCT03288493|531987868|FG000|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|6|||
147501536|NCT03288493|531987869|FG001|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|0|||
147501537|NCT03288493|531987870|FG002|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|0|||
147501538|NCT03288493|531987871|FG003|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|2|||
147501539|NCT03288493|531987872|FG004|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|0|||
147501540|NCT03288493|531987873|FG005|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|4|||
147501541|NCT03288493|531987874|FG006|Overall Study|Termination of the study by the PI, the sponsor, the study funder, the IRB/IEC or the FDA|0|||
147501542|NCT03288493|531987868|FG000|Overall Study|Death|2|||
147501543|NCT03288493|531987869|FG001|Overall Study|Death|0|||
147501544|NCT03288493|531987870|FG002|Overall Study|Death|0|||
147501545|NCT03288493|531987871|FG003|Overall Study|Death|0|||
147501546|NCT03288493|531987872|FG004|Overall Study|Death|0|||
147501547|NCT03288493|531987873|FG005|Overall Study|Death|0|||
147501548|NCT03288493|531987874|FG006|Overall Study|Death|0|||
147501549|NCT03288493|531987868|FG000|Overall Study|other reason not listed above|2|||
147501550|NCT03288493|531987869|FG001|Overall Study|other reason not listed above|0|||
147501551|NCT03288493|531987870|FG002|Overall Study|other reason not listed above|0|||
147501552|NCT03288493|531987871|FG003|Overall Study|other reason not listed above|0|||
147501553|NCT03288493|531987872|FG004|Overall Study|other reason not listed above|0|||
147501554|NCT03288493|531987873|FG005|Overall Study|other reason not listed above|0|||
147501555|NCT03288493|531987874|FG006|Overall Study|other reason not listed above|0|||
147501556|NCT06025396|531989130|FG000|Overall Study|Protocol-Specified Withdrawal|5|||
147501557|NCT06025396|531989131|FG001|Overall Study|Protocol-Specified Withdrawal|0|||
147501558|NCT06025396|531989132|FG002|Overall Study|Protocol-Specified Withdrawal|0|||
147501559|NCT06025396|531989133|FG003|Overall Study|Protocol-Specified Withdrawal|1|||
147501560|NCT06025396|531989134|FG004|Overall Study|Protocol-Specified Withdrawal|1|||
147501561|NCT06025396|531989130|FG000|Overall Study|Withdrawal by Subject|0|||
147501562|NCT06025396|531989131|FG001|Overall Study|Withdrawal by Subject|1|||
147501563|NCT06025396|531989132|FG002|Overall Study|Withdrawal by Subject|1|||
147501564|NCT06025396|531989133|FG003|Overall Study|Withdrawal by Subject|0|||
147501565|NCT06025396|531989134|FG004|Overall Study|Withdrawal by Subject|0|||
147501566|NCT01512108|531989135|FG000|Overall Study|Adverse Event|9|||
147501567|NCT01512108|531989136|FG001|Overall Study|Adverse Event|4|||
147501568|NCT01512108|531989135|FG000|Overall Study|Protocol Violation|1|||
147501569|NCT01512108|531989136|FG001|Overall Study|Protocol Violation|2|||
147501570|NCT01512108|531989135|FG000|Overall Study|Withdrawal Criteria|1|||
147501571|NCT01512108|531989136|FG001|Overall Study|Withdrawal Criteria|0|||
147501572|NCT01512108|531989135|FG000|Overall Study|Unclassified|11|||
147501573|NCT01512108|531989136|FG001|Overall Study|Unclassified|3|||
147501574|NCT06422377|531989139|FG000|Overall Study|Study Terminated by Sponsor|1|||
147501575|NCT02017899|531989140|FG000|Overall Study|Withdrawal by Subject|0|||
147501576|NCT02017899|531989141|FG001|Overall Study|Withdrawal by Subject|0|||
147501577|NCT02017899|531989142|FG002|Overall Study|Withdrawal by Subject|0|||
147501578|NCT02017899|531989143|FG003|Overall Study|Withdrawal by Subject|1|||
147501579|NCT02017899|531989144|FG004|Overall Study|Withdrawal by Subject|1|||
147501580|NCT02017899|531989145|FG005|Overall Study|Withdrawal by Subject|0|||
147501581|NCT00646113|531989147|FG000|Overall Study|Lost to Follow-up|5|||
147501582|NCT00646113|531989147|FG000|Overall Study|Adverse Event|3|||
147501583|NCT00804843|531989148|FG000|Overall Study|Protocol Violation|1|||
147501584|NCT00804843|531989149|FG001|Overall Study|Protocol Violation|0|||
147501585|NCT00804843|531989148|FG000|Overall Study|Adverse Event|8|||
147501586|NCT00804843|531989149|FG001|Overall Study|Adverse Event|5|||
147501587|NCT00804843|531989148|FG000|Overall Study|Withdrawal by Subject|1|||
147501588|NCT00804843|531989149|FG001|Overall Study|Withdrawal by Subject|2|||
147501589|NCT02150213|531989153|FG000|Overall Study|Lost to Follow-up|1|||
147501590|NCT02150213|531989153|FG000|Overall Study|Withdrawal by Subject|1|||
147501591|NCT01297309|531989155|FG000|Overall Study|Eligibility failure|2|||
147501592|NCT01297309|531989155|FG000|Overall Study|Screen failure|2|||
147501593|NCT01297309|531989155|FG000|Overall Study|Withdrawal by Subject|5|||
147668672|NCT03098979|532613348|FG001|Overall Study|Non-compliance|0|||
147501594|NCT01297309|531989155|FG000|Overall Study|Adverse Event|1|||
147501595|NCT01297309|531989155|FG000|Overall Study|Investigator Decision|2|||
147501596|NCT01297309|531989155|FG000|Overall Study|Death|1|||
147501597|NCT01297309|531989155|FG000|Overall Study|Participant not entering extensionperiod|1|||
147501598|NCT00640146|531989159|FG000|Overall Study|Adverse Event|2|||
147501599|NCT00640146|531989160|FG001|Overall Study|Adverse Event|0|||
147501600|NCT00640146|531989159|FG000|Overall Study|Lost to Follow-up|0|||
147501601|NCT00640146|531989160|FG001|Overall Study|Lost to Follow-up|1|||
147501602|NCT00640146|531989159|FG000|Overall Study|Lack of Efficacy|0|||
147501603|NCT00640146|531989160|FG001|Overall Study|Lack of Efficacy|1|||
147501604|NCT00640146|531989159|FG000|Overall Study|Withdrawal by Subject|1|||
147501605|NCT00640146|531989160|FG001|Overall Study|Withdrawal by Subject|1|||
147501606|NCT00640146|531989159|FG000|Overall Study|Randomized but not treated|1|||
147501607|NCT00640146|531989160|FG001|Overall Study|Randomized but not treated|3|||
147501608|NCT03024255|531989164|FG000|Overall Study|Adverse Event|1|||
147501609|NCT03024255|531989165|FG001|Overall Study|Adverse Event|4|||
147501610|NCT03024255|531989166|FG002|Overall Study|Adverse Event|8|||
147501611|NCT03024255|531989167|FG003|Overall Study|Adverse Event|0|||
147501612|NCT03024255|531989164|FG000|Overall Study|Withdrawal by Subject|3|||
147501613|NCT03024255|531989165|FG001|Overall Study|Withdrawal by Subject|1|||
147501614|NCT03024255|531989166|FG002|Overall Study|Withdrawal by Subject|0|||
147501615|NCT03024255|531989167|FG003|Overall Study|Withdrawal by Subject|3|||
147501616|NCT03024255|531989164|FG000|Overall Study|Protocol Violation|0|||
147501617|NCT03024255|531989165|FG001|Overall Study|Protocol Violation|0|||
147501618|NCT03024255|531989166|FG002|Overall Study|Protocol Violation|2|||
147501619|NCT03024255|531989167|FG003|Overall Study|Protocol Violation|0|||
147501620|NCT03024255|531989164|FG000|Overall Study|Lost to Follow-up|1|||
147501621|NCT03024255|531989165|FG001|Overall Study|Lost to Follow-up|2|||
147501622|NCT03024255|531989166|FG002|Overall Study|Lost to Follow-up|1|||
147501623|NCT03024255|531989167|FG003|Overall Study|Lost to Follow-up|1|||
147501624|NCT03024255|531989164|FG000|Overall Study|Lack of Efficacy|1|||
147501625|NCT03024255|531989165|FG001|Overall Study|Lack of Efficacy|0|||
147501626|NCT03024255|531989166|FG002|Overall Study|Lack of Efficacy|0|||
147501627|NCT03024255|531989167|FG003|Overall Study|Lack of Efficacy|0|||
147501628|NCT03024255|531989164|FG000|Overall Study|Protocol Noncompliance|1|||
147501629|NCT03024255|531989165|FG001|Overall Study|Protocol Noncompliance|1|||
147501630|NCT03024255|531989166|FG002|Overall Study|Protocol Noncompliance|0|||
147501631|NCT03024255|531989167|FG003|Overall Study|Protocol Noncompliance|1|||
147501632|NCT01415908|531989168|FG000|Overall Study|Withdrawal by Subject|1|||
147501633|NCT01415908|531989169|FG001|Overall Study|Withdrawal by Subject|0|||
147501634|NCT02685995|531989170|FG000|Overall Study|Insertion of immediately puncturable graft.|1|||
147501635|NCT02685995|531989171|FG001|Overall Study|Insertion of immediately puncturable graft.|1|||
147501636|NCT02168803|531989172|FG000|Overall Study|Lost to Follow-up|1|||
147501637|NCT02168803|531989173|FG001|Overall Study|Lost to Follow-up|0|||
147501638|NCT02168803|531989174|FG002|Overall Study|Lost to Follow-up|1|||
147501639|NCT02168803|531989172|FG000|Overall Study|Withdrawal by Subject|1|||
147501640|NCT02168803|531989173|FG001|Overall Study|Withdrawal by Subject|1|||
147501641|NCT02168803|531989174|FG002|Overall Study|Withdrawal by Subject|2|||
147501642|NCT02168803|531989172|FG000|Overall Study|Physician Decision|0|||
147501643|NCT02168803|531989173|FG001|Overall Study|Physician Decision|1|||
147501644|NCT02168803|531989174|FG002|Overall Study|Physician Decision|0|||
147501645|NCT02168803|531989172|FG000|Overall Study|Adverse Event|0|||
147501646|NCT02168803|531989173|FG001|Overall Study|Adverse Event|1|||
147501647|NCT02168803|531989174|FG002|Overall Study|Adverse Event|1|||
147501648|NCT02168803|531989172|FG000|Overall Study|Death|0|||
147501649|NCT02168803|531989173|FG001|Overall Study|Death|0|||
147501650|NCT02168803|531989174|FG002|Overall Study|Death|1|||
147501651|NCT02168803|531989172|FG000|Overall Study|Sponsor Decision|0|||
147501652|NCT02168803|531989173|FG001|Overall Study|Sponsor Decision|0|||
147501653|NCT02168803|531989174|FG002|Overall Study|Sponsor Decision|1|||
147501654|NCT01114373|531989176|FG000|Intervention 1 (4 Weeks)|Lost to Follow-up|1|||
147501655|NCT01114373|531989177|FG001|Intervention 1 (4 Weeks)|Lost to Follow-up|0|||
147501656|NCT01114373|531989176|FG000|Intervention 1 (4 Weeks)|Incarceration|1|||
147501657|NCT01114373|531989177|FG001|Intervention 1 (4 Weeks)|Incarceration|0|||
147501658|NCT01114373|531989176|FG000|Intervention 1 (4 Weeks)|Terminated by PI after protocol violatio|1|||
147632753|NCT02564900|532474471|FG002|Dose Expansion|Adverse Event|0|||
147501659|NCT01114373|531989177|FG001|Intervention 1 (4 Weeks)|Terminated by PI after protocol violatio|0|||
147501660|NCT01114373|531989176|FG000|Intervention 2 (4 Weeks)|Lost to Follow-up|0|||
147501661|NCT01114373|531989177|FG001|Intervention 2 (4 Weeks)|Lost to Follow-up|1|||
147501662|NCT00868166|531989178|FG000|Overall Study|Death|58|||
147501663|NCT00868166|531989179|FG001|Overall Study|Death|65|||
147501664|NCT00868166|531989178|FG000|Overall Study|Withdrawal by Subject|33|||
147501665|NCT00868166|531989179|FG001|Overall Study|Withdrawal by Subject|25|||
147501666|NCT00868166|531989178|FG000|Overall Study|Protocol Violation|1|||
147632754|NCT02564900|532474472|FG003|Dose Expansion|Adverse Event|0|||
147501667|NCT00868166|531989179|FG001|Overall Study|Protocol Violation|0|||
147501668|NCT00868166|531989178|FG000|Overall Study|Lost to Follow-up|1|||
147501669|NCT00868166|531989179|FG001|Overall Study|Lost to Follow-up|3|||
147501670|NCT00868166|531989178|FG000|Overall Study|Adverse Event|9|||
147501671|NCT00868166|531989179|FG001|Overall Study|Adverse Event|10|||
147501672|NCT00868166|531989178|FG000|Overall Study|Lack of efficacy, logistics, unwell|9|||
147501673|NCT00868166|531989179|FG001|Overall Study|Lack of efficacy, logistics, unwell|10|||
147501674|NCT00868166|531989178|FG000|Overall Study|Non-compliance with IMP|1|||
147501675|NCT00868166|531989179|FG001|Overall Study|Non-compliance with IMP|1|||
147501676|NCT02034552|531989186|FG000|Overall Study|Never treated|3|||
147501677|NCT02034552|531989187|FG001|Overall Study|Never treated|2|||
147501678|NCT02034552|531989188|FG002|Overall Study|Never treated|0|||
147501679|NCT02034552|531989186|FG000|Overall Study|Radiological progression|3|||
147501680|NCT02034552|531989187|FG001|Overall Study|Radiological progression|5|||
147501681|NCT02034552|531989188|FG002|Overall Study|Radiological progression|4|||
147501682|NCT02034552|531989186|FG000|Overall Study|AE not assoc. with disease progression|1|||
147501683|NCT02034552|531989187|FG001|Overall Study|AE not assoc. with disease progression|4|||
147501684|NCT02034552|531989188|FG002|Overall Study|AE not assoc. with disease progression|2|||
147501685|NCT02034552|531989186|FG000|Overall Study|AE associated with disease progression|0|||
147501686|NCT02034552|531989187|FG001|Overall Study|AE associated with disease progression|1|||
147501687|NCT02034552|531989188|FG002|Overall Study|AE associated with disease progression|0|||
147501688|NCT02034552|531989186|FG000|Overall Study|Withdrawal by Subject|2|||
147501689|NCT02034552|531989187|FG001|Overall Study|Withdrawal by Subject|1|||
147501690|NCT02034552|531989188|FG002|Overall Study|Withdrawal by Subject|1|||
147501691|NCT02034552|531989186|FG000|Overall Study|Non-compliance with study drug|0|||
147501692|NCT02034552|531989187|FG001|Overall Study|Non-compliance with study drug|0|||
147501693|NCT02034552|531989188|FG002|Overall Study|Non-compliance with study drug|1|||
147501694|NCT02034552|531989186|FG000|Overall Study|Clinical progression|5|||
147501695|NCT02034552|531989187|FG001|Overall Study|Clinical progression|7|||
147501696|NCT02034552|531989188|FG002|Overall Study|Clinical progression|9|||
147501697|NCT02197897|531989189|FG000|Overall Study|not eligible|1|||
147501698|NCT00688545|531989192|FG000|Overall Study|Lost to Follow-up|1|||
147501699|NCT00688545|531989193|FG001|Overall Study|Lost to Follow-up|4|||
147501700|NCT00688545|531989192|FG000|Overall Study|Insurance/cost of drug|0|||
147501701|NCT00688545|531989193|FG001|Overall Study|Insurance/cost of drug|1|||
147501702|NCT00688545|531989192|FG000|Overall Study|Withdrawal by Subject|2|||
147501703|NCT00688545|531989193|FG001|Overall Study|Withdrawal by Subject|3|||
147501704|NCT00688545|531989192|FG000|Overall Study|Unspecified, unrelated to AE/Toxicity|2|||
147501705|NCT00688545|531989193|FG001|Overall Study|Unspecified, unrelated to AE/Toxicity|7|||
147501706|NCT01878097|531989194|FG000|Baseline|Surveys not fully completed|2497|||
147501707|NCT01878097|531989195|FG001|Baseline|Surveys not fully completed|1800|||
147501708|NCT01878097|531989194|FG000|Implementation Year 1|Surveys not fully completed|3202|||
147501709|NCT01878097|531989195|FG001|Implementation Year 1|Surveys not fully completed|2549|||
147501710|NCT01878097|531989194|FG000|Implementation Year 2|Surveys not fully completed|3281|||
147501711|NCT01878097|531989195|FG001|Implementation Year 2|Surveys not fully completed|2841|||
147501712|NCT01878097|531989194|FG000|Implementation Year 3|Surveys not fully completed|3494|||
147501713|NCT01878097|531989195|FG001|Implementation Year 3|Surveys not fully completed|2980|||
147501714|NCT01878097|531989194|FG000|Implementation Year 4|Surveys not fully completed|3604|||
147501715|NCT01878097|531989195|FG001|Implementation Year 4|Surveys not fully completed|3007|||
147501716|NCT04116073|531989201|FG000|Overall Study|Withdrawal by Subject|2|||
147501717|NCT04116073|531989201|FG000|Overall Study|failed to maintained eligibility|1|||
147501718|NCT03783442|531989202|FG000|Overall Study|Death|252|||
147501719|NCT03783442|531989203|FG001|Overall Study|Death|268|||
147501720|NCT03783442|531989202|FG000|Overall Study|Withdrawal by Subject|19|||
147501721|NCT03783442|531989203|FG001|Overall Study|Withdrawal by Subject|21|||
147501722|NCT03783442|531989202|FG000|Overall Study|Lost to Follow-up|7|||
147501723|NCT03783442|531989203|FG001|Overall Study|Lost to Follow-up|6|||
147501724|NCT03783442|531989202|FG000|Overall Study|Sponsor Ended Study|48|||
147501725|NCT03783442|531989203|FG001|Overall Study|Sponsor Ended Study|28|||
147501726|NCT01381718|531989204|FG000|Overall Study|Withdrawal by Subject|2|||
147501727|NCT01381718|531989205|FG001|Overall Study|Withdrawal by Subject|5|||
147501728|NCT01381718|531989204|FG000|Overall Study|Lost to Follow-up|3|||
147501729|NCT01381718|531989205|FG001|Overall Study|Lost to Follow-up|5|||
147501730|NCT01381718|531989204|FG000|Overall Study|Toxicity, side effects or complications related to study|0|||
147501731|NCT01381718|531989205|FG001|Overall Study|Toxicity, side effects or complications related to study|3|||
147501732|NCT02505542|531989206|FG000|Part A: Open-Label Period|Adverse Event|31|||
147501733|NCT02505542|531989207|FG001|Part A: Open-Label Period|Adverse Event|0|||
147501734|NCT02505542|531989208|FG002|Part A: Open-Label Period|Adverse Event|0|||
147501735|NCT02505542|531989209|FG003|Part A: Open-Label Period|Adverse Event|0|||
147501736|NCT02505542|531989206|FG000|Part A: Open-Label Period|Lack of Efficacy|5|||
147501737|NCT02505542|531989207|FG001|Part A: Open-Label Period|Lack of Efficacy|0|||
147501738|NCT02505542|531989208|FG002|Part A: Open-Label Period|Lack of Efficacy|0|||
147632755|NCT02564900|532474473|FG004|Dose Expansion|Adverse Event|0|||
147632756|NCT02564900|532474474|FG005|Dose Expansion|Adverse Event|0|||
147632757|NCT02564900|532474475|FG006|Dose Expansion|Adverse Event|9|||
147632758|NCT02564900|532474476|FG007|Dose Expansion|Adverse Event|22|||
147632759|NCT02564900|532474477|FG008|Dose Expansion|Adverse Event|0|||
147501739|NCT02505542|531989209|FG003|Part A: Open-Label Period|Lack of Efficacy|0|||
147501740|NCT02505542|531989206|FG000|Part A: Open-Label Period|Protocol Violation|1|||
147501741|NCT02505542|531989207|FG001|Part A: Open-Label Period|Protocol Violation|0|||
147501742|NCT02505542|531989208|FG002|Part A: Open-Label Period|Protocol Violation|0|||
147501743|NCT02505542|531989209|FG003|Part A: Open-Label Period|Protocol Violation|0|||
147501744|NCT02505542|531989206|FG000|Part A: Open-Label Period|Lost to Follow-up|5|||
147501745|NCT02505542|531989207|FG001|Part A: Open-Label Period|Lost to Follow-up|0|||
147501746|NCT02505542|531989208|FG002|Part A: Open-Label Period|Lost to Follow-up|0|||
147501747|NCT02505542|531989209|FG003|Part A: Open-Label Period|Lost to Follow-up|0|||
147501748|NCT02505542|531989206|FG000|Part A: Open-Label Period|Withdrawal by Subject|27|||
147501749|NCT02505542|531989207|FG001|Part A: Open-Label Period|Withdrawal by Subject|0|||
147501750|NCT02505542|531989208|FG002|Part A: Open-Label Period|Withdrawal by Subject|0|||
147501751|NCT02505542|531989209|FG003|Part A: Open-Label Period|Withdrawal by Subject|0|||
147501752|NCT02505542|531989206|FG000|Part A: Open-Label Period|New medical history available|1|||
147501753|NCT02505542|531989207|FG001|Part A: Open-Label Period|New medical history available|0|||
147501754|NCT02505542|531989208|FG002|Part A: Open-Label Period|New medical history available|0|||
147501755|NCT02505542|531989209|FG003|Part A: Open-Label Period|New medical history available|0|||
147501756|NCT02505542|531989206|FG000|Part A: Open-Label Period|Participant did not attend week 48 visit|1|||
147501757|NCT02505542|531989207|FG001|Part A: Open-Label Period|Participant did not attend week 48 visit|0|||
147501758|NCT02505542|531989208|FG002|Part A: Open-Label Period|Participant did not attend week 48 visit|0|||
147501759|NCT02505542|531989209|FG003|Part A: Open-Label Period|Participant did not attend week 48 visit|0|||
147501760|NCT02505542|531989206|FG000|Part A: Open-Label Period|Pregnancy|2|||
147501761|NCT02505542|531989207|FG001|Part A: Open-Label Period|Pregnancy|0|||
147501762|NCT02505542|531989208|FG002|Part A: Open-Label Period|Pregnancy|0|||
147501763|NCT02505542|531989209|FG003|Part A: Open-Label Period|Pregnancy|0|||
147501764|NCT02505542|531989206|FG000|Part A: Open-Label Period|Sponsor directive|1|||
147501765|NCT02505542|531989207|FG001|Part A: Open-Label Period|Sponsor directive|0|||
147501766|NCT02505542|531989208|FG002|Part A: Open-Label Period|Sponsor directive|0|||
147501767|NCT02505542|531989209|FG003|Part A: Open-Label Period|Sponsor directive|0|||
147501768|NCT02505542|531989206|FG000|Part A: Open-Label Period|Medical monitor decision|1|||
147501769|NCT02505542|531989207|FG001|Part A: Open-Label Period|Medical monitor decision|0|||
147501770|NCT02505542|531989208|FG002|Part A: Open-Label Period|Medical monitor decision|0|||
147501771|NCT02505542|531989209|FG003|Part A: Open-Label Period|Medical monitor decision|0|||
147501772|NCT02505542|531989206|FG000|Part A: Open-Label Period|Screening failure (detected too late)|1|||
147501773|NCT02505542|531989207|FG001|Part A: Open-Label Period|Screening failure (detected too late)|0|||
147501774|NCT02505542|531989208|FG002|Part A: Open-Label Period|Screening failure (detected too late)|0|||
147501775|NCT02505542|531989209|FG003|Part A: Open-Label Period|Screening failure (detected too late)|0|||
147501776|NCT02505542|531989206|FG000|Part A: Open-Label Period|Non-compliance|1|||
147501777|NCT02505542|531989207|FG001|Part A: Open-Label Period|Non-compliance|0|||
147501778|NCT02505542|531989208|FG002|Part A: Open-Label Period|Non-compliance|0|||
147501779|NCT02505542|531989209|FG003|Part A: Open-Label Period|Non-compliance|0|||
147501780|NCT02505542|531989206|FG000|Completed Part A, Did Not Enter Part B|Lack of Efficacy|2|||
147501781|NCT02505542|531989207|FG001|Completed Part A, Did Not Enter Part B|Lack of Efficacy|0|||
147501782|NCT02505542|531989208|FG002|Completed Part A, Did Not Enter Part B|Lack of Efficacy|0|||
147501783|NCT02505542|531989209|FG003|Completed Part A, Did Not Enter Part B|Lack of Efficacy|0|||
147501784|NCT02505542|531989206|FG000|Completed Part A, Did Not Enter Part B|Withdrawal by Subject|3|||
147501785|NCT02505542|531989207|FG001|Completed Part A, Did Not Enter Part B|Withdrawal by Subject|0|||
147501786|NCT02505542|531989208|FG002|Completed Part A, Did Not Enter Part B|Withdrawal by Subject|0|||
147501787|NCT02505542|531989209|FG003|Completed Part A, Did Not Enter Part B|Withdrawal by Subject|0|||
147501788|NCT02505542|531989206|FG000|Completed Part A, Did Not Enter Part B|The subject was not eligible for Part B|341|||
147501789|NCT02505542|531989207|FG001|Completed Part A, Did Not Enter Part B|The subject was not eligible for Part B|0|||
147501790|NCT02505542|531989208|FG002|Completed Part A, Did Not Enter Part B|The subject was not eligible for Part B|0|||
147501791|NCT02505542|531989209|FG003|Completed Part A, Did Not Enter Part B|The subject was not eligible for Part B|0|||
147501792|NCT02505542|531989206|FG000|Part B: Double-Blind Period|Adverse Event|0|||
147501793|NCT02505542|531989207|FG001|Part B: Double-Blind Period|Adverse Event|0|||
147501794|NCT02505542|531989208|FG002|Part B: Double-Blind Period|Adverse Event|1|||
147501795|NCT02505542|531989209|FG003|Part B: Double-Blind Period|Adverse Event|3|||
147501796|NCT02505542|531989206|FG000|Part B: Double-Blind Period|Lost to Follow-up|0|||
147501797|NCT02505542|531989207|FG001|Part B: Double-Blind Period|Lost to Follow-up|0|||
147501798|NCT02505542|531989208|FG002|Part B: Double-Blind Period|Lost to Follow-up|0|||
147501799|NCT02505542|531989209|FG003|Part B: Double-Blind Period|Lost to Follow-up|1|||
147501800|NCT02505542|531989206|FG000|Part B: Double-Blind Period|Withdrawal by Subject|0|||
147501801|NCT02505542|531989207|FG001|Part B: Double-Blind Period|Withdrawal by Subject|8|||
147668673|NCT03098979|532613349|FG002|Overall Study|Non-compliance|0|||
147668674|NCT03098979|532613350|FG003|Overall Study|Non-compliance|0|||
147668675|NCT03098979|532613351|FG004|Overall Study|Non-compliance|0|||
147668676|NCT03098979|532613352|FG005|Overall Study|Non-compliance|1|||
147668677|NCT03098979|532613347|FG000|Overall Study|Protocol Violation|0|||
147501802|NCT02505542|531989208|FG002|Part B: Double-Blind Period|Withdrawal by Subject|7|||
147501803|NCT02505542|531989209|FG003|Part B: Double-Blind Period|Withdrawal by Subject|2|||
147501804|NCT02505542|531989206|FG000|Part B: Double-Blind Period|Planning pregnancy|0|||
147501805|NCT02505542|531989207|FG001|Part B: Double-Blind Period|Planning pregnancy|1|||
147501806|NCT02505542|531989208|FG002|Part B: Double-Blind Period|Planning pregnancy|0|||
147501807|NCT02505542|531989209|FG003|Part B: Double-Blind Period|Planning pregnancy|0|||
147501808|NCT02505542|531989206|FG000|Part B: Double-Blind Period|Week 94 missed|0|||
147501809|NCT02505542|531989207|FG001|Part B: Double-Blind Period|Week 94 missed|0|||
147501810|NCT02505542|531989208|FG002|Part B: Double-Blind Period|Week 94 missed|1|||
147501811|NCT02505542|531989209|FG003|Part B: Double-Blind Period|Week 94 missed|0|||
147501812|NCT02505542|531989206|FG000|Part B: Double-Blind Period|Patient was moved from the country|0|||
147501813|NCT02505542|531989207|FG001|Part B: Double-Blind Period|Patient was moved from the country|0|||
147501814|NCT02505542|531989208|FG002|Part B: Double-Blind Period|Patient was moved from the country|0|||
147501815|NCT02505542|531989209|FG003|Part B: Double-Blind Period|Patient was moved from the country|1|||
147501816|NCT02505542|531989206|FG000|Part B: Double-Blind Period|Lack of Efficacy|0|||
147501817|NCT02505542|531989207|FG001|Part B: Double-Blind Period|Lack of Efficacy|1|||
147501818|NCT02505542|531989208|FG002|Part B: Double-Blind Period|Lack of Efficacy|0|||
147501819|NCT02505542|531989209|FG003|Part B: Double-Blind Period|Lack of Efficacy|0|||
147501820|NCT02505542|531989206|FG000|Part B: Double-Blind Period|Miscalculation|0|||
147501821|NCT02505542|531989207|FG001|Part B: Double-Blind Period|Miscalculation|1|||
147501822|NCT02505542|531989208|FG002|Part B: Double-Blind Period|Miscalculation|0|||
147501823|NCT02505542|531989209|FG003|Part B: Double-Blind Period|Miscalculation|0|||
147501824|NCT02505542|531989206|FG000|Part B: Double-Blind Period|Subject did not complete all visits|0|||
147501825|NCT02505542|531989207|FG001|Part B: Double-Blind Period|Subject did not complete all visits|1|||
147501826|NCT02505542|531989208|FG002|Part B: Double-Blind Period|Subject did not complete all visits|0|||
147501827|NCT02505542|531989209|FG003|Part B: Double-Blind Period|Subject did not complete all visits|0|||
147501828|NCT00168064|531989211|FG000|Overall Study|Adverse Event|26|||
147501829|NCT00168064|531989212|FG001|Overall Study|Adverse Event|22|||
147501830|NCT00168064|531989211|FG000|Overall Study|Withdrawal by Subject|3|||
147501831|NCT00168064|531989212|FG001|Overall Study|Withdrawal by Subject|4|||
147501832|NCT00168064|531989211|FG000|Overall Study|Lack of Efficacy|4|||
147501833|NCT00168064|531989212|FG001|Overall Study|Lack of Efficacy|4|||
147501834|NCT00168064|531989211|FG000|Overall Study|Lost to Follow-up|4|||
147501835|NCT00168064|531989212|FG001|Overall Study|Lost to Follow-up|3|||
147501836|NCT00168064|531989211|FG000|Overall Study|Non-compliance|2|||
147501837|NCT00168064|531989212|FG001|Overall Study|Non-compliance|3|||
147501838|NCT00168064|531989211|FG000|Overall Study|Concurrent Illness|4|||
147501839|NCT00168064|531989212|FG001|Overall Study|Concurrent Illness|3|||
147501840|NCT00168064|531989211|FG000|Overall Study|Subject's Best interest|2|||
147501841|NCT00168064|531989212|FG001|Overall Study|Subject's Best interest|2|||
147501842|NCT00168064|531989211|FG000|Overall Study|Various|4|||
147501843|NCT00168064|531989212|FG001|Overall Study|Various|3|||
147501844|NCT05489081|531989216|FG000|Overall Study|student left classroom|0|||
147501845|NCT05489081|531989217|FG001|Overall Study|student left classroom|1|||
147501846|NCT05489081|531989216|FG000|Overall Study|teacher left school|0|||
147501847|NCT05489081|531989217|FG001|Overall Study|teacher left school|2|||
147501848|NCT00400712|531989218|FG000|Overall Study|Death|1|||
147501849|NCT00400712|531989219|FG001|Overall Study|Death|0|||
147501850|NCT00400712|531989218|FG000|Overall Study|Withdrawal by Subject|11|||
147501851|NCT00400712|531989219|FG001|Overall Study|Withdrawal by Subject|12|||
147501852|NCT00400712|531989218|FG000|Overall Study|Physician Decision|5|||
147501853|NCT00400712|531989219|FG001|Overall Study|Physician Decision|4|||
147501854|NCT01181102|531989220|FG000|Overall Study|Adverse Event|28|||
147501855|NCT01181102|531989221|FG001|Overall Study|Adverse Event|26|||
147501856|NCT01181102|531989220|FG000|Overall Study|Lack of Efficacy|3|||
147501857|NCT01181102|531989221|FG001|Overall Study|Lack of Efficacy|1|||
147501858|NCT01181102|531989220|FG000|Overall Study|Lost to Follow-up|2|||
147632760|NCT02564900|532474478|FG009|Dose Expansion|Adverse Event|11|||
147632761|NCT02564900|532474479|FG010|Dose Expansion|Adverse Event|0|||
147632762|NCT02564900|532474480|FG011|Dose Expansion|Adverse Event|5|||
147632763|NCT02564900|532474481|FG012|Dose Expansion|Adverse Event|2|||
147632764|NCT02564900|532474482|FG013|Dose Expansion|Adverse Event|2|||
147632765|NCT02564900|532474483|FG014|Dose Expansion|Adverse Event|1|||
147501859|NCT01181102|531989221|FG001|Overall Study|Lost to Follow-up|0|||
147501860|NCT01181102|531989220|FG000|Overall Study|Physician Decision|3|||
147501861|NCT01181102|531989221|FG001|Overall Study|Physician Decision|1|||
147632766|NCT02564900|532474469|FG000|Dose Expansion|Ongoing|0|||
147632767|NCT02564900|532474470|FG001|Dose Expansion|Ongoing|0|||
147632768|NCT02564900|532474471|FG002|Dose Expansion|Ongoing|0|||
147632769|NCT02564900|532474472|FG003|Dose Expansion|Ongoing|0|||
147632770|NCT02564900|532474473|FG004|Dose Expansion|Ongoing|0|||
147632771|NCT02564900|532474474|FG005|Dose Expansion|Ongoing|0|||
147632772|NCT02564900|532474475|FG006|Dose Expansion|Ongoing|9|||
147501862|NCT01181102|531989220|FG000|Overall Study|Protocol Violation|5|||
147501863|NCT01181102|531989221|FG001|Overall Study|Protocol Violation|6|||
147632773|NCT02564900|532474476|FG007|Dose Expansion|Ongoing|10|||
147501864|NCT01181102|531989220|FG000|Overall Study|Withdrawal by Subject|10|||
147501865|NCT01181102|531989221|FG001|Overall Study|Withdrawal by Subject|12|||
147501866|NCT01309841|531989224|FG000|Overall Study|Other|0|||
147501867|NCT01309841|531989225|FG001|Overall Study|Other|1|||
147501868|NCT01309841|531989226|FG002|Overall Study|Other|1|||
147501869|NCT01309841|531989224|FG000|Overall Study|Lost to Follow-up|7|||
147501870|NCT01309841|531989225|FG001|Overall Study|Lost to Follow-up|6|||
147501871|NCT01309841|531989226|FG002|Overall Study|Lost to Follow-up|4|||
147501872|NCT01309841|531989224|FG000|Overall Study|Study-Specific Withdrawal Criteria|3|||
147501873|NCT01309841|531989225|FG001|Overall Study|Study-Specific Withdrawal Criteria|1|||
147501874|NCT01309841|531989226|FG002|Overall Study|Study-Specific Withdrawal Criteria|2|||
147501875|NCT01309841|531989224|FG000|Overall Study|Lack of Efficacy|0|||
147501876|NCT01309841|531989225|FG001|Overall Study|Lack of Efficacy|0|||
147501877|NCT01309841|531989226|FG002|Overall Study|Lack of Efficacy|2|||
147501878|NCT01309841|531989224|FG000|Overall Study|Adverse Event|9|||
147501879|NCT01309841|531989225|FG001|Overall Study|Adverse Event|22|||
147501880|NCT01309841|531989226|FG002|Overall Study|Adverse Event|11|||
147501881|NCT01309841|531989224|FG000|Overall Study|Death|1|||
147501882|NCT01309841|531989225|FG001|Overall Study|Death|0|||
147501883|NCT01309841|531989226|FG002|Overall Study|Death|0|||
147501884|NCT01309841|531989224|FG000|Overall Study|Eligibility Criteria Not Fulfilled|0|||
147501885|NCT01309841|531989225|FG001|Overall Study|Eligibility Criteria Not Fulfilled|0|||
147501886|NCT01309841|531989226|FG002|Overall Study|Eligibility Criteria Not Fulfilled|1|||
147501887|NCT01309841|531989224|FG000|Overall Study|Withdrawal by Subject|17|||
147501888|NCT01309841|531989225|FG001|Overall Study|Withdrawal by Subject|6|||
147501889|NCT01309841|531989226|FG002|Overall Study|Withdrawal by Subject|13|||
147501890|NCT01309841|531989224|FG000|Overall Study|Did Not Receive Treatment|2|||
147501891|NCT01309841|531989225|FG001|Overall Study|Did Not Receive Treatment|0|||
147501892|NCT01309841|531989226|FG002|Overall Study|Did Not Receive Treatment|1|||
147501893|NCT01309841|531989224|FG000|Overall Study|Severe non-compliance with protocol|0|||
147501894|NCT01309841|531989225|FG001|Overall Study|Severe non-compliance with protocol|5|||
147501895|NCT01309841|531989226|FG002|Overall Study|Severe non-compliance with protocol|2|||
147501896|NCT01441115|531989227|FG000|Overall Study|Taken off study - Principal Investigator discretion|1|||
147501897|NCT00878215|531989230|FG000|Overall Study|Determined to be ineligible|0|||
147501898|NCT00878215|531989231|FG001|Overall Study|Determined to be ineligible|10|||
147501899|NCT00878215|531989232|FG002|Overall Study|Determined to be ineligible|0|||
147501900|NCT00878215|531989233|FG003|Overall Study|Determined to be ineligible|0|||
147501901|NCT01969799|531989234|FG000|Overall Study|Adverse Event|0|||
147501902|NCT01969799|531989235|FG001|Overall Study|Adverse Event|1|||
147501903|NCT01969799|531989234|FG000|Overall Study|Death|16|||
147501904|NCT01969799|531989235|FG001|Overall Study|Death|11|||
147501905|NCT01969799|531989234|FG000|Overall Study|Lost to Follow-up|0|||
147501906|NCT01969799|531989235|FG001|Overall Study|Lost to Follow-up|2|||
147501907|NCT01969799|531989234|FG000|Overall Study|Physician Decision|1|||
147501908|NCT01969799|531989235|FG001|Overall Study|Physician Decision|0|||
147501909|NCT01361919|531989236|FG000|Overall Study|technical issues|10|||
147501910|NCT01361919|531989237|FG001|Overall Study|technical issues|12|||
147501911|NCT01361919|531989238|FG002|Overall Study|technical issues|10|||
147501912|NCT01681576|531989241|FG000|Period 1|Adverse Event|1|||
147501913|NCT01681576|531989242|FG001|Period 1|Adverse Event|0|||
147501914|NCT01681576|531989241|FG000|Period 1|Protocol Deviation|1|||
147501915|NCT01681576|531989242|FG001|Period 1|Protocol Deviation|0|||
147501916|NCT01681576|531989241|FG000|Period 2|subject/guardian decision|3|||
147501917|NCT01681576|531989242|FG001|Period 2|subject/guardian decision|1|||
147501918|NCT01681576|531989241|FG000|Period 2|Non-compliance with study treatment|1|||
147501919|NCT01681576|531989242|FG001|Period 2|Non-compliance with study treatment|0|||
147501920|NCT00178464|531989243|FG000|Overall Study|Withdrawal by Subject|1|||
147501921|NCT00178464|531989243|FG000|Overall Study|Physician Decision|1|||
147501922|NCT04111107|531989244|FG000|Overall Study|Withdrawal by Subject|6|||
147501923|NCT04111107|531989244|FG000|Overall Study|Declining Health|5|||
147501924|NCT03956225|531989245|FG000|Overall Study|Lack of Efficacy|1|||
147501925|NCT03956225|531989246|FG001|Overall Study|Lack of Efficacy|1|||
147501926|NCT03956225|531989245|FG000|Overall Study|Lost to Follow-up|0|||
147501927|NCT03956225|531989246|FG001|Overall Study|Lost to Follow-up|1|||
147501928|NCT03956225|531989245|FG000|Overall Study|Withdrawal by Subject|2|||
147501929|NCT03956225|531989246|FG001|Overall Study|Withdrawal by Subject|1|||
147501930|NCT03956225|531989245|FG000|Overall Study|Other Reasons|2|||
147501931|NCT03956225|531989246|FG001|Overall Study|Other Reasons|1|||
147501932|NCT00805545|531989249|FG000|Overall Study|Protocol Violation|3|||
147501933|NCT00805545|531989250|FG001|Overall Study|Protocol Violation|2|||
147501934|NCT00805545|531989249|FG000|Overall Study|Protocol Violation|3|||
147501935|NCT00805545|531989250|FG001|Overall Study|Protocol Violation|1|||
147501936|NCT01195363|531989259|FG000|Overall Study|Lost to Follow-up|7|||
147501937|NCT01195363|531989260|FG001|Overall Study|Lost to Follow-up|4|||
147501938|NCT01195363|531989259|FG000|Overall Study|Adverse Event|3|||
147501939|NCT01195363|531989260|FG001|Overall Study|Adverse Event|1|||
147501940|NCT01195363|531989259|FG000|Overall Study|Lack of Efficacy|0|||
147501941|NCT01195363|531989260|FG001|Overall Study|Lack of Efficacy|4|||
147501942|NCT01195363|531989259|FG000|Overall Study|incarceration|1|||
147501943|NCT01195363|531989260|FG001|Overall Study|incarceration|0|||
147501944|NCT03337139|531989262|FG000|Phase I|Withdrawal by Subject|10|||
147501945|NCT03337139|531989263|FG001|Phase I|Withdrawal by Subject|0|||
147501946|NCT01871896|531989264|FG000|Overall Study|Lost to Follow-up|1|||
147501947|NCT05691829|531990305|FG000|Overall Study|Physician Decision|2|||
147501948|NCT05691829|531990305|FG000|Overall Study|Eligibility criteria not met|3|||
147501949|NCT00453180|531990308|FG000|Overall Study|Lost to Follow-up|2|||
147501950|NCT00453180|531990309|FG001|Overall Study|Lost to Follow-up|1|||
147501951|NCT00453180|531990308|FG000|Overall Study|Adverse Event|1|||
147501952|NCT00453180|531990309|FG001|Overall Study|Adverse Event|2|||
147501953|NCT03326869|531990310|FG000|Overall Study|Study data has been lost to natural disa|1|||
147501954|NCT03326869|531990311|FG001|Overall Study|Study data has been lost to natural disa|1|||
147501955|NCT03927911|531990312|FG000|Overall Study|problems with eDiary|0|||
147501956|NCT03927911|531990313|FG001|Overall Study|problems with eDiary|1|||
147501957|NCT03927911|531990314|FG002|Overall Study|problems with eDiary|0|||
147501958|NCT03927911|531990315|FG003|Overall Study|problems with eDiary|1|||
147501959|NCT03927911|531990316|FG004|Overall Study|problems with eDiary|0|||
147501960|NCT03927911|531990317|FG005|Overall Study|problems with eDiary|4|||
147501961|NCT03927911|531990312|FG000|Overall Study|Adverse Event|0|||
147501962|NCT03927911|531990313|FG001|Overall Study|Adverse Event|0|||
147501963|NCT03927911|531990314|FG002|Overall Study|Adverse Event|0|||
147501964|NCT03927911|531990315|FG003|Overall Study|Adverse Event|0|||
147501965|NCT03927911|531990316|FG004|Overall Study|Adverse Event|0|||
147501966|NCT03927911|531990317|FG005|Overall Study|Adverse Event|1|||
147501967|NCT03927911|531990312|FG000|Overall Study|not treated -study terminated by sponsor|0|||
147501968|NCT03927911|531990313|FG001|Overall Study|not treated -study terminated by sponsor|1|||
147501969|NCT03927911|531990314|FG002|Overall Study|not treated -study terminated by sponsor|0|||
147501970|NCT03927911|531990315|FG003|Overall Study|not treated -study terminated by sponsor|0|||
147501971|NCT03927911|531990316|FG004|Overall Study|not treated -study terminated by sponsor|0|||
147501972|NCT03927911|531990317|FG005|Overall Study|not treated -study terminated by sponsor|0|||
147501973|NCT03927911|531990312|FG000|Overall Study|Surgery cancelled|0|||
147501974|NCT03927911|531990313|FG001|Overall Study|Surgery cancelled|0|||
147501975|NCT03927911|531990314|FG002|Overall Study|Surgery cancelled|0|||
147501976|NCT03927911|531990315|FG003|Overall Study|Surgery cancelled|1|||
147501977|NCT03927911|531990316|FG004|Overall Study|Surgery cancelled|0|||
147501978|NCT03927911|531990317|FG005|Overall Study|Surgery cancelled|1|||
147501979|NCT03927911|531990312|FG000|Overall Study|Protocol Violation|0|||
147501980|NCT03927911|531990313|FG001|Overall Study|Protocol Violation|0|||
147501981|NCT03927911|531990314|FG002|Overall Study|Protocol Violation|0|||
147501982|NCT03927911|531990315|FG003|Overall Study|Protocol Violation|0|||
147501983|NCT03927911|531990316|FG004|Overall Study|Protocol Violation|0|||
147501984|NCT03927911|531990317|FG005|Overall Study|Protocol Violation|1|||
147501985|NCT00562640|531990318|FG000|Overall Study|Death|0|||
147501986|NCT00562640|531990319|FG001|Overall Study|Death|1|||
147501987|NCT00562640|531990320|FG002|Overall Study|Death|1|||
147501988|NCT00562640|531990321|FG003|Overall Study|Death|0|||
147501989|NCT01412151|531990322|FG000|Week 0 - 306 - Treatment Period|Death|1|||
147501990|NCT01412151|531990322|FG000|Week 0 - 306 - Treatment Period|Withdrawal by Subject|1|||
147501991|NCT01412151|531990322|FG000|Week 0 - 306 - Treatment Period|Withdrawal by Investigator|3|||
147501992|NCT01412151|531990322|FG000|Week 306 - 310 - Washout Period|Withdrawal by Subject|2|||
147501993|NCT03127852|531990323|FG000|Overall Study|Withdrawal by Subject|4|||
147501994|NCT03127852|531990324|FG001|Overall Study|Withdrawal by Subject|1|||
147501995|NCT03127852|531990323|FG000|Overall Study|Death|1|||
147501996|NCT03127852|531990324|FG001|Overall Study|Death|1|||
147501997|NCT01824693|531990325|FG000|Overall Study|Death|0|||
147501998|NCT01824693|531990326|FG001|Overall Study|Death|1|||
147501999|NCT01824693|531990327|FG002|Overall Study|Death|0|||
147502000|NCT01824693|531990325|FG000|Overall Study|Physician Decision|1|||
147502001|NCT01824693|531990326|FG001|Overall Study|Physician Decision|1|||
147502002|NCT01824693|531990327|FG002|Overall Study|Physician Decision|1|||
147502003|NCT01824693|531990325|FG000|Overall Study|Withdrawal by Subject|0|||
147502004|NCT01824693|531990326|FG001|Overall Study|Withdrawal by Subject|0|||
147502005|NCT01824693|531990327|FG002|Overall Study|Withdrawal by Subject|1|||
147502006|NCT01824693|531990325|FG000|Overall Study|Progressive Disease|0|||
147502007|NCT01824693|531990326|FG001|Overall Study|Progressive Disease|5|||
147502008|NCT01824693|531990327|FG002|Overall Study|Progressive Disease|0|||
147502009|NCT01824693|531990325|FG000|Overall Study|Ineligible|0|||
147502010|NCT01824693|531990326|FG001|Overall Study|Ineligible|0|||
147502011|NCT01824693|531990327|FG002|Overall Study|Ineligible|3|||
147668678|NCT03098979|532613348|FG001|Overall Study|Protocol Violation|0|||
147502012|NCT01824693|531990325|FG000|Overall Study|No Transplant Planned|0|||
147502013|NCT01824693|531990326|FG001|Overall Study|No Transplant Planned|0|||
147502014|NCT01824693|531990327|FG002|Overall Study|No Transplant Planned|10|||
147502015|NCT02591238|531990328|FG000|Overall Study|Pregnancy|1|||
147502016|NCT02591238|531990329|FG001|Overall Study|Pregnancy|0|||
147502017|NCT02591238|531990330|FG002|Overall Study|Pregnancy|0|||
147502018|NCT02591238|531990331|FG003|Overall Study|Pregnancy|0|||
147502019|NCT02591238|531990328|FG000|Overall Study|Withdrawal by Subject|0|||
147502020|NCT02591238|531990329|FG001|Overall Study|Withdrawal by Subject|0|||
147502021|NCT02591238|531990330|FG002|Overall Study|Withdrawal by Subject|0|||
147502022|NCT02591238|531990331|FG003|Overall Study|Withdrawal by Subject|1|||
147502023|NCT02591238|531990328|FG000|Overall Study|influenza|0|||
147502024|NCT02591238|531990329|FG001|Overall Study|influenza|0|||
147502025|NCT02591238|531990330|FG002|Overall Study|influenza|0|||
147502026|NCT02591238|531990331|FG003|Overall Study|influenza|1|||
147502027|NCT02591238|531990328|FG000|Overall Study|personal circumstances|0|||
147502028|NCT02591238|531990329|FG001|Overall Study|personal circumstances|0|||
147502029|NCT02591238|531990330|FG002|Overall Study|personal circumstances|0|||
147502030|NCT02591238|531990331|FG003|Overall Study|personal circumstances|1|||
147502031|NCT02591238|531990328|FG000|Overall Study|personal circumstances|0|||
147502032|NCT02591238|531990329|FG001|Overall Study|personal circumstances|1|||
147502033|NCT02591238|531990330|FG002|Overall Study|personal circumstances|0|||
147502034|NCT02591238|531990331|FG003|Overall Study|personal circumstances|0|||
147502035|NCT00656084|531990332|FG000|Overall Study|Adverse Event|4|||
147502036|NCT00656084|531990332|FG000|Overall Study|Withdrawal by Subject|1|||
147502037|NCT00656084|531990332|FG000|Overall Study|Patient Request|1|||
147502038|NCT00656084|531990332|FG000|Overall Study|Investigator Request|1|||
147502039|NCT00525785|531990336|FG000|Overall Study|Withdrawal by Subject|1|||
147502040|NCT00525785|531990336|FG000|Overall Study|Lack of Efficacy|1|||
147502041|NCT00525785|531990336|FG000|Overall Study|Physician Decision|1|||
147502042|NCT03628599|531990337|FG000|Overall Study|Adverse Event|0|||
147502043|NCT03628599|531990338|FG001|Overall Study|Adverse Event|1|||
147502044|NCT01624506|531990339|FG000|Overall Study|Lost to Follow-up|29|||
147502045|NCT01624506|531990340|FG001|Overall Study|Lost to Follow-up|15|||
147502046|NCT01624506|531990339|FG000|Overall Study|Withdrawal by Subject|9|||
147502047|NCT01624506|531990340|FG001|Overall Study|Withdrawal by Subject|2|||
147502048|NCT01624506|531990339|FG000|Overall Study|Death|1|||
147502049|NCT01624506|531990340|FG001|Overall Study|Death|0|||
147502050|NCT01624506|531990339|FG000|Overall Study|LINX explants|23|||
147502051|NCT01624506|531990340|FG001|Overall Study|LINX explants|0|||
147502052|NCT01624506|531990339|FG000|Overall Study|Adverse Event|3|||
147502053|NCT01624506|531990340|FG001|Overall Study|Adverse Event|0|||
147502054|NCT00132314|531990346|FG000|Overall Study|Lost to Follow-up|70|||
147502055|NCT00132314|531990347|FG001|Overall Study|Lost to Follow-up|62|||
147502056|NCT00132314|531990346|FG000|Overall Study|Lacked SSN|1|||
147502057|NCT00132314|531990347|FG001|Overall Study|Lacked SSN|3|||
147502058|NCT00132314|531990346|FG000|Overall Study|Refused intervention at baseline|2|||
147502059|NCT00132314|531990347|FG001|Overall Study|Refused intervention at baseline|7|||
147502060|NCT04295356|531990358|FG000|Overall Study|Physician Decision|1|||
147502061|NCT04295356|531990359|FG001|Overall Study|Physician Decision|0|||
147502062|NCT04295356|531990358|FG000|Overall Study|Lost to Follow-up|0|||
147502063|NCT04295356|531990359|FG001|Overall Study|Lost to Follow-up|3|||
147502064|NCT04295356|531990358|FG000|Overall Study|Protocol Violation|0|||
147502065|NCT04295356|531990359|FG001|Overall Study|Protocol Violation|1|||
147502066|NCT03939637|531990366|FG000|Overall Study|patient retrospectively deemed ineligible (did not have primary ITP)|2|||
147502067|NCT03939637|531990367|FG001|Overall Study|patient retrospectively deemed ineligible (did not have primary ITP)|0|||
147502068|NCT03939637|531990366|FG000|Overall Study|patient retrospectively deemed ineligible (Day 0 plt ct >30 x 10^9/L)|1|||
147502069|NCT03939637|531990367|FG001|Overall Study|patient retrospectively deemed ineligible (Day 0 plt ct >30 x 10^9/L)|1|||
147502070|NCT04325906|531990370|FG000|Overall Study|Withdrawal by Subject|2|||
147502071|NCT04325906|531990371|FG001|Overall Study|Withdrawal by Subject|0|||
147502072|NCT02016898|531990372|FG000|Overall Study|Death|1|||
147502073|NCT02016898|531990373|FG001|Overall Study|Death|1|||
147502074|NCT02016898|531990372|FG000|Overall Study|Lost to Follow-up|4|||
147502075|NCT02016898|531990373|FG001|Overall Study|Lost to Follow-up|4|||
147502076|NCT00992186|531990378|FG000|Overall Study|Withdrawal by Subject|2|||
147502077|NCT00992186|531990378|FG000|Overall Study|Protocol Violation|1|||
147502078|NCT00992186|531990378|FG000|Overall Study|Physician Decision|1|||
147502079|NCT00992186|531990378|FG000|Overall Study|Adverse Event|9|||
147502080|NCT00992186|531990378|FG000|Overall Study|Progressive Disease|30|||
147502081|NCT00992186|531990378|FG000|Overall Study|Refusal To Receive Study Agent|3|||
147502082|NCT05127421|531990380|FG000|4-Week Double-Blind Period|Lost to Follow-up|1|||
147502083|NCT05127421|531990381|FG001|4-Week Double-Blind Period|Lost to Follow-up|0|||
147632774|NCT02564900|532474477|FG008|Dose Expansion|Ongoing|11|||
147502084|NCT05127421|531990382|FG002|4-Week Double-Blind Period|Lost to Follow-up|0|||
147632775|NCT02564900|532474478|FG009|Dose Expansion|Ongoing|3|||
147632776|NCT02564900|532474479|FG010|Dose Expansion|Ongoing|0|||
147502085|NCT05127421|531990383|FG003|4-Week Double-Blind Period|Lost to Follow-up|0|||
147632777|NCT02564900|532474480|FG011|Dose Expansion|Ongoing|0|||
147502086|NCT05127421|531990380|FG000|4-Week Double-Blind Period|Physician Decision|1|||
147502087|NCT05127421|531990381|FG001|4-Week Double-Blind Period|Physician Decision|0|||
147502088|NCT05127421|531990382|FG002|4-Week Double-Blind Period|Physician Decision|0|||
147502089|NCT05127421|531990383|FG003|4-Week Double-Blind Period|Physician Decision|0|||
147632778|NCT02564900|532474481|FG012|Dose Expansion|Ongoing|4|||
147632779|NCT02564900|532474482|FG013|Dose Expansion|Ongoing|0|||
147502090|NCT05127421|531990380|FG000|4-Week Double-Blind Period|Withdrawal by Subject|3|||
147502091|NCT05127421|531990381|FG001|4-Week Double-Blind Period|Withdrawal by Subject|1|||
147502092|NCT05127421|531990382|FG002|4-Week Double-Blind Period|Withdrawal by Subject|0|||
147502093|NCT05127421|531990383|FG003|4-Week Double-Blind Period|Withdrawal by Subject|0|||
147502094|NCT05127421|531990380|FG000|4-Week Double-Blind Period|Withdrawn by Sponsor|0|||
147502095|NCT05127421|531990381|FG001|4-Week Double-Blind Period|Withdrawn by Sponsor|4|||
147502096|NCT05127421|531990382|FG002|4-Week Double-Blind Period|Withdrawn by Sponsor|0|||
147502097|NCT05127421|531990383|FG003|4-Week Double-Blind Period|Withdrawn by Sponsor|0|||
147502098|NCT05127421|531990380|FG000|4-Week Double-Blind Period|Withdrawn Due to E-diary Compliance|0|||
147502099|NCT05127421|531990381|FG001|4-Week Double-Blind Period|Withdrawn Due to E-diary Compliance|1|||
147502100|NCT05127421|531990382|FG002|4-Week Double-Blind Period|Withdrawn Due to E-diary Compliance|0|||
147502101|NCT05127421|531990383|FG003|4-Week Double-Blind Period|Withdrawn Due to E-diary Compliance|0|||
147502102|NCT05127421|531990380|FG000|4-Week Open-Label Period|Lost to Follow-up|0|||
147502103|NCT05127421|531990381|FG001|4-Week Open-Label Period|Lost to Follow-up|0|||
147502104|NCT05127421|531990382|FG002|4-Week Open-Label Period|Lost to Follow-up|0|||
147502105|NCT05127421|531990383|FG003|4-Week Open-Label Period|Lost to Follow-up|1|||
147502106|NCT05127421|531990380|FG000|4-Week Open-Label Period|Withdrawal by Subject|0|||
147502107|NCT05127421|531990381|FG001|4-Week Open-Label Period|Withdrawal by Subject|0|||
147502108|NCT05127421|531990382|FG002|4-Week Open-Label Period|Withdrawal by Subject|1|||
147502109|NCT05127421|531990383|FG003|4-Week Open-Label Period|Withdrawal by Subject|1|||
147502110|NCT05127421|531990380|FG000|4-Week Open-Label Period|Withdrawn by Sponsor|0|||
147502111|NCT05127421|531990381|FG001|4-Week Open-Label Period|Withdrawn by Sponsor|0|||
147502112|NCT05127421|531990382|FG002|4-Week Open-Label Period|Withdrawn by Sponsor|0|||
147502113|NCT05127421|531990383|FG003|4-Week Open-Label Period|Withdrawn by Sponsor|1|||
147502114|NCT00574496|531990389|FG000|Overall Study|Withdrawal by Subject|1|||
147502115|NCT02815293|531990392|FG000|Overall Study|Study termination by sponsor|10|||
147502116|NCT02815293|531990393|FG001|Overall Study|Study termination by sponsor|7|||
147502117|NCT02815293|531990394|FG002|Overall Study|Study termination by sponsor|0|||
147502118|NCT02815293|531990392|FG000|Overall Study|Participants not randomized|0|||
147502119|NCT02815293|531990393|FG001|Overall Study|Participants not randomized|0|||
147502120|NCT02815293|531990394|FG002|Overall Study|Participants not randomized|18|||
147502121|NCT02815293|531990392|FG000|Overall Study|Adverse Event|0|||
147502122|NCT02815293|531990393|FG001|Overall Study|Adverse Event|1|||
147502123|NCT02815293|531990394|FG002|Overall Study|Adverse Event|0|||
147502124|NCT02431468|531990395|FG000|Overall Study|Adverse Event|2|||
147502125|NCT02431468|531990396|FG001|Overall Study|Adverse Event|4|||
147502126|NCT02431468|531990397|FG002|Overall Study|Adverse Event|5|||
147502127|NCT02431468|531990395|FG000|Overall Study|Withdrawal by Subject|4|||
147502128|NCT02431468|531990396|FG001|Overall Study|Withdrawal by Subject|12|||
147502129|NCT02431468|531990397|FG002|Overall Study|Withdrawal by Subject|2|||
147502130|NCT02431468|531990395|FG000|Overall Study|noncompliance, investigator termination,|2|||
147502131|NCT02431468|531990396|FG001|Overall Study|noncompliance, investigator termination,|2|||
147502132|NCT02431468|531990397|FG002|Overall Study|noncompliance, investigator termination,|2|||
147502133|NCT00006604|531990400|FG000|Overall Study|Met study objective - no further FU|1|||
147502134|NCT00006604|531990401|FG001|Overall Study|Met study objective - no further FU|0|||
147502135|NCT00006604|531990402|FG002|Overall Study|Met study objective - no further FU|0|||
147502136|NCT00006604|531990403|FG003|Overall Study|Met study objective - no further FU|0|||
147502137|NCT00006604|531990404|FG004|Overall Study|Met study objective - no further FU|0|||
147502138|NCT00006604|531990405|FG005|Overall Study|Met study objective - no further FU|0|||
147502139|NCT00006604|531990406|FG006|Overall Study|Met study objective - no further FU|0|||
147502140|NCT00006604|531990407|FG007|Overall Study|Met study objective - no further FU|0|||
147502141|NCT00006604|531990408|FG008|Overall Study|Met study objective - no further FU|0|||
147502142|NCT00006604|531990409|FG009|Overall Study|Met study objective - no further FU|0|||
147502143|NCT00006604|531990410|FG010|Overall Study|Met study objective - no further FU|0|||
147502144|NCT00006604|531990411|FG011|Overall Study|Met study objective - no further FU|0|||
147502145|NCT00006604|531990412|FG012|Overall Study|Met study objective - no further FU|0|||
147502146|NCT00006604|531990413|FG013|Overall Study|Met study objective - no further FU|0|||
147502147|NCT00006604|531990414|FG014|Overall Study|Met study objective - no further FU|1|||
147502148|NCT00006604|531990415|FG015|Overall Study|Met study objective - no further FU|1|||
147502149|NCT00006604|531990416|FG016|Overall Study|Met study objective - no further FU|0|||
147502150|NCT00006604|531990400|FG000|Overall Study|Randomization entry error-no RX, no FU|0|||
147502151|NCT00006604|531990401|FG001|Overall Study|Randomization entry error-no RX, no FU|0|||
147502152|NCT00006604|531990402|FG002|Overall Study|Randomization entry error-no RX, no FU|0|||
147668679|NCT03098979|532613349|FG002|Overall Study|Protocol Violation|0|||
147668680|NCT03098979|532613350|FG003|Overall Study|Protocol Violation|0|||
147668681|NCT03098979|532613351|FG004|Overall Study|Protocol Violation|0|||
147668682|NCT03098979|532613352|FG005|Overall Study|Protocol Violation|1|||
147668683|NCT02419807|532613353|FG000|Overall Study|Withdrawal by Subject|4|||
147502153|NCT00006604|531990403|FG003|Overall Study|Randomization entry error-no RX, no FU|0|||
147502154|NCT00006604|531990404|FG004|Overall Study|Randomization entry error-no RX, no FU|0|||
147502155|NCT00006604|531990405|FG005|Overall Study|Randomization entry error-no RX, no FU|0|||
147668684|NCT02419807|532613353|FG000|Overall Study|Physician Decision|1|||
147668685|NCT02419807|532613353|FG000|Overall Study|Protocol Violation|5|||
147668686|NCT01065818|532613354|FG000|Overall Study|Withdrawal by Subject|1|||
147668687|NCT01065818|532613354|FG000|Overall Study|Not a candidate for surgery|1|||
147668688|NCT04459338|532613357|FG000|Overall Study|Loss of IV during study|1|||
147668689|NCT04459338|532613358|FG001|Overall Study|Loss of IV during study|0|||
147668690|NCT03157089|532613359|FG000|Overall Study|Treated only with pembrolizumab|1|||
147668691|NCT03157089|532613360|FG001|Overall Study|Treated only with pembrolizumab|0|||
147668692|NCT03157089|532613359|FG000|Overall Study|Adverse Event|5|||
147668693|NCT03157089|532613360|FG001|Overall Study|Adverse Event|4|||
147668694|NCT03157089|532613359|FG000|Overall Study|Progressive disease|6|||
147668695|NCT03157089|532613360|FG001|Overall Study|Progressive disease|8|||
147668696|NCT00784875|532613361|FG000|Period A - Baseline|Entry Criteria Not Met|0|||
147668697|NCT00784875|532613362|FG001|Period A - Baseline|Entry Criteria Not Met|0|||
147668698|NCT00784875|532613363|FG002|Period A - Baseline|Entry Criteria Not Met|0|||
147668699|NCT00784875|532613364|FG003|Period A - Baseline|Entry Criteria Not Met|5|||
147668700|NCT00784875|532613361|FG000|Period A - Baseline|Adverse Event|0|||
147668701|NCT00784875|532613362|FG001|Period A - Baseline|Adverse Event|0|||
147668702|NCT00784875|532613363|FG002|Period A - Baseline|Adverse Event|0|||
147668703|NCT00784875|532613364|FG003|Period A - Baseline|Adverse Event|8|||
147668704|NCT00784875|532613361|FG000|Period A - Baseline|Protocol Violation|0|||
147668705|NCT00784875|532613362|FG001|Period A - Baseline|Protocol Violation|0|||
147668706|NCT00784875|532613363|FG002|Period A - Baseline|Protocol Violation|0|||
147668707|NCT00784875|532613364|FG003|Period A - Baseline|Protocol Violation|25|||
147668708|NCT00784875|532613361|FG000|Period A - Baseline|Withdrawal by Subject|0|||
147668709|NCT00784875|532613362|FG001|Period A - Baseline|Withdrawal by Subject|0|||
147502156|NCT00006604|531990406|FG006|Overall Study|Randomization entry error-no RX, no FU|0|||
147632780|NCT02564900|532474483|FG014|Dose Expansion|Ongoing|6|||
147632781|NCT02564900|532474469|FG000|Dose Expansion|Death|0|||
147632782|NCT02564900|532474470|FG001|Dose Expansion|Death|0|||
147632783|NCT02564900|532474471|FG002|Dose Expansion|Death|0|||
147632784|NCT02564900|532474472|FG003|Dose Expansion|Death|0|||
147632785|NCT02564900|532474473|FG004|Dose Expansion|Death|0|||
147632786|NCT02564900|532474474|FG005|Dose Expansion|Death|0|||
147632787|NCT02564900|532474475|FG006|Dose Expansion|Death|1|||
147632788|NCT02564900|532474476|FG007|Dose Expansion|Death|0|||
147632789|NCT02564900|532474477|FG008|Dose Expansion|Death|0|||
147632790|NCT02564900|532474478|FG009|Dose Expansion|Death|0|||
147632791|NCT02564900|532474479|FG010|Dose Expansion|Death|1|||
147632792|NCT02564900|532474480|FG011|Dose Expansion|Death|0|||
147632793|NCT02564900|532474481|FG012|Dose Expansion|Death|1|||
147632794|NCT02564900|532474482|FG013|Dose Expansion|Death|1|||
147632795|NCT02564900|532474483|FG014|Dose Expansion|Death|0|||
147632796|NCT02564900|532474469|FG000|Dose Expansion|Withdrawal by Subject|0|||
147632797|NCT02564900|532474470|FG001|Dose Expansion|Withdrawal by Subject|0|||
147632798|NCT02564900|532474471|FG002|Dose Expansion|Withdrawal by Subject|0|||
147632799|NCT02564900|532474472|FG003|Dose Expansion|Withdrawal by Subject|0|||
147632800|NCT02564900|532474473|FG004|Dose Expansion|Withdrawal by Subject|0|||
147632801|NCT02564900|532474474|FG005|Dose Expansion|Withdrawal by Subject|0|||
147632802|NCT02564900|532474475|FG006|Dose Expansion|Withdrawal by Subject|4|||
147632803|NCT02564900|532474476|FG007|Dose Expansion|Withdrawal by Subject|0|||
147632804|NCT02564900|532474477|FG008|Dose Expansion|Withdrawal by Subject|0|||
147632805|NCT02564900|532474478|FG009|Dose Expansion|Withdrawal by Subject|0|||
147632806|NCT02564900|532474479|FG010|Dose Expansion|Withdrawal by Subject|1|||
147632807|NCT02564900|532474480|FG011|Dose Expansion|Withdrawal by Subject|0|||
147632808|NCT02564900|532474481|FG012|Dose Expansion|Withdrawal by Subject|0|||
147632809|NCT02564900|532474482|FG013|Dose Expansion|Withdrawal by Subject|1|||
147632810|NCT02564900|532474483|FG014|Dose Expansion|Withdrawal by Subject|1|||
147632811|NCT02564900|532474469|FG000|Dose Expansion|Other|0|||
147632812|NCT02564900|532474470|FG001|Dose Expansion|Other|0|||
147632813|NCT02564900|532474471|FG002|Dose Expansion|Other|0|||
147632814|NCT02564900|532474472|FG003|Dose Expansion|Other|0|||
147668710|NCT00784875|532613363|FG002|Period A - Baseline|Withdrawal by Subject|0|||
147668711|NCT00784875|532613364|FG003|Period A - Baseline|Withdrawal by Subject|27|||
147668712|NCT00784875|532613361|FG000|Period A - Baseline|Physician Decision|0|||
147668713|NCT00784875|532613362|FG001|Period A - Baseline|Physician Decision|0|||
147632815|NCT02564900|532474473|FG004|Dose Expansion|Other|0|||
147668714|NCT00784875|532613363|FG002|Period A - Baseline|Physician Decision|0|||
147632816|NCT02564900|532474474|FG005|Dose Expansion|Other|0|||
147632817|NCT02564900|532474475|FG006|Dose Expansion|Other|1|||
147632818|NCT02564900|532474476|FG007|Dose Expansion|Other|0|||
147632819|NCT02564900|532474477|FG008|Dose Expansion|Other|1|||
147632820|NCT02564900|532474478|FG009|Dose Expansion|Other|0|||
147632821|NCT02564900|532474479|FG010|Dose Expansion|Other|0|||
147632822|NCT02564900|532474480|FG011|Dose Expansion|Other|0|||
147668715|NCT00784875|532613364|FG003|Period A - Baseline|Physician Decision|2|||
147632823|NCT02564900|532474481|FG012|Dose Expansion|Other|0|||
147632824|NCT02564900|532474482|FG013|Dose Expansion|Other|0|||
147632825|NCT02564900|532474483|FG014|Dose Expansion|Other|1|||
147632826|NCT02564900|532474469|FG000|Dose Expansion|Did not receive treatment|0|||
147668716|NCT00784875|532613361|FG000|Period A - Baseline|Sponsor Decision|0|||
147668717|NCT00784875|532613362|FG001|Period A - Baseline|Sponsor Decision|0|||
147668718|NCT00784875|532613363|FG002|Period A - Baseline|Sponsor Decision|0|||
147668719|NCT00784875|532613364|FG003|Period A - Baseline|Sponsor Decision|113|||
147502157|NCT00006604|531990407|FG007|Overall Study|Randomization entry error-no RX, no FU|0|||
147502158|NCT00006604|531990408|FG008|Overall Study|Randomization entry error-no RX, no FU|0|||
147502159|NCT00006604|531990409|FG009|Overall Study|Randomization entry error-no RX, no FU|0|||
147502160|NCT00006604|531990410|FG010|Overall Study|Randomization entry error-no RX, no FU|0|||
147502161|NCT00006604|531990411|FG011|Overall Study|Randomization entry error-no RX, no FU|1|||
147502162|NCT00006604|531990412|FG012|Overall Study|Randomization entry error-no RX, no FU|0|||
147502163|NCT00006604|531990413|FG013|Overall Study|Randomization entry error-no RX, no FU|0|||
147502164|NCT00006604|531990414|FG014|Overall Study|Randomization entry error-no RX, no FU|0|||
147502165|NCT00006604|531990415|FG015|Overall Study|Randomization entry error-no RX, no FU|0|||
147502166|NCT00006604|531990416|FG016|Overall Study|Randomization entry error-no RX, no FU|0|||
147502167|NCT00006604|531990400|FG000|Overall Study|Death|0|||
147502168|NCT00006604|531990401|FG001|Overall Study|Death|0|||
147502169|NCT00006604|531990402|FG002|Overall Study|Death|0|||
147502170|NCT00006604|531990403|FG003|Overall Study|Death|0|||
147502171|NCT00006604|531990404|FG004|Overall Study|Death|0|||
147502172|NCT00006604|531990405|FG005|Overall Study|Death|0|||
147502173|NCT00006604|531990406|FG006|Overall Study|Death|0|||
147502174|NCT00006604|531990407|FG007|Overall Study|Death|0|||
147502175|NCT00006604|531990408|FG008|Overall Study|Death|0|||
147502176|NCT00006604|531990409|FG009|Overall Study|Death|1|||
147502177|NCT00006604|531990410|FG010|Overall Study|Death|1|||
147502178|NCT00006604|531990411|FG011|Overall Study|Death|1|||
147502179|NCT00006604|531990412|FG012|Overall Study|Death|0|||
147502180|NCT00006604|531990413|FG013|Overall Study|Death|0|||
147502181|NCT00006604|531990414|FG014|Overall Study|Death|0|||
147502182|NCT00006604|531990415|FG015|Overall Study|Death|0|||
147502183|NCT00006604|531990416|FG016|Overall Study|Death|0|||
147502184|NCT00006604|531990400|FG000|Overall Study|Severe debilitation, unable to continue|0|||
147502185|NCT00006604|531990401|FG001|Overall Study|Severe debilitation, unable to continue|0|||
147502186|NCT00006604|531990402|FG002|Overall Study|Severe debilitation, unable to continue|0|||
147502187|NCT00006604|531990403|FG003|Overall Study|Severe debilitation, unable to continue|0|||
147502188|NCT00006604|531990404|FG004|Overall Study|Severe debilitation, unable to continue|0|||
147502189|NCT00006604|531990405|FG005|Overall Study|Severe debilitation, unable to continue|0|||
147502190|NCT00006604|531990406|FG006|Overall Study|Severe debilitation, unable to continue|3|||
147502191|NCT00006604|531990407|FG007|Overall Study|Severe debilitation, unable to continue|0|||
147502192|NCT00006604|531990408|FG008|Overall Study|Severe debilitation, unable to continue|0|||
147502193|NCT00006604|531990409|FG009|Overall Study|Severe debilitation, unable to continue|5|||
147502194|NCT00006604|531990410|FG010|Overall Study|Severe debilitation, unable to continue|0|||
147502195|NCT00006604|531990411|FG011|Overall Study|Severe debilitation, unable to continue|2|||
147502196|NCT00006604|531990412|FG012|Overall Study|Severe debilitation, unable to continue|1|||
147502197|NCT00006604|531990413|FG013|Overall Study|Severe debilitation, unable to continue|0|||
147502198|NCT00006604|531990414|FG014|Overall Study|Severe debilitation, unable to continue|2|||
147502199|NCT00006604|531990415|FG015|Overall Study|Severe debilitation, unable to continue|0|||
147502200|NCT00006604|531990416|FG016|Overall Study|Severe debilitation, unable to continue|0|||
147502201|NCT00006604|531990400|FG000|Overall Study|Subj/Parent not able to get to clinic|0|||
147502202|NCT00006604|531990401|FG001|Overall Study|Subj/Parent not able to get to clinic|0|||
147502203|NCT00006604|531990402|FG002|Overall Study|Subj/Parent not able to get to clinic|0|||
147502204|NCT00006604|531990403|FG003|Overall Study|Subj/Parent not able to get to clinic|1|||
147502205|NCT00006604|531990404|FG004|Overall Study|Subj/Parent not able to get to clinic|1|||
147502206|NCT00006604|531990405|FG005|Overall Study|Subj/Parent not able to get to clinic|0|||
147502207|NCT00006604|531990406|FG006|Overall Study|Subj/Parent not able to get to clinic|1|||
147502208|NCT00006604|531990407|FG007|Overall Study|Subj/Parent not able to get to clinic|0|||
147502209|NCT00006604|531990408|FG008|Overall Study|Subj/Parent not able to get to clinic|0|||
147502210|NCT00006604|531990409|FG009|Overall Study|Subj/Parent not able to get to clinic|1|||
147502211|NCT00006604|531990410|FG010|Overall Study|Subj/Parent not able to get to clinic|2|||
147502212|NCT00006604|531990411|FG011|Overall Study|Subj/Parent not able to get to clinic|1|||
147502213|NCT00006604|531990412|FG012|Overall Study|Subj/Parent not able to get to clinic|1|||
147502214|NCT00006604|531990413|FG013|Overall Study|Subj/Parent not able to get to clinic|1|||
147502215|NCT00006604|531990414|FG014|Overall Study|Subj/Parent not able to get to clinic|3|||
147502216|NCT00006604|531990415|FG015|Overall Study|Subj/Parent not able to get to clinic|0|||
147502217|NCT00006604|531990416|FG016|Overall Study|Subj/Parent not able to get to clinic|0|||
147502218|NCT00006604|531990400|FG000|Overall Study|Site closing|0|||
147502219|NCT00006604|531990401|FG001|Overall Study|Site closing|0|||
147502220|NCT00006604|531990402|FG002|Overall Study|Site closing|1|||
147502221|NCT00006604|531990403|FG003|Overall Study|Site closing|1|||
147502222|NCT00006604|531990404|FG004|Overall Study|Site closing|0|||
147502223|NCT00006604|531990405|FG005|Overall Study|Site closing|0|||
147668720|NCT00784875|532613361|FG000|Period A - Baseline|Lost to Follow-up|0|||
147632827|NCT02564900|532474470|FG001|Dose Expansion|Did not receive treatment|0|||
147632828|NCT02564900|532474471|FG002|Dose Expansion|Did not receive treatment|0|||
147632829|NCT02564900|532474472|FG003|Dose Expansion|Did not receive treatment|0|||
147632830|NCT02564900|532474473|FG004|Dose Expansion|Did not receive treatment|0|||
147632831|NCT02564900|532474474|FG005|Dose Expansion|Did not receive treatment|0|||
147632832|NCT02564900|532474475|FG006|Dose Expansion|Did not receive treatment|1|||
147632833|NCT02564900|532474476|FG007|Dose Expansion|Did not receive treatment|1|||
147632834|NCT02564900|532474477|FG008|Dose Expansion|Did not receive treatment|0|||
147632835|NCT02564900|532474478|FG009|Dose Expansion|Did not receive treatment|0|||
147632836|NCT02564900|532474479|FG010|Dose Expansion|Did not receive treatment|0|||
147632837|NCT02564900|532474480|FG011|Dose Expansion|Did not receive treatment|0|||
147632838|NCT02564900|532474481|FG012|Dose Expansion|Did not receive treatment|0|||
147632839|NCT02564900|532474482|FG013|Dose Expansion|Did not receive treatment|0|||
147632840|NCT02564900|532474483|FG014|Dose Expansion|Did not receive treatment|1|||
147632841|NCT01089608|532474484|FG000|Overall Study|Adverse Event|0|||
147632842|NCT01089608|532474485|FG001|Overall Study|Adverse Event|4|||
147502224|NCT00006604|531990406|FG006|Overall Study|Site closing|0|||
147502225|NCT00006604|531990407|FG007|Overall Study|Site closing|1|||
147502226|NCT00006604|531990408|FG008|Overall Study|Site closing|0|||
147502227|NCT00006604|531990409|FG009|Overall Study|Site closing|0|||
147502228|NCT00006604|531990410|FG010|Overall Study|Site closing|0|||
147502229|NCT00006604|531990411|FG011|Overall Study|Site closing|1|||
147502230|NCT00006604|531990412|FG012|Overall Study|Site closing|1|||
147502231|NCT00006604|531990413|FG013|Overall Study|Site closing|1|||
147502232|NCT00006604|531990414|FG014|Overall Study|Site closing|0|||
147502233|NCT00006604|531990415|FG015|Overall Study|Site closing|0|||
147502234|NCT00006604|531990416|FG016|Overall Study|Site closing|1|||
147502235|NCT00006604|531990400|FG000|Overall Study|Withdrawal by Subject|1|||
147502236|NCT00006604|531990401|FG001|Overall Study|Withdrawal by Subject|0|||
147502237|NCT00006604|531990402|FG002|Overall Study|Withdrawal by Subject|2|||
147502238|NCT00006604|531990403|FG003|Overall Study|Withdrawal by Subject|0|||
147502239|NCT00006604|531990404|FG004|Overall Study|Withdrawal by Subject|1|||
147502240|NCT00006604|531990405|FG005|Overall Study|Withdrawal by Subject|2|||
147502241|NCT00006604|531990406|FG006|Overall Study|Withdrawal by Subject|2|||
147502242|NCT00006604|531990407|FG007|Overall Study|Withdrawal by Subject|0|||
147502243|NCT00006604|531990408|FG008|Overall Study|Withdrawal by Subject|1|||
147502244|NCT00006604|531990409|FG009|Overall Study|Withdrawal by Subject|3|||
147502245|NCT00006604|531990410|FG010|Overall Study|Withdrawal by Subject|2|||
147502246|NCT00006604|531990411|FG011|Overall Study|Withdrawal by Subject|0|||
147502247|NCT00006604|531990412|FG012|Overall Study|Withdrawal by Subject|1|||
147502248|NCT00006604|531990413|FG013|Overall Study|Withdrawal by Subject|2|||
147502249|NCT00006604|531990414|FG014|Overall Study|Withdrawal by Subject|1|||
147502250|NCT00006604|531990415|FG015|Overall Study|Withdrawal by Subject|0|||
147502251|NCT00006604|531990416|FG016|Overall Study|Withdrawal by Subject|1|||
147502252|NCT00006604|531990400|FG000|Overall Study|Subj/parent not willing to adhere to req|0|||
147502253|NCT00006604|531990401|FG001|Overall Study|Subj/parent not willing to adhere to req|0|||
147502254|NCT00006604|531990402|FG002|Overall Study|Subj/parent not willing to adhere to req|1|||
147502255|NCT00006604|531990403|FG003|Overall Study|Subj/parent not willing to adhere to req|3|||
147502256|NCT00006604|531990404|FG004|Overall Study|Subj/parent not willing to adhere to req|0|||
147502257|NCT00006604|531990405|FG005|Overall Study|Subj/parent not willing to adhere to req|0|||
147502258|NCT00006604|531990406|FG006|Overall Study|Subj/parent not willing to adhere to req|3|||
147502259|NCT00006604|531990407|FG007|Overall Study|Subj/parent not willing to adhere to req|1|||
147502260|NCT00006604|531990408|FG008|Overall Study|Subj/parent not willing to adhere to req|0|||
147502261|NCT00006604|531990409|FG009|Overall Study|Subj/parent not willing to adhere to req|6|||
147502262|NCT00006604|531990410|FG010|Overall Study|Subj/parent not willing to adhere to req|3|||
147502263|NCT00006604|531990411|FG011|Overall Study|Subj/parent not willing to adhere to req|0|||
147502264|NCT00006604|531990412|FG012|Overall Study|Subj/parent not willing to adhere to req|0|||
147502265|NCT00006604|531990413|FG013|Overall Study|Subj/parent not willing to adhere to req|2|||
147502266|NCT00006604|531990414|FG014|Overall Study|Subj/parent not willing to adhere to req|3|||
147502267|NCT00006604|531990415|FG015|Overall Study|Subj/parent not willing to adhere to req|3|||
147632843|NCT01089608|532474484|FG000|Overall Study|Lost to Follow-up|0|||
147502268|NCT00006604|531990416|FG016|Overall Study|Subj/parent not willing to adhere to req|4|||
147632844|NCT01089608|532474485|FG001|Overall Study|Lost to Follow-up|2|||
147632845|NCT05338502|532474486|FG000|Period 2 - Day 8 to Day 19|Withdrawal by Subject|0|||
147632846|NCT05338502|532474487|FG001|Period 2 - Day 8 to Day 19|Withdrawal by Subject|2|||
147632847|NCT05338502|532474488|FG002|Period 2 - Day 8 to Day 19|Withdrawal by Subject|0|||
147502269|NCT00006604|531990400|FG000|Overall Study|Lost to Follow-up|0|||
147502270|NCT00006604|531990401|FG001|Overall Study|Lost to Follow-up|0|||
147502271|NCT00006604|531990402|FG002|Overall Study|Lost to Follow-up|0|||
147502272|NCT00006604|531990403|FG003|Overall Study|Lost to Follow-up|0|||
147502273|NCT00006604|531990404|FG004|Overall Study|Lost to Follow-up|0|||
147502274|NCT00006604|531990405|FG005|Overall Study|Lost to Follow-up|0|||
147502275|NCT00006604|531990406|FG006|Overall Study|Lost to Follow-up|0|||
147502276|NCT00006604|531990407|FG007|Overall Study|Lost to Follow-up|1|||
147502277|NCT00006604|531990408|FG008|Overall Study|Lost to Follow-up|0|||
147502278|NCT00006604|531990409|FG009|Overall Study|Lost to Follow-up|2|||
147502279|NCT00006604|531990410|FG010|Overall Study|Lost to Follow-up|0|||
147502280|NCT00006604|531990411|FG011|Overall Study|Lost to Follow-up|0|||
147502281|NCT00006604|531990412|FG012|Overall Study|Lost to Follow-up|0|||
147502282|NCT00006604|531990413|FG013|Overall Study|Lost to Follow-up|0|||
147502283|NCT00006604|531990414|FG014|Overall Study|Lost to Follow-up|0|||
147502284|NCT00006604|531990415|FG015|Overall Study|Lost to Follow-up|1|||
147502285|NCT00006604|531990416|FG016|Overall Study|Lost to Follow-up|3|||
147502286|NCT00006604|531990400|FG000|Overall Study|Other Reason|0|||
147502287|NCT00006604|531990401|FG001|Overall Study|Other Reason|0|||
147502288|NCT00006604|531990402|FG002|Overall Study|Other Reason|0|||
147502289|NCT00006604|531990403|FG003|Overall Study|Other Reason|0|||
147502290|NCT00006604|531990404|FG004|Overall Study|Other Reason|0|||
147502291|NCT00006604|531990405|FG005|Overall Study|Other Reason|1|||
147502292|NCT00006604|531990406|FG006|Overall Study|Other Reason|0|||
147502293|NCT00006604|531990407|FG007|Overall Study|Other Reason|0|||
147502294|NCT00006604|531990408|FG008|Overall Study|Other Reason|0|||
147502295|NCT00006604|531990409|FG009|Overall Study|Other Reason|1|||
147502296|NCT00006604|531990410|FG010|Overall Study|Other Reason|0|||
147502297|NCT00006604|531990411|FG011|Overall Study|Other Reason|0|||
147502298|NCT00006604|531990412|FG012|Overall Study|Other Reason|0|||
147502299|NCT00006604|531990413|FG013|Overall Study|Other Reason|0|||
147502300|NCT00006604|531990414|FG014|Overall Study|Other Reason|0|||
147502301|NCT00006604|531990415|FG015|Overall Study|Other Reason|0|||
147502302|NCT00006604|531990416|FG016|Overall Study|Other Reason|0|||
147502303|NCT01056341|531990417|FG000|Overall Study|Treatment Intolerance|0|||
147502304|NCT01056341|531990418|FG001|Overall Study|Treatment Intolerance|2|||
147502305|NCT01056341|531990419|FG002|Overall Study|Treatment Intolerance|0|||
147502306|NCT01056341|531990420|FG003|Overall Study|Treatment Intolerance|2|||
147502307|NCT01056341|531990421|FG004|Overall Study|Treatment Intolerance|0|||
147502308|NCT01056341|531990417|FG000|Overall Study|Lack of Efficacy|32|||
147502309|NCT01056341|531990418|FG001|Overall Study|Lack of Efficacy|30|||
147502310|NCT01056341|531990419|FG002|Overall Study|Lack of Efficacy|7|||
147502311|NCT01056341|531990420|FG003|Overall Study|Lack of Efficacy|25|||
147502312|NCT01056341|531990421|FG004|Overall Study|Lack of Efficacy|9|||
147502313|NCT01056341|531990417|FG000|Overall Study|Other reasons|4|||
147502314|NCT01056341|531990418|FG001|Overall Study|Other reasons|4|||
147502315|NCT01056341|531990419|FG002|Overall Study|Other reasons|8|||
147502316|NCT01056341|531990420|FG003|Overall Study|Other reasons|9|||
147502317|NCT01056341|531990421|FG004|Overall Study|Other reasons|5|||
147502318|NCT01086150|531990422|FG000|Overall Study|Withdrawal by Subject|0|||
147502319|NCT01086150|531990423|FG001|Overall Study|Withdrawal by Subject|4|||
147502320|NCT01086150|531990424|FG002|Overall Study|Withdrawal by Subject|1|||
147502321|NCT01086150|531990422|FG000|Overall Study|Lost to Follow-up|0|||
147502322|NCT01086150|531990423|FG001|Overall Study|Lost to Follow-up|1|||
147502323|NCT01086150|531990424|FG002|Overall Study|Lost to Follow-up|0|||
147502324|NCT01086150|531990422|FG000|Overall Study|Screen Failure|0|||
147502325|NCT01086150|531990423|FG001|Overall Study|Screen Failure|1|||
147502326|NCT01086150|531990424|FG002|Overall Study|Screen Failure|0|||
147502327|NCT03543358|531990428|FG000|Overall Study|Death|1|||
147502328|NCT03543358|531990429|FG001|Overall Study|Death|0|||
147502329|NCT03543358|531990428|FG000|Overall Study|Disease Progression|1|||
147502330|NCT03543358|531990429|FG001|Overall Study|Disease Progression|0|||
147502331|NCT03543358|531990428|FG000|Overall Study|Parent Study Closure|1|||
147502332|NCT03543358|531990429|FG001|Overall Study|Parent Study Closure|0|||
147502333|NCT02260648|531990430|FG000|Overall Study|Adverse Event|3|||
147502334|NCT02260648|531990431|FG001|Overall Study|Adverse Event|0|||
147502335|NCT02260648|531990432|FG002|Overall Study|Adverse Event|1|||
147502336|NCT02260648|531990430|FG000|Overall Study|Withdrawal by Subject|1|||
147502337|NCT02260648|531990431|FG001|Overall Study|Withdrawal by Subject|1|||
147502338|NCT02260648|531990432|FG002|Overall Study|Withdrawal by Subject|0|||
147502339|NCT02260648|531990430|FG000|Overall Study|Protocol Violation|1|||
147502340|NCT02260648|531990431|FG001|Overall Study|Protocol Violation|0|||
147502341|NCT02260648|531990432|FG002|Overall Study|Protocol Violation|0|||
147502342|NCT02260648|531990430|FG000|Overall Study|Discontinue Due to Study Termination|13|||
147502343|NCT02260648|531990431|FG001|Overall Study|Discontinue Due to Study Termination|12|||
147502344|NCT02260648|531990432|FG002|Overall Study|Discontinue Due to Study Termination|7|||
147502345|NCT00643604|531990436|FG000|Overall Study|Death|1|||
147502346|NCT01054976|531990441|FG000|Overall Study|Adverse Event|16|||
147502347|NCT01054976|531990441|FG000|Overall Study|Uncooperative participations to study|7|||
147502348|NCT01054976|531990441|FG000|Overall Study|Withdrawal by Subject|4|||
147502349|NCT01054976|531990441|FG000|Overall Study|Other|8|||
147502350|NCT01164865|531990442|FG000|Overall Study|Lost to Follow-up|2|||
147502351|NCT01164865|531990443|FG001|Overall Study|Lost to Follow-up|1|||
147502352|NCT00171314|531990444|FG000|Overall Study|Adverse Event|44|||
147502353|NCT00171314|531990445|FG001|Overall Study|Adverse Event|41|||
147502354|NCT00171314|531990444|FG000|Overall Study|Lack of Efficacy|19|||
147502355|NCT00171314|531990445|FG001|Overall Study|Lack of Efficacy|14|||
147632848|NCT05338502|532474486|FG000|Period 2 - Day 8 to Day 19|Adverse Event|0|||
147632849|NCT05338502|532474487|FG001|Period 2 - Day 8 to Day 19|Adverse Event|1|||
147632850|NCT05338502|532474488|FG002|Period 2 - Day 8 to Day 19|Adverse Event|0|||
147632851|NCT03575793|532474489|FG000|Overall Study|Withdrawal by Subject|0|||
147632852|NCT03575793|532474490|FG001|Overall Study|Withdrawal by Subject|1|||
147632853|NCT03575793|532474489|FG000|Overall Study|Never Treated|0|||
147632854|NCT03575793|532474490|FG001|Overall Study|Never Treated|2|||
147632855|NCT01127451|532474491|FG000|Overall Study|Other|2|||
147632856|NCT01127451|532474492|FG001|Overall Study|Other|1|||
147632857|NCT01127451|532474491|FG000|Overall Study|Completed 1 Year Follow-up after last dose of study drug|14|||
147632858|NCT01127451|532474492|FG001|Overall Study|Completed 1 Year Follow-up after last dose of study drug|12|||
147632859|NCT01127451|532474491|FG000|Overall Study|Death|22|||
147632860|NCT01127451|532474492|FG001|Overall Study|Death|17|||
147632861|NCT01127451|532474491|FG000|Overall Study|Lost to Follow-up|3|||
147632862|NCT01127451|532474492|FG001|Overall Study|Lost to Follow-up|0|||
147632863|NCT01127451|532474491|FG000|Overall Study|Administrative Reason by Sponsor|2|||
147632864|NCT01127451|532474492|FG001|Overall Study|Administrative Reason by Sponsor|2|||
147632865|NCT02111577|532474493|FG000|Overall Study|Protocol Violation|2|||
147632866|NCT02111577|532474494|FG001|Overall Study|Protocol Violation|0|||
147632867|NCT02111577|532474493|FG000|Overall Study|Unable to tolerate leukapheresis|1|||
147632868|NCT02111577|532474494|FG001|Overall Study|Unable to tolerate leukapheresis|0|||
147632869|NCT02111577|532474493|FG000|Overall Study|Failure to produce study treatment|6|||
147632870|NCT02111577|532474494|FG001|Overall Study|Failure to produce study treatment|0|||
147632871|NCT02111577|532474493|FG000|Overall Study|Death|518|||
147632872|NCT02111577|532474494|FG001|Overall Study|Death|254|||
147632873|NCT02111577|532474493|FG000|Overall Study|Medical monitor's decision (active hepatitis B)|1|||
147632874|NCT02111577|532474494|FG001|Overall Study|Medical monitor's decision (active hepatitis B)|0|||
147632875|NCT02111577|532474493|FG000|Overall Study|Adverse Event|1|||
147632876|NCT02111577|532474494|FG001|Overall Study|Adverse Event|1|||
147632877|NCT02111577|532474493|FG000|Overall Study|Withdrawal by Subject|51|||
147632878|NCT02111577|532474494|FG001|Overall Study|Withdrawal by Subject|23|||
147632879|NCT02111577|532474493|FG000|Overall Study|Disease progression|0|||
147632880|NCT02111577|532474494|FG001|Overall Study|Disease progression|1|||
147632881|NCT02111577|532474493|FG000|Overall Study|Lost to Follow-up|19|||
147632882|NCT02111577|532474494|FG001|Overall Study|Lost to Follow-up|10|||
147632883|NCT01014988|532474495|FG000|Overall Study|Adverse Event|20|||
147632884|NCT01014988|532474496|FG001|Overall Study|Adverse Event|0|||
147632885|NCT01014988|532474497|FG002|Overall Study|Adverse Event|1|||
147632886|NCT01014988|532474498|FG003|Overall Study|Adverse Event|0|||
147632887|NCT01014988|532474499|FG004|Overall Study|Adverse Event|1|||
147632888|NCT01014988|532474500|FG005|Overall Study|Adverse Event|3|||
147632889|NCT01014988|532474495|FG000|Overall Study|Lost to Follow-up|1|||
147632890|NCT01014988|532474496|FG001|Overall Study|Lost to Follow-up|0|||
147632891|NCT01014988|532474497|FG002|Overall Study|Lost to Follow-up|1|||
147632892|NCT01014988|532474498|FG003|Overall Study|Lost to Follow-up|0|||
147632893|NCT01014988|532474499|FG004|Overall Study|Lost to Follow-up|0|||
147632894|NCT01014988|532474500|FG005|Overall Study|Lost to Follow-up|0|||
147632895|NCT01014988|532474495|FG000|Overall Study|Physician Decision|1|||
147632896|NCT01014988|532474496|FG001|Overall Study|Physician Decision|0|||
147632897|NCT01014988|532474497|FG002|Overall Study|Physician Decision|0|||
147632898|NCT01014988|532474498|FG003|Overall Study|Physician Decision|0|||
147632899|NCT01014988|532474499|FG004|Overall Study|Physician Decision|0|||
147632900|NCT01014988|532474500|FG005|Overall Study|Physician Decision|0|||
147632901|NCT01014988|532474495|FG000|Overall Study|Withdrawal by Subject|1|||
147632902|NCT01014988|532474496|FG001|Overall Study|Withdrawal by Subject|0|||
147632903|NCT01014988|532474497|FG002|Overall Study|Withdrawal by Subject|0|||
147632904|NCT01014988|532474498|FG003|Overall Study|Withdrawal by Subject|0|||
147632905|NCT01014988|532474499|FG004|Overall Study|Withdrawal by Subject|0|||
147632906|NCT01014988|532474500|FG005|Overall Study|Withdrawal by Subject|0|||
147632907|NCT00729157|532474501|FG000|Overall Study|Withdrawal by Subject|1|||
147632908|NCT00886743|532474502|FG000|Overall Study|Adverse Event|3|||
147632909|NCT00886743|532474502|FG000|Overall Study|Other|1|||
147632910|NCT03521115|532474505|FG000|Time 1 Survey (6 Months Post Baseline)|Lost to Follow-up|56|||
147632911|NCT03521115|532474506|FG001|Time 1 Survey (6 Months Post Baseline)|Lost to Follow-up|40|||
147632912|NCT03521115|532474505|FG000|Time 2 Survey (12 Months Post Baseline)|Lost to Follow-up|3|||
147632913|NCT03521115|532474506|FG001|Time 2 Survey (12 Months Post Baseline)|Lost to Follow-up|1|||
147632914|NCT03655470|532474514|FG000|Overall Study|Lost to Follow-up|6|||
147632915|NCT03655470|532474515|FG001|Overall Study|Lost to Follow-up|7|||
147632916|NCT03063086|532474516|FG000|Overall Study|technical problems|1|||
147632917|NCT03063086|532474517|FG001|Overall Study|technical problems|0|||
147632918|NCT03063086|532474518|FG002|Overall Study|technical problems|0|||
147632919|NCT03063086|532474519|FG003|Overall Study|technical problems|0|||
147632920|NCT03063086|532474520|FG004|Overall Study|technical problems|0|||
147632921|NCT03063086|532474521|FG005|Overall Study|technical problems|0|||
147632922|NCT03063086|532474516|FG000|Overall Study|Adverse Event|1|||
147632923|NCT03063086|532474517|FG001|Overall Study|Adverse Event|1|||
147632924|NCT03063086|532474518|FG002|Overall Study|Adverse Event|1|||
147502356|NCT00171314|531990444|FG000|Overall Study|Withdrawal by Subject|9|||
147502357|NCT00171314|531990445|FG001|Overall Study|Withdrawal by Subject|6|||
147502358|NCT00171314|531990444|FG000|Overall Study|Abnormal Test Procedure Results|9|||
147502359|NCT00171314|531990445|FG001|Overall Study|Abnormal Test Procedure Results|3|||
147502360|NCT00171314|531990444|FG000|Overall Study|Protocol Violation|3|||
147502361|NCT00171314|531990445|FG001|Overall Study|Protocol Violation|7|||
147502362|NCT00171314|531990444|FG000|Overall Study|Administrative Problems|4|||
147502363|NCT00171314|531990445|FG001|Overall Study|Administrative Problems|3|||
147502364|NCT00171314|531990444|FG000|Overall Study|Lost to Follow-up|1|||
147502365|NCT00171314|531990445|FG001|Overall Study|Lost to Follow-up|3|||
147502366|NCT00171314|531990444|FG000|Overall Study|Death|2|||
147502367|NCT00171314|531990445|FG001|Overall Study|Death|1|||
147502368|NCT00377429|531990446|FG000|Overall Study|Withdrawal by Subject|5|||
147502369|NCT00377429|531990446|FG000|Overall Study|Adverse Event|8|||
147502370|NCT00377429|531990446|FG000|Overall Study|Physician Decision|1|||
147502371|NCT00377429|531990446|FG000|Overall Study|Patient non-compliance|1|||
147502372|NCT02394795|531990449|FG000|Overall Study|Adverse Event|92|||
147502373|NCT02394795|531990450|FG001|Overall Study|Adverse Event|70|||
147502374|NCT02394795|531990449|FG000|Overall Study|Lost to Follow-up|0|||
147502375|NCT02394795|531990450|FG001|Overall Study|Lost to Follow-up|1|||
147502376|NCT02394795|531990449|FG000|Overall Study|Withdrawal by Subject|17|||
147502377|NCT02394795|531990450|FG001|Overall Study|Withdrawal by Subject|26|||
147502378|NCT02394795|531990449|FG000|Overall Study|Lack of Efficacy|181|||
147502379|NCT02394795|531990450|FG001|Overall Study|Lack of Efficacy|211|||
147502380|NCT02394795|531990449|FG000|Overall Study|Death|4|||
147502381|NCT02394795|531990450|FG001|Overall Study|Death|5|||
147502382|NCT02394795|531990449|FG000|Overall Study|Physician Decision|109|||
147502383|NCT02394795|531990450|FG001|Overall Study|Physician Decision|93|||
147502384|NCT02939599|531990452|FG000|Overall Study|Adverse Event|1|||
147502385|NCT02939599|531990453|FG001|Overall Study|Adverse Event|0|||
147502386|NCT02939599|531990452|FG000|Overall Study|Study Terminated By Sponsor|2|||
147502387|NCT02939599|531990453|FG001|Overall Study|Study Terminated By Sponsor|2|||
147502388|NCT01669811|531990454|FG000|Overall Study|Investigator decision|0|||
147502389|NCT01669811|531990455|FG001|Overall Study|Investigator decision|1|||
147502390|NCT01669811|531990454|FG000|Overall Study|Withdrawal by Subject|1|||
147502391|NCT01669811|531990455|FG001|Overall Study|Withdrawal by Subject|2|||
147502392|NCT01669811|531990454|FG000|Overall Study|Adverse Event|2|||
147502393|NCT01669811|531990455|FG001|Overall Study|Adverse Event|6|||
147502394|NCT01669811|531990454|FG000|Overall Study|Eligibility Criteria Not Fulfilled|0|||
147502395|NCT01669811|531990455|FG001|Overall Study|Eligibility Criteria Not Fulfilled|2|||
147502396|NCT02559206|531990459|FG000|Overall Study|Adverse Event|0|||
147502397|NCT02559206|531990460|FG001|Overall Study|Adverse Event|4|||
147502398|NCT02559206|531990461|FG002|Overall Study|Adverse Event|1|||
147502399|NCT02559206|531990462|FG003|Overall Study|Adverse Event|5|||
147502400|NCT02559206|531990463|FG004|Overall Study|Adverse Event|3|||
147502401|NCT02559206|531990464|FG005|Overall Study|Adverse Event|0|||
147502402|NCT02559206|531990465|FG006|Overall Study|Adverse Event|1|||
147502403|NCT02559206|531990466|FG007|Overall Study|Adverse Event|0|||
147502404|NCT02559206|531990459|FG000|Overall Study|Protocol Violation|1|||
147502405|NCT02559206|531990460|FG001|Overall Study|Protocol Violation|0|||
147502406|NCT02559206|531990461|FG002|Overall Study|Protocol Violation|1|||
147502407|NCT02559206|531990462|FG003|Overall Study|Protocol Violation|0|||
147502408|NCT02559206|531990463|FG004|Overall Study|Protocol Violation|0|||
147502409|NCT02559206|531990464|FG005|Overall Study|Protocol Violation|2|||
147502410|NCT02559206|531990465|FG006|Overall Study|Protocol Violation|0|||
147502411|NCT02559206|531990466|FG007|Overall Study|Protocol Violation|0|||
147502412|NCT02559206|531990459|FG000|Overall Study|Withdrawal by Subject|3|||
147502413|NCT02559206|531990460|FG001|Overall Study|Withdrawal by Subject|3|||
147502414|NCT02559206|531990461|FG002|Overall Study|Withdrawal by Subject|1|||
147502415|NCT02559206|531990462|FG003|Overall Study|Withdrawal by Subject|3|||
147502416|NCT02559206|531990463|FG004|Overall Study|Withdrawal by Subject|5|||
147502417|NCT02559206|531990464|FG005|Overall Study|Withdrawal by Subject|4|||
147502418|NCT02559206|531990465|FG006|Overall Study|Withdrawal by Subject|1|||
147502419|NCT02559206|531990466|FG007|Overall Study|Withdrawal by Subject|2|||
147502420|NCT02559206|531990459|FG000|Overall Study|Lost to Follow-up|3|||
147502421|NCT02559206|531990460|FG001|Overall Study|Lost to Follow-up|5|||
147502422|NCT02559206|531990461|FG002|Overall Study|Lost to Follow-up|3|||
147502423|NCT02559206|531990462|FG003|Overall Study|Lost to Follow-up|3|||
147502424|NCT02559206|531990463|FG004|Overall Study|Lost to Follow-up|2|||
147502425|NCT02559206|531990464|FG005|Overall Study|Lost to Follow-up|5|||
147502426|NCT02559206|531990465|FG006|Overall Study|Lost to Follow-up|1|||
147502427|NCT02559206|531990466|FG007|Overall Study|Lost to Follow-up|4|||
147502428|NCT02559206|531990459|FG000|Overall Study|Lack of Efficacy|1|||
147502429|NCT02559206|531990460|FG001|Overall Study|Lack of Efficacy|0|||
147502430|NCT02559206|531990461|FG002|Overall Study|Lack of Efficacy|3|||
147502431|NCT02559206|531990462|FG003|Overall Study|Lack of Efficacy|2|||
147502432|NCT02559206|531990463|FG004|Overall Study|Lack of Efficacy|2|||
147502433|NCT02559206|531990464|FG005|Overall Study|Lack of Efficacy|3|||
147502434|NCT02559206|531990465|FG006|Overall Study|Lack of Efficacy|3|||
147502435|NCT02559206|531990466|FG007|Overall Study|Lack of Efficacy|3|||
147502436|NCT02559206|531990459|FG000|Overall Study|Other Not Specified|0|||
147502437|NCT02559206|531990460|FG001|Overall Study|Other Not Specified|0|||
147502438|NCT02559206|531990461|FG002|Overall Study|Other Not Specified|0|||
147502439|NCT02559206|531990462|FG003|Overall Study|Other Not Specified|1|||
147502440|NCT02559206|531990463|FG004|Overall Study|Other Not Specified|0|||
147502441|NCT02559206|531990464|FG005|Overall Study|Other Not Specified|0|||
147502442|NCT02559206|531990465|FG006|Overall Study|Other Not Specified|0|||
147502443|NCT02559206|531990466|FG007|Overall Study|Other Not Specified|0|||
147502444|NCT01002742|531992350|FG000|Overall Study|Determined to be ineligible|0|||
147502445|NCT01002742|531992351|FG001|Overall Study|Determined to be ineligible|1|||
147502446|NCT02670928|531992352|FG000|Overall Study|Adverse Event|3|||
147502447|NCT02670928|531992353|FG001|Overall Study|Adverse Event|1|||
147502448|NCT02670928|531992352|FG000|Overall Study|Withdrawal by Subject|4|||
147502449|NCT02670928|531992353|FG001|Overall Study|Withdrawal by Subject|0|||
147502450|NCT02670928|531992352|FG000|Overall Study|Lost to Follow-up|1|||
147502451|NCT02670928|531992353|FG001|Overall Study|Lost to Follow-up|0|||
147502452|NCT02670928|531992352|FG000|Overall Study|Miss 3 classes in a row in first 12 wks|2|||
147502453|NCT02670928|531992353|FG001|Overall Study|Miss 3 classes in a row in first 12 wks|0|||
147502454|NCT02678312|531992354|FG000|Part 1 Open Label Epoch- Period 1|Adverse Event|1|||
147502455|NCT02678312|531992355|FG001|Part 1 Open Label Epoch- Period 1|Adverse Event|0|||
147502456|NCT02678312|531992356|FG002|Part 1 Open Label Epoch- Period 1|Adverse Event|0|||
147502457|NCT02678312|531992357|FG003|Part 1 Open Label Epoch- Period 1|Adverse Event|0|||
147502458|NCT02678312|531992358|FG004|Part 1 Open Label Epoch- Period 1|Adverse Event|0|||
147502459|NCT02678312|531992354|FG000|Part 1 Open Label Epoch- Period 1|Lost to Follow-up|1|||
147502460|NCT02678312|531992355|FG001|Part 1 Open Label Epoch- Period 1|Lost to Follow-up|0|||
147502461|NCT02678312|531992356|FG002|Part 1 Open Label Epoch- Period 1|Lost to Follow-up|0|||
147502462|NCT02678312|531992357|FG003|Part 1 Open Label Epoch- Period 1|Lost to Follow-up|0|||
147502463|NCT02678312|531992358|FG004|Part 1 Open Label Epoch- Period 1|Lost to Follow-up|0|||
147502464|NCT02678312|531992354|FG000|Part 1 Open Label Epoch- Period 1|Physician Decision|1|||
147502465|NCT02678312|531992355|FG001|Part 1 Open Label Epoch- Period 1|Physician Decision|0|||
147502466|NCT02678312|531992356|FG002|Part 1 Open Label Epoch- Period 1|Physician Decision|0|||
147502467|NCT02678312|531992357|FG003|Part 1 Open Label Epoch- Period 1|Physician Decision|0|||
147502468|NCT02678312|531992358|FG004|Part 1 Open Label Epoch- Period 1|Physician Decision|0|||
147502469|NCT02678312|531992354|FG000|Part 2 Double Blind Epoch|Adverse Event|0|||
147502470|NCT02678312|531992355|FG001|Part 2 Double Blind Epoch|Adverse Event|0|||
147502471|NCT02678312|531992356|FG002|Part 2 Double Blind Epoch|Adverse Event|0|||
147502472|NCT02678312|531992357|FG003|Part 2 Double Blind Epoch|Adverse Event|1|||
147502473|NCT02678312|531992358|FG004|Part 2 Double Blind Epoch|Adverse Event|2|||
147502474|NCT02678312|531992354|FG000|Part 2 Double Blind Epoch|Death|0|||
147502475|NCT02678312|531992355|FG001|Part 2 Double Blind Epoch|Death|0|||
147502476|NCT02678312|531992356|FG002|Part 2 Double Blind Epoch|Death|0|||
147502477|NCT02678312|531992357|FG003|Part 2 Double Blind Epoch|Death|8|||
147502478|NCT02678312|531992358|FG004|Part 2 Double Blind Epoch|Death|12|||
147502479|NCT02678312|531992354|FG000|Part 2 Double Blind Epoch|Technical Problems|0|||
147502480|NCT02678312|531992355|FG001|Part 2 Double Blind Epoch|Technical Problems|0|||
147502481|NCT02678312|531992356|FG002|Part 2 Double Blind Epoch|Technical Problems|0|||
147502482|NCT02678312|531992357|FG003|Part 2 Double Blind Epoch|Technical Problems|4|||
147502483|NCT02678312|531992358|FG004|Part 2 Double Blind Epoch|Technical Problems|2|||
147502484|NCT02678312|531992354|FG000|Part 2 Double Blind Epoch|Lost to Follow-up|0|||
147502485|NCT02678312|531992355|FG001|Part 2 Double Blind Epoch|Lost to Follow-up|0|||
147502486|NCT02678312|531992356|FG002|Part 2 Double Blind Epoch|Lost to Follow-up|0|||
147502487|NCT02678312|531992357|FG003|Part 2 Double Blind Epoch|Lost to Follow-up|0|||
147502488|NCT02678312|531992358|FG004|Part 2 Double Blind Epoch|Lost to Follow-up|2|||
147502489|NCT02678312|531992354|FG000|Part 2 Double Blind Epoch|Subject/guardian Decision|0|||
147502490|NCT02678312|531992355|FG001|Part 2 Double Blind Epoch|Subject/guardian Decision|0|||
147502491|NCT02678312|531992356|FG002|Part 2 Double Blind Epoch|Subject/guardian Decision|0|||
147502492|NCT02678312|531992357|FG003|Part 2 Double Blind Epoch|Subject/guardian Decision|5|||
147502493|NCT02678312|531992358|FG004|Part 2 Double Blind Epoch|Subject/guardian Decision|6|||
147502494|NCT02966353|531992367|FG000|Overall Study|Withdrawal by Subject|7|||
147502495|NCT02966353|531992367|FG000|Overall Study|Adverse Event|4|||
147502496|NCT02966353|531992367|FG000|Overall Study|Death|4|||
147502497|NCT02966353|531992367|FG000|Overall Study|Physician Decision|3|||
147502498|NCT02966353|531992367|FG000|Overall Study|Progressive disease|2|||
147502499|NCT02966353|531992367|FG000|Overall Study|Protocol deviation|2|||
147502500|NCT00877006|531992371|FG000|Treatment Period|Death|2|||
147502501|NCT00877006|531992372|FG001|Treatment Period|Death|1|||
147502502|NCT00877006|531992371|FG000|Treatment Period|Adverse Event|10|||
147502503|NCT00877006|531992372|FG001|Treatment Period|Adverse Event|3|||
147632925|NCT03063086|532474519|FG003|Overall Study|Adverse Event|1|||
147502504|NCT00877006|531992371|FG000|Treatment Period|Withdrawal by Subject|2|||
147502505|NCT00877006|531992372|FG001|Treatment Period|Withdrawal by Subject|3|||
147502506|NCT00877006|531992371|FG000|Treatment Period|Protocol Violation|1|||
147502507|NCT00877006|531992372|FG001|Treatment Period|Protocol Violation|0|||
147502508|NCT00877006|531992371|FG000|Treatment Period|Lost to Follow-up|0|||
147502509|NCT00877006|531992372|FG001|Treatment Period|Lost to Follow-up|1|||
147502510|NCT00877006|531992371|FG000|Treatment Period|Disease Progression|1|||
147502511|NCT00877006|531992372|FG001|Treatment Period|Disease Progression|2|||
147502512|NCT00877006|531992371|FG000|Treatment Period|Started New Treatment Regimen|2|||
147502513|NCT00877006|531992372|FG001|Treatment Period|Started New Treatment Regimen|5|||
147502514|NCT00877006|531992371|FG000|Treatment Period|Other|4|||
147502515|NCT00877006|531992372|FG001|Treatment Period|Other|4|||
147502516|NCT00877006|531992371|FG000|Treatment Period|Randomized but Not Treated|3|||
147502517|NCT00877006|531992372|FG001|Treatment Period|Randomized but Not Treated|8|||
147502518|NCT00877006|531992371|FG000|Long-Term Follow-up Period|Withdrawal by Subject|12|||
147502519|NCT00877006|531992372|FG001|Long-Term Follow-up Period|Withdrawal by Subject|19|||
147502520|NCT00877006|531992371|FG000|Long-Term Follow-up Period|Lost to Follow-up|8|||
147502521|NCT00877006|531992372|FG001|Long-Term Follow-up Period|Lost to Follow-up|9|||
147502522|NCT00877006|531992371|FG000|Long-Term Follow-up Period|Death|26|||
147502523|NCT00877006|531992372|FG001|Long-Term Follow-up Period|Death|18|||
147502524|NCT00877006|531992371|FG000|Long-Term Follow-up Period|Other|7|||
147502525|NCT00877006|531992372|FG001|Long-Term Follow-up Period|Other|9|||
147502526|NCT05224076|531992374|FG000|Overall Study|Lost to Follow-up|24|||
147502527|NCT01807949|531992375|FG000|Overall Study|Adverse Event|1|||
147502528|NCT01807949|531992376|FG001|Overall Study|Adverse Event|2|||
147502529|NCT01807949|531992377|FG002|Overall Study|Adverse Event|2|||
147502530|NCT01807949|531992375|FG000|Overall Study|Withdrawal by Subject|1|||
147502531|NCT01807949|531992376|FG001|Overall Study|Withdrawal by Subject|2|||
147502532|NCT01807949|531992377|FG002|Overall Study|Withdrawal by Subject|2|||
147502533|NCT01807949|531992375|FG000|Overall Study|Non-Compliance|0|||
147502534|NCT01807949|531992376|FG001|Overall Study|Non-Compliance|0|||
147502535|NCT01807949|531992377|FG002|Overall Study|Non-Compliance|1|||
147502536|NCT01807949|531992375|FG000|Overall Study|Undefined|0|||
147502537|NCT01807949|531992376|FG001|Overall Study|Undefined|1|||
147502538|NCT01807949|531992377|FG002|Overall Study|Undefined|2|||
147502539|NCT01807949|531992375|FG000|Overall Study|Randomized But Not Treated|0|||
147502540|NCT01807949|531992376|FG001|Overall Study|Randomized But Not Treated|2|||
147502541|NCT01807949|531992377|FG002|Overall Study|Randomized But Not Treated|2|||
147502542|NCT00973622|531992380|FG000|Overall Study|did not attend MRI|14|||
147502543|NCT00973622|531992381|FG001|Overall Study|did not attend MRI|3|||
147502544|NCT00973622|531992380|FG000|Overall Study|did not pass MRI screen|6|||
147502545|NCT00973622|531992381|FG001|Overall Study|did not pass MRI screen|0|||
147502546|NCT00973622|531992380|FG000|Overall Study|did not complete rTMS sessions|11|||
147502547|NCT00973622|531992381|FG001|Overall Study|did not complete rTMS sessions|2|||
147502548|NCT00830960|531992386|FG000|Overall Study|Death|5|||
147502549|NCT00830960|531992387|FG001|Overall Study|Death|4|||
147502550|NCT00830960|531992388|FG002|Overall Study|Death|3|||
147502551|NCT00830960|531992389|FG003|Overall Study|Death|2|||
147502552|NCT00830960|531992390|FG004|Overall Study|Death|6|||
147502553|NCT00830960|531992391|FG005|Overall Study|Death|1|||
147502554|NCT00830960|531992386|FG000|Overall Study|Lost to Follow-up|1|||
147502555|NCT00830960|531992387|FG001|Overall Study|Lost to Follow-up|1|||
147502556|NCT00830960|531992388|FG002|Overall Study|Lost to Follow-up|1|||
147502557|NCT00830960|531992389|FG003|Overall Study|Lost to Follow-up|0|||
147502558|NCT00830960|531992390|FG004|Overall Study|Lost to Follow-up|0|||
147502559|NCT00830960|531992391|FG005|Overall Study|Lost to Follow-up|1|||
147502560|NCT00830960|531992386|FG000|Overall Study|Withdrawal by Subject|19|||
147502561|NCT00830960|531992387|FG001|Overall Study|Withdrawal by Subject|19|||
147502562|NCT00830960|531992388|FG002|Overall Study|Withdrawal by Subject|18|||
147502563|NCT00830960|531992389|FG003|Overall Study|Withdrawal by Subject|23|||
147502564|NCT00830960|531992390|FG004|Overall Study|Withdrawal by Subject|16|||
147502565|NCT00830960|531992391|FG005|Overall Study|Withdrawal by Subject|21|||
147502566|NCT00830960|531992386|FG000|Overall Study|Sponsor Decision|1|||
147502567|NCT00830960|531992387|FG001|Overall Study|Sponsor Decision|2|||
147502568|NCT00830960|531992388|FG002|Overall Study|Sponsor Decision|3|||
147502569|NCT00830960|531992389|FG003|Overall Study|Sponsor Decision|4|||
147632926|NCT03063086|532474520|FG004|Overall Study|Adverse Event|0|||
147502570|NCT00830960|531992390|FG004|Overall Study|Sponsor Decision|5|||
147502571|NCT00830960|531992391|FG005|Overall Study|Sponsor Decision|7|||
147632927|NCT03063086|532474521|FG005|Overall Study|Adverse Event|0|||
147502572|NCT00830960|531992386|FG000|Overall Study|No study drug received|7|||
147502573|NCT00830960|531992387|FG001|Overall Study|No study drug received|2|||
147502574|NCT00830960|531992388|FG002|Overall Study|No study drug received|4|||
147502575|NCT00830960|531992389|FG003|Overall Study|No study drug received|3|||
147502576|NCT00830960|531992390|FG004|Overall Study|No study drug received|5|||
147502577|NCT00830960|531992391|FG005|Overall Study|No study drug received|7|||
147632928|NCT03063086|532474516|FG000|Overall Study|subject/guardian decision|1|||
147502578|NCT03074149|531992392|FG000|Overall Study|Reason unknown|22|||
147502579|NCT03074149|531992393|FG001|Overall Study|Reason unknown|35|||
147502580|NCT03074149|531992392|FG000|Overall Study|Death|10|||
147502581|NCT03074149|531992393|FG001|Overall Study|Death|45|||
147502582|NCT02855450|531992398|FG000|Overall Study|Adverse Event|1|||
147502583|NCT02855450|531992399|FG001|Overall Study|Adverse Event|0|||
147632929|NCT03063086|532474517|FG001|Overall Study|subject/guardian decision|0|||
147632930|NCT03063086|532474518|FG002|Overall Study|subject/guardian decision|0|||
147632931|NCT03063086|532474519|FG003|Overall Study|subject/guardian decision|0|||
147632932|NCT03063086|532474520|FG004|Overall Study|subject/guardian decision|0|||
147632933|NCT03063086|532474521|FG005|Overall Study|subject/guardian decision|0|||
147632934|NCT03063086|532474516|FG000|Overall Study|Non-compliance with study treatment|0|||
147632935|NCT03063086|532474517|FG001|Overall Study|Non-compliance with study treatment|0|||
147632936|NCT03063086|532474518|FG002|Overall Study|Non-compliance with study treatment|0|||
147632937|NCT03063086|532474519|FG003|Overall Study|Non-compliance with study treatment|1|||
147632938|NCT03063086|532474520|FG004|Overall Study|Non-compliance with study treatment|0|||
147632939|NCT03063086|532474521|FG005|Overall Study|Non-compliance with study treatment|1|||
147632940|NCT03063086|532474516|FG000|Overall Study|Physician Decision|0|||
147632941|NCT03063086|532474517|FG001|Overall Study|Physician Decision|0|||
147632942|NCT03063086|532474518|FG002|Overall Study|Physician Decision|0|||
147632943|NCT03063086|532474519|FG003|Overall Study|Physician Decision|1|||
147632944|NCT03063086|532474520|FG004|Overall Study|Physician Decision|0|||
147632945|NCT03063086|532474521|FG005|Overall Study|Physician Decision|0|||
147632946|NCT04590586|532474522|FG000|Overall Study|Death|7|||
147632947|NCT04590586|532474523|FG001|Overall Study|Death|1|||
147632948|NCT04590586|532474524|FG002|Overall Study|Death|37|||
147632949|NCT04590586|532474525|FG003|Overall Study|Death|34|||
147632950|NCT04590586|532474526|FG004|Overall Study|Death|19|||
147632951|NCT04590586|532474527|FG005|Overall Study|Death|3|||
147632952|NCT04590586|532474522|FG000|Overall Study|Lost to Follow-up|3|||
147632953|NCT04590586|532474523|FG001|Overall Study|Lost to Follow-up|0|||
147632954|NCT04590586|532474524|FG002|Overall Study|Lost to Follow-up|11|||
147632955|NCT04590586|532474525|FG003|Overall Study|Lost to Follow-up|11|||
147632956|NCT04590586|532474526|FG004|Overall Study|Lost to Follow-up|6|||
147632957|NCT04590586|532474527|FG005|Overall Study|Lost to Follow-up|0|||
147632958|NCT04590586|532474522|FG000|Overall Study|Withdrawal by Subject|0|||
147632959|NCT04590586|532474523|FG001|Overall Study|Withdrawal by Subject|0|||
147632960|NCT04590586|532474524|FG002|Overall Study|Withdrawal by Subject|6|||
147632961|NCT04590586|532474525|FG003|Overall Study|Withdrawal by Subject|0|||
147632962|NCT04590586|532474526|FG004|Overall Study|Withdrawal by Subject|3|||
147632963|NCT04590586|532474527|FG005|Overall Study|Withdrawal by Subject|0|||
147632964|NCT04590586|532474522|FG000|Overall Study|Other|3|||
147632965|NCT04590586|532474523|FG001|Overall Study|Other|0|||
147632966|NCT04590586|532474524|FG002|Overall Study|Other|1|||
147632967|NCT04590586|532474525|FG003|Overall Study|Other|1|||
147632968|NCT04590586|532474526|FG004|Overall Study|Other|2|||
147632969|NCT04590586|532474527|FG005|Overall Study|Other|1|||
147632970|NCT01893281|532474528|FG000|Overall Study|Adverse Event|1|||
147632971|NCT01893281|532474528|FG000|Overall Study|Protocol Violation|1|||
147632972|NCT01893281|532474528|FG000|Overall Study|Withdrawal by Subject|1|||
147632973|NCT05481125|532474531|FG000|Overall Study|Adverse Event|1|||
147632974|NCT05481125|532474532|FG001|Overall Study|Adverse Event|0|||
147632975|NCT05481125|532474531|FG000|Overall Study|Lost to Follow-up|0|||
147632976|NCT05481125|532474532|FG001|Overall Study|Lost to Follow-up|1|||
147632977|NCT05481125|532474531|FG000|Overall Study|Withdrawal by Subject|0|||
147632978|NCT05481125|532474532|FG001|Overall Study|Withdrawal by Subject|1|||
147632979|NCT02244463|532474533|FG000|Period 1: PI DL1 Dose Escalation|Disease Progression|3|||
147632980|NCT02244463|532474534|FG001|Period 1: PI DL1 Dose Escalation|Disease Progression|0|||
147632981|NCT02244463|532474535|FG002|Period 1: PI DL1 Dose Escalation|Disease Progression|0|||
147632982|NCT02244463|532474536|FG003|Period 1: PI DL1 Dose Escalation|Disease Progression|0|||
147632983|NCT02244463|532474537|FG004|Period 1: PI DL1 Dose Escalation|Disease Progression|0|||
147632984|NCT02244463|532474538|FG005|Period 1: PI DL1 Dose Escalation|Disease Progression|0|||
147632985|NCT02244463|532474533|FG000|Period 2: PI DL2 Dose Escalation|Death|0|||
147632986|NCT02244463|532474534|FG001|Period 2: PI DL2 Dose Escalation|Death|1|||
147632987|NCT02244463|532474535|FG002|Period 2: PI DL2 Dose Escalation|Death|0|||
147632988|NCT02244463|532474536|FG003|Period 2: PI DL2 Dose Escalation|Death|0|||
147632989|NCT02244463|532474537|FG004|Period 2: PI DL2 Dose Escalation|Death|0|||
147632990|NCT02244463|532474538|FG005|Period 2: PI DL2 Dose Escalation|Death|0|||
147632991|NCT02244463|532474533|FG000|Period 2: PI DL2 Dose Escalation|Disease Progression|0|||
147632992|NCT02244463|532474534|FG001|Period 2: PI DL2 Dose Escalation|Disease Progression|2|||
147632993|NCT02244463|532474535|FG002|Period 2: PI DL2 Dose Escalation|Disease Progression|0|||
147632994|NCT02244463|532474536|FG003|Period 2: PI DL2 Dose Escalation|Disease Progression|0|||
147632995|NCT02244463|532474537|FG004|Period 2: PI DL2 Dose Escalation|Disease Progression|0|||
147632996|NCT02244463|532474538|FG005|Period 2: PI DL2 Dose Escalation|Disease Progression|0|||
147632997|NCT02244463|532474533|FG000|Period 3: PI DL3 Dose Escalation|Disease Progression|0|||
147632998|NCT02244463|532474534|FG001|Period 3: PI DL3 Dose Escalation|Disease Progression|0|||
147632999|NCT02244463|532474535|FG002|Period 3: PI DL3 Dose Escalation|Disease Progression|3|||
147633000|NCT02244463|532474536|FG003|Period 3: PI DL3 Dose Escalation|Disease Progression|0|||
147633001|NCT02244463|532474537|FG004|Period 3: PI DL3 Dose Escalation|Disease Progression|0|||
147633002|NCT02244463|532474538|FG005|Period 3: PI DL3 Dose Escalation|Disease Progression|0|||
147633003|NCT02244463|532474533|FG000|Period 4: PI DL3 Dose Expansion|Adverse Event|0|||
147668721|NCT00784875|532613362|FG001|Period A - Baseline|Lost to Follow-up|0|||
147668722|NCT00784875|532613363|FG002|Period A - Baseline|Lost to Follow-up|0|||
147668723|NCT00784875|532613364|FG003|Period A - Baseline|Lost to Follow-up|2|||
147668724|NCT00784875|532613361|FG000|Period B - Efficacy Endpoint|Entry Criteria Not Met|0|||
147668725|NCT00784875|532613362|FG001|Period B - Efficacy Endpoint|Entry Criteria Not Met|0|||
147502584|NCT02855450|531992398|FG000|Overall Study|Lost to Follow-up|4|||
147502585|NCT02855450|531992399|FG001|Overall Study|Lost to Follow-up|0|||
147502586|NCT01376245|531992406|FG000|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|66|||
147502587|NCT01376245|531992407|FG001|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0|||
147502588|NCT01376245|531992408|FG002|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0|||
147502589|NCT01376245|531992409|FG003|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0|||
147502590|NCT01376245|531992410|FG004|2-wk Single-blind Placebo Run-in Period|Did Not Meet Continuation Criteria|0|||
147502591|NCT01376245|531992406|FG000|2-wk Single-blind Placebo Run-in Period|Adverse Event|4|||
147502592|NCT01376245|531992407|FG001|2-wk Single-blind Placebo Run-in Period|Adverse Event|0|||
147502593|NCT01376245|531992408|FG002|2-wk Single-blind Placebo Run-in Period|Adverse Event|0|||
147502594|NCT01376245|531992409|FG003|2-wk Single-blind Placebo Run-in Period|Adverse Event|0|||
147502595|NCT01376245|531992410|FG004|2-wk Single-blind Placebo Run-in Period|Adverse Event|0|||
147502596|NCT01376245|531992406|FG000|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|1|||
147502597|NCT01376245|531992407|FG001|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0|||
147502598|NCT01376245|531992408|FG002|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0|||
147502599|NCT01376245|531992409|FG003|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0|||
147502600|NCT01376245|531992410|FG004|2-wk Single-blind Placebo Run-in Period|Lost to Follow-up|0|||
147502601|NCT01376245|531992406|FG000|2-wk Single-blind Placebo Run-in Period|Physician Decision|2|||
147502602|NCT01376245|531992407|FG001|2-wk Single-blind Placebo Run-in Period|Physician Decision|0|||
147502603|NCT01376245|531992408|FG002|2-wk Single-blind Placebo Run-in Period|Physician Decision|0|||
147502604|NCT01376245|531992409|FG003|2-wk Single-blind Placebo Run-in Period|Physician Decision|0|||
147502605|NCT01376245|531992410|FG004|2-wk Single-blind Placebo Run-in Period|Physician Decision|0|||
147502606|NCT01376245|531992406|FG000|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|28|||
147502607|NCT01376245|531992407|FG001|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0|||
147502608|NCT01376245|531992408|FG002|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0|||
147502609|NCT01376245|531992409|FG003|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0|||
147502610|NCT01376245|531992410|FG004|2-wk Single-blind Placebo Run-in Period|Withdrawal by Subject|0|||
147502611|NCT01376245|531992406|FG000|24-week, Double-blind Treatment Period|Adverse Event|0|||
147502612|NCT01376245|531992407|FG001|24-week, Double-blind Treatment Period|Adverse Event|16|||
147502613|NCT01376245|531992408|FG002|24-week, Double-blind Treatment Period|Adverse Event|7|||
147502614|NCT01376245|531992409|FG003|24-week, Double-blind Treatment Period|Adverse Event|8|||
147502615|NCT01376245|531992410|FG004|24-week, Double-blind Treatment Period|Adverse Event|18|||
147502616|NCT01376245|531992406|FG000|24-week, Double-blind Treatment Period|Lack of Efficacy|0|||
147502617|NCT01376245|531992407|FG001|24-week, Double-blind Treatment Period|Lack of Efficacy|4|||
147502618|NCT01376245|531992408|FG002|24-week, Double-blind Treatment Period|Lack of Efficacy|5|||
147502619|NCT01376245|531992409|FG003|24-week, Double-blind Treatment Period|Lack of Efficacy|4|||
147502620|NCT01376245|531992410|FG004|24-week, Double-blind Treatment Period|Lack of Efficacy|3|||
147502621|NCT01376245|531992406|FG000|24-week, Double-blind Treatment Period|Protocol Violation|0|||
147502622|NCT01376245|531992407|FG001|24-week, Double-blind Treatment Period|Protocol Violation|2|||
147502623|NCT01376245|531992408|FG002|24-week, Double-blind Treatment Period|Protocol Violation|0|||
147502624|NCT01376245|531992409|FG003|24-week, Double-blind Treatment Period|Protocol Violation|2|||
147502625|NCT01376245|531992410|FG004|24-week, Double-blind Treatment Period|Protocol Violation|1|||
147502626|NCT01376245|531992406|FG000|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0|||
147502627|NCT01376245|531992407|FG001|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|2|||
147502628|NCT01376245|531992408|FG002|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|3|||
147502629|NCT01376245|531992409|FG003|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|1|||
147502630|NCT01376245|531992410|FG004|24-week, Double-blind Treatment Period|Met Protocol-Defined Stopping Criteria|0|||
147502631|NCT01376245|531992406|FG000|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
147502632|NCT01376245|531992407|FG001|24-week, Double-blind Treatment Period|Lost to Follow-up|2|||
147502633|NCT01376245|531992408|FG002|24-week, Double-blind Treatment Period|Lost to Follow-up|0|||
147502634|NCT01376245|531992409|FG003|24-week, Double-blind Treatment Period|Lost to Follow-up|1|||
147502635|NCT01376245|531992410|FG004|24-week, Double-blind Treatment Period|Lost to Follow-up|1|||
147502636|NCT01376245|531992406|FG000|24-week, Double-blind Treatment Period|Physician Decision|0|||
147502637|NCT01376245|531992407|FG001|24-week, Double-blind Treatment Period|Physician Decision|0|||
147502638|NCT01376245|531992408|FG002|24-week, Double-blind Treatment Period|Physician Decision|1|||
147502639|NCT01376245|531992409|FG003|24-week, Double-blind Treatment Period|Physician Decision|1|||
147502640|NCT01376245|531992410|FG004|24-week, Double-blind Treatment Period|Physician Decision|0|||
147502641|NCT01376245|531992406|FG000|24-week, Double-blind Treatment Period|Withdrawal by Subject|0|||
147668726|NCT00784875|532613363|FG002|Period B - Efficacy Endpoint|Entry Criteria Not Met|2|||
147502642|NCT01376245|531992407|FG001|24-week, Double-blind Treatment Period|Withdrawal by Subject|6|||
147502643|NCT01376245|531992408|FG002|24-week, Double-blind Treatment Period|Withdrawal by Subject|9|||
147502644|NCT01376245|531992409|FG003|24-week, Double-blind Treatment Period|Withdrawal by Subject|6|||
147502645|NCT01376245|531992410|FG004|24-week, Double-blind Treatment Period|Withdrawal by Subject|3|||
147502646|NCT05159362|531992411|FG000|Field Testing (4 Weeks)|Withdrawal by Subject|1|||
147502647|NCT05159362|531992412|FG001|Field Testing (4 Weeks)|Withdrawal by Subject|0|||
147502648|NCT05159362|531992413|FG002|Field Testing (4 Weeks)|Withdrawal by Subject|0|||
147502649|NCT01335698|531992414|FG000|Treatment Stage 1|Lack of Efficacy|3|||
147502650|NCT01335698|531992415|FG001|Treatment Stage 1|Lack of Efficacy|1|||
147502651|NCT01335698|531992416|FG002|Treatment Stage 1|Lack of Efficacy|3|||
147502652|NCT01335698|531992417|FG003|Treatment Stage 1|Lack of Efficacy|3|||
147502653|NCT01335698|531992418|FG004|Treatment Stage 1|Lack of Efficacy|1|||
147502654|NCT01335698|531992414|FG000|Treatment Stage 1|Adverse Event|1|||
147502655|NCT01335698|531992415|FG001|Treatment Stage 1|Adverse Event|2|||
147502656|NCT01335698|531992416|FG002|Treatment Stage 1|Adverse Event|2|||
147502657|NCT01335698|531992417|FG003|Treatment Stage 1|Adverse Event|1|||
147502658|NCT01335698|531992418|FG004|Treatment Stage 1|Adverse Event|1|||
147502659|NCT01335698|531992414|FG000|Treatment Stage 1|Withdrawal by Subject|1|||
147502660|NCT01335698|531992415|FG001|Treatment Stage 1|Withdrawal by Subject|2|||
147502661|NCT01335698|531992416|FG002|Treatment Stage 1|Withdrawal by Subject|0|||
147502662|NCT01335698|531992417|FG003|Treatment Stage 1|Withdrawal by Subject|1|||
147502663|NCT01335698|531992418|FG004|Treatment Stage 1|Withdrawal by Subject|0|||
147502664|NCT01335698|531992414|FG000|Treatment Stage 1|Lost to Follow-up|1|||
147502665|NCT01335698|531992415|FG001|Treatment Stage 1|Lost to Follow-up|1|||
147502666|NCT01335698|531992416|FG002|Treatment Stage 1|Lost to Follow-up|0|||
147502667|NCT01335698|531992417|FG003|Treatment Stage 1|Lost to Follow-up|0|||
147502668|NCT01335698|531992418|FG004|Treatment Stage 1|Lost to Follow-up|0|||
147502669|NCT01335698|531992414|FG000|Treatment Stage 1|Poor compliance/noncompliance|0|||
147502670|NCT01335698|531992415|FG001|Treatment Stage 1|Poor compliance/noncompliance|1|||
147502671|NCT01335698|531992416|FG002|Treatment Stage 1|Poor compliance/noncompliance|0|||
147502672|NCT01335698|531992417|FG003|Treatment Stage 1|Poor compliance/noncompliance|2|||
147502673|NCT01335698|531992418|FG004|Treatment Stage 1|Poor compliance/noncompliance|0|||
147502674|NCT01335698|531992414|FG000|Treatment Stage 1|No longer meets study criteria|1|||
147502675|NCT01335698|531992415|FG001|Treatment Stage 1|No longer meets study criteria|1|||
147502676|NCT01335698|531992416|FG002|Treatment Stage 1|No longer meets study criteria|0|||
147502677|NCT01335698|531992417|FG003|Treatment Stage 1|No longer meets study criteria|1|||
147502678|NCT01335698|531992418|FG004|Treatment Stage 1|No longer meets study criteria|0|||
147502679|NCT01335698|531992414|FG000|Treatment Stage 1|Other|1|||
147502680|NCT01335698|531992415|FG001|Treatment Stage 1|Other|0|||
147502681|NCT01335698|531992416|FG002|Treatment Stage 1|Other|0|||
147502682|NCT01335698|531992417|FG003|Treatment Stage 1|Other|1|||
147502683|NCT01335698|531992418|FG004|Treatment Stage 1|Other|0|||
147502684|NCT01335698|531992414|FG000|Treatment Stage 2|Lack of Efficacy|2|||
147502685|NCT01335698|531992415|FG001|Treatment Stage 2|Lack of Efficacy|1|||
147502686|NCT01335698|531992416|FG002|Treatment Stage 2|Lack of Efficacy|3|||
147502687|NCT01335698|531992417|FG003|Treatment Stage 2|Lack of Efficacy|1|||
147502688|NCT01335698|531992418|FG004|Treatment Stage 2|Lack of Efficacy|0|||
147502689|NCT01335698|531992414|FG000|Treatment Stage 2|Adverse Event|2|||
147502690|NCT01335698|531992415|FG001|Treatment Stage 2|Adverse Event|0|||
147502691|NCT01335698|531992416|FG002|Treatment Stage 2|Adverse Event|0|||
147502692|NCT01335698|531992417|FG003|Treatment Stage 2|Adverse Event|3|||
147502693|NCT01335698|531992418|FG004|Treatment Stage 2|Adverse Event|0|||
147502694|NCT01335698|531992414|FG000|Treatment Stage 2|Withdrawal by Subject|3|||
147502695|NCT01335698|531992415|FG001|Treatment Stage 2|Withdrawal by Subject|1|||
147502696|NCT01335698|531992416|FG002|Treatment Stage 2|Withdrawal by Subject|1|||
147502697|NCT01335698|531992417|FG003|Treatment Stage 2|Withdrawal by Subject|0|||
147502698|NCT01335698|531992418|FG004|Treatment Stage 2|Withdrawal by Subject|0|||
147502699|NCT01335698|531992414|FG000|Treatment Stage 2|Poor compliance/noncompliance|1|||
147502700|NCT01335698|531992415|FG001|Treatment Stage 2|Poor compliance/noncompliance|0|||
147502701|NCT01335698|531992416|FG002|Treatment Stage 2|Poor compliance/noncompliance|1|||
147502702|NCT01335698|531992417|FG003|Treatment Stage 2|Poor compliance/noncompliance|3|||
147502703|NCT01335698|531992418|FG004|Treatment Stage 2|Poor compliance/noncompliance|1|||
147502704|NCT01335698|531992414|FG000|Treatment Stage 2|Lost to Follow-up|1|||
147502705|NCT01335698|531992415|FG001|Treatment Stage 2|Lost to Follow-up|0|||
147502706|NCT01335698|531992416|FG002|Treatment Stage 2|Lost to Follow-up|0|||
147502707|NCT01335698|531992417|FG003|Treatment Stage 2|Lost to Follow-up|0|||
147502708|NCT01335698|531992418|FG004|Treatment Stage 2|Lost to Follow-up|0|||
147502709|NCT01335698|531992414|FG000|Treatment Stage 2|Capsules received at state hospital|1|||
147502710|NCT01335698|531992415|FG001|Treatment Stage 2|Capsules received at state hospital|0|||
147502711|NCT01335698|531992416|FG002|Treatment Stage 2|Capsules received at state hospital|0|||
147502712|NCT01335698|531992417|FG003|Treatment Stage 2|Capsules received at state hospital|0|||
147502713|NCT01335698|531992418|FG004|Treatment Stage 2|Capsules received at state hospital|0|||
147502714|NCT01335698|531992414|FG000|Treatment Stage 2|Subject no longer meets study criteria|0|||
147633004|NCT02244463|532474534|FG001|Period 4: PI DL3 Dose Expansion|Adverse Event|0|||
147633005|NCT02244463|532474535|FG002|Period 4: PI DL3 Dose Expansion|Adverse Event|0|||
147633006|NCT02244463|532474536|FG003|Period 4: PI DL3 Dose Expansion|Adverse Event|1|||
147633007|NCT02244463|532474537|FG004|Period 4: PI DL3 Dose Expansion|Adverse Event|0|||
147633008|NCT02244463|532474538|FG005|Period 4: PI DL3 Dose Expansion|Adverse Event|0|||
147633009|NCT02244463|532474533|FG000|Period 4: PI DL3 Dose Expansion|Disease Progression|0|||
147633010|NCT02244463|532474534|FG001|Period 4: PI DL3 Dose Expansion|Disease Progression|0|||
147633011|NCT02244463|532474535|FG002|Period 4: PI DL3 Dose Expansion|Disease Progression|0|||
147633012|NCT02244463|532474536|FG003|Period 4: PI DL3 Dose Expansion|Disease Progression|5|||
147633013|NCT02244463|532474537|FG004|Period 4: PI DL3 Dose Expansion|Disease Progression|0|||
147633014|NCT02244463|532474538|FG005|Period 4: PI DL3 Dose Expansion|Disease Progression|0|||
147633015|NCT02244463|532474533|FG000|Period 4: PI DL3 Dose Expansion|Physician Decision|0|||
147633016|NCT02244463|532474534|FG001|Period 4: PI DL3 Dose Expansion|Physician Decision|0|||
147633017|NCT02244463|532474535|FG002|Period 4: PI DL3 Dose Expansion|Physician Decision|0|||
147633018|NCT02244463|532474536|FG003|Period 4: PI DL3 Dose Expansion|Physician Decision|2|||
147633019|NCT02244463|532474537|FG004|Period 4: PI DL3 Dose Expansion|Physician Decision|0|||
147633020|NCT02244463|532474538|FG005|Period 4: PI DL3 Dose Expansion|Physician Decision|0|||
147633021|NCT02244463|532474533|FG000|Period 4: PI DL3 Dose Expansion|Withdrawal by Subject|0|||
147633022|NCT02244463|532474534|FG001|Period 4: PI DL3 Dose Expansion|Withdrawal by Subject|0|||
147633023|NCT02244463|532474535|FG002|Period 4: PI DL3 Dose Expansion|Withdrawal by Subject|0|||
147633024|NCT02244463|532474536|FG003|Period 4: PI DL3 Dose Expansion|Withdrawal by Subject|1|||
147633025|NCT02244463|532474537|FG004|Period 4: PI DL3 Dose Expansion|Withdrawal by Subject|0|||
147633026|NCT02244463|532474538|FG005|Period 4: PI DL3 Dose Expansion|Withdrawal by Subject|0|||
147633027|NCT02244463|532474533|FG000|Period 4: PI DL3 Dose Expansion|Intercurrent Illness|0|||
147633028|NCT02244463|532474534|FG001|Period 4: PI DL3 Dose Expansion|Intercurrent Illness|0|||
147633029|NCT02244463|532474535|FG002|Period 4: PI DL3 Dose Expansion|Intercurrent Illness|0|||
147633030|NCT02244463|532474536|FG003|Period 4: PI DL3 Dose Expansion|Intercurrent Illness|1|||
147633031|NCT02244463|532474537|FG004|Period 4: PI DL3 Dose Expansion|Intercurrent Illness|0|||
147633032|NCT02244463|532474538|FG005|Period 4: PI DL3 Dose Expansion|Intercurrent Illness|0|||
147633033|NCT02244463|532474533|FG000|Period 5: Phase II|Disease Progression|0|||
147633034|NCT02244463|532474534|FG001|Period 5: Phase II|Disease Progression|0|||
147633035|NCT02244463|532474535|FG002|Period 5: Phase II|Disease Progression|0|||
147633036|NCT02244463|532474536|FG003|Period 5: Phase II|Disease Progression|0|||
147633037|NCT02244463|532474537|FG004|Period 5: Phase II|Disease Progression|10|||
147633038|NCT02244463|532474538|FG005|Period 5: Phase II|Disease Progression|11|||
147633039|NCT02244463|532474533|FG000|Period 5: Phase II|Physician Decision|0|||
147633040|NCT02244463|532474534|FG001|Period 5: Phase II|Physician Decision|0|||
147633041|NCT02244463|532474535|FG002|Period 5: Phase II|Physician Decision|0|||
147633042|NCT02244463|532474536|FG003|Period 5: Phase II|Physician Decision|0|||
147633043|NCT02244463|532474537|FG004|Period 5: Phase II|Physician Decision|3|||
147633044|NCT02244463|532474538|FG005|Period 5: Phase II|Physician Decision|2|||
147633045|NCT02244463|532474533|FG000|Period 5: Phase II|Withdrawal by Subject|0|||
147633046|NCT02244463|532474534|FG001|Period 5: Phase II|Withdrawal by Subject|0|||
147633047|NCT02244463|532474535|FG002|Period 5: Phase II|Withdrawal by Subject|0|||
147633048|NCT02244463|532474536|FG003|Period 5: Phase II|Withdrawal by Subject|0|||
147633049|NCT02244463|532474537|FG004|Period 5: Phase II|Withdrawal by Subject|3|||
147633050|NCT02244463|532474538|FG005|Period 5: Phase II|Withdrawal by Subject|4|||
147633051|NCT02244463|532474533|FG000|Period 5: Phase II|Intercurrent Illness|0|||
147633052|NCT02244463|532474534|FG001|Period 5: Phase II|Intercurrent Illness|0|||
147633053|NCT02244463|532474535|FG002|Period 5: Phase II|Intercurrent Illness|0|||
147633054|NCT02244463|532474536|FG003|Period 5: Phase II|Intercurrent Illness|0|||
147633055|NCT02244463|532474537|FG004|Period 5: Phase II|Intercurrent Illness|2|||
147633056|NCT02244463|532474538|FG005|Period 5: Phase II|Intercurrent Illness|0|||
147633057|NCT02244463|532474533|FG000|Period 5: Phase II|Adverse Event|0|||
147633058|NCT02244463|532474534|FG001|Period 5: Phase II|Adverse Event|0|||
147633059|NCT02244463|532474535|FG002|Period 5: Phase II|Adverse Event|0|||
147633060|NCT02244463|532474536|FG003|Period 5: Phase II|Adverse Event|0|||
147633061|NCT02244463|532474537|FG004|Period 5: Phase II|Adverse Event|0|||
147633062|NCT02244463|532474538|FG005|Period 5: Phase II|Adverse Event|2|||
147633063|NCT02244463|532474533|FG000|Period 5: Phase II|Still On treatment|0|||
147633064|NCT02244463|532474534|FG001|Period 5: Phase II|Still On treatment|0|||
147633065|NCT02244463|532474535|FG002|Period 5: Phase II|Still On treatment|0|||
147633066|NCT02244463|532474536|FG003|Period 5: Phase II|Still On treatment|0|||
147502715|NCT01335698|531992415|FG001|Treatment Stage 2|Subject no longer meets study criteria|0|||
147502716|NCT01335698|531992416|FG002|Treatment Stage 2|Subject no longer meets study criteria|0|||
147633067|NCT02244463|532474537|FG004|Period 5: Phase II|Still On treatment|0|||
147633068|NCT02244463|532474538|FG005|Period 5: Phase II|Still On treatment|3|||
147633069|NCT01769508|532474539|FG000|Overall Study|Death|3|||
147633070|NCT01769508|532474539|FG000|Overall Study|Withdrawal by Subject|1|||
147502717|NCT01335698|531992417|FG003|Treatment Stage 2|Subject no longer meets study criteria|1|||
147633071|NCT01769508|532474539|FG000|Overall Study|Adverse Event|1|||
147633072|NCT01769508|532474539|FG000|Overall Study|Lost to Follow-up|1|||
147633073|NCT03615144|532474543|FG000|Overall Study|Participant no longer eligible for this protocol|1|||
147633074|NCT03615144|532474544|FG001|Overall Study|Participant no longer eligible for this protocol|0|||
147633075|NCT02587598|532474545|FG000|Overall Study|Death|4|||
147633076|NCT02587598|532474546|FG001|Overall Study|Death|8|||
147633077|NCT02587598|532474547|FG002|Overall Study|Death|4|||
147633078|NCT02587598|532474548|FG003|Overall Study|Death|16|||
147633079|NCT02587598|532474549|FG004|Overall Study|Death|9|||
147633080|NCT02587598|532474550|FG005|Overall Study|Death|4|||
147633081|NCT02587598|532474551|FG006|Overall Study|Death|6|||
147633082|NCT02587598|532474552|FG007|Overall Study|Death|7|||
147633083|NCT02587598|532474553|FG008|Overall Study|Death|9|||
147633084|NCT02587598|532474554|FG009|Overall Study|Death|1|||
147633085|NCT02587598|532474555|FG010|Overall Study|Death|3|||
147633086|NCT02587598|532474545|FG000|Overall Study|Study Terminated by the Sponsor|0|||
147633087|NCT02587598|532474546|FG001|Overall Study|Study Terminated by the Sponsor|1|||
147633088|NCT02587598|532474547|FG002|Overall Study|Study Terminated by the Sponsor|0|||
147633089|NCT02587598|532474548|FG003|Overall Study|Study Terminated by the Sponsor|3|||
147633090|NCT02587598|532474549|FG004|Overall Study|Study Terminated by the Sponsor|0|||
147633091|NCT02587598|532474550|FG005|Overall Study|Study Terminated by the Sponsor|1|||
147633092|NCT02587598|532474551|FG006|Overall Study|Study Terminated by the Sponsor|0|||
147633093|NCT02587598|532474552|FG007|Overall Study|Study Terminated by the Sponsor|0|||
147633094|NCT02587598|532474553|FG008|Overall Study|Study Terminated by the Sponsor|0|||
147633095|NCT02587598|532474554|FG009|Overall Study|Study Terminated by the Sponsor|1|||
147633096|NCT02587598|532474555|FG010|Overall Study|Study Terminated by the Sponsor|6|||
147633097|NCT02587598|532474545|FG000|Overall Study|Reason for study withdrawal not specified|0|||
147633098|NCT02587598|532474546|FG001|Overall Study|Reason for study withdrawal not specified|1|||
147633099|NCT02587598|532474547|FG002|Overall Study|Reason for study withdrawal not specified|0|||
147633100|NCT02587598|532474548|FG003|Overall Study|Reason for study withdrawal not specified|0|||
147633101|NCT02587598|532474549|FG004|Overall Study|Reason for study withdrawal not specified|0|||
147633102|NCT02587598|532474550|FG005|Overall Study|Reason for study withdrawal not specified|0|||
147633103|NCT02587598|532474551|FG006|Overall Study|Reason for study withdrawal not specified|0|||
147633104|NCT02587598|532474552|FG007|Overall Study|Reason for study withdrawal not specified|0|||
147633105|NCT02587598|532474553|FG008|Overall Study|Reason for study withdrawal not specified|0|||
147633106|NCT02587598|532474554|FG009|Overall Study|Reason for study withdrawal not specified|0|||
147633107|NCT02587598|532474555|FG010|Overall Study|Reason for study withdrawal not specified|0|||
147417972|NCT00700427|531694564|FG001|Study Period 3B (Randomized Withdrawal)|Death|0|||
147417973|NCT00700427|531694565|FG002|Study Period 3B (Randomized Withdrawal)|Death|1|||
147417974|NCT00700427|531694566|FG003|Study Period 3B (Randomized Withdrawal)|Death|0|||
147417975|NCT00700427|531694567|FG004|Study Period 3B (Randomized Withdrawal)|Death|0|||
147417976|NCT00700427|531694563|FG000|Study Period 4 (Open-Label Extension)|Adverse Event|0|||
147417977|NCT00700427|531694564|FG001|Study Period 4 (Open-Label Extension)|Adverse Event|0|||
147417978|NCT00700427|531694565|FG002|Study Period 4 (Open-Label Extension)|Adverse Event|0|||
147417979|NCT00700427|531694566|FG003|Study Period 4 (Open-Label Extension)|Adverse Event|0|||
147417980|NCT00700427|531694567|FG004|Study Period 4 (Open-Label Extension)|Adverse Event|16|||
147417981|NCT00700427|531694563|FG000|Study Period 4 (Open-Label Extension)|Death|0|||
147417982|NCT00700427|531694564|FG001|Study Period 4 (Open-Label Extension)|Death|0|||
147417983|NCT00700427|531694565|FG002|Study Period 4 (Open-Label Extension)|Death|0|||
147417984|NCT00700427|531694566|FG003|Study Period 4 (Open-Label Extension)|Death|0|||
147417985|NCT00700427|531694567|FG004|Study Period 4 (Open-Label Extension)|Death|1|||
147417986|NCT00700427|531694563|FG000|Study Period 4 (Open-Label Extension)|Protocol Violation|0|||
147417987|NCT00700427|531694564|FG001|Study Period 4 (Open-Label Extension)|Protocol Violation|0|||
147417988|NCT00700427|531694565|FG002|Study Period 4 (Open-Label Extension)|Protocol Violation|0|||
147417989|NCT00700427|531694566|FG003|Study Period 4 (Open-Label Extension)|Protocol Violation|0|||
147502718|NCT01335698|531992418|FG004|Treatment Stage 2|Subject no longer meets study criteria|0|||
147502719|NCT01335698|531992414|FG000|Treatment Stage 2|Switched to another formulation|1|||
147502720|NCT01335698|531992415|FG001|Treatment Stage 2|Switched to another formulation|1|||
147502721|NCT01335698|531992416|FG002|Treatment Stage 2|Switched to another formulation|0|||
147502722|NCT01335698|531992417|FG003|Treatment Stage 2|Switched to another formulation|0|||
147502723|NCT01335698|531992418|FG004|Treatment Stage 2|Switched to another formulation|0|||
147502724|NCT01170221|531992419|FG000|Overall Study|Lost to Follow-up|22|||
147502725|NCT01170221|531992420|FG001|Overall Study|Lost to Follow-up|21|||
147502726|NCT01170221|531992419|FG000|Overall Study|Withdrawal by Subject|9|||
147417990|NCT00700427|531694567|FG004|Study Period 4 (Open-Label Extension)|Protocol Violation|12|||
147417991|NCT00700427|531694563|FG000|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0|||
147417992|NCT00700427|531694564|FG001|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0|||
147417993|NCT00700427|531694565|FG002|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0|||
147417994|NCT00700427|531694566|FG003|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|0|||
147417995|NCT00700427|531694567|FG004|Study Period 4 (Open-Label Extension)|Withdrawal by Subject|38|||
147502727|NCT01170221|531992420|FG001|Overall Study|Withdrawal by Subject|7|||
147502728|NCT01170221|531992419|FG000|Overall Study|Subject completed only screening and LFU|1|||
147417996|NCT00700427|531694563|FG000|Study Period 4 (Open-Label Extension)|Physician Decision|0|||
147633108|NCT02587598|532474545|FG000|Overall Study|Withdrawal by Subject|0|||
147633109|NCT02587598|532474546|FG001|Overall Study|Withdrawal by Subject|1|||
147633110|NCT02587598|532474547|FG002|Overall Study|Withdrawal by Subject|0|||
147633111|NCT02587598|532474548|FG003|Overall Study|Withdrawal by Subject|2|||
147633112|NCT02587598|532474549|FG004|Overall Study|Withdrawal by Subject|3|||
147633113|NCT02587598|532474550|FG005|Overall Study|Withdrawal by Subject|1|||
147633114|NCT02587598|532474551|FG006|Overall Study|Withdrawal by Subject|0|||
147633115|NCT02587598|532474552|FG007|Overall Study|Withdrawal by Subject|0|||
147633116|NCT02587598|532474553|FG008|Overall Study|Withdrawal by Subject|0|||
147633117|NCT02587598|532474554|FG009|Overall Study|Withdrawal by Subject|1|||
147633118|NCT02587598|532474555|FG010|Overall Study|Withdrawal by Subject|2|||
147633119|NCT02587598|532474545|FG000|Overall Study|Physician Decision|0|||
147633120|NCT02587598|532474546|FG001|Overall Study|Physician Decision|0|||
147633121|NCT02587598|532474547|FG002|Overall Study|Physician Decision|0|||
147633122|NCT02587598|532474548|FG003|Overall Study|Physician Decision|0|||
147633123|NCT02587598|532474549|FG004|Overall Study|Physician Decision|0|||
147633124|NCT02587598|532474550|FG005|Overall Study|Physician Decision|0|||
147633125|NCT02587598|532474551|FG006|Overall Study|Physician Decision|0|||
147633126|NCT02587598|532474552|FG007|Overall Study|Physician Decision|0|||
147633127|NCT02587598|532474553|FG008|Overall Study|Physician Decision|0|||
147633128|NCT02587598|532474554|FG009|Overall Study|Physician Decision|0|||
147633129|NCT02587598|532474555|FG010|Overall Study|Physician Decision|3|||
147633130|NCT00791661|532474562|FG000|7 Day Wash-out|Adverse Event|0|||
147633131|NCT00791661|532474563|FG001|7 Day Wash-out|Adverse Event|0|||
147633132|NCT00791661|532474564|FG002|7 Day Wash-out|Adverse Event|1|||
147633133|NCT00791661|532474562|FG000|7 Day Wash-out|Abnormal Clinical Laboratory Test|0|||
147633134|NCT00791661|532474563|FG001|7 Day Wash-out|Abnormal Clinical Laboratory Test|0|||
147633135|NCT00791661|532474564|FG002|7 Day Wash-out|Abnormal Clinical Laboratory Test|1|||
147633136|NCT03605862|532474565|FG000|Overall Study|Withdrawal by Subject|12|||
147633137|NCT03605862|532474566|FG001|Overall Study|Withdrawal by Subject|9|||
147633138|NCT03605862|532474565|FG000|Overall Study|Adverse Event|2|||
147633139|NCT03605862|532474566|FG001|Overall Study|Adverse Event|1|||
147633140|NCT03605862|532474565|FG000|Overall Study|Physician Decision|3|||
147633141|NCT03605862|532474566|FG001|Overall Study|Physician Decision|1|||
147633142|NCT03605862|532474565|FG000|Overall Study|"Other reasons included failure to attend follow up visits or inability to use the eDiary."|11|||
147633143|NCT03605862|532474566|FG001|Overall Study|"Other reasons included failure to attend follow up visits or inability to use the eDiary."|15|||
147633144|NCT00697463|532474567|FG000|Overall Study|Withdrawal by Subject|1|||
147633145|NCT03307252|532474568|FG000|Part 2, Period 1|Treatment not received|0|||
147633146|NCT03307252|532474569|FG001|Part 2, Period 1|Treatment not received|0|||
147633147|NCT03307252|532474570|FG002|Part 2, Period 1|Treatment not received|0|||
147633148|NCT03307252|532474571|FG003|Part 2, Period 1|Treatment not received|0|||
147633149|NCT03307252|532474572|FG004|Part 2, Period 1|Treatment not received|0|||
147633150|NCT03307252|532474573|FG005|Part 2, Period 1|Treatment not received|1|||
147633151|NCT03307252|532474574|FG006|Part 2, Period 1|Treatment not received|0|||
147633152|NCT03307252|532474575|FG007|Part 2, Period 1|Treatment not received|0|||
147633153|NCT03307252|532474576|FG008|Part 2, Period 1|Treatment not received|0|||
147633154|NCT03307252|532474577|FG009|Part 2, Period 1|Treatment not received|0|||
147633155|NCT03307252|532474578|FG010|Part 2, Period 1|Treatment not received|0|||
147633156|NCT03307252|532474568|FG000|Part 2, Period 3|Other than listed|0|||
147633157|NCT03307252|532474569|FG001|Part 2, Period 3|Other than listed|0|||
147633158|NCT03307252|532474570|FG002|Part 2, Period 3|Other than listed|0|||
147633159|NCT03307252|532474571|FG003|Part 2, Period 3|Other than listed|0|||
147633160|NCT03307252|532474572|FG004|Part 2, Period 3|Other than listed|1|||
147633161|NCT03307252|532474573|FG005|Part 2, Period 3|Other than listed|0|||
147633162|NCT03307252|532474574|FG006|Part 2, Period 3|Other than listed|0|||
147633163|NCT03307252|532474575|FG007|Part 2, Period 3|Other than listed|0|||
147633164|NCT03307252|532474576|FG008|Part 2, Period 3|Other than listed|0|||
147633165|NCT03307252|532474577|FG009|Part 2, Period 3|Other than listed|0|||
147633166|NCT03307252|532474578|FG010|Part 2, Period 3|Other than listed|0|||
147633167|NCT03307252|532474568|FG000|Part 2, Period 4|Other than listed|0|||
147633168|NCT03307252|532474569|FG001|Part 2, Period 4|Other than listed|0|||
147633169|NCT03307252|532474570|FG002|Part 2, Period 4|Other than listed|0|||
147633170|NCT03307252|532474571|FG003|Part 2, Period 4|Other than listed|0|||
147633171|NCT03307252|532474572|FG004|Part 2, Period 4|Other than listed|0|||
147633172|NCT03307252|532474573|FG005|Part 2, Period 4|Other than listed|0|||
147633173|NCT03307252|532474574|FG006|Part 2, Period 4|Other than listed|1|||
147633174|NCT03307252|532474575|FG007|Part 2, Period 4|Other than listed|0|||
147633175|NCT03307252|532474576|FG008|Part 2, Period 4|Other than listed|0|||
147633176|NCT03307252|532474577|FG009|Part 2, Period 4|Other than listed|0|||
147633177|NCT03307252|532474578|FG010|Part 2, Period 4|Other than listed|0|||
147417997|NCT00700427|531694564|FG001|Study Period 4 (Open-Label Extension)|Physician Decision|0|||
147417998|NCT00700427|531694565|FG002|Study Period 4 (Open-Label Extension)|Physician Decision|0|||
147633178|NCT03307252|532474568|FG000|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
147633179|NCT03307252|532474569|FG001|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
147633180|NCT03307252|532474570|FG002|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
147633181|NCT03307252|532474571|FG003|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
147633182|NCT03307252|532474572|FG004|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
147633183|NCT03307252|532474573|FG005|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
147633184|NCT03307252|532474574|FG006|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
147633185|NCT03307252|532474575|FG007|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
147633186|NCT03307252|532474576|FG008|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
147633187|NCT03307252|532474577|FG009|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|0|||
147633188|NCT03307252|532474578|FG010|Part 3, Washout Period 3 (7 Days)|Treatment not received due to AE|1|||
147633189|NCT03482453|532474579|FG000|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
147633190|NCT03482453|532474580|FG001|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
147633191|NCT03482453|532474581|FG002|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
147633192|NCT03482453|532474582|FG003|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
147633193|NCT03482453|532474583|FG004|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
147633194|NCT03482453|532474584|FG005|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
147633195|NCT03482453|532474585|FG006|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
147633196|NCT03482453|532474586|FG007|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
147633197|NCT03482453|532474587|FG008|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
147633198|NCT03482453|532474588|FG009|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
147633199|NCT03482453|532474589|FG010|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|1|||
147633200|NCT03482453|532474590|FG011|Parts 2, 3 Intervention Period 1 (1 Day)|Adverse Event|0|||
147633201|NCT01314872|532474597|FG000|Treatment Period 1|Protocol Violation|2|||
147633202|NCT01314872|532474598|FG001|Treatment Period 1|Protocol Violation|1|||
147633203|NCT01314872|532474599|FG002|Treatment Period 1|Protocol Violation|1|||
147633204|NCT01314872|532474600|FG003|Treatment Period 1|Protocol Violation|0|||
147633205|NCT01314872|532474601|FG004|Treatment Period 1|Protocol Violation|1|||
147633206|NCT01314872|532474602|FG005|Treatment Period 1|Protocol Violation|0|||
147633207|NCT01314872|532474603|FG006|Treatment Period 1|Protocol Violation|0|||
147633208|NCT01314872|532474604|FG007|Treatment Period 1|Protocol Violation|0|||
147633209|NCT01314872|532474605|FG008|Treatment Period 1|Protocol Violation|0|||
147633210|NCT01314872|532474606|FG009|Treatment Period 1|Protocol Violation|1|||
147633211|NCT01314872|532474607|FG010|Treatment Period 1|Protocol Violation|1|||
147633212|NCT01314872|532474608|FG011|Treatment Period 1|Protocol Violation|0|||
147633213|NCT01314872|532474609|FG012|Treatment Period 1|Protocol Violation|0|||
147633214|NCT01314872|532474610|FG013|Treatment Period 1|Protocol Violation|0|||
147633215|NCT01314872|532474611|FG014|Treatment Period 1|Protocol Violation|0|||
147633216|NCT01314872|532474597|FG000|Treatment Period 1|Physician Decision|0|||
147633217|NCT01314872|532474598|FG001|Treatment Period 1|Physician Decision|1|||
147633218|NCT01314872|532474599|FG002|Treatment Period 1|Physician Decision|0|||
147633219|NCT01314872|532474600|FG003|Treatment Period 1|Physician Decision|1|||
147633220|NCT01314872|532474601|FG004|Treatment Period 1|Physician Decision|0|||
147633221|NCT01314872|532474602|FG005|Treatment Period 1|Physician Decision|0|||
147633222|NCT01314872|532474603|FG006|Treatment Period 1|Physician Decision|0|||
147633223|NCT01314872|532474604|FG007|Treatment Period 1|Physician Decision|0|||
147633224|NCT01314872|532474605|FG008|Treatment Period 1|Physician Decision|0|||
147633225|NCT01314872|532474606|FG009|Treatment Period 1|Physician Decision|1|||
147633226|NCT01314872|532474607|FG010|Treatment Period 1|Physician Decision|0|||
147633227|NCT01314872|532474608|FG011|Treatment Period 1|Physician Decision|0|||
147633228|NCT01314872|532474609|FG012|Treatment Period 1|Physician Decision|0|||
147633229|NCT01314872|532474610|FG013|Treatment Period 1|Physician Decision|0|||
147633230|NCT01314872|532474611|FG014|Treatment Period 1|Physician Decision|0|||
147633231|NCT01314872|532474597|FG000|Treatment Period 1|Lack of Efficacy|1|||
147633232|NCT01314872|532474598|FG001|Treatment Period 1|Lack of Efficacy|0|||
147633233|NCT01314872|532474599|FG002|Treatment Period 1|Lack of Efficacy|0|||
147633234|NCT01314872|532474600|FG003|Treatment Period 1|Lack of Efficacy|0|||
147633235|NCT01314872|532474601|FG004|Treatment Period 1|Lack of Efficacy|0|||
147633236|NCT01314872|532474602|FG005|Treatment Period 1|Lack of Efficacy|1|||
147633237|NCT01314872|532474603|FG006|Treatment Period 1|Lack of Efficacy|0|||
147633238|NCT01314872|532474604|FG007|Treatment Period 1|Lack of Efficacy|2|||
147633239|NCT01314872|532474605|FG008|Treatment Period 1|Lack of Efficacy|0|||
147633240|NCT01314872|532474606|FG009|Treatment Period 1|Lack of Efficacy|0|||
147633241|NCT01314872|532474607|FG010|Treatment Period 1|Lack of Efficacy|0|||
147633242|NCT01314872|532474608|FG011|Treatment Period 1|Lack of Efficacy|0|||
147633243|NCT01314872|532474609|FG012|Treatment Period 1|Lack of Efficacy|0|||
147633244|NCT01314872|532474610|FG013|Treatment Period 1|Lack of Efficacy|0|||
147633245|NCT01314872|532474611|FG014|Treatment Period 1|Lack of Efficacy|0|||
147633246|NCT01314872|532474597|FG000|Treatment Period 1|Adverse event, non-fatal|4|||
147633247|NCT01314872|532474598|FG001|Treatment Period 1|Adverse event, non-fatal|2|||
147633248|NCT01314872|532474599|FG002|Treatment Period 1|Adverse event, non-fatal|3|||
147502729|NCT01170221|531992420|FG001|Overall Study|Subject completed only screening and LFU|0|||
147502730|NCT01170221|531992419|FG000|Overall Study|Randomized but not treated|1|||
147502731|NCT01170221|531992420|FG001|Overall Study|Randomized but not treated|0|||
147502732|NCT00050960|531992422|FG000|Overall Study|Progressive Disease|137|||
147502733|NCT00050960|531992423|FG001|Overall Study|Progressive Disease|93|||
147502734|NCT00050960|531992422|FG000|Overall Study|Stable Disease|19|||
147502735|NCT00050960|531992423|FG001|Overall Study|Stable Disease|48|||
147502736|NCT00050960|531992422|FG000|Overall Study|Partial Response|14|||
147502737|NCT00050960|531992423|FG001|Overall Study|Partial Response|19|||
147502738|NCT00050960|531992422|FG000|Overall Study|Complete Response|0|||
147502739|NCT00050960|531992423|FG001|Overall Study|Complete Response|2|||
147502740|NCT00050960|531992422|FG000|Overall Study|Adverse Event|62|||
147502741|NCT00050960|531992423|FG001|Overall Study|Adverse Event|61|||
147502742|NCT00050960|531992422|FG000|Overall Study|Lost to Follow-up|0|||
147502743|NCT00050960|531992423|FG001|Overall Study|Lost to Follow-up|1|||
147502744|NCT00050960|531992422|FG000|Overall Study|Withdrawal by Subject|23|||
147502745|NCT00050960|531992423|FG001|Overall Study|Withdrawal by Subject|18|||
147502746|NCT00050960|531992422|FG000|Overall Study|Administrative|31|||
147502747|NCT00050960|531992423|FG001|Overall Study|Administrative|46|||
147502748|NCT00050960|531992422|FG000|Overall Study|Non-compliance|3|||
147502749|NCT00050960|531992423|FG001|Overall Study|Non-compliance|1|||
147502750|NCT00050960|531992422|FG000|Overall Study|Death|13|||
147502751|NCT00050960|531992423|FG001|Overall Study|Death|15|||
147502752|NCT01996904|531992427|FG000|Overall Study|Lost to Follow-up|38|||
147502753|NCT01996904|531992428|FG001|Overall Study|Lost to Follow-up|27|||
147502754|NCT00585923|531992429|FG000|Overall Study|Physician decided not to continue|31|||
147502755|NCT00585923|531992430|FG001|Overall Study|Physician decided not to continue|33|||
147502756|NCT01324622|531992431|FG000|Overall Study|Lost to Follow-up|7|||
147502757|NCT01324622|531992432|FG001|Overall Study|Lost to Follow-up|7|||
147502758|NCT01324622|531992431|FG000|Overall Study|Death|1|||
147502759|NCT01324622|531992432|FG001|Overall Study|Death|0|||
147502760|NCT01324622|531992431|FG000|Overall Study|Lack of Efficacy|1|||
147502761|NCT01324622|531992432|FG001|Overall Study|Lack of Efficacy|0|||
147502762|NCT02219087|531992433|FG000|Overall Study|Randomization envelope pulled out of seq|0|||
147502763|NCT02219087|531992434|FG001|Overall Study|Randomization envelope pulled out of seq|1|||
147502764|NCT00618449|531992435|FG000|Overall Study|Lost to Follow-up|98|||
147502765|NCT00618449|531992436|FG001|Overall Study|Lost to Follow-up|110|||
147502766|NCT00138424|531992437|FG000|Overall Study|Physician Decision|0|||
147502767|NCT00138424|531992438|FG001|Overall Study|Physician Decision|1|||
147502768|NCT00138424|531992439|FG002|Overall Study|Physician Decision|0|||
147502769|NCT00138424|531992440|FG003|Overall Study|Physician Decision|0|||
147502770|NCT04311177|531992441|FG000|Overall Study|Adverse Event|3|||
147502771|NCT04311177|531992442|FG001|Overall Study|Adverse Event|1|||
147502772|NCT04311177|531992441|FG000|Overall Study|Physician Decision|4|||
147502773|NCT04311177|531992442|FG001|Overall Study|Physician Decision|3|||
147502774|NCT04311177|531992441|FG000|Overall Study|Withdrawal by Subject|1|||
147502775|NCT04311177|531992442|FG001|Overall Study|Withdrawal by Subject|0|||
147502776|NCT02157506|531992449|FG000|Overall Study|Adverse Event|0|||
147502777|NCT02157506|531992450|FG001|Overall Study|Adverse Event|1|||
147502778|NCT02157506|531992451|FG002|Overall Study|Adverse Event|0|||
147502779|NCT02157506|531992452|FG003|Overall Study|Adverse Event|0|||
147502780|NCT02157506|531992453|FG004|Overall Study|Adverse Event|0|||
147502781|NCT02157506|531992449|FG000|Overall Study|Lost to Follow-up|0|||
147502782|NCT02157506|531992450|FG001|Overall Study|Lost to Follow-up|0|||
147502783|NCT02157506|531992451|FG002|Overall Study|Lost to Follow-up|1|||
147502784|NCT02157506|531992452|FG003|Overall Study|Lost to Follow-up|0|||
147502785|NCT02157506|531992453|FG004|Overall Study|Lost to Follow-up|0|||
147502786|NCT00764478|531992454|FG000|Overall Study|Adverse Event|1|||
147502787|NCT00764478|531992455|FG001|Overall Study|Adverse Event|1|||
147502788|NCT00764478|531992456|FG002|Overall Study|Adverse Event|1|||
147502789|NCT00764478|531992454|FG000|Overall Study|Withdrawal by Subject|7|||
147502790|NCT00764478|531992455|FG001|Overall Study|Withdrawal by Subject|12|||
147502791|NCT00764478|531992456|FG002|Overall Study|Withdrawal by Subject|1|||
147502792|NCT00764478|531992454|FG000|Overall Study|Lost to Follow-up|7|||
147502793|NCT00764478|531992455|FG001|Overall Study|Lost to Follow-up|8|||
147502794|NCT00764478|531992456|FG002|Overall Study|Lost to Follow-up|5|||
147502795|NCT00764478|531992454|FG000|Overall Study|Protocol Violation|0|||
147502796|NCT00764478|531992455|FG001|Overall Study|Protocol Violation|1|||
147502797|NCT00764478|531992456|FG002|Overall Study|Protocol Violation|1|||
147502798|NCT02702011|531992457|FG000|Overall Study|Withdrawal by Subject|0|||
147502799|NCT02702011|531992458|FG001|Overall Study|Withdrawal by Subject|1|||
147502800|NCT02702011|531992459|FG002|Overall Study|Withdrawal by Subject|0|||
147502801|NCT02702011|531992460|FG003|Overall Study|Withdrawal by Subject|0|||
147502802|NCT03498287|531992466|FG000|Overall Study|Withdrawal by Subject|3|||
147502803|NCT03498287|531992467|FG001|Overall Study|Withdrawal by Subject|0|||
147502804|NCT03498287|531992466|FG000|Overall Study|Protocol Violation|0|||
147502805|NCT03498287|531992467|FG001|Overall Study|Protocol Violation|4|||
147502806|NCT03498287|531992466|FG000|Overall Study|Adverse Event|0|||
147502807|NCT03498287|531992467|FG001|Overall Study|Adverse Event|1|||
147633249|NCT01314872|532474600|FG003|Treatment Period 1|Adverse event, non-fatal|2|||
147633250|NCT01314872|532474601|FG004|Treatment Period 1|Adverse event, non-fatal|2|||
147633251|NCT01314872|532474602|FG005|Treatment Period 1|Adverse event, non-fatal|4|||
147633252|NCT01314872|532474603|FG006|Treatment Period 1|Adverse event, non-fatal|4|||
147633253|NCT01314872|532474604|FG007|Treatment Period 1|Adverse event, non-fatal|2|||
147633254|NCT01314872|532474605|FG008|Treatment Period 1|Adverse event, non-fatal|3|||
147633255|NCT01314872|532474606|FG009|Treatment Period 1|Adverse event, non-fatal|0|||
147633256|NCT01314872|532474607|FG010|Treatment Period 1|Adverse event, non-fatal|1|||
147633257|NCT01314872|532474608|FG011|Treatment Period 1|Adverse event, non-fatal|0|||
147633258|NCT01314872|532474609|FG012|Treatment Period 1|Adverse event, non-fatal|0|||
147633259|NCT01314872|532474610|FG013|Treatment Period 1|Adverse event, non-fatal|0|||
147633260|NCT01314872|532474611|FG014|Treatment Period 1|Adverse event, non-fatal|0|||
147633261|NCT01314872|532474597|FG000|Treatment Period 1|Withdrawal by Subject|3|||
147633262|NCT01314872|532474598|FG001|Treatment Period 1|Withdrawal by Subject|1|||
147633263|NCT01314872|532474599|FG002|Treatment Period 1|Withdrawal by Subject|0|||
147633264|NCT01314872|532474600|FG003|Treatment Period 1|Withdrawal by Subject|2|||
147633265|NCT01314872|532474601|FG004|Treatment Period 1|Withdrawal by Subject|3|||
147633266|NCT01314872|532474602|FG005|Treatment Period 1|Withdrawal by Subject|1|||
147633267|NCT01314872|532474603|FG006|Treatment Period 1|Withdrawal by Subject|3|||
147633268|NCT01314872|532474604|FG007|Treatment Period 1|Withdrawal by Subject|2|||
147633269|NCT01314872|532474605|FG008|Treatment Period 1|Withdrawal by Subject|2|||
147633270|NCT01314872|532474606|FG009|Treatment Period 1|Withdrawal by Subject|2|||
147633271|NCT01314872|532474607|FG010|Treatment Period 1|Withdrawal by Subject|1|||
147633272|NCT01314872|532474608|FG011|Treatment Period 1|Withdrawal by Subject|0|||
147633273|NCT01314872|532474609|FG012|Treatment Period 1|Withdrawal by Subject|0|||
147633274|NCT01314872|532474610|FG013|Treatment Period 1|Withdrawal by Subject|0|||
147633275|NCT01314872|532474611|FG014|Treatment Period 1|Withdrawal by Subject|0|||
147633276|NCT01314872|532474597|FG000|Treatment Period 1|Lost to Follow-up|0|||
147633277|NCT01314872|532474598|FG001|Treatment Period 1|Lost to Follow-up|1|||
147633278|NCT01314872|532474599|FG002|Treatment Period 1|Lost to Follow-up|2|||
147633279|NCT01314872|532474600|FG003|Treatment Period 1|Lost to Follow-up|2|||
147633280|NCT01314872|532474601|FG004|Treatment Period 1|Lost to Follow-up|1|||
147633281|NCT01314872|532474602|FG005|Treatment Period 1|Lost to Follow-up|1|||
147633282|NCT01314872|532474603|FG006|Treatment Period 1|Lost to Follow-up|1|||
147633283|NCT01314872|532474604|FG007|Treatment Period 1|Lost to Follow-up|1|||
147633284|NCT01314872|532474605|FG008|Treatment Period 1|Lost to Follow-up|1|||
147633285|NCT01314872|532474606|FG009|Treatment Period 1|Lost to Follow-up|0|||
147633286|NCT01314872|532474607|FG010|Treatment Period 1|Lost to Follow-up|0|||
147633287|NCT01314872|532474608|FG011|Treatment Period 1|Lost to Follow-up|0|||
147633288|NCT01314872|532474609|FG012|Treatment Period 1|Lost to Follow-up|0|||
147633289|NCT01314872|532474610|FG013|Treatment Period 1|Lost to Follow-up|0|||
147633290|NCT01314872|532474611|FG014|Treatment Period 1|Lost to Follow-up|0|||
147633291|NCT01314872|532474597|FG000|Period 2|Protocol Violation|0|||
147633292|NCT01314872|532474598|FG001|Period 2|Protocol Violation|0|||
147633293|NCT01314872|532474599|FG002|Period 2|Protocol Violation|0|||
147633294|NCT01314872|532474600|FG003|Period 2|Protocol Violation|0|||
147633295|NCT01314872|532474601|FG004|Period 2|Protocol Violation|0|||
147633296|NCT01314872|532474602|FG005|Period 2|Protocol Violation|0|||
147633297|NCT01314872|532474603|FG006|Period 2|Protocol Violation|0|||
147633298|NCT01314872|532474604|FG007|Period 2|Protocol Violation|0|||
147633299|NCT01314872|532474605|FG008|Period 2|Protocol Violation|0|||
147633300|NCT01314872|532474606|FG009|Period 2|Protocol Violation|0|||
147633301|NCT01314872|532474607|FG010|Period 2|Protocol Violation|0|||
147633302|NCT01314872|532474608|FG011|Period 2|Protocol Violation|3|||
147633303|NCT01314872|532474609|FG012|Period 2|Protocol Violation|3|||
147633304|NCT01314872|532474610|FG013|Period 2|Protocol Violation|2|||
147633305|NCT01314872|532474611|FG014|Period 2|Protocol Violation|0|||
147633306|NCT01314872|532474597|FG000|Period 2|Non-compliance with study drug|0|||
147633307|NCT01314872|532474598|FG001|Period 2|Non-compliance with study drug|0|||
147633308|NCT01314872|532474599|FG002|Period 2|Non-compliance with study drug|0|||
147633309|NCT01314872|532474600|FG003|Period 2|Non-compliance with study drug|0|||
147502808|NCT01740388|531992470|FG000|Overall Study|Withdrawal by Subject|1|||
147502809|NCT01740388|531992471|FG001|Overall Study|Withdrawal by Subject|2|||
147502810|NCT01740388|531992470|FG000|Overall Study|Lost to Follow-up|2|||
147633310|NCT01314872|532474601|FG004|Period 2|Non-compliance with study drug|0|||
147633311|NCT01314872|532474602|FG005|Period 2|Non-compliance with study drug|0|||
147633312|NCT01314872|532474603|FG006|Period 2|Non-compliance with study drug|0|||
147633313|NCT01314872|532474604|FG007|Period 2|Non-compliance with study drug|0|||
147633314|NCT01314872|532474605|FG008|Period 2|Non-compliance with study drug|0|||
147502811|NCT01740388|531992471|FG001|Overall Study|Lost to Follow-up|0|||
147502812|NCT01740388|531992470|FG000|Overall Study|Physician Decision|2|||
147633315|NCT01314872|532474606|FG009|Period 2|Non-compliance with study drug|0|||
147633316|NCT01314872|532474607|FG010|Period 2|Non-compliance with study drug|0|||
147633317|NCT01314872|532474608|FG011|Period 2|Non-compliance with study drug|3|||
147633318|NCT01314872|532474609|FG012|Period 2|Non-compliance with study drug|3|||
147633319|NCT01314872|532474610|FG013|Period 2|Non-compliance with study drug|1|||
147502813|NCT01740388|531992471|FG001|Overall Study|Physician Decision|6|||
147502814|NCT01740388|531992470|FG000|Overall Study|Subjects missing data, completed|41|||
147502815|NCT01740388|531992471|FG001|Overall Study|Subjects missing data, completed|36|||
147502816|NCT04142216|531992472|FG000|Overall Study|Hospitalization|0|||
147502817|NCT04142216|531992473|FG001|Overall Study|Hospitalization|2|||
147502818|NCT04142216|531992472|FG000|Overall Study|Death|3|||
147502819|NCT04142216|531992473|FG001|Overall Study|Death|1|||
147502820|NCT04142216|531992472|FG000|Overall Study|Referral to another hemodialysis unit|3|||
147502821|NCT04142216|531992473|FG001|Overall Study|Referral to another hemodialysis unit|2|||
147502822|NCT04142216|531992472|FG000|Overall Study|Use of clove|0|||
147502823|NCT04142216|531992473|FG001|Overall Study|Use of clove|1|||
147502824|NCT01641991|531992474|FG000|Overall Study|Physician Decision|0|||
147502825|NCT01641991|531992475|FG001|Overall Study|Physician Decision|1|||
147502826|NCT01641991|531992476|FG002|Overall Study|Physician Decision|7|||
147502827|NCT01641991|531992477|FG003|Overall Study|Physician Decision|5|||
147502828|NCT01641991|531992474|FG000|Overall Study|Withdrawal by Subject|4|||
147502829|NCT01641991|531992475|FG001|Overall Study|Withdrawal by Subject|2|||
147502830|NCT01641991|531992476|FG002|Overall Study|Withdrawal by Subject|1|||
147502831|NCT01641991|531992477|FG003|Overall Study|Withdrawal by Subject|5|||
147502832|NCT01641991|531992474|FG000|Overall Study|Adverse Event|2|||
147502833|NCT01641991|531992475|FG001|Overall Study|Adverse Event|1|||
147502834|NCT01641991|531992476|FG002|Overall Study|Adverse Event|2|||
147502835|NCT01641991|531992477|FG003|Overall Study|Adverse Event|1|||
147502836|NCT01641991|531992474|FG000|Overall Study|Lost to Follow-up|0|||
147502837|NCT01641991|531992475|FG001|Overall Study|Lost to Follow-up|2|||
147502838|NCT01641991|531992476|FG002|Overall Study|Lost to Follow-up|3|||
147502839|NCT01641991|531992477|FG003|Overall Study|Lost to Follow-up|1|||
147502840|NCT01641991|531992474|FG000|Overall Study|Protocol Violation|1|||
147502841|NCT01641991|531992475|FG001|Overall Study|Protocol Violation|1|||
147502842|NCT01641991|531992476|FG002|Overall Study|Protocol Violation|3|||
147502843|NCT01641991|531992477|FG003|Overall Study|Protocol Violation|0|||
147502844|NCT01641991|531992474|FG000|Overall Study|Pregnancy|0|||
147502845|NCT01641991|531992475|FG001|Overall Study|Pregnancy|0|||
147502846|NCT01641991|531992476|FG002|Overall Study|Pregnancy|1|||
147502847|NCT01641991|531992477|FG003|Overall Study|Pregnancy|0|||
147502848|NCT01641991|531992474|FG000|Overall Study|no longer eligible|2|||
147502849|NCT01641991|531992475|FG001|Overall Study|no longer eligible|1|||
147502850|NCT01641991|531992476|FG002|Overall Study|no longer eligible|0|||
147502851|NCT01641991|531992477|FG003|Overall Study|no longer eligible|4|||
147502852|NCT02555657|531992478|FG000|Overall Study|Death|274|||
147502853|NCT02555657|531992479|FG001|Overall Study|Death|262|||
147502854|NCT02555657|531992478|FG000|Overall Study|Physician Decision|0|||
147502855|NCT02555657|531992479|FG001|Overall Study|Physician Decision|1|||
147502856|NCT02555657|531992478|FG000|Overall Study|Sponsor Decision|27|||
147502857|NCT02555657|531992479|FG001|Overall Study|Sponsor Decision|15|||
147502858|NCT02555657|531992478|FG000|Overall Study|Withdrawal by Subject|11|||
147502859|NCT02555657|531992479|FG001|Overall Study|Withdrawal by Subject|32|||
147502860|NCT01578785|531992485|FG000|Overall Study|Withdrawal by Subject|0|||
147502861|NCT01578785|531992486|FG001|Overall Study|Withdrawal by Subject|1|||
147502862|NCT01578785|531992485|FG000|Overall Study|Study terminated by sponsor|59|||
147502863|NCT01578785|531992486|FG001|Overall Study|Study terminated by sponsor|118|||
147502864|NCT00599027|531992491|FG000|Overall Study|Withdrawal by Subject|1|||
147502865|NCT00599027|531992492|FG001|Overall Study|Withdrawal by Subject|1|||
147502866|NCT00599027|531992491|FG000|Overall Study|Adverse Event|0|||
147502867|NCT00599027|531992492|FG001|Overall Study|Adverse Event|1|||
147502868|NCT00599027|531992491|FG000|Overall Study|Treatment Failure|0|||
147502869|NCT00599027|531992492|FG001|Overall Study|Treatment Failure|1|||
147502870|NCT00475540|531992493|FG000|36 Months|Lost to Follow-up|4|||
147502871|NCT00475540|531992494|FG001|36 Months|Lost to Follow-up|4|||
147502872|NCT00475540|531992493|FG000|36 Months|Death|1|||
147502873|NCT00475540|531992494|FG001|36 Months|Death|2|||
147633320|NCT01314872|532474611|FG014|Period 2|Non-compliance with study drug|2|||
147502874|NCT00475540|531992493|FG000|36 Months|Censored due to reoperation|3|||
147502875|NCT00475540|531992494|FG001|36 Months|Censored due to reoperation|0|||
147502876|NCT02133742|531992509|FG000|Period 2:Dose Expansion Phase (1344days)|Lost to Follow-up|2|||
147502877|NCT02133742|531992509|FG000|Period 2:Dose Expansion Phase (1344days)|End of survival follow-up/treatment|31|||
147502878|NCT02133742|531992509|FG000|Period 2:Dose Expansion Phase (1344days)|Death|13|||
147502879|NCT02133742|531992509|FG000|Period 2:Dose Expansion Phase (1344days)|Participant refused further follow-up|5|||
147502880|NCT02133742|531992509|FG000|Period 2:Dose Expansion Phase (1344days)|Adverse Event|1|||
147502881|NCT01617187|531992510|FG000|Randomization Through Start Treatment|Not Treated: Administrative Reason|0|||
147502882|NCT01617187|531992511|FG001|Randomization Through Start Treatment|Not Treated: Administrative Reason|0|||
147502883|NCT01617187|531992512|FG002|Randomization Through Start Treatment|Not Treated: Administrative Reason|0|||
147502884|NCT01617187|531992513|FG003|Randomization Through Start Treatment|Not Treated: Administrative Reason|1|||
147502885|NCT01617187|531992510|FG000|Randomization Through Start Treatment|Not Treated: Adverse Event|0|||
147502886|NCT01617187|531992511|FG001|Randomization Through Start Treatment|Not Treated: Adverse Event|0|||
147633321|NCT01314872|532474597|FG000|Period 2|Lack of Efficacy|0|||
147502887|NCT01617187|531992512|FG002|Randomization Through Start Treatment|Not Treated: Adverse Event|0|||
147502888|NCT01617187|531992513|FG003|Randomization Through Start Treatment|Not Treated: Adverse Event|1|||
147502889|NCT01617187|531992510|FG000|Randomization Through Start Treatment|Not Treated: Completed study in database|1|||
147502890|NCT01617187|531992511|FG001|Randomization Through Start Treatment|Not Treated: Completed study in database|0|||
147502891|NCT01617187|531992512|FG002|Randomization Through Start Treatment|Not Treated: Completed study in database|0|||
147502892|NCT01617187|531992513|FG003|Randomization Through Start Treatment|Not Treated: Completed study in database|0|||
147502893|NCT01617187|531992510|FG000|Treatment Through Study Completion|Adverse Event|1|||
147502894|NCT01617187|531992511|FG001|Treatment Through Study Completion|Adverse Event|1|||
147502895|NCT01617187|531992512|FG002|Treatment Through Study Completion|Adverse Event|0|||
147502896|NCT01617187|531992513|FG003|Treatment Through Study Completion|Adverse Event|1|||
147502897|NCT01617187|531992510|FG000|Treatment Through Study Completion|Lost to Follow-up|4|||
147502898|NCT01617187|531992511|FG001|Treatment Through Study Completion|Lost to Follow-up|2|||
147502899|NCT01617187|531992512|FG002|Treatment Through Study Completion|Lost to Follow-up|2|||
147502900|NCT01617187|531992513|FG003|Treatment Through Study Completion|Lost to Follow-up|2|||
147502901|NCT01617187|531992510|FG000|Treatment Through Study Completion|Withdrawal by Subject|5|||
147502902|NCT01617187|531992511|FG001|Treatment Through Study Completion|Withdrawal by Subject|8|||
147502903|NCT01617187|531992512|FG002|Treatment Through Study Completion|Withdrawal by Subject|3|||
147502904|NCT01617187|531992513|FG003|Treatment Through Study Completion|Withdrawal by Subject|6|||
147502905|NCT01617187|531992510|FG000|Treatment Through Study Completion|Protocol Violation|1|||
147502906|NCT01617187|531992511|FG001|Treatment Through Study Completion|Protocol Violation|0|||
147502907|NCT01617187|531992512|FG002|Treatment Through Study Completion|Protocol Violation|0|||
147502908|NCT01617187|531992513|FG003|Treatment Through Study Completion|Protocol Violation|1|||
147502909|NCT01265420|531992514|FG000|Overall Study|Lost to Follow-up|1|||
147502910|NCT02554253|531992516|FG000|Overall Study|ineligible after enrollment|1|||
147502911|NCT02554253|531992517|FG001|Overall Study|ineligible after enrollment|0|||
147502912|NCT02554253|531992516|FG000|Overall Study|converted to transcatheter procedure|0|||
147502913|NCT02554253|531992517|FG001|Overall Study|converted to transcatheter procedure|1|||
147502914|NCT02554253|531992516|FG000|Overall Study|received both drugs|0|||
147502915|NCT02554253|531992517|FG001|Overall Study|received both drugs|1|||
147502916|NCT01736254|531992524|FG000|Period 2 (Days 2 to 12)|Adverse Event|3|||
147502917|NCT01736254|531992524|FG000|Period 3 (Days 13 to 23)|Adverse Event|1|||
147502918|NCT01561560|531992525|FG000|First Two Weeks of Wear|Time/job conflict|0|||
147502919|NCT01561560|531992526|FG001|First Two Weeks of Wear|Time/job conflict|1|||
147502920|NCT01561560|531992525|FG000|First Two Weeks of Wear|Adverse Event|0|||
147502921|NCT01561560|531992526|FG001|First Two Weeks of Wear|Adverse Event|1|||
147502922|NCT01561560|531992525|FG000|Second Two Weeks of Wear|Adverse Event|0|||
147502923|NCT01561560|531992526|FG001|Second Two Weeks of Wear|Adverse Event|1|||
147502924|NCT03862131|531992527|FG000|Overall Study|Lost to Follow-up|1|||
147502925|NCT03862131|531992528|FG001|Overall Study|Lost to Follow-up|0|||
147502926|NCT03862131|531992529|FG002|Overall Study|Lost to Follow-up|1|||
147502927|NCT03862131|531992527|FG000|Overall Study|Determined to be ineligible|0|||
147502928|NCT03862131|531992528|FG001|Overall Study|Determined to be ineligible|0|||
147502929|NCT03862131|531992529|FG002|Overall Study|Determined to be ineligible|5|||
147502930|NCT03862131|531992527|FG000|Overall Study|Death|4|||
147502931|NCT03862131|531992528|FG001|Overall Study|Death|4|||
147502932|NCT03862131|531992529|FG002|Overall Study|Death|0|||
147502933|NCT03862131|531992527|FG000|Overall Study|Withdrawal by Subject|5|||
147502934|NCT03862131|531992528|FG001|Overall Study|Withdrawal by Subject|3|||
147502935|NCT03862131|531992529|FG002|Overall Study|Withdrawal by Subject|0|||
147502936|NCT03862131|531992527|FG000|Overall Study|Physician Decision|0|||
147502937|NCT03862131|531992528|FG001|Overall Study|Physician Decision|1|||
147502938|NCT03862131|531992529|FG002|Overall Study|Physician Decision|0|||
147502939|NCT05263921|531993985|FG000|Overall Study|Other: family emergency.|0|||
147502940|NCT05263921|531993986|FG001|Overall Study|Other: family emergency.|0|||
147502941|NCT05263921|531993987|FG002|Overall Study|Other: family emergency.|1|||
147502942|NCT05263921|531993988|FG003|Overall Study|Other: family emergency.|0|||
147502943|NCT00093470|531993994|FG000|Overall Study|Disease progression|39|||
147502944|NCT00093470|531993995|FG001|Overall Study|Disease progression|0|||
147502945|NCT00093470|531993994|FG000|Overall Study|Adverse Event|15|||
147502946|NCT00093470|531993995|FG001|Overall Study|Adverse Event|0|||
147502947|NCT00093470|531993994|FG000|Overall Study|Death|2|||
147502948|NCT00093470|531993995|FG001|Overall Study|Death|0|||
147502949|NCT00093470|531993994|FG000|Overall Study|Withdrawal by Subject|8|||
147502950|NCT00093470|531993995|FG001|Overall Study|Withdrawal by Subject|0|||
147502951|NCT00093470|531993994|FG000|Overall Study|Alternative therapy|2|||
147502952|NCT00093470|531993995|FG001|Overall Study|Alternative therapy|0|||
147502953|NCT00093470|531993994|FG000|Overall Study|Other complicating disease|3|||
147502954|NCT00093470|531993995|FG001|Overall Study|Other complicating disease|0|||
147502955|NCT00093470|531993994|FG000|Overall Study|Physician Decision|2|||
147502956|NCT00093470|531993995|FG001|Overall Study|Physician Decision|0|||
147502957|NCT00093470|531993994|FG000|Overall Study|Never started treatment|1|||
147502958|NCT00093470|531993995|FG001|Overall Study|Never started treatment|0|||
147502959|NCT00093470|531993994|FG000|Overall Study|ANC < 1000 on day 1 of cycle 1|1|||
147633322|NCT01314872|532474598|FG001|Period 2|Lack of Efficacy|0|||
147633323|NCT01314872|532474599|FG002|Period 2|Lack of Efficacy|0|||
147633324|NCT01314872|532474600|FG003|Period 2|Lack of Efficacy|0|||
147633325|NCT01314872|532474601|FG004|Period 2|Lack of Efficacy|0|||
147633326|NCT01314872|532474602|FG005|Period 2|Lack of Efficacy|0|||
147633327|NCT01314872|532474603|FG006|Period 2|Lack of Efficacy|0|||
147633328|NCT01314872|532474604|FG007|Period 2|Lack of Efficacy|0|||
147633329|NCT01314872|532474605|FG008|Period 2|Lack of Efficacy|0|||
147633330|NCT01314872|532474606|FG009|Period 2|Lack of Efficacy|0|||
147633331|NCT01314872|532474607|FG010|Period 2|Lack of Efficacy|0|||
147633332|NCT01314872|532474608|FG011|Period 2|Lack of Efficacy|7|||
147633333|NCT01314872|532474609|FG012|Period 2|Lack of Efficacy|12|||
147633334|NCT01314872|532474610|FG013|Period 2|Lack of Efficacy|9|||
147633335|NCT01314872|532474611|FG014|Period 2|Lack of Efficacy|2|||
147633336|NCT01314872|532474597|FG000|Period 2|Pregnancy|0|||
147633337|NCT01314872|532474598|FG001|Period 2|Pregnancy|0|||
147633338|NCT01314872|532474599|FG002|Period 2|Pregnancy|0|||
147633339|NCT01314872|532474600|FG003|Period 2|Pregnancy|0|||
147633340|NCT01314872|532474601|FG004|Period 2|Pregnancy|0|||
147633341|NCT01314872|532474602|FG005|Period 2|Pregnancy|0|||
147633342|NCT01314872|532474603|FG006|Period 2|Pregnancy|0|||
147633343|NCT01314872|532474604|FG007|Period 2|Pregnancy|0|||
147633344|NCT01314872|532474605|FG008|Period 2|Pregnancy|0|||
147633345|NCT01314872|532474606|FG009|Period 2|Pregnancy|0|||
147633346|NCT01314872|532474607|FG010|Period 2|Pregnancy|0|||
147633347|NCT01314872|532474608|FG011|Period 2|Pregnancy|0|||
147633348|NCT01314872|532474609|FG012|Period 2|Pregnancy|0|||
147633349|NCT01314872|532474610|FG013|Period 2|Pregnancy|0|||
147633350|NCT01314872|532474611|FG014|Period 2|Pregnancy|1|||
147633351|NCT01314872|532474597|FG000|Period 2|Study terminated by Sponsor|0|||
147633352|NCT01314872|532474598|FG001|Period 2|Study terminated by Sponsor|0|||
147633353|NCT01314872|532474599|FG002|Period 2|Study terminated by Sponsor|0|||
147633354|NCT01314872|532474600|FG003|Period 2|Study terminated by Sponsor|0|||
147633355|NCT01314872|532474601|FG004|Period 2|Study terminated by Sponsor|0|||
147633356|NCT01314872|532474602|FG005|Period 2|Study terminated by Sponsor|0|||
147633357|NCT01314872|532474603|FG006|Period 2|Study terminated by Sponsor|0|||
147633358|NCT01314872|532474604|FG007|Period 2|Study terminated by Sponsor|0|||
147633359|NCT01314872|532474605|FG008|Period 2|Study terminated by Sponsor|0|||
147633360|NCT01314872|532474606|FG009|Period 2|Study terminated by Sponsor|0|||
147633361|NCT01314872|532474607|FG010|Period 2|Study terminated by Sponsor|0|||
147633362|NCT01314872|532474608|FG011|Period 2|Study terminated by Sponsor|2|||
147633363|NCT01314872|532474609|FG012|Period 2|Study terminated by Sponsor|2|||
147633364|NCT01314872|532474610|FG013|Period 2|Study terminated by Sponsor|3|||
147633365|NCT01314872|532474611|FG014|Period 2|Study terminated by Sponsor|0|||
147633366|NCT01314872|532474597|FG000|Period 2|Adverse event, non-fatal|0|||
147633367|NCT01314872|532474598|FG001|Period 2|Adverse event, non-fatal|0|||
147633368|NCT01314872|532474599|FG002|Period 2|Adverse event, non-fatal|0|||
147633369|NCT01314872|532474600|FG003|Period 2|Adverse event, non-fatal|0|||
147633370|NCT01314872|532474601|FG004|Period 2|Adverse event, non-fatal|0|||
147633371|NCT01314872|532474602|FG005|Period 2|Adverse event, non-fatal|0|||
147633372|NCT01314872|532474603|FG006|Period 2|Adverse event, non-fatal|0|||
147633373|NCT01314872|532474604|FG007|Period 2|Adverse event, non-fatal|0|||
147633374|NCT01314872|532474605|FG008|Period 2|Adverse event, non-fatal|0|||
147633375|NCT01314872|532474606|FG009|Period 2|Adverse event, non-fatal|0|||
147633376|NCT01314872|532474607|FG010|Period 2|Adverse event, non-fatal|0|||
147633377|NCT01314872|532474608|FG011|Period 2|Adverse event, non-fatal|13|||
147633378|NCT01314872|532474609|FG012|Period 2|Adverse event, non-fatal|16|||
147633379|NCT01314872|532474610|FG013|Period 2|Adverse event, non-fatal|24|||
147633380|NCT01314872|532474611|FG014|Period 2|Adverse event, non-fatal|9|||
147633381|NCT01314872|532474597|FG000|Period 2|Withdrawal by Subject|0|||
147633382|NCT01314872|532474598|FG001|Period 2|Withdrawal by Subject|0|||
147633383|NCT01314872|532474599|FG002|Period 2|Withdrawal by Subject|0|||
147633384|NCT01314872|532474600|FG003|Period 2|Withdrawal by Subject|0|||
147633385|NCT01314872|532474601|FG004|Period 2|Withdrawal by Subject|0|||
147633386|NCT01314872|532474602|FG005|Period 2|Withdrawal by Subject|0|||
147633387|NCT01314872|532474603|FG006|Period 2|Withdrawal by Subject|0|||
147633388|NCT01314872|532474604|FG007|Period 2|Withdrawal by Subject|0|||
147633389|NCT01314872|532474605|FG008|Period 2|Withdrawal by Subject|0|||
147633390|NCT01314872|532474606|FG009|Period 2|Withdrawal by Subject|0|||
147633391|NCT01314872|532474607|FG010|Period 2|Withdrawal by Subject|0|||
147633392|NCT01314872|532474608|FG011|Period 2|Withdrawal by Subject|14|||
147633393|NCT01314872|532474609|FG012|Period 2|Withdrawal by Subject|17|||
147668727|NCT00784875|532613364|FG003|Period B - Efficacy Endpoint|Entry Criteria Not Met|1|||
147633394|NCT01314872|532474610|FG013|Period 2|Withdrawal by Subject|12|||
147633395|NCT01314872|532474611|FG014|Period 2|Withdrawal by Subject|4|||
147633396|NCT01314872|532474597|FG000|Period 2|Lost to Follow-up|0|||
147633397|NCT01314872|532474598|FG001|Period 2|Lost to Follow-up|0|||
147633398|NCT01314872|532474599|FG002|Period 2|Lost to Follow-up|0|||
147633399|NCT01314872|532474600|FG003|Period 2|Lost to Follow-up|0|||
147633400|NCT01314872|532474601|FG004|Period 2|Lost to Follow-up|0|||
147633401|NCT01314872|532474602|FG005|Period 2|Lost to Follow-up|0|||
147633402|NCT01314872|532474603|FG006|Period 2|Lost to Follow-up|0|||
147633403|NCT01314872|532474604|FG007|Period 2|Lost to Follow-up|0|||
147633404|NCT01314872|532474605|FG008|Period 2|Lost to Follow-up|0|||
147633405|NCT01314872|532474606|FG009|Period 2|Lost to Follow-up|0|||
147633406|NCT01314872|532474607|FG010|Period 2|Lost to Follow-up|0|||
147633407|NCT01314872|532474608|FG011|Period 2|Lost to Follow-up|6|||
147633408|NCT01314872|532474609|FG012|Period 2|Lost to Follow-up|7|||
147633409|NCT01314872|532474610|FG013|Period 2|Lost to Follow-up|2|||
147633410|NCT01314872|532474611|FG014|Period 2|Lost to Follow-up|6|||
147633411|NCT03214380|532476079|FG000|Lead-in|Adverse Event|3|||
147633412|NCT03214380|532476080|FG001|Lead-in|Adverse Event|0|||
147633413|NCT03214380|532476081|FG002|Lead-in|Adverse Event|0|||
147633414|NCT03214380|532476082|FG003|Lead-in|Adverse Event|1|||
147633415|NCT03214380|532476083|FG004|Lead-in|Adverse Event|0|||
147633416|NCT03214380|532476084|FG005|Lead-in|Adverse Event|0|||
147633417|NCT03214380|532476079|FG000|Lead-in|Lost to Follow-up|4|||
147633418|NCT03214380|532476080|FG001|Lead-in|Lost to Follow-up|0|||
147633419|NCT03214380|532476081|FG002|Lead-in|Lost to Follow-up|0|||
147633420|NCT03214380|532476082|FG003|Lead-in|Lost to Follow-up|1|||
147633421|NCT03214380|532476083|FG004|Lead-in|Lost to Follow-up|0|||
147633422|NCT03214380|532476084|FG005|Lead-in|Lost to Follow-up|0|||
147633423|NCT03214380|532476079|FG000|Lead-in|Eligibility Criteria|3|||
147633424|NCT03214380|532476080|FG001|Lead-in|Eligibility Criteria|0|||
147633425|NCT03214380|532476081|FG002|Lead-in|Eligibility Criteria|0|||
147633426|NCT03214380|532476082|FG003|Lead-in|Eligibility Criteria|0|||
147633427|NCT03214380|532476083|FG004|Lead-in|Eligibility Criteria|0|||
147633428|NCT03214380|532476084|FG005|Lead-in|Eligibility Criteria|0|||
147633429|NCT03214380|532476079|FG000|Lead-in|Physician Decision|6|||
147633430|NCT03214380|532476080|FG001|Lead-in|Physician Decision|0|||
147633431|NCT03214380|532476081|FG002|Lead-in|Physician Decision|0|||
147633432|NCT03214380|532476082|FG003|Lead-in|Physician Decision|0|||
147633433|NCT03214380|532476083|FG004|Lead-in|Physician Decision|0|||
147633434|NCT03214380|532476084|FG005|Lead-in|Physician Decision|0|||
147633435|NCT03214380|532476079|FG000|Lead-in|Protocol Deviation|7|||
147633436|NCT03214380|532476080|FG001|Lead-in|Protocol Deviation|0|||
147633437|NCT03214380|532476081|FG002|Lead-in|Protocol Deviation|0|||
147633438|NCT03214380|532476082|FG003|Lead-in|Protocol Deviation|3|||
147633439|NCT03214380|532476083|FG004|Lead-in|Protocol Deviation|0|||
147633440|NCT03214380|532476084|FG005|Lead-in|Protocol Deviation|0|||
147633441|NCT03214380|532476079|FG000|Lead-in|Withdrawal by Subject|41|||
147633442|NCT03214380|532476080|FG001|Lead-in|Withdrawal by Subject|0|||
147633443|NCT03214380|532476081|FG002|Lead-in|Withdrawal by Subject|0|||
147633444|NCT03214380|532476082|FG003|Lead-in|Withdrawal by Subject|14|||
147633445|NCT03214380|532476083|FG004|Lead-in|Withdrawal by Subject|0|||
147633446|NCT03214380|532476084|FG005|Lead-in|Withdrawal by Subject|0|||
147633447|NCT03214380|532476079|FG000|Lead-in|Family Emergency|1|||
147633448|NCT03214380|532476080|FG001|Lead-in|Family Emergency|0|||
147633449|NCT03214380|532476081|FG002|Lead-in|Family Emergency|0|||
147633450|NCT03214380|532476082|FG003|Lead-in|Family Emergency|0|||
147633451|NCT03214380|532476083|FG004|Lead-in|Family Emergency|0|||
147633452|NCT03214380|532476084|FG005|Lead-in|Family Emergency|0|||
147633453|NCT03214380|532476079|FG000|Lead-in|Natural Disaster|9|||
147633454|NCT03214380|532476080|FG001|Lead-in|Natural Disaster|0|||
147633455|NCT03214380|532476081|FG002|Lead-in|Natural Disaster|0|||
147633456|NCT03214380|532476082|FG003|Lead-in|Natural Disaster|0|||
147633457|NCT03214380|532476083|FG004|Lead-in|Natural Disaster|0|||
147633458|NCT03214380|532476084|FG005|Lead-in|Natural Disaster|0|||
147633459|NCT03214380|532476079|FG000|Lead-in|Non Compliance|1|||
147633460|NCT03214380|532476080|FG001|Lead-in|Non Compliance|0|||
147633461|NCT03214380|532476081|FG002|Lead-in|Non Compliance|0|||
147633462|NCT03214380|532476082|FG003|Lead-in|Non Compliance|0|||
147633463|NCT03214380|532476083|FG004|Lead-in|Non Compliance|0|||
147668728|NCT00784875|532613361|FG000|Period B - Efficacy Endpoint|Adverse Event|0|||
147668729|NCT00784875|532613362|FG001|Period B - Efficacy Endpoint|Adverse Event|3|||
147668730|NCT00784875|532613363|FG002|Period B - Efficacy Endpoint|Adverse Event|2|||
147668731|NCT00784875|532613364|FG003|Period B - Efficacy Endpoint|Adverse Event|1|||
147633464|NCT03214380|532476084|FG005|Lead-in|Non Compliance|0|||
147633465|NCT03214380|532476079|FG000|Lead-in|Participant Schedule|2|||
147633466|NCT03214380|532476080|FG001|Lead-in|Participant Schedule|0|||
147633467|NCT03214380|532476081|FG002|Lead-in|Participant Schedule|0|||
147633468|NCT03214380|532476082|FG003|Lead-in|Participant Schedule|0|||
147633469|NCT03214380|532476083|FG004|Lead-in|Participant Schedule|0|||
147633470|NCT03214380|532476084|FG005|Lead-in|Participant Schedule|0|||
147633471|NCT03214380|532476079|FG000|Treatment Period|Adverse Event|0|||
147668732|NCT00784875|532613361|FG000|Period B - Efficacy Endpoint|Protocol Violation|1|||
147633472|NCT03214380|532476080|FG001|Treatment Period|Adverse Event|1|||
147633473|NCT03214380|532476081|FG002|Treatment Period|Adverse Event|1|||
147633474|NCT03214380|532476082|FG003|Treatment Period|Adverse Event|0|||
147633475|NCT03214380|532476083|FG004|Treatment Period|Adverse Event|1|||
147633476|NCT03214380|532476084|FG005|Treatment Period|Adverse Event|0|||
147633477|NCT03214380|532476079|FG000|Treatment Period|Non-Compliance with Study Drug|0|||
147633478|NCT03214380|532476080|FG001|Treatment Period|Non-Compliance with Study Drug|0|||
147633479|NCT03214380|532476081|FG002|Treatment Period|Non-Compliance with Study Drug|0|||
147633480|NCT03214380|532476082|FG003|Treatment Period|Non-Compliance with Study Drug|0|||
147633481|NCT03214380|532476083|FG004|Treatment Period|Non-Compliance with Study Drug|1|||
147633482|NCT03214380|532476084|FG005|Treatment Period|Non-Compliance with Study Drug|0|||
147633483|NCT03214380|532476079|FG000|Treatment Period|Withdrawal by Subject|0|||
147633484|NCT03214380|532476080|FG001|Treatment Period|Withdrawal by Subject|10|||
147633485|NCT03214380|532476081|FG002|Treatment Period|Withdrawal by Subject|8|||
147633486|NCT03214380|532476082|FG003|Treatment Period|Withdrawal by Subject|0|||
147633487|NCT03214380|532476083|FG004|Treatment Period|Withdrawal by Subject|7|||
147633488|NCT03214380|532476084|FG005|Treatment Period|Withdrawal by Subject|11|||
147633489|NCT03214380|532476079|FG000|Treatment Period|Death|0|||
147633490|NCT03214380|532476080|FG001|Treatment Period|Death|1|||
147633491|NCT03214380|532476081|FG002|Treatment Period|Death|2|||
147633492|NCT03214380|532476082|FG003|Treatment Period|Death|0|||
147633493|NCT03214380|532476083|FG004|Treatment Period|Death|0|||
147633494|NCT03214380|532476084|FG005|Treatment Period|Death|0|||
147633495|NCT03214380|532476079|FG000|Treatment Period|Lost to Follow-up|0|||
147633496|NCT03214380|532476080|FG001|Treatment Period|Lost to Follow-up|6|||
147633497|NCT03214380|532476081|FG002|Treatment Period|Lost to Follow-up|3|||
147633498|NCT03214380|532476082|FG003|Treatment Period|Lost to Follow-up|0|||
147633499|NCT03214380|532476083|FG004|Treatment Period|Lost to Follow-up|0|||
147633500|NCT03214380|532476084|FG005|Treatment Period|Lost to Follow-up|0|||
147633501|NCT03214380|532476079|FG000|Treatment Period|Participant schedule|0|||
147633502|NCT03214380|532476080|FG001|Treatment Period|Participant schedule|0|||
147633503|NCT03214380|532476081|FG002|Treatment Period|Participant schedule|1|||
147633504|NCT03214380|532476082|FG003|Treatment Period|Participant schedule|0|||
147633505|NCT03214380|532476083|FG004|Treatment Period|Participant schedule|0|||
147633506|NCT03214380|532476084|FG005|Treatment Period|Participant schedule|0|||
147633507|NCT03214380|532476079|FG000|Treatment Period|Treatment Interruption|0|||
147633508|NCT03214380|532476080|FG001|Treatment Period|Treatment Interruption|0|||
147633509|NCT03214380|532476081|FG002|Treatment Period|Treatment Interruption|1|||
147633510|NCT03214380|532476082|FG003|Treatment Period|Treatment Interruption|0|||
147633511|NCT03214380|532476083|FG004|Treatment Period|Treatment Interruption|0|||
147633512|NCT03214380|532476084|FG005|Treatment Period|Treatment Interruption|0|||
147633513|NCT01905553|532476088|FG000|Period 2|Adverse Event|1|||
147633514|NCT01905553|532476089|FG001|Period 2|Adverse Event|0|||
147633515|NCT03692325|532476093|FG000|Overall Study|Adverse Event|2|||
147633516|NCT03692325|532476093|FG000|Overall Study|Progression/Recurrence|2|||
147633517|NCT02817516|532476094|FG000|Overall Study|Other|0|||
147633518|NCT02817516|532476095|FG001|Overall Study|Other|0|||
147633519|NCT02817516|532476096|FG002|Overall Study|Other|1|||
147633520|NCT02817516|532476097|FG003|Overall Study|Other|0|||
147633521|NCT00664859|532476098|FG000|Overall Study|Adverse Event|2|||
147633522|NCT00664859|532476099|FG001|Overall Study|Adverse Event|1|||
147633523|NCT00664859|532476100|FG002|Overall Study|Adverse Event|3|||
147633524|NCT00664859|532476098|FG000|Overall Study|DB Study (LCP-AtorFen-2001) AE|6|||
147633525|NCT00664859|532476099|FG001|Overall Study|DB Study (LCP-AtorFen-2001) AE|4|||
147633526|NCT00664859|532476100|FG002|Overall Study|DB Study (LCP-AtorFen-2001) AE|4|||
147633527|NCT00664859|532476098|FG000|Overall Study|Noncompliance with protocol|1|||
147633528|NCT00664859|532476099|FG001|Overall Study|Noncompliance with protocol|0|||
147633529|NCT00664859|532476100|FG002|Overall Study|Noncompliance with protocol|4|||
147633530|NCT00664859|532476098|FG000|Overall Study|Laboratory abnormality|2|||
147633531|NCT00664859|532476099|FG001|Overall Study|Laboratory abnormality|1|||
147633532|NCT00664859|532476100|FG002|Overall Study|Laboratory abnormality|4|||
147633533|NCT00664859|532476098|FG000|Overall Study|Withdrawal by Subject|4|||
147633534|NCT00664859|532476099|FG001|Overall Study|Withdrawal by Subject|1|||
147633535|NCT00664859|532476100|FG002|Overall Study|Withdrawal by Subject|3|||
147633536|NCT00664859|532476098|FG000|Overall Study|Lost to Follow-up|2|||
147633537|NCT00664859|532476099|FG001|Overall Study|Lost to Follow-up|2|||
147633538|NCT00664859|532476100|FG002|Overall Study|Lost to Follow-up|1|||
147633539|NCT00664859|532476098|FG000|Overall Study|Other|0|||
147633540|NCT00664859|532476099|FG001|Overall Study|Other|1|||
147502960|NCT00093470|531993995|FG001|Overall Study|ANC < 1000 on day 1 of cycle 1|0|||
147502961|NCT05905601|531993996|FG000|Overall Study|Lost to Follow-up|1|||
147502962|NCT05905601|531993997|FG001|Overall Study|Lost to Follow-up|3|||
147502963|NCT02514772|531993998|FG000|Overall Study|Adverse Event|1|||
147502964|NCT02514772|531993999|FG001|Overall Study|Adverse Event|0|||
147502965|NCT02514772|531993998|FG000|Overall Study|Death|0|||
147502966|NCT02514772|531993999|FG001|Overall Study|Death|1|||
147502967|NCT02514772|531993998|FG000|Overall Study|Withdrawal by Subject|2|||
147633541|NCT00664859|532476100|FG002|Overall Study|Other|2|||
147633542|NCT00348595|532476101|FG000|Overall Study|Adverse Event|5|||
147633543|NCT00348595|532476102|FG001|Overall Study|Adverse Event|8|||
147633544|NCT04481191|532476103|FG000|Overall Study|Withdrawn by parent/guardian|15|||
147633545|NCT04481191|532476104|FG001|Overall Study|Withdrawn by parent/guardian|10|||
147633546|NCT00546117|532476105|FG000|Overall Study|Withdrawal by Subject|3|||
147633547|NCT00546117|532476106|FG001|Overall Study|Withdrawal by Subject|0|||
147633548|NCT00546117|532476105|FG000|Overall Study|Inability to schedule follow-up visit|1|||
147633549|NCT00546117|532476106|FG001|Overall Study|Inability to schedule follow-up visit|0|||
147633550|NCT01560234|532476109|FG000|Overall Study|Lost to Follow-up|3|||
147633551|NCT01560234|532476110|FG001|Overall Study|Lost to Follow-up|0|||
147633552|NCT01560234|532476111|FG002|Overall Study|Lost to Follow-up|1|||
147633553|NCT01560234|532476112|FG003|Overall Study|Lost to Follow-up|0|||
147633554|NCT01560234|532476113|FG004|Overall Study|Lost to Follow-up|0|||
147633555|NCT01560234|532476114|FG005|Overall Study|Lost to Follow-up|2|||
147633556|NCT01560234|532476115|FG006|Overall Study|Lost to Follow-up|0|||
147633557|NCT01560234|532476116|FG007|Overall Study|Lost to Follow-up|2|||
147633558|NCT04292912|532476121|FG000|Overall Study|Physician Decision|1|||
147633559|NCT04292912|532476121|FG000|Overall Study|Protocol Violation|6|||
147633560|NCT00280397|532476122|FG000|Overall Study|Adverse Event|1|||
147633561|NCT01250873|532476132|FG000|Period 1: LY2216684 (Days 1-3)|Adverse Event|2|||
147633562|NCT01250873|532476132|FG000|Period 3:LY2216684+Sertraline(Days11-13)|Adverse Event|1|||
147633563|NCT02278939|532476133|FG000|Overall Study|lack of time|1|||
147633564|NCT02278939|532476134|FG001|Overall Study|lack of time|0|||
147633565|NCT02278939|532476133|FG000|Overall Study|Lost to Follow-up|1|||
147633566|NCT02278939|532476134|FG001|Overall Study|Lost to Follow-up|1|||
147633567|NCT02278939|532476133|FG000|Overall Study|death in family|1|||
147633568|NCT02278939|532476134|FG001|Overall Study|death in family|0|||
147633569|NCT02278939|532476133|FG000|Overall Study|family emergency unable to commit|2|||
147502968|NCT02514772|531993999|FG001|Overall Study|Withdrawal by Subject|1|||
147502969|NCT03583606|531994000|FG000|Overall Study|Lost to Follow-up|0|||
147502970|NCT03583606|531994001|FG001|Overall Study|Lost to Follow-up|1|||
147502971|NCT03583606|531994002|FG002|Overall Study|Lost to Follow-up|0|||
147502972|NCT03583606|531994000|FG000|Overall Study|Ineligible at baseline|1|||
147502973|NCT03583606|531994001|FG001|Overall Study|Ineligible at baseline|0|||
147502974|NCT03583606|531994002|FG002|Overall Study|Ineligible at baseline|0|||
147502975|NCT00817206|531994007|FG000|Overall Study|Adverse Event|10|||
147502976|NCT00817206|531994008|FG001|Overall Study|Adverse Event|3|||
147502977|NCT00817206|531994007|FG000|Overall Study|Protocol Violation|0|||
147502978|NCT00817206|531994008|FG001|Overall Study|Protocol Violation|2|||
147502979|NCT00817206|531994007|FG000|Overall Study|Lost to Follow-up|0|||
147502980|NCT00817206|531994008|FG001|Overall Study|Lost to Follow-up|1|||
147502981|NCT00817206|531994007|FG000|Overall Study|Death|2|||
147502982|NCT00817206|531994008|FG001|Overall Study|Death|0|||
147502983|NCT00817206|531994007|FG000|Overall Study|Withdrawal by Subject|7|||
147502984|NCT00817206|531994008|FG001|Overall Study|Withdrawal by Subject|3|||
147502985|NCT00817206|531994007|FG000|Overall Study|Physician Decision|2|||
147502986|NCT00817206|531994008|FG001|Overall Study|Physician Decision|0|||
147502987|NCT00126581|531994009|FG000|Overall Study|Adverse Event|3|||
147502988|NCT00126581|531994010|FG001|Overall Study|Adverse Event|7|||
147502989|NCT00126581|531994009|FG000|Overall Study|Death|3|||
147502990|NCT00126581|531994010|FG001|Overall Study|Death|2|||
147502991|NCT00126581|531994009|FG000|Overall Study|Withdrawal by Subject|1|||
147502992|NCT00126581|531994010|FG001|Overall Study|Withdrawal by Subject|4|||
147502993|NCT00126581|531994009|FG000|Overall Study|Alternative therapy|3|||
147502994|NCT00126581|531994010|FG001|Overall Study|Alternative therapy|3|||
147502995|NCT00126581|531994009|FG000|Overall Study|Other illness/MD discretion|3|||
147502996|NCT00126581|531994010|FG001|Overall Study|Other illness/MD discretion|4|||
147502997|NCT00793182|531994011|FG000|Overall Study|Adverse Event|0|||
147502998|NCT00793182|531994012|FG001|Overall Study|Adverse Event|1|||
147502999|NCT03728140|531994014|FG000|Overall Study|Abnormal embryo transfer operation|10|||
147503000|NCT03728140|531994015|FG001|Overall Study|Abnormal embryo transfer operation|7|||
147503001|NCT01188096|531994016|FG000|Overall Study|progression of disease|4|||
147503002|NCT01188096|531994016|FG000|Overall Study|Withdrawal by Subject|2|||
147503003|NCT00851253|531994017|FG000|Overall Study|Disease Progression|1|||
147503004|NCT00851253|531994018|FG001|Overall Study|Disease Progression|0|||
147503005|NCT02384395|531994019|FG000|Overall Study|Physician Decision|4|||
147503006|NCT02384395|531994019|FG000|Overall Study|Withdrawal by Subject|3|||
147503007|NCT02384395|531994019|FG000|Overall Study|Lost to Follow-up|3|||
147633570|NCT02278939|532476134|FG001|Overall Study|family emergency unable to commit|0|||
147633571|NCT02423343|532476137|FG000|Overall Study|Withdrawal by Subject|0|||
147633572|NCT02423343|532476138|FG001|Overall Study|Withdrawal by Subject|1|||
147633573|NCT02423343|532476139|FG002|Overall Study|Withdrawal by Subject|0|||
147633574|NCT02423343|532476140|FG003|Overall Study|Withdrawal by Subject|0|||
147633575|NCT02423343|532476141|FG004|Overall Study|Withdrawal by Subject|0|||
147503008|NCT01779648|531994020|FG000|Overall Study|Protocol Violation|1|||
147503009|NCT01779648|531994021|FG001|Overall Study|Protocol Violation|0|||
147503010|NCT03485222|531994024|FG000|Overall Study|Death|0|||
147503011|NCT03485222|531994025|FG001|Overall Study|Death|1|||
147503012|NCT03485222|531994024|FG000|Overall Study|Lost to Follow-up|2|||
147503013|NCT03485222|531994025|FG001|Overall Study|Lost to Follow-up|1|||
147503014|NCT00367341|531994027|FG000|Overall Study|Physician Decision|1|||
147503015|NCT00367341|531994028|FG001|Overall Study|Physician Decision|0|||
147503016|NCT00367341|531994027|FG000|Overall Study|Protocol Violation|1|||
147503017|NCT00367341|531994028|FG001|Overall Study|Protocol Violation|0|||
147633576|NCT02423343|532476142|FG005|Overall Study|Withdrawal by Subject|0|||
147633577|NCT02423343|532476137|FG000|Overall Study|Progressive Disease|0|||
147633578|NCT02423343|532476138|FG001|Overall Study|Progressive Disease|0|||
147503018|NCT03004976|531994034|FG000|Overall Study|Lost to Follow-up|7|||
147503019|NCT03004976|531994035|FG001|Overall Study|Lost to Follow-up|5|||
147503020|NCT03004976|531994034|FG000|Overall Study|Physician Decision|1|||
147503021|NCT03004976|531994035|FG001|Overall Study|Physician Decision|0|||
147503022|NCT03004976|531994034|FG000|Overall Study|Withdrawal by Subject|1|||
147503023|NCT03004976|531994035|FG001|Overall Study|Withdrawal by Subject|0|||
147503024|NCT03004976|531994034|FG000|Overall Study|Death|4|||
147503025|NCT03004976|531994035|FG001|Overall Study|Death|1|||
147503026|NCT01143714|531994036|FG000|Overall Study|Adverse Event|4|||
147503027|NCT01143714|531994037|FG001|Overall Study|Adverse Event|2|||
147503028|NCT01143714|531994036|FG000|Overall Study|Withdrawal by Subject|1|||
147503029|NCT01143714|531994037|FG001|Overall Study|Withdrawal by Subject|0|||
147503030|NCT01143714|531994036|FG000|Overall Study|Subject non-compliance|0|||
147503031|NCT01143714|531994037|FG001|Overall Study|Subject non-compliance|1|||
147503032|NCT01143714|531994036|FG000|Overall Study|wound closed = deemed healed|1|||
147503033|NCT01143714|531994037|FG001|Overall Study|wound closed = deemed healed|0|||
147503034|NCT01143714|531994036|FG000|Overall Study|wound size increased|1|||
147503035|NCT01143714|531994037|FG001|Overall Study|wound size increased|0|||
147503036|NCT01106391|531994038|FG000|Overall Study|Death|12|||
147503037|NCT01106391|531994038|FG000|Overall Study|Withdrawal by Subject|7|||
147503038|NCT00150345|531994039|FG000|Overall Study|Death|5|||
147503039|NCT00150345|531994040|FG001|Overall Study|Death|2|||
147503040|NCT00150345|531994039|FG000|Overall Study|Adverse Event|8|||
147503041|NCT00150345|531994040|FG001|Overall Study|Adverse Event|6|||
147503042|NCT00150345|531994039|FG000|Overall Study|Lack of Efficacy|5|||
147503043|NCT00150345|531994040|FG001|Overall Study|Lack of Efficacy|4|||
147503044|NCT00150345|531994039|FG000|Overall Study|Withdrawal by Subject|3|||
147503045|NCT00150345|531994040|FG001|Overall Study|Withdrawal by Subject|4|||
147503046|NCT00150345|531994039|FG000|Overall Study|Laboratory abnormality|1|||
147503047|NCT00150345|531994040|FG001|Overall Study|Laboratory abnormality|2|||
147503048|NCT00150345|531994039|FG000|Overall Study|Other|12|||
147503049|NCT00150345|531994040|FG001|Overall Study|Other|14|||
147503050|NCT00555568|531994043|FG000|Overall Study|Lost to Follow-up|26|||
147503051|NCT00555568|531994044|FG001|Overall Study|Lost to Follow-up|16|||
147503052|NCT00555568|531994045|FG002|Overall Study|Lost to Follow-up|16|||
147503053|NCT01588353|531994046|FG000|Step2|Withdrawal by Subject|0|||
147503054|NCT01588353|531994047|FG001|Step2|Withdrawal by Subject|1|||
147503055|NCT01588353|531994048|FG002|Step2|Withdrawal by Subject|0|||
147503056|NCT01588353|531994046|FG000|Step3|Adverse Event|0|||
147503057|NCT01588353|531994047|FG001|Step3|Adverse Event|0|||
147503058|NCT01588353|531994048|FG002|Step3|Adverse Event|2|||
147503059|NCT01409993|531994049|FG000|Overall Study|Adverse Event|4|||
147503060|NCT01409993|531994050|FG001|Overall Study|Adverse Event|4|||
147503061|NCT01409993|531994051|FG002|Overall Study|Adverse Event|3|||
147503062|NCT01409993|531994052|FG003|Overall Study|Adverse Event|1|||
147503063|NCT01409993|531994049|FG000|Overall Study|Withdrawal by Subject|0|||
147503064|NCT01409993|531994050|FG001|Overall Study|Withdrawal by Subject|0|||
147503065|NCT01409993|531994051|FG002|Overall Study|Withdrawal by Subject|0|||
147503066|NCT01409993|531994052|FG003|Overall Study|Withdrawal by Subject|4|||
147503067|NCT01409993|531994049|FG000|Overall Study|Lost to Follow-up|0|||
147503068|NCT01409993|531994050|FG001|Overall Study|Lost to Follow-up|1|||
147503069|NCT01409993|531994051|FG002|Overall Study|Lost to Follow-up|0|||
147503070|NCT01409993|531994052|FG003|Overall Study|Lost to Follow-up|0|||
147503071|NCT02677220|531994053|FG000|Overall Study|Adverse Event|1|||
147503072|NCT00965146|531994054|FG000|Overall Study|Death|7|||
147503073|NCT00965146|531994054|FG000|Overall Study|Lost to Follow-up|22|||
147503074|NCT00965146|531994054|FG000|Overall Study|Withdrawal by Subject|17|||
147503075|NCT00965146|531994054|FG000|Overall Study|Unable to return|1|||
147503076|NCT00965146|531994054|FG000|Overall Study|Unwilling to return|11|||
147503077|NCT00965146|531994054|FG000|Overall Study|Intercurrent illness|1|||
147503078|NCT00965146|531994054|FG000|Overall Study|Revision / Removal of Study Implant|6|||
147503079|NCT00965146|531994054|FG000|Overall Study|Overall Study Termination|145|||
147503080|NCT05067452|531994055|FG000|Overall Study|Lost to Follow-up|0|||
147503081|NCT05067452|531994056|FG001|Overall Study|Lost to Follow-up|4|||
147503082|NCT00067470|531994057|FG000|Overall Study|Withdrawal by Subject|0|||
147503083|NCT00067470|531994058|FG001|Overall Study|Withdrawal by Subject|1|||
147503084|NCT01135017|531994059|FG000|Overall Study|Adverse Event|3|||
147503085|NCT01135017|531994060|FG001|Overall Study|Adverse Event|8|||
147503086|NCT01135017|531994059|FG000|Overall Study|Other than above|3|||
147503087|NCT01135017|531994060|FG001|Overall Study|Other than above|4|||
147503088|NCT01148693|531994061|FG000|Overall Study|Attempts for cannulation were failed|13|||
147503089|NCT01148693|531994062|FG001|Overall Study|Attempts for cannulation were failed|10|||
147503090|NCT01504971|531994064|FG000|Overall Study|Physician Decision|13|||
147503091|NCT00050622|531994065|FG000|Overall Study|Adverse Event|1|||
147503092|NCT00936117|531994068|FG000|Overall Study|Adverse Event|7|||
147503093|NCT00936117|531994068|FG000|Overall Study|Unable to continue oral medication|3|||
147503094|NCT04581863|531994069|FG000|Overall Study|Patients in alternate home program (e.g., home health care, inpatient rehab, etc.) were unenrolled.|17|||
147503095|NCT04581863|531994070|FG001|Overall Study|Patients in alternate home program (e.g., home health care, inpatient rehab, etc.) were unenrolled.|31|||
147633579|NCT02423343|532476139|FG002|Overall Study|Progressive Disease|0|||
147633580|NCT02423343|532476140|FG003|Overall Study|Progressive Disease|0|||
147633581|NCT02423343|532476141|FG004|Overall Study|Progressive Disease|2|||
147633582|NCT02423343|532476142|FG005|Overall Study|Progressive Disease|0|||
147633583|NCT02423343|532476137|FG000|Overall Study|Adverse Event|0|||
147633584|NCT02423343|532476138|FG001|Overall Study|Adverse Event|0|||
147633585|NCT02423343|532476139|FG002|Overall Study|Adverse Event|0|||
147633586|NCT02423343|532476140|FG003|Overall Study|Adverse Event|0|||
147633587|NCT02423343|532476141|FG004|Overall Study|Adverse Event|2|||
147633588|NCT02423343|532476142|FG005|Overall Study|Adverse Event|0|||
147633589|NCT02423343|532476137|FG000|Overall Study|Death|0|||
147633590|NCT02423343|532476138|FG001|Overall Study|Death|0|||
147633591|NCT02423343|532476139|FG002|Overall Study|Death|0|||
147633592|NCT02423343|532476140|FG003|Overall Study|Death|0|||
147633593|NCT02423343|532476141|FG004|Overall Study|Death|1|||
147633594|NCT02423343|532476142|FG005|Overall Study|Death|0|||
147633595|NCT00626821|532476148|FG000|Overall Study|Adverse Event|44|||
147633596|NCT00626821|532476148|FG000|Overall Study|Protocol Violation|33|||
147633597|NCT00626821|532476148|FG000|Overall Study|Withdrawal by Subject|10|||
147633598|NCT00626821|532476148|FG000|Overall Study|Physician Decision|9|||
147633599|NCT00626821|532476148|FG000|Overall Study|Product dysfunction|21|||
147633600|NCT00626821|532476148|FG000|Overall Study|other/unknown reason|104|||
147633601|NCT01940887|532476156|FG000|Year 1|Protocol Violation|0|||
147633602|NCT01940887|532476157|FG001|Year 1|Protocol Violation|1|||
147633603|NCT01940887|532476156|FG000|Year 1|Physician Decision|7|||
147633604|NCT01940887|532476157|FG001|Year 1|Physician Decision|3|||
147633605|NCT01940887|532476156|FG000|Year 1|Death|5|||
147633606|NCT01940887|532476157|FG001|Year 1|Death|3|||
147633607|NCT01940887|532476156|FG000|Year 1|Adverse Event|7|||
147633608|NCT01940887|532476157|FG001|Year 1|Adverse Event|6|||
147633609|NCT01940887|532476156|FG000|Year 1|Withdrawal by Subject|18|||
147633610|NCT01940887|532476157|FG001|Year 1|Withdrawal by Subject|9|||
147633611|NCT01940887|532476156|FG000|Year 1|Lost to Follow-up|2|||
147633612|NCT01940887|532476157|FG001|Year 1|Lost to Follow-up|1|||
147503096|NCT01803711|531994071|FG000|Overall Study|Adverse Event|1|||
147503097|NCT01803711|531994072|FG001|Overall Study|Adverse Event|1|||
147503098|NCT00225212|531994073|FG000|Overall Study|Disease progression|2|||
147503099|NCT00225212|531994073|FG000|Overall Study|Death|1|||
147503100|NCT00225212|531994073|FG000|Overall Study|Adverse Event|2|||
147503101|NCT00225212|531994073|FG000|Overall Study|Intercurrent illness|1|||
147503102|NCT01357889|531994076|FG000|Single-dose Phase (BE Phase: 28 Days)|Withdrawal by Subject|2|||
147503103|NCT01357889|531994077|FG001|Single-dose Phase (BE Phase: 28 Days)|Withdrawal by Subject|1|||
147503104|NCT01357889|531994076|FG000|Single-dose Phase (BE Phase: 28 Days)|Persistent Hyperglycemia|1|||
147503105|NCT01357889|531994077|FG001|Single-dose Phase (BE Phase: 28 Days)|Persistent Hyperglycemia|1|||
147503106|NCT01357889|531994076|FG000|Single-dose Phase (BE Phase: 28 Days)|Physician Decision|1|||
147503107|NCT01357889|531994077|FG001|Single-dose Phase (BE Phase: 28 Days)|Physician Decision|0|||
147503108|NCT01357889|531994076|FG000|Multiple-dose Phase (MDP) (Overall)|Adverse Event|2|||
147503109|NCT01357889|531994077|FG001|Multiple-dose Phase (MDP) (Overall)|Adverse Event|2|||
147503110|NCT01357889|531994076|FG000|Multiple-dose Phase (MDP) (Overall)|Noncompliance|0|||
147503111|NCT01357889|531994077|FG001|Multiple-dose Phase (MDP) (Overall)|Noncompliance|2|||
147503112|NCT01357889|531994076|FG000|Multiple-dose Phase (MDP) (Overall)|Lost to Follow-up|0|||
147503113|NCT01357889|531994077|FG001|Multiple-dose Phase (MDP) (Overall)|Lost to Follow-up|2|||
147503114|NCT01357889|531994076|FG000|Multiple-dose Phase (MDP) (Overall)|Withdrawal by Subject|5|||
147503115|NCT01357889|531994077|FG001|Multiple-dose Phase (MDP) (Overall)|Withdrawal by Subject|2|||
147503116|NCT01357889|531994076|FG000|Multiple-dose Phase (MDP) (Overall)|Physician Decision|2|||
147503117|NCT01357889|531994077|FG001|Multiple-dose Phase (MDP) (Overall)|Physician Decision|1|||
147503118|NCT01357889|531994076|FG000|Multiple-dose Phase (MDP) (Overall)|Withdrawn Due to Hyperglycemia|7|||
147503119|NCT01357889|531994077|FG001|Multiple-dose Phase (MDP) (Overall)|Withdrawn Due to Hyperglycemia|7|||
147503120|NCT01357889|531994076|FG000|Follow-up Phase (FUP) (8 Weeks)|Noncompliance|1|||
147503121|NCT01357889|531994077|FG001|Follow-up Phase (FUP) (8 Weeks)|Noncompliance|0|||
147503122|NCT01357889|531994076|FG000|Follow-up Phase (FUP) (8 Weeks)|Lost to Follow-up|0|||
147503123|NCT01357889|531994077|FG001|Follow-up Phase (FUP) (8 Weeks)|Lost to Follow-up|4|||
147503124|NCT01357889|531994076|FG000|Follow-up Phase (FUP) (8 Weeks)|Withdrawal by Subject|1|||
147503125|NCT01357889|531994077|FG001|Follow-up Phase (FUP) (8 Weeks)|Withdrawal by Subject|0|||
147633613|NCT01940887|532476156|FG000|Year 2|Physician Decision|8|||
147633614|NCT01940887|532476157|FG001|Year 2|Physician Decision|1|||
147633615|NCT01940887|532476156|FG000|Year 2|Death|0|||
147668733|NCT00784875|532613362|FG001|Period B - Efficacy Endpoint|Protocol Violation|1|||
147633616|NCT01940887|532476157|FG001|Year 2|Death|2|||
147633617|NCT01940887|532476156|FG000|Year 2|Sponsor Decision, early termination|192|||
147633618|NCT01940887|532476157|FG001|Year 2|Sponsor Decision, early termination|203|||
147633619|NCT01940887|532476156|FG000|Year 2|Adverse Event|8|||
147633620|NCT01940887|532476157|FG001|Year 2|Adverse Event|2|||
147633621|NCT01940887|532476156|FG000|Year 2|Withdrawal by Subject|8|||
147633622|NCT01940887|532476157|FG001|Year 2|Withdrawal by Subject|8|||
147633623|NCT01940887|532476156|FG000|Year 2|Lost to Follow-up|1|||
147633624|NCT01940887|532476157|FG001|Year 2|Lost to Follow-up|6|||
147503126|NCT01357889|531994076|FG000|Follow-up Phase (FUP) (8 Weeks)|Hyperglycemia|1|||
147503127|NCT01357889|531994077|FG001|Follow-up Phase (FUP) (8 Weeks)|Hyperglycemia|0|||
147503128|NCT02693691|531994078|FG000|Primary Endpoint Analysis (First 12M)|Death|30|||
147503129|NCT02693691|531994078|FG000|Primary Endpoint Analysis (First 12M)|Withdrawal by Subject|12|||
147503130|NCT02693691|531994078|FG000|Primary Endpoint Analysis (First 12M)|Physician Decision|7|||
147503131|NCT02693691|531994078|FG000|Primary Endpoint Analysis (First 12M)|Adverse Event|1|||
147503132|NCT02693691|531994078|FG000|Extended Follow-Up (Until Last pt 12M)|Death|12|||
147503133|NCT02693691|531994078|FG000|Extended Follow-Up (Until Last pt 12M)|Withdrawal by Subject|11|||
147503134|NCT02693691|531994078|FG000|Extended Follow-Up (Until Last pt 12M)|Physician Decision|1|||
147503135|NCT02727660|531994079|FG000|Overall Study|Lack of Efficacy|40|||
147503136|NCT02727660|531994080|FG001|Overall Study|Lack of Efficacy|40|||
147503137|NCT02727660|531994081|FG002|Overall Study|Lack of Efficacy|70|||
147503138|NCT02727660|531994079|FG000|Overall Study|Adverse Event|28|||
147503139|NCT02727660|531994080|FG001|Overall Study|Adverse Event|21|||
147503140|NCT02727660|531994081|FG002|Overall Study|Adverse Event|32|||
147503141|NCT02727660|531994079|FG000|Overall Study|Withdrawal by Subject|26|||
147503142|NCT02727660|531994080|FG001|Overall Study|Withdrawal by Subject|25|||
147503143|NCT02727660|531994081|FG002|Overall Study|Withdrawal by Subject|30|||
147503144|NCT02727660|531994079|FG000|Overall Study|Physician Decision|3|||
147503145|NCT02727660|531994080|FG001|Overall Study|Physician Decision|8|||
147503146|NCT02727660|531994081|FG002|Overall Study|Physician Decision|14|||
147503147|NCT02727660|531994079|FG000|Overall Study|Lost to Follow-up|5|||
147503148|NCT02727660|531994080|FG001|Overall Study|Lost to Follow-up|9|||
147503149|NCT02727660|531994081|FG002|Overall Study|Lost to Follow-up|8|||
147503150|NCT02727660|531994079|FG000|Overall Study|Protocol Violation|7|||
147503151|NCT02727660|531994080|FG001|Overall Study|Protocol Violation|5|||
147503152|NCT02727660|531994081|FG002|Overall Study|Protocol Violation|5|||
147503153|NCT02727660|531994079|FG000|Overall Study|Protocol Specified Disc. Criteria|5|||
147503154|NCT02727660|531994080|FG001|Overall Study|Protocol Specified Disc. Criteria|5|||
147503155|NCT02727660|531994081|FG002|Overall Study|Protocol Specified Disc. Criteria|2|||
147503156|NCT02727660|531994079|FG000|Overall Study|Administrative Reasons|2|||
147503157|NCT02727660|531994080|FG001|Overall Study|Administrative Reasons|3|||
147503158|NCT02727660|531994081|FG002|Overall Study|Administrative Reasons|4|||
147503159|NCT00764946|531994084|FG000|Overall Study|Lack of Efficacy|1|||
147503160|NCT00764946|531994085|FG001|Overall Study|Lack of Efficacy|0|||
147503161|NCT00764946|531994086|FG002|Overall Study|Lack of Efficacy|0|||
147503162|NCT00764946|531994084|FG000|Overall Study|Lost to Follow-up|3|||
147503163|NCT00764946|531994085|FG001|Overall Study|Lost to Follow-up|4|||
147503164|NCT00764946|531994086|FG002|Overall Study|Lost to Follow-up|0|||
147503165|NCT00764946|531994084|FG000|Overall Study|Physician Decision|2|||
147503166|NCT00764946|531994085|FG001|Overall Study|Physician Decision|4|||
147503167|NCT00764946|531994086|FG002|Overall Study|Physician Decision|0|||
147503168|NCT00764946|531994084|FG000|Overall Study|Adverse Event|3|||
147503169|NCT00764946|531994085|FG001|Overall Study|Adverse Event|2|||
147503170|NCT00764946|531994086|FG002|Overall Study|Adverse Event|1|||
147503171|NCT00764946|531994084|FG000|Overall Study|Withdrawal by Subject|3|||
147503172|NCT00764946|531994085|FG001|Overall Study|Withdrawal by Subject|6|||
147503173|NCT00764946|531994086|FG002|Overall Study|Withdrawal by Subject|2|||
147503174|NCT00764946|531994084|FG000|Overall Study|Never Treated|1|||
147503175|NCT00764946|531994085|FG001|Overall Study|Never Treated|1|||
147503176|NCT00764946|531994086|FG002|Overall Study|Never Treated|1|||
147503177|NCT01162304|531994087|FG000|Overall Study|Beck scale to high|11|||
147503178|NCT00413062|531994088|FG000|Overall Study|Adverse event/serious adverse event|289|||
147503179|NCT00413062|531994089|FG001|Overall Study|Adverse event/serious adverse event|56|||
147503180|NCT00413062|531994088|FG000|Overall Study|Pre-treatment (serious) adverse event|1|||
147503181|NCT00413062|531994089|FG001|Overall Study|Pre-treatment (serious) adverse event|0|||
147503182|NCT00413062|531994088|FG000|Overall Study|Withdrawal of informed consent|111|||
147503183|NCT00413062|531994089|FG001|Overall Study|Withdrawal of informed consent|36|||
147503184|NCT00413062|531994088|FG000|Overall Study|Pregnancy|15|||
147503185|NCT00413062|531994089|FG001|Overall Study|Pregnancy|5|||
147503186|NCT00413062|531994088|FG000|Overall Study|Pregnancy wish|17|||
147503187|NCT00413062|531994089|FG001|Overall Study|Pregnancy wish|6|||
147633625|NCT01062113|532476158|FG000|Overall Study|Adverse Event|1|||
147633626|NCT01062113|532476159|FG001|Overall Study|Adverse Event|0|||
147633627|NCT01062113|532476160|FG002|Overall Study|Adverse Event|0|||
147633628|NCT01062113|532476158|FG000|Overall Study|Lack of Efficacy|38|||
147503188|NCT00413062|531994088|FG000|Overall Study|Lost to Follow-up|175|||
147503189|NCT00413062|531994089|FG001|Overall Study|Lost to Follow-up|73|||
147503190|NCT00413062|531994088|FG000|Overall Study|Other reason|70|||
147503191|NCT00413062|531994089|FG001|Overall Study|Other reason|34|||
147503192|NCT02176291|531994090|FG000|Overall Study|Death|1|||
147503193|NCT02176291|531994091|FG001|Overall Study|Death|0|||
147503194|NCT02176291|531994090|FG000|Overall Study|non compliance with protocol|2|||
147503195|NCT02176291|531994091|FG001|Overall Study|non compliance with protocol|0|||
147503196|NCT02176291|531994090|FG000|Overall Study|Withdrawal by Subject|2|||
147633629|NCT01062113|532476159|FG001|Overall Study|Lack of Efficacy|22|||
147503197|NCT02176291|531994091|FG001|Overall Study|Withdrawal by Subject|0|||
147633630|NCT01062113|532476160|FG002|Overall Study|Lack of Efficacy|31|||
147633631|NCT01062113|532476158|FG000|Overall Study|Withdrawal by Subject|1|||
147633632|NCT01062113|532476159|FG001|Overall Study|Withdrawal by Subject|0|||
147633633|NCT01062113|532476160|FG002|Overall Study|Withdrawal by Subject|0|||
147633634|NCT01290679|532476161|FG000|Overall Study|Adverse Event|2|||
147633635|NCT01290679|532476162|FG001|Overall Study|Adverse Event|0|||
147633636|NCT01290679|532476161|FG000|Overall Study|Lost to Follow-up|8|||
147633637|NCT01290679|532476162|FG001|Overall Study|Lost to Follow-up|10|||
147633638|NCT01290679|532476161|FG000|Overall Study|Protocol Violation|0|||
147633639|NCT01290679|532476162|FG001|Overall Study|Protocol Violation|1|||
147633640|NCT01290679|532476161|FG000|Overall Study|Withdrawal by Subject|6|||
147633641|NCT01290679|532476162|FG001|Overall Study|Withdrawal by Subject|5|||
147633642|NCT01290679|532476161|FG000|Overall Study|Subject Entered Another Trial|0|||
147633643|NCT01290679|532476162|FG001|Overall Study|Subject Entered Another Trial|5|||
147633644|NCT00562302|532476163|FG000|Overall Study|Lost to Follow-up|3|||
147633645|NCT00562302|532476164|FG001|Overall Study|Lost to Follow-up|3|||
147633646|NCT00562302|532476163|FG000|Overall Study|Adverse Event|0|||
147633647|NCT00562302|532476164|FG001|Overall Study|Adverse Event|6|||
147633648|NCT00562302|532476163|FG000|Overall Study|Non-compliance|1|||
147633649|NCT00562302|532476164|FG001|Overall Study|Non-compliance|2|||
147633650|NCT00562302|532476163|FG000|Overall Study|Withdrawal by Subject|7|||
147633651|NCT00562302|532476164|FG001|Overall Study|Withdrawal by Subject|8|||
147633652|NCT00562302|532476163|FG000|Overall Study|Death|1|||
147633653|NCT00562302|532476164|FG001|Overall Study|Death|2|||
147633654|NCT00562302|532476163|FG000|Overall Study|Lung resection prior to study completion|7|||
147633655|NCT00562302|532476164|FG001|Overall Study|Lung resection prior to study completion|7|||
147633656|NCT00562302|532476163|FG000|Overall Study|Not stated|1|||
147633657|NCT00562302|532476164|FG001|Overall Study|Not stated|4|||
147633658|NCT04791319|532476165|FG000|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|4|||
147633659|NCT04791319|532476166|FG001|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|2|||
147633660|NCT04791319|532476167|FG002|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|9|||
147633661|NCT04791319|532476168|FG003|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|3|||
147633662|NCT04791319|532476169|FG004|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
147633663|NCT04791319|532476170|FG005|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
147633664|NCT04791319|532476171|FG006|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
147633665|NCT04791319|532476172|FG007|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
147633666|NCT04791319|532476173|FG008|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
147633667|NCT04791319|532476174|FG009|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
147633668|NCT04791319|532476175|FG010|Placebo Controlled Period (Week 0-15)|Withdrawal by Subject|0|||
147633669|NCT04791319|532476165|FG000|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|1|||
147633670|NCT04791319|532476166|FG001|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
147633671|NCT04791319|532476167|FG002|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|2|||
147633672|NCT04791319|532476168|FG003|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|1|||
147633673|NCT04791319|532476169|FG004|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
147633674|NCT04791319|532476170|FG005|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
147633675|NCT04791319|532476171|FG006|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
147633676|NCT04791319|532476172|FG007|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
147633677|NCT04791319|532476173|FG008|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
147633678|NCT04791319|532476174|FG009|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
147633679|NCT04791319|532476175|FG010|Placebo Controlled Period (Week 0-15)|Lost to Follow-up|0|||
147633680|NCT04791319|532476165|FG000|Placebo Controlled Period (Week 0-15)|Trial termination|2|||
147633681|NCT04791319|532476166|FG001|Placebo Controlled Period (Week 0-15)|Trial termination|4|||
147633682|NCT04791319|532476167|FG002|Placebo Controlled Period (Week 0-15)|Trial termination|5|||
147633683|NCT04791319|532476168|FG003|Placebo Controlled Period (Week 0-15)|Trial termination|4|||
147633684|NCT04791319|532476169|FG004|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
147633685|NCT04791319|532476170|FG005|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
147633686|NCT04791319|532476171|FG006|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
147633687|NCT04791319|532476172|FG007|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
147633688|NCT04791319|532476173|FG008|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
147633689|NCT04791319|532476174|FG009|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
147633690|NCT04791319|532476175|FG010|Placebo Controlled Period (Week 0-15)|Trial termination|0|||
147633691|NCT04791319|532476165|FG000|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|7|||
147633692|NCT04791319|532476166|FG001|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|6|||
147633693|NCT04791319|532476167|FG002|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|21|||
147633694|NCT04791319|532476168|FG003|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|19|||
147633695|NCT04791319|532476169|FG004|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
147633696|NCT04791319|532476170|FG005|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
147644036|NCT00738062|532516706|FG002|Open Label Treatment|Protocol Violation|0|||
147503198|NCT03454412|531994092|FG000|Baseline Assesment|Physician Decision|12|||
147503199|NCT01167582|531994093|FG000|Overall Study|Lost to Follow-up|0|||
147503200|NCT01167582|531994094|FG001|Overall Study|Lost to Follow-up|1|||
147503201|NCT03589885|531994095|FG000|Treatment Period 1-Randomized Set|Adverse Event|0|||
147503202|NCT03589885|531994096|FG001|Treatment Period 1-Randomized Set|Adverse Event|1|||
147503203|NCT03589885|531994097|FG002|Treatment Period 1-Randomized Set|Adverse Event|0|||
147503204|NCT03589885|531994098|FG003|Treatment Period 1-Randomized Set|Adverse Event|0|||
147503205|NCT03589885|531994099|FG004|Treatment Period 1-Randomized Set|Adverse Event|0|||
147503206|NCT03589885|531994095|FG000|Treatment Period 1-Randomized Set|Lack of Efficacy|0|||
147503207|NCT03589885|531994096|FG001|Treatment Period 1-Randomized Set|Lack of Efficacy|0|||
147503208|NCT03589885|531994097|FG002|Treatment Period 1-Randomized Set|Lack of Efficacy|2|||
147503209|NCT03589885|531994098|FG003|Treatment Period 1-Randomized Set|Lack of Efficacy|0|||
147503210|NCT03589885|531994099|FG004|Treatment Period 1-Randomized Set|Lack of Efficacy|0|||
147503211|NCT03589885|531994095|FG000|Treatment Period 1-Randomized Set|Lost to Follow-up|0|||
147503212|NCT03589885|531994096|FG001|Treatment Period 1-Randomized Set|Lost to Follow-up|1|||
147503213|NCT03589885|531994097|FG002|Treatment Period 1-Randomized Set|Lost to Follow-up|0|||
147503214|NCT03589885|531994098|FG003|Treatment Period 1-Randomized Set|Lost to Follow-up|0|||
147503215|NCT03589885|531994099|FG004|Treatment Period 1-Randomized Set|Lost to Follow-up|0|||
147503216|NCT03589885|531994095|FG000|Treatment Period 1-Randomized Set|Withdrawal by Subject|0|||
147503217|NCT03589885|531994096|FG001|Treatment Period 1-Randomized Set|Withdrawal by Subject|0|||
147503218|NCT03589885|531994097|FG002|Treatment Period 1-Randomized Set|Withdrawal by Subject|1|||
147503219|NCT03589885|531994098|FG003|Treatment Period 1-Randomized Set|Withdrawal by Subject|0|||
147503220|NCT03589885|531994099|FG004|Treatment Period 1-Randomized Set|Withdrawal by Subject|0|||
147503221|NCT03589885|531994095|FG000|Treatment Period 2-Randomized Set|Adverse Event|0|||
147503222|NCT03589885|531994096|FG001|Treatment Period 2-Randomized Set|Adverse Event|1|||
147503223|NCT03589885|531994097|FG002|Treatment Period 2-Randomized Set|Adverse Event|0|||
147503224|NCT03589885|531994098|FG003|Treatment Period 2-Randomized Set|Adverse Event|0|||
147503225|NCT03589885|531994099|FG004|Treatment Period 2-Randomized Set|Adverse Event|0|||
147503226|NCT03589885|531994095|FG000|Treatment Period 2-Randomized Set|Pregnancy|1|||
147503227|NCT03589885|531994096|FG001|Treatment Period 2-Randomized Set|Pregnancy|0|||
147503228|NCT03589885|531994097|FG002|Treatment Period 2-Randomized Set|Pregnancy|0|||
147503229|NCT03589885|531994098|FG003|Treatment Period 2-Randomized Set|Pregnancy|0|||
147503230|NCT03589885|531994099|FG004|Treatment Period 2-Randomized Set|Pregnancy|0|||
147503231|NCT03589885|531994095|FG000|Treatment Period 2-Randomized Set|Lost to Follow-up|0|||
147503232|NCT03589885|531994096|FG001|Treatment Period 2-Randomized Set|Lost to Follow-up|3|||
147503233|NCT03589885|531994097|FG002|Treatment Period 2-Randomized Set|Lost to Follow-up|1|||
147503234|NCT03589885|531994098|FG003|Treatment Period 2-Randomized Set|Lost to Follow-up|0|||
147503235|NCT03589885|531994099|FG004|Treatment Period 2-Randomized Set|Lost to Follow-up|1|||
147503236|NCT03589885|531994095|FG000|Treatment Period 2-Randomized Set|Withdrawal by Subject|0|||
147503237|NCT03589885|531994096|FG001|Treatment Period 2-Randomized Set|Withdrawal by Subject|1|||
147503238|NCT03589885|531994097|FG002|Treatment Period 2-Randomized Set|Withdrawal by Subject|0|||
147503239|NCT03589885|531994098|FG003|Treatment Period 2-Randomized Set|Withdrawal by Subject|0|||
147503240|NCT03589885|531994099|FG004|Treatment Period 2-Randomized Set|Withdrawal by Subject|0|||
147503241|NCT01928485|531994100|FG000|Overall Study|Physician Decision|0|||
147503242|NCT01928485|531994101|FG001|Overall Study|Physician Decision|1|||
147503243|NCT00039741|531994102|FG000|Overall Study|Death|0|||
147503244|NCT00039741|531994103|FG001|Overall Study|Death|1|||
147503245|NCT00039741|531994104|FG002|Overall Study|Death|0|||
147503246|NCT00039741|531994105|FG003|Overall Study|Death|0|||
147503247|NCT00039741|531994102|FG000|Overall Study|Lost to Follow-up|3|||
147503248|NCT00039741|531994103|FG001|Overall Study|Lost to Follow-up|1|||
147503249|NCT00039741|531994104|FG002|Overall Study|Lost to Follow-up|5|||
147503250|NCT00039741|531994105|FG003|Overall Study|Lost to Follow-up|2|||
147503251|NCT00039741|531994102|FG000|Overall Study|Confounding medical condition|1|||
147503252|NCT00039741|531994103|FG001|Overall Study|Confounding medical condition|0|||
147503253|NCT00039741|531994104|FG002|Overall Study|Confounding medical condition|0|||
147503254|NCT00039741|531994105|FG003|Overall Study|Confounding medical condition|0|||
147503255|NCT00039741|531994102|FG000|Overall Study|Not able to get to clinic|5|||
147503256|NCT00039741|531994103|FG001|Overall Study|Not able to get to clinic|2|||
147503257|NCT00039741|531994104|FG002|Overall Study|Not able to get to clinic|0|||
147503258|NCT00039741|531994105|FG003|Overall Study|Not able to get to clinic|3|||
147503259|NCT00039741|531994102|FG000|Overall Study|Moved|3|||
147503260|NCT00039741|531994103|FG001|Overall Study|Moved|2|||
147503261|NCT00039741|531994104|FG002|Overall Study|Moved|3|||
147503262|NCT00039741|531994105|FG003|Overall Study|Moved|6|||
147503263|NCT00039741|531994102|FG000|Overall Study|Non-compliance with protocol|1|||
147503264|NCT00039741|531994103|FG001|Overall Study|Non-compliance with protocol|0|||
147503265|NCT00039741|531994104|FG002|Overall Study|Non-compliance with protocol|1|||
147503266|NCT00039741|531994105|FG003|Overall Study|Non-compliance with protocol|0|||
147503267|NCT00039741|531994102|FG000|Overall Study|Withdrew consent|0|||
147503268|NCT00039741|531994103|FG001|Overall Study|Withdrew consent|5|||
147503269|NCT00039741|531994104|FG002|Overall Study|Withdrew consent|0|||
147633697|NCT04791319|532476171|FG006|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
147633698|NCT04791319|532476172|FG007|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
147633699|NCT04791319|532476173|FG008|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
147633700|NCT04791319|532476174|FG009|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
147633701|NCT04791319|532476175|FG010|Placebo Controlled Period (Week 0-15)|Participants who completed only safety follow-up|0|||
147633702|NCT04791319|532476165|FG000|Placebo Controlled Period (Week 0-15)|Not treated|0|||
147633703|NCT04791319|532476166|FG001|Placebo Controlled Period (Week 0-15)|Not treated|0|||
147633704|NCT04791319|532476167|FG002|Placebo Controlled Period (Week 0-15)|Not treated|0|||
147633705|NCT04791319|532476168|FG003|Placebo Controlled Period (Week 0-15)|Not treated|1|||
147633706|NCT04791319|532476169|FG004|Placebo Controlled Period (Week 0-15)|Not treated|0|||
147633707|NCT04791319|532476170|FG005|Placebo Controlled Period (Week 0-15)|Not treated|0|||
147633708|NCT04791319|532476171|FG006|Placebo Controlled Period (Week 0-15)|Not treated|0|||
147633709|NCT04791319|532476172|FG007|Placebo Controlled Period (Week 0-15)|Not treated|0|||
147633710|NCT04791319|532476173|FG008|Placebo Controlled Period (Week 0-15)|Not treated|0|||
147633711|NCT04791319|532476174|FG009|Placebo Controlled Period (Week 0-15)|Not treated|0|||
147633712|NCT04791319|532476175|FG010|Placebo Controlled Period (Week 0-15)|Not treated|0|||
147633713|NCT04791319|532476165|FG000|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
147633714|NCT04791319|532476166|FG001|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
147633715|NCT04791319|532476167|FG002|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
147633716|NCT04791319|532476168|FG003|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
147633717|NCT04791319|532476169|FG004|Active Treatment Period (Week 16-31)|Withdrawal by Subject|2|||
147633718|NCT04791319|532476170|FG005|Active Treatment Period (Week 16-31)|Withdrawal by Subject|2|||
147633719|NCT04791319|532476171|FG006|Active Treatment Period (Week 16-31)|Withdrawal by Subject|1|||
147633720|NCT04791319|532476172|FG007|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
147633721|NCT04791319|532476173|FG008|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
147633722|NCT04791319|532476174|FG009|Active Treatment Period (Week 16-31)|Withdrawal by Subject|0|||
147633723|NCT04791319|532476175|FG010|Active Treatment Period (Week 16-31)|Withdrawal by Subject|3|||
147633724|NCT04791319|532476165|FG000|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
147633725|NCT04791319|532476166|FG001|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
147633726|NCT04791319|532476167|FG002|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
147633727|NCT04791319|532476168|FG003|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
147633728|NCT04791319|532476169|FG004|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
147633729|NCT04791319|532476170|FG005|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
147633730|NCT04791319|532476171|FG006|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
147633731|NCT04791319|532476172|FG007|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
147633732|NCT04791319|532476173|FG008|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
147633733|NCT04791319|532476174|FG009|Active Treatment Period (Week 16-31)|Lost to Follow-up|1|||
147633734|NCT04791319|532476175|FG010|Active Treatment Period (Week 16-31)|Lost to Follow-up|0|||
147633735|NCT04791319|532476165|FG000|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|0|||
147633736|NCT04791319|532476166|FG001|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|0|||
147633737|NCT04791319|532476167|FG002|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|0|||
147633738|NCT04791319|532476168|FG003|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|0|||
147503270|NCT00039741|531994105|FG003|Overall Study|Withdrew consent|1|||
147503271|NCT00039741|531994102|FG000|Overall Study|Missed final visit|2|||
147503272|NCT00039741|531994103|FG001|Overall Study|Missed final visit|1|||
147503273|NCT00039741|531994104|FG002|Overall Study|Missed final visit|2|||
147503274|NCT00039741|531994105|FG003|Overall Study|Missed final visit|2|||
147503275|NCT00946881|531994106|FG000|First Treatment|Withdrawal by Subject|1|||
147503276|NCT00946881|531994106|FG000|First Treatment|Patient relocated to another state|1|||
147503277|NCT00946881|531994106|FG000|Retreatment|Withdrawal by Subject|1|||
147503278|NCT03448224|531994107|FG000|Overall Study|Provided same answer to every question|1|||
147503279|NCT03448224|531994108|FG001|Overall Study|Provided same answer to every question|0|||
147503280|NCT03103906|531994109|FG000|Overall Study|Adverse Event|2|||
147503281|NCT03103906|531994110|FG001|Overall Study|Adverse Event|3|||
147503282|NCT03103906|531994109|FG000|Overall Study|Other|2|||
147503283|NCT03103906|531994110|FG001|Overall Study|Other|0|||
147503284|NCT03479216|531994118|FG000|Overall Study|Withdrawal by Subject|3|||
147503285|NCT03479216|531994119|FG001|Overall Study|Withdrawal by Subject|2|||
147503286|NCT03479216|531994118|FG000|Overall Study|Physician Decision|2|||
147503287|NCT03479216|531994119|FG001|Overall Study|Physician Decision|3|||
147503288|NCT02031432|531994120|FG000|Overall Study|Protocol Violation|1|||
147503289|NCT02031432|531994120|FG000|Overall Study|Lack of Efficacy|5|||
147503290|NCT02031432|531994120|FG000|Overall Study|Cancer Progression|2|||
147503291|NCT02031432|531994120|FG000|Overall Study|Withdrawn as forbidden meds required|1|||
147503292|NCT02031432|531994120|FG000|Overall Study|Adverse Event|8|||
147503293|NCT02031432|531994120|FG000|Overall Study|Withdrawal by Subject|5|||
147503294|NCT02031432|531994120|FG000|Overall Study|Lost to Follow-up|1|||
147633739|NCT04791319|532476169|FG004|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|4|||
147633740|NCT04791319|532476170|FG005|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|5|||
147633741|NCT04791319|532476171|FG006|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|2|||
147633742|NCT04791319|532476172|FG007|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|0|||
147633743|NCT04791319|532476173|FG008|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|1|||
147633744|NCT04791319|532476174|FG009|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|9|||
147633745|NCT04791319|532476175|FG010|Active Treatment Period (Week 16-31)|Trial termination and COVID-19 related|2|||
147633746|NCT04791319|532476165|FG000|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|0|||
147633747|NCT04791319|532476166|FG001|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|0|||
147633748|NCT04791319|532476167|FG002|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|0|||
147633749|NCT04791319|532476168|FG003|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|0|||
147633750|NCT04791319|532476169|FG004|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|12|||
147633751|NCT04791319|532476170|FG005|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|8|||
147633752|NCT04791319|532476171|FG006|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|16|||
147633753|NCT04791319|532476172|FG007|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|2|||
147633754|NCT04791319|532476173|FG008|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|3|||
147633755|NCT04791319|532476174|FG009|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|11|||
147633756|NCT04791319|532476175|FG010|Active Treatment Period (Week 16-31)|Participants who completed safety follow-up|4|||
147633757|NCT01704651|532476176|FG000|Overall Study|Pre-op withdrawal by subject|1|||
147633758|NCT01704651|532476177|FG001|Overall Study|Pre-op withdrawal by subject|1|||
147633759|NCT01704651|532476176|FG000|Overall Study|Pre-op change in treatment plan|1|||
147633760|NCT01704651|532476177|FG001|Overall Study|Pre-op change in treatment plan|4|||
147633761|NCT01704651|532476176|FG000|Overall Study|Nasogastric tube placement in surgery|1|||
147633762|NCT01704651|532476177|FG001|Overall Study|Nasogastric tube placement in surgery|1|||
147633763|NCT01704651|532476176|FG000|Overall Study|Post-op did not have laparotomy|2|||
147633764|NCT01704651|532476177|FG001|Overall Study|Post-op did not have laparotomy|1|||
147633765|NCT00679289|532476178|FG000|Overall Study|Progressive disease|4|||
147633766|NCT00679289|532476179|FG001|Overall Study|Progressive disease|5|||
147633767|NCT00679289|532476180|FG002|Overall Study|Progressive disease|18|||
147633768|NCT00679289|532476178|FG000|Overall Study|Withdrawal by Subject|0|||
147633769|NCT00679289|532476179|FG001|Overall Study|Withdrawal by Subject|1|||
147633770|NCT00679289|532476180|FG002|Overall Study|Withdrawal by Subject|1|||
147633771|NCT00679289|532476178|FG000|Overall Study|Adverse Event|0|||
147633772|NCT00679289|532476179|FG001|Overall Study|Adverse Event|0|||
147633773|NCT00679289|532476180|FG002|Overall Study|Adverse Event|3|||
147633774|NCT00679289|532476178|FG000|Overall Study|Physician Decision|1|||
147633775|NCT00679289|532476179|FG001|Overall Study|Physician Decision|0|||
147633776|NCT00679289|532476180|FG002|Overall Study|Physician Decision|1|||
147633777|NCT00937040|532476181|FG000|Overall Study|Adverse Event|5|||
147633778|NCT00937040|532476182|FG001|Overall Study|Adverse Event|8|||
147633779|NCT00937040|532476181|FG000|Overall Study|Lost to Follow-up|12|||
147633780|NCT00937040|532476182|FG001|Overall Study|Lost to Follow-up|12|||
147633781|NCT00937040|532476181|FG000|Overall Study|Protocol Violation|3|||
147633782|NCT00937040|532476182|FG001|Overall Study|Protocol Violation|0|||
147503295|NCT02031432|531994120|FG000|Overall Study|Inclusion/Exclusion criteria not met|5|||
147503296|NCT02031432|531994120|FG000|Overall Study|Death|10|||
147503297|NCT02148211|531994121|FG000|Overall Study|Lost to Follow-up|352|||
147503298|NCT02726113|531994122|FG000|Total Enrollment|Physician Decision|0|||
147503299|NCT02726113|531994123|FG001|Total Enrollment|Physician Decision|1|||
147503300|NCT02726113|531994122|FG000|Total Enrollment|Protocol Violation|1|||
147503301|NCT02726113|531994123|FG001|Total Enrollment|Protocol Violation|0|||
147503302|NCT02726113|531994122|FG000|Total Enrollment|Withdrawal by Subject|2|||
147503303|NCT02726113|531994123|FG001|Total Enrollment|Withdrawal by Subject|1|||
147503304|NCT02726113|531994122|FG000|Total Enrollment|Insurance non-coverage for surgery|1|||
147503305|NCT02726113|531994123|FG001|Total Enrollment|Insurance non-coverage for surgery|1|||
147503306|NCT02726113|531994122|FG000|Genomic Analysis|Protocol Violation|1|||
147633783|NCT00937040|532476181|FG000|Overall Study|Withdrawal by Subject|13|||
147633784|NCT00937040|532476182|FG001|Overall Study|Withdrawal by Subject|7|||
147633785|NCT00937040|532476181|FG000|Overall Study|NONCOMPLIANCE WITH STUDY DRUG|3|||
147633786|NCT00937040|532476182|FG001|Overall Study|NONCOMPLIANCE WITH STUDY DRUG|2|||
147633787|NCT00937040|532476181|FG000|Overall Study|POST ENROLL EXCLUSIONARY LAB(S)/ECG FIND|5|||
147633788|NCT00937040|532476182|FG001|Overall Study|POST ENROLL EXCLUSIONARY LAB(S)/ECG FIND|8|||
147503307|NCT02726113|531994123|FG001|Genomic Analysis|Protocol Violation|0|||
147633789|NCT00634803|532476185|FG000|Overall Study|Lost to Follow-up|6|||
147633790|NCT00634803|532476186|FG001|Overall Study|Lost to Follow-up|7|||
147633791|NCT00634803|532476187|FG002|Overall Study|Lost to Follow-up|7|||
147633792|NCT00364923|532476189|FG000|Treatment With Pralatrexate|Treatment with pralatrexate ongoing|4|||
147503308|NCT02726113|531994122|FG000|Genomic Analysis|Withdrawal by Subject|2|||
147503309|NCT02726113|531994123|FG001|Genomic Analysis|Withdrawal by Subject|1|||
147503310|NCT02726113|531994122|FG000|Genomic Analysis|Insurance non-coverage for surgery|1|||
147503311|NCT02726113|531994123|FG001|Genomic Analysis|Insurance non-coverage for surgery|1|||
147503312|NCT00859573|531996515|FG000|Overall Study|Withdrawal by Subject|4|||
147503313|NCT00859573|531996516|FG001|Overall Study|Withdrawal by Subject|1|||
147503314|NCT00859573|531996515|FG000|Overall Study|Physician Decision|1|||
147503315|NCT00859573|531996516|FG001|Overall Study|Physician Decision|1|||
147503316|NCT03488238|531996517|FG000|Overall Study|Equipment malfunction|1|||
147503317|NCT03488238|531996517|FG000|Overall Study|Adverse Event|1|||
147503318|NCT01316939|531996518|FG000|Overall Study|Study closed/terminated|26|||
147503319|NCT01316939|531996519|FG001|Overall Study|Study closed/terminated|25|||
147503320|NCT01316939|531996520|FG002|Overall Study|Study closed/terminated|23|||
147503321|NCT01316939|531996518|FG000|Overall Study|Lack of Efficacy|24|||
147503322|NCT01316939|531996519|FG001|Overall Study|Lack of Efficacy|25|||
147503323|NCT01316939|531996520|FG002|Overall Study|Lack of Efficacy|25|||
147503324|NCT01316939|531996518|FG000|Overall Study|Adverse Event|9|||
147503325|NCT01316939|531996519|FG001|Overall Study|Adverse Event|12|||
147503326|NCT01316939|531996520|FG002|Overall Study|Adverse Event|11|||
147503327|NCT01316939|531996518|FG000|Overall Study|Withdrawal by Subject|1|||
147503328|NCT01316939|531996519|FG001|Overall Study|Withdrawal by Subject|3|||
147503329|NCT01316939|531996520|FG002|Overall Study|Withdrawal by Subject|6|||
147503330|NCT01316939|531996518|FG000|Overall Study|Physician Decision|2|||
147503331|NCT01316939|531996519|FG001|Overall Study|Physician Decision|2|||
147503332|NCT01316939|531996520|FG002|Overall Study|Physician Decision|1|||
147503333|NCT01316939|531996518|FG000|Overall Study|Lost to Follow-up|0|||
147503334|NCT01316939|531996519|FG001|Overall Study|Lost to Follow-up|0|||
147503335|NCT01316939|531996520|FG002|Overall Study|Lost to Follow-up|2|||
147503336|NCT01316939|531996518|FG000|Overall Study|Met Liver chemistry stopping criteria|1|||
147503337|NCT01316939|531996519|FG001|Overall Study|Met Liver chemistry stopping criteria|0|||
147503338|NCT01316939|531996520|FG002|Overall Study|Met Liver chemistry stopping criteria|1|||
147503339|NCT01316939|531996518|FG000|Overall Study|Protocol Violation|0|||
147503340|NCT01316939|531996519|FG001|Overall Study|Protocol Violation|1|||
147503341|NCT01316939|531996520|FG002|Overall Study|Protocol Violation|0|||
147503342|NCT01432457|531996521|FG000|Overall Study|Adverse Event|7|||
147503343|NCT01432457|531996522|FG001|Overall Study|Adverse Event|10|||
147503344|NCT01432457|531996523|FG002|Overall Study|Adverse Event|16|||
147503345|NCT01432457|531996521|FG000|Overall Study|Lack of Efficacy|2|||
147503346|NCT01432457|531996522|FG001|Overall Study|Lack of Efficacy|1|||
147503347|NCT01432457|531996523|FG002|Overall Study|Lack of Efficacy|1|||
147503348|NCT01432457|531996521|FG000|Overall Study|Lost to Follow-up|11|||
147503349|NCT01432457|531996522|FG001|Overall Study|Lost to Follow-up|15|||
147503350|NCT01432457|531996523|FG002|Overall Study|Lost to Follow-up|20|||
147503351|NCT01432457|531996521|FG000|Overall Study|Protocol Violation|3|||
147503352|NCT01432457|531996522|FG001|Overall Study|Protocol Violation|2|||
147503353|NCT01432457|531996523|FG002|Overall Study|Protocol Violation|6|||
147503354|NCT01432457|531996521|FG000|Overall Study|Withdrawal by Subject|6|||
147503355|NCT01432457|531996522|FG001|Overall Study|Withdrawal by Subject|11|||
147503356|NCT01432457|531996523|FG002|Overall Study|Withdrawal by Subject|9|||
147503357|NCT01432457|531996521|FG000|Overall Study|Reasons not defined|2|||
147503358|NCT01432457|531996522|FG001|Overall Study|Reasons not defined|3|||
147503359|NCT01432457|531996523|FG002|Overall Study|Reasons not defined|4|||
147503360|NCT01432457|531996521|FG000|Overall Study|Did not take study drug|6|||
147503361|NCT01432457|531996522|FG001|Overall Study|Did not take study drug|6|||
147503362|NCT01432457|531996523|FG002|Overall Study|Did not take study drug|3|||
147503363|NCT04507776|531996524|FG000|Overall Study|Participants did not meet the entrance criteria|201|||
147503364|NCT01136746|531996530|FG000|Overall Study|Lost to Follow-up|0|||
147503365|NCT01136746|531996531|FG001|Overall Study|Lost to Follow-up|2|||
147503366|NCT01136746|531996530|FG000|Overall Study|Protocol Violation|2|||
147503367|NCT01136746|531996531|FG001|Overall Study|Protocol Violation|1|||
147503368|NCT01136746|531996530|FG000|Overall Study|Death|1|||
147503369|NCT01136746|531996531|FG001|Overall Study|Death|0|||
147503370|NCT00092677|531996537|FG000|Overall Study|Lost to Follow-up|0|||
147503371|NCT00092677|531996538|FG001|Overall Study|Lost to Follow-up|2|||
147503372|NCT00092677|531996537|FG000|Overall Study|Adminstrative|5|||
147503373|NCT00092677|531996538|FG001|Overall Study|Adminstrative|9|||
147503374|NCT00010803|531996546|FG000|Overall Study|Withdrawal by Subject|97|||
147503375|NCT00010803|531996547|FG001|Overall Study|Withdrawal by Subject|98|||
147503376|NCT04671342|531996548|FG000|Consented and Screened (Visit 1)|Screen Failure|3|||
147503377|NCT04671342|531996548|FG000|Consented and Screened (Visit 1)|Lost to Follow-up|4|||
147503378|NCT04671342|531996548|FG000|Consented and Screened (Visit 1)|Withdrawal by Subject|1|||
147503379|NCT04671342|531996548|FG000|Consented and Screened (Visit 1)|Withdrawn by sponsor due to recruitment consideration (CSA patients)|39|||
147503380|NCT04671342|531996548|FG000|Completed Visit 2 With Evaluable Data|Unusable device data|58|||
147503381|NCT04671342|531996548|FG000|Completed Visit 2 With Evaluable Data|Unusable PSG data|1|||
147503382|NCT03351478|531996551|FG000|Overall Study|At the subject's own request|11|||
147503383|NCT03351478|531996552|FG001|Overall Study|At the subject's own request|12|||
147633793|NCT00364923|532476189|FG000|Survival Follow-up, After Pralatrexate|Pts still in follow-up at data cutoff|24|||
147633794|NCT03474731|532476193|FG000|Overall Study|Withdrawal by Subject|36|||
147633795|NCT03474731|532476194|FG001|Overall Study|Withdrawal by Subject|29|||
147633796|NCT03474731|532476195|FG002|Overall Study|Withdrawal by Subject|11|||
147633797|NCT03474731|532476196|FG003|Overall Study|Withdrawal by Subject|27|||
147633798|NCT03474731|532476193|FG000|Overall Study|COVID|0|||
147633799|NCT03474731|532476194|FG001|Overall Study|COVID|23|||
147633800|NCT03474731|532476195|FG002|Overall Study|COVID|0|||
147633801|NCT03474731|532476196|FG003|Overall Study|COVID|0|||
147633802|NCT03474731|532476193|FG000|Overall Study|Participant moved from area|1|||
147633803|NCT03474731|532476194|FG001|Overall Study|Participant moved from area|0|||
147633804|NCT03474731|532476195|FG002|Overall Study|Participant moved from area|0|||
147633805|NCT03474731|532476196|FG003|Overall Study|Participant moved from area|0|||
147633806|NCT03474731|532476193|FG000|Overall Study|Lost to Follow-up|11|||
147633807|NCT03474731|532476194|FG001|Overall Study|Lost to Follow-up|3|||
147633808|NCT03474731|532476195|FG002|Overall Study|Lost to Follow-up|18|||
147633809|NCT03474731|532476196|FG003|Overall Study|Lost to Follow-up|17|||
147633810|NCT03474731|532476193|FG000|Overall Study|Death|0|||
147633811|NCT03474731|532476194|FG001|Overall Study|Death|1|||
147633812|NCT03474731|532476195|FG002|Overall Study|Death|0|||
147633813|NCT03474731|532476196|FG003|Overall Study|Death|0|||
147633814|NCT03474731|532476193|FG000|Overall Study|Participant Removed|0|||
147633815|NCT03474731|532476194|FG001|Overall Study|Participant Removed|0|||
147633816|NCT03474731|532476195|FG002|Overall Study|Participant Removed|0|||
147633817|NCT03474731|532476196|FG003|Overall Study|Participant Removed|1|||
147633818|NCT02887248|532476202|FG000|Overall Study|Withdrawal by Subject|1|||
147633819|NCT02887248|532476202|FG000|Overall Study|Adverse Event|1|||
147633820|NCT02887248|532476202|FG000|Overall Study|Progressive Disease|1|||
147633821|NCT00765336|532476205|FG000|Overall Study|Protocol Violation|4|||
147633822|NCT00765336|532476206|FG001|Overall Study|Protocol Violation|2|||
147633823|NCT00765336|532476205|FG000|Overall Study|Withdrawal by Subject|6|||
147633824|NCT00765336|532476206|FG001|Overall Study|Withdrawal by Subject|4|||
147633825|NCT00765336|532476205|FG000|Overall Study|Lost to Follow-up|7|||
147633826|NCT00765336|532476206|FG001|Overall Study|Lost to Follow-up|9|||
147633827|NCT00765336|532476205|FG000|Overall Study|Adverse Event|2|||
147633828|NCT00765336|532476206|FG001|Overall Study|Adverse Event|1|||
147633829|NCT00478777|532476207|FG000|Overall Study|Adverse Event|29|||
147633830|NCT00478777|532476207|FG000|Overall Study|Lack of Efficacy|23|||
147633831|NCT00478777|532476207|FG000|Overall Study|Withdrawal by Subject|4|||
147633832|NCT00478777|532476207|FG000|Overall Study|Death|3|||
147633833|NCT00478777|532476207|FG000|Overall Study|Protocol Violation|3|||
147633834|NCT00478777|532476207|FG000|Overall Study|Lost to Follow-up|3|||
147633835|NCT00478777|532476207|FG000|Overall Study|Physician Decision|1|||
147633836|NCT00478777|532476207|FG000|Overall Study|Intolerance of therapy|1|||
147633837|NCT00478777|532476207|FG000|Overall Study|Lack of compliance|1|||
147633838|NCT00478777|532476207|FG000|Overall Study|Lymphocytes infusion|1|||
147633839|NCT00478777|532476207|FG000|Overall Study|End of therapy|2|||
147633840|NCT00478777|532476207|FG000|Overall Study|Not treated with lenalidomide|6|||
147633841|NCT04105218|532476213|FG000|Overall Study|Withdrawal by Subject|3|||
147633842|NCT04105218|532476214|FG001|Overall Study|Withdrawal by Subject|2|||
147633843|NCT04105218|532476213|FG000|Overall Study|Study was terminated; unable to complete study visits|1|||
147633844|NCT04105218|532476214|FG001|Overall Study|Study was terminated; unable to complete study visits|3|||
147633845|NCT04105218|532476213|FG000|Overall Study|Failed screening tests|2|||
147633846|NCT04105218|532476214|FG001|Overall Study|Failed screening tests|1|||
147633847|NCT01323387|532476223|FG000|Overall Study|Withdrawal by Subject|41|||
147633848|NCT01323387|532476223|FG000|Overall Study|Radiographic Data Unavailable|1|||
147633849|NCT01323387|532476223|FG000|Overall Study|Revision|14|||
147633850|NCT01323387|532476223|FG000|Overall Study|Protocol Violation|12|||
147633851|NCT01323387|532476223|FG000|Overall Study|Randomized but Never Treated|16|||
147633852|NCT00570063|532476226|FG000|Overall Study|Adverse Event|4|||
147633853|NCT00570063|532476227|FG001|Overall Study|Adverse Event|1|||
147633854|NCT00570063|532476226|FG000|Overall Study|Lack of Efficacy|0|||
147633855|NCT00570063|532476227|FG001|Overall Study|Lack of Efficacy|1|||
147633856|NCT00570063|532476226|FG000|Overall Study|Withdrawal by Subject|4|||
147633857|NCT00570063|532476227|FG001|Overall Study|Withdrawal by Subject|3|||
147633858|NCT00570063|532476226|FG000|Overall Study|Sponsor's Decision|7|||
147633859|NCT00570063|532476227|FG001|Overall Study|Sponsor's Decision|3|||
147633860|NCT01554527|532476228|FG000|Overall Study|Withdrawal by Subject|1|||
147633861|NCT01554527|532476229|FG001|Overall Study|Withdrawal by Subject|0|||
147633862|NCT01554527|532476230|FG002|Overall Study|Withdrawal by Subject|3|||
147633863|NCT01554527|532476228|FG000|Overall Study|Lost to Follow-up|0|||
147633864|NCT01554527|532476229|FG001|Overall Study|Lost to Follow-up|0|||
147633865|NCT01554527|532476230|FG002|Overall Study|Lost to Follow-up|4|||
147633866|NCT01554527|532476228|FG000|Overall Study|Physician Decision|0|||
147633867|NCT01554527|532476229|FG001|Overall Study|Physician Decision|0|||
147633868|NCT01554527|532476230|FG002|Overall Study|Physician Decision|1|||
147633869|NCT00550043|532476231|FG000|Overall Study|Adverse Event|0|||
147633870|NCT00550043|532476232|FG001|Overall Study|Adverse Event|0|||
147633871|NCT00550043|532476233|FG002|Overall Study|Adverse Event|0|||
147633872|NCT00550043|532476234|FG003|Overall Study|Adverse Event|1|||
147633873|NCT00550043|532476235|FG004|Overall Study|Adverse Event|1|||
147633874|NCT00550043|532476231|FG000|Overall Study|Subject Withdrew Consent|0|||
147633875|NCT00550043|532476232|FG001|Overall Study|Subject Withdrew Consent|2|||
147633876|NCT00550043|532476233|FG002|Overall Study|Subject Withdrew Consent|1|||
147633877|NCT00550043|532476234|FG003|Overall Study|Subject Withdrew Consent|0|||
147633878|NCT00550043|532476235|FG004|Overall Study|Subject Withdrew Consent|0|||
147633879|NCT00550043|532476231|FG000|Overall Study|Other Reasons- Unspecified|0|||
147633880|NCT00550043|532476232|FG001|Overall Study|Other Reasons- Unspecified|1|||
147633881|NCT00550043|532476233|FG002|Overall Study|Other Reasons- Unspecified|0|||
147633882|NCT00550043|532476234|FG003|Overall Study|Other Reasons- Unspecified|1|||
147633883|NCT00550043|532476235|FG004|Overall Study|Other Reasons- Unspecified|0|||
147633884|NCT02073929|532476236|FG000|Overall Study|Lost to Follow-up|2|||
147633885|NCT02073929|532476237|FG001|Overall Study|Lost to Follow-up|1|||
147633886|NCT02073929|532476236|FG000|Overall Study|Adverse Event|2|||
147633887|NCT02073929|532476237|FG001|Overall Study|Adverse Event|1|||
147633888|NCT02073929|532476236|FG000|Overall Study|Withdrawal by Subject|0|||
147633889|NCT02073929|532476237|FG001|Overall Study|Withdrawal by Subject|1|||
147633890|NCT01483027|532476238|FG000|Overall Study|Administrative Reasons|2|||
147633891|NCT01483027|532476239|FG001|Overall Study|Administrative Reasons|1|||
147633892|NCT01483027|532476238|FG000|Overall Study|Withdrawal by Subject|21|||
147633893|NCT01483027|532476239|FG001|Overall Study|Withdrawal by Subject|32|||
147633894|NCT01483027|532476238|FG000|Overall Study|Discontinuation by Investigator or Sponsor for any reason|22|||
147633895|NCT01483027|532476239|FG001|Overall Study|Discontinuation by Investigator or Sponsor for any reason|24|||
147633896|NCT01483027|532476238|FG000|Overall Study|Lost to Follow-up|1|||
147633897|NCT01483027|532476239|FG001|Overall Study|Lost to Follow-up|1|||
147633898|NCT01483027|532476238|FG000|Overall Study|Adverse Event|0|||
147633899|NCT01483027|532476239|FG001|Overall Study|Adverse Event|1|||
147633900|NCT01483027|532476238|FG000|Overall Study|Withdrawal by Subject|0|||
147633901|NCT01483027|532476239|FG001|Overall Study|Withdrawal by Subject|1|||
147633902|NCT00972816|532477591|FG000|Overall Study|Adverse Event|0|||
147633903|NCT00972816|532477592|FG001|Overall Study|Adverse Event|0|||
147633904|NCT00972816|532477593|FG002|Overall Study|Adverse Event|1|||
147633905|NCT00972816|532477594|FG003|Overall Study|Adverse Event|0|||
147633906|NCT00972816|532477595|FG004|Overall Study|Adverse Event|0|||
147633907|NCT00972816|532477596|FG005|Overall Study|Adverse Event|0|||
147633908|NCT00972816|532477597|FG006|Overall Study|Adverse Event|0|||
147633909|NCT00972816|532477598|FG007|Overall Study|Adverse Event|0|||
147633910|NCT00972816|532477591|FG000|Overall Study|Withdrawal by Subject|4|||
147633911|NCT00972816|532477592|FG001|Overall Study|Withdrawal by Subject|2|||
147633912|NCT00972816|532477593|FG002|Overall Study|Withdrawal by Subject|1|||
147633913|NCT00972816|532477594|FG003|Overall Study|Withdrawal by Subject|3|||
147633914|NCT00972816|532477595|FG004|Overall Study|Withdrawal by Subject|0|||
147633915|NCT00972816|532477596|FG005|Overall Study|Withdrawal by Subject|1|||
147633916|NCT00972816|532477597|FG006|Overall Study|Withdrawal by Subject|1|||
147633917|NCT00972816|532477598|FG007|Overall Study|Withdrawal by Subject|2|||
147633918|NCT00972816|532477591|FG000|Overall Study|Lost to Follow-up|11|||
147633919|NCT00972816|532477592|FG001|Overall Study|Lost to Follow-up|9|||
147633920|NCT00972816|532477593|FG002|Overall Study|Lost to Follow-up|7|||
147633921|NCT00972816|532477594|FG003|Overall Study|Lost to Follow-up|5|||
147633922|NCT00972816|532477595|FG004|Overall Study|Lost to Follow-up|11|||
147633923|NCT00972816|532477596|FG005|Overall Study|Lost to Follow-up|10|||
147633924|NCT00972816|532477597|FG006|Overall Study|Lost to Follow-up|7|||
147633925|NCT00972816|532477598|FG007|Overall Study|Lost to Follow-up|7|||
147633926|NCT00972816|532477591|FG000|Overall Study|Inappropriate enrolment|0|||
147633927|NCT00972816|532477592|FG001|Overall Study|Inappropriate enrolment|0|||
147633928|NCT00972816|532477593|FG002|Overall Study|Inappropriate enrolment|0|||
147633929|NCT00972816|532477594|FG003|Overall Study|Inappropriate enrolment|0|||
147633930|NCT00972816|532477595|FG004|Overall Study|Inappropriate enrolment|0|||
147633931|NCT00972816|532477596|FG005|Overall Study|Inappropriate enrolment|0|||
147633932|NCT00972816|532477597|FG006|Overall Study|Inappropriate enrolment|2|||
147633933|NCT00972816|532477598|FG007|Overall Study|Inappropriate enrolment|0|||
147633934|NCT00972816|532477591|FG000|Overall Study|Unable to classify|2|||
147633935|NCT00972816|532477592|FG001|Overall Study|Unable to classify|0|||
147633936|NCT00972816|532477593|FG002|Overall Study|Unable to classify|0|||
147668734|NCT00784875|532613363|FG002|Period B - Efficacy Endpoint|Protocol Violation|2|||
147633937|NCT00972816|532477594|FG003|Overall Study|Unable to classify|0|||
147633938|NCT00972816|532477595|FG004|Overall Study|Unable to classify|1|||
147633939|NCT00972816|532477596|FG005|Overall Study|Unable to classify|0|||
147633940|NCT00972816|532477597|FG006|Overall Study|Unable to classify|0|||
147633941|NCT00972816|532477598|FG007|Overall Study|Unable to classify|0|||
147633942|NCT00593684|532477601|FG000|Overall Study|Death|2|||
147633943|NCT00593684|532477602|FG001|Overall Study|Death|1|||
147633944|NCT03625466|532477603|FG000|Placebo-controlled Period (48 Weeks)|Adverse Event|0|||
147633945|NCT03625466|532477604|FG001|Placebo-controlled Period (48 Weeks)|Adverse Event|1|||
147633946|NCT03625466|532477605|FG002|Placebo-controlled Period (48 Weeks)|Adverse Event|0|||
147633947|NCT03625466|532477603|FG000|Placebo-controlled Period (48 Weeks)|Withdrawal of Consent (not due to AE)|0|||
147503384|NCT03351478|531996553|FG002|Overall Study|At the subject's own request|5|||
147503385|NCT03351478|531996551|FG000|Overall Study|Adverse Event|1|||
147503386|NCT03351478|531996552|FG001|Overall Study|Adverse Event|2|||
147503387|NCT03351478|531996553|FG002|Overall Study|Adverse Event|1|||
147503388|NCT03351478|531996551|FG000|Overall Study|Poor compliance to protocol|1|||
147503389|NCT03351478|531996552|FG001|Overall Study|Poor compliance to protocol|0|||
147503390|NCT03351478|531996553|FG002|Overall Study|Poor compliance to protocol|0|||
147503391|NCT03351478|531996551|FG000|Overall Study|Reason not Specified|1|||
147503392|NCT03351478|531996552|FG001|Overall Study|Reason not Specified|3|||
147503393|NCT03351478|531996553|FG002|Overall Study|Reason not Specified|0|||
147503394|NCT03351478|531996551|FG000|Overall Study|Lost to Follow-up|0|||
147503395|NCT03351478|531996552|FG001|Overall Study|Lost to Follow-up|0|||
147503396|NCT03351478|531996553|FG002|Overall Study|Lost to Follow-up|1|||
147503397|NCT03911869|531996554|FG000|Safety Lead-in Phase|Death|7|||
147503398|NCT03911869|531996555|FG001|Safety Lead-in Phase|Death|0|||
147503399|NCT03911869|531996556|FG002|Safety Lead-in Phase|Death|0|||
147503400|NCT03911869|531996554|FG000|Safety Lead-in Phase|Study termination by sponsor|2|||
147503401|NCT03911869|531996555|FG001|Safety Lead-in Phase|Study termination by sponsor|0|||
147503402|NCT03911869|531996556|FG002|Safety Lead-in Phase|Study termination by sponsor|0|||
147503403|NCT03911869|531996554|FG000|Safety Lead-in Phase|Other|1|||
147503404|NCT03911869|531996555|FG001|Safety Lead-in Phase|Other|0|||
147503405|NCT03911869|531996556|FG002|Safety Lead-in Phase|Other|0|||
147503406|NCT03911869|531996554|FG000|Phase 2|Death|0|||
147503407|NCT03911869|531996555|FG001|Phase 2|Death|3|||
147503408|NCT03911869|531996556|FG002|Phase 2|Death|0|||
147503409|NCT00985738|531996558|FG000|Overall Study|Study closed prematurely|8|||
147503410|NCT00985738|531996559|FG001|Overall Study|Study closed prematurely|8|||
147503411|NCT02119026|531996562|FG000|1st-line Treatment|Adverse Event|9|||
147503412|NCT02119026|531996563|FG001|1st-line Treatment|Adverse Event|14|||
147503413|NCT02119026|531996562|FG000|1st-line Treatment|Physician Decision|3|||
147503414|NCT02119026|531996563|FG001|1st-line Treatment|Physician Decision|8|||
147503415|NCT02119026|531996562|FG000|1st-line Treatment|Withdrawal by Subject|4|||
147503416|NCT02119026|531996563|FG001|1st-line Treatment|Withdrawal by Subject|10|||
147503417|NCT02119026|531996562|FG000|1st-line Treatment|Patient condition or compliance|6|||
147503418|NCT02119026|531996563|FG001|1st-line Treatment|Patient condition or compliance|4|||
147503419|NCT02119026|531996562|FG000|1st-line Treatment|Surgery of metastases|2|||
147503420|NCT02119026|531996563|FG001|1st-line Treatment|Surgery of metastases|1|||
147503421|NCT02119026|531996562|FG000|1st-line Treatment|Death|2|||
147503422|NCT02119026|531996563|FG001|1st-line Treatment|Death|1|||
147503423|NCT02119026|531996562|FG000|2nd-line Treatment|Lost to Follow-up|2|||
147503424|NCT02119026|531996563|FG001|2nd-line Treatment|Lost to Follow-up|0|||
147503425|NCT02119026|531996562|FG000|2nd-line Treatment|Withdrawal by Subject|3|||
147503426|NCT02119026|531996563|FG001|2nd-line Treatment|Withdrawal by Subject|1|||
147503427|NCT02119026|531996562|FG000|2nd-line Treatment|Adverse Event|4|||
147503428|NCT02119026|531996563|FG001|2nd-line Treatment|Adverse Event|1|||
147503429|NCT01373918|531996566|FG000|Overall Study|Physician Decision|0|||
147503430|NCT01373918|531996567|FG001|Overall Study|Physician Decision|1|||
147503431|NCT00340834|531996568|FG000|Core Phase of Study|Adverse Event|26|||
147503432|NCT00340834|531996569|FG001|Core Phase of Study|Adverse Event|9|||
147503433|NCT00340834|531996570|FG002|Core Phase of Study|Adverse Event|9|||
147503434|NCT00340834|531996571|FG003|Core Phase of Study|Adverse Event|0|||
147503435|NCT00340834|531996572|FG004|Core Phase of Study|Adverse Event|0|||
147503436|NCT00340834|531996568|FG000|Core Phase of Study|Withdrawal by Subject|11|||
147503437|NCT00340834|531996569|FG001|Core Phase of Study|Withdrawal by Subject|9|||
147503438|NCT00340834|531996570|FG002|Core Phase of Study|Withdrawal by Subject|16|||
147503439|NCT00340834|531996571|FG003|Core Phase of Study|Withdrawal by Subject|0|||
147503440|NCT00340834|531996572|FG004|Core Phase of Study|Withdrawal by Subject|0|||
147503441|NCT00340834|531996568|FG000|Core Phase of Study|Administrative Problems|6|||
147503442|NCT00340834|531996569|FG001|Core Phase of Study|Administrative Problems|2|||
147503443|NCT00340834|531996570|FG002|Core Phase of Study|Administrative Problems|7|||
147503444|NCT00340834|531996571|FG003|Core Phase of Study|Administrative Problems|0|||
147503445|NCT00340834|531996572|FG004|Core Phase of Study|Administrative Problems|0|||
147503446|NCT00340834|531996568|FG000|Core Phase of Study|Lack of Efficacy|3|||
147503447|NCT00340834|531996569|FG001|Core Phase of Study|Lack of Efficacy|3|||
147503448|NCT00340834|531996570|FG002|Core Phase of Study|Lack of Efficacy|7|||
147503449|NCT00340834|531996571|FG003|Core Phase of Study|Lack of Efficacy|0|||
147503450|NCT00340834|531996572|FG004|Core Phase of Study|Lack of Efficacy|0|||
147503451|NCT00340834|531996568|FG000|Core Phase of Study|Abnormal laboratory value(s)|4|||
147503452|NCT00340834|531996569|FG001|Core Phase of Study|Abnormal laboratory value(s)|6|||
147644037|NCT00738062|532516704|FG000|Open Label Treatment|Withdrawal by Subject|9|||
147503453|NCT00340834|531996570|FG002|Core Phase of Study|Abnormal laboratory value(s)|1|||
147503454|NCT00340834|531996571|FG003|Core Phase of Study|Abnormal laboratory value(s)|0|||
147503455|NCT00340834|531996572|FG004|Core Phase of Study|Abnormal laboratory value(s)|0|||
147503456|NCT00340834|531996568|FG000|Core Phase of Study|Abnormal test procedure result(s)|4|||
147503457|NCT00340834|531996569|FG001|Core Phase of Study|Abnormal test procedure result(s)|3|||
147503458|NCT00340834|531996570|FG002|Core Phase of Study|Abnormal test procedure result(s)|3|||
147633948|NCT03625466|532477604|FG001|Placebo-controlled Period (48 Weeks)|Withdrawal of Consent (not due to AE)|1|||
147633949|NCT03625466|532477605|FG002|Placebo-controlled Period (48 Weeks)|Withdrawal of Consent (not due to AE)|0|||
147633950|NCT03625466|532477603|FG000|Open-label Period (48 Weeks)|Withdrawal of Consent (not due to AE)|0|||
147633951|NCT03625466|532477604|FG001|Open-label Period (48 Weeks)|Withdrawal of Consent (not due to AE)|0|||
147633952|NCT03625466|532477605|FG002|Open-label Period (48 Weeks)|Withdrawal of Consent (not due to AE)|1|||
147633953|NCT00809471|532477607|FG000|Overall Study|Protocol non-compliance|15|||
147633954|NCT00809471|532477608|FG001|Overall Study|Protocol non-compliance|15|||
147633955|NCT00809471|532477609|FG002|Overall Study|Protocol non-compliance|6|||
147633956|NCT00809471|532477607|FG000|Overall Study|Lost to Follow-up|4|||
147633957|NCT00809471|532477608|FG001|Overall Study|Lost to Follow-up|2|||
147633958|NCT00809471|532477609|FG002|Overall Study|Lost to Follow-up|9|||
147633959|NCT00809471|532477607|FG000|Overall Study|Adverse Event|0|||
147633960|NCT00809471|532477608|FG001|Overall Study|Adverse Event|2|||
147633961|NCT00809471|532477609|FG002|Overall Study|Adverse Event|2|||
147633962|NCT00809471|532477607|FG000|Overall Study|Requirement for restricted medication|1|||
147633963|NCT00809471|532477608|FG001|Overall Study|Requirement for restricted medication|1|||
147633964|NCT00809471|532477609|FG002|Overall Study|Requirement for restricted medication|0|||
147633965|NCT00831311|532477611|FG000|Overall Study|Definitive Contraindication|3|||
147633966|NCT00831311|532477612|FG001|Overall Study|Definitive Contraindication|3|||
147633967|NCT00831311|532477611|FG000|Overall Study|Lost to Follow-up|3|||
147633968|NCT00831311|532477612|FG001|Overall Study|Lost to Follow-up|0|||
147633969|NCT00831311|532477611|FG000|Overall Study|Physician Decision|0|||
147633970|NCT00831311|532477612|FG001|Overall Study|Physician Decision|1|||
147633971|NCT00831311|532477611|FG000|Overall Study|Withdrawal by Subject|6|||
147633972|NCT00831311|532477612|FG001|Overall Study|Withdrawal by Subject|4|||
147633973|NCT02780713|532477616|FG000|Period 3: Variant B (100mg)|Withdrawal by Subject|0|||
147633974|NCT02780713|532477617|FG001|Period 3: Variant B (100mg)|Withdrawal by Subject|0|||
147633975|NCT02780713|532477618|FG002|Period 3: Variant B (100mg)|Withdrawal by Subject|2|||
147633976|NCT02780713|532477619|FG003|Period 3: Variant B (100mg)|Withdrawal by Subject|0|||
147633977|NCT02780713|532477620|FG004|Period 3: Variant B (100mg)|Withdrawal by Subject|0|||
147633978|NCT01931475|532477621|FG000|Period 1: Double-Blind Treatment Phase|Adverse Event|20|||
147633979|NCT01931475|532477622|FG001|Period 1: Double-Blind Treatment Phase|Adverse Event|10|||
147633980|NCT01931475|532477621|FG000|Period 1: Double-Blind Treatment Phase|Lost to Follow-up|1|||
147633981|NCT01931475|532477622|FG001|Period 1: Double-Blind Treatment Phase|Lost to Follow-up|0|||
147633982|NCT01931475|532477621|FG000|Period 1: Double-Blind Treatment Phase|Withdrawal by Subject|16|||
147633983|NCT01931475|532477622|FG001|Period 1: Double-Blind Treatment Phase|Withdrawal by Subject|12|||
147633984|NCT01931475|532477621|FG000|Period 1: Double-Blind Treatment Phase|Lack of Efficacy|2|||
147633985|NCT01931475|532477622|FG001|Period 1: Double-Blind Treatment Phase|Lack of Efficacy|3|||
147633986|NCT01931475|532477621|FG000|Period 1: Double-Blind Treatment Phase|Physician Decision|0|||
147633987|NCT01931475|532477622|FG001|Period 1: Double-Blind Treatment Phase|Physician Decision|1|||
147633988|NCT01931475|532477621|FG000|Period 2: Extension Treatment Phase|Adverse Event|0|||
147633989|NCT01931475|532477622|FG001|Period 2: Extension Treatment Phase|Adverse Event|8|||
147633990|NCT01931475|532477621|FG000|Period 2: Extension Treatment Phase|Protocol Violation|1|||
147633991|NCT01931475|532477622|FG001|Period 2: Extension Treatment Phase|Protocol Violation|0|||
147633992|NCT01931475|532477621|FG000|Period 2: Extension Treatment Phase|Withdrawal by Subject|0|||
147633993|NCT01931475|532477622|FG001|Period 2: Extension Treatment Phase|Withdrawal by Subject|9|||
147633994|NCT01931475|532477621|FG000|Period 2: Extension Treatment Phase|Physician Decision|1|||
147633995|NCT01931475|532477622|FG001|Period 2: Extension Treatment Phase|Physician Decision|1|||
147633996|NCT01931475|532477621|FG000|Period 2: Extension Treatment Phase|Study Terminated by Sponsor|1|||
147633997|NCT01931475|532477622|FG001|Period 2: Extension Treatment Phase|Study Terminated by Sponsor|0|||
147633998|NCT01931475|532477621|FG000|Period 2: Extension Treatment Phase|Lack of Efficacy|1|||
147633999|NCT01931475|532477622|FG001|Period 2: Extension Treatment Phase|Lack of Efficacy|1|||
147634000|NCT03991299|532477625|FG000|Overall Study|Study closed, sponsor decision|3|||
147634001|NCT03991299|532477625|FG000|Overall Study|Withdrawal by Subject|1|||
147634002|NCT00930774|532477627|FG000|Overall Study|Withdrawal by Subject|1|||
147634003|NCT00930774|532477628|FG001|Overall Study|Withdrawal by Subject|9|||
147634004|NCT00930774|532477629|FG002|Overall Study|Withdrawal by Subject|2|||
147634005|NCT00930774|532477630|FG003|Overall Study|Withdrawal by Subject|0|||
147634006|NCT03200704|532477631|FG000|Overall Study|Withdrawal by Subject|1|||
147634007|NCT01680861|532477632|FG000|Early Post-transplant Period|Protocol Violation|1|||
147634008|NCT01680861|532477633|FG001|Early Post-transplant Period|Protocol Violation|1|||
147634009|NCT00654875|532477634|FG000|Overall Study|Adverse Event|5|||
147634010|NCT00654875|532477635|FG001|Overall Study|Adverse Event|5|||
147634011|NCT00654875|532477634|FG000|Overall Study|Withdrawal by Subject|4|||
147634012|NCT00654875|532477635|FG001|Overall Study|Withdrawal by Subject|4|||
147634013|NCT00654875|532477634|FG000|Overall Study|Protocol Violation|3|||
147634014|NCT00654875|532477635|FG001|Overall Study|Protocol Violation|3|||
147634015|NCT00654875|532477634|FG000|Overall Study|Lack of Efficacy|2|||
147634016|NCT00654875|532477635|FG001|Overall Study|Lack of Efficacy|2|||
147634017|NCT00654875|532477634|FG000|Overall Study|Lost to Follow-up|1|||
147634018|NCT00654875|532477635|FG001|Overall Study|Lost to Follow-up|3|||
147634019|NCT00654875|532477634|FG000|Overall Study|Abnormal Test Procedure Result(s)|1|||
147634020|NCT00654875|532477635|FG001|Overall Study|Abnormal Test Procedure Result(s)|0|||
147634021|NCT00654875|532477634|FG000|Overall Study|Administrative Problems|1|||
147634022|NCT00654875|532477635|FG001|Overall Study|Administrative Problems|0|||
147634023|NCT01011465|532477636|FG000|Overall Study|Withdrawal by Subject|2|||
147634024|NCT01011465|532477637|FG001|Overall Study|Withdrawal by Subject|1|||
147634025|NCT01011465|532477638|FG002|Overall Study|Withdrawal by Subject|0|||
147634026|NCT01011465|532477639|FG003|Overall Study|Withdrawal by Subject|0|||
147634027|NCT01011465|532477640|FG004|Overall Study|Withdrawal by Subject|1|||
147634028|NCT01011465|532477641|FG005|Overall Study|Withdrawal by Subject|0|||
147634029|NCT01011465|532477642|FG006|Overall Study|Withdrawal by Subject|1|||
147634030|NCT01011465|532477643|FG007|Overall Study|Withdrawal by Subject|0|||
147634031|NCT02042950|532477646|FG000|Overall Study|Progressive Disease|4|||
147634032|NCT01683266|532477651|FG000|Overall Study|Adverse Event|5|||
147634033|NCT01683266|532477652|FG001|Overall Study|Adverse Event|4|||
147634034|NCT01683266|532477651|FG000|Overall Study|Lack of Efficacy|5|||
147634035|NCT01683266|532477652|FG001|Overall Study|Lack of Efficacy|2|||
147634036|NCT01683266|532477651|FG000|Overall Study|Protocol Violation|13|||
147634037|NCT01683266|532477652|FG001|Overall Study|Protocol Violation|6|||
147634038|NCT01683266|532477651|FG000|Overall Study|Personal Reason|17|||
147634039|NCT01683266|532477652|FG001|Overall Study|Personal Reason|25|||
147634040|NCT01683266|532477651|FG000|Overall Study|Selection Criterion / Protocol Violation|7|||
147634041|NCT01683266|532477652|FG001|Overall Study|Selection Criterion / Protocol Violation|5|||
147634042|NCT01683266|532477651|FG000|Overall Study|Lost to Follow-up|5|||
147634043|NCT01683266|532477652|FG001|Overall Study|Lost to Follow-up|0|||
147634044|NCT01683266|532477651|FG000|Overall Study|Site Closure / Site Withdrawal|1|||
147634045|NCT01683266|532477652|FG001|Overall Study|Site Closure / Site Withdrawal|3|||
147634046|NCT01683266|532477651|FG000|Overall Study|Nonserious Hypoglycemia|0|||
147634047|NCT01683266|532477652|FG001|Overall Study|Nonserious Hypoglycemia|3|||
147634048|NCT01683266|532477651|FG000|Overall Study|Perceived Lack of Efficacy|1|||
147634049|NCT01683266|532477652|FG001|Overall Study|Perceived Lack of Efficacy|1|||
147634050|NCT01683266|532477651|FG000|Overall Study|Possibly Hypoglycemia|1|||
147634051|NCT01683266|532477652|FG001|Overall Study|Possibly Hypoglycemia|0|||
147634052|NCT01683266|532477651|FG000|Overall Study|Serious Adverse Event of Hypoglycemia|0|||
147634053|NCT01683266|532477652|FG001|Overall Study|Serious Adverse Event of Hypoglycemia|1|||
147634054|NCT02217410|532477655|FG000|Overall Study|Graft Loss|0|||
147634055|NCT02217410|532477656|FG001|Overall Study|Graft Loss|0|||
147634056|NCT02217410|532477657|FG002|Overall Study|Graft Loss|2|||
147634057|NCT02217410|532477655|FG000|Overall Study|Withdrawal by Subject|0|||
147634058|NCT02217410|532477656|FG001|Overall Study|Withdrawal by Subject|0|||
147634059|NCT02217410|532477657|FG002|Overall Study|Withdrawal by Subject|2|||
147634060|NCT02217410|532477655|FG000|Overall Study|Lost to Follow-up|0|||
147634061|NCT02217410|532477656|FG001|Overall Study|Lost to Follow-up|0|||
147634062|NCT02217410|532477657|FG002|Overall Study|Lost to Follow-up|1|||
147634063|NCT02217410|532477655|FG000|Overall Study|Lack of Efficacy|0|||
147634064|NCT02217410|532477656|FG001|Overall Study|Lack of Efficacy|1|||
147668735|NCT00784875|532613364|FG003|Period B - Efficacy Endpoint|Protocol Violation|3|||
147503459|NCT00340834|531996571|FG003|Core Phase of Study|Abnormal test procedure result(s)|0|||
147503460|NCT00340834|531996572|FG004|Core Phase of Study|Abnormal test procedure result(s)|0|||
147503461|NCT00340834|531996568|FG000|Core Phase of Study|Lost to Follow-up|1|||
147503462|NCT00340834|531996569|FG001|Core Phase of Study|Lost to Follow-up|1|||
147503463|NCT00340834|531996570|FG002|Core Phase of Study|Lost to Follow-up|4|||
147503464|NCT00340834|531996571|FG003|Core Phase of Study|Lost to Follow-up|0|||
147503465|NCT00340834|531996572|FG004|Core Phase of Study|Lost to Follow-up|0|||
147503466|NCT00340834|531996568|FG000|Core Phase of Study|Death|2|||
147503467|NCT00340834|531996569|FG001|Core Phase of Study|Death|0|||
147503468|NCT00340834|531996570|FG002|Core Phase of Study|Death|0|||
147503469|NCT00340834|531996571|FG003|Core Phase of Study|Death|0|||
147503470|NCT00340834|531996572|FG004|Core Phase of Study|Death|0|||
147503471|NCT00340834|531996568|FG000|Core Phase of Study|Protocol Violation|0|||
147503472|NCT00340834|531996569|FG001|Core Phase of Study|Protocol Violation|0|||
147503473|NCT00340834|531996570|FG002|Core Phase of Study|Protocol Violation|2|||
147503474|NCT00340834|531996571|FG003|Core Phase of Study|Protocol Violation|0|||
147503475|NCT00340834|531996572|FG004|Core Phase of Study|Protocol Violation|0|||
147503476|NCT00340834|531996568|FG000|Extension Phase of Study|Subject did not receive study drug|0|||
147634065|NCT02217410|532477657|FG002|Overall Study|Lack of Efficacy|0|||
147634066|NCT02217410|532477655|FG000|Overall Study|Physician Decision|1|||
147634067|NCT02217410|532477656|FG001|Overall Study|Physician Decision|3|||
147634068|NCT02217410|532477657|FG002|Overall Study|Physician Decision|0|||
147634069|NCT01254318|532477658|FG000|Overall Study|Lost to Follow-up|5|||
147634070|NCT01254318|532477658|FG000|Overall Study|Death|47|||
147634071|NCT02295020|532477663|FG000|Overall Study|Adverse Event|0|||
147634072|NCT02295020|532477664|FG001|Overall Study|Adverse Event|1|||
147634073|NCT02295020|532477663|FG000|Overall Study|Withdrawal by Subject|3|||
147634074|NCT02295020|532477664|FG001|Overall Study|Withdrawal by Subject|2|||
147634075|NCT00355147|532477667|FG000|Overall Study|Lost to Follow-up|10|||
147503477|NCT00340834|531996569|FG001|Extension Phase of Study|Subject did not receive study drug|1|||
147503478|NCT00340834|531996570|FG002|Extension Phase of Study|Subject did not receive study drug|0|||
147634076|NCT00355147|532477668|FG001|Overall Study|Lost to Follow-up|8|||
147634077|NCT00355147|532477667|FG000|Overall Study|Withdrawal by Subject|8|||
147634078|NCT00355147|532477668|FG001|Overall Study|Withdrawal by Subject|12|||
147634079|NCT03557931|532477675|FG000|Overall Study|Adverse Event|4|||
147634080|NCT03557931|532477676|FG001|Overall Study|Adverse Event|6|||
147634081|NCT03557931|532477677|FG002|Overall Study|Adverse Event|1|||
147634082|NCT03557931|532477675|FG000|Overall Study|Lost to Follow-up|4|||
147634083|NCT03557931|532477676|FG001|Overall Study|Lost to Follow-up|4|||
147634084|NCT03557931|532477677|FG002|Overall Study|Lost to Follow-up|1|||
147634085|NCT03557931|532477675|FG000|Overall Study|Protocol Violation|1|||
147634086|NCT03557931|532477676|FG001|Overall Study|Protocol Violation|4|||
147634087|NCT03557931|532477677|FG002|Overall Study|Protocol Violation|1|||
147634088|NCT03557931|532477675|FG000|Overall Study|Withdrawal by Subject|14|||
147634089|NCT03557931|532477676|FG001|Overall Study|Withdrawal by Subject|0|||
147634090|NCT03557931|532477677|FG002|Overall Study|Withdrawal by Subject|7|||
147634091|NCT03557931|532477675|FG000|Overall Study|Miscellaneous|8|||
147634092|NCT03557931|532477676|FG001|Overall Study|Miscellaneous|5|||
147634093|NCT03557931|532477677|FG002|Overall Study|Miscellaneous|3|||
147634094|NCT01355575|532477681|FG000|Overall Study|Withdrawal by Subject|2|||
147634095|NCT02438826|532477686|FG000|Double-Blind Treatment Phase|Adverse Event|1|||
147634096|NCT02438826|532477687|FG001|Double-Blind Treatment Phase|Adverse Event|1|||
147634097|NCT02438826|532477688|FG002|Double-Blind Treatment Phase|Adverse Event|0|||
147634098|NCT02438826|532477689|FG003|Double-Blind Treatment Phase|Adverse Event|0|||
147634099|NCT02438826|532477686|FG000|Double-Blind Treatment Phase|Lack of Efficacy|1|||
147634100|NCT02438826|532477687|FG001|Double-Blind Treatment Phase|Lack of Efficacy|0|||
147634101|NCT02438826|532477688|FG002|Double-Blind Treatment Phase|Lack of Efficacy|0|||
147634102|NCT02438826|532477689|FG003|Double-Blind Treatment Phase|Lack of Efficacy|0|||
147634103|NCT02438826|532477686|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|1|||
147634104|NCT02438826|532477687|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|1|||
147634105|NCT02438826|532477688|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
147634106|NCT02438826|532477689|FG003|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
147634107|NCT02438826|532477686|FG000|Double-Blind Treatment Phase|Protocol Violation|1|||
147634108|NCT02438826|532477687|FG001|Double-Blind Treatment Phase|Protocol Violation|2|||
147634109|NCT02438826|532477688|FG002|Double-Blind Treatment Phase|Protocol Violation|0|||
147634110|NCT02438826|532477689|FG003|Double-Blind Treatment Phase|Protocol Violation|0|||
147634111|NCT02438826|532477686|FG000|Double-Blind Treatment Phase|Screen Failure|2|||
147634112|NCT02438826|532477687|FG001|Double-Blind Treatment Phase|Screen Failure|0|||
147634113|NCT02438826|532477688|FG002|Double-Blind Treatment Phase|Screen Failure|0|||
147634114|NCT02438826|532477689|FG003|Double-Blind Treatment Phase|Screen Failure|0|||
147634115|NCT02438826|532477686|FG000|Open-Label Treatment Phase|Adverse Event|11|||
147634116|NCT02438826|532477687|FG001|Open-Label Treatment Phase|Adverse Event|6|||
147634117|NCT02438826|532477688|FG002|Open-Label Treatment Phase|Adverse Event|0|||
147634118|NCT02438826|532477689|FG003|Open-Label Treatment Phase|Adverse Event|0|||
147634119|NCT02438826|532477686|FG000|Open-Label Treatment Phase|Lack of Efficacy|27|||
147634120|NCT02438826|532477687|FG001|Open-Label Treatment Phase|Lack of Efficacy|18|||
147634121|NCT02438826|532477688|FG002|Open-Label Treatment Phase|Lack of Efficacy|0|||
147634122|NCT02438826|532477689|FG003|Open-Label Treatment Phase|Lack of Efficacy|0|||
147634123|NCT02438826|532477686|FG000|Open-Label Treatment Phase|Lost to Follow-up|0|||
147634124|NCT02438826|532477687|FG001|Open-Label Treatment Phase|Lost to Follow-up|2|||
147634125|NCT02438826|532477688|FG002|Open-Label Treatment Phase|Lost to Follow-up|0|||
147634126|NCT02438826|532477689|FG003|Open-Label Treatment Phase|Lost to Follow-up|0|||
147634127|NCT02438826|532477686|FG000|Open-Label Treatment Phase|Withdrawal by Subject|6|||
147634128|NCT02438826|532477687|FG001|Open-Label Treatment Phase|Withdrawal by Subject|7|||
147634129|NCT02438826|532477688|FG002|Open-Label Treatment Phase|Withdrawal by Subject|0|||
147634130|NCT02438826|532477689|FG003|Open-Label Treatment Phase|Withdrawal by Subject|0|||
147634131|NCT02438826|532477686|FG000|Post-Treatment Phase|Adverse Event|3|||
147634132|NCT02438826|532477687|FG001|Post-Treatment Phase|Adverse Event|0|||
147634133|NCT02438826|532477688|FG002|Post-Treatment Phase|Adverse Event|0|||
147634134|NCT02438826|532477689|FG003|Post-Treatment Phase|Adverse Event|0|||
147634135|NCT02438826|532477686|FG000|Post-Treatment Phase|Lack of Efficacy|4|||
147634136|NCT02438826|532477687|FG001|Post-Treatment Phase|Lack of Efficacy|0|||
147503479|NCT00340834|531996571|FG003|Extension Phase of Study|Subject did not receive study drug|2|||
147634137|NCT02438826|532477688|FG002|Post-Treatment Phase|Lack of Efficacy|0|||
147634138|NCT02438826|532477689|FG003|Post-Treatment Phase|Lack of Efficacy|0|||
147634139|NCT02438826|532477686|FG000|Post-Treatment Phase|Physician Decision|1|||
147634140|NCT02438826|532477687|FG001|Post-Treatment Phase|Physician Decision|0|||
147634141|NCT02438826|532477688|FG002|Post-Treatment Phase|Physician Decision|0|||
147634142|NCT02438826|532477689|FG003|Post-Treatment Phase|Physician Decision|0|||
147634143|NCT02438826|532477686|FG000|Post-Treatment Phase|Withdrawal by Subject|1|||
147634144|NCT02438826|532477687|FG001|Post-Treatment Phase|Withdrawal by Subject|1|||
147634145|NCT02438826|532477688|FG002|Post-Treatment Phase|Withdrawal by Subject|0|||
147503480|NCT00340834|531996572|FG004|Extension Phase of Study|Subject did not receive study drug|0|||
147503481|NCT00340834|531996568|FG000|Extension Phase of Study|Subject withdrew consent|26|||
147503482|NCT00340834|531996569|FG001|Extension Phase of Study|Subject withdrew consent|31|||
147503483|NCT00340834|531996570|FG002|Extension Phase of Study|Subject withdrew consent|0|||
147503484|NCT00340834|531996571|FG003|Extension Phase of Study|Subject withdrew consent|12|||
147503485|NCT00340834|531996572|FG004|Extension Phase of Study|Subject withdrew consent|15|||
147503486|NCT00340834|531996568|FG000|Extension Phase of Study|Adverse Event|21|||
147503487|NCT00340834|531996569|FG001|Extension Phase of Study|Adverse Event|22|||
147503488|NCT00340834|531996570|FG002|Extension Phase of Study|Adverse Event|0|||
147503489|NCT00340834|531996571|FG003|Extension Phase of Study|Adverse Event|19|||
147503490|NCT00340834|531996572|FG004|Extension Phase of Study|Adverse Event|7|||
147503491|NCT00340834|531996568|FG000|Extension Phase of Study|Abnormal laboratory value(s)|14|||
147503492|NCT00340834|531996569|FG001|Extension Phase of Study|Abnormal laboratory value(s)|13|||
147503493|NCT00340834|531996570|FG002|Extension Phase of Study|Abnormal laboratory value(s)|0|||
147503494|NCT00340834|531996571|FG003|Extension Phase of Study|Abnormal laboratory value(s)|13|||
147503495|NCT00340834|531996572|FG004|Extension Phase of Study|Abnormal laboratory value(s)|4|||
147503496|NCT00340834|531996568|FG000|Extension Phase of Study|Unsatisfactory therapeutic effect|13|||
147503497|NCT00340834|531996569|FG001|Extension Phase of Study|Unsatisfactory therapeutic effect|7|||
147503498|NCT00340834|531996570|FG002|Extension Phase of Study|Unsatisfactory therapeutic effect|0|||
147503499|NCT00340834|531996571|FG003|Extension Phase of Study|Unsatisfactory therapeutic effect|4|||
147503500|NCT00340834|531996572|FG004|Extension Phase of Study|Unsatisfactory therapeutic effect|9|||
147503501|NCT00340834|531996568|FG000|Extension Phase of Study|Lost to Follow-up|1|||
147503502|NCT00340834|531996569|FG001|Extension Phase of Study|Lost to Follow-up|1|||
147503503|NCT00340834|531996570|FG002|Extension Phase of Study|Lost to Follow-up|0|||
147503504|NCT00340834|531996571|FG003|Extension Phase of Study|Lost to Follow-up|2|||
147503505|NCT00340834|531996572|FG004|Extension Phase of Study|Lost to Follow-up|3|||
147503506|NCT00340834|531996568|FG000|Extension Phase of Study|Subject no longer requires study drug|4|||
147503507|NCT00340834|531996569|FG001|Extension Phase of Study|Subject no longer requires study drug|0|||
147503508|NCT00340834|531996570|FG002|Extension Phase of Study|Subject no longer requires study drug|0|||
147503509|NCT00340834|531996571|FG003|Extension Phase of Study|Subject no longer requires study drug|0|||
147503510|NCT00340834|531996572|FG004|Extension Phase of Study|Subject no longer requires study drug|2|||
147503511|NCT00340834|531996568|FG000|Extension Phase of Study|Administrative problems|3|||
147503512|NCT00340834|531996569|FG001|Extension Phase of Study|Administrative problems|0|||
147503513|NCT00340834|531996570|FG002|Extension Phase of Study|Administrative problems|0|||
147503514|NCT00340834|531996571|FG003|Extension Phase of Study|Administrative problems|1|||
147503515|NCT00340834|531996572|FG004|Extension Phase of Study|Administrative problems|1|||
147503516|NCT00340834|531996568|FG000|Extension Phase of Study|Abnormal test procedure result(s)|0|||
147503517|NCT00340834|531996569|FG001|Extension Phase of Study|Abnormal test procedure result(s)|1|||
147503518|NCT00340834|531996570|FG002|Extension Phase of Study|Abnormal test procedure result(s)|0|||
147503519|NCT00340834|531996571|FG003|Extension Phase of Study|Abnormal test procedure result(s)|0|||
147503520|NCT00340834|531996572|FG004|Extension Phase of Study|Abnormal test procedure result(s)|2|||
147503521|NCT00340834|531996568|FG000|Extension Phase of Study|Protocol Violation|3|||
147503522|NCT00340834|531996569|FG001|Extension Phase of Study|Protocol Violation|0|||
147503523|NCT00340834|531996570|FG002|Extension Phase of Study|Protocol Violation|0|||
147503524|NCT00340834|531996571|FG003|Extension Phase of Study|Protocol Violation|0|||
147503525|NCT00340834|531996572|FG004|Extension Phase of Study|Protocol Violation|0|||
147503526|NCT00340834|531996568|FG000|Extension Phase of Study|Death|0|||
147503527|NCT00340834|531996569|FG001|Extension Phase of Study|Death|0|||
147503528|NCT00340834|531996570|FG002|Extension Phase of Study|Death|0|||
147503529|NCT00340834|531996571|FG003|Extension Phase of Study|Death|0|||
147503530|NCT00340834|531996572|FG004|Extension Phase of Study|Death|1|||
147503531|NCT00291499|531996573|FG000|Overall Study|Adverse Event|3|||
147503532|NCT00291499|531996574|FG001|Overall Study|Adverse Event|8|||
147503533|NCT00291499|531996573|FG000|Overall Study|Change to other therapy|2|||
147503534|NCT00291499|531996574|FG001|Overall Study|Change to other therapy|1|||
147503535|NCT00291499|531996573|FG000|Overall Study|Intercurrent illness|1|||
147503536|NCT00291499|531996574|FG001|Overall Study|Intercurrent illness|0|||
147503537|NCT00291499|531996573|FG000|Overall Study|Protocol Violation|2|||
147503538|NCT00291499|531996574|FG001|Overall Study|Protocol Violation|2|||
147503539|NCT00291499|531996573|FG000|Overall Study|Other reasons|1|||
147503540|NCT00291499|531996574|FG001|Overall Study|Other reasons|4|||
147503541|NCT02786836|531996578|FG000|Overall Study|Death|1|||
147503542|NCT02786836|531996578|FG000|Overall Study|Lack of Efficacy|2|||
147503543|NCT02786836|531996578|FG000|Overall Study|Protocol Violation|3|||
147503544|NCT02786836|531996578|FG000|Overall Study|Withdrawal by Subject|3|||
147503545|NCT02786836|531996578|FG000|Overall Study|Liver Transplantation|2|||
147503546|NCT02786836|531996578|FG000|Overall Study|Device or Pharmacy Issues|3|||
147503547|NCT01387074|531996581|FG000|Overall Study|Lost to Follow-up|7|||
147503548|NCT01387074|531996581|FG000|Overall Study|Lack of Efficacy|1|||
147503549|NCT01532570|531996591|FG000|Overall Study|Lack of Efficacy|1|||
147503550|NCT01532570|531996592|FG001|Overall Study|Lack of Efficacy|0|||
147634146|NCT02438826|532477689|FG003|Post-Treatment Phase|Withdrawal by Subject|0|||
147634147|NCT00675428|532477690|FG000|Overall Study|Disease Progression|2|||
147634148|NCT00675428|532477691|FG001|Overall Study|Disease Progression|2|||
147634149|NCT00675428|532477690|FG000|Overall Study|No Disease Response After Cycle 6|0|||
147634150|NCT00675428|532477691|FG001|Overall Study|No Disease Response After Cycle 6|1|||
147634151|NCT00675428|532477690|FG000|Overall Study|Physician Decision|1|||
147634152|NCT00675428|532477691|FG001|Overall Study|Physician Decision|0|||
147634153|NCT00552396|532477696|FG000|Overall Study|protocol withdrawal criteria|3|||
147634154|NCT00552396|532477697|FG001|Overall Study|protocol withdrawal criteria|3|||
147634155|NCT00552396|532477698|FG002|Overall Study|protocol withdrawal criteria|3|||
147634156|NCT00552396|532477699|FG003|Overall Study|protocol withdrawal criteria|6|||
147634157|NCT00552396|532477700|FG004|Overall Study|protocol withdrawal criteria|3|||
147634158|NCT00552396|532477701|FG005|Overall Study|protocol withdrawal criteria|3|||
147634159|NCT00552396|532477702|FG006|Overall Study|protocol withdrawal criteria|9|||
147634160|NCT00101166|532477705|FG000|Overall Study|progressive disease|10|||
147634161|NCT00686829|532477706|FG000|Overall Study|Adverse Event|5|||
147634162|NCT00686829|532477706|FG000|Overall Study|Lack of Efficacy|6|||
147634163|NCT00686829|532477706|FG000|Overall Study|Lost to Follow-up|4|||
147634164|NCT00686829|532477706|FG000|Overall Study|Withdrawal by Subject|14|||
147634165|NCT00686829|532477706|FG000|Overall Study|Protocol Violation|3|||
147634166|NCT00686829|532477706|FG000|Overall Study|Sponsor discontinued VCV|47|||
147634167|NCT01732640|532477707|FG000|Overall Study|Adverse Event|0|||
147634168|NCT01732640|532477708|FG001|Overall Study|Adverse Event|1|||
147634169|NCT01732640|532477707|FG000|Overall Study|Death|0|||
147634170|NCT01732640|532477708|FG001|Overall Study|Death|1|||
147634171|NCT00712543|532477711|FG000|Day 8-14|Lost to Follow-up|0|||
147634172|NCT00712543|532477712|FG001|Day 8-14|Lost to Follow-up|2|||
147634173|NCT04520997|532477725|FG000|Overall Study|Lost to Follow-up|1|||
147634174|NCT04520997|532477726|FG001|Overall Study|Lost to Follow-up|1|||
147634175|NCT04520997|532477725|FG000|Overall Study|Withdrawal by Subject|1|||
147634176|NCT04520997|532477726|FG001|Overall Study|Withdrawal by Subject|0|||
147634177|NCT04520997|532477725|FG000|Overall Study|Not Treated|0|||
147634178|NCT04520997|532477726|FG001|Overall Study|Not Treated|1|||
147634179|NCT02981082|532477727|FG000|Overall Study|Withdrawal by Subject|2|||
147634180|NCT02981082|532477728|FG001|Overall Study|Withdrawal by Subject|0|||
147634181|NCT02981082|532477727|FG000|Overall Study|Met stopping rule of low absolute lymphocyte count (<0.5L) at two visits|1|||
147634182|NCT02981082|532477728|FG001|Overall Study|Met stopping rule of low absolute lymphocyte count (<0.5L) at two visits|0|||
147634183|NCT02981082|532477727|FG000|Overall Study|Adverse Event|0|||
147634184|NCT02981082|532477728|FG001|Overall Study|Adverse Event|1|||
147634185|NCT00199797|532480140|FG000|Overall Study|Progressive Disease|1|||
147634186|NCT00199797|532480140|FG000|Overall Study|Adverse Event|1|||
147634187|NCT00199797|532480140|FG000|Overall Study|Physician Decision|1|||
147634188|NCT00504725|532480145|FG000|Overall Study|Protocol Violation|1|||
147634189|NCT00504725|532480146|FG001|Overall Study|Protocol Violation|0|||
147634190|NCT00378508|532480147|FG000|Overall Study|Withdrawal by Subject|1|||
147634191|NCT00378508|532480148|FG001|Overall Study|Withdrawal by Subject|3|||
147634192|NCT00378508|532480147|FG000|Overall Study|Lost to Follow-up|1|||
147634193|NCT00378508|532480148|FG001|Overall Study|Lost to Follow-up|0|||
147634194|NCT01435018|532480149|FG000|Overall Study|Death|37|||
147634195|NCT01435018|532480150|FG001|Overall Study|Death|18|||
147634196|NCT01435018|532480151|FG002|Overall Study|Death|25|||
147634197|NCT01435018|532480149|FG000|Overall Study|Site is closing|4|||
147634198|NCT01435018|532480150|FG001|Overall Study|Site is closing|9|||
147634199|NCT01435018|532480151|FG002|Overall Study|Site is closing|7|||
147503551|NCT01532570|531996593|FG002|Overall Study|Lack of Efficacy|0|||
147634200|NCT01435018|532480149|FG000|Overall Study|Withdrew consent|0|||
147634201|NCT01435018|532480150|FG001|Overall Study|Withdrew consent|3|||
147634202|NCT01435018|532480151|FG002|Overall Study|Withdrew consent|1|||
147634203|NCT01435018|532480149|FG000|Overall Study|Not willing to adhere to requirements|0|||
147634204|NCT01435018|532480150|FG001|Overall Study|Not willing to adhere to requirements|2|||
147634205|NCT01435018|532480151|FG002|Overall Study|Not willing to adhere to requirements|3|||
147634206|NCT01435018|532480149|FG000|Overall Study|Not able to get to clinic|2|||
147503552|NCT01532570|531996594|FG003|Overall Study|Lack of Efficacy|0|||
147503553|NCT01532570|531996591|FG000|Overall Study|Withdrawal by Subject|0|||
147503554|NCT01532570|531996592|FG001|Overall Study|Withdrawal by Subject|1|||
147634207|NCT01435018|532480150|FG001|Overall Study|Not able to get to clinic|0|||
147634208|NCT01435018|532480151|FG002|Overall Study|Not able to get to clinic|2|||
147634209|NCT01435018|532480149|FG000|Overall Study|Severe debilitation, unable to continue|0|||
147634210|NCT01435018|532480150|FG001|Overall Study|Severe debilitation, unable to continue|0|||
147634211|NCT01435018|532480151|FG002|Overall Study|Severe debilitation, unable to continue|1|||
147634212|NCT01435018|532480149|FG000|Overall Study|Unable to contact participant/parent|1|||
147634213|NCT01435018|532480150|FG001|Overall Study|Unable to contact participant/parent|1|||
147634214|NCT01435018|532480151|FG002|Overall Study|Unable to contact participant/parent|1|||
147634215|NCT01435018|532480149|FG000|Overall Study|Enrollment Violation|0|||
147634216|NCT01435018|532480150|FG001|Overall Study|Enrollment Violation|1|||
147634217|NCT01435018|532480151|FG002|Overall Study|Enrollment Violation|0|||
147634218|NCT01435018|532480149|FG000|Overall Study|Never started chemotherapy|3|||
147634219|NCT01435018|532480150|FG001|Overall Study|Never started chemotherapy|0|||
147634220|NCT01435018|532480151|FG002|Overall Study|Never started chemotherapy|1|||
147634221|NCT02656290|532480162|FG000|Overall Study|Lost to Follow-up|1|||
147634222|NCT02656290|532480162|FG000|Overall Study|Reintervention|3|||
147634223|NCT01608087|532480163|FG000|Overall Study|Lost to Follow-up|0|||
147634224|NCT01608087|532480164|FG001|Overall Study|Lost to Follow-up|1|||
147634225|NCT01608087|532480165|FG002|Overall Study|Lost to Follow-up|0|||
147634226|NCT01608087|532480163|FG000|Overall Study|Other Reason|0|||
147634227|NCT01608087|532480164|FG001|Overall Study|Other Reason|1|||
147634228|NCT01608087|532480165|FG002|Overall Study|Other Reason|0|||
147634229|NCT02461524|532480167|FG000|Overall Study|Death|16|||
147634230|NCT02461524|532480167|FG000|Overall Study|Withdrawal by Subject|4|||
147634231|NCT02461524|532480167|FG000|Overall Study|Device Explanted|5|||
147634232|NCT02461524|532480167|FG000|Overall Study|Missed Visit|6|||
147634233|NCT01943851|532480171|FG000|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
147634234|NCT01943851|532480172|FG001|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
147634235|NCT01943851|532480173|FG002|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
147634236|NCT01943851|532480174|FG003|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|1|||
147634237|NCT01943851|532480175|FG004|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
147634238|NCT01943851|532480176|FG005|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
147634239|NCT01943851|532480177|FG006|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|1|||
147634240|NCT01943851|532480178|FG007|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|1|||
147634241|NCT01943851|532480179|FG008|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|1|||
147634242|NCT01943851|532480180|FG009|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
147634243|NCT01943851|532480181|FG010|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
147634244|NCT01943851|532480182|FG011|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
147634245|NCT01943851|532480183|FG012|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
147634246|NCT01943851|532480184|FG013|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
147634247|NCT01943851|532480185|FG014|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
147634248|NCT01943851|532480186|FG015|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
147634249|NCT01943851|532480187|FG016|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
147634250|NCT01943851|532480188|FG017|Part 1 (Up to 86.9 Weeks)|Withdrawal by Subject|0|||
147634251|NCT01943851|532480171|FG000|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
147634252|NCT01943851|532480172|FG001|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
147634253|NCT01943851|532480173|FG002|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
147634254|NCT01943851|532480174|FG003|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
147634255|NCT01943851|532480175|FG004|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|1|||
147634256|NCT01943851|532480176|FG005|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
147634257|NCT01943851|532480177|FG006|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
147634258|NCT01943851|532480178|FG007|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|1|||
147634259|NCT01943851|532480179|FG008|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
147634260|NCT01943851|532480180|FG009|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
147634261|NCT01943851|532480181|FG010|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
147634262|NCT01943851|532480182|FG011|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
147634263|NCT01943851|532480183|FG012|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
147634264|NCT01943851|532480184|FG013|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
147634265|NCT01943851|532480185|FG014|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
147634266|NCT01943851|532480186|FG015|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
147634267|NCT01943851|532480187|FG016|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
147634268|NCT01943851|532480188|FG017|Part 1 (Up to 86.9 Weeks)|Lost to Follow-up|0|||
147634269|NCT01943851|532480171|FG000|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
147634270|NCT01943851|532480172|FG001|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
147634271|NCT01943851|532480173|FG002|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
147634272|NCT01943851|532480174|FG003|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
147634273|NCT01943851|532480175|FG004|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
147634274|NCT01943851|532480176|FG005|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
147634275|NCT01943851|532480177|FG006|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
147634276|NCT01943851|532480178|FG007|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
147634277|NCT01943851|532480179|FG008|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
147634278|NCT01943851|532480180|FG009|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
147634279|NCT01943851|532480181|FG010|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
147634280|NCT01943851|532480182|FG011|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
147634281|NCT01943851|532480183|FG012|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
147503555|NCT01532570|531996593|FG002|Overall Study|Withdrawal by Subject|0|||
147503556|NCT01532570|531996594|FG003|Overall Study|Withdrawal by Subject|0|||
147634282|NCT01943851|532480184|FG013|Part 1 (Up to 86.9 Weeks)|Investigator discretion|1|||
147634283|NCT01943851|532480185|FG014|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
147634284|NCT01943851|532480186|FG015|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
147634285|NCT01943851|532480187|FG016|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
147634286|NCT01943851|532480188|FG017|Part 1 (Up to 86.9 Weeks)|Investigator discretion|0|||
147634287|NCT01943851|532480171|FG000|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
147634288|NCT01943851|532480172|FG001|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
147634289|NCT01943851|532480173|FG002|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
147634290|NCT01943851|532480174|FG003|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
147634291|NCT01943851|532480175|FG004|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
147634292|NCT01943851|532480176|FG005|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
147634293|NCT01943851|532480177|FG006|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
147503557|NCT03892707|531996597|FG000|Overall Study|Screen failure|6|||
147503558|NCT03892707|531996598|FG001|Overall Study|Screen failure|0|||
147503559|NCT03892707|531996597|FG000|Overall Study|Pain resolution|0|||
147503560|NCT03892707|531996598|FG001|Overall Study|Pain resolution|4|||
147503561|NCT03892707|531996597|FG000|Overall Study|Withdrawal by Subject|0|||
147503562|NCT03892707|531996598|FG001|Overall Study|Withdrawal by Subject|1|||
147503563|NCT03892707|531996597|FG000|Overall Study|Other (long business trip)|0|||
147503564|NCT03892707|531996598|FG001|Overall Study|Other (long business trip)|1|||
147503565|NCT04190186|531996600|FG000|Overall Study|ILR is no longer functioning|0|||
147503566|NCT04190186|531996601|FG001|Overall Study|ILR is no longer functioning|1|||
147503567|NCT04190186|531996600|FG000|Overall Study|Lost to Follow-up|0|||
147503568|NCT04190186|531996601|FG001|Overall Study|Lost to Follow-up|1|||
147503569|NCT04190186|531996600|FG000|Overall Study|Withdrawal by Subject|2|||
147503570|NCT04190186|531996601|FG001|Overall Study|Withdrawal by Subject|0|||
147503571|NCT04190186|531996600|FG000|Overall Study|Subject choice to explant|1|||
147503572|NCT04190186|531996601|FG001|Overall Study|Subject choice to explant|0|||
147503573|NCT04190186|531996600|FG000|Overall Study|Physician Decision|0|||
147503574|NCT04190186|531996601|FG001|Overall Study|Physician Decision|1|||
147503575|NCT04190186|531996600|FG000|Overall Study|Study was stopped|4|||
147503576|NCT04190186|531996601|FG001|Overall Study|Study was stopped|5|||
147503577|NCT02141217|531996602|FG000|Overall Study|Adverse Event|1|||
147503578|NCT02141217|531996603|FG001|Overall Study|Adverse Event|2|||
147503579|NCT02141217|531996602|FG000|Overall Study|Protocol Violation|1|||
147503580|NCT02141217|531996603|FG001|Overall Study|Protocol Violation|4|||
147503581|NCT02141217|531996602|FG000|Overall Study|Withdrawal by Subject|6|||
147503582|NCT02141217|531996603|FG001|Overall Study|Withdrawal by Subject|0|||
147503583|NCT02141217|531996602|FG000|Overall Study|Lost to Follow-up|1|||
147503584|NCT02141217|531996603|FG001|Overall Study|Lost to Follow-up|1|||
147503585|NCT02141217|531996602|FG000|Overall Study|Physician Decision|1|||
147503586|NCT02141217|531996603|FG001|Overall Study|Physician Decision|0|||
147503587|NCT02141217|531996602|FG000|Overall Study|Surgical Intervention|1|||
147503588|NCT02141217|531996603|FG001|Overall Study|Surgical Intervention|1|||
147503589|NCT01665768|531996604|FG000|Overall Study|Adverse Event|3|||
147503590|NCT01665768|531996604|FG000|Overall Study|Lack of Efficacy|19|||
147503591|NCT01665768|531996604|FG000|Overall Study|Withdrawal by Subject|1|||
147503592|NCT04603391|531996605|FG000|First Intervention (4 Days)|Adverse Event|1|||
147503593|NCT04603391|531996606|FG001|First Intervention (4 Days)|Adverse Event|0|||
147503594|NCT04603391|531996605|FG000|First Intervention (4 Days)|Lost to Follow-up|1|||
147503595|NCT04603391|531996606|FG001|First Intervention (4 Days)|Lost to Follow-up|0|||
147503596|NCT02759861|531996609|FG000|Overall Study|Death|1|||
147503597|NCT02151682|531996610|FG000|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0|||
147503598|NCT02151682|531996611|FG001|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|2|||
147503599|NCT02151682|531996612|FG002|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0|||
147503600|NCT02151682|531996613|FG003|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0|||
147503601|NCT02151682|531996614|FG004|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0|||
147503602|NCT02151682|531996615|FG005|Part 1: 14 Days Morphine or Tapentadol|Adverse Event|0|||
147503603|NCT02151682|531996610|FG000|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0|||
147503604|NCT02151682|531996611|FG001|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|1|||
147503605|NCT02151682|531996612|FG002|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0|||
147503606|NCT02151682|531996613|FG003|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0|||
147503607|NCT02151682|531996614|FG004|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0|||
147503608|NCT02151682|531996615|FG005|Part 1: 14 Days Morphine or Tapentadol|Withdrawal by Subject|0|||
147503609|NCT02151682|531996610|FG000|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0|||
147503610|NCT02151682|531996611|FG001|Part 1: 14 Days Morphine or Tapentadol|Technical problems|1|||
147503611|NCT02151682|531996612|FG002|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0|||
147503612|NCT02151682|531996613|FG003|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0|||
147503613|NCT02151682|531996614|FG004|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0|||
147503614|NCT02151682|531996615|FG005|Part 1: 14 Days Morphine or Tapentadol|Technical problems|0|||
147503615|NCT02151682|531996610|FG000|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|1|||
147503616|NCT02151682|531996611|FG001|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|1|||
147503617|NCT02151682|531996612|FG002|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|0|||
147503618|NCT02151682|531996613|FG003|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|0|||
147503619|NCT02151682|531996614|FG004|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|0|||
147503620|NCT02151682|531996615|FG005|Part 1: 14 Days Morphine or Tapentadol|No need for opioid|0|||
147634294|NCT01943851|532480178|FG007|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
147634295|NCT01943851|532480179|FG008|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
147634296|NCT01943851|532480180|FG009|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
147634297|NCT01943851|532480181|FG010|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
147634298|NCT01943851|532480182|FG011|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
147634299|NCT01943851|532480183|FG012|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
147634300|NCT01943851|532480184|FG013|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
147634301|NCT01943851|532480185|FG014|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
147634302|NCT01943851|532480186|FG015|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|2|||
147634303|NCT01943851|532480187|FG016|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
147634304|NCT01943851|532480188|FG017|Part 2 (Up to 36.4 Weeks)|Withdrawal by Subject|0|||
147634305|NCT01943851|532480171|FG000|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
147634306|NCT01943851|532480172|FG001|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
147634307|NCT01943851|532480173|FG002|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
147634308|NCT01943851|532480174|FG003|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
147634309|NCT01943851|532480175|FG004|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
147634310|NCT01943851|532480176|FG005|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
147634311|NCT01943851|532480177|FG006|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
147634312|NCT01943851|532480178|FG007|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
147634313|NCT01943851|532480179|FG008|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
147634314|NCT01943851|532480180|FG009|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
147634315|NCT01943851|532480181|FG010|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
147634316|NCT01943851|532480182|FG011|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
147634317|NCT01943851|532480183|FG012|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
147634318|NCT01943851|532480184|FG013|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
147634319|NCT01943851|532480185|FG014|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|0|||
147634320|NCT01943851|532480186|FG015|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|4|||
147634321|NCT01943851|532480187|FG016|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|3|||
147634322|NCT01943851|532480188|FG017|Part 2 (Up to 36.4 Weeks)|Study closed/terminated|1|||
147634323|NCT04984278|532480195|FG000|Period 1|Withdrawal by Subject|1|||
147634324|NCT04984278|532480196|FG001|Period 1|Withdrawal by Subject|0|||
147634325|NCT04984278|532480195|FG000|Period 1|Other|0|||
147634326|NCT04984278|532480196|FG001|Period 1|Other|1|||
147634327|NCT04984278|532480195|FG000|Period 2|Adverse Event|1|||
147634328|NCT04984278|532480196|FG001|Period 2|Adverse Event|0|||
147634329|NCT04984278|532480195|FG000|Period 2|Other|0|||
147634330|NCT04984278|532480196|FG001|Period 2|Other|1|||
147634331|NCT03535194|532480197|FG000|Induction Period|Adverse Event|2|||
147634332|NCT03535194|532480198|FG001|Induction Period|Adverse Event|2|||
147634333|NCT03535194|532480199|FG002|Induction Period|Adverse Event|1|||
147634334|NCT03535194|532480200|FG003|Induction Period|Adverse Event|3|||
147634335|NCT03535194|532480201|FG004|Induction Period|Adverse Event|0|||
147634336|NCT03535194|532480197|FG000|Induction Period|Death|0|||
147634337|NCT03535194|532480198|FG001|Induction Period|Death|1|||
147634338|NCT03535194|532480199|FG002|Induction Period|Death|0|||
147634339|NCT03535194|532480200|FG003|Induction Period|Death|0|||
147634340|NCT03535194|532480201|FG004|Induction Period|Death|0|||
147634341|NCT03535194|532480197|FG000|Induction Period|Lack of Efficacy|1|||
147634342|NCT03535194|532480198|FG001|Induction Period|Lack of Efficacy|3|||
147634343|NCT03535194|532480199|FG002|Induction Period|Lack of Efficacy|2|||
147634344|NCT03535194|532480200|FG003|Induction Period|Lack of Efficacy|2|||
147634345|NCT03535194|532480201|FG004|Induction Period|Lack of Efficacy|0|||
147634346|NCT03535194|532480197|FG000|Induction Period|Lost to Follow-up|3|||
147634347|NCT03535194|532480198|FG001|Induction Period|Lost to Follow-up|5|||
147634348|NCT03535194|532480199|FG002|Induction Period|Lost to Follow-up|2|||
147634349|NCT03535194|532480200|FG003|Induction Period|Lost to Follow-up|3|||
147634350|NCT03535194|532480201|FG004|Induction Period|Lost to Follow-up|0|||
147634351|NCT03535194|532480197|FG000|Induction Period|Physician Decision|1|||
147634352|NCT03535194|532480198|FG001|Induction Period|Physician Decision|1|||
147634353|NCT03535194|532480199|FG002|Induction Period|Physician Decision|0|||
147634354|NCT03535194|532480200|FG003|Induction Period|Physician Decision|0|||
147634355|NCT03535194|532480201|FG004|Induction Period|Physician Decision|0|||
147634356|NCT03535194|532480197|FG000|Induction Period|Protocol Violation|1|||
147634357|NCT03535194|532480198|FG001|Induction Period|Protocol Violation|0|||
147634358|NCT03535194|532480199|FG002|Induction Period|Protocol Violation|0|||
147634359|NCT03535194|532480200|FG003|Induction Period|Protocol Violation|1|||
147634360|NCT03535194|532480201|FG004|Induction Period|Protocol Violation|0|||
147503621|NCT02151682|531996610|FG000|Part 1: 14 Days Morphine or Tapentadol|Missing|1|||
147634361|NCT03535194|532480197|FG000|Induction Period|Screen Failure|0|||
147634362|NCT03535194|532480198|FG001|Induction Period|Screen Failure|1|||
147634363|NCT03535194|532480199|FG002|Induction Period|Screen Failure|0|||
147634364|NCT03535194|532480200|FG003|Induction Period|Screen Failure|0|||
147634365|NCT03535194|532480201|FG004|Induction Period|Screen Failure|0|||
147634366|NCT03535194|532480197|FG000|Induction Period|Withdrawal by Subject|3|||
147634367|NCT03535194|532480198|FG001|Induction Period|Withdrawal by Subject|4|||
147634368|NCT03535194|532480199|FG002|Induction Period|Withdrawal by Subject|3|||
147634369|NCT03535194|532480200|FG003|Induction Period|Withdrawal by Subject|2|||
147634370|NCT03535194|532480201|FG004|Induction Period|Withdrawal by Subject|0|||
147503622|NCT02151682|531996611|FG001|Part 1: 14 Days Morphine or Tapentadol|Missing|0|||
147503623|NCT02151682|531996612|FG002|Part 1: 14 Days Morphine or Tapentadol|Missing|0|||
147503624|NCT02151682|531996613|FG003|Part 1: 14 Days Morphine or Tapentadol|Missing|0|||
147503625|NCT02151682|531996614|FG004|Part 1: 14 Days Morphine or Tapentadol|Missing|0|||
147503626|NCT02151682|531996615|FG005|Part 1: 14 Days Morphine or Tapentadol|Missing|0|||
147503627|NCT02151682|531996610|FG000|Part 2: Tapent. Extension or Observation|Adverse Event|0|||
147503628|NCT02151682|531996611|FG001|Part 2: Tapent. Extension or Observation|Adverse Event|0|||
147503629|NCT02151682|531996612|FG002|Part 2: Tapent. Extension or Observation|Adverse Event|3|||
147503630|NCT02151682|531996613|FG003|Part 2: Tapent. Extension or Observation|Adverse Event|0|||
147503631|NCT02151682|531996614|FG004|Part 2: Tapent. Extension or Observation|Adverse Event|0|||
147503632|NCT02151682|531996615|FG005|Part 2: Tapent. Extension or Observation|Adverse Event|0|||
147503633|NCT02151682|531996610|FG000|Part 2: Tapent. Extension or Observation|Death|0|||
147503634|NCT02151682|531996611|FG001|Part 2: Tapent. Extension or Observation|Death|0|||
147503635|NCT02151682|531996612|FG002|Part 2: Tapent. Extension or Observation|Death|0|||
147503636|NCT02151682|531996613|FG003|Part 2: Tapent. Extension or Observation|Death|2|||
147503637|NCT02151682|531996614|FG004|Part 2: Tapent. Extension or Observation|Death|0|||
147503638|NCT02151682|531996615|FG005|Part 2: Tapent. Extension or Observation|Death|0|||
147503639|NCT02151682|531996610|FG000|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|0|||
147503640|NCT02151682|531996611|FG001|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|0|||
147503641|NCT02151682|531996612|FG002|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|1|||
147503642|NCT02151682|531996613|FG003|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|1|||
147503643|NCT02151682|531996614|FG004|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|0|||
147503644|NCT02151682|531996615|FG005|Part 2: Tapent. Extension or Observation|Withdrawal by Subject|0|||
147503645|NCT02151682|531996610|FG000|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0|||
147503646|NCT02151682|531996611|FG001|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0|||
147503647|NCT02151682|531996612|FG002|Part 2: Tapent. Extension or Observation|Lack of Efficacy|3|||
147503648|NCT02151682|531996613|FG003|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0|||
147503649|NCT02151682|531996614|FG004|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0|||
147503650|NCT02151682|531996615|FG005|Part 2: Tapent. Extension or Observation|Lack of Efficacy|0|||
147503651|NCT02151682|531996610|FG000|Part 2: Tapent. Extension or Observation|Protocol Violation|0|||
147503652|NCT02151682|531996611|FG001|Part 2: Tapent. Extension or Observation|Protocol Violation|0|||
147503653|NCT02151682|531996612|FG002|Part 2: Tapent. Extension or Observation|Protocol Violation|1|||
147503654|NCT02151682|531996613|FG003|Part 2: Tapent. Extension or Observation|Protocol Violation|0|||
147503655|NCT02151682|531996614|FG004|Part 2: Tapent. Extension or Observation|Protocol Violation|0|||
147503656|NCT02151682|531996615|FG005|Part 2: Tapent. Extension or Observation|Protocol Violation|0|||
147503657|NCT02151682|531996610|FG000|Part 2: Tapent. Extension or Observation|No need for opioid|0|||
147503658|NCT02151682|531996611|FG001|Part 2: Tapent. Extension or Observation|No need for opioid|0|||
147503659|NCT02151682|531996612|FG002|Part 2: Tapent. Extension or Observation|No need for opioid|13|||
147503660|NCT02151682|531996613|FG003|Part 2: Tapent. Extension or Observation|No need for opioid|0|||
147503661|NCT02151682|531996614|FG004|Part 2: Tapent. Extension or Observation|No need for opioid|0|||
147503662|NCT02151682|531996615|FG005|Part 2: Tapent. Extension or Observation|No need for opioid|0|||
147503663|NCT02151682|531996610|FG000|Part 2: Tapent. Extension or Observation|Missing|0|||
147503664|NCT02151682|531996611|FG001|Part 2: Tapent. Extension or Observation|Missing|0|||
147503665|NCT02151682|531996612|FG002|Part 2: Tapent. Extension or Observation|Missing|0|||
147503666|NCT02151682|531996613|FG003|Part 2: Tapent. Extension or Observation|Missing|1|||
147503667|NCT02151682|531996614|FG004|Part 2: Tapent. Extension or Observation|Missing|0|||
147503668|NCT02151682|531996615|FG005|Part 2: Tapent. Extension or Observation|Missing|0|||
147503669|NCT02151682|531996610|FG000|Part 2: Tapent. Extension or Observation|Various other|0|||
147503670|NCT02151682|531996611|FG001|Part 2: Tapent. Extension or Observation|Various other|0|||
147503671|NCT02151682|531996612|FG002|Part 2: Tapent. Extension or Observation|Various other|6|||
147503672|NCT02151682|531996613|FG003|Part 2: Tapent. Extension or Observation|Various other|0|||
147503673|NCT02151682|531996614|FG004|Part 2: Tapent. Extension or Observation|Various other|0|||
147503674|NCT02151682|531996615|FG005|Part 2: Tapent. Extension or Observation|Various other|0|||
147503675|NCT02151682|531996610|FG000|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0|||
147503676|NCT02151682|531996611|FG001|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0|||
147503677|NCT02151682|531996612|FG002|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|1|||
147503678|NCT02151682|531996613|FG003|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0|||
147503679|NCT02151682|531996614|FG004|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0|||
147503680|NCT02151682|531996615|FG005|Part 2: Tapent. Extension or Observation|Final post-treatment visit not performed|0|||
147503681|NCT02151682|531996610|FG000|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0|||
147503682|NCT02151682|531996611|FG001|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0|||
147634371|NCT03535194|532480197|FG000|Maintenance Period|Adverse Event|6|||
147634372|NCT03535194|532480198|FG001|Maintenance Period|Adverse Event|5|||
147634373|NCT03535194|532480199|FG002|Maintenance Period|Adverse Event|1|||
147634374|NCT03535194|532480200|FG003|Maintenance Period|Adverse Event|11|||
147634375|NCT03535194|532480201|FG004|Maintenance Period|Adverse Event|4|||
147634376|NCT03535194|532480197|FG000|Maintenance Period|Lack of Efficacy|3|||
147634377|NCT03535194|532480198|FG001|Maintenance Period|Lack of Efficacy|2|||
147634378|NCT03535194|532480199|FG002|Maintenance Period|Lack of Efficacy|5|||
147634379|NCT03535194|532480200|FG003|Maintenance Period|Lack of Efficacy|9|||
147634380|NCT03535194|532480201|FG004|Maintenance Period|Lack of Efficacy|0|||
147634381|NCT03535194|532480197|FG000|Maintenance Period|Lost to Follow-up|4|||
147634382|NCT03535194|532480198|FG001|Maintenance Period|Lost to Follow-up|2|||
147634383|NCT03535194|532480199|FG002|Maintenance Period|Lost to Follow-up|1|||
147634384|NCT03535194|532480200|FG003|Maintenance Period|Lost to Follow-up|5|||
147634385|NCT03535194|532480201|FG004|Maintenance Period|Lost to Follow-up|2|||
147634386|NCT03535194|532480197|FG000|Maintenance Period|Other|1|||
147634387|NCT03535194|532480198|FG001|Maintenance Period|Other|2|||
147634388|NCT03535194|532480199|FG002|Maintenance Period|Other|0|||
147634389|NCT03535194|532480200|FG003|Maintenance Period|Other|0|||
147634390|NCT03535194|532480201|FG004|Maintenance Period|Other|0|||
147634391|NCT03535194|532480197|FG000|Maintenance Period|Physician Decision|1|||
147634392|NCT03535194|532480198|FG001|Maintenance Period|Physician Decision|2|||
147634393|NCT03535194|532480199|FG002|Maintenance Period|Physician Decision|0|||
147634394|NCT03535194|532480200|FG003|Maintenance Period|Physician Decision|2|||
147634395|NCT03535194|532480201|FG004|Maintenance Period|Physician Decision|0|||
147634396|NCT03535194|532480197|FG000|Maintenance Period|Pregnancy|0|||
147634397|NCT03535194|532480198|FG001|Maintenance Period|Pregnancy|0|||
147634398|NCT03535194|532480199|FG002|Maintenance Period|Pregnancy|0|||
147634399|NCT03535194|532480200|FG003|Maintenance Period|Pregnancy|2|||
147634400|NCT03535194|532480201|FG004|Maintenance Period|Pregnancy|0|||
147634401|NCT03535194|532480197|FG000|Maintenance Period|Protocol Violation|0|||
147634402|NCT03535194|532480198|FG001|Maintenance Period|Protocol Violation|1|||
147634403|NCT03535194|532480199|FG002|Maintenance Period|Protocol Violation|0|||
147634404|NCT03535194|532480200|FG003|Maintenance Period|Protocol Violation|0|||
147634405|NCT03535194|532480201|FG004|Maintenance Period|Protocol Violation|0|||
147634406|NCT03535194|532480197|FG000|Maintenance Period|Withdrawal by Subject|7|||
147634407|NCT03535194|532480198|FG001|Maintenance Period|Withdrawal by Subject|2|||
147634408|NCT03535194|532480199|FG002|Maintenance Period|Withdrawal by Subject|1|||
147634409|NCT03535194|532480200|FG003|Maintenance Period|Withdrawal by Subject|8|||
147634410|NCT03535194|532480201|FG004|Maintenance Period|Withdrawal by Subject|0|||
147634411|NCT03535194|532480197|FG000|Post-Treatment Followup Period|Adverse Event|4|||
147634412|NCT03535194|532480198|FG001|Post-Treatment Followup Period|Adverse Event|5|||
147634413|NCT03535194|532480199|FG002|Post-Treatment Followup Period|Adverse Event|1|||
147634414|NCT03535194|532480200|FG003|Post-Treatment Followup Period|Adverse Event|8|||
147634415|NCT03535194|532480201|FG004|Post-Treatment Followup Period|Adverse Event|0|||
147634416|NCT03535194|532480197|FG000|Post-Treatment Followup Period|Lack of Efficacy|3|||
147634417|NCT03535194|532480198|FG001|Post-Treatment Followup Period|Lack of Efficacy|4|||
147634418|NCT03535194|532480199|FG002|Post-Treatment Followup Period|Lack of Efficacy|5|||
147634419|NCT03535194|532480200|FG003|Post-Treatment Followup Period|Lack of Efficacy|4|||
147634420|NCT03535194|532480201|FG004|Post-Treatment Followup Period|Lack of Efficacy|0|||
147634421|NCT03535194|532480197|FG000|Post-Treatment Followup Period|Lost to Follow-up|1|||
147634422|NCT03535194|532480198|FG001|Post-Treatment Followup Period|Lost to Follow-up|1|||
147634423|NCT03535194|532480199|FG002|Post-Treatment Followup Period|Lost to Follow-up|1|||
147634424|NCT03535194|532480200|FG003|Post-Treatment Followup Period|Lost to Follow-up|0|||
147634425|NCT03535194|532480201|FG004|Post-Treatment Followup Period|Lost to Follow-up|0|||
147634426|NCT03535194|532480197|FG000|Post-Treatment Followup Period|Other|1|||
147634427|NCT03535194|532480198|FG001|Post-Treatment Followup Period|Other|0|||
147634428|NCT03535194|532480199|FG002|Post-Treatment Followup Period|Other|0|||
147634429|NCT03535194|532480200|FG003|Post-Treatment Followup Period|Other|5|||
147634430|NCT03535194|532480201|FG004|Post-Treatment Followup Period|Other|0|||
147634431|NCT03535194|532480197|FG000|Post-Treatment Followup Period|Physician Decision|0|||
147634432|NCT03535194|532480198|FG001|Post-Treatment Followup Period|Physician Decision|2|||
147634433|NCT03535194|532480199|FG002|Post-Treatment Followup Period|Physician Decision|1|||
147634434|NCT03535194|532480200|FG003|Post-Treatment Followup Period|Physician Decision|1|||
147634435|NCT03535194|532480201|FG004|Post-Treatment Followup Period|Physician Decision|0|||
147634436|NCT03535194|532480197|FG000|Post-Treatment Followup Period|Withdrawal by Subject|2|||
147634437|NCT03535194|532480198|FG001|Post-Treatment Followup Period|Withdrawal by Subject|2|||
147634438|NCT03535194|532480199|FG002|Post-Treatment Followup Period|Withdrawal by Subject|3|||
147634439|NCT03535194|532480200|FG003|Post-Treatment Followup Period|Withdrawal by Subject|6|||
147634440|NCT03535194|532480201|FG004|Post-Treatment Followup Period|Withdrawal by Subject|0|||
147634441|NCT01289639|532480202|FG000|Overall Study|Lost to Follow-up|1|||
147634442|NCT01289639|532480203|FG001|Overall Study|Lost to Follow-up|0|||
147634443|NCT01289639|532480204|FG002|Overall Study|Lost to Follow-up|0|||
147634444|NCT04304235|532480205|FG000|Overall Study|incomplete triage data|0|||
147668736|NCT00784875|532613361|FG000|Period B - Efficacy Endpoint|Lack of Efficacy|0|||
147668737|NCT00784875|532613362|FG001|Period B - Efficacy Endpoint|Lack of Efficacy|1|||
147634445|NCT04304235|532480206|FG001|Overall Study|incomplete triage data|69|||
147634446|NCT04304235|532480207|FG002|Overall Study|incomplete triage data|0|||
147634447|NCT04304235|532480208|FG003|Overall Study|incomplete triage data|0|||
147634448|NCT04304235|532480209|FG004|Overall Study|incomplete triage data|289|||
147634449|NCT04304235|532480210|FG005|Overall Study|incomplete triage data|123|||
147634450|NCT04304235|532480211|FG006|Overall Study|incomplete triage data|65|||
147634451|NCT04429555|532480218|FG000|Overall Study|Death|0|||
147634452|NCT04429555|532480219|FG001|Overall Study|Death|2|||
147634453|NCT04429555|532480218|FG000|Overall Study|Other|2|||
147634454|NCT04429555|532480219|FG001|Overall Study|Other|0|||
147634455|NCT04967885|532480220|FG000|Week 1 Follow-Up|Lost to Follow-up|7|||
147634456|NCT04967885|532480221|FG001|Week 1 Follow-Up|Lost to Follow-up|4|||
147634457|NCT04967885|532480220|FG000|Week 2 Follow-Up|Lost to Follow-up|14|||
147634458|NCT04967885|532480221|FG001|Week 2 Follow-Up|Lost to Follow-up|6|||
147634459|NCT04967885|532480220|FG000|Week 3 Follow-Up|Lost to Follow-up|16|||
147634460|NCT04967885|532480221|FG001|Week 3 Follow-Up|Lost to Follow-up|11|||
147634461|NCT04967885|532480220|FG000|Week 4 Follow-Up|Lost to Follow-up|16|||
147634462|NCT04967885|532480221|FG001|Week 4 Follow-Up|Lost to Follow-up|10|||
147634463|NCT04967885|532480220|FG000|EMI-II Intervention|Lost to Follow-up|14|||
147634464|NCT04967885|532480221|FG001|EMI-II Intervention|Lost to Follow-up|10|||
147634465|NCT00723008|532480222|FG000|Enrollment|Lost to Follow-up|1|||
147634466|NCT00723008|532480223|FG001|Enrollment|Lost to Follow-up|0|||
147634467|NCT00723008|532480222|FG000|4-Week Double Blinded|Lack of Efficacy|0|||
147634468|NCT00723008|532480223|FG001|4-Week Double Blinded|Lack of Efficacy|1|||
147634469|NCT00723008|532480222|FG000|4-Week Double Blinded|Withdrawal by Subject|1|||
147634470|NCT00723008|532480223|FG001|4-Week Double Blinded|Withdrawal by Subject|1|||
147634471|NCT00723008|532480222|FG000|4-Week Double Blinded|Lost to Follow-up|4|||
147634472|NCT00723008|532480223|FG001|4-Week Double Blinded|Lost to Follow-up|3|||
147634473|NCT00723008|532480222|FG000|4-Week Unblinded Treatment|Adverse Event|1|||
147634474|NCT00723008|532480223|FG001|4-Week Unblinded Treatment|Adverse Event|0|||
147634475|NCT00723008|532480222|FG000|4-Week Unblinded Treatment|Lost to Follow-up|0|||
147634476|NCT00723008|532480223|FG001|4-Week Unblinded Treatment|Lost to Follow-up|1|||
147634477|NCT05835011|532480224|FG000|Overall Study|Study Terminated by the Sponsor|1|||
147634478|NCT05835011|532480224|FG000|Overall Study|Enrolled but did not receive study treatment|1|||
147634479|NCT01867710|532480232|FG000|Overall Study|Death|25|||
147634480|NCT01867710|532480233|FG001|Overall Study|Death|15|||
147634481|NCT01867710|532480234|FG002|Overall Study|Death|27|||
147634482|NCT01867710|532480235|FG003|Overall Study|Death|20|||
147634483|NCT01867710|532480232|FG000|Overall Study|Lost to Follow-up|3|||
147634484|NCT01867710|532480233|FG001|Overall Study|Lost to Follow-up|4|||
147634485|NCT01867710|532480234|FG002|Overall Study|Lost to Follow-up|3|||
147634486|NCT01867710|532480235|FG003|Overall Study|Lost to Follow-up|2|||
147634487|NCT01867710|532480232|FG000|Overall Study|Withdrawal of consent|2|||
147634488|NCT01867710|532480233|FG001|Overall Study|Withdrawal of consent|5|||
147634489|NCT01867710|532480234|FG002|Overall Study|Withdrawal of consent|1|||
147634490|NCT01867710|532480235|FG003|Overall Study|Withdrawal of consent|2|||
147634491|NCT01867710|532480232|FG000|Overall Study|Study Terminated by Sponsor|9|||
147634492|NCT01867710|532480233|FG001|Overall Study|Study Terminated by Sponsor|13|||
147634493|NCT01867710|532480234|FG002|Overall Study|Study Terminated by Sponsor|8|||
147634494|NCT01867710|532480235|FG003|Overall Study|Study Terminated by Sponsor|16|||
147634495|NCT01867710|532480232|FG000|Overall Study|Biochemical progression|0|||
147634496|NCT01867710|532480233|FG001|Overall Study|Biochemical progression|1|||
147634497|NCT01867710|532480234|FG002|Overall Study|Biochemical progression|0|||
147634498|NCT01867710|532480235|FG003|Overall Study|Biochemical progression|0|||
147634499|NCT01867710|532480232|FG000|Overall Study|Clinical progression|0|||
147634500|NCT01867710|532480233|FG001|Overall Study|Clinical progression|0|||
147634501|NCT01867710|532480234|FG002|Overall Study|Clinical progression|1|||
147634502|NCT01867710|532480235|FG003|Overall Study|Clinical progression|0|||
147634503|NCT01867710|532480232|FG000|Overall Study|Disease progression|1|||
147634504|NCT01867710|532480233|FG001|Overall Study|Disease progression|0|||
147634505|NCT01867710|532480234|FG002|Overall Study|Disease progression|0|||
147634506|NCT01867710|532480235|FG003|Overall Study|Disease progression|0|||
147634507|NCT01867710|532480232|FG000|Overall Study|Patient decision|0|||
147634508|NCT01867710|532480233|FG001|Overall Study|Patient decision|0|||
147634509|NCT01867710|532480234|FG002|Overall Study|Patient decision|0|||
147634510|NCT01867710|532480235|FG003|Overall Study|Patient decision|1|||
147634511|NCT01867710|532480232|FG000|Overall Study|Patient to follow subsequent treatment|0|||
147634512|NCT01867710|532480233|FG001|Overall Study|Patient to follow subsequent treatment|1|||
147634513|NCT01867710|532480234|FG002|Overall Study|Patient to follow subsequent treatment|0|||
147634514|NCT01867710|532480235|FG003|Overall Study|Patient to follow subsequent treatment|0|||
147634515|NCT01867710|532480232|FG000|Overall Study|Progressive disease|1|||
147634516|NCT01867710|532480233|FG001|Overall Study|Progressive disease|0|||
147634517|NCT01867710|532480234|FG002|Overall Study|Progressive disease|0|||
147634518|NCT01867710|532480235|FG003|Overall Study|Progressive disease|0|||
147634519|NCT01867710|532480232|FG000|Overall Study|Protocol Violation|0|||
147634520|NCT01867710|532480233|FG001|Overall Study|Protocol Violation|0|||
147634521|NCT01867710|532480234|FG002|Overall Study|Protocol Violation|0|||
147634522|NCT01867710|532480235|FG003|Overall Study|Protocol Violation|1|||
147634523|NCT01867710|532480232|FG000|Overall Study|PSA-progression|0|||
147634524|NCT01867710|532480233|FG001|Overall Study|PSA-progression|1|||
147634525|NCT01867710|532480234|FG002|Overall Study|PSA-progression|0|||
147634526|NCT01867710|532480235|FG003|Overall Study|PSA-progression|0|||
147634527|NCT01867710|532480232|FG000|Overall Study|Study medication no longer effective|0|||
147634528|NCT01867710|532480233|FG001|Overall Study|Study medication no longer effective|1|||
147634529|NCT01867710|532480234|FG002|Overall Study|Study medication no longer effective|0|||
147634530|NCT01867710|532480235|FG003|Overall Study|Study medication no longer effective|0|||
147634531|NCT01471340|532480236|FG000|Overall Study|Death|5|||
147634532|NCT01471340|532480237|FG001|Overall Study|Death|4|||
147634533|NCT01471340|532480236|FG000|Overall Study|Lost to Follow-up|0|||
147634534|NCT01471340|532480237|FG001|Overall Study|Lost to Follow-up|1|||
147634535|NCT01471340|532480236|FG000|Overall Study|Investigational site closure|0|||
147634536|NCT01471340|532480237|FG001|Overall Study|Investigational site closure|1|||
147634537|NCT01471340|532480236|FG000|Overall Study|Invalid informed consent|1|||
147634538|NCT01471340|532480237|FG001|Overall Study|Invalid informed consent|0|||
147634539|NCT00526669|532480238|FG000|Combined Treatment Phase|Lost to Follow-up|0|||
147634540|NCT00526669|532480239|FG001|Combined Treatment Phase|Lost to Follow-up|2|||
147634541|NCT00526669|532480238|FG000|Combined Treatment Phase|Withdrawal by Subject|0|||
147634542|NCT00526669|532480239|FG001|Combined Treatment Phase|Withdrawal by Subject|2|||
147634543|NCT00526669|532480238|FG000|Combined Treatment Phase|Sponsor Terminated Study|0|||
147634544|NCT00526669|532480239|FG001|Combined Treatment Phase|Sponsor Terminated Study|2|||
147634545|NCT00526669|532480238|FG000|Combined Treatment Phase|Death|0|||
147634546|NCT00526669|532480239|FG001|Combined Treatment Phase|Death|2|||
147634547|NCT03499899|532480240|FG000|Overall Study|Adverse Event|2|||
147634548|NCT03499899|532480241|FG001|Overall Study|Adverse Event|3|||
147634549|NCT03499899|532480242|FG002|Overall Study|Adverse Event|3|||
147634550|NCT03499899|532480240|FG000|Overall Study|Death|0|||
147634551|NCT03499899|532480241|FG001|Overall Study|Death|0|||
147634552|NCT03499899|532480242|FG002|Overall Study|Death|1|||
147634553|NCT03499899|532480240|FG000|Overall Study|Physician Decision|3|||
147634554|NCT03499899|532480241|FG001|Overall Study|Physician Decision|6|||
147634555|NCT03499899|532480242|FG002|Overall Study|Physician Decision|6|||
147634556|NCT03499899|532480240|FG000|Overall Study|Progressive disease|15|||
147634557|NCT03499899|532480241|FG001|Overall Study|Progressive disease|23|||
147634558|NCT03499899|532480242|FG002|Overall Study|Progressive disease|23|||
147634559|NCT03499899|532480240|FG000|Overall Study|Patient decision|0|||
147634560|NCT03499899|532480241|FG001|Overall Study|Patient decision|1|||
147634561|NCT03499899|532480242|FG002|Overall Study|Patient decision|1|||
147634562|NCT03499899|532480240|FG000|Overall Study|Terminated by sponsor (end of study definition was met)|0|||
147634563|NCT03499899|532480241|FG001|Overall Study|Terminated by sponsor (end of study definition was met)|1|||
147634564|NCT03499899|532480242|FG002|Overall Study|Terminated by sponsor (end of study definition was met)|0|||
147634565|NCT01981954|532480247|FG000|Titration Period|Protocol Deviation|1|||
147634566|NCT01981954|532480247|FG000|Fixed-Dose Assessment Period|Lack of Efficacy|1|||
147634567|NCT01609543|532480257|FG000|Overall Study|Disease Progression|28|||
147634568|NCT01609543|532480257|FG000|Overall Study|Adverse Event|5|||
147634569|NCT01609543|532480257|FG000|Overall Study|Withdrawal by Subject|1|||
147634570|NCT01609543|532480257|FG000|Overall Study|Protocol Violation|1|||
147634571|NCT01609543|532480257|FG000|Overall Study|Death|7|||
147634572|NCT02218736|532480258|FG000|Overall Study|Withdrawal by Subject|10|||
147634573|NCT02218736|532480259|FG001|Overall Study|Withdrawal by Subject|9|||
147634574|NCT02218736|532480258|FG000|Overall Study|Protocol Violation|2|||
147634575|NCT02218736|532480259|FG001|Overall Study|Protocol Violation|0|||
147634576|NCT03702010|532480266|FG000|Follow-up (30days)|Lack of Efficacy|2|||
147634577|NCT03702010|532480267|FG001|Follow-up (30days)|Lack of Efficacy|2|||
147634578|NCT01137110|532480276|FG000|Overall Study|Protocol Violation|1|||
147634579|NCT01137110|532480277|FG001|Overall Study|Protocol Violation|0|||
147634580|NCT02553499|532480284|FG000|Overall Study|Adverse Event|0|||
147634581|NCT02553499|532480285|FG001|Overall Study|Adverse Event|0|||
147634582|NCT02553499|532480286|FG002|Overall Study|Adverse Event|0|||
147634583|NCT02553499|532480287|FG003|Overall Study|Adverse Event|0|||
147634584|NCT02553499|532480288|FG004|Overall Study|Adverse Event|0|||
147634585|NCT02553499|532480289|FG005|Overall Study|Adverse Event|0|||
147634586|NCT02553499|532480290|FG006|Overall Study|Adverse Event|1|||
147634587|NCT02553499|532480291|FG007|Overall Study|Adverse Event|1|||
147634588|NCT02553499|532480292|FG008|Overall Study|Adverse Event|0|||
147634589|NCT02553499|532480293|FG009|Overall Study|Adverse Event|0|||
147634590|NCT02553499|532480294|FG010|Overall Study|Adverse Event|0|||
147634591|NCT02553499|532480295|FG011|Overall Study|Adverse Event|0|||
147634592|NCT02553499|532480296|FG012|Overall Study|Adverse Event|0|||
147634593|NCT02553499|532480297|FG013|Overall Study|Adverse Event|1|||
147634594|NCT02553499|532480284|FG000|Overall Study|Death|0|||
147634595|NCT02553499|532480285|FG001|Overall Study|Death|1|||
147634596|NCT02553499|532480286|FG002|Overall Study|Death|1|||
147634597|NCT02553499|532480287|FG003|Overall Study|Death|0|||
147634598|NCT02553499|532480288|FG004|Overall Study|Death|1|||
147634599|NCT02553499|532480289|FG005|Overall Study|Death|2|||
147634600|NCT02553499|532480290|FG006|Overall Study|Death|0|||
147634601|NCT02553499|532480291|FG007|Overall Study|Death|0|||
147634602|NCT02553499|532480292|FG008|Overall Study|Death|0|||
147634603|NCT02553499|532480293|FG009|Overall Study|Death|0|||
147634604|NCT02553499|532480294|FG010|Overall Study|Death|1|||
147634605|NCT02553499|532480295|FG011|Overall Study|Death|0|||
147634606|NCT02553499|532480296|FG012|Overall Study|Death|0|||
147634607|NCT02553499|532480297|FG013|Overall Study|Death|0|||
147503683|NCT02151682|531996612|FG002|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0|||
147503684|NCT02151682|531996613|FG003|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0|||
147503685|NCT02151682|531996614|FG004|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|0|||
147503686|NCT02151682|531996615|FG005|Part 2: Observ. Aft. Tapent. Extension|Withdrawal by Subject|1|||
147503687|NCT02151682|531996610|FG000|Part 2: Observ. Aft. Tapent. Extension|Death|0|||
147503688|NCT02151682|531996611|FG001|Part 2: Observ. Aft. Tapent. Extension|Death|0|||
147503689|NCT02151682|531996612|FG002|Part 2: Observ. Aft. Tapent. Extension|Death|0|||
147503690|NCT02151682|531996613|FG003|Part 2: Observ. Aft. Tapent. Extension|Death|0|||
147503691|NCT02151682|531996614|FG004|Part 2: Observ. Aft. Tapent. Extension|Death|0|||
147503692|NCT02151682|531996615|FG005|Part 2: Observ. Aft. Tapent. Extension|Death|1|||
147503693|NCT02151682|531996610|FG000|Part 2: Observ. Aft. Tapent. Extension|Missing|0|||
147503694|NCT02151682|531996611|FG001|Part 2: Observ. Aft. Tapent. Extension|Missing|0|||
147503695|NCT02151682|531996612|FG002|Part 2: Observ. Aft. Tapent. Extension|Missing|0|||
147503696|NCT02151682|531996613|FG003|Part 2: Observ. Aft. Tapent. Extension|Missing|0|||
147503697|NCT02151682|531996614|FG004|Part 2: Observ. Aft. Tapent. Extension|Missing|0|||
147503698|NCT02151682|531996615|FG005|Part 2: Observ. Aft. Tapent. Extension|Missing|3|||
147503699|NCT02151682|531996610|FG000|Part 2: Observ. Aft. Tapent. Extension|Various other|0|||
147503700|NCT02151682|531996611|FG001|Part 2: Observ. Aft. Tapent. Extension|Various other|0|||
147503701|NCT02151682|531996612|FG002|Part 2: Observ. Aft. Tapent. Extension|Various other|0|||
147503702|NCT02151682|531996613|FG003|Part 2: Observ. Aft. Tapent. Extension|Various other|0|||
147503703|NCT02151682|531996614|FG004|Part 2: Observ. Aft. Tapent. Extension|Various other|0|||
147503704|NCT02151682|531996615|FG005|Part 2: Observ. Aft. Tapent. Extension|Various other|2|||
147503705|NCT02988219|531996618|FG000|Overall Study|Lack of Efficacy|1|||
147503706|NCT02988219|531996619|FG001|Overall Study|Lack of Efficacy|1|||
147503707|NCT02988219|531996618|FG000|Overall Study|Withdrawal by Subject|0|||
147503708|NCT02988219|531996619|FG001|Overall Study|Withdrawal by Subject|2|||
147503709|NCT01306032|531996620|FG000|First Intervention|Adverse Event|1|||
147503710|NCT01306032|531996621|FG001|First Intervention|Adverse Event|0|||
147503711|NCT01306032|531996622|FG002|First Intervention|Adverse Event|1|||
147503712|NCT01306032|531996623|FG003|First Intervention|Adverse Event|0|||
147503713|NCT01306032|531996624|FG004|First Intervention|Adverse Event|0|||
147503714|NCT01306032|531996625|FG005|First Intervention|Adverse Event|1|||
147503715|NCT01306032|531996620|FG000|First Intervention|Withdrawal by Subject|0|||
147503716|NCT01306032|531996621|FG001|First Intervention|Withdrawal by Subject|2|||
147503717|NCT01306032|531996622|FG002|First Intervention|Withdrawal by Subject|0|||
147503718|NCT01306032|531996623|FG003|First Intervention|Withdrawal by Subject|1|||
147503719|NCT01306032|531996624|FG004|First Intervention|Withdrawal by Subject|0|||
147503720|NCT01306032|531996625|FG005|First Intervention|Withdrawal by Subject|0|||
147503721|NCT01306032|531996620|FG000|First Intervention|Death|0|||
147503722|NCT01306032|531996621|FG001|First Intervention|Death|0|||
147503723|NCT01306032|531996622|FG002|First Intervention|Death|1|||
147503724|NCT01306032|531996623|FG003|First Intervention|Death|0|||
147503725|NCT01306032|531996624|FG004|First Intervention|Death|0|||
147503726|NCT01306032|531996625|FG005|First Intervention|Death|0|||
147503727|NCT01306032|531996620|FG000|First Intervention|Ineligible|0|||
147503728|NCT01306032|531996621|FG001|First Intervention|Ineligible|0|||
147503729|NCT01306032|531996622|FG002|First Intervention|Ineligible|0|||
147503730|NCT01306032|531996623|FG003|First Intervention|Ineligible|0|||
147503731|NCT01306032|531996624|FG004|First Intervention|Ineligible|0|||
147503732|NCT01306032|531996625|FG005|First Intervention|Ineligible|1|||
147503733|NCT01306032|531996620|FG000|First Intervention|Progressive disease|0|||
147503734|NCT01306032|531996621|FG001|First Intervention|Progressive disease|0|||
147503735|NCT01306032|531996622|FG002|First Intervention|Progressive disease|0|||
147503736|NCT01306032|531996623|FG003|First Intervention|Progressive disease|0|||
147503737|NCT01306032|531996624|FG004|First Intervention|Progressive disease|2|||
147503738|NCT01306032|531996625|FG005|First Intervention|Progressive disease|0|||
147634608|NCT02553499|532480284|FG000|Overall Study|Lost to Follow-up|0|||
147634609|NCT02553499|532480285|FG001|Overall Study|Lost to Follow-up|0|||
147634610|NCT02553499|532480286|FG002|Overall Study|Lost to Follow-up|0|||
147634611|NCT02553499|532480287|FG003|Overall Study|Lost to Follow-up|0|||
147503739|NCT01306032|531996620|FG000|Disease Progression/Crossover|Withdrawal by Subject|0|||
147503740|NCT01306032|531996621|FG001|Disease Progression/Crossover|Withdrawal by Subject|0|||
147503741|NCT01306032|531996622|FG002|Disease Progression/Crossover|Withdrawal by Subject|0|||
147503742|NCT01306032|531996623|FG003|Disease Progression/Crossover|Withdrawal by Subject|1|||
147503743|NCT01306032|531996624|FG004|Disease Progression/Crossover|Withdrawal by Subject|0|||
147634612|NCT02553499|532480288|FG004|Overall Study|Lost to Follow-up|0|||
147634613|NCT02553499|532480289|FG005|Overall Study|Lost to Follow-up|0|||
147634614|NCT02553499|532480290|FG006|Overall Study|Lost to Follow-up|1|||
147634615|NCT02553499|532480291|FG007|Overall Study|Lost to Follow-up|0|||
147634616|NCT02553499|532480292|FG008|Overall Study|Lost to Follow-up|0|||
147634617|NCT02553499|532480293|FG009|Overall Study|Lost to Follow-up|0|||
147634618|NCT02553499|532480294|FG010|Overall Study|Lost to Follow-up|0|||
147634619|NCT02553499|532480295|FG011|Overall Study|Lost to Follow-up|0|||
147634620|NCT02553499|532480296|FG012|Overall Study|Lost to Follow-up|0|||
147634621|NCT02553499|532480297|FG013|Overall Study|Lost to Follow-up|0|||
147634622|NCT02553499|532480284|FG000|Overall Study|Physician Decision|0|||
147634623|NCT02553499|532480285|FG001|Overall Study|Physician Decision|1|||
147634624|NCT02553499|532480286|FG002|Overall Study|Physician Decision|1|||
147634625|NCT02553499|532480287|FG003|Overall Study|Physician Decision|0|||
147634626|NCT02553499|532480288|FG004|Overall Study|Physician Decision|1|||
147634627|NCT02553499|532480289|FG005|Overall Study|Physician Decision|0|||
147634628|NCT02553499|532480290|FG006|Overall Study|Physician Decision|0|||
147634629|NCT02553499|532480291|FG007|Overall Study|Physician Decision|1|||
147634630|NCT02553499|532480292|FG008|Overall Study|Physician Decision|1|||
147634631|NCT02553499|532480293|FG009|Overall Study|Physician Decision|2|||
147634632|NCT02553499|532480294|FG010|Overall Study|Physician Decision|1|||
147634633|NCT02553499|532480295|FG011|Overall Study|Physician Decision|3|||
147634634|NCT02553499|532480296|FG012|Overall Study|Physician Decision|1|||
147634635|NCT02553499|532480297|FG013|Overall Study|Physician Decision|0|||
147634636|NCT02553499|532480284|FG000|Overall Study|Progressive Disease|0|||
147634637|NCT02553499|532480285|FG001|Overall Study|Progressive Disease|0|||
147634638|NCT02553499|532480286|FG002|Overall Study|Progressive Disease|0|||
147634639|NCT02553499|532480287|FG003|Overall Study|Progressive Disease|2|||
147634640|NCT02553499|532480288|FG004|Overall Study|Progressive Disease|1|||
147634641|NCT02553499|532480289|FG005|Overall Study|Progressive Disease|1|||
147634642|NCT02553499|532480290|FG006|Overall Study|Progressive Disease|1|||
147634643|NCT02553499|532480291|FG007|Overall Study|Progressive Disease|0|||
147634644|NCT02553499|532480292|FG008|Overall Study|Progressive Disease|0|||
147634645|NCT02553499|532480293|FG009|Overall Study|Progressive Disease|1|||
147634646|NCT02553499|532480294|FG010|Overall Study|Progressive Disease|0|||
147634647|NCT02553499|532480295|FG011|Overall Study|Progressive Disease|0|||
147634648|NCT02553499|532480296|FG012|Overall Study|Progressive Disease|2|||
147634649|NCT02553499|532480297|FG013|Overall Study|Progressive Disease|1|||
147634650|NCT02553499|532480284|FG000|Overall Study|Study Terminated by Sponsor|0|||
147634651|NCT02553499|532480285|FG001|Overall Study|Study Terminated by Sponsor|0|||
147634652|NCT02553499|532480286|FG002|Overall Study|Study Terminated by Sponsor|0|||
147634653|NCT02553499|532480287|FG003|Overall Study|Study Terminated by Sponsor|0|||
147634654|NCT02553499|532480288|FG004|Overall Study|Study Terminated by Sponsor|0|||
147634655|NCT02553499|532480289|FG005|Overall Study|Study Terminated by Sponsor|0|||
147634656|NCT02553499|532480290|FG006|Overall Study|Study Terminated by Sponsor|0|||
147634657|NCT02553499|532480291|FG007|Overall Study|Study Terminated by Sponsor|0|||
147634658|NCT02553499|532480292|FG008|Overall Study|Study Terminated by Sponsor|1|||
147634659|NCT02553499|532480293|FG009|Overall Study|Study Terminated by Sponsor|0|||
147634660|NCT02553499|532480294|FG010|Overall Study|Study Terminated by Sponsor|0|||
147634661|NCT02553499|532480295|FG011|Overall Study|Study Terminated by Sponsor|0|||
147634662|NCT02553499|532480296|FG012|Overall Study|Study Terminated by Sponsor|0|||
147634663|NCT02553499|532480297|FG013|Overall Study|Study Terminated by Sponsor|0|||
147634664|NCT02553499|532480284|FG000|Overall Study|Withdrawal by Subject|2|||
147634665|NCT02553499|532480285|FG001|Overall Study|Withdrawal by Subject|0|||
147634666|NCT02553499|532480286|FG002|Overall Study|Withdrawal by Subject|0|||
147634667|NCT02553499|532480287|FG003|Overall Study|Withdrawal by Subject|0|||
147634668|NCT02553499|532480288|FG004|Overall Study|Withdrawal by Subject|0|||
147634669|NCT02553499|532480289|FG005|Overall Study|Withdrawal by Subject|0|||
147634670|NCT02553499|532480290|FG006|Overall Study|Withdrawal by Subject|0|||
147634671|NCT02553499|532480291|FG007|Overall Study|Withdrawal by Subject|1|||
147634672|NCT02553499|532480292|FG008|Overall Study|Withdrawal by Subject|1|||
147634673|NCT02553499|532480293|FG009|Overall Study|Withdrawal by Subject|0|||
147634674|NCT02553499|532480294|FG010|Overall Study|Withdrawal by Subject|1|||
147503744|NCT01306032|531996625|FG005|Disease Progression/Crossover|Withdrawal by Subject|0|||
147503745|NCT01306032|531996620|FG000|Disease Progression/Crossover|other/symptomatic progression|0|||
147503746|NCT01306032|531996621|FG001|Disease Progression/Crossover|other/symptomatic progression|2|||
147503747|NCT01306032|531996622|FG002|Disease Progression/Crossover|other/symptomatic progression|0|||
147503748|NCT01306032|531996623|FG003|Disease Progression/Crossover|other/symptomatic progression|2|||
147634675|NCT02553499|532480295|FG011|Overall Study|Withdrawal by Subject|0|||
147634676|NCT02553499|532480296|FG012|Overall Study|Withdrawal by Subject|0|||
147634677|NCT02553499|532480297|FG013|Overall Study|Withdrawal by Subject|0|||
147634678|NCT01582178|532480298|FG000|Overall Study|Physician Decision|6|||
147634679|NCT01582178|532480299|FG001|Overall Study|Physician Decision|5|||
147634680|NCT01726270|532480300|FG000|Part 1, Self-Selection Phase|Withdrawal by Subject|10|||
147634681|NCT01726270|532480300|FG000|Eligibility for Part 2|Eligible but did not enter Part 2|20|||
147634682|NCT01726270|532480300|FG000|Part 2, Actual-Use Phase|Withdrawal by Subject|21|||
147634683|NCT01726270|532480300|FG000|Part 2, Actual-Use Phase|Adverse Event|6|||
147634684|NCT01726270|532480300|FG000|Part 2, Actual-Use Phase|Lost to Follow-up|5|||
147634685|NCT01726270|532480300|FG000|Part 2, Actual-Use Phase|Other than reason specified above|7|||
147634686|NCT00582608|532480302|FG000|Overall Study|Not Treated|7|||
147503749|NCT01306032|531996624|FG004|Disease Progression/Crossover|other/symptomatic progression|0|||
147503750|NCT01306032|531996625|FG005|Disease Progression/Crossover|other/symptomatic progression|0|||
147503751|NCT01522443|531996626|FG000|Overall Study|No longer receiving clinical benefit|36|||
147503752|NCT01522443|531996627|FG001|Overall Study|No longer receiving clinical benefit|28|||
147503753|NCT01522443|531996626|FG000|Overall Study|Adverse Event|10|||
147503754|NCT01522443|531996627|FG001|Overall Study|Adverse Event|15|||
147503755|NCT01522443|531996626|FG000|Overall Study|Withdrawal by Subject|5|||
147503756|NCT01522443|531996627|FG001|Overall Study|Withdrawal by Subject|8|||
147503757|NCT01522443|531996626|FG000|Overall Study|No study treatment given|1|||
147503758|NCT01522443|531996627|FG001|Overall Study|No study treatment given|1|||
147503759|NCT01522443|531996626|FG000|Overall Study|Other|1|||
147503760|NCT01522443|531996627|FG001|Overall Study|Other|3|||
147503761|NCT03260894|531996628|FG000|Overall Study|Death|6|||
147503762|NCT03260894|531996629|FG001|Overall Study|Death|8|||
147503763|NCT03260894|531996628|FG000|Overall Study|Withdrawal by Subject|4|||
147503764|NCT03260894|531996629|FG001|Overall Study|Withdrawal by Subject|11|||
147503765|NCT03260894|531996628|FG000|Overall Study|On-going at clinical cut off date|36|||
147503766|NCT03260894|531996629|FG001|Overall Study|On-going at clinical cut off date|31|||
147503767|NCT00290589|531996631|FG000|Overall Study|Lost to Follow-up|2|||
147503768|NCT00290589|531996632|FG001|Overall Study|Lost to Follow-up|2|||
147503769|NCT00318565|531996633|FG000|Overall Study|Excluded per protocol|24|||
147503770|NCT00691093|531996634|FG000|Overall Study|Adverse Event|1|||
147503771|NCT00691093|531996634|FG000|Overall Study|Lost to Follow-up|1|||
147503772|NCT00691093|531996634|FG000|Overall Study|Lack of Efficacy|1|||
147503773|NCT00691093|531996634|FG000|Overall Study|Ongoing at Date of Cut-Off|4|||
147503774|NCT03814005|531996637|FG000|Part B: Day 8 to Day 343|Adverse Event|2|||
147503775|NCT03814005|531996638|FG001|Part B: Day 8 to Day 343|Adverse Event|0|||
147503776|NCT03814005|531996639|FG002|Part B: Day 8 to Day 343|Adverse Event|0|||
147503777|NCT03814005|531996637|FG000|Part B: Day 8 to Day 343|Withdrawal by Subject|0|||
147503778|NCT03814005|531996638|FG001|Part B: Day 8 to Day 343|Withdrawal by Subject|0|||
147503779|NCT03814005|531996639|FG002|Part B: Day 8 to Day 343|Withdrawal by Subject|3|||
147503780|NCT03814005|531996637|FG000|Part B: Day 8 to Day 343|Progressive Disease|4|||
147503781|NCT03814005|531996638|FG001|Part B: Day 8 to Day 343|Progressive Disease|2|||
147503782|NCT03814005|531996639|FG002|Part B: Day 8 to Day 343|Progressive Disease|0|||
147503783|NCT03814005|531996637|FG000|Part B: Day 8 to Day 343|Unsatisfactory Therapeutic Response|2|||
147503784|NCT03814005|531996638|FG001|Part B: Day 8 to Day 343|Unsatisfactory Therapeutic Response|0|||
147503785|NCT03814005|531996639|FG002|Part B: Day 8 to Day 343|Unsatisfactory Therapeutic Response|0|||
147503786|NCT03814005|531996637|FG000|Part B: Day 8 to Day 343|Symptomatic Deterioration|1|||
147503787|NCT03814005|531996638|FG001|Part B: Day 8 to Day 343|Symptomatic Deterioration|2|||
147503788|NCT03814005|531996639|FG002|Part B: Day 8 to Day 343|Symptomatic Deterioration|0|||
147503789|NCT03814005|531996637|FG000|Part B: Day 8 to Day 343|Reason not Specified|1|||
147503790|NCT03814005|531996638|FG001|Part B: Day 8 to Day 343|Reason not Specified|0|||
147503791|NCT03814005|531996639|FG002|Part B: Day 8 to Day 343|Reason not Specified|0|||
147503792|NCT01896856|531996640|FG000|Overall Study|Transportation issues / Non-compliance|0|||
147503793|NCT01896856|531996641|FG001|Overall Study|Transportation issues / Non-compliance|0|||
147503794|NCT01896856|531996642|FG002|Overall Study|Transportation issues / Non-compliance|1|||
147503795|NCT01896856|531996643|FG003|Overall Study|Transportation issues / Non-compliance|0|||
147503796|NCT01896856|531996644|FG004|Overall Study|Transportation issues / Non-compliance|0|||
147503797|NCT01896856|531996645|FG005|Overall Study|Transportation issues / Non-compliance|0|||
147503798|NCT01700985|531996648|FG000|Overall Study|Incarcerated|0|||
147503799|NCT01700985|531996649|FG001|Overall Study|Incarcerated|1|||
147503800|NCT01192204|531996653|FG000|Overall Study|could not keep recall appointments|1|||
147503801|NCT01192204|531996654|FG001|Overall Study|could not keep recall appointments|0|||
147503802|NCT02940626|531996655|FG000|Overall Study|Death|40|||
147503803|NCT02940626|531996656|FG001|Overall Study|Death|32|||
147503804|NCT02940626|531996655|FG000|Overall Study|Lost to Follow-up|5|||
147503805|NCT02940626|531996656|FG001|Overall Study|Lost to Follow-up|2|||
147503806|NCT02940626|531996655|FG000|Overall Study|Withdrawal by Subject|1|||
147503807|NCT02940626|531996656|FG001|Overall Study|Withdrawal by Subject|0|||
147503808|NCT02940626|531996655|FG000|Overall Study|Transfer to Hospice Care|1|||
147503809|NCT02940626|531996656|FG001|Overall Study|Transfer to Hospice Care|0|||
147503810|NCT02940626|531996655|FG000|Overall Study|Prohibited Concomitant Medication|0|||
147503811|NCT02940626|531996656|FG001|Overall Study|Prohibited Concomitant Medication|1|||
147503812|NCT01767519|531996659|FG000|Overall Study|Other Reasons|4|||
147503813|NCT01767519|531996660|FG001|Overall Study|Other Reasons|4|||
147503814|NCT01767519|531996661|FG002|Overall Study|Other Reasons|2|||
147503815|NCT01767519|531996659|FG000|Overall Study|Protocol Violation|0|||
147503816|NCT01767519|531996660|FG001|Overall Study|Protocol Violation|3|||
147503817|NCT01767519|531996661|FG002|Overall Study|Protocol Violation|0|||
147503818|NCT01767519|531996659|FG000|Overall Study|Personal Reasons|1|||
147503819|NCT01767519|531996660|FG001|Overall Study|Personal Reasons|0|||
147503820|NCT01767519|531996661|FG002|Overall Study|Personal Reasons|0|||
147503821|NCT01767519|531996659|FG000|Overall Study|Lost to Follow-up|3|||
147503822|NCT01767519|531996660|FG001|Overall Study|Lost to Follow-up|1|||
147634687|NCT00582608|532480302|FG000|Overall Study|Patient Ineligible|1|||
147634688|NCT00582608|532480302|FG000|Overall Study|Lack of accrual|4|||
147634689|NCT03478644|532480306|FG000|Phase 2|Withdrawal by Subject|2|||
147634690|NCT03478644|532480307|FG001|Phase 2|Withdrawal by Subject|1|||
147634691|NCT03478644|532480306|FG000|Phase 2|Lost to Follow-up|1|||
147634692|NCT03478644|532480307|FG001|Phase 2|Lost to Follow-up|0|||
147634693|NCT04152837|532480310|FG000|Baseline Period (No Treatment)|Baseline Failure|1|||
147634694|NCT04152837|532480310|FG000|Maintenance Period|Adverse Event|1|||
147634695|NCT04152837|532480310|FG000|Maintenance Period|Withdrawal by Subject|1|||
147634696|NCT04152837|532480310|FG000|Maintenance Period|Sponsor Termination of Study|2|||
147634697|NCT00586820|532480311|FG000|Overall Study|Unsuccessful PCI|1|||
147634698|NCT00586820|532480312|FG001|Overall Study|Unsuccessful PCI|0|||
147634699|NCT04463251|532480315|FG000|Overall Study|Death|1|||
147634700|NCT04463251|532480316|FG001|Overall Study|Death|0|||
147634701|NCT04463251|532480317|FG002|Overall Study|Death|1|||
147634702|NCT04463251|532480315|FG000|Overall Study|Adverse Event|0|||
147634703|NCT04463251|532480316|FG001|Overall Study|Adverse Event|1|||
147634704|NCT04463251|532480317|FG002|Overall Study|Adverse Event|0|||
147634705|NCT04463251|532480315|FG000|Overall Study|Lost to Follow-up|0|||
147634706|NCT04463251|532480316|FG001|Overall Study|Lost to Follow-up|1|||
147634707|NCT04463251|532480317|FG002|Overall Study|Lost to Follow-up|0|||
147634708|NCT04463251|532480315|FG000|Overall Study|Withdrawal by Subject|0|||
147634709|NCT04463251|532480316|FG001|Overall Study|Withdrawal by Subject|2|||
147634710|NCT04463251|532480317|FG002|Overall Study|Withdrawal by Subject|2|||
147634711|NCT01827267|532480320|FG000|Overall Study|Did not receive study drug|1|||
147634712|NCT01827267|532480321|FG001|Overall Study|Did not receive study drug|1|||
147634713|NCT01827267|532480320|FG000|Overall Study|Physician Decision|1|||
147634714|NCT01827267|532480321|FG001|Overall Study|Physician Decision|0|||
147634715|NCT01827267|532480320|FG000|Overall Study|Disease Progression|1|||
147634716|NCT01827267|532480321|FG001|Overall Study|Disease Progression|1|||
147634717|NCT01827267|532480320|FG000|Overall Study|Sponsor Discontinued Study|2|||
147634718|NCT01827267|532480321|FG001|Overall Study|Sponsor Discontinued Study|8|||
147634719|NCT01827267|532480320|FG000|Overall Study|Still on study|0|||
147634720|NCT01827267|532480321|FG001|Overall Study|Still on study|2|||
147634721|NCT03070002|532480322|FG000|Follow up for 2 Years|Death|1|||
147634722|NCT03689374|532480325|FG000|Run-in Period (12 Weeks)|Run-in failure|526|||
147634723|NCT03689374|532480326|FG001|Run-in Period (12 Weeks)|Run-in failure|0|||
147634724|NCT03689374|532480327|FG002|Run-in Period (12 Weeks)|Run-in failure|0|||
147634725|NCT03689374|532480325|FG000|Treatment Period (Week 0 to 52)|Withdrawal by Subject|0|||
147634726|NCT03689374|532480326|FG001|Treatment Period (Week 0 to 52)|Withdrawal by Subject|10|||
147634727|NCT03689374|532480327|FG002|Treatment Period (Week 0 to 52)|Withdrawal by Subject|38|||
147634728|NCT03689374|532480325|FG000|Treatment Period (Week 0 to 52)|Lost to Follow-up|0|||
147634729|NCT03689374|532480326|FG001|Treatment Period (Week 0 to 52)|Lost to Follow-up|3|||
147634730|NCT03689374|532480327|FG002|Treatment Period (Week 0 to 52)|Lost to Follow-up|4|||
147634731|NCT03689374|532480325|FG000|Treatment Period (Week 0 to 52)|Death|0|||
147634732|NCT03689374|532480326|FG001|Treatment Period (Week 0 to 52)|Death|11|||
147634733|NCT03689374|532480327|FG002|Treatment Period (Week 0 to 52)|Death|1|||
147634734|NCT05367973|532480328|FG000|Overall Study|Adverse Event|0|||
147634735|NCT05367973|532480329|FG001|Overall Study|Adverse Event|2|||
147634736|NCT04250350|532482754|FG000|Overall Study|Withdrawal by Subject|13|||
147634737|NCT04250350|532482754|FG000|Overall Study|Lost to Follow-up|8|||
147634738|NCT04250350|532482754|FG000|Overall Study|Adverse Event|5|||
147634739|NCT04250350|532482754|FG000|Overall Study|Lack of Efficacy|4|||
147634740|NCT04250350|532482754|FG000|Overall Study|Physician Decision|1|||
147634741|NCT04250350|532482754|FG000|Overall Study|Participant moved out of the country/non-compliance|3|||
147634742|NCT03937908|532482755|FG000|Overall Study|Study discontinuation due to pandemic restrictions|0|||
147634743|NCT03937908|532482756|FG001|Overall Study|Study discontinuation due to pandemic restrictions|1|||
147634744|NCT03205761|532482757|FG000|Overall Study|Withdrawal by Subject|1|||
147634745|NCT03205761|532482757|FG000|Overall Study|Progressive Disease|10|||
147634746|NCT00636194|532482758|FG000|Overall Study|Study related symptoms and complaints|1|||
147634747|NCT00636194|532482759|FG001|Overall Study|Study related symptoms and complaints|0|||
147634748|NCT00636194|532482758|FG000|Overall Study|Protocol Violation|2|||
147634749|NCT00636194|532482759|FG001|Overall Study|Protocol Violation|0|||
147634750|NCT02163226|532482761|FG000|Overall Study|Death|2|||
147634751|NCT02163226|532482762|FG001|Overall Study|Death|1|||
147634752|NCT02163226|532482761|FG000|Overall Study|Withdrawal by Subject|5|||
147634753|NCT02163226|532482762|FG001|Overall Study|Withdrawal by Subject|2|||
147634754|NCT02163226|532482761|FG000|Overall Study|Returned home, local radiotherapy|3|||
147634755|NCT02163226|532482762|FG001|Overall Study|Returned home, local radiotherapy|0|||
147634756|NCT02163226|532482761|FG000|Overall Study|Repeat imaging showed no disease|2|||
147634757|NCT02163226|532482762|FG001|Overall Study|Repeat imaging showed no disease|0|||
147634758|NCT02163226|532482761|FG000|Overall Study|Incomplete radiotherapy|3|||
147634759|NCT02163226|532482762|FG001|Overall Study|Incomplete radiotherapy|0|||
147634760|NCT02163226|532482761|FG000|Overall Study|Treatment was to >3 radiotherapy fields|1|||
147634761|NCT02163226|532482762|FG001|Overall Study|Treatment was to >3 radiotherapy fields|0|||
147634762|NCT02163226|532482761|FG000|Overall Study|"Insurance denied for single-fraction treatment"|0|||
147634763|NCT02163226|532482762|FG001|Overall Study|"Insurance denied for single-fraction treatment"|5|||
147503823|NCT01767519|531996661|FG002|Overall Study|Lost to Follow-up|2|||
147503824|NCT01767519|531996659|FG000|Overall Study|Lack of Efficacy|1|||
147503825|NCT01767519|531996660|FG001|Overall Study|Lack of Efficacy|0|||
147503826|NCT01767519|531996661|FG002|Overall Study|Lack of Efficacy|0|||
147503827|NCT01767519|531996659|FG000|Overall Study|Adverse Event|5|||
147503828|NCT01767519|531996660|FG001|Overall Study|Adverse Event|5|||
147503829|NCT01767519|531996661|FG002|Overall Study|Adverse Event|1|||
147503830|NCT00293423|531996662|FG000|Surgical Resection|Less than a 90% extent of resection|0|||
147503831|NCT00293423|531996663|FG001|Surgical Resection|Less than a 90% extent of resection|1|||
147503832|NCT00293423|531996662|FG000|Surgical Resection|Postoperative Karnofsky Performance Score <70%|0|||
147503833|NCT00293423|531996663|FG001|Surgical Resection|Postoperative Karnofsky Performance Score <70%|4|||
147503834|NCT00293423|531996662|FG000|Surgical Resection|Insufficient tumor obtained to generate vaccine|9|||
147503835|NCT00293423|531996663|FG001|Surgical Resection|Insufficient tumor obtained to generate vaccine|13|||
147503836|NCT00293423|531996662|FG000|Surgical Resection|disease progression prior to initial vaccination|2|||
147503837|NCT00293423|531996663|FG001|Surgical Resection|disease progression prior to initial vaccination|9|||
147503838|NCT00293423|531996662|FG000|Surgical Resection|processing error during surgical resection|1|||
147503839|NCT00293423|531996663|FG001|Surgical Resection|processing error during surgical resection|0|||
147503840|NCT00293423|531996662|FG000|Surgical Resection|Withdrawal by Subject|4|||
147503841|NCT00293423|531996663|FG001|Surgical Resection|Withdrawal by Subject|0|||
147503842|NCT00293423|531996662|FG000|Vaccination Treatment Period|Received < 4 required vaccinations|0|||
147503843|NCT00293423|531996663|FG001|Vaccination Treatment Period|Received < 4 required vaccinations|3|||
147503844|NCT00507416|531996664|FG000|Overall Study|Adverse Event|58|||
147503845|NCT00507416|531996665|FG001|Overall Study|Adverse Event|67|||
147503846|NCT00507416|531996666|FG002|Overall Study|Adverse Event|65|||
147503847|NCT00507416|531996664|FG000|Overall Study|Protocol Violation|1|||
147503848|NCT00507416|531996665|FG001|Overall Study|Protocol Violation|2|||
147503849|NCT00507416|531996666|FG002|Overall Study|Protocol Violation|0|||
147503850|NCT00507416|531996664|FG000|Overall Study|Lack ofEfficacy / Physician Decision|7|||
147503851|NCT00507416|531996665|FG001|Overall Study|Lack ofEfficacy / Physician Decision|7|||
147503852|NCT00507416|531996666|FG002|Overall Study|Lack ofEfficacy / Physician Decision|8|||
147503853|NCT00507416|531996664|FG000|Overall Study|Progressive Disease|20|||
147503854|NCT00507416|531996665|FG001|Overall Study|Progressive Disease|10|||
147503855|NCT00507416|531996666|FG002|Overall Study|Progressive Disease|13|||
147503856|NCT00507416|531996664|FG000|Overall Study|Patient declined further treatment|18|||
147503857|NCT00507416|531996665|FG001|Overall Study|Patient declined further treatment|14|||
147503858|NCT00507416|531996666|FG002|Overall Study|Patient declined further treatment|11|||
147503859|NCT00507416|531996664|FG000|Overall Study|Other|11|||
147503860|NCT00507416|531996665|FG001|Overall Study|Other|16|||
147503861|NCT00507416|531996666|FG002|Overall Study|Other|13|||
147503862|NCT00507416|531996664|FG000|Overall Study|Did not Receive Study Treatment|3|||
147503863|NCT00507416|531996665|FG001|Overall Study|Did not Receive Study Treatment|9|||
147503864|NCT00507416|531996666|FG002|Overall Study|Did not Receive Study Treatment|4|||
147503865|NCT03571256|531996667|FG000|Overall Study|Adverse Event|3|||
147503866|NCT03571256|531996668|FG001|Overall Study|Adverse Event|0|||
147503867|NCT03571256|531996669|FG002|Overall Study|Adverse Event|1|||
147503868|NCT03571256|531996667|FG000|Overall Study|Withdrawal by Subject|3|||
147503869|NCT03571256|531996668|FG001|Overall Study|Withdrawal by Subject|1|||
147503870|NCT03571256|531996669|FG002|Overall Study|Withdrawal by Subject|1|||
147503871|NCT03571256|531996667|FG000|Overall Study|Other than specified|0|||
147503872|NCT03571256|531996668|FG001|Overall Study|Other than specified|1|||
147503873|NCT03571256|531996669|FG002|Overall Study|Other than specified|1|||
147503874|NCT03571256|531996667|FG000|Overall Study|Protocol Violation|0|||
147503875|NCT03571256|531996668|FG001|Overall Study|Protocol Violation|1|||
147503876|NCT03571256|531996669|FG002|Overall Study|Protocol Violation|1|||
147503877|NCT02247401|531996676|FG000|Overall Study|Adverse Event|1|||
147503878|NCT02247401|531996677|FG001|Overall Study|Adverse Event|0|||
147503879|NCT02247401|531996678|FG002|Overall Study|Adverse Event|0|||
147503880|NCT02247401|531996676|FG000|Overall Study|Withdrawal by Subject|4|||
147503881|NCT02247401|531996677|FG001|Overall Study|Withdrawal by Subject|1|||
147503882|NCT02247401|531996678|FG002|Overall Study|Withdrawal by Subject|1|||
147503883|NCT02247401|531996676|FG000|Overall Study|Lost to Follow-up|1|||
147503884|NCT02247401|531996677|FG001|Overall Study|Lost to Follow-up|1|||
147503885|NCT02247401|531996678|FG002|Overall Study|Lost to Follow-up|1|||
147503886|NCT01714817|531996679|FG000|Year 1 Period|Lack of Efficacy|11|||
147503887|NCT01714817|531996680|FG001|Year 1 Period|Lack of Efficacy|9|||
147503888|NCT01714817|531996679|FG000|Year 1 Period|Adverse Event|20|||
147503889|NCT01714817|531996680|FG001|Year 1 Period|Adverse Event|17|||
147503890|NCT01714817|531996679|FG000|Year 1 Period|Withdrawal by Subject|6|||
147503891|NCT01714817|531996680|FG001|Year 1 Period|Withdrawal by Subject|7|||
147503892|NCT01714817|531996679|FG000|Year 1 Period|Death|1|||
147634764|NCT02163226|532482761|FG000|Overall Study|ineligible|0|||
147503893|NCT01714817|531996680|FG001|Year 1 Period|Death|1|||
147503894|NCT01714817|531996679|FG000|Year 1 Period|Lost to Follow-up|0|||
147503895|NCT01714817|531996680|FG001|Year 1 Period|Lost to Follow-up|2|||
147634765|NCT02163226|532482762|FG001|Overall Study|ineligible|3|||
147634766|NCT05318092|532482766|FG000|Overall Study|Lost to Follow-up|3|||
147634767|NCT05318092|532482766|FG000|Overall Study|Withdrawal by Subject|1|||
147634768|NCT03854370|532482767|FG000|Overall Study|samples not collected|1|||
147634769|NCT03854370|532482768|FG001|Overall Study|samples not collected|1|||
147634770|NCT03854370|532482769|FG002|Overall Study|samples not collected|1|||
147634771|NCT03854370|532482770|FG003|Overall Study|samples not collected|1|||
147634772|NCT01300338|532482772|FG000|Overall Study|Lost to Follow-up|5|||
147634773|NCT01300338|532482773|FG001|Overall Study|Lost to Follow-up|0|||
147634774|NCT00381238|532482778|FG000|Overall Study|Adverse Event|3|||
147634775|NCT00381238|532482778|FG000|Overall Study|Protocol Violation|1|||
147634776|NCT00381238|532482778|FG000|Overall Study|Withdrawal by Subject|4|||
147634777|NCT00381238|532482778|FG000|Overall Study|Lack of Efficacy|2|||
147634778|NCT00381238|532482778|FG000|Overall Study|Withdrew by physician|1|||
147634779|NCT00381238|532482778|FG000|Overall Study|Disease progression|1|||
147634780|NCT00843037|532482782|FG000|Overall Study|Lost to Follow-up|1|||
147634781|NCT00401544|532482785|FG000|Overall Study|Adverse Event|5|||
147634782|NCT00401544|532482786|FG001|Overall Study|Adverse Event|1|||
147634783|NCT00401544|532482787|FG002|Overall Study|Adverse Event|1|||
147634784|NCT00401544|532482788|FG003|Overall Study|Adverse Event|1|||
147634785|NCT00401544|532482785|FG000|Overall Study|Death|3|||
147634786|NCT00401544|532482786|FG001|Overall Study|Death|6|||
147634787|NCT00401544|532482787|FG002|Overall Study|Death|2|||
147634788|NCT00401544|532482788|FG003|Overall Study|Death|5|||
147634789|NCT00401544|532482785|FG000|Overall Study|Lost to Follow-up|2|||
147634790|NCT00401544|532482786|FG001|Overall Study|Lost to Follow-up|0|||
147634791|NCT00401544|532482787|FG002|Overall Study|Lost to Follow-up|1|||
147634792|NCT00401544|532482788|FG003|Overall Study|Lost to Follow-up|1|||
147634793|NCT00401544|532482785|FG000|Overall Study|Withdrawal by Subject|7|||
147634794|NCT00401544|532482786|FG001|Overall Study|Withdrawal by Subject|6|||
147634795|NCT00401544|532482787|FG002|Overall Study|Withdrawal by Subject|6|||
147634796|NCT00401544|532482788|FG003|Overall Study|Withdrawal by Subject|5|||
147634797|NCT00401544|532482785|FG000|Overall Study|Physician Decision|1|||
147634798|NCT00401544|532482786|FG001|Overall Study|Physician Decision|3|||
147634799|NCT00401544|532482787|FG002|Overall Study|Physician Decision|0|||
147634800|NCT00401544|532482788|FG003|Overall Study|Physician Decision|0|||
147634801|NCT00401544|532482785|FG000|Overall Study|Ineligibility determined|0|||
147634802|NCT00401544|532482786|FG001|Overall Study|Ineligibility determined|1|||
147634803|NCT00401544|532482787|FG002|Overall Study|Ineligibility determined|0|||
147634804|NCT00401544|532482788|FG003|Overall Study|Ineligibility determined|2|||
147634805|NCT00401544|532482785|FG000|Overall Study|Disease progression|0|||
147634806|NCT00401544|532482786|FG001|Overall Study|Disease progression|1|||
147634807|NCT00401544|532482787|FG002|Overall Study|Disease progression|0|||
147634808|NCT00401544|532482788|FG003|Overall Study|Disease progression|0|||
147634809|NCT00401544|532482785|FG000|Overall Study|Other|0|||
147634810|NCT00401544|532482786|FG001|Overall Study|Other|0|||
147634811|NCT00401544|532482787|FG002|Overall Study|Other|2|||
147634812|NCT00401544|532482788|FG003|Overall Study|Other|2|||
147634813|NCT00425061|532482791|FG000|Overall Study|Adverse Event|1|||
147634814|NCT00425061|532482792|FG001|Overall Study|Adverse Event|0|||
147634815|NCT00425061|532482793|FG002|Overall Study|Adverse Event|0|||
147634816|NCT00425061|532482794|FG003|Overall Study|Adverse Event|2|||
147634817|NCT00425061|532482795|FG004|Overall Study|Adverse Event|2|||
147634818|NCT00425061|532482796|FG005|Overall Study|Adverse Event|0|||
147634819|NCT00425061|532482797|FG006|Overall Study|Adverse Event|0|||
147634820|NCT00425061|532482791|FG000|Overall Study|Lost to Follow-up|0|||
147634821|NCT00425061|532482792|FG001|Overall Study|Lost to Follow-up|1|||
147634822|NCT00425061|532482793|FG002|Overall Study|Lost to Follow-up|0|||
147634823|NCT00425061|532482794|FG003|Overall Study|Lost to Follow-up|0|||
147634824|NCT00425061|532482795|FG004|Overall Study|Lost to Follow-up|0|||
147634825|NCT00425061|532482796|FG005|Overall Study|Lost to Follow-up|0|||
147634826|NCT00425061|532482797|FG006|Overall Study|Lost to Follow-up|0|||
147634827|NCT00425061|532482791|FG000|Overall Study|Protocol Violation|1|||
147634828|NCT00425061|532482792|FG001|Overall Study|Protocol Violation|0|||
147634829|NCT00425061|532482793|FG002|Overall Study|Protocol Violation|0|||
147634830|NCT00425061|532482794|FG003|Overall Study|Protocol Violation|0|||
147634831|NCT00425061|532482795|FG004|Overall Study|Protocol Violation|0|||
147634832|NCT00425061|532482796|FG005|Overall Study|Protocol Violation|0|||
147503896|NCT01714817|531996679|FG000|Year 1 Period|Poor / non-compliance|0|||
147634833|NCT00425061|532482797|FG006|Overall Study|Protocol Violation|0|||
147634834|NCT00425061|532482791|FG000|Overall Study|Withdrawal by Subject|0|||
147634835|NCT00425061|532482792|FG001|Overall Study|Withdrawal by Subject|1|||
147634836|NCT00425061|532482793|FG002|Overall Study|Withdrawal by Subject|0|||
147634837|NCT00425061|532482794|FG003|Overall Study|Withdrawal by Subject|0|||
147634838|NCT00425061|532482795|FG004|Overall Study|Withdrawal by Subject|1|||
147634839|NCT00425061|532482796|FG005|Overall Study|Withdrawal by Subject|0|||
147634840|NCT00425061|532482797|FG006|Overall Study|Withdrawal by Subject|3|||
147634841|NCT00425061|532482791|FG000|Overall Study|Sponsor's request|0|||
147634842|NCT00425061|532482792|FG001|Overall Study|Sponsor's request|0|||
147634843|NCT00425061|532482793|FG002|Overall Study|Sponsor's request|0|||
147634844|NCT00425061|532482794|FG003|Overall Study|Sponsor's request|0|||
147634845|NCT00425061|532482795|FG004|Overall Study|Sponsor's request|19|||
147634846|NCT00425061|532482796|FG005|Overall Study|Sponsor's request|4|||
147634847|NCT00425061|532482797|FG006|Overall Study|Sponsor's request|15|||
147634848|NCT00425061|532482791|FG000|Overall Study|Physician Decision|0|||
147634849|NCT00425061|532482792|FG001|Overall Study|Physician Decision|0|||
147634850|NCT00425061|532482793|FG002|Overall Study|Physician Decision|0|||
147634851|NCT00425061|532482794|FG003|Overall Study|Physician Decision|0|||
147634852|NCT00425061|532482795|FG004|Overall Study|Physician Decision|1|||
147634853|NCT00425061|532482796|FG005|Overall Study|Physician Decision|0|||
147634854|NCT00425061|532482797|FG006|Overall Study|Physician Decision|0|||
147634855|NCT00425061|532482791|FG000|Overall Study|Other|0|||
147634856|NCT00425061|532482792|FG001|Overall Study|Other|0|||
147634857|NCT00425061|532482793|FG002|Overall Study|Other|0|||
147634858|NCT00425061|532482794|FG003|Overall Study|Other|0|||
147634859|NCT00425061|532482795|FG004|Overall Study|Other|3|||
147634860|NCT00425061|532482796|FG005|Overall Study|Other|0|||
147634861|NCT00425061|532482797|FG006|Overall Study|Other|1|||
147634862|NCT03436693|532482798|FG000|Overall Study|Adverse Event|22|||
147634863|NCT03436693|532482799|FG001|Overall Study|Adverse Event|10|||
147634864|NCT03436693|532482798|FG000|Overall Study|Physician Decision|3|||
147634865|NCT03436693|532482799|FG001|Overall Study|Physician Decision|3|||
147634866|NCT03436693|532482798|FG000|Overall Study|Withdrawal by Subject|4|||
147634867|NCT03436693|532482799|FG001|Overall Study|Withdrawal by Subject|13|||
147634868|NCT03436693|532482798|FG000|Overall Study|Progressive Disease|1|||
147634869|NCT03436693|532482799|FG001|Overall Study|Progressive Disease|1|||
147634870|NCT04720911|532482804|FG000|Overall Study|Withdrawal by Subject|0|||
147634871|NCT04720911|532482805|FG001|Overall Study|Withdrawal by Subject|1|||
147634872|NCT04720911|532482806|FG002|Overall Study|Withdrawal by Subject|0|||
147634873|NCT00090220|532482807|FG000|Base Study Vaccination Period|Randomized not Vaccinated|1|||
147634874|NCT00090220|532482808|FG001|Base Study Vaccination Period|Randomized not Vaccinated|1|||
147634875|NCT00090220|532482809|FG002|Base Study Vaccination Period|Randomized not Vaccinated|0|||
147634876|NCT00090220|532482810|FG003|Base Study Vaccination Period|Randomized not Vaccinated|0|||
147634877|NCT00090220|532482811|FG004|Base Study Vaccination Period|Randomized not Vaccinated|0|||
147634878|NCT00090220|532482812|FG005|Base Study Vaccination Period|Randomized not Vaccinated|0|||
147634879|NCT00090220|532482807|FG000|Base Study Vaccination Period|Adverse Event|6|||
147634880|NCT00090220|532482808|FG001|Base Study Vaccination Period|Adverse Event|1|||
147634881|NCT00090220|532482809|FG002|Base Study Vaccination Period|Adverse Event|0|||
147634882|NCT00090220|532482810|FG003|Base Study Vaccination Period|Adverse Event|0|||
147634883|NCT00090220|532482811|FG004|Base Study Vaccination Period|Adverse Event|0|||
147634884|NCT00090220|532482812|FG005|Base Study Vaccination Period|Adverse Event|0|||
147634885|NCT00090220|532482807|FG000|Base Study Vaccination Period|Lost to Follow-up|24|||
147634886|NCT00090220|532482808|FG001|Base Study Vaccination Period|Lost to Follow-up|28|||
147634887|NCT00090220|532482809|FG002|Base Study Vaccination Period|Lost to Follow-up|0|||
147634888|NCT00090220|532482810|FG003|Base Study Vaccination Period|Lost to Follow-up|0|||
147634889|NCT00090220|532482811|FG004|Base Study Vaccination Period|Lost to Follow-up|0|||
147634890|NCT00090220|532482812|FG005|Base Study Vaccination Period|Lost to Follow-up|0|||
147634891|NCT00090220|532482807|FG000|Base Study Vaccination Period|Withdrawal by Subject|23|||
147634892|NCT00090220|532482808|FG001|Base Study Vaccination Period|Withdrawal by Subject|27|||
147634893|NCT00090220|532482809|FG002|Base Study Vaccination Period|Withdrawal by Subject|0|||
147634894|NCT00090220|532482810|FG003|Base Study Vaccination Period|Withdrawal by Subject|0|||
147634895|NCT00090220|532482811|FG004|Base Study Vaccination Period|Withdrawal by Subject|0|||
147634896|NCT00090220|532482812|FG005|Base Study Vaccination Period|Withdrawal by Subject|0|||
147634897|NCT00090220|532482807|FG000|Base Study Vaccination Period|Patient Moved|6|||
147634898|NCT00090220|532482808|FG001|Base Study Vaccination Period|Patient Moved|2|||
147634899|NCT00090220|532482809|FG002|Base Study Vaccination Period|Patient Moved|0|||
147634900|NCT00090220|532482810|FG003|Base Study Vaccination Period|Patient Moved|0|||
147634901|NCT00090220|532482811|FG004|Base Study Vaccination Period|Patient Moved|0|||
147634902|NCT00090220|532482812|FG005|Base Study Vaccination Period|Patient Moved|0|||
147634903|NCT00090220|532482807|FG000|Base Study Vaccination Period|Other|4|||
147634904|NCT00090220|532482808|FG001|Base Study Vaccination Period|Other|4|||
147634905|NCT00090220|532482809|FG002|Base Study Vaccination Period|Other|0|||
147634906|NCT00090220|532482810|FG003|Base Study Vaccination Period|Other|0|||
147634907|NCT00090220|532482811|FG004|Base Study Vaccination Period|Other|0|||
147503897|NCT01714817|531996680|FG001|Year 1 Period|Poor / non-compliance|1|||
147503898|NCT01714817|531996679|FG000|Year 1 Period|Pregnancy|2|||
147634908|NCT00090220|532482812|FG005|Base Study Vaccination Period|Other|0|||
147634909|NCT00090220|532482807|FG000|Base Study Follow-up Period|Adverse Event|6|||
147634910|NCT00090220|532482808|FG001|Base Study Follow-up Period|Adverse Event|1|||
147634911|NCT00090220|532482809|FG002|Base Study Follow-up Period|Adverse Event|0|||
147634912|NCT00090220|532482810|FG003|Base Study Follow-up Period|Adverse Event|0|||
147634913|NCT00090220|532482811|FG004|Base Study Follow-up Period|Adverse Event|0|||
147634914|NCT00090220|532482812|FG005|Base Study Follow-up Period|Adverse Event|0|||
147634915|NCT00090220|532482807|FG000|Base Study Follow-up Period|Lost to Follow-up|88|||
147634916|NCT00090220|532482808|FG001|Base Study Follow-up Period|Lost to Follow-up|78|||
147634917|NCT00090220|532482809|FG002|Base Study Follow-up Period|Lost to Follow-up|0|||
147634918|NCT00090220|532482810|FG003|Base Study Follow-up Period|Lost to Follow-up|0|||
147634919|NCT00090220|532482811|FG004|Base Study Follow-up Period|Lost to Follow-up|0|||
147634920|NCT00090220|532482812|FG005|Base Study Follow-up Period|Lost to Follow-up|0|||
147634921|NCT00090220|532482807|FG000|Base Study Follow-up Period|Withdrawal by Subject|27|||
147634922|NCT00090220|532482808|FG001|Base Study Follow-up Period|Withdrawal by Subject|36|||
147634923|NCT00090220|532482809|FG002|Base Study Follow-up Period|Withdrawal by Subject|0|||
147634924|NCT00090220|532482810|FG003|Base Study Follow-up Period|Withdrawal by Subject|0|||
147634925|NCT00090220|532482811|FG004|Base Study Follow-up Period|Withdrawal by Subject|0|||
147634926|NCT00090220|532482812|FG005|Base Study Follow-up Period|Withdrawal by Subject|0|||
147634927|NCT00090220|532482807|FG000|Base Study Follow-up Period|Patient Moved|20|||
147634928|NCT00090220|532482808|FG001|Base Study Follow-up Period|Patient Moved|28|||
147634929|NCT00090220|532482809|FG002|Base Study Follow-up Period|Patient Moved|0|||
147634930|NCT00090220|532482810|FG003|Base Study Follow-up Period|Patient Moved|0|||
147634931|NCT00090220|532482811|FG004|Base Study Follow-up Period|Patient Moved|0|||
147634932|NCT00090220|532482812|FG005|Base Study Follow-up Period|Patient Moved|0|||
147634933|NCT00090220|532482807|FG000|Base Study Follow-up Period|Other|19|||
147634934|NCT00090220|532482808|FG001|Base Study Follow-up Period|Other|21|||
147634935|NCT00090220|532482809|FG002|Base Study Follow-up Period|Other|0|||
147634936|NCT00090220|532482810|FG003|Base Study Follow-up Period|Other|0|||
147634937|NCT00090220|532482811|FG004|Base Study Follow-up Period|Other|0|||
147634938|NCT00090220|532482812|FG005|Base Study Follow-up Period|Other|0|||
147634939|NCT00090220|532482807|FG000|Extension 1 (EXT1)|Adverse Event|0|||
147634940|NCT00090220|532482808|FG001|Extension 1 (EXT1)|Adverse Event|0|||
147634941|NCT00090220|532482809|FG002|Extension 1 (EXT1)|Adverse Event|4|||
147634942|NCT00090220|532482810|FG003|Extension 1 (EXT1)|Adverse Event|0|||
147634943|NCT00090220|532482811|FG004|Extension 1 (EXT1)|Adverse Event|0|||
147634944|NCT00090220|532482812|FG005|Extension 1 (EXT1)|Adverse Event|0|||
147634945|NCT00090220|532482807|FG000|Extension 1 (EXT1)|Lost to Follow-up|0|||
147634946|NCT00090220|532482808|FG001|Extension 1 (EXT1)|Lost to Follow-up|0|||
147634947|NCT00090220|532482809|FG002|Extension 1 (EXT1)|Lost to Follow-up|22|||
147634948|NCT00090220|532482810|FG003|Extension 1 (EXT1)|Lost to Follow-up|0|||
147634949|NCT00090220|532482811|FG004|Extension 1 (EXT1)|Lost to Follow-up|0|||
147634950|NCT00090220|532482812|FG005|Extension 1 (EXT1)|Lost to Follow-up|0|||
147634951|NCT00090220|532482807|FG000|Extension 1 (EXT1)|Moved|0|||
147634952|NCT00090220|532482808|FG001|Extension 1 (EXT1)|Moved|0|||
147634953|NCT00090220|532482809|FG002|Extension 1 (EXT1)|Moved|2|||
147634954|NCT00090220|532482810|FG003|Extension 1 (EXT1)|Moved|1|||
147634955|NCT00090220|532482811|FG004|Extension 1 (EXT1)|Moved|0|||
147634956|NCT00090220|532482812|FG005|Extension 1 (EXT1)|Moved|0|||
147634957|NCT00090220|532482807|FG000|Extension 1 (EXT1)|Withdrawal by Subject|0|||
147634958|NCT00090220|532482808|FG001|Extension 1 (EXT1)|Withdrawal by Subject|0|||
147634959|NCT00090220|532482809|FG002|Extension 1 (EXT1)|Withdrawal by Subject|25|||
147634960|NCT00090220|532482810|FG003|Extension 1 (EXT1)|Withdrawal by Subject|0|||
147634961|NCT00090220|532482811|FG004|Extension 1 (EXT1)|Withdrawal by Subject|0|||
147634962|NCT00090220|532482812|FG005|Extension 1 (EXT1)|Withdrawal by Subject|0|||
147634963|NCT00090220|532482807|FG000|Extension 1 (EXT1)|Protocol Violation|0|||
147634964|NCT00090220|532482808|FG001|Extension 1 (EXT1)|Protocol Violation|0|||
147634965|NCT00090220|532482809|FG002|Extension 1 (EXT1)|Protocol Violation|0|||
147634966|NCT00090220|532482810|FG003|Extension 1 (EXT1)|Protocol Violation|1|||
147634967|NCT00090220|532482811|FG004|Extension 1 (EXT1)|Protocol Violation|0|||
147634968|NCT00090220|532482812|FG005|Extension 1 (EXT1)|Protocol Violation|0|||
147634969|NCT00090220|532482807|FG000|Extension 1 (EXT1)|Other reason|0|||
147634970|NCT00090220|532482808|FG001|Extension 1 (EXT1)|Other reason|0|||
147634971|NCT00090220|532482809|FG002|Extension 1 (EXT1)|Other reason|2|||
147634972|NCT00090220|532482810|FG003|Extension 1 (EXT1)|Other reason|0|||
147634973|NCT00090220|532482811|FG004|Extension 1 (EXT1)|Other reason|0|||
147634974|NCT00090220|532482812|FG005|Extension 1 (EXT1)|Other reason|0|||
147634975|NCT00090220|532482807|FG000|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
147634976|NCT00090220|532482808|FG001|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
147634977|NCT00090220|532482809|FG002|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
147634978|NCT00090220|532482810|FG003|Long-term Follow-up (EXT2)|Lost to Follow-up|0|||
147634979|NCT00090220|532482811|FG004|Long-term Follow-up (EXT2)|Lost to Follow-up|38|||
147634980|NCT00090220|532482812|FG005|Long-term Follow-up (EXT2)|Lost to Follow-up|23|||
147634981|NCT00090220|532482807|FG000|Long-term Follow-up (EXT2)|Death|0|||
147634982|NCT00090220|532482808|FG001|Long-term Follow-up (EXT2)|Death|0|||
147634983|NCT00090220|532482809|FG002|Long-term Follow-up (EXT2)|Death|0|||
147634984|NCT00090220|532482810|FG003|Long-term Follow-up (EXT2)|Death|0|||
147634985|NCT00090220|532482811|FG004|Long-term Follow-up (EXT2)|Death|1|||
147634986|NCT00090220|532482812|FG005|Long-term Follow-up (EXT2)|Death|1|||
147634987|NCT00090220|532482807|FG000|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
147634988|NCT00090220|532482808|FG001|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
147634989|NCT00090220|532482809|FG002|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
147634990|NCT00090220|532482810|FG003|Long-term Follow-up (EXT2)|Withdrawal by Subject|0|||
147634991|NCT00090220|532482811|FG004|Long-term Follow-up (EXT2)|Withdrawal by Subject|4|||
147634992|NCT00090220|532482812|FG005|Long-term Follow-up (EXT2)|Withdrawal by Subject|4|||
147634993|NCT00090220|532482807|FG000|Long-term Follow-up (EXT2)|Other|0|||
147634994|NCT00090220|532482808|FG001|Long-term Follow-up (EXT2)|Other|0|||
147634995|NCT00090220|532482809|FG002|Long-term Follow-up (EXT2)|Other|0|||
147634996|NCT00090220|532482810|FG003|Long-term Follow-up (EXT2)|Other|0|||
147634997|NCT00090220|532482811|FG004|Long-term Follow-up (EXT2)|Other|1|||
147634998|NCT00090220|532482812|FG005|Long-term Follow-up (EXT2)|Other|0|||
147634999|NCT00941863|532482813|FG000|Until Primary Completion Date (PCD)|Adverse Event|1|||
147635000|NCT00941863|532482814|FG001|Until Primary Completion Date (PCD)|Adverse Event|2|||
147635001|NCT00941863|532482815|FG002|Until Primary Completion Date (PCD)|Adverse Event|2|||
147635002|NCT00941863|532482816|FG003|Until Primary Completion Date (PCD)|Adverse Event|1|||
147635003|NCT00941863|532482817|FG004|Until Primary Completion Date (PCD)|Adverse Event|5|||
147635004|NCT00941863|532482813|FG000|Until Primary Completion Date (PCD)|Physician Decision|0|||
147635005|NCT00941863|532482814|FG001|Until Primary Completion Date (PCD)|Physician Decision|0|||
147635006|NCT00941863|532482815|FG002|Until Primary Completion Date (PCD)|Physician Decision|0|||
147635007|NCT00941863|532482816|FG003|Until Primary Completion Date (PCD)|Physician Decision|0|||
147635008|NCT00941863|532482817|FG004|Until Primary Completion Date (PCD)|Physician Decision|1|||
147635009|NCT00941863|532482813|FG000|Until Primary Completion Date (PCD)|Withdrawal by Subject|0|||
147635010|NCT00941863|532482814|FG001|Until Primary Completion Date (PCD)|Withdrawal by Subject|0|||
147635011|NCT00941863|532482815|FG002|Until Primary Completion Date (PCD)|Withdrawal by Subject|1|||
147635012|NCT00941863|532482816|FG003|Until Primary Completion Date (PCD)|Withdrawal by Subject|0|||
147635013|NCT00941863|532482817|FG004|Until Primary Completion Date (PCD)|Withdrawal by Subject|8|||
147635014|NCT00941863|532482813|FG000|Until Primary Completion Date (PCD)|Death|0|||
147635015|NCT00941863|532482814|FG001|Until Primary Completion Date (PCD)|Death|0|||
147635016|NCT00941863|532482815|FG002|Until Primary Completion Date (PCD)|Death|1|||
147635017|NCT00941863|532482816|FG003|Until Primary Completion Date (PCD)|Death|2|||
147635018|NCT00941863|532482817|FG004|Until Primary Completion Date (PCD)|Death|7|||
147635019|NCT00941863|532482813|FG000|Until Primary Completion Date (PCD)|Disease progression|6|||
147635020|NCT00941863|532482814|FG001|Until Primary Completion Date (PCD)|Disease progression|1|||
147635021|NCT00941863|532482815|FG002|Until Primary Completion Date (PCD)|Disease progression|8|||
147635022|NCT00941863|532482816|FG003|Until Primary Completion Date (PCD)|Disease progression|14|||
147635023|NCT00941863|532482817|FG004|Until Primary Completion Date (PCD)|Disease progression|73|||
147635024|NCT00941863|532482813|FG000|Continued After PCD|Withdrawal by Subject|0|||
147635025|NCT00941863|532482814|FG001|Continued After PCD|Withdrawal by Subject|0|||
147635026|NCT00941863|532482815|FG002|Continued After PCD|Withdrawal by Subject|0|||
147635027|NCT00941863|532482816|FG003|Continued After PCD|Withdrawal by Subject|0|||
147635028|NCT00941863|532482817|FG004|Continued After PCD|Withdrawal by Subject|1|||
147635029|NCT00941863|532482813|FG000|Continued After PCD|Disease progression, recurrence, relapse|0|||
147635030|NCT00941863|532482814|FG001|Continued After PCD|Disease progression, recurrence, relapse|0|||
147635031|NCT00941863|532482815|FG002|Continued After PCD|Disease progression, recurrence, relapse|0|||
147635032|NCT00941863|532482816|FG003|Continued After PCD|Disease progression, recurrence, relapse|0|||
147635033|NCT00941863|532482817|FG004|Continued After PCD|Disease progression, recurrence, relapse|18|||
147635034|NCT02394340|532482818|FG000|Overall Study|Failed drug screen test|1|||
147635035|NCT02394340|532482818|FG000|Overall Study|Adverse Event|1|||
147635036|NCT03315286|532482821|FG000|Overall Study|Lost to Follow-up|0|||
147635037|NCT03315286|532482822|FG001|Overall Study|Lost to Follow-up|3|||
147635038|NCT03315286|532482821|FG000|Overall Study|Withdrawal by Subject|1|||
147635039|NCT03315286|532482822|FG001|Overall Study|Withdrawal by Subject|0|||
147635040|NCT03315286|532482821|FG000|Overall Study|Protocol Violation|0|||
147635041|NCT03315286|532482822|FG001|Overall Study|Protocol Violation|1|||
147635042|NCT02828124|532482823|FG000|Overall Study|Disease Progression|1|||
147635043|NCT02828124|532482824|FG001|Overall Study|Disease Progression|2|||
147635044|NCT02828124|532482825|FG002|Overall Study|Disease Progression|1|||
147635045|NCT02828124|532482826|FG003|Overall Study|Disease Progression|4|||
147635046|NCT02828124|532482823|FG000|Overall Study|AE Unrelated to Study Drug|0|||
147635047|NCT02828124|532482824|FG001|Overall Study|AE Unrelated to Study Drug|0|||
147635048|NCT02828124|532482825|FG002|Overall Study|AE Unrelated to Study Drug|0|||
147635049|NCT02828124|532482826|FG003|Overall Study|AE Unrelated to Study Drug|1|||
147635050|NCT02828124|532482823|FG000|Overall Study|Subject Withdrew Consent|0|||
147635051|NCT02828124|532482824|FG001|Overall Study|Subject Withdrew Consent|0|||
147635052|NCT02828124|532482825|FG002|Overall Study|Subject Withdrew Consent|0|||
147635053|NCT02828124|532482826|FG003|Overall Study|Subject Withdrew Consent|1|||
147635054|NCT00747474|532482828|FG000|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
147635055|NCT00747474|532482829|FG001|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
147635056|NCT00747474|532482830|FG002|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
147635057|NCT00747474|532482831|FG003|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
147635058|NCT00747474|532482832|FG004|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
147635059|NCT00747474|532482833|FG005|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
147635060|NCT00747474|532482834|FG006|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
147635061|NCT00747474|532482835|FG007|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|1|||
147635062|NCT00747474|532482836|FG008|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
147635063|NCT00747474|532482837|FG009|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
147635064|NCT00747474|532482838|FG010|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
147635065|NCT00747474|532482839|FG011|Cohort 8 (40 mg/m^2) Period|with efficacy and continued treatment|0|||
147635066|NCT02829723|532482840|FG000|Overall Study|Adverse Event|0|||
147635067|NCT02829723|532482841|FG001|Overall Study|Adverse Event|0|||
147635068|NCT02829723|532482842|FG002|Overall Study|Adverse Event|1|||
147635069|NCT02829723|532482843|FG003|Overall Study|Adverse Event|1|||
147635070|NCT02829723|532482844|FG004|Overall Study|Adverse Event|0|||
147635071|NCT02829723|532482845|FG005|Overall Study|Adverse Event|0|||
147635072|NCT02829723|532482846|FG006|Overall Study|Adverse Event|0|||
147635073|NCT02829723|532482847|FG007|Overall Study|Adverse Event|1|||
147635074|NCT02829723|532482848|FG008|Overall Study|Adverse Event|0|||
147635075|NCT02829723|532482849|FG009|Overall Study|Adverse Event|0|||
147635076|NCT02829723|532482850|FG010|Overall Study|Adverse Event|0|||
147635077|NCT02829723|532482851|FG011|Overall Study|Adverse Event|0|||
147635078|NCT02829723|532482852|FG012|Overall Study|Adverse Event|0|||
147635079|NCT02829723|532482853|FG013|Overall Study|Adverse Event|0|||
147635080|NCT02829723|532482854|FG014|Overall Study|Adverse Event|1|||
147635081|NCT02829723|532482855|FG015|Overall Study|Adverse Event|1|||
147635082|NCT02829723|532482856|FG016|Overall Study|Adverse Event|1|||
147635083|NCT02829723|532482857|FG017|Overall Study|Adverse Event|2|||
147635084|NCT02829723|532482858|FG018|Overall Study|Adverse Event|1|||
147635085|NCT02829723|532482859|FG019|Overall Study|Adverse Event|1|||
147635086|NCT02829723|532482860|FG020|Overall Study|Adverse Event|3|||
147635087|NCT02829723|532482861|FG021|Overall Study|Adverse Event|0|||
147635088|NCT02829723|532482862|FG022|Overall Study|Adverse Event|0|||
147635089|NCT02829723|532482863|FG023|Overall Study|Adverse Event|1|||
147635090|NCT02829723|532482864|FG024|Overall Study|Adverse Event|1|||
147635091|NCT02829723|532482865|FG025|Overall Study|Adverse Event|3|||
147635092|NCT02829723|532482866|FG026|Overall Study|Adverse Event|5|||
147635093|NCT02829723|532482840|FG000|Overall Study|Death|1|||
147635094|NCT02829723|532482841|FG001|Overall Study|Death|0|||
147635095|NCT02829723|532482842|FG002|Overall Study|Death|1|||
147635096|NCT02829723|532482843|FG003|Overall Study|Death|1|||
147668738|NCT00784875|532613363|FG002|Period B - Efficacy Endpoint|Lack of Efficacy|0|||
147668739|NCT00784875|532613364|FG003|Period B - Efficacy Endpoint|Lack of Efficacy|0|||
147668740|NCT00784875|532613361|FG000|Period B - Efficacy Endpoint|Withdrawal by Subject|4|||
147503899|NCT01714817|531996680|FG001|Year 1 Period|Pregnancy|0|||
147503900|NCT01714817|531996679|FG000|Year 1 Period|Participant no longer meets criteria|6|||
147503901|NCT01714817|531996680|FG001|Year 1 Period|Participant no longer meets criteria|2|||
147503902|NCT01714817|531996679|FG000|Year 1 Period|Not treated- received ACE inhibition|1|||
147503903|NCT01714817|531996680|FG001|Year 1 Period|Not treated- received ACE inhibition|0|||
147503904|NCT01714817|531996679|FG000|Year 1 Period|Change in Concomitant Medication|0|||
147503905|NCT01714817|531996680|FG001|Year 1 Period|Change in Concomitant Medication|1|||
147503906|NCT01714817|531996679|FG000|Year 1 Period|Need of use of Prohibited Medications|1|||
147503907|NCT01714817|531996680|FG001|Year 1 Period|Need of use of Prohibited Medications|0|||
147503908|NCT01714817|531996679|FG000|Year 1 Period|Antiproteinuric changed/dose increased|0|||
147503909|NCT01714817|531996680|FG001|Year 1 Period|Antiproteinuric changed/dose increased|1|||
147503910|NCT01714817|531996679|FG000|Year 1 Period|Hypersensitivity to the medication|0|||
147503911|NCT01714817|531996680|FG001|Year 1 Period|Hypersensitivity to the medication|1|||
147503912|NCT01714817|531996679|FG000|Year 2 Period|Lack of Efficacy|4|||
147503913|NCT01714817|531996680|FG001|Year 2 Period|Lack of Efficacy|12|||
147503914|NCT01714817|531996679|FG000|Year 2 Period|Adverse Event|7|||
147503915|NCT01714817|531996680|FG001|Year 2 Period|Adverse Event|6|||
147503916|NCT01714817|531996679|FG000|Year 2 Period|Participant request to stop treatment|4|||
147503917|NCT01714817|531996680|FG001|Year 2 Period|Participant request to stop treatment|4|||
147503918|NCT01714817|531996679|FG000|Year 2 Period|Administrative reason by Sponsor|4|||
147503919|NCT01714817|531996680|FG001|Year 2 Period|Administrative reason by Sponsor|3|||
147503920|NCT01714817|531996679|FG000|Year 2 Period|Participant withdrew consent|1|||
147503921|NCT01714817|531996680|FG001|Year 2 Period|Participant withdrew consent|5|||
147503922|NCT01714817|531996679|FG000|Year 2 Period|Participant no longer meets criteria|1|||
147503923|NCT01714817|531996680|FG001|Year 2 Period|Participant no longer meets criteria|4|||
147503924|NCT01714817|531996679|FG000|Year 2 Period|Lost to Follow-up|2|||
147635097|NCT02829723|532482844|FG004|Overall Study|Death|0|||
147635098|NCT02829723|532482845|FG005|Overall Study|Death|0|||
147635099|NCT02829723|532482846|FG006|Overall Study|Death|2|||
147635100|NCT02829723|532482847|FG007|Overall Study|Death|0|||
147635101|NCT02829723|532482848|FG008|Overall Study|Death|1|||
147503925|NCT01714817|531996680|FG001|Year 2 Period|Lost to Follow-up|0|||
147503926|NCT01714817|531996679|FG000|Year 2 Period|Participant went to US stopped treatment|0|||
147635102|NCT02829723|532482849|FG009|Overall Study|Death|0|||
147503927|NCT01714817|531996680|FG001|Year 2 Period|Participant went to US stopped treatment|1|||
147503928|NCT01714817|531996679|FG000|Year 2 Period|Pregnancy|1|||
147635103|NCT02829723|532482850|FG010|Overall Study|Death|0|||
147635104|NCT02829723|532482851|FG011|Overall Study|Death|0|||
147635105|NCT02829723|532482852|FG012|Overall Study|Death|2|||
147635106|NCT02829723|532482853|FG013|Overall Study|Death|1|||
147635107|NCT02829723|532482854|FG014|Overall Study|Death|0|||
147635108|NCT02829723|532482855|FG015|Overall Study|Death|0|||
147635109|NCT02829723|532482856|FG016|Overall Study|Death|0|||
147635110|NCT02829723|532482857|FG017|Overall Study|Death|0|||
147635111|NCT02829723|532482858|FG018|Overall Study|Death|0|||
147635112|NCT02829723|532482859|FG019|Overall Study|Death|0|||
147635113|NCT02829723|532482860|FG020|Overall Study|Death|0|||
147635114|NCT02829723|532482861|FG021|Overall Study|Death|2|||
147635115|NCT02829723|532482862|FG022|Overall Study|Death|0|||
147635116|NCT02829723|532482863|FG023|Overall Study|Death|0|||
147635117|NCT02829723|532482864|FG024|Overall Study|Death|0|||
147635118|NCT02829723|532482865|FG025|Overall Study|Death|1|||
147635119|NCT02829723|532482866|FG026|Overall Study|Death|2|||
147635120|NCT02829723|532482840|FG000|Overall Study|Physician Decision|0|||
147635121|NCT02829723|532482841|FG001|Overall Study|Physician Decision|0|||
147635122|NCT02829723|532482842|FG002|Overall Study|Physician Decision|0|||
147635123|NCT02829723|532482843|FG003|Overall Study|Physician Decision|0|||
147635124|NCT02829723|532482844|FG004|Overall Study|Physician Decision|0|||
147635125|NCT02829723|532482845|FG005|Overall Study|Physician Decision|0|||
147635126|NCT02829723|532482846|FG006|Overall Study|Physician Decision|0|||
147635127|NCT02829723|532482847|FG007|Overall Study|Physician Decision|0|||
147635128|NCT02829723|532482848|FG008|Overall Study|Physician Decision|0|||
147635129|NCT02829723|532482849|FG009|Overall Study|Physician Decision|1|||
147635130|NCT02829723|532482850|FG010|Overall Study|Physician Decision|1|||
147503929|NCT01714817|531996680|FG001|Year 2 Period|Pregnancy|1|||
147503930|NCT01714817|531996679|FG000|Year 2 Period|Completed Year 1, did not enter Year 2|2|||
147503931|NCT01714817|531996680|FG001|Year 2 Period|Completed Year 1, did not enter Year 2|1|||
147503932|NCT01714817|531996679|FG000|Year 2 Period|Given cyclophosphamide, corticosteroids|0|||
147503933|NCT01714817|531996680|FG001|Year 2 Period|Given cyclophosphamide, corticosteroids|1|||
147635131|NCT02829723|532482851|FG011|Overall Study|Physician Decision|0|||
147635132|NCT02829723|532482852|FG012|Overall Study|Physician Decision|0|||
147635133|NCT02829723|532482853|FG013|Overall Study|Physician Decision|1|||
147635134|NCT02829723|532482854|FG014|Overall Study|Physician Decision|0|||
147635135|NCT02829723|532482855|FG015|Overall Study|Physician Decision|0|||
147635136|NCT02829723|532482856|FG016|Overall Study|Physician Decision|2|||
147635137|NCT02829723|532482857|FG017|Overall Study|Physician Decision|0|||
147635138|NCT02829723|532482858|FG018|Overall Study|Physician Decision|0|||
147635139|NCT02829723|532482859|FG019|Overall Study|Physician Decision|0|||
147635140|NCT02829723|532482860|FG020|Overall Study|Physician Decision|0|||
147635141|NCT02829723|532482861|FG021|Overall Study|Physician Decision|0|||
147635142|NCT02829723|532482862|FG022|Overall Study|Physician Decision|1|||
147503934|NCT01714817|531996679|FG000|Long-Term Extension (LTE) Period|Administrative reason by Sponsor|27|||
147503935|NCT01714817|531996680|FG001|Long-Term Extension (LTE) Period|Administrative reason by Sponsor|21|||
147503936|NCT01714817|531996679|FG000|Long-Term Extension (LTE) Period|Disease progression|1|||
147503937|NCT01714817|531996680|FG001|Long-Term Extension (LTE) Period|Disease progression|4|||
147503938|NCT01714817|531996679|FG000|Long-Term Extension (LTE) Period|Not effective|0|||
147503939|NCT01714817|531996680|FG001|Long-Term Extension (LTE) Period|Not effective|1|||
147503940|NCT01714817|531996679|FG000|Long-Term Extension (LTE) Period|Participant request to stop treatment|1|||
147635143|NCT02829723|532482863|FG023|Overall Study|Physician Decision|1|||
147635144|NCT02829723|532482864|FG024|Overall Study|Physician Decision|1|||
147635145|NCT02829723|532482865|FG025|Overall Study|Physician Decision|1|||
147635146|NCT02829723|532482866|FG026|Overall Study|Physician Decision|3|||
147635147|NCT02829723|532482840|FG000|Overall Study|Progressive disease|4|||
147635148|NCT02829723|532482841|FG001|Overall Study|Progressive disease|6|||
147635149|NCT02829723|532482842|FG002|Overall Study|Progressive disease|3|||
147635150|NCT02829723|532482843|FG003|Overall Study|Progressive disease|3|||
147635151|NCT02829723|532482844|FG004|Overall Study|Progressive disease|3|||
147635152|NCT02829723|532482845|FG005|Overall Study|Progressive disease|5|||
147635153|NCT02829723|532482846|FG006|Overall Study|Progressive disease|4|||
147635154|NCT02829723|532482847|FG007|Overall Study|Progressive disease|6|||
147635155|NCT02829723|532482848|FG008|Overall Study|Progressive disease|8|||
147635156|NCT02829723|532482849|FG009|Overall Study|Progressive disease|4|||
147668741|NCT00784875|532613362|FG001|Period B - Efficacy Endpoint|Withdrawal by Subject|1|||
147668742|NCT00784875|532613363|FG002|Period B - Efficacy Endpoint|Withdrawal by Subject|1|||
147635157|NCT02829723|532482850|FG010|Overall Study|Progressive disease|9|||
147635158|NCT02829723|532482851|FG011|Overall Study|Progressive disease|0|||
147635159|NCT02829723|532482852|FG012|Overall Study|Progressive disease|3|||
147635160|NCT02829723|532482853|FG013|Overall Study|Progressive disease|4|||
147635161|NCT02829723|532482854|FG014|Overall Study|Progressive disease|2|||
147668743|NCT00784875|532613364|FG003|Period B - Efficacy Endpoint|Withdrawal by Subject|2|||
147503941|NCT01714817|531996680|FG001|Long-Term Extension (LTE) Period|Participant request to stop treatment|1|||
147635162|NCT02829723|532482855|FG015|Overall Study|Progressive disease|4|||
147635163|NCT02829723|532482856|FG016|Overall Study|Progressive disease|5|||
147635164|NCT02829723|532482857|FG017|Overall Study|Progressive disease|3|||
147635165|NCT02829723|532482858|FG018|Overall Study|Progressive disease|4|||
147635166|NCT02829723|532482859|FG019|Overall Study|Progressive disease|4|||
147635167|NCT02829723|532482860|FG020|Overall Study|Progressive disease|7|||
147503942|NCT01714817|531996679|FG000|Long-Term Extension (LTE) Period|Participant withdrew consent|1|||
147503943|NCT01714817|531996680|FG001|Long-Term Extension (LTE) Period|Participant withdrew consent|1|||
147503944|NCT01714817|531996679|FG000|Long-Term Extension (LTE) Period|Adverse Event unrelated to study drug|1|||
147503945|NCT01714817|531996680|FG001|Long-Term Extension (LTE) Period|Adverse Event unrelated to study drug|0|||
147503946|NCT01714817|531996679|FG000|Long-Term Extension (LTE) Period|Lost to Follow-up|0|||
147503947|NCT01714817|531996680|FG001|Long-Term Extension (LTE) Period|Lost to Follow-up|1|||
147503948|NCT01714817|531996679|FG000|Long-Term Extension (LTE) Period|Pregnancy|1|||
147503949|NCT01714817|531996680|FG001|Long-Term Extension (LTE) Period|Pregnancy|0|||
147503950|NCT01714817|531996679|FG000|Long-Term Extension (LTE) Period|Study drug toxicity|1|||
147503951|NCT01714817|531996680|FG001|Long-Term Extension (LTE) Period|Study drug toxicity|0|||
147503952|NCT01714817|531996679|FG000|Long-Term Extension (LTE) Period|Participant no longer meets criteria|1|||
147503953|NCT01714817|531996680|FG001|Long-Term Extension (LTE) Period|Participant no longer meets criteria|0|||
147503954|NCT01714817|531996679|FG000|Long-Term Extension (LTE) Period|Completed Year 2, did not enter LTE|33|||
147503955|NCT01714817|531996680|FG001|Long-Term Extension (LTE) Period|Completed Year 2, did not enter LTE|38|||
147503956|NCT01714817|531996679|FG000|Long-Term Extension (LTE) Period|Absence of renal response|0|||
147503957|NCT01714817|531996680|FG001|Long-Term Extension (LTE) Period|Absence of renal response|1|||
147503958|NCT01714817|531996679|FG000|Long-Term Extension (LTE) Period|Investigator decision, study termination|0|||
147503959|NCT01714817|531996680|FG001|Long-Term Extension (LTE) Period|Investigator decision, study termination|1|||
147503960|NCT01714817|531996679|FG000|Long-Term Extension (LTE) Period|Study was terminated|0|||
147503961|NCT01714817|531996680|FG001|Long-Term Extension (LTE) Period|Study was terminated|1|||
147503962|NCT00476996|531996681|FG000|Blinded Treatment Phase (up to Week 48)|Withdrawal by Subject|12|||
147503963|NCT00476996|531996682|FG001|Blinded Treatment Phase (up to Week 48)|Withdrawal by Subject|7|||
147503964|NCT00476996|531996683|FG002|Blinded Treatment Phase (up to Week 48)|Withdrawal by Subject|7|||
147503965|NCT00476996|531996684|FG003|Blinded Treatment Phase (up to Week 48)|Withdrawal by Subject|0|||
147503966|NCT00476996|531996681|FG000|Blinded Treatment Phase (up to Week 48)|Protocol Violation|1|||
147503967|NCT00476996|531996682|FG001|Blinded Treatment Phase (up to Week 48)|Protocol Violation|3|||
147503968|NCT00476996|531996683|FG002|Blinded Treatment Phase (up to Week 48)|Protocol Violation|0|||
147503969|NCT00476996|531996684|FG003|Blinded Treatment Phase (up to Week 48)|Protocol Violation|0|||
147503970|NCT00476996|531996681|FG000|Blinded Treatment Phase (up to Week 48)|Early termination of the study|24|||
147503971|NCT00476996|531996682|FG001|Blinded Treatment Phase (up to Week 48)|Early termination of the study|20|||
147503972|NCT00476996|531996683|FG002|Blinded Treatment Phase (up to Week 48)|Early termination of the study|21|||
147503973|NCT00476996|531996684|FG003|Blinded Treatment Phase (up to Week 48)|Early termination of the study|0|||
147503974|NCT00476996|531996681|FG000|Blinded Treatment Phase (up to Week 48)|Non-Compliance with Study Drug|0|||
147503975|NCT00476996|531996682|FG001|Blinded Treatment Phase (up to Week 48)|Non-Compliance with Study Drug|2|||
147503976|NCT00476996|531996683|FG002|Blinded Treatment Phase (up to Week 48)|Non-Compliance with Study Drug|0|||
147503977|NCT00476996|531996684|FG003|Blinded Treatment Phase (up to Week 48)|Non-Compliance with Study Drug|0|||
147503978|NCT00476996|531996681|FG000|Blinded Treatment Phase (up to Week 48)|Lost to Follow-up|0|||
147503979|NCT00476996|531996682|FG001|Blinded Treatment Phase (up to Week 48)|Lost to Follow-up|4|||
147503980|NCT00476996|531996683|FG002|Blinded Treatment Phase (up to Week 48)|Lost to Follow-up|3|||
147503981|NCT00476996|531996684|FG003|Blinded Treatment Phase (up to Week 48)|Lost to Follow-up|0|||
147503982|NCT00476996|531996681|FG000|Blinded Treatment Phase (up to Week 48)|Lack of Efficacy|22|||
147503983|NCT00476996|531996682|FG001|Blinded Treatment Phase (up to Week 48)|Lack of Efficacy|5|||
147503984|NCT00476996|531996683|FG002|Blinded Treatment Phase (up to Week 48)|Lack of Efficacy|6|||
147503985|NCT00476996|531996684|FG003|Blinded Treatment Phase (up to Week 48)|Lack of Efficacy|0|||
147503986|NCT00476996|531996681|FG000|Blinded Treatment Phase (up to Week 48)|Death|2|||
147503987|NCT00476996|531996682|FG001|Blinded Treatment Phase (up to Week 48)|Death|1|||
147503988|NCT00476996|531996683|FG002|Blinded Treatment Phase (up to Week 48)|Death|1|||
147503989|NCT00476996|531996684|FG003|Blinded Treatment Phase (up to Week 48)|Death|0|||
147503990|NCT00476996|531996681|FG000|Blinded Treatment Phase (up to Week 48)|Adverse Event|11|||
147503991|NCT00476996|531996682|FG001|Blinded Treatment Phase (up to Week 48)|Adverse Event|13|||
147503992|NCT00476996|531996683|FG002|Blinded Treatment Phase (up to Week 48)|Adverse Event|7|||
147503993|NCT00476996|531996684|FG003|Blinded Treatment Phase (up to Week 48)|Adverse Event|0|||
147503994|NCT00476996|531996681|FG000|OLE Phase (From Week 48)|Withdrawal by Subject|0|||
147503995|NCT00476996|531996682|FG001|OLE Phase (From Week 48)|Withdrawal by Subject|0|||
147503996|NCT00476996|531996683|FG002|OLE Phase (From Week 48)|Withdrawal by Subject|0|||
147503997|NCT00476996|531996684|FG003|OLE Phase (From Week 48)|Withdrawal by Subject|50|||
147503998|NCT00476996|531996681|FG000|OLE Phase (From Week 48)|Adverse Event|0|||
147503999|NCT00476996|531996682|FG001|OLE Phase (From Week 48)|Adverse Event|0|||
147504000|NCT00476996|531996683|FG002|OLE Phase (From Week 48)|Adverse Event|0|||
147504001|NCT00476996|531996684|FG003|OLE Phase (From Week 48)|Adverse Event|8|||
147504002|NCT00476996|531996681|FG000|OLE Phase (From Week 48)|Death|0|||
147504003|NCT00476996|531996682|FG001|OLE Phase (From Week 48)|Death|0|||
147504004|NCT00476996|531996683|FG002|OLE Phase (From Week 48)|Death|0|||
147504005|NCT00476996|531996684|FG003|OLE Phase (From Week 48)|Death|7|||
147504006|NCT00476996|531996681|FG000|OLE Phase (From Week 48)|Lack of Efficacy|0|||
147635168|NCT02829723|532482861|FG021|Overall Study|Progressive disease|6|||
147635169|NCT02829723|532482862|FG022|Overall Study|Progressive disease|3|||
147635170|NCT02829723|532482863|FG023|Overall Study|Progressive disease|3|||
147635171|NCT02829723|532482864|FG024|Overall Study|Progressive disease|3|||
147635172|NCT02829723|532482865|FG025|Overall Study|Progressive disease|16|||
147635173|NCT02829723|532482866|FG026|Overall Study|Progressive disease|10|||
147635174|NCT02829723|532482840|FG000|Overall Study|Subject/guardian decision|0|||
147635175|NCT02829723|532482841|FG001|Overall Study|Subject/guardian decision|1|||
147504007|NCT00476996|531996682|FG001|OLE Phase (From Week 48)|Lack of Efficacy|0|||
147635176|NCT02829723|532482842|FG002|Overall Study|Subject/guardian decision|0|||
147635177|NCT02829723|532482843|FG003|Overall Study|Subject/guardian decision|1|||
147635178|NCT02829723|532482844|FG004|Overall Study|Subject/guardian decision|0|||
147635179|NCT02829723|532482845|FG005|Overall Study|Subject/guardian decision|0|||
147635180|NCT02829723|532482846|FG006|Overall Study|Subject/guardian decision|0|||
147635181|NCT02829723|532482847|FG007|Overall Study|Subject/guardian decision|1|||
147635182|NCT02829723|532482848|FG008|Overall Study|Subject/guardian decision|0|||
147635183|NCT02829723|532482849|FG009|Overall Study|Subject/guardian decision|0|||
147635184|NCT02829723|532482850|FG010|Overall Study|Subject/guardian decision|0|||
147635185|NCT02829723|532482851|FG011|Overall Study|Subject/guardian decision|0|||
147635186|NCT02829723|532482852|FG012|Overall Study|Subject/guardian decision|0|||
147635187|NCT02829723|532482853|FG013|Overall Study|Subject/guardian decision|0|||
147635188|NCT02829723|532482854|FG014|Overall Study|Subject/guardian decision|1|||
147635189|NCT02829723|532482855|FG015|Overall Study|Subject/guardian decision|0|||
147635190|NCT02829723|532482856|FG016|Overall Study|Subject/guardian decision|1|||
147635191|NCT02829723|532482857|FG017|Overall Study|Subject/guardian decision|0|||
147635192|NCT02829723|532482858|FG018|Overall Study|Subject/guardian decision|1|||
147635193|NCT02829723|532482859|FG019|Overall Study|Subject/guardian decision|0|||
147635194|NCT02829723|532482860|FG020|Overall Study|Subject/guardian decision|1|||
147635195|NCT02829723|532482861|FG021|Overall Study|Subject/guardian decision|0|||
147635196|NCT02829723|532482862|FG022|Overall Study|Subject/guardian decision|0|||
147635197|NCT02829723|532482863|FG023|Overall Study|Subject/guardian decision|1|||
147635198|NCT02829723|532482864|FG024|Overall Study|Subject/guardian decision|0|||
147635199|NCT02829723|532482865|FG025|Overall Study|Subject/guardian decision|1|||
147635200|NCT02829723|532482866|FG026|Overall Study|Subject/guardian decision|1|||
147635201|NCT02829723|532482840|FG000|Overall Study|Study terminated by sponsor|0|||
147635202|NCT02829723|532482841|FG001|Overall Study|Study terminated by sponsor|0|||
147635203|NCT02829723|532482842|FG002|Overall Study|Study terminated by sponsor|0|||
147635204|NCT02829723|532482843|FG003|Overall Study|Study terminated by sponsor|0|||
147635205|NCT02829723|532482844|FG004|Overall Study|Study terminated by sponsor|0|||
147635206|NCT02829723|532482845|FG005|Overall Study|Study terminated by sponsor|0|||
147635207|NCT02829723|532482846|FG006|Overall Study|Study terminated by sponsor|0|||
147635208|NCT02829723|532482847|FG007|Overall Study|Study terminated by sponsor|0|||
147635209|NCT02829723|532482848|FG008|Overall Study|Study terminated by sponsor|0|||
147635210|NCT02829723|532482849|FG009|Overall Study|Study terminated by sponsor|0|||
147635211|NCT02829723|532482850|FG010|Overall Study|Study terminated by sponsor|0|||
147635212|NCT02829723|532482851|FG011|Overall Study|Study terminated by sponsor|0|||
147635213|NCT02829723|532482852|FG012|Overall Study|Study terminated by sponsor|0|||
147635214|NCT02829723|532482853|FG013|Overall Study|Study terminated by sponsor|0|||
147635215|NCT02829723|532482854|FG014|Overall Study|Study terminated by sponsor|0|||
147635216|NCT02829723|532482855|FG015|Overall Study|Study terminated by sponsor|0|||
147635217|NCT02829723|532482856|FG016|Overall Study|Study terminated by sponsor|0|||
147635218|NCT02829723|532482857|FG017|Overall Study|Study terminated by sponsor|0|||
147635219|NCT02829723|532482858|FG018|Overall Study|Study terminated by sponsor|0|||
147504008|NCT00476996|531996683|FG002|OLE Phase (From Week 48)|Lack of Efficacy|0|||
147635220|NCT02829723|532482859|FG019|Overall Study|Study terminated by sponsor|0|||
147635221|NCT02829723|532482860|FG020|Overall Study|Study terminated by sponsor|0|||
147635222|NCT02829723|532482861|FG021|Overall Study|Study terminated by sponsor|1|||
147635223|NCT02829723|532482862|FG022|Overall Study|Study terminated by sponsor|0|||
147635224|NCT02829723|532482863|FG023|Overall Study|Study terminated by sponsor|0|||
147635225|NCT02829723|532482864|FG024|Overall Study|Study terminated by sponsor|0|||
147635226|NCT02829723|532482865|FG025|Overall Study|Study terminated by sponsor|0|||
147635227|NCT02829723|532482866|FG026|Overall Study|Study terminated by sponsor|0|||
147635228|NCT02989649|532482867|FG000|Overall Study|Patient/Investigator's Decision to Stop|403|||
147635229|NCT02989649|532482867|FG000|Overall Study|Adverse Event/Adverse Drug Reaction|1|||
147635230|NCT02989649|532482867|FG000|Overall Study|Lost For Observation During Study|3|||
147635231|NCT02989649|532482867|FG000|Overall Study|Reason Not Specified|13|||
147635232|NCT00256854|532482868|FG000|Overall Study|Withdrawal by Subject|2|||
147635233|NCT00256854|532482869|FG001|Overall Study|Withdrawal by Subject|3|||
147635234|NCT00256854|532482870|FG002|Overall Study|Withdrawal by Subject|0|||
147635235|NCT00256854|532482871|FG003|Overall Study|Withdrawal by Subject|0|||
147635236|NCT00256854|532482872|FG004|Overall Study|Withdrawal by Subject|0|||
147635237|NCT00256854|532482873|FG005|Overall Study|Withdrawal by Subject|0|||
147635238|NCT00256854|532482868|FG000|Overall Study|Lack of Efficacy|1|||
147635239|NCT00256854|532482869|FG001|Overall Study|Lack of Efficacy|0|||
147635240|NCT00256854|532482870|FG002|Overall Study|Lack of Efficacy|0|||
147635241|NCT00256854|532482871|FG003|Overall Study|Lack of Efficacy|0|||
147504009|NCT00476996|531996684|FG003|OLE Phase (From Week 48)|Lack of Efficacy|13|||
147504010|NCT00476996|531996681|FG000|OLE Phase (From Week 48)|Lost to Follow-up|0|||
147504011|NCT00476996|531996682|FG001|OLE Phase (From Week 48)|Lost to Follow-up|0|||
147504012|NCT00476996|531996683|FG002|OLE Phase (From Week 48)|Lost to Follow-up|0|||
147504013|NCT00476996|531996684|FG003|OLE Phase (From Week 48)|Lost to Follow-up|4|||
147504014|NCT00476996|531996681|FG000|OLE Phase (From Week 48)|Non-Compliance with Study Drug|0|||
147504015|NCT00476996|531996682|FG001|OLE Phase (From Week 48)|Non-Compliance with Study Drug|0|||
147504016|NCT00476996|531996683|FG002|OLE Phase (From Week 48)|Non-Compliance with Study Drug|0|||
147504017|NCT00476996|531996684|FG003|OLE Phase (From Week 48)|Non-Compliance with Study Drug|4|||
147504018|NCT00476996|531996681|FG000|OLE Phase (From Week 48)|Early termination of the study|0|||
147504019|NCT00476996|531996682|FG001|OLE Phase (From Week 48)|Early termination of the study|0|||
147504020|NCT00476996|531996683|FG002|OLE Phase (From Week 48)|Early termination of the study|0|||
147504021|NCT00476996|531996684|FG003|OLE Phase (From Week 48)|Early termination of the study|578|||
147504022|NCT01769469|531996691|FG000|Overall Study|Consent Withdrawn|5|||
147504023|NCT01769469|531996691|FG000|Overall Study|Moved Out Of Area|3|||
147504024|NCT01769469|531996691|FG000|Overall Study|Lost to Follow-up|17|||
147504025|NCT01769469|531996691|FG000|Overall Study|Prem D/C from ATN 110/113 For Any Reason|7|||
147504026|NCT01769469|531996691|FG000|Overall Study|Subject Confirmed HIV Positive|3|||
147504027|NCT02447458|531996694|FG000|Overall Study|Other|0|||
147504028|NCT02447458|531996695|FG001|Overall Study|Other|0|||
147504029|NCT02447458|531996696|FG002|Overall Study|Other|1|||
147504030|NCT02447458|531996697|FG003|Overall Study|Other|0|||
147504031|NCT02447458|531996698|FG004|Overall Study|Other|0|||
147504032|NCT02447458|531996699|FG005|Overall Study|Other|0|||
147504033|NCT03148756|531996705|FG000|Overall Study|Study Terminated|0|||
147504034|NCT03148756|531996706|FG001|Overall Study|Study Terminated|1|||
147527307|NCT00594958|532084214|FG002|Overall Study|Withdrawal by Subject|1|||
147527308|NCT00594958|532084212|FG000|Overall Study|Adverse Event|4|||
147527309|NCT00594958|532084213|FG001|Overall Study|Adverse Event|1|||
147527310|NCT00594958|532084214|FG002|Overall Study|Adverse Event|2|||
147527311|NCT00594958|532084212|FG000|Overall Study|Pregnancy|0|||
147527312|NCT00594958|532084213|FG001|Overall Study|Pregnancy|2|||
147527313|NCT00594958|532084214|FG002|Overall Study|Pregnancy|0|||
147527314|NCT00594958|532084212|FG000|Overall Study|Protocol Violation|1|||
147527315|NCT00594958|532084213|FG001|Overall Study|Protocol Violation|0|||
147527316|NCT00594958|532084214|FG002|Overall Study|Protocol Violation|2|||
147527317|NCT00594958|532084212|FG000|Overall Study|Lost to Follow-up|5|||
147527318|NCT00594958|532084213|FG001|Overall Study|Lost to Follow-up|0|||
147527319|NCT00594958|532084214|FG002|Overall Study|Lost to Follow-up|3|||
147527320|NCT00594958|532084212|FG000|Overall Study|administrative|3|||
147527321|NCT00594958|532084213|FG001|Overall Study|administrative|0|||
147527322|NCT00594958|532084214|FG002|Overall Study|administrative|2|||
147527323|NCT01855607|532084225|FG000|Overall Study|Withdrawal by Subject|1|||
147527324|NCT01855607|532084225|FG000|Overall Study|Study was terminated|11|||
147527325|NCT02181634|532084226|FG000|Overall Study|Lack of Efficacy|33|||
147527326|NCT02181634|532084226|FG000|Overall Study|Adverse Event|17|||
147527327|NCT02181634|532084226|FG000|Overall Study|Physician Decision|8|||
147527328|NCT02181634|532084226|FG000|Overall Study|Withdrawal by Subject|5|||
147527329|NCT02181634|532084226|FG000|Overall Study|Death|2|||
147527330|NCT02181634|532084226|FG000|Overall Study|Treatment delayed greater than 4 weeks|3|||
147527331|NCT02181634|532084226|FG000|Overall Study|Ineligible|1|||
147527332|NCT02181634|532084226|FG000|Overall Study|Max number of dose reduction|1|||
147527333|NCT02181634|532084226|FG000|Overall Study|Symptomatic progression|1|||
147527334|NCT02181634|532084226|FG000|Overall Study|Patient opted to proceed to surgery|1|||
147527335|NCT02528331|532084227|FG000|Overall Study|Withdrawal by Subject|2|||
147527336|NCT02392078|532084228|FG000|Overall Study|Did not have procedure|32|||
147527337|NCT02392078|532084229|FG001|Overall Study|Did not have procedure|43|||
147527338|NCT02392078|532084230|FG002|Overall Study|Did not have procedure|20|||
147527339|NCT02392078|532084231|FG003|Overall Study|Did not have procedure|1|||
147527340|NCT02079077|532084232|FG000|Overall Study|Lost to Follow-up|5|||
147527341|NCT02079077|532084233|FG001|Overall Study|Lost to Follow-up|7|||
147527342|NCT02079077|532084232|FG000|Overall Study|Became STIs Positive|1|||
147527343|NCT02079077|532084233|FG001|Overall Study|Became STIs Positive|2|||
147527344|NCT01425268|532084234|FG000|Overall Study|Withdrawal by Subject|2|||
147527345|NCT01425268|532084235|FG001|Overall Study|Withdrawal by Subject|0|||
147527346|NCT01425268|532084234|FG000|Overall Study|Sponsor Decision|5|||
147527347|NCT01425268|532084235|FG001|Overall Study|Sponsor Decision|0|||
147527348|NCT01425268|532084234|FG000|Overall Study|Physician Decision|1|||
147527349|NCT01425268|532084235|FG001|Overall Study|Physician Decision|0|||
147527350|NCT00719706|532084236|FG000|Overall Study|Adverse Event|5|||
147527351|NCT00719706|532084237|FG001|Overall Study|Adverse Event|4|||
147527352|NCT00719706|532084236|FG000|Overall Study|Withdrawal by Subject|1|||
147527353|NCT00719706|532084237|FG001|Overall Study|Withdrawal by Subject|2|||
147527354|NCT00719706|532084236|FG000|Overall Study|Protocol Violation|3|||
147527355|NCT00719706|532084237|FG001|Overall Study|Protocol Violation|0|||
147527356|NCT00682539|532084238|FG000|Bevacizumab vs Triamcinolone|Lost to Follow-up|3|||
147527357|NCT00682539|532084239|FG001|Bevacizumab vs Triamcinolone|Lost to Follow-up|1|||
147635242|NCT00256854|532482872|FG004|Overall Study|Lack of Efficacy|0|||
147635243|NCT00256854|532482873|FG005|Overall Study|Lack of Efficacy|0|||
147635244|NCT00256854|532482868|FG000|Overall Study|Protocol Violation|0|||
147635245|NCT00256854|532482869|FG001|Overall Study|Protocol Violation|1|||
147635246|NCT00256854|532482870|FG002|Overall Study|Protocol Violation|1|||
147635247|NCT00256854|532482871|FG003|Overall Study|Protocol Violation|1|||
147635248|NCT00256854|532482872|FG004|Overall Study|Protocol Violation|0|||
147635249|NCT00256854|532482873|FG005|Overall Study|Protocol Violation|0|||
147635250|NCT00256854|532482868|FG000|Overall Study|Adverse Event|0|||
147635251|NCT00256854|532482869|FG001|Overall Study|Adverse Event|0|||
147635252|NCT00256854|532482870|FG002|Overall Study|Adverse Event|2|||
147635253|NCT00256854|532482871|FG003|Overall Study|Adverse Event|2|||
147635254|NCT00256854|532482872|FG004|Overall Study|Adverse Event|0|||
147635255|NCT00256854|532482873|FG005|Overall Study|Adverse Event|1|||
147635256|NCT00256854|532482868|FG000|Overall Study|Not compliant with the study drug|0|||
147635257|NCT00256854|532482869|FG001|Overall Study|Not compliant with the study drug|0|||
147635258|NCT00256854|532482870|FG002|Overall Study|Not compliant with the study drug|0|||
147635259|NCT00256854|532482871|FG003|Overall Study|Not compliant with the study drug|0|||
147635260|NCT00256854|532482872|FG004|Overall Study|Not compliant with the study drug|1|||
147635261|NCT00256854|532482873|FG005|Overall Study|Not compliant with the study drug|0|||
147635262|NCT02353442|532482874|FG000|Overall Study|Withdrawal by Subject|3|||
147635263|NCT02353442|532482875|FG001|Overall Study|Withdrawal by Subject|4|||
147635264|NCT03990571|532482877|FG000|Overall Study|Withdrawal by Subject|1|||
147635265|NCT03990571|532482877|FG000|Overall Study|Insurance Issues|3|||
147635266|NCT03990571|532482877|FG000|Overall Study|Covid Restrictions|2|||
147635267|NCT03514485|532482878|FG000|Overall Study|Lost to Follow-up|5|||
147635268|NCT03514485|532482879|FG001|Overall Study|Lost to Follow-up|3|||
147635269|NCT03514485|532482880|FG002|Overall Study|Lost to Follow-up|2|||
147635270|NCT03514485|532482881|FG003|Overall Study|Lost to Follow-up|0|||
147635271|NCT03514485|532482882|FG004|Overall Study|Lost to Follow-up|1|||
147635272|NCT03514485|532482883|FG005|Overall Study|Lost to Follow-up|4|||
147635273|NCT03514485|532482878|FG000|Overall Study|Withdrawal by Subject|0|||
147635274|NCT03514485|532482879|FG001|Overall Study|Withdrawal by Subject|1|||
147635275|NCT03514485|532482880|FG002|Overall Study|Withdrawal by Subject|3|||
147635276|NCT03514485|532482881|FG003|Overall Study|Withdrawal by Subject|1|||
147635277|NCT03514485|532482882|FG004|Overall Study|Withdrawal by Subject|2|||
147635278|NCT03514485|532482883|FG005|Overall Study|Withdrawal by Subject|1|||
147635279|NCT03075891|532482885|FG000|Overall Study|Withdrawal by Subject|3|||
147635280|NCT03075891|532482886|FG001|Overall Study|Withdrawal by Subject|6|||
147635281|NCT03075891|532482885|FG000|Overall Study|Lost to Follow-up|1|||
147635282|NCT03075891|532482886|FG001|Overall Study|Lost to Follow-up|0|||
147635283|NCT03075891|532482885|FG000|Overall Study|Pregnancy|3|||
147635284|NCT03075891|532482886|FG001|Overall Study|Pregnancy|1|||
147635285|NCT03075891|532482885|FG000|Overall Study|visits not performed (no time)|1|||
147635286|NCT03075891|532482886|FG001|Overall Study|visits not performed (no time)|0|||
147635287|NCT03075891|532482885|FG000|Overall Study|Drug abuse relapse issue|0|||
147635288|NCT03075891|532482886|FG001|Overall Study|Drug abuse relapse issue|1|||
147635289|NCT03075891|532482885|FG000|Overall Study|Participant requiring study withdrawal|0|||
147635290|NCT03075891|532482886|FG001|Overall Study|Participant requiring study withdrawal|1|||
147635291|NCT03075891|532482885|FG000|Overall Study|Adverse event, non-fatal|1|||
147635292|NCT03075891|532482886|FG001|Overall Study|Adverse event, non-fatal|4|||
147635293|NCT02004886|532482887|FG000|Overall Study|Adverse Event|0|||
147635294|NCT02004886|532482888|FG001|Overall Study|Adverse Event|1|||
147635295|NCT02004886|532482889|FG002|Overall Study|Adverse Event|0|||
147635296|NCT02004886|532482890|FG003|Overall Study|Adverse Event|0|||
147635297|NCT02004886|532482887|FG000|Overall Study|Unable to attend future visits|1|||
147635298|NCT02004886|532482888|FG001|Overall Study|Unable to attend future visits|0|||
147635299|NCT02004886|532482889|FG002|Overall Study|Unable to attend future visits|0|||
147635300|NCT02004886|532482890|FG003|Overall Study|Unable to attend future visits|0|||
147635301|NCT00638443|532482891|FG000|First Intervention|Adverse Event|2|||
147635302|NCT00638443|532482892|FG001|First Intervention|Adverse Event|1|||
147635303|NCT01343277|532482901|FG000|Overall Study|Other|3|||
147635304|NCT01343277|532482902|FG001|Overall Study|Other|3|||
147635305|NCT01343277|532482901|FG000|Overall Study|Withdrawal by Subject|18|||
147635306|NCT01343277|532482902|FG001|Overall Study|Withdrawal by Subject|13|||
147504035|NCT05406440|531998705|FG000|Overall Study|Lost to Follow-up|0|||
147504036|NCT05406440|531998706|FG001|Overall Study|Lost to Follow-up|0|||
147635307|NCT01343277|532482901|FG000|Overall Study|Physician Decision|1|||
147635308|NCT01343277|532482902|FG001|Overall Study|Physician Decision|2|||
147635309|NCT01343277|532482901|FG000|Overall Study|Death|10|||
147635310|NCT01343277|532482902|FG001|Overall Study|Death|1|||
147635311|NCT01343277|532482901|FG000|Overall Study|Adverse Event|67|||
147635312|NCT01343277|532482902|FG001|Overall Study|Adverse Event|13|||
147635313|NCT01343277|532482901|FG000|Overall Study|Disease progression|270|||
147635314|NCT01343277|532482902|FG001|Overall Study|Disease progression|138|||
147635315|NCT01343277|532482901|FG000|Overall Study|Randomized not treated|6|||
147635316|NCT01343277|532482902|FG001|Overall Study|Randomized not treated|21|||
147635317|NCT01343277|532482901|FG000|Overall Study|Treatment ongoing|8|||
147668744|NCT00784875|532613361|FG000|Period B - Efficacy Endpoint|Physician Decision|0|||
147668745|NCT00784875|532613362|FG001|Period B - Efficacy Endpoint|Physician Decision|0|||
147668746|NCT00784875|532613363|FG002|Period B - Efficacy Endpoint|Physician Decision|1|||
147668747|NCT00784875|532613364|FG003|Period B - Efficacy Endpoint|Physician Decision|0|||
147668748|NCT00784875|532613361|FG000|Period B - Efficacy Endpoint|Sponsor Decision|9|||
147668749|NCT00784875|532613362|FG001|Period B - Efficacy Endpoint|Sponsor Decision|6|||
147668750|NCT00784875|532613363|FG002|Period B - Efficacy Endpoint|Sponsor Decision|12|||
147668751|NCT00784875|532613364|FG003|Period B - Efficacy Endpoint|Sponsor Decision|12|||
147668752|NCT00784875|532613361|FG000|Period B - Efficacy Endpoint|Lost to Follow-up|0|||
147668753|NCT00784875|532613362|FG001|Period B - Efficacy Endpoint|Lost to Follow-up|0|||
147668754|NCT00784875|532613363|FG002|Period B - Efficacy Endpoint|Lost to Follow-up|1|||
147668755|NCT00784875|532613364|FG003|Period B - Efficacy Endpoint|Lost to Follow-up|0|||
147668756|NCT00784875|532613361|FG000|Period C|Adverse Event|1|||
147668757|NCT00784875|532613362|FG001|Period C|Adverse Event|0|||
147668758|NCT00784875|532613363|FG002|Period C|Adverse Event|4|||
147668759|NCT00784875|532613364|FG003|Period C|Adverse Event|2|||
147668760|NCT00784875|532613361|FG000|Period C|Protocol Violation|0|||
147668761|NCT00784875|532613362|FG001|Period C|Protocol Violation|0|||
147668762|NCT00784875|532613363|FG002|Period C|Protocol Violation|1|||
147668763|NCT00784875|532613364|FG003|Period C|Protocol Violation|2|||
147668764|NCT00784875|532613361|FG000|Period C|Lack of Efficacy|0|||
147668765|NCT00784875|532613362|FG001|Period C|Lack of Efficacy|0|||
147668766|NCT00784875|532613363|FG002|Period C|Lack of Efficacy|1|||
147668767|NCT00784875|532613364|FG003|Period C|Lack of Efficacy|0|||
147668768|NCT00784875|532613361|FG000|Period C|Withdrawal by Subject|1|||
147668769|NCT00784875|532613362|FG001|Period C|Withdrawal by Subject|1|||
147668770|NCT00784875|532613363|FG002|Period C|Withdrawal by Subject|2|||
147668771|NCT00784875|532613364|FG003|Period C|Withdrawal by Subject|0|||
147668772|NCT00784875|532613361|FG000|Period C|Physician Decision|0|||
147668773|NCT00784875|532613362|FG001|Period C|Physician Decision|0|||
147668774|NCT00784875|532613363|FG002|Period C|Physician Decision|1|||
147668775|NCT00784875|532613364|FG003|Period C|Physician Decision|1|||
147668776|NCT00784875|532613361|FG000|Period C|Sponsor Decision|5|||
147668777|NCT00784875|532613362|FG001|Period C|Sponsor Decision|5|||
147668778|NCT00784875|532613363|FG002|Period C|Sponsor Decision|4|||
147668779|NCT00784875|532613364|FG003|Period C|Sponsor Decision|2|||
147668780|NCT00784875|532613361|FG000|Period D|Adverse Event|0|||
147668781|NCT00784875|532613362|FG001|Period D|Adverse Event|2|||
147668782|NCT00784875|532613363|FG002|Period D|Adverse Event|2|||
147668783|NCT00784875|532613364|FG003|Period D|Adverse Event|0|||
147668784|NCT00784875|532613361|FG000|Period D|Protocol Violation|1|||
147668785|NCT00784875|532613362|FG001|Period D|Protocol Violation|0|||
147668786|NCT00784875|532613363|FG002|Period D|Protocol Violation|0|||
147668787|NCT00784875|532613364|FG003|Period D|Protocol Violation|0|||
147668788|NCT00784875|532613361|FG000|Period D|Withdrawal by Subject|2|||
147668789|NCT00784875|532613362|FG001|Period D|Withdrawal by Subject|0|||
147668790|NCT00784875|532613363|FG002|Period D|Withdrawal by Subject|2|||
147668791|NCT00784875|532613364|FG003|Period D|Withdrawal by Subject|0|||
147668792|NCT00784875|532613361|FG000|Period D|Physician Decision|0|||
147668793|NCT00784875|532613362|FG001|Period D|Physician Decision|1|||
147668794|NCT00784875|532613363|FG002|Period D|Physician Decision|0|||
147635318|NCT01343277|532482902|FG001|Overall Study|Treatment ongoing|2|||
147635319|NCT01343277|532482901|FG000|Overall Study|Subsequent anticancer therapy|1|||
147635320|NCT01343277|532482902|FG001|Overall Study|Subsequent anticancer therapy|0|||
147635321|NCT01894100|532482903|FG000|Overall Study|Lost to Follow-up|0|||
147635322|NCT01894100|532482904|FG001|Overall Study|Lost to Follow-up|1|||
147635323|NCT01894100|532482903|FG000|Overall Study|Withdrawal by Subject|3|||
147635324|NCT01894100|532482904|FG001|Overall Study|Withdrawal by Subject|0|||
147635325|NCT01094301|532482905|FG000|Trial Stage|Withdrawal by Subject|1|||
147635326|NCT01094301|532482905|FG000|Implant Stage|Adverse Event|1|||
147635327|NCT01094301|532482905|FG000|Implant Stage|Protocol Violation|1|||
147635328|NCT01094301|532482905|FG000|Implant Stage|Withdrawal by Subject|2|||
147668795|NCT00784875|532613364|FG003|Period D|Physician Decision|0|||
147668796|NCT00784875|532613361|FG000|Period D|Sponsor Decision|1|||
147668797|NCT00784875|532613362|FG001|Period D|Sponsor Decision|1|||
147668798|NCT00784875|532613363|FG002|Period D|Sponsor Decision|1|||
147635329|NCT01094301|532482905|FG000|Implant Stage|No return of pain|4|||
147668799|NCT00784875|532613364|FG003|Period D|Sponsor Decision|0|||
147668800|NCT00784875|532613361|FG000|Period D|Lost to Follow-up|1|||
147635330|NCT00135512|532482906|FG000|Overall Study|Adverse Event|56|||
147635331|NCT00135512|532482906|FG000|Overall Study|Lack of Efficacy|25|||
147668801|NCT00784875|532613362|FG001|Period D|Lost to Follow-up|0|||
147668802|NCT00784875|532613363|FG002|Period D|Lost to Follow-up|1|||
147668803|NCT00784875|532613364|FG003|Period D|Lost to Follow-up|1|||
147668804|NCT00853385|532613365|FG000|Overall Study|Death|0|||
147668805|NCT00853385|532613366|FG001|Overall Study|Death|0|||
147668806|NCT00853385|532613367|FG002|Overall Study|Death|0|||
147668807|NCT00853385|532613368|FG003|Overall Study|Death|0|||
147668808|NCT00853385|532613369|FG004|Overall Study|Death|1|||
147668809|NCT00853385|532613365|FG000|Overall Study|Adverse Event|24|||
147668810|NCT00853385|532613366|FG001|Overall Study|Adverse Event|24|||
147635332|NCT00135512|532482906|FG000|Overall Study|Other|42|||
147635333|NCT04013672|532482908|FG000|Overall Study|Withdrawal by Subject|3|||
147635334|NCT04013672|532482909|FG001|Overall Study|Withdrawal by Subject|0|||
147635335|NCT04013672|532482908|FG000|Overall Study|Death|1|||
147635336|NCT04013672|532482909|FG001|Overall Study|Death|0|||
147635337|NCT04013672|532482908|FG000|Overall Study|Physician Decision|5|||
147635338|NCT04013672|532482909|FG001|Overall Study|Physician Decision|0|||
147635339|NCT00430573|532482910|FG000|Overall Study|Withdrawal by Subject|5|||
147635340|NCT04740827|532482913|FG000|Double-blind Treatment (Up to Week 12)|Adverse Event|2|||
147635341|NCT04740827|532482914|FG001|Double-blind Treatment (Up to Week 12)|Adverse Event|4|||
147635342|NCT04740827|532482913|FG000|Double-blind Treatment (Up to Week 12)|Lack of Efficacy|0|||
147635343|NCT04740827|532482914|FG001|Double-blind Treatment (Up to Week 12)|Lack of Efficacy|1|||
147635344|NCT04740827|532482913|FG000|Double-blind Treatment (Up to Week 12)|Withdrawal by Subject|2|||
147635345|NCT04740827|532482914|FG001|Double-blind Treatment (Up to Week 12)|Withdrawal by Subject|2|||
147635346|NCT04740827|532482913|FG000|Double-blind Treatment (Up to Week 12)|Pregnancy|0|||
147635347|NCT04740827|532482914|FG001|Double-blind Treatment (Up to Week 12)|Pregnancy|1|||
147635348|NCT04740827|532482913|FG000|Double-blind Treatment (Up to Week 12)|Protocol Deviation|3|||
147635349|NCT04740827|532482914|FG001|Double-blind Treatment (Up to Week 12)|Protocol Deviation|5|||
147635350|NCT04740827|532482913|FG000|Follow-up Period (Week 13 to Week 16)|Withdrawal by Subject|1|||
147635351|NCT04740827|532482914|FG001|Follow-up Period (Week 13 to Week 16)|Withdrawal by Subject|0|||
147635352|NCT02147158|532482915|FG000|Treatment Course 1|Adverse Event|1|||
147635353|NCT02147158|532482916|FG001|Treatment Course 1|Adverse Event|4|||
147635354|NCT02147158|532482917|FG002|Treatment Course 1|Adverse Event|3|||
147635355|NCT02147158|532482918|FG003|Treatment Course 1|Adverse Event|4|||
147635356|NCT02147158|532482919|FG004|Treatment Course 1|Adverse Event|1|||
147635357|NCT02147158|532482920|FG005|Treatment Course 1|Adverse Event|2|||
147635358|NCT02147158|532482915|FG000|Treatment Course 1|Lost to Follow-up|2|||
147635359|NCT02147158|532482916|FG001|Treatment Course 1|Lost to Follow-up|4|||
147635360|NCT02147158|532482917|FG002|Treatment Course 1|Lost to Follow-up|3|||
147635361|NCT02147158|532482918|FG003|Treatment Course 1|Lost to Follow-up|3|||
147635362|NCT02147158|532482919|FG004|Treatment Course 1|Lost to Follow-up|2|||
147635363|NCT02147158|532482920|FG005|Treatment Course 1|Lost to Follow-up|4|||
147635364|NCT02147158|532482915|FG000|Treatment Course 1|Protocol Violation|0|||
147635365|NCT02147158|532482916|FG001|Treatment Course 1|Protocol Violation|0|||
147635366|NCT02147158|532482917|FG002|Treatment Course 1|Protocol Violation|1|||
147635367|NCT02147158|532482918|FG003|Treatment Course 1|Protocol Violation|1|||
147635368|NCT02147158|532482919|FG004|Treatment Course 1|Protocol Violation|0|||
147635369|NCT02147158|532482920|FG005|Treatment Course 1|Protocol Violation|0|||
147635370|NCT02147158|532482915|FG000|Treatment Course 1|Withdrawal of Consent|1|||
147635371|NCT02147158|532482916|FG001|Treatment Course 1|Withdrawal of Consent|1|||
147635372|NCT02147158|532482917|FG002|Treatment Course 1|Withdrawal of Consent|1|||
147635373|NCT02147158|532482918|FG003|Treatment Course 1|Withdrawal of Consent|5|||
147635374|NCT02147158|532482919|FG004|Treatment Course 1|Withdrawal of Consent|3|||
147635375|NCT02147158|532482920|FG005|Treatment Course 1|Withdrawal of Consent|2|||
147635376|NCT02147158|532482915|FG000|Off-Treatment Interval 1|Adverse Event|1|||
147635377|NCT02147158|532482916|FG001|Off-Treatment Interval 1|Adverse Event|0|||
147635378|NCT02147158|532482917|FG002|Off-Treatment Interval 1|Adverse Event|0|||
147635379|NCT02147158|532482918|FG003|Off-Treatment Interval 1|Adverse Event|1|||
147635380|NCT02147158|532482919|FG004|Off-Treatment Interval 1|Adverse Event|0|||
147635381|NCT02147158|532482920|FG005|Off-Treatment Interval 1|Adverse Event|0|||
147635382|NCT02147158|532482915|FG000|Off-Treatment Interval 1|Lost to Follow-up|2|||
147635383|NCT02147158|532482916|FG001|Off-Treatment Interval 1|Lost to Follow-up|1|||
147635384|NCT02147158|532482917|FG002|Off-Treatment Interval 1|Lost to Follow-up|3|||
147635385|NCT02147158|532482918|FG003|Off-Treatment Interval 1|Lost to Follow-up|2|||
147635386|NCT02147158|532482919|FG004|Off-Treatment Interval 1|Lost to Follow-up|4|||
147635387|NCT02147158|532482920|FG005|Off-Treatment Interval 1|Lost to Follow-up|2|||
147635388|NCT02147158|532482915|FG000|Off-Treatment Interval 1|Protocol Violation|1|||
147635389|NCT02147158|532482916|FG001|Off-Treatment Interval 1|Protocol Violation|0|||
147668811|NCT00853385|532613367|FG002|Overall Study|Adverse Event|2|||
147668812|NCT00853385|532613368|FG003|Overall Study|Adverse Event|5|||
147668813|NCT00853385|532613369|FG004|Overall Study|Adverse Event|22|||
147668814|NCT00853385|532613365|FG000|Overall Study|Lack of Efficacy|6|||
147668815|NCT00853385|532613366|FG001|Overall Study|Lack of Efficacy|7|||
147668816|NCT00853385|532613367|FG002|Overall Study|Lack of Efficacy|3|||
147668817|NCT00853385|532613368|FG003|Overall Study|Lack of Efficacy|3|||
147635390|NCT02147158|532482917|FG002|Off-Treatment Interval 1|Protocol Violation|2|||
147635391|NCT02147158|532482918|FG003|Off-Treatment Interval 1|Protocol Violation|0|||
147635392|NCT02147158|532482919|FG004|Off-Treatment Interval 1|Protocol Violation|1|||
147635393|NCT02147158|532482920|FG005|Off-Treatment Interval 1|Protocol Violation|0|||
147635394|NCT02147158|532482915|FG000|Off-Treatment Interval 1|Withdrawal of Consent|4|||
147504037|NCT05406440|531998707|FG002|Overall Study|Lost to Follow-up|0|||
147635395|NCT02147158|532482916|FG001|Off-Treatment Interval 1|Withdrawal of Consent|3|||
147635396|NCT02147158|532482917|FG002|Off-Treatment Interval 1|Withdrawal of Consent|5|||
147668818|NCT00853385|532613369|FG004|Overall Study|Lack of Efficacy|6|||
147635397|NCT02147158|532482918|FG003|Off-Treatment Interval 1|Withdrawal of Consent|10|||
147635398|NCT02147158|532482919|FG004|Off-Treatment Interval 1|Withdrawal of Consent|2|||
147635399|NCT02147158|532482920|FG005|Off-Treatment Interval 1|Withdrawal of Consent|3|||
147635400|NCT02147158|532482915|FG000|Off-Treatment Interval 1|Lack of Efficacy|0|||
147635401|NCT02147158|532482916|FG001|Off-Treatment Interval 1|Lack of Efficacy|0|||
147635402|NCT02147158|532482917|FG002|Off-Treatment Interval 1|Lack of Efficacy|2|||
147635403|NCT02147158|532482918|FG003|Off-Treatment Interval 1|Lack of Efficacy|0|||
147635404|NCT02147158|532482919|FG004|Off-Treatment Interval 1|Lack of Efficacy|1|||
147635405|NCT02147158|532482920|FG005|Off-Treatment Interval 1|Lack of Efficacy|0|||
147635406|NCT02147158|532482915|FG000|Off-Treatment Interval 1|Other Miscellaneous Reasons|2|||
147635407|NCT02147158|532482916|FG001|Off-Treatment Interval 1|Other Miscellaneous Reasons|0|||
147635408|NCT02147158|532482917|FG002|Off-Treatment Interval 1|Other Miscellaneous Reasons|3|||
147635409|NCT02147158|532482918|FG003|Off-Treatment Interval 1|Other Miscellaneous Reasons|2|||
147635410|NCT02147158|532482919|FG004|Off-Treatment Interval 1|Other Miscellaneous Reasons|0|||
147635411|NCT02147158|532482920|FG005|Off-Treatment Interval 1|Other Miscellaneous Reasons|0|||
147635412|NCT02147158|532482915|FG000|Treatment Course 2|Adverse Event|0|||
147635413|NCT02147158|532482916|FG001|Treatment Course 2|Adverse Event|4|||
147635414|NCT02147158|532482917|FG002|Treatment Course 2|Adverse Event|2|||
147635415|NCT02147158|532482918|FG003|Treatment Course 2|Adverse Event|1|||
147635416|NCT02147158|532482919|FG004|Treatment Course 2|Adverse Event|0|||
147635417|NCT02147158|532482920|FG005|Treatment Course 2|Adverse Event|1|||
147635418|NCT02147158|532482915|FG000|Treatment Course 2|Withdrawal of Consent|0|||
147635419|NCT02147158|532482916|FG001|Treatment Course 2|Withdrawal of Consent|1|||
147635420|NCT02147158|532482917|FG002|Treatment Course 2|Withdrawal of Consent|2|||
147635421|NCT02147158|532482918|FG003|Treatment Course 2|Withdrawal of Consent|3|||
147635422|NCT02147158|532482919|FG004|Treatment Course 2|Withdrawal of Consent|0|||
147635423|NCT02147158|532482920|FG005|Treatment Course 2|Withdrawal of Consent|0|||
147635424|NCT02147158|532482915|FG000|Treatment Course 2|Lost to Follow-up|1|||
147635425|NCT02147158|532482916|FG001|Treatment Course 2|Lost to Follow-up|0|||
147635426|NCT02147158|532482917|FG002|Treatment Course 2|Lost to Follow-up|1|||
147635427|NCT02147158|532482918|FG003|Treatment Course 2|Lost to Follow-up|1|||
147635428|NCT02147158|532482919|FG004|Treatment Course 2|Lost to Follow-up|0|||
147635429|NCT02147158|532482920|FG005|Treatment Course 2|Lost to Follow-up|1|||
147635430|NCT02147158|532482915|FG000|Off-Treatment Interval 2|Lack of Efficacy|0|||
147635431|NCT02147158|532482916|FG001|Off-Treatment Interval 2|Lack of Efficacy|1|||
147635432|NCT02147158|532482917|FG002|Off-Treatment Interval 2|Lack of Efficacy|1|||
147635433|NCT02147158|532482918|FG003|Off-Treatment Interval 2|Lack of Efficacy|0|||
147635434|NCT02147158|532482919|FG004|Off-Treatment Interval 2|Lack of Efficacy|0|||
147635435|NCT02147158|532482920|FG005|Off-Treatment Interval 2|Lack of Efficacy|0|||
147635436|NCT02147158|532482915|FG000|Off-Treatment Interval 2|Withdrawal of Consent|4|||
147635437|NCT02147158|532482916|FG001|Off-Treatment Interval 2|Withdrawal of Consent|0|||
147635438|NCT02147158|532482917|FG002|Off-Treatment Interval 2|Withdrawal of Consent|5|||
147635439|NCT02147158|532482918|FG003|Off-Treatment Interval 2|Withdrawal of Consent|4|||
147635440|NCT02147158|532482919|FG004|Off-Treatment Interval 2|Withdrawal of Consent|0|||
147635441|NCT02147158|532482920|FG005|Off-Treatment Interval 2|Withdrawal of Consent|1|||
147635442|NCT02147158|532482915|FG000|Off-Treatment Interval 2|Lost to Follow-up|0|||
147635443|NCT02147158|532482916|FG001|Off-Treatment Interval 2|Lost to Follow-up|0|||
147635444|NCT02147158|532482917|FG002|Off-Treatment Interval 2|Lost to Follow-up|3|||
147635445|NCT02147158|532482918|FG003|Off-Treatment Interval 2|Lost to Follow-up|2|||
147668819|NCT00853385|532613365|FG000|Overall Study|Lost to Follow-up|2|||
147668820|NCT00853385|532613366|FG001|Overall Study|Lost to Follow-up|1|||
147504038|NCT05406440|531998708|FG003|Overall Study|Lost to Follow-up|0|||
147504039|NCT05406440|531998709|FG004|Overall Study|Lost to Follow-up|2|||
147504040|NCT05406440|531998710|FG005|Overall Study|Lost to Follow-up|0|||
147504041|NCT05406440|531998711|FG006|Overall Study|Lost to Follow-up|0|||
147504042|NCT05406440|531998705|FG000|Overall Study|Physician Decision|0|||
147504043|NCT05406440|531998706|FG001|Overall Study|Physician Decision|0|||
147504044|NCT05406440|531998707|FG002|Overall Study|Physician Decision|0|||
147504045|NCT05406440|531998708|FG003|Overall Study|Physician Decision|0|||
147504046|NCT05406440|531998709|FG004|Overall Study|Physician Decision|1|||
147504047|NCT05406440|531998710|FG005|Overall Study|Physician Decision|0|||
147504048|NCT05406440|531998711|FG006|Overall Study|Physician Decision|0|||
147504049|NCT05406440|531998705|FG000|Overall Study|Withdrawal by Subject|0|||
147504050|NCT05406440|531998706|FG001|Overall Study|Withdrawal by Subject|0|||
147635446|NCT02147158|532482919|FG004|Off-Treatment Interval 2|Lost to Follow-up|2|||
147635447|NCT02147158|532482920|FG005|Off-Treatment Interval 2|Lost to Follow-up|2|||
147635448|NCT02147158|532482915|FG000|Off-Treatment Interval 2|Protocol Violation|0|||
147635449|NCT02147158|532482916|FG001|Off-Treatment Interval 2|Protocol Violation|0|||
147635450|NCT02147158|532482917|FG002|Off-Treatment Interval 2|Protocol Violation|0|||
147635451|NCT02147158|532482918|FG003|Off-Treatment Interval 2|Protocol Violation|1|||
147635452|NCT02147158|532482919|FG004|Off-Treatment Interval 2|Protocol Violation|0|||
147668821|NCT00853385|532613367|FG002|Overall Study|Lost to Follow-up|0|||
147504051|NCT05406440|531998707|FG002|Overall Study|Withdrawal by Subject|0|||
147504052|NCT05406440|531998708|FG003|Overall Study|Withdrawal by Subject|0|||
147504053|NCT05406440|531998709|FG004|Overall Study|Withdrawal by Subject|0|||
147504054|NCT05406440|531998710|FG005|Overall Study|Withdrawal by Subject|2|||
147504055|NCT05406440|531998711|FG006|Overall Study|Withdrawal by Subject|0|||
147635453|NCT02147158|532482920|FG005|Off-Treatment Interval 2|Protocol Violation|0|||
147635454|NCT02147158|532482915|FG000|Off-Treatment Interval 2|Other Miscellaneous Reasons|0|||
147635455|NCT02147158|532482916|FG001|Off-Treatment Interval 2|Other Miscellaneous Reasons|3|||
147635456|NCT02147158|532482917|FG002|Off-Treatment Interval 2|Other Miscellaneous Reasons|1|||
147635457|NCT02147158|532482918|FG003|Off-Treatment Interval 2|Other Miscellaneous Reasons|4|||
147635458|NCT02147158|532482919|FG004|Off-Treatment Interval 2|Other Miscellaneous Reasons|0|||
147635459|NCT02147158|532482920|FG005|Off-Treatment Interval 2|Other Miscellaneous Reasons|1|||
147635460|NCT03425396|532482921|FG000|Overall Study|Lost to Follow-up|2|||
147635461|NCT03425396|532482922|FG001|Overall Study|Lost to Follow-up|5|||
147635462|NCT03425396|532482923|FG002|Overall Study|Lost to Follow-up|2|||
147635463|NCT03425396|532482924|FG003|Overall Study|Lost to Follow-up|0|||
147635464|NCT03425396|532482925|FG004|Overall Study|Lost to Follow-up|0|||
147635465|NCT03425396|532482921|FG000|Overall Study|Withdrawal by Subject|0|||
147635466|NCT03425396|532482922|FG001|Overall Study|Withdrawal by Subject|1|||
147635467|NCT03425396|532482923|FG002|Overall Study|Withdrawal by Subject|0|||
147635468|NCT03425396|532482924|FG003|Overall Study|Withdrawal by Subject|1|||
147635469|NCT03425396|532482925|FG004|Overall Study|Withdrawal by Subject|0|||
147635470|NCT03425396|532482921|FG000|Overall Study|Other|0|||
147635471|NCT03425396|532482922|FG001|Overall Study|Other|1|||
147635472|NCT03425396|532482923|FG002|Overall Study|Other|1|||
147635473|NCT03425396|532482924|FG003|Overall Study|Other|0|||
147635474|NCT03425396|532482925|FG004|Overall Study|Other|1|||
147635475|NCT03033602|532482926|FG000|Overall Study|Withdrawal by Subject|11|||
147635476|NCT03033602|532482927|FG001|Overall Study|Withdrawal by Subject|21|||
147635477|NCT03033602|532482926|FG000|Overall Study|discontinued for medical reason or decision by study team|9|||
147635478|NCT03033602|532482927|FG001|Overall Study|discontinued for medical reason or decision by study team|16|||
147635479|NCT01441765|532482928|FG000|Overall Study|Death|1|||
147635480|NCT01441765|532482929|FG001|Overall Study|Death|0|||
147635481|NCT00940823|532482930|FG000|Overall Study|Death|8|||
147635482|NCT00940823|532482931|FG001|Overall Study|Death|12|||
147635483|NCT00940823|532482930|FG000|Overall Study|Lost to Follow-up|27|||
147635484|NCT00940823|532482931|FG001|Overall Study|Lost to Follow-up|20|||
147635485|NCT01082211|532482934|FG000|Overall Study|Protocol Violation|4|||
147635486|NCT01082211|532482934|FG000|Overall Study|No protocol treatment received|3|||
147635487|NCT04999163|532482935|FG000|Overall Study|Surgery completed at hospital not participating in the study.|1|||
147635488|NCT04999163|532482936|FG001|Overall Study|Surgery completed at hospital not participating in the study.|0|||
147635489|NCT04999163|532482935|FG000|Overall Study|Study enrollment stopped prior to implant.|1|||
147635490|NCT04999163|532482936|FG001|Overall Study|Study enrollment stopped prior to implant.|0|||
147635491|NCT04999163|532482935|FG000|Overall Study|Withdrawal by Subject|1|||
147635492|NCT04999163|532482936|FG001|Overall Study|Withdrawal by Subject|0|||
147635493|NCT01106677|532485175|FG000|Core Period: Baseline to Week 26|Adverse Event|7|||
147635494|NCT01106677|532485176|FG001|Core Period: Baseline to Week 26|Adverse Event|18|||
147635495|NCT01106677|532485177|FG002|Core Period: Baseline to Week 26|Adverse Event|6|||
147635496|NCT01106677|532485178|FG003|Core Period: Baseline to Week 26|Adverse Event|8|||
147635497|NCT01106677|532485175|FG000|Core Period: Baseline to Week 26|Death|0|||
147504056|NCT02088541|531998712|FG000|Overall Study|Adverse Event|3|||
147504057|NCT02088541|531998713|FG001|Overall Study|Adverse Event|0|||
147504058|NCT02088541|531998714|FG002|Overall Study|Adverse Event|3|||
147504059|NCT02088541|531998715|FG003|Overall Study|Adverse Event|3|||
147504060|NCT02088541|531998716|FG004|Overall Study|Adverse Event|0|||
147504061|NCT02088541|531998712|FG000|Overall Study|Death|51|||
147504062|NCT02088541|531998713|FG001|Overall Study|Death|21|||
147504063|NCT02088541|531998714|FG002|Overall Study|Death|85|||
147504064|NCT02088541|531998715|FG003|Overall Study|Death|28|||
147504065|NCT02088541|531998716|FG004|Overall Study|Death|38|||
147504066|NCT02088541|531998712|FG000|Overall Study|Lost to Follow-up|2|||
147504067|NCT02088541|531998713|FG001|Overall Study|Lost to Follow-up|0|||
147504068|NCT02088541|531998714|FG002|Overall Study|Lost to Follow-up|1|||
147504069|NCT02088541|531998715|FG003|Overall Study|Lost to Follow-up|0|||
147504070|NCT02088541|531998716|FG004|Overall Study|Lost to Follow-up|0|||
147504071|NCT02088541|531998712|FG000|Overall Study|Physician Decision|2|||
147504072|NCT02088541|531998713|FG001|Overall Study|Physician Decision|1|||
147504073|NCT02088541|531998714|FG002|Overall Study|Physician Decision|2|||
147504074|NCT02088541|531998715|FG003|Overall Study|Physician Decision|0|||
147504075|NCT02088541|531998716|FG004|Overall Study|Physician Decision|2|||
147635498|NCT01106677|532485176|FG001|Core Period: Baseline to Week 26|Death|0|||
147668822|NCT00853385|532613368|FG003|Overall Study|Lost to Follow-up|0|||
147635499|NCT01106677|532485177|FG002|Core Period: Baseline to Week 26|Death|1|||
147504076|NCT02088541|531998712|FG000|Overall Study|Disease progression|7|||
147504077|NCT02088541|531998713|FG001|Overall Study|Disease progression|1|||
147635500|NCT01106677|532485178|FG003|Core Period: Baseline to Week 26|Death|0|||
147668823|NCT00853385|532613369|FG004|Overall Study|Lost to Follow-up|0|||
147504078|NCT02088541|531998714|FG002|Overall Study|Disease progression|2|||
147504079|NCT02088541|531998715|FG003|Overall Study|Disease progression|3|||
147504080|NCT02088541|531998716|FG004|Overall Study|Disease progression|1|||
147504081|NCT02088541|531998712|FG000|Overall Study|Study terminated by sponsor|1|||
147504082|NCT02088541|531998713|FG001|Overall Study|Study terminated by sponsor|1|||
147504083|NCT02088541|531998714|FG002|Overall Study|Study terminated by sponsor|12|||
147504084|NCT02088541|531998715|FG003|Overall Study|Study terminated by sponsor|2|||
147504085|NCT02088541|531998716|FG004|Overall Study|Study terminated by sponsor|6|||
147504086|NCT02088541|531998712|FG000|Overall Study|Withdrawal by Subject|3|||
147504087|NCT02088541|531998713|FG001|Overall Study|Withdrawal by Subject|2|||
147504088|NCT02088541|531998714|FG002|Overall Study|Withdrawal by Subject|9|||
147504089|NCT02088541|531998715|FG003|Overall Study|Withdrawal by Subject|7|||
147504090|NCT02088541|531998716|FG004|Overall Study|Withdrawal by Subject|10|||
147504091|NCT02088541|531998712|FG000|Overall Study|Other|2|||
147504092|NCT02088541|531998713|FG001|Overall Study|Other|1|||
147504093|NCT02088541|531998714|FG002|Overall Study|Other|3|||
147504094|NCT02088541|531998715|FG003|Overall Study|Other|1|||
147504095|NCT02088541|531998716|FG004|Overall Study|Other|1|||
147504096|NCT05742841|531998717|FG000|Overall Study|Withdrawal by Subject|1|||
147504097|NCT05742841|531998717|FG000|Overall Study|Lost to Follow-up|1|||
147504098|NCT04134728|531998718|FG000|Overall Study|Adverse Event|3|||
147504099|NCT04134728|531998719|FG001|Overall Study|Adverse Event|2|||
147504100|NCT04134728|531998720|FG002|Overall Study|Adverse Event|9|||
147504101|NCT04134728|531998721|FG003|Overall Study|Adverse Event|0|||
147504102|NCT04134728|531998722|FG004|Overall Study|Adverse Event|0|||
147504103|NCT04134728|531998723|FG005|Overall Study|Adverse Event|0|||
147504104|NCT04134728|531998718|FG000|Overall Study|Lack of Efficacy|3|||
147504105|NCT04134728|531998719|FG001|Overall Study|Lack of Efficacy|3|||
147504106|NCT04134728|531998720|FG002|Overall Study|Lack of Efficacy|1|||
147504107|NCT04134728|531998721|FG003|Overall Study|Lack of Efficacy|2|||
147504108|NCT04134728|531998722|FG004|Overall Study|Lack of Efficacy|0|||
147504109|NCT04134728|531998723|FG005|Overall Study|Lack of Efficacy|0|||
147504110|NCT04134728|531998718|FG000|Overall Study|Protocol-Specified Withdrawal Criterion Met|1|||
147504111|NCT04134728|531998719|FG001|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
147504112|NCT04134728|531998720|FG002|Overall Study|Protocol-Specified Withdrawal Criterion Met|2|||
147504113|NCT04134728|531998721|FG003|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
147504114|NCT04134728|531998722|FG004|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
147504115|NCT04134728|531998723|FG005|Overall Study|Protocol-Specified Withdrawal Criterion Met|0|||
147504116|NCT04134728|531998718|FG000|Overall Study|Protocol Deviation|0|||
147504117|NCT04134728|531998719|FG001|Overall Study|Protocol Deviation|0|||
147504118|NCT04134728|531998720|FG002|Overall Study|Protocol Deviation|1|||
147504119|NCT04134728|531998721|FG003|Overall Study|Protocol Deviation|0|||
147504120|NCT04134728|531998722|FG004|Overall Study|Protocol Deviation|0|||
147504121|NCT04134728|531998723|FG005|Overall Study|Protocol Deviation|0|||
147668824|NCT00853385|532613365|FG000|Overall Study|Withdrawal by Subject|4|||
147668825|NCT00853385|532613366|FG001|Overall Study|Withdrawal by Subject|2|||
147668826|NCT00853385|532613367|FG002|Overall Study|Withdrawal by Subject|0|||
147668827|NCT00853385|532613368|FG003|Overall Study|Withdrawal by Subject|1|||
147668828|NCT00853385|532613369|FG004|Overall Study|Withdrawal by Subject|1|||
147668829|NCT00853385|532613365|FG000|Overall Study|Other|18|||
147668830|NCT00853385|532613366|FG001|Overall Study|Other|9|||
147668831|NCT00853385|532613367|FG002|Overall Study|Other|4|||
147668832|NCT00853385|532613368|FG003|Overall Study|Other|4|||
147668833|NCT00853385|532613369|FG004|Overall Study|Other|12|||
147668834|NCT00941928|532613376|FG000|Overall Study|Withdrawal by Subject|1|||
147668835|NCT00941928|532613376|FG000|Overall Study|Disease Progression|1|||
147668836|NCT02300610|532613379|FG000|Overall Study|Withdrawal by Subject|1|||
147668837|NCT02300610|532613380|FG001|Overall Study|Withdrawal by Subject|0|||
147668838|NCT02300610|532613381|FG002|Overall Study|Withdrawal by Subject|1|||
147668839|NCT04018066|532613382|FG000|Overall Study|participants started taking medications during the study period|3|||
147668840|NCT04018066|532613382|FG000|Overall Study|participant dropped out due to schedule conflicts.|1|||
147668841|NCT02515227|532613386|FG000|Overall Study|Adverse Event|0|||
147668842|NCT02515227|532613387|FG001|Overall Study|Adverse Event|2|||
147668843|NCT02515227|532613386|FG000|Overall Study|Progressive disease|2|||
147668844|NCT02515227|532613387|FG001|Overall Study|Progressive disease|9|||
147504122|NCT04134728|531998718|FG000|Overall Study|Informed Consent Withdrawn|3|||
147504123|NCT04134728|531998719|FG001|Overall Study|Informed Consent Withdrawn|6|||
147504124|NCT04134728|531998720|FG002|Overall Study|Informed Consent Withdrawn|8|||
147504125|NCT04134728|531998721|FG003|Overall Study|Informed Consent Withdrawn|1|||
147504126|NCT04134728|531998722|FG004|Overall Study|Informed Consent Withdrawn|1|||
147668845|NCT03451071|532613390|FG000|First Vaccine|Withdrawal by Subject|1|||
147668846|NCT03451071|532613390|FG000|Second Vaccine|Lost to Follow-up|19|||
147668847|NCT03451071|532613390|FG000|Third Vaccine|Lost to Follow-up|22|||
147504127|NCT04134728|531998723|FG005|Overall Study|Informed Consent Withdrawn|0|||
147504128|NCT04134728|531998718|FG000|Overall Study|Physician Decision|2|||
147504129|NCT04134728|531998719|FG001|Overall Study|Physician Decision|0|||
147504130|NCT04134728|531998720|FG002|Overall Study|Physician Decision|0|||
147504131|NCT04134728|531998721|FG003|Overall Study|Physician Decision|0|||
147504132|NCT04134728|531998722|FG004|Overall Study|Physician Decision|0|||
147504133|NCT04134728|531998723|FG005|Overall Study|Physician Decision|0|||
147504134|NCT04134728|531998718|FG000|Overall Study|Lost to Follow-up|1|||
147504135|NCT04134728|531998719|FG001|Overall Study|Lost to Follow-up|2|||
147504136|NCT04134728|531998720|FG002|Overall Study|Lost to Follow-up|1|||
147504137|NCT04134728|531998721|FG003|Overall Study|Lost to Follow-up|0|||
147504138|NCT04134728|531998722|FG004|Overall Study|Lost to Follow-up|0|||
147504139|NCT04134728|531998723|FG005|Overall Study|Lost to Follow-up|1|||
147504140|NCT04134728|531998718|FG000|Overall Study|Investigator Site Closed|0|||
147504141|NCT04134728|531998719|FG001|Overall Study|Investigator Site Closed|1|||
147504142|NCT04134728|531998720|FG002|Overall Study|Investigator Site Closed|1|||
147504143|NCT04134728|531998721|FG003|Overall Study|Investigator Site Closed|0|||
147504144|NCT04134728|531998722|FG004|Overall Study|Investigator Site Closed|0|||
147504145|NCT04134728|531998723|FG005|Overall Study|Investigator Site Closed|0|||
147504146|NCT01711541|531998731|FG000|Overall Study|Cancel prior to treatment|0|||
147504147|NCT01711541|531998732|FG001|Overall Study|Cancel prior to treatment|0|||
147504148|NCT01711541|531998733|FG002|Overall Study|Cancel prior to treatment|0|||
147504149|NCT01711541|531998734|FG003|Overall Study|Cancel prior to treatment|1|||
147504150|NCT01711541|531998735|FG004|Overall Study|Cancel prior to treatment|0|||
147504151|NCT01711541|531998731|FG000|Overall Study|Ineligible|0|||
147504152|NCT01711541|531998732|FG001|Overall Study|Ineligible|1|||
147504153|NCT01711541|531998733|FG002|Overall Study|Ineligible|0|||
147504154|NCT01711541|531998734|FG003|Overall Study|Ineligible|0|||
147504155|NCT01711541|531998735|FG004|Overall Study|Ineligible|0|||
147504156|NCT03943446|531998736|FG000|Overall Study|Lost to Follow-up|0|||
147504157|NCT03943446|531998737|FG001|Overall Study|Lost to Follow-up|0|||
147504158|NCT03943446|531998738|FG002|Overall Study|Lost to Follow-up|1|||
147504159|NCT03943446|531998736|FG000|Overall Study|Withdrawal by Subject|1|||
147504160|NCT03943446|531998737|FG001|Overall Study|Withdrawal by Subject|1|||
147504161|NCT03943446|531998738|FG002|Overall Study|Withdrawal by Subject|2|||
147504162|NCT03943446|531998736|FG000|Overall Study|Study Terminated by Sponsor|1|||
147504163|NCT03943446|531998737|FG001|Overall Study|Study Terminated by Sponsor|2|||
147504164|NCT03943446|531998738|FG002|Overall Study|Study Terminated by Sponsor|1|||
147504165|NCT03943446|531998736|FG000|Overall Study|Reason not Specified|5|||
147504166|NCT03943446|531998737|FG001|Overall Study|Reason not Specified|1|||
147504167|NCT03943446|531998738|FG002|Overall Study|Reason not Specified|3|||
147504168|NCT01281189|531998743|FG000|Overall Study|Adverse Event|7|||
147504169|NCT01281189|531998744|FG001|Overall Study|Adverse Event|9|||
147504170|NCT01281189|531998743|FG000|Overall Study|Lost to Follow-up|6|||
147504171|NCT01281189|531998744|FG001|Overall Study|Lost to Follow-up|4|||
147504172|NCT01281189|531998743|FG000|Overall Study|Withdrawal by Subject|21|||
147504173|NCT01281189|531998744|FG001|Overall Study|Withdrawal by Subject|24|||
147504174|NCT01281189|531998743|FG000|Overall Study|Physician Decision|2|||
147504175|NCT01281189|531998744|FG001|Overall Study|Physician Decision|3|||
147504176|NCT01281189|531998743|FG000|Overall Study|Death|103|||
147504177|NCT01281189|531998744|FG001|Overall Study|Death|91|||
147504178|NCT01281189|531998743|FG000|Overall Study|Other|8|||
147504179|NCT01281189|531998744|FG001|Overall Study|Other|12|||
147504180|NCT05355818|531998745|FG000|Overall Study|Adverse Event|1|||
147504181|NCT05355818|531998746|FG001|Overall Study|Adverse Event|1|||
147504182|NCT05355818|531998745|FG000|Overall Study|Lack of Efficacy|2|||
147504183|NCT05355818|531998746|FG001|Overall Study|Lack of Efficacy|1|||
147504184|NCT05355818|531998745|FG000|Overall Study|Lost to Follow-up|0|||
147504185|NCT05355818|531998746|FG001|Overall Study|Lost to Follow-up|1|||
147504186|NCT01175590|531998747|FG000|Overall Study|Lost to Follow-up|1|||
147504187|NCT01175590|531998748|FG001|Overall Study|Lost to Follow-up|0|||
147504188|NCT01175590|531998747|FG000|Overall Study|Withdrawal by Subject|0|||
147504189|NCT01175590|531998748|FG001|Overall Study|Withdrawal by Subject|2|||
147504190|NCT01175590|531998747|FG000|Overall Study|Adverse Event|4|||
147635501|NCT01106677|532485175|FG000|Core Period: Baseline to Week 26|Lack of Efficacy|1|||
147635502|NCT01106677|532485176|FG001|Core Period: Baseline to Week 26|Lack of Efficacy|0|||
147635503|NCT01106677|532485177|FG002|Core Period: Baseline to Week 26|Lack of Efficacy|0|||
147635504|NCT01106677|532485178|FG003|Core Period: Baseline to Week 26|Lack of Efficacy|0|||
147635505|NCT01106677|532485175|FG000|Core Period: Baseline to Week 26|Lost to Follow-up|3|||
147635506|NCT01106677|532485176|FG001|Core Period: Baseline to Week 26|Lost to Follow-up|1|||
147635507|NCT01106677|532485177|FG002|Core Period: Baseline to Week 26|Lost to Follow-up|6|||
147635508|NCT01106677|532485178|FG003|Core Period: Baseline to Week 26|Lost to Follow-up|3|||
147635509|NCT01106677|532485175|FG000|Core Period: Baseline to Week 26|Physician Decision|2|||
147635510|NCT01106677|532485176|FG001|Core Period: Baseline to Week 26|Physician Decision|1|||
147668848|NCT03451071|532613390|FG000|Final Questionnaire and Blood Draw|Lost to Follow-up|4|||
147504191|NCT01175590|531998748|FG001|Overall Study|Adverse Event|0|||
147504192|NCT01175590|531998747|FG000|Overall Study|Physician Decision|1|||
147504193|NCT01175590|531998748|FG001|Overall Study|Physician Decision|4|||
147504194|NCT01175590|531998747|FG000|Overall Study|Lack of Efficacy|1|||
147504195|NCT01175590|531998748|FG001|Overall Study|Lack of Efficacy|1|||
147504196|NCT01175590|531998747|FG000|Overall Study|Residual Bacterial Conjunctivitis|1|||
147504197|NCT01175590|531998748|FG001|Overall Study|Residual Bacterial Conjunctivitis|0|||
147635511|NCT01106677|532485177|FG002|Core Period: Baseline to Week 26|Physician Decision|3|||
147504198|NCT01175590|531998747|FG000|Overall Study|Treated not as randomized|3|||
147504199|NCT01175590|531998748|FG001|Overall Study|Treated not as randomized|2|||
147635512|NCT01106677|532485178|FG003|Core Period: Baseline to Week 26|Physician Decision|1|||
147635513|NCT01106677|532485175|FG000|Core Period: Baseline to Week 26|Protocol Violation|0|||
147635514|NCT01106677|532485176|FG001|Core Period: Baseline to Week 26|Protocol Violation|1|||
147635515|NCT01106677|532485177|FG002|Core Period: Baseline to Week 26|Protocol Violation|0|||
147635516|NCT01106677|532485178|FG003|Core Period: Baseline to Week 26|Protocol Violation|3|||
147635517|NCT01106677|532485175|FG000|Core Period: Baseline to Week 26|Withdrawal by Subject|5|||
147635518|NCT01106677|532485176|FG001|Core Period: Baseline to Week 26|Withdrawal by Subject|3|||
147635519|NCT01106677|532485177|FG002|Core Period: Baseline to Week 26|Withdrawal by Subject|15|||
147635520|NCT01106677|532485178|FG003|Core Period: Baseline to Week 26|Withdrawal by Subject|6|||
147635521|NCT01106677|532485175|FG000|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|1|||
147635522|NCT01106677|532485176|FG001|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|2|||
147635523|NCT01106677|532485177|FG002|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|2|||
147635524|NCT01106677|532485178|FG003|Core Period: Baseline to Week 26|Creatinine or eGFR withdrawal criteria|3|||
147635525|NCT01106677|532485175|FG000|Core Period: Baseline to Week 26|Noncompliance with study drug|1|||
147635526|NCT01106677|532485176|FG001|Core Period: Baseline to Week 26|Noncompliance with study drug|3|||
147635527|NCT01106677|532485177|FG002|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
147635528|NCT01106677|532485178|FG003|Core Period: Baseline to Week 26|Noncompliance with study drug|0|||
147635529|NCT01106677|532485175|FG000|Core Period: Baseline to Week 26|Study terminated by sponsor|0|||
147635530|NCT01106677|532485176|FG001|Core Period: Baseline to Week 26|Study terminated by sponsor|1|||
147635531|NCT01106677|532485177|FG002|Core Period: Baseline to Week 26|Study terminated by sponsor|2|||
147635532|NCT01106677|532485178|FG003|Core Period: Baseline to Week 26|Study terminated by sponsor|0|||
147635533|NCT01106677|532485175|FG000|Core Period: Baseline to Week 26|Product quality complaint|0|||
147635534|NCT01106677|532485176|FG001|Core Period: Baseline to Week 26|Product quality complaint|1|||
147635535|NCT01106677|532485177|FG002|Core Period: Baseline to Week 26|Product quality complaint|1|||
147635536|NCT01106677|532485178|FG003|Core Period: Baseline to Week 26|Product quality complaint|0|||
147635537|NCT01106677|532485175|FG000|Core Period: Baseline to Week 26|Other|8|||
147635538|NCT01106677|532485176|FG001|Core Period: Baseline to Week 26|Other|14|||
147635539|NCT01106677|532485177|FG002|Core Period: Baseline to Week 26|Other|8|||
147635540|NCT01106677|532485178|FG003|Core Period: Baseline to Week 26|Other|23|||
147635541|NCT01106677|532485175|FG000|Core Period: Baseline to Week 26|Pregnancy|0|||
147635542|NCT01106677|532485176|FG001|Core Period: Baseline to Week 26|Pregnancy|1|||
147635543|NCT01106677|532485177|FG002|Core Period: Baseline to Week 26|Pregnancy|0|||
147635544|NCT01106677|532485178|FG003|Core Period: Baseline to Week 26|Pregnancy|0|||
147635545|NCT01106677|532485175|FG000|Extension Period: Week 26 to Week 52|Adverse Event|1|||
147635546|NCT01106677|532485176|FG001|Extension Period: Week 26 to Week 52|Adverse Event|1|||
147635547|NCT01106677|532485177|FG002|Extension Period: Week 26 to Week 52|Adverse Event|5|||
147635548|NCT01106677|532485178|FG003|Extension Period: Week 26 to Week 52|Adverse Event|9|||
147635549|NCT01106677|532485175|FG000|Extension Period: Week 26 to Week 52|Death|0|||
147635550|NCT01106677|532485176|FG001|Extension Period: Week 26 to Week 52|Death|0|||
147635551|NCT01106677|532485177|FG002|Extension Period: Week 26 to Week 52|Death|0|||
147635552|NCT01106677|532485178|FG003|Extension Period: Week 26 to Week 52|Death|1|||
147635553|NCT01106677|532485175|FG000|Extension Period: Week 26 to Week 52|Lack of Efficacy|2|||
147635554|NCT01106677|532485176|FG001|Extension Period: Week 26 to Week 52|Lack of Efficacy|0|||
147635555|NCT01106677|532485177|FG002|Extension Period: Week 26 to Week 52|Lack of Efficacy|0|||
147635556|NCT01106677|532485178|FG003|Extension Period: Week 26 to Week 52|Lack of Efficacy|4|||
147635557|NCT01106677|532485175|FG000|Extension Period: Week 26 to Week 52|Lost to Follow-up|0|||
147635558|NCT01106677|532485176|FG001|Extension Period: Week 26 to Week 52|Lost to Follow-up|2|||
147635559|NCT01106677|532485177|FG002|Extension Period: Week 26 to Week 52|Lost to Follow-up|2|||
147635560|NCT01106677|532485178|FG003|Extension Period: Week 26 to Week 52|Lost to Follow-up|2|||
147635561|NCT01106677|532485175|FG000|Extension Period: Week 26 to Week 52|Physician Decision|2|||
147635562|NCT01106677|532485176|FG001|Extension Period: Week 26 to Week 52|Physician Decision|3|||
147635563|NCT01106677|532485177|FG002|Extension Period: Week 26 to Week 52|Physician Decision|2|||
147635564|NCT01106677|532485178|FG003|Extension Period: Week 26 to Week 52|Physician Decision|3|||
147635565|NCT01106677|532485175|FG000|Extension Period: Week 26 to Week 52|Protocol Violation|1|||
147635566|NCT01106677|532485176|FG001|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
147635567|NCT01106677|532485177|FG002|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
147635568|NCT01106677|532485178|FG003|Extension Period: Week 26 to Week 52|Protocol Violation|0|||
147635569|NCT01106677|532485175|FG000|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
147635570|NCT01106677|532485176|FG001|Extension Period: Week 26 to Week 52|Withdrawal by Subject|3|||
147504200|NCT01175590|531998747|FG000|Overall Study|Herpes Simplex Dermatitis|1|||
147504201|NCT01175590|531998748|FG001|Overall Study|Herpes Simplex Dermatitis|0|||
147504202|NCT01175590|531998747|FG000|Overall Study|Protocol Violation|0|||
147504203|NCT01175590|531998748|FG001|Overall Study|Protocol Violation|1|||
147504204|NCT01019252|531998749|FG000|Initial CBT for ADHD vs. Wait List|Time constraints|2|||
147504205|NCT01019252|531998750|FG001|Initial CBT for ADHD vs. Wait List|Time constraints|0|||
147504206|NCT01019252|531998749|FG000|Initial CBT for ADHD vs. Wait List|Moved out of Boston area|1|||
147504207|NCT01019252|531998750|FG001|Initial CBT for ADHD vs. Wait List|Moved out of Boston area|0|||
147504208|NCT01019252|531998749|FG000|Wait List Cross-over to CBT for ADHD|Time constraints|0|||
147504209|NCT01019252|531998750|FG001|Wait List Cross-over to CBT for ADHD|Time constraints|2|||
147504210|NCT01019252|531998749|FG000|Wait List Cross-over to CBT for ADHD|Lost to Follow-up|0|||
147504211|NCT01019252|531998750|FG001|Wait List Cross-over to CBT for ADHD|Lost to Follow-up|5|||
147504212|NCT03657810|531998755|FG000|Overall Study|Adverse Event|0|||
147504213|NCT03657810|531998756|FG001|Overall Study|Adverse Event|1|||
147504214|NCT03657810|531998757|FG002|Overall Study|Adverse Event|0|||
147504215|NCT03657810|531998755|FG000|Overall Study|Lack of Efficacy|4|||
147504216|NCT03657810|531998756|FG001|Overall Study|Lack of Efficacy|1|||
147504217|NCT03657810|531998757|FG002|Overall Study|Lack of Efficacy|3|||
147504218|NCT03657810|531998755|FG000|Overall Study|Protocol Violation|1|||
147504219|NCT03657810|531998756|FG001|Overall Study|Protocol Violation|0|||
147504220|NCT03657810|531998757|FG002|Overall Study|Protocol Violation|0|||
147504221|NCT03657810|531998755|FG000|Overall Study|Lost to Follow-up|0|||
147504222|NCT03657810|531998756|FG001|Overall Study|Lost to Follow-up|1|||
147504223|NCT03657810|531998757|FG002|Overall Study|Lost to Follow-up|0|||
147504224|NCT03657810|531998755|FG000|Overall Study|Not provided|0|||
147504225|NCT03657810|531998756|FG001|Overall Study|Not provided|1|||
147504226|NCT03657810|531998757|FG002|Overall Study|Not provided|0|||
147504227|NCT03325556|531998758|FG000|Open-label Period|Lack of Response in OL period|70|||
147504228|NCT03325556|531998759|FG001|Open-label Period|Lack of Response in OL period|0|||
147504229|NCT03325556|531998760|FG002|Open-label Period|Lack of Response in OL period|0|||
147504230|NCT03325556|531998758|FG000|Open-label Period|Adverse Event|27|||
147504231|NCT03325556|531998759|FG001|Open-label Period|Adverse Event|0|||
147504232|NCT03325556|531998760|FG002|Open-label Period|Adverse Event|0|||
147504233|NCT03325556|531998758|FG000|Open-label Period|Death|1|||
147504234|NCT03325556|531998759|FG001|Open-label Period|Death|0|||
147504235|NCT03325556|531998760|FG002|Open-label Period|Death|0|||
147504236|NCT03325556|531998758|FG000|Open-label Period|Lost to Follow-up|1|||
147504237|NCT03325556|531998759|FG001|Open-label Period|Lost to Follow-up|0|||
147504238|NCT03325556|531998760|FG002|Open-label Period|Lost to Follow-up|0|||
147504239|NCT03325556|531998758|FG000|Open-label Period|Non-compliance with study drug|5|||
147504240|NCT03325556|531998759|FG001|Open-label Period|Non-compliance with study drug|0|||
147504241|NCT03325556|531998760|FG002|Open-label Period|Non-compliance with study drug|0|||
147504242|NCT03325556|531998758|FG000|Open-label Period|Use of prohibited medication|1|||
147504243|NCT03325556|531998759|FG001|Open-label Period|Use of prohibited medication|0|||
147504244|NCT03325556|531998760|FG002|Open-label Period|Use of prohibited medication|0|||
147504245|NCT03325556|531998758|FG000|Open-label Period|Protocol Violation|4|||
147504246|NCT03325556|531998759|FG001|Open-label Period|Protocol Violation|0|||
147504247|NCT03325556|531998760|FG002|Open-label Period|Protocol Violation|0|||
147504248|NCT03325556|531998758|FG000|Open-label Period|Withdrawal by Subject|17|||
147504249|NCT03325556|531998759|FG001|Open-label Period|Withdrawal by Subject|0|||
147504250|NCT03325556|531998760|FG002|Open-label Period|Withdrawal by Subject|0|||
147504251|NCT03325556|531998758|FG000|Open-label Period|Not otherwise specified|8|||
147504252|NCT03325556|531998759|FG001|Open-label Period|Not otherwise specified|0|||
147504253|NCT03325556|531998760|FG002|Open-label Period|Not otherwise specified|0|||
147504254|NCT03325556|531998758|FG000|Open-label Period|Administrative discont. at study termination|41|||
147504255|NCT03325556|531998759|FG001|Open-label Period|Administrative discont. at study termination|0|||
147504256|NCT03325556|531998760|FG002|Open-label Period|Administrative discont. at study termination|0|||
147504257|NCT03325556|531998758|FG000|Double-blind Period|Relapse|0|||
147504258|NCT03325556|531998759|FG001|Double-blind Period|Relapse|15|||
147504259|NCT03325556|531998760|FG002|Double-blind Period|Relapse|34|||
147504260|NCT03325556|531998758|FG000|Double-blind Period|Adverse Event|0|||
147504261|NCT03325556|531998759|FG001|Double-blind Period|Adverse Event|3|||
147504262|NCT03325556|531998760|FG002|Double-blind Period|Adverse Event|1|||
147668849|NCT03363906|532613391|FG000|Period 1 (Reference or Test)|Adverse Event|1|||
147668850|NCT03363906|532613392|FG001|Period 1 (Reference or Test)|Adverse Event|2|||
147668851|NCT03363906|532613391|FG000|Period 2 (Test or Reference)|Adverse Event|2|||
147504263|NCT03325556|531998758|FG000|Double-blind Period|Noncompliance with study drug|0|||
147504264|NCT03325556|531998759|FG001|Double-blind Period|Noncompliance with study drug|0|||
147504265|NCT03325556|531998760|FG002|Double-blind Period|Noncompliance with study drug|1|||
147504266|NCT03325556|531998758|FG000|Double-blind Period|Use of prohibited medication|0|||
147504267|NCT03325556|531998759|FG001|Double-blind Period|Use of prohibited medication|1|||
147504268|NCT03325556|531998760|FG002|Double-blind Period|Use of prohibited medication|0|||
147504269|NCT03325556|531998758|FG000|Double-blind Period|Physician Decision|0|||
147504270|NCT03325556|531998759|FG001|Double-blind Period|Physician Decision|0|||
147504271|NCT03325556|531998760|FG002|Double-blind Period|Physician Decision|1|||
147504272|NCT03325556|531998758|FG000|Double-blind Period|Withdrawal by Subject|0|||
147504273|NCT03325556|531998759|FG001|Double-blind Period|Withdrawal by Subject|6|||
147504274|NCT03325556|531998760|FG002|Double-blind Period|Withdrawal by Subject|4|||
147635571|NCT01106677|532485177|FG002|Extension Period: Week 26 to Week 52|Withdrawal by Subject|2|||
147635572|NCT01106677|532485178|FG003|Extension Period: Week 26 to Week 52|Withdrawal by Subject|1|||
147635573|NCT01106677|532485175|FG000|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|2|||
147635574|NCT01106677|532485176|FG001|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|4|||
147635575|NCT01106677|532485177|FG002|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|3|||
147635576|NCT01106677|532485178|FG003|Extension Period: Week 26 to Week 52|Creatinine or eGFR withdrawal criteria|2|||
147635577|NCT01106677|532485175|FG000|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
147635578|NCT01106677|532485176|FG001|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
147635579|NCT01106677|532485177|FG002|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|0|||
147635580|NCT01106677|532485178|FG003|Extension Period: Week 26 to Week 52|Unable to take rescue therapy|1|||
147635581|NCT01106677|532485175|FG000|Extension Period: Week 26 to Week 52|Other|6|||
147635582|NCT01106677|532485176|FG001|Extension Period: Week 26 to Week 52|Other|5|||
147635583|NCT01106677|532485177|FG002|Extension Period: Week 26 to Week 52|Other|8|||
147635584|NCT01106677|532485178|FG003|Extension Period: Week 26 to Week 52|Other|5|||
147635585|NCT03875092|532485179|FG000|Overall Study|Adverse Event|2|||
147635586|NCT03875092|532485180|FG001|Overall Study|Adverse Event|5|||
147635587|NCT03875092|532485179|FG000|Overall Study|Death|44|||
147635588|NCT03875092|532485180|FG001|Overall Study|Death|51|||
147635589|NCT03875092|532485179|FG000|Overall Study|Participation Was Terminated By Sponsor|19|||
147635590|NCT03875092|532485180|FG001|Overall Study|Participation Was Terminated By Sponsor|4|||
147635591|NCT04114357|532485181|FG000|Baseline-Randomization|Adverse Event|2|||
147635592|NCT04114357|532485182|FG001|Baseline-Randomization|Adverse Event|1|||
147635593|NCT04114357|532485181|FG000|Baseline-Randomization|Lost to Follow-up|1|||
147635594|NCT04114357|532485182|FG001|Baseline-Randomization|Lost to Follow-up|1|||
147635595|NCT04114357|532485181|FG000|Cross-over|Adverse Event|0|||
147635596|NCT04114357|532485182|FG001|Cross-over|Adverse Event|1|||
147635597|NCT03693612|532485183|FG000|Overall Study|Lost to Follow-up|0|||
147635598|NCT03693612|532485184|FG001|Overall Study|Lost to Follow-up|0|||
147635599|NCT03693612|532485185|FG002|Overall Study|Lost to Follow-up|0|||
147635600|NCT03693612|532485186|FG003|Overall Study|Lost to Follow-up|0|||
147635601|NCT03693612|532485187|FG004|Overall Study|Lost to Follow-up|1|||
147635602|NCT03693612|532485188|FG005|Overall Study|Lost to Follow-up|0|||
147635603|NCT03693612|532485189|FG006|Overall Study|Lost to Follow-up|0|||
147635604|NCT03693612|532485183|FG000|Overall Study|Withdrawal by Subject|0|||
147635605|NCT03693612|532485184|FG001|Overall Study|Withdrawal by Subject|0|||
147635606|NCT03693612|532485185|FG002|Overall Study|Withdrawal by Subject|1|||
147635607|NCT03693612|532485186|FG003|Overall Study|Withdrawal by Subject|0|||
147635608|NCT03693612|532485187|FG004|Overall Study|Withdrawal by Subject|2|||
147635609|NCT03693612|532485188|FG005|Overall Study|Withdrawal by Subject|0|||
147635610|NCT03693612|532485189|FG006|Overall Study|Withdrawal by Subject|0|||
147635611|NCT03693612|532485183|FG000|Overall Study|Study Terminated by Sponsor|0|||
147635612|NCT03693612|532485184|FG001|Overall Study|Study Terminated by Sponsor|1|||
147635613|NCT03693612|532485185|FG002|Overall Study|Study Terminated by Sponsor|0|||
147635614|NCT03693612|532485186|FG003|Overall Study|Study Terminated by Sponsor|0|||
147635615|NCT03693612|532485187|FG004|Overall Study|Study Terminated by Sponsor|3|||
147635616|NCT03693612|532485188|FG005|Overall Study|Study Terminated by Sponsor|0|||
147635617|NCT03693612|532485189|FG006|Overall Study|Study Terminated by Sponsor|0|||
147635618|NCT01669174|532485196|FG000|Overall Study|Subject withdrew consent|2|||
147635619|NCT01669174|532485197|FG001|Overall Study|Subject withdrew consent|2|||
147635620|NCT01669174|532485196|FG000|Overall Study|Lost to Follow-up|1|||
147635621|NCT01669174|532485197|FG001|Overall Study|Lost to Follow-up|0|||
147635622|NCT01669174|532485196|FG000|Overall Study|Adverse Event|2|||
147635623|NCT01669174|532485197|FG001|Overall Study|Adverse Event|2|||
147635624|NCT01669174|532485196|FG000|Overall Study|Administrative problems|1|||
147635625|NCT01669174|532485197|FG001|Overall Study|Administrative problems|2|||
147635626|NCT01953601|532485198|FG000|Part 1 (Base Study)|Adverse Event|24|||
147635627|NCT01953601|532485199|FG001|Part 1 (Base Study)|Adverse Event|37|||
147635628|NCT01953601|532485200|FG002|Part 1 (Base Study)|Adverse Event|15|||
147504275|NCT03325556|531998758|FG000|Double-blind Period|Not otherwise specified|0|||
147635629|NCT01953601|532485198|FG000|Part 1 (Base Study)|Death|2|||
147635630|NCT01953601|532485199|FG001|Part 1 (Base Study)|Death|0|||
147635631|NCT01953601|532485200|FG002|Part 1 (Base Study)|Death|3|||
147635632|NCT01953601|532485198|FG000|Part 1 (Base Study)|Lack of Efficacy|3|||
147635633|NCT01953601|532485199|FG001|Part 1 (Base Study)|Lack of Efficacy|1|||
147635634|NCT01953601|532485200|FG002|Part 1 (Base Study)|Lack of Efficacy|4|||
147635635|NCT01953601|532485198|FG000|Part 1 (Base Study)|Lost to Follow-up|1|||
147635636|NCT01953601|532485199|FG001|Part 1 (Base Study)|Lost to Follow-up|3|||
147635637|NCT01953601|532485200|FG002|Part 1 (Base Study)|Lost to Follow-up|6|||
147635638|NCT01953601|532485198|FG000|Part 1 (Base Study)|Non-compliance with study drug|0|||
147635639|NCT01953601|532485199|FG001|Part 1 (Base Study)|Non-compliance with study drug|3|||
147635640|NCT01953601|532485200|FG002|Part 1 (Base Study)|Non-compliance with study drug|1|||
147635641|NCT01953601|532485198|FG000|Part 1 (Base Study)|Physician Decision|3|||
147635642|NCT01953601|532485199|FG001|Part 1 (Base Study)|Physician Decision|7|||
147504276|NCT03325556|531998759|FG001|Double-blind Period|Not otherwise specified|1|||
147504277|NCT03325556|531998760|FG002|Double-blind Period|Not otherwise specified|5|||
147504278|NCT03325556|531998758|FG000|Double-blind Period|Administrative discont. at study termination|0|||
147504279|NCT03325556|531998759|FG001|Double-blind Period|Administrative discont. at study termination|35|||
147504280|NCT03325556|531998760|FG002|Double-blind Period|Administrative discont. at study termination|31|||
147504281|NCT01705587|531998761|FG000|Overall Study|Withdrawal by Subject|0|||
147504282|NCT01705587|531998762|FG001|Overall Study|Withdrawal by Subject|1|||
147504283|NCT02227849|531998763|FG000|Overall Study|Adverse Event|4|||
147504284|NCT02227849|531998763|FG000|Overall Study|Physician Decision|1|||
147504285|NCT02227849|531998763|FG000|Overall Study|Withdrawal by Subject|3|||
147504286|NCT00762268|531998764|FG000|Overall Study|Withdrawal by Subject|3|||
147504287|NCT00762268|531998765|FG001|Overall Study|Withdrawal by Subject|3|||
147504288|NCT04897594|531998767|FG000|Overall Study|Lost to Follow-up|0|||
147504289|NCT04897594|531998768|FG001|Overall Study|Lost to Follow-up|1|||
147504290|NCT04897594|531998769|FG002|Overall Study|Lost to Follow-up|1|||
147504291|NCT04897594|531998767|FG000|Overall Study|Sponsor Decision|0|||
147635643|NCT01953601|532485200|FG002|Part 1 (Base Study)|Physician Decision|4|||
147635644|NCT01953601|532485198|FG000|Part 1 (Base Study)|Screen failure|1|||
147635645|NCT01953601|532485199|FG001|Part 1 (Base Study)|Screen failure|0|||
147635646|NCT01953601|532485200|FG002|Part 1 (Base Study)|Screen failure|1|||
147635647|NCT01953601|532485198|FG000|Part 1 (Base Study)|Site discontinued study participation|2|||
147635648|NCT01953601|532485199|FG001|Part 1 (Base Study)|Site discontinued study participation|0|||
147635649|NCT01953601|532485200|FG002|Part 1 (Base Study)|Site discontinued study participation|0|||
147635650|NCT01953601|532485198|FG000|Part 1 (Base Study)|Study terminated by sponsor|174|||
147635651|NCT01953601|532485199|FG001|Part 1 (Base Study)|Study terminated by sponsor|169|||
147635652|NCT01953601|532485200|FG002|Part 1 (Base Study)|Study terminated by sponsor|179|||
147635653|NCT01953601|532485198|FG000|Part 1 (Base Study)|Discontinued due to caregiver withdrawal|7|||
147635654|NCT01953601|532485199|FG001|Part 1 (Base Study)|Discontinued due to caregiver withdrawal|8|||
147635655|NCT01953601|532485200|FG002|Part 1 (Base Study)|Discontinued due to caregiver withdrawal|10|||
147635656|NCT01953601|532485198|FG000|Part 1 (Base Study)|Subject moved|2|||
147635657|NCT01953601|532485199|FG001|Part 1 (Base Study)|Subject moved|2|||
147635658|NCT01953601|532485200|FG002|Part 1 (Base Study)|Subject moved|1|||
147635659|NCT01953601|532485198|FG000|Part 1 (Base Study)|Withdrawal by Subject|32|||
147635660|NCT01953601|532485199|FG001|Part 1 (Base Study)|Withdrawal by Subject|23|||
147635661|NCT01953601|532485200|FG002|Part 1 (Base Study)|Withdrawal by Subject|22|||
147635662|NCT01953601|532485198|FG000|Part 2 (Extension Study)|Adverse Event|1|||
147635663|NCT01953601|532485199|FG001|Part 2 (Extension Study)|Adverse Event|1|||
147635664|NCT01953601|532485200|FG002|Part 2 (Extension Study)|Adverse Event|10|||
147635665|NCT01953601|532485198|FG000|Part 2 (Extension Study)|Death|0|||
147635666|NCT01953601|532485199|FG001|Part 2 (Extension Study)|Death|3|||
147635667|NCT01953601|532485200|FG002|Part 2 (Extension Study)|Death|0|||
147635668|NCT01953601|532485198|FG000|Part 2 (Extension Study)|Lack of Efficacy|2|||
147635669|NCT01953601|532485199|FG001|Part 2 (Extension Study)|Lack of Efficacy|0|||
147635670|NCT01953601|532485200|FG002|Part 2 (Extension Study)|Lack of Efficacy|0|||
147635671|NCT01953601|532485198|FG000|Part 2 (Extension Study)|Lost to Follow-up|2|||
147635672|NCT01953601|532485199|FG001|Part 2 (Extension Study)|Lost to Follow-up|1|||
147635673|NCT01953601|532485200|FG002|Part 2 (Extension Study)|Lost to Follow-up|1|||
147635674|NCT01953601|532485198|FG000|Part 2 (Extension Study)|Physician Decision|2|||
147635675|NCT01953601|532485199|FG001|Part 2 (Extension Study)|Physician Decision|0|||
147635676|NCT01953601|532485200|FG002|Part 2 (Extension Study)|Physician Decision|2|||
147635677|NCT01953601|532485198|FG000|Part 2 (Extension Study)|Site discontinued study participation|0|||
147635678|NCT01953601|532485199|FG001|Part 2 (Extension Study)|Site discontinued study participation|1|||
147635679|NCT01953601|532485200|FG002|Part 2 (Extension Study)|Site discontinued study participation|1|||
147635680|NCT01953601|532485198|FG000|Part 2 (Extension Study)|Study terminated by sponsor|185|||
147635681|NCT01953601|532485199|FG001|Part 2 (Extension Study)|Study terminated by sponsor|178|||
147635682|NCT01953601|532485200|FG002|Part 2 (Extension Study)|Study terminated by sponsor|187|||
147635683|NCT01953601|532485198|FG000|Part 2 (Extension Study)|Discontinued due to caregiver withdrawal|1|||
147635684|NCT01953601|532485199|FG001|Part 2 (Extension Study)|Discontinued due to caregiver withdrawal|3|||
147635685|NCT01953601|532485200|FG002|Part 2 (Extension Study)|Discontinued due to caregiver withdrawal|0|||
147635686|NCT01953601|532485198|FG000|Part 2 (Extension Study)|Subject moved|0|||
147635687|NCT01953601|532485199|FG001|Part 2 (Extension Study)|Subject moved|0|||
147635688|NCT01953601|532485200|FG002|Part 2 (Extension Study)|Subject moved|1|||
147635689|NCT01953601|532485198|FG000|Part 2 (Extension Study)|Withdrawal by Subject|5|||
147635690|NCT01953601|532485199|FG001|Part 2 (Extension Study)|Withdrawal by Subject|4|||
147635691|NCT01953601|532485200|FG002|Part 2 (Extension Study)|Withdrawal by Subject|2|||
147635692|NCT04310397|532485207|FG000|Overall Study|Lack of Efficacy|3|||
147635693|NCT04310397|532485207|FG000|Overall Study|Withdrawal by Subject|1|||
147504292|NCT04897594|531998768|FG001|Overall Study|Sponsor Decision|0|||
147504293|NCT04897594|531998769|FG002|Overall Study|Sponsor Decision|1|||
147635694|NCT00723255|532485208|FG000|Overall Study|Ineligible: Inadequate pathology|1|||
147635695|NCT00723255|532485208|FG000|Overall Study|Ineligible: Second primary|1|||
147635696|NCT00723255|532485208|FG000|Overall Study|Ineligible: Wrong Primary|2|||
147504294|NCT04897594|531998767|FG000|Overall Study|Withdrawal by Subject|1|||
147504295|NCT04897594|531998768|FG001|Overall Study|Withdrawal by Subject|0|||
147504296|NCT04897594|531998769|FG002|Overall Study|Withdrawal by Subject|1|||
147504297|NCT01457924|531998774|FG000|Treatment Phase (Weeks 0-24)|Adverse Event|0|||
147504298|NCT01457924|531998775|FG001|Treatment Phase (Weeks 0-24)|Adverse Event|4|||
147504299|NCT01457924|531998776|FG002|Treatment Phase (Weeks 0-24)|Adverse Event|1|||
147504300|NCT01457924|531998777|FG003|Treatment Phase (Weeks 0-24)|Adverse Event|0|||
147504301|NCT01457924|531998778|FG004|Treatment Phase (Weeks 0-24)|Adverse Event|2|||
147504302|NCT01457924|531998774|FG000|Treatment Phase (Weeks 0-24)|Physician Decision|0|||
147504303|NCT01457924|531998775|FG001|Treatment Phase (Weeks 0-24)|Physician Decision|0|||
147504304|NCT01457924|531998776|FG002|Treatment Phase (Weeks 0-24)|Physician Decision|0|||
147504305|NCT01457924|531998777|FG003|Treatment Phase (Weeks 0-24)|Physician Decision|0|||
147504306|NCT01457924|531998778|FG004|Treatment Phase (Weeks 0-24)|Physician Decision|1|||
147504307|NCT01457924|531998774|FG000|Treatment Phase (Weeks 0-24)|Lack of Efficacy|1|||
147504308|NCT01457924|531998775|FG001|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0|||
147504309|NCT01457924|531998776|FG002|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0|||
147504310|NCT01457924|531998777|FG003|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0|||
147504311|NCT01457924|531998778|FG004|Treatment Phase (Weeks 0-24)|Lack of Efficacy|0|||
147504312|NCT01457924|531998774|FG000|Treatment Phase (Weeks 0-24)|Protocol Violation|1|||
147504313|NCT01457924|531998775|FG001|Treatment Phase (Weeks 0-24)|Protocol Violation|0|||
147504314|NCT01457924|531998776|FG002|Treatment Phase (Weeks 0-24)|Protocol Violation|1|||
147504315|NCT01457924|531998777|FG003|Treatment Phase (Weeks 0-24)|Protocol Violation|0|||
147504316|NCT01457924|531998778|FG004|Treatment Phase (Weeks 0-24)|Protocol Violation|0|||
147504317|NCT01457924|531998774|FG000|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|0|||
147504318|NCT01457924|531998775|FG001|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|0|||
147504319|NCT01457924|531998776|FG002|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|0|||
147504320|NCT01457924|531998777|FG003|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|1|||
147504321|NCT01457924|531998778|FG004|Treatment Phase (Weeks 0-24)|Withdrawal by Subject|1|||
147504322|NCT01457924|531998774|FG000|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|1|||
147504323|NCT01457924|531998775|FG001|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|1|||
147504324|NCT01457924|531998776|FG002|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|0|||
147504325|NCT01457924|531998777|FG003|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|0|||
147504326|NCT01457924|531998778|FG004|Treatment Phase (Weeks 0-24)|Other-Protocol defined stopping criteria|2|||
147504327|NCT01457924|531998774|FG000|FUP (Weeks 24-48)|Adverse Event|0|||
147504328|NCT01457924|531998775|FG001|FUP (Weeks 24-48)|Adverse Event|0|||
147504329|NCT01457924|531998776|FG002|FUP (Weeks 24-48)|Adverse Event|1|||
147504330|NCT01457924|531998777|FG003|FUP (Weeks 24-48)|Adverse Event|0|||
147504331|NCT01457924|531998778|FG004|FUP (Weeks 24-48)|Adverse Event|0|||
147504332|NCT01457924|531998774|FG000|FUP (Weeks 24-48)|Physician Decision|1|||
147504333|NCT01457924|531998775|FG001|FUP (Weeks 24-48)|Physician Decision|0|||
147504334|NCT01457924|531998776|FG002|FUP (Weeks 24-48)|Physician Decision|1|||
147504335|NCT01457924|531998777|FG003|FUP (Weeks 24-48)|Physician Decision|0|||
147504336|NCT01457924|531998778|FG004|FUP (Weeks 24-48)|Physician Decision|0|||
147504337|NCT01457924|531998774|FG000|FUP (Weeks 24-48)|Lost to Follow-up|0|||
147504338|NCT01457924|531998775|FG001|FUP (Weeks 24-48)|Lost to Follow-up|0|||
147504339|NCT01457924|531998776|FG002|FUP (Weeks 24-48)|Lost to Follow-up|0|||
147504340|NCT01457924|531998777|FG003|FUP (Weeks 24-48)|Lost to Follow-up|1|||
147504341|NCT01457924|531998778|FG004|FUP (Weeks 24-48)|Lost to Follow-up|0|||
147504342|NCT01457924|531998774|FG000|FUP (Weeks 24-48)|Withdrawal by Subject|2|||
147504343|NCT01457924|531998775|FG001|FUP (Weeks 24-48)|Withdrawal by Subject|1|||
147504344|NCT01457924|531998776|FG002|FUP (Weeks 24-48)|Withdrawal by Subject|0|||
147504345|NCT01457924|531998777|FG003|FUP (Weeks 24-48)|Withdrawal by Subject|0|||
147504346|NCT01457924|531998778|FG004|FUP (Weeks 24-48)|Withdrawal by Subject|2|||
147504347|NCT01457924|531998774|FG000|Individualized FUP (Weeks 48+)|Lost to Follow-up|1|||
147504348|NCT01457924|531998775|FG001|Individualized FUP (Weeks 48+)|Lost to Follow-up|0|||
147504349|NCT01457924|531998776|FG002|Individualized FUP (Weeks 48+)|Lost to Follow-up|1|||
147504350|NCT01457924|531998777|FG003|Individualized FUP (Weeks 48+)|Lost to Follow-up|0|||
147504351|NCT01457924|531998778|FG004|Individualized FUP (Weeks 48+)|Lost to Follow-up|0|||
147504352|NCT01457924|531998774|FG000|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|3|||
147504353|NCT01457924|531998775|FG001|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|4|||
147504354|NCT01457924|531998776|FG002|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|2|||
147504355|NCT01457924|531998777|FG003|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|3|||
147504356|NCT01457924|531998778|FG004|Individualized FUP (Weeks 48+)|Other-Protocol defined stopping criteria|5|||
147504357|NCT01457924|531998774|FG000|Individualized FUP (Weeks 48+)|Withdrawal by Subject|1|||
147504358|NCT01457924|531998775|FG001|Individualized FUP (Weeks 48+)|Withdrawal by Subject|0|||
147504359|NCT01457924|531998776|FG002|Individualized FUP (Weeks 48+)|Withdrawal by Subject|1|||
147504360|NCT01457924|531998777|FG003|Individualized FUP (Weeks 48+)|Withdrawal by Subject|2|||
147504361|NCT01457924|531998778|FG004|Individualized FUP (Weeks 48+)|Withdrawal by Subject|1|||
147504362|NCT01329341|531998779|FG000|Overall Study|Withdrawal by Subject|44|||
147635697|NCT00614523|532485209|FG000|Overall Study|Adverse Event|4|||
147635698|NCT00614523|532485210|FG001|Overall Study|Adverse Event|20|||
147635699|NCT00614523|532485209|FG000|Overall Study|Death|5|||
147635700|NCT00614523|532485210|FG001|Overall Study|Death|8|||
147635701|NCT00614523|532485209|FG000|Overall Study|Lack of Efficacy|9|||
147635702|NCT00614523|532485210|FG001|Overall Study|Lack of Efficacy|11|||
147635703|NCT00614523|532485209|FG000|Overall Study|Lost to Follow-up|0|||
147635704|NCT00614523|532485210|FG001|Overall Study|Lost to Follow-up|1|||
147635705|NCT00614523|532485209|FG000|Overall Study|Protocol Violation|3|||
147635706|NCT00614523|532485210|FG001|Overall Study|Protocol Violation|2|||
147635707|NCT00614523|532485209|FG000|Overall Study|Withdrawal by Subject|12|||
147635708|NCT00614523|532485210|FG001|Overall Study|Withdrawal by Subject|22|||
147635709|NCT00614523|532485209|FG000|Overall Study|Other|6|||
147635710|NCT00614523|532485210|FG001|Overall Study|Other|11|||
147635711|NCT00614523|532485209|FG000|Overall Study|Ineligibility Determined|1|||
147635712|NCT00614523|532485210|FG001|Overall Study|Ineligibility Determined|2|||
147635713|NCT00614523|532485209|FG000|Overall Study|Disease Progression|0|||
147635714|NCT00614523|532485210|FG001|Overall Study|Disease Progression|8|||
147635715|NCT00614523|532485209|FG000|Overall Study|Administrative Decision|23|||
147635716|NCT00614523|532485210|FG001|Overall Study|Administrative Decision|46|||
147635717|NCT03962790|532485211|FG000|Period 1|Adverse Event|0|||
147635718|NCT03962790|532485212|FG001|Period 1|Adverse Event|1|||
147635719|NCT03962790|532485211|FG000|Period 1|Failed to meet all eligibility criteria|1|||
147635720|NCT03962790|532485212|FG001|Period 1|Failed to meet all eligibility criteria|1|||
147635721|NCT03962790|532485211|FG000|Period 1|No Longer Meets Eligibility Criteria|1|||
147635722|NCT03962790|532485212|FG001|Period 1|No Longer Meets Eligibility Criteria|0|||
147635723|NCT03962790|532485211|FG000|Period 1|Withdrawal by Subject|1|||
147635724|NCT03962790|532485212|FG001|Period 1|Withdrawal by Subject|0|||
147635725|NCT00452673|532485219|FG000|Dose Escalation Period|Disease Progression|6|||
147635726|NCT00452673|532485220|FG001|Dose Escalation Period|Disease Progression|6|||
147635727|NCT00452673|532485221|FG002|Dose Escalation Period|Disease Progression|2|||
147635728|NCT00452673|532485222|FG003|Dose Escalation Period|Disease Progression|6|||
147635729|NCT00452673|532485223|FG004|Dose Escalation Period|Disease Progression|0|||
147635730|NCT00452673|532485219|FG000|Dose Escalation Period|study drug toxicity|1|||
147635731|NCT00452673|532485220|FG001|Dose Escalation Period|study drug toxicity|3|||
147635732|NCT00452673|532485221|FG002|Dose Escalation Period|study drug toxicity|3|||
147635733|NCT00452673|532485222|FG003|Dose Escalation Period|study drug toxicity|1|||
147635734|NCT00452673|532485223|FG004|Dose Escalation Period|study drug toxicity|0|||
147635735|NCT00452673|532485219|FG000|Dose Escalation Period|Other|0|||
147635736|NCT00452673|532485220|FG001|Dose Escalation Period|Other|0|||
147635737|NCT00452673|532485221|FG002|Dose Escalation Period|Other|1|||
147635738|NCT00452673|532485222|FG003|Dose Escalation Period|Other|0|||
147635739|NCT00452673|532485223|FG004|Dose Escalation Period|Other|0|||
147635740|NCT00452673|532485219|FG000|Dose Escalation Period|Adverse Event|0|||
147635741|NCT00452673|532485220|FG001|Dose Escalation Period|Adverse Event|0|||
147635742|NCT00452673|532485221|FG002|Dose Escalation Period|Adverse Event|0|||
147635743|NCT00452673|532485222|FG003|Dose Escalation Period|Adverse Event|1|||
147635744|NCT00452673|532485223|FG004|Dose Escalation Period|Adverse Event|0|||
147635745|NCT00452673|532485219|FG000|Dose Escalation Period|Withdrawal by Subject|0|||
147635746|NCT00452673|532485220|FG001|Dose Escalation Period|Withdrawal by Subject|0|||
147635747|NCT00452673|532485221|FG002|Dose Escalation Period|Withdrawal by Subject|0|||
147635748|NCT00452673|532485222|FG003|Dose Escalation Period|Withdrawal by Subject|1|||
147635749|NCT00452673|532485223|FG004|Dose Escalation Period|Withdrawal by Subject|0|||
147635750|NCT00452673|532485219|FG000|Dose Expansion Period|Disease Progression|0|||
147635751|NCT00452673|532485220|FG001|Dose Expansion Period|Disease Progression|0|||
147635752|NCT00452673|532485221|FG002|Dose Expansion Period|Disease Progression|0|||
147635753|NCT00452673|532485222|FG003|Dose Expansion Period|Disease Progression|0|||
147635754|NCT00452673|532485223|FG004|Dose Expansion Period|Disease Progression|19|||
147635755|NCT00452673|532485219|FG000|Dose Expansion Period|Other|0|||
147635756|NCT00452673|532485220|FG001|Dose Expansion Period|Other|0|||
147635757|NCT00452673|532485221|FG002|Dose Expansion Period|Other|0|||
147635758|NCT00452673|532485222|FG003|Dose Expansion Period|Other|0|||
147635759|NCT00452673|532485223|FG004|Dose Expansion Period|Other|2|||
147635760|NCT02048826|532485235|FG000|Overall Study|Withdrawal by Subject|1|||
147635761|NCT02048826|532485236|FG001|Overall Study|Withdrawal by Subject|0|||
147635762|NCT04470544|532485239|FG000|Overall Study|Withdrawal by Subject|4|||
147635763|NCT04470544|532485240|FG001|Overall Study|Withdrawal by Subject|6|||
147635764|NCT00712881|532485242|FG000|Overall Study|Adverse Event|3|||
147635765|NCT00712881|532485243|FG001|Overall Study|Adverse Event|3|||
147635766|NCT00712881|532485242|FG000|Overall Study|Withdrawal by Subject|1|||
147635767|NCT00712881|532485243|FG001|Overall Study|Withdrawal by Subject|1|||
147635768|NCT00712881|532485242|FG000|Overall Study|Disease Progression|2|||
147635769|NCT00712881|532485243|FG001|Overall Study|Disease Progression|1|||
147635770|NCT00712881|532485242|FG000|Overall Study|Lost to Follow-up|1|||
147635771|NCT00712881|532485243|FG001|Overall Study|Lost to Follow-up|1|||
147635772|NCT00712881|532485242|FG000|Overall Study|Non-Compliance To Study Procedures|1|||
147635773|NCT00712881|532485243|FG001|Overall Study|Non-Compliance To Study Procedures|0|||
147635774|NCT00712881|532485242|FG000|Overall Study|Protocol Violation|1|||
147635775|NCT00712881|532485243|FG001|Overall Study|Protocol Violation|1|||
147635776|NCT00712881|532485242|FG000|Overall Study|Randomized but not treated|1|||
147635777|NCT00712881|532485243|FG001|Overall Study|Randomized but not treated|0|||
147635778|NCT02222545|532485246|FG000|Overall Study|Adverse Event|1|||
147635779|NCT02222545|532485247|FG001|Overall Study|Adverse Event|0|||
147635780|NCT02222545|532485248|FG002|Overall Study|Adverse Event|2|||
147635781|NCT02222545|532485246|FG000|Overall Study|Death|0|||
147635782|NCT02222545|532485247|FG001|Overall Study|Death|0|||
147635783|NCT02222545|532485248|FG002|Overall Study|Death|9|||
147635784|NCT02222545|532485246|FG000|Overall Study|Deaths based on Long Term Chart Review of HSCT patients|0|||
147635785|NCT02222545|532485247|FG001|Overall Study|Deaths based on Long Term Chart Review of HSCT patients|0|||
147635786|NCT02222545|532485248|FG002|Overall Study|Deaths based on Long Term Chart Review of HSCT patients|10|||
147635787|NCT02222545|532485246|FG000|Overall Study|Withdrawal by Subject|0|||
147635788|NCT02222545|532485247|FG001|Overall Study|Withdrawal by Subject|0|||
147635789|NCT02222545|532485248|FG002|Overall Study|Withdrawal by Subject|3|||
147635790|NCT02222545|532485246|FG000|Overall Study|Proceeded to compassionate use of OMS721|0|||
147635791|NCT02222545|532485247|FG001|Overall Study|Proceeded to compassionate use of OMS721|0|||
147635792|NCT02222545|532485248|FG002|Overall Study|Proceeded to compassionate use of OMS721|1|||
147635793|NCT00537316|532485250|FG000|Part 1|Adverse Event|7|||
147635794|NCT00537316|532485251|FG001|Part 1|Adverse Event|11|||
147635795|NCT00537316|532485252|FG002|Part 1|Adverse Event|8|||
147635796|NCT00537316|532485253|FG003|Part 1|Adverse Event|0|||
147635797|NCT00537316|532485254|FG004|Part 1|Adverse Event|0|||
147635798|NCT00537316|532485255|FG005|Part 1|Adverse Event|0|||
147635799|NCT00537316|532485256|FG006|Part 1|Adverse Event|0|||
147635800|NCT00537316|532485250|FG000|Part 1|Protocol defined clinical event|1|||
147635801|NCT00537316|532485251|FG001|Part 1|Protocol defined clinical event|0|||
147635802|NCT00537316|532485252|FG002|Part 1|Protocol defined clinical event|0|||
147635803|NCT00537316|532485253|FG003|Part 1|Protocol defined clinical event|0|||
147635804|NCT00537316|532485254|FG004|Part 1|Protocol defined clinical event|0|||
147635805|NCT00537316|532485255|FG005|Part 1|Protocol defined clinical event|0|||
147635806|NCT00537316|532485256|FG006|Part 1|Protocol defined clinical event|0|||
147635807|NCT00537316|532485250|FG000|Part 1|Lost to Follow-up|1|||
147635808|NCT00537316|532485251|FG001|Part 1|Lost to Follow-up|0|||
147635809|NCT00537316|532485252|FG002|Part 1|Lost to Follow-up|0|||
147635810|NCT00537316|532485253|FG003|Part 1|Lost to Follow-up|0|||
147635811|NCT00537316|532485254|FG004|Part 1|Lost to Follow-up|0|||
147635812|NCT00537316|532485255|FG005|Part 1|Lost to Follow-up|0|||
147635813|NCT00537316|532485256|FG006|Part 1|Lost to Follow-up|0|||
147635814|NCT00537316|532485250|FG000|Part 1|Withdrawal by Subject|3|||
147635815|NCT00537316|532485251|FG001|Part 1|Withdrawal by Subject|8|||
147635816|NCT00537316|532485252|FG002|Part 1|Withdrawal by Subject|4|||
147635817|NCT00537316|532485253|FG003|Part 1|Withdrawal by Subject|0|||
147635818|NCT00537316|532485254|FG004|Part 1|Withdrawal by Subject|0|||
147635819|NCT00537316|532485255|FG005|Part 1|Withdrawal by Subject|0|||
147635820|NCT00537316|532485256|FG006|Part 1|Withdrawal by Subject|0|||
147635821|NCT00537316|532485250|FG000|Part 1|Protocol Violation|1|||
147635822|NCT00537316|532485251|FG001|Part 1|Protocol Violation|5|||
147635823|NCT00537316|532485252|FG002|Part 1|Protocol Violation|1|||
147635824|NCT00537316|532485253|FG003|Part 1|Protocol Violation|0|||
147635825|NCT00537316|532485254|FG004|Part 1|Protocol Violation|0|||
147635826|NCT00537316|532485255|FG005|Part 1|Protocol Violation|0|||
147635827|NCT00537316|532485256|FG006|Part 1|Protocol Violation|0|||
147635828|NCT00537316|532485250|FG000|Part 1|Did not meet protocol eligibility|1|||
147635829|NCT00537316|532485251|FG001|Part 1|Did not meet protocol eligibility|3|||
147635830|NCT00537316|532485252|FG002|Part 1|Did not meet protocol eligibility|2|||
147635831|NCT00537316|532485253|FG003|Part 1|Did not meet protocol eligibility|0|||
147635832|NCT00537316|532485254|FG004|Part 1|Did not meet protocol eligibility|0|||
147635833|NCT00537316|532485255|FG005|Part 1|Did not meet protocol eligibility|0|||
147635834|NCT00537316|532485256|FG006|Part 1|Did not meet protocol eligibility|0|||
147635835|NCT00537316|532485250|FG000|Part 1|Administrative|0|||
147635836|NCT00537316|532485251|FG001|Part 1|Administrative|0|||
147635837|NCT00537316|532485252|FG002|Part 1|Administrative|2|||
147635838|NCT00537316|532485253|FG003|Part 1|Administrative|0|||
147635839|NCT00537316|532485254|FG004|Part 1|Administrative|0|||
147635840|NCT00537316|532485255|FG005|Part 1|Administrative|0|||
147635841|NCT00537316|532485256|FG006|Part 1|Administrative|0|||
147635842|NCT00537316|532485250|FG000|Part 2|Never entered follow-up|0|||
147635843|NCT00537316|532485251|FG001|Part 2|Never entered follow-up|0|||
147635844|NCT00537316|532485252|FG002|Part 2|Never entered follow-up|0|||
147635845|NCT00537316|532485253|FG003|Part 2|Never entered follow-up|0|||
147635846|NCT00537316|532485254|FG004|Part 2|Never entered follow-up|0|||
147635847|NCT00537316|532485255|FG005|Part 2|Never entered follow-up|0|||
147635848|NCT00537316|532485256|FG006|Part 2|Never entered follow-up|1|||
147635849|NCT00537316|532485250|FG000|Part 2|Adverse Event|4|||
147635850|NCT00537316|532485251|FG001|Part 2|Adverse Event|0|||
147635851|NCT00537316|532485252|FG002|Part 2|Adverse Event|2|||
147635852|NCT00537316|532485253|FG003|Part 2|Adverse Event|0|||
147635853|NCT00537316|532485254|FG004|Part 2|Adverse Event|0|||
147635854|NCT00537316|532485255|FG005|Part 2|Adverse Event|0|||
147635855|NCT00537316|532485256|FG006|Part 2|Adverse Event|0|||
147635856|NCT00537316|532485250|FG000|Part 2|Lost to Follow-up|1|||
147635857|NCT00537316|532485251|FG001|Part 2|Lost to Follow-up|0|||
147635858|NCT00537316|532485252|FG002|Part 2|Lost to Follow-up|2|||
147635859|NCT00537316|532485253|FG003|Part 2|Lost to Follow-up|0|||
147635860|NCT00537316|532485254|FG004|Part 2|Lost to Follow-up|0|||
147635861|NCT00537316|532485255|FG005|Part 2|Lost to Follow-up|0|||
147635862|NCT00537316|532485256|FG006|Part 2|Lost to Follow-up|0|||
147635863|NCT00537316|532485250|FG000|Part 2|Withdrawal by Subject|5|||
147635864|NCT00537316|532485251|FG001|Part 2|Withdrawal by Subject|1|||
147635865|NCT00537316|532485252|FG002|Part 2|Withdrawal by Subject|4|||
147635866|NCT00537316|532485253|FG003|Part 2|Withdrawal by Subject|0|||
147635867|NCT00537316|532485254|FG004|Part 2|Withdrawal by Subject|0|||
147635868|NCT00537316|532485255|FG005|Part 2|Withdrawal by Subject|0|||
147635869|NCT00537316|532485256|FG006|Part 2|Withdrawal by Subject|0|||
147635870|NCT00537316|532485250|FG000|Part 2|Administrative|16|||
147635871|NCT00537316|532485251|FG001|Part 2|Administrative|8|||
147635872|NCT00537316|532485252|FG002|Part 2|Administrative|24|||
147635873|NCT00537316|532485253|FG003|Part 2|Administrative|3|||
147635874|NCT00537316|532485254|FG004|Part 2|Administrative|1|||
147635875|NCT00537316|532485255|FG005|Part 2|Administrative|4|||
147635876|NCT00537316|532485256|FG006|Part 2|Administrative|1|||
147635877|NCT04533412|532485257|FG000|Overall Study|Withdrawal by Subject|1|||
147635878|NCT04533412|532485258|FG001|Overall Study|Withdrawal by Subject|1|||
147635879|NCT04533412|532485257|FG000|Overall Study|Lost to Follow-up|1|||
147635880|NCT04533412|532485258|FG001|Overall Study|Lost to Follow-up|4|||
147635881|NCT05113979|532485259|FG000|Overall Study|Death|2|||
147635882|NCT05113979|532485259|FG000|Overall Study|Lost to Follow-up|1|||
147504363|NCT00448760|531998780|FG000|Overall Study|Death|3|||
147504364|NCT03017846|531998783|FG000|Overall Study|Lost to Follow-up|3|||
147504365|NCT03017846|531998783|FG000|Overall Study|Adverse Event|2|||
147504366|NCT00618995|531998785|FG000|Period 1|Adverse Event|0|||
147504367|NCT00618995|531998786|FG001|Period 1|Adverse Event|0|||
147504368|NCT00618995|531998787|FG002|Period 1|Adverse Event|1|||
147504369|NCT00618995|531998788|FG003|Period 1|Adverse Event|0|||
147504370|NCT00618995|531998785|FG000|Period 1|Protocol Violation|0|||
147504371|NCT00618995|531998786|FG001|Period 1|Protocol Violation|1|||
147504372|NCT00618995|531998787|FG002|Period 1|Protocol Violation|1|||
147504373|NCT00618995|531998788|FG003|Period 1|Protocol Violation|0|||
147504374|NCT00618995|531998785|FG000|Period 2|Protocol Violation|0|||
147504375|NCT00618995|531998786|FG001|Period 2|Protocol Violation|0|||
147504376|NCT00618995|531998787|FG002|Period 2|Protocol Violation|1|||
147504377|NCT00618995|531998788|FG003|Period 2|Protocol Violation|0|||
147504378|NCT00618995|531998785|FG000|Period 4|Adverse Event|1|||
147504379|NCT00618995|531998786|FG001|Period 4|Adverse Event|0|||
147504380|NCT00618995|531998787|FG002|Period 4|Adverse Event|0|||
147504381|NCT00618995|531998788|FG003|Period 4|Adverse Event|0|||
147504382|NCT01213264|531998789|FG000|Overall Study|Adverse Event|1|||
147504383|NCT01213264|531998790|FG001|Overall Study|Adverse Event|0|||
147504384|NCT01213264|531998791|FG002|Overall Study|Adverse Event|0|||
147504385|NCT01213264|531998789|FG000|Overall Study|Lost to Follow-up|1|||
147504386|NCT01213264|531998790|FG001|Overall Study|Lost to Follow-up|2|||
147504387|NCT01213264|531998791|FG002|Overall Study|Lost to Follow-up|6|||
147504388|NCT05014542|531998793|FG000|Week 1-24, Between Group Analysis|Withdrawal by Subject|6|||
147504389|NCT05014542|531998794|FG001|Week 1-24, Between Group Analysis|Withdrawal by Subject|3|||
147504390|NCT05014542|531998793|FG000|Week 1-24, Between Group Analysis|Lost to Follow-up|1|||
147504391|NCT05014542|531998794|FG001|Week 1-24, Between Group Analysis|Lost to Follow-up|0|||
147504392|NCT05014542|531998793|FG000|Week 25-39, Within Group Analysis|Withdrawal by Subject|0|||
147504393|NCT05014542|531998794|FG001|Week 25-39, Within Group Analysis|Withdrawal by Subject|5|||
147504394|NCT05014542|531998793|FG000|Week 25-39, Within Group Analysis|Lost to Follow-up|2|||
147504395|NCT05014542|531998794|FG001|Week 25-39, Within Group Analysis|Lost to Follow-up|1|||
147635883|NCT00968981|532485262|FG000|Overall Study|Adverse Event|2|||
147635884|NCT00968981|532485263|FG001|Overall Study|Adverse Event|0|||
147504396|NCT01438307|531998795|FG000|Overall Study|Death|1|||
147504397|NCT01438307|531998796|FG001|Overall Study|Death|1|||
147504398|NCT02378883|531998798|FG000|Enrollment|Subject did not meet Inclusion criteria|6|||
147635885|NCT00968981|532485264|FG002|Overall Study|Adverse Event|0|||
147635886|NCT00968981|532485262|FG000|Overall Study|Disease Progression|14|||
147635887|NCT00968981|532485263|FG001|Overall Study|Disease Progression|16|||
147635888|NCT00968981|532485264|FG002|Overall Study|Disease Progression|13|||
147504399|NCT02378883|531998798|FG000|Enrollment|Attempt to use Apollo was not performed|3|||
147504400|NCT02378883|531998798|FG000|30 Day Follow-Up|Withdrawal by Subject|1|||
147504401|NCT02378883|531998798|FG000|30 Day Follow-Up|Physician Decision|2|||
147504402|NCT02378883|531998798|FG000|30 Day Follow-Up|Missed Visit|2|||
147504403|NCT02378883|531998798|FG000|30 Day Follow-Up|Death|1|||
147635889|NCT00968981|532485262|FG000|Overall Study|Lost to Follow-up|0|||
147635890|NCT00968981|532485263|FG001|Overall Study|Lost to Follow-up|0|||
147635891|NCT00968981|532485264|FG002|Overall Study|Lost to Follow-up|1|||
147635892|NCT00968981|532485262|FG000|Overall Study|Physician Decision|5|||
147504404|NCT02378883|531998798|FG000|12 Months Follow-Up|Lost to Follow-up|3|||
147504405|NCT02378883|531998798|FG000|12 Months Follow-Up|Death|2|||
147504406|NCT00810810|531998800|FG000|Overall Study|Withdrawal by Subject|0|||
147504407|NCT00810810|531998801|FG001|Overall Study|Withdrawal by Subject|8|||
147504408|NCT00810810|531998802|FG002|Overall Study|Withdrawal by Subject|10|||
147504409|NCT00810810|531998803|FG003|Overall Study|Withdrawal by Subject|8|||
147504410|NCT00810810|531998800|FG000|Overall Study|Physician Decision|0|||
147504411|NCT00810810|531998801|FG001|Overall Study|Physician Decision|3|||
147504412|NCT00810810|531998802|FG002|Overall Study|Physician Decision|1|||
147504413|NCT00810810|531998803|FG003|Overall Study|Physician Decision|5|||
147504414|NCT02563925|531998804|FG000|Overall Study|Withdrawal by Subject|2|||
147504415|NCT00282867|531998805|FG000|Overall Study|d/c prior to prim outcome, 3 m f/u done|1|||
147504416|NCT00282867|531998806|FG001|Overall Study|d/c prior to prim outcome, 3 m f/u done|1|||
147504417|NCT00282867|531998807|FG002|Overall Study|d/c prior to prim outcome, 3 m f/u done|0|||
147504418|NCT01342952|531998808|FG000|Overall Study|Adverse Event|0|||
147504419|NCT01342952|531998809|FG001|Overall Study|Adverse Event|5|||
147504420|NCT01342952|531998810|FG002|Overall Study|Adverse Event|1|||
147504421|NCT01342952|531998811|FG003|Overall Study|Adverse Event|0|||
147504422|NCT01342952|531998808|FG000|Overall Study|Lost to Follow-up|0|||
147504423|NCT01342952|531998809|FG001|Overall Study|Lost to Follow-up|2|||
147504424|NCT01342952|531998810|FG002|Overall Study|Lost to Follow-up|0|||
147504425|NCT01342952|531998811|FG003|Overall Study|Lost to Follow-up|0|||
147504426|NCT01342952|531998808|FG000|Overall Study|Withdrawal by Subject|1|||
147504427|NCT01342952|531998809|FG001|Overall Study|Withdrawal by Subject|1|||
147504428|NCT01342952|531998810|FG002|Overall Study|Withdrawal by Subject|0|||
147504429|NCT01342952|531998811|FG003|Overall Study|Withdrawal by Subject|0|||
147504430|NCT01342952|531998808|FG000|Overall Study|Physician Decision|3|||
147504431|NCT01342952|531998809|FG001|Overall Study|Physician Decision|3|||
147504432|NCT01342952|531998810|FG002|Overall Study|Physician Decision|1|||
147504433|NCT01342952|531998811|FG003|Overall Study|Physician Decision|0|||
147504434|NCT00426556|531998814|FG000|Phase I - Core Phase|Disease Progression|0|||
147504435|NCT00426556|531998815|FG001|Phase I - Core Phase|Disease Progression|6|||
147504436|NCT00426556|531998816|FG002|Phase I - Core Phase|Disease Progression|2|||
147504437|NCT00426556|531998817|FG003|Phase I - Core Phase|Disease Progression|0|||
147504438|NCT00426556|531998814|FG000|Phase I - Core Phase|Adverse Event|1|||
147504439|NCT00426556|531998815|FG001|Phase I - Core Phase|Adverse Event|3|||
147504440|NCT00426556|531998816|FG002|Phase I - Core Phase|Adverse Event|1|||
147504441|NCT00426556|531998817|FG003|Phase I - Core Phase|Adverse Event|0|||
147504442|NCT00426556|531998814|FG000|Phase I - Core Phase|Death|0|||
147504443|NCT00426556|531998815|FG001|Phase I - Core Phase|Death|1|||
147504444|NCT00426556|531998816|FG002|Phase I - Core Phase|Death|0|||
147504445|NCT00426556|531998817|FG003|Phase I - Core Phase|Death|0|||
147504446|NCT00426556|531998814|FG000|Phase I - Extension Phase|Adverse Event|0|||
147504447|NCT00426556|531998815|FG001|Phase I - Extension Phase|Adverse Event|1|||
147504448|NCT00426556|531998816|FG002|Phase I - Extension Phase|Adverse Event|1|||
147504449|NCT00426556|531998817|FG003|Phase I - Extension Phase|Adverse Event|0|||
147504450|NCT00426556|531998814|FG000|Phase I - Extension Phase|Disease Progression|5|||
147504451|NCT00426556|531998815|FG001|Phase I - Extension Phase|Disease Progression|5|||
147504452|NCT00426556|531998816|FG002|Phase I - Extension Phase|Disease Progression|6|||
147504453|NCT00426556|531998817|FG003|Phase I - Extension Phase|Disease Progression|0|||
147504454|NCT00426556|531998814|FG000|Phase II - Core Phase|Withdrawal by Subject|0|||
147504455|NCT00426556|531998815|FG001|Phase II - Core Phase|Withdrawal by Subject|0|||
147504456|NCT00426556|531998816|FG002|Phase II - Core Phase|Withdrawal by Subject|0|||
147504457|NCT00426556|531998817|FG003|Phase II - Core Phase|Withdrawal by Subject|3|||
147504458|NCT00426556|531998814|FG000|Phase II - Core Phase|Disease Progression|0|||
147504459|NCT00426556|531998815|FG001|Phase II - Core Phase|Disease Progression|0|||
147504460|NCT00426556|531998816|FG002|Phase II - Core Phase|Disease Progression|0|||
147504461|NCT00426556|531998817|FG003|Phase II - Core Phase|Disease Progression|16|||
147504462|NCT00426556|531998814|FG000|Phase II - Core Phase|Adverse Event|0|||
147504463|NCT00426556|531998815|FG001|Phase II - Core Phase|Adverse Event|0|||
147504464|NCT00426556|531998816|FG002|Phase II - Core Phase|Adverse Event|0|||
147504465|NCT00426556|531998817|FG003|Phase II - Core Phase|Adverse Event|8|||
147504466|NCT00426556|531998814|FG000|Phase II - Extension Phase|Disease Progression|0|||
147504467|NCT00426556|531998815|FG001|Phase II - Extension Phase|Disease Progression|0|||
147504468|NCT00426556|531998816|FG002|Phase II - Extension Phase|Disease Progression|0|||
147504469|NCT00426556|531998817|FG003|Phase II - Extension Phase|Disease Progression|21|||
147504470|NCT00426556|531998814|FG000|Phase II - Extension Phase|Adverse Event|0|||
147504471|NCT00426556|531998815|FG001|Phase II - Extension Phase|Adverse Event|0|||
147504472|NCT00426556|531998816|FG002|Phase II - Extension Phase|Adverse Event|0|||
147504473|NCT00426556|531998817|FG003|Phase II - Extension Phase|Adverse Event|2|||
147504474|NCT03970824|531998819|FG000|Overall Study|Withdrawal by Subject|1|||
147504475|NCT03970824|531998820|FG001|Overall Study|Withdrawal by Subject|1|||
147504476|NCT03970824|531998821|FG002|Overall Study|Withdrawal by Subject|3|||
147504477|NCT03970824|531998819|FG000|Overall Study|Lost to Follow-up|0|||
147504478|NCT03970824|531998820|FG001|Overall Study|Lost to Follow-up|2|||
147504479|NCT03970824|531998821|FG002|Overall Study|Lost to Follow-up|1|||
147504480|NCT03970824|531998819|FG000|Overall Study|Adverse Event|1|||
147504481|NCT03970824|531998820|FG001|Overall Study|Adverse Event|0|||
147504482|NCT03970824|531998821|FG002|Overall Study|Adverse Event|0|||
147504483|NCT00105560|531998824|FG000|Overall Study|Lost to Follow-up|1|||
147504484|NCT01315847|531998826|FG000|Part I, Period 1|Reached maximum number of arterial lines|3|||
147504485|NCT01315847|531998827|FG001|Part I, Period 1|Reached maximum number of arterial lines|0|||
147504486|NCT01315847|531998826|FG000|Part III, Period 1|[11C]MK-4232 synthesis failure|0|||
147635893|NCT00968981|532485263|FG001|Overall Study|Physician Decision|3|||
147635894|NCT00968981|532485264|FG002|Overall Study|Physician Decision|5|||
147635895|NCT00968981|532485262|FG000|Overall Study|Withdrawal by Subject|1|||
147635896|NCT00968981|532485263|FG001|Overall Study|Withdrawal by Subject|3|||
147635897|NCT00968981|532485264|FG002|Overall Study|Withdrawal by Subject|3|||
147635898|NCT01878084|532485270|FG000|Overall Study|Physician Decision|2|||
147635899|NCT01876784|532485271|FG000|Randomized Treatment Period (40 Months)|Withdrawal by Subject|20|||
147635900|NCT01876784|532485272|FG001|Randomized Treatment Period (40 Months)|Withdrawal by Subject|4|||
147635901|NCT01876784|532485271|FG000|Randomized Treatment Period (40 Months)|Adverse Event|22|||
147635902|NCT01876784|532485272|FG001|Randomized Treatment Period (40 Months)|Adverse Event|5|||
147635903|NCT01876784|532485271|FG000|Randomized Treatment Period (40 Months)|Protocol Violation|1|||
147635904|NCT01876784|532485272|FG001|Randomized Treatment Period (40 Months)|Protocol Violation|0|||
147635905|NCT01876784|532485271|FG000|Randomized Treatment Period (40 Months)|Disease progression|43|||
147635906|NCT01876784|532485272|FG001|Randomized Treatment Period (40 Months)|Disease progression|81|||
147635907|NCT01876784|532485271|FG000|Randomized Treatment Period (40 Months)|Lost to Follow-up|1|||
147635908|NCT01876784|532485272|FG001|Randomized Treatment Period (40 Months)|Lost to Follow-up|1|||
147635909|NCT01876784|532485271|FG000|Randomized Treatment Period (40 Months)|Death|1|||
147635910|NCT01876784|532485272|FG001|Randomized Treatment Period (40 Months)|Death|0|||
147635911|NCT01876784|532485271|FG000|Randomized Treatment Period (40 Months)|Development of study-specific discontinuation criteria|5|||
147635912|NCT01876784|532485272|FG001|Randomized Treatment Period (40 Months)|Development of study-specific discontinuation criteria|2|||
147635913|NCT01876784|532485271|FG000|Randomized Treatment Period (40 Months)|Randomized but not treated|2|||
147635914|NCT01876784|532485272|FG001|Randomized Treatment Period (40 Months)|Randomized but not treated|1|||
147635915|NCT01876784|532485271|FG000|Randomized Treatment Period (40 Months)|Other than specified above|24|||
147635916|NCT01876784|532485272|FG001|Randomized Treatment Period (40 Months)|Other than specified above|25|||
147635917|NCT01876784|532485271|FG000|Open-label Period (31 Months)|Withdrawal by Subject|6|||
147635918|NCT01876784|532485272|FG001|Open-label Period (31 Months)|Withdrawal by Subject|8|||
147635919|NCT01876784|532485271|FG000|Open-label Period (31 Months)|Adverse Event|2|||
147635920|NCT01876784|532485272|FG001|Open-label Period (31 Months)|Adverse Event|6|||
147635921|NCT01876784|532485271|FG000|Open-label Period (31 Months)|Protocol Violation|0|||
147635922|NCT01876784|532485272|FG001|Open-label Period (31 Months)|Protocol Violation|1|||
147635923|NCT01876784|532485271|FG000|Open-label Period (31 Months)|Progressive disease|4|||
147635924|NCT01876784|532485272|FG001|Open-label Period (31 Months)|Progressive disease|35|||
147635925|NCT01876784|532485271|FG000|Open-label Period (31 Months)|Development of study-specific discontinuation criteria|1|||
147635926|NCT01876784|532485272|FG001|Open-label Period (31 Months)|Development of study-specific discontinuation criteria|5|||
147635927|NCT01876784|532485271|FG000|Open-label Period (31 Months)|Lost to Follow-up|1|||
147635928|NCT01876784|532485272|FG001|Open-label Period (31 Months)|Lost to Follow-up|0|||
147635929|NCT01876784|532485271|FG000|Open-label Period (31 Months)|Death|0|||
147635930|NCT01876784|532485272|FG001|Open-label Period (31 Months)|Death|1|||
147635931|NCT01876784|532485271|FG000|Open-label Period (31 Months)|Other than specified above|9|||
147635932|NCT01876784|532485272|FG001|Open-label Period (31 Months)|Other than specified above|18|||
147635933|NCT01194531|532485274|FG000|Overall Study|Withdrawal by Subject|1|||
147635934|NCT01194531|532485275|FG001|Overall Study|Withdrawal by Subject|0|||
147635935|NCT01194531|532485274|FG000|Overall Study|Protocol Violation|4|||
147635936|NCT01194531|532485275|FG001|Overall Study|Protocol Violation|1|||
147635937|NCT01194531|532485274|FG000|Overall Study|Physician Decision|0|||
147635938|NCT01194531|532485275|FG001|Overall Study|Physician Decision|2|||
147635939|NCT03891862|532485276|FG000|Open-label Period|Adverse Event|2|||
147635940|NCT03891862|532485277|FG001|Open-label Period|Adverse Event|0|||
147635941|NCT03891862|532485278|FG002|Open-label Period|Adverse Event|0|||
147635942|NCT03891862|532485276|FG000|Open-label Period|Protocol Violation|5|||
147635943|NCT03891862|532485277|FG001|Open-label Period|Protocol Violation|0|||
147635944|NCT03891862|532485278|FG002|Open-label Period|Protocol Violation|0|||
147635945|NCT03891862|532485276|FG000|Open-label Period|Withdrawal by Subject|6|||
147635946|NCT03891862|532485277|FG001|Open-label Period|Withdrawal by Subject|0|||
147635947|NCT03891862|532485278|FG002|Open-label Period|Withdrawal by Subject|0|||
147635948|NCT03891862|532485276|FG000|Open-label Period|Death|1|||
147635949|NCT03891862|532485277|FG001|Open-label Period|Death|0|||
147635950|NCT03891862|532485278|FG002|Open-label Period|Death|0|||
147635951|NCT03891862|532485276|FG000|Open-label Period|Lost to Follow-up|2|||
147635952|NCT03891862|532485277|FG001|Open-label Period|Lost to Follow-up|0|||
147635953|NCT03891862|532485278|FG002|Open-label Period|Lost to Follow-up|0|||
147635954|NCT03891862|532485276|FG000|Placebo-controlled Period and Follow-up|Adverse Event|0|||
147635955|NCT03891862|532485277|FG001|Placebo-controlled Period and Follow-up|Adverse Event|1|||
147635956|NCT03891862|532485278|FG002|Placebo-controlled Period and Follow-up|Adverse Event|1|||
147635957|NCT03891862|532485276|FG000|Placebo-controlled Period and Follow-up|Protocol Violation|0|||
147635958|NCT03891862|532485277|FG001|Placebo-controlled Period and Follow-up|Protocol Violation|2|||
147635959|NCT03891862|532485278|FG002|Placebo-controlled Period and Follow-up|Protocol Violation|1|||
147635960|NCT03891862|532485276|FG000|Placebo-controlled Period and Follow-up|Withdrawal by Subject|0|||
147635961|NCT03891862|532485277|FG001|Placebo-controlled Period and Follow-up|Withdrawal by Subject|1|||
147635962|NCT03891862|532485278|FG002|Placebo-controlled Period and Follow-up|Withdrawal by Subject|2|||
147635963|NCT03891862|532485276|FG000|Placebo-controlled Period and Follow-up|Lost to Follow-up|0|||
147635964|NCT03891862|532485277|FG001|Placebo-controlled Period and Follow-up|Lost to Follow-up|2|||
147635965|NCT03891862|532485278|FG002|Placebo-controlled Period and Follow-up|Lost to Follow-up|0|||
147635966|NCT00373958|532485290|FG000|Infant Series|Withdrawal by Subject|13|||
147635967|NCT00373958|532485291|FG001|Infant Series|Withdrawal by Subject|15|||
147635968|NCT00373958|532485290|FG000|Infant Series|Failed to return|8|||
147635969|NCT00373958|532485291|FG001|Infant Series|Failed to return|13|||
147635970|NCT00373958|532485290|FG000|Infant Series|Lost to Follow-up|6|||
147635971|NCT00373958|532485291|FG001|Infant Series|Lost to Follow-up|5|||
147635972|NCT00373958|532485290|FG000|Infant Series|Protocol Violation|3|||
147635973|NCT00373958|532485291|FG001|Infant Series|Protocol Violation|7|||
147635974|NCT00373958|532485290|FG000|Infant Series|Lost Kaiser coverage|4|||
147635975|NCT00373958|532485291|FG001|Infant Series|Lost Kaiser coverage|0|||
147635976|NCT00373958|532485290|FG000|Infant Series|Child relocated|1|||
147635977|NCT00373958|532485291|FG001|Infant Series|Child relocated|0|||
147635978|NCT00373958|532485290|FG000|Infant Series|Consent was not received|1|||
147635979|NCT00373958|532485291|FG001|Infant Series|Consent was not received|0|||
147635980|NCT00373958|532485290|FG000|Infant Series|Adverse Event|3|||
147635981|NCT00373958|532485291|FG001|Infant Series|Adverse Event|1|||
147635982|NCT00373958|532485290|FG000|Infant Series|Physician Decision|1|||
147635983|NCT00373958|532485291|FG001|Infant Series|Physician Decision|1|||
147635984|NCT00373958|532485290|FG000|Toddler Dose|Lost to Follow-up|5|||
147635985|NCT00373958|532485291|FG001|Toddler Dose|Lost to Follow-up|8|||
147635986|NCT00373958|532485290|FG000|Toddler Dose|Withdrawal by Subject|2|||
147635987|NCT00373958|532485291|FG001|Toddler Dose|Withdrawal by Subject|2|||
147635988|NCT00373958|532485290|FG000|Toddler Dose|Failed to return|1|||
147635989|NCT00373958|532485291|FG001|Toddler Dose|Failed to return|2|||
147635990|NCT00373958|532485290|FG000|Toddler Dose|Protocol Violation|0|||
147635991|NCT00373958|532485291|FG001|Toddler Dose|Protocol Violation|1|||
147635992|NCT00373958|532485290|FG000|Toddler Dose|Withdrawn after infant series|22|||
147635993|NCT00373958|532485291|FG001|Toddler Dose|Withdrawn after infant series|25|||
147635994|NCT00492648|532485295|FG000|Month 30 (109671 Study)|Protocol Violation|0|||
147635995|NCT00492648|532485296|FG001|Month 30 (109671 Study)|Protocol Violation|1|||
147635996|NCT00282113|532485297|FG000|Overall Study|Removed at parents request|1|||
147635997|NCT00282113|532485298|FG001|Overall Study|Removed at parents request|0|||
147635998|NCT00282113|532485299|FG002|Overall Study|Removed at parents request|0|||
147635999|NCT03382834|532485300|FG000|Step 1|Lost to Follow-up|0|||
147636000|NCT03382834|532485301|FG001|Step 1|Lost to Follow-up|1|||
147636001|NCT03382834|532485300|FG000|Step 2|Death|1|||
147636002|NCT03382834|532485301|FG001|Step 2|Death|0|||
147636003|NCT03382834|532485300|FG000|Step 2|Lost to Follow-up|2|||
147636004|NCT03382834|532485301|FG001|Step 2|Lost to Follow-up|2|||
147636005|NCT03382834|532485300|FG000|Step 2|Site Terminated by Sponsor|1|||
147636006|NCT03382834|532485301|FG001|Step 2|Site Terminated by Sponsor|0|||
147636007|NCT02387957|532485302|FG000|Overall Study|The study was discontinued|21|||
147636008|NCT02387957|532485303|FG001|Overall Study|The study was discontinued|21|||
147636009|NCT02387957|532485304|FG002|Overall Study|The study was discontinued|20|||
147636010|NCT02294396|532485305|FG000|Overall Study|Adverse Event|26|||
147636011|NCT02294396|532485306|FG001|Overall Study|Adverse Event|25|||
147636012|NCT02294396|532485307|FG002|Overall Study|Adverse Event|21|||
147636013|NCT02294396|532485308|FG003|Overall Study|Adverse Event|24|||
147636014|NCT02294396|532485305|FG000|Overall Study|Electrocardiogram adviser's judgment|1|||
147636015|NCT02294396|532485306|FG001|Overall Study|Electrocardiogram adviser's judgment|0|||
147636016|NCT02294396|532485307|FG002|Overall Study|Electrocardiogram adviser's judgment|0|||
147636017|NCT02294396|532485308|FG003|Overall Study|Electrocardiogram adviser's judgment|1|||
147636018|NCT02294396|532485305|FG000|Overall Study|Withdrawal by Subject|8|||
147636019|NCT02294396|532485306|FG001|Overall Study|Withdrawal by Subject|6|||
147636020|NCT02294396|532485307|FG002|Overall Study|Withdrawal by Subject|6|||
147636021|NCT02294396|532485308|FG003|Overall Study|Withdrawal by Subject|8|||
147636022|NCT02294396|532485305|FG000|Overall Study|Lost to Follow-up|0|||
147636023|NCT02294396|532485306|FG001|Overall Study|Lost to Follow-up|0|||
147636024|NCT02294396|532485307|FG002|Overall Study|Lost to Follow-up|1|||
147636025|NCT02294396|532485308|FG003|Overall Study|Lost to Follow-up|1|||
147636026|NCT02294396|532485305|FG000|Overall Study|Protocol Deviation|3|||
147636027|NCT02294396|532485306|FG001|Overall Study|Protocol Deviation|2|||
147636028|NCT02294396|532485307|FG002|Overall Study|Protocol Deviation|2|||
147636029|NCT02294396|532485308|FG003|Overall Study|Protocol Deviation|1|||
147636030|NCT02294396|532485305|FG000|Overall Study|Miscellaneous|2|||
147636031|NCT02294396|532485306|FG001|Overall Study|Miscellaneous|0|||
147636032|NCT02294396|532485307|FG002|Overall Study|Miscellaneous|5|||
147636033|NCT02294396|532485308|FG003|Overall Study|Miscellaneous|2|||
147636034|NCT02949843|532485309|FG000|Overall Study|Withdrawal by Subject|0|||
147636035|NCT02949843|532485310|FG001|Overall Study|Withdrawal by Subject|1|||
147636036|NCT02949843|532485311|FG002|Overall Study|Withdrawal by Subject|1|||
147636037|NCT02120833|532485312|FG000|Overall Study|Adverse Event|1|||
147636038|NCT02120833|532485313|FG001|Overall Study|Adverse Event|0|||
147636039|NCT02120833|532485312|FG000|Overall Study|Withdrawal by Subject|2|||
147636040|NCT02120833|532485313|FG001|Overall Study|Withdrawal by Subject|0|||
147636041|NCT02120833|532485312|FG000|Overall Study|Lost to Follow-up|1|||
147636042|NCT02120833|532485313|FG001|Overall Study|Lost to Follow-up|1|||
147636043|NCT03613649|532485314|FG000|Second Treatment|Lost to Follow-up|0|||
147636044|NCT03613649|532485315|FG001|Second Treatment|Lost to Follow-up|0|||
147636045|NCT03613649|532485316|FG002|Second Treatment|Lost to Follow-up|1|||
147636046|NCT03613649|532485317|FG003|Second Treatment|Lost to Follow-up|0|||
147636047|NCT03613649|532485318|FG004|Second Treatment|Lost to Follow-up|0|||
147636048|NCT03613649|532485319|FG005|Second Treatment|Lost to Follow-up|0|||
147636049|NCT03613649|532485320|FG006|Second Treatment|Lost to Follow-up|0|||
147636050|NCT03613649|532485321|FG007|Second Treatment|Lost to Follow-up|0|||
147636051|NCT03613649|532485322|FG008|Second Treatment|Lost to Follow-up|0|||
147636052|NCT03613649|532485323|FG009|Second Treatment|Lost to Follow-up|0|||
147636053|NCT03613649|532485324|FG010|Second Treatment|Lost to Follow-up|0|||
147636054|NCT03613649|532485325|FG011|Second Treatment|Lost to Follow-up|0|||
147636055|NCT03613649|532485314|FG000|Second Treatment|Withdrawal by Subject|0|||
147636056|NCT03613649|532485315|FG001|Second Treatment|Withdrawal by Subject|0|||
147636057|NCT03613649|532485316|FG002|Second Treatment|Withdrawal by Subject|0|||
147636058|NCT03613649|532485317|FG003|Second Treatment|Withdrawal by Subject|0|||
147636059|NCT03613649|532485318|FG004|Second Treatment|Withdrawal by Subject|1|||
147636060|NCT03613649|532485319|FG005|Second Treatment|Withdrawal by Subject|0|||
147636061|NCT03613649|532485320|FG006|Second Treatment|Withdrawal by Subject|0|||
147636062|NCT03613649|532485321|FG007|Second Treatment|Withdrawal by Subject|0|||
147636063|NCT03613649|532485322|FG008|Second Treatment|Withdrawal by Subject|0|||
147636064|NCT03613649|532485323|FG009|Second Treatment|Withdrawal by Subject|0|||
147636065|NCT03613649|532485324|FG010|Second Treatment|Withdrawal by Subject|0|||
147636066|NCT03613649|532485325|FG011|Second Treatment|Withdrawal by Subject|0|||
147636067|NCT03613649|532485314|FG000|Third Treatment|Lost to Follow-up|0|||
147636068|NCT03613649|532485315|FG001|Third Treatment|Lost to Follow-up|0|||
147636069|NCT03613649|532485316|FG002|Third Treatment|Lost to Follow-up|0|||
147636070|NCT03613649|532485317|FG003|Third Treatment|Lost to Follow-up|0|||
147636071|NCT03613649|532485318|FG004|Third Treatment|Lost to Follow-up|1|||
147636072|NCT03613649|532485319|FG005|Third Treatment|Lost to Follow-up|0|||
147636073|NCT03613649|532485320|FG006|Third Treatment|Lost to Follow-up|0|||
147636074|NCT03613649|532485321|FG007|Third Treatment|Lost to Follow-up|0|||
147636075|NCT03613649|532485322|FG008|Third Treatment|Lost to Follow-up|0|||
147636076|NCT03613649|532485323|FG009|Third Treatment|Lost to Follow-up|0|||
147636077|NCT03613649|532485324|FG010|Third Treatment|Lost to Follow-up|0|||
147636078|NCT03613649|532485325|FG011|Third Treatment|Lost to Follow-up|1|||
147636079|NCT03613649|532485314|FG000|Third Treatment|Protocol Violation|0|||
147636080|NCT03613649|532485315|FG001|Third Treatment|Protocol Violation|0|||
147636081|NCT03613649|532485316|FG002|Third Treatment|Protocol Violation|0|||
147636082|NCT03613649|532485317|FG003|Third Treatment|Protocol Violation|0|||
147636083|NCT03613649|532485318|FG004|Third Treatment|Protocol Violation|0|||
147636084|NCT03613649|532485319|FG005|Third Treatment|Protocol Violation|0|||
147636085|NCT03613649|532485320|FG006|Third Treatment|Protocol Violation|1|||
147636086|NCT03613649|532485321|FG007|Third Treatment|Protocol Violation|0|||
147636087|NCT03613649|532485322|FG008|Third Treatment|Protocol Violation|0|||
147636088|NCT03613649|532485323|FG009|Third Treatment|Protocol Violation|0|||
147636089|NCT03613649|532485324|FG010|Third Treatment|Protocol Violation|0|||
147636090|NCT03613649|532485325|FG011|Third Treatment|Protocol Violation|1|||
147636091|NCT03613649|532485314|FG000|Fourth Treatment|Protocol Violation|1|||
147668852|NCT03363906|532613392|FG001|Period 2 (Test or Reference)|Adverse Event|0|||
147668853|NCT03363906|532613391|FG000|Period 2 (Test or Reference)|Withdrawal by Subject|1|||
147668854|NCT03363906|532613392|FG001|Period 2 (Test or Reference)|Withdrawal by Subject|1|||
147636092|NCT03613649|532485315|FG001|Fourth Treatment|Protocol Violation|0|||
147636093|NCT03613649|532485316|FG002|Fourth Treatment|Protocol Violation|0|||
147636094|NCT03613649|532485317|FG003|Fourth Treatment|Protocol Violation|0|||
147636095|NCT03613649|532485318|FG004|Fourth Treatment|Protocol Violation|1|||
147636096|NCT03613649|532485319|FG005|Fourth Treatment|Protocol Violation|0|||
147636097|NCT03613649|532485320|FG006|Fourth Treatment|Protocol Violation|0|||
147636098|NCT03613649|532485321|FG007|Fourth Treatment|Protocol Violation|0|||
147636099|NCT03613649|532485322|FG008|Fourth Treatment|Protocol Violation|0|||
147636100|NCT03613649|532485323|FG009|Fourth Treatment|Protocol Violation|0|||
147636101|NCT03613649|532485324|FG010|Fourth Treatment|Protocol Violation|0|||
147668855|NCT03363906|532613391|FG000|Period 2 (Test or Reference)|Lost to Follow-up|1|||
147636102|NCT03613649|532485325|FG011|Fourth Treatment|Protocol Violation|0|||
147636103|NCT03613649|532485314|FG000|Fourth Treatment|Physician Decision|0|||
147504487|NCT01315847|531998827|FG001|Part III, Period 1|[11C]MK-4232 synthesis failure|1|||
147504488|NCT03699631|531998831|FG000|Overall Study|Adverse Event|3|||
147504489|NCT00964158|531998832|FG000|Overall Study|Lost to Follow-up|0|||
147504490|NCT00964158|531998833|FG001|Overall Study|Lost to Follow-up|1|||
147504491|NCT00964158|531998834|FG002|Overall Study|Lost to Follow-up|2|||
147504492|NCT00964158|531998832|FG000|Overall Study|Withdrawal by Subject|0|||
147504493|NCT00964158|531998833|FG001|Overall Study|Withdrawal by Subject|0|||
147504494|NCT00964158|531998834|FG002|Overall Study|Withdrawal by Subject|6|||
147504495|NCT01182337|531998835|FG000|Overall Study|Withdrawal by Subject|3|||
147504496|NCT01182337|531998836|FG001|Overall Study|Withdrawal by Subject|1|||
147504497|NCT01182337|531998835|FG000|Overall Study|Lost to Follow-up|0|||
147504498|NCT01182337|531998836|FG001|Overall Study|Lost to Follow-up|1|||
147504499|NCT03101514|531998837|FG000|Overall Study|Withdrawal by Subject|4|||
147504500|NCT03101514|531998837|FG000|Overall Study|Protocol Violation|2|||
147504501|NCT03101514|531998837|FG000|Overall Study|patient's information was incomplete|1|||
147504502|NCT01021813|531998838|FG000|DB Treatment Phase|Adverse Event|60|||
147504503|NCT01021813|531998839|FG001|DB Treatment Phase|Adverse Event|22|||
147504504|NCT01021813|531998840|FG002|DB Treatment Phase|Adverse Event|0|||
147504505|NCT01021813|531998841|FG003|DB Treatment Phase|Adverse Event|0|||
147504506|NCT01021813|531998842|FG004|DB Treatment Phase|Adverse Event|0|||
147504507|NCT01021813|531998838|FG000|DB Treatment Phase|Lack of Efficacy|44|||
147504508|NCT01021813|531998839|FG001|DB Treatment Phase|Lack of Efficacy|28|||
147504509|NCT01021813|531998840|FG002|DB Treatment Phase|Lack of Efficacy|0|||
147504510|NCT01021813|531998841|FG003|DB Treatment Phase|Lack of Efficacy|0|||
147504511|NCT01021813|531998842|FG004|DB Treatment Phase|Lack of Efficacy|0|||
147504512|NCT01021813|531998838|FG000|DB Treatment Phase|Lost to Follow-up|14|||
147504513|NCT01021813|531998839|FG001|DB Treatment Phase|Lost to Follow-up|12|||
147504514|NCT01021813|531998840|FG002|DB Treatment Phase|Lost to Follow-up|0|||
147504515|NCT01021813|531998841|FG003|DB Treatment Phase|Lost to Follow-up|0|||
147504516|NCT01021813|531998842|FG004|DB Treatment Phase|Lost to Follow-up|0|||
147504517|NCT01021813|531998838|FG000|DB Treatment Phase|Physician Decision|17|||
147504518|NCT01021813|531998839|FG001|DB Treatment Phase|Physician Decision|8|||
147504519|NCT01021813|531998840|FG002|DB Treatment Phase|Physician Decision|0|||
147504520|NCT01021813|531998841|FG003|DB Treatment Phase|Physician Decision|0|||
147504521|NCT01021813|531998842|FG004|DB Treatment Phase|Physician Decision|0|||
147504522|NCT01021813|531998838|FG000|DB Treatment Phase|Pregnancy|1|||
147504523|NCT01021813|531998839|FG001|DB Treatment Phase|Pregnancy|0|||
147504524|NCT01021813|531998840|FG002|DB Treatment Phase|Pregnancy|0|||
147504525|NCT01021813|531998841|FG003|DB Treatment Phase|Pregnancy|0|||
147504526|NCT01021813|531998842|FG004|DB Treatment Phase|Pregnancy|0|||
147504527|NCT01021813|531998838|FG000|DB Treatment Phase|Protocol Violation|4|||
147504528|NCT01021813|531998839|FG001|DB Treatment Phase|Protocol Violation|3|||
147504529|NCT01021813|531998840|FG002|DB Treatment Phase|Protocol Violation|0|||
147504530|NCT01021813|531998841|FG003|DB Treatment Phase|Protocol Violation|0|||
147504531|NCT01021813|531998842|FG004|DB Treatment Phase|Protocol Violation|0|||
147504532|NCT01021813|531998838|FG000|DB Treatment Phase|Withdrawal by Subject|60|||
147504533|NCT01021813|531998839|FG001|DB Treatment Phase|Withdrawal by Subject|24|||
147504534|NCT01021813|531998840|FG002|DB Treatment Phase|Withdrawal by Subject|0|||
147504535|NCT01021813|531998841|FG003|DB Treatment Phase|Withdrawal by Subject|0|||
147504536|NCT01021813|531998842|FG004|DB Treatment Phase|Withdrawal by Subject|0|||
147504537|NCT01021813|531998838|FG000|DB Randomized Discontinuation Phase|Adverse Event|0|||
147504538|NCT01021813|531998839|FG001|DB Randomized Discontinuation Phase|Adverse Event|0|||
147504539|NCT01021813|531998840|FG002|DB Randomized Discontinuation Phase|Adverse Event|0|||
147504540|NCT01021813|531998841|FG003|DB Randomized Discontinuation Phase|Adverse Event|3|||
147504541|NCT01021813|531998842|FG004|DB Randomized Discontinuation Phase|Adverse Event|1|||
147504542|NCT01021813|531998838|FG000|DB Randomized Discontinuation Phase|Lack of Efficacy|0|||
147504543|NCT01021813|531998839|FG001|DB Randomized Discontinuation Phase|Lack of Efficacy|0|||
147504544|NCT01021813|531998840|FG002|DB Randomized Discontinuation Phase|Lack of Efficacy|0|||
147504545|NCT01021813|531998841|FG003|DB Randomized Discontinuation Phase|Lack of Efficacy|1|||
147504546|NCT01021813|531998842|FG004|DB Randomized Discontinuation Phase|Lack of Efficacy|0|||
147504547|NCT01021813|531998838|FG000|DB Randomized Discontinuation Phase|Lost to Follow-up|0|||
147504548|NCT01021813|531998839|FG001|DB Randomized Discontinuation Phase|Lost to Follow-up|0|||
147504549|NCT01021813|531998840|FG002|DB Randomized Discontinuation Phase|Lost to Follow-up|0|||
147504550|NCT01021813|531998841|FG003|DB Randomized Discontinuation Phase|Lost to Follow-up|0|||
147504551|NCT01021813|531998842|FG004|DB Randomized Discontinuation Phase|Lost to Follow-up|1|||
147504552|NCT01021813|531998838|FG000|DB Randomized Discontinuation Phase|Protocol Violation|0|||
147504553|NCT01021813|531998839|FG001|DB Randomized Discontinuation Phase|Protocol Violation|0|||
147668856|NCT03363906|532613392|FG001|Period 2 (Test or Reference)|Lost to Follow-up|0|||
147504554|NCT01021813|531998840|FG002|DB Randomized Discontinuation Phase|Protocol Violation|1|||
147504555|NCT01021813|531998841|FG003|DB Randomized Discontinuation Phase|Protocol Violation|0|||
147504556|NCT01021813|531998842|FG004|DB Randomized Discontinuation Phase|Protocol Violation|0|||
147504557|NCT01021813|531998838|FG000|DB Randomized Discontinuation Phase|Withdrawal by Subject|0|||
147504558|NCT01021813|531998839|FG001|DB Randomized Discontinuation Phase|Withdrawal by Subject|0|||
147636104|NCT03613649|532485315|FG001|Fourth Treatment|Physician Decision|0|||
147636105|NCT03613649|532485316|FG002|Fourth Treatment|Physician Decision|0|||
147636106|NCT03613649|532485317|FG003|Fourth Treatment|Physician Decision|0|||
147636107|NCT03613649|532485318|FG004|Fourth Treatment|Physician Decision|0|||
147636108|NCT03613649|532485319|FG005|Fourth Treatment|Physician Decision|0|||
147636109|NCT03613649|532485320|FG006|Fourth Treatment|Physician Decision|1|||
147636110|NCT03613649|532485321|FG007|Fourth Treatment|Physician Decision|0|||
147636111|NCT03613649|532485322|FG008|Fourth Treatment|Physician Decision|0|||
147636112|NCT03613649|532485323|FG009|Fourth Treatment|Physician Decision|0|||
147636113|NCT03613649|532485324|FG010|Fourth Treatment|Physician Decision|0|||
147636114|NCT03613649|532485325|FG011|Fourth Treatment|Physician Decision|0|||
147636115|NCT03429244|532485326|FG000|Overall Study|Withdrawal by Subject|2|||
147636116|NCT03429244|532485327|FG001|Overall Study|Withdrawal by Subject|1|||
147636117|NCT03429244|532485328|FG002|Overall Study|Withdrawal by Subject|1|||
147636118|NCT01500187|532485330|FG000|Overall Study|Lost to Follow-up|6|||
147636119|NCT01500187|532485331|FG001|Overall Study|Lost to Follow-up|0|||
147636120|NCT00750139|532485332|FG000|Overall Study|Adverse Event|1|||
147636121|NCT00750139|532485333|FG001|Overall Study|Adverse Event|2|||
147636122|NCT00750139|532485334|FG002|Overall Study|Adverse Event|0|||
147636123|NCT00750139|532485335|FG003|Overall Study|Adverse Event|1|||
147636124|NCT00750139|532485332|FG000|Overall Study|Lost to Follow-up|17|||
147636125|NCT00750139|532485333|FG001|Overall Study|Lost to Follow-up|12|||
147636126|NCT00750139|532485334|FG002|Overall Study|Lost to Follow-up|15|||
147636127|NCT00750139|532485335|FG003|Overall Study|Lost to Follow-up|6|||
147636128|NCT00750139|532485332|FG000|Overall Study|Withdrawal by Subject|3|||
147636129|NCT00750139|532485333|FG001|Overall Study|Withdrawal by Subject|2|||
147636130|NCT00750139|532485334|FG002|Overall Study|Withdrawal by Subject|6|||
147636131|NCT00750139|532485335|FG003|Overall Study|Withdrawal by Subject|2|||
147636132|NCT00750139|532485332|FG000|Overall Study|Physician Decision|1|||
147636133|NCT00750139|532485333|FG001|Overall Study|Physician Decision|1|||
147636134|NCT00750139|532485334|FG002|Overall Study|Physician Decision|0|||
147636135|NCT00750139|532485335|FG003|Overall Study|Physician Decision|0|||
147636136|NCT00750139|532485332|FG000|Overall Study|Non-compliance|1|||
147636137|NCT00750139|532485333|FG001|Overall Study|Non-compliance|0|||
147636138|NCT00750139|532485334|FG002|Overall Study|Non-compliance|1|||
147636139|NCT00750139|532485335|FG003|Overall Study|Non-compliance|3|||
147636140|NCT00750139|532485332|FG000|Overall Study|Termination by sponsor|4|||
147636141|NCT00750139|532485333|FG001|Overall Study|Termination by sponsor|0|||
147636142|NCT00750139|532485334|FG002|Overall Study|Termination by sponsor|0|||
147636143|NCT00750139|532485335|FG003|Overall Study|Termination by sponsor|1|||
147636144|NCT00750139|532485332|FG000|Overall Study|Non-specific|62|||
147636145|NCT00750139|532485333|FG001|Overall Study|Non-specific|42|||
147636146|NCT00750139|532485334|FG002|Overall Study|Non-specific|79|||
147636147|NCT00750139|532485335|FG003|Overall Study|Non-specific|33|||
147636148|NCT00595517|532485336|FG000|Overall Study|Adverse Event|6|||
147636149|NCT00595517|532485336|FG000|Overall Study|Withdrawal by Subject|4|||
147636150|NCT00595517|532485336|FG000|Overall Study|Protocol Violation|2|||
147636151|NCT00595517|532485336|FG000|Overall Study|Recurrence of ulcer|5|||
147636152|NCT00595517|532485336|FG000|Overall Study|usage of prohibited treatment|1|||
147636153|NCT00595517|532485336|FG000|Overall Study|No intention to attend regularly|1|||
147636154|NCT00658775|532485337|FG000|Overall Study|Adverse Event|4|||
147636155|NCT00658775|532485338|FG001|Overall Study|Adverse Event|6|||
147636156|NCT00658775|532485337|FG000|Overall Study|Lost to Follow-up|17|||
147636157|NCT00658775|532485338|FG001|Overall Study|Lost to Follow-up|18|||
147636158|NCT00658775|532485337|FG000|Overall Study|Withdrawal by Subject|6|||
147636159|NCT00658775|532485338|FG001|Overall Study|Withdrawal by Subject|4|||
147636160|NCT00658775|532485337|FG000|Overall Study|Withdrawal of consent|8|||
147636161|NCT00658775|532485338|FG001|Overall Study|Withdrawal of consent|7|||
147636162|NCT00658775|532485337|FG000|Overall Study|Other|7|||
147636163|NCT00658775|532485338|FG001|Overall Study|Other|8|||
147636164|NCT01435460|532485346|FG000|Overall Study|Adverse Event|2|||
147636165|NCT01435460|532485347|FG001|Overall Study|Adverse Event|1|||
147636166|NCT01435460|532485346|FG000|Overall Study|Lost to Follow-up|6|||
147636167|NCT01435460|532485347|FG001|Overall Study|Lost to Follow-up|1|||
147636168|NCT01435460|532485346|FG000|Overall Study|Withdrawal by Subject|1|||
147636169|NCT01435460|532485347|FG001|Overall Study|Withdrawal by Subject|3|||
147636170|NCT01435460|532485346|FG000|Overall Study|Protocol Violation|0|||
147636171|NCT01435460|532485347|FG001|Overall Study|Protocol Violation|1|||
147636172|NCT01435460|532485346|FG000|Overall Study|Did not meet eligibility criteria|2|||
147636173|NCT01435460|532485347|FG001|Overall Study|Did not meet eligibility criteria|0|||
147636174|NCT01706939|532485348|FG000|Pre Randomization|Screen Failure|1|||
147636175|NCT01706939|532485349|FG001|Pre Randomization|Screen Failure|0|||
147636176|NCT01706939|532485350|FG002|Pre Randomization|Screen Failure|0|||
147636177|NCT01706939|532485348|FG000|Pre Randomization|Ineligible for Randomization|1|||
147636178|NCT01706939|532485349|FG001|Pre Randomization|Ineligible for Randomization|0|||
147636179|NCT01706939|532485350|FG002|Pre Randomization|Ineligible for Randomization|0|||
147636180|NCT01706939|532485348|FG000|Pre Randomization|Withdrawal by Subject|1|||
147636181|NCT01706939|532485349|FG001|Pre Randomization|Withdrawal by Subject|0|||
147636182|NCT01706939|532485350|FG002|Pre Randomization|Withdrawal by Subject|0|||
147636183|NCT01706939|532485348|FG000|Randomization|Insufficient QoL survey compliance|0|||
147636184|NCT01706939|532485349|FG001|Randomization|Insufficient QoL survey compliance|1|||
147636185|NCT01706939|532485350|FG002|Randomization|Insufficient QoL survey compliance|1|||
147636186|NCT01706939|532485348|FG000|Randomization|Progression of disease|0|||
147636187|NCT01706939|532485349|FG001|Randomization|Progression of disease|2|||
147636188|NCT01706939|532485350|FG002|Randomization|Progression of disease|1|||
147636189|NCT01046903|532485351|FG000|Overall Study|Lost to Follow-up|16|||
147636190|NCT01046903|532485351|FG000|Overall Study|Adverse Event|4|||
147636191|NCT01046903|532485351|FG000|Overall Study|Withdrawal by Subject|3|||
147636192|NCT01046903|532485351|FG000|Overall Study|Other|5|||
147636193|NCT05020665|532485352|FG000|Overall Study|Study terminated by Sponsor|5|||
147636194|NCT05020665|532485353|FG001|Overall Study|Study terminated by Sponsor|4|||
147636195|NCT05020665|532485352|FG000|Overall Study|Death|2|||
147636196|NCT05020665|532485353|FG001|Overall Study|Death|1|||
147636197|NCT05020665|532485352|FG000|Overall Study|Physician Decision|0|||
147636198|NCT05020665|532485353|FG001|Overall Study|Physician Decision|1|||
147636199|NCT05020665|532485352|FG000|Overall Study|Withdrawal by Subject|0|||
147636200|NCT05020665|532485353|FG001|Overall Study|Withdrawal by Subject|1|||
147636201|NCT05020665|532485352|FG000|Overall Study|Reason not specified|1|||
147636202|NCT05020665|532485353|FG001|Overall Study|Reason not specified|0|||
147636203|NCT01868022|532485354|FG000|Overall Study|Withdrawal by Subject|0|||
147636204|NCT01868022|532485355|FG001|Overall Study|Withdrawal by Subject|0|||
147636205|NCT01868022|532485356|FG002|Overall Study|Withdrawal by Subject|1|||
147636206|NCT01868022|532485357|FG003|Overall Study|Withdrawal by Subject|1|||
147636207|NCT01868022|532485358|FG004|Overall Study|Withdrawal by Subject|0|||
147636208|NCT01868022|532485359|FG005|Overall Study|Withdrawal by Subject|0|||
147504559|NCT01021813|531998840|FG002|DB Randomized Discontinuation Phase|Withdrawal by Subject|3|||
147504560|NCT01021813|531998841|FG003|DB Randomized Discontinuation Phase|Withdrawal by Subject|1|||
147504561|NCT01021813|531998842|FG004|DB Randomized Discontinuation Phase|Withdrawal by Subject|3|||
147504562|NCT02270684|531998843|FG000|Overall Study|Lost to Follow-up|0|||
147504563|NCT02270684|531998844|FG001|Overall Study|Lost to Follow-up|3|||
147504564|NCT02270684|531998843|FG000|Overall Study|Study terminated|1|||
147504565|NCT02270684|531998844|FG001|Overall Study|Study terminated|0|||
147504566|NCT02581982|531998845|FG000|Overall Study|Lack of Efficacy|12|||
147504567|NCT02581982|531998845|FG000|Overall Study|Adverse Event|3|||
147504568|NCT02581982|531998845|FG000|Overall Study|Physician Decision|1|||
147504569|NCT00405821|531998846|FG000|Overall Study|Death|5|||
147636209|NCT01868022|532485360|FG006|Overall Study|Withdrawal by Subject|0|||
147636210|NCT01868022|532485361|FG007|Overall Study|Withdrawal by Subject|1|||
147636211|NCT01868022|532485362|FG008|Overall Study|Withdrawal by Subject|0|||
147636212|NCT01868022|532485354|FG000|Overall Study|Adverse Event|0|||
147636213|NCT01868022|532485355|FG001|Overall Study|Adverse Event|0|||
147636214|NCT01868022|532485356|FG002|Overall Study|Adverse Event|0|||
147636215|NCT01868022|532485357|FG003|Overall Study|Adverse Event|0|||
147636216|NCT01868022|532485358|FG004|Overall Study|Adverse Event|2|||
147636217|NCT01868022|532485359|FG005|Overall Study|Adverse Event|0|||
147636218|NCT01868022|532485360|FG006|Overall Study|Adverse Event|0|||
147636219|NCT01868022|532485361|FG007|Overall Study|Adverse Event|2|||
147636220|NCT01868022|532485362|FG008|Overall Study|Adverse Event|2|||
147636221|NCT01868022|532485354|FG000|Overall Study|Physician Decision|0|||
147636222|NCT01868022|532485355|FG001|Overall Study|Physician Decision|0|||
147636223|NCT01868022|532485356|FG002|Overall Study|Physician Decision|0|||
147636224|NCT01868022|532485357|FG003|Overall Study|Physician Decision|0|||
147636225|NCT01868022|532485358|FG004|Overall Study|Physician Decision|0|||
147636226|NCT01868022|532485359|FG005|Overall Study|Physician Decision|1|||
147636227|NCT01868022|532485360|FG006|Overall Study|Physician Decision|0|||
147636228|NCT01868022|532485361|FG007|Overall Study|Physician Decision|2|||
147636229|NCT01868022|532485362|FG008|Overall Study|Physician Decision|0|||
147636230|NCT01868022|532485354|FG000|Overall Study|Study closed/terminated|0|||
147636231|NCT01868022|532485355|FG001|Overall Study|Study closed/terminated|0|||
147636232|NCT01868022|532485356|FG002|Overall Study|Study closed/terminated|0|||
147636233|NCT01868022|532485357|FG003|Overall Study|Study closed/terminated|0|||
147636234|NCT01868022|532485358|FG004|Overall Study|Study closed/terminated|0|||
147636235|NCT01868022|532485359|FG005|Overall Study|Study closed/terminated|0|||
147504570|NCT00405821|531998847|FG001|Overall Study|Death|7|||
147504571|NCT00405821|531998846|FG000|Overall Study|Lost to Follow-up|7|||
147636236|NCT01868022|532485360|FG006|Overall Study|Study closed/terminated|0|||
147636237|NCT01868022|532485361|FG007|Overall Study|Study closed/terminated|1|||
147504572|NCT00405821|531998847|FG001|Overall Study|Lost to Follow-up|7|||
147636238|NCT01868022|532485362|FG008|Overall Study|Study closed/terminated|0|||
147636239|NCT01868022|532485354|FG000|Overall Study|Ongoing|0|||
147636240|NCT01868022|532485355|FG001|Overall Study|Ongoing|0|||
147636241|NCT01868022|532485356|FG002|Overall Study|Ongoing|0|||
147636242|NCT01868022|532485357|FG003|Overall Study|Ongoing|0|||
147636243|NCT01868022|532485358|FG004|Overall Study|Ongoing|0|||
147636244|NCT01868022|532485359|FG005|Overall Study|Ongoing|0|||
147636245|NCT01868022|532485360|FG006|Overall Study|Ongoing|0|||
147636246|NCT01868022|532485361|FG007|Overall Study|Ongoing|3|||
147636247|NCT01868022|532485362|FG008|Overall Study|Ongoing|0|||
147636248|NCT02504827|532485366|FG000|Overall Study|Could not produce sputum|1|||
147636249|NCT03386994|532485367|FG000|Overall Study|Lung transplant|1|||
147636250|NCT03386994|532485367|FG000|Overall Study|Adverse Event|14|||
147636251|NCT03386994|532485367|FG000|Overall Study|Lost to Follow-up|4|||
147636252|NCT03386994|532485367|FG000|Overall Study|Withdrawal by Subject|3|||
147636253|NCT03386994|532485367|FG000|Overall Study|Death|16|||
147636254|NCT06366087|532487206|FG000|Overall Study|Withdrawal by Subject|0|||
147636255|NCT06366087|532487207|FG001|Overall Study|Withdrawal by Subject|1|||
147636256|NCT00860249|532487210|FG000|Overall Study|trial was terminated prior to completion|21|||
147636257|NCT00860249|532487211|FG001|Overall Study|trial was terminated prior to completion|18|||
147636258|NCT00860249|532487212|FG002|Overall Study|trial was terminated prior to completion|21|||
147636259|NCT00519428|532487213|FG000|Overall Study|Adverse Event|5|||
147636260|NCT00519428|532487214|FG001|Overall Study|Adverse Event|2|||
147636261|NCT00519428|532487215|FG002|Overall Study|Adverse Event|10|||
147636262|NCT00519428|532487213|FG000|Overall Study|Lost to Follow-up|7|||
147636263|NCT00519428|532487214|FG001|Overall Study|Lost to Follow-up|7|||
147636264|NCT00519428|532487215|FG002|Overall Study|Lost to Follow-up|6|||
147636265|NCT00519428|532487213|FG000|Overall Study|Withdrawal by Subject|8|||
147636266|NCT00519428|532487214|FG001|Overall Study|Withdrawal by Subject|3|||
147636267|NCT00519428|532487215|FG002|Overall Study|Withdrawal by Subject|7|||
147636268|NCT00519428|532487213|FG000|Overall Study|unstated|1|||
147636269|NCT00519428|532487214|FG001|Overall Study|unstated|3|||
147636270|NCT00519428|532487215|FG002|Overall Study|unstated|2|||
147636271|NCT01275755|532487218|FG000|Double-blind Treatment Period|Adverse Event|0|||
147636272|NCT01275755|532487219|FG001|Double-blind Treatment Period|Adverse Event|2|||
147636273|NCT01275755|532487218|FG000|Double-blind Treatment Period|Lost to Follow-up|1|||
147636274|NCT01275755|532487219|FG001|Double-blind Treatment Period|Lost to Follow-up|1|||
147636275|NCT01275755|532487218|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
147636276|NCT01275755|532487219|FG001|Double-blind Treatment Period|Withdrawal by Subject|0|||
147636277|NCT01275755|532487218|FG000|Run-out Placebo Period|Lost to Follow-up|1|||
147636278|NCT01275755|532487219|FG001|Run-out Placebo Period|Lost to Follow-up|0|||
147636279|NCT02703272|532487222|FG000|Overall Study|Death|4|||
147636280|NCT02703272|532487223|FG001|Overall Study|Death|9|||
147636281|NCT02703272|532487224|FG002|Overall Study|Death|19|||
147636282|NCT02703272|532487225|FG003|Overall Study|Death|10|||
147636283|NCT02703272|532487222|FG000|Overall Study|Withdrawal by Subject|0|||
147636284|NCT02703272|532487223|FG001|Overall Study|Withdrawal by Subject|0|||
147636285|NCT02703272|532487224|FG002|Overall Study|Withdrawal by Subject|4|||
147636286|NCT02703272|532487225|FG003|Overall Study|Withdrawal by Subject|2|||
147636287|NCT02703272|532487222|FG000|Overall Study|Study Terminated by Sponsor|6|||
147636288|NCT02703272|532487223|FG001|Overall Study|Study Terminated by Sponsor|1|||
147636289|NCT02703272|532487224|FG002|Overall Study|Study Terminated by Sponsor|12|||
147636290|NCT02703272|532487225|FG003|Overall Study|Study Terminated by Sponsor|4|||
147636291|NCT02703272|532487222|FG000|Overall Study|Other|1|||
147636292|NCT02703272|532487223|FG001|Overall Study|Other|0|||
147636293|NCT02703272|532487224|FG002|Overall Study|Other|0|||
147636294|NCT02703272|532487225|FG003|Overall Study|Other|0|||
147636295|NCT02651155|532487226|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
147636296|NCT02651155|532487227|FG001|Overall Study|Pretreatment Event/Adverse Event|2|||
147636297|NCT02651155|532487226|FG000|Overall Study|Voluntary Withdrawal|5|||
147636298|NCT02651155|532487227|FG001|Overall Study|Voluntary Withdrawal|0|||
147636299|NCT00976820|532487228|FG000|Overall Study|Lost to Follow-up|5|||
147636300|NCT00976820|532487229|FG001|Overall Study|Lost to Follow-up|16|||
147636301|NCT00976820|532487230|FG002|Overall Study|Lost to Follow-up|2|||
147636302|NCT00976820|532487231|FG003|Overall Study|Lost to Follow-up|3|||
147636303|NCT00976820|532487228|FG000|Overall Study|Poor Compliance. Numerous Visits Booked|1|||
147636304|NCT00976820|532487229|FG001|Overall Study|Poor Compliance. Numerous Visits Booked|0|||
147636305|NCT00976820|532487230|FG002|Overall Study|Poor Compliance. Numerous Visits Booked|1|||
147636306|NCT00976820|532487231|FG003|Overall Study|Poor Compliance. Numerous Visits Booked|0|||
147636307|NCT00976820|532487228|FG000|Overall Study|Withdrawal by Subject|2|||
147636308|NCT00976820|532487229|FG001|Overall Study|Withdrawal by Subject|4|||
147636309|NCT00976820|532487230|FG002|Overall Study|Withdrawal by Subject|1|||
147668857|NCT00929669|532613394|FG000|Overall Study|elevated glucose levels|1|||
147636310|NCT00976820|532487231|FG003|Overall Study|Withdrawal by Subject|4|||
147636311|NCT03452488|532487233|FG000|Overall Study|Adverse Event|4|||
147636312|NCT03452488|532487234|FG001|Overall Study|Adverse Event|6|||
147636313|NCT03452488|532487235|FG002|Overall Study|Adverse Event|1|||
147636314|NCT03452488|532487233|FG000|Overall Study|Death|0|||
147636315|NCT03452488|532487234|FG001|Overall Study|Death|0|||
147636316|NCT03452488|532487235|FG002|Overall Study|Death|1|||
147636317|NCT03452488|532487233|FG000|Overall Study|Lost to Follow-up|1|||
147636318|NCT03452488|532487234|FG001|Overall Study|Lost to Follow-up|2|||
147668858|NCT02714153|532613395|FG000|Overall Study|Death|1|||
147636319|NCT03452488|532487235|FG002|Overall Study|Lost to Follow-up|0|||
147636320|NCT03452488|532487233|FG000|Overall Study|PI Decision|1|||
147636321|NCT03452488|532487234|FG001|Overall Study|PI Decision|0|||
147636322|NCT03452488|532487235|FG002|Overall Study|PI Decision|0|||
147636323|NCT03452488|532487233|FG000|Overall Study|Withdrew consent|4|||
147636324|NCT03452488|532487234|FG001|Overall Study|Withdrew consent|2|||
147636325|NCT03452488|532487235|FG002|Overall Study|Withdrew consent|2|||
147636326|NCT03452488|532487233|FG000|Overall Study|Withdraw due to the COVID-19 outbreak|1|||
147636327|NCT03452488|532487234|FG001|Overall Study|Withdraw due to the COVID-19 outbreak|0|||
147636328|NCT03452488|532487235|FG002|Overall Study|Withdraw due to the COVID-19 outbreak|1|||
147636329|NCT03452488|532487233|FG000|Overall Study|Other|0|||
147636330|NCT03452488|532487234|FG001|Overall Study|Other|2|||
147636331|NCT03452488|532487235|FG002|Overall Study|Other|2|||
147636332|NCT04016779|532487236|FG000|Overall Study|Adverse Event|9|||
147636333|NCT04016779|532487237|FG001|Overall Study|Adverse Event|17|||
147636334|NCT04016779|532487236|FG000|Overall Study|Lack of Efficacy|4|||
147636335|NCT04016779|532487237|FG001|Overall Study|Lack of Efficacy|1|||
147636336|NCT04016779|532487236|FG000|Overall Study|Lost to Follow-up|5|||
147636337|NCT04016779|532487237|FG001|Overall Study|Lost to Follow-up|14|||
147636338|NCT04016779|532487236|FG000|Overall Study|Physician Decision|1|||
147636339|NCT04016779|532487237|FG001|Overall Study|Physician Decision|3|||
147636340|NCT04016779|532487236|FG000|Overall Study|Withdrawal by Subject|6|||
147636341|NCT04016779|532487237|FG001|Overall Study|Withdrawal by Subject|8|||
147636342|NCT04016779|532487236|FG000|Overall Study|Non-compliance with Study Drug|2|||
147636343|NCT04016779|532487237|FG001|Overall Study|Non-compliance with Study Drug|3|||
147636344|NCT04016779|532487236|FG000|Overall Study|Other, Multiple categories|17|||
147636345|NCT04016779|532487237|FG001|Overall Study|Other, Multiple categories|17|||
147636346|NCT00330343|532487238|FG000|Overall Study|Lost to Follow-up|5|||
147636347|NCT00281632|532487239|FG000|Overall Study|Adverse Event|7|||
147636348|NCT00281632|532487239|FG000|Overall Study|Withdrawal by Subject|2|||
147636349|NCT00281632|532487239|FG000|Overall Study|Disease Progression|22|||
147636350|NCT00281632|532487239|FG000|Overall Study|Death|1|||
147636351|NCT00281632|532487239|FG000|Overall Study|Physician Decision|1|||
147636352|NCT00281632|532487239|FG000|Overall Study|Ongoing|3|||
147636353|NCT06586788|532487240|FG000|Overall Study|Eye-tracking calibration / validation could not be completed with eight children|8|||
147636354|NCT02980341|532487241|FG000|Dose Escalation|Progressive disease per RECIST v1.1|3|||
147636355|NCT02980341|532487242|FG001|Dose Escalation|Progressive disease per RECIST v1.1|3|||
147636356|NCT02980341|532487243|FG002|Dose Escalation|Progressive disease per RECIST v1.1|11|||
147636357|NCT02980341|532487244|FG003|Dose Escalation|Progressive disease per RECIST v1.1|10|||
147636358|NCT02980341|532487245|FG004|Dose Escalation|Progressive disease per RECIST v1.1|3|||
147636359|NCT02980341|532487246|FG005|Dose Escalation|Progressive disease per RECIST v1.1|0|||
147636360|NCT02980341|532487247|FG006|Dose Escalation|Progressive disease per RECIST v1.1|0|||
147636361|NCT02980341|532487248|FG007|Dose Escalation|Progressive disease per RECIST v1.1|0|||
147636362|NCT02980341|532487249|FG008|Dose Escalation|Progressive disease per RECIST v1.1|0|||
147636363|NCT02980341|532487250|FG009|Dose Escalation|Progressive disease per RECIST v1.1|0|||
147636364|NCT02980341|532487251|FG010|Dose Escalation|Progressive disease per RECIST v1.1|0|||
147636365|NCT02980341|532487241|FG000|Dose Escalation|Clinical progression|0|||
147636366|NCT02980341|532487242|FG001|Dose Escalation|Clinical progression|0|||
147636367|NCT02980341|532487243|FG002|Dose Escalation|Clinical progression|2|||
147636368|NCT02980341|532487244|FG003|Dose Escalation|Clinical progression|1|||
147636369|NCT02980341|532487245|FG004|Dose Escalation|Clinical progression|0|||
147636370|NCT02980341|532487246|FG005|Dose Escalation|Clinical progression|0|||
147636371|NCT02980341|532487247|FG006|Dose Escalation|Clinical progression|0|||
147636372|NCT02980341|532487248|FG007|Dose Escalation|Clinical progression|0|||
147636373|NCT02980341|532487249|FG008|Dose Escalation|Clinical progression|0|||
147636374|NCT02980341|532487250|FG009|Dose Escalation|Clinical progression|0|||
147636375|NCT02980341|532487251|FG010|Dose Escalation|Clinical progression|0|||
147636376|NCT02980341|532487241|FG000|Dose Escalation|Adverse Event|0|||
147636377|NCT02980341|532487242|FG001|Dose Escalation|Adverse Event|0|||
147636378|NCT02980341|532487243|FG002|Dose Escalation|Adverse Event|1|||
147636379|NCT02980341|532487244|FG003|Dose Escalation|Adverse Event|2|||
147668859|NCT01901185|532613396|FG000|Overall Study|Withdrawal by Subject|2|||
147668860|NCT00250588|532613397|FG000|Overall Study|Withdrawal by Subject|3|||
147668861|NCT00250588|532613398|FG001|Overall Study|Withdrawal by Subject|6|||
147668862|NCT00250588|532613399|FG002|Overall Study|Withdrawal by Subject|0|||
147636380|NCT02980341|532487245|FG004|Dose Escalation|Adverse Event|2|||
147668863|NCT00250588|532613397|FG000|Overall Study|Lost to Follow-up|6|||
147668864|NCT00250588|532613398|FG001|Overall Study|Lost to Follow-up|13|||
147668865|NCT00250588|532613399|FG002|Overall Study|Lost to Follow-up|13|||
147504573|NCT00405821|531998846|FG000|Overall Study|Protocol Violation|1|||
147636381|NCT02980341|532487246|FG005|Dose Escalation|Adverse Event|0|||
147636382|NCT02980341|532487247|FG006|Dose Escalation|Adverse Event|0|||
147636383|NCT02980341|532487248|FG007|Dose Escalation|Adverse Event|0|||
147636384|NCT02980341|532487249|FG008|Dose Escalation|Adverse Event|0|||
147636385|NCT02980341|532487250|FG009|Dose Escalation|Adverse Event|0|||
147636386|NCT02980341|532487251|FG010|Dose Escalation|Adverse Event|0|||
147636387|NCT02980341|532487241|FG000|Dose Escalation|Withdrawal by Subject|0|||
147636388|NCT02980341|532487242|FG001|Dose Escalation|Withdrawal by Subject|0|||
147668866|NCT03502798|532613402|FG000|Overall Study|equipment failure|0|||
147668867|NCT03502798|532613403|FG001|Overall Study|equipment failure|7|||
147668868|NCT00485303|532613404|FG000|Overall Study|Adverse Event|5|||
147668869|NCT00485303|532613404|FG000|Overall Study|Progressive Disease|44|||
147668870|NCT00485303|532613404|FG000|Overall Study|Other|3|||
147668871|NCT00485303|532613404|FG000|Overall Study|Initiation of new anti-cancer treatment|2|||
147668872|NCT00485303|532613404|FG000|Overall Study|Treatment ongoing at cutoff date|2|||
147668873|NCT00296335|532613405|FG000|Overall Study|Recurrence|3|||
147668874|NCT00296335|532613406|FG001|Overall Study|Recurrence|51|||
147668875|NCT00296335|532613405|FG000|Overall Study|Adverse Event|17|||
147668876|NCT00296335|532613406|FG001|Overall Study|Adverse Event|27|||
147668877|NCT00296335|532613405|FG000|Overall Study|Lost to Follow-up|7|||
147668878|NCT00296335|532613406|FG001|Overall Study|Lost to Follow-up|33|||
147668879|NCT00296335|532613405|FG000|Overall Study|Physician Decision|3|||
147668880|NCT00296335|532613406|FG001|Overall Study|Physician Decision|11|||
147668881|NCT01286129|532613410|FG000|Overall Study|Withdrawal by Subject|4|||
147668882|NCT01286129|532613411|FG001|Overall Study|Withdrawal by Subject|1|||
147668883|NCT01286129|532613410|FG000|Overall Study|Could not comply with study requirements|4|||
147668884|NCT01286129|532613411|FG001|Overall Study|Could not comply with study requirements|4|||
147668885|NCT04142242|532613412|FG000|Stage I|Non-compliance with the protocol|1|||
147668886|NCT04142242|532613413|FG001|Stage I|Non-compliance with the protocol|0|||
147668887|NCT04142242|532613414|FG002|Stage I|Non-compliance with the protocol|0|||
147668888|NCT04142242|532613415|FG003|Stage I|Non-compliance with the protocol|0|||
147668889|NCT04142242|532613416|FG004|Stage I|Non-compliance with the protocol|0|||
147668890|NCT04142242|532613417|FG005|Stage I|Non-compliance with the protocol|1|||
147668891|NCT04142242|532613412|FG000|Stage I|Voluntary withdrawal not due to an adverse event (AE)|0|||
147668892|NCT04142242|532613413|FG001|Stage I|Voluntary withdrawal not due to an adverse event (AE)|1|||
147668893|NCT04142242|532613414|FG002|Stage I|Voluntary withdrawal not due to an adverse event (AE)|0|||
147668894|NCT04142242|532613415|FG003|Stage I|Voluntary withdrawal not due to an adverse event (AE)|0|||
147668895|NCT04142242|532613416|FG004|Stage I|Voluntary withdrawal not due to an adverse event (AE)|0|||
147668896|NCT04142242|532613417|FG005|Stage I|Voluntary withdrawal not due to an adverse event (AE)|0|||
147668897|NCT04142242|532613412|FG000|Stage II|Non-compliance with the protocol|0|||
147668898|NCT04142242|532613413|FG001|Stage II|Non-compliance with the protocol|0|||
147668899|NCT04142242|532613414|FG002|Stage II|Non-compliance with the protocol|0|||
147668900|NCT04142242|532613415|FG003|Stage II|Non-compliance with the protocol|2|||
147668901|NCT04142242|532613416|FG004|Stage II|Non-compliance with the protocol|0|||
147668902|NCT04142242|532613417|FG005|Stage II|Non-compliance with the protocol|0|||
147668903|NCT04142242|532613412|FG000|Stage II|Lost to Follow-up|0|||
147668904|NCT04142242|532613413|FG001|Stage II|Lost to Follow-up|0|||
147668905|NCT04142242|532613414|FG002|Stage II|Lost to Follow-up|1|||
147668906|NCT04142242|532613415|FG003|Stage II|Lost to Follow-up|2|||
147668907|NCT04142242|532613416|FG004|Stage II|Lost to Follow-up|0|||
147668908|NCT04142242|532613417|FG005|Stage II|Lost to Follow-up|0|||
147668909|NCT04142242|532613412|FG000|Stage II|Withdrawal by Subject|0|||
147668910|NCT04142242|532613413|FG001|Stage II|Withdrawal by Subject|0|||
147668911|NCT04142242|532613414|FG002|Stage II|Withdrawal by Subject|5|||
147668912|NCT04142242|532613415|FG003|Stage II|Withdrawal by Subject|9|||
147668913|NCT04142242|532613416|FG004|Stage II|Withdrawal by Subject|0|||
147668914|NCT04142242|532613417|FG005|Stage II|Withdrawal by Subject|0|||
147668915|NCT00846053|532613418|FG000|Overall Study|Physician Decision|3|||
147668916|NCT00846053|532613419|FG001|Overall Study|Physician Decision|0|||
147668917|NCT00111761|532613420|FG000|Part 1|Physician Decision|0|||
147668918|NCT00111761|532613421|FG001|Part 1|Physician Decision|1|||
147668919|NCT00111761|532613420|FG000|Part 1|Death|0|||
147668920|NCT00111761|532613421|FG001|Part 1|Death|2|||
147668921|NCT00111761|532613420|FG000|Part 1|Other|0|||
147668922|NCT00111761|532613421|FG001|Part 1|Other|1|||
147668923|NCT00111761|532613420|FG000|Part 1|Withdrawal by Subject|0|||
147668924|NCT00111761|532613421|FG001|Part 1|Withdrawal by Subject|1|||
147668925|NCT00111761|532613420|FG000|Part 2|Adverse Event|1|||
147504574|NCT00405821|531998847|FG001|Overall Study|Protocol Violation|0|||
147636389|NCT02980341|532487243|FG002|Dose Escalation|Withdrawal by Subject|1|||
147636390|NCT02980341|532487244|FG003|Dose Escalation|Withdrawal by Subject|0|||
147636391|NCT02980341|532487245|FG004|Dose Escalation|Withdrawal by Subject|0|||
147636392|NCT02980341|532487246|FG005|Dose Escalation|Withdrawal by Subject|0|||
147636393|NCT02980341|532487247|FG006|Dose Escalation|Withdrawal by Subject|0|||
147636394|NCT02980341|532487248|FG007|Dose Escalation|Withdrawal by Subject|0|||
147636395|NCT02980341|532487249|FG008|Dose Escalation|Withdrawal by Subject|0|||
147636396|NCT02980341|532487250|FG009|Dose Escalation|Withdrawal by Subject|0|||
147636397|NCT02980341|532487251|FG010|Dose Escalation|Withdrawal by Subject|0|||
147636398|NCT02980341|532487241|FG000|Dose Escalation|Due to side effect management of chemotherapy|0|||
147668926|NCT00111761|532613421|FG001|Part 2|Adverse Event|0|||
147668927|NCT00111761|532613420|FG000|Part 2|Physician Decision|1|||
147668928|NCT00111761|532613421|FG001|Part 2|Physician Decision|0|||
147668929|NCT00111761|532613420|FG000|Part 2|Death|1|||
147668930|NCT00111761|532613421|FG001|Part 2|Death|0|||
147668931|NCT00111761|532613420|FG000|Part 2|Disease progression|3|||
147636399|NCT02980341|532487242|FG001|Dose Escalation|Due to side effect management of chemotherapy|0|||
147668932|NCT00111761|532613421|FG001|Part 2|Disease progression|0|||
147636400|NCT02980341|532487243|FG002|Dose Escalation|Due to side effect management of chemotherapy|0|||
147636401|NCT02980341|532487244|FG003|Dose Escalation|Due to side effect management of chemotherapy|2|||
147636402|NCT02980341|532487245|FG004|Dose Escalation|Due to side effect management of chemotherapy|0|||
147636403|NCT02980341|532487246|FG005|Dose Escalation|Due to side effect management of chemotherapy|0|||
147636404|NCT02980341|532487247|FG006|Dose Escalation|Due to side effect management of chemotherapy|0|||
147636405|NCT02980341|532487248|FG007|Dose Escalation|Due to side effect management of chemotherapy|0|||
147636406|NCT02980341|532487249|FG008|Dose Escalation|Due to side effect management of chemotherapy|0|||
147636407|NCT02980341|532487250|FG009|Dose Escalation|Due to side effect management of chemotherapy|0|||
147636408|NCT02980341|532487251|FG010|Dose Escalation|Due to side effect management of chemotherapy|0|||
147636409|NCT02980341|532487241|FG000|Dose Escalation|Due to investigator's decision|0|||
147636410|NCT02980341|532487242|FG001|Dose Escalation|Due to investigator's decision|0|||
147636411|NCT02980341|532487243|FG002|Dose Escalation|Due to investigator's decision|0|||
147636412|NCT02980341|532487244|FG003|Dose Escalation|Due to investigator's decision|0|||
147636413|NCT02980341|532487245|FG004|Dose Escalation|Due to investigator's decision|1|||
147636414|NCT02980341|532487246|FG005|Dose Escalation|Due to investigator's decision|0|||
147636415|NCT02980341|532487247|FG006|Dose Escalation|Due to investigator's decision|0|||
147636416|NCT02980341|532487248|FG007|Dose Escalation|Due to investigator's decision|0|||
147636417|NCT02980341|532487249|FG008|Dose Escalation|Due to investigator's decision|0|||
147636418|NCT02980341|532487250|FG009|Dose Escalation|Due to investigator's decision|0|||
147636419|NCT02980341|532487251|FG010|Dose Escalation|Due to investigator's decision|0|||
147636420|NCT02980341|532487241|FG000|Dose Finding|Progressive disease per RECIST v1.1|0|||
147636421|NCT02980341|532487242|FG001|Dose Finding|Progressive disease per RECIST v1.1|0|||
147636422|NCT02980341|532487243|FG002|Dose Finding|Progressive disease per RECIST v1.1|0|||
147636423|NCT02980341|532487244|FG003|Dose Finding|Progressive disease per RECIST v1.1|0|||
147636424|NCT02980341|532487245|FG004|Dose Finding|Progressive disease per RECIST v1.1|0|||
147636425|NCT02980341|532487246|FG005|Dose Finding|Progressive disease per RECIST v1.1|8|||
147636426|NCT02980341|532487247|FG006|Dose Finding|Progressive disease per RECIST v1.1|11|||
147636427|NCT02980341|532487248|FG007|Dose Finding|Progressive disease per RECIST v1.1|0|||
147636428|NCT02980341|532487249|FG008|Dose Finding|Progressive disease per RECIST v1.1|0|||
147636429|NCT02980341|532487250|FG009|Dose Finding|Progressive disease per RECIST v1.1|0|||
147636430|NCT02980341|532487251|FG010|Dose Finding|Progressive disease per RECIST v1.1|0|||
147636431|NCT02980341|532487241|FG000|Dose Finding|Adverse Event|0|||
147636432|NCT02980341|532487242|FG001|Dose Finding|Adverse Event|0|||
147636433|NCT02980341|532487243|FG002|Dose Finding|Adverse Event|0|||
147636434|NCT02980341|532487244|FG003|Dose Finding|Adverse Event|0|||
147636435|NCT02980341|532487245|FG004|Dose Finding|Adverse Event|0|||
147636436|NCT02980341|532487246|FG005|Dose Finding|Adverse Event|3|||
147636437|NCT02980341|532487247|FG006|Dose Finding|Adverse Event|0|||
147636438|NCT02980341|532487248|FG007|Dose Finding|Adverse Event|0|||
147636439|NCT02980341|532487249|FG008|Dose Finding|Adverse Event|0|||
147636440|NCT02980341|532487250|FG009|Dose Finding|Adverse Event|0|||
147636441|NCT02980341|532487251|FG010|Dose Finding|Adverse Event|0|||
147636442|NCT02980341|532487241|FG000|Dose Finding|Withdrawal by Subject|0|||
147636443|NCT02980341|532487242|FG001|Dose Finding|Withdrawal by Subject|0|||
147636444|NCT02980341|532487243|FG002|Dose Finding|Withdrawal by Subject|0|||
147636445|NCT02980341|532487244|FG003|Dose Finding|Withdrawal by Subject|0|||
147636446|NCT02980341|532487245|FG004|Dose Finding|Withdrawal by Subject|0|||
147636447|NCT02980341|532487246|FG005|Dose Finding|Withdrawal by Subject|1|||
147636448|NCT02980341|532487247|FG006|Dose Finding|Withdrawal by Subject|1|||
147636449|NCT02980341|532487248|FG007|Dose Finding|Withdrawal by Subject|0|||
147636450|NCT02980341|532487249|FG008|Dose Finding|Withdrawal by Subject|0|||
147636451|NCT02980341|532487250|FG009|Dose Finding|Withdrawal by Subject|0|||
147636452|NCT02980341|532487251|FG010|Dose Finding|Withdrawal by Subject|0|||
147636453|NCT02980341|532487241|FG000|Dose Expansion|Progressive disease per RECIST v1.1|0|||
147636454|NCT02980341|532487242|FG001|Dose Expansion|Progressive disease per RECIST v1.1|0|||
147636455|NCT02980341|532487243|FG002|Dose Expansion|Progressive disease per RECIST v1.1|0|||
147636456|NCT02980341|532487244|FG003|Dose Expansion|Progressive disease per RECIST v1.1|0|||
147636457|NCT02980341|532487245|FG004|Dose Expansion|Progressive disease per RECIST v1.1|0|||
147636458|NCT02980341|532487246|FG005|Dose Expansion|Progressive disease per RECIST v1.1|0|||
147636459|NCT02980341|532487247|FG006|Dose Expansion|Progressive disease per RECIST v1.1|0|||
147636460|NCT02980341|532487248|FG007|Dose Expansion|Progressive disease per RECIST v1.1|23|||
147636461|NCT02980341|532487249|FG008|Dose Expansion|Progressive disease per RECIST v1.1|24|||
147636462|NCT02980341|532487250|FG009|Dose Expansion|Progressive disease per RECIST v1.1|17|||
147636463|NCT02980341|532487251|FG010|Dose Expansion|Progressive disease per RECIST v1.1|23|||
147636464|NCT02980341|532487241|FG000|Dose Expansion|Clinical progression|0|||
147636465|NCT02980341|532487242|FG001|Dose Expansion|Clinical progression|0|||
147636466|NCT02980341|532487243|FG002|Dose Expansion|Clinical progression|0|||
147636467|NCT02980341|532487244|FG003|Dose Expansion|Clinical progression|0|||
147636468|NCT02980341|532487245|FG004|Dose Expansion|Clinical progression|0|||
147636469|NCT02980341|532487246|FG005|Dose Expansion|Clinical progression|0|||
147636470|NCT02980341|532487247|FG006|Dose Expansion|Clinical progression|0|||
147636471|NCT02980341|532487248|FG007|Dose Expansion|Clinical progression|4|||
147636472|NCT02980341|532487249|FG008|Dose Expansion|Clinical progression|3|||
147636473|NCT02980341|532487250|FG009|Dose Expansion|Clinical progression|1|||
147636474|NCT02980341|532487251|FG010|Dose Expansion|Clinical progression|4|||
147636475|NCT02980341|532487241|FG000|Dose Expansion|Adverse Event|0|||
147636476|NCT02980341|532487242|FG001|Dose Expansion|Adverse Event|0|||
147636477|NCT02980341|532487243|FG002|Dose Expansion|Adverse Event|0|||
147636478|NCT02980341|532487244|FG003|Dose Expansion|Adverse Event|0|||
147636479|NCT02980341|532487245|FG004|Dose Expansion|Adverse Event|0|||
147636480|NCT02980341|532487246|FG005|Dose Expansion|Adverse Event|0|||
147636481|NCT02980341|532487247|FG006|Dose Expansion|Adverse Event|0|||
147636482|NCT02980341|532487248|FG007|Dose Expansion|Adverse Event|3|||
147636483|NCT02980341|532487249|FG008|Dose Expansion|Adverse Event|0|||
147636484|NCT02980341|532487250|FG009|Dose Expansion|Adverse Event|1|||
147636485|NCT02980341|532487251|FG010|Dose Expansion|Adverse Event|3|||
147636486|NCT02980341|532487241|FG000|Dose Expansion|Death|0|||
147636487|NCT02980341|532487242|FG001|Dose Expansion|Death|0|||
147636488|NCT02980341|532487243|FG002|Dose Expansion|Death|0|||
147636489|NCT02980341|532487244|FG003|Dose Expansion|Death|0|||
147636490|NCT02980341|532487245|FG004|Dose Expansion|Death|0|||
147636491|NCT02980341|532487246|FG005|Dose Expansion|Death|0|||
147636492|NCT02980341|532487247|FG006|Dose Expansion|Death|0|||
147636493|NCT02980341|532487248|FG007|Dose Expansion|Death|0|||
147636494|NCT02980341|532487249|FG008|Dose Expansion|Death|2|||
147636495|NCT02980341|532487250|FG009|Dose Expansion|Death|1|||
147636496|NCT02980341|532487251|FG010|Dose Expansion|Death|0|||
147636497|NCT02980341|532487241|FG000|Dose Expansion|Withdrawal by Subject|0|||
147636498|NCT02980341|532487242|FG001|Dose Expansion|Withdrawal by Subject|0|||
147636499|NCT02980341|532487243|FG002|Dose Expansion|Withdrawal by Subject|0|||
147636500|NCT02980341|532487244|FG003|Dose Expansion|Withdrawal by Subject|0|||
147636501|NCT02980341|532487245|FG004|Dose Expansion|Withdrawal by Subject|0|||
147636502|NCT02980341|532487246|FG005|Dose Expansion|Withdrawal by Subject|0|||
147636503|NCT02980341|532487247|FG006|Dose Expansion|Withdrawal by Subject|0|||
147636504|NCT02980341|532487248|FG007|Dose Expansion|Withdrawal by Subject|2|||
147636505|NCT02980341|532487249|FG008|Dose Expansion|Withdrawal by Subject|0|||
147636506|NCT02980341|532487250|FG009|Dose Expansion|Withdrawal by Subject|1|||
147636507|NCT02980341|532487251|FG010|Dose Expansion|Withdrawal by Subject|0|||
147636508|NCT02980341|532487241|FG000|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
147636509|NCT02980341|532487242|FG001|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
147636510|NCT02980341|532487243|FG002|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
147636511|NCT02980341|532487244|FG003|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
147636512|NCT02980341|532487245|FG004|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
147636513|NCT02980341|532487246|FG005|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
147636514|NCT02980341|532487247|FG006|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
147636515|NCT02980341|532487248|FG007|Dose Expansion|Due to investigator's decision considering patient's liver condition|1|||
147636516|NCT02980341|532487249|FG008|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
147636517|NCT02980341|532487250|FG009|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
147636518|NCT02980341|532487251|FG010|Dose Expansion|Due to investigator's decision considering patient's liver condition|0|||
147636519|NCT02980341|532487241|FG000|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
147636520|NCT02980341|532487242|FG001|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
147636521|NCT02980341|532487243|FG002|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
147636522|NCT02980341|532487244|FG003|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
147636523|NCT02980341|532487245|FG004|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
147636524|NCT02980341|532487246|FG005|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
147636525|NCT02980341|532487247|FG006|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
147636526|NCT02980341|532487248|FG007|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
147636527|NCT02980341|532487249|FG008|Dose Expansion|Due to investigator's decision due to patient's general condition|1|||
147636528|NCT02980341|532487250|FG009|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
147636529|NCT02980341|532487251|FG010|Dose Expansion|Due to investigator's decision due to patient's general condition|0|||
147636530|NCT02980341|532487241|FG000|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
147636531|NCT02980341|532487242|FG001|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
147644038|NCT00738062|532516705|FG001|Open Label Treatment|Withdrawal by Subject|0|||
147504575|NCT00405821|531998846|FG000|Overall Study|initiated ART|9|||
147504576|NCT00405821|531998847|FG001|Overall Study|initiated ART|8|||
147504577|NCT01033487|531998853|FG000|Fourth Intervention Period|Adverse Event|0|||
147504578|NCT01033487|531998854|FG001|Fourth Intervention Period|Adverse Event|0|||
147504579|NCT01033487|531998855|FG002|Fourth Intervention Period|Adverse Event|0|||
147504580|NCT01033487|531998856|FG003|Fourth Intervention Period|Adverse Event|0|||
147636532|NCT02980341|532487243|FG002|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
147636533|NCT02980341|532487244|FG003|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
147636534|NCT02980341|532487245|FG004|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
147636535|NCT02980341|532487246|FG005|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
147636536|NCT02980341|532487247|FG006|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
147636537|NCT02980341|532487248|FG007|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
147636538|NCT02980341|532487249|FG008|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|1|||
147636539|NCT02980341|532487250|FG009|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
147636540|NCT02980341|532487251|FG010|Dose Expansion|Due to investigator's decision because patient was a candidate for surgery|0|||
147636541|NCT02980341|532487241|FG000|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
147636542|NCT02980341|532487242|FG001|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
147636543|NCT02980341|532487243|FG002|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
147636544|NCT02980341|532487244|FG003|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
147636545|NCT02980341|532487245|FG004|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
147636546|NCT02980341|532487246|FG005|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
147636547|NCT02980341|532487247|FG006|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
147636548|NCT02980341|532487248|FG007|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
147636549|NCT02980341|532487249|FG008|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
147636550|NCT02980341|532487250|FG009|Dose Expansion|Patient withdrew consent following 50 treatment cycles|0|||
147636551|NCT02980341|532487251|FG010|Dose Expansion|Patient withdrew consent following 50 treatment cycles|1|||
147636552|NCT02691936|532487257|FG000|Overall Study|Withdrawal by Subject|2|||
147636553|NCT02691936|532487258|FG001|Overall Study|Withdrawal by Subject|5|||
147636554|NCT00749684|532487259|FG000|Overall Study|Death|1|||
147636555|NCT00749684|532487259|FG000|Overall Study|Adverse Event|27|||
147636556|NCT00749684|532487259|FG000|Overall Study|Participant's Wish|10|||
147636557|NCT00749684|532487259|FG000|Overall Study|Not Documented|1|||
147636558|NCT00749684|532487259|FG000|Overall Study|Progressive Desease|31|||
147636559|NCT00749684|532487259|FG000|Overall Study|Therapy according to protocol + AE|2|||
147636560|NCT00749684|532487259|FG000|Overall Study|AE+discontinuation on participants wish|1|||
147636561|NCT00749684|532487259|FG000|Overall Study|Missing|9|||
147636562|NCT03696108|532487260|FG000|Overall Study|Physician Decision|1|||
147636563|NCT03696108|532487261|FG001|Overall Study|Physician Decision|0|||
147636564|NCT03696108|532487260|FG000|Overall Study|Withdrawal by Subject|3|||
147636565|NCT03696108|532487261|FG001|Overall Study|Withdrawal by Subject|6|||
147636566|NCT05239494|532487262|FG000|Overall Study|Lost to Follow-up|1|||
147636567|NCT01053962|532487263|FG000|Pretreatment Period|Withdrew Consent (Patient/PI)|0|||
147636568|NCT01053962|532487264|FG001|Pretreatment Period|Withdrew Consent (Patient/PI)|0|||
147636569|NCT01053962|532487265|FG002|Pretreatment Period|Withdrew Consent (Patient/PI)|0|||
147636570|NCT01053962|532487266|FG003|Pretreatment Period|Withdrew Consent (Patient/PI)|1|||
147636571|NCT01053962|532487267|FG004|Pretreatment Period|Withdrew Consent (Patient/PI)|2|||
147636572|NCT01053962|532487263|FG000|Pretreatment Period|Venipuncture Failure|0|||
147636573|NCT01053962|532487264|FG001|Pretreatment Period|Venipuncture Failure|0|||
147636574|NCT01053962|532487265|FG002|Pretreatment Period|Venipuncture Failure|1|||
147636575|NCT01053962|532487266|FG003|Pretreatment Period|Venipuncture Failure|0|||
147636576|NCT01053962|532487267|FG004|Pretreatment Period|Venipuncture Failure|0|||
147636577|NCT01053962|532487263|FG000|Pretreatment Period|Failed Urine drug screen Day 1|0|||
147636578|NCT01053962|532487264|FG001|Pretreatment Period|Failed Urine drug screen Day 1|1|||
147636579|NCT01053962|532487265|FG002|Pretreatment Period|Failed Urine drug screen Day 1|0|||
147636580|NCT01053962|532487266|FG003|Pretreatment Period|Failed Urine drug screen Day 1|0|||
147636581|NCT01053962|532487267|FG004|Pretreatment Period|Failed Urine drug screen Day 1|0|||
147636582|NCT01053962|532487263|FG000|Pretreatment Period|Abnormal Lab values Exl 16|0|||
147636583|NCT01053962|532487264|FG001|Pretreatment Period|Abnormal Lab values Exl 16|0|||
147636584|NCT01053962|532487265|FG002|Pretreatment Period|Abnormal Lab values Exl 16|0|||
147636585|NCT01053962|532487266|FG003|Pretreatment Period|Abnormal Lab values Exl 16|1|||
147636586|NCT01053962|532487267|FG004|Pretreatment Period|Abnormal Lab values Exl 16|0|||
147636587|NCT01053962|532487263|FG000|Treatment Period|Lack of Efficacy|0|||
147636588|NCT01053962|532487264|FG001|Treatment Period|Lack of Efficacy|0|||
147636589|NCT01053962|532487265|FG002|Treatment Period|Lack of Efficacy|0|||
147636590|NCT01053962|532487266|FG003|Treatment Period|Lack of Efficacy|0|||
147636591|NCT01053962|532487267|FG004|Treatment Period|Lack of Efficacy|1|||
147636592|NCT01053962|532487263|FG000|Treatment Period|Adverse Event|0|||
147636593|NCT01053962|532487264|FG001|Treatment Period|Adverse Event|0|||
147636594|NCT01053962|532487265|FG002|Treatment Period|Adverse Event|0|||
147636595|NCT01053962|532487266|FG003|Treatment Period|Adverse Event|0|||
147636596|NCT01053962|532487267|FG004|Treatment Period|Adverse Event|1|||
147636597|NCT01053962|532487263|FG000|Treatment Period|Withdrawal by Subject|0|||
147636598|NCT01053962|532487264|FG001|Treatment Period|Withdrawal by Subject|0|||
147636599|NCT01053962|532487265|FG002|Treatment Period|Withdrawal by Subject|0|||
147504581|NCT01033487|531998857|FG004|Fourth Intervention Period|Adverse Event|0|||
147504582|NCT01033487|531998858|FG005|Fourth Intervention Period|Adverse Event|0|||
147504583|NCT01033487|531998859|FG006|Fourth Intervention Period|Adverse Event|0|||
147504584|NCT01033487|531998860|FG007|Fourth Intervention Period|Adverse Event|0|||
147504585|NCT01033487|531998861|FG008|Fourth Intervention Period|Adverse Event|1|||
147504586|NCT01033487|531998862|FG009|Fourth Intervention Period|Adverse Event|0|||
147504587|NCT00862654|531998863|FG000|Overall Study|Lack of Efficacy|1|||
147504588|NCT00862654|531998864|FG001|Overall Study|Lack of Efficacy|0|||
147504589|NCT00862654|531998865|FG002|Overall Study|Lack of Efficacy|1|||
147504590|NCT00862654|531998866|FG003|Overall Study|Lack of Efficacy|0|||
147504591|NCT00862654|531998863|FG000|Overall Study|Lost to Follow-up|1|||
147504592|NCT00862654|531998864|FG001|Overall Study|Lost to Follow-up|2|||
147504593|NCT00862654|531998865|FG002|Overall Study|Lost to Follow-up|1|||
147504594|NCT00862654|531998866|FG003|Overall Study|Lost to Follow-up|3|||
147504595|NCT00862654|531998863|FG000|Overall Study|Adverse Event|0|||
147504596|NCT00862654|531998864|FG001|Overall Study|Adverse Event|1|||
147504597|NCT00862654|531998865|FG002|Overall Study|Adverse Event|1|||
147504598|NCT00862654|531998866|FG003|Overall Study|Adverse Event|0|||
147504599|NCT00862654|531998863|FG000|Overall Study|Pregnancy|1|||
147504600|NCT00862654|531998864|FG001|Overall Study|Pregnancy|1|||
147504601|NCT00862654|531998865|FG002|Overall Study|Pregnancy|0|||
147504602|NCT00862654|531998866|FG003|Overall Study|Pregnancy|0|||
147504603|NCT00862654|531998863|FG000|Overall Study|Withdrawal by Subject|2|||
147504604|NCT00862654|531998864|FG001|Overall Study|Withdrawal by Subject|2|||
147504605|NCT00862654|531998865|FG002|Overall Study|Withdrawal by Subject|2|||
147504606|NCT00862654|531998866|FG003|Overall Study|Withdrawal by Subject|3|||
147504607|NCT00862654|531998863|FG000|Overall Study|Subject mistake|0|||
147504608|NCT00862654|531998864|FG001|Overall Study|Subject mistake|1|||
147504609|NCT00862654|531998865|FG002|Overall Study|Subject mistake|0|||
147504610|NCT00862654|531998866|FG003|Overall Study|Subject mistake|0|||
147504611|NCT00862654|531998863|FG000|Overall Study|Familly constraint|0|||
147504612|NCT00862654|531998864|FG001|Overall Study|Familly constraint|1|||
147504613|NCT00862654|531998865|FG002|Overall Study|Familly constraint|0|||
147504614|NCT00862654|531998866|FG003|Overall Study|Familly constraint|0|||
147504615|NCT00862654|531998863|FG000|Overall Study|Never used study drugs|1|||
147504616|NCT00862654|531998864|FG001|Overall Study|Never used study drugs|0|||
147504617|NCT00862654|531998865|FG002|Overall Study|Never used study drugs|0|||
147504618|NCT00862654|531998866|FG003|Overall Study|Never used study drugs|0|||
147504619|NCT00862654|531998863|FG000|Overall Study|Included after end of inclusions|0|||
147504620|NCT00862654|531998864|FG001|Overall Study|Included after end of inclusions|0|||
147504621|NCT00862654|531998865|FG002|Overall Study|Included after end of inclusions|1|||
147504622|NCT00862654|531998866|FG003|Overall Study|Included after end of inclusions|0|||
147504623|NCT03954444|531998867|FG000|Overall Study|Withdrawal by Subject|5|||
147504624|NCT03954444|531998868|FG001|Overall Study|Withdrawal by Subject|5|||
147504625|NCT03954444|531998869|FG002|Overall Study|Withdrawal by Subject|5|||
147504626|NCT03954444|531998867|FG000|Overall Study|Adverse Event|1|||
147504627|NCT03954444|531998868|FG001|Overall Study|Adverse Event|3|||
147504628|NCT03954444|531998869|FG002|Overall Study|Adverse Event|2|||
147504629|NCT03954444|531998867|FG000|Overall Study|Protocol Violation|0|||
147504630|NCT03954444|531998868|FG001|Overall Study|Protocol Violation|3|||
147504631|NCT03954444|531998869|FG002|Overall Study|Protocol Violation|5|||
147504632|NCT03954444|531998867|FG000|Overall Study|Use of prohibited therapy|1|||
147504633|NCT03954444|531998868|FG001|Overall Study|Use of prohibited therapy|1|||
147504634|NCT03954444|531998869|FG002|Overall Study|Use of prohibited therapy|2|||
147504635|NCT03954444|531998867|FG000|Overall Study|Lost to Follow-up|1|||
147504636|NCT03954444|531998868|FG001|Overall Study|Lost to Follow-up|0|||
147504637|NCT03954444|531998869|FG002|Overall Study|Lost to Follow-up|1|||
147504638|NCT03954444|531998867|FG000|Overall Study|Non-compliant with study drug application|2|||
147504639|NCT03954444|531998868|FG001|Overall Study|Non-compliant with study drug application|2|||
147504640|NCT03954444|531998869|FG002|Overall Study|Non-compliant with study drug application|0|||
147504641|NCT03954444|531998867|FG000|Overall Study|Administrative reasons|0|||
147504642|NCT03954444|531998868|FG001|Overall Study|Administrative reasons|0|||
147504643|NCT03954444|531998869|FG002|Overall Study|Administrative reasons|1|||
147504644|NCT03954444|531998867|FG000|Overall Study|Miscellaneous|3|||
147504645|NCT03954444|531998868|FG001|Overall Study|Miscellaneous|2|||
147504646|NCT03954444|531998869|FG002|Overall Study|Miscellaneous|1|||
147504647|NCT03094832|531998874|FG000|Overall Study|Lost to Follow-up|0|||
147504648|NCT03094832|531998875|FG001|Overall Study|Lost to Follow-up|0|||
147504649|NCT03094832|531998876|FG002|Overall Study|Lost to Follow-up|0|||
147504650|NCT03094832|531998877|FG003|Overall Study|Lost to Follow-up|1|||
147504651|NCT03094832|531998878|FG004|Overall Study|Lost to Follow-up|1|||
147504652|NCT03094832|531998874|FG000|Overall Study|Death|1|||
147504653|NCT03094832|531998875|FG001|Overall Study|Death|0|||
147504654|NCT03094832|531998876|FG002|Overall Study|Death|0|||
147504655|NCT03094832|531998877|FG003|Overall Study|Death|0|||
147504656|NCT03094832|531998878|FG004|Overall Study|Death|0|||
147504657|NCT03094832|531998874|FG000|Overall Study|Withdrawal by Parent/Guardian|1|||
147504658|NCT03094832|531998875|FG001|Overall Study|Withdrawal by Parent/Guardian|0|||
147504659|NCT03094832|531998876|FG002|Overall Study|Withdrawal by Parent/Guardian|0|||
147504660|NCT03094832|531998877|FG003|Overall Study|Withdrawal by Parent/Guardian|0|||
147504661|NCT03094832|531998878|FG004|Overall Study|Withdrawal by Parent/Guardian|0|||
147504662|NCT03094832|531998874|FG000|Overall Study|Other|13|||
147636600|NCT01053962|532487266|FG003|Treatment Period|Withdrawal by Subject|0|||
147636601|NCT01053962|532487267|FG004|Treatment Period|Withdrawal by Subject|1|||
147636602|NCT01053962|532487263|FG000|Treatment Period|Noncompliance with protocol|1|||
147636603|NCT01053962|532487264|FG001|Treatment Period|Noncompliance with protocol|0|||
147636604|NCT01053962|532487265|FG002|Treatment Period|Noncompliance with protocol|0|||
147636605|NCT01053962|532487266|FG003|Treatment Period|Noncompliance with protocol|0|||
147636606|NCT01053962|532487267|FG004|Treatment Period|Noncompliance with protocol|0|||
147636607|NCT02892422|532487270|FG000|Overall Study|Enrolled not treated|4|||
147636608|NCT02892422|532487270|FG000|Overall Study|Adverse Event|38|||
147636609|NCT02892422|532487270|FG000|Overall Study|Lack of Efficacy|32|||
147636610|NCT02892422|532487270|FG000|Overall Study|Non-compliance with study drug|11|||
147636611|NCT02892422|532487270|FG000|Overall Study|Protocol Violation|4|||
147636612|NCT02892422|532487270|FG000|Overall Study|Withdrawal by Subject|56|||
147636613|NCT02892422|532487270|FG000|Overall Study|Lost to Follow-up|5|||
147636614|NCT02892422|532487270|FG000|Overall Study|sponsor information 16159A results|21|||
147636615|NCT02892422|532487270|FG000|Overall Study|withdrawal of consent|13|||
147636616|NCT02892422|532487270|FG000|Overall Study|exclusion criteria met|3|||
147636617|NCT02892422|532487270|FG000|Overall Study|moving elsewhere|4|||
147636618|NCT02892422|532487270|FG000|Overall Study|non-compliance|10|||
147636619|NCT02892422|532487270|FG000|Overall Study|patient legally incapable|1|||
147636620|NCT02892422|532487270|FG000|Overall Study|patient decision|7|||
147636621|NCT02892422|532487270|FG000|Overall Study|Investigator decision|1|||
147636622|NCT03089697|532487271|FG000|Overall Study|Adverse Event|1|||
147636623|NCT03089697|532487272|FG001|Overall Study|Adverse Event|2|||
147636624|NCT03089697|532487271|FG000|Overall Study|Withdrawal by Subject|1|||
147636625|NCT03089697|532487272|FG001|Overall Study|Withdrawal by Subject|0|||
147636626|NCT02693171|532487273|FG000|Overall Study|Adverse Event|1|||
147636627|NCT02693171|532487273|FG000|Overall Study|Discontinuation of Study by Sponsor|8|||
147636628|NCT01167881|532487274|FG000|Overall Study|Adverse Event|47|||
147636629|NCT01167881|532487275|FG001|Overall Study|Adverse Event|51|||
147636630|NCT01167881|532487274|FG000|Overall Study|Lack of Efficacy|4|||
147636631|NCT01167881|532487275|FG001|Overall Study|Lack of Efficacy|7|||
147636632|NCT01167881|532487274|FG000|Overall Study|Non compliant with protocol|9|||
147636633|NCT01167881|532487275|FG001|Overall Study|Non compliant with protocol|18|||
147636634|NCT01167881|532487274|FG000|Overall Study|Lost to Follow-up|19|||
147636635|NCT01167881|532487275|FG001|Overall Study|Lost to Follow-up|20|||
147636636|NCT01167881|532487274|FG000|Overall Study|Patient refusal to cont., not due to AE|45|||
147636637|NCT01167881|532487275|FG001|Overall Study|Patient refusal to cont., not due to AE|40|||
147636638|NCT01167881|532487274|FG000|Overall Study|Not treated|4|||
147636639|NCT01167881|532487275|FG001|Overall Study|Not treated|0|||
147636640|NCT01167881|532487274|FG000|Overall Study|Other not defined above|31|||
147636641|NCT01167881|532487275|FG001|Overall Study|Other not defined above|55|||
147636642|NCT01992653|532487276|FG000|Overall Study|Death|0|||
147636643|NCT01992653|532487277|FG001|Overall Study|Death|0|||
147636644|NCT01992653|532487278|FG002|Overall Study|Death|1|||
147636645|NCT01992653|532487279|FG003|Overall Study|Death|0|||
147636646|NCT01992653|532487280|FG004|Overall Study|Death|1|||
147636647|NCT01992653|532487281|FG005|Overall Study|Death|0|||
147636648|NCT01992653|532487282|FG006|Overall Study|Death|4|||
147636649|NCT01992653|532487283|FG007|Overall Study|Death|2|||
147636650|NCT01992653|532487276|FG000|Overall Study|Lost to Follow-up|0|||
147636651|NCT01992653|532487277|FG001|Overall Study|Lost to Follow-up|0|||
147636652|NCT01992653|532487278|FG002|Overall Study|Lost to Follow-up|0|||
147636653|NCT01992653|532487279|FG003|Overall Study|Lost to Follow-up|0|||
147636654|NCT01992653|532487280|FG004|Overall Study|Lost to Follow-up|0|||
147504663|NCT03094832|531998875|FG001|Overall Study|Other|20|||
147504664|NCT03094832|531998876|FG002|Overall Study|Other|1|||
147636655|NCT01992653|532487281|FG005|Overall Study|Lost to Follow-up|0|||
147636656|NCT01992653|532487282|FG006|Overall Study|Lost to Follow-up|0|||
147636657|NCT01992653|532487283|FG007|Overall Study|Lost to Follow-up|1|||
147636658|NCT01992653|532487276|FG000|Overall Study|Study Completed|0|||
147636659|NCT01992653|532487277|FG001|Overall Study|Study Completed|0|||
147504665|NCT03094832|531998877|FG003|Overall Study|Other|7|||
147504666|NCT03094832|531998878|FG004|Overall Study|Other|1|||
147504667|NCT01181778|531998880|FG000|Overall Study|Physician Decision|48|||
147504668|NCT02674685|531998881|FG000|Overall Study|Withdrawal by Subject|4|||
147636660|NCT01992653|532487278|FG002|Overall Study|Study Completed|0|||
147636661|NCT01992653|532487279|FG003|Overall Study|Study Completed|0|||
147636662|NCT01992653|532487280|FG004|Overall Study|Study Completed|0|||
147636663|NCT01992653|532487281|FG005|Overall Study|Study Completed|0|||
147636664|NCT01992653|532487282|FG006|Overall Study|Study Completed|0|||
147636665|NCT01992653|532487283|FG007|Overall Study|Study Completed|1|||
147636666|NCT01992653|532487276|FG000|Overall Study|Disease Progression|0|||
147504669|NCT02661464|531998882|FG000|Overall Study|Lost to Follow-up|28|||
147504670|NCT02661464|531998883|FG001|Overall Study|Lost to Follow-up|0|||
147636667|NCT01992653|532487277|FG001|Overall Study|Disease Progression|0|||
147636668|NCT01992653|532487278|FG002|Overall Study|Disease Progression|0|||
147636669|NCT01992653|532487279|FG003|Overall Study|Disease Progression|0|||
147636670|NCT01992653|532487280|FG004|Overall Study|Disease Progression|0|||
147636671|NCT01992653|532487281|FG005|Overall Study|Disease Progression|0|||
147636672|NCT01992653|532487282|FG006|Overall Study|Disease Progression|4|||
147636673|NCT01992653|532487283|FG007|Overall Study|Disease Progression|0|||
147636674|NCT00977314|532487284|FG000|Overall Study|Withdrawal by Subject|1|||
147636675|NCT00977314|532487285|FG001|Overall Study|Withdrawal by Subject|0|||
147636676|NCT00977314|532487284|FG000|Overall Study|Physician Decision|1|||
147636677|NCT00977314|532487285|FG001|Overall Study|Physician Decision|0|||
147636678|NCT02107859|532487288|FG000|Overall Study|Withdrawal by Subject|14|||
147636679|NCT02107859|532487288|FG000|Overall Study|Adverse Event|3|||
147636680|NCT02107859|532487288|FG000|Overall Study|Study closure|41|||
147636681|NCT02107859|532487288|FG000|Overall Study|Other than specified|3|||
147636682|NCT00556933|532487296|FG000|Single vs. Divided-dose rATG Induction|Protocol Violation|2|||
147636683|NCT00556933|532487297|FG001|Single vs. Divided-dose rATG Induction|Protocol Violation|3|||
147636684|NCT00556933|532487298|FG002|Single vs. Divided-dose rATG Induction|Protocol Violation|3|||
147636685|NCT00556933|532487299|FG003|Single vs. Divided-dose rATG Induction|Protocol Violation|0|||
147636686|NCT00556933|532487296|FG000|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|0|||
147636687|NCT00556933|532487297|FG001|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|0|||
147636688|NCT00556933|532487298|FG002|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|1|||
147636689|NCT00556933|532487299|FG003|Single vs. Divided-dose rATG Induction|Withdrawal by Subject|0|||
147636690|NCT00556933|532487296|FG000|Single vs. Divided-dose rATG Induction|Pancreas transplantation|0|||
147636691|NCT00556933|532487297|FG001|Single vs. Divided-dose rATG Induction|Pancreas transplantation|2|||
147636692|NCT00556933|532487298|FG002|Single vs. Divided-dose rATG Induction|Pancreas transplantation|2|||
147636693|NCT00556933|532487299|FG003|Single vs. Divided-dose rATG Induction|Pancreas transplantation|2|||
147636694|NCT00556933|532487296|FG000|Single vs. Divided-dose rATG Induction|Death|0|||
147636695|NCT00556933|532487297|FG001|Single vs. Divided-dose rATG Induction|Death|1|||
147636696|NCT00556933|532487298|FG002|Single vs. Divided-dose rATG Induction|Death|0|||
147636697|NCT00556933|532487299|FG003|Single vs. Divided-dose rATG Induction|Death|0|||
147636698|NCT00556933|532487296|FG000|Single vs. Divided-dose rATG Induction|Lost to Follow-up|0|||
147636699|NCT00556933|532487297|FG001|Single vs. Divided-dose rATG Induction|Lost to Follow-up|1|||
147636700|NCT00556933|532487298|FG002|Single vs. Divided-dose rATG Induction|Lost to Follow-up|0|||
147636701|NCT00556933|532487299|FG003|Single vs. Divided-dose rATG Induction|Lost to Follow-up|0|||
147636702|NCT00556933|532487296|FG000|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|0|||
147636703|NCT00556933|532487297|FG001|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|1|||
147636704|NCT00556933|532487298|FG002|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|0|||
147636705|NCT00556933|532487299|FG003|Single vs. Divided-dose rATG Induction|Kidney graft primary non-function|0|||
147636706|NCT00556933|532487296|FG000|CNI Withdrawal vs. Minimization|Pancreas transplantation|1|||
147636707|NCT00556933|532487297|FG001|CNI Withdrawal vs. Minimization|Pancreas transplantation|1|||
147636708|NCT00556933|532487298|FG002|CNI Withdrawal vs. Minimization|Pancreas transplantation|0|||
147636709|NCT00556933|532487299|FG003|CNI Withdrawal vs. Minimization|Pancreas transplantation|0|||
147636710|NCT00556933|532487296|FG000|CNI Withdrawal vs. Minimization|Lost to Follow-up|0|||
147636711|NCT00556933|532487297|FG001|CNI Withdrawal vs. Minimization|Lost to Follow-up|1|||
147636712|NCT00556933|532487298|FG002|CNI Withdrawal vs. Minimization|Lost to Follow-up|0|||
147636713|NCT00556933|532487299|FG003|CNI Withdrawal vs. Minimization|Lost to Follow-up|1|||
147636714|NCT00556933|532487296|FG000|CNI Withdrawal vs. Minimization|Withdrawal by Subject|0|||
147636715|NCT00556933|532487297|FG001|CNI Withdrawal vs. Minimization|Withdrawal by Subject|1|||
147636716|NCT00556933|532487298|FG002|CNI Withdrawal vs. Minimization|Withdrawal by Subject|1|||
147636717|NCT00556933|532487299|FG003|CNI Withdrawal vs. Minimization|Withdrawal by Subject|0|||
147636718|NCT00556933|532487296|FG000|CNI Withdrawal vs. Minimization|Graft loss|0|||
147636719|NCT00556933|532487297|FG001|CNI Withdrawal vs. Minimization|Graft loss|1|||
147636720|NCT00556933|532487298|FG002|CNI Withdrawal vs. Minimization|Graft loss|2|||
147636721|NCT00556933|532487299|FG003|CNI Withdrawal vs. Minimization|Graft loss|0|||
147636722|NCT00556933|532487296|FG000|CNI Withdrawal vs. Minimization|Death|0|||
147636723|NCT00556933|532487297|FG001|CNI Withdrawal vs. Minimization|Death|0|||
147636724|NCT00556933|532487298|FG002|CNI Withdrawal vs. Minimization|Death|0|||
147636725|NCT00556933|532487299|FG003|CNI Withdrawal vs. Minimization|Death|1|||
147636726|NCT03887442|532487300|FG000|Overall Study|Adverse Event|1|||
147636727|NCT03887442|532487301|FG001|Overall Study|Adverse Event|0|||
147636728|NCT01628198|532487304|FG000|Overall Study|Lost to Follow-up|7|||
147636729|NCT01628198|532487304|FG000|Overall Study|Withdrawal by Subject|10|||
147636730|NCT01628198|532487304|FG000|Overall Study|Screen failure|1|||
147636731|NCT00022698|532487305|FG000|Overall Study|Adverse Event|5|||
147636732|NCT00022698|532487306|FG001|Overall Study|Adverse Event|9|||
147636733|NCT00022698|532487305|FG000|Overall Study|Death|0|||
147636734|NCT00022698|532487306|FG001|Overall Study|Death|2|||
147636735|NCT00022698|532487305|FG000|Overall Study|Failure to return|0|||
147636736|NCT00022698|532487306|FG001|Overall Study|Failure to return|1|||
147636737|NCT00022698|532487305|FG000|Overall Study|Refused treatment|0|||
147636738|NCT00022698|532487306|FG001|Overall Study|Refused treatment|2|||
147636739|NCT00022698|532487305|FG000|Overall Study|Insufficient therapeutic response|2|||
147636740|NCT00022698|532487306|FG001|Overall Study|Insufficient therapeutic response|14|||
147636741|NCT00022698|532487305|FG000|Overall Study|Administrative /other|1|||
147636742|NCT00022698|532487306|FG001|Overall Study|Administrative /other|7|||
147636743|NCT01743560|532487308|FG000|Overall Study|Disease progression|26|||
147636744|NCT01743560|532487308|FG000|Overall Study|Adverse Event|8|||
147636745|NCT01743560|532487308|FG000|Overall Study|Death|3|||
147636746|NCT01743560|532487308|FG000|Overall Study|Withdrawal by Subject|2|||
147636747|NCT01743560|532487308|FG000|Overall Study|Protocol Violation|1|||
147636748|NCT01743560|532487308|FG000|Overall Study|>1 dose of study drug|3|||
147636749|NCT00877487|532487311|FG000|Open-label Treatment Phase|Adverse Event|1|||
147636750|NCT00877487|532487312|FG001|Open-label Treatment Phase|Adverse Event|0|||
147636751|NCT00877487|532487311|FG000|Open-label Treatment Phase|Protocol Violation|3|||
147636752|NCT00877487|532487312|FG001|Open-label Treatment Phase|Protocol Violation|0|||
147636753|NCT00877487|532487311|FG000|Open-label Treatment Phase|Withdrawal by Subject|1|||
147636754|NCT00877487|532487312|FG001|Open-label Treatment Phase|Withdrawal by Subject|0|||
147636755|NCT00877487|532487311|FG000|Open-label Treatment Phase|Lost to Follow-up|1|||
147636756|NCT00877487|532487312|FG001|Open-label Treatment Phase|Lost to Follow-up|0|||
147636757|NCT00877487|532487311|FG000|Open-label Treatment Phase|Out of country for business|1|||
147636758|NCT00877487|532487312|FG001|Open-label Treatment Phase|Out of country for business|0|||
147636759|NCT00877487|532487311|FG000|Double-blind Randomized Withdrawal Phase|Relapse criteria met|5|||
147636760|NCT00877487|532487312|FG001|Double-blind Randomized Withdrawal Phase|Relapse criteria met|45|||
147636761|NCT00877487|532487311|FG000|Double-blind Randomized Withdrawal Phase|Adverse Event|0|||
147636762|NCT00877487|532487312|FG001|Double-blind Randomized Withdrawal Phase|Adverse Event|1|||
147636763|NCT00877487|532487311|FG000|Double-blind Randomized Withdrawal Phase|Protocol Violation|0|||
147636764|NCT00877487|532487312|FG001|Double-blind Randomized Withdrawal Phase|Protocol Violation|1|||
147636765|NCT00877487|532487311|FG000|Double-blind Randomized Withdrawal Phase|Moved out of state|1|||
147636766|NCT00877487|532487312|FG001|Double-blind Randomized Withdrawal Phase|Moved out of state|0|||
147636767|NCT01516008|532487313|FG000|Overall Study|Adverse Event|0|||
147636768|NCT01516008|532487314|FG001|Overall Study|Adverse Event|2|||
147636769|NCT01516008|532487315|FG002|Overall Study|Adverse Event|7|||
147636770|NCT01516008|532487313|FG000|Overall Study|Lack of Efficacy|44|||
147636771|NCT01516008|532487314|FG001|Overall Study|Lack of Efficacy|14|||
147636772|NCT01516008|532487315|FG002|Overall Study|Lack of Efficacy|10|||
147636773|NCT01516008|532487313|FG000|Overall Study|Protocol Violation|1|||
147636774|NCT01516008|532487314|FG001|Overall Study|Protocol Violation|0|||
147636775|NCT01516008|532487315|FG002|Overall Study|Protocol Violation|0|||
147636776|NCT01516008|532487313|FG000|Overall Study|Reason not specified|0|||
147636777|NCT01516008|532487314|FG001|Overall Study|Reason not specified|0|||
147636778|NCT01516008|532487315|FG002|Overall Study|Reason not specified|1|||
147636779|NCT01217476|532487316|FG000|Overall Study|Adverse Event|6|||
147636780|NCT01217476|532487317|FG001|Overall Study|Adverse Event|1|||
147636781|NCT01217476|532487316|FG000|Overall Study|Physician Decision|0|||
147636782|NCT01217476|532487317|FG001|Overall Study|Physician Decision|1|||
147636783|NCT01217476|532487316|FG000|Overall Study|Withdrawal by Subject|3|||
147636784|NCT01217476|532487317|FG001|Overall Study|Withdrawal by Subject|3|||
147636785|NCT01217476|532487316|FG000|Overall Study|Surgery on the Target Limb|0|||
147636786|NCT01217476|532487317|FG001|Overall Study|Surgery on the Target Limb|2|||
147636787|NCT01217476|532487316|FG000|Overall Study|Protocol Deviation|1|||
147636788|NCT01217476|532487317|FG001|Overall Study|Protocol Deviation|0|||
147636789|NCT01217476|532487316|FG000|Overall Study|Other|2|||
147636790|NCT01217476|532487317|FG001|Overall Study|Other|0|||
147636791|NCT00813813|532487322|FG000|Overall Study|Withdrawal by Subject|1|||
147636792|NCT00813813|532487323|FG001|Overall Study|Withdrawal by Subject|1|||
147636793|NCT00813813|532487322|FG000|Overall Study|Lost to Follow-up|2|||
147636794|NCT00813813|532487323|FG001|Overall Study|Lost to Follow-up|7|||
147636795|NCT00813813|532487322|FG000|Overall Study|Other|0|||
147636796|NCT00813813|532487323|FG001|Overall Study|Other|1|||
147636797|NCT00986921|532487324|FG000|Overall Study|Physician Decision|1|||
147636798|NCT00986921|532487325|FG001|Overall Study|Physician Decision|0|||
147636799|NCT04445714|532487326|FG000|Overall Study|Discontinuation of the study|14|||
147636800|NCT04445714|532487326|FG000|Overall Study|High plasma glucose-fasting and HbA1c; investigator decision to withdraw participant|1|||
147636801|NCT04445714|532487326|FG000|Overall Study|Withdrawal of Informed Consent|8|||
147636802|NCT02805660|532487327|FG000|Overall Study|Death|5|||
147636803|NCT02805660|532487328|FG001|Overall Study|Death|2|||
147636804|NCT02805660|532487329|FG002|Overall Study|Death|9|||
147636805|NCT02805660|532487330|FG003|Overall Study|Death|5|||
147636806|NCT02805660|532487331|FG004|Overall Study|Death|0|||
147636807|NCT02805660|532487332|FG005|Overall Study|Death|14|||
147636808|NCT02805660|532487333|FG006|Overall Study|Death|12|||
147636809|NCT02805660|532487327|FG000|Overall Study|Lost to Follow-up|0|||
147636810|NCT02805660|532487328|FG001|Overall Study|Lost to Follow-up|1|||
147636811|NCT02805660|532487329|FG002|Overall Study|Lost to Follow-up|1|||
147636812|NCT02805660|532487330|FG003|Overall Study|Lost to Follow-up|2|||
147504671|NCT02661464|531998884|FG002|Overall Study|Lost to Follow-up|0|||
147504672|NCT02661464|531998885|FG003|Overall Study|Lost to Follow-up|0|||
147504673|NCT02661464|531998882|FG000|Overall Study|Withdrawal by Subject|3|||
147504674|NCT02661464|531998883|FG001|Overall Study|Withdrawal by Subject|1|||
147504675|NCT02661464|531998884|FG002|Overall Study|Withdrawal by Subject|0|||
147504676|NCT02661464|531998885|FG003|Overall Study|Withdrawal by Subject|0|||
147504677|NCT02661464|531998882|FG000|Overall Study|Participants terminated prematurely|288|||
147504678|NCT02661464|531998883|FG001|Overall Study|Participants terminated prematurely|52|||
147504679|NCT02661464|531998884|FG002|Overall Study|Participants terminated prematurely|1|||
147504680|NCT02661464|531998885|FG003|Overall Study|Participants terminated prematurely|1|||
147504681|NCT02661464|531998882|FG000|Overall Study|Participants who had no post-baseline visits.|3|||
147504682|NCT02661464|531998883|FG001|Overall Study|Participants who had no post-baseline visits.|4|||
147504683|NCT02661464|531998884|FG002|Overall Study|Participants who had no post-baseline visits.|0|||
147504684|NCT02661464|531998885|FG003|Overall Study|Participants who had no post-baseline visits.|0|||
147504685|NCT00903370|531998886|FG000|Overall Study|Death|13|||
147504686|NCT00903370|531998887|FG001|Overall Study|Death|10|||
147504687|NCT00903370|531998886|FG000|Overall Study|Withdrawal by Subject|9|||
147504688|NCT00903370|531998887|FG001|Overall Study|Withdrawal by Subject|6|||
147504689|NCT00903370|531998886|FG000|Overall Study|Lost to Follow-up|6|||
147504690|NCT00903370|531998887|FG001|Overall Study|Lost to Follow-up|8|||
147504691|NCT00719862|531998888|FG000|Overall Study|Adverse Event|1|||
147504692|NCT00719862|531998889|FG001|Overall Study|Adverse Event|2|||
147504693|NCT00719862|531998888|FG000|Overall Study|Lack of Efficacy|3|||
147504694|NCT00719862|531998889|FG001|Overall Study|Lack of Efficacy|0|||
147504695|NCT00719862|531998888|FG000|Overall Study|Non-Compliance|1|||
147504696|NCT00719862|531998889|FG001|Overall Study|Non-Compliance|0|||
147504697|NCT00719862|531998888|FG000|Overall Study|Withdrawal by Subject|1|||
147504698|NCT00719862|531998889|FG001|Overall Study|Withdrawal by Subject|0|||
147504699|NCT00719862|531998888|FG000|Overall Study|Lost to Follow-up|0|||
147504700|NCT00719862|531998889|FG001|Overall Study|Lost to Follow-up|1|||
147504701|NCT00719862|531998888|FG000|Overall Study|Other|2|||
147504702|NCT00719862|531998889|FG001|Overall Study|Other|3|||
147504703|NCT01184846|531998890|FG000|Overall Study|Adverse Event|2|||
147504704|NCT01184846|531998890|FG000|Overall Study|Insufficient response|1|||
147504705|NCT01999946|531998891|FG000|Overall Study|Participant not released from jail|2|||
147504706|NCT01999946|531998892|FG001|Overall Study|Participant not released from jail|2|||
147504707|NCT01999946|531998893|FG002|Overall Study|Participant not released from jail|0|||
147504708|NCT01999946|531998891|FG000|Overall Study|Not included in primary outcome analysis|0|||
147504709|NCT01999946|531998892|FG001|Overall Study|Not included in primary outcome analysis|0|||
147504710|NCT01999946|531998893|FG002|Overall Study|Not included in primary outcome analysis|79|||
147504711|NCT01770145|532000562|FG000|Baseline|Adverse Event|20|||
147504712|NCT01770145|532000562|FG000|Baseline|Withdrawal by Subject|1|||
147504713|NCT01770145|532000562|FG000|Baseline|Lost to Follow-up|1|||
147504714|NCT01770145|532000562|FG000|Baseline|Unable to define optimal dose|4|||
147504715|NCT01770145|532000562|FG000|Treatment|Adverse Event|3|||
147504716|NCT01770145|532000562|FG000|Treatment|Withdrawal by Subject|1|||
147504717|NCT04268303|532000563|FG000|Overall Study|Lost to Follow-up|1|||
147504718|NCT04268303|532000564|FG001|Overall Study|Lost to Follow-up|1|||
147504719|NCT04268303|532000565|FG002|Overall Study|Lost to Follow-up|2|||
147504720|NCT04268303|532000563|FG000|Overall Study|Withdrawal by Subject|0|||
147504721|NCT04268303|532000564|FG001|Overall Study|Withdrawal by Subject|1|||
147504722|NCT04268303|532000565|FG002|Overall Study|Withdrawal by Subject|1|||
147504723|NCT04268303|532000563|FG000|Overall Study|Adverse Event|2|||
147504724|NCT04268303|532000564|FG001|Overall Study|Adverse Event|0|||
147504725|NCT04268303|532000565|FG002|Overall Study|Adverse Event|0|||
147504726|NCT00355134|532000566|FG000|Core Phase|Withdrawal by Subject|35|||
147504727|NCT00355134|532000567|FG001|Core Phase|Withdrawal by Subject|24|||
147504728|NCT00355134|532000568|FG002|Core Phase|Withdrawal by Subject|35|||
147504729|NCT00355134|532000569|FG003|Core Phase|Withdrawal by Subject|0|||
147504730|NCT00355134|532000570|FG004|Core Phase|Withdrawal by Subject|0|||
147504731|NCT00355134|532000566|FG000|Core Phase|Adverse Event|28|||
147504732|NCT00355134|532000567|FG001|Core Phase|Adverse Event|22|||
147504733|NCT00355134|532000568|FG002|Core Phase|Adverse Event|16|||
147504734|NCT00355134|532000569|FG003|Core Phase|Adverse Event|0|||
147504735|NCT00355134|532000570|FG004|Core Phase|Adverse Event|0|||
147504736|NCT00355134|532000566|FG000|Core Phase|Lost to Follow-up|17|||
147504737|NCT00355134|532000567|FG001|Core Phase|Lost to Follow-up|13|||
147504738|NCT00355134|532000568|FG002|Core Phase|Lost to Follow-up|21|||
147504739|NCT00355134|532000569|FG003|Core Phase|Lost to Follow-up|0|||
147504740|NCT00355134|532000570|FG004|Core Phase|Lost to Follow-up|0|||
147504741|NCT00355134|532000566|FG000|Core Phase|Abnormal laboratory value(s)|19|||
147504742|NCT00355134|532000567|FG001|Core Phase|Abnormal laboratory value(s)|14|||
147504743|NCT00355134|532000568|FG002|Core Phase|Abnormal laboratory value(s)|2|||
147504744|NCT00355134|532000569|FG003|Core Phase|Abnormal laboratory value(s)|0|||
147504745|NCT00355134|532000570|FG004|Core Phase|Abnormal laboratory value(s)|0|||
147504746|NCT00355134|532000566|FG000|Core Phase|Unsatisfactory therapeutic effect|10|||
147504747|NCT00355134|532000567|FG001|Core Phase|Unsatisfactory therapeutic effect|6|||
147636813|NCT02805660|532487331|FG004|Overall Study|Lost to Follow-up|0|||
147636814|NCT02805660|532487332|FG005|Overall Study|Lost to Follow-up|0|||
147636815|NCT02805660|532487333|FG006|Overall Study|Lost to Follow-up|0|||
147636816|NCT02805660|532487327|FG000|Overall Study|Withdrawal by Subject|0|||
147636817|NCT02805660|532487328|FG001|Overall Study|Withdrawal by Subject|0|||
147636818|NCT02805660|532487329|FG002|Overall Study|Withdrawal by Subject|0|||
147636819|NCT02805660|532487330|FG003|Overall Study|Withdrawal by Subject|3|||
147636820|NCT02805660|532487331|FG004|Overall Study|Withdrawal by Subject|1|||
147636821|NCT02805660|532487332|FG005|Overall Study|Withdrawal by Subject|0|||
147636822|NCT02805660|532487333|FG006|Overall Study|Withdrawal by Subject|2|||
147636823|NCT02805660|532487327|FG000|Overall Study|Study terminated by Sponsor|0|||
147636824|NCT02805660|532487328|FG001|Overall Study|Study terminated by Sponsor|0|||
147636825|NCT02805660|532487329|FG002|Overall Study|Study terminated by Sponsor|1|||
147636826|NCT02805660|532487330|FG003|Overall Study|Study terminated by Sponsor|4|||
147636827|NCT02805660|532487331|FG004|Overall Study|Study terminated by Sponsor|2|||
147636828|NCT02805660|532487332|FG005|Overall Study|Study terminated by Sponsor|3|||
147636829|NCT02805660|532487333|FG006|Overall Study|Study terminated by Sponsor|1|||
147636830|NCT02805660|532487327|FG000|Overall Study|Miscellaneous|0|||
147636831|NCT02805660|532487328|FG001|Overall Study|Miscellaneous|1|||
147636832|NCT02805660|532487329|FG002|Overall Study|Miscellaneous|0|||
147636833|NCT02805660|532487330|FG003|Overall Study|Miscellaneous|4|||
147636834|NCT02805660|532487331|FG004|Overall Study|Miscellaneous|0|||
147636835|NCT02805660|532487332|FG005|Overall Study|Miscellaneous|6|||
147636836|NCT02805660|532487333|FG006|Overall Study|Miscellaneous|4|||
147636837|NCT01684943|532487334|FG000|Overall Study|Inadequate Venous Access|3|||
147636838|NCT01684943|532487335|FG001|Overall Study|Inadequate Venous Access|0|||
147636839|NCT01684943|532487336|FG002|Overall Study|Inadequate Venous Access|0|||
147636840|NCT01684943|532487334|FG000|Overall Study|Principal Investigator Determination|1|||
147636841|NCT01684943|532487335|FG001|Overall Study|Principal Investigator Determination|0|||
147636842|NCT01684943|532487336|FG002|Overall Study|Principal Investigator Determination|0|||
147636843|NCT01684943|532487334|FG000|Overall Study|Excluded from Analysis|1|||
147636844|NCT01684943|532487335|FG001|Overall Study|Excluded from Analysis|1|||
147636845|NCT01684943|532487336|FG002|Overall Study|Excluded from Analysis|1|||
147636846|NCT01684943|532487334|FG000|Overall Study|Lost to Follow-up|3|||
147636847|NCT01684943|532487335|FG001|Overall Study|Lost to Follow-up|0|||
147636848|NCT01684943|532487336|FG002|Overall Study|Lost to Follow-up|0|||
147636849|NCT01684943|532487334|FG000|Overall Study|Planning Pregnancy|1|||
147636850|NCT01684943|532487335|FG001|Overall Study|Planning Pregnancy|0|||
147636851|NCT01684943|532487336|FG002|Overall Study|Planning Pregnancy|0|||
147636852|NCT01493284|532487341|FG000|Overall Study|Death|29|||
147636853|NCT01493284|532487341|FG000|Overall Study|Withdrawal by Subject|32|||
147636854|NCT01672710|532487343|FG000|Waitlist Assessed After Sauna Regimen|Withdrawal by Subject|0|||
147636855|NCT01672710|532487344|FG001|Waitlist Assessed After Sauna Regimen|Withdrawal by Subject|1|||
147636856|NCT01672710|532487343|FG000|3 Month Follow up|Lost to Follow-up|2|||
147636857|NCT01672710|532487344|FG001|3 Month Follow up|Lost to Follow-up|3|||
147636858|NCT01672710|532487343|FG000|3 Month Follow up|follow up due after termination date|4|||
147636859|NCT01672710|532487344|FG001|3 Month Follow up|follow up due after termination date|1|||
147636860|NCT02122887|532487345|FG000|Overall Study|Withdrawal by Subject|20|||
147636861|NCT02122887|532487346|FG001|Overall Study|Withdrawal by Subject|2|||
147636862|NCT03725761|532487347|FG000|Overall Study|still on study|1|||
147636863|NCT03634033|532488854|FG000|Overall Study|Did not have a post-assessment|384|||
147636864|NCT03634033|532488855|FG001|Overall Study|Did not have a post-assessment|291|||
147636865|NCT03634033|532488856|FG002|Overall Study|Did not have a post-assessment|114|||
147636866|NCT03634033|532488857|FG003|Overall Study|Did not have a post-assessment|161|||
147636867|NCT03634033|532488858|FG004|Overall Study|Did not have a post-assessment|5|||
147636868|NCT03634033|532488859|FG005|Overall Study|Did not have a post-assessment|0|||
147636869|NCT03634033|532488860|FG006|Overall Study|Did not have a post-assessment|0|||
147636870|NCT03634033|532488854|FG000|Overall Study|Death|0|||
147636871|NCT03634033|532488855|FG001|Overall Study|Death|0|||
147636872|NCT03634033|532488856|FG002|Overall Study|Death|0|||
147636873|NCT03634033|532488857|FG003|Overall Study|Death|0|||
147636874|NCT03634033|532488858|FG004|Overall Study|Death|0|||
147636875|NCT03634033|532488859|FG005|Overall Study|Death|7|||
147636876|NCT03634033|532488860|FG006|Overall Study|Death|7|||
147636877|NCT03634033|532488854|FG000|Overall Study|In Assisted Living/Nursing Home/Hospice|0|||
147636878|NCT03634033|532488855|FG001|Overall Study|In Assisted Living/Nursing Home/Hospice|0|||
147636879|NCT03634033|532488856|FG002|Overall Study|In Assisted Living/Nursing Home/Hospice|0|||
147636880|NCT03634033|532488857|FG003|Overall Study|In Assisted Living/Nursing Home/Hospice|0|||
147636881|NCT03634033|532488858|FG004|Overall Study|In Assisted Living/Nursing Home/Hospice|0|||
147636882|NCT03634033|532488859|FG005|Overall Study|In Assisted Living/Nursing Home/Hospice|5|||
147636883|NCT03634033|532488860|FG006|Overall Study|In Assisted Living/Nursing Home/Hospice|5|||
147636884|NCT03634033|532488854|FG000|Overall Study|Lost to Follow-up|0|||
147636885|NCT03634033|532488855|FG001|Overall Study|Lost to Follow-up|0|||
147636886|NCT03634033|532488856|FG002|Overall Study|Lost to Follow-up|0|||
147636887|NCT03634033|532488857|FG003|Overall Study|Lost to Follow-up|0|||
147504748|NCT00355134|532000568|FG002|Core Phase|Unsatisfactory therapeutic effect|17|||
147504749|NCT00355134|532000569|FG003|Core Phase|Unsatisfactory therapeutic effect|0|||
147504750|NCT00355134|532000570|FG004|Core Phase|Unsatisfactory therapeutic effect|0|||
147504751|NCT00355134|532000566|FG000|Core Phase|Administrative problems|5|||
147504752|NCT00355134|532000567|FG001|Core Phase|Administrative problems|3|||
147504753|NCT00355134|532000568|FG002|Core Phase|Administrative problems|5|||
147504754|NCT00355134|532000569|FG003|Core Phase|Administrative problems|0|||
147504755|NCT00355134|532000570|FG004|Core Phase|Administrative problems|0|||
147504756|NCT00355134|532000566|FG000|Core Phase|Protocol Violation|3|||
147504757|NCT00355134|532000567|FG001|Core Phase|Protocol Violation|2|||
147504758|NCT00355134|532000568|FG002|Core Phase|Protocol Violation|2|||
147504759|NCT00355134|532000569|FG003|Core Phase|Protocol Violation|0|||
147504760|NCT00355134|532000570|FG004|Core Phase|Protocol Violation|0|||
147504761|NCT00355134|532000566|FG000|Core Phase|Abnormal test procedure result(s)|1|||
147504762|NCT00355134|532000567|FG001|Core Phase|Abnormal test procedure result(s)|2|||
147668933|NCT00111761|532613420|FG000|Part 2|Protocol-specified criteria|1|||
147668934|NCT00111761|532613421|FG001|Part 2|Protocol-specified criteria|0|||
147668935|NCT00111761|532613420|FG000|Part 2|Other|1|||
147668936|NCT00111761|532613421|FG001|Part 2|Other|0|||
147668937|NCT01123655|532613424|FG000|Overall Study|Medication for RA had to be changed|1|||
147668938|NCT01123655|532613425|FG001|Overall Study|Medication for RA had to be changed|0|||
147668939|NCT01123655|532613426|FG002|Overall Study|Medication for RA had to be changed|0|||
147668940|NCT01123655|532613424|FG000|Overall Study|new illness|0|||
147668941|NCT01123655|532613425|FG001|Overall Study|new illness|1|||
147668942|NCT01123655|532613426|FG002|Overall Study|new illness|0|||
147668943|NCT01123655|532613424|FG000|Overall Study|began prohibitive drug|0|||
147668944|NCT01123655|532613425|FG001|Overall Study|began prohibitive drug|0|||
147668945|NCT01123655|532613426|FG002|Overall Study|began prohibitive drug|1|||
147668946|NCT00062166|532613427|FG000|Overall Study|Withdrawal by Subject|6|||
147668947|NCT03642990|532613430|FG000|300 mg/Day for One Week|Withdrawal by Subject|1|||
147668948|NCT03642990|532613430|FG000|1000 mg/Day for Weeks 2-12|Physician Decision|4|||
147668949|NCT02717195|532613431|FG000|Prospective Confirmation (PC) Period|Adverse Event|19|||
147504763|NCT00355134|532000568|FG002|Core Phase|Abnormal test procedure result(s)|1|||
147636888|NCT03634033|532488858|FG004|Overall Study|Lost to Follow-up|0|||
147636889|NCT03634033|532488859|FG005|Overall Study|Lost to Follow-up|1|||
147636890|NCT03634033|532488860|FG006|Overall Study|Lost to Follow-up|2|||
147636891|NCT03634033|532488854|FG000|Overall Study|Withdrawal by Subject|0|||
147636892|NCT03634033|532488855|FG001|Overall Study|Withdrawal by Subject|0|||
147636893|NCT03634033|532488856|FG002|Overall Study|Withdrawal by Subject|0|||
147636894|NCT03634033|532488857|FG003|Overall Study|Withdrawal by Subject|0|||
147636895|NCT03634033|532488858|FG004|Overall Study|Withdrawal by Subject|0|||
147636896|NCT03634033|532488859|FG005|Overall Study|Withdrawal by Subject|0|||
147636897|NCT03634033|532488860|FG006|Overall Study|Withdrawal by Subject|1|||
147636898|NCT01397786|532488861|FG000|Phase A|Lost to Follow-up|0|||
147636899|NCT01397786|532488862|FG001|Phase A|Lost to Follow-up|0|||
147636900|NCT01397786|532488863|FG002|Phase A|Lost to Follow-up|6|||
147636901|NCT01397786|532488861|FG000|Phase A|Adverse Event|0|||
147636902|NCT01397786|532488862|FG001|Phase A|Adverse Event|0|||
147636903|NCT01397786|532488863|FG002|Phase A|Adverse Event|8|||
147636904|NCT01397786|532488861|FG000|Phase A|Subject Met Withdrawal Criteria|0|||
147636905|NCT01397786|532488862|FG001|Phase A|Subject Met Withdrawal Criteria|0|||
147636906|NCT01397786|532488863|FG002|Phase A|Subject Met Withdrawal Criteria|7|||
147636907|NCT01397786|532488861|FG000|Phase A|Physician Decision|0|||
147636908|NCT01397786|532488862|FG001|Phase A|Physician Decision|0|||
147636909|NCT01397786|532488863|FG002|Phase A|Physician Decision|1|||
147636910|NCT01397786|532488861|FG000|Phase A|Withdrawal by Subject|0|||
147636911|NCT01397786|532488862|FG001|Phase A|Withdrawal by Subject|0|||
147636912|NCT01397786|532488863|FG002|Phase A|Withdrawal by Subject|5|||
147636913|NCT01397786|532488861|FG000|Phase A|Lack of Efficacy|0|||
147636914|NCT01397786|532488862|FG001|Phase A|Lack of Efficacy|0|||
147636915|NCT01397786|532488863|FG002|Phase A|Lack of Efficacy|1|||
147636916|NCT01397786|532488861|FG000|Phase B|Lost to Follow-up|22|||
147636917|NCT01397786|532488862|FG001|Phase B|Lost to Follow-up|12|||
147636918|NCT01397786|532488863|FG002|Phase B|Lost to Follow-up|22|||
147504764|NCT00355134|532000569|FG003|Core Phase|Abnormal test procedure result(s)|0|||
147636919|NCT01397786|532488861|FG000|Phase B|Adverse Event|109|||
147636920|NCT01397786|532488862|FG001|Phase B|Adverse Event|23|||
147636921|NCT01397786|532488863|FG002|Phase B|Adverse Event|27|||
147636922|NCT01397786|532488861|FG000|Phase B|Subject Met Withdrawal Criteria|38|||
147668950|NCT02717195|532613432|FG001|Prospective Confirmation (PC) Period|Adverse Event|7|||
147668951|NCT02717195|532613433|FG002|Prospective Confirmation (PC) Period|Adverse Event|0|||
147504765|NCT00355134|532000570|FG004|Core Phase|Abnormal test procedure result(s)|0|||
147504766|NCT00355134|532000566|FG000|Core Phase|Condition no longer requires study drug|1|||
147504767|NCT00355134|532000567|FG001|Core Phase|Condition no longer requires study drug|0|||
147636923|NCT01397786|532488862|FG001|Phase B|Subject Met Withdrawal Criteria|5|||
147636924|NCT01397786|532488863|FG002|Phase B|Subject Met Withdrawal Criteria|38|||
147636925|NCT01397786|532488861|FG000|Phase B|Physician Decision|9|||
147636926|NCT01397786|532488862|FG001|Phase B|Physician Decision|1|||
147636927|NCT01397786|532488863|FG002|Phase B|Physician Decision|3|||
147636928|NCT01397786|532488861|FG000|Phase B|Withdrawal by Subject|102|||
147636929|NCT01397786|532488862|FG001|Phase B|Withdrawal by Subject|45|||
147636930|NCT01397786|532488863|FG002|Phase B|Withdrawal by Subject|30|||
147636931|NCT01397786|532488861|FG000|Phase B|Protocol Deviation|1|||
147636932|NCT01397786|532488862|FG001|Phase B|Protocol Deviation|2|||
147636933|NCT01397786|532488863|FG002|Phase B|Protocol Deviation|4|||
147636934|NCT01397786|532488861|FG000|Phase B|Lack of Efficacy|22|||
147636935|NCT01397786|532488862|FG001|Phase B|Lack of Efficacy|7|||
147636936|NCT01397786|532488863|FG002|Phase B|Lack of Efficacy|14|||
147636937|NCT02836236|532488870|FG000|Double-Blind Treatment Phase|Withdrew Consent|3|||
147636938|NCT02836236|532488871|FG001|Double-Blind Treatment Phase|Withdrew Consent|1|||
147636939|NCT02836236|532488872|FG002|Double-Blind Treatment Phase|Withdrew Consent|0|||
147636940|NCT02836236|532488873|FG003|Double-Blind Treatment Phase|Withdrew Consent|0|||
147636941|NCT02836236|532488870|FG000|Double-Blind Treatment Phase|Investigator's Discretion|2|||
147636942|NCT02836236|532488871|FG001|Double-Blind Treatment Phase|Investigator's Discretion|1|||
147636943|NCT02836236|532488872|FG002|Double-Blind Treatment Phase|Investigator's Discretion|0|||
147636944|NCT02836236|532488873|FG003|Double-Blind Treatment Phase|Investigator's Discretion|0|||
147636945|NCT02836236|532488870|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
147636946|NCT02836236|532488871|FG001|Double-Blind Treatment Phase|Adverse Event|1|||
147636947|NCT02836236|532488872|FG002|Double-Blind Treatment Phase|Adverse Event|0|||
147636948|NCT02836236|532488873|FG003|Double-Blind Treatment Phase|Adverse Event|0|||
147636949|NCT02836236|532488870|FG000|Double-Blind Treatment Phase|Randomized but Never Treated|1|||
147636950|NCT02836236|532488871|FG001|Double-Blind Treatment Phase|Randomized but Never Treated|0|||
147636951|NCT02836236|532488872|FG002|Double-Blind Treatment Phase|Randomized but Never Treated|0|||
147636952|NCT02836236|532488873|FG003|Double-Blind Treatment Phase|Randomized but Never Treated|0|||
147636953|NCT02836236|532488870|FG000|Open-Label TAF Treatment Phase|Withdrew consent|0|||
147636954|NCT02836236|532488871|FG001|Open-Label TAF Treatment Phase|Withdrew consent|0|||
147636955|NCT02836236|532488872|FG002|Open-Label TAF Treatment Phase|Withdrew consent|3|||
147636956|NCT02836236|532488873|FG003|Open-Label TAF Treatment Phase|Withdrew consent|2|||
147636957|NCT02836236|532488870|FG000|Open-Label TAF Treatment Phase|Lost to Follow-up|0|||
147636958|NCT02836236|532488871|FG001|Open-Label TAF Treatment Phase|Lost to Follow-up|0|||
147636959|NCT02836236|532488872|FG002|Open-Label TAF Treatment Phase|Lost to Follow-up|2|||
147636960|NCT02836236|532488873|FG003|Open-Label TAF Treatment Phase|Lost to Follow-up|1|||
147636961|NCT02836236|532488870|FG000|Open-Label TAF Treatment Phase|Death|0|||
147636962|NCT02836236|532488871|FG001|Open-Label TAF Treatment Phase|Death|0|||
147636963|NCT02836236|532488872|FG002|Open-Label TAF Treatment Phase|Death|1|||
147636964|NCT02836236|532488873|FG003|Open-Label TAF Treatment Phase|Death|1|||
147636965|NCT02836236|532488870|FG000|Open-Label TAF Treatment Phase|Investigator's discretion|0|||
147636966|NCT02836236|532488871|FG001|Open-Label TAF Treatment Phase|Investigator's discretion|0|||
147636967|NCT02836236|532488872|FG002|Open-Label TAF Treatment Phase|Investigator's discretion|1|||
147636968|NCT02836236|532488873|FG003|Open-Label TAF Treatment Phase|Investigator's discretion|0|||
147636969|NCT00174967|532488877|FG000|Overall Study|Adverse Event|1|||
147636970|NCT00174967|532488878|FG001|Overall Study|Adverse Event|2|||
147636971|NCT00174967|532488879|FG002|Overall Study|Adverse Event|2|||
147636972|NCT00174967|532488880|FG003|Overall Study|Adverse Event|1|||
147636973|NCT00174967|532488877|FG000|Overall Study|Gout Flare|0|||
147636974|NCT00174967|532488878|FG001|Overall Study|Gout Flare|0|||
147636975|NCT00174967|532488879|FG002|Overall Study|Gout Flare|0|||
147636976|NCT00174967|532488880|FG003|Overall Study|Gout Flare|1|||
147636977|NCT00174967|532488877|FG000|Overall Study|Other|0|||
147636978|NCT00174967|532488878|FG001|Overall Study|Other|1|||
147636979|NCT00174967|532488879|FG002|Overall Study|Other|0|||
147636980|NCT00174967|532488880|FG003|Overall Study|Other|0|||
147636981|NCT04420585|532488881|FG000|Overall Study|Adverse Event|1|||
147636982|NCT04420585|532488881|FG000|Overall Study|Never initiated medication|2|||
147636983|NCT00477750|532488882|FG000|Overall Study|Currently Receiving Treatment|11|||
147636984|NCT03558152|532488883|FG000|Overall Study|Adverse Event|0|||
147636985|NCT03558152|532488884|FG001|Overall Study|Adverse Event|0|||
147636986|NCT03558152|532488885|FG002|Overall Study|Adverse Event|1|||
147636987|NCT03558152|532488886|FG003|Overall Study|Adverse Event|1|||
147636988|NCT03558152|532488887|FG004|Overall Study|Adverse Event|2|||
147636989|NCT03558152|532488888|FG005|Overall Study|Adverse Event|1|||
147636990|NCT03558152|532488889|FG006|Overall Study|Adverse Event|1|||
147636991|NCT03558152|532488890|FG007|Overall Study|Adverse Event|0|||
147636992|NCT03558152|532488883|FG000|Overall Study|Death|0|||
147636993|NCT03558152|532488884|FG001|Overall Study|Death|0|||
147636994|NCT03558152|532488885|FG002|Overall Study|Death|0|||
147636995|NCT03558152|532488886|FG003|Overall Study|Death|0|||
147636996|NCT03558152|532488887|FG004|Overall Study|Death|1|||
147636997|NCT03558152|532488888|FG005|Overall Study|Death|0|||
147636998|NCT03558152|532488889|FG006|Overall Study|Death|0|||
147636999|NCT03558152|532488890|FG007|Overall Study|Death|0|||
147637000|NCT03558152|532488883|FG000|Overall Study|Rolled over in GA40209 due to worsening of disease|1|||
147637001|NCT03558152|532488884|FG001|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
147637002|NCT03558152|532488885|FG002|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
147637003|NCT03558152|532488886|FG003|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
147637004|NCT03558152|532488887|FG004|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
147637005|NCT03558152|532488888|FG005|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
147637006|NCT03558152|532488889|FG006|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
147637007|NCT03558152|532488890|FG007|Overall Study|Rolled over in GA40209 due to worsening of disease|0|||
147637008|NCT03558152|532488883|FG000|Overall Study|Miscalculation in mmcs|0|||
147637009|NCT03558152|532488884|FG001|Overall Study|Miscalculation in mmcs|0|||
147637010|NCT03558152|532488885|FG002|Overall Study|Miscalculation in mmcs|0|||
147637011|NCT03558152|532488886|FG003|Overall Study|Miscalculation in mmcs|0|||
147637012|NCT03558152|532488887|FG004|Overall Study|Miscalculation in mmcs|0|||
147637013|NCT03558152|532488888|FG005|Overall Study|Miscalculation in mmcs|0|||
147637014|NCT03558152|532488889|FG006|Overall Study|Miscalculation in mmcs|1|||
147637015|NCT03558152|532488890|FG007|Overall Study|Miscalculation in mmcs|0|||
147637016|NCT03558152|532488883|FG000|Overall Study|Mistake in calculation|0|||
147637017|NCT03558152|532488884|FG001|Overall Study|Mistake in calculation|0|||
147637018|NCT03558152|532488885|FG002|Overall Study|Mistake in calculation|0|||
147637019|NCT03558152|532488886|FG003|Overall Study|Mistake in calculation|1|||
147637020|NCT03558152|532488887|FG004|Overall Study|Mistake in calculation|0|||
147637021|NCT03558152|532488888|FG005|Overall Study|Mistake in calculation|0|||
147637022|NCT03558152|532488889|FG006|Overall Study|Mistake in calculation|0|||
147637023|NCT03558152|532488890|FG007|Overall Study|Mistake in calculation|0|||
147637024|NCT03558152|532488883|FG000|Overall Study|Mistake in evaluation of disease status|0|||
147637025|NCT03558152|532488884|FG001|Overall Study|Mistake in evaluation of disease status|0|||
147637026|NCT03558152|532488885|FG002|Overall Study|Mistake in evaluation of disease status|0|||
147637027|NCT03558152|532488886|FG003|Overall Study|Mistake in evaluation of disease status|0|||
147637028|NCT03558152|532488887|FG004|Overall Study|Mistake in evaluation of disease status|0|||
147637029|NCT03558152|532488888|FG005|Overall Study|Mistake in evaluation of disease status|0|||
147637030|NCT03558152|532488889|FG006|Overall Study|Mistake in evaluation of disease status|0|||
147637031|NCT03558152|532488890|FG007|Overall Study|Mistake in evaluation of disease status|1|||
147637032|NCT03558152|532488883|FG000|Overall Study|Physician Decision|0|||
147637033|NCT03558152|532488884|FG001|Overall Study|Physician Decision|0|||
147637034|NCT03558152|532488885|FG002|Overall Study|Physician Decision|0|||
147637035|NCT03558152|532488886|FG003|Overall Study|Physician Decision|0|||
147637036|NCT03558152|532488887|FG004|Overall Study|Physician Decision|0|||
147637037|NCT03558152|532488888|FG005|Overall Study|Physician Decision|0|||
147637038|NCT03558152|532488889|FG006|Overall Study|Physician Decision|1|||
147637039|NCT03558152|532488890|FG007|Overall Study|Physician Decision|0|||
147637040|NCT03558152|532488883|FG000|Overall Study|Withdrawal by Subject|2|||
147637041|NCT03558152|532488884|FG001|Overall Study|Withdrawal by Subject|3|||
147637042|NCT03558152|532488885|FG002|Overall Study|Withdrawal by Subject|2|||
147637043|NCT03558152|532488886|FG003|Overall Study|Withdrawal by Subject|1|||
147637044|NCT03558152|532488887|FG004|Overall Study|Withdrawal by Subject|1|||
147637045|NCT03558152|532488888|FG005|Overall Study|Withdrawal by Subject|1|||
147637046|NCT03558152|532488889|FG006|Overall Study|Withdrawal by Subject|3|||
147637047|NCT03558152|532488890|FG007|Overall Study|Withdrawal by Subject|2|||
147637048|NCT03558152|532488883|FG000|Overall Study|Lack of Efficacy|11|||
147637049|NCT03558152|532488884|FG001|Overall Study|Lack of Efficacy|11|||
147637050|NCT03558152|532488885|FG002|Overall Study|Lack of Efficacy|10|||
147637051|NCT03558152|532488886|FG003|Overall Study|Lack of Efficacy|11|||
147637052|NCT03558152|532488887|FG004|Overall Study|Lack of Efficacy|14|||
147637053|NCT03558152|532488888|FG005|Overall Study|Lack of Efficacy|12|||
147637054|NCT03558152|532488889|FG006|Overall Study|Lack of Efficacy|14|||
147637055|NCT03558152|532488890|FG007|Overall Study|Lack of Efficacy|13|||
147637056|NCT03558152|532488883|FG000|Overall Study|Protocol Violation|1|||
147637057|NCT03558152|532488884|FG001|Overall Study|Protocol Violation|1|||
147637058|NCT03558152|532488885|FG002|Overall Study|Protocol Violation|0|||
147637059|NCT03558152|532488886|FG003|Overall Study|Protocol Violation|1|||
147637060|NCT03558152|532488887|FG004|Overall Study|Protocol Violation|1|||
147637061|NCT03558152|532488888|FG005|Overall Study|Protocol Violation|0|||
147637062|NCT03558152|532488889|FG006|Overall Study|Protocol Violation|2|||
147637063|NCT03558152|532488890|FG007|Overall Study|Protocol Violation|0|||
147637064|NCT00601172|532488891|FG000|Overall Study|Adverse Event|43|||
147637065|NCT00601172|532488892|FG001|Overall Study|Adverse Event|32|||
147637066|NCT00601172|532488891|FG000|Overall Study|Lack of Efficacy|11|||
147637067|NCT00601172|532488892|FG001|Overall Study|Lack of Efficacy|12|||
147637068|NCT00601172|532488891|FG000|Overall Study|Protocol Violation|2|||
147637069|NCT00601172|532488892|FG001|Overall Study|Protocol Violation|5|||
147637070|NCT00601172|532488891|FG000|Overall Study|Lost to Follow-up|4|||
147637071|NCT00601172|532488892|FG001|Overall Study|Lost to Follow-up|3|||
147637072|NCT00601172|532488891|FG000|Overall Study|Physician Decision|27|||
147637073|NCT00601172|532488892|FG001|Overall Study|Physician Decision|28|||
147637074|NCT00601172|532488891|FG000|Overall Study|Withdrawal by Subject|35|||
147637075|NCT00601172|532488892|FG001|Overall Study|Withdrawal by Subject|27|||
147637076|NCT00601172|532488891|FG000|Overall Study|Did not meet continuation criteria|19|||
147504768|NCT00355134|532000568|FG002|Core Phase|Condition no longer requires study drug|1|||
147504769|NCT00355134|532000569|FG003|Core Phase|Condition no longer requires study drug|0|||
147504770|NCT00355134|532000570|FG004|Core Phase|Condition no longer requires study drug|0|||
147504771|NCT00355134|532000566|FG000|Extension Phase|Withdrawal by Subject|7|||
147504772|NCT00355134|532000567|FG001|Extension Phase|Withdrawal by Subject|11|||
147504773|NCT00355134|532000568|FG002|Extension Phase|Withdrawal by Subject|0|||
147504774|NCT00355134|532000569|FG003|Extension Phase|Withdrawal by Subject|7|||
147504775|NCT00355134|532000570|FG004|Extension Phase|Withdrawal by Subject|5|||
147504776|NCT00355134|532000566|FG000|Extension Phase|Adverse Event|13|||
147504777|NCT00355134|532000567|FG001|Extension Phase|Adverse Event|9|||
147504778|NCT00355134|532000568|FG002|Extension Phase|Adverse Event|0|||
147504779|NCT00355134|532000569|FG003|Extension Phase|Adverse Event|3|||
147504780|NCT00355134|532000570|FG004|Extension Phase|Adverse Event|5|||
147504781|NCT00355134|532000566|FG000|Extension Phase|Lost to Follow-up|2|||
147504782|NCT00355134|532000567|FG001|Extension Phase|Lost to Follow-up|6|||
147504783|NCT00355134|532000568|FG002|Extension Phase|Lost to Follow-up|0|||
147504784|NCT00355134|532000569|FG003|Extension Phase|Lost to Follow-up|2|||
147504785|NCT00355134|532000570|FG004|Extension Phase|Lost to Follow-up|4|||
147504786|NCT00355134|532000566|FG000|Extension Phase|Abnormal laboratory value(s)|4|||
147504787|NCT00355134|532000567|FG001|Extension Phase|Abnormal laboratory value(s)|2|||
147504788|NCT00355134|532000568|FG002|Extension Phase|Abnormal laboratory value(s)|0|||
147504789|NCT00355134|532000569|FG003|Extension Phase|Abnormal laboratory value(s)|2|||
147504790|NCT00355134|532000570|FG004|Extension Phase|Abnormal laboratory value(s)|2|||
147504791|NCT00355134|532000566|FG000|Extension Phase|Administrative problems|2|||
147504792|NCT00355134|532000567|FG001|Extension Phase|Administrative problems|4|||
147504793|NCT00355134|532000568|FG002|Extension Phase|Administrative problems|0|||
147504794|NCT00355134|532000569|FG003|Extension Phase|Administrative problems|1|||
147504795|NCT00355134|532000570|FG004|Extension Phase|Administrative problems|1|||
147504796|NCT00355134|532000566|FG000|Extension Phase|Unsatisfactory therapeutic effect|3|||
147504797|NCT00355134|532000567|FG001|Extension Phase|Unsatisfactory therapeutic effect|4|||
147504798|NCT00355134|532000568|FG002|Extension Phase|Unsatisfactory therapeutic effect|0|||
147504799|NCT00355134|532000569|FG003|Extension Phase|Unsatisfactory therapeutic effect|0|||
147504800|NCT00355134|532000570|FG004|Extension Phase|Unsatisfactory therapeutic effect|1|||
147504801|NCT00355134|532000566|FG000|Extension Phase|Abnormal test procedure result(s)|0|||
147504802|NCT00355134|532000567|FG001|Extension Phase|Abnormal test procedure result(s)|1|||
147504803|NCT00355134|532000568|FG002|Extension Phase|Abnormal test procedure result(s)|0|||
147504804|NCT00355134|532000569|FG003|Extension Phase|Abnormal test procedure result(s)|0|||
147504805|NCT00355134|532000570|FG004|Extension Phase|Abnormal test procedure result(s)|1|||
147504806|NCT00355134|532000566|FG000|Extension Phase|Protocol Violation|0|||
147504807|NCT00355134|532000567|FG001|Extension Phase|Protocol Violation|0|||
147504808|NCT00355134|532000568|FG002|Extension Phase|Protocol Violation|0|||
147504809|NCT00355134|532000569|FG003|Extension Phase|Protocol Violation|1|||
147504810|NCT00355134|532000570|FG004|Extension Phase|Protocol Violation|0|||
147504811|NCT03621189|532000586|FG000|Overall Study|Withdrawal by Subject|0|||
147504812|NCT03621189|532000587|FG001|Overall Study|Withdrawal by Subject|3|||
147504813|NCT03621189|532000586|FG000|Overall Study|Physician Decision|0|||
147504814|NCT03621189|532000587|FG001|Overall Study|Physician Decision|2|||
147504815|NCT01135394|532000588|FG000|Screening|Lost to Follow-up|2|||
147504816|NCT01135394|532000588|FG000|Screening|Withdrawal by Subject|10|||
147504817|NCT01135394|532000588|FG000|Screening|Screening failure|16|||
147504818|NCT01135394|532000588|FG000|Screening|Physician Decision|5|||
147504819|NCT01135394|532000588|FG000|Baseline Assessment|Withdrawal by Subject|9|||
147504820|NCT01135394|532000588|FG000|Baseline Assessment|Physician Decision|3|||
147504821|NCT01135394|532000588|FG000|Baseline Assessment|Lost to Follow-up|2|||
147504822|NCT01135394|532000588|FG000|Baseline Assessment|Adverse Event|1|||
147504823|NCT01135394|532000588|FG000|Study Treatment|Withdrawal by Subject|1|||
147504824|NCT01135394|532000588|FG000|Study Treatment|Physician Decision|1|||
147504825|NCT01135394|532000588|FG000|Study Treatment|Adverse Event|2|||
147504826|NCT04432376|532000589|FG000|Double-blind Treatment Period|Adverse Event|2|||
147637077|NCT00601172|532488892|FG001|Overall Study|Did not meet continuation criteria|20|||
147637078|NCT04434469|532488896|FG000|Overall Study|Death|2|||
147637079|NCT04434469|532488897|FG001|Overall Study|Death|3|||
147637080|NCT04434469|532488898|FG002|Overall Study|Death|2|||
147637081|NCT04434469|532488899|FG003|Overall Study|Death|2|||
147504827|NCT04432376|532000590|FG001|Double-blind Treatment Period|Adverse Event|6|||
147504828|NCT04432376|532000591|FG002|Double-blind Treatment Period|Adverse Event|0|||
147504829|NCT04432376|532000589|FG000|Double-blind Treatment Period|Lost to Follow-up|2|||
147504830|NCT04432376|532000590|FG001|Double-blind Treatment Period|Lost to Follow-up|1|||
147504831|NCT04432376|532000591|FG002|Double-blind Treatment Period|Lost to Follow-up|0|||
147504832|NCT04432376|532000589|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
147504833|NCT04432376|532000590|FG001|Double-blind Treatment Period|Withdrawal by Subject|2|||
147504834|NCT04432376|532000591|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
147504835|NCT04432376|532000589|FG000|Double-blind Treatment Period|Protocol Violation|0|||
147637082|NCT04434469|532488900|FG004|Overall Study|Death|2|||
147637083|NCT04434469|532488901|FG005|Overall Study|Death|0|||
147504836|NCT04432376|532000590|FG001|Double-blind Treatment Period|Protocol Violation|1|||
147504837|NCT04432376|532000591|FG002|Double-blind Treatment Period|Protocol Violation|0|||
147504838|NCT04432376|532000589|FG000|Double-blind Treatment Period|subject enrolled in the Optional Open Label arm|0|||
147504839|NCT04432376|532000590|FG001|Double-blind Treatment Period|subject enrolled in the Optional Open Label arm|1|||
147504840|NCT04432376|532000591|FG002|Double-blind Treatment Period|subject enrolled in the Optional Open Label arm|0|||
147504841|NCT00379236|532000592|FG000|Double-blind|Adverse Event|11|||
147504842|NCT00379236|532000593|FG001|Double-blind|Adverse Event|6|||
147504843|NCT00379236|532000594|FG002|Double-blind|Adverse Event|0|||
147504844|NCT00379236|532000592|FG000|Double-blind|Protocol Violation|3|||
147504845|NCT00379236|532000593|FG001|Double-blind|Protocol Violation|3|||
147504846|NCT00379236|532000594|FG002|Double-blind|Protocol Violation|0|||
147504847|NCT00379236|532000592|FG000|Double-blind|Withdrawal by Subject|12|||
147504848|NCT00379236|532000593|FG001|Double-blind|Withdrawal by Subject|13|||
147504849|NCT00379236|532000594|FG002|Double-blind|Withdrawal by Subject|0|||
147504850|NCT00379236|532000592|FG000|Double-blind|Lost to Follow-up|4|||
147504851|NCT00379236|532000593|FG001|Double-blind|Lost to Follow-up|3|||
147504852|NCT00379236|532000594|FG002|Double-blind|Lost to Follow-up|0|||
147504853|NCT00379236|532000592|FG000|Double-blind|Use of exclusionary medication|1|||
147504854|NCT00379236|532000593|FG001|Double-blind|Use of exclusionary medication|2|||
147504855|NCT00379236|532000594|FG002|Double-blind|Use of exclusionary medication|0|||
147504856|NCT00379236|532000592|FG000|Double-blind|Other|3|||
147504857|NCT00379236|532000593|FG001|Double-blind|Other|7|||
147504858|NCT00379236|532000594|FG002|Double-blind|Other|0|||
147504859|NCT00379236|532000592|FG000|Double-blind|Data could not be retrieved|2|||
147504860|NCT00379236|532000593|FG001|Double-blind|Data could not be retrieved|2|||
147504861|NCT00379236|532000594|FG002|Double-blind|Data could not be retrieved|0|||
147504862|NCT00379236|532000592|FG000|Open-label Extension|Adverse Event|0|||
147504863|NCT00379236|532000593|FG001|Open-label Extension|Adverse Event|0|||
147504864|NCT00379236|532000594|FG002|Open-label Extension|Adverse Event|13|||
147504865|NCT00379236|532000592|FG000|Open-label Extension|Protocol Violation|0|||
147504866|NCT00379236|532000593|FG001|Open-label Extension|Protocol Violation|0|||
147504867|NCT00379236|532000594|FG002|Open-label Extension|Protocol Violation|7|||
147504868|NCT00379236|532000592|FG000|Open-label Extension|Withdrawal by Subject|0|||
147504869|NCT00379236|532000593|FG001|Open-label Extension|Withdrawal by Subject|0|||
147504870|NCT00379236|532000594|FG002|Open-label Extension|Withdrawal by Subject|13|||
147504871|NCT00379236|532000592|FG000|Open-label Extension|Lost to Follow-up|0|||
147504872|NCT00379236|532000593|FG001|Open-label Extension|Lost to Follow-up|0|||
147504873|NCT00379236|532000594|FG002|Open-label Extension|Lost to Follow-up|12|||
147504874|NCT00379236|532000592|FG000|Open-label Extension|Use of exclusionary medication|0|||
147504875|NCT00379236|532000593|FG001|Open-label Extension|Use of exclusionary medication|0|||
147504876|NCT00379236|532000594|FG002|Open-label Extension|Use of exclusionary medication|3|||
147504877|NCT00379236|532000592|FG000|Open-label Extension|Other|0|||
147504878|NCT00379236|532000593|FG001|Open-label Extension|Other|0|||
147504879|NCT00379236|532000594|FG002|Open-label Extension|Other|7|||
147504880|NCT00801892|532000595|FG000|Main Study Period|Withdrawal by Subject|0|||
147504881|NCT00801892|532000596|FG001|Main Study Period|Withdrawal by Subject|1|||
147504882|NCT00801892|532000595|FG000|Sham Crossover Period|Lost to Follow-up|0|||
147504883|NCT00801892|532000596|FG001|Sham Crossover Period|Lost to Follow-up|2|||
147504884|NCT00438464|532000597|FG000|Overall Study|Terminated Early|14|||
147504885|NCT00438464|532000598|FG001|Overall Study|Terminated Early|5|||
147504886|NCT00438464|532000597|FG000|Overall Study|Incomplete data submission|0|||
147504887|NCT00438464|532000598|FG001|Overall Study|Incomplete data submission|2|||
147504888|NCT00728936|532000599|FG000|Overall Study|Withdrawal by Subject|0|||
147504889|NCT00728936|532000600|FG001|Overall Study|Withdrawal by Subject|0|||
147504890|NCT00728936|532000601|FG002|Overall Study|Withdrawal by Subject|0|||
147504891|NCT00728936|532000602|FG003|Overall Study|Withdrawal by Subject|0|||
147504892|NCT00728936|532000603|FG004|Overall Study|Withdrawal by Subject|0|||
147504893|NCT00728936|532000604|FG005|Overall Study|Withdrawal by Subject|1|||
147504894|NCT00728936|532000605|FG006|Overall Study|Withdrawal by Subject|0|||
147504895|NCT01601704|532000606|FG000|Overall Study|Randomized but not dispensed study med|1|||
147637084|NCT04434469|532488896|FG000|Overall Study|Lost to Follow-up|0|||
147637085|NCT04434469|532488897|FG001|Overall Study|Lost to Follow-up|0|||
147637086|NCT04434469|532488898|FG002|Overall Study|Lost to Follow-up|0|||
147504896|NCT01601704|532000607|FG001|Overall Study|Randomized but not dispensed study med|4|||
147504897|NCT01090102|532000608|FG000|First 12 Weeks|Withdrawal by Subject|1|||
147504898|NCT01090102|532000609|FG001|First 12 Weeks|Withdrawal by Subject|1|||
147637087|NCT04434469|532488899|FG003|Overall Study|Lost to Follow-up|1|||
147637088|NCT04434469|532488900|FG004|Overall Study|Lost to Follow-up|1|||
147637089|NCT04434469|532488901|FG005|Overall Study|Lost to Follow-up|0|||
147504899|NCT01090102|532000608|FG000|First 12 Weeks|Adverse Event|2|||
147637090|NCT04434469|532488896|FG000|Overall Study|Study terminated by sponsor|1|||
147637091|NCT04434469|532488897|FG001|Overall Study|Study terminated by sponsor|1|||
147504900|NCT01090102|532000609|FG001|First 12 Weeks|Adverse Event|0|||
147504901|NCT01090102|532000608|FG000|First 12 Weeks|Death|1|||
147504902|NCT01090102|532000609|FG001|First 12 Weeks|Death|1|||
147637092|NCT04434469|532488898|FG002|Overall Study|Study terminated by sponsor|1|||
147637093|NCT04434469|532488899|FG003|Overall Study|Study terminated by sponsor|2|||
147637094|NCT04434469|532488900|FG004|Overall Study|Study terminated by sponsor|3|||
147637095|NCT04434469|532488901|FG005|Overall Study|Study terminated by sponsor|3|||
147637096|NCT04434469|532488896|FG000|Overall Study|Withdrawal by Subject|0|||
147637097|NCT04434469|532488897|FG001|Overall Study|Withdrawal by Subject|0|||
147637098|NCT04434469|532488898|FG002|Overall Study|Withdrawal by Subject|1|||
147637099|NCT04434469|532488899|FG003|Overall Study|Withdrawal by Subject|0|||
147637100|NCT04434469|532488900|FG004|Overall Study|Withdrawal by Subject|0|||
147637101|NCT04434469|532488901|FG005|Overall Study|Withdrawal by Subject|0|||
147637102|NCT01936181|532488908|FG000|Randomised, Double-blind|Adverse Event|27|||
147637103|NCT01936181|532488909|FG001|Randomised, Double-blind|Adverse Event|21|||
147637104|NCT01936181|532488910|FG002|Randomised, Double-blind|Adverse Event|0|||
147637105|NCT01936181|532488911|FG003|Randomised, Double-blind|Adverse Event|0|||
147637106|NCT01936181|532488908|FG000|Randomised, Double-blind|Protocol Violation|1|||
147637107|NCT01936181|532488909|FG001|Randomised, Double-blind|Protocol Violation|5|||
147637108|NCT01936181|532488910|FG002|Randomised, Double-blind|Protocol Violation|0|||
147637109|NCT01936181|532488911|FG003|Randomised, Double-blind|Protocol Violation|0|||
147637110|NCT01936181|532488908|FG000|Randomised, Double-blind|Lack of Efficacy|5|||
147637111|NCT01936181|532488909|FG001|Randomised, Double-blind|Lack of Efficacy|6|||
147637112|NCT01936181|532488910|FG002|Randomised, Double-blind|Lack of Efficacy|0|||
147637113|NCT01936181|532488911|FG003|Randomised, Double-blind|Lack of Efficacy|0|||
147637114|NCT01936181|532488908|FG000|Randomised, Double-blind|Lost to Follow-up|0|||
147637115|NCT01936181|532488909|FG001|Randomised, Double-blind|Lost to Follow-up|1|||
147637116|NCT01936181|532488910|FG002|Randomised, Double-blind|Lost to Follow-up|0|||
147637117|NCT01936181|532488911|FG003|Randomised, Double-blind|Lost to Follow-up|0|||
147637118|NCT01936181|532488908|FG000|Randomised, Double-blind|Pregnancy|0|||
147637119|NCT01936181|532488909|FG001|Randomised, Double-blind|Pregnancy|1|||
147637120|NCT01936181|532488910|FG002|Randomised, Double-blind|Pregnancy|0|||
147637121|NCT01936181|532488911|FG003|Randomised, Double-blind|Pregnancy|0|||
147637122|NCT01936181|532488908|FG000|Randomised, Double-blind|Physician Decision|4|||
147637123|NCT01936181|532488909|FG001|Randomised, Double-blind|Physician Decision|4|||
147637124|NCT01936181|532488910|FG002|Randomised, Double-blind|Physician Decision|0|||
147637125|NCT01936181|532488911|FG003|Randomised, Double-blind|Physician Decision|0|||
147637126|NCT01936181|532488908|FG000|Randomised, Double-blind|Withdrawal by Subject|23|||
147637127|NCT01936181|532488909|FG001|Randomised, Double-blind|Withdrawal by Subject|26|||
147637128|NCT01936181|532488910|FG002|Randomised, Double-blind|Withdrawal by Subject|0|||
147637129|NCT01936181|532488911|FG003|Randomised, Double-blind|Withdrawal by Subject|0|||
147637130|NCT01936181|532488908|FG000|Randomised, Double-blind|Subjects from Eastern Ukraine sites|4|||
147637131|NCT01936181|532488909|FG001|Randomised, Double-blind|Subjects from Eastern Ukraine sites|4|||
147637132|NCT01936181|532488910|FG002|Randomised, Double-blind|Subjects from Eastern Ukraine sites|0|||
147637133|NCT01936181|532488911|FG003|Randomised, Double-blind|Subjects from Eastern Ukraine sites|0|||
147637134|NCT01936181|532488908|FG000|Transition-extension|Adverse Event|3|||
147637135|NCT01936181|532488909|FG001|Transition-extension|Adverse Event|0|||
147637136|NCT01936181|532488910|FG002|Transition-extension|Adverse Event|3|||
147637137|NCT01936181|532488911|FG003|Transition-extension|Adverse Event|1|||
147637138|NCT01936181|532488908|FG000|Transition-extension|Lost to Follow-up|3|||
147637139|NCT01936181|532488909|FG001|Transition-extension|Lost to Follow-up|0|||
147637140|NCT01936181|532488910|FG002|Transition-extension|Lost to Follow-up|1|||
147637141|NCT01936181|532488911|FG003|Transition-extension|Lost to Follow-up|2|||
147637142|NCT01936181|532488908|FG000|Transition-extension|Physician Decision|2|||
147637143|NCT01936181|532488909|FG001|Transition-extension|Physician Decision|0|||
147637144|NCT01936181|532488910|FG002|Transition-extension|Physician Decision|0|||
147637145|NCT01936181|532488911|FG003|Transition-extension|Physician Decision|1|||
147637146|NCT01936181|532488908|FG000|Transition-extension|Withdrawal by Subject|7|||
147637147|NCT01936181|532488909|FG001|Transition-extension|Withdrawal by Subject|0|||
147637148|NCT01936181|532488910|FG002|Transition-extension|Withdrawal by Subject|2|||
147637149|NCT01936181|532488911|FG003|Transition-extension|Withdrawal by Subject|1|||
147637150|NCT00900757|532488912|FG000|Overall Study|screen failure|19|||
147637151|NCT01489254|532488913|FG000|Double-blind Part|Adverse Event|7|||
147637152|NCT01489254|532488914|FG001|Double-blind Part|Adverse Event|2|||
147637153|NCT01489254|532488915|FG002|Double-blind Part|Adverse Event|2|||
147637154|NCT01489254|532488916|FG003|Double-blind Part|Adverse Event|0|||
147637155|NCT01489254|532488913|FG000|Double-blind Part|Pregnancy|1|||
147637156|NCT01489254|532488914|FG001|Double-blind Part|Pregnancy|3|||
147637157|NCT01489254|532488915|FG002|Double-blind Part|Pregnancy|0|||
147637158|NCT01489254|532488916|FG003|Double-blind Part|Pregnancy|0|||
147637159|NCT01489254|532488913|FG000|Double-blind Part|Withdrawal by Subject|12|||
147637160|NCT01489254|532488914|FG001|Double-blind Part|Withdrawal by Subject|20|||
147637161|NCT01489254|532488915|FG002|Double-blind Part|Withdrawal by Subject|1|||
147637162|NCT01489254|532488916|FG003|Double-blind Part|Withdrawal by Subject|0|||
147637163|NCT01489254|532488913|FG000|Double-blind Part|Lost to Follow-up|1|||
147637164|NCT01489254|532488914|FG001|Double-blind Part|Lost to Follow-up|2|||
147637165|NCT01489254|532488915|FG002|Double-blind Part|Lost to Follow-up|0|||
147637166|NCT01489254|532488916|FG003|Double-blind Part|Lost to Follow-up|0|||
147637167|NCT01489254|532488913|FG000|Double-blind Part|Other reasons for not completing study|4|||
147637168|NCT01489254|532488914|FG001|Double-blind Part|Other reasons for not completing study|6|||
147637169|NCT01489254|532488915|FG002|Double-blind Part|Other reasons for not completing study|0|||
147637170|NCT01489254|532488916|FG003|Double-blind Part|Other reasons for not completing study|0|||
147637171|NCT01489254|532488913|FG000|Open-label Extension Part|Adverse Event|0|||
147637172|NCT01489254|532488914|FG001|Open-label Extension Part|Adverse Event|0|||
147637173|NCT01489254|532488915|FG002|Open-label Extension Part|Adverse Event|0|||
147637174|NCT01489254|532488916|FG003|Open-label Extension Part|Adverse Event|10|||
147637175|NCT01489254|532488913|FG000|Open-label Extension Part|Pregnancy|0|||
147637176|NCT01489254|532488914|FG001|Open-label Extension Part|Pregnancy|0|||
147637177|NCT01489254|532488915|FG002|Open-label Extension Part|Pregnancy|0|||
147637178|NCT01489254|532488916|FG003|Open-label Extension Part|Pregnancy|3|||
147637179|NCT01489254|532488913|FG000|Open-label Extension Part|Withdrawal by Subject|0|||
147637180|NCT01489254|532488914|FG001|Open-label Extension Part|Withdrawal by Subject|0|||
147637181|NCT01489254|532488915|FG002|Open-label Extension Part|Withdrawal by Subject|0|||
147637182|NCT01489254|532488916|FG003|Open-label Extension Part|Withdrawal by Subject|30|||
147637183|NCT01489254|532488913|FG000|Open-label Extension Part|Protocol Violation|0|||
147637184|NCT01489254|532488914|FG001|Open-label Extension Part|Protocol Violation|0|||
147637185|NCT01489254|532488915|FG002|Open-label Extension Part|Protocol Violation|0|||
147637186|NCT01489254|532488916|FG003|Open-label Extension Part|Protocol Violation|1|||
147637187|NCT01489254|532488913|FG000|Open-label Extension Part|Lost to Follow-up|0|||
147637188|NCT01489254|532488914|FG001|Open-label Extension Part|Lost to Follow-up|0|||
147637189|NCT01489254|532488915|FG002|Open-label Extension Part|Lost to Follow-up|0|||
147637190|NCT01489254|532488916|FG003|Open-label Extension Part|Lost to Follow-up|9|||
147637191|NCT01489254|532488913|FG000|Open-label Extension Part|Other reasons for not completing study|0|||
147637192|NCT01489254|532488914|FG001|Open-label Extension Part|Other reasons for not completing study|0|||
147637193|NCT01489254|532488915|FG002|Open-label Extension Part|Other reasons for not completing study|0|||
147637194|NCT01489254|532488916|FG003|Open-label Extension Part|Other reasons for not completing study|5|||
147637195|NCT04603482|532488920|FG000|Overall Study|Lost to Follow-up|15|||
147637196|NCT04603482|532488921|FG001|Overall Study|Lost to Follow-up|15|||
147637197|NCT04603482|532488922|FG002|Overall Study|Lost to Follow-up|15|||
147637198|NCT00732758|532488923|FG000|Overall Study|Lost to Follow-up|8|||
147637199|NCT00732758|532488924|FG001|Overall Study|Lost to Follow-up|16|||
147637200|NCT01552915|532488925|FG000|Overall Study|Adverse Event|3|||
147637201|NCT01552915|532488926|FG001|Overall Study|Adverse Event|14|||
147637202|NCT01552915|532488927|FG002|Overall Study|Adverse Event|3|||
147637203|NCT01552915|532488925|FG000|Overall Study|Lost to Follow-up|4|||
147637204|NCT01552915|532488926|FG001|Overall Study|Lost to Follow-up|6|||
147637205|NCT01552915|532488927|FG002|Overall Study|Lost to Follow-up|5|||
147637206|NCT01552915|532488925|FG000|Overall Study|Withdrawal by Subject|6|||
147637207|NCT01552915|532488926|FG001|Overall Study|Withdrawal by Subject|4|||
147637208|NCT01552915|532488927|FG002|Overall Study|Withdrawal by Subject|5|||
147637209|NCT01552915|532488925|FG000|Overall Study|Protocol Violation|0|||
147637210|NCT01552915|532488926|FG001|Overall Study|Protocol Violation|4|||
147637211|NCT01552915|532488927|FG002|Overall Study|Protocol Violation|4|||
147637212|NCT01552915|532488925|FG000|Overall Study|Lack of Efficacy|8|||
147637213|NCT01552915|532488926|FG001|Overall Study|Lack of Efficacy|1|||
147637214|NCT01552915|532488927|FG002|Overall Study|Lack of Efficacy|4|||
147637215|NCT01552915|532488925|FG000|Overall Study|Other|2|||
147637216|NCT01552915|532488926|FG001|Overall Study|Other|0|||
147637217|NCT01552915|532488927|FG002|Overall Study|Other|6|||
147637218|NCT04240457|532488931|FG000|Overall Study|Lost to Follow-up|5|||
147637219|NCT04240457|532488932|FG001|Overall Study|Lost to Follow-up|1|||
147668952|NCT02717195|532613434|FG003|Prospective Confirmation (PC) Period|Adverse Event|0|||
147504903|NCT01090102|532000608|FG000|Second 12 Weeks|Withdrawal by Subject|0|||
147504904|NCT01090102|532000609|FG001|Second 12 Weeks|Withdrawal by Subject|1|||
147637220|NCT00844480|532488933|FG000|Overall Study|Withdrawal by Subject|2|||
147637221|NCT00844480|532488934|FG001|Overall Study|Withdrawal by Subject|3|||
147637222|NCT02858180|532488935|FG000|Overall Study|Lost to Follow-up|0|||
147637223|NCT02858180|532488936|FG001|Overall Study|Lost to Follow-up|2|||
147637224|NCT01054196|532488938|FG000|Overall Study|Physician Decision|0|||
147637225|NCT01054196|532488939|FG001|Overall Study|Physician Decision|0|||
147637226|NCT01054196|532488940|FG002|Overall Study|Physician Decision|0|||
147504905|NCT03518034|532000610|FG000|Overall Study|Not Treated|5|||
147504906|NCT03518034|532000611|FG001|Overall Study|Not Treated|1|||
147504907|NCT03518034|532000610|FG000|Overall Study|Withdrawal by Subject|309|||
147637227|NCT01054196|532488941|FG003|Overall Study|Physician Decision|1|||
147637228|NCT01054196|532488942|FG004|Overall Study|Physician Decision|0|||
147637229|NCT01054196|532488943|FG005|Overall Study|Physician Decision|0|||
147637230|NCT01054196|532488944|FG006|Overall Study|Physician Decision|1|||
147637231|NCT00179673|532488946|FG000|Overall Study|Adverse Event|7|||
147637232|NCT00179673|532488946|FG000|Overall Study|Lack of Efficacy|15|||
147637233|NCT00179673|532488946|FG000|Overall Study|Withdrawal by Subject|3|||
147637234|NCT00179673|532488946|FG000|Overall Study|Death|4|||
147504908|NCT03518034|532000611|FG001|Overall Study|Withdrawal by Subject|351|||
147504909|NCT03518034|532000610|FG000|Overall Study|Lost to Follow-up|446|||
147504910|NCT03518034|532000611|FG001|Overall Study|Lost to Follow-up|458|||
147504911|NCT03518034|532000610|FG000|Overall Study|Adverse Event|138|||
147504912|NCT03518034|532000611|FG001|Overall Study|Adverse Event|130|||
147504913|NCT03518034|532000610|FG000|Overall Study|Lack of Efficacy|11|||
147504914|NCT03518034|532000611|FG001|Overall Study|Lack of Efficacy|23|||
147504915|NCT03518034|532000610|FG000|Overall Study|COVID-19 Logistical Restriction|7|||
147504916|NCT03518034|532000611|FG001|Overall Study|COVID-19 Logistical Restriction|3|||
147504917|NCT03518034|532000610|FG000|Overall Study|Serum Testosterone Level >750 ng/dL|5|||
147504918|NCT03518034|532000611|FG001|Overall Study|Serum Testosterone Level >750 ng/dL|0|||
147504919|NCT03518034|532000610|FG000|Overall Study|Other, Not Specified|84|||
147504920|NCT03518034|532000611|FG001|Overall Study|Other, Not Specified|53|||
147504921|NCT03518034|532000610|FG000|Overall Study|Reason Missing|2|||
147504922|NCT03518034|532000611|FG001|Overall Study|Reason Missing|3|||
147504923|NCT02273037|532000613|FG000|Overall Study|Lost to Follow-up|1|||
147504924|NCT02273037|532000614|FG001|Overall Study|Lost to Follow-up|0|||
147504925|NCT02273037|532000613|FG000|Overall Study|Delivered before monitoring initiated|1|||
147504926|NCT02273037|532000614|FG001|Overall Study|Delivered before monitoring initiated|3|||
147504927|NCT02273037|532000613|FG000|Overall Study|Breech delivery|2|||
147504928|NCT02273037|532000614|FG001|Overall Study|Breech delivery|3|||
147504929|NCT02273037|532000613|FG000|Overall Study|Multiple delivery|2|||
147504930|NCT02273037|532000614|FG001|Overall Study|Multiple delivery|2|||
147504931|NCT02273037|532000613|FG000|Overall Study|Other complication|2|||
147504932|NCT02273037|532000614|FG001|Overall Study|Other complication|0|||
147504933|NCT02062398|532000615|FG000|Overall Study|Implant removal|1|||
147504934|NCT00415519|532000617|FG000|Overall Study|Adverse Event|1|||
147504935|NCT00415519|532000618|FG001|Overall Study|Adverse Event|0|||
147504936|NCT00415519|532000617|FG000|Overall Study|Withdrawal by Subject|2|||
147504937|NCT00415519|532000618|FG001|Overall Study|Withdrawal by Subject|0|||
147504938|NCT00415519|532000617|FG000|Overall Study|Patient's convenience|1|||
147504939|NCT00415519|532000618|FG001|Overall Study|Patient's convenience|0|||
147504940|NCT00510484|532000620|FG000|Wash-out Period|Adverse Event|0|||
147504941|NCT00510484|532000621|FG001|Wash-out Period|Adverse Event|1|||
147504942|NCT01590212|532000622|FG000|Overall Study|Withdrawal by Subject|2|||
147504943|NCT01590212|532000623|FG001|Overall Study|Withdrawal by Subject|2|||
147504944|NCT01590212|532000624|FG002|Overall Study|Withdrawal by Subject|2|||
147504945|NCT01590212|532000622|FG000|Overall Study|Lost to Follow-up|1|||
147504946|NCT01590212|532000623|FG001|Overall Study|Lost to Follow-up|2|||
147504947|NCT01590212|532000624|FG002|Overall Study|Lost to Follow-up|3|||
147504948|NCT02533401|532000625|FG000|Overall Study|Adverse Event/Intercurrent Disease|3|||
147504949|NCT02533401|532000625|FG000|Overall Study|Death|5|||
147504950|NCT02533401|532000625|FG000|Overall Study|Insufficient Response/Progressed Disease|1|||
147504951|NCT02533401|532000625|FG000|Overall Study|Lost to Follow-up|1|||
147504952|NCT02533401|532000625|FG000|Overall Study|Violation of Selection Criteria|1|||
147504953|NCT00881361|532000632|FG000|Overall Study|Terminated prior to surgery|27|||
147504954|NCT00881361|532000633|FG001|Overall Study|Terminated prior to surgery|7|||
147504955|NCT00881361|532000634|FG002|Overall Study|Terminated prior to surgery|0|||
147504956|NCT00881361|532000632|FG000|Overall Study|Ineligible|17|||
147504957|NCT00881361|532000633|FG001|Overall Study|Ineligible|2|||
147504958|NCT00881361|532000634|FG002|Overall Study|Ineligible|2|||
147504959|NCT06000501|532000635|FG000|Overall Study|Screen failure|3|||
147504960|NCT06000501|532000635|FG000|Overall Study|Severe past drug dependence determined by the MINI|2|||
147504961|NCT06000501|532000635|FG000|Overall Study|Physician Decision|4|||
147504962|NCT06000501|532000635|FG000|Overall Study|Positive Urine Drug Test (UDT)|1|||
147504963|NCT06000501|532000635|FG000|Overall Study|Scheduling issues|2|||
147504964|NCT03496662|532000636|FG000|Overall Study|Adverse Event|0|||
147637235|NCT00179673|532488946|FG000|Overall Study|Other Observations and options|14|||
147637236|NCT00319592|532488948|FG000|Overall Study|Protocol Violation|1|||
147637237|NCT00319592|532488949|FG001|Overall Study|Protocol Violation|0|||
147637238|NCT00319592|532488948|FG000|Overall Study|Physician Decision|0|||
147637239|NCT00319592|532488949|FG001|Overall Study|Physician Decision|1|||
147637240|NCT01820572|532488956|FG000|Randomization|Not Treated|2|||
147504965|NCT03496662|532000637|FG001|Overall Study|Adverse Event|0|||
147504966|NCT03496662|532000638|FG002|Overall Study|Adverse Event|4|||
147504967|NCT03496662|532000636|FG000|Overall Study|Withdrawal by Subject|1|||
147504968|NCT03496662|532000637|FG001|Overall Study|Withdrawal by Subject|0|||
147504969|NCT03496662|532000638|FG002|Overall Study|Withdrawal by Subject|2|||
147504970|NCT03496662|532000636|FG000|Overall Study|Death|0|||
147504971|NCT03496662|532000637|FG001|Overall Study|Death|0|||
147504972|NCT03496662|532000638|FG002|Overall Study|Death|2|||
147504973|NCT03496662|532000636|FG000|Overall Study|Noncompliance|0|||
147504974|NCT03496662|532000637|FG001|Overall Study|Noncompliance|0|||
147504975|NCT03496662|532000638|FG002|Overall Study|Noncompliance|1|||
147504976|NCT00493467|532000639|FG000|Overall Study|Death|1|||
147504977|NCT01074658|532000643|FG000|Overall Study|No implant attempted|19|||
147504978|NCT00432562|532000647|FG000|Overall Study|Death|3|||
147637241|NCT01820572|532488957|FG001|Randomization|Not Treated|1|||
147504979|NCT00432562|532000648|FG001|Overall Study|Death|0|||
147504980|NCT00416312|532000649|FG000|Overall Study|tumors not visible on imaging|2|||
147504981|NCT02146248|532000650|FG000|Overall Study|Withdrawal by Subject|2|||
147504982|NCT00425100|532000651|FG000|Overall Study|Adverse Event|36|||
147504983|NCT00425100|532000651|FG000|Overall Study|Lack of Efficacy|4|||
147504984|NCT00425100|532000651|FG000|Overall Study|Lost to Follow-up|2|||
147504985|NCT00425100|532000651|FG000|Overall Study|Protocol Violation|4|||
147504986|NCT00425100|532000651|FG000|Overall Study|Withdrawal by Subject|7|||
147504987|NCT02559713|532000654|FG000|Overall Study|Pretreatment Event/ Adverse Event|1|||
147504988|NCT01374217|532000660|FG000|Overall Study|Lack of Efficacy|13|||
147504989|NCT03695393|532000666|FG000|Overall Study|Death|3|||
147504990|NCT03695393|532000667|FG001|Overall Study|Death|1|||
147504991|NCT03695393|532000666|FG000|Overall Study|Lost to Follow-up|0|||
147504992|NCT03695393|532000667|FG001|Overall Study|Lost to Follow-up|1|||
147504993|NCT04169061|532000668|FG000|Overall Study|Adverse Event|2|||
147504994|NCT04169061|532000668|FG000|Overall Study|Death|1|||
147504995|NCT04169061|532000668|FG000|Overall Study|Withdrawal by Subject|1|||
147504996|NCT04169061|532000668|FG000|Overall Study|Protocol Violation|1|||
147504997|NCT04585451|532000669|FG000|Overall Study|Withdrawal by Subject|26|||
147504998|NCT04585451|532000670|FG001|Overall Study|Withdrawal by Subject|0|||
147504999|NCT00673894|532000671|FG000|First Intervention 4 Weeks|Withdrawal by Subject|1|||
147505000|NCT00673894|532000672|FG001|First Intervention 4 Weeks|Withdrawal by Subject|0|||
147505001|NCT00673894|532000671|FG000|First Intervention 4 Weeks|Adverse Event|1|||
147505002|NCT00673894|532000672|FG001|First Intervention 4 Weeks|Adverse Event|0|||
147505003|NCT00493974|532000673|FG000|Overall Study|Death|1|||
147505004|NCT00493974|532000674|FG001|Overall Study|Death|2|||
147505005|NCT00493974|532000673|FG000|Overall Study|Withdrawal by Subject|8|||
147505006|NCT00493974|532000674|FG001|Overall Study|Withdrawal by Subject|6|||
147505007|NCT00493974|532000673|FG000|Overall Study|Lost to Follow-up|4|||
147505008|NCT00493974|532000674|FG001|Overall Study|Lost to Follow-up|6|||
147505009|NCT02807363|532000675|FG000|Dosing Period|Adverse Event|0|||
147505010|NCT02807363|532000676|FG001|Dosing Period|Adverse Event|1|||
147505011|NCT02807363|532000677|FG002|Dosing Period|Adverse Event|0|||
147505012|NCT02807363|532000678|FG003|Dosing Period|Adverse Event|0|||
147505013|NCT02188719|532000679|FG000|Overall Study|Screen B Ineligible (Page 55, Protocol)|0|||
147505014|NCT02188719|532000680|FG001|Overall Study|Screen B Ineligible (Page 55, Protocol)|1|||
147505015|NCT02188719|532000681|FG002|Overall Study|Screen B Ineligible (Page 55, Protocol)|0|||
147505016|NCT02188719|532000682|FG003|Overall Study|Screen B Ineligible (Page 55, Protocol)|0|||
147505017|NCT00966693|532000683|FG000|Overall Study|Adverse Event|0|||
147505018|NCT00966693|532000684|FG001|Overall Study|Adverse Event|0|||
147505019|NCT00966693|532000685|FG002|Overall Study|Adverse Event|1|||
147505020|NCT00966693|532000686|FG003|Overall Study|Adverse Event|2|||
147505021|NCT00966693|532000683|FG000|Overall Study|Death|0|||
147505022|NCT00966693|532000684|FG001|Overall Study|Death|0|||
147505023|NCT00966693|532000685|FG002|Overall Study|Death|1|||
147505024|NCT00966693|532000686|FG003|Overall Study|Death|0|||
147505025|NCT00966693|532000683|FG000|Overall Study|Withdrawal by Subject|1|||
147505026|NCT00966693|532000684|FG001|Overall Study|Withdrawal by Subject|0|||
147505027|NCT00966693|532000685|FG002|Overall Study|Withdrawal by Subject|0|||
147505028|NCT00966693|532000686|FG003|Overall Study|Withdrawal by Subject|5|||
147505029|NCT00966693|532000683|FG000|Overall Study|Disease Progression|0|||
147505030|NCT00966693|532000684|FG001|Overall Study|Disease Progression|0|||
147505031|NCT00966693|532000685|FG002|Overall Study|Disease Progression|1|||
147505032|NCT00966693|532000686|FG003|Overall Study|Disease Progression|16|||
147505033|NCT00192036|532000687|FG000|Overall Study|Protocol Violation|3|||
147505034|NCT00192036|532000687|FG000|Overall Study|Adverse Event|6|||
147505035|NCT00192036|532000687|FG000|Overall Study|Patient/Physician Perception|1|||
147505036|NCT00192036|532000687|FG000|Overall Study|Objective Tumor Progression|4|||
147505037|NCT00192036|532000687|FG000|Overall Study|Clinical Disease Progression|1|||
147637242|NCT01820572|532488956|FG000|Treatment Period|Adverse Event|12|||
147637243|NCT01820572|532488957|FG001|Treatment Period|Adverse Event|7|||
147637244|NCT01820572|532488956|FG000|Treatment Period|Death|3|||
147637245|NCT01820572|532488957|FG001|Treatment Period|Death|3|||
147505038|NCT00192036|532000687|FG000|Overall Study|Death|1|||
147505039|NCT00192036|532000687|FG000|Overall Study|Unknown or Not Specified|5|||
147637246|NCT01820572|532488956|FG000|Treatment Period|Lack of Efficacy|1|||
147505040|NCT03371732|532000688|FG000|Overall Study|Withdrawal by Subject|9|||
147505041|NCT03371732|532000689|FG001|Overall Study|Withdrawal by Subject|3|||
147505042|NCT03371732|532000688|FG000|Overall Study|Refusal to continue|3|||
147505043|NCT03371732|532000689|FG001|Overall Study|Refusal to continue|4|||
147505044|NCT00555906|532000692|FG000|Phase 1|Objective Progression or Relapse|3|||
147505045|NCT00555906|532000693|FG001|Phase 1|Objective Progression or Relapse|5|||
147505046|NCT00555906|532000694|FG002|Phase 1|Objective Progression or Relapse|3|||
147505047|NCT00555906|532000695|FG003|Phase 1|Objective Progression or Relapse|1|||
147505048|NCT00555906|532000696|FG004|Phase 1|Objective Progression or Relapse|0|||
147505049|NCT00555906|532000692|FG000|Phase 1|Global Deterioration of Health Status|0|||
147505050|NCT00555906|532000693|FG001|Phase 1|Global Deterioration of Health Status|1|||
147505051|NCT00555906|532000694|FG002|Phase 1|Global Deterioration of Health Status|1|||
147637247|NCT01820572|532488957|FG001|Treatment Period|Lack of Efficacy|0|||
147637248|NCT01820572|532488956|FG000|Treatment Period|poor/non compliance|0|||
147505052|NCT00555906|532000695|FG003|Phase 1|Global Deterioration of Health Status|1|||
147505053|NCT00555906|532000696|FG004|Phase 1|Global Deterioration of Health Status|0|||
147505054|NCT00555906|532000692|FG000|Phase 1|Adverse Event|0|||
147505055|NCT00555906|532000693|FG001|Phase 1|Adverse Event|0|||
147505056|NCT00555906|532000694|FG002|Phase 1|Adverse Event|3|||
147505057|NCT00555906|532000695|FG003|Phase 1|Adverse Event|2|||
147505058|NCT00555906|532000696|FG004|Phase 1|Adverse Event|0|||
147505059|NCT00555906|532000692|FG000|Phase 1|Withdrawal by Subject|0|||
147505060|NCT00555906|532000693|FG001|Phase 1|Withdrawal by Subject|0|||
147505061|NCT00555906|532000694|FG002|Phase 1|Withdrawal by Subject|0|||
147505062|NCT00555906|532000695|FG003|Phase 1|Withdrawal by Subject|1|||
147505063|NCT00555906|532000696|FG004|Phase 1|Withdrawal by Subject|0|||
147505064|NCT00555906|532000692|FG000|Phase 2|Adverse Event|0|||
147505065|NCT00555906|532000693|FG001|Phase 2|Adverse Event|0|||
147505066|NCT00555906|532000694|FG002|Phase 2|Adverse Event|0|||
147505067|NCT00555906|532000695|FG003|Phase 2|Adverse Event|0|||
147505068|NCT00555906|532000696|FG004|Phase 2|Adverse Event|4|||
147505069|NCT00555906|532000692|FG000|Phase 2|Global Deterioration of Health Status|0|||
147505070|NCT00555906|532000693|FG001|Phase 2|Global Deterioration of Health Status|0|||
147505071|NCT00555906|532000694|FG002|Phase 2|Global Deterioration of Health Status|0|||
147505072|NCT00555906|532000695|FG003|Phase 2|Global Deterioration of Health Status|0|||
147505073|NCT00555906|532000696|FG004|Phase 2|Global Deterioration of Health Status|2|||
147505074|NCT00555906|532000692|FG000|Phase 2|Objective Progression or Relapse|0|||
147505075|NCT00555906|532000693|FG001|Phase 2|Objective Progression or Relapse|0|||
147505076|NCT00555906|532000694|FG002|Phase 2|Objective Progression or Relapse|0|||
147505077|NCT00555906|532000695|FG003|Phase 2|Objective Progression or Relapse|0|||
147505078|NCT00555906|532000696|FG004|Phase 2|Objective Progression or Relapse|16|||
147505079|NCT00555906|532000692|FG000|Phase 2|Withdrawal by Subject|0|||
147505080|NCT00555906|532000693|FG001|Phase 2|Withdrawal by Subject|0|||
147505081|NCT00555906|532000694|FG002|Phase 2|Withdrawal by Subject|0|||
147505082|NCT00555906|532000695|FG003|Phase 2|Withdrawal by Subject|0|||
147505083|NCT00555906|532000696|FG004|Phase 2|Withdrawal by Subject|2|||
147505084|NCT00555906|532000692|FG000|Phase 2|Other|0|||
147505085|NCT00555906|532000693|FG001|Phase 2|Other|0|||
147505086|NCT00555906|532000694|FG002|Phase 2|Other|0|||
147505087|NCT00555906|532000695|FG003|Phase 2|Other|0|||
147505088|NCT00555906|532000696|FG004|Phase 2|Other|6|||
147505089|NCT00555906|532000692|FG000|Phase 2|Randomized but not Treated|0|||
147505090|NCT00555906|532000693|FG001|Phase 2|Randomized but not Treated|0|||
147505091|NCT00555906|532000694|FG002|Phase 2|Randomized but not Treated|0|||
147505092|NCT00555906|532000695|FG003|Phase 2|Randomized but not Treated|0|||
147505093|NCT00555906|532000696|FG004|Phase 2|Randomized but not Treated|2|||
147505094|NCT02193828|532000697|FG000|Overall Study|Withdrawal by Subject|0|||
147505095|NCT02193828|532000698|FG001|Overall Study|Withdrawal by Subject|0|||
147505096|NCT02193828|532000699|FG002|Overall Study|Withdrawal by Subject|1|||
147505097|NCT02193828|532000700|FG003|Overall Study|Withdrawal by Subject|1|||
147505098|NCT03219567|532000701|FG000|Overall Study|Withdrawal by Subject|0|||
147505099|NCT03219567|532000702|FG001|Overall Study|Withdrawal by Subject|1|||
147505100|NCT00889681|532000703|FG000|Overall Study|Not meeting qualification Criteria|2|||
147505101|NCT00889681|532000703|FG000|Overall Study|Insurance disapproval|1|||
147505102|NCT04176445|532000704|FG000|Overall Study|Adverse Event|0|||
147505103|NCT04176445|532000705|FG001|Overall Study|Adverse Event|1|||
147505104|NCT04176445|532000704|FG000|Overall Study|change plans weaning after first intervention|0|||
147505105|NCT04176445|532000705|FG001|Overall Study|change plans weaning after first intervention|1|||
147505106|NCT04046341|532000707|FG000|Overall Study|Lost to Follow-up|2|||
147505107|NCT04046341|532000707|FG000|Overall Study|Withdrawal by Subject|1|||
147505108|NCT04377672|532000708|FG000|Overall Study|Participants was withdrawn from study due to false positive COVID-19 test|1|||
147505109|NCT00405652|532000712|FG000|Overall Study|Adverse Event|4|||
147637249|NCT01820572|532488957|FG001|Treatment Period|poor/non compliance|3|||
147637250|NCT01820572|532488956|FG000|Treatment Period|request to discontinue|6|||
147637251|NCT01820572|532488957|FG001|Treatment Period|request to discontinue|11|||
147637252|NCT01820572|532488956|FG000|Treatment Period|No longer meets study criteria|3|||
147637253|NCT01820572|532488957|FG001|Treatment Period|No longer meets study criteria|10|||
147637254|NCT01820572|532488956|FG000|Treatment Period|withdrew consent|1|||
147505110|NCT05109702|532000713|FG000|Treatment Period (8 Weeks)|Adverse Event|0|||
147505111|NCT05109702|532000714|FG001|Treatment Period (8 Weeks)|Adverse Event|5|||
147505112|NCT05109702|532000715|FG002|Treatment Period (8 Weeks)|Adverse Event|2|||
147505113|NCT05109702|532000713|FG000|Treatment Period (8 Weeks)|Protocol Violation|0|||
147505114|NCT05109702|532000714|FG001|Treatment Period (8 Weeks)|Protocol Violation|0|||
147505115|NCT05109702|532000715|FG002|Treatment Period (8 Weeks)|Protocol Violation|1|||
147505116|NCT05109702|532000713|FG000|Treatment Period (8 Weeks)|Withdrawal by Subject|0|||
147505117|NCT05109702|532000714|FG001|Treatment Period (8 Weeks)|Withdrawal by Subject|5|||
147505118|NCT05109702|532000715|FG002|Treatment Period (8 Weeks)|Withdrawal by Subject|3|||
147505119|NCT05109702|532000713|FG000|Treatment Period (8 Weeks)|Administrative reasons|0|||
147505120|NCT05109702|532000714|FG001|Treatment Period (8 Weeks)|Administrative reasons|1|||
147505121|NCT05109702|532000715|FG002|Treatment Period (8 Weeks)|Administrative reasons|1|||
147505122|NCT05109702|532000713|FG000|Treatment Period (8 Weeks)|Other than specified|0|||
147505123|NCT05109702|532000714|FG001|Treatment Period (8 Weeks)|Other than specified|3|||
147505124|NCT05109702|532000715|FG002|Treatment Period (8 Weeks)|Other than specified|1|||
147505125|NCT02713789|532000716|FG000|Overall Study|Lost to Follow-up|0|||
147505126|NCT02713789|532000717|FG001|Overall Study|Lost to Follow-up|1|||
147505127|NCT02713789|532000718|FG002|Overall Study|Lost to Follow-up|1|||
147505128|NCT00719953|532000724|FG000|Overall Study|Adverse Event|4|||
147505129|NCT02947022|532000725|FG000|Overall Study|Study Stopped|1|||
147505130|NCT04021706|532002712|FG000|Overall Study|Adverse Event|2|||
147505131|NCT04021706|532002713|FG001|Overall Study|Adverse Event|0|||
147505132|NCT04021706|532002712|FG000|Overall Study|Withdrawal by Subject|1|||
147505133|NCT04021706|532002713|FG001|Overall Study|Withdrawal by Subject|2|||
147505134|NCT04021706|532002712|FG000|Overall Study|Physician Decision|1|||
147505135|NCT04021706|532002713|FG001|Overall Study|Physician Decision|0|||
147505136|NCT01375647|532002714|FG000|Overall Study|Lost to Follow-up|3|||
147505137|NCT01375647|532002715|FG001|Overall Study|Lost to Follow-up|3|||
147505138|NCT01375647|532002716|FG002|Overall Study|Lost to Follow-up|7|||
147505139|NCT01375647|532002717|FG003|Overall Study|Lost to Follow-up|10|||
147505140|NCT01375647|532002714|FG000|Overall Study|Death|1|||
147505141|NCT01375647|532002715|FG001|Overall Study|Death|2|||
147505142|NCT01375647|532002716|FG002|Overall Study|Death|1|||
147505143|NCT01375647|532002717|FG003|Overall Study|Death|0|||
147505144|NCT01375647|532002714|FG000|Overall Study|Withdrawal by Subject|17|||
147505145|NCT01375647|532002715|FG001|Overall Study|Withdrawal by Subject|20|||
147505146|NCT01375647|532002716|FG002|Overall Study|Withdrawal by Subject|26|||
147505147|NCT01375647|532002717|FG003|Overall Study|Withdrawal by Subject|14|||
147505148|NCT01375647|532002714|FG000|Overall Study|Physician Decision|1|||
147505149|NCT01375647|532002715|FG001|Overall Study|Physician Decision|0|||
147505150|NCT01375647|532002716|FG002|Overall Study|Physician Decision|0|||
147505151|NCT01375647|532002717|FG003|Overall Study|Physician Decision|0|||
147505152|NCT02332798|532002720|FG000|Overall Study|Unwilling to Participate in Study|0|||
147637255|NCT01820572|532488957|FG001|Treatment Period|withdrew consent|2|||
147637256|NCT04439214|532488963|FG000|Overall Study|Adverse Event|13|||
147637257|NCT04439214|532488963|FG000|Overall Study|Disease progression|16|||
147637258|NCT04439214|532488963|FG000|Overall Study|Death|1|||
147637259|NCT04439214|532488963|FG000|Overall Study|Withdrawal by Subject|2|||
147637260|NCT04439214|532488963|FG000|Overall Study|Declining health|1|||
147637261|NCT04439214|532488963|FG000|Overall Study|Still receiving treatment at the time of the analysis|9|||
147637262|NCT04439214|532488963|FG000|Overall Study|Ineligible|5|||
147637263|NCT02235077|532488964|FG000|Overall Study|Death|5|||
147637264|NCT02235077|532488965|FG001|Overall Study|Death|7|||
147637265|NCT02235077|532488964|FG000|Overall Study|Lost to Follow-up|5|||
147637266|NCT02235077|532488965|FG001|Overall Study|Lost to Follow-up|6|||
147637267|NCT02235077|532488964|FG000|Overall Study|Withdrawal by Subject|8|||
147637268|NCT02235077|532488965|FG001|Overall Study|Withdrawal by Subject|5|||
147637269|NCT02235077|532488964|FG000|Overall Study|Physician Decision|0|||
147637270|NCT02235077|532488965|FG001|Overall Study|Physician Decision|1|||
147637271|NCT03852628|532488966|FG000|Overall Study|Lost to Follow-up|7|||
147637272|NCT03852628|532488967|FG001|Overall Study|Lost to Follow-up|6|||
147637273|NCT03852628|532488966|FG000|Overall Study|Lack of Efficacy|6|||
147637274|NCT03852628|532488967|FG001|Overall Study|Lack of Efficacy|6|||
147637275|NCT02964208|532488968|FG000|Overall Study|Death|103|||
147637276|NCT02964208|532488968|FG000|Overall Study|Withdrawal by Subject|6|||
147637277|NCT02964208|532488968|FG000|Overall Study|Lost to Follow-up|6|||
147637278|NCT02964208|532488968|FG000|Overall Study|Unsuccessful Procedure|5|||
147637279|NCT02964208|532488968|FG000|Overall Study|Device Explant|1|||
147637280|NCT02964208|532488968|FG000|Overall Study|Anatomical Heart Structure of the Patient; LAA Occluder Was Not Implanted; Heart Transplant|3|||
147637281|NCT00957268|532488969|FG000|Overall Study|Voluntary Withdrawal|0|||
147637282|NCT00957268|532488970|FG001|Overall Study|Voluntary Withdrawal|0|||
147637283|NCT00957268|532488971|FG002|Overall Study|Voluntary Withdrawal|1|||
147637284|NCT00957268|532488972|FG003|Overall Study|Voluntary Withdrawal|0|||
147637285|NCT00957268|532488973|FG004|Overall Study|Voluntary Withdrawal|0|||
147637286|NCT01758731|532488975|FG000|Overall Study|Physician Decision|1|||
147637287|NCT02572076|532488977|FG000|Overall Study|Protocol Violation|1|||
147637288|NCT02778074|532488978|FG000|Overall Study|Lost to Follow-up|7|||
147637289|NCT02778074|532488979|FG001|Overall Study|Lost to Follow-up|10|||
147637290|NCT02396420|532488982|FG000|Overall Study|Death|1|||
147637291|NCT01273623|532488985|FG000|Overall Study|did not meet IVUS criteria|29|||
147637292|NCT03489707|532488988|FG000|Baseline|These individuals simply did not comply with baseline screening in this compliance study.|13|||
147505153|NCT02332798|532002721|FG001|Overall Study|Unwilling to Participate in Study|1|||
147505154|NCT02332798|532002722|FG002|Overall Study|Unwilling to Participate in Study|1|||
147505155|NCT02332798|532002720|FG000|Overall Study|Positive Urine Drug Test|0|||
147505156|NCT02332798|532002721|FG001|Overall Study|Positive Urine Drug Test|1|||
147505157|NCT02332798|532002722|FG002|Overall Study|Positive Urine Drug Test|0|||
147505158|NCT02332798|532002720|FG000|Overall Study|Abnormal Laboratory Findings|1|||
147505159|NCT02332798|532002721|FG001|Overall Study|Abnormal Laboratory Findings|0|||
147637293|NCT03489707|532488989|FG001|Baseline|These individuals simply did not comply with baseline screening in this compliance study.|31|||
147637294|NCT03489707|532488988|FG000|12 Months|These individuals simply did not comply with 12-month screening in this compliance study.|42|||
147637295|NCT03489707|532488989|FG001|12 Months|These individuals simply did not comply with 12-month screening in this compliance study.|57|||
147637296|NCT00325156|532488990|FG000|Overall Study|Protocol Violation|8|||
147637297|NCT00325156|532488990|FG000|Overall Study|Lost to follow-up (complete vaccination)|41|||
147637298|NCT00325156|532488990|FG000|Overall Study|Migrated/moved from study area|12|||
147637299|NCT00325156|532488990|FG000|Overall Study|Adverse event, non-fatal|3|||
147637300|NCT00325156|532488990|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|16|||
147637301|NCT00325156|532488990|FG000|Overall Study|Other|1|||
147637302|NCT00325156|532488990|FG000|Overall Study|Withdrawal by Subject|31|||
147637303|NCT04064411|532488991|FG000|Overall Study|Adverse Event|29|||
147637304|NCT04064411|532488992|FG001|Overall Study|Adverse Event|19|||
147637305|NCT04064411|532488991|FG000|Overall Study|Significant Deterioration from Baseline (≥7%) of Bone Mineral Density (BMD) at Spine or Hip|0|||
147637306|NCT04064411|532488992|FG001|Overall Study|Significant Deterioration from Baseline (≥7%) of Bone Mineral Density (BMD) at Spine or Hip|2|||
147637307|NCT04064411|532488991|FG000|Overall Study|Protocol Deviation|0|||
147637308|NCT04064411|532488992|FG001|Overall Study|Protocol Deviation|2|||
147637309|NCT04064411|532488991|FG000|Overall Study|Withdrawal by Subject|25|||
147637310|NCT04064411|532488992|FG001|Overall Study|Withdrawal by Subject|29|||
147637311|NCT04064411|532488991|FG000|Overall Study|Lost to Follow-up|5|||
147637312|NCT04064411|532488992|FG001|Overall Study|Lost to Follow-up|2|||
147637313|NCT04064411|532488991|FG000|Overall Study|Other than Specified|4|||
147637314|NCT04064411|532488992|FG001|Overall Study|Other than Specified|1|||
147637315|NCT04064411|532488991|FG000|Overall Study|Death|1|||
147637316|NCT04064411|532488992|FG001|Overall Study|Death|0|||
147637317|NCT03395184|532488993|FG000|Induction Period (Up to 12 Weeks)|Adverse Event|6|||
147637318|NCT03395184|532488994|FG001|Induction Period (Up to 12 Weeks)|Adverse Event|4|||
147637319|NCT03395184|532488995|FG002|Induction Period (Up to 12 Weeks)|Adverse Event|4|||
147637320|NCT03395184|532488996|FG003|Induction Period (Up to 12 Weeks)|Adverse Event|0|||
147637321|NCT03395184|532488997|FG004|Induction Period (Up to 12 Weeks)|Adverse Event|0|||
147637322|NCT03395184|532488998|FG005|Induction Period (Up to 12 Weeks)|Adverse Event|0|||
147637323|NCT03395184|532488999|FG006|Induction Period (Up to 12 Weeks)|Adverse Event|0|||
147637324|NCT03395184|532488993|FG000|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|0|||
147637325|NCT03395184|532488994|FG001|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|2|||
147637326|NCT03395184|532488995|FG002|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|1|||
147637327|NCT03395184|532488996|FG003|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|0|||
147637328|NCT03395184|532488997|FG004|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|0|||
147637329|NCT03395184|532488998|FG005|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|0|||
147637330|NCT03395184|532488999|FG006|Induction Period (Up to 12 Weeks)|No longer meets eligibility criteria|0|||
147637331|NCT03395184|532488993|FG000|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|2|||
147637332|NCT03395184|532488994|FG001|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|2|||
147637333|NCT03395184|532488995|FG002|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|0|||
147637334|NCT03395184|532488996|FG003|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|0|||
147637335|NCT03395184|532488997|FG004|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|0|||
147637336|NCT03395184|532488998|FG005|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|0|||
147637337|NCT03395184|532488999|FG006|Induction Period (Up to 12 Weeks)|Withdrawal by Subject|0|||
147637338|NCT03395184|532488993|FG000|Induction Period (Up to 12 Weeks)|Lost to Follow-up|0|||
147637339|NCT03395184|532488994|FG001|Induction Period (Up to 12 Weeks)|Lost to Follow-up|1|||
147637340|NCT03395184|532488995|FG002|Induction Period (Up to 12 Weeks)|Lost to Follow-up|0|||
147637341|NCT03395184|532488996|FG003|Induction Period (Up to 12 Weeks)|Lost to Follow-up|0|||
147637342|NCT03395184|532488997|FG004|Induction Period (Up to 12 Weeks)|Lost to Follow-up|0|||
147637343|NCT03395184|532488998|FG005|Induction Period (Up to 12 Weeks)|Lost to Follow-up|0|||
147637344|NCT03395184|532488999|FG006|Induction Period (Up to 12 Weeks)|Lost to Follow-up|0|||
147637345|NCT03395184|532488993|FG000|Induction Period (Up to 12 Weeks)|Lack of Efficacy|2|||
147637346|NCT03395184|532488994|FG001|Induction Period (Up to 12 Weeks)|Lack of Efficacy|0|||
147637347|NCT03395184|532488995|FG002|Induction Period (Up to 12 Weeks)|Lack of Efficacy|2|||
147637348|NCT03395184|532488996|FG003|Induction Period (Up to 12 Weeks)|Lack of Efficacy|0|||
147637349|NCT03395184|532488997|FG004|Induction Period (Up to 12 Weeks)|Lack of Efficacy|0|||
147637350|NCT03395184|532488998|FG005|Induction Period (Up to 12 Weeks)|Lack of Efficacy|0|||
147637351|NCT03395184|532488999|FG006|Induction Period (Up to 12 Weeks)|Lack of Efficacy|0|||
147637352|NCT03395184|532488993|FG000|Induction Period (Up to 12 Weeks)|Other|1|||
147637353|NCT03395184|532488994|FG001|Induction Period (Up to 12 Weeks)|Other|0|||
147637354|NCT03395184|532488995|FG002|Induction Period (Up to 12 Weeks)|Other|0|||
147637355|NCT03395184|532488996|FG003|Induction Period (Up to 12 Weeks)|Other|0|||
147637356|NCT03395184|532488997|FG004|Induction Period (Up to 12 Weeks)|Other|0|||
147637357|NCT03395184|532488998|FG005|Induction Period (Up to 12 Weeks)|Other|0|||
147637358|NCT03395184|532488999|FG006|Induction Period (Up to 12 Weeks)|Other|0|||
147637359|NCT03395184|532488993|FG000|OLE Period (Up to 52 Weeks)|Other|0|||
147637360|NCT03395184|532488994|FG001|OLE Period (Up to 52 Weeks)|Other|0|||
147637361|NCT03395184|532488995|FG002|OLE Period (Up to 52 Weeks)|Other|0|||
147637362|NCT03395184|532488996|FG003|OLE Period (Up to 52 Weeks)|Other|0|||
147637363|NCT03395184|532488997|FG004|OLE Period (Up to 52 Weeks)|Other|2|||
147637364|NCT03395184|532488998|FG005|OLE Period (Up to 52 Weeks)|Other|0|||
147637365|NCT03395184|532488999|FG006|OLE Period (Up to 52 Weeks)|Other|2|||
147637366|NCT03395184|532488993|FG000|OLE Period (Up to 52 Weeks)|Lack of Efficacy|0|||
147637367|NCT03395184|532488994|FG001|OLE Period (Up to 52 Weeks)|Lack of Efficacy|0|||
147637368|NCT03395184|532488995|FG002|OLE Period (Up to 52 Weeks)|Lack of Efficacy|0|||
147637369|NCT03395184|532488996|FG003|OLE Period (Up to 52 Weeks)|Lack of Efficacy|5|||
147637370|NCT03395184|532488997|FG004|OLE Period (Up to 52 Weeks)|Lack of Efficacy|11|||
147637371|NCT03395184|532488998|FG005|OLE Period (Up to 52 Weeks)|Lack of Efficacy|3|||
147637372|NCT03395184|532488999|FG006|OLE Period (Up to 52 Weeks)|Lack of Efficacy|5|||
147637373|NCT03395184|532488993|FG000|OLE Period (Up to 52 Weeks)|Lost to Follow-up|0|||
147637374|NCT03395184|532488994|FG001|OLE Period (Up to 52 Weeks)|Lost to Follow-up|0|||
147637375|NCT03395184|532488995|FG002|OLE Period (Up to 52 Weeks)|Lost to Follow-up|0|||
147637376|NCT03395184|532488996|FG003|OLE Period (Up to 52 Weeks)|Lost to Follow-up|0|||
147637377|NCT03395184|532488997|FG004|OLE Period (Up to 52 Weeks)|Lost to Follow-up|2|||
147637378|NCT03395184|532488998|FG005|OLE Period (Up to 52 Weeks)|Lost to Follow-up|0|||
147637379|NCT03395184|532488999|FG006|OLE Period (Up to 52 Weeks)|Lost to Follow-up|0|||
147637380|NCT03395184|532488993|FG000|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|0|||
147637381|NCT03395184|532488994|FG001|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|0|||
147637382|NCT03395184|532488995|FG002|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|0|||
147637383|NCT03395184|532488996|FG003|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|3|||
147637384|NCT03395184|532488997|FG004|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|11|||
147637385|NCT03395184|532488998|FG005|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|3|||
147637386|NCT03395184|532488999|FG006|OLE Period (Up to 52 Weeks)|Withdrawal by Subject|8|||
147637387|NCT03395184|532488993|FG000|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|0|||
147637388|NCT03395184|532488994|FG001|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|0|||
147637389|NCT03395184|532488995|FG002|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|0|||
147637390|NCT03395184|532488996|FG003|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|1|||
147637391|NCT03395184|532488997|FG004|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|0|||
147637392|NCT03395184|532488998|FG005|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|1|||
147637393|NCT03395184|532488999|FG006|OLE Period (Up to 52 Weeks)|No longer met eligibility criteria|0|||
147637394|NCT03395184|532488993|FG000|OLE Period (Up to 52 Weeks)|Adverse Event|0|||
147637395|NCT03395184|532488994|FG001|OLE Period (Up to 52 Weeks)|Adverse Event|0|||
147637396|NCT03395184|532488995|FG002|OLE Period (Up to 52 Weeks)|Adverse Event|0|||
147637397|NCT03395184|532488996|FG003|OLE Period (Up to 52 Weeks)|Adverse Event|7|||
147637398|NCT03395184|532488997|FG004|OLE Period (Up to 52 Weeks)|Adverse Event|13|||
147637399|NCT03395184|532488998|FG005|OLE Period (Up to 52 Weeks)|Adverse Event|4|||
147637400|NCT03395184|532488999|FG006|OLE Period (Up to 52 Weeks)|Adverse Event|15|||
147637401|NCT01817582|532489000|FG000|Overall Study|Withdrawal by Subject|0|||
147637402|NCT01817582|532489001|FG001|Overall Study|Withdrawal by Subject|1|||
147637403|NCT01817582|532489002|FG002|Overall Study|Withdrawal by Subject|0|||
147637404|NCT01817582|532489000|FG000|Overall Study|Participant revealed masked treatment|1|||
147637405|NCT01817582|532489001|FG001|Overall Study|Participant revealed masked treatment|0|||
147637406|NCT01817582|532489002|FG002|Overall Study|Participant revealed masked treatment|0|||
147637407|NCT01817582|532489000|FG000|Overall Study|Randomized but exclusion criteria met|1|||
147637408|NCT01817582|532489001|FG001|Overall Study|Randomized but exclusion criteria met|0|||
147637409|NCT01817582|532489002|FG002|Overall Study|Randomized but exclusion criteria met|0|||
147637410|NCT03053063|532489003|FG000|Randomized Phase|Study Terminated by Sponsor|326|||
147637411|NCT03053063|532489004|FG001|Randomized Phase|Study Terminated by Sponsor|317|||
147637412|NCT03053063|532489005|FG002|Randomized Phase|Study Terminated by Sponsor|161|||
147637413|NCT03053063|532489006|FG003|Randomized Phase|Study Terminated by Sponsor|0|||
147637414|NCT03053063|532489003|FG000|Randomized Phase|Withdrew consent|8|||
147637415|NCT03053063|532489004|FG001|Randomized Phase|Withdrew consent|11|||
147637416|NCT03053063|532489005|FG002|Randomized Phase|Withdrew consent|5|||
147637417|NCT03053063|532489006|FG003|Randomized Phase|Withdrew consent|0|||
147637418|NCT03053063|532489003|FG000|Randomized Phase|Investigator's Discretion|8|||
147637419|NCT03053063|532489004|FG001|Randomized Phase|Investigator's Discretion|6|||
147637420|NCT03053063|532489005|FG002|Randomized Phase|Investigator's Discretion|2|||
147637421|NCT03053063|532489006|FG003|Randomized Phase|Investigator's Discretion|0|||
147637422|NCT03053063|532489003|FG000|Randomized Phase|Lost to Follow-up|3|||
147637423|NCT03053063|532489004|FG001|Randomized Phase|Lost to Follow-up|5|||
147637424|NCT03053063|532489005|FG002|Randomized Phase|Lost to Follow-up|1|||
147637425|NCT03053063|532489006|FG003|Randomized Phase|Lost to Follow-up|0|||
147637426|NCT03053063|532489003|FG000|Randomized Phase|Adverse Event|0|||
147637427|NCT03053063|532489004|FG001|Randomized Phase|Adverse Event|1|||
147637428|NCT03053063|532489005|FG002|Randomized Phase|Adverse Event|0|||
147637429|NCT03053063|532489006|FG003|Randomized Phase|Adverse Event|0|||
147637430|NCT03053063|532489003|FG000|Randomized Phase|Randomized but Never Treated|1|||
147637431|NCT03053063|532489004|FG001|Randomized Phase|Randomized but Never Treated|3|||
147637432|NCT03053063|532489005|FG002|Randomized Phase|Randomized but Never Treated|2|||
147637433|NCT03053063|532489006|FG003|Randomized Phase|Randomized but Never Treated|0|||
147637434|NCT03053063|532489003|FG000|Randomized Phase|Entered the Open-Label Phase|9|||
147637435|NCT03053063|532489004|FG001|Randomized Phase|Entered the Open-Label Phase|11|||
147637436|NCT03053063|532489005|FG002|Randomized Phase|Entered the Open-Label Phase|3|||
147637437|NCT03053063|532489006|FG003|Randomized Phase|Entered the Open-Label Phase|0|||
147637438|NCT03053063|532489003|FG000|Open-Label Phase|Study Terminated by Sponsor|0|||
147637439|NCT03053063|532489004|FG001|Open-Label Phase|Study Terminated by Sponsor|0|||
147637440|NCT03053063|532489005|FG002|Open-Label Phase|Study Terminated by Sponsor|0|||
147637441|NCT03053063|532489006|FG003|Open-Label Phase|Study Terminated by Sponsor|19|||
147637442|NCT03053063|532489003|FG000|Open-Label Phase|Death|0|||
147637443|NCT03053063|532489004|FG001|Open-Label Phase|Death|0|||
147637444|NCT03053063|532489005|FG002|Open-Label Phase|Death|0|||
147637445|NCT03053063|532489006|FG003|Open-Label Phase|Death|2|||
147637446|NCT03053063|532489003|FG000|Open-Label Phase|Investigator's discretion|0|||
147637447|NCT03053063|532489004|FG001|Open-Label Phase|Investigator's discretion|0|||
147637448|NCT03053063|532489005|FG002|Open-Label Phase|Investigator's discretion|0|||
147637449|NCT03053063|532489006|FG003|Open-Label Phase|Investigator's discretion|2|||
147637450|NCT03617770|532489013|FG000|Overall Study|Lost to Follow-up|1|||
147637451|NCT03617770|532489014|FG001|Overall Study|Lost to Follow-up|0|||
147637452|NCT00356135|532489015|FG000|Overall Study|Protocol Violation|1|||
147637453|NCT00356135|532489016|FG001|Overall Study|Protocol Violation|0|||
147637454|NCT00356135|532489017|FG002|Overall Study|Protocol Violation|0|||
147637455|NCT00356135|532489015|FG000|Overall Study|Adverse Event|1|||
147637456|NCT00356135|532489016|FG001|Overall Study|Adverse Event|0|||
147637457|NCT00356135|532489017|FG002|Overall Study|Adverse Event|0|||
147637458|NCT00356135|532489015|FG000|Overall Study|Lost to Follow-up|0|||
147637459|NCT00356135|532489016|FG001|Overall Study|Lost to Follow-up|0|||
147637460|NCT00356135|532489017|FG002|Overall Study|Lost to Follow-up|1|||
147637461|NCT00356135|532489015|FG000|Overall Study|Physician Decision|1|||
147637462|NCT00356135|532489016|FG001|Overall Study|Physician Decision|1|||
147637463|NCT00356135|532489017|FG002|Overall Study|Physician Decision|1|||
147637464|NCT00356135|532489015|FG000|Overall Study|Subject non-compliance|1|||
147637465|NCT00356135|532489016|FG001|Overall Study|Subject non-compliance|1|||
147637466|NCT00356135|532489017|FG002|Overall Study|Subject non-compliance|3|||
147637467|NCT03963232|532489018|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
147637468|NCT03963232|532489019|FG001|Double-Blind Treatment Phase|Adverse Event|6|||
147637469|NCT03963232|532489018|FG000|Double-Blind Treatment Phase|Protocol Violation|1|||
147637470|NCT03963232|532489019|FG001|Double-Blind Treatment Phase|Protocol Violation|1|||
147637471|NCT03963232|532489018|FG000|Double-Blind Treatment Phase|Pregnancy|2|||
147637472|NCT03963232|532489019|FG001|Double-Blind Treatment Phase|Pregnancy|1|||
147637473|NCT03963232|532489018|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|13|||
147637474|NCT03963232|532489019|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|5|||
147637475|NCT03963232|532489018|FG000|Double-Blind Treatment Phase|Physician Decision|1|||
147637476|NCT03963232|532489019|FG001|Double-Blind Treatment Phase|Physician Decision|3|||
147637477|NCT03963232|532489018|FG000|Open-Label Treatment Phase|Adverse Event|1|||
147637478|NCT03963232|532489019|FG001|Open-Label Treatment Phase|Adverse Event|2|||
147637479|NCT03963232|532489018|FG000|Open-Label Treatment Phase|Protocol Violation|0|||
147637480|NCT03963232|532489019|FG001|Open-Label Treatment Phase|Protocol Violation|2|||
147637481|NCT03963232|532489018|FG000|Open-Label Treatment Phase|Withdrawal by Subject|5|||
147637482|NCT03963232|532489019|FG001|Open-Label Treatment Phase|Withdrawal by Subject|7|||
147637483|NCT03963232|532489018|FG000|Open-Label Treatment Phase|Pregnancy|1|||
147637484|NCT03963232|532489019|FG001|Open-Label Treatment Phase|Pregnancy|0|||
147637485|NCT03963232|532489018|FG000|Follow-up Phase|Withdrawal by Subject|7|||
147637486|NCT03963232|532489019|FG001|Follow-up Phase|Withdrawal by Subject|5|||
147637487|NCT03963232|532489018|FG000|Follow-up Phase|Protocol Violation|0|||
147637488|NCT03963232|532489019|FG001|Follow-up Phase|Protocol Violation|2|||
147637489|NCT03963232|532489018|FG000|Follow-up Phase|Adverse Event|0|||
147637490|NCT03963232|532489019|FG001|Follow-up Phase|Adverse Event|1|||
147637491|NCT03963232|532489018|FG000|Follow-up Phase|Lost to Follow-up|0|||
147637492|NCT03963232|532489019|FG001|Follow-up Phase|Lost to Follow-up|1|||
147637493|NCT03512210|532489020|FG000|Step 1: MINMON Intervention|Lost to Follow-up|3|||
147637494|NCT03512210|532489020|FG000|Step 1: MINMON Intervention|Protocol Violation|1|||
147637495|NCT03512210|532489020|FG000|Step 2:Post-MINMON|Death|2|||
147637496|NCT03512210|532489020|FG000|Step 2:Post-MINMON|Lost to Follow-up|30|||
147637497|NCT03512210|532489020|FG000|Step 2:Post-MINMON|Withdrawal by Subject|2|||
147637498|NCT05033262|532489023|FG000|Overall Study|Lost to Follow-up|1|||
147637499|NCT05033262|532489024|FG001|Overall Study|Lost to Follow-up|0|||
147637500|NCT05033262|532489025|FG002|Overall Study|Lost to Follow-up|0|||
147637501|NCT05033262|532489026|FG003|Overall Study|Lost to Follow-up|1|||
147637502|NCT05270395|532489027|FG000|Overall Study|Lost to Follow-up|2|||
147637503|NCT05270395|532489028|FG001|Overall Study|Lost to Follow-up|2|||
147637504|NCT05270395|532489027|FG000|Overall Study|Death|1|||
147637505|NCT05270395|532489028|FG001|Overall Study|Death|2|||
147637506|NCT05270395|532489027|FG000|Overall Study|Study Team Withdrew|1|||
147505160|NCT02332798|532002722|FG002|Overall Study|Abnormal Laboratory Findings|0|||
147505161|NCT00595868|532002723|FG000|Overall Study|Lost to Follow-up|45|||
147505162|NCT00595868|532002724|FG001|Overall Study|Lost to Follow-up|50|||
147505163|NCT01102140|532002725|FG000|Overall Study|Lost to Follow-up|1|||
147505164|NCT01102140|532002726|FG001|Overall Study|Lost to Follow-up|0|||
147505165|NCT01102140|532002725|FG000|Overall Study|Investigator terminated study|2|||
147505166|NCT01102140|532002726|FG001|Overall Study|Investigator terminated study|2|||
147505167|NCT03788967|532002729|FG000|Overall Study|Lost to Follow-up|14|||
147505168|NCT03788967|532002730|FG001|Overall Study|Lost to Follow-up|10|||
147505169|NCT03788967|532002729|FG000|Overall Study|Participant Non-Compliance/Uncooperativeness|3|||
147637507|NCT05270395|532489028|FG001|Overall Study|Study Team Withdrew|0|||
147637508|NCT00784550|532491261|FG000|Overall Study|Adverse Event|12|||
147637509|NCT00784550|532491262|FG001|Overall Study|Adverse Event|10|||
147637510|NCT00784550|532491261|FG000|Overall Study|Lack of Efficacy|0|||
147505170|NCT03788967|532002730|FG001|Overall Study|Participant Non-Compliance/Uncooperativeness|6|||
147505171|NCT03788967|532002729|FG000|Overall Study|Participant Withdrawal of Consent|13|||
147505172|NCT03788967|532002730|FG001|Overall Study|Participant Withdrawal of Consent|5|||
147505173|NCT03788967|532002729|FG000|Overall Study|Adverse Event|1|||
147505174|NCT03788967|532002730|FG001|Overall Study|Adverse Event|1|||
147505175|NCT03788967|532002729|FG000|Overall Study|COVID-19|1|||
147505176|NCT03788967|532002730|FG001|Overall Study|COVID-19|2|||
147505177|NCT01625611|532002731|FG000|Overall Study|No adlib drinks Lab 1|3|||
147505178|NCT01625611|532002732|FG001|Overall Study|No adlib drinks Lab 1|0|||
147505179|NCT01625611|532002731|FG000|Overall Study|Technical issues with PET|1|||
147505180|NCT01625611|532002732|FG001|Overall Study|Technical issues with PET|0|||
147505181|NCT01625611|532002731|FG000|Overall Study|Unable to complete study procedures|1|||
147505182|NCT01625611|532002732|FG001|Overall Study|Unable to complete study procedures|0|||
147505183|NCT01625611|532002731|FG000|Overall Study|Withdrawal by Subject|3|||
147505184|NCT01625611|532002732|FG001|Overall Study|Withdrawal by Subject|0|||
147505185|NCT00233324|532002733|FG000|Main Study|Death|68|||
147505186|NCT00233324|532002734|FG001|Main Study|Death|60|||
147505187|NCT00233324|532002735|FG002|Main Study|Death|62|||
147505188|NCT00233324|532002736|FG003|Main Study|Death|47|||
147505189|NCT00233324|532002733|FG000|Follow up at 18-22 Months Corrected Age|Death|5|||
147505190|NCT00233324|532002734|FG001|Follow up at 18-22 Months Corrected Age|Death|7|||
147505191|NCT00233324|532002735|FG002|Follow up at 18-22 Months Corrected Age|Death|5|||
147505192|NCT00233324|532002736|FG003|Follow up at 18-22 Months Corrected Age|Death|4|||
147505193|NCT00233324|532002733|FG000|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|8|||
147505194|NCT00233324|532002734|FG001|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|7|||
147505195|NCT00233324|532002735|FG002|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|13|||
147505196|NCT00233324|532002736|FG003|Follow up at 18-22 Months Corrected Age|Undetermined retinopathy status|7|||
147505197|NCT02137837|532002737|FG000|Overall Study|Adverse Event|0|||
147505198|NCT02137837|532002738|FG001|Overall Study|Adverse Event|2|||
147505199|NCT02137837|532002739|FG002|Overall Study|Adverse Event|1|||
147505200|NCT02137837|532002737|FG000|Overall Study|Refusal unrelated to adverse event|2|||
147505201|NCT02137837|532002738|FG001|Overall Study|Refusal unrelated to adverse event|2|||
147505202|NCT02137837|532002739|FG002|Overall Study|Refusal unrelated to adverse event|1|||
147505203|NCT02137837|532002737|FG000|Overall Study|Progression/relapse|9|||
147505204|NCT02137837|532002738|FG001|Overall Study|Progression/relapse|7|||
147505205|NCT02137837|532002739|FG002|Overall Study|Progression/relapse|7|||
147505206|NCT02137837|532002737|FG000|Overall Study|Not protocol specified|2|||
147505207|NCT02137837|532002738|FG001|Overall Study|Not protocol specified|1|||
147505208|NCT02137837|532002739|FG002|Overall Study|Not protocol specified|3|||
147505209|NCT01181141|532002742|FG000|Overall Study|Adverse Event|2|||
147505210|NCT01181141|532002743|FG001|Overall Study|Adverse Event|1|||
147505211|NCT01181141|532002742|FG000|Overall Study|Lack of Efficacy|1|||
147505212|NCT01181141|532002743|FG001|Overall Study|Lack of Efficacy|0|||
147505213|NCT01181141|532002742|FG000|Overall Study|Lost to Follow-up|1|||
147505214|NCT01181141|532002743|FG001|Overall Study|Lost to Follow-up|1|||
147505215|NCT01181141|532002742|FG000|Overall Study|Physician Decision|2|||
147505216|NCT01181141|532002743|FG001|Overall Study|Physician Decision|0|||
147505217|NCT01181141|532002742|FG000|Overall Study|Protocol Violation|3|||
147505218|NCT01181141|532002743|FG001|Overall Study|Protocol Violation|1|||
147505219|NCT01181141|532002742|FG000|Overall Study|Withdrawal by Subject|3|||
147637511|NCT00784550|532491262|FG001|Overall Study|Lack of Efficacy|1|||
147637512|NCT00784550|532491261|FG000|Overall Study|Protocol Violation|10|||
147637513|NCT00784550|532491262|FG001|Overall Study|Protocol Violation|10|||
147505220|NCT01181141|532002743|FG001|Overall Study|Withdrawal by Subject|1|||
147505221|NCT00118911|532002744|FG000|Overall Study|Withdrawal by Subject|2|||
147505222|NCT00118911|532002745|FG001|Overall Study|Withdrawal by Subject|5|||
147505223|NCT05507580|532002746|FG000|Double-Blind Treatment Period|Lost to Follow-up|0|||
147505224|NCT05507580|532002747|FG001|Double-Blind Treatment Period|Lost to Follow-up|1|||
147505225|NCT05507580|532002748|FG002|Double-Blind Treatment Period|Lost to Follow-up|0|||
147505226|NCT05507580|532002749|FG003|Double-Blind Treatment Period|Lost to Follow-up|0|||
147505227|NCT05507580|532002750|FG004|Double-Blind Treatment Period|Lost to Follow-up|0|||
147637514|NCT00784550|532491261|FG000|Overall Study|Lost to Follow-up|8|||
147637515|NCT00784550|532491262|FG001|Overall Study|Lost to Follow-up|5|||
147637516|NCT00784550|532491261|FG000|Overall Study|Physician Decision|2|||
147637517|NCT00784550|532491262|FG001|Overall Study|Physician Decision|3|||
147637518|NCT00784550|532491261|FG000|Overall Study|Withdrawal by Subject|4|||
147637519|NCT00784550|532491262|FG001|Overall Study|Withdrawal by Subject|13|||
147637520|NCT00743288|532491263|FG000|Overall Study|Adverse Event|1|||
147637521|NCT00743288|532491264|FG001|Overall Study|Adverse Event|1|||
147637522|NCT00743288|532491265|FG002|Overall Study|Adverse Event|2|||
147637523|NCT00743288|532491266|FG003|Overall Study|Adverse Event|2|||
147637524|NCT00743288|532491267|FG004|Overall Study|Adverse Event|1|||
147637525|NCT00743288|532491268|FG005|Overall Study|Adverse Event|1|||
147637526|NCT00743288|532491269|FG006|Overall Study|Adverse Event|2|||
147637527|NCT00743288|532491263|FG000|Overall Study|Withdrawal by Subject|0|||
147637528|NCT00743288|532491264|FG001|Overall Study|Withdrawal by Subject|0|||
147637529|NCT00743288|532491265|FG002|Overall Study|Withdrawal by Subject|1|||
147637530|NCT00743288|532491266|FG003|Overall Study|Withdrawal by Subject|0|||
147637531|NCT00743288|532491267|FG004|Overall Study|Withdrawal by Subject|0|||
147637532|NCT00743288|532491268|FG005|Overall Study|Withdrawal by Subject|1|||
147637533|NCT00743288|532491269|FG006|Overall Study|Withdrawal by Subject|1|||
147637534|NCT00743288|532491263|FG000|Overall Study|Progressive disease (PD)|2|||
147637535|NCT00743288|532491264|FG001|Overall Study|Progressive disease (PD)|0|||
147637536|NCT00743288|532491265|FG002|Overall Study|Progressive disease (PD)|1|||
147637537|NCT00743288|532491266|FG003|Overall Study|Progressive disease (PD)|4|||
147637538|NCT00743288|532491267|FG004|Overall Study|Progressive disease (PD)|5|||
147637539|NCT00743288|532491268|FG005|Overall Study|Progressive disease (PD)|3|||
147637540|NCT00743288|532491269|FG006|Overall Study|Progressive disease (PD)|6|||
147637541|NCT00743288|532491263|FG000|Overall Study|Worsening of condition (Not PD)|0|||
147637542|NCT00743288|532491264|FG001|Overall Study|Worsening of condition (Not PD)|2|||
147637543|NCT00743288|532491265|FG002|Overall Study|Worsening of condition (Not PD)|1|||
147637544|NCT00743288|532491266|FG003|Overall Study|Worsening of condition (Not PD)|1|||
147637545|NCT00743288|532491267|FG004|Overall Study|Worsening of condition (Not PD)|0|||
147637546|NCT00743288|532491268|FG005|Overall Study|Worsening of condition (Not PD)|0|||
147637547|NCT00743288|532491269|FG006|Overall Study|Worsening of condition (Not PD)|0|||
147637548|NCT05903924|532491270|FG000|Overall Study|Lost to Follow-up|1|||
147637549|NCT05903924|532491271|FG001|Overall Study|Lost to Follow-up|0|||
147637550|NCT05903924|532491272|FG002|Overall Study|Lost to Follow-up|0|||
147637551|NCT00688701|532491273|FG000|Overall Study|Adverse Event|1|||
147637552|NCT00688701|532491274|FG001|Overall Study|Adverse Event|0|||
147637553|NCT00688701|532491275|FG002|Overall Study|Adverse Event|5|||
147637554|NCT00688701|532491276|FG003|Overall Study|Adverse Event|3|||
147637555|NCT00688701|532491273|FG000|Overall Study|Lack of Efficacy|0|||
147637556|NCT00688701|532491274|FG001|Overall Study|Lack of Efficacy|1|||
147637557|NCT00688701|532491275|FG002|Overall Study|Lack of Efficacy|0|||
147637558|NCT00688701|532491276|FG003|Overall Study|Lack of Efficacy|0|||
147637559|NCT00688701|532491273|FG000|Overall Study|Withdrawal by Subject|3|||
147637560|NCT00688701|532491274|FG001|Overall Study|Withdrawal by Subject|3|||
147637561|NCT00688701|532491275|FG002|Overall Study|Withdrawal by Subject|4|||
147637562|NCT00688701|532491276|FG003|Overall Study|Withdrawal by Subject|8|||
147637563|NCT00688701|532491273|FG000|Overall Study|Poor compliance to protocol|0|||
147637564|NCT00688701|532491274|FG001|Overall Study|Poor compliance to protocol|1|||
147637565|NCT00688701|532491275|FG002|Overall Study|Poor compliance to protocol|1|||
147637566|NCT00688701|532491276|FG003|Overall Study|Poor compliance to protocol|0|||
147637567|NCT04166591|532491282|FG000|First Behavioral Task (3 Minutes)|Withdrawal by Subject|9|||
147637568|NCT04166591|532491283|FG001|First Behavioral Task (3 Minutes)|Withdrawal by Subject|11|||
147637569|NCT04166591|532491284|FG002|First Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
147637570|NCT04166591|532491285|FG003|First Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
147637571|NCT04166591|532491282|FG000|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|9|||
147637572|NCT04166591|532491283|FG001|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|11|||
147637573|NCT04166591|532491284|FG002|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
147637574|NCT04166591|532491285|FG003|Second Behavioral Task (3 Minutes)|Withdrawal by Subject|2|||
147637575|NCT03030989|532491286|FG000|Overall Study|Fever|2|||
147637576|NCT03030989|532491287|FG001|Overall Study|Fever|2|||
147637577|NCT03030989|532491286|FG000|Overall Study|Rash|2|||
147637578|NCT03030989|532491287|FG001|Overall Study|Rash|1|||
147637579|NCT03030989|532491286|FG000|Overall Study|Fatigue/Overwhelmed|1|||
147637580|NCT03030989|532491287|FG001|Overall Study|Fatigue/Overwhelmed|5|||
147637581|NCT03030989|532491286|FG000|Overall Study|Positive Blood Cultures|2|||
147637582|NCT03030989|532491287|FG001|Overall Study|Positive Blood Cultures|1|||
147637583|NCT03030989|532491286|FG000|Overall Study|Line Removed|0|||
147637584|NCT03030989|532491287|FG001|Overall Study|Line Removed|2|||
147637585|NCT03030989|532491286|FG000|Overall Study|No longer interested|5|||
147637586|NCT03030989|532491287|FG001|Overall Study|No longer interested|3|||
147637587|NCT02730377|532491288|FG000|Overall Study|Other|5|||
147637588|NCT02730377|532491289|FG001|Overall Study|Other|4|||
147637589|NCT02730377|532491288|FG000|Overall Study|Death|1|||
147637590|NCT02730377|532491289|FG001|Overall Study|Death|8|||
147637591|NCT02730377|532491288|FG000|Overall Study|Inadequate glycaemic control|368|||
147637592|NCT02730377|532491289|FG001|Overall Study|Inadequate glycaemic control|473|||
147637593|NCT02730377|532491288|FG000|Overall Study|Adverse Event|79|||
147637594|NCT02730377|532491289|FG001|Overall Study|Adverse Event|41|||
147637595|NCT02730377|532491288|FG000|Overall Study|Protocol Violation|23|||
147637596|NCT02730377|532491289|FG001|Overall Study|Protocol Violation|30|||
147637597|NCT02730377|532491288|FG000|Overall Study|Lack of Efficacy|4|||
147637598|NCT02730377|532491289|FG001|Overall Study|Lack of Efficacy|13|||
147637599|NCT02730377|532491288|FG000|Overall Study|Pregnancy|0|||
147637600|NCT02730377|532491289|FG001|Overall Study|Pregnancy|1|||
147637601|NCT02730377|532491288|FG000|Overall Study|Withdrawal by Subject|45|||
147637602|NCT02730377|532491289|FG001|Overall Study|Withdrawal by Subject|42|||
147637603|NCT02730377|532491288|FG000|Overall Study|Lost to Follow-up|25|||
147637604|NCT02730377|532491289|FG001|Overall Study|Lost to Follow-up|21|||
147637605|NCT03917472|532491290|FG000|Overall Study|Physician Decision|4|||
147637606|NCT03917472|532491291|FG001|Overall Study|Physician Decision|0|||
147637607|NCT03917472|532491290|FG000|Overall Study|Adverse Event|3|||
147637608|NCT03917472|532491291|FG001|Overall Study|Adverse Event|1|||
147637609|NCT03917472|532491290|FG000|Overall Study|Death|7|||
147637610|NCT03917472|532491291|FG001|Overall Study|Death|5|||
147637611|NCT03917472|532491290|FG000|Overall Study|Withdrawal by Subject|11|||
147637612|NCT03917472|532491291|FG001|Overall Study|Withdrawal by Subject|4|||
147637613|NCT03917472|532491290|FG000|Overall Study|Lost to Follow-up|10|||
147637614|NCT03917472|532491291|FG001|Overall Study|Lost to Follow-up|5|||
147637615|NCT01154296|532491292|FG000|Randomization and Intervention|Decided to decline|1|||
147637616|NCT01154296|532491293|FG001|Randomization and Intervention|Decided to decline|1|||
147637617|NCT01154296|532491292|FG000|Randomization and Intervention|Declined by staff|1|||
147637618|NCT01154296|532491293|FG001|Randomization and Intervention|Declined by staff|0|||
147637619|NCT01154296|532491292|FG000|Randomization and Intervention|Did not return|1|||
147637620|NCT01154296|532491293|FG001|Randomization and Intervention|Did not return|0|||
147637621|NCT01154296|532491292|FG000|Randomization and Intervention|Left before test|0|||
147637622|NCT01154296|532491293|FG001|Randomization and Intervention|Left before test|1|||
147637623|NCT01154296|532491292|FG000|Randomization and Intervention|Left clinic early|2|||
147637624|NCT01154296|532491293|FG001|Randomization and Intervention|Left clinic early|0|||
147637625|NCT01154296|532491292|FG000|6-month Follow-up|Lost contact|269|||
147637626|NCT01154296|532491293|FG001|6-month Follow-up|Lost contact|275|||
147637627|NCT01154296|532491292|FG000|6-month Follow-up|Incarcerated|37|||
147637628|NCT01154296|532491293|FG001|6-month Follow-up|Incarcerated|32|||
147637629|NCT01154296|532491292|FG000|6-month Follow-up|Withdrew consent|14|||
147637630|NCT01154296|532491293|FG001|6-month Follow-up|Withdrew consent|15|||
147637631|NCT01154296|532491292|FG000|6-month Follow-up|Death|3|||
147637632|NCT01154296|532491293|FG001|6-month Follow-up|Death|2|||
147637633|NCT01154296|532491292|FG000|6-month Follow-up|Declined by Study Coordinator|5|||
147637634|NCT01154296|532491293|FG001|6-month Follow-up|Declined by Study Coordinator|4|||
147637635|NCT02759055|532491294|FG000|Overall Study|Patients with no follow-up visit and/or age 18-39 were not included in analyses.|1927|||
147637636|NCT02759055|532491295|FG001|Overall Study|Patients with no follow-up visit and/or age 18-39 were not included in analyses.|1508|||
147637637|NCT00970632|532491300|FG000|Overall Study|Adverse Event|2|||
147637638|NCT00970632|532491301|FG001|Overall Study|Adverse Event|2|||
147637639|NCT00970632|532491302|FG002|Overall Study|Adverse Event|1|||
147637640|NCT00970632|532491300|FG000|Overall Study|Lack of Efficacy|3|||
147637641|NCT00970632|532491301|FG001|Overall Study|Lack of Efficacy|0|||
147637642|NCT00970632|532491302|FG002|Overall Study|Lack of Efficacy|0|||
147637643|NCT00970632|532491300|FG000|Overall Study|Lost to Follow-up|3|||
147637644|NCT00970632|532491301|FG001|Overall Study|Lost to Follow-up|0|||
147637645|NCT00970632|532491302|FG002|Overall Study|Lost to Follow-up|2|||
147637646|NCT00970632|532491300|FG000|Overall Study|Protocol Violation|8|||
147637647|NCT00970632|532491301|FG001|Overall Study|Protocol Violation|5|||
147637648|NCT00970632|532491302|FG002|Overall Study|Protocol Violation|8|||
147637649|NCT00970632|532491300|FG000|Overall Study|Withdrawal by Subject|7|||
147637650|NCT00970632|532491301|FG001|Overall Study|Withdrawal by Subject|6|||
147637651|NCT00970632|532491302|FG002|Overall Study|Withdrawal by Subject|4|||
147637652|NCT00970632|532491300|FG000|Overall Study|Entry criteria not met|0|||
147637653|NCT00970632|532491301|FG001|Overall Study|Entry criteria not met|2|||
147637654|NCT00970632|532491302|FG002|Overall Study|Entry criteria not met|2|||
147637655|NCT00970632|532491300|FG000|Overall Study|Sponsor decision|1|||
147637656|NCT00970632|532491301|FG001|Overall Study|Sponsor decision|0|||
147637657|NCT00970632|532491302|FG002|Overall Study|Sponsor decision|1|||
147637658|NCT01871402|532491309|FG000|Overall Study|Lost to Follow-up|1|||
147637659|NCT01871402|532491310|FG001|Overall Study|Lost to Follow-up|0|||
147637660|NCT01871402|532491309|FG000|Overall Study|Withdrawal by Subject|0|||
147637661|NCT01871402|532491310|FG001|Overall Study|Withdrawal by Subject|2|||
147637662|NCT01871402|532491309|FG000|Overall Study|Non-compliance|0|||
147637663|NCT01871402|532491310|FG001|Overall Study|Non-compliance|1|||
147637664|NCT04594941|532491311|FG000|Overall Study|Other|0|||
147637665|NCT04594941|532491312|FG001|Overall Study|Other|3|||
147637666|NCT04594941|532491313|FG002|Overall Study|Other|1|||
147637667|NCT04594941|532491314|FG003|Overall Study|Other|0|||
147637668|NCT00231114|532491315|FG000|Randomized|Withdrawal by Subject|6|||
147637669|NCT00231114|532491316|FG001|Randomized|Withdrawal by Subject|3|||
147637670|NCT00231114|532491315|FG000|Treatment Period|Death: Motor Vehicle Accident|1|||
147637671|NCT00231114|532491316|FG001|Treatment Period|Death: Motor Vehicle Accident|0|||
147637672|NCT00231114|532491315|FG000|Post-Treatment Period|Lost to Follow-up|6|||
147637673|NCT00231114|532491316|FG001|Post-Treatment Period|Lost to Follow-up|1|||
147637674|NCT00231114|532491315|FG000|Post-Treatment Period|Physician Decision|1|||
147637675|NCT00231114|532491316|FG001|Post-Treatment Period|Physician Decision|0|||
147637676|NCT00231114|532491315|FG000|Post-Treatment Period|Withdrawal by Subject|1|||
147637677|NCT00231114|532491316|FG001|Post-Treatment Period|Withdrawal by Subject|0|||
147637678|NCT02005692|532491317|FG000|Overall Study|Protocol Violation|1|||
147637679|NCT02005692|532491317|FG000|Overall Study|Withdrawal by Subject|1|||
147637680|NCT02005692|532491317|FG000|Overall Study|Discharged earlier than anticipated|5|||
147637681|NCT01194999|532491318|FG000|Overall Study|Lost to Follow-up|17|||
147637682|NCT02682823|532491319|FG000|Overall Study|Withdrawal by Subject|0|||
147637683|NCT02682823|532491320|FG001|Overall Study|Withdrawal by Subject|0|||
147637684|NCT02682823|532491321|FG002|Overall Study|Withdrawal by Subject|1|||
147637685|NCT02682823|532491322|FG003|Overall Study|Withdrawal by Subject|0|||
147637686|NCT02682823|532491323|FG004|Overall Study|Withdrawal by Subject|1|||
147637687|NCT02682823|532491319|FG000|Overall Study|Protocol Deviation|0|||
147637688|NCT02682823|532491320|FG001|Overall Study|Protocol Deviation|1|||
147637689|NCT02682823|532491321|FG002|Overall Study|Protocol Deviation|0|||
147637690|NCT02682823|532491322|FG003|Overall Study|Protocol Deviation|0|||
147637691|NCT02682823|532491323|FG004|Overall Study|Protocol Deviation|0|||
147637692|NCT02682823|532491319|FG000|Overall Study|Adverse Event|0|||
147637693|NCT02682823|532491320|FG001|Overall Study|Adverse Event|0|||
147637694|NCT02682823|532491321|FG002|Overall Study|Adverse Event|0|||
147637695|NCT02682823|532491322|FG003|Overall Study|Adverse Event|1|||
147637696|NCT02682823|532491323|FG004|Overall Study|Adverse Event|0|||
147637697|NCT03781583|532491324|FG000|Overall Study|Technical issue prevents the device from starting properly|1|||
147637698|NCT03781583|532491325|FG001|Overall Study|Technical issue prevents the device from starting properly|0|||
147637699|NCT03781583|532491326|FG002|Overall Study|Technical issue prevents the device from starting properly|0|||
147637700|NCT03781583|532491327|FG003|Overall Study|Technical issue prevents the device from starting properly|0|||
147637701|NCT03781583|532491324|FG000|Overall Study|Technology did not work for that person in that environment|1|||
147637702|NCT03781583|532491325|FG001|Overall Study|Technology did not work for that person in that environment|0|||
147637703|NCT03781583|532491326|FG002|Overall Study|Technology did not work for that person in that environment|0|||
147637704|NCT03781583|532491327|FG003|Overall Study|Technology did not work for that person in that environment|0|||
147637705|NCT03781583|532491324|FG000|Overall Study|Participant was not sufficiently visually impaired|0|||
147637706|NCT03781583|532491325|FG001|Overall Study|Participant was not sufficiently visually impaired|1|||
147637707|NCT03781583|532491326|FG002|Overall Study|Participant was not sufficiently visually impaired|0|||
147637708|NCT03781583|532491327|FG003|Overall Study|Participant was not sufficiently visually impaired|0|||
147637709|NCT03781583|532491324|FG000|Overall Study|Pilot test of course took place in different location, data not comparable to other participant data|0|||
147637710|NCT03781583|532491325|FG001|Overall Study|Pilot test of course took place in different location, data not comparable to other participant data|1|||
147637711|NCT03781583|532491326|FG002|Overall Study|Pilot test of course took place in different location, data not comparable to other participant data|0|||
147637712|NCT03781583|532491327|FG003|Overall Study|Pilot test of course took place in different location, data not comparable to other participant data|0|||
147637713|NCT05139303|532491328|FG000|Overall Study|Lost to Follow-up|3|||
147637714|NCT05139303|532491329|FG001|Overall Study|Lost to Follow-up|0|||
147637715|NCT05139303|532491328|FG000|Overall Study|Adverse Event|1|||
147637716|NCT05139303|532491329|FG001|Overall Study|Adverse Event|0|||
147637717|NCT01938430|532491330|FG000|Overall Study|Randomized but Not Treated|0|||
147637718|NCT01938430|532491331|FG001|Overall Study|Randomized but Not Treated|0|||
147637719|NCT01938430|532491332|FG002|Overall Study|Randomized but Not Treated|0|||
147637720|NCT01938430|532491333|FG003|Overall Study|Randomized but Not Treated|0|||
147637721|NCT01938430|532491334|FG004|Overall Study|Randomized but Not Treated|0|||
147637722|NCT01938430|532491335|FG005|Overall Study|Randomized but Not Treated|0|||
147637723|NCT01938430|532491336|FG006|Overall Study|Randomized but Not Treated|0|||
147637724|NCT01938430|532491337|FG007|Overall Study|Randomized but Not Treated|0|||
147637725|NCT01938430|532491338|FG008|Overall Study|Randomized but Not Treated|0|||
147637726|NCT01938430|532491339|FG009|Overall Study|Randomized but Not Treated|0|||
147637727|NCT01938430|532491340|FG010|Overall Study|Randomized but Not Treated|1|||
147637728|NCT01938430|532491341|FG011|Overall Study|Randomized but Not Treated|0|||
147637729|NCT01938430|532491342|FG012|Overall Study|Randomized but Not Treated|0|||
147637730|NCT01938430|532491343|FG013|Overall Study|Randomized but Not Treated|1|||
147637731|NCT01938430|532491330|FG000|Overall Study|Adverse Event|0|||
147637732|NCT01938430|532491331|FG001|Overall Study|Adverse Event|0|||
147637733|NCT01938430|532491332|FG002|Overall Study|Adverse Event|0|||
147637734|NCT01938430|532491333|FG003|Overall Study|Adverse Event|0|||
147637735|NCT01938430|532491334|FG004|Overall Study|Adverse Event|0|||
147637736|NCT01938430|532491335|FG005|Overall Study|Adverse Event|0|||
147637737|NCT01938430|532491336|FG006|Overall Study|Adverse Event|1|||
147505228|NCT05507580|532002751|FG005|Double-Blind Treatment Period|Lost to Follow-up|0|||
147505229|NCT05507580|532002746|FG000|Double-Blind Treatment Period|Withdrawal by Subject|7|||
147505230|NCT05507580|532002747|FG001|Double-Blind Treatment Period|Withdrawal by Subject|1|||
147505231|NCT05507580|532002748|FG002|Double-Blind Treatment Period|Withdrawal by Subject|0|||
147505232|NCT05507580|532002749|FG003|Double-Blind Treatment Period|Withdrawal by Subject|0|||
147505233|NCT05507580|532002750|FG004|Double-Blind Treatment Period|Withdrawal by Subject|0|||
147505234|NCT05507580|532002751|FG005|Double-Blind Treatment Period|Withdrawal by Subject|0|||
147505235|NCT05507580|532002746|FG000|Double-Blind Treatment Period|Other, not specified|5|||
147505236|NCT05507580|532002747|FG001|Double-Blind Treatment Period|Other, not specified|4|||
147505237|NCT05507580|532002748|FG002|Double-Blind Treatment Period|Other, not specified|0|||
147505238|NCT05507580|532002749|FG003|Double-Blind Treatment Period|Other, not specified|0|||
147505239|NCT05507580|532002750|FG004|Double-Blind Treatment Period|Other, not specified|0|||
147505240|NCT05507580|532002751|FG005|Double-Blind Treatment Period|Other, not specified|0|||
147505241|NCT05507580|532002746|FG000|Single-Blind Treatment Period|Lost to Follow-up|0|||
147505242|NCT05507580|532002747|FG001|Single-Blind Treatment Period|Lost to Follow-up|0|||
147505243|NCT05507580|532002748|FG002|Single-Blind Treatment Period|Lost to Follow-up|0|||
147505244|NCT05507580|532002749|FG003|Single-Blind Treatment Period|Lost to Follow-up|0|||
147505245|NCT05507580|532002750|FG004|Single-Blind Treatment Period|Lost to Follow-up|2|||
147505246|NCT05507580|532002751|FG005|Single-Blind Treatment Period|Lost to Follow-up|1|||
147505247|NCT05507580|532002746|FG000|Single-Blind Treatment Period|Withdrawal by Subject|0|||
147505248|NCT05507580|532002747|FG001|Single-Blind Treatment Period|Withdrawal by Subject|0|||
147505249|NCT05507580|532002748|FG002|Single-Blind Treatment Period|Withdrawal by Subject|0|||
147505250|NCT05507580|532002749|FG003|Single-Blind Treatment Period|Withdrawal by Subject|5|||
147505251|NCT05507580|532002750|FG004|Single-Blind Treatment Period|Withdrawal by Subject|2|||
147505252|NCT05507580|532002751|FG005|Single-Blind Treatment Period|Withdrawal by Subject|6|||
147505253|NCT05507580|532002746|FG000|Single-Blind Treatment Period|Other, not specified|0|||
147505254|NCT05507580|532002747|FG001|Single-Blind Treatment Period|Other, not specified|0|||
147505255|NCT05507580|532002748|FG002|Single-Blind Treatment Period|Other, not specified|2|||
147505256|NCT05507580|532002749|FG003|Single-Blind Treatment Period|Other, not specified|7|||
147505257|NCT05507580|532002750|FG004|Single-Blind Treatment Period|Other, not specified|3|||
147505258|NCT05507580|532002751|FG005|Single-Blind Treatment Period|Other, not specified|5|||
147505259|NCT03395223|532002752|FG000|Overall Study|Lost to Follow-up|3|||
147505260|NCT03395223|532002752|FG000|Overall Study|Other|1|||
147505261|NCT01248364|532002756|FG000|Overall Study|Adverse Event|0|||
147505262|NCT01248364|532002757|FG001|Overall Study|Adverse Event|1|||
147505263|NCT01248364|532002758|FG002|Overall Study|Adverse Event|0|||
147505264|NCT01248364|532002759|FG003|Overall Study|Adverse Event|0|||
147505265|NCT01117012|532002762|FG000|Overall Study|Adverse Event|0|||
147505266|NCT01117012|532002763|FG001|Overall Study|Adverse Event|1|||
147505267|NCT01117012|532002762|FG000|Overall Study|Death|1|||
147505268|NCT01117012|532002763|FG001|Overall Study|Death|1|||
147505269|NCT01117012|532002762|FG000|Overall Study|Withdrawal by Subject|3|||
147505270|NCT01117012|532002763|FG001|Overall Study|Withdrawal by Subject|0|||
147505271|NCT01117012|532002762|FG000|Overall Study|Undefined|4|||
147505272|NCT01117012|532002763|FG001|Overall Study|Undefined|3|||
147505273|NCT05425719|532002769|FG000|Overall Study|Lost to Follow-up|4|||
147505274|NCT05425719|532002770|FG001|Overall Study|Lost to Follow-up|0|||
147505275|NCT05425719|532002769|FG000|Overall Study|Withdrew consent|1|||
147505276|NCT05425719|532002770|FG001|Overall Study|Withdrew consent|1|||
147505277|NCT04682353|532002773|FG000|Overall Study|Lost to Follow-up|0|||
147505278|NCT04682353|532002774|FG001|Overall Study|Lost to Follow-up|1|||
147505279|NCT04682353|532002775|FG002|Overall Study|Lost to Follow-up|0|||
147505280|NCT04682353|532002776|FG003|Overall Study|Lost to Follow-up|1|||
147505281|NCT04682353|532002773|FG000|Overall Study|Personal reasons|0|||
147505282|NCT04682353|532002774|FG001|Overall Study|Personal reasons|1|||
147505283|NCT04682353|532002775|FG002|Overall Study|Personal reasons|0|||
147505284|NCT04682353|532002776|FG003|Overall Study|Personal reasons|0|||
147505285|NCT02849626|532002777|FG000|Core Phase (up to 23 Weeks)|Adverse Event|11|||
147505286|NCT02849626|532002778|FG001|Core Phase (up to 23 Weeks)|Adverse Event|3|||
147505287|NCT02849626|532002779|FG002|Core Phase (up to 23 Weeks)|Adverse Event|0|||
147505288|NCT02849626|532002780|FG003|Core Phase (up to 23 Weeks)|Adverse Event|0|||
147505289|NCT02849626|532002777|FG000|Core Phase (up to 23 Weeks)|Withdrawal by Subject|7|||
147637738|NCT01938430|532491337|FG007|Overall Study|Adverse Event|0|||
147637739|NCT01938430|532491338|FG008|Overall Study|Adverse Event|0|||
147637740|NCT01938430|532491339|FG009|Overall Study|Adverse Event|0|||
147505290|NCT02849626|532002778|FG001|Core Phase (up to 23 Weeks)|Withdrawal by Subject|2|||
147505291|NCT02849626|532002779|FG002|Core Phase (up to 23 Weeks)|Withdrawal by Subject|0|||
147505292|NCT02849626|532002780|FG003|Core Phase (up to 23 Weeks)|Withdrawal by Subject|0|||
147505293|NCT02849626|532002777|FG000|Core Phase (up to 23 Weeks)|Inadequate Therapeutic Effect|6|||
147505294|NCT02849626|532002778|FG001|Core Phase (up to 23 Weeks)|Inadequate Therapeutic Effect|2|||
147505295|NCT02849626|532002779|FG002|Core Phase (up to 23 Weeks)|Inadequate Therapeutic Effect|0|||
147505296|NCT02849626|532002780|FG003|Core Phase (up to 23 Weeks)|Inadequate Therapeutic Effect|0|||
147637741|NCT01938430|532491340|FG010|Overall Study|Adverse Event|0|||
147637742|NCT01938430|532491341|FG011|Overall Study|Adverse Event|0|||
147637743|NCT01938430|532491342|FG012|Overall Study|Adverse Event|0|||
147637744|NCT01938430|532491343|FG013|Overall Study|Adverse Event|0|||
147637745|NCT01938430|532491330|FG000|Overall Study|Death|1|||
147637746|NCT01938430|532491331|FG001|Overall Study|Death|2|||
147637747|NCT01938430|532491332|FG002|Overall Study|Death|2|||
147637748|NCT01938430|532491333|FG003|Overall Study|Death|1|||
147637749|NCT01938430|532491334|FG004|Overall Study|Death|0|||
147637750|NCT01938430|532491335|FG005|Overall Study|Death|0|||
147637751|NCT01938430|532491336|FG006|Overall Study|Death|1|||
147637752|NCT01938430|532491337|FG007|Overall Study|Death|1|||
147637753|NCT01938430|532491338|FG008|Overall Study|Death|2|||
147637754|NCT01938430|532491339|FG009|Overall Study|Death|3|||
147637755|NCT01938430|532491340|FG010|Overall Study|Death|0|||
147637756|NCT01938430|532491341|FG011|Overall Study|Death|0|||
147637757|NCT01938430|532491342|FG012|Overall Study|Death|0|||
147637758|NCT01938430|532491343|FG013|Overall Study|Death|0|||
147637759|NCT01938430|532491330|FG000|Overall Study|Investigator's Discretion|0|||
147637760|NCT01938430|532491331|FG001|Overall Study|Investigator's Discretion|0|||
147637761|NCT01938430|532491332|FG002|Overall Study|Investigator's Discretion|1|||
147637762|NCT01938430|532491333|FG003|Overall Study|Investigator's Discretion|0|||
147637763|NCT01938430|532491334|FG004|Overall Study|Investigator's Discretion|0|||
147637764|NCT01938430|532491335|FG005|Overall Study|Investigator's Discretion|0|||
147637765|NCT01938430|532491336|FG006|Overall Study|Investigator's Discretion|0|||
147637766|NCT01938430|532491337|FG007|Overall Study|Investigator's Discretion|0|||
147637767|NCT01938430|532491338|FG008|Overall Study|Investigator's Discretion|0|||
147637768|NCT01938430|532491339|FG009|Overall Study|Investigator's Discretion|0|||
147637769|NCT01938430|532491340|FG010|Overall Study|Investigator's Discretion|0|||
147637770|NCT01938430|532491341|FG011|Overall Study|Investigator's Discretion|0|||
147637771|NCT01938430|532491342|FG012|Overall Study|Investigator's Discretion|0|||
147637772|NCT01938430|532491343|FG013|Overall Study|Investigator's Discretion|0|||
147637773|NCT01938430|532491330|FG000|Overall Study|Lack of Efficacy|3|||
147637774|NCT01938430|532491331|FG001|Overall Study|Lack of Efficacy|1|||
147637775|NCT01938430|532491332|FG002|Overall Study|Lack of Efficacy|1|||
147637776|NCT01938430|532491333|FG003|Overall Study|Lack of Efficacy|1|||
147637777|NCT01938430|532491334|FG004|Overall Study|Lack of Efficacy|0|||
147637778|NCT01938430|532491335|FG005|Overall Study|Lack of Efficacy|0|||
147668953|NCT02717195|532613435|FG004|Prospective Confirmation (PC) Period|Adverse Event|0|||
147668954|NCT02717195|532613431|FG000|Prospective Confirmation (PC) Period|Lack of Efficacy|2|||
147668955|NCT02717195|532613432|FG001|Prospective Confirmation (PC) Period|Lack of Efficacy|1|||
147668956|NCT02717195|532613433|FG002|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
147668957|NCT02717195|532613434|FG003|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
147668958|NCT02717195|532613435|FG004|Prospective Confirmation (PC) Period|Lack of Efficacy|0|||
147668959|NCT02717195|532613431|FG000|Prospective Confirmation (PC) Period|Non-compliance with IMP|7|||
147637779|NCT01938430|532491336|FG006|Overall Study|Lack of Efficacy|0|||
147637780|NCT01938430|532491337|FG007|Overall Study|Lack of Efficacy|0|||
147637781|NCT01938430|532491338|FG008|Overall Study|Lack of Efficacy|1|||
147637782|NCT01938430|532491339|FG009|Overall Study|Lack of Efficacy|0|||
147637783|NCT01938430|532491340|FG010|Overall Study|Lack of Efficacy|2|||
147637784|NCT01938430|532491341|FG011|Overall Study|Lack of Efficacy|1|||
147637785|NCT01938430|532491342|FG012|Overall Study|Lack of Efficacy|0|||
147637786|NCT01938430|532491343|FG013|Overall Study|Lack of Efficacy|0|||
147637787|NCT01938430|532491330|FG000|Overall Study|Lost to Follow-up|0|||
147668960|NCT02717195|532613432|FG001|Prospective Confirmation (PC) Period|Non-compliance with IMP|1|||
147668961|NCT02717195|532613433|FG002|Prospective Confirmation (PC) Period|Non-compliance with IMP|0|||
147505297|NCT02849626|532002777|FG000|Core Phase (up to 23 Weeks)|Non-specified|3|||
147505298|NCT02849626|532002778|FG001|Core Phase (up to 23 Weeks)|Non-specified|0|||
147505299|NCT02849626|532002779|FG002|Core Phase (up to 23 Weeks)|Non-specified|0|||
147505300|NCT02849626|532002780|FG003|Core Phase (up to 23 Weeks)|Non-specified|0|||
147505301|NCT02849626|532002777|FG000|Extension Phase A (up to 29 Weeks)|Adverse Event|3|||
147637788|NCT01938430|532491331|FG001|Overall Study|Lost to Follow-up|0|||
147637789|NCT01938430|532491332|FG002|Overall Study|Lost to Follow-up|1|||
147637790|NCT01938430|532491333|FG003|Overall Study|Lost to Follow-up|0|||
147637791|NCT01938430|532491334|FG004|Overall Study|Lost to Follow-up|0|||
147637792|NCT01938430|532491335|FG005|Overall Study|Lost to Follow-up|1|||
147637793|NCT01938430|532491336|FG006|Overall Study|Lost to Follow-up|0|||
147637794|NCT01938430|532491337|FG007|Overall Study|Lost to Follow-up|0|||
147637795|NCT01938430|532491338|FG008|Overall Study|Lost to Follow-up|0|||
147637796|NCT01938430|532491339|FG009|Overall Study|Lost to Follow-up|0|||
147637797|NCT01938430|532491340|FG010|Overall Study|Lost to Follow-up|0|||
147637798|NCT01938430|532491341|FG011|Overall Study|Lost to Follow-up|0|||
147637799|NCT01938430|532491342|FG012|Overall Study|Lost to Follow-up|0|||
147637800|NCT01938430|532491343|FG013|Overall Study|Lost to Follow-up|0|||
147637801|NCT01938430|532491330|FG000|Overall Study|Withdrew Consent|0|||
147637802|NCT01938430|532491331|FG001|Overall Study|Withdrew Consent|0|||
147637803|NCT01938430|532491332|FG002|Overall Study|Withdrew Consent|0|||
147637804|NCT01938430|532491333|FG003|Overall Study|Withdrew Consent|0|||
147637805|NCT01938430|532491334|FG004|Overall Study|Withdrew Consent|0|||
147637806|NCT01938430|532491335|FG005|Overall Study|Withdrew Consent|0|||
147637807|NCT01938430|532491336|FG006|Overall Study|Withdrew Consent|0|||
147637808|NCT01938430|532491337|FG007|Overall Study|Withdrew Consent|0|||
147637809|NCT01938430|532491338|FG008|Overall Study|Withdrew Consent|1|||
147637810|NCT01938430|532491339|FG009|Overall Study|Withdrew Consent|0|||
147637811|NCT01938430|532491340|FG010|Overall Study|Withdrew Consent|0|||
147637812|NCT01938430|532491341|FG011|Overall Study|Withdrew Consent|0|||
147637813|NCT01938430|532491342|FG012|Overall Study|Withdrew Consent|0|||
147637814|NCT01938430|532491343|FG013|Overall Study|Withdrew Consent|0|||
147637815|NCT03875482|532491344|FG000|Overall Study|Adverse Event|0|||
147637816|NCT03875482|532491345|FG001|Overall Study|Adverse Event|1|||
147637817|NCT03875482|532491344|FG000|Overall Study|Withdrew consent|5|||
147637818|NCT03875482|532491345|FG001|Overall Study|Withdrew consent|6|||
147637819|NCT03875482|532491344|FG000|Overall Study|Lost to Follow-up|8|||
147637820|NCT03875482|532491345|FG001|Overall Study|Lost to Follow-up|2|||
147637821|NCT03875482|532491344|FG000|Overall Study|Lack of Efficacy|0|||
147637822|NCT03875482|532491345|FG001|Overall Study|Lack of Efficacy|11|||
147637823|NCT02822573|532491348|FG000|Overall Study|Lost to Follow-up|5|||
147637824|NCT02822573|532491349|FG001|Overall Study|Lost to Follow-up|3|||
147637825|NCT02822573|532491348|FG000|Overall Study|Physician Decision|1|||
147637826|NCT02822573|532491349|FG001|Overall Study|Physician Decision|1|||
147637827|NCT02822573|532491348|FG000|Overall Study|Withdrawal by Subject|9|||
147637828|NCT02822573|532491349|FG001|Overall Study|Withdrawal by Subject|5|||
147637829|NCT02822573|532491348|FG000|Overall Study|Protocol Violation|6|||
147637830|NCT02822573|532491349|FG001|Overall Study|Protocol Violation|4|||
147637831|NCT02822573|532491348|FG000|Overall Study|Too sick or ill|2|||
147637832|NCT02822573|532491349|FG001|Overall Study|Too sick or ill|1|||
147637833|NCT02822573|532491348|FG000|Overall Study|Disease Progression|1|||
147637834|NCT02822573|532491349|FG001|Overall Study|Disease Progression|1|||
147637835|NCT02822573|532491348|FG000|Overall Study|No reason given|6|||
147637836|NCT02822573|532491349|FG001|Overall Study|No reason given|4|||
147637837|NCT04143594|532491350|FG000|Overall Study|Withdrew consent|3|||
147637838|NCT04143594|532491351|FG001|Overall Study|Withdrew consent|10|||
147637839|NCT04143594|532491352|FG002|Overall Study|Withdrew consent|3|||
147637840|NCT04143594|532491353|FG003|Overall Study|Withdrew consent|1|||
147637841|NCT04143594|532491350|FG000|Overall Study|Lost to Follow-up|3|||
147637842|NCT04143594|532491351|FG001|Overall Study|Lost to Follow-up|5|||
147637843|NCT04143594|532491352|FG002|Overall Study|Lost to Follow-up|11|||
147637844|NCT04143594|532491353|FG003|Overall Study|Lost to Follow-up|0|||
147637845|NCT04143594|532491350|FG000|Overall Study|Investigator's discretion|2|||
147637846|NCT04143594|532491351|FG001|Overall Study|Investigator's discretion|2|||
147637847|NCT04143594|532491352|FG002|Overall Study|Investigator's discretion|0|||
147637848|NCT04143594|532491353|FG003|Overall Study|Investigator's discretion|0|||
147637849|NCT04143594|532491350|FG000|Overall Study|Randomized but never treated|0|||
147637850|NCT04143594|532491351|FG001|Overall Study|Randomized but never treated|0|||
147637851|NCT04143594|532491352|FG002|Overall Study|Randomized but never treated|0|||
147637852|NCT04143594|532491353|FG003|Overall Study|Randomized but never treated|1|||
147637853|NCT04143594|532491350|FG000|Overall Study|Death|1|||
147637854|NCT04143594|532491351|FG001|Overall Study|Death|0|||
147637855|NCT04143594|532491352|FG002|Overall Study|Death|1|||
147637856|NCT04143594|532491353|FG003|Overall Study|Death|0|||
147637857|NCT04143594|532491350|FG000|Overall Study|Adverse Event|1|||
147637858|NCT04143594|532491351|FG001|Overall Study|Adverse Event|0|||
147637859|NCT04143594|532491352|FG002|Overall Study|Adverse Event|0|||
147637860|NCT04143594|532491353|FG003|Overall Study|Adverse Event|0|||
147637861|NCT04143594|532491350|FG000|Overall Study|Pregnancy|0|||
147637862|NCT04143594|532491351|FG001|Overall Study|Pregnancy|0|||
147637863|NCT04143594|532491352|FG002|Overall Study|Pregnancy|1|||
147637864|NCT04143594|532491353|FG003|Overall Study|Pregnancy|0|||
147637865|NCT04143594|532491350|FG000|Overall Study|Lack of Efficacy|1|||
147637866|NCT04143594|532491351|FG001|Overall Study|Lack of Efficacy|1|||
147637867|NCT04143594|532491352|FG002|Overall Study|Lack of Efficacy|0|||
147668962|NCT02717195|532613434|FG003|Prospective Confirmation (PC) Period|Non-compliance with IMP|0|||
147668963|NCT02717195|532613435|FG004|Prospective Confirmation (PC) Period|Non-compliance with IMP|0|||
147637868|NCT04143594|532491353|FG003|Overall Study|Lack of Efficacy|0|||
147637869|NCT01023256|532491354|FG000|Overall Study|Protocol Violation|2|||
147637870|NCT01023256|532491355|FG001|Overall Study|Protocol Violation|3|||
147637871|NCT01023256|532491356|FG002|Overall Study|Protocol Violation|0|||
147637872|NCT01023256|532491357|FG003|Overall Study|Protocol Violation|0|||
147637873|NCT01023256|532491354|FG000|Overall Study|Randomized but not treated|1|||
147637874|NCT01023256|532491355|FG001|Overall Study|Randomized but not treated|0|||
147637875|NCT01023256|532491356|FG002|Overall Study|Randomized but not treated|1|||
147637876|NCT01023256|532491357|FG003|Overall Study|Randomized but not treated|0|||
147637877|NCT01023256|532491354|FG000|Overall Study|Other|1|||
147637878|NCT01023256|532491355|FG001|Overall Study|Other|0|||
147637879|NCT01023256|532491356|FG002|Overall Study|Other|0|||
147637880|NCT01023256|532491357|FG003|Overall Study|Other|2|||
147637881|NCT01023256|532491354|FG000|Overall Study|Adverse Event|0|||
147637882|NCT01023256|532491355|FG001|Overall Study|Adverse Event|0|||
147637883|NCT01023256|532491356|FG002|Overall Study|Adverse Event|0|||
147637884|NCT01023256|532491357|FG003|Overall Study|Adverse Event|1|||
147637885|NCT01023256|532491354|FG000|Overall Study|Withdrawal by Subject|0|||
147637886|NCT01023256|532491355|FG001|Overall Study|Withdrawal by Subject|0|||
147637887|NCT01023256|532491356|FG002|Overall Study|Withdrawal by Subject|0|||
147637888|NCT01023256|532491357|FG003|Overall Study|Withdrawal by Subject|2|||
147637889|NCT00308087|532491358|FG000|Overall Study|Progressive Disease|19|||
147637890|NCT00308087|532491359|FG001|Overall Study|Progressive Disease|21|||
147637891|NCT00308087|532491358|FG000|Overall Study|Study Closure|11|||
147668964|NCT02717195|532613431|FG000|Prospective Confirmation (PC) Period|Protocol Violation|3|||
147637892|NCT00308087|532491359|FG001|Overall Study|Study Closure|12|||
147637893|NCT00308087|532491358|FG000|Overall Study|Withdrawal by Subject|2|||
147637894|NCT00308087|532491359|FG001|Overall Study|Withdrawal by Subject|1|||
147637895|NCT00308087|532491358|FG000|Overall Study|Other|4|||
147637896|NCT00308087|532491359|FG001|Overall Study|Other|3|||
147637897|NCT01044290|532491360|FG000|Follow-up 1|Death|3|||
147637898|NCT01044290|532491361|FG001|Follow-up 1|Death|3|||
147637899|NCT01044290|532491362|FG002|Follow-up 1|Death|1|||
147637900|NCT01044290|532491360|FG000|Follow-up 1|Withdrawal by Subject|2|||
147637901|NCT01044290|532491361|FG001|Follow-up 1|Withdrawal by Subject|2|||
147637902|NCT01044290|532491362|FG002|Follow-up 1|Withdrawal by Subject|0|||
147637903|NCT01044290|532491360|FG000|Follow-Up 2|Death|0|||
147637904|NCT01044290|532491361|FG001|Follow-Up 2|Death|1|||
147637905|NCT01044290|532491362|FG002|Follow-Up 2|Death|1|||
147637906|NCT01044290|532491360|FG000|Follow-Up 2|Withdrawal by Subject|0|||
147637907|NCT01044290|532491361|FG001|Follow-Up 2|Withdrawal by Subject|1|||
147637908|NCT01044290|532491362|FG002|Follow-Up 2|Withdrawal by Subject|1|||
147637909|NCT04323306|532491363|FG000|Overall Study|Physician Decision|1|||
147637910|NCT04323306|532491364|FG001|Overall Study|Physician Decision|0|||
147637911|NCT04323306|532491365|FG002|Overall Study|Physician Decision|0|||
147637912|NCT04323306|532491366|FG003|Overall Study|Physician Decision|0|||
147637913|NCT04323306|532491367|FG004|Overall Study|Physician Decision|0|||
147637914|NCT04323306|532491368|FG005|Overall Study|Physician Decision|0|||
147637915|NCT04323306|532491369|FG006|Overall Study|Physician Decision|0|||
147637916|NCT04323306|532491370|FG007|Overall Study|Physician Decision|0|||
147637917|NCT04323306|532491371|FG008|Overall Study|Physician Decision|0|||
147637918|NCT04323306|532491363|FG000|Overall Study|Withdrawal by Subject|0|||
147637919|NCT04323306|532491364|FG001|Overall Study|Withdrawal by Subject|0|||
147637920|NCT04323306|532491365|FG002|Overall Study|Withdrawal by Subject|0|||
147637921|NCT04323306|532491366|FG003|Overall Study|Withdrawal by Subject|0|||
147637922|NCT04323306|532491367|FG004|Overall Study|Withdrawal by Subject|0|||
147637923|NCT04323306|532491368|FG005|Overall Study|Withdrawal by Subject|1|||
147637924|NCT04323306|532491369|FG006|Overall Study|Withdrawal by Subject|3|||
147637925|NCT04323306|532491370|FG007|Overall Study|Withdrawal by Subject|0|||
147637926|NCT04323306|532491371|FG008|Overall Study|Withdrawal by Subject|1|||
147637927|NCT01646021|532491374|FG000|Overall Study|Death|77|||
147637928|NCT01646021|532491375|FG001|Overall Study|Death|83|||
147637929|NCT01646021|532491374|FG000|Overall Study|Study Terminated by Sponsor|50|||
147637930|NCT01646021|532491375|FG001|Overall Study|Study Terminated by Sponsor|41|||
147637931|NCT01646021|532491374|FG000|Overall Study|Lost to Follow-up|2|||
147637932|NCT01646021|532491375|FG001|Overall Study|Lost to Follow-up|2|||
147637933|NCT01646021|532491374|FG000|Overall Study|Withdrawal by Subject|10|||
147637934|NCT01646021|532491375|FG001|Overall Study|Withdrawal by Subject|15|||
147637935|NCT01967706|532491380|FG000|First Intervention (Day 1)|Withdrawal by Subject|1|||
147637936|NCT01967706|532491381|FG001|First Intervention (Day 1)|Withdrawal by Subject|0|||
147637937|NCT01967706|532491382|FG002|First Intervention (Day 1)|Withdrawal by Subject|0|||
147637938|NCT01967706|532491383|FG003|First Intervention (Day 1)|Withdrawal by Subject|0|||
147637939|NCT00725608|532491384|FG000|Overall Study|Lost to Follow-up|60|||
147637940|NCT00725608|532491384|FG000|Overall Study|Adverse Event|14|||
147637941|NCT00725608|532491384|FG000|Overall Study|Individual reasons|86|||
147637942|NCT00725608|532491384|FG000|Overall Study|Other|7|||
147637943|NCT00614120|532491388|FG000|Overall Study|Adverse Event|9|||
147637944|NCT00614120|532491389|FG001|Overall Study|Adverse Event|22|||
147637945|NCT00614120|532491390|FG002|Overall Study|Adverse Event|30|||
147637946|NCT00614120|532491391|FG003|Overall Study|Adverse Event|3|||
147668965|NCT02717195|532613432|FG001|Prospective Confirmation (PC) Period|Protocol Violation|1|||
147637947|NCT00614120|532491388|FG000|Overall Study|Lack of Efficacy|3|||
147637948|NCT00614120|532491389|FG001|Overall Study|Lack of Efficacy|3|||
147637949|NCT00614120|532491390|FG002|Overall Study|Lack of Efficacy|2|||
147637950|NCT00614120|532491391|FG003|Overall Study|Lack of Efficacy|2|||
147637951|NCT00614120|532491388|FG000|Overall Study|Protocol Violation|2|||
147637952|NCT00614120|532491389|FG001|Overall Study|Protocol Violation|5|||
147637953|NCT00614120|532491390|FG002|Overall Study|Protocol Violation|3|||
147637954|NCT00614120|532491391|FG003|Overall Study|Protocol Violation|1|||
147637955|NCT00614120|532491388|FG000|Overall Study|Withdrawal criteria|1|||
147637956|NCT00614120|532491389|FG001|Overall Study|Withdrawal criteria|0|||
147637957|NCT00614120|532491390|FG002|Overall Study|Withdrawal criteria|0|||
147637958|NCT00614120|532491391|FG003|Overall Study|Withdrawal criteria|0|||
147637959|NCT00614120|532491388|FG000|Overall Study|Withdrawal by Subject|9|||
147637960|NCT00614120|532491389|FG001|Overall Study|Withdrawal by Subject|10|||
147637961|NCT00614120|532491390|FG002|Overall Study|Withdrawal by Subject|16|||
147637962|NCT00614120|532491391|FG003|Overall Study|Withdrawal by Subject|3|||
147637963|NCT00614120|532491388|FG000|Overall Study|Did not meet trial criteria|0|||
147637964|NCT00614120|532491389|FG001|Overall Study|Did not meet trial criteria|1|||
147637965|NCT00614120|532491390|FG002|Overall Study|Did not meet trial criteria|1|||
147637966|NCT00614120|532491391|FG003|Overall Study|Did not meet trial criteria|1|||
147637967|NCT00614120|532491388|FG000|Overall Study|hCG positive (not pregnant)|0|||
147637968|NCT00614120|532491389|FG001|Overall Study|hCG positive (not pregnant)|0|||
147637969|NCT00614120|532491390|FG002|Overall Study|hCG positive (not pregnant)|1|||
147637970|NCT00614120|532491391|FG003|Overall Study|hCG positive (not pregnant)|0|||
147637971|NCT00614120|532491388|FG000|Overall Study|Hypoglycaemia|0|||
147637972|NCT00614120|532491389|FG001|Overall Study|Hypoglycaemia|0|||
147637973|NCT00614120|532491390|FG002|Overall Study|Hypoglycaemia|0|||
147637974|NCT00614120|532491391|FG003|Overall Study|Hypoglycaemia|1|||
147637975|NCT00614120|532491388|FG000|Overall Study|Lack of trial product|3|||
147637976|NCT00614120|532491389|FG001|Overall Study|Lack of trial product|3|||
147637977|NCT00614120|532491390|FG002|Overall Study|Lack of trial product|2|||
147637978|NCT00614120|532491391|FG003|Overall Study|Lack of trial product|0|||
147637979|NCT00614120|532491388|FG000|Overall Study|Late syphilis, latent|1|||
147637980|NCT00614120|532491389|FG001|Overall Study|Late syphilis, latent|0|||
147637981|NCT00614120|532491390|FG002|Overall Study|Late syphilis, latent|0|||
147637982|NCT00614120|532491391|FG003|Overall Study|Late syphilis, latent|0|||
147637983|NCT00614120|532491388|FG000|Overall Study|Taken inhibition medication eg Prandin|0|||
147637984|NCT00614120|532491389|FG001|Overall Study|Taken inhibition medication eg Prandin|0|||
147637985|NCT00614120|532491390|FG002|Overall Study|Taken inhibition medication eg Prandin|1|||
147637986|NCT00614120|532491391|FG003|Overall Study|Taken inhibition medication eg Prandin|1|||
147637987|NCT00614120|532491388|FG000|Overall Study|Lost to Follow-up|1|||
147637988|NCT00614120|532491389|FG001|Overall Study|Lost to Follow-up|2|||
147637989|NCT00614120|532491390|FG002|Overall Study|Lost to Follow-up|3|||
147637990|NCT00614120|532491391|FG003|Overall Study|Lost to Follow-up|4|||
147637991|NCT03047720|532491392|FG000|First Intervention (6weeks)|Participant data entry insufficient|7|||
147637992|NCT03047720|532491393|FG001|First Intervention (6weeks)|Participant data entry insufficient|0|||
147637993|NCT01154088|532491394|FG000|Overall Study|Lost to Follow-up|4|||
147637994|NCT01154088|532491395|FG001|Overall Study|Lost to Follow-up|6|||
147637995|NCT01154088|532491396|FG002|Overall Study|Lost to Follow-up|7|||
147637996|NCT05129137|532491399|FG000|Second Period|Adverse Event|1|||
147637997|NCT05129137|532491400|FG001|Second Period|Adverse Event|0|||
147637998|NCT05129137|532491401|FG002|Second Period|Adverse Event|0|||
147637999|NCT05129137|532491402|FG003|Second Period|Adverse Event|0|||
147638000|NCT05129137|532491399|FG000|Second Period|Protocol Violation|0|||
147638001|NCT05129137|532491400|FG001|Second Period|Protocol Violation|0|||
147638002|NCT05129137|532491401|FG002|Second Period|Protocol Violation|0|||
147638003|NCT05129137|532491402|FG003|Second Period|Protocol Violation|1|||
147638004|NCT05129137|532491399|FG000|Third Period|Protocol Violation|0|||
147638005|NCT05129137|532491400|FG001|Third Period|Protocol Violation|0|||
147638006|NCT05129137|532491401|FG002|Third Period|Protocol Violation|0|||
147638007|NCT05129137|532491402|FG003|Third Period|Protocol Violation|1|||
147638008|NCT05129137|532491399|FG000|Forth Period|Protocol Violation|0|||
147638009|NCT05129137|532491400|FG001|Forth Period|Protocol Violation|1|||
147638010|NCT05129137|532491401|FG002|Forth Period|Protocol Violation|0|||
147638011|NCT05129137|532491402|FG003|Forth Period|Protocol Violation|0|||
147638012|NCT05129137|532491399|FG000|Forth Period|Withdrawal by Subject|0|||
147638013|NCT05129137|532491400|FG001|Forth Period|Withdrawal by Subject|0|||
147638014|NCT05129137|532491401|FG002|Forth Period|Withdrawal by Subject|1|||
147638015|NCT05129137|532491402|FG003|Forth Period|Withdrawal by Subject|0|||
147638016|NCT01084668|532491403|FG000|Overall Study|Lack of Efficacy|5|||
147638017|NCT01084668|532491403|FG000|Overall Study|Withdrawal by Subject|2|||
147638018|NCT01084668|532491403|FG000|Overall Study|Pregnancy|1|||
147638019|NCT01084668|532491403|FG000|Overall Study|Non-compliance|1|||
147638020|NCT01869699|532491405|FG000|Overall Study|Withdrawal by Subject|1|||
147638021|NCT01869699|532491406|FG001|Overall Study|Withdrawal by Subject|0|||
147638022|NCT01475851|532491409|FG000|Overall Study|Protocol defined stopping criteria|1|||
147638023|NCT01475851|532491410|FG001|Overall Study|Protocol defined stopping criteria|0|||
147638024|NCT02447497|532491413|FG000|Overall Study|Did not meet treatment day baseline.|6|||
147638025|NCT02447497|532491414|FG001|Overall Study|Did not meet treatment day baseline.|5|||
147638026|NCT02447497|532491415|FG002|Overall Study|Did not meet treatment day baseline.|2|||
147638027|NCT02447497|532491416|FG003|Overall Study|Did not meet treatment day baseline.|2|||
147638028|NCT02447497|532491413|FG000|Overall Study|Dressing was compromised|0|||
147638029|NCT02447497|532491414|FG001|Overall Study|Dressing was compromised|1|||
147638030|NCT02447497|532491415|FG002|Overall Study|Dressing was compromised|0|||
147638031|NCT02447497|532491416|FG003|Overall Study|Dressing was compromised|0|||
147638032|NCT01322035|532491417|FG000|Overall Study|Lost to Follow-up|8|||
147638033|NCT01322035|532491418|FG001|Overall Study|Lost to Follow-up|3|||
147638034|NCT00727844|532491419|FG000|Initial Randomization|Physician Decision|2|||
147638035|NCT00727844|532491420|FG001|Initial Randomization|Physician Decision|0|||
147638036|NCT00727844|532491421|FG002|Initial Randomization|Physician Decision|0|||
147638037|NCT00727844|532491422|FG003|Initial Randomization|Physician Decision|0|||
147638038|NCT04569968|532491423|FG000|Overall Study|Lost to Follow-up|2|||
147638039|NCT04569968|532491424|FG001|Overall Study|Lost to Follow-up|5|||
147638040|NCT04569968|532491423|FG000|Overall Study|Story of head and/or neck surgery|2|||
147638041|NCT04569968|532491424|FG001|Overall Study|Story of head and/or neck surgery|2|||
147638042|NCT04569968|532491423|FG000|Overall Study|Time of stroke onset|8|||
147638043|NCT04569968|532491424|FG001|Overall Study|Time of stroke onset|7|||
147638044|NCT04569968|532491423|FG000|Overall Study|Type of strokr|12|||
147638045|NCT04569968|532491424|FG001|Overall Study|Type of strokr|8|||
147638046|NCT04569968|532491423|FG000|Overall Study|Cooperation|8|||
147638047|NCT04569968|532491424|FG001|Overall Study|Cooperation|8|||
147638048|NCT04569968|532491423|FG000|Overall Study|Age interval|17|||
147638049|NCT04569968|532491424|FG001|Overall Study|Age interval|6|||
147638050|NCT04569968|532491423|FG000|Overall Study|Denial of participation to the study|0|||
147638051|NCT04569968|532491424|FG001|Overall Study|Denial of participation to the study|3|||
147638052|NCT04569968|532491423|FG000|Overall Study|Free of temporomandibular joint dysfunction|4|||
147638053|NCT04569968|532491424|FG001|Overall Study|Free of temporomandibular joint dysfunction|2|||
147638054|NCT04569968|532491423|FG000|Overall Study|Lack of incisor and/or canin tooth|5|||
147638055|NCT04569968|532491424|FG001|Overall Study|Lack of incisor and/or canin tooth|3|||
147638056|NCT04569968|532491423|FG000|Overall Study|Quarantine|1|||
147638057|NCT04569968|532491424|FG001|Overall Study|Quarantine|0|||
147638058|NCT04569968|532491423|FG000|Overall Study|Previous recruitment to the expiratory muscle training|2|||
147638059|NCT04569968|532491424|FG001|Overall Study|Previous recruitment to the expiratory muscle training|0|||
147638060|NCT04569968|532491423|FG000|Overall Study|Repetitive stroke|8|||
147638061|NCT04569968|532491424|FG001|Overall Study|Repetitive stroke|0|||
147638062|NCT04569968|532491423|FG000|Overall Study|Insufficient mastication|1|||
147638063|NCT04569968|532491424|FG001|Overall Study|Insufficient mastication|0|||
147638064|NCT04569968|532491423|FG000|Overall Study|Infection|1|||
147638065|NCT04569968|532491424|FG001|Overall Study|Infection|0|||
147638066|NCT00979420|532491429|FG000|Overall Study|Adverse Event|1|||
147638067|NCT00979420|532491430|FG001|Overall Study|Adverse Event|0|||
147638068|NCT00979420|532491431|FG002|Overall Study|Adverse Event|0|||
147638069|NCT00979420|532491432|FG003|Overall Study|Adverse Event|0|||
147638070|NCT00979420|532491429|FG000|Overall Study|Lack of Efficacy|3|||
147638071|NCT00979420|532491430|FG001|Overall Study|Lack of Efficacy|0|||
147638072|NCT00979420|532491431|FG002|Overall Study|Lack of Efficacy|1|||
147638073|NCT00979420|532491432|FG003|Overall Study|Lack of Efficacy|1|||
147638074|NCT00979420|532491429|FG000|Overall Study|Other reasons not related to Viramune|3|||
147638075|NCT00979420|532491430|FG001|Overall Study|Other reasons not related to Viramune|0|||
147638076|NCT00979420|532491431|FG002|Overall Study|Other reasons not related to Viramune|0|||
147638077|NCT00979420|532491432|FG003|Overall Study|Other reasons not related to Viramune|1|||
147638078|NCT01295827|532491442|FG000|Overall Study|Adverse Event|1|||
147638079|NCT01295827|532491443|FG001|Overall Study|Adverse Event|2|||
147638080|NCT01295827|532491444|FG002|Overall Study|Adverse Event|2|||
147638081|NCT01295827|532491445|FG003|Overall Study|Adverse Event|1|||
147638082|NCT01295827|532491446|FG004|Overall Study|Adverse Event|1|||
147638083|NCT01295827|532491447|FG005|Overall Study|Adverse Event|4|||
147638084|NCT01295827|532491448|FG006|Overall Study|Adverse Event|15|||
147638085|NCT01295827|532491449|FG007|Overall Study|Adverse Event|49|||
147638086|NCT01295827|532491450|FG008|Overall Study|Adverse Event|22|||
147638087|NCT01295827|532491451|FG009|Overall Study|Adverse Event|7|||
147638088|NCT01295827|532491452|FG010|Overall Study|Adverse Event|50|||
147638089|NCT01295827|532491453|FG011|Overall Study|Adverse Event|21|||
147638090|NCT01295827|532491454|FG012|Overall Study|Adverse Event|0|||
147638091|NCT01295827|532491455|FG013|Overall Study|Adverse Event|0|||
147638092|NCT01295827|532491456|FG014|Overall Study|Adverse Event|0|||
147638093|NCT01295827|532491442|FG000|Overall Study|Lost to Follow-up|0|||
147638094|NCT01295827|532491443|FG001|Overall Study|Lost to Follow-up|0|||
147638095|NCT01295827|532491444|FG002|Overall Study|Lost to Follow-up|3|||
147638096|NCT01295827|532491445|FG003|Overall Study|Lost to Follow-up|0|||
147638097|NCT01295827|532491446|FG004|Overall Study|Lost to Follow-up|1|||
147638098|NCT01295827|532491447|FG005|Overall Study|Lost to Follow-up|0|||
147638099|NCT01295827|532491448|FG006|Overall Study|Lost to Follow-up|4|||
147638100|NCT01295827|532491449|FG007|Overall Study|Lost to Follow-up|8|||
147638101|NCT01295827|532491450|FG008|Overall Study|Lost to Follow-up|7|||
147638102|NCT01295827|532491451|FG009|Overall Study|Lost to Follow-up|4|||
147638103|NCT01295827|532491452|FG010|Overall Study|Lost to Follow-up|7|||
147638104|NCT01295827|532491453|FG011|Overall Study|Lost to Follow-up|3|||
147638105|NCT01295827|532491454|FG012|Overall Study|Lost to Follow-up|0|||
147638106|NCT01295827|532491455|FG013|Overall Study|Lost to Follow-up|0|||
147638107|NCT01295827|532491456|FG014|Overall Study|Lost to Follow-up|0|||
147638108|NCT01295827|532491442|FG000|Overall Study|Not Reported|0|||
147638109|NCT01295827|532491443|FG001|Overall Study|Not Reported|0|||
147638110|NCT01295827|532491444|FG002|Overall Study|Not Reported|0|||
147638111|NCT01295827|532491445|FG003|Overall Study|Not Reported|1|||
147638112|NCT01295827|532491446|FG004|Overall Study|Not Reported|0|||
147638113|NCT01295827|532491447|FG005|Overall Study|Not Reported|0|||
147638114|NCT01295827|532491448|FG006|Overall Study|Not Reported|24|||
147505302|NCT02849626|532002778|FG001|Extension Phase A (up to 29 Weeks)|Adverse Event|2|||
147505303|NCT02849626|532002779|FG002|Extension Phase A (up to 29 Weeks)|Adverse Event|0|||
147505304|NCT02849626|532002780|FG003|Extension Phase A (up to 29 Weeks)|Adverse Event|0|||
147505305|NCT02849626|532002777|FG000|Extension Phase A (up to 29 Weeks)|Withdrawal by Subject|4|||
147505306|NCT02849626|532002778|FG001|Extension Phase A (up to 29 Weeks)|Withdrawal by Subject|0|||
147505307|NCT02849626|532002779|FG002|Extension Phase A (up to 29 Weeks)|Withdrawal by Subject|0|||
147505308|NCT02849626|532002780|FG003|Extension Phase A (up to 29 Weeks)|Withdrawal by Subject|0|||
147505309|NCT02849626|532002777|FG000|Extension Phase A (up to 29 Weeks)|Inadequate Therapeutic Effect|3|||
147505310|NCT02849626|532002778|FG001|Extension Phase A (up to 29 Weeks)|Inadequate Therapeutic Effect|1|||
147505311|NCT02849626|532002779|FG002|Extension Phase A (up to 29 Weeks)|Inadequate Therapeutic Effect|0|||
147505312|NCT02849626|532002780|FG003|Extension Phase A (up to 29 Weeks)|Inadequate Therapeutic Effect|0|||
147505313|NCT02849626|532002777|FG000|Extension Phase A (up to 29 Weeks)|Non-specified|1|||
147505314|NCT02849626|532002778|FG001|Extension Phase A (up to 29 Weeks)|Non-specified|0|||
147505315|NCT02849626|532002779|FG002|Extension Phase A (up to 29 Weeks)|Non-specified|0|||
147505316|NCT02849626|532002780|FG003|Extension Phase A (up to 29 Weeks)|Non-specified|0|||
147505317|NCT02849626|532002777|FG000|Extension Phase B (up to 89 Weeks)|Inadequate Therapeutic Effect|0|||
147505318|NCT02849626|532002778|FG001|Extension Phase B (up to 89 Weeks)|Inadequate Therapeutic Effect|0|||
147505319|NCT02849626|532002779|FG002|Extension Phase B (up to 89 Weeks)|Inadequate Therapeutic Effect|3|||
147505320|NCT02849626|532002780|FG003|Extension Phase B (up to 89 Weeks)|Inadequate Therapeutic Effect|0|||
147505321|NCT02849626|532002777|FG000|Extension Phase B (up to 89 Weeks)|Participant choice|0|||
147505322|NCT02849626|532002778|FG001|Extension Phase B (up to 89 Weeks)|Participant choice|0|||
147505323|NCT02849626|532002779|FG002|Extension Phase B (up to 89 Weeks)|Participant choice|1|||
147505324|NCT02849626|532002780|FG003|Extension Phase B (up to 89 Weeks)|Participant choice|0|||
147505325|NCT02849626|532002777|FG000|Extension Phase B (up to 89 Weeks)|Other|0|||
147505326|NCT02849626|532002778|FG001|Extension Phase B (up to 89 Weeks)|Other|0|||
147505327|NCT02849626|532002779|FG002|Extension Phase B (up to 89 Weeks)|Other|1|||
147505328|NCT02849626|532002780|FG003|Extension Phase B (up to 89 Weeks)|Other|0|||
147505329|NCT01185704|532002781|FG000|Overall Study|Randomized but not treated|3|||
147505330|NCT01185704|532002782|FG001|Overall Study|Randomized but not treated|3|||
147505331|NCT01185704|532002781|FG000|Overall Study|Lack of ovarian response|5|||
147505332|NCT01185704|532002782|FG001|Overall Study|Lack of ovarian response|1|||
147505333|NCT01185704|532002781|FG000|Overall Study|Ovarian hyperstimulation syndrome risk|5|||
147505334|NCT01185704|532002782|FG001|Overall Study|Ovarian hyperstimulation syndrome risk|3|||
147505335|NCT01185704|532002781|FG000|Overall Study|Ectopic pregnancy|0|||
147505336|NCT01185704|532002782|FG001|Overall Study|Ectopic pregnancy|1|||
147505337|NCT01313208|532002783|FG000|Double-blind Phase (Weeks 1 - 12)|Withdrawal by Subject|3|||
147505338|NCT01313208|532002784|FG001|Double-blind Phase (Weeks 1 - 12)|Withdrawal by Subject|2|||
147505339|NCT01313208|532002783|FG000|Double-blind Phase (Weeks 1 - 12)|Adverse Event|1|||
147505340|NCT01313208|532002784|FG001|Double-blind Phase (Weeks 1 - 12)|Adverse Event|2|||
147505341|NCT01313208|532002783|FG000|Double-blind Phase (Weeks 1 - 12)|Ineligibility determined|0|||
147505342|NCT01313208|532002784|FG001|Double-blind Phase (Weeks 1 - 12)|Ineligibility determined|1|||
147505343|NCT01313208|532002783|FG000|Double-blind Phase (Weeks 1 - 12)|Lost to Follow-up|1|||
147505344|NCT01313208|532002784|FG001|Double-blind Phase (Weeks 1 - 12)|Lost to Follow-up|0|||
147505345|NCT01313208|532002783|FG000|Double-blind Phase (Weeks 1 - 12)|Noncompliance|1|||
147505346|NCT01313208|532002784|FG001|Double-blind Phase (Weeks 1 - 12)|Noncompliance|0|||
147505347|NCT01313208|532002783|FG000|Open-label Phase (Weeks 13 - 24)|Withdrawal by Subject|3|||
147505348|NCT01313208|532002784|FG001|Open-label Phase (Weeks 13 - 24)|Withdrawal by Subject|1|||
147505349|NCT01313208|532002783|FG000|Open-label Phase (Weeks 13 - 24)|Noncompliance|0|||
147505350|NCT01313208|532002784|FG001|Open-label Phase (Weeks 13 - 24)|Noncompliance|2|||
147505351|NCT01313208|532002783|FG000|Open-label Phase (Weeks 13 - 24)|Adverse Event|1|||
147505352|NCT01313208|532002784|FG001|Open-label Phase (Weeks 13 - 24)|Adverse Event|0|||
147505353|NCT01313208|532002783|FG000|Open-label Phase (Weeks 13 - 24)|Other|2|||
147505354|NCT01313208|532002784|FG001|Open-label Phase (Weeks 13 - 24)|Other|0|||
147505355|NCT01957787|532002785|FG000|Overall Study|Death|18|||
147505356|NCT01957787|532002785|FG000|Overall Study|Lost to Follow-up|3|||
147505357|NCT01957787|532002785|FG000|Overall Study|Withdrawal by Subject|3|||
147505358|NCT01957787|532002785|FG000|Overall Study|Entered Hospice or Similar Program|2|||
147505359|NCT01957787|532002785|FG000|Overall Study|Index Tumor(s) Resected|2|||
147505360|NCT01957787|532002785|FG000|Overall Study|Index Tumor was Primary Lung Cancer|2|||
147505361|NCT01957787|532002785|FG000|Overall Study|Local therapy, not cryoablation|6|||
147505362|NCT00187889|532002788|FG000|Overall Study|Withdrawal by Subject|6|||
147505363|NCT00187889|532002789|FG001|Overall Study|Withdrawal by Subject|4|||
147505364|NCT03505749|532002790|FG000|Overall Study|Lost to Follow-up|7|||
147505365|NCT03505749|532002791|FG001|Overall Study|Lost to Follow-up|11|||
147505366|NCT03505749|532002790|FG000|Overall Study|Withdrawal by Subject|6|||
147505367|NCT03505749|532002791|FG001|Overall Study|Withdrawal by Subject|0|||
147505368|NCT03505749|532002790|FG000|Overall Study|Discharged from treatment|3|||
147505369|NCT03505749|532002791|FG001|Overall Study|Discharged from treatment|6|||
147505370|NCT01151540|532002792|FG000|Overall Study|Other|2|||
147505371|NCT01151540|532002792|FG000|Overall Study|Adverse event, non-fatal|4|||
147638115|NCT01295827|532491449|FG007|Overall Study|Not Reported|58|||
147638116|NCT01295827|532491450|FG008|Overall Study|Not Reported|41|||
147638117|NCT01295827|532491451|FG009|Overall Study|Not Reported|2|||
147638118|NCT01295827|532491452|FG010|Overall Study|Not Reported|23|||
147638119|NCT01295827|532491453|FG011|Overall Study|Not Reported|13|||
147638120|NCT01295827|532491454|FG012|Overall Study|Not Reported|0|||
147638121|NCT01295827|532491455|FG013|Overall Study|Not Reported|0|||
147638122|NCT01295827|532491456|FG014|Overall Study|Not Reported|0|||
147638123|NCT01295827|532491442|FG000|Overall Study|Progressive Disease|2|||
147638124|NCT01295827|532491443|FG001|Overall Study|Progressive Disease|1|||
147638125|NCT01295827|532491444|FG002|Overall Study|Progressive Disease|5|||
147638126|NCT01295827|532491445|FG003|Overall Study|Progressive Disease|2|||
147638127|NCT01295827|532491446|FG004|Overall Study|Progressive Disease|0|||
147638128|NCT01295827|532491447|FG005|Overall Study|Progressive Disease|1|||
147638129|NCT01295827|532491448|FG006|Overall Study|Progressive Disease|87|||
147638130|NCT01295827|532491449|FG007|Overall Study|Progressive Disease|144|||
147638131|NCT01295827|532491450|FG008|Overall Study|Progressive Disease|85|||
147638132|NCT01295827|532491451|FG009|Overall Study|Progressive Disease|40|||
147638133|NCT01295827|532491452|FG010|Overall Study|Progressive Disease|175|||
147638134|NCT01295827|532491453|FG011|Overall Study|Progressive Disease|136|||
147638135|NCT01295827|532491454|FG012|Overall Study|Progressive Disease|0|||
147638136|NCT01295827|532491455|FG013|Overall Study|Progressive Disease|0|||
147638137|NCT01295827|532491456|FG014|Overall Study|Progressive Disease|0|||
147638138|NCT01295827|532491442|FG000|Overall Study|Screen Failure|0|||
147638139|NCT01295827|532491443|FG001|Overall Study|Screen Failure|0|||
147638140|NCT01295827|532491444|FG002|Overall Study|Screen Failure|0|||
147638141|NCT01295827|532491445|FG003|Overall Study|Screen Failure|0|||
147638142|NCT01295827|532491446|FG004|Overall Study|Screen Failure|0|||
147638143|NCT01295827|532491447|FG005|Overall Study|Screen Failure|0|||
147638144|NCT01295827|532491448|FG006|Overall Study|Screen Failure|2|||
147638145|NCT01295827|532491449|FG007|Overall Study|Screen Failure|2|||
147638146|NCT01295827|532491450|FG008|Overall Study|Screen Failure|2|||
147638147|NCT01295827|532491451|FG009|Overall Study|Screen Failure|0|||
147638148|NCT01295827|532491452|FG010|Overall Study|Screen Failure|1|||
147638149|NCT01295827|532491453|FG011|Overall Study|Screen Failure|0|||
147638150|NCT01295827|532491454|FG012|Overall Study|Screen Failure|0|||
147638151|NCT01295827|532491455|FG013|Overall Study|Screen Failure|0|||
147638152|NCT01295827|532491456|FG014|Overall Study|Screen Failure|0|||
147638153|NCT01295827|532491442|FG000|Overall Study|Withdrawal by Subject|1|||
147638154|NCT01295827|532491443|FG001|Overall Study|Withdrawal by Subject|0|||
147638155|NCT01295827|532491444|FG002|Overall Study|Withdrawal by Subject|2|||
147638156|NCT01295827|532491445|FG003|Overall Study|Withdrawal by Subject|0|||
147638157|NCT01295827|532491446|FG004|Overall Study|Withdrawal by Subject|0|||
147638158|NCT01295827|532491447|FG005|Overall Study|Withdrawal by Subject|1|||
147638159|NCT01295827|532491448|FG006|Overall Study|Withdrawal by Subject|13|||
147638160|NCT01295827|532491449|FG007|Overall Study|Withdrawal by Subject|35|||
147638161|NCT01295827|532491450|FG008|Overall Study|Withdrawal by Subject|11|||
147638162|NCT01295827|532491451|FG009|Overall Study|Withdrawal by Subject|2|||
147638163|NCT01295827|532491452|FG010|Overall Study|Withdrawal by Subject|18|||
147638164|NCT01295827|532491453|FG011|Overall Study|Withdrawal by Subject|13|||
147638165|NCT01295827|532491454|FG012|Overall Study|Withdrawal by Subject|0|||
147638166|NCT01295827|532491455|FG013|Overall Study|Withdrawal by Subject|0|||
147638167|NCT01295827|532491456|FG014|Overall Study|Withdrawal by Subject|0|||
147638168|NCT01295827|532491442|FG000|Overall Study|Other|0|||
147638169|NCT01295827|532491443|FG001|Overall Study|Other|0|||
147638170|NCT01295827|532491444|FG002|Overall Study|Other|0|||
147638171|NCT01295827|532491445|FG003|Overall Study|Other|0|||
147638172|NCT01295827|532491446|FG004|Overall Study|Other|0|||
147638173|NCT01295827|532491447|FG005|Overall Study|Other|0|||
147638174|NCT01295827|532491448|FG006|Overall Study|Other|1|||
147638175|NCT01295827|532491449|FG007|Overall Study|Other|1|||
147638176|NCT01295827|532491450|FG008|Overall Study|Other|1|||
147638177|NCT01295827|532491451|FG009|Overall Study|Other|0|||
147638178|NCT01295827|532491452|FG010|Overall Study|Other|2|||
147638179|NCT01295827|532491453|FG011|Overall Study|Other|0|||
147638180|NCT01295827|532491454|FG012|Overall Study|Other|0|||
147638181|NCT01295827|532491455|FG013|Overall Study|Other|0|||
147638182|NCT01295827|532491456|FG014|Overall Study|Other|0|||
147638183|NCT01668173|532491457|FG000|Overall Study|Adverse Event|3|||
147638184|NCT01668173|532491457|FG000|Overall Study|Trial suspension|4|||
147638185|NCT00072280|532491460|FG000|Treatment|Found ineligible|1|||
147638186|NCT00072280|532491461|FG001|Treatment|Found ineligible|2|||
147638187|NCT00072280|532491460|FG000|Follow-up|Early termination of study|2|||
147638188|NCT00072280|532491461|FG001|Follow-up|Early termination of study|2|||
147638189|NCT00746564|532491462|FG000|Overall Study|Required Pacemaker/ICD Implant|2|||
147638190|NCT03226769|532491465|FG000|Overall Study|Withdrawal by Subject|0|||
147638191|NCT03226769|532491466|FG001|Overall Study|Withdrawal by Subject|1|||
147638192|NCT02640677|532491469|FG000|Overall Study|Lost to Follow-up|1|||
147638193|NCT02640677|532491469|FG000|Overall Study|Withdrawal by Subject|1|||
147638194|NCT02706886|532493598|FG000|Part A: SAD Period|Withdrawal by Subject|0|||
147668966|NCT02717195|532613433|FG002|Prospective Confirmation (PC) Period|Protocol Violation|0|||
147668967|NCT02717195|532613434|FG003|Prospective Confirmation (PC) Period|Protocol Violation|0|||
147668968|NCT02717195|532613435|FG004|Prospective Confirmation (PC) Period|Protocol Violation|0|||
147668969|NCT02717195|532613431|FG000|Prospective Confirmation (PC) Period|Withdrawal by Subject|43|||
147668970|NCT02717195|532613432|FG001|Prospective Confirmation (PC) Period|Withdrawal by Subject|12|||
147668971|NCT02717195|532613433|FG002|Prospective Confirmation (PC) Period|Withdrawal by Subject|0|||
147668972|NCT02717195|532613434|FG003|Prospective Confirmation (PC) Period|Withdrawal by Subject|0|||
147668973|NCT02717195|532613435|FG004|Prospective Confirmation (PC) Period|Withdrawal by Subject|0|||
147668974|NCT02717195|532613431|FG000|Prospective Confirmation (PC) Period|Lost to Follow-up|9|||
147668975|NCT02717195|532613432|FG001|Prospective Confirmation (PC) Period|Lost to Follow-up|4|||
147668976|NCT02717195|532613433|FG002|Prospective Confirmation (PC) Period|Lost to Follow-up|0|||
147668977|NCT02717195|532613434|FG003|Prospective Confirmation (PC) Period|Lost to Follow-up|0|||
147668978|NCT02717195|532613435|FG004|Prospective Confirmation (PC) Period|Lost to Follow-up|0|||
147668979|NCT02717195|532613431|FG000|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|189|||
147668980|NCT02717195|532613432|FG001|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|75|||
147668981|NCT02717195|532613433|FG002|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|0|||
147668982|NCT02717195|532613434|FG003|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|0|||
147668983|NCT02717195|532613435|FG004|Prospective Confirmation (PC) Period|Did not fulfill rand criteria for DBT|0|||
147668984|NCT02717195|532613431|FG000|Prospective Confirmation (PC) Period|Enrolled but not treated|3|||
147668985|NCT02717195|532613432|FG001|Prospective Confirmation (PC) Period|Enrolled but not treated|3|||
147668986|NCT02717195|532613433|FG002|Prospective Confirmation (PC) Period|Enrolled but not treated|0|||
147668987|NCT02717195|532613434|FG003|Prospective Confirmation (PC) Period|Enrolled but not treated|0|||
147668988|NCT02717195|532613435|FG004|Prospective Confirmation (PC) Period|Enrolled but not treated|0|||
147668989|NCT02717195|532613431|FG000|Prospective Confirmation (PC) Period|Lack of results for blood levels|1|||
147668990|NCT02717195|532613432|FG001|Prospective Confirmation (PC) Period|Lack of results for blood levels|0|||
147668991|NCT02717195|532613433|FG002|Prospective Confirmation (PC) Period|Lack of results for blood levels|0|||
147668992|NCT02717195|532613434|FG003|Prospective Confirmation (PC) Period|Lack of results for blood levels|0|||
147668993|NCT02717195|532613435|FG004|Prospective Confirmation (PC) Period|Lack of results for blood levels|0|||
147668994|NCT02717195|532613431|FG000|Prospective Confirmation (PC) Period|Technical error|1|||
147668995|NCT02717195|532613432|FG001|Prospective Confirmation (PC) Period|Technical error|0|||
147668996|NCT02717195|532613433|FG002|Prospective Confirmation (PC) Period|Technical error|0|||
147668997|NCT02717195|532613434|FG003|Prospective Confirmation (PC) Period|Technical error|0|||
147668998|NCT02717195|532613435|FG004|Prospective Confirmation (PC) Period|Technical error|0|||
147668999|NCT02717195|532613431|FG000|Prospective Confirmation (PC) Period|Patient decision|5|||
147669000|NCT02717195|532613432|FG001|Prospective Confirmation (PC) Period|Patient decision|2|||
147669001|NCT02717195|532613433|FG002|Prospective Confirmation (PC) Period|Patient decision|0|||
147669002|NCT02717195|532613434|FG003|Prospective Confirmation (PC) Period|Patient decision|0|||
147669003|NCT02717195|532613435|FG004|Prospective Confirmation (PC) Period|Patient decision|0|||
147669004|NCT02717195|532613431|FG000|Prospective Confirmation (PC) Period|Low level of drug in the blood|1|||
147669005|NCT02717195|532613432|FG001|Prospective Confirmation (PC) Period|Low level of drug in the blood|0|||
147669006|NCT02717195|532613433|FG002|Prospective Confirmation (PC) Period|Low level of drug in the blood|0|||
147669007|NCT02717195|532613434|FG003|Prospective Confirmation (PC) Period|Low level of drug in the blood|0|||
147669008|NCT02717195|532613435|FG004|Prospective Confirmation (PC) Period|Low level of drug in the blood|0|||
147669009|NCT02717195|532613431|FG000|Prospective Confirmation (PC) Period|Change of place of residence|1|||
147669010|NCT02717195|532613432|FG001|Prospective Confirmation (PC) Period|Change of place of residence|0|||
147669011|NCT02717195|532613433|FG002|Prospective Confirmation (PC) Period|Change of place of residence|0|||
147669012|NCT02717195|532613434|FG003|Prospective Confirmation (PC) Period|Change of place of residence|0|||
147669013|NCT02717195|532613435|FG004|Prospective Confirmation (PC) Period|Change of place of residence|0|||
147669014|NCT02717195|532613431|FG000|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|0|||
147669015|NCT02717195|532613432|FG001|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|1|||
147669016|NCT02717195|532613433|FG002|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|0|||
147669017|NCT02717195|532613434|FG003|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|0|||
147669018|NCT02717195|532613435|FG004|Prospective Confirmation (PC) Period|Apato Abulcasis Syndrome|0|||
147669019|NCT02717195|532613431|FG000|Prospective Confirmation (PC) Period|Investigator decision|2|||
147505372|NCT01151540|532002792|FG000|Overall Study|Withdrawal by Subject|7|||
147669020|NCT02717195|532613432|FG001|Prospective Confirmation (PC) Period|Investigator decision|1|||
147669021|NCT02717195|532613433|FG002|Prospective Confirmation (PC) Period|Investigator decision|0|||
147505373|NCT03846219|532002793|FG000|Overall Study|Withdrawal by Subject|3|||
147505374|NCT03846219|532002794|FG001|Overall Study|Withdrawal by Subject|2|||
147505375|NCT03846219|532002795|FG002|Overall Study|Withdrawal by Subject|2|||
147505376|NCT03846219|532002793|FG000|Overall Study|Fulfilled hepatoxicity-related stopping rules|0|||
147505377|NCT03846219|532002794|FG001|Overall Study|Fulfilled hepatoxicity-related stopping rules|2|||
147505378|NCT03846219|532002795|FG002|Overall Study|Fulfilled hepatoxicity-related stopping rules|1|||
147505379|NCT03846219|532002793|FG000|Overall Study|Physician Decision|0|||
147505380|NCT03846219|532002794|FG001|Overall Study|Physician Decision|0|||
147505381|NCT03846219|532002795|FG002|Overall Study|Physician Decision|2|||
147505382|NCT01392378|532002798|FG000|Infant Series|Adverse Event|0|||
147505383|NCT01392378|532002799|FG001|Infant Series|Adverse Event|0|||
147505384|NCT01392378|532002800|FG002|Infant Series|Adverse Event|0|||
147505385|NCT01392378|532002801|FG003|Infant Series|Adverse Event|1|||
147505386|NCT01392378|532002802|FG004|Infant Series|Adverse Event|0|||
147505387|NCT01392378|532002798|FG000|Infant Series|Lost to Follow-up|0|||
147505388|NCT01392378|532002799|FG001|Infant Series|Lost to Follow-up|0|||
147505389|NCT01392378|532002800|FG002|Infant Series|Lost to Follow-up|0|||
147505390|NCT01392378|532002801|FG003|Infant Series|Lost to Follow-up|1|||
147505391|NCT01392378|532002802|FG004|Infant Series|Lost to Follow-up|0|||
147505392|NCT01392378|532002798|FG000|Infant Series|Protocol Violation|0|||
147505393|NCT01392378|532002799|FG001|Infant Series|Protocol Violation|1|||
147505394|NCT01392378|532002800|FG002|Infant Series|Protocol Violation|0|||
147505395|NCT01392378|532002801|FG003|Infant Series|Protocol Violation|0|||
147505396|NCT01392378|532002802|FG004|Infant Series|Protocol Violation|0|||
147505397|NCT01392378|532002798|FG000|Infant Series|Withdrawal by Parent|4|||
147505398|NCT01392378|532002799|FG001|Infant Series|Withdrawal by Parent|1|||
147505399|NCT01392378|532002800|FG002|Infant Series|Withdrawal by Parent|0|||
147505400|NCT01392378|532002801|FG003|Infant Series|Withdrawal by Parent|0|||
147505401|NCT01392378|532002802|FG004|Infant Series|Withdrawal by Parent|0|||
147505402|NCT01392378|532002798|FG000|After Infant Series|Lost to Follow-up|0|||
147505403|NCT01392378|532002799|FG001|After Infant Series|Lost to Follow-up|0|||
147505404|NCT01392378|532002800|FG002|After Infant Series|Lost to Follow-up|1|||
147505405|NCT01392378|532002801|FG003|After Infant Series|Lost to Follow-up|0|||
147505406|NCT01392378|532002802|FG004|After Infant Series|Lost to Follow-up|0|||
147505407|NCT01392378|532002798|FG000|After Infant Series|Withdrawal by Parent|0|||
147505408|NCT01392378|532002799|FG001|After Infant Series|Withdrawal by Parent|1|||
147505409|NCT01392378|532002800|FG002|After Infant Series|Withdrawal by Parent|1|||
147505410|NCT01392378|532002801|FG003|After Infant Series|Withdrawal by Parent|0|||
147505411|NCT01392378|532002802|FG004|After Infant Series|Withdrawal by Parent|1|||
147505412|NCT01392378|532002798|FG000|Toddler Dose|Lost to Follow-up|0|||
147505413|NCT01392378|532002799|FG001|Toddler Dose|Lost to Follow-up|0|||
147505414|NCT01392378|532002800|FG002|Toddler Dose|Lost to Follow-up|0|||
147505415|NCT01392378|532002801|FG003|Toddler Dose|Lost to Follow-up|1|||
147505416|NCT01392378|532002802|FG004|Toddler Dose|Lost to Follow-up|0|||
147505417|NCT01392378|532002798|FG000|Toddler Dose|Withdrawal by Parent|0|||
147505418|NCT01392378|532002799|FG001|Toddler Dose|Withdrawal by Parent|1|||
147505419|NCT01392378|532002800|FG002|Toddler Dose|Withdrawal by Parent|0|||
147505420|NCT01392378|532002801|FG003|Toddler Dose|Withdrawal by Parent|1|||
147505421|NCT01392378|532002802|FG004|Toddler Dose|Withdrawal by Parent|1|||
147505422|NCT02322411|532002805|FG000|Overall Study|Lost to Follow-up|4|||
147505423|NCT02322411|532002806|FG001|Overall Study|Lost to Follow-up|7|||
147505424|NCT02322411|532002805|FG000|Overall Study|Withdrawal by Subject|1|||
147505425|NCT02322411|532002806|FG001|Overall Study|Withdrawal by Subject|0|||
147505426|NCT02671461|532002811|FG000|Treatment|Adverse Event|0|||
147505427|NCT02671461|532002812|FG001|Treatment|Adverse Event|0|||
147505428|NCT02671461|532002813|FG002|Treatment|Adverse Event|1|||
147505429|NCT02671461|532002811|FG000|Treatment|Administrative Reason by Sponsor|1|||
147505430|NCT02671461|532002812|FG001|Treatment|Administrative Reason by Sponsor|3|||
147638195|NCT02706886|532493599|FG001|Part A: SAD Period|Withdrawal by Subject|0|||
147638196|NCT02706886|532493600|FG002|Part A: SAD Period|Withdrawal by Subject|0|||
147638197|NCT02706886|532493601|FG003|Part A: SAD Period|Withdrawal by Subject|2|||
147638198|NCT02706886|532493602|FG004|Part A: SAD Period|Withdrawal by Subject|0|||
147638199|NCT02706886|532493603|FG005|Part A: SAD Period|Withdrawal by Subject|0|||
147638200|NCT02706886|532493604|FG006|Part A: SAD Period|Withdrawal by Subject|0|||
147638201|NCT02706886|532493605|FG007|Part A: SAD Period|Withdrawal by Subject|0|||
147638202|NCT02706886|532493606|FG008|Part A: SAD Period|Withdrawal by Subject|0|||
147638203|NCT04934189|532493607|FG000|Overall Study|Lost to Follow-up|4|||
147638204|NCT04934189|532493607|FG000|Overall Study|Withdrawal by Subject|17|||
147638205|NCT03320850|532493609|FG000|Overall Study|Lost to Follow-up|0|||
147638206|NCT03320850|532493610|FG001|Overall Study|Lost to Follow-up|0|||
147638207|NCT03320850|532493611|FG002|Overall Study|Lost to Follow-up|0|||
147638208|NCT03320850|532493612|FG003|Overall Study|Lost to Follow-up|0|||
147638209|NCT03320850|532493613|FG004|Overall Study|Lost to Follow-up|1|||
147638210|NCT03320850|532493614|FG005|Overall Study|Lost to Follow-up|2|||
147669022|NCT02717195|532613434|FG003|Prospective Confirmation (PC) Period|Investigator decision|0|||
147505431|NCT02671461|532002813|FG002|Treatment|Administrative Reason by Sponsor|4|||
147505432|NCT02671461|532002811|FG000|Treatment|Randomized, not treated|1|||
147505433|NCT02671461|532002812|FG001|Treatment|Randomized, not treated|0|||
147505434|NCT02671461|532002813|FG002|Treatment|Randomized, not treated|0|||
147505435|NCT02671461|532002811|FG000|Follow-up|Withdrawal by Subject|1|||
147505436|NCT02671461|532002812|FG001|Follow-up|Withdrawal by Subject|0|||
147505437|NCT02671461|532002813|FG002|Follow-up|Withdrawal by Subject|0|||
147505438|NCT02671461|532002811|FG000|Follow-up|Lost to Follow-up|0|||
147669023|NCT02717195|532613435|FG004|Prospective Confirmation (PC) Period|Investigator decision|0|||
147669024|NCT02717195|532613431|FG000|Prospective Confirmation (PC) Period|Subject took exclusionary medication|0|||
147669025|NCT02717195|532613432|FG001|Prospective Confirmation (PC) Period|Subject took exclusionary medication|1|||
147669026|NCT02717195|532613433|FG002|Prospective Confirmation (PC) Period|Subject took exclusionary medication|0|||
147669027|NCT02717195|532613434|FG003|Prospective Confirmation (PC) Period|Subject took exclusionary medication|0|||
147669028|NCT02717195|532613435|FG004|Prospective Confirmation (PC) Period|Subject took exclusionary medication|0|||
147669029|NCT02717195|532613431|FG000|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|1|||
147669030|NCT02717195|532613432|FG001|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|0|||
147669031|NCT02717195|532613433|FG002|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|0|||
147669032|NCT02717195|532613434|FG003|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|0|||
147669033|NCT02717195|532613435|FG004|Prospective Confirmation (PC) Period|Sub therapeutic blood levels Olanzapine|0|||
147669034|NCT02717195|532613431|FG000|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|0|||
147669035|NCT02717195|532613432|FG001|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|1|||
147669036|NCT02717195|532613433|FG002|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|0|||
147669037|NCT02717195|532613434|FG003|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|0|||
147669038|NCT02717195|532613435|FG004|Prospective Confirmation (PC) Period|Positive Urine Drug Screen|0|||
147669039|NCT02717195|532613431|FG000|Prospective Confirmation (PC) Period|Duplicate subject|1|||
147669040|NCT02717195|532613432|FG001|Prospective Confirmation (PC) Period|Duplicate subject|0|||
147669041|NCT02717195|532613433|FG002|Prospective Confirmation (PC) Period|Duplicate subject|0|||
147669042|NCT02717195|532613434|FG003|Prospective Confirmation (PC) Period|Duplicate subject|0|||
147669043|NCT02717195|532613435|FG004|Prospective Confirmation (PC) Period|Duplicate subject|0|||
147669044|NCT02717195|532613431|FG000|Prospective Confirmation (PC) Period|Sponsor requested|0|||
147669045|NCT02717195|532613432|FG001|Prospective Confirmation (PC) Period|Sponsor requested|1|||
147669046|NCT02717195|532613433|FG002|Prospective Confirmation (PC) Period|Sponsor requested|0|||
147669047|NCT02717195|532613434|FG003|Prospective Confirmation (PC) Period|Sponsor requested|0|||
147669048|NCT02717195|532613435|FG004|Prospective Confirmation (PC) Period|Sponsor requested|0|||
147669049|NCT02717195|532613431|FG000|Prospective Confirmation (PC) Period|Patient fraud with payment|1|||
147669050|NCT02717195|532613432|FG001|Prospective Confirmation (PC) Period|Patient fraud with payment|0|||
147669051|NCT02717195|532613433|FG002|Prospective Confirmation (PC) Period|Patient fraud with payment|0|||
147669052|NCT02717195|532613434|FG003|Prospective Confirmation (PC) Period|Patient fraud with payment|0|||
147669053|NCT02717195|532613435|FG004|Prospective Confirmation (PC) Period|Patient fraud with payment|0|||
147669054|NCT02717195|532613431|FG000|Prospective Confirmation (PC) Period|Noncompliance with protocol|1|||
147669055|NCT02717195|532613432|FG001|Prospective Confirmation (PC) Period|Noncompliance with protocol|0|||
147669056|NCT02717195|532613433|FG002|Prospective Confirmation (PC) Period|Noncompliance with protocol|0|||
147669057|NCT02717195|532613434|FG003|Prospective Confirmation (PC) Period|Noncompliance with protocol|0|||
147669058|NCT02717195|532613435|FG004|Prospective Confirmation (PC) Period|Noncompliance with protocol|0|||
147669059|NCT02717195|532613431|FG000|Double-blind Treatment (DBT) Period|Adverse Event|0|||
147669060|NCT02717195|532613432|FG001|Double-blind Treatment (DBT) Period|Adverse Event|0|||
147669061|NCT02717195|532613433|FG002|Double-blind Treatment (DBT) Period|Adverse Event|10|||
147669062|NCT02717195|532613434|FG003|Double-blind Treatment (DBT) Period|Adverse Event|11|||
147669063|NCT02717195|532613435|FG004|Double-blind Treatment (DBT) Period|Adverse Event|8|||
147669064|NCT02717195|532613431|FG000|Double-blind Treatment (DBT) Period|Lack of Efficacy|0|||
147669065|NCT02717195|532613432|FG001|Double-blind Treatment (DBT) Period|Lack of Efficacy|0|||
147669066|NCT02717195|532613433|FG002|Double-blind Treatment (DBT) Period|Lack of Efficacy|6|||
147669067|NCT02717195|532613434|FG003|Double-blind Treatment (DBT) Period|Lack of Efficacy|9|||
147669068|NCT02717195|532613435|FG004|Double-blind Treatment (DBT) Period|Lack of Efficacy|2|||
147669069|NCT02717195|532613431|FG000|Double-blind Treatment (DBT) Period|Non-compliance with IMP|0|||
147669070|NCT02717195|532613432|FG001|Double-blind Treatment (DBT) Period|Non-compliance with IMP|0|||
147669071|NCT02717195|532613433|FG002|Double-blind Treatment (DBT) Period|Non-compliance with IMP|4|||
147669072|NCT02717195|532613434|FG003|Double-blind Treatment (DBT) Period|Non-compliance with IMP|3|||
147669073|NCT02717195|532613435|FG004|Double-blind Treatment (DBT) Period|Non-compliance with IMP|2|||
147669074|NCT02717195|532613431|FG000|Double-blind Treatment (DBT) Period|Protocol Violation|0|||
147669075|NCT02717195|532613432|FG001|Double-blind Treatment (DBT) Period|Protocol Violation|0|||
147669076|NCT02717195|532613433|FG002|Double-blind Treatment (DBT) Period|Protocol Violation|1|||
147669077|NCT02717195|532613434|FG003|Double-blind Treatment (DBT) Period|Protocol Violation|0|||
147669078|NCT02717195|532613435|FG004|Double-blind Treatment (DBT) Period|Protocol Violation|1|||
147669079|NCT02717195|532613431|FG000|Double-blind Treatment (DBT) Period|Withdrawal by Subject|0|||
147669080|NCT02717195|532613432|FG001|Double-blind Treatment (DBT) Period|Withdrawal by Subject|0|||
147669081|NCT02717195|532613433|FG002|Double-blind Treatment (DBT) Period|Withdrawal by Subject|14|||
147669082|NCT02717195|532613434|FG003|Double-blind Treatment (DBT) Period|Withdrawal by Subject|13|||
147669083|NCT02717195|532613435|FG004|Double-blind Treatment (DBT) Period|Withdrawal by Subject|8|||
147505439|NCT02671461|532002812|FG001|Follow-up|Lost to Follow-up|0|||
147669084|NCT02717195|532613431|FG000|Double-blind Treatment (DBT) Period|Lost to Follow-up|0|||
147669085|NCT02717195|532613432|FG001|Double-blind Treatment (DBT) Period|Lost to Follow-up|0|||
147669086|NCT02717195|532613433|FG002|Double-blind Treatment (DBT) Period|Lost to Follow-up|0|||
147669087|NCT02717195|532613434|FG003|Double-blind Treatment (DBT) Period|Lost to Follow-up|3|||
147669088|NCT02717195|532613435|FG004|Double-blind Treatment (DBT) Period|Lost to Follow-up|2|||
147669089|NCT02717195|532613431|FG000|Double-blind Treatment (DBT) Period|Enrolled but not treated|0|||
147669090|NCT02717195|532613432|FG001|Double-blind Treatment (DBT) Period|Enrolled but not treated|0|||
147669091|NCT02717195|532613433|FG002|Double-blind Treatment (DBT) Period|Enrolled but not treated|1|||
147669092|NCT02717195|532613434|FG003|Double-blind Treatment (DBT) Period|Enrolled but not treated|0|||
147669093|NCT02717195|532613435|FG004|Double-blind Treatment (DBT) Period|Enrolled but not treated|0|||
147669094|NCT02717195|532613431|FG000|Double-blind Treatment (DBT) Period|Patient decision|0|||
147669095|NCT02717195|532613432|FG001|Double-blind Treatment (DBT) Period|Patient decision|0|||
147669096|NCT02717195|532613433|FG002|Double-blind Treatment (DBT) Period|Patient decision|0|||
147669097|NCT02717195|532613434|FG003|Double-blind Treatment (DBT) Period|Patient decision|2|||
147669098|NCT02717195|532613435|FG004|Double-blind Treatment (DBT) Period|Patient decision|2|||
147669099|NCT02717195|532613431|FG000|Double-blind Treatment (DBT) Period|Investigator decision|0|||
147669100|NCT02717195|532613432|FG001|Double-blind Treatment (DBT) Period|Investigator decision|0|||
147669101|NCT02717195|532613433|FG002|Double-blind Treatment (DBT) Period|Investigator decision|0|||
147669102|NCT02717195|532613434|FG003|Double-blind Treatment (DBT) Period|Investigator decision|1|||
147669103|NCT02717195|532613435|FG004|Double-blind Treatment (DBT) Period|Investigator decision|1|||
147669104|NCT02717195|532613431|FG000|Double-blind Treatment (DBT) Period|Family circumstances|0|||
147669105|NCT02717195|532613432|FG001|Double-blind Treatment (DBT) Period|Family circumstances|0|||
147669106|NCT02717195|532613433|FG002|Double-blind Treatment (DBT) Period|Family circumstances|0|||
147669107|NCT02717195|532613434|FG003|Double-blind Treatment (DBT) Period|Family circumstances|0|||
147669108|NCT02717195|532613435|FG004|Double-blind Treatment (DBT) Period|Family circumstances|1|||
147669109|NCT02717195|532613431|FG000|Double-blind Treatment (DBT) Period|Change of residence|0|||
147669110|NCT02717195|532613432|FG001|Double-blind Treatment (DBT) Period|Change of residence|0|||
147669111|NCT02717195|532613433|FG002|Double-blind Treatment (DBT) Period|Change of residence|0|||
147669112|NCT02717195|532613434|FG003|Double-blind Treatment (DBT) Period|Change of residence|1|||
147669113|NCT02717195|532613435|FG004|Double-blind Treatment (DBT) Period|Change of residence|1|||
147669114|NCT02717195|532613431|FG000|Double-blind Treatment (DBT) Period|Needed antidepressant medication|0|||
147669115|NCT02717195|532613432|FG001|Double-blind Treatment (DBT) Period|Needed antidepressant medication|0|||
147669116|NCT02717195|532613433|FG002|Double-blind Treatment (DBT) Period|Needed antidepressant medication|0|||
147669117|NCT02717195|532613434|FG003|Double-blind Treatment (DBT) Period|Needed antidepressant medication|0|||
147669118|NCT02717195|532613435|FG004|Double-blind Treatment (DBT) Period|Needed antidepressant medication|1|||
147669119|NCT02717195|532613431|FG000|Double-blind Treatment (DBT) Period|Psychosocial issues|0|||
147669120|NCT02717195|532613432|FG001|Double-blind Treatment (DBT) Period|Psychosocial issues|0|||
147505440|NCT02671461|532002813|FG002|Follow-up|Lost to Follow-up|1|||
147505441|NCT02671461|532002811|FG000|Follow-up|Administrative Reason by Sponsor|0|||
147505442|NCT02671461|532002812|FG001|Follow-up|Administrative Reason by Sponsor|1|||
147505443|NCT02671461|532002813|FG002|Follow-up|Administrative Reason by Sponsor|0|||
147505444|NCT01412060|532002814|FG000|Open-label Run-in Period (RIP)|Adverse Event|86|||
147505445|NCT01412060|532002815|FG001|Open-label Run-in Period (RIP)|Adverse Event|0|||
147505446|NCT01412060|532002816|FG002|Open-label Run-in Period (RIP)|Adverse Event|0|||
147505447|NCT01412060|532002814|FG000|Open-label Run-in Period (RIP)|Insufficient Therapeutic Response|66|||
147505448|NCT01412060|532002815|FG001|Open-label Run-in Period (RIP)|Insufficient Therapeutic Response|0|||
147505449|NCT01412060|532002816|FG002|Open-label Run-in Period (RIP)|Insufficient Therapeutic Response|0|||
147505450|NCT01412060|532002814|FG000|Open-label Run-in Period (RIP)|Protocol Violation|27|||
147505451|NCT01412060|532002815|FG001|Open-label Run-in Period (RIP)|Protocol Violation|0|||
147505452|NCT01412060|532002816|FG002|Open-label Run-in Period (RIP)|Protocol Violation|0|||
147505453|NCT01412060|532002814|FG000|Open-label Run-in Period (RIP)|Withdrawal of Consent|117|||
147505454|NCT01412060|532002815|FG001|Open-label Run-in Period (RIP)|Withdrawal of Consent|0|||
147505455|NCT01412060|532002816|FG002|Open-label Run-in Period (RIP)|Withdrawal of Consent|0|||
147505456|NCT01412060|532002814|FG000|Open-label Run-in Period (RIP)|Lost to Follow-up|32|||
147505457|NCT01412060|532002815|FG001|Open-label Run-in Period (RIP)|Lost to Follow-up|0|||
147505458|NCT01412060|532002816|FG002|Open-label Run-in Period (RIP)|Lost to Follow-up|0|||
147505459|NCT01412060|532002814|FG000|Open-label Run-in Period (RIP)|Other Miscellaneous Reasons|19|||
147505460|NCT01412060|532002815|FG001|Open-label Run-in Period (RIP)|Other Miscellaneous Reasons|0|||
147505461|NCT01412060|532002816|FG002|Open-label Run-in Period (RIP)|Other Miscellaneous Reasons|0|||
147505462|NCT01412060|532002814|FG000|Period Between RIP and SP|Adverse Event|4|||
147505463|NCT01412060|532002815|FG001|Period Between RIP and SP|Adverse Event|0|||
147505464|NCT01412060|532002816|FG002|Period Between RIP and SP|Adverse Event|0|||
147505465|NCT01412060|532002814|FG000|Period Between RIP and SP|Insufficient Therapeutic Response|19|||
147505466|NCT01412060|532002815|FG001|Period Between RIP and SP|Insufficient Therapeutic Response|0|||
147505467|NCT01412060|532002816|FG002|Period Between RIP and SP|Insufficient Therapeutic Response|0|||
147505468|NCT01412060|532002814|FG000|Period Between RIP and SP|Protocol Violation|2|||
147638211|NCT03320850|532493615|FG006|Overall Study|Lost to Follow-up|2|||
147638212|NCT03320850|532493616|FG007|Overall Study|Lost to Follow-up|0|||
147638213|NCT03320850|532493617|FG008|Overall Study|Lost to Follow-up|6|||
147638214|NCT03320850|532493618|FG009|Overall Study|Lost to Follow-up|4|||
147638215|NCT03320850|532493609|FG000|Overall Study|Withdrawal by Subject|0|||
147638216|NCT03320850|532493610|FG001|Overall Study|Withdrawal by Subject|0|||
147638217|NCT03320850|532493611|FG002|Overall Study|Withdrawal by Subject|0|||
147638218|NCT03320850|532493612|FG003|Overall Study|Withdrawal by Subject|0|||
147638219|NCT03320850|532493613|FG004|Overall Study|Withdrawal by Subject|1|||
147638220|NCT03320850|532493614|FG005|Overall Study|Withdrawal by Subject|2|||
147638221|NCT03320850|532493615|FG006|Overall Study|Withdrawal by Subject|4|||
147638222|NCT03320850|532493616|FG007|Overall Study|Withdrawal by Subject|5|||
147638223|NCT03320850|532493617|FG008|Overall Study|Withdrawal by Subject|2|||
147638224|NCT03320850|532493618|FG009|Overall Study|Withdrawal by Subject|1|||
147638225|NCT03320850|532493609|FG000|Overall Study|Lack of Efficacy|0|||
147638226|NCT03320850|532493610|FG001|Overall Study|Lack of Efficacy|0|||
147638227|NCT03320850|532493611|FG002|Overall Study|Lack of Efficacy|0|||
147638228|NCT03320850|532493612|FG003|Overall Study|Lack of Efficacy|1|||
147638229|NCT03320850|532493613|FG004|Overall Study|Lack of Efficacy|0|||
147638230|NCT03320850|532493614|FG005|Overall Study|Lack of Efficacy|1|||
147638231|NCT03320850|532493615|FG006|Overall Study|Lack of Efficacy|0|||
147638232|NCT03320850|532493616|FG007|Overall Study|Lack of Efficacy|2|||
147638233|NCT03320850|532493617|FG008|Overall Study|Lack of Efficacy|0|||
147638234|NCT03320850|532493618|FG009|Overall Study|Lack of Efficacy|3|||
147638235|NCT03320850|532493609|FG000|Overall Study|Failure to Meet Randomization Criteria|0|||
147638236|NCT03320850|532493610|FG001|Overall Study|Failure to Meet Randomization Criteria|0|||
147638237|NCT03320850|532493611|FG002|Overall Study|Failure to Meet Randomization Criteria|0|||
147638238|NCT03320850|532493612|FG003|Overall Study|Failure to Meet Randomization Criteria|0|||
147638239|NCT03320850|532493613|FG004|Overall Study|Failure to Meet Randomization Criteria|0|||
147638240|NCT03320850|532493614|FG005|Overall Study|Failure to Meet Randomization Criteria|1|||
147638241|NCT03320850|532493615|FG006|Overall Study|Failure to Meet Randomization Criteria|0|||
147638242|NCT03320850|532493616|FG007|Overall Study|Failure to Meet Randomization Criteria|0|||
147638243|NCT03320850|532493617|FG008|Overall Study|Failure to Meet Randomization Criteria|0|||
147638244|NCT03320850|532493618|FG009|Overall Study|Failure to Meet Randomization Criteria|0|||
147638245|NCT03320850|532493609|FG000|Overall Study|Adverse Event|0|||
147638246|NCT03320850|532493610|FG001|Overall Study|Adverse Event|0|||
147638247|NCT03320850|532493611|FG002|Overall Study|Adverse Event|0|||
147638248|NCT03320850|532493612|FG003|Overall Study|Adverse Event|0|||
147638249|NCT03320850|532493613|FG004|Overall Study|Adverse Event|0|||
147638250|NCT03320850|532493614|FG005|Overall Study|Adverse Event|2|||
147638251|NCT03320850|532493615|FG006|Overall Study|Adverse Event|1|||
147638252|NCT03320850|532493616|FG007|Overall Study|Adverse Event|0|||
147638253|NCT03320850|532493617|FG008|Overall Study|Adverse Event|2|||
147638254|NCT03320850|532493618|FG009|Overall Study|Adverse Event|0|||
147638255|NCT03320850|532493609|FG000|Overall Study|Reason Not Specified|0|||
147638256|NCT03320850|532493610|FG001|Overall Study|Reason Not Specified|0|||
147638257|NCT03320850|532493611|FG002|Overall Study|Reason Not Specified|0|||
147638258|NCT03320850|532493612|FG003|Overall Study|Reason Not Specified|0|||
147638259|NCT03320850|532493613|FG004|Overall Study|Reason Not Specified|0|||
147638260|NCT03320850|532493614|FG005|Overall Study|Reason Not Specified|1|||
147638261|NCT03320850|532493615|FG006|Overall Study|Reason Not Specified|0|||
147638262|NCT03320850|532493616|FG007|Overall Study|Reason Not Specified|0|||
147638263|NCT03320850|532493617|FG008|Overall Study|Reason Not Specified|0|||
147638264|NCT03320850|532493618|FG009|Overall Study|Reason Not Specified|1|||
147638265|NCT01286168|532493625|FG000|Overall Study|Withdrawal by Subject|1|||
147638266|NCT01286168|532493625|FG000|Overall Study|Surgical Drains Fell Out at Home|2|||
147638267|NCT01424514|532493626|FG000|Period 1:Intervention Period 1 (14 Days)|Protocol Violation|1|||
147638268|NCT01424514|532493627|FG001|Period 1:Intervention Period 1 (14 Days)|Protocol Violation|1|||
147638269|NCT01424514|532493626|FG000|Period 3:Intervention Period 2 (14 Days)|Protocol Violation|1|||
147638270|NCT01424514|532493627|FG001|Period 3:Intervention Period 2 (14 Days)|Protocol Violation|0|||
147638271|NCT02487771|532493630|FG000|Overall Study|Lost to Follow-up|2|||
147638272|NCT02487771|532493631|FG001|Overall Study|Lost to Follow-up|3|||
147638273|NCT02487771|532493630|FG000|Overall Study|Moved out of area|5|||
147638274|NCT02487771|532493631|FG001|Overall Study|Moved out of area|6|||
147638275|NCT02487771|532493630|FG000|Overall Study|Withdrawal by Subject|3|||
147638276|NCT02487771|532493631|FG001|Overall Study|Withdrawal by Subject|5|||
147638277|NCT04598451|532493632|FG000|Overall Study|Adverse Event|3|||
147638278|NCT04598451|532493633|FG001|Overall Study|Adverse Event|2|||
147638279|NCT04598451|532493632|FG000|Overall Study|Withdrawal by Subject|3|||
147638280|NCT04598451|532493633|FG001|Overall Study|Withdrawal by Subject|7|||
147638281|NCT04598451|532493632|FG000|Overall Study|Lost to Follow-up|2|||
147638282|NCT04598451|532493633|FG001|Overall Study|Lost to Follow-up|0|||
147638283|NCT04598451|532493632|FG000|Overall Study|Physician Decision|4|||
147638284|NCT04598451|532493633|FG001|Overall Study|Physician Decision|1|||
147669121|NCT02717195|532613433|FG002|Double-blind Treatment (DBT) Period|Psychosocial issues|1|||
147669122|NCT02717195|532613434|FG003|Double-blind Treatment (DBT) Period|Psychosocial issues|0|||
147669123|NCT02717195|532613435|FG004|Double-blind Treatment (DBT) Period|Psychosocial issues|0|||
147669124|NCT02717195|532613431|FG000|Double-blind Treatment (DBT) Period|Patient missed required visits|0|||
147669125|NCT02717195|532613432|FG001|Double-blind Treatment (DBT) Period|Patient missed required visits|0|||
147669126|NCT02717195|532613433|FG002|Double-blind Treatment (DBT) Period|Patient missed required visits|0|||
147669127|NCT02717195|532613434|FG003|Double-blind Treatment (DBT) Period|Patient missed required visits|1|||
147669128|NCT02717195|532613435|FG004|Double-blind Treatment (DBT) Period|Patient missed required visits|1|||
147669129|NCT03092752|532613436|FG000|Overall Study|Aged <40 years|14209|||
147669130|NCT03092752|532613436|FG000|Overall Study|At least one claim with T2DM|61299|||
147669131|NCT03092752|532613436|FG000|Overall Study|Having no claim of study drugs|29282|||
147669132|NCT03092752|532613436|FG000|Overall Study|Average hospital visit interval >92 days|10779|||
147669133|NCT03092752|532613436|FG000|Overall Study|<6 month history|245900|||
147669134|NCT03882918|532613437|FG000|Overall Study|Study terminated by sponsor|98|||
147669135|NCT03882918|532613437|FG000|Overall Study|Protocol Violation|1|||
147669136|NCT03882918|532613437|FG000|Overall Study|Other|9|||
147669137|NCT03882918|532613437|FG000|Overall Study|Lack of Efficacy|14|||
147669138|NCT03882918|532613437|FG000|Overall Study|Adverse Event|13|||
147669139|NCT03882918|532613437|FG000|Overall Study|Withdrawal by Subject|5|||
147669140|NCT06996301|532613438|FG000|Overall Study|Patients with negative microbiological evidence by both diagnostic methods|54|||
147669141|NCT06996301|532613439|FG001|Overall Study|Patients with negative microbiological evidence by both diagnostic methods|54|||
147669142|NCT06996301|532613438|FG000|Overall Study|Patients with discordant diagnostic results|107|||
147669143|NCT06996301|532613439|FG001|Overall Study|Patients with discordant diagnostic results|90|||
147669144|NCT06996301|532613438|FG000|Overall Study|Lost to Follow-up|31|||
147669145|NCT06996301|532613439|FG001|Overall Study|Lost to Follow-up|56|||
147669146|NCT06996301|532613438|FG000|Overall Study|Withdrawal by Subject|12|||
147669147|NCT06996301|532613439|FG001|Overall Study|Withdrawal by Subject|7|||
147669148|NCT04030598|532613440|FG000|Overall Study|Voluntary Withdrawal|0|||
147669149|NCT04030598|532613441|FG001|Overall Study|Voluntary Withdrawal|1|||
147669150|NCT04030598|532613442|FG002|Overall Study|Voluntary Withdrawal|0|||
147669151|NCT01419535|532613445|FG000|Overall Study|could not maintain iv line|1|||
147669152|NCT01419535|532613446|FG001|Overall Study|could not maintain iv line|1|||
147669153|NCT01419535|532613445|FG000|Overall Study|Withdrawal by Subject|0|||
147669154|NCT01419535|532613446|FG001|Overall Study|Withdrawal by Subject|1|||
147669155|NCT05965752|532613450|FG000|Overall Study|Adverse Event|0|||
147669156|NCT05965752|532613451|FG001|Overall Study|Adverse Event|1|||
147669157|NCT05965752|532613452|FG002|Overall Study|Adverse Event|0|||
147669158|NCT05965752|532613453|FG003|Overall Study|Adverse Event|1|||
147669159|NCT05965752|532613454|FG004|Overall Study|Adverse Event|3|||
147669160|NCT05965752|532613450|FG000|Overall Study|Lost to Follow-up|2|||
147669161|NCT05965752|532613451|FG001|Overall Study|Lost to Follow-up|0|||
147669162|NCT05965752|532613452|FG002|Overall Study|Lost to Follow-up|1|||
147669163|NCT05965752|532613453|FG003|Overall Study|Lost to Follow-up|1|||
147669164|NCT05965752|532613454|FG004|Overall Study|Lost to Follow-up|1|||
147669165|NCT05965752|532613450|FG000|Overall Study|Withdrawal by Subject|2|||
147669166|NCT05965752|532613451|FG001|Overall Study|Withdrawal by Subject|2|||
147669167|NCT05965752|532613452|FG002|Overall Study|Withdrawal by Subject|1|||
147669168|NCT05965752|532613453|FG003|Overall Study|Withdrawal by Subject|5|||
147669169|NCT05965752|532613454|FG004|Overall Study|Withdrawal by Subject|0|||
147669170|NCT05965752|532613450|FG000|Overall Study|Disease Relapse|1|||
147669171|NCT05965752|532613451|FG001|Overall Study|Disease Relapse|0|||
147669172|NCT05965752|532613452|FG002|Overall Study|Disease Relapse|1|||
147669173|NCT05965752|532613453|FG003|Overall Study|Disease Relapse|0|||
147669174|NCT05965752|532613454|FG004|Overall Study|Disease Relapse|0|||
147669175|NCT05965752|532613450|FG000|Overall Study|Failure to Meet Randomization Criteria|0|||
147669176|NCT05965752|532613451|FG001|Overall Study|Failure to Meet Randomization Criteria|1|||
147669177|NCT05965752|532613452|FG002|Overall Study|Failure to Meet Randomization Criteria|0|||
147669178|NCT05965752|532613453|FG003|Overall Study|Failure to Meet Randomization Criteria|1|||
147669179|NCT05965752|532613454|FG004|Overall Study|Failure to Meet Randomization Criteria|0|||
147505469|NCT01412060|532002815|FG001|Period Between RIP and SP|Protocol Violation|0|||
147505470|NCT01412060|532002816|FG002|Period Between RIP and SP|Protocol Violation|0|||
147669180|NCT05965752|532613450|FG000|Overall Study|Unable to Return for Study Visits|0|||
147669181|NCT05965752|532613451|FG001|Overall Study|Unable to Return for Study Visits|1|||
147669182|NCT05965752|532613452|FG002|Overall Study|Unable to Return for Study Visits|0|||
147669183|NCT05965752|532613453|FG003|Overall Study|Unable to Return for Study Visits|3|||
147669184|NCT05965752|532613454|FG004|Overall Study|Unable to Return for Study Visits|1|||
147669185|NCT05965752|532613450|FG000|Overall Study|Early Termination|0|||
147669186|NCT05965752|532613451|FG001|Overall Study|Early Termination|0|||
147669187|NCT05965752|532613452|FG002|Overall Study|Early Termination|1|||
147669188|NCT05965752|532613453|FG003|Overall Study|Early Termination|0|||
147669189|NCT05965752|532613454|FG004|Overall Study|Early Termination|0|||
147669190|NCT05965752|532613450|FG000|Overall Study|Reported Unwanted Symptoms|0|||
147669191|NCT05965752|532613451|FG001|Overall Study|Reported Unwanted Symptoms|0|||
147638285|NCT04598451|532493632|FG000|Overall Study|Requires Prohibited Medication|1|||
147638286|NCT04598451|532493633|FG001|Overall Study|Requires Prohibited Medication|0|||
147638287|NCT04598451|532493632|FG000|Overall Study|lack of efficacy, geopolitical situation in Ukraine, flares after CRmin, SAE due to prednisone, etc|30|||
147638288|NCT04598451|532493633|FG001|Overall Study|lack of efficacy, geopolitical situation in Ukraine, flares after CRmin, SAE due to prednisone, etc|19|||
147638289|NCT02653170|532493634|FG000|Overall Study|Withdrawal by Subject|3|||
147638290|NCT02653170|532493635|FG001|Overall Study|Withdrawal by Subject|8|||
147638291|NCT02653170|532493636|FG002|Overall Study|Withdrawal by Subject|3|||
147638292|NCT02653170|532493634|FG000|Overall Study|withdrawn by study team|2|||
147638293|NCT02653170|532493635|FG001|Overall Study|withdrawn by study team|4|||
147638294|NCT02653170|532493636|FG002|Overall Study|withdrawn by study team|5|||
147638295|NCT02653170|532493634|FG000|Overall Study|Lost to Follow-up|12|||
147638296|NCT02653170|532493635|FG001|Overall Study|Lost to Follow-up|4|||
147638297|NCT02653170|532493636|FG002|Overall Study|Lost to Follow-up|10|||
147638298|NCT02002533|532493637|FG000|Overall Study|Withdrawal by Subject|6|||
147638299|NCT02002533|532493638|FG001|Overall Study|Withdrawal by Subject|13|||
147638300|NCT02002533|532493637|FG000|Overall Study|Protocol Violation|0|||
147638301|NCT02002533|532493638|FG001|Overall Study|Protocol Violation|1|||
147638302|NCT02002533|532493637|FG000|Overall Study|Adverse Event|0|||
147638303|NCT02002533|532493638|FG001|Overall Study|Adverse Event|3|||
147638304|NCT02002533|532493637|FG000|Overall Study|Lost to Follow-up|0|||
147638305|NCT02002533|532493638|FG001|Overall Study|Lost to Follow-up|1|||
147638306|NCT02086448|532493644|FG000|Overall Study|Withdrawal by Subject|1|||
147638307|NCT02086448|532493645|FG001|Overall Study|Withdrawal by Subject|0|||
147638308|NCT02086448|532493646|FG002|Overall Study|Withdrawal by Subject|0|||
147638309|NCT02086448|532493647|FG003|Overall Study|Withdrawal by Subject|2|||
147638310|NCT01482065|532493666|FG000|Overall Study|Withdrawal by Subject|0|||
147638311|NCT01482065|532493667|FG001|Overall Study|Withdrawal by Subject|1|||
147638312|NCT01942486|532493668|FG000|Overall Study|Lost to Follow-up|27|||
147638313|NCT03728426|532493669|FG000|Overall Study|Death|3|||
147638314|NCT02637895|532493670|FG000|Overall Study|Lost to Follow-up|4|||
147638315|NCT02637895|532493671|FG001|Overall Study|Lost to Follow-up|0|||
147638316|NCT02637895|532493670|FG000|Overall Study|Protocol Violation|0|||
147638317|NCT02637895|532493671|FG001|Overall Study|Protocol Violation|1|||
147638318|NCT02637895|532493670|FG000|Overall Study|Lack of Efficacy|1|||
147638319|NCT02637895|532493671|FG001|Overall Study|Lack of Efficacy|0|||
147638320|NCT02637895|532493670|FG000|Overall Study|Withdrawal by Subject|1|||
147638321|NCT02637895|532493671|FG001|Overall Study|Withdrawal by Subject|1|||
147638322|NCT02637895|532493670|FG000|Overall Study|Abnormal baseline lab|0|||
147638323|NCT02637895|532493671|FG001|Overall Study|Abnormal baseline lab|1|||
147638324|NCT02091375|532493679|FG000|Overall Study|Adverse Event|8|||
147638325|NCT02091375|532493680|FG001|Overall Study|Adverse Event|1|||
147638326|NCT02091375|532493679|FG000|Overall Study|Lost to Follow-up|0|||
147638327|NCT02091375|532493680|FG001|Overall Study|Lost to Follow-up|1|||
147638328|NCT02091375|532493679|FG000|Overall Study|Withdrawal by Subject|0|||
147638329|NCT02091375|532493680|FG001|Overall Study|Withdrawal by Subject|1|||
147638330|NCT02091375|532493679|FG000|Overall Study|Withdrawn by the investigator|1|||
147638331|NCT02091375|532493680|FG001|Overall Study|Withdrawn by the investigator|0|||
147638332|NCT05896527|532493681|FG000|Overall Study|Withdrawal by Subject|11|||
147638333|NCT05896527|532493682|FG001|Overall Study|Withdrawal by Subject|10|||
147638334|NCT05896527|532493683|FG002|Overall Study|Withdrawal by Subject|4|||
147638335|NCT05896527|532493684|FG003|Overall Study|Withdrawal by Subject|3|||
147638336|NCT05896527|532493685|FG004|Overall Study|Withdrawal by Subject|2|||
147638337|NCT05896527|532493681|FG000|Overall Study|Lost to Follow-up|0|||
147638338|NCT05896527|532493682|FG001|Overall Study|Lost to Follow-up|2|||
147638339|NCT05896527|532493683|FG002|Overall Study|Lost to Follow-up|2|||
147638340|NCT05896527|532493684|FG003|Overall Study|Lost to Follow-up|2|||
147638341|NCT05896527|532493685|FG004|Overall Study|Lost to Follow-up|1|||
147638342|NCT05896527|532493681|FG000|Overall Study|Significant protocol noncompliance|0|||
147638343|NCT05896527|532493682|FG001|Overall Study|Significant protocol noncompliance|1|||
147638344|NCT05896527|532493683|FG002|Overall Study|Significant protocol noncompliance|0|||
147638345|NCT05896527|532493684|FG003|Overall Study|Significant protocol noncompliance|0|||
147638346|NCT05896527|532493685|FG004|Overall Study|Significant protocol noncompliance|0|||
147638347|NCT05896527|532493681|FG000|Overall Study|Eligibility criteria not met|1|||
147638348|NCT05896527|532493682|FG001|Overall Study|Eligibility criteria not met|0|||
147638349|NCT05896527|532493683|FG002|Overall Study|Eligibility criteria not met|0|||
147638350|NCT05896527|532493684|FG003|Overall Study|Eligibility criteria not met|0|||
147638351|NCT05896527|532493685|FG004|Overall Study|Eligibility criteria not met|0|||
147638352|NCT05896527|532493681|FG000|Overall Study|Sponsor's decision|0|||
147638353|NCT05896527|532493682|FG001|Overall Study|Sponsor's decision|0|||
147638354|NCT05896527|532493683|FG002|Overall Study|Sponsor's decision|0|||
147638355|NCT05896527|532493684|FG003|Overall Study|Sponsor's decision|1|||
147638356|NCT05896527|532493685|FG004|Overall Study|Sponsor's decision|0|||
147638357|NCT05896527|532493681|FG000|Overall Study|Investigator's decision|0|||
147638358|NCT05896527|532493682|FG001|Overall Study|Investigator's decision|1|||
147638359|NCT05896527|532493683|FG002|Overall Study|Investigator's decision|0|||
147638360|NCT05896527|532493684|FG003|Overall Study|Investigator's decision|0|||
147638361|NCT05896527|532493685|FG004|Overall Study|Investigator's decision|0|||
147638362|NCT05896527|532493681|FG000|Overall Study|Pregnancy of his partner|0|||
147638363|NCT05896527|532493682|FG001|Overall Study|Pregnancy of his partner|0|||
147638364|NCT05896527|532493683|FG002|Overall Study|Pregnancy of his partner|0|||
147638365|NCT05896527|532493684|FG003|Overall Study|Pregnancy of his partner|1|||
147638366|NCT05896527|532493685|FG004|Overall Study|Pregnancy of his partner|0|||
147638367|NCT00507819|532493688|FG000|Washout (6 Weeks)|Withdrawal by Subject|1|||
147638368|NCT00507819|532493689|FG001|Washout (6 Weeks)|Withdrawal by Subject|0|||
147638369|NCT03261674|532493692|FG000|Overall Study|Lost to Follow-up|6|||
147638370|NCT03261674|532493693|FG001|Overall Study|Lost to Follow-up|7|||
147638371|NCT03261674|532493692|FG000|Overall Study|Protocol Violation|1|||
147638372|NCT03261674|532493693|FG001|Overall Study|Protocol Violation|4|||
147638373|NCT03261674|532493692|FG000|Overall Study|Withdrawal by Subject|1|||
147638374|NCT03261674|532493693|FG001|Overall Study|Withdrawal by Subject|4|||
147638375|NCT03261674|532493692|FG000|Overall Study|Physician Decision|1|||
147638376|NCT03261674|532493693|FG001|Overall Study|Physician Decision|0|||
147638377|NCT02045862|532493696|FG000|Overall Study|Death|0|||
147638378|NCT02045862|532493697|FG001|Overall Study|Death|0|||
147638379|NCT02045862|532493698|FG002|Overall Study|Death|1|||
147638380|NCT02045862|532493696|FG000|Overall Study|Miscellaneous|5|||
147638381|NCT02045862|532493697|FG001|Overall Study|Miscellaneous|0|||
147638382|NCT02045862|532493698|FG002|Overall Study|Miscellaneous|8|||
147638383|NCT02045862|532493696|FG000|Overall Study|Withdrawal by Patient|18|||
147638384|NCT02045862|532493697|FG001|Overall Study|Withdrawal by Patient|27|||
147638385|NCT02045862|532493698|FG002|Overall Study|Withdrawal by Patient|57|||
147638386|NCT02045862|532493696|FG000|Overall Study|Protocol Violation|0|||
147638387|NCT02045862|532493697|FG001|Overall Study|Protocol Violation|0|||
147638388|NCT02045862|532493698|FG002|Overall Study|Protocol Violation|6|||
147638389|NCT02045862|532493696|FG000|Overall Study|Lack of Efficacy|8|||
147638390|NCT02045862|532493697|FG001|Overall Study|Lack of Efficacy|4|||
147638391|NCT02045862|532493698|FG002|Overall Study|Lack of Efficacy|13|||
147638392|NCT02045862|532493696|FG000|Overall Study|Randomized but not Received Study Drug|0|||
147638393|NCT02045862|532493697|FG001|Overall Study|Randomized but not Received Study Drug|2|||
147638394|NCT02045862|532493698|FG002|Overall Study|Randomized but not Received Study Drug|8|||
147638395|NCT02045862|532493696|FG000|Overall Study|Adverse Event|7|||
147638396|NCT02045862|532493697|FG001|Overall Study|Adverse Event|5|||
147638397|NCT02045862|532493698|FG002|Overall Study|Adverse Event|27|||
147638398|NCT02045862|532493696|FG000|Overall Study|Lost to Follow-up|1|||
147638399|NCT02045862|532493697|FG001|Overall Study|Lost to Follow-up|2|||
147638400|NCT02045862|532493698|FG002|Overall Study|Lost to Follow-up|6|||
147638401|NCT00623935|532493699|FG000|Overall Study|Death|1|||
147638402|NCT00623935|532493699|FG000|Overall Study|Patient Declined Transplant|1|||
147638403|NCT04507256|532493702|FG000|Overall Study|Withdrawal by Subject|1|||
147638404|NCT04507256|532493703|FG001|Overall Study|Withdrawal by Subject|0|||
147638405|NCT04507256|532493704|FG002|Overall Study|Withdrawal by Subject|0|||
147638406|NCT04507256|532493705|FG003|Overall Study|Withdrawal by Subject|1|||
147638407|NCT04507256|532493706|FG004|Overall Study|Withdrawal by Subject|0|||
147638408|NCT04507256|532493707|FG005|Overall Study|Withdrawal by Subject|0|||
147638409|NCT00631410|532493708|FG000|Overall Study|Adverse Event|1|||
147638410|NCT00631410|532493709|FG001|Overall Study|Adverse Event|3|||
147638411|NCT00631410|532493708|FG000|Overall Study|Objective Progression or Relapse|4|||
147638412|NCT00631410|532493709|FG001|Overall Study|Objective Progression or Relapse|3|||
147638413|NCT00631410|532493708|FG000|Overall Study|Surgery|1|||
147638414|NCT00631410|532493709|FG001|Overall Study|Surgery|0|||
147638415|NCT00782184|532493722|FG000|Overall Study|Adverse Event|1|||
147638416|NCT00782184|532493723|FG001|Overall Study|Adverse Event|2|||
147638417|NCT00782184|532493722|FG000|Overall Study|Protocol Violation|0|||
147638418|NCT00782184|532493723|FG001|Overall Study|Protocol Violation|1|||
147638419|NCT00782184|532493722|FG000|Overall Study|Withdrawal by Subject|3|||
147638420|NCT00782184|532493723|FG001|Overall Study|Withdrawal by Subject|2|||
147638421|NCT02738879|532493724|FG000|Overall Study|Adverse Event|1|||
147638422|NCT02738879|532493725|FG001|Overall Study|Adverse Event|1|||
147638423|NCT02738879|532493724|FG000|Overall Study|Death|0|||
147638424|NCT02738879|532493725|FG001|Overall Study|Death|2|||
147638425|NCT02738879|532493724|FG000|Overall Study|Lost to Follow-up|1|||
147638426|NCT02738879|532493725|FG001|Overall Study|Lost to Follow-up|5|||
147638427|NCT02738879|532493724|FG000|Overall Study|Protocol Violation|1|||
147638428|NCT02738879|532493725|FG001|Overall Study|Protocol Violation|3|||
147638429|NCT02738879|532493724|FG000|Overall Study|Physician Decision|3|||
147638430|NCT02738879|532493725|FG001|Overall Study|Physician Decision|4|||
147638431|NCT02738879|532493724|FG000|Overall Study|Pregnancy|0|||
147638432|NCT02738879|532493725|FG001|Overall Study|Pregnancy|1|||
147638433|NCT02738879|532493724|FG000|Overall Study|Screen Failure|1|||
147638434|NCT02738879|532493725|FG001|Overall Study|Screen Failure|2|||
147638435|NCT02738879|532493724|FG000|Overall Study|Site Discontinued Study Participation|1|||
147638436|NCT02738879|532493725|FG001|Overall Study|Site Discontinued Study Participation|0|||
147638437|NCT02738879|532493724|FG000|Overall Study|Withdrawal by Subject|5|||
147505471|NCT01412060|532002814|FG000|Period Between RIP and SP|Withdrawal of Consent|1|||
147505472|NCT01412060|532002815|FG001|Period Between RIP and SP|Withdrawal of Consent|0|||
147505473|NCT01412060|532002816|FG002|Period Between RIP and SP|Withdrawal of Consent|0|||
147505474|NCT01412060|532002814|FG000|Period Between RIP and SP|Lost to Follow-up|5|||
147505475|NCT01412060|532002815|FG001|Period Between RIP and SP|Lost to Follow-up|0|||
147505476|NCT01412060|532002816|FG002|Period Between RIP and SP|Lost to Follow-up|0|||
147505477|NCT01412060|532002814|FG000|Period Between RIP and SP|Other Miscellaneous Reasons|23|||
147505478|NCT01412060|532002815|FG001|Period Between RIP and SP|Other Miscellaneous Reasons|0|||
147505479|NCT01412060|532002816|FG002|Period Between RIP and SP|Other Miscellaneous Reasons|0|||
147505480|NCT01412060|532002814|FG000|Open-label Stabilization Period (SP)|Adverse Event|9|||
147505481|NCT01412060|532002815|FG001|Open-label Stabilization Period (SP)|Adverse Event|0|||
147505482|NCT01412060|532002816|FG002|Open-label Stabilization Period (SP)|Adverse Event|0|||
147505483|NCT01412060|532002814|FG000|Open-label Stabilization Period (SP)|Insufficient Therapeutic Response|9|||
147505484|NCT01412060|532002815|FG001|Open-label Stabilization Period (SP)|Insufficient Therapeutic Response|0|||
147505485|NCT01412060|532002816|FG002|Open-label Stabilization Period (SP)|Insufficient Therapeutic Response|0|||
147505486|NCT01412060|532002814|FG000|Open-label Stabilization Period (SP)|Protocol Violation|14|||
147505487|NCT01412060|532002815|FG001|Open-label Stabilization Period (SP)|Protocol Violation|0|||
147505488|NCT01412060|532002816|FG002|Open-label Stabilization Period (SP)|Protocol Violation|0|||
147505489|NCT01412060|532002814|FG000|Open-label Stabilization Period (SP)|Withdrawal of Consent|40|||
147505490|NCT01412060|532002815|FG001|Open-label Stabilization Period (SP)|Withdrawal of Consent|0|||
147505491|NCT01412060|532002816|FG002|Open-label Stabilization Period (SP)|Withdrawal of Consent|0|||
147505492|NCT01412060|532002814|FG000|Open-label Stabilization Period (SP)|Lost to Follow-up|9|||
147505493|NCT01412060|532002815|FG001|Open-label Stabilization Period (SP)|Lost to Follow-up|0|||
147505494|NCT01412060|532002816|FG002|Open-label Stabilization Period (SP)|Lost to Follow-up|0|||
147505495|NCT01412060|532002814|FG000|Open-label Stabilization Period (SP)|Other Miscellaneous Reasons|19|||
147505496|NCT01412060|532002815|FG001|Open-label Stabilization Period (SP)|Other Miscellaneous Reasons|0|||
147505497|NCT01412060|532002816|FG002|Open-label Stabilization Period (SP)|Other Miscellaneous Reasons|0|||
147505498|NCT01412060|532002814|FG000|Period Between SP and DBP|Protocol Violation|2|||
147505499|NCT01412060|532002815|FG001|Period Between SP and DBP|Protocol Violation|0|||
147505500|NCT01412060|532002816|FG002|Period Between SP and DBP|Protocol Violation|0|||
147505501|NCT01412060|532002814|FG000|Period Between SP and DBP|Withdrawal of Consent|2|||
147505502|NCT01412060|532002815|FG001|Period Between SP and DBP|Withdrawal of Consent|0|||
147505503|NCT01412060|532002816|FG002|Period Between SP and DBP|Withdrawal of Consent|0|||
147505504|NCT01412060|532002814|FG000|Period Between SP and DBP|Lost to Follow-up|1|||
147505505|NCT01412060|532002815|FG001|Period Between SP and DBP|Lost to Follow-up|0|||
147505506|NCT01412060|532002816|FG002|Period Between SP and DBP|Lost to Follow-up|0|||
147505507|NCT01412060|532002814|FG000|Period Between SP and DBP|Did Not Met Criteria to Enter Next Phase|4|||
147505508|NCT01412060|532002815|FG001|Period Between SP and DBP|Did Not Met Criteria to Enter Next Phase|0|||
147505509|NCT01412060|532002816|FG002|Period Between SP and DBP|Did Not Met Criteria to Enter Next Phase|0|||
147505510|NCT01412060|532002814|FG000|Period Between SP and DBP|Other Miscellaneous Reasons|55|||
147505511|NCT01412060|532002815|FG001|Period Between SP and DBP|Other Miscellaneous Reasons|0|||
147505512|NCT01412060|532002816|FG002|Period Between SP and DBP|Other Miscellaneous Reasons|0|||
147505513|NCT01412060|532002814|FG000|Double-blind Treatment Phase (DBP)|Adverse Event|0|||
147505514|NCT01412060|532002815|FG001|Double-blind Treatment Phase (DBP)|Adverse Event|5|||
147505515|NCT01412060|532002816|FG002|Double-blind Treatment Phase (DBP)|Adverse Event|6|||
147505516|NCT01412060|532002814|FG000|Double-blind Treatment Phase (DBP)|Protocol Violation|0|||
147505517|NCT01412060|532002815|FG001|Double-blind Treatment Phase (DBP)|Protocol Violation|4|||
147505518|NCT01412060|532002816|FG002|Double-blind Treatment Phase (DBP)|Protocol Violation|5|||
147505519|NCT01412060|532002814|FG000|Double-blind Treatment Phase (DBP)|Withdrawal of Consent|0|||
147505520|NCT01412060|532002815|FG001|Double-blind Treatment Phase (DBP)|Withdrawal of Consent|10|||
147505521|NCT01412060|532002816|FG002|Double-blind Treatment Phase (DBP)|Withdrawal of Consent|15|||
147505522|NCT01412060|532002814|FG000|Double-blind Treatment Phase (DBP)|Lost to Follow-up|0|||
147505523|NCT01412060|532002815|FG001|Double-blind Treatment Phase (DBP)|Lost to Follow-up|6|||
147505524|NCT01412060|532002816|FG002|Double-blind Treatment Phase (DBP)|Lost to Follow-up|5|||
147505525|NCT01412060|532002814|FG000|Double-blind Treatment Phase (DBP)|Other Miscellaneous Reasons|0|||
147505526|NCT01412060|532002815|FG001|Double-blind Treatment Phase (DBP)|Other Miscellaneous Reasons|11|||
147505527|NCT01412060|532002816|FG002|Double-blind Treatment Phase (DBP)|Other Miscellaneous Reasons|27|||
147505528|NCT01412060|532002814|FG000|Double-blind Treatment Phase (DBP)|Relapse|0|||
147505529|NCT01412060|532002815|FG001|Double-blind Treatment Phase (DBP)|Relapse|47|||
147505530|NCT01412060|532002816|FG002|Double-blind Treatment Phase (DBP)|Relapse|25|||
147505531|NCT00004732|532002818|FG000|Overall Study|Withdrawal by Subject|36|||
147638438|NCT02738879|532493725|FG001|Overall Study|Withdrawal by Subject|7|||
147638439|NCT00890084|532493726|FG000|Overall Study|Adverse Event|16|||
147638440|NCT00890084|532493726|FG000|Overall Study|Lost to Follow-up|126|||
147638441|NCT01438294|532493727|FG000|Overall Study|Lost to Follow-up|3|||
147638442|NCT01438294|532493728|FG001|Overall Study|Lost to Follow-up|7|||
147638443|NCT01346189|532493729|FG000|Overall Study|Withdrawal by Subject|7|||
147638444|NCT01346189|532493730|FG001|Overall Study|Withdrawal by Subject|5|||
147638445|NCT01346189|532493731|FG002|Overall Study|Withdrawal by Subject|3|||
147638446|NCT01346189|532493732|FG003|Overall Study|Withdrawal by Subject|5|||
147638447|NCT01346189|532493729|FG000|Overall Study|Physician Decision|4|||
147638448|NCT01346189|532493730|FG001|Overall Study|Physician Decision|0|||
147638449|NCT01346189|532493731|FG002|Overall Study|Physician Decision|0|||
147638450|NCT01346189|532493732|FG003|Overall Study|Physician Decision|0|||
147638451|NCT01346189|532493729|FG000|Overall Study|Moved|3|||
147638452|NCT01346189|532493730|FG001|Overall Study|Moved|0|||
147638453|NCT01346189|532493731|FG002|Overall Study|Moved|4|||
147638454|NCT01346189|532493732|FG003|Overall Study|Moved|0|||
147638455|NCT01346189|532493729|FG000|Overall Study|Other|2|||
147638456|NCT01346189|532493730|FG001|Overall Study|Other|4|||
147638457|NCT01346189|532493731|FG002|Overall Study|Other|7|||
147638458|NCT01346189|532493732|FG003|Overall Study|Other|3|||
147638459|NCT01346189|532493729|FG000|Overall Study|Death|0|||
147638460|NCT01346189|532493730|FG001|Overall Study|Death|3|||
147638461|NCT01346189|532493731|FG002|Overall Study|Death|0|||
147638462|NCT01346189|532493732|FG003|Overall Study|Death|0|||
147638463|NCT01346189|532493729|FG000|Overall Study|Non-health system primary care physician|0|||
147638464|NCT01346189|532493730|FG001|Overall Study|Non-health system primary care physician|5|||
147638465|NCT01346189|532493731|FG002|Overall Study|Non-health system primary care physician|0|||
147638466|NCT01346189|532493732|FG003|Overall Study|Non-health system primary care physician|0|||
147638467|NCT01346189|532493729|FG000|Overall Study|Travel|0|||
147638468|NCT01346189|532493730|FG001|Overall Study|Travel|0|||
147638469|NCT01346189|532493731|FG002|Overall Study|Travel|0|||
147638470|NCT01346189|532493732|FG003|Overall Study|Travel|3|||
147638471|NCT01075646|532493736|FG000|Overall Study|Lost to Follow-up|4|||
147638472|NCT01075646|532493737|FG001|Overall Study|Lost to Follow-up|3|||
147638473|NCT01075646|532493738|FG002|Overall Study|Lost to Follow-up|1|||
147638474|NCT01075646|532493739|FG003|Overall Study|Lost to Follow-up|2|||
147638475|NCT01730534|532493740|FG000|Overall Study|Withdrawal by Subject|97|||
147638476|NCT01730534|532493741|FG001|Overall Study|Withdrawal by Subject|127|||
147638477|NCT01730534|532493740|FG000|Overall Study|Lost to Follow-up|12|||
147638478|NCT01730534|532493741|FG001|Overall Study|Lost to Follow-up|18|||
147638479|NCT01676896|532493745|FG000|Overall Study|Withdrawal by Subject|12|||
147638480|NCT01676896|532493746|FG001|Overall Study|Withdrawal by Subject|7|||
147638481|NCT01676896|532493747|FG002|Overall Study|Withdrawal by Subject|19|||
147638482|NCT01647516|532493748|FG000|Induction Period (IP)|Physician Decision|2|||
147638483|NCT01647516|532493749|FG001|Induction Period (IP)|Physician Decision|0|||
147638484|NCT01647516|532493750|FG002|Induction Period (IP)|Physician Decision|0|||
147638485|NCT01647516|532493751|FG003|Induction Period (IP)|Physician Decision|0|||
147638486|NCT01647516|532493752|FG004|Induction Period (IP)|Physician Decision|0|||
147638487|NCT01647516|532493753|FG005|Induction Period (IP)|Physician Decision|0|||
147638488|NCT01647516|532493748|FG000|Induction Period (IP)|Adverse Event|1|||
147638489|NCT01647516|532493749|FG001|Induction Period (IP)|Adverse Event|2|||
147638490|NCT01647516|532493750|FG002|Induction Period (IP)|Adverse Event|0|||
147638491|NCT01647516|532493751|FG003|Induction Period (IP)|Adverse Event|0|||
147638492|NCT01647516|532493752|FG004|Induction Period (IP)|Adverse Event|0|||
147638493|NCT01647516|532493753|FG005|Induction Period (IP)|Adverse Event|0|||
147638494|NCT01647516|532493748|FG000|Induction Period (IP)|Withdrawal by Subject|1|||
147638495|NCT01647516|532493749|FG001|Induction Period (IP)|Withdrawal by Subject|0|||
147638496|NCT01647516|532493750|FG002|Induction Period (IP)|Withdrawal by Subject|3|||
147638497|NCT01647516|532493751|FG003|Induction Period (IP)|Withdrawal by Subject|0|||
147638498|NCT01647516|532493752|FG004|Induction Period (IP)|Withdrawal by Subject|0|||
147638499|NCT01647516|532493753|FG005|Induction Period (IP)|Withdrawal by Subject|0|||
147638500|NCT01647516|532493748|FG000|Induction Period (IP)|Participant Choice|0|||
147638501|NCT01647516|532493749|FG001|Induction Period (IP)|Participant Choice|0|||
147638502|NCT01647516|532493750|FG002|Induction Period (IP)|Participant Choice|1|||
147638503|NCT01647516|532493751|FG003|Induction Period (IP)|Participant Choice|0|||
147638504|NCT01647516|532493752|FG004|Induction Period (IP)|Participant Choice|0|||
147638505|NCT01647516|532493753|FG005|Induction Period (IP)|Participant Choice|0|||
147638506|NCT01647516|532493748|FG000|Induction Period (IP)|Lack of Efficacy|1|||
147638507|NCT01647516|532493749|FG001|Induction Period (IP)|Lack of Efficacy|0|||
147638508|NCT01647516|532493750|FG002|Induction Period (IP)|Lack of Efficacy|0|||
147638509|NCT01647516|532493751|FG003|Induction Period (IP)|Lack of Efficacy|0|||
147638510|NCT01647516|532493752|FG004|Induction Period (IP)|Lack of Efficacy|0|||
147638511|NCT01647516|532493753|FG005|Induction Period (IP)|Lack of Efficacy|0|||
147638512|NCT01647516|532493748|FG000|Induction Period (IP)|No study drug received|1|||
147638513|NCT01647516|532493749|FG001|Induction Period (IP)|No study drug received|1|||
147638514|NCT01647516|532493750|FG002|Induction Period (IP)|No study drug received|0|||
147638515|NCT01647516|532493751|FG003|Induction Period (IP)|No study drug received|0|||
147638516|NCT01647516|532493752|FG004|Induction Period (IP)|No study drug received|0|||
147638517|NCT01647516|532493753|FG005|Induction Period (IP)|No study drug received|0|||
147638518|NCT01647516|532493748|FG000|Maintenance Period (MP)|Adverse Event|2|||
147638519|NCT01647516|532493749|FG001|Maintenance Period (MP)|Adverse Event|1|||
147638520|NCT01647516|532493750|FG002|Maintenance Period (MP)|Adverse Event|0|||
147669192|NCT05965752|532613452|FG002|Overall Study|Reported Unwanted Symptoms|0|||
147669193|NCT05965752|532613453|FG003|Overall Study|Reported Unwanted Symptoms|0|||
147669194|NCT05965752|532613454|FG004|Overall Study|Reported Unwanted Symptoms|1|||
147669195|NCT05965752|532613450|FG000|Overall Study|Did Not Want to be Randomized to Intervention|0|||
147669196|NCT05965752|532613451|FG001|Overall Study|Did Not Want to be Randomized to Intervention|0|||
147669197|NCT05965752|532613452|FG002|Overall Study|Did Not Want to be Randomized to Intervention|0|||
147669198|NCT05965752|532613453|FG003|Overall Study|Did Not Want to be Randomized to Intervention|0|||
147669199|NCT05965752|532613454|FG004|Overall Study|Did Not Want to be Randomized to Intervention|1|||
147669200|NCT01274351|532613455|FG000|Overall Study|Lost to Follow-up|1|||
147669201|NCT01274351|532613455|FG000|Overall Study|patient not compliant with the protocol|1|||
147669202|NCT01274351|532613455|FG000|Overall Study|Pregnancy|1|||
147669203|NCT01274351|532613455|FG000|Overall Study|Death|2|||
147669204|NCT01274351|532613455|FG000|Overall Study|Withdrawal by Subject|3|||
147669205|NCT01274351|532613455|FG000|Overall Study|Adverse Event|8|||
147669206|NCT01274351|532613455|FG000|Overall Study|progression of disease|3|||
147669207|NCT01274351|532613455|FG000|Overall Study|hospitalization|1|||
147669208|NCT05399680|532615412|FG000|Overall Study|Lost to Follow-up|1|||
147669209|NCT05399680|532615413|FG001|Overall Study|Lost to Follow-up|0|||
147669210|NCT05399680|532615412|FG000|Overall Study|Death|0|||
147669211|NCT05399680|532615413|FG001|Overall Study|Death|1|||
147669212|NCT03370172|532615414|FG000|Overall Study|Withdrawal by Subject|0|||
147669213|NCT03370172|532615415|FG001|Overall Study|Withdrawal by Subject|1|||
147669214|NCT01113749|532615417|FG000|Overall Study|Lost to Follow-up|1|||
147669215|NCT01113749|532615418|FG001|Overall Study|Lost to Follow-up|2|||
147669216|NCT03427892|532615419|FG000|Overall Study|Lost to Follow-up|2|||
147669217|NCT03255187|532615420|FG000|Periodfrom Enrollment to First Follow-up|Withdrawal by Subject|1|||
147669218|NCT03255187|532615421|FG001|Periodfrom Enrollment to First Follow-up|Withdrawal by Subject|3|||
147669219|NCT03255187|532615420|FG000|Period From First to Second Follow-up|Withdrawal by Subject|0|||
147669220|NCT03255187|532615421|FG001|Period From First to Second Follow-up|Withdrawal by Subject|1|||
147669221|NCT02034006|532615422|FG000|Overall Study|Withdrawal by Subject|7|||
147669222|NCT02034006|532615422|FG000|Overall Study|Lost to Follow-up|5|||
147669223|NCT02034006|532615422|FG000|Overall Study|Death|1|||
147669224|NCT02034006|532615422|FG000|Overall Study|Pregnancy|1|||
147669225|NCT02934178|532615423|FG000|Received Vaccination 2|Death|0|||
147669226|NCT02934178|532615424|FG001|Received Vaccination 2|Death|1|||
147669227|NCT02934178|532615423|FG000|Received Vaccination 3|Withdrawal by Subject|1|||
147669228|NCT02934178|532615424|FG001|Received Vaccination 3|Withdrawal by Subject|0|||
147669229|NCT00296244|532615428|FG000|Overall Study|Underwent retransplant|0|||
147669230|NCT00296244|532615429|FG001|Overall Study|Underwent retransplant|1|||
147669231|NCT00703534|532615430|FG000|Overall Study|Adverse Event|14|||
147669232|NCT00703534|532615431|FG001|Overall Study|Adverse Event|3|||
147669233|NCT00703534|532615430|FG000|Overall Study|Withdrawal by Subject|8|||
147669234|NCT00703534|532615431|FG001|Overall Study|Withdrawal by Subject|7|||
147669235|NCT00703534|532615430|FG000|Overall Study|Incorrect Enrollment|6|||
147669236|NCT00703534|532615431|FG001|Overall Study|Incorrect Enrollment|6|||
147669237|NCT00703534|532615430|FG000|Overall Study|Lost to Follow-up|1|||
147669238|NCT00703534|532615431|FG001|Overall Study|Lost to Follow-up|4|||
147669239|NCT00703534|532615430|FG000|Overall Study|Severe Non Compliance|1|||
147669240|NCT00703534|532615431|FG001|Overall Study|Severe Non Compliance|5|||
147669241|NCT01125930|532615432|FG000|Overall Study|Adverse Event|0|||
147669242|NCT01125930|532615433|FG001|Overall Study|Adverse Event|1|||
147669243|NCT01125930|532615432|FG000|Overall Study|Withdrawal by Subject|1|||
147669244|NCT01125930|532615433|FG001|Overall Study|Withdrawal by Subject|6|||
147669245|NCT01125930|532615432|FG000|Overall Study|Protocol Violation|0|||
147669246|NCT01125930|532615433|FG001|Overall Study|Protocol Violation|1|||
147669247|NCT01125930|532615432|FG000|Overall Study|Lost to Follow-up|0|||
147669248|NCT01125930|532615433|FG001|Overall Study|Lost to Follow-up|2|||
147669249|NCT03617588|532615434|FG000|Overall Study|Withdrawal by Subject|1|||
147669250|NCT03617588|532615435|FG001|Overall Study|Withdrawal by Subject|0|||
147505532|NCT00004732|532002819|FG001|Overall Study|Withdrawal by Subject|64|||
147505533|NCT00004732|532002818|FG000|Overall Study|Lost to Follow-up|33|||
147505534|NCT00004732|532002819|FG001|Overall Study|Lost to Follow-up|47|||
147505535|NCT01688635|532002822|FG000|Washout 1|Withdrawal by Subject|1|||
147505536|NCT01688635|532002823|FG001|Washout 1|Withdrawal by Subject|0|||
147505537|NCT01688635|532002822|FG000|Washout 1|Adverse Event|0|||
147669251|NCT03261401|532615436|FG000|Overall Study|Withdrawal by Subject|0|||
147669252|NCT03261401|532615437|FG001|Overall Study|Withdrawal by Subject|0|||
147669253|NCT03261401|532615438|FG002|Overall Study|Withdrawal by Subject|0|||
147669254|NCT03261401|532615439|FG003|Overall Study|Withdrawal by Subject|0|||
147669255|NCT03261401|532615440|FG004|Overall Study|Withdrawal by Subject|0|||
147669256|NCT03261401|532615441|FG005|Overall Study|Withdrawal by Subject|1|||
147669257|NCT03261401|532615442|FG006|Overall Study|Withdrawal by Subject|0|||
147669258|NCT03261401|532615443|FG007|Overall Study|Withdrawal by Subject|0|||
147669259|NCT03261401|532615444|FG008|Overall Study|Withdrawal by Subject|0|||
147505538|NCT01688635|532002823|FG001|Washout 1|Adverse Event|1|||
147505539|NCT01688635|532002822|FG000|Washout 1|Physician Decision|0|||
147638521|NCT01647516|532493751|FG003|Maintenance Period (MP)|Adverse Event|0|||
147638522|NCT01647516|532493752|FG004|Maintenance Period (MP)|Adverse Event|0|||
147638523|NCT01647516|532493753|FG005|Maintenance Period (MP)|Adverse Event|0|||
147638524|NCT01647516|532493748|FG000|Maintenance Period (MP)|Non-compliance|1|||
147638525|NCT01647516|532493749|FG001|Maintenance Period (MP)|Non-compliance|0|||
147638526|NCT01647516|532493750|FG002|Maintenance Period (MP)|Non-compliance|0|||
147638527|NCT01647516|532493751|FG003|Maintenance Period (MP)|Non-compliance|0|||
147638528|NCT01647516|532493752|FG004|Maintenance Period (MP)|Non-compliance|0|||
147638529|NCT01647516|532493753|FG005|Maintenance Period (MP)|Non-compliance|0|||
147638530|NCT01647516|532493748|FG000|Maintenance Period (MP)|Withdrawal by Subject|0|||
147638531|NCT01647516|532493749|FG001|Maintenance Period (MP)|Withdrawal by Subject|1|||
147638532|NCT01647516|532493750|FG002|Maintenance Period (MP)|Withdrawal by Subject|1|||
147638533|NCT01647516|532493751|FG003|Maintenance Period (MP)|Withdrawal by Subject|0|||
147638534|NCT01647516|532493752|FG004|Maintenance Period (MP)|Withdrawal by Subject|0|||
147638535|NCT01647516|532493753|FG005|Maintenance Period (MP)|Withdrawal by Subject|0|||
147638536|NCT01647516|532493748|FG000|Maintenance Period (MP)|Lack of Efficacy|1|||
147638537|NCT01647516|532493749|FG001|Maintenance Period (MP)|Lack of Efficacy|4|||
147638538|NCT01647516|532493750|FG002|Maintenance Period (MP)|Lack of Efficacy|1|||
147638539|NCT01647516|532493751|FG003|Maintenance Period (MP)|Lack of Efficacy|0|||
147638540|NCT01647516|532493752|FG004|Maintenance Period (MP)|Lack of Efficacy|0|||
147638541|NCT01647516|532493753|FG005|Maintenance Period (MP)|Lack of Efficacy|0|||
147638542|NCT01647516|532493748|FG000|Open-Label Period|Adverse Event|0|||
147638543|NCT01647516|532493749|FG001|Open-Label Period|Adverse Event|0|||
147638544|NCT01647516|532493750|FG002|Open-Label Period|Adverse Event|0|||
147638545|NCT01647516|532493751|FG003|Open-Label Period|Adverse Event|5|||
147638546|NCT01647516|532493752|FG004|Open-Label Period|Adverse Event|6|||
147638547|NCT01647516|532493753|FG005|Open-Label Period|Adverse Event|3|||
147638548|NCT01647516|532493748|FG000|Open-Label Period|Pregnancy|0|||
147638549|NCT01647516|532493749|FG001|Open-Label Period|Pregnancy|0|||
147638550|NCT01647516|532493750|FG002|Open-Label Period|Pregnancy|0|||
147638551|NCT01647516|532493751|FG003|Open-Label Period|Pregnancy|0|||
147638552|NCT01647516|532493752|FG004|Open-Label Period|Pregnancy|0|||
147638553|NCT01647516|532493753|FG005|Open-Label Period|Pregnancy|1|||
147638554|NCT01647516|532493748|FG000|Open-Label Period|Non-compliance|0|||
147638555|NCT01647516|532493749|FG001|Open-Label Period|Non-compliance|0|||
147638556|NCT01647516|532493750|FG002|Open-Label Period|Non-compliance|0|||
147638557|NCT01647516|532493751|FG003|Open-Label Period|Non-compliance|1|||
147638558|NCT01647516|532493752|FG004|Open-Label Period|Non-compliance|0|||
147638559|NCT01647516|532493753|FG005|Open-Label Period|Non-compliance|1|||
147638560|NCT01647516|532493748|FG000|Open-Label Period|Physician Decision|0|||
147638561|NCT01647516|532493749|FG001|Open-Label Period|Physician Decision|0|||
147638562|NCT01647516|532493750|FG002|Open-Label Period|Physician Decision|0|||
147638563|NCT01647516|532493751|FG003|Open-Label Period|Physician Decision|1|||
147638564|NCT01647516|532493752|FG004|Open-Label Period|Physician Decision|1|||
147638565|NCT01647516|532493753|FG005|Open-Label Period|Physician Decision|0|||
147638566|NCT01647516|532493748|FG000|Open-Label Period|Withdrawal by Subject|0|||
147638567|NCT01647516|532493749|FG001|Open-Label Period|Withdrawal by Subject|0|||
147638568|NCT01647516|532493750|FG002|Open-Label Period|Withdrawal by Subject|0|||
147638569|NCT01647516|532493751|FG003|Open-Label Period|Withdrawal by Subject|9|||
147638570|NCT01647516|532493752|FG004|Open-Label Period|Withdrawal by Subject|11|||
147638571|NCT01647516|532493753|FG005|Open-Label Period|Withdrawal by Subject|6|||
147638572|NCT01647516|532493748|FG000|Open-Label Period|Lost to Follow-up|0|||
147638573|NCT01647516|532493749|FG001|Open-Label Period|Lost to Follow-up|0|||
147638574|NCT01647516|532493750|FG002|Open-Label Period|Lost to Follow-up|0|||
147638575|NCT01647516|532493751|FG003|Open-Label Period|Lost to Follow-up|1|||
147638576|NCT01647516|532493752|FG004|Open-Label Period|Lost to Follow-up|0|||
147638577|NCT01647516|532493753|FG005|Open-Label Period|Lost to Follow-up|1|||
147638578|NCT01647516|532493748|FG000|Open-Label Period|Sponsor Termination; moved to 3102 study|0|||
147638579|NCT01647516|532493749|FG001|Open-Label Period|Sponsor Termination; moved to 3102 study|0|||
147638580|NCT01647516|532493750|FG002|Open-Label Period|Sponsor Termination; moved to 3102 study|0|||
147638581|NCT01647516|532493751|FG003|Open-Label Period|Sponsor Termination; moved to 3102 study|18|||
147638582|NCT01647516|532493752|FG004|Open-Label Period|Sponsor Termination; moved to 3102 study|13|||
147638583|NCT01647516|532493753|FG005|Open-Label Period|Sponsor Termination; moved to 3102 study|23|||
147638584|NCT01647516|532493748|FG000|Open-Label Period|Lack of Efficacy|0|||
147638585|NCT01647516|532493749|FG001|Open-Label Period|Lack of Efficacy|0|||
147638586|NCT01647516|532493750|FG002|Open-Label Period|Lack of Efficacy|0|||
147638587|NCT01647516|532493751|FG003|Open-Label Period|Lack of Efficacy|7|||
147638588|NCT01647516|532493752|FG004|Open-Label Period|Lack of Efficacy|9|||
147638589|NCT01647516|532493753|FG005|Open-Label Period|Lack of Efficacy|10|||
147669260|NCT03261401|532615445|FG009|Overall Study|Withdrawal by Subject|0|||
147638590|NCT01647516|532493748|FG000|Open-Label Period|Participant Choice to Stop Study Drug|0|||
147638591|NCT01647516|532493749|FG001|Open-Label Period|Participant Choice to Stop Study Drug|0|||
147638592|NCT01647516|532493750|FG002|Open-Label Period|Participant Choice to Stop Study Drug|0|||
147638593|NCT01647516|532493751|FG003|Open-Label Period|Participant Choice to Stop Study Drug|7|||
147638594|NCT01647516|532493752|FG004|Open-Label Period|Participant Choice to Stop Study Drug|9|||
147638595|NCT01647516|532493753|FG005|Open-Label Period|Participant Choice to Stop Study Drug|10|||
147638596|NCT01647516|532493748|FG000|Open-Label Period|No completion / discontinuation visit|0|||
147638597|NCT01647516|532493749|FG001|Open-Label Period|No completion / discontinuation visit|0|||
147638598|NCT01647516|532493750|FG002|Open-Label Period|No completion / discontinuation visit|0|||
147638599|NCT01647516|532493751|FG003|Open-Label Period|No completion / discontinuation visit|0|||
147638600|NCT01647516|532493752|FG004|Open-Label Period|No completion / discontinuation visit|2|||
147638601|NCT01647516|532493753|FG005|Open-Label Period|No completion / discontinuation visit|1|||
147638602|NCT01613222|532493756|FG000|Overall Study|Physician Decision|1|||
147638603|NCT01613222|532493756|FG000|Overall Study|Unable to place arterial line|1|||
147638604|NCT01613222|532493756|FG000|Overall Study|Reused disposable sensors|10|||
147638605|NCT01895608|532493757|FG000|Overall Study|change in health status|0|||
147638606|NCT01895608|532493758|FG001|Overall Study|change in health status|1|||
147638607|NCT01895608|532493759|FG002|Overall Study|change in health status|1|||
147638608|NCT01895608|532493760|FG003|Overall Study|change in health status|0|||
147638609|NCT01895608|532493757|FG000|Overall Study|Withdrawal by Subject|0|||
147638610|NCT01895608|532493758|FG001|Overall Study|Withdrawal by Subject|0|||
147638611|NCT01895608|532493759|FG002|Overall Study|Withdrawal by Subject|2|||
147638612|NCT01895608|532493760|FG003|Overall Study|Withdrawal by Subject|0|||
147638613|NCT03505593|532493761|FG000|Overall Study|Withdrawal by Subject|1|||
147638614|NCT03505593|532493761|FG000|Overall Study|Died before procedure|1|||
147638615|NCT03505593|532493761|FG000|Overall Study|Anatomical abnormality|1|||
147638616|NCT03505593|532493761|FG000|Overall Study|Unable to pass through esophagus|1|||
147638617|NCT03505593|532493761|FG000|Overall Study|Obstruction by Endotracheal tube|1|||
147638618|NCT02855359|532493765|FG000|Overall Study|Death|2|||
147638619|NCT02855359|532493766|FG001|Overall Study|Death|2|||
147638620|NCT02855359|532493767|FG002|Overall Study|Death|0|||
147638621|NCT02855359|532493768|FG003|Overall Study|Death|0|||
147638622|NCT02855359|532493765|FG000|Overall Study|Study Termination by Sponsor|9|||
147638623|NCT02855359|532493766|FG001|Overall Study|Study Termination by Sponsor|11|||
147638624|NCT02855359|532493767|FG002|Overall Study|Study Termination by Sponsor|0|||
147638625|NCT02855359|532493768|FG003|Overall Study|Study Termination by Sponsor|0|||
147638626|NCT03155178|532493769|FG000|Overall Study|Did not meet treatment day baseline|7|||
147638627|NCT03155178|532493770|FG001|Overall Study|Did not meet treatment day baseline|7|||
147638628|NCT03155178|532493771|FG002|Overall Study|Did not meet treatment day baseline|7|||
147638629|NCT03155178|532493772|FG003|Overall Study|Did not meet treatment day baseline|7|||
147638630|NCT04712019|532493773|FG000|Overall Study|Withdrawal by Subject|2|||
147638631|NCT04712019|532493774|FG001|Overall Study|Withdrawal by Subject|2|||
147638632|NCT04712019|532493773|FG000|Overall Study|Protocol required withdrawal - crossover treatment|1|||
147638633|NCT04712019|532493774|FG001|Overall Study|Protocol required withdrawal - crossover treatment|1|||
147638634|NCT02347891|532493780|FG000|Week 0 - Week 40 (Randomized Phase)|Lost to Follow-up|2|||
147638635|NCT02347891|532493781|FG001|Week 0 - Week 40 (Randomized Phase)|Lost to Follow-up|1|||
147638636|NCT02347891|532493780|FG000|Week 40 - Week 64 (Open Lable Phase)|Lost to Follow-up|1|||
147638637|NCT02347891|532493781|FG001|Week 40 - Week 64 (Open Lable Phase)|Lost to Follow-up|1|||
147638638|NCT02541669|532493784|FG000|Double-Blinded Treatment Period|Withdrawal by Subject|0|||
147638639|NCT02541669|532493785|FG001|Double-Blinded Treatment Period|Withdrawal by Subject|0|||
147638640|NCT02541669|532493786|FG002|Double-Blinded Treatment Period|Withdrawal by Subject|1|||
147638641|NCT02541669|532493787|FG003|Double-Blinded Treatment Period|Withdrawal by Subject|0|||
147638642|NCT02541669|532493788|FG004|Double-Blinded Treatment Period|Withdrawal by Subject|1|||
147638643|NCT04739722|532493789|FG000|Overall Study|Lost to Follow-up|5301|||
147638644|NCT04739722|532493789|FG000|Overall Study|Withdrawal by Subject|42|||
147638645|NCT04739722|532493789|FG000|Overall Study|Non Average-risk|1157|||
147638646|NCT00834639|532493790|FG000|Second Intervention|Physician Decision|0|||
147638647|NCT00834639|532493791|FG001|Second Intervention|Physician Decision|2|||
147638648|NCT03729570|532493793|FG000|Overall Study|Lost to Follow-up|16|||
147638649|NCT03729570|532493794|FG001|Overall Study|Lost to Follow-up|20|||
147638650|NCT03729570|532493793|FG000|Overall Study|Seroconversion|5|||
147638651|NCT03729570|532493794|FG001|Overall Study|Seroconversion|0|||
147638652|NCT03729570|532493793|FG000|Overall Study|Moved out of the city|1|||
147638653|NCT03729570|532493794|FG001|Overall Study|Moved out of the city|0|||
147638654|NCT03729570|532493793|FG000|Overall Study|Time Conflict|1|||
147638655|NCT03729570|532493794|FG001|Overall Study|Time Conflict|0|||
147638656|NCT03729570|532493793|FG000|Overall Study|Time Commitment|2|||
147638657|NCT03729570|532493794|FG001|Overall Study|Time Commitment|0|||
147638658|NCT03729570|532493793|FG000|Overall Study|Bad Experience|0|||
147638659|NCT03729570|532493794|FG001|Overall Study|Bad Experience|1|||
147638660|NCT03729570|532493793|FG000|Overall Study|No reason provided|2|||
147638661|NCT03729570|532493794|FG001|Overall Study|No reason provided|1|||
147638662|NCT03729570|532493793|FG000|Overall Study|Family Conflict|0|||
147638663|NCT03729570|532493794|FG001|Overall Study|Family Conflict|1|||
147638664|NCT03729570|532493793|FG000|Overall Study|Did not want to continue taking medications|0|||
147638665|NCT03729570|532493794|FG001|Overall Study|Did not want to continue taking medications|1|||
147638666|NCT03729570|532493793|FG000|Overall Study|Found another PrEP provider|1|||
147638667|NCT03729570|532493794|FG001|Overall Study|Found another PrEP provider|0|||
147638668|NCT03729570|532493793|FG000|Overall Study|Did not enjoy being in the control group|0|||
147638669|NCT03729570|532493794|FG001|Overall Study|Did not enjoy being in the control group|1|||
147638670|NCT00278148|532493797|FG000|Phase II - Expansion Phase|Disease progression|0|||
147638671|NCT00278148|532493798|FG001|Phase II - Expansion Phase|Disease progression|0|||
147638672|NCT00278148|532493799|FG002|Phase II - Expansion Phase|Disease progression|4|||
147638673|NCT00278148|532493797|FG000|Phase II - Expansion Phase|Adverse Event|0|||
147638674|NCT00278148|532493798|FG001|Phase II - Expansion Phase|Adverse Event|0|||
147638675|NCT00278148|532493799|FG002|Phase II - Expansion Phase|Adverse Event|2|||
147638676|NCT02083185|532493801|FG000|Overall Study|Lost to Follow-up|0|||
147638677|NCT02083185|532493802|FG001|Overall Study|Lost to Follow-up|3|||
147638678|NCT02083185|532493803|FG002|Overall Study|Lost to Follow-up|0|||
147638679|NCT02083185|532493801|FG000|Overall Study|Withdrawal by Subject|9|||
147638680|NCT02083185|532493802|FG001|Overall Study|Withdrawal by Subject|15|||
147638681|NCT02083185|532493803|FG002|Overall Study|Withdrawal by Subject|1|||
147638682|NCT02083185|532493801|FG000|Overall Study|Death|2|||
147638683|NCT02083185|532493802|FG001|Overall Study|Death|2|||
147638684|NCT02083185|532493803|FG002|Overall Study|Death|1|||
147638685|NCT02083185|532493801|FG000|Overall Study|Reason not Specified|9|||
147638686|NCT02083185|532493802|FG001|Overall Study|Reason not Specified|6|||
147638687|NCT02083185|532493803|FG002|Overall Study|Reason not Specified|5|||
147638688|NCT02083185|532493801|FG000|Overall Study|Study Terminated by Sponsor|0|||
147638689|NCT02083185|532493802|FG001|Overall Study|Study Terminated by Sponsor|1|||
147638690|NCT02083185|532493803|FG002|Overall Study|Study Terminated by Sponsor|0|||
147638691|NCT02083185|532493801|FG000|Overall Study|Did not Receive Study Drug|0|||
147638692|NCT02083185|532493802|FG001|Overall Study|Did not Receive Study Drug|2|||
147638693|NCT02083185|532493803|FG002|Overall Study|Did not Receive Study Drug|0|||
147638694|NCT03419598|532493804|FG000|Overall Study|Poor quality CT scans could not be adequately segmented to create virtual patient tibial geometry|2|||
147638695|NCT00985959|532493808|FG000|Overall Study|Adverse Event|0|||
147638696|NCT00985959|532493809|FG001|Overall Study|Adverse Event|0|||
147638697|NCT00985959|532493810|FG002|Overall Study|Adverse Event|19|||
147638698|NCT00985959|532493808|FG000|Overall Study|Withdrawal by Subject|0|||
147638699|NCT00985959|532493809|FG001|Overall Study|Withdrawal by Subject|0|||
147638700|NCT00985959|532493810|FG002|Overall Study|Withdrawal by Subject|8|||
147638701|NCT00985959|532493808|FG000|Overall Study|Progressive disease|1|||
147638702|NCT00985959|532493809|FG001|Overall Study|Progressive disease|2|||
147638703|NCT00985959|532493810|FG002|Overall Study|Progressive disease|8|||
147638704|NCT00985959|532493808|FG000|Overall Study|Unrecovered toxicity|0|||
147638705|NCT00985959|532493809|FG001|Overall Study|Unrecovered toxicity|0|||
147638706|NCT00985959|532493810|FG002|Overall Study|Unrecovered toxicity|7|||
147638707|NCT00985959|532493808|FG000|Overall Study|Pneumonitis or pulmonary fibrosis|2|||
147638708|NCT00985959|532493809|FG001|Overall Study|Pneumonitis or pulmonary fibrosis|0|||
147638709|NCT00985959|532493810|FG002|Overall Study|Pneumonitis or pulmonary fibrosis|2|||
147638710|NCT00985959|532493808|FG000|Overall Study|Complete response observed over 2 cycles|0|||
147638711|NCT00985959|532493809|FG001|Overall Study|Complete response observed over 2 cycles|1|||
147638712|NCT00985959|532493810|FG002|Overall Study|Complete response observed over 2 cycles|4|||
147638713|NCT00985959|532493808|FG000|Overall Study|Other|0|||
147638714|NCT00985959|532493809|FG001|Overall Study|Other|0|||
147638715|NCT00985959|532493810|FG002|Overall Study|Other|11|||
147638716|NCT03055494|532495599|FG000|Overall Study|Lost to Follow-up|6|||
147638717|NCT03055494|532495600|FG001|Overall Study|Lost to Follow-up|0|||
147638718|NCT03055494|532495599|FG000|Overall Study|Physician Decision|2|||
147638719|NCT03055494|532495600|FG001|Overall Study|Physician Decision|0|||
147638720|NCT03055494|532495599|FG000|Overall Study|Withdrawal by Subject|1|||
147638721|NCT03055494|532495600|FG001|Overall Study|Withdrawal by Subject|0|||
147638722|NCT03055494|532495599|FG000|Overall Study|Adverse Event|0|||
147638723|NCT03055494|532495600|FG001|Overall Study|Adverse Event|1|||
147638724|NCT03055494|532495599|FG000|Overall Study|Non-compliance with study treatment|1|||
147638725|NCT03055494|532495600|FG001|Overall Study|Non-compliance with study treatment|0|||
147638726|NCT03197467|532495603|FG000|Overall Study|Withdrawal by Subject|1|||
147638727|NCT04338269|532495607|FG000|Overall Study|Death|86|||
147638728|NCT04338269|532495608|FG001|Overall Study|Death|89|||
147638729|NCT04338269|532495607|FG000|Overall Study|Lost to Follow-up|1|||
147638730|NCT04338269|532495608|FG001|Overall Study|Lost to Follow-up|2|||
147638731|NCT04338269|532495607|FG000|Overall Study|Physician Decision|1|||
147638732|NCT04338269|532495608|FG001|Overall Study|Physician Decision|0|||
147638733|NCT04338269|532495607|FG000|Overall Study|Withdrawal by Subject|14|||
147638734|NCT04338269|532495608|FG001|Overall Study|Withdrawal by Subject|11|||
147638735|NCT02424630|532495610|FG000|Overall Study|No rotator cuff tear|1|||
147638736|NCT02424630|532495611|FG001|Overall Study|No rotator cuff tear|2|||
147638737|NCT02424630|532495610|FG000|Overall Study|Open procedure|0|||
147638738|NCT02424630|532495611|FG001|Overall Study|Open procedure|1|||
147638739|NCT02031640|532495612|FG000|Screening Period|Adverse Event|1|||
147638740|NCT02031640|532495613|FG001|Screening Period|Adverse Event|0|||
147638741|NCT02031640|532495614|FG002|Screening Period|Adverse Event|0|||
147638742|NCT02031640|532495615|FG003|Screening Period|Adverse Event|0|||
147505540|NCT01688635|532002823|FG001|Washout 1|Physician Decision|1|||
147505541|NCT01688635|532002822|FG000|Washout 2|Physician Decision|1|||
147638743|NCT02031640|532495616|FG004|Screening Period|Adverse Event|0|||
147638744|NCT02031640|532495617|FG005|Screening Period|Adverse Event|0|||
147638745|NCT02031640|532495612|FG000|Screening Period|Withdrawal by Subject|29|||
147638746|NCT02031640|532495613|FG001|Screening Period|Withdrawal by Subject|0|||
147638747|NCT02031640|532495614|FG002|Screening Period|Withdrawal by Subject|0|||
147638748|NCT02031640|532495615|FG003|Screening Period|Withdrawal by Subject|0|||
147638749|NCT02031640|532495616|FG004|Screening Period|Withdrawal by Subject|0|||
147638750|NCT02031640|532495617|FG005|Screening Period|Withdrawal by Subject|0|||
147638751|NCT02031640|532495612|FG000|Screening Period|Inclusion criteria not met|312|||
147638752|NCT02031640|532495613|FG001|Screening Period|Inclusion criteria not met|0|||
147638753|NCT02031640|532495614|FG002|Screening Period|Inclusion criteria not met|0|||
147638754|NCT02031640|532495615|FG003|Screening Period|Inclusion criteria not met|0|||
147638755|NCT02031640|532495616|FG004|Screening Period|Inclusion criteria not met|0|||
147638756|NCT02031640|532495617|FG005|Screening Period|Inclusion criteria not met|0|||
147638757|NCT02031640|532495612|FG000|Screening Period|Exclusion criteria met|30|||
147638758|NCT02031640|532495613|FG001|Screening Period|Exclusion criteria met|0|||
147638759|NCT02031640|532495614|FG002|Screening Period|Exclusion criteria met|0|||
147638760|NCT02031640|532495615|FG003|Screening Period|Exclusion criteria met|0|||
147638761|NCT02031640|532495616|FG004|Screening Period|Exclusion criteria met|0|||
147638762|NCT02031640|532495617|FG005|Screening Period|Exclusion criteria met|0|||
147638763|NCT02031640|532495612|FG000|Screening Period|Lost to Follow-up|14|||
147638764|NCT02031640|532495613|FG001|Screening Period|Lost to Follow-up|0|||
147638765|NCT02031640|532495614|FG002|Screening Period|Lost to Follow-up|0|||
147638766|NCT02031640|532495615|FG003|Screening Period|Lost to Follow-up|0|||
147638767|NCT02031640|532495616|FG004|Screening Period|Lost to Follow-up|0|||
147638768|NCT02031640|532495617|FG005|Screening Period|Lost to Follow-up|0|||
147638769|NCT02031640|532495612|FG000|Screening Period|Enrollment closed|26|||
147638770|NCT02031640|532495613|FG001|Screening Period|Enrollment closed|0|||
147638771|NCT02031640|532495614|FG002|Screening Period|Enrollment closed|0|||
147638772|NCT02031640|532495615|FG003|Screening Period|Enrollment closed|0|||
147638773|NCT02031640|532495616|FG004|Screening Period|Enrollment closed|0|||
147638774|NCT02031640|532495617|FG005|Screening Period|Enrollment closed|0|||
147638775|NCT02031640|532495612|FG000|Run-In Period|Adverse Event|4|||
147638776|NCT02031640|532495613|FG001|Run-In Period|Adverse Event|0|||
147638777|NCT02031640|532495614|FG002|Run-In Period|Adverse Event|0|||
147638778|NCT02031640|532495615|FG003|Run-In Period|Adverse Event|0|||
147638779|NCT02031640|532495616|FG004|Run-In Period|Adverse Event|0|||
147638780|NCT02031640|532495617|FG005|Run-In Period|Adverse Event|0|||
147638781|NCT02031640|532495612|FG000|Run-In Period|Withdrawal by Subject|17|||
147638782|NCT02031640|532495613|FG001|Run-In Period|Withdrawal by Subject|0|||
147638783|NCT02031640|532495614|FG002|Run-In Period|Withdrawal by Subject|0|||
147638784|NCT02031640|532495615|FG003|Run-In Period|Withdrawal by Subject|0|||
147638785|NCT02031640|532495616|FG004|Run-In Period|Withdrawal by Subject|0|||
147638786|NCT02031640|532495617|FG005|Run-In Period|Withdrawal by Subject|0|||
147638787|NCT02031640|532495612|FG000|Run-In Period|Inclusion criteria not met|38|||
147638788|NCT02031640|532495613|FG001|Run-In Period|Inclusion criteria not met|0|||
147638789|NCT02031640|532495614|FG002|Run-In Period|Inclusion criteria not met|0|||
147638790|NCT02031640|532495615|FG003|Run-In Period|Inclusion criteria not met|0|||
147638791|NCT02031640|532495616|FG004|Run-In Period|Inclusion criteria not met|0|||
147638792|NCT02031640|532495617|FG005|Run-In Period|Inclusion criteria not met|0|||
147638793|NCT02031640|532495612|FG000|Run-In Period|Exclusion criteria met|8|||
147638794|NCT02031640|532495613|FG001|Run-In Period|Exclusion criteria met|0|||
147638795|NCT02031640|532495614|FG002|Run-In Period|Exclusion criteria met|0|||
147638796|NCT02031640|532495615|FG003|Run-In Period|Exclusion criteria met|0|||
147638797|NCT02031640|532495616|FG004|Run-In Period|Exclusion criteria met|0|||
147638798|NCT02031640|532495617|FG005|Run-In Period|Exclusion criteria met|0|||
147638799|NCT02031640|532495612|FG000|Run-In Period|Randomization criteria not met|85|||
147638800|NCT02031640|532495613|FG001|Run-In Period|Randomization criteria not met|0|||
147638801|NCT02031640|532495614|FG002|Run-In Period|Randomization criteria not met|0|||
147638802|NCT02031640|532495615|FG003|Run-In Period|Randomization criteria not met|0|||
147638803|NCT02031640|532495616|FG004|Run-In Period|Randomization criteria not met|0|||
147638804|NCT02031640|532495617|FG005|Run-In Period|Randomization criteria not met|0|||
147638805|NCT02031640|532495612|FG000|Run-In Period|Various administrative reasons|17|||
147638806|NCT02031640|532495613|FG001|Run-In Period|Various administrative reasons|0|||
147638807|NCT02031640|532495614|FG002|Run-In Period|Various administrative reasons|0|||
147638808|NCT02031640|532495615|FG003|Run-In Period|Various administrative reasons|0|||
147638809|NCT02031640|532495616|FG004|Run-In Period|Various administrative reasons|0|||
147638810|NCT02031640|532495617|FG005|Run-In Period|Various administrative reasons|0|||
147638811|NCT02031640|532495612|FG000|Double-blind Treatment Period|Protocol deviation|0|||
147638812|NCT02031640|532495613|FG001|Double-blind Treatment Period|Protocol deviation|2|||
147638813|NCT02031640|532495614|FG002|Double-blind Treatment Period|Protocol deviation|0|||
147638814|NCT02031640|532495615|FG003|Double-blind Treatment Period|Protocol deviation|1|||
147638815|NCT02031640|532495616|FG004|Double-blind Treatment Period|Protocol deviation|3|||
147638816|NCT02031640|532495617|FG005|Double-blind Treatment Period|Protocol deviation|1|||
147638817|NCT02031640|532495612|FG000|Double-blind Treatment Period|Lack of Efficacy|0|||
147638818|NCT02031640|532495613|FG001|Double-blind Treatment Period|Lack of Efficacy|14|||
147638819|NCT02031640|532495614|FG002|Double-blind Treatment Period|Lack of Efficacy|3|||
147638820|NCT02031640|532495615|FG003|Double-blind Treatment Period|Lack of Efficacy|2|||
147638821|NCT02031640|532495616|FG004|Double-blind Treatment Period|Lack of Efficacy|5|||
147638822|NCT02031640|532495617|FG005|Double-blind Treatment Period|Lack of Efficacy|1|||
147638823|NCT02031640|532495612|FG000|Double-blind Treatment Period|Non-compliance|0|||
147638824|NCT02031640|532495613|FG001|Double-blind Treatment Period|Non-compliance|1|||
147638825|NCT02031640|532495614|FG002|Double-blind Treatment Period|Non-compliance|0|||
147638826|NCT02031640|532495615|FG003|Double-blind Treatment Period|Non-compliance|1|||
147638827|NCT02031640|532495616|FG004|Double-blind Treatment Period|Non-compliance|1|||
147638828|NCT02031640|532495617|FG005|Double-blind Treatment Period|Non-compliance|0|||
147638829|NCT02031640|532495612|FG000|Double-blind Treatment Period|Adverse Event|0|||
147638830|NCT02031640|532495613|FG001|Double-blind Treatment Period|Adverse Event|0|||
147638831|NCT02031640|532495614|FG002|Double-blind Treatment Period|Adverse Event|0|||
147638832|NCT02031640|532495615|FG003|Double-blind Treatment Period|Adverse Event|2|||
147638833|NCT02031640|532495616|FG004|Double-blind Treatment Period|Adverse Event|0|||
147638834|NCT02031640|532495617|FG005|Double-blind Treatment Period|Adverse Event|0|||
147638835|NCT02031640|532495612|FG000|Double-blind Treatment Period|Withdrawal by Subject|0|||
147638836|NCT02031640|532495613|FG001|Double-blind Treatment Period|Withdrawal by Subject|2|||
147638837|NCT02031640|532495614|FG002|Double-blind Treatment Period|Withdrawal by Subject|3|||
147638838|NCT02031640|532495615|FG003|Double-blind Treatment Period|Withdrawal by Subject|1|||
147638839|NCT02031640|532495616|FG004|Double-blind Treatment Period|Withdrawal by Subject|1|||
147638840|NCT02031640|532495617|FG005|Double-blind Treatment Period|Withdrawal by Subject|1|||
147638841|NCT02031640|532495612|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
147638842|NCT02031640|532495613|FG001|Double-blind Treatment Period|Lost to Follow-up|3|||
147638843|NCT02031640|532495614|FG002|Double-blind Treatment Period|Lost to Follow-up|0|||
147638844|NCT02031640|532495615|FG003|Double-blind Treatment Period|Lost to Follow-up|0|||
147638845|NCT02031640|532495616|FG004|Double-blind Treatment Period|Lost to Follow-up|1|||
147638846|NCT02031640|532495617|FG005|Double-blind Treatment Period|Lost to Follow-up|0|||
147638847|NCT01895270|532495618|FG000|Study Medications Induction (W1-4)|Withdrawal by Subject|0|||
147638848|NCT01895270|532495619|FG001|Study Medications Induction (W1-4)|Withdrawal by Subject|2|||
147638849|NCT01895270|532495618|FG000|Study Medications Induction (W1-4)|Vitals outside of ISR dosing parameters|3|||
147638850|NCT01895270|532495619|FG001|Study Medications Induction (W1-4)|Vitals outside of ISR dosing parameters|2|||
147638851|NCT01895270|532495618|FG000|Study Medications Induction (W1-4)|noncompliance- missed medications|3|||
147638852|NCT01895270|532495619|FG001|Study Medications Induction (W1-4)|noncompliance- missed medications|1|||
147638853|NCT01895270|532495618|FG000|Study Medications Induction (W1-4)|Blood pressure issues|0|||
147638854|NCT01895270|532495619|FG001|Study Medications Induction (W1-4)|Blood pressure issues|1|||
147638855|NCT01895270|532495618|FG000|Buprenorphine Taper (W5 to W6D3)|noncompliance - missed medication|3|||
147638856|NCT01895270|532495619|FG001|Buprenorphine Taper (W5 to W6D3)|noncompliance - missed medication|5|||
147638857|NCT01895270|532495618|FG000|Isradipine Taper (W7-8)|Lost to Follow-up|0|||
147638858|NCT01895270|532495619|FG001|Isradipine Taper (W7-8)|Lost to Follow-up|1|||
147638859|NCT01895270|532495618|FG000|Isradipine Taper (W7-8)|Withdrawal by Subject|0|||
147638860|NCT01895270|532495619|FG001|Isradipine Taper (W7-8)|Withdrawal by Subject|1|||
147638861|NCT03085238|532495620|FG000|Overall Study|Adverse Event|2|||
147638862|NCT03085238|532495620|FG000|Overall Study|Death|2|||
147638863|NCT01279070|532495621|FG000|Overall Study|Withdrawal by Subject|2|||
147638864|NCT01279070|532495622|FG001|Overall Study|Withdrawal by Subject|3|||
147638865|NCT01279070|532495621|FG000|Overall Study|Acute exacerbation|3|||
147638866|NCT01279070|532495622|FG001|Overall Study|Acute exacerbation|1|||
147638867|NCT01741792|532495623|FG000|Overall Study|Death|6|||
147638868|NCT01741792|532495624|FG001|Overall Study|Death|1|||
147638869|NCT01741792|532495625|FG002|Overall Study|Death|12|||
147638870|NCT00761280|532495626|FG000|Randomization to First Dose|Withdrawal by Subject|0|||
147638871|NCT00761280|532495627|FG001|Randomization to First Dose|Withdrawal by Subject|2|||
147638872|NCT00761280|532495626|FG000|Randomization to First Dose|Sponsor decision|1|||
147638873|NCT00761280|532495627|FG001|Randomization to First Dose|Sponsor decision|0|||
147638874|NCT00761280|532495626|FG000|Randomization to First Dose|Other|1|||
147638875|NCT00761280|532495627|FG001|Randomization to First Dose|Other|0|||
147638876|NCT00761280|532495626|FG000|First Dose to End of Study|End of trial|5|||
147638877|NCT00761280|532495627|FG001|First Dose to End of Study|End of trial|5|||
147638878|NCT00761280|532495626|FG000|First Dose to End of Study|Progressive disease|5|||
147638879|NCT00761280|532495627|FG001|First Dose to End of Study|Progressive disease|3|||
147638880|NCT00761280|532495626|FG000|First Dose to End of Study|Sponsor decision|1|||
147669261|NCT03261401|532615446|FG010|Overall Study|Withdrawal by Subject|0|||
147638881|NCT00761280|532495627|FG001|First Dose to End of Study|Sponsor decision|2|||
147638882|NCT00761280|532495626|FG000|First Dose to End of Study|Death|1|||
147638883|NCT00761280|532495627|FG001|First Dose to End of Study|Death|0|||
147669262|NCT03261401|532615447|FG011|Overall Study|Withdrawal by Subject|0|||
147669263|NCT03261401|532615448|FG012|Overall Study|Withdrawal by Subject|0|||
147669264|NCT03261401|532615436|FG000|Overall Study|Participant Unable To Attend Final Visit|0|||
147669265|NCT03261401|532615437|FG001|Overall Study|Participant Unable To Attend Final Visit|0|||
147669266|NCT03261401|532615438|FG002|Overall Study|Participant Unable To Attend Final Visit|0|||
147669267|NCT03261401|532615439|FG003|Overall Study|Participant Unable To Attend Final Visit|0|||
147669268|NCT03261401|532615440|FG004|Overall Study|Participant Unable To Attend Final Visit|0|||
147669269|NCT03261401|532615441|FG005|Overall Study|Participant Unable To Attend Final Visit|0|||
147669270|NCT03261401|532615442|FG006|Overall Study|Participant Unable To Attend Final Visit|0|||
147669271|NCT03261401|532615443|FG007|Overall Study|Participant Unable To Attend Final Visit|0|||
147669272|NCT03261401|532615444|FG008|Overall Study|Participant Unable To Attend Final Visit|0|||
147669273|NCT03261401|532615445|FG009|Overall Study|Participant Unable To Attend Final Visit|0|||
147669274|NCT03261401|532615446|FG010|Overall Study|Participant Unable To Attend Final Visit|0|||
147669275|NCT03261401|532615447|FG011|Overall Study|Participant Unable To Attend Final Visit|0|||
147669276|NCT03261401|532615448|FG012|Overall Study|Participant Unable To Attend Final Visit|1|||
147669277|NCT01715298|532615449|FG000|Overall Study|Lost to Follow-up|0|||
147669278|NCT01715298|532615450|FG001|Overall Study|Lost to Follow-up|2|||
147669279|NCT01715298|532615449|FG000|Overall Study|Patient/guardian decision|7|||
147669280|NCT01715298|532615450|FG001|Overall Study|Patient/guardian decision|9|||
147669281|NCT03248037|532615454|FG000|Overall Study|Withdrawal by Subject|6|||
147669282|NCT03248037|532615455|FG001|Overall Study|Withdrawal by Subject|9|||
147669283|NCT03248037|532615454|FG000|Overall Study|Adverse Event|15|||
147669284|NCT03248037|532615455|FG001|Overall Study|Adverse Event|0|||
147669285|NCT02765035|532615459|FG000|First Intervention (90 Days)|Adverse Event|1|||
147669286|NCT02765035|532615460|FG001|First Intervention (90 Days)|Adverse Event|1|||
147638884|NCT00761280|532495626|FG000|First Dose to End of Study|Lost to Follow-up|0|||
147638885|NCT00761280|532495627|FG001|First Dose to End of Study|Lost to Follow-up|1|||
147638886|NCT02256982|532495629|FG000|Overall Study|Disease Progression|0|||
147638887|NCT02256982|532495630|FG001|Overall Study|Disease Progression|1|||
147638888|NCT03614078|532495631|FG000|Overall Study|Withdrawal by Subject|2|||
147638889|NCT03614078|532495632|FG001|Overall Study|Withdrawal by Subject|2|||
147638890|NCT03614078|532495633|FG002|Overall Study|Withdrawal by Subject|3|||
147638891|NCT03614078|532495631|FG000|Overall Study|Participant Did Not Return for Visit|0|||
147638892|NCT03614078|532495632|FG001|Overall Study|Participant Did Not Return for Visit|1|||
147638893|NCT03614078|532495633|FG002|Overall Study|Participant Did Not Return for Visit|0|||
147638894|NCT03614078|532495631|FG000|Overall Study|High Neutrophils|0|||
147638895|NCT03614078|532495632|FG001|Overall Study|High Neutrophils|0|||
147638896|NCT03614078|532495633|FG002|Overall Study|High Neutrophils|2|||
147638897|NCT03614078|532495631|FG000|Overall Study|Patient Did Not Meet Eligibility|1|||
147638898|NCT03614078|532495632|FG001|Overall Study|Patient Did Not Meet Eligibility|0|||
147638899|NCT03614078|532495633|FG002|Overall Study|Patient Did Not Meet Eligibility|0|||
147638900|NCT03614078|532495631|FG000|Overall Study|Exacerbation of Psoriasis|0|||
147638901|NCT03614078|532495632|FG001|Overall Study|Exacerbation of Psoriasis|1|||
147638902|NCT03614078|532495633|FG002|Overall Study|Exacerbation of Psoriasis|0|||
147638903|NCT03614078|532495631|FG000|Overall Study|Adverse Event|0|||
147638904|NCT03614078|532495632|FG001|Overall Study|Adverse Event|2|||
147638905|NCT03614078|532495633|FG002|Overall Study|Adverse Event|0|||
147638906|NCT03614078|532495631|FG000|Overall Study|Dizziness and Rash|0|||
147638907|NCT03614078|532495632|FG001|Overall Study|Dizziness and Rash|1|||
147638908|NCT03614078|532495633|FG002|Overall Study|Dizziness and Rash|0|||
147638909|NCT04964544|532495636|FG000|Overall Study|Screen failure or other uncategorised|10|||
147638910|NCT04964544|532495636|FG000|Overall Study|Physician Decision|4|||
147638911|NCT04964544|532495636|FG000|Overall Study|Lost to Follow-up|9|||
147638912|NCT04964544|532495636|FG000|Overall Study|Withdrawal by Subject|18|||
147638913|NCT04964544|532495636|FG000|Overall Study|Death|1|||
147638914|NCT02833844|532495642|FG000|Double-Blind Period|Withdrawal by Subject|2|||
147638915|NCT02833844|532495643|FG001|Double-Blind Period|Withdrawal by Subject|3|||
147669287|NCT02765035|532615459|FG000|Second Intervention (30 Days)|Protocol Violation|2|||
147669288|NCT02765035|532615460|FG001|Second Intervention (30 Days)|Protocol Violation|2|||
147669289|NCT02732639|532615466|FG000|Overall Study|Lost to Follow-up|1|||
147638916|NCT02833844|532495642|FG000|Double-Blind Period|Protocol Violation|0|||
147638917|NCT02833844|532495643|FG001|Double-Blind Period|Protocol Violation|4|||
147638918|NCT02833844|532495642|FG000|Open-Label Period|Death|0|||
147669290|NCT01668797|532615467|FG000|Phase A (Conversion Phase)|Lost to Follow-up|3|||
147669291|NCT01668797|532615468|FG001|Phase A (Conversion Phase)|Lost to Follow-up|0|||
147669292|NCT01668797|532615469|FG002|Phase A (Conversion Phase)|Lost to Follow-up|0|||
147669293|NCT01668797|532615470|FG003|Phase A (Conversion Phase)|Lost to Follow-up|0|||
147669294|NCT01668797|532615467|FG000|Phase A (Conversion Phase)|Met Withdrawal Criteria|3|||
147638919|NCT02833844|532495643|FG001|Open-Label Period|Death|2|||
147638920|NCT02833844|532495642|FG000|Open-Label Period|Lost to Follow-up|1|||
147638921|NCT02833844|532495643|FG001|Open-Label Period|Lost to Follow-up|0|||
147638922|NCT02833844|532495642|FG000|Open-Label Period|Withdrawal by Subject|1|||
147638923|NCT02833844|532495643|FG001|Open-Label Period|Withdrawal by Subject|0|||
147638924|NCT01899742|532495646|FG000|Overall Study|Adverse Event|5|||
147638925|NCT01899742|532495647|FG001|Overall Study|Adverse Event|4|||
147638926|NCT01899742|532495646|FG000|Overall Study|Lack of Efficacy|1|||
147638927|NCT01899742|532495647|FG001|Overall Study|Lack of Efficacy|5|||
147638928|NCT01899742|532495646|FG000|Overall Study|Protocol Violation|2|||
147638929|NCT01899742|532495647|FG001|Overall Study|Protocol Violation|2|||
147638930|NCT01899742|532495646|FG000|Overall Study|Withdrawal by Subject|9|||
147638931|NCT01899742|532495647|FG001|Overall Study|Withdrawal by Subject|5|||
147638932|NCT02662764|532495648|FG000|Overall Study|Adverse Event|6|||
147638933|NCT02662764|532495648|FG000|Overall Study|Lack of Efficacy|8|||
147638934|NCT02662764|532495648|FG000|Overall Study|Protocol Violation|1|||
147638935|NCT02662764|532495648|FG000|Overall Study|Withdrawal by Subject|5|||
147638936|NCT02662764|532495648|FG000|Overall Study|Device failure|4|||
147638937|NCT02662764|532495648|FG000|Overall Study|Patient changed treatment|1|||
147638938|NCT02662764|532495648|FG000|Overall Study|Patient discharged prior to 24 hrs|5|||
147638939|NCT00089778|532495655|FG000|Overall Study|Protocol Violation|0|||
147638940|NCT00089778|532495656|FG001|Overall Study|Protocol Violation|0|||
147638941|NCT00089778|532495657|FG002|Overall Study|Protocol Violation|1|||
147638942|NCT00177307|532495658|FG000|Overall Study|Withdrawal by Subject|1|||
147638943|NCT01104246|532495659|FG000|Overall Study|Withdrawal by Subject|1|||
147638944|NCT01104246|532495659|FG000|Overall Study|did not meet inclusion criteria|4|||
147638945|NCT01867294|532495666|FG000|Overall Study|Withdrawal by Subject|1|||
147638946|NCT01867294|532495667|FG001|Overall Study|Withdrawal by Subject|1|||
147638947|NCT01867294|532495668|FG002|Overall Study|Withdrawal by Subject|0|||
147638948|NCT01867294|532495669|FG003|Overall Study|Withdrawal by Subject|0|||
147638949|NCT00380081|532495672|FG000|Overall Study|Withdrawal by Subject|0|||
147638950|NCT00380081|532495673|FG001|Overall Study|Withdrawal by Subject|0|||
147638951|NCT00380081|532495674|FG002|Overall Study|Withdrawal by Subject|0|||
147638952|NCT00380081|532495675|FG003|Overall Study|Withdrawal by Subject|0|||
147638953|NCT00380081|532495676|FG004|Overall Study|Withdrawal by Subject|1|||
147638954|NCT00380081|532495677|FG005|Overall Study|Withdrawal by Subject|0|||
147638955|NCT00380081|532495672|FG000|Overall Study|Family Emergency|0|||
147638956|NCT00380081|532495673|FG001|Overall Study|Family Emergency|0|||
147638957|NCT00380081|532495674|FG002|Overall Study|Family Emergency|0|||
147638958|NCT00380081|532495675|FG003|Overall Study|Family Emergency|0|||
147638959|NCT00380081|532495676|FG004|Overall Study|Family Emergency|0|||
147638960|NCT00380081|532495677|FG005|Overall Study|Family Emergency|1|||
147638961|NCT00070018|532495678|FG000|Overall Study|Adverse Event|2|||
147638962|NCT00070018|532495678|FG000|Overall Study|Lack of Efficacy|1|||
147638963|NCT00070018|532495678|FG000|Overall Study|Withdrawal by Subject|1|||
147638964|NCT00574249|532495684|FG000|Overall Study|Adverse Event|6|||
147638965|NCT00574249|532495685|FG001|Overall Study|Adverse Event|18|||
147638966|NCT00574249|532495684|FG000|Overall Study|Lack of Efficacy|5|||
147638967|NCT00574249|532495685|FG001|Overall Study|Lack of Efficacy|3|||
147638968|NCT00574249|532495684|FG000|Overall Study|Lost to Follow-up|4|||
147638969|NCT00574249|532495685|FG001|Overall Study|Lost to Follow-up|3|||
147638970|NCT00574249|532495684|FG000|Overall Study|Protocol Violation|5|||
147638971|NCT00574249|532495685|FG001|Overall Study|Protocol Violation|2|||
147638972|NCT00574249|532495684|FG000|Overall Study|History of carcinoma|1|||
147638973|NCT00574249|532495685|FG001|Overall Study|History of carcinoma|0|||
147638974|NCT00574249|532495684|FG000|Overall Study|Withdrawal by Subject|3|||
147638975|NCT00574249|532495685|FG001|Overall Study|Withdrawal by Subject|0|||
147638976|NCT00574249|532495684|FG000|Overall Study|Physician Decision|1|||
147638977|NCT00574249|532495685|FG001|Overall Study|Physician Decision|0|||
147638978|NCT00574249|532495684|FG000|Overall Study|Pregnancy|1|||
147638979|NCT00574249|532495685|FG001|Overall Study|Pregnancy|0|||
147638980|NCT00574249|532495684|FG000|Overall Study|Excluded by company|0|||
147638981|NCT00574249|532495685|FG001|Overall Study|Excluded by company|1|||
147638982|NCT00574249|532495684|FG000|Overall Study|PPD test taken twice|0|||
147638983|NCT00574249|532495685|FG001|Overall Study|PPD test taken twice|1|||
147638984|NCT03197870|532495686|FG000|Overall Study|Adverse Event|9|||
147638985|NCT03197870|532495687|FG001|Overall Study|Adverse Event|4|||
147638986|NCT03197870|532495688|FG002|Overall Study|Adverse Event|6|||
147638987|NCT03197870|532495686|FG000|Overall Study|Withdrawal by Subject|2|||
147638988|NCT03197870|532495687|FG001|Overall Study|Withdrawal by Subject|3|||
147638989|NCT03197870|532495688|FG002|Overall Study|Withdrawal by Subject|0|||
147638990|NCT03197870|532495686|FG000|Overall Study|Lost to Follow-up|2|||
147638991|NCT03197870|532495687|FG001|Overall Study|Lost to Follow-up|2|||
147638992|NCT03197870|532495688|FG002|Overall Study|Lost to Follow-up|0|||
147638993|NCT03197870|532495686|FG000|Overall Study|data not available|1|||
147638994|NCT03197870|532495687|FG001|Overall Study|data not available|1|||
147638995|NCT03197870|532495688|FG002|Overall Study|data not available|0|||
147669295|NCT01668797|532615468|FG001|Phase A (Conversion Phase)|Met Withdrawal Criteria|0|||
147638996|NCT01508130|532495689|FG000|Overall Study|Adverse Event|81|||
147638997|NCT01508130|532495690|FG001|Overall Study|Adverse Event|28|||
147638998|NCT01508130|532495689|FG000|Overall Study|Death|3|||
147638999|NCT01508130|532495690|FG001|Overall Study|Death|1|||
147639000|NCT01508130|532495689|FG000|Overall Study|Protocol Violation|2|||
147639001|NCT01508130|532495690|FG001|Overall Study|Protocol Violation|0|||
147505542|NCT01688635|532002823|FG001|Washout 2|Physician Decision|0|||
147505543|NCT01688635|532002822|FG000|Washout 2|Withdrawal by Subject|1|||
147505544|NCT01688635|532002823|FG001|Washout 2|Withdrawal by Subject|0|||
147505545|NCT01688635|532002822|FG000|Washout 2|Sponsor Decision|1|||
147505546|NCT01688635|532002823|FG001|Washout 2|Sponsor Decision|2|||
147505547|NCT01688635|532002822|FG000|Washout 3|Withdrawal by Subject|1|||
147505548|NCT01688635|532002823|FG001|Washout 3|Withdrawal by Subject|0|||
147505549|NCT00367432|532002827|FG000|First Period (16 Weeks)|Adverse Event|6|||
147505550|NCT00367432|532002828|FG001|First Period (16 Weeks)|Adverse Event|0|||
147639002|NCT01508130|532495689|FG000|Overall Study|Lost to Follow-up|25|||
147639003|NCT01508130|532495690|FG001|Overall Study|Lost to Follow-up|2|||
147639004|NCT01508130|532495689|FG000|Overall Study|Withdrawal by Subject|3|||
147639005|NCT01508130|532495690|FG001|Overall Study|Withdrawal by Subject|3|||
147639006|NCT01508130|532495689|FG000|Overall Study|Subject's substantial non-compliance|25|||
147639007|NCT01508130|532495690|FG001|Overall Study|Subject's substantial non-compliance|9|||
147639008|NCT01508130|532495689|FG000|Overall Study|Insufficient therapeutic response|74|||
147639009|NCT01508130|532495690|FG001|Overall Study|Insufficient therapeutic response|23|||
147639010|NCT01508130|532495689|FG000|Overall Study|Administrative|14|||
147639011|NCT01508130|532495690|FG001|Overall Study|Administrative|3|||
147639012|NCT01680159|532495691|FG000|Screening Period|Not meet criteria for dose-up period|7|||
147639013|NCT01680159|532495691|FG000|Increased Dose Period|Adverse Event|6|||
147639014|NCT01680159|532495691|FG000|Increased Dose Period|Withdrawal by Subject|2|||
147639015|NCT02783729|532495695|FG000|Overall Study|Lack of Efficacy|1|||
147639016|NCT02783729|532495696|FG001|Overall Study|Lack of Efficacy|0|||
147639017|NCT02783729|532495697|FG002|Overall Study|Lack of Efficacy|0|||
147639018|NCT02783729|532495698|FG003|Overall Study|Lack of Efficacy|0|||
147639019|NCT02783729|532495695|FG000|Overall Study|Adverse Event|2|||
147639020|NCT02783729|532495696|FG001|Overall Study|Adverse Event|6|||
147639021|NCT02783729|532495697|FG002|Overall Study|Adverse Event|2|||
147639022|NCT02783729|532495698|FG003|Overall Study|Adverse Event|3|||
147639023|NCT02783729|532495695|FG000|Overall Study|Other|1|||
147639024|NCT02783729|532495696|FG001|Overall Study|Other|6|||
147639025|NCT02783729|532495697|FG002|Overall Study|Other|2|||
147639026|NCT02783729|532495698|FG003|Overall Study|Other|3|||
147639027|NCT02783729|532495695|FG000|Overall Study|Withdrawal by Subject|2|||
147639028|NCT02783729|532495696|FG001|Overall Study|Withdrawal by Subject|3|||
147639029|NCT02783729|532495697|FG002|Overall Study|Withdrawal by Subject|1|||
147639030|NCT02783729|532495698|FG003|Overall Study|Withdrawal by Subject|2|||
147639031|NCT02783729|532495695|FG000|Overall Study|Participant's choice|2|||
147639032|NCT02783729|532495696|FG001|Overall Study|Participant's choice|1|||
147639033|NCT02783729|532495697|FG002|Overall Study|Participant's choice|2|||
147639034|NCT02783729|532495698|FG003|Overall Study|Participant's choice|1|||
147639035|NCT02783729|532495695|FG000|Overall Study|Lost to Follow-up|2|||
147639036|NCT02783729|532495696|FG001|Overall Study|Lost to Follow-up|1|||
147639037|NCT02783729|532495697|FG002|Overall Study|Lost to Follow-up|1|||
147639038|NCT02783729|532495698|FG003|Overall Study|Lost to Follow-up|0|||
147639039|NCT04021121|532495701|FG000|Overall Study|Death|3|||
147639040|NCT04021121|532495702|FG001|Overall Study|Death|3|||
147639041|NCT04021121|532495703|FG002|Overall Study|Death|5|||
147639042|NCT04021121|532495704|FG003|Overall Study|Death|4|||
147639043|NCT02288091|532495707|FG000|Overall Study|Lost to Follow-up|1|||
147639044|NCT02288091|532495707|FG000|Overall Study|Screen fail|7|||
147639045|NCT03843632|532495713|FG000|Overall Study|Withdrawal by Subject|1|||
147639046|NCT03843632|532495714|FG001|Overall Study|Withdrawal by Subject|0|||
147639047|NCT03843632|532495715|FG002|Overall Study|Withdrawal by Subject|0|||
147639048|NCT03843632|532495716|FG003|Overall Study|Withdrawal by Subject|0|||
147639049|NCT03403751|532495717|FG000|Overall Study|Death|5|||
147639050|NCT03403751|532495718|FG001|Overall Study|Death|6|||
147639051|NCT03403751|532495717|FG000|Overall Study|Discontinuation (includes missing from Day 29)|2|||
147639052|NCT03403751|532495718|FG001|Overall Study|Discontinuation (includes missing from Day 29)|2|||
147639053|NCT05036668|532495719|FG000|Overall Study|lost to follow Up|0|||
147639054|NCT05036668|532495720|FG001|Overall Study|lost to follow Up|0|||
147639055|NCT05036668|532495721|FG002|Overall Study|lost to follow Up|1|||
147639056|NCT00471718|532495727|FG000|Overall Study|Adverse Event|3|||
147639057|NCT00471718|532495727|FG000|Overall Study|other complicating disease|1|||
147639058|NCT00471718|532495727|FG000|Overall Study|disease progression|22|||
147639059|NCT00471718|532495727|FG000|Overall Study|Withdrawal by Subject|1|||
147639060|NCT01446237|532495728|FG000|Overall Study|Adverse Event|1|||
147639061|NCT01446237|532495728|FG000|Overall Study|Lost to Follow-up|2|||
147639062|NCT01446237|532495728|FG000|Overall Study|Withdrawal by Subject|7|||
147639063|NCT01931956|532495729|FG000|Overall Study|Death|42|||
147639064|NCT01931956|532495730|FG001|Overall Study|Death|7|||
147669296|NCT01668797|532615469|FG002|Phase A (Conversion Phase)|Met Withdrawal Criteria|0|||
147505551|NCT00367432|532002827|FG000|First Period (16 Weeks)|Lack of Efficacy|24|||
147639065|NCT01931956|532495731|FG002|Overall Study|Death|379|||
147639066|NCT01931956|532495732|FG003|Overall Study|Death|96|||
147639067|NCT01931956|532495729|FG000|Overall Study|Withdrawal by Subject|5|||
147639068|NCT01931956|532495730|FG001|Overall Study|Withdrawal by Subject|0|||
147639069|NCT01931956|532495731|FG002|Overall Study|Withdrawal by Subject|70|||
147639070|NCT01931956|532495732|FG003|Overall Study|Withdrawal by Subject|30|||
147639071|NCT01931956|532495729|FG000|Overall Study|Lost to Follow-up|2|||
147639072|NCT01931956|532495730|FG001|Overall Study|Lost to Follow-up|0|||
147639073|NCT01931956|532495731|FG002|Overall Study|Lost to Follow-up|11|||
147639074|NCT01931956|532495732|FG003|Overall Study|Lost to Follow-up|7|||
147639075|NCT01931956|532495729|FG000|Overall Study|Expected|2|||
147639076|NCT01931956|532495730|FG001|Overall Study|Expected|0|||
147639077|NCT01931956|532495731|FG002|Overall Study|Expected|6|||
147639078|NCT01931956|532495732|FG003|Overall Study|Expected|0|||
147639079|NCT01931956|532495729|FG000|Overall Study|Not due|0|||
147639080|NCT01931956|532495730|FG001|Overall Study|Not due|0|||
147639081|NCT01931956|532495731|FG002|Overall Study|Not due|21|||
147639082|NCT01931956|532495732|FG003|Overall Study|Not due|0|||
147639083|NCT02272842|532495733|FG000|Overall Study|Lost to Follow-up|8|||
147639084|NCT02272842|532495734|FG001|Overall Study|Lost to Follow-up|8|||
147639085|NCT02272842|532495733|FG000|Overall Study|Withdrawal by Subject|8|||
147639086|NCT02272842|532495734|FG001|Overall Study|Withdrawal by Subject|2|||
147639087|NCT03666533|532497710|FG000|Overall Study|Lost to Follow-up|2|||
147639088|NCT03666533|532497711|FG001|Overall Study|Lost to Follow-up|2|||
147639089|NCT02017717|532497712|FG000|Before Treatment Period|Adverse Event unrelated to study drug|0|||
147639090|NCT02017717|532497713|FG001|Before Treatment Period|Adverse Event unrelated to study drug|0|||
147639091|NCT02017717|532497714|FG002|Before Treatment Period|Adverse Event unrelated to study drug|0|||
147639092|NCT02017717|532497715|FG003|Before Treatment Period|Adverse Event unrelated to study drug|0|||
147639093|NCT02017717|532497716|FG004|Before Treatment Period|Adverse Event unrelated to study drug|0|||
147639094|NCT02017717|532497717|FG005|Before Treatment Period|Adverse Event unrelated to study drug|0|||
147639095|NCT02017717|532497718|FG006|Before Treatment Period|Adverse Event unrelated to study drug|0|||
147639096|NCT02017717|532497719|FG007|Before Treatment Period|Adverse Event unrelated to study drug|1|||
147639097|NCT02017717|532497720|FG008|Before Treatment Period|Adverse Event unrelated to study drug|0|||
147639098|NCT02017717|532497712|FG000|Before Treatment Period|Participant request to stop therapy|0|||
147639099|NCT02017717|532497713|FG001|Before Treatment Period|Participant request to stop therapy|0|||
147639100|NCT02017717|532497714|FG002|Before Treatment Period|Participant request to stop therapy|0|||
147639101|NCT02017717|532497715|FG003|Before Treatment Period|Participant request to stop therapy|0|||
147639102|NCT02017717|532497716|FG004|Before Treatment Period|Participant request to stop therapy|0|||
147639103|NCT02017717|532497717|FG005|Before Treatment Period|Participant request to stop therapy|0|||
147639104|NCT02017717|532497718|FG006|Before Treatment Period|Participant request to stop therapy|0|||
147639105|NCT02017717|532497719|FG007|Before Treatment Period|Participant request to stop therapy|0|||
147639106|NCT02017717|532497720|FG008|Before Treatment Period|Participant request to stop therapy|5|||
147639107|NCT02017717|532497712|FG000|Before Treatment Period|Participant withdrew consent|0|||
147639108|NCT02017717|532497713|FG001|Before Treatment Period|Participant withdrew consent|0|||
147639109|NCT02017717|532497714|FG002|Before Treatment Period|Participant withdrew consent|0|||
147639110|NCT02017717|532497715|FG003|Before Treatment Period|Participant withdrew consent|0|||
147639111|NCT02017717|532497716|FG004|Before Treatment Period|Participant withdrew consent|0|||
147639112|NCT02017717|532497717|FG005|Before Treatment Period|Participant withdrew consent|0|||
147639113|NCT02017717|532497718|FG006|Before Treatment Period|Participant withdrew consent|2|||
147639114|NCT02017717|532497719|FG007|Before Treatment Period|Participant withdrew consent|0|||
147639115|NCT02017717|532497720|FG008|Before Treatment Period|Participant withdrew consent|11|||
147639116|NCT02017717|532497712|FG000|Before Treatment Period|Lost to Follow-up|0|||
147639117|NCT02017717|532497713|FG001|Before Treatment Period|Lost to Follow-up|0|||
147639118|NCT02017717|532497714|FG002|Before Treatment Period|Lost to Follow-up|0|||
147639119|NCT02017717|532497715|FG003|Before Treatment Period|Lost to Follow-up|0|||
147639120|NCT02017717|532497716|FG004|Before Treatment Period|Lost to Follow-up|0|||
147639121|NCT02017717|532497717|FG005|Before Treatment Period|Lost to Follow-up|0|||
147639122|NCT02017717|532497718|FG006|Before Treatment Period|Lost to Follow-up|0|||
147639123|NCT02017717|532497719|FG007|Before Treatment Period|Lost to Follow-up|0|||
147639124|NCT02017717|532497720|FG008|Before Treatment Period|Lost to Follow-up|1|||
147639125|NCT02017717|532497712|FG000|Before Treatment Period|Participant no longer met criteria|0|||
147639126|NCT02017717|532497713|FG001|Before Treatment Period|Participant no longer met criteria|0|||
147639127|NCT02017717|532497714|FG002|Before Treatment Period|Participant no longer met criteria|0|||
147639128|NCT02017717|532497715|FG003|Before Treatment Period|Participant no longer met criteria|0|||
147639129|NCT02017717|532497716|FG004|Before Treatment Period|Participant no longer met criteria|0|||
147639130|NCT02017717|532497717|FG005|Before Treatment Period|Participant no longer met criteria|1|||
147639131|NCT02017717|532497718|FG006|Before Treatment Period|Participant no longer met criteria|0|||
147639132|NCT02017717|532497719|FG007|Before Treatment Period|Participant no longer met criteria|1|||
147639133|NCT02017717|532497720|FG008|Before Treatment Period|Participant no longer met criteria|2|||
147505552|NCT00367432|532002828|FG001|First Period (16 Weeks)|Lack of Efficacy|0|||
147639134|NCT02017717|532497712|FG000|Before Treatment Period|other reason|0|||
147639135|NCT02017717|532497713|FG001|Before Treatment Period|other reason|0|||
147639136|NCT02017717|532497714|FG002|Before Treatment Period|other reason|0|||
147639137|NCT02017717|532497715|FG003|Before Treatment Period|other reason|0|||
147639138|NCT02017717|532497716|FG004|Before Treatment Period|other reason|0|||
147639139|NCT02017717|532497717|FG005|Before Treatment Period|other reason|0|||
147639140|NCT02017717|532497718|FG006|Before Treatment Period|other reason|0|||
147639141|NCT02017717|532497719|FG007|Before Treatment Period|other reason|0|||
147639142|NCT02017717|532497720|FG008|Before Treatment Period|other reason|1|||
147639143|NCT02017717|532497712|FG000|Treatment Period|Disease progression|7|||
147639144|NCT02017717|532497713|FG001|Treatment Period|Disease progression|9|||
147639145|NCT02017717|532497714|FG002|Treatment Period|Disease progression|12|||
147639146|NCT02017717|532497715|FG003|Treatment Period|Disease progression|20|||
147639147|NCT02017717|532497716|FG004|Treatment Period|Disease progression|26|||
147639148|NCT02017717|532497717|FG005|Treatment Period|Disease progression|16|||
147639149|NCT02017717|532497718|FG006|Treatment Period|Disease progression|22|||
147639150|NCT02017717|532497719|FG007|Treatment Period|Disease progression|165|||
147639151|NCT02017717|532497720|FG008|Treatment Period|Disease progression|135|||
147639152|NCT02017717|532497712|FG000|Treatment Period|Study drug toxicity|3|||
147639153|NCT02017717|532497713|FG001|Treatment Period|Study drug toxicity|0|||
147639154|NCT02017717|532497714|FG002|Treatment Period|Study drug toxicity|1|||
147639155|NCT02017717|532497715|FG003|Treatment Period|Study drug toxicity|4|||
147639156|NCT02017717|532497716|FG004|Treatment Period|Study drug toxicity|4|||
147639157|NCT02017717|532497717|FG005|Treatment Period|Study drug toxicity|5|||
147639158|NCT02017717|532497718|FG006|Treatment Period|Study drug toxicity|3|||
147639159|NCT02017717|532497719|FG007|Treatment Period|Study drug toxicity|7|||
147639160|NCT02017717|532497720|FG008|Treatment Period|Study drug toxicity|11|||
147639161|NCT02017717|532497712|FG000|Treatment Period|Death|0|||
147639162|NCT02017717|532497713|FG001|Treatment Period|Death|0|||
147639163|NCT02017717|532497714|FG002|Treatment Period|Death|1|||
147639164|NCT02017717|532497715|FG003|Treatment Period|Death|0|||
147639165|NCT02017717|532497716|FG004|Treatment Period|Death|0|||
147639166|NCT02017717|532497717|FG005|Treatment Period|Death|2|||
147639167|NCT02017717|532497718|FG006|Treatment Period|Death|0|||
147639168|NCT02017717|532497719|FG007|Treatment Period|Death|0|||
147639169|NCT02017717|532497720|FG008|Treatment Period|Death|0|||
147639170|NCT02017717|532497712|FG000|Treatment Period|Adverse event unrelated to study drug|0|||
147639171|NCT02017717|532497713|FG001|Treatment Period|Adverse event unrelated to study drug|0|||
147639172|NCT02017717|532497714|FG002|Treatment Period|Adverse event unrelated to study drug|2|||
147639173|NCT02017717|532497715|FG003|Treatment Period|Adverse event unrelated to study drug|0|||
147639174|NCT02017717|532497716|FG004|Treatment Period|Adverse event unrelated to study drug|0|||
147639175|NCT02017717|532497717|FG005|Treatment Period|Adverse event unrelated to study drug|0|||
147639176|NCT02017717|532497718|FG006|Treatment Period|Adverse event unrelated to study drug|1|||
147639177|NCT02017717|532497719|FG007|Treatment Period|Adverse event unrelated to study drug|4|||
147639178|NCT02017717|532497720|FG008|Treatment Period|Adverse event unrelated to study drug|5|||
147639179|NCT02017717|532497712|FG000|Treatment Period|Participant request to stop therapy|0|||
147639180|NCT02017717|532497713|FG001|Treatment Period|Participant request to stop therapy|0|||
147639181|NCT02017717|532497714|FG002|Treatment Period|Participant request to stop therapy|3|||
147639182|NCT02017717|532497715|FG003|Treatment Period|Participant request to stop therapy|6|||
147639183|NCT02017717|532497716|FG004|Treatment Period|Participant request to stop therapy|0|||
147639184|NCT02017717|532497717|FG005|Treatment Period|Participant request to stop therapy|2|||
147639185|NCT02017717|532497718|FG006|Treatment Period|Participant request to stop therapy|1|||
147639186|NCT02017717|532497719|FG007|Treatment Period|Participant request to stop therapy|4|||
147639187|NCT02017717|532497720|FG008|Treatment Period|Participant request to stop therapy|7|||
147639188|NCT02017717|532497712|FG000|Treatment Period|Participant withdrew consent|0|||
147639189|NCT02017717|532497713|FG001|Treatment Period|Participant withdrew consent|0|||
147639190|NCT02017717|532497714|FG002|Treatment Period|Participant withdrew consent|1|||
147639191|NCT02017717|532497715|FG003|Treatment Period|Participant withdrew consent|0|||
147639192|NCT02017717|532497716|FG004|Treatment Period|Participant withdrew consent|0|||
147639193|NCT02017717|532497717|FG005|Treatment Period|Participant withdrew consent|2|||
147639194|NCT02017717|532497718|FG006|Treatment Period|Participant withdrew consent|0|||
147639195|NCT02017717|532497719|FG007|Treatment Period|Participant withdrew consent|1|||
147639196|NCT02017717|532497720|FG008|Treatment Period|Participant withdrew consent|4|||
147639197|NCT02017717|532497712|FG000|Treatment Period|Participant no longer met criteria|0|||
147639198|NCT02017717|532497713|FG001|Treatment Period|Participant no longer met criteria|0|||
147639199|NCT02017717|532497714|FG002|Treatment Period|Participant no longer met criteria|0|||
147639200|NCT02017717|532497715|FG003|Treatment Period|Participant no longer met criteria|0|||
147639201|NCT02017717|532497716|FG004|Treatment Period|Participant no longer met criteria|0|||
147639202|NCT02017717|532497717|FG005|Treatment Period|Participant no longer met criteria|0|||
147639203|NCT02017717|532497718|FG006|Treatment Period|Participant no longer met criteria|0|||
147639204|NCT02017717|532497719|FG007|Treatment Period|Participant no longer met criteria|0|||
147639205|NCT02017717|532497720|FG008|Treatment Period|Participant no longer met criteria|1|||
147639206|NCT02017717|532497712|FG000|Treatment Period|Other reasons|0|||
147639207|NCT02017717|532497713|FG001|Treatment Period|Other reasons|0|||
147639208|NCT02017717|532497714|FG002|Treatment Period|Other reasons|0|||
147669297|NCT01668797|532615470|FG003|Phase A (Conversion Phase)|Met Withdrawal Criteria|0|||
147505553|NCT00367432|532002827|FG000|First Period (16 Weeks)|Withdrawal by Subject|6|||
147505554|NCT00367432|532002828|FG001|First Period (16 Weeks)|Withdrawal by Subject|0|||
147505555|NCT00367432|532002827|FG000|First Period (16 Weeks)|Other Reason|2|||
147505556|NCT00367432|532002828|FG001|First Period (16 Weeks)|Other Reason|0|||
147505557|NCT00367432|532002827|FG000|Second Period (up to 54 Months)|Adverse Event|14|||
147505558|NCT00367432|532002828|FG001|Second Period (up to 54 Months)|Adverse Event|3|||
147505559|NCT00367432|532002827|FG000|Second Period (up to 54 Months)|Lack of Efficacy|59|||
147505560|NCT00367432|532002828|FG001|Second Period (up to 54 Months)|Lack of Efficacy|5|||
147505561|NCT00367432|532002827|FG000|Second Period (up to 54 Months)|Lost to Follow-up|0|||
147505562|NCT00367432|532002828|FG001|Second Period (up to 54 Months)|Lost to Follow-up|1|||
147505563|NCT00367432|532002827|FG000|Second Period (up to 54 Months)|Withdrawal by Subject|8|||
147505564|NCT00367432|532002828|FG001|Second Period (up to 54 Months)|Withdrawal by Subject|5|||
147505565|NCT00367432|532002827|FG000|Second Period (up to 54 Months)|Other Reason|6|||
147505566|NCT00367432|532002828|FG001|Second Period (up to 54 Months)|Other Reason|2|||
147505567|NCT05567393|532002829|FG000|Overall Study|Voluntary Withdrawal|0|||
147505568|NCT05567393|532002830|FG001|Overall Study|Voluntary Withdrawal|0|||
147505569|NCT05567393|532002831|FG002|Overall Study|Voluntary Withdrawal|0|||
147505570|NCT05567393|532002832|FG003|Overall Study|Voluntary Withdrawal|0|||
147505571|NCT05567393|532002833|FG004|Overall Study|Voluntary Withdrawal|0|||
147505572|NCT05567393|532002834|FG005|Overall Study|Voluntary Withdrawal|0|||
147505573|NCT05567393|532002835|FG006|Overall Study|Voluntary Withdrawal|0|||
147505574|NCT05567393|532002836|FG007|Overall Study|Voluntary Withdrawal|0|||
147505575|NCT05567393|532002837|FG008|Overall Study|Voluntary Withdrawal|0|||
147505576|NCT05567393|532002838|FG009|Overall Study|Voluntary Withdrawal|0|||
147505577|NCT05567393|532002839|FG010|Overall Study|Voluntary Withdrawal|0|||
147505578|NCT05567393|532002840|FG011|Overall Study|Voluntary Withdrawal|0|||
147505579|NCT05567393|532002841|FG012|Overall Study|Voluntary Withdrawal|0|||
147505580|NCT05567393|532002842|FG013|Overall Study|Voluntary Withdrawal|1|||
147505581|NCT05567393|532002843|FG014|Overall Study|Voluntary Withdrawal|0|||
147505582|NCT05567393|532002844|FG015|Overall Study|Voluntary Withdrawal|0|||
147505583|NCT05567393|532002845|FG016|Overall Study|Voluntary Withdrawal|0|||
147505584|NCT05567393|532002846|FG017|Overall Study|Voluntary Withdrawal|0|||
147505585|NCT02177175|532002851|FG000|Overall Study|stopped trastuzumab so was taken off study|1|||
147505586|NCT02177175|532002852|FG001|Overall Study|stopped trastuzumab so was taken off study|0|||
147505587|NCT01924299|532002853|FG000|Period 2|Withdrawal by Subject|1|||
147505588|NCT01924299|532002854|FG001|Period 2|Withdrawal by Subject|0|||
147505589|NCT01924299|532002853|FG000|Period 2|Adverse Event|0|||
147505590|NCT01924299|532002854|FG001|Period 2|Adverse Event|1|||
147505591|NCT00888615|532002859|FG000|Overall Study|No treatment|2|||
147505592|NCT00141037|532002860|FG000|Overall Study|Physician Decision|1|||
147505593|NCT00141037|532002861|FG001|Overall Study|Physician Decision|2|||
147505594|NCT00141037|532002860|FG000|Overall Study|Lost to Follow-up|3|||
147505595|NCT00141037|532002861|FG001|Overall Study|Lost to Follow-up|1|||
147505596|NCT00141037|532002860|FG000|Overall Study|Protocol Violation|0|||
147505597|NCT00141037|532002861|FG001|Overall Study|Protocol Violation|2|||
147505598|NCT00141037|532002860|FG000|Overall Study|Withdrawal by Subject|2|||
147505599|NCT00141037|532002861|FG001|Overall Study|Withdrawal by Subject|1|||
147505600|NCT00141037|532002860|FG000|Overall Study|Other|0|||
147505601|NCT00141037|532002861|FG001|Overall Study|Other|1|||
147505602|NCT00141037|532002860|FG000|Overall Study|Moved from area|1|||
147505603|NCT00141037|532002861|FG001|Overall Study|Moved from area|7|||
147505604|NCT00141037|532002860|FG000|Overall Study|Graft Failure|3|||
147505605|NCT00141037|532002861|FG001|Overall Study|Graft Failure|4|||
147505606|NCT00637377|532002862|FG000|Overall Study|Adverse Event|2|||
147505607|NCT00637377|532002863|FG001|Overall Study|Adverse Event|6|||
147505608|NCT00637377|532002864|FG002|Overall Study|Adverse Event|8|||
147505609|NCT00637377|532002865|FG003|Overall Study|Adverse Event|9|||
147505610|NCT00637377|532002862|FG000|Overall Study|Death|1|||
147505611|NCT00637377|532002863|FG001|Overall Study|Death|3|||
147505612|NCT00637377|532002864|FG002|Overall Study|Death|2|||
147505613|NCT00637377|532002865|FG003|Overall Study|Death|1|||
147505614|NCT00637377|532002862|FG000|Overall Study|Lack of Efficacy|0|||
147505615|NCT00637377|532002863|FG001|Overall Study|Lack of Efficacy|0|||
147505616|NCT00637377|532002864|FG002|Overall Study|Lack of Efficacy|1|||
147505617|NCT00637377|532002865|FG003|Overall Study|Lack of Efficacy|1|||
147505618|NCT00637377|532002862|FG000|Overall Study|Lost to Follow-up|4|||
147505619|NCT00637377|532002863|FG001|Overall Study|Lost to Follow-up|1|||
147505620|NCT00637377|532002864|FG002|Overall Study|Lost to Follow-up|2|||
147505621|NCT00637377|532002865|FG003|Overall Study|Lost to Follow-up|2|||
147505622|NCT00637377|532002862|FG000|Overall Study|Protocol Violation|2|||
147505623|NCT00637377|532002863|FG001|Overall Study|Protocol Violation|1|||
147505624|NCT00637377|532002864|FG002|Overall Study|Protocol Violation|1|||
147505625|NCT00637377|532002865|FG003|Overall Study|Protocol Violation|0|||
147669298|NCT01668797|532615467|FG000|Phase A (Conversion Phase)|Physician Decision|2|||
147505626|NCT00637377|532002862|FG000|Overall Study|Withdrawal by Subject|11|||
147505627|NCT00637377|532002863|FG001|Overall Study|Withdrawal by Subject|15|||
147505628|NCT00637377|532002864|FG002|Overall Study|Withdrawal by Subject|13|||
147505629|NCT00637377|532002865|FG003|Overall Study|Withdrawal by Subject|11|||
147505630|NCT00637377|532002862|FG000|Overall Study|Other (no further information available)|7|||
147505631|NCT00637377|532002863|FG001|Overall Study|Other (no further information available)|6|||
147505632|NCT00637377|532002864|FG002|Overall Study|Other (no further information available)|10|||
147505633|NCT00637377|532002865|FG003|Overall Study|Other (no further information available)|5|||
147505634|NCT01293084|532002866|FG000|Overall Study|Physician Decision|3|||
147505635|NCT01293084|532002866|FG000|Overall Study|Withdrawal by Subject|2|||
147505636|NCT04186663|532002867|FG000|Overall Study|Lost to Follow-up|1|||
147505637|NCT04186663|532002867|FG000|Overall Study|Unable to complete blood draw|3|||
147505638|NCT01626989|532002870|FG000|Screening Period|Screen Failure|15|||
147505639|NCT01626989|532002871|FG001|Screening Period|Screen Failure|0|||
147505640|NCT01626989|532002872|FG002|Screening Period|Screen Failure|0|||
147505641|NCT01626989|532002870|FG000|Screening Period|Withdrawal by Subject|2|||
147639209|NCT02017717|532497715|FG003|Treatment Period|Other reasons|1|||
147639210|NCT02017717|532497716|FG004|Treatment Period|Other reasons|0|||
147639211|NCT02017717|532497717|FG005|Treatment Period|Other reasons|1|||
147639212|NCT02017717|532497718|FG006|Treatment Period|Other reasons|1|||
147639213|NCT02017717|532497719|FG007|Treatment Period|Other reasons|1|||
147639214|NCT02017717|532497720|FG008|Treatment Period|Other reasons|1|||
147639215|NCT02017717|532497712|FG000|Treatment Period|Maximum clinical benefit|0|||
147639216|NCT02017717|532497713|FG001|Treatment Period|Maximum clinical benefit|0|||
147639217|NCT02017717|532497714|FG002|Treatment Period|Maximum clinical benefit|0|||
147639218|NCT02017717|532497715|FG003|Treatment Period|Maximum clinical benefit|0|||
147639219|NCT02017717|532497716|FG004|Treatment Period|Maximum clinical benefit|0|||
147639220|NCT02017717|532497717|FG005|Treatment Period|Maximum clinical benefit|0|||
147639221|NCT02017717|532497718|FG006|Treatment Period|Maximum clinical benefit|0|||
147639222|NCT02017717|532497719|FG007|Treatment Period|Maximum clinical benefit|0|||
147639223|NCT02017717|532497720|FG008|Treatment Period|Maximum clinical benefit|1|||
147639224|NCT02017717|532497712|FG000|Treatment Period|Not reported|0|||
147639225|NCT02017717|532497713|FG001|Treatment Period|Not reported|1|||
147639226|NCT02017717|532497714|FG002|Treatment Period|Not reported|0|||
147639227|NCT02017717|532497715|FG003|Treatment Period|Not reported|0|||
147639228|NCT02017717|532497716|FG004|Treatment Period|Not reported|0|||
147639229|NCT02017717|532497717|FG005|Treatment Period|Not reported|0|||
147639230|NCT02017717|532497718|FG006|Treatment Period|Not reported|0|||
147639231|NCT02017717|532497719|FG007|Treatment Period|Not reported|0|||
147639232|NCT02017717|532497720|FG008|Treatment Period|Not reported|0|||
147639233|NCT04488419|532497721|FG000|Safety Population, >=1 Dose Administered|Adverse Event|10|||
147639234|NCT04488419|532497722|FG001|Safety Population, >=1 Dose Administered|Adverse Event|22|||
147639235|NCT04488419|532497723|FG002|Safety Population, >=1 Dose Administered|Adverse Event|18|||
147639236|NCT04488419|532497721|FG000|Safety Population, >=1 Dose Administered|Withdrawal by Subject|3|||
147639237|NCT04488419|532497722|FG001|Safety Population, >=1 Dose Administered|Withdrawal by Subject|6|||
147639238|NCT04488419|532497723|FG002|Safety Population, >=1 Dose Administered|Withdrawal by Subject|1|||
147639239|NCT04488419|532497721|FG000|Safety Population, >=1 Dose Administered|Lost to Follow-up|0|||
147639240|NCT04488419|532497722|FG001|Safety Population, >=1 Dose Administered|Lost to Follow-up|3|||
147639241|NCT04488419|532497723|FG002|Safety Population, >=1 Dose Administered|Lost to Follow-up|2|||
147639242|NCT04488419|532497721|FG000|Safety Population, >=1 Dose Administered|Protocol Violation|2|||
147639243|NCT04488419|532497722|FG001|Safety Population, >=1 Dose Administered|Protocol Violation|1|||
147639244|NCT04488419|532497723|FG002|Safety Population, >=1 Dose Administered|Protocol Violation|0|||
147639245|NCT04488419|532497721|FG000|Safety Population, >=1 Dose Administered|Lack of Efficacy|1|||
147639246|NCT04488419|532497722|FG001|Safety Population, >=1 Dose Administered|Lack of Efficacy|1|||
147639247|NCT04488419|532497723|FG002|Safety Population, >=1 Dose Administered|Lack of Efficacy|0|||
147639248|NCT04488419|532497721|FG000|Safety Population, >=1 Dose Administered|Physician Decision|0|||
147639249|NCT04488419|532497722|FG001|Safety Population, >=1 Dose Administered|Physician Decision|1|||
147639250|NCT04488419|532497723|FG002|Safety Population, >=1 Dose Administered|Physician Decision|0|||
147639251|NCT04488419|532497721|FG000|Safety Population, >=1 Dose Administered|Undetermined|15|||
147639252|NCT04488419|532497722|FG001|Safety Population, >=1 Dose Administered|Undetermined|9|||
147639253|NCT04488419|532497723|FG002|Safety Population, >=1 Dose Administered|Undetermined|5|||
147639254|NCT04488419|532497721|FG000|Safety Population, >=1 Dose Administered|>1 Reason|4|||
147639255|NCT04488419|532497722|FG001|Safety Population, >=1 Dose Administered|>1 Reason|7|||
147639256|NCT04488419|532497723|FG002|Safety Population, >=1 Dose Administered|>1 Reason|12|||
147639257|NCT04488419|532497721|FG000|Primary Analysis Population|Adverse Event|6|||
147639258|NCT04488419|532497722|FG001|Primary Analysis Population|Adverse Event|9|||
147639259|NCT04488419|532497723|FG002|Primary Analysis Population|Adverse Event|0|||
147639260|NCT04488419|532497721|FG000|Primary Analysis Population|Withdrawal by Subject|0|||
147639261|NCT04488419|532497722|FG001|Primary Analysis Population|Withdrawal by Subject|4|||
147639262|NCT04488419|532497723|FG002|Primary Analysis Population|Withdrawal by Subject|0|||
147639263|NCT04488419|532497721|FG000|Primary Analysis Population|Protocol Violation|1|||
147639264|NCT04488419|532497722|FG001|Primary Analysis Population|Protocol Violation|1|||
147505642|NCT01626989|532002871|FG001|Screening Period|Withdrawal by Subject|0|||
147505643|NCT01626989|532002872|FG002|Screening Period|Withdrawal by Subject|0|||
147669299|NCT01668797|532615468|FG001|Phase A (Conversion Phase)|Physician Decision|0|||
147669300|NCT01668797|532615469|FG002|Phase A (Conversion Phase)|Physician Decision|0|||
147669301|NCT01668797|532615470|FG003|Phase A (Conversion Phase)|Physician Decision|0|||
147669302|NCT01668797|532615467|FG000|Phase A (Conversion Phase)|Withdrawal by Subject|16|||
147669303|NCT01668797|532615468|FG001|Phase A (Conversion Phase)|Withdrawal by Subject|0|||
147669304|NCT01668797|532615469|FG002|Phase A (Conversion Phase)|Withdrawal by Subject|0|||
147669305|NCT01668797|532615470|FG003|Phase A (Conversion Phase)|Withdrawal by Subject|0|||
147669306|NCT01668797|532615467|FG000|Phase A (Conversion Phase)|Protocol Violation|2|||
147669307|NCT01668797|532615468|FG001|Phase A (Conversion Phase)|Protocol Violation|0|||
147669308|NCT01668797|532615469|FG002|Phase A (Conversion Phase)|Protocol Violation|0|||
147669309|NCT01668797|532615470|FG003|Phase A (Conversion Phase)|Protocol Violation|0|||
147669310|NCT01668797|532615467|FG000|Phase A (Conversion Phase)|Lack of Efficacy|7|||
147669311|NCT01668797|532615468|FG001|Phase A (Conversion Phase)|Lack of Efficacy|0|||
147669312|NCT01668797|532615469|FG002|Phase A (Conversion Phase)|Lack of Efficacy|0|||
147669313|NCT01668797|532615470|FG003|Phase A (Conversion Phase)|Lack of Efficacy|0|||
147669314|NCT01668797|532615467|FG000|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|8|||
147669315|NCT01668797|532615468|FG001|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|0|||
147669316|NCT01668797|532615469|FG002|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|0|||
147669317|NCT01668797|532615470|FG003|Phase A (Conversion Phase)|Adverse Event Without Impending Relapse|0|||
147669318|NCT01668797|532615467|FG000|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|19|||
147669319|NCT01668797|532615468|FG001|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|0|||
147669320|NCT01668797|532615469|FG002|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|0|||
147669321|NCT01668797|532615470|FG003|Phase A (Conversion Phase)|Terminated Study on Interim Analysis|0|||
147669322|NCT01668797|532615467|FG000|Phase B (Stabilization Phase)|Lost to Follow-up|0|||
147669323|NCT01668797|532615468|FG001|Phase B (Stabilization Phase)|Lost to Follow-up|16|||
147669324|NCT01668797|532615469|FG002|Phase B (Stabilization Phase)|Lost to Follow-up|0|||
147669325|NCT01668797|532615470|FG003|Phase B (Stabilization Phase)|Lost to Follow-up|0|||
147669326|NCT01668797|532615467|FG000|Phase B (Stabilization Phase)|Met Withdrawal Criteria|0|||
147669327|NCT01668797|532615468|FG001|Phase B (Stabilization Phase)|Met Withdrawal Criteria|22|||
147669328|NCT01668797|532615469|FG002|Phase B (Stabilization Phase)|Met Withdrawal Criteria|0|||
147669329|NCT01668797|532615470|FG003|Phase B (Stabilization Phase)|Met Withdrawal Criteria|0|||
147669330|NCT01668797|532615467|FG000|Phase B (Stabilization Phase)|Physician Decision|0|||
147669331|NCT01668797|532615468|FG001|Phase B (Stabilization Phase)|Physician Decision|11|||
147669332|NCT01668797|532615469|FG002|Phase B (Stabilization Phase)|Physician Decision|0|||
147669333|NCT01668797|532615470|FG003|Phase B (Stabilization Phase)|Physician Decision|0|||
147669334|NCT01668797|532615467|FG000|Phase B (Stabilization Phase)|Withdrawal by Subject|0|||
147669335|NCT01668797|532615468|FG001|Phase B (Stabilization Phase)|Withdrawal by Subject|60|||
147669336|NCT01668797|532615469|FG002|Phase B (Stabilization Phase)|Withdrawal by Subject|0|||
147669337|NCT01668797|532615470|FG003|Phase B (Stabilization Phase)|Withdrawal by Subject|0|||
147669338|NCT01668797|532615467|FG000|Phase B (Stabilization Phase)|Protocol Violation|0|||
147669339|NCT01668797|532615468|FG001|Phase B (Stabilization Phase)|Protocol Violation|3|||
147669340|NCT01668797|532615469|FG002|Phase B (Stabilization Phase)|Protocol Violation|0|||
147669341|NCT01668797|532615470|FG003|Phase B (Stabilization Phase)|Protocol Violation|0|||
147669342|NCT01668797|532615467|FG000|Phase B (Stabilization Phase)|Lack of Efficacy|0|||
147669343|NCT01668797|532615468|FG001|Phase B (Stabilization Phase)|Lack of Efficacy|21|||
147669344|NCT01668797|532615469|FG002|Phase B (Stabilization Phase)|Lack of Efficacy|0|||
147669345|NCT01668797|532615470|FG003|Phase B (Stabilization Phase)|Lack of Efficacy|0|||
147669346|NCT01668797|532615467|FG000|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|0|||
147669347|NCT01668797|532615468|FG001|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|43|||
147669348|NCT01668797|532615469|FG002|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|0|||
147669349|NCT01668797|532615470|FG003|Phase B (Stabilization Phase)|Adverse Event Without Impending Relapse|0|||
147669350|NCT01668797|532615467|FG000|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|0|||
147669351|NCT01668797|532615468|FG001|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|86|||
147669352|NCT01668797|532615469|FG002|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|0|||
147669353|NCT01668797|532615470|FG003|Phase B (Stabilization Phase)|Terminated Study on Interim Analysis|0|||
147669354|NCT01668797|532615467|FG000|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|0|||
147669355|NCT01668797|532615468|FG001|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|0|||
147669356|NCT01668797|532615469|FG002|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|4|||
147669357|NCT01668797|532615470|FG003|Phase C (Double-Blind Maintenance Phase)|Lost to Follow-up|6|||
147669358|NCT01668797|532615467|FG000|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|0|||
147669359|NCT01668797|532615468|FG001|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|0|||
147669360|NCT01668797|532615469|FG002|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|3|||
147669361|NCT01668797|532615470|FG003|Phase C (Double-Blind Maintenance Phase)|Met Withdrawal Criteria|3|||
147669362|NCT01668797|532615467|FG000|Phase C (Double-Blind Maintenance Phase)|Physician Decision|0|||
147669363|NCT01668797|532615468|FG001|Phase C (Double-Blind Maintenance Phase)|Physician Decision|0|||
147669364|NCT01668797|532615469|FG002|Phase C (Double-Blind Maintenance Phase)|Physician Decision|5|||
147669365|NCT01668797|532615470|FG003|Phase C (Double-Blind Maintenance Phase)|Physician Decision|2|||
147669366|NCT01668797|532615467|FG000|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|0|||
147669367|NCT01668797|532615468|FG001|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|0|||
147669368|NCT01668797|532615469|FG002|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|3|||
147669369|NCT01668797|532615470|FG003|Phase C (Double-Blind Maintenance Phase)|Withdrawal by Subject|5|||
147669370|NCT01668797|532615467|FG000|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|0|||
147669371|NCT01668797|532615468|FG001|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|0|||
147669372|NCT01668797|532615469|FG002|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|2|||
147669373|NCT01668797|532615470|FG003|Phase C (Double-Blind Maintenance Phase)|Protocol Violation|0|||
147669374|NCT01668797|532615467|FG000|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|0|||
147669375|NCT01668797|532615468|FG001|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|0|||
147669376|NCT01668797|532615469|FG002|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|2|||
147669377|NCT01668797|532615470|FG003|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy|10|||
147669378|NCT01668797|532615467|FG000|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|0|||
147669379|NCT01668797|532615468|FG001|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|0|||
147669380|NCT01668797|532615469|FG002|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|11|||
147669381|NCT01668797|532615470|FG003|Phase C (Double-Blind Maintenance Phase)|Lack of Efficacy without AE|30|||
147669382|NCT01668797|532615467|FG000|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|0|||
147669383|NCT01668797|532615468|FG001|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|0|||
147669384|NCT01668797|532615469|FG002|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|4|||
147669385|NCT01668797|532615470|FG003|Phase C (Double-Blind Maintenance Phase)|Adverse Event Without Impending Relapse|2|||
147669386|NCT01668797|532615467|FG000|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|0|||
147669387|NCT01668797|532615468|FG001|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|0|||
147669388|NCT01668797|532615469|FG002|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|49|||
147669389|NCT01668797|532615470|FG003|Phase C (Double-Blind Maintenance Phase)|Terminated Study on Interim Analysis|38|||
147669390|NCT02834975|532615471|FG000|Overall Study|Physician Decision|2|||
147669391|NCT02834975|532615471|FG000|Overall Study|Adverse Event|1|||
147669392|NCT02834975|532615471|FG000|Overall Study|Withdrawal by Subject|1|||
147669393|NCT02834975|532615471|FG000|Overall Study|Lack of Efficacy|1|||
147669394|NCT01027845|532615478|FG000|Primary Vaccination Phase|Serious Adverse Event|2|||
147669395|NCT01027845|532615479|FG001|Primary Vaccination Phase|Serious Adverse Event|0|||
147669396|NCT01027845|532615480|FG002|Primary Vaccination Phase|Serious Adverse Event|0|||
147669397|NCT01027845|532615481|FG003|Primary Vaccination Phase|Serious Adverse Event|0|||
147669398|NCT01027845|532615478|FG000|Primary Vaccination Phase|Adverse Event|1|||
147669399|NCT01027845|532615479|FG001|Primary Vaccination Phase|Adverse Event|0|||
147669400|NCT01027845|532615480|FG002|Primary Vaccination Phase|Adverse Event|0|||
147669401|NCT01027845|532615481|FG003|Primary Vaccination Phase|Adverse Event|0|||
147669402|NCT01027845|532615478|FG000|Primary Vaccination Phase|Protocol Violation|1|||
147669403|NCT01027845|532615479|FG001|Primary Vaccination Phase|Protocol Violation|0|||
147669404|NCT01027845|532615480|FG002|Primary Vaccination Phase|Protocol Violation|0|||
147669405|NCT01027845|532615481|FG003|Primary Vaccination Phase|Protocol Violation|0|||
147669406|NCT01027845|532615478|FG000|Primary Vaccination Phase|Migrated/moved from study area|0|||
147669407|NCT01027845|532615479|FG001|Primary Vaccination Phase|Migrated/moved from study area|1|||
147669408|NCT01027845|532615480|FG002|Primary Vaccination Phase|Migrated/moved from study area|0|||
147669409|NCT01027845|532615481|FG003|Primary Vaccination Phase|Migrated/moved from study area|0|||
147669410|NCT01027845|532615478|FG000|Booster Vaccination Phase|Withdrawal by Subject|1|||
147669411|NCT01027845|532615479|FG001|Booster Vaccination Phase|Withdrawal by Subject|0|||
147669412|NCT01027845|532615480|FG002|Booster Vaccination Phase|Withdrawal by Subject|0|||
147669413|NCT01027845|532615481|FG003|Booster Vaccination Phase|Withdrawal by Subject|0|||
147669414|NCT01027845|532615478|FG000|Booster Vaccination Phase|Migrated/moved from study area|1|||
147669415|NCT01027845|532615479|FG001|Booster Vaccination Phase|Migrated/moved from study area|0|||
147669416|NCT01027845|532615480|FG002|Booster Vaccination Phase|Migrated/moved from study area|0|||
147669417|NCT01027845|532615481|FG003|Booster Vaccination Phase|Migrated/moved from study area|0|||
147669418|NCT01670292|532615482|FG000|Overall Study|Lost to Follow-up|14|||
147669419|NCT01603277|532615486|FG000|Overall Study|Adverse Event|1|||
147669420|NCT01603277|532615487|FG001|Overall Study|Adverse Event|2|||
147669421|NCT01603277|532615486|FG000|Overall Study|Physician Decision|0|||
147669422|NCT01603277|532615487|FG001|Overall Study|Physician Decision|1|||
147669423|NCT01603277|532615486|FG000|Overall Study|Protocol Violation|6|||
147669424|NCT01603277|532615487|FG001|Overall Study|Protocol Violation|10|||
147669425|NCT01603277|532615486|FG000|Overall Study|Withdrawal by Subject|5|||
147669426|NCT01603277|532615487|FG001|Overall Study|Withdrawal by Subject|4|||
147669427|NCT01603277|532615486|FG000|Overall Study|Non-Compliance|2|||
147669428|NCT01603277|532615487|FG001|Overall Study|Non-Compliance|1|||
147669429|NCT00087178|532615488|FG000|Overall Study|No follow up data|5|||
147669430|NCT00087178|532615489|FG001|Overall Study|No follow up data|15|||
147669431|NCT00087178|532615488|FG000|Overall Study|No clinical assessment|1|||
147669432|NCT00087178|532615489|FG001|Overall Study|No clinical assessment|2|||
147669433|NCT00087178|532615488|FG000|Overall Study|Patient not at risk for primary endpoint|0|||
147669434|NCT00087178|532615489|FG001|Overall Study|Patient not at risk for primary endpoint|1|||
147669435|NCT04494646|532615490|FG000|Overall Study|Adverse Event|0|||
147669436|NCT04494646|532615491|FG001|Overall Study|Adverse Event|1|||
147669437|NCT04494646|532615490|FG000|Overall Study|Withdrawal by Subject|0|||
147669438|NCT04494646|532615491|FG001|Overall Study|Withdrawal by Subject|1|||
147669439|NCT01692119|532615492|FG000|Overall Study|Protocol Violation|3|||
147669440|NCT01692119|532615493|FG001|Overall Study|Protocol Violation|1|||
147669441|NCT01692119|532615492|FG000|Overall Study|Intervention: pts. did not present to participating pharmacy|17|||
147669442|NCT01692119|532615493|FG001|Overall Study|Intervention: pts. did not present to participating pharmacy|0|||
147669443|NCT00112957|532615500|FG000|Overall Study|Progressive disease|18|||
147669444|NCT00112957|532615500|FG000|Overall Study|Physician Decision|1|||
147669445|NCT03451045|532615505|FG000|Overall Study|Lack of Efficacy|3|||
147669446|NCT03451045|532615506|FG001|Overall Study|Lack of Efficacy|2|||
147669447|NCT03451045|532615507|FG002|Overall Study|Lack of Efficacy|2|||
147669448|NCT03451045|532615505|FG000|Overall Study|Physician Decision|1|||
147669449|NCT03451045|532615506|FG001|Overall Study|Physician Decision|1|||
147669450|NCT03451045|532615507|FG002|Overall Study|Physician Decision|1|||
147669451|NCT03451045|532615505|FG000|Overall Study|Withdrawal by Subject|4|||
147669452|NCT03451045|532615506|FG001|Overall Study|Withdrawal by Subject|0|||
147669453|NCT03451045|532615507|FG002|Overall Study|Withdrawal by Subject|5|||
147669454|NCT03451045|532615505|FG000|Overall Study|Pregnancy|0|||
147669455|NCT03451045|532615506|FG001|Overall Study|Pregnancy|0|||
147669456|NCT03451045|532615507|FG002|Overall Study|Pregnancy|2|||
147669457|NCT03451045|532615505|FG000|Overall Study|Adverse Event|7|||
147505644|NCT02293902|532002875|FG000|Double-Blind Period (Up to Week 24)|Adverse Event|5|||
147639265|NCT04488419|532497723|FG002|Primary Analysis Population|Protocol Violation|0|||
147639266|NCT04488419|532497721|FG000|Primary Analysis Population|Undetermined|7|||
147639267|NCT04488419|532497722|FG001|Primary Analysis Population|Undetermined|3|||
147639268|NCT04488419|532497723|FG002|Primary Analysis Population|Undetermined|0|||
147639269|NCT04488419|532497721|FG000|Primary Analysis Population|>1 Reason|2|||
147639270|NCT04488419|532497722|FG001|Primary Analysis Population|>1 Reason|4|||
147639271|NCT04488419|532497723|FG002|Primary Analysis Population|>1 Reason|0|||
147639272|NCT03339726|532497724|FG000|Overall Study|Withdrawal by Subject|1|||
147639273|NCT03339726|532497725|FG001|Overall Study|Withdrawal by Subject|0|||
147639274|NCT03339726|532497726|FG002|Overall Study|Withdrawal by Subject|0|||
147639275|NCT03339726|532497724|FG000|Overall Study|Lost to Follow-up|0|||
147639276|NCT03339726|532497725|FG001|Overall Study|Lost to Follow-up|1|||
147639277|NCT03339726|532497726|FG002|Overall Study|Lost to Follow-up|0|||
147639278|NCT03960021|532497732|FG000|Overall Study|did not undergo the 2 radiofrequency ablations.|3|||
147639279|NCT02203851|532497733|FG000|Overall Study|Lost to Follow-up|4|||
147639280|NCT02203851|532497733|FG000|Overall Study|Withdrawal by Subject|6|||
147639281|NCT02203851|532497733|FG000|Overall Study|Other|1|||
147639282|NCT02677038|532497739|FG000|Overall Study|Physician Decision|1|||
147639283|NCT02677038|532497739|FG000|Overall Study|Withdrawal by Subject|1|||
147639284|NCT03671564|532497741|FG000|Overall Study|Progressive Disease|3|||
147639285|NCT03671564|532497742|FG001|Overall Study|Progressive Disease|5|||
147639286|NCT03671564|532497743|FG002|Overall Study|Progressive Disease|3|||
147639287|NCT03671564|532497741|FG000|Overall Study|Confirmed TP53 Genotyping Mutation|0|||
147639288|NCT03671564|532497742|FG001|Overall Study|Confirmed TP53 Genotyping Mutation|0|||
147639289|NCT03671564|532497743|FG002|Overall Study|Confirmed TP53 Genotyping Mutation|1|||
147639290|NCT03671564|532497741|FG000|Overall Study|Withdrawal by Subject|1|||
147639291|NCT03671564|532497742|FG001|Overall Study|Withdrawal by Subject|1|||
147639292|NCT03671564|532497743|FG002|Overall Study|Withdrawal by Subject|0|||
147639293|NCT04521621|532497744|FG000|Overall Study|Death|17|||
147639294|NCT04521621|532497745|FG001|Overall Study|Death|8|||
147639295|NCT04521621|532497746|FG002|Overall Study|Death|8|||
147639296|NCT04521621|532497747|FG003|Overall Study|Death|5|||
147639297|NCT04521621|532497748|FG004|Overall Study|Death|2|||
147639298|NCT04521621|532497749|FG005|Overall Study|Death|7|||
147639299|NCT04521621|532497750|FG006|Overall Study|Death|0|||
147639300|NCT04521621|532497751|FG007|Overall Study|Death|0|||
147639301|NCT04521621|532497744|FG000|Overall Study|Study Terminated by Sponsor|4|||
147639302|NCT04521621|532497745|FG001|Overall Study|Study Terminated by Sponsor|6|||
147639303|NCT04521621|532497746|FG002|Overall Study|Study Terminated by Sponsor|8|||
147639304|NCT04521621|532497747|FG003|Overall Study|Study Terminated by Sponsor|0|||
147639305|NCT04521621|532497748|FG004|Overall Study|Study Terminated by Sponsor|1|||
147639306|NCT04521621|532497749|FG005|Overall Study|Study Terminated by Sponsor|7|||
147669458|NCT03451045|532615506|FG001|Overall Study|Adverse Event|1|||
147669459|NCT03451045|532615507|FG002|Overall Study|Adverse Event|3|||
147669460|NCT03451045|532615505|FG000|Overall Study|Non-compliance with study|2|||
147669461|NCT03451045|532615506|FG001|Overall Study|Non-compliance with study|0|||
147669462|NCT03451045|532615507|FG002|Overall Study|Non-compliance with study|1|||
147669463|NCT03451045|532615505|FG000|Overall Study|any other reason|10|||
147669464|NCT03451045|532615506|FG001|Overall Study|any other reason|2|||
147505645|NCT02293902|532002876|FG001|Double-Blind Period (Up to Week 24)|Adverse Event|6|||
147505646|NCT02293902|532002877|FG002|Double-Blind Period (Up to Week 24)|Adverse Event|8|||
147505647|NCT02293902|532002878|FG003|Double-Blind Period (Up to Week 24)|Adverse Event|0|||
147505648|NCT02293902|532002879|FG004|Double-Blind Period (Up to Week 24)|Adverse Event|0|||
147505649|NCT02293902|532002875|FG000|Double-Blind Period (Up to Week 24)|Lack of Efficacy|5|||
147505650|NCT02293902|532002876|FG001|Double-Blind Period (Up to Week 24)|Lack of Efficacy|1|||
147505651|NCT02293902|532002877|FG002|Double-Blind Period (Up to Week 24)|Lack of Efficacy|2|||
147505652|NCT02293902|532002878|FG003|Double-Blind Period (Up to Week 24)|Lack of Efficacy|0|||
147505653|NCT02293902|532002879|FG004|Double-Blind Period (Up to Week 24)|Lack of Efficacy|0|||
147505654|NCT02293902|532002875|FG000|Double-Blind Period (Up to Week 24)|Randomized but not Treated|1|||
147505655|NCT02293902|532002876|FG001|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0|||
147505656|NCT02293902|532002877|FG002|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0|||
147505657|NCT02293902|532002878|FG003|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0|||
147505658|NCT02293902|532002879|FG004|Double-Blind Period (Up to Week 24)|Randomized but not Treated|0|||
147639307|NCT04521621|532497750|FG006|Overall Study|Study Terminated by Sponsor|0|||
147639308|NCT04521621|532497751|FG007|Overall Study|Study Terminated by Sponsor|0|||
147639309|NCT04521621|532497744|FG000|Overall Study|Withdrawal by Subject|0|||
147639310|NCT04521621|532497745|FG001|Overall Study|Withdrawal by Subject|0|||
147639311|NCT04521621|532497746|FG002|Overall Study|Withdrawal by Subject|1|||
147639312|NCT04521621|532497747|FG003|Overall Study|Withdrawal by Subject|1|||
147639313|NCT04521621|532497748|FG004|Overall Study|Withdrawal by Subject|0|||
147639314|NCT04521621|532497749|FG005|Overall Study|Withdrawal by Subject|0|||
147639315|NCT04521621|532497750|FG006|Overall Study|Withdrawal by Subject|0|||
147639316|NCT04521621|532497751|FG007|Overall Study|Withdrawal by Subject|0|||
147639317|NCT04521621|532497744|FG000|Overall Study|Allocated in error without study intervention|1|||
147639318|NCT04521621|532497745|FG001|Overall Study|Allocated in error without study intervention|0|||
147639319|NCT04521621|532497746|FG002|Overall Study|Allocated in error without study intervention|0|||
147639320|NCT04521621|532497747|FG003|Overall Study|Allocated in error without study intervention|0|||
147639321|NCT04521621|532497748|FG004|Overall Study|Allocated in error without study intervention|0|||
147639322|NCT04521621|532497749|FG005|Overall Study|Allocated in error without study intervention|0|||
147639323|NCT04521621|532497750|FG006|Overall Study|Allocated in error without study intervention|0|||
147639324|NCT04521621|532497751|FG007|Overall Study|Allocated in error without study intervention|0|||
147639325|NCT02777970|532497757|FG000|Overall Study|Lost to Follow-up|0|||
147639326|NCT02777970|532497758|FG001|Overall Study|Lost to Follow-up|1|||
147639327|NCT02777970|532497759|FG002|Overall Study|Lost to Follow-up|0|||
147639328|NCT02777970|532497757|FG000|Overall Study|Protocol Violation|1|||
147639329|NCT02777970|532497758|FG001|Overall Study|Protocol Violation|0|||
147639330|NCT02777970|532497759|FG002|Overall Study|Protocol Violation|0|||
147639331|NCT05845567|532497763|FG000|Overall Study|Withdrawal by Subject|1|||
147639332|NCT01968707|532497769|FG000|Overall Study|Did not meet treatment day baseline|49|||
147639333|NCT01968707|532497770|FG001|Overall Study|Did not meet treatment day baseline|12|||
147639334|NCT01968707|532497771|FG002|Overall Study|Did not meet treatment day baseline|41|||
147639335|NCT01968707|532497772|FG003|Overall Study|Did not meet treatment day baseline|44|||
147639336|NCT01968707|532497773|FG004|Overall Study|Did not meet treatment day baseline|36|||
147639337|NCT01968707|532497774|FG005|Overall Study|Did not meet treatment day baseline|11|||
147639338|NCT01968707|532497775|FG006|Overall Study|Did not meet treatment day baseline|34|||
147639339|NCT01968707|532497776|FG007|Overall Study|Did not meet treatment day baseline|35|||
147639340|NCT05178641|532497777|FG000|First 3 Weeks of Study (Week 1-3)|Protocol Violation|4|||
147639341|NCT05178641|532497778|FG001|First 3 Weeks of Study (Week 1-3)|Protocol Violation|1|||
147639342|NCT05178641|532497777|FG000|First 3 Weeks of Study (Week 1-3)|Withdrawal by Subject|0|||
147639343|NCT05178641|532497778|FG001|First 3 Weeks of Study (Week 1-3)|Withdrawal by Subject|1|||
147639344|NCT01083186|532497781|FG000|Overall Study|Lost to Follow-up|48|||
147639345|NCT01083186|532497781|FG000|Overall Study|Consent Withdrawal|7|||
147639346|NCT01083186|532497781|FG000|Overall Study|Death|3|||
147639347|NCT01083186|532497781|FG000|Overall Study|Adverse Event|3|||
147639348|NCT01083186|532497781|FG000|Overall Study|Lack of Efficacy|2|||
147639349|NCT01083186|532497781|FG000|Overall Study|Hemodialysis Initiation|28|||
147639350|NCT01083186|532497781|FG000|Overall Study|Administrative Reasons|2|||
147639351|NCT01083186|532497781|FG000|Overall Study|Non-compliance to Study Treatment|1|||
147639352|NCT02474589|532497782|FG000|Overall Study|Adverse Event|6|||
147639353|NCT02474589|532497783|FG001|Overall Study|Adverse Event|2|||
147639354|NCT02474589|532497782|FG000|Overall Study|Lost to Follow-up|6|||
147639355|NCT02474589|532497783|FG001|Overall Study|Lost to Follow-up|1|||
147639356|NCT02474589|532497782|FG000|Overall Study|Protocol Violation|4|||
147639357|NCT02474589|532497783|FG001|Overall Study|Protocol Violation|1|||
147639358|NCT02474589|532497782|FG000|Overall Study|Withdrawal by Subject|4|||
147639359|NCT02474589|532497783|FG001|Overall Study|Withdrawal by Subject|0|||
147639360|NCT02474589|532497782|FG000|Overall Study|Inability to complete study procedures|5|||
147639361|NCT02474589|532497783|FG001|Overall Study|Inability to complete study procedures|1|||
147639362|NCT01740128|532497784|FG000|Overall Study|Pregnancy|0|||
147639363|NCT01740128|532497785|FG001|Overall Study|Pregnancy|1|||
147669465|NCT03451045|532615507|FG002|Overall Study|any other reason|13|||
147669466|NCT02391337|532615508|FG000|6 Months Follow-up|Death|5|||
147669467|NCT02391337|532615509|FG001|6 Months Follow-up|Death|4|||
147669468|NCT02391337|532615508|FG000|6 Months Follow-up|Withdrawal by Subject|1|||
147669469|NCT02391337|532615509|FG001|6 Months Follow-up|Withdrawal by Subject|1|||
147669470|NCT02391337|532615508|FG000|12 Months Follow-up|Death|2|||
147669471|NCT02391337|532615509|FG001|12 Months Follow-up|Death|0|||
147669472|NCT02391337|532615508|FG000|12 Months Follow-up|Withdrawal by Subject|0|||
147669473|NCT02391337|532615509|FG001|12 Months Follow-up|Withdrawal by Subject|1|||
147669474|NCT02391337|532615508|FG000|12 Months Follow-up|Lost to Follow-up|0|||
147669475|NCT02391337|532615509|FG001|12 Months Follow-up|Lost to Follow-up|2|||
147669476|NCT03704064|532615510|FG000|Overall Study|Lost to Follow-up|8|||
147669477|NCT03704064|532615511|FG001|Overall Study|Lost to Follow-up|4|||
147669478|NCT03704064|532615510|FG000|Overall Study|Withdrawal by Subject|1|||
147669479|NCT03704064|532615511|FG001|Overall Study|Withdrawal by Subject|1|||
147669480|NCT03704064|532615510|FG000|Overall Study|No longer available for study visits|0|||
147669481|NCT03704064|532615511|FG001|Overall Study|No longer available for study visits|1|||
147669482|NCT03704064|532615510|FG000|Overall Study|Censoring event|1|||
147669483|NCT03704064|532615511|FG001|Overall Study|Censoring event|0|||
147669484|NCT00830128|532615512|FG000|Overall Study|Adverse Event|5|||
147669485|NCT00830128|532615512|FG000|Overall Study|Lack of Efficacy|7|||
147669486|NCT00830128|532615512|FG000|Overall Study|Protocol Violation|1|||
147669487|NCT00830128|532615512|FG000|Overall Study|Withdrawal by Subject|2|||
147669488|NCT00830128|532615512|FG000|Overall Study|Family obligation|1|||
147669489|NCT00830128|532615512|FG000|Overall Study|Relocation|1|||
147669490|NCT00830128|532615512|FG000|Overall Study|Work obligation|1|||
147669491|NCT00830128|532615512|FG000|Overall Study|Operating a vehicle|1|||
147669492|NCT04798027|532615521|FG000|Overall Study|Protocol Violation|0|||
147669493|NCT04798027|532615522|FG001|Overall Study|Protocol Violation|0|||
147669494|NCT04798027|532615523|FG002|Overall Study|Protocol Violation|0|||
147669495|NCT04798027|532615524|FG003|Overall Study|Protocol Violation|0|||
147669496|NCT04798027|532615525|FG004|Overall Study|Protocol Violation|1|||
147669497|NCT04798027|532615526|FG005|Overall Study|Protocol Violation|0|||
147669498|NCT04798027|532615527|FG006|Overall Study|Protocol Violation|0|||
147669499|NCT04798027|532615528|FG007|Overall Study|Protocol Violation|1|||
147669500|NCT04798027|532615529|FG008|Overall Study|Protocol Violation|0|||
147669501|NCT04798027|532615521|FG000|Overall Study|Withdrawal by Subject|1|||
147669502|NCT04798027|532615522|FG001|Overall Study|Withdrawal by Subject|0|||
147669503|NCT04798027|532615523|FG002|Overall Study|Withdrawal by Subject|1|||
147669504|NCT04798027|532615524|FG003|Overall Study|Withdrawal by Subject|1|||
147669505|NCT04798027|532615525|FG004|Overall Study|Withdrawal by Subject|1|||
147669506|NCT04798027|532615526|FG005|Overall Study|Withdrawal by Subject|1|||
147669507|NCT04798027|532615527|FG006|Overall Study|Withdrawal by Subject|3|||
147669508|NCT04798027|532615528|FG007|Overall Study|Withdrawal by Subject|2|||
147669509|NCT04798027|532615529|FG008|Overall Study|Withdrawal by Subject|2|||
147669510|NCT04798027|532615521|FG000|Overall Study|Lost to Follow-up|1|||
147669511|NCT04798027|532615522|FG001|Overall Study|Lost to Follow-up|3|||
147669512|NCT04798027|532615523|FG002|Overall Study|Lost to Follow-up|0|||
147669513|NCT04798027|532615524|FG003|Overall Study|Lost to Follow-up|0|||
147669514|NCT04798027|532615525|FG004|Overall Study|Lost to Follow-up|0|||
147669515|NCT04798027|532615526|FG005|Overall Study|Lost to Follow-up|1|||
147669516|NCT04798027|532615527|FG006|Overall Study|Lost to Follow-up|0|||
147669517|NCT04798027|532615528|FG007|Overall Study|Lost to Follow-up|0|||
147669518|NCT04798027|532615529|FG008|Overall Study|Lost to Follow-up|1|||
147669519|NCT04798027|532615521|FG000|Overall Study|Withdrawal by Sponsor|8|||
147669520|NCT04798027|532615522|FG001|Overall Study|Withdrawal by Sponsor|22|||
147669521|NCT04798027|532615523|FG002|Overall Study|Withdrawal by Sponsor|9|||
147669522|NCT04798027|532615524|FG003|Overall Study|Withdrawal by Sponsor|26|||
147669523|NCT04798027|532615525|FG004|Overall Study|Withdrawal by Sponsor|24|||
147669524|NCT04798027|532615526|FG005|Overall Study|Withdrawal by Sponsor|11|||
147669525|NCT04798027|532615527|FG006|Overall Study|Withdrawal by Sponsor|25|||
147669526|NCT04798027|532615528|FG007|Overall Study|Withdrawal by Sponsor|26|||
147669527|NCT04798027|532615529|FG008|Overall Study|Withdrawal by Sponsor|11|||
147669528|NCT04609514|532615530|FG000|Overall Study|Lost to Follow-up|5|||
147669529|NCT04609514|532615531|FG001|Overall Study|Lost to Follow-up|4|||
147669530|NCT04609514|532615530|FG000|Overall Study|Withdrawal by PI|0|||
147669531|NCT04609514|532615531|FG001|Overall Study|Withdrawal by PI|2|||
147669532|NCT01981616|532615536|FG000|Overall Study|Adverse Event|0|||
147669533|NCT01981616|532615537|FG001|Overall Study|Adverse Event|1|||
147669534|NCT01981616|532615536|FG000|Overall Study|Protocol Violation|1|||
147669535|NCT01981616|532615537|FG001|Overall Study|Protocol Violation|0|||
147669536|NCT01773928|532615538|FG000|Overall Study|Adverse Event|0|||
147669537|NCT01773928|532615539|FG001|Overall Study|Adverse Event|0|||
147669538|NCT01773928|532615540|FG002|Overall Study|Adverse Event|0|||
147669539|NCT01773928|532615541|FG003|Overall Study|Adverse Event|0|||
147669540|NCT01773928|532615542|FG004|Overall Study|Adverse Event|0|||
147669541|NCT01773928|532615543|FG005|Overall Study|Adverse Event|0|||
147669542|NCT01773928|532615544|FG006|Overall Study|Adverse Event|0|||
147669543|NCT01773928|532615545|FG007|Overall Study|Adverse Event|1|||
147505659|NCT02293902|532002875|FG000|Single-Blind Period (Week 25 to Week 52)|Adverse Event|0|||
147505660|NCT02293902|532002876|FG001|Single-Blind Period (Week 25 to Week 52)|Adverse Event|7|||
147505661|NCT02293902|532002877|FG002|Single-Blind Period (Week 25 to Week 52)|Adverse Event|1|||
147505662|NCT02293902|532002878|FG003|Single-Blind Period (Week 25 to Week 52)|Adverse Event|1|||
147505663|NCT02293902|532002879|FG004|Single-Blind Period (Week 25 to Week 52)|Adverse Event|6|||
147505664|NCT02293902|532002875|FG000|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|0|||
147505665|NCT02293902|532002876|FG001|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|1|||
147505666|NCT02293902|532002877|FG002|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|1|||
147505667|NCT02293902|532002878|FG003|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|0|||
147505668|NCT02293902|532002879|FG004|Single-Blind Period (Week 25 to Week 52)|Lack of Efficacy|0|||
147505669|NCT00462488|532004516|FG000|Overall Study|Protocol Violation|1|||
147505670|NCT00462488|532004517|FG001|Overall Study|Protocol Violation|0|||
147505671|NCT00462488|532004516|FG000|Overall Study|Lack of Efficacy|19|||
147505672|NCT00462488|532004517|FG001|Overall Study|Lack of Efficacy|17|||
147505673|NCT02848313|532004522|FG000|Overall Study|Adverse Event|1|||
147505674|NCT02848313|532004523|FG001|Overall Study|Adverse Event|2|||
147505675|NCT02848313|532004522|FG000|Overall Study|Lack of Efficacy|0|||
147505676|NCT02848313|532004523|FG001|Overall Study|Lack of Efficacy|1|||
147505677|NCT02848313|532004522|FG000|Overall Study|Withdrawal by Subject|1|||
147505678|NCT02848313|532004523|FG001|Overall Study|Withdrawal by Subject|1|||
147505679|NCT02848313|532004522|FG000|Overall Study|Lost to follow up|1|||
147505680|NCT02848313|532004523|FG001|Overall Study|Lost to follow up|0|||
147505681|NCT03510910|532004526|FG000|Overall Study|Incomplete Survey|2|||
147505682|NCT03510910|532004527|FG001|Overall Study|Incomplete Survey|3|||
147505683|NCT01673490|532004528|FG000|Overall Study|Lost to Follow-up|1|||
147505684|NCT01673490|532004528|FG000|Overall Study|Adverse Event|3|||
147505685|NCT01673490|532004528|FG000|Overall Study|Withdrawal by Subject|3|||
147505686|NCT03382262|532004531|FG000|Overall Study|Physician Decision|0|||
147505687|NCT03382262|532004532|FG001|Overall Study|Physician Decision|0|||
147505688|NCT03382262|532004533|FG002|Overall Study|Physician Decision|1|||
147505689|NCT03382262|532004534|FG003|Overall Study|Physician Decision|0|||
147505690|NCT03382262|532004531|FG000|Overall Study|Withdrawal by Subject|0|||
147505691|NCT03382262|532004532|FG001|Overall Study|Withdrawal by Subject|0|||
147505692|NCT03382262|532004533|FG002|Overall Study|Withdrawal by Subject|0|||
147505693|NCT03382262|532004534|FG003|Overall Study|Withdrawal by Subject|1|||
147505694|NCT02940860|532004535|FG000|Overall Study|Non-serious AE|1|||
147505695|NCT02940860|532004536|FG001|Overall Study|Non-serious AE|2|||
147505696|NCT02940860|532004535|FG000|Overall Study|Serious AE|7|||
147505697|NCT02940860|532004536|FG001|Overall Study|Serious AE|3|||
147505698|NCT02940860|532004535|FG000|Overall Study|Withdrawal by Subject|19|||
147505699|NCT02940860|532004536|FG001|Overall Study|Withdrawal by Subject|9|||
147505700|NCT02940860|532004535|FG000|Overall Study|Lost to Follow-up|13|||
147505701|NCT02940860|532004536|FG001|Overall Study|Lost to Follow-up|7|||
147505702|NCT02940860|532004535|FG000|Overall Study|Physician Decision|5|||
147505703|NCT02940860|532004536|FG001|Overall Study|Physician Decision|3|||
147505704|NCT02940860|532004535|FG000|Overall Study|Sponsor Decision|0|||
147505705|NCT02940860|532004536|FG001|Overall Study|Sponsor Decision|1|||
147505706|NCT02940860|532004535|FG000|Overall Study|Protocol Violation|0|||
147505707|NCT02940860|532004536|FG001|Overall Study|Protocol Violation|2|||
147505708|NCT02940860|532004535|FG000|Overall Study|Death|3|||
147505709|NCT02940860|532004536|FG001|Overall Study|Death|2|||
147505710|NCT02940860|532004535|FG000|Overall Study|Moved, poor venous access, transport|6|||
147505711|NCT02940860|532004536|FG001|Overall Study|Moved, poor venous access, transport|4|||
147505712|NCT02940860|532004535|FG000|Overall Study|Not treated|2|||
147505713|NCT02940860|532004536|FG001|Overall Study|Not treated|2|||
147505714|NCT04914819|532004537|FG000|Overall Study|Pregnancy|3|||
147669544|NCT01773928|532615546|FG008|Overall Study|Adverse Event|0|||
147669545|NCT01773928|532615538|FG000|Overall Study|Physician Decision|0|||
147669546|NCT01773928|532615539|FG001|Overall Study|Physician Decision|0|||
147669547|NCT01773928|532615540|FG002|Overall Study|Physician Decision|0|||
147669548|NCT01773928|532615541|FG003|Overall Study|Physician Decision|1|||
147505715|NCT04914819|532004538|FG001|Overall Study|Pregnancy|1|||
147505716|NCT04914819|532004537|FG000|Overall Study|Discontinued study|4|||
147505717|NCT04914819|532004538|FG001|Overall Study|Discontinued study|1|||
147505718|NCT04914819|532004537|FG000|Overall Study|Lost to Follow-up|7|||
147505719|NCT04914819|532004538|FG001|Overall Study|Lost to Follow-up|0|||
147669549|NCT01773928|532615542|FG004|Overall Study|Physician Decision|0|||
147505720|NCT02715804|532004540|FG000|Overall Study|Death|222|||
147669550|NCT01773928|532615543|FG005|Overall Study|Physician Decision|0|||
147505721|NCT02715804|532004541|FG001|Overall Study|Death|106|||
147505722|NCT02715804|532004540|FG000|Overall Study|Withdrawal by Subject|5|||
147505723|NCT02715804|532004541|FG001|Overall Study|Withdrawal by Subject|4|||
147505724|NCT02715804|532004540|FG000|Overall Study|Other than specified|2|||
147505725|NCT02715804|532004541|FG001|Overall Study|Other than specified|3|||
147505726|NCT00948194|532004544|FG000|Overall Study|Blood drawn using incorrect test tube; sample invalid|1|||
147505727|NCT00948194|532004545|FG001|Overall Study|Blood drawn using incorrect test tube; sample invalid|0|||
147505728|NCT02905825|532004548|FG000|Overall Study|Protocol Violation|11|||
147505729|NCT02905825|532004548|FG000|Overall Study|Device Malfunction|1|||
147505730|NCT01709708|532004550|FG000|Overall Study|Protocol Violation|1|||
147505731|NCT01709708|532004551|FG001|Overall Study|Protocol Violation|2|||
147505732|NCT01527110|532004552|FG000|Overall Study|Adverse Event|1|||
147505733|NCT02657434|532004553|FG000|Overall Study|Study Terminated By Sponsor|64|||
147505734|NCT02657434|532004554|FG001|Overall Study|Study Terminated By Sponsor|82|||
147505735|NCT02657434|532004553|FG000|Overall Study|Death|189|||
147505736|NCT02657434|532004554|FG001|Overall Study|Death|190|||
147505737|NCT02657434|532004553|FG000|Overall Study|Lost to Follow-up|2|||
147505738|NCT02657434|532004554|FG001|Overall Study|Lost to Follow-up|2|||
147505739|NCT02657434|532004553|FG000|Overall Study|Randomization by Error|2|||
147505740|NCT02657434|532004554|FG001|Overall Study|Randomization by Error|0|||
147505741|NCT02657434|532004553|FG000|Overall Study|Withdrawal by Subject|28|||
147505742|NCT02657434|532004554|FG001|Overall Study|Withdrawal by Subject|17|||
147505743|NCT02657434|532004553|FG000|Overall Study|Protocol Violation|1|||
147505744|NCT02657434|532004554|FG001|Overall Study|Protocol Violation|0|||
147505745|NCT02657434|532004553|FG000|Overall Study|Physician Decision|0|||
147505746|NCT02657434|532004554|FG001|Overall Study|Physician Decision|1|||
147505747|NCT00511108|532004557|FG000|Overall Study|Adverse Event|2|||
147505748|NCT00511108|532004558|FG001|Overall Study|Adverse Event|0|||
147505749|NCT00511108|532004559|FG002|Overall Study|Adverse Event|1|||
147505750|NCT00511108|532004560|FG003|Overall Study|Adverse Event|2|||
147505751|NCT00511108|532004557|FG000|Overall Study|Lost to Follow-up|0|||
147505752|NCT00511108|532004558|FG001|Overall Study|Lost to Follow-up|2|||
147505753|NCT00511108|532004559|FG002|Overall Study|Lost to Follow-up|1|||
147505754|NCT00511108|532004560|FG003|Overall Study|Lost to Follow-up|0|||
147505755|NCT00511108|532004557|FG000|Overall Study|Physician Decision|0|||
147505756|NCT00511108|532004558|FG001|Overall Study|Physician Decision|0|||
147505757|NCT00511108|532004559|FG002|Overall Study|Physician Decision|0|||
147505758|NCT00511108|532004560|FG003|Overall Study|Physician Decision|1|||
147505759|NCT00511108|532004557|FG000|Overall Study|Withdrawal by Subject|4|||
147505760|NCT00511108|532004558|FG001|Overall Study|Withdrawal by Subject|0|||
147505761|NCT00511108|532004559|FG002|Overall Study|Withdrawal by Subject|3|||
147505762|NCT00511108|532004560|FG003|Overall Study|Withdrawal by Subject|2|||
147505763|NCT02147691|532004563|FG000|Overall Study|Withdrawal by Subject|2|||
147505764|NCT02147691|532004564|FG001|Overall Study|Withdrawal by Subject|0|||
147505765|NCT02147691|532004563|FG000|Overall Study|Adverse Event|2|||
147505766|NCT02147691|532004564|FG001|Overall Study|Adverse Event|0|||
147505767|NCT02147691|532004563|FG000|Overall Study|Lost to Follow-up|0|||
147505768|NCT02147691|532004564|FG001|Overall Study|Lost to Follow-up|1|||
147505769|NCT01392742|532004567|FG000|Overall Study|Premature study termination|42|||
147505770|NCT01392742|532004567|FG000|Overall Study|Failure to return|35|||
147505771|NCT01392742|532004567|FG000|Overall Study|No treatment/no cooperation/withdrew|12|||
147505772|NCT01392742|532004567|FG000|Overall Study|Lost to Follow-up|34|||
147505773|NCT01392742|532004567|FG000|Overall Study|Insufficient therapeutic response (ITR)|30|||
147505774|NCT01392742|532004567|FG000|Overall Study|ITR and Protocol deviation|1|||
147505775|NCT01392742|532004567|FG000|Overall Study|Adverse event/intercurrent illness|17|||
147505776|NCT01392742|532004567|FG000|Overall Study|Protocol Violation|14|||
147505777|NCT01392742|532004567|FG000|Overall Study|Other|3|||
147505778|NCT01392742|532004567|FG000|Overall Study|Missing information|13|||
147505779|NCT01998958|532004568|FG000|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
147505780|NCT01998958|532004569|FG001|Period 1 (Panel A and B)|Withdrawal by Subject|1|||
147505781|NCT01998958|532004570|FG002|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
147505782|NCT01998958|532004571|FG003|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
147505783|NCT01998958|532004572|FG004|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
147505784|NCT01998958|532004573|FG005|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
147505785|NCT01998958|532004574|FG006|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
147505786|NCT01998958|532004575|FG007|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
147505787|NCT01998958|532004576|FG008|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
147505788|NCT01998958|532004577|FG009|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
147505789|NCT01998958|532004578|FG010|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
147505790|NCT01998958|532004579|FG011|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
147505791|NCT01998958|532004580|FG012|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
147505792|NCT01998958|532004581|FG013|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
147505793|NCT01998958|532004582|FG014|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
147505794|NCT01998958|532004583|FG015|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
147505795|NCT01998958|532004584|FG016|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
147505796|NCT01998958|532004585|FG017|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
147505797|NCT01998958|532004586|FG018|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
147505798|NCT01998958|532004587|FG019|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
147505799|NCT01998958|532004588|FG020|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
147505800|NCT01998958|532004589|FG021|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
147505801|NCT01998958|532004590|FG022|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
147505802|NCT01998958|532004591|FG023|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
147505803|NCT01998958|532004592|FG024|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
147505804|NCT01998958|532004593|FG025|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
147505805|NCT01998958|532004594|FG026|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
147505806|NCT01998958|532004595|FG027|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
147505807|NCT01998958|532004596|FG028|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
147505808|NCT01998958|532004597|FG029|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
147505809|NCT01998958|532004598|FG030|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
147505810|NCT01998958|532004599|FG031|Period 1 (Panel A and B)|Withdrawal by Subject|0|||
147505811|NCT01998958|532004568|FG000|Period 1 (Panel A and B)|Lack of Efficacy|0|||
147505812|NCT01998958|532004569|FG001|Period 1 (Panel A and B)|Lack of Efficacy|1|||
147505813|NCT01998958|532004570|FG002|Period 1 (Panel A and B)|Lack of Efficacy|0|||
147505814|NCT01998958|532004571|FG003|Period 1 (Panel A and B)|Lack of Efficacy|0|||
147505815|NCT01998958|532004572|FG004|Period 1 (Panel A and B)|Lack of Efficacy|0|||
147505816|NCT01998958|532004573|FG005|Period 1 (Panel A and B)|Lack of Efficacy|0|||
147505817|NCT01998958|532004574|FG006|Period 1 (Panel A and B)|Lack of Efficacy|0|||
147505818|NCT01998958|532004575|FG007|Period 1 (Panel A and B)|Lack of Efficacy|0|||
147505819|NCT01998958|532004576|FG008|Period 1 (Panel A and B)|Lack of Efficacy|0|||
147505820|NCT01998958|532004577|FG009|Period 1 (Panel A and B)|Lack of Efficacy|0|||
147505821|NCT01998958|532004578|FG010|Period 1 (Panel A and B)|Lack of Efficacy|0|||
147505822|NCT01998958|532004579|FG011|Period 1 (Panel A and B)|Lack of Efficacy|0|||
147505823|NCT01998958|532004580|FG012|Period 1 (Panel A and B)|Lack of Efficacy|0|||
147505824|NCT01998958|532004581|FG013|Period 1 (Panel A and B)|Lack of Efficacy|0|||
147505825|NCT01998958|532004582|FG014|Period 1 (Panel A and B)|Lack of Efficacy|0|||
147505826|NCT01998958|532004583|FG015|Period 1 (Panel A and B)|Lack of Efficacy|0|||
147505827|NCT01998958|532004584|FG016|Period 1 (Panel A and B)|Lack of Efficacy|0|||
147505828|NCT01998958|532004585|FG017|Period 1 (Panel A and B)|Lack of Efficacy|0|||
147505829|NCT01998958|532004586|FG018|Period 1 (Panel A and B)|Lack of Efficacy|0|||
147505830|NCT01998958|532004587|FG019|Period 1 (Panel A and B)|Lack of Efficacy|0|||
147505831|NCT01998958|532004588|FG020|Period 1 (Panel A and B)|Lack of Efficacy|0|||
147505832|NCT01998958|532004589|FG021|Period 1 (Panel A and B)|Lack of Efficacy|0|||
147669551|NCT01773928|532615544|FG006|Overall Study|Physician Decision|0|||
147669552|NCT01773928|532615545|FG007|Overall Study|Physician Decision|0|||
147669553|NCT01773928|532615546|FG008|Overall Study|Physician Decision|0|||
147669554|NCT01773928|532615538|FG000|Overall Study|Withdrawal by Subject|5|||
147669555|NCT01773928|532615539|FG001|Overall Study|Withdrawal by Subject|4|||
147669556|NCT01773928|532615540|FG002|Overall Study|Withdrawal by Subject|4|||
147669557|NCT01773928|532615541|FG003|Overall Study|Withdrawal by Subject|4|||
147669558|NCT01773928|532615542|FG004|Overall Study|Withdrawal by Subject|7|||
147669559|NCT01773928|532615543|FG005|Overall Study|Withdrawal by Subject|1|||
147669560|NCT01773928|532615544|FG006|Overall Study|Withdrawal by Subject|0|||
147669561|NCT01773928|532615545|FG007|Overall Study|Withdrawal by Subject|0|||
147669562|NCT01773928|532615546|FG008|Overall Study|Withdrawal by Subject|1|||
147669563|NCT01773928|532615538|FG000|Overall Study|Lost to Follow-up|0|||
147669564|NCT01773928|532615539|FG001|Overall Study|Lost to Follow-up|0|||
147669565|NCT01773928|532615540|FG002|Overall Study|Lost to Follow-up|0|||
147669566|NCT01773928|532615541|FG003|Overall Study|Lost to Follow-up|0|||
147669567|NCT01773928|532615542|FG004|Overall Study|Lost to Follow-up|0|||
147669568|NCT01773928|532615543|FG005|Overall Study|Lost to Follow-up|1|||
147669569|NCT01773928|532615544|FG006|Overall Study|Lost to Follow-up|0|||
147669570|NCT01773928|532615545|FG007|Overall Study|Lost to Follow-up|0|||
147669571|NCT01773928|532615546|FG008|Overall Study|Lost to Follow-up|0|||
147669572|NCT01773928|532615538|FG000|Overall Study|Subject misrepresented age|0|||
147669573|NCT01773928|532615539|FG001|Overall Study|Subject misrepresented age|1|||
147669574|NCT01773928|532615540|FG002|Overall Study|Subject misrepresented age|0|||
147669575|NCT01773928|532615541|FG003|Overall Study|Subject misrepresented age|0|||
147669576|NCT01773928|532615542|FG004|Overall Study|Subject misrepresented age|0|||
147669577|NCT01773928|532615543|FG005|Overall Study|Subject misrepresented age|0|||
147669578|NCT01773928|532615544|FG006|Overall Study|Subject misrepresented age|0|||
147669579|NCT01773928|532615545|FG007|Overall Study|Subject misrepresented age|0|||
147669580|NCT01773928|532615546|FG008|Overall Study|Subject misrepresented age|0|||
147669581|NCT01773928|532615538|FG000|Overall Study|Subject met exclusion criteria|0|||
147669582|NCT01773928|532615539|FG001|Overall Study|Subject met exclusion criteria|0|||
147669583|NCT01773928|532615540|FG002|Overall Study|Subject met exclusion criteria|0|||
147669584|NCT01773928|532615541|FG003|Overall Study|Subject met exclusion criteria|0|||
147669585|NCT01773928|532615542|FG004|Overall Study|Subject met exclusion criteria|0|||
147505833|NCT01998958|532004590|FG022|Period 1 (Panel A and B)|Lack of Efficacy|0|||
147505834|NCT01998958|532004591|FG023|Period 1 (Panel A and B)|Lack of Efficacy|0|||
147505835|NCT01998958|532004592|FG024|Period 1 (Panel A and B)|Lack of Efficacy|0|||
147505836|NCT01998958|532004593|FG025|Period 1 (Panel A and B)|Lack of Efficacy|0|||
147669586|NCT01773928|532615543|FG005|Overall Study|Subject met exclusion criteria|0|||
147669587|NCT01773928|532615544|FG006|Overall Study|Subject met exclusion criteria|0|||
147669588|NCT01773928|532615545|FG007|Overall Study|Subject met exclusion criteria|0|||
147505837|NCT01998958|532004594|FG026|Period 1 (Panel A and B)|Lack of Efficacy|0|||
147505838|NCT01998958|532004595|FG027|Period 1 (Panel A and B)|Lack of Efficacy|0|||
147669589|NCT01773928|532615546|FG008|Overall Study|Subject met exclusion criteria|1|||
147669590|NCT01773928|532615538|FG000|Overall Study|Randomized, had to leave, never returned|0|||
147669591|NCT01773928|532615539|FG001|Overall Study|Randomized, had to leave, never returned|0|||
147505839|NCT01998958|532004596|FG028|Period 1 (Panel A and B)|Lack of Efficacy|0|||
147505840|NCT01998958|532004597|FG029|Period 1 (Panel A and B)|Lack of Efficacy|0|||
147505841|NCT01998958|532004598|FG030|Period 1 (Panel A and B)|Lack of Efficacy|0|||
147505842|NCT01998958|532004599|FG031|Period 1 (Panel A and B)|Lack of Efficacy|0|||
147505843|NCT01998958|532004568|FG000|Period 1 (Panel A and B)|Adverse Event|0|||
147505844|NCT01998958|532004569|FG001|Period 1 (Panel A and B)|Adverse Event|1|||
147505845|NCT01998958|532004570|FG002|Period 1 (Panel A and B)|Adverse Event|0|||
147505846|NCT01998958|532004571|FG003|Period 1 (Panel A and B)|Adverse Event|0|||
147505847|NCT01998958|532004572|FG004|Period 1 (Panel A and B)|Adverse Event|0|||
147505848|NCT01998958|532004573|FG005|Period 1 (Panel A and B)|Adverse Event|0|||
147505849|NCT01998958|532004574|FG006|Period 1 (Panel A and B)|Adverse Event|0|||
147505850|NCT01998958|532004575|FG007|Period 1 (Panel A and B)|Adverse Event|0|||
147505851|NCT01998958|532004576|FG008|Period 1 (Panel A and B)|Adverse Event|0|||
147505852|NCT01998958|532004577|FG009|Period 1 (Panel A and B)|Adverse Event|0|||
147505853|NCT01998958|532004578|FG010|Period 1 (Panel A and B)|Adverse Event|0|||
147505854|NCT01998958|532004579|FG011|Period 1 (Panel A and B)|Adverse Event|0|||
147505855|NCT01998958|532004580|FG012|Period 1 (Panel A and B)|Adverse Event|0|||
147505856|NCT01998958|532004581|FG013|Period 1 (Panel A and B)|Adverse Event|0|||
147505857|NCT01998958|532004582|FG014|Period 1 (Panel A and B)|Adverse Event|0|||
147505858|NCT01998958|532004583|FG015|Period 1 (Panel A and B)|Adverse Event|0|||
147505859|NCT01998958|532004584|FG016|Period 1 (Panel A and B)|Adverse Event|0|||
147505860|NCT01998958|532004585|FG017|Period 1 (Panel A and B)|Adverse Event|0|||
147505861|NCT01998958|532004586|FG018|Period 1 (Panel A and B)|Adverse Event|0|||
147505862|NCT01998958|532004587|FG019|Period 1 (Panel A and B)|Adverse Event|0|||
147505863|NCT01998958|532004588|FG020|Period 1 (Panel A and B)|Adverse Event|0|||
147505864|NCT01998958|532004589|FG021|Period 1 (Panel A and B)|Adverse Event|0|||
147505865|NCT01998958|532004590|FG022|Period 1 (Panel A and B)|Adverse Event|0|||
147505866|NCT01998958|532004591|FG023|Period 1 (Panel A and B)|Adverse Event|0|||
147505867|NCT01998958|532004592|FG024|Period 1 (Panel A and B)|Adverse Event|0|||
147505868|NCT01998958|532004593|FG025|Period 1 (Panel A and B)|Adverse Event|0|||
147505869|NCT01998958|532004594|FG026|Period 1 (Panel A and B)|Adverse Event|0|||
147505870|NCT01998958|532004595|FG027|Period 1 (Panel A and B)|Adverse Event|0|||
147505871|NCT01998958|532004596|FG028|Period 1 (Panel A and B)|Adverse Event|0|||
147505872|NCT01998958|532004597|FG029|Period 1 (Panel A and B)|Adverse Event|0|||
147505873|NCT01998958|532004598|FG030|Period 1 (Panel A and B)|Adverse Event|0|||
147505874|NCT01998958|532004599|FG031|Period 1 (Panel A and B)|Adverse Event|0|||
147505875|NCT01998958|532004568|FG000|Period 1 (Panel A and B)|Other|1|||
147505876|NCT01998958|532004569|FG001|Period 1 (Panel A and B)|Other|0|||
147505877|NCT01998958|532004570|FG002|Period 1 (Panel A and B)|Other|0|||
147505878|NCT01998958|532004571|FG003|Period 1 (Panel A and B)|Other|0|||
147505879|NCT01998958|532004572|FG004|Period 1 (Panel A and B)|Other|0|||
147505880|NCT01998958|532004573|FG005|Period 1 (Panel A and B)|Other|0|||
147505881|NCT01998958|532004574|FG006|Period 1 (Panel A and B)|Other|0|||
147505882|NCT01998958|532004575|FG007|Period 1 (Panel A and B)|Other|0|||
147505883|NCT01998958|532004576|FG008|Period 1 (Panel A and B)|Other|0|||
147505884|NCT01998958|532004577|FG009|Period 1 (Panel A and B)|Other|0|||
147505885|NCT01998958|532004578|FG010|Period 1 (Panel A and B)|Other|0|||
147505886|NCT01998958|532004579|FG011|Period 1 (Panel A and B)|Other|0|||
147505887|NCT01998958|532004580|FG012|Period 1 (Panel A and B)|Other|0|||
147505888|NCT01998958|532004581|FG013|Period 1 (Panel A and B)|Other|0|||
147505889|NCT01998958|532004582|FG014|Period 1 (Panel A and B)|Other|0|||
147505890|NCT01998958|532004583|FG015|Period 1 (Panel A and B)|Other|0|||
147505891|NCT01998958|532004584|FG016|Period 1 (Panel A and B)|Other|0|||
147505892|NCT01998958|532004585|FG017|Period 1 (Panel A and B)|Other|0|||
147505893|NCT01998958|532004586|FG018|Period 1 (Panel A and B)|Other|0|||
147505894|NCT01998958|532004587|FG019|Period 1 (Panel A and B)|Other|0|||
147505895|NCT01998958|532004588|FG020|Period 1 (Panel A and B)|Other|0|||
147505896|NCT01998958|532004589|FG021|Period 1 (Panel A and B)|Other|0|||
147505897|NCT01998958|532004590|FG022|Period 1 (Panel A and B)|Other|0|||
147505898|NCT01998958|532004591|FG023|Period 1 (Panel A and B)|Other|0|||
147505899|NCT01998958|532004592|FG024|Period 1 (Panel A and B)|Other|0|||
147505900|NCT01998958|532004593|FG025|Period 1 (Panel A and B)|Other|0|||
147505901|NCT01998958|532004594|FG026|Period 1 (Panel A and B)|Other|0|||
147505902|NCT01998958|532004595|FG027|Period 1 (Panel A and B)|Other|0|||
147505903|NCT01998958|532004596|FG028|Period 1 (Panel A and B)|Other|0|||
147505904|NCT01998958|532004597|FG029|Period 1 (Panel A and B)|Other|0|||
147505905|NCT01998958|532004598|FG030|Period 1 (Panel A and B)|Other|0|||
147505906|NCT01998958|532004599|FG031|Period 1 (Panel A and B)|Other|0|||
147505907|NCT01998958|532004568|FG000|Period 2 (Panel A and B)|Adverse Event|0|||
147639364|NCT01740128|532497784|FG000|Overall Study|Protocol Violation|1|||
147639365|NCT01740128|532497785|FG001|Overall Study|Protocol Violation|2|||
147639366|NCT01740128|532497784|FG000|Overall Study|Lost to Follow-up|2|||
147505908|NCT01998958|532004569|FG001|Period 2 (Panel A and B)|Adverse Event|0|||
147639367|NCT01740128|532497785|FG001|Overall Study|Lost to Follow-up|2|||
147505909|NCT01998958|532004570|FG002|Period 2 (Panel A and B)|Adverse Event|0|||
147505910|NCT01998958|532004571|FG003|Period 2 (Panel A and B)|Adverse Event|0|||
147505911|NCT01998958|532004572|FG004|Period 2 (Panel A and B)|Adverse Event|0|||
147505912|NCT01998958|532004573|FG005|Period 2 (Panel A and B)|Adverse Event|0|||
147505913|NCT01998958|532004574|FG006|Period 2 (Panel A and B)|Adverse Event|0|||
147505914|NCT01998958|532004575|FG007|Period 2 (Panel A and B)|Adverse Event|0|||
147669592|NCT01773928|532615540|FG002|Overall Study|Randomized, had to leave, never returned|0|||
147669593|NCT01773928|532615541|FG003|Overall Study|Randomized, had to leave, never returned|1|||
147669594|NCT01773928|532615542|FG004|Overall Study|Randomized, had to leave, never returned|0|||
147669595|NCT01773928|532615543|FG005|Overall Study|Randomized, had to leave, never returned|0|||
147669596|NCT01773928|532615544|FG006|Overall Study|Randomized, had to leave, never returned|0|||
147669597|NCT01773928|532615545|FG007|Overall Study|Randomized, had to leave, never returned|0|||
147669598|NCT01773928|532615546|FG008|Overall Study|Randomized, had to leave, never returned|0|||
147669599|NCT01773928|532615538|FG000|Overall Study|Refused vaccine, withdrew consent|0|||
147669600|NCT01773928|532615539|FG001|Overall Study|Refused vaccine, withdrew consent|0|||
147669601|NCT01773928|532615540|FG002|Overall Study|Refused vaccine, withdrew consent|0|||
147669602|NCT01773928|532615541|FG003|Overall Study|Refused vaccine, withdrew consent|0|||
147669603|NCT01773928|532615542|FG004|Overall Study|Refused vaccine, withdrew consent|1|||
147669604|NCT01773928|532615543|FG005|Overall Study|Refused vaccine, withdrew consent|0|||
147669605|NCT01773928|532615544|FG006|Overall Study|Refused vaccine, withdrew consent|0|||
147669606|NCT01773928|532615545|FG007|Overall Study|Refused vaccine, withdrew consent|0|||
147669607|NCT01773928|532615546|FG008|Overall Study|Refused vaccine, withdrew consent|0|||
147669608|NCT03225287|532615547|FG000|Overall Study|Adverse Event|0|||
147669609|NCT03225287|532615548|FG001|Overall Study|Adverse Event|0|||
147669610|NCT03225287|532615549|FG002|Overall Study|Adverse Event|1|||
147505915|NCT01998958|532004576|FG008|Period 2 (Panel A and B)|Adverse Event|0|||
147505916|NCT01998958|532004577|FG009|Period 2 (Panel A and B)|Adverse Event|0|||
147505917|NCT01998958|532004578|FG010|Period 2 (Panel A and B)|Adverse Event|1|||
147505918|NCT01998958|532004579|FG011|Period 2 (Panel A and B)|Adverse Event|0|||
147505919|NCT01998958|532004580|FG012|Period 2 (Panel A and B)|Adverse Event|0|||
147505920|NCT01998958|532004581|FG013|Period 2 (Panel A and B)|Adverse Event|0|||
147505921|NCT01998958|532004582|FG014|Period 2 (Panel A and B)|Adverse Event|1|||
147505922|NCT01998958|532004583|FG015|Period 2 (Panel A and B)|Adverse Event|0|||
147505923|NCT01998958|532004584|FG016|Period 2 (Panel A and B)|Adverse Event|0|||
147505924|NCT01998958|532004585|FG017|Period 2 (Panel A and B)|Adverse Event|0|||
147505925|NCT01998958|532004586|FG018|Period 2 (Panel A and B)|Adverse Event|0|||
147505926|NCT01998958|532004587|FG019|Period 2 (Panel A and B)|Adverse Event|0|||
147505927|NCT01998958|532004588|FG020|Period 2 (Panel A and B)|Adverse Event|0|||
147505928|NCT01998958|532004589|FG021|Period 2 (Panel A and B)|Adverse Event|0|||
147505929|NCT01998958|532004590|FG022|Period 2 (Panel A and B)|Adverse Event|0|||
147505930|NCT01998958|532004591|FG023|Period 2 (Panel A and B)|Adverse Event|0|||
147505931|NCT01998958|532004592|FG024|Period 2 (Panel A and B)|Adverse Event|0|||
147505932|NCT01998958|532004593|FG025|Period 2 (Panel A and B)|Adverse Event|0|||
147505933|NCT01998958|532004594|FG026|Period 2 (Panel A and B)|Adverse Event|0|||
147505934|NCT01998958|532004595|FG027|Period 2 (Panel A and B)|Adverse Event|0|||
147505935|NCT01998958|532004596|FG028|Period 2 (Panel A and B)|Adverse Event|0|||
147505936|NCT01998958|532004597|FG029|Period 2 (Panel A and B)|Adverse Event|0|||
147505937|NCT01998958|532004598|FG030|Period 2 (Panel A and B)|Adverse Event|0|||
147505938|NCT01998958|532004599|FG031|Period 2 (Panel A and B)|Adverse Event|0|||
147505939|NCT01998958|532004568|FG000|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
147505940|NCT01998958|532004569|FG001|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
147505941|NCT01998958|532004570|FG002|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
147505942|NCT01998958|532004571|FG003|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
147505943|NCT01998958|532004572|FG004|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
147505944|NCT01998958|532004573|FG005|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
147505945|NCT01998958|532004574|FG006|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
147669611|NCT03225287|532615547|FG000|Overall Study|Protocol non-compliance|0|||
147669612|NCT03225287|532615548|FG001|Overall Study|Protocol non-compliance|0|||
147669613|NCT03225287|532615549|FG002|Overall Study|Protocol non-compliance|1|||
147669614|NCT03225287|532615547|FG000|Overall Study|Subject withdraws consent|3|||
147669615|NCT03225287|532615548|FG001|Overall Study|Subject withdraws consent|0|||
147669616|NCT03225287|532615549|FG002|Overall Study|Subject withdraws consent|0|||
147669617|NCT03225287|532615547|FG000|Overall Study|Sponsor, regulatory, or EC/IRB request|7|||
147669618|NCT03225287|532615548|FG001|Overall Study|Sponsor, regulatory, or EC/IRB request|3|||
147669619|NCT03225287|532615549|FG002|Overall Study|Sponsor, regulatory, or EC/IRB request|1|||
147669620|NCT03225287|532615547|FG000|Overall Study|Trial drug not effective|0|||
147669621|NCT03225287|532615548|FG001|Overall Study|Trial drug not effective|1|||
147669622|NCT03225287|532615549|FG002|Overall Study|Trial drug not effective|0|||
147505946|NCT01998958|532004575|FG007|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
147505947|NCT01998958|532004576|FG008|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
147505948|NCT01998958|532004577|FG009|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
147505949|NCT01998958|532004578|FG010|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
147669623|NCT03225287|532615547|FG000|Overall Study|Need of transfusions and signs of hemolysis|0|||
147669624|NCT03225287|532615548|FG001|Overall Study|Need of transfusions and signs of hemolysis|1|||
147669625|NCT03225287|532615549|FG002|Overall Study|Need of transfusions and signs of hemolysis|0|||
147669626|NCT03225287|532615547|FG000|Overall Study|Stem cell transplantation|0|||
147505950|NCT01998958|532004579|FG011|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
147505951|NCT01998958|532004580|FG012|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
147505952|NCT01998958|532004581|FG013|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
147505953|NCT01998958|532004582|FG014|Period 2 (Panel A and B)|Withdrawal by Subject|1|||
147505954|NCT01998958|532004583|FG015|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
147505955|NCT01998958|532004584|FG016|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
147505956|NCT01998958|532004585|FG017|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
147505957|NCT01998958|532004586|FG018|Period 2 (Panel A and B)|Withdrawal by Subject|1|||
147505958|NCT01998958|532004587|FG019|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
147505959|NCT01998958|532004588|FG020|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
147505960|NCT01998958|532004589|FG021|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
147505961|NCT01998958|532004590|FG022|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
147505962|NCT01998958|532004591|FG023|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
147505963|NCT01998958|532004592|FG024|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
147505964|NCT01998958|532004593|FG025|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
147505965|NCT01998958|532004594|FG026|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
147505966|NCT01998958|532004595|FG027|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
147505967|NCT01998958|532004596|FG028|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
147505968|NCT01998958|532004597|FG029|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
147505969|NCT01998958|532004598|FG030|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
147505970|NCT01998958|532004599|FG031|Period 2 (Panel A and B)|Withdrawal by Subject|0|||
147505971|NCT01998958|532004568|FG000|Open Label Phase (Optional)|Adverse Event|0|||
147505972|NCT01998958|532004569|FG001|Open Label Phase (Optional)|Adverse Event|0|||
147505973|NCT01998958|532004570|FG002|Open Label Phase (Optional)|Adverse Event|0|||
147505974|NCT01998958|532004571|FG003|Open Label Phase (Optional)|Adverse Event|0|||
147505975|NCT01998958|532004572|FG004|Open Label Phase (Optional)|Adverse Event|0|||
147505976|NCT01998958|532004573|FG005|Open Label Phase (Optional)|Adverse Event|0|||
147505977|NCT01998958|532004574|FG006|Open Label Phase (Optional)|Adverse Event|0|||
147505978|NCT01998958|532004575|FG007|Open Label Phase (Optional)|Adverse Event|0|||
147505979|NCT01998958|532004576|FG008|Open Label Phase (Optional)|Adverse Event|0|||
147505980|NCT01998958|532004577|FG009|Open Label Phase (Optional)|Adverse Event|0|||
147505981|NCT01998958|532004578|FG010|Open Label Phase (Optional)|Adverse Event|0|||
147505982|NCT01998958|532004579|FG011|Open Label Phase (Optional)|Adverse Event|0|||
147505983|NCT01998958|532004580|FG012|Open Label Phase (Optional)|Adverse Event|0|||
147505984|NCT01998958|532004581|FG013|Open Label Phase (Optional)|Adverse Event|0|||
147505985|NCT01998958|532004582|FG014|Open Label Phase (Optional)|Adverse Event|0|||
147505986|NCT01998958|532004583|FG015|Open Label Phase (Optional)|Adverse Event|0|||
147505987|NCT01998958|532004584|FG016|Open Label Phase (Optional)|Adverse Event|0|||
147505988|NCT01998958|532004585|FG017|Open Label Phase (Optional)|Adverse Event|0|||
147505989|NCT01998958|532004586|FG018|Open Label Phase (Optional)|Adverse Event|0|||
147505990|NCT01998958|532004587|FG019|Open Label Phase (Optional)|Adverse Event|0|||
147505991|NCT01998958|532004588|FG020|Open Label Phase (Optional)|Adverse Event|0|||
147505992|NCT01998958|532004589|FG021|Open Label Phase (Optional)|Adverse Event|0|||
147505993|NCT01998958|532004590|FG022|Open Label Phase (Optional)|Adverse Event|0|||
147505994|NCT01998958|532004591|FG023|Open Label Phase (Optional)|Adverse Event|1|||
147505995|NCT01998958|532004592|FG024|Open Label Phase (Optional)|Adverse Event|0|||
147505996|NCT01998958|532004593|FG025|Open Label Phase (Optional)|Adverse Event|0|||
147505997|NCT01998958|532004594|FG026|Open Label Phase (Optional)|Adverse Event|0|||
147505998|NCT01998958|532004595|FG027|Open Label Phase (Optional)|Adverse Event|0|||
147505999|NCT01998958|532004596|FG028|Open Label Phase (Optional)|Adverse Event|0|||
147506000|NCT01998958|532004597|FG029|Open Label Phase (Optional)|Adverse Event|0|||
147506001|NCT01998958|532004598|FG030|Open Label Phase (Optional)|Adverse Event|0|||
147506002|NCT01998958|532004599|FG031|Open Label Phase (Optional)|Adverse Event|0|||
147506003|NCT01998958|532004568|FG000|Open Label Phase (Optional)|Other|0|||
147506004|NCT01998958|532004569|FG001|Open Label Phase (Optional)|Other|0|||
147506005|NCT01998958|532004570|FG002|Open Label Phase (Optional)|Other|0|||
147506006|NCT01998958|532004571|FG003|Open Label Phase (Optional)|Other|0|||
147506007|NCT01998958|532004572|FG004|Open Label Phase (Optional)|Other|0|||
147506008|NCT01998958|532004573|FG005|Open Label Phase (Optional)|Other|0|||
147506009|NCT01998958|532004574|FG006|Open Label Phase (Optional)|Other|0|||
147506010|NCT01998958|532004575|FG007|Open Label Phase (Optional)|Other|0|||
147506011|NCT01998958|532004576|FG008|Open Label Phase (Optional)|Other|0|||
147506012|NCT01998958|532004577|FG009|Open Label Phase (Optional)|Other|0|||
147506013|NCT01998958|532004578|FG010|Open Label Phase (Optional)|Other|0|||
147506014|NCT01998958|532004579|FG011|Open Label Phase (Optional)|Other|0|||
147506015|NCT01998958|532004580|FG012|Open Label Phase (Optional)|Other|0|||
147506016|NCT01998958|532004581|FG013|Open Label Phase (Optional)|Other|0|||
147506017|NCT01998958|532004582|FG014|Open Label Phase (Optional)|Other|0|||
147506018|NCT01998958|532004583|FG015|Open Label Phase (Optional)|Other|0|||
147506019|NCT01998958|532004584|FG016|Open Label Phase (Optional)|Other|0|||
147506020|NCT01998958|532004585|FG017|Open Label Phase (Optional)|Other|0|||
147506021|NCT01998958|532004586|FG018|Open Label Phase (Optional)|Other|0|||
147506022|NCT01998958|532004587|FG019|Open Label Phase (Optional)|Other|0|||
147506023|NCT01998958|532004588|FG020|Open Label Phase (Optional)|Other|0|||
147506024|NCT01998958|532004589|FG021|Open Label Phase (Optional)|Other|0|||
147669627|NCT03225287|532615548|FG001|Overall Study|Stem cell transplantation|1|||
147669628|NCT03225287|532615549|FG002|Overall Study|Stem cell transplantation|0|||
147669629|NCT05117060|532615551|FG000|Overall Study|Adverse Event|3|||
147669630|NCT05117060|532615552|FG001|Overall Study|Adverse Event|5|||
147506025|NCT01998958|532004590|FG022|Open Label Phase (Optional)|Other|5|||
147506026|NCT01998958|532004591|FG023|Open Label Phase (Optional)|Other|1|||
147506027|NCT01998958|532004592|FG024|Open Label Phase (Optional)|Other|0|||
147506028|NCT01998958|532004593|FG025|Open Label Phase (Optional)|Other|0|||
147506029|NCT01998958|532004594|FG026|Open Label Phase (Optional)|Other|0|||
147506030|NCT01998958|532004595|FG027|Open Label Phase (Optional)|Other|0|||
147506031|NCT01998958|532004596|FG028|Open Label Phase (Optional)|Other|0|||
147506032|NCT01998958|532004597|FG029|Open Label Phase (Optional)|Other|0|||
147506033|NCT01998958|532004598|FG030|Open Label Phase (Optional)|Other|0|||
147506034|NCT01998958|532004599|FG031|Open Label Phase (Optional)|Other|0|||
147506035|NCT01998958|532004568|FG000|Open Label Phase (Optional)|Lost to Follow-up|0|||
147506036|NCT01998958|532004569|FG001|Open Label Phase (Optional)|Lost to Follow-up|0|||
147506037|NCT01998958|532004570|FG002|Open Label Phase (Optional)|Lost to Follow-up|0|||
147506038|NCT01998958|532004571|FG003|Open Label Phase (Optional)|Lost to Follow-up|0|||
147506039|NCT01998958|532004572|FG004|Open Label Phase (Optional)|Lost to Follow-up|0|||
147506040|NCT01998958|532004573|FG005|Open Label Phase (Optional)|Lost to Follow-up|0|||
147506041|NCT01998958|532004574|FG006|Open Label Phase (Optional)|Lost to Follow-up|0|||
147506042|NCT01998958|532004575|FG007|Open Label Phase (Optional)|Lost to Follow-up|0|||
147506043|NCT01998958|532004576|FG008|Open Label Phase (Optional)|Lost to Follow-up|0|||
147506044|NCT01998958|532004577|FG009|Open Label Phase (Optional)|Lost to Follow-up|0|||
147506045|NCT01998958|532004578|FG010|Open Label Phase (Optional)|Lost to Follow-up|0|||
147506046|NCT01998958|532004579|FG011|Open Label Phase (Optional)|Lost to Follow-up|0|||
147506047|NCT01998958|532004580|FG012|Open Label Phase (Optional)|Lost to Follow-up|0|||
147506048|NCT01998958|532004581|FG013|Open Label Phase (Optional)|Lost to Follow-up|0|||
147506049|NCT01998958|532004582|FG014|Open Label Phase (Optional)|Lost to Follow-up|0|||
147506050|NCT01998958|532004583|FG015|Open Label Phase (Optional)|Lost to Follow-up|0|||
147506051|NCT01998958|532004584|FG016|Open Label Phase (Optional)|Lost to Follow-up|0|||
147506052|NCT01998958|532004585|FG017|Open Label Phase (Optional)|Lost to Follow-up|0|||
147506053|NCT01998958|532004586|FG018|Open Label Phase (Optional)|Lost to Follow-up|0|||
147506054|NCT01998958|532004587|FG019|Open Label Phase (Optional)|Lost to Follow-up|0|||
147506055|NCT01998958|532004588|FG020|Open Label Phase (Optional)|Lost to Follow-up|0|||
147506056|NCT01998958|532004589|FG021|Open Label Phase (Optional)|Lost to Follow-up|0|||
147506057|NCT01998958|532004590|FG022|Open Label Phase (Optional)|Lost to Follow-up|1|||
147506058|NCT01998958|532004591|FG023|Open Label Phase (Optional)|Lost to Follow-up|0|||
147506059|NCT01998958|532004592|FG024|Open Label Phase (Optional)|Lost to Follow-up|0|||
147506060|NCT01998958|532004593|FG025|Open Label Phase (Optional)|Lost to Follow-up|0|||
147506061|NCT01998958|532004594|FG026|Open Label Phase (Optional)|Lost to Follow-up|0|||
147506062|NCT01998958|532004595|FG027|Open Label Phase (Optional)|Lost to Follow-up|0|||
147506063|NCT01998958|532004596|FG028|Open Label Phase (Optional)|Lost to Follow-up|0|||
147506064|NCT01998958|532004597|FG029|Open Label Phase (Optional)|Lost to Follow-up|0|||
147506065|NCT01998958|532004598|FG030|Open Label Phase (Optional)|Lost to Follow-up|0|||
147506066|NCT01998958|532004599|FG031|Open Label Phase (Optional)|Lost to Follow-up|0|||
147506067|NCT01998958|532004568|FG000|Open Label Phase (Optional)|Lack of Efficacy|0|||
147506068|NCT01998958|532004569|FG001|Open Label Phase (Optional)|Lack of Efficacy|0|||
147506069|NCT01998958|532004570|FG002|Open Label Phase (Optional)|Lack of Efficacy|0|||
147506070|NCT01998958|532004571|FG003|Open Label Phase (Optional)|Lack of Efficacy|0|||
147506071|NCT01998958|532004572|FG004|Open Label Phase (Optional)|Lack of Efficacy|0|||
147506072|NCT01998958|532004573|FG005|Open Label Phase (Optional)|Lack of Efficacy|0|||
147506073|NCT01998958|532004574|FG006|Open Label Phase (Optional)|Lack of Efficacy|0|||
147506074|NCT01998958|532004575|FG007|Open Label Phase (Optional)|Lack of Efficacy|0|||
147506075|NCT01998958|532004576|FG008|Open Label Phase (Optional)|Lack of Efficacy|0|||
147506076|NCT01998958|532004577|FG009|Open Label Phase (Optional)|Lack of Efficacy|0|||
147506077|NCT01998958|532004578|FG010|Open Label Phase (Optional)|Lack of Efficacy|0|||
147506078|NCT01998958|532004579|FG011|Open Label Phase (Optional)|Lack of Efficacy|0|||
147506079|NCT01998958|532004580|FG012|Open Label Phase (Optional)|Lack of Efficacy|0|||
147506080|NCT01998958|532004581|FG013|Open Label Phase (Optional)|Lack of Efficacy|0|||
147506081|NCT01998958|532004582|FG014|Open Label Phase (Optional)|Lack of Efficacy|0|||
147506082|NCT01998958|532004583|FG015|Open Label Phase (Optional)|Lack of Efficacy|0|||
147506083|NCT01998958|532004584|FG016|Open Label Phase (Optional)|Lack of Efficacy|0|||
147506084|NCT01998958|532004585|FG017|Open Label Phase (Optional)|Lack of Efficacy|0|||
147506085|NCT01998958|532004586|FG018|Open Label Phase (Optional)|Lack of Efficacy|0|||
147669631|NCT05117060|532615553|FG002|Overall Study|Adverse Event|6|||
147669632|NCT05117060|532615554|FG003|Overall Study|Adverse Event|1|||
147506086|NCT01998958|532004587|FG019|Open Label Phase (Optional)|Lack of Efficacy|0|||
147506087|NCT01998958|532004588|FG020|Open Label Phase (Optional)|Lack of Efficacy|0|||
147506088|NCT01998958|532004589|FG021|Open Label Phase (Optional)|Lack of Efficacy|1|||
147506089|NCT01998958|532004590|FG022|Open Label Phase (Optional)|Lack of Efficacy|2|||
147506090|NCT01998958|532004591|FG023|Open Label Phase (Optional)|Lack of Efficacy|0|||
147506091|NCT01998958|532004592|FG024|Open Label Phase (Optional)|Lack of Efficacy|0|||
147506092|NCT01998958|532004593|FG025|Open Label Phase (Optional)|Lack of Efficacy|0|||
147506093|NCT01998958|532004594|FG026|Open Label Phase (Optional)|Lack of Efficacy|0|||
147506094|NCT01998958|532004595|FG027|Open Label Phase (Optional)|Lack of Efficacy|0|||
147506095|NCT01998958|532004596|FG028|Open Label Phase (Optional)|Lack of Efficacy|0|||
147506096|NCT01998958|532004597|FG029|Open Label Phase (Optional)|Lack of Efficacy|0|||
147506097|NCT01998958|532004598|FG030|Open Label Phase (Optional)|Lack of Efficacy|0|||
147506098|NCT01998958|532004599|FG031|Open Label Phase (Optional)|Lack of Efficacy|0|||
147506099|NCT01998958|532004568|FG000|Open Label Phase (Optional)|Withdrawal by Subject|0|||
147506100|NCT01998958|532004569|FG001|Open Label Phase (Optional)|Withdrawal by Subject|0|||
147506101|NCT01998958|532004570|FG002|Open Label Phase (Optional)|Withdrawal by Subject|0|||
147506102|NCT01998958|532004571|FG003|Open Label Phase (Optional)|Withdrawal by Subject|0|||
147506103|NCT01998958|532004572|FG004|Open Label Phase (Optional)|Withdrawal by Subject|0|||
147506104|NCT01998958|532004573|FG005|Open Label Phase (Optional)|Withdrawal by Subject|0|||
147506105|NCT01998958|532004574|FG006|Open Label Phase (Optional)|Withdrawal by Subject|0|||
147506106|NCT01998958|532004575|FG007|Open Label Phase (Optional)|Withdrawal by Subject|0|||
147506107|NCT01998958|532004576|FG008|Open Label Phase (Optional)|Withdrawal by Subject|0|||
147506108|NCT01998958|532004577|FG009|Open Label Phase (Optional)|Withdrawal by Subject|0|||
147506109|NCT01998958|532004578|FG010|Open Label Phase (Optional)|Withdrawal by Subject|0|||
147506110|NCT01998958|532004579|FG011|Open Label Phase (Optional)|Withdrawal by Subject|0|||
147506111|NCT01998958|532004580|FG012|Open Label Phase (Optional)|Withdrawal by Subject|0|||
147506112|NCT01998958|532004581|FG013|Open Label Phase (Optional)|Withdrawal by Subject|0|||
147506113|NCT01998958|532004582|FG014|Open Label Phase (Optional)|Withdrawal by Subject|0|||
147506114|NCT01998958|532004583|FG015|Open Label Phase (Optional)|Withdrawal by Subject|0|||
147506115|NCT01998958|532004584|FG016|Open Label Phase (Optional)|Withdrawal by Subject|0|||
147506116|NCT01998958|532004585|FG017|Open Label Phase (Optional)|Withdrawal by Subject|0|||
147506117|NCT01998958|532004586|FG018|Open Label Phase (Optional)|Withdrawal by Subject|0|||
147506118|NCT01998958|532004587|FG019|Open Label Phase (Optional)|Withdrawal by Subject|0|||
147506119|NCT01998958|532004588|FG020|Open Label Phase (Optional)|Withdrawal by Subject|0|||
147506120|NCT01998958|532004589|FG021|Open Label Phase (Optional)|Withdrawal by Subject|2|||
147506121|NCT01998958|532004590|FG022|Open Label Phase (Optional)|Withdrawal by Subject|1|||
147506122|NCT01998958|532004591|FG023|Open Label Phase (Optional)|Withdrawal by Subject|2|||
147506123|NCT01998958|532004592|FG024|Open Label Phase (Optional)|Withdrawal by Subject|0|||
147506124|NCT01998958|532004593|FG025|Open Label Phase (Optional)|Withdrawal by Subject|0|||
147506125|NCT01998958|532004594|FG026|Open Label Phase (Optional)|Withdrawal by Subject|0|||
147506126|NCT01998958|532004595|FG027|Open Label Phase (Optional)|Withdrawal by Subject|0|||
147506127|NCT01998958|532004596|FG028|Open Label Phase (Optional)|Withdrawal by Subject|0|||
147506128|NCT01998958|532004597|FG029|Open Label Phase (Optional)|Withdrawal by Subject|0|||
147506129|NCT01998958|532004598|FG030|Open Label Phase (Optional)|Withdrawal by Subject|0|||
147506130|NCT01998958|532004599|FG031|Open Label Phase (Optional)|Withdrawal by Subject|0|||
147506131|NCT02432703|532004600|FG000|Overall Study|Adverse Event|1|||
147506132|NCT02432703|532004601|FG001|Overall Study|Adverse Event|4|||
147506133|NCT02432703|532004600|FG000|Overall Study|Lack of Efficacy|1|||
147506134|NCT02432703|532004601|FG001|Overall Study|Lack of Efficacy|0|||
147506135|NCT02432703|532004600|FG000|Overall Study|Lost to Follow-up|5|||
147506136|NCT02432703|532004601|FG001|Overall Study|Lost to Follow-up|3|||
147506137|NCT02432703|532004600|FG000|Overall Study|Withdrawal by Subject|9|||
147506138|NCT02432703|532004601|FG001|Overall Study|Withdrawal by Subject|6|||
147506139|NCT02432703|532004600|FG000|Overall Study|Other|6|||
147506140|NCT02432703|532004601|FG001|Overall Study|Other|5|||
147506141|NCT00724815|532004602|FG000|Overall Study|Randomized, not treated|31|||
147506142|NCT00724815|532004603|FG001|Overall Study|Randomized, not treated|30|||
147506143|NCT00724815|532004602|FG000|Overall Study|Adverse Event|5|||
147506144|NCT00724815|532004603|FG001|Overall Study|Adverse Event|3|||
147506145|NCT00724815|532004602|FG000|Overall Study|Lost to Follow-up|4|||
147506146|NCT00724815|532004603|FG001|Overall Study|Lost to Follow-up|1|||
147506147|NCT00724815|532004602|FG000|Overall Study|Other Various|3|||
147506148|NCT00724815|532004603|FG001|Overall Study|Other Various|5|||
147506149|NCT01628393|532004604|FG000|Placebo-controlled Treatment Period|Lost to Follow-up|1|||
147506150|NCT01628393|532004605|FG001|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
147639368|NCT01740128|532497784|FG000|Overall Study|Withdrawal by Subject|1|||
147639369|NCT01740128|532497785|FG001|Overall Study|Withdrawal by Subject|0|||
147639370|NCT01740128|532497784|FG000|Overall Study|Insufficient protocol compliance|2|||
147506151|NCT01628393|532004606|FG002|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
147506152|NCT01628393|532004607|FG003|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
147506153|NCT01628393|532004608|FG004|Placebo-controlled Treatment Period|Lost to Follow-up|0|||
147639371|NCT01740128|532497785|FG001|Overall Study|Insufficient protocol compliance|2|||
147506154|NCT01628393|532004604|FG000|Placebo-controlled Treatment Period|Protocol Violation|0|||
147506155|NCT01628393|532004605|FG001|Placebo-controlled Treatment Period|Protocol Violation|1|||
147506156|NCT01628393|532004606|FG002|Placebo-controlled Treatment Period|Protocol Violation|0|||
147506157|NCT01628393|532004607|FG003|Placebo-controlled Treatment Period|Protocol Violation|0|||
147506158|NCT01628393|532004608|FG004|Placebo-controlled Treatment Period|Protocol Violation|0|||
147506159|NCT01628393|532004604|FG000|Placebo-controlled Treatment Period|Withdrawal by Subject|2|||
147506160|NCT01628393|532004605|FG001|Placebo-controlled Treatment Period|Withdrawal by Subject|1|||
147506161|NCT01628393|532004606|FG002|Placebo-controlled Treatment Period|Withdrawal by Subject|1|||
147506162|NCT01628393|532004607|FG003|Placebo-controlled Treatment Period|Withdrawal by Subject|0|||
147506163|NCT01628393|532004608|FG004|Placebo-controlled Treatment Period|Withdrawal by Subject|0|||
147506164|NCT01628393|532004604|FG000|Blinded Active Extension Period|Adverse Event|0|||
147506165|NCT01628393|532004605|FG001|Blinded Active Extension Period|Adverse Event|1|||
147506166|NCT01628393|532004606|FG002|Blinded Active Extension Period|Adverse Event|0|||
147506167|NCT01628393|532004607|FG003|Blinded Active Extension Period|Adverse Event|2|||
147506168|NCT01628393|532004608|FG004|Blinded Active Extension Period|Adverse Event|2|||
147506169|NCT01628393|532004604|FG000|Blinded Active Extension Period|Lack of Efficacy|0|||
147506170|NCT01628393|532004605|FG001|Blinded Active Extension Period|Lack of Efficacy|0|||
147506171|NCT01628393|532004606|FG002|Blinded Active Extension Period|Lack of Efficacy|2|||
147506172|NCT01628393|532004607|FG003|Blinded Active Extension Period|Lack of Efficacy|0|||
147506173|NCT01628393|532004608|FG004|Blinded Active Extension Period|Lack of Efficacy|2|||
147506174|NCT01628393|532004604|FG000|Blinded Active Extension Period|Physician Decision|0|||
147506175|NCT01628393|532004605|FG001|Blinded Active Extension Period|Physician Decision|3|||
147506176|NCT01628393|532004606|FG002|Blinded Active Extension Period|Physician Decision|0|||
147506177|NCT01628393|532004607|FG003|Blinded Active Extension Period|Physician Decision|1|||
147506178|NCT01628393|532004608|FG004|Blinded Active Extension Period|Physician Decision|0|||
147506179|NCT01628393|532004604|FG000|Blinded Active Extension Period|Protocol Violation|0|||
147506180|NCT01628393|532004605|FG001|Blinded Active Extension Period|Protocol Violation|0|||
147506181|NCT01628393|532004606|FG002|Blinded Active Extension Period|Protocol Violation|2|||
147506182|NCT01628393|532004607|FG003|Blinded Active Extension Period|Protocol Violation|1|||
147506183|NCT01628393|532004608|FG004|Blinded Active Extension Period|Protocol Violation|0|||
147506184|NCT01628393|532004604|FG000|Blinded Active Extension Period|Withdrawal by Subject|0|||
147506185|NCT01628393|532004605|FG001|Blinded Active Extension Period|Withdrawal by Subject|6|||
147506186|NCT01628393|532004606|FG002|Blinded Active Extension Period|Withdrawal by Subject|2|||
147506187|NCT01628393|532004607|FG003|Blinded Active Extension Period|Withdrawal by Subject|0|||
147506188|NCT01628393|532004608|FG004|Blinded Active Extension Period|Withdrawal by Subject|2|||
147506189|NCT00561340|532004609|FG000|Overall Study|refused to drink pediasure|6|||
147506190|NCT00561340|532004610|FG001|Overall Study|refused to drink pediasure|0|||
147506191|NCT01989754|532004611|FG000|Overall Study|Withdrawal by Subject|10|||
147506192|NCT01989754|532004612|FG001|Overall Study|Withdrawal by Subject|14|||
147506193|NCT01989754|532004611|FG000|Overall Study|Lost to Follow-up|28|||
147506194|NCT01989754|532004612|FG001|Overall Study|Lost to Follow-up|20|||
147506195|NCT01989754|532004611|FG000|Overall Study|Closed Site|1|||
147506196|NCT01989754|532004612|FG001|Overall Study|Closed Site|1|||
147506197|NCT01369225|532004615|FG000|Overall Study|Withdrawal by Subject|1|||
147506198|NCT01369225|532004616|FG001|Overall Study|Withdrawal by Subject|0|||
147506199|NCT01369225|532004617|FG002|Overall Study|Withdrawal by Subject|2|||
147506200|NCT01369225|532004618|FG003|Overall Study|Withdrawal by Subject|1|||
147506201|NCT01369225|532004619|FG004|Overall Study|Withdrawal by Subject|0|||
147506202|NCT01369225|532004620|FG005|Overall Study|Withdrawal by Subject|0|||
147506203|NCT01369225|532004615|FG000|Overall Study|Does Not Meet Entrance Criteria|0|||
147506204|NCT01369225|532004616|FG001|Overall Study|Does Not Meet Entrance Criteria|0|||
147506205|NCT01369225|532004617|FG002|Overall Study|Does Not Meet Entrance Criteria|1|||
147506206|NCT01369225|532004618|FG003|Overall Study|Does Not Meet Entrance Criteria|0|||
147506207|NCT01369225|532004619|FG004|Overall Study|Does Not Meet Entrance Criteria|0|||
147506208|NCT01369225|532004620|FG005|Overall Study|Does Not Meet Entrance Criteria|0|||
147506209|NCT01369225|532004615|FG000|Overall Study|Other|1|||
147506210|NCT01369225|532004616|FG001|Overall Study|Other|0|||
147506211|NCT01369225|532004617|FG002|Overall Study|Other|0|||
147506212|NCT01369225|532004618|FG003|Overall Study|Other|0|||
147506213|NCT01369225|532004619|FG004|Overall Study|Other|1|||
147506214|NCT01369225|532004620|FG005|Overall Study|Other|0|||
147506215|NCT01369225|532004615|FG000|Overall Study|Adverse Event|0|||
147506216|NCT01369225|532004616|FG001|Overall Study|Adverse Event|0|||
147506217|NCT01369225|532004617|FG002|Overall Study|Adverse Event|0|||
147639372|NCT02658734|532497786|FG000|Overall Study|Adverse Event|2|||
147639373|NCT02658734|532497786|FG000|Overall Study|Death|4|||
147639374|NCT02658734|532497786|FG000|Overall Study|Lost to Follow-up|7|||
147506218|NCT01369225|532004618|FG003|Overall Study|Adverse Event|1|||
147506219|NCT01369225|532004619|FG004|Overall Study|Adverse Event|1|||
147506220|NCT01369225|532004620|FG005|Overall Study|Adverse Event|0|||
147506221|NCT00105183|532004624|FG000|Overall Study|Death|19|||
147506222|NCT00105183|532004625|FG001|Overall Study|Death|13|||
147506223|NCT00105183|532004626|FG002|Overall Study|Death|15|||
147506224|NCT00105183|532004624|FG000|Overall Study|Withdrawal by Subject|1|||
147639375|NCT02658734|532497786|FG000|Overall Study|Withdrawal of Consent|16|||
147639376|NCT02658734|532497786|FG000|Overall Study|Disease Progression|28|||
147506225|NCT00105183|532004625|FG001|Overall Study|Withdrawal by Subject|1|||
147506226|NCT00105183|532004626|FG002|Overall Study|Withdrawal by Subject|4|||
147506227|NCT00105183|532004624|FG000|Overall Study|Physician Decision|1|||
147506228|NCT00105183|532004625|FG001|Overall Study|Physician Decision|2|||
147506229|NCT00105183|532004626|FG002|Overall Study|Physician Decision|3|||
147506230|NCT00105183|532004624|FG000|Overall Study|Lost to Follow-up|0|||
147506231|NCT00105183|532004625|FG001|Overall Study|Lost to Follow-up|1|||
147506232|NCT00105183|532004626|FG002|Overall Study|Lost to Follow-up|1|||
147506233|NCT00105183|532004624|FG000|Overall Study|Other reason|1|||
147506234|NCT00105183|532004625|FG001|Overall Study|Other reason|2|||
147506235|NCT00105183|532004626|FG002|Overall Study|Other reason|0|||
147506236|NCT04702984|532004628|FG000|Overall Study|Adverse Event Unrelated to the Study Device|1|||
147506237|NCT01467661|532004631|FG000|Overall Study|Adverse Event|16|||
147506238|NCT01467661|532004631|FG000|Overall Study|Withdrawal by Subject|1|||
147506239|NCT01467661|532004631|FG000|Overall Study|Lack of Efficacy|3|||
147506240|NCT01467661|532004631|FG000|Overall Study|Not enrolled to SPD422-309 (NCT01467661)|1|||
147506241|NCT03037307|532004632|FG000|Period 1|Did Not Meet Study Criteria|0|||
147506242|NCT03037307|532004633|FG001|Period 1|Did Not Meet Study Criteria|0|||
147506243|NCT03037307|532004634|FG002|Period 1|Did Not Meet Study Criteria|0|||
147506244|NCT03037307|532004635|FG003|Period 1|Did Not Meet Study Criteria|1|||
147506245|NCT03037307|532004636|FG004|Period 1|Did Not Meet Study Criteria|0|||
147506246|NCT03037307|532004637|FG005|Period 1|Did Not Meet Study Criteria|0|||
147506247|NCT00270998|532004638|FG000|3 Month Follow-up|Adverse Event|1|||
147669633|NCT05117060|532615551|FG000|Overall Study|Lost to Follow-up|0|||
147669634|NCT05117060|532615552|FG001|Overall Study|Lost to Follow-up|0|||
147669635|NCT05117060|532615553|FG002|Overall Study|Lost to Follow-up|0|||
147669636|NCT05117060|532615554|FG003|Overall Study|Lost to Follow-up|1|||
147669637|NCT05117060|532615551|FG000|Overall Study|Lack of Efficacy|4|||
147669638|NCT05117060|532615552|FG001|Overall Study|Lack of Efficacy|5|||
147669639|NCT05117060|532615553|FG002|Overall Study|Lack of Efficacy|2|||
147669640|NCT05117060|532615554|FG003|Overall Study|Lack of Efficacy|6|||
147669641|NCT05117060|532615551|FG000|Overall Study|Withdrawal by Subject|8|||
147669642|NCT05117060|532615552|FG001|Overall Study|Withdrawal by Subject|5|||
147669643|NCT05117060|532615553|FG002|Overall Study|Withdrawal by Subject|5|||
147669644|NCT05117060|532615554|FG003|Overall Study|Withdrawal by Subject|6|||
147669645|NCT05117060|532615551|FG000|Overall Study|Other|2|||
147669646|NCT05117060|532615552|FG001|Overall Study|Other|1|||
147669647|NCT05117060|532615553|FG002|Overall Study|Other|3|||
147669648|NCT05117060|532615554|FG003|Overall Study|Other|1|||
147669649|NCT02074514|532615556|FG000|Overall Study|Lack of Efficacy|3|||
147669650|NCT02074514|532615557|FG001|Overall Study|Lack of Efficacy|2|||
147669651|NCT02074514|532615556|FG000|Overall Study|Lost to Follow-up|0|||
147669652|NCT02074514|532615557|FG001|Overall Study|Lost to Follow-up|1|||
147669653|NCT02074514|532615556|FG000|Overall Study|Withdrew Consent|0|||
147669654|NCT02074514|532615557|FG001|Overall Study|Withdrew Consent|1|||
147669655|NCT04239924|532615560|FG000|Overall Study|Lost to Follow-up|2|||
147669656|NCT00666237|532615561|FG000|Overall Study|Death|5|||
147669657|NCT00666237|532615562|FG001|Overall Study|Death|5|||
147669658|NCT00666237|532615561|FG000|Overall Study|Lost to Follow-up|29|||
147669659|NCT00666237|532615562|FG001|Overall Study|Lost to Follow-up|25|||
147669660|NCT02659865|532617334|FG000|Period 1|Withdrawal by Subject|1|||
147669661|NCT02659865|532617335|FG001|Period 1|Withdrawal by Subject|0|||
147669662|NCT02659865|532617336|FG002|Period 1|Withdrawal by Subject|0|||
147669663|NCT02659865|532617337|FG003|Period 1|Withdrawal by Subject|0|||
147669664|NCT02659865|532617338|FG004|Period 1|Withdrawal by Subject|0|||
147669665|NCT02659865|532617334|FG000|Period 1|Adverse Event|0|||
147669666|NCT02659865|532617335|FG001|Period 1|Adverse Event|0|||
147669667|NCT02659865|532617336|FG002|Period 1|Adverse Event|0|||
147669668|NCT02659865|532617337|FG003|Period 1|Adverse Event|0|||
147669669|NCT02659865|532617338|FG004|Period 1|Adverse Event|1|||
147669670|NCT00753519|532617339|FG000|Overall Study|Withdrawal by Subject|0|||
147669671|NCT00753519|532617340|FG001|Overall Study|Withdrawal by Subject|2|||
147669672|NCT00959751|532617341|FG000|Overall Study|Lost to Follow-up|2|||
147669673|NCT00959751|532617342|FG001|Overall Study|Lost to Follow-up|3|||
147669674|NCT00959751|532617341|FG000|Overall Study|Consent Withdrawn|0|||
147669675|NCT00959751|532617342|FG001|Overall Study|Consent Withdrawn|1|||
147669676|NCT00959751|532617341|FG000|Overall Study|Non-compliance to Study Procedures|0|||
147669677|NCT00959751|532617342|FG001|Overall Study|Non-compliance to Study Procedures|1|||
147506248|NCT00270998|532004639|FG001|3 Month Follow-up|Adverse Event|0|||
147669678|NCT00959751|532617341|FG000|Overall Study|No migraine headache without aura|7|||
147669679|NCT00959751|532617342|FG001|Overall Study|No migraine headache without aura|7|||
147669680|NCT01171534|532617345|FG000|Overall Study|Lost to Follow-up|0|||
147669681|NCT01171534|532617346|FG001|Overall Study|Lost to Follow-up|2|||
147506249|NCT00270998|532004640|FG002|3 Month Follow-up|Adverse Event|0|||
147506250|NCT00270998|532004638|FG000|3 Month Follow-up|Lack of Efficacy|1|||
147669682|NCT01171534|532617345|FG000|Overall Study|screen failure|0|||
147669683|NCT01171534|532617346|FG001|Overall Study|screen failure|1|||
147669684|NCT03861039|532617347|FG000|Overall Study|Adverse Event|2|||
147669685|NCT03861039|532617348|FG001|Overall Study|Adverse Event|5|||
147669686|NCT03861039|532617349|FG002|Overall Study|Adverse Event|11|||
147669687|NCT03861039|532617347|FG000|Overall Study|Withdrawal by Subject|1|||
147669688|NCT03861039|532617348|FG001|Overall Study|Withdrawal by Subject|3|||
147669689|NCT03861039|532617349|FG002|Overall Study|Withdrawal by Subject|4|||
147506251|NCT00270998|532004639|FG001|3 Month Follow-up|Lack of Efficacy|2|||
147506252|NCT00270998|532004640|FG002|3 Month Follow-up|Lack of Efficacy|1|||
147506253|NCT00270998|532004638|FG000|3 Month Follow-up|Withdrawal by Subject|11|||
147506254|NCT00270998|532004639|FG001|3 Month Follow-up|Withdrawal by Subject|14|||
147506255|NCT00270998|532004640|FG002|3 Month Follow-up|Withdrawal by Subject|15|||
147506256|NCT00270998|532004638|FG000|3 Month Follow-up|Pessary did not fit|12|||
147506257|NCT00270998|532004639|FG001|3 Month Follow-up|Pessary did not fit|0|||
147506258|NCT00270998|532004640|FG002|3 Month Follow-up|Pessary did not fit|0|||
147506259|NCT00270998|532004638|FG000|3 Month Follow-up|Personal/family health|1|||
147506260|NCT00270998|532004639|FG001|3 Month Follow-up|Personal/family health|1|||
147506261|NCT00270998|532004640|FG002|3 Month Follow-up|Personal/family health|0|||
147506262|NCT00270998|532004638|FG000|3 Month Follow-up|Received/desired alternate treatment|13|||
147506263|NCT00270998|532004639|FG001|3 Month Follow-up|Received/desired alternate treatment|5|||
147506264|NCT00270998|532004640|FG002|3 Month Follow-up|Received/desired alternate treatment|2|||
147506265|NCT00270998|532004638|FG000|12 Month Follow-up|Lack of Efficacy|5|||
147506266|NCT00270998|532004639|FG001|12 Month Follow-up|Lack of Efficacy|4|||
147506267|NCT00270998|532004640|FG002|12 Month Follow-up|Lack of Efficacy|3|||
147506268|NCT00270998|532004638|FG000|12 Month Follow-up|Withdrawal by Subject|7|||
147506269|NCT00270998|532004639|FG001|12 Month Follow-up|Withdrawal by Subject|12|||
147506270|NCT00270998|532004640|FG002|12 Month Follow-up|Withdrawal by Subject|16|||
147506271|NCT00270998|532004638|FG000|12 Month Follow-up|Pessary did not fit|1|||
147506272|NCT00270998|532004639|FG001|12 Month Follow-up|Pessary did not fit|0|||
147506273|NCT00270998|532004640|FG002|12 Month Follow-up|Pessary did not fit|0|||
147506274|NCT00270998|532004638|FG000|12 Month Follow-up|Personal/family health|0|||
147506275|NCT00270998|532004639|FG001|12 Month Follow-up|Personal/family health|5|||
147506276|NCT00270998|532004640|FG002|12 Month Follow-up|Personal/family health|1|||
147506277|NCT00270998|532004638|FG000|12 Month Follow-up|Received/desired alternate treatment|1|||
147506278|NCT00270998|532004639|FG001|12 Month Follow-up|Received/desired alternate treatment|4|||
147506279|NCT00270998|532004640|FG002|12 Month Follow-up|Received/desired alternate treatment|1|||
147506280|NCT01855945|532004643|FG000|Overall Study|Adverse Event|0|||
147506281|NCT01855945|532004644|FG001|Overall Study|Adverse Event|0|||
147506282|NCT01855945|532004645|FG002|Overall Study|Adverse Event|0|||
147506283|NCT01855945|532004646|FG003|Overall Study|Adverse Event|0|||
147506284|NCT01855945|532004647|FG004|Overall Study|Adverse Event|0|||
147506285|NCT01855945|532004648|FG005|Overall Study|Adverse Event|0|||
147506286|NCT01855945|532004649|FG006|Overall Study|Adverse Event|1|||
147506287|NCT01855945|532004650|FG007|Overall Study|Adverse Event|0|||
147506288|NCT01855945|532004651|FG008|Overall Study|Adverse Event|0|||
147506289|NCT01855945|532004652|FG009|Overall Study|Adverse Event|0|||
147506290|NCT01855945|532004653|FG010|Overall Study|Adverse Event|0|||
147506291|NCT01855945|532004654|FG011|Overall Study|Adverse Event|0|||
147506292|NCT01855945|532004643|FG000|Overall Study|Death|0|||
147506293|NCT01855945|532004644|FG001|Overall Study|Death|0|||
147506294|NCT01855945|532004645|FG002|Overall Study|Death|0|||
147506295|NCT01855945|532004646|FG003|Overall Study|Death|0|||
147506296|NCT01855945|532004647|FG004|Overall Study|Death|0|||
147506297|NCT01855945|532004648|FG005|Overall Study|Death|0|||
147506298|NCT01855945|532004649|FG006|Overall Study|Death|2|||
147506299|NCT01855945|532004650|FG007|Overall Study|Death|0|||
147506300|NCT01855945|532004651|FG008|Overall Study|Death|0|||
147506301|NCT01855945|532004652|FG009|Overall Study|Death|0|||
147506302|NCT01855945|532004653|FG010|Overall Study|Death|0|||
147506303|NCT01855945|532004654|FG011|Overall Study|Death|0|||
147506304|NCT01855945|532004643|FG000|Overall Study|Lost to Follow-up|11|||
147506305|NCT01855945|532004644|FG001|Overall Study|Lost to Follow-up|10|||
147506306|NCT01855945|532004645|FG002|Overall Study|Lost to Follow-up|7|||
147506307|NCT01855945|532004646|FG003|Overall Study|Lost to Follow-up|3|||
147506308|NCT01855945|532004647|FG004|Overall Study|Lost to Follow-up|0|||
147506309|NCT01855945|532004648|FG005|Overall Study|Lost to Follow-up|3|||
147506310|NCT01855945|532004649|FG006|Overall Study|Lost to Follow-up|4|||
147506311|NCT01855945|532004650|FG007|Overall Study|Lost to Follow-up|7|||
147506312|NCT01855945|532004651|FG008|Overall Study|Lost to Follow-up|2|||
147506313|NCT01855945|532004652|FG009|Overall Study|Lost to Follow-up|0|||
147506314|NCT01855945|532004653|FG010|Overall Study|Lost to Follow-up|0|||
147506315|NCT01855945|532004654|FG011|Overall Study|Lost to Follow-up|2|||
147506316|NCT01855945|532004643|FG000|Overall Study|Other - Unclassified|1|||
147506317|NCT01855945|532004644|FG001|Overall Study|Other - Unclassified|1|||
147506318|NCT01855945|532004645|FG002|Overall Study|Other - Unclassified|1|||
147506319|NCT01855945|532004646|FG003|Overall Study|Other - Unclassified|0|||
147506320|NCT01855945|532004647|FG004|Overall Study|Other - Unclassified|0|||
147506321|NCT01855945|532004648|FG005|Overall Study|Other - Unclassified|0|||
147506322|NCT01855945|532004649|FG006|Overall Study|Other - Unclassified|2|||
147506323|NCT01855945|532004650|FG007|Overall Study|Other - Unclassified|1|||
147506324|NCT01855945|532004651|FG008|Overall Study|Other - Unclassified|0|||
147506325|NCT01855945|532004652|FG009|Overall Study|Other - Unclassified|0|||
147506326|NCT01855945|532004653|FG010|Overall Study|Other - Unclassified|1|||
147506327|NCT01855945|532004654|FG011|Overall Study|Other - Unclassified|0|||
147506328|NCT01855945|532004643|FG000|Overall Study|Withdrawal by Subject|4|||
147506329|NCT01855945|532004644|FG001|Overall Study|Withdrawal by Subject|0|||
147506330|NCT01855945|532004645|FG002|Overall Study|Withdrawal by Subject|4|||
147506331|NCT01855945|532004646|FG003|Overall Study|Withdrawal by Subject|1|||
147506332|NCT01855945|532004647|FG004|Overall Study|Withdrawal by Subject|1|||
147506333|NCT01855945|532004648|FG005|Overall Study|Withdrawal by Subject|0|||
147506334|NCT01855945|532004649|FG006|Overall Study|Withdrawal by Subject|1|||
147506335|NCT01855945|532004650|FG007|Overall Study|Withdrawal by Subject|0|||
147506336|NCT01855945|532004651|FG008|Overall Study|Withdrawal by Subject|0|||
147506337|NCT01855945|532004652|FG009|Overall Study|Withdrawal by Subject|2|||
147506338|NCT01855945|532004653|FG010|Overall Study|Withdrawal by Subject|4|||
147506339|NCT01855945|532004654|FG011|Overall Study|Withdrawal by Subject|1|||
147506340|NCT02156804|532004655|FG000|Overall Study|Withdrawal by Subject|1|||
147506341|NCT00389441|532004656|FG000|Overall Study|Adverse Event|7|||
147506342|NCT00389441|532004656|FG000|Overall Study|Death|4|||
147506343|NCT00389441|532004656|FG000|Overall Study|Lost to Follow-up|2|||
147506344|NCT00389441|532004656|FG000|Overall Study|Withdrawal by Subject|4|||
147506345|NCT00389441|532004656|FG000|Overall Study|Physician Decision|1|||
147506346|NCT00389441|532004656|FG000|Overall Study|Protocol Violation|1|||
147506347|NCT00389441|532004656|FG000|Overall Study|Global deterioration of health status|4|||
147506348|NCT00389441|532004656|FG000|Overall Study|Objective progression or relapse|26|||
147506349|NCT00389441|532004656|FG000|Overall Study|Ongoing in study A4061008 (NCT00828919)|2|||
147506350|NCT00389441|532004656|FG000|Overall Study|Clinical progression|1|||
147506351|NCT00636441|532004658|FG000|Overall Study|Adverse Event|0|||
147506352|NCT00636441|532004659|FG001|Overall Study|Adverse Event|1|||
147506353|NCT00636441|532004660|FG002|Overall Study|Adverse Event|1|||
147506354|NCT00636441|532004661|FG003|Overall Study|Adverse Event|0|||
147506355|NCT00636441|532004662|FG004|Overall Study|Adverse Event|0|||
147506356|NCT00636441|532004663|FG005|Overall Study|Adverse Event|1|||
147506357|NCT00636441|532004664|FG006|Overall Study|Adverse Event|0|||
147506358|NCT00636441|532004658|FG000|Overall Study|Late, ineligible|0|||
147506359|NCT00636441|532004659|FG001|Overall Study|Late, ineligible|0|||
147506360|NCT00636441|532004660|FG002|Overall Study|Late, ineligible|0|||
147639377|NCT02231879|532497787|FG000|Overall Study|Adverse Event|2|||
147639378|NCT02231879|532497788|FG001|Overall Study|Adverse Event|1|||
147639379|NCT02231879|532497787|FG000|Overall Study|Lack of Efficacy|0|||
147639380|NCT02231879|532497788|FG001|Overall Study|Lack of Efficacy|1|||
147639381|NCT00459706|532497789|FG000|Overall Study|Adverse Event|19|||
147639382|NCT00459706|532497790|FG001|Overall Study|Adverse Event|13|||
147639383|NCT00459706|532497789|FG000|Overall Study|Withdrawal by Subject|1|||
147639384|NCT00459706|532497790|FG001|Overall Study|Withdrawal by Subject|6|||
147639385|NCT00459706|532497789|FG000|Overall Study|Physician Decision|2|||
147639386|NCT00459706|532497790|FG001|Overall Study|Physician Decision|0|||
147639387|NCT00459706|532497789|FG000|Overall Study|Discontinuation of Study by Sponsor|1|||
147639388|NCT00459706|532497790|FG001|Overall Study|Discontinuation of Study by Sponsor|0|||
147639389|NCT00459706|532497789|FG000|Overall Study|Protocol Violation|2|||
147639390|NCT00459706|532497790|FG001|Overall Study|Protocol Violation|1|||
147639391|NCT00459706|532497789|FG000|Overall Study|Failed to Return|1|||
147639392|NCT00459706|532497790|FG001|Overall Study|Failed to Return|0|||
147639393|NCT00459706|532497789|FG000|Overall Study|Other|0|||
147639394|NCT00459706|532497790|FG001|Overall Study|Other|1|||
147639395|NCT00189306|532497791|FG000|Treatment Period|Withdrawal by Subject|2|||
147639396|NCT00189306|532497791|FG000|Treatment Period|Adverse Event|2|||
147639397|NCT00189306|532497791|FG000|Treatment Period|Protocol Violation|1|||
147639398|NCT00189306|532497791|FG000|Posttreatment Period|Death|1|||
147639399|NCT00189306|532497791|FG000|Posttreatment Period|Withdrawal by Subject|2|||
147639400|NCT00189306|532497791|FG000|Posttreatment Period|Noncompliance|1|||
147639401|NCT00189306|532497791|FG000|Posttreatment Period|Target lesion excised|1|||
147639402|NCT00189306|532497791|FG000|Posttreatment Period|Protocol Violation|1|||
147639403|NCT00189306|532497791|FG000|Posttreatment Period|Evidence of Superficial Basal Cell Ca|5|||
147639404|NCT00189306|532497791|FG000|Posttreatment Period|Local skin reaction/sign|1|||
147639405|NCT00189306|532497791|FG000|Long-Term Follow-up|Adverse Event|2|||
147639406|NCT00189306|532497791|FG000|Long-Term Follow-up|Death|4|||
147639407|NCT00189306|532497791|FG000|Long-Term Follow-up|Withdrawal by Subject|1|||
147639408|NCT00189306|532497791|FG000|Long-Term Follow-up|Intercurrent disease|2|||
147639409|NCT00189306|532497791|FG000|Long-Term Follow-up|Lost to Follow-up|9|||
147639410|NCT00189306|532497791|FG000|Long-Term Follow-up|Evidence of Superficial Basal Cell Ca|20|||
147639411|NCT02017912|532497792|FG000|Overall Study|Withdrawal by Subject|2|||
147639412|NCT02017912|532497793|FG001|Overall Study|Withdrawal by Subject|1|||
147639413|NCT02017912|532497792|FG000|Overall Study|miscellaneous|1|||
147639414|NCT02017912|532497793|FG001|Overall Study|miscellaneous|1|||
147639415|NCT03640481|532497794|FG000|Overall Study|Death|14|||
147639416|NCT03640481|532497795|FG001|Overall Study|Death|14|||
147639417|NCT03640481|532497796|FG002|Overall Study|Death|0|||
147639418|NCT03640481|532497797|FG003|Overall Study|Death|0|||
147639419|NCT03640481|532497794|FG000|Overall Study|Lost to Follow-up|2|||
147639420|NCT03640481|532497795|FG001|Overall Study|Lost to Follow-up|0|||
147639421|NCT03640481|532497796|FG002|Overall Study|Lost to Follow-up|0|||
147506361|NCT00636441|532004661|FG003|Overall Study|Late, ineligible|0|||
147506362|NCT00636441|532004662|FG004|Overall Study|Late, ineligible|0|||
147506363|NCT00636441|532004663|FG005|Overall Study|Late, ineligible|0|||
147506364|NCT00636441|532004664|FG006|Overall Study|Late, ineligible|1|||
147506365|NCT00636441|532004658|FG000|Overall Study|Screen Failure|0|||
147506366|NCT00636441|532004659|FG001|Overall Study|Screen Failure|0|||
147506367|NCT00636441|532004660|FG002|Overall Study|Screen Failure|0|||
147506368|NCT00636441|532004661|FG003|Overall Study|Screen Failure|0|||
147506369|NCT00636441|532004662|FG004|Overall Study|Screen Failure|0|||
147506370|NCT00636441|532004663|FG005|Overall Study|Screen Failure|0|||
147506371|NCT00636441|532004664|FG006|Overall Study|Screen Failure|17|||
147506372|NCT00844285|532004667|FG000|Overall Study|Other|0|||
147506373|NCT00844285|532004668|FG001|Overall Study|Other|1|||
147506374|NCT00844285|532004669|FG002|Overall Study|Other|0|||
147506375|NCT00844285|532004667|FG000|Overall Study|Other than specified|95|||
147506376|NCT00844285|532004668|FG001|Overall Study|Other than specified|129|||
147506377|NCT00844285|532004669|FG002|Overall Study|Other than specified|12|||
147506378|NCT00844285|532004667|FG000|Overall Study|Site closure|256|||
147506379|NCT00844285|532004668|FG001|Overall Study|Site closure|450|||
147506380|NCT00844285|532004669|FG002|Overall Study|Site closure|50|||
147506381|NCT00844285|532004667|FG000|Overall Study|Follow-up < 8 years|16|||
147506382|NCT00844285|532004668|FG001|Overall Study|Follow-up < 8 years|23|||
147506383|NCT00844285|532004669|FG002|Overall Study|Follow-up < 8 years|4|||
147506384|NCT00844285|532004667|FG000|Overall Study|Protocol Violation|26|||
147506385|NCT00844285|532004668|FG001|Overall Study|Protocol Violation|28|||
147506386|NCT00844285|532004669|FG002|Overall Study|Protocol Violation|54|||
147506387|NCT00844285|532004667|FG000|Overall Study|Death|22|||
147506388|NCT00844285|532004668|FG001|Overall Study|Death|21|||
147506389|NCT00844285|532004669|FG002|Overall Study|Death|8|||
147506390|NCT00844285|532004667|FG000|Overall Study|Withdrew Consent|344|||
147506391|NCT00844285|532004668|FG001|Overall Study|Withdrew Consent|466|||
147506392|NCT00844285|532004669|FG002|Overall Study|Withdrew Consent|70|||
147506393|NCT00844285|532004667|FG000|Overall Study|Lost to Follow-up|330|||
147506394|NCT00844285|532004668|FG001|Overall Study|Lost to Follow-up|486|||
147506395|NCT00844285|532004669|FG002|Overall Study|Lost to Follow-up|74|||
147506396|NCT01586806|532004670|FG000|Overall Study|Protocol Violation|0|||
147506397|NCT01586806|532004671|FG001|Overall Study|Protocol Violation|1|||
147506398|NCT01586806|532004672|FG002|Overall Study|Protocol Violation|0|||
147506399|NCT01586806|532004670|FG000|Overall Study|Withdrawal by Subject|1|||
147506400|NCT01586806|532004671|FG001|Overall Study|Withdrawal by Subject|0|||
147506401|NCT01586806|532004672|FG002|Overall Study|Withdrawal by Subject|0|||
147506402|NCT01586806|532004670|FG000|Overall Study|Lost to Follow-up|2|||
147506403|NCT01586806|532004671|FG001|Overall Study|Lost to Follow-up|3|||
147506404|NCT01586806|532004672|FG002|Overall Study|Lost to Follow-up|2|||
147506405|NCT00788697|532004674|FG000|Overall Study|No study drug administered|12|||
147506406|NCT00788697|532004674|FG000|Overall Study|Training Patients|74|||
147506407|NCT00788697|532004674|FG000|Overall Study|no truth standard procedure available|5|||
147506408|NCT00788697|532004674|FG000|Overall Study|Technically inadequate truth standard|1|||
147506409|NCT00788697|532004674|FG000|Overall Study|Indeterminate diagnosis from truth stand|17|||
147506410|NCT01998880|532004675|FG000|Overall Study|Adverse Events or Intercurrent Illness|16|||
147506411|NCT01998880|532004676|FG001|Overall Study|Adverse Events or Intercurrent Illness|16|||
147506412|NCT01998880|532004675|FG000|Overall Study|Disease Progression|1|||
147506413|NCT01998880|532004676|FG001|Overall Study|Disease Progression|8|||
147506414|NCT01998880|532004675|FG000|Overall Study|Withdrew Consent|2|||
147506415|NCT01998880|532004676|FG001|Overall Study|Withdrew Consent|1|||
147506416|NCT01998880|532004675|FG000|Overall Study|Death|3|||
147506417|NCT01998880|532004676|FG001|Overall Study|Death|6|||
147506418|NCT01998880|532004675|FG000|Overall Study|Insufficient Therapeutic Response|1|||
147506419|NCT01998880|532004676|FG001|Overall Study|Insufficient Therapeutic Response|5|||
147506420|NCT01998880|532004675|FG000|Overall Study|Administrative/Other|1|||
147506421|NCT01998880|532004676|FG001|Overall Study|Administrative/Other|1|||
147506422|NCT01998880|532004675|FG000|Overall Study|Refused Treatment/Did Not Cooperate|1|||
147506423|NCT01998880|532004676|FG001|Overall Study|Refused Treatment/Did Not Cooperate|0|||
147506424|NCT01998880|532004675|FG000|Overall Study|Violation of Selection Criteria at Entry|0|||
147506425|NCT01998880|532004676|FG001|Overall Study|Violation of Selection Criteria at Entry|1|||
147506426|NCT01998880|532004675|FG000|Overall Study|Did Not Receive Treatment|3|||
147506427|NCT01998880|532004676|FG001|Overall Study|Did Not Receive Treatment|2|||
147506428|NCT02248857|532004677|FG000|3 Month|Withdrawal by Subject|9|||
147506429|NCT02248857|532004678|FG001|3 Month|Withdrawal by Subject|3|||
147506430|NCT02248857|532004679|FG002|3 Month|Withdrawal by Subject|4|||
147506431|NCT02248857|532004677|FG000|3 Month|Unable to reach for 3 month|35|||
147506432|NCT02248857|532004678|FG001|3 Month|Unable to reach for 3 month|29|||
147506433|NCT02248857|532004679|FG002|3 Month|Unable to reach for 3 month|26|||
147506434|NCT02248857|532004677|FG000|3 Month|Partially completed, unable to finish|2|||
147506435|NCT02248857|532004678|FG001|3 Month|Partially completed, unable to finish|2|||
147506436|NCT02248857|532004679|FG002|3 Month|Partially completed, unable to finish|1|||
147506437|NCT02248857|532004677|FG000|6 Month|Lost to Follow-up|27|||
147506438|NCT02248857|532004678|FG001|6 Month|Lost to Follow-up|26|||
147506439|NCT02248857|532004679|FG002|6 Month|Lost to Follow-up|15|||
147506440|NCT02248857|532004677|FG000|6 Month|Partially completed, unable to finish|0|||
147506441|NCT02248857|532004678|FG001|6 Month|Partially completed, unable to finish|1|||
147506442|NCT02248857|532004679|FG002|6 Month|Partially completed, unable to finish|0|||
147506443|NCT02248857|532004677|FG000|6 Month|Withdrawal by Subject|0|||
147506444|NCT02248857|532004678|FG001|6 Month|Withdrawal by Subject|2|||
147506445|NCT02248857|532004679|FG002|6 Month|Withdrawal by Subject|2|||
147506446|NCT02248857|532004677|FG000|6 Month|Death|1|||
147506447|NCT02248857|532004678|FG001|6 Month|Death|0|||
147506448|NCT02248857|532004679|FG002|6 Month|Death|0|||
147506449|NCT02261883|532004680|FG000|Overall Study|Death|3|||
147506450|NCT02261883|532004681|FG001|Overall Study|Death|2|||
147506451|NCT02261883|532004680|FG000|Overall Study|Physician Decision|1|||
147506452|NCT02261883|532004681|FG001|Overall Study|Physician Decision|0|||
147506453|NCT02261883|532004680|FG000|Overall Study|Protocol Violation|1|||
147639422|NCT03640481|532497797|FG003|Overall Study|Lost to Follow-up|0|||
147639423|NCT03640481|532497794|FG000|Overall Study|Site terminated by sponsor|1|||
147639424|NCT03640481|532497795|FG001|Overall Study|Site terminated by sponsor|3|||
147639425|NCT03640481|532497796|FG002|Overall Study|Site terminated by sponsor|0|||
147639426|NCT03640481|532497797|FG003|Overall Study|Site terminated by sponsor|0|||
147639427|NCT03640481|532497794|FG000|Overall Study|Study terminated by sponsor|29|||
147639428|NCT03640481|532497795|FG001|Overall Study|Study terminated by sponsor|42|||
147639429|NCT03640481|532497796|FG002|Overall Study|Study terminated by sponsor|1|||
147639430|NCT03640481|532497797|FG003|Overall Study|Study terminated by sponsor|0|||
147639431|NCT03640481|532497794|FG000|Overall Study|Withdrawal by Subject|5|||
147639432|NCT03640481|532497795|FG001|Overall Study|Withdrawal by Subject|4|||
147639433|NCT03640481|532497796|FG002|Overall Study|Withdrawal by Subject|0|||
147639434|NCT03640481|532497797|FG003|Overall Study|Withdrawal by Subject|1|||
147639435|NCT03640481|532497794|FG000|Overall Study|Other|26|||
147639436|NCT03640481|532497795|FG001|Overall Study|Other|12|||
147639437|NCT03640481|532497796|FG002|Overall Study|Other|1|||
147639438|NCT03640481|532497797|FG003|Overall Study|Other|0|||
147639439|NCT03640481|532497794|FG000|Overall Study|Randomized, but not treated|1|||
147639440|NCT03640481|532497795|FG001|Overall Study|Randomized, but not treated|3|||
147639441|NCT03640481|532497796|FG002|Overall Study|Randomized, but not treated|0|||
147639442|NCT03640481|532497797|FG003|Overall Study|Randomized, but not treated|0|||
147639443|NCT00535847|532497798|FG000|Overall Study|Adverse Event|5|||
147639444|NCT00535847|532497799|FG001|Overall Study|Adverse Event|3|||
147639445|NCT00535847|532497800|FG002|Overall Study|Adverse Event|2|||
147639446|NCT00535847|532497798|FG000|Overall Study|Non compliance|1|||
147639447|NCT00535847|532497799|FG001|Overall Study|Non compliance|1|||
147639448|NCT00535847|532497800|FG002|Overall Study|Non compliance|0|||
147639449|NCT00535847|532497798|FG000|Overall Study|Protocol-defined Virologic Stopping Rule|16|||
147639450|NCT00535847|532497799|FG001|Overall Study|Protocol-defined Virologic Stopping Rule|10|||
147639451|NCT00535847|532497800|FG002|Overall Study|Protocol-defined Virologic Stopping Rule|0|||
147639452|NCT05007041|532497801|FG000|Overall Study|Missing Diary Entries|0|||
147639453|NCT05007041|532497802|FG001|Overall Study|Missing Diary Entries|1|||
147639454|NCT01546168|532497805|FG000|Overall Study|Lost to Follow-up|1|||
147639455|NCT01546168|532497806|FG001|Overall Study|Lost to Follow-up|0|||
147639456|NCT01546168|532497805|FG000|Overall Study|Withdrawal by Subject|1|||
147639457|NCT01546168|532497806|FG001|Overall Study|Withdrawal by Subject|0|||
147639458|NCT01546168|532497805|FG000|Overall Study|ineligible after signing consent|2|||
147639459|NCT01546168|532497806|FG001|Overall Study|ineligible after signing consent|0|||
147639460|NCT00423189|532497809|FG000|Overall Study|Death|0|||
147639461|NCT00423189|532497810|FG001|Overall Study|Death|1|||
147639462|NCT00423189|532497811|FG002|Overall Study|Death|0|||
147639463|NCT01618019|532497821|FG000|Overall Study|Withdrawal by Subject|14|||
147639464|NCT01618019|532497822|FG001|Overall Study|Withdrawal by Subject|14|||
147639465|NCT01542034|532497823|FG000|Overall Study|Consent Withdrawn (Subject Convenience)|20|||
147639466|NCT01542034|532497824|FG001|Overall Study|Consent Withdrawn (Subject Convenience)|12|||
147639467|NCT01542034|532497823|FG000|Overall Study|Administrative decision|0|||
147639468|NCT01542034|532497824|FG001|Overall Study|Administrative decision|3|||
147639469|NCT01542034|532497823|FG000|Overall Study|Subject Noncompliance|1|||
147639470|NCT01542034|532497824|FG001|Overall Study|Subject Noncompliance|0|||
147639471|NCT01542034|532497823|FG000|Overall Study|Adverse Event|2|||
147506454|NCT02261883|532004681|FG001|Overall Study|Protocol Violation|0|||
147506455|NCT02261883|532004680|FG000|Overall Study|Withdrawal by Subject|0|||
147639472|NCT01542034|532497824|FG001|Overall Study|Adverse Event|2|||
147639473|NCT01542034|532497823|FG000|Overall Study|Lost to Follow-up|7|||
147506456|NCT02261883|532004681|FG001|Overall Study|Withdrawal by Subject|1|||
147506457|NCT02261883|532004680|FG000|Overall Study|Required ECMO Prior to Study Drug Administration|1|||
147506458|NCT02261883|532004681|FG001|Overall Study|Required ECMO Prior to Study Drug Administration|0|||
147639474|NCT01542034|532497824|FG001|Overall Study|Lost to Follow-up|6|||
147639475|NCT00978250|532497829|FG000|Overall Study|Late determination of ineligibility|0|||
147639476|NCT00978250|532497830|FG001|Overall Study|Late determination of ineligibility|1|||
147639477|NCT00978250|532497831|FG002|Overall Study|Late determination of ineligibility|0|||
147639478|NCT00978250|532497832|FG003|Overall Study|Late determination of ineligibility|1|||
147639479|NCT00387010|532497833|FG000|Dose Titration Period|Adverse Event|12|||
147506459|NCT03549117|532004685|FG000|Overall Study|Withdrawal by Subject|1|||
147669690|NCT02100631|532617350|FG000|Overall Study|Withdrawal by Subject|1|||
147669691|NCT02100631|532617351|FG001|Overall Study|Withdrawal by Subject|0|||
147506460|NCT03549117|532004686|FG001|Overall Study|Withdrawal by Subject|0|||
147506461|NCT00014911|532004687|FG000|Overall Study|Adverse Event|1|||
147506462|NCT00014911|532004687|FG000|Overall Study|Lost to Follow-up|1|||
147506463|NCT00014911|532004687|FG000|Overall Study|Withdrawal by Subject|6|||
147506464|NCT00014911|532004687|FG000|Overall Study|Unknown Reasons|2|||
147506465|NCT00014911|532004687|FG000|Overall Study|Immunosuppression-related Side Effects|1|||
147506466|NCT04199793|532004688|FG000|Overall Study|Sponsor Withdrew the device off market; study stopped|2|||
147506467|NCT04199793|532004689|FG001|Overall Study|Sponsor Withdrew the device off market; study stopped|2|||
147506468|NCT04199793|532004688|FG000|Overall Study|Withdrawal by Subject|1|||
147506469|NCT04199793|532004689|FG001|Overall Study|Withdrawal by Subject|1|||
147506470|NCT03820726|532004690|FG000|Overall Study|Other than listed|23|||
147506471|NCT03820726|532004690|FG000|Overall Study|Withdrawal by Subject|37|||
147506472|NCT03820726|532004690|FG000|Overall Study|Lost to Follow-up|3|||
147506473|NCT03820726|532004690|FG000|Overall Study|Protocol deviation|1|||
147506474|NCT03820726|532004690|FG000|Overall Study|Adverse Event|146|||
147506475|NCT03820726|532004690|FG000|Overall Study|Not treated|1|||
147506476|NCT00345540|532004695|FG000|Overall Study|Withdrawal by Subject|1|||
147506477|NCT01938001|532004696|FG000|Pre-Treatment|Adverse Event unrelated to Study Drug|1|||
147506478|NCT01938001|532004697|FG001|Pre-Treatment|Adverse Event unrelated to Study Drug|0|||
147506479|NCT01938001|532004696|FG000|Pre-Treatment|Death|1|||
147506480|NCT01938001|532004697|FG001|Pre-Treatment|Death|0|||
147506481|NCT01938001|532004696|FG000|Treatment|Death|2|||
147506482|NCT01938001|532004697|FG001|Treatment|Death|0|||
147506483|NCT01938001|532004696|FG000|Treatment|Adverse Event|14|||
147506484|NCT01938001|532004697|FG001|Treatment|Adverse Event|8|||
147506485|NCT01938001|532004696|FG000|Treatment|Progressive Disease|21|||
147506486|NCT01938001|532004697|FG001|Treatment|Progressive Disease|54|||
147506487|NCT01938001|532004696|FG000|Treatment|Withdrawal by Subject|13|||
147506488|NCT01938001|532004697|FG001|Treatment|Withdrawal by Subject|7|||
147506489|NCT01938001|532004696|FG000|Treatment|Other reasons|2|||
147506490|NCT01938001|532004697|FG001|Treatment|Other reasons|1|||
147506491|NCT00107172|532006707|FG000|Overall Study|Withdrawal by Subject|1|||
147506492|NCT00107172|532006708|FG001|Overall Study|Withdrawal by Subject|0|||
147506493|NCT00107172|532006707|FG000|Overall Study|Death|0|||
147506494|NCT00107172|532006708|FG001|Overall Study|Death|2|||
147506495|NCT00107172|532006707|FG000|Overall Study|Other Reason|4|||
147506496|NCT00107172|532006708|FG001|Overall Study|Other Reason|3|||
147506497|NCT02688153|532006709|FG000|Overall Study|Death|7|||
147506498|NCT02688153|532006710|FG001|Overall Study|Death|5|||
147506499|NCT02688153|532006709|FG000|Overall Study|Withdrawal by Subject|4|||
147506500|NCT02688153|532006710|FG001|Overall Study|Withdrawal by Subject|2|||
147506501|NCT02688153|532006709|FG000|Overall Study|Valve Explant|1|||
147669692|NCT02100631|532617352|FG002|Overall Study|Withdrawal by Subject|0|||
147669693|NCT02100631|532617350|FG000|Overall Study|Lost to Follow-up|3|||
147669694|NCT02100631|532617351|FG001|Overall Study|Lost to Follow-up|4|||
147669695|NCT02100631|532617352|FG002|Overall Study|Lost to Follow-up|0|||
147669696|NCT02100631|532617350|FG000|Overall Study|3 subjects randomized to treatment unable to receive vaccine as product not available,|3|||
147669697|NCT02100631|532617351|FG001|Overall Study|3 subjects randomized to treatment unable to receive vaccine as product not available,|0|||
147669698|NCT02100631|532617352|FG002|Overall Study|3 subjects randomized to treatment unable to receive vaccine as product not available,|0|||
147669699|NCT03944616|532617353|FG000|Overall Study|Lost to Follow-up|0|||
147669700|NCT03944616|532617354|FG001|Overall Study|Lost to Follow-up|2|||
147669701|NCT01287936|532617355|FG000|Overall Study|Lost to Follow-up|0|||
147669702|NCT01287936|532617356|FG001|Overall Study|Lost to Follow-up|1|||
147506502|NCT02688153|532006710|FG001|Overall Study|Valve Explant|0|||
147506503|NCT02688153|532006709|FG000|Overall Study|Conversion to Commercial Valve|3|||
147506504|NCT02688153|532006710|FG001|Overall Study|Conversion to Commercial Valve|0|||
147506505|NCT01742091|532006713|FG000|Overall Study|Adverse Event|0|||
147506506|NCT01742091|532006714|FG001|Overall Study|Adverse Event|0|||
147669703|NCT01287936|532617357|FG002|Overall Study|Lost to Follow-up|1|||
147669704|NCT00427934|532617358|FG000|Overall Study|Adverse Event|1|||
147669705|NCT00427934|532617359|FG001|Overall Study|Adverse Event|0|||
147669706|NCT00427934|532617360|FG002|Overall Study|Adverse Event|5|||
147669707|NCT00427934|532617361|FG003|Overall Study|Adverse Event|4|||
147669708|NCT00427934|532617358|FG000|Overall Study|Lack of Efficacy|0|||
147506507|NCT01742091|532006715|FG002|Overall Study|Adverse Event|0|||
147506508|NCT01742091|532006716|FG003|Overall Study|Adverse Event|0|||
147506509|NCT01742091|532006717|FG004|Overall Study|Adverse Event|1|||
147506510|NCT01742091|532006718|FG005|Overall Study|Adverse Event|0|||
147506511|NCT01742091|532006713|FG000|Overall Study|Physician Decision|0|||
147506512|NCT01742091|532006714|FG001|Overall Study|Physician Decision|0|||
147506513|NCT01742091|532006715|FG002|Overall Study|Physician Decision|0|||
147506514|NCT01742091|532006716|FG003|Overall Study|Physician Decision|0|||
147506515|NCT01742091|532006717|FG004|Overall Study|Physician Decision|0|||
147506516|NCT01742091|532006718|FG005|Overall Study|Physician Decision|1|||
147506517|NCT01742091|532006713|FG000|Overall Study|Withdrawal by Subject|0|||
147506518|NCT01742091|532006714|FG001|Overall Study|Withdrawal by Subject|0|||
147506519|NCT01742091|532006715|FG002|Overall Study|Withdrawal by Subject|0|||
147506520|NCT01742091|532006716|FG003|Overall Study|Withdrawal by Subject|1|||
147506521|NCT01742091|532006717|FG004|Overall Study|Withdrawal by Subject|0|||
147506522|NCT01742091|532006718|FG005|Overall Study|Withdrawal by Subject|0|||
147506523|NCT01742091|532006713|FG000|Overall Study|Lost to Follow-up|0|||
147506524|NCT01742091|532006714|FG001|Overall Study|Lost to Follow-up|0|||
147506525|NCT01742091|532006715|FG002|Overall Study|Lost to Follow-up|0|||
147506526|NCT01742091|532006716|FG003|Overall Study|Lost to Follow-up|0|||
147506527|NCT01742091|532006717|FG004|Overall Study|Lost to Follow-up|0|||
147506528|NCT01742091|532006718|FG005|Overall Study|Lost to Follow-up|1|||
147506529|NCT03750240|532006720|FG000|Overall Study|Technical Difficulties|2|||
147506530|NCT03706040|532006721|FG000|Period A (Week 0 to Week 16)|Adverse Event|3|||
147506531|NCT03706040|532006722|FG001|Period A (Week 0 to Week 16)|Adverse Event|2|||
147506532|NCT03706040|532006723|FG002|Period A (Week 0 to Week 16)|Adverse Event|1|||
147506533|NCT03706040|532006724|FG003|Period A (Week 0 to Week 16)|Adverse Event|0|||
147506534|NCT03706040|532006725|FG004|Period A (Week 0 to Week 16)|Adverse Event|0|||
147506535|NCT03706040|532006726|FG005|Period A (Week 0 to Week 16)|Adverse Event|0|||
147506536|NCT03706040|532006727|FG006|Period A (Week 0 to Week 16)|Adverse Event|0|||
147506537|NCT03706040|532006721|FG000|Period A (Week 0 to Week 16)|Withdrew Consent|3|||
147506538|NCT03706040|532006722|FG001|Period A (Week 0 to Week 16)|Withdrew Consent|5|||
147506539|NCT03706040|532006723|FG002|Period A (Week 0 to Week 16)|Withdrew Consent|4|||
147506540|NCT03706040|532006724|FG003|Period A (Week 0 to Week 16)|Withdrew Consent|0|||
147506541|NCT03706040|532006725|FG004|Period A (Week 0 to Week 16)|Withdrew Consent|0|||
147506542|NCT03706040|532006726|FG005|Period A (Week 0 to Week 16)|Withdrew Consent|0|||
147506543|NCT03706040|532006727|FG006|Period A (Week 0 to Week 16)|Withdrew Consent|0|||
147506544|NCT03706040|532006721|FG000|Period A (Week 0 to Week 16)|Lost to Follow-up|1|||
147506545|NCT03706040|532006722|FG001|Period A (Week 0 to Week 16)|Lost to Follow-up|1|||
147506546|NCT03706040|532006723|FG002|Period A (Week 0 to Week 16)|Lost to Follow-up|4|||
147506547|NCT03706040|532006724|FG003|Period A (Week 0 to Week 16)|Lost to Follow-up|0|||
147506548|NCT03706040|532006725|FG004|Period A (Week 0 to Week 16)|Lost to Follow-up|0|||
147506549|NCT03706040|532006726|FG005|Period A (Week 0 to Week 16)|Lost to Follow-up|0|||
147506550|NCT03706040|532006727|FG006|Period A (Week 0 to Week 16)|Lost to Follow-up|0|||
147506551|NCT03706040|532006721|FG000|Period A (Week 0 to Week 16)|Other|2|||
147506552|NCT03706040|532006722|FG001|Period A (Week 0 to Week 16)|Other|0|||
147506553|NCT03706040|532006723|FG002|Period A (Week 0 to Week 16)|Other|2|||
147506554|NCT03706040|532006724|FG003|Period A (Week 0 to Week 16)|Other|0|||
147506555|NCT03706040|532006725|FG004|Period A (Week 0 to Week 16)|Other|0|||
147506556|NCT03706040|532006726|FG005|Period A (Week 0 to Week 16)|Other|0|||
147506557|NCT03706040|532006727|FG006|Period A (Week 0 to Week 16)|Other|0|||
147506558|NCT03706040|532006721|FG000|Period B (Week 16 to Week 52)|Adverse Event|0|||
147506559|NCT03706040|532006722|FG001|Period B (Week 16 to Week 52)|Adverse Event|0|||
147506560|NCT03706040|532006723|FG002|Period B (Week 16 to Week 52)|Adverse Event|0|||
147506561|NCT03706040|532006724|FG003|Period B (Week 16 to Week 52)|Adverse Event|1|||
147506562|NCT03706040|532006725|FG004|Period B (Week 16 to Week 52)|Adverse Event|2|||
147506563|NCT03706040|532006726|FG005|Period B (Week 16 to Week 52)|Adverse Event|3|||
147506564|NCT03706040|532006727|FG006|Period B (Week 16 to Week 52)|Adverse Event|0|||
147506565|NCT03706040|532006721|FG000|Period B (Week 16 to Week 52)|Withdrew Consent|0|||
147506566|NCT03706040|532006722|FG001|Period B (Week 16 to Week 52)|Withdrew Consent|0|||
147506567|NCT03706040|532006723|FG002|Period B (Week 16 to Week 52)|Withdrew Consent|0|||
147506568|NCT03706040|532006724|FG003|Period B (Week 16 to Week 52)|Withdrew Consent|3|||
147506569|NCT03706040|532006725|FG004|Period B (Week 16 to Week 52)|Withdrew Consent|2|||
147506570|NCT03706040|532006726|FG005|Period B (Week 16 to Week 52)|Withdrew Consent|1|||
147506571|NCT03706040|532006727|FG006|Period B (Week 16 to Week 52)|Withdrew Consent|10|||
147506572|NCT03706040|532006721|FG000|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
147506573|NCT03706040|532006722|FG001|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
147506574|NCT03706040|532006723|FG002|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
147506575|NCT03706040|532006724|FG003|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
147506576|NCT03706040|532006725|FG004|Period B (Week 16 to Week 52)|Lost to Follow-up|0|||
147506577|NCT03706040|532006726|FG005|Period B (Week 16 to Week 52)|Lost to Follow-up|1|||
147506578|NCT03706040|532006727|FG006|Period B (Week 16 to Week 52)|Lost to Follow-up|1|||
147506579|NCT03706040|532006721|FG000|Period B (Week 16 to Week 52)|Other|0|||
147506580|NCT03706040|532006722|FG001|Period B (Week 16 to Week 52)|Other|0|||
147639480|NCT00387010|532497833|FG000|Dose Titration Period|Lack of Efficacy|5|||
147639481|NCT00387010|532497833|FG000|Dose Titration Period|Withdrawal by Subject|3|||
147639482|NCT00387010|532497833|FG000|Dose Titration Period|Protocol Violation|1|||
147639483|NCT00387010|532497833|FG000|Dose Titration Period|Lost to Follow-up|2|||
147639484|NCT00387010|532497833|FG000|Dose Titration Period|Noncompliance with study medication|8|||
147506581|NCT03706040|532006723|FG002|Period B (Week 16 to Week 52)|Other|0|||
147506582|NCT03706040|532006724|FG003|Period B (Week 16 to Week 52)|Other|4|||
147639485|NCT00387010|532497833|FG000|Dose Titration Period|Noncompliance with study procedures|7|||
147506583|NCT03706040|532006725|FG004|Period B (Week 16 to Week 52)|Other|5|||
147506584|NCT03706040|532006726|FG005|Period B (Week 16 to Week 52)|Other|23|||
147506585|NCT03706040|532006727|FG006|Period B (Week 16 to Week 52)|Other|17|||
147506586|NCT00927758|532006728|FG000|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0|||
147506587|NCT00927758|532006729|FG001|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0|||
147506588|NCT00927758|532006730|FG002|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0|||
147506589|NCT00927758|532006731|FG003|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|1|||
147506590|NCT00927758|532006732|FG004|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|0|||
147506591|NCT00927758|532006733|FG005|Treatment Cycle 1 (Day 1 - Day 7)|Withdrawal by Subject|1|||
147506592|NCT00927758|532006728|FG000|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|0|||
147506593|NCT00927758|532006729|FG001|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|0|||
147506594|NCT00927758|532006730|FG002|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|1|||
147506595|NCT00927758|532006731|FG003|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|1|||
147506596|NCT00927758|532006732|FG004|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|0|||
147506597|NCT00927758|532006733|FG005|Treatment Cycle 2 (Day 1 - Day 7)|Did not meet eNO criteria|1|||
147506598|NCT00439725|532006735|FG000|Treatment Period|Withdrawal by Subject|22|||
147506599|NCT00439725|532006736|FG001|Treatment Period|Withdrawal by Subject|19|||
147506600|NCT00439725|532006735|FG000|Treatment Period|Study terminated by sponsor|156|||
147506601|NCT00439725|532006736|FG001|Treatment Period|Study terminated by sponsor|148|||
147506602|NCT00439725|532006735|FG000|Treatment Period|Site closed by investigator|1|||
147506603|NCT00439725|532006736|FG001|Treatment Period|Site closed by investigator|2|||
147506604|NCT00439725|532006735|FG000|Treatment Period|Adverse Event|39|||
147506605|NCT00439725|532006736|FG001|Treatment Period|Adverse Event|18|||
147506606|NCT00439725|532006735|FG000|Treatment Period|Physician Decision|1|||
147506607|NCT00439725|532006736|FG001|Treatment Period|Physician Decision|1|||
147506608|NCT00439725|532006735|FG000|Treatment Period|Protocol Violation|2|||
147506609|NCT00439725|532006736|FG001|Treatment Period|Protocol Violation|1|||
147506610|NCT00439725|532006735|FG000|Treatment Period|Clinical endpoint reached|6|||
147506611|NCT00439725|532006736|FG001|Treatment Period|Clinical endpoint reached|50|||
147506612|NCT00439725|532006735|FG000|Treatment Period|Technical problems|1|||
147506613|NCT00439725|532006736|FG001|Treatment Period|Technical problems|0|||
147506614|NCT00439725|532006735|FG000|Treatment Period|Lost to Follow-up|1|||
147506615|NCT00439725|532006736|FG001|Treatment Period|Lost to Follow-up|1|||
147506616|NCT00439725|532006735|FG000|Treatment Period|Participant convenience|1|||
147506617|NCT00439725|532006736|FG001|Treatment Period|Participant convenience|0|||
147506618|NCT00439725|532006735|FG000|Treatment Period|Protocol driven decision point|1|||
147506619|NCT00439725|532006736|FG001|Treatment Period|Protocol driven decision point|1|||
147506620|NCT00439725|532006735|FG000|Treatment Period|Death|1|||
147506621|NCT00439725|532006736|FG001|Treatment Period|Death|1|||
147506622|NCT00439725|532006735|FG000|Treatment Period|Participant did not receive treatment|4|||
147506623|NCT00439725|532006736|FG001|Treatment Period|Participant did not receive treatment|4|||
147506624|NCT00439725|532006735|FG000|Observational Period|Withdrawal by Subject|2|||
147506625|NCT00439725|532006736|FG001|Observational Period|Withdrawal by Subject|2|||
147506626|NCT00439725|532006735|FG000|Observational Period|Lost to Follow-up|0|||
147506627|NCT00439725|532006736|FG001|Observational Period|Lost to Follow-up|1|||
147506628|NCT00439725|532006735|FG000|Observational Period|Death|0|||
147506629|NCT00439725|532006736|FG001|Observational Period|Death|2|||
147506630|NCT00439725|532006735|FG000|Observational Period|Study termination by sponsor|1|||
147506631|NCT00439725|532006736|FG001|Observational Period|Study termination by sponsor|1|||
147506632|NCT00439725|532006735|FG000|Observational Period|Clinical endpoint reached|3|||
147506633|NCT00439725|532006736|FG001|Observational Period|Clinical endpoint reached|1|||
147506634|NCT00439725|532006735|FG000|Observational Period|Technical problems|1|||
147506635|NCT00439725|532006736|FG001|Observational Period|Technical problems|0|||
147506636|NCT00439725|532006735|FG000|Observational Period|Participant convenience|1|||
147506637|NCT00439725|532006736|FG001|Observational Period|Participant convenience|0|||
147506638|NCT01544478|532006737|FG000|Overall Study|Adverse Event|1|||
147506639|NCT01544478|532006737|FG000|Overall Study|Death|1|||
147506640|NCT01544478|532006737|FG000|Overall Study|Lost to Follow-up|48|||
147506641|NCT01544478|532006737|FG000|Overall Study|Physician Decision|15|||
147506642|NCT01544478|532006737|FG000|Overall Study|Pregnancy|1|||
147506643|NCT01544478|532006737|FG000|Overall Study|Withdrawal by Subject|52|||
147506644|NCT00212758|532006739|FG000|Standard Therapy of GH (12 Months)|Adverse Event|1|||
147506645|NCT00212758|532006740|FG001|Standard Therapy of GH (12 Months)|Adverse Event|0|||
147506646|NCT00212758|532006739|FG000|Standard Therapy of GH (12 Months)|Lost to Follow-up|1|||
147506647|NCT00212758|532006740|FG001|Standard Therapy of GH (12 Months)|Lost to Follow-up|1|||
147506648|NCT02574481|532006741|FG000|Overall Study|Withdrawal by Subject|29|||
147506649|NCT02574481|532006742|FG001|Overall Study|Withdrawal by Subject|15|||
147506650|NCT02574481|532006743|FG002|Overall Study|Withdrawal by Subject|4|||
147506651|NCT02574481|532006744|FG003|Overall Study|Withdrawal by Subject|1|||
147506652|NCT02574481|532006741|FG000|Overall Study|Adverse Event|5|||
147506653|NCT02574481|532006742|FG001|Overall Study|Adverse Event|1|||
147506654|NCT02574481|532006743|FG002|Overall Study|Adverse Event|1|||
147506655|NCT02574481|532006744|FG003|Overall Study|Adverse Event|0|||
147506656|NCT02574481|532006741|FG000|Overall Study|Visit Missed|15|||
147506657|NCT02574481|532006742|FG001|Overall Study|Visit Missed|7|||
147506658|NCT02574481|532006743|FG002|Overall Study|Visit Missed|5|||
147506659|NCT02574481|532006744|FG003|Overall Study|Visit Missed|0|||
147506660|NCT02574481|532006741|FG000|Overall Study|Other|7|||
147506661|NCT02574481|532006742|FG001|Overall Study|Other|2|||
147506662|NCT02574481|532006743|FG002|Overall Study|Other|0|||
147506663|NCT02574481|532006744|FG003|Overall Study|Other|0|||
147506664|NCT02574481|532006741|FG000|Overall Study|Death|48|||
147506665|NCT02574481|532006742|FG001|Overall Study|Death|26|||
147506666|NCT02574481|532006743|FG002|Overall Study|Death|12|||
147506667|NCT02574481|532006744|FG003|Overall Study|Death|4|||
147506668|NCT02574481|532006741|FG000|Overall Study|Physician Decision|5|||
147506669|NCT02574481|532006742|FG001|Overall Study|Physician Decision|2|||
147506670|NCT02574481|532006743|FG002|Overall Study|Physician Decision|0|||
147506671|NCT02574481|532006744|FG003|Overall Study|Physician Decision|0|||
147506672|NCT02574481|532006741|FG000|Overall Study|Lost to Follow-up|5|||
147506673|NCT02574481|532006742|FG001|Overall Study|Lost to Follow-up|1|||
147506674|NCT02574481|532006743|FG002|Overall Study|Lost to Follow-up|3|||
147506675|NCT02574481|532006744|FG003|Overall Study|Lost to Follow-up|0|||
147506676|NCT01105936|532006748|FG000|Period 1|Adverse Event|0|||
147506677|NCT01105936|532006749|FG001|Period 1|Adverse Event|0|||
147506678|NCT01105936|532006750|FG002|Period 1|Adverse Event|0|||
147506679|NCT01105936|532006751|FG003|Period 1|Adverse Event|1|||
147506680|NCT01105936|532006748|FG000|Period 2|Adverse Event|1|||
147506681|NCT01105936|532006749|FG001|Period 2|Adverse Event|0|||
147506682|NCT01105936|532006750|FG002|Period 2|Adverse Event|0|||
147506683|NCT01105936|532006751|FG003|Period 2|Adverse Event|0|||
147506684|NCT01105936|532006748|FG000|Period 3|Protocol Violation|0|||
147506685|NCT01105936|532006749|FG001|Period 3|Protocol Violation|2|||
147506686|NCT01105936|532006750|FG002|Period 3|Protocol Violation|0|||
147506687|NCT01105936|532006751|FG003|Period 3|Protocol Violation|0|||
147506688|NCT00247273|532006758|FG000|Overall Study|Adverse Event|85|||
147506689|NCT00247273|532006759|FG001|Overall Study|Adverse Event|80|||
147506690|NCT00247273|532006758|FG000|Overall Study|Physician Decision|6|||
147506691|NCT00247273|532006759|FG001|Overall Study|Physician Decision|3|||
147506692|NCT00247273|532006758|FG000|Overall Study|Lost to Follow-up|7|||
147506693|NCT00247273|532006759|FG001|Overall Study|Lost to Follow-up|7|||
147506694|NCT00247273|532006758|FG000|Overall Study|Withdrawal by Subject|46|||
147506695|NCT00247273|532006759|FG001|Overall Study|Withdrawal by Subject|47|||
147506696|NCT00247273|532006758|FG000|Overall Study|Did not take any study drug|2|||
147506697|NCT00247273|532006759|FG001|Overall Study|Did not take any study drug|0|||
147506698|NCT04209530|532006760|FG000|Overall Study|Terminated due to the major disruption in study visits and protocol assessments due to COVID-19|4|||
147506699|NCT04209530|532006761|FG001|Overall Study|Terminated due to the major disruption in study visits and protocol assessments due to COVID-19|2|||
147506700|NCT04209530|532006760|FG000|Overall Study|Withdrawal by Subject|0|||
147506701|NCT04209530|532006761|FG001|Overall Study|Withdrawal by Subject|1|||
147506702|NCT03276572|532006762|FG000|Overall Study|In follow-up|0|||
147506703|NCT03276572|532006763|FG001|Overall Study|In follow-up|0|||
147506704|NCT03276572|532006764|FG002|Overall Study|In follow-up|0|||
147506705|NCT03276572|532006765|FG003|Overall Study|In follow-up|0|||
147506706|NCT03276572|532006766|FG004|Overall Study|In follow-up|0|||
147506707|NCT03276572|532006767|FG005|Overall Study|In follow-up|1|||
147506708|NCT03276572|532006768|FG006|Overall Study|In follow-up|1|||
147639486|NCT00387010|532497833|FG000|Treatment Period|Adverse Event|4|||
147639487|NCT00387010|532497833|FG000|Treatment Period|Withdrawal by Subject|1|||
147639488|NCT00387010|532497833|FG000|Treatment Period|Noncompliance with study medication|2|||
147639489|NCT00387010|532497833|FG000|Treatment Period|Noncompliance with study procedures|3|||
147639490|NCT00387010|532497833|FG000|Treatment Period|Participant reported study drug stolen|1|||
147639491|NCT00520481|532497839|FG000|Overall Study|Adverse Event|4|||
147639492|NCT00520481|532497840|FG001|Overall Study|Adverse Event|1|||
147639493|NCT00520481|532497839|FG000|Overall Study|Withdrawal by Subject|3|||
147639494|NCT00520481|532497840|FG001|Overall Study|Withdrawal by Subject|0|||
147639495|NCT00381043|532497843|FG000|Overall Study|Lost to Follow-up|8|||
147639496|NCT00381043|532497844|FG001|Overall Study|Lost to Follow-up|6|||
147639497|NCT00381043|532497843|FG000|Overall Study|Withdrawal by Subject|3|||
147639498|NCT00381043|532497844|FG001|Overall Study|Withdrawal by Subject|1|||
147639499|NCT00381043|532497843|FG000|Overall Study|wanted more care|0|||
147639500|NCT00381043|532497844|FG001|Overall Study|wanted more care|1|||
147639501|NCT00381043|532497843|FG000|Overall Study|incarcerated|1|||
147639502|NCT00381043|532497844|FG001|Overall Study|incarcerated|0|||
147639503|NCT02847494|532497845|FG000|Overall Study|Lost to Follow-up|8|||
147639504|NCT02847494|532497846|FG001|Overall Study|Lost to Follow-up|5|||
147639505|NCT02841280|532497849|FG000|Overall Study|Adverse Event|2|||
147639506|NCT02841280|532497850|FG001|Overall Study|Adverse Event|1|||
147506709|NCT03276572|532006762|FG000|Overall Study|Lost to Follow-up|0|||
147639507|NCT02841280|532497849|FG000|Overall Study|Death|1|||
147639508|NCT02841280|532497850|FG001|Overall Study|Death|0|||
147506710|NCT03276572|532006763|FG001|Overall Study|Lost to Follow-up|0|||
147506711|NCT03276572|532006764|FG002|Overall Study|Lost to Follow-up|0|||
147506712|NCT03276572|532006765|FG003|Overall Study|Lost to Follow-up|0|||
147506713|NCT03276572|532006766|FG004|Overall Study|Lost to Follow-up|0|||
147506714|NCT03276572|532006767|FG005|Overall Study|Lost to Follow-up|0|||
147506715|NCT03276572|532006768|FG006|Overall Study|Lost to Follow-up|1|||
147506716|NCT00607919|532006769|FG000|Acute Phase|Adverse Event|9|||
147506717|NCT00607919|532006770|FG001|Acute Phase|Adverse Event|2|||
147506718|NCT00607919|532006769|FG000|Acute Phase|Entry Criteria Not Met|1|||
147506719|NCT00607919|532006770|FG001|Acute Phase|Entry Criteria Not Met|1|||
147506720|NCT00607919|532006769|FG000|Acute Phase|Lack of Efficacy|1|||
147506721|NCT00607919|532006770|FG001|Acute Phase|Lack of Efficacy|2|||
147506722|NCT00607919|532006769|FG000|Acute Phase|Lost to Follow-up|9|||
147506723|NCT00607919|532006770|FG001|Acute Phase|Lost to Follow-up|3|||
147506724|NCT00607919|532006769|FG000|Acute Phase|Parent/Caregiver Decision|6|||
147506725|NCT00607919|532006770|FG001|Acute Phase|Parent/Caregiver Decision|4|||
147506726|NCT00607919|532006769|FG000|Acute Phase|Protocol Violation|5|||
147506727|NCT00607919|532006770|FG001|Acute Phase|Protocol Violation|1|||
147506728|NCT00607919|532006769|FG000|Acute Phase|Withdrawal by Subject|3|||
147506729|NCT00607919|532006770|FG001|Acute Phase|Withdrawal by Subject|3|||
147506730|NCT00607919|532006769|FG000|Open-Label Phase|Adverse Event|1|||
147506731|NCT00607919|532006770|FG001|Open-Label Phase|Adverse Event|5|||
147506732|NCT00607919|532006769|FG000|Open-Label Phase|Lost to Follow-up|4|||
147506733|NCT00607919|532006770|FG001|Open-Label Phase|Lost to Follow-up|1|||
147506734|NCT00607919|532006769|FG000|Open-Label Phase|Protocol Violation|2|||
147506735|NCT00607919|532006770|FG001|Open-Label Phase|Protocol Violation|2|||
147506736|NCT00607919|532006769|FG000|Open-Label Phase|Withdrawal by Subject|2|||
147506737|NCT00607919|532006770|FG001|Open-Label Phase|Withdrawal by Subject|2|||
147506738|NCT00607919|532006769|FG000|Open-Label Phase|Parent/Caregiver Decision|1|||
147506739|NCT00607919|532006770|FG001|Open-Label Phase|Parent/Caregiver Decision|2|||
147506740|NCT02580240|532006783|FG000|Overall Study|Physician Decision|2|||
147506741|NCT02580240|532006784|FG001|Overall Study|Physician Decision|0|||
147506742|NCT00527072|532006787|FG000|Overall Study|Adverse Event|13|||
147506743|NCT00527072|532006787|FG000|Overall Study|Lack of Efficacy|11|||
147506744|NCT00527072|532006787|FG000|Overall Study|Lost to Follow-up|3|||
147506745|NCT00527072|532006787|FG000|Overall Study|Protocol Violation|2|||
147506746|NCT00527072|532006787|FG000|Overall Study|Withdrawal by Subject|7|||
147506747|NCT02007252|532006788|FG000|Overall Study|Administrative problems|3|||
147506748|NCT02007252|532006789|FG001|Overall Study|Administrative problems|7|||
147506749|NCT02007252|532006788|FG000|Overall Study|Abnormal laboratory value(s)|1|||
147506750|NCT02007252|532006789|FG001|Overall Study|Abnormal laboratory value(s)|0|||
147506751|NCT02007252|532006788|FG000|Overall Study|Adverse Event|7|||
147506752|NCT02007252|532006789|FG001|Overall Study|Adverse Event|4|||
147506753|NCT00608881|532006790|FG000|Overall Study|Death|22|||
147506754|NCT00608881|532006791|FG001|Overall Study|Death|13|||
147506755|NCT00608881|532006790|FG000|Overall Study|Adverse Event|5|||
147506756|NCT00608881|532006791|FG001|Overall Study|Adverse Event|3|||
147506757|NCT00608881|532006790|FG000|Overall Study|Lost to Follow-up|28|||
147506758|NCT00608881|532006791|FG001|Overall Study|Lost to Follow-up|14|||
147506759|NCT00608881|532006790|FG000|Overall Study|Withdrawal by Subject|18|||
147506760|NCT00608881|532006791|FG001|Overall Study|Withdrawal by Subject|29|||
147506761|NCT00608881|532006790|FG000|Overall Study|Physician Decision|5|||
147506762|NCT00608881|532006791|FG001|Overall Study|Physician Decision|5|||
147506763|NCT00608881|532006790|FG000|Overall Study|Institutionalized|1|||
147506764|NCT00608881|532006791|FG001|Overall Study|Institutionalized|2|||
147506765|NCT02954952|532006792|FG000|Overall Study|Withdrawal by Subject|1|||
147506766|NCT02954952|532006793|FG001|Overall Study|Withdrawal by Subject|0|||
147506767|NCT02954952|532006794|FG002|Overall Study|Withdrawal by Subject|0|||
147506768|NCT02954952|532006792|FG000|Overall Study|No data collected|0|||
147506769|NCT02954952|532006793|FG001|Overall Study|No data collected|1|||
147506770|NCT02954952|532006794|FG002|Overall Study|No data collected|0|||
147506771|NCT00810043|532006803|FG000|Overall Study|Withdrawal by Subject|1|||
147506772|NCT00810043|532006804|FG001|Overall Study|Withdrawal by Subject|0|||
147506773|NCT00810043|532006805|FG002|Overall Study|Withdrawal by Subject|2|||
147506774|NCT00810043|532006803|FG000|Overall Study|Lost to Follow-up|1|||
147669709|NCT00427934|532617359|FG001|Overall Study|Lack of Efficacy|0|||
147506775|NCT00810043|532006804|FG001|Overall Study|Lost to Follow-up|0|||
147506776|NCT00810043|532006805|FG002|Overall Study|Lost to Follow-up|0|||
147506777|NCT00810043|532006803|FG000|Overall Study|Physician Decision|0|||
147506778|NCT00810043|532006804|FG001|Overall Study|Physician Decision|0|||
147506779|NCT00810043|532006805|FG002|Overall Study|Physician Decision|2|||
147506780|NCT00810043|532006803|FG000|Overall Study|Death|2|||
147506781|NCT00810043|532006804|FG001|Overall Study|Death|0|||
147506782|NCT00810043|532006805|FG002|Overall Study|Death|0|||
147506783|NCT00810043|532006803|FG000|Overall Study|Unrelated medical problem|0|||
147506784|NCT00810043|532006804|FG001|Overall Study|Unrelated medical problem|1|||
147506785|NCT00810043|532006805|FG002|Overall Study|Unrelated medical problem|0|||
147506786|NCT00810043|532006803|FG000|Overall Study|Non-medical problem|0|||
147506787|NCT00810043|532006804|FG001|Overall Study|Non-medical problem|0|||
147506788|NCT00810043|532006805|FG002|Overall Study|Non-medical problem|1|||
147506789|NCT00810043|532006803|FG000|Overall Study|No longer met enrollment criteria|0|||
147506790|NCT00810043|532006804|FG001|Overall Study|No longer met enrollment criteria|0|||
147506791|NCT00810043|532006805|FG002|Overall Study|No longer met enrollment criteria|3|||
147506792|NCT02001688|532006806|FG000|Overall Study|Withdrawal by Subject|0|||
147506793|NCT02001688|532006807|FG001|Overall Study|Withdrawal by Subject|0|||
147506794|NCT02001688|532006808|FG002|Overall Study|Withdrawal by Subject|1|||
147506795|NCT02001688|532006806|FG000|Overall Study|Adverse Event|0|||
147506796|NCT02001688|532006807|FG001|Overall Study|Adverse Event|1|||
147506797|NCT02001688|532006808|FG002|Overall Study|Adverse Event|0|||
147506798|NCT00445341|532006812|FG000|Overall Study|refused further treatment|1|||
147506799|NCT00445341|532006812|FG000|Overall Study|taken off treatment too early|1|||
147506800|NCT03051217|532006813|FG000|Initial Period (Week 0 to Week 16)|Adverse Event|2|||
147506801|NCT03051217|532006814|FG001|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
147506802|NCT03051217|532006815|FG002|Initial Period (Week 0 to Week 16)|Adverse Event|1|||
147506803|NCT03051217|532006816|FG003|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
147506804|NCT03051217|532006817|FG004|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
147506805|NCT03051217|532006818|FG005|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
147506806|NCT03051217|532006819|FG006|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
147506807|NCT03051217|532006813|FG000|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
147506808|NCT03051217|532006814|FG001|Initial Period (Week 0 to Week 16)|Protocol Violation|1|||
147506809|NCT03051217|532006815|FG002|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
147506810|NCT03051217|532006816|FG003|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
147506811|NCT03051217|532006817|FG004|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
147506812|NCT03051217|532006818|FG005|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
147506813|NCT03051217|532006819|FG006|Initial Period (Week 0 to Week 16)|Protocol Violation|0|||
147506814|NCT03051217|532006813|FG000|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|1|||
147506815|NCT03051217|532006814|FG001|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|1|||
147506816|NCT03051217|532006815|FG002|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|1|||
147506817|NCT03051217|532006816|FG003|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
147506818|NCT03051217|532006817|FG004|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
147506819|NCT03051217|532006818|FG005|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
147506820|NCT03051217|532006819|FG006|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
147506821|NCT03051217|532006813|FG000|Maintenance Period (Week 16 to Week 52)|Adverse Event|0|||
147506822|NCT03051217|532006814|FG001|Maintenance Period (Week 16 to Week 52)|Adverse Event|0|||
147506823|NCT03051217|532006815|FG002|Maintenance Period (Week 16 to Week 52)|Adverse Event|0|||
147506824|NCT03051217|532006816|FG003|Maintenance Period (Week 16 to Week 52)|Adverse Event|1|||
147506825|NCT03051217|532006817|FG004|Maintenance Period (Week 16 to Week 52)|Adverse Event|2|||
147506826|NCT03051217|532006818|FG005|Maintenance Period (Week 16 to Week 52)|Adverse Event|1|||
147506827|NCT03051217|532006819|FG006|Maintenance Period (Week 16 to Week 52)|Adverse Event|1|||
147506828|NCT03051217|532006813|FG000|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
147506829|NCT03051217|532006814|FG001|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
147506830|NCT03051217|532006815|FG002|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
147506831|NCT03051217|532006816|FG003|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|1|||
147506832|NCT03051217|532006817|FG004|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
147506833|NCT03051217|532006818|FG005|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
147506834|NCT03051217|532006819|FG006|Maintenance Period (Week 16 to Week 52)|Lack of Efficacy|0|||
147506835|NCT03051217|532006813|FG000|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
147506836|NCT03051217|532006814|FG001|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
147506837|NCT03051217|532006815|FG002|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
147506838|NCT03051217|532006816|FG003|Maintenance Period (Week 16 to Week 52)|Protocol Violation|1|||
147506839|NCT03051217|532006817|FG004|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
147506840|NCT03051217|532006818|FG005|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
147506841|NCT03051217|532006819|FG006|Maintenance Period (Week 16 to Week 52)|Protocol Violation|0|||
147506842|NCT03051217|532006813|FG000|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
147506843|NCT03051217|532006814|FG001|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
147506844|NCT03051217|532006815|FG002|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
147506845|NCT03051217|532006816|FG003|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
147506846|NCT03051217|532006817|FG004|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|1|||
147506847|NCT03051217|532006818|FG005|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
147506848|NCT03051217|532006819|FG006|Maintenance Period (Week 16 to Week 52)|Withdrawal by Subject|0|||
147506849|NCT03051217|532006813|FG000|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
147506850|NCT03051217|532006814|FG001|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
147506851|NCT03051217|532006815|FG002|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
147639509|NCT02841280|532497849|FG000|Overall Study|Lost to Follow-up|2|||
147639510|NCT02841280|532497850|FG001|Overall Study|Lost to Follow-up|2|||
147506852|NCT03051217|532006816|FG003|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
147506853|NCT03051217|532006817|FG004|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
147506854|NCT03051217|532006818|FG005|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|1|||
147506855|NCT03051217|532006819|FG006|Maintenance Period (Week 16 to Week 52)|Difficulty in going to hospital|0|||
147506856|NCT00641706|532006822|FG000|Overall Study|Adverse Event|2|||
147506857|NCT00641706|532006823|FG001|Overall Study|Adverse Event|1|||
147506858|NCT00641706|532006822|FG000|Overall Study|Withdrawal by Subject|6|||
147506859|NCT00641706|532006823|FG001|Overall Study|Withdrawal by Subject|1|||
147506860|NCT00641706|532006822|FG000|Overall Study|Clinical Decline|1|||
147506861|NCT00641706|532006823|FG001|Overall Study|Clinical Decline|0|||
147506862|NCT00641706|532006822|FG000|Overall Study|Lead Investigator Decision|0|||
147506863|NCT00641706|532006823|FG001|Overall Study|Lead Investigator Decision|1|||
147506864|NCT05441540|532006824|FG000|Overall Study|Withdrawal by Subject|2|||
147506865|NCT01359046|532006825|FG000|Overall Study|Did not receive allocated intervention|6|||
147506866|NCT01359046|532006826|FG001|Overall Study|Did not receive allocated intervention|6|||
147506867|NCT01359046|532006825|FG000|Overall Study|Physician Decision|1|||
147506868|NCT01359046|532006826|FG001|Overall Study|Physician Decision|11|||
147506869|NCT04539262|532006829|FG000|Overall Study|Adverse Event|0|||
147506870|NCT04539262|532006830|FG001|Overall Study|Adverse Event|0|||
147506871|NCT04539262|532006831|FG002|Overall Study|Adverse Event|1|||
147506872|NCT04539262|532006832|FG003|Overall Study|Adverse Event|0|||
147506873|NCT04539262|532006833|FG004|Overall Study|Adverse Event|0|||
147506874|NCT04539262|532006834|FG005|Overall Study|Adverse Event|0|||
147506875|NCT04539262|532006835|FG006|Overall Study|Adverse Event|0|||
147506876|NCT04539262|532006836|FG007|Overall Study|Adverse Event|0|||
147506877|NCT04539262|532006829|FG000|Overall Study|Withdrew Consent|0|||
147506878|NCT04539262|532006830|FG001|Overall Study|Withdrew Consent|0|||
147506879|NCT04539262|532006831|FG002|Overall Study|Withdrew Consent|0|||
147506880|NCT04539262|532006832|FG003|Overall Study|Withdrew Consent|1|||
147506881|NCT04539262|532006833|FG004|Overall Study|Withdrew Consent|0|||
147506882|NCT04539262|532006834|FG005|Overall Study|Withdrew Consent|0|||
147506883|NCT04539262|532006835|FG006|Overall Study|Withdrew Consent|0|||
147506884|NCT04539262|532006836|FG007|Overall Study|Withdrew Consent|0|||
147506885|NCT04539262|532006829|FG000|Overall Study|Randomized, Not treated|0|||
147506886|NCT04539262|532006830|FG001|Overall Study|Randomized, Not treated|1|||
147506887|NCT04539262|532006831|FG002|Overall Study|Randomized, Not treated|0|||
147506888|NCT04539262|532006832|FG003|Overall Study|Randomized, Not treated|0|||
147506889|NCT04539262|532006833|FG004|Overall Study|Randomized, Not treated|0|||
147506890|NCT04539262|532006834|FG005|Overall Study|Randomized, Not treated|0|||
147506891|NCT04539262|532006835|FG006|Overall Study|Randomized, Not treated|1|||
147506892|NCT04539262|532006836|FG007|Overall Study|Randomized, Not treated|0|||
147506893|NCT03673956|532006839|FG000|Overall Study|Lost to Follow-up|1|||
147506894|NCT03673956|532006840|FG001|Overall Study|Lost to Follow-up|0|||
147506895|NCT03673956|532006841|FG002|Overall Study|Lost to Follow-up|0|||
147506896|NCT03673956|532006842|FG003|Overall Study|Lost to Follow-up|0|||
147506897|NCT03673956|532006839|FG000|Overall Study|Did not use the prescribed topical antibiotics as directed|1|||
147506898|NCT03673956|532006840|FG001|Overall Study|Did not use the prescribed topical antibiotics as directed|0|||
147506899|NCT03673956|532006841|FG002|Overall Study|Did not use the prescribed topical antibiotics as directed|0|||
147506900|NCT03673956|532006842|FG003|Overall Study|Did not use the prescribed topical antibiotics as directed|0|||
147506901|NCT04075396|532006847|FG000|Overall Study|Death|11|||
147506902|NCT04075396|532006848|FG001|Overall Study|Death|9|||
147506903|NCT04075396|532006847|FG000|Overall Study|Withdrawal by Subject|1|||
147506904|NCT04075396|532006848|FG001|Overall Study|Withdrawal by Subject|2|||
147506905|NCT04075396|532006847|FG000|Overall Study|Participants did not complete the 28 days follow-up after implementation of protocol amendment 11|3|||
147506906|NCT04075396|532006848|FG001|Overall Study|Participants did not complete the 28 days follow-up after implementation of protocol amendment 11|2|||
147506907|NCT04075396|532006847|FG000|Overall Study|Enrolled but not-treated|0|||
147506908|NCT04075396|532006848|FG001|Overall Study|Enrolled but not-treated|1|||
147506909|NCT02260388|532006851|FG000|Overall Study|Lost to Follow-up|2|||
147506910|NCT02260388|532006852|FG001|Overall Study|Lost to Follow-up|8|||
147506911|NCT02260388|532006853|FG002|Overall Study|Lost to Follow-up|3|||
147506912|NCT02260388|532006854|FG003|Overall Study|Lost to Follow-up|4|||
147506913|NCT00305604|532006855|FG000|Overall Study|Adverse Event|6|||
147506914|NCT00305604|532006856|FG001|Overall Study|Adverse Event|3|||
147506915|NCT00305604|532006855|FG000|Overall Study|Lack of Efficacy|11|||
147506916|NCT00305604|532006856|FG001|Overall Study|Lack of Efficacy|18|||
147506917|NCT00305604|532006855|FG000|Overall Study|Lost to Follow-up|0|||
147506918|NCT00305604|532006856|FG001|Overall Study|Lost to Follow-up|4|||
147506919|NCT00305604|532006855|FG000|Overall Study|Protocol Violation|2|||
147506920|NCT00305604|532006856|FG001|Overall Study|Protocol Violation|1|||
147506921|NCT00305604|532006855|FG000|Overall Study|Withdrawal by Subject|12|||
147506922|NCT00305604|532006856|FG001|Overall Study|Withdrawal by Subject|21|||
147506923|NCT00305604|532006855|FG000|Overall Study|Patient moved|1|||
147506924|NCT00305604|532006856|FG001|Overall Study|Patient moved|0|||
147506925|NCT00753623|532006857|FG000|Phase I (14 Days)|Withdrawal by Subject|1|||
147506926|NCT00753623|532006858|FG001|Phase I (14 Days)|Withdrawal by Subject|1|||
147669710|NCT00427934|532617360|FG002|Overall Study|Lack of Efficacy|5|||
147506927|NCT00753623|532006857|FG000|Phase I (14 Days)|Physician Decision|1|||
147506928|NCT00753623|532006858|FG001|Phase I (14 Days)|Physician Decision|2|||
147506929|NCT00753623|532006857|FG000|Phase I (14 Days)|Adverse Event|0|||
147506930|NCT00753623|532006858|FG001|Phase I (14 Days)|Adverse Event|1|||
147506931|NCT00753623|532006857|FG000|Washout (7 Days)|Physician Decision|1|||
147506932|NCT00753623|532006858|FG001|Washout (7 Days)|Physician Decision|0|||
147506933|NCT00753623|532006857|FG000|Phase II (14 Days)|Physician Decision|0|||
147506934|NCT00753623|532006858|FG001|Phase II (14 Days)|Physician Decision|1|||
147506935|NCT03332303|532006859|FG000|Overall Study|Participant did not dose|1|||
147506936|NCT03332303|532006860|FG001|Overall Study|Participant did not dose|2|||
147506937|NCT03332303|532006861|FG002|Overall Study|Participant did not dose|0|||
147506938|NCT03332303|532006859|FG000|Overall Study|Participant did not have at least one post-randomization evaluation|0|||
147506939|NCT03332303|532006860|FG001|Overall Study|Participant did not have at least one post-randomization evaluation|1|||
147506940|NCT03332303|532006861|FG002|Overall Study|Participant did not have at least one post-randomization evaluation|0|||
147506941|NCT03332303|532006859|FG000|Overall Study|Participant developed concurrent vaginal infection/illness|4|||
147506942|NCT03332303|532006860|FG001|Overall Study|Participant developed concurrent vaginal infection/illness|1|||
147506943|NCT03332303|532006861|FG002|Overall Study|Participant developed concurrent vaginal infection/illness|0|||
147506944|NCT03332303|532006859|FG000|Overall Study|Participant did not administer 75-125% of intended dose|0|||
147506945|NCT03332303|532006860|FG001|Overall Study|Participant did not administer 75-125% of intended dose|3|||
147506946|NCT03332303|532006861|FG002|Overall Study|Participant did not administer 75-125% of intended dose|0|||
147506947|NCT03332303|532006859|FG000|Overall Study|Participant did not complete Study Visit 3 within Day 8 - Day 9 window|10|||
147506948|NCT03332303|532006860|FG001|Overall Study|Participant did not complete Study Visit 3 within Day 8 - Day 9 window|10|||
147506949|NCT03332303|532006861|FG002|Overall Study|Participant did not complete Study Visit 3 within Day 8 - Day 9 window|3|||
147506950|NCT03332303|532006859|FG000|Overall Study|Participant did not meet all inclusion/exclusion criteria|4|||
147506951|NCT03332303|532006860|FG001|Overall Study|Participant did not meet all inclusion/exclusion criteria|2|||
147506952|NCT03332303|532006861|FG002|Overall Study|Participant did not meet all inclusion/exclusion criteria|2|||
147506953|NCT03332303|532006859|FG000|Overall Study|Participant had a significant protocol deviation|0|||
147506954|NCT03332303|532006860|FG001|Overall Study|Participant had a significant protocol deviation|1|||
147506955|NCT03332303|532006861|FG002|Overall Study|Participant had a significant protocol deviation|0|||
147506956|NCT03495817|532006862|FG000|26 Week Open Label|Adverse Event|3|||
147506957|NCT03495817|532006862|FG000|26 Week Open Label|Withdrawal by Subject|4|||
147506958|NCT03495817|532006862|FG000|26 Week Open Label|Lost to Follow-up|1|||
147506959|NCT03495817|532006862|FG000|26 Week Extension|Lost to Follow-up|2|||
147506960|NCT00326417|532006863|FG000|Overall Study|Withdrawal by Subject|0|||
147506961|NCT00326417|532006864|FG001|Overall Study|Withdrawal by Subject|0|||
147506962|NCT00326417|532006865|FG002|Overall Study|Withdrawal by Subject|1|||
147506963|NCT00326417|532006866|FG003|Overall Study|Withdrawal by Subject|0|||
147506964|NCT00326417|532006863|FG000|Overall Study|Arm Closed|7|||
147506965|NCT00326417|532006864|FG001|Overall Study|Arm Closed|0|||
147506966|NCT00326417|532006865|FG002|Overall Study|Arm Closed|0|||
147506967|NCT00326417|532006866|FG003|Overall Study|Arm Closed|3|||
147506968|NCT00326417|532006863|FG000|Overall Study|Death|7|||
147506969|NCT00326417|532006864|FG001|Overall Study|Death|0|||
147506970|NCT00326417|532006865|FG002|Overall Study|Death|0|||
147506971|NCT00326417|532006866|FG003|Overall Study|Death|0|||
147506972|NCT00435994|532006867|FG000|Overall Study|Lost to Follow-up|7|||
147506973|NCT00435994|532006868|FG001|Overall Study|Lost to Follow-up|0|||
147506974|NCT00435994|532006869|FG002|Overall Study|Lost to Follow-up|0|||
147506975|NCT00628758|532006871|FG000|Overall Study|Adverse Event|2|||
147506976|NCT00628758|532006872|FG001|Overall Study|Adverse Event|3|||
147506977|NCT00628758|532006871|FG000|Overall Study|Withdrawal by Subject|6|||
147506978|NCT00628758|532006872|FG001|Overall Study|Withdrawal by Subject|3|||
147506979|NCT00628758|532006871|FG000|Overall Study|Death|1|||
147506980|NCT00628758|532006872|FG001|Overall Study|Death|0|||
147506981|NCT00628758|532006871|FG000|Overall Study|Protocol Violation|5|||
147506982|NCT00628758|532006872|FG001|Overall Study|Protocol Violation|1|||
147506983|NCT00628758|532006871|FG000|Overall Study|Lost to Follow-up|25|||
147506984|NCT00628758|532006872|FG001|Overall Study|Lost to Follow-up|31|||
147506985|NCT00628758|532006871|FG000|Overall Study|Pregnancy|2|||
147506986|NCT00628758|532006872|FG001|Overall Study|Pregnancy|2|||
147506987|NCT00628758|532006871|FG000|Overall Study|Investigator Moved|3|||
147639511|NCT02841280|532497849|FG000|Overall Study|Withdrawal by Subject|7|||
147639512|NCT02841280|532497850|FG001|Overall Study|Withdrawal by Subject|3|||
147639513|NCT02841280|532497849|FG000|Overall Study|Stop Point: BP above threshold|2|||
147639514|NCT02841280|532497850|FG001|Overall Study|Stop Point: BP above threshold|0|||
147506988|NCT00628758|532006872|FG001|Overall Study|Investigator Moved|0|||
147506989|NCT00628758|532006871|FG000|Overall Study|Treatment Failure|0|||
147639515|NCT04553471|532497851|FG000|Overall Study|Did not start treatment on protocol|3|||
147506990|NCT00628758|532006872|FG001|Overall Study|Treatment Failure|2|||
147506991|NCT04179786|532006873|FG000|Overall Study|Withdrawal by Subject|8|||
147506992|NCT03310580|532006874|FG000|Overall Study|Adverse Event|0|||
147506993|NCT03310580|532006875|FG001|Overall Study|Adverse Event|1|||
147506994|NCT03310580|532006876|FG002|Overall Study|Adverse Event|0|||
147506995|NCT00376246|532006878|FG000|First Intervention (2 Weeks)|Adverse Event|2|||
147506996|NCT00376246|532006879|FG001|First Intervention (2 Weeks)|Adverse Event|0|||
147506997|NCT00376246|532006878|FG000|First Intervention (2 Weeks)|Withdrawal by Subject|1|||
147506998|NCT00376246|532006879|FG001|First Intervention (2 Weeks)|Withdrawal by Subject|2|||
147506999|NCT00376246|532006878|FG000|First Intervention (2 Weeks)|Lost to Follow-up|1|||
147507000|NCT00376246|532006879|FG001|First Intervention (2 Weeks)|Lost to Follow-up|0|||
147507001|NCT03205982|532006880|FG000|Overall Study|Lost to Follow-up|20|||
147507002|NCT03205982|532006881|FG001|Overall Study|Lost to Follow-up|19|||
147507003|NCT03205982|532006880|FG000|Overall Study|Withdrawal by Subject|4|||
147507004|NCT03205982|532006881|FG001|Overall Study|Withdrawal by Subject|3|||
147507005|NCT03205982|532006880|FG000|Overall Study|Withdrawal by PI|0|||
147507006|NCT03205982|532006881|FG001|Overall Study|Withdrawal by PI|1|||
147507007|NCT00994162|532006884|FG000|Overall Study|Withdrawal by Subject|1|||
147507008|NCT00994162|532006884|FG000|Overall Study|Lost to Follow-up|2|||
147507009|NCT00994162|532006884|FG000|Overall Study|Product Complaint|1|||
147507010|NCT00994162|532006884|FG000|Overall Study|Poor Compliance|5|||
147507011|NCT00994162|532006884|FG000|Overall Study|Lack of Response|3|||
147507012|NCT00994162|532006884|FG000|Overall Study|Discharged from Hospital|4|||
147507013|NCT00994162|532006884|FG000|Overall Study|Death|2|||
147507014|NCT00994162|532006884|FG000|Overall Study|Care Transferred to Another Physician|2|||
147507015|NCT00994162|532006884|FG000|Overall Study|Discontinued and Changed to Iodoflex|1|||
147507016|NCT00994162|532006884|FG000|Overall Study|Physician Decision|2|||
147507017|NCT00994162|532006884|FG000|Overall Study|Surrounding Wound Erythematous|1|||
147507018|NCT00994162|532006884|FG000|Overall Study|Machine Losing Vaccum|1|||
147507019|NCT00994162|532006884|FG000|Overall Study|Patient Lived Too Far Away|1|||
147507020|NCT00994162|532006884|FG000|Overall Study|Above Knee Amputation|1|||
147507021|NCT00994162|532006884|FG000|Overall Study|Reason Not Reported By Site|1|||
147507022|NCT02983799|532006885|FG000|Overall Study|Withdrawn from study before data cut-off|28|||
147507023|NCT02983799|532006886|FG001|Overall Study|Withdrawn from study before data cut-off|12|||
147507024|NCT02983799|532006887|FG002|Overall Study|Withdrawn from study before data cut-off|23|||
147507025|NCT02983799|532006888|FG003|Overall Study|Withdrawn from study before data cut-off|25|||
147507026|NCT02983799|532006889|FG004|Overall Study|Withdrawn from study before data cut-off|1|||
147507027|NCT02983799|532006885|FG000|Overall Study|Death|20|||
147507028|NCT02983799|532006886|FG001|Overall Study|Death|5|||
147507029|NCT02983799|532006887|FG002|Overall Study|Death|23|||
147507030|NCT02983799|532006888|FG003|Overall Study|Death|47|||
147507031|NCT02983799|532006889|FG004|Overall Study|Death|7|||
147507032|NCT02983799|532006885|FG000|Overall Study|Withdrawal by Subject|1|||
147507033|NCT02983799|532006886|FG001|Overall Study|Withdrawal by Subject|0|||
147507034|NCT02983799|532006887|FG002|Overall Study|Withdrawal by Subject|3|||
147507035|NCT02983799|532006888|FG003|Overall Study|Withdrawal by Subject|4|||
147507036|NCT02983799|532006889|FG004|Overall Study|Withdrawal by Subject|1|||
147507037|NCT02983799|532006885|FG000|Overall Study|Protocol Violation|0|||
147507038|NCT02983799|532006886|FG001|Overall Study|Protocol Violation|1|||
147507039|NCT02983799|532006887|FG002|Overall Study|Protocol Violation|0|||
147507040|NCT02983799|532006888|FG003|Overall Study|Protocol Violation|0|||
147507041|NCT02983799|532006889|FG004|Overall Study|Protocol Violation|1|||
147507042|NCT02983799|532006885|FG000|Overall Study|Lost to Follow-up|1|||
147507043|NCT02983799|532006886|FG001|Overall Study|Lost to Follow-up|0|||
147507044|NCT02983799|532006887|FG002|Overall Study|Lost to Follow-up|1|||
147507045|NCT02983799|532006888|FG003|Overall Study|Lost to Follow-up|0|||
147507046|NCT02983799|532006889|FG004|Overall Study|Lost to Follow-up|0|||
147507047|NCT03136367|532006900|FG000|T1 Consultation|discontinued mistakenly included|2|||
147507048|NCT03136367|532006901|FG001|T1 Consultation|discontinued mistakenly included|6|||
147507049|NCT03136367|532006902|FG002|T1 Consultation|discontinued mistakenly included|1|||
147507050|NCT03136367|532006900|FG000|T1 Consultation|Discontinued other|0|||
147507051|NCT03136367|532006901|FG001|T1 Consultation|Discontinued other|1|||
147507052|NCT03136367|532006902|FG002|T1 Consultation|Discontinued other|0|||
147507053|NCT03136367|532006900|FG000|T2 Post-consultation|Withdrawal by Subject|1|||
147507054|NCT03136367|532006901|FG001|T2 Post-consultation|Withdrawal by Subject|1|||
147507055|NCT03136367|532006902|FG002|T2 Post-consultation|Withdrawal by Subject|5|||
147507056|NCT03136367|532006900|FG000|T2 Post-consultation|discontinued mistakenly included|2|||
147507057|NCT03136367|532006901|FG001|T2 Post-consultation|discontinued mistakenly included|2|||
147507058|NCT03136367|532006902|FG002|T2 Post-consultation|discontinued mistakenly included|17|||
147507059|NCT03136367|532006900|FG000|T2 Post-consultation|Discontinued other|0|||
147507060|NCT03136367|532006901|FG001|T2 Post-consultation|Discontinued other|2|||
147507061|NCT03136367|532006902|FG002|T2 Post-consultation|Discontinued other|6|||
147507062|NCT03136367|532006900|FG000|T2 Post-consultation|Discontinued transferred care|0|||
147507063|NCT03136367|532006901|FG001|T2 Post-consultation|Discontinued transferred care|0|||
147507064|NCT03136367|532006902|FG002|T2 Post-consultation|Discontinued transferred care|3|||
147507065|NCT03136367|532006900|FG000|T2 Post-consultation|Discontinued lost contact|0|||
147507066|NCT03136367|532006901|FG001|T2 Post-consultation|Discontinued lost contact|1|||
147507067|NCT03136367|532006902|FG002|T2 Post-consultation|Discontinued lost contact|0|||
147507068|NCT03136367|532006900|FG000|T3 1 Week After Surgery|Discontinued mistakenly included|5|||
147507069|NCT03136367|532006901|FG001|T3 1 Week After Surgery|Discontinued mistakenly included|9|||
147507070|NCT03136367|532006902|FG002|T3 1 Week After Surgery|Discontinued mistakenly included|8|||
147507071|NCT03136367|532006900|FG000|T3 1 Week After Surgery|Discontinued transferred care|2|||
147507072|NCT03136367|532006901|FG001|T3 1 Week After Surgery|Discontinued transferred care|11|||
147507073|NCT03136367|532006902|FG002|T3 1 Week After Surgery|Discontinued transferred care|14|||
147507074|NCT03136367|532006900|FG000|T3 1 Week After Surgery|other discontinued|2|||
147507075|NCT03136367|532006901|FG001|T3 1 Week After Surgery|other discontinued|4|||
147507076|NCT03136367|532006902|FG002|T3 1 Week After Surgery|other discontinued|3|||
147507077|NCT03136367|532006900|FG000|T3 1 Week After Surgery|Withdrawal by Subject|0|||
147507078|NCT03136367|532006901|FG001|T3 1 Week After Surgery|Withdrawal by Subject|6|||
147507079|NCT03136367|532006902|FG002|T3 1 Week After Surgery|Withdrawal by Subject|2|||
147507080|NCT03136367|532006900|FG000|T3 1 Week After Surgery|Discontinued lost contact|1|||
147507081|NCT03136367|532006901|FG001|T3 1 Week After Surgery|Discontinued lost contact|2|||
147507082|NCT03136367|532006902|FG002|T3 1 Week After Surgery|Discontinued lost contact|4|||
147507083|NCT03136367|532006900|FG000|T4 12 Weeks After Surgery|Withdrawal by Subject|1|||
147507084|NCT03136367|532006901|FG001|T4 12 Weeks After Surgery|Withdrawal by Subject|3|||
147507085|NCT03136367|532006902|FG002|T4 12 Weeks After Surgery|Withdrawal by Subject|0|||
147507086|NCT03136367|532006900|FG000|T4 12 Weeks After Surgery|Death|0|||
147507087|NCT03136367|532006901|FG001|T4 12 Weeks After Surgery|Death|1|||
147507088|NCT03136367|532006902|FG002|T4 12 Weeks After Surgery|Death|3|||
147507089|NCT03136367|532006900|FG000|T4 12 Weeks After Surgery|discontinued lost contact|1|||
147507090|NCT03136367|532006901|FG001|T4 12 Weeks After Surgery|discontinued lost contact|0|||
147507091|NCT03136367|532006902|FG002|T4 12 Weeks After Surgery|discontinued lost contact|0|||
147507092|NCT03136367|532006900|FG000|T4 12 Weeks After Surgery|discontinued transferred care|0|||
147507093|NCT03136367|532006901|FG001|T4 12 Weeks After Surgery|discontinued transferred care|1|||
147507094|NCT03136367|532006902|FG002|T4 12 Weeks After Surgery|discontinued transferred care|5|||
147507095|NCT03136367|532006900|FG000|T4 12 Weeks After Surgery|discontinued mistakenly included|0|||
147507096|NCT03136367|532006901|FG001|T4 12 Weeks After Surgery|discontinued mistakenly included|0|||
147507097|NCT03136367|532006902|FG002|T4 12 Weeks After Surgery|discontinued mistakenly included|1|||
147507098|NCT03136367|532006900|FG000|T5 1 Year After Surgery|discontinued mistakenly included|1|||
147507099|NCT03136367|532006901|FG001|T5 1 Year After Surgery|discontinued mistakenly included|1|||
147507100|NCT03136367|532006902|FG002|T5 1 Year After Surgery|discontinued mistakenly included|1|||
147507101|NCT03136367|532006900|FG000|T5 1 Year After Surgery|Withdrawal by Subject|1|||
147507102|NCT03136367|532006901|FG001|T5 1 Year After Surgery|Withdrawal by Subject|0|||
147507103|NCT03136367|532006902|FG002|T5 1 Year After Surgery|Withdrawal by Subject|0|||
147507104|NCT03136367|532006900|FG000|T5 1 Year After Surgery|Death|0|||
147507105|NCT03136367|532006901|FG001|T5 1 Year After Surgery|Death|0|||
147507106|NCT03136367|532006902|FG002|T5 1 Year After Surgery|Death|1|||
147507107|NCT03136367|532006900|FG000|T5 1 Year After Surgery|Discontinued lost contact|1|||
147507108|NCT03136367|532006901|FG001|T5 1 Year After Surgery|Discontinued lost contact|6|||
147507109|NCT03136367|532006902|FG002|T5 1 Year After Surgery|Discontinued lost contact|0|||
147507110|NCT03136367|532006900|FG000|T5 1 Year After Surgery|Lost to Follow-up|2|||
147507111|NCT03136367|532006901|FG001|T5 1 Year After Surgery|Lost to Follow-up|22|||
147507112|NCT03136367|532006902|FG002|T5 1 Year After Surgery|Lost to Follow-up|15|||
147639516|NCT04553471|532497851|FG000|Overall Study|Death|1|||
147639517|NCT01340027|532497853|FG000|Overall Study|Randomized but Never Received Study Drug|0|||
147639518|NCT01340027|532497854|FG001|Overall Study|Randomized but Never Received Study Drug|0|||
147639519|NCT01340027|532497855|FG002|Overall Study|Randomized but Never Received Study Drug|1|||
147639520|NCT01340027|532497856|FG003|Overall Study|Randomized but Never Received Study Drug|0|||
147639521|NCT01340027|532497857|FG004|Overall Study|Randomized but Never Received Study Drug|0|||
147639522|NCT01340027|532497858|FG005|Overall Study|Randomized but Never Received Study Drug|0|||
147639523|NCT01340027|532497859|FG006|Overall Study|Randomized but Never Received Study Drug|0|||
147639524|NCT01340027|532497860|FG007|Overall Study|Randomized but Never Received Study Drug|0|||
147639525|NCT01340027|532497861|FG008|Overall Study|Randomized but Never Received Study Drug|0|||
147639526|NCT01340027|532497862|FG009|Overall Study|Randomized but Never Received Study Drug|0|||
147639527|NCT01340027|532497863|FG010|Overall Study|Randomized but Never Received Study Drug|0|||
147639528|NCT01340027|532497864|FG011|Overall Study|Randomized but Never Received Study Drug|0|||
147639529|NCT01340027|532497853|FG000|Overall Study|Adverse Event|0|||
147639530|NCT01340027|532497854|FG001|Overall Study|Adverse Event|1|||
147639531|NCT01340027|532497855|FG002|Overall Study|Adverse Event|2|||
147639532|NCT01340027|532497856|FG003|Overall Study|Adverse Event|0|||
147639533|NCT01340027|532497857|FG004|Overall Study|Adverse Event|1|||
147639534|NCT01340027|532497858|FG005|Overall Study|Adverse Event|2|||
147639535|NCT01340027|532497859|FG006|Overall Study|Adverse Event|2|||
147639536|NCT01340027|532497860|FG007|Overall Study|Adverse Event|1|||
147639537|NCT01340027|532497861|FG008|Overall Study|Adverse Event|4|||
147639538|NCT01340027|532497862|FG009|Overall Study|Adverse Event|1|||
147507113|NCT03136367|532006900|FG000|T5 1 Year After Surgery|study ended before due|31|||
147639539|NCT01340027|532497863|FG010|Overall Study|Adverse Event|1|||
147639540|NCT01340027|532497864|FG011|Overall Study|Adverse Event|3|||
147507114|NCT03136367|532006901|FG001|T5 1 Year After Surgery|study ended before due|103|||
147507115|NCT03136367|532006902|FG002|T5 1 Year After Surgery|study ended before due|110|||
147507116|NCT03136367|532006900|FG000|T5 1 Year After Surgery|logistical issues prevented contact|0|||
147507117|NCT03136367|532006901|FG001|T5 1 Year After Surgery|logistical issues prevented contact|4|||
147507118|NCT03136367|532006902|FG002|T5 1 Year After Surgery|logistical issues prevented contact|2|||
147507119|NCT03175562|532006906|FG000|Overall Study|Adverse Event|1|||
147507120|NCT03175562|532006906|FG000|Overall Study|Lost to Follow-up|3|||
147507121|NCT03175562|532006906|FG000|Overall Study|Withdrawal by Subject|7|||
147507122|NCT03175562|532006906|FG000|Overall Study|Other (Not Specified)|5|||
147507123|NCT01230749|532006907|FG000|Overall Study|Adverse Event|0|||
147507124|NCT01230749|532006908|FG001|Overall Study|Adverse Event|0|||
147507125|NCT01230749|532006909|FG002|Overall Study|Adverse Event|0|||
147507126|NCT01230749|532006910|FG003|Overall Study|Adverse Event|1|||
147507127|NCT01230749|532006907|FG000|Overall Study|Physician Decision|0|||
147507128|NCT01230749|532006908|FG001|Overall Study|Physician Decision|0|||
147507129|NCT01230749|532006909|FG002|Overall Study|Physician Decision|1|||
147507130|NCT01230749|532006910|FG003|Overall Study|Physician Decision|0|||
147507131|NCT01230749|532006907|FG000|Overall Study|Withdrawal by Subject|0|||
147507132|NCT01230749|532006908|FG001|Overall Study|Withdrawal by Subject|1|||
147507133|NCT01230749|532006909|FG002|Overall Study|Withdrawal by Subject|0|||
147507134|NCT01230749|532006910|FG003|Overall Study|Withdrawal by Subject|0|||
147507135|NCT01230749|532006907|FG000|Overall Study|Fasting glucose more than 270 mg/dL|0|||
147507136|NCT01230749|532006908|FG001|Overall Study|Fasting glucose more than 270 mg/dL|1|||
147507137|NCT01230749|532006909|FG002|Overall Study|Fasting glucose more than 270 mg/dL|1|||
147507138|NCT01230749|532006910|FG003|Overall Study|Fasting glucose more than 270 mg/dL|1|||
147507139|NCT03366844|532008710|FG000|Overall Study|Physician Decision|1|||
147507140|NCT03366844|532008710|FG000|Overall Study|Unevaluable for co-primary endpoint (did not complete all required biopsies)|5|||
147507141|NCT02687711|532008713|FG000|Overall Study|Adverse Event|89|||
147507142|NCT02687711|532008713|FG000|Overall Study|Lack of Efficacy|70|||
147507143|NCT02687711|532008713|FG000|Overall Study|Lost to Follow-up|20|||
147507144|NCT02687711|532008713|FG000|Overall Study|Consent withdrawn|15|||
147507145|NCT02687711|532008713|FG000|Overall Study|Participant moved to another country and continued treatment for epilepsy in that country|1|||
147507146|NCT02687711|532008713|FG000|Overall Study|Too expensive|4|||
147507147|NCT02687711|532008713|FG000|Overall Study|Participant moved abroad|1|||
147507148|NCT02687711|532008713|FG000|Overall Study|Progression of other medical condition (dementia, pneumonia)|1|||
147507149|NCT02687711|532008713|FG000|Overall Study|Perceived increase in seizures but diary records show no increase compared to pre-study|1|||
147507150|NCT02687711|532008713|FG000|Overall Study|Disliked taste|1|||
147507151|NCT02687711|532008713|FG000|Overall Study|Low mood|1|||
147507152|NCT02687711|532008713|FG000|Overall Study|Side effects|1|||
147507153|NCT02687711|532008713|FG000|Overall Study|Change of Hospital|1|||
147507154|NCT02687711|532008713|FG000|Overall Study|Liver Encephalopathy|1|||
147507155|NCT02687711|532008713|FG000|Overall Study|Participant experience side effects, fatigue. Most likely not related to investigational product|1|||
147507156|NCT02687711|532008713|FG000|Overall Study|Withdrawn due to intake interruption|1|||
147507157|NCT02687711|532008713|FG000|Overall Study|Stopped in preparation for epilepsy surgery|1|||
147507158|NCT02687711|532008713|FG000|Overall Study|Diagnosis epilepsy revised to psychogenic seizures|1|||
147507159|NCT02687711|532008713|FG000|Overall Study|Participant was not able to come in our clinic because participant could not find a car driver|1|||
147507160|NCT00191386|532008714|FG000|Overall Study|Adverse Event|16|||
147507161|NCT00191386|532008714|FG000|Overall Study|Lost to Follow-up|1|||
147507162|NCT00191386|532008714|FG000|Overall Study|Entry Criteria Exclusion|3|||
147507163|NCT00191386|532008714|FG000|Overall Study|Protocol Violation|18|||
147507164|NCT00191386|532008714|FG000|Overall Study|Withdrawal by Subject|96|||
147507165|NCT00191386|532008714|FG000|Overall Study|Physician Decision|11|||
147507166|NCT00191386|532008714|FG000|Overall Study|Lack of Efficacy|15|||
147507167|NCT03077243|532008715|FG000|Overall Study|Death|1|||
147507168|NCT03077243|532008716|FG001|Overall Study|Death|2|||
147507169|NCT03077243|532008717|FG002|Overall Study|Death|0|||
147507170|NCT03077243|532008718|FG003|Overall Study|Death|0|||
147507171|NCT03077243|532008715|FG000|Overall Study|Withdrawal by Subject|1|||
147507172|NCT03077243|532008716|FG001|Overall Study|Withdrawal by Subject|3|||
147507173|NCT03077243|532008717|FG002|Overall Study|Withdrawal by Subject|0|||
147507174|NCT03077243|532008718|FG003|Overall Study|Withdrawal by Subject|0|||
147507175|NCT03077243|532008715|FG000|Overall Study|Physician Decision|1|||
147507176|NCT03077243|532008716|FG001|Overall Study|Physician Decision|0|||
147507177|NCT03077243|532008717|FG002|Overall Study|Physician Decision|0|||
147507178|NCT03077243|532008718|FG003|Overall Study|Physician Decision|0|||
147507179|NCT03077243|532008715|FG000|Overall Study|Research at two study sites terminated early|0|||
147507180|NCT03077243|532008716|FG001|Overall Study|Research at two study sites terminated early|0|||
147507181|NCT03077243|532008717|FG002|Overall Study|Research at two study sites terminated early|0|||
147507182|NCT03077243|532008718|FG003|Overall Study|Research at two study sites terminated early|69|||
147507183|NCT03984812|532008719|FG000|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
147507184|NCT03984812|532008720|FG001|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
147507185|NCT03984812|532008721|FG002|Part 1 (Up to Day 28)|Withdrawal by Subject|1|||
147507186|NCT03984812|532008722|FG003|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
147507187|NCT03984812|532008723|FG004|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
147507188|NCT03984812|532008724|FG005|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
147507189|NCT03984812|532008725|FG006|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
147507190|NCT03984812|532008726|FG007|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
147507191|NCT03984812|532008727|FG008|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
147507192|NCT03984812|532008728|FG009|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
147507193|NCT03984812|532008729|FG010|Part 1 (Up to Day 28)|Withdrawal by Subject|0|||
147507194|NCT04038385|532008730|FG000|Overall Study|Completed baseline assessment only|7|||
147507195|NCT04038385|532008731|FG001|Overall Study|Completed baseline assessment only|4|||
147507196|NCT04038385|532008730|FG000|Overall Study|Moved out of area|4|||
147507197|NCT04038385|532008731|FG001|Overall Study|Moved out of area|2|||
147507198|NCT04038385|532008730|FG000|Overall Study|Discontinued study involvement|6|||
147507199|NCT04038385|532008731|FG001|Overall Study|Discontinued study involvement|1|||
147507200|NCT02038790|532008732|FG000|Day 0 - First Treatment|Withdrawal by Subject|1|||
147507201|NCT02038790|532008733|FG001|Day 0 - First Treatment|Withdrawal by Subject|1|||
147507202|NCT02431793|532008734|FG000|Overall Study|Ineligible doe to not filling Rx|11|||
147507203|NCT02431793|532008735|FG001|Overall Study|Ineligible doe to not filling Rx|7|||
147507204|NCT02431793|532008736|FG002|Overall Study|Ineligible doe to not filling Rx|8|||
147507205|NCT02431793|532008734|FG000|Overall Study|Withdrawal by Subject|7|||
147507206|NCT02431793|532008735|FG001|Overall Study|Withdrawal by Subject|5|||
147507207|NCT02431793|532008736|FG002|Overall Study|Withdrawal by Subject|5|||
147507208|NCT02431793|532008734|FG000|Overall Study|Lost to Follow-up|101|||
147507209|NCT02431793|532008735|FG001|Overall Study|Lost to Follow-up|122|||
147507210|NCT02431793|532008736|FG002|Overall Study|Lost to Follow-up|104|||
147507211|NCT03170258|532008744|FG000|Overall Study|Physician Decision|4|||
147507212|NCT03170258|532008745|FG001|Overall Study|Physician Decision|0|||
147507213|NCT03170258|532008744|FG000|Overall Study|Equipment issues|1|||
147507214|NCT03170258|532008745|FG001|Overall Study|Equipment issues|0|||
147507215|NCT03170258|532008744|FG000|Overall Study|Medication|1|||
147507216|NCT03170258|532008745|FG001|Overall Study|Medication|0|||
147507217|NCT03170258|532008744|FG000|Overall Study|Sleep issues|1|||
147507218|NCT03170258|532008745|FG001|Overall Study|Sleep issues|0|||
147507219|NCT01563107|532008746|FG000|Overall Study|Physician Decision|0|||
147507220|NCT01563107|532008747|FG001|Overall Study|Physician Decision|1|||
147507221|NCT01563107|532008748|FG002|Overall Study|Physician Decision|1|||
147507222|NCT01563107|532008749|FG003|Overall Study|Physician Decision|3|||
147507223|NCT01563107|532008746|FG000|Overall Study|Withdrawal by Subject|1|||
147507224|NCT01563107|532008747|FG001|Overall Study|Withdrawal by Subject|2|||
147507225|NCT01563107|532008748|FG002|Overall Study|Withdrawal by Subject|1|||
147507226|NCT01563107|532008749|FG003|Overall Study|Withdrawal by Subject|2|||
147507227|NCT02707601|532008750|FG000|Overall Study|Death|0|||
147507228|NCT02707601|532008751|FG001|Overall Study|Death|1|||
147507229|NCT02707601|532008750|FG000|Overall Study|Lack of Efficacy|0|||
147507230|NCT02707601|532008751|FG001|Overall Study|Lack of Efficacy|1|||
147507231|NCT02707601|532008750|FG000|Overall Study|Investigator's Discretion|1|||
147507232|NCT02707601|532008751|FG001|Overall Study|Investigator's Discretion|0|||
147507233|NCT02707601|532008750|FG000|Overall Study|Withdrew Consent|0|||
147507234|NCT02707601|532008751|FG001|Overall Study|Withdrew Consent|1|||
147507235|NCT02707601|532008750|FG000|Overall Study|Lost to Follow-up|1|||
147507236|NCT02707601|532008751|FG001|Overall Study|Lost to Follow-up|1|||
147507237|NCT02707601|532008750|FG000|Overall Study|Participants Randomized but Not Treated|2|||
147507238|NCT02707601|532008751|FG001|Overall Study|Participants Randomized but Not Treated|0|||
147507239|NCT03907969|532008753|FG000|Monotherapy Part A|Withdrawal by Subject|0|||
147507240|NCT03907969|532008754|FG001|Monotherapy Part A|Withdrawal by Subject|0|||
147507241|NCT03907969|532008755|FG002|Monotherapy Part A|Withdrawal by Subject|0|||
147507242|NCT03907969|532008756|FG003|Monotherapy Part A|Withdrawal by Subject|0|||
147639541|NCT01340027|532497853|FG000|Overall Study|Lack of Efficacy|0|||
147639542|NCT01340027|532497854|FG001|Overall Study|Lack of Efficacy|0|||
147639543|NCT01340027|532497855|FG002|Overall Study|Lack of Efficacy|0|||
147639544|NCT01340027|532497856|FG003|Overall Study|Lack of Efficacy|0|||
147639545|NCT01340027|532497857|FG004|Overall Study|Lack of Efficacy|0|||
147639546|NCT01340027|532497858|FG005|Overall Study|Lack of Efficacy|0|||
147507243|NCT03907969|532008757|FG004|Monotherapy Part A|Withdrawal by Subject|1|||
147507244|NCT03907969|532008758|FG005|Monotherapy Part A|Withdrawal by Subject|1|||
147507245|NCT03907969|532008759|FG006|Monotherapy Part A|Withdrawal by Subject|0|||
147507246|NCT03907969|532008760|FG007|Monotherapy Part A|Withdrawal by Subject|0|||
147507247|NCT03907969|532008761|FG008|Monotherapy Part A|Withdrawal by Subject|0|||
147507248|NCT03907969|532008762|FG009|Monotherapy Part A|Withdrawal by Subject|0|||
147507249|NCT03907969|532008763|FG010|Monotherapy Part A|Withdrawal by Subject|0|||
147507250|NCT03907969|532008753|FG000|Monotherapy Part A|Progressive Disease|0|||
147507251|NCT03907969|532008754|FG001|Monotherapy Part A|Progressive Disease|1|||
147507252|NCT03907969|532008755|FG002|Monotherapy Part A|Progressive Disease|0|||
147507253|NCT03907969|532008756|FG003|Monotherapy Part A|Progressive Disease|0|||
147507254|NCT03907969|532008757|FG004|Monotherapy Part A|Progressive Disease|0|||
147639547|NCT01340027|532497859|FG006|Overall Study|Lack of Efficacy|1|||
147507255|NCT03907969|532008758|FG005|Monotherapy Part A|Progressive Disease|1|||
147507256|NCT03907969|532008759|FG006|Monotherapy Part A|Progressive Disease|2|||
147507257|NCT03907969|532008760|FG007|Monotherapy Part A|Progressive Disease|0|||
147507258|NCT03907969|532008761|FG008|Monotherapy Part A|Progressive Disease|0|||
147507259|NCT03907969|532008762|FG009|Monotherapy Part A|Progressive Disease|0|||
147507260|NCT03907969|532008763|FG010|Monotherapy Part A|Progressive Disease|0|||
147507261|NCT03907969|532008753|FG000|Monotherapy Part A|Death|0|||
147507262|NCT03907969|532008754|FG001|Monotherapy Part A|Death|0|||
147507263|NCT03907969|532008755|FG002|Monotherapy Part A|Death|1|||
147507264|NCT03907969|532008756|FG003|Monotherapy Part A|Death|1|||
147507265|NCT03907969|532008757|FG004|Monotherapy Part A|Death|0|||
147507266|NCT03907969|532008758|FG005|Monotherapy Part A|Death|1|||
147507267|NCT03907969|532008759|FG006|Monotherapy Part A|Death|0|||
147507268|NCT03907969|532008760|FG007|Monotherapy Part A|Death|0|||
147507269|NCT03907969|532008761|FG008|Monotherapy Part A|Death|0|||
147507270|NCT03907969|532008762|FG009|Monotherapy Part A|Death|0|||
147507271|NCT03907969|532008763|FG010|Monotherapy Part A|Death|0|||
147507272|NCT03907969|532008753|FG000|Combination Therapy Part A|Adverse Event|0|||
147507273|NCT03907969|532008754|FG001|Combination Therapy Part A|Adverse Event|0|||
147507274|NCT03907969|532008755|FG002|Combination Therapy Part A|Adverse Event|0|||
147507275|NCT03907969|532008756|FG003|Combination Therapy Part A|Adverse Event|0|||
147507276|NCT03907969|532008757|FG004|Combination Therapy Part A|Adverse Event|0|||
147507277|NCT03907969|532008758|FG005|Combination Therapy Part A|Adverse Event|0|||
147507278|NCT03907969|532008759|FG006|Combination Therapy Part A|Adverse Event|0|||
147507279|NCT03907969|532008760|FG007|Combination Therapy Part A|Adverse Event|0|||
147507280|NCT03907969|532008761|FG008|Combination Therapy Part A|Adverse Event|0|||
147507281|NCT03907969|532008762|FG009|Combination Therapy Part A|Adverse Event|1|||
147507282|NCT03907969|532008763|FG010|Combination Therapy Part A|Adverse Event|1|||
147507283|NCT03907969|532008753|FG000|Combination Therapy Part A|Progressive disease|0|||
147507284|NCT03907969|532008754|FG001|Combination Therapy Part A|Progressive disease|0|||
147507285|NCT03907969|532008755|FG002|Combination Therapy Part A|Progressive disease|0|||
147507286|NCT03907969|532008756|FG003|Combination Therapy Part A|Progressive disease|0|||
147507287|NCT03907969|532008757|FG004|Combination Therapy Part A|Progressive disease|0|||
147507288|NCT03907969|532008758|FG005|Combination Therapy Part A|Progressive disease|0|||
147507289|NCT03907969|532008759|FG006|Combination Therapy Part A|Progressive disease|0|||
147507290|NCT03907969|532008760|FG007|Combination Therapy Part A|Progressive disease|1|||
147507291|NCT03907969|532008761|FG008|Combination Therapy Part A|Progressive disease|0|||
147507292|NCT03907969|532008762|FG009|Combination Therapy Part A|Progressive disease|2|||
147507293|NCT03907969|532008763|FG010|Combination Therapy Part A|Progressive disease|3|||
147507294|NCT03907969|532008753|FG000|Combination Therapy Part A|Death|0|||
147507295|NCT03907969|532008754|FG001|Combination Therapy Part A|Death|0|||
147507296|NCT03907969|532008755|FG002|Combination Therapy Part A|Death|0|||
147507297|NCT03907969|532008756|FG003|Combination Therapy Part A|Death|0|||
147507298|NCT03907969|532008757|FG004|Combination Therapy Part A|Death|0|||
147507299|NCT03907969|532008758|FG005|Combination Therapy Part A|Death|0|||
147507300|NCT03907969|532008759|FG006|Combination Therapy Part A|Death|0|||
147639548|NCT01340027|532497860|FG007|Overall Study|Lack of Efficacy|1|||
147639549|NCT01340027|532497861|FG008|Overall Study|Lack of Efficacy|1|||
147639550|NCT01340027|532497862|FG009|Overall Study|Lack of Efficacy|0|||
147639551|NCT01340027|532497863|FG010|Overall Study|Lack of Efficacy|0|||
147639552|NCT01340027|532497864|FG011|Overall Study|Lack of Efficacy|0|||
147639553|NCT01340027|532497853|FG000|Overall Study|Lost to Follow-up|0|||
147639554|NCT01340027|532497854|FG001|Overall Study|Lost to Follow-up|1|||
147639555|NCT01340027|532497855|FG002|Overall Study|Lost to Follow-up|0|||
147639556|NCT01340027|532497856|FG003|Overall Study|Lost to Follow-up|0|||
147639557|NCT01340027|532497857|FG004|Overall Study|Lost to Follow-up|0|||
147639558|NCT01340027|532497858|FG005|Overall Study|Lost to Follow-up|0|||
147639559|NCT01340027|532497859|FG006|Overall Study|Lost to Follow-up|1|||
147639560|NCT01340027|532497860|FG007|Overall Study|Lost to Follow-up|0|||
147639561|NCT01340027|532497861|FG008|Overall Study|Lost to Follow-up|0|||
147639562|NCT01340027|532497862|FG009|Overall Study|Lost to Follow-up|1|||
147639563|NCT01340027|532497863|FG010|Overall Study|Lost to Follow-up|0|||
147639564|NCT01340027|532497864|FG011|Overall Study|Lost to Follow-up|0|||
147639565|NCT01340027|532497853|FG000|Overall Study|Protocol Violation|1|||
147639566|NCT01340027|532497854|FG001|Overall Study|Protocol Violation|2|||
147639567|NCT01340027|532497855|FG002|Overall Study|Protocol Violation|0|||
147639568|NCT01340027|532497856|FG003|Overall Study|Protocol Violation|0|||
147507301|NCT03907969|532008760|FG007|Combination Therapy Part A|Death|0|||
147507302|NCT03907969|532008761|FG008|Combination Therapy Part A|Death|1|||
147507303|NCT03907969|532008762|FG009|Combination Therapy Part A|Death|0|||
147507304|NCT03907969|532008763|FG010|Combination Therapy Part A|Death|1|||
147507305|NCT03907969|532008753|FG000|Combination Therapy Part A|Withdrawal by Subject|0|||
147507306|NCT03907969|532008754|FG001|Combination Therapy Part A|Withdrawal by Subject|0|||
147507307|NCT03907969|532008755|FG002|Combination Therapy Part A|Withdrawal by Subject|0|||
147639569|NCT01340027|532497857|FG004|Overall Study|Protocol Violation|6|||
147639570|NCT01340027|532497858|FG005|Overall Study|Protocol Violation|0|||
147639571|NCT01340027|532497859|FG006|Overall Study|Protocol Violation|0|||
147639572|NCT01340027|532497860|FG007|Overall Study|Protocol Violation|1|||
147507308|NCT03907969|532008756|FG003|Combination Therapy Part A|Withdrawal by Subject|0|||
147507309|NCT03907969|532008757|FG004|Combination Therapy Part A|Withdrawal by Subject|0|||
147507310|NCT03907969|532008758|FG005|Combination Therapy Part A|Withdrawal by Subject|0|||
147507311|NCT03907969|532008759|FG006|Combination Therapy Part A|Withdrawal by Subject|0|||
147507312|NCT03907969|532008760|FG007|Combination Therapy Part A|Withdrawal by Subject|0|||
147507313|NCT03907969|532008761|FG008|Combination Therapy Part A|Withdrawal by Subject|0|||
147507314|NCT03907969|532008762|FG009|Combination Therapy Part A|Withdrawal by Subject|1|||
147507315|NCT03907969|532008763|FG010|Combination Therapy Part A|Withdrawal by Subject|0|||
147507316|NCT03907969|532008753|FG000|Combination Therapy Part A|Other than specified main reasons|0|||
147507317|NCT03907969|532008754|FG001|Combination Therapy Part A|Other than specified main reasons|0|||
147507318|NCT03907969|532008755|FG002|Combination Therapy Part A|Other than specified main reasons|0|||
147507319|NCT03907969|532008756|FG003|Combination Therapy Part A|Other than specified main reasons|0|||
147507320|NCT03907969|532008757|FG004|Combination Therapy Part A|Other than specified main reasons|0|||
147507321|NCT03907969|532008758|FG005|Combination Therapy Part A|Other than specified main reasons|0|||
147507322|NCT03907969|532008759|FG006|Combination Therapy Part A|Other than specified main reasons|0|||
147507323|NCT03907969|532008760|FG007|Combination Therapy Part A|Other than specified main reasons|0|||
147507324|NCT03907969|532008761|FG008|Combination Therapy Part A|Other than specified main reasons|1|||
147507325|NCT03907969|532008762|FG009|Combination Therapy Part A|Other than specified main reasons|0|||
147507326|NCT03907969|532008763|FG010|Combination Therapy Part A|Other than specified main reasons|0|||
147507327|NCT03907969|532008753|FG000|Combination Therapy Part A|Physician Decision|0|||
147507328|NCT03907969|532008754|FG001|Combination Therapy Part A|Physician Decision|0|||
147507329|NCT03907969|532008755|FG002|Combination Therapy Part A|Physician Decision|0|||
147507330|NCT03907969|532008756|FG003|Combination Therapy Part A|Physician Decision|0|||
147507331|NCT03907969|532008757|FG004|Combination Therapy Part A|Physician Decision|0|||
147507332|NCT03907969|532008758|FG005|Combination Therapy Part A|Physician Decision|0|||
147507333|NCT03907969|532008759|FG006|Combination Therapy Part A|Physician Decision|0|||
147507334|NCT03907969|532008760|FG007|Combination Therapy Part A|Physician Decision|1|||
147507335|NCT03907969|532008761|FG008|Combination Therapy Part A|Physician Decision|0|||
147507336|NCT03907969|532008762|FG009|Combination Therapy Part A|Physician Decision|0|||
147507337|NCT03907969|532008763|FG010|Combination Therapy Part A|Physician Decision|1|||
147507338|NCT00063986|532008767|FG000|Overall Study|Withdrawal by Subject|1|||
147507339|NCT00063986|532008767|FG000|Overall Study|Ineligible|1|||
147507340|NCT00063986|532008767|FG000|Overall Study|Intra-operatively ineligible|4|||
147507341|NCT01675141|532008775|FG000|Overall Study|Lenalidomide outside NIH|3|||
147507342|NCT01675141|532008775|FG000|Overall Study|Withdrawal by Subject|3|||
147507343|NCT01675141|532008775|FG000|Overall Study|Physician Decision|4|||
147507344|NCT01675141|532008775|FG000|Overall Study|No treatment, per protocol|1|||
147507345|NCT00109772|532008776|FG000|Double-blind Treatment|Adverse Event|14|||
147507346|NCT00109772|532008777|FG001|Double-blind Treatment|Adverse Event|5|||
147507347|NCT00109772|532008776|FG000|Double-blind Treatment|Lack of Efficacy|1|||
147507348|NCT00109772|532008777|FG001|Double-blind Treatment|Lack of Efficacy|0|||
147507349|NCT00109772|532008776|FG000|Double-blind Treatment|Withdrawal by Subject|2|||
147507350|NCT00109772|532008777|FG001|Double-blind Treatment|Withdrawal by Subject|1|||
147507351|NCT00109772|532008776|FG000|Double-blind Treatment|Lost to Follow-up|2|||
147507352|NCT00109772|532008777|FG001|Double-blind Treatment|Lost to Follow-up|3|||
147507353|NCT00109772|532008776|FG000|Double-blind Treatment|Protocol Violation|0|||
147507354|NCT00109772|532008777|FG001|Double-blind Treatment|Protocol Violation|1|||
147507355|NCT00109772|532008776|FG000|Double-blind Treatment|Other|0|||
147507356|NCT00109772|532008777|FG001|Double-blind Treatment|Other|4|||
147507357|NCT00109772|532008776|FG000|Double-blind Treatment|Withdrew prior to treatment|3|||
147507358|NCT00109772|532008777|FG001|Double-blind Treatment|Withdrew prior to treatment|1|||
147507359|NCT00109772|532008776|FG000|Open-label Extension|Adverse Event|10|||
147507360|NCT00109772|532008777|FG001|Open-label Extension|Adverse Event|19|||
147507361|NCT00109772|532008776|FG000|Open-label Extension|Lack of Efficacy|19|||
147507362|NCT00109772|532008777|FG001|Open-label Extension|Lack of Efficacy|11|||
147507363|NCT00109772|532008776|FG000|Open-label Extension|Withdrawal by Subject|9|||
147507364|NCT00109772|532008777|FG001|Open-label Extension|Withdrawal by Subject|6|||
147507365|NCT00109772|532008776|FG000|Open-label Extension|Lost to Follow-up|1|||
147507366|NCT00109772|532008777|FG001|Open-label Extension|Lost to Follow-up|0|||
147507367|NCT00109772|532008776|FG000|Open-label Extension|Death|0|||
147507368|NCT00109772|532008777|FG001|Open-label Extension|Death|1|||
147507369|NCT00109772|532008776|FG000|Open-label Extension|Protocol Violation|2|||
147507370|NCT00109772|532008777|FG001|Open-label Extension|Protocol Violation|2|||
147669711|NCT00427934|532617361|FG003|Overall Study|Lack of Efficacy|2|||
147507371|NCT00109772|532008776|FG000|Open-label Extension|Other|4|||
147507372|NCT00109772|532008777|FG001|Open-label Extension|Other|10|||
147507373|NCT00813917|532008780|FG000|Overall Study|Adverse Event|0|||
147507374|NCT00813917|532008781|FG001|Overall Study|Adverse Event|1|||
147507375|NCT00813917|532008780|FG000|Overall Study|Withdrawal by Subject|3|||
147507376|NCT00813917|532008781|FG001|Overall Study|Withdrawal by Subject|4|||
147507377|NCT00813917|532008780|FG000|Overall Study|Lost to Follow-up|3|||
147507378|NCT00813917|532008781|FG001|Overall Study|Lost to Follow-up|1|||
147507379|NCT00792701|532008787|FG000|Overall Study|Adverse Event|0|||
147507380|NCT00792701|532008788|FG001|Overall Study|Adverse Event|22|||
147507381|NCT00792701|532008787|FG000|Overall Study|Ineligible|1|||
147507382|NCT00792701|532008788|FG001|Overall Study|Ineligible|3|||
147507383|NCT00792701|532008787|FG000|Overall Study|Withdrawal by Subject|1|||
147507384|NCT00792701|532008788|FG001|Overall Study|Withdrawal by Subject|19|||
147507385|NCT00792701|532008787|FG000|Overall Study|Not protocol specified|17|||
147507386|NCT00792701|532008788|FG001|Overall Study|Not protocol specified|0|||
147507387|NCT00615914|532008789|FG000|Overall Study|Adverse Event|274|||
147507388|NCT00615914|532008789|FG000|Overall Study|Death|20|||
147507389|NCT00615914|532008789|FG000|Overall Study|Lack of Efficacy|59|||
147507390|NCT00615914|532008789|FG000|Overall Study|Lost to Follow-up|187|||
147507391|NCT00615914|532008789|FG000|Overall Study|Withdrawal by Subject|16|||
147507392|NCT00615914|532008789|FG000|Overall Study|Physician Decision|4|||
147507393|NCT00615914|532008789|FG000|Overall Study|No data was collected.|65|||
147507394|NCT00615914|532008789|FG000|Overall Study|No treatment|2|||
147507395|NCT00615914|532008789|FG000|Overall Study|Irregularly enrolled patients|10|||
147507396|NCT00802867|532008790|FG000|Overall Study|Lost to Follow-up|6|||
147507397|NCT00802867|532008790|FG000|Overall Study|Protocol Violation|6|||
147507398|NCT00802867|532008790|FG000|Overall Study|Withdrawal by Subject|1|||
147507399|NCT01156532|532008791|FG000|Overall Study|Family Reasons|1|||
147507400|NCT01156532|532008791|FG000|Overall Study|Lost to Follow-up|1|||
147507401|NCT01809197|532008792|FG000|Overall Study|Lost to Follow-up|4|||
147507402|NCT01809197|532008793|FG001|Overall Study|Lost to Follow-up|2|||
147507403|NCT01809197|532008792|FG000|Overall Study|Adverse Event|2|||
147507404|NCT01809197|532008793|FG001|Overall Study|Adverse Event|3|||
147507405|NCT01809197|532008792|FG000|Overall Study|Failed slit lamp exam|1|||
147507406|NCT01809197|532008793|FG001|Overall Study|Failed slit lamp exam|0|||
147507407|NCT01809197|532008792|FG000|Overall Study|Non-Compliance|1|||
147507408|NCT01809197|532008793|FG001|Overall Study|Non-Compliance|1|||
147507409|NCT01809197|532008792|FG000|Overall Study|Decision Unrelated to an Adverse Event|1|||
147507410|NCT01809197|532008793|FG001|Overall Study|Decision Unrelated to an Adverse Event|0|||
147507411|NCT01809197|532008792|FG000|Overall Study|Withdrawal by Subject|1|||
147507412|NCT01809197|532008793|FG001|Overall Study|Withdrawal by Subject|1|||
147507413|NCT01809197|532008792|FG000|Overall Study|Product not available|0|||
147507414|NCT01809197|532008793|FG001|Overall Study|Product not available|1|||
147507415|NCT03228394|532008794|FG000|Overall Study|Lost to Follow-up|0|||
147507416|NCT03228394|532008795|FG001|Overall Study|Lost to Follow-up|0|||
147507417|NCT03228394|532008796|FG002|Overall Study|Lost to Follow-up|1|||
147507418|NCT03228394|532008797|FG003|Overall Study|Lost to Follow-up|1|||
147507419|NCT03228394|532008798|FG004|Overall Study|Lost to Follow-up|0|||
147507420|NCT03228394|532008799|FG005|Overall Study|Lost to Follow-up|0|||
147507421|NCT03228394|532008800|FG006|Overall Study|Lost to Follow-up|2|||
147507422|NCT03228394|532008801|FG007|Overall Study|Lost to Follow-up|0|||
147507423|NCT03228394|532008794|FG000|Overall Study|Withdrawal by Subject|0|||
147507424|NCT03228394|532008795|FG001|Overall Study|Withdrawal by Subject|0|||
147507425|NCT03228394|532008796|FG002|Overall Study|Withdrawal by Subject|1|||
147507426|NCT03228394|532008797|FG003|Overall Study|Withdrawal by Subject|0|||
147507427|NCT03228394|532008798|FG004|Overall Study|Withdrawal by Subject|0|||
147507428|NCT03228394|532008799|FG005|Overall Study|Withdrawal by Subject|0|||
147507429|NCT03228394|532008800|FG006|Overall Study|Withdrawal by Subject|1|||
147507430|NCT03228394|532008801|FG007|Overall Study|Withdrawal by Subject|3|||
147507431|NCT03228394|532008794|FG000|Overall Study|Protocol Violation|0|||
147507432|NCT03228394|532008795|FG001|Overall Study|Protocol Violation|0|||
147507433|NCT03228394|532008796|FG002|Overall Study|Protocol Violation|0|||
147507434|NCT03228394|532008797|FG003|Overall Study|Protocol Violation|1|||
147507435|NCT03228394|532008798|FG004|Overall Study|Protocol Violation|0|||
147507436|NCT03228394|532008799|FG005|Overall Study|Protocol Violation|0|||
147507437|NCT03228394|532008800|FG006|Overall Study|Protocol Violation|0|||
147507438|NCT03228394|532008801|FG007|Overall Study|Protocol Violation|0|||
147507439|NCT03228394|532008794|FG000|Overall Study|Physician Decision|0|||
147507440|NCT03228394|532008795|FG001|Overall Study|Physician Decision|0|||
147507441|NCT03228394|532008796|FG002|Overall Study|Physician Decision|0|||
147507442|NCT03228394|532008797|FG003|Overall Study|Physician Decision|0|||
147507443|NCT03228394|532008798|FG004|Overall Study|Physician Decision|0|||
147507444|NCT03228394|532008799|FG005|Overall Study|Physician Decision|0|||
147507445|NCT03228394|532008800|FG006|Overall Study|Physician Decision|1|||
147507446|NCT03228394|532008801|FG007|Overall Study|Physician Decision|0|||
147507447|NCT03228394|532008794|FG000|Overall Study|Noncompliance|0|||
147507448|NCT03228394|532008795|FG001|Overall Study|Noncompliance|0|||
147507449|NCT03228394|532008796|FG002|Overall Study|Noncompliance|0|||
147507450|NCT03228394|532008797|FG003|Overall Study|Noncompliance|0|||
147507451|NCT03228394|532008798|FG004|Overall Study|Noncompliance|0|||
147507452|NCT03228394|532008799|FG005|Overall Study|Noncompliance|0|||
147507453|NCT03228394|532008800|FG006|Overall Study|Noncompliance|1|||
147507454|NCT03228394|532008801|FG007|Overall Study|Noncompliance|0|||
147507455|NCT00294684|532008806|FG000|Overall Study|Lost to Follow-up|5|||
147507456|NCT00294684|532008807|FG001|Overall Study|Lost to Follow-up|8|||
147507457|NCT02443805|532008808|FG000|Overall Study|Adverse Event|100|||
147507458|NCT02443805|532008809|FG001|Overall Study|Adverse Event|18|||
147507459|NCT02443805|532008808|FG000|Overall Study|Withdrawal by Subject|73|||
147507460|NCT02443805|532008809|FG001|Overall Study|Withdrawal by Subject|74|||
147507461|NCT02443805|532008808|FG000|Overall Study|Lost to Follow-up|19|||
147507462|NCT02443805|532008809|FG001|Overall Study|Lost to Follow-up|14|||
147507463|NCT02443805|532008808|FG000|Overall Study|Pregnancy|6|||
147507464|NCT02443805|532008809|FG001|Overall Study|Pregnancy|5|||
147507465|NCT02443805|532008808|FG000|Overall Study|Protocol Violation|2|||
147507466|NCT02443805|532008809|FG001|Overall Study|Protocol Violation|4|||
147507467|NCT02443805|532008808|FG000|Overall Study|Lack of Efficacy|1|||
147507468|NCT02443805|532008809|FG001|Overall Study|Lack of Efficacy|1|||
147507469|NCT02443805|532008808|FG000|Overall Study|Non-compliance with study drug|6|||
147507470|NCT02443805|532008809|FG001|Overall Study|Non-compliance with study drug|4|||
147507471|NCT02443805|532008808|FG000|Overall Study|Withdrawal by parent/guardian|3|||
147507472|NCT02443805|532008809|FG001|Overall Study|Withdrawal by parent/guardian|5|||
147507473|NCT02443805|532008808|FG000|Overall Study|Any other reason not above-mentioned|3|||
147507474|NCT02443805|532008809|FG001|Overall Study|Any other reason not above-mentioned|2|||
147507475|NCT00968708|532008810|FG000|Overall Study|Adverse Event|169|||
147507476|NCT00968708|532008811|FG001|Overall Study|Adverse Event|150|||
147507477|NCT00968708|532008810|FG000|Overall Study|Major Protocol Deviation|0|||
147507478|NCT00968708|532008811|FG001|Overall Study|Major Protocol Deviation|1|||
147507479|NCT00968708|532008810|FG000|Overall Study|Lost to Follow-up|19|||
147507480|NCT00968708|532008811|FG001|Overall Study|Lost to Follow-up|11|||
147507481|NCT00968708|532008810|FG000|Overall Study|Voluntary Withdrawal|104|||
147507482|NCT00968708|532008811|FG001|Overall Study|Voluntary Withdrawal|101|||
147507483|NCT00968708|532008810|FG000|Overall Study|Investigator Discretion|0|||
147507484|NCT00968708|532008811|FG001|Overall Study|Investigator Discretion|1|||
147507485|NCT00968708|532008810|FG000|Overall Study|Other|26|||
147507486|NCT00968708|532008811|FG001|Overall Study|Other|34|||
147507487|NCT02708966|532008812|FG000|Overall Study|Lost to Follow-up|2|||
147507488|NCT02708966|532008813|FG001|Overall Study|Lost to Follow-up|2|||
147507489|NCT03407170|532008816|FG000|Overall Study|Adverse Event|1|||
147507490|NCT00126672|532008818|FG000|Overall Study|Adverse Event|4|||
147507491|NCT00126672|532008818|FG000|Overall Study|Lost to Follow-up|4|||
147507492|NCT01001234|532008821|FG000|Overall Study|Withdrawal by Subject|2|||
147507493|NCT01001234|532008822|FG001|Overall Study|Withdrawal by Subject|0|||
147507494|NCT01001234|532008823|FG002|Overall Study|Withdrawal by Subject|3|||
147507495|NCT01001234|532008824|FG003|Overall Study|Withdrawal by Subject|0|||
147507496|NCT01001234|532008825|FG004|Overall Study|Withdrawal by Subject|0|||
147507497|NCT01001234|532008821|FG000|Overall Study|Protocol Violation|34|||
147507498|NCT01001234|532008822|FG001|Overall Study|Protocol Violation|3|||
147507499|NCT01001234|532008823|FG002|Overall Study|Protocol Violation|19|||
147507500|NCT01001234|532008824|FG003|Overall Study|Protocol Violation|18|||
147507501|NCT01001234|532008825|FG004|Overall Study|Protocol Violation|0|||
147507502|NCT01001234|532008821|FG000|Overall Study|Lost to Follow-up|0|||
147507503|NCT01001234|532008822|FG001|Overall Study|Lost to Follow-up|0|||
147507504|NCT01001234|532008823|FG002|Overall Study|Lost to Follow-up|1|||
147507505|NCT01001234|532008824|FG003|Overall Study|Lost to Follow-up|2|||
147507506|NCT01001234|532008825|FG004|Overall Study|Lost to Follow-up|0|||
147507507|NCT01001234|532008821|FG000|Overall Study|Physician Decision|1|||
147507508|NCT01001234|532008822|FG001|Overall Study|Physician Decision|0|||
147507509|NCT01001234|532008823|FG002|Overall Study|Physician Decision|0|||
147507510|NCT01001234|532008824|FG003|Overall Study|Physician Decision|0|||
147507511|NCT01001234|532008825|FG004|Overall Study|Physician Decision|0|||
147507512|NCT01001234|532008821|FG000|Overall Study|Not Treated: Adverse Event|1|||
147507513|NCT01001234|532008822|FG001|Overall Study|Not Treated: Adverse Event|0|||
147507514|NCT01001234|532008823|FG002|Overall Study|Not Treated: Adverse Event|0|||
147507515|NCT01001234|532008824|FG003|Overall Study|Not Treated: Adverse Event|0|||
147507516|NCT01001234|532008825|FG004|Overall Study|Not Treated: Adverse Event|0|||
147507517|NCT01001234|532008821|FG000|Overall Study|Not Treated: Withdrawal by Subject|23|||
147507518|NCT01001234|532008822|FG001|Overall Study|Not Treated: Withdrawal by Subject|2|||
147507519|NCT01001234|532008823|FG002|Overall Study|Not Treated: Withdrawal by Subject|2|||
147507520|NCT01001234|532008824|FG003|Overall Study|Not Treated: Withdrawal by Subject|0|||
147507521|NCT01001234|532008825|FG004|Overall Study|Not Treated: Withdrawal by Subject|0|||
147507522|NCT01001234|532008821|FG000|Overall Study|Not Treated: Protocol Violation|3|||
147507523|NCT01001234|532008822|FG001|Overall Study|Not Treated: Protocol Violation|0|||
147507524|NCT01001234|532008823|FG002|Overall Study|Not Treated: Protocol Violation|0|||
147507525|NCT01001234|532008824|FG003|Overall Study|Not Treated: Protocol Violation|0|||
147507526|NCT01001234|532008825|FG004|Overall Study|Not Treated: Protocol Violation|0|||
147639573|NCT01340027|532497861|FG008|Overall Study|Protocol Violation|2|||
147639574|NCT01340027|532497862|FG009|Overall Study|Protocol Violation|2|||
147639575|NCT01340027|532497863|FG010|Overall Study|Protocol Violation|0|||
147639576|NCT01340027|532497864|FG011|Overall Study|Protocol Violation|0|||
147507527|NCT01001234|532008821|FG000|Overall Study|Not Treated: Lost to Follow-up|53|||
147507528|NCT01001234|532008822|FG001|Overall Study|Not Treated: Lost to Follow-up|4|||
147639577|NCT01340027|532497853|FG000|Overall Study|Withdrawal by Subject|4|||
147507529|NCT01001234|532008823|FG002|Overall Study|Not Treated: Lost to Follow-up|7|||
147507530|NCT01001234|532008824|FG003|Overall Study|Not Treated: Lost to Follow-up|5|||
147507531|NCT01001234|532008825|FG004|Overall Study|Not Treated: Lost to Follow-up|0|||
147507532|NCT01001234|532008821|FG000|Overall Study|Not Treated: Pregnancy|3|||
147507533|NCT01001234|532008822|FG001|Overall Study|Not Treated: Pregnancy|0|||
147507534|NCT01001234|532008823|FG002|Overall Study|Not Treated: Pregnancy|0|||
147507535|NCT01001234|532008824|FG003|Overall Study|Not Treated: Pregnancy|0|||
147507536|NCT01001234|532008825|FG004|Overall Study|Not Treated: Pregnancy|0|||
147507537|NCT01001234|532008821|FG000|Overall Study|Not Treated: Physician Decision|37|||
147507538|NCT01001234|532008822|FG001|Overall Study|Not Treated: Physician Decision|4|||
147507539|NCT01001234|532008823|FG002|Overall Study|Not Treated: Physician Decision|0|||
147507540|NCT01001234|532008824|FG003|Overall Study|Not Treated: Physician Decision|0|||
147507541|NCT01001234|532008825|FG004|Overall Study|Not Treated: Physician Decision|0|||
147507542|NCT01001234|532008821|FG000|Overall Study|Not Treated: Lack of Qualifying Event|248|||
147507543|NCT01001234|532008822|FG001|Overall Study|Not Treated: Lack of Qualifying Event|13|||
147507544|NCT01001234|532008823|FG002|Overall Study|Not Treated: Lack of Qualifying Event|0|||
147507545|NCT01001234|532008824|FG003|Overall Study|Not Treated: Lack of Qualifying Event|0|||
147507546|NCT01001234|532008825|FG004|Overall Study|Not Treated: Lack of Qualifying Event|0|||
147507547|NCT01851863|532008829|FG000|Overall Study|Did not receive study medication|2|||
147507548|NCT01851863|532008830|FG001|Overall Study|Did not receive study medication|5|||
147507549|NCT01851863|532008831|FG002|Overall Study|Did not receive study medication|3|||
147507550|NCT01851863|532008832|FG003|Overall Study|Did not receive study medication|0|||
147507551|NCT01851863|532008829|FG000|Overall Study|Lost to Follow-up|3|||
147507552|NCT01851863|532008830|FG001|Overall Study|Lost to Follow-up|4|||
147507553|NCT01851863|532008831|FG002|Overall Study|Lost to Follow-up|2|||
147507554|NCT01851863|532008832|FG003|Overall Study|Lost to Follow-up|3|||
147507555|NCT02076334|532008833|FG000|Overall Study|Protocol Violation|1|||
147507556|NCT02076334|532008834|FG001|Overall Study|Protocol Violation|0|||
147507557|NCT02076334|532008835|FG002|Overall Study|Protocol Violation|0|||
147507558|NCT02076334|532008836|FG003|Overall Study|Protocol Violation|0|||
147507559|NCT02076334|532008833|FG000|Overall Study|Lost to Follow-up|0|||
147507560|NCT02076334|532008834|FG001|Overall Study|Lost to Follow-up|1|||
147507561|NCT02076334|532008835|FG002|Overall Study|Lost to Follow-up|1|||
147507562|NCT02076334|532008836|FG003|Overall Study|Lost to Follow-up|0|||
147507563|NCT02076334|532008833|FG000|Overall Study|muscle soreness|0|||
147507564|NCT02076334|532008834|FG001|Overall Study|muscle soreness|0|||
147507565|NCT02076334|532008835|FG002|Overall Study|muscle soreness|0|||
147507566|NCT02076334|532008836|FG003|Overall Study|muscle soreness|1|||
147507567|NCT03379376|532008837|FG000|Overall Study|Lost to Follow-up|2|||
147507568|NCT03379376|532008837|FG000|Overall Study|Did not wish to complete follow up|1|||
147507569|NCT03379376|532008837|FG000|Overall Study|Overwhelmed, didn't want to continue|1|||
147507570|NCT03379376|532008837|FG000|Overall Study|Death|1|||
147507571|NCT01611298|532008838|FG000|Overall Study|Relapsed|2|||
147507572|NCT04294095|532008840|FG000|Overall Study|Adverse Event|1|||
147507573|NCT04294095|532008841|FG001|Overall Study|Adverse Event|0|||
147507574|NCT02224638|532008844|FG000|Overall Study|Adverse Event|1|||
147507575|NCT02224638|532008845|FG001|Overall Study|Adverse Event|1|||
147507576|NCT01406652|532008846|FG000|Overall Study|Lost-to-follow-up|3|||
147507577|NCT01406652|532008847|FG001|Overall Study|Lost-to-follow-up|4|||
147507578|NCT01406652|532008846|FG000|Overall Study|Withdrawal by Subject|2|||
147507579|NCT01406652|532008847|FG001|Overall Study|Withdrawal by Subject|2|||
147507580|NCT01406652|532008846|FG000|Overall Study|Insufficient follow-up|5|||
147507581|NCT01406652|532008847|FG001|Overall Study|Insufficient follow-up|4|||
147507582|NCT01406652|532008846|FG000|Overall Study|Infection not sure|10|||
147507583|NCT01406652|532008847|FG001|Overall Study|Infection not sure|10|||
147507584|NCT00861380|532008848|FG000|Overall Study|Withdrawal Information not recorded|8427|||
147507585|NCT00861380|532008849|FG001|Overall Study|Withdrawal Information not recorded|9112|||
147507586|NCT00861380|532008850|FG002|Overall Study|Withdrawal Information not recorded|8872|||
147507587|NCT00861380|532008851|FG003|Overall Study|Withdrawal Information not recorded|3689|||
147507588|NCT00861380|532008852|FG004|Overall Study|Withdrawal Information not recorded|1812|||
147507589|NCT00861380|532008853|FG005|Overall Study|Withdrawal Information not recorded|6249|||
147507590|NCT00861380|532008854|FG006|Overall Study|Withdrawal Information not recorded|3020|||
147507591|NCT01998399|532008856|FG000|Overall Study|Lost to Follow-up|1|||
147507592|NCT01998399|532008857|FG001|Overall Study|Lost to Follow-up|3|||
147507593|NCT01998399|532008856|FG000|Overall Study|Death|4|||
147507594|NCT01998399|532008857|FG001|Overall Study|Death|2|||
147507595|NCT01998399|532008856|FG000|Overall Study|Study stopped before dosing completed|3|||
147507596|NCT01998399|532008857|FG001|Overall Study|Study stopped before dosing completed|3|||
147507597|NCT01998399|532008856|FG000|Overall Study|Withdrawal by Subject|0|||
147507598|NCT01998399|532008857|FG001|Overall Study|Withdrawal by Subject|1|||
147507599|NCT00795509|532008867|FG000|Overall Study|Protocol Violation|31|||
147507600|NCT00970268|532008868|FG000|Overall Study|Withdrawal by Subject|12|||
147507601|NCT00970268|532008869|FG001|Overall Study|Withdrawal by Subject|19|||
147507602|NCT00970268|532008868|FG000|Overall Study|Adverse Event|15|||
147507603|NCT00970268|532008869|FG001|Overall Study|Adverse Event|12|||
147507604|NCT00970268|532008868|FG000|Overall Study|Lack of Efficacy|3|||
147507605|NCT00970268|532008869|FG001|Overall Study|Lack of Efficacy|6|||
147507606|NCT00970268|532008868|FG000|Overall Study|Protocol Violation|4|||
147507607|NCT00970268|532008869|FG001|Overall Study|Protocol Violation|7|||
147507608|NCT00970268|532008868|FG000|Overall Study|Other Reason|3|||
147507609|NCT00970268|532008869|FG001|Overall Study|Other Reason|1|||
147507610|NCT00970268|532008868|FG000|Overall Study|COPD Exacerbation|4|||
147507611|NCT00970268|532008869|FG001|Overall Study|COPD Exacerbation|2|||
147507612|NCT00970268|532008868|FG000|Overall Study|Lost to Follow-up|1|||
147507613|NCT00970268|532008869|FG001|Overall Study|Lost to Follow-up|2|||
147507614|NCT00970268|532008868|FG000|Overall Study|Inclusion/Exclusion Criteria|1|||
147507615|NCT00970268|532008869|FG001|Overall Study|Inclusion/Exclusion Criteria|0|||
147507616|NCT01079195|532008870|FG000|Overall Study|No Documentation of Tarka Therapy|739|||
147507617|NCT01079195|532008870|FG000|Overall Study|No Documentation Available|437|||
147507618|NCT01079195|532008870|FG000|Overall Study|Adverse Event|157|||
147507619|NCT01079195|532008870|FG000|Overall Study|Reason Unknown|39|||
147507620|NCT01079195|532008870|FG000|Overall Study|Withdrawal by Subject|18|||
147507621|NCT01079195|532008870|FG000|Overall Study|Financial Reasons|15|||
147507622|NCT01079195|532008870|FG000|Overall Study|Lack of Effectiveness|12|||
147507623|NCT01079195|532008870|FG000|Overall Study|Physician Decision|4|||
147507624|NCT01079195|532008870|FG000|Overall Study|Improved Status of Participant|4|||
147507625|NCT01079195|532008870|FG000|Overall Study|No Follow-up Documentation Available|4|||
147507626|NCT01079195|532008870|FG000|Overall Study|Non-compliance|2|||
147507627|NCT02146833|532008873|FG000|Overall Study|Death|10|||
147507628|NCT02146833|532008873|FG000|Overall Study|No longer consented to study treatment|1|||
147507629|NCT03726333|532008874|FG000|Overall Study|Progressive Disease|0|||
147507630|NCT03726333|532008875|FG001|Overall Study|Progressive Disease|0|||
147507631|NCT03726333|532008876|FG002|Overall Study|Progressive Disease|1|||
147507632|NCT03726333|532008877|FG003|Overall Study|Progressive Disease|0|||
147507633|NCT03726333|532008878|FG004|Overall Study|Progressive Disease|0|||
147507634|NCT02971007|532010558|FG000|Overall Study|Adverse Event|1|||
147507635|NCT02971007|532010559|FG001|Overall Study|Adverse Event|0|||
147507636|NCT02971007|532010560|FG002|Overall Study|Adverse Event|0|||
147507637|NCT02971007|532010558|FG000|Overall Study|Lost to Follow-up|0|||
147507638|NCT02971007|532010559|FG001|Overall Study|Lost to Follow-up|1|||
147507639|NCT02971007|532010560|FG002|Overall Study|Lost to Follow-up|1|||
147507640|NCT02971007|532010558|FG000|Overall Study|Withdrawal by Subject|0|||
147507641|NCT02971007|532010559|FG001|Overall Study|Withdrawal by Subject|1|||
147507642|NCT02971007|532010560|FG002|Overall Study|Withdrawal by Subject|0|||
147507643|NCT02971007|532010558|FG000|Overall Study|Patient had yeast at Day 5 visit|1|||
147507644|NCT02971007|532010559|FG001|Overall Study|Patient had yeast at Day 5 visit|0|||
147507645|NCT02971007|532010560|FG002|Overall Study|Patient had yeast at Day 5 visit|0|||
147507646|NCT02971007|532010558|FG000|Overall Study|Patient discontinued study drug|0|||
147507647|NCT02971007|532010559|FG001|Overall Study|Patient discontinued study drug|1|||
147507648|NCT02971007|532010560|FG002|Overall Study|Patient discontinued study drug|0|||
147507649|NCT01419015|532010564|FG000|Overall Study|Death|2|||
147507650|NCT02911519|532010565|FG000|Overall Study|Lost to Follow-up|2|||
147507651|NCT02911519|532010566|FG001|Overall Study|Lost to Follow-up|2|||
147507652|NCT02911519|532010565|FG000|Overall Study|Death|0|||
147507653|NCT02911519|532010566|FG001|Overall Study|Death|2|||
147507654|NCT00653328|532010567|FG000|Overall Study|Withdrawal by Subject|1|||
147507655|NCT00653328|532010567|FG000|Overall Study|Adverse Event|2|||
147507656|NCT00653328|532010567|FG000|Overall Study|Disease progression|10|||
147507657|NCT00653328|532010567|FG000|Overall Study|Drug manufacturer no longing making drug|2|||
147507658|NCT01237223|532010568|FG000|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|29|||
147507659|NCT01237223|532010569|FG001|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0|||
147507660|NCT01237223|532010570|FG002|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0|||
147507661|NCT01237223|532010571|FG003|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0|||
147507662|NCT01237223|532010572|FG004|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0|||
147507663|NCT01237223|532010573|FG005|Single Blind(Run-in Period, 4 Weeks)|Adverse Event|0|||
147507664|NCT01237223|532010568|FG000|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|25|||
147507665|NCT01237223|532010569|FG001|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0|||
147507666|NCT01237223|532010570|FG002|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0|||
147507667|NCT01237223|532010571|FG003|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0|||
147507668|NCT01237223|532010572|FG004|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0|||
147507669|NCT01237223|532010573|FG005|Single Blind(Run-in Period, 4 Weeks)|Abnormal laboratory value(s)|0|||
147507670|NCT01237223|532010568|FG000|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|308|||
147507671|NCT01237223|532010569|FG001|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0|||
147507672|NCT01237223|532010570|FG002|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0|||
147507673|NCT01237223|532010571|FG003|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0|||
147507674|NCT01237223|532010572|FG004|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0|||
147507675|NCT01237223|532010573|FG005|Single Blind(Run-in Period, 4 Weeks)|Abnormal test procedure result(s)|0|||
147507676|NCT01237223|532010568|FG000|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|28|||
147507677|NCT01237223|532010569|FG001|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0|||
147507678|NCT01237223|532010570|FG002|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0|||
147507679|NCT01237223|532010571|FG003|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0|||
147507680|NCT01237223|532010572|FG004|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0|||
147507681|NCT01237223|532010573|FG005|Single Blind(Run-in Period, 4 Weeks)|Subject withdrew consent|0|||
147507682|NCT01237223|532010568|FG000|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|8|||
147507683|NCT01237223|532010569|FG001|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0|||
147507684|NCT01237223|532010570|FG002|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0|||
147507685|NCT01237223|532010571|FG003|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0|||
147507686|NCT01237223|532010572|FG004|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0|||
147507687|NCT01237223|532010573|FG005|Single Blind(Run-in Period, 4 Weeks)|Protocol deviation(s)|0|||
147507688|NCT01237223|532010568|FG000|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|12|||
147507689|NCT01237223|532010569|FG001|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|4|||
147507690|NCT01237223|532010570|FG002|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|3|||
147507691|NCT01237223|532010571|FG003|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|2|||
147507692|NCT01237223|532010572|FG004|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|2|||
147507693|NCT01237223|532010573|FG005|Double Blind (Treatment Period, 8 Weeks)|Adverse Event|1|||
147507694|NCT01237223|532010568|FG000|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|20|||
147507695|NCT01237223|532010569|FG001|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|6|||
147507696|NCT01237223|532010570|FG002|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|7|||
147507697|NCT01237223|532010571|FG003|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|1|||
147507698|NCT01237223|532010572|FG004|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|0|||
147507699|NCT01237223|532010573|FG005|Double Blind (Treatment Period, 8 Weeks)|Unsatisfactory therapeutic effect|1|||
147507700|NCT01237223|532010568|FG000|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|1|||
147507701|NCT01237223|532010569|FG001|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|4|||
147507702|NCT01237223|532010570|FG002|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|4|||
147507703|NCT01237223|532010571|FG003|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|0|||
147507704|NCT01237223|532010572|FG004|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|1|||
147507705|NCT01237223|532010573|FG005|Double Blind (Treatment Period, 8 Weeks)|Withdrawal by Subject|1|||
147507706|NCT01237223|532010568|FG000|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0|||
147507707|NCT01237223|532010569|FG001|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0|||
147507708|NCT01237223|532010570|FG002|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0|||
147507709|NCT01237223|532010571|FG003|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0|||
147507710|NCT01237223|532010572|FG004|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|0|||
147507711|NCT01237223|532010573|FG005|Double Blind (Treatment Period, 8 Weeks)|Administrative problems|1|||
147507712|NCT01237223|532010568|FG000|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|0|||
147507713|NCT01237223|532010569|FG001|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1|||
147507714|NCT01237223|532010570|FG002|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1|||
147507715|NCT01237223|532010571|FG003|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|2|||
147507716|NCT01237223|532010572|FG004|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1|||
147507717|NCT01237223|532010573|FG005|Double Blind (Treatment Period, 8 Weeks)|Protocol deviation(s)|1|||
147507718|NCT00064077|532010581|FG000|Overall Study|Improper prior treatment|1|||
147507719|NCT00064077|532010582|FG001|Overall Study|Improper prior treatment|0|||
147507720|NCT00064077|532010583|FG002|Overall Study|Improper prior treatment|0|||
147507721|NCT00064077|532010584|FG003|Overall Study|Improper prior treatment|0|||
147507722|NCT00064077|532010581|FG000|Overall Study|Poor risk|2|||
147507723|NCT00064077|532010582|FG001|Overall Study|Poor risk|0|||
147507724|NCT00064077|532010583|FG002|Overall Study|Poor risk|1|||
147507725|NCT00064077|532010584|FG003|Overall Study|Poor risk|1|||
147507726|NCT00064077|532010581|FG000|Overall Study|Pathology|10|||
147507727|NCT00064077|532010582|FG001|Overall Study|Pathology|7|||
147507728|NCT00064077|532010583|FG002|Overall Study|Pathology|3|||
147507729|NCT00064077|532010584|FG003|Overall Study|Pathology|4|||
147507730|NCT00064077|532010581|FG000|Overall Study|No surgery|0|||
147507731|NCT00064077|532010582|FG001|Overall Study|No surgery|0|||
147507732|NCT00064077|532010583|FG002|Overall Study|No surgery|1|||
147507733|NCT00064077|532010584|FG003|Overall Study|No surgery|0|||
147507734|NCT00064077|532010581|FG000|Overall Study|No tumor|0|||
147507735|NCT00064077|532010582|FG001|Overall Study|No tumor|0|||
147507736|NCT00064077|532010583|FG002|Overall Study|No tumor|1|||
147507737|NCT00064077|532010584|FG003|Overall Study|No tumor|0|||
147639578|NCT01340027|532497854|FG001|Overall Study|Withdrawal by Subject|3|||
147639579|NCT01340027|532497855|FG002|Overall Study|Withdrawal by Subject|1|||
147639580|NCT01340027|532497856|FG003|Overall Study|Withdrawal by Subject|3|||
147639581|NCT01340027|532497857|FG004|Overall Study|Withdrawal by Subject|3|||
147507738|NCT00064077|532010581|FG000|Overall Study|Other reasons|2|||
147507739|NCT00064077|532010582|FG001|Overall Study|Other reasons|2|||
147507740|NCT00064077|532010583|FG002|Overall Study|Other reasons|1|||
147669712|NCT00427934|532617358|FG000|Overall Study|Randomized But Did Not Receive Treatment|0|||
147669713|NCT00427934|532617359|FG001|Overall Study|Randomized But Did Not Receive Treatment|0|||
147669714|NCT00427934|532617360|FG002|Overall Study|Randomized But Did Not Receive Treatment|1|||
147669715|NCT00427934|532617361|FG003|Overall Study|Randomized But Did Not Receive Treatment|1|||
147669716|NCT00427934|532617358|FG000|Overall Study|Other|0|||
147669717|NCT00427934|532617359|FG001|Overall Study|Other|0|||
147669718|NCT00427934|532617360|FG002|Overall Study|Other|11|||
147669719|NCT00427934|532617361|FG003|Overall Study|Other|5|||
147669720|NCT00427934|532617358|FG000|Overall Study|Withdrawal by Subject|0|||
147669721|NCT00427934|532617359|FG001|Overall Study|Withdrawal by Subject|0|||
147669722|NCT00427934|532617360|FG002|Overall Study|Withdrawal by Subject|1|||
147669723|NCT00427934|532617361|FG003|Overall Study|Withdrawal by Subject|3|||
147669724|NCT02058095|532617364|FG000|Overall Study|Adverse Event|1|||
147669725|NCT02058095|532617365|FG001|Overall Study|Adverse Event|0|||
147669726|NCT01499511|532617366|FG000|Overall Study|Death|1|||
147669727|NCT01499511|532617367|FG001|Overall Study|Death|0|||
147669728|NCT00998946|532617368|FG000|Overall Study|Lost to Follow-up|1|||
147669729|NCT00998946|532617368|FG000|Overall Study|Withdrawal by Subject|1|||
147669730|NCT00998946|532617368|FG000|Overall Study|Death|2|||
147669731|NCT00998946|532617368|FG000|Overall Study|Reason Unspecified|3|||
147669732|NCT00998946|532617368|FG000|Overall Study|Enrolled but not Dosed|2|||
147669733|NCT00915525|532617372|FG000|Overall Study|Protocol Violation|9|||
147669734|NCT00915525|532617373|FG001|Overall Study|Protocol Violation|4|||
147669735|NCT00915525|532617372|FG000|Overall Study|Withdrawal by Subject|59|||
147669736|NCT00915525|532617373|FG001|Overall Study|Withdrawal by Subject|21|||
147669737|NCT00915525|532617372|FG000|Overall Study|Lost to Follow-up|27|||
147669738|NCT00915525|532617373|FG001|Overall Study|Lost to Follow-up|16|||
147669739|NCT00915525|532617372|FG000|Overall Study|Pregnancy|2|||
147669740|NCT00915525|532617373|FG001|Overall Study|Pregnancy|0|||
147669741|NCT00915525|532617372|FG000|Overall Study|Lack of Efficacy|15|||
147669742|NCT00915525|532617373|FG001|Overall Study|Lack of Efficacy|32|||
147669743|NCT00915525|532617372|FG000|Overall Study|Adverse Event|29|||
147669744|NCT00915525|532617373|FG001|Overall Study|Adverse Event|13|||
147669745|NCT00915525|532617372|FG000|Overall Study|Missing|12|||
147669746|NCT00915525|532617373|FG001|Overall Study|Missing|1|||
147669747|NCT00915525|532617372|FG000|Overall Study|Other Reason|35|||
147669748|NCT00915525|532617373|FG001|Overall Study|Other Reason|12|||
147669749|NCT00915525|532617372|FG000|Overall Study|Site Closed|27|||
147669750|NCT00915525|532617373|FG001|Overall Study|Site Closed|9|||
147669751|NCT00915525|532617372|FG000|Overall Study|Retreat Request >Wk 144 (exclusionary)|4|||
147669752|NCT00915525|532617373|FG001|Overall Study|Retreat Request >Wk 144 (exclusionary)|5|||
147669753|NCT00915525|532617372|FG000|Overall Study|Study Burden|28|||
147669754|NCT00915525|532617373|FG001|Overall Study|Study Burden|12|||
147669755|NCT00915525|532617372|FG000|Overall Study|Non-Compliance|3|||
147669756|NCT00915525|532617373|FG001|Overall Study|Non-Compliance|1|||
147669757|NCT00915525|532617372|FG000|Overall Study|Patient Moved|15|||
147669758|NCT00915525|532617373|FG001|Overall Study|Patient Moved|9|||
147669759|NCT02842866|532617374|FG000|Overall Study|Serious Adverse Event|0|||
147669760|NCT02842866|532617375|FG001|Overall Study|Serious Adverse Event|1|||
147669761|NCT02842866|532617374|FG000|Overall Study|Protocol Violation|4|||
147669762|NCT02842866|532617375|FG001|Overall Study|Protocol Violation|2|||
147669763|NCT02842866|532617374|FG000|Overall Study|Lost to Follow-up|2|||
147669764|NCT02842866|532617375|FG001|Overall Study|Lost to Follow-up|0|||
147669765|NCT02842866|532617374|FG000|Overall Study|Withdrawal by Subject|1|||
147669766|NCT02842866|532617375|FG001|Overall Study|Withdrawal by Subject|0|||
147669767|NCT01432327|532617376|FG000|Posttest 3 Months|depression|3|||
147669768|NCT01432327|532617377|FG001|Posttest 3 Months|depression|0|||
147669769|NCT01432327|532617378|FG002|Posttest 3 Months|depression|0|||
147669770|NCT01432327|532617379|FG003|Posttest 3 Months|depression|0|||
147669771|NCT01432327|532617376|FG000|Posttest 3 Months|Lost to Follow-up|1|||
147669772|NCT01432327|532617377|FG001|Posttest 3 Months|Lost to Follow-up|0|||
147669773|NCT01432327|532617378|FG002|Posttest 3 Months|Lost to Follow-up|2|||
147669774|NCT01432327|532617379|FG003|Posttest 3 Months|Lost to Follow-up|1|||
147669775|NCT01432327|532617376|FG000|Posttest 3 Months|Allergic reaction|0|||
147669776|NCT01432327|532617377|FG001|Posttest 3 Months|Allergic reaction|2|||
147669777|NCT01432327|532617378|FG002|Posttest 3 Months|Allergic reaction|0|||
147669778|NCT01432327|532617379|FG003|Posttest 3 Months|Allergic reaction|0|||
147669779|NCT01432327|532617376|FG000|Posttest 6 Months|Lost to Follow-up|0|||
147669780|NCT01432327|532617377|FG001|Posttest 6 Months|Lost to Follow-up|0|||
147669781|NCT01432327|532617378|FG002|Posttest 6 Months|Lost to Follow-up|3|||
147669782|NCT01432327|532617379|FG003|Posttest 6 Months|Lost to Follow-up|2|||
147507741|NCT00064077|532010584|FG003|Overall Study|Other reasons|2|||
147669783|NCT01432327|532617376|FG000|Posttest 6 Months|Allergic reaction|0|||
147669784|NCT01432327|532617377|FG001|Posttest 6 Months|Allergic reaction|0|||
147669785|NCT01432327|532617378|FG002|Posttest 6 Months|Allergic reaction|1|||
147669786|NCT01432327|532617379|FG003|Posttest 6 Months|Allergic reaction|0|||
147669787|NCT01432327|532617376|FG000|Posttest 6 Months|Withdrawal by Subject|0|||
147669788|NCT01432327|532617377|FG001|Posttest 6 Months|Withdrawal by Subject|0|||
147507742|NCT00879437|532010589|FG000|Overall Study|Protocol Violation|0|||
147507743|NCT00879437|532010590|FG001|Overall Study|Protocol Violation|1|||
147507744|NCT00879437|532010589|FG000|Overall Study|Death|1|||
147507745|NCT00879437|532010590|FG001|Overall Study|Death|0|||
147507746|NCT00268463|532010591|FG000|Overall Study|study terminated due to low accrual|10|||
147507747|NCT00268463|532010592|FG001|Overall Study|study terminated due to low accrual|12|||
147507748|NCT03000686|532010593|FG000|Part 1, Period 1 (1 Day)|Adverse Event|0|||
147507749|NCT03000686|532010594|FG001|Part 1, Period 1 (1 Day)|Adverse Event|1|||
147507750|NCT03000686|532010595|FG002|Part 1, Period 1 (1 Day)|Adverse Event|0|||
147507751|NCT03000686|532010596|FG003|Part 1, Period 1 (1 Day)|Adverse Event|0|||
147507752|NCT02920450|532010597|FG000|Overall Study|Death|1|||
147507753|NCT02920450|532010598|FG001|Overall Study|Death|0|||
147507754|NCT02920450|532010599|FG002|Overall Study|Death|0|||
147507755|NCT02920450|532010600|FG003|Overall Study|Death|0|||
147507756|NCT02920450|532010597|FG000|Overall Study|Withdrawal by Subject|1|||
147507757|NCT02920450|532010598|FG001|Overall Study|Withdrawal by Subject|0|||
147507758|NCT02920450|532010599|FG002|Overall Study|Withdrawal by Subject|0|||
147507759|NCT02920450|532010600|FG003|Overall Study|Withdrawal by Subject|0|||
147507760|NCT00770224|532010605|FG000|Step 1: Induction|Adverse Event|3|||
147507761|NCT00770224|532010606|FG001|Step 1: Induction|Adverse Event|0|||
147507762|NCT00770224|532010605|FG000|Step 1: Induction|Refusal unrelated to adverse event|6|||
147507763|NCT00770224|532010606|FG001|Step 1: Induction|Refusal unrelated to adverse event|0|||
147507764|NCT00770224|532010605|FG000|Step 1: Induction|Other reason not protocol specified|2|||
147507765|NCT00770224|532010606|FG001|Step 1: Induction|Other reason not protocol specified|0|||
147507766|NCT00770224|532010605|FG000|Step 1: Induction|Ineligible|2|||
147507767|NCT00770224|532010606|FG001|Step 1: Induction|Ineligible|0|||
147507768|NCT00770224|532010605|FG000|Step 1: Induction|No protocol treatment given|1|||
147507769|NCT00770224|532010606|FG001|Step 1: Induction|No protocol treatment given|0|||
147507770|NCT00770224|532010605|FG000|Step 2: Maintenance|Adverse Event|0|||
147507771|NCT00770224|532010606|FG001|Step 2: Maintenance|Adverse Event|10|||
147507772|NCT00770224|532010605|FG000|Step 2: Maintenance|Refusal unrelated to adverse event|0|||
147507773|NCT00770224|532010606|FG001|Step 2: Maintenance|Refusal unrelated to adverse event|8|||
147507774|NCT00770224|532010605|FG000|Step 2: Maintenance|Progression/relapse|0|||
147507775|NCT00770224|532010606|FG001|Step 2: Maintenance|Progression/relapse|1|||
147507776|NCT00770224|532010605|FG000|Step 2: Maintenance|Death|0|||
147507777|NCT00770224|532010606|FG001|Step 2: Maintenance|Death|2|||
147507778|NCT00770224|532010605|FG000|Step 2: Maintenance|Other reason not protocol specified|0|||
147507779|NCT00770224|532010606|FG001|Step 2: Maintenance|Other reason not protocol specified|7|||
147507780|NCT00770224|532010605|FG000|Step 2: Maintenance|Ineligible|0|||
147507781|NCT00770224|532010606|FG001|Step 2: Maintenance|Ineligible|2|||
147507782|NCT01112982|532010607|FG000|Overall Study|Withdrawal by Subject|1|||
147507783|NCT01112982|532010607|FG000|Overall Study|exceeded weight limit to complete MRI|1|||
147507784|NCT01296698|532010612|FG000|Overall Study|Adverse Event|1|||
147507785|NCT01296698|532010613|FG001|Overall Study|Adverse Event|0|||
147507786|NCT01296698|532010612|FG000|Overall Study|Death|1|||
147507787|NCT01296698|532010613|FG001|Overall Study|Death|0|||
147507788|NCT01296698|532010612|FG000|Overall Study|Lost to Follow-up|19|||
147507789|NCT01296698|532010613|FG001|Overall Study|Lost to Follow-up|1|||
147507790|NCT01296698|532010612|FG000|Overall Study|Withdrawal by Subject|12|||
147507791|NCT01296698|532010613|FG001|Overall Study|Withdrawal by Subject|0|||
147507792|NCT01296698|532010612|FG000|Overall Study|Difficulty Contacting Subject|2|||
147507793|NCT01296698|532010613|FG001|Overall Study|Difficulty Contacting Subject|0|||
147507794|NCT01296698|532010612|FG000|Overall Study|Study Terminated by Sponsor|209|||
147507795|NCT01296698|532010613|FG001|Overall Study|Study Terminated by Sponsor|12|||
147507796|NCT03639987|532010616|FG000|Overall Study|Study terminated by sponsor|26|||
147507797|NCT03639987|532010617|FG001|Overall Study|Study terminated by sponsor|25|||
147507798|NCT03639987|532010616|FG000|Overall Study|Lost to Follow-up|0|||
147507799|NCT03639987|532010617|FG001|Overall Study|Lost to Follow-up|1|||
147507800|NCT00996593|532010619|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|7|||
147507801|NCT00996593|532010619|FG000|Dosimetric and Therapeutic Treatment|Withdrawal by Subject|3|||
147507802|NCT00996593|532010619|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|22|||
147507803|NCT00996593|532010619|FG000|Dosimetric and Therapeutic Treatment|Death|1|||
147507804|NCT00996593|532010619|FG000|Dosimetric and Therapeutic Treatment|Enrolled in BEX104526|6|||
147507805|NCT00996593|532010619|FG000|Dosimetric and Therapeutic Treatment|Did Not Receive Any Study Drug|3|||
147507806|NCT00996593|532010619|FG000|Dosimetric and Therapeutic Treatment|Non-compliance|1|||
147507807|NCT00996593|532010619|FG000|Long-Term Follow-Up|Withdrawal by Subject|2|||
147507808|NCT00996593|532010619|FG000|Long-Term Follow-Up|Site Closed|1|||
147507809|NCT01202760|532010620|FG000|Overall Study|Entry Criteria Not Met|0|||
147507810|NCT01202760|532010621|FG001|Overall Study|Entry Criteria Not Met|3|||
147507811|NCT01202760|532010622|FG002|Overall Study|Entry Criteria Not Met|1|||
147507812|NCT01202760|532010620|FG000|Overall Study|Adverse Event|11|||
147507813|NCT01202760|532010621|FG001|Overall Study|Adverse Event|9|||
147507814|NCT01202760|532010622|FG002|Overall Study|Adverse Event|10|||
147507815|NCT01202760|532010620|FG000|Overall Study|Death|2|||
147507816|NCT01202760|532010621|FG001|Overall Study|Death|1|||
147507817|NCT01202760|532010622|FG002|Overall Study|Death|0|||
147669789|NCT01432327|532617378|FG002|Posttest 6 Months|Withdrawal by Subject|1|||
147669790|NCT01432327|532617379|FG003|Posttest 6 Months|Withdrawal by Subject|0|||
147669791|NCT01432327|532617376|FG000|Posttest 1 Year|Measurement have to take place in future|24|||
147669792|NCT01432327|532617377|FG001|Posttest 1 Year|Measurement have to take place in future|28|||
147669793|NCT01432327|532617378|FG002|Posttest 1 Year|Measurement have to take place in future|15|||
147669794|NCT01432327|532617379|FG003|Posttest 1 Year|Measurement have to take place in future|20|||
147669795|NCT01432327|532617376|FG000|Posttest 1 Year|Lost to Follow-up|0|||
147669796|NCT01432327|532617377|FG001|Posttest 1 Year|Lost to Follow-up|0|||
147669797|NCT01432327|532617378|FG002|Posttest 1 Year|Lost to Follow-up|4|||
147669798|NCT01432327|532617379|FG003|Posttest 1 Year|Lost to Follow-up|2|||
147669799|NCT01432327|532617376|FG000|Posttest 1 Year|Allergic reaction|0|||
147669800|NCT01432327|532617377|FG001|Posttest 1 Year|Allergic reaction|0|||
147669801|NCT01432327|532617378|FG002|Posttest 1 Year|Allergic reaction|1|||
147669802|NCT01432327|532617379|FG003|Posttest 1 Year|Allergic reaction|1|||
147669803|NCT00577408|532617380|FG000|Overall Study|Stopped attending study visits|9|||
147669804|NCT00577408|532617381|FG001|Overall Study|Stopped attending study visits|11|||
147669805|NCT00577408|532617380|FG000|Overall Study|Continued opioid use|3|||
147669806|NCT00577408|532617381|FG001|Overall Study|Continued opioid use|2|||
147669807|NCT00577408|532617380|FG000|Overall Study|Non-compliance with study meds|0|||
147669808|NCT00577408|532617381|FG001|Overall Study|Non-compliance with study meds|3|||
147669809|NCT00577408|532617380|FG000|Overall Study|Refused Oral Naltrexone|0|||
147669810|NCT00577408|532617381|FG001|Overall Study|Refused Oral Naltrexone|1|||
147669811|NCT00577408|532617380|FG000|Overall Study|Moved out of state|0|||
147669812|NCT00577408|532617381|FG001|Overall Study|Moved out of state|1|||
147669813|NCT00577408|532617380|FG000|Overall Study|Scheduling Issues|0|||
147669814|NCT00577408|532617381|FG001|Overall Study|Scheduling Issues|3|||
147669815|NCT00577408|532617380|FG000|Overall Study|Death|0|||
147669816|NCT00577408|532617381|FG001|Overall Study|Death|1|||
147669817|NCT00577408|532617380|FG000|Overall Study|Psychiatric hospitalization|0|||
147669818|NCT00577408|532617381|FG001|Overall Study|Psychiatric hospitalization|1|||
147669819|NCT02897349|532617382|FG000|Overall Study|Lost to Follow-up|2|||
147669820|NCT02897349|532617383|FG001|Overall Study|Lost to Follow-up|2|||
147669821|NCT02897349|532617382|FG000|Overall Study|Adverse Event|3|||
147669822|NCT02897349|532617383|FG001|Overall Study|Adverse Event|3|||
147669823|NCT02897349|532617382|FG000|Overall Study|Other than listed above|0|||
147669824|NCT02897349|532617383|FG001|Overall Study|Other than listed above|1|||
147669825|NCT03435055|532617386|FG000|Screening|Physician Decision|2|||
147507818|NCT01202760|532010620|FG000|Overall Study|Lack of Efficacy|6|||
147507819|NCT01202760|532010621|FG001|Overall Study|Lack of Efficacy|8|||
147507820|NCT01202760|532010622|FG002|Overall Study|Lack of Efficacy|7|||
147507821|NCT01202760|532010620|FG000|Overall Study|Lost to Follow-up|0|||
147507822|NCT01202760|532010621|FG001|Overall Study|Lost to Follow-up|2|||
147507823|NCT01202760|532010622|FG002|Overall Study|Lost to Follow-up|1|||
147507824|NCT01202760|532010620|FG000|Overall Study|Parent / Caregiver Decision|0|||
147507825|NCT01202760|532010621|FG001|Overall Study|Parent / Caregiver Decision|1|||
147507826|NCT01202760|532010622|FG002|Overall Study|Parent / Caregiver Decision|0|||
147507827|NCT01202760|532010620|FG000|Overall Study|Withdrawal by Subject|17|||
147507828|NCT01202760|532010621|FG001|Overall Study|Withdrawal by Subject|18|||
147507829|NCT01202760|532010622|FG002|Overall Study|Withdrawal by Subject|14|||
147507830|NCT01202760|532010620|FG000|Overall Study|Physician Decision|0|||
147507831|NCT01202760|532010621|FG001|Overall Study|Physician Decision|1|||
147507832|NCT01202760|532010622|FG002|Overall Study|Physician Decision|0|||
147507833|NCT01202760|532010620|FG000|Overall Study|Protocol Violation|7|||
147507834|NCT01202760|532010621|FG001|Overall Study|Protocol Violation|5|||
147507835|NCT01202760|532010622|FG002|Overall Study|Protocol Violation|2|||
147507836|NCT01202760|532010620|FG000|Overall Study|Sponsor Decision|4|||
147507837|NCT01202760|532010621|FG001|Overall Study|Sponsor Decision|4|||
147507838|NCT01202760|532010622|FG002|Overall Study|Sponsor Decision|0|||
147507839|NCT00871572|532010623|FG000|Overall Study|Adverse Event|0|||
147507840|NCT00871572|532010624|FG001|Overall Study|Adverse Event|2|||
147507841|NCT00871572|532010625|FG002|Overall Study|Adverse Event|0|||
147507842|NCT00871572|532010626|FG003|Overall Study|Adverse Event|3|||
147507843|NCT00871572|532010623|FG000|Overall Study|Investigator Decision|0|||
147507844|NCT00871572|532010624|FG001|Overall Study|Investigator Decision|1|||
147669826|NCT03435055|532617386|FG000|Received Intervention|Did not complete nitrous administration|3|||
147507845|NCT00871572|532010625|FG002|Overall Study|Investigator Decision|0|||
147507846|NCT00871572|532010626|FG003|Overall Study|Investigator Decision|1|||
147507847|NCT00871572|532010623|FG000|Overall Study|Lost to Follow-up|0|||
147507848|NCT00871572|532010624|FG001|Overall Study|Lost to Follow-up|1|||
147507849|NCT00871572|532010625|FG002|Overall Study|Lost to Follow-up|0|||
147669827|NCT03817528|532617393|FG000|Overall Study|Withdrawal by Subject|1|||
147669828|NCT03817528|532617393|FG000|Overall Study|Adverse Event|2|||
147669829|NCT01027949|532617399|FG000|Overall Study|Death|174|||
147669830|NCT01027949|532617399|FG000|Overall Study|Progressive Disease|163|||
147669831|NCT01027949|532617399|FG000|Overall Study|Adverse Event|172|||
147669832|NCT01027949|532617399|FG000|Overall Study|Withdrawal by Subject|113|||
147507850|NCT00871572|532010626|FG003|Overall Study|Lost to Follow-up|1|||
147507851|NCT00871572|532010623|FG000|Overall Study|Protocol Violation|0|||
147507852|NCT00871572|532010624|FG001|Overall Study|Protocol Violation|0|||
147507853|NCT00871572|532010625|FG002|Overall Study|Protocol Violation|1|||
147507854|NCT00871572|532010626|FG003|Overall Study|Protocol Violation|1|||
147507855|NCT00871572|532010623|FG000|Overall Study|Sponsor Decision|1|||
147507856|NCT00871572|532010624|FG001|Overall Study|Sponsor Decision|0|||
147507857|NCT00871572|532010625|FG002|Overall Study|Sponsor Decision|0|||
147507858|NCT00871572|532010626|FG003|Overall Study|Sponsor Decision|0|||
147507859|NCT00871572|532010623|FG000|Overall Study|Withdrawal by Subject|1|||
147507860|NCT00871572|532010624|FG001|Overall Study|Withdrawal by Subject|2|||
147507861|NCT00871572|532010625|FG002|Overall Study|Withdrawal by Subject|3|||
147507862|NCT00871572|532010626|FG003|Overall Study|Withdrawal by Subject|1|||
147507863|NCT01654523|532010627|FG000|Overall Study|Withdrawal by Subject|1|||
147507864|NCT04354155|532010632|FG000|Overall Study|Withdrawal by Subject|1|||
147507865|NCT04354155|532010632|FG000|Overall Study|Did not meet criteria for study intervention|1|||
147507866|NCT01686958|532010633|FG000|Overall Study|Withdrawal by Subject|1|||
147507867|NCT01455415|532010655|FG000|Period 1|Adverse Event (AE) Related to Study Drug|9|||
147507868|NCT01455415|532010656|FG001|Period 1|Adverse Event (AE) Related to Study Drug|6|||
147507869|NCT01455415|532010655|FG000|Period 1|Lost To Follow-up Related to Study Drug|3|||
147507870|NCT01455415|532010656|FG001|Period 1|Lost To Follow-up Related to Study Drug|3|||
147507871|NCT01455415|532010655|FG000|Period 1|Drug Error not Associated to AE|0|||
147507872|NCT01455415|532010656|FG001|Period 1|Drug Error not Associated to AE|1|||
147507873|NCT01455415|532010655|FG000|Period 1|AE Not Related to Study Drug|2|||
147507874|NCT01455415|532010656|FG001|Period 1|AE Not Related to Study Drug|6|||
147507875|NCT01455415|532010655|FG000|Period 1|Withdrawal by Subject|4|||
147507876|NCT01455415|532010656|FG001|Period 1|Withdrawal by Subject|5|||
147507877|NCT01455415|532010655|FG000|Period 1|Unspecified Reason|1|||
147507878|NCT01455415|532010656|FG001|Period 1|Unspecified Reason|1|||
147507879|NCT01455415|532010655|FG000|Period 1|Protocol Violation|0|||
147507880|NCT01455415|532010656|FG001|Period 1|Protocol Violation|2|||
147507881|NCT01455415|532010655|FG000|Washout|AE Related to Study Drug|2|||
147507882|NCT01455415|532010656|FG001|Washout|AE Related to Study Drug|0|||
147507883|NCT01455415|532010655|FG000|Washout|Lost to Follow-up|1|||
147507884|NCT01455415|532010656|FG001|Washout|Lost to Follow-up|0|||
147507885|NCT01455415|532010655|FG000|Washout|Drug Error not Associated to AE|2|||
147507886|NCT01455415|532010656|FG001|Washout|Drug Error not Associated to AE|1|||
147507887|NCT01455415|532010655|FG000|Washout|AE Not Related to Study Drug|2|||
147507888|NCT01455415|532010656|FG001|Washout|AE Not Related to Study Drug|3|||
147507889|NCT01455415|532010655|FG000|Washout|Unspecified Reason|1|||
147507890|NCT01455415|532010656|FG001|Washout|Unspecified Reason|2|||
147507891|NCT01455415|532010655|FG000|Washout|Protocol Violation|0|||
147507892|NCT01455415|532010656|FG001|Washout|Protocol Violation|1|||
147507893|NCT01455415|532010655|FG000|Period 2|AE Related to Study Drug|1|||
147507894|NCT01455415|532010656|FG001|Period 2|AE Related to Study Drug|2|||
147507895|NCT01455415|532010655|FG000|Period 2|Lost to Follow-up|2|||
147507896|NCT01455415|532010656|FG001|Period 2|Lost to Follow-up|1|||
147507897|NCT01455415|532010655|FG000|Period 2|AE Not Related to Study Drug|2|||
147507898|NCT01455415|532010656|FG001|Period 2|AE Not Related to Study Drug|1|||
147507899|NCT01455415|532010655|FG000|Period 2|Lack of Efficacy|2|||
147507900|NCT01455415|532010656|FG001|Period 2|Lack of Efficacy|0|||
147507901|NCT01455415|532010655|FG000|Period 2|Withdrawal by Subject|2|||
147507902|NCT01455415|532010656|FG001|Period 2|Withdrawal by Subject|3|||
147639582|NCT01340027|532497858|FG005|Overall Study|Withdrawal by Subject|2|||
147639583|NCT01340027|532497859|FG006|Overall Study|Withdrawal by Subject|3|||
147639584|NCT01340027|532497860|FG007|Overall Study|Withdrawal by Subject|4|||
147639585|NCT01340027|532497861|FG008|Overall Study|Withdrawal by Subject|1|||
147507903|NCT01455415|532010655|FG000|Period 2|Unspecified Reason|2|||
147507904|NCT01455415|532010656|FG001|Period 2|Unspecified Reason|3|||
147507905|NCT01455415|532010655|FG000|Period 2|Protocol Violation|2|||
147507906|NCT01455415|532010656|FG001|Period 2|Protocol Violation|0|||
147507907|NCT01455415|532010655|FG000|Follow-up|AE Related to Study Drug|0|||
147507908|NCT01455415|532010656|FG001|Follow-up|AE Related to Study Drug|1|||
147507909|NCT01455415|532010655|FG000|Follow-up|Lack of Efficacy|0|||
147507910|NCT01455415|532010656|FG001|Follow-up|Lack of Efficacy|1|||
147507911|NCT01455415|532010655|FG000|Follow-up|Withdrawal by Subject|2|||
147507912|NCT01455415|532010656|FG001|Follow-up|Withdrawal by Subject|0|||
147507913|NCT01455415|532010655|FG000|Follow-up|Unspecified Reason|1|||
147507914|NCT01455415|532010656|FG001|Follow-up|Unspecified Reason|0|||
147507915|NCT00587301|532010657|FG000|Overall Study|Screen Failure|9|||
147507916|NCT00587301|532010657|FG000|Overall Study|Lost to Follow-up|22|||
147507917|NCT00587301|532010657|FG000|Overall Study|Withdrawal by Subject|7|||
147507918|NCT00587301|532010657|FG000|Overall Study|Protocol Violation|7|||
147507919|NCT00351819|532010658|FG000|Overall Study|Lost to Follow-up|4|||
147507920|NCT00351819|532010659|FG001|Overall Study|Lost to Follow-up|4|||
147507921|NCT00351819|532010658|FG000|Overall Study|Withdrawal by Subject|0|||
147507922|NCT00351819|532010659|FG001|Overall Study|Withdrawal by Subject|4|||
147507923|NCT00351819|532010658|FG000|Overall Study|Elevated PSA|1|||
147507924|NCT00351819|532010659|FG001|Overall Study|Elevated PSA|1|||
147507925|NCT00351819|532010658|FG000|Overall Study|Traumatic ankle fracture|1|||
147507926|NCT00351819|532010659|FG001|Overall Study|Traumatic ankle fracture|0|||
147507927|NCT00351819|532010658|FG000|Overall Study|Unprofessional behavior|1|||
147507928|NCT00351819|532010659|FG001|Overall Study|Unprofessional behavior|0|||
147507929|NCT00351819|532010658|FG000|Overall Study|Non-compliance|0|||
147507930|NCT00351819|532010659|FG001|Overall Study|Non-compliance|1|||
147507931|NCT00351819|532010658|FG000|Overall Study|Incarcerated|0|||
147507932|NCT00351819|532010659|FG001|Overall Study|Incarcerated|1|||
147507933|NCT00351819|532010658|FG000|Overall Study|Enrolled in another trial|0|||
147507934|NCT00351819|532010659|FG001|Overall Study|Enrolled in another trial|1|||
147507935|NCT01400139|532010660|FG000|HYD Core Study|Adverse Event|210|||
147507936|NCT01400139|532010660|FG000|HYD Core Study|Lack of Efficacy|59|||
147507937|NCT01400139|532010660|FG000|HYD Core Study|Withdrawal by Subject|114|||
147507938|NCT01400139|532010660|FG000|HYD Core Study|Lost to Follow-up|39|||
147507939|NCT01400139|532010660|FG000|HYD Core Study|Confirmed or suspected diversion|20|||
147507940|NCT01400139|532010660|FG000|HYD Core Study|Administrative|56|||
147507941|NCT01400139|532010660|FG000|HYD Core Study|Did not qualify for Maintenance Period|14|||
147507942|NCT01400139|532010660|FG000|HYD Extension Period|Adverse Event|8|||
147507943|NCT01400139|532010660|FG000|HYD Extension Period|Withdrawal by Subject|5|||
147507944|NCT01400139|532010660|FG000|HYD Extension Period|Administrative|10|||
147507945|NCT00418717|532010661|FG000|Treatment Period A - Weeks 1-4|Protocol Violation|1|||
147507946|NCT00418717|532010661|FG000|Treatment Period B - Weeks 5-12|Adverse Event|2|||
147507947|NCT00249795|532010663|FG000|Overall Study|Not treated|16|||
147507948|NCT00249795|532010664|FG001|Overall Study|Not treated|14|||
147507949|NCT00249795|532010663|FG000|Overall Study|Symptomatic hypotension|127|||
147507950|NCT00249795|532010664|FG001|Overall Study|Symptomatic hypotension|64|||
147507951|NCT00249795|532010663|FG000|Overall Study|Other Serious Adverse Event|84|||
147507952|NCT00249795|532010664|FG001|Overall Study|Other Serious Adverse Event|93|||
147507953|NCT00249795|532010663|FG000|Overall Study|Qualifying condition not present|26|||
147507954|NCT00249795|532010664|FG001|Overall Study|Qualifying condition not present|29|||
147507955|NCT00249795|532010663|FG000|Overall Study|Withdrawal by Subject|678|||
147507956|NCT00249795|532010664|FG001|Overall Study|Withdrawal by Subject|742|||
147507957|NCT00249795|532010663|FG000|Overall Study|Thromboembolic / outcome event|39|||
147507958|NCT00249795|532010664|FG001|Overall Study|Thromboembolic / outcome event|45|||
147507959|NCT00249795|532010663|FG000|Overall Study|Oral anticoagulant required|2|||
147507960|NCT00249795|532010664|FG001|Overall Study|Oral anticoagulant required|0|||
147507961|NCT00249795|532010663|FG000|Overall Study|Minor bleeding (e.g.,bruising,epistaxis)|7|||
147507962|NCT00249795|532010664|FG001|Overall Study|Minor bleeding (e.g.,bruising,epistaxis)|3|||
147507963|NCT00249795|532010663|FG000|Overall Study|Non-compliance|71|||
147507964|NCT00249795|532010664|FG001|Overall Study|Non-compliance|69|||
147507965|NCT00249795|532010663|FG000|Overall Study|Study drug intolerance|3|||
147507966|NCT00249795|532010664|FG001|Overall Study|Study drug intolerance|3|||
147507967|NCT00249795|532010663|FG000|Overall Study|Other adverse events (non-serious)|188|||
147507968|NCT00249795|532010664|FG001|Overall Study|Other adverse events (non-serious)|159|||
147507969|NCT00249795|532010663|FG000|Overall Study|Physician withdrew consent|71|||
147507970|NCT00249795|532010664|FG001|Overall Study|Physician withdrew consent|63|||
147507971|NCT00249795|532010663|FG000|Overall Study|Surgery / procedure|4|||
147507972|NCT00249795|532010664|FG001|Overall Study|Surgery / procedure|5|||
147507973|NCT00249795|532010663|FG000|Overall Study|Angiotensin II receptor blocker required|35|||
147507974|NCT00249795|532010664|FG001|Overall Study|Angiotensin II receptor blocker required|58|||
147507975|NCT00249795|532010663|FG000|Overall Study|Lightheadedness / dizziness|15|||
147507976|NCT00249795|532010664|FG001|Overall Study|Lightheadedness / dizziness|11|||
147507977|NCT00249795|532010663|FG000|Overall Study|Hypotension (non-symptomatic)|5|||
147507978|NCT00249795|532010664|FG001|Overall Study|Hypotension (non-symptomatic)|5|||
147507979|NCT00249795|532010663|FG000|Overall Study|Other contraindicated medication|1|||
147507980|NCT00249795|532010664|FG001|Overall Study|Other contraindicated medication|1|||
147507981|NCT00249795|532010663|FG000|Overall Study|Event related to cardiac condition|17|||
147507982|NCT00249795|532010664|FG001|Overall Study|Event related to cardiac condition|16|||
147507983|NCT00249795|532010663|FG000|Overall Study|Patient not wish to continue after May08|4|||
147507984|NCT00249795|532010664|FG001|Overall Study|Patient not wish to continue after May08|6|||
147507985|NCT00249795|532010663|FG000|Overall Study|Site not agree to continue after May08|1|||
147507986|NCT00249795|532010664|FG001|Overall Study|Site not agree to continue after May08|1|||
147669833|NCT01027949|532617399|FG000|Overall Study|Lost to Follow-up|17|||
147507987|NCT00249795|532010663|FG000|Overall Study|Lost to Follow-up|0|||
147507988|NCT00249795|532010664|FG001|Overall Study|Lost to Follow-up|2|||
147507989|NCT00249795|532010663|FG000|Overall Study|Missing|0|||
147507990|NCT00249795|532010664|FG001|Overall Study|Missing|1|||
147507991|NCT00719537|532010667|FG000|Overall Study|Withdrawal by Subject|1|||
147507992|NCT00719537|532010668|FG001|Overall Study|Withdrawal by Subject|0|||
147507993|NCT00719537|532010667|FG000|Overall Study|Lost to Follow-up|0|||
147507994|NCT00719537|532010668|FG001|Overall Study|Lost to Follow-up|1|||
147507995|NCT01142193|532010671|FG000|Overall Study|Adverse Event|12|||
147669834|NCT01027949|532617399|FG000|Overall Study|Protocol Violation|13|||
147507996|NCT01142193|532010672|FG001|Overall Study|Adverse Event|4|||
147507997|NCT01142193|532010671|FG000|Overall Study|Lack of Efficacy|2|||
147507998|NCT01142193|532010672|FG001|Overall Study|Lack of Efficacy|1|||
147507999|NCT01142193|532010671|FG000|Overall Study|Physician Decision|1|||
147508000|NCT01142193|532010672|FG001|Overall Study|Physician Decision|1|||
147508001|NCT01142193|532010671|FG000|Overall Study|Withdrawal by Subject|4|||
147508002|NCT01142193|532010672|FG001|Overall Study|Withdrawal by Subject|3|||
147508003|NCT01142193|532010671|FG000|Overall Study|Protocol Discontinuation Criterion Met|1|||
147508004|NCT01142193|532010672|FG001|Overall Study|Protocol Discontinuation Criterion Met|0|||
147508005|NCT01142193|532010671|FG000|Overall Study|Other|1|||
147508006|NCT01142193|532010672|FG001|Overall Study|Other|2|||
147508007|NCT01425749|532010673|FG000|Overall Study|progression of melanoma|0|||
147508008|NCT01425749|532010674|FG001|Overall Study|progression of melanoma|1|||
147508009|NCT00631540|532010684|FG000|Overall Study|Withdrawal by Subject|5|||
147508010|NCT00631540|532010684|FG000|Overall Study|Death|4|||
147508011|NCT00631540|532010684|FG000|Overall Study|Lost to Follow-up|2|||
147508012|NCT00631540|532010684|FG000|Overall Study|Core Lab Data Unavailable|3|||
147508013|NCT00807014|532010685|FG000|Overall Study|Participant Considered Disease Cured|13|||
147508014|NCT00807014|532010686|FG001|Overall Study|Participant Considered Disease Cured|2|||
147508015|NCT00807014|532010685|FG000|Overall Study|Participant Considered Disease Not Cured|2|||
147508016|NCT00807014|532010686|FG001|Overall Study|Participant Considered Disease Not Cured|7|||
147508017|NCT00807014|532010685|FG000|Overall Study|Protocol Violation|2|||
147508018|NCT00807014|532010686|FG001|Overall Study|Protocol Violation|8|||
147508019|NCT00807014|532010685|FG000|Overall Study|Adverse Event|0|||
147508020|NCT00807014|532010686|FG001|Overall Study|Adverse Event|2|||
147508021|NCT00807014|532010685|FG000|Overall Study|Lost to Follow-up|9|||
147508022|NCT00807014|532010686|FG001|Overall Study|Lost to Follow-up|7|||
147508023|NCT00807014|532010685|FG000|Overall Study|Recovery|1|||
147508024|NCT00807014|532010686|FG001|Overall Study|Recovery|0|||
147508025|NCT00807014|532010685|FG000|Overall Study|Missed Visit 2 Due to Personal Reasons|0|||
147508026|NCT00807014|532010686|FG001|Overall Study|Missed Visit 2 Due to Personal Reasons|1|||
147508027|NCT02091921|532010690|FG000|Overall Study|Adverse Event|3|||
147508028|NCT03307629|532010691|FG000|Overall Study|Withdrawal by Subject|0|||
147508029|NCT03307629|532010692|FG001|Overall Study|Withdrawal by Subject|0|||
147508030|NCT03307629|532010693|FG002|Overall Study|Withdrawal by Subject|0|||
147508031|NCT03307629|532010694|FG003|Overall Study|Withdrawal by Subject|2|||
147508032|NCT03307629|532010691|FG000|Overall Study|Disease Progression|0|||
147508033|NCT03307629|532010692|FG001|Overall Study|Disease Progression|0|||
147508034|NCT03307629|532010693|FG002|Overall Study|Disease Progression|0|||
147508035|NCT03307629|532010694|FG003|Overall Study|Disease Progression|3|||
147508036|NCT03307629|532010691|FG000|Overall Study|Death|0|||
147508037|NCT03307629|532010692|FG001|Overall Study|Death|3|||
147508038|NCT03307629|532010693|FG002|Overall Study|Death|0|||
147508039|NCT03307629|532010694|FG003|Overall Study|Death|1|||
147508040|NCT02483078|532010699|FG000|Part 1 One-week Randomized|Lost to Follow-up|0|||
147508041|NCT02483078|532010700|FG001|Part 1 One-week Randomized|Lost to Follow-up|1|||
147508042|NCT02483078|532010699|FG000|Part 2 Open Label Treatment Period|Non-medical|0|||
147508043|NCT02483078|532010700|FG001|Part 2 Open Label Treatment Period|Non-medical|1|||
147508044|NCT02483078|532010699|FG000|Part 2 Open Label Treatment Period|Withdrawal by Subject|0|||
147508045|NCT02483078|532010700|FG001|Part 2 Open Label Treatment Period|Withdrawal by Subject|1|||
147508046|NCT02483078|532010699|FG000|Part 2 Open Label Treatment Period|Subject non compliant|0|||
147508047|NCT02483078|532010700|FG001|Part 2 Open Label Treatment Period|Subject non compliant|1|||
147508048|NCT02483078|532010699|FG000|Part 2 Open Label Treatment Period|Lost to Follow-up|0|||
147508049|NCT02483078|532010700|FG001|Part 2 Open Label Treatment Period|Lost to Follow-up|1|||
147508050|NCT02483078|532010699|FG000|Part 2 Open Label Treatment Period|Adverse Event|0|||
147508051|NCT02483078|532010700|FG001|Part 2 Open Label Treatment Period|Adverse Event|1|||
147508052|NCT02853032|532010701|FG000|Overall Study|Adverse Event|4|||
147508053|NCT02853032|532010702|FG001|Overall Study|Adverse Event|0|||
147508054|NCT02853032|532010701|FG000|Overall Study|Withdrawal by Subject|3|||
147508055|NCT02853032|532010702|FG001|Overall Study|Withdrawal by Subject|1|||
147508056|NCT02853032|532010701|FG000|Overall Study|Requested to withdraw from all treatment|2|||
147508057|NCT02853032|532010702|FG001|Overall Study|Requested to withdraw from all treatment|2|||
147508058|NCT04876599|532010703|FG000|Overall Study|Missed|2|||
147508059|NCT04876599|532010704|FG001|Overall Study|Missed|0|||
147508060|NCT04876599|532010703|FG000|Overall Study|Declined|2|||
147508061|NCT04876599|532010704|FG001|Overall Study|Declined|3|||
147508062|NCT03700736|532010707|FG000|Overall Study|Pregnancy|1|||
147508063|NCT03700736|532010708|FG001|Overall Study|Pregnancy|1|||
147508064|NCT03700736|532010707|FG000|Overall Study|Withdrawal by Subject|2|||
147508065|NCT03700736|532010708|FG001|Overall Study|Withdrawal by Subject|6|||
147508066|NCT03682055|532012523|FG000|Overall Study|Lack of Efficacy|1|||
147508067|NCT03682055|532012524|FG001|Overall Study|Lack of Efficacy|2|||
147508068|NCT03682055|532012525|FG002|Overall Study|Lack of Efficacy|1|||
147508069|NCT03682055|532012526|FG003|Overall Study|Lack of Efficacy|2|||
147508070|NCT03682055|532012527|FG004|Overall Study|Lack of Efficacy|1|||
147508071|NCT03682055|532012528|FG005|Overall Study|Lack of Efficacy|3|||
147508072|NCT03682055|532012523|FG000|Overall Study|Withdrawal by Subject|0|||
147508073|NCT03682055|532012524|FG001|Overall Study|Withdrawal by Subject|0|||
147508074|NCT03682055|532012525|FG002|Overall Study|Withdrawal by Subject|0|||
147508075|NCT03682055|532012526|FG003|Overall Study|Withdrawal by Subject|0|||
147508076|NCT03682055|532012527|FG004|Overall Study|Withdrawal by Subject|0|||
147508077|NCT03682055|532012528|FG005|Overall Study|Withdrawal by Subject|1|||
147508078|NCT03682055|532012523|FG000|Overall Study|Termination of Study by Sponsor|0|||
147508079|NCT03682055|532012524|FG001|Overall Study|Termination of Study by Sponsor|0|||
147508080|NCT03682055|532012525|FG002|Overall Study|Termination of Study by Sponsor|0|||
147508081|NCT03682055|532012526|FG003|Overall Study|Termination of Study by Sponsor|0|||
147508082|NCT03682055|532012527|FG004|Overall Study|Termination of Study by Sponsor|0|||
147508083|NCT03682055|532012528|FG005|Overall Study|Termination of Study by Sponsor|3|||
147508084|NCT01826448|532012529|FG000|Overall Study|Adverse Event|1|||
147508085|NCT01826448|532012530|FG001|Overall Study|Adverse Event|3|||
147508086|NCT01826448|532012529|FG000|Overall Study|Disease progression|2|||
147508087|NCT01826448|532012530|FG001|Overall Study|Disease progression|4|||
147508088|NCT01826448|532012529|FG000|Overall Study|Withdrawal by Subject|1|||
147508089|NCT01826448|532012530|FG001|Overall Study|Withdrawal by Subject|0|||
147508090|NCT01826448|532012529|FG000|Overall Study|Physician Decision|0|||
147508091|NCT01826448|532012530|FG001|Overall Study|Physician Decision|1|||
147508092|NCT01826448|532012529|FG000|Overall Study|2 active cancers|0|||
147508093|NCT01826448|532012530|FG001|Overall Study|2 active cancers|1|||
147508094|NCT00880100|532012531|FG000|Baseline Phase-Usual Pancreatic Enzymes|Protocol Violation|1|||
147508095|NCT00880100|532012531|FG000|Treatment Phase With Ultrase® MT12|Adverse Event|1|||
147508096|NCT00880100|532012531|FG000|Treatment Phase With Ultrase® MT12|Protocol Violation|2|||
147508097|NCT00402285|532012533|FG000|Overall Study|insufficient RNA quality|7|||
147508098|NCT00402285|532012534|FG001|Overall Study|insufficient RNA quality|6|||
147508099|NCT00402285|532012535|FG002|Overall Study|insufficient RNA quality|2|||
147508100|NCT02431702|532012536|FG000|Part 1: 2-Month Oral Run-in Phase|Adverse Event|7|||
147508101|NCT02431702|532012537|FG001|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
147508102|NCT02431702|532012538|FG002|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
147508103|NCT02431702|532012539|FG003|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
147508104|NCT02431702|532012540|FG004|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
147508105|NCT02431702|532012541|FG005|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
147508106|NCT02431702|532012542|FG006|Part 1: 2-Month Oral Run-in Phase|Adverse Event|0|||
147508107|NCT02431702|532012536|FG000|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|11|||
147508108|NCT02431702|532012537|FG001|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0|||
147508109|NCT02431702|532012538|FG002|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0|||
147508110|NCT02431702|532012539|FG003|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0|||
147508111|NCT02431702|532012540|FG004|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0|||
147508112|NCT02431702|532012541|FG005|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|0|||
147508113|NCT02431702|532012542|FG006|Part 1: 2-Month Oral Run-in Phase|Lost to Follow-up|23|||
147508114|NCT02431702|532012536|FG000|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|9|||
147508115|NCT02431702|532012537|FG001|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0|||
147508116|NCT02431702|532012538|FG002|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0|||
147508117|NCT02431702|532012539|FG003|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0|||
147508118|NCT02431702|532012540|FG004|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0|||
147508119|NCT02431702|532012541|FG005|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|0|||
147508120|NCT02431702|532012542|FG006|Part 1: 2-Month Oral Run-in Phase|Withdrawal of Consent|6|||
147508121|NCT02431702|532012536|FG000|Part 1: 2-Month Oral Run-in Phase|Other|5|||
147508122|NCT02431702|532012537|FG001|Part 1: 2-Month Oral Run-in Phase|Other|0|||
147508123|NCT02431702|532012538|FG002|Part 1: 2-Month Oral Run-in Phase|Other|0|||
147508124|NCT02431702|532012539|FG003|Part 1: 2-Month Oral Run-in Phase|Other|0|||
147508125|NCT02431702|532012540|FG004|Part 1: 2-Month Oral Run-in Phase|Other|0|||
147508126|NCT02431702|532012541|FG005|Part 1: 2-Month Oral Run-in Phase|Other|0|||
147508127|NCT02431702|532012542|FG006|Part 1: 2-Month Oral Run-in Phase|Other|3|||
147508128|NCT02431702|532012536|FG000|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|2|||
147508129|NCT02431702|532012537|FG001|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
147508130|NCT02431702|532012538|FG002|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
147508131|NCT02431702|532012539|FG003|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
147508132|NCT02431702|532012540|FG004|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
147508133|NCT02431702|532012541|FG005|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
147508134|NCT02431702|532012542|FG006|Part 1: 2-Month Oral Run-in Phase|Does not Tolerate Paliperidone ER|0|||
147508135|NCT02431702|532012536|FG000|Part 2: 9Month Disease Progression Phase|Adverse Event|0|||
147508136|NCT02431702|532012537|FG001|Part 2: 9Month Disease Progression Phase|Adverse Event|5|||
147508137|NCT02431702|532012538|FG002|Part 2: 9Month Disease Progression Phase|Adverse Event|1|||
147508138|NCT02431702|532012539|FG003|Part 2: 9Month Disease Progression Phase|Adverse Event|0|||
147508139|NCT02431702|532012540|FG004|Part 2: 9Month Disease Progression Phase|Adverse Event|0|||
147669835|NCT01027949|532617399|FG000|Overall Study|PI Decision|8|||
147508140|NCT02431702|532012541|FG005|Part 2: 9Month Disease Progression Phase|Adverse Event|0|||
147508141|NCT02431702|532012542|FG006|Part 2: 9Month Disease Progression Phase|Adverse Event|0|||
147508142|NCT02431702|532012536|FG000|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0|||
147508143|NCT02431702|532012537|FG001|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|6|||
147508144|NCT02431702|532012538|FG002|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|13|||
147508145|NCT02431702|532012539|FG003|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0|||
147508146|NCT02431702|532012540|FG004|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0|||
147508147|NCT02431702|532012541|FG005|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0|||
147508148|NCT02431702|532012542|FG006|Part 2: 9Month Disease Progression Phase|Lost to Follow-up|0|||
147508149|NCT02431702|532012536|FG000|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0|||
147508150|NCT02431702|532012537|FG001|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|11|||
147508151|NCT02431702|532012538|FG002|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|8|||
147508152|NCT02431702|532012539|FG003|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0|||
147508153|NCT02431702|532012540|FG004|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0|||
147508154|NCT02431702|532012541|FG005|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0|||
147508155|NCT02431702|532012542|FG006|Part 2: 9Month Disease Progression Phase|Withdrawal by Subject|0|||
147508156|NCT02431702|532012536|FG000|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
147508157|NCT02431702|532012537|FG001|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|2|||
147508158|NCT02431702|532012538|FG002|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
147508159|NCT02431702|532012539|FG003|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
147508160|NCT02431702|532012540|FG004|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
147508161|NCT02431702|532012541|FG005|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
147508162|NCT02431702|532012542|FG006|Part 2: 9Month Disease Progression Phase|Assigned PP, but required OAP|0|||
147508163|NCT02431702|532012536|FG000|Part 2: 9Month Disease Progression Phase|Other|0|||
147508164|NCT02431702|532012537|FG001|Part 2: 9Month Disease Progression Phase|Other|2|||
147508165|NCT02431702|532012538|FG002|Part 2: 9Month Disease Progression Phase|Other|2|||
147508166|NCT02431702|532012539|FG003|Part 2: 9Month Disease Progression Phase|Other|0|||
147508167|NCT02431702|532012540|FG004|Part 2: 9Month Disease Progression Phase|Other|0|||
147508168|NCT02431702|532012541|FG005|Part 2: 9Month Disease Progression Phase|Other|0|||
147508169|NCT02431702|532012542|FG006|Part 2: 9Month Disease Progression Phase|Other|0|||
147508170|NCT02431702|532012536|FG000|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
147508171|NCT02431702|532012537|FG001|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
147508172|NCT02431702|532012538|FG002|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|5|||
147508173|NCT02431702|532012539|FG003|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
147508174|NCT02431702|532012540|FG004|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
147508175|NCT02431702|532012541|FG005|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
147508176|NCT02431702|532012542|FG006|Part 2: 9Month Disease Progression Phase|Assigned OAP, but required PP|0|||
147508177|NCT02431702|532012536|FG000|Part 3: 9 Month of Additional Treatment|Adverse Event|0|||
147508178|NCT02431702|532012537|FG001|Part 3: 9 Month of Additional Treatment|Adverse Event|0|||
147508179|NCT02431702|532012538|FG002|Part 3: 9 Month of Additional Treatment|Adverse Event|0|||
147508180|NCT02431702|532012539|FG003|Part 3: 9 Month of Additional Treatment|Adverse Event|2|||
147508181|NCT02431702|532012540|FG004|Part 3: 9 Month of Additional Treatment|Adverse Event|3|||
147508182|NCT02431702|532012541|FG005|Part 3: 9 Month of Additional Treatment|Adverse Event|0|||
147508183|NCT02431702|532012542|FG006|Part 3: 9 Month of Additional Treatment|Adverse Event|0|||
147508184|NCT02431702|532012536|FG000|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0|||
147508185|NCT02431702|532012537|FG001|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0|||
147508186|NCT02431702|532012538|FG002|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0|||
147508187|NCT02431702|532012539|FG003|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|1|||
147508188|NCT02431702|532012540|FG004|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0|||
147508189|NCT02431702|532012541|FG005|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|5|||
147508190|NCT02431702|532012542|FG006|Part 3: 9 Month of Additional Treatment|Lost to Follow-up|0|||
147508191|NCT02431702|532012536|FG000|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|0|||
147508192|NCT02431702|532012537|FG001|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|0|||
147508193|NCT02431702|532012538|FG002|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|0|||
147508194|NCT02431702|532012539|FG003|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|5|||
147508195|NCT02431702|532012540|FG004|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|6|||
147508196|NCT02431702|532012541|FG005|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|6|||
147508197|NCT02431702|532012542|FG006|Part 3: 9 Month of Additional Treatment|Withdrawal by Subject|0|||
147508198|NCT02431702|532012536|FG000|Part 3: 9 Month of Additional Treatment|Other|0|||
147508199|NCT02431702|532012537|FG001|Part 3: 9 Month of Additional Treatment|Other|0|||
147669836|NCT01027949|532617399|FG000|Overall Study|Limited Study Drug Effectiveness|7|||
147669837|NCT01027949|532617399|FG000|Overall Study|Non-compliance with Study Procedures|7|||
147669838|NCT01027949|532617399|FG000|Overall Study|Lung Transplant|5|||
147669839|NCT01027949|532617399|FG000|Overall Study|Unable to Tolerate Study Drug|2|||
147669840|NCT01027949|532617399|FG000|Overall Study|Use of Excluded Medication|2|||
147669841|NCT01027949|532617399|FG000|Overall Study|Patient Self-discontinuation|1|||
147669842|NCT01027949|532617399|FG000|Overall Study|Pregnancy|1|||
147508200|NCT02431702|532012538|FG002|Part 3: 9 Month of Additional Treatment|Other|0|||
147508201|NCT02431702|532012539|FG003|Part 3: 9 Month of Additional Treatment|Other|1|||
147508202|NCT02431702|532012540|FG004|Part 3: 9 Month of Additional Treatment|Other|1|||
147508203|NCT02431702|532012541|FG005|Part 3: 9 Month of Additional Treatment|Other|6|||
147508204|NCT02431702|532012542|FG006|Part 3: 9 Month of Additional Treatment|Other|0|||
147508205|NCT03551626|532012543|FG000|Overall Study|Adverse Event|88|||
147508206|NCT03551626|532012543|FG000|Overall Study|Disease relapse|18|||
147508207|NCT03551626|532012543|FG000|Overall Study|Withdrawal of informed consent|6|||
147508208|NCT03551626|532012543|FG000|Overall Study|Patient decision|5|||
147508209|NCT03551626|532012543|FG000|Overall Study|Physician Decision|4|||
147508210|NCT03551626|532012543|FG000|Overall Study|Lost to Follow-up|3|||
147508211|NCT03551626|532012543|FG000|Overall Study|Pregnancy|1|||
147508212|NCT03551626|532012543|FG000|Overall Study|Protocol deviation|1|||
147508213|NCT03551626|532012543|FG000|Overall Study|Technical problems|1|||
147508214|NCT01017549|532012546|FG000|Eligibility Through 6 Month Follow-up|Lost to Follow-up|1|||
147508215|NCT01017549|532012546|FG000|One-year Follow-up|Lost to Follow-up|2|||
147508216|NCT01017549|532012546|FG000|One-year Follow-up|Withdrawal by Subject|5|||
147508217|NCT01017549|532012546|FG000|5 Year Follow-up|Lost to Follow-up|9|||
147508218|NCT01017549|532012546|FG000|5 Year Follow-up|Mastectomy|3|||
147508219|NCT00443846|532012547|FG000|Overall Study|Withdrawn due to intercurrent disease|1|||
147508220|NCT00443846|532012548|FG001|Overall Study|Withdrawn due to intercurrent disease|0|||
147508221|NCT00443846|532012547|FG000|Overall Study|Not vaccinated, no blood sample drawn|1|||
147508222|NCT00443846|532012548|FG001|Overall Study|Not vaccinated, no blood sample drawn|0|||
147508223|NCT00443846|532012547|FG000|Overall Study|Adverse Event|0|||
147508224|NCT00443846|532012548|FG001|Overall Study|Adverse Event|1|||
147508225|NCT00443846|532012547|FG000|Overall Study|Personal reason|8|||
147508226|NCT00443846|532012548|FG001|Overall Study|Personal reason|3|||
147508227|NCT00443846|532012547|FG000|Overall Study|Lost to Follow-up|1|||
147508228|NCT00443846|532012548|FG001|Overall Study|Lost to Follow-up|2|||
147508229|NCT02980692|532012553|FG000|Double Blind Placebo Controlled Period|Adverse Event|1|||
147508230|NCT02980692|532012554|FG001|Double Blind Placebo Controlled Period|Adverse Event|2|||
147508231|NCT02980692|532012555|FG002|Double Blind Placebo Controlled Period|Adverse Event|1|||
147508232|NCT02980692|532012556|FG003|Double Blind Placebo Controlled Period|Adverse Event|2|||
147508233|NCT02980692|532012557|FG004|Double Blind Placebo Controlled Period|Adverse Event|0|||
147508234|NCT02980692|532012553|FG000|Double Blind Placebo Controlled Period|Lost to Follow-up|1|||
147508235|NCT02980692|532012554|FG001|Double Blind Placebo Controlled Period|Lost to Follow-up|0|||
147508236|NCT02980692|532012555|FG002|Double Blind Placebo Controlled Period|Lost to Follow-up|1|||
147508237|NCT02980692|532012556|FG003|Double Blind Placebo Controlled Period|Lost to Follow-up|1|||
147508238|NCT02980692|532012557|FG004|Double Blind Placebo Controlled Period|Lost to Follow-up|0|||
147508239|NCT02980692|532012553|FG000|Double Blind Placebo Controlled Period|Investigator Decision|0|||
147508240|NCT02980692|532012554|FG001|Double Blind Placebo Controlled Period|Investigator Decision|0|||
147508241|NCT02980692|532012555|FG002|Double Blind Placebo Controlled Period|Investigator Decision|0|||
147508242|NCT02980692|532012556|FG003|Double Blind Placebo Controlled Period|Investigator Decision|2|||
147508243|NCT02980692|532012557|FG004|Double Blind Placebo Controlled Period|Investigator Decision|0|||
147508244|NCT02980692|532012553|FG000|Double Blind Placebo Controlled Period|Withdrawal by Subject|2|||
147508245|NCT02980692|532012554|FG001|Double Blind Placebo Controlled Period|Withdrawal by Subject|1|||
147508246|NCT02980692|532012555|FG002|Double Blind Placebo Controlled Period|Withdrawal by Subject|1|||
147508247|NCT02980692|532012556|FG003|Double Blind Placebo Controlled Period|Withdrawal by Subject|2|||
147508248|NCT02980692|532012557|FG004|Double Blind Placebo Controlled Period|Withdrawal by Subject|4|||
147508249|NCT02980692|532012553|FG000|Double Blind Placebo Controlled Period|Protocol Violation|2|||
147508250|NCT02980692|532012554|FG001|Double Blind Placebo Controlled Period|Protocol Violation|0|||
147508251|NCT02980692|532012555|FG002|Double Blind Placebo Controlled Period|Protocol Violation|1|||
147508252|NCT02980692|532012556|FG003|Double Blind Placebo Controlled Period|Protocol Violation|0|||
147508253|NCT02980692|532012557|FG004|Double Blind Placebo Controlled Period|Protocol Violation|0|||
147508254|NCT02980692|532012553|FG000|Double Blind Placebo Controlled Period|Other|1|||
147508255|NCT02980692|532012554|FG001|Double Blind Placebo Controlled Period|Other|0|||
147508256|NCT02980692|532012555|FG002|Double Blind Placebo Controlled Period|Other|0|||
147508257|NCT02980692|532012556|FG003|Double Blind Placebo Controlled Period|Other|0|||
147508258|NCT02980692|532012557|FG004|Double Blind Placebo Controlled Period|Other|1|||
147639586|NCT01340027|532497862|FG009|Overall Study|Withdrawal by Subject|2|||
147639587|NCT01340027|532497863|FG010|Overall Study|Withdrawal by Subject|0|||
147639588|NCT01340027|532497864|FG011|Overall Study|Withdrawal by Subject|1|||
147639589|NCT01340027|532497853|FG000|Overall Study|Miscellaneous|0|||
147639590|NCT01340027|532497854|FG001|Overall Study|Miscellaneous|0|||
147508259|NCT02980692|532012553|FG000|Double Blind Placebo Controlled Period|Failure to show sufficient response to treatment at Week 24|9|||
147508260|NCT02980692|532012554|FG001|Double Blind Placebo Controlled Period|Failure to show sufficient response to treatment at Week 24|12|||
147508261|NCT02980692|532012555|FG002|Double Blind Placebo Controlled Period|Failure to show sufficient response to treatment at Week 24|13|||
147639591|NCT01340027|532497855|FG002|Overall Study|Miscellaneous|0|||
147639592|NCT01340027|532497856|FG003|Overall Study|Miscellaneous|1|||
147508262|NCT02980692|532012556|FG003|Double Blind Placebo Controlled Period|Failure to show sufficient response to treatment at Week 24|0|||
147508263|NCT02980692|532012557|FG004|Double Blind Placebo Controlled Period|Failure to show sufficient response to treatment at Week 24|0|||
147508264|NCT02980692|532012553|FG000|Double-blind Follow-up Period|Adverse Event|0|||
147508265|NCT02980692|532012554|FG001|Double-blind Follow-up Period|Adverse Event|0|||
147508266|NCT02980692|532012555|FG002|Double-blind Follow-up Period|Adverse Event|0|||
147508267|NCT02980692|532012556|FG003|Double-blind Follow-up Period|Adverse Event|1|||
147508268|NCT02980692|532012557|FG004|Double-blind Follow-up Period|Adverse Event|1|||
147508269|NCT02980692|532012553|FG000|Double-blind Follow-up Period|Failure to show sufficient response to treatment at Week 24|0|||
147508270|NCT02980692|532012554|FG001|Double-blind Follow-up Period|Failure to show sufficient response to treatment at Week 24|2|||
147508271|NCT02980692|532012555|FG002|Double-blind Follow-up Period|Failure to show sufficient response to treatment at Week 24|1|||
147508272|NCT02980692|532012556|FG003|Double-blind Follow-up Period|Failure to show sufficient response to treatment at Week 24|0|||
147508273|NCT02980692|532012557|FG004|Double-blind Follow-up Period|Failure to show sufficient response to treatment at Week 24|0|||
147508274|NCT02980692|532012553|FG000|Double-blind Follow-up Period|Lost to Follow-up|0|||
147508275|NCT02980692|532012554|FG001|Double-blind Follow-up Period|Lost to Follow-up|0|||
147508276|NCT02980692|532012555|FG002|Double-blind Follow-up Period|Lost to Follow-up|1|||
147508277|NCT02980692|532012556|FG003|Double-blind Follow-up Period|Lost to Follow-up|0|||
147508278|NCT02980692|532012557|FG004|Double-blind Follow-up Period|Lost to Follow-up|0|||
147508279|NCT02980692|532012553|FG000|Double-blind Follow-up Period|Pregnancy|0|||
147508280|NCT02980692|532012554|FG001|Double-blind Follow-up Period|Pregnancy|0|||
147508281|NCT02980692|532012555|FG002|Double-blind Follow-up Period|Pregnancy|1|||
147508282|NCT02980692|532012556|FG003|Double-blind Follow-up Period|Pregnancy|1|||
147508283|NCT02980692|532012557|FG004|Double-blind Follow-up Period|Pregnancy|0|||
147508284|NCT02980692|532012553|FG000|Double-blind Follow-up Period|Withdrawal by Subject|0|||
147508285|NCT02980692|532012554|FG001|Double-blind Follow-up Period|Withdrawal by Subject|1|||
147508286|NCT02980692|532012555|FG002|Double-blind Follow-up Period|Withdrawal by Subject|0|||
147508287|NCT02980692|532012556|FG003|Double-blind Follow-up Period|Withdrawal by Subject|1|||
147508288|NCT02980692|532012557|FG004|Double-blind Follow-up Period|Withdrawal by Subject|1|||
147508289|NCT02980692|532012553|FG000|Double-blind Follow-up Period|Other|0|||
147508290|NCT02980692|532012554|FG001|Double-blind Follow-up Period|Other|0|||
147508291|NCT02980692|532012555|FG002|Double-blind Follow-up Period|Other|1|||
147508292|NCT02980692|532012556|FG003|Double-blind Follow-up Period|Other|1|||
147508293|NCT02980692|532012557|FG004|Double-blind Follow-up Period|Other|3|||
147508294|NCT03862495|532012560|FG000|Overall Study|Lost to Follow-up|37|||
147508295|NCT03862495|532012561|FG001|Overall Study|Lost to Follow-up|35|||
147508296|NCT04397796|532012562|FG000|Overall Study|Death|3|||
147508297|NCT04397796|532012563|FG001|Overall Study|Death|1|||
147508298|NCT01057862|532012564|FG000|Overall Study|Withdrawal by Subject|1|||
147508299|NCT01057862|532012565|FG001|Overall Study|Withdrawal by Subject|2|||
147508300|NCT03363165|532012568|FG000|3-month Follow-up|Death|0|||
147508301|NCT03363165|532012569|FG001|3-month Follow-up|Death|1|||
147508302|NCT03363165|532012568|FG000|6-month Follow-up|Death|0|||
147508303|NCT03363165|532012569|FG001|6-month Follow-up|Death|1|||
147508304|NCT03363165|532012568|FG000|6-month Follow-up|Withdrawal by Subject|1|||
147508305|NCT03363165|532012569|FG001|6-month Follow-up|Withdrawal by Subject|1|||
147508306|NCT03363165|532012568|FG000|12-month Follow-up|Death|1|||
147508307|NCT03363165|532012569|FG001|12-month Follow-up|Death|1|||
147508308|NCT03363165|532012568|FG000|12-month Follow-up|Withdrawal by Subject|1|||
147508309|NCT03363165|532012569|FG001|12-month Follow-up|Withdrawal by Subject|1|||
147508310|NCT02255760|532012570|FG000|Overall Study|Lost to Follow-up|0|||
147508311|NCT02255760|532012571|FG001|Overall Study|Lost to Follow-up|1|||
147508312|NCT02255760|532012572|FG002|Overall Study|Lost to Follow-up|0|||
147508313|NCT02255760|532012573|FG003|Overall Study|Lost to Follow-up|0|||
147508314|NCT02255760|532012574|FG004|Overall Study|Lost to Follow-up|0|||
147508315|NCT00618813|532012575|FG000|Overall Study|Lack of Efficacy|1|||
147508316|NCT00618813|532012575|FG000|Overall Study|Physician Decision|2|||
147508317|NCT00618813|532012575|FG000|Overall Study|Withdrawal by Subject|1|||
147508318|NCT00003838|532012576|FG000|Overall Study|Death|0|||
147508319|NCT00003838|532012577|FG001|Overall Study|Death|12|||
147508320|NCT00003838|532012578|FG002|Overall Study|Death|7|||
147508321|NCT00003838|532012576|FG000|Overall Study|Lost to Follow-up|0|||
147508322|NCT00003838|532012577|FG001|Overall Study|Lost to Follow-up|1|||
147508323|NCT00003838|532012578|FG002|Overall Study|Lost to Follow-up|1|||
147508324|NCT00003838|532012576|FG000|Overall Study|Disease Progression|0|||
147508325|NCT00003838|532012577|FG001|Overall Study|Disease Progression|12|||
147508326|NCT00003838|532012578|FG002|Overall Study|Disease Progression|0|||
147508327|NCT00425113|532012579|FG000|Overall Study|uncontrolled diabetes mellitus|1|||
147508328|NCT00425113|532012580|FG001|Overall Study|uncontrolled diabetes mellitus|0|||
147508329|NCT00425113|532012579|FG000|Overall Study|diagnosis of abdominal TB|0|||
147508330|NCT00425113|532012580|FG001|Overall Study|diagnosis of abdominal TB|1|||
147508331|NCT00425113|532012579|FG000|Overall Study|missing study drug more than 14 days|0|||
147508332|NCT00425113|532012580|FG001|Overall Study|missing study drug more than 14 days|1|||
147639593|NCT01340027|532497857|FG004|Overall Study|Miscellaneous|0|||
147639594|NCT01340027|532497858|FG005|Overall Study|Miscellaneous|0|||
147508333|NCT00425113|532012579|FG000|Overall Study|Withdrawal by Subject|1|||
147508334|NCT00425113|532012580|FG001|Overall Study|Withdrawal by Subject|0|||
147508335|NCT04737759|532012581|FG000|Overall Study|Patient and spouse withdrew as adult with heart failure too sick/health decline|12|||
147508336|NCT04737759|532012582|FG001|Overall Study|Patient and spouse withdrew as adult with heart failure too sick/health decline|4|||
147508337|NCT04737759|532012581|FG000|Overall Study|Death|2|||
147508338|NCT04737759|532012582|FG001|Overall Study|Death|0|||
147508339|NCT04737759|532012581|FG000|Overall Study|spouse dropped when adult with heart failure died|2|||
147508340|NCT04737759|532012582|FG001|Overall Study|spouse dropped when adult with heart failure died|0|||
147508341|NCT04737759|532012581|FG000|Overall Study|Lost to Follow-up|4|||
147508342|NCT04737759|532012582|FG001|Overall Study|Lost to Follow-up|12|||
147508343|NCT01484561|532012583|FG000|Overall Study|Lack of Efficacy|3|||
147508344|NCT01484561|532012584|FG001|Overall Study|Lack of Efficacy|1|||
147508345|NCT01484561|532012583|FG000|Overall Study|Lost to Follow-up|1|||
147508346|NCT01484561|532012584|FG001|Overall Study|Lost to Follow-up|0|||
147508347|NCT01484561|532012583|FG000|Overall Study|Withdrawal by Subject|3|||
147508348|NCT01484561|532012584|FG001|Overall Study|Withdrawal by Subject|0|||
147508349|NCT01484561|532012583|FG000|Overall Study|Other|1|||
147508350|NCT01484561|532012584|FG001|Overall Study|Other|1|||
147508351|NCT01484561|532012583|FG000|Overall Study|Adverse Event|1|||
147508352|NCT01484561|532012584|FG001|Overall Study|Adverse Event|4|||
147508353|NCT03371251|532012585|FG000|Overall Study|Withdrawal by Subject|1|||
147508354|NCT03371251|532012586|FG001|Overall Study|Withdrawal by Subject|0|||
147508355|NCT03371251|532012587|FG002|Overall Study|Withdrawal by Subject|1|||
147508356|NCT03371251|532012588|FG003|Overall Study|Withdrawal by Subject|0|||
147508357|NCT03371251|532012589|FG004|Overall Study|Withdrawal by Subject|2|||
147508358|NCT03371251|532012590|FG005|Overall Study|Withdrawal by Subject|2|||
147508359|NCT03371251|532012585|FG000|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|1|||
147508360|NCT03371251|532012586|FG001|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|0|||
147508361|NCT03371251|532012587|FG002|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|0|||
147508362|NCT03371251|532012588|FG003|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|0|||
147508363|NCT03371251|532012589|FG004|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|2|||
147508364|NCT03371251|532012590|FG005|Overall Study|Phase 1b: Pregnancy, Phase 2: fear of COVID-19 or local restrictions|3|||
147508365|NCT03371251|532012585|FG000|Overall Study|Adverse Event|0|||
147508366|NCT03371251|532012586|FG001|Overall Study|Adverse Event|0|||
147508367|NCT03371251|532012587|FG002|Overall Study|Adverse Event|0|||
147508368|NCT03371251|532012588|FG003|Overall Study|Adverse Event|0|||
147508369|NCT03371251|532012589|FG004|Overall Study|Adverse Event|1|||
147508370|NCT03371251|532012590|FG005|Overall Study|Adverse Event|0|||
147508371|NCT03371251|532012585|FG000|Overall Study|Decision by Sponsor|0|||
147508372|NCT03371251|532012586|FG001|Overall Study|Decision by Sponsor|0|||
147508373|NCT03371251|532012587|FG002|Overall Study|Decision by Sponsor|0|||
147508374|NCT03371251|532012588|FG003|Overall Study|Decision by Sponsor|0|||
147508375|NCT03371251|532012589|FG004|Overall Study|Decision by Sponsor|2|||
147508376|NCT03371251|532012590|FG005|Overall Study|Decision by Sponsor|0|||
147508377|NCT00291187|532012591|FG000|Overall Study|Protocol Violation- No Drug Administered|0|||
147508378|NCT00291187|532012592|FG001|Overall Study|Protocol Violation- No Drug Administered|0|||
147508379|NCT00291187|532012593|FG002|Overall Study|Protocol Violation- No Drug Administered|1|||
147508380|NCT00291187|532012594|FG003|Overall Study|Protocol Violation- No Drug Administered|0|||
147508381|NCT04362813|532012595|FG000|Overall Study|Death|12|||
147508382|NCT04362813|532012596|FG001|Overall Study|Death|16|||
147508383|NCT04362813|532012595|FG000|Overall Study|Withdrawal by Subject|3|||
147508384|NCT04362813|532012596|FG001|Overall Study|Withdrawal by Subject|1|||
147508385|NCT04362813|532012595|FG000|Overall Study|Protocol Violation|0|||
147639595|NCT01340027|532497859|FG006|Overall Study|Miscellaneous|0|||
147639596|NCT01340027|532497860|FG007|Overall Study|Miscellaneous|0|||
147639597|NCT01340027|532497861|FG008|Overall Study|Miscellaneous|0|||
147639598|NCT01340027|532497862|FG009|Overall Study|Miscellaneous|0|||
147639599|NCT01340027|532497863|FG010|Overall Study|Miscellaneous|1|||
147639600|NCT01340027|532497864|FG011|Overall Study|Miscellaneous|0|||
147508386|NCT04362813|532012596|FG001|Overall Study|Protocol Violation|3|||
147508387|NCT04362813|532012595|FG000|Overall Study|Lost to Follow-up|1|||
147508388|NCT04362813|532012596|FG001|Overall Study|Lost to Follow-up|1|||
147508389|NCT04362813|532012595|FG000|Overall Study|Enrolled but did not receive treatment|2|||
147508390|NCT04362813|532012596|FG001|Overall Study|Enrolled but did not receive treatment|4|||
147508391|NCT00961116|532012597|FG000|Washout Period of 7 Days|Adverse Event|1|||
147508392|NCT00961116|532012598|FG001|Washout Period of 7 Days|Adverse Event|1|||
147639601|NCT00833482|532497865|FG000|Days 11-20|Adverse Event|0|||
147508393|NCT00961116|532012597|FG000|Washout Period of 7 Days|Withdrawal by Subject|1|||
147508394|NCT00961116|532012598|FG001|Washout Period of 7 Days|Withdrawal by Subject|1|||
147508395|NCT00961116|532012597|FG000|Washout Period of 7 Days|Protocol Violation|0|||
147508396|NCT00961116|532012598|FG001|Washout Period of 7 Days|Protocol Violation|1|||
147508397|NCT01981109|532012599|FG000|Overall Study|Death|36|||
147639602|NCT00833482|532497866|FG001|Days 11-20|Adverse Event|2|||
147639603|NCT00833482|532497867|FG002|Days 11-20|Adverse Event|0|||
147508398|NCT01981109|532012599|FG000|Overall Study|Withdrawal by Subject|40|||
147508399|NCT01981109|532012599|FG000|Overall Study|Lost to Follow-up|9|||
147508400|NCT01981109|532012599|FG000|Overall Study|No Discontinuation Documentation|37|||
147508401|NCT01981109|532012599|FG000|Overall Study|Study Termination|100|||
147508402|NCT01981109|532012599|FG000|Overall Study|No data available|2|||
147508403|NCT02023268|532012600|FG000|Overall Study|Lack of Efficacy|0|||
147508404|NCT02023268|532012601|FG001|Overall Study|Lack of Efficacy|1|||
147508405|NCT02023268|532012600|FG000|Overall Study|Adverse Event|0|||
147508406|NCT02023268|532012601|FG001|Overall Study|Adverse Event|2|||
147508407|NCT02023268|532012600|FG000|Overall Study|Withdrawal by Subject|0|||
147508408|NCT02023268|532012601|FG001|Overall Study|Withdrawal by Subject|1|||
147508409|NCT00615459|532012603|FG000|Period I|Adverse Event|2|||
147508410|NCT00615459|532012604|FG001|Period I|Adverse Event|0|||
147508411|NCT00615459|532012605|FG002|Period I|Adverse Event|1|||
147508412|NCT00615459|532012606|FG003|Period I|Adverse Event|0|||
147508413|NCT00615459|532012603|FG000|Period I|Subject withdrew consent|1|||
147508414|NCT00615459|532012604|FG001|Period I|Subject withdrew consent|0|||
147508415|NCT00615459|532012605|FG002|Period I|Subject withdrew consent|0|||
147508416|NCT00615459|532012606|FG003|Period I|Subject withdrew consent|1|||
147508417|NCT00615459|532012603|FG000|Period I|Abnormal test procedure results|1|||
147508418|NCT00615459|532012604|FG001|Period I|Abnormal test procedure results|1|||
147508419|NCT00615459|532012605|FG002|Period I|Abnormal test procedure results|1|||
147508420|NCT00615459|532012606|FG003|Period I|Abnormal test procedure results|0|||
147508421|NCT00615459|532012603|FG000|Period II|Adverse Event|1|||
147508422|NCT00615459|532012604|FG001|Period II|Adverse Event|0|||
147508423|NCT00615459|532012605|FG002|Period II|Adverse Event|0|||
147508424|NCT00615459|532012606|FG003|Period II|Adverse Event|0|||
147508425|NCT00615459|532012603|FG000|Period II|Lost to Follow-up|0|||
147508426|NCT00615459|532012604|FG001|Period II|Lost to Follow-up|0|||
147508427|NCT00615459|532012605|FG002|Period II|Lost to Follow-up|0|||
147508428|NCT00615459|532012606|FG003|Period II|Lost to Follow-up|1|||
147508429|NCT00615459|532012603|FG000|Period III|Adverse Event|0|||
147508430|NCT00615459|532012604|FG001|Period III|Adverse Event|1|||
147508431|NCT00615459|532012605|FG002|Period III|Adverse Event|0|||
147508432|NCT00615459|532012606|FG003|Period III|Adverse Event|0|||
147508433|NCT00615459|532012603|FG000|Period III|Administrative problems|0|||
147508434|NCT00615459|532012604|FG001|Period III|Administrative problems|1|||
147508435|NCT00615459|532012605|FG002|Period III|Administrative problems|1|||
147508436|NCT00615459|532012606|FG003|Period III|Administrative problems|0|||
147508437|NCT00615459|532012603|FG000|Period III|Unsatisfactory therapeutic effect|0|||
147508438|NCT00615459|532012604|FG001|Period III|Unsatisfactory therapeutic effect|1|||
147508439|NCT00615459|532012605|FG002|Period III|Unsatisfactory therapeutic effect|0|||
147508440|NCT00615459|532012606|FG003|Period III|Unsatisfactory therapeutic effect|0|||
147508441|NCT00918346|532012609|FG000|First Treatment Period (4 Weeks)|Lack of Efficacy|0|||
147508442|NCT00918346|532012610|FG001|First Treatment Period (4 Weeks)|Lack of Efficacy|1|||
147508443|NCT03238352|532012611|FG000|Overall Study|Lost to Follow-up|0|||
147508444|NCT03238352|532012612|FG001|Overall Study|Lost to Follow-up|2|||
147508445|NCT03238352|532012613|FG002|Overall Study|Lost to Follow-up|1|||
147508446|NCT03238352|532012611|FG000|Overall Study|Withdrawal by Subject|0|||
147508447|NCT03238352|532012612|FG001|Overall Study|Withdrawal by Subject|1|||
147508448|NCT03238352|532012613|FG002|Overall Study|Withdrawal by Subject|0|||
147508449|NCT00928512|532012614|FG000|Overall Study|Adverse Event|4|||
147508450|NCT00928512|532012615|FG001|Overall Study|Adverse Event|3|||
147508451|NCT00928512|532012616|FG002|Overall Study|Adverse Event|2|||
147508452|NCT00928512|532012617|FG003|Overall Study|Adverse Event|8|||
147508453|NCT00928512|532012618|FG004|Overall Study|Adverse Event|6|||
147508454|NCT00928512|532012614|FG000|Overall Study|Lack of Efficacy|2|||
147508455|NCT00928512|532012615|FG001|Overall Study|Lack of Efficacy|0|||
147508456|NCT00928512|532012616|FG002|Overall Study|Lack of Efficacy|4|||
147508457|NCT00928512|532012617|FG003|Overall Study|Lack of Efficacy|7|||
147669843|NCT01027949|532617399|FG000|Overall Study|Surgery|1|||
147669844|NCT01712178|532617404|FG000|Overall Study|Withdrew consent due to an adverse event|1|||
147669845|NCT01712178|532617405|FG001|Overall Study|Withdrew consent due to an adverse event|1|||
147508458|NCT00928512|532012618|FG004|Overall Study|Lack of Efficacy|3|||
147508459|NCT00928512|532012614|FG000|Overall Study|Protocol Violation|0|||
147508460|NCT00928512|532012615|FG001|Overall Study|Protocol Violation|1|||
147508461|NCT00928512|532012616|FG002|Overall Study|Protocol Violation|0|||
147508462|NCT00928512|532012617|FG003|Overall Study|Protocol Violation|1|||
147508463|NCT00928512|532012618|FG004|Overall Study|Protocol Violation|3|||
147508464|NCT00928512|532012614|FG000|Overall Study|Withdrawal by Subject|3|||
147508465|NCT00928512|532012615|FG001|Overall Study|Withdrawal by Subject|0|||
147508466|NCT00928512|532012616|FG002|Overall Study|Withdrawal by Subject|3|||
147508467|NCT00928512|532012617|FG003|Overall Study|Withdrawal by Subject|4|||
147508468|NCT00928512|532012618|FG004|Overall Study|Withdrawal by Subject|0|||
147508469|NCT00928512|532012614|FG000|Overall Study|Lost to Follow-up|1|||
147508470|NCT00928512|532012615|FG001|Overall Study|Lost to Follow-up|1|||
147508471|NCT00928512|532012616|FG002|Overall Study|Lost to Follow-up|2|||
147508472|NCT00928512|532012617|FG003|Overall Study|Lost to Follow-up|1|||
147508473|NCT00928512|532012618|FG004|Overall Study|Lost to Follow-up|3|||
147508474|NCT00928512|532012614|FG000|Overall Study|Administrative Problems|0|||
147508475|NCT00928512|532012615|FG001|Overall Study|Administrative Problems|1|||
147508476|NCT00928512|532012616|FG002|Overall Study|Administrative Problems|0|||
147508477|NCT00928512|532012617|FG003|Overall Study|Administrative Problems|0|||
147508478|NCT00928512|532012618|FG004|Overall Study|Administrative Problems|0|||
147508479|NCT04153929|532012619|FG000|Overall Study|Other than listed|2|||
147508480|NCT04153929|532012620|FG001|Overall Study|Other than listed|2|||
147508481|NCT04153929|532012621|FG002|Overall Study|Other than listed|0|||
147508482|NCT04153929|532012622|FG003|Overall Study|Other than listed|1|||
147508483|NCT04153929|532012623|FG004|Overall Study|Other than listed|0|||
147508484|NCT04153929|532012624|FG005|Overall Study|Other than listed|2|||
147508485|NCT04153929|532012625|FG006|Overall Study|Other than listed|2|||
147508486|NCT04153929|532012626|FG007|Overall Study|Other than listed|1|||
147508487|NCT04153929|532012619|FG000|Overall Study|Lost to Follow-up|2|||
147508488|NCT04153929|532012620|FG001|Overall Study|Lost to Follow-up|1|||
147508489|NCT04153929|532012621|FG002|Overall Study|Lost to Follow-up|0|||
147508490|NCT04153929|532012622|FG003|Overall Study|Lost to Follow-up|1|||
147508491|NCT04153929|532012623|FG004|Overall Study|Lost to Follow-up|1|||
147508492|NCT04153929|532012624|FG005|Overall Study|Lost to Follow-up|0|||
147508493|NCT04153929|532012625|FG006|Overall Study|Lost to Follow-up|0|||
147508494|NCT04153929|532012626|FG007|Overall Study|Lost to Follow-up|0|||
147508495|NCT04153929|532012619|FG000|Overall Study|Withdrawal by Subject|3|||
147508496|NCT04153929|532012620|FG001|Overall Study|Withdrawal by Subject|1|||
147508497|NCT04153929|532012621|FG002|Overall Study|Withdrawal by Subject|0|||
147508498|NCT04153929|532012622|FG003|Overall Study|Withdrawal by Subject|3|||
147508499|NCT04153929|532012623|FG004|Overall Study|Withdrawal by Subject|1|||
147508500|NCT04153929|532012624|FG005|Overall Study|Withdrawal by Subject|0|||
147508501|NCT04153929|532012625|FG006|Overall Study|Withdrawal by Subject|1|||
147508502|NCT04153929|532012626|FG007|Overall Study|Withdrawal by Subject|0|||
147508503|NCT04153929|532012619|FG000|Overall Study|Protocol Violation|0|||
147508504|NCT04153929|532012620|FG001|Overall Study|Protocol Violation|0|||
147508505|NCT04153929|532012621|FG002|Overall Study|Protocol Violation|0|||
147508506|NCT04153929|532012622|FG003|Overall Study|Protocol Violation|0|||
147508507|NCT04153929|532012623|FG004|Overall Study|Protocol Violation|0|||
147508508|NCT04153929|532012624|FG005|Overall Study|Protocol Violation|0|||
147508509|NCT04153929|532012625|FG006|Overall Study|Protocol Violation|1|||
147508510|NCT04153929|532012626|FG007|Overall Study|Protocol Violation|2|||
147508511|NCT04153929|532012619|FG000|Overall Study|Adverse Event|3|||
147508512|NCT04153929|532012620|FG001|Overall Study|Adverse Event|5|||
147508513|NCT04153929|532012621|FG002|Overall Study|Adverse Event|5|||
147508514|NCT04153929|532012622|FG003|Overall Study|Adverse Event|11|||
147508515|NCT04153929|532012623|FG004|Overall Study|Adverse Event|15|||
147508516|NCT04153929|532012624|FG005|Overall Study|Adverse Event|4|||
147508517|NCT04153929|532012625|FG006|Overall Study|Adverse Event|8|||
147508518|NCT04153929|532012626|FG007|Overall Study|Adverse Event|2|||
147508519|NCT04153929|532012619|FG000|Overall Study|Not treated|1|||
147508520|NCT04153929|532012620|FG001|Overall Study|Not treated|0|||
147508521|NCT04153929|532012621|FG002|Overall Study|Not treated|0|||
147508522|NCT04153929|532012622|FG003|Overall Study|Not treated|0|||
147508523|NCT04153929|532012623|FG004|Overall Study|Not treated|0|||
147508524|NCT04153929|532012624|FG005|Overall Study|Not treated|0|||
147508525|NCT04153929|532012625|FG006|Overall Study|Not treated|1|||
147508526|NCT04153929|532012626|FG007|Overall Study|Not treated|0|||
147508527|NCT04083794|532012627|FG000|Overall Study|Lost to Follow-up|9|||
147508528|NCT00729326|532012632|FG000|Overall Study|Lost to Follow-up|2|||
147669846|NCT01712178|532617404|FG000|Overall Study|Serious adverse event/withdrew consent|0|||
147669847|NCT01712178|532617405|FG001|Overall Study|Serious adverse event/withdrew consent|1|||
147669848|NCT01712178|532617404|FG000|Overall Study|Lost to Follow-up|0|||
147669849|NCT01712178|532617405|FG001|Overall Study|Lost to Follow-up|1|||
147669850|NCT00856180|532617406|FG000|Overall Study|Adverse Event|4|||
147508529|NCT00729326|532012633|FG001|Overall Study|Lost to Follow-up|0|||
147669851|NCT00856180|532617406|FG000|Overall Study|Progressive Disease|16|||
147508530|NCT00729326|532012632|FG000|Overall Study|Physician Decision|0|||
147508531|NCT00729326|532012633|FG001|Overall Study|Physician Decision|1|||
147508532|NCT00729326|532012632|FG000|Overall Study|Protocol Violation|3|||
147508533|NCT00729326|532012633|FG001|Overall Study|Protocol Violation|2|||
147508534|NCT00729326|532012632|FG000|Overall Study|Subject Decision|4|||
147508535|NCT00729326|532012633|FG001|Overall Study|Subject Decision|4|||
147508536|NCT00729326|532012632|FG000|Overall Study|Sponsor Decision|1|||
147508537|NCT00729326|532012633|FG001|Overall Study|Sponsor Decision|2|||
147669852|NCT00671749|532617407|FG000|Overall Study|Adverse Event|2|||
147508538|NCT01235728|532012636|FG000|Overall Study|Protocol Violation|0|||
147508539|NCT01235728|532012637|FG001|Overall Study|Protocol Violation|0|||
147508540|NCT01235728|532012638|FG002|Overall Study|Protocol Violation|0|||
147508541|NCT01235728|532012639|FG003|Overall Study|Protocol Violation|1|||
147508542|NCT01235728|532012640|FG004|Overall Study|Protocol Violation|0|||
147508543|NCT01235728|532012641|FG005|Overall Study|Protocol Violation|0|||
147508544|NCT01235728|532012642|FG006|Overall Study|Protocol Violation|0|||
147508545|NCT01235728|532012643|FG007|Overall Study|Protocol Violation|0|||
147508546|NCT02810951|532012644|FG000|Overall Study|Adverse Event|1|||
147508547|NCT03199638|532012645|FG000|Overall Study|inability to drink glutamine during regularly|0|||
147508548|NCT03199638|532012646|FG001|Overall Study|inability to drink glutamine during regularly|2|||
147508549|NCT03097029|532012647|FG000|Overall Study|Withdrawal by Subject|1|||
147508550|NCT01125293|532012656|FG000|Overall Study|Disease Progression|1|||
147508551|NCT01125293|532012657|FG001|Overall Study|Disease Progression|3|||
147508552|NCT01125293|532012658|FG002|Overall Study|Disease Progression|4|||
147508553|NCT01125293|532012659|FG003|Overall Study|Disease Progression|3|||
147508554|NCT01125293|532012660|FG004|Overall Study|Disease Progression|5|||
147508555|NCT01125293|532012661|FG005|Overall Study|Disease Progression|12|||
147508556|NCT01125293|532012656|FG000|Overall Study|Adverse Event|1|||
147508557|NCT01125293|532012657|FG001|Overall Study|Adverse Event|0|||
147508558|NCT01125293|532012658|FG002|Overall Study|Adverse Event|0|||
147508559|NCT01125293|532012659|FG003|Overall Study|Adverse Event|0|||
147508560|NCT01125293|532012660|FG004|Overall Study|Adverse Event|2|||
147508561|NCT01125293|532012661|FG005|Overall Study|Adverse Event|8|||
147508562|NCT01125293|532012656|FG000|Overall Study|Symptomatic Deterioration|1|||
147508563|NCT01125293|532012657|FG001|Overall Study|Symptomatic Deterioration|0|||
147508564|NCT01125293|532012658|FG002|Overall Study|Symptomatic Deterioration|0|||
147508565|NCT01125293|532012659|FG003|Overall Study|Symptomatic Deterioration|0|||
147508566|NCT01125293|532012660|FG004|Overall Study|Symptomatic Deterioration|0|||
147508567|NCT01125293|532012661|FG005|Overall Study|Symptomatic Deterioration|0|||
147508568|NCT01125293|532012656|FG000|Overall Study|Death|0|||
147508569|NCT01125293|532012657|FG001|Overall Study|Death|0|||
147508570|NCT01125293|532012658|FG002|Overall Study|Death|0|||
147508571|NCT01125293|532012659|FG003|Overall Study|Death|0|||
147508572|NCT01125293|532012660|FG004|Overall Study|Death|1|||
147508573|NCT01125293|532012661|FG005|Overall Study|Death|0|||
147508574|NCT01125293|532012656|FG000|Overall Study|Withdrawal by Subject|0|||
147508575|NCT01125293|532012657|FG001|Overall Study|Withdrawal by Subject|0|||
147508576|NCT01125293|532012658|FG002|Overall Study|Withdrawal by Subject|0|||
147508577|NCT01125293|532012659|FG003|Overall Study|Withdrawal by Subject|0|||
147508578|NCT01125293|532012660|FG004|Overall Study|Withdrawal by Subject|2|||
147508579|NCT01125293|532012661|FG005|Overall Study|Withdrawal by Subject|1|||
147508580|NCT01125293|532012656|FG000|Overall Study|Physician Decision|0|||
147508581|NCT01125293|532012657|FG001|Overall Study|Physician Decision|0|||
147508582|NCT01125293|532012658|FG002|Overall Study|Physician Decision|0|||
147508583|NCT01125293|532012659|FG003|Overall Study|Physician Decision|0|||
147508584|NCT01125293|532012660|FG004|Overall Study|Physician Decision|0|||
147508585|NCT01125293|532012661|FG005|Overall Study|Physician Decision|2|||
147508586|NCT00260429|532012664|FG000|Overall Study|failure to follow appointments|1|||
147508587|NCT00260429|532012665|FG001|Overall Study|failure to follow appointments|0|||
147508588|NCT00260429|532012664|FG000|Overall Study|scheduled hand surgery|1|||
147508589|NCT00260429|532012665|FG001|Overall Study|scheduled hand surgery|0|||
147508590|NCT00659126|532012666|FG000|Overall Study|Adverse Event|2|||
147508591|NCT00659126|532012667|FG001|Overall Study|Adverse Event|2|||
147508592|NCT00659126|532012666|FG000|Overall Study|Screen failure|1|||
147508593|NCT00659126|532012667|FG001|Overall Study|Screen failure|1|||
147508594|NCT00659126|532012666|FG000|Overall Study|Technical problems with MRI|0|||
147508595|NCT00659126|532012667|FG001|Overall Study|Technical problems with MRI|1|||
147508596|NCT02228564|532012668|FG000|Overall Study|Withdrawal by Subject|10|||
147508597|NCT02228564|532012668|FG000|Overall Study|Death|11|||
147508598|NCT02228564|532012668|FG000|Overall Study|Physician Decision|5|||
147508599|NCT02228564|532012668|FG000|Overall Study|Lost to Follow-up|17|||
147669853|NCT00671749|532617407|FG000|Overall Study|Withdrawal by Subject|4|||
147508600|NCT02228564|532012668|FG000|Overall Study|Other|6|||
147508601|NCT02633046|532012672|FG000|Overall Study|Adverse Event|8|||
147508602|NCT02633046|532012672|FG000|Overall Study|Physician Decision|7|||
147508603|NCT02633046|532012672|FG000|Overall Study|Withdrawal by Subject|8|||
147508604|NCT02633046|532012672|FG000|Overall Study|Increased proteinuria|2|||
147508605|NCT02633046|532012672|FG000|Overall Study|Participant decided not to continue with open label extension|1|||
147508606|NCT02633046|532012672|FG000|Overall Study|Mutual decision patient and physician|1|||
147508607|NCT01496274|532012674|FG000|Overall Study|Protocol Violation|0|||
147508608|NCT01496274|532012675|FG001|Overall Study|Protocol Violation|1|||
147508609|NCT01496274|532012674|FG000|Overall Study|Adverse Event|1|||
147508610|NCT01496274|532012675|FG001|Overall Study|Adverse Event|1|||
147508611|NCT01496274|532012674|FG000|Overall Study|Withdrawal by Subject|2|||
147508612|NCT01496274|532012675|FG001|Overall Study|Withdrawal by Subject|0|||
147508613|NCT01496274|532012674|FG000|Overall Study|Lost to Follow-up|0|||
147669854|NCT00671749|532617407|FG000|Overall Study|Protocol Violation|1|||
147508614|NCT01496274|532012675|FG001|Overall Study|Lost to Follow-up|3|||
147508615|NCT02758613|532012676|FG000|Treatment|Physician and Sponsor Decision|1|||
147508616|NCT02758613|532012677|FG001|Treatment|Physician and Sponsor Decision|0|||
147508617|NCT02758613|532012678|FG002|Treatment|Physician and Sponsor Decision|0|||
147508618|NCT02758613|532012679|FG003|Treatment|Physician and Sponsor Decision|0|||
147508619|NCT02758613|532012676|FG000|Treatment|Withdrawal by Subject|1|||
147508620|NCT02758613|532012677|FG001|Treatment|Withdrawal by Subject|0|||
147508621|NCT02758613|532012678|FG002|Treatment|Withdrawal by Subject|1|||
147508622|NCT02758613|532012679|FG003|Treatment|Withdrawal by Subject|0|||
147508623|NCT03549429|532012681|FG000|Overall Study|Protocol Violation|5|||
147508624|NCT03549429|532012682|FG001|Overall Study|Protocol Violation|3|||
147508625|NCT02910219|532012683|FG000|Overall Study|Withdrawal by Subject|1|||
147508626|NCT02910219|532012684|FG001|Overall Study|Withdrawal by Subject|1|||
147508627|NCT02096042|532012685|FG000|Overall Study|Disease Progression|1|||
147508628|NCT02096042|532012686|FG001|Overall Study|Disease Progression|0|||
147508629|NCT02096042|532012687|FG002|Overall Study|Disease Progression|0|||
147508630|NCT02762708|532012692|FG000|Study 1 - RYGB vs Caloric Restriction|Withdrawal by Subject|0|||
147508631|NCT02762708|532012693|FG001|Study 1 - RYGB vs Caloric Restriction|Withdrawal by Subject|2|||
147508632|NCT02762708|532012694|FG002|Study 1 - RYGB vs Caloric Restriction|Withdrawal by Subject|0|||
147508633|NCT02762708|532012695|FG003|Study 1 - RYGB vs Caloric Restriction|Withdrawal by Subject|0|||
147508634|NCT01468701|532012701|FG000|Overall Study|Not eligible|91|||
147508635|NCT01468701|532012702|FG001|Overall Study|Not eligible|140|||
147508636|NCT01468701|532012703|FG002|Overall Study|Not eligible|29|||
147508637|NCT01468701|532012704|FG003|Overall Study|Not eligible|12|||
147508638|NCT01468701|532012705|FG004|Overall Study|Not eligible|22|||
147508639|NCT01468701|532012706|FG005|Overall Study|Not eligible|2|||
147508640|NCT01468701|532012707|FG006|Overall Study|Not eligible|39|||
147508641|NCT01468701|532012708|FG007|Overall Study|Not eligible|1|||
147508642|NCT01468701|532012709|FG008|Overall Study|Not eligible|40|||
147508643|NCT01468701|532012710|FG009|Overall Study|Not eligible|126|||
147508644|NCT01468701|532012711|FG010|Overall Study|Not eligible|39|||
147508645|NCT01468701|532012712|FG011|Overall Study|Not eligible|33|||
147508646|NCT01468701|532012713|FG012|Overall Study|Not eligible|1|||
147508647|NCT01468701|532012714|FG013|Overall Study|Not eligible|19|||
147508648|NCT01468701|532012715|FG014|Overall Study|Not eligible|1|||
147508649|NCT01468701|532012716|FG015|Overall Study|Not eligible|32|||
147508650|NCT01468701|532012717|FG016|Overall Study|Not eligible|0|||
147508651|NCT01468701|532012701|FG000|Overall Study|Lost to Follow-up|306|||
147508652|NCT01468701|532012702|FG001|Overall Study|Lost to Follow-up|0|||
147508653|NCT01468701|532012703|FG002|Overall Study|Lost to Follow-up|0|||
147508654|NCT01468701|532012704|FG003|Overall Study|Lost to Follow-up|0|||
147508655|NCT01468701|532012705|FG004|Overall Study|Lost to Follow-up|0|||
147508656|NCT01468701|532012706|FG005|Overall Study|Lost to Follow-up|0|||
147508657|NCT01468701|532012707|FG006|Overall Study|Lost to Follow-up|0|||
147508658|NCT01468701|532012708|FG007|Overall Study|Lost to Follow-up|0|||
147508659|NCT01468701|532012709|FG008|Overall Study|Lost to Follow-up|215|||
147508660|NCT01468701|532012710|FG009|Overall Study|Lost to Follow-up|309|||
147508661|NCT01468701|532012711|FG010|Overall Study|Lost to Follow-up|224|||
147508662|NCT01468701|532012712|FG011|Overall Study|Lost to Follow-up|212|||
147508663|NCT01468701|532012713|FG012|Overall Study|Lost to Follow-up|11|||
147508664|NCT01468701|532012714|FG013|Overall Study|Lost to Follow-up|164|||
147508665|NCT01468701|532012715|FG014|Overall Study|Lost to Follow-up|17|||
147508666|NCT01468701|532012716|FG015|Overall Study|Lost to Follow-up|127|||
147669855|NCT00671749|532617407|FG000|Overall Study|Lost to Follow-up|1|||
147669856|NCT00827567|532617408|FG000|Overall Study|Progression of Disease/Screen Failure|4|||
147669857|NCT01259245|532617414|FG000|Overall Study|Withdrawal by Subject|27|||
147669858|NCT01259245|532617415|FG001|Overall Study|Withdrawal by Subject|24|||
147669859|NCT01259245|532617414|FG000|Overall Study|Death|1|||
147669860|NCT01259245|532617415|FG001|Overall Study|Death|2|||
147669861|NCT03482024|532617422|FG000|Overall Study|Physician Decision|1|||
147669862|NCT03482024|532617423|FG001|Overall Study|Physician Decision|0|||
147669863|NCT03482024|532617424|FG002|Overall Study|Physician Decision|0|||
147669864|NCT03482024|532617425|FG003|Overall Study|Physician Decision|0|||
147669865|NCT03482024|532617426|FG004|Overall Study|Physician Decision|0|||
147669866|NCT00676143|532617433|FG000|Overall Study|Adverse Event|34|||
147669867|NCT00676143|532617434|FG001|Overall Study|Adverse Event|60|||
147669868|NCT00676143|532617433|FG000|Overall Study|Death|4|||
147669869|NCT00676143|532617434|FG001|Overall Study|Death|4|||
147669870|NCT00676143|532617433|FG000|Overall Study|Lack of Efficacy|0|||
147669871|NCT00676143|532617434|FG001|Overall Study|Lack of Efficacy|6|||
147669872|NCT00676143|532617433|FG000|Overall Study|Lost to Follow-up|0|||
147669873|NCT00676143|532617434|FG001|Overall Study|Lost to Follow-up|13|||
147508667|NCT01468701|532012717|FG016|Overall Study|Lost to Follow-up|1|||
147508668|NCT01468701|532012701|FG000|Overall Study|Withdrawal by Subject|165|||
147508669|NCT01468701|532012702|FG001|Overall Study|Withdrawal by Subject|0|||
147508670|NCT01468701|532012703|FG002|Overall Study|Withdrawal by Subject|0|||
147508671|NCT01468701|532012704|FG003|Overall Study|Withdrawal by Subject|0|||
147669874|NCT00676143|532617433|FG000|Overall Study|Physician Decision|5|||
147669875|NCT00676143|532617434|FG001|Overall Study|Physician Decision|8|||
147669876|NCT00676143|532617433|FG000|Overall Study|Protocol Violation|4|||
147669877|NCT00676143|532617434|FG001|Overall Study|Protocol Violation|8|||
147508672|NCT01468701|532012705|FG004|Overall Study|Withdrawal by Subject|0|||
147508673|NCT01468701|532012706|FG005|Overall Study|Withdrawal by Subject|0|||
147508674|NCT01468701|532012707|FG006|Overall Study|Withdrawal by Subject|0|||
147508675|NCT01468701|532012708|FG007|Overall Study|Withdrawal by Subject|0|||
147508676|NCT01468701|532012709|FG008|Overall Study|Withdrawal by Subject|83|||
147508677|NCT01468701|532012710|FG009|Overall Study|Withdrawal by Subject|88|||
147508678|NCT01468701|532012711|FG010|Overall Study|Withdrawal by Subject|100|||
147508679|NCT01468701|532012712|FG011|Overall Study|Withdrawal by Subject|114|||
147508680|NCT01468701|532012713|FG012|Overall Study|Withdrawal by Subject|9|||
147508681|NCT01468701|532012714|FG013|Overall Study|Withdrawal by Subject|47|||
147508682|NCT01468701|532012715|FG014|Overall Study|Withdrawal by Subject|6|||
147508683|NCT01468701|532012716|FG015|Overall Study|Withdrawal by Subject|31|||
147508684|NCT01468701|532012717|FG016|Overall Study|Withdrawal by Subject|0|||
147508685|NCT01468701|532012701|FG000|Overall Study|Other reasons than listed|437|||
147508686|NCT01468701|532012702|FG001|Overall Study|Other reasons than listed|0|||
147508687|NCT01468701|532012703|FG002|Overall Study|Other reasons than listed|0|||
147508688|NCT01468701|532012704|FG003|Overall Study|Other reasons than listed|0|||
147508689|NCT01468701|532012705|FG004|Overall Study|Other reasons than listed|0|||
147508690|NCT01468701|532012706|FG005|Overall Study|Other reasons than listed|0|||
147508691|NCT01468701|532012707|FG006|Overall Study|Other reasons than listed|0|||
147508692|NCT01468701|532012708|FG007|Overall Study|Other reasons than listed|0|||
147508693|NCT01468701|532012709|FG008|Overall Study|Other reasons than listed|318|||
147508694|NCT01468701|532012710|FG009|Overall Study|Other reasons than listed|658|||
147508695|NCT01468701|532012711|FG010|Overall Study|Other reasons than listed|433|||
147508696|NCT01468701|532012712|FG011|Overall Study|Other reasons than listed|504|||
147508697|NCT01468701|532012713|FG012|Overall Study|Other reasons than listed|28|||
147508698|NCT01468701|532012714|FG013|Overall Study|Other reasons than listed|239|||
147508699|NCT01468701|532012715|FG014|Overall Study|Other reasons than listed|39|||
147508700|NCT01468701|532012716|FG015|Overall Study|Other reasons than listed|172|||
147508701|NCT01468701|532012717|FG016|Overall Study|Other reasons than listed|0|||
147508702|NCT01468701|532012701|FG000|Overall Study|No end of study case report form|0|||
147508703|NCT01468701|532012702|FG001|Overall Study|No end of study case report form|0|||
147508704|NCT01468701|532012703|FG002|Overall Study|No end of study case report form|0|||
147508705|NCT01468701|532012704|FG003|Overall Study|No end of study case report form|0|||
147508706|NCT01468701|532012705|FG004|Overall Study|No end of study case report form|0|||
147508707|NCT01468701|532012706|FG005|Overall Study|No end of study case report form|0|||
147508708|NCT01468701|532012707|FG006|Overall Study|No end of study case report form|0|||
147508709|NCT01468701|532012708|FG007|Overall Study|No end of study case report form|0|||
147508710|NCT01468701|532012709|FG008|Overall Study|No end of study case report form|4|||
147508711|NCT01468701|532012710|FG009|Overall Study|No end of study case report form|1|||
147508712|NCT01468701|532012711|FG010|Overall Study|No end of study case report form|2|||
147508713|NCT01468701|532012712|FG011|Overall Study|No end of study case report form|3|||
147508714|NCT01468701|532012713|FG012|Overall Study|No end of study case report form|0|||
147508715|NCT01468701|532012714|FG013|Overall Study|No end of study case report form|1|||
147508716|NCT01468701|532012715|FG014|Overall Study|No end of study case report form|0|||
147508717|NCT01468701|532012716|FG015|Overall Study|No end of study case report form|0|||
147508718|NCT01468701|532012717|FG016|Overall Study|No end of study case report form|0|||
147508719|NCT01468701|532012701|FG000|Overall Study|Not being followed up|0|||
147508720|NCT01468701|532012702|FG001|Overall Study|Not being followed up|4963|||
147508721|NCT01468701|532012703|FG002|Overall Study|Not being followed up|1755|||
147508722|NCT01468701|532012704|FG003|Overall Study|Not being followed up|703|||
147508723|NCT01468701|532012705|FG004|Overall Study|Not being followed up|1714|||
147508724|NCT01468701|532012706|FG005|Overall Study|Not being followed up|126|||
147508725|NCT01468701|532012707|FG006|Overall Study|Not being followed up|1170|||
147508726|NCT01468701|532012708|FG007|Overall Study|Not being followed up|4|||
147508727|NCT01468701|532012709|FG008|Overall Study|Not being followed up|0|||
147508728|NCT01468701|532012710|FG009|Overall Study|Not being followed up|0|||
147508729|NCT01468701|532012711|FG010|Overall Study|Not being followed up|0|||
147508730|NCT01468701|532012712|FG011|Overall Study|Not being followed up|0|||
147508731|NCT01468701|532012713|FG012|Overall Study|Not being followed up|0|||
147508732|NCT01468701|532012714|FG013|Overall Study|Not being followed up|0|||
147508733|NCT01468701|532012715|FG014|Overall Study|Not being followed up|0|||
147508734|NCT01468701|532012716|FG015|Overall Study|Not being followed up|0|||
147508735|NCT01468701|532012717|FG016|Overall Study|Not being followed up|0|||
147508736|NCT01068717|532012718|FG000|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|1|||
147508737|NCT01068717|532012719|FG001|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|0|||
147508738|NCT01068717|532012720|FG002|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|0|||
147508739|NCT01068717|532012721|FG003|Period 1: Treatment Schedule Phase 1|Patient withdrew; returned for period 3|0|||
147639604|NCT00833482|532497868|FG003|Days 11-20|Adverse Event|0|||
147508740|NCT01822223|532012724|FG000|Overall Study|Death|0|||
147508741|NCT01822223|532012725|FG001|Overall Study|Death|1|||
147508742|NCT02679781|532012726|FG000|Overall Study|Lost to Follow-up|1|||
147508743|NCT02679781|532012727|FG001|Overall Study|Lost to Follow-up|2|||
147508744|NCT02679781|532012726|FG000|Overall Study|low cooperation, referral to treatment under general anesthesia|6|||
147508745|NCT02679781|532012727|FG001|Overall Study|low cooperation, referral to treatment under general anesthesia|1|||
147508746|NCT04209400|532012728|FG000|Overall Study|Withdrawal by Subject|0|||
147639605|NCT00833482|532497869|FG004|Days 11-20|Adverse Event|0|||
147508747|NCT04209400|532012729|FG001|Overall Study|Withdrawal by Subject|1|||
147508748|NCT01602549|532012732|FG000|Overall Study|Protocol Violation|0|||
147639606|NCT00833482|532497870|FG005|Days 11-20|Adverse Event|0|||
147508749|NCT01602549|532012733|FG001|Overall Study|Protocol Violation|1|||
147508750|NCT01602549|532012732|FG000|Overall Study|Withdrawal by Subject|1|||
147508751|NCT01602549|532012733|FG001|Overall Study|Withdrawal by Subject|0|||
147508752|NCT05200455|532012734|FG000|Overall Study|These patients were not implanted with intracranial electrodes for clinical reasons .|4|||
147508753|NCT01280812|532015369|FG000|Overall Study|Withdrawal by Subject|2|||
147508754|NCT01280812|532015370|FG001|Overall Study|Withdrawal by Subject|1|||
147508755|NCT01280812|532015371|FG002|Overall Study|Withdrawal by Subject|0|||
147508756|NCT01280812|532015369|FG000|Overall Study|Lost to Follow-up|1|||
147508757|NCT01280812|532015370|FG001|Overall Study|Lost to Follow-up|1|||
147508758|NCT01280812|532015371|FG002|Overall Study|Lost to Follow-up|1|||
147508759|NCT00086385|532015374|FG000|Overall Study|Death|2|||
147508760|NCT00086385|532015375|FG001|Overall Study|Death|2|||
147508761|NCT00086385|532015376|FG002|Overall Study|Death|1|||
147508762|NCT00086385|532015377|FG003|Overall Study|Death|1|||
147508763|NCT03424044|532015380|FG000|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
147508764|NCT03424044|532015381|FG001|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
147508765|NCT03424044|532015382|FG002|First Rest Period (1-12 Weeks)|Withdrawal by Subject|1|||
147508766|NCT03424044|532015383|FG003|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
147508767|NCT03424044|532015384|FG004|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
147508768|NCT03424044|532015385|FG005|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
147508769|NCT03424044|532015386|FG006|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
147508770|NCT03424044|532015387|FG007|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
147508771|NCT03424044|532015388|FG008|First Rest Period (1-12 Weeks)|Withdrawal by Subject|0|||
147508772|NCT03424044|532015380|FG000|First Intervention (76 Hours)|Adverse Event|0|||
147508773|NCT03424044|532015381|FG001|First Intervention (76 Hours)|Adverse Event|0|||
147508774|NCT03424044|532015382|FG002|First Intervention (76 Hours)|Adverse Event|0|||
147508775|NCT03424044|532015383|FG003|First Intervention (76 Hours)|Adverse Event|0|||
147508776|NCT03424044|532015384|FG004|First Intervention (76 Hours)|Adverse Event|1|||
147508777|NCT03424044|532015385|FG005|First Intervention (76 Hours)|Adverse Event|0|||
147508778|NCT03424044|532015386|FG006|First Intervention (76 Hours)|Adverse Event|0|||
147508779|NCT03424044|532015387|FG007|First Intervention (76 Hours)|Adverse Event|0|||
147508780|NCT03424044|532015388|FG008|First Intervention (76 Hours)|Adverse Event|0|||
147508781|NCT03424044|532015380|FG000|First Intervention (76 Hours)|device issues|0|||
147508782|NCT03424044|532015381|FG001|First Intervention (76 Hours)|device issues|0|||
147508783|NCT03424044|532015382|FG002|First Intervention (76 Hours)|device issues|0|||
147508784|NCT03424044|532015383|FG003|First Intervention (76 Hours)|device issues|0|||
147508785|NCT03424044|532015384|FG004|First Intervention (76 Hours)|device issues|0|||
147508786|NCT03424044|532015385|FG005|First Intervention (76 Hours)|device issues|0|||
147508787|NCT03424044|532015386|FG006|First Intervention (76 Hours)|device issues|1|||
147508788|NCT03424044|532015387|FG007|First Intervention (76 Hours)|device issues|1|||
147508789|NCT03424044|532015388|FG008|First Intervention (76 Hours)|device issues|1|||
147508790|NCT03424044|532015380|FG000|Third Intervention (76 Hours)|Adverse Event|1|||
147508791|NCT03424044|532015381|FG001|Third Intervention (76 Hours)|Adverse Event|0|||
147508792|NCT03424044|532015382|FG002|Third Intervention (76 Hours)|Adverse Event|0|||
147508793|NCT03424044|532015383|FG003|Third Intervention (76 Hours)|Adverse Event|0|||
147508794|NCT03424044|532015384|FG004|Third Intervention (76 Hours)|Adverse Event|0|||
147508795|NCT03424044|532015385|FG005|Third Intervention (76 Hours)|Adverse Event|0|||
147508796|NCT03424044|532015386|FG006|Third Intervention (76 Hours)|Adverse Event|1|||
147508797|NCT03424044|532015387|FG007|Third Intervention (76 Hours)|Adverse Event|0|||
147508798|NCT03424044|532015388|FG008|Third Intervention (76 Hours)|Adverse Event|0|||
147508799|NCT03424044|532015380|FG000|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
147508800|NCT03424044|532015381|FG001|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
147508801|NCT03424044|532015382|FG002|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
147508802|NCT03424044|532015383|FG003|Third Intervention (76 Hours)|Withdrawal by Subject|1|||
147508803|NCT03424044|532015384|FG004|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
147508804|NCT03424044|532015385|FG005|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
147508805|NCT03424044|532015386|FG006|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
147508806|NCT03424044|532015387|FG007|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
147508807|NCT03424044|532015388|FG008|Third Intervention (76 Hours)|Withdrawal by Subject|0|||
147508808|NCT00784459|532015392|FG000|Overall Study|Adverse Event|0|||
147508809|NCT00784459|532015393|FG001|Overall Study|Adverse Event|2|||
147508810|NCT01376388|532015394|FG000|Overall Study|Adverse Event|13|||
147508811|NCT01376388|532015394|FG000|Overall Study|Lack of Efficacy|2|||
147508812|NCT01376388|532015394|FG000|Overall Study|Withdrawal by Subject|3|||
147508813|NCT02471586|532015403|FG000|Overall Study|Lost to Follow-up|3|||
147508814|NCT02471586|532015404|FG001|Overall Study|Lost to Follow-up|8|||
147508815|NCT02471586|532015405|FG002|Overall Study|Lost to Follow-up|4|||
147508816|NCT02471586|532015403|FG000|Overall Study|Death|2|||
147508817|NCT02471586|532015404|FG001|Overall Study|Death|2|||
147508818|NCT02471586|532015405|FG002|Overall Study|Death|0|||
147508819|NCT04839393|532015408|FG000|Overall Study|Adverse Event|0|||
147639607|NCT00833482|532497865|FG000|Days 11-20|Withdrawal by Subject|0|||
147508820|NCT04839393|532015409|FG001|Overall Study|Adverse Event|0|||
147508821|NCT04839393|532015410|FG002|Overall Study|Adverse Event|2|||
147508822|NCT04839393|532015408|FG000|Overall Study|Withdrawal by participant|0|||
147508823|NCT04839393|532015409|FG001|Overall Study|Withdrawal by participant|0|||
147508824|NCT04839393|532015410|FG002|Overall Study|Withdrawal by participant|1|||
147508825|NCT01510028|532015413|FG000|Overall Study|Lack of Efficacy|1|||
147508826|NCT01510028|532015414|FG001|Overall Study|Lack of Efficacy|0|||
147508827|NCT01510028|532015415|FG002|Overall Study|Lack of Efficacy|0|||
147508828|NCT01510028|532015416|FG003|Overall Study|Lack of Efficacy|0|||
147508829|NCT00633893|532015417|FG000|Overall Study|Death|1|||
147508830|NCT00633893|532015418|FG001|Overall Study|Death|3|||
147508831|NCT00633893|532015419|FG002|Overall Study|Death|9|||
147508832|NCT00633893|532015417|FG000|Overall Study|Adverse Event|65|||
147508833|NCT00633893|532015418|FG001|Overall Study|Adverse Event|58|||
147508834|NCT00633893|532015419|FG002|Overall Study|Adverse Event|126|||
147508835|NCT00633893|532015417|FG000|Overall Study|Withdrawal by Subject|7|||
147508836|NCT00633893|532015418|FG001|Overall Study|Withdrawal by Subject|12|||
147508837|NCT00633893|532015419|FG002|Overall Study|Withdrawal by Subject|6|||
147508838|NCT00633893|532015417|FG000|Overall Study|Lost to Follow-up|2|||
147508839|NCT00633893|532015418|FG001|Overall Study|Lost to Follow-up|4|||
147508840|NCT00633893|532015419|FG002|Overall Study|Lost to Follow-up|8|||
147508841|NCT00633893|532015417|FG000|Overall Study|Poor/non-compliance|5|||
147508842|NCT00633893|532015418|FG001|Overall Study|Poor/non-compliance|12|||
147508843|NCT00633893|532015419|FG002|Overall Study|Poor/non-compliance|3|||
147508844|NCT00633893|532015417|FG000|Overall Study|Pregnancy|2|||
147508845|NCT00633893|532015418|FG001|Overall Study|Pregnancy|1|||
147508846|NCT00633893|532015419|FG002|Overall Study|Pregnancy|1|||
147508847|NCT00633893|532015417|FG000|Overall Study|Not meet/no longer meets criteria|4|||
147508848|NCT00633893|532015418|FG001|Overall Study|Not meet/no longer meets criteria|6|||
147508849|NCT00633893|532015419|FG002|Overall Study|Not meet/no longer meets criteria|4|||
147508850|NCT00633893|532015417|FG000|Overall Study|Other|28|||
147508851|NCT00633893|532015418|FG001|Overall Study|Other|33|||
147508852|NCT00633893|532015419|FG002|Overall Study|Other|31|||
147508853|NCT02741310|532015420|FG000|Overall Study|Sponsor Decision|2|||
147508854|NCT02741310|532015421|FG001|Overall Study|Sponsor Decision|2|||
147508855|NCT05091918|532015422|FG000|Overall Study|Adverse Event|1|||
147508856|NCT05091918|532015422|FG000|Overall Study|Withdrawal by Subject|81|||
147508857|NCT01100658|532015426|FG000|Overall Study|Withdrawal by Subject|1|||
147508858|NCT01784211|532015427|FG000|Part A (Days 1-15)|Adverse Event|1|||
147508859|NCT01784211|532015428|FG001|Part A (Days 1-15)|Adverse Event|1|||
147508860|NCT01784211|532015429|FG002|Part A (Days 1-15)|Adverse Event|0|||
147508861|NCT01784211|532015430|FG003|Part A (Days 1-15)|Adverse Event|0|||
147508862|NCT01784211|532015431|FG004|Part A (Days 1-15)|Adverse Event|0|||
147508863|NCT01784211|532015432|FG005|Part A (Days 1-15)|Adverse Event|0|||
147508864|NCT01784211|532015427|FG000|Part A (Days 1-15)|Withdrawal by Subject|2|||
147508865|NCT01784211|532015428|FG001|Part A (Days 1-15)|Withdrawal by Subject|1|||
147508866|NCT01784211|532015429|FG002|Part A (Days 1-15)|Withdrawal by Subject|0|||
147508867|NCT01784211|532015430|FG003|Part A (Days 1-15)|Withdrawal by Subject|0|||
147508868|NCT01784211|532015431|FG004|Part A (Days 1-15)|Withdrawal by Subject|0|||
147508869|NCT01784211|532015432|FG005|Part A (Days 1-15)|Withdrawal by Subject|0|||
147508870|NCT00239356|532015435|FG000|Overall Study|Lack of Efficacy|1|||
147508871|NCT00239356|532015436|FG001|Overall Study|Lack of Efficacy|0|||
147508872|NCT00239356|532015435|FG000|Overall Study|Adverse Event|6|||
147508873|NCT00239356|532015436|FG001|Overall Study|Adverse Event|0|||
147508874|NCT00239356|532015435|FG000|Overall Study|Withdrawal by Subject|15|||
147669878|NCT00676143|532617433|FG000|Overall Study|Withdrawal by Subject|24|||
147669879|NCT00676143|532617434|FG001|Overall Study|Withdrawal by Subject|42|||
147669880|NCT00676143|532617433|FG000|Overall Study|Discontinuation of study by sponsor|65|||
147508875|NCT00239356|532015436|FG001|Overall Study|Withdrawal by Subject|6|||
147508876|NCT00239356|532015435|FG000|Overall Study|Lost to Follow-up|3|||
147508877|NCT00239356|532015436|FG001|Overall Study|Lost to Follow-up|0|||
147508878|NCT00239356|532015435|FG000|Overall Study|poor/non-compliance|2|||
147508879|NCT00239356|532015436|FG001|Overall Study|poor/non-compliance|0|||
147508880|NCT00239356|532015435|FG000|Overall Study|Pregnancy|1|||
147508881|NCT00239356|532015436|FG001|Overall Study|Pregnancy|0|||
147508882|NCT00239356|532015435|FG000|Overall Study|Administrative reason|0|||
147508883|NCT00239356|532015436|FG001|Overall Study|Administrative reason|1|||
147508884|NCT00239356|532015435|FG000|Overall Study|Drug available on market|11|||
147508885|NCT00239356|532015436|FG001|Overall Study|Drug available on market|2|||
147508886|NCT02044822|532015437|FG000|Overall Study|Study Terminated by Sponsor|77|||
147508887|NCT02044822|532015437|FG000|Overall Study|Investigator's Discretion|10|||
147508888|NCT02044822|532015437|FG000|Overall Study|Withdrew Consent|3|||
147669881|NCT00676143|532617434|FG001|Overall Study|Discontinuation of study by sponsor|88|||
147508889|NCT02044822|532015437|FG000|Overall Study|Initiation of Anti-Neoplastic Therapy|2|||
147508890|NCT02044822|532015437|FG000|Overall Study|Lost to Follow-up|1|||
147508891|NCT03417505|532015438|FG000|First Lens Type (30 Days)|Lost to Follow-up|1|||
147508892|NCT03417505|532015439|FG001|First Lens Type (30 Days)|Lost to Follow-up|1|||
147508893|NCT00391807|532015447|FG000|Overall Study|Did not receive study medication|23|||
147508894|NCT00391807|532015447|FG000|Overall Study|Adverse Event|177|||
147508895|NCT00391807|532015447|FG000|Overall Study|Pregnancy|25|||
147508896|NCT00391807|532015447|FG000|Overall Study|Lost to Follow-up|227|||
147508897|NCT00391807|532015447|FG000|Overall Study|Withdrawal by Subject|147|||
147508898|NCT00391807|532015447|FG000|Overall Study|Protocol Violation|20|||
147508899|NCT00391807|532015447|FG000|Overall Study|Various|96|||
147508900|NCT03725293|532015453|FG000|Overall Study|Physician Decision|9|||
147508901|NCT03725293|532015454|FG001|Overall Study|Physician Decision|6|||
147508902|NCT03725293|532015453|FG000|Overall Study|alternative vascular access needs|1|||
147508903|NCT03725293|532015454|FG001|Overall Study|alternative vascular access needs|2|||
147508904|NCT03725293|532015453|FG000|Overall Study|venous anatomy screen failures|2|||
147508905|NCT03725293|532015454|FG001|Overall Study|venous anatomy screen failures|1|||
147508906|NCT02143141|532015455|FG000|Overall Study|pain scores at 24 hours not collected|1|||
147508907|NCT02143141|532015456|FG001|Overall Study|pain scores at 24 hours not collected|0|||
147508908|NCT01975675|532015460|FG000|Overall Study|Death|0|||
147508909|NCT01975675|532015461|FG001|Overall Study|Death|1|||
147508910|NCT01975675|532015462|FG002|Overall Study|Death|0|||
147508911|NCT01975675|532015463|FG003|Overall Study|Death|0|||
147508912|NCT00224003|532015464|FG000|Overall Study|Adverse Event|1|||
147508913|NCT00224003|532015464|FG000|Overall Study|Protocol Violation|2|||
147508914|NCT00224003|532015464|FG000|Overall Study|Withdrawal by Subject|1|||
147508915|NCT00224003|532015464|FG000|Overall Study|unk|3|||
147508916|NCT01575899|532015465|FG000|Overall Study|Lost to Follow-up|3|||
147508917|NCT01575899|532015466|FG001|Overall Study|Lost to Follow-up|4|||
147508918|NCT01575899|532015467|FG002|Overall Study|Lost to Follow-up|2|||
147508919|NCT01575899|532015465|FG000|Overall Study|Protocol Violation|2|||
147508920|NCT01575899|532015466|FG001|Overall Study|Protocol Violation|1|||
147508921|NCT01575899|532015467|FG002|Overall Study|Protocol Violation|0|||
147508922|NCT02807844|532015468|FG000|Overall Study|Physician Decision|0|||
147669882|NCT00676143|532617433|FG000|Overall Study|Failed to return|2|||
147669883|NCT00676143|532617434|FG001|Overall Study|Failed to return|1|||
147669884|NCT00676143|532617433|FG000|Overall Study|Loss of caregiver|5|||
147669885|NCT00676143|532617434|FG001|Overall Study|Loss of caregiver|3|||
147669886|NCT00676143|532617433|FG000|Overall Study|Other|11|||
147669887|NCT00676143|532617434|FG001|Overall Study|Other|20|||
147669888|NCT00676143|532617433|FG000|Overall Study|Participant participation unknown|1|||
147669889|NCT00676143|532617434|FG001|Overall Study|Participant participation unknown|4|||
147669890|NCT00676143|532617433|FG000|Overall Study|Vasogenic edema recurrence|1|||
147669891|NCT00676143|532617434|FG001|Overall Study|Vasogenic edema recurrence|3|||
147669892|NCT03937778|532617435|FG000|Overall Study|Withdrawal by Subject|1|||
147669893|NCT03937778|532617435|FG000|Overall Study|Unable to obtain loss of A-beta sensation prior to loss of C-fiber sensation|1|||
147669894|NCT02065557|532617438|FG000|Induction Period|Withdrawal by Subject|2|||
147669895|NCT02065557|532617439|FG001|Induction Period|Withdrawal by Subject|1|||
147669896|NCT02065557|532617440|FG002|Induction Period|Withdrawal by Subject|0|||
147669897|NCT02065557|532617441|FG003|Induction Period|Withdrawal by Subject|0|||
147669898|NCT02065557|532617442|FG004|Induction Period|Withdrawal by Subject|0|||
147669899|NCT02065557|532617443|FG005|Induction Period|Withdrawal by Subject|0|||
147669900|NCT02065557|532617438|FG000|Induction Period|Lack of Efficacy|2|||
147669901|NCT02065557|532617439|FG001|Induction Period|Lack of Efficacy|1|||
147669902|NCT02065557|532617440|FG002|Induction Period|Lack of Efficacy|1|||
147669903|NCT02065557|532617441|FG003|Induction Period|Lack of Efficacy|0|||
147669904|NCT02065557|532617442|FG004|Induction Period|Lack of Efficacy|0|||
147669905|NCT02065557|532617443|FG005|Induction Period|Lack of Efficacy|0|||
147669906|NCT02065557|532617438|FG000|Induction Period|Requires Alternative/Prohibited Therapy|1|||
147669907|NCT02065557|532617439|FG001|Induction Period|Requires Alternative/Prohibited Therapy|1|||
147669908|NCT02065557|532617440|FG002|Induction Period|Requires Alternative/Prohibited Therapy|1|||
147669909|NCT02065557|532617441|FG003|Induction Period|Requires Alternative/Prohibited Therapy|0|||
147669910|NCT02065557|532617442|FG004|Induction Period|Requires Alternative/Prohibited Therapy|0|||
147669911|NCT02065557|532617443|FG005|Induction Period|Requires Alternative/Prohibited Therapy|0|||
147669912|NCT02065557|532617438|FG000|Induction Period|Non-Responder at Week 8|4|||
147669913|NCT02065557|532617439|FG001|Induction Period|Non-Responder at Week 8|4|||
147669914|NCT02065557|532617440|FG002|Induction Period|Non-Responder at Week 8|0|||
147669915|NCT02065557|532617441|FG003|Induction Period|Non-Responder at Week 8|0|||
147669916|NCT02065557|532617442|FG004|Induction Period|Non-Responder at Week 8|0|||
147669917|NCT02065557|532617443|FG005|Induction Period|Non-Responder at Week 8|0|||
147669918|NCT02065557|532617438|FG000|Induction Period|Adverse Event|1|||
147669919|NCT02065557|532617439|FG001|Induction Period|Adverse Event|1|||
147508923|NCT02807844|532015469|FG001|Overall Study|Physician Decision|0|||
147508924|NCT02807844|532015470|FG002|Overall Study|Physician Decision|0|||
147508925|NCT02807844|532015471|FG003|Overall Study|Physician Decision|0|||
147669920|NCT02065557|532617440|FG002|Induction Period|Adverse Event|0|||
147508926|NCT02807844|532015472|FG004|Overall Study|Physician Decision|0|||
147508927|NCT02807844|532015473|FG005|Overall Study|Physician Decision|0|||
147669921|NCT02065557|532617441|FG003|Induction Period|Adverse Event|0|||
147669922|NCT02065557|532617442|FG004|Induction Period|Adverse Event|0|||
147669923|NCT02065557|532617443|FG005|Induction Period|Adverse Event|0|||
147508928|NCT02807844|532015474|FG006|Overall Study|Physician Decision|3|||
147508929|NCT02807844|532015475|FG007|Overall Study|Physician Decision|0|||
147508930|NCT02807844|532015476|FG008|Overall Study|Physician Decision|1|||
147508931|NCT02807844|532015477|FG009|Overall Study|Physician Decision|2|||
147508932|NCT02807844|532015468|FG000|Overall Study|Death|0|||
147508933|NCT02807844|532015469|FG001|Overall Study|Death|0|||
147508934|NCT02807844|532015470|FG002|Overall Study|Death|2|||
147508935|NCT02807844|532015471|FG003|Overall Study|Death|4|||
147508936|NCT02807844|532015472|FG004|Overall Study|Death|1|||
147508937|NCT02807844|532015473|FG005|Overall Study|Death|2|||
147508938|NCT02807844|532015474|FG006|Overall Study|Death|1|||
147508939|NCT02807844|532015475|FG007|Overall Study|Death|2|||
147508940|NCT02807844|532015476|FG008|Overall Study|Death|0|||
147508941|NCT02807844|532015477|FG009|Overall Study|Death|1|||
147508942|NCT02807844|532015468|FG000|Overall Study|Withdrawal by Subject|0|||
147508943|NCT02807844|532015469|FG001|Overall Study|Withdrawal by Subject|0|||
147508944|NCT02807844|532015470|FG002|Overall Study|Withdrawal by Subject|2|||
147508945|NCT02807844|532015471|FG003|Overall Study|Withdrawal by Subject|1|||
147508946|NCT02807844|532015472|FG004|Overall Study|Withdrawal by Subject|1|||
147508947|NCT02807844|532015473|FG005|Overall Study|Withdrawal by Subject|0|||
147508948|NCT02807844|532015474|FG006|Overall Study|Withdrawal by Subject|1|||
147508949|NCT02807844|532015475|FG007|Overall Study|Withdrawal by Subject|0|||
147508950|NCT02807844|532015476|FG008|Overall Study|Withdrawal by Subject|0|||
147508951|NCT02807844|532015477|FG009|Overall Study|Withdrawal by Subject|0|||
147508952|NCT02807844|532015468|FG000|Overall Study|Progressive disease|5|||
147508953|NCT02807844|532015469|FG001|Overall Study|Progressive disease|12|||
147508954|NCT02807844|532015470|FG002|Overall Study|Progressive disease|8|||
147508955|NCT02807844|532015471|FG003|Overall Study|Progressive disease|8|||
147508956|NCT02807844|532015472|FG004|Overall Study|Progressive disease|3|||
147508957|NCT02807844|532015473|FG005|Overall Study|Progressive disease|8|||
147508958|NCT02807844|532015474|FG006|Overall Study|Progressive disease|14|||
147508959|NCT02807844|532015475|FG007|Overall Study|Progressive disease|17|||
147508960|NCT02807844|532015476|FG008|Overall Study|Progressive disease|19|||
147508961|NCT02807844|532015477|FG009|Overall Study|Progressive disease|15|||
147508962|NCT02807844|532015468|FG000|Overall Study|Adverse Event|1|||
147508963|NCT02807844|532015469|FG001|Overall Study|Adverse Event|0|||
147508964|NCT02807844|532015470|FG002|Overall Study|Adverse Event|0|||
147508965|NCT02807844|532015471|FG003|Overall Study|Adverse Event|0|||
147508966|NCT02807844|532015472|FG004|Overall Study|Adverse Event|1|||
147508967|NCT02807844|532015473|FG005|Overall Study|Adverse Event|1|||
147508968|NCT02807844|532015474|FG006|Overall Study|Adverse Event|1|||
147508969|NCT02807844|532015475|FG007|Overall Study|Adverse Event|1|||
147508970|NCT02807844|532015476|FG008|Overall Study|Adverse Event|1|||
147508971|NCT02807844|532015477|FG009|Overall Study|Adverse Event|2|||
147508972|NCT00709124|532015478|FG000|Overall Study|Death|3|||
147508973|NCT00709124|532015479|FG001|Overall Study|Death|1|||
147508974|NCT00709124|532015478|FG000|Overall Study|encephalopathy; can't do assessment|1|||
147508975|NCT00709124|532015479|FG001|Overall Study|encephalopathy; can't do assessment|0|||
147508976|NCT00373490|532015480|FG000|Overall Study|Adverse Event|0|||
147508977|NCT00373490|532015481|FG001|Overall Study|Adverse Event|1|||
147508978|NCT00373490|532015480|FG000|Overall Study|Lack of Efficacy|9|||
147508979|NCT00373490|532015481|FG001|Overall Study|Lack of Efficacy|4|||
147508980|NCT00373490|532015480|FG000|Overall Study|Withdrawal by Subject|0|||
147508981|NCT00373490|532015481|FG001|Overall Study|Withdrawal by Subject|1|||
147508982|NCT00108953|532015482|FG000|Follow-up|Death|18|||
147508983|NCT00108953|532015483|FG001|Follow-up|Death|26|||
147508984|NCT00108953|532015482|FG000|Follow-up|Lost to Follow-up|1|||
147508985|NCT00108953|532015483|FG001|Follow-up|Lost to Follow-up|1|||
147508986|NCT00108953|532015482|FG000|Follow-up|Study terminated by sponsor|10|||
147508987|NCT00108953|532015483|FG001|Follow-up|Study terminated by sponsor|6|||
147508988|NCT00753688|532015484|FG000|Overall Study|Death|102|||
147639608|NCT00833482|532497866|FG001|Days 11-20|Withdrawal by Subject|1|||
147639609|NCT00833482|532497867|FG002|Days 11-20|Withdrawal by Subject|0|||
147639610|NCT00833482|532497868|FG003|Days 11-20|Withdrawal by Subject|0|||
147639611|NCT00833482|532497869|FG004|Days 11-20|Withdrawal by Subject|0|||
147639612|NCT00833482|532497870|FG005|Days 11-20|Withdrawal by Subject|0|||
147639613|NCT00833482|532497865|FG000|Days 21-30|Adverse Event|0|||
147639614|NCT00833482|532497866|FG001|Days 21-30|Adverse Event|0|||
147639615|NCT00833482|532497867|FG002|Days 21-30|Adverse Event|1|||
147639616|NCT00833482|532497868|FG003|Days 21-30|Adverse Event|0|||
147508989|NCT00753688|532015485|FG001|Overall Study|Death|203|||
147508990|NCT00753688|532015484|FG000|Overall Study|Missing|4|||
147508991|NCT00753688|532015485|FG001|Overall Study|Missing|9|||
147508992|NCT00753688|532015484|FG000|Overall Study|Participant Withdrew Consent|2|||
147508993|NCT00753688|532015485|FG001|Overall Study|Participant Withdrew Consent|2|||
147508994|NCT00753688|532015484|FG000|Overall Study|Ongoing - in Follow-up|15|||
147508995|NCT00753688|532015485|FG001|Overall Study|Ongoing - in Follow-up|31|||
147508996|NCT00753688|532015484|FG000|Overall Study|Adverse Event|0|||
147508997|NCT00753688|532015485|FG001|Overall Study|Adverse Event|1|||
147508998|NCT03803202|532015486|FG000|Overall Study|Other|0|||
147508999|NCT03803202|532015487|FG001|Overall Study|Other|1|||
147639617|NCT00833482|532497869|FG004|Days 21-30|Adverse Event|0|||
147639618|NCT00833482|532497870|FG005|Days 21-30|Adverse Event|0|||
147639619|NCT00833482|532497865|FG000|Days 21-30|Withdrawal by Subject|0|||
147509000|NCT03803202|532015488|FG002|Overall Study|Other|0|||
147509001|NCT03803202|532015489|FG003|Overall Study|Other|0|||
147509002|NCT03803202|532015490|FG004|Overall Study|Other|0|||
147509003|NCT03803202|532015491|FG005|Overall Study|Other|0|||
147509004|NCT03803202|532015492|FG006|Overall Study|Other|0|||
147509005|NCT03803202|532015493|FG007|Overall Study|Other|0|||
147509006|NCT03803202|532015494|FG008|Overall Study|Other|0|||
147509007|NCT03803202|532015486|FG000|Overall Study|Death|0|||
147509008|NCT03803202|532015487|FG001|Overall Study|Death|0|||
147509009|NCT03803202|532015488|FG002|Overall Study|Death|0|||
147509010|NCT03803202|532015489|FG003|Overall Study|Death|0|||
147509011|NCT03803202|532015490|FG004|Overall Study|Death|0|||
147509012|NCT03803202|532015491|FG005|Overall Study|Death|1|||
147509013|NCT03803202|532015492|FG006|Overall Study|Death|0|||
147509014|NCT03803202|532015493|FG007|Overall Study|Death|0|||
147509015|NCT03803202|532015494|FG008|Overall Study|Death|0|||
147509016|NCT03803202|532015486|FG000|Overall Study|Withdrawal by Subject|0|||
147509017|NCT03803202|532015487|FG001|Overall Study|Withdrawal by Subject|0|||
147509018|NCT03803202|532015488|FG002|Overall Study|Withdrawal by Subject|1|||
147509019|NCT03803202|532015489|FG003|Overall Study|Withdrawal by Subject|0|||
147509020|NCT03803202|532015490|FG004|Overall Study|Withdrawal by Subject|0|||
147509021|NCT03803202|532015491|FG005|Overall Study|Withdrawal by Subject|0|||
147509022|NCT03803202|532015492|FG006|Overall Study|Withdrawal by Subject|0|||
147509023|NCT03803202|532015493|FG007|Overall Study|Withdrawal by Subject|1|||
147509024|NCT03803202|532015494|FG008|Overall Study|Withdrawal by Subject|0|||
147509025|NCT03803202|532015486|FG000|Overall Study|Lost to Follow-up|0|||
147509026|NCT03803202|532015487|FG001|Overall Study|Lost to Follow-up|0|||
147509027|NCT03803202|532015488|FG002|Overall Study|Lost to Follow-up|0|||
147509028|NCT03803202|532015489|FG003|Overall Study|Lost to Follow-up|1|||
147509029|NCT03803202|532015490|FG004|Overall Study|Lost to Follow-up|1|||
147509030|NCT03803202|532015491|FG005|Overall Study|Lost to Follow-up|0|||
147509031|NCT03803202|532015492|FG006|Overall Study|Lost to Follow-up|1|||
147509032|NCT03803202|532015493|FG007|Overall Study|Lost to Follow-up|0|||
147509033|NCT03803202|532015494|FG008|Overall Study|Lost to Follow-up|0|||
147509034|NCT02925312|532015497|FG000|Overall Study|Lost to Follow-up|25|||
147509035|NCT02925312|532015498|FG001|Overall Study|Lost to Follow-up|0|||
147509036|NCT02925312|532015497|FG000|Overall Study|Adverse Event|2|||
147509037|NCT02925312|532015498|FG001|Overall Study|Adverse Event|0|||
147509038|NCT00701441|532015501|FG000|Overall Study|failure in cpap compliance|0|||
147509039|NCT00701441|532015502|FG001|Overall Study|failure in cpap compliance|4|||
147509040|NCT01225172|532015506|FG000|Overall Study|Subject decision to stop|1|||
147509041|NCT01225172|532015507|FG001|Overall Study|Subject decision to stop|0|||
147509042|NCT01225172|532015506|FG000|Overall Study|Subject request to discontinue treatment|3|||
147509043|NCT01225172|532015507|FG001|Overall Study|Subject request to discontinue treatment|1|||
147509044|NCT01225172|532015506|FG000|Overall Study|Subject no longer meets study criteria|1|||
147509045|NCT01225172|532015507|FG001|Overall Study|Subject no longer meets study criteria|0|||
147509046|NCT01225172|532015506|FG000|Overall Study|Withdrawal by Subject|1|||
147509047|NCT01225172|532015507|FG001|Overall Study|Withdrawal by Subject|0|||
147509048|NCT03404518|532015512|FG000|Overall Study|Lost to Follow-up|28|||
147509049|NCT03404518|532015513|FG001|Overall Study|Lost to Follow-up|30|||
147509050|NCT03404518|532015512|FG000|Overall Study|Protocol Violation|13|||
147509051|NCT03404518|532015513|FG001|Overall Study|Protocol Violation|6|||
147509052|NCT03693404|532015515|FG000|Overall Study|Withdrawal by Subject|1|||
147509053|NCT03693404|532015516|FG001|Overall Study|Withdrawal by Subject|0|||
147509054|NCT03693404|532015515|FG000|Overall Study|Lost to Follow-up|0|||
147639620|NCT00833482|532497866|FG001|Days 21-30|Withdrawal by Subject|0|||
147509055|NCT03693404|532015516|FG001|Overall Study|Lost to Follow-up|5|||
147509056|NCT03693404|532015515|FG000|Overall Study|Excluded from Analysis|0|||
147509057|NCT03693404|532015516|FG001|Overall Study|Excluded from Analysis|1|||
147509058|NCT01576406|532015517|FG000|Overall Study|Lost to Follow-up|1|||
147509059|NCT01576406|532015518|FG001|Overall Study|Lost to Follow-up|2|||
147509060|NCT01576406|532015519|FG002|Overall Study|Lost to Follow-up|0|||
147509061|NCT01576406|532015520|FG003|Overall Study|Lost to Follow-up|0|||
147509062|NCT01576406|532015521|FG004|Overall Study|Lost to Follow-up|0|||
147509063|NCT01576406|532015522|FG005|Overall Study|Lost to Follow-up|0|||
147509064|NCT01576406|532015517|FG000|Overall Study|Death|3|||
147509065|NCT01576406|532015518|FG001|Overall Study|Death|4|||
147509066|NCT01576406|532015519|FG002|Overall Study|Death|8|||
147509067|NCT01576406|532015520|FG003|Overall Study|Death|5|||
147509068|NCT01576406|532015521|FG004|Overall Study|Death|7|||
147509069|NCT01576406|532015522|FG005|Overall Study|Death|9|||
147509070|NCT01576406|532015517|FG000|Overall Study|Non-clinical trial supply of Crizotinib|0|||
147509071|NCT01576406|532015518|FG001|Overall Study|Non-clinical trial supply of Crizotinib|0|||
147509072|NCT01576406|532015519|FG002|Overall Study|Non-clinical trial supply of Crizotinib|1|||
147509073|NCT01576406|532015520|FG003|Overall Study|Non-clinical trial supply of Crizotinib|1|||
147509074|NCT01576406|532015521|FG004|Overall Study|Non-clinical trial supply of Crizotinib|0|||
147509075|NCT01576406|532015522|FG005|Overall Study|Non-clinical trial supply of Crizotinib|0|||
147509076|NCT01576406|532015517|FG000|Overall Study|Withdrawal the consent|2|||
147509077|NCT01576406|532015518|FG001|Overall Study|Withdrawal the consent|2|||
147509078|NCT01576406|532015519|FG002|Overall Study|Withdrawal the consent|5|||
147509079|NCT01576406|532015520|FG003|Overall Study|Withdrawal the consent|1|||
147509080|NCT01576406|532015521|FG004|Overall Study|Withdrawal the consent|1|||
147509081|NCT01576406|532015522|FG005|Overall Study|Withdrawal the consent|3|||
147509082|NCT01576406|532015517|FG000|Overall Study|Other|0|||
147509083|NCT01576406|532015518|FG001|Overall Study|Other|0|||
147509084|NCT01576406|532015519|FG002|Overall Study|Other|2|||
147509085|NCT01576406|532015520|FG003|Overall Study|Other|2|||
147509086|NCT01576406|532015521|FG004|Overall Study|Other|0|||
147509087|NCT01576406|532015522|FG005|Overall Study|Other|0|||
147509088|NCT00651313|532015523|FG000|Overall Study|Adverse Event|0|||
147509089|NCT00651313|532015524|FG001|Overall Study|Adverse Event|1|||
147509090|NCT00651313|532015523|FG000|Overall Study|Withdrawal by Subject|3|||
147509091|NCT00651313|532015524|FG001|Overall Study|Withdrawal by Subject|1|||
147509092|NCT00651313|532015523|FG000|Overall Study|Lost to Follow-up|1|||
147509093|NCT00651313|532015524|FG001|Overall Study|Lost to Follow-up|1|||
147509094|NCT00651313|532015523|FG000|Overall Study|Adminstrative Discontinuation|2|||
147509095|NCT00651313|532015524|FG001|Overall Study|Adminstrative Discontinuation|3|||
147509096|NCT00892957|532015526|FG000|Between Postoperative Day 1 and Day 14|Death|0|||
147509097|NCT00892957|532015527|FG001|Between Postoperative Day 1 and Day 14|Death|2|||
147509098|NCT00892957|532015526|FG000|Between Postoperative Day 1 and Day 14|Lost to Follow-up|0|||
147509099|NCT00892957|532015527|FG001|Between Postoperative Day 1 and Day 14|Lost to Follow-up|2|||
147509100|NCT00676208|532015541|FG000|Overall Study|Lost to Follow-up|0|||
147509101|NCT00676208|532015542|FG001|Overall Study|Lost to Follow-up|2|||
147509102|NCT00676208|532015541|FG000|Overall Study|Incomplete data|2|||
147509103|NCT00676208|532015542|FG001|Overall Study|Incomplete data|4|||
147509104|NCT00669032|532015543|FG000|Overall Study|Lost to Follow-up|6|||
147509105|NCT00669032|532015544|FG001|Overall Study|Lost to Follow-up|5|||
147509106|NCT00669032|532015543|FG000|Overall Study|Lack of Efficacy|8|||
147509107|NCT00669032|532015544|FG001|Overall Study|Lack of Efficacy|19|||
147509108|NCT00669032|532015543|FG000|Overall Study|Withdrawal by Subject|12|||
147509109|NCT00669032|532015544|FG001|Overall Study|Withdrawal by Subject|13|||
147509110|NCT00669032|532015543|FG000|Overall Study|Adverse Event|12|||
147509111|NCT00669032|532015544|FG001|Overall Study|Adverse Event|16|||
147509112|NCT00669032|532015543|FG000|Overall Study|Physician Decision|1|||
147509113|NCT00669032|532015544|FG001|Overall Study|Physician Decision|1|||
147509114|NCT00669032|532015543|FG000|Overall Study|No fulfilment of the selection criteria|5|||
147509115|NCT00669032|532015544|FG001|Overall Study|No fulfilment of the selection criteria|5|||
147509116|NCT01607073|532015545|FG000|Overall Study|Adverse Event|1|||
147639621|NCT00833482|532497867|FG002|Days 21-30|Withdrawal by Subject|0|||
147639622|NCT00833482|532497868|FG003|Days 21-30|Withdrawal by Subject|0|||
147639623|NCT00833482|532497869|FG004|Days 21-30|Withdrawal by Subject|1|||
147639624|NCT00833482|532497870|FG005|Days 21-30|Withdrawal by Subject|0|||
147639625|NCT02496091|532497871|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
147639626|NCT02600845|532497882|FG000|Overall Study|Reason Not Specified|3|||
147639627|NCT02600845|532497882|FG000|Overall Study|Non-compliance with Study Procedures|10|||
147639628|NCT02600845|532497882|FG000|Overall Study|Consent Withdrawal|5|||
147639629|NCT04161079|532499361|FG000|Clinical Investigation 2010-040|Adverse Event|1|||
147639630|NCT02515994|532499362|FG000|Overall Study|Protocol Violation|3|||
147639631|NCT02515994|532499363|FG001|Overall Study|Protocol Violation|5|||
147639632|NCT02515994|532499362|FG000|Overall Study|No Longer Meets Eligibility Criteria|2|||
147639633|NCT02515994|532499363|FG001|Overall Study|No Longer Meets Eligibility Criteria|1|||
147639634|NCT02515994|532499362|FG000|Overall Study|Adverse Event|3|||
147639635|NCT02515994|532499363|FG001|Overall Study|Adverse Event|1|||
147639636|NCT02515994|532499362|FG000|Overall Study|Withdrawal by Subject|2|||
147639637|NCT02515994|532499363|FG001|Overall Study|Withdrawal by Subject|0|||
147639638|NCT04045132|532499366|FG000|Overall Study|Lost to Follow-up|3|||
147639639|NCT04045132|532499367|FG001|Overall Study|Lost to Follow-up|6|||
147639640|NCT01632150|532499368|FG000|Overall Study|Disease progression|27|||
147639641|NCT01632150|532499368|FG000|Overall Study|Study drug toxicity|1|||
147639642|NCT01632150|532499368|FG000|Overall Study|Unrelated adverse event|7|||
147639643|NCT01632150|532499368|FG000|Overall Study|Withdrawal by Subject|2|||
147639644|NCT01632150|532499368|FG000|Overall Study|Patient underwent autologous transplant|1|||
147639645|NCT01632150|532499368|FG000|Overall Study|Moved to compassionate program|2|||
147639646|NCT02879994|532499371|FG000|Overall Study|off treatment early|7|||
147639647|NCT02879994|532499371|FG000|Overall Study|Adverse Event|2|||
147639648|NCT02879994|532499371|FG000|Overall Study|Death|2|||
147509117|NCT00642018|532015546|FG000|Overall Study|Adverse Event|11|||
147509118|NCT00642018|532015547|FG001|Overall Study|Adverse Event|36|||
147509119|NCT00642018|532015546|FG000|Overall Study|Withdrawal by Subject|4|||
147509120|NCT00642018|532015547|FG001|Overall Study|Withdrawal by Subject|10|||
147509121|NCT00642018|532015546|FG000|Overall Study|Progressive Disease|13|||
147509122|NCT00642018|532015547|FG001|Overall Study|Progressive Disease|18|||
147509123|NCT00642018|532015546|FG000|Overall Study|Physician Decision|0|||
147509124|NCT00642018|532015547|FG001|Overall Study|Physician Decision|10|||
147509125|NCT00642018|532015546|FG000|Overall Study|Protocol Violation|0|||
147639649|NCT02143791|532499372|FG000|Enrolled|Withdrawal by Subject|4|||
147509126|NCT00642018|532015547|FG001|Overall Study|Protocol Violation|1|||
147509127|NCT00642018|532015546|FG000|Overall Study|Death|0|||
147509128|NCT00642018|532015547|FG001|Overall Study|Death|3|||
147669924|NCT02065557|532617438|FG000|Maintenance Period|Requires Alternative/Prohibited Therapy|0|||
147669925|NCT02065557|532617439|FG001|Maintenance Period|Requires Alternative/Prohibited Therapy|0|||
147669926|NCT02065557|532617440|FG002|Maintenance Period|Requires Alternative/Prohibited Therapy|0|||
147669927|NCT02065557|532617441|FG003|Maintenance Period|Requires Alternative/Prohibited Therapy|1|||
147669928|NCT02065557|532617442|FG004|Maintenance Period|Requires Alternative/Prohibited Therapy|1|||
147669929|NCT02065557|532617443|FG005|Maintenance Period|Requires Alternative/Prohibited Therapy|0|||
147669930|NCT02065557|532617438|FG000|Maintenance Period|Withdrawal by Subject|0|||
147669931|NCT02065557|532617439|FG001|Maintenance Period|Withdrawal by Subject|0|||
147669932|NCT02065557|532617440|FG002|Maintenance Period|Withdrawal by Subject|0|||
147669933|NCT02065557|532617441|FG003|Maintenance Period|Withdrawal by Subject|0|||
147669934|NCT02065557|532617442|FG004|Maintenance Period|Withdrawal by Subject|2|||
147669935|NCT02065557|532617443|FG005|Maintenance Period|Withdrawal by Subject|1|||
147669936|NCT02065557|532617438|FG000|Maintenance Period|Lack of Efficacy|0|||
147669937|NCT02065557|532617439|FG001|Maintenance Period|Lack of Efficacy|0|||
147669938|NCT02065557|532617440|FG002|Maintenance Period|Lack of Efficacy|0|||
147669939|NCT02065557|532617441|FG003|Maintenance Period|Lack of Efficacy|0|||
147669940|NCT02065557|532617442|FG004|Maintenance Period|Lack of Efficacy|5|||
147669941|NCT02065557|532617443|FG005|Maintenance Period|Lack of Efficacy|2|||
147669942|NCT02065557|532617438|FG000|Maintenance Period|Subject Non-Compliance|0|||
147669943|NCT02065557|532617439|FG001|Maintenance Period|Subject Non-Compliance|0|||
147669944|NCT02065557|532617440|FG002|Maintenance Period|Subject Non-Compliance|0|||
147669945|NCT02065557|532617441|FG003|Maintenance Period|Subject Non-Compliance|0|||
147669946|NCT02065557|532617442|FG004|Maintenance Period|Subject Non-Compliance|0|||
147669947|NCT02065557|532617443|FG005|Maintenance Period|Subject Non-Compliance|1|||
147669948|NCT01200355|532617444|FG000|Overall Study|Death|7|||
147669949|NCT01200355|532617445|FG001|Overall Study|Death|2|||
147669950|NCT00706797|532617446|FG000|Overall Study|Lack of Efficacy|3|||
147669951|NCT00706797|532617447|FG001|Overall Study|Lack of Efficacy|0|||
147669952|NCT00706797|532617446|FG000|Overall Study|Adverse Event|0|||
147669953|NCT00706797|532617447|FG001|Overall Study|Adverse Event|3|||
147669954|NCT00706797|532617446|FG000|Overall Study|Withdrawal by Subject|8|||
147669955|NCT00706797|532617447|FG001|Overall Study|Withdrawal by Subject|1|||
147669956|NCT00706797|532617446|FG000|Overall Study|Death|1|||
147669957|NCT00706797|532617447|FG001|Overall Study|Death|0|||
147669958|NCT00706797|532617446|FG000|Overall Study|Discontinuation of study by sponsor|52|||
147669959|NCT00706797|532617447|FG001|Overall Study|Discontinuation of study by sponsor|63|||
147669960|NCT00706797|532617446|FG000|Overall Study|Protocol Violation|3|||
147669961|NCT00706797|532617447|FG001|Overall Study|Protocol Violation|2|||
147669962|NCT00706797|532617446|FG000|Overall Study|Lost to Follow-up|1|||
147669963|NCT00706797|532617447|FG001|Overall Study|Lost to Follow-up|2|||
147669964|NCT00706797|532617446|FG000|Overall Study|Other|1|||
147669965|NCT00706797|532617447|FG001|Overall Study|Other|0|||
147669966|NCT00368550|532617452|FG000|Overall Study|Adverse Event|7|||
147669967|NCT00368550|532617453|FG001|Overall Study|Adverse Event|4|||
147669968|NCT00368550|532617452|FG000|Overall Study|Lack of Efficacy|4|||
147669969|NCT00368550|532617453|FG001|Overall Study|Lack of Efficacy|9|||
147669970|NCT00368550|532617452|FG000|Overall Study|Withdrawal by Subject|17|||
147669971|NCT00368550|532617453|FG001|Overall Study|Withdrawal by Subject|10|||
147669972|NCT02309359|532617457|FG000|Overall Study|Adverse Event|4|||
147669973|NCT02309359|532617458|FG001|Overall Study|Adverse Event|5|||
147669974|NCT02309359|532617459|FG002|Overall Study|Adverse Event|5|||
147669975|NCT02309359|532617460|FG003|Overall Study|Adverse Event|4|||
147669976|NCT02309359|532617461|FG004|Overall Study|Adverse Event|4|||
147669977|NCT02309359|532617457|FG000|Overall Study|Death|1|||
147669978|NCT02309359|532617458|FG001|Overall Study|Death|0|||
147669979|NCT02309359|532617459|FG002|Overall Study|Death|0|||
147669980|NCT02309359|532617460|FG003|Overall Study|Death|0|||
147669981|NCT02309359|532617461|FG004|Overall Study|Death|0|||
147669982|NCT02309359|532617457|FG000|Overall Study|Withdrawal by Subject|2|||
147669983|NCT02309359|532617458|FG001|Overall Study|Withdrawal by Subject|2|||
147669984|NCT02309359|532617459|FG002|Overall Study|Withdrawal by Subject|4|||
147669985|NCT02309359|532617460|FG003|Overall Study|Withdrawal by Subject|4|||
147669986|NCT02309359|532617461|FG004|Overall Study|Withdrawal by Subject|0|||
147669987|NCT02309359|532617457|FG000|Overall Study|Lack of Efficacy|3|||
147669988|NCT02309359|532617458|FG001|Overall Study|Lack of Efficacy|1|||
147669989|NCT02309359|532617459|FG002|Overall Study|Lack of Efficacy|0|||
147669990|NCT02309359|532617460|FG003|Overall Study|Lack of Efficacy|0|||
147669991|NCT02309359|532617461|FG004|Overall Study|Lack of Efficacy|3|||
147669992|NCT02309359|532617457|FG000|Overall Study|Lost to Follow-up|0|||
147669993|NCT02309359|532617458|FG001|Overall Study|Lost to Follow-up|0|||
147669994|NCT02309359|532617459|FG002|Overall Study|Lost to Follow-up|0|||
147669995|NCT02309359|532617460|FG003|Overall Study|Lost to Follow-up|1|||
147669996|NCT02309359|532617461|FG004|Overall Study|Lost to Follow-up|0|||
147669997|NCT02309359|532617457|FG000|Overall Study|Other|2|||
147509129|NCT00642018|532015546|FG000|Overall Study|Entry Criteria Not Met|0|||
147509130|NCT00642018|532015547|FG001|Overall Study|Entry Criteria Not Met|1|||
147509131|NCT01410799|532015548|FG000|Overall Study|PI decision|13|||
147509132|NCT04126031|532015550|FG000|Part A|Withdrawal by Subject|0|||
147509133|NCT04126031|532015551|FG001|Part A|Withdrawal by Subject|0|||
147509134|NCT04126031|532015552|FG002|Part A|Withdrawal by Subject|1|||
147509135|NCT04126031|532015553|FG003|Part A|Withdrawal by Subject|0|||
147509136|NCT04126031|532015554|FG004|Part A|Withdrawal by Subject|0|||
147509137|NCT04126031|532015555|FG005|Part A|Withdrawal by Subject|0|||
147509138|NCT04126031|532015550|FG000|Part A|Other|1|||
147509139|NCT04126031|532015551|FG001|Part A|Other|0|||
147509140|NCT04126031|532015552|FG002|Part A|Other|0|||
147509141|NCT04126031|532015553|FG003|Part A|Other|0|||
147509142|NCT04126031|532015554|FG004|Part A|Other|0|||
147509143|NCT04126031|532015555|FG005|Part A|Other|0|||
147509144|NCT04126031|532015550|FG000|Part B|Adverse Event|0|||
147509145|NCT04126031|532015551|FG001|Part B|Adverse Event|0|||
147509146|NCT04126031|532015552|FG002|Part B|Adverse Event|0|||
147509147|NCT04126031|532015553|FG003|Part B|Adverse Event|0|||
147509148|NCT04126031|532015554|FG004|Part B|Adverse Event|0|||
147509149|NCT04126031|532015555|FG005|Part B|Adverse Event|2|||
147509150|NCT04126031|532015550|FG000|Part B|Pre-existing hypertransaminasemia|0|||
147509151|NCT04126031|532015551|FG001|Part B|Pre-existing hypertransaminasemia|0|||
147509152|NCT04126031|532015552|FG002|Part B|Pre-existing hypertransaminasemia|0|||
147509153|NCT04126031|532015553|FG003|Part B|Pre-existing hypertransaminasemia|0|||
147509154|NCT04126031|532015554|FG004|Part B|Pre-existing hypertransaminasemia|1|||
147509155|NCT04126031|532015555|FG005|Part B|Pre-existing hypertransaminasemia|0|||
147509156|NCT00617656|532015556|FG000|Overall Study|Inclusion error|4|||
147509157|NCT00617656|532015557|FG001|Overall Study|Inclusion error|4|||
147509158|NCT00617656|532015558|FG002|Overall Study|Inclusion error|0|||
147509159|NCT00617656|532015559|FG003|Overall Study|Inclusion error|0|||
147509160|NCT00617656|532015556|FG000|Overall Study|Missing data|44|||
147509161|NCT00617656|532015557|FG001|Overall Study|Missing data|30|||
147509162|NCT00617656|532015558|FG002|Overall Study|Missing data|13|||
147509163|NCT00617656|532015559|FG003|Overall Study|Missing data|6|||
147509164|NCT00617656|532015556|FG000|Overall Study|Withdrawal by Subject|0|||
147509165|NCT00617656|532015557|FG001|Overall Study|Withdrawal by Subject|2|||
147509166|NCT00617656|532015558|FG002|Overall Study|Withdrawal by Subject|0|||
147509167|NCT00617656|532015559|FG003|Overall Study|Withdrawal by Subject|0|||
147509168|NCT01946412|532015560|FG000|Overall Study|Adverse Event|1|||
147509169|NCT01946412|532015560|FG000|Overall Study|Non-Compliance|1|||
147509170|NCT01946412|532015560|FG000|Overall Study|Continued with commercial Kalydeco|2|||
147509171|NCT01946412|532015560|FG000|Overall Study|Difficulty in swallowing|1|||
147509172|NCT00131664|532015561|FG000|First Period (First 6 Months)|Lost to Follow-up|7|||
147509173|NCT00131664|532015562|FG001|First Period (First 6 Months)|Lost to Follow-up|3|||
147509174|NCT00131664|532015563|FG002|First Period (First 6 Months)|Lost to Follow-up|3|||
147509175|NCT00131664|532015564|FG003|First Period (First 6 Months)|Lost to Follow-up|0|||
147509176|NCT00131664|532015565|FG004|First Period (First 6 Months)|Lost to Follow-up|0|||
147509177|NCT00131664|532015566|FG005|First Period (First 6 Months)|Lost to Follow-up|0|||
147509178|NCT00131664|532015561|FG000|First Period (First 6 Months)|Death|0|||
147509179|NCT00131664|532015562|FG001|First Period (First 6 Months)|Death|1|||
147509180|NCT00131664|532015563|FG002|First Period (First 6 Months)|Death|0|||
147509181|NCT00131664|532015564|FG003|First Period (First 6 Months)|Death|0|||
147509182|NCT00131664|532015565|FG004|First Period (First 6 Months)|Death|0|||
147509183|NCT00131664|532015566|FG005|First Period (First 6 Months)|Death|0|||
147509184|NCT00131664|532015561|FG000|First Period (First 6 Months)|Protocol Violation|2|||
147509185|NCT00131664|532015562|FG001|First Period (First 6 Months)|Protocol Violation|2|||
147509186|NCT00131664|532015563|FG002|First Period (First 6 Months)|Protocol Violation|1|||
147509187|NCT00131664|532015564|FG003|First Period (First 6 Months)|Protocol Violation|0|||
147509188|NCT00131664|532015565|FG004|First Period (First 6 Months)|Protocol Violation|0|||
147509189|NCT00131664|532015566|FG005|First Period (First 6 Months)|Protocol Violation|0|||
147509190|NCT00131664|532015561|FG000|First Period (First 6 Months)|Withdrawal by Subject|4|||
147509191|NCT00131664|532015562|FG001|First Period (First 6 Months)|Withdrawal by Subject|6|||
147509192|NCT00131664|532015563|FG002|First Period (First 6 Months)|Withdrawal by Subject|2|||
147509193|NCT00131664|532015564|FG003|First Period (First 6 Months)|Withdrawal by Subject|0|||
147509194|NCT00131664|532015565|FG004|First Period (First 6 Months)|Withdrawal by Subject|0|||
147509195|NCT00131664|532015566|FG005|First Period (First 6 Months)|Withdrawal by Subject|0|||
147509196|NCT00131664|532015561|FG000|First Period (First 6 Months)|Adverse Event|9|||
147509197|NCT00131664|532015562|FG001|First Period (First 6 Months)|Adverse Event|4|||
147509198|NCT00131664|532015563|FG002|First Period (First 6 Months)|Adverse Event|5|||
147509199|NCT00131664|532015564|FG003|First Period (First 6 Months)|Adverse Event|0|||
147509200|NCT00131664|532015565|FG004|First Period (First 6 Months)|Adverse Event|0|||
147509201|NCT00131664|532015566|FG005|First Period (First 6 Months)|Adverse Event|0|||
147509202|NCT00131664|532015561|FG000|First Period (First 6 Months)|Clinically significant lab abnormalities|1|||
147509203|NCT00131664|532015562|FG001|First Period (First 6 Months)|Clinically significant lab abnormalities|2|||
147509204|NCT00131664|532015563|FG002|First Period (First 6 Months)|Clinically significant lab abnormalities|0|||
147669998|NCT02309359|532617458|FG001|Overall Study|Other|0|||
147509205|NCT00131664|532015564|FG003|First Period (First 6 Months)|Clinically significant lab abnormalities|0|||
147509206|NCT00131664|532015565|FG004|First Period (First 6 Months)|Clinically significant lab abnormalities|0|||
147509207|NCT00131664|532015566|FG005|First Period (First 6 Months)|Clinically significant lab abnormalities|0|||
147509208|NCT00131664|532015561|FG000|First Period (First 6 Months)|Administrative reasons|2|||
147509209|NCT00131664|532015562|FG001|First Period (First 6 Months)|Administrative reasons|0|||
147509210|NCT00131664|532015563|FG002|First Period (First 6 Months)|Administrative reasons|5|||
147509211|NCT00131664|532015564|FG003|First Period (First 6 Months)|Administrative reasons|0|||
147509212|NCT00131664|532015565|FG004|First Period (First 6 Months)|Administrative reasons|0|||
147509213|NCT00131664|532015566|FG005|First Period (First 6 Months)|Administrative reasons|0|||
147509214|NCT00131664|532015561|FG000|Second Period (Additional Drug Added)|Lost to Follow-up|3|||
147509215|NCT00131664|532015562|FG001|Second Period (Additional Drug Added)|Lost to Follow-up|0|||
147509216|NCT00131664|532015563|FG002|Second Period (Additional Drug Added)|Lost to Follow-up|2|||
147509217|NCT00131664|532015564|FG003|Second Period (Additional Drug Added)|Lost to Follow-up|1|||
147509218|NCT00131664|532015565|FG004|Second Period (Additional Drug Added)|Lost to Follow-up|0|||
147509219|NCT00131664|532015566|FG005|Second Period (Additional Drug Added)|Lost to Follow-up|2|||
147509220|NCT00131664|532015561|FG000|Second Period (Additional Drug Added)|Protocol Violation|0|||
147509221|NCT00131664|532015562|FG001|Second Period (Additional Drug Added)|Protocol Violation|1|||
147509222|NCT00131664|532015563|FG002|Second Period (Additional Drug Added)|Protocol Violation|1|||
147509223|NCT00131664|532015564|FG003|Second Period (Additional Drug Added)|Protocol Violation|0|||
147509224|NCT00131664|532015565|FG004|Second Period (Additional Drug Added)|Protocol Violation|0|||
147509225|NCT00131664|532015566|FG005|Second Period (Additional Drug Added)|Protocol Violation|0|||
147509226|NCT00131664|532015561|FG000|Second Period (Additional Drug Added)|Withdrawal by Subject|2|||
147509227|NCT00131664|532015562|FG001|Second Period (Additional Drug Added)|Withdrawal by Subject|0|||
147509228|NCT00131664|532015563|FG002|Second Period (Additional Drug Added)|Withdrawal by Subject|0|||
147509229|NCT00131664|532015564|FG003|Second Period (Additional Drug Added)|Withdrawal by Subject|0|||
147509230|NCT00131664|532015565|FG004|Second Period (Additional Drug Added)|Withdrawal by Subject|0|||
147509231|NCT00131664|532015566|FG005|Second Period (Additional Drug Added)|Withdrawal by Subject|0|||
147509232|NCT00131664|532015561|FG000|Second Period (Additional Drug Added)|Adverse Event|0|||
147509233|NCT00131664|532015562|FG001|Second Period (Additional Drug Added)|Adverse Event|1|||
147509234|NCT00131664|532015563|FG002|Second Period (Additional Drug Added)|Adverse Event|0|||
147509235|NCT00131664|532015564|FG003|Second Period (Additional Drug Added)|Adverse Event|0|||
147509236|NCT00131664|532015565|FG004|Second Period (Additional Drug Added)|Adverse Event|0|||
147509237|NCT00131664|532015566|FG005|Second Period (Additional Drug Added)|Adverse Event|1|||
147509238|NCT00131664|532015561|FG000|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0|||
147509239|NCT00131664|532015562|FG001|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0|||
147509240|NCT00131664|532015563|FG002|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0|||
147509241|NCT00131664|532015564|FG003|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|1|||
147509242|NCT00131664|532015565|FG004|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0|||
147509243|NCT00131664|532015566|FG005|Second Period (Additional Drug Added)|Clinically significant lab abnormalities|0|||
147509244|NCT00131664|532015561|FG000|Second Period (Additional Drug Added)|Administrative reasons|4|||
147509245|NCT00131664|532015562|FG001|Second Period (Additional Drug Added)|Administrative reasons|2|||
147509246|NCT00131664|532015563|FG002|Second Period (Additional Drug Added)|Administrative reasons|0|||
147509247|NCT00131664|532015564|FG003|Second Period (Additional Drug Added)|Administrative reasons|0|||
147509248|NCT00131664|532015565|FG004|Second Period (Additional Drug Added)|Administrative reasons|1|||
147509249|NCT00131664|532015566|FG005|Second Period (Additional Drug Added)|Administrative reasons|0|||
147509250|NCT00323310|532017594|FG000|Overall Study|Withdrawal by Subject|1|||
147509251|NCT00323310|532017594|FG000|Overall Study|a parent refused blood draw|1|||
147509252|NCT00323310|532017594|FG000|Overall Study|did not complete the 24-hr f-up visit|1|||
147509253|NCT00446641|532017595|FG000|Overall Study|Withdrawal by Subject|8|||
147509254|NCT00446641|532017596|FG001|Overall Study|Withdrawal by Subject|3|||
147509255|NCT00446641|532017595|FG000|Overall Study|poor compliance|8|||
147509256|NCT00446641|532017596|FG001|Overall Study|poor compliance|6|||
147669999|NCT02309359|532617459|FG002|Overall Study|Other|2|||
147670000|NCT02309359|532617460|FG003|Overall Study|Other|3|||
147670001|NCT02309359|532617461|FG004|Overall Study|Other|2|||
147670002|NCT01604785|532617463|FG000|Overall Study|Repeat Visits Not Included in Analysis|7|||
147670003|NCT01604785|532617464|FG001|Overall Study|Repeat Visits Not Included in Analysis|1|||
147509257|NCT00446641|532017595|FG000|Overall Study|Lost to Follow-up|1|||
147509258|NCT00446641|532017596|FG001|Overall Study|Lost to Follow-up|1|||
147509259|NCT03565991|532017597|FG000|Overall Study|Other|11|||
147509260|NCT03565991|532017598|FG001|Overall Study|Other|0|||
147670004|NCT03040726|532617465|FG000|Overall Study|Reasons for not completing Placebo run in phase phase; Drop Out|4|||
147670005|NCT03040726|532617466|FG001|Overall Study|Reasons for not completing Placebo run in phase phase; Drop Out|0|||
147670006|NCT03040726|532617465|FG000|Overall Study|Reasons for not completing Placebo run in phase phase; withdrawal|1|||
147670007|NCT03040726|532617466|FG001|Overall Study|Reasons for not completing Placebo run in phase phase; withdrawal|1|||
147509261|NCT03565991|532017597|FG000|Overall Study|Global deterioration of health status|14|||
147509262|NCT03565991|532017598|FG001|Overall Study|Global deterioration of health status|4|||
147509263|NCT03565991|532017597|FG000|Overall Study|Withdrawal by Subject|2|||
147509264|NCT03565991|532017598|FG001|Overall Study|Withdrawal by Subject|6|||
147509265|NCT03565991|532017597|FG000|Overall Study|Progressive disease|121|||
147509266|NCT03565991|532017598|FG001|Overall Study|Progressive disease|29|||
147509267|NCT03565991|532017597|FG000|Overall Study|Death|3|||
147509268|NCT03565991|532017598|FG001|Overall Study|Death|0|||
147509269|NCT03565991|532017597|FG000|Overall Study|Adverse Event|7|||
147509270|NCT03565991|532017598|FG001|Overall Study|Adverse Event|2|||
147509271|NCT02009930|532017608|FG000|Overall Study|withdrawn|5|||
147509272|NCT02959970|532017611|FG000|Overall Study|Adverse Event|1|||
147509273|NCT02959970|532017612|FG001|Overall Study|Adverse Event|0|||
147509274|NCT02959970|532017611|FG000|Overall Study|Withdrawal by Subject|0|||
147509275|NCT02959970|532017612|FG001|Overall Study|Withdrawal by Subject|2|||
147509276|NCT02959970|532017611|FG000|Overall Study|Lost to Follow-up|1|||
147509277|NCT02959970|532017612|FG001|Overall Study|Lost to Follow-up|5|||
147509278|NCT00666536|532017613|FG000|Overall Study|Adverse Event|9|||
147509279|NCT00666536|532017614|FG001|Overall Study|Adverse Event|19|||
147509280|NCT00666536|532017613|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
147509281|NCT00666536|532017614|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
147509282|NCT00666536|532017613|FG000|Overall Study|Protocol deviation(s)|8|||
147509283|NCT00666536|532017614|FG001|Overall Study|Protocol deviation(s)|6|||
147509284|NCT00666536|532017613|FG000|Overall Study|Withdrawal by Subject|10|||
147509285|NCT00666536|532017614|FG001|Overall Study|Withdrawal by Subject|9|||
147509286|NCT00666536|532017613|FG000|Overall Study|Lost to Follow-up|4|||
147509287|NCT00666536|532017614|FG001|Overall Study|Lost to Follow-up|3|||
147509288|NCT03805971|532017626|FG000|Overall Study|Withdrawal by Subject|1|||
147509289|NCT03805971|532017626|FG000|Overall Study|Protocol Violation|2|||
147509290|NCT00254163|532017633|FG000|Overall Study|Adverse Event|29|||
147509291|NCT00254163|532017634|FG001|Overall Study|Adverse Event|26|||
147509292|NCT00254163|532017633|FG000|Overall Study|Patient request/withdrew consent|6|||
147509293|NCT00254163|532017634|FG001|Overall Study|Patient request/withdrew consent|4|||
147509294|NCT00254163|532017633|FG000|Overall Study|Investigator request|1|||
147509295|NCT00254163|532017634|FG001|Overall Study|Investigator request|3|||
147509296|NCT00254163|532017633|FG000|Overall Study|Failed entry|1|||
147509297|NCT00254163|532017634|FG001|Overall Study|Failed entry|3|||
147509298|NCT00254163|532017633|FG000|Overall Study|Progressive disease|0|||
147509299|NCT00254163|532017634|FG001|Overall Study|Progressive disease|1|||
147509300|NCT00254163|532017633|FG000|Overall Study|Death|0|||
147509301|NCT00254163|532017634|FG001|Overall Study|Death|1|||
147509302|NCT00254163|532017633|FG000|Overall Study|Other|8|||
147509303|NCT00254163|532017634|FG001|Overall Study|Other|8|||
147509304|NCT01355497|532017644|FG000|Overall Study|Death|19|||
147509305|NCT01355497|532017645|FG001|Overall Study|Death|18|||
147509306|NCT01355497|532017644|FG000|Overall Study|Lost to Follow-up|3|||
147509307|NCT01355497|532017645|FG001|Overall Study|Lost to Follow-up|0|||
147509308|NCT01355497|532017644|FG000|Overall Study|Protocol Violation|0|||
147509309|NCT01355497|532017645|FG001|Overall Study|Protocol Violation|1|||
147509310|NCT01355497|532017644|FG000|Overall Study|other-not provided|9|||
147509311|NCT01355497|532017645|FG001|Overall Study|other-not provided|4|||
147509312|NCT01355497|532017644|FG000|Overall Study|Withdrawal by Subject|12|||
147509313|NCT01355497|532017645|FG001|Overall Study|Withdrawal by Subject|20|||
147509314|NCT01355497|532017644|FG000|Overall Study|noncompliance|1|||
147509315|NCT01355497|532017645|FG001|Overall Study|noncompliance|2|||
147509316|NCT01355497|532017644|FG000|Overall Study|progressive disease|11|||
147509317|NCT01355497|532017645|FG001|Overall Study|progressive disease|8|||
147509318|NCT01355497|532017644|FG000|Overall Study|Adverse Event|11|||
147509319|NCT01355497|532017645|FG001|Overall Study|Adverse Event|10|||
147509320|NCT01001572|532017647|FG000|Single-Blind Valsartan 160 mg|Withdrawal by Subject|32|||
147509321|NCT01001572|532017648|FG001|Single-Blind Valsartan 160 mg|Withdrawal by Subject|0|||
147509322|NCT01001572|532017649|FG002|Single-Blind Valsartan 160 mg|Withdrawal by Subject|0|||
147509323|NCT01001572|532017647|FG000|Single-Blind Valsartan 160 mg|Adverse Event|11|||
147509324|NCT01001572|532017648|FG001|Single-Blind Valsartan 160 mg|Adverse Event|0|||
147509325|NCT01001572|532017649|FG002|Single-Blind Valsartan 160 mg|Adverse Event|0|||
147509326|NCT01001572|532017647|FG000|Single-Blind Valsartan 160 mg|Abnormal Test Procedure Result(s)|96|||
147509327|NCT01001572|532017648|FG001|Single-Blind Valsartan 160 mg|Abnormal Test Procedure Result(s)|0|||
147509328|NCT01001572|532017649|FG002|Single-Blind Valsartan 160 mg|Abnormal Test Procedure Result(s)|0|||
147509329|NCT01001572|532017647|FG000|Single-Blind Valsartan 160 mg|Unsatisfactory therapeutic effect|7|||
147509330|NCT01001572|532017648|FG001|Single-Blind Valsartan 160 mg|Unsatisfactory therapeutic effect|0|||
147509331|NCT01001572|532017649|FG002|Single-Blind Valsartan 160 mg|Unsatisfactory therapeutic effect|0|||
147509332|NCT01001572|532017647|FG000|Single-Blind Valsartan 160 mg|Abnormal Laboratory Value|1|||
147509333|NCT01001572|532017648|FG001|Single-Blind Valsartan 160 mg|Abnormal Laboratory Value|0|||
147509334|NCT01001572|532017649|FG002|Single-Blind Valsartan 160 mg|Abnormal Laboratory Value|0|||
147509335|NCT01001572|532017647|FG000|Single-Blind Valsartan 160 mg|Lost to Follow-up|4|||
147509336|NCT01001572|532017648|FG001|Single-Blind Valsartan 160 mg|Lost to Follow-up|0|||
147509337|NCT01001572|532017649|FG002|Single-Blind Valsartan 160 mg|Lost to Follow-up|0|||
147509338|NCT01001572|532017647|FG000|Single-Blind Valsartan 160 mg|Administrative problems|82|||
147509339|NCT01001572|532017648|FG001|Single-Blind Valsartan 160 mg|Administrative problems|0|||
147509340|NCT01001572|532017649|FG002|Single-Blind Valsartan 160 mg|Administrative problems|0|||
147509341|NCT01001572|532017647|FG000|Single-Blind Valsartan 160 mg|Condition no longer requires study drug|45|||
147509342|NCT01001572|532017648|FG001|Single-Blind Valsartan 160 mg|Condition no longer requires study drug|0|||
147509343|NCT01001572|532017649|FG002|Single-Blind Valsartan 160 mg|Condition no longer requires study drug|0|||
147509344|NCT01001572|532017647|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
147509345|NCT01001572|532017648|FG001|Double-Blind Treatment Phase|Adverse Event|2|||
147509346|NCT01001572|532017649|FG002|Double-Blind Treatment Phase|Adverse Event|2|||
147509347|NCT01001572|532017647|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
147509348|NCT01001572|532017648|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|8|||
147509349|NCT01001572|532017649|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|13|||
147509350|NCT01001572|532017647|FG000|Double-Blind Treatment Phase|Abnormal test procedure result(s)|0|||
147509351|NCT01001572|532017648|FG001|Double-Blind Treatment Phase|Abnormal test procedure result(s)|0|||
147639650|NCT02143791|532499372|FG000|Trial Stimulation|Lack of Efficacy|21|||
147639651|NCT02143791|532499372|FG000|Burst Stimulation Only (3 Months)|Withdrawal by Subject|4|||
147639652|NCT02143791|532499372|FG000|Burst Stimulation Only (3 Months)|Missing Data|4|||
147639653|NCT02143791|532499372|FG000|Any Programming (3-6 Months)|Withdrawal by Subject|3|||
147639654|NCT02143791|532499372|FG000|Any Programming (3-6 Months)|Missing Data|1|||
147639655|NCT02143791|532499372|FG000|Any Program (6-12 Months)|Withdrawal by Subject|2|||
147639656|NCT04327661|532499378|FG000|Overall Study|Withdrawal by Subject|1|||
147639657|NCT04327661|532499379|FG001|Overall Study|Withdrawal by Subject|0|||
147639658|NCT04327661|532499380|FG002|Overall Study|Withdrawal by Subject|0|||
147639659|NCT02111785|532499381|FG000|Overall Study|Death|0|||
147639660|NCT02111785|532499382|FG001|Overall Study|Death|1|||
147639661|NCT02111785|532499383|FG002|Overall Study|Death|0|||
147639662|NCT02111785|532499384|FG003|Overall Study|Death|0|||
147639663|NCT00759785|532499389|FG000|Overall Study|Participant sample not evaluable|11|||
147639664|NCT00759785|532499390|FG001|Overall Study|Participant sample not evaluable|2|||
147639665|NCT00759785|532499389|FG000|Overall Study|Participant sample lost|0|||
147639666|NCT00759785|532499390|FG001|Overall Study|Participant sample lost|1|||
147639667|NCT00759785|532499389|FG000|Overall Study|Protocol Violation|1|||
147639668|NCT00759785|532499390|FG001|Overall Study|Protocol Violation|0|||
147639669|NCT00759785|532499389|FG000|Overall Study|Physician Decision|0|||
147639670|NCT00759785|532499390|FG001|Overall Study|Physician Decision|1|||
147639671|NCT00759785|532499389|FG000|Overall Study|Withdrawal by Subject|0|||
147639672|NCT00759785|532499390|FG001|Overall Study|Withdrawal by Subject|1|||
147639673|NCT02062944|532499398|FG000|Overall Study|Lost to Follow-up|1|||
147639674|NCT02062944|532499398|FG000|Overall Study|New hemotological disorder identified|1|||
147639675|NCT02062944|532499398|FG000|Overall Study|Uncontrolled Hypertension|1|||
147639676|NCT02062944|532499398|FG000|Overall Study|underwent pre-weaning biospsy and excluded for mild subclinical ACR|3|||
147639677|NCT02122770|532499399|FG000|Part A: Drug-drug Interaction 2|Adverse Event|3|||
147639678|NCT02122770|532499400|FG001|Part A: Drug-drug Interaction 2|Adverse Event|0|||
147639679|NCT02122770|532499401|FG002|Part A: Drug-drug Interaction 2|Adverse Event|1|||
147639680|NCT02122770|532499402|FG003|Part A: Drug-drug Interaction 2|Adverse Event|2|||
147639681|NCT02122770|532499403|FG004|Part A: Drug-drug Interaction 2|Adverse Event|0|||
147639682|NCT02122770|532499404|FG005|Part A: Drug-drug Interaction 2|Adverse Event|0|||
147639683|NCT02122770|532499399|FG000|Part A: Drug-drug Interaction 2|Other|0|||
147639684|NCT02122770|532499400|FG001|Part A: Drug-drug Interaction 2|Other|0|||
147639685|NCT02122770|532499401|FG002|Part A: Drug-drug Interaction 2|Other|1|||
147639686|NCT02122770|532499402|FG003|Part A: Drug-drug Interaction 2|Other|0|||
147639687|NCT02122770|532499403|FG004|Part A: Drug-drug Interaction 2|Other|0|||
147639688|NCT02122770|532499404|FG005|Part A: Drug-drug Interaction 2|Other|0|||
147639689|NCT02122770|532499399|FG000|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0|||
147639690|NCT02122770|532499400|FG001|Part A: Drug-drug Interaction 2|Withdrawal by Subject|1|||
147639691|NCT02122770|532499401|FG002|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0|||
147639692|NCT02122770|532499402|FG003|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0|||
147639693|NCT02122770|532499403|FG004|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0|||
147639694|NCT02122770|532499404|FG005|Part A: Drug-drug Interaction 2|Withdrawal by Subject|0|||
147639695|NCT02122770|532499399|FG000|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|1|||
147639696|NCT02122770|532499400|FG001|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|5|||
147639697|NCT02122770|532499401|FG002|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|0|||
147639698|NCT02122770|532499402|FG003|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|1|||
147639699|NCT02122770|532499403|FG004|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|0|||
147639700|NCT02122770|532499404|FG005|Part A: Drug-drug Interaction 2|Symptomatic Deterioration|0|||
147639701|NCT02122770|532499399|FG000|Part B: Standard of Care|Adverse Event|0|||
147639702|NCT02122770|532499400|FG001|Part B: Standard of Care|Adverse Event|0|||
147509352|NCT01001572|532017649|FG002|Double-Blind Treatment Phase|Abnormal test procedure result(s)|1|||
147670008|NCT03040726|532617465|FG000|Overall Study|Reasons for not completing Placebo run in phase: Nausea NRS score >4|4|||
147670009|NCT03040726|532617466|FG001|Overall Study|Reasons for not completing Placebo run in phase: Nausea NRS score >4|3|||
147670010|NCT03040726|532617465|FG000|Overall Study|Reasons for not completing Blinded phase: Hospitalization|0|||
147670011|NCT03040726|532617466|FG001|Overall Study|Reasons for not completing Blinded phase: Hospitalization|2|||
147670012|NCT03040726|532617465|FG000|Overall Study|Reasons for not completing Blinded phase : Withdrawal|1|||
147670013|NCT03040726|532617466|FG001|Overall Study|Reasons for not completing Blinded phase : Withdrawal|0|||
147670014|NCT02908347|532617467|FG000|Overall Study|Adverse Event|0|||
147670015|NCT02908347|532617468|FG001|Overall Study|Adverse Event|1|||
147670016|NCT02908347|532617467|FG000|Overall Study|Lost to Follow-up|1|||
147670017|NCT02908347|532617468|FG001|Overall Study|Lost to Follow-up|0|||
147670018|NCT03104374|532617469|FG000|Period 1|Adverse Event|7|||
147670019|NCT03104374|532617470|FG001|Period 1|Adverse Event|7|||
147670020|NCT03104374|532617471|FG002|Period 1|Adverse Event|12|||
147670021|NCT03104374|532617472|FG003|Period 1|Adverse Event|14|||
147670022|NCT03104374|532617469|FG000|Period 1|Withdrawal by Subject|18|||
147670023|NCT03104374|532617470|FG001|Period 1|Withdrawal by Subject|9|||
147670024|NCT03104374|532617471|FG002|Period 1|Withdrawal by Subject|10|||
147670025|NCT03104374|532617472|FG003|Period 1|Withdrawal by Subject|17|||
147670026|NCT03104374|532617469|FG000|Period 1|Lost to Follow-up|4|||
147670027|NCT03104374|532617470|FG001|Period 1|Lost to Follow-up|4|||
147670028|NCT03104374|532617471|FG002|Period 1|Lost to Follow-up|6|||
147670029|NCT03104374|532617472|FG003|Period 1|Lost to Follow-up|8|||
147670030|NCT03104374|532617469|FG000|Period 1|Lack of Efficacy|6|||
147670031|NCT03104374|532617470|FG001|Period 1|Lack of Efficacy|7|||
147670032|NCT03104374|532617471|FG002|Period 1|Lack of Efficacy|12|||
147670033|NCT03104374|532617472|FG003|Period 1|Lack of Efficacy|6|||
147670034|NCT03104374|532617469|FG000|Period 1|Other|2|||
147509353|NCT01001572|532017647|FG000|Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|0|||
147509354|NCT01001572|532017648|FG001|Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|0|||
147509355|NCT01001572|532017649|FG002|Double-Blind Treatment Phase|Unsatisfactory therapeutic effect|1|||
147509356|NCT01001572|532017647|FG000|Double-Blind Treatment Phase|Protocol deviation|0|||
147509357|NCT01001572|532017648|FG001|Double-Blind Treatment Phase|Protocol deviation|0|||
147509358|NCT01001572|532017649|FG002|Double-Blind Treatment Phase|Protocol deviation|1|||
147509359|NCT01001572|532017647|FG000|Double-Blind Treatment Phase|Lost to Follow-up|0|||
147509360|NCT01001572|532017648|FG001|Double-Blind Treatment Phase|Lost to Follow-up|0|||
147509361|NCT01001572|532017649|FG002|Double-Blind Treatment Phase|Lost to Follow-up|1|||
147509362|NCT01094808|532017650|FG000|Overall Study|Withdrawal by Subject|1|||
147509363|NCT01094808|532017651|FG001|Overall Study|Withdrawal by Subject|1|||
147509364|NCT01094808|532017652|FG002|Overall Study|Withdrawal by Subject|0|||
147509365|NCT00369278|532017653|FG000|Overall Study|Adverse Event|14|||
147509366|NCT00369278|532017654|FG001|Overall Study|Adverse Event|11|||
147509367|NCT00369278|532017653|FG000|Overall Study|Unsatisfactory therapeutic effect|4|||
147509368|NCT00369278|532017654|FG001|Overall Study|Unsatisfactory therapeutic effect|5|||
147509369|NCT00369278|532017653|FG000|Overall Study|Protocol Violation|2|||
147509370|NCT00369278|532017654|FG001|Overall Study|Protocol Violation|1|||
147509371|NCT00369278|532017653|FG000|Overall Study|Withdrawal by Subject|2|||
147509372|NCT00369278|532017654|FG001|Overall Study|Withdrawal by Subject|2|||
147509373|NCT00369278|532017653|FG000|Overall Study|Lost to Follow-up|1|||
147509374|NCT00369278|532017654|FG001|Overall Study|Lost to Follow-up|0|||
147509375|NCT00369278|532017653|FG000|Overall Study|Graft loss|1|||
147509376|NCT00369278|532017654|FG001|Overall Study|Graft loss|2|||
147509377|NCT02025530|532017657|FG000|Overall Study|No longer met elligibility criteria|5|||
147509378|NCT02025530|532017658|FG001|Overall Study|No longer met elligibility criteria|1|||
147509379|NCT04583969|532017665|FG000|Overall Study|Death|31|||
147509380|NCT04583969|532017666|FG001|Overall Study|Death|38|||
147509381|NCT04583969|532017665|FG000|Overall Study|Lost to Follow-up|16|||
147509382|NCT04583969|532017666|FG001|Overall Study|Lost to Follow-up|13|||
147509383|NCT04583969|532017665|FG000|Overall Study|Protocol Violation|1|||
147509384|NCT04583969|532017666|FG001|Overall Study|Protocol Violation|0|||
147670035|NCT03104374|532617470|FG001|Period 1|Other|2|||
147509385|NCT04583969|532017665|FG000|Overall Study|Withdrawal by Subject|3|||
147670036|NCT03104374|532617471|FG002|Period 1|Other|4|||
147670037|NCT03104374|532617472|FG003|Period 1|Other|7|||
147509386|NCT04583969|532017666|FG001|Overall Study|Withdrawal by Subject|3|||
147670038|NCT03104374|532617469|FG000|Period 1|One participant did not qualify per inclusion/exclusion criteria and discontinued prior to treatment|0|||
147670039|NCT03104374|532617470|FG001|Period 1|One participant did not qualify per inclusion/exclusion criteria and discontinued prior to treatment|0|||
147670040|NCT03104374|532617471|FG002|Period 1|One participant did not qualify per inclusion/exclusion criteria and discontinued prior to treatment|0|||
147509387|NCT04583969|532017665|FG000|Overall Study|RANDOMIZED BUT NOT DOSED|2|||
147509388|NCT04583969|532017666|FG001|Overall Study|RANDOMIZED BUT NOT DOSED|4|||
147509389|NCT04583969|532017665|FG000|Overall Study|TECHNICAL DIFFICULTIES, NOT ENOUGH STUDY DRUG ON SITE|1|||
147509390|NCT04583969|532017666|FG001|Overall Study|TECHNICAL DIFFICULTIES, NOT ENOUGH STUDY DRUG ON SITE|0|||
147509391|NCT04583969|532017665|FG000|Overall Study|RECEIVED PROHIBITED CONCOMITANT THERAPY|1|||
147509392|NCT04583969|532017666|FG001|Overall Study|RECEIVED PROHIBITED CONCOMITANT THERAPY|0|||
147509393|NCT04583969|532017665|FG000|Overall Study|WITHDRAWAL OF CONSENT BEFORE PRODUCT ADMINISTRATION|1|||
147509394|NCT04583969|532017666|FG001|Overall Study|WITHDRAWAL OF CONSENT BEFORE PRODUCT ADMINISTRATION|1|||
147509395|NCT04583969|532017665|FG000|Overall Study|TRANSITION TO COMFORT CARE/HOSPICE|1|||
147509396|NCT04583969|532017666|FG001|Overall Study|TRANSITION TO COMFORT CARE/HOSPICE|0|||
147509397|NCT00563368|532017667|FG000|Overall Study|Lost to Follow-up|14|||
147509398|NCT00563368|532017668|FG001|Overall Study|Lost to Follow-up|14|||
147509399|NCT00563368|532017669|FG002|Overall Study|Lost to Follow-up|12|||
147509400|NCT00563368|532017670|FG003|Overall Study|Lost to Follow-up|6|||
147509401|NCT00563368|532017671|FG004|Overall Study|Lost to Follow-up|9|||
147509402|NCT00563368|532017672|FG005|Overall Study|Lost to Follow-up|8|||
147509403|NCT00563368|532017673|FG006|Overall Study|Lost to Follow-up|9|||
147509404|NCT00563368|532017667|FG000|Overall Study|Adverse Event|3|||
147509405|NCT00563368|532017668|FG001|Overall Study|Adverse Event|4|||
147509406|NCT00563368|532017669|FG002|Overall Study|Adverse Event|5|||
147509407|NCT00563368|532017670|FG003|Overall Study|Adverse Event|9|||
147509408|NCT00563368|532017671|FG004|Overall Study|Adverse Event|6|||
147509409|NCT00563368|532017672|FG005|Overall Study|Adverse Event|10|||
147509410|NCT00563368|532017673|FG006|Overall Study|Adverse Event|17|||
147509411|NCT00563368|532017667|FG000|Overall Study|Withdrawal by Subject|11|||
147509412|NCT00563368|532017668|FG001|Overall Study|Withdrawal by Subject|6|||
147509413|NCT00563368|532017669|FG002|Overall Study|Withdrawal by Subject|5|||
147509414|NCT00563368|532017670|FG003|Overall Study|Withdrawal by Subject|7|||
147509415|NCT00563368|532017671|FG004|Overall Study|Withdrawal by Subject|8|||
147509416|NCT00563368|532017672|FG005|Overall Study|Withdrawal by Subject|5|||
147509417|NCT00563368|532017673|FG006|Overall Study|Withdrawal by Subject|4|||
147509418|NCT00563368|532017667|FG000|Overall Study|protocol non-compliance|1|||
147509419|NCT00563368|532017668|FG001|Overall Study|protocol non-compliance|1|||
147509420|NCT00563368|532017669|FG002|Overall Study|protocol non-compliance|2|||
147509421|NCT00563368|532017670|FG003|Overall Study|protocol non-compliance|1|||
147509422|NCT00563368|532017671|FG004|Overall Study|protocol non-compliance|0|||
147509423|NCT00563368|532017672|FG005|Overall Study|protocol non-compliance|1|||
147509424|NCT00563368|532017673|FG006|Overall Study|protocol non-compliance|3|||
147509425|NCT00563368|532017667|FG000|Overall Study|Pregnancy|1|||
147509426|NCT00563368|532017668|FG001|Overall Study|Pregnancy|0|||
147509427|NCT00563368|532017669|FG002|Overall Study|Pregnancy|1|||
147509428|NCT00563368|532017670|FG003|Overall Study|Pregnancy|2|||
147509429|NCT00563368|532017671|FG004|Overall Study|Pregnancy|1|||
147509430|NCT00563368|532017672|FG005|Overall Study|Pregnancy|2|||
147509431|NCT00563368|532017673|FG006|Overall Study|Pregnancy|0|||
147509432|NCT00563368|532017667|FG000|Overall Study|requirement for restricted medication|0|||
147509433|NCT00563368|532017668|FG001|Overall Study|requirement for restricted medication|0|||
147509434|NCT00563368|532017669|FG002|Overall Study|requirement for restricted medication|2|||
147509435|NCT00563368|532017670|FG003|Overall Study|requirement for restricted medication|0|||
147509436|NCT00563368|532017671|FG004|Overall Study|requirement for restricted medication|0|||
147509437|NCT00563368|532017672|FG005|Overall Study|requirement for restricted medication|0|||
147509438|NCT00563368|532017673|FG006|Overall Study|requirement for restricted medication|0|||
147509439|NCT00563368|532017667|FG000|Overall Study|Other|5|||
147509440|NCT00563368|532017668|FG001|Overall Study|Other|5|||
147509441|NCT00563368|532017669|FG002|Overall Study|Other|3|||
147509442|NCT00563368|532017670|FG003|Overall Study|Other|4|||
147509443|NCT00563368|532017671|FG004|Overall Study|Other|4|||
147509444|NCT00563368|532017672|FG005|Overall Study|Other|4|||
147509445|NCT00563368|532017673|FG006|Overall Study|Other|0|||
147509446|NCT01061567|532017674|FG000|Overall Study|Adverse Event|32|||
147509447|NCT01061567|532017674|FG000|Overall Study|Death|2|||
147509448|NCT01061567|532017674|FG000|Overall Study|Lack of Efficacy|3|||
147509449|NCT01061567|532017674|FG000|Overall Study|Lost to Follow-up|24|||
147509450|NCT01061567|532017674|FG000|Overall Study|Protocol Violation|1|||
147509451|NCT01061567|532017674|FG000|Overall Study|Withdrawal by Subject|11|||
147509452|NCT01061567|532017674|FG000|Overall Study|Other reason than stated above|3|||
147509453|NCT01831804|532017675|FG000|Overall Study|Adverse Event|0|||
147509454|NCT01831804|532017676|FG001|Overall Study|Adverse Event|0|||
147509455|NCT01831804|532017677|FG002|Overall Study|Adverse Event|0|||
147509456|NCT01831804|532017678|FG003|Overall Study|Adverse Event|0|||
147509457|NCT01831804|532017679|FG004|Overall Study|Adverse Event|0|||
147509458|NCT01831804|532017680|FG005|Overall Study|Adverse Event|0|||
147509459|NCT01831804|532017681|FG006|Overall Study|Adverse Event|1|||
147639703|NCT02122770|532499401|FG002|Part B: Standard of Care|Adverse Event|0|||
147639704|NCT02122770|532499402|FG003|Part B: Standard of Care|Adverse Event|0|||
147509460|NCT01831804|532017682|FG007|Overall Study|Adverse Event|0|||
147509461|NCT01831804|532017683|FG008|Overall Study|Adverse Event|1|||
147509462|NCT01831804|532017675|FG000|Overall Study|Protocol Violation|0|||
147509463|NCT01831804|532017676|FG001|Overall Study|Protocol Violation|0|||
147509464|NCT01831804|532017677|FG002|Overall Study|Protocol Violation|2|||
147509465|NCT01831804|532017678|FG003|Overall Study|Protocol Violation|0|||
147509466|NCT01831804|532017679|FG004|Overall Study|Protocol Violation|0|||
147509467|NCT01831804|532017680|FG005|Overall Study|Protocol Violation|0|||
147509468|NCT01831804|532017681|FG006|Overall Study|Protocol Violation|0|||
147509469|NCT01831804|532017682|FG007|Overall Study|Protocol Violation|0|||
147509470|NCT01831804|532017683|FG008|Overall Study|Protocol Violation|0|||
147509471|NCT01831804|532017675|FG000|Overall Study|Protocol defined stopping criteria|1|||
147509472|NCT01831804|532017676|FG001|Overall Study|Protocol defined stopping criteria|1|||
147509473|NCT01831804|532017677|FG002|Overall Study|Protocol defined stopping criteria|3|||
147509474|NCT01831804|532017678|FG003|Overall Study|Protocol defined stopping criteria|0|||
147509475|NCT01831804|532017679|FG004|Overall Study|Protocol defined stopping criteria|1|||
147509476|NCT01831804|532017680|FG005|Overall Study|Protocol defined stopping criteria|0|||
147509477|NCT01831804|532017681|FG006|Overall Study|Protocol defined stopping criteria|0|||
147509478|NCT01831804|532017682|FG007|Overall Study|Protocol defined stopping criteria|0|||
147509479|NCT01831804|532017683|FG008|Overall Study|Protocol defined stopping criteria|0|||
147509480|NCT01831804|532017675|FG000|Overall Study|Lost to Follow-up|0|||
147509481|NCT01831804|532017676|FG001|Overall Study|Lost to Follow-up|0|||
147509482|NCT01831804|532017677|FG002|Overall Study|Lost to Follow-up|1|||
147509483|NCT01831804|532017678|FG003|Overall Study|Lost to Follow-up|0|||
147509484|NCT01831804|532017679|FG004|Overall Study|Lost to Follow-up|0|||
147509485|NCT01831804|532017680|FG005|Overall Study|Lost to Follow-up|0|||
147509486|NCT01831804|532017681|FG006|Overall Study|Lost to Follow-up|0|||
147509487|NCT01831804|532017682|FG007|Overall Study|Lost to Follow-up|0|||
147509488|NCT01831804|532017683|FG008|Overall Study|Lost to Follow-up|1|||
147509489|NCT01831804|532017675|FG000|Overall Study|Investigator discretion|0|||
147509490|NCT01831804|532017676|FG001|Overall Study|Investigator discretion|0|||
147509491|NCT01831804|532017677|FG002|Overall Study|Investigator discretion|0|||
147509492|NCT01831804|532017678|FG003|Overall Study|Investigator discretion|0|||
147509493|NCT01831804|532017679|FG004|Overall Study|Investigator discretion|1|||
147509494|NCT01831804|532017680|FG005|Overall Study|Investigator discretion|0|||
147509495|NCT01831804|532017681|FG006|Overall Study|Investigator discretion|0|||
147509496|NCT01831804|532017682|FG007|Overall Study|Investigator discretion|1|||
147509497|NCT01831804|532017683|FG008|Overall Study|Investigator discretion|0|||
147509498|NCT01831804|532017675|FG000|Overall Study|Withdrew Consent|0|||
147509499|NCT01831804|532017676|FG001|Overall Study|Withdrew Consent|1|||
147509500|NCT01831804|532017677|FG002|Overall Study|Withdrew Consent|0|||
147509501|NCT01831804|532017678|FG003|Overall Study|Withdrew Consent|0|||
147509502|NCT01831804|532017679|FG004|Overall Study|Withdrew Consent|0|||
147509503|NCT01831804|532017680|FG005|Overall Study|Withdrew Consent|0|||
147509504|NCT01831804|532017681|FG006|Overall Study|Withdrew Consent|0|||
147509505|NCT01831804|532017682|FG007|Overall Study|Withdrew Consent|2|||
147509506|NCT01831804|532017683|FG008|Overall Study|Withdrew Consent|0|||
147509507|NCT01819506|532017684|FG000|Overall Study|Physician Decision|5|||
147509508|NCT01819506|532017685|FG001|Overall Study|Physician Decision|2|||
147509509|NCT01819506|532017684|FG000|Overall Study|Withdrawal by Subject|3|||
147509510|NCT01819506|532017685|FG001|Overall Study|Withdrawal by Subject|3|||
147509511|NCT00114218|532017689|FG000|Overall Study|Wrong Cell Type|2|||
147509512|NCT00114218|532017689|FG000|Overall Study|Wrong Primary|1|||
147509513|NCT00114218|532017689|FG000|Overall Study|Never Treated|1|||
147509514|NCT01040845|532017691|FG000|Overall Study|Withdrawal by Subject|1|||
147509515|NCT01040845|532017692|FG001|Overall Study|Withdrawal by Subject|1|||
147509516|NCT01040845|532017691|FG000|Overall Study|Physician Decision|1|||
147509517|NCT01040845|532017692|FG001|Overall Study|Physician Decision|0|||
147509518|NCT04445688|532017693|FG000|Washout (One Week)|Adverse Event|2|||
147509519|NCT04445688|532017693|FG000|Washout (One Week)|Withdrawal by Subject|1|||
147509520|NCT01963780|532017700|FG000|Overall Study|Death|7|||
147509521|NCT01749800|532017701|FG000|Overall Study|not meeting inclusion criteria|3|||
147509522|NCT01749800|532017702|FG001|Overall Study|not meeting inclusion criteria|0|||
147509523|NCT01749800|532017703|FG002|Overall Study|not meeting inclusion criteria|0|||
147509524|NCT01749800|532017701|FG000|Overall Study|Withdrawal by Subject|0|||
147509525|NCT01749800|532017702|FG001|Overall Study|Withdrawal by Subject|1|||
147509526|NCT01749800|532017703|FG002|Overall Study|Withdrawal by Subject|0|||
147509527|NCT01000025|532017707|FG000|Overall Study|Adverse Event|43|||
147509528|NCT01000025|532017708|FG001|Overall Study|Adverse Event|2|||
147509529|NCT01000025|532017707|FG000|Overall Study|Withdrawal by Subject|13|||
147509530|NCT01000025|532017708|FG001|Overall Study|Withdrawal by Subject|8|||
147509531|NCT01000025|532017707|FG000|Overall Study|Death|23|||
147509532|NCT01000025|532017708|FG001|Overall Study|Death|13|||
147509533|NCT01000025|532017707|FG000|Overall Study|Lack of Efficacy|363|||
147509534|NCT01000025|532017708|FG001|Overall Study|Lack of Efficacy|208|||
147509535|NCT01000025|532017707|FG000|Overall Study|Intercurrent Illness|26|||
147509536|NCT01000025|532017708|FG001|Overall Study|Intercurrent Illness|7|||
147509537|NCT04423757|532017709|FG000|Overall Study|Adverse Event|2|||
147509538|NCT04423757|532017710|FG001|Overall Study|Adverse Event|0|||
147509539|NCT04423757|532017709|FG000|Overall Study|Not treated|1|||
147509540|NCT04423757|532017710|FG001|Overall Study|Not treated|1|||
147509541|NCT02738580|532017711|FG000|Overall Study|Adverse Event|1|||
147509542|NCT02738580|532017712|FG001|Overall Study|Adverse Event|0|||
147509543|NCT02738580|532017711|FG000|Overall Study|Lack of Efficacy|3|||
147509544|NCT02738580|532017712|FG001|Overall Study|Lack of Efficacy|2|||
147509545|NCT02738580|532017711|FG000|Overall Study|Withdrawal by Subject|0|||
147509546|NCT02738580|532017712|FG001|Overall Study|Withdrawal by Subject|1|||
147509547|NCT02738580|532017711|FG000|Overall Study|EXCLUDED FROM DONNOR PROGRAM|0|||
147509548|NCT02738580|532017712|FG001|Overall Study|EXCLUDED FROM DONNOR PROGRAM|1|||
147509549|NCT01250756|532017715|FG000|Infant Series|Withdrawal by Subject|4|||
147509550|NCT01250756|532017716|FG001|Infant Series|Withdrawal by Subject|5|||
147509551|NCT01250756|532017715|FG000|Infant Series|Randomized, Not Vaccinated|2|||
147509552|NCT01250756|532017716|FG001|Infant Series|Randomized, Not Vaccinated|2|||
147509553|NCT01250756|532017715|FG000|Infant Series|Other|22|||
147509554|NCT01250756|532017716|FG001|Infant Series|Other|0|||
147509555|NCT01250756|532017715|FG000|After Infant Series|Adverse Event|5|||
147509556|NCT01250756|532017716|FG001|After Infant Series|Adverse Event|2|||
147509557|NCT01250756|532017715|FG000|After Infant Series|Withdrawal by Subject|4|||
147509558|NCT01250756|532017716|FG001|After Infant Series|Withdrawal by Subject|1|||
147509559|NCT01250756|532017715|FG000|After Infant Series|Other|2|||
147509560|NCT01250756|532017716|FG001|After Infant Series|Other|1|||
147509561|NCT01250756|532017715|FG000|Toddler Dose|Adverse Event|0|||
147509562|NCT01250756|532017716|FG001|Toddler Dose|Adverse Event|1|||
147509563|NCT01250756|532017715|FG000|After Toddler Dose|Adverse Event|0|||
147509564|NCT01250756|532017716|FG001|After Toddler Dose|Adverse Event|1|||
147509565|NCT02999100|532017717|FG000|Part 1 (up to 15 Days)|Adverse Event|0|||
147509566|NCT02999100|532017718|FG001|Part 1 (up to 15 Days)|Adverse Event|1|||
147509567|NCT02999100|532017719|FG002|Part 1 (up to 15 Days)|Adverse Event|0|||
147509568|NCT02999100|532017720|FG003|Part 1 (up to 15 Days)|Adverse Event|0|||
147509569|NCT02999100|532017721|FG004|Part 1 (up to 15 Days)|Adverse Event|0|||
147509570|NCT02999100|532017722|FG005|Part 1 (up to 15 Days)|Adverse Event|0|||
147509571|NCT02999100|532017717|FG000|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0|||
147509572|NCT02999100|532017718|FG001|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0|||
147509573|NCT02999100|532017719|FG002|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0|||
147509574|NCT02999100|532017720|FG003|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0|||
147509575|NCT02999100|532017721|FG004|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|0|||
147509576|NCT02999100|532017722|FG005|Part 2 (Day 1): Dosing Session 1|Withdrawal by Subject|1|||
147509577|NCT02999100|532017717|FG000|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0|||
147509578|NCT02999100|532017718|FG001|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0|||
147509579|NCT02999100|532017719|FG002|Part 2 (Day 1): Dosing Session 1|Protocol Violation|1|||
147509580|NCT02999100|532017720|FG003|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0|||
147509581|NCT02999100|532017721|FG004|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0|||
147509582|NCT02999100|532017722|FG005|Part 2 (Day 1): Dosing Session 1|Protocol Violation|0|||
147509583|NCT03595384|532017723|FG000|Overall Study|Other time commitments|8|||
147509584|NCT03595384|532017723|FG000|Overall Study|Changes to session time|7|||
147509585|NCT03595384|532017723|FG000|Overall Study|Relocation out of country|1|||
147509586|NCT00293241|532017724|FG000|Overall Study|Lost to Follow-up|9|||
147509587|NCT00293241|532017725|FG001|Overall Study|Lost to Follow-up|16|||
147509588|NCT00293241|532017724|FG000|Overall Study|Physician Decision|23|||
147509589|NCT00293241|532017725|FG001|Overall Study|Physician Decision|17|||
147509590|NCT00293241|532017724|FG000|Overall Study|Withdrawal by Subject|4|||
147509591|NCT00293241|532017725|FG001|Overall Study|Withdrawal by Subject|8|||
147509592|NCT01270958|532017727|FG000|Overall Study|Lost to Follow-up|2|||
147509593|NCT01270958|532017727|FG000|Overall Study|Did not meet inclusion criteria for age|2|||
147509594|NCT02142504|532017728|FG000|Overall Study|Protocol Violation|2|||
147509595|NCT02142504|532017729|FG001|Overall Study|Protocol Violation|1|||
147509596|NCT02142504|532017730|FG002|Overall Study|Protocol Violation|2|||
147509597|NCT02142504|532017728|FG000|Overall Study|Adverse Event|2|||
147509598|NCT02142504|532017729|FG001|Overall Study|Adverse Event|3|||
147509599|NCT02142504|532017730|FG002|Overall Study|Adverse Event|4|||
147509600|NCT02142504|532017728|FG000|Overall Study|Lost to Follow-up|12|||
147509601|NCT02142504|532017729|FG001|Overall Study|Lost to Follow-up|19|||
147509602|NCT02142504|532017730|FG002|Overall Study|Lost to Follow-up|17|||
147509603|NCT02142504|532017728|FG000|Overall Study|Withdrawal by Subject|7|||
147509604|NCT02142504|532017729|FG001|Overall Study|Withdrawal by Subject|9|||
147509605|NCT02142504|532017730|FG002|Overall Study|Withdrawal by Subject|11|||
147509606|NCT02142504|532017728|FG000|Overall Study|Pregnancy|4|||
147509607|NCT02142504|532017729|FG001|Overall Study|Pregnancy|4|||
147670041|NCT03104374|532617472|FG003|Period 1|One participant did not qualify per inclusion/exclusion criteria and discontinued prior to treatment|1|||
147509608|NCT02142504|532017730|FG002|Overall Study|Pregnancy|2|||
147509609|NCT02142504|532017728|FG000|Overall Study|Physician Decision|0|||
147509610|NCT02142504|532017729|FG001|Overall Study|Physician Decision|1|||
147509611|NCT02142504|532017730|FG002|Overall Study|Physician Decision|3|||
147509612|NCT02142504|532017728|FG000|Overall Study|Reason Not Specified|4|||
147509613|NCT02142504|532017729|FG001|Overall Study|Reason Not Specified|5|||
147509614|NCT02142504|532017730|FG002|Overall Study|Reason Not Specified|4|||
147509615|NCT04114539|532017733|FG000|Overall Study|Adverse Event|14|||
147509616|NCT04114539|532017733|FG000|Overall Study|Lost to Follow-up|2|||
147509617|NCT04114539|532017733|FG000|Overall Study|Non-compliance with Protocol|2|||
147509618|NCT04114539|532017733|FG000|Overall Study|Non-compliance with Study Drug|1|||
147509619|NCT04114539|532017733|FG000|Overall Study|Withdrawal by Parent/Caregiver|8|||
147509620|NCT04114539|532017733|FG000|Overall Study|Withdrew consent|10|||
147509621|NCT04114539|532017733|FG000|Overall Study|Others not specified|5|||
147509622|NCT04114539|532017733|FG000|Overall Study|Investigator Decision|2|||
147509623|NCT00617591|532017735|FG000|Overall Study|Withdrew consent during Induction|4|||
147509624|NCT00617591|532017735|FG000|Overall Study|Withdrew consent during Maintenance|6|||
147509625|NCT00166517|532017738|FG000|Overall Study|Lost to Follow-up|1|||
147509626|NCT00166517|532017739|FG001|Overall Study|Lost to Follow-up|0|||
147509627|NCT00166517|532017738|FG000|Overall Study|Protocol Violation|4|||
147509628|NCT00166517|532017739|FG001|Overall Study|Protocol Violation|1|||
147509629|NCT00166517|532017738|FG000|Overall Study|Withdrawal by Subject|0|||
147509630|NCT00166517|532017739|FG001|Overall Study|Withdrawal by Subject|1|||
147509631|NCT00842361|532017743|FG000|Overall Study|Protocol Violation|1|||
147509632|NCT00842361|532017744|FG001|Overall Study|Protocol Violation|0|||
147509633|NCT00842361|532017743|FG000|Overall Study|Unclassified|0|||
147509634|NCT00842361|532017744|FG001|Overall Study|Unclassified|2|||
147509635|NCT02186561|532017745|FG000|Enrollment|Did Not Meet Inclusion Criteria|46|||
147509636|NCT02186561|532017745|FG000|Enrollment|Enrollment Cap Reached|5|||
147509637|NCT02186561|532017745|FG000|Enrollment|Insurance Denial|2|||
147509638|NCT02186561|532017745|FG000|Enrollment|Withdrawal by Subject|2|||
147509639|NCT02186561|532017745|FG000|Enrollment|Investigator Withdrew Consent|1|||
147509640|NCT02186561|532017745|FG000|30-Day Post Index Procedure Visit|Death|1|||
147509641|NCT02186561|532017745|FG000|1- Year Post Index Procedure Visit|Death|1|||
147509642|NCT02186561|532017745|FG000|1- Year Post Index Procedure Visit|Missed|1|||
147509643|NCT03094611|532017746|FG000|Overall Study|Lack of Efficacy|1|||
147509644|NCT03094611|532017746|FG000|Overall Study|Stem Cell Transplant|1|||
147509645|NCT04285853|532017747|FG000|Overall Study|Withdrawal by Subject|1|||
147509646|NCT04285853|532017748|FG001|Overall Study|Withdrawal by Subject|0|||
147509647|NCT04285853|532017747|FG000|Overall Study|Lost to Follow-up|9|||
147509648|NCT04285853|532017748|FG001|Overall Study|Lost to Follow-up|5|||
147509649|NCT01072448|532017749|FG000|Overall Study|Adverse Event|9|||
147509650|NCT01072448|532017750|FG001|Overall Study|Adverse Event|10|||
147509651|NCT01072448|532017749|FG000|Overall Study|Subject withdrew consent|4|||
147509652|NCT01072448|532017750|FG001|Overall Study|Subject withdrew consent|9|||
147509653|NCT01072448|532017749|FG000|Overall Study|Protocol deviation|3|||
147509654|NCT01072448|532017750|FG001|Overall Study|Protocol deviation|4|||
147509655|NCT01072448|532017749|FG000|Overall Study|Abnormal test procedure result(s)|1|||
147509656|NCT01072448|532017750|FG001|Overall Study|Abnormal test procedure result(s)|0|||
147509657|NCT01072448|532017749|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
147509658|NCT01072448|532017750|FG001|Overall Study|Unsatisfactory therapeutic effect|3|||
147509659|NCT01072448|532017749|FG000|Overall Study|Lost to Follow-up|1|||
147509660|NCT01072448|532017750|FG001|Overall Study|Lost to Follow-up|1|||
147509661|NCT01072448|532017749|FG000|Overall Study|Abnormal laboratory value(s)|0|||
147509662|NCT01072448|532017750|FG001|Overall Study|Abnormal laboratory value(s)|1|||
147509663|NCT01072448|532017749|FG000|Overall Study|Death|0|||
147509664|NCT01072448|532017750|FG001|Overall Study|Death|2|||
147509665|NCT02460978|532017755|FG000|Overall Study|Adverse Event|17|||
147509666|NCT02460978|532017756|FG001|Overall Study|Adverse Event|11|||
147509667|NCT02460978|532017757|FG002|Overall Study|Adverse Event|11|||
147509668|NCT02460978|532017755|FG000|Overall Study|Withdrawal by Subject|5|||
147509669|NCT02460978|532017756|FG001|Overall Study|Withdrawal by Subject|5|||
147509670|NCT02460978|532017757|FG002|Overall Study|Withdrawal by Subject|14|||
147509671|NCT02460978|532017755|FG000|Overall Study|Lost to Follow-up|2|||
147509672|NCT02460978|532017756|FG001|Overall Study|Lost to Follow-up|3|||
147509673|NCT02460978|532017757|FG002|Overall Study|Lost to Follow-up|1|||
147509674|NCT02460978|532017755|FG000|Overall Study|Protocol Violation|1|||
147509675|NCT02460978|532017756|FG001|Overall Study|Protocol Violation|1|||
147509676|NCT02460978|532017757|FG002|Overall Study|Protocol Violation|1|||
147509677|NCT02460978|532017755|FG000|Overall Study|Discontinued due to DKA/hypoglycemia|2|||
147509678|NCT02460978|532017756|FG001|Overall Study|Discontinued due to DKA/hypoglycemia|5|||
147509679|NCT02460978|532017757|FG002|Overall Study|Discontinued due to DKA/hypoglycemia|4|||
147509680|NCT02460978|532017755|FG000|Overall Study|Pregnancy|0|||
147509681|NCT02460978|532017756|FG001|Overall Study|Pregnancy|0|||
147639705|NCT02122770|532499403|FG004|Part B: Standard of Care|Adverse Event|4|||
147639706|NCT02122770|532499404|FG005|Part B: Standard of Care|Adverse Event|1|||
147639707|NCT02122770|532499399|FG000|Part B: Standard of Care|Other|0|||
147509682|NCT02460978|532017757|FG002|Overall Study|Pregnancy|2|||
147509683|NCT00588523|532017761|FG000|Overall Study|Not treated|3|||
147509684|NCT01459068|532017766|FG000|Overall Study|Withdrawal by Subject|8|||
147509685|NCT01459068|532017767|FG001|Overall Study|Withdrawal by Subject|18|||
147509686|NCT01459068|532017766|FG000|Overall Study|Lost to Follow-up|31|||
147509687|NCT01459068|532017767|FG001|Overall Study|Lost to Follow-up|15|||
147509688|NCT01459068|532017766|FG000|Overall Study|Death|0|||
147509689|NCT01459068|532017767|FG001|Overall Study|Death|1|||
147509690|NCT02023112|532017768|FG000|Overall Study|Withdrawal by Subject|2|||
147509691|NCT02023112|532017769|FG001|Overall Study|Withdrawal by Subject|1|||
147509692|NCT01449955|532017772|FG000|Overall Study|Withdrawal by Subject|1|||
147509693|NCT01449955|532017773|FG001|Overall Study|Withdrawal by Subject|2|||
147509694|NCT01203787|532017774|FG000|Overall Study|Death|12|||
147509695|NCT01203787|532017775|FG001|Overall Study|Death|10|||
147509696|NCT01203787|532017774|FG000|Overall Study|Withdrawal by Subject|6|||
147509697|NCT01203787|532017775|FG001|Overall Study|Withdrawal by Subject|2|||
147509698|NCT01203787|532017774|FG000|Overall Study|Lost to Follow-up|2|||
147509699|NCT01203787|532017775|FG001|Overall Study|Lost to Follow-up|0|||
147509700|NCT01203787|532017774|FG000|Overall Study|Adverse Event|11|||
147509701|NCT01203787|532017775|FG001|Overall Study|Adverse Event|15|||
147509702|NCT01601470|532017776|FG000|Period 2 - LCZ696|Physician Decision|1|||
147509703|NCT02079519|532017777|FG000|Overall Study|Disease Progression|9|||
147509704|NCT02079519|532017777|FG000|Overall Study|Adverse Event|1|||
147509705|NCT03627494|532017778|FG000|Part A Washout 2 (7 Days)|Adverse Event|1|||
147509706|NCT03627494|532017779|FG001|Part A Washout 2 (7 Days)|Adverse Event|0|||
147509707|NCT03627494|532017780|FG002|Part A Washout 2 (7 Days)|Adverse Event|1|||
147509708|NCT03627494|532017781|FG003|Part A Washout 2 (7 Days)|Adverse Event|0|||
147509709|NCT03627494|532017782|FG004|Part A Washout 2 (7 Days)|Adverse Event|0|||
147509710|NCT03627494|532017783|FG005|Part A Washout 2 (7 Days)|Adverse Event|0|||
147509711|NCT03627494|532017784|FG006|Part A Washout 2 (7 Days)|Adverse Event|0|||
147509712|NCT03627494|532017785|FG007|Part A Washout 2 (7 Days)|Adverse Event|0|||
147509713|NCT03627494|532017786|FG008|Part A Washout 2 (7 Days)|Adverse Event|0|||
147509714|NCT03627494|532017787|FG009|Part A Washout 2 (7 Days)|Adverse Event|0|||
147509715|NCT03627494|532017788|FG010|Part A Washout 2 (7 Days)|Adverse Event|0|||
147509716|NCT03627494|532017789|FG011|Part A Washout 2 (7 Days)|Adverse Event|0|||
147509717|NCT03627494|532017778|FG000|Part B (Maximum of 34 Days)|Adverse Event|0|||
147509718|NCT03627494|532017779|FG001|Part B (Maximum of 34 Days)|Adverse Event|0|||
147509719|NCT03627494|532017780|FG002|Part B (Maximum of 34 Days)|Adverse Event|0|||
147509720|NCT03627494|532017781|FG003|Part B (Maximum of 34 Days)|Adverse Event|0|||
147509721|NCT03627494|532017782|FG004|Part B (Maximum of 34 Days)|Adverse Event|0|||
147509722|NCT03627494|532017783|FG005|Part B (Maximum of 34 Days)|Adverse Event|0|||
147509723|NCT03627494|532017784|FG006|Part B (Maximum of 34 Days)|Adverse Event|0|||
147509724|NCT03627494|532017785|FG007|Part B (Maximum of 34 Days)|Adverse Event|0|||
147509725|NCT03627494|532017786|FG008|Part B (Maximum of 34 Days)|Adverse Event|2|||
147509726|NCT03627494|532017787|FG009|Part B (Maximum of 34 Days)|Adverse Event|0|||
147509727|NCT03627494|532017788|FG010|Part B (Maximum of 34 Days)|Adverse Event|0|||
147509728|NCT03627494|532017789|FG011|Part B (Maximum of 34 Days)|Adverse Event|0|||
147509729|NCT03627494|532017778|FG000|Part C Washout 1 (7 Days)|Adverse Event|0|||
147509730|NCT03627494|532017779|FG001|Part C Washout 1 (7 Days)|Adverse Event|0|||
147509731|NCT03627494|532017780|FG002|Part C Washout 1 (7 Days)|Adverse Event|0|||
147509732|NCT03627494|532017781|FG003|Part C Washout 1 (7 Days)|Adverse Event|0|||
147509733|NCT03627494|532017782|FG004|Part C Washout 1 (7 Days)|Adverse Event|0|||
147509734|NCT03627494|532017783|FG005|Part C Washout 1 (7 Days)|Adverse Event|0|||
147509735|NCT03627494|532017784|FG006|Part C Washout 1 (7 Days)|Adverse Event|0|||
147509736|NCT03627494|532017785|FG007|Part C Washout 1 (7 Days)|Adverse Event|0|||
147509737|NCT03627494|532017786|FG008|Part C Washout 1 (7 Days)|Adverse Event|0|||
147509738|NCT03627494|532017787|FG009|Part C Washout 1 (7 Days)|Adverse Event|0|||
147509739|NCT03627494|532017788|FG010|Part C Washout 1 (7 Days)|Adverse Event|1|||
147509740|NCT03627494|532017789|FG011|Part C Washout 1 (7 Days)|Adverse Event|1|||
147509741|NCT00959894|532019699|FG000|Overall Study|Lost to Follow-up|10|||
147509742|NCT00959894|532019699|FG000|Overall Study|Adverse Event|3|||
147509743|NCT00959894|532019699|FG000|Overall Study|Withdrawal by Subject|1|||
147509744|NCT00959894|532019699|FG000|Overall Study|Need for contraindicated medication|1|||
147509745|NCT00959894|532019699|FG000|Overall Study|Subject moved out of town|1|||
147509746|NCT00405275|532019701|FG000|Overall Study|Death|1|||
147509747|NCT00405275|532019702|FG001|Overall Study|Death|0|||
147509748|NCT00405275|532019701|FG000|Overall Study|Lost to Follow-up|5|||
147509749|NCT00405275|532019702|FG001|Overall Study|Lost to Follow-up|1|||
147509750|NCT00405275|532019701|FG000|Overall Study|Withdrawal by Subject|7|||
147509751|NCT00405275|532019702|FG001|Overall Study|Withdrawal by Subject|9|||
147509752|NCT00405275|532019701|FG000|Overall Study|Unwilling to continue|10|||
147509753|NCT00405275|532019702|FG001|Overall Study|Unwilling to continue|9|||
147509754|NCT01308853|532019705|FG000|Overall Study|Adverse Event|1|||
147509755|NCT01308853|532019705|FG000|Overall Study|Lost to Follow-up|2|||
147509756|NCT01308853|532019705|FG000|Overall Study|Insertion of permanent implants|1|||
147509757|NCT00693420|532019708|FG000|Overall Study|Adverse Event|4|||
147509758|NCT00693420|532019709|FG001|Overall Study|Adverse Event|4|||
147509759|NCT00693420|532019708|FG000|Overall Study|Lost to Follow-up|0|||
147639708|NCT02122770|532499400|FG001|Part B: Standard of Care|Other|0|||
147509760|NCT00693420|532019709|FG001|Overall Study|Lost to Follow-up|3|||
147509761|NCT00693420|532019708|FG000|Overall Study|Withdrawal by Subject|1|||
147509762|NCT00693420|532019709|FG001|Overall Study|Withdrawal by Subject|0|||
147509763|NCT00693420|532019708|FG000|Overall Study|Protocol Violation|0|||
147509764|NCT00693420|532019709|FG001|Overall Study|Protocol Violation|2|||
147509765|NCT00693420|532019708|FG000|Overall Study|Sponsor Request - Conflict of Interest|0|||
147509766|NCT00693420|532019709|FG001|Overall Study|Sponsor Request - Conflict of Interest|2|||
147509767|NCT00693420|532019708|FG000|Overall Study|Personal Reasons|1|||
147509768|NCT00693420|532019709|FG001|Overall Study|Personal Reasons|4|||
147509769|NCT02853123|532019713|FG000|Treatment Period 1|Adverse Event|0|||
147509770|NCT02853123|532019714|FG001|Treatment Period 1|Adverse Event|3|||
147509771|NCT02853123|532019713|FG000|Washout Period|Worsening of COPD|0|||
147509772|NCT02853123|532019714|FG001|Washout Period|Worsening of COPD|3|||
147509773|NCT02853123|532019713|FG000|Washout Period|Adverse Event|1|||
147509774|NCT02853123|532019714|FG001|Washout Period|Adverse Event|0|||
147509775|NCT01473355|532019715|FG000|Overall Study|Protocol Violation|2|||
147509776|NCT01473355|532019715|FG000|Overall Study|Adverse Event|2|||
147509777|NCT01473355|532019715|FG000|Overall Study|Lost to Follow-up|2|||
147509778|NCT03250624|532019716|FG000|Overall Study|Lack of Efficacy|1|||
147509779|NCT03250624|532019717|FG001|Overall Study|Lack of Efficacy|4|||
147509780|NCT03250624|532019716|FG000|Overall Study|Adverse Event|0|||
147509781|NCT03250624|532019717|FG001|Overall Study|Adverse Event|1|||
147509782|NCT03250624|532019716|FG000|Overall Study|Other|1|||
147509783|NCT03250624|532019717|FG001|Overall Study|Other|2|||
147509784|NCT00106249|532019719|FG000|Overall Study|Lost to Follow-up|3|||
147509785|NCT00106249|532019720|FG001|Overall Study|Lost to Follow-up|2|||
147509786|NCT02809118|532019723|FG000|Overall Study|Withdrawal by Subject|0|||
147509787|NCT02809118|532019724|FG001|Overall Study|Withdrawal by Subject|1|||
147509788|NCT02809118|532019725|FG002|Overall Study|Withdrawal by Subject|1|||
147509789|NCT01235338|532019726|FG000|Overall Study|Adverse Event|3|||
147509790|NCT01235338|532019727|FG001|Overall Study|Adverse Event|2|||
147509791|NCT01235338|532019726|FG000|Overall Study|Protocol Violation|1|||
147509792|NCT01235338|532019727|FG001|Overall Study|Protocol Violation|1|||
147509793|NCT01235338|532019726|FG000|Overall Study|Withdrawal by Subject|5|||
147509794|NCT01235338|532019727|FG001|Overall Study|Withdrawal by Subject|0|||
147509795|NCT01235338|532019726|FG000|Overall Study|Exclusion criteria violations|1|||
147509796|NCT01235338|532019727|FG001|Overall Study|Exclusion criteria violations|1|||
147509797|NCT01235338|532019726|FG000|Overall Study|Positive drug screen|0|||
147509798|NCT01235338|532019727|FG001|Overall Study|Positive drug screen|1|||
147509799|NCT01235338|532019726|FG000|Overall Study|Prohibited meds|1|||
147509800|NCT01235338|532019727|FG001|Overall Study|Prohibited meds|0|||
147509801|NCT00509028|532019730|FG000|Overall Study|Adverse Event|2|||
147509802|NCT00509028|532019731|FG001|Overall Study|Adverse Event|0|||
147509803|NCT00509028|532019730|FG000|Overall Study|Withdrawal by Subject|4|||
147509804|NCT00509028|532019731|FG001|Overall Study|Withdrawal by Subject|3|||
147509805|NCT00509028|532019730|FG000|Overall Study|Lost to Follow-up|0|||
147509806|NCT00509028|532019731|FG001|Overall Study|Lost to Follow-up|1|||
147509807|NCT00509028|532019730|FG000|Overall Study|Protocol Violation|4|||
147509808|NCT00509028|532019731|FG001|Overall Study|Protocol Violation|2|||
147509809|NCT00509028|532019730|FG000|Overall Study|Non-compliance|2|||
147509810|NCT00509028|532019731|FG001|Overall Study|Non-compliance|1|||
147509811|NCT00948428|532019732|FG000|Overall Study|Withdrawal by Subject|6|||
147509812|NCT00948428|532019733|FG001|Overall Study|Withdrawal by Subject|12|||
147509813|NCT00948428|532019734|FG002|Overall Study|Withdrawal by Subject|7|||
147509814|NCT00948428|532019732|FG000|Overall Study|Adverse Event|6|||
147509815|NCT00948428|532019733|FG001|Overall Study|Adverse Event|3|||
147509816|NCT00948428|532019734|FG002|Overall Study|Adverse Event|0|||
147509817|NCT00948428|532019732|FG000|Overall Study|Lost to Follow-up|2|||
147509818|NCT00948428|532019733|FG001|Overall Study|Lost to Follow-up|1|||
147509819|NCT00948428|532019734|FG002|Overall Study|Lost to Follow-up|1|||
147509820|NCT00948428|532019732|FG000|Overall Study|Death|2|||
147509821|NCT00948428|532019733|FG001|Overall Study|Death|0|||
147509822|NCT00948428|532019734|FG002|Overall Study|Death|0|||
147509823|NCT00948428|532019732|FG000|Overall Study|Intercurrent Illness|1|||
147509824|NCT00948428|532019733|FG001|Overall Study|Intercurrent Illness|0|||
147509825|NCT00948428|532019734|FG002|Overall Study|Intercurrent Illness|0|||
147509826|NCT00948428|532019732|FG000|Overall Study|Non-compliance|1|||
147509827|NCT00948428|532019733|FG001|Overall Study|Non-compliance|2|||
147509828|NCT00948428|532019734|FG002|Overall Study|Non-compliance|0|||
147509829|NCT01495689|532019737|FG000|Overall Study|Death|0|||
147509830|NCT01495689|532019738|FG001|Overall Study|Death|1|||
147509831|NCT01495689|532019737|FG000|Overall Study|Withdrawal by Subject|3|||
147509832|NCT01495689|532019738|FG001|Overall Study|Withdrawal by Subject|0|||
147509833|NCT01495689|532019737|FG000|Overall Study|Lost to Follow-up|7|||
147509834|NCT01495689|532019738|FG001|Overall Study|Lost to Follow-up|6|||
147509835|NCT05516134|532019739|FG000|Overall Study|Lost to Follow-up|1|||
147639709|NCT02122770|532499401|FG002|Part B: Standard of Care|Other|0|||
147639710|NCT02122770|532499402|FG003|Part B: Standard of Care|Other|0|||
147509836|NCT05516134|532019740|FG001|Overall Study|Lost to Follow-up|0|||
147509837|NCT05516134|532019741|FG002|Overall Study|Lost to Follow-up|0|||
147509838|NCT01843205|532019742|FG000|First Treatment (11 Days)|Withdrawal by Subject|1|||
147509839|NCT01843205|532019743|FG001|First Treatment (11 Days)|Withdrawal by Subject|0|||
147509840|NCT00517413|532019744|FG000|Overall Study|Adverse Event|7|||
147509841|NCT00517413|532019744|FG000|Overall Study|Death|13|||
147639711|NCT02122770|532499403|FG004|Part B: Standard of Care|Other|0|||
147509842|NCT00517413|532019744|FG000|Overall Study|Protocol Violation|15|||
147509843|NCT00517413|532019744|FG000|Overall Study|Withdrawal by Subject|2|||
147509844|NCT00517413|532019744|FG000|Overall Study|Failure to return|1|||
147509845|NCT00517413|532019744|FG000|Overall Study|Other-Reasons|23|||
147509846|NCT00606177|532019745|FG000|Overall Study|Adverse Event|9|||
147639712|NCT02122770|532499404|FG005|Part B: Standard of Care|Other|2|||
147509847|NCT00606177|532019746|FG001|Overall Study|Adverse Event|5|||
147509848|NCT00606177|532019745|FG000|Overall Study|Lack of Efficacy|3|||
147509849|NCT00606177|532019746|FG001|Overall Study|Lack of Efficacy|7|||
147509850|NCT00606177|532019745|FG000|Overall Study|Physician Decision|1|||
147509851|NCT00606177|532019746|FG001|Overall Study|Physician Decision|0|||
147509852|NCT00606177|532019745|FG000|Overall Study|Protocol Violation|1|||
147509853|NCT00606177|532019746|FG001|Overall Study|Protocol Violation|4|||
147509854|NCT00606177|532019745|FG000|Overall Study|Withdrawal by Subject|5|||
147509855|NCT00606177|532019746|FG001|Overall Study|Withdrawal by Subject|6|||
147509856|NCT00606177|532019745|FG000|Overall Study|Progression to depressive phase|6|||
147509857|NCT00606177|532019746|FG001|Overall Study|Progression to depressive phase|1|||
147509858|NCT00606177|532019745|FG000|Overall Study|Diabetic blood glucose level/ High HbA1c|1|||
147509859|NCT00606177|532019746|FG001|Overall Study|Diabetic blood glucose level/ High HbA1c|1|||
147509860|NCT00606177|532019745|FG000|Overall Study|Change of residence or other commitments|1|||
147509861|NCT00606177|532019746|FG001|Overall Study|Change of residence or other commitments|1|||
147509862|NCT00136357|532019747|FG000|Overall Study|Withdrawal by Subject|3|||
147509863|NCT00136357|532019748|FG001|Overall Study|Withdrawal by Subject|2|||
147509864|NCT02603172|532019754|FG000|Part A (Approximately 16 Weeks)|Adverse Event|0|||
147509865|NCT02603172|532019755|FG001|Part A (Approximately 16 Weeks)|Adverse Event|0|||
147509866|NCT02603172|532019756|FG002|Part A (Approximately 16 Weeks)|Adverse Event|1|||
147509867|NCT02603172|532019757|FG003|Part A (Approximately 16 Weeks)|Adverse Event|0|||
147509868|NCT02603172|532019758|FG004|Part A (Approximately 16 Weeks)|Adverse Event|0|||
147509869|NCT02603172|532019759|FG005|Part A (Approximately 16 Weeks)|Adverse Event|0|||
147509870|NCT02603172|532019760|FG006|Part A (Approximately 16 Weeks)|Adverse Event|0|||
147509871|NCT02603172|532019761|FG007|Part A (Approximately 16 Weeks)|Adverse Event|0|||
147509872|NCT00441727|532019764|FG000|Overall Study|Protocol Violation|19|||
147509873|NCT00441727|532019765|FG001|Overall Study|Protocol Violation|28|||
147509874|NCT00441727|532019766|FG002|Overall Study|Protocol Violation|32|||
147509875|NCT00441727|532019764|FG000|Overall Study|Adverse Event|26|||
147509876|NCT00441727|532019765|FG001|Overall Study|Adverse Event|33|||
147509877|NCT00441727|532019766|FG002|Overall Study|Adverse Event|28|||
147509878|NCT00441727|532019764|FG000|Overall Study|Lack of Efficacy|7|||
147509879|NCT00441727|532019765|FG001|Overall Study|Lack of Efficacy|8|||
147509880|NCT00441727|532019766|FG002|Overall Study|Lack of Efficacy|48|||
147509881|NCT00441727|532019764|FG000|Overall Study|Withdrawal by Subject|40|||
147509882|NCT00441727|532019765|FG001|Overall Study|Withdrawal by Subject|34|||
147509883|NCT00441727|532019766|FG002|Overall Study|Withdrawal by Subject|47|||
147509884|NCT00441727|532019764|FG000|Overall Study|Lost to Follow-up|5|||
147509885|NCT00441727|532019765|FG001|Overall Study|Lost to Follow-up|6|||
147509886|NCT00441727|532019766|FG002|Overall Study|Lost to Follow-up|5|||
147509887|NCT00441727|532019764|FG000|Overall Study|Safety Reasons|3|||
147509888|NCT00441727|532019765|FG001|Overall Study|Safety Reasons|1|||
147509889|NCT00441727|532019766|FG002|Overall Study|Safety Reasons|3|||
147509890|NCT00441727|532019764|FG000|Overall Study|Various reason specified|6|||
147509891|NCT00441727|532019765|FG001|Overall Study|Various reason specified|8|||
147509892|NCT00441727|532019766|FG002|Overall Study|Various reason specified|5|||
147509893|NCT02133001|532019767|FG000|Double Blind (Day 1-25)|Adverse Event|1|||
147509894|NCT02133001|532019768|FG001|Double Blind (Day 1-25)|Adverse Event|5|||
147509895|NCT02133001|532019767|FG000|Double Blind (Day 1-25)|Lack of Efficacy|4|||
147509896|NCT02133001|532019768|FG001|Double Blind (Day 1-25)|Lack of Efficacy|1|||
147509897|NCT02133001|532019767|FG000|Double Blind (Day 1-25)|Lost to Follow-up|2|||
147509898|NCT02133001|532019768|FG001|Double Blind (Day 1-25)|Lost to Follow-up|0|||
147509899|NCT02133001|532019767|FG000|Double Blind (Day 1-25)|Other|2|||
147509900|NCT02133001|532019768|FG001|Double Blind (Day 1-25)|Other|2|||
147509901|NCT02133001|532019767|FG000|Double Blind (Day 1-25)|Withdrawal by Subject|1|||
147509902|NCT02133001|532019768|FG001|Double Blind (Day 1-25)|Withdrawal by Subject|1|||
147509903|NCT02133001|532019767|FG000|Follow-Up Phase (Day 26-81)|Lost to Follow-up|1|||
147509904|NCT02133001|532019768|FG001|Follow-Up Phase (Day 26-81)|Lost to Follow-up|1|||
147509905|NCT02133001|532019767|FG000|Follow-Up Phase (Day 26-81)|Withdrawal by Subject|1|||
147509906|NCT02133001|532019768|FG001|Follow-Up Phase (Day 26-81)|Withdrawal by Subject|1|||
147509907|NCT02133001|532019767|FG000|Follow-Up Phase (Day 26-81)|Other|0|||
147509908|NCT02133001|532019768|FG001|Follow-Up Phase (Day 26-81)|Other|1|||
147509909|NCT04211961|532019769|FG000|Overall Study|Death|0|||
147509910|NCT04211961|532019770|FG001|Overall Study|Death|1|||
147509911|NCT04211961|532019769|FG000|Overall Study|Lost to Follow-up|0|||
147509912|NCT04211961|532019770|FG001|Overall Study|Lost to Follow-up|1|||
147509913|NCT04211961|532019769|FG000|Overall Study|Withdrawal by Subject|0|||
147509914|NCT04211961|532019770|FG001|Overall Study|Withdrawal by Subject|1|||
147509915|NCT03210220|532019771|FG000|Overall Study|Physician Decision|1|||
147509916|NCT03210220|532019772|FG001|Overall Study|Physician Decision|0|||
147509917|NCT01444898|532019773|FG000|Overall Study|Withdrawal by Subject|1|||
147509918|NCT03235726|532019774|FG000|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
147509919|NCT03235726|532019775|FG001|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
147509920|NCT03235726|532019776|FG002|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
147509921|NCT03235726|532019777|FG003|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
147509922|NCT03235726|532019778|FG004|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|1|||
147509923|NCT03235726|532019779|FG005|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
147509924|NCT03235726|532019780|FG006|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
147509925|NCT03235726|532019781|FG007|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
147509926|NCT03235726|532019782|FG008|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
147509927|NCT03235726|532019783|FG009|Part 1 (Cohort B and C- Days 1 to 14)|Withdrawal by Subject|0|||
147509928|NCT03235726|532019774|FG000|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
147509929|NCT03235726|532019775|FG001|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
147509930|NCT03235726|532019776|FG002|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
147509931|NCT03235726|532019777|FG003|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
147509932|NCT03235726|532019778|FG004|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|1|||
147509933|NCT03235726|532019779|FG005|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
147509934|NCT03235726|532019780|FG006|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
147509935|NCT03235726|532019781|FG007|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
147509936|NCT03235726|532019782|FG008|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
147509937|NCT03235726|532019783|FG009|Part 1 (Cohort B and C- Days 1 to 14)|Drug was prematurely discontinued|0|||
147509938|NCT00282568|532019792|FG000|Pharmacokinetic Treatment Period|Discontinued prior to Day 1|2|||
147509939|NCT00282568|532019792|FG000|Pharmacokinetic Treatment Period|Enrolled erroneously|1|||
147509940|NCT00282568|532019792|FG000|Extended Treatment Period|Adverse Event|17|||
147509941|NCT00282568|532019792|FG000|Extended Treatment Period|Non-compliance|4|||
147509942|NCT00282568|532019792|FG000|Extended Treatment Period|Physician Decision|1|||
147509943|NCT00282568|532019792|FG000|Extended Treatment Period|Lost to Follow-up|2|||
147509944|NCT00990249|532019797|FG000|Overall Study|Disease Progression|8|||
147509945|NCT00990249|532019797|FG000|Overall Study|Non-Compliance|1|||
147509946|NCT00990249|532019797|FG000|Overall Study|Death|2|||
147509947|NCT00990249|532019797|FG000|Overall Study|Not treated|2|||
147509948|NCT01548417|532019798|FG000|Overall Study|Withdrawal by Subject|0|||
147509949|NCT01548417|532019799|FG001|Overall Study|Withdrawal by Subject|2|||
147509950|NCT02873208|532019802|FG000|Overall Study|Withdrawal by Subject|36|||
147509951|NCT02873208|532019802|FG000|Overall Study|Lost to Follow-up|22|||
147509952|NCT02873208|532019802|FG000|Overall Study|Adverse Event|15|||
147509953|NCT02873208|532019802|FG000|Overall Study|Non-compliance with study drug|12|||
147509954|NCT02873208|532019802|FG000|Overall Study|Protocol Violation|8|||
147509955|NCT02873208|532019802|FG000|Overall Study|Pregnancy|2|||
147509956|NCT02873208|532019802|FG000|Overall Study|Incarceration|1|||
147509957|NCT02873208|532019802|FG000|Overall Study|Lack of Efficacy|1|||
147509958|NCT02873208|532019802|FG000|Overall Study|Physician Decision|1|||
147509959|NCT00415584|532019803|FG000|Overall Study|Withdrawal by Subject|1|||
147509960|NCT02640755|532019804|FG000|Multiple Dose Period (Day 8 - EoS)|Condition under investigation worsened|0|||
147509961|NCT02640755|532019805|FG001|Multiple Dose Period (Day 8 - EoS)|Condition under investigation worsened|1|||
147509962|NCT02640755|532019804|FG000|Multiple Dose Period (Day 8 - EoS)|Subjective progression of disease|1|||
147509963|NCT02640755|532019805|FG001|Multiple Dose Period (Day 8 - EoS)|Subjective progression of disease|0|||
147509964|NCT02640755|532019804|FG000|Multiple Dose Period (Day 8 - EoS)|Withdrawal by Subject|1|||
147509965|NCT02640755|532019805|FG001|Multiple Dose Period (Day 8 - EoS)|Withdrawal by Subject|0|||
147509966|NCT03434041|532019806|FG000|Double Blind Treatment Phase (4 Weeks)|Lost to Follow-up|1|||
147509967|NCT03434041|532019807|FG001|Double Blind Treatment Phase (4 Weeks)|Lost to Follow-up|0|||
147509968|NCT03434041|532019806|FG000|Double Blind Treatment Phase (4 Weeks)|Withdrawal by Subject|2|||
147509969|NCT03434041|532019807|FG001|Double Blind Treatment Phase (4 Weeks)|Withdrawal by Subject|1|||
147509970|NCT03434041|532019806|FG000|Double Blind Treatment Phase (4 Weeks)|Lack of Efficacy|3|||
147509971|NCT03434041|532019807|FG001|Double Blind Treatment Phase (4 Weeks)|Lack of Efficacy|14|||
147509972|NCT03434041|532019806|FG000|Double Blind Treatment Phase (4 Weeks)|Adverse Event|7|||
147509973|NCT03434041|532019807|FG001|Double Blind Treatment Phase (4 Weeks)|Adverse Event|2|||
147509974|NCT03434041|532019806|FG000|Double Blind Treatment Phase (4 Weeks)|Death|1|||
147509975|NCT03434041|532019807|FG001|Double Blind Treatment Phase (4 Weeks)|Death|0|||
147509976|NCT03434041|532019806|FG000|Double Blind Treatment Phase (4 Weeks)|Covid-19 related|2|||
147509977|NCT03434041|532019807|FG001|Double Blind Treatment Phase (4 Weeks)|Covid-19 related|2|||
147509978|NCT03434041|532019806|FG000|Double Blind Treatment Phase (4 Weeks)|Non-compliance with study drug|0|||
147509979|NCT03434041|532019807|FG001|Double Blind Treatment Phase (4 Weeks)|Non-compliance with study drug|1|||
147509980|NCT03434041|532019806|FG000|Double Blind Treatment Phase (4 Weeks)|Other|2|||
147509981|NCT03434041|532019807|FG001|Double Blind Treatment Phase (4 Weeks)|Other|0|||
147509982|NCT03434041|532019806|FG000|Follow-up Phase (Up to 8 Weeks)|Withdrawal by Subject|4|||
147509983|NCT03434041|532019807|FG001|Follow-up Phase (Up to 8 Weeks)|Withdrawal by Subject|3|||
147639713|NCT02122770|532499399|FG000|Part B: Standard of Care|Withdrawal by Subject|0|||
147639714|NCT02122770|532499400|FG001|Part B: Standard of Care|Withdrawal by Subject|0|||
147639715|NCT02122770|532499401|FG002|Part B: Standard of Care|Withdrawal by Subject|0|||
147639716|NCT02122770|532499402|FG003|Part B: Standard of Care|Withdrawal by Subject|0|||
147639717|NCT02122770|532499403|FG004|Part B: Standard of Care|Withdrawal by Subject|4|||
147509984|NCT03434041|532019806|FG000|Follow-up Phase (Up to 8 Weeks)|Adverse Event|2|||
147509985|NCT03434041|532019807|FG001|Follow-up Phase (Up to 8 Weeks)|Adverse Event|0|||
147509986|NCT03434041|532019806|FG000|Follow-up Phase (Up to 8 Weeks)|Investigator decision to discontinue follow-up and proceed to 54135419TRD3008 (NCT02782104)|1|||
147509987|NCT03434041|532019807|FG001|Follow-up Phase (Up to 8 Weeks)|Investigator decision to discontinue follow-up and proceed to 54135419TRD3008 (NCT02782104)|0|||
147509988|NCT02057068|532019810|FG000|Overall Study|Withdrawal by Subject|2|||
147509989|NCT02057068|532019811|FG001|Overall Study|Withdrawal by Subject|2|||
147509990|NCT02057068|532019810|FG000|Overall Study|Caregiver (CG) Health|0|||
147509991|NCT02057068|532019811|FG001|Overall Study|Caregiver (CG) Health|2|||
147509992|NCT02057068|532019810|FG000|Overall Study|Carepartner (CP) Health|4|||
147509993|NCT02057068|532019811|FG001|Overall Study|Carepartner (CP) Health|2|||
147509994|NCT02057068|532019810|FG000|Overall Study|Lost to Follow-up|2|||
147509995|NCT02057068|532019811|FG001|Overall Study|Lost to Follow-up|2|||
147509996|NCT03447821|532019815|FG000|Overall Study|Withdrawal by Subject|1|||
147509997|NCT03447821|532019816|FG001|Overall Study|Withdrawal by Subject|1|||
147509998|NCT03447821|532019817|FG002|Overall Study|Withdrawal by Subject|0|||
147509999|NCT03447821|532019815|FG000|Overall Study|Lost to Follow-up|0|||
147510000|NCT03447821|532019816|FG001|Overall Study|Lost to Follow-up|0|||
147510001|NCT03447821|532019817|FG002|Overall Study|Lost to Follow-up|1|||
147510002|NCT04685538|532019818|FG000|Overall Study|Adverse Event|0|||
147510003|NCT04685538|532019819|FG001|Overall Study|Adverse Event|1|||
147510004|NCT04685538|532019818|FG000|Overall Study|Lost to Follow-up|0|||
147510005|NCT04685538|532019819|FG001|Overall Study|Lost to Follow-up|2|||
147510006|NCT01505114|532019828|FG000|Overall Study|Withdrawal by Subject|5|||
147510007|NCT01505114|532019829|FG001|Overall Study|Withdrawal by Subject|4|||
147510008|NCT01505114|532019830|FG002|Overall Study|Withdrawal by Subject|4|||
147510009|NCT01505114|532019831|FG003|Overall Study|Withdrawal by Subject|7|||
147510010|NCT01505114|532019828|FG000|Overall Study|Death|1|||
147510011|NCT01505114|532019829|FG001|Overall Study|Death|0|||
147510012|NCT01505114|532019830|FG002|Overall Study|Death|0|||
147510013|NCT01505114|532019831|FG003|Overall Study|Death|1|||
147510014|NCT01505114|532019828|FG000|Overall Study|unable to adhere to visit schedule|3|||
147510015|NCT01505114|532019829|FG001|Overall Study|unable to adhere to visit schedule|2|||
147639718|NCT02122770|532499404|FG005|Part B: Standard of Care|Withdrawal by Subject|2|||
147639719|NCT02122770|532499399|FG000|Part B: Standard of Care|Symptomatic Deterioration|0|||
147639720|NCT02122770|532499400|FG001|Part B: Standard of Care|Symptomatic Deterioration|0|||
147639721|NCT02122770|532499401|FG002|Part B: Standard of Care|Symptomatic Deterioration|0|||
147639722|NCT02122770|532499402|FG003|Part B: Standard of Care|Symptomatic Deterioration|0|||
147639723|NCT02122770|532499403|FG004|Part B: Standard of Care|Symptomatic Deterioration|5|||
147639724|NCT02122770|532499404|FG005|Part B: Standard of Care|Symptomatic Deterioration|0|||
147639725|NCT02122770|532499399|FG000|Part B: Standard of Care|Progressive Disease|0|||
147639726|NCT02122770|532499400|FG001|Part B: Standard of Care|Progressive Disease|0|||
147639727|NCT02122770|532499401|FG002|Part B: Standard of Care|Progressive Disease|0|||
147639728|NCT02122770|532499402|FG003|Part B: Standard of Care|Progressive Disease|0|||
147639729|NCT02122770|532499403|FG004|Part B: Standard of Care|Progressive Disease|10|||
147639730|NCT02122770|532499404|FG005|Part B: Standard of Care|Progressive Disease|8|||
147639731|NCT01041976|532499405|FG000|Overall Study|Withdrawal by Subject|3|||
147639732|NCT01041976|532499406|FG001|Overall Study|Withdrawal by Subject|0|||
147639733|NCT01041976|532499405|FG000|Overall Study|Incarceration|2|||
147639734|NCT01041976|532499406|FG001|Overall Study|Incarceration|0|||
147639735|NCT01041976|532499405|FG000|Overall Study|Death|0|||
147639736|NCT01041976|532499406|FG001|Overall Study|Death|4|||
147639737|NCT02850016|532499407|FG000|Overall Study|Withdrawal by Subject|1|||
147639738|NCT02850016|532499408|FG001|Overall Study|Withdrawal by Subject|2|||
147639739|NCT01258075|532499412|FG000|Overall Study|Adverse Event|8|||
147639740|NCT01258075|532499413|FG001|Overall Study|Adverse Event|3|||
147639741|NCT01258075|532499412|FG000|Overall Study|Lost to Follow-up|11|||
147639742|NCT01258075|532499413|FG001|Overall Study|Lost to Follow-up|6|||
147639743|NCT01258075|532499412|FG000|Overall Study|Withdrawal by Subject|10|||
147639744|NCT01258075|532499413|FG001|Overall Study|Withdrawal by Subject|7|||
147639745|NCT01258075|532499412|FG000|Overall Study|Hyperglycemia meeting protocol-specified discontinuation criteria|1|||
147639746|NCT01258075|532499413|FG001|Overall Study|Hyperglycemia meeting protocol-specified discontinuation criteria|2|||
147639747|NCT01258075|532499412|FG000|Overall Study|Other|12|||
147639748|NCT01258075|532499413|FG001|Overall Study|Other|5|||
147639749|NCT02939716|532499414|FG000|Overall Study|scanner failure|0|||
147639750|NCT02939716|532499415|FG001|Overall Study|scanner failure|0|||
147639751|NCT02939716|532499416|FG002|Overall Study|scanner failure|0|||
147639752|NCT02939716|532499417|FG003|Overall Study|scanner failure|1|||
147639753|NCT02939716|532499418|FG004|Overall Study|scanner failure|1|||
147510016|NCT01505114|532019830|FG002|Overall Study|unable to adhere to visit schedule|3|||
147510017|NCT01505114|532019831|FG003|Overall Study|unable to adhere to visit schedule|3|||
147510018|NCT01505114|532019828|FG000|Overall Study|Lost to Follow-up|11|||
147510019|NCT01505114|532019829|FG001|Overall Study|Lost to Follow-up|5|||
147510020|NCT01505114|532019830|FG002|Overall Study|Lost to Follow-up|8|||
147510021|NCT01505114|532019831|FG003|Overall Study|Lost to Follow-up|7|||
147510022|NCT01505114|532019828|FG000|Overall Study|relocated|4|||
147510023|NCT01505114|532019829|FG001|Overall Study|relocated|2|||
147510024|NCT01505114|532019830|FG002|Overall Study|relocated|2|||
147510025|NCT01505114|532019831|FG003|Overall Study|relocated|3|||
147510026|NCT01505114|532019828|FG000|Overall Study|inadvertent enrollment due to peanut all|0|||
147510027|NCT01505114|532019829|FG001|Overall Study|inadvertent enrollment due to peanut all|0|||
147510028|NCT01505114|532019830|FG002|Overall Study|inadvertent enrollment due to peanut all|0|||
147510029|NCT01505114|532019831|FG003|Overall Study|inadvertent enrollment due to peanut all|1|||
147510030|NCT01505114|532019828|FG000|Overall Study|staff safety concerns|0|||
147510031|NCT01505114|532019829|FG001|Overall Study|staff safety concerns|0|||
147510032|NCT01505114|532019830|FG002|Overall Study|staff safety concerns|0|||
147510033|NCT01505114|532019831|FG003|Overall Study|staff safety concerns|1|||
147510034|NCT01505114|532019828|FG000|Overall Study|investigator decision|1|||
147510035|NCT01505114|532019829|FG001|Overall Study|investigator decision|0|||
147510036|NCT01505114|532019830|FG002|Overall Study|investigator decision|1|||
147510037|NCT01505114|532019831|FG003|Overall Study|investigator decision|0|||
147510038|NCT03168555|532019832|FG000|Visit 1 (Pro-operative)|intercurrent disease, drop-out before visit 1|1|||
147510039|NCT03168555|532019832|FG000|Visit 2 (Post-operative)|Lost to Follow-up|1|||
147510040|NCT03168555|532019832|FG000|Visit 2 (Post-operative)|Adverse Event|1|||
147510041|NCT03168555|532019832|FG000|Visit 2 (Post-operative)|Withdrawal by Subject|2|||
147510042|NCT01732107|532019834|FG000|Overall Study|Adverse Event|2|||
147510043|NCT01732107|532019834|FG000|Overall Study|Disease Progression|8|||
147510044|NCT01732107|532019834|FG000|Overall Study|Physician Decision|1|||
147510045|NCT01732107|532019834|FG000|Overall Study|Withdrawal by Subject|2|||
147510046|NCT02959190|532019836|FG000|Open Label|Adverse Event|5|||
147639754|NCT02939716|532499419|FG005|Overall Study|scanner failure|1|||
147639755|NCT00976209|532499420|FG000|Treatment Period 1|Protocol Violation|1|||
147639756|NCT00976209|532499421|FG001|Treatment Period 1|Protocol Violation|0|||
147639757|NCT00976209|532499420|FG000|Treatment Period 1|Lost to Follow-up|2|||
147639758|NCT00976209|532499421|FG001|Treatment Period 1|Lost to Follow-up|0|||
147639759|NCT00976209|532499420|FG000|Treatment Period 1|Other|0|||
147639760|NCT00976209|532499421|FG001|Treatment Period 1|Other|1|||
147639761|NCT00976209|532499420|FG000|Wash-out Period|Adverse Event|1|||
147639762|NCT00976209|532499421|FG001|Wash-out Period|Adverse Event|2|||
147639763|NCT00976209|532499420|FG000|Wash-out Period|Lost to Follow-up|1|||
147639764|NCT00976209|532499421|FG001|Wash-out Period|Lost to Follow-up|0|||
147639765|NCT00976209|532499420|FG000|Wash-out Period|Protocol Violation|1|||
147639766|NCT00976209|532499421|FG001|Wash-out Period|Protocol Violation|0|||
147639767|NCT00976209|532499420|FG000|Wash-out Period|Other|1|||
147639768|NCT00976209|532499421|FG001|Wash-out Period|Other|0|||
147639769|NCT00976209|532499420|FG000|Treatment Period 2|Withdrawal by Subject|0|||
147639770|NCT00976209|532499421|FG001|Treatment Period 2|Withdrawal by Subject|1|||
147639771|NCT00976209|532499420|FG000|Treatment Period 2|Lost to Follow-up|0|||
147639772|NCT00976209|532499421|FG001|Treatment Period 2|Lost to Follow-up|1|||
147639773|NCT01252563|532499422|FG000|Overall Study|Contract Deviation|41|||
147639774|NCT01252563|532499422|FG000|Overall Study|Centralized Registration Deviation|30|||
147639775|NCT01252563|532499422|FG000|Overall Study|Lost to Follow-up|161|||
147639776|NCT01252563|532499422|FG000|Overall Study|No visit after first day of treatment|194|||
147639777|NCT01252563|532499422|FG000|Overall Study|No drug administration|6|||
147639778|NCT02951533|532499426|FG000|Part I (Week 0 Through Week 24)|Adverse Event|0|||
147639779|NCT02951533|532499427|FG001|Part I (Week 0 Through Week 24)|Adverse Event|16|||
147639780|NCT02951533|532499428|FG002|Part I (Week 0 Through Week 24)|Adverse Event|0|||
147639781|NCT02951533|532499426|FG000|Part I (Week 0 Through Week 24)|Lost to Follow-up|2|||
147639782|NCT02951533|532499427|FG001|Part I (Week 0 Through Week 24)|Lost to Follow-up|2|||
147639783|NCT02951533|532499428|FG002|Part I (Week 0 Through Week 24)|Lost to Follow-up|0|||
147639784|NCT02951533|532499426|FG000|Part I (Week 0 Through Week 24)|Withdrawal by Subject|2|||
147639785|NCT02951533|532499427|FG001|Part I (Week 0 Through Week 24)|Withdrawal by Subject|4|||
147639786|NCT02951533|532499428|FG002|Part I (Week 0 Through Week 24)|Withdrawal by Subject|0|||
147639787|NCT02951533|532499426|FG000|Part I (Week 0 Through Week 24)|Noncompliance with Study Drug|0|||
147639788|NCT02951533|532499427|FG001|Part I (Week 0 Through Week 24)|Noncompliance with Study Drug|1|||
147639789|NCT02951533|532499428|FG002|Part I (Week 0 Through Week 24)|Noncompliance with Study Drug|0|||
147639790|NCT02951533|532499426|FG000|Part IIa (Week 24 Through Week 32)|Adverse Event|0|||
147639791|NCT02951533|532499427|FG001|Part IIa (Week 24 Through Week 32)|Adverse Event|1|||
147639792|NCT02951533|532499428|FG002|Part IIa (Week 24 Through Week 32)|Adverse Event|0|||
147639793|NCT02951533|532499426|FG000|Part IIa (Week 24 Through Week 32)|Withdrawal by Subject|1|||
147639794|NCT02951533|532499427|FG001|Part IIa (Week 24 Through Week 32)|Withdrawal by Subject|0|||
147639795|NCT02951533|532499428|FG002|Part IIa (Week 24 Through Week 32)|Withdrawal by Subject|0|||
147639796|NCT02951533|532499426|FG000|Part IIb (Week 32 Through Week 56)|Adverse Event|0|||
147670042|NCT03104374|532617469|FG000|Period 2|Adverse Event|4|||
147510047|NCT02959190|532019837|FG001|Open Label|Adverse Event|7|||
147510048|NCT02959190|532019838|FG002|Open Label|Adverse Event|3|||
147510049|NCT02959190|532019839|FG003|Open Label|Adverse Event|4|||
147510050|NCT02959190|532019836|FG000|Open Label|Pregnancy|0|||
147510051|NCT02959190|532019837|FG001|Open Label|Pregnancy|1|||
147510052|NCT02959190|532019838|FG002|Open Label|Pregnancy|0|||
147510053|NCT02959190|532019839|FG003|Open Label|Pregnancy|0|||
147510054|NCT02959190|532019836|FG000|Open Label|Withdrawal by Subject|2|||
147510055|NCT02959190|532019837|FG001|Open Label|Withdrawal by Subject|8|||
147510056|NCT02959190|532019838|FG002|Open Label|Withdrawal by Subject|0|||
147510057|NCT02959190|532019839|FG003|Open Label|Withdrawal by Subject|0|||
147510058|NCT02959190|532019836|FG000|Open Label|Physician Decision|0|||
147510059|NCT02959190|532019837|FG001|Open Label|Physician Decision|0|||
147510060|NCT02959190|532019838|FG002|Open Label|Physician Decision|1|||
147510061|NCT02959190|532019839|FG003|Open Label|Physician Decision|0|||
147510062|NCT02959190|532019836|FG000|Open Label|Protocol Violation|0|||
147510063|NCT02959190|532019837|FG001|Open Label|Protocol Violation|0|||
147510064|NCT02959190|532019838|FG002|Open Label|Protocol Violation|0|||
147510065|NCT02959190|532019839|FG003|Open Label|Protocol Violation|2|||
147510066|NCT02959190|532019836|FG000|Post Treatment Follow Up|Adverse Event|1|||
147510067|NCT02959190|532019837|FG001|Post Treatment Follow Up|Adverse Event|1|||
147510068|NCT02959190|532019838|FG002|Post Treatment Follow Up|Adverse Event|0|||
147510069|NCT02959190|532019839|FG003|Post Treatment Follow Up|Adverse Event|0|||
147510070|NCT02959190|532019836|FG000|Post Treatment Follow Up|Withdrawal by Subject|2|||
147510071|NCT02959190|532019837|FG001|Post Treatment Follow Up|Withdrawal by Subject|0|||
147510072|NCT02959190|532019838|FG002|Post Treatment Follow Up|Withdrawal by Subject|1|||
147510073|NCT02959190|532019839|FG003|Post Treatment Follow Up|Withdrawal by Subject|0|||
147510074|NCT01421069|532019841|FG000|Parent Study|drug ineffective+prohibited drug taken|1|||
147510075|NCT01421069|532019841|FG000|Parent Study|Failed to return|3|||
147510076|NCT01421069|532019841|FG000|Parent Study|Withdrawal by Subject|1|||
147510077|NCT01421069|532019841|FG000|Parent Study|Lost to Follow-up|2|||
147510078|NCT01421069|532019841|FG000|Parent Study|Lack of Efficacy|1|||
147510079|NCT01421069|532019841|FG000|Overall Period for Extension Study|Other|2|||
147510080|NCT01421069|532019841|FG000|Overall Period for Extension Study|Medication error without associated adverse event|1|||
147510081|NCT01421069|532019841|FG000|Overall Period for Extension Study|No longer willing to participate|14|||
147510082|NCT01421069|532019841|FG000|Overall Period for Extension Study|Pregnancy|1|||
147510083|NCT01421069|532019841|FG000|Overall Period for Extension Study|Adverse Event|1|||
147510084|NCT01421069|532019841|FG000|Overall Period for Extension Study|Protocol Violation|1|||
147510085|NCT01421069|532019841|FG000|Overall Period for Extension Study|Lost to Follow-up|4|||
147510086|NCT01421069|532019841|FG000|Overall Period for Extension Study|Lack of Efficacy|1|||
147510087|NCT01421069|532019841|FG000|Active Treatment Period|Other|1|||
147510088|NCT01421069|532019841|FG000|Active Treatment Period|No longer willing to participate in study|8|||
147510089|NCT01421069|532019841|FG000|Active Treatment Period|Insufficient clinical response|1|||
147510090|NCT01421069|532019841|FG000|Active Treatment Period|Medication error without associated adverse event|1|||
147510091|NCT01421069|532019841|FG000|Active Treatment Period|Pregnancy|1|||
147510092|NCT01421069|532019841|FG000|Active Treatment Period|Adverse Event|1|||
147510093|NCT01421069|532019841|FG000|Active Treatment Period|Enrolled in withdrawal period|30|||
147510094|NCT01421069|532019841|FG000|Active Treatment Period|Enrolled in observational period|29|||
147510095|NCT01421069|532019841|FG000|2a. Withdrawal Period|No longer willing to participate in study|2|||
147510096|NCT01421069|532019841|FG000|2a. Withdrawal Period|Lost to Follow-up|1|||
147510097|NCT01421069|532019841|FG000|2a. Withdrawal Period|Enrolled in observational period|7|||
147510098|NCT01421069|532019841|FG000|2a. Withdrawal Period|Enrolled in re-treatment period|13|||
147510099|NCT01421069|532019841|FG000|2b. Retreatment Period|Enrolled in observational period|7|||
147510100|NCT01421069|532019841|FG000|2b. Retreatment Period|Protocol Violation|1|||
147510101|NCT01421069|532019841|FG000|Observational Period|Other|1|||
147510102|NCT01421069|532019841|FG000|Observational Period|No longer willing to participate in study|4|||
147510103|NCT01421069|532019841|FG000|Observational Period|Lost to Follow-up|3|||
147510104|NCT01641081|532019842|FG000|Period 1|Sponsor request (potential unblinding)|0|||
147510105|NCT01641081|532019843|FG001|Period 1|Sponsor request (potential unblinding)|0|||
147510106|NCT01641081|532019844|FG002|Period 1|Sponsor request (potential unblinding)|0|||
147510107|NCT01641081|532019845|FG003|Period 1|Sponsor request (potential unblinding)|0|||
147510108|NCT01641081|532019846|FG004|Period 1|Sponsor request (potential unblinding)|0|||
147510109|NCT01641081|532019847|FG005|Period 1|Sponsor request (potential unblinding)|0|||
147510110|NCT01641081|532019848|FG006|Period 1|Sponsor request (potential unblinding)|1|||
147510111|NCT01641081|532019849|FG007|Period 1|Sponsor request (potential unblinding)|0|||
147510112|NCT01641081|532019850|FG008|Period 1|Sponsor request (potential unblinding)|0|||
147510113|NCT01641081|532019851|FG009|Period 1|Sponsor request (potential unblinding)|0|||
147510114|NCT01641081|532019842|FG000|Period 1|Protocol Violation|0|||
147510115|NCT01641081|532019843|FG001|Period 1|Protocol Violation|0|||
147510116|NCT01641081|532019844|FG002|Period 1|Protocol Violation|0|||
147510117|NCT01641081|532019845|FG003|Period 1|Protocol Violation|0|||
147510118|NCT01641081|532019846|FG004|Period 1|Protocol Violation|1|||
147510119|NCT01641081|532019847|FG005|Period 1|Protocol Violation|0|||
147510120|NCT01641081|532019848|FG006|Period 1|Protocol Violation|0|||
147510121|NCT01641081|532019849|FG007|Period 1|Protocol Violation|1|||
147510122|NCT01641081|532019850|FG008|Period 1|Protocol Violation|0|||
147639797|NCT02951533|532499427|FG001|Part IIb (Week 32 Through Week 56)|Adverse Event|2|||
147639798|NCT02951533|532499428|FG002|Part IIb (Week 32 Through Week 56)|Adverse Event|0|||
147510123|NCT01641081|532019851|FG009|Period 1|Protocol Violation|0|||
147510124|NCT01641081|532019842|FG000|Period 1|Adverse Event|1|||
147510125|NCT01641081|532019843|FG001|Period 1|Adverse Event|0|||
147510126|NCT01641081|532019844|FG002|Period 1|Adverse Event|0|||
147510127|NCT01641081|532019845|FG003|Period 1|Adverse Event|0|||
147510128|NCT01641081|532019846|FG004|Period 1|Adverse Event|0|||
147510129|NCT01641081|532019847|FG005|Period 1|Adverse Event|0|||
147510130|NCT01641081|532019848|FG006|Period 1|Adverse Event|0|||
147510131|NCT01641081|532019849|FG007|Period 1|Adverse Event|2|||
147510132|NCT01641081|532019850|FG008|Period 1|Adverse Event|0|||
147510133|NCT01641081|532019851|FG009|Period 1|Adverse Event|0|||
147510134|NCT01641081|532019842|FG000|Period 2|Adverse Event|0|||
147510135|NCT01641081|532019843|FG001|Period 2|Adverse Event|0|||
147510136|NCT01641081|532019844|FG002|Period 2|Adverse Event|0|||
147510137|NCT01641081|532019845|FG003|Period 2|Adverse Event|0|||
147510138|NCT01641081|532019846|FG004|Period 2|Adverse Event|0|||
147510139|NCT01641081|532019847|FG005|Period 2|Adverse Event|1|||
147510140|NCT01641081|532019848|FG006|Period 2|Adverse Event|0|||
147510141|NCT01641081|532019849|FG007|Period 2|Adverse Event|0|||
147510142|NCT01641081|532019850|FG008|Period 2|Adverse Event|0|||
147510143|NCT01641081|532019851|FG009|Period 2|Adverse Event|0|||
147510144|NCT01641081|532019842|FG000|Period 2|Withdrawal by Subject|0|||
147510145|NCT01641081|532019843|FG001|Period 2|Withdrawal by Subject|0|||
147510146|NCT01641081|532019844|FG002|Period 2|Withdrawal by Subject|0|||
147510147|NCT01641081|532019845|FG003|Period 2|Withdrawal by Subject|1|||
147510148|NCT01641081|532019846|FG004|Period 2|Withdrawal by Subject|0|||
147510149|NCT01641081|532019847|FG005|Period 2|Withdrawal by Subject|0|||
147510150|NCT01641081|532019848|FG006|Period 2|Withdrawal by Subject|2|||
147510151|NCT01641081|532019849|FG007|Period 2|Withdrawal by Subject|0|||
147510152|NCT01641081|532019850|FG008|Period 2|Withdrawal by Subject|0|||
147510153|NCT01641081|532019851|FG009|Period 2|Withdrawal by Subject|0|||
147510154|NCT01641081|532019842|FG000|Period 2|Protocol Violation|1|||
147510155|NCT01641081|532019843|FG001|Period 2|Protocol Violation|0|||
147510156|NCT01641081|532019844|FG002|Period 2|Protocol Violation|0|||
147510157|NCT01641081|532019845|FG003|Period 2|Protocol Violation|0|||
147510158|NCT01641081|532019846|FG004|Period 2|Protocol Violation|0|||
147510159|NCT01641081|532019847|FG005|Period 2|Protocol Violation|0|||
147510160|NCT01641081|532019848|FG006|Period 2|Protocol Violation|0|||
147510161|NCT01641081|532019849|FG007|Period 2|Protocol Violation|0|||
147510162|NCT01641081|532019850|FG008|Period 2|Protocol Violation|0|||
147510163|NCT01641081|532019851|FG009|Period 2|Protocol Violation|0|||
147510164|NCT01641081|532019842|FG000|Period 3|Adverse Event|0|||
147510165|NCT01641081|532019843|FG001|Period 3|Adverse Event|0|||
147510166|NCT01641081|532019844|FG002|Period 3|Adverse Event|1|||
147510167|NCT01641081|532019845|FG003|Period 3|Adverse Event|0|||
147510168|NCT01641081|532019846|FG004|Period 3|Adverse Event|0|||
147510169|NCT01641081|532019847|FG005|Period 3|Adverse Event|0|||
147510170|NCT01641081|532019848|FG006|Period 3|Adverse Event|0|||
147510171|NCT01641081|532019849|FG007|Period 3|Adverse Event|0|||
147510172|NCT01641081|532019850|FG008|Period 3|Adverse Event|0|||
147510173|NCT01641081|532019851|FG009|Period 3|Adverse Event|0|||
147510174|NCT01641081|532019842|FG000|Period 3|Withdrawal by Subject|0|||
147510175|NCT01641081|532019843|FG001|Period 3|Withdrawal by Subject|0|||
147510176|NCT01641081|532019844|FG002|Period 3|Withdrawal by Subject|0|||
147510177|NCT01641081|532019845|FG003|Period 3|Withdrawal by Subject|0|||
147510178|NCT01641081|532019846|FG004|Period 3|Withdrawal by Subject|0|||
147510179|NCT01641081|532019847|FG005|Period 3|Withdrawal by Subject|0|||
147510180|NCT01641081|532019848|FG006|Period 3|Withdrawal by Subject|0|||
147510181|NCT01641081|532019849|FG007|Period 3|Withdrawal by Subject|0|||
147510182|NCT01641081|532019850|FG008|Period 3|Withdrawal by Subject|1|||
147510183|NCT01641081|532019851|FG009|Period 3|Withdrawal by Subject|0|||
147510184|NCT01641081|532019842|FG000|Period 4|Adverse Event|0|||
147510185|NCT01641081|532019843|FG001|Period 4|Adverse Event|1|||
147510186|NCT01641081|532019844|FG002|Period 4|Adverse Event|0|||
147510187|NCT01641081|532019845|FG003|Period 4|Adverse Event|1|||
147510188|NCT01641081|532019846|FG004|Period 4|Adverse Event|0|||
147510189|NCT01641081|532019847|FG005|Period 4|Adverse Event|0|||
147510190|NCT01641081|532019848|FG006|Period 4|Adverse Event|0|||
147510191|NCT01641081|532019849|FG007|Period 4|Adverse Event|0|||
147639799|NCT02951533|532499426|FG000|Part IIb (Week 32 Through Week 56)|Lost to Follow-up|1|||
147639800|NCT02951533|532499427|FG001|Part IIb (Week 32 Through Week 56)|Lost to Follow-up|2|||
147639801|NCT02951533|532499428|FG002|Part IIb (Week 32 Through Week 56)|Lost to Follow-up|0|||
147510192|NCT01641081|532019850|FG008|Period 4|Adverse Event|0|||
147510193|NCT01641081|532019851|FG009|Period 4|Adverse Event|0|||
147510194|NCT01641081|532019842|FG000|Period 5|Adverse Event|0|||
147510195|NCT01641081|532019843|FG001|Period 5|Adverse Event|0|||
147510196|NCT01641081|532019844|FG002|Period 5|Adverse Event|2|||
147510197|NCT01641081|532019845|FG003|Period 5|Adverse Event|0|||
147510198|NCT01641081|532019846|FG004|Period 5|Adverse Event|0|||
147510199|NCT01641081|532019847|FG005|Period 5|Adverse Event|0|||
147510200|NCT01641081|532019848|FG006|Period 5|Adverse Event|0|||
147510201|NCT01641081|532019849|FG007|Period 5|Adverse Event|0|||
147510202|NCT01641081|532019850|FG008|Period 5|Adverse Event|0|||
147510203|NCT01641081|532019851|FG009|Period 5|Adverse Event|0|||
147510204|NCT01015820|532019853|FG000|Overall Study|Suboptimal measurements|1|||
147510205|NCT01015820|532019854|FG001|Overall Study|Suboptimal measurements|0|||
147510206|NCT01313078|532019855|FG000|Overall Study|Death|1|||
147510207|NCT01313078|532019855|FG000|Overall Study|Discontinued study drug|1|||
147510208|NCT01313078|532019855|FG000|Overall Study|Withdrawal by Subject|1|||
147510209|NCT03136484|532019856|FG000|Overall Study|Withdrawal by Subject|19|||
147510210|NCT03136484|532019857|FG001|Overall Study|Withdrawal by Subject|14|||
147510211|NCT03136484|532019856|FG000|Overall Study|Lost to Follow-up|7|||
147510212|NCT03136484|532019857|FG001|Overall Study|Lost to Follow-up|8|||
147510213|NCT03136484|532019856|FG000|Overall Study|Death|1|||
147510214|NCT03136484|532019857|FG001|Overall Study|Death|0|||
147510215|NCT01176240|532019864|FG000|Study 306A|Lack of Efficacy|2|||
147510216|NCT01176240|532019865|FG001|Study 306A|Lack of Efficacy|1|||
147510217|NCT01176240|532019864|FG000|Study 306A|Protocol Violation|0|||
147510218|NCT01176240|532019865|FG001|Study 306A|Protocol Violation|1|||
147510219|NCT01176240|532019864|FG000|Study 306A|Withdrawal by Subject|0|||
147510220|NCT01176240|532019865|FG001|Study 306A|Withdrawal by Subject|1|||
147510221|NCT01176240|532019864|FG000|Study 306A|Stop due to diverse problems|1|||
147510222|NCT01176240|532019865|FG001|Study 306A|Stop due to diverse problems|0|||
147510223|NCT01176240|532019864|FG000|Study 306B|Lack of Efficacy|5|||
147510224|NCT01176240|532019865|FG001|Study 306B|Lack of Efficacy|3|||
147510225|NCT01176240|532019864|FG000|Study 306B|Adverse Event|10|||
147510226|NCT01176240|532019865|FG001|Study 306B|Adverse Event|5|||
147510227|NCT01176240|532019864|FG000|Study 306B|Protocol Violation|2|||
147510228|NCT01176240|532019865|FG001|Study 306B|Protocol Violation|3|||
147510229|NCT01176240|532019864|FG000|Study 306B|Withdrawal by Subject|4|||
147510230|NCT01176240|532019865|FG001|Study 306B|Withdrawal by Subject|1|||
147510231|NCT01176240|532019864|FG000|Study 306B|Physician Decision|2|||
147510232|NCT01176240|532019865|FG001|Study 306B|Physician Decision|1|||
147510233|NCT01176240|532019864|FG000|Study 306B|Supine Hypertension|1|||
147510234|NCT01176240|532019865|FG001|Study 306B|Supine Hypertension|2|||
147510235|NCT01176240|532019864|FG000|Study 306B|Lost to Follow-up|0|||
147510236|NCT01176240|532019865|FG001|Study 306B|Lost to Follow-up|1|||
147510237|NCT01176240|532019864|FG000|Study 306B|withdrew prior to dosing|2|||
147510238|NCT01176240|532019865|FG001|Study 306B|withdrew prior to dosing|1|||
147510239|NCT03906136|532022135|FG000|Overall Study|Adverse Event|1|||
147510240|NCT03906136|532022136|FG001|Overall Study|Adverse Event|0|||
147510241|NCT03906136|532022135|FG000|Overall Study|Lost to Follow-up|7|||
147510242|NCT03906136|532022136|FG001|Overall Study|Lost to Follow-up|4|||
147510243|NCT03906136|532022135|FG000|Overall Study|Physician Decision|1|||
147510244|NCT03906136|532022136|FG001|Overall Study|Physician Decision|0|||
147510245|NCT03906136|532022135|FG000|Overall Study|Withdrawal by Subject|3|||
147510246|NCT03906136|532022136|FG001|Overall Study|Withdrawal by Subject|7|||
147510247|NCT02371980|532022144|FG000|Open-label Period|Pretreatment Event/Adverse Event|63|||
147510248|NCT02371980|532022145|FG001|Open-label Period|Pretreatment Event/Adverse Event|0|||
147510249|NCT02371980|532022146|FG002|Open-label Period|Pretreatment Event/Adverse Event|0|||
147510250|NCT02371980|532022147|FG003|Open-label Period|Pretreatment Event/Adverse Event|0|||
147510251|NCT02371980|532022148|FG004|Open-label Period|Pretreatment Event/Adverse Event|0|||
147510252|NCT02371980|532022144|FG000|Open-label Period|Significant Protocol Deviation|19|||
147670043|NCT03104374|532617470|FG001|Period 2|Adverse Event|7|||
147670044|NCT03104374|532617471|FG002|Period 2|Adverse Event|10|||
147670045|NCT03104374|532617472|FG003|Period 2|Adverse Event|10|||
147670046|NCT03104374|532617469|FG000|Period 2|Withdrawal by Subject|3|||
147670047|NCT03104374|532617470|FG001|Period 2|Withdrawal by Subject|7|||
147670048|NCT03104374|532617471|FG002|Period 2|Withdrawal by Subject|13|||
147670049|NCT03104374|532617472|FG003|Period 2|Withdrawal by Subject|16|||
147670050|NCT03104374|532617469|FG000|Period 2|Lost to Follow-up|2|||
147510253|NCT02371980|532022145|FG001|Open-label Period|Significant Protocol Deviation|0|||
147510254|NCT02371980|532022146|FG002|Open-label Period|Significant Protocol Deviation|0|||
147510255|NCT02371980|532022147|FG003|Open-label Period|Significant Protocol Deviation|0|||
147510256|NCT02371980|532022148|FG004|Open-label Period|Significant Protocol Deviation|0|||
147510257|NCT02371980|532022144|FG000|Open-label Period|Noncompliance with Study Drug|10|||
147510258|NCT02371980|532022145|FG001|Open-label Period|Noncompliance with Study Drug|0|||
147510259|NCT02371980|532022146|FG002|Open-label Period|Noncompliance with Study Drug|0|||
147510260|NCT02371980|532022147|FG003|Open-label Period|Noncompliance with Study Drug|0|||
147510261|NCT02371980|532022148|FG004|Open-label Period|Noncompliance with Study Drug|0|||
147510262|NCT02371980|532022144|FG000|Open-label Period|Lost to Follow-up|55|||
147510263|NCT02371980|532022145|FG001|Open-label Period|Lost to Follow-up|0|||
147510264|NCT02371980|532022146|FG002|Open-label Period|Lost to Follow-up|0|||
147510265|NCT02371980|532022147|FG003|Open-label Period|Lost to Follow-up|0|||
147510266|NCT02371980|532022148|FG004|Open-label Period|Lost to Follow-up|0|||
147670051|NCT03104374|532617470|FG001|Period 2|Lost to Follow-up|2|||
147510267|NCT02371980|532022144|FG000|Open-label Period|Voluntary Withdrawal|91|||
147510268|NCT02371980|532022145|FG001|Open-label Period|Voluntary Withdrawal|0|||
147510269|NCT02371980|532022146|FG002|Open-label Period|Voluntary Withdrawal|0|||
147510270|NCT02371980|532022147|FG003|Open-label Period|Voluntary Withdrawal|0|||
147670052|NCT03104374|532617471|FG002|Period 2|Lost to Follow-up|3|||
147670053|NCT03104374|532617472|FG003|Period 2|Lost to Follow-up|5|||
147670054|NCT03104374|532617469|FG000|Period 2|Lack of Efficacy|2|||
147510271|NCT02371980|532022148|FG004|Open-label Period|Voluntary Withdrawal|0|||
147510272|NCT02371980|532022144|FG000|Open-label Period|Pregnancy|1|||
147510273|NCT02371980|532022145|FG001|Open-label Period|Pregnancy|0|||
147510274|NCT02371980|532022146|FG002|Open-label Period|Pregnancy|0|||
147510275|NCT02371980|532022147|FG003|Open-label Period|Pregnancy|0|||
147510276|NCT02371980|532022148|FG004|Open-label Period|Pregnancy|0|||
147510277|NCT02371980|532022144|FG000|Open-label Period|Lack of Efficacy|116|||
147510278|NCT02371980|532022145|FG001|Open-label Period|Lack of Efficacy|0|||
147510279|NCT02371980|532022146|FG002|Open-label Period|Lack of Efficacy|0|||
147510280|NCT02371980|532022147|FG003|Open-label Period|Lack of Efficacy|0|||
147510281|NCT02371980|532022148|FG004|Open-label Period|Lack of Efficacy|0|||
147510282|NCT02371980|532022144|FG000|Open-label Period|Did not Meet Randomization Criteria|162|||
147510283|NCT02371980|532022145|FG001|Open-label Period|Did not Meet Randomization Criteria|0|||
147510284|NCT02371980|532022146|FG002|Open-label Period|Did not Meet Randomization Criteria|0|||
147510285|NCT02371980|532022147|FG003|Open-label Period|Did not Meet Randomization Criteria|0|||
147510286|NCT02371980|532022148|FG004|Open-label Period|Did not Meet Randomization Criteria|0|||
147510287|NCT02371980|532022144|FG000|Open-label Period|Reason not Specified|9|||
147639802|NCT02951533|532499426|FG000|Part III (Week 64 Through Week 100)|Prohibited Medication Therapy|1|||
147639803|NCT02951533|532499427|FG001|Part III (Week 64 Through Week 100)|Prohibited Medication Therapy|0|||
147639804|NCT02951533|532499428|FG002|Part III (Week 64 Through Week 100)|Prohibited Medication Therapy|0|||
147639805|NCT02951533|532499426|FG000|Part III (Week 64 Through Week 100)|Lost to Follow-up|1|||
147639806|NCT02951533|532499427|FG001|Part III (Week 64 Through Week 100)|Lost to Follow-up|0|||
147639807|NCT02951533|532499428|FG002|Part III (Week 64 Through Week 100)|Lost to Follow-up|0|||
147639808|NCT02951533|532499426|FG000|Part III (Week 64 Through Week 100)|Withdrawal by Subject|2|||
147639809|NCT02951533|532499427|FG001|Part III (Week 64 Through Week 100)|Withdrawal by Subject|0|||
147639810|NCT02951533|532499428|FG002|Part III (Week 64 Through Week 100)|Withdrawal by Subject|2|||
147639811|NCT02029989|532499429|FG000|Overall Study|Withdrawal by Subject|1|||
147639812|NCT02029989|532499430|FG001|Overall Study|Withdrawal by Subject|0|||
147639813|NCT02029989|532499429|FG000|Overall Study|Withdrawal: Fear of needles|1|||
147639814|NCT02029989|532499430|FG001|Overall Study|Withdrawal: Fear of needles|0|||
147639815|NCT02029989|532499429|FG000|Overall Study|Change of location|2|||
147639816|NCT02029989|532499430|FG001|Overall Study|Change of location|3|||
147639817|NCT02029989|532499429|FG000|Overall Study|Physician Decision|2|||
147639818|NCT02029989|532499430|FG001|Overall Study|Physician Decision|0|||
147639819|NCT02029989|532499429|FG000|Overall Study|Lost to Follow-up|9|||
147639820|NCT02029989|532499430|FG001|Overall Study|Lost to Follow-up|7|||
147639821|NCT02029989|532499429|FG000|Overall Study|Death|0|||
147639822|NCT02029989|532499430|FG001|Overall Study|Death|1|||
147639823|NCT02029989|532499429|FG000|Overall Study|Protocol Violation|1|||
147639824|NCT02029989|532499430|FG001|Overall Study|Protocol Violation|0|||
147639825|NCT02880865|532499432|FG000|Overall Study|Adverse Event|1|||
147639826|NCT02880865|532499433|FG001|Overall Study|Adverse Event|0|||
147639827|NCT02880865|532499432|FG000|Overall Study|Withdrawal by Subject|0|||
147639828|NCT02880865|532499433|FG001|Overall Study|Withdrawal by Subject|2|||
147639829|NCT02880865|532499432|FG000|Overall Study|Physician Decision|0|||
147639830|NCT02880865|532499433|FG001|Overall Study|Physician Decision|1|||
147639831|NCT03045276|532499436|FG000|Intervention Phase|Withdrawal by Subject|7|||
147639832|NCT03045276|532499437|FG001|Intervention Phase|Withdrawal by Subject|2|||
147639833|NCT03045276|532499438|FG002|Intervention Phase|Withdrawal by Subject|3|||
147639834|NCT03045276|532499439|FG003|Intervention Phase|Withdrawal by Subject|7|||
147639835|NCT03045276|532499436|FG000|Intervention Phase|Developed exclusionary criteria|3|||
147639836|NCT03045276|532499437|FG001|Intervention Phase|Developed exclusionary criteria|3|||
147639837|NCT03045276|532499438|FG002|Intervention Phase|Developed exclusionary criteria|0|||
147639838|NCT03045276|532499439|FG003|Intervention Phase|Developed exclusionary criteria|0|||
147639839|NCT03045276|532499436|FG000|Follow-Up Phase|Withdrawal by Subject|0|||
147639840|NCT03045276|532499437|FG001|Follow-Up Phase|Withdrawal by Subject|4|||
147639841|NCT03045276|532499438|FG002|Follow-Up Phase|Withdrawal by Subject|4|||
147639842|NCT03045276|532499439|FG003|Follow-Up Phase|Withdrawal by Subject|4|||
147639843|NCT03045276|532499436|FG000|Follow-Up Phase|Lost to Follow-up|0|||
147639844|NCT03045276|532499437|FG001|Follow-Up Phase|Lost to Follow-up|1|||
147639845|NCT03045276|532499438|FG002|Follow-Up Phase|Lost to Follow-up|0|||
147639846|NCT03045276|532499439|FG003|Follow-Up Phase|Lost to Follow-up|1|||
147639847|NCT03045276|532499436|FG000|Follow-Up Phase|Developed exclusionary criteria|1|||
147639848|NCT03045276|532499437|FG001|Follow-Up Phase|Developed exclusionary criteria|0|||
147639849|NCT03045276|532499438|FG002|Follow-Up Phase|Developed exclusionary criteria|0|||
147639850|NCT03045276|532499439|FG003|Follow-Up Phase|Developed exclusionary criteria|0|||
147639851|NCT02375555|532499462|FG000|Induction Period|Adverse Event|7|||
147510288|NCT02371980|532022145|FG001|Open-label Period|Reason not Specified|0|||
147510289|NCT02371980|532022146|FG002|Open-label Period|Reason not Specified|0|||
147510290|NCT02371980|532022147|FG003|Open-label Period|Reason not Specified|0|||
147510291|NCT02371980|532022148|FG004|Open-label Period|Reason not Specified|0|||
147510292|NCT02371980|532022144|FG000|Double-blind Period|Pretreatment Event/Adverse Event|0|||
147639852|NCT02375555|532499462|FG000|Induction Period|Withdrawal by Subject|2|||
147639853|NCT02375555|532499462|FG000|Induction Period|Other|1|||
147510293|NCT02371980|532022145|FG001|Double-blind Period|Pretreatment Event/Adverse Event|4|||
147510294|NCT02371980|532022146|FG002|Double-blind Period|Pretreatment Event/Adverse Event|3|||
147510295|NCT02371980|532022147|FG003|Double-blind Period|Pretreatment Event/Adverse Event|2|||
147510296|NCT02371980|532022148|FG004|Double-blind Period|Pretreatment Event/Adverse Event|9|||
147510297|NCT02371980|532022144|FG000|Double-blind Period|Significant Protocol Deviation|0|||
147510298|NCT02371980|532022145|FG001|Double-blind Period|Significant Protocol Deviation|2|||
147510299|NCT02371980|532022146|FG002|Double-blind Period|Significant Protocol Deviation|7|||
147510300|NCT02371980|532022147|FG003|Double-blind Period|Significant Protocol Deviation|3|||
147510301|NCT02371980|532022148|FG004|Double-blind Period|Significant Protocol Deviation|3|||
147510302|NCT02371980|532022144|FG000|Double-blind Period|Noncompliance with Study Drug|0|||
147510303|NCT02371980|532022145|FG001|Double-blind Period|Noncompliance with Study Drug|1|||
147510304|NCT02371980|532022146|FG002|Double-blind Period|Noncompliance with Study Drug|2|||
147510305|NCT02371980|532022147|FG003|Double-blind Period|Noncompliance with Study Drug|2|||
147510306|NCT02371980|532022148|FG004|Double-blind Period|Noncompliance with Study Drug|3|||
147510307|NCT02371980|532022144|FG000|Double-blind Period|Lost to Follow-up|0|||
147510308|NCT02371980|532022145|FG001|Double-blind Period|Lost to Follow-up|8|||
147510309|NCT02371980|532022146|FG002|Double-blind Period|Lost to Follow-up|8|||
147510310|NCT02371980|532022147|FG003|Double-blind Period|Lost to Follow-up|6|||
147510311|NCT02371980|532022148|FG004|Double-blind Period|Lost to Follow-up|5|||
147510312|NCT02371980|532022144|FG000|Double-blind Period|Voluntary Withdrawal|0|||
147510313|NCT02371980|532022145|FG001|Double-blind Period|Voluntary Withdrawal|12|||
147510314|NCT02371980|532022146|FG002|Double-blind Period|Voluntary Withdrawal|8|||
147510315|NCT02371980|532022147|FG003|Double-blind Period|Voluntary Withdrawal|9|||
147510316|NCT02371980|532022148|FG004|Double-blind Period|Voluntary Withdrawal|11|||
147510317|NCT02371980|532022144|FG000|Double-blind Period|Relapse|0|||
147510318|NCT02371980|532022145|FG001|Double-blind Period|Relapse|50|||
147510319|NCT02371980|532022146|FG002|Double-blind Period|Relapse|25|||
147510320|NCT02371980|532022147|FG003|Double-blind Period|Relapse|25|||
147510321|NCT02371980|532022148|FG004|Double-blind Period|Relapse|26|||
147510322|NCT02371980|532022144|FG000|Double-blind Period|Reason not Specified|0|||
147510323|NCT02371980|532022145|FG001|Double-blind Period|Reason not Specified|3|||
147510324|NCT02371980|532022146|FG002|Double-blind Period|Reason not Specified|3|||
147510325|NCT02371980|532022147|FG003|Double-blind Period|Reason not Specified|2|||
147510326|NCT02371980|532022148|FG004|Double-blind Period|Reason not Specified|1|||
147510327|NCT02371980|532022144|FG000|Double-blind Period|Missing|0|||
147510328|NCT02371980|532022145|FG001|Double-blind Period|Missing|1|||
147510329|NCT02371980|532022146|FG002|Double-blind Period|Missing|0|||
147510330|NCT02371980|532022147|FG003|Double-blind Period|Missing|0|||
147510331|NCT02371980|532022148|FG004|Double-blind Period|Missing|0|||
147510332|NCT00922974|532022149|FG000|Phase II Component|Protocol Violation|2|||
147510333|NCT00922974|532022150|FG001|Phase II Component|Protocol Violation|0|||
147510334|NCT00922974|532022149|FG000|Phase II Component|Not evaluable for treatment review|5|||
147510335|NCT00922974|532022150|FG001|Phase II Component|Not evaluable for treatment review|0|||
147510336|NCT00922974|532022149|FG000|Phase III Component|Protocol Violation|8|||
147510337|NCT00922974|532022150|FG001|Phase III Component|Protocol Violation|6|||
147510338|NCT02944513|532022151|FG000|Overall Study|Withdrawal by Subject|4|||
147510339|NCT02944513|532022152|FG001|Overall Study|Withdrawal by Subject|1|||
147510340|NCT00937326|532022154|FG000|Overall Study|Adverse Event|0|||
147510341|NCT00937326|532022155|FG001|Overall Study|Adverse Event|3|||
147510342|NCT00937326|532022156|FG002|Overall Study|Adverse Event|1|||
147510343|NCT00937326|532022157|FG003|Overall Study|Adverse Event|1|||
147510344|NCT00937326|532022158|FG004|Overall Study|Adverse Event|2|||
147510345|NCT00937326|532022154|FG000|Overall Study|Death|0|||
147510346|NCT00937326|532022155|FG001|Overall Study|Death|0|||
147510347|NCT00937326|532022156|FG002|Overall Study|Death|1|||
147510348|NCT00937326|532022157|FG003|Overall Study|Death|0|||
147510349|NCT00937326|532022158|FG004|Overall Study|Death|0|||
147510350|NCT00937326|532022154|FG000|Overall Study|Withdrawal by Subject|3|||
147510351|NCT00937326|532022155|FG001|Overall Study|Withdrawal by Subject|4|||
147510352|NCT00937326|532022156|FG002|Overall Study|Withdrawal by Subject|1|||
147510353|NCT00937326|532022157|FG003|Overall Study|Withdrawal by Subject|4|||
147510354|NCT00937326|532022158|FG004|Overall Study|Withdrawal by Subject|3|||
147510355|NCT00937326|532022154|FG000|Overall Study|Chest X-ray showed a suspicious shadow|0|||
147639854|NCT02375555|532499462|FG000|Induction Period|Didn't meet criteria for maintenance therapy|1|||
147639855|NCT02375555|532499462|FG000|Maintenance Period|Adverse Event|2|||
147510356|NCT00937326|532022155|FG001|Overall Study|Chest X-ray showed a suspicious shadow|0|||
147510357|NCT00937326|532022156|FG002|Overall Study|Chest X-ray showed a suspicious shadow|1|||
147510358|NCT00937326|532022157|FG003|Overall Study|Chest X-ray showed a suspicious shadow|0|||
147510359|NCT00937326|532022158|FG004|Overall Study|Chest X-ray showed a suspicious shadow|0|||
147510360|NCT02578992|532022159|FG000|Overall Study|equipment not available or malfunction|3|||
147510361|NCT02578992|532022160|FG001|Overall Study|equipment not available or malfunction|3|||
147510362|NCT00790218|532022161|FG000|Overall Study|Death|1|||
147510363|NCT00790218|532022162|FG001|Overall Study|Death|0|||
147510364|NCT00790218|532022163|FG002|Overall Study|Death|0|||
147510365|NCT02443155|532022164|FG000|Overall Study|Adverse Event|3|||
147510366|NCT02443155|532022165|FG001|Overall Study|Adverse Event|4|||
147510367|NCT02443155|532022166|FG002|Overall Study|Adverse Event|1|||
147510368|NCT02443155|532022167|FG003|Overall Study|Adverse Event|2|||
147510369|NCT02443155|532022164|FG000|Overall Study|Unclassified|0|||
147510370|NCT02443155|532022165|FG001|Overall Study|Unclassified|0|||
147510371|NCT02443155|532022166|FG002|Overall Study|Unclassified|2|||
147510372|NCT02443155|532022167|FG003|Overall Study|Unclassified|1|||
147510373|NCT02443155|532022164|FG000|Overall Study|Withdrawal by Subject|4|||
147510374|NCT02443155|532022165|FG001|Overall Study|Withdrawal by Subject|7|||
147510375|NCT02443155|532022166|FG002|Overall Study|Withdrawal by Subject|3|||
147510376|NCT02443155|532022167|FG003|Overall Study|Withdrawal by Subject|9|||
147510377|NCT02443155|532022164|FG000|Overall Study|Pregnancy|3|||
147510378|NCT02443155|532022165|FG001|Overall Study|Pregnancy|1|||
147510379|NCT02443155|532022166|FG002|Overall Study|Pregnancy|1|||
147510380|NCT02443155|532022167|FG003|Overall Study|Pregnancy|2|||
147510381|NCT02443155|532022164|FG000|Overall Study|Lost to Follow-up|1|||
147510382|NCT02443155|532022165|FG001|Overall Study|Lost to Follow-up|2|||
147510383|NCT02443155|532022166|FG002|Overall Study|Lost to Follow-up|0|||
147510384|NCT02443155|532022167|FG003|Overall Study|Lost to Follow-up|1|||
147510385|NCT02443155|532022164|FG000|Overall Study|Protocol Violation|1|||
147510386|NCT02443155|532022165|FG001|Overall Study|Protocol Violation|0|||
147510387|NCT02443155|532022166|FG002|Overall Study|Protocol Violation|1|||
147510388|NCT02443155|532022167|FG003|Overall Study|Protocol Violation|1|||
147510389|NCT02443155|532022164|FG000|Overall Study|Death|0|||
147510390|NCT02443155|532022165|FG001|Overall Study|Death|0|||
147510391|NCT02443155|532022166|FG002|Overall Study|Death|1|||
147510392|NCT02443155|532022167|FG003|Overall Study|Death|0|||
147510393|NCT00731666|532022175|FG000|Overall Study|Adverse Event|2|||
147510394|NCT00731666|532022175|FG000|Overall Study|Lost to Follow-up|8|||
147510395|NCT00731666|532022175|FG000|Overall Study|Withdrawal by Subject|2|||
147510396|NCT00088595|532022176|FG000|Overall Study|Adverse Event|11|||
147510397|NCT00088595|532022176|FG000|Overall Study|Withdrawal by Subject|8|||
147510398|NCT00088595|532022176|FG000|Overall Study|Ongoing (After Core)|7|||
147510399|NCT00088595|532022176|FG000|Overall Study|New Cancer Therapy|2|||
147510400|NCT00420342|532022192|FG000|Overall Study|Lost to Follow-up|1|||
147510401|NCT00420342|532022193|FG001|Overall Study|Lost to Follow-up|0|||
147510402|NCT00420342|532022194|FG002|Overall Study|Lost to Follow-up|1|||
147510403|NCT00420342|532022192|FG000|Overall Study|Withdrawal by Subject|0|||
147510404|NCT00420342|532022193|FG001|Overall Study|Withdrawal by Subject|2|||
147510405|NCT00420342|532022194|FG002|Overall Study|Withdrawal by Subject|0|||
147510406|NCT01599806|532022197|FG000|Overall Study|Lost to Follow-up|20|||
147510407|NCT01599806|532022198|FG001|Overall Study|Lost to Follow-up|20|||
147510408|NCT01599806|532022197|FG000|Overall Study|Withdrawal by Subject|12|||
147510409|NCT01599806|532022198|FG001|Overall Study|Withdrawal by Subject|12|||
147510410|NCT01599806|532022197|FG000|Overall Study|Other Eligibility criteria|11|||
147510411|NCT01599806|532022198|FG001|Overall Study|Other Eligibility criteria|9|||
147510412|NCT03006926|532022202|FG000|Overall Study|Adverse Event|0|||
147510413|NCT03006926|532022203|FG001|Overall Study|Adverse Event|27|||
147510414|NCT03006926|532022202|FG000|Overall Study|Withdrawal by Subject|0|||
147510415|NCT03006926|532022203|FG001|Overall Study|Withdrawal by Subject|1|||
147510416|NCT03006926|532022202|FG000|Overall Study|Radiological Disease Progression|0|||
147510417|NCT03006926|532022203|FG001|Overall Study|Radiological Disease Progression|52|||
147510418|NCT03006926|532022202|FG000|Overall Study|Clinical Disease Progression|0|||
147510419|NCT03006926|532022203|FG001|Overall Study|Clinical Disease Progression|10|||
147510420|NCT03006926|532022202|FG000|Overall Study|Other|0|||
147510421|NCT03006926|532022203|FG001|Overall Study|Other|8|||
147510422|NCT03689972|532022204|FG000|Part 1 (Day 1 up to Week 72)|Adverse Event|1|||
147510423|NCT03689972|532022205|FG001|Part 1 (Day 1 up to Week 72)|Adverse Event|3|||
147510424|NCT03689972|532022206|FG002|Part 1 (Day 1 up to Week 72)|Adverse Event|0|||
147510425|NCT03689972|532022207|FG003|Part 1 (Day 1 up to Week 72)|Adverse Event|0|||
147510426|NCT03689972|532022208|FG004|Part 1 (Day 1 up to Week 72)|Adverse Event|0|||
147510427|NCT03689972|532022204|FG000|Part 1 (Day 1 up to Week 72)|Lost to Follow-up|0|||
147510428|NCT03689972|532022205|FG001|Part 1 (Day 1 up to Week 72)|Lost to Follow-up|2|||
147510429|NCT03689972|532022206|FG002|Part 1 (Day 1 up to Week 72)|Lost to Follow-up|0|||
147510430|NCT03689972|532022207|FG003|Part 1 (Day 1 up to Week 72)|Lost to Follow-up|0|||
147510431|NCT03689972|532022208|FG004|Part 1 (Day 1 up to Week 72)|Lost to Follow-up|0|||
147510432|NCT03689972|532022204|FG000|Part 1 (Day 1 up to Week 72)|Protocol-Defined Rescue Criteria|0|||
147510433|NCT03689972|532022205|FG001|Part 1 (Day 1 up to Week 72)|Protocol-Defined Rescue Criteria|6|||
147639856|NCT02375555|532499462|FG000|Maintenance Period|Withdrawal by Subject|4|||
147639857|NCT02375555|532499462|FG000|Maintenance Period|Death|1|||
147510434|NCT03689972|532022206|FG002|Part 1 (Day 1 up to Week 72)|Protocol-Defined Rescue Criteria|0|||
147510435|NCT03689972|532022207|FG003|Part 1 (Day 1 up to Week 72)|Protocol-Defined Rescue Criteria|0|||
147510436|NCT03689972|532022208|FG004|Part 1 (Day 1 up to Week 72)|Protocol-Defined Rescue Criteria|0|||
147510437|NCT03689972|532022204|FG000|Part 1 (Day 1 up to Week 72)|Developed Persistent Anti-Natalizumab Antibodies|1|||
147510438|NCT03689972|532022205|FG001|Part 1 (Day 1 up to Week 72)|Developed Persistent Anti-Natalizumab Antibodies|3|||
147670055|NCT03104374|532617470|FG001|Period 2|Lack of Efficacy|4|||
147670056|NCT03104374|532617471|FG002|Period 2|Lack of Efficacy|7|||
147670057|NCT03104374|532617472|FG003|Period 2|Lack of Efficacy|4|||
147670058|NCT03104374|532617469|FG000|Period 2|COVID-19 Infection|0|||
147670059|NCT03104374|532617470|FG001|Period 2|COVID-19 Infection|0|||
147670060|NCT03104374|532617471|FG002|Period 2|COVID-19 Infection|1|||
147670061|NCT03104374|532617472|FG003|Period 2|COVID-19 Infection|0|||
147670062|NCT03104374|532617469|FG000|Period 2|Other|3|||
147670063|NCT03104374|532617470|FG001|Period 2|Other|2|||
147670064|NCT03104374|532617471|FG002|Period 2|Other|2|||
147670065|NCT03104374|532617472|FG003|Period 2|Other|4|||
147670066|NCT02121210|532617473|FG000|Overall Study|Adverse Event|5|||
147670067|NCT02121210|532617474|FG001|Overall Study|Adverse Event|7|||
147670068|NCT02121210|532617473|FG000|Overall Study|Lack of Efficacy|2|||
147670069|NCT02121210|532617474|FG001|Overall Study|Lack of Efficacy|0|||
147670070|NCT02121210|532617473|FG000|Overall Study|Other than specified above|0|||
147670071|NCT02121210|532617474|FG001|Overall Study|Other than specified above|2|||
147670072|NCT00909870|532617475|FG000|Overall Study|Adverse Event|13|||
147670073|NCT00909870|532617476|FG001|Overall Study|Adverse Event|7|||
147670074|NCT00909870|532617475|FG000|Overall Study|Protocol Violation|1|||
147670075|NCT00909870|532617476|FG001|Overall Study|Protocol Violation|2|||
147670076|NCT00909870|532617475|FG000|Overall Study|Withdrawal by Subject|5|||
147670077|NCT00909870|532617476|FG001|Overall Study|Withdrawal by Subject|8|||
147670078|NCT00909870|532617475|FG000|Overall Study|Lost to Follow-up|3|||
147670079|NCT00909870|532617476|FG001|Overall Study|Lost to Follow-up|3|||
147670080|NCT00909870|532617475|FG000|Overall Study|Physician Decision|0|||
147670081|NCT00909870|532617476|FG001|Overall Study|Physician Decision|2|||
147670082|NCT00909870|532617475|FG000|Overall Study|Other|1|||
147670083|NCT00909870|532617476|FG001|Overall Study|Other|5|||
147670084|NCT01232283|532617477|FG000|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|12|||
147670085|NCT01232283|532617478|FG001|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|8|||
147670086|NCT01232283|532617479|FG002|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
147670087|NCT01232283|532617480|FG003|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
147670088|NCT01232283|532617481|FG004|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
147670089|NCT01232283|532617482|FG005|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
147670090|NCT01232283|532617483|FG006|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
147670091|NCT01232283|532617484|FG007|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
147670092|NCT01232283|532617485|FG008|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
147670093|NCT01232283|532617486|FG009|Placebo Controlled Phase (Weeks 0-16)|Adverse Event|0|||
147670094|NCT01232283|532617477|FG000|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|3|||
147670095|NCT01232283|532617478|FG001|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|2|||
147670096|NCT01232283|532617479|FG002|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
147670097|NCT01232283|532617480|FG003|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
147670098|NCT01232283|532617481|FG004|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
147670099|NCT01232283|532617482|FG005|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
147670100|NCT01232283|532617483|FG006|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
147670101|NCT01232283|532617484|FG007|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
147670102|NCT01232283|532617485|FG008|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
147670103|NCT01232283|532617486|FG009|Placebo Controlled Phase (Weeks 0-16)|Lack of Efficacy|0|||
147670104|NCT01232283|532617477|FG000|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|1|||
147670105|NCT01232283|532617478|FG001|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
147670106|NCT01232283|532617479|FG002|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
147670107|NCT01232283|532617480|FG003|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
147670108|NCT01232283|532617481|FG004|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
147670109|NCT01232283|532617482|FG005|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
147670110|NCT01232283|532617483|FG006|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
147670111|NCT01232283|532617484|FG007|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
147670112|NCT01232283|532617485|FG008|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
147670113|NCT01232283|532617486|FG009|Placebo Controlled Phase (Weeks 0-16)|Noncompliance with study drug|0|||
147670114|NCT01232283|532617477|FG000|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|9|||
147670115|NCT01232283|532617478|FG001|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|7|||
147670116|NCT01232283|532617479|FG002|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
147670117|NCT01232283|532617480|FG003|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
147670118|NCT01232283|532617481|FG004|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
147670119|NCT01232283|532617482|FG005|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
147670120|NCT01232283|532617483|FG006|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
147670121|NCT01232283|532617484|FG007|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
147670122|NCT01232283|532617485|FG008|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
147670123|NCT01232283|532617486|FG009|Placebo Controlled Phase (Weeks 0-16)|Withdrawal by Subject|0|||
147670124|NCT01232283|532617477|FG000|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|6|||
147510439|NCT03689972|532022206|FG002|Part 1 (Day 1 up to Week 72)|Developed Persistent Anti-Natalizumab Antibodies|0|||
147510440|NCT03689972|532022207|FG003|Part 1 (Day 1 up to Week 72)|Developed Persistent Anti-Natalizumab Antibodies|0|||
147510441|NCT03689972|532022208|FG004|Part 1 (Day 1 up to Week 72)|Developed Persistent Anti-Natalizumab Antibodies|0|||
147510442|NCT03689972|532022204|FG000|Part 1 (Day 1 up to Week 72)|Consent Withdrawn|14|||
147510443|NCT03689972|532022205|FG001|Part 1 (Day 1 up to Week 72)|Consent Withdrawn|9|||
147510444|NCT03689972|532022206|FG002|Part 1 (Day 1 up to Week 72)|Consent Withdrawn|0|||
147510445|NCT03689972|532022207|FG003|Part 1 (Day 1 up to Week 72)|Consent Withdrawn|0|||
147510446|NCT03689972|532022208|FG004|Part 1 (Day 1 up to Week 72)|Consent Withdrawn|0|||
147510447|NCT03689972|532022204|FG000|Part 1 (Day 1 up to Week 72)|Investigator Decision|9|||
147510448|NCT03689972|532022205|FG001|Part 1 (Day 1 up to Week 72)|Investigator Decision|6|||
147510449|NCT03689972|532022206|FG002|Part 1 (Day 1 up to Week 72)|Investigator Decision|0|||
147510450|NCT03689972|532022207|FG003|Part 1 (Day 1 up to Week 72)|Investigator Decision|0|||
147510451|NCT03689972|532022208|FG004|Part 1 (Day 1 up to Week 72)|Investigator Decision|0|||
147510452|NCT03689972|532022204|FG000|Part 1 (Day 1 up to Week 72)|Pregnancy|5|||
147510453|NCT03689972|532022205|FG001|Part 1 (Day 1 up to Week 72)|Pregnancy|1|||
147510454|NCT03689972|532022206|FG002|Part 1 (Day 1 up to Week 72)|Pregnancy|0|||
147510455|NCT03689972|532022207|FG003|Part 1 (Day 1 up to Week 72)|Pregnancy|0|||
147510456|NCT03689972|532022208|FG004|Part 1 (Day 1 up to Week 72)|Pregnancy|0|||
147510457|NCT03689972|532022204|FG000|Part 1 (Day 1 up to Week 72)|Unwilling to Comply With Protocol|3|||
147510458|NCT03689972|532022205|FG001|Part 1 (Day 1 up to Week 72)|Unwilling to Comply With Protocol|2|||
147510459|NCT03689972|532022206|FG002|Part 1 (Day 1 up to Week 72)|Unwilling to Comply With Protocol|0|||
147510460|NCT03689972|532022207|FG003|Part 1 (Day 1 up to Week 72)|Unwilling to Comply With Protocol|0|||
147510461|NCT03689972|532022208|FG004|Part 1 (Day 1 up to Week 72)|Unwilling to Comply With Protocol|0|||
147510462|NCT03689972|532022204|FG000|Part 1 (Day 1 up to Week 72)|Randomized but not Dosed|1|||
147510463|NCT03689972|532022205|FG001|Part 1 (Day 1 up to Week 72)|Randomized but not Dosed|1|||
147510464|NCT03689972|532022206|FG002|Part 1 (Day 1 up to Week 72)|Randomized but not Dosed|0|||
147510465|NCT03689972|532022207|FG003|Part 1 (Day 1 up to Week 72)|Randomized but not Dosed|0|||
147510466|NCT03689972|532022208|FG004|Part 1 (Day 1 up to Week 72)|Randomized but not Dosed|0|||
147510467|NCT03689972|532022204|FG000|Part 1 (Day 1 up to Week 72)|Reason not Specified|20|||
147510468|NCT03689972|532022205|FG001|Part 1 (Day 1 up to Week 72)|Reason not Specified|16|||
147510469|NCT03689972|532022206|FG002|Part 1 (Day 1 up to Week 72)|Reason not Specified|0|||
147510470|NCT03689972|532022207|FG003|Part 1 (Day 1 up to Week 72)|Reason not Specified|0|||
147510471|NCT03689972|532022208|FG004|Part 1 (Day 1 up to Week 72)|Reason not Specified|0|||
147510472|NCT03689972|532022204|FG000|Part 2:Run-in Period (Week73uptoWeek107)|Consent Withdrawn|0|||
147510473|NCT03689972|532022205|FG001|Part 2:Run-in Period (Week73uptoWeek107)|Consent Withdrawn|0|||
147510474|NCT03689972|532022206|FG002|Part 2:Run-in Period (Week73uptoWeek107)|Consent Withdrawn|2|||
147510475|NCT03689972|532022207|FG003|Part 2:Run-in Period (Week73uptoWeek107)|Consent Withdrawn|0|||
147510476|NCT03689972|532022208|FG004|Part 2:Run-in Period (Week73uptoWeek107)|Consent Withdrawn|0|||
147510477|NCT03689972|532022204|FG000|Part 2:Run-in Period (Week73uptoWeek107)|Pregnancy|0|||
147510478|NCT03689972|532022205|FG001|Part 2:Run-in Period (Week73uptoWeek107)|Pregnancy|0|||
147510479|NCT03689972|532022206|FG002|Part 2:Run-in Period (Week73uptoWeek107)|Pregnancy|1|||
147510480|NCT03689972|532022207|FG003|Part 2:Run-in Period (Week73uptoWeek107)|Pregnancy|0|||
147510481|NCT03689972|532022208|FG004|Part 2:Run-in Period (Week73uptoWeek107)|Pregnancy|0|||
147510482|NCT03689972|532022204|FG000|Part 2:Run-in Period (Week73uptoWeek107)|Reason not Specified|0|||
147510483|NCT03689972|532022205|FG001|Part 2:Run-in Period (Week73uptoWeek107)|Reason not Specified|0|||
147510484|NCT03689972|532022206|FG002|Part 2:Run-in Period (Week73uptoWeek107)|Reason not Specified|2|||
147510485|NCT03689972|532022207|FG003|Part 2:Run-in Period (Week73uptoWeek107)|Reason not Specified|0|||
147510486|NCT03689972|532022208|FG004|Part 2:Run-in Period (Week73uptoWeek107)|Reason not Specified|0|||
147510487|NCT03689972|532022204|FG000|Part2CrossoverPeriod(Week108uptoWeek156)|Adverse Event|0|||
147510488|NCT03689972|532022205|FG001|Part2CrossoverPeriod(Week108uptoWeek156)|Adverse Event|0|||
147510489|NCT03689972|532022206|FG002|Part2CrossoverPeriod(Week108uptoWeek156)|Adverse Event|0|||
147510490|NCT03689972|532022207|FG003|Part2CrossoverPeriod(Week108uptoWeek156)|Adverse Event|1|||
147510491|NCT03689972|532022208|FG004|Part2CrossoverPeriod(Week108uptoWeek156)|Adverse Event|1|||
147510492|NCT03689972|532022204|FG000|Part2CrossoverPeriod(Week108uptoWeek156)|Consent Withdrawn|0|||
147510493|NCT03689972|532022205|FG001|Part2CrossoverPeriod(Week108uptoWeek156)|Consent Withdrawn|0|||
147510494|NCT03689972|532022206|FG002|Part2CrossoverPeriod(Week108uptoWeek156)|Consent Withdrawn|0|||
147510495|NCT03689972|532022207|FG003|Part2CrossoverPeriod(Week108uptoWeek156)|Consent Withdrawn|7|||
147510496|NCT03689972|532022208|FG004|Part2CrossoverPeriod(Week108uptoWeek156)|Consent Withdrawn|1|||
147510497|NCT03689972|532022204|FG000|Part2CrossoverPeriod(Week108uptoWeek156)|Investigator Decision|0|||
147510498|NCT03689972|532022205|FG001|Part2CrossoverPeriod(Week108uptoWeek156)|Investigator Decision|0|||
147639858|NCT02375555|532499462|FG000|Maintenance Period|Disease Progression|5|||
147639859|NCT02375555|532499462|FG000|Maintenance Period|Patient Non-compliance|1|||
147639860|NCT02375555|532499462|FG000|Maintenance Period|Still on maintenance|16|||
147639861|NCT02294175|532499466|FG000|Overall Study|Withdrawal by Subject|1|||
147639862|NCT02294175|532499467|FG001|Overall Study|Withdrawal by Subject|2|||
147510499|NCT03689972|532022206|FG002|Part2CrossoverPeriod(Week108uptoWeek156)|Investigator Decision|0|||
147510500|NCT03689972|532022207|FG003|Part2CrossoverPeriod(Week108uptoWeek156)|Investigator Decision|2|||
147510501|NCT03689972|532022208|FG004|Part2CrossoverPeriod(Week108uptoWeek156)|Investigator Decision|2|||
147510502|NCT03689972|532022204|FG000|Part2CrossoverPeriod(Week108uptoWeek156)|Pregnancy|0|||
147510503|NCT03689972|532022205|FG001|Part2CrossoverPeriod(Week108uptoWeek156)|Pregnancy|0|||
147510504|NCT03689972|532022206|FG002|Part2CrossoverPeriod(Week108uptoWeek156)|Pregnancy|0|||
147510505|NCT03689972|532022207|FG003|Part2CrossoverPeriod(Week108uptoWeek156)|Pregnancy|0|||
147510506|NCT03689972|532022208|FG004|Part2CrossoverPeriod(Week108uptoWeek156)|Pregnancy|1|||
147510507|NCT03689972|532022204|FG000|Part2CrossoverPeriod(Week108uptoWeek156)|Reason not Specified|0|||
147670125|NCT01232283|532617478|FG001|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|6|||
147670126|NCT01232283|532617479|FG002|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
147670127|NCT01232283|532617480|FG003|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
147670128|NCT01232283|532617481|FG004|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
147670129|NCT01232283|532617482|FG005|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
147670130|NCT01232283|532617483|FG006|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
147670131|NCT01232283|532617484|FG007|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
147670132|NCT01232283|532617485|FG008|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
147670133|NCT01232283|532617486|FG009|Placebo Controlled Phase (Weeks 0-16)|Lost to Follow-up|0|||
147670134|NCT01232283|532617477|FG000|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|3|||
147670135|NCT01232283|532617478|FG001|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|2|||
147670136|NCT01232283|532617479|FG002|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
147670137|NCT01232283|532617480|FG003|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
147670138|NCT01232283|532617481|FG004|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
147670139|NCT01232283|532617482|FG005|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
147670140|NCT01232283|532617483|FG006|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
147670141|NCT01232283|532617484|FG007|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
147670142|NCT01232283|532617485|FG008|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
147670143|NCT01232283|532617486|FG009|Placebo Controlled Phase (Weeks 0-16)|Protocol Violation|0|||
147670144|NCT01232283|532617477|FG000|Placebo Controlled Phase (Weeks 0-16)|Other|2|||
147670145|NCT01232283|532617478|FG001|Placebo Controlled Phase (Weeks 0-16)|Other|1|||
147670146|NCT01232283|532617479|FG002|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
147670147|NCT01232283|532617480|FG003|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
147670148|NCT01232283|532617481|FG004|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
147670149|NCT01232283|532617482|FG005|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
147670150|NCT01232283|532617483|FG006|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
147670151|NCT01232283|532617484|FG007|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
147670152|NCT01232283|532617485|FG008|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
147670153|NCT01232283|532617486|FG009|Placebo Controlled Phase (Weeks 0-16)|Other|0|||
147670154|NCT01232283|532617477|FG000|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
147670155|NCT01232283|532617478|FG001|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
147670156|NCT01232283|532617479|FG002|Maintenance Phase (Weeks16-32)|Adverse Event|8|||
147670157|NCT01232283|532617480|FG003|Maintenance Phase (Weeks16-32)|Adverse Event|2|||
147670158|NCT01232283|532617481|FG004|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
147670159|NCT01232283|532617482|FG005|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
147670160|NCT01232283|532617483|FG006|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
147670161|NCT01232283|532617484|FG007|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
147670162|NCT01232283|532617485|FG008|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
147670163|NCT01232283|532617486|FG009|Maintenance Phase (Weeks16-32)|Adverse Event|0|||
147670164|NCT01232283|532617477|FG000|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
147670165|NCT01232283|532617478|FG001|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
147670166|NCT01232283|532617479|FG002|Maintenance Phase (Weeks16-32)|Lack of Efficacy|19|||
147670167|NCT01232283|532617480|FG003|Maintenance Phase (Weeks16-32)|Lack of Efficacy|3|||
147670168|NCT01232283|532617481|FG004|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
147670169|NCT01232283|532617482|FG005|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
147670170|NCT01232283|532617483|FG006|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
147670171|NCT01232283|532617484|FG007|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
147670172|NCT01232283|532617485|FG008|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
147670173|NCT01232283|532617486|FG009|Maintenance Phase (Weeks16-32)|Lack of Efficacy|0|||
147670174|NCT01232283|532617477|FG000|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
147670175|NCT01232283|532617478|FG001|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
147670176|NCT01232283|532617479|FG002|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|1|||
147670177|NCT01232283|532617480|FG003|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
147670178|NCT01232283|532617481|FG004|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
147670179|NCT01232283|532617482|FG005|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
147670180|NCT01232283|532617483|FG006|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
147670181|NCT01232283|532617484|FG007|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
147510508|NCT03689972|532022205|FG001|Part2CrossoverPeriod(Week108uptoWeek156)|Reason not Specified|0|||
147510509|NCT03689972|532022206|FG002|Part2CrossoverPeriod(Week108uptoWeek156)|Reason not Specified|0|||
147510510|NCT03689972|532022207|FG003|Part2CrossoverPeriod(Week108uptoWeek156)|Reason not Specified|2|||
147510511|NCT03689972|532022208|FG004|Part2CrossoverPeriod(Week108uptoWeek156)|Reason not Specified|1|||
147510512|NCT03689972|532022204|FG000|Part2CrossoverPeriod(Week108uptoWeek156)|Randomized but not Dosed|0|||
147510513|NCT03689972|532022205|FG001|Part2CrossoverPeriod(Week108uptoWeek156)|Randomized but not Dosed|0|||
147510514|NCT03689972|532022206|FG002|Part2CrossoverPeriod(Week108uptoWeek156)|Randomized but not Dosed|0|||
147510515|NCT03689972|532022207|FG003|Part2CrossoverPeriod(Week108uptoWeek156)|Randomized but not Dosed|0|||
147510516|NCT03689972|532022208|FG004|Part2CrossoverPeriod(Week108uptoWeek156)|Randomized but not Dosed|12|||
147510517|NCT02417064|532022209|FG000|Double-blind Induction Phase (4 Weeks)|Adverse Event|1|||
147510518|NCT02417064|532022210|FG001|Double-blind Induction Phase (4 Weeks)|Adverse Event|7|||
147510519|NCT02417064|532022211|FG002|Double-blind Induction Phase (4 Weeks)|Adverse Event|2|||
147510520|NCT02417064|532022209|FG000|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|1|||
147510521|NCT02417064|532022210|FG001|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|1|||
147510522|NCT02417064|532022211|FG002|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|0|||
147510523|NCT02417064|532022209|FG000|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|0|||
147510524|NCT02417064|532022210|FG001|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|1|||
147510525|NCT02417064|532022211|FG002|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|0|||
147510526|NCT02417064|532022209|FG000|Double-blind Induction Phase (4 Weeks)|Protocol Violation|2|||
147510527|NCT02417064|532022210|FG001|Double-blind Induction Phase (4 Weeks)|Protocol Violation|1|||
147510528|NCT02417064|532022211|FG002|Double-blind Induction Phase (4 Weeks)|Protocol Violation|1|||
147510529|NCT02417064|532022209|FG000|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|1|||
147510530|NCT02417064|532022210|FG001|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|5|||
147510531|NCT02417064|532022211|FG002|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|1|||
147510532|NCT02417064|532022209|FG000|Double-blind Induction Phase (4 Weeks)|Other|1|||
147510533|NCT02417064|532022210|FG001|Double-blind Induction Phase (4 Weeks)|Other|4|||
147510534|NCT02417064|532022211|FG002|Double-blind Induction Phase (4 Weeks)|Other|2|||
147510535|NCT02417064|532022209|FG000|Follow-up Phase (24 Weeks)|Lost to Follow-up|0|||
147510536|NCT02417064|532022210|FG001|Follow-up Phase (24 Weeks)|Lost to Follow-up|2|||
147510537|NCT02417064|532022211|FG002|Follow-up Phase (24 Weeks)|Lost to Follow-up|1|||
147510538|NCT02417064|532022209|FG000|Follow-up Phase (24 Weeks)|Protocol Violation|0|||
147510539|NCT02417064|532022210|FG001|Follow-up Phase (24 Weeks)|Protocol Violation|0|||
147510540|NCT02417064|532022211|FG002|Follow-up Phase (24 Weeks)|Protocol Violation|1|||
147510541|NCT02417064|532022209|FG000|Follow-up Phase (24 Weeks)|Withdrawal by Subject|3|||
147510542|NCT02417064|532022210|FG001|Follow-up Phase (24 Weeks)|Withdrawal by Subject|9|||
147510543|NCT02417064|532022211|FG002|Follow-up Phase (24 Weeks)|Withdrawal by Subject|2|||
147510544|NCT02417064|532022209|FG000|Follow-up Phase (24 Weeks)|PI Decision|34|||
147510545|NCT02417064|532022210|FG001|Follow-up Phase (24 Weeks)|PI Decision|29|||
147510546|NCT02417064|532022211|FG002|Follow-up Phase (24 Weeks)|PI Decision|44|||
147510547|NCT02417064|532022209|FG000|Follow-up Phase (24 Weeks)|Other|2|||
147510548|NCT02417064|532022210|FG001|Follow-up Phase (24 Weeks)|Other|2|||
147510549|NCT02417064|532022211|FG002|Follow-up Phase (24 Weeks)|Other|3|||
147510550|NCT01192100|532022212|FG000|Overall Study|Withdrawal by Subject|0|||
147510551|NCT01192100|532022213|FG001|Overall Study|Withdrawal by Subject|0|||
147510552|NCT01192100|532022214|FG002|Overall Study|Withdrawal by Subject|0|||
147510553|NCT01192100|532022215|FG003|Overall Study|Withdrawal by Subject|0|||
147510554|NCT01192100|532022216|FG004|Overall Study|Withdrawal by Subject|1|||
147510555|NCT01192100|532022217|FG005|Overall Study|Withdrawal by Subject|0|||
147510556|NCT01192100|532022212|FG000|Overall Study|Protocol Violation|0|||
147510557|NCT01192100|532022213|FG001|Overall Study|Protocol Violation|0|||
147510558|NCT01192100|532022214|FG002|Overall Study|Protocol Violation|0|||
147510559|NCT01192100|532022215|FG003|Overall Study|Protocol Violation|1|||
147510560|NCT01192100|532022216|FG004|Overall Study|Protocol Violation|0|||
147510561|NCT01192100|532022217|FG005|Overall Study|Protocol Violation|0|||
147510562|NCT01235507|532022218|FG000|Overall Study|Adverse Event|1|||
147510563|NCT01235507|532022218|FG000|Overall Study|Withdrawal by Subject|1|||
147510564|NCT02017704|532022221|FG000|Overall Study|Withdrawal by Subject|2|||
147510565|NCT02017704|532022222|FG001|Overall Study|Withdrawal by Subject|0|||
147510566|NCT01587274|532022223|FG000|Overall Study|Lost to Follow-up|4|||
147510567|NCT01587274|532022224|FG001|Overall Study|Lost to Follow-up|5|||
147510568|NCT01587274|532022225|FG002|Overall Study|Lost to Follow-up|3|||
147510569|NCT02475629|532022226|FG000|Overall Study|Adverse Event|1|||
147510570|NCT02475629|532022226|FG000|Overall Study|Death|4|||
147510571|NCT02475629|532022226|FG000|Overall Study|Physician Decision|1|||
147670182|NCT01232283|532617485|FG008|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
147670183|NCT01232283|532617486|FG009|Maintenance Phase (Weeks16-32)|Non-compliance with study drug|0|||
147670184|NCT01232283|532617477|FG000|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
147670185|NCT01232283|532617478|FG001|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
147670186|NCT01232283|532617479|FG002|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|7|||
147670187|NCT01232283|532617480|FG003|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|1|||
147510572|NCT02475629|532022226|FG000|Overall Study|Withdrawal by Subject|1|||
147510573|NCT02475629|532022226|FG000|Overall Study|Lost to Follow-up|1|||
147510574|NCT02475629|532022226|FG000|Overall Study|Subject non-compliance|1|||
147510575|NCT01095666|532022230|FG000|Overall Study|Lack of Efficacy|0|||
147510576|NCT01095666|532022231|FG001|Overall Study|Lack of Efficacy|0|||
147510577|NCT01095666|532022232|FG002|Overall Study|Lack of Efficacy|1|||
147510578|NCT01095666|532022230|FG000|Overall Study|Adverse Event|2|||
147510579|NCT01095666|532022231|FG001|Overall Study|Adverse Event|1|||
147510580|NCT01095666|532022232|FG002|Overall Study|Adverse Event|3|||
147510581|NCT01095666|532022230|FG000|Overall Study|Lost to Follow-up|2|||
147510582|NCT01095666|532022231|FG001|Overall Study|Lost to Follow-up|2|||
147510583|NCT01095666|532022232|FG002|Overall Study|Lost to Follow-up|0|||
147510584|NCT01095666|532022230|FG000|Overall Study|Withdrawal by Subject|6|||
147510585|NCT01095666|532022231|FG001|Overall Study|Withdrawal by Subject|6|||
147510586|NCT01095666|532022232|FG002|Overall Study|Withdrawal by Subject|1|||
147510587|NCT01095666|532022230|FG000|Overall Study|Non-compliance, not met criteria etc.|7|||
147510588|NCT01095666|532022231|FG001|Overall Study|Non-compliance, not met criteria etc.|2|||
147510589|NCT01095666|532022232|FG002|Overall Study|Non-compliance, not met criteria etc.|2|||
147510590|NCT03383614|532022234|FG000|Overall Study|Withdrawal by Subject|0|||
147510591|NCT03383614|532022235|FG001|Overall Study|Withdrawal by Subject|1|||
147510592|NCT03383614|532022236|FG002|Overall Study|Withdrawal by Subject|0|||
147510593|NCT03383614|532022237|FG003|Overall Study|Withdrawal by Subject|0|||
147510594|NCT00841672|532022246|FG000|Overall Study|Adverse Event|7|||
147510595|NCT00841672|532022247|FG001|Overall Study|Adverse Event|16|||
147510596|NCT00841672|532022246|FG000|Overall Study|Abnormal test procedure result(s)|0|||
147510597|NCT00841672|532022247|FG001|Overall Study|Abnormal test procedure result(s)|1|||
147510598|NCT00841672|532022246|FG000|Overall Study|Subject withdrew consent|2|||
147510599|NCT00841672|532022247|FG001|Overall Study|Subject withdrew consent|4|||
147510600|NCT00841672|532022246|FG000|Overall Study|Lost to Follow-up|1|||
147510601|NCT00841672|532022247|FG001|Overall Study|Lost to Follow-up|1|||
147510602|NCT00841672|532022246|FG000|Overall Study|Administrative problems|9|||
147510603|NCT00841672|532022247|FG001|Overall Study|Administrative problems|9|||
147510604|NCT00841672|532022246|FG000|Overall Study|Misrandomized|1|||
147510605|NCT00841672|532022247|FG001|Overall Study|Misrandomized|0|||
147510606|NCT00841672|532022246|FG000|Overall Study|Protocol Deviation|0|||
147510607|NCT00841672|532022247|FG001|Overall Study|Protocol Deviation|1|||
147510608|NCT02709109|532022248|FG000|Treatment Period 1 (28 Days)|Adverse Event|3|||
147510609|NCT02709109|532022249|FG001|Treatment Period 1 (28 Days)|Adverse Event|3|||
147510610|NCT02709109|532022250|FG002|Treatment Period 1 (28 Days)|Adverse Event|1|||
147510611|NCT02709109|532022251|FG003|Treatment Period 1 (28 Days)|Adverse Event|0|||
147510612|NCT02709109|532022248|FG000|Treatment Period 1 (28 Days)|Participant refused further dosing|0|||
147639863|NCT02294175|532499466|FG000|Overall Study|pt taking excluded medication|3|||
147639864|NCT02294175|532499467|FG001|Overall Study|pt taking excluded medication|1|||
147639865|NCT02294175|532499466|FG000|Overall Study|Protocol Violation|1|||
147639866|NCT02294175|532499467|FG001|Overall Study|Protocol Violation|0|||
147639867|NCT02294175|532499466|FG000|Overall Study|Lost to Follow-up|0|||
147639868|NCT02294175|532499467|FG001|Overall Study|Lost to Follow-up|1|||
147639869|NCT02294175|532499466|FG000|Overall Study|wound healed|0|||
147639870|NCT02294175|532499467|FG001|Overall Study|wound healed|2|||
147639871|NCT01901653|532499468|FG000|Overall Study|Death|2|||
147639872|NCT01901653|532499469|FG001|Overall Study|Death|1|||
147639873|NCT01901653|532499470|FG002|Overall Study|Death|8|||
147639874|NCT01901653|532499471|FG003|Overall Study|Death|3|||
147639875|NCT01901653|532499472|FG004|Overall Study|Death|2|||
147639876|NCT01901653|532499473|FG005|Overall Study|Death|2|||
147639877|NCT01901653|532499474|FG006|Overall Study|Death|6|||
147639878|NCT01901653|532499475|FG007|Overall Study|Death|9|||
147639879|NCT01901653|532499476|FG008|Overall Study|Death|1|||
147639880|NCT01901653|532499477|FG009|Overall Study|Death|16|||
147639881|NCT01901653|532499478|FG010|Overall Study|Death|2|||
147639882|NCT01901653|532499479|FG011|Overall Study|Death|15|||
147639883|NCT01901653|532499480|FG012|Overall Study|Death|4|||
147639884|NCT01901653|532499468|FG000|Overall Study|Lost to Follow-up|1|||
147639885|NCT01901653|532499469|FG001|Overall Study|Lost to Follow-up|0|||
147639886|NCT01901653|532499470|FG002|Overall Study|Lost to Follow-up|2|||
147639887|NCT01901653|532499471|FG003|Overall Study|Lost to Follow-up|0|||
147639888|NCT01901653|532499472|FG004|Overall Study|Lost to Follow-up|0|||
147639889|NCT01901653|532499473|FG005|Overall Study|Lost to Follow-up|1|||
147639890|NCT01901653|532499474|FG006|Overall Study|Lost to Follow-up|0|||
147639891|NCT01901653|532499475|FG007|Overall Study|Lost to Follow-up|1|||
147639892|NCT01901653|532499476|FG008|Overall Study|Lost to Follow-up|0|||
147639893|NCT01901653|532499477|FG009|Overall Study|Lost to Follow-up|0|||
147510613|NCT02709109|532022249|FG001|Treatment Period 1 (28 Days)|Participant refused further dosing|2|||
147510614|NCT02709109|532022250|FG002|Treatment Period 1 (28 Days)|Participant refused further dosing|0|||
147510615|NCT02709109|532022251|FG003|Treatment Period 1 (28 Days)|Participant refused further dosing|0|||
147639894|NCT01901653|532499478|FG010|Overall Study|Lost to Follow-up|0|||
147639895|NCT01901653|532499479|FG011|Overall Study|Lost to Follow-up|0|||
147639896|NCT01901653|532499480|FG012|Overall Study|Lost to Follow-up|0|||
147510616|NCT02709109|532022248|FG000|Treatment Period 1 (28 Days)|Non-compliance with study drug|1|||
147510617|NCT02709109|532022249|FG001|Treatment Period 1 (28 Days)|Non-compliance with study drug|0|||
147510618|NCT02709109|532022250|FG002|Treatment Period 1 (28 Days)|Non-compliance with study drug|0|||
147510619|NCT02709109|532022251|FG003|Treatment Period 1 (28 Days)|Non-compliance with study drug|0|||
147510620|NCT02709109|532022248|FG000|Washout Period (28 Days)|Other|2|||
147510621|NCT02709109|532022249|FG001|Washout Period (28 Days)|Other|2|||
147510622|NCT02709109|532022250|FG002|Washout Period (28 Days)|Other|3|||
147510623|NCT02709109|532022251|FG003|Washout Period (28 Days)|Other|0|||
147510624|NCT02709109|532022248|FG000|Treatment Period 2 (28 Days)|Adverse Event|2|||
147510625|NCT02709109|532022249|FG001|Treatment Period 2 (28 Days)|Adverse Event|3|||
147510626|NCT02709109|532022250|FG002|Treatment Period 2 (28 Days)|Adverse Event|0|||
147510627|NCT02709109|532022251|FG003|Treatment Period 2 (28 Days)|Adverse Event|0|||
147510628|NCT02709109|532022248|FG000|Treatment Period 2 (28 Days)|Other non-compliance|0|||
147510629|NCT02709109|532022249|FG001|Treatment Period 2 (28 Days)|Other non-compliance|1|||
147510630|NCT02709109|532022250|FG002|Treatment Period 2 (28 Days)|Other non-compliance|1|||
147510631|NCT02709109|532022251|FG003|Treatment Period 2 (28 Days)|Other non-compliance|0|||
147510632|NCT02709109|532022248|FG000|Treatment Period 2 (28 Days)|Requires prohibited medication|0|||
147510633|NCT02709109|532022249|FG001|Treatment Period 2 (28 Days)|Requires prohibited medication|0|||
147510634|NCT02709109|532022250|FG002|Treatment Period 2 (28 Days)|Requires prohibited medication|1|||
147510635|NCT02709109|532022251|FG003|Treatment Period 2 (28 Days)|Requires prohibited medication|0|||
147510636|NCT02709109|532022248|FG000|Treatment Period 2 (28 Days)|Other|0|||
147510637|NCT02709109|532022249|FG001|Treatment Period 2 (28 Days)|Other|0|||
147510638|NCT02709109|532022250|FG002|Treatment Period 2 (28 Days)|Other|1|||
147510639|NCT02709109|532022251|FG003|Treatment Period 2 (28 Days)|Other|0|||
147510640|NCT01928082|532022253|FG000|Overall Study|Study terminated.|1|||
147510641|NCT01815580|532022255|FG000|Overall Study|Lost to Follow-up|4|||
147510642|NCT01815580|532022256|FG001|Overall Study|Lost to Follow-up|7|||
147510643|NCT01815580|532022255|FG000|Overall Study|Withdrawal by Subject|3|||
147510644|NCT01815580|532022256|FG001|Overall Study|Withdrawal by Subject|4|||
147510645|NCT01815580|532022255|FG000|Overall Study|Excluded from analysis|5|||
147510646|NCT01815580|532022256|FG001|Overall Study|Excluded from analysis|4|||
147510647|NCT01814826|532022263|FG000|Overall Study|Other|3|||
147510648|NCT01814826|532022264|FG001|Overall Study|Other|5|||
147510649|NCT01814826|532022265|FG002|Overall Study|Other|0|||
147510650|NCT01814826|532022263|FG000|Overall Study|Death|29|||
147510651|NCT01814826|532022264|FG001|Overall Study|Death|24|||
147510652|NCT01814826|532022265|FG002|Overall Study|Death|3|||
147510653|NCT03034057|532022266|FG000|Overall Study|Withdrawal by Subject|10|||
147510654|NCT03034057|532022266|FG000|Overall Study|Protocol Violation|1|||
147510655|NCT03034057|532022266|FG000|Overall Study|Not defined|2|||
147510656|NCT03034057|532022266|FG000|Overall Study|Lost to Follow-up|19|||
147510657|NCT03034057|532022266|FG000|Overall Study|Adverse Event|22|||
147510658|NCT03034057|532022266|FG000|Overall Study|Medication error without associated AE|1|||
147510659|NCT03339401|532022267|FG000|Overall Study|Death|2|||
147510660|NCT03339401|532022268|FG001|Overall Study|Death|1|||
147510661|NCT03339401|532022267|FG000|Overall Study|Withdrawal by Subject|2|||
147510662|NCT03339401|532022268|FG001|Overall Study|Withdrawal by Subject|0|||
147510663|NCT03339401|532022267|FG000|Overall Study|Study terminated|4|||
147510664|NCT03339401|532022268|FG001|Overall Study|Study terminated|3|||
147510665|NCT03339401|532022267|FG000|Overall Study|Investigator Decision|1|||
147510666|NCT03339401|532022268|FG001|Overall Study|Investigator Decision|0|||
147510667|NCT02566109|532022269|FG000|Overall Study|Withdrawal by Subject|1|||
147510668|NCT01993667|532022273|FG000|Overall Study|Insufficient data to analyze|16|||
147510669|NCT01993667|532022274|FG001|Overall Study|Insufficient data to analyze|16|||
147510670|NCT01993667|532022273|FG000|Overall Study|Insufficient altitude reached|3|||
147510671|NCT01993667|532022274|FG001|Overall Study|Insufficient altitude reached|1|||
147510672|NCT01993667|532022273|FG000|Overall Study|Lost to Follow-up|2|||
147510673|NCT01993667|532022274|FG001|Overall Study|Lost to Follow-up|2|||
147510674|NCT03619837|532022278|FG000|Screening|received organs from HCV-negative donors|47|||
147510675|NCT03619837|532022278|FG000|Screening|died on the wait-list|2|||
147639897|NCT01901653|532499468|FG000|Overall Study|Withdrawal by Subject|0|||
147510676|NCT03619837|532022278|FG000|Screening|remained on the wait list|40|||
147510677|NCT03619837|532022278|FG000|Screening|didn't meet eligibility criteria|3|||
147510678|NCT03619837|532022278|FG000|Screening|withdrew consent|2|||
147510679|NCT03619837|532022278|FG000|Screening|never listed for HCV-viremic donor|1|||
147510680|NCT03619837|532022278|FG000|Screening|developed exclusion criteria|2|||
147510681|NCT03619837|532022278|FG000|Screening|excluded by the investigator due to non-compliance|1|||
147510682|NCT02650895|532022279|FG000|Overall Study|Withdrawal by Subject|0|||
147510683|NCT02650895|532022280|FG001|Overall Study|Withdrawal by Subject|1|||
147510684|NCT02650895|532022281|FG002|Overall Study|Withdrawal by Subject|0|||
147510685|NCT02650895|532022282|FG003|Overall Study|Withdrawal by Subject|0|||
147510686|NCT02650895|532022283|FG004|Overall Study|Withdrawal by Subject|0|||
147510687|NCT02650895|532022284|FG005|Overall Study|Withdrawal by Subject|0|||
147510688|NCT00981682|532022288|FG000|Overall Study|Adverse Event|48|||
147510689|NCT00981682|532022288|FG000|Overall Study|Withdrawal by Subject|52|||
147510690|NCT00981682|532022288|FG000|Overall Study|Lost to Follow-up|14|||
147510691|NCT00981682|532022288|FG000|Overall Study|Lack of Efficacy|13|||
147510692|NCT00981682|532022288|FG000|Overall Study|Protocol Violation|6|||
147510693|NCT00981682|532022288|FG000|Overall Study|administrative|9|||
147510694|NCT05283499|532023890|FG000|Overall Study|Did not receive intervention|1|||
147510695|NCT05283499|532023891|FG001|Overall Study|Did not receive intervention|2|||
147510696|NCT02408484|532023892|FG000|Overall Study|Withdrawal by Subject|3|||
147510697|NCT02408484|532023892|FG000|Overall Study|Not treated during study period|1|||
147510698|NCT02436915|532023893|FG000|Overall Study|Withdrawal by Subject|0|||
147510699|NCT02436915|532023894|FG001|Overall Study|Withdrawal by Subject|1|||
147510700|NCT01117181|532023896|FG000|Overall Study|Lost to Follow-up|1|||
147510701|NCT01117181|532023897|FG001|Overall Study|Lost to Follow-up|0|||
147510702|NCT01117181|532023896|FG000|Overall Study|Withdrawal by Subject|0|||
147510703|NCT01117181|532023897|FG001|Overall Study|Withdrawal by Subject|2|||
147510704|NCT00863317|532023898|FG000|Overall Study|Lost to Follow-up|8|||
147510705|NCT00863317|532023899|FG001|Overall Study|Lost to Follow-up|9|||
147510706|NCT00216086|532023902|FG000|Overall Study|Protocol Violation|1|||
147510707|NCT00216086|532023902|FG000|Overall Study|Diagnosis of Metastatic Disease|1|||
147510708|NCT00216086|532023902|FG000|Overall Study|Social Reasons|2|||
147510709|NCT00809614|532023903|FG000|Overall Study|Lack of Efficacy|2|||
147510710|NCT00809614|532023904|FG001|Overall Study|Lack of Efficacy|3|||
147510711|NCT00809614|532023903|FG000|Overall Study|Withdrawal by Subject|1|||
147510712|NCT00809614|532023904|FG001|Overall Study|Withdrawal by Subject|1|||
147510713|NCT01080625|532023905|FG000|Overall Study|Physician Decision|0|||
147510714|NCT01080625|532023906|FG001|Overall Study|Physician Decision|2|||
147510715|NCT01080625|532023907|FG002|Overall Study|Physician Decision|1|||
147510716|NCT01224106|532023908|FG000|Double-Blind Treatment Phase|Death|3|||
147510717|NCT01224106|532023909|FG001|Double-Blind Treatment Phase|Death|0|||
147510718|NCT01224106|532023910|FG002|Double-Blind Treatment Phase|Death|0|||
147510719|NCT01224106|532023911|FG003|Double-Blind Treatment Phase|Death|0|||
147510720|NCT01224106|532023912|FG004|Double-Blind Treatment Phase|Death|0|||
147510721|NCT01224106|532023908|FG000|Double-Blind Treatment Phase|Physician Decision|6|||
147510722|NCT01224106|532023909|FG001|Double-Blind Treatment Phase|Physician Decision|5|||
147510723|NCT01224106|532023910|FG002|Double-Blind Treatment Phase|Physician Decision|4|||
147510724|NCT01224106|532023911|FG003|Double-Blind Treatment Phase|Physician Decision|0|||
147510725|NCT01224106|532023912|FG004|Double-Blind Treatment Phase|Physician Decision|0|||
147510726|NCT01224106|532023908|FG000|Double-Blind Treatment Phase|Adverse Event|0|||
147510727|NCT01224106|532023909|FG001|Double-Blind Treatment Phase|Adverse Event|5|||
147510728|NCT01224106|532023910|FG002|Double-Blind Treatment Phase|Adverse Event|3|||
147510729|NCT01224106|532023911|FG003|Double-Blind Treatment Phase|Adverse Event|0|||
147510730|NCT01224106|532023912|FG004|Double-Blind Treatment Phase|Adverse Event|0|||
147510731|NCT01224106|532023908|FG000|Double-Blind Treatment Phase|Other|0|||
147510732|NCT01224106|532023909|FG001|Double-Blind Treatment Phase|Other|0|||
147510733|NCT01224106|532023910|FG002|Double-Blind Treatment Phase|Other|1|||
147510734|NCT01224106|532023911|FG003|Double-Blind Treatment Phase|Other|0|||
147510735|NCT01224106|532023912|FG004|Double-Blind Treatment Phase|Other|0|||
147510736|NCT01224106|532023908|FG000|Double-Blind Treatment Phase|Participant/legal guardian decision|7|||
147510737|NCT01224106|532023909|FG001|Double-Blind Treatment Phase|Participant/legal guardian decision|8|||
147510738|NCT01224106|532023910|FG002|Double-Blind Treatment Phase|Participant/legal guardian decision|8|||
147510739|NCT01224106|532023911|FG003|Double-Blind Treatment Phase|Participant/legal guardian decision|0|||
147510740|NCT01224106|532023912|FG004|Double-Blind Treatment Phase|Participant/legal guardian decision|0|||
147510741|NCT01224106|532023908|FG000|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|62|||
147510742|NCT01224106|532023909|FG001|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|68|||
147510743|NCT01224106|532023910|FG002|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|63|||
147510744|NCT01224106|532023911|FG003|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|0|||
147510745|NCT01224106|532023912|FG004|Double-Blind Treatment Phase|Parts 1 and 2 Termination by Sponsor|0|||
147510746|NCT01224106|532023908|FG000|Double-Blind Treatment Phase|Lost to Follow-up|1|||
147510747|NCT01224106|532023909|FG001|Double-Blind Treatment Phase|Lost to Follow-up|0|||
147510748|NCT01224106|532023910|FG002|Double-Blind Treatment Phase|Lost to Follow-up|1|||
147510749|NCT01224106|532023911|FG003|Double-Blind Treatment Phase|Lost to Follow-up|0|||
147510750|NCT01224106|532023912|FG004|Double-Blind Treatment Phase|Lost to Follow-up|0|||
147510751|NCT01224106|532023908|FG000|Open-Label Extension (OLE) Phase|Death|0|||
147510752|NCT01224106|532023909|FG001|Open-Label Extension (OLE) Phase|Death|0|||
147510753|NCT01224106|532023910|FG002|Open-Label Extension (OLE) Phase|Death|0|||
147510754|NCT01224106|532023911|FG003|Open-Label Extension (OLE) Phase|Death|1|||
147510755|NCT01224106|532023912|FG004|Open-Label Extension (OLE) Phase|Death|3|||
147510756|NCT01224106|532023908|FG000|Open-Label Extension (OLE) Phase|Adverse Event|0|||
147510757|NCT01224106|532023909|FG001|Open-Label Extension (OLE) Phase|Adverse Event|0|||
147510758|NCT01224106|532023910|FG002|Open-Label Extension (OLE) Phase|Adverse Event|0|||
147510759|NCT01224106|532023911|FG003|Open-Label Extension (OLE) Phase|Adverse Event|2|||
147510760|NCT01224106|532023912|FG004|Open-Label Extension (OLE) Phase|Adverse Event|6|||
147510761|NCT01224106|532023908|FG000|Open-Label Extension (OLE) Phase|Physician Decision|0|||
147510762|NCT01224106|532023909|FG001|Open-Label Extension (OLE) Phase|Physician Decision|0|||
147510763|NCT01224106|532023910|FG002|Open-Label Extension (OLE) Phase|Physician Decision|0|||
147510764|NCT01224106|532023911|FG003|Open-Label Extension (OLE) Phase|Physician Decision|2|||
147510765|NCT01224106|532023912|FG004|Open-Label Extension (OLE) Phase|Physician Decision|7|||
147510766|NCT01224106|532023908|FG000|Open-Label Extension (OLE) Phase|Withdrawal by Subject|0|||
147510767|NCT01224106|532023909|FG001|Open-Label Extension (OLE) Phase|Withdrawal by Subject|0|||
147510768|NCT01224106|532023910|FG002|Open-Label Extension (OLE) Phase|Withdrawal by Subject|0|||
147510769|NCT01224106|532023911|FG003|Open-Label Extension (OLE) Phase|Withdrawal by Subject|6|||
147510770|NCT01224106|532023912|FG004|Open-Label Extension (OLE) Phase|Withdrawal by Subject|15|||
147510771|NCT01224106|532023908|FG000|Open-Label Extension (OLE) Phase|Other|0|||
147510772|NCT01224106|532023909|FG001|Open-Label Extension (OLE) Phase|Other|0|||
147510773|NCT01224106|532023910|FG002|Open-Label Extension (OLE) Phase|Other|0|||
147510774|NCT01224106|532023911|FG003|Open-Label Extension (OLE) Phase|Other|5|||
147510775|NCT01224106|532023912|FG004|Open-Label Extension (OLE) Phase|Other|3|||
147510776|NCT00839436|532023917|FG000|Overall Study|Developed exclusionary condition|1|||
147510777|NCT00839436|532023918|FG001|Overall Study|Developed exclusionary condition|0|||
147510778|NCT00839436|532023919|FG002|Overall Study|Developed exclusionary condition|0|||
147510779|NCT00839436|532023917|FG000|Overall Study|Withdrawal by Subject|0|||
147510780|NCT00839436|532023918|FG001|Overall Study|Withdrawal by Subject|1|||
147510781|NCT00839436|532023919|FG002|Overall Study|Withdrawal by Subject|0|||
147510782|NCT00839436|532023917|FG000|Overall Study|Study drug no longer available|0|||
147510783|NCT00839436|532023918|FG001|Overall Study|Study drug no longer available|0|||
147510784|NCT00839436|532023919|FG002|Overall Study|Study drug no longer available|1|||
147510785|NCT01440972|532023920|FG000|Overall Study|Withdrawal by Subject|3|||
147510786|NCT01440972|532023921|FG001|Overall Study|Withdrawal by Subject|2|||
147510787|NCT03933215|532023922|FG000|Overall Study|Other|6|||
147510788|NCT03933215|532023922|FG000|Overall Study|Sponsor decision|5|||
147510789|NCT03933215|532023922|FG000|Overall Study|Protocol Violation|5|||
147510790|NCT03933215|532023922|FG000|Overall Study|Withdrawal by Subject|6|||
147510791|NCT03933215|532023922|FG000|Overall Study|Lost to Follow-up|6|||
147510792|NCT03933215|532023922|FG000|Overall Study|Enrolled but not treated|38|||
147510793|NCT05784129|532023923|FG000|Overall Study|Study terminated by sponsor|2|||
147510794|NCT05784129|532023924|FG001|Overall Study|Study terminated by sponsor|2|||
147510795|NCT00407550|532023925|FG000|Overall Study|Adverse Event|0|||
147510796|NCT00407550|532023926|FG001|Overall Study|Adverse Event|1|||
147510797|NCT00407550|532023925|FG000|Overall Study|Withdrawal by Subject|0|||
147510798|NCT00407550|532023926|FG001|Overall Study|Withdrawal by Subject|2|||
147510799|NCT00407550|532023925|FG000|Overall Study|Death|1|||
147510800|NCT00407550|532023926|FG001|Overall Study|Death|0|||
147510801|NCT00407550|532023925|FG000|Overall Study|Insurance or Other medical condition|2|||
147510802|NCT00407550|532023926|FG001|Overall Study|Insurance or Other medical condition|1|||
147510803|NCT02580591|532023928|FG000|Overall Study|Adverse Event|0|||
147510804|NCT02580591|532023929|FG001|Overall Study|Adverse Event|1|||
147510805|NCT02580591|532023930|FG002|Overall Study|Adverse Event|2|||
147510806|NCT02580591|532023931|FG003|Overall Study|Adverse Event|5|||
147510807|NCT02580591|532023928|FG000|Overall Study|Protocol Violation|3|||
147510808|NCT02580591|532023929|FG001|Overall Study|Protocol Violation|2|||
147510809|NCT02580591|532023930|FG002|Overall Study|Protocol Violation|1|||
147510810|NCT02580591|532023931|FG003|Overall Study|Protocol Violation|1|||
147510811|NCT02580591|532023928|FG000|Overall Study|Lost to Follow-up|5|||
147510812|NCT02580591|532023929|FG001|Overall Study|Lost to Follow-up|3|||
147510813|NCT02580591|532023930|FG002|Overall Study|Lost to Follow-up|3|||
147510814|NCT02580591|532023931|FG003|Overall Study|Lost to Follow-up|1|||
147510815|NCT02580591|532023928|FG000|Overall Study|Withdrawal by Subject|6|||
147510816|NCT02580591|532023929|FG001|Overall Study|Withdrawal by Subject|1|||
147510817|NCT02580591|532023930|FG002|Overall Study|Withdrawal by Subject|2|||
147510818|NCT02580591|532023931|FG003|Overall Study|Withdrawal by Subject|3|||
147639898|NCT01901653|532499469|FG001|Overall Study|Withdrawal by Subject|0|||
147639899|NCT01901653|532499470|FG002|Overall Study|Withdrawal by Subject|0|||
147639900|NCT01901653|532499471|FG003|Overall Study|Withdrawal by Subject|0|||
147639901|NCT01901653|532499472|FG004|Overall Study|Withdrawal by Subject|0|||
147639902|NCT01901653|532499473|FG005|Overall Study|Withdrawal by Subject|0|||
147639903|NCT01901653|532499474|FG006|Overall Study|Withdrawal by Subject|1|||
147639904|NCT01901653|532499475|FG007|Overall Study|Withdrawal by Subject|0|||
147510819|NCT02580591|532023928|FG000|Overall Study|Not treated|1|||
147510820|NCT02580591|532023929|FG001|Overall Study|Not treated|1|||
147510821|NCT02580591|532023930|FG002|Overall Study|Not treated|0|||
147510822|NCT02580591|532023931|FG003|Overall Study|Not treated|0|||
147510823|NCT02580591|532023928|FG000|Overall Study|Other than specified|3|||
147510824|NCT02580591|532023929|FG001|Overall Study|Other than specified|2|||
147510825|NCT02580591|532023930|FG002|Overall Study|Other than specified|5|||
147510826|NCT02580591|532023931|FG003|Overall Study|Other than specified|2|||
147510827|NCT00732641|532023933|FG000|Overall Study|Relapse or Progressive Disease|65|||
147510828|NCT00732641|532023934|FG001|Overall Study|Relapse or Progressive Disease|101|||
147510829|NCT00732641|532023933|FG000|Overall Study|Serious Adverse Events|12|||
147510830|NCT00732641|532023934|FG001|Overall Study|Serious Adverse Events|3|||
147510831|NCT00732641|532023933|FG000|Overall Study|Physician Decision|6|||
147510832|NCT00732641|532023934|FG001|Overall Study|Physician Decision|0|||
147510833|NCT00732641|532023933|FG000|Overall Study|Withdrawal by Subject|4|||
147510834|NCT00732641|532023934|FG001|Overall Study|Withdrawal by Subject|2|||
147510835|NCT00732641|532023933|FG000|Overall Study|Unable to Complete|1|||
147510836|NCT00732641|532023934|FG001|Overall Study|Unable to Complete|1|||
147510837|NCT00732641|532023933|FG000|Overall Study|Other|18|||
147510838|NCT00732641|532023934|FG001|Overall Study|Other|5|||
147510839|NCT00865046|532023939|FG000|Overall Study|Lost to Follow-up|1|||
147510840|NCT00865046|532023940|FG001|Overall Study|Lost to Follow-up|4|||
147510841|NCT00865046|532023941|FG002|Overall Study|Lost to Follow-up|0|||
147510842|NCT00865046|532023939|FG000|Overall Study|Death|0|||
147510843|NCT00865046|532023940|FG001|Overall Study|Death|1|||
147510844|NCT00865046|532023941|FG002|Overall Study|Death|1|||
147510845|NCT00865046|532023939|FG000|Overall Study|Withdrawal by Subject|5|||
147510846|NCT00865046|532023940|FG001|Overall Study|Withdrawal by Subject|0|||
147510847|NCT00865046|532023941|FG002|Overall Study|Withdrawal by Subject|0|||
147510848|NCT00481988|532023942|FG000|Overall Study|Withdrawal by Subject|1|||
147510849|NCT00481988|532023943|FG001|Overall Study|Withdrawal by Subject|1|||
147510850|NCT00654420|532023944|FG000|Phase I (Dose Escalation)|Adverse Event|0|||
147510851|NCT00654420|532023945|FG001|Phase I (Dose Escalation)|Adverse Event|1|||
147510852|NCT00654420|532023946|FG002|Phase I (Dose Escalation)|Adverse Event|0|||
147510853|NCT00654420|532023947|FG003|Phase I (Dose Escalation)|Adverse Event|0|||
147510854|NCT00654420|532023944|FG000|Phase I (Dose Escalation)|Progressive Disease|4|||
147510855|NCT00654420|532023945|FG001|Phase I (Dose Escalation)|Progressive Disease|15|||
147510856|NCT00654420|532023946|FG002|Phase I (Dose Escalation)|Progressive Disease|0|||
147510857|NCT00654420|532023947|FG003|Phase I (Dose Escalation)|Progressive Disease|0|||
147510858|NCT00654420|532023944|FG000|Phase II|Adverse Event|0|||
147510859|NCT00654420|532023945|FG001|Phase II|Adverse Event|0|||
147510860|NCT00654420|532023946|FG002|Phase II|Adverse Event|3|||
147510861|NCT00654420|532023947|FG003|Phase II|Adverse Event|3|||
147510862|NCT00654420|532023944|FG000|Phase II|Lost to Follow-up|0|||
147510863|NCT00654420|532023945|FG001|Phase II|Lost to Follow-up|0|||
147510864|NCT00654420|532023946|FG002|Phase II|Lost to Follow-up|0|||
147510865|NCT00654420|532023947|FG003|Phase II|Lost to Follow-up|1|||
147510866|NCT00654420|532023944|FG000|Phase II|Physician Decision|0|||
147510867|NCT00654420|532023945|FG001|Phase II|Physician Decision|0|||
147510868|NCT00654420|532023946|FG002|Phase II|Physician Decision|0|||
147510869|NCT00654420|532023947|FG003|Phase II|Physician Decision|4|||
147510870|NCT00654420|532023944|FG000|Phase II|Progressive Disease|0|||
147510871|NCT00654420|532023945|FG001|Phase II|Progressive Disease|0|||
147510872|NCT00654420|532023946|FG002|Phase II|Progressive Disease|29|||
147510873|NCT00654420|532023947|FG003|Phase II|Progressive Disease|29|||
147510874|NCT00654420|532023944|FG000|Phase II|Withdrawal by Subject|0|||
147510875|NCT00654420|532023945|FG001|Phase II|Withdrawal by Subject|0|||
147510876|NCT00654420|532023946|FG002|Phase II|Withdrawal by Subject|4|||
147510877|NCT00654420|532023947|FG003|Phase II|Withdrawal by Subject|1|||
147510878|NCT00654420|532023944|FG000|Phase II|Missing Disposition Record|0|||
147510879|NCT00654420|532023945|FG001|Phase II|Missing Disposition Record|0|||
147510880|NCT00654420|532023946|FG002|Phase II|Missing Disposition Record|1|||
147510881|NCT00654420|532023947|FG003|Phase II|Missing Disposition Record|0|||
147510882|NCT01451398|532023960|FG000|Overall Study|Adverse Event|7|||
147510883|NCT01451398|532023961|FG001|Overall Study|Adverse Event|9|||
147670188|NCT01232283|532617481|FG004|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
147670189|NCT01232283|532617482|FG005|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
147670190|NCT01232283|532617483|FG006|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
147510884|NCT01451398|532023960|FG000|Overall Study|Protocol Violation|1|||
147670191|NCT01232283|532617484|FG007|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
147670192|NCT01232283|532617485|FG008|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
147510885|NCT01451398|532023961|FG001|Overall Study|Protocol Violation|2|||
147510886|NCT01451398|532023960|FG000|Overall Study|Physician Decision|1|||
147510887|NCT01451398|532023961|FG001|Overall Study|Physician Decision|1|||
147510888|NCT01451398|532023960|FG000|Overall Study|Withdrawal by Subject|10|||
147510889|NCT01451398|532023961|FG001|Overall Study|Withdrawal by Subject|14|||
147510890|NCT01451398|532023960|FG000|Overall Study|Lost to Follow-up|6|||
147510891|NCT01451398|532023961|FG001|Overall Study|Lost to Follow-up|4|||
147510892|NCT01451398|532023960|FG000|Overall Study|Non-compliance with study drug|1|||
147510893|NCT01451398|532023961|FG001|Overall Study|Non-compliance with study drug|3|||
147510894|NCT01451398|532023960|FG000|Overall Study|Non-compliance with protocol|1|||
147510895|NCT01451398|532023961|FG001|Overall Study|Non-compliance with protocol|1|||
147510896|NCT01451398|532023960|FG000|Overall Study|Moved out of country|0|||
147510897|NCT01451398|532023961|FG001|Overall Study|Moved out of country|1|||
147510898|NCT01451398|532023960|FG000|Overall Study|Adverse Event + Elevated Fasting Glucose|0|||
147510899|NCT01451398|532023961|FG001|Overall Study|Adverse Event + Elevated Fasting Glucose|1|||
147510900|NCT01451398|532023960|FG000|Overall Study|Lack of Efficacy|0|||
147510901|NCT01451398|532023961|FG001|Overall Study|Lack of Efficacy|1|||
147510902|NCT00422669|532023962|FG000|Overall Study|The study was terminated early.|98|||
147510903|NCT00422669|532023963|FG001|Overall Study|The study was terminated early.|100|||
147510904|NCT00422669|532023964|FG002|Overall Study|The study was terminated early.|7|||
147510905|NCT00924729|532023972|FG000|Overall Study|insufficient volume for analysis|1|||
147510906|NCT00924729|532023973|FG001|Overall Study|insufficient volume for analysis|0|||
147510907|NCT00924729|532023972|FG000|Overall Study|Protocol Violation|1|||
147510908|NCT00924729|532023973|FG001|Overall Study|Protocol Violation|0|||
147510909|NCT00196196|532023974|FG000|Overall Study|Withdrawal by Subject|2|||
147510910|NCT00196196|532023974|FG000|Overall Study|Did not have required condition (hydroce|5|||
147510911|NCT02917629|532023975|FG000|Overall Study|Withdrawal by Subject|0|||
147510912|NCT02917629|532023976|FG001|Overall Study|Withdrawal by Subject|1|||
147510913|NCT00718523|532023977|FG000|Overall Study|Withdrawal by Subject|5|||
147510914|NCT00718523|532023978|FG001|Overall Study|Withdrawal by Subject|7|||
147510915|NCT00718523|532023977|FG000|Overall Study|Death|13|||
147510916|NCT00718523|532023978|FG001|Overall Study|Death|17|||
147510917|NCT03271307|532023979|FG000|Overall Study|Lost to Follow-up|0|||
147510918|NCT03271307|532023980|FG001|Overall Study|Lost to Follow-up|0|||
147510919|NCT03271307|532023981|FG002|Overall Study|Lost to Follow-up|0|||
147510920|NCT03271307|532023982|FG003|Overall Study|Lost to Follow-up|28|||
147510921|NCT03271307|532023983|FG004|Overall Study|Lost to Follow-up|91|||
147510922|NCT00910728|532023984|FG000|Overall Study|Lack of Efficacy|2|||
147510923|NCT00910728|532023985|FG001|Overall Study|Lack of Efficacy|3|||
147510924|NCT00910728|532023986|FG002|Overall Study|Lack of Efficacy|1|||
147510925|NCT00910728|532023987|FG003|Overall Study|Lack of Efficacy|2|||
147510926|NCT00910728|532023988|FG004|Overall Study|Lack of Efficacy|1|||
147510927|NCT00910728|532023989|FG005|Overall Study|Lack of Efficacy|0|||
147510928|NCT00910728|532023990|FG006|Overall Study|Lack of Efficacy|2|||
147510929|NCT00910728|532023991|FG007|Overall Study|Lack of Efficacy|2|||
147670193|NCT01232283|532617486|FG009|Maintenance Phase (Weeks16-32)|Withdrawal by Subject|0|||
147670194|NCT01232283|532617477|FG000|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
147670195|NCT01232283|532617478|FG001|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
147670196|NCT01232283|532617479|FG002|Maintenance Phase (Weeks16-32)|Lost to Follow-up|3|||
147670197|NCT01232283|532617480|FG003|Maintenance Phase (Weeks16-32)|Lost to Follow-up|2|||
147670198|NCT01232283|532617481|FG004|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
147670199|NCT01232283|532617482|FG005|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
147670200|NCT01232283|532617483|FG006|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
147670201|NCT01232283|532617484|FG007|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
147670202|NCT01232283|532617485|FG008|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
147670203|NCT01232283|532617486|FG009|Maintenance Phase (Weeks16-32)|Lost to Follow-up|0|||
147670204|NCT01232283|532617477|FG000|Maintenance Phase (Weeks16-32)|Other|0|||
147670205|NCT01232283|532617478|FG001|Maintenance Phase (Weeks16-32)|Other|0|||
147670206|NCT01232283|532617479|FG002|Maintenance Phase (Weeks16-32)|Other|2|||
147670207|NCT01232283|532617480|FG003|Maintenance Phase (Weeks16-32)|Other|0|||
147670208|NCT01232283|532617481|FG004|Maintenance Phase (Weeks16-32)|Other|0|||
147670209|NCT01232283|532617482|FG005|Maintenance Phase (Weeks16-32)|Other|0|||
147670210|NCT01232283|532617483|FG006|Maintenance Phase (Weeks16-32)|Other|0|||
147670211|NCT01232283|532617484|FG007|Maintenance Phase (Weeks16-32)|Other|0|||
147670212|NCT01232283|532617485|FG008|Maintenance Phase (Weeks16-32)|Other|0|||
147670213|NCT01232283|532617486|FG009|Maintenance Phase (Weeks16-32)|Other|0|||
147670214|NCT01232283|532617477|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
147670215|NCT01232283|532617478|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
147670216|NCT01232283|532617479|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
147670217|NCT01232283|532617480|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
147670218|NCT01232283|532617481|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|2|||
147670219|NCT01232283|532617482|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|1|||
147670220|NCT01232283|532617483|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
147670221|NCT01232283|532617484|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|1|||
147670222|NCT01232283|532617485|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
147670223|NCT01232283|532617486|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Adverse Event|0|||
147510930|NCT00910728|532023992|FG008|Overall Study|Lack of Efficacy|2|||
147510931|NCT00910728|532023984|FG000|Overall Study|Withdrawal by Subject|0|||
147510932|NCT00910728|532023985|FG001|Overall Study|Withdrawal by Subject|0|||
147510933|NCT00910728|532023986|FG002|Overall Study|Withdrawal by Subject|0|||
147510934|NCT00910728|532023987|FG003|Overall Study|Withdrawal by Subject|0|||
147510935|NCT00910728|532023988|FG004|Overall Study|Withdrawal by Subject|3|||
147510936|NCT00910728|532023989|FG005|Overall Study|Withdrawal by Subject|1|||
147510937|NCT00910728|532023990|FG006|Overall Study|Withdrawal by Subject|2|||
147510938|NCT00910728|532023991|FG007|Overall Study|Withdrawal by Subject|0|||
147670224|NCT01232283|532617477|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
147670225|NCT01232283|532617478|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
147670226|NCT01232283|532617479|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
147670227|NCT01232283|532617480|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
147510939|NCT00910728|532023992|FG008|Overall Study|Withdrawal by Subject|0|||
147510940|NCT00910728|532023984|FG000|Overall Study|(not specified)|2|||
147510941|NCT00910728|532023985|FG001|Overall Study|(not specified)|0|||
147510942|NCT00910728|532023986|FG002|Overall Study|(not specified)|1|||
147510943|NCT00910728|532023987|FG003|Overall Study|(not specified)|0|||
147510944|NCT00910728|532023988|FG004|Overall Study|(not specified)|1|||
147510945|NCT00910728|532023989|FG005|Overall Study|(not specified)|0|||
147510946|NCT00910728|532023990|FG006|Overall Study|(not specified)|0|||
147510947|NCT00910728|532023991|FG007|Overall Study|(not specified)|0|||
147510948|NCT00910728|532023992|FG008|Overall Study|(not specified)|0|||
147510949|NCT00910728|532023984|FG000|Overall Study|Adverse Event|2|||
147510950|NCT00910728|532023985|FG001|Overall Study|Adverse Event|0|||
147510951|NCT00910728|532023986|FG002|Overall Study|Adverse Event|1|||
147510952|NCT00910728|532023987|FG003|Overall Study|Adverse Event|1|||
147510953|NCT00910728|532023988|FG004|Overall Study|Adverse Event|0|||
147510954|NCT00910728|532023989|FG005|Overall Study|Adverse Event|0|||
147510955|NCT00910728|532023990|FG006|Overall Study|Adverse Event|2|||
147510956|NCT00910728|532023991|FG007|Overall Study|Adverse Event|1|||
147510957|NCT00910728|532023992|FG008|Overall Study|Adverse Event|1|||
147510958|NCT01042938|532023993|FG000|Overall Study|Withdrawal by Subject|1|||
147510959|NCT01042938|532023994|FG001|Overall Study|Withdrawal by Subject|1|||
147510960|NCT01042938|532023993|FG000|Overall Study|Protocol Violation|1|||
147510961|NCT01042938|532023994|FG001|Overall Study|Protocol Violation|1|||
147510962|NCT01042938|532023993|FG000|Overall Study|Ineligible: RTOG study conflict|1|||
147510963|NCT01042938|532023994|FG001|Overall Study|Ineligible: RTOG study conflict|0|||
147510964|NCT03997760|532023995|FG000|Overall Study|Protocol Deviation|0|||
147510965|NCT03997760|532023996|FG001|Overall Study|Protocol Deviation|1|||
147510966|NCT03997760|532023997|FG002|Overall Study|Protocol Deviation|0|||
147510967|NCT03997760|532023998|FG003|Overall Study|Protocol Deviation|0|||
147510968|NCT03032510|532023999|FG000|Overall Study|Adverse Event|5|||
147510969|NCT03032510|532024000|FG001|Overall Study|Adverse Event|2|||
147510970|NCT03032510|532023999|FG000|Overall Study|Lost to Follow-up|8|||
147510971|NCT03032510|532024000|FG001|Overall Study|Lost to Follow-up|7|||
147510972|NCT03032510|532023999|FG000|Overall Study|Withdrawal by Subject|8|||
147510973|NCT03032510|532024000|FG001|Overall Study|Withdrawal by Subject|7|||
147510974|NCT03032510|532023999|FG000|Overall Study|Subject noncompliance|4|||
147510975|NCT03032510|532024000|FG001|Overall Study|Subject noncompliance|2|||
147510976|NCT03032510|532023999|FG000|Overall Study|Physician Decision|2|||
147510977|NCT03032510|532024000|FG001|Overall Study|Physician Decision|0|||
147510978|NCT00856986|532024001|FG000|Run-in Period, Weeks -12-0|Adverse Event|0|||
147510979|NCT00856986|532024002|FG001|Run-in Period, Weeks -12-0|Adverse Event|0|||
147510980|NCT00856986|532024003|FG002|Run-in Period, Weeks -12-0|Adverse Event|0|||
147510981|NCT00856986|532024004|FG003|Run-in Period, Weeks -12-0|Adverse Event|92|||
147510982|NCT00856986|532024005|FG004|Run-in Period, Weeks -12-0|Adverse Event|0|||
147510983|NCT00856986|532024001|FG000|Run-in Period, Weeks -12-0|Protocol Violation|0|||
147510984|NCT00856986|532024002|FG001|Run-in Period, Weeks -12-0|Protocol Violation|0|||
147510985|NCT00856986|532024003|FG002|Run-in Period, Weeks -12-0|Protocol Violation|0|||
147510986|NCT00856986|532024004|FG003|Run-in Period, Weeks -12-0|Protocol Violation|24|||
147510987|NCT00856986|532024005|FG004|Run-in Period, Weeks -12-0|Protocol Violation|0|||
147510988|NCT00856986|532024001|FG000|Run-in Period, Weeks -12-0|Withdrawal Criteria|0|||
147510989|NCT00856986|532024002|FG001|Run-in Period, Weeks -12-0|Withdrawal Criteria|0|||
147510990|NCT00856986|532024003|FG002|Run-in Period, Weeks -12-0|Withdrawal Criteria|0|||
147510991|NCT00856986|532024004|FG003|Run-in Period, Weeks -12-0|Withdrawal Criteria|10|||
147510992|NCT00856986|532024005|FG004|Run-in Period, Weeks -12-0|Withdrawal Criteria|0|||
147510993|NCT00856986|532024001|FG000|Run-in Period, Weeks -12-0|Lost to Follow-up|0|||
147670228|NCT01232283|532617481|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|4|||
147670229|NCT01232283|532617482|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
147670230|NCT01232283|532617483|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|13|||
147670231|NCT01232283|532617484|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|5|||
147670232|NCT01232283|532617485|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
147670233|NCT01232283|532617486|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Lack of Efficacy|0|||
147670234|NCT01232283|532617477|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
147510994|NCT00856986|532024002|FG001|Run-in Period, Weeks -12-0|Lost to Follow-up|0|||
147510995|NCT00856986|532024003|FG002|Run-in Period, Weeks -12-0|Lost to Follow-up|0|||
147510996|NCT00856986|532024004|FG003|Run-in Period, Weeks -12-0|Lost to Follow-up|11|||
147510997|NCT00856986|532024005|FG004|Run-in Period, Weeks -12-0|Lost to Follow-up|0|||
147510998|NCT00856986|532024001|FG000|Run-in Period, Weeks -12-0|Lack of Efficacy|0|||
147510999|NCT00856986|532024002|FG001|Run-in Period, Weeks -12-0|Lack of Efficacy|0|||
147511000|NCT00856986|532024003|FG002|Run-in Period, Weeks -12-0|Lack of Efficacy|0|||
147511001|NCT00856986|532024004|FG003|Run-in Period, Weeks -12-0|Lack of Efficacy|6|||
147511002|NCT00856986|532024005|FG004|Run-in Period, Weeks -12-0|Lack of Efficacy|0|||
147511003|NCT00856986|532024001|FG000|Run-in Period, Weeks -12-0|Unclassified|0|||
147511004|NCT00856986|532024002|FG001|Run-in Period, Weeks -12-0|Unclassified|0|||
147511005|NCT00856986|532024003|FG002|Run-in Period, Weeks -12-0|Unclassified|0|||
147670235|NCT01232283|532617478|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
147670236|NCT01232283|532617479|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
147670237|NCT01232283|532617480|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
147670238|NCT01232283|532617481|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|3|||
147670239|NCT01232283|532617482|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|3|||
147670240|NCT01232283|532617483|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|3|||
147670241|NCT01232283|532617484|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|4|||
147670242|NCT01232283|532617485|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
147670243|NCT01232283|532617486|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Withdrawal by Subject|0|||
147670244|NCT01232283|532617477|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
147670245|NCT01232283|532617478|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
147670246|NCT01232283|532617479|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
147670247|NCT01232283|532617480|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
147670248|NCT01232283|532617481|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Death|1|||
147670249|NCT01232283|532617482|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
147670250|NCT01232283|532617483|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
147670251|NCT01232283|532617484|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
147670252|NCT01232283|532617485|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
147670253|NCT01232283|532617486|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Death|0|||
147670254|NCT01232283|532617477|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
147670255|NCT01232283|532617478|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
147670256|NCT01232283|532617479|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
147670257|NCT01232283|532617480|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
147670258|NCT01232283|532617481|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|2|||
147670259|NCT01232283|532617482|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
147670260|NCT01232283|532617483|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|1|||
147670261|NCT01232283|532617484|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|1|||
147670262|NCT01232283|532617485|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
147670263|NCT01232283|532617486|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Lost to Follow-up|0|||
147670264|NCT01232283|532617477|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
147670265|NCT01232283|532617478|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
147670266|NCT01232283|532617479|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
147670267|NCT01232283|532617480|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
147670268|NCT01232283|532617481|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
147670269|NCT01232283|532617482|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
147670270|NCT01232283|532617483|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
147670271|NCT01232283|532617484|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|1|||
147670272|NCT01232283|532617485|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
147670273|NCT01232283|532617486|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Protocol Violation|0|||
147670274|NCT01232283|532617477|FG000|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
147670275|NCT01232283|532617478|FG001|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
147670276|NCT01232283|532617479|FG002|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
147670277|NCT01232283|532617480|FG003|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
147670278|NCT01232283|532617481|FG004|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
147670279|NCT01232283|532617482|FG005|Randomized Withdrawal Phase(Weeks 32-52)|Other|1|||
147670280|NCT01232283|532617483|FG006|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
147670281|NCT01232283|532617484|FG007|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
147670282|NCT01232283|532617485|FG008|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
147670283|NCT01232283|532617486|FG009|Randomized Withdrawal Phase(Weeks 32-52)|Other|0|||
147670284|NCT01232283|532617477|FG000|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
147670285|NCT01232283|532617478|FG001|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
147670286|NCT01232283|532617479|FG002|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
147670287|NCT01232283|532617480|FG003|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
147670288|NCT01232283|532617481|FG004|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
147670289|NCT01232283|532617482|FG005|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
147670290|NCT01232283|532617483|FG006|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
147670291|NCT01232283|532617484|FG007|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|0|||
147670292|NCT01232283|532617485|FG008|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|11|||
147670293|NCT01232283|532617486|FG009|Long-Term Extension Phase (Weeks 52-260)|Adverse Event|6|||
147670294|NCT01232283|532617477|FG000|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
147670295|NCT01232283|532617478|FG001|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
147670296|NCT01232283|532617479|FG002|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
147670297|NCT01232283|532617480|FG003|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
147670298|NCT01232283|532617481|FG004|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
147670299|NCT01232283|532617482|FG005|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
147511006|NCT00856986|532024004|FG003|Run-in Period, Weeks -12-0|Unclassified|24|||
147511007|NCT00856986|532024005|FG004|Run-in Period, Weeks -12-0|Unclassified|0|||
147511008|NCT00856986|532024001|FG000|Main Period, Weeks 0-26|Adverse Event|6|||
147511009|NCT00856986|532024002|FG001|Main Period, Weeks 0-26|Adverse Event|4|||
147511010|NCT00856986|532024003|FG002|Main Period, Weeks 0-26|Adverse Event|9|||
147511011|NCT00856986|532024004|FG003|Main Period, Weeks 0-26|Adverse Event|0|||
147511012|NCT00856986|532024005|FG004|Main Period, Weeks 0-26|Adverse Event|0|||
147511013|NCT00856986|532024001|FG000|Main Period, Weeks 0-26|Protocol Violation|4|||
147511014|NCT00856986|532024002|FG001|Main Period, Weeks 0-26|Protocol Violation|5|||
147511015|NCT00856986|532024003|FG002|Main Period, Weeks 0-26|Protocol Violation|7|||
147511016|NCT00856986|532024004|FG003|Main Period, Weeks 0-26|Protocol Violation|0|||
147511017|NCT00856986|532024005|FG004|Main Period, Weeks 0-26|Protocol Violation|0|||
147511018|NCT00856986|532024001|FG000|Main Period, Weeks 0-26|Withdrawal Criteria|11|||
147511019|NCT00856986|532024002|FG001|Main Period, Weeks 0-26|Withdrawal Criteria|0|||
147511020|NCT00856986|532024003|FG002|Main Period, Weeks 0-26|Withdrawal Criteria|3|||
147511021|NCT00856986|532024004|FG003|Main Period, Weeks 0-26|Withdrawal Criteria|0|||
147511022|NCT00856986|532024005|FG004|Main Period, Weeks 0-26|Withdrawal Criteria|0|||
147511023|NCT00856986|532024001|FG000|Main Period, Weeks 0-26|Lost to Follow-up|1|||
147511024|NCT00856986|532024002|FG001|Main Period, Weeks 0-26|Lost to Follow-up|1|||
147511025|NCT00856986|532024003|FG002|Main Period, Weeks 0-26|Lost to Follow-up|2|||
147511026|NCT00856986|532024004|FG003|Main Period, Weeks 0-26|Lost to Follow-up|0|||
147511027|NCT00856986|532024005|FG004|Main Period, Weeks 0-26|Lost to Follow-up|0|||
147511028|NCT00856986|532024001|FG000|Main Period, Weeks 0-26|Lack of Efficacy|5|||
147670300|NCT01232283|532617483|FG006|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
147670301|NCT01232283|532617484|FG007|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|0|||
147670302|NCT01232283|532617485|FG008|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|46|||
147670303|NCT01232283|532617486|FG009|Long-Term Extension Phase (Weeks 52-260)|Lack of Efficacy|30|||
147670304|NCT01232283|532617477|FG000|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
147670305|NCT01232283|532617478|FG001|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
147670306|NCT01232283|532617479|FG002|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
147670307|NCT01232283|532617480|FG003|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
147670308|NCT01232283|532617481|FG004|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
147670309|NCT01232283|532617482|FG005|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
147670310|NCT01232283|532617483|FG006|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
147670311|NCT01232283|532617484|FG007|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|0|||
147670312|NCT01232283|532617485|FG008|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|3|||
147670313|NCT01232283|532617486|FG009|Long-Term Extension Phase (Weeks 52-260)|Non-compliance|2|||
147670314|NCT01232283|532617477|FG000|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
147670315|NCT01232283|532617478|FG001|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
147670316|NCT01232283|532617479|FG002|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
147670317|NCT01232283|532617480|FG003|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
147670318|NCT01232283|532617481|FG004|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
147670319|NCT01232283|532617482|FG005|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
147670320|NCT01232283|532617483|FG006|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
147670321|NCT01232283|532617484|FG007|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|0|||
147670322|NCT01232283|532617485|FG008|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|30|||
147670323|NCT01232283|532617486|FG009|Long-Term Extension Phase (Weeks 52-260)|Withdrawal by Subject|14|||
147670324|NCT01232283|532617477|FG000|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
147670325|NCT01232283|532617478|FG001|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
147670326|NCT01232283|532617479|FG002|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
147670327|NCT01232283|532617480|FG003|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
147670328|NCT01232283|532617481|FG004|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
147670329|NCT01232283|532617482|FG005|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
147670330|NCT01232283|532617483|FG006|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
147670331|NCT01232283|532617484|FG007|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|0|||
147670332|NCT01232283|532617485|FG008|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|9|||
147670333|NCT01232283|532617486|FG009|Long-Term Extension Phase (Weeks 52-260)|Lost to Follow-up|6|||
147670334|NCT01232283|532617477|FG000|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
147670335|NCT01232283|532617478|FG001|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
147670336|NCT01232283|532617479|FG002|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
147670337|NCT01232283|532617480|FG003|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
147670338|NCT01232283|532617481|FG004|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
147511029|NCT00856986|532024002|FG001|Main Period, Weeks 0-26|Lack of Efficacy|2|||
147511030|NCT00856986|532024003|FG002|Main Period, Weeks 0-26|Lack of Efficacy|0|||
147511031|NCT00856986|532024004|FG003|Main Period, Weeks 0-26|Lack of Efficacy|0|||
147511032|NCT00856986|532024005|FG004|Main Period, Weeks 0-26|Lack of Efficacy|0|||
147511033|NCT00856986|532024001|FG000|Main Period, Weeks 0-26|Unclassified|7|||
147670339|NCT01232283|532617482|FG005|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
147670340|NCT01232283|532617483|FG006|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
147670341|NCT01232283|532617484|FG007|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
147670342|NCT01232283|532617485|FG008|Long-Term Extension Phase (Weeks 52-260)|Death|1|||
147670343|NCT01232283|532617486|FG009|Long-Term Extension Phase (Weeks 52-260)|Death|0|||
147670344|NCT01232283|532617477|FG000|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
147670345|NCT01232283|532617478|FG001|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
147670346|NCT01232283|532617479|FG002|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
147670347|NCT01232283|532617480|FG003|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
147670348|NCT01232283|532617481|FG004|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
147670349|NCT01232283|532617482|FG005|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
147670350|NCT01232283|532617483|FG006|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
147670351|NCT01232283|532617484|FG007|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
147670352|NCT01232283|532617485|FG008|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|1|||
147670353|NCT01232283|532617486|FG009|Long-Term Extension Phase (Weeks 52-260)|Protocol Violation|0|||
147670354|NCT01232283|532617477|FG000|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
147670355|NCT01232283|532617478|FG001|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
147670356|NCT01232283|532617479|FG002|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
147670357|NCT01232283|532617480|FG003|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
147670358|NCT01232283|532617481|FG004|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
147670359|NCT01232283|532617482|FG005|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
147670360|NCT01232283|532617483|FG006|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
147670361|NCT01232283|532617484|FG007|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|0|||
147670362|NCT01232283|532617485|FG008|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|7|||
147670363|NCT01232283|532617486|FG009|Long-Term Extension Phase (Weeks 52-260)|Miscellaneous|3|||
147670364|NCT03054428|532617490|FG000|Overall Study|Physician Decision|0|||
147670365|NCT03054428|532617491|FG001|Overall Study|Physician Decision|1|||
147670366|NCT03054428|532617492|FG002|Overall Study|Physician Decision|1|||
147670367|NCT03054428|532617490|FG000|Overall Study|Lack of Efficacy|3|||
147670368|NCT03054428|532617491|FG001|Overall Study|Lack of Efficacy|1|||
147670369|NCT03054428|532617492|FG002|Overall Study|Lack of Efficacy|0|||
147670370|NCT03054428|532617490|FG000|Overall Study|Discontinued to enroll in OLE: enrolled|0|||
147670371|NCT03054428|532617491|FG001|Overall Study|Discontinued to enroll in OLE: enrolled|0|||
147670372|NCT03054428|532617492|FG002|Overall Study|Discontinued to enroll in OLE: enrolled|1|||
147670373|NCT03054428|532617490|FG000|Overall Study|Discont'd to enroll in OLE: not enrolled|1|||
147670374|NCT03054428|532617491|FG001|Overall Study|Discont'd to enroll in OLE: not enrolled|0|||
147670375|NCT03054428|532617492|FG002|Overall Study|Discont'd to enroll in OLE: not enrolled|0|||
147670376|NCT03054428|532617490|FG000|Overall Study|Transitioned to OLE study|76|||
147670377|NCT03054428|532617491|FG001|Overall Study|Transitioned to OLE study|76|||
147670378|NCT03054428|532617492|FG002|Overall Study|Transitioned to OLE study|73|||
147670379|NCT03054428|532617490|FG000|Overall Study|Withdrawal by Subject|3|||
147670380|NCT03054428|532617491|FG001|Overall Study|Withdrawal by Subject|2|||
147670381|NCT03054428|532617492|FG002|Overall Study|Withdrawal by Subject|3|||
147670382|NCT03054428|532617490|FG000|Overall Study|Lost to Follow-up|0|||
147670383|NCT03054428|532617491|FG001|Overall Study|Lost to Follow-up|0|||
147670384|NCT03054428|532617492|FG002|Overall Study|Lost to Follow-up|1|||
147670385|NCT01652690|532617493|FG000|Overall Study|Withdrawal by Subject|16|||
147670386|NCT01652690|532617494|FG001|Overall Study|Withdrawal by Subject|4|||
147670387|NCT01652690|532617493|FG000|Overall Study|Other|8|||
147670388|NCT01652690|532617494|FG001|Overall Study|Other|9|||
147670389|NCT01652690|532617493|FG000|Overall Study|Lost to Follow-up|6|||
147670390|NCT01652690|532617494|FG001|Overall Study|Lost to Follow-up|6|||
147670391|NCT01652690|532617493|FG000|Overall Study|Death|5|||
147670392|NCT01652690|532617494|FG001|Overall Study|Death|2|||
147670393|NCT01499810|532617495|FG000|Overall Study|Lost to Follow-up|10|||
147670394|NCT01499810|532617495|FG000|Overall Study|Protocol Violation|1|||
147670395|NCT01499810|532617495|FG000|Overall Study|Withdrawal by Subject|1|||
147670396|NCT05079321|532617496|FG000|Overall Study|Withdrawal by Subject|2|||
147670397|NCT05079321|532617497|FG001|Overall Study|Withdrawal by Subject|2|||
147670398|NCT05079321|532617496|FG000|Overall Study|Lost to Follow-up|0|||
147670399|NCT05079321|532617497|FG001|Overall Study|Lost to Follow-up|1|||
147670400|NCT01884597|532617498|FG000|Overall Study|Adverse Event|0|||
147670401|NCT01884597|532617499|FG001|Overall Study|Adverse Event|0|||
147670402|NCT01884597|532617500|FG002|Overall Study|Adverse Event|1|||
147670403|NCT01884597|532617498|FG000|Overall Study|Lack of Efficacy|1|||
147670404|NCT01884597|532617499|FG001|Overall Study|Lack of Efficacy|0|||
147670405|NCT01884597|532617500|FG002|Overall Study|Lack of Efficacy|0|||
147670406|NCT01884597|532617498|FG000|Overall Study|Death|0|||
147670407|NCT01884597|532617499|FG001|Overall Study|Death|1|||
147670408|NCT01884597|532617500|FG002|Overall Study|Death|0|||
147670409|NCT02097823|532617501|FG000|Overall Study|Withdrawal by Subject|1|||
147670410|NCT02097823|532617502|FG001|Overall Study|Withdrawal by Subject|1|||
147670411|NCT01081626|532617503|FG000|Overall Study|Dosing error|1|||
147639905|NCT01901653|532499476|FG008|Overall Study|Withdrawal by Subject|0|||
147639906|NCT01901653|532499477|FG009|Overall Study|Withdrawal by Subject|0|||
147639907|NCT01901653|532499478|FG010|Overall Study|Withdrawal by Subject|0|||
147639908|NCT01901653|532499479|FG011|Overall Study|Withdrawal by Subject|0|||
147639909|NCT01901653|532499480|FG012|Overall Study|Withdrawal by Subject|0|||
147639910|NCT01901653|532499468|FG000|Overall Study|Alive at Study Termination by Sponsor|0|||
147639911|NCT01901653|532499469|FG001|Overall Study|Alive at Study Termination by Sponsor|0|||
147639912|NCT01901653|532499470|FG002|Overall Study|Alive at Study Termination by Sponsor|1|||
147639913|NCT01901653|532499471|FG003|Overall Study|Alive at Study Termination by Sponsor|0|||
147639914|NCT01901653|532499472|FG004|Overall Study|Alive at Study Termination by Sponsor|0|||
147639915|NCT01901653|532499473|FG005|Overall Study|Alive at Study Termination by Sponsor|0|||
147639916|NCT01901653|532499474|FG006|Overall Study|Alive at Study Termination by Sponsor|0|||
147639917|NCT01901653|532499475|FG007|Overall Study|Alive at Study Termination by Sponsor|0|||
147639918|NCT01901653|532499476|FG008|Overall Study|Alive at Study Termination by Sponsor|0|||
147639919|NCT01901653|532499477|FG009|Overall Study|Alive at Study Termination by Sponsor|2|||
147639920|NCT01901653|532499478|FG010|Overall Study|Alive at Study Termination by Sponsor|0|||
147639921|NCT01901653|532499479|FG011|Overall Study|Alive at Study Termination by Sponsor|1|||
147639922|NCT01901653|532499480|FG012|Overall Study|Alive at Study Termination by Sponsor|1|||
147639923|NCT02548351|532499481|FG000|Overall Study|Withdrawal by Subject|149|||
147639924|NCT02548351|532499482|FG001|Overall Study|Withdrawal by Subject|154|||
147639925|NCT02548351|532499483|FG002|Overall Study|Withdrawal by Subject|152|||
147639926|NCT02548351|532499481|FG000|Overall Study|Death|11|||
147639927|NCT02548351|532499482|FG001|Overall Study|Death|15|||
147639928|NCT02548351|532499483|FG002|Overall Study|Death|12|||
147639929|NCT02548351|532499481|FG000|Overall Study|Adverse Event|22|||
147639930|NCT02548351|532499482|FG001|Overall Study|Adverse Event|56|||
147639931|NCT02548351|532499483|FG002|Overall Study|Adverse Event|36|||
147639932|NCT02548351|532499481|FG000|Overall Study|Study Terminated by Sponsor|549|||
147639933|NCT02548351|532499482|FG001|Overall Study|Study Terminated by Sponsor|509|||
147639934|NCT02548351|532499483|FG002|Overall Study|Study Terminated by Sponsor|528|||
147639935|NCT02548351|532499481|FG000|Overall Study|Site Closure|14|||
147639936|NCT02548351|532499482|FG001|Overall Study|Site Closure|5|||
147639937|NCT02548351|532499483|FG002|Overall Study|Site Closure|7|||
147639938|NCT02548351|532499481|FG000|Overall Study|Non-compliance with Study Drug|4|||
147639939|NCT02548351|532499482|FG001|Overall Study|Non-compliance with Study Drug|2|||
147639940|NCT02548351|532499483|FG002|Overall Study|Non-compliance with Study Drug|0|||
147639941|NCT02548351|532499481|FG000|Overall Study|Protocol Violation|2|||
147639942|NCT02548351|532499482|FG001|Overall Study|Protocol Violation|1|||
147639943|NCT02548351|532499483|FG002|Overall Study|Protocol Violation|2|||
147639944|NCT02548351|532499481|FG000|Overall Study|Physician Decision|11|||
147639945|NCT02548351|532499482|FG001|Overall Study|Physician Decision|18|||
147639946|NCT02548351|532499483|FG002|Overall Study|Physician Decision|11|||
147639947|NCT02548351|532499481|FG000|Overall Study|Lost to Follow-up|43|||
147639948|NCT02548351|532499482|FG001|Overall Study|Lost to Follow-up|50|||
147639949|NCT02548351|532499483|FG002|Overall Study|Lost to Follow-up|57|||
147639950|NCT02548351|532499481|FG000|Overall Study|Other|19|||
147639951|NCT02548351|532499482|FG001|Overall Study|Other|16|||
147639952|NCT02548351|532499483|FG002|Overall Study|Other|20|||
147639953|NCT02548351|532499481|FG000|Overall Study|Missing|1|||
147639954|NCT02548351|532499482|FG001|Overall Study|Missing|1|||
147639955|NCT02548351|532499483|FG002|Overall Study|Missing|0|||
147639956|NCT01744184|532499484|FG000|Overall Study|Adverse Event|1|||
147639957|NCT01744184|532499485|FG001|Overall Study|Adverse Event|0|||
147639958|NCT01744184|532499484|FG000|Overall Study|Withdrawal by Subject|0|||
147639959|NCT01744184|532499485|FG001|Overall Study|Withdrawal by Subject|1|||
147639960|NCT02091986|532499489|FG000|Overall Study|7 rand in error 1 patient decision|2|||
147639961|NCT02091986|532499490|FG001|Overall Study|7 rand in error 1 patient decision|3|||
147639962|NCT02091986|532499491|FG002|Overall Study|7 rand in error 1 patient decision|3|||
147639963|NCT02091986|532499489|FG000|Overall Study|Lost to Follow-up|1|||
147639964|NCT02091986|532499490|FG001|Overall Study|Lost to Follow-up|0|||
147639965|NCT02091986|532499491|FG002|Overall Study|Lost to Follow-up|0|||
147639966|NCT02091986|532499489|FG000|Overall Study|Withdrawal by Subject|4|||
147639967|NCT02091986|532499490|FG001|Overall Study|Withdrawal by Subject|8|||
147639968|NCT02091986|532499491|FG002|Overall Study|Withdrawal by Subject|3|||
147639969|NCT02091986|532499489|FG000|Overall Study|Adverse Event|0|||
147639970|NCT02091986|532499490|FG001|Overall Study|Adverse Event|0|||
147639971|NCT02091986|532499491|FG002|Overall Study|Adverse Event|2|||
147639972|NCT00125242|532499492|FG000|Overall Study|did not qualify|7|||
147639973|NCT00125242|532499493|FG001|Overall Study|did not qualify|2|||
147639974|NCT01664949|532499496|FG000|Overall Study|Adverse Event|11|||
147639975|NCT01664949|532499497|FG001|Overall Study|Adverse Event|12|||
147639976|NCT01664949|532499496|FG000|Overall Study|Lack of Efficacy|1|||
147639977|NCT01664949|532499497|FG001|Overall Study|Lack of Efficacy|1|||
147639978|NCT01664949|532499496|FG000|Overall Study|Lost to Follow-up|1|||
147639979|NCT01664949|532499497|FG001|Overall Study|Lost to Follow-up|2|||
147639980|NCT01664949|532499496|FG000|Overall Study|Personal Reasons|3|||
147639981|NCT01664949|532499497|FG001|Overall Study|Personal Reasons|4|||
147511034|NCT00856986|532024002|FG001|Main Period, Weeks 0-26|Unclassified|6|||
147511035|NCT00856986|532024003|FG002|Main Period, Weeks 0-26|Unclassified|7|||
147511036|NCT00856986|532024004|FG003|Main Period, Weeks 0-26|Unclassified|0|||
147511037|NCT00856986|532024005|FG004|Main Period, Weeks 0-26|Unclassified|0|||
147511038|NCT00856986|532024001|FG000|Extension Period, Weeks 26-52|Adverse Event|3|||
147511039|NCT00856986|532024002|FG001|Extension Period, Weeks 26-52|Adverse Event|3|||
147511040|NCT00856986|532024003|FG002|Extension Period, Weeks 26-52|Adverse Event|10|||
147511041|NCT00856986|532024004|FG003|Extension Period, Weeks 26-52|Adverse Event|0|||
147511042|NCT00856986|532024005|FG004|Extension Period, Weeks 26-52|Adverse Event|0|||
147511043|NCT00856986|532024001|FG000|Extension Period, Weeks 26-52|Protocol Violation|6|||
147511044|NCT00856986|532024002|FG001|Extension Period, Weeks 26-52|Protocol Violation|2|||
147511045|NCT00856986|532024003|FG002|Extension Period, Weeks 26-52|Protocol Violation|5|||
147511046|NCT00856986|532024004|FG003|Extension Period, Weeks 26-52|Protocol Violation|0|||
147511047|NCT00856986|532024005|FG004|Extension Period, Weeks 26-52|Protocol Violation|0|||
147511048|NCT00856986|532024001|FG000|Extension Period, Weeks 26-52|Withdrawal Criteria|2|||
147511049|NCT00856986|532024002|FG001|Extension Period, Weeks 26-52|Withdrawal Criteria|0|||
147511050|NCT00856986|532024003|FG002|Extension Period, Weeks 26-52|Withdrawal Criteria|8|||
147511051|NCT00856986|532024004|FG003|Extension Period, Weeks 26-52|Withdrawal Criteria|0|||
147511052|NCT00856986|532024005|FG004|Extension Period, Weeks 26-52|Withdrawal Criteria|0|||
147511053|NCT00856986|532024001|FG000|Extension Period, Weeks 26-52|Lost to Follow-up|0|||
147511054|NCT00856986|532024002|FG001|Extension Period, Weeks 26-52|Lost to Follow-up|5|||
147511055|NCT00856986|532024003|FG002|Extension Period, Weeks 26-52|Lost to Follow-up|2|||
147511056|NCT00856986|532024004|FG003|Extension Period, Weeks 26-52|Lost to Follow-up|0|||
147511057|NCT00856986|532024005|FG004|Extension Period, Weeks 26-52|Lost to Follow-up|0|||
147511058|NCT00856986|532024001|FG000|Extension Period, Weeks 26-52|Lack of Efficacy|4|||
147511059|NCT00856986|532024002|FG001|Extension Period, Weeks 26-52|Lack of Efficacy|2|||
147511060|NCT00856986|532024003|FG002|Extension Period, Weeks 26-52|Lack of Efficacy|2|||
147639982|NCT01664949|532499496|FG000|Overall Study|Protocol Violation|5|||
147639983|NCT01664949|532499497|FG001|Overall Study|Protocol Violation|5|||
147639984|NCT01664949|532499496|FG000|Overall Study|Other Miscellaneous Reasons|3|||
147639985|NCT01664949|532499497|FG001|Overall Study|Other Miscellaneous Reasons|1|||
147639986|NCT02727777|532499498|FG000|Overall Study|Screen Failure|2|||
147639987|NCT02727777|532499499|FG001|Overall Study|Screen Failure|0|||
147639988|NCT02727777|532499500|FG002|Overall Study|Screen Failure|0|||
147639989|NCT02727777|532499498|FG000|Overall Study|Progressive disease|2|||
147639990|NCT02727777|532499499|FG001|Overall Study|Progressive disease|0|||
147639991|NCT02727777|532499500|FG002|Overall Study|Progressive disease|0|||
147639992|NCT01738503|532499501|FG000|Induction/Stabilization (Days -14 to -1)|Other|35|||
147639993|NCT01738503|532499502|FG001|Induction/Stabilization (Days -14 to -1)|Other|0|||
147639994|NCT01738503|532499503|FG002|Induction/Stabilization (Days -14 to -1)|Other|0|||
147639995|NCT01738503|532499504|FG003|Induction/Stabilization (Days -14 to -1)|Other|0|||
147639996|NCT01738503|532499505|FG004|Induction/Stabilization (Days -14 to -1)|Other|0|||
147639997|NCT01738503|532499506|FG005|Induction/Stabilization (Days -14 to -1)|Other|0|||
147639998|NCT01738503|532499507|FG006|Induction/Stabilization (Days -14 to -1)|Other|0|||
147639999|NCT01738503|532499501|FG000|Treatment Period|Adverse Event|0|||
147640000|NCT01738503|532499502|FG001|Treatment Period|Adverse Event|1|||
147640001|NCT01738503|532499503|FG002|Treatment Period|Adverse Event|0|||
147640002|NCT01738503|532499504|FG003|Treatment Period|Adverse Event|1|||
147640003|NCT01738503|532499505|FG004|Treatment Period|Adverse Event|2|||
147640004|NCT01738503|532499506|FG005|Treatment Period|Adverse Event|2|||
147640005|NCT01738503|532499507|FG006|Treatment Period|Adverse Event|2|||
147640006|NCT01738503|532499501|FG000|Treatment Period|Lost to Follow-up|0|||
147640007|NCT01738503|532499502|FG001|Treatment Period|Lost to Follow-up|0|||
147640008|NCT01738503|532499503|FG002|Treatment Period|Lost to Follow-up|3|||
147640009|NCT01738503|532499504|FG003|Treatment Period|Lost to Follow-up|4|||
147640010|NCT01738503|532499505|FG004|Treatment Period|Lost to Follow-up|1|||
147640011|NCT01738503|532499506|FG005|Treatment Period|Lost to Follow-up|1|||
147640012|NCT01738503|532499507|FG006|Treatment Period|Lost to Follow-up|5|||
147640013|NCT01738503|532499501|FG000|Treatment Period|Withdrawal by Subject|0|||
147640014|NCT01738503|532499502|FG001|Treatment Period|Withdrawal by Subject|1|||
147640015|NCT01738503|532499503|FG002|Treatment Period|Withdrawal by Subject|0|||
147640016|NCT01738503|532499504|FG003|Treatment Period|Withdrawal by Subject|1|||
147640017|NCT01738503|532499505|FG004|Treatment Period|Withdrawal by Subject|1|||
147640018|NCT01738503|532499506|FG005|Treatment Period|Withdrawal by Subject|1|||
147640019|NCT01738503|532499507|FG006|Treatment Period|Withdrawal by Subject|1|||
147640020|NCT01738503|532499501|FG000|Treatment Period|Protocol Violation|0|||
147640021|NCT01738503|532499502|FG001|Treatment Period|Protocol Violation|3|||
147640022|NCT01738503|532499503|FG002|Treatment Period|Protocol Violation|1|||
147640023|NCT01738503|532499504|FG003|Treatment Period|Protocol Violation|0|||
147640024|NCT01738503|532499505|FG004|Treatment Period|Protocol Violation|4|||
147511061|NCT00856986|532024004|FG003|Extension Period, Weeks 26-52|Lack of Efficacy|0|||
147511062|NCT00856986|532024005|FG004|Extension Period, Weeks 26-52|Lack of Efficacy|0|||
147640025|NCT01738503|532499506|FG005|Treatment Period|Protocol Violation|2|||
147640026|NCT01738503|532499507|FG006|Treatment Period|Protocol Violation|0|||
147670412|NCT01081626|532617504|FG001|Overall Study|Dosing error|1|||
147670413|NCT01081626|532617503|FG000|Overall Study|Missing Estradiol|25|||
147670414|NCT01081626|532617504|FG001|Overall Study|Missing Estradiol|28|||
147670415|NCT01081626|532617503|FG000|Overall Study|Low antral follicle count|1|||
147670416|NCT01081626|532617504|FG001|Overall Study|Low antral follicle count|0|||
147670417|NCT01081626|532617503|FG000|Overall Study|Overstimulation|0|||
147670418|NCT01081626|532617504|FG001|Overall Study|Overstimulation|1|||
147670419|NCT01081626|532617503|FG000|Overall Study|Lost to Follow-up|0|||
147670420|NCT01081626|532617504|FG001|Overall Study|Lost to Follow-up|1|||
147670421|NCT01081626|532617503|FG000|Overall Study|Other|33|||
147670422|NCT01081626|532617504|FG001|Overall Study|Other|30|||
147670423|NCT03759379|532620056|FG000|Treatment Period|Remained in this Period at Time of Data Cut|119|||
147670424|NCT03759379|532620057|FG001|Treatment Period|Remained in this Period at Time of Data Cut|38|||
147670425|NCT03759379|532620056|FG000|Treatment Period|Death|2|||
147670426|NCT03759379|532620057|FG001|Treatment Period|Death|3|||
147670427|NCT03759379|532620056|FG000|Treatment Period|Lost to Follow-up|1|||
147670428|NCT03759379|532620057|FG001|Treatment Period|Lost to Follow-up|0|||
147670429|NCT03759379|532620056|FG000|Treatment Period|Physician Decision|0|||
147670430|NCT03759379|532620057|FG001|Treatment Period|Physician Decision|1|||
147670431|NCT04021043|532620058|FG000|Overall Study|Adverse Event|3|||
147670432|NCT04021043|532620059|FG001|Overall Study|Adverse Event|1|||
147670433|NCT04021043|532620060|FG002|Overall Study|Adverse Event|1|||
147670434|NCT04021043|532620061|FG003|Overall Study|Adverse Event|0|||
147670435|NCT04021043|532620058|FG000|Overall Study|Death|2|||
147670436|NCT04021043|532620059|FG001|Overall Study|Death|3|||
147670437|NCT04021043|532620060|FG002|Overall Study|Death|1|||
147670438|NCT04021043|532620061|FG003|Overall Study|Death|3|||
147670439|NCT04021043|532620058|FG000|Overall Study|Withdrawal by Subject|1|||
147670440|NCT04021043|532620059|FG001|Overall Study|Withdrawal by Subject|1|||
147670441|NCT04021043|532620060|FG002|Overall Study|Withdrawal by Subject|1|||
147670442|NCT04021043|532620061|FG003|Overall Study|Withdrawal by Subject|6|||
147670443|NCT04021043|532620058|FG000|Overall Study|Discontinued due to disease progression|4|||
147670444|NCT04021043|532620059|FG001|Overall Study|Discontinued due to disease progression|5|||
147670445|NCT04021043|532620060|FG002|Overall Study|Discontinued due to disease progression|7|||
147670446|NCT04021043|532620061|FG003|Overall Study|Discontinued due to disease progression|10|||
147670447|NCT02325414|532620062|FG000|Overall Study|Withdrawal by Subject|3|||
147670448|NCT02325414|532620063|FG001|Overall Study|Withdrawal by Subject|1|||
147670449|NCT02325414|532620062|FG000|Overall Study|Lost to Follow-up|5|||
147670450|NCT02325414|532620063|FG001|Overall Study|Lost to Follow-up|5|||
147670451|NCT05722522|532620064|FG000|Overall Study|Adverse Event|0|||
147670452|NCT05722522|532620065|FG001|Overall Study|Adverse Event|1|||
147670453|NCT04441905|532620066|FG000|Overall Study|Lost to Follow-up|1|||
147670454|NCT04441905|532620067|FG001|Overall Study|Lost to Follow-up|0|||
147670455|NCT04441905|532620068|FG002|Overall Study|Lost to Follow-up|0|||
147670456|NCT04441905|532620069|FG003|Overall Study|Lost to Follow-up|0|||
147670457|NCT04441905|532620070|FG004|Overall Study|Lost to Follow-up|0|||
147670458|NCT04441905|532620071|FG005|Overall Study|Lost to Follow-up|0|||
147670459|NCT04441905|532620066|FG000|Overall Study|Enrolled but treatment not administered|0|||
147670460|NCT04441905|532620067|FG001|Overall Study|Enrolled but treatment not administered|1|||
147670461|NCT04441905|532620068|FG002|Overall Study|Enrolled but treatment not administered|0|||
147670462|NCT04441905|532620069|FG003|Overall Study|Enrolled but treatment not administered|0|||
147670463|NCT04441905|532620070|FG004|Overall Study|Enrolled but treatment not administered|0|||
147670464|NCT04441905|532620071|FG005|Overall Study|Enrolled but treatment not administered|0|||
147670465|NCT04441905|532620066|FG000|Overall Study|Became ineligible after enrollment|0|||
147670466|NCT04441905|532620067|FG001|Overall Study|Became ineligible after enrollment|0|||
147670467|NCT04441905|532620068|FG002|Overall Study|Became ineligible after enrollment|0|||
147670468|NCT04441905|532620069|FG003|Overall Study|Became ineligible after enrollment|0|||
147670469|NCT04441905|532620070|FG004|Overall Study|Became ineligible after enrollment|1|||
147670470|NCT04441905|532620071|FG005|Overall Study|Became ineligible after enrollment|0|||
147670471|NCT03834961|532620074|FG000|Overall Study|Lack of Efficacy|1|||
147670472|NCT03834961|532620075|FG001|Overall Study|Lack of Efficacy|1|||
147670473|NCT03834961|532620076|FG002|Overall Study|Lack of Efficacy|0|||
147670474|NCT03834961|532620074|FG000|Overall Study|Physician Decision|0|||
147670475|NCT03834961|532620075|FG001|Overall Study|Physician Decision|1|||
147670476|NCT03834961|532620076|FG002|Overall Study|Physician Decision|0|||
147670477|NCT04736199|532620079|FG000|Overall Study|Adverse Event|28|||
147670478|NCT04736199|532620080|FG001|Overall Study|Adverse Event|22|||
147670479|NCT04736199|532620079|FG000|Overall Study|Death|9|||
147670480|NCT04736199|532620080|FG001|Overall Study|Death|3|||
147670481|NCT04736199|532620079|FG000|Overall Study|Lost to Follow-up|4|||
147670482|NCT04736199|532620080|FG001|Overall Study|Lost to Follow-up|1|||
147670483|NCT04736199|532620079|FG000|Overall Study|Physician Decision|5|||
147670484|NCT04736199|532620080|FG001|Overall Study|Physician Decision|9|||
147670485|NCT04736199|532620079|FG000|Overall Study|Withdrawal by Subject|21|||
147670486|NCT04736199|532620080|FG001|Overall Study|Withdrawal by Subject|9|||
147670487|NCT04736199|532620079|FG000|Overall Study|Progressive disease|120|||
147670488|NCT04736199|532620080|FG001|Overall Study|Progressive disease|101|||
147670489|NCT04736199|532620079|FG000|Overall Study|Subject decision|13|||
147670490|NCT04736199|532620080|FG001|Overall Study|Subject decision|13|||
147670491|NCT04736199|532620079|FG000|Overall Study|Required study drug interruption longer than allowed per protocol|2|||
147670492|NCT04736199|532620080|FG001|Overall Study|Required study drug interruption longer than allowed per protocol|0|||
147670493|NCT04736199|532620079|FG000|Overall Study|Additional primary malignancy|1|||
147670494|NCT04736199|532620080|FG001|Overall Study|Additional primary malignancy|0|||
147670495|NCT04736199|532620079|FG000|Overall Study|Non-compliance with study drug|0|||
147670496|NCT04736199|532620080|FG001|Overall Study|Non-compliance with study drug|1|||
147670497|NCT04736199|532620079|FG000|Overall Study|Other reason|0|||
147670498|NCT04736199|532620080|FG001|Overall Study|Other reason|1|||
147670499|NCT04736199|532620079|FG000|Overall Study|Ongoing with study drug|240|||
147670500|NCT04736199|532620080|FG001|Overall Study|Ongoing with study drug|63|||
147670501|NCT04736199|532620079|FG000|Overall Study|Study drug never administered|3|||
147670502|NCT04736199|532620080|FG001|Overall Study|Study drug never administered|0|||
147670503|NCT03526679|532620081|FG000|Overall Study|still under treatment|2|||
147670504|NCT04770753|532620082|FG000|Overall Study|Randomized, never treated|1|||
147670505|NCT04770753|532620083|FG001|Overall Study|Randomized, never treated|1|||
147670506|NCT04770753|532620082|FG000|Overall Study|Withdrawal by Subject|3|||
147670507|NCT04770753|532620083|FG001|Overall Study|Withdrawal by Subject|1|||
147670508|NCT04770753|532620082|FG000|Overall Study|Adverse Event|2|||
147670509|NCT04770753|532620083|FG001|Overall Study|Adverse Event|0|||
147670510|NCT04770753|532620082|FG000|Overall Study|Pregnancy|1|||
147670511|NCT04770753|532620083|FG001|Overall Study|Pregnancy|0|||
147670512|NCT04770753|532620082|FG000|Overall Study|Other un-specified|1|||
147670513|NCT04770753|532620083|FG001|Overall Study|Other un-specified|0|||
147670514|NCT02775851|532620084|FG000|Overall Study|Adverse Event|1|||
147670515|NCT02775851|532620085|FG001|Overall Study|Adverse Event|10|||
147670516|NCT02775851|532620084|FG000|Overall Study|Refusal Unrelated to Adverse Event|0|||
147670517|NCT02775851|532620085|FG001|Overall Study|Refusal Unrelated to Adverse Event|1|||
147670518|NCT02775851|532620084|FG000|Overall Study|Progression/Relapse|0|||
147670519|NCT02775851|532620085|FG001|Overall Study|Progression/Relapse|4|||
147670520|NCT02775851|532620084|FG000|Overall Study|Other - Not Protocol Specified|0|||
147670521|NCT02775851|532620085|FG001|Overall Study|Other - Not Protocol Specified|7|||
147670522|NCT02775851|532620084|FG000|Overall Study|Withdrawal by Subject|1|||
147670523|NCT02775851|532620085|FG001|Overall Study|Withdrawal by Subject|0|||
147670524|NCT04780659|532620086|FG000|Overall Study|Adverse event, serious fatal|3|||
147670525|NCT04780659|532620087|FG001|Overall Study|Adverse event, serious fatal|0|||
147670526|NCT04780659|532620086|FG000|Overall Study|Withdrawal by Subject|3|||
147670527|NCT04780659|532620087|FG001|Overall Study|Withdrawal by Subject|0|||
147670528|NCT04780659|532620086|FG000|Overall Study|Physician Decision|1|||
147670529|NCT04780659|532620087|FG001|Overall Study|Physician Decision|0|||
147670530|NCT04780659|532620086|FG000|Overall Study|Died in original disease|2|||
147670531|NCT04780659|532620087|FG001|Overall Study|Died in original disease|0|||
147670532|NCT04780659|532620086|FG000|Overall Study|Leukemia relapse (more than 6 weeks after dose 2)|1|||
147670533|NCT04780659|532620087|FG001|Overall Study|Leukemia relapse (more than 6 weeks after dose 2)|0|||
147670534|NCT04369053|532620088|FG000|Overall Study|Enrolled prior to the Pre-specified Cut-off Date|16264|||
147670535|NCT04369053|532620088|FG000|Overall Study|Withdrawal by Subject|773|||
147670536|NCT04369053|532620088|FG000|Overall Study|Lost to Follow-up|182|||
147670537|NCT04369053|532620088|FG000|Overall Study|Blood Test and/or Colonoscopy Reasons|4766|||
147670538|NCT05507437|532620089|FG000|Overall Study|Withdrawal by Subject|1|||
147670539|NCT05507437|532620090|FG001|Overall Study|Withdrawal by Subject|1|||
147670540|NCT05507437|532620089|FG000|Overall Study|Death|3|||
147670541|NCT05507437|532620090|FG001|Overall Study|Death|0|||
147670542|NCT05064488|532620091|FG000|Overall Study|Withdrawal by Subject|2|||
147670543|NCT05064488|532620092|FG001|Overall Study|Withdrawal by Subject|0|||
147670544|NCT05918055|532620093|FG000|Phase I - Dose Level 1|Ineligible|0|||
147670545|NCT05918055|532620094|FG001|Phase I - Dose Level 1|Ineligible|0|||
147670546|NCT05918055|532620095|FG002|Phase I - Dose Level 1|Ineligible|1|||
147511063|NCT00856986|532024001|FG000|Extension Period, Weeks 26-52|Unclassified|4|||
147511064|NCT00856986|532024002|FG001|Extension Period, Weeks 26-52|Unclassified|2|||
147670547|NCT05918055|532620093|FG000|Phase I - Dose Level -1|Physician Decision|1|||
147670548|NCT05918055|532620094|FG001|Phase I - Dose Level -1|Physician Decision|0|||
147511065|NCT00856986|532024003|FG002|Extension Period, Weeks 26-52|Unclassified|11|||
147511066|NCT00856986|532024004|FG003|Extension Period, Weeks 26-52|Unclassified|0|||
147670549|NCT05918055|532620095|FG002|Phase I - Dose Level -1|Physician Decision|0|||
147670550|NCT06583096|532620098|FG000|Overall Study|Lost to Follow-up|4|||
147670551|NCT06583096|532620099|FG001|Overall Study|Lost to Follow-up|10|||
147670552|NCT06583096|532620098|FG000|Overall Study|Withdrawal by Subject|0|||
147670553|NCT06583096|532620099|FG001|Overall Study|Withdrawal by Subject|2|||
147670554|NCT02562235|532620100|FG000|Overall Study|Adverse Event|3|||
147670555|NCT03945773|532620101|FG000|Overall Study|Consent Withdrawn|1|||
147670556|NCT03945773|532620102|FG001|Overall Study|Consent Withdrawn|1|||
147670557|NCT03945773|532620101|FG000|Overall Study|Lost to Follow-up|1|||
147511067|NCT00856986|532024005|FG004|Extension Period, Weeks 26-52|Unclassified|0|||
147511068|NCT05041062|532024008|FG000|Overall Study|Adverse Event|2|||
147511069|NCT04018612|532024009|FG000|Overall Study|Withdrawal by Subject|1|||
147511070|NCT04018612|532024010|FG001|Overall Study|Withdrawal by Subject|0|||
147511071|NCT04018612|532024011|FG002|Overall Study|Withdrawal by Subject|1|||
147511072|NCT00361218|532024012|FG000|Overall Study|Lost to Follow-up|11|||
147511073|NCT00361218|532024012|FG000|Overall Study|Personal Reasons|7|||
147511074|NCT00361218|532024012|FG000|Overall Study|terminated / withdrawn due to toxicity /|5|||
147511075|NCT02671760|532024014|FG000|Overall Study|Lost to Follow-up|0|||
147511076|NCT02671760|532024015|FG001|Overall Study|Lost to Follow-up|1|||
147511077|NCT02671760|532024016|FG002|Overall Study|Lost to Follow-up|0|||
147511078|NCT02999191|532024017|FG000|Wash-out Period 1 [21 Days]|Adverse Event|0|||
147511079|NCT02999191|532024018|FG001|Wash-out Period 1 [21 Days]|Adverse Event|1|||
147511080|NCT02999191|532024019|FG002|Wash-out Period 1 [21 Days]|Adverse Event|0|||
147511081|NCT01802515|532024029|FG000|Overall Study|Withdrawal by Subject|3|||
147511082|NCT01802515|532024030|FG001|Overall Study|Withdrawal by Subject|0|||
147511083|NCT01802515|532024031|FG002|Overall Study|Withdrawal by Subject|0|||
147511084|NCT01906476|532024032|FG000|Overall Study|Lost to Follow-up|17|||
147511085|NCT01906476|532024033|FG001|Overall Study|Lost to Follow-up|16|||
147511086|NCT01041404|532024036|FG000|Overall Study|Adverse Event|45|||
147511087|NCT01041404|532024037|FG001|Overall Study|Adverse Event|35|||
147511088|NCT01041404|532024036|FG000|Overall Study|Lack of Efficacy|200|||
147511089|NCT01041404|532024037|FG001|Overall Study|Lack of Efficacy|210|||
147511090|NCT01041404|532024036|FG000|Overall Study|Violation of Selection Criteria|0|||
147511091|NCT01041404|532024037|FG001|Overall Study|Violation of Selection Criteria|1|||
147511092|NCT01041404|532024036|FG000|Overall Study|Protocol Violation|4|||
147511093|NCT01041404|532024037|FG001|Overall Study|Protocol Violation|0|||
147511094|NCT01041404|532024036|FG000|Overall Study|Withdrawal by Subject|29|||
147511095|NCT01041404|532024037|FG001|Overall Study|Withdrawal by Subject|23|||
147511096|NCT01041404|532024036|FG000|Overall Study|Failure to Return|1|||
147511097|NCT01041404|532024037|FG001|Overall Study|Failure to Return|2|||
147511098|NCT01041404|532024036|FG000|Overall Study|Other|11|||
147511099|NCT01041404|532024037|FG001|Overall Study|Other|23|||
147511100|NCT01931150|532024038|FG000|Overall Study|Withdrawal by Subject|1|||
147511101|NCT01931150|532024039|FG001|Overall Study|Withdrawal by Subject|2|||
147511102|NCT04968353|532024042|FG000|Overall Study|Non-compliance|1|||
147511103|NCT04968353|532024043|FG001|Overall Study|Non-compliance|0|||
147511104|NCT04968353|532024044|FG002|Overall Study|Non-compliance|2|||
147511105|NCT04968353|532024045|FG003|Overall Study|Non-compliance|0|||
147511106|NCT01685203|532024046|FG000|Overall Study|Lost to Follow-up|3|||
147511107|NCT01685203|532024047|FG001|Overall Study|Lost to Follow-up|3|||
147511108|NCT01685203|532024048|FG002|Overall Study|Lost to Follow-up|0|||
147511109|NCT01685203|532024049|FG003|Overall Study|Lost to Follow-up|1|||
147511110|NCT01685203|532024050|FG004|Overall Study|Lost to Follow-up|0|||
147511111|NCT01685203|532024051|FG005|Overall Study|Lost to Follow-up|0|||
147511112|NCT01685203|532024052|FG006|Overall Study|Lost to Follow-up|0|||
147511113|NCT01685203|532024046|FG000|Overall Study|Adverse Event|0|||
147511114|NCT01685203|532024047|FG001|Overall Study|Adverse Event|0|||
147511115|NCT01685203|532024048|FG002|Overall Study|Adverse Event|0|||
147511116|NCT01685203|532024049|FG003|Overall Study|Adverse Event|0|||
147511117|NCT01685203|532024050|FG004|Overall Study|Adverse Event|0|||
147511118|NCT01685203|532024051|FG005|Overall Study|Adverse Event|2|||
147511119|NCT01685203|532024052|FG006|Overall Study|Adverse Event|0|||
147511120|NCT01685203|532024046|FG000|Overall Study|Adverse event and withdrew consent|1|||
147511121|NCT01685203|532024047|FG001|Overall Study|Adverse event and withdrew consent|0|||
147511122|NCT01685203|532024048|FG002|Overall Study|Adverse event and withdrew consent|0|||
147511123|NCT01685203|532024049|FG003|Overall Study|Adverse event and withdrew consent|0|||
147511124|NCT01685203|532024050|FG004|Overall Study|Adverse event and withdrew consent|0|||
147511125|NCT01685203|532024051|FG005|Overall Study|Adverse event and withdrew consent|0|||
147511126|NCT01685203|532024052|FG006|Overall Study|Adverse event and withdrew consent|0|||
147511127|NCT01685203|532024046|FG000|Overall Study|Patient's decision|0|||
147511128|NCT01685203|532024047|FG001|Overall Study|Patient's decision|0|||
147511129|NCT01685203|532024048|FG002|Overall Study|Patient's decision|0|||
147511130|NCT01685203|532024049|FG003|Overall Study|Patient's decision|0|||
147511131|NCT01685203|532024050|FG004|Overall Study|Patient's decision|0|||
147511132|NCT01685203|532024051|FG005|Overall Study|Patient's decision|1|||
147511133|NCT01685203|532024052|FG006|Overall Study|Patient's decision|0|||
147511134|NCT02896192|532024053|FG000|Open-Label Period (10 Weeks)|Lack of Efficacy|1|||
147511135|NCT02896192|532024053|FG000|Open-Label Period (10 Weeks)|Protocol Violation|1|||
147511136|NCT02896192|532024053|FG000|Open-Label Period (32 Weeks)|Lost to Follow-up|1|||
147511137|NCT01696396|532025913|FG000|Overall Study|Withdrawal by Subject|19|||
147511138|NCT01696396|532025914|FG001|Overall Study|Withdrawal by Subject|5|||
147511139|NCT01696396|532025915|FG002|Overall Study|Withdrawal by Subject|19|||
147511140|NCT01696396|532025916|FG003|Overall Study|Withdrawal by Subject|11|||
147511141|NCT01696396|532025913|FG000|Overall Study|Decision by Sponsor|3|||
147511142|NCT01696396|532025914|FG001|Overall Study|Decision by Sponsor|1|||
147511143|NCT01696396|532025915|FG002|Overall Study|Decision by Sponsor|2|||
147511144|NCT01696396|532025916|FG003|Overall Study|Decision by Sponsor|2|||
147511145|NCT01696396|532025913|FG000|Overall Study|Lost to Follow-up|9|||
147511146|NCT01696396|532025914|FG001|Overall Study|Lost to Follow-up|1|||
147511147|NCT01696396|532025915|FG002|Overall Study|Lost to Follow-up|4|||
147511148|NCT01696396|532025916|FG003|Overall Study|Lost to Follow-up|1|||
147640027|NCT01738503|532499501|FG000|Treatment Period|Other|0|||
147640028|NCT01738503|532499502|FG001|Treatment Period|Other|0|||
147640029|NCT01738503|532499503|FG002|Treatment Period|Other|1|||
147640030|NCT01738503|532499504|FG003|Treatment Period|Other|0|||
147640031|NCT01738503|532499505|FG004|Treatment Period|Other|0|||
147640032|NCT01738503|532499506|FG005|Treatment Period|Other|0|||
147640033|NCT01738503|532499507|FG006|Treatment Period|Other|0|||
147640034|NCT01738503|532499501|FG000|PET Imaging Sub-study|Adverse Event|0|||
147640035|NCT01738503|532499502|FG001|PET Imaging Sub-study|Adverse Event|0|||
147640036|NCT01738503|532499503|FG002|PET Imaging Sub-study|Adverse Event|0|||
147640037|NCT01738503|532499504|FG003|PET Imaging Sub-study|Adverse Event|0|||
147640038|NCT01738503|532499505|FG004|PET Imaging Sub-study|Adverse Event|0|||
147640039|NCT01738503|532499506|FG005|PET Imaging Sub-study|Adverse Event|1|||
147640040|NCT01738503|532499507|FG006|PET Imaging Sub-study|Adverse Event|0|||
147640041|NCT01738503|532499501|FG000|PET Imaging Sub-study|Scheduling issues with imaging facility|0|||
147640042|NCT01738503|532499502|FG001|PET Imaging Sub-study|Scheduling issues with imaging facility|0|||
147640043|NCT01738503|532499503|FG002|PET Imaging Sub-study|Scheduling issues with imaging facility|0|||
147640044|NCT01738503|532499504|FG003|PET Imaging Sub-study|Scheduling issues with imaging facility|0|||
147640045|NCT01738503|532499505|FG004|PET Imaging Sub-study|Scheduling issues with imaging facility|0|||
147640046|NCT01738503|532499506|FG005|PET Imaging Sub-study|Scheduling issues with imaging facility|1|||
147640047|NCT01738503|532499507|FG006|PET Imaging Sub-study|Scheduling issues with imaging facility|1|||
147640048|NCT00965341|532499519|FG000|Overall Study|Withdrew consent|1|||
147640049|NCT00965341|532499520|FG001|Overall Study|Withdrew consent|5|||
147640050|NCT00965341|532499519|FG000|Overall Study|Lost to Follow-up|1|||
147640051|NCT00965341|532499520|FG001|Overall Study|Lost to Follow-up|0|||
147640052|NCT00965341|532499519|FG000|Overall Study|Transportation issues|4|||
147640053|NCT00965341|532499520|FG001|Overall Study|Transportation issues|3|||
147640054|NCT01970475|532499521|FG000|Overall Study|Withdrawal by Subject|11|||
147640055|NCT01970475|532499522|FG001|Overall Study|Withdrawal by Subject|6|||
147640056|NCT01970475|532499521|FG000|Overall Study|Adverse Event|7|||
147640057|NCT01970475|532499522|FG001|Overall Study|Adverse Event|3|||
147640058|NCT01970475|532499521|FG000|Overall Study|Lost to Follow-up|2|||
147640059|NCT01970475|532499522|FG001|Overall Study|Lost to Follow-up|2|||
147640060|NCT01970475|532499521|FG000|Overall Study|Protocol Violation|1|||
147640061|NCT01970475|532499522|FG001|Overall Study|Protocol Violation|0|||
147640062|NCT02234596|532499523|FG000|Overall Study|Participant not treated|2|||
147640063|NCT05072106|532501429|FG000|Overall Study|Progressive disease|3|||
147640064|NCT05072106|532501430|FG001|Overall Study|Progressive disease|3|||
147640065|NCT05072106|532501429|FG000|Overall Study|Compassionate use|3|||
147640066|NCT05072106|532501430|FG001|Overall Study|Compassionate use|1|||
147640067|NCT05072106|532501429|FG000|Overall Study|Withdrawal by Subject|1|||
147640068|NCT05072106|532501430|FG001|Overall Study|Withdrawal by Subject|0|||
147640069|NCT04240886|532501435|FG000|Treatment Phase|Death|4|||
147640070|NCT04240886|532501435|FG000|Treatment Phase|Discontinuation by Subject|1|||
147640071|NCT04240886|532501435|FG000|Treatment Phase|Adverse Event|5|||
147640072|NCT04240886|532501435|FG000|Follow-up Phase|Withdrawal by Subject|1|||
147640073|NCT04240886|532501435|FG000|Follow-up Phase|Discontinuation by Subject|1|||
147640074|NCT04240886|532501435|FG000|Follow-up Phase|Death|2|||
147640075|NCT04743804|532501438|FG000|Overall Study|Other|1|||
147640076|NCT04743804|532501439|FG001|Overall Study|Other|0|||
147640077|NCT04743804|532501438|FG000|Overall Study|Withdrawal by Subject|0|||
147640078|NCT04743804|532501439|FG001|Overall Study|Withdrawal by Subject|1|||
147640079|NCT04743804|532501438|FG000|Overall Study|Study Terminated by Sponsor|1|||
147640080|NCT04743804|532501439|FG001|Overall Study|Study Terminated by Sponsor|4|||
147640081|NCT04743804|532501438|FG000|Overall Study|Physician Decision|0|||
147640082|NCT04743804|532501439|FG001|Overall Study|Physician Decision|1|||
147640083|NCT04743804|532501438|FG000|Overall Study|Death|3|||
147640084|NCT04743804|532501439|FG001|Overall Study|Death|0|||
147640085|NCT01944670|532501442|FG000|Overall Study|Lost to Follow-up|2|||
147640086|NCT04063657|532501445|FG000|Overall Study|Lost to Follow-up|1|||
147640087|NCT04063657|532501446|FG001|Overall Study|Lost to Follow-up|0|||
147640088|NCT03408444|532501447|FG000|Overall Study|Subject No Longer Meets Eligibility Criteria|1|||
147640089|NCT03408444|532501448|FG001|Overall Study|Subject No Longer Meets Eligibility Criteria|0|||
147640090|NCT03408444|532501449|FG002|Overall Study|Subject No Longer Meets Eligibility Criteria|0|||
147640091|NCT03408444|532501450|FG003|Overall Study|Subject No Longer Meets Eligibility Criteria|0|||
147640092|NCT03408444|532501447|FG000|Overall Study|Lens Discomfort|0|||
147640093|NCT03408444|532501448|FG001|Overall Study|Lens Discomfort|1|||
147640094|NCT03408444|532501449|FG002|Overall Study|Lens Discomfort|0|||
147640095|NCT03408444|532501450|FG003|Overall Study|Lens Discomfort|0|||
147640096|NCT03408444|532501447|FG000|Overall Study|Unsatisfactory Visual Response due to Test Article|0|||
147640097|NCT03408444|532501448|FG001|Overall Study|Unsatisfactory Visual Response due to Test Article|0|||
147640098|NCT03408444|532501449|FG002|Overall Study|Unsatisfactory Visual Response due to Test Article|1|||
147640099|NCT03408444|532501450|FG003|Overall Study|Unsatisfactory Visual Response due to Test Article|0|||
147670558|NCT03945773|532620102|FG001|Overall Study|Lost to Follow-up|0|||
147670559|NCT03945773|532620101|FG000|Overall Study|Death|46|||
147670560|NCT03945773|532620102|FG001|Overall Study|Death|22|||
147670561|NCT03945773|532620101|FG000|Overall Study|Physician Decision|1|||
147670562|NCT03945773|532620102|FG001|Overall Study|Physician Decision|0|||
147670563|NCT03945773|532620101|FG000|Overall Study|Other|1|||
147670564|NCT03945773|532620102|FG001|Overall Study|Other|0|||
147670565|NCT03945773|532620101|FG000|Overall Study|Ongoing at the time of DCO|4|||
147670566|NCT03945773|532620102|FG001|Overall Study|Ongoing at the time of DCO|3|||
147670567|NCT04090528|532620103|FG000|Overall Study|participants still on study|9|||
147670568|NCT04090528|532620104|FG001|Overall Study|participants still on study|13|||
147670569|NCT03595124|532620105|FG000|Overall Study|Physician Decision|1|||
147670570|NCT03595124|532620106|FG001|Overall Study|Physician Decision|1|||
147670571|NCT03595124|532620107|FG002|Overall Study|Physician Decision|1|||
147670572|NCT03595124|532620105|FG000|Overall Study|Ineligible|1|||
147670573|NCT03595124|532620106|FG001|Overall Study|Ineligible|1|||
147670574|NCT03595124|532620107|FG002|Overall Study|Ineligible|0|||
147670575|NCT03595124|532620105|FG000|Overall Study|Disease Progression|4|||
147670576|NCT03595124|532620106|FG001|Overall Study|Disease Progression|1|||
147670577|NCT03595124|532620107|FG002|Overall Study|Disease Progression|4|||
147670578|NCT05610605|532620112|FG000|6-month Assessment|Death|1|||
147670579|NCT05610605|532620113|FG001|6-month Assessment|Death|1|||
147670580|NCT05610605|532620112|FG000|6-month Assessment|Lost to Follow-up|20|||
147670581|NCT05610605|532620113|FG001|6-month Assessment|Lost to Follow-up|0|||
147670582|NCT05610605|532620112|FG000|6-month Assessment|Institutionalized|1|||
147670583|NCT05610605|532620113|FG001|6-month Assessment|Institutionalized|2|||
147670584|NCT05610605|532620112|FG000|12-month Assessment|Death|2|||
147670585|NCT05610605|532620113|FG001|12-month Assessment|Death|1|||
147670586|NCT05610605|532620112|FG000|12-month Assessment|Lost to Follow-up|1|||
147670587|NCT05610605|532620113|FG001|12-month Assessment|Lost to Follow-up|4|||
147670588|NCT05610605|532620112|FG000|12-month Assessment|Institutionalized|2|||
147670589|NCT05610605|532620113|FG001|12-month Assessment|Institutionalized|1|||
147670590|NCT03607422|532620114|FG000|Overall Study|Adverse Event|7|||
147670591|NCT03607422|532620115|FG001|Overall Study|Adverse Event|3|||
147670592|NCT03607422|532620116|FG002|Overall Study|Adverse Event|2|||
147670593|NCT03607422|532620117|FG003|Overall Study|Adverse Event|0|||
147670594|NCT03607422|532620118|FG004|Overall Study|Adverse Event|2|||
147670595|NCT03607422|532620119|FG005|Overall Study|Adverse Event|0|||
147670596|NCT03607422|532620114|FG000|Overall Study|Withdrawal by Subject|11|||
147670597|NCT03607422|532620115|FG001|Overall Study|Withdrawal by Subject|3|||
147670598|NCT03607422|532620116|FG002|Overall Study|Withdrawal by Subject|6|||
147670599|NCT03607422|532620117|FG003|Overall Study|Withdrawal by Subject|2|||
147670600|NCT03607422|532620118|FG004|Overall Study|Withdrawal by Subject|0|||
147670601|NCT03607422|532620119|FG005|Overall Study|Withdrawal by Subject|0|||
147670602|NCT03607422|532620114|FG000|Overall Study|Lost to Follow-up|0|||
147670603|NCT03607422|532620115|FG001|Overall Study|Lost to Follow-up|0|||
147670604|NCT03607422|532620116|FG002|Overall Study|Lost to Follow-up|1|||
147670605|NCT03607422|532620117|FG003|Overall Study|Lost to Follow-up|0|||
147670606|NCT03607422|532620118|FG004|Overall Study|Lost to Follow-up|0|||
147670607|NCT03607422|532620119|FG005|Overall Study|Lost to Follow-up|0|||
147670608|NCT03607422|532620114|FG000|Overall Study|Other|12|||
147670609|NCT03607422|532620115|FG001|Overall Study|Other|4|||
147670610|NCT03607422|532620116|FG002|Overall Study|Other|1|||
147670611|NCT03607422|532620117|FG003|Overall Study|Other|2|||
147511149|NCT01696396|532025913|FG000|Overall Study|Death|0|||
147511150|NCT01696396|532025914|FG001|Overall Study|Death|0|||
147511151|NCT01696396|532025915|FG002|Overall Study|Death|1|||
147511152|NCT01696396|532025916|FG003|Overall Study|Death|0|||
147511153|NCT02712008|532025917|FG000|Baseline (Day 1) up to Week 12|Death|3|||
147511154|NCT02712008|532025918|FG001|Baseline (Day 1) up to Week 12|Death|0|||
147511155|NCT02712008|532025919|FG002|Baseline (Day 1) up to Week 12|Death|0|||
147511156|NCT02712008|532025920|FG003|Baseline (Day 1) up to Week 12|Death|0|||
147511157|NCT02712008|532025921|FG004|Baseline (Day 1) up to Week 12|Death|0|||
147511158|NCT02712008|532025922|FG005|Baseline (Day 1) up to Week 12|Death|0|||
147670612|NCT03607422|532620118|FG004|Overall Study|Other|0|||
147670613|NCT03607422|532620119|FG005|Overall Study|Other|2|||
147670614|NCT03607422|532620114|FG000|Overall Study|Ongoing at Time of Analysis|8|||
147670615|NCT03607422|532620115|FG001|Overall Study|Ongoing at Time of Analysis|0|||
147670616|NCT03607422|532620116|FG002|Overall Study|Ongoing at Time of Analysis|2|||
147511159|NCT02712008|532025923|FG006|Baseline (Day 1) up to Week 12|Death|0|||
147670617|NCT03607422|532620117|FG003|Overall Study|Ongoing at Time of Analysis|1|||
147511160|NCT02712008|532025924|FG007|Baseline (Day 1) up to Week 12|Death|0|||
147670618|NCT03607422|532620118|FG004|Overall Study|Ongoing at Time of Analysis|1|||
147670619|NCT03607422|532620119|FG005|Overall Study|Ongoing at Time of Analysis|1|||
147670620|NCT00042289|532620120|FG000|Overall Study|Lost to Follow-up|3|||
147670621|NCT00042289|532620121|FG001|Overall Study|Lost to Follow-up|0|||
147670622|NCT00042289|532620122|FG002|Overall Study|Lost to Follow-up|0|||
147670623|NCT00042289|532620123|FG003|Overall Study|Lost to Follow-up|1|||
147670624|NCT00042289|532620124|FG004|Overall Study|Lost to Follow-up|3|||
147670625|NCT00042289|532620125|FG005|Overall Study|Lost to Follow-up|3|||
147511161|NCT02712008|532025917|FG000|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
147511162|NCT02712008|532025918|FG001|Baseline (Day 1) up to Week 12|Withdrawal by Subject|2|||
147511163|NCT02712008|532025919|FG002|Baseline (Day 1) up to Week 12|Withdrawal by Subject|1|||
147511164|NCT02712008|532025920|FG003|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
147511165|NCT02712008|532025921|FG004|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
147511166|NCT02712008|532025922|FG005|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
147511167|NCT02712008|532025923|FG006|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
147511168|NCT02712008|532025924|FG007|Baseline (Day 1) up to Week 12|Withdrawal by Subject|0|||
147511169|NCT02712008|532025917|FG000|Baseline (Day 1) up to Week 12|Lost to Follow-up|1|||
147511170|NCT02712008|532025918|FG001|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
147670626|NCT00042289|532620126|FG006|Overall Study|Lost to Follow-up|6|||
147670627|NCT00042289|532620127|FG007|Overall Study|Lost to Follow-up|1|||
147670628|NCT00042289|532620128|FG008|Overall Study|Lost to Follow-up|1|||
147670629|NCT00042289|532620129|FG009|Overall Study|Lost to Follow-up|0|||
147670630|NCT00042289|532620130|FG010|Overall Study|Lost to Follow-up|0|||
147670631|NCT00042289|532620131|FG011|Overall Study|Lost to Follow-up|0|||
147670632|NCT00042289|532620132|FG012|Overall Study|Lost to Follow-up|0|||
147670633|NCT00042289|532620133|FG013|Overall Study|Lost to Follow-up|0|||
147670634|NCT00042289|532620134|FG014|Overall Study|Lost to Follow-up|0|||
147670635|NCT00042289|532620135|FG015|Overall Study|Lost to Follow-up|1|||
147670636|NCT00042289|532620136|FG016|Overall Study|Lost to Follow-up|1|||
147670637|NCT00042289|532620137|FG017|Overall Study|Lost to Follow-up|0|||
147670638|NCT00042289|532620138|FG018|Overall Study|Lost to Follow-up|3|||
147670639|NCT00042289|532620139|FG019|Overall Study|Lost to Follow-up|2|||
147670640|NCT00042289|532620140|FG020|Overall Study|Lost to Follow-up|0|||
147670641|NCT00042289|532620141|FG021|Overall Study|Lost to Follow-up|0|||
147670642|NCT00042289|532620142|FG022|Overall Study|Lost to Follow-up|0|||
147670643|NCT00042289|532620143|FG023|Overall Study|Lost to Follow-up|0|||
147670644|NCT00042289|532620144|FG024|Overall Study|Lost to Follow-up|0|||
147670645|NCT00042289|532620145|FG025|Overall Study|Lost to Follow-up|0|||
147670646|NCT00042289|532620146|FG026|Overall Study|Lost to Follow-up|2|||
147670647|NCT00042289|532620147|FG027|Overall Study|Lost to Follow-up|2|||
147670648|NCT00042289|532620148|FG028|Overall Study|Lost to Follow-up|2|||
147670649|NCT00042289|532620149|FG029|Overall Study|Lost to Follow-up|0|||
147670650|NCT00042289|532620150|FG030|Overall Study|Lost to Follow-up|0|||
147670651|NCT00042289|532620151|FG031|Overall Study|Lost to Follow-up|2|||
147670652|NCT00042289|532620152|FG032|Overall Study|Lost to Follow-up|1|||
147670653|NCT00042289|532620153|FG033|Overall Study|Lost to Follow-up|1|||
147670654|NCT00042289|532620154|FG034|Overall Study|Lost to Follow-up|1|||
147670655|NCT00042289|532620155|FG035|Overall Study|Lost to Follow-up|2|||
147670656|NCT00042289|532620156|FG036|Overall Study|Lost to Follow-up|1|||
147670657|NCT00042289|532620157|FG037|Overall Study|Lost to Follow-up|1|||
147670658|NCT00042289|532620158|FG038|Overall Study|Lost to Follow-up|0|||
147670659|NCT00042289|532620159|FG039|Overall Study|Lost to Follow-up|5|||
147670660|NCT00042289|532620160|FG040|Overall Study|Lost to Follow-up|0|||
147670661|NCT00042289|532620161|FG041|Overall Study|Lost to Follow-up|2|||
147670662|NCT00042289|532620162|FG042|Overall Study|Lost to Follow-up|2|||
147670663|NCT00042289|532620163|FG043|Overall Study|Lost to Follow-up|0|||
147670664|NCT00042289|532620164|FG044|Overall Study|Lost to Follow-up|0|||
147670665|NCT00042289|532620165|FG045|Overall Study|Lost to Follow-up|1|||
147670666|NCT00042289|532620166|FG046|Overall Study|Lost to Follow-up|0|||
147670667|NCT00042289|532620120|FG000|Overall Study|Other reason|0|||
147670668|NCT00042289|532620121|FG001|Overall Study|Other reason|0|||
147670669|NCT00042289|532620122|FG002|Overall Study|Other reason|0|||
147670670|NCT00042289|532620123|FG003|Overall Study|Other reason|2|||
147670671|NCT00042289|532620124|FG004|Overall Study|Other reason|0|||
147670672|NCT00042289|532620125|FG005|Overall Study|Other reason|0|||
147670673|NCT00042289|532620126|FG006|Overall Study|Other reason|0|||
147670674|NCT00042289|532620127|FG007|Overall Study|Other reason|0|||
147670675|NCT00042289|532620128|FG008|Overall Study|Other reason|0|||
147511171|NCT02712008|532025919|FG002|Baseline (Day 1) up to Week 12|Lost to Follow-up|2|||
147511172|NCT02712008|532025920|FG003|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
147511173|NCT02712008|532025921|FG004|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
147511174|NCT02712008|532025922|FG005|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
147670676|NCT00042289|532620129|FG009|Overall Study|Other reason|0|||
147670677|NCT00042289|532620130|FG010|Overall Study|Other reason|0|||
147670678|NCT00042289|532620131|FG011|Overall Study|Other reason|0|||
147670679|NCT00042289|532620132|FG012|Overall Study|Other reason|0|||
147670680|NCT00042289|532620133|FG013|Overall Study|Other reason|0|||
147670681|NCT00042289|532620134|FG014|Overall Study|Other reason|0|||
147670682|NCT00042289|532620135|FG015|Overall Study|Other reason|0|||
147670683|NCT00042289|532620136|FG016|Overall Study|Other reason|0|||
147670684|NCT00042289|532620137|FG017|Overall Study|Other reason|0|||
147670685|NCT00042289|532620138|FG018|Overall Study|Other reason|1|||
147670686|NCT00042289|532620139|FG019|Overall Study|Other reason|0|||
147670687|NCT00042289|532620140|FG020|Overall Study|Other reason|0|||
147670688|NCT00042289|532620141|FG021|Overall Study|Other reason|0|||
147670689|NCT00042289|532620142|FG022|Overall Study|Other reason|0|||
147670690|NCT00042289|532620143|FG023|Overall Study|Other reason|1|||
147670691|NCT00042289|532620144|FG024|Overall Study|Other reason|0|||
147670692|NCT00042289|532620145|FG025|Overall Study|Other reason|0|||
147670693|NCT00042289|532620146|FG026|Overall Study|Other reason|1|||
147670694|NCT00042289|532620147|FG027|Overall Study|Other reason|0|||
147670695|NCT00042289|532620148|FG028|Overall Study|Other reason|3|||
147670696|NCT00042289|532620149|FG029|Overall Study|Other reason|0|||
147670697|NCT00042289|532620150|FG030|Overall Study|Other reason|0|||
147670698|NCT00042289|532620151|FG031|Overall Study|Other reason|1|||
147670699|NCT00042289|532620152|FG032|Overall Study|Other reason|0|||
147670700|NCT00042289|532620153|FG033|Overall Study|Other reason|1|||
147670701|NCT00042289|532620154|FG034|Overall Study|Other reason|0|||
147670702|NCT00042289|532620155|FG035|Overall Study|Other reason|2|||
147670703|NCT00042289|532620156|FG036|Overall Study|Other reason|0|||
147670704|NCT00042289|532620157|FG037|Overall Study|Other reason|0|||
147670705|NCT00042289|532620158|FG038|Overall Study|Other reason|0|||
147670706|NCT00042289|532620159|FG039|Overall Study|Other reason|0|||
147670707|NCT00042289|532620160|FG040|Overall Study|Other reason|0|||
147670708|NCT00042289|532620161|FG041|Overall Study|Other reason|0|||
147670709|NCT00042289|532620162|FG042|Overall Study|Other reason|0|||
147670710|NCT00042289|532620163|FG043|Overall Study|Other reason|1|||
147670711|NCT00042289|532620164|FG044|Overall Study|Other reason|0|||
147670712|NCT00042289|532620165|FG045|Overall Study|Other reason|0|||
147670713|NCT00042289|532620166|FG046|Overall Study|Other reason|0|||
147670714|NCT00042289|532620120|FG000|Overall Study|Severe debilitation, unable to continue|0|||
147670715|NCT00042289|532620121|FG001|Overall Study|Severe debilitation, unable to continue|0|||
147670716|NCT00042289|532620122|FG002|Overall Study|Severe debilitation, unable to continue|0|||
147670717|NCT00042289|532620123|FG003|Overall Study|Severe debilitation, unable to continue|0|||
147670718|NCT00042289|532620124|FG004|Overall Study|Severe debilitation, unable to continue|0|||
147670719|NCT00042289|532620125|FG005|Overall Study|Severe debilitation, unable to continue|0|||
147670720|NCT00042289|532620126|FG006|Overall Study|Severe debilitation, unable to continue|0|||
147670721|NCT00042289|532620127|FG007|Overall Study|Severe debilitation, unable to continue|0|||
147670722|NCT00042289|532620128|FG008|Overall Study|Severe debilitation, unable to continue|0|||
147670723|NCT00042289|532620129|FG009|Overall Study|Severe debilitation, unable to continue|0|||
147670724|NCT00042289|532620130|FG010|Overall Study|Severe debilitation, unable to continue|0|||
147670725|NCT00042289|532620131|FG011|Overall Study|Severe debilitation, unable to continue|0|||
147670726|NCT00042289|532620132|FG012|Overall Study|Severe debilitation, unable to continue|0|||
147670727|NCT00042289|532620133|FG013|Overall Study|Severe debilitation, unable to continue|0|||
147670728|NCT00042289|532620134|FG014|Overall Study|Severe debilitation, unable to continue|0|||
147670729|NCT00042289|532620135|FG015|Overall Study|Severe debilitation, unable to continue|0|||
147670730|NCT00042289|532620136|FG016|Overall Study|Severe debilitation, unable to continue|0|||
147670731|NCT00042289|532620137|FG017|Overall Study|Severe debilitation, unable to continue|0|||
147670732|NCT00042289|532620138|FG018|Overall Study|Severe debilitation, unable to continue|0|||
147670733|NCT00042289|532620139|FG019|Overall Study|Severe debilitation, unable to continue|0|||
147670734|NCT00042289|532620140|FG020|Overall Study|Severe debilitation, unable to continue|0|||
147670735|NCT00042289|532620141|FG021|Overall Study|Severe debilitation, unable to continue|1|||
147670736|NCT00042289|532620142|FG022|Overall Study|Severe debilitation, unable to continue|0|||
147670737|NCT00042289|532620143|FG023|Overall Study|Severe debilitation, unable to continue|1|||
147670738|NCT00042289|532620144|FG024|Overall Study|Severe debilitation, unable to continue|0|||
147670739|NCT00042289|532620145|FG025|Overall Study|Severe debilitation, unable to continue|0|||
147670740|NCT00042289|532620146|FG026|Overall Study|Severe debilitation, unable to continue|0|||
147670741|NCT00042289|532620147|FG027|Overall Study|Severe debilitation, unable to continue|1|||
147670742|NCT00042289|532620148|FG028|Overall Study|Severe debilitation, unable to continue|0|||
147670743|NCT00042289|532620149|FG029|Overall Study|Severe debilitation, unable to continue|0|||
147670744|NCT00042289|532620150|FG030|Overall Study|Severe debilitation, unable to continue|0|||
147670745|NCT00042289|532620151|FG031|Overall Study|Severe debilitation, unable to continue|1|||
147670746|NCT00042289|532620152|FG032|Overall Study|Severe debilitation, unable to continue|1|||
147670747|NCT00042289|532620153|FG033|Overall Study|Severe debilitation, unable to continue|0|||
147670748|NCT00042289|532620154|FG034|Overall Study|Severe debilitation, unable to continue|0|||
147670749|NCT00042289|532620155|FG035|Overall Study|Severe debilitation, unable to continue|0|||
147670750|NCT00042289|532620156|FG036|Overall Study|Severe debilitation, unable to continue|0|||
147670751|NCT00042289|532620157|FG037|Overall Study|Severe debilitation, unable to continue|0|||
147670752|NCT00042289|532620158|FG038|Overall Study|Severe debilitation, unable to continue|0|||
147670753|NCT00042289|532620159|FG039|Overall Study|Severe debilitation, unable to continue|0|||
147670754|NCT00042289|532620160|FG040|Overall Study|Severe debilitation, unable to continue|0|||
147670755|NCT00042289|532620161|FG041|Overall Study|Severe debilitation, unable to continue|0|||
147670756|NCT00042289|532620162|FG042|Overall Study|Severe debilitation, unable to continue|0|||
147670757|NCT00042289|532620163|FG043|Overall Study|Severe debilitation, unable to continue|0|||
147670758|NCT00042289|532620164|FG044|Overall Study|Severe debilitation, unable to continue|0|||
147670759|NCT00042289|532620165|FG045|Overall Study|Severe debilitation, unable to continue|0|||
147670760|NCT00042289|532620166|FG046|Overall Study|Severe debilitation, unable to continue|0|||
147670761|NCT00042289|532620120|FG000|Overall Study|Site closed|0|||
147670762|NCT00042289|532620121|FG001|Overall Study|Site closed|0|||
147670763|NCT00042289|532620122|FG002|Overall Study|Site closed|0|||
147670764|NCT00042289|532620123|FG003|Overall Study|Site closed|0|||
147670765|NCT00042289|532620124|FG004|Overall Study|Site closed|0|||
147670766|NCT00042289|532620125|FG005|Overall Study|Site closed|0|||
147670767|NCT00042289|532620126|FG006|Overall Study|Site closed|0|||
147670768|NCT00042289|532620127|FG007|Overall Study|Site closed|0|||
147670769|NCT00042289|532620128|FG008|Overall Study|Site closed|0|||
147670770|NCT00042289|532620129|FG009|Overall Study|Site closed|0|||
147670771|NCT00042289|532620130|FG010|Overall Study|Site closed|0|||
147670772|NCT00042289|532620131|FG011|Overall Study|Site closed|0|||
147670773|NCT00042289|532620132|FG012|Overall Study|Site closed|0|||
147670774|NCT00042289|532620133|FG013|Overall Study|Site closed|0|||
147670775|NCT00042289|532620134|FG014|Overall Study|Site closed|0|||
147670776|NCT00042289|532620135|FG015|Overall Study|Site closed|0|||
147670777|NCT00042289|532620136|FG016|Overall Study|Site closed|0|||
147670778|NCT00042289|532620137|FG017|Overall Study|Site closed|0|||
147670779|NCT00042289|532620138|FG018|Overall Study|Site closed|0|||
147670780|NCT00042289|532620139|FG019|Overall Study|Site closed|0|||
147670781|NCT00042289|532620140|FG020|Overall Study|Site closed|0|||
147670782|NCT00042289|532620141|FG021|Overall Study|Site closed|0|||
147670783|NCT00042289|532620142|FG022|Overall Study|Site closed|0|||
147670784|NCT00042289|532620143|FG023|Overall Study|Site closed|0|||
147670785|NCT00042289|532620144|FG024|Overall Study|Site closed|0|||
147670786|NCT00042289|532620145|FG025|Overall Study|Site closed|0|||
147670787|NCT00042289|532620146|FG026|Overall Study|Site closed|0|||
147670788|NCT00042289|532620147|FG027|Overall Study|Site closed|0|||
147670789|NCT00042289|532620148|FG028|Overall Study|Site closed|0|||
147670790|NCT00042289|532620149|FG029|Overall Study|Site closed|0|||
147670791|NCT00042289|532620150|FG030|Overall Study|Site closed|0|||
147670792|NCT00042289|532620151|FG031|Overall Study|Site closed|3|||
147670793|NCT00042289|532620152|FG032|Overall Study|Site closed|0|||
147670794|NCT00042289|532620153|FG033|Overall Study|Site closed|0|||
147670795|NCT00042289|532620154|FG034|Overall Study|Site closed|0|||
147670796|NCT00042289|532620155|FG035|Overall Study|Site closed|0|||
147670797|NCT00042289|532620156|FG036|Overall Study|Site closed|1|||
147670798|NCT00042289|532620157|FG037|Overall Study|Site closed|0|||
147670799|NCT00042289|532620158|FG038|Overall Study|Site closed|0|||
147670800|NCT00042289|532620159|FG039|Overall Study|Site closed|0|||
147670801|NCT00042289|532620160|FG040|Overall Study|Site closed|0|||
147670802|NCT00042289|532620161|FG041|Overall Study|Site closed|0|||
147670803|NCT00042289|532620162|FG042|Overall Study|Site closed|1|||
147670804|NCT00042289|532620163|FG043|Overall Study|Site closed|0|||
147670805|NCT00042289|532620164|FG044|Overall Study|Site closed|0|||
147670806|NCT00042289|532620165|FG045|Overall Study|Site closed|0|||
147670807|NCT00042289|532620166|FG046|Overall Study|Site closed|0|||
147670808|NCT00042289|532620120|FG000|Overall Study|Participant not willing to adhere to requirements|0|||
147670809|NCT00042289|532620121|FG001|Overall Study|Participant not willing to adhere to requirements|0|||
147670810|NCT00042289|532620122|FG002|Overall Study|Participant not willing to adhere to requirements|0|||
147670811|NCT00042289|532620123|FG003|Overall Study|Participant not willing to adhere to requirements|3|||
147670812|NCT00042289|532620124|FG004|Overall Study|Participant not willing to adhere to requirements|0|||
147670813|NCT00042289|532620125|FG005|Overall Study|Participant not willing to adhere to requirements|0|||
147670814|NCT00042289|532620126|FG006|Overall Study|Participant not willing to adhere to requirements|0|||
147670815|NCT00042289|532620127|FG007|Overall Study|Participant not willing to adhere to requirements|0|||
147670816|NCT00042289|532620128|FG008|Overall Study|Participant not willing to adhere to requirements|0|||
147670817|NCT00042289|532620129|FG009|Overall Study|Participant not willing to adhere to requirements|0|||
147670818|NCT00042289|532620130|FG010|Overall Study|Participant not willing to adhere to requirements|0|||
147670819|NCT00042289|532620131|FG011|Overall Study|Participant not willing to adhere to requirements|0|||
147670820|NCT00042289|532620132|FG012|Overall Study|Participant not willing to adhere to requirements|0|||
147670821|NCT00042289|532620133|FG013|Overall Study|Participant not willing to adhere to requirements|0|||
147670822|NCT00042289|532620134|FG014|Overall Study|Participant not willing to adhere to requirements|0|||
147670823|NCT00042289|532620135|FG015|Overall Study|Participant not willing to adhere to requirements|0|||
147670824|NCT00042289|532620136|FG016|Overall Study|Participant not willing to adhere to requirements|0|||
147670825|NCT00042289|532620137|FG017|Overall Study|Participant not willing to adhere to requirements|0|||
147670826|NCT00042289|532620138|FG018|Overall Study|Participant not willing to adhere to requirements|4|||
147670827|NCT00042289|532620139|FG019|Overall Study|Participant not willing to adhere to requirements|2|||
147670828|NCT00042289|532620140|FG020|Overall Study|Participant not willing to adhere to requirements|0|||
147670829|NCT00042289|532620141|FG021|Overall Study|Participant not willing to adhere to requirements|2|||
147670830|NCT00042289|532620142|FG022|Overall Study|Participant not willing to adhere to requirements|1|||
147670831|NCT00042289|532620143|FG023|Overall Study|Participant not willing to adhere to requirements|1|||
147670832|NCT00042289|532620144|FG024|Overall Study|Participant not willing to adhere to requirements|0|||
147670833|NCT00042289|532620145|FG025|Overall Study|Participant not willing to adhere to requirements|1|||
147670834|NCT00042289|532620146|FG026|Overall Study|Participant not willing to adhere to requirements|2|||
147670835|NCT00042289|532620147|FG027|Overall Study|Participant not willing to adhere to requirements|0|||
147670836|NCT00042289|532620148|FG028|Overall Study|Participant not willing to adhere to requirements|1|||
147670837|NCT00042289|532620149|FG029|Overall Study|Participant not willing to adhere to requirements|0|||
147670838|NCT00042289|532620150|FG030|Overall Study|Participant not willing to adhere to requirements|0|||
147670839|NCT00042289|532620151|FG031|Overall Study|Participant not willing to adhere to requirements|1|||
147670840|NCT00042289|532620152|FG032|Overall Study|Participant not willing to adhere to requirements|1|||
147670841|NCT00042289|532620153|FG033|Overall Study|Participant not willing to adhere to requirements|3|||
147670842|NCT00042289|532620154|FG034|Overall Study|Participant not willing to adhere to requirements|1|||
147670843|NCT00042289|532620155|FG035|Overall Study|Participant not willing to adhere to requirements|1|||
147670844|NCT00042289|532620156|FG036|Overall Study|Participant not willing to adhere to requirements|2|||
147670845|NCT00042289|532620157|FG037|Overall Study|Participant not willing to adhere to requirements|0|||
147670846|NCT00042289|532620158|FG038|Overall Study|Participant not willing to adhere to requirements|2|||
147670847|NCT00042289|532620159|FG039|Overall Study|Participant not willing to adhere to requirements|0|||
147670848|NCT00042289|532620160|FG040|Overall Study|Participant not willing to adhere to requirements|0|||
147670849|NCT00042289|532620161|FG041|Overall Study|Participant not willing to adhere to requirements|0|||
147670850|NCT00042289|532620162|FG042|Overall Study|Participant not willing to adhere to requirements|2|||
147670851|NCT00042289|532620163|FG043|Overall Study|Participant not willing to adhere to requirements|1|||
147670852|NCT00042289|532620164|FG044|Overall Study|Participant not willing to adhere to requirements|0|||
147670853|NCT00042289|532620165|FG045|Overall Study|Participant not willing to adhere to requirements|0|||
147670854|NCT00042289|532620166|FG046|Overall Study|Participant not willing to adhere to requirements|1|||
147670855|NCT00042289|532620120|FG000|Overall Study|Protocol Violation|0|||
147670856|NCT00042289|532620121|FG001|Overall Study|Protocol Violation|0|||
147670857|NCT00042289|532620122|FG002|Overall Study|Protocol Violation|0|||
147670858|NCT00042289|532620123|FG003|Overall Study|Protocol Violation|0|||
147670859|NCT00042289|532620124|FG004|Overall Study|Protocol Violation|0|||
147670860|NCT00042289|532620125|FG005|Overall Study|Protocol Violation|1|||
147670861|NCT00042289|532620126|FG006|Overall Study|Protocol Violation|0|||
147670862|NCT00042289|532620127|FG007|Overall Study|Protocol Violation|1|||
147670863|NCT00042289|532620128|FG008|Overall Study|Protocol Violation|0|||
147670864|NCT00042289|532620129|FG009|Overall Study|Protocol Violation|0|||
147670865|NCT00042289|532620130|FG010|Overall Study|Protocol Violation|0|||
147670866|NCT00042289|532620131|FG011|Overall Study|Protocol Violation|0|||
147670867|NCT00042289|532620132|FG012|Overall Study|Protocol Violation|0|||
147670868|NCT00042289|532620133|FG013|Overall Study|Protocol Violation|0|||
147670869|NCT00042289|532620134|FG014|Overall Study|Protocol Violation|0|||
147670870|NCT00042289|532620135|FG015|Overall Study|Protocol Violation|0|||
147670871|NCT00042289|532620136|FG016|Overall Study|Protocol Violation|0|||
147670872|NCT00042289|532620137|FG017|Overall Study|Protocol Violation|0|||
147670873|NCT00042289|532620138|FG018|Overall Study|Protocol Violation|0|||
147670874|NCT00042289|532620139|FG019|Overall Study|Protocol Violation|0|||
147670875|NCT00042289|532620140|FG020|Overall Study|Protocol Violation|0|||
147670876|NCT00042289|532620141|FG021|Overall Study|Protocol Violation|0|||
147670877|NCT00042289|532620142|FG022|Overall Study|Protocol Violation|0|||
147670878|NCT00042289|532620143|FG023|Overall Study|Protocol Violation|1|||
147670879|NCT00042289|532620144|FG024|Overall Study|Protocol Violation|1|||
147670880|NCT00042289|532620145|FG025|Overall Study|Protocol Violation|0|||
147670881|NCT00042289|532620146|FG026|Overall Study|Protocol Violation|2|||
147670882|NCT00042289|532620147|FG027|Overall Study|Protocol Violation|0|||
147670883|NCT00042289|532620148|FG028|Overall Study|Protocol Violation|0|||
147670884|NCT00042289|532620149|FG029|Overall Study|Protocol Violation|0|||
147670885|NCT00042289|532620150|FG030|Overall Study|Protocol Violation|1|||
147670886|NCT00042289|532620151|FG031|Overall Study|Protocol Violation|0|||
147670887|NCT00042289|532620152|FG032|Overall Study|Protocol Violation|0|||
147670888|NCT00042289|532620153|FG033|Overall Study|Protocol Violation|0|||
147670889|NCT00042289|532620154|FG034|Overall Study|Protocol Violation|0|||
147670890|NCT00042289|532620155|FG035|Overall Study|Protocol Violation|0|||
147670891|NCT00042289|532620156|FG036|Overall Study|Protocol Violation|0|||
147670892|NCT00042289|532620157|FG037|Overall Study|Protocol Violation|0|||
147670893|NCT00042289|532620158|FG038|Overall Study|Protocol Violation|0|||
147670894|NCT00042289|532620159|FG039|Overall Study|Protocol Violation|0|||
147670895|NCT00042289|532620160|FG040|Overall Study|Protocol Violation|0|||
147670896|NCT00042289|532620161|FG041|Overall Study|Protocol Violation|1|||
147670897|NCT00042289|532620162|FG042|Overall Study|Protocol Violation|1|||
147670898|NCT00042289|532620163|FG043|Overall Study|Protocol Violation|1|||
147511175|NCT02712008|532025923|FG006|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
147511176|NCT02712008|532025924|FG007|Baseline (Day 1) up to Week 12|Lost to Follow-up|0|||
147670899|NCT00042289|532620164|FG044|Overall Study|Protocol Violation|0|||
147670900|NCT00042289|532620165|FG045|Overall Study|Protocol Violation|0|||
147670901|NCT00042289|532620166|FG046|Overall Study|Protocol Violation|0|||
147670902|NCT00042289|532620120|FG000|Overall Study|Withdrawal by Subject|4|||
147511177|NCT02712008|532025917|FG000|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
147511178|NCT02712008|532025918|FG001|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
147511179|NCT02712008|532025919|FG002|Baseline (Day 1) up to Week 12|Protocol Violation|1|||
147670903|NCT00042289|532620121|FG001|Overall Study|Withdrawal by Subject|1|||
147670904|NCT00042289|532620122|FG002|Overall Study|Withdrawal by Subject|0|||
147670905|NCT00042289|532620123|FG003|Overall Study|Withdrawal by Subject|2|||
147670906|NCT00042289|532620124|FG004|Overall Study|Withdrawal by Subject|0|||
147670907|NCT00042289|532620125|FG005|Overall Study|Withdrawal by Subject|2|||
147670908|NCT00042289|532620126|FG006|Overall Study|Withdrawal by Subject|0|||
147670909|NCT00042289|532620127|FG007|Overall Study|Withdrawal by Subject|0|||
147670910|NCT00042289|532620128|FG008|Overall Study|Withdrawal by Subject|0|||
147670911|NCT00042289|532620129|FG009|Overall Study|Withdrawal by Subject|1|||
147670912|NCT00042289|532620130|FG010|Overall Study|Withdrawal by Subject|0|||
147670913|NCT00042289|532620131|FG011|Overall Study|Withdrawal by Subject|0|||
147670914|NCT00042289|532620132|FG012|Overall Study|Withdrawal by Subject|2|||
147670915|NCT00042289|532620133|FG013|Overall Study|Withdrawal by Subject|0|||
147670916|NCT00042289|532620134|FG014|Overall Study|Withdrawal by Subject|0|||
147670917|NCT00042289|532620135|FG015|Overall Study|Withdrawal by Subject|0|||
147670918|NCT00042289|532620136|FG016|Overall Study|Withdrawal by Subject|0|||
147670919|NCT00042289|532620137|FG017|Overall Study|Withdrawal by Subject|0|||
147670920|NCT00042289|532620138|FG018|Overall Study|Withdrawal by Subject|0|||
147670921|NCT00042289|532620139|FG019|Overall Study|Withdrawal by Subject|0|||
147670922|NCT00042289|532620140|FG020|Overall Study|Withdrawal by Subject|0|||
147670923|NCT00042289|532620141|FG021|Overall Study|Withdrawal by Subject|1|||
147670924|NCT00042289|532620142|FG022|Overall Study|Withdrawal by Subject|1|||
147670925|NCT00042289|532620143|FG023|Overall Study|Withdrawal by Subject|1|||
147670926|NCT00042289|532620144|FG024|Overall Study|Withdrawal by Subject|0|||
147670927|NCT00042289|532620145|FG025|Overall Study|Withdrawal by Subject|0|||
147670928|NCT00042289|532620146|FG026|Overall Study|Withdrawal by Subject|1|||
147670929|NCT00042289|532620147|FG027|Overall Study|Withdrawal by Subject|0|||
147670930|NCT00042289|532620148|FG028|Overall Study|Withdrawal by Subject|2|||
147670931|NCT00042289|532620149|FG029|Overall Study|Withdrawal by Subject|0|||
147670932|NCT00042289|532620150|FG030|Overall Study|Withdrawal by Subject|0|||
147670933|NCT00042289|532620151|FG031|Overall Study|Withdrawal by Subject|1|||
147670934|NCT00042289|532620152|FG032|Overall Study|Withdrawal by Subject|2|||
147670935|NCT00042289|532620153|FG033|Overall Study|Withdrawal by Subject|1|||
147670936|NCT00042289|532620154|FG034|Overall Study|Withdrawal by Subject|0|||
147670937|NCT00042289|532620155|FG035|Overall Study|Withdrawal by Subject|0|||
147670938|NCT00042289|532620156|FG036|Overall Study|Withdrawal by Subject|0|||
147670939|NCT00042289|532620157|FG037|Overall Study|Withdrawal by Subject|1|||
147670940|NCT00042289|532620158|FG038|Overall Study|Withdrawal by Subject|0|||
147670941|NCT00042289|532620159|FG039|Overall Study|Withdrawal by Subject|0|||
147670942|NCT00042289|532620160|FG040|Overall Study|Withdrawal by Subject|0|||
147670943|NCT00042289|532620161|FG041|Overall Study|Withdrawal by Subject|0|||
147670944|NCT00042289|532620162|FG042|Overall Study|Withdrawal by Subject|1|||
147670945|NCT00042289|532620163|FG043|Overall Study|Withdrawal by Subject|0|||
147670946|NCT00042289|532620164|FG044|Overall Study|Withdrawal by Subject|0|||
147670947|NCT00042289|532620165|FG045|Overall Study|Withdrawal by Subject|0|||
147670948|NCT00042289|532620166|FG046|Overall Study|Withdrawal by Subject|0|||
147670949|NCT04588259|532620167|FG000|Run-in period|Run-in failure|0|||
147670950|NCT04588259|532620168|FG001|Run-in period|Run-in failure|23|||
147670951|NCT04588259|532620167|FG000|Run-in period|Withdrawn before randomisation|0|||
147670952|NCT04588259|532620168|FG001|Run-in period|Withdrawn before randomisation|8|||
147670953|NCT04588259|532620167|FG000|Treatment period|Withdrawal by Subject|6|||
147670954|NCT04588259|532620168|FG001|Treatment period|Withdrawal by Subject|6|||
147670955|NCT03973996|532620169|FG000|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
147670956|NCT03973996|532620170|FG001|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
147670957|NCT03973996|532620171|FG002|First Intervention (4 Weeks)|Withdrawal by Subject|1|||
147670958|NCT03973996|532620172|FG003|First Intervention (4 Weeks)|Withdrawal by Subject|3|||
147670959|NCT04916002|532620173|FG000|Overall Study|Adverse Event|0|||
147670960|NCT04916002|532620174|FG001|Overall Study|Adverse Event|1|||
147670961|NCT04916002|532620175|FG002|Overall Study|Adverse Event|0|||
147670962|NCT04916002|532620176|FG003|Overall Study|Adverse Event|1|||
147670963|NCT04916002|532620177|FG004|Overall Study|Adverse Event|0|||
147670964|NCT04916002|532620173|FG000|Overall Study|Withdrawal by Subject|3|||
147670965|NCT04916002|532620174|FG001|Overall Study|Withdrawal by Subject|1|||
147511180|NCT02712008|532025920|FG003|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
147670966|NCT04916002|532620175|FG002|Overall Study|Withdrawal by Subject|0|||
147670967|NCT04916002|532620176|FG003|Overall Study|Withdrawal by Subject|1|||
147670968|NCT04916002|532620177|FG004|Overall Study|Withdrawal by Subject|0|||
147670969|NCT04916002|532620173|FG000|Overall Study|Death|8|||
147511181|NCT02712008|532025921|FG004|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
147511182|NCT02712008|532025922|FG005|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
147511183|NCT02712008|532025923|FG006|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
147670970|NCT04916002|532620174|FG001|Overall Study|Death|7|||
147670971|NCT04916002|532620175|FG002|Overall Study|Death|4|||
147670972|NCT04916002|532620176|FG003|Overall Study|Death|9|||
147670973|NCT04916002|532620177|FG004|Overall Study|Death|0|||
147670974|NCT04916002|532620173|FG000|Overall Study|Study Terminated by Sponsor|11|||
147670975|NCT04916002|532620174|FG001|Overall Study|Study Terminated by Sponsor|10|||
147640100|NCT03408444|532501447|FG000|Overall Study|Withdrawal by Subject|0|||
147640101|NCT03408444|532501448|FG001|Overall Study|Withdrawal by Subject|2|||
147640102|NCT03408444|532501449|FG002|Overall Study|Withdrawal by Subject|3|||
147640103|NCT03408444|532501450|FG003|Overall Study|Withdrawal by Subject|0|||
147640104|NCT03408444|532501447|FG000|Overall Study|Lost to Follow-up|0|||
147640105|NCT03408444|532501448|FG001|Overall Study|Lost to Follow-up|0|||
147640106|NCT03408444|532501449|FG002|Overall Study|Lost to Follow-up|1|||
147640107|NCT03408444|532501450|FG003|Overall Study|Lost to Follow-up|0|||
147640108|NCT03408444|532501447|FG000|Overall Study|Adverse Event|0|||
147640109|NCT03408444|532501448|FG001|Overall Study|Adverse Event|0|||
147640110|NCT03408444|532501449|FG002|Overall Study|Adverse Event|0|||
147640111|NCT03408444|532501450|FG003|Overall Study|Adverse Event|1|||
147640112|NCT03408444|532501447|FG000|Overall Study|Lens Handling Difficulties|0|||
147640113|NCT03408444|532501448|FG001|Overall Study|Lens Handling Difficulties|0|||
147640114|NCT03408444|532501449|FG002|Overall Study|Lens Handling Difficulties|1|||
147640115|NCT03408444|532501450|FG003|Overall Study|Lens Handling Difficulties|0|||
147640116|NCT03408444|532501447|FG000|Overall Study|Subject Decided to Not Wear Contact Lenses|0|||
147640117|NCT03408444|532501448|FG001|Overall Study|Subject Decided to Not Wear Contact Lenses|0|||
147640118|NCT03408444|532501449|FG002|Overall Study|Subject Decided to Not Wear Contact Lenses|0|||
147640119|NCT03408444|532501450|FG003|Overall Study|Subject Decided to Not Wear Contact Lenses|3|||
147640120|NCT04984681|532501451|FG000|Overall Study|Lost to Follow-up|3|||
147640121|NCT04984681|532501452|FG001|Overall Study|Lost to Follow-up|1|||
147640122|NCT01214252|532501453|FG000|Overall Study|Not eligible per protocol|82|||
147640123|NCT01473394|532501454|FG000|Overall Study|Adverse Event|13|||
147640124|NCT01473394|532501455|FG001|Overall Study|Adverse Event|16|||
147640125|NCT01473394|532501454|FG000|Overall Study|Insufficient Therapeutic Response|4|||
147640126|NCT01473394|532501455|FG001|Overall Study|Insufficient Therapeutic Response|1|||
147640127|NCT01473394|532501454|FG000|Overall Study|Protocol Violation|7|||
147640128|NCT01473394|532501455|FG001|Overall Study|Protocol Violation|5|||
147640129|NCT01473394|532501454|FG000|Overall Study|Withdrew Consent|12|||
147640130|NCT01473394|532501455|FG001|Overall Study|Withdrew Consent|10|||
147640131|NCT01473394|532501454|FG000|Overall Study|Lost to Follow-up|9|||
147640132|NCT01473394|532501455|FG001|Overall Study|Lost to Follow-up|11|||
147640133|NCT03391232|532501456|FG000|Part B - Additional 2 Doses (13-38weeks)|Physician Decision|0|||
147640134|NCT03391232|532501457|FG001|Part B - Additional 2 Doses (13-38weeks)|Physician Decision|1|||
147640135|NCT03391232|532501456|FG000|Part B - Additional 2 Doses (13-38weeks)|Withdrawal by Subject|0|||
147640136|NCT03391232|532501457|FG001|Part B - Additional 2 Doses (13-38weeks)|Withdrawal by Subject|2|||
147640137|NCT00552032|532501458|FG000|Overall Study|Withdrawal by Subject|2|||
147640138|NCT00552032|532501459|FG001|Overall Study|Withdrawal by Subject|2|||
147640139|NCT00552032|532501458|FG000|Overall Study|Protocol Violation|7|||
147640140|NCT00552032|532501459|FG001|Overall Study|Protocol Violation|12|||
147640141|NCT00552032|532501458|FG000|Overall Study|Lost to Follow-up|8|||
147640142|NCT00552032|532501459|FG001|Overall Study|Lost to Follow-up|5|||
147640143|NCT04430738|532501460|FG000|Phase 1: Dose Escalation|Death|1|||
147640144|NCT04430738|532501461|FG001|Phase 1: Dose Escalation|Death|4|||
147640145|NCT04430738|532501462|FG002|Phase 1: Dose Escalation|Death|4|||
147640146|NCT04430738|532501463|FG003|Phase 1: Dose Escalation|Death|1|||
147640147|NCT04430738|532501464|FG004|Phase 1: Dose Escalation|Death|6|||
147640148|NCT04430738|532501465|FG005|Phase 1: Dose Escalation|Death|0|||
147640149|NCT04430738|532501460|FG000|Phase 1: Dose Escalation|Participation terminated by sponsor|0|||
147640150|NCT04430738|532501461|FG001|Phase 1: Dose Escalation|Participation terminated by sponsor|2|||
147640151|NCT04430738|532501462|FG002|Phase 1: Dose Escalation|Participation terminated by sponsor|3|||
147640152|NCT04430738|532501463|FG003|Phase 1: Dose Escalation|Participation terminated by sponsor|2|||
147640153|NCT04430738|532501464|FG004|Phase 1: Dose Escalation|Participation terminated by sponsor|2|||
147640154|NCT04430738|532501465|FG005|Phase 1: Dose Escalation|Participation terminated by sponsor|0|||
147640155|NCT04430738|532501460|FG000|Phase 1: Dose Escalation|Continuing to long term extension phase (LTEP)|0|||
147640156|NCT04430738|532501461|FG001|Phase 1: Dose Escalation|Continuing to long term extension phase (LTEP)|1|||
147640157|NCT04430738|532501462|FG002|Phase 1: Dose Escalation|Continuing to long term extension phase (LTEP)|0|||
147640158|NCT04430738|532501463|FG003|Phase 1: Dose Escalation|Continuing to long term extension phase (LTEP)|1|||
147640159|NCT04430738|532501464|FG004|Phase 1: Dose Escalation|Continuing to long term extension phase (LTEP)|0|||
147640160|NCT04430738|532501465|FG005|Phase 1: Dose Escalation|Continuing to long term extension phase (LTEP)|0|||
147640161|NCT04430738|532501460|FG000|Phase 1: Dose Escalation|Other|1|||
147640162|NCT04430738|532501461|FG001|Phase 1: Dose Escalation|Other|0|||
147640163|NCT04430738|532501462|FG002|Phase 1: Dose Escalation|Other|0|||
147640164|NCT04430738|532501463|FG003|Phase 1: Dose Escalation|Other|0|||
147640165|NCT04430738|532501464|FG004|Phase 1: Dose Escalation|Other|0|||
147640166|NCT04430738|532501465|FG005|Phase 1: Dose Escalation|Other|0|||
147640167|NCT04430738|532501460|FG000|Phase 1: Dose Expansion|Participation terminated by sponsor|0|||
147640168|NCT04430738|532501461|FG001|Phase 1: Dose Expansion|Participation terminated by sponsor|0|||
147640169|NCT04430738|532501462|FG002|Phase 1: Dose Expansion|Participation terminated by sponsor|0|||
147640170|NCT04430738|532501463|FG003|Phase 1: Dose Expansion|Participation terminated by sponsor|0|||
147640171|NCT04430738|532501464|FG004|Phase 1: Dose Expansion|Participation terminated by sponsor|0|||
147670976|NCT04916002|532620175|FG002|Overall Study|Study Terminated by Sponsor|8|||
147670977|NCT04916002|532620176|FG003|Overall Study|Study Terminated by Sponsor|5|||
147670978|NCT04916002|532620177|FG004|Overall Study|Study Terminated by Sponsor|4|||
147670979|NCT04916002|532620173|FG000|Overall Study|End of trial|1|||
147670980|NCT04916002|532620174|FG001|Overall Study|End of trial|0|||
147670981|NCT04916002|532620175|FG002|Overall Study|End of trial|0|||
147670982|NCT04916002|532620176|FG003|Overall Study|End of trial|0|||
147670983|NCT04916002|532620177|FG004|Overall Study|End of trial|0|||
147670984|NCT04916002|532620173|FG000|Overall Study|Progressive disease|0|||
147670985|NCT04916002|532620174|FG001|Overall Study|Progressive disease|0|||
147670986|NCT04916002|532620175|FG002|Overall Study|Progressive disease|1|||
147670987|NCT04916002|532620176|FG003|Overall Study|Progressive disease|0|||
147670988|NCT04916002|532620177|FG004|Overall Study|Progressive disease|0|||
147670989|NCT04916002|532620173|FG000|Overall Study|Participant non-compliance|2|||
147670990|NCT04916002|532620174|FG001|Overall Study|Participant non-compliance|0|||
147670991|NCT04916002|532620175|FG002|Overall Study|Participant non-compliance|0|||
147670992|NCT04916002|532620176|FG003|Overall Study|Participant non-compliance|0|||
147670993|NCT04916002|532620177|FG004|Overall Study|Participant non-compliance|0|||
147670994|NCT04832971|532620178|FG000|Double-Blind (DB) Treatment Period|Death|1|||
147670995|NCT04832971|532620179|FG001|Double-Blind (DB) Treatment Period|Death|0|||
147670996|NCT04832971|532620180|FG002|Double-Blind (DB) Treatment Period|Death|0|||
147670997|NCT04832971|532620181|FG003|Double-Blind (DB) Treatment Period|Death|0|||
147670998|NCT04832971|532620182|FG004|Double-Blind (DB) Treatment Period|Death|0|||
147670999|NCT04832971|532620183|FG005|Double-Blind (DB) Treatment Period|Death|0|||
147671000|NCT04832971|532620184|FG006|Double-Blind (DB) Treatment Period|Death|0|||
147671001|NCT04832971|532620185|FG007|Double-Blind (DB) Treatment Period|Death|0|||
147671002|NCT04832971|532620186|FG008|Double-Blind (DB) Treatment Period|Death|0|||
147671003|NCT04832971|532620187|FG009|Double-Blind (DB) Treatment Period|Death|0|||
147671004|NCT04832971|532620178|FG000|Double-Blind (DB) Treatment Period|Lost to Follow-up|1|||
147671005|NCT04832971|532620179|FG001|Double-Blind (DB) Treatment Period|Lost to Follow-up|1|||
147671006|NCT04832971|532620180|FG002|Double-Blind (DB) Treatment Period|Lost to Follow-up|1|||
147671007|NCT04832971|532620181|FG003|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
147671008|NCT04832971|532620182|FG004|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
147671009|NCT04832971|532620183|FG005|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
147671010|NCT04832971|532620184|FG006|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
147671011|NCT04832971|532620185|FG007|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
147671012|NCT04832971|532620186|FG008|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
147671013|NCT04832971|532620187|FG009|Double-Blind (DB) Treatment Period|Lost to Follow-up|0|||
147671014|NCT04832971|532620178|FG000|Double-Blind (DB) Treatment Period|Withdrawal by Subject|1|||
147671015|NCT04832971|532620179|FG001|Double-Blind (DB) Treatment Period|Withdrawal by Subject|3|||
147671016|NCT04832971|532620180|FG002|Double-Blind (DB) Treatment Period|Withdrawal by Subject|3|||
147671017|NCT04832971|532620181|FG003|Double-Blind (DB) Treatment Period|Withdrawal by Subject|1|||
147671018|NCT04832971|532620182|FG004|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
147671019|NCT04832971|532620183|FG005|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
147671020|NCT04832971|532620184|FG006|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
147671021|NCT04832971|532620185|FG007|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
147671022|NCT04832971|532620186|FG008|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
147671023|NCT04832971|532620187|FG009|Double-Blind (DB) Treatment Period|Withdrawal by Subject|0|||
147671024|NCT04832971|532620178|FG000|Double-Blind (DB) Treatment Period|Other, Not Specified|0|||
147671025|NCT04832971|532620179|FG001|Double-Blind (DB) Treatment Period|Other, Not Specified|1|||
147671026|NCT04832971|532620180|FG002|Double-Blind (DB) Treatment Period|Other, Not Specified|0|||
147671027|NCT04832971|532620181|FG003|Double-Blind (DB) Treatment Period|Other, Not Specified|0|||
147671028|NCT04832971|532620182|FG004|Double-Blind (DB) Treatment Period|Other, Not Specified|0|||
147671029|NCT04832971|532620183|FG005|Double-Blind (DB) Treatment Period|Other, Not Specified|0|||
147671030|NCT04832971|532620184|FG006|Double-Blind (DB) Treatment Period|Other, Not Specified|0|||
147671031|NCT04832971|532620185|FG007|Double-Blind (DB) Treatment Period|Other, Not Specified|0|||
147671032|NCT04832971|532620186|FG008|Double-Blind (DB) Treatment Period|Other, Not Specified|0|||
147671033|NCT04832971|532620187|FG009|Double-Blind (DB) Treatment Period|Other, Not Specified|0|||
147671034|NCT04832971|532620178|FG000|Open-Label Extension (OLE) Period|Adverse Event|0|||
147511184|NCT02712008|532025924|FG007|Baseline (Day 1) up to Week 12|Protocol Violation|0|||
147511185|NCT02712008|532025917|FG000|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
147511186|NCT02712008|532025918|FG001|Baseline (Day 1) up to Week 12|Other Unspecified|1|||
147511187|NCT02712008|532025919|FG002|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
147511188|NCT02712008|532025920|FG003|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
147511189|NCT02712008|532025921|FG004|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
147671035|NCT04832971|532620179|FG001|Open-Label Extension (OLE) Period|Adverse Event|0|||
147671036|NCT04832971|532620180|FG002|Open-Label Extension (OLE) Period|Adverse Event|0|||
147671037|NCT04832971|532620181|FG003|Open-Label Extension (OLE) Period|Adverse Event|0|||
147671038|NCT04832971|532620182|FG004|Open-Label Extension (OLE) Period|Adverse Event|0|||
147671039|NCT04832971|532620183|FG005|Open-Label Extension (OLE) Period|Adverse Event|0|||
147671040|NCT04832971|532620184|FG006|Open-Label Extension (OLE) Period|Adverse Event|2|||
147671041|NCT04832971|532620185|FG007|Open-Label Extension (OLE) Period|Adverse Event|1|||
147671042|NCT04832971|532620186|FG008|Open-Label Extension (OLE) Period|Adverse Event|1|||
147671043|NCT04832971|532620187|FG009|Open-Label Extension (OLE) Period|Adverse Event|1|||
147671044|NCT04832971|532620178|FG000|Open-Label Extension (OLE) Period|Death|0|||
147671045|NCT04832971|532620179|FG001|Open-Label Extension (OLE) Period|Death|0|||
147671046|NCT04832971|532620180|FG002|Open-Label Extension (OLE) Period|Death|0|||
147671047|NCT04832971|532620181|FG003|Open-Label Extension (OLE) Period|Death|0|||
147671048|NCT04832971|532620182|FG004|Open-Label Extension (OLE) Period|Death|0|||
147671049|NCT04832971|532620183|FG005|Open-Label Extension (OLE) Period|Death|0|||
147671050|NCT04832971|532620184|FG006|Open-Label Extension (OLE) Period|Death|0|||
147671051|NCT04832971|532620185|FG007|Open-Label Extension (OLE) Period|Death|1|||
147671052|NCT04832971|532620186|FG008|Open-Label Extension (OLE) Period|Death|0|||
147671053|NCT04832971|532620187|FG009|Open-Label Extension (OLE) Period|Death|0|||
147671054|NCT04832971|532620178|FG000|Open-Label Extension (OLE) Period|Lost to Follow-up|0|||
147671055|NCT04832971|532620179|FG001|Open-Label Extension (OLE) Period|Lost to Follow-up|0|||
147671056|NCT04832971|532620180|FG002|Open-Label Extension (OLE) Period|Lost to Follow-up|0|||
147671057|NCT04832971|532620181|FG003|Open-Label Extension (OLE) Period|Lost to Follow-up|0|||
147671058|NCT04832971|532620182|FG004|Open-Label Extension (OLE) Period|Lost to Follow-up|0|||
147671059|NCT04832971|532620183|FG005|Open-Label Extension (OLE) Period|Lost to Follow-up|0|||
147671060|NCT04832971|532620184|FG006|Open-Label Extension (OLE) Period|Lost to Follow-up|1|||
147671061|NCT04832971|532620185|FG007|Open-Label Extension (OLE) Period|Lost to Follow-up|1|||
147671062|NCT04832971|532620186|FG008|Open-Label Extension (OLE) Period|Lost to Follow-up|0|||
147671063|NCT04832971|532620187|FG009|Open-Label Extension (OLE) Period|Lost to Follow-up|0|||
147671064|NCT04832971|532620178|FG000|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|0|||
147671065|NCT04832971|532620179|FG001|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|0|||
147671066|NCT04832971|532620180|FG002|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|0|||
147671067|NCT04832971|532620181|FG003|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|0|||
147671068|NCT04832971|532620182|FG004|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|7|||
147671069|NCT04832971|532620183|FG005|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|18|||
147671070|NCT04832971|532620184|FG006|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|7|||
147671071|NCT04832971|532620185|FG007|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|19|||
147671072|NCT04832971|532620186|FG008|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|4|||
147511190|NCT02712008|532025922|FG005|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
147511191|NCT02712008|532025923|FG006|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
147511192|NCT02712008|532025924|FG007|Baseline (Day 1) up to Week 12|Other Unspecified|0|||
147511193|NCT02712008|532025917|FG000|From Week 12 up to Week 36|Adverse Event|0|||
147511194|NCT02712008|532025918|FG001|From Week 12 up to Week 36|Adverse Event|0|||
147511195|NCT02712008|532025919|FG002|From Week 12 up to Week 36|Adverse Event|0|||
147511196|NCT02712008|532025920|FG003|From Week 12 up to Week 36|Adverse Event|0|||
147511197|NCT02712008|532025921|FG004|From Week 12 up to Week 36|Adverse Event|1|||
147511198|NCT02712008|532025922|FG005|From Week 12 up to Week 36|Adverse Event|0|||
147511199|NCT02712008|532025923|FG006|From Week 12 up to Week 36|Adverse Event|0|||
147511200|NCT02712008|532025924|FG007|From Week 12 up to Week 36|Adverse Event|2|||
147511201|NCT02712008|532025917|FG000|From Week 12 up to Week 36|Death|1|||
147511202|NCT02712008|532025918|FG001|From Week 12 up to Week 36|Death|0|||
147511203|NCT02712008|532025919|FG002|From Week 12 up to Week 36|Death|0|||
147511204|NCT02712008|532025920|FG003|From Week 12 up to Week 36|Death|0|||
147511205|NCT02712008|532025921|FG004|From Week 12 up to Week 36|Death|0|||
147511206|NCT02712008|532025922|FG005|From Week 12 up to Week 36|Death|0|||
147511207|NCT02712008|532025923|FG006|From Week 12 up to Week 36|Death|1|||
147511208|NCT02712008|532025924|FG007|From Week 12 up to Week 36|Death|0|||
147511209|NCT02712008|532025917|FG000|From Week 12 up to Week 36|Lost to Follow-up|0|||
147511210|NCT02712008|532025918|FG001|From Week 12 up to Week 36|Lost to Follow-up|0|||
147511211|NCT02712008|532025919|FG002|From Week 12 up to Week 36|Lost to Follow-up|0|||
147511212|NCT02712008|532025920|FG003|From Week 12 up to Week 36|Lost to Follow-up|1|||
147511213|NCT02712008|532025921|FG004|From Week 12 up to Week 36|Lost to Follow-up|0|||
147511214|NCT02712008|532025922|FG005|From Week 12 up to Week 36|Lost to Follow-up|0|||
147511215|NCT02712008|532025923|FG006|From Week 12 up to Week 36|Lost to Follow-up|1|||
147511216|NCT02712008|532025924|FG007|From Week 12 up to Week 36|Lost to Follow-up|0|||
147511217|NCT02712008|532025917|FG000|From Week 12 up to Week 36|Physician Decision|0|||
147511218|NCT02712008|532025918|FG001|From Week 12 up to Week 36|Physician Decision|0|||
147511219|NCT02712008|532025919|FG002|From Week 12 up to Week 36|Physician Decision|0|||
147511220|NCT02712008|532025920|FG003|From Week 12 up to Week 36|Physician Decision|1|||
147511221|NCT02712008|532025921|FG004|From Week 12 up to Week 36|Physician Decision|1|||
147511222|NCT02712008|532025922|FG005|From Week 12 up to Week 36|Physician Decision|0|||
147511223|NCT02712008|532025923|FG006|From Week 12 up to Week 36|Physician Decision|0|||
147511224|NCT02712008|532025924|FG007|From Week 12 up to Week 36|Physician Decision|0|||
147511225|NCT02712008|532025917|FG000|From Week 12 up to Week 36|Withdrawal by Subject|0|||
147511226|NCT02712008|532025918|FG001|From Week 12 up to Week 36|Withdrawal by Subject|0|||
147511227|NCT02712008|532025919|FG002|From Week 12 up to Week 36|Withdrawal by Subject|0|||
147511228|NCT02712008|532025920|FG003|From Week 12 up to Week 36|Withdrawal by Subject|0|||
147511229|NCT02712008|532025921|FG004|From Week 12 up to Week 36|Withdrawal by Subject|0|||
147511230|NCT02712008|532025922|FG005|From Week 12 up to Week 36|Withdrawal by Subject|0|||
147511231|NCT02712008|532025923|FG006|From Week 12 up to Week 36|Withdrawal by Subject|3|||
147511232|NCT02712008|532025924|FG007|From Week 12 up to Week 36|Withdrawal by Subject|2|||
147511233|NCT01731990|532025925|FG000|Overall Study|Adverse Event|1|||
147511234|NCT01731990|532025926|FG001|Overall Study|Adverse Event|5|||
147511235|NCT01731990|532025925|FG000|Overall Study|Withdrawal by Subject|1|||
147511236|NCT01731990|532025926|FG001|Overall Study|Withdrawal by Subject|1|||
147511237|NCT01731990|532025925|FG000|Overall Study|Protocol deviation|1|||
147511238|NCT01731990|532025926|FG001|Overall Study|Protocol deviation|2|||
147511239|NCT01731990|532025925|FG000|Overall Study|Death|1|||
147511240|NCT01731990|532025926|FG001|Overall Study|Death|0|||
147511241|NCT02177786|532025931|FG000|Overall Study|Withdrew Consent|2|||
147511242|NCT02177786|532025932|FG001|Overall Study|Withdrew Consent|6|||
147511243|NCT02177786|532025933|FG002|Overall Study|Withdrew Consent|9|||
147511244|NCT02177786|532025934|FG003|Overall Study|Withdrew Consent|5|||
147511245|NCT02177786|532025931|FG000|Overall Study|Progression to End Stage Renal Disease|2|||
147511246|NCT02177786|532025932|FG001|Overall Study|Progression to End Stage Renal Disease|3|||
147511247|NCT02177786|532025933|FG002|Overall Study|Progression to End Stage Renal Disease|2|||
147511248|NCT02177786|532025934|FG003|Overall Study|Progression to End Stage Renal Disease|1|||
147511249|NCT02177786|532025931|FG000|Overall Study|Adverse Event|1|||
147511250|NCT02177786|532025932|FG001|Overall Study|Adverse Event|1|||
147511251|NCT02177786|532025933|FG002|Overall Study|Adverse Event|2|||
147511252|NCT02177786|532025934|FG003|Overall Study|Adverse Event|3|||
147511253|NCT02177786|532025931|FG000|Overall Study|Death|1|||
147511254|NCT02177786|532025932|FG001|Overall Study|Death|1|||
147511255|NCT02177786|532025933|FG002|Overall Study|Death|1|||
147511256|NCT02177786|532025934|FG003|Overall Study|Death|1|||
147511257|NCT02177786|532025931|FG000|Overall Study|Lost to Follow-up|0|||
147511258|NCT02177786|532025932|FG001|Overall Study|Lost to Follow-up|0|||
147511259|NCT02177786|532025933|FG002|Overall Study|Lost to Follow-up|2|||
147511260|NCT02177786|532025934|FG003|Overall Study|Lost to Follow-up|2|||
147511261|NCT02177786|532025931|FG000|Overall Study|Non-Compliance with Study Drug|0|||
147671073|NCT04832971|532620187|FG009|Open-Label Extension (OLE) Period|Study Terminated by Sponsor|19|||
147671074|NCT04832971|532620178|FG000|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
147671075|NCT04832971|532620179|FG001|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
147671076|NCT04832971|532620180|FG002|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
147671077|NCT04832971|532620181|FG003|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
147671078|NCT04832971|532620182|FG004|Open-Label Extension (OLE) Period|Withdrawal by Subject|1|||
147671079|NCT04832971|532620183|FG005|Open-Label Extension (OLE) Period|Withdrawal by Subject|1|||
147671080|NCT04832971|532620184|FG006|Open-Label Extension (OLE) Period|Withdrawal by Subject|0|||
147671081|NCT04832971|532620185|FG007|Open-Label Extension (OLE) Period|Withdrawal by Subject|2|||
147671082|NCT04832971|532620186|FG008|Open-Label Extension (OLE) Period|Withdrawal by Subject|2|||
147671083|NCT04832971|532620187|FG009|Open-Label Extension (OLE) Period|Withdrawal by Subject|3|||
147671084|NCT04832971|532620178|FG000|Open-Label Extension (OLE) Period|Other, Not Specified|0|||
147671085|NCT04832971|532620179|FG001|Open-Label Extension (OLE) Period|Other, Not Specified|0|||
147671086|NCT04832971|532620180|FG002|Open-Label Extension (OLE) Period|Other, Not Specified|0|||
147671087|NCT04832971|532620181|FG003|Open-Label Extension (OLE) Period|Other, Not Specified|0|||
147671088|NCT04832971|532620182|FG004|Open-Label Extension (OLE) Period|Other, Not Specified|0|||
147671089|NCT04832971|532620183|FG005|Open-Label Extension (OLE) Period|Other, Not Specified|0|||
147671090|NCT04832971|532620184|FG006|Open-Label Extension (OLE) Period|Other, Not Specified|1|||
147671091|NCT04832971|532620185|FG007|Open-Label Extension (OLE) Period|Other, Not Specified|1|||
147671092|NCT04832971|532620186|FG008|Open-Label Extension (OLE) Period|Other, Not Specified|0|||
147671093|NCT04832971|532620187|FG009|Open-Label Extension (OLE) Period|Other, Not Specified|1|||
147671094|NCT04460885|532620188|FG000|Overall Study|Withdrawal by Subject|6|||
147671095|NCT04460885|532620189|FG001|Overall Study|Withdrawal by Subject|8|||
147671096|NCT04460885|532620188|FG000|Overall Study|Site closure|1|||
147671097|NCT04460885|532620189|FG001|Overall Study|Site closure|0|||
147671098|NCT04460885|532620188|FG000|Overall Study|Death|5|||
147511262|NCT02177786|532025932|FG001|Overall Study|Non-Compliance with Study Drug|1|||
147511263|NCT02177786|532025933|FG002|Overall Study|Non-Compliance with Study Drug|0|||
147511264|NCT02177786|532025934|FG003|Overall Study|Non-Compliance with Study Drug|1|||
147511265|NCT02177786|532025931|FG000|Overall Study|Protocol Violation|0|||
147671099|NCT04460885|532620189|FG001|Overall Study|Death|4|||
147511266|NCT02177786|532025932|FG001|Overall Study|Protocol Violation|0|||
147511267|NCT02177786|532025933|FG002|Overall Study|Protocol Violation|2|||
147511268|NCT02177786|532025934|FG003|Overall Study|Protocol Violation|0|||
147511269|NCT02177786|532025931|FG000|Overall Study|Progressive Disease|0|||
147511270|NCT02177786|532025932|FG001|Overall Study|Progressive Disease|1|||
147511271|NCT02177786|532025933|FG002|Overall Study|Progressive Disease|0|||
147511272|NCT02177786|532025934|FG003|Overall Study|Progressive Disease|0|||
147511273|NCT02177786|532025931|FG000|Overall Study|Missing study completion status|0|||
147511274|NCT02177786|532025932|FG001|Overall Study|Missing study completion status|1|||
147511275|NCT02177786|532025933|FG002|Overall Study|Missing study completion status|0|||
147511276|NCT02177786|532025934|FG003|Overall Study|Missing study completion status|0|||
147511277|NCT01305941|532025935|FG000|Overall Study|Adverse Event|6|||
147511278|NCT01305941|532025935|FG000|Overall Study|Clinical decline|2|||
147511279|NCT01305941|532025935|FG000|Overall Study|Withdrawal by Subject|1|||
147511280|NCT01305941|532025935|FG000|Overall Study|Death|1|||
147511281|NCT03950440|532025936|FG000|Overall Study|Death|8|||
147511282|NCT03950440|532025937|FG001|Overall Study|Death|2|||
147511283|NCT03950440|532025938|FG002|Overall Study|Death|1|||
147511284|NCT02892734|532025939|FG000|Treatment on Study|Progressive Disease|2|||
147511285|NCT02892734|532025939|FG000|Follow up for 2 Years|Death|2|||
147511286|NCT02892734|532025939|FG000|Follow up for 2 Years|Study closed early|1|||
147511287|NCT02043509|532025940|FG000|Baseline to 1st Follow-up|Lost to Follow-up|61|||
147511288|NCT02043509|532025941|FG001|Baseline to 1st Follow-up|Lost to Follow-up|47|||
147511289|NCT02043509|532025940|FG000|Baseline to 1st Follow-up|Withdrawal by Subject|4|||
147511290|NCT02043509|532025941|FG001|Baseline to 1st Follow-up|Withdrawal by Subject|0|||
147511291|NCT02043509|532025940|FG000|Baseline to 2nd Follow-up|Lost to Follow-up|67|||
147511292|NCT02043509|532025941|FG001|Baseline to 2nd Follow-up|Lost to Follow-up|67|||
147511293|NCT02043509|532025940|FG000|Baseline to 2nd Follow-up|Withdrawal by Subject|7|||
147511294|NCT02043509|532025941|FG001|Baseline to 2nd Follow-up|Withdrawal by Subject|5|||
147511295|NCT00608244|532025946|FG000|Overall Study|Adverse Event|1|||
147511296|NCT00608244|532025946|FG000|Overall Study|Low trough levels|1|||
147511297|NCT01957215|532025951|FG000|Overall Study|Adverse Event|2|||
147511298|NCT01957215|532025952|FG001|Overall Study|Adverse Event|2|||
147511299|NCT01957215|532025951|FG000|Overall Study|Lost to Follow-up|3|||
147511300|NCT01957215|532025952|FG001|Overall Study|Lost to Follow-up|3|||
147511301|NCT01957215|532025951|FG000|Overall Study|Protocol Violation|1|||
147511302|NCT01957215|532025952|FG001|Overall Study|Protocol Violation|2|||
147511303|NCT01957215|532025951|FG000|Overall Study|Withdrawal by Subject|7|||
147511304|NCT01957215|532025952|FG001|Overall Study|Withdrawal by Subject|5|||
147511305|NCT03597503|532025960|FG000|Overall Study|Withdrawal by Subject|0|||
147511306|NCT03597503|532025961|FG001|Overall Study|Withdrawal by Subject|2|||
147511307|NCT03597503|532025960|FG000|Overall Study|Lost to Follow-up|1|||
147511308|NCT03597503|532025961|FG001|Overall Study|Lost to Follow-up|2|||
147511309|NCT03597503|532025960|FG000|Overall Study|Protocol Violation|1|||
147511310|NCT03597503|532025961|FG001|Overall Study|Protocol Violation|0|||
147511311|NCT00688623|532025966|FG000|Overall Study|Adverse Event|22|||
147511312|NCT00688623|532025966|FG000|Overall Study|abnormal lab value|1|||
147511313|NCT00688623|532025966|FG000|Overall Study|Withdrawal by Subject|4|||
147511314|NCT00688623|532025966|FG000|Overall Study|Death|3|||
147511315|NCT00688623|532025966|FG000|Overall Study|disease progression|23|||
147511316|NCT00688623|532025966|FG000|Overall Study|Protocol Violation|2|||
147511317|NCT02000219|532025967|FG000|14-Week Study Period|Physician Decision|1|||
147511318|NCT02000219|532025967|FG000|14-Week Study Period|Adverse Event|1|||
147511319|NCT02000219|532025967|FG000|14-Week Study Period|Underwent transplantation|1|||
147511320|NCT02000219|532025967|FG000|Continuation Period|Withdrawal by Subject|1|||
147511321|NCT02000219|532025967|FG000|Continuation Period|Had liver transplant|2|||
147511322|NCT02000219|532025967|FG000|Continuation Period|Non-compliance with study drug|2|||
147511323|NCT02667236|532025968|FG000|Overall Study|Adverse Event|1|||
147511324|NCT02667236|532025969|FG001|Overall Study|Adverse Event|1|||
147511325|NCT02667236|532025968|FG000|Overall Study|Withdrawal by Subject|2|||
147511326|NCT02667236|532025969|FG001|Overall Study|Withdrawal by Subject|0|||
147511327|NCT04402385|532025974|FG000|Overall Study|Withdrawal by Subject|4|||
147511328|NCT04402385|532025975|FG001|Overall Study|Withdrawal by Subject|4|||
147511329|NCT04402385|532025974|FG000|Overall Study|Lost to Follow-up|1|||
147511330|NCT04402385|532025975|FG001|Overall Study|Lost to Follow-up|1|||
147511331|NCT04402385|532025974|FG000|Overall Study|Physician Decision|0|||
147511332|NCT04402385|532025975|FG001|Overall Study|Physician Decision|1|||
147511333|NCT00608894|532025976|FG000|Overall Study|Withdrawal by Subject|0|||
147511334|NCT00608894|532025977|FG001|Overall Study|Withdrawal by Subject|2|||
147511335|NCT01518309|532025978|FG000|Overall Study|Adverse Event|6|||
147511336|NCT01518309|532025978|FG000|Overall Study|Death|6|||
147511337|NCT01518309|532025978|FG000|Overall Study|Lack of Efficacy|7|||
147511338|NCT01518309|532025978|FG000|Overall Study|Withdrawal by Subject|6|||
147511339|NCT01518309|532025978|FG000|Overall Study|Physician Decision|3|||
147511340|NCT01518309|532025978|FG000|Overall Study|Sponsor Decision|2|||
147511341|NCT01518309|532025978|FG000|Overall Study|Not in Predefined Categories|9|||
147511342|NCT00038142|532025979|FG000|Overall Study|Ineligible|1|||
147511343|NCT00038142|532025980|FG001|Overall Study|Ineligible|0|||
147511344|NCT00038142|532025979|FG000|Overall Study|Progressive Disease|11|||
147511345|NCT00038142|532025980|FG001|Overall Study|Progressive Disease|7|||
147511346|NCT00038142|532025979|FG000|Overall Study|Death|1|||
147511347|NCT00038142|532025980|FG001|Overall Study|Death|0|||
147511348|NCT00038142|532025979|FG000|Overall Study|Adverse Event|1|||
147511349|NCT00038142|532025980|FG001|Overall Study|Adverse Event|0|||
147511350|NCT00038142|532025979|FG000|Overall Study|Unknown Reason|8|||
147511351|NCT00038142|532025980|FG001|Overall Study|Unknown Reason|0|||
147511352|NCT00364832|532025981|FG000|Core Period|Early Withdrawals|2|||
147511353|NCT00364832|532025982|FG001|Core Period|Early Withdrawals|2|||
147511354|NCT00364832|532025983|FG002|Core Period|Early Withdrawals|1|||
147511355|NCT00364832|532025984|FG003|Core Period|Early Withdrawals|1|||
147511356|NCT00364832|532025985|FG004|Core Period|Early Withdrawals|0|||
147511357|NCT00364832|532025986|FG005|Core Period|Early Withdrawals|0|||
147511358|NCT00364832|532025987|FG006|Core Period|Early Withdrawals|4|||
147511359|NCT00364832|532025988|FG007|Core Period|Early Withdrawals|1|||
147511360|NCT00364832|532025989|FG008|Core Period|Early Withdrawals|0|||
147511361|NCT00364832|532025990|FG009|Core Period|Early Withdrawals|0|||
147511362|NCT00364832|532025991|FG010|Core Period|Early Withdrawals|0|||
147511363|NCT00364832|532025992|FG011|Core Period|Early Withdrawals|0|||
147511364|NCT00364832|532025981|FG000|Extension Year 1|Early Withdrawals|0|||
147511365|NCT00364832|532025982|FG001|Extension Year 1|Early Withdrawals|0|||
147511366|NCT00364832|532025983|FG002|Extension Year 1|Early Withdrawals|0|||
147511367|NCT00364832|532025984|FG003|Extension Year 1|Early Withdrawals|0|||
147511368|NCT00364832|532025985|FG004|Extension Year 1|Early Withdrawals|0|||
147511369|NCT00364832|532025986|FG005|Extension Year 1|Early Withdrawals|0|||
147511370|NCT00364832|532025987|FG006|Extension Year 1|Early Withdrawals|0|||
147511371|NCT00364832|532025988|FG007|Extension Year 1|Early Withdrawals|0|||
147511372|NCT00364832|532025989|FG008|Extension Year 1|Early Withdrawals|0|||
147511373|NCT00364832|532025990|FG009|Extension Year 1|Early Withdrawals|4|||
147511374|NCT00364832|532025991|FG010|Extension Year 1|Early Withdrawals|2|||
147511375|NCT00364832|532025992|FG011|Extension Year 1|Early Withdrawals|10|||
147511376|NCT00364832|532025981|FG000|Extension Year 2|Early Withdrawals|0|||
147511377|NCT00364832|532025982|FG001|Extension Year 2|Early Withdrawals|0|||
147511378|NCT00364832|532025983|FG002|Extension Year 2|Early Withdrawals|0|||
147511379|NCT00364832|532025984|FG003|Extension Year 2|Early Withdrawals|0|||
147511380|NCT00364832|532025985|FG004|Extension Year 2|Early Withdrawals|0|||
147511381|NCT00364832|532025986|FG005|Extension Year 2|Early Withdrawals|0|||
147511382|NCT00364832|532025987|FG006|Extension Year 2|Early Withdrawals|0|||
147511383|NCT00364832|532025988|FG007|Extension Year 2|Early Withdrawals|0|||
147511384|NCT00364832|532025989|FG008|Extension Year 2|Early Withdrawals|0|||
147511385|NCT00364832|532025990|FG009|Extension Year 2|Early Withdrawals|5|||
147511386|NCT00364832|532025991|FG010|Extension Year 2|Early Withdrawals|5|||
147511387|NCT00364832|532025992|FG011|Extension Year 2|Early Withdrawals|3|||
147511388|NCT01266070|532025995|FG000|Overall Study|Adverse Event|3|||
147511389|NCT01266070|532025995|FG000|Overall Study|Protocol Violation|1|||
147511390|NCT01838213|532025996|FG000|Overall Study|Ineligible|166|||
147511391|NCT01838213|532025997|FG001|Overall Study|Ineligible|191|||
147511392|NCT04882072|532025998|FG000|Double Blind: Week 0 to Week 71.1|Withdrawal by Subject|1|||
147511393|NCT04882072|532025999|FG001|Double Blind: Week 0 to Week 71.1|Withdrawal by Subject|0|||
147511394|NCT04882072|532025998|FG000|Double Blind: Week 0 to Week 71.1|Withdrawal Criterion Met|1|||
147511395|NCT04882072|532025999|FG001|Double Blind: Week 0 to Week 71.1|Withdrawal Criterion Met|0|||
147511396|NCT04882072|532025998|FG000|OL Extension: OL Week 0 to OL Week 63.1|Withdrawal by Subject|0|||
147511397|NCT04882072|532025999|FG001|OL Extension: OL Week 0 to OL Week 63.1|Withdrawal by Subject|1|||
147511398|NCT03185819|532026000|FG000|Double-Blind Phase: Day 1 to Day 25|Withdrawal by parent/guardian|0|||
147511399|NCT03185819|532026001|FG001|Double-Blind Phase: Day 1 to Day 25|Withdrawal by parent/guardian|0|||
147511400|NCT03185819|532026002|FG002|Double-Blind Phase: Day 1 to Day 25|Withdrawal by parent/guardian|0|||
147511401|NCT03185819|532026003|FG003|Double-Blind Phase: Day 1 to Day 25|Withdrawal by parent/guardian|1|||
147511402|NCT03185819|532026000|FG000|Double-Blind Phase: Day 1 to Day 25|Other|1|||
147511403|NCT03185819|532026001|FG001|Double-Blind Phase: Day 1 to Day 25|Other|0|||
147511404|NCT03185819|532026002|FG002|Double-Blind Phase: Day 1 to Day 25|Other|1|||
147511405|NCT03185819|532026003|FG003|Double-Blind Phase: Day 1 to Day 25|Other|0|||
147511406|NCT03185819|532026000|FG000|Double-Blind Phase: Day 1 to Day 25|Adverse Event|1|||
147511407|NCT03185819|532026001|FG001|Double-Blind Phase: Day 1 to Day 25|Adverse Event|0|||
147511408|NCT03185819|532026002|FG002|Double-Blind Phase: Day 1 to Day 25|Adverse Event|0|||
147511409|NCT03185819|532026003|FG003|Double-Blind Phase: Day 1 to Day 25|Adverse Event|0|||
147671100|NCT04460885|532620188|FG000|Overall Study|Physician Decision|2|||
147671101|NCT04460885|532620189|FG001|Overall Study|Physician Decision|1|||
147671102|NCT04460885|532620188|FG000|Overall Study|Lost to Follow-up|4|||
147511410|NCT03185819|532026000|FG000|Double-Blind Phase: Day 1 to Day 25|Lack of Efficacy|2|||
147671103|NCT04460885|532620189|FG001|Overall Study|Lost to Follow-up|4|||
147511411|NCT03185819|532026001|FG001|Double-Blind Phase: Day 1 to Day 25|Lack of Efficacy|0|||
147511412|NCT03185819|532026002|FG002|Double-Blind Phase: Day 1 to Day 25|Lack of Efficacy|1|||
147511413|NCT03185819|532026003|FG003|Double-Blind Phase: Day 1 to Day 25|Lack of Efficacy|0|||
147511414|NCT03185819|532026000|FG000|Double-Blind Phase: Day 1 to Day 25|Subject refused further study treatment|0|||
147511415|NCT03185819|532026001|FG001|Double-Blind Phase: Day 1 to Day 25|Subject refused further study treatment|0|||
147511416|NCT03185819|532026002|FG002|Double-Blind Phase: Day 1 to Day 25|Subject refused further study treatment|0|||
147511417|NCT03185819|532026003|FG003|Double-Blind Phase: Day 1 to Day 25|Subject refused further study treatment|1|||
147511418|NCT03185819|532026000|FG000|Post-treatment Follow-up: Days 26 to 200|Withdrawal by parent/guardian|1|||
147527358|NCT00682539|532084240|FG002|Bevacizumab vs Triamcinolone|Lost to Follow-up|0|||
147511419|NCT03185819|532026001|FG001|Post-treatment Follow-up: Days 26 to 200|Withdrawal by parent/guardian|0|||
147511420|NCT03185819|532026002|FG002|Post-treatment Follow-up: Days 26 to 200|Withdrawal by parent/guardian|1|||
147511421|NCT03185819|532026003|FG003|Post-treatment Follow-up: Days 26 to 200|Withdrawal by parent/guardian|0|||
147511422|NCT03185819|532026000|FG000|Post-treatment Follow-up: Days 26 to 200|Other|1|||
147511423|NCT03185819|532026001|FG001|Post-treatment Follow-up: Days 26 to 200|Other|0|||
147511424|NCT03185819|532026002|FG002|Post-treatment Follow-up: Days 26 to 200|Other|3|||
147511425|NCT03185819|532026003|FG003|Post-treatment Follow-up: Days 26 to 200|Other|1|||
147511426|NCT03185819|532026000|FG000|Post-treatment Follow-up: Days 26 to 200|Adverse Event|0|||
147511427|NCT03185819|532026001|FG001|Post-treatment Follow-up: Days 26 to 200|Adverse Event|1|||
147511428|NCT03185819|532026002|FG002|Post-treatment Follow-up: Days 26 to 200|Adverse Event|0|||
147511429|NCT03185819|532026003|FG003|Post-treatment Follow-up: Days 26 to 200|Adverse Event|0|||
147511430|NCT03185819|532026000|FG000|Post-treatment Follow-up: Days 26 to 200|Requires treatment with electroconvulsive therapy, transcranial magnetic stimulation, ketamine|1|||
147511431|NCT03185819|532026001|FG001|Post-treatment Follow-up: Days 26 to 200|Requires treatment with electroconvulsive therapy, transcranial magnetic stimulation, ketamine|0|||
147511432|NCT03185819|532026002|FG002|Post-treatment Follow-up: Days 26 to 200|Requires treatment with electroconvulsive therapy, transcranial magnetic stimulation, ketamine|0|||
147511433|NCT03185819|532026003|FG003|Post-treatment Follow-up: Days 26 to 200|Requires treatment with electroconvulsive therapy, transcranial magnetic stimulation, ketamine|0|||
147511434|NCT03185819|532026000|FG000|Post-treatment Follow-up: Days 26 to 200|Withdrawal by Subject|3|||
147511435|NCT03185819|532026001|FG001|Post-treatment Follow-up: Days 26 to 200|Withdrawal by Subject|3|||
147511436|NCT03185819|532026002|FG002|Post-treatment Follow-up: Days 26 to 200|Withdrawal by Subject|2|||
147671104|NCT04082429|532620193|FG000|Main Part (Before the Treatment Pause)|Withdrawal by Subject|1|||
147671105|NCT04082429|532620194|FG001|Main Part (Before the Treatment Pause)|Withdrawal by Subject|0|||
147511437|NCT03185819|532026003|FG003|Post-treatment Follow-up: Days 26 to 200|Withdrawal by Subject|0|||
147511438|NCT03185819|532026000|FG000|Post-treatment Follow-up: Days 26 to 200|Physician Decision|2|||
147511439|NCT03185819|532026001|FG001|Post-treatment Follow-up: Days 26 to 200|Physician Decision|0|||
147511440|NCT03185819|532026002|FG002|Post-treatment Follow-up: Days 26 to 200|Physician Decision|2|||
147511441|NCT03185819|532026003|FG003|Post-treatment Follow-up: Days 26 to 200|Physician Decision|0|||
147511442|NCT03185819|532026000|FG000|Post-treatment Follow-up: Days 26 to 200|Lost to Follow-up|2|||
147511443|NCT03185819|532026001|FG001|Post-treatment Follow-up: Days 26 to 200|Lost to Follow-up|1|||
147511444|NCT03185819|532026002|FG002|Post-treatment Follow-up: Days 26 to 200|Lost to Follow-up|0|||
147511445|NCT03185819|532026003|FG003|Post-treatment Follow-up: Days 26 to 200|Lost to Follow-up|2|||
147511446|NCT03185819|532026000|FG000|Post-treatment Follow-up: Days 26 to 200|Death|1|||
147511447|NCT03185819|532026001|FG001|Post-treatment Follow-up: Days 26 to 200|Death|0|||
147511448|NCT03185819|532026002|FG002|Post-treatment Follow-up: Days 26 to 200|Death|0|||
147511449|NCT03185819|532026003|FG003|Post-treatment Follow-up: Days 26 to 200|Death|0|||
147511450|NCT03097133|532026004|FG000|Overall Study|Lost to Follow-up|3|||
147511451|NCT03097133|532026005|FG001|Overall Study|Lost to Follow-up|2|||
147511452|NCT03097133|532026004|FG000|Overall Study|Withdrawal by Subject|2|||
147511453|NCT03097133|532026005|FG001|Overall Study|Withdrawal by Subject|5|||
147511454|NCT03097133|532026004|FG000|Overall Study|Discontinued DB, not entered FU Phase|21|||
147511455|NCT03097133|532026005|FG001|Overall Study|Discontinued DB, not entered FU Phase|25|||
147511456|NCT03097133|532026004|FG000|Overall Study|Other|3|||
147511457|NCT03097133|532026005|FG001|Overall Study|Other|2|||
147511458|NCT03097133|532026004|FG000|Overall Study|Adverse Event|1|||
147511459|NCT03097133|532026005|FG001|Overall Study|Adverse Event|0|||
147511460|NCT02910089|532026008|FG000|Overall Study|Lost insurance eligibility|22|||
147511461|NCT02910089|532026009|FG001|Overall Study|Lost insurance eligibility|16|||
147511462|NCT00732238|532026010|FG000|Overall Study|Bacteremia|4|||
147511463|NCT00732238|532026011|FG001|Overall Study|Bacteremia|1|||
147511464|NCT00732238|532026010|FG000|Overall Study|Asymptomatic bacteriuria|1|||
147511465|NCT00732238|532026011|FG001|Overall Study|Asymptomatic bacteriuria|0|||
147511466|NCT02939976|532026012|FG000|Overall Study|Lost to Follow-up|7|||
147511467|NCT02939976|532026013|FG001|Overall Study|Lost to Follow-up|1|||
147511468|NCT02939976|532026014|FG002|Overall Study|Lost to Follow-up|1|||
147511469|NCT02939976|532026015|FG003|Overall Study|Lost to Follow-up|2|||
147511470|NCT02939976|532026012|FG000|Overall Study|Withdrawal by Subject|4|||
147511471|NCT02939976|532026013|FG001|Overall Study|Withdrawal by Subject|0|||
147511472|NCT02939976|532026014|FG002|Overall Study|Withdrawal by Subject|2|||
147511473|NCT02939976|532026015|FG003|Overall Study|Withdrawal by Subject|4|||
147511474|NCT02939976|532026012|FG000|Overall Study|Due to early study closure|4|||
147511475|NCT02939976|532026013|FG001|Overall Study|Due to early study closure|3|||
147511476|NCT02939976|532026014|FG002|Overall Study|Due to early study closure|2|||
147511477|NCT02939976|532026015|FG003|Overall Study|Due to early study closure|3|||
147511478|NCT04080752|532026016|FG000|Overall Study|Adverse Event|2|||
147511479|NCT04080752|532026017|FG001|Overall Study|Adverse Event|3|||
147511480|NCT04080752|532026016|FG000|Overall Study|Lack of Efficacy|1|||
147511481|NCT04080752|532026017|FG001|Overall Study|Lack of Efficacy|0|||
147511482|NCT04080752|532026016|FG000|Overall Study|Lost to Follow-up|1|||
147511483|NCT04080752|532026017|FG001|Overall Study|Lost to Follow-up|0|||
147671106|NCT04082429|532620195|FG002|Main Part (Before the Treatment Pause)|Withdrawal by Subject|1|||
147511484|NCT04080752|532026016|FG000|Overall Study|Pregnancy|0|||
147511485|NCT04080752|532026017|FG001|Overall Study|Pregnancy|1|||
147511486|NCT04080752|532026016|FG000|Overall Study|Withdrawal by Subject|7|||
147511487|NCT04080752|532026017|FG001|Overall Study|Withdrawal by Subject|0|||
147511488|NCT04080752|532026016|FG000|Overall Study|Non-Compliance with Study Drug|0|||
147511489|NCT04080752|532026017|FG001|Overall Study|Non-Compliance with Study Drug|1|||
147511490|NCT04080752|532026016|FG000|Overall Study|Other|2|||
147511491|NCT04080752|532026017|FG001|Overall Study|Other|1|||
147511492|NCT01585168|532026018|FG000|Overall Study|Lost to Follow-up|3|||
147511493|NCT01585168|532026019|FG001|Overall Study|Lost to Follow-up|1|||
147511494|NCT01585168|532026020|FG002|Overall Study|Lost to Follow-up|1|||
147511495|NCT01585168|532026021|FG003|Overall Study|Lost to Follow-up|1|||
147511496|NCT01194414|532026022|FG000|24 Weeks Double Blind Period|Insufficient Therapeutic Response|11|||
147511497|NCT01194414|532026023|FG001|24 Weeks Double Blind Period|Insufficient Therapeutic Response|8|||
147511498|NCT01194414|532026024|FG002|24 Weeks Double Blind Period|Insufficient Therapeutic Response|0|||
147511499|NCT01194414|532026025|FG003|24 Weeks Double Blind Period|Insufficient Therapeutic Response|0|||
147511500|NCT01194414|532026022|FG000|24 Weeks Double Blind Period|Subject/legal Guardian Decision|9|||
147511501|NCT01194414|532026023|FG001|24 Weeks Double Blind Period|Subject/legal Guardian Decision|5|||
147511502|NCT01194414|532026024|FG002|24 Weeks Double Blind Period|Subject/legal Guardian Decision|0|||
147511503|NCT01194414|532026025|FG003|24 Weeks Double Blind Period|Subject/legal Guardian Decision|0|||
147511504|NCT01194414|532026022|FG000|24 Weeks Double Blind Period|Protocol Violation|5|||
147511505|NCT01194414|532026023|FG001|24 Weeks Double Blind Period|Protocol Violation|3|||
147511506|NCT01194414|532026024|FG002|24 Weeks Double Blind Period|Protocol Violation|0|||
147511507|NCT01194414|532026025|FG003|24 Weeks Double Blind Period|Protocol Violation|0|||
147511508|NCT01194414|532026022|FG000|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|0|||
147511509|NCT01194414|532026023|FG001|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|5|||
147511510|NCT01194414|532026024|FG002|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|0|||
147511511|NCT01194414|532026025|FG003|24 Weeks Double Blind Period|Physician Decision to Withdraw Subject|0|||
147511512|NCT01194414|532026022|FG000|24 Weeks Double Blind Period|Pregnancy|2|||
147511513|NCT01194414|532026023|FG001|24 Weeks Double Blind Period|Pregnancy|2|||
147511514|NCT01194414|532026024|FG002|24 Weeks Double Blind Period|Pregnancy|0|||
147511515|NCT01194414|532026025|FG003|24 Weeks Double Blind Period|Pregnancy|0|||
147511516|NCT01194414|532026022|FG000|24 Weeks Double Blind Period|Lost to Follow-up|2|||
147511517|NCT01194414|532026023|FG001|24 Weeks Double Blind Period|Lost to Follow-up|1|||
147511518|NCT01194414|532026024|FG002|24 Weeks Double Blind Period|Lost to Follow-up|0|||
147511519|NCT01194414|532026025|FG003|24 Weeks Double Blind Period|Lost to Follow-up|0|||
147511520|NCT01194414|532026022|FG000|24 Weeks Double Blind Period|Other|0|||
147511521|NCT01194414|532026023|FG001|24 Weeks Double Blind Period|Other|1|||
147511522|NCT01194414|532026024|FG002|24 Weeks Double Blind Period|Other|0|||
147511523|NCT01194414|532026025|FG003|24 Weeks Double Blind Period|Other|0|||
147511524|NCT01194414|532026022|FG000|24 Weeks Double Blind Period|Adverse Event|28|||
147511525|NCT01194414|532026023|FG001|24 Weeks Double Blind Period|Adverse Event|40|||
147511526|NCT01194414|532026024|FG002|24 Weeks Double Blind Period|Adverse Event|0|||
147511527|NCT01194414|532026025|FG003|24 Weeks Double Blind Period|Adverse Event|0|||
147511528|NCT01194414|532026022|FG000|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|2|||
147511529|NCT01194414|532026023|FG001|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|1|||
147511530|NCT01194414|532026024|FG002|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|0|||
147511531|NCT01194414|532026025|FG003|24 Weeks Double Blind Period|Anaphylaxis or Hypersensitivity Reaction|0|||
147511532|NCT01194414|532026022|FG000|24 Weeks Double Blind Period|Death|0|||
147511533|NCT01194414|532026023|FG001|24 Weeks Double Blind Period|Death|1|||
147511534|NCT01194414|532026024|FG002|24 Weeks Double Blind Period|Death|0|||
147511535|NCT01194414|532026025|FG003|24 Weeks Double Blind Period|Death|0|||
147511536|NCT01194414|532026022|FG000|72 Weeks Open Label Extension|Randomized but not Treated|3|||
147511537|NCT01194414|532026023|FG001|72 Weeks Open Label Extension|Randomized but not Treated|5|||
147511538|NCT01194414|532026024|FG002|72 Weeks Open Label Extension|Randomized but not Treated|0|||
147511539|NCT01194414|532026025|FG003|72 Weeks Open Label Extension|Randomized but not Treated|0|||
147511540|NCT01194414|532026022|FG000|72 Weeks Open Label Extension|Subject/legal Guardian Decision|20|||
147511541|NCT01194414|532026023|FG001|72 Weeks Open Label Extension|Subject/legal Guardian Decision|14|||
147511542|NCT01194414|532026024|FG002|72 Weeks Open Label Extension|Subject/legal Guardian Decision|1|||
147511543|NCT01194414|532026025|FG003|72 Weeks Open Label Extension|Subject/legal Guardian Decision|6|||
147511544|NCT01194414|532026022|FG000|72 Weeks Open Label Extension|Insufficient Therapeutic Response|9|||
147511545|NCT01194414|532026023|FG001|72 Weeks Open Label Extension|Insufficient Therapeutic Response|11|||
147511546|NCT01194414|532026024|FG002|72 Weeks Open Label Extension|Insufficient Therapeutic Response|2|||
147511547|NCT01194414|532026025|FG003|72 Weeks Open Label Extension|Insufficient Therapeutic Response|3|||
147511548|NCT01194414|532026022|FG000|72 Weeks Open Label Extension|Lost to Follow-up|4|||
147511549|NCT01194414|532026023|FG001|72 Weeks Open Label Extension|Lost to Follow-up|3|||
147511550|NCT01194414|532026024|FG002|72 Weeks Open Label Extension|Lost to Follow-up|2|||
147511551|NCT01194414|532026025|FG003|72 Weeks Open Label Extension|Lost to Follow-up|1|||
147511552|NCT01194414|532026022|FG000|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|3|||
147511553|NCT01194414|532026023|FG001|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|5|||
147511554|NCT01194414|532026024|FG002|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|0|||
147511555|NCT01194414|532026025|FG003|72 Weeks Open Label Extension|Physician Decision to Withdraw Subject|0|||
147511556|NCT01194414|532026022|FG000|72 Weeks Open Label Extension|Pregnancy|1|||
147511557|NCT01194414|532026023|FG001|72 Weeks Open Label Extension|Pregnancy|3|||
147511558|NCT01194414|532026024|FG002|72 Weeks Open Label Extension|Pregnancy|1|||
147511559|NCT01194414|532026025|FG003|72 Weeks Open Label Extension|Pregnancy|1|||
147511560|NCT01194414|532026022|FG000|72 Weeks Open Label Extension|Other|2|||
147511561|NCT01194414|532026023|FG001|72 Weeks Open Label Extension|Other|1|||
147511562|NCT01194414|532026024|FG002|72 Weeks Open Label Extension|Other|0|||
147511563|NCT01194414|532026025|FG003|72 Weeks Open Label Extension|Other|0|||
147511564|NCT01194414|532026022|FG000|72 Weeks Open Label Extension|Protocol Violation|0|||
147511565|NCT01194414|532026023|FG001|72 Weeks Open Label Extension|Protocol Violation|0|||
147511566|NCT01194414|532026024|FG002|72 Weeks Open Label Extension|Protocol Violation|0|||
147511567|NCT01194414|532026025|FG003|72 Weeks Open Label Extension|Protocol Violation|1|||
147511568|NCT01194414|532026022|FG000|72 Weeks Open Label Extension|Adverse Event|35|||
147511569|NCT01194414|532026023|FG001|72 Weeks Open Label Extension|Adverse Event|21|||
147511570|NCT01194414|532026024|FG002|72 Weeks Open Label Extension|Adverse Event|2|||
147511571|NCT01194414|532026025|FG003|72 Weeks Open Label Extension|Adverse Event|12|||
147511572|NCT01194414|532026022|FG000|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|1|||
147511573|NCT01194414|532026023|FG001|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|1|||
147511574|NCT01194414|532026024|FG002|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|0|||
147511575|NCT01194414|532026025|FG003|72 Weeks Open Label Extension|Anaphylaxis or Hypersensitivity Reaction|0|||
147511576|NCT01194414|532026022|FG000|72 Weeks Open Label Extension|Death|1|||
147511577|NCT01194414|532026023|FG001|72 Weeks Open Label Extension|Death|2|||
147511578|NCT01194414|532026024|FG002|72 Weeks Open Label Extension|Death|0|||
147511579|NCT01194414|532026025|FG003|72 Weeks Open Label Extension|Death|2|||
147511580|NCT03605836|532026026|FG000|OL Placebo Run-in Period [1 Week]|Adverse Event|2|||
147511581|NCT03605836|532026027|FG001|OL Placebo Run-in Period [1 Week]|Adverse Event|0|||
147511582|NCT03605836|532026028|FG002|OL Placebo Run-in Period [1 Week]|Adverse Event|0|||
147511583|NCT03605836|532026029|FG003|OL Placebo Run-in Period [1 Week]|Adverse Event|0|||
147511584|NCT03605836|532026026|FG000|OL Placebo Run-in Period [1 Week]|Lack of Efficacy|2|||
147511585|NCT03605836|532026027|FG001|OL Placebo Run-in Period [1 Week]|Lack of Efficacy|0|||
147511586|NCT03605836|532026028|FG002|OL Placebo Run-in Period [1 Week]|Lack of Efficacy|0|||
147511587|NCT03605836|532026029|FG003|OL Placebo Run-in Period [1 Week]|Lack of Efficacy|0|||
147511588|NCT03605836|532026026|FG000|OL Placebo Run-in Period [1 Week]|Lost to Follow-up|8|||
147511589|NCT03605836|532026027|FG001|OL Placebo Run-in Period [1 Week]|Lost to Follow-up|0|||
147511590|NCT03605836|532026028|FG002|OL Placebo Run-in Period [1 Week]|Lost to Follow-up|0|||
147511591|NCT03605836|532026029|FG003|OL Placebo Run-in Period [1 Week]|Lost to Follow-up|0|||
147511592|NCT03605836|532026026|FG000|OL Placebo Run-in Period [1 Week]|Non-Compliance With Study Drug|4|||
147511593|NCT03605836|532026027|FG001|OL Placebo Run-in Period [1 Week]|Non-Compliance With Study Drug|0|||
147511594|NCT03605836|532026028|FG002|OL Placebo Run-in Period [1 Week]|Non-Compliance With Study Drug|0|||
147511595|NCT03605836|532026029|FG003|OL Placebo Run-in Period [1 Week]|Non-Compliance With Study Drug|0|||
147511596|NCT03605836|532026026|FG000|OL Placebo Run-in Period [1 Week]|Protocol Deviation|4|||
147511597|NCT03605836|532026027|FG001|OL Placebo Run-in Period [1 Week]|Protocol Deviation|0|||
147511598|NCT03605836|532026028|FG002|OL Placebo Run-in Period [1 Week]|Protocol Deviation|0|||
147511599|NCT03605836|532026029|FG003|OL Placebo Run-in Period [1 Week]|Protocol Deviation|0|||
147511600|NCT03605836|532026026|FG000|OL Placebo Run-in Period [1 Week]|Withdrawal by Subject|17|||
147511601|NCT03605836|532026027|FG001|OL Placebo Run-in Period [1 Week]|Withdrawal by Subject|0|||
147511602|NCT03605836|532026028|FG002|OL Placebo Run-in Period [1 Week]|Withdrawal by Subject|0|||
147511603|NCT03605836|532026029|FG003|OL Placebo Run-in Period [1 Week]|Withdrawal by Subject|0|||
147511604|NCT03605836|532026026|FG000|OL Placebo Run-in Period [1 Week]|Site Terminated by Sponsor|5|||
147511605|NCT03605836|532026027|FG001|OL Placebo Run-in Period [1 Week]|Site Terminated by Sponsor|0|||
147511606|NCT03605836|532026028|FG002|OL Placebo Run-in Period [1 Week]|Site Terminated by Sponsor|0|||
147511607|NCT03605836|532026029|FG003|OL Placebo Run-in Period [1 Week]|Site Terminated by Sponsor|0|||
147511608|NCT03605836|532026026|FG000|OL Placebo Run-in Period [1 Week]|Physician Decision|7|||
147511609|NCT03605836|532026027|FG001|OL Placebo Run-in Period [1 Week]|Physician Decision|0|||
147511610|NCT03605836|532026028|FG002|OL Placebo Run-in Period [1 Week]|Physician Decision|0|||
147511611|NCT03605836|532026029|FG003|OL Placebo Run-in Period [1 Week]|Physician Decision|0|||
147511612|NCT03605836|532026026|FG000|OL Placebo Run-in Period [1 Week]|Reason not Related to COVID-19|85|||
147511613|NCT03605836|532026027|FG001|OL Placebo Run-in Period [1 Week]|Reason not Related to COVID-19|0|||
147511614|NCT03605836|532026028|FG002|OL Placebo Run-in Period [1 Week]|Reason not Related to COVID-19|0|||
147511615|NCT03605836|532026029|FG003|OL Placebo Run-in Period [1 Week]|Reason not Related to COVID-19|0|||
147511616|NCT03605836|532026026|FG000|OL Placebo Run-in Period [1 Week]|COVID-19 Related|15|||
147511617|NCT03605836|532026027|FG001|OL Placebo Run-in Period [1 Week]|COVID-19 Related|0|||
147511618|NCT03605836|532026028|FG002|OL Placebo Run-in Period [1 Week]|COVID-19 Related|0|||
147511619|NCT03605836|532026029|FG003|OL Placebo Run-in Period [1 Week]|COVID-19 Related|0|||
147511620|NCT03605836|532026026|FG000|OL Placebo Run-in Period [1 Week]|Discontinued Prior to the Treatment.|1|||
147511621|NCT03605836|532026027|FG001|OL Placebo Run-in Period [1 Week]|Discontinued Prior to the Treatment.|0|||
147511622|NCT03605836|532026028|FG002|OL Placebo Run-in Period [1 Week]|Discontinued Prior to the Treatment.|0|||
147511623|NCT03605836|532026029|FG003|OL Placebo Run-in Period [1 Week]|Discontinued Prior to the Treatment.|0|||
147511624|NCT03605836|532026026|FG000|Double-blind Treatment Period [6 Weeks]|Randomized but Not Treated in Double-Blind Treatment Period|0|||
147511625|NCT03605836|532026027|FG001|Double-blind Treatment Period [6 Weeks]|Randomized but Not Treated in Double-Blind Treatment Period|2|||
147511626|NCT03605836|532026028|FG002|Double-blind Treatment Period [6 Weeks]|Randomized but Not Treated in Double-Blind Treatment Period|4|||
147511627|NCT03605836|532026029|FG003|Double-blind Treatment Period [6 Weeks]|Randomized but Not Treated in Double-Blind Treatment Period|4|||
147511628|NCT03605836|532026026|FG000|Double-blind Treatment Period [6 Weeks]|Adverse Event|0|||
147511629|NCT03605836|532026027|FG001|Double-blind Treatment Period [6 Weeks]|Adverse Event|5|||
147511630|NCT03605836|532026028|FG002|Double-blind Treatment Period [6 Weeks]|Adverse Event|8|||
147511631|NCT03605836|532026029|FG003|Double-blind Treatment Period [6 Weeks]|Adverse Event|0|||
147511632|NCT03605836|532026026|FG000|Double-blind Treatment Period [6 Weeks]|Lack of Efficacy|0|||
147511633|NCT03605836|532026027|FG001|Double-blind Treatment Period [6 Weeks]|Lack of Efficacy|0|||
147511634|NCT03605836|532026028|FG002|Double-blind Treatment Period [6 Weeks]|Lack of Efficacy|2|||
147511635|NCT03605836|532026029|FG003|Double-blind Treatment Period [6 Weeks]|Lack of Efficacy|1|||
147511636|NCT03605836|532026026|FG000|Double-blind Treatment Period [6 Weeks]|Lost to Follow-up|0|||
147511637|NCT03605836|532026027|FG001|Double-blind Treatment Period [6 Weeks]|Lost to Follow-up|3|||
147511638|NCT03605836|532026028|FG002|Double-blind Treatment Period [6 Weeks]|Lost to Follow-up|5|||
147511639|NCT03605836|532026029|FG003|Double-blind Treatment Period [6 Weeks]|Lost to Follow-up|1|||
147511640|NCT03605836|532026026|FG000|Double-blind Treatment Period [6 Weeks]|Non-compliance with Study Drug|0|||
147511641|NCT03605836|532026027|FG001|Double-blind Treatment Period [6 Weeks]|Non-compliance with Study Drug|1|||
147511642|NCT03605836|532026028|FG002|Double-blind Treatment Period [6 Weeks]|Non-compliance with Study Drug|0|||
147511643|NCT03605836|532026029|FG003|Double-blind Treatment Period [6 Weeks]|Non-compliance with Study Drug|4|||
147511644|NCT03605836|532026026|FG000|Double-blind Treatment Period [6 Weeks]|Pregnancy|0|||
147511645|NCT03605836|532026027|FG001|Double-blind Treatment Period [6 Weeks]|Pregnancy|1|||
147511646|NCT03605836|532026028|FG002|Double-blind Treatment Period [6 Weeks]|Pregnancy|0|||
147511647|NCT03605836|532026029|FG003|Double-blind Treatment Period [6 Weeks]|Pregnancy|0|||
147511648|NCT03605836|532026026|FG000|Double-blind Treatment Period [6 Weeks]|Protocol Deviation|0|||
147511649|NCT03605836|532026027|FG001|Double-blind Treatment Period [6 Weeks]|Protocol Deviation|5|||
147511650|NCT03605836|532026028|FG002|Double-blind Treatment Period [6 Weeks]|Protocol Deviation|1|||
147640172|NCT04430738|532501465|FG005|Phase 1: Dose Expansion|Participation terminated by sponsor|3|||
147640173|NCT04430738|532501460|FG000|Phase 1: Dose Expansion|Continuing to LTEP|0|||
147640174|NCT04430738|532501461|FG001|Phase 1: Dose Expansion|Continuing to LTEP|0|||
147640175|NCT04430738|532501462|FG002|Phase 1: Dose Expansion|Continuing to LTEP|0|||
147640176|NCT04430738|532501463|FG003|Phase 1: Dose Expansion|Continuing to LTEP|0|||
147640177|NCT04430738|532501464|FG004|Phase 1: Dose Expansion|Continuing to LTEP|0|||
147640178|NCT04430738|532501465|FG005|Phase 1: Dose Expansion|Continuing to LTEP|2|||
147640179|NCT02091960|532501466|FG000|Overall Study|Death|7|||
147640180|NCT02091960|532501466|FG000|Overall Study|Withdrawal by Subject|1|||
147640181|NCT02091960|532501466|FG000|Overall Study|Miscellaneous Reasons|37|||
147640182|NCT01995175|532501472|FG000|Period 1 - From 0 up to 2 Years of Age|Withdrawal by Subject|35|||
147640183|NCT01995175|532501472|FG000|Period 1 - From 0 up to 2 Years of Age|Lost to Follow-up|102|||
147640184|NCT01995175|532501472|FG000|Period 1 - From 0 up to 2 Years of Age|Other|67|||
147640185|NCT01995175|532501472|FG000|Period 1 - From 0 up to 2 Years of Age|Migrated / moved from the study area|49|||
147640186|NCT01995175|532501472|FG000|Period 2 - From 2 up to 6 Years of Age|Other|21|||
147640187|NCT01995175|532501472|FG000|Period 2 - From 2 up to 6 Years of Age|Lost to Follow-up|22|||
147640188|NCT01995175|532501472|FG000|Period 2 - From 2 up to 6 Years of Age|Migrated/moved from the study area|6|||
147640189|NCT01995175|532501472|FG000|Period 2 - From 2 up to 6 Years of Age|Consent withdrawal, not due to a Serious Adverse Event|7|||
147640190|NCT01995175|532501472|FG000|Period 2 - From 2 up to 6 Years of Age|Protocol Violation|1|||
147640191|NCT01877551|532501473|FG000|Overall Study|Physician Decision|0|||
147640192|NCT01877551|532501474|FG001|Overall Study|Physician Decision|1|||
147640193|NCT00984061|532501475|FG000|Clarithromycin Alone|Protocol Violation|1|||
147640194|NCT04777201|532501479|FG000|Main Study|Withdrawal by Subject|19|||
147640195|NCT04777201|532501480|FG001|Main Study|Withdrawal by Subject|27|||
147640196|NCT04777201|532501481|FG002|Main Study|Withdrawal by Subject|0|||
147640197|NCT04777201|532501479|FG000|Main Study|Death|13|||
147640198|NCT04777201|532501480|FG001|Main Study|Death|27|||
147640199|NCT04777201|532501481|FG002|Main Study|Death|0|||
147640200|NCT04777201|532501479|FG000|Main Study|Subject missed the safety follow-up visit|9|||
147640201|NCT04777201|532501480|FG001|Main Study|Subject missed the safety follow-up visit|10|||
147640202|NCT04777201|532501481|FG002|Main Study|Subject missed the safety follow-up visit|0|||
147640203|NCT04777201|532501479|FG000|Main Study|Physician Decision|8|||
147640204|NCT04777201|532501480|FG001|Main Study|Physician Decision|10|||
147511651|NCT03605836|532026029|FG003|Double-blind Treatment Period [6 Weeks]|Protocol Deviation|1|||
147511652|NCT03605836|532026026|FG000|Double-blind Treatment Period [6 Weeks]|Withdrawal by Subject|0|||
147511653|NCT03605836|532026027|FG001|Double-blind Treatment Period [6 Weeks]|Withdrawal by Subject|10|||
147511654|NCT03605836|532026028|FG002|Double-blind Treatment Period [6 Weeks]|Withdrawal by Subject|6|||
147511655|NCT03605836|532026029|FG003|Double-blind Treatment Period [6 Weeks]|Withdrawal by Subject|4|||
147511656|NCT03605836|532026026|FG000|Double-blind Treatment Period [6 Weeks]|Physician Decision|0|||
147511657|NCT03605836|532026027|FG001|Double-blind Treatment Period [6 Weeks]|Physician Decision|3|||
147511658|NCT03605836|532026028|FG002|Double-blind Treatment Period [6 Weeks]|Physician Decision|1|||
147511659|NCT03605836|532026029|FG003|Double-blind Treatment Period [6 Weeks]|Physician Decision|0|||
147511660|NCT03605836|532026026|FG000|Double-blind Treatment Period [6 Weeks]|Reason not Specified|0|||
147511661|NCT03605836|532026027|FG001|Double-blind Treatment Period [6 Weeks]|Reason not Specified|6|||
147511662|NCT03605836|532026028|FG002|Double-blind Treatment Period [6 Weeks]|Reason not Specified|16|||
147511663|NCT03605836|532026029|FG003|Double-blind Treatment Period [6 Weeks]|Reason not Specified|7|||
147511664|NCT03605836|532026026|FG000|Double-blind Treatment Period [6 Weeks]|Covid-19 Related|0|||
147511665|NCT03605836|532026027|FG001|Double-blind Treatment Period [6 Weeks]|Covid-19 Related|0|||
147511666|NCT03605836|532026028|FG002|Double-blind Treatment Period [6 Weeks]|Covid-19 Related|2|||
147511667|NCT03605836|532026029|FG003|Double-blind Treatment Period [6 Weeks]|Covid-19 Related|1|||
147511668|NCT02977507|532026031|FG000|Overall Study|Protocol Deviation|1|||
147511669|NCT02977507|532026032|FG001|Overall Study|Protocol Deviation|0|||
147511670|NCT02977507|532026031|FG000|Overall Study|Lost to Follow-up|1|||
147511671|NCT02977507|532026032|FG001|Overall Study|Lost to Follow-up|0|||
147511672|NCT00741260|532026045|FG000|Overall Study|Disease Progression|3|||
147511673|NCT00741260|532026046|FG001|Overall Study|Disease Progression|5|||
147511674|NCT00741260|532026047|FG002|Overall Study|Disease Progression|3|||
147511675|NCT00741260|532026048|FG003|Overall Study|Disease Progression|3|||
147511676|NCT00741260|532026049|FG004|Overall Study|Disease Progression|5|||
147511677|NCT00741260|532026050|FG005|Overall Study|Disease Progression|37|||
147511678|NCT00741260|532026051|FG006|Overall Study|Disease Progression|4|||
147511679|NCT00741260|532026045|FG000|Overall Study|Death|0|||
147511680|NCT00741260|532026046|FG001|Overall Study|Death|1|||
147511681|NCT00741260|532026047|FG002|Overall Study|Death|0|||
147511682|NCT00741260|532026048|FG003|Overall Study|Death|1|||
147511683|NCT00741260|532026049|FG004|Overall Study|Death|2|||
147511684|NCT00741260|532026050|FG005|Overall Study|Death|2|||
147511685|NCT00741260|532026051|FG006|Overall Study|Death|1|||
147511686|NCT00741260|532026045|FG000|Overall Study|Withdrawal by Subject|0|||
147511687|NCT00741260|532026046|FG001|Overall Study|Withdrawal by Subject|0|||
147511688|NCT00741260|532026047|FG002|Overall Study|Withdrawal by Subject|0|||
147511689|NCT00741260|532026048|FG003|Overall Study|Withdrawal by Subject|0|||
147511690|NCT00741260|532026049|FG004|Overall Study|Withdrawal by Subject|1|||
147511691|NCT00741260|532026050|FG005|Overall Study|Withdrawal by Subject|3|||
147511692|NCT00741260|532026051|FG006|Overall Study|Withdrawal by Subject|1|||
147511693|NCT00741260|532026045|FG000|Overall Study|Physician Decision|1|||
147511694|NCT00741260|532026046|FG001|Overall Study|Physician Decision|1|||
147511695|NCT00741260|532026047|FG002|Overall Study|Physician Decision|0|||
147511696|NCT00741260|532026048|FG003|Overall Study|Physician Decision|0|||
147511697|NCT00741260|532026049|FG004|Overall Study|Physician Decision|0|||
147511698|NCT00741260|532026050|FG005|Overall Study|Physician Decision|0|||
147511699|NCT00741260|532026051|FG006|Overall Study|Physician Decision|0|||
147511700|NCT00741260|532026045|FG000|Overall Study|Other|2|||
147511701|NCT00741260|532026046|FG001|Overall Study|Other|1|||
147511702|NCT00741260|532026047|FG002|Overall Study|Other|1|||
147511703|NCT00741260|532026048|FG003|Overall Study|Other|2|||
147511704|NCT00741260|532026049|FG004|Overall Study|Other|1|||
147511705|NCT00741260|532026050|FG005|Overall Study|Other|3|||
147511706|NCT00741260|532026051|FG006|Overall Study|Other|1|||
147511707|NCT02565615|532026052|FG000|Overall Study|Death|0|||
147511708|NCT02565615|532026053|FG001|Overall Study|Death|1|||
147640205|NCT04777201|532501481|FG002|Main Study|Physician Decision|0|||
147640206|NCT04777201|532501479|FG000|Main Study|Adverse Event|8|||
147640207|NCT04777201|532501480|FG001|Main Study|Adverse Event|8|||
147640208|NCT04777201|532501481|FG002|Main Study|Adverse Event|0|||
147640209|NCT04777201|532501479|FG000|Main Study|Lost to Follow-up|9|||
147640210|NCT04777201|532501480|FG001|Main Study|Lost to Follow-up|4|||
147640211|NCT04777201|532501481|FG002|Main Study|Lost to Follow-up|0|||
147671107|NCT04082429|532620196|FG003|Main Part (Before the Treatment Pause)|Withdrawal by Subject|1|||
147511709|NCT02565615|532026054|FG002|Overall Study|Death|0|||
147511710|NCT02565615|532026055|FG003|Overall Study|Death|0|||
147511711|NCT02565615|532026056|FG004|Overall Study|Death|4|||
147511712|NCT02565615|532026052|FG000|Overall Study|Not willing to participate in study|2|||
147511713|NCT02565615|532026053|FG001|Overall Study|Not willing to participate in study|21|||
147511714|NCT02565615|532026054|FG002|Overall Study|Not willing to participate in study|0|||
147511715|NCT02565615|532026055|FG003|Overall Study|Not willing to participate in study|1|||
147511716|NCT02565615|532026056|FG004|Overall Study|Not willing to participate in study|169|||
147640212|NCT04777201|532501479|FG000|Main Study|Reason not specified|3|||
147640213|NCT04777201|532501480|FG001|Main Study|Reason not specified|3|||
147511717|NCT02565615|532026052|FG000|Overall Study|Lost to Follow-up|0|||
147511718|NCT02565615|532026053|FG001|Overall Study|Lost to Follow-up|4|||
147511719|NCT02565615|532026054|FG002|Overall Study|Lost to Follow-up|0|||
147511720|NCT02565615|532026055|FG003|Overall Study|Lost to Follow-up|1|||
147511721|NCT02565615|532026056|FG004|Overall Study|Lost to Follow-up|765|||
147511722|NCT02565615|532026052|FG000|Overall Study|Not meeting eligibility criteria|0|||
147511723|NCT02565615|532026053|FG001|Overall Study|Not meeting eligibility criteria|7|||
147511724|NCT02565615|532026054|FG002|Overall Study|Not meeting eligibility criteria|0|||
147511725|NCT02565615|532026055|FG003|Overall Study|Not meeting eligibility criteria|0|||
147511726|NCT02565615|532026056|FG004|Overall Study|Not meeting eligibility criteria|25|||
147511727|NCT02565615|532026052|FG000|Overall Study|Reason not defined|0|||
147511728|NCT02565615|532026053|FG001|Overall Study|Reason not defined|2|||
147511729|NCT02565615|532026054|FG002|Overall Study|Reason not defined|0|||
147511730|NCT02565615|532026055|FG003|Overall Study|Reason not defined|1|||
147511731|NCT02565615|532026056|FG004|Overall Study|Reason not defined|62|||
147511732|NCT02565615|532026052|FG000|Overall Study|Adverse Event|1|||
147511733|NCT02565615|532026053|FG001|Overall Study|Adverse Event|1|||
147511734|NCT02565615|532026054|FG002|Overall Study|Adverse Event|0|||
147511735|NCT02565615|532026055|FG003|Overall Study|Adverse Event|0|||
147511736|NCT02565615|532026056|FG004|Overall Study|Adverse Event|9|||
147511737|NCT02565615|532026052|FG000|Overall Study|Untreated|0|||
147511738|NCT02565615|532026053|FG001|Overall Study|Untreated|0|||
147511739|NCT02565615|532026054|FG002|Overall Study|Untreated|0|||
147511740|NCT02565615|532026055|FG003|Overall Study|Untreated|0|||
147511741|NCT02565615|532026056|FG004|Overall Study|Untreated|567|||
147511742|NCT05563714|532026060|FG000|Overall Study|Death|2|||
147511743|NCT05563714|532026061|FG001|Overall Study|Death|2|||
147511744|NCT05563714|532026062|FG002|Overall Study|Death|0|||
147511745|NCT05563714|532026063|FG003|Overall Study|Death|0|||
147511746|NCT05563714|532026060|FG000|Overall Study|Patient unenrollment from Anticoagulation Monitoring Service prior to primary outcome assessment|4|||
147511747|NCT05563714|532026061|FG001|Overall Study|Patient unenrollment from Anticoagulation Monitoring Service prior to primary outcome assessment|3|||
147511748|NCT05563714|532026062|FG002|Overall Study|Patient unenrollment from Anticoagulation Monitoring Service prior to primary outcome assessment|0|||
147511749|NCT05563714|532026063|FG003|Overall Study|Patient unenrollment from Anticoagulation Monitoring Service prior to primary outcome assessment|0|||
147511750|NCT05563714|532026060|FG000|Overall Study|Patient medication change - warfarin discontinuation, switch to DOAC therapy|1|||
147511751|NCT05563714|532026061|FG001|Overall Study|Patient medication change - warfarin discontinuation, switch to DOAC therapy|2|||
147511752|NCT05563714|532026062|FG002|Overall Study|Patient medication change - warfarin discontinuation, switch to DOAC therapy|0|||
147511753|NCT05563714|532026063|FG003|Overall Study|Patient medication change - warfarin discontinuation, switch to DOAC therapy|0|||
147511754|NCT05563714|532026060|FG000|Overall Study|Patient hospitalized for entirety of primary outcome assessment timeframe|0|||
147511755|NCT05563714|532026061|FG001|Overall Study|Patient hospitalized for entirety of primary outcome assessment timeframe|1|||
147511756|NCT05563714|532026062|FG002|Overall Study|Patient hospitalized for entirety of primary outcome assessment timeframe|0|||
147511757|NCT05563714|532026063|FG003|Overall Study|Patient hospitalized for entirety of primary outcome assessment timeframe|0|||
147511758|NCT05563714|532026060|FG000|Overall Study|Lost to Follow-up|22|||
147511759|NCT05563714|532026061|FG001|Overall Study|Lost to Follow-up|19|||
147511760|NCT05563714|532026062|FG002|Overall Study|Lost to Follow-up|0|||
147511761|NCT05563714|532026063|FG003|Overall Study|Lost to Follow-up|0|||
147511762|NCT02120352|532026066|FG000|Induction Period (20 Weeks)|Adverse Event|3|||
147511763|NCT02120352|532026067|FG001|Induction Period (20 Weeks)|Adverse Event|0|||
147511764|NCT02120352|532026068|FG002|Induction Period (20 Weeks)|Adverse Event|0|||
147511765|NCT02120352|532026069|FG003|Induction Period (20 Weeks)|Adverse Event|0|||
147511766|NCT02120352|532026070|FG004|Induction Period (20 Weeks)|Adverse Event|0|||
147511767|NCT02120352|532026071|FG005|Induction Period (20 Weeks)|Adverse Event|0|||
147511768|NCT02120352|532026072|FG006|Induction Period (20 Weeks)|Adverse Event|0|||
147511769|NCT02120352|532026066|FG000|Induction Period (20 Weeks)|Lack of Efficacy|5|||
147511770|NCT02120352|532026067|FG001|Induction Period (20 Weeks)|Lack of Efficacy|0|||
147511771|NCT02120352|532026068|FG002|Induction Period (20 Weeks)|Lack of Efficacy|0|||
147511772|NCT02120352|532026069|FG003|Induction Period (20 Weeks)|Lack of Efficacy|0|||
147640214|NCT04777201|532501481|FG002|Main Study|Reason not specified|0|||
147640215|NCT04777201|532501479|FG000|Main Study|Lack of Efficacy|1|||
147640216|NCT04777201|532501480|FG001|Main Study|Lack of Efficacy|1|||
147640217|NCT04777201|532501481|FG002|Main Study|Lack of Efficacy|0|||
147640218|NCT04777201|532501479|FG000|Main Study|Protocol Violation|1|||
147640219|NCT04777201|532501480|FG001|Main Study|Protocol Violation|0|||
147640220|NCT04777201|532501481|FG002|Main Study|Protocol Violation|0|||
147640221|NCT04777201|532501479|FG000|Substudy (Concurrent With Main Study)|Withdrawal by Subject|0|||
147640222|NCT04777201|532501480|FG001|Substudy (Concurrent With Main Study)|Withdrawal by Subject|0|||
147640223|NCT04777201|532501481|FG002|Substudy (Concurrent With Main Study)|Withdrawal by Subject|4|||
147640224|NCT04777201|532501479|FG000|Substudy (Concurrent With Main Study)|Prohibited Medication|0|||
147640225|NCT04777201|532501480|FG001|Substudy (Concurrent With Main Study)|Prohibited Medication|0|||
147640226|NCT04777201|532501481|FG002|Substudy (Concurrent With Main Study)|Prohibited Medication|2|||
147640227|NCT04777201|532501479|FG000|Substudy (Concurrent With Main Study)|Adverse Event|0|||
147511773|NCT02120352|532026070|FG004|Induction Period (20 Weeks)|Lack of Efficacy|0|||
147511774|NCT02120352|532026071|FG005|Induction Period (20 Weeks)|Lack of Efficacy|0|||
147511775|NCT02120352|532026072|FG006|Induction Period (20 Weeks)|Lack of Efficacy|0|||
147511776|NCT02120352|532026066|FG000|Induction Period (20 Weeks)|Protocol Violation|2|||
147511777|NCT02120352|532026067|FG001|Induction Period (20 Weeks)|Protocol Violation|0|||
147511778|NCT02120352|532026068|FG002|Induction Period (20 Weeks)|Protocol Violation|0|||
147511779|NCT02120352|532026069|FG003|Induction Period (20 Weeks)|Protocol Violation|0|||
147511780|NCT02120352|532026070|FG004|Induction Period (20 Weeks)|Protocol Violation|0|||
147511781|NCT02120352|532026071|FG005|Induction Period (20 Weeks)|Protocol Violation|0|||
147511782|NCT02120352|532026072|FG006|Induction Period (20 Weeks)|Protocol Violation|0|||
147511783|NCT02120352|532026066|FG000|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|3|||
147511784|NCT02120352|532026067|FG001|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
147511785|NCT02120352|532026068|FG002|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
147511786|NCT02120352|532026069|FG003|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
147511787|NCT02120352|532026070|FG004|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
147511788|NCT02120352|532026071|FG005|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
147511789|NCT02120352|532026072|FG006|Induction Period (20 Weeks)|Met protocol-defined stopping criteria|0|||
147511790|NCT02120352|532026066|FG000|Induction Period (20 Weeks)|Lost to Follow-up|2|||
147511791|NCT02120352|532026067|FG001|Induction Period (20 Weeks)|Lost to Follow-up|0|||
147511792|NCT02120352|532026068|FG002|Induction Period (20 Weeks)|Lost to Follow-up|0|||
147511793|NCT02120352|532026069|FG003|Induction Period (20 Weeks)|Lost to Follow-up|0|||
147511794|NCT02120352|532026070|FG004|Induction Period (20 Weeks)|Lost to Follow-up|0|||
147511795|NCT02120352|532026071|FG005|Induction Period (20 Weeks)|Lost to Follow-up|0|||
147511796|NCT02120352|532026072|FG006|Induction Period (20 Weeks)|Lost to Follow-up|0|||
147511797|NCT02120352|532026066|FG000|Induction Period (20 Weeks)|Withdrawal by Subject|5|||
147511798|NCT02120352|532026067|FG001|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
147511799|NCT02120352|532026068|FG002|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
147511800|NCT02120352|532026069|FG003|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
147511801|NCT02120352|532026070|FG004|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
147511802|NCT02120352|532026071|FG005|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
147511803|NCT02120352|532026072|FG006|Induction Period (20 Weeks)|Withdrawal by Subject|0|||
147511804|NCT02120352|532026066|FG000|Induction Period (20 Weeks)|Physician Decision|1|||
147511805|NCT02120352|532026067|FG001|Induction Period (20 Weeks)|Physician Decision|0|||
147511806|NCT02120352|532026068|FG002|Induction Period (20 Weeks)|Physician Decision|0|||
147511807|NCT02120352|532026069|FG003|Induction Period (20 Weeks)|Physician Decision|0|||
147511808|NCT02120352|532026070|FG004|Induction Period (20 Weeks)|Physician Decision|0|||
147511809|NCT02120352|532026071|FG005|Induction Period (20 Weeks)|Physician Decision|0|||
147511810|NCT02120352|532026072|FG006|Induction Period (20 Weeks)|Physician Decision|0|||
147511811|NCT02120352|532026066|FG000|Maintenance Period (Up to Week 96)|Adverse Event|0|||
147511812|NCT02120352|532026067|FG001|Maintenance Period (Up to Week 96)|Adverse Event|1|||
147511813|NCT02120352|532026068|FG002|Maintenance Period (Up to Week 96)|Adverse Event|8|||
147511814|NCT02120352|532026069|FG003|Maintenance Period (Up to Week 96)|Adverse Event|1|||
147511815|NCT02120352|532026070|FG004|Maintenance Period (Up to Week 96)|Adverse Event|0|||
147511816|NCT02120352|532026071|FG005|Maintenance Period (Up to Week 96)|Adverse Event|0|||
147511817|NCT02120352|532026072|FG006|Maintenance Period (Up to Week 96)|Adverse Event|0|||
147511818|NCT02120352|532026066|FG000|Maintenance Period (Up to Week 96)|Lack of Efficacy|0|||
147511819|NCT02120352|532026067|FG001|Maintenance Period (Up to Week 96)|Lack of Efficacy|1|||
147511820|NCT02120352|532026068|FG002|Maintenance Period (Up to Week 96)|Lack of Efficacy|0|||
147511821|NCT02120352|532026069|FG003|Maintenance Period (Up to Week 96)|Lack of Efficacy|1|||
147511822|NCT02120352|532026070|FG004|Maintenance Period (Up to Week 96)|Lack of Efficacy|0|||
147511823|NCT02120352|532026071|FG005|Maintenance Period (Up to Week 96)|Lack of Efficacy|0|||
147511824|NCT02120352|532026072|FG006|Maintenance Period (Up to Week 96)|Lack of Efficacy|0|||
147511825|NCT02120352|532026066|FG000|Maintenance Period (Up to Week 96)|Protocol Violation|0|||
147511826|NCT02120352|532026067|FG001|Maintenance Period (Up to Week 96)|Protocol Violation|1|||
147511827|NCT02120352|532026068|FG002|Maintenance Period (Up to Week 96)|Protocol Violation|2|||
147511828|NCT02120352|532026069|FG003|Maintenance Period (Up to Week 96)|Protocol Violation|0|||
147511829|NCT02120352|532026070|FG004|Maintenance Period (Up to Week 96)|Protocol Violation|0|||
147511830|NCT02120352|532026071|FG005|Maintenance Period (Up to Week 96)|Protocol Violation|0|||
147511831|NCT02120352|532026072|FG006|Maintenance Period (Up to Week 96)|Protocol Violation|0|||
147511832|NCT02120352|532026066|FG000|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|0|||
147511833|NCT02120352|532026067|FG001|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|0|||
147511834|NCT02120352|532026068|FG002|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|1|||
147511835|NCT02120352|532026069|FG003|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|1|||
147511836|NCT02120352|532026070|FG004|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|0|||
147511837|NCT02120352|532026071|FG005|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|0|||
147511838|NCT02120352|532026072|FG006|Maintenance Period (Up to Week 96)|Met protocol-defined stopping criteria|0|||
147511839|NCT02120352|532026066|FG000|Maintenance Period (Up to Week 96)|Lost to Follow-up|0|||
147511840|NCT02120352|532026067|FG001|Maintenance Period (Up to Week 96)|Lost to Follow-up|0|||
147671108|NCT04082429|532620197|FG004|Main Part (Before the Treatment Pause)|Withdrawal by Subject|3|||
147671109|NCT04082429|532620198|FG005|Main Part (Before the Treatment Pause)|Withdrawal by Subject|0|||
147671110|NCT04082429|532620199|FG006|Main Part (Before the Treatment Pause)|Withdrawal by Subject|0|||
147671111|NCT04082429|532620200|FG007|Main Part (Before the Treatment Pause)|Withdrawal by Subject|0|||
147671112|NCT04082429|532620201|FG008|Main Part (Before the Treatment Pause)|Withdrawal by Subject|0|||
147671113|NCT04082429|532620193|FG000|Main Part (Before the Treatment Pause)|Physician Decision|0|||
147671114|NCT04082429|532620194|FG001|Main Part (Before the Treatment Pause)|Physician Decision|0|||
147671115|NCT04082429|532620195|FG002|Main Part (Before the Treatment Pause)|Physician Decision|0|||
147671116|NCT04082429|532620196|FG003|Main Part (Before the Treatment Pause)|Physician Decision|0|||
147671117|NCT04082429|532620197|FG004|Main Part (Before the Treatment Pause)|Physician Decision|2|||
147671118|NCT04082429|532620198|FG005|Main Part (Before the Treatment Pause)|Physician Decision|0|||
147671119|NCT04082429|532620199|FG006|Main Part (Before the Treatment Pause)|Physician Decision|0|||
147511841|NCT02120352|532026068|FG002|Maintenance Period (Up to Week 96)|Lost to Follow-up|0|||
147511842|NCT02120352|532026069|FG003|Maintenance Period (Up to Week 96)|Lost to Follow-up|1|||
147511843|NCT02120352|532026070|FG004|Maintenance Period (Up to Week 96)|Lost to Follow-up|0|||
147671120|NCT04082429|532620200|FG007|Main Part (Before the Treatment Pause)|Physician Decision|0|||
147671121|NCT04082429|532620201|FG008|Main Part (Before the Treatment Pause)|Physician Decision|0|||
147671122|NCT04082429|532620193|FG000|Main Part (After the Treatment Pause)|Death|0|||
147671123|NCT04082429|532620194|FG001|Main Part (After the Treatment Pause)|Death|0|||
147511844|NCT02120352|532026071|FG005|Maintenance Period (Up to Week 96)|Lost to Follow-up|0|||
147511845|NCT02120352|532026072|FG006|Maintenance Period (Up to Week 96)|Lost to Follow-up|0|||
147671124|NCT04082429|532620195|FG002|Main Part (After the Treatment Pause)|Death|0|||
147671125|NCT04082429|532620196|FG003|Main Part (After the Treatment Pause)|Death|0|||
147671126|NCT04082429|532620197|FG004|Main Part (After the Treatment Pause)|Death|1|||
147671127|NCT04082429|532620198|FG005|Main Part (After the Treatment Pause)|Death|0|||
147671128|NCT04082429|532620199|FG006|Main Part (After the Treatment Pause)|Death|0|||
147671129|NCT04082429|532620200|FG007|Main Part (After the Treatment Pause)|Death|0|||
147671130|NCT04082429|532620201|FG008|Main Part (After the Treatment Pause)|Death|0|||
147671131|NCT04082429|532620193|FG000|Main Part (After the Treatment Pause)|Physician Decision|0|||
147671132|NCT04082429|532620194|FG001|Main Part (After the Treatment Pause)|Physician Decision|0|||
147671133|NCT04082429|532620195|FG002|Main Part (After the Treatment Pause)|Physician Decision|0|||
147671134|NCT04082429|532620196|FG003|Main Part (After the Treatment Pause)|Physician Decision|2|||
147671135|NCT04082429|532620197|FG004|Main Part (After the Treatment Pause)|Physician Decision|0|||
147671136|NCT04082429|532620198|FG005|Main Part (After the Treatment Pause)|Physician Decision|1|||
147671137|NCT04082429|532620199|FG006|Main Part (After the Treatment Pause)|Physician Decision|0|||
147671138|NCT04082429|532620200|FG007|Main Part (After the Treatment Pause)|Physician Decision|0|||
147671139|NCT04082429|532620201|FG008|Main Part (After the Treatment Pause)|Physician Decision|0|||
147671140|NCT04082429|532620193|FG000|Main Part (After the Treatment Pause)|Withdrawal by Subject|0|||
147671141|NCT04082429|532620194|FG001|Main Part (After the Treatment Pause)|Withdrawal by Subject|0|||
147671142|NCT04082429|532620195|FG002|Main Part (After the Treatment Pause)|Withdrawal by Subject|1|||
147671143|NCT04082429|532620196|FG003|Main Part (After the Treatment Pause)|Withdrawal by Subject|1|||
147671144|NCT04082429|532620197|FG004|Main Part (After the Treatment Pause)|Withdrawal by Subject|0|||
147511846|NCT02120352|532026066|FG000|Maintenance Period (Up to Week 96)|Withdrawal by Subject|0|||
147511847|NCT02120352|532026067|FG001|Maintenance Period (Up to Week 96)|Withdrawal by Subject|1|||
147511848|NCT02120352|532026068|FG002|Maintenance Period (Up to Week 96)|Withdrawal by Subject|3|||
147511849|NCT02120352|532026069|FG003|Maintenance Period (Up to Week 96)|Withdrawal by Subject|5|||
147511850|NCT02120352|532026070|FG004|Maintenance Period (Up to Week 96)|Withdrawal by Subject|0|||
147511851|NCT02120352|532026071|FG005|Maintenance Period (Up to Week 96)|Withdrawal by Subject|0|||
147511852|NCT02120352|532026072|FG006|Maintenance Period (Up to Week 96)|Withdrawal by Subject|0|||
147511853|NCT02120352|532026066|FG000|Maintenance Period (Up to Week 96)|Physician Decision|0|||
147511854|NCT02120352|532026067|FG001|Maintenance Period (Up to Week 96)|Physician Decision|1|||
147511855|NCT02120352|532026068|FG002|Maintenance Period (Up to Week 96)|Physician Decision|0|||
147511856|NCT02120352|532026069|FG003|Maintenance Period (Up to Week 96)|Physician Decision|0|||
147511857|NCT02120352|532026070|FG004|Maintenance Period (Up to Week 96)|Physician Decision|0|||
147511858|NCT02120352|532026071|FG005|Maintenance Period (Up to Week 96)|Physician Decision|0|||
147511859|NCT02120352|532026072|FG006|Maintenance Period (Up to Week 96)|Physician Decision|0|||
147511860|NCT02120352|532026066|FG000|Extension Period (Week 97 to Study End)|Adverse Event|0|||
147511861|NCT02120352|532026067|FG001|Extension Period (Week 97 to Study End)|Adverse Event|3|||
147511862|NCT02120352|532026068|FG002|Extension Period (Week 97 to Study End)|Adverse Event|11|||
147511863|NCT02120352|532026069|FG003|Extension Period (Week 97 to Study End)|Adverse Event|0|||
147511864|NCT02120352|532026070|FG004|Extension Period (Week 97 to Study End)|Adverse Event|2|||
147511865|NCT02120352|532026071|FG005|Extension Period (Week 97 to Study End)|Adverse Event|1|||
147511866|NCT02120352|532026072|FG006|Extension Period (Week 97 to Study End)|Adverse Event|0|||
147511867|NCT02120352|532026066|FG000|Extension Period (Week 97 to Study End)|Lack of Efficacy|0|||
147511868|NCT02120352|532026067|FG001|Extension Period (Week 97 to Study End)|Lack of Efficacy|0|||
147511869|NCT02120352|532026068|FG002|Extension Period (Week 97 to Study End)|Lack of Efficacy|0|||
147511870|NCT02120352|532026069|FG003|Extension Period (Week 97 to Study End)|Lack of Efficacy|0|||
147511871|NCT02120352|532026070|FG004|Extension Period (Week 97 to Study End)|Lack of Efficacy|1|||
147511872|NCT02120352|532026071|FG005|Extension Period (Week 97 to Study End)|Lack of Efficacy|0|||
147511873|NCT02120352|532026072|FG006|Extension Period (Week 97 to Study End)|Lack of Efficacy|0|||
147511874|NCT02120352|532026066|FG000|Extension Period (Week 97 to Study End)|Protocol Violation|0|||
147511875|NCT02120352|532026067|FG001|Extension Period (Week 97 to Study End)|Protocol Violation|1|||
147511876|NCT02120352|532026068|FG002|Extension Period (Week 97 to Study End)|Protocol Violation|1|||
147511877|NCT02120352|532026069|FG003|Extension Period (Week 97 to Study End)|Protocol Violation|0|||
147511878|NCT02120352|532026070|FG004|Extension Period (Week 97 to Study End)|Protocol Violation|2|||
147511879|NCT02120352|532026071|FG005|Extension Period (Week 97 to Study End)|Protocol Violation|0|||
147511880|NCT02120352|532026072|FG006|Extension Period (Week 97 to Study End)|Protocol Violation|0|||
147511881|NCT02120352|532026066|FG000|Extension Period (Week 97 to Study End)|Withdrawal by Subject|0|||
147511882|NCT02120352|532026067|FG001|Extension Period (Week 97 to Study End)|Withdrawal by Subject|7|||
147511883|NCT02120352|532026068|FG002|Extension Period (Week 97 to Study End)|Withdrawal by Subject|9|||
147511884|NCT02120352|532026069|FG003|Extension Period (Week 97 to Study End)|Withdrawal by Subject|0|||
147511885|NCT02120352|532026070|FG004|Extension Period (Week 97 to Study End)|Withdrawal by Subject|2|||
147511886|NCT02120352|532026071|FG005|Extension Period (Week 97 to Study End)|Withdrawal by Subject|0|||
147511887|NCT02120352|532026072|FG006|Extension Period (Week 97 to Study End)|Withdrawal by Subject|0|||
147511888|NCT02120352|532026066|FG000|Extension Period (Week 97 to Study End)|Lost to Follow-up|0|||
147511889|NCT02120352|532026067|FG001|Extension Period (Week 97 to Study End)|Lost to Follow-up|2|||
147511890|NCT02120352|532026068|FG002|Extension Period (Week 97 to Study End)|Lost to Follow-up|1|||
147511891|NCT02120352|532026069|FG003|Extension Period (Week 97 to Study End)|Lost to Follow-up|0|||
147511892|NCT02120352|532026070|FG004|Extension Period (Week 97 to Study End)|Lost to Follow-up|1|||
147511893|NCT02120352|532026071|FG005|Extension Period (Week 97 to Study End)|Lost to Follow-up|0|||
147511894|NCT02120352|532026072|FG006|Extension Period (Week 97 to Study End)|Lost to Follow-up|0|||
147511895|NCT02120352|532026066|FG000|Extension Period (Week 97 to Study End)|Physician Decision|0|||
147511896|NCT02120352|532026067|FG001|Extension Period (Week 97 to Study End)|Physician Decision|2|||
147511897|NCT02120352|532026068|FG002|Extension Period (Week 97 to Study End)|Physician Decision|2|||
147511898|NCT02120352|532026069|FG003|Extension Period (Week 97 to Study End)|Physician Decision|0|||
147511899|NCT02120352|532026070|FG004|Extension Period (Week 97 to Study End)|Physician Decision|0|||
147511900|NCT02120352|532026071|FG005|Extension Period (Week 97 to Study End)|Physician Decision|0|||
147511901|NCT02120352|532026072|FG006|Extension Period (Week 97 to Study End)|Physician Decision|0|||
147511902|NCT02120352|532026066|FG000|Extension Period (Week 97 to Study End)|Site closed|0|||
147511903|NCT02120352|532026067|FG001|Extension Period (Week 97 to Study End)|Site closed|0|||
147511904|NCT02120352|532026068|FG002|Extension Period (Week 97 to Study End)|Site closed|1|||
147511905|NCT02120352|532026069|FG003|Extension Period (Week 97 to Study End)|Site closed|0|||
147511906|NCT02120352|532026070|FG004|Extension Period (Week 97 to Study End)|Site closed|0|||
147511907|NCT02120352|532026071|FG005|Extension Period (Week 97 to Study End)|Site closed|1|||
147511908|NCT02120352|532026072|FG006|Extension Period (Week 97 to Study End)|Site closed|0|||
147511909|NCT02120352|532026066|FG000|Long-Term Follow-up Period (52 Weeks)|Other|0|||
147511910|NCT02120352|532026067|FG001|Long-Term Follow-up Period (52 Weeks)|Other|0|||
147511911|NCT02120352|532026068|FG002|Long-Term Follow-up Period (52 Weeks)|Other|0|||
147511912|NCT02120352|532026069|FG003|Long-Term Follow-up Period (52 Weeks)|Other|0|||
147511913|NCT02120352|532026070|FG004|Long-Term Follow-up Period (52 Weeks)|Other|0|||
147511914|NCT02120352|532026071|FG005|Long-Term Follow-up Period (52 Weeks)|Other|0|||
147511915|NCT02120352|532026072|FG006|Long-Term Follow-up Period (52 Weeks)|Other|6|||
147511916|NCT02427100|532026073|FG000|Overall Study|Lost to Follow-up|0|||
147511917|NCT02427100|532026074|FG001|Overall Study|Lost to Follow-up|2|||
147511918|NCT01610206|532026075|FG000|Overall Study|Adverse Event|10|||
147511919|NCT01610206|532026076|FG001|Overall Study|Adverse Event|30|||
147511920|NCT01929707|532026078|FG000|Intervention Period 1|Lost to Follow-up|0|||
147511921|NCT01929707|532026079|FG001|Intervention Period 1|Lost to Follow-up|0|||
147511922|NCT01929707|532026080|FG002|Intervention Period 1|Lost to Follow-up|0|||
147511923|NCT01929707|532026081|FG003|Intervention Period 1|Lost to Follow-up|1|||
147511924|NCT01929707|532026082|FG004|Intervention Period 1|Lost to Follow-up|0|||
147511925|NCT01929707|532026083|FG005|Intervention Period 1|Lost to Follow-up|0|||
147511926|NCT01929707|532026084|FG006|Intervention Period 1|Lost to Follow-up|0|||
147511927|NCT01929707|532026085|FG007|Intervention Period 1|Lost to Follow-up|0|||
147511928|NCT01929707|532026078|FG000|Intervention Period 1|Withdrawal by Subject|0|||
147511929|NCT01929707|532026079|FG001|Intervention Period 1|Withdrawal by Subject|0|||
147511930|NCT01929707|532026080|FG002|Intervention Period 1|Withdrawal by Subject|0|||
147511931|NCT01929707|532026081|FG003|Intervention Period 1|Withdrawal by Subject|2|||
147671145|NCT04082429|532620198|FG005|Main Part (After the Treatment Pause)|Withdrawal by Subject|0|||
147511932|NCT01929707|532026082|FG004|Intervention Period 1|Withdrawal by Subject|0|||
147511933|NCT01929707|532026083|FG005|Intervention Period 1|Withdrawal by Subject|0|||
147511934|NCT01929707|532026084|FG006|Intervention Period 1|Withdrawal by Subject|0|||
147511935|NCT01929707|532026085|FG007|Intervention Period 1|Withdrawal by Subject|0|||
147511936|NCT01929707|532026078|FG000|Intervention Period 2|Withdrawal by Subject|0|||
147511937|NCT01929707|532026079|FG001|Intervention Period 2|Withdrawal by Subject|0|||
147511938|NCT01929707|532026080|FG002|Intervention Period 2|Withdrawal by Subject|0|||
147511939|NCT01929707|532026081|FG003|Intervention Period 2|Withdrawal by Subject|0|||
147511940|NCT01929707|532026082|FG004|Intervention Period 2|Withdrawal by Subject|0|||
147511941|NCT01929707|532026083|FG005|Intervention Period 2|Withdrawal by Subject|2|||
147511942|NCT01929707|532026084|FG006|Intervention Period 2|Withdrawal by Subject|0|||
147511943|NCT01929707|532026085|FG007|Intervention Period 2|Withdrawal by Subject|0|||
147511944|NCT00431496|532026092|FG000|Overall Study|Adverse Event|3|||
147511945|NCT00431496|532026092|FG000|Overall Study|Lost to Follow-up|1|||
147511946|NCT00431496|532026092|FG000|Overall Study|Withdrawal by Subject|2|||
147511947|NCT00431496|532026092|FG000|Overall Study|Protocol-specified criteria|5|||
147511948|NCT02343952|532026093|FG000|Study Treatment|Disease Progression|23|||
147511949|NCT02343952|532026093|FG000|Study Treatment|Death|3|||
147511950|NCT02343952|532026093|FG000|Study Treatment|Adverse Event|19|||
147511951|NCT02343952|532026093|FG000|Study Treatment|Withdrawal by Subject|7|||
147511952|NCT02343952|532026093|FG000|Study Treatment|other complicating Diseases|1|||
147511953|NCT02343952|532026093|FG000|Follow up|Withdrawal by Subject|3|||
147511954|NCT02343952|532026093|FG000|Follow up|Death|33|||
147511955|NCT02343952|532026093|FG000|Follow up|Patient does not meet eligibility for study.|1|||
147511956|NCT02343952|532026093|FG000|Follow up|Research department closed by the practice.|5|||
147511957|NCT02343952|532026093|FG000|Follow up|Patient went home to Russia|1|||
147511958|NCT02343952|532026093|FG000|Follow up|Disease Progression|1|||
147511959|NCT02343952|532026093|FG000|Follow up|study terminated|1|||
147511960|NCT01915095|532026094|FG000|Overall Study|Some subjects were unable to commit to the training study.|0|||
147511961|NCT01915095|532026095|FG001|Overall Study|Some subjects were unable to commit to the training study.|0|||
147511962|NCT01915095|532026096|FG002|Overall Study|Some subjects were unable to commit to the training study.|0|||
147511963|NCT01915095|532026097|FG003|Overall Study|Some subjects were unable to commit to the training study.|4|||
147511964|NCT01915095|532026098|FG004|Overall Study|Some subjects were unable to commit to the training study.|6|||
147511965|NCT02067533|532026099|FG000|Overall Study|Lost to Follow-up|4|||
147511966|NCT02067533|532026100|FG001|Overall Study|Lost to Follow-up|2|||
147511967|NCT00845845|532026101|FG000|Overall Study|Lost to Follow-up|0|||
147511968|NCT00845845|532026102|FG001|Overall Study|Lost to Follow-up|4|||
147511969|NCT00383708|532026103|FG000|Enrolment Through Start Treatment|Withdrawal by Subject|1|||
147511970|NCT00383708|532026103|FG000|Enrolment Through Start Treatment|Did not meet entry criteria|32|||
147511971|NCT00383708|532026103|FG000|Run-in Period|Protocol Violation|4|||
147511972|NCT00383708|532026103|FG000|Run-in Period|Adverse Event|2|||
147511973|NCT00383708|532026103|FG000|Run-in Period|Claustrophobia|1|||
147511974|NCT00383708|532026103|FG000|Co-administration Period|Adverse Event|5|||
147511975|NCT00318370|532026104|FG000|Period 1|Lack of Efficacy|5|||
147511976|NCT00318370|532026105|FG001|Period 1|Lack of Efficacy|0|||
147511977|NCT00318370|532026106|FG002|Period 1|Lack of Efficacy|0|||
147511978|NCT00318370|532026104|FG000|Period 1|Physician Decision|1|||
147511979|NCT00318370|532026105|FG001|Period 1|Physician Decision|0|||
147511980|NCT00318370|532026106|FG002|Period 1|Physician Decision|0|||
147511981|NCT00318370|532026104|FG000|Period 1|Withdrawal by Subject|1|||
147511982|NCT00318370|532026105|FG001|Period 1|Withdrawal by Subject|0|||
147511983|NCT00318370|532026106|FG002|Period 1|Withdrawal by Subject|0|||
147511984|NCT00318370|532026104|FG000|Period 2|Adverse Event|0|||
147511985|NCT00318370|532026105|FG001|Period 2|Adverse Event|3|||
147511986|NCT00318370|532026106|FG002|Period 2|Adverse Event|0|||
147511987|NCT00318370|532026104|FG000|Period 2|Lack of Efficacy|0|||
147511988|NCT00318370|532026105|FG001|Period 2|Lack of Efficacy|5|||
147511989|NCT00318370|532026106|FG002|Period 2|Lack of Efficacy|0|||
147511990|NCT00318370|532026104|FG000|Period 2|Physician Decision|0|||
147511991|NCT00318370|532026105|FG001|Period 2|Physician Decision|1|||
147511992|NCT00318370|532026106|FG002|Period 2|Physician Decision|0|||
147511993|NCT00318370|532026104|FG000|Period 2|Withdrawal by Subject|0|||
147511994|NCT00318370|532026105|FG001|Period 2|Withdrawal by Subject|1|||
147511995|NCT00318370|532026106|FG002|Period 2|Withdrawal by Subject|0|||
147511996|NCT00318370|532026104|FG000|Period 2|Other|0|||
147671146|NCT04082429|532620199|FG006|Main Part (After the Treatment Pause)|Withdrawal by Subject|0|||
147671147|NCT04082429|532620200|FG007|Main Part (After the Treatment Pause)|Withdrawal by Subject|1|||
147511997|NCT00318370|532026105|FG001|Period 2|Other|1|||
147511998|NCT00318370|532026106|FG002|Period 2|Other|0|||
147511999|NCT00318370|532026104|FG000|Period 3|Adverse Event|0|||
147512000|NCT00318370|532026105|FG001|Period 3|Adverse Event|0|||
147512001|NCT00318370|532026106|FG002|Period 3|Adverse Event|1|||
147512002|NCT00318370|532026104|FG000|Period 3|Lack of Efficacy|0|||
147512003|NCT00318370|532026105|FG001|Period 3|Lack of Efficacy|0|||
147512004|NCT00318370|532026106|FG002|Period 3|Lack of Efficacy|24|||
147512005|NCT00318370|532026104|FG000|Period 3|Death|0|||
147512006|NCT00318370|532026105|FG001|Period 3|Death|0|||
147512007|NCT00318370|532026106|FG002|Period 3|Death|1|||
147512008|NCT00318370|532026104|FG000|Period 3|Physician Decision|0|||
147512009|NCT00318370|532026105|FG001|Period 3|Physician Decision|0|||
147512010|NCT00318370|532026106|FG002|Period 3|Physician Decision|1|||
147512011|NCT00318370|532026104|FG000|Period 3|Withdrawal by Subject|0|||
147512012|NCT00318370|532026105|FG001|Period 3|Withdrawal by Subject|0|||
147512013|NCT00318370|532026106|FG002|Period 3|Withdrawal by Subject|3|||
147512014|NCT00318370|532026104|FG000|Period 3|Other|0|||
147512015|NCT00318370|532026105|FG001|Period 3|Other|0|||
147512016|NCT00318370|532026106|FG002|Period 3|Other|3|||
147512017|NCT01750840|532026108|FG000|Overall Study|Lost to Follow-up|4|||
147512018|NCT01997281|532026109|FG000|Overall Study|Withdrawal by Subject|1|||
147512019|NCT01997281|532026110|FG001|Overall Study|Withdrawal by Subject|0|||
147512020|NCT00560794|532026113|FG000|Overall Study|Adverse Event|2|||
147512021|NCT00560794|532026113|FG000|Overall Study|Patient was not Compliant|1|||
147512022|NCT00560794|532026113|FG000|Overall Study|Minimal Residual Disease Relapse|1|||
147512023|NCT00560794|532026113|FG000|Overall Study|Hematological Relapse|1|||
147512024|NCT00560794|532026113|FG000|Overall Study|Received Bone Marrow Transplant|6|||
147512025|NCT04507360|532027961|FG000|Week 1|Lost to Follow-up|0|||
147512026|NCT04507360|532027962|FG001|Week 1|Lost to Follow-up|0|||
147512027|NCT04507360|532027963|FG002|Week 1|Lost to Follow-up|0|||
147512028|NCT04507360|532027964|FG003|Week 1|Lost to Follow-up|0|||
147512029|NCT04507360|532027965|FG004|Week 1|Lost to Follow-up|0|||
147512030|NCT04507360|532027966|FG005|Week 1|Lost to Follow-up|0|||
147512031|NCT04507360|532027967|FG006|Week 1|Lost to Follow-up|0|||
147512032|NCT04507360|532027968|FG007|Week 1|Lost to Follow-up|0|||
147512033|NCT04507360|532027969|FG008|Week 1|Lost to Follow-up|72|||
147512034|NCT04507360|532027970|FG009|Week 1|Lost to Follow-up|22|||
147512035|NCT04507360|532027971|FG010|Week 1|Lost to Follow-up|10|||
147512036|NCT04507360|532027961|FG000|Week 2|Lost to Follow-up|0|||
147512037|NCT04507360|532027962|FG001|Week 2|Lost to Follow-up|0|||
147512038|NCT04507360|532027963|FG002|Week 2|Lost to Follow-up|0|||
147671148|NCT04082429|532620201|FG008|Main Part (After the Treatment Pause)|Withdrawal by Subject|5|||
147671149|NCT04082429|532620193|FG000|Main Part (After the Treatment Pause)|Unspecified reason|2|||
147671150|NCT04082429|532620194|FG001|Main Part (After the Treatment Pause)|Unspecified reason|0|||
147671151|NCT04082429|532620195|FG002|Main Part (After the Treatment Pause)|Unspecified reason|0|||
147671152|NCT04082429|532620196|FG003|Main Part (After the Treatment Pause)|Unspecified reason|0|||
147671153|NCT04082429|532620197|FG004|Main Part (After the Treatment Pause)|Unspecified reason|0|||
147671154|NCT04082429|532620198|FG005|Main Part (After the Treatment Pause)|Unspecified reason|1|||
147671155|NCT04082429|532620199|FG006|Main Part (After the Treatment Pause)|Unspecified reason|0|||
147671156|NCT04082429|532620200|FG007|Main Part (After the Treatment Pause)|Unspecified reason|0|||
147671157|NCT04082429|532620201|FG008|Main Part (After the Treatment Pause)|Unspecified reason|0|||
147671158|NCT04082429|532620193|FG000|Extension Part|Ongoing|0|||
147671159|NCT04082429|532620194|FG001|Extension Part|Ongoing|7|||
147671160|NCT04082429|532620195|FG002|Extension Part|Ongoing|17|||
147671161|NCT04082429|532620196|FG003|Extension Part|Ongoing|6|||
147671162|NCT04082429|532620197|FG004|Extension Part|Ongoing|45|||
147671163|NCT04082429|532620198|FG005|Extension Part|Ongoing|0|||
147671164|NCT04082429|532620199|FG006|Extension Part|Ongoing|10|||
147671165|NCT04082429|532620200|FG007|Extension Part|Ongoing|23|||
147671166|NCT04082429|532620201|FG008|Extension Part|Ongoing|25|||
147671167|NCT01920932|532620202|FG000|Overall Study|Death|1|||
147671168|NCT01920932|532620202|FG000|Overall Study|Withdrawal of consent|1|||
147671169|NCT05923112|532620205|FG000|Overall Study|Protocol Violation|4|||
147671170|NCT05923112|532620205|FG000|Overall Study|No informed consent on publication of study results|243|||
147671171|NCT03584152|532620208|FG000|Overall Study|Discontinued intervention|7|||
147512039|NCT04507360|532027964|FG003|Week 2|Lost to Follow-up|0|||
147512040|NCT04507360|532027965|FG004|Week 2|Lost to Follow-up|0|||
147512041|NCT04507360|532027966|FG005|Week 2|Lost to Follow-up|0|||
147512042|NCT04507360|532027967|FG006|Week 2|Lost to Follow-up|0|||
147512043|NCT04507360|532027968|FG007|Week 2|Lost to Follow-up|0|||
147512044|NCT04507360|532027969|FG008|Week 2|Lost to Follow-up|121|||
147512045|NCT04507360|532027970|FG009|Week 2|Lost to Follow-up|85|||
147512046|NCT04507360|532027971|FG010|Week 2|Lost to Follow-up|82|||
147671172|NCT03584152|532620209|FG001|Overall Study|Discontinued intervention|4|||
147512047|NCT04507360|532027961|FG000|Week 3|Lost to Follow-up|0|||
147671173|NCT04024462|532620210|FG000|Overall Study|Withdrawal by Subject|6|||
147671174|NCT04024462|532620211|FG001|Overall Study|Withdrawal by Subject|7|||
147671175|NCT04024462|532620210|FG000|Overall Study|Progressive Disease|0|||
147512048|NCT04507360|532027962|FG001|Week 3|Lost to Follow-up|0|||
147512049|NCT04507360|532027963|FG002|Week 3|Lost to Follow-up|0|||
147512050|NCT04507360|532027964|FG003|Week 3|Lost to Follow-up|0|||
147671176|NCT04024462|532620211|FG001|Overall Study|Progressive Disease|1|||
147671177|NCT04024462|532620210|FG000|Overall Study|Adverse Event|0|||
147671178|NCT04024462|532620211|FG001|Overall Study|Adverse Event|1|||
147512051|NCT04507360|532027965|FG004|Week 3|Lost to Follow-up|0|||
147512052|NCT04507360|532027966|FG005|Week 3|Lost to Follow-up|0|||
147512053|NCT04507360|532027967|FG006|Week 3|Lost to Follow-up|0|||
147512054|NCT04507360|532027968|FG007|Week 3|Lost to Follow-up|0|||
147512055|NCT04507360|532027969|FG008|Week 3|Lost to Follow-up|123|||
147512056|NCT04507360|532027970|FG009|Week 3|Lost to Follow-up|92|||
147512057|NCT04507360|532027971|FG010|Week 3|Lost to Follow-up|84|||
147512058|NCT04507360|532027961|FG000|Week 4|Lost to Follow-up|0|||
147512059|NCT04507360|532027962|FG001|Week 4|Lost to Follow-up|0|||
147512060|NCT04507360|532027963|FG002|Week 4|Lost to Follow-up|0|||
147512061|NCT04507360|532027964|FG003|Week 4|Lost to Follow-up|0|||
147671179|NCT04024462|532620210|FG000|Overall Study|Death|0|||
147671180|NCT04024462|532620211|FG001|Overall Study|Death|1|||
147671181|NCT04024462|532620210|FG000|Overall Study|Lost to Follow-up|1|||
147671182|NCT04024462|532620211|FG001|Overall Study|Lost to Follow-up|0|||
147671183|NCT04024462|532620210|FG000|Overall Study|Ongoing in the Study|94|||
147671184|NCT04024462|532620211|FG001|Overall Study|Ongoing in the Study|89|||
147671185|NCT03055013|532620215|FG000|Overall Study|Adverse Event|78|||
147671186|NCT03055013|532620216|FG001|Overall Study|Adverse Event|0|||
147671187|NCT03055013|532620215|FG000|Overall Study|Death|6|||
147671188|NCT03055013|532620216|FG001|Overall Study|Death|0|||
147671189|NCT03055013|532620215|FG000|Overall Study|Disease relapse|33|||
147671190|NCT03055013|532620216|FG001|Overall Study|Disease relapse|0|||
147671191|NCT03055013|532620215|FG000|Overall Study|Withdrawal by Subject|28|||
147512062|NCT04507360|532027965|FG004|Week 4|Lost to Follow-up|0|||
147512063|NCT04507360|532027966|FG005|Week 4|Lost to Follow-up|0|||
147512064|NCT04507360|532027967|FG006|Week 4|Lost to Follow-up|0|||
147512065|NCT04507360|532027968|FG007|Week 4|Lost to Follow-up|0|||
147512066|NCT04507360|532027969|FG008|Week 4|Lost to Follow-up|131|||
147512067|NCT04507360|532027970|FG009|Week 4|Lost to Follow-up|115|||
147512068|NCT04507360|532027971|FG010|Week 4|Lost to Follow-up|102|||
147512069|NCT04507360|532027961|FG000|Week 5|Lost to Follow-up|0|||
147512070|NCT04507360|532027962|FG001|Week 5|Lost to Follow-up|0|||
147512071|NCT04507360|532027963|FG002|Week 5|Lost to Follow-up|0|||
147512072|NCT04507360|532027964|FG003|Week 5|Lost to Follow-up|0|||
147512073|NCT04507360|532027965|FG004|Week 5|Lost to Follow-up|0|||
147512074|NCT04507360|532027966|FG005|Week 5|Lost to Follow-up|0|||
147512075|NCT04507360|532027967|FG006|Week 5|Lost to Follow-up|0|||
147512076|NCT04507360|532027968|FG007|Week 5|Lost to Follow-up|0|||
147512077|NCT04507360|532027969|FG008|Week 5|Lost to Follow-up|103|||
147512078|NCT04507360|532027970|FG009|Week 5|Lost to Follow-up|135|||
147512079|NCT04507360|532027971|FG010|Week 5|Lost to Follow-up|143|||
147512080|NCT04507360|532027961|FG000|Week 8|Lost to Follow-up|0|||
147512081|NCT04507360|532027962|FG001|Week 8|Lost to Follow-up|0|||
147512082|NCT04507360|532027963|FG002|Week 8|Lost to Follow-up|0|||
147512083|NCT04507360|532027964|FG003|Week 8|Lost to Follow-up|0|||
147512084|NCT04507360|532027965|FG004|Week 8|Lost to Follow-up|0|||
147512085|NCT04507360|532027966|FG005|Week 8|Lost to Follow-up|0|||
147512086|NCT04507360|532027967|FG006|Week 8|Lost to Follow-up|0|||
147512087|NCT04507360|532027968|FG007|Week 8|Lost to Follow-up|0|||
147512088|NCT04507360|532027969|FG008|Week 8|Lost to Follow-up|139|||
147512089|NCT04507360|532027970|FG009|Week 8|Lost to Follow-up|145|||
147512090|NCT04507360|532027971|FG010|Week 8|Lost to Follow-up|152|||
147512091|NCT01131078|532027976|FG000|Overall Study|Adverse Event|22|||
147512092|NCT01131078|532027977|FG001|Overall Study|Adverse Event|12|||
147512093|NCT01131078|532027978|FG002|Overall Study|Adverse Event|17|||
147512094|NCT01131078|532027976|FG000|Overall Study|Progressive Disease|58|||
147512095|NCT01131078|532027977|FG001|Overall Study|Progressive Disease|77|||
147512096|NCT01131078|532027978|FG002|Overall Study|Progressive Disease|71|||
147512097|NCT01131078|532027976|FG000|Overall Study|Protocol Violation|1|||
147512098|NCT01131078|532027977|FG001|Overall Study|Protocol Violation|0|||
147512099|NCT01131078|532027978|FG002|Overall Study|Protocol Violation|0|||
147512100|NCT01131078|532027976|FG000|Overall Study|Lost to Follow-up|1|||
147512101|NCT01131078|532027977|FG001|Overall Study|Lost to Follow-up|1|||
147512102|NCT01131078|532027978|FG002|Overall Study|Lost to Follow-up|1|||
147512103|NCT01131078|532027976|FG000|Overall Study|Withdrawal by Subject|2|||
147512104|NCT01131078|532027977|FG001|Overall Study|Withdrawal by Subject|4|||
147512105|NCT01131078|532027978|FG002|Overall Study|Withdrawal by Subject|3|||
147512106|NCT01131078|532027976|FG000|Overall Study|Non-compliance|3|||
147512107|NCT01131078|532027977|FG001|Overall Study|Non-compliance|0|||
147671192|NCT03055013|532620216|FG001|Overall Study|Withdrawal by Subject|0|||
147512108|NCT01131078|532027978|FG002|Overall Study|Non-compliance|0|||
147512109|NCT01131078|532027976|FG000|Overall Study|Physician Decision|10|||
147512110|NCT01131078|532027977|FG001|Overall Study|Physician Decision|6|||
147512111|NCT01131078|532027978|FG002|Overall Study|Physician Decision|8|||
147512112|NCT01131078|532027976|FG000|Overall Study|Death|4|||
147512113|NCT01131078|532027977|FG001|Overall Study|Death|0|||
147512114|NCT01131078|532027978|FG002|Overall Study|Death|2|||
147512115|NCT01131078|532027976|FG000|Overall Study|Other|0|||
147512116|NCT01131078|532027977|FG001|Overall Study|Other|1|||
147512117|NCT01131078|532027978|FG002|Overall Study|Other|0|||
147512118|NCT04315298|532027979|FG000|Overall Study|Withdrawal by Subject|0|||
147512119|NCT04315298|532027980|FG001|Overall Study|Withdrawal by Subject|0|||
147512120|NCT04315298|532027981|FG002|Overall Study|Withdrawal by Subject|0|||
147512121|NCT04315298|532027982|FG003|Overall Study|Withdrawal by Subject|2|||
147512122|NCT04315298|532027983|FG004|Overall Study|Withdrawal by Subject|2|||
147671193|NCT03055013|532620215|FG000|Overall Study|Other complicating disease|5|||
147671194|NCT03055013|532620216|FG001|Overall Study|Other complicating disease|0|||
147671195|NCT03055013|532620215|FG000|Overall Study|Physician Decision|1|||
147671196|NCT03055013|532620216|FG001|Overall Study|Physician Decision|0|||
147671197|NCT03055013|532620215|FG000|Overall Study|Benign mass/non-RCC|4|||
147671198|NCT03055013|532620216|FG001|Overall Study|Benign mass/non-RCC|0|||
147671199|NCT03055013|532620215|FG000|Overall Study|Enrolled in another trial|1|||
147671200|NCT03055013|532620216|FG001|Overall Study|Enrolled in another trial|0|||
147671201|NCT03055013|532620215|FG000|Overall Study|Non-protocol therapy|1|||
147671202|NCT03055013|532620216|FG001|Overall Study|Non-protocol therapy|0|||
147671203|NCT03055013|532620215|FG000|Overall Study|Incompliance|1|||
147671204|NCT03055013|532620216|FG001|Overall Study|Incompliance|0|||
147671205|NCT03055013|532620215|FG000|Overall Study|Insurance issues|1|||
147671206|NCT03055013|532620216|FG001|Overall Study|Insurance issues|0|||
147512123|NCT04315298|532027984|FG005|Overall Study|Withdrawal by Subject|2|||
147512124|NCT04315298|532027985|FG006|Overall Study|Withdrawal by Subject|0|||
147512125|NCT04315298|532027986|FG007|Overall Study|Withdrawal by Subject|1|||
147512126|NCT04315298|532027987|FG008|Overall Study|Withdrawal by Subject|1|||
147512127|NCT04315298|532027988|FG009|Overall Study|Withdrawal by Subject|1|||
147512128|NCT04315298|532027989|FG010|Overall Study|Withdrawal by Subject|0|||
147512129|NCT04315298|532027990|FG011|Overall Study|Withdrawal by Subject|0|||
147512130|NCT04315298|532027991|FG012|Overall Study|Withdrawal by Subject|0|||
147512131|NCT04315298|532027992|FG013|Overall Study|Withdrawal by Subject|0|||
147512132|NCT04315298|532027993|FG014|Overall Study|Withdrawal by Subject|0|||
147512133|NCT04315298|532027994|FG015|Overall Study|Withdrawal by Subject|0|||
147512134|NCT04315298|532027995|FG016|Overall Study|Withdrawal by Subject|0|||
147512135|NCT04315298|532027996|FG017|Overall Study|Withdrawal by Subject|0|||
147512136|NCT04315298|532027997|FG018|Overall Study|Withdrawal by Subject|0|||
147512137|NCT04315298|532027979|FG000|Overall Study|Physician Decision|0|||
147512138|NCT04315298|532027980|FG001|Overall Study|Physician Decision|0|||
147512139|NCT04315298|532027981|FG002|Overall Study|Physician Decision|0|||
147512140|NCT04315298|532027982|FG003|Overall Study|Physician Decision|0|||
147512141|NCT04315298|532027983|FG004|Overall Study|Physician Decision|1|||
147512142|NCT04315298|532027984|FG005|Overall Study|Physician Decision|0|||
147512143|NCT04315298|532027985|FG006|Overall Study|Physician Decision|0|||
147512144|NCT04315298|532027986|FG007|Overall Study|Physician Decision|0|||
147512145|NCT04315298|532027987|FG008|Overall Study|Physician Decision|0|||
147512146|NCT04315298|532027988|FG009|Overall Study|Physician Decision|0|||
147512147|NCT04315298|532027989|FG010|Overall Study|Physician Decision|0|||
147512148|NCT04315298|532027990|FG011|Overall Study|Physician Decision|0|||
147512149|NCT04315298|532027991|FG012|Overall Study|Physician Decision|0|||
147512150|NCT04315298|532027992|FG013|Overall Study|Physician Decision|0|||
147512151|NCT04315298|532027993|FG014|Overall Study|Physician Decision|0|||
147512152|NCT04315298|532027994|FG015|Overall Study|Physician Decision|0|||
147512153|NCT04315298|532027995|FG016|Overall Study|Physician Decision|0|||
147512154|NCT04315298|532027996|FG017|Overall Study|Physician Decision|0|||
147512155|NCT04315298|532027997|FG018|Overall Study|Physician Decision|0|||
147512156|NCT04315298|532027979|FG000|Overall Study|Lost to Follow-up|5|||
147512157|NCT04315298|532027980|FG001|Overall Study|Lost to Follow-up|10|||
147512158|NCT04315298|532027981|FG002|Overall Study|Lost to Follow-up|6|||
147512159|NCT04315298|532027982|FG003|Overall Study|Lost to Follow-up|8|||
147512160|NCT04315298|532027983|FG004|Overall Study|Lost to Follow-up|12|||
147512161|NCT04315298|532027984|FG005|Overall Study|Lost to Follow-up|13|||
147512162|NCT04315298|532027985|FG006|Overall Study|Lost to Follow-up|9|||
147512163|NCT04315298|532027986|FG007|Overall Study|Lost to Follow-up|16|||
147512164|NCT04315298|532027987|FG008|Overall Study|Lost to Follow-up|14|||
147512165|NCT04315298|532027988|FG009|Overall Study|Lost to Follow-up|0|||
147512166|NCT04315298|532027989|FG010|Overall Study|Lost to Follow-up|2|||
147512167|NCT04315298|532027990|FG011|Overall Study|Lost to Follow-up|1|||
147512168|NCT04315298|532027991|FG012|Overall Study|Lost to Follow-up|0|||
147512169|NCT04315298|532027992|FG013|Overall Study|Lost to Follow-up|0|||
147512170|NCT04315298|532027993|FG014|Overall Study|Lost to Follow-up|0|||
147512171|NCT04315298|532027994|FG015|Overall Study|Lost to Follow-up|2|||
147512172|NCT04315298|532027995|FG016|Overall Study|Lost to Follow-up|0|||
147512173|NCT04315298|532027996|FG017|Overall Study|Lost to Follow-up|0|||
147417999|NCT00700427|531694566|FG003|Study Period 4 (Open-Label Extension)|Physician Decision|0|||
147418000|NCT00700427|531694567|FG004|Study Period 4 (Open-Label Extension)|Physician Decision|2|||
147418001|NCT00700427|531694563|FG000|Study Period 4 (Open-Label Extension)|Sponsor Decision|0|||
147418002|NCT00700427|531694564|FG001|Study Period 4 (Open-Label Extension)|Sponsor Decision|0|||
147418003|NCT00700427|531694565|FG002|Study Period 4 (Open-Label Extension)|Sponsor Decision|0|||
147418004|NCT00700427|531694566|FG003|Study Period 4 (Open-Label Extension)|Sponsor Decision|0|||
147418005|NCT00700427|531694567|FG004|Study Period 4 (Open-Label Extension)|Sponsor Decision|2|||
147418006|NCT00700427|531694563|FG000|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0|||
147418007|NCT00700427|531694564|FG001|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0|||
147418008|NCT00700427|531694565|FG002|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0|||
147418009|NCT00700427|531694566|FG003|Study Period 4 (Open-Label Extension)|Lack of Efficacy|0|||
147418010|NCT00700427|531694567|FG004|Study Period 4 (Open-Label Extension)|Lack of Efficacy|1|||
147418011|NCT00700427|531694563|FG000|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0|||
147418012|NCT00700427|531694564|FG001|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0|||
147418013|NCT00700427|531694565|FG002|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0|||
147512174|NCT04315298|532027997|FG018|Overall Study|Lost to Follow-up|0|||
147512175|NCT04315298|532027979|FG000|Overall Study|Death|24|||
147512176|NCT04315298|532027980|FG001|Overall Study|Death|60|||
147512177|NCT04315298|532027981|FG002|Overall Study|Death|49|||
147512178|NCT04315298|532027982|FG003|Overall Study|Death|59|||
147512179|NCT04315298|532027983|FG004|Overall Study|Death|70|||
147512180|NCT04315298|532027984|FG005|Overall Study|Death|114|||
147512181|NCT04315298|532027985|FG006|Overall Study|Death|9|||
147512182|NCT04315298|532027986|FG007|Overall Study|Death|12|||
147512183|NCT04315298|532027987|FG008|Overall Study|Death|21|||
147512184|NCT04315298|532027988|FG009|Overall Study|Death|16|||
147512185|NCT04315298|532027989|FG010|Overall Study|Death|40|||
147512186|NCT04315298|532027990|FG011|Overall Study|Death|40|||
147512187|NCT04315298|532027991|FG012|Overall Study|Death|3|||
147512188|NCT04315298|532027992|FG013|Overall Study|Death|4|||
147512189|NCT04315298|532027993|FG014|Overall Study|Death|6|||
147512190|NCT04315298|532027994|FG015|Overall Study|Death|4|||
147512191|NCT04315298|532027995|FG016|Overall Study|Death|3|||
147512192|NCT04315298|532027996|FG017|Overall Study|Death|1|||
147512193|NCT04315298|532027997|FG018|Overall Study|Death|0|||
147512194|NCT01199198|532027998|FG000|Overall Study|Adverse Event|3|||
147512195|NCT01199198|532027999|FG001|Overall Study|Adverse Event|0|||
147512196|NCT01199198|532027998|FG000|Overall Study|Lost to Follow-up|1|||
147512197|NCT01199198|532027999|FG001|Overall Study|Lost to Follow-up|5|||
147512198|NCT01199198|532027998|FG000|Overall Study|Withdrawal by Subject|1|||
147512199|NCT01199198|532027999|FG001|Overall Study|Withdrawal by Subject|2|||
147512200|NCT01199198|532027998|FG000|Overall Study|ICU Transfer|1|||
147512201|NCT01199198|532027999|FG001|Overall Study|ICU Transfer|2|||
147512202|NCT01199198|532027998|FG000|Overall Study|Hospice-care transfer|1|||
147512203|NCT01199198|532027999|FG001|Overall Study|Hospice-care transfer|2|||
147512204|NCT00736385|532028000|FG000|Overall Study|Withdrawal by Subject|2|||
147512205|NCT00736385|532028001|FG001|Overall Study|Withdrawal by Subject|2|||
147512206|NCT00736385|532028000|FG000|Overall Study|Adverse Event|0|||
147512207|NCT00736385|532028001|FG001|Overall Study|Adverse Event|1|||
147512208|NCT03267511|532028002|FG000|Overall Study|Lost to Follow-up|0|||
147512209|NCT03267511|532028003|FG001|Overall Study|Lost to Follow-up|0|||
147512210|NCT03267511|532028004|FG002|Overall Study|Lost to Follow-up|0|||
147512211|NCT03267511|532028005|FG003|Overall Study|Lost to Follow-up|1|||
147512212|NCT01594749|532028006|FG000|Overall Study|Adverse Event|2|||
147512213|NCT01594749|532028007|FG001|Overall Study|Adverse Event|1|||
147512214|NCT01594749|532028006|FG000|Overall Study|Withdrawal by Subject|2|||
147512215|NCT01594749|532028007|FG001|Overall Study|Withdrawal by Subject|2|||
147512216|NCT01594749|532028006|FG000|Overall Study|Protocol Violation|2|||
147512217|NCT01594749|532028007|FG001|Overall Study|Protocol Violation|0|||
147512218|NCT01594749|532028006|FG000|Overall Study|Physician Decision|1|||
147512219|NCT01594749|532028007|FG001|Overall Study|Physician Decision|1|||
147512220|NCT01594749|532028006|FG000|Overall Study|Non-compliance with Protocol|0|||
147512221|NCT01594749|532028007|FG001|Overall Study|Non-compliance with Protocol|1|||
147512222|NCT01594749|532028006|FG000|Overall Study|Lost to Follow-up|1|||
147512223|NCT01594749|532028007|FG001|Overall Study|Lost to Follow-up|0|||
147512224|NCT01594749|532028006|FG000|Overall Study|Death|9|||
147512225|NCT01594749|532028007|FG001|Overall Study|Death|3|||
147512226|NCT01594749|532028006|FG000|Overall Study|Not Treated|4|||
147512227|NCT01594749|532028007|FG001|Overall Study|Not Treated|10|||
147512228|NCT01594749|532028006|FG000|Overall Study|Lost Source Documentation|1|||
147512229|NCT01594749|532028007|FG001|Overall Study|Lost Source Documentation|0|||
147512230|NCT00364351|532028008|FG000|Overall Study|Adverse Event|90|||
147512231|NCT00364351|532028009|FG001|Overall Study|Adverse Event|44|||
147512232|NCT00364351|532028008|FG000|Overall Study|Condition under investigation worsened|469|||
147512233|NCT00364351|532028009|FG001|Overall Study|Condition under investigation worsened|497|||
147512234|NCT00364351|532028008|FG000|Overall Study|Prohibited concomitant medication|0|||
147512235|NCT00364351|532028009|FG001|Overall Study|Prohibited concomitant medication|2|||
147512236|NCT00364351|532028008|FG000|Overall Study|Lost to Follow-up|1|||
147512237|NCT00364351|532028009|FG001|Overall Study|Lost to Follow-up|1|||
147512238|NCT00364351|532028008|FG000|Overall Study|Withdrawal by Subject|30|||
147512239|NCT00364351|532028009|FG001|Overall Study|Withdrawal by Subject|29|||
147512240|NCT00364351|532028008|FG000|Overall Study|Incorrect enrollment|1|||
147512241|NCT00364351|532028009|FG001|Overall Study|Incorrect enrollment|1|||
147512242|NCT00364351|532028008|FG000|Overall Study|Sponsor decision|1|||
147512243|NCT00364351|532028009|FG001|Overall Study|Sponsor decision|0|||
147512244|NCT00364351|532028008|FG000|Overall Study|Poor treatment compliance|0|||
147512245|NCT00364351|532028009|FG001|Overall Study|Poor treatment compliance|3|||
147512246|NCT00364351|532028008|FG000|Overall Study|Investigator error|0|||
147512247|NCT00364351|532028009|FG001|Overall Study|Investigator error|2|||
147512248|NCT00364351|532028008|FG000|Overall Study|Patient could not travel to site|0|||
147512249|NCT00364351|532028009|FG001|Overall Study|Patient could not travel to site|1|||
147512250|NCT00364351|532028008|FG000|Overall Study|Randomised treatment not started|0|||
147512251|NCT00364351|532028009|FG001|Overall Study|Randomised treatment not started|3|||
147512252|NCT00653068|532028010|FG000|Overall Study|Death|9|||
147512253|NCT00653068|532028010|FG000|Overall Study|Lack of Efficacy|34|||
147512254|NCT00653068|532028010|FG000|Overall Study|Physician Decision|4|||
147512255|NCT00653068|532028010|FG000|Overall Study|Withdrawal by Subject|1|||
147512256|NCT00653068|532028010|FG000|Overall Study|Ineligible|2|||
147418014|NCT00700427|531694566|FG003|Study Period 4 (Open-Label Extension)|Lost to Follow-up|0|||
147418015|NCT00700427|531694567|FG004|Study Period 4 (Open-Label Extension)|Lost to Follow-up|11|||
147418016|NCT00700427|531694563|FG000|Study Period 4 (Open-Label Extension)|Clinical Relapse|0|||
147418017|NCT00700427|531694564|FG001|Study Period 4 (Open-Label Extension)|Clinical Relapse|0|||
147418018|NCT00700427|531694565|FG002|Study Period 4 (Open-Label Extension)|Clinical Relapse|0|||
147512257|NCT03654560|532028015|FG000|Overall Study|Death|3|||
147512258|NCT03654560|532028016|FG001|Overall Study|Death|1|||
147512259|NCT03654560|532028015|FG000|Overall Study|Lost to Follow-up|1|||
147512260|NCT03654560|532028016|FG001|Overall Study|Lost to Follow-up|0|||
147512261|NCT00209092|532028017|FG000|Overall Study|Progression of disease|7|||
147512262|NCT00209092|532028018|FG001|Overall Study|Progression of disease|1|||
147512263|NCT00209092|532028017|FG000|Overall Study|Adverse Event|0|||
147512264|NCT00209092|532028018|FG001|Overall Study|Adverse Event|1|||
147512265|NCT00209092|532028017|FG000|Overall Study|Withdrawal by Subject|1|||
147512266|NCT00209092|532028018|FG001|Overall Study|Withdrawal by Subject|0|||
147512267|NCT01119963|532028022|FG000|Overall Study|Lost to Follow-up|1|||
147512268|NCT01119963|532028023|FG001|Overall Study|Lost to Follow-up|1|||
147512269|NCT03938636|532028024|FG000|Overall Study|Protocol Violation|0|||
147512270|NCT03938636|532028025|FG001|Overall Study|Protocol Violation|1|||
147512271|NCT03938636|532028026|FG002|Overall Study|Protocol Violation|1|||
147418019|NCT00700427|531694566|FG003|Study Period 4 (Open-Label Extension)|Clinical Relapse|0|||
147418020|NCT00700427|531694567|FG004|Study Period 4 (Open-Label Extension)|Clinical Relapse|1|||
147418021|NCT00560066|531694574|FG000|Overall Study|Death|2|||
147418022|NCT00560066|531694575|FG001|Overall Study|Death|1|||
147418023|NCT00560066|531694574|FG000|Overall Study|Withdrawal by Subject|0|||
147418024|NCT00560066|531694575|FG001|Overall Study|Withdrawal by Subject|3|||
147418025|NCT00560066|531694574|FG000|Overall Study|Lost to Follow-up|4|||
147418026|NCT00560066|531694575|FG001|Overall Study|Lost to Follow-up|10|||
147418027|NCT00560066|531694574|FG000|Overall Study|Protocol Violation|0|||
147418028|NCT00560066|531694575|FG001|Overall Study|Protocol Violation|1|||
147418029|NCT00560066|531694574|FG000|Overall Study|Administrative reason|0|||
147418030|NCT00560066|531694575|FG001|Overall Study|Administrative reason|5|||
147418031|NCT00560066|531694574|FG000|Overall Study|Missing primary reason|0|||
147418032|NCT00560066|531694575|FG001|Overall Study|Missing primary reason|2|||
147418033|NCT00506441|531694576|FG000|Period 1; Open-label Period|Adverse Event|21|||
147418034|NCT00506441|531694577|FG001|Period 1; Open-label Period|Adverse Event|0|||
147671207|NCT03055013|532620215|FG000|Overall Study|Did not receive nivolumab and surgery|38|||
147671208|NCT03055013|532620216|FG001|Overall Study|Did not receive nivolumab and surgery|0|||
147671209|NCT03055013|532620215|FG000|Overall Study|Did not receive nivolumab|10|||
147671210|NCT03055013|532620216|FG001|Overall Study|Did not receive nivolumab|0|||
147671211|NCT03055013|532620215|FG000|Overall Study|Did not receive surgery|0|||
147671212|NCT03055013|532620216|FG001|Overall Study|Did not receive surgery|28|||
147671213|NCT03118050|532620217|FG000|Overall Study|Did not meet inclusion criteria after signing consent form|14|||
147671214|NCT03118050|532620218|FG001|Overall Study|Did not meet inclusion criteria after signing consent form|5|||
147671215|NCT03118050|532620219|FG002|Overall Study|Did not meet inclusion criteria after signing consent form|6|||
147671216|NCT03118050|532620220|FG003|Overall Study|Did not meet inclusion criteria after signing consent form|5|||
147671217|NCT03118050|532620221|FG004|Overall Study|Did not meet inclusion criteria after signing consent form|4|||
147671218|NCT03118050|532620222|FG005|Overall Study|Did not meet inclusion criteria after signing consent form|6|||
147671219|NCT03118050|532620223|FG006|Overall Study|Did not meet inclusion criteria after signing consent form|5|||
147671220|NCT04991766|532620224|FG000|Overall Study|Withdrawal by Subject|2|||
147671221|NCT04991766|532620225|FG001|Overall Study|Withdrawal by Subject|0|||
147671222|NCT03466346|532620229|FG000|Stage 1 - 1st Line Trt (IPT or FLX)|Death|0|||
147671223|NCT03466346|532620230|FG001|Stage 1 - 1st Line Trt (IPT or FLX)|Death|3|||
147671224|NCT03466346|532620231|FG002|Stage 1 - 1st Line Trt (IPT or FLX)|Death|0|||
147671225|NCT03466346|532620232|FG003|Stage 1 - 1st Line Trt (IPT or FLX)|Death|0|||
147671226|NCT03466346|532620233|FG004|Stage 1 - 1st Line Trt (IPT or FLX)|Death|0|||
147671227|NCT03466346|532620229|FG000|Stage 1 - 1st Line Trt (IPT or FLX)|Physician Decision|12|||
147671228|NCT03466346|532620230|FG001|Stage 1 - 1st Line Trt (IPT or FLX)|Physician Decision|26|||
147671229|NCT03466346|532620231|FG002|Stage 1 - 1st Line Trt (IPT or FLX)|Physician Decision|0|||
147671230|NCT03466346|532620232|FG003|Stage 1 - 1st Line Trt (IPT or FLX)|Physician Decision|0|||
147512272|NCT03938636|532028024|FG000|Overall Study|Subject withdrew due to death in family|0|||
147512273|NCT03938636|532028025|FG001|Overall Study|Subject withdrew due to death in family|1|||
147512274|NCT03938636|532028026|FG002|Overall Study|Subject withdrew due to death in family|0|||
147512275|NCT03938636|532028024|FG000|Overall Study|Missed visit|0|||
147512276|NCT03938636|532028025|FG001|Overall Study|Missed visit|1|||
147512277|NCT03938636|532028026|FG002|Overall Study|Missed visit|0|||
147512278|NCT03938636|532028024|FG000|Overall Study|Adverse Event|0|||
147512279|NCT03938636|532028025|FG001|Overall Study|Adverse Event|0|||
147512280|NCT03938636|532028026|FG002|Overall Study|Adverse Event|1|||
147418035|NCT00506441|531694576|FG000|Period 1; Open-label Period|Lack of Efficacy|13|||
147671231|NCT03466346|532620233|FG004|Stage 1 - 1st Line Trt (IPT or FLX)|Physician Decision|0|||
147671232|NCT03466346|532620229|FG000|Stage 1 - 1st Line Trt (IPT or FLX)|Participant withdrawal or relocated|15|||
147671233|NCT03466346|532620230|FG001|Stage 1 - 1st Line Trt (IPT or FLX)|Participant withdrawal or relocated|31|||
147671234|NCT03466346|532620231|FG002|Stage 1 - 1st Line Trt (IPT or FLX)|Participant withdrawal or relocated|0|||
147671235|NCT03466346|532620232|FG003|Stage 1 - 1st Line Trt (IPT or FLX)|Participant withdrawal or relocated|0|||
147671236|NCT03466346|532620233|FG004|Stage 1 - 1st Line Trt (IPT or FLX)|Participant withdrawal or relocated|0|||
147671237|NCT03466346|532620229|FG000|Stage 1 - 1st Line Trt (IPT or FLX)|Lost to Follow-up|69|||
147671238|NCT03466346|532620230|FG001|Stage 1 - 1st Line Trt (IPT or FLX)|Lost to Follow-up|142|||
147671239|NCT03466346|532620231|FG002|Stage 1 - 1st Line Trt (IPT or FLX)|Lost to Follow-up|0|||
147671240|NCT03466346|532620232|FG003|Stage 1 - 1st Line Trt (IPT or FLX)|Lost to Follow-up|0|||
147671241|NCT03466346|532620233|FG004|Stage 1 - 1st Line Trt (IPT or FLX)|Lost to Follow-up|0|||
147671242|NCT03466346|532620229|FG000|Stage 2 - 2nd Line Trt (Combo or Switch)|Physician Decision|0|||
147671243|NCT03466346|532620230|FG001|Stage 2 - 2nd Line Trt (Combo or Switch)|Physician Decision|0|||
147671244|NCT03466346|532620231|FG002|Stage 2 - 2nd Line Trt (Combo or Switch)|Physician Decision|2|||
147671245|NCT03466346|532620232|FG003|Stage 2 - 2nd Line Trt (Combo or Switch)|Physician Decision|1|||
147512281|NCT03938636|532028024|FG000|Overall Study|Lost to Follow-up|0|||
147512282|NCT03938636|532028025|FG001|Overall Study|Lost to Follow-up|0|||
147671246|NCT03466346|532620233|FG004|Stage 2 - 2nd Line Trt (Combo or Switch)|Physician Decision|4|||
147671247|NCT03466346|532620229|FG000|Stage 2 - 2nd Line Trt (Combo or Switch)|Participant withdrawal or relocated|0|||
147671248|NCT03466346|532620230|FG001|Stage 2 - 2nd Line Trt (Combo or Switch)|Participant withdrawal or relocated|0|||
147512283|NCT03938636|532028026|FG002|Overall Study|Lost to Follow-up|1|||
147512284|NCT02579863|532028027|FG000|Overall Study|Final Disposition Unknown|2|||
147512285|NCT02579863|532028028|FG001|Overall Study|Final Disposition Unknown|1|||
147512286|NCT02579863|532028027|FG000|Overall Study|Adverse Event|18|||
147671249|NCT03466346|532620231|FG002|Stage 2 - 2nd Line Trt (Combo or Switch)|Participant withdrawal or relocated|0|||
147671250|NCT03466346|532620232|FG003|Stage 2 - 2nd Line Trt (Combo or Switch)|Participant withdrawal or relocated|2|||
147671251|NCT03466346|532620233|FG004|Stage 2 - 2nd Line Trt (Combo or Switch)|Participant withdrawal or relocated|2|||
147671252|NCT03466346|532620229|FG000|Stage 2 - 2nd Line Trt (Combo or Switch)|Lost to Follow-up|0|||
147671253|NCT03466346|532620230|FG001|Stage 2 - 2nd Line Trt (Combo or Switch)|Lost to Follow-up|0|||
147671254|NCT03466346|532620231|FG002|Stage 2 - 2nd Line Trt (Combo or Switch)|Lost to Follow-up|16|||
147671255|NCT03466346|532620232|FG003|Stage 2 - 2nd Line Trt (Combo or Switch)|Lost to Follow-up|24|||
147671256|NCT03466346|532620233|FG004|Stage 2 - 2nd Line Trt (Combo or Switch)|Lost to Follow-up|45|||
147671257|NCT00433511|532620244|FG000|Step 1|Adverse Event|50|||
147671258|NCT00433511|532620245|FG001|Step 1|Adverse Event|157|||
147671259|NCT00433511|532620246|FG002|Step 1|Adverse Event|153|||
147671260|NCT00433511|532620244|FG000|Step 1|Withdrawal by Subject|45|||
147671261|NCT00433511|532620245|FG001|Step 1|Withdrawal by Subject|143|||
147671262|NCT00433511|532620246|FG002|Step 1|Withdrawal by Subject|154|||
147671263|NCT00433511|532620244|FG000|Step 1|Death|3|||
147671264|NCT00433511|532620245|FG001|Step 1|Death|1|||
147671265|NCT00433511|532620246|FG002|Step 1|Death|1|||
147671266|NCT00433511|532620244|FG000|Step 1|Physician Decision|1|||
147671267|NCT00433511|532620245|FG001|Step 1|Physician Decision|4|||
147512287|NCT02579863|532028028|FG001|Overall Study|Adverse Event|11|||
147512288|NCT02579863|532028027|FG000|Overall Study|Death|31|||
147512289|NCT02579863|532028028|FG001|Overall Study|Death|29|||
147512290|NCT02579863|532028027|FG000|Overall Study|Lost to Follow-up|2|||
147512291|NCT02579863|532028028|FG001|Overall Study|Lost to Follow-up|1|||
147512292|NCT02579863|532028027|FG000|Overall Study|Physician Decision|1|||
147512293|NCT02579863|532028028|FG001|Overall Study|Physician Decision|2|||
147512294|NCT02579863|532028027|FG000|Overall Study|Screen Failure|0|||
147512295|NCT02579863|532028028|FG001|Overall Study|Screen Failure|2|||
147512296|NCT02579863|532028027|FG000|Overall Study|Study Terminated at Selected Sites|82|||
147512297|NCT02579863|532028028|FG001|Overall Study|Study Terminated at Selected Sites|88|||
147512298|NCT02579863|532028027|FG000|Overall Study|Withdrawal by Subject|20|||
147512299|NCT02579863|532028028|FG001|Overall Study|Withdrawal by Subject|20|||
147512300|NCT00446797|532028035|FG000|Overall Study|Lack of Efficacy|0|||
147512301|NCT00446797|532028036|FG001|Overall Study|Lack of Efficacy|2|||
147512302|NCT00446797|532028035|FG000|Overall Study|Lost to Follow-up|5|||
147512303|NCT00446797|532028036|FG001|Overall Study|Lost to Follow-up|3|||
147512304|NCT00446797|532028035|FG000|Overall Study|Withdrawal by Subject|2|||
147512305|NCT00446797|532028036|FG001|Overall Study|Withdrawal by Subject|2|||
147671268|NCT00433511|532620246|FG002|Step 1|Physician Decision|3|||
147671269|NCT00433511|532620244|FG000|Step 1|Never started protocol therapy|28|||
147671270|NCT00433511|532620245|FG001|Step 1|Never started protocol therapy|64|||
147512306|NCT00446797|532028035|FG000|Overall Study|Protocol Violation|1|||
147512307|NCT00446797|532028036|FG001|Overall Study|Protocol Violation|3|||
147512308|NCT00446797|532028035|FG000|Overall Study|subject entered at another site|0|||
147512309|NCT00446797|532028036|FG001|Overall Study|subject entered at another site|1|||
147512310|NCT00446797|532028035|FG000|Overall Study|did not meet entrance criteria|0|||
147512311|NCT00446797|532028036|FG001|Overall Study|did not meet entrance criteria|1|||
147512312|NCT04072575|532028042|FG000|Overall Study|Physician Decision|1|||
147512313|NCT04072575|532028042|FG000|Overall Study|Adverse Event|7|||
147512314|NCT04072575|532028042|FG000|Overall Study|Withdrawal by Subject|14|||
147512315|NCT04072575|532028042|FG000|Overall Study|Other|2|||
147512316|NCT02498392|532028043|FG000|Double-blind(DB) Lead-in Period(3 Weeks)|Did not receive treatment|7|||
147512317|NCT02498392|532028044|FG001|Double-blind(DB) Lead-in Period(3 Weeks)|Did not receive treatment|0|||
147512318|NCT02498392|532028043|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Adverse Event|3|||
147512319|NCT02498392|532028044|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Adverse Event|0|||
147512320|NCT02498392|532028043|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Lack of Efficacy|0|||
147512321|NCT02498392|532028044|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Lack of Efficacy|2|||
147512322|NCT02498392|532028043|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Lost to Follow-up|0|||
147512323|NCT02498392|532028044|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Lost to Follow-up|2|||
147512324|NCT02498392|532028043|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Withdrawal by Subject|2|||
147512325|NCT02498392|532028044|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Withdrawal by Subject|3|||
147512326|NCT02498392|532028043|FG000|DB Treatment (6 Weeks)+Withdrawal Period|Other|1|||
147512327|NCT02498392|532028044|FG001|DB Treatment (6 Weeks)+Withdrawal Period|Other|3|||
147512328|NCT02473289|532028045|FG000|Overall Study|Adverse Event|2|||
147512329|NCT02473289|532028046|FG001|Overall Study|Adverse Event|3|||
147512330|NCT02473289|532028045|FG000|Overall Study|Lost to Follow-up|1|||
147512331|NCT02473289|532028046|FG001|Overall Study|Lost to Follow-up|1|||
147512332|NCT02473289|532028045|FG000|Overall Study|Protocol Violation|0|||
147512333|NCT02473289|532028046|FG001|Overall Study|Protocol Violation|1|||
147512334|NCT02473289|532028045|FG000|Overall Study|Withdrawal of consent|6|||
147512335|NCT02473289|532028046|FG001|Overall Study|Withdrawal of consent|7|||
147512336|NCT02473289|532028045|FG000|Overall Study|Treatment Unblinded + Adverse event|0|||
147512337|NCT02473289|532028046|FG001|Overall Study|Treatment Unblinded + Adverse event|1|||
147512338|NCT02473289|532028045|FG000|Overall Study|Other|2|||
147512339|NCT02473289|532028046|FG001|Overall Study|Other|0|||
147512340|NCT02244619|532028047|FG000|Overall Study|Did not receive study intervention|8|||
147512341|NCT02244619|532028048|FG001|Overall Study|Did not receive study intervention|21|||
147512342|NCT03135262|532028049|FG000|Overall Study|discontinued due to worsening of pre-existing medical condition|1|||
147512343|NCT03135262|532028050|FG001|Overall Study|discontinued due to worsening of pre-existing medical condition|0|||
147512344|NCT03135262|532028051|FG002|Overall Study|discontinued due to worsening of pre-existing medical condition|0|||
147512345|NCT03135262|532028052|FG003|Overall Study|discontinued due to worsening of pre-existing medical condition|0|||
147512346|NCT03135262|532028053|FG004|Overall Study|discontinued due to worsening of pre-existing medical condition|0|||
147512347|NCT03135262|532028049|FG000|Overall Study|Progression of disease|0|||
147512348|NCT03135262|532028050|FG001|Overall Study|Progression of disease|0|||
147512349|NCT03135262|532028051|FG002|Overall Study|Progression of disease|0|||
147512350|NCT03135262|532028052|FG003|Overall Study|Progression of disease|1|||
147512351|NCT03135262|532028053|FG004|Overall Study|Progression of disease|0|||
147512352|NCT03135262|532028049|FG000|Overall Study|Death|6|||
147512353|NCT03135262|532028050|FG001|Overall Study|Death|2|||
147512354|NCT03135262|532028051|FG002|Overall Study|Death|2|||
147512355|NCT03135262|532028052|FG003|Overall Study|Death|2|||
147512356|NCT03135262|532028053|FG004|Overall Study|Death|0|||
147512357|NCT03135262|532028049|FG000|Overall Study|Withdrawal by Subject|0|||
147512358|NCT03135262|532028050|FG001|Overall Study|Withdrawal by Subject|0|||
147512359|NCT03135262|532028051|FG002|Overall Study|Withdrawal by Subject|1|||
147512360|NCT03135262|532028052|FG003|Overall Study|Withdrawal by Subject|0|||
147512361|NCT03135262|532028053|FG004|Overall Study|Withdrawal by Subject|1|||
147512362|NCT03135262|532028049|FG000|Overall Study|Study terminated by sponsor|2|||
147512363|NCT03135262|532028050|FG001|Overall Study|Study terminated by sponsor|4|||
147512364|NCT03135262|532028051|FG002|Overall Study|Study terminated by sponsor|4|||
147512365|NCT03135262|532028052|FG003|Overall Study|Study terminated by sponsor|3|||
147512366|NCT03135262|532028053|FG004|Overall Study|Study terminated by sponsor|0|||
147512367|NCT03745989|532028055|FG000|Overall Study|Death|3|||
147512368|NCT03745989|532028056|FG001|Overall Study|Death|7|||
147512369|NCT03745989|532028057|FG002|Overall Study|Death|4|||
147512370|NCT03745989|532028055|FG000|Overall Study|Lost to Follow-up|0|||
147512371|NCT03745989|532028056|FG001|Overall Study|Lost to Follow-up|2|||
147512372|NCT03745989|532028057|FG002|Overall Study|Lost to Follow-up|0|||
147512373|NCT03745989|532028055|FG000|Overall Study|Sponsor Decision|0|||
147512374|NCT03745989|532028056|FG001|Overall Study|Sponsor Decision|2|||
147512375|NCT03745989|532028057|FG002|Overall Study|Sponsor Decision|8|||
147512376|NCT03745989|532028055|FG000|Overall Study|Withdrawal by Subject|0|||
147512377|NCT03745989|532028056|FG001|Overall Study|Withdrawal by Subject|1|||
147512378|NCT03745989|532028057|FG002|Overall Study|Withdrawal by Subject|3|||
147671271|NCT00433511|532620246|FG002|Step 1|Never started protocol therapy|66|||
147671272|NCT00433511|532620244|FG000|Step 1|Alternative therapy|2|||
147512379|NCT02728206|532028058|FG000|Overall Study|Death|1|||
147512380|NCT02918318|532028063|FG000|Double-blind Induction Phase: 4 Weeks|Adverse Event|1|||
147512381|NCT02918318|532028064|FG001|Double-blind Induction Phase: 4 Weeks|Adverse Event|4|||
147512382|NCT02918318|532028065|FG002|Double-blind Induction Phase: 4 Weeks|Adverse Event|2|||
147512383|NCT02918318|532028066|FG003|Double-blind Induction Phase: 4 Weeks|Adverse Event|3|||
147512384|NCT02918318|532028067|FG004|Double-blind Induction Phase: 4 Weeks|Adverse Event|0|||
147512385|NCT02918318|532028063|FG000|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|0|||
147512386|NCT02918318|532028064|FG001|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|0|||
147512387|NCT02918318|532028065|FG002|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|0|||
147512388|NCT02918318|532028066|FG003|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|2|||
147512389|NCT02918318|532028067|FG004|Double-blind Induction Phase: 4 Weeks|Lack of Efficacy|0|||
147512390|NCT02918318|532028063|FG000|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|0|||
147512391|NCT02918318|532028064|FG001|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|0|||
147512392|NCT02918318|532028065|FG002|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|0|||
147512393|NCT02918318|532028066|FG003|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|1|||
147512394|NCT02918318|532028067|FG004|Double-blind Induction Phase: 4 Weeks|Lost to Follow-up|0|||
147512395|NCT02918318|532028063|FG000|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|1|||
147512396|NCT02918318|532028064|FG001|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|1|||
147512397|NCT02918318|532028065|FG002|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|0|||
147512398|NCT02918318|532028066|FG003|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|0|||
147512399|NCT02918318|532028067|FG004|Double-blind Induction Phase: 4 Weeks|Withdrawal by Subject|0|||
147512400|NCT02918318|532028063|FG000|Double-blind Induction Phase: 4 Weeks|Non-compliance|0|||
147512401|NCT02918318|532028064|FG001|Double-blind Induction Phase: 4 Weeks|Non-compliance|0|||
147512402|NCT02918318|532028065|FG002|Double-blind Induction Phase: 4 Weeks|Non-compliance|0|||
147512403|NCT02918318|532028066|FG003|Double-blind Induction Phase: 4 Weeks|Non-compliance|1|||
147512404|NCT02918318|532028067|FG004|Double-blind Induction Phase: 4 Weeks|Non-compliance|0|||
147512405|NCT02918318|532028063|FG000|Double-blind Induction Phase: 4 Weeks|Other|0|||
147512406|NCT02918318|532028064|FG001|Double-blind Induction Phase: 4 Weeks|Other|2|||
147512407|NCT02918318|532028065|FG002|Double-blind Induction Phase: 4 Weeks|Other|0|||
147512408|NCT02918318|532028066|FG003|Double-blind Induction Phase: 4 Weeks|Other|1|||
147512409|NCT02918318|532028067|FG004|Double-blind Induction Phase: 4 Weeks|Other|0|||
147512410|NCT02918318|532028063|FG000|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|0|||
147512411|NCT02918318|532028064|FG001|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|0|||
147512412|NCT02918318|532028065|FG002|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|0|||
147512413|NCT02918318|532028066|FG003|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|2|||
147512414|NCT02918318|532028067|FG004|Double-blind Follow-up Phase: 4 Weeks|Withdrawal by Subject|0|||
147512415|NCT02918318|532028063|FG000|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|1|||
147512416|NCT02918318|532028064|FG001|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|0|||
147512417|NCT02918318|532028065|FG002|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|1|||
147512418|NCT02918318|532028066|FG003|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|1|||
147512419|NCT02918318|532028067|FG004|Double-blind Follow-up Phase: 4 Weeks|Adverse Event|0|||
147512420|NCT02918318|532028063|FG000|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|1|||
147512421|NCT02918318|532028064|FG001|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|0|||
147512422|NCT02918318|532028065|FG002|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|0|||
147512423|NCT02918318|532028066|FG003|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|1|||
147512424|NCT02918318|532028067|FG004|Posttreatment Phase: Up to 24 Weeks|Withdrawal by Subject|0|||
147512425|NCT02918318|532028063|FG000|Posttreatment Phase: Up to 24 Weeks|Other|0|||
147512426|NCT02918318|532028064|FG001|Posttreatment Phase: Up to 24 Weeks|Other|3|||
147512427|NCT02918318|532028065|FG002|Posttreatment Phase: Up to 24 Weeks|Other|1|||
147512428|NCT02918318|532028066|FG003|Posttreatment Phase: Up to 24 Weeks|Other|1|||
147512429|NCT02918318|532028067|FG004|Posttreatment Phase: Up to 24 Weeks|Other|0|||
147512430|NCT02918318|532028063|FG000|Open Label Treatment Phase: 4 Weeks|Adverse Event|0|||
147671273|NCT00433511|532620245|FG001|Step 1|Alternative therapy|1|||
147671274|NCT00433511|532620246|FG002|Step 1|Alternative therapy|3|||
147671275|NCT00433511|532620244|FG000|Step 1|Disease progression, relapse|5|||
147671276|NCT00433511|532620245|FG001|Step 1|Disease progression, relapse|3|||
147671277|NCT00433511|532620246|FG002|Step 1|Disease progression, relapse|3|||
147671278|NCT00433511|532620244|FG000|Step 1|Other complicating disease|2|||
147671279|NCT00433511|532620245|FG001|Step 1|Other complicating disease|6|||
147512431|NCT02918318|532028064|FG001|Open Label Treatment Phase: 4 Weeks|Adverse Event|0|||
147512432|NCT02918318|532028065|FG002|Open Label Treatment Phase: 4 Weeks|Adverse Event|0|||
147512433|NCT02918318|532028066|FG003|Open Label Treatment Phase: 4 Weeks|Adverse Event|0|||
147512434|NCT02918318|532028067|FG004|Open Label Treatment Phase: 4 Weeks|Adverse Event|1|||
147512435|NCT02918318|532028063|FG000|Open Label Follow-up Phase: 4 Weeks|Adverse Event|0|||
147512436|NCT02918318|532028064|FG001|Open Label Follow-up Phase: 4 Weeks|Adverse Event|0|||
147512437|NCT02918318|532028065|FG002|Open Label Follow-up Phase: 4 Weeks|Adverse Event|0|||
147512438|NCT02918318|532028066|FG003|Open Label Follow-up Phase: 4 Weeks|Adverse Event|0|||
147671280|NCT00433511|532620246|FG002|Step 1|Other complicating disease|3|||
147671281|NCT00433511|532620244|FG000|Step 1|Non-breast cancer surgery/wound issues|0|||
147512439|NCT02918318|532028067|FG004|Open Label Follow-up Phase: 4 Weeks|Adverse Event|1|||
147671282|NCT00433511|532620245|FG001|Step 1|Non-breast cancer surgery/wound issues|4|||
147671283|NCT00433511|532620246|FG002|Step 1|Non-breast cancer surgery/wound issues|1|||
147512440|NCT01782885|532028068|FG000|Overall Study|Lost to Follow-up|4|||
147512441|NCT01782885|532028069|FG001|Overall Study|Lost to Follow-up|6|||
147512442|NCT00633360|532028073|FG000|Overall Study|Lost to Follow-up|1|||
147512443|NCT00633360|532028074|FG001|Overall Study|Lost to Follow-up|1|||
147512444|NCT00633360|532028073|FG000|Overall Study|Adverse Event|3|||
147512445|NCT00633360|532028074|FG001|Overall Study|Adverse Event|1|||
147512446|NCT00633360|532028073|FG000|Overall Study|Protocol Violation|0|||
147512447|NCT00633360|532028074|FG001|Overall Study|Protocol Violation|1|||
147512448|NCT01098032|532028075|FG000|Overall Study|Withdrawal by Subject|1|||
147512449|NCT01098032|532028076|FG001|Overall Study|Withdrawal by Subject|1|||
147512450|NCT00610207|532028078|FG000|Overall Study|Lost to Follow-up|3|||
147512451|NCT01594411|532028097|FG000|Overall Study|Lost to Follow-up|2|||
147512452|NCT00437203|532028100|FG000|Overall Study|Death|0|||
147512453|NCT00437203|532028101|FG001|Overall Study|Death|0|||
147512454|NCT00437203|532028102|FG002|Overall Study|Death|1|||
147512455|NCT00437203|532028103|FG003|Overall Study|Death|0|||
147512456|NCT00437203|532028104|FG004|Overall Study|Death|0|||
147512457|NCT00437203|532028105|FG005|Overall Study|Death|0|||
147512458|NCT00437203|532028106|FG006|Overall Study|Death|0|||
147512459|NCT00437203|532028107|FG007|Overall Study|Death|1|||
147512460|NCT00437203|532028108|FG008|Overall Study|Death|0|||
147512461|NCT00437203|532028109|FG009|Overall Study|Death|1|||
147512462|NCT00437203|532028100|FG000|Overall Study|Adverse Event|1|||
147512463|NCT00437203|532028101|FG001|Overall Study|Adverse Event|1|||
147671284|NCT00433511|532620244|FG000|Step 1|Suspected recurrence|0|||
147671285|NCT00433511|532620245|FG001|Step 1|Suspected recurrence|1|||
147671286|NCT00433511|532620246|FG002|Step 1|Suspected recurrence|0|||
147671287|NCT00433511|532620244|FG000|Step 1|Insurance/drug distribution issues|0|||
147671288|NCT00433511|532620245|FG001|Step 1|Insurance/drug distribution issues|1|||
147671289|NCT00433511|532620246|FG002|Step 1|Insurance/drug distribution issues|2|||
147671290|NCT00433511|532620244|FG000|Step 1|Patient moved|0|||
147671291|NCT00433511|532620245|FG001|Step 1|Patient moved|0|||
147671292|NCT00433511|532620246|FG002|Step 1|Patient moved|1|||
147671293|NCT00433511|532620244|FG000|Step 2 (Arm D)|Adverse Event|0|||
147671294|NCT00433511|532620245|FG001|Step 2 (Arm D)|Adverse Event|0|||
147671295|NCT00433511|532620246|FG002|Step 2 (Arm D)|Adverse Event|135|||
147671296|NCT00433511|532620244|FG000|Step 2 (Arm D)|Withdrawal by Subject|0|||
147671297|NCT00433511|532620245|FG001|Step 2 (Arm D)|Withdrawal by Subject|0|||
147671298|NCT00433511|532620246|FG002|Step 2 (Arm D)|Withdrawal by Subject|181|||
147671299|NCT00433511|532620244|FG000|Step 2 (Arm D)|Never started protocol therapy|0|||
147671300|NCT00433511|532620245|FG001|Step 2 (Arm D)|Never started protocol therapy|0|||
147671301|NCT00433511|532620246|FG002|Step 2 (Arm D)|Never started protocol therapy|148|||
147671302|NCT00433511|532620244|FG000|Step 2 (Arm D)|Physician Decision|0|||
147671303|NCT00433511|532620245|FG001|Step 2 (Arm D)|Physician Decision|0|||
147671304|NCT00433511|532620246|FG002|Step 2 (Arm D)|Physician Decision|9|||
147671305|NCT00433511|532620244|FG000|Step 2 (Arm D)|Disease progression, relapse|0|||
147671306|NCT00433511|532620245|FG001|Step 2 (Arm D)|Disease progression, relapse|0|||
147671307|NCT00433511|532620246|FG002|Step 2 (Arm D)|Disease progression, relapse|7|||
147671308|NCT00433511|532620244|FG000|Step 2 (Arm D)|Other complicating disease|0|||
147671309|NCT00433511|532620245|FG001|Step 2 (Arm D)|Other complicating disease|0|||
147671310|NCT00433511|532620246|FG002|Step 2 (Arm D)|Other complicating disease|3|||
147671311|NCT00433511|532620244|FG000|Step 2 (Arm D)|Non-breast cancer surgery/wound issues|0|||
147671312|NCT00433511|532620245|FG001|Step 2 (Arm D)|Non-breast cancer surgery/wound issues|0|||
147671313|NCT00433511|532620246|FG002|Step 2 (Arm D)|Non-breast cancer surgery/wound issues|2|||
147671314|NCT00433511|532620244|FG000|Step 2 (Arm D)|Suspected recurrence|0|||
147671315|NCT00433511|532620245|FG001|Step 2 (Arm D)|Suspected recurrence|0|||
147671316|NCT00433511|532620246|FG002|Step 2 (Arm D)|Suspected recurrence|1|||
147671317|NCT00433511|532620244|FG000|Step 2 (Arm D)|Insurance/drug distribution issues|0|||
147671318|NCT00433511|532620245|FG001|Step 2 (Arm D)|Insurance/drug distribution issues|0|||
147671319|NCT00433511|532620246|FG002|Step 2 (Arm D)|Insurance/drug distribution issues|4|||
147671320|NCT00433511|532620244|FG000|Step 2 (Arm D)|Unknown (Missing off treatment form)|0|||
147671321|NCT00433511|532620245|FG001|Step 2 (Arm D)|Unknown (Missing off treatment form)|0|||
147671322|NCT00433511|532620246|FG002|Step 2 (Arm D)|Unknown (Missing off treatment form)|1|||
147671323|NCT05274750|532620247|FG000|Overall Study|Adverse Event|0|||
147671324|NCT05274750|532620248|FG001|Overall Study|Adverse Event|1|||
147671325|NCT05274750|532620247|FG000|Overall Study|Lost to Follow-up|2|||
147671326|NCT05274750|532620248|FG001|Overall Study|Lost to Follow-up|3|||
147671327|NCT05274750|532620247|FG000|Overall Study|Physician Decision|3|||
147512464|NCT00437203|532028102|FG002|Overall Study|Adverse Event|0|||
147512465|NCT00437203|532028103|FG003|Overall Study|Adverse Event|0|||
147512466|NCT00437203|532028104|FG004|Overall Study|Adverse Event|0|||
147512467|NCT00437203|532028105|FG005|Overall Study|Adverse Event|0|||
147512468|NCT00437203|532028106|FG006|Overall Study|Adverse Event|0|||
147671328|NCT05274750|532620248|FG001|Overall Study|Physician Decision|0|||
147512469|NCT00437203|532028107|FG007|Overall Study|Adverse Event|1|||
147512470|NCT00437203|532028108|FG008|Overall Study|Adverse Event|0|||
147512471|NCT00437203|532028109|FG009|Overall Study|Adverse Event|1|||
147512472|NCT00437203|532028100|FG000|Overall Study|Study terminated by sponsor|0|||
147671329|NCT05274750|532620247|FG000|Overall Study|Withdrawal by Subject|10|||
147671330|NCT05274750|532620248|FG001|Overall Study|Withdrawal by Subject|9|||
147671331|NCT05274750|532620247|FG000|Overall Study|GCP Violation|0|||
147671332|NCT05274750|532620248|FG001|Overall Study|GCP Violation|4|||
147671333|NCT05274750|532620247|FG000|Overall Study|Randomized, not treated|0|||
147671334|NCT05274750|532620248|FG001|Overall Study|Randomized, not treated|1|||
147671335|NCT05282823|532620251|FG000|Overall Study|Withdrawal by Subject|9|||
147671336|NCT05282823|532620251|FG000|Overall Study|Adverse Event|1|||
147671337|NCT05282823|532620251|FG000|Overall Study|did not meet protocol criteria|2|||
147671338|NCT05282823|532620251|FG000|Overall Study|Withdrawal by Subject|7|||
147671339|NCT05569174|532620252|FG000|Overall Study|Adverse Event|0|||
147671340|NCT05569174|532620253|FG001|Overall Study|Adverse Event|1|||
147671341|NCT05569174|532620252|FG000|Overall Study|Lack of compliance|0|||
147671342|NCT05569174|532620253|FG001|Overall Study|Lack of compliance|1|||
147671343|NCT05569174|532620252|FG000|Overall Study|Withdrawal of consent|0|||
147671344|NCT05569174|532620253|FG001|Overall Study|Withdrawal of consent|1|||
147671345|NCT05569174|532620252|FG000|Overall Study|Participant wish|0|||
147671346|NCT05569174|532620253|FG001|Overall Study|Participant wish|1|||
147671347|NCT05569174|532620252|FG000|Overall Study|Lost to Follow-up|0|||
147671348|NCT05569174|532620253|FG001|Overall Study|Lost to Follow-up|1|||
147671349|NCT05352815|532620254|FG000|Overall Study|Withdrawal by Subject|28|||
147671350|NCT05352815|532620255|FG001|Overall Study|Withdrawal by Subject|24|||
147671351|NCT05352815|532620254|FG000|Overall Study|Lost to Follow-up|4|||
147671352|NCT05352815|532620255|FG001|Overall Study|Lost to Follow-up|7|||
147671353|NCT05352815|532620254|FG000|Overall Study|Death|2|||
147671354|NCT05352815|532620255|FG001|Overall Study|Death|3|||
147671355|NCT05352815|532620254|FG000|Overall Study|Site closure|1|||
147671356|NCT05352815|532620255|FG001|Overall Study|Site closure|0|||
147671357|NCT05499130|532620256|FG000|Overall Study|Adverse Event|2|||
147671358|NCT05499130|532620257|FG001|Overall Study|Adverse Event|0|||
147671359|NCT05499130|532620258|FG002|Overall Study|Adverse Event|1|||
147671360|NCT05499130|532620259|FG003|Overall Study|Adverse Event|0|||
147671361|NCT05499130|532620260|FG004|Overall Study|Adverse Event|1|||
147671362|NCT05499130|532620261|FG005|Overall Study|Adverse Event|4|||
147671363|NCT05499130|532620262|FG006|Overall Study|Adverse Event|1|||
147671364|NCT05499130|532620263|FG007|Overall Study|Adverse Event|0|||
147671365|NCT05499130|532620256|FG000|Overall Study|Lack of Efficacy|1|||
147671366|NCT05499130|532620257|FG001|Overall Study|Lack of Efficacy|0|||
147671367|NCT05499130|532620258|FG002|Overall Study|Lack of Efficacy|0|||
147671368|NCT05499130|532620259|FG003|Overall Study|Lack of Efficacy|0|||
147671369|NCT05499130|532620260|FG004|Overall Study|Lack of Efficacy|5|||
147671370|NCT05499130|532620261|FG005|Overall Study|Lack of Efficacy|0|||
147671371|NCT05499130|532620262|FG006|Overall Study|Lack of Efficacy|1|||
147671372|NCT05499130|532620263|FG007|Overall Study|Lack of Efficacy|0|||
147671373|NCT05499130|532620256|FG000|Overall Study|Withdrawal by Subject|2|||
147671374|NCT05499130|532620257|FG001|Overall Study|Withdrawal by Subject|0|||
147671375|NCT05499130|532620258|FG002|Overall Study|Withdrawal by Subject|0|||
147671376|NCT05499130|532620259|FG003|Overall Study|Withdrawal by Subject|0|||
147671377|NCT05499130|532620260|FG004|Overall Study|Withdrawal by Subject|1|||
147671378|NCT05499130|532620261|FG005|Overall Study|Withdrawal by Subject|2|||
147671379|NCT05499130|532620262|FG006|Overall Study|Withdrawal by Subject|0|||
147671380|NCT05499130|532620263|FG007|Overall Study|Withdrawal by Subject|0|||
147671381|NCT05499130|532620256|FG000|Overall Study|Lost to Follow-up|0|||
147671382|NCT05499130|532620257|FG001|Overall Study|Lost to Follow-up|0|||
147671383|NCT05499130|532620258|FG002|Overall Study|Lost to Follow-up|0|||
147671384|NCT05499130|532620259|FG003|Overall Study|Lost to Follow-up|0|||
147671385|NCT05499130|532620260|FG004|Overall Study|Lost to Follow-up|0|||
147671386|NCT05499130|532620261|FG005|Overall Study|Lost to Follow-up|2|||
147671387|NCT05499130|532620262|FG006|Overall Study|Lost to Follow-up|0|||
147671388|NCT05499130|532620263|FG007|Overall Study|Lost to Follow-up|0|||
147671389|NCT05499130|532620256|FG000|Overall Study|Other Than Specified|0|||
147671390|NCT05499130|532620257|FG001|Overall Study|Other Than Specified|0|||
147671391|NCT05499130|532620258|FG002|Overall Study|Other Than Specified|0|||
147671392|NCT05499130|532620259|FG003|Overall Study|Other Than Specified|0|||
147671393|NCT05499130|532620260|FG004|Overall Study|Other Than Specified|1|||
147671394|NCT05499130|532620261|FG005|Overall Study|Other Than Specified|1|||
147671395|NCT05499130|532620262|FG006|Overall Study|Other Than Specified|2|||
147671396|NCT05499130|532620263|FG007|Overall Study|Other Than Specified|0|||
147671397|NCT05499130|532620256|FG000|Overall Study|Protocol Violation|0|||
147671398|NCT05499130|532620257|FG001|Overall Study|Protocol Violation|0|||
147671399|NCT05499130|532620258|FG002|Overall Study|Protocol Violation|0|||
147671400|NCT05499130|532620259|FG003|Overall Study|Protocol Violation|0|||
147671401|NCT05499130|532620260|FG004|Overall Study|Protocol Violation|1|||
147512473|NCT00437203|532028101|FG001|Overall Study|Study terminated by sponsor|0|||
147671402|NCT05499130|532620261|FG005|Overall Study|Protocol Violation|0|||
147671403|NCT05499130|532620262|FG006|Overall Study|Protocol Violation|0|||
147671404|NCT05499130|532620263|FG007|Overall Study|Protocol Violation|0|||
147671405|NCT04328623|532620268|FG000|Overall Study|Protocol Violation|0|||
147671406|NCT04328623|532620269|FG001|Overall Study|Protocol Violation|1|||
147671407|NCT02312557|532620273|FG000|Overall Study|Survival follow-up|4|||
147671408|NCT03895086|532620274|FG000|Overall Study|Early termination study|1|||
147671409|NCT03895086|532620275|FG001|Overall Study|Early termination study|0|||
147671410|NCT04464421|532620276|FG000|Overall Study|Lost to Follow-up|2|||
147671411|NCT04464421|532620277|FG001|Overall Study|Lost to Follow-up|2|||
147671412|NCT05687032|532620278|FG000|Treatment Phase|Adverse Event|13|||
147671413|NCT05687032|532620278|FG000|Treatment Phase|Death|1|||
147671414|NCT05687032|532620278|FG000|Treatment Phase|Physician Decision|3|||
147671415|NCT05687032|532620278|FG000|Treatment Phase|Progressive disease|9|||
147671416|NCT05687032|532620278|FG000|Treatment Phase|Withdrawal by Subject|5|||
147671417|NCT05687032|532620278|FG000|Follow-Up Phase|Death|16|||
147671418|NCT05687032|532620278|FG000|Follow-Up Phase|Ongoing|26|||
147671419|NCT05452239|532620279|FG000|Placebo-controlled Period|Withdrawal by Subject|0|||
147671420|NCT05452239|532620280|FG001|Placebo-controlled Period|Withdrawal by Subject|4|||
147671421|NCT05452239|532620279|FG000|Placebo-controlled Period|Lost to Follow-up|1|||
147671422|NCT05452239|532620280|FG001|Placebo-controlled Period|Lost to Follow-up|0|||
147671423|NCT05452239|532620279|FG000|Placebo-controlled Period|Failure to comply with trial procedures|0|||
147671424|NCT05452239|532620280|FG001|Placebo-controlled Period|Failure to comply with trial procedures|1|||
147671425|NCT05452239|532620279|FG000|Placebo-controlled Period|Randomized but not treated|2|||
147671426|NCT05452239|532620280|FG001|Placebo-controlled Period|Randomized but not treated|2|||
147671427|NCT05452239|532620279|FG000|Placebo-controlled Period|Other than specified|1|||
147671428|NCT05452239|532620280|FG001|Placebo-controlled Period|Other than specified|1|||
147671429|NCT05452239|532620279|FG000|Open-label Period|Withdrawal by Subject|2|||
147671430|NCT05452239|532620280|FG001|Open-label Period|Withdrawal by Subject|1|||
147671431|NCT05452239|532620279|FG000|Open-label Period|Lost to Follow-up|3|||
147671432|NCT05452239|532620280|FG001|Open-label Period|Lost to Follow-up|0|||
147671433|NCT05452239|532620279|FG000|Open-label Period|Other than specified|1|||
147671434|NCT05452239|532620280|FG001|Open-label Period|Other than specified|2|||
147671435|NCT06129149|532620283|FG000|Overall Study|Death|1|||
147671436|NCT04649359|532620287|FG000|Overall Study|Withdrawal by Subject|7|||
147671437|NCT04649359|532620288|FG001|Overall Study|Withdrawal by Subject|7|||
147671438|NCT04649359|532620287|FG000|Overall Study|Death|41|||
147671439|NCT04649359|532620288|FG001|Overall Study|Death|26|||
147671440|NCT04649359|532620287|FG000|Overall Study|Ongoing in the study|75|||
147671441|NCT04649359|532620288|FG001|Overall Study|Ongoing in the study|31|||
147671442|NCT03912662|532620289|FG000|Overall Study|Adverse Event|3|||
147671443|NCT03912662|532620289|FG000|Overall Study|Adverse Event and Death|1|||
147671444|NCT03912662|532620289|FG000|Overall Study|Death|1|||
147671445|NCT03912662|532620289|FG000|Overall Study|Screen Failure: Subjects who provide study consent, but then were determined to be ineligible.|1|||
147671446|NCT03912662|532620289|FG000|Overall Study|Mesh Removal|1|||
147671447|NCT03912662|532620289|FG000|Overall Study|Discontinued: Eligible consented subjects who did not undergo the procedure with the study device.|2|||
147671448|NCT03912662|532620289|FG000|Overall Study|Early study termination|20|||
147671449|NCT04656652|532620292|FG000|Overall Study|Lost to Follow-up|2|||
147671450|NCT04656652|532620293|FG001|Overall Study|Lost to Follow-up|2|||
147512474|NCT00437203|532028102|FG002|Overall Study|Study terminated by sponsor|0|||
147512475|NCT00437203|532028103|FG003|Overall Study|Study terminated by sponsor|0|||
147671451|NCT04656652|532620292|FG000|Overall Study|Death|213|||
147671452|NCT04656652|532620293|FG001|Overall Study|Death|212|||
147671453|NCT04656652|532620292|FG000|Overall Study|Other|1|||
147671454|NCT04656652|532620293|FG001|Overall Study|Other|0|||
147671455|NCT04656652|532620292|FG000|Overall Study|Withdrawal by Subject|15|||
147671456|NCT04656652|532620293|FG001|Overall Study|Withdrawal by Subject|29|||
147671457|NCT01385176|532620301|FG000|Randomization Phase|Death|1|||
147671458|NCT01385176|532620302|FG001|Randomization Phase|Death|2|||
147671459|NCT01385176|532620301|FG000|6-18 Month All VNS Active|Death|1|||
147671460|NCT01385176|532620302|FG001|6-18 Month All VNS Active|Death|2|||
147671461|NCT01385176|532620301|FG000|6-18 Month All VNS Active|Physician Decision|0|||
147671462|NCT01385176|532620302|FG001|6-18 Month All VNS Active|Physician Decision|1|||
147671463|NCT01385176|532620301|FG000|6-18 Month All VNS Active|Withdrawal by Subject|2|||
147671464|NCT01385176|532620302|FG001|6-18 Month All VNS Active|Withdrawal by Subject|0|||
147671465|NCT01385176|532620301|FG000|6-18 Month All VNS Active|Heart Transplant|1|||
147671466|NCT01385176|532620302|FG001|6-18 Month All VNS Active|Heart Transplant|0|||
147671467|NCT05911841|532621075|FG000|Induction Period|Study Terminated by Sponsor|2|||
147671468|NCT05911841|532621076|FG001|Induction Period|Study Terminated by Sponsor|0|||
147671469|NCT05911841|532621077|FG002|Induction Period|Study Terminated by Sponsor|14|||
147671470|NCT05911841|532621078|FG003|Induction Period|Study Terminated by Sponsor|6|||
147671471|NCT05911841|532621079|FG004|Induction Period|Study Terminated by Sponsor|0|||
147671472|NCT05911841|532621080|FG005|Induction Period|Study Terminated by Sponsor|0|||
147671473|NCT05911841|532621081|FG006|Induction Period|Study Terminated by Sponsor|0|||
147512476|NCT00437203|532028104|FG004|Overall Study|Study terminated by sponsor|0|||
147671474|NCT05911841|532621082|FG007|Induction Period|Study Terminated by Sponsor|0|||
147671475|NCT05911841|532621083|FG008|Induction Period|Study Terminated by Sponsor|0|||
147671476|NCT05911841|532621084|FG009|Induction Period|Study Terminated by Sponsor|0|||
147671477|NCT05911841|532621075|FG000|Induction Period|Withdrawal by Subject|4|||
147671478|NCT05911841|532621076|FG001|Induction Period|Withdrawal by Subject|3|||
147671479|NCT05911841|532621077|FG002|Induction Period|Withdrawal by Subject|4|||
147671480|NCT05911841|532621078|FG003|Induction Period|Withdrawal by Subject|6|||
147671481|NCT05911841|532621079|FG004|Induction Period|Withdrawal by Subject|0|||
147671482|NCT05911841|532621080|FG005|Induction Period|Withdrawal by Subject|0|||
147671483|NCT05911841|532621081|FG006|Induction Period|Withdrawal by Subject|0|||
147671484|NCT05911841|532621082|FG007|Induction Period|Withdrawal by Subject|0|||
147671485|NCT05911841|532621083|FG008|Induction Period|Withdrawal by Subject|0|||
147671486|NCT05911841|532621084|FG009|Induction Period|Withdrawal by Subject|0|||
147671487|NCT05911841|532621075|FG000|Induction Period|Lack of Efficacy|3|||
147671488|NCT05911841|532621076|FG001|Induction Period|Lack of Efficacy|0|||
147671489|NCT05911841|532621077|FG002|Induction Period|Lack of Efficacy|3|||
147671490|NCT05911841|532621078|FG003|Induction Period|Lack of Efficacy|3|||
147671491|NCT05911841|532621079|FG004|Induction Period|Lack of Efficacy|0|||
147671492|NCT05911841|532621080|FG005|Induction Period|Lack of Efficacy|0|||
147671493|NCT05911841|532621081|FG006|Induction Period|Lack of Efficacy|0|||
147671494|NCT05911841|532621082|FG007|Induction Period|Lack of Efficacy|0|||
147671495|NCT05911841|532621083|FG008|Induction Period|Lack of Efficacy|0|||
147671496|NCT05911841|532621084|FG009|Induction Period|Lack of Efficacy|0|||
147671497|NCT05911841|532621075|FG000|Induction Period|Adverse Event|3|||
147671498|NCT05911841|532621076|FG001|Induction Period|Adverse Event|1|||
147671499|NCT05911841|532621077|FG002|Induction Period|Adverse Event|2|||
147671500|NCT05911841|532621078|FG003|Induction Period|Adverse Event|0|||
147671501|NCT05911841|532621079|FG004|Induction Period|Adverse Event|0|||
147671502|NCT05911841|532621080|FG005|Induction Period|Adverse Event|0|||
147671503|NCT05911841|532621081|FG006|Induction Period|Adverse Event|0|||
147671504|NCT05911841|532621082|FG007|Induction Period|Adverse Event|0|||
147671505|NCT05911841|532621083|FG008|Induction Period|Adverse Event|0|||
147671506|NCT05911841|532621084|FG009|Induction Period|Adverse Event|0|||
147671507|NCT05911841|532621075|FG000|Induction Period|Assigned Treatment by Mistake|0|||
147671508|NCT05911841|532621076|FG001|Induction Period|Assigned Treatment by Mistake|1|||
147671509|NCT05911841|532621077|FG002|Induction Period|Assigned Treatment by Mistake|0|||
147671510|NCT05911841|532621078|FG003|Induction Period|Assigned Treatment by Mistake|1|||
147671511|NCT05911841|532621079|FG004|Induction Period|Assigned Treatment by Mistake|0|||
147671512|NCT05911841|532621080|FG005|Induction Period|Assigned Treatment by Mistake|0|||
147671513|NCT05911841|532621081|FG006|Induction Period|Assigned Treatment by Mistake|0|||
147671514|NCT05911841|532621082|FG007|Induction Period|Assigned Treatment by Mistake|0|||
147671515|NCT05911841|532621083|FG008|Induction Period|Assigned Treatment by Mistake|0|||
147671516|NCT05911841|532621084|FG009|Induction Period|Assigned Treatment by Mistake|0|||
147671517|NCT05911841|532621075|FG000|Induction Period|Lost to Follow-up|0|||
147671518|NCT05911841|532621076|FG001|Induction Period|Lost to Follow-up|0|||
147671519|NCT05911841|532621077|FG002|Induction Period|Lost to Follow-up|1|||
147671520|NCT05911841|532621078|FG003|Induction Period|Lost to Follow-up|1|||
147671521|NCT05911841|532621079|FG004|Induction Period|Lost to Follow-up|0|||
147671522|NCT05911841|532621080|FG005|Induction Period|Lost to Follow-up|0|||
147671523|NCT05911841|532621081|FG006|Induction Period|Lost to Follow-up|0|||
147671524|NCT05911841|532621082|FG007|Induction Period|Lost to Follow-up|0|||
147671525|NCT05911841|532621083|FG008|Induction Period|Lost to Follow-up|0|||
147671526|NCT05911841|532621084|FG009|Induction Period|Lost to Follow-up|0|||
147671527|NCT05911841|532621075|FG000|Maintenance Period|Enrolled to Escape Arm|0|||
147671528|NCT05911841|532621076|FG001|Maintenance Period|Enrolled to Escape Arm|0|||
147671529|NCT05911841|532621077|FG002|Maintenance Period|Enrolled to Escape Arm|0|||
147671530|NCT05911841|532621078|FG003|Maintenance Period|Enrolled to Escape Arm|0|||
147671531|NCT05911841|532621079|FG004|Maintenance Period|Enrolled to Escape Arm|0|||
147671532|NCT05911841|532621080|FG005|Maintenance Period|Enrolled to Escape Arm|0|||
147671533|NCT05911841|532621081|FG006|Maintenance Period|Enrolled to Escape Arm|3|||
147671534|NCT05911841|532621082|FG007|Maintenance Period|Enrolled to Escape Arm|4|||
147671535|NCT05911841|532621083|FG008|Maintenance Period|Enrolled to Escape Arm|4|||
147671536|NCT05911841|532621084|FG009|Maintenance Period|Enrolled to Escape Arm|0|||
147671537|NCT05911841|532621075|FG000|Maintenance Period|Lack of Efficacy|0|||
147671538|NCT05911841|532621076|FG001|Maintenance Period|Lack of Efficacy|0|||
147671539|NCT05911841|532621077|FG002|Maintenance Period|Lack of Efficacy|0|||
147671540|NCT05911841|532621078|FG003|Maintenance Period|Lack of Efficacy|0|||
147671541|NCT05911841|532621079|FG004|Maintenance Period|Lack of Efficacy|1|||
147671542|NCT05911841|532621080|FG005|Maintenance Period|Lack of Efficacy|0|||
147671543|NCT05911841|532621081|FG006|Maintenance Period|Lack of Efficacy|1|||
147671544|NCT05911841|532621082|FG007|Maintenance Period|Lack of Efficacy|0|||
147671545|NCT05911841|532621083|FG008|Maintenance Period|Lack of Efficacy|0|||
147671546|NCT05911841|532621084|FG009|Maintenance Period|Lack of Efficacy|0|||
147671547|NCT05911841|532621075|FG000|Maintenance Period|Study Terminated by Sponsor|0|||
147671548|NCT05911841|532621076|FG001|Maintenance Period|Study Terminated by Sponsor|0|||
147671549|NCT05911841|532621077|FG002|Maintenance Period|Study Terminated by Sponsor|0|||
147671550|NCT05911841|532621078|FG003|Maintenance Period|Study Terminated by Sponsor|0|||
147671551|NCT05911841|532621079|FG004|Maintenance Period|Study Terminated by Sponsor|11|||
147671552|NCT05911841|532621080|FG005|Maintenance Period|Study Terminated by Sponsor|5|||
147671553|NCT05911841|532621081|FG006|Maintenance Period|Study Terminated by Sponsor|1|||
147671554|NCT05911841|532621082|FG007|Maintenance Period|Study Terminated by Sponsor|7|||
147671555|NCT05911841|532621083|FG008|Maintenance Period|Study Terminated by Sponsor|7|||
147671556|NCT05911841|532621084|FG009|Maintenance Period|Study Terminated by Sponsor|0|||
147671557|NCT05911841|532621075|FG000|Maintenance Period|Withdrawal by Subject|0|||
147671558|NCT05911841|532621076|FG001|Maintenance Period|Withdrawal by Subject|0|||
147671559|NCT05911841|532621077|FG002|Maintenance Period|Withdrawal by Subject|0|||
147671560|NCT05911841|532621078|FG003|Maintenance Period|Withdrawal by Subject|0|||
147671561|NCT05911841|532621079|FG004|Maintenance Period|Withdrawal by Subject|0|||
147671562|NCT05911841|532621080|FG005|Maintenance Period|Withdrawal by Subject|1|||
147671563|NCT05911841|532621081|FG006|Maintenance Period|Withdrawal by Subject|0|||
147671564|NCT05911841|532621082|FG007|Maintenance Period|Withdrawal by Subject|1|||
147671565|NCT05911841|532621083|FG008|Maintenance Period|Withdrawal by Subject|0|||
147671566|NCT05911841|532621084|FG009|Maintenance Period|Withdrawal by Subject|0|||
147671567|NCT05911841|532621075|FG000|Maintenance Period|Adverse Event|0|||
147671568|NCT05911841|532621076|FG001|Maintenance Period|Adverse Event|0|||
147671569|NCT05911841|532621077|FG002|Maintenance Period|Adverse Event|0|||
147671570|NCT05911841|532621078|FG003|Maintenance Period|Adverse Event|0|||
147671571|NCT05911841|532621079|FG004|Maintenance Period|Adverse Event|0|||
147671572|NCT05911841|532621080|FG005|Maintenance Period|Adverse Event|0|||
147671573|NCT05911841|532621081|FG006|Maintenance Period|Adverse Event|0|||
147671574|NCT05911841|532621082|FG007|Maintenance Period|Adverse Event|1|||
147671575|NCT05911841|532621083|FG008|Maintenance Period|Adverse Event|0|||
147671576|NCT05911841|532621084|FG009|Maintenance Period|Adverse Event|0|||
147671577|NCT05911841|532621075|FG000|Escape Period|Adverse Event|0|||
147671578|NCT05911841|532621076|FG001|Escape Period|Adverse Event|0|||
147671579|NCT05911841|532621077|FG002|Escape Period|Adverse Event|0|||
147671580|NCT05911841|532621078|FG003|Escape Period|Adverse Event|0|||
147671581|NCT05911841|532621079|FG004|Escape Period|Adverse Event|0|||
147671582|NCT05911841|532621080|FG005|Escape Period|Adverse Event|0|||
147671583|NCT05911841|532621081|FG006|Escape Period|Adverse Event|0|||
147671584|NCT05911841|532621082|FG007|Escape Period|Adverse Event|0|||
147671585|NCT05911841|532621083|FG008|Escape Period|Adverse Event|0|||
147671586|NCT05911841|532621084|FG009|Escape Period|Adverse Event|1|||
147671587|NCT05911841|532621075|FG000|Escape Period|Lack of Efficacy|0|||
147671588|NCT05911841|532621076|FG001|Escape Period|Lack of Efficacy|0|||
147671589|NCT05911841|532621077|FG002|Escape Period|Lack of Efficacy|0|||
147671590|NCT05911841|532621078|FG003|Escape Period|Lack of Efficacy|0|||
147671591|NCT05911841|532621079|FG004|Escape Period|Lack of Efficacy|0|||
147671592|NCT05911841|532621080|FG005|Escape Period|Lack of Efficacy|0|||
147671593|NCT05911841|532621081|FG006|Escape Period|Lack of Efficacy|0|||
147671594|NCT05911841|532621082|FG007|Escape Period|Lack of Efficacy|0|||
147671595|NCT05911841|532621083|FG008|Escape Period|Lack of Efficacy|0|||
147671596|NCT05911841|532621084|FG009|Escape Period|Lack of Efficacy|31|||
147671597|NCT05911841|532621075|FG000|Escape Period|Lost to Follow-up|0|||
147671598|NCT05911841|532621076|FG001|Escape Period|Lost to Follow-up|0|||
147671599|NCT05911841|532621077|FG002|Escape Period|Lost to Follow-up|0|||
147671600|NCT05911841|532621078|FG003|Escape Period|Lost to Follow-up|0|||
147671601|NCT05911841|532621079|FG004|Escape Period|Lost to Follow-up|0|||
147671602|NCT05911841|532621080|FG005|Escape Period|Lost to Follow-up|0|||
147671603|NCT05911841|532621081|FG006|Escape Period|Lost to Follow-up|0|||
147671604|NCT05911841|532621082|FG007|Escape Period|Lost to Follow-up|0|||
147671605|NCT05911841|532621083|FG008|Escape Period|Lost to Follow-up|0|||
147671606|NCT05911841|532621084|FG009|Escape Period|Lost to Follow-up|1|||
147671607|NCT05911841|532621075|FG000|Escape Period|Discontinued Due to Failure to Achieve an EASI-50 Response|0|||
147671608|NCT05911841|532621076|FG001|Escape Period|Discontinued Due to Failure to Achieve an EASI-50 Response|0|||
147671609|NCT05911841|532621077|FG002|Escape Period|Discontinued Due to Failure to Achieve an EASI-50 Response|0|||
147671610|NCT05911841|532621078|FG003|Escape Period|Discontinued Due to Failure to Achieve an EASI-50 Response|0|||
147671611|NCT05911841|532621079|FG004|Escape Period|Discontinued Due to Failure to Achieve an EASI-50 Response|0|||
147671612|NCT05911841|532621080|FG005|Escape Period|Discontinued Due to Failure to Achieve an EASI-50 Response|0|||
147671613|NCT05911841|532621081|FG006|Escape Period|Discontinued Due to Failure to Achieve an EASI-50 Response|0|||
147671614|NCT05911841|532621082|FG007|Escape Period|Discontinued Due to Failure to Achieve an EASI-50 Response|0|||
147671615|NCT05911841|532621083|FG008|Escape Period|Discontinued Due to Failure to Achieve an EASI-50 Response|0|||
147671616|NCT05911841|532621084|FG009|Escape Period|Discontinued Due to Failure to Achieve an EASI-50 Response|4|||
147671617|NCT05911841|532621075|FG000|Escape Period|Site Terminated by Sponsor|0|||
147671618|NCT05911841|532621076|FG001|Escape Period|Site Terminated by Sponsor|0|||
147671619|NCT05911841|532621077|FG002|Escape Period|Site Terminated by Sponsor|0|||
147671620|NCT05911841|532621078|FG003|Escape Period|Site Terminated by Sponsor|0|||
147671621|NCT05911841|532621079|FG004|Escape Period|Site Terminated by Sponsor|0|||
147671622|NCT05911841|532621080|FG005|Escape Period|Site Terminated by Sponsor|0|||
147671623|NCT05911841|532621081|FG006|Escape Period|Site Terminated by Sponsor|0|||
147671624|NCT05911841|532621082|FG007|Escape Period|Site Terminated by Sponsor|0|||
147671625|NCT05911841|532621083|FG008|Escape Period|Site Terminated by Sponsor|0|||
147671626|NCT05911841|532621084|FG009|Escape Period|Site Terminated by Sponsor|1|||
147671627|NCT05911841|532621075|FG000|Escape Period|Study Terminated by Sponsor|0|||
147671628|NCT05911841|532621076|FG001|Escape Period|Study Terminated by Sponsor|0|||
147671629|NCT05911841|532621077|FG002|Escape Period|Study Terminated by Sponsor|0|||
147671630|NCT05911841|532621078|FG003|Escape Period|Study Terminated by Sponsor|0|||
147671631|NCT05911841|532621079|FG004|Escape Period|Study Terminated by Sponsor|0|||
147671632|NCT05911841|532621080|FG005|Escape Period|Study Terminated by Sponsor|0|||
147671633|NCT05911841|532621081|FG006|Escape Period|Study Terminated by Sponsor|0|||
147671634|NCT05911841|532621082|FG007|Escape Period|Study Terminated by Sponsor|0|||
147671635|NCT05911841|532621083|FG008|Escape Period|Study Terminated by Sponsor|0|||
147671636|NCT05911841|532621084|FG009|Escape Period|Study Terminated by Sponsor|34|||
147671637|NCT05911841|532621075|FG000|Escape Period|Withdrawal by Subject|0|||
147671638|NCT05911841|532621076|FG001|Escape Period|Withdrawal by Subject|0|||
147671639|NCT05911841|532621077|FG002|Escape Period|Withdrawal by Subject|0|||
147671640|NCT05911841|532621078|FG003|Escape Period|Withdrawal by Subject|0|||
147671641|NCT05911841|532621079|FG004|Escape Period|Withdrawal by Subject|0|||
147671642|NCT05911841|532621080|FG005|Escape Period|Withdrawal by Subject|0|||
147671643|NCT05911841|532621081|FG006|Escape Period|Withdrawal by Subject|0|||
147671644|NCT05911841|532621082|FG007|Escape Period|Withdrawal by Subject|0|||
147671645|NCT05911841|532621083|FG008|Escape Period|Withdrawal by Subject|0|||
147671646|NCT05911841|532621084|FG009|Escape Period|Withdrawal by Subject|10|||
147671647|NCT03880019|532621085|FG000|Overall Study|Competing disease|1|||
147671648|NCT04889118|532621086|FG000|Overall Study|Death|49|||
147671649|NCT04889118|532621087|FG001|Overall Study|Death|47|||
147671650|NCT04889118|532621086|FG000|Overall Study|Sponsor Decision|15|||
147671651|NCT04889118|532621087|FG001|Overall Study|Sponsor Decision|20|||
147671652|NCT03934099|532621088|FG000|Overall Study|Adverse Event|0|||
147671653|NCT03934099|532621089|FG001|Overall Study|Adverse Event|3|||
147671654|NCT03934099|532621090|FG002|Overall Study|Adverse Event|1|||
147671655|NCT03934099|532621091|FG003|Overall Study|Adverse Event|0|||
147671656|NCT03934099|532621088|FG000|Overall Study|Lost to Follow-up|1|||
147671657|NCT03934099|532621089|FG001|Overall Study|Lost to Follow-up|2|||
147671658|NCT03934099|532621090|FG002|Overall Study|Lost to Follow-up|1|||
147671659|NCT03934099|532621091|FG003|Overall Study|Lost to Follow-up|1|||
147671660|NCT03934099|532621088|FG000|Overall Study|Protocol Violation|1|||
147671661|NCT03934099|532621089|FG001|Overall Study|Protocol Violation|0|||
147671662|NCT03934099|532621090|FG002|Overall Study|Protocol Violation|0|||
147671663|NCT03934099|532621091|FG003|Overall Study|Protocol Violation|0|||
147671664|NCT03934099|532621088|FG000|Overall Study|Withdrawal by Subject|2|||
147671665|NCT03934099|532621089|FG001|Overall Study|Withdrawal by Subject|0|||
147671666|NCT03934099|532621090|FG002|Overall Study|Withdrawal by Subject|1|||
147671667|NCT03934099|532621091|FG003|Overall Study|Withdrawal by Subject|1|||
147671668|NCT03934099|532621088|FG000|Overall Study|Other reasons|0|||
147671669|NCT03934099|532621089|FG001|Overall Study|Other reasons|1|||
147671670|NCT03934099|532621090|FG002|Overall Study|Other reasons|0|||
147671671|NCT03934099|532621091|FG003|Overall Study|Other reasons|0|||
147671672|NCT05595369|532621092|FG000|Overall Study|Adverse Event|2|||
147671673|NCT05595369|532621093|FG001|Overall Study|Adverse Event|0|||
147671674|NCT05595369|532621094|FG002|Overall Study|Adverse Event|0|||
147671675|NCT05595369|532621092|FG000|Overall Study|Lost to Follow-up|11|||
147671676|NCT05595369|532621093|FG001|Overall Study|Lost to Follow-up|10|||
147671677|NCT05595369|532621094|FG002|Overall Study|Lost to Follow-up|10|||
147671678|NCT05595369|532621092|FG000|Overall Study|Physician Decision|1|||
147671679|NCT05595369|532621093|FG001|Overall Study|Physician Decision|0|||
147671680|NCT05595369|532621094|FG002|Overall Study|Physician Decision|0|||
147671681|NCT05595369|532621092|FG000|Overall Study|Withdrawal by Subject|5|||
147671682|NCT05595369|532621093|FG001|Overall Study|Withdrawal by Subject|7|||
147671683|NCT05595369|532621094|FG002|Overall Study|Withdrawal by Subject|6|||
147671684|NCT05595369|532621092|FG000|Overall Study|Did Not Meet Eligibility Criteria|0|||
147671685|NCT05595369|532621093|FG001|Overall Study|Did Not Meet Eligibility Criteria|4|||
147671686|NCT05595369|532621094|FG002|Overall Study|Did Not Meet Eligibility Criteria|0|||
147671687|NCT05595369|532621092|FG000|Overall Study|Study Drug Non-compliance|0|||
147671688|NCT05595369|532621093|FG001|Overall Study|Study Drug Non-compliance|1|||
147671689|NCT05595369|532621094|FG002|Overall Study|Study Drug Non-compliance|0|||
147671690|NCT05595369|532621092|FG000|Overall Study|Moved Out of State Unexpectedly|0|||
147671691|NCT05595369|532621093|FG001|Overall Study|Moved Out of State Unexpectedly|1|||
147671692|NCT05595369|532621094|FG002|Overall Study|Moved Out of State Unexpectedly|0|||
147671693|NCT05628285|532621095|FG000|Overall Study|Lost to Follow-up|1|||
147671694|NCT02339506|532621096|FG000|Period 1 (Placebo or Cosyntropin)|Withdrawal by Subject|0|||
147671695|NCT02339506|532621097|FG001|Period 1 (Placebo or Cosyntropin)|Withdrawal by Subject|1|||
147671696|NCT02339506|532621096|FG000|Washout (Period 2)|Withdrawal by Subject|2|||
147671697|NCT02339506|532621097|FG001|Washout (Period 2)|Withdrawal by Subject|0|||
147671698|NCT05147350|532621099|FG000|Overall Study|Death|2|||
147671699|NCT05147350|532621100|FG001|Overall Study|Death|3|||
147671700|NCT05147350|532621101|FG002|Overall Study|Death|3|||
147671701|NCT05147350|532621102|FG003|Overall Study|Death|2|||
147671702|NCT05147350|532621103|FG004|Overall Study|Death|2|||
147671703|NCT05147350|532621104|FG005|Overall Study|Death|1|||
147671704|NCT05147350|532621105|FG006|Overall Study|Death|1|||
147671705|NCT05147350|532621106|FG007|Overall Study|Death|3|||
147671706|NCT05147350|532621099|FG000|Overall Study|Sponsor Decision to Terminate Study|0|||
147671707|NCT05147350|532621100|FG001|Overall Study|Sponsor Decision to Terminate Study|0|||
147671708|NCT05147350|532621101|FG002|Overall Study|Sponsor Decision to Terminate Study|1|||
147671709|NCT05147350|532621102|FG003|Overall Study|Sponsor Decision to Terminate Study|0|||
147671710|NCT05147350|532621103|FG004|Overall Study|Sponsor Decision to Terminate Study|4|||
147671711|NCT05147350|532621104|FG005|Overall Study|Sponsor Decision to Terminate Study|0|||
147671712|NCT05147350|532621105|FG006|Overall Study|Sponsor Decision to Terminate Study|0|||
147671713|NCT05147350|532621106|FG007|Overall Study|Sponsor Decision to Terminate Study|1|||
147671714|NCT05147350|532621099|FG000|Overall Study|Withdrawal by Subject|0|||
147671715|NCT05147350|532621100|FG001|Overall Study|Withdrawal by Subject|0|||
147671716|NCT05147350|532621101|FG002|Overall Study|Withdrawal by Subject|3|||
147671717|NCT05147350|532621102|FG003|Overall Study|Withdrawal by Subject|1|||
147671718|NCT05147350|532621103|FG004|Overall Study|Withdrawal by Subject|1|||
147671719|NCT05147350|532621104|FG005|Overall Study|Withdrawal by Subject|0|||
147671720|NCT05147350|532621105|FG006|Overall Study|Withdrawal by Subject|1|||
147671721|NCT05147350|532621106|FG007|Overall Study|Withdrawal by Subject|0|||
147671722|NCT05147350|532621099|FG000|Overall Study|Other Reasons|0|||
147671723|NCT05147350|532621100|FG001|Overall Study|Other Reasons|0|||
147671724|NCT05147350|532621101|FG002|Overall Study|Other Reasons|2|||
147671725|NCT05147350|532621102|FG003|Overall Study|Other Reasons|0|||
147671726|NCT05147350|532621103|FG004|Overall Study|Other Reasons|0|||
147671727|NCT05147350|532621104|FG005|Overall Study|Other Reasons|2|||
147671728|NCT05147350|532621105|FG006|Overall Study|Other Reasons|1|||
147671729|NCT05147350|532621106|FG007|Overall Study|Other Reasons|1|||
147671730|NCT02869867|532621107|FG000|Overall Study|Protocol Violation|1|||
147671731|NCT02869867|532621108|FG001|Overall Study|Protocol Violation|0|||
147671732|NCT02869867|532621107|FG000|Overall Study|Lost to Follow-up|5|||
147671733|NCT02869867|532621108|FG001|Overall Study|Lost to Follow-up|5|||
147671734|NCT05218499|532621109|FG000|Overall Study|Not treated|1|||
147671735|NCT05218499|532621110|FG001|Overall Study|Not treated|1|||
147671736|NCT05218499|532621111|FG002|Overall Study|Not treated|8|||
147671737|NCT05218499|532621109|FG000|Overall Study|Death|2|||
147671738|NCT05218499|532621110|FG001|Overall Study|Death|0|||
147671739|NCT05218499|532621111|FG002|Overall Study|Death|0|||
147671740|NCT05218499|532621109|FG000|Overall Study|Other than listed|3|||
147671741|NCT05218499|532621110|FG001|Overall Study|Other than listed|7|||
147671742|NCT05218499|532621111|FG002|Overall Study|Other than listed|10|||
147671743|NCT05218499|532621109|FG000|Overall Study|Protocol deviation|5|||
147671744|NCT05218499|532621110|FG001|Overall Study|Protocol deviation|6|||
147671745|NCT05218499|532621111|FG002|Overall Study|Protocol deviation|4|||
147671746|NCT05218499|532621109|FG000|Overall Study|Technical problems|0|||
147671747|NCT05218499|532621110|FG001|Overall Study|Technical problems|1|||
147671748|NCT05218499|532621111|FG002|Overall Study|Technical problems|0|||
147671749|NCT05218499|532621109|FG000|Overall Study|Burden of trial procedures|0|||
147671750|NCT05218499|532621110|FG001|Overall Study|Burden of trial procedures|1|||
147671751|NCT05218499|532621111|FG002|Overall Study|Burden of trial procedures|2|||
147671752|NCT05218499|532621109|FG000|Overall Study|Clinical disease progression|6|||
147671753|NCT05218499|532621110|FG001|Overall Study|Clinical disease progression|6|||
147671754|NCT05218499|532621111|FG002|Overall Study|Clinical disease progression|11|||
147671755|NCT05218499|532621109|FG000|Overall Study|Objective disease progression|44|||
147671756|NCT05218499|532621110|FG001|Overall Study|Objective disease progression|61|||
147671757|NCT05218499|532621111|FG002|Overall Study|Objective disease progression|42|||
147671758|NCT05218499|532621109|FG000|Overall Study|Adverse Event|11|||
147671759|NCT05218499|532621110|FG001|Overall Study|Adverse Event|36|||
147671760|NCT05218499|532621111|FG002|Overall Study|Adverse Event|9|||
147671761|NCT05218499|532621109|FG000|Overall Study|On treatment at time of snapshot|18|||
147671762|NCT05218499|532621110|FG001|Overall Study|On treatment at time of snapshot|29|||
147671763|NCT05218499|532621111|FG002|Overall Study|On treatment at time of snapshot|0|||
147671764|NCT04530552|532621115|FG000|Overall Study|Physician Decision|0|||
147671765|NCT04530552|532621116|FG001|Overall Study|Physician Decision|1|||
147671766|NCT04530552|532621115|FG000|Overall Study|Withdrawal by Subject|0|||
147671767|NCT04530552|532621116|FG001|Overall Study|Withdrawal by Subject|1|||
147671768|NCT04530552|532621115|FG000|Overall Study|Adverse Event|0|||
147671769|NCT04530552|532621116|FG001|Overall Study|Adverse Event|1|||
147671770|NCT04530552|532621115|FG000|Overall Study|No surgery|0|||
147671771|NCT04530552|532621116|FG001|Overall Study|No surgery|1|||
147671772|NCT05555615|532621119|FG000|Overall Study|Adverse Event|7|||
147671773|NCT05555615|532621119|FG000|Overall Study|Lack of Efficacy|12|||
147671774|NCT05555615|532621119|FG000|Overall Study|Lost to Follow-up|10|||
147671775|NCT05555615|532621119|FG000|Overall Study|Noncompliance with study drug|5|||
147671776|NCT05555615|532621119|FG000|Overall Study|Physician Decision|2|||
147671777|NCT05555615|532621119|FG000|Overall Study|Study terminated by sponsor|80|||
147671778|NCT05555615|532621119|FG000|Overall Study|Prohibited medication use|2|||
147671779|NCT05555615|532621119|FG000|Overall Study|Withdrawal by Subject|20|||
147671780|NCT05555615|532621119|FG000|Overall Study|Not further specified|4|||
147671781|NCT06136897|532621120|FG000|Overall Study|Ineligible|3|||
147671782|NCT06136897|532621120|FG000|Overall Study|Mutation status not confirmed|7|||
147671783|NCT06136897|532621120|FG000|Overall Study|Adverse Event|2|||
147671784|NCT06136897|532621120|FG000|Overall Study|Death|1|||
147671785|NCT06136897|532621120|FG000|Overall Study|Disease progression|18|||
147671786|NCT06136897|532621120|FG000|Overall Study|Other complicating disease|1|||
147671787|NCT06136897|532621120|FG000|Overall Study|Withdrawal by Subject|1|||
147671788|NCT06136897|532621120|FG000|Overall Study|Still on treatment|1|||
147671789|NCT06136897|532621120|FG000|Overall Study|Lost to Follow-up|1|||
147671790|NCT03377361|532621121|FG000|Pre-Treatment|Subject withdrew consent|0|||
147671791|NCT03377361|532621122|FG001|Pre-Treatment|Subject withdrew consent|0|||
147671792|NCT03377361|532621123|FG002|Pre-Treatment|Subject withdrew consent|0|||
147671793|NCT03377361|532621124|FG003|Pre-Treatment|Subject withdrew consent|0|||
147671794|NCT03377361|532621125|FG004|Pre-Treatment|Subject withdrew consent|0|||
147671795|NCT03377361|532621126|FG005|Pre-Treatment|Subject withdrew consent|0|||
147671796|NCT03377361|532621127|FG006|Pre-Treatment|Subject withdrew consent|0|||
147671797|NCT03377361|532621128|FG007|Pre-Treatment|Subject withdrew consent|3|||
147671798|NCT03377361|532621129|FG008|Pre-Treatment|Subject withdrew consent|1|||
147671799|NCT03377361|532621130|FG009|Pre-Treatment|Subject withdrew consent|0|||
147671800|NCT03377361|532621121|FG000|Pre-Treatment|Not Reported|0|||
147671801|NCT03377361|532621122|FG001|Pre-Treatment|Not Reported|0|||
147671802|NCT03377361|532621123|FG002|Pre-Treatment|Not Reported|0|||
147671803|NCT03377361|532621124|FG003|Pre-Treatment|Not Reported|0|||
147671804|NCT03377361|532621125|FG004|Pre-Treatment|Not Reported|0|||
147671805|NCT03377361|532621126|FG005|Pre-Treatment|Not Reported|0|||
147671806|NCT03377361|532621127|FG006|Pre-Treatment|Not Reported|0|||
147671807|NCT03377361|532621128|FG007|Pre-Treatment|Not Reported|0|||
147671808|NCT03377361|532621129|FG008|Pre-Treatment|Not Reported|3|||
147671809|NCT03377361|532621130|FG009|Pre-Treatment|Not Reported|0|||
147671810|NCT03377361|532621121|FG000|Treatment Period|Disease Progression|3|||
147671811|NCT03377361|532621122|FG001|Treatment Period|Disease Progression|2|||
147671812|NCT03377361|532621123|FG002|Treatment Period|Disease Progression|5|||
147671813|NCT03377361|532621124|FG003|Treatment Period|Disease Progression|3|||
147671814|NCT03377361|532621125|FG004|Treatment Period|Disease Progression|3|||
147671815|NCT03377361|532621126|FG005|Treatment Period|Disease Progression|3|||
147671816|NCT03377361|532621127|FG006|Treatment Period|Disease Progression|6|||
147671817|NCT03377361|532621128|FG007|Treatment Period|Disease Progression|106|||
147671818|NCT03377361|532621129|FG008|Treatment Period|Disease Progression|48|||
147671819|NCT03377361|532621130|FG009|Treatment Period|Disease Progression|59|||
147671820|NCT03377361|532621121|FG000|Treatment Period|Study Drug Toxicity|0|||
147671821|NCT03377361|532621122|FG001|Treatment Period|Study Drug Toxicity|0|||
147671822|NCT03377361|532621123|FG002|Treatment Period|Study Drug Toxicity|0|||
147671823|NCT03377361|532621124|FG003|Treatment Period|Study Drug Toxicity|1|||
147671824|NCT03377361|532621125|FG004|Treatment Period|Study Drug Toxicity|0|||
147671825|NCT03377361|532621126|FG005|Treatment Period|Study Drug Toxicity|0|||
147671826|NCT03377361|532621127|FG006|Treatment Period|Study Drug Toxicity|0|||
147671827|NCT03377361|532621128|FG007|Treatment Period|Study Drug Toxicity|7|||
147671828|NCT03377361|532621129|FG008|Treatment Period|Study Drug Toxicity|2|||
147671829|NCT03377361|532621130|FG009|Treatment Period|Study Drug Toxicity|16|||
147671830|NCT03377361|532621121|FG000|Treatment Period|Death|0|||
147671831|NCT03377361|532621122|FG001|Treatment Period|Death|0|||
147671832|NCT03377361|532621123|FG002|Treatment Period|Death|1|||
147671833|NCT03377361|532621124|FG003|Treatment Period|Death|0|||
147671834|NCT03377361|532621125|FG004|Treatment Period|Death|0|||
147671835|NCT03377361|532621126|FG005|Treatment Period|Death|0|||
147671836|NCT03377361|532621127|FG006|Treatment Period|Death|0|||
147671837|NCT03377361|532621128|FG007|Treatment Period|Death|2|||
147671838|NCT03377361|532621129|FG008|Treatment Period|Death|1|||
147671839|NCT03377361|532621130|FG009|Treatment Period|Death|3|||
147671840|NCT03377361|532621121|FG000|Treatment Period|Adverse Event Unrelated to Study Drug|0|||
147671841|NCT03377361|532621122|FG001|Treatment Period|Adverse Event Unrelated to Study Drug|0|||
147671842|NCT03377361|532621123|FG002|Treatment Period|Adverse Event Unrelated to Study Drug|0|||
147671843|NCT03377361|532621124|FG003|Treatment Period|Adverse Event Unrelated to Study Drug|0|||
147671844|NCT03377361|532621125|FG004|Treatment Period|Adverse Event Unrelated to Study Drug|0|||
147671845|NCT03377361|532621126|FG005|Treatment Period|Adverse Event Unrelated to Study Drug|0|||
147671846|NCT03377361|532621127|FG006|Treatment Period|Adverse Event Unrelated to Study Drug|1|||
147671847|NCT03377361|532621128|FG007|Treatment Period|Adverse Event Unrelated to Study Drug|2|||
147671848|NCT03377361|532621129|FG008|Treatment Period|Adverse Event Unrelated to Study Drug|3|||
147671849|NCT03377361|532621130|FG009|Treatment Period|Adverse Event Unrelated to Study Drug|0|||
147671850|NCT03377361|532621121|FG000|Treatment Period|Subject request to discontinue study treatment|0|||
147671851|NCT03377361|532621122|FG001|Treatment Period|Subject request to discontinue study treatment|0|||
147671852|NCT03377361|532621123|FG002|Treatment Period|Subject request to discontinue study treatment|0|||
147671853|NCT03377361|532621124|FG003|Treatment Period|Subject request to discontinue study treatment|0|||
147671854|NCT03377361|532621125|FG004|Treatment Period|Subject request to discontinue study treatment|0|||
147671855|NCT03377361|532621126|FG005|Treatment Period|Subject request to discontinue study treatment|0|||
147671856|NCT03377361|532621127|FG006|Treatment Period|Subject request to discontinue study treatment|0|||
147671857|NCT03377361|532621128|FG007|Treatment Period|Subject request to discontinue study treatment|0|||
147671858|NCT03377361|532621129|FG008|Treatment Period|Subject request to discontinue study treatment|1|||
147671859|NCT03377361|532621130|FG009|Treatment Period|Subject request to discontinue study treatment|1|||
147671860|NCT03377361|532621121|FG000|Treatment Period|Subject Withdrew Consent|0|||
147671861|NCT03377361|532621122|FG001|Treatment Period|Subject Withdrew Consent|0|||
147671862|NCT03377361|532621123|FG002|Treatment Period|Subject Withdrew Consent|0|||
147671863|NCT03377361|532621124|FG003|Treatment Period|Subject Withdrew Consent|0|||
147671864|NCT03377361|532621125|FG004|Treatment Period|Subject Withdrew Consent|0|||
147671865|NCT03377361|532621126|FG005|Treatment Period|Subject Withdrew Consent|0|||
147671866|NCT03377361|532621127|FG006|Treatment Period|Subject Withdrew Consent|0|||
147671867|NCT03377361|532621128|FG007|Treatment Period|Subject Withdrew Consent|0|||
147671868|NCT03377361|532621129|FG008|Treatment Period|Subject Withdrew Consent|2|||
147671869|NCT03377361|532621130|FG009|Treatment Period|Subject Withdrew Consent|1|||
147671870|NCT03377361|532621121|FG000|Treatment Period|No longer meets study criteria|0|||
147671871|NCT03377361|532621122|FG001|Treatment Period|No longer meets study criteria|1|||
147671872|NCT03377361|532621123|FG002|Treatment Period|No longer meets study criteria|0|||
147671873|NCT03377361|532621124|FG003|Treatment Period|No longer meets study criteria|0|||
147671874|NCT03377361|532621125|FG004|Treatment Period|No longer meets study criteria|0|||
147671875|NCT03377361|532621126|FG005|Treatment Period|No longer meets study criteria|0|||
147671876|NCT03377361|532621127|FG006|Treatment Period|No longer meets study criteria|0|||
147671877|NCT03377361|532621128|FG007|Treatment Period|No longer meets study criteria|1|||
147671878|NCT03377361|532621129|FG008|Treatment Period|No longer meets study criteria|0|||
147671879|NCT03377361|532621130|FG009|Treatment Period|No longer meets study criteria|0|||
147671880|NCT03377361|532621121|FG000|Treatment Period|Other Reasons|0|||
147671881|NCT03377361|532621122|FG001|Treatment Period|Other Reasons|0|||
147671882|NCT03377361|532621123|FG002|Treatment Period|Other Reasons|0|||
147671883|NCT03377361|532621124|FG003|Treatment Period|Other Reasons|3|||
147671884|NCT03377361|532621125|FG004|Treatment Period|Other Reasons|0|||
147671885|NCT03377361|532621126|FG005|Treatment Period|Other Reasons|0|||
147671886|NCT03377361|532621127|FG006|Treatment Period|Other Reasons|0|||
147671887|NCT03377361|532621128|FG007|Treatment Period|Other Reasons|2|||
147671888|NCT03377361|532621129|FG008|Treatment Period|Other Reasons|0|||
147671889|NCT03377361|532621130|FG009|Treatment Period|Other Reasons|1|||
147671890|NCT03698994|532621147|FG000|Overall Study|Adverse Event|2|||
147671891|NCT03698994|532621147|FG000|Overall Study|Death|1|||
147671892|NCT03698994|532621147|FG000|Overall Study|Physician Decision|1|||
147671893|NCT03698994|532621147|FG000|Overall Study|Withdrawal by Subject|3|||
147671894|NCT03698994|532621147|FG000|Overall Study|Progressive Disease|12|||
147671895|NCT02437071|532621148|FG000|Overall Study|Withdrawal by Subject|1|||
147671896|NCT02437071|532621149|FG001|Overall Study|Withdrawal by Subject|0|||
147671897|NCT05082025|532621150|FG000|Overall Study|Not evaluable for DLT per protocol (dosing less than 1 full cycle of treatment)|1|||
147671898|NCT03802617|532621153|FG000|Overall Study|Adverse Event|0|||
147671899|NCT03802617|532621154|FG001|Overall Study|Adverse Event|4|||
147671900|NCT03802617|532621155|FG002|Overall Study|Adverse Event|5|||
147671901|NCT03802617|532621156|FG003|Overall Study|Adverse Event|1|||
147671902|NCT03802617|532621153|FG000|Overall Study|Lack of Efficacy|0|||
147671903|NCT03802617|532621154|FG001|Overall Study|Lack of Efficacy|1|||
147671904|NCT03802617|532621155|FG002|Overall Study|Lack of Efficacy|0|||
147671905|NCT03802617|532621156|FG003|Overall Study|Lack of Efficacy|2|||
147671906|NCT03802617|532621153|FG000|Overall Study|Protocol Violation|1|||
147671907|NCT03802617|532621154|FG001|Overall Study|Protocol Violation|1|||
147671908|NCT03802617|532621155|FG002|Overall Study|Protocol Violation|1|||
147671909|NCT03802617|532621156|FG003|Overall Study|Protocol Violation|0|||
147671910|NCT03802617|532621153|FG000|Overall Study|Withdrawal by Subject|1|||
147671911|NCT03802617|532621154|FG001|Overall Study|Withdrawal by Subject|1|||
147671912|NCT03802617|532621155|FG002|Overall Study|Withdrawal by Subject|1|||
147671913|NCT03802617|532621156|FG003|Overall Study|Withdrawal by Subject|0|||
147671914|NCT03802617|532621153|FG000|Overall Study|Four consecutive missed doses of the study drug|0|||
147671915|NCT03802617|532621154|FG001|Overall Study|Four consecutive missed doses of the study drug|1|||
147671916|NCT03802617|532621155|FG002|Overall Study|Four consecutive missed doses of the study drug|1|||
147671917|NCT03802617|532621156|FG003|Overall Study|Four consecutive missed doses of the study drug|1|||
147671918|NCT04788511|532621159|FG000|Overall Study|Withdrawal by Subject|2|||
147671919|NCT04788511|532621160|FG001|Overall Study|Withdrawal by Subject|1|||
147512477|NCT00437203|532028105|FG005|Overall Study|Study terminated by sponsor|0|||
147671920|NCT04788511|532621159|FG000|Overall Study|Lost to Follow-up|2|||
147671921|NCT04788511|532621160|FG001|Overall Study|Lost to Follow-up|7|||
147671922|NCT04788511|532621159|FG000|Overall Study|Death|3|||
147671923|NCT04788511|532621160|FG001|Overall Study|Death|4|||
147671924|NCT04458922|532623227|FG000|Overall Study|Withdrawal by Subject|1|||
147671925|NCT04458922|532623228|FG001|Overall Study|Withdrawal by Subject|0|||
147671926|NCT04458922|532623229|FG002|Overall Study|Withdrawal by Subject|2|||
147671927|NCT04458922|532623227|FG000|Overall Study|Protocol -specified withdrawal criterion met|0|||
147671928|NCT04458922|532623228|FG001|Overall Study|Protocol -specified withdrawal criterion met|0|||
147671929|NCT04458922|532623229|FG002|Overall Study|Protocol -specified withdrawal criterion met|1|||
147671930|NCT04458922|532623227|FG000|Overall Study|Adverse Event|1|||
147671931|NCT04458922|532623228|FG001|Overall Study|Adverse Event|0|||
147671932|NCT04458922|532623229|FG002|Overall Study|Adverse Event|0|||
147671933|NCT04458922|532623227|FG000|Overall Study|Started new study|0|||
147671934|NCT04458922|532623228|FG001|Overall Study|Started new study|0|||
147671935|NCT04458922|532623229|FG002|Overall Study|Started new study|1|||
147671936|NCT04458922|532623227|FG000|Overall Study|Progressive disease|6|||
147671937|NCT04458922|532623228|FG001|Overall Study|Progressive disease|8|||
147671938|NCT04458922|532623229|FG002|Overall Study|Progressive disease|2|||
147671939|NCT04458922|532623227|FG000|Overall Study|Death|1|||
147671940|NCT04458922|532623228|FG001|Overall Study|Death|0|||
147671941|NCT04458922|532623229|FG002|Overall Study|Death|2|||
147671942|NCT04458922|532623227|FG000|Overall Study|Participant started chemotherapy|0|||
147671943|NCT04458922|532623228|FG001|Overall Study|Participant started chemotherapy|1|||
147671944|NCT04458922|532623229|FG002|Overall Study|Participant started chemotherapy|0|||
147671945|NCT03025035|532623230|FG000|Overall Study|Death|2|||
147671946|NCT03025035|532623230|FG000|Overall Study|Disease progression and was taken off study. Only received pembrolizumab & is not evaluable.|1|||
147671947|NCT02921256|532623231|FG000|Arm 1a v. Arm II|Adverse Event|6|||
147671948|NCT02921256|532623232|FG001|Arm 1a v. Arm II|Adverse Event|15|||
147671949|NCT02921256|532623233|FG002|Arm 1a v. Arm II|Adverse Event|0|||
147671950|NCT02921256|532623231|FG000|Arm 1a v. Arm II|Death|0|||
147671951|NCT02921256|532623232|FG001|Arm 1a v. Arm II|Death|2|||
147671952|NCT02921256|532623233|FG002|Arm 1a v. Arm II|Death|0|||
147671953|NCT02921256|532623231|FG000|Arm 1a v. Arm II|Lack of Efficacy|2|||
147671954|NCT02921256|532623232|FG001|Arm 1a v. Arm II|Lack of Efficacy|0|||
147671955|NCT02921256|532623233|FG002|Arm 1a v. Arm II|Lack of Efficacy|0|||
147671956|NCT02921256|532623231|FG000|Arm 1a v. Arm II|Lost to Follow-up|2|||
147671957|NCT02921256|532623232|FG001|Arm 1a v. Arm II|Lost to Follow-up|9|||
147671958|NCT02921256|532623233|FG002|Arm 1a v. Arm II|Lost to Follow-up|0|||
147671959|NCT02921256|532623231|FG000|Arm 1a v. Arm II|Physician Decision|1|||
147671960|NCT02921256|532623232|FG001|Arm 1a v. Arm II|Physician Decision|1|||
147671961|NCT02921256|532623233|FG002|Arm 1a v. Arm II|Physician Decision|0|||
147671962|NCT02921256|532623231|FG000|Arm 1a v. Arm II|Withdrawal by Subject|5|||
147671963|NCT02921256|532623232|FG001|Arm 1a v. Arm II|Withdrawal by Subject|6|||
147671964|NCT02921256|532623233|FG002|Arm 1a v. Arm II|Withdrawal by Subject|0|||
147671965|NCT02921256|532623231|FG000|Arm Ib v Arm III|Adverse Event|9|||
147671966|NCT02921256|532623232|FG001|Arm Ib v Arm III|Adverse Event|0|||
147671967|NCT02921256|532623233|FG002|Arm Ib v Arm III|Adverse Event|4|||
147671968|NCT02921256|532623231|FG000|Arm Ib v Arm III|Death|1|||
147671969|NCT02921256|532623232|FG001|Arm Ib v Arm III|Death|0|||
147671970|NCT02921256|532623233|FG002|Arm Ib v Arm III|Death|1|||
147671971|NCT02921256|532623231|FG000|Arm Ib v Arm III|Lack of Efficacy|2|||
147671972|NCT02921256|532623232|FG001|Arm Ib v Arm III|Lack of Efficacy|0|||
147671973|NCT02921256|532623233|FG002|Arm Ib v Arm III|Lack of Efficacy|2|||
147671974|NCT02921256|532623231|FG000|Arm Ib v Arm III|Lost to Follow-up|1|||
147671975|NCT02921256|532623232|FG001|Arm Ib v Arm III|Lost to Follow-up|0|||
147671976|NCT02921256|532623233|FG002|Arm Ib v Arm III|Lost to Follow-up|3|||
147671977|NCT02921256|532623231|FG000|Arm Ib v Arm III|Physician Decision|4|||
147671978|NCT02921256|532623232|FG001|Arm Ib v Arm III|Physician Decision|0|||
147671979|NCT02921256|532623233|FG002|Arm Ib v Arm III|Physician Decision|1|||
147671980|NCT02921256|532623231|FG000|Arm Ib v Arm III|Withdrawal by Subject|7|||
147671981|NCT02921256|532623232|FG001|Arm Ib v Arm III|Withdrawal by Subject|0|||
147671982|NCT02921256|532623233|FG002|Arm Ib v Arm III|Withdrawal by Subject|4|||
147671983|NCT02282917|532623236|FG000|Overall Study|Withdrawal by Subject|1|||
147671984|NCT02282917|532623236|FG000|Overall Study|Screen Failure/Not Eligible|1|||
147671985|NCT04848480|532623237|FG000|Main Phase (26 Weeks)|Death|1|||
147671986|NCT04848480|532623238|FG001|Main Phase (26 Weeks)|Death|0|||
147671987|NCT04848480|532623237|FG000|Main Phase (26 Weeks)|Lost to Follow-up|1|||
147671988|NCT04848480|532623238|FG001|Main Phase (26 Weeks)|Lost to Follow-up|1|||
147671989|NCT04848480|532623237|FG000|Main Phase (26 Weeks)|Withdrawal by Subject|9|||
147671990|NCT04848480|532623238|FG001|Main Phase (26 Weeks)|Withdrawal by Subject|7|||
147671991|NCT04848480|532623237|FG000|Extension Phase (26 Weeks)|Physician Decision|1|||
147671992|NCT04848480|532623238|FG001|Extension Phase (26 Weeks)|Physician Decision|0|||
147671993|NCT04848480|532623237|FG000|Extension Phase (26 Weeks)|Lost to Follow-up|0|||
147671994|NCT04848480|532623238|FG001|Extension Phase (26 Weeks)|Lost to Follow-up|1|||
147671995|NCT04848480|532623237|FG000|Extension Phase (26 Weeks)|Withdrawal by Subject|4|||
147671996|NCT04848480|532623238|FG001|Extension Phase (26 Weeks)|Withdrawal by Subject|2|||
147671997|NCT02615938|532623239|FG000|First 4 Wks Start, First 3 Mon Stop|Physician Decision|3|||
147671998|NCT02615938|532623240|FG001|First 4 Wks Start, First 3 Mon Stop|Physician Decision|2|||
147671999|NCT02615938|532623241|FG002|First 4 Wks Start, First 3 Mon Stop|Physician Decision|0|||
147672000|NCT02615938|532623242|FG003|First 4 Wks Start, First 3 Mon Stop|Physician Decision|0|||
147672001|NCT02615938|532623239|FG000|First 4 Wks Start, First 3 Mon Stop|Withdrawal by Subject|1|||
147672002|NCT02615938|532623240|FG001|First 4 Wks Start, First 3 Mon Stop|Withdrawal by Subject|0|||
147672003|NCT02615938|532623241|FG002|First 4 Wks Start, First 3 Mon Stop|Withdrawal by Subject|0|||
147672004|NCT02615938|532623242|FG003|First 4 Wks Start, First 3 Mon Stop|Withdrawal by Subject|0|||
147512478|NCT00437203|532028106|FG006|Overall Study|Study terminated by sponsor|0|||
147672005|NCT02615938|532623239|FG000|First 4 Wks Start, First 3 Mon Stop|Physician Decision|0|||
147672006|NCT02615938|532623240|FG001|First 4 Wks Start, First 3 Mon Stop|Physician Decision|0|||
147672007|NCT02615938|532623241|FG002|First 4 Wks Start, First 3 Mon Stop|Physician Decision|1|||
147672008|NCT02615938|532623242|FG003|First 4 Wks Start, First 3 Mon Stop|Physician Decision|0|||
147672009|NCT04590404|532623246|FG000|Overall Study|Death|16|||
147672010|NCT04590404|532623247|FG001|Overall Study|Death|17|||
147672011|NCT04590404|532623246|FG000|Overall Study|Withdrawal by Subject|7|||
147672012|NCT04590404|532623247|FG001|Overall Study|Withdrawal by Subject|2|||
147672013|NCT05063448|532623250|FG000|Overall Study|Withdrawal by Subject|1|||
147672014|NCT05903183|532623251|FG000|Main Trial Part (365 Days)|Death|1|||
147672015|NCT05903183|532623252|FG001|Main Trial Part (365 Days)|Death|0|||
147672016|NCT05903183|532623253|FG002|Main Trial Part (365 Days)|Death|0|||
147672017|NCT05903183|532623254|FG003|Main Trial Part (365 Days)|Death|0|||
147672018|NCT05903183|532623255|FG004|Main Trial Part (365 Days)|Death|0|||
147672019|NCT05903183|532623251|FG000|Main Trial Part (365 Days)|Other|1|||
147672020|NCT05903183|532623252|FG001|Main Trial Part (365 Days)|Other|2|||
147672021|NCT05903183|532623253|FG002|Main Trial Part (365 Days)|Other|1|||
147672022|NCT05903183|532623254|FG003|Main Trial Part (365 Days)|Other|0|||
147672023|NCT05903183|532623255|FG004|Main Trial Part (365 Days)|Other|0|||
147672024|NCT05903183|532623251|FG000|Main Trial Part (365 Days)|Lost to Follow-up|0|||
147672025|NCT05903183|532623252|FG001|Main Trial Part (365 Days)|Lost to Follow-up|0|||
147672026|NCT05903183|532623253|FG002|Main Trial Part (365 Days)|Lost to Follow-up|1|||
147672027|NCT05903183|532623254|FG003|Main Trial Part (365 Days)|Lost to Follow-up|0|||
147672028|NCT05903183|532623255|FG004|Main Trial Part (365 Days)|Lost to Follow-up|0|||
147672029|NCT05903183|532623251|FG000|Main Trial Part (365 Days)|Withdrawal by Subject|1|||
147672030|NCT05903183|532623252|FG001|Main Trial Part (365 Days)|Withdrawal by Subject|0|||
147672031|NCT05903183|532623253|FG002|Main Trial Part (365 Days)|Withdrawal by Subject|0|||
147672032|NCT05903183|532623254|FG003|Main Trial Part (365 Days)|Withdrawal by Subject|0|||
147672033|NCT05903183|532623255|FG004|Main Trial Part (365 Days)|Withdrawal by Subject|0|||
147672034|NCT05903183|532623251|FG000|Observation Extension Part (144 Days)|Sponsor's decision|0|||
147672035|NCT05903183|532623252|FG001|Observation Extension Part (144 Days)|Sponsor's decision|0|||
147672036|NCT05903183|532623253|FG002|Observation Extension Part (144 Days)|Sponsor's decision|0|||
147672037|NCT05903183|532623254|FG003|Observation Extension Part (144 Days)|Sponsor's decision|35|||
147672038|NCT05903183|532623255|FG004|Observation Extension Part (144 Days)|Sponsor's decision|20|||
147672039|NCT03698019|532623257|FG000|Step 1: Registration|Still receiving protocol therapy|0|||
147672040|NCT03698019|532623258|FG001|Step 1: Registration|Still receiving protocol therapy|10|||
147672041|NCT03698019|532623257|FG000|Step 1: Registration|Withdrawal by Subject|7|||
147672042|NCT03698019|532623258|FG001|Step 1: Registration|Withdrawal by Subject|2|||
147672043|NCT03698019|532623257|FG000|Step 1: Registration|Toxicity|0|||
147672044|NCT03698019|532623258|FG001|Step 1: Registration|Toxicity|1|||
147672045|NCT03698019|532623257|FG000|Step 1: Registration|Disease Progression|0|||
147672046|NCT03698019|532623258|FG001|Step 1: Registration|Disease Progression|12|||
147672047|NCT03698019|532623257|FG000|Step 1: Registration|Co-morbidities|0|||
147672048|NCT03698019|532623258|FG001|Step 1: Registration|Co-morbidities|1|||
147672049|NCT03698019|532623257|FG000|Step 1: Registration|Scheduling Issues|1|||
147672050|NCT03698019|532623258|FG001|Step 1: Registration|Scheduling Issues|0|||
147672051|NCT03698019|532623257|FG000|Step 1: Registration|Participant Refusal|0|||
147672052|NCT03698019|532623258|FG001|Step 1: Registration|Participant Refusal|1|||
147672053|NCT03698019|532623257|FG000|Step 2: Surgery|Participant Refusal|2|||
147672054|NCT03698019|532623258|FG001|Step 2: Surgery|Participant Refusal|1|||
147672055|NCT03698019|532623257|FG000|Step 2: Surgery|Neoadjuvant Toxicity|0|||
147672056|NCT03698019|532623258|FG001|Step 2: Surgery|Neoadjuvant Toxicity|3|||
147672057|NCT03698019|532623257|FG000|Step 2: Surgery|Metastatic Disease|16|||
147672058|NCT03698019|532623258|FG001|Step 2: Surgery|Metastatic Disease|9|||
147672059|NCT03698019|532623257|FG000|Step 2: Surgery|Residual Disease|2|||
147672060|NCT03698019|532623258|FG001|Step 2: Surgery|Residual Disease|1|||
147672061|NCT03698019|532623257|FG000|Step 2: Surgery|Trial Closed due to Covid-19|0|||
147672062|NCT03698019|532623258|FG001|Step 2: Surgery|Trial Closed due to Covid-19|1|||
147672063|NCT03698019|532623257|FG000|Step 2: Surgery|Concerns about Exposure to Covid-19|0|||
147672064|NCT03698019|532623258|FG001|Step 2: Surgery|Concerns about Exposure to Covid-19|1|||
147672065|NCT03698019|532623257|FG000|Step 2: Surgery|Disease other than melanoma identified at surgery|0|||
147672066|NCT03698019|532623258|FG001|Step 2: Surgery|Disease other than melanoma identified at surgery|2|||
147672067|NCT03698019|532623257|FG000|Step 2: Surgery|Radiotherapy-related Delays|1|||
147672068|NCT03698019|532623258|FG001|Step 2: Surgery|Radiotherapy-related Delays|0|||
147672069|NCT03698019|532623257|FG000|Step 3: Adjuvant Pembrolizumab|Still receiving protocol therapy|41|||
147672070|NCT03698019|532623258|FG001|Step 3: Adjuvant Pembrolizumab|Still receiving protocol therapy|33|||
147672071|NCT03698019|532623257|FG000|Step 3: Adjuvant Pembrolizumab|Disease Progression|41|||
147672072|NCT03698019|532623258|FG001|Step 3: Adjuvant Pembrolizumab|Disease Progression|9|||
147672073|NCT03698019|532623257|FG000|Step 3: Adjuvant Pembrolizumab|Death|4|||
147672074|NCT03698019|532623258|FG001|Step 3: Adjuvant Pembrolizumab|Death|1|||
147672075|NCT03698019|532623257|FG000|Step 3: Adjuvant Pembrolizumab|Other, unspecified reasons|6|||
147672076|NCT03698019|532623258|FG001|Step 3: Adjuvant Pembrolizumab|Other, unspecified reasons|16|||
147672077|NCT00569127|532623259|FG000|Overall Study|Adverse Event|57|||
147672078|NCT00569127|532623260|FG001|Overall Study|Adverse Event|47|||
147672079|NCT00569127|532623259|FG000|Overall Study|Withdrawal by Subject|13|||
147672080|NCT00569127|532623260|FG001|Overall Study|Withdrawal by Subject|27|||
147672081|NCT00569127|532623259|FG000|Overall Study|Progression|99|||
147672082|NCT00569127|532623260|FG001|Overall Study|Progression|100|||
147672083|NCT00569127|532623259|FG000|Overall Study|Death|4|||
147672084|NCT00569127|532623260|FG001|Overall Study|Death|3|||
147672085|NCT00569127|532623259|FG000|Overall Study|Other|20|||
147672086|NCT00569127|532623260|FG001|Overall Study|Other|19|||
147672087|NCT00569127|532623259|FG000|Overall Study|Lost to Follow-up|0|||
147672088|NCT00569127|532623260|FG001|Overall Study|Lost to Follow-up|3|||
147672089|NCT00569127|532623259|FG000|Overall Study|Not Eligible|14|||
147672090|NCT00569127|532623260|FG001|Overall Study|Not Eligible|11|||
147672091|NCT00569127|532623259|FG000|Overall Study|Still on Treatment|7|||
147672092|NCT00569127|532623260|FG001|Overall Study|Still on Treatment|3|||
147672093|NCT04428151|532623261|FG000|Overall Study|Death|100|||
147672094|NCT04428151|532623262|FG001|Overall Study|Death|86|||
147672095|NCT04428151|532623263|FG002|Overall Study|Death|57|||
147672096|NCT04428151|532623261|FG000|Overall Study|Lost to Follow-up|1|||
147672097|NCT04428151|532623262|FG001|Overall Study|Lost to Follow-up|1|||
147672098|NCT04428151|532623263|FG002|Overall Study|Lost to Follow-up|0|||
147672099|NCT04428151|532623261|FG000|Overall Study|Withdrawal by Subject|2|||
147672100|NCT04428151|532623262|FG001|Overall Study|Withdrawal by Subject|2|||
147672101|NCT04428151|532623263|FG002|Overall Study|Withdrawal by Subject|3|||
147672102|NCT04428151|532623261|FG000|Overall Study|Participant Ongoing in Study|41|||
147672103|NCT04428151|532623262|FG001|Overall Study|Participant Ongoing in Study|53|||
147672104|NCT04428151|532623263|FG002|Overall Study|Participant Ongoing in Study|28|||
147672105|NCT04777331|532623264|FG000|DBT Period|Death|2|||
147672106|NCT04777331|532623265|FG001|DBT Period|Death|1|||
147672107|NCT04777331|532623266|FG002|DBT Period|Death|0|||
147672108|NCT04777331|532623264|FG000|DBT Period|Reason not Specified|1|||
147672109|NCT04777331|532623265|FG001|DBT Period|Reason not Specified|1|||
147672110|NCT04777331|532623266|FG002|DBT Period|Reason not Specified|0|||
147672111|NCT04777331|532623264|FG000|DBT Period|Physician Decision|4|||
147672112|NCT04777331|532623265|FG001|DBT Period|Physician Decision|0|||
147672113|NCT04777331|532623266|FG002|DBT Period|Physician Decision|0|||
147672114|NCT04777331|532623264|FG000|DBT Period|Withdrawal by Subject|12|||
147672115|NCT04777331|532623265|FG001|DBT Period|Withdrawal by Subject|11|||
147672116|NCT04777331|532623266|FG002|DBT Period|Withdrawal by Subject|0|||
147672117|NCT04777331|532623264|FG000|DBT Period|Randomized but not Treated|1|||
147672118|NCT04777331|532623265|FG001|DBT Period|Randomized but not Treated|3|||
147672119|NCT04777331|532623266|FG002|DBT Period|Randomized but not Treated|0|||
147672120|NCT04777331|532623264|FG000|OLE Period|Ongoing in OLE|0|||
147672121|NCT04777331|532623265|FG001|OLE Period|Ongoing in OLE|0|||
147672122|NCT04777331|532623266|FG002|OLE Period|Ongoing in OLE|534|||
147672123|NCT02642042|532623267|FG000|Overall Study|Adverse Event|22|||
147672124|NCT02642042|532623267|FG000|Overall Study|Refusal Unrelated to Adverse Event|1|||
147672125|NCT02642042|532623267|FG000|Overall Study|Progression/Relapse|28|||
147672126|NCT02642042|532623267|FG000|Overall Study|Death|1|||
147672127|NCT02642042|532623267|FG000|Overall Study|Not Protocol Specified|2|||
147672128|NCT03375320|532623282|FG000|Overall Study|Adverse Event|34|||
147672129|NCT03375320|532623283|FG001|Overall Study|Adverse Event|9|||
147672130|NCT03375320|532623284|FG002|Overall Study|Adverse Event|10|||
147672131|NCT03375320|532623285|FG003|Overall Study|Adverse Event|0|||
147672132|NCT03375320|532623282|FG000|Overall Study|Death|6|||
147672133|NCT03375320|532623283|FG001|Overall Study|Death|3|||
147672134|NCT03375320|532623284|FG002|Overall Study|Death|0|||
147672135|NCT03375320|532623285|FG003|Overall Study|Death|0|||
147672136|NCT03375320|532623282|FG000|Overall Study|Withdrawal by Subject|7|||
147672137|NCT03375320|532623283|FG001|Overall Study|Withdrawal by Subject|4|||
147672138|NCT03375320|532623284|FG002|Overall Study|Withdrawal by Subject|5|||
147672139|NCT03375320|532623285|FG003|Overall Study|Withdrawal by Subject|4|||
147672140|NCT03375320|532623282|FG000|Overall Study|Progressive disease|55|||
147512479|NCT00437203|532028107|FG007|Overall Study|Study terminated by sponsor|0|||
147512480|NCT00437203|532028108|FG008|Overall Study|Study terminated by sponsor|1|||
147672141|NCT03375320|532623283|FG001|Overall Study|Progressive disease|41|||
147672142|NCT03375320|532623284|FG002|Overall Study|Progressive disease|29|||
147672143|NCT03375320|532623285|FG003|Overall Study|Progressive disease|24|||
147672144|NCT03375320|532623282|FG000|Overall Study|Alternative treatment|6|||
147672145|NCT03375320|532623283|FG001|Overall Study|Alternative treatment|1|||
147672146|NCT03375320|532623284|FG002|Overall Study|Alternative treatment|1|||
147672147|NCT03375320|532623285|FG003|Overall Study|Alternative treatment|0|||
147672148|NCT03375320|532623282|FG000|Overall Study|Other disease|1|||
147672149|NCT03375320|532623283|FG001|Overall Study|Other disease|1|||
147672150|NCT03375320|532623284|FG002|Overall Study|Other disease|3|||
147672151|NCT03375320|532623285|FG003|Overall Study|Other disease|0|||
147672152|NCT03375320|532623282|FG000|Overall Study|Withdrawal prior to initiation|2|||
147672153|NCT03375320|532623283|FG001|Overall Study|Withdrawal prior to initiation|2|||
147672154|NCT03375320|532623284|FG002|Overall Study|Withdrawal prior to initiation|1|||
147672155|NCT03375320|532623285|FG003|Overall Study|Withdrawal prior to initiation|0|||
147672156|NCT03375320|532623282|FG000|Overall Study|Physician Decision|1|||
147672157|NCT03375320|532623283|FG001|Overall Study|Physician Decision|1|||
147672158|NCT03375320|532623284|FG002|Overall Study|Physician Decision|1|||
147672159|NCT03375320|532623285|FG003|Overall Study|Physician Decision|1|||
147672160|NCT03375320|532623282|FG000|Overall Study|Non-compliance|1|||
147672161|NCT03375320|532623283|FG001|Overall Study|Non-compliance|0|||
147672162|NCT03375320|532623284|FG002|Overall Study|Non-compliance|0|||
147672163|NCT03375320|532623285|FG003|Overall Study|Non-compliance|0|||
147672164|NCT04108468|532623286|FG000|Overall Study|Physician Decision|0|||
147672165|NCT04108468|532623287|FG001|Overall Study|Physician Decision|1|||
147672166|NCT04108468|532623286|FG000|Overall Study|Lost to Follow-up|0|||
147672167|NCT04108468|532623287|FG001|Overall Study|Lost to Follow-up|1|||
147672168|NCT04108468|532623286|FG000|Overall Study|Non-compliance|1|||
147672169|NCT04108468|532623287|FG001|Overall Study|Non-compliance|1|||
147672170|NCT04108468|532623286|FG000|Overall Study|Unable to attend final visit|2|||
147672171|NCT04108468|532623287|FG001|Overall Study|Unable to attend final visit|0|||
147672172|NCT04108468|532623286|FG000|Overall Study|Missed study medication|0|||
147672173|NCT04108468|532623287|FG001|Overall Study|Missed study medication|1|||
147672174|NCT03348631|532623288|FG000|Overall Study|Not Eligible, No treatment|0|||
147672175|NCT03348631|532623289|FG001|Overall Study|Not Eligible, No treatment|1|||
147672176|NCT03348631|532623288|FG000|Overall Study|Not Eligible, Treated|2|||
147672177|NCT03348631|532623289|FG001|Overall Study|Not Eligible, Treated|0|||
147672178|NCT03348631|532623288|FG000|Overall Study|Eligible, No Treatment|1|||
147672179|NCT03348631|532623289|FG001|Overall Study|Eligible, No Treatment|0|||
147672180|NCT03260023|532623290|FG000|Overall Study|Adverse Event|0|||
147672181|NCT03260023|532623291|FG001|Overall Study|Adverse Event|0|||
147672182|NCT03260023|532623292|FG002|Overall Study|Adverse Event|4|||
147672183|NCT03260023|532623293|FG003|Overall Study|Adverse Event|4|||
147672184|NCT03260023|532623294|FG004|Overall Study|Adverse Event|4|||
147672185|NCT03260023|532623295|FG005|Overall Study|Adverse Event|1|||
147672186|NCT03260023|532623296|FG006|Overall Study|Adverse Event|2|||
147672187|NCT03260023|532623290|FG000|Overall Study|Clinical Progression|0|||
147672188|NCT03260023|532623291|FG001|Overall Study|Clinical Progression|1|||
147672189|NCT03260023|532623292|FG002|Overall Study|Clinical Progression|3|||
147672190|NCT03260023|532623293|FG003|Overall Study|Clinical Progression|1|||
147672191|NCT03260023|532623294|FG004|Overall Study|Clinical Progression|0|||
147672192|NCT03260023|532623295|FG005|Overall Study|Clinical Progression|0|||
147672193|NCT03260023|532623296|FG006|Overall Study|Clinical Progression|0|||
147672194|NCT03260023|532623290|FG000|Overall Study|Physician Decision|0|||
147512481|NCT00437203|532028109|FG009|Overall Study|Study terminated by sponsor|0|||
147512482|NCT00437203|532028100|FG000|Overall Study|Objective progression or relapse|5|||
147512483|NCT00437203|532028101|FG001|Overall Study|Objective progression or relapse|6|||
147512484|NCT00437203|532028102|FG002|Overall Study|Objective progression or relapse|2|||
147512485|NCT00437203|532028103|FG003|Overall Study|Objective progression or relapse|3|||
147512486|NCT00437203|532028104|FG004|Overall Study|Objective progression or relapse|3|||
147672195|NCT03260023|532623291|FG001|Overall Study|Physician Decision|0|||
147672196|NCT03260023|532623292|FG002|Overall Study|Physician Decision|0|||
147672197|NCT03260023|532623293|FG003|Overall Study|Physician Decision|1|||
147672198|NCT03260023|532623294|FG004|Overall Study|Physician Decision|1|||
147672199|NCT03260023|532623295|FG005|Overall Study|Physician Decision|0|||
147672200|NCT03260023|532623296|FG006|Overall Study|Physician Decision|0|||
147672201|NCT03260023|532623290|FG000|Overall Study|Withdrawal by Subject|0|||
147672202|NCT03260023|532623291|FG001|Overall Study|Withdrawal by Subject|0|||
147672203|NCT03260023|532623292|FG002|Overall Study|Withdrawal by Subject|0|||
147672204|NCT03260023|532623293|FG003|Overall Study|Withdrawal by Subject|0|||
147672205|NCT03260023|532623294|FG004|Overall Study|Withdrawal by Subject|3|||
147672206|NCT03260023|532623295|FG005|Overall Study|Withdrawal by Subject|0|||
147672207|NCT03260023|532623296|FG006|Overall Study|Withdrawal by Subject|0|||
147672208|NCT03260023|532623290|FG000|Overall Study|Under trial intervention|0|||
147672209|NCT03260023|532623291|FG001|Overall Study|Under trial intervention|0|||
147672210|NCT03260023|532623292|FG002|Overall Study|Under trial intervention|2|||
147512487|NCT00437203|532028105|FG005|Overall Study|Objective progression or relapse|3|||
147672211|NCT03260023|532623293|FG003|Overall Study|Under trial intervention|5|||
147672212|NCT03260023|532623294|FG004|Overall Study|Under trial intervention|3|||
147672213|NCT03260023|532623295|FG005|Overall Study|Under trial intervention|0|||
147672214|NCT03260023|532623296|FG006|Overall Study|Under trial intervention|0|||
147672215|NCT03388632|532623297|FG000|Triplet C|Clinical progression|0|||
147672216|NCT03388632|532623298|FG001|Triplet C|Clinical progression|0|||
147672217|NCT03388632|532623299|FG002|Triplet C|Clinical progression|0|||
147672218|NCT03388632|532623300|FG003|Triplet C|Clinical progression|0|||
147672219|NCT03388632|532623301|FG004|Triplet C|Clinical progression|1|||
147672220|NCT03388632|532623302|FG005|Triplet C|Clinical progression|0|||
147672221|NCT03388632|532623303|FG006|Triplet C|Clinical progression|0|||
147672222|NCT03388632|532623304|FG007|Triplet C|Clinical progression|0|||
147672223|NCT03388632|532623305|FG008|Triplet C|Clinical progression|0|||
147672224|NCT03388632|532623297|FG000|Triplet C|42-day lapse in tx|0|||
147672225|NCT03388632|532623298|FG001|Triplet C|42-day lapse in tx|0|||
147672226|NCT03388632|532623299|FG002|Triplet C|42-day lapse in tx|0|||
147512488|NCT00437203|532028106|FG006|Overall Study|Objective progression or relapse|6|||
147512489|NCT00437203|532028107|FG007|Overall Study|Objective progression or relapse|1|||
147512490|NCT00437203|532028108|FG008|Overall Study|Objective progression or relapse|2|||
147512491|NCT00437203|532028109|FG009|Overall Study|Objective progression or relapse|2|||
147512492|NCT00437203|532028100|FG000|Overall Study|Other|0|||
147512493|NCT00437203|532028101|FG001|Overall Study|Other|1|||
147512494|NCT00437203|532028102|FG002|Overall Study|Other|0|||
147512495|NCT00437203|532028103|FG003|Overall Study|Other|0|||
147512496|NCT00437203|532028104|FG004|Overall Study|Other|0|||
147512497|NCT00437203|532028105|FG005|Overall Study|Other|0|||
147512498|NCT00437203|532028106|FG006|Overall Study|Other|1|||
147512499|NCT00437203|532028107|FG007|Overall Study|Other|0|||
147512500|NCT00437203|532028108|FG008|Overall Study|Other|0|||
147512501|NCT00437203|532028109|FG009|Overall Study|Other|0|||
147512502|NCT00479167|532028110|FG000|Overall Study|Withdrawal by Subject|1|||
147512503|NCT02384993|532028113|FG000|Overall Study|Adverse Event|0|||
147512504|NCT02384993|532028114|FG001|Overall Study|Adverse Event|1|||
147512505|NCT00880607|532028115|FG000|Overall Study|Physician Decision|2|||
147512506|NCT00880607|532028116|FG001|Overall Study|Physician Decision|2|||
147512507|NCT00880607|532028115|FG000|Overall Study|Protocol Violation|2|||
147512508|NCT00880607|532028116|FG001|Overall Study|Protocol Violation|1|||
147512509|NCT00880607|532028115|FG000|Overall Study|surgery did not extend past L1 level|3|||
147512510|NCT00880607|532028116|FG001|Overall Study|surgery did not extend past L1 level|0|||
147512511|NCT01004159|532029524|FG000|Overall Study|Adverse Event|2|||
147512512|NCT01004159|532029524|FG000|Overall Study|Disease Progression|18|||
147512513|NCT04483544|532029526|FG000|Treatment (Completed 1 or More Cycles)|Death|1|||
147512514|NCT04483544|532029526|FG000|Post-Treatment|Admitted to hospice|2|||
147512515|NCT04483544|532029526|FG000|Post-Treatment|Study terminated|3|||
147512516|NCT01183104|532029527|FG000|Overall Study|Adverse Event|8|||
147672227|NCT03388632|532623300|FG003|Triplet C|42-day lapse in tx|0|||
147672228|NCT03388632|532623301|FG004|Triplet C|42-day lapse in tx|1|||
147672229|NCT03388632|532623302|FG005|Triplet C|42-day lapse in tx|0|||
147672230|NCT03388632|532623303|FG006|Triplet C|42-day lapse in tx|0|||
147672231|NCT03388632|532623304|FG007|Triplet C|42-day lapse in tx|0|||
147672232|NCT03388632|532623305|FG008|Triplet C|42-day lapse in tx|0|||
147672233|NCT03388632|532623297|FG000|Triplet C|Adverse Event|0|||
147672234|NCT03388632|532623298|FG001|Triplet C|Adverse Event|0|||
147672235|NCT03388632|532623299|FG002|Triplet C|Adverse Event|0|||
147672236|NCT03388632|532623300|FG003|Triplet C|Adverse Event|0|||
147672237|NCT03388632|532623301|FG004|Triplet C|Adverse Event|0|||
147672238|NCT03388632|532623302|FG005|Triplet C|Adverse Event|0|||
147672239|NCT03388632|532623303|FG006|Triplet C|Adverse Event|0|||
147672240|NCT03388632|532623304|FG007|Triplet C|Adverse Event|0|||
147672241|NCT03388632|532623305|FG008|Triplet C|Adverse Event|1|||
147672242|NCT03388632|532623297|FG000|Triplet C|Switched to alternative treatment|0|||
147672243|NCT03388632|532623298|FG001|Triplet C|Switched to alternative treatment|0|||
147672244|NCT03388632|532623299|FG002|Triplet C|Switched to alternative treatment|0|||
147672245|NCT03388632|532623300|FG003|Triplet C|Switched to alternative treatment|0|||
147672246|NCT03388632|532623301|FG004|Triplet C|Switched to alternative treatment|0|||
147672247|NCT03388632|532623302|FG005|Triplet C|Switched to alternative treatment|0|||
147672248|NCT03388632|532623303|FG006|Triplet C|Switched to alternative treatment|0|||
147672249|NCT03388632|532623304|FG007|Triplet C|Switched to alternative treatment|1|||
147672250|NCT03388632|532623305|FG008|Triplet C|Switched to alternative treatment|0|||
147672251|NCT03388632|532623297|FG000|Triplet C|Participant choice|0|||
147672252|NCT03388632|532623298|FG001|Triplet C|Participant choice|0|||
147672253|NCT03388632|532623299|FG002|Triplet C|Participant choice|0|||
147672254|NCT03388632|532623300|FG003|Triplet C|Participant choice|0|||
147672255|NCT03388632|532623301|FG004|Triplet C|Participant choice|0|||
147672256|NCT03388632|532623302|FG005|Triplet C|Participant choice|1|||
147512517|NCT01183104|532029528|FG001|Overall Study|Adverse Event|6|||
147512518|NCT01183104|532029527|FG000|Overall Study|Death|0|||
147512519|NCT01183104|532029528|FG001|Overall Study|Death|1|||
147672257|NCT03388632|532623303|FG006|Triplet C|Participant choice|0|||
147672258|NCT03388632|532623304|FG007|Triplet C|Participant choice|0|||
147672259|NCT03388632|532623305|FG008|Triplet C|Participant choice|0|||
147512520|NCT01183104|532029527|FG000|Overall Study|Lost to Follow-up|14|||
147512521|NCT01183104|532029528|FG001|Overall Study|Lost to Follow-up|7|||
147512522|NCT01183104|532029527|FG000|Overall Study|Physician Decision|5|||
147512523|NCT01183104|532029528|FG001|Overall Study|Physician Decision|8|||
147672260|NCT05035407|532623306|FG000|Overall Study|Consented/enrolled on screening only. No participants signed the treatment consent for this study|36|||
147672261|NCT05035407|532623307|FG001|Overall Study|Consented/enrolled on screening only. No participants signed the treatment consent for this study|0|||
147512524|NCT01183104|532029527|FG000|Overall Study|Withdrawal by Subject|6|||
147512525|NCT01183104|532029528|FG001|Overall Study|Withdrawal by Subject|11|||
147512526|NCT01183104|532029527|FG000|Overall Study|Nonparticipation in Extension Study|39|||
147672262|NCT05035407|532623308|FG002|Overall Study|Consented/enrolled on screening only. No participants signed the treatment consent for this study|0|||
147672263|NCT05035407|532623309|FG003|Overall Study|Consented/enrolled on screening only. No participants signed the treatment consent for this study|0|||
147672264|NCT05035407|532623310|FG004|Overall Study|Consented/enrolled on screening only. No participants signed the treatment consent for this study|0|||
147672265|NCT05035407|532623311|FG005|Overall Study|Consented/enrolled on screening only. No participants signed the treatment consent for this study|0|||
147672266|NCT04220021|532623312|FG000|Overall Study|Withdrawal by Subject|11|||
147672267|NCT04220021|532623312|FG000|Overall Study|Physician Decision|2|||
147672268|NCT04220021|532623312|FG000|Overall Study|Non-study related illness|5|||
147672269|NCT03149029|532623313|FG000|Overall Study|Adverse Event|2|||
147672270|NCT03149029|532623314|FG001|Overall Study|Adverse Event|0|||
147672271|NCT03892746|532623315|FG000|Overall Study|Withdrawal by Subject|2|||
147672272|NCT03892746|532623316|FG001|Overall Study|Withdrawal by Subject|1|||
147672273|NCT03892746|532623315|FG000|Overall Study|Lost to Follow-up|2|||
147672274|NCT03892746|532623316|FG001|Overall Study|Lost to Follow-up|0|||
147672275|NCT02783690|532623321|FG000|Overall Study|Withdrawal by Subject|3|||
147672276|NCT02783690|532623322|FG001|Overall Study|Withdrawal by Subject|3|||
147672277|NCT02421939|532623323|FG000|Randomization Period: Up to 3 Years|Progressive disease|76|||
147672278|NCT02421939|532623324|FG001|Randomization Period: Up to 3 Years|Progressive disease|16|||
147672279|NCT02421939|532623323|FG000|Randomization Period: Up to 3 Years|Lack of Efficacy|21|||
147672280|NCT02421939|532623324|FG001|Randomization Period: Up to 3 Years|Lack of Efficacy|31|||
147672281|NCT02421939|532623323|FG000|Randomization Period: Up to 3 Years|Death|38|||
147672282|NCT02421939|532623324|FG001|Randomization Period: Up to 3 Years|Death|10|||
147672283|NCT02421939|532623323|FG000|Randomization Period: Up to 3 Years|Disease relapse|37|||
147672284|NCT02421939|532623324|FG001|Randomization Period: Up to 3 Years|Disease relapse|2|||
147672285|NCT02421939|532623323|FG000|Randomization Period: Up to 3 Years|Adverse Event|32|||
147672286|NCT02421939|532623324|FG001|Randomization Period: Up to 3 Years|Adverse Event|5|||
147672287|NCT02421939|532623323|FG000|Randomization Period: Up to 3 Years|Withdrawal by Subject|9|||
147672288|NCT02421939|532623324|FG001|Randomization Period: Up to 3 Years|Withdrawal by Subject|24|||
147672289|NCT02421939|532623323|FG000|Randomization Period: Up to 3 Years|Physician Decision|13|||
147672290|NCT02421939|532623324|FG001|Randomization Period: Up to 3 Years|Physician Decision|11|||
147672291|NCT02421939|532623323|FG000|Randomization Period: Up to 3 Years|Protocol deviation|1|||
147672292|NCT02421939|532623324|FG001|Randomization Period: Up to 3 Years|Protocol deviation|1|||
147672293|NCT02421939|532623323|FG000|Randomization Period: Up to 3 Years|Miscellaneous|20|||
147672294|NCT02421939|532623324|FG001|Randomization Period: Up to 3 Years|Miscellaneous|5|||
147672295|NCT02421939|532623323|FG000|Long Term Follow up: up to 3 Years|Withdrawal by Subject|4|||
147672296|NCT02421939|532623324|FG001|Long Term Follow up: up to 3 Years|Withdrawal by Subject|5|||
147672297|NCT02421939|532623323|FG000|Long Term Follow up: up to 3 Years|Lost to Follow-up|1|||
147672298|NCT02421939|532623324|FG001|Long Term Follow up: up to 3 Years|Lost to Follow-up|2|||
147672299|NCT02421939|532623323|FG000|Long Term Follow up: up to 3 Years|Death|118|||
147672300|NCT02421939|532623324|FG001|Long Term Follow up: up to 3 Years|Death|65|||
147672301|NCT02421939|532623323|FG000|Long Term Follow up: up to 3 Years|Miscellaneous|10|||
147672302|NCT02421939|532623324|FG001|Long Term Follow up: up to 3 Years|Miscellaneous|1|||
147672303|NCT05739994|532623331|FG000|Overall Study|Withdrawal by Subject|2|||
147672304|NCT05739994|532623332|FG001|Overall Study|Withdrawal by Subject|2|||
147672305|NCT05739994|532623333|FG002|Overall Study|Withdrawal by Subject|4|||
147672306|NCT04004000|532623336|FG000|Extension Phase (Up to 68 Weeks)|Sponsor terminated OLE as REACH (NCT05397470) Phase 3 study in FSHD did not meet primary endpoint.|12|||
147672307|NCT06121609|532623337|FG000|Overall Study|Lack of Efficacy|0|||
147672308|NCT06121609|532623338|FG001|Overall Study|Lack of Efficacy|0|||
147672309|NCT06121609|532623339|FG002|Overall Study|Lack of Efficacy|45|||
147672310|NCT03299959|532623340|FG000|Overall Study|Lost to Follow-up|7|||
147672311|NCT03299959|532623341|FG001|Overall Study|Lost to Follow-up|9|||
147672312|NCT03299959|532623340|FG000|Overall Study|Death|1|||
147672313|NCT03299959|532623341|FG001|Overall Study|Death|0|||
147672314|NCT03299959|532623340|FG000|Overall Study|Withdrawal by Subject|13|||
147672315|NCT03299959|532623341|FG001|Overall Study|Withdrawal by Subject|9|||
147672316|NCT03299959|532623340|FG000|Overall Study|Changes in study team and government regulations|1|||
147672317|NCT03299959|532623341|FG001|Overall Study|Changes in study team and government regulations|1|||
147672318|NCT03299959|532623340|FG000|Overall Study|Participant underwent surgical intervention in the index knee|15|||
147672319|NCT03299959|532623341|FG001|Overall Study|Participant underwent surgical intervention in the index knee|8|||
147672320|NCT06494761|532623342|FG000|Period 2: (Test Period) (15 days)|Adverse Event|1|||
147672321|NCT06494761|532623342|FG000|Period 2: (Test Period) (15 days)|Physician Decision|1|||
147672322|NCT03735121|532623343|FG000|Overall Study|Death|3|||
147672323|NCT03735121|532623344|FG001|Overall Study|Death|6|||
147672324|NCT03735121|532623345|FG002|Overall Study|Death|19|||
147672325|NCT03735121|532623346|FG003|Overall Study|Death|97|||
147672326|NCT03735121|532623347|FG004|Overall Study|Death|205|||
147672327|NCT03735121|532623343|FG000|Overall Study|Lost to Follow-up|0|||
147672328|NCT03735121|532623344|FG001|Overall Study|Lost to Follow-up|0|||
147672329|NCT03735121|532623345|FG002|Overall Study|Lost to Follow-up|0|||
147672330|NCT03735121|532623346|FG003|Overall Study|Lost to Follow-up|2|||
147672331|NCT03735121|532623347|FG004|Overall Study|Lost to Follow-up|3|||
147672332|NCT03735121|532623343|FG000|Overall Study|New Therapy|0|||
147672333|NCT03735121|532623344|FG001|Overall Study|New Therapy|1|||
147672334|NCT03735121|532623345|FG002|Overall Study|New Therapy|0|||
147672335|NCT03735121|532623346|FG003|Overall Study|New Therapy|0|||
147672336|NCT03735121|532623347|FG004|Overall Study|New Therapy|0|||
147672337|NCT03735121|532623343|FG000|Overall Study|Study Ended by Sponsor|1|||
147672338|NCT03735121|532623344|FG001|Overall Study|Study Ended by Sponsor|0|||
147672339|NCT03735121|532623345|FG002|Overall Study|Study Ended by Sponsor|1|||
147672340|NCT03735121|532623346|FG003|Overall Study|Study Ended by Sponsor|17|||
147672341|NCT03735121|532623347|FG004|Overall Study|Study Ended by Sponsor|28|||
147672342|NCT03735121|532623343|FG000|Overall Study|Withdrawal by Subject|1|||
147672343|NCT03735121|532623344|FG001|Overall Study|Withdrawal by Subject|1|||
147672344|NCT03735121|532623345|FG002|Overall Study|Withdrawal by Subject|6|||
147672345|NCT03735121|532623346|FG003|Overall Study|Withdrawal by Subject|8|||
147672346|NCT03735121|532623347|FG004|Overall Study|Withdrawal by Subject|11|||
147672347|NCT04865289|532623351|FG000|Overall Study|Death|34|||
147672348|NCT04865289|532623352|FG001|Overall Study|Death|25|||
147672349|NCT04865289|532623351|FG000|Overall Study|Physician Decision|27|||
147672350|NCT04865289|532623352|FG001|Overall Study|Physician Decision|27|||
147672351|NCT04865289|532623351|FG000|Overall Study|Sponsor Decision|11|||
147672352|NCT04865289|532623352|FG001|Overall Study|Sponsor Decision|1|||
147672353|NCT04865289|532623351|FG000|Overall Study|Withdrawal by Subject|2|||
147672354|NCT04865289|532623352|FG001|Overall Study|Withdrawal by Subject|3|||
147672355|NCT04770779|532623354|FG000|Overall Study|Randomized, never treated|0|||
147672356|NCT04770779|532623355|FG001|Overall Study|Randomized, never treated|1|||
147672357|NCT04770779|532623354|FG000|Overall Study|Adverse Event|9|||
147672358|NCT04770779|532623355|FG001|Overall Study|Adverse Event|1|||
147672359|NCT04770779|532623354|FG000|Overall Study|Withdrawal by Subject|7|||
147672360|NCT04770779|532623355|FG001|Overall Study|Withdrawal by Subject|1|||
147672361|NCT04770779|532623354|FG000|Overall Study|Pregnancy|0|||
147672362|NCT04770779|532623355|FG001|Overall Study|Pregnancy|1|||
147672363|NCT02176863|532623356|FG000|Overall Study|Physician Decision|1|||
147672364|NCT02176863|532623357|FG001|Overall Study|Physician Decision|0|||
147672365|NCT02176863|532623358|FG002|Overall Study|Physician Decision|0|||
147672366|NCT02176863|532623359|FG003|Overall Study|Physician Decision|0|||
147672367|NCT02176863|532623360|FG004|Overall Study|Physician Decision|0|||
147672368|NCT02176863|532623356|FG000|Overall Study|Adverse Event|10|||
147672369|NCT02176863|532623357|FG001|Overall Study|Adverse Event|4|||
147672370|NCT02176863|532623358|FG002|Overall Study|Adverse Event|4|||
147672371|NCT02176863|532623359|FG003|Overall Study|Adverse Event|1|||
147672372|NCT02176863|532623360|FG004|Overall Study|Adverse Event|1|||
147672373|NCT02176863|532623356|FG000|Overall Study|Protocol Violation|2|||
147672374|NCT02176863|532623357|FG001|Overall Study|Protocol Violation|0|||
147672375|NCT02176863|532623358|FG002|Overall Study|Protocol Violation|1|||
147672376|NCT02176863|532623359|FG003|Overall Study|Protocol Violation|1|||
147672377|NCT02176863|532623360|FG004|Overall Study|Protocol Violation|0|||
147672378|NCT02176863|532623356|FG000|Overall Study|Withdrawal by Subject|4|||
147672379|NCT02176863|532623357|FG001|Overall Study|Withdrawal by Subject|2|||
147672380|NCT02176863|532623358|FG002|Overall Study|Withdrawal by Subject|2|||
147672381|NCT02176863|532623359|FG003|Overall Study|Withdrawal by Subject|3|||
147672382|NCT02176863|532623360|FG004|Overall Study|Withdrawal by Subject|4|||
147672383|NCT02176863|532623356|FG000|Overall Study|Reason not specified|0|||
147672384|NCT02176863|532623357|FG001|Overall Study|Reason not specified|1|||
147672385|NCT02176863|532623358|FG002|Overall Study|Reason not specified|1|||
147672386|NCT02176863|532623359|FG003|Overall Study|Reason not specified|2|||
147672387|NCT02176863|532623360|FG004|Overall Study|Reason not specified|1|||
147672388|NCT02176863|532623356|FG000|Overall Study|Lost to Follow-up|0|||
147672389|NCT02176863|532623357|FG001|Overall Study|Lost to Follow-up|1|||
147672390|NCT02176863|532623358|FG002|Overall Study|Lost to Follow-up|1|||
147672391|NCT02176863|532623359|FG003|Overall Study|Lost to Follow-up|0|||
147672392|NCT02176863|532623360|FG004|Overall Study|Lost to Follow-up|0|||
147672393|NCT02799602|532623361|FG000|Overall Study|Protocol Violation|1|||
147672394|NCT02799602|532623362|FG001|Overall Study|Protocol Violation|0|||
147672395|NCT02799602|532623361|FG000|Overall Study|Physician Decision|5|||
147672396|NCT02799602|532623362|FG001|Overall Study|Physician Decision|6|||
147672397|NCT02799602|532623361|FG000|Overall Study|Lost to Follow-up|4|||
147672398|NCT02799602|532623362|FG001|Overall Study|Lost to Follow-up|2|||
147672399|NCT02799602|532623361|FG000|Overall Study|Additional primary malignancy|11|||
147672400|NCT02799602|532623362|FG001|Overall Study|Additional primary malignancy|6|||
147672401|NCT02799602|532623361|FG000|Overall Study|Non-compliance with study drug|14|||
147672402|NCT02799602|532623362|FG001|Overall Study|Non-compliance with study drug|12|||
147672403|NCT02799602|532623361|FG000|Overall Study|Adverse event associated with clinical disease progression|24|||
147672404|NCT02799602|532623362|FG001|Overall Study|Adverse event associated with clinical disease progression|26|||
147672405|NCT02799602|532623361|FG000|Overall Study|Withdrawal by Subject|26|||
147672406|NCT02799602|532623362|FG001|Overall Study|Withdrawal by Subject|40|||
147672407|NCT02799602|532623361|FG000|Overall Study|Progressive disease - clinical progression|131|||
147672408|NCT02799602|532623362|FG001|Overall Study|Progressive disease - clinical progression|276|||
147672409|NCT02799602|532623361|FG000|Overall Study|Progressive disease - radiological progression|90|||
147672410|NCT02799602|532623362|FG001|Overall Study|Progressive disease - radiological progression|133|||
147672411|NCT02799602|532623361|FG000|Overall Study|Adverse event not associated with clinical disease progression|49|||
147672412|NCT02799602|532623362|FG001|Overall Study|Adverse event not associated with clinical disease progression|27|||
147672413|NCT02799602|532623361|FG000|Overall Study|Death|9|||
147672414|NCT02799602|532623362|FG001|Overall Study|Death|5|||
147672415|NCT02799602|532623361|FG000|Overall Study|Other|287|||
147672416|NCT02799602|532623362|FG001|Overall Study|Other|118|||
147672417|NCT02799602|532623361|FG000|Overall Study|Study drug never administered|0|||
147672418|NCT02799602|532623362|FG001|Overall Study|Study drug never administered|3|||
147672419|NCT03692052|532623363|FG000|Core Period (Day 1 to Week 24)|Adverse Event|1|||
147672420|NCT03692052|532623363|FG000|Extension Period (Week 25 to 10 Years)|Withdrawal of Consent|1|||
147672421|NCT03692052|532623363|FG000|Extension Period (Week 25 to 10 Years)|Physician Decision|1|||
147672422|NCT03692052|532623363|FG000|Extension Period (Week 25 to 10 Years)|Ongoing|17|||
147672423|NCT06077773|532623364|FG000|Overall Study|Withdrawal by Subject|1|||
147672424|NCT06077773|532623365|FG001|Overall Study|Withdrawal by Subject|0|||
147672425|NCT06077773|532623366|FG002|Overall Study|Withdrawal by Subject|1|||
147672426|NCT06077773|532623364|FG000|Overall Study|Lost to Follow-up|0|||
147672427|NCT06077773|532623365|FG001|Overall Study|Lost to Follow-up|1|||
147672428|NCT06077773|532623366|FG002|Overall Study|Lost to Follow-up|0|||
147672429|NCT06077773|532623364|FG000|Overall Study|Adverse Event|0|||
147672430|NCT06077773|532623365|FG001|Overall Study|Adverse Event|0|||
147672431|NCT06077773|532623366|FG002|Overall Study|Adverse Event|2|||
147672432|NCT03342196|532623367|FG000|Overall Study|Physician Decision|1|||
147672433|NCT02473042|532623370|FG000|Overall Study|Withdrawal by Subject|1|||
147672434|NCT02473042|532623371|FG001|Overall Study|Withdrawal by Subject|0|||
147672435|NCT02473042|532623370|FG000|Overall Study|Patient became ineligible after enrollment|2|||
147672436|NCT02473042|532623371|FG001|Overall Study|Patient became ineligible after enrollment|5|||
147672437|NCT02473042|532623370|FG000|Overall Study|Surgery started before study preparation could be completed|0|||
147672438|NCT02473042|532623371|FG001|Overall Study|Surgery started before study preparation could be completed|1|||
147672439|NCT02473042|532623370|FG000|Overall Study|PACU data unable to be collected|3|||
147672440|NCT02473042|532623371|FG001|Overall Study|PACU data unable to be collected|0|||
147672441|NCT03007732|532623374|FG000|Overall Study|Withdrawal from study post randomization but just prior to receiving any treatment|0|||
147672442|NCT03007732|532623375|FG001|Overall Study|Withdrawal from study post randomization but just prior to receiving any treatment|0|||
147672443|NCT03007732|532623376|FG002|Overall Study|Withdrawal from study post randomization but just prior to receiving any treatment|1|||
147672444|NCT03007732|532623377|FG003|Overall Study|Withdrawal from study post randomization but just prior to receiving any treatment|1|||
147672445|NCT03725605|532623382|FG000|Overall Study|Unsuccessful TIL expansion|2|||
147672446|NCT04596540|532623383|FG000|Overall Study|Withdrawal by Subject|9|||
147672447|NCT04596540|532623384|FG001|Overall Study|Withdrawal by Subject|8|||
147672448|NCT04596540|532623385|FG002|Overall Study|Withdrawal by Subject|5|||
147672449|NCT04596540|532623383|FG000|Overall Study|Lost to Follow-up|1|||
147672450|NCT04596540|532623384|FG001|Overall Study|Lost to Follow-up|2|||
147672451|NCT04596540|532623385|FG002|Overall Study|Lost to Follow-up|1|||
147672452|NCT04596540|532623383|FG000|Overall Study|Sponsor Decision|2|||
147672453|NCT04596540|532623384|FG001|Overall Study|Sponsor Decision|0|||
147672454|NCT04596540|532623385|FG002|Overall Study|Sponsor Decision|0|||
147672455|NCT04596540|532623383|FG000|Overall Study|Physician Decision|0|||
147672456|NCT04596540|532623384|FG001|Overall Study|Physician Decision|1|||
147672457|NCT04596540|532623385|FG002|Overall Study|Physician Decision|1|||
147672458|NCT04596540|532623383|FG000|Overall Study|Coronavirus Disease 2019 (COVID-19)|1|||
147672459|NCT04596540|532623384|FG001|Overall Study|Coronavirus Disease 2019 (COVID-19)|0|||
147672460|NCT04596540|532623385|FG002|Overall Study|Coronavirus Disease 2019 (COVID-19)|0|||
147672461|NCT04596540|532623383|FG000|Overall Study|Other Than Specified|5|||
147672462|NCT04596540|532623384|FG001|Overall Study|Other Than Specified|5|||
147672463|NCT04596540|532623385|FG002|Overall Study|Other Than Specified|2|||
147672464|NCT03668223|532623386|FG000|Overall Study|Death|10|||
147672465|NCT03668223|532623387|FG001|Overall Study|Death|5|||
147672466|NCT03668223|532623386|FG000|Overall Study|Lost to Follow-up|12|||
147672467|NCT03668223|532623387|FG001|Overall Study|Lost to Follow-up|12|||
147672468|NCT03668223|532623386|FG000|Overall Study|Withdrawal by Subject|8|||
147672469|NCT03668223|532623387|FG001|Overall Study|Withdrawal by Subject|3|||
147672470|NCT01503086|532623388|FG000|Overall Study|Lost to Follow-up|0|||
147672471|NCT01503086|532623389|FG001|Overall Study|Lost to Follow-up|1|||
147672472|NCT01503086|532623390|FG002|Overall Study|Lost to Follow-up|0|||
147512527|NCT01183104|532029528|FG001|Overall Study|Nonparticipation in Extension Study|50|||
147512528|NCT01183104|532029527|FG000|Overall Study|Did not receive study drug|5|||
147672473|NCT01503086|532623388|FG000|Overall Study|Did Not Start Treatment|4|||
147672474|NCT01503086|532623389|FG001|Overall Study|Did Not Start Treatment|3|||
147672475|NCT01503086|532623390|FG002|Overall Study|Did Not Start Treatment|3|||
147672476|NCT01503086|532623388|FG000|Overall Study|Progressive disease|3|||
147672477|NCT01503086|532623389|FG001|Overall Study|Progressive disease|1|||
147672478|NCT01503086|532623390|FG002|Overall Study|Progressive disease|0|||
147672479|NCT01503086|532623388|FG000|Overall Study|Patient did not complete cognitive training within 9 weeks|3|||
147672480|NCT01503086|532623389|FG001|Overall Study|Patient did not complete cognitive training within 9 weeks|3|||
147672481|NCT01503086|532623390|FG002|Overall Study|Patient did not complete cognitive training within 9 weeks|0|||
147672482|NCT01503086|532623388|FG000|Overall Study|Refusal of further protocol therapy by patient/parent/guardian|0|||
147672483|NCT01503086|532623389|FG001|Overall Study|Refusal of further protocol therapy by patient/parent/guardian|2|||
147672484|NCT01503086|532623390|FG002|Overall Study|Refusal of further protocol therapy by patient/parent/guardian|0|||
147672485|NCT03210714|532623394|FG000|Overall Study|Adverse Event|6|||
147672486|NCT03210714|532623394|FG000|Overall Study|Physician Decision|1|||
147672487|NCT03210714|532623394|FG000|Overall Study|Progressive disease|11|||
147672488|NCT03210714|532623394|FG000|Overall Study|Refusal by patient/parent/guardian|2|||
147672489|NCT02867592|532623397|FG000|Overall Study|Adverse Event|3|||
147672490|NCT02867592|532623398|FG001|Overall Study|Adverse Event|0|||
147672491|NCT02867592|532623399|FG002|Overall Study|Adverse Event|2|||
147672492|NCT02867592|532623400|FG003|Overall Study|Adverse Event|1|||
147672493|NCT02867592|532623401|FG004|Overall Study|Adverse Event|1|||
147672494|NCT02867592|532623402|FG005|Overall Study|Adverse Event|5|||
147672495|NCT02867592|532623397|FG000|Overall Study|Death|0|||
147672496|NCT02867592|532623398|FG001|Overall Study|Death|0|||
147672497|NCT02867592|532623399|FG002|Overall Study|Death|0|||
147672498|NCT02867592|532623400|FG003|Overall Study|Death|1|||
147672499|NCT02867592|532623401|FG004|Overall Study|Death|0|||
147672500|NCT02867592|532623402|FG005|Overall Study|Death|1|||
147672501|NCT02867592|532623397|FG000|Overall Study|Lack of Efficacy|8|||
147672502|NCT02867592|532623398|FG001|Overall Study|Lack of Efficacy|10|||
147672503|NCT02867592|532623399|FG002|Overall Study|Lack of Efficacy|8|||
147672504|NCT02867592|532623400|FG003|Overall Study|Lack of Efficacy|8|||
147672505|NCT02867592|532623401|FG004|Overall Study|Lack of Efficacy|12|||
147672506|NCT02867592|532623402|FG005|Overall Study|Lack of Efficacy|17|||
147672507|NCT02867592|532623397|FG000|Overall Study|Physician Decision|1|||
147672508|NCT02867592|532623398|FG001|Overall Study|Physician Decision|2|||
147672509|NCT02867592|532623399|FG002|Overall Study|Physician Decision|2|||
147672510|NCT02867592|532623400|FG003|Overall Study|Physician Decision|0|||
147672511|NCT02867592|532623401|FG004|Overall Study|Physician Decision|5|||
147672512|NCT02867592|532623402|FG005|Overall Study|Physician Decision|1|||
147672513|NCT02867592|532623397|FG000|Overall Study|Protocol Violation|0|||
147672514|NCT02867592|532623398|FG001|Overall Study|Protocol Violation|0|||
147672515|NCT02867592|532623399|FG002|Overall Study|Protocol Violation|0|||
147672516|NCT02867592|532623400|FG003|Overall Study|Protocol Violation|0|||
147672517|NCT02867592|532623401|FG004|Overall Study|Protocol Violation|1|||
147672518|NCT02867592|532623402|FG005|Overall Study|Protocol Violation|1|||
147672519|NCT02867592|532623397|FG000|Overall Study|Withdrawal by Subject|0|||
147672520|NCT02867592|532623398|FG001|Overall Study|Withdrawal by Subject|1|||
147672521|NCT02867592|532623399|FG002|Overall Study|Withdrawal by Subject|0|||
147672522|NCT02867592|532623400|FG003|Overall Study|Withdrawal by Subject|1|||
147672523|NCT02867592|532623401|FG004|Overall Study|Withdrawal by Subject|3|||
147672524|NCT02867592|532623402|FG005|Overall Study|Withdrawal by Subject|3|||
147672525|NCT02867592|532623397|FG000|Overall Study|Ineligible|1|||
147672526|NCT02867592|532623398|FG001|Overall Study|Ineligible|1|||
147672527|NCT02867592|532623399|FG002|Overall Study|Ineligible|0|||
147672528|NCT02867592|532623400|FG003|Overall Study|Ineligible|0|||
147672529|NCT02867592|532623401|FG004|Overall Study|Ineligible|2|||
147672530|NCT02867592|532623402|FG005|Overall Study|Ineligible|0|||
147672531|NCT02867592|532623397|FG000|Overall Study|No Treatment|1|||
147672532|NCT02867592|532623398|FG001|Overall Study|No Treatment|0|||
147672533|NCT02867592|532623399|FG002|Overall Study|No Treatment|0|||
147672534|NCT02867592|532623400|FG003|Overall Study|No Treatment|0|||
147672535|NCT02867592|532623401|FG004|Overall Study|No Treatment|0|||
147672536|NCT02867592|532623402|FG005|Overall Study|No Treatment|0|||
147672537|NCT02867592|532623397|FG000|Overall Study|Still on Therapy|0|||
147672538|NCT02867592|532623398|FG001|Overall Study|Still on Therapy|0|||
147672539|NCT02867592|532623399|FG002|Overall Study|Still on Therapy|0|||
147672540|NCT02867592|532623400|FG003|Overall Study|Still on Therapy|0|||
147672541|NCT02867592|532623401|FG004|Overall Study|Still on Therapy|1|||
147672542|NCT02867592|532623402|FG005|Overall Study|Still on Therapy|0|||
147672543|NCT02867592|532623397|FG000|Overall Study|Patient received concurrent anticancer or investigational therapy|0|||
147672544|NCT02867592|532623398|FG001|Overall Study|Patient received concurrent anticancer or investigational therapy|0|||
147672545|NCT02867592|532623399|FG002|Overall Study|Patient received concurrent anticancer or investigational therapy|0|||
147672546|NCT02867592|532623400|FG003|Overall Study|Patient received concurrent anticancer or investigational therapy|0|||
147672547|NCT02867592|532623401|FG004|Overall Study|Patient received concurrent anticancer or investigational therapy|0|||
147672548|NCT02867592|532623402|FG005|Overall Study|Patient received concurrent anticancer or investigational therapy|1|||
147672549|NCT02867592|532623397|FG000|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|1|||
147672550|NCT02867592|532623398|FG001|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|0|||
147672551|NCT02867592|532623399|FG002|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|1|||
147672552|NCT02867592|532623400|FG003|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|2|||
147672553|NCT02867592|532623401|FG004|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|0|||
147672554|NCT02867592|532623402|FG005|Overall Study|Repeat Eligibility Studies (If Required) Are Outside The Parameters Required For Eligibility|0|||
147672555|NCT00803179|532623403|FG000|Overall Study|Lost to Follow-up|3|||
147672556|NCT03358472|532623404|FG000|Overall Study|Death|6|||
147672557|NCT03358472|532623405|FG001|Overall Study|Death|3|||
147672558|NCT03358472|532623406|FG002|Overall Study|Death|10|||
147672559|NCT03358472|532623404|FG000|Overall Study|Physician Decision|0|||
147672560|NCT03358472|532623405|FG001|Overall Study|Physician Decision|1|||
147672561|NCT03358472|532623406|FG002|Overall Study|Physician Decision|0|||
147672562|NCT03358472|532623404|FG000|Overall Study|Withdrawal by Subject|0|||
147672563|NCT03358472|532623405|FG001|Overall Study|Withdrawal by Subject|0|||
147672564|NCT03358472|532623406|FG002|Overall Study|Withdrawal by Subject|1|||
147640228|NCT04777201|532501480|FG001|Substudy (Concurrent With Main Study)|Adverse Event|0|||
147640229|NCT04777201|532501481|FG002|Substudy (Concurrent With Main Study)|Adverse Event|1|||
147640230|NCT04777201|532501479|FG000|Substudy (Concurrent With Main Study)|Cataract Surgery|0|||
147640231|NCT04777201|532501480|FG001|Substudy (Concurrent With Main Study)|Cataract Surgery|0|||
147640232|NCT04777201|532501481|FG002|Substudy (Concurrent With Main Study)|Cataract Surgery|1|||
147640233|NCT04777201|532501479|FG000|Substudy (Concurrent With Main Study)|Lost to Follow-up|0|||
147640234|NCT04777201|532501480|FG001|Substudy (Concurrent With Main Study)|Lost to Follow-up|0|||
147640235|NCT04777201|532501481|FG002|Substudy (Concurrent With Main Study)|Lost to Follow-up|1|||
147640236|NCT04777201|532501479|FG000|Substudy (Concurrent With Main Study)|Physician Decision|0|||
147640237|NCT04777201|532501480|FG001|Substudy (Concurrent With Main Study)|Physician Decision|0|||
147640238|NCT04777201|532501481|FG002|Substudy (Concurrent With Main Study)|Physician Decision|1|||
147640239|NCT02691013|532501484|FG000|Overall Study|Withdrawal by Subject|3|||
147640240|NCT02691013|532501485|FG001|Overall Study|Withdrawal by Subject|0|||
147640241|NCT02275780|532501491|FG000|Base Study: 96 Weeks|Adverse Event|6|||
147640242|NCT02275780|532501492|FG001|Base Study: 96 Weeks|Adverse Event|14|||
147640243|NCT02275780|532501491|FG000|Base Study: 96 Weeks|Death|3|||
147640244|NCT02275780|532501492|FG001|Base Study: 96 Weeks|Death|1|||
147640245|NCT02275780|532501491|FG000|Base Study: 96 Weeks|Lack of Efficacy|21|||
147640246|NCT02275780|532501492|FG001|Base Study: 96 Weeks|Lack of Efficacy|32|||
147640247|NCT02275780|532501491|FG000|Base Study: 96 Weeks|Lost to Follow-up|28|||
147640248|NCT02275780|532501492|FG001|Base Study: 96 Weeks|Lost to Follow-up|24|||
147640249|NCT02275780|532501491|FG000|Base Study: 96 Weeks|Protocol Violation|1|||
147640250|NCT02275780|532501492|FG001|Base Study: 96 Weeks|Protocol Violation|6|||
147640251|NCT02275780|532501491|FG000|Base Study: 96 Weeks|Withdrawal by Subject|19|||
147640252|NCT02275780|532501492|FG001|Base Study: 96 Weeks|Withdrawal by Subject|22|||
147640253|NCT02275780|532501491|FG000|Base Study: 96 Weeks|Noncompliance with drug|9|||
147640254|NCT02275780|532501492|FG001|Base Study: 96 Weeks|Noncompliance with drug|6|||
147640255|NCT02275780|532501491|FG000|Base Study: 96 Weeks|Physician Decision|2|||
147640256|NCT02275780|532501492|FG001|Base Study: 96 Weeks|Physician Decision|4|||
147640257|NCT02275780|532501491|FG000|Base Study: 96 Weeks|Pregnancy|2|||
147640258|NCT02275780|532501492|FG001|Base Study: 96 Weeks|Pregnancy|1|||
147640259|NCT02275780|532501491|FG000|Base Study: 96 Weeks|Randomized not treated|2|||
147640260|NCT02275780|532501492|FG001|Base Study: 96 Weeks|Randomized not treated|1|||
147640261|NCT02275780|532501491|FG000|Study Extension 1: Week 96 to Week 192|Adverse Event|6|||
147640262|NCT02275780|532501492|FG001|Study Extension 1: Week 96 to Week 192|Adverse Event|1|||
147640263|NCT02275780|532501491|FG000|Study Extension 1: Week 96 to Week 192|Availability of study medication locally|2|||
147640264|NCT02275780|532501492|FG001|Study Extension 1: Week 96 to Week 192|Availability of study medication locally|0|||
147640265|NCT02275780|532501491|FG000|Study Extension 1: Week 96 to Week 192|Lack of Efficacy|8|||
147640266|NCT02275780|532501492|FG001|Study Extension 1: Week 96 to Week 192|Lack of Efficacy|11|||
147640267|NCT02275780|532501491|FG000|Study Extension 1: Week 96 to Week 192|Lost to Follow-up|8|||
147640268|NCT02275780|532501492|FG001|Study Extension 1: Week 96 to Week 192|Lost to Follow-up|7|||
147640269|NCT02275780|532501491|FG000|Study Extension 1: Week 96 to Week 192|Non-compliance with study drug|1|||
147640270|NCT02275780|532501492|FG001|Study Extension 1: Week 96 to Week 192|Non-compliance with study drug|2|||
147640271|NCT02275780|532501491|FG000|Study Extension 1: Week 96 to Week 192|Physician Decision|3|||
147640272|NCT02275780|532501492|FG001|Study Extension 1: Week 96 to Week 192|Physician Decision|7|||
147640273|NCT02275780|532501491|FG000|Study Extension 1: Week 96 to Week 192|Pregnancy|2|||
147640274|NCT02275780|532501492|FG001|Study Extension 1: Week 96 to Week 192|Pregnancy|1|||
147640275|NCT02275780|532501491|FG000|Study Extension 1: Week 96 to Week 192|Withdrawal by Subject|19|||
147640276|NCT02275780|532501492|FG001|Study Extension 1: Week 96 to Week 192|Withdrawal by Subject|14|||
147640277|NCT02275780|532501491|FG000|Study Extension 2: Week 192 to Week 288|Adverse Event|0|||
147640278|NCT02275780|532501492|FG001|Study Extension 2: Week 192 to Week 288|Adverse Event|1|||
147640279|NCT02275780|532501491|FG000|Study Extension 2: Week 192 to Week 288|Availability of study medication locally|38|||
147640280|NCT02275780|532501492|FG001|Study Extension 2: Week 192 to Week 288|Availability of study medication locally|29|||
147640281|NCT02275780|532501491|FG000|Study Extension 2: Week 192 to Week 288|Lack of Efficacy|2|||
147640282|NCT02275780|532501492|FG001|Study Extension 2: Week 192 to Week 288|Lack of Efficacy|3|||
147640283|NCT02275780|532501491|FG000|Study Extension 2: Week 192 to Week 288|Lost to Follow-up|0|||
147672565|NCT03358472|532623404|FG000|Overall Study|On-going at clinical cut off date|9|||
147672566|NCT03358472|532623405|FG001|Overall Study|On-going at clinical cut off date|6|||
147672567|NCT03358472|532623406|FG002|Overall Study|On-going at clinical cut off date|5|||
147672568|NCT03974022|532623408|FG000|Overall Study|Death|0|||
147672569|NCT03974022|532623409|FG001|Overall Study|Death|1|||
147672570|NCT03974022|532623410|FG002|Overall Study|Death|0|||
147672571|NCT03974022|532623411|FG003|Overall Study|Death|2|||
147672572|NCT03974022|532623412|FG004|Overall Study|Death|0|||
147672573|NCT03974022|532623413|FG005|Overall Study|Death|1|||
147672574|NCT03974022|532623414|FG006|Overall Study|Death|0|||
147672575|NCT03974022|532623415|FG007|Overall Study|Death|2|||
147672576|NCT03974022|532623416|FG008|Overall Study|Death|1|||
147672577|NCT03974022|532623417|FG009|Overall Study|Death|4|||
147672578|NCT03974022|532623418|FG010|Overall Study|Death|0|||
147672579|NCT03974022|532623419|FG011|Overall Study|Death|0|||
147672580|NCT03974022|532623420|FG012|Overall Study|Death|0|||
147672581|NCT03974022|532623421|FG013|Overall Study|Death|33|||
147672582|NCT03974022|532623422|FG014|Overall Study|Death|40|||
147672583|NCT03974022|532623408|FG000|Overall Study|Withdrawal by Subject|0|||
147672584|NCT03974022|532623409|FG001|Overall Study|Withdrawal by Subject|0|||
147672585|NCT03974022|532623410|FG002|Overall Study|Withdrawal by Subject|0|||
147672586|NCT03974022|532623411|FG003|Overall Study|Withdrawal by Subject|0|||
147672587|NCT03974022|532623412|FG004|Overall Study|Withdrawal by Subject|0|||
147672588|NCT03974022|532623413|FG005|Overall Study|Withdrawal by Subject|4|||
147672589|NCT03974022|532623414|FG006|Overall Study|Withdrawal by Subject|4|||
147672590|NCT03974022|532623415|FG007|Overall Study|Withdrawal by Subject|2|||
147672591|NCT03974022|532623416|FG008|Overall Study|Withdrawal by Subject|2|||
147672592|NCT03974022|532623417|FG009|Overall Study|Withdrawal by Subject|3|||
147672593|NCT03974022|532623418|FG010|Overall Study|Withdrawal by Subject|0|||
147672594|NCT03974022|532623419|FG011|Overall Study|Withdrawal by Subject|1|||
147672595|NCT03974022|532623420|FG012|Overall Study|Withdrawal by Subject|0|||
147672596|NCT03974022|532623421|FG013|Overall Study|Withdrawal by Subject|3|||
147672597|NCT03974022|532623422|FG014|Overall Study|Withdrawal by Subject|9|||
147672598|NCT03974022|532623408|FG000|Overall Study|Lost to Follow-up|0|||
147672599|NCT03974022|532623409|FG001|Overall Study|Lost to Follow-up|0|||
147672600|NCT03974022|532623410|FG002|Overall Study|Lost to Follow-up|0|||
147672601|NCT03974022|532623411|FG003|Overall Study|Lost to Follow-up|0|||
147672602|NCT03974022|532623412|FG004|Overall Study|Lost to Follow-up|0|||
147672603|NCT03974022|532623413|FG005|Overall Study|Lost to Follow-up|0|||
147672604|NCT03974022|532623414|FG006|Overall Study|Lost to Follow-up|1|||
147672605|NCT03974022|532623415|FG007|Overall Study|Lost to Follow-up|0|||
147672606|NCT03974022|532623416|FG008|Overall Study|Lost to Follow-up|0|||
147672607|NCT03974022|532623417|FG009|Overall Study|Lost to Follow-up|0|||
147672608|NCT03974022|532623418|FG010|Overall Study|Lost to Follow-up|0|||
147672609|NCT03974022|532623419|FG011|Overall Study|Lost to Follow-up|0|||
147672610|NCT03974022|532623420|FG012|Overall Study|Lost to Follow-up|0|||
147672611|NCT03974022|532623421|FG013|Overall Study|Lost to Follow-up|1|||
147672612|NCT03974022|532623422|FG014|Overall Study|Lost to Follow-up|1|||
147672613|NCT03974022|532623408|FG000|Overall Study|site terminated by sponsor or non compliance|0|||
147672614|NCT03974022|532623409|FG001|Overall Study|site terminated by sponsor or non compliance|0|||
147672615|NCT03974022|532623410|FG002|Overall Study|site terminated by sponsor or non compliance|0|||
147672616|NCT03974022|532623411|FG003|Overall Study|site terminated by sponsor or non compliance|0|||
147672617|NCT03974022|532623412|FG004|Overall Study|site terminated by sponsor or non compliance|1|||
147672618|NCT03974022|532623413|FG005|Overall Study|site terminated by sponsor or non compliance|0|||
147672619|NCT03974022|532623414|FG006|Overall Study|site terminated by sponsor or non compliance|1|||
147672620|NCT03974022|532623415|FG007|Overall Study|site terminated by sponsor or non compliance|0|||
147672621|NCT03974022|532623416|FG008|Overall Study|site terminated by sponsor or non compliance|1|||
147672622|NCT03974022|532623417|FG009|Overall Study|site terminated by sponsor or non compliance|0|||
147672623|NCT03974022|532623418|FG010|Overall Study|site terminated by sponsor or non compliance|0|||
147672624|NCT03974022|532623419|FG011|Overall Study|site terminated by sponsor or non compliance|0|||
147672625|NCT03974022|532623420|FG012|Overall Study|site terminated by sponsor or non compliance|1|||
147672626|NCT03974022|532623421|FG013|Overall Study|site terminated by sponsor or non compliance|0|||
147672627|NCT03974022|532623422|FG014|Overall Study|site terminated by sponsor or non compliance|0|||
147672628|NCT05516758|532623423|FG000|Overall Study|Adverse Event|5|||
147672629|NCT05516758|532623424|FG001|Overall Study|Adverse Event|1|||
147672630|NCT05516758|532623425|FG002|Overall Study|Adverse Event|3|||
147672631|NCT05516758|532623426|FG003|Overall Study|Adverse Event|0|||
147672632|NCT05516758|532623427|FG004|Overall Study|Adverse Event|1|||
147672633|NCT05516758|532623428|FG005|Overall Study|Adverse Event|3|||
147672634|NCT05516758|532623429|FG006|Overall Study|Adverse Event|5|||
147672635|NCT05516758|532623423|FG000|Overall Study|Assigned treatment by mistake|1|||
147672636|NCT05516758|532623424|FG001|Overall Study|Assigned treatment by mistake|0|||
147672637|NCT05516758|532623425|FG002|Overall Study|Assigned treatment by mistake|0|||
147672638|NCT05516758|532623426|FG003|Overall Study|Assigned treatment by mistake|0|||
147672639|NCT05516758|532623427|FG004|Overall Study|Assigned treatment by mistake|1|||
147672640|NCT05516758|532623428|FG005|Overall Study|Assigned treatment by mistake|0|||
147672641|NCT05516758|532623429|FG006|Overall Study|Assigned treatment by mistake|0|||
147672642|NCT05516758|532623423|FG000|Overall Study|Lack of Efficacy|6|||
147672643|NCT05516758|532623424|FG001|Overall Study|Lack of Efficacy|0|||
147672644|NCT05516758|532623425|FG002|Overall Study|Lack of Efficacy|2|||
147672645|NCT05516758|532623426|FG003|Overall Study|Lack of Efficacy|0|||
147672646|NCT05516758|532623427|FG004|Overall Study|Lack of Efficacy|3|||
147672647|NCT05516758|532623428|FG005|Overall Study|Lack of Efficacy|6|||
147672648|NCT05516758|532623429|FG006|Overall Study|Lack of Efficacy|3|||
147672649|NCT05516758|532623423|FG000|Overall Study|Lost to Follow-up|2|||
147672650|NCT05516758|532623424|FG001|Overall Study|Lost to Follow-up|0|||
147672651|NCT05516758|532623425|FG002|Overall Study|Lost to Follow-up|2|||
147672652|NCT05516758|532623426|FG003|Overall Study|Lost to Follow-up|0|||
147672653|NCT05516758|532623427|FG004|Overall Study|Lost to Follow-up|3|||
147672654|NCT05516758|532623428|FG005|Overall Study|Lost to Follow-up|2|||
147672655|NCT05516758|532623429|FG006|Overall Study|Lost to Follow-up|1|||
147672656|NCT05516758|532623423|FG000|Overall Study|Other- As reported by the site|2|||
147672657|NCT05516758|532623424|FG001|Overall Study|Other- As reported by the site|1|||
147672658|NCT05516758|532623425|FG002|Overall Study|Other- As reported by the site|8|||
147672659|NCT05516758|532623426|FG003|Overall Study|Other- As reported by the site|1|||
147672660|NCT05516758|532623427|FG004|Overall Study|Other- As reported by the site|2|||
147672661|NCT05516758|532623428|FG005|Overall Study|Other- As reported by the site|3|||
147672662|NCT05516758|532623429|FG006|Overall Study|Other- As reported by the site|8|||
147672663|NCT05516758|532623423|FG000|Overall Study|Physician Decision|1|||
147672664|NCT05516758|532623424|FG001|Overall Study|Physician Decision|0|||
147672665|NCT05516758|532623425|FG002|Overall Study|Physician Decision|7|||
147672666|NCT05516758|532623426|FG003|Overall Study|Physician Decision|0|||
147672667|NCT05516758|532623427|FG004|Overall Study|Physician Decision|1|||
147672668|NCT05516758|532623428|FG005|Overall Study|Physician Decision|1|||
147672669|NCT05516758|532623429|FG006|Overall Study|Physician Decision|2|||
147672670|NCT05516758|532623423|FG000|Overall Study|Protocol Deviation|1|||
147672671|NCT05516758|532623424|FG001|Overall Study|Protocol Deviation|0|||
147672672|NCT05516758|532623425|FG002|Overall Study|Protocol Deviation|0|||
147672673|NCT05516758|532623426|FG003|Overall Study|Protocol Deviation|0|||
147672674|NCT05516758|532623427|FG004|Overall Study|Protocol Deviation|0|||
147672675|NCT05516758|532623428|FG005|Overall Study|Protocol Deviation|1|||
147672676|NCT05516758|532623429|FG006|Overall Study|Protocol Deviation|5|||
147672677|NCT05516758|532623423|FG000|Overall Study|Withdrawal by Subject|11|||
147672678|NCT05516758|532623424|FG001|Overall Study|Withdrawal by Subject|1|||
147672679|NCT05516758|532623425|FG002|Overall Study|Withdrawal by Subject|15|||
147672680|NCT05516758|532623426|FG003|Overall Study|Withdrawal by Subject|2|||
147672681|NCT05516758|532623427|FG004|Overall Study|Withdrawal by Subject|7|||
147672682|NCT05516758|532623428|FG005|Overall Study|Withdrawal by Subject|7|||
147672683|NCT05516758|532623429|FG006|Overall Study|Withdrawal by Subject|6|||
147672684|NCT05516758|532623423|FG000|Overall Study|Death|1|||
147672685|NCT05516758|532623424|FG001|Overall Study|Death|0|||
147672686|NCT05516758|532623425|FG002|Overall Study|Death|0|||
147672687|NCT05516758|532623426|FG003|Overall Study|Death|0|||
147672688|NCT05516758|532623427|FG004|Overall Study|Death|0|||
147672689|NCT05516758|532623428|FG005|Overall Study|Death|0|||
147672690|NCT05516758|532623429|FG006|Overall Study|Death|0|||
147672691|NCT05516758|532623423|FG000|Overall Study|Non-compliance With Study Drug|0|||
147672692|NCT05516758|532623424|FG001|Overall Study|Non-compliance With Study Drug|0|||
147672693|NCT05516758|532623425|FG002|Overall Study|Non-compliance With Study Drug|1|||
147672694|NCT05516758|532623426|FG003|Overall Study|Non-compliance With Study Drug|0|||
147672695|NCT05516758|532623427|FG004|Overall Study|Non-compliance With Study Drug|0|||
147672696|NCT05516758|532623428|FG005|Overall Study|Non-compliance With Study Drug|0|||
147672697|NCT05516758|532623429|FG006|Overall Study|Non-compliance With Study Drug|0|||
147672698|NCT05516758|532623423|FG000|Overall Study|Site Terminated by Sponsor|2|||
147672699|NCT05516758|532623424|FG001|Overall Study|Site Terminated by Sponsor|0|||
147672700|NCT05516758|532623425|FG002|Overall Study|Site Terminated by Sponsor|0|||
147672701|NCT05516758|532623426|FG003|Overall Study|Site Terminated by Sponsor|0|||
147672702|NCT05516758|532623427|FG004|Overall Study|Site Terminated by Sponsor|0|||
147672703|NCT05516758|532623428|FG005|Overall Study|Site Terminated by Sponsor|0|||
147672704|NCT05516758|532623429|FG006|Overall Study|Site Terminated by Sponsor|0|||
147672705|NCT05516758|532623423|FG000|Overall Study|Study Terminated by Sponsor|4|||
147672706|NCT05516758|532623424|FG001|Overall Study|Study Terminated by Sponsor|0|||
147672707|NCT05516758|532623425|FG002|Overall Study|Study Terminated by Sponsor|3|||
147672708|NCT05516758|532623426|FG003|Overall Study|Study Terminated by Sponsor|0|||
147672709|NCT05516758|532623427|FG004|Overall Study|Study Terminated by Sponsor|2|||
147672710|NCT05516758|532623428|FG005|Overall Study|Study Terminated by Sponsor|3|||
147672711|NCT05516758|532623429|FG006|Overall Study|Study Terminated by Sponsor|0|||
147672712|NCT05516758|532623423|FG000|Overall Study|Participants not proceeding to Follow-up phase|1|||
147672713|NCT05516758|532623424|FG001|Overall Study|Participants not proceeding to Follow-up phase|0|||
147672714|NCT05516758|532623425|FG002|Overall Study|Participants not proceeding to Follow-up phase|2|||
147672715|NCT05516758|532623426|FG003|Overall Study|Participants not proceeding to Follow-up phase|0|||
147672716|NCT05516758|532623427|FG004|Overall Study|Participants not proceeding to Follow-up phase|1|||
147672717|NCT05516758|532623428|FG005|Overall Study|Participants not proceeding to Follow-up phase|0|||
147672718|NCT05516758|532623429|FG006|Overall Study|Participants not proceeding to Follow-up phase|0|||
147672719|NCT05516758|532623423|FG000|Overall Study|Other|0|||
147672720|NCT05516758|532623424|FG001|Overall Study|Other|0|||
147672721|NCT05516758|532623425|FG002|Overall Study|Other|0|||
147672722|NCT05516758|532623426|FG003|Overall Study|Other|0|||
147672723|NCT05516758|532623427|FG004|Overall Study|Other|0|||
147672724|NCT05516758|532623428|FG005|Overall Study|Other|0|||
147672725|NCT05516758|532623429|FG006|Overall Study|Other|1|||
147672726|NCT04158648|532623430|FG000|Overall Study|Ongoing in the Study|69|||
147672727|NCT04158648|532623430|FG000|Overall Study|Withdrawal by Subject|4|||
147672728|NCT05502783|532623431|FG000|Overall Study|Lack of Efficacy|1|||
147672729|NCT04589650|532623435|FG000|Overall Study|Subject decision|6|||
147672730|NCT04589650|532623436|FG001|Overall Study|Subject decision|2|||
147672731|NCT04589650|532623437|FG002|Overall Study|Subject decision|2|||
147672732|NCT04589650|532623438|FG003|Overall Study|Subject decision|0|||
147672733|NCT04589650|532623439|FG004|Overall Study|Subject decision|0|||
147672734|NCT04589650|532623440|FG005|Overall Study|Subject decision|0|||
147672735|NCT04589650|532623435|FG000|Overall Study|Adverse Event|3|||
147672736|NCT04589650|532623436|FG001|Overall Study|Adverse Event|1|||
147672737|NCT04589650|532623437|FG002|Overall Study|Adverse Event|1|||
147672738|NCT04589650|532623438|FG003|Overall Study|Adverse Event|1|||
147672739|NCT04589650|532623439|FG004|Overall Study|Adverse Event|0|||
147672740|NCT04589650|532623440|FG005|Overall Study|Adverse Event|1|||
147672741|NCT04589650|532623435|FG000|Overall Study|Physician Decision|1|||
147672742|NCT04589650|532623436|FG001|Overall Study|Physician Decision|1|||
147672743|NCT04589650|532623437|FG002|Overall Study|Physician Decision|0|||
147672744|NCT04589650|532623438|FG003|Overall Study|Physician Decision|0|||
147672745|NCT04589650|532623439|FG004|Overall Study|Physician Decision|0|||
147672746|NCT04589650|532623440|FG005|Overall Study|Physician Decision|0|||
147672747|NCT04589650|532623435|FG000|Overall Study|Unsatisfactory therapeutic effect|2|||
147672748|NCT04589650|532623436|FG001|Overall Study|Unsatisfactory therapeutic effect|0|||
147672749|NCT04589650|532623437|FG002|Overall Study|Unsatisfactory therapeutic effect|0|||
147672750|NCT04589650|532623438|FG003|Overall Study|Unsatisfactory therapeutic effect|0|||
147672751|NCT04589650|532623439|FG004|Overall Study|Unsatisfactory therapeutic effect|0|||
147672752|NCT04589650|532623440|FG005|Overall Study|Unsatisfactory therapeutic effect|0|||
147672753|NCT04589650|532623435|FG000|Overall Study|Death|0|||
147672754|NCT04589650|532623436|FG001|Overall Study|Death|0|||
147672755|NCT04589650|532623437|FG002|Overall Study|Death|0|||
147672756|NCT04589650|532623438|FG003|Overall Study|Death|1|||
147672757|NCT04589650|532623439|FG004|Overall Study|Death|0|||
147672758|NCT04589650|532623440|FG005|Overall Study|Death|0|||
147672759|NCT04589650|532623435|FG000|Overall Study|Guardian Decision|0|||
147672760|NCT04589650|532623436|FG001|Overall Study|Guardian Decision|0|||
147672761|NCT04589650|532623437|FG002|Overall Study|Guardian Decision|0|||
147672762|NCT04589650|532623438|FG003|Overall Study|Guardian Decision|1|||
147672763|NCT04589650|532623439|FG004|Overall Study|Guardian Decision|0|||
147672764|NCT04589650|532623440|FG005|Overall Study|Guardian Decision|0|||
147672765|NCT04870957|532623445|FG000|T1 - Pre-Randomization: PainGuide run-in|Withdrawal by Subject|0|||
147672766|NCT04870957|532623446|FG001|T1 - Pre-Randomization: PainGuide run-in|Withdrawal by Subject|0|||
147672767|NCT04870957|532623447|FG002|T1 - Pre-Randomization: PainGuide run-in|Withdrawal by Subject|0|||
147672768|NCT04870957|532623448|FG003|T1 - Pre-Randomization: PainGuide run-in|Withdrawal by Subject|0|||
147672769|NCT04870957|532623449|FG004|T1 - Pre-Randomization: PainGuide run-in|Withdrawal by Subject|35|||
147672770|NCT04870957|532623450|FG005|T1 - Pre-Randomization: PainGuide run-in|Withdrawal by Subject|0|||
147672771|NCT04870957|532623445|FG000|T1 - Pre-Randomization: PainGuide run-in|Screen Failure|0|||
147672772|NCT04870957|532623446|FG001|T1 - Pre-Randomization: PainGuide run-in|Screen Failure|0|||
147672773|NCT04870957|532623447|FG002|T1 - Pre-Randomization: PainGuide run-in|Screen Failure|0|||
147672774|NCT04870957|532623448|FG003|T1 - Pre-Randomization: PainGuide run-in|Screen Failure|0|||
147672775|NCT04870957|532623449|FG004|T1 - Pre-Randomization: PainGuide run-in|Screen Failure|2|||
147672776|NCT04870957|532623450|FG005|T1 - Pre-Randomization: PainGuide run-in|Screen Failure|0|||
147672777|NCT04870957|532623445|FG000|T1 - Pre-Randomization: PainGuide run-in|Lost to Follow-up|0|||
147672778|NCT04870957|532623446|FG001|T1 - Pre-Randomization: PainGuide run-in|Lost to Follow-up|0|||
147672779|NCT04870957|532623447|FG002|T1 - Pre-Randomization: PainGuide run-in|Lost to Follow-up|0|||
147672780|NCT04870957|532623448|FG003|T1 - Pre-Randomization: PainGuide run-in|Lost to Follow-up|0|||
147672781|NCT04870957|532623449|FG004|T1 - Pre-Randomization: PainGuide run-in|Lost to Follow-up|37|||
147672782|NCT04870957|532623450|FG005|T1 - Pre-Randomization: PainGuide run-in|Lost to Follow-up|0|||
147672783|NCT04870957|532623445|FG000|T1 - Pre-Randomization: PainGuide run-in|Physician Decision|0|||
147672784|NCT04870957|532623446|FG001|T1 - Pre-Randomization: PainGuide run-in|Physician Decision|0|||
147672785|NCT04870957|532623447|FG002|T1 - Pre-Randomization: PainGuide run-in|Physician Decision|0|||
147672786|NCT04870957|532623448|FG003|T1 - Pre-Randomization: PainGuide run-in|Physician Decision|0|||
147672787|NCT04870957|532623449|FG004|T1 - Pre-Randomization: PainGuide run-in|Physician Decision|3|||
147672788|NCT04870957|532623450|FG005|T1 - Pre-Randomization: PainGuide run-in|Physician Decision|0|||
147672789|NCT04870957|532623445|FG000|T2 (Randomization) - T3|Adverse Event|1|||
147672790|NCT04870957|532623446|FG001|T2 (Randomization) - T3|Adverse Event|1|||
147672791|NCT04870957|532623447|FG002|T2 (Randomization) - T3|Adverse Event|0|||
147672792|NCT04870957|532623448|FG003|T2 (Randomization) - T3|Adverse Event|0|||
147672793|NCT04870957|532623449|FG004|T2 (Randomization) - T3|Adverse Event|0|||
147672794|NCT04870957|532623450|FG005|T2 (Randomization) - T3|Adverse Event|0|||
147672795|NCT04870957|532623445|FG000|T2 (Randomization) - T3|Lost to Follow-up|7|||
147672796|NCT04870957|532623446|FG001|T2 (Randomization) - T3|Lost to Follow-up|0|||
147672797|NCT04870957|532623447|FG002|T2 (Randomization) - T3|Lost to Follow-up|7|||
147672798|NCT04870957|532623448|FG003|T2 (Randomization) - T3|Lost to Follow-up|3|||
147672799|NCT04870957|532623449|FG004|T2 (Randomization) - T3|Lost to Follow-up|0|||
147672800|NCT04870957|532623450|FG005|T2 (Randomization) - T3|Lost to Follow-up|0|||
147672801|NCT04870957|532623445|FG000|T2 (Randomization) - T3|Withdrawal by Subject|11|||
147672802|NCT04870957|532623446|FG001|T2 (Randomization) - T3|Withdrawal by Subject|8|||
147672803|NCT04870957|532623447|FG002|T2 (Randomization) - T3|Withdrawal by Subject|11|||
147672804|NCT04870957|532623448|FG003|T2 (Randomization) - T3|Withdrawal by Subject|7|||
147672805|NCT04870957|532623449|FG004|T2 (Randomization) - T3|Withdrawal by Subject|0|||
147672806|NCT04870957|532623450|FG005|T2 (Randomization) - T3|Withdrawal by Subject|1|||
147672807|NCT04870957|532623445|FG000|T2 (Randomization) - T3|Physician Decision|0|||
147672808|NCT04870957|532623446|FG001|T2 (Randomization) - T3|Physician Decision|0|||
147672809|NCT04870957|532623447|FG002|T2 (Randomization) - T3|Physician Decision|2|||
147672810|NCT04870957|532623448|FG003|T2 (Randomization) - T3|Physician Decision|1|||
147672811|NCT04870957|532623449|FG004|T2 (Randomization) - T3|Physician Decision|0|||
147672812|NCT04870957|532623450|FG005|T2 (Randomization) - T3|Physician Decision|0|||
147672813|NCT04870957|532623445|FG000|T2 (Randomization) - T3|Missed Timepoint|4|||
147672814|NCT04870957|532623446|FG001|T2 (Randomization) - T3|Missed Timepoint|3|||
147672815|NCT04870957|532623447|FG002|T2 (Randomization) - T3|Missed Timepoint|3|||
147672816|NCT04870957|532623448|FG003|T2 (Randomization) - T3|Missed Timepoint|2|||
147672817|NCT04870957|532623449|FG004|T2 (Randomization) - T3|Missed Timepoint|0|||
147672818|NCT04870957|532623450|FG005|T2 (Randomization) - T3|Missed Timepoint|12|||
147672819|NCT04870957|532623445|FG000|T3 (Re-randomization) - T4|Adverse Event|0|||
147672820|NCT04870957|532623446|FG001|T3 (Re-randomization) - T4|Adverse Event|1|||
147672821|NCT04870957|532623447|FG002|T3 (Re-randomization) - T4|Adverse Event|0|||
147672822|NCT04870957|532623448|FG003|T3 (Re-randomization) - T4|Adverse Event|1|||
147672823|NCT04870957|532623449|FG004|T3 (Re-randomization) - T4|Adverse Event|0|||
147672824|NCT04870957|532623450|FG005|T3 (Re-randomization) - T4|Adverse Event|0|||
147672825|NCT04870957|532623445|FG000|T3 (Re-randomization) - T4|Lost to Follow-up|8|||
147672826|NCT04870957|532623446|FG001|T3 (Re-randomization) - T4|Lost to Follow-up|6|||
147672827|NCT04870957|532623447|FG002|T3 (Re-randomization) - T4|Lost to Follow-up|7|||
147672828|NCT04870957|532623448|FG003|T3 (Re-randomization) - T4|Lost to Follow-up|6|||
147672829|NCT04870957|532623449|FG004|T3 (Re-randomization) - T4|Lost to Follow-up|0|||
147672830|NCT04870957|532623450|FG005|T3 (Re-randomization) - T4|Lost to Follow-up|2|||
147672831|NCT04870957|532623445|FG000|T3 (Re-randomization) - T4|Withdrawal by Subject|11|||
147672832|NCT04870957|532623446|FG001|T3 (Re-randomization) - T4|Withdrawal by Subject|5|||
147672833|NCT04870957|532623447|FG002|T3 (Re-randomization) - T4|Withdrawal by Subject|10|||
147672834|NCT04870957|532623448|FG003|T3 (Re-randomization) - T4|Withdrawal by Subject|3|||
147672835|NCT04870957|532623449|FG004|T3 (Re-randomization) - T4|Withdrawal by Subject|0|||
147672836|NCT04870957|532623450|FG005|T3 (Re-randomization) - T4|Withdrawal by Subject|1|||
147672837|NCT04870957|532623445|FG000|T3 (Re-randomization) - T4|Physician Decision|2|||
147672838|NCT04870957|532623446|FG001|T3 (Re-randomization) - T4|Physician Decision|0|||
147672839|NCT04870957|532623447|FG002|T3 (Re-randomization) - T4|Physician Decision|0|||
147672840|NCT04870957|532623448|FG003|T3 (Re-randomization) - T4|Physician Decision|0|||
147672841|NCT04870957|532623449|FG004|T3 (Re-randomization) - T4|Physician Decision|0|||
147672842|NCT04870957|532623450|FG005|T3 (Re-randomization) - T4|Physician Decision|0|||
147672843|NCT04870957|532623445|FG000|T3 (Re-randomization) - T4|Missed Timepoint|3|||
147672844|NCT04870957|532623446|FG001|T3 (Re-randomization) - T4|Missed Timepoint|1|||
147672845|NCT04870957|532623447|FG002|T3 (Re-randomization) - T4|Missed Timepoint|2|||
147672846|NCT04870957|532623448|FG003|T3 (Re-randomization) - T4|Missed Timepoint|2|||
147672847|NCT04870957|532623449|FG004|T3 (Re-randomization) - T4|Missed Timepoint|0|||
147672848|NCT04870957|532623450|FG005|T3 (Re-randomization) - T4|Missed Timepoint|23|||
147672849|NCT04870957|532623445|FG000|T4 - T5 (Follow-Up)|Lost to Follow-up|0|||
147672850|NCT04870957|532623446|FG001|T4 - T5 (Follow-Up)|Lost to Follow-up|0|||
147672851|NCT04870957|532623447|FG002|T4 - T5 (Follow-Up)|Lost to Follow-up|0|||
147672852|NCT04870957|532623448|FG003|T4 - T5 (Follow-Up)|Lost to Follow-up|0|||
147672853|NCT04870957|532623449|FG004|T4 - T5 (Follow-Up)|Lost to Follow-up|0|||
147672854|NCT04870957|532623450|FG005|T4 - T5 (Follow-Up)|Lost to Follow-up|21|||
147672855|NCT04870957|532623445|FG000|T4 - T5 (Follow-Up)|Withdrawal by Subject|0|||
147672856|NCT04870957|532623446|FG001|T4 - T5 (Follow-Up)|Withdrawal by Subject|0|||
147672857|NCT04870957|532623447|FG002|T4 - T5 (Follow-Up)|Withdrawal by Subject|0|||
147672858|NCT04870957|532623448|FG003|T4 - T5 (Follow-Up)|Withdrawal by Subject|0|||
147672859|NCT04870957|532623449|FG004|T4 - T5 (Follow-Up)|Withdrawal by Subject|0|||
147672860|NCT04870957|532623450|FG005|T4 - T5 (Follow-Up)|Withdrawal by Subject|7|||
147672861|NCT04870957|532623445|FG000|T4 - T5 (Follow-Up)|Physician Decision|0|||
147672862|NCT04870957|532623446|FG001|T4 - T5 (Follow-Up)|Physician Decision|0|||
147672863|NCT04870957|532623447|FG002|T4 - T5 (Follow-Up)|Physician Decision|0|||
147672864|NCT04870957|532623448|FG003|T4 - T5 (Follow-Up)|Physician Decision|0|||
147672865|NCT04870957|532623449|FG004|T4 - T5 (Follow-Up)|Physician Decision|0|||
147672866|NCT04870957|532623450|FG005|T4 - T5 (Follow-Up)|Physician Decision|2|||
147672867|NCT05970640|532624444|FG000|Overall Study|Adverse Event|1|||
147672868|NCT05970640|532624445|FG001|Overall Study|Adverse Event|3|||
147672869|NCT05970640|532624446|FG002|Overall Study|Adverse Event|1|||
147672870|NCT05970640|532624447|FG003|Overall Study|Adverse Event|0|||
147672871|NCT05970640|532624444|FG000|Overall Study|Withdrawal by Subject|0|||
147672872|NCT05970640|532624445|FG001|Overall Study|Withdrawal by Subject|0|||
147672873|NCT05970640|532624446|FG002|Overall Study|Withdrawal by Subject|1|||
147672874|NCT05970640|532624447|FG003|Overall Study|Withdrawal by Subject|1|||
147672875|NCT05970640|532624444|FG000|Overall Study|Sponsor decision|0|||
147672876|NCT05970640|532624445|FG001|Overall Study|Sponsor decision|0|||
147672877|NCT05970640|532624446|FG002|Overall Study|Sponsor decision|1|||
147672878|NCT05970640|532624447|FG003|Overall Study|Sponsor decision|1|||
147672879|NCT04935879|532624449|FG000|Overall Study|Adverse Event|2|||
147672880|NCT04935879|532624450|FG001|Overall Study|Adverse Event|1|||
147672881|NCT04935879|532624449|FG000|Overall Study|Lost to Follow-up|1|||
147672882|NCT04935879|532624450|FG001|Overall Study|Lost to Follow-up|1|||
147672883|NCT04935879|532624449|FG000|Overall Study|Pregnancy|2|||
147672884|NCT04935879|532624450|FG001|Overall Study|Pregnancy|3|||
147672885|NCT04935879|532624449|FG000|Overall Study|Withdrawal by Subject|8|||
147672886|NCT04935879|532624450|FG001|Overall Study|Withdrawal by Subject|6|||
147672887|NCT04935879|532624449|FG000|Overall Study|Other|3|||
147672888|NCT04935879|532624450|FG001|Overall Study|Other|3|||
147672889|NCT04340843|532624451|FG000|Overall Study|Adverse Event|0|||
147672890|NCT04340843|532624452|FG001|Overall Study|Adverse Event|2|||
147672891|NCT04340843|532624451|FG000|Overall Study|Withdrawal by Subject|0|||
147672892|NCT04340843|532624452|FG001|Overall Study|Withdrawal by Subject|2|||
147672893|NCT05032066|532624453|FG000|Part 1: Core Phase|Withdrawal by Subject/Guardian|4|||
147672894|NCT05032066|532624454|FG001|Part 1: Core Phase|Withdrawal by Subject/Guardian|6|||
147672895|NCT05032066|532624455|FG002|Part 1: Core Phase|Withdrawal by Subject/Guardian|5|||
147672896|NCT05032066|532624453|FG000|Part 1: Core Phase|Physician Decision|0|||
147672897|NCT05032066|532624454|FG001|Part 1: Core Phase|Physician Decision|1|||
147672898|NCT05032066|532624455|FG002|Part 1: Core Phase|Physician Decision|1|||
147672899|NCT05032066|532624453|FG000|Part 1: Core Phase|Lost to Follow-up|0|||
147672900|NCT05032066|532624454|FG001|Part 1: Core Phase|Lost to Follow-up|0|||
147672901|NCT05032066|532624455|FG002|Part 1: Core Phase|Lost to Follow-up|1|||
147672902|NCT05032066|532624453|FG000|Part 1: Core Phase|Death|3|||
147672903|NCT05032066|532624454|FG001|Part 1: Core Phase|Death|4|||
147672904|NCT05032066|532624455|FG002|Part 1: Core Phase|Death|2|||
147672905|NCT05032066|532624453|FG000|Part 1: Core Phase|Adverse Event|2|||
147672906|NCT05032066|532624454|FG001|Part 1: Core Phase|Adverse Event|3|||
147672907|NCT05032066|532624455|FG002|Part 1: Core Phase|Adverse Event|0|||
147672908|NCT05032066|532624453|FG000|Part 2: Extension Phase|Withdrawal by Subject/Guardian|2|||
147672909|NCT05032066|532624454|FG001|Part 2: Extension Phase|Withdrawal by Subject/Guardian|1|||
147672910|NCT05032066|532624455|FG002|Part 2: Extension Phase|Withdrawal by Subject/Guardian|2|||
147672911|NCT05032066|532624453|FG000|Part 2: Extension Phase|Study Terminated by Sponsor|27|||
147672912|NCT05032066|532624454|FG001|Part 2: Extension Phase|Study Terminated by Sponsor|22|||
147672913|NCT05032066|532624455|FG002|Part 2: Extension Phase|Study Terminated by Sponsor|27|||
147672914|NCT05032066|532624453|FG000|Part 2: Extension Phase|Physician Decision|1|||
147672915|NCT05032066|532624454|FG001|Part 2: Extension Phase|Physician Decision|2|||
147672916|NCT05032066|532624455|FG002|Part 2: Extension Phase|Physician Decision|0|||
147672917|NCT05032066|532624453|FG000|Part 2: Extension Phase|Death|2|||
147672918|NCT05032066|532624454|FG001|Part 2: Extension Phase|Death|4|||
147672919|NCT05032066|532624455|FG002|Part 2: Extension Phase|Death|5|||
147672920|NCT06178991|532624458|FG000|Overall Study|Withdrawal by Subject|2|||
147672921|NCT06178991|532624459|FG001|Overall Study|Withdrawal by Subject|6|||
147512529|NCT01183104|532029528|FG001|Overall Study|Did not receive study drug|9|||
147512530|NCT01977040|532029530|FG000|Overall Study|Vasa previa not confirmed|2|||
147672922|NCT06178991|532624460|FG002|Overall Study|Withdrawal by Subject|44|||
147672923|NCT06178991|532624461|FG003|Overall Study|Withdrawal by Subject|23|||
147672924|NCT06178991|532624462|FG004|Overall Study|Withdrawal by Subject|7|||
147672925|NCT06178991|532624463|FG005|Overall Study|Withdrawal by Subject|7|||
147672926|NCT06178991|532624464|FG006|Overall Study|Withdrawal by Subject|7|||
147672927|NCT06178991|532624465|FG007|Overall Study|Withdrawal by Subject|5|||
147672928|NCT06178991|532624458|FG000|Overall Study|Lost to Follow-up|2|||
147512531|NCT01685060|532029531|FG000|Overall Study|Rollover patients|16|||
147672929|NCT06178991|532624459|FG001|Overall Study|Lost to Follow-up|4|||
147672930|NCT06178991|532624460|FG002|Overall Study|Lost to Follow-up|133|||
147672931|NCT06178991|532624461|FG003|Overall Study|Lost to Follow-up|65|||
147672932|NCT06178991|532624462|FG004|Overall Study|Lost to Follow-up|68|||
147672933|NCT06178991|532624463|FG005|Overall Study|Lost to Follow-up|57|||
147672934|NCT06178991|532624464|FG006|Overall Study|Lost to Follow-up|25|||
147512532|NCT01685060|532029531|FG000|Overall Study|Adverse Event|12|||
147512533|NCT01685060|532029531|FG000|Overall Study|Progressive disease|69|||
147512534|NCT01685060|532029531|FG000|Overall Study|Physician Decision|14|||
147512535|NCT01685060|532029531|FG000|Overall Study|Subject/guardian decision|20|||
147512536|NCT01685060|532029531|FG000|Overall Study|Lost to Follow-up|1|||
147512537|NCT01685060|532029531|FG000|Overall Study|Death|8|||
147512538|NCT00634751|532029532|FG000|Phase I: 200mg Sorafenib+2DOC|Death|1|||
147512539|NCT00634751|532029533|FG001|Phase I: 200mg Sorafenib+2DOC|Death|0|||
147512540|NCT00634751|532029534|FG002|Phase I: 200mg Sorafenib+2DOC|Death|0|||
147512541|NCT00634751|532029535|FG003|Phase I: 200mg Sorafenib+2DOC|Death|0|||
147512542|NCT00634751|532029532|FG000|Phase I: 400mg Sorafenib BID+2DOC|Death|0|||
147512543|NCT00634751|532029533|FG001|Phase I: 400mg Sorafenib BID+2DOC|Death|1|||
147512544|NCT00634751|532029534|FG002|Phase I: 400mg Sorafenib BID+2DOC|Death|0|||
147512545|NCT00634751|532029535|FG003|Phase I: 400mg Sorafenib BID+2DOC|Death|0|||
147512546|NCT00634751|532029532|FG000|Pancreatic and Bilial Tract Cancer|Death|0|||
147512547|NCT00634751|532029533|FG001|Pancreatic and Bilial Tract Cancer|Death|0|||
147512548|NCT00634751|532029534|FG002|Pancreatic and Bilial Tract Cancer|Death|1|||
147512549|NCT00634751|532029535|FG003|Pancreatic and Bilial Tract Cancer|Death|1|||
147512550|NCT02828644|532029536|FG000|Overall Study|Lost to Follow-up|23|||
147512551|NCT02828644|532029537|FG001|Overall Study|Lost to Follow-up|22|||
147512552|NCT02996110|532029538|FG000|Pre-Treatment|Other Reasons|0|||
147512553|NCT02996110|532029539|FG001|Pre-Treatment|Other Reasons|1|||
147512554|NCT02996110|532029540|FG002|Pre-Treatment|Other Reasons|0|||
147512555|NCT02996110|532029541|FG003|Pre-Treatment|Other Reasons|0|||
147512556|NCT02996110|532029542|FG004|Pre-Treatment|Other Reasons|1|||
147512557|NCT02996110|532029538|FG000|Pre-Treatment|Participant Withdrew Consent|0|||
147672935|NCT06178991|532624465|FG007|Overall Study|Lost to Follow-up|18|||
147672936|NCT06178991|532624458|FG000|Overall Study|Death|1|||
147672937|NCT06178991|532624459|FG001|Overall Study|Death|0|||
147672938|NCT06178991|532624460|FG002|Overall Study|Death|2|||
147672939|NCT06178991|532624461|FG003|Overall Study|Death|1|||
147672940|NCT06178991|532624462|FG004|Overall Study|Death|1|||
147672941|NCT06178991|532624463|FG005|Overall Study|Death|0|||
147672942|NCT06178991|532624464|FG006|Overall Study|Death|1|||
147672943|NCT06178991|532624465|FG007|Overall Study|Death|1|||
147672944|NCT06178991|532624458|FG000|Overall Study|Randomized but not Vaccinated|4|||
147672945|NCT06178991|532624459|FG001|Overall Study|Randomized but not Vaccinated|1|||
147672946|NCT06178991|532624460|FG002|Overall Study|Randomized but not Vaccinated|15|||
147672947|NCT06178991|532624461|FG003|Overall Study|Randomized but not Vaccinated|9|||
147672948|NCT06178991|532624462|FG004|Overall Study|Randomized but not Vaccinated|8|||
147672949|NCT06178991|532624463|FG005|Overall Study|Randomized but not Vaccinated|4|||
147672950|NCT06178991|532624464|FG006|Overall Study|Randomized but not Vaccinated|2|||
147672951|NCT06178991|532624465|FG007|Overall Study|Randomized but not Vaccinated|2|||
147672952|NCT06178991|532624458|FG000|Overall Study|Other: Unspecified|0|||
147672953|NCT06178991|532624459|FG001|Overall Study|Other: Unspecified|1|||
147672954|NCT06178991|532624460|FG002|Overall Study|Other: Unspecified|7|||
147672955|NCT06178991|532624461|FG003|Overall Study|Other: Unspecified|6|||
147672956|NCT06178991|532624462|FG004|Overall Study|Other: Unspecified|1|||
147672957|NCT06178991|532624463|FG005|Overall Study|Other: Unspecified|1|||
147672958|NCT06178991|532624464|FG006|Overall Study|Other: Unspecified|1|||
147672959|NCT06178991|532624465|FG007|Overall Study|Other: Unspecified|0|||
147672960|NCT06178991|532624458|FG000|Overall Study|Physician Decision|0|||
147672961|NCT06178991|532624459|FG001|Overall Study|Physician Decision|0|||
147672962|NCT06178991|532624460|FG002|Overall Study|Physician Decision|2|||
147672963|NCT06178991|532624461|FG003|Overall Study|Physician Decision|0|||
147672964|NCT06178991|532624462|FG004|Overall Study|Physician Decision|2|||
147672965|NCT06178991|532624463|FG005|Overall Study|Physician Decision|1|||
147672966|NCT06178991|532624464|FG006|Overall Study|Physician Decision|0|||
147672967|NCT06178991|532624465|FG007|Overall Study|Physician Decision|0|||
147672968|NCT06178991|532624458|FG000|Overall Study|Protocol Violation|0|||
147672969|NCT06178991|532624459|FG001|Overall Study|Protocol Violation|0|||
147672970|NCT06178991|532624460|FG002|Overall Study|Protocol Violation|1|||
147672971|NCT06178991|532624461|FG003|Overall Study|Protocol Violation|0|||
147672972|NCT06178991|532624462|FG004|Overall Study|Protocol Violation|0|||
147672973|NCT06178991|532624463|FG005|Overall Study|Protocol Violation|0|||
147672974|NCT06178991|532624464|FG006|Overall Study|Protocol Violation|0|||
147672975|NCT06178991|532624465|FG007|Overall Study|Protocol Violation|0|||
147672976|NCT04739800|532624466|FG000|Overall Study|Adverse Event|2|||
147512558|NCT02996110|532029539|FG001|Pre-Treatment|Participant Withdrew Consent|0|||
147512559|NCT02996110|532029540|FG002|Pre-Treatment|Participant Withdrew Consent|1|||
147512560|NCT02996110|532029541|FG003|Pre-Treatment|Participant Withdrew Consent|0|||
147512561|NCT02996110|532029542|FG004|Pre-Treatment|Participant Withdrew Consent|1|||
147672977|NCT04739800|532624467|FG001|Overall Study|Adverse Event|1|||
147672978|NCT04739800|532624468|FG002|Overall Study|Adverse Event|4|||
147672979|NCT04739800|532624469|FG003|Overall Study|Adverse Event|5|||
147512562|NCT02996110|532029538|FG000|Track 1|Disease Progression|15|||
147672980|NCT04739800|532624466|FG000|Overall Study|Never Treated|2|||
147672981|NCT04739800|532624467|FG001|Overall Study|Never Treated|0|||
147672982|NCT04739800|532624468|FG002|Overall Study|Never Treated|1|||
147512563|NCT02996110|532029539|FG001|Track 1|Disease Progression|17|||
147512564|NCT02996110|532029540|FG002|Track 1|Disease Progression|0|||
147512565|NCT02996110|532029541|FG003|Track 1|Disease Progression|0|||
147512566|NCT02996110|532029542|FG004|Track 1|Disease Progression|0|||
147512567|NCT02996110|532029538|FG000|Track 1|Adverse Event Unrelated to Study Drug|1|||
147512568|NCT02996110|532029539|FG001|Track 1|Adverse Event Unrelated to Study Drug|1|||
147512569|NCT02996110|532029540|FG002|Track 1|Adverse Event Unrelated to Study Drug|0|||
147512570|NCT02996110|532029541|FG003|Track 1|Adverse Event Unrelated to Study Drug|0|||
147512571|NCT02996110|532029542|FG004|Track 1|Adverse Event Unrelated to Study Drug|0|||
147512572|NCT02996110|532029538|FG000|Track 1|Study Drug Toxicity|5|||
147512573|NCT02996110|532029539|FG001|Track 1|Study Drug Toxicity|3|||
147512574|NCT02996110|532029540|FG002|Track 1|Study Drug Toxicity|0|||
147512575|NCT02996110|532029541|FG003|Track 1|Study Drug Toxicity|0|||
147512576|NCT02996110|532029542|FG004|Track 1|Study Drug Toxicity|0|||
147512577|NCT02996110|532029538|FG000|Track 1|Participant Requested to Discontinue Study Treatment|1|||
147512578|NCT02996110|532029539|FG001|Track 1|Participant Requested to Discontinue Study Treatment|0|||
147512579|NCT02996110|532029540|FG002|Track 1|Participant Requested to Discontinue Study Treatment|0|||
147512580|NCT02996110|532029541|FG003|Track 1|Participant Requested to Discontinue Study Treatment|0|||
147512581|NCT02996110|532029542|FG004|Track 1|Participant Requested to Discontinue Study Treatment|0|||
147512582|NCT02996110|532029538|FG000|Track 1|Administrative Reason by Sponsor|0|||
147512583|NCT02996110|532029539|FG001|Track 1|Administrative Reason by Sponsor|1|||
147512584|NCT02996110|532029540|FG002|Track 1|Administrative Reason by Sponsor|0|||
147512585|NCT02996110|532029541|FG003|Track 1|Administrative Reason by Sponsor|0|||
147512586|NCT02996110|532029542|FG004|Track 1|Administrative Reason by Sponsor|0|||
147512587|NCT02996110|532029538|FG000|Track 1|Participant no Longer Met Study Criteria|1|||
147512588|NCT02996110|532029539|FG001|Track 1|Participant no Longer Met Study Criteria|0|||
147512589|NCT02996110|532029540|FG002|Track 1|Participant no Longer Met Study Criteria|0|||
147512590|NCT02996110|532029541|FG003|Track 1|Participant no Longer Met Study Criteria|0|||
147512591|NCT02996110|532029542|FG004|Track 1|Participant no Longer Met Study Criteria|0|||
147512592|NCT02996110|532029538|FG000|Track 2|Disease Progression|33|||
147512593|NCT02996110|532029539|FG001|Track 2|Disease Progression|26|||
147512594|NCT02996110|532029540|FG002|Track 2|Disease Progression|19|||
147512595|NCT02996110|532029541|FG003|Track 2|Disease Progression|16|||
147512596|NCT02996110|532029542|FG004|Track 2|Disease Progression|15|||
147512597|NCT02996110|532029538|FG000|Track 2|Adverse Event Unrelated to Study Drug|4|||
147512598|NCT02996110|532029539|FG001|Track 2|Adverse Event Unrelated to Study Drug|0|||
147512599|NCT02996110|532029540|FG002|Track 2|Adverse Event Unrelated to Study Drug|0|||
147512600|NCT02996110|532029541|FG003|Track 2|Adverse Event Unrelated to Study Drug|1|||
147512601|NCT02996110|532029542|FG004|Track 2|Adverse Event Unrelated to Study Drug|1|||
147512602|NCT02996110|532029538|FG000|Track 2|Death|0|||
147512603|NCT02996110|532029539|FG001|Track 2|Death|0|||
147512604|NCT02996110|532029540|FG002|Track 2|Death|1|||
147512605|NCT02996110|532029541|FG003|Track 2|Death|0|||
147512606|NCT02996110|532029542|FG004|Track 2|Death|1|||
147512607|NCT02996110|532029538|FG000|Track 2|Study Drug Toxicity|4|||
147512608|NCT02996110|532029539|FG001|Track 2|Study Drug Toxicity|1|||
147512609|NCT02996110|532029540|FG002|Track 2|Study Drug Toxicity|4|||
147512610|NCT02996110|532029541|FG003|Track 2|Study Drug Toxicity|1|||
147512611|NCT02996110|532029542|FG004|Track 2|Study Drug Toxicity|0|||
147672983|NCT04739800|532624469|FG003|Overall Study|Never Treated|1|||
147672984|NCT04739800|532624466|FG000|Overall Study|On Treatment|5|||
147672985|NCT04739800|532624467|FG001|Overall Study|On Treatment|9|||
147672986|NCT04739800|532624468|FG002|Overall Study|On Treatment|9|||
147672987|NCT04739800|532624469|FG003|Overall Study|On Treatment|9|||
147672988|NCT04739800|532624466|FG000|Overall Study|Symptomatic Deterioration|1|||
147672989|NCT04739800|532624467|FG001|Overall Study|Symptomatic Deterioration|1|||
147672990|NCT04739800|532624468|FG002|Overall Study|Symptomatic Deterioration|3|||
147672991|NCT04739800|532624469|FG003|Overall Study|Symptomatic Deterioration|0|||
147672992|NCT04739800|532624466|FG000|Overall Study|Withdrawal by Subject|1|||
147672993|NCT04739800|532624467|FG001|Overall Study|Withdrawal by Subject|2|||
147672994|NCT04739800|532624468|FG002|Overall Study|Withdrawal by Subject|1|||
147672995|NCT04739800|532624469|FG003|Overall Study|Withdrawal by Subject|3|||
147672996|NCT04739800|532624466|FG000|Overall Study|Other Reason|1|||
147672997|NCT04739800|532624467|FG001|Overall Study|Other Reason|3|||
147512612|NCT02996110|532029538|FG000|Track 2|Participant Requested to Discontinue Study Treatment|0|||
147512613|NCT02996110|532029539|FG001|Track 2|Participant Requested to Discontinue Study Treatment|0|||
147512614|NCT02996110|532029540|FG002|Track 2|Participant Requested to Discontinue Study Treatment|2|||
147512615|NCT02996110|532029541|FG003|Track 2|Participant Requested to Discontinue Study Treatment|1|||
147512616|NCT02996110|532029542|FG004|Track 2|Participant Requested to Discontinue Study Treatment|2|||
147512617|NCT02996110|532029538|FG000|Track 2|Participant Withdrew Consent|1|||
147512618|NCT02996110|532029539|FG001|Track 2|Participant Withdrew Consent|2|||
147512619|NCT02996110|532029540|FG002|Track 2|Participant Withdrew Consent|3|||
147512620|NCT02996110|532029541|FG003|Track 2|Participant Withdrew Consent|1|||
147672998|NCT04739800|532624468|FG002|Overall Study|Other Reason|5|||
147672999|NCT04739800|532624469|FG003|Overall Study|Other Reason|4|||
147512621|NCT02996110|532029542|FG004|Track 2|Participant Withdrew Consent|1|||
147512622|NCT02996110|532029538|FG000|Track 2|Other Reasons|0|||
147512623|NCT02996110|532029539|FG001|Track 2|Other Reasons|0|||
147512624|NCT02996110|532029540|FG002|Track 2|Other Reasons|1|||
147512625|NCT02996110|532029541|FG003|Track 2|Other Reasons|0|||
147512626|NCT02996110|532029542|FG004|Track 2|Other Reasons|1|||
147512627|NCT00524043|532029543|FG000|Overall Study|Lack of Efficacy|15|||
147512628|NCT00524043|532029544|FG001|Overall Study|Lack of Efficacy|13|||
147512629|NCT00524043|532029545|FG002|Overall Study|Lack of Efficacy|14|||
147512630|NCT00524043|532029543|FG000|Overall Study|Withdrawal by Subject|5|||
147512631|NCT00524043|532029544|FG001|Overall Study|Withdrawal by Subject|7|||
147512632|NCT00524043|532029545|FG002|Overall Study|Withdrawal by Subject|7|||
147512633|NCT00524043|532029543|FG000|Overall Study|Adverse Event|5|||
147512634|NCT00524043|532029544|FG001|Overall Study|Adverse Event|2|||
147512635|NCT00524043|532029545|FG002|Overall Study|Adverse Event|7|||
147512636|NCT00524043|532029543|FG000|Overall Study|Lost to Follow-up|3|||
147512637|NCT00524043|532029544|FG001|Overall Study|Lost to Follow-up|5|||
147512638|NCT00524043|532029545|FG002|Overall Study|Lost to Follow-up|3|||
147512639|NCT00524043|532029543|FG000|Overall Study|Various (eg, incarceration)|2|||
147512640|NCT00524043|532029544|FG001|Overall Study|Various (eg, incarceration)|1|||
147512641|NCT00524043|532029545|FG002|Overall Study|Various (eg, incarceration)|0|||
147512642|NCT01536418|532029552|FG000|Overall Study|Protocol Violation|2|||
147512643|NCT01536418|532029553|FG001|Overall Study|Protocol Violation|3|||
147512644|NCT01536418|532029552|FG000|Overall Study|Physician Decision|1|||
147512645|NCT01536418|532029553|FG001|Overall Study|Physician Decision|3|||
147512646|NCT01536418|532029552|FG000|Overall Study|Study closed/terminated|41|||
147512647|NCT01536418|532029553|FG001|Overall Study|Study closed/terminated|37|||
147512648|NCT01536418|532029552|FG000|Overall Study|Lack of Efficacy|10|||
147512649|NCT01536418|532029553|FG001|Overall Study|Lack of Efficacy|16|||
147512650|NCT01536418|532029552|FG000|Overall Study|Adverse Event|9|||
147512651|NCT01536418|532029553|FG001|Overall Study|Adverse Event|4|||
147512652|NCT01536418|532029552|FG000|Overall Study|Met Liver Chemistry Stopping criteria|1|||
147512653|NCT01536418|532029553|FG001|Overall Study|Met Liver Chemistry Stopping criteria|0|||
147512654|NCT01536418|532029552|FG000|Overall Study|Withdrawal by Subject|5|||
147512655|NCT01536418|532029553|FG001|Overall Study|Withdrawal by Subject|3|||
147512656|NCT02658149|532029558|FG000|Overall Study|Physician Decision|1|||
147512657|NCT02658149|532029559|FG001|Overall Study|Physician Decision|0|||
147512658|NCT00711412|532029560|FG000|Induction Treatment|Death|2|||
147512659|NCT00711412|532029560|FG000|Induction Treatment|Adverse Event|1|||
147512660|NCT00711412|532029560|FG000|Induction Treatment|Other|1|||
147512661|NCT00711412|532029560|FG000|Evaluated for Combination Treatment|Adverse Event|2|||
147512662|NCT00711412|532029560|FG000|Evaluated for Combination Treatment|Death|1|||
147512663|NCT00711412|532029560|FG000|Evaluated for Combination Treatment|Withdrawal by Subject|1|||
147512664|NCT00711412|532029560|FG000|Evaluated for Combination Treatment|Progressive disease|2|||
147512665|NCT00711412|532029560|FG000|Combination Treatment|Progressive Disease|1|||
147512666|NCT00711412|532029560|FG000|Evaluation for Response and Surgery|Progressive Disease|2|||
147512667|NCT00711412|532029560|FG000|Evaluation for Response and Surgery|Too high risk for surgery|2|||
147512668|NCT00711412|532029560|FG000|Evaluation for Response and Surgery|Withdrawal by Subject|1|||
147512669|NCT00711412|532029560|FG000|Evaluation for Response and Surgery|Death|1|||
147512670|NCT00711412|532029560|FG000|Survival Follow up Until Death|Other|12|||
147512671|NCT04097028|532029571|FG000|Overall Study|Disease Progression Prior to completion of Chemoradiation|2|||
147512672|NCT04097028|532029571|FG000|Overall Study|Adverse Event prior to Completion of Chemoradiation|2|||
147512673|NCT04097028|532029571|FG000|Overall Study|Disease Progression prior to Surgery|2|||
147512674|NCT04097028|532029571|FG000|Overall Study|Adverse Event prior to Surgery|1|||
147512675|NCT03687827|532029572|FG000|Treatment Period 1|Death|0|||
147512676|NCT03687827|532029573|FG001|Treatment Period 1|Death|1|||
147512677|NCT03687827|532029572|FG000|Treatment Period 1|Lost to Follow-up|2|||
147512678|NCT03687827|532029573|FG001|Treatment Period 1|Lost to Follow-up|2|||
147512679|NCT03687827|532029572|FG000|Treatment Period 1|Physician Decision|5|||
147673000|NCT04526665|532624474|FG000|Overall Study|Withdrawal by Subject|6|||
147673001|NCT04526665|532624475|FG001|Overall Study|Withdrawal by Subject|3|||
147673002|NCT04526665|532624474|FG000|Overall Study|Adverse Event|4|||
147673003|NCT04526665|532624475|FG001|Overall Study|Adverse Event|1|||
147673004|NCT04526665|532624474|FG000|Overall Study|Physician Decision|2|||
147673005|NCT04526665|532624475|FG001|Overall Study|Physician Decision|2|||
147512680|NCT03687827|532029573|FG001|Treatment Period 1|Physician Decision|2|||
147512681|NCT03687827|532029572|FG000|Treatment Period 1|Withdrawal by Subject|7|||
147512682|NCT03687827|532029573|FG001|Treatment Period 1|Withdrawal by Subject|3|||
147512683|NCT03687827|532029572|FG000|Treatment Period 2|Physician Decision|4|||
147512684|NCT03687827|532029573|FG001|Treatment Period 2|Physician Decision|1|||
147512685|NCT03687827|532029572|FG000|Treatment Period 2|Withdrawal by Subject|1|||
147512686|NCT03687827|532029573|FG001|Treatment Period 2|Withdrawal by Subject|2|||
147512687|NCT01156363|532029574|FG000|Overall Study|Adverse Event|6|||
147512688|NCT01156363|532029574|FG000|Overall Study|Insufficient Therapeutic Response|5|||
147512689|NCT01156363|532029574|FG000|Overall Study|Failure to Return|1|||
147512690|NCT01156363|532029574|FG000|Overall Study|Refused Treatment|4|||
147512691|NCT01156363|532029574|FG000|Overall Study|Other|6|||
147512692|NCT03285490|532029575|FG000|Recurrence Follow-up Period|Withdrawal by Subject|0|||
147512693|NCT03285490|532029576|FG001|Recurrence Follow-up Period|Withdrawal by Subject|1|||
147512694|NCT03285490|532029575|FG000|Recurrence Follow-up Period|AK recurrence during Recurrence Follow-Up Period|18|||
147512695|NCT03285490|532029576|FG001|Recurrence Follow-up Period|AK recurrence during Recurrence Follow-Up Period|60|||
147512696|NCT00735072|532029582|FG000|Overall Study|interrupted study med during ARV change|1|||
147512697|NCT00735072|532029583|FG001|Overall Study|interrupted study med during ARV change|0|||
147512698|NCT00735072|532029582|FG000|Overall Study|Subject interrupted ARVs (non-adherence)|0|||
147512699|NCT00735072|532029583|FG001|Overall Study|Subject interrupted ARVs (non-adherence)|1|||
147512700|NCT00911144|532029584|FG000|Overall Study|Withdrawal by Subject|16|||
147512701|NCT00911144|532029585|FG001|Overall Study|Withdrawal by Subject|5|||
147512702|NCT01291511|532029586|FG000|Cross-Titration and Stabilization Phase|Withdrawal by Subject|107|||
147512703|NCT01291511|532029587|FG001|Cross-Titration and Stabilization Phase|Withdrawal by Subject|0|||
147512704|NCT01291511|532029586|FG000|Cross-Titration and Stabilization Phase|Adverse Event|92|||
147512705|NCT01291511|532029587|FG001|Cross-Titration and Stabilization Phase|Adverse Event|0|||
147512706|NCT01291511|532029586|FG000|Cross-Titration and Stabilization Phase|Administrative problems|30|||
147512707|NCT01291511|532029587|FG001|Cross-Titration and Stabilization Phase|Administrative problems|0|||
147512708|NCT01291511|532029586|FG000|Cross-Titration and Stabilization Phase|Lack of Efficacy|28|||
147512709|NCT01291511|532029587|FG001|Cross-Titration and Stabilization Phase|Lack of Efficacy|0|||
147512710|NCT01291511|532029586|FG000|Cross-Titration and Stabilization Phase|Abnormal Laboratory Value|25|||
147512711|NCT01291511|532029587|FG001|Cross-Titration and Stabilization Phase|Abnormal Laboratory Value|0|||
147512712|NCT01291511|532029586|FG000|Cross-Titration and Stabilization Phase|Lost to Follow-up|24|||
147512713|NCT01291511|532029587|FG001|Cross-Titration and Stabilization Phase|Lost to Follow-up|0|||
147512714|NCT01291511|532029586|FG000|Cross-Titration and Stabilization Phase|Protocol Violation|13|||
147512715|NCT01291511|532029587|FG001|Cross-Titration and Stabilization Phase|Protocol Violation|0|||
147512716|NCT01291511|532029586|FG000|Cross-Titration and Stabilization Phase|Abnormal test|6|||
147512717|NCT01291511|532029587|FG001|Cross-Titration and Stabilization Phase|Abnormal test|0|||
147512718|NCT01291511|532029586|FG000|Cross-Titration and Stabilization Phase|Death|1|||
147512719|NCT01291511|532029587|FG001|Cross-Titration and Stabilization Phase|Death|0|||
147512720|NCT01291511|532029586|FG000|Double-blind Relapse Prevention Phase|Administrative problems|45|||
147512721|NCT01291511|532029587|FG001|Double-blind Relapse Prevention Phase|Administrative problems|29|||
147512722|NCT01291511|532029586|FG000|Double-blind Relapse Prevention Phase|Withdrawal by Subject|14|||
147512723|NCT01291511|532029587|FG001|Double-blind Relapse Prevention Phase|Withdrawal by Subject|10|||
147512724|NCT01291511|532029586|FG000|Double-blind Relapse Prevention Phase|Lost to Follow-up|6|||
147512725|NCT01291511|532029587|FG001|Double-blind Relapse Prevention Phase|Lost to Follow-up|4|||
147512726|NCT01291511|532029586|FG000|Double-blind Relapse Prevention Phase|Adverse Event|5|||
147512727|NCT01291511|532029587|FG001|Double-blind Relapse Prevention Phase|Adverse Event|0|||
147512728|NCT01291511|532029586|FG000|Double-blind Relapse Prevention Phase|Abnormal Laboratory Value|4|||
147512729|NCT01291511|532029587|FG001|Double-blind Relapse Prevention Phase|Abnormal Laboratory Value|2|||
147512730|NCT01291511|532029586|FG000|Double-blind Relapse Prevention Phase|Protocol Violation|1|||
147512731|NCT01291511|532029587|FG001|Double-blind Relapse Prevention Phase|Protocol Violation|1|||
147512732|NCT01291511|532029586|FG000|Double-blind Relapse Prevention Phase|Lack of Efficacy|0|||
147512733|NCT01291511|532029587|FG001|Double-blind Relapse Prevention Phase|Lack of Efficacy|2|||
147512734|NCT01291511|532029586|FG000|Double-blind Relapse Prevention Phase|Abnormal test|1|||
147512735|NCT01291511|532029587|FG001|Double-blind Relapse Prevention Phase|Abnormal test|0|||
147512736|NCT01291511|532029586|FG000|Double-blind Relapse Prevention Phase|Death|1|||
147512737|NCT01291511|532029587|FG001|Double-blind Relapse Prevention Phase|Death|0|||
147512738|NCT00047008|532029589|FG000|Overall Study|Withdrawn consent|2|||
147512739|NCT00047008|532029590|FG001|Overall Study|Withdrawn consent|3|||
147512740|NCT00047008|532029589|FG000|Overall Study|Ineligible|9|||
147512741|NCT00047008|532029590|FG001|Overall Study|Ineligible|8|||
147512742|NCT02773368|532029591|FG000|Overall Study|Lost to Follow-up|4|||
147512743|NCT02773368|532029592|FG001|Overall Study|Lost to Follow-up|1|||
147512744|NCT02773368|532029591|FG000|Overall Study|Withdrawal by Subject|5|||
147512745|NCT02773368|532029592|FG001|Overall Study|Withdrawal by Subject|1|||
147512746|NCT02773368|532029591|FG000|Overall Study|Unclassified|1|||
147512747|NCT02773368|532029592|FG001|Overall Study|Unclassified|1|||
147512748|NCT02773368|532029591|FG000|Overall Study|Missing|0|||
147512749|NCT02773368|532029592|FG001|Overall Study|Missing|1|||
147512750|NCT01929018|532029593|FG000|Overall Study|Lost to Follow-up|1|||
147512751|NCT01929018|532029594|FG001|Overall Study|Lost to Follow-up|0|||
147512752|NCT01929018|532029593|FG000|Overall Study|Hospitalization|0|||
147673006|NCT04526665|532624474|FG000|Overall Study|Death|2|||
147673007|NCT04526665|532624475|FG001|Overall Study|Death|0|||
147673008|NCT04526665|532624474|FG000|Overall Study|Other|0|||
147673009|NCT04526665|532624475|FG001|Overall Study|Other|1|||
147673010|NCT06070610|532624476|FG000|Washout period|Adverse Event|1|||
147673011|NCT06070610|532624476|FG000|Period 2 (Test treatment period)|Adverse Event|1|||
147512753|NCT01929018|532029594|FG001|Overall Study|Hospitalization|1|||
147512754|NCT01366534|532029597|FG000|Overall Study|Lost to Follow-up|1|||
147512755|NCT01366534|532029598|FG001|Overall Study|Lost to Follow-up|0|||
147512756|NCT01366534|532029599|FG002|Overall Study|Lost to Follow-up|0|||
147512757|NCT01366534|532029597|FG000|Overall Study|Migrated|1|||
147512758|NCT01366534|532029598|FG001|Overall Study|Migrated|1|||
147512759|NCT01366534|532029599|FG002|Overall Study|Migrated|0|||
147512760|NCT01366534|532029597|FG000|Overall Study|Declined challenged|0|||
147512761|NCT01366534|532029598|FG001|Overall Study|Declined challenged|1|||
147512762|NCT01366534|532029599|FG002|Overall Study|Declined challenged|0|||
147512763|NCT01047436|532029601|FG000|Overall Study|Protocol Violation|1|||
147512764|NCT01047436|532029602|FG001|Overall Study|Protocol Violation|0|||
147512765|NCT02635867|532029604|FG000|Overall Study|Lost to Follow-up|4|||
147512766|NCT02635867|532029605|FG001|Overall Study|Lost to Follow-up|3|||
147512767|NCT02635867|532029606|FG002|Overall Study|Lost to Follow-up|3|||
147512768|NCT02635867|532029607|FG003|Overall Study|Lost to Follow-up|4|||
147512769|NCT02635867|532029608|FG004|Overall Study|Lost to Follow-up|1|||
147512770|NCT01024920|532029619|FG000|Overall Study|Progressive disease|47|||
147512771|NCT01024920|532029620|FG001|Overall Study|Progressive disease|25|||
147512772|NCT01024920|532029619|FG000|Overall Study|Adverse Event|8|||
147512773|NCT01024920|532029620|FG001|Overall Study|Adverse Event|4|||
147512774|NCT01024920|532029619|FG000|Overall Study|Lost to Follow-up|0|||
147512775|NCT01024920|532029620|FG001|Overall Study|Lost to Follow-up|1|||
147512776|NCT01024920|532029619|FG000|Overall Study|Patient refusal to continue|4|||
147512777|NCT01024920|532029620|FG001|Overall Study|Patient refusal to continue|0|||
147512778|NCT01024920|532029619|FG000|Overall Study|Other than listed|5|||
147512779|NCT01024920|532029620|FG001|Overall Study|Other than listed|1|||
147512780|NCT01024920|532029619|FG000|Overall Study|Not treated|3|||
147512781|NCT01024920|532029620|FG001|Overall Study|Not treated|0|||
147512782|NCT01024920|532029619|FG000|Overall Study|Protocol Violation|0|||
147512783|NCT01024920|532029620|FG001|Overall Study|Protocol Violation|1|||
147512784|NCT03236506|532029630|FG000|Overall Study|Death|1|||
147512785|NCT03236506|532029631|FG001|Overall Study|Death|1|||
147512786|NCT03236506|532029632|FG002|Overall Study|Death|1|||
147512787|NCT03236506|532029630|FG000|Overall Study|Withdrawal by Subject|3|||
147512788|NCT03236506|532029631|FG001|Overall Study|Withdrawal by Subject|3|||
147512789|NCT03236506|532029632|FG002|Overall Study|Withdrawal by Subject|4|||
147512790|NCT03236506|532029630|FG000|Overall Study|Did not initiate treatment|2|||
147512791|NCT03236506|532029631|FG001|Overall Study|Did not initiate treatment|1|||
147512792|NCT03236506|532029632|FG002|Overall Study|Did not initiate treatment|2|||
147512793|NCT00023712|532029633|FG000|Overall Study|Not platinum sensitive|1|||
147512794|NCT00023712|532029634|FG001|Overall Study|Not platinum sensitive|0|||
147512795|NCT00023712|532029633|FG000|Overall Study|Never treated|1|||
147512796|NCT00023712|532029634|FG001|Overall Study|Never treated|1|||
147512797|NCT01570309|532029636|FG000|Overall Study|Withdrawal by Subject|3|||
147512798|NCT01570309|532029637|FG001|Overall Study|Withdrawal by Subject|3|||
147512799|NCT04857892|532029638|FG000|Part 1: Period 1 (Day 1)|Adverse Event|1|||
147512800|NCT04857892|532029639|FG001|Part 1: Period 1 (Day 1)|Adverse Event|0|||
147512801|NCT04857892|532029640|FG002|Part 1: Period 1 (Day 1)|Adverse Event|0|||
147512802|NCT04857892|532029641|FG003|Part 1: Period 1 (Day 1)|Adverse Event|0|||
147512803|NCT04857892|532029642|FG004|Part 1: Period 1 (Day 1)|Adverse Event|0|||
147512804|NCT04857892|532029638|FG000|Part 1: Washout Period 2 (Up to 7 Days)|Withdrawal by Subject|2|||
147512805|NCT04857892|532029639|FG001|Part 1: Washout Period 2 (Up to 7 Days)|Withdrawal by Subject|1|||
147512806|NCT04857892|532029640|FG002|Part 1: Washout Period 2 (Up to 7 Days)|Withdrawal by Subject|1|||
147512807|NCT04857892|532029641|FG003|Part 1: Washout Period 2 (Up to 7 Days)|Withdrawal by Subject|0|||
147512808|NCT04857892|532029642|FG004|Part 1: Washout Period 2 (Up to 7 Days)|Withdrawal by Subject|0|||
147512809|NCT04857892|532029638|FG000|Part 2: Washout Period 1 (Up to 7 Days)|Protocol Violation|0|||
147512810|NCT04857892|532029639|FG001|Part 2: Washout Period 1 (Up to 7 Days)|Protocol Violation|0|||
147512811|NCT04857892|532029640|FG002|Part 2: Washout Period 1 (Up to 7 Days)|Protocol Violation|0|||
147512812|NCT04857892|532029641|FG003|Part 2: Washout Period 1 (Up to 7 Days)|Protocol Violation|0|||
147512813|NCT04857892|532029642|FG004|Part 2: Washout Period 1 (Up to 7 Days)|Protocol Violation|1|||
147512814|NCT00368472|532029647|FG000|Overall Study|Adverse Event|22|||
147512815|NCT00368472|532029647|FG000|Overall Study|Medication non-compliance|4|||
147512816|NCT00368472|532029647|FG000|Overall Study|Protocol Violation|2|||
147512817|NCT00368472|532029647|FG000|Overall Study|Request of Investigator or Sponsor|3|||
147512818|NCT00368472|532029647|FG000|Overall Study|Withdrawal by Subject|40|||
147512819|NCT00368472|532029647|FG000|Overall Study|Diary non-compliance|1|||
147512820|NCT00368472|532029647|FG000|Overall Study|Other|32|||
147512821|NCT00368472|532029647|FG000|Overall Study|Missing Final Disposition Date|1|||
147512822|NCT04095793|532029651|FG000|Overall Study|Adverse Event|3|||
147512823|NCT04095793|532029651|FG000|Overall Study|Study Terminated by Sponsor|103|||
147512824|NCT04095793|532029651|FG000|Overall Study|Withdrawal by Subject|4|||
147512825|NCT00044213|532029652|FG000|Overall Study|Withdrawal by Subject|50|||
147512826|NCT00044213|532029653|FG001|Overall Study|Withdrawal by Subject|65|||
147512827|NCT00044213|532029654|FG002|Overall Study|Withdrawal by Subject|91|||
147512828|NCT00044213|532029655|FG003|Overall Study|Withdrawal by Subject|83|||
147512829|NCT00044213|532029652|FG000|Overall Study|Death|42|||
147512830|NCT00044213|532029653|FG001|Overall Study|Death|42|||
147512831|NCT00044213|532029654|FG002|Overall Study|Death|42|||
147512832|NCT00044213|532029655|FG003|Overall Study|Death|49|||
147512833|NCT00044213|532029652|FG000|Overall Study|Lost to Follow-up|8|||
147512834|NCT00044213|532029653|FG001|Overall Study|Lost to Follow-up|5|||
147512835|NCT00044213|532029654|FG002|Overall Study|Lost to Follow-up|5|||
147512836|NCT00044213|532029655|FG003|Overall Study|Lost to Follow-up|4|||
147512837|NCT01167153|532029662|FG000|Overall Study|Non-effective therapy|1|||
147512838|NCT01167153|532029663|FG001|Overall Study|Non-effective therapy|4|||
147512839|NCT01167153|532029662|FG000|Overall Study|AE including clinical laboratory AE|2|||
147512840|NCT01167153|532029663|FG001|Overall Study|AE including clinical laboratory AE|8|||
147512841|NCT01167153|532029662|FG000|Overall Study|Hypotension|1|||
147512842|NCT01167153|532029663|FG001|Overall Study|Hypotension|0|||
147512843|NCT01167153|532029662|FG000|Overall Study|Lost to Follow-up|7|||
147512844|NCT01167153|532029663|FG001|Overall Study|Lost to Follow-up|9|||
147512845|NCT01167153|532029662|FG000|Overall Study|Non-compliance to concomitant medication|0|||
147512846|NCT01167153|532029663|FG001|Overall Study|Non-compliance to concomitant medication|2|||
147512847|NCT01167153|532029662|FG000|Overall Study|Investigator initiation withdrawal,Other|1|||
147512848|NCT01167153|532029663|FG001|Overall Study|Investigator initiation withdrawal,Other|1|||
147512849|NCT01167153|532029662|FG000|Overall Study|Withdrawal consent|1|||
147512850|NCT01167153|532029663|FG001|Overall Study|Withdrawal consent|1|||
147512851|NCT01167153|532029662|FG000|Overall Study|Subject initiation withdrawal, Other|5|||
147512852|NCT01167153|532029663|FG001|Overall Study|Subject initiation withdrawal, Other|8|||
147512853|NCT00098865|532032479|FG000|Overall Study|Progressive Disease|6|||
147512854|NCT00098865|532032479|FG000|Overall Study|Adverse Event|2|||
147512855|NCT00098865|532032479|FG000|Overall Study|Alternative Therapy|1|||
147512856|NCT03050307|532032480|FG000|Overall Study|Adverse Event|4|||
147512857|NCT03050307|532032481|FG001|Overall Study|Adverse Event|2|||
147512858|NCT03050307|532032480|FG000|Overall Study|Significant Protocol Deviation|0|||
147512859|NCT03050307|532032481|FG001|Overall Study|Significant Protocol Deviation|1|||
147512860|NCT03050307|532032480|FG000|Overall Study|Lost to Follow-up|0|||
147512861|NCT03050307|532032481|FG001|Overall Study|Lost to Follow-up|1|||
147512862|NCT03050307|532032480|FG000|Overall Study|Voluntary Withdrawal|3|||
147512863|NCT03050307|532032481|FG001|Overall Study|Voluntary Withdrawal|4|||
147512864|NCT03050307|532032480|FG000|Overall Study|Reason not Specified|1|||
147512865|NCT03050307|532032481|FG001|Overall Study|Reason not Specified|1|||
147512866|NCT00439309|532032482|FG000|Follow-Up|Death|1|||
147512867|NCT00439309|532032483|FG001|Follow-Up|Death|0|||
147512868|NCT00439309|532032482|FG000|Follow-Up|Lost to Follow-up|2|||
147512869|NCT00439309|532032483|FG001|Follow-Up|Lost to Follow-up|0|||
147512870|NCT00439309|532032482|FG000|Follow-Up|Withdrawal by Subject|0|||
147512871|NCT00439309|532032483|FG001|Follow-Up|Withdrawal by Subject|1|||
147512872|NCT00439309|532032482|FG000|Follow-Up|Late response by subject|0|||
147512873|NCT00439309|532032483|FG001|Follow-Up|Late response by subject|1|||
147512874|NCT01998906|532032484|FG000|Overall Study|Participants ongoing in follow-up|77|||
147512875|NCT01998906|532032485|FG001|Overall Study|Participants ongoing in follow-up|60|||
147512876|NCT01998906|532032486|FG002|Overall Study|Participants ongoing in follow-up|58|||
147512877|NCT01998906|532032484|FG000|Overall Study|Death|21|||
147512878|NCT01998906|532032485|FG001|Overall Study|Death|30|||
147512879|NCT01998906|532032486|FG002|Overall Study|Death|17|||
147512880|NCT01998906|532032484|FG000|Overall Study|Lack of Efficacy|10|||
147512881|NCT01998906|532032485|FG001|Overall Study|Lack of Efficacy|9|||
147512882|NCT01998906|532032486|FG002|Overall Study|Lack of Efficacy|8|||
147512883|NCT01998906|532032484|FG000|Overall Study|Failure to return|0|||
147512884|NCT01998906|532032485|FG001|Overall Study|Failure to return|2|||
147512885|NCT01998906|532032486|FG002|Overall Study|Failure to return|4|||
147512886|NCT01998906|532032484|FG000|Overall Study|Violation of Selection Criteria|0|||
147512887|NCT01998906|532032485|FG001|Overall Study|Violation of Selection Criteria|0|||
147512888|NCT01998906|532032486|FG002|Overall Study|Violation of Selection Criteria|1|||
147512889|NCT01998906|532032484|FG000|Overall Study|Withdrawal by Subject|1|||
147673012|NCT03459846|532624481|FG000|Overall Study|Death|52|||
147673013|NCT03459846|532624482|FG001|Overall Study|Death|46|||
147673014|NCT03459846|532624481|FG000|Overall Study|Study terminated by sponsor|24|||
147673015|NCT03459846|532624482|FG001|Overall Study|Study terminated by sponsor|28|||
147512890|NCT01998906|532032485|FG001|Overall Study|Withdrawal by Subject|4|||
147512891|NCT01998906|532032486|FG002|Overall Study|Withdrawal by Subject|3|||
147512892|NCT01998906|532032484|FG000|Overall Study|Administrative/Other|2|||
147512893|NCT01998906|532032485|FG001|Overall Study|Administrative/Other|1|||
147512894|NCT01998906|532032486|FG002|Overall Study|Administrative/Other|3|||
147512895|NCT01998906|532032484|FG000|Overall Study|Other|3|||
147512896|NCT01998906|532032485|FG001|Overall Study|Other|8|||
147512897|NCT01998906|532032486|FG002|Overall Study|Other|4|||
147512898|NCT00429572|532032488|FG000|Overall Study|Disease progression|1|||
147512899|NCT01678313|532032493|FG000|Completed the 3-month Therapy|Lost to Follow-up|3|||
147673016|NCT03459846|532624481|FG000|Overall Study|Withdrawal by Subject|2|||
147512900|NCT01678313|532032494|FG001|Completed the 3-month Therapy|Lost to Follow-up|8|||
147512901|NCT01678313|532032493|FG000|Completed the 3-month Therapy|Physician Decision|3|||
147512902|NCT01678313|532032494|FG001|Completed the 3-month Therapy|Physician Decision|4|||
147673017|NCT03459846|532624482|FG001|Overall Study|Withdrawal by Subject|2|||
147512903|NCT01678313|532032493|FG000|PSA >4 ng/dL at 3 Months|PSA≦4|8|||
147512904|NCT01678313|532032494|FG001|PSA >4 ng/dL at 3 Months|PSA≦4|9|||
147512905|NCT01678313|532032493|FG000|Prostate Biopsy at 3 Months|Not received prostate biopsy|11|||
147512906|NCT01678313|532032494|FG001|Prostate Biopsy at 3 Months|Not received prostate biopsy|12|||
147512907|NCT02565576|532032498|FG000|Overall Study|abnormal lab value|2|||
147512908|NCT02565576|532032499|FG001|Overall Study|abnormal lab value|0|||
147512909|NCT02565576|532032498|FG000|Overall Study|subject / guardian decision|1|||
147512910|NCT02565576|532032499|FG001|Overall Study|subject / guardian decision|3|||
147512911|NCT02565576|532032498|FG000|Overall Study|Lost to Follow-up|1|||
147512912|NCT02565576|532032499|FG001|Overall Study|Lost to Follow-up|0|||
147512913|NCT02565576|532032498|FG000|Overall Study|Death|0|||
147512914|NCT02565576|532032499|FG001|Overall Study|Death|2|||
147512915|NCT02565576|532032498|FG000|Overall Study|Adverse Event|1|||
147512916|NCT02565576|532032499|FG001|Overall Study|Adverse Event|0|||
147512917|NCT00939341|532032500|FG000|Overall Study|Adverse Event|15|||
147512918|NCT00939341|532032500|FG000|Overall Study|Pregnancy|1|||
147512919|NCT00939341|532032500|FG000|Overall Study|Lost to Follow-up|23|||
147512920|NCT00939341|532032500|FG000|Overall Study|Withdrawal by Subject|13|||
147512921|NCT00939341|532032500|FG000|Overall Study|Protocol Violation|6|||
147512922|NCT00939341|532032500|FG000|Overall Study|Incorrect enrolment|8|||
147512923|NCT01131130|532032501|FG000|Period 1 - Baseline|Pregnancy|1|||
147512924|NCT01131130|532032501|FG000|Period 3- Crossover|+ Slit lamp finding|1|||
147512925|NCT02437162|532032506|FG000|Overall Study|Protocol Violation|0|||
147512926|NCT02437162|532032507|FG001|Overall Study|Protocol Violation|1|||
147512927|NCT02437162|532032508|FG002|Overall Study|Protocol Violation|0|||
147512928|NCT02437162|532032506|FG000|Overall Study|Randomized but not treated|0|||
147512929|NCT02437162|532032507|FG001|Overall Study|Randomized but not treated|0|||
147512930|NCT02437162|532032508|FG002|Overall Study|Randomized but not treated|1|||
147512931|NCT02437162|532032506|FG000|Overall Study|Study discontinued by Sponsor|93|||
147512932|NCT02437162|532032507|FG001|Overall Study|Study discontinued by Sponsor|98|||
147512933|NCT02437162|532032508|FG002|Overall Study|Study discontinued by Sponsor|97|||
147512934|NCT02437162|532032506|FG000|Overall Study|Withdrawal by Subject|13|||
147512935|NCT02437162|532032507|FG001|Overall Study|Withdrawal by Subject|7|||
147512936|NCT02437162|532032508|FG002|Overall Study|Withdrawal by Subject|9|||
147512937|NCT02437162|532032506|FG000|Overall Study|Adverse Event|0|||
147512938|NCT02437162|532032507|FG001|Overall Study|Adverse Event|1|||
147512939|NCT02437162|532032508|FG002|Overall Study|Adverse Event|0|||
147512940|NCT02437162|532032506|FG000|Overall Study|Lost to Follow-up|1|||
147512941|NCT02437162|532032507|FG001|Overall Study|Lost to Follow-up|0|||
147512942|NCT02437162|532032508|FG002|Overall Study|Lost to Follow-up|1|||
147512943|NCT02437162|532032506|FG000|Overall Study|Death|0|||
147512944|NCT02437162|532032507|FG001|Overall Study|Death|1|||
147512945|NCT02437162|532032508|FG002|Overall Study|Death|0|||
147512946|NCT02437162|532032506|FG000|Overall Study|Other|0|||
147512947|NCT02437162|532032507|FG001|Overall Study|Other|0|||
147512948|NCT02437162|532032508|FG002|Overall Study|Other|1|||
147512949|NCT03981744|532032509|FG000|First Intervention (Prior to Week 24)|Withdrawal by Subject|0|||
147512950|NCT03981744|532032510|FG001|First Intervention (Prior to Week 24)|Withdrawal by Subject|2|||
147512951|NCT03981744|532032511|FG002|First Intervention (Prior to Week 24)|Withdrawal by Subject|0|||
147512952|NCT03981744|532032512|FG003|First Intervention (Prior to Week 24)|Withdrawal by Subject|0|||
147512953|NCT03981744|532032509|FG000|Second Intervention (Week 24 to Week 72)|Adverse Event|0|||
147512954|NCT03981744|532032510|FG001|Second Intervention (Week 24 to Week 72)|Adverse Event|0|||
147512955|NCT03981744|532032511|FG002|Second Intervention (Week 24 to Week 72)|Adverse Event|1|||
147512956|NCT03981744|532032512|FG003|Second Intervention (Week 24 to Week 72)|Adverse Event|0|||
147512957|NCT03981744|532032509|FG000|Second Intervention (Week 24 to Week 72)|Withdrawal by Subject|0|||
147512958|NCT03981744|532032510|FG001|Second Intervention (Week 24 to Week 72)|Withdrawal by Subject|0|||
147512959|NCT03981744|532032511|FG002|Second Intervention (Week 24 to Week 72)|Withdrawal by Subject|1|||
147512960|NCT03981744|532032512|FG003|Second Intervention (Week 24 to Week 72)|Withdrawal by Subject|0|||
147512961|NCT02782104|532032513|FG000|Overall Study|Other|215|||
147512962|NCT02782104|532032513|FG000|Overall Study|Induction Day 28 Non Responder|9|||
147512963|NCT02782104|532032513|FG000|Overall Study|Non-Compliance with Study Drug|2|||
147512964|NCT02782104|532032513|FG000|Overall Study|Death|8|||
147512965|NCT02782104|532032513|FG000|Overall Study|Pregnancy|6|||
147673018|NCT04880850|532624489|FG000|Overall Study|Death|2|||
147673019|NCT04880850|532624490|FG001|Overall Study|Death|1|||
147673020|NCT04880850|532624489|FG000|Overall Study|Lost to Follow-up|3|||
147673021|NCT04880850|532624490|FG001|Overall Study|Lost to Follow-up|6|||
147512966|NCT02782104|532032513|FG000|Overall Study|Withdrawal by Subject|63|||
147512967|NCT02782104|532032513|FG000|Overall Study|Protocol Violation|7|||
147512968|NCT02782104|532032513|FG000|Overall Study|Lack of Efficacy|61|||
147512969|NCT02782104|532032513|FG000|Overall Study|Lost to Follow-up|23|||
147512970|NCT02782104|532032513|FG000|Overall Study|Adverse Event|74|||
147512971|NCT03464136|532032514|FG000|Overall Study|Lost to Follow-up|5|||
147512972|NCT03464136|532032515|FG001|Overall Study|Lost to Follow-up|8|||
147512973|NCT03464136|532032514|FG000|Overall Study|Withdrawal by Subject|16|||
147673022|NCT04880850|532624489|FG000|Overall Study|Physician Decision|2|||
147673023|NCT04880850|532624490|FG001|Overall Study|Physician Decision|1|||
147673024|NCT04880850|532624489|FG000|Overall Study|Withdrawal by Subject|9|||
147512974|NCT03464136|532032515|FG001|Overall Study|Withdrawal by Subject|13|||
147512975|NCT03464136|532032514|FG000|Overall Study|Death|1|||
147512976|NCT03464136|532032515|FG001|Overall Study|Death|0|||
147512977|NCT03464136|532032514|FG000|Overall Study|Other|8|||
147512978|NCT03464136|532032515|FG001|Overall Study|Other|4|||
147512979|NCT04338321|532032516|FG000|Overall Study|Adverse Event|4|||
147512980|NCT04338321|532032517|FG001|Overall Study|Adverse Event|10|||
147512981|NCT04338321|532032516|FG000|Overall Study|Death|1|||
147512982|NCT04338321|532032517|FG001|Overall Study|Death|1|||
147512983|NCT04338321|532032516|FG000|Overall Study|Lost to Follow-up|4|||
147512984|NCT04338321|532032517|FG001|Overall Study|Lost to Follow-up|9|||
147512985|NCT04338321|532032516|FG000|Overall Study|Withdrawal by Subject|45|||
147512986|NCT04338321|532032517|FG001|Overall Study|Withdrawal by Subject|69|||
147512987|NCT04338321|532032516|FG000|Overall Study|Physician Decision|5|||
147512988|NCT04338321|532032517|FG001|Overall Study|Physician Decision|9|||
147512989|NCT04338321|532032516|FG000|Overall Study|Other|3|||
147512990|NCT04338321|532032517|FG001|Overall Study|Other|10|||
147512991|NCT02438787|532032518|FG000|Overall Study|Adverse Event|1|||
147512992|NCT02438787|532032519|FG001|Overall Study|Adverse Event|0|||
147512993|NCT02438787|532032520|FG002|Overall Study|Adverse Event|2|||
147512994|NCT02438787|532032518|FG000|Overall Study|Lack of Efficacy|1|||
147512995|NCT02438787|532032519|FG001|Overall Study|Lack of Efficacy|2|||
147512996|NCT02438787|532032520|FG002|Overall Study|Lack of Efficacy|0|||
147512997|NCT02438787|532032518|FG000|Overall Study|Lost to Follow-up|0|||
147512998|NCT02438787|532032519|FG001|Overall Study|Lost to Follow-up|1|||
147512999|NCT02438787|532032520|FG002|Overall Study|Lost to Follow-up|0|||
147513000|NCT02438787|532032518|FG000|Overall Study|Protocol Violation|0|||
147513001|NCT02438787|532032519|FG001|Overall Study|Protocol Violation|0|||
147513002|NCT02438787|532032520|FG002|Overall Study|Protocol Violation|1|||
147513003|NCT02438787|532032518|FG000|Overall Study|Withdrawal by Subject|15|||
147513004|NCT02438787|532032519|FG001|Overall Study|Withdrawal by Subject|7|||
147513005|NCT02438787|532032520|FG002|Overall Study|Withdrawal by Subject|10|||
147513006|NCT02438787|532032518|FG000|Overall Study|Study discontinued by sponsor|64|||
147513007|NCT02438787|532032519|FG001|Overall Study|Study discontinued by sponsor|72|||
147513008|NCT02438787|532032520|FG002|Overall Study|Study discontinued by sponsor|69|||
147513009|NCT02438787|532032518|FG000|Overall Study|Other|0|||
147513010|NCT02438787|532032519|FG001|Overall Study|Other|1|||
147513011|NCT02438787|532032520|FG002|Overall Study|Other|0|||
147513012|NCT02438787|532032518|FG000|Overall Study|Site terminated by sponsor|0|||
147513013|NCT02438787|532032519|FG001|Overall Study|Site terminated by sponsor|0|||
147513014|NCT02438787|532032520|FG002|Overall Study|Site terminated by sponsor|1|||
147513015|NCT03412565|532032521|FG000|Overall Study|Lost to Follow-up|0|||
147513016|NCT03412565|532032522|FG001|Overall Study|Lost to Follow-up|0|||
147513017|NCT03412565|532032523|FG002|Overall Study|Lost to Follow-up|1|||
147513018|NCT03412565|532032524|FG003|Overall Study|Lost to Follow-up|0|||
147513019|NCT03412565|532032521|FG000|Overall Study|Physician Decision|0|||
147513020|NCT03412565|532032522|FG001|Overall Study|Physician Decision|0|||
147513021|NCT03412565|532032523|FG002|Overall Study|Physician Decision|0|||
147513022|NCT03412565|532032524|FG003|Overall Study|Physician Decision|1|||
147513023|NCT03412565|532032521|FG000|Overall Study|Withdrawal by Subject|0|||
147513024|NCT03412565|532032522|FG001|Overall Study|Withdrawal by Subject|4|||
147673025|NCT04880850|532624490|FG001|Overall Study|Withdrawal by Subject|10|||
147673026|NCT02485860|532624496|FG000|Overall Study|Lost to Follow-up|4|||
147673027|NCT02485860|532624497|FG001|Overall Study|Lost to Follow-up|1|||
147673028|NCT02485860|532624496|FG000|Overall Study|Physician Decision|1|||
147673029|NCT02485860|532624497|FG001|Overall Study|Physician Decision|2|||
147673030|NCT02485860|532624496|FG000|Overall Study|Health context (COVID-19)|1|||
147673031|NCT02485860|532624497|FG001|Overall Study|Health context (COVID-19)|0|||
147673032|NCT04091451|532624500|FG000|Overall Study|Adverse Event|15|||
147673033|NCT04091451|532624501|FG001|Overall Study|Adverse Event|10|||
147673034|NCT04091451|532624500|FG000|Overall Study|Lost to Follow-up|8|||
147673035|NCT04091451|532624501|FG001|Overall Study|Lost to Follow-up|8|||
147673036|NCT04091451|532624500|FG000|Overall Study|Protocol Violation|5|||
147673037|NCT04091451|532624501|FG001|Overall Study|Protocol Violation|4|||
147673038|NCT04091451|532624500|FG000|Overall Study|Withdrawal by Subject|21|||
147513025|NCT03412565|532032523|FG002|Overall Study|Withdrawal by Subject|5|||
147513026|NCT03412565|532032524|FG003|Overall Study|Withdrawal by Subject|5|||
147513027|NCT03412565|532032521|FG000|Overall Study|Death|1|||
147513028|NCT03412565|532032522|FG001|Overall Study|Death|3|||
147513029|NCT03412565|532032523|FG002|Overall Study|Death|4|||
147513030|NCT03412565|532032524|FG003|Overall Study|Death|5|||
147513031|NCT03412565|532032521|FG000|Overall Study|Data collection ended|0|||
147513032|NCT03412565|532032522|FG001|Overall Study|Data collection ended|41|||
147513033|NCT03412565|532032523|FG002|Overall Study|Data collection ended|41|||
147513034|NCT03412565|532032524|FG003|Overall Study|Data collection ended|40|||
147513035|NCT03375203|532032525|FG000|Overall Study|Protocol Violation|0|||
147513036|NCT03375203|532032526|FG001|Overall Study|Protocol Violation|0|||
147513037|NCT03375203|532032527|FG002|Overall Study|Protocol Violation|1|||
147673039|NCT04091451|532624501|FG001|Overall Study|Withdrawal by Subject|27|||
147513038|NCT03375203|532032528|FG003|Overall Study|Protocol Violation|0|||
147513039|NCT03375203|532032529|FG004|Overall Study|Protocol Violation|0|||
147513040|NCT03375203|532032525|FG000|Overall Study|Adverse Event|2|||
147513041|NCT03375203|532032526|FG001|Overall Study|Adverse Event|3|||
147513042|NCT03375203|532032527|FG002|Overall Study|Adverse Event|0|||
147513043|NCT03375203|532032528|FG003|Overall Study|Adverse Event|2|||
147513044|NCT03375203|532032529|FG004|Overall Study|Adverse Event|2|||
147513045|NCT03375203|532032525|FG000|Overall Study|Withdrawal by Subject|3|||
147513046|NCT03375203|532032526|FG001|Overall Study|Withdrawal by Subject|0|||
147513047|NCT03375203|532032527|FG002|Overall Study|Withdrawal by Subject|1|||
147513048|NCT03375203|532032528|FG003|Overall Study|Withdrawal by Subject|0|||
147513049|NCT03375203|532032529|FG004|Overall Study|Withdrawal by Subject|2|||
147513050|NCT03375203|532032525|FG000|Overall Study|Non-compliance with study drug|1|||
147513051|NCT03375203|532032526|FG001|Overall Study|Non-compliance with study drug|0|||
147513052|NCT03375203|532032527|FG002|Overall Study|Non-compliance with study drug|0|||
147513053|NCT03375203|532032528|FG003|Overall Study|Non-compliance with study drug|0|||
147513054|NCT03375203|532032529|FG004|Overall Study|Non-compliance with study drug|0|||
147513055|NCT03375203|532032525|FG000|Overall Study|Randomized, not treated.|0|||
147513056|NCT03375203|532032526|FG001|Overall Study|Randomized, not treated.|1|||
147513057|NCT03375203|532032527|FG002|Overall Study|Randomized, not treated.|0|||
147513058|NCT03375203|532032528|FG003|Overall Study|Randomized, not treated.|0|||
147513059|NCT03375203|532032529|FG004|Overall Study|Randomized, not treated.|0|||
147513060|NCT03107793|532032530|FG000|Induction Period (16 Weeks)|Adverse Event|5|||
147513061|NCT03107793|532032531|FG001|Induction Period (16 Weeks)|Adverse Event|0|||
147513062|NCT03107793|532032532|FG002|Induction Period (16 Weeks)|Adverse Event|0|||
147513063|NCT03107793|532032533|FG003|Induction Period (16 Weeks)|Adverse Event|0|||
147513064|NCT03107793|532032534|FG004|Induction Period (16 Weeks)|Adverse Event|0|||
147513065|NCT03107793|532032530|FG000|Induction Period (16 Weeks)|Physician Decision|1|||
147513066|NCT03107793|532032531|FG001|Induction Period (16 Weeks)|Physician Decision|0|||
147513067|NCT03107793|532032532|FG002|Induction Period (16 Weeks)|Physician Decision|0|||
147513068|NCT03107793|532032533|FG003|Induction Period (16 Weeks)|Physician Decision|0|||
147513069|NCT03107793|532032534|FG004|Induction Period (16 Weeks)|Physician Decision|0|||
147513070|NCT03107793|532032530|FG000|Induction Period (16 Weeks)|Progressive disease|1|||
147513071|NCT03107793|532032531|FG001|Induction Period (16 Weeks)|Progressive disease|0|||
147513072|NCT03107793|532032532|FG002|Induction Period (16 Weeks)|Progressive disease|0|||
147513073|NCT03107793|532032533|FG003|Induction Period (16 Weeks)|Progressive disease|0|||
147513074|NCT03107793|532032534|FG004|Induction Period (16 Weeks)|Progressive disease|0|||
147513075|NCT03107793|532032530|FG000|Induction Period (16 Weeks)|Withdrawal by Subject|3|||
147513076|NCT03107793|532032531|FG001|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
147513077|NCT03107793|532032532|FG002|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
147513078|NCT03107793|532032533|FG003|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
147513079|NCT03107793|532032534|FG004|Induction Period (16 Weeks)|Withdrawal by Subject|0|||
147513080|NCT03107793|532032530|FG000|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
147513081|NCT03107793|532032531|FG001|Maintenance Period (Week 16-Week 48)|Adverse Event|6|||
147513082|NCT03107793|532032532|FG002|Maintenance Period (Week 16-Week 48)|Adverse Event|10|||
147513083|NCT03107793|532032533|FG003|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
147513084|NCT03107793|532032534|FG004|Maintenance Period (Week 16-Week 48)|Adverse Event|0|||
147513085|NCT03107793|532032530|FG000|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
147513086|NCT03107793|532032531|FG001|Maintenance Period (Week 16-Week 48)|Physician Decision|1|||
147513087|NCT03107793|532032532|FG002|Maintenance Period (Week 16-Week 48)|Physician Decision|2|||
147513088|NCT03107793|532032533|FG003|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
147513089|NCT03107793|532032534|FG004|Maintenance Period (Week 16-Week 48)|Physician Decision|0|||
147513090|NCT03107793|532032530|FG000|Maintenance Period (Week 16-Week 48)|Progressive disease|0|||
147513091|NCT03107793|532032531|FG001|Maintenance Period (Week 16-Week 48)|Progressive disease|0|||
147513092|NCT03107793|532032532|FG002|Maintenance Period (Week 16-Week 48)|Progressive disease|1|||
147513093|NCT03107793|532032533|FG003|Maintenance Period (Week 16-Week 48)|Progressive disease|0|||
147513094|NCT03107793|532032534|FG004|Maintenance Period (Week 16-Week 48)|Progressive disease|0|||
147513095|NCT03107793|532032530|FG000|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
147513096|NCT03107793|532032531|FG001|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|21|||
147673040|NCT04091451|532624500|FG000|Overall Study|Non-emergency unblinding/Non-compliance|15|||
147673041|NCT04091451|532624501|FG001|Overall Study|Non-emergency unblinding/Non-compliance|18|||
147673042|NCT04091451|532624500|FG000|Overall Study|Migrated/moved from the study area|3|||
147673043|NCT04091451|532624501|FG001|Overall Study|Migrated/moved from the study area|5|||
147673044|NCT04091451|532624500|FG000|Overall Study|Suspected HZ episode|1|||
147513097|NCT03107793|532032532|FG002|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|8|||
147513098|NCT03107793|532032533|FG003|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
147513099|NCT03107793|532032534|FG004|Maintenance Period (Week 16-Week 48)|Lack of Efficacy|0|||
147673045|NCT04091451|532624501|FG001|Overall Study|Suspected HZ episode|0|||
147673046|NCT03907488|532624504|FG000|Overall Study|Adverse Event|20|||
147673047|NCT03907488|532624505|FG001|Overall Study|Adverse Event|20|||
147513100|NCT03107793|532032530|FG000|Maintenance Period (Week 16-Week 48)|Death|0|||
147513101|NCT03107793|532032531|FG001|Maintenance Period (Week 16-Week 48)|Death|2|||
147513102|NCT03107793|532032532|FG002|Maintenance Period (Week 16-Week 48)|Death|0|||
147513103|NCT03107793|532032533|FG003|Maintenance Period (Week 16-Week 48)|Death|0|||
147513104|NCT03107793|532032534|FG004|Maintenance Period (Week 16-Week 48)|Death|0|||
147513105|NCT03107793|532032530|FG000|Maintenance Period (Week 16-Week 48)|Disease relapse|0|||
147513106|NCT03107793|532032531|FG001|Maintenance Period (Week 16-Week 48)|Disease relapse|2|||
147513107|NCT03107793|532032532|FG002|Maintenance Period (Week 16-Week 48)|Disease relapse|1|||
147513108|NCT03107793|532032533|FG003|Maintenance Period (Week 16-Week 48)|Disease relapse|0|||
147513109|NCT03107793|532032534|FG004|Maintenance Period (Week 16-Week 48)|Disease relapse|0|||
147513110|NCT03107793|532032530|FG000|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
147513111|NCT03107793|532032531|FG001|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|1|||
147513112|NCT03107793|532032532|FG002|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
147513113|NCT03107793|532032533|FG003|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
147513114|NCT03107793|532032534|FG004|Maintenance Period (Week 16-Week 48)|Lost to Follow-up|0|||
147513115|NCT03107793|532032530|FG000|Maintenance Period (Week 16-Week 48)|Pregnancy|0|||
147513116|NCT03107793|532032531|FG001|Maintenance Period (Week 16-Week 48)|Pregnancy|1|||
147513117|NCT03107793|532032532|FG002|Maintenance Period (Week 16-Week 48)|Pregnancy|1|||
147513118|NCT03107793|532032533|FG003|Maintenance Period (Week 16-Week 48)|Pregnancy|0|||
147513119|NCT03107793|532032534|FG004|Maintenance Period (Week 16-Week 48)|Pregnancy|0|||
147513120|NCT03107793|532032530|FG000|Maintenance Period (Week 16-Week 48)|Received a disallowed concomitant treatment|0|||
147513121|NCT03107793|532032531|FG001|Maintenance Period (Week 16-Week 48)|Received a disallowed concomitant treatment|0|||
147513122|NCT03107793|532032532|FG002|Maintenance Period (Week 16-Week 48)|Received a disallowed concomitant treatment|1|||
147513123|NCT03107793|532032533|FG003|Maintenance Period (Week 16-Week 48)|Received a disallowed concomitant treatment|0|||
147513124|NCT03107793|532032534|FG004|Maintenance Period (Week 16-Week 48)|Received a disallowed concomitant treatment|0|||
147513125|NCT03107793|532032530|FG000|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|0|||
147513126|NCT03107793|532032531|FG001|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|12|||
147513127|NCT03107793|532032532|FG002|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|4|||
147513128|NCT03107793|532032533|FG003|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|0|||
147513129|NCT03107793|532032534|FG004|Maintenance Period (Week 16-Week 48)|Withdrawal by Subject|0|||
147513130|NCT03107793|532032530|FG000|Extension Period (Week 48- Week 104)|Adverse Event|0|||
147513131|NCT03107793|532032531|FG001|Extension Period (Week 48- Week 104)|Adverse Event|0|||
147513132|NCT03107793|532032532|FG002|Extension Period (Week 48- Week 104)|Adverse Event|0|||
147513133|NCT03107793|532032533|FG003|Extension Period (Week 48- Week 104)|Adverse Event|10|||
147513134|NCT03107793|532032534|FG004|Extension Period (Week 48- Week 104)|Adverse Event|3|||
147513135|NCT03107793|532032530|FG000|Extension Period (Week 48- Week 104)|Physician Decision|0|||
147513136|NCT03107793|532032531|FG001|Extension Period (Week 48- Week 104)|Physician Decision|0|||
147513137|NCT03107793|532032532|FG002|Extension Period (Week 48- Week 104)|Physician Decision|0|||
147513138|NCT03107793|532032533|FG003|Extension Period (Week 48- Week 104)|Physician Decision|0|||
147513139|NCT03107793|532032534|FG004|Extension Period (Week 48- Week 104)|Physician Decision|2|||
147513140|NCT03107793|532032530|FG000|Extension Period (Week 48- Week 104)|Lack of Efficacy|0|||
147513141|NCT03107793|532032531|FG001|Extension Period (Week 48- Week 104)|Lack of Efficacy|0|||
147513142|NCT03107793|532032532|FG002|Extension Period (Week 48- Week 104)|Lack of Efficacy|0|||
147513143|NCT03107793|532032533|FG003|Extension Period (Week 48- Week 104)|Lack of Efficacy|8|||
147513144|NCT03107793|532032534|FG004|Extension Period (Week 48- Week 104)|Lack of Efficacy|9|||
147513145|NCT03107793|532032530|FG000|Extension Period (Week 48- Week 104)|Death|0|||
147513146|NCT03107793|532032531|FG001|Extension Period (Week 48- Week 104)|Death|0|||
147513147|NCT03107793|532032532|FG002|Extension Period (Week 48- Week 104)|Death|0|||
147513148|NCT03107793|532032533|FG003|Extension Period (Week 48- Week 104)|Death|0|||
147513149|NCT03107793|532032534|FG004|Extension Period (Week 48- Week 104)|Death|1|||
147513150|NCT03107793|532032530|FG000|Extension Period (Week 48- Week 104)|Disease relapse|0|||
147513151|NCT03107793|532032531|FG001|Extension Period (Week 48- Week 104)|Disease relapse|0|||
147513152|NCT03107793|532032532|FG002|Extension Period (Week 48- Week 104)|Disease relapse|0|||
147513153|NCT03107793|532032533|FG003|Extension Period (Week 48- Week 104)|Disease relapse|0|||
147513154|NCT03107793|532032534|FG004|Extension Period (Week 48- Week 104)|Disease relapse|3|||
147513155|NCT03107793|532032530|FG000|Extension Period (Week 48- Week 104)|Lost to Follow-up|0|||
147513156|NCT03107793|532032531|FG001|Extension Period (Week 48- Week 104)|Lost to Follow-up|0|||
147513157|NCT03107793|532032532|FG002|Extension Period (Week 48- Week 104)|Lost to Follow-up|0|||
147513158|NCT03107793|532032533|FG003|Extension Period (Week 48- Week 104)|Lost to Follow-up|1|||
147513159|NCT03107793|532032534|FG004|Extension Period (Week 48- Week 104)|Lost to Follow-up|2|||
147513160|NCT03107793|532032530|FG000|Extension Period (Week 48- Week 104)|Pregnancy|0|||
147673048|NCT03907488|532624504|FG000|Overall Study|Withdrawal by Subject|9|||
147673049|NCT03907488|532624505|FG001|Overall Study|Withdrawal by Subject|13|||
147513161|NCT03107793|532032531|FG001|Extension Period (Week 48- Week 104)|Pregnancy|0|||
147673050|NCT03907488|532624504|FG000|Overall Study|Lack of Efficacy|0|||
147673051|NCT03907488|532624505|FG001|Overall Study|Lack of Efficacy|9|||
147673052|NCT03907488|532624504|FG000|Overall Study|Death|3|||
147513162|NCT03107793|532032532|FG002|Extension Period (Week 48- Week 104)|Pregnancy|0|||
147513163|NCT03107793|532032533|FG003|Extension Period (Week 48- Week 104)|Pregnancy|2|||
147513164|NCT03107793|532032534|FG004|Extension Period (Week 48- Week 104)|Pregnancy|4|||
147513165|NCT03107793|532032530|FG000|Extension Period (Week 48- Week 104)|Did not re-consent to protocol amendment 3|0|||
147513166|NCT03107793|532032531|FG001|Extension Period (Week 48- Week 104)|Did not re-consent to protocol amendment 3|0|||
147513167|NCT03107793|532032532|FG002|Extension Period (Week 48- Week 104)|Did not re-consent to protocol amendment 3|0|||
147513168|NCT03107793|532032533|FG003|Extension Period (Week 48- Week 104)|Did not re-consent to protocol amendment 3|0|||
147513169|NCT03107793|532032534|FG004|Extension Period (Week 48- Week 104)|Did not re-consent to protocol amendment 3|1|||
147513170|NCT03107793|532032530|FG000|Extension Period (Week 48- Week 104)|Non-compliance with study drug|0|||
147513171|NCT03107793|532032531|FG001|Extension Period (Week 48- Week 104)|Non-compliance with study drug|0|||
147513172|NCT03107793|532032532|FG002|Extension Period (Week 48- Week 104)|Non-compliance with study drug|0|||
147513173|NCT03107793|532032533|FG003|Extension Period (Week 48- Week 104)|Non-compliance with study drug|1|||
147513174|NCT03107793|532032534|FG004|Extension Period (Week 48- Week 104)|Non-compliance with study drug|0|||
147513175|NCT03107793|532032530|FG000|Extension Period (Week 48- Week 104)|Other|0|||
147513176|NCT03107793|532032531|FG001|Extension Period (Week 48- Week 104)|Other|0|||
147513177|NCT03107793|532032532|FG002|Extension Period (Week 48- Week 104)|Other|0|||
147513178|NCT03107793|532032533|FG003|Extension Period (Week 48- Week 104)|Other|1|||
147513179|NCT03107793|532032534|FG004|Extension Period (Week 48- Week 104)|Other|3|||
147513180|NCT03107793|532032530|FG000|Extension Period (Week 48- Week 104)|Withdrawal by Subject|0|||
147513181|NCT03107793|532032531|FG001|Extension Period (Week 48- Week 104)|Withdrawal by Subject|0|||
147513182|NCT03107793|532032532|FG002|Extension Period (Week 48- Week 104)|Withdrawal by Subject|0|||
147513183|NCT03107793|532032533|FG003|Extension Period (Week 48- Week 104)|Withdrawal by Subject|5|||
147513184|NCT03107793|532032534|FG004|Extension Period (Week 48- Week 104)|Withdrawal by Subject|9|||
147513185|NCT00246376|532032544|FG000|Overall Study|Dropped/withdrew during dietary run-in|11|||
147513186|NCT00246376|532032545|FG001|Overall Study|Dropped/withdrew during dietary run-in|5|||
147513187|NCT00246376|532032546|FG002|Overall Study|Dropped/withdrew during dietary run-in|4|||
147513188|NCT00246376|532032547|FG003|Overall Study|Dropped/withdrew during dietary run-in|7|||
147513189|NCT00246376|532032548|FG004|Overall Study|Dropped/withdrew during dietary run-in|3|||
147513190|NCT00246376|532032544|FG000|Overall Study|Adverse Event|2|||
147513191|NCT00246376|532032545|FG001|Overall Study|Adverse Event|3|||
147513192|NCT00246376|532032546|FG002|Overall Study|Adverse Event|1|||
147513193|NCT00246376|532032547|FG003|Overall Study|Adverse Event|3|||
147513194|NCT00246376|532032548|FG004|Overall Study|Adverse Event|1|||
147513195|NCT00246376|532032544|FG000|Overall Study|Lost to Follow-up|2|||
147513196|NCT00246376|532032545|FG001|Overall Study|Lost to Follow-up|11|||
147513197|NCT00246376|532032546|FG002|Overall Study|Lost to Follow-up|11|||
147513198|NCT00246376|532032547|FG003|Overall Study|Lost to Follow-up|16|||
147513199|NCT00246376|532032548|FG004|Overall Study|Lost to Follow-up|13|||
147513200|NCT01872897|532032549|FG000|Overall Study|Withdrawal by Subject|1|||
147513201|NCT01872897|532032550|FG001|Overall Study|Withdrawal by Subject|0|||
147513202|NCT02418585|532032551|FG000|Double Blind (DB) Phase (4 Weeks)|Lost to Follow-up|1|||
147513203|NCT02418585|532032552|FG001|Double Blind (DB) Phase (4 Weeks)|Lost to Follow-up|1|||
147513204|NCT02418585|532032551|FG000|Double Blind (DB) Phase (4 Weeks)|Protocol Violation|2|||
147513205|NCT02418585|532032552|FG001|Double Blind (DB) Phase (4 Weeks)|Protocol Violation|2|||
147513206|NCT02418585|532032551|FG000|Double Blind (DB) Phase (4 Weeks)|Withdrawal by Subject|4|||
147513207|NCT02418585|532032552|FG001|Double Blind (DB) Phase (4 Weeks)|Withdrawal by Subject|7|||
147513208|NCT02418585|532032551|FG000|Double Blind (DB) Phase (4 Weeks)|Lack of Efficacy|2|||
147513209|NCT02418585|532032552|FG001|Double Blind (DB) Phase (4 Weeks)|Lack of Efficacy|0|||
147513210|NCT02418585|532032551|FG000|Double Blind (DB) Phase (4 Weeks)|Adverse Event|9|||
147513211|NCT02418585|532032552|FG001|Double Blind (DB) Phase (4 Weeks)|Adverse Event|1|||
147513212|NCT02418585|532032551|FG000|Double Blind (DB) Phase (4 Weeks)|Other|0|||
147513213|NCT02418585|532032552|FG001|Double Blind (DB) Phase (4 Weeks)|Other|1|||
147513214|NCT02418585|532032551|FG000|Follow-up Phase (24 Weeks)|Lost to Follow-up|3|||
147513215|NCT02418585|532032552|FG001|Follow-up Phase (24 Weeks)|Lost to Follow-up|3|||
147513216|NCT02418585|532032551|FG000|Follow-up Phase (24 Weeks)|Withdrawal by Subject|6|||
147513217|NCT02418585|532032552|FG001|Follow-up Phase (24 Weeks)|Withdrawal by Subject|3|||
147513218|NCT02418585|532032551|FG000|Follow-up Phase (24 Weeks)|Investigator Decision|6|||
147513219|NCT02418585|532032552|FG001|Follow-up Phase (24 Weeks)|Investigator Decision|17|||
147513220|NCT02418585|532032551|FG000|Follow-up Phase (24 Weeks)|Other|3|||
147513221|NCT02418585|532032552|FG001|Follow-up Phase (24 Weeks)|Other|2|||
147513222|NCT02040857|532032553|FG000|Overall Study|Adverse Event|14|||
147513223|NCT02040857|532032553|FG000|Overall Study|Physician Decision|5|||
147513224|NCT02040857|532032553|FG000|Overall Study|Withdrawal by Subject|31|||
147513225|NCT02040857|532032553|FG000|Overall Study|patient non-compliance|3|||
147513226|NCT02040857|532032553|FG000|Overall Study|Lost to Follow-up|2|||
147513227|NCT02040857|532032553|FG000|Overall Study|recurrence|4|||
147513228|NCT02040857|532032553|FG000|Overall Study|ineligible|1|||
147513229|NCT04159701|532032554|FG000|Period 1: Treatment Period|Pregnancy|1|||
147513230|NCT04159701|532032555|FG001|Period 1: Treatment Period|Pregnancy|0|||
147513231|NCT04159701|532032554|FG000|Period 1: Treatment Period|Study Terminated by sponsor|4|||
147513232|NCT04159701|532032555|FG001|Period 1: Treatment Period|Study Terminated by sponsor|1|||
147513233|NCT04159701|532032554|FG000|Period 1: Treatment Period|Withdrawal by Subject|3|||
147513234|NCT04159701|532032555|FG001|Period 1: Treatment Period|Withdrawal by Subject|0|||
147513235|NCT04159701|532032554|FG000|Washout Period|site terminated by sponsor|0|||
147513236|NCT04159701|532032555|FG001|Washout Period|site terminated by sponsor|1|||
147513237|NCT04159701|532032554|FG000|Washout Period|study terminated by sponsor|10|||
147513238|NCT04159701|532032555|FG001|Washout Period|study terminated by sponsor|3|||
147513239|NCT04159701|532032554|FG000|Washout Period|Withdrawal by Subject|1|||
147513240|NCT04159701|532032555|FG001|Washout Period|Withdrawal by Subject|0|||
147513241|NCT04159701|532032554|FG000|Washout Period|Inadvertent Enrollment|1|||
147513242|NCT04159701|532032555|FG001|Washout Period|Inadvertent Enrollment|0|||
147513243|NCT04159701|532032554|FG000|Washout Period|Miscellaneous|1|||
147513244|NCT04159701|532032555|FG001|Washout Period|Miscellaneous|0|||
147513245|NCT04159701|532032554|FG000|Period 2: Treatment Period (Crossover)|Study Terminated by Sponsor|0|||
147513246|NCT04159701|532032555|FG001|Period 2: Treatment Period (Crossover)|Study Terminated by Sponsor|2|||
147513247|NCT04159701|532032554|FG000|Period 2: Treatment Period (Crossover)|Withdrawal by Subject|0|||
147513248|NCT04159701|532032555|FG001|Period 2: Treatment Period (Crossover)|Withdrawal by Subject|1|||
147513249|NCT04159701|532032554|FG000|Post-treatment Follow-up|Study Terminated by Sponsor|6|||
147513250|NCT04159701|532032555|FG001|Post-treatment Follow-up|Study Terminated by Sponsor|3|||
147513251|NCT04159701|532032554|FG000|Post-treatment Follow-up|Withdrawal by Subject|3|||
147513252|NCT04159701|532032555|FG001|Post-treatment Follow-up|Withdrawal by Subject|0|||
147513253|NCT04159701|532032554|FG000|Post-treatment Follow-up|Inadvertent Enrollment|1|||
147513254|NCT04159701|532032555|FG001|Post-treatment Follow-up|Inadvertent Enrollment|0|||
147513255|NCT01849562|532032561|FG000|Overall Study|Lost to Follow-up|1|||
147513256|NCT01849562|532032562|FG001|Overall Study|Lost to Follow-up|0|||
147513257|NCT01849562|532032563|FG002|Overall Study|Lost to Follow-up|0|||
147513258|NCT01849562|532032561|FG000|Overall Study|Non-compliance with Study Drug|1|||
147513259|NCT01849562|532032562|FG001|Overall Study|Non-compliance with Study Drug|0|||
147513260|NCT01849562|532032563|FG002|Overall Study|Non-compliance with Study Drug|0|||
147513261|NCT00329784|532032564|FG000|Overall Study|Lost to Follow-up|0|||
147513262|NCT00329784|532032565|FG001|Overall Study|Lost to Follow-up|1|||
147513263|NCT00329784|532032566|FG002|Overall Study|Lost to Follow-up|0|||
147513264|NCT00329784|532032567|FG003|Overall Study|Lost to Follow-up|0|||
147513265|NCT00329784|532032564|FG000|Overall Study|Withdrawal by Subject|4|||
147513266|NCT00329784|532032565|FG001|Overall Study|Withdrawal by Subject|2|||
147513267|NCT00329784|532032566|FG002|Overall Study|Withdrawal by Subject|0|||
147513268|NCT00329784|532032567|FG003|Overall Study|Withdrawal by Subject|0|||
147513269|NCT00329784|532032564|FG000|Overall Study|Other|1|||
147513270|NCT00329784|532032565|FG001|Overall Study|Other|2|||
147513271|NCT00329784|532032566|FG002|Overall Study|Other|0|||
147513272|NCT00329784|532032567|FG003|Overall Study|Other|0|||
147513273|NCT04599972|532032568|FG000|Overall Study|Withdrawal by Subject|6|||
147513274|NCT04599972|532032569|FG001|Overall Study|Withdrawal by Subject|1|||
147513275|NCT04599972|532032568|FG000|Overall Study|Adverse Event|1|||
147673053|NCT03907488|532624505|FG001|Overall Study|Death|8|||
147673054|NCT03907488|532624504|FG000|Overall Study|not protocol specified|5|||
147673055|NCT03907488|532624505|FG001|Overall Study|not protocol specified|8|||
147673056|NCT03907488|532624504|FG000|Overall Study|Ineligible|9|||
147673057|NCT03907488|532624505|FG001|Overall Study|Ineligible|15|||
147673058|NCT04704219|532624509|FG000|Overall Study|Screen Failure|1|||
147673059|NCT04704219|532624509|FG000|Overall Study|Withdrawal by Subject|1|||
147673060|NCT04704219|532624509|FG000|Overall Study|Death|78|||
147673061|NCT04704219|532624509|FG000|Overall Study|Participants Ongoing|80|||
147673062|NCT02839707|532624511|FG000|Phase I|Not eligible for analysis|9|||
147673063|NCT02839707|532624512|FG001|Phase I|Not eligible for analysis|0|||
147673064|NCT02839707|532624513|FG002|Phase I|Not eligible for analysis|0|||
147673065|NCT02839707|532624511|FG000|Phase II|Not treated according to protocol|4|||
147673066|NCT02839707|532624512|FG001|Phase II|Not treated according to protocol|0|||
147673067|NCT02839707|532624513|FG002|Phase II|Not treated according to protocol|2|||
147673068|NCT02839707|532624511|FG000|Phase III|Not treated according to protocol|0|||
147673069|NCT02839707|532624512|FG001|Phase III|Not treated according to protocol|0|||
147673070|NCT02839707|532624513|FG002|Phase III|Not treated according to protocol|4|||
147673071|NCT03570892|532624514|FG000|Overall Study|Death|51|||
147673072|NCT03570892|532624515|FG001|Overall Study|Death|45|||
147673073|NCT03570892|532624514|FG000|Overall Study|Subject decision|5|||
147673074|NCT03570892|532624515|FG001|Overall Study|Subject decision|3|||
147673075|NCT03570892|532624514|FG000|Overall Study|Protocol Violation|1|||
147673076|NCT03570892|532624515|FG001|Overall Study|Protocol Violation|4|||
147513276|NCT04599972|532032569|FG001|Overall Study|Adverse Event|1|||
147513277|NCT04599972|532032568|FG000|Overall Study|Lost to Follow-up|1|||
147513278|NCT04599972|532032569|FG001|Overall Study|Lost to Follow-up|6|||
147513279|NCT04599972|532032568|FG000|Overall Study|Protocol Violation|1|||
147513280|NCT04599972|532032569|FG001|Overall Study|Protocol Violation|0|||
147513281|NCT04599972|532032568|FG000|Overall Study|Other reason|1|||
147513282|NCT04599972|532032569|FG001|Overall Study|Other reason|0|||
147673077|NCT03570892|532624514|FG000|Overall Study|Physician Decision|0|||
147673078|NCT03570892|532624515|FG001|Overall Study|Physician Decision|2|||
147673079|NCT03586479|532624521|FG000|Overall Study|Treatment schedule disrupted during pandemic|4|||
147673080|NCT03586479|532624522|FG001|Overall Study|Treatment schedule disrupted during pandemic|2|||
147673081|NCT03586479|532624523|FG002|Overall Study|Treatment schedule disrupted during pandemic|2|||
147673082|NCT03586479|532624521|FG000|Overall Study|Protocol Violation|2|||
147673083|NCT03586479|532624522|FG001|Overall Study|Protocol Violation|0|||
147673084|NCT03586479|532624523|FG002|Overall Study|Protocol Violation|0|||
147673085|NCT03586479|532624521|FG000|Overall Study|Lost to Follow-up|1|||
147673086|NCT03586479|532624522|FG001|Overall Study|Lost to Follow-up|1|||
147673087|NCT03586479|532624523|FG002|Overall Study|Lost to Follow-up|2|||
147673088|NCT03586479|532624521|FG000|Overall Study|Behavioral Issues|1|||
147673089|NCT03586479|532624522|FG001|Overall Study|Behavioral Issues|0|||
147673090|NCT03586479|532624523|FG002|Overall Study|Behavioral Issues|0|||
147673091|NCT05938920|532624528|FG000|Overall Study|Adverse Event|1|||
147673092|NCT05938920|532624529|FG001|Overall Study|Adverse Event|3|||
147673093|NCT05938920|532624530|FG002|Overall Study|Adverse Event|2|||
147673094|NCT05938920|532624531|FG003|Overall Study|Adverse Event|1|||
147673095|NCT05938920|532624528|FG000|Overall Study|Death|0|||
147673096|NCT05938920|532624529|FG001|Overall Study|Death|1|||
147673097|NCT05938920|532624530|FG002|Overall Study|Death|0|||
147673098|NCT05938920|532624531|FG003|Overall Study|Death|0|||
147673099|NCT05938920|532624528|FG000|Overall Study|Lost to Follow-up|0|||
147673100|NCT05938920|532624529|FG001|Overall Study|Lost to Follow-up|0|||
147673101|NCT05938920|532624530|FG002|Overall Study|Lost to Follow-up|1|||
147513283|NCT00638690|532032570|FG000|Overall Study|Death|655|||
147513284|NCT00638690|532032571|FG001|Overall Study|Death|335|||
147513285|NCT00638690|532032570|FG000|Overall Study|Withdrawal by Subject|22|||
147513286|NCT00638690|532032571|FG001|Overall Study|Withdrawal by Subject|5|||
147513287|NCT00638690|532032570|FG000|Overall Study|Lost to Follow-up|4|||
147513288|NCT00638690|532032571|FG001|Overall Study|Lost to Follow-up|2|||
147513289|NCT02348840|532032572|FG000|Overall Study|Withdrawal by Subject|2|||
147513290|NCT02348840|532032573|FG001|Overall Study|Withdrawal by Subject|1|||
147513291|NCT02348840|532032574|FG002|Overall Study|Withdrawal by Subject|0|||
147513292|NCT02348840|532032575|FG003|Overall Study|Withdrawal by Subject|0|||
147513293|NCT00373880|532032576|FG000|Overall Study|Physician Decision|3|||
147513294|NCT00373880|532032576|FG000|Overall Study|Arrested|1|||
147513295|NCT00373880|532032576|FG000|Overall Study|Protocol Violation|14|||
147673102|NCT05938920|532624531|FG003|Overall Study|Lost to Follow-up|0|||
147673103|NCT05938920|532624528|FG000|Overall Study|Participant Asked to Withdraw from the Trial|1|||
147673104|NCT05938920|532624529|FG001|Overall Study|Participant Asked to Withdraw from the Trial|0|||
147673105|NCT05938920|532624530|FG002|Overall Study|Participant Asked to Withdraw from the Trial|0|||
147673106|NCT05938920|532624531|FG003|Overall Study|Participant Asked to Withdraw from the Trial|0|||
147673107|NCT05938920|532624528|FG000|Overall Study|Participant Withdrew from Treatment and Refused to do Visit 7 Follow Up Visit|0|||
147673108|NCT05938920|532624529|FG001|Overall Study|Participant Withdrew from Treatment and Refused to do Visit 7 Follow Up Visit|0|||
147673109|NCT05938920|532624530|FG002|Overall Study|Participant Withdrew from Treatment and Refused to do Visit 7 Follow Up Visit|1|||
147673110|NCT05938920|532624531|FG003|Overall Study|Participant Withdrew from Treatment and Refused to do Visit 7 Follow Up Visit|0|||
147673111|NCT05938920|532624528|FG000|Overall Study|Participant Refused to Come In|0|||
147673112|NCT05938920|532624529|FG001|Overall Study|Participant Refused to Come In|0|||
147673113|NCT05938920|532624530|FG002|Overall Study|Participant Refused to Come In|1|||
147673114|NCT05938920|532624531|FG003|Overall Study|Participant Refused to Come In|0|||
147673115|NCT02634710|532624532|FG000|Overall Study|Death|4|||
147673116|NCT00217737|532624770|FG000|Step 1 Registration (Risk Assessment)|Withdrawal by Subject|0|||
147673117|NCT00217737|532624771|FG001|Step 1 Registration (Risk Assessment)|Withdrawal by Subject|0|||
147673118|NCT00217737|532624772|FG002|Step 1 Registration (Risk Assessment)|Withdrawal by Subject|0|||
147673119|NCT00217737|532624773|FG003|Step 1 Registration (Risk Assessment)|Withdrawal by Subject|252|||
147513296|NCT01347073|532032579|FG000|Overall Study|Adverse Event|1|||
147513297|NCT01347073|532032579|FG000|Overall Study|Liver Transplant|1|||
147513298|NCT00621244|532032580|FG000|Overall Study|Withdrawal by Subject|7|||
147513299|NCT00621244|532032581|FG001|Overall Study|Withdrawal by Subject|3|||
147513300|NCT00621244|532032582|FG002|Overall Study|Withdrawal by Subject|3|||
147673120|NCT00217737|532624770|FG000|Step 1 Registration (Risk Assessment)|No tumor block assessments|0|||
147673121|NCT00217737|532624771|FG001|Step 1 Registration (Risk Assessment)|No tumor block assessments|0|||
147673122|NCT00217737|532624772|FG002|Step 1 Registration (Risk Assessment)|No tumor block assessments|0|||
147673123|NCT00217737|532624773|FG003|Step 1 Registration (Risk Assessment)|No tumor block assessments|83|||
147673124|NCT00217737|532624770|FG000|Step 1 Registration (Risk Assessment)|Ineligible|0|||
147513301|NCT00621244|532032583|FG003|Overall Study|Withdrawal by Subject|3|||
147513302|NCT00621244|532032580|FG000|Overall Study|Disease progression|44|||
147513303|NCT00621244|532032581|FG001|Overall Study|Disease progression|20|||
147513304|NCT00621244|532032582|FG002|Overall Study|Disease progression|20|||
147513305|NCT00621244|532032583|FG003|Overall Study|Disease progression|15|||
147513306|NCT00621244|532032580|FG000|Overall Study|Death|3|||
147513307|NCT00621244|532032581|FG001|Overall Study|Death|3|||
147673125|NCT00217737|532624771|FG001|Step 1 Registration (Risk Assessment)|Ineligible|0|||
147673126|NCT00217737|532624772|FG002|Step 1 Registration (Risk Assessment)|Ineligible|0|||
147673127|NCT00217737|532624773|FG003|Step 1 Registration (Risk Assessment)|Ineligible|68|||
147673128|NCT00217737|532624770|FG000|Step 1 Registration (Risk Assessment)|Uninformative tumor block|0|||
147673129|NCT00217737|532624771|FG001|Step 1 Registration (Risk Assessment)|Uninformative tumor block|0|||
147673130|NCT00217737|532624772|FG002|Step 1 Registration (Risk Assessment)|Uninformative tumor block|0|||
147673131|NCT00217737|532624773|FG003|Step 1 Registration (Risk Assessment)|Uninformative tumor block|18|||
147513308|NCT00621244|532032582|FG002|Overall Study|Death|1|||
147513309|NCT00621244|532032583|FG003|Overall Study|Death|1|||
147513310|NCT00621244|532032580|FG000|Overall Study|Adverse Event|27|||
147513311|NCT00621244|532032581|FG001|Overall Study|Adverse Event|7|||
147513312|NCT00621244|532032582|FG002|Overall Study|Adverse Event|9|||
147513313|NCT00621244|532032583|FG003|Overall Study|Adverse Event|2|||
147513314|NCT00621244|532032580|FG000|Overall Study|Administrative problems|5|||
147513315|NCT00621244|532032581|FG001|Overall Study|Administrative problems|1|||
147513316|NCT00621244|532032582|FG002|Overall Study|Administrative problems|0|||
147513317|NCT00621244|532032583|FG003|Overall Study|Administrative problems|2|||
147673132|NCT00217737|532624770|FG000|Step 1 Registration (Risk Assessment)|Physician Decision|0|||
147673133|NCT00217737|532624771|FG001|Step 1 Registration (Risk Assessment)|Physician Decision|0|||
147673134|NCT00217737|532624772|FG002|Step 1 Registration (Risk Assessment)|Physician Decision|0|||
147673135|NCT00217737|532624773|FG003|Step 1 Registration (Risk Assessment)|Physician Decision|16|||
147673136|NCT00217737|532624770|FG000|Step 1 Registration (Risk Assessment)|Study suspension/closure before treatment|0|||
147673137|NCT00217737|532624771|FG001|Step 1 Registration (Risk Assessment)|Study suspension/closure before treatment|0|||
147673138|NCT00217737|532624772|FG002|Step 1 Registration (Risk Assessment)|Study suspension/closure before treatment|0|||
147673139|NCT00217737|532624773|FG003|Step 1 Registration (Risk Assessment)|Study suspension/closure before treatment|16|||
147673140|NCT00217737|532624770|FG000|Step 1 Registration (Risk Assessment)|Staff/site error|0|||
147673141|NCT00217737|532624771|FG001|Step 1 Registration (Risk Assessment)|Staff/site error|0|||
147673142|NCT00217737|532624772|FG002|Step 1 Registration (Risk Assessment)|Staff/site error|0|||
147673143|NCT00217737|532624773|FG003|Step 1 Registration (Risk Assessment)|Staff/site error|9|||
147673144|NCT00217737|532624770|FG000|Step 1 Registration (Risk Assessment)|Unable to follow treatment schedule|0|||
147673145|NCT00217737|532624771|FG001|Step 1 Registration (Risk Assessment)|Unable to follow treatment schedule|0|||
147673146|NCT00217737|532624772|FG002|Step 1 Registration (Risk Assessment)|Unable to follow treatment schedule|0|||
147673147|NCT00217737|532624773|FG003|Step 1 Registration (Risk Assessment)|Unable to follow treatment schedule|9|||
147673148|NCT00217737|532624770|FG000|Step 1 Registration (Risk Assessment)|Adverse Event|0|||
147673149|NCT00217737|532624771|FG001|Step 1 Registration (Risk Assessment)|Adverse Event|0|||
147673150|NCT00217737|532624772|FG002|Step 1 Registration (Risk Assessment)|Adverse Event|0|||
147673151|NCT00217737|532624773|FG003|Step 1 Registration (Risk Assessment)|Adverse Event|6|||
147673152|NCT00217737|532624770|FG000|Step 1 Registration (Risk Assessment)|Insurance issues|0|||
147673153|NCT00217737|532624771|FG001|Step 1 Registration (Risk Assessment)|Insurance issues|0|||
147673154|NCT00217737|532624772|FG002|Step 1 Registration (Risk Assessment)|Insurance issues|0|||
147673155|NCT00217737|532624773|FG003|Step 1 Registration (Risk Assessment)|Insurance issues|4|||
147673156|NCT00217737|532624770|FG000|Step 1 Registration (Risk Assessment)|Non-compliance|0|||
147673157|NCT00217737|532624771|FG001|Step 1 Registration (Risk Assessment)|Non-compliance|0|||
147673158|NCT00217737|532624772|FG002|Step 1 Registration (Risk Assessment)|Non-compliance|0|||
147673159|NCT00217737|532624773|FG003|Step 1 Registration (Risk Assessment)|Non-compliance|2|||
147673160|NCT00217737|532624770|FG000|Step 1 Registration (Risk Assessment)|Death|0|||
147673161|NCT00217737|532624771|FG001|Step 1 Registration (Risk Assessment)|Death|0|||
147673162|NCT00217737|532624772|FG002|Step 1 Registration (Risk Assessment)|Death|0|||
147673163|NCT00217737|532624773|FG003|Step 1 Registration (Risk Assessment)|Death|1|||
147673164|NCT00217737|532624770|FG000|Step 1 Registration (Risk Assessment)|Disease progression|0|||
147673165|NCT00217737|532624771|FG001|Step 1 Registration (Risk Assessment)|Disease progression|0|||
147673166|NCT00217737|532624772|FG002|Step 1 Registration (Risk Assessment)|Disease progression|0|||
147673167|NCT00217737|532624773|FG003|Step 1 Registration (Risk Assessment)|Disease progression|1|||
147673168|NCT00217737|532624770|FG000|Step 1 Registration (Risk Assessment)|Inadequate supply of Leucovorin|0|||
147673169|NCT00217737|532624771|FG001|Step 1 Registration (Risk Assessment)|Inadequate supply of Leucovorin|0|||
147673170|NCT00217737|532624772|FG002|Step 1 Registration (Risk Assessment)|Inadequate supply of Leucovorin|0|||
147673171|NCT00217737|532624773|FG003|Step 1 Registration (Risk Assessment)|Inadequate supply of Leucovorin|1|||
147673172|NCT00217737|532624770|FG000|Step 1 Registration (Risk Assessment)|Lost to Follow-up|0|||
147673173|NCT00217737|532624771|FG001|Step 1 Registration (Risk Assessment)|Lost to Follow-up|0|||
147673174|NCT00217737|532624772|FG002|Step 1 Registration (Risk Assessment)|Lost to Follow-up|0|||
147673175|NCT00217737|532624773|FG003|Step 1 Registration (Risk Assessment)|Lost to Follow-up|1|||
147673176|NCT00217737|532624770|FG000|Step 1 Registration (Risk Assessment)|Other|0|||
147673177|NCT00217737|532624771|FG001|Step 1 Registration (Risk Assessment)|Other|0|||
147513318|NCT01466062|532032584|FG000|Overall Study|Adverse Event|1|||
147513319|NCT01466062|532032584|FG000|Overall Study|Withdrawal by Subject|1|||
147513320|NCT02865928|532032587|FG000|Overall Study|Withdrawal by Subject|1|||
147513321|NCT02865928|532032588|FG001|Overall Study|Withdrawal by Subject|0|||
147513322|NCT02865928|532032587|FG000|Overall Study|Subject is a screen failure. Miscommunication with the randomization request.|1|||
147513323|NCT02865928|532032588|FG001|Overall Study|Subject is a screen failure. Miscommunication with the randomization request.|0|||
147513324|NCT02865928|532032587|FG000|Overall Study|Patient experience and satisfaction category lost one patient in each group to follow-up call.|1|||
147513325|NCT02865928|532032588|FG001|Overall Study|Patient experience and satisfaction category lost one patient in each group to follow-up call.|1|||
147513326|NCT03152110|532032595|FG000|Overall Study|Withdrawal by Subject|3|||
147513327|NCT01925014|532032596|FG000|Overall Study|Inappropriate enrollment|4|||
147513328|NCT01925014|532032597|FG001|Overall Study|Inappropriate enrollment|6|||
147513329|NCT01925014|532032596|FG000|Overall Study|Withdrawal by Subject|5|||
147513330|NCT01925014|532032597|FG001|Overall Study|Withdrawal by Subject|13|||
147513331|NCT01690988|532032598|FG000|Overall Study|Withdrawal by Subject|2|||
147513332|NCT01690988|532032599|FG001|Overall Study|Withdrawal by Subject|2|||
147513333|NCT01690988|532032600|FG002|Overall Study|Withdrawal by Subject|3|||
147513334|NCT01690988|532032598|FG000|Overall Study|Physician Decision|0|||
147513335|NCT01690988|532032599|FG001|Overall Study|Physician Decision|0|||
147513336|NCT01690988|532032600|FG002|Overall Study|Physician Decision|1|||
147513337|NCT01690988|532032598|FG000|Overall Study|Operation Cancelled|1|||
147513338|NCT01690988|532032599|FG001|Overall Study|Operation Cancelled|1|||
147513339|NCT01690988|532032600|FG002|Overall Study|Operation Cancelled|0|||
147513340|NCT01690988|532032598|FG000|Overall Study|Determined ineligible|1|||
147513341|NCT01690988|532032599|FG001|Overall Study|Determined ineligible|0|||
147513342|NCT01690988|532032600|FG002|Overall Study|Determined ineligible|0|||
147513343|NCT01690988|532032598|FG000|Overall Study|Death|1|||
147513344|NCT01690988|532032599|FG001|Overall Study|Death|1|||
147513345|NCT01690988|532032600|FG002|Overall Study|Death|1|||
147513346|NCT01690988|532032598|FG000|Overall Study|Sedated|1|||
147513347|NCT01690988|532032599|FG001|Overall Study|Sedated|1|||
147513348|NCT01690988|532032600|FG002|Overall Study|Sedated|2|||
147513349|NCT01634100|532032603|FG000|Overall Study|Withdrawal by Subject|1|||
147513350|NCT01634100|532032604|FG001|Overall Study|Withdrawal by Subject|0|||
147513351|NCT01634100|532032605|FG002|Overall Study|Withdrawal by Subject|1|||
147513352|NCT01634100|532032606|FG003|Overall Study|Withdrawal by Subject|0|||
147513353|NCT01634100|532032607|FG004|Overall Study|Withdrawal by Subject|0|||
147513354|NCT01634100|532032608|FG005|Overall Study|Withdrawal by Subject|0|||
147513355|NCT00552344|532032609|FG000|Overall Study|Lack of Efficacy|55|||
147513356|NCT00552344|532032609|FG000|Overall Study|Loss of efficacy|75|||
147513357|NCT00552344|532032609|FG000|Overall Study|Lost to Follow-up|8|||
147513358|NCT00552344|532032609|FG000|Overall Study|Withdrawal by Subject|48|||
147513359|NCT00552344|532032609|FG000|Overall Study|SAE, non-fatal|6|||
147513360|NCT00552344|532032609|FG000|Overall Study|AE, non-serious non-fatal|38|||
147513361|NCT00552344|532032609|FG000|Overall Study|SAE,non-fatal+AE,non-serious non-fatal|62|||
147513362|NCT00552344|532032609|FG000|Overall Study|SAE, fatal + AE, non-serious non-fatal|1|||
147513363|NCT00552344|532032609|FG000|Overall Study|Other Reason|22|||
147513364|NCT00471276|532032610|FG000|Overall Study|Death|2|||
147513365|NCT00471276|532032610|FG000|Overall Study|Adverse Event|16|||
147513366|NCT00471276|532032610|FG000|Overall Study|Protocol Violation|1|||
147513367|NCT00471276|532032610|FG000|Overall Study|Objective progression or relapse|54|||
147513368|NCT00471276|532032610|FG000|Overall Study|Global deterioration of health status|1|||
147513369|NCT00471276|532032610|FG000|Overall Study|Other|3|||
147513370|NCT00471276|532032610|FG000|Overall Study|Refused treatment|6|||
147513371|NCT00744991|532032611|FG000|Overall Study|Progressive Disease|11|||
147513372|NCT00744991|532032611|FG000|Overall Study|Withdrawal by Subject|8|||
147513373|NCT00744991|532032611|FG000|Overall Study|Physician Decision|3|||
147513374|NCT00744991|532032611|FG000|Overall Study|Adverse Event|2|||
147513375|NCT00744991|532032611|FG000|Overall Study|Protocol Entry Criteria Unmet|1|||
147513376|NCT01662986|532032612|FG000|Overall Study|Adverse Event|5|||
147513377|NCT01662986|532032613|FG001|Overall Study|Adverse Event|4|||
147513378|NCT01662986|532032612|FG000|Overall Study|Protocol Violation|2|||
147513379|NCT01662986|532032613|FG001|Overall Study|Protocol Violation|3|||
147513380|NCT01662986|532032612|FG000|Overall Study|Lost to Follow-up|5|||
147513381|NCT01662986|532032613|FG001|Overall Study|Lost to Follow-up|4|||
147513382|NCT01662986|532032612|FG000|Overall Study|Withdrawal by Subject|2|||
147513383|NCT01662986|532032613|FG001|Overall Study|Withdrawal by Subject|2|||
147513384|NCT01662986|532032612|FG000|Overall Study|Not Treated|1|||
147513385|NCT01662986|532032613|FG001|Overall Study|Not Treated|0|||
147513386|NCT01662986|532032612|FG000|Overall Study|Other than stated above|3|||
147513387|NCT01662986|532032613|FG001|Overall Study|Other than stated above|0|||
147513388|NCT01487863|532032614|FG000|Overall Study|Death|19|||
147513389|NCT01487863|532032615|FG001|Overall Study|Death|19|||
147513390|NCT01975376|532032616|FG000|Overall Study|Adverse Event|5|||
147513391|NCT01975376|532032617|FG001|Overall Study|Adverse Event|5|||
147513392|NCT01975376|532032616|FG000|Overall Study|Death|65|||
147513393|NCT01975376|532032617|FG001|Overall Study|Death|72|||
147513394|NCT01975376|532032616|FG000|Overall Study|Lost to Follow-up|70|||
147513395|NCT01975376|532032617|FG001|Overall Study|Lost to Follow-up|66|||
147513396|NCT01975376|532032616|FG000|Overall Study|Withdrew consent|68|||
147513397|NCT01975376|532032617|FG001|Overall Study|Withdrew consent|62|||
147513398|NCT01975376|532032616|FG000|Overall Study|Other|2|||
147513399|NCT01975376|532032617|FG001|Overall Study|Other|4|||
147513400|NCT01975376|532032616|FG000|Overall Study|Randomized, Not Treated|16|||
147513401|NCT01975376|532032617|FG001|Overall Study|Randomized, Not Treated|8|||
147513402|NCT01614795|532032621|FG000|Overall Study|Adverse Event|0|||
147513403|NCT01614795|532032622|FG001|Overall Study|Adverse Event|0|||
147513404|NCT01614795|532032623|FG002|Overall Study|Adverse Event|1|||
147513405|NCT01614795|532032624|FG003|Overall Study|Adverse Event|1|||
147513406|NCT01614795|532032621|FG000|Overall Study|Lack of Efficacy|10|||
147513407|NCT01614795|532032622|FG001|Overall Study|Lack of Efficacy|10|||
147513408|NCT01614795|532032623|FG002|Overall Study|Lack of Efficacy|9|||
147513409|NCT01614795|532032624|FG003|Overall Study|Lack of Efficacy|8|||
147513410|NCT01614795|532032621|FG000|Overall Study|Physician Decision|1|||
147513411|NCT01614795|532032622|FG001|Overall Study|Physician Decision|0|||
147513412|NCT01614795|532032623|FG002|Overall Study|Physician Decision|1|||
147513413|NCT01614795|532032624|FG003|Overall Study|Physician Decision|1|||
147513414|NCT01614795|532032621|FG000|Overall Study|Withdrawal by Subject|0|||
147513415|NCT01614795|532032622|FG001|Overall Study|Withdrawal by Subject|1|||
147513416|NCT01614795|532032623|FG002|Overall Study|Withdrawal by Subject|0|||
147513417|NCT01614795|532032624|FG003|Overall Study|Withdrawal by Subject|2|||
147513418|NCT01614795|532032621|FG000|Overall Study|Ineligible|0|||
147513419|NCT01614795|532032622|FG001|Overall Study|Ineligible|1|||
147513420|NCT01614795|532032623|FG002|Overall Study|Ineligible|0|||
147513421|NCT01614795|532032624|FG003|Overall Study|Ineligible|0|||
147513422|NCT00179517|532032628|FG000|Overall Study|Withdrawal by Subject|2|||
147513423|NCT00179517|532032629|FG001|Overall Study|Withdrawal by Subject|1|||
147513424|NCT00565812|532032630|FG000|Overall Study|Death|2|||
147513425|NCT00565812|532032631|FG001|Overall Study|Death|1|||
147513426|NCT00565812|532032632|FG002|Overall Study|Death|3|||
147513427|NCT00565812|532032630|FG000|Overall Study|Did not Meet Entrance Criteria|1|||
147513428|NCT00565812|532032631|FG001|Overall Study|Did not Meet Entrance Criteria|0|||
147513429|NCT00565812|532032632|FG002|Overall Study|Did not Meet Entrance Criteria|1|||
147513430|NCT00565812|532032630|FG000|Overall Study|Lost to Follow-up|10|||
147513431|NCT00565812|532032631|FG001|Overall Study|Lost to Follow-up|8|||
147513432|NCT00565812|532032632|FG002|Overall Study|Lost to Follow-up|8|||
147513433|NCT00565812|532032630|FG000|Overall Study|Withdrawal by Subject|58|||
147513434|NCT00565812|532032631|FG001|Overall Study|Withdrawal by Subject|47|||
147513435|NCT00565812|532032632|FG002|Overall Study|Withdrawal by Subject|48|||
147513436|NCT00565812|532032630|FG000|Overall Study|Work Schedule|5|||
147513437|NCT00565812|532032631|FG001|Overall Study|Work Schedule|3|||
147513438|NCT00565812|532032632|FG002|Overall Study|Work Schedule|1|||
147513439|NCT00565812|532032630|FG000|Overall Study|Protocol Violation|2|||
147513440|NCT00565812|532032631|FG001|Overall Study|Protocol Violation|6|||
147513441|NCT00565812|532032632|FG002|Overall Study|Protocol Violation|4|||
147673178|NCT00217737|532624772|FG002|Step 1 Registration (Risk Assessment)|Other|0|||
147513442|NCT00565812|532032630|FG000|Overall Study|Adverse Event|41|||
147513443|NCT00565812|532032631|FG001|Overall Study|Adverse Event|54|||
147513444|NCT00565812|532032632|FG002|Overall Study|Adverse Event|40|||
147513445|NCT00565812|532032630|FG000|Overall Study|Jury Duty|1|||
147513446|NCT00565812|532032631|FG001|Overall Study|Jury Duty|0|||
147513447|NCT00565812|532032632|FG002|Overall Study|Jury Duty|0|||
147513448|NCT00565812|532032630|FG000|Overall Study|Relocated Out of Area|5|||
147513449|NCT00565812|532032631|FG001|Overall Study|Relocated Out of Area|8|||
147673179|NCT00217737|532624773|FG003|Step 1 Registration (Risk Assessment)|Other|12|||
147673180|NCT00217737|532624770|FG000|Step 1 Registration (Risk Assessment)|Registration error|0|||
147673181|NCT00217737|532624771|FG001|Step 1 Registration (Risk Assessment)|Registration error|0|||
147513450|NCT00565812|532032632|FG002|Overall Study|Relocated Out of Area|9|||
147513451|NCT00565812|532032630|FG000|Overall Study|Sponsor Decision|1|||
147513452|NCT00565812|532032631|FG001|Overall Study|Sponsor Decision|5|||
147513453|NCT00565812|532032632|FG002|Overall Study|Sponsor Decision|1|||
147513454|NCT00565812|532032630|FG000|Overall Study|Domestic Reasons|7|||
147513455|NCT00565812|532032631|FG001|Overall Study|Domestic Reasons|1|||
147673182|NCT00217737|532624772|FG002|Step 1 Registration (Risk Assessment)|Registration error|0|||
147513456|NCT00565812|532032632|FG002|Overall Study|Domestic Reasons|3|||
147513457|NCT00565812|532032630|FG000|Overall Study|Research Site Closure|6|||
147513458|NCT00565812|532032631|FG001|Overall Study|Research Site Closure|1|||
147513459|NCT00565812|532032632|FG002|Overall Study|Research Site Closure|8|||
147513460|NCT00565812|532032630|FG000|Overall Study|Surgical Intervention|0|||
147513461|NCT00565812|532032631|FG001|Overall Study|Surgical Intervention|1|||
147513462|NCT00565812|532032632|FG002|Overall Study|Surgical Intervention|2|||
147513463|NCT00565812|532032630|FG000|Overall Study|Low Compliance|1|||
147673183|NCT00217737|532624773|FG003|Step 1 Registration (Risk Assessment)|Registration error|1|||
147513464|NCT00565812|532032631|FG001|Overall Study|Low Compliance|0|||
147513465|NCT00565812|532032632|FG002|Overall Study|Low Compliance|1|||
147513466|NCT00565812|532032630|FG000|Overall Study|Follow-up Visit Not Completed|2|||
147513467|NCT00565812|532032631|FG001|Overall Study|Follow-up Visit Not Completed|0|||
147513468|NCT00565812|532032632|FG002|Overall Study|Follow-up Visit Not Completed|1|||
147513469|NCT00565812|532032630|FG000|Overall Study|Physician Decision|2|||
147513470|NCT00565812|532032631|FG001|Overall Study|Physician Decision|0|||
147513471|NCT00565812|532032632|FG002|Overall Study|Physician Decision|0|||
147513472|NCT00614991|532032639|FG000|Overall Study|Adverse Event|3|||
147513473|NCT00614991|532032640|FG001|Overall Study|Adverse Event|3|||
147513474|NCT00614991|532032641|FG002|Overall Study|Adverse Event|0|||
147513475|NCT00614991|532032642|FG003|Overall Study|Adverse Event|0|||
147513476|NCT00614991|532032643|FG004|Overall Study|Adverse Event|1|||
147513477|NCT00614991|532032644|FG005|Overall Study|Adverse Event|0|||
147513478|NCT02623699|532032645|FG000|Part A (Up to 63 Days)|Consent Withdrawn|0|||
147513479|NCT02623699|532032646|FG001|Part A (Up to 63 Days)|Consent Withdrawn|1|||
147513480|NCT02623699|532032647|FG002|Part A (Up to 63 Days)|Consent Withdrawn|0|||
147513481|NCT02623699|532032648|FG003|Part A (Up to 63 Days)|Consent Withdrawn|0|||
147513482|NCT02623699|532032649|FG004|Part A (Up to 63 Days)|Consent Withdrawn|0|||
147513483|NCT02623699|532032650|FG005|Part A (Up to 63 Days)|Consent Withdrawn|0|||
147513484|NCT02623699|532032651|FG006|Part A (Up to 63 Days)|Consent Withdrawn|0|||
147513485|NCT02623699|532032652|FG007|Part A (Up to 63 Days)|Consent Withdrawn|0|||
147513486|NCT02623699|532032653|FG008|Part A (Up to 63 Days)|Consent Withdrawn|0|||
147513487|NCT02623699|532032654|FG009|Part A (Up to 63 Days)|Consent Withdrawn|0|||
147513488|NCT02623699|532032655|FG010|Part A (Up to 63 Days)|Consent Withdrawn|0|||
147513489|NCT02623699|532032656|FG011|Part A (Up to 63 Days)|Consent Withdrawn|0|||
147513490|NCT02623699|532032645|FG000|Part B (Up to 289 Days)|Lost to Follow-up|0|||
147513491|NCT02623699|532032646|FG001|Part B (Up to 289 Days)|Lost to Follow-up|0|||
147513492|NCT02623699|532032647|FG002|Part B (Up to 289 Days)|Lost to Follow-up|0|||
147513493|NCT02623699|532032648|FG003|Part B (Up to 289 Days)|Lost to Follow-up|0|||
147513494|NCT02623699|532032649|FG004|Part B (Up to 289 Days)|Lost to Follow-up|0|||
147513495|NCT02623699|532032650|FG005|Part B (Up to 289 Days)|Lost to Follow-up|0|||
147513496|NCT02623699|532032651|FG006|Part B (Up to 289 Days)|Lost to Follow-up|1|||
147513497|NCT02623699|532032652|FG007|Part B (Up to 289 Days)|Lost to Follow-up|0|||
147513498|NCT02623699|532032653|FG008|Part B (Up to 289 Days)|Lost to Follow-up|0|||
147513499|NCT02623699|532032654|FG009|Part B (Up to 289 Days)|Lost to Follow-up|0|||
147513500|NCT02623699|532032655|FG010|Part B (Up to 289 Days)|Lost to Follow-up|0|||
147513501|NCT02623699|532032656|FG011|Part B (Up to 289 Days)|Lost to Follow-up|0|||
147513502|NCT02623699|532032645|FG000|Part B (Up to 289 Days)|Consent Withdrawn|0|||
147513503|NCT02623699|532032646|FG001|Part B (Up to 289 Days)|Consent Withdrawn|0|||
147513504|NCT02623699|532032647|FG002|Part B (Up to 289 Days)|Consent Withdrawn|0|||
147513505|NCT02623699|532032648|FG003|Part B (Up to 289 Days)|Consent Withdrawn|0|||
147513506|NCT02623699|532032649|FG004|Part B (Up to 289 Days)|Consent Withdrawn|0|||
147513507|NCT02623699|532032650|FG005|Part B (Up to 289 Days)|Consent Withdrawn|1|||
147513508|NCT02623699|532032651|FG006|Part B (Up to 289 Days)|Consent Withdrawn|0|||
147513509|NCT02623699|532032652|FG007|Part B (Up to 289 Days)|Consent Withdrawn|0|||
147513510|NCT02623699|532032653|FG008|Part B (Up to 289 Days)|Consent Withdrawn|0|||
147513511|NCT02623699|532032654|FG009|Part B (Up to 289 Days)|Consent Withdrawn|0|||
147513512|NCT02623699|532032655|FG010|Part B (Up to 289 Days)|Consent Withdrawn|0|||
147513513|NCT02623699|532032656|FG011|Part B (Up to 289 Days)|Consent Withdrawn|0|||
147513514|NCT02623699|532032645|FG000|Part B (Up to 289 Days)|Death|0|||
147513515|NCT02623699|532032646|FG001|Part B (Up to 289 Days)|Death|0|||
147513516|NCT02623699|532032647|FG002|Part B (Up to 289 Days)|Death|0|||
147513517|NCT02623699|532032648|FG003|Part B (Up to 289 Days)|Death|0|||
147513518|NCT02623699|532032649|FG004|Part B (Up to 289 Days)|Death|0|||
147513519|NCT02623699|532032650|FG005|Part B (Up to 289 Days)|Death|1|||
147513520|NCT02623699|532032651|FG006|Part B (Up to 289 Days)|Death|1|||
147513521|NCT02623699|532032652|FG007|Part B (Up to 289 Days)|Death|0|||
147513522|NCT02623699|532032653|FG008|Part B (Up to 289 Days)|Death|1|||
147513523|NCT02623699|532032654|FG009|Part B (Up to 289 Days)|Death|0|||
147513524|NCT02623699|532032655|FG010|Part B (Up to 289 Days)|Death|0|||
147513525|NCT02623699|532032656|FG011|Part B (Up to 289 Days)|Death|0|||
147513526|NCT02623699|532032645|FG000|Part C (Up to 236 Days)|Adverse Event|0|||
147513527|NCT02623699|532032646|FG001|Part C (Up to 236 Days)|Adverse Event|0|||
147513528|NCT02623699|532032647|FG002|Part C (Up to 236 Days)|Adverse Event|0|||
147673184|NCT00217737|532624770|FG000|Step 2 Randomization/Registration|Adverse Event|59|||
147673185|NCT00217737|532624771|FG001|Step 2 Randomization/Registration|Adverse Event|98|||
147673186|NCT00217737|532624772|FG002|Step 2 Randomization/Registration|Adverse Event|0|||
147673187|NCT00217737|532624773|FG003|Step 2 Randomization/Registration|Adverse Event|0|||
147673188|NCT00217737|532624770|FG000|Step 2 Randomization/Registration|Withdrawal by Subject|53|||
147673189|NCT00217737|532624771|FG001|Step 2 Randomization/Registration|Withdrawal by Subject|105|||
147673190|NCT00217737|532624772|FG002|Step 2 Randomization/Registration|Withdrawal by Subject|0|||
147513529|NCT02623699|532032648|FG003|Part C (Up to 236 Days)|Adverse Event|0|||
147513530|NCT02623699|532032649|FG004|Part C (Up to 236 Days)|Adverse Event|0|||
147513531|NCT02623699|532032650|FG005|Part C (Up to 236 Days)|Adverse Event|0|||
147513532|NCT02623699|532032651|FG006|Part C (Up to 236 Days)|Adverse Event|0|||
147513533|NCT02623699|532032652|FG007|Part C (Up to 236 Days)|Adverse Event|0|||
147673191|NCT00217737|532624773|FG003|Step 2 Randomization/Registration|Withdrawal by Subject|0|||
147513534|NCT02623699|532032653|FG008|Part C (Up to 236 Days)|Adverse Event|0|||
147513535|NCT02623699|532032654|FG009|Part C (Up to 236 Days)|Adverse Event|0|||
147513536|NCT02623699|532032655|FG010|Part C (Up to 236 Days)|Adverse Event|0|||
147513537|NCT02623699|532032656|FG011|Part C (Up to 236 Days)|Adverse Event|2|||
147513538|NCT02623699|532032645|FG000|Part C (Up to 236 Days)|Consent Withdrawn|0|||
147513539|NCT02623699|532032646|FG001|Part C (Up to 236 Days)|Consent Withdrawn|0|||
147513540|NCT02623699|532032647|FG002|Part C (Up to 236 Days)|Consent Withdrawn|0|||
147513541|NCT02623699|532032648|FG003|Part C (Up to 236 Days)|Consent Withdrawn|0|||
147513542|NCT02623699|532032649|FG004|Part C (Up to 236 Days)|Consent Withdrawn|0|||
147513543|NCT02623699|532032650|FG005|Part C (Up to 236 Days)|Consent Withdrawn|0|||
147513544|NCT02623699|532032651|FG006|Part C (Up to 236 Days)|Consent Withdrawn|0|||
147513545|NCT02623699|532032652|FG007|Part C (Up to 236 Days)|Consent Withdrawn|0|||
147513546|NCT02623699|532032653|FG008|Part C (Up to 236 Days)|Consent Withdrawn|0|||
147513547|NCT02623699|532032654|FG009|Part C (Up to 236 Days)|Consent Withdrawn|0|||
147513548|NCT02623699|532032655|FG010|Part C (Up to 236 Days)|Consent Withdrawn|1|||
147513549|NCT02623699|532032656|FG011|Part C (Up to 236 Days)|Consent Withdrawn|2|||
147513550|NCT02623699|532032645|FG000|Part C (Up to 236 Days)|Death|0|||
147513551|NCT02623699|532032646|FG001|Part C (Up to 236 Days)|Death|0|||
147513552|NCT02623699|532032647|FG002|Part C (Up to 236 Days)|Death|0|||
147513553|NCT02623699|532032648|FG003|Part C (Up to 236 Days)|Death|0|||
147513554|NCT02623699|532032649|FG004|Part C (Up to 236 Days)|Death|0|||
147513555|NCT02623699|532032650|FG005|Part C (Up to 236 Days)|Death|0|||
147513556|NCT02623699|532032651|FG006|Part C (Up to 236 Days)|Death|0|||
147513557|NCT02623699|532032652|FG007|Part C (Up to 236 Days)|Death|0|||
147513558|NCT02623699|532032653|FG008|Part C (Up to 236 Days)|Death|0|||
147513559|NCT02623699|532032654|FG009|Part C (Up to 236 Days)|Death|0|||
147513560|NCT02623699|532032655|FG010|Part C (Up to 236 Days)|Death|0|||
147513561|NCT02623699|532032656|FG011|Part C (Up to 236 Days)|Death|1|||
147513562|NCT02623699|532032645|FG000|Part C (Up to 236 Days)|Disease Progression|0|||
147513563|NCT02623699|532032646|FG001|Part C (Up to 236 Days)|Disease Progression|0|||
147513564|NCT02623699|532032647|FG002|Part C (Up to 236 Days)|Disease Progression|0|||
147513565|NCT02623699|532032648|FG003|Part C (Up to 236 Days)|Disease Progression|0|||
147513566|NCT02623699|532032649|FG004|Part C (Up to 236 Days)|Disease Progression|0|||
147513567|NCT02623699|532032650|FG005|Part C (Up to 236 Days)|Disease Progression|0|||
147513568|NCT02623699|532032651|FG006|Part C (Up to 236 Days)|Disease Progression|0|||
147513569|NCT02623699|532032652|FG007|Part C (Up to 236 Days)|Disease Progression|0|||
147513570|NCT02623699|532032653|FG008|Part C (Up to 236 Days)|Disease Progression|0|||
147513571|NCT02623699|532032654|FG009|Part C (Up to 236 Days)|Disease Progression|0|||
147513572|NCT02623699|532032655|FG010|Part C (Up to 236 Days)|Disease Progression|2|||
147513573|NCT02623699|532032656|FG011|Part C (Up to 236 Days)|Disease Progression|3|||
147513574|NCT00033371|532032657|FG000|Overall Study|Adverse Event|1|||
147513575|NCT00033371|532032658|FG001|Overall Study|Adverse Event|5|||
147513576|NCT00033371|532032657|FG000|Overall Study|Lost to Follow-up|2|||
147513577|NCT00033371|532032658|FG001|Overall Study|Lost to Follow-up|1|||
147513578|NCT00033371|532032657|FG000|Overall Study|Withdrawal by Subject|3|||
147513579|NCT00033371|532032658|FG001|Overall Study|Withdrawal by Subject|3|||
147513580|NCT00033371|532032657|FG000|Overall Study|Disease Progression|0|||
147513581|NCT00033371|532032658|FG001|Overall Study|Disease Progression|1|||
147513582|NCT00251589|532032659|FG000|Overall Study|Adverse Event|5|||
147513583|NCT00251589|532032660|FG001|Overall Study|Adverse Event|1|||
147513584|NCT00251589|532032661|FG002|Overall Study|Adverse Event|2|||
147513585|NCT00251589|532032662|FG003|Overall Study|Adverse Event|1|||
147513586|NCT00251589|532032659|FG000|Overall Study|Withdrawal by Subject|1|||
147513587|NCT00251589|532032660|FG001|Overall Study|Withdrawal by Subject|1|||
147513588|NCT00251589|532032661|FG002|Overall Study|Withdrawal by Subject|0|||
147513589|NCT00251589|532032662|FG003|Overall Study|Withdrawal by Subject|0|||
147513590|NCT00251589|532032659|FG000|Overall Study|Discontinued due to progressive disease|9|||
147513591|NCT00251589|532032660|FG001|Overall Study|Discontinued due to progressive disease|1|||
147513592|NCT00251589|532032661|FG002|Overall Study|Discontinued due to progressive disease|0|||
147513593|NCT00251589|532032662|FG003|Overall Study|Discontinued due to progressive disease|1|||
147513594|NCT02493868|532032665|FG000|Induction Phase: DE Participants|Adverse Event|22|||
147513595|NCT02493868|532032666|FG001|Induction Phase: DE Participants|Adverse Event|0|||
147513596|NCT02493868|532032665|FG000|Induction Phase: DE Participants|Lost to Follow-up|1|||
147513597|NCT02493868|532032666|FG001|Induction Phase: DE Participants|Lost to Follow-up|0|||
147513598|NCT02493868|532032665|FG000|Induction Phase: DE Participants|Lack of Efficacy|2|||
147513599|NCT02493868|532032666|FG001|Induction Phase: DE Participants|Lack of Efficacy|0|||
147513600|NCT02493868|532032665|FG000|Induction Phase: DE Participants|Protocol Violation|2|||
147513601|NCT02493868|532032666|FG001|Induction Phase: DE Participants|Protocol Violation|0|||
147513602|NCT02493868|532032665|FG000|Induction Phase: DE Participants|Withdrawal by Subject|15|||
147513603|NCT02493868|532032666|FG001|Induction Phase: DE Participants|Withdrawal by Subject|0|||
147513604|NCT02493868|532032665|FG000|Induction Phase: DE Participants|Not meet criteria to continue next phase|114|||
147513605|NCT02493868|532032666|FG001|Induction Phase: DE Participants|Not meet criteria to continue next phase|0|||
147513606|NCT02493868|532032665|FG000|Induction Phase: DE Participants|Other|8|||
147513607|NCT02493868|532032666|FG001|Induction Phase: DE Participants|Other|0|||
147513608|NCT02493868|532032665|FG000|Optimization Phase: DE+TE Participants|Adverse Event|5|||
147513609|NCT02493868|532032666|FG001|Optimization Phase: DE+TE Participants|Adverse Event|0|||
147513610|NCT02493868|532032665|FG000|Optimization Phase: DE+TE Participants|Lost to Follow-up|2|||
147513611|NCT02493868|532032666|FG001|Optimization Phase: DE+TE Participants|Lost to Follow-up|1|||
147513612|NCT02493868|532032665|FG000|Optimization Phase: DE+TE Participants|Lack of Efficacy|8|||
147513613|NCT02493868|532032666|FG001|Optimization Phase: DE+TE Participants|Lack of Efficacy|0|||
147513614|NCT02493868|532032665|FG000|Optimization Phase: DE+TE Participants|Protocol Violation|4|||
147513615|NCT02493868|532032666|FG001|Optimization Phase: DE+TE Participants|Protocol Violation|1|||
147513616|NCT02493868|532032665|FG000|Optimization Phase: DE+TE Participants|Withdrawal by Subject|8|||
147513617|NCT02493868|532032666|FG001|Optimization Phase: DE+TE Participants|Withdrawal by Subject|3|||
147513618|NCT02493868|532032665|FG000|Optimization Phase: DE+TE Participants|MADRS >= 22 for 2 Consecutive Visit|14|||
147513619|NCT02493868|532032666|FG001|Optimization Phase: DE+TE Participants|MADRS >= 22 for 2 Consecutive Visit|5|||
147513620|NCT02493868|532032665|FG000|Optimization Phase: DE+TE Participants|Not meet criteria to continue next phase|107|||
147513621|NCT02493868|532032666|FG001|Optimization Phase: DE+TE Participants|Not meet criteria to continue next phase|20|||
147513622|NCT02493868|532032665|FG000|Optimization Phase: DE+TE Participants|Other|10|||
147513623|NCT02493868|532032666|FG001|Optimization Phase: DE+TE Participants|Other|2|||
147513624|NCT02493868|532032665|FG000|Maintenance Phase: DE+TE Participants|Adverse Event|1|||
147513625|NCT02493868|532032666|FG001|Maintenance Phase: DE+TE Participants|Adverse Event|4|||
147513626|NCT02493868|532032665|FG000|Maintenance Phase: DE+TE Participants|Lost to Follow-up|1|||
147513627|NCT02493868|532032666|FG001|Maintenance Phase: DE+TE Participants|Lost to Follow-up|0|||
147513628|NCT02493868|532032665|FG000|Maintenance Phase: DE+TE Participants|Protocol Violation|1|||
147513629|NCT02493868|532032666|FG001|Maintenance Phase: DE+TE Participants|Protocol Violation|1|||
147513630|NCT02493868|532032665|FG000|Maintenance Phase: DE+TE Participants|Withdrawal by Subject|5|||
147513631|NCT02493868|532032666|FG001|Maintenance Phase: DE+TE Participants|Withdrawal by Subject|7|||
147513632|NCT02493868|532032665|FG000|Maintenance Phase: DE+TE Participants|Pregnancy|1|||
147513633|NCT02493868|532032666|FG001|Maintenance Phase: DE+TE Participants|Pregnancy|0|||
147513634|NCT02493868|532032665|FG000|Maintenance Phase: DE+TE Participants|Non Compliance with Study Drug|0|||
147673192|NCT00217737|532624770|FG000|Step 2 Randomization/Registration|Study suspension|0|||
147673193|NCT00217737|532624771|FG001|Step 2 Randomization/Registration|Study suspension|45|||
147673194|NCT00217737|532624772|FG002|Step 2 Randomization/Registration|Study suspension|0|||
147673195|NCT00217737|532624773|FG003|Step 2 Randomization/Registration|Study suspension|0|||
147513635|NCT02493868|532032666|FG001|Maintenance Phase: DE+TE Participants|Non Compliance with Study Drug|1|||
147513636|NCT02493868|532032665|FG000|Maintenance Phase: DE+TE Participants|Other|4|||
147513637|NCT02493868|532032666|FG001|Maintenance Phase: DE+TE Participants|Other|9|||
147513638|NCT02493868|532032665|FG000|Follow-up Phase|Lost to Follow-up|1|||
147513639|NCT02493868|532032666|FG001|Follow-up Phase|Lost to Follow-up|0|||
147513640|NCT02493868|532032665|FG000|Follow-up Phase|Withdrawal by Subject|3|||
147513641|NCT02493868|532032666|FG001|Follow-up Phase|Withdrawal by Subject|0|||
147513642|NCT02493868|532032665|FG000|Follow-up Phase|Investigator Decision|5|||
147513643|NCT02493868|532032666|FG001|Follow-up Phase|Investigator Decision|1|||
147513644|NCT02493868|532032665|FG000|Follow-up Phase|Other|2|||
147513645|NCT02493868|532032666|FG001|Follow-up Phase|Other|1|||
147513646|NCT02407236|532032667|FG000|Induction Study (8 Weeks)|Adverse Event|3|||
147513647|NCT02407236|532032668|FG001|Induction Study (8 Weeks)|Adverse Event|0|||
147513648|NCT02407236|532032669|FG002|Induction Study (8 Weeks)|Adverse Event|1|||
147513649|NCT02407236|532032670|FG003|Induction Study (8 Weeks)|Adverse Event|0|||
147673196|NCT00217737|532624770|FG000|Step 2 Randomization/Registration|Complicating disease|5|||
147513650|NCT02407236|532032671|FG004|Induction Study (8 Weeks)|Adverse Event|0|||
147513651|NCT02407236|532032672|FG005|Induction Study (8 Weeks)|Adverse Event|0|||
147513652|NCT02407236|532032673|FG006|Induction Study (8 Weeks)|Adverse Event|0|||
147513653|NCT02407236|532032674|FG007|Induction Study (8 Weeks)|Adverse Event|0|||
147513654|NCT02407236|532032675|FG008|Induction Study (8 Weeks)|Adverse Event|0|||
147513655|NCT02407236|532032676|FG009|Induction Study (8 Weeks)|Adverse Event|0|||
147513656|NCT02407236|532032677|FG010|Induction Study (8 Weeks)|Adverse Event|0|||
147513657|NCT02407236|532032678|FG011|Induction Study (8 Weeks)|Adverse Event|0|||
147513658|NCT02407236|532032679|FG012|Induction Study (8 Weeks)|Adverse Event|0|||
147513659|NCT02407236|532032667|FG000|Induction Study (8 Weeks)|Death|0|||
147513660|NCT02407236|532032668|FG001|Induction Study (8 Weeks)|Death|0|||
147673197|NCT00217737|532624771|FG001|Step 2 Randomization/Registration|Complicating disease|5|||
147673198|NCT00217737|532624772|FG002|Step 2 Randomization/Registration|Complicating disease|0|||
147673199|NCT00217737|532624773|FG003|Step 2 Randomization/Registration|Complicating disease|0|||
147513661|NCT02407236|532032669|FG002|Induction Study (8 Weeks)|Death|1|||
147513662|NCT02407236|532032670|FG003|Induction Study (8 Weeks)|Death|0|||
147513663|NCT02407236|532032671|FG004|Induction Study (8 Weeks)|Death|0|||
147513664|NCT02407236|532032672|FG005|Induction Study (8 Weeks)|Death|0|||
147673200|NCT00217737|532624770|FG000|Step 2 Randomization/Registration|Death|2|||
147673201|NCT00217737|532624771|FG001|Step 2 Randomization/Registration|Death|3|||
147513665|NCT02407236|532032673|FG006|Induction Study (8 Weeks)|Death|0|||
147513666|NCT02407236|532032674|FG007|Induction Study (8 Weeks)|Death|0|||
147513667|NCT02407236|532032675|FG008|Induction Study (8 Weeks)|Death|0|||
147513668|NCT02407236|532032676|FG009|Induction Study (8 Weeks)|Death|0|||
147513669|NCT02407236|532032677|FG010|Induction Study (8 Weeks)|Death|0|||
147513670|NCT02407236|532032678|FG011|Induction Study (8 Weeks)|Death|0|||
147513671|NCT02407236|532032679|FG012|Induction Study (8 Weeks)|Death|0|||
147513672|NCT02407236|532032667|FG000|Induction Study (8 Weeks)|Withdrawal by Subject|17|||
147513673|NCT02407236|532032668|FG001|Induction Study (8 Weeks)|Withdrawal by Subject|9|||
147513674|NCT02407236|532032669|FG002|Induction Study (8 Weeks)|Withdrawal by Subject|7|||
147513675|NCT02407236|532032670|FG003|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
147513676|NCT02407236|532032671|FG004|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
147513677|NCT02407236|532032672|FG005|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
147513678|NCT02407236|532032673|FG006|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
147513679|NCT02407236|532032674|FG007|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
147513680|NCT02407236|532032675|FG008|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
147513681|NCT02407236|532032676|FG009|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
147513682|NCT02407236|532032677|FG010|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
147513683|NCT02407236|532032678|FG011|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
147513684|NCT02407236|532032679|FG012|Induction Study (8 Weeks)|Withdrawal by Subject|0|||
147513685|NCT02407236|532032667|FG000|Induction Study (8 Weeks)|Lack of Efficacy|0|||
147513686|NCT02407236|532032668|FG001|Induction Study (8 Weeks)|Lack of Efficacy|0|||
147513687|NCT02407236|532032669|FG002|Induction Study (8 Weeks)|Lack of Efficacy|1|||
147513688|NCT02407236|532032670|FG003|Induction Study (8 Weeks)|Lack of Efficacy|0|||
147513689|NCT02407236|532032671|FG004|Induction Study (8 Weeks)|Lack of Efficacy|0|||
147513690|NCT02407236|532032672|FG005|Induction Study (8 Weeks)|Lack of Efficacy|0|||
147513691|NCT02407236|532032673|FG006|Induction Study (8 Weeks)|Lack of Efficacy|0|||
147513692|NCT02407236|532032674|FG007|Induction Study (8 Weeks)|Lack of Efficacy|0|||
147513693|NCT02407236|532032675|FG008|Induction Study (8 Weeks)|Lack of Efficacy|0|||
147513694|NCT02407236|532032676|FG009|Induction Study (8 Weeks)|Lack of Efficacy|0|||
147513695|NCT02407236|532032677|FG010|Induction Study (8 Weeks)|Lack of Efficacy|0|||
147513696|NCT02407236|532032678|FG011|Induction Study (8 Weeks)|Lack of Efficacy|0|||
147513697|NCT02407236|532032679|FG012|Induction Study (8 Weeks)|Lack of Efficacy|0|||
147513698|NCT02407236|532032667|FG000|Induction Study (8 Weeks)|Physician Decision|1|||
147513699|NCT02407236|532032668|FG001|Induction Study (8 Weeks)|Physician Decision|1|||
147513700|NCT02407236|532032669|FG002|Induction Study (8 Weeks)|Physician Decision|0|||
147513701|NCT02407236|532032670|FG003|Induction Study (8 Weeks)|Physician Decision|0|||
147513702|NCT02407236|532032671|FG004|Induction Study (8 Weeks)|Physician Decision|0|||
147513703|NCT02407236|532032672|FG005|Induction Study (8 Weeks)|Physician Decision|0|||
147513704|NCT02407236|532032673|FG006|Induction Study (8 Weeks)|Physician Decision|0|||
147513705|NCT02407236|532032674|FG007|Induction Study (8 Weeks)|Physician Decision|0|||
147513706|NCT02407236|532032675|FG008|Induction Study (8 Weeks)|Physician Decision|0|||
147513707|NCT02407236|532032676|FG009|Induction Study (8 Weeks)|Physician Decision|0|||
147513708|NCT02407236|532032677|FG010|Induction Study (8 Weeks)|Physician Decision|0|||
147513709|NCT02407236|532032678|FG011|Induction Study (8 Weeks)|Physician Decision|0|||
147513710|NCT02407236|532032679|FG012|Induction Study (8 Weeks)|Physician Decision|0|||
147513711|NCT02407236|532032667|FG000|Induction Study (8 Weeks)|Other|2|||
147513712|NCT02407236|532032668|FG001|Induction Study (8 Weeks)|Other|1|||
147513713|NCT02407236|532032669|FG002|Induction Study (8 Weeks)|Other|5|||
147513714|NCT02407236|532032670|FG003|Induction Study (8 Weeks)|Other|0|||
147513715|NCT02407236|532032671|FG004|Induction Study (8 Weeks)|Other|0|||
147513716|NCT02407236|532032672|FG005|Induction Study (8 Weeks)|Other|0|||
147513717|NCT02407236|532032673|FG006|Induction Study (8 Weeks)|Other|0|||
147513718|NCT02407236|532032674|FG007|Induction Study (8 Weeks)|Other|0|||
147513719|NCT02407236|532032675|FG008|Induction Study (8 Weeks)|Other|0|||
147513720|NCT02407236|532032676|FG009|Induction Study (8 Weeks)|Other|0|||
147513721|NCT02407236|532032677|FG010|Induction Study (8 Weeks)|Other|0|||
147513722|NCT02407236|532032678|FG011|Induction Study (8 Weeks)|Other|0|||
147513723|NCT02407236|532032679|FG012|Induction Study (8 Weeks)|Other|0|||
147513724|NCT02407236|532032667|FG000|Maintenance Study (44 Weeks)|Adverse Event|0|||
147513725|NCT02407236|532032668|FG001|Maintenance Study (44 Weeks)|Adverse Event|0|||
147513726|NCT02407236|532032669|FG002|Maintenance Study (44 Weeks)|Adverse Event|0|||
147513727|NCT02407236|532032670|FG003|Maintenance Study (44 Weeks)|Adverse Event|19|||
147513728|NCT02407236|532032671|FG004|Maintenance Study (44 Weeks)|Adverse Event|8|||
147513729|NCT02407236|532032672|FG005|Maintenance Study (44 Weeks)|Adverse Event|4|||
147513730|NCT02407236|532032673|FG006|Maintenance Study (44 Weeks)|Adverse Event|11|||
147673202|NCT00217737|532624772|FG002|Step 2 Randomization/Registration|Death|0|||
147673203|NCT00217737|532624773|FG003|Step 2 Randomization/Registration|Death|0|||
147673204|NCT00217737|532624770|FG000|Step 2 Randomization/Registration|Non-compliant|2|||
147513731|NCT02407236|532032674|FG007|Maintenance Study (44 Weeks)|Adverse Event|10|||
147513732|NCT02407236|532032675|FG008|Maintenance Study (44 Weeks)|Adverse Event|0|||
147513733|NCT02407236|532032676|FG009|Maintenance Study (44 Weeks)|Adverse Event|0|||
147513734|NCT02407236|532032677|FG010|Maintenance Study (44 Weeks)|Adverse Event|0|||
147513735|NCT02407236|532032678|FG011|Maintenance Study (44 Weeks)|Adverse Event|0|||
147513736|NCT02407236|532032679|FG012|Maintenance Study (44 Weeks)|Adverse Event|0|||
147513737|NCT02407236|532032667|FG000|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
147513738|NCT02407236|532032668|FG001|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
147513739|NCT02407236|532032669|FG002|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
147513740|NCT02407236|532032670|FG003|Maintenance Study (44 Weeks)|Lack of Efficacy|19|||
147513741|NCT02407236|532032671|FG004|Maintenance Study (44 Weeks)|Lack of Efficacy|9|||
147513742|NCT02407236|532032672|FG005|Maintenance Study (44 Weeks)|Lack of Efficacy|6|||
147513743|NCT02407236|532032673|FG006|Maintenance Study (44 Weeks)|Lack of Efficacy|12|||
147513744|NCT02407236|532032674|FG007|Maintenance Study (44 Weeks)|Lack of Efficacy|12|||
147513745|NCT02407236|532032675|FG008|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
147513746|NCT02407236|532032676|FG009|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
147513747|NCT02407236|532032677|FG010|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
147513748|NCT02407236|532032678|FG011|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
147513749|NCT02407236|532032679|FG012|Maintenance Study (44 Weeks)|Lack of Efficacy|0|||
147513750|NCT02407236|532032667|FG000|Maintenance Study (44 Weeks)|Other|0|||
147513751|NCT02407236|532032668|FG001|Maintenance Study (44 Weeks)|Other|0|||
147513752|NCT02407236|532032669|FG002|Maintenance Study (44 Weeks)|Other|0|||
147513753|NCT02407236|532032670|FG003|Maintenance Study (44 Weeks)|Other|5|||
147513754|NCT02407236|532032671|FG004|Maintenance Study (44 Weeks)|Other|7|||
147513755|NCT02407236|532032672|FG005|Maintenance Study (44 Weeks)|Other|8|||
147513756|NCT02407236|532032673|FG006|Maintenance Study (44 Weeks)|Other|4|||
147513757|NCT02407236|532032674|FG007|Maintenance Study (44 Weeks)|Other|6|||
147513758|NCT02407236|532032675|FG008|Maintenance Study (44 Weeks)|Other|0|||
147513759|NCT02407236|532032676|FG009|Maintenance Study (44 Weeks)|Other|0|||
147673205|NCT00217737|532624771|FG001|Step 2 Randomization/Registration|Non-compliant|4|||
147673206|NCT00217737|532624772|FG002|Step 2 Randomization/Registration|Non-compliant|0|||
147673207|NCT00217737|532624773|FG003|Step 2 Randomization/Registration|Non-compliant|0|||
147673208|NCT00217737|532624770|FG000|Step 2 Randomization/Registration|Physician Decision|2|||
147673209|NCT00217737|532624771|FG001|Step 2 Randomization/Registration|Physician Decision|2|||
147673210|NCT00217737|532624772|FG002|Step 2 Randomization/Registration|Physician Decision|0|||
147673211|NCT00217737|532624773|FG003|Step 2 Randomization/Registration|Physician Decision|0|||
147673212|NCT00217737|532624770|FG000|Step 2 Randomization/Registration|Alternative therapy|0|||
147673213|NCT00217737|532624771|FG001|Step 2 Randomization/Registration|Alternative therapy|1|||
147673214|NCT00217737|532624772|FG002|Step 2 Randomization/Registration|Alternative therapy|0|||
147673215|NCT00217737|532624773|FG003|Step 2 Randomization/Registration|Alternative therapy|0|||
147673216|NCT00217737|532624770|FG000|Step 2 Randomization/Registration|Extraordinary Medical Circumstances|0|||
147673217|NCT00217737|532624771|FG001|Step 2 Randomization/Registration|Extraordinary Medical Circumstances|1|||
147673218|NCT00217737|532624772|FG002|Step 2 Randomization/Registration|Extraordinary Medical Circumstances|0|||
147673219|NCT00217737|532624773|FG003|Step 2 Randomization/Registration|Extraordinary Medical Circumstances|0|||
147673220|NCT00217737|532624770|FG000|Step 2 Randomization/Registration|Found to be Ineligible After Treatment|0|||
147673221|NCT00217737|532624771|FG001|Step 2 Randomization/Registration|Found to be Ineligible After Treatment|1|||
147673222|NCT00217737|532624772|FG002|Step 2 Randomization/Registration|Found to be Ineligible After Treatment|0|||
147673223|NCT00217737|532624773|FG003|Step 2 Randomization/Registration|Found to be Ineligible After Treatment|0|||
147673224|NCT00217737|532624770|FG000|Step 2 Randomization/Registration|Incorrect Cancer Stage|1|||
147513760|NCT02407236|532032677|FG010|Maintenance Study (44 Weeks)|Other|0|||
147513761|NCT02407236|532032678|FG011|Maintenance Study (44 Weeks)|Other|0|||
147513762|NCT02407236|532032679|FG012|Maintenance Study (44 Weeks)|Other|0|||
147513763|NCT02407236|532032667|FG000|Maintenance Study (44 Weeks)|Death|0|||
147513764|NCT02407236|532032668|FG001|Maintenance Study (44 Weeks)|Death|0|||
147513765|NCT02407236|532032669|FG002|Maintenance Study (44 Weeks)|Death|0|||
147513766|NCT02407236|532032670|FG003|Maintenance Study (44 Weeks)|Death|0|||
147513767|NCT02407236|532032671|FG004|Maintenance Study (44 Weeks)|Death|0|||
147513768|NCT02407236|532032672|FG005|Maintenance Study (44 Weeks)|Death|0|||
147513769|NCT02407236|532032673|FG006|Maintenance Study (44 Weeks)|Death|0|||
147673225|NCT00217737|532624771|FG001|Step 2 Randomization/Registration|Incorrect Cancer Stage|0|||
147673226|NCT00217737|532624772|FG002|Step 2 Randomization/Registration|Incorrect Cancer Stage|0|||
147513770|NCT02407236|532032674|FG007|Maintenance Study (44 Weeks)|Death|1|||
147513771|NCT02407236|532032675|FG008|Maintenance Study (44 Weeks)|Death|0|||
147513772|NCT02407236|532032676|FG009|Maintenance Study (44 Weeks)|Death|0|||
147513773|NCT02407236|532032677|FG010|Maintenance Study (44 Weeks)|Death|0|||
147513774|NCT02407236|532032678|FG011|Maintenance Study (44 Weeks)|Death|0|||
147673227|NCT00217737|532624773|FG003|Step 2 Randomization/Registration|Incorrect Cancer Stage|0|||
147673228|NCT00217737|532624770|FG000|Step 2 Randomization/Registration|Never started protocol therapy|31|||
147673229|NCT00217737|532624771|FG001|Step 2 Randomization/Registration|Never started protocol therapy|48|||
147673230|NCT00217737|532624772|FG002|Step 2 Randomization/Registration|Never started protocol therapy|0|||
147673231|NCT00217737|532624773|FG003|Step 2 Randomization/Registration|Never started protocol therapy|0|||
147513775|NCT02407236|532032679|FG012|Maintenance Study (44 Weeks)|Death|0|||
147513776|NCT02407236|532032667|FG000|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
147513777|NCT02407236|532032668|FG001|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
147513778|NCT02407236|532032669|FG002|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
147513779|NCT02407236|532032670|FG003|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
147513780|NCT02407236|532032671|FG004|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
147513781|NCT02407236|532032672|FG005|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
147513782|NCT02407236|532032673|FG006|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
147513783|NCT02407236|532032674|FG007|Long-term Extension Period (176 Weeks)|Adverse Event|0|||
147513784|NCT02407236|532032675|FG008|Long-term Extension Period (176 Weeks)|Adverse Event|9|||
147513785|NCT02407236|532032676|FG009|Long-term Extension Period (176 Weeks)|Adverse Event|17|||
147513786|NCT02407236|532032677|FG010|Long-term Extension Period (176 Weeks)|Adverse Event|10|||
147513787|NCT02407236|532032678|FG011|Long-term Extension Period (176 Weeks)|Adverse Event|11|||
147513788|NCT02407236|532032679|FG012|Long-term Extension Period (176 Weeks)|Adverse Event|9|||
147513789|NCT02407236|532032667|FG000|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
147513790|NCT02407236|532032668|FG001|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
147513791|NCT02407236|532032669|FG002|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
147513792|NCT02407236|532032670|FG003|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
147513793|NCT02407236|532032671|FG004|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
147513794|NCT02407236|532032672|FG005|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
147513795|NCT02407236|532032673|FG006|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
147513796|NCT02407236|532032674|FG007|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
147513797|NCT02407236|532032675|FG008|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
147513798|NCT02407236|532032676|FG009|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
147513799|NCT02407236|532032677|FG010|Long-term Extension Period (176 Weeks)|Lost to Follow-up|1|||
147513800|NCT02407236|532032678|FG011|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
147513801|NCT02407236|532032679|FG012|Long-term Extension Period (176 Weeks)|Lost to Follow-up|0|||
147513802|NCT02407236|532032667|FG000|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
147513803|NCT02407236|532032668|FG001|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
147513804|NCT02407236|532032669|FG002|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
147513805|NCT02407236|532032670|FG003|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
147513806|NCT02407236|532032671|FG004|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
147513807|NCT02407236|532032672|FG005|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
147513808|NCT02407236|532032673|FG006|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
147513809|NCT02407236|532032674|FG007|Long-term Extension Period (176 Weeks)|Lack of Efficacy|0|||
147513810|NCT02407236|532032675|FG008|Long-term Extension Period (176 Weeks)|Lack of Efficacy|9|||
147513811|NCT02407236|532032676|FG009|Long-term Extension Period (176 Weeks)|Lack of Efficacy|6|||
147513812|NCT02407236|532032677|FG010|Long-term Extension Period (176 Weeks)|Lack of Efficacy|12|||
147513813|NCT02407236|532032678|FG011|Long-term Extension Period (176 Weeks)|Lack of Efficacy|7|||
147513814|NCT02407236|532032679|FG012|Long-term Extension Period (176 Weeks)|Lack of Efficacy|6|||
147513815|NCT02407236|532032667|FG000|Long-term Extension Period (176 Weeks)|Other|0|||
147513816|NCT02407236|532032668|FG001|Long-term Extension Period (176 Weeks)|Other|0|||
147513817|NCT02407236|532032669|FG002|Long-term Extension Period (176 Weeks)|Other|0|||
147513818|NCT02407236|532032670|FG003|Long-term Extension Period (176 Weeks)|Other|0|||
147513819|NCT02407236|532032671|FG004|Long-term Extension Period (176 Weeks)|Other|0|||
147513820|NCT02407236|532032672|FG005|Long-term Extension Period (176 Weeks)|Other|0|||
147513821|NCT02407236|532032673|FG006|Long-term Extension Period (176 Weeks)|Other|0|||
147513822|NCT02407236|532032674|FG007|Long-term Extension Period (176 Weeks)|Other|0|||
147513823|NCT02407236|532032675|FG008|Long-term Extension Period (176 Weeks)|Other|63|||
147513824|NCT02407236|532032676|FG009|Long-term Extension Period (176 Weeks)|Other|19|||
147513825|NCT02407236|532032677|FG010|Long-term Extension Period (176 Weeks)|Other|19|||
147513826|NCT02407236|532032678|FG011|Long-term Extension Period (176 Weeks)|Other|55|||
147513827|NCT02407236|532032679|FG012|Long-term Extension Period (176 Weeks)|Other|6|||
147673232|NCT00217737|532624770|FG000|Step 2 Randomization/Registration|Other|1|||
147673233|NCT00217737|532624771|FG001|Step 2 Randomization/Registration|Other|2|||
147673234|NCT00217737|532624772|FG002|Step 2 Randomization/Registration|Other|0|||
147673235|NCT00217737|532624773|FG003|Step 2 Randomization/Registration|Other|0|||
147673236|NCT03213704|532624774|FG000|Overall Study|Physician Decision|3|||
147673237|NCT03213704|532624774|FG000|Overall Study|Protocol Violation|1|||
147673238|NCT03213704|532624774|FG000|Overall Study|Progressive disease|4|||
147673239|NCT04284774|532624778|FG000|Overall Study|Progressive disease|5|||
147673240|NCT04680533|532624791|FG000|Overall Study|Screen failure|1|||
147513828|NCT01627782|532032684|FG000|Overall Study|Adverse Event|1|||
147513829|NCT01627782|532032685|FG001|Overall Study|Adverse Event|2|||
147513830|NCT01627782|532032686|FG002|Overall Study|Adverse Event|0|||
147513831|NCT01627782|532032687|FG003|Overall Study|Adverse Event|1|||
147513832|NCT01627782|532032684|FG000|Overall Study|Lack of Efficacy|11|||
147513833|NCT01627782|532032685|FG001|Overall Study|Lack of Efficacy|1|||
147513834|NCT01627782|532032686|FG002|Overall Study|Lack of Efficacy|15|||
147513835|NCT01627782|532032687|FG003|Overall Study|Lack of Efficacy|2|||
147513836|NCT01627782|532032684|FG000|Overall Study|Protocol Violation|1|||
147513837|NCT01627782|532032685|FG001|Overall Study|Protocol Violation|0|||
147513838|NCT01627782|532032686|FG002|Overall Study|Protocol Violation|0|||
147513839|NCT01627782|532032687|FG003|Overall Study|Protocol Violation|0|||
147513840|NCT01627782|532032684|FG000|Overall Study|Withdrawal by Subject|2|||
147513841|NCT01627782|532032685|FG001|Overall Study|Withdrawal by Subject|1|||
147513842|NCT01627782|532032686|FG002|Overall Study|Withdrawal by Subject|0|||
147513843|NCT01627782|532032687|FG003|Overall Study|Withdrawal by Subject|0|||
147513844|NCT01627782|532032684|FG000|Overall Study|Other|0|||
147513845|NCT01627782|532032685|FG001|Overall Study|Other|2|||
147513846|NCT01627782|532032686|FG002|Overall Study|Other|0|||
147513847|NCT01627782|532032687|FG003|Overall Study|Other|3|||
147513848|NCT01627782|532032684|FG000|Overall Study|Randomized But Not Treated|1|||
147513849|NCT01627782|532032685|FG001|Overall Study|Randomized But Not Treated|0|||
147513850|NCT01627782|532032686|FG002|Overall Study|Randomized But Not Treated|0|||
147513851|NCT01627782|532032687|FG003|Overall Study|Randomized But Not Treated|0|||
147513852|NCT00643448|532032688|FG000|Overall Study|Lack of Efficacy|2|||
147513853|NCT00643448|532032689|FG001|Overall Study|Lack of Efficacy|0|||
147513854|NCT00643448|532032690|FG002|Overall Study|Lack of Efficacy|4|||
147513855|NCT00643448|532032688|FG000|Overall Study|Adverse Event|2|||
147513856|NCT00643448|532032689|FG001|Overall Study|Adverse Event|2|||
147513857|NCT00643448|532032690|FG002|Overall Study|Adverse Event|2|||
147513858|NCT00643448|532032688|FG000|Overall Study|QTcF>550 ms|0|||
147513859|NCT00643448|532032689|FG001|Overall Study|QTcF>550 ms|3|||
147513860|NCT00643448|532032690|FG002|Overall Study|QTcF>550 ms|0|||
147513861|NCT02177812|532032694|FG000|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
147513862|NCT02177812|532032695|FG001|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
147513863|NCT02177812|532032696|FG002|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
147513864|NCT02177812|532032697|FG003|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
147513865|NCT02177812|532032698|FG004|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
147513866|NCT02177812|532032699|FG005|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|1|||
147513867|NCT02177812|532032700|FG006|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|2|||
147513868|NCT02177812|532032701|FG007|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|1|||
147513869|NCT02177812|532032702|FG008|Part 1 (Median of 4 Weeks)|Withdrawal by Subject|0|||
147513870|NCT02177812|532032694|FG000|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
147513871|NCT02177812|532032695|FG001|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
147513872|NCT02177812|532032696|FG002|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
147513873|NCT02177812|532032697|FG003|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
147513874|NCT02177812|532032698|FG004|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
147513875|NCT02177812|532032699|FG005|Part 1 (Median of 4 Weeks)|Physician Decision|1|||
147513876|NCT02177812|532032700|FG006|Part 1 (Median of 4 Weeks)|Physician Decision|1|||
147513877|NCT02177812|532032701|FG007|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
147513878|NCT02177812|532032702|FG008|Part 1 (Median of 4 Weeks)|Physician Decision|0|||
147513879|NCT02177812|532032694|FG000|Part 1 (Median of 4 Weeks)|Adverse Event|0|||
147513880|NCT02177812|532032695|FG001|Part 1 (Median of 4 Weeks)|Adverse Event|0|||
147513881|NCT02177812|532032696|FG002|Part 1 (Median of 4 Weeks)|Adverse Event|0|||
147513882|NCT02177812|532032697|FG003|Part 1 (Median of 4 Weeks)|Adverse Event|1|||
147513883|NCT02177812|532032698|FG004|Part 1 (Median of 4 Weeks)|Adverse Event|1|||
147513884|NCT02177812|532032699|FG005|Part 1 (Median of 4 Weeks)|Adverse Event|1|||
147513885|NCT02177812|532032700|FG006|Part 1 (Median of 4 Weeks)|Adverse Event|6|||
147513886|NCT02177812|532032701|FG007|Part 1 (Median of 4 Weeks)|Adverse Event|1|||
147513887|NCT02177812|532032702|FG008|Part 1 (Median of 4 Weeks)|Adverse Event|0|||
147513888|NCT00089999|532032703|FG000|Overall Study|Adverse Event|4|||
147513889|NCT00089999|532032704|FG001|Overall Study|Adverse Event|7|||
147513890|NCT00089999|532032703|FG000|Overall Study|Withdrawal by Subject|0|||
147513891|NCT00089999|532032704|FG001|Overall Study|Withdrawal by Subject|4|||
147513892|NCT00089999|532032703|FG000|Overall Study|Lost to Follow-up|2|||
147513893|NCT00089999|532032704|FG001|Overall Study|Lost to Follow-up|1|||
147513894|NCT00089999|532032703|FG000|Overall Study|Radiological Progression of Cancer|52|||
147513895|NCT00089999|532032704|FG001|Overall Study|Radiological Progression of Cancer|44|||
147513896|NCT00089999|532032703|FG000|Overall Study|Symptomatic Progression of Cancer|2|||
147513897|NCT00089999|532032704|FG001|Overall Study|Symptomatic Progression of Cancer|5|||
147513898|NCT00089999|532032703|FG000|Overall Study|Death|3|||
147513899|NCT00089999|532032704|FG001|Overall Study|Death|3|||
147513900|NCT00089999|532032703|FG000|Overall Study|Poor General Condition|1|||
147513901|NCT00089999|532032704|FG001|Overall Study|Poor General Condition|0|||
147513902|NCT00089999|532032703|FG000|Overall Study|Clinical Progression|1|||
147513903|NCT00089999|532032704|FG001|Overall Study|Clinical Progression|2|||
147513904|NCT00089999|532032703|FG000|Overall Study|Physician Decision|2|||
147513905|NCT00089999|532032704|FG001|Overall Study|Physician Decision|2|||
147513906|NCT00089999|532032703|FG000|Overall Study|Patient Underwent Surgery|2|||
147513907|NCT00089999|532032704|FG001|Overall Study|Patient Underwent Surgery|0|||
147513908|NCT00089999|532032703|FG000|Overall Study|Skin Nodule Over Right Mastectomy|0|||
147513909|NCT00089999|532032704|FG001|Overall Study|Skin Nodule Over Right Mastectomy|1|||
147513910|NCT03695471|532034674|FG000|Overall Study|Cancellation|1|||
147513911|NCT00430027|532034676|FG000|Overall Study|Study terminated|8|||
147513912|NCT00464620|532034677|FG000|Overall Study|Physician Decision|1|||
147513913|NCT00464620|532034678|FG001|Overall Study|Physician Decision|0|||
147513914|NCT00464620|532034679|FG002|Overall Study|Physician Decision|0|||
147513915|NCT00464620|532034677|FG000|Overall Study|Withdrawal by Subject|1|||
147513916|NCT00464620|532034678|FG001|Overall Study|Withdrawal by Subject|0|||
147513917|NCT00464620|532034679|FG002|Overall Study|Withdrawal by Subject|3|||
147513918|NCT00464620|532034677|FG000|Overall Study|Ineligible sarcoma subtype|0|||
147513919|NCT00464620|532034678|FG001|Overall Study|Ineligible sarcoma subtype|2|||
147513920|NCT00464620|532034679|FG002|Overall Study|Ineligible sarcoma subtype|2|||
147513921|NCT00464620|532034677|FG000|Overall Study|Use of prohibited concomitant medication|0|||
147513922|NCT00464620|532034678|FG001|Overall Study|Use of prohibited concomitant medication|0|||
147513923|NCT00464620|532034679|FG002|Overall Study|Use of prohibited concomitant medication|2|||
147513924|NCT01572844|532034680|FG000|Overall Study|Physician Decision|1|||
147513925|NCT01572844|532034681|FG001|Overall Study|Physician Decision|1|||
147513926|NCT01680991|532034705|FG000|Overall Study|Adverse Event|1|||
147513927|NCT01680991|532034706|FG001|Overall Study|Adverse Event|0|||
147513928|NCT01680991|532034707|FG002|Overall Study|Adverse Event|0|||
147513929|NCT01680991|532034705|FG000|Overall Study|Death|1|||
147513930|NCT01680991|532034706|FG001|Overall Study|Death|0|||
147513931|NCT01680991|532034707|FG002|Overall Study|Death|1|||
147513932|NCT01680991|532034705|FG000|Overall Study|Protocol Violation|0|||
147513933|NCT01680991|532034706|FG001|Overall Study|Protocol Violation|1|||
147513934|NCT01680991|532034707|FG002|Overall Study|Protocol Violation|0|||
147513935|NCT01680991|532034705|FG000|Overall Study|Withdrawal by Subject|5|||
147513936|NCT01680991|532034706|FG001|Overall Study|Withdrawal by Subject|1|||
147513937|NCT01680991|532034707|FG002|Overall Study|Withdrawal by Subject|0|||
147513938|NCT01680991|532034705|FG000|Overall Study|Progressive disease (PD)|0|||
147513939|NCT01680991|532034706|FG001|Overall Study|Progressive disease (PD)|10|||
147513940|NCT01680991|532034707|FG002|Overall Study|Progressive disease (PD)|0|||
147513941|NCT01680991|532034705|FG000|Overall Study|Physician Decision|0|||
147513942|NCT01680991|532034706|FG001|Overall Study|Physician Decision|7|||
147513943|NCT01680991|532034707|FG002|Overall Study|Physician Decision|2|||
147513944|NCT01680991|532034705|FG000|Overall Study|Bad physical condition|0|||
147513945|NCT01680991|532034706|FG001|Overall Study|Bad physical condition|0|||
147513946|NCT01680991|532034707|FG002|Overall Study|Bad physical condition|1|||
147513947|NCT01680991|532034705|FG000|Overall Study|PD confirmed in other hospital|1|||
147513948|NCT01680991|532034706|FG001|Overall Study|PD confirmed in other hospital|0|||
147513949|NCT01680991|532034707|FG002|Overall Study|PD confirmed in other hospital|0|||
147513950|NCT06073054|532034708|FG000|Overall Study|Withdrawal by Subject|2|||
147513951|NCT00068822|532034709|FG000|First Randomized Intervention|Lost to Follow-up|1|||
147513952|NCT00068822|532034710|FG001|First Randomized Intervention|Lost to Follow-up|2|||
147513953|NCT00981292|532034711|FG000|Day 1|Protocol Violation|1|||
147513954|NCT00981292|532034712|FG001|Day 1|Protocol Violation|0|||
147513955|NCT00981292|532034713|FG002|Day 1|Protocol Violation|0|||
147513956|NCT00981292|532034714|FG003|Day 1|Protocol Violation|0|||
147513957|NCT00981292|532034715|FG004|Day 1|Protocol Violation|0|||
147513958|NCT00981292|532034716|FG005|Day 1|Protocol Violation|2|||
147513959|NCT00981292|532034711|FG000|Day 2|Protocol Violation|2|||
147513960|NCT00981292|532034712|FG001|Day 2|Protocol Violation|0|||
147513961|NCT00981292|532034713|FG002|Day 2|Protocol Violation|0|||
147513962|NCT00981292|532034714|FG003|Day 2|Protocol Violation|0|||
147513963|NCT00981292|532034715|FG004|Day 2|Protocol Violation|0|||
147513964|NCT00981292|532034716|FG005|Day 2|Protocol Violation|0|||
147513965|NCT00981292|532034711|FG000|Day 3|Protocol Violation|0|||
147513966|NCT00981292|532034712|FG001|Day 3|Protocol Violation|0|||
147513967|NCT00981292|532034713|FG002|Day 3|Protocol Violation|0|||
147513968|NCT00981292|532034714|FG003|Day 3|Protocol Violation|0|||
147513969|NCT00981292|532034715|FG004|Day 3|Protocol Violation|0|||
147513970|NCT00981292|532034716|FG005|Day 3|Protocol Violation|1|||
147513971|NCT01408732|532034717|FG000|Overall Study|Withdrawal by Subject|2|||
147513972|NCT01408732|532034718|FG001|Overall Study|Withdrawal by Subject|2|||
147513973|NCT03377452|532034719|FG000|Overall Study|Refused assessment|0|||
147513974|NCT03377452|532034720|FG001|Overall Study|Refused assessment|2|||
147513975|NCT03377452|532034719|FG000|Overall Study|Lost to Follow-up|5|||
147513976|NCT03377452|532034720|FG001|Overall Study|Lost to Follow-up|4|||
147513977|NCT00424099|532034721|FG000|Overall Study|Adverse Event|0|||
147513978|NCT00424099|532034722|FG001|Overall Study|Adverse Event|1|||
147513979|NCT00424099|532034723|FG002|Overall Study|Adverse Event|1|||
147513980|NCT00424099|532034724|FG003|Overall Study|Adverse Event|0|||
147513981|NCT00424099|532034721|FG000|Overall Study|Death|0|||
147513982|NCT00424099|532034722|FG001|Overall Study|Death|1|||
147513983|NCT00424099|532034723|FG002|Overall Study|Death|0|||
147513984|NCT00424099|532034724|FG003|Overall Study|Death|0|||
147513985|NCT00424099|532034721|FG000|Overall Study|Illness|2|||
147513986|NCT00424099|532034722|FG001|Overall Study|Illness|0|||
147513987|NCT00424099|532034723|FG002|Overall Study|Illness|1|||
147513988|NCT00424099|532034724|FG003|Overall Study|Illness|4|||
147513989|NCT00424099|532034721|FG000|Overall Study|Lost to Follow-up|0|||
147513990|NCT00424099|532034722|FG001|Overall Study|Lost to Follow-up|0|||
147513991|NCT00424099|532034723|FG002|Overall Study|Lost to Follow-up|3|||
147513992|NCT00424099|532034724|FG003|Overall Study|Lost to Follow-up|0|||
147513993|NCT00424099|532034721|FG000|Overall Study|Hospitalized|1|||
147513994|NCT00424099|532034722|FG001|Overall Study|Hospitalized|2|||
147513995|NCT00424099|532034723|FG002|Overall Study|Hospitalized|1|||
147513996|NCT00424099|532034724|FG003|Overall Study|Hospitalized|3|||
147513997|NCT00424099|532034721|FG000|Overall Study|UNABLE OR Unavailable to complete questionnaires|3|||
147513998|NCT00424099|532034722|FG001|Overall Study|UNABLE OR Unavailable to complete questionnaires|3|||
147513999|NCT00424099|532034723|FG002|Overall Study|UNABLE OR Unavailable to complete questionnaires|0|||
147514000|NCT00424099|532034724|FG003|Overall Study|UNABLE OR Unavailable to complete questionnaires|0|||
147514001|NCT00424099|532034721|FG000|Overall Study|Withdrawal by Subject|1|||
147514002|NCT00424099|532034722|FG001|Overall Study|Withdrawal by Subject|9|||
147514003|NCT00424099|532034723|FG002|Overall Study|Withdrawal by Subject|4|||
147514004|NCT00424099|532034724|FG003|Overall Study|Withdrawal by Subject|6|||
147514005|NCT00424099|532034721|FG000|Overall Study|Physician Decision|0|||
147514006|NCT00424099|532034722|FG001|Overall Study|Physician Decision|0|||
147514007|NCT00424099|532034723|FG002|Overall Study|Physician Decision|1|||
147514008|NCT00424099|532034724|FG003|Overall Study|Physician Decision|0|||
147514009|NCT00424099|532034721|FG000|Overall Study|Missing|0|||
147514010|NCT00424099|532034722|FG001|Overall Study|Missing|0|||
147514011|NCT00424099|532034723|FG002|Overall Study|Missing|1|||
147514012|NCT00424099|532034724|FG003|Overall Study|Missing|0|||
147514013|NCT00764322|532034725|FG000|Overall Study|Withdrawal by Subject|11|||
147514014|NCT00764322|532034725|FG000|Overall Study|No CYP2D6 genotyping|9|||
147514015|NCT03345342|532034726|FG000|Open-Label Phase|Adverse Event|30|||
147514016|NCT03345342|532034727|FG001|Open-Label Phase|Adverse Event|0|||
147514017|NCT03345342|532034728|FG002|Open-Label Phase|Adverse Event|0|||
147514018|NCT03345342|532034729|FG003|Open-Label Phase|Adverse Event|0|||
147514019|NCT03345342|532034730|FG004|Open-Label Phase|Adverse Event|0|||
147514020|NCT03345342|532034726|FG000|Open-Label Phase|Death|1|||
147514021|NCT03345342|532034727|FG001|Open-Label Phase|Death|0|||
147514022|NCT03345342|532034728|FG002|Open-Label Phase|Death|0|||
147514023|NCT03345342|532034729|FG003|Open-Label Phase|Death|0|||
147514024|NCT03345342|532034730|FG004|Open-Label Phase|Death|0|||
147514025|NCT03345342|532034726|FG000|Open-Label Phase|Initiated Prohibited Medication|2|||
147514026|NCT03345342|532034727|FG001|Open-Label Phase|Initiated Prohibited Medication|0|||
147514027|NCT03345342|532034728|FG002|Open-Label Phase|Initiated Prohibited Medication|0|||
147514028|NCT03345342|532034729|FG003|Open-Label Phase|Initiated Prohibited Medication|0|||
147514029|NCT03345342|532034730|FG004|Open-Label Phase|Initiated Prohibited Medication|0|||
147514030|NCT03345342|532034726|FG000|Open-Label Phase|Lack of Efficacy|6|||
147514031|NCT03345342|532034727|FG001|Open-Label Phase|Lack of Efficacy|0|||
147514032|NCT03345342|532034728|FG002|Open-Label Phase|Lack of Efficacy|0|||
147514033|NCT03345342|532034729|FG003|Open-Label Phase|Lack of Efficacy|0|||
147514034|NCT03345342|532034730|FG004|Open-Label Phase|Lack of Efficacy|0|||
147514035|NCT03345342|532034726|FG000|Open-Label Phase|Lost to Follow-up|9|||
147514036|NCT03345342|532034727|FG001|Open-Label Phase|Lost to Follow-up|0|||
147514037|NCT03345342|532034728|FG002|Open-Label Phase|Lost to Follow-up|0|||
147514038|NCT03345342|532034729|FG003|Open-Label Phase|Lost to Follow-up|0|||
147514039|NCT03345342|532034730|FG004|Open-Label Phase|Lost to Follow-up|0|||
147514040|NCT03345342|532034726|FG000|Open-Label Phase|Non-Compliance with Study Drug|4|||
147514041|NCT03345342|532034727|FG001|Open-Label Phase|Non-Compliance with Study Drug|0|||
147514042|NCT03345342|532034728|FG002|Open-Label Phase|Non-Compliance with Study Drug|0|||
147514043|NCT03345342|532034729|FG003|Open-Label Phase|Non-Compliance with Study Drug|0|||
147514044|NCT03345342|532034730|FG004|Open-Label Phase|Non-Compliance with Study Drug|0|||
147514045|NCT03345342|532034726|FG000|Open-Label Phase|Physician Decision|4|||
147514046|NCT03345342|532034727|FG001|Open-Label Phase|Physician Decision|0|||
147514047|NCT03345342|532034728|FG002|Open-Label Phase|Physician Decision|0|||
147514048|NCT03345342|532034729|FG003|Open-Label Phase|Physician Decision|0|||
147514049|NCT03345342|532034730|FG004|Open-Label Phase|Physician Decision|0|||
147514050|NCT03345342|532034726|FG000|Open-Label Phase|Protocol Violation|8|||
147514051|NCT03345342|532034727|FG001|Open-Label Phase|Protocol Violation|0|||
147514052|NCT03345342|532034728|FG002|Open-Label Phase|Protocol Violation|0|||
147514053|NCT03345342|532034729|FG003|Open-Label Phase|Protocol Violation|0|||
147514054|NCT03345342|532034730|FG004|Open-Label Phase|Protocol Violation|0|||
147514055|NCT03345342|532034726|FG000|Open-Label Phase|Withdrawal by Subject|57|||
147514056|NCT03345342|532034727|FG001|Open-Label Phase|Withdrawal by Subject|0|||
147514057|NCT03345342|532034728|FG002|Open-Label Phase|Withdrawal by Subject|0|||
147514058|NCT03345342|532034729|FG003|Open-Label Phase|Withdrawal by Subject|0|||
147514059|NCT03345342|532034730|FG004|Open-Label Phase|Withdrawal by Subject|0|||
147514060|NCT03345342|532034726|FG000|Open-Label Phase|Other|15|||
147514061|NCT03345342|532034727|FG001|Open-Label Phase|Other|0|||
147514062|NCT03345342|532034728|FG002|Open-Label Phase|Other|0|||
147514063|NCT03345342|532034729|FG003|Open-Label Phase|Other|0|||
147514064|NCT03345342|532034730|FG004|Open-Label Phase|Other|0|||
147514065|NCT03345342|532034726|FG000|Double-Blind Phase|Adverse Event|0|||
147514066|NCT03345342|532034727|FG001|Double-Blind Phase|Adverse Event|1|||
147514067|NCT03345342|532034728|FG002|Double-Blind Phase|Adverse Event|6|||
147514068|NCT03345342|532034729|FG003|Double-Blind Phase|Adverse Event|0|||
147514069|NCT03345342|532034730|FG004|Double-Blind Phase|Adverse Event|0|||
147514070|NCT03345342|532034726|FG000|Double-Blind Phase|Death|0|||
147514071|NCT03345342|532034727|FG001|Double-Blind Phase|Death|2|||
147514072|NCT03345342|532034728|FG002|Double-Blind Phase|Death|1|||
147514073|NCT03345342|532034729|FG003|Double-Blind Phase|Death|0|||
147514074|NCT03345342|532034730|FG004|Double-Blind Phase|Death|0|||
147514075|NCT03345342|532034726|FG000|Double-Blind Phase|Initiated Prohibited Medication|0|||
147514076|NCT03345342|532034727|FG001|Double-Blind Phase|Initiated Prohibited Medication|0|||
147514077|NCT03345342|532034728|FG002|Double-Blind Phase|Initiated Prohibited Medication|2|||
147514078|NCT03345342|532034729|FG003|Double-Blind Phase|Initiated Prohibited Medication|0|||
147514079|NCT03345342|532034730|FG004|Double-Blind Phase|Initiated Prohibited Medication|0|||
147514080|NCT03345342|532034726|FG000|Double-Blind Phase|Lost to Follow-up|0|||
147514081|NCT03345342|532034727|FG001|Double-Blind Phase|Lost to Follow-up|1|||
147514082|NCT03345342|532034728|FG002|Double-Blind Phase|Lost to Follow-up|7|||
147514083|NCT03345342|532034729|FG003|Double-Blind Phase|Lost to Follow-up|0|||
147514084|NCT03345342|532034730|FG004|Double-Blind Phase|Lost to Follow-up|0|||
147514085|NCT03345342|532034726|FG000|Double-Blind Phase|Physician Decision|0|||
147514086|NCT03345342|532034727|FG001|Double-Blind Phase|Physician Decision|1|||
147514087|NCT03345342|532034728|FG002|Double-Blind Phase|Physician Decision|4|||
147514088|NCT03345342|532034729|FG003|Double-Blind Phase|Physician Decision|0|||
147514089|NCT03345342|532034730|FG004|Double-Blind Phase|Physician Decision|0|||
147514090|NCT03345342|532034726|FG000|Double-Blind Phase|Protocol Violation|0|||
147514091|NCT03345342|532034727|FG001|Double-Blind Phase|Protocol Violation|0|||
147514092|NCT03345342|532034728|FG002|Double-Blind Phase|Protocol Violation|1|||
147514093|NCT03345342|532034729|FG003|Double-Blind Phase|Protocol Violation|0|||
147514094|NCT03345342|532034730|FG004|Double-Blind Phase|Protocol Violation|0|||
147514095|NCT03345342|532034726|FG000|Double-Blind Phase|Withdrawal by Subject|0|||
147514096|NCT03345342|532034727|FG001|Double-Blind Phase|Withdrawal by Subject|16|||
147514097|NCT03345342|532034728|FG002|Double-Blind Phase|Withdrawal by Subject|38|||
147514098|NCT03345342|532034729|FG003|Double-Blind Phase|Withdrawal by Subject|0|||
147514099|NCT03345342|532034730|FG004|Double-Blind Phase|Withdrawal by Subject|0|||
147514100|NCT03345342|532034726|FG000|Double-Blind Phase|Other|0|||
147514101|NCT03345342|532034727|FG001|Double-Blind Phase|Other|1|||
147514102|NCT03345342|532034728|FG002|Double-Blind Phase|Other|3|||
147514103|NCT03345342|532034729|FG003|Double-Blind Phase|Other|0|||
147514104|NCT03345342|532034730|FG004|Double-Blind Phase|Other|0|||
147514105|NCT03345342|532034726|FG000|Follow-Up Phase|Adverse Event|0|||
147514106|NCT03345342|532034727|FG001|Follow-Up Phase|Adverse Event|0|||
147514107|NCT03345342|532034728|FG002|Follow-Up Phase|Adverse Event|0|||
147514108|NCT03345342|532034729|FG003|Follow-Up Phase|Adverse Event|0|||
147514109|NCT03345342|532034730|FG004|Follow-Up Phase|Adverse Event|4|||
147514110|NCT03345342|532034726|FG000|Follow-Up Phase|Lost to Follow-up|0|||
147514111|NCT03345342|532034727|FG001|Follow-Up Phase|Lost to Follow-up|0|||
147514112|NCT03345342|532034728|FG002|Follow-Up Phase|Lost to Follow-up|0|||
147514113|NCT03345342|532034729|FG003|Follow-Up Phase|Lost to Follow-up|0|||
147514114|NCT03345342|532034730|FG004|Follow-Up Phase|Lost to Follow-up|6|||
147514115|NCT03345342|532034726|FG000|Follow-Up Phase|Physician Decision|0|||
147514116|NCT03345342|532034727|FG001|Follow-Up Phase|Physician Decision|0|||
147514117|NCT03345342|532034728|FG002|Follow-Up Phase|Physician Decision|0|||
147514118|NCT03345342|532034729|FG003|Follow-Up Phase|Physician Decision|0|||
147514119|NCT03345342|532034730|FG004|Follow-Up Phase|Physician Decision|5|||
147514120|NCT03345342|532034726|FG000|Follow-Up Phase|Withdrawal by Subject|0|||
147514121|NCT03345342|532034727|FG001|Follow-Up Phase|Withdrawal by Subject|0|||
147514122|NCT03345342|532034728|FG002|Follow-Up Phase|Withdrawal by Subject|0|||
147514123|NCT03345342|532034729|FG003|Follow-Up Phase|Withdrawal by Subject|5|||
147514124|NCT03345342|532034730|FG004|Follow-Up Phase|Withdrawal by Subject|15|||
147514125|NCT03345342|532034726|FG000|Follow-Up Phase|Other|0|||
147514126|NCT03345342|532034727|FG001|Follow-Up Phase|Other|0|||
147514127|NCT03345342|532034728|FG002|Follow-Up Phase|Other|0|||
147514128|NCT03345342|532034729|FG003|Follow-Up Phase|Other|3|||
147514129|NCT03345342|532034730|FG004|Follow-Up Phase|Other|1|||
147514130|NCT03277105|532034731|FG000|Overall Study|Death|129|||
147514131|NCT03277105|532034732|FG001|Overall Study|Death|124|||
147514132|NCT03277105|532034731|FG000|Overall Study|Lost to Follow-up|2|||
147514133|NCT03277105|532034732|FG001|Overall Study|Lost to Follow-up|4|||
147514134|NCT03277105|532034731|FG000|Overall Study|Withdrawal by Subject|10|||
147514135|NCT03277105|532034732|FG001|Overall Study|Withdrawal by Subject|10|||
147514136|NCT03277105|532034731|FG000|Overall Study|Other|118|||
147514137|NCT03277105|532034732|FG001|Overall Study|Other|125|||
147514138|NCT03321526|532034733|FG000|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|2|||
147514139|NCT03321526|532034734|FG001|Double-blind Treatment Phase (24 Weeks)|Lost to Follow-up|2|||
147514140|NCT03321526|532034733|FG000|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|9|||
147514141|NCT03321526|532034734|FG001|Double-blind Treatment Phase (24 Weeks)|Withdrawal by Subject|3|||
147514142|NCT03321526|532034733|FG000|Double-blind Treatment Phase (24 Weeks)|Lack of Efficacy|1|||
147514143|NCT03321526|532034734|FG001|Double-blind Treatment Phase (24 Weeks)|Lack of Efficacy|3|||
147514144|NCT03321526|532034733|FG000|Double-blind Treatment Phase (24 Weeks)|Adverse Event|7|||
147514145|NCT03321526|532034734|FG001|Double-blind Treatment Phase (24 Weeks)|Adverse Event|8|||
147514146|NCT03321526|532034733|FG000|Double-blind Treatment Phase (24 Weeks)|Death|1|||
147514147|NCT03321526|532034734|FG001|Double-blind Treatment Phase (24 Weeks)|Death|0|||
147514148|NCT03321526|532034733|FG000|Double-blind Treatment Phase (24 Weeks)|Non-Compliance with Study Drug|3|||
147514149|NCT03321526|532034734|FG001|Double-blind Treatment Phase (24 Weeks)|Non-Compliance with Study Drug|6|||
147514150|NCT03321526|532034733|FG000|Double-blind Treatment Phase (24 Weeks)|Other|1|||
147514151|NCT03321526|532034734|FG001|Double-blind Treatment Phase (24 Weeks)|Other|4|||
147514152|NCT03321526|532034733|FG000|Follow-up Phase (2 Weeks)|Other|24|||
147514153|NCT03321526|532034734|FG001|Follow-up Phase (2 Weeks)|Other|24|||
147514154|NCT01989572|532034735|FG000|Overall Study|Lack of Efficacy|35|||
147514155|NCT01989572|532034736|FG001|Overall Study|Lack of Efficacy|48|||
147514156|NCT01989572|532034737|FG002|Overall Study|Lack of Efficacy|48|||
147514157|NCT01989572|532034738|FG003|Overall Study|Lack of Efficacy|43|||
147514158|NCT01989572|532034739|FG004|Overall Study|Lack of Efficacy|71|||
147514159|NCT01989572|532034740|FG005|Overall Study|Lack of Efficacy|79|||
147514160|NCT01989572|532034735|FG000|Overall Study|Adverse Event|2|||
147514161|NCT01989572|532034736|FG001|Overall Study|Adverse Event|1|||
147514162|NCT01989572|532034737|FG002|Overall Study|Adverse Event|3|||
147514163|NCT01989572|532034738|FG003|Overall Study|Adverse Event|0|||
147514164|NCT01989572|532034739|FG004|Overall Study|Adverse Event|3|||
147514165|NCT01989572|532034740|FG005|Overall Study|Adverse Event|0|||
147514166|NCT01989572|532034735|FG000|Overall Study|Death|0|||
147514167|NCT01989572|532034736|FG001|Overall Study|Death|0|||
147514168|NCT01989572|532034737|FG002|Overall Study|Death|0|||
147514169|NCT01989572|532034738|FG003|Overall Study|Death|0|||
147514170|NCT01989572|532034739|FG004|Overall Study|Death|1|||
147514171|NCT01989572|532034740|FG005|Overall Study|Death|0|||
147514172|NCT01989572|532034735|FG000|Overall Study|Withdrawal by Subject|4|||
147514173|NCT01989572|532034736|FG001|Overall Study|Withdrawal by Subject|1|||
147514174|NCT01989572|532034737|FG002|Overall Study|Withdrawal by Subject|5|||
147514175|NCT01989572|532034738|FG003|Overall Study|Withdrawal by Subject|1|||
147514176|NCT01989572|532034739|FG004|Overall Study|Withdrawal by Subject|12|||
147514177|NCT01989572|532034740|FG005|Overall Study|Withdrawal by Subject|4|||
147514178|NCT01989572|532034735|FG000|Overall Study|complicating disease|1|||
147514179|NCT01989572|532034736|FG001|Overall Study|complicating disease|1|||
147514180|NCT01989572|532034737|FG002|Overall Study|complicating disease|2|||
147514181|NCT01989572|532034738|FG003|Overall Study|complicating disease|0|||
147514182|NCT01989572|532034739|FG004|Overall Study|complicating disease|1|||
147514183|NCT01989572|532034740|FG005|Overall Study|complicating disease|0|||
147514184|NCT01989572|532034735|FG000|Overall Study|error|2|||
147514185|NCT01989572|532034736|FG001|Overall Study|error|1|||
147514186|NCT01989572|532034737|FG002|Overall Study|error|1|||
147514187|NCT01989572|532034738|FG003|Overall Study|error|1|||
147514188|NCT01989572|532034739|FG004|Overall Study|error|1|||
147514189|NCT01989572|532034740|FG005|Overall Study|error|1|||
147514190|NCT01989572|532034735|FG000|Overall Study|maximum dose reached|0|||
147514191|NCT01989572|532034736|FG001|Overall Study|maximum dose reached|1|||
147514192|NCT01989572|532034737|FG002|Overall Study|maximum dose reached|0|||
147514193|NCT01989572|532034738|FG003|Overall Study|maximum dose reached|0|||
147514194|NCT01989572|532034739|FG004|Overall Study|maximum dose reached|1|||
147514195|NCT01989572|532034740|FG005|Overall Study|maximum dose reached|0|||
147514196|NCT01989572|532034735|FG000|Overall Study|unknown/not specify|3|||
147514197|NCT01989572|532034736|FG001|Overall Study|unknown/not specify|4|||
147514198|NCT01989572|532034737|FG002|Overall Study|unknown/not specify|1|||
147514199|NCT01989572|532034738|FG003|Overall Study|unknown/not specify|3|||
147514200|NCT01989572|532034739|FG004|Overall Study|unknown/not specify|3|||
147514201|NCT01989572|532034740|FG005|Overall Study|unknown/not specify|5|||
147514202|NCT01989572|532034735|FG000|Overall Study|not start protocol therapy|5|||
147514203|NCT01989572|532034736|FG001|Overall Study|not start protocol therapy|1|||
147514204|NCT01989572|532034737|FG002|Overall Study|not start protocol therapy|2|||
147514205|NCT01989572|532034738|FG003|Overall Study|not start protocol therapy|3|||
147514206|NCT01989572|532034739|FG004|Overall Study|not start protocol therapy|4|||
147514207|NCT01989572|532034740|FG005|Overall Study|not start protocol therapy|18|||
147514208|NCT01989572|532034735|FG000|Overall Study|alternative therapy|3|||
147514209|NCT01989572|532034736|FG001|Overall Study|alternative therapy|0|||
147514210|NCT01989572|532034737|FG002|Overall Study|alternative therapy|0|||
147514211|NCT01989572|532034738|FG003|Overall Study|alternative therapy|0|||
147514212|NCT01989572|532034739|FG004|Overall Study|alternative therapy|1|||
147514213|NCT01989572|532034740|FG005|Overall Study|alternative therapy|3|||
147514214|NCT02280096|532034741|FG000|Overall Study|Pregnancy|1|||
147514215|NCT02280096|532034742|FG001|Overall Study|Pregnancy|0|||
147514216|NCT02280096|532034741|FG000|Overall Study|Functional neurological disorder|1|||
147514217|NCT02280096|532034742|FG001|Overall Study|Functional neurological disorder|0|||
147514218|NCT02280096|532034741|FG000|Overall Study|Lack of attachment|0|||
147514219|NCT02280096|532034742|FG001|Overall Study|Lack of attachment|1|||
147514220|NCT00285649|532034743|FG000|Overall Study|Lost to Follow-up|6|||
147514221|NCT00285649|532034744|FG001|Overall Study|Lost to Follow-up|4|||
147514222|NCT00285649|532034745|FG002|Overall Study|Lost to Follow-up|4|||
147514223|NCT00285649|532034743|FG000|Overall Study|Withdrawal by Subject|3|||
147514224|NCT00285649|532034744|FG001|Overall Study|Withdrawal by Subject|2|||
147514225|NCT00285649|532034745|FG002|Overall Study|Withdrawal by Subject|2|||
147514226|NCT00693693|532034746|FG000|Overall Study|Lost to Follow-up|1|||
147514227|NCT00693693|532034747|FG001|Overall Study|Lost to Follow-up|1|||
147514228|NCT00693693|532034748|FG002|Overall Study|Lost to Follow-up|2|||
147514229|NCT02465489|532034749|FG000|Overall Study|Adverse Event|5|||
147514230|NCT02972593|532034750|FG000|Overall Study|Lost to Follow-up|19|||
147514231|NCT02972593|532034751|FG001|Overall Study|Lost to Follow-up|15|||
147514232|NCT02972593|532034750|FG000|Overall Study|Protocol Violation|1|||
147514233|NCT02972593|532034751|FG001|Overall Study|Protocol Violation|0|||
147514234|NCT02203916|532034754|FG000|Overall Study|Pretreatment Event/Adverse Event|1|||
147514235|NCT02203916|532034755|FG001|Overall Study|Pretreatment Event/Adverse Event|3|||
147514236|NCT02203916|532034756|FG002|Overall Study|Pretreatment Event/Adverse Event|2|||
147514237|NCT02203916|532034754|FG000|Overall Study|Major Protocol Deviation|1|||
147514238|NCT02203916|532034755|FG001|Overall Study|Major Protocol Deviation|1|||
147514239|NCT02203916|532034756|FG002|Overall Study|Major Protocol Deviation|0|||
147514240|NCT02203916|532034754|FG000|Overall Study|Lost to Follow-up|0|||
147514241|NCT02203916|532034755|FG001|Overall Study|Lost to Follow-up|1|||
147514242|NCT02203916|532034756|FG002|Overall Study|Lost to Follow-up|0|||
147514243|NCT02203916|532034754|FG000|Overall Study|Voluntary Withdrawal|3|||
147514244|NCT02203916|532034755|FG001|Overall Study|Voluntary Withdrawal|3|||
147514245|NCT02203916|532034756|FG002|Overall Study|Voluntary Withdrawal|8|||
147514246|NCT02203916|532034754|FG000|Overall Study|Lack of Efficacy|3|||
147514247|NCT02203916|532034755|FG001|Overall Study|Lack of Efficacy|0|||
147514248|NCT02203916|532034756|FG002|Overall Study|Lack of Efficacy|0|||
147514249|NCT02203916|532034754|FG000|Overall Study|Reason Not Specified|0|||
147514250|NCT02203916|532034755|FG001|Overall Study|Reason Not Specified|2|||
147514251|NCT02203916|532034756|FG002|Overall Study|Reason Not Specified|1|||
147514252|NCT03696576|532034757|FG000|Overall Study|Soreness of throat after therapy|1|||
147514253|NCT03696576|532034758|FG001|Overall Study|Soreness of throat after therapy|1|||
147514254|NCT03696576|532034757|FG000|Overall Study|Lost to Follow-up|2|||
147514255|NCT03696576|532034758|FG001|Overall Study|Lost to Follow-up|4|||
147514256|NCT00312728|532034766|FG000|Overall Study|Progressive disease|53|||
147514257|NCT00312728|532034766|FG000|Overall Study|Adverse Event|32|||
147514258|NCT00312728|532034766|FG000|Overall Study|Withdrawal by Subject|10|||
147514259|NCT00312728|532034766|FG000|Overall Study|Required non-protocol cancer treatment|2|||
147514260|NCT00312728|532034766|FG000|Overall Study|Protocol Violation|2|||
147514261|NCT00312728|532034766|FG000|Overall Study|Other|10|||
147514262|NCT00312728|532034766|FG000|Overall Study|Other|1|||
147514263|NCT00338806|532034769|FG000|Acute Phase|Withdrawal by Subject|0|||
147514264|NCT00338806|532034770|FG001|Acute Phase|Withdrawal by Subject|1|||
147514265|NCT00338806|532034769|FG000|Follow-up|Lost to Follow-up|1|||
147514266|NCT00338806|532034770|FG001|Follow-up|Lost to Follow-up|3|||
147514267|NCT01819194|532034773|FG000|Overall Study|Loss of study articles|2|||
147514268|NCT00045630|532034774|FG000|Overall Study|Adverse Event|1|||
147514269|NCT00045630|532034774|FG000|Overall Study|Refusal unrelated to adverse event|1|||
147514270|NCT00045630|532034774|FG000|Overall Study|Progression/relapse|1|||
147514271|NCT00045630|532034774|FG000|Overall Study|Death|1|||
147514272|NCT00045630|532034774|FG000|Overall Study|Ineligible|2|||
147514273|NCT04449276|532034775|FG000|Overall Study|Adverse Event|1|||
147514274|NCT04449276|532034776|FG001|Overall Study|Adverse Event|2|||
147514275|NCT04449276|532034777|FG002|Overall Study|Adverse Event|0|||
147514276|NCT04449276|532034778|FG003|Overall Study|Adverse Event|0|||
147514277|NCT04449276|532034779|FG004|Overall Study|Adverse Event|2|||
147514278|NCT04449276|532034780|FG005|Overall Study|Adverse Event|0|||
147514279|NCT04449276|532034781|FG006|Overall Study|Adverse Event|0|||
147514280|NCT04449276|532034782|FG007|Overall Study|Adverse Event|1|||
147514281|NCT04449276|532034775|FG000|Overall Study|Withdrawal by Subject|2|||
147514282|NCT04449276|532034776|FG001|Overall Study|Withdrawal by Subject|0|||
147514283|NCT04449276|532034777|FG002|Overall Study|Withdrawal by Subject|0|||
147514284|NCT04449276|532034778|FG003|Overall Study|Withdrawal by Subject|1|||
147514285|NCT04449276|532034779|FG004|Overall Study|Withdrawal by Subject|0|||
147514286|NCT04449276|532034780|FG005|Overall Study|Withdrawal by Subject|0|||
147514287|NCT04449276|532034781|FG006|Overall Study|Withdrawal by Subject|0|||
147514288|NCT04449276|532034782|FG007|Overall Study|Withdrawal by Subject|0|||
147514289|NCT04449276|532034775|FG000|Overall Study|Other|0|||
147514290|NCT04449276|532034776|FG001|Overall Study|Other|2|||
147514291|NCT04449276|532034777|FG002|Overall Study|Other|3|||
147514292|NCT04449276|532034778|FG003|Overall Study|Other|2|||
147514293|NCT04449276|532034779|FG004|Overall Study|Other|0|||
147514294|NCT04449276|532034780|FG005|Overall Study|Other|0|||
147514295|NCT04449276|532034781|FG006|Overall Study|Other|0|||
147514296|NCT04449276|532034782|FG007|Overall Study|Other|1|||
147514297|NCT00701103|532034785|FG000|Overall Study|Adverse Event|0|||
147514298|NCT00701103|532034786|FG001|Overall Study|Adverse Event|0|||
147514299|NCT00701103|532034787|FG002|Overall Study|Adverse Event|1|||
147514300|NCT00701103|532034788|FG003|Overall Study|Adverse Event|1|||
147514301|NCT00701103|532034789|FG004|Overall Study|Adverse Event|0|||
147514302|NCT00701103|532034790|FG005|Overall Study|Adverse Event|1|||
147514303|NCT00701103|532034791|FG006|Overall Study|Adverse Event|1|||
147514304|NCT00701103|532034792|FG007|Overall Study|Adverse Event|0|||
147514305|NCT00701103|532034793|FG008|Overall Study|Adverse Event|0|||
147514306|NCT00701103|532034794|FG009|Overall Study|Adverse Event|2|||
147514307|NCT00701103|532034795|FG010|Overall Study|Adverse Event|0|||
147514308|NCT00701103|532034785|FG000|Overall Study|Progressive Disease|5|||
147514309|NCT00701103|532034786|FG001|Overall Study|Progressive Disease|2|||
147514310|NCT00701103|532034787|FG002|Overall Study|Progressive Disease|6|||
147514311|NCT00701103|532034788|FG003|Overall Study|Progressive Disease|5|||
147514312|NCT00701103|532034789|FG004|Overall Study|Progressive Disease|6|||
147514313|NCT00701103|532034790|FG005|Overall Study|Progressive Disease|5|||
147514314|NCT00701103|532034791|FG006|Overall Study|Progressive Disease|7|||
147514315|NCT00701103|532034792|FG007|Overall Study|Progressive Disease|7|||
147514316|NCT00701103|532034793|FG008|Overall Study|Progressive Disease|8|||
147514317|NCT00701103|532034794|FG009|Overall Study|Progressive Disease|8|||
147514318|NCT00701103|532034795|FG010|Overall Study|Progressive Disease|11|||
147514319|NCT00701103|532034785|FG000|Overall Study|Withdrawal by Subject|0|||
147514320|NCT00701103|532034786|FG001|Overall Study|Withdrawal by Subject|1|||
147514321|NCT00701103|532034787|FG002|Overall Study|Withdrawal by Subject|1|||
147514322|NCT00701103|532034788|FG003|Overall Study|Withdrawal by Subject|0|||
147514323|NCT00701103|532034789|FG004|Overall Study|Withdrawal by Subject|0|||
147514324|NCT00701103|532034790|FG005|Overall Study|Withdrawal by Subject|0|||
147514325|NCT00701103|532034791|FG006|Overall Study|Withdrawal by Subject|0|||
147514326|NCT00701103|532034792|FG007|Overall Study|Withdrawal by Subject|0|||
147514327|NCT00701103|532034793|FG008|Overall Study|Withdrawal by Subject|0|||
147514328|NCT00701103|532034794|FG009|Overall Study|Withdrawal by Subject|0|||
147514329|NCT00701103|532034795|FG010|Overall Study|Withdrawal by Subject|0|||
147514330|NCT00701103|532034785|FG000|Overall Study|Other|0|||
147514331|NCT00701103|532034786|FG001|Overall Study|Other|0|||
147514332|NCT00701103|532034787|FG002|Overall Study|Other|0|||
147514333|NCT00701103|532034788|FG003|Overall Study|Other|0|||
147514334|NCT00701103|532034789|FG004|Overall Study|Other|0|||
147514335|NCT00701103|532034790|FG005|Overall Study|Other|0|||
147514336|NCT00701103|532034791|FG006|Overall Study|Other|0|||
147514337|NCT00701103|532034792|FG007|Overall Study|Other|0|||
147514338|NCT00701103|532034793|FG008|Overall Study|Other|1|||
147514339|NCT00701103|532034794|FG009|Overall Study|Other|1|||
147514340|NCT00701103|532034795|FG010|Overall Study|Other|0|||
147514341|NCT01448707|532034801|FG000|Overall Study|Adverse Event|3|||
147514342|NCT01448707|532034802|FG001|Overall Study|Adverse Event|1|||
147514343|NCT01448707|532034801|FG000|Overall Study|Lost to Follow-up|2|||
147514344|NCT01448707|532034802|FG001|Overall Study|Lost to Follow-up|6|||
147514345|NCT01448707|532034801|FG000|Overall Study|Withdrawal by Subject|6|||
147514346|NCT01448707|532034802|FG001|Overall Study|Withdrawal by Subject|7|||
147514347|NCT01448707|532034801|FG000|Overall Study|Other|7|||
147514348|NCT01448707|532034802|FG001|Overall Study|Other|4|||
147514349|NCT02820038|532034806|FG000|Overall Study|Lost to Follow-up|7|||
147514350|NCT02820038|532034807|FG001|Overall Study|Lost to Follow-up|11|||
147514351|NCT02820038|532034808|FG002|Overall Study|Lost to Follow-up|2|||
147514352|NCT02820038|532034809|FG003|Overall Study|Lost to Follow-up|9|||
147514353|NCT02820038|532034806|FG000|Overall Study|Withdrawal by Subject|3|||
147514354|NCT02820038|532034807|FG001|Overall Study|Withdrawal by Subject|14|||
147514355|NCT02820038|532034808|FG002|Overall Study|Withdrawal by Subject|3|||
147514356|NCT02820038|532034809|FG003|Overall Study|Withdrawal by Subject|13|||
147514357|NCT03215667|532034810|FG000|Overall Study|Physician Decision|4|||
147514358|NCT00441480|532034812|FG000|Overall Study|Protocol Violation|1|||
147514359|NCT00441480|532034813|FG001|Overall Study|Protocol Violation|1|||
147514360|NCT00441480|532034812|FG000|Overall Study|Withdrawal by Subject|2|||
147514361|NCT00441480|532034813|FG001|Overall Study|Withdrawal by Subject|3|||
147514362|NCT01922739|532034814|FG000|Titration/Adjustment Period|Adverse Event|3|||
147514363|NCT01922739|532034814|FG000|Titration/Adjustment Period|Withdrawal by Subject|5|||
147514364|NCT01922739|532034814|FG000|Titration/Adjustment Period|Lost to Follow-up|1|||
147514365|NCT01922739|532034814|FG000|Titration/Adjustment Period|Lack of Efficacy|3|||
147514366|NCT01922739|532034814|FG000|Open-label Treatment Period|Adverse Event|6|||
147514367|NCT01922739|532034814|FG000|Open-label Treatment Period|Withdrawal by Subject|14|||
147514368|NCT01922739|532034814|FG000|Open-label Treatment Period|Noncompliance to study medication|3|||
147514369|NCT01922739|532034814|FG000|Open-label Treatment Period|Protocol Violation|5|||
147514370|NCT01922739|532034814|FG000|Open-label Treatment Period|Pregnancy|1|||
147514371|NCT01922739|532034814|FG000|Open-label Treatment Period|Noncompliance to study procedures|1|||
147514372|NCT01922739|532034814|FG000|Open-label Treatment Period|Lost to Follow-up|2|||
147514373|NCT01922739|532034814|FG000|Open-label Treatment Period|Physician Decision|1|||
147514374|NCT01922739|532034814|FG000|Open-label Treatment Period|Sponsor request - investigator leaving|1|||
147514375|NCT00422240|532034815|FG000|Overall Study|Lack of Efficacy|1|||
147514376|NCT00422240|532034816|FG001|Overall Study|Lack of Efficacy|2|||
147514377|NCT00422240|532034817|FG002|Overall Study|Lack of Efficacy|0|||
147514378|NCT00422240|532034818|FG003|Overall Study|Lack of Efficacy|1|||
147514379|NCT00422240|532034815|FG000|Overall Study|Adverse Event|11|||
147514380|NCT00422240|532034816|FG001|Overall Study|Adverse Event|4|||
147514381|NCT00422240|532034817|FG002|Overall Study|Adverse Event|5|||
147514382|NCT00422240|532034818|FG003|Overall Study|Adverse Event|2|||
147514383|NCT00422240|532034815|FG000|Overall Study|Subject request|21|||
147514384|NCT00422240|532034816|FG001|Overall Study|Subject request|17|||
147514385|NCT00422240|532034817|FG002|Overall Study|Subject request|18|||
147514386|NCT00422240|532034818|FG003|Overall Study|Subject request|30|||
147514387|NCT00422240|532034815|FG000|Overall Study|Protocol Violation|0|||
147514388|NCT00422240|532034816|FG001|Overall Study|Protocol Violation|1|||
147514389|NCT00422240|532034817|FG002|Overall Study|Protocol Violation|0|||
147514390|NCT00422240|532034818|FG003|Overall Study|Protocol Violation|1|||
147514391|NCT00422240|532034815|FG000|Overall Study|Lost to Follow-up|31|||
147514392|NCT00422240|532034816|FG001|Overall Study|Lost to Follow-up|32|||
147514393|NCT00422240|532034817|FG002|Overall Study|Lost to Follow-up|19|||
147514394|NCT00422240|532034818|FG003|Overall Study|Lost to Follow-up|34|||
147514395|NCT00422240|532034815|FG000|Overall Study|Other|1|||
147514396|NCT00422240|532034816|FG001|Overall Study|Other|0|||
147514397|NCT00422240|532034817|FG002|Overall Study|Other|0|||
147514398|NCT00422240|532034818|FG003|Overall Study|Other|1|||
147514399|NCT00422240|532034815|FG000|Overall Study|Pregnancy|3|||
147514400|NCT00422240|532034816|FG001|Overall Study|Pregnancy|1|||
147514401|NCT00422240|532034817|FG002|Overall Study|Pregnancy|1|||
147514402|NCT00422240|532034818|FG003|Overall Study|Pregnancy|2|||
147514403|NCT01927068|532034819|FG000|Overall Study|Death|37|||
147514404|NCT01927068|532034820|FG001|Overall Study|Death|3|||
147514405|NCT01927068|532034819|FG000|Overall Study|Withdrawal by Subject|50|||
147514406|NCT01927068|532034820|FG001|Overall Study|Withdrawal by Subject|3|||
147514407|NCT01927068|532034819|FG000|Overall Study|Lost to Follow-up|10|||
147514408|NCT01927068|532034820|FG001|Overall Study|Lost to Follow-up|2|||
147514409|NCT01927068|532034819|FG000|Overall Study|Physician Decision|9|||
147514410|NCT01927068|532034820|FG001|Overall Study|Physician Decision|0|||
147514411|NCT01927068|532034819|FG000|Overall Study|Missed last follow-up visit|2|||
147514412|NCT01927068|532034820|FG001|Overall Study|Missed last follow-up visit|0|||
147514413|NCT04489940|532034821|FG000|Overall Study|Other|2|||
147514414|NCT04489940|532034821|FG000|Overall Study|Withdrawal by Subject|2|||
147514415|NCT04489940|532034821|FG000|Overall Study|Death|5|||
147514416|NCT04489940|532034821|FG000|Overall Study|Lost to Follow-up|1|||
147514417|NCT01624467|532034822|FG000|Overall Study|Withdrawal by Subject|2|||
147514418|NCT01624467|532034822|FG000|Overall Study|Lost to Follow-up|1|||
147514419|NCT01624467|532034822|FG000|Overall Study|Adverse Event|7|||
147514420|NCT01624467|532034822|FG000|Overall Study|Progressive Disease|19|||
147514421|NCT01624467|532034822|FG000|Overall Study|Per Sponsor Requirement|1|||
147514422|NCT01624467|532034822|FG000|Overall Study|Subject Withdrew from Treatment|1|||
147514423|NCT02725268|532034823|FG000|Overall Study|Death|58|||
147514424|NCT02725268|532034824|FG001|Overall Study|Death|59|||
147514425|NCT02725268|532034825|FG002|Overall Study|Death|30|||
147514426|NCT02725268|532034826|FG003|Overall Study|Death|16|||
147514427|NCT02725268|532034823|FG000|Overall Study|Lost to Follow-up|4|||
147514428|NCT02725268|532034824|FG001|Overall Study|Lost to Follow-up|3|||
147514429|NCT02725268|532034825|FG002|Overall Study|Lost to Follow-up|0|||
147514430|NCT02725268|532034826|FG003|Overall Study|Lost to Follow-up|1|||
147514431|NCT02725268|532034823|FG000|Overall Study|Site Terminated by Sponsor|0|||
147514432|NCT02725268|532034824|FG001|Overall Study|Site Terminated by Sponsor|1|||
147514433|NCT02725268|532034825|FG002|Overall Study|Site Terminated by Sponsor|0|||
147514434|NCT02725268|532034826|FG003|Overall Study|Site Terminated by Sponsor|0|||
147514435|NCT02725268|532034823|FG000|Overall Study|Withdrawal by Subject|8|||
147514436|NCT02725268|532034824|FG001|Overall Study|Withdrawal by Subject|6|||
147514437|NCT02725268|532034825|FG002|Overall Study|Withdrawal by Subject|8|||
147514438|NCT02725268|532034826|FG003|Overall Study|Withdrawal by Subject|1|||
147514439|NCT02725268|532034823|FG000|Overall Study|Reason not Specified|2|||
147514440|NCT02725268|532034824|FG001|Overall Study|Reason not Specified|1|||
147514441|NCT02725268|532034825|FG002|Overall Study|Reason not Specified|0|||
147514442|NCT02725268|532034826|FG003|Overall Study|Reason not Specified|0|||
147514443|NCT04498468|532034827|FG000|Overall Study|Lost to Follow-up|3|||
147514444|NCT00262314|532034833|FG000|Overall Study|Changing physicians|38|||
147514445|NCT00262314|532034833|FG000|Overall Study|Death|12|||
147514446|NCT00262314|532034833|FG000|Overall Study|Patient's decision|92|||
147514447|NCT00262314|532034833|FG000|Overall Study|Other|95|||
147514448|NCT00262314|532034833|FG000|Overall Study|Lost to Follow-up|70|||
147514449|NCT00262314|532034833|FG000|Overall Study|Administrative withdrawal|30|||
147514450|NCT05104749|532034834|FG000|Overall Study|Lost to Follow-up|2|||
147514451|NCT05104749|532034835|FG001|Overall Study|Lost to Follow-up|3|||
147514452|NCT03964493|532034836|FG000|Overall Study|Withdrawal by Subject|4|||
147514453|NCT03964493|532034837|FG001|Overall Study|Withdrawal by Subject|1|||
147514454|NCT03964493|532034836|FG000|Overall Study|Lost to Follow-up|13|||
147514455|NCT03964493|532034837|FG001|Overall Study|Lost to Follow-up|4|||
147514456|NCT02963766|532034838|FG000|Double-Blind Period|Adverse Event|1|||
147514457|NCT02963766|532034839|FG001|Double-Blind Period|Adverse Event|0|||
147514458|NCT02963766|532034840|FG002|Double-Blind Period|Adverse Event|1|||
147514459|NCT02963766|532034838|FG000|Double-Blind Period|Physician Decision|1|||
147514460|NCT02963766|532034839|FG001|Double-Blind Period|Physician Decision|0|||
147514461|NCT02963766|532034840|FG002|Double-Blind Period|Physician Decision|0|||
147514462|NCT02963766|532034838|FG000|Double-Blind Period|Withdrawal by Subject|1|||
147514463|NCT02963766|532034839|FG001|Double-Blind Period|Withdrawal by Subject|1|||
147514464|NCT02963766|532034840|FG002|Double-Blind Period|Withdrawal by Subject|0|||
147514465|NCT02963766|532034838|FG000|Double-Blind Period|Withdrawal by Parent or Guardian|0|||
147514466|NCT02963766|532034839|FG001|Double-Blind Period|Withdrawal by Parent or Guardian|0|||
147514467|NCT02963766|532034840|FG002|Double-Blind Period|Withdrawal by Parent or Guardian|1|||
147514468|NCT02963766|532034838|FG000|Double-Blind Period|Protocol Violation|1|||
147514469|NCT02963766|532034839|FG001|Double-Blind Period|Protocol Violation|0|||
147514470|NCT02963766|532034840|FG002|Double-Blind Period|Protocol Violation|0|||
147514471|NCT02963766|532034838|FG000|Double-Blind Period|Lost to Follow-up|0|||
147514472|NCT02963766|532034839|FG001|Double-Blind Period|Lost to Follow-up|1|||
147514473|NCT02963766|532034840|FG002|Double-Blind Period|Lost to Follow-up|0|||
147514474|NCT02963766|532034838|FG000|Open Label Extension (OLE)|Physician Decision|1|||
147514475|NCT02963766|532034839|FG001|Open Label Extension (OLE)|Physician Decision|2|||
147514476|NCT02963766|532034840|FG002|Open Label Extension (OLE)|Physician Decision|2|||
147514477|NCT02963766|532034838|FG000|Open Label Extension (OLE)|Withdrawal by Subject|1|||
147514478|NCT02963766|532034839|FG001|Open Label Extension (OLE)|Withdrawal by Subject|1|||
147514479|NCT02963766|532034840|FG002|Open Label Extension (OLE)|Withdrawal by Subject|0|||
147514480|NCT02224274|532034843|FG000|Overall Study|Death|1|||
147514481|NCT02224274|532034844|FG001|Overall Study|Death|0|||
147514482|NCT00887068|532034845|FG000|Overall Study|Withdrawal by Subject|2|||
147514483|NCT00887068|532034846|FG001|Overall Study|Withdrawal by Subject|0|||
147514484|NCT00887068|532034845|FG000|Overall Study|Didn't meet eligibility to start cycle 1|4|||
147514485|NCT00887068|532034846|FG001|Overall Study|Didn't meet eligibility to start cycle 1|0|||
147514486|NCT00499460|532034847|FG000|Intervention 1 (30 Days)|Withdrawal by Subject|1|||
147514487|NCT00499460|532034848|FG001|Intervention 1 (30 Days)|Withdrawal by Subject|0|||
147514488|NCT00499460|532034847|FG000|Intervention 1 (30 Days)|Fainting upon Blood Draw|1|||
147514489|NCT00499460|532034848|FG001|Intervention 1 (30 Days)|Fainting upon Blood Draw|0|||
147514490|NCT00499460|532034847|FG000|Intervention 2 (30 Days)|Withdrawal by Subject|0|||
147514491|NCT00499460|532034848|FG001|Intervention 2 (30 Days)|Withdrawal by Subject|1|||
147514492|NCT00901394|532034849|FG000|Overall Study|Physician Decision|1|||
147514493|NCT00901394|532034850|FG001|Overall Study|Physician Decision|1|||
147514494|NCT00901394|532034851|FG002|Overall Study|Physician Decision|2|||
147514495|NCT02290340|532034852|FG000|Overall Study|Lost to Follow-up|0|||
147514496|NCT02290340|532034853|FG001|Overall Study|Lost to Follow-up|0|||
147514497|NCT02290340|532034854|FG002|Overall Study|Lost to Follow-up|0|||
147514498|NCT02290340|532034855|FG003|Overall Study|Lost to Follow-up|1|||
147514499|NCT02290340|532034852|FG000|Overall Study|Withdrawal by Subject|1|||
147514500|NCT02290340|532034853|FG001|Overall Study|Withdrawal by Subject|0|||
147514501|NCT02290340|532034854|FG002|Overall Study|Withdrawal by Subject|0|||
147514502|NCT02290340|532034855|FG003|Overall Study|Withdrawal by Subject|0|||
147514503|NCT02290340|532034852|FG000|Overall Study|Other|1|||
147514504|NCT02290340|532034853|FG001|Overall Study|Other|0|||
147514505|NCT02290340|532034854|FG002|Overall Study|Other|0|||
147514506|NCT02290340|532034855|FG003|Overall Study|Other|1|||
147514507|NCT03209362|532034856|FG000|Overall Study|Adverse Event|0|||
147514508|NCT03209362|532034857|FG001|Overall Study|Adverse Event|1|||
147514509|NCT03209362|532034856|FG000|Overall Study|Lost to Follow-up|0|||
147514510|NCT03209362|532034857|FG001|Overall Study|Lost to Follow-up|1|||
147514511|NCT03209362|532034856|FG000|Overall Study|Withdrawal by Subject|2|||
147514512|NCT03209362|532034857|FG001|Overall Study|Withdrawal by Subject|0|||
147514513|NCT03209362|532034856|FG000|Overall Study|Other|0|||
147514514|NCT03209362|532034857|FG001|Overall Study|Other|1|||
147514515|NCT03039569|532034858|FG000|Overall Study|Lost to Follow-up|5|||
147514516|NCT03039569|532034859|FG001|Overall Study|Lost to Follow-up|4|||
147514517|NCT02859558|532037036|FG000|Step 1|Not Eligible|0|||
147514518|NCT02859558|532037037|FG001|Step 1|Not Eligible|0|||
147514519|NCT02859558|532037038|FG002|Step 1|Not Eligible|0|||
147514520|NCT02859558|532037039|FG003|Step 1|Not Eligible|0|||
147514521|NCT02859558|532037040|FG004|Step 1|Not Eligible|3|||
147514522|NCT02859558|532037036|FG000|Step 1|Lost to Follow-up|1|||
147514523|NCT02859558|532037037|FG001|Step 1|Lost to Follow-up|3|||
147514524|NCT02859558|532037038|FG002|Step 1|Lost to Follow-up|3|||
147514525|NCT02859558|532037039|FG003|Step 1|Lost to Follow-up|0|||
147514526|NCT02859558|532037040|FG004|Step 1|Lost to Follow-up|0|||
147514527|NCT02859558|532037036|FG000|Step 1|Did Not Return to Clinic|2|||
147514528|NCT02859558|532037037|FG001|Step 1|Did Not Return to Clinic|3|||
147514529|NCT02859558|532037038|FG002|Step 1|Did Not Return to Clinic|4|||
147514530|NCT02859558|532037039|FG003|Step 1|Did Not Return to Clinic|0|||
147514531|NCT02859558|532037040|FG004|Step 1|Did Not Return to Clinic|0|||
147514532|NCT02859558|532037036|FG000|Step 1|Moved|0|||
147514533|NCT02859558|532037037|FG001|Step 1|Moved|1|||
147514534|NCT02859558|532037038|FG002|Step 1|Moved|1|||
147514535|NCT02859558|532037039|FG003|Step 1|Moved|0|||
147514536|NCT02859558|532037040|FG004|Step 1|Moved|0|||
147514537|NCT02859558|532037036|FG000|Step 1|Withdrawal By Participant|1|||
147514538|NCT02859558|532037037|FG001|Step 1|Withdrawal By Participant|2|||
147514539|NCT02859558|532037038|FG002|Step 1|Withdrawal By Participant|1|||
147514540|NCT02859558|532037039|FG003|Step 1|Withdrawal By Participant|0|||
147514541|NCT02859558|532037040|FG004|Step 1|Withdrawal By Participant|0|||
147514542|NCT02859558|532037036|FG000|Step 1|Had to Interrupt antiretroviral (ARV)|1|||
147514543|NCT02859558|532037037|FG001|Step 1|Had to Interrupt antiretroviral (ARV)|0|||
147514544|NCT02859558|532037038|FG002|Step 1|Had to Interrupt antiretroviral (ARV)|0|||
147514545|NCT02859558|532037039|FG003|Step 1|Had to Interrupt antiretroviral (ARV)|0|||
147514546|NCT02859558|532037040|FG004|Step 1|Had to Interrupt antiretroviral (ARV)|0|||
147514547|NCT02859558|532037036|FG000|Step 1|Incarceration|0|||
147514548|NCT02859558|532037037|FG001|Step 1|Incarceration|1|||
147514549|NCT02859558|532037038|FG002|Step 1|Incarceration|0|||
147514550|NCT02859558|532037039|FG003|Step 1|Incarceration|0|||
147514551|NCT02859558|532037040|FG004|Step 1|Incarceration|0|||
147514552|NCT02859558|532037036|FG000|Step 1|Non-Adherence to Study Drug|2|||
147514553|NCT02859558|532037037|FG001|Step 1|Non-Adherence to Study Drug|0|||
147514554|NCT02859558|532037038|FG002|Step 1|Non-Adherence to Study Drug|1|||
147514555|NCT02859558|532037039|FG003|Step 1|Non-Adherence to Study Drug|0|||
147514556|NCT02859558|532037040|FG004|Step 1|Non-Adherence to Study Drug|0|||
147514557|NCT02859558|532037036|FG000|Step 1|Non-Adherence to Study Requirements|3|||
147514558|NCT02859558|532037037|FG001|Step 1|Non-Adherence to Study Requirements|1|||
147514559|NCT02859558|532037038|FG002|Step 1|Non-Adherence to Study Requirements|0|||
147514560|NCT02859558|532037039|FG003|Step 1|Non-Adherence to Study Requirements|0|||
147514561|NCT02859558|532037040|FG004|Step 1|Non-Adherence to Study Requirements|0|||
147514562|NCT02859558|532037036|FG000|Step 1|Virologic Failure|2|||
147514563|NCT02859558|532037037|FG001|Step 1|Virologic Failure|1|||
147514564|NCT02859558|532037038|FG002|Step 1|Virologic Failure|1|||
147514565|NCT02859558|532037039|FG003|Step 1|Virologic Failure|0|||
147514566|NCT02859558|532037040|FG004|Step 1|Virologic Failure|0|||
147514567|NCT02859558|532037036|FG000|Step 2|Lost to Follow-up|3|||
147514568|NCT02859558|532037037|FG001|Step 2|Lost to Follow-up|3|||
147514569|NCT02859558|532037038|FG002|Step 2|Lost to Follow-up|1|||
147514570|NCT02859558|532037039|FG003|Step 2|Lost to Follow-up|0|||
147514571|NCT02859558|532037040|FG004|Step 2|Lost to Follow-up|0|||
147514572|NCT02859558|532037036|FG000|Step 2|Withdrawal by Subject|0|||
147514573|NCT02859558|532037037|FG001|Step 2|Withdrawal by Subject|1|||
147514574|NCT02859558|532037038|FG002|Step 2|Withdrawal by Subject|1|||
147514575|NCT02859558|532037039|FG003|Step 2|Withdrawal by Subject|0|||
147514576|NCT02859558|532037040|FG004|Step 2|Withdrawal by Subject|0|||
147514577|NCT02859558|532037036|FG000|Step 2|Unexpected Closure of Site|0|||
147514578|NCT02859558|532037037|FG001|Step 2|Unexpected Closure of Site|1|||
147514579|NCT02859558|532037038|FG002|Step 2|Unexpected Closure of Site|1|||
147514580|NCT02859558|532037039|FG003|Step 2|Unexpected Closure of Site|0|||
147514581|NCT02859558|532037040|FG004|Step 2|Unexpected Closure of Site|0|||
147514582|NCT02859558|532037036|FG000|Step 2|Death|1|||
147514583|NCT02859558|532037037|FG001|Step 2|Death|0|||
147514584|NCT02859558|532037038|FG002|Step 2|Death|0|||
147514585|NCT02859558|532037039|FG003|Step 2|Death|0|||
147514586|NCT02859558|532037040|FG004|Step 2|Death|0|||
147514587|NCT02859558|532037036|FG000|Step 2|Incarceration|0|||
147514588|NCT02859558|532037037|FG001|Step 2|Incarceration|0|||
147514589|NCT02859558|532037038|FG002|Step 2|Incarceration|1|||
147514590|NCT02859558|532037039|FG003|Step 2|Incarceration|0|||
147514591|NCT02859558|532037040|FG004|Step 2|Incarceration|0|||
147514592|NCT01432756|532037041|FG000|Overall Study|Lost to Follow-up|1|||
147514593|NCT01432756|532037042|FG001|Overall Study|Lost to Follow-up|0|||
147514594|NCT01432756|532037043|FG002|Overall Study|Lost to Follow-up|2|||
147514595|NCT01432756|532037044|FG003|Overall Study|Lost to Follow-up|1|||
147514596|NCT00777257|532037052|FG000|Overall Study|Adverse Event|3|||
147514597|NCT00777257|532037053|FG001|Overall Study|Adverse Event|1|||
147514598|NCT00777257|532037054|FG002|Overall Study|Adverse Event|0|||
147514599|NCT00777257|532037052|FG000|Overall Study|Lost to Follow-up|3|||
147514600|NCT00777257|532037053|FG001|Overall Study|Lost to Follow-up|3|||
147514601|NCT00777257|532037054|FG002|Overall Study|Lost to Follow-up|2|||
147514602|NCT00777257|532037052|FG000|Overall Study|Protocol Violation|2|||
147514603|NCT00777257|532037053|FG001|Overall Study|Protocol Violation|2|||
147514604|NCT00777257|532037054|FG002|Overall Study|Protocol Violation|2|||
147514605|NCT00777257|532037052|FG000|Overall Study|Withdrawal by Subject|3|||
147514606|NCT00777257|532037053|FG001|Overall Study|Withdrawal by Subject|6|||
147514607|NCT00777257|532037054|FG002|Overall Study|Withdrawal by Subject|5|||
147514608|NCT02973997|532037059|FG000|Overall Study|Withdrawal by Subject|4|||
147514609|NCT02973997|532037060|FG001|Overall Study|Withdrawal by Subject|0|||
147514610|NCT02973997|532037059|FG000|Overall Study|Adverse Event|4|||
147514611|NCT02973997|532037060|FG001|Overall Study|Adverse Event|1|||
147514612|NCT02973997|532037059|FG000|Overall Study|Disease Progression|11|||
147514613|NCT02973997|532037060|FG001|Overall Study|Disease Progression|20|||
147514614|NCT02973997|532037059|FG000|Overall Study|Alternative Therapy|3|||
147514615|NCT02973997|532037060|FG001|Overall Study|Alternative Therapy|0|||
147514616|NCT02973997|532037059|FG000|Overall Study|Other complicating disease|0|||
147514617|NCT02973997|532037060|FG001|Overall Study|Other complicating disease|1|||
147514618|NCT02973997|532037059|FG000|Overall Study|Death|0|||
147514619|NCT02973997|532037060|FG001|Overall Study|Death|1|||
147514620|NCT01431521|532037061|FG000|Overall Study|Withdrawal by Subject|0|||
147514621|NCT01431521|532037062|FG001|Overall Study|Withdrawal by Subject|0|||
147514622|NCT01431521|532037063|FG002|Overall Study|Withdrawal by Subject|1|||
147514623|NCT01431521|532037064|FG003|Overall Study|Withdrawal by Subject|0|||
147514624|NCT00444951|532037065|FG000|Overall Study|Lost to Follow-up|1|||
147514625|NCT00444951|532037066|FG001|Overall Study|Lost to Follow-up|1|||
147514626|NCT00444951|532037067|FG002|Overall Study|Lost to Follow-up|0|||
147514627|NCT00444951|532037065|FG000|Overall Study|Withdrawal by Subject|4|||
147514628|NCT00444951|532037066|FG001|Overall Study|Withdrawal by Subject|5|||
147514629|NCT00444951|532037067|FG002|Overall Study|Withdrawal by Subject|3|||
147514630|NCT00366444|532037069|FG000|Overall Study|Withdrawal by Subject|1|||
147514631|NCT00366444|532037070|FG001|Overall Study|Withdrawal by Subject|1|||
147514632|NCT00366444|532037069|FG000|Overall Study|Lack of Efficacy|0|||
147514633|NCT00366444|532037070|FG001|Overall Study|Lack of Efficacy|1|||
147514634|NCT04984876|532037071|FG000|Overall Study|Subject decision|2|||
147514635|NCT04984876|532037072|FG001|Overall Study|Subject decision|10|||
147514636|NCT04984876|532037073|FG002|Overall Study|Subject decision|3|||
147514637|NCT04984876|532037074|FG003|Overall Study|Subject decision|3|||
147514638|NCT04984876|532037075|FG004|Overall Study|Subject decision|3|||
147514639|NCT04984876|532037076|FG005|Overall Study|Subject decision|0|||
147514640|NCT04984876|532037071|FG000|Overall Study|Guardian decision|0|||
147514641|NCT04984876|532037072|FG001|Overall Study|Guardian decision|1|||
147514642|NCT04984876|532037073|FG002|Overall Study|Guardian decision|0|||
147514643|NCT04984876|532037074|FG003|Overall Study|Guardian decision|2|||
147514644|NCT04984876|532037075|FG004|Overall Study|Guardian decision|0|||
147514645|NCT04984876|532037076|FG005|Overall Study|Guardian decision|1|||
147514646|NCT04984876|532037071|FG000|Overall Study|Lost to Follow-up|0|||
147514647|NCT04984876|532037072|FG001|Overall Study|Lost to Follow-up|0|||
147514648|NCT04984876|532037073|FG002|Overall Study|Lost to Follow-up|1|||
147514649|NCT04984876|532037074|FG003|Overall Study|Lost to Follow-up|1|||
147514650|NCT04984876|532037075|FG004|Overall Study|Lost to Follow-up|0|||
147514651|NCT04984876|532037076|FG005|Overall Study|Lost to Follow-up|0|||
147514652|NCT04984876|532037071|FG000|Overall Study|Physician Decision|1|||
147514653|NCT04984876|532037072|FG001|Overall Study|Physician Decision|0|||
147514654|NCT04984876|532037073|FG002|Overall Study|Physician Decision|0|||
147514655|NCT04984876|532037074|FG003|Overall Study|Physician Decision|1|||
147514656|NCT04984876|532037075|FG004|Overall Study|Physician Decision|0|||
147514657|NCT04984876|532037076|FG005|Overall Study|Physician Decision|0|||
147514658|NCT04984876|532037071|FG000|Overall Study|Adverse Event|0|||
147514659|NCT04984876|532037072|FG001|Overall Study|Adverse Event|0|||
147514660|NCT04984876|532037073|FG002|Overall Study|Adverse Event|1|||
147514661|NCT04984876|532037074|FG003|Overall Study|Adverse Event|0|||
147514662|NCT04984876|532037075|FG004|Overall Study|Adverse Event|0|||
147514663|NCT04984876|532037076|FG005|Overall Study|Adverse Event|0|||
147514664|NCT02204410|532037077|FG000|Overall Study|Lost to Follow-up|5|||
147514665|NCT02204410|532037077|FG000|Overall Study|Physician Decision|2|||
147514666|NCT02204410|532037077|FG000|Overall Study|Protocol Violation|1|||
147514667|NCT02204410|532037077|FG000|Overall Study|Withdrawal by Subject|3|||
147514668|NCT02000622|532037080|FG000|Overall Study|Withdrawal by Subject|5|||
147514669|NCT02000622|532037081|FG001|Overall Study|Withdrawal by Subject|7|||
147514670|NCT02000622|532037080|FG000|Overall Study|Lost to Follow-up|4|||
147514671|NCT02000622|532037081|FG001|Overall Study|Lost to Follow-up|0|||
147514672|NCT02000622|532037080|FG000|Overall Study|Death|159|||
147514673|NCT02000622|532037081|FG001|Overall Study|Death|73|||
147514674|NCT02000622|532037080|FG000|Overall Study|Withdrawn due to site closure|1|||
147514675|NCT02000622|532037081|FG001|Overall Study|Withdrawn due to site closure|0|||
147514676|NCT01405027|532037082|FG000|Overall Study|Withdrawn consent|3|||
147514677|NCT01405027|532037083|FG001|Overall Study|Withdrawn consent|0|||
147514678|NCT01405027|532037082|FG000|Overall Study|Lost to Follow-up|16|||
147514679|NCT01405027|532037083|FG001|Overall Study|Lost to Follow-up|24|||
147514680|NCT01405027|532037082|FG000|Overall Study|Investigator judgement|0|||
147514681|NCT01405027|532037083|FG001|Overall Study|Investigator judgement|2|||
147514682|NCT01405027|532037082|FG000|Overall Study|Death|1|||
147514683|NCT01405027|532037083|FG001|Overall Study|Death|0|||
147514684|NCT01405027|532037082|FG000|Overall Study|Other or Unknown|12|||
147514685|NCT01405027|532037083|FG001|Overall Study|Other or Unknown|25|||
147514686|NCT01462045|532037084|FG000|Overall Study|Family matter|0|||
147514687|NCT01462045|532037085|FG001|Overall Study|Family matter|1|||
147514688|NCT01462045|532037086|FG002|Overall Study|Family matter|0|||
147514689|NCT01938391|532037092|FG000|6 Month Follow up|Withdrawal by Subject|1|||
147514690|NCT01938391|532037092|FG000|12 Month Follow up|Physician Decision|1|||
147514691|NCT01938391|532037092|FG000|12 Month Follow up|Withdrawal by Subject|1|||
147514692|NCT01077193|532037099|FG000|Overall Study|Lost to Follow-up|1|||
147514693|NCT01077193|532037099|FG000|Overall Study|Withdrawal by Subject|2|||
147514694|NCT01077193|532037099|FG000|Overall Study|Lack of Efficacy|1|||
147514695|NCT01077193|532037099|FG000|Overall Study|Study Terminated by Sponsor|40|||
147514696|NCT06048809|532037104|FG000|Overall Study|Adverse Event|2|||
147514697|NCT06048809|532037105|FG001|Overall Study|Adverse Event|0|||
147514698|NCT06048809|532037104|FG000|Overall Study|Withdrawal by Subject|1|||
147514699|NCT06048809|532037105|FG001|Overall Study|Withdrawal by Subject|1|||
147514700|NCT04960202|532037107|FG000|Overall Study|Other|5|||
147514701|NCT04960202|532037108|FG001|Overall Study|Other|0|||
147514702|NCT04960202|532037107|FG000|Overall Study|Withdrawal by Subject|37|||
147514703|NCT04960202|532037108|FG001|Overall Study|Withdrawal by Subject|43|||
147514704|NCT04960202|532037107|FG000|Overall Study|Lost to Follow-up|20|||
147514705|NCT04960202|532037108|FG001|Overall Study|Lost to Follow-up|16|||
147514706|NCT04960202|532037107|FG000|Overall Study|Death|0|||
147514707|NCT04960202|532037108|FG001|Overall Study|Death|15|||
147514708|NCT02158728|532037109|FG000|Overall Study|no procedure according to CIP done|3|||
147514709|NCT02158728|532037109|FG000|Overall Study|no qualified dataset|24|||
147514710|NCT03558828|532037110|FG000|Overall Study|Lost to Follow-up|4|||
147514711|NCT03558828|532037111|FG001|Overall Study|Lost to Follow-up|3|||
147514712|NCT03558828|532037112|FG002|Overall Study|Lost to Follow-up|3|||
147514713|NCT03558828|532037113|FG003|Overall Study|Lost to Follow-up|5|||
147514714|NCT03558828|532037114|FG004|Overall Study|Lost to Follow-up|2|||
147514715|NCT03558828|532037115|FG005|Overall Study|Lost to Follow-up|3|||
147514716|NCT03558828|532037110|FG000|Overall Study|dropped before the intervention|1|||
147514717|NCT03558828|532037111|FG001|Overall Study|dropped before the intervention|1|||
147514718|NCT03558828|532037112|FG002|Overall Study|dropped before the intervention|0|||
147514719|NCT03558828|532037113|FG003|Overall Study|dropped before the intervention|0|||
147514720|NCT03558828|532037114|FG004|Overall Study|dropped before the intervention|0|||
147514721|NCT03558828|532037115|FG005|Overall Study|dropped before the intervention|0|||
147514722|NCT00673816|532037118|FG000|Overall Study|Adverse Event|1|||
147514723|NCT00673816|532037118|FG000|Overall Study|Withdrawal by Subject|1|||
147514724|NCT02234050|532037120|FG000|Overall Study|Lack of Efficacy|38|||
147514725|NCT02234050|532037121|FG001|Overall Study|Lack of Efficacy|22|||
147514726|NCT02234050|532037120|FG000|Overall Study|Adverse Event|13|||
147514727|NCT02234050|532037121|FG001|Overall Study|Adverse Event|1|||
147514728|NCT02234050|532037120|FG000|Overall Study|Withdrawal by Subject|4|||
147514729|NCT02234050|532037121|FG001|Overall Study|Withdrawal by Subject|2|||
147514730|NCT02234050|532037120|FG000|Overall Study|Sponsor's decision|6|||
147514731|NCT02234050|532037121|FG001|Overall Study|Sponsor's decision|0|||
147514732|NCT03774875|532037122|FG000|Placebo-controlled Period (Week 1-16)|Adverse Event|8|||
147514733|NCT03774875|532037123|FG001|Placebo-controlled Period (Week 1-16)|Adverse Event|16|||
147514734|NCT03774875|532037122|FG000|Placebo-controlled Period (Week 1-16)|Lack of Efficacy|2|||
147514735|NCT03774875|532037123|FG001|Placebo-controlled Period (Week 1-16)|Lack of Efficacy|4|||
147514736|NCT03774875|532037122|FG000|Placebo-controlled Period (Week 1-16)|Withdrawal by Subject|12|||
147514737|NCT03774875|532037123|FG001|Placebo-controlled Period (Week 1-16)|Withdrawal by Subject|10|||
147514738|NCT03774875|532037122|FG000|Placebo-controlled Period (Week 1-16)|Lost to Follow-up|0|||
147514739|NCT03774875|532037123|FG001|Placebo-controlled Period (Week 1-16)|Lost to Follow-up|2|||
147514740|NCT03774875|532037122|FG000|Placebo-controlled Period (Week 1-16)|Protocol Deviation|0|||
147514741|NCT03774875|532037123|FG001|Placebo-controlled Period (Week 1-16)|Protocol Deviation|1|||
147514742|NCT03774875|532037122|FG000|Placebo-controlled Period (Week 1-16)|Reason Unknown|1|||
147514743|NCT03774875|532037123|FG001|Placebo-controlled Period (Week 1-16)|Reason Unknown|0|||
147514744|NCT03774875|532037122|FG000|Apremilast Extension Period (Week 16-52)|Adverse Event|6|||
147514745|NCT03774875|532037123|FG001|Apremilast Extension Period (Week 16-52)|Adverse Event|9|||
147514746|NCT03774875|532037122|FG000|Apremilast Extension Period (Week 16-52)|Lack of Efficacy|2|||
147514747|NCT03774875|532037123|FG001|Apremilast Extension Period (Week 16-52)|Lack of Efficacy|11|||
147514748|NCT03774875|532037122|FG000|Apremilast Extension Period (Week 16-52)|Withdrawal by Subject|7|||
147514749|NCT03774875|532037123|FG001|Apremilast Extension Period (Week 16-52)|Withdrawal by Subject|20|||
147514750|NCT03774875|532037122|FG000|Apremilast Extension Period (Week 16-52)|Non-compliance with Study Drug|0|||
147514751|NCT03774875|532037123|FG001|Apremilast Extension Period (Week 16-52)|Non-compliance with Study Drug|2|||
147514752|NCT03774875|532037122|FG000|Apremilast Extension Period (Week 16-52)|Other|1|||
147514753|NCT03774875|532037123|FG001|Apremilast Extension Period (Week 16-52)|Other|1|||
147514754|NCT03774875|532037122|FG000|Apremilast Extension Period (Week 16-52)|Protocol Deviation|0|||
147514755|NCT03774875|532037123|FG001|Apremilast Extension Period (Week 16-52)|Protocol Deviation|1|||
147514756|NCT03774875|532037122|FG000|Apremilast Extension Period (Week 16-52)|Lost to Follow-up|0|||
147514757|NCT03774875|532037123|FG001|Apremilast Extension Period (Week 16-52)|Lost to Follow-up|3|||
147514758|NCT02352090|532037124|FG000|Overall Study|general malaise|1|||
147514759|NCT02352090|532037125|FG001|Overall Study|general malaise|0|||
147514760|NCT02352090|532037126|FG002|Overall Study|general malaise|0|||
147514761|NCT02352090|532037124|FG000|Overall Study|non-specified mild side-effects|0|||
147514762|NCT02352090|532037125|FG001|Overall Study|non-specified mild side-effects|0|||
147514763|NCT02352090|532037126|FG002|Overall Study|non-specified mild side-effects|2|||
147514764|NCT00796003|532037129|FG000|Overall Study|Disease Progression|2|||
147514765|NCT00796003|532037130|FG001|Overall Study|Disease Progression|13|||
147514766|NCT00796003|532037129|FG000|Overall Study|Adverse Event|1|||
147514767|NCT00796003|532037130|FG001|Overall Study|Adverse Event|7|||
147514768|NCT00796003|532037129|FG000|Overall Study|Specified organ function not met|0|||
147514769|NCT00796003|532037130|FG001|Overall Study|Specified organ function not met|1|||
147514770|NCT00796003|532037129|FG000|Overall Study|Physician Decision|0|||
147514771|NCT00796003|532037130|FG001|Overall Study|Physician Decision|4|||
147514772|NCT00796003|532037129|FG000|Overall Study|Withdrawal by Subject|0|||
147514773|NCT00796003|532037130|FG001|Overall Study|Withdrawal by Subject|1|||
147514774|NCT00796003|532037129|FG000|Overall Study|Other|0|||
147514775|NCT00796003|532037130|FG001|Overall Study|Other|1|||
147514776|NCT00796003|532037129|FG000|Overall Study|Participants Not treated|0|||
147514777|NCT00796003|532037130|FG001|Overall Study|Participants Not treated|2|||
147514778|NCT05179057|532037131|FG000|Overall Study|Adverse Event|3|||
147514779|NCT05179057|532037132|FG001|Overall Study|Adverse Event|2|||
147514780|NCT05179057|532037131|FG000|Overall Study|Non-compliance with protocol requirements or study-related procedures|1|||
147514781|NCT05179057|532037132|FG001|Overall Study|Non-compliance with protocol requirements or study-related procedures|0|||
147514782|NCT05179057|532037131|FG000|Overall Study|Study terminated|13|||
147514783|NCT05179057|532037132|FG001|Overall Study|Study terminated|7|||
147514784|NCT05179057|532037131|FG000|Overall Study|Discontinuation or withdrawal by participants/parent/legal guardian|2|||
147514785|NCT05179057|532037132|FG001|Overall Study|Discontinuation or withdrawal by participants/parent/legal guardian|2|||
147514786|NCT05179057|532037131|FG000|Overall Study|Never received primary or cross-over study treatment|1|||
147514787|NCT05179057|532037132|FG001|Overall Study|Never received primary or cross-over study treatment|3|||
147514788|NCT03146403|532037140|FG000|Overall Study|Withdrawal by Subject|0|||
147514789|NCT03146403|532037141|FG001|Overall Study|Withdrawal by Subject|3|||
147514790|NCT03146403|532037140|FG000|Overall Study|Lost to Follow-up|2|||
147514791|NCT03146403|532037141|FG001|Overall Study|Lost to Follow-up|0|||
147514792|NCT02182999|532037143|FG000|Overall Study|Adverse Event|4|||
147514793|NCT02182999|532037144|FG001|Overall Study|Adverse Event|3|||
147514794|NCT02182999|532037143|FG000|Overall Study|Physician Decision|1|||
147514795|NCT02182999|532037144|FG001|Overall Study|Physician Decision|0|||
147514796|NCT02252588|532037146|FG000|Overall Study|Withdrawal by Subject|4|||
147514797|NCT02252588|532037147|FG001|Overall Study|Withdrawal by Subject|0|||
147514798|NCT02736929|532037149|FG000|Main Study|Lost to Follow-up|7|||
147514799|NCT02736929|532037150|FG001|Main Study|Lost to Follow-up|1|||
147514800|NCT02736929|532037151|FG002|Main Study|Lost to Follow-up|0|||
147514801|NCT02736929|532037149|FG000|Main Study|Withdrawal by Subject|1|||
147514802|NCT02736929|532037150|FG001|Main Study|Withdrawal by Subject|1|||
147514803|NCT02736929|532037151|FG002|Main Study|Withdrawal by Subject|0|||
147514804|NCT02736929|532037149|FG000|Optional Cross-Over|Withdrawal by Subject|0|||
147514805|NCT02736929|532037150|FG001|Optional Cross-Over|Withdrawal by Subject|0|||
147514806|NCT02736929|532037151|FG002|Optional Cross-Over|Withdrawal by Subject|6|||
147514807|NCT02148952|532037154|FG000|Assessing Eligibility and Consent|Were not eligible for inclusion|1241|||
147514808|NCT02148952|532037155|FG001|Assessing Eligibility and Consent|Were not eligible for inclusion|1591|||
147514809|NCT02148952|532037154|FG000|Assessing Eligibility and Consent|Did not consent or declined follow-up|1862|||
147514810|NCT02148952|532037155|FG001|Assessing Eligibility and Consent|Did not consent or declined follow-up|1556|||
147514811|NCT02148952|532037154|FG000|Follow-Up|Lost to Follow-up|219|||
147514812|NCT02148952|532037155|FG001|Follow-Up|Lost to Follow-up|231|||
147514813|NCT02148952|532037154|FG000|Follow-Up|Withdrawal by Subject|46|||
147514814|NCT02148952|532037155|FG001|Follow-Up|Withdrawal by Subject|48|||
147514815|NCT04007367|532037156|FG000|Open-Label Phase (8-Weeks)|Study Terminated by Sponsor|43|||
147514816|NCT04007367|532037157|FG001|Open-Label Phase (8-Weeks)|Study Terminated by Sponsor|0|||
147514817|NCT04007367|532037158|FG002|Open-Label Phase (8-Weeks)|Study Terminated by Sponsor|0|||
147514818|NCT04007367|532037156|FG000|Open-Label Phase (8-Weeks)|Adverse Event|2|||
147514819|NCT04007367|532037157|FG001|Open-Label Phase (8-Weeks)|Adverse Event|0|||
147514820|NCT04007367|532037158|FG002|Open-Label Phase (8-Weeks)|Adverse Event|0|||
147514821|NCT04007367|532037156|FG000|Open-Label Phase (8-Weeks)|Withdrawal by Participant|2|||
147514822|NCT04007367|532037157|FG001|Open-Label Phase (8-Weeks)|Withdrawal by Participant|0|||
147514823|NCT04007367|532037158|FG002|Open-Label Phase (8-Weeks)|Withdrawal by Participant|0|||
147514824|NCT04007367|532037156|FG000|Open-Label Phase (8-Weeks)|Non-compliance|1|||
147514825|NCT04007367|532037157|FG001|Open-Label Phase (8-Weeks)|Non-compliance|0|||
147514826|NCT04007367|532037158|FG002|Open-Label Phase (8-Weeks)|Non-compliance|0|||
147514827|NCT04007367|532037156|FG000|Double-Blind Phase (14-Weeks)|Withdrawal by Participant|0|||
147514828|NCT04007367|532037157|FG001|Double-Blind Phase (14-Weeks)|Withdrawal by Participant|0|||
147514829|NCT04007367|532037158|FG002|Double-Blind Phase (14-Weeks)|Withdrawal by Participant|2|||
147514830|NCT01764022|532037159|FG000|Overall Study|Death|3|||
147514831|NCT01764022|532037160|FG001|Overall Study|Death|5|||
147514832|NCT01764022|532037159|FG000|Overall Study|Withdrawal by Subject|2|||
147514833|NCT01764022|532037160|FG001|Overall Study|Withdrawal by Subject|6|||
147514834|NCT01764022|532037159|FG000|Overall Study|Lack of Efficacy|0|||
147514835|NCT01764022|532037160|FG001|Overall Study|Lack of Efficacy|1|||
147514836|NCT01764022|532037159|FG000|Overall Study|Physician Decision|0|||
147514837|NCT01764022|532037160|FG001|Overall Study|Physician Decision|2|||
147514838|NCT01764022|532037159|FG000|Overall Study|Lost to Follow-up|2|||
147514839|NCT01764022|532037160|FG001|Overall Study|Lost to Follow-up|0|||
147514840|NCT01764022|532037159|FG000|Overall Study|Protocol Violation|1|||
147514841|NCT01764022|532037160|FG001|Overall Study|Protocol Violation|0|||
147514842|NCT04731922|532037170|FG000|Overall Study|Adverse Event|0|||
147514843|NCT04731922|532037171|FG001|Overall Study|Adverse Event|0|||
147514844|NCT04731922|532037172|FG002|Overall Study|Adverse Event|0|||
147514845|NCT04731922|532037173|FG003|Overall Study|Adverse Event|0|||
147514846|NCT04731922|532037174|FG004|Overall Study|Adverse Event|0|||
147514847|NCT04731922|532037175|FG005|Overall Study|Adverse Event|0|||
147514848|NCT04731922|532037176|FG006|Overall Study|Adverse Event|0|||
147514849|NCT04731922|532037177|FG007|Overall Study|Adverse Event|0|||
147514850|NCT04731922|532037178|FG008|Overall Study|Adverse Event|0|||
147514851|NCT04731922|532037179|FG009|Overall Study|Adverse Event|0|||
147514852|NCT04731922|532037180|FG010|Overall Study|Adverse Event|1|||
147514853|NCT04731922|532037181|FG011|Overall Study|Adverse Event|0|||
147514854|NCT04731922|532037182|FG012|Overall Study|Adverse Event|0|||
147514855|NCT04731922|532037183|FG013|Overall Study|Adverse Event|0|||
147514856|NCT04731922|532037184|FG014|Overall Study|Adverse Event|0|||
147514857|NCT04731922|532037185|FG015|Overall Study|Adverse Event|0|||
147514858|NCT04731922|532037186|FG016|Overall Study|Adverse Event|0|||
147514859|NCT04731922|532037170|FG000|Overall Study|Lost to Follow-up|0|||
147514860|NCT04731922|532037171|FG001|Overall Study|Lost to Follow-up|0|||
147514861|NCT04731922|532037172|FG002|Overall Study|Lost to Follow-up|0|||
147514862|NCT04731922|532037173|FG003|Overall Study|Lost to Follow-up|1|||
147514863|NCT04731922|532037174|FG004|Overall Study|Lost to Follow-up|0|||
147514864|NCT04731922|532037175|FG005|Overall Study|Lost to Follow-up|1|||
147514865|NCT04731922|532037176|FG006|Overall Study|Lost to Follow-up|0|||
147514866|NCT04731922|532037177|FG007|Overall Study|Lost to Follow-up|0|||
147514867|NCT04731922|532037178|FG008|Overall Study|Lost to Follow-up|0|||
147514868|NCT04731922|532037179|FG009|Overall Study|Lost to Follow-up|0|||
147514869|NCT04731922|532037180|FG010|Overall Study|Lost to Follow-up|0|||
147514870|NCT04731922|532037181|FG011|Overall Study|Lost to Follow-up|0|||
147514871|NCT04731922|532037182|FG012|Overall Study|Lost to Follow-up|0|||
147514872|NCT04731922|532037183|FG013|Overall Study|Lost to Follow-up|0|||
147514873|NCT04731922|532037184|FG014|Overall Study|Lost to Follow-up|0|||
147514874|NCT04731922|532037185|FG015|Overall Study|Lost to Follow-up|0|||
147514875|NCT04731922|532037186|FG016|Overall Study|Lost to Follow-up|0|||
147514876|NCT04731922|532037170|FG000|Overall Study|Withdrawal by Subject|1|||
147514877|NCT04731922|532037171|FG001|Overall Study|Withdrawal by Subject|0|||
147514878|NCT04731922|532037172|FG002|Overall Study|Withdrawal by Subject|0|||
147514879|NCT04731922|532037173|FG003|Overall Study|Withdrawal by Subject|0|||
147514880|NCT04731922|532037174|FG004|Overall Study|Withdrawal by Subject|1|||
147514881|NCT04731922|532037175|FG005|Overall Study|Withdrawal by Subject|0|||
147514882|NCT04731922|532037176|FG006|Overall Study|Withdrawal by Subject|1|||
147514883|NCT04731922|532037177|FG007|Overall Study|Withdrawal by Subject|0|||
147514884|NCT04731922|532037178|FG008|Overall Study|Withdrawal by Subject|0|||
147514885|NCT04731922|532037179|FG009|Overall Study|Withdrawal by Subject|0|||
147514886|NCT04731922|532037180|FG010|Overall Study|Withdrawal by Subject|0|||
147514887|NCT04731922|532037181|FG011|Overall Study|Withdrawal by Subject|0|||
147514888|NCT04731922|532037182|FG012|Overall Study|Withdrawal by Subject|0|||
147514889|NCT04731922|532037183|FG013|Overall Study|Withdrawal by Subject|1|||
147514890|NCT04731922|532037184|FG014|Overall Study|Withdrawal by Subject|0|||
147514891|NCT04731922|532037185|FG015|Overall Study|Withdrawal by Subject|0|||
147514892|NCT04731922|532037186|FG016|Overall Study|Withdrawal by Subject|0|||
147514893|NCT04731922|532037170|FG000|Overall Study|Other|0|||
147514894|NCT04731922|532037171|FG001|Overall Study|Other|0|||
147514895|NCT04731922|532037172|FG002|Overall Study|Other|0|||
147514896|NCT04731922|532037173|FG003|Overall Study|Other|0|||
147514897|NCT04731922|532037174|FG004|Overall Study|Other|0|||
147514898|NCT04731922|532037175|FG005|Overall Study|Other|0|||
147514899|NCT04731922|532037176|FG006|Overall Study|Other|1|||
147514900|NCT04731922|532037177|FG007|Overall Study|Other|0|||
147514901|NCT04731922|532037178|FG008|Overall Study|Other|0|||
147514902|NCT04731922|532037179|FG009|Overall Study|Other|0|||
147514903|NCT04731922|532037180|FG010|Overall Study|Other|0|||
147514904|NCT04731922|532037181|FG011|Overall Study|Other|0|||
147514905|NCT04731922|532037182|FG012|Overall Study|Other|0|||
147514906|NCT04731922|532037183|FG013|Overall Study|Other|0|||
147514907|NCT04731922|532037184|FG014|Overall Study|Other|0|||
147514908|NCT04731922|532037185|FG015|Overall Study|Other|0|||
147514909|NCT04731922|532037186|FG016|Overall Study|Other|0|||
147514910|NCT00981747|532037192|FG000|Losartan|Withdrawal by Subject|1|||
147514911|NCT00981747|532037192|FG000|Losartan|Death|1|||
147514912|NCT00981747|532037192|FG000|Placebo Oral Tablet|Withdrawal by Subject|1|||
147514913|NCT02033850|532037196|FG000|Overall Study|Death|1|||
147514914|NCT02033850|532037197|FG001|Overall Study|Death|0|||
147514915|NCT02033850|532037196|FG000|Overall Study|unrelated medical reason|1|||
147514916|NCT02033850|532037197|FG001|Overall Study|unrelated medical reason|1|||
147514917|NCT01437267|532037198|FG000|Overall Study|Withdrawal by Subject|0|||
147514918|NCT01437267|532037199|FG001|Overall Study|Withdrawal by Subject|0|||
147514919|NCT01437267|532037200|FG002|Overall Study|Withdrawal by Subject|0|||
147514920|NCT01437267|532037201|FG003|Overall Study|Withdrawal by Subject|1|||
147514921|NCT01437267|532037202|FG004|Overall Study|Withdrawal by Subject|0|||
147514922|NCT01437267|532037203|FG005|Overall Study|Withdrawal by Subject|0|||
147514923|NCT01437267|532037198|FG000|Overall Study|Protocol Violation|0|||
147514924|NCT01437267|532037199|FG001|Overall Study|Protocol Violation|1|||
147514925|NCT01437267|532037200|FG002|Overall Study|Protocol Violation|0|||
147514926|NCT01437267|532037201|FG003|Overall Study|Protocol Violation|0|||
147514927|NCT01437267|532037202|FG004|Overall Study|Protocol Violation|0|||
147514928|NCT01437267|532037203|FG005|Overall Study|Protocol Violation|0|||
147514929|NCT03934203|532037204|FG000|Overall Study|Adverse Event|0|||
147514930|NCT03934203|532037205|FG001|Overall Study|Adverse Event|0|||
147514931|NCT03934203|532037206|FG002|Overall Study|Adverse Event|1|||
147514932|NCT03934203|532037207|FG003|Overall Study|Adverse Event|0|||
147514933|NCT03934203|532037208|FG004|Overall Study|Adverse Event|1|||
147514934|NCT03934203|532037209|FG005|Overall Study|Adverse Event|0|||
147514935|NCT03934203|532037210|FG006|Overall Study|Adverse Event|2|||
147514936|NCT03934203|532037211|FG007|Overall Study|Adverse Event|0|||
147514937|NCT03934203|532037212|FG008|Overall Study|Adverse Event|0|||
147514938|NCT03934203|532037213|FG009|Overall Study|Adverse Event|0|||
147514939|NCT03934203|532037214|FG010|Overall Study|Adverse Event|0|||
147514940|NCT03934203|532037215|FG011|Overall Study|Adverse Event|0|||
147514941|NCT03934203|532037216|FG012|Overall Study|Adverse Event|0|||
147514942|NCT03934203|532037217|FG013|Overall Study|Adverse Event|1|||
147514943|NCT03934203|532037218|FG014|Overall Study|Adverse Event|0|||
147514944|NCT01810380|532037221|FG000|Overall Study|Randomised not treated|2|||
147514945|NCT01810380|532037222|FG001|Overall Study|Randomised not treated|1|||
147514946|NCT01810380|532037223|FG002|Overall Study|Randomised not treated|1|||
147514947|NCT01810380|532037221|FG000|Overall Study|Adverse Event|11|||
147514948|NCT01810380|532037222|FG001|Overall Study|Adverse Event|14|||
147514949|NCT01810380|532037223|FG002|Overall Study|Adverse Event|4|||
147514950|NCT01810380|532037221|FG000|Overall Study|Lack of Efficacy|24|||
147514951|NCT01810380|532037222|FG001|Overall Study|Lack of Efficacy|10|||
147514952|NCT01810380|532037223|FG002|Overall Study|Lack of Efficacy|11|||
147514953|NCT01810380|532037221|FG000|Overall Study|Protocol Violation|1|||
147514954|NCT01810380|532037222|FG001|Overall Study|Protocol Violation|0|||
147514955|NCT01810380|532037223|FG002|Overall Study|Protocol Violation|1|||
147514956|NCT01810380|532037221|FG000|Overall Study|Withdrawal by Subject|6|||
147514957|NCT01810380|532037222|FG001|Overall Study|Withdrawal by Subject|0|||
147514958|NCT01810380|532037223|FG002|Overall Study|Withdrawal by Subject|6|||
147514959|NCT01810380|532037221|FG000|Overall Study|Administrative or other reasons|11|||
147514960|NCT01810380|532037222|FG001|Overall Study|Administrative or other reasons|13|||
147514961|NCT01810380|532037223|FG002|Overall Study|Administrative or other reasons|9|||
147514962|NCT00608842|532037224|FG000|Overall Study|Participant's Request|0|||
147514963|NCT00608842|532037225|FG001|Overall Study|Participant's Request|1|||
147514964|NCT00608842|532037226|FG002|Overall Study|Participant's Request|2|||
147514965|NCT00608842|532037227|FG003|Overall Study|Participant's Request|1|||
147514966|NCT00608842|532037224|FG000|Overall Study|Lost to Follow-up|1|||
147514967|NCT00608842|532037225|FG001|Overall Study|Lost to Follow-up|0|||
147514968|NCT00608842|532037226|FG002|Overall Study|Lost to Follow-up|0|||
147514969|NCT00608842|532037227|FG003|Overall Study|Lost to Follow-up|0|||
147514970|NCT01390038|532037228|FG000|Overall Study|Death|1|||
147514971|NCT01390038|532037228|FG000|Overall Study|Lost to Follow-up|1|||
147514972|NCT01390038|532037228|FG000|Overall Study|Withdrawal by Subject|4|||
147514973|NCT01390038|532037228|FG000|Overall Study|Simpliciti System Removal|2|||
147514974|NCT03799627|532037229|FG000|Overall Study|Adverse Event|1|||
147514975|NCT03799627|532037230|FG001|Overall Study|Adverse Event|2|||
147514976|NCT03799627|532037231|FG002|Overall Study|Adverse Event|0|||
147514977|NCT03799627|532037232|FG003|Overall Study|Adverse Event|0|||
147514978|NCT03799627|532037233|FG004|Overall Study|Adverse Event|2|||
147514979|NCT03799627|532037234|FG005|Overall Study|Adverse Event|5|||
147514980|NCT03799627|532037235|FG006|Overall Study|Adverse Event|0|||
147514981|NCT03799627|532037236|FG007|Overall Study|Adverse Event|2|||
147514982|NCT03799627|532037237|FG008|Overall Study|Adverse Event|0|||
147514983|NCT03799627|532037229|FG000|Overall Study|Physician Decision|2|||
147514984|NCT03799627|532037230|FG001|Overall Study|Physician Decision|2|||
147514985|NCT03799627|532037231|FG002|Overall Study|Physician Decision|0|||
147514986|NCT03799627|532037232|FG003|Overall Study|Physician Decision|0|||
147514987|NCT03799627|532037233|FG004|Overall Study|Physician Decision|2|||
147514988|NCT03799627|532037234|FG005|Overall Study|Physician Decision|2|||
147514989|NCT03799627|532037235|FG006|Overall Study|Physician Decision|0|||
147514990|NCT03799627|532037236|FG007|Overall Study|Physician Decision|0|||
147514991|NCT03799627|532037237|FG008|Overall Study|Physician Decision|0|||
147514992|NCT03799627|532037229|FG000|Overall Study|Withdrawal by Subject|1|||
147514993|NCT03799627|532037230|FG001|Overall Study|Withdrawal by Subject|1|||
147514994|NCT03799627|532037231|FG002|Overall Study|Withdrawal by Subject|0|||
147514995|NCT03799627|532037232|FG003|Overall Study|Withdrawal by Subject|2|||
147514996|NCT03799627|532037233|FG004|Overall Study|Withdrawal by Subject|0|||
147514997|NCT03799627|532037234|FG005|Overall Study|Withdrawal by Subject|3|||
147514998|NCT03799627|532037235|FG006|Overall Study|Withdrawal by Subject|0|||
147514999|NCT03799627|532037236|FG007|Overall Study|Withdrawal by Subject|0|||
147515000|NCT03799627|532037237|FG008|Overall Study|Withdrawal by Subject|0|||
147515001|NCT03799627|532037229|FG000|Overall Study|Lack of Efficacy|0|||
147515002|NCT03799627|532037230|FG001|Overall Study|Lack of Efficacy|0|||
147515003|NCT03799627|532037231|FG002|Overall Study|Lack of Efficacy|0|||
147515004|NCT03799627|532037232|FG003|Overall Study|Lack of Efficacy|1|||
147515005|NCT03799627|532037233|FG004|Overall Study|Lack of Efficacy|0|||
147515006|NCT03799627|532037234|FG005|Overall Study|Lack of Efficacy|0|||
147515007|NCT03799627|532037235|FG006|Overall Study|Lack of Efficacy|0|||
147515008|NCT03799627|532037236|FG007|Overall Study|Lack of Efficacy|0|||
147515009|NCT03799627|532037237|FG008|Overall Study|Lack of Efficacy|0|||
147515010|NCT03799627|532037229|FG000|Overall Study|Lost to Follow-up|0|||
147515011|NCT03799627|532037230|FG001|Overall Study|Lost to Follow-up|0|||
147515012|NCT03799627|532037231|FG002|Overall Study|Lost to Follow-up|0|||
147515013|NCT03799627|532037232|FG003|Overall Study|Lost to Follow-up|0|||
147515014|NCT03799627|532037233|FG004|Overall Study|Lost to Follow-up|0|||
147515015|NCT03799627|532037234|FG005|Overall Study|Lost to Follow-up|0|||
147515016|NCT03799627|532037235|FG006|Overall Study|Lost to Follow-up|1|||
147515017|NCT03799627|532037236|FG007|Overall Study|Lost to Follow-up|0|||
147515018|NCT03799627|532037237|FG008|Overall Study|Lost to Follow-up|1|||
147515019|NCT03799627|532037229|FG000|Overall Study|Death|0|||
147515020|NCT03799627|532037230|FG001|Overall Study|Death|0|||
147515021|NCT03799627|532037231|FG002|Overall Study|Death|0|||
147515022|NCT03799627|532037232|FG003|Overall Study|Death|1|||
147515023|NCT03799627|532037233|FG004|Overall Study|Death|0|||
147515024|NCT03799627|532037234|FG005|Overall Study|Death|0|||
147515025|NCT03799627|532037235|FG006|Overall Study|Death|0|||
147515026|NCT03799627|532037236|FG007|Overall Study|Death|0|||
147515027|NCT03799627|532037237|FG008|Overall Study|Death|0|||
147515028|NCT03799627|532037229|FG000|Overall Study|Study Drug Put on Hold|1|||
147515029|NCT03799627|532037230|FG001|Overall Study|Study Drug Put on Hold|0|||
147515030|NCT03799627|532037231|FG002|Overall Study|Study Drug Put on Hold|0|||
147515031|NCT03799627|532037232|FG003|Overall Study|Study Drug Put on Hold|0|||
147515032|NCT03799627|532037233|FG004|Overall Study|Study Drug Put on Hold|0|||
147515033|NCT03799627|532037234|FG005|Overall Study|Study Drug Put on Hold|0|||
147515034|NCT03799627|532037235|FG006|Overall Study|Study Drug Put on Hold|0|||
147515035|NCT03799627|532037236|FG007|Overall Study|Study Drug Put on Hold|0|||
147515036|NCT03799627|532037237|FG008|Overall Study|Study Drug Put on Hold|0|||
147515037|NCT03799627|532037229|FG000|Overall Study|Due to Urgent Safety Measures Letter|1|||
147515038|NCT03799627|532037230|FG001|Overall Study|Due to Urgent Safety Measures Letter|2|||
147515039|NCT03799627|532037231|FG002|Overall Study|Due to Urgent Safety Measures Letter|0|||
147515040|NCT03799627|532037232|FG003|Overall Study|Due to Urgent Safety Measures Letter|2|||
147515041|NCT03799627|532037233|FG004|Overall Study|Due to Urgent Safety Measures Letter|1|||
147515042|NCT03799627|532037234|FG005|Overall Study|Due to Urgent Safety Measures Letter|0|||
147515043|NCT03799627|532037235|FG006|Overall Study|Due to Urgent Safety Measures Letter|0|||
147515044|NCT03799627|532037236|FG007|Overall Study|Due to Urgent Safety Measures Letter|0|||
147515045|NCT03799627|532037237|FG008|Overall Study|Due to Urgent Safety Measures Letter|0|||
147515046|NCT03799627|532037229|FG000|Overall Study|Kidney Transplantation|1|||
147515047|NCT03799627|532037230|FG001|Overall Study|Kidney Transplantation|0|||
147515048|NCT03799627|532037231|FG002|Overall Study|Kidney Transplantation|0|||
147515049|NCT03799627|532037232|FG003|Overall Study|Kidney Transplantation|1|||
147515050|NCT03799627|532037233|FG004|Overall Study|Kidney Transplantation|1|||
147515051|NCT03799627|532037234|FG005|Overall Study|Kidney Transplantation|0|||
147515052|NCT03799627|532037235|FG006|Overall Study|Kidney Transplantation|0|||
147515053|NCT03799627|532037236|FG007|Overall Study|Kidney Transplantation|0|||
147515054|NCT03799627|532037237|FG008|Overall Study|Kidney Transplantation|0|||
147515055|NCT03799627|532037229|FG000|Overall Study|Participant Was on Rescue Epogen|0|||
147515056|NCT03799627|532037230|FG001|Overall Study|Participant Was on Rescue Epogen|1|||
147515057|NCT03799627|532037231|FG002|Overall Study|Participant Was on Rescue Epogen|0|||
147515058|NCT03799627|532037232|FG003|Overall Study|Participant Was on Rescue Epogen|0|||
147515059|NCT03799627|532037233|FG004|Overall Study|Participant Was on Rescue Epogen|0|||
147515060|NCT03799627|532037234|FG005|Overall Study|Participant Was on Rescue Epogen|0|||
147515061|NCT03799627|532037235|FG006|Overall Study|Participant Was on Rescue Epogen|1|||
147515062|NCT03799627|532037236|FG007|Overall Study|Participant Was on Rescue Epogen|0|||
147515063|NCT03799627|532037237|FG008|Overall Study|Participant Was on Rescue Epogen|1|||
147515064|NCT03799627|532037229|FG000|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
147515065|NCT03799627|532037230|FG001|Overall Study|Placed on Dose Hold Until End of Treatment|1|||
147515066|NCT03799627|532037231|FG002|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
147515067|NCT03799627|532037232|FG003|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
147515068|NCT03799627|532037233|FG004|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
147515069|NCT03799627|532037234|FG005|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
147515070|NCT03799627|532037235|FG006|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
147515071|NCT03799627|532037236|FG007|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
147515072|NCT03799627|532037237|FG008|Overall Study|Placed on Dose Hold Until End of Treatment|0|||
147515073|NCT03799627|532037229|FG000|Overall Study|Met Exclusion Criteria|0|||
147515074|NCT03799627|532037230|FG001|Overall Study|Met Exclusion Criteria|0|||
147515075|NCT03799627|532037231|FG002|Overall Study|Met Exclusion Criteria|0|||
147515076|NCT03799627|532037232|FG003|Overall Study|Met Exclusion Criteria|1|||
147515077|NCT03799627|532037233|FG004|Overall Study|Met Exclusion Criteria|0|||
147515078|NCT03799627|532037234|FG005|Overall Study|Met Exclusion Criteria|0|||
147515079|NCT03799627|532037235|FG006|Overall Study|Met Exclusion Criteria|0|||
147515080|NCT03799627|532037236|FG007|Overall Study|Met Exclusion Criteria|0|||
147515081|NCT03799627|532037237|FG008|Overall Study|Met Exclusion Criteria|0|||
147515082|NCT03799627|532037229|FG000|Overall Study|Investigational Product Noncompliance|0|||
147515083|NCT03799627|532037230|FG001|Overall Study|Investigational Product Noncompliance|0|||
147515084|NCT03799627|532037231|FG002|Overall Study|Investigational Product Noncompliance|0|||
147515085|NCT03799627|532037232|FG003|Overall Study|Investigational Product Noncompliance|1|||
147515086|NCT03799627|532037233|FG004|Overall Study|Investigational Product Noncompliance|0|||
147515087|NCT03799627|532037234|FG005|Overall Study|Investigational Product Noncompliance|0|||
147515088|NCT03799627|532037235|FG006|Overall Study|Investigational Product Noncompliance|0|||
147515089|NCT03799627|532037236|FG007|Overall Study|Investigational Product Noncompliance|0|||
147515090|NCT03799627|532037237|FG008|Overall Study|Investigational Product Noncompliance|0|||
147515091|NCT03799627|532037229|FG000|Overall Study|Participant Relocation|0|||
147515092|NCT03799627|532037230|FG001|Overall Study|Participant Relocation|0|||
147515093|NCT03799627|532037231|FG002|Overall Study|Participant Relocation|0|||
147515094|NCT03799627|532037232|FG003|Overall Study|Participant Relocation|1|||
147515095|NCT03799627|532037233|FG004|Overall Study|Participant Relocation|0|||
147515096|NCT03799627|532037234|FG005|Overall Study|Participant Relocation|1|||
147515097|NCT03799627|532037235|FG006|Overall Study|Participant Relocation|0|||
147515098|NCT03799627|532037236|FG007|Overall Study|Participant Relocation|0|||
147515099|NCT03799627|532037237|FG008|Overall Study|Participant Relocation|0|||
147515100|NCT03799627|532037229|FG000|Overall Study|Eurofin Issue|0|||
147515101|NCT03799627|532037230|FG001|Overall Study|Eurofin Issue|0|||
147515102|NCT03799627|532037231|FG002|Overall Study|Eurofin Issue|0|||
147515103|NCT03799627|532037232|FG003|Overall Study|Eurofin Issue|0|||
147515104|NCT03799627|532037233|FG004|Overall Study|Eurofin Issue|1|||
147515105|NCT03799627|532037234|FG005|Overall Study|Eurofin Issue|0|||
147515106|NCT03799627|532037235|FG006|Overall Study|Eurofin Issue|0|||
147515107|NCT03799627|532037236|FG007|Overall Study|Eurofin Issue|0|||
147515108|NCT03799627|532037237|FG008|Overall Study|Eurofin Issue|0|||
147515109|NCT03799627|532037229|FG000|Overall Study|Noncompliance with Site Instructions|0|||
147515110|NCT03799627|532037230|FG001|Overall Study|Noncompliance with Site Instructions|0|||
147515111|NCT03799627|532037231|FG002|Overall Study|Noncompliance with Site Instructions|0|||
147515112|NCT03799627|532037232|FG003|Overall Study|Noncompliance with Site Instructions|0|||
147515113|NCT03799627|532037233|FG004|Overall Study|Noncompliance with Site Instructions|1|||
147515114|NCT03799627|532037234|FG005|Overall Study|Noncompliance with Site Instructions|0|||
147515115|NCT03799627|532037235|FG006|Overall Study|Noncompliance with Site Instructions|0|||
147515116|NCT03799627|532037236|FG007|Overall Study|Noncompliance with Site Instructions|0|||
147515117|NCT03799627|532037237|FG008|Overall Study|Noncompliance with Site Instructions|0|||
147515118|NCT03799627|532037229|FG000|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
147515119|NCT03799627|532037230|FG001|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
147515120|NCT03799627|532037231|FG002|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
147515121|NCT03799627|532037232|FG003|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
147515122|NCT03799627|532037233|FG004|Overall Study|Participant's Last Dose Prior to End of Treatment|1|||
147515123|NCT03799627|532037234|FG005|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
147515124|NCT03799627|532037235|FG006|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
147515125|NCT03799627|532037236|FG007|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
147515126|NCT03799627|532037237|FG008|Overall Study|Participant's Last Dose Prior to End of Treatment|0|||
147515127|NCT03799627|532037229|FG000|Overall Study|Changes In Hemoglobin Values|1|||
147515128|NCT03799627|532037230|FG001|Overall Study|Changes In Hemoglobin Values|2|||
147515129|NCT03799627|532037231|FG002|Overall Study|Changes In Hemoglobin Values|1|||
147515130|NCT03799627|532037232|FG003|Overall Study|Changes In Hemoglobin Values|0|||
147515131|NCT03799627|532037233|FG004|Overall Study|Changes In Hemoglobin Values|0|||
147515132|NCT03799627|532037234|FG005|Overall Study|Changes In Hemoglobin Values|2|||
147515133|NCT03799627|532037235|FG006|Overall Study|Changes In Hemoglobin Values|1|||
147515134|NCT03799627|532037236|FG007|Overall Study|Changes In Hemoglobin Values|0|||
147515135|NCT03799627|532037237|FG008|Overall Study|Changes In Hemoglobin Values|1|||
147515136|NCT00441012|532037242|FG000|Overall Study|Adverse Event|0|||
147515137|NCT00441012|532037243|FG001|Overall Study|Adverse Event|1|||
147515138|NCT00441012|532037242|FG000|Overall Study|Lost to Follow-up|3|||
147515139|NCT00441012|532037243|FG001|Overall Study|Lost to Follow-up|3|||
147515140|NCT00441012|532037242|FG000|Overall Study|Protocol Violation|10|||
147515141|NCT00441012|532037243|FG001|Overall Study|Protocol Violation|9|||
147515142|NCT00441012|532037242|FG000|Overall Study|Withdrawal by Subject|4|||
147515143|NCT00441012|532037243|FG001|Overall Study|Withdrawal by Subject|0|||
147515144|NCT00441012|532037242|FG000|Overall Study|Subject Randomized but Not Vaccinated|1|||
147515145|NCT00441012|532037243|FG001|Overall Study|Subject Randomized but Not Vaccinated|0|||
147515146|NCT00814307|532037244|FG000|Overall Study|Randomized but not treated|1|||
147515147|NCT00814307|532037245|FG001|Overall Study|Randomized but not treated|0|||
147515148|NCT00814307|532037246|FG002|Overall Study|Randomized but not treated|0|||
147515149|NCT00814307|532037247|FG003|Overall Study|Randomized but not treated|0|||
147515150|NCT00814307|532037244|FG000|Overall Study|Adverse Event|3|||
147515151|NCT00814307|532037245|FG001|Overall Study|Adverse Event|9|||
147515152|NCT00814307|532037246|FG002|Overall Study|Adverse Event|3|||
147515153|NCT00814307|532037247|FG003|Overall Study|Adverse Event|2|||
147515154|NCT00814307|532037244|FG000|Overall Study|Lack of Efficacy|1|||
147515155|NCT00814307|532037245|FG001|Overall Study|Lack of Efficacy|1|||
147515156|NCT00814307|532037246|FG002|Overall Study|Lack of Efficacy|3|||
147515157|NCT00814307|532037247|FG003|Overall Study|Lack of Efficacy|4|||
147515158|NCT00814307|532037244|FG000|Overall Study|Other|1|||
147515159|NCT00814307|532037245|FG001|Overall Study|Other|2|||
147515160|NCT00814307|532037246|FG002|Overall Study|Other|0|||
147515161|NCT00814307|532037247|FG003|Overall Study|Other|1|||
147515162|NCT00814307|532037244|FG000|Overall Study|Protocol Violation|2|||
147515163|NCT00814307|532037245|FG001|Overall Study|Protocol Violation|8|||
147515164|NCT00814307|532037246|FG002|Overall Study|Protocol Violation|1|||
147515165|NCT00814307|532037247|FG003|Overall Study|Protocol Violation|1|||
147515166|NCT00814307|532037244|FG000|Overall Study|Withdrawal by Subject|4|||
147515167|NCT00814307|532037245|FG001|Overall Study|Withdrawal by Subject|6|||
147515168|NCT00814307|532037246|FG002|Overall Study|Withdrawal by Subject|0|||
147515169|NCT00814307|532037247|FG003|Overall Study|Withdrawal by Subject|2|||
147515170|NCT00814307|532037244|FG000|Overall Study|Death|0|||
147515171|NCT00814307|532037245|FG001|Overall Study|Death|1|||
147515172|NCT00814307|532037246|FG002|Overall Study|Death|0|||
147515173|NCT00814307|532037247|FG003|Overall Study|Death|0|||
147515174|NCT02569398|532037252|FG000|Overall Study|Adverse Event|0|||
147515175|NCT02569398|532037253|FG001|Overall Study|Adverse Event|1|||
147515176|NCT02569398|532037254|FG002|Overall Study|Adverse Event|6|||
147515177|NCT02569398|532037252|FG000|Overall Study|Withdrawal by Subject|43|||
147515178|NCT02569398|532037253|FG001|Overall Study|Withdrawal by Subject|43|||
147515179|NCT02569398|532037254|FG002|Overall Study|Withdrawal by Subject|30|||
147515180|NCT02569398|532037252|FG000|Overall Study|Study terminated by sponsor|130|||
147515181|NCT02569398|532037253|FG001|Overall Study|Study terminated by sponsor|131|||
147515182|NCT02569398|532037254|FG002|Overall Study|Study terminated by sponsor|134|||
147515183|NCT02569398|532037252|FG000|Overall Study|Other|12|||
147515184|NCT02569398|532037253|FG001|Overall Study|Other|14|||
147515185|NCT02569398|532037254|FG002|Overall Study|Other|13|||
147515186|NCT03039192|532037257|FG000|Overall Study|Lost to Follow-up|4|||
147515187|NCT03039192|532037258|FG001|Overall Study|Lost to Follow-up|4|||
147515188|NCT03039192|532037257|FG000|Overall Study|Adverse event, serious fatal|0|||
147515189|NCT03039192|532037258|FG001|Overall Study|Adverse event, serious fatal|1|||
147515190|NCT03039192|532037257|FG000|Overall Study|Adverse event, non-fatal|0|||
147515191|NCT03039192|532037258|FG001|Overall Study|Adverse event, non-fatal|2|||
147515192|NCT03039192|532037257|FG000|Overall Study|Withdrawal by Subject|6|||
147515193|NCT03039192|532037258|FG001|Overall Study|Withdrawal by Subject|9|||
147515194|NCT03039192|532037257|FG000|Overall Study|Discontinued from treatment phase|19|||
147515195|NCT03039192|532037258|FG001|Overall Study|Discontinued from treatment phase|12|||
147515196|NCT03039192|532037257|FG000|Overall Study|Other|3|||
147515197|NCT03039192|532037258|FG001|Overall Study|Other|2|||
147515198|NCT04888507|532038535|FG000|Open-Label Treatment (OLTP) (32 Weeks)|Adverse Event|1|||
147515199|NCT00636155|532038536|FG000|Overall Study|Adverse Event|8|||
147515200|NCT00636155|532038536|FG000|Overall Study|Lack of Efficacy|1|||
147515201|NCT00636155|532038536|FG000|Overall Study|Withdrawal by Subject|3|||
147515202|NCT00636155|532038536|FG000|Overall Study|Stem cell transplant|1|||
147515203|NCT00636155|532038536|FG000|Overall Study|Physician Decision|5|||
147515204|NCT00766142|532038537|FG000|Overall Study|Protocol Violation|4|||
147515205|NCT00400946|532038538|FG000|Overall Study|Ineligible|0|||
147515206|NCT00400946|532038539|FG001|Overall Study|Ineligible|0|||
147515207|NCT00400946|532038540|FG002|Overall Study|Ineligible|0|||
147515208|NCT00400946|532038541|FG003|Overall Study|Ineligible|5|||
147515209|NCT00400946|532038542|FG004|Overall Study|Ineligible|1|||
147515210|NCT00400946|532038538|FG000|Overall Study|Induction Failure|0|||
147515211|NCT00400946|532038539|FG001|Overall Study|Induction Failure|0|||
147515212|NCT00400946|532038540|FG002|Overall Study|Induction Failure|0|||
147515213|NCT00400946|532038541|FG003|Overall Study|Induction Failure|11|||
147515214|NCT00400946|532038542|FG004|Overall Study|Induction Failure|8|||
147515215|NCT00400946|532038538|FG000|Overall Study|Induction Death|0|||
147515216|NCT00400946|532038539|FG001|Overall Study|Induction Death|0|||
147515217|NCT00400946|532038540|FG002|Overall Study|Induction Death|0|||
147515218|NCT00400946|532038541|FG003|Overall Study|Induction Death|13|||
147515219|NCT00400946|532038542|FG004|Overall Study|Induction Death|3|||
147515220|NCT00400946|532038538|FG000|Overall Study|Lost to Follow-up|1|||
147515221|NCT00400946|532038539|FG001|Overall Study|Lost to Follow-up|1|||
147515222|NCT00400946|532038540|FG002|Overall Study|Lost to Follow-up|0|||
147515223|NCT00400946|532038541|FG003|Overall Study|Lost to Follow-up|0|||
147515224|NCT00400946|532038542|FG004|Overall Study|Lost to Follow-up|1|||
147515225|NCT00400946|532038538|FG000|Overall Study|Remission Death|1|||
147515226|NCT00400946|532038539|FG001|Overall Study|Remission Death|1|||
147515227|NCT00400946|532038540|FG002|Overall Study|Remission Death|0|||
147515228|NCT00400946|532038541|FG003|Overall Study|Remission Death|0|||
147515229|NCT00400946|532038542|FG004|Overall Study|Remission Death|1|||
147515230|NCT00400946|532038538|FG000|Overall Study|Relapse|9|||
147515231|NCT00400946|532038539|FG001|Overall Study|Relapse|2|||
147515232|NCT00400946|532038540|FG002|Overall Study|Relapse|1|||
147515233|NCT00400946|532038541|FG003|Overall Study|Relapse|1|||
147515234|NCT00400946|532038542|FG004|Overall Study|Relapse|5|||
147515235|NCT00400946|532038538|FG000|Overall Study|Transplant in CR1|0|||
147515236|NCT00400946|532038539|FG001|Overall Study|Transplant in CR1|0|||
147515237|NCT00400946|532038540|FG002|Overall Study|Transplant in CR1|0|||
147515238|NCT00400946|532038541|FG003|Overall Study|Transplant in CR1|10|||
147515239|NCT00400946|532038542|FG004|Overall Study|Transplant in CR1|1|||
147515240|NCT00400946|532038538|FG000|Overall Study|Withdrawal by Subject|2|||
147515241|NCT00400946|532038539|FG001|Overall Study|Withdrawal by Subject|5|||
147515242|NCT00400946|532038540|FG002|Overall Study|Withdrawal by Subject|1|||
147515243|NCT00400946|532038541|FG003|Overall Study|Withdrawal by Subject|5|||
147515244|NCT00400946|532038542|FG004|Overall Study|Withdrawal by Subject|8|||
147515245|NCT00400946|532038538|FG000|Overall Study|Clinical|1|||
147515246|NCT00400946|532038539|FG001|Overall Study|Clinical|2|||
147515247|NCT00400946|532038540|FG002|Overall Study|Clinical|0|||
147515248|NCT00400946|532038541|FG003|Overall Study|Clinical|2|||
147515249|NCT00400946|532038542|FG004|Overall Study|Clinical|9|||
147515250|NCT00400946|532038538|FG000|Overall Study|Other|0|||
147515251|NCT00400946|532038539|FG001|Overall Study|Other|0|||
147515252|NCT00400946|532038540|FG002|Overall Study|Other|0|||
147515253|NCT00400946|532038541|FG003|Overall Study|Other|0|||
147515254|NCT00400946|532038542|FG004|Overall Study|Other|1|||
147515255|NCT05643170|532038548|FG000|Overall Study|Withdrew from study treatment due to study termination|3|||
147515256|NCT05643170|532038548|FG000|Overall Study|Adverse event (AE) that lead to treatment discontinuation|1|||
147515257|NCT02358863|532038553|FG000|Overall Study|Physician Decision|3|||
147515258|NCT02632344|532038561|FG000|Overall Study|Adverse Event|3|||
147515259|NCT02632344|532038561|FG000|Overall Study|Lack of Efficacy|3|||
147515260|NCT02632344|532038561|FG000|Overall Study|Withdrawal by Subject|2|||
147515261|NCT05426460|532038562|FG000|Overall Study|Protocol Violation|1|||
147515262|NCT05426460|532038563|FG001|Overall Study|Protocol Violation|1|||
147515263|NCT05426460|532038564|FG002|Overall Study|Protocol Violation|1|||
147515264|NCT05426460|532038565|FG003|Overall Study|Protocol Violation|0|||
147515265|NCT00589602|532038568|FG000|Overall Study|Did not collect enough CD34+ cells|1|||
147515266|NCT01804842|532038569|FG000|Overall Study|Adverse Event|1|||
147515267|NCT01804842|532038570|FG001|Overall Study|Adverse Event|1|||
147515268|NCT01804842|532038571|FG002|Overall Study|Adverse Event|0|||
147515269|NCT01804842|532038569|FG000|Overall Study|Lost to Follow-up|1|||
147515270|NCT01804842|532038570|FG001|Overall Study|Lost to Follow-up|0|||
147515271|NCT01804842|532038571|FG002|Overall Study|Lost to Follow-up|0|||
147515272|NCT01804842|532038569|FG000|Overall Study|Non-Compliance|1|||
147515273|NCT01804842|532038570|FG001|Overall Study|Non-Compliance|1|||
147515274|NCT01804842|532038571|FG002|Overall Study|Non-Compliance|0|||
147515275|NCT01804842|532038569|FG000|Overall Study|Personal Reason|0|||
147515276|NCT01804842|532038570|FG001|Overall Study|Personal Reason|0|||
147515277|NCT01804842|532038571|FG002|Overall Study|Personal Reason|1|||
147515278|NCT00413777|532038573|FG000|Fixed-dose Period|Lost to Follow-up|1|||
147515279|NCT00413777|532038574|FG001|Fixed-dose Period|Lost to Follow-up|1|||
147515280|NCT00413777|532038573|FG000|Fixed-dose Period|Adverse Event|2|||
147515281|NCT00413777|532038574|FG001|Fixed-dose Period|Adverse Event|1|||
147515282|NCT00413777|532038573|FG000|Fixed-dose Period|Met Withdrawal Criteria|1|||
147515283|NCT00413777|532038574|FG001|Fixed-dose Period|Met Withdrawal Criteria|0|||
147515284|NCT00413777|532038573|FG000|Fixed-dose Period|Withdrew Consent|0|||
147515285|NCT00413777|532038574|FG001|Fixed-dose Period|Withdrew Consent|1|||
147515286|NCT04288089|532038577|FG000|Overall Study|Ongoing Treatment|2|||
147515287|NCT04288089|532038578|FG001|Overall Study|Ongoing Treatment|1|||
147515288|NCT04288089|532038579|FG002|Overall Study|Ongoing Treatment|1|||
147515289|NCT04288089|532038580|FG003|Overall Study|Ongoing Treatment|4|||
147515290|NCT00557323|532038586|FG000|Overall Study|Death|3|||
147515291|NCT00557323|532038586|FG000|Overall Study|Withdrawal by Subject|2|||
147515292|NCT00557323|532038586|FG000|Overall Study|Administrative change|2|||
147515293|NCT00498368|532038596|FG000|Overall Study|Withdrawal by Subject|3|||
147515294|NCT00498368|532038597|FG001|Overall Study|Withdrawal by Subject|2|||
147515295|NCT02266004|532038598|FG000|Overall Study|unrelated adverse event|1|||
147515296|NCT02266004|532038598|FG000|Overall Study|Physician Decision|1|||
147515297|NCT00537771|532038603|FG000|Overall Study|Withdrawal by Subject|6|||
147515298|NCT00537771|532038604|FG001|Overall Study|Withdrawal by Subject|23|||
147515299|NCT00537771|532038603|FG000|Overall Study|Adverse Event|8|||
147515300|NCT00537771|532038604|FG001|Overall Study|Adverse Event|15|||
147515301|NCT00537771|532038603|FG000|Overall Study|Lost to Follow-up|9|||
147515302|NCT00537771|532038604|FG001|Overall Study|Lost to Follow-up|15|||
147515303|NCT00537771|532038603|FG000|Overall Study|Protocol Violation|2|||
147515304|NCT00537771|532038604|FG001|Overall Study|Protocol Violation|6|||
147515305|NCT00537771|532038603|FG000|Overall Study|Severe Non-Compliance to Protocol|4|||
147515306|NCT00537771|532038604|FG001|Overall Study|Severe Non-Compliance to Protocol|2|||
147515307|NCT00414973|532038611|FG000|Overall Study|Withdrawal by Subject|14|||
147515308|NCT00414973|532038612|FG001|Overall Study|Withdrawal by Subject|4|||
147515309|NCT00414973|532038613|FG002|Overall Study|Withdrawal by Subject|1|||
147515310|NCT00414973|532038614|FG003|Overall Study|Withdrawal by Subject|0|||
147515311|NCT00414973|532038611|FG000|Overall Study|Adverse Event|10|||
147515312|NCT00414973|532038612|FG001|Overall Study|Adverse Event|0|||
147515313|NCT00414973|532038613|FG002|Overall Study|Adverse Event|1|||
147515314|NCT00414973|532038614|FG003|Overall Study|Adverse Event|0|||
147515315|NCT00414973|532038611|FG000|Overall Study|Protocol Violation|3|||
147515316|NCT00414973|532038612|FG001|Overall Study|Protocol Violation|4|||
147515317|NCT00414973|532038613|FG002|Overall Study|Protocol Violation|0|||
147515318|NCT00414973|532038614|FG003|Overall Study|Protocol Violation|0|||
147515319|NCT00414973|532038611|FG000|Overall Study|Lost to Follow-up|0|||
147515320|NCT00414973|532038612|FG001|Overall Study|Lost to Follow-up|2|||
147515321|NCT00414973|532038613|FG002|Overall Study|Lost to Follow-up|0|||
147515322|NCT00414973|532038614|FG003|Overall Study|Lost to Follow-up|0|||
147515323|NCT00414973|532038611|FG000|Overall Study|Sponsor Decision|1|||
147515324|NCT00414973|532038612|FG001|Overall Study|Sponsor Decision|0|||
147515325|NCT00414973|532038613|FG002|Overall Study|Sponsor Decision|0|||
147515326|NCT00414973|532038614|FG003|Overall Study|Sponsor Decision|0|||
147515327|NCT00414973|532038611|FG000|Overall Study|Death|0|||
147515328|NCT00414973|532038612|FG001|Overall Study|Death|0|||
147515329|NCT00414973|532038613|FG002|Overall Study|Death|1|||
147515330|NCT00414973|532038614|FG003|Overall Study|Death|0|||
147515331|NCT04247828|532038620|FG000|Overall Study|covid-19 mandated patient recruitment restrictions|9|||
147515332|NCT01512693|532038621|FG000|Overall Study|Withdrawal by Subject|0|||
147515333|NCT01512693|532038622|FG001|Overall Study|Withdrawal by Subject|1|||
147515334|NCT02699125|532038634|FG000|Placebo|Lost to Follow-up|2|||
147515335|NCT02699125|532038635|FG001|Placebo|Lost to Follow-up|0|||
147515336|NCT02699125|532038634|FG000|Placebo|Protocol Violation|1|||
147515337|NCT02699125|532038635|FG001|Placebo|Protocol Violation|0|||
147515338|NCT02699125|532038634|FG000|Placebo|Withdrawal by Subject|0|||
147515339|NCT02699125|532038635|FG001|Placebo|Withdrawal by Subject|4|||
147515340|NCT02699125|532038634|FG000|Second Intervention (6 Weeks).|Withdrawal by Subject|7|||
147515341|NCT02699125|532038635|FG001|Second Intervention (6 Weeks).|Withdrawal by Subject|2|||
147515342|NCT04445051|532038637|FG000|Overall Study|Adverse Event|0|||
147515343|NCT04445051|532038638|FG001|Overall Study|Adverse Event|0|||
147515344|NCT04445051|532038639|FG002|Overall Study|Adverse Event|1|||
147515345|NCT04445051|532038640|FG003|Overall Study|Adverse Event|0|||
147515346|NCT04445051|532038641|FG004|Overall Study|Adverse Event|0|||
147515347|NCT04445051|532038642|FG005|Overall Study|Adverse Event|0|||
147515348|NCT02092324|532038649|FG000|Overall Study|Adverse Event|1|||
147515349|NCT02092324|532038649|FG000|Overall Study|Lack of Efficacy|6|||
147515350|NCT02092324|532038649|FG000|Overall Study|Proceed to Transplant|3|||
147515351|NCT02092324|532038649|FG000|Overall Study|Physician Decision|7|||
147515352|NCT02092324|532038649|FG000|Overall Study|Misdiagnosis|2|||
147515353|NCT00398138|532038652|FG000|Overall Study|Adverse Event|2|||
147515354|NCT04973085|532038657|FG000|First Intervention|Claustrophobia in the MRI machine.|1|||
147515355|NCT04973085|532038658|FG001|First Intervention|Claustrophobia in the MRI machine.|0|||
147515356|NCT01316380|532038664|FG000|Overall Study|Adverse Event|0|||
147515357|NCT01316380|532038665|FG001|Overall Study|Adverse Event|2|||
147515358|NCT01316380|532038666|FG002|Overall Study|Adverse Event|1|||
147515359|NCT01316380|532038664|FG000|Overall Study|Protocol Violation|0|||
147515360|NCT01316380|532038665|FG001|Overall Study|Protocol Violation|0|||
147515361|NCT01316380|532038666|FG002|Overall Study|Protocol Violation|1|||
147515362|NCT01316380|532038664|FG000|Overall Study|Withdrawal by Subject|1|||
147515363|NCT01316380|532038665|FG001|Overall Study|Withdrawal by Subject|2|||
147515364|NCT01316380|532038666|FG002|Overall Study|Withdrawal by Subject|0|||
147515365|NCT01316380|532038664|FG000|Overall Study|Other|0|||
147515366|NCT01316380|532038665|FG001|Overall Study|Other|1|||
147515367|NCT01316380|532038666|FG002|Overall Study|Other|1|||
147515368|NCT01316380|532038664|FG000|Overall Study|Not treated|1|||
147515369|NCT01316380|532038665|FG001|Overall Study|Not treated|0|||
147515370|NCT01316380|532038666|FG002|Overall Study|Not treated|0|||
147515371|NCT03073200|532038674|FG000|Double Blind Treatment Period|Protocol Violation|1|||
147515372|NCT03073200|532038675|FG001|Double Blind Treatment Period|Protocol Violation|0|||
147515373|NCT03073200|532038676|FG002|Double Blind Treatment Period|Protocol Violation|0|||
147515374|NCT03073200|532038677|FG003|Double Blind Treatment Period|Protocol Violation|0|||
147515375|NCT03073200|532038678|FG004|Double Blind Treatment Period|Protocol Violation|0|||
147515376|NCT03073200|532038679|FG005|Double Blind Treatment Period|Protocol Violation|0|||
147515377|NCT03073200|532038680|FG006|Double Blind Treatment Period|Protocol Violation|0|||
147515378|NCT03073200|532038681|FG007|Double Blind Treatment Period|Protocol Violation|0|||
147515379|NCT03073200|532038682|FG008|Double Blind Treatment Period|Protocol Violation|0|||
147515380|NCT03073200|532038683|FG009|Double Blind Treatment Period|Protocol Violation|0|||
147515381|NCT03073200|532038684|FG010|Double Blind Treatment Period|Protocol Violation|0|||
147515382|NCT03073200|532038685|FG011|Double Blind Treatment Period|Protocol Violation|0|||
147515383|NCT03073200|532038686|FG012|Double Blind Treatment Period|Protocol Violation|0|||
147515384|NCT03073200|532038687|FG013|Double Blind Treatment Period|Protocol Violation|0|||
147515385|NCT03073200|532038688|FG014|Double Blind Treatment Period|Protocol Violation|0|||
147515386|NCT03073200|532038674|FG000|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
147515387|NCT03073200|532038675|FG001|Double Blind Treatment Period|Withdrawal by Parent/Guardian|1|||
147515388|NCT03073200|532038676|FG002|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
147515389|NCT03073200|532038677|FG003|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
147515390|NCT03073200|532038678|FG004|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
147515391|NCT03073200|532038679|FG005|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
147515392|NCT03073200|532038680|FG006|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
147515393|NCT03073200|532038681|FG007|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
147515394|NCT03073200|532038682|FG008|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
147515395|NCT03073200|532038683|FG009|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
147515396|NCT03073200|532038684|FG010|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
147515397|NCT03073200|532038685|FG011|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
147515398|NCT03073200|532038686|FG012|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
147515399|NCT03073200|532038687|FG013|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
147515400|NCT03073200|532038688|FG014|Double Blind Treatment Period|Withdrawal by Parent/Guardian|0|||
147515401|NCT03073200|532038674|FG000|Double Blind Treatment Period|Withdrawal by Subject|1|||
147515402|NCT03073200|532038675|FG001|Double Blind Treatment Period|Withdrawal by Subject|0|||
147515403|NCT03073200|532038676|FG002|Double Blind Treatment Period|Withdrawal by Subject|0|||
147515404|NCT03073200|532038677|FG003|Double Blind Treatment Period|Withdrawal by Subject|0|||
147515405|NCT03073200|532038678|FG004|Double Blind Treatment Period|Withdrawal by Subject|0|||
147515406|NCT03073200|532038679|FG005|Double Blind Treatment Period|Withdrawal by Subject|0|||
147515407|NCT03073200|532038680|FG006|Double Blind Treatment Period|Withdrawal by Subject|0|||
147515408|NCT03073200|532038681|FG007|Double Blind Treatment Period|Withdrawal by Subject|0|||
147515409|NCT03073200|532038682|FG008|Double Blind Treatment Period|Withdrawal by Subject|0|||
147515410|NCT03073200|532038683|FG009|Double Blind Treatment Period|Withdrawal by Subject|0|||
147515411|NCT03073200|532038684|FG010|Double Blind Treatment Period|Withdrawal by Subject|0|||
147515412|NCT03073200|532038685|FG011|Double Blind Treatment Period|Withdrawal by Subject|0|||
147515413|NCT03073200|532038686|FG012|Double Blind Treatment Period|Withdrawal by Subject|0|||
147515414|NCT03073200|532038687|FG013|Double Blind Treatment Period|Withdrawal by Subject|0|||
147515415|NCT03073200|532038688|FG014|Double Blind Treatment Period|Withdrawal by Subject|0|||
147515416|NCT03073200|532038674|FG000|Open-Label Maintenance Period|Lost to Follow-up|0|||
147515417|NCT03073200|532038675|FG001|Open-Label Maintenance Period|Lost to Follow-up|0|||
147515418|NCT03073200|532038676|FG002|Open-Label Maintenance Period|Lost to Follow-up|0|||
147515419|NCT03073200|532038677|FG003|Open-Label Maintenance Period|Lost to Follow-up|1|||
147515420|NCT03073200|532038678|FG004|Open-Label Maintenance Period|Lost to Follow-up|2|||
147515421|NCT03073200|532038679|FG005|Open-Label Maintenance Period|Lost to Follow-up|0|||
147515422|NCT03073200|532038680|FG006|Open-Label Maintenance Period|Lost to Follow-up|0|||
147515423|NCT03073200|532038681|FG007|Open-Label Maintenance Period|Lost to Follow-up|0|||
147515424|NCT03073200|532038682|FG008|Open-Label Maintenance Period|Lost to Follow-up|0|||
147515425|NCT03073200|532038683|FG009|Open-Label Maintenance Period|Lost to Follow-up|0|||
147515426|NCT03073200|532038684|FG010|Open-Label Maintenance Period|Lost to Follow-up|0|||
147515427|NCT03073200|532038685|FG011|Open-Label Maintenance Period|Lost to Follow-up|0|||
147515428|NCT03073200|532038686|FG012|Open-Label Maintenance Period|Lost to Follow-up|0|||
147515429|NCT03073200|532038687|FG013|Open-Label Maintenance Period|Lost to Follow-up|0|||
147515430|NCT03073200|532038688|FG014|Open-Label Maintenance Period|Lost to Follow-up|0|||
147515431|NCT03073200|532038674|FG000|Open-Label Maintenance Period|Participant moved to another city|0|||
147515432|NCT03073200|532038675|FG001|Open-Label Maintenance Period|Participant moved to another city|0|||
147515433|NCT03073200|532038676|FG002|Open-Label Maintenance Period|Participant moved to another city|0|||
147515434|NCT03073200|532038677|FG003|Open-Label Maintenance Period|Participant moved to another city|1|||
147515435|NCT03073200|532038678|FG004|Open-Label Maintenance Period|Participant moved to another city|0|||
147515436|NCT03073200|532038679|FG005|Open-Label Maintenance Period|Participant moved to another city|0|||
147515437|NCT03073200|532038680|FG006|Open-Label Maintenance Period|Participant moved to another city|0|||
147515438|NCT03073200|532038681|FG007|Open-Label Maintenance Period|Participant moved to another city|0|||
147515439|NCT03073200|532038682|FG008|Open-Label Maintenance Period|Participant moved to another city|0|||
147515440|NCT03073200|532038683|FG009|Open-Label Maintenance Period|Participant moved to another city|0|||
147515441|NCT03073200|532038684|FG010|Open-Label Maintenance Period|Participant moved to another city|0|||
147515442|NCT03073200|532038685|FG011|Open-Label Maintenance Period|Participant moved to another city|0|||
147515443|NCT03073200|532038686|FG012|Open-Label Maintenance Period|Participant moved to another city|0|||
147515444|NCT03073200|532038687|FG013|Open-Label Maintenance Period|Participant moved to another city|0|||
147515445|NCT03073200|532038688|FG014|Open-Label Maintenance Period|Participant moved to another city|0|||
147515446|NCT03073200|532038674|FG000|Open-Label Maintenance Period|Lack of Efficacy|0|||
147515447|NCT03073200|532038675|FG001|Open-Label Maintenance Period|Lack of Efficacy|0|||
147515448|NCT03073200|532038676|FG002|Open-Label Maintenance Period|Lack of Efficacy|0|||
147515449|NCT03073200|532038677|FG003|Open-Label Maintenance Period|Lack of Efficacy|0|||
147515450|NCT03073200|532038678|FG004|Open-Label Maintenance Period|Lack of Efficacy|1|||
147515451|NCT03073200|532038679|FG005|Open-Label Maintenance Period|Lack of Efficacy|0|||
147515452|NCT03073200|532038680|FG006|Open-Label Maintenance Period|Lack of Efficacy|0|||
147515453|NCT03073200|532038681|FG007|Open-Label Maintenance Period|Lack of Efficacy|0|||
147515454|NCT03073200|532038682|FG008|Open-Label Maintenance Period|Lack of Efficacy|0|||
147515455|NCT03073200|532038683|FG009|Open-Label Maintenance Period|Lack of Efficacy|0|||
147515456|NCT03073200|532038684|FG010|Open-Label Maintenance Period|Lack of Efficacy|0|||
147515457|NCT03073200|532038685|FG011|Open-Label Maintenance Period|Lack of Efficacy|0|||
147515458|NCT03073200|532038686|FG012|Open-Label Maintenance Period|Lack of Efficacy|0|||
147515459|NCT03073200|532038687|FG013|Open-Label Maintenance Period|Lack of Efficacy|0|||
147515460|NCT03073200|532038688|FG014|Open-Label Maintenance Period|Lack of Efficacy|0|||
147515461|NCT03073200|532038674|FG000|Open-Label Maintenance Period|Withdrawal by Subject|0|||
147515462|NCT03073200|532038675|FG001|Open-Label Maintenance Period|Withdrawal by Subject|0|||
147515463|NCT03073200|532038676|FG002|Open-Label Maintenance Period|Withdrawal by Subject|0|||
147515464|NCT03073200|532038677|FG003|Open-Label Maintenance Period|Withdrawal by Subject|2|||
147515465|NCT03073200|532038678|FG004|Open-Label Maintenance Period|Withdrawal by Subject|1|||
147515466|NCT03073200|532038679|FG005|Open-Label Maintenance Period|Withdrawal by Subject|0|||
147515467|NCT03073200|532038680|FG006|Open-Label Maintenance Period|Withdrawal by Subject|0|||
147515468|NCT03073200|532038681|FG007|Open-Label Maintenance Period|Withdrawal by Subject|0|||
147515469|NCT03073200|532038682|FG008|Open-Label Maintenance Period|Withdrawal by Subject|0|||
147515470|NCT03073200|532038683|FG009|Open-Label Maintenance Period|Withdrawal by Subject|0|||
147515471|NCT03073200|532038684|FG010|Open-Label Maintenance Period|Withdrawal by Subject|0|||
147515472|NCT03073200|532038685|FG011|Open-Label Maintenance Period|Withdrawal by Subject|0|||
147515473|NCT03073200|532038686|FG012|Open-Label Maintenance Period|Withdrawal by Subject|0|||
147515474|NCT03073200|532038687|FG013|Open-Label Maintenance Period|Withdrawal by Subject|0|||
147515475|NCT03073200|532038688|FG014|Open-Label Maintenance Period|Withdrawal by Subject|0|||
147515476|NCT03073200|532038674|FG000|Extension Period|Lost to Follow-up|0|||
147515477|NCT03073200|532038675|FG001|Extension Period|Lost to Follow-up|0|||
147515478|NCT03073200|532038676|FG002|Extension Period|Lost to Follow-up|0|||
147515479|NCT03073200|532038677|FG003|Extension Period|Lost to Follow-up|0|||
147515480|NCT03073200|532038678|FG004|Extension Period|Lost to Follow-up|0|||
147515481|NCT03073200|532038679|FG005|Extension Period|Lost to Follow-up|0|||
147515482|NCT03073200|532038680|FG006|Extension Period|Lost to Follow-up|1|||
147515483|NCT03073200|532038681|FG007|Extension Period|Lost to Follow-up|1|||
147515484|NCT03073200|532038682|FG008|Extension Period|Lost to Follow-up|0|||
147515485|NCT03073200|532038683|FG009|Extension Period|Lost to Follow-up|0|||
147515486|NCT03073200|532038684|FG010|Extension Period|Lost to Follow-up|0|||
147515487|NCT03073200|532038685|FG011|Extension Period|Lost to Follow-up|0|||
147515488|NCT03073200|532038686|FG012|Extension Period|Lost to Follow-up|0|||
147515489|NCT03073200|532038687|FG013|Extension Period|Lost to Follow-up|0|||
147515490|NCT03073200|532038688|FG014|Extension Period|Lost to Follow-up|0|||
147515491|NCT03073200|532038674|FG000|Extension Period|Sponsor Decision|0|||
147515492|NCT03073200|532038675|FG001|Extension Period|Sponsor Decision|0|||
147515493|NCT03073200|532038676|FG002|Extension Period|Sponsor Decision|0|||
147515494|NCT03073200|532038677|FG003|Extension Period|Sponsor Decision|0|||
147515495|NCT03073200|532038678|FG004|Extension Period|Sponsor Decision|0|||
147515496|NCT03073200|532038679|FG005|Extension Period|Sponsor Decision|0|||
147515497|NCT03073200|532038680|FG006|Extension Period|Sponsor Decision|0|||
147515498|NCT03073200|532038681|FG007|Extension Period|Sponsor Decision|0|||
147515499|NCT03073200|532038682|FG008|Extension Period|Sponsor Decision|1|||
147515500|NCT03073200|532038683|FG009|Extension Period|Sponsor Decision|0|||
147515501|NCT03073200|532038684|FG010|Extension Period|Sponsor Decision|0|||
147515502|NCT03073200|532038685|FG011|Extension Period|Sponsor Decision|0|||
147515503|NCT03073200|532038686|FG012|Extension Period|Sponsor Decision|0|||
147515504|NCT03073200|532038687|FG013|Extension Period|Sponsor Decision|0|||
147515505|NCT03073200|532038688|FG014|Extension Period|Sponsor Decision|0|||
147515506|NCT03073200|532038674|FG000|Extension Period|Withdrawal by Parent/Guardian|0|||
147515507|NCT03073200|532038675|FG001|Extension Period|Withdrawal by Parent/Guardian|0|||
147515508|NCT03073200|532038676|FG002|Extension Period|Withdrawal by Parent/Guardian|0|||
147515509|NCT03073200|532038677|FG003|Extension Period|Withdrawal by Parent/Guardian|0|||
147515510|NCT03073200|532038678|FG004|Extension Period|Withdrawal by Parent/Guardian|0|||
147515511|NCT03073200|532038679|FG005|Extension Period|Withdrawal by Parent/Guardian|0|||
147515512|NCT03073200|532038680|FG006|Extension Period|Withdrawal by Parent/Guardian|1|||
147515513|NCT03073200|532038681|FG007|Extension Period|Withdrawal by Parent/Guardian|3|||
147515514|NCT03073200|532038682|FG008|Extension Period|Withdrawal by Parent/Guardian|1|||
147515515|NCT03073200|532038683|FG009|Extension Period|Withdrawal by Parent/Guardian|0|||
147515516|NCT03073200|532038684|FG010|Extension Period|Withdrawal by Parent/Guardian|0|||
147515517|NCT03073200|532038685|FG011|Extension Period|Withdrawal by Parent/Guardian|0|||
147515518|NCT03073200|532038686|FG012|Extension Period|Withdrawal by Parent/Guardian|0|||
147515519|NCT03073200|532038687|FG013|Extension Period|Withdrawal by Parent/Guardian|0|||
147515520|NCT03073200|532038688|FG014|Extension Period|Withdrawal by Parent/Guardian|0|||
147515521|NCT03073200|532038674|FG000|Extension Period|Withdrawal by Subject|0|||
147515522|NCT03073200|532038675|FG001|Extension Period|Withdrawal by Subject|0|||
147515523|NCT03073200|532038676|FG002|Extension Period|Withdrawal by Subject|0|||
147515524|NCT03073200|532038677|FG003|Extension Period|Withdrawal by Subject|0|||
147515525|NCT03073200|532038678|FG004|Extension Period|Withdrawal by Subject|0|||
147515526|NCT03073200|532038679|FG005|Extension Period|Withdrawal by Subject|0|||
147515527|NCT03073200|532038680|FG006|Extension Period|Withdrawal by Subject|1|||
147515528|NCT03073200|532038681|FG007|Extension Period|Withdrawal by Subject|2|||
147515529|NCT03073200|532038682|FG008|Extension Period|Withdrawal by Subject|0|||
147515530|NCT03073200|532038683|FG009|Extension Period|Withdrawal by Subject|0|||
147515531|NCT03073200|532038684|FG010|Extension Period|Withdrawal by Subject|0|||
147515532|NCT03073200|532038685|FG011|Extension Period|Withdrawal by Subject|0|||
147515533|NCT03073200|532038686|FG012|Extension Period|Withdrawal by Subject|0|||
147515534|NCT03073200|532038687|FG013|Extension Period|Withdrawal by Subject|0|||
147515535|NCT03073200|532038688|FG014|Extension Period|Withdrawal by Subject|0|||
147515536|NCT03073200|532038674|FG000|Randomized Withdrawal Period|Lost to Follow-up|0|||
147515537|NCT03073200|532038675|FG001|Randomized Withdrawal Period|Lost to Follow-up|0|||
147515538|NCT03073200|532038676|FG002|Randomized Withdrawal Period|Lost to Follow-up|0|||
147515539|NCT03073200|532038677|FG003|Randomized Withdrawal Period|Lost to Follow-up|0|||
147515540|NCT03073200|532038678|FG004|Randomized Withdrawal Period|Lost to Follow-up|0|||
147515541|NCT03073200|532038679|FG005|Randomized Withdrawal Period|Lost to Follow-up|0|||
147515542|NCT03073200|532038680|FG006|Randomized Withdrawal Period|Lost to Follow-up|0|||
147515543|NCT03073200|532038681|FG007|Randomized Withdrawal Period|Lost to Follow-up|0|||
147515544|NCT03073200|532038682|FG008|Randomized Withdrawal Period|Lost to Follow-up|0|||
147515545|NCT03073200|532038683|FG009|Randomized Withdrawal Period|Lost to Follow-up|0|||
147515546|NCT03073200|532038684|FG010|Randomized Withdrawal Period|Lost to Follow-up|0|||
147515547|NCT03073200|532038685|FG011|Randomized Withdrawal Period|Lost to Follow-up|1|||
147515548|NCT03073200|532038686|FG012|Randomized Withdrawal Period|Lost to Follow-up|0|||
147515549|NCT03073200|532038687|FG013|Randomized Withdrawal Period|Lost to Follow-up|0|||
147515550|NCT03073200|532038688|FG014|Randomized Withdrawal Period|Lost to Follow-up|0|||
147515551|NCT03073200|532038674|FG000|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
147515552|NCT03073200|532038675|FG001|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
147515553|NCT03073200|532038676|FG002|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
147515554|NCT03073200|532038677|FG003|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
147515555|NCT03073200|532038678|FG004|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
147515556|NCT03073200|532038679|FG005|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
147515557|NCT03073200|532038680|FG006|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
147515558|NCT03073200|532038681|FG007|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
147515559|NCT03073200|532038682|FG008|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
147515560|NCT03073200|532038683|FG009|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
147515561|NCT03073200|532038684|FG010|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
147515562|NCT03073200|532038685|FG011|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|1|||
147515563|NCT03073200|532038686|FG012|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
147515564|NCT03073200|532038687|FG013|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
147515565|NCT03073200|532038688|FG014|Randomized Withdrawal Period|Withdrawal by Parent/Guardian|0|||
147515566|NCT03073200|532038674|FG000|Randomized Withdrawal Period|Withdrawal by Subject|0|||
147515567|NCT03073200|532038675|FG001|Randomized Withdrawal Period|Withdrawal by Subject|0|||
147515568|NCT03073200|532038676|FG002|Randomized Withdrawal Period|Withdrawal by Subject|0|||
147515569|NCT03073200|532038677|FG003|Randomized Withdrawal Period|Withdrawal by Subject|0|||
147515570|NCT03073200|532038678|FG004|Randomized Withdrawal Period|Withdrawal by Subject|0|||
147515571|NCT03073200|532038679|FG005|Randomized Withdrawal Period|Withdrawal by Subject|0|||
147515572|NCT03073200|532038680|FG006|Randomized Withdrawal Period|Withdrawal by Subject|0|||
147515573|NCT03073200|532038681|FG007|Randomized Withdrawal Period|Withdrawal by Subject|0|||
147515574|NCT03073200|532038682|FG008|Randomized Withdrawal Period|Withdrawal by Subject|0|||
147515575|NCT03073200|532038683|FG009|Randomized Withdrawal Period|Withdrawal by Subject|0|||
147515576|NCT03073200|532038684|FG010|Randomized Withdrawal Period|Withdrawal by Subject|1|||
147515577|NCT03073200|532038685|FG011|Randomized Withdrawal Period|Withdrawal by Subject|1|||
147515578|NCT03073200|532038686|FG012|Randomized Withdrawal Period|Withdrawal by Subject|0|||
147515579|NCT03073200|532038687|FG013|Randomized Withdrawal Period|Withdrawal by Subject|0|||
147515580|NCT03073200|532038688|FG014|Randomized Withdrawal Period|Withdrawal by Subject|0|||
147515581|NCT03073200|532038674|FG000|Randomized Withdrawal Period|Adverse Event|0|||
147515582|NCT03073200|532038675|FG001|Randomized Withdrawal Period|Adverse Event|0|||
147515583|NCT03073200|532038676|FG002|Randomized Withdrawal Period|Adverse Event|0|||
147515584|NCT03073200|532038677|FG003|Randomized Withdrawal Period|Adverse Event|0|||
147515585|NCT03073200|532038678|FG004|Randomized Withdrawal Period|Adverse Event|0|||
147515586|NCT03073200|532038679|FG005|Randomized Withdrawal Period|Adverse Event|0|||
147515587|NCT03073200|532038680|FG006|Randomized Withdrawal Period|Adverse Event|0|||
147515588|NCT03073200|532038681|FG007|Randomized Withdrawal Period|Adverse Event|0|||
147515589|NCT03073200|532038682|FG008|Randomized Withdrawal Period|Adverse Event|0|||
147515590|NCT03073200|532038683|FG009|Randomized Withdrawal Period|Adverse Event|0|||
147515591|NCT03073200|532038684|FG010|Randomized Withdrawal Period|Adverse Event|1|||
147515592|NCT03073200|532038685|FG011|Randomized Withdrawal Period|Adverse Event|0|||
147515593|NCT03073200|532038686|FG012|Randomized Withdrawal Period|Adverse Event|0|||
147515594|NCT03073200|532038687|FG013|Randomized Withdrawal Period|Adverse Event|0|||
147515595|NCT03073200|532038688|FG014|Randomized Withdrawal Period|Adverse Event|0|||
147515596|NCT03073200|532038674|FG000|Post-Treatment Follow-Up Period|Adverse Event|0|||
147515597|NCT03073200|532038675|FG001|Post-Treatment Follow-Up Period|Adverse Event|0|||
147515598|NCT03073200|532038676|FG002|Post-Treatment Follow-Up Period|Adverse Event|0|||
147515599|NCT03073200|532038677|FG003|Post-Treatment Follow-Up Period|Adverse Event|0|||
147515600|NCT03073200|532038678|FG004|Post-Treatment Follow-Up Period|Adverse Event|0|||
147515601|NCT03073200|532038679|FG005|Post-Treatment Follow-Up Period|Adverse Event|0|||
147515602|NCT03073200|532038680|FG006|Post-Treatment Follow-Up Period|Adverse Event|0|||
147515603|NCT03073200|532038681|FG007|Post-Treatment Follow-Up Period|Adverse Event|0|||
147515604|NCT03073200|532038682|FG008|Post-Treatment Follow-Up Period|Adverse Event|0|||
147515605|NCT03073200|532038683|FG009|Post-Treatment Follow-Up Period|Adverse Event|0|||
147515606|NCT03073200|532038684|FG010|Post-Treatment Follow-Up Period|Adverse Event|0|||
147515607|NCT03073200|532038685|FG011|Post-Treatment Follow-Up Period|Adverse Event|0|||
147515608|NCT03073200|532038686|FG012|Post-Treatment Follow-Up Period|Adverse Event|0|||
147515609|NCT03073200|532038687|FG013|Post-Treatment Follow-Up Period|Adverse Event|2|||
147515610|NCT03073200|532038688|FG014|Post-Treatment Follow-Up Period|Adverse Event|0|||
147515611|NCT03073200|532038674|FG000|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
147515612|NCT03073200|532038675|FG001|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
147515613|NCT03073200|532038676|FG002|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
147515614|NCT03073200|532038677|FG003|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
147515615|NCT03073200|532038678|FG004|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
147515616|NCT03073200|532038679|FG005|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
147515617|NCT03073200|532038680|FG006|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
147515618|NCT03073200|532038681|FG007|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
147515619|NCT03073200|532038682|FG008|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
147515620|NCT03073200|532038683|FG009|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
147515621|NCT03073200|532038684|FG010|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
147515622|NCT03073200|532038685|FG011|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
147515623|NCT03073200|532038686|FG012|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
147515624|NCT03073200|532038687|FG013|Post-Treatment Follow-Up Period|Lost to Follow-up|1|||
147515625|NCT03073200|532038688|FG014|Post-Treatment Follow-Up Period|Lost to Follow-up|0|||
147515626|NCT03073200|532038674|FG000|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
147515627|NCT03073200|532038675|FG001|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
147515628|NCT03073200|532038676|FG002|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
147515629|NCT03073200|532038677|FG003|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
147515630|NCT03073200|532038678|FG004|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
147515631|NCT03073200|532038679|FG005|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
147515632|NCT03073200|532038680|FG006|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
147515633|NCT03073200|532038681|FG007|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
147515634|NCT03073200|532038682|FG008|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
147515635|NCT03073200|532038683|FG009|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
147515636|NCT03073200|532038684|FG010|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
147515637|NCT03073200|532038685|FG011|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
147515638|NCT03073200|532038686|FG012|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
147515639|NCT03073200|532038687|FG013|Post-Treatment Follow-Up Period|Participant moved to another city|1|||
147515640|NCT03073200|532038688|FG014|Post-Treatment Follow-Up Period|Participant moved to another city|0|||
147515641|NCT03073200|532038674|FG000|Post-Treatment Follow-Up Period|Protocol Violation|0|||
147515642|NCT03073200|532038675|FG001|Post-Treatment Follow-Up Period|Protocol Violation|0|||
147515643|NCT03073200|532038676|FG002|Post-Treatment Follow-Up Period|Protocol Violation|0|||
147515644|NCT03073200|532038677|FG003|Post-Treatment Follow-Up Period|Protocol Violation|0|||
147515645|NCT03073200|532038678|FG004|Post-Treatment Follow-Up Period|Protocol Violation|0|||
147515646|NCT03073200|532038679|FG005|Post-Treatment Follow-Up Period|Protocol Violation|0|||
147515647|NCT03073200|532038680|FG006|Post-Treatment Follow-Up Period|Protocol Violation|0|||
147515648|NCT03073200|532038681|FG007|Post-Treatment Follow-Up Period|Protocol Violation|0|||
147515649|NCT03073200|532038682|FG008|Post-Treatment Follow-Up Period|Protocol Violation|0|||
147515650|NCT03073200|532038683|FG009|Post-Treatment Follow-Up Period|Protocol Violation|0|||
147515651|NCT03073200|532038684|FG010|Post-Treatment Follow-Up Period|Protocol Violation|0|||
147515652|NCT03073200|532038685|FG011|Post-Treatment Follow-Up Period|Protocol Violation|0|||
147515653|NCT03073200|532038686|FG012|Post-Treatment Follow-Up Period|Protocol Violation|0|||
147515654|NCT03073200|532038687|FG013|Post-Treatment Follow-Up Period|Protocol Violation|1|||
147515655|NCT03073200|532038688|FG014|Post-Treatment Follow-Up Period|Protocol Violation|0|||
147515656|NCT03073200|532038674|FG000|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
147515657|NCT03073200|532038675|FG001|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
147515658|NCT03073200|532038676|FG002|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
147515659|NCT03073200|532038677|FG003|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
147515660|NCT03073200|532038678|FG004|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
147515661|NCT03073200|532038679|FG005|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
147515662|NCT03073200|532038680|FG006|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
147515663|NCT03073200|532038681|FG007|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
147515664|NCT03073200|532038682|FG008|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
147515665|NCT03073200|532038683|FG009|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
147515666|NCT03073200|532038684|FG010|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
147515667|NCT03073200|532038685|FG011|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
147515668|NCT03073200|532038686|FG012|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
147515669|NCT03073200|532038687|FG013|Post-Treatment Follow-Up Period|Site terminated by sponsor|0|||
147515670|NCT03073200|532038688|FG014|Post-Treatment Follow-Up Period|Site terminated by sponsor|1|||
147515671|NCT03073200|532038674|FG000|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
147515672|NCT03073200|532038675|FG001|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
147515673|NCT03073200|532038676|FG002|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
147515674|NCT03073200|532038677|FG003|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
147515675|NCT03073200|532038678|FG004|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
147515676|NCT03073200|532038679|FG005|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
147515677|NCT03073200|532038680|FG006|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
147515678|NCT03073200|532038681|FG007|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
147515679|NCT03073200|532038682|FG008|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
147515680|NCT03073200|532038683|FG009|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
147515681|NCT03073200|532038684|FG010|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
147515682|NCT03073200|532038685|FG011|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
147515683|NCT03073200|532038686|FG012|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
147515684|NCT03073200|532038687|FG013|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|11|||
147515685|NCT03073200|532038688|FG014|Post-Treatment Follow-Up Period|Withdrawal by Parent/Guardian|0|||
147515686|NCT03073200|532038674|FG000|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
147515687|NCT03073200|532038675|FG001|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
147515688|NCT03073200|532038676|FG002|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
147515689|NCT03073200|532038677|FG003|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
147515690|NCT03073200|532038678|FG004|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
147515691|NCT03073200|532038679|FG005|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
147515692|NCT03073200|532038680|FG006|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
147515693|NCT03073200|532038681|FG007|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
147515694|NCT03073200|532038682|FG008|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
147515695|NCT03073200|532038683|FG009|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
147515696|NCT03073200|532038684|FG010|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
147515697|NCT03073200|532038685|FG011|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
147515698|NCT03073200|532038686|FG012|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
147515699|NCT03073200|532038687|FG013|Post-Treatment Follow-Up Period|Withdrawal by Subject|9|||
147515700|NCT03073200|532038688|FG014|Post-Treatment Follow-Up Period|Withdrawal by Subject|0|||
147515701|NCT03073200|532038674|FG000|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
147515702|NCT03073200|532038675|FG001|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
147515703|NCT03073200|532038676|FG002|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
147515704|NCT03073200|532038677|FG003|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
147515705|NCT03073200|532038678|FG004|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
147515706|NCT03073200|532038679|FG005|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
147515707|NCT03073200|532038680|FG006|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
147515708|NCT03073200|532038681|FG007|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
147515709|NCT03073200|532038682|FG008|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
147515710|NCT03073200|532038683|FG009|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
147515711|NCT03073200|532038684|FG010|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
147515712|NCT03073200|532038685|FG011|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
147515713|NCT03073200|532038686|FG012|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
147515714|NCT03073200|532038687|FG013|Post-Treatment Follow-Up Period|Other-determined by Investigator|2|||
147515715|NCT03073200|532038688|FG014|Post-Treatment Follow-Up Period|Other-determined by Investigator|0|||
147515716|NCT05116683|532038689|FG000|Overall Study|Physician Decision|4|||
147515717|NCT01474889|532038690|FG000|Overall Study|Physician Decision|1|||
147515718|NCT01474889|532038691|FG001|Overall Study|Physician Decision|0|||
147515719|NCT01474889|532038692|FG002|Overall Study|Physician Decision|0|||
147515720|NCT01474889|532038690|FG000|Overall Study|Did not meet inclusion|1|||
147515721|NCT01474889|532038691|FG001|Overall Study|Did not meet inclusion|0|||
147515722|NCT01474889|532038692|FG002|Overall Study|Did not meet inclusion|0|||
147515723|NCT01474889|532038690|FG000|Overall Study|Withdrawal by Subject|0|||
147515724|NCT01474889|532038691|FG001|Overall Study|Withdrawal by Subject|1|||
147515725|NCT01474889|532038692|FG002|Overall Study|Withdrawal by Subject|0|||
147515726|NCT04964557|532038694|FG000|Overall Study|Withdrawal by Subject|3|||
147515727|NCT04964557|532038695|FG001|Overall Study|Withdrawal by Subject|2|||
147515728|NCT04964557|532038694|FG000|Overall Study|Lost to Follow-up|1|||
147515729|NCT04964557|532038695|FG001|Overall Study|Lost to Follow-up|2|||
147515730|NCT04964557|532038694|FG000|Overall Study|Physician Decision|2|||
147515731|NCT04964557|532038695|FG001|Overall Study|Physician Decision|0|||
147515732|NCT04964557|532038694|FG000|Overall Study|Death|3|||
147515733|NCT04964557|532038695|FG001|Overall Study|Death|0|||
147515734|NCT04964557|532038694|FG000|Overall Study|Reported by investigator as completed but did not fulfil the Completed study definition.|1|||
147515735|NCT04964557|532038695|FG001|Overall Study|Reported by investigator as completed but did not fulfil the Completed study definition.|0|||
147515736|NCT02571972|532038698|FG000|Overall Study|Protocol Violation|2|||
147515737|NCT02571972|532038698|FG000|Overall Study|Withdrawal by Subject|2|||
147515738|NCT03559192|532038699|FG000|Lead-in Period (3 Weeks)|Protocol Violation|1|||
147515739|NCT03559192|532038700|FG001|Lead-in Period (3 Weeks)|Protocol Violation|0|||
147515740|NCT03559192|532038701|FG002|Lead-in Period (3 Weeks)|Protocol Violation|0|||
147515741|NCT03559192|532038699|FG000|Lead-in Period (3 Weeks)|Withdrawal by Subject|6|||
147515742|NCT03559192|532038700|FG001|Lead-in Period (3 Weeks)|Withdrawal by Subject|0|||
147515743|NCT03559192|532038701|FG002|Lead-in Period (3 Weeks)|Withdrawal by Subject|0|||
147515744|NCT03559192|532038699|FG000|Lead-in Period (3 Weeks)|Adverse Event|5|||
147515745|NCT03559192|532038700|FG001|Lead-in Period (3 Weeks)|Adverse Event|0|||
147515746|NCT03559192|532038701|FG002|Lead-in Period (3 Weeks)|Adverse Event|0|||
147515747|NCT03559192|532038699|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Protocol Violation|0|||
147515748|NCT03559192|532038700|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Protocol Violation|0|||
147515749|NCT03559192|532038701|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Protocol Violation|1|||
147515750|NCT03559192|532038699|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Withdrawal by Subject|0|||
147515751|NCT03559192|532038700|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Withdrawal by Subject|1|||
147515752|NCT03559192|532038701|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Withdrawal by Subject|0|||
147515753|NCT03559192|532038699|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Lack of Efficacy|0|||
147515754|NCT03559192|532038700|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Lack of Efficacy|0|||
147515755|NCT03559192|532038701|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Lack of Efficacy|2|||
147515756|NCT03559192|532038699|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Adverse Event|0|||
147515757|NCT03559192|532038700|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Adverse Event|1|||
147515758|NCT03559192|532038701|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Adverse Event|1|||
147515759|NCT03559192|532038699|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Non-compliance with study drug|0|||
147515760|NCT03559192|532038700|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Non-compliance with study drug|0|||
147515761|NCT03559192|532038701|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Non-compliance with study drug|1|||
147515762|NCT03559192|532038699|FG000|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Other|0|||
147515763|NCT03559192|532038700|FG001|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Other|1|||
147515764|NCT03559192|532038701|FG002|DB Treatment(6 Wks) + Withdrawal(2 Wks)|Other|1|||
147515765|NCT01673373|532040246|FG000|Overall Study|Death|2|||
147515766|NCT04924114|532040252|FG000|Overall Study|Withdrawal by Subject|0|||
147515767|NCT04924114|532040253|FG001|Overall Study|Withdrawal by Subject|2|||
147515768|NCT04924114|532040254|FG002|Overall Study|Withdrawal by Subject|2|||
147515769|NCT04924114|532040255|FG003|Overall Study|Withdrawal by Subject|0|||
147515770|NCT04924114|532040256|FG004|Overall Study|Withdrawal by Subject|2|||
147515771|NCT03287830|532040257|FG000|Overall Study|Withdrawal by Subject|1|||
147515772|NCT03287830|532040258|FG001|Overall Study|Withdrawal by Subject|1|||
147515773|NCT03287830|532040257|FG000|Overall Study|not meeting inclusion criteria|5|||
147515774|NCT03287830|532040258|FG001|Overall Study|not meeting inclusion criteria|12|||
147515775|NCT05505734|532040259|FG000|Overall Study|Withdrawal by Subject|51|||
147515776|NCT05505734|532040260|FG001|Overall Study|Withdrawal by Subject|64|||
147515777|NCT05505734|532040259|FG000|Overall Study|Adverse Event|6|||
147515778|NCT05505734|532040260|FG001|Overall Study|Adverse Event|20|||
147515779|NCT05505734|532040259|FG000|Overall Study|Protocol Violation|8|||
147515780|NCT05505734|532040260|FG001|Overall Study|Protocol Violation|15|||
147515781|NCT05505734|532040259|FG000|Overall Study|Lack of therapeutic response|0|||
147515782|NCT05505734|532040260|FG001|Overall Study|Lack of therapeutic response|1|||
147515783|NCT05505734|532040259|FG000|Overall Study|Lost to Follow-up|247|||
147515784|NCT05505734|532040260|FG001|Overall Study|Lost to Follow-up|237|||
147515785|NCT05505734|532040259|FG000|Overall Study|Physician Decision|22|||
147515786|NCT05505734|532040260|FG001|Overall Study|Physician Decision|13|||
147515787|NCT05505734|532040259|FG000|Overall Study|Death|2|||
147515788|NCT05505734|532040260|FG001|Overall Study|Death|1|||
147515789|NCT05505734|532040259|FG000|Overall Study|Withdrawal by parent/guardian|0|||
147515790|NCT05505734|532040260|FG001|Overall Study|Withdrawal by parent/guardian|1|||
147515791|NCT05505734|532040259|FG000|Overall Study|Pregnancy|1|||
147515792|NCT05505734|532040260|FG001|Overall Study|Pregnancy|0|||
147515793|NCT05505734|532040259|FG000|Overall Study|Other|17|||
147515794|NCT05505734|532040260|FG001|Overall Study|Other|13|||
147515795|NCT02155712|532040263|FG000|Overall Study|Death|12|||
147515796|NCT02155712|532040264|FG001|Overall Study|Death|0|||
147515797|NCT02155712|532040263|FG000|Overall Study|Lost to Follow-up|37|||
147515798|NCT02155712|532040264|FG001|Overall Study|Lost to Follow-up|22|||
147515799|NCT02155712|532040263|FG000|Overall Study|Revision of device|4|||
147515800|NCT02155712|532040264|FG001|Overall Study|Revision of device|3|||
147515801|NCT02155712|532040263|FG000|Overall Study|Withdrawal by Subject|39|||
147515802|NCT02155712|532040264|FG001|Overall Study|Withdrawal by Subject|21|||
147515803|NCT02155712|532040263|FG000|Overall Study|Site termination|77|||
147515804|NCT02155712|532040264|FG001|Overall Study|Site termination|19|||
147515805|NCT02155712|532040263|FG000|Overall Study|Sponsor terminated study early|150|||
147515806|NCT02155712|532040264|FG001|Overall Study|Sponsor terminated study early|0|||
147515807|NCT02155712|532040263|FG000|Overall Study|Missed final 5-year protocol visit|0|||
147515808|NCT02155712|532040264|FG001|Overall Study|Missed final 5-year protocol visit|32|||
147515809|NCT02155712|532040263|FG000|Overall Study|Censored because surgery cancelled|6|||
147515810|NCT02155712|532040264|FG001|Overall Study|Censored because surgery cancelled|10|||
147515811|NCT02155712|532040263|FG000|Overall Study|Censored because study device was not implanted|61|||
147515812|NCT02155712|532040264|FG001|Overall Study|Censored because study device was not implanted|66|||
147515813|NCT02155712|532040263|FG000|Overall Study|Censored because of inclusion/exclusion violation|11|||
147515814|NCT02155712|532040264|FG001|Overall Study|Censored because of inclusion/exclusion violation|6|||
147515815|NCT05180721|532040265|FG000|Overall Study|Lost to Follow-up|4|||
147515816|NCT03575351|532040266|FG000|Overall Study|Adverse Event|1|||
147515817|NCT03575351|532040267|FG001|Overall Study|Adverse Event|0|||
147515818|NCT03575351|532040266|FG000|Overall Study|Death|2|||
147515819|NCT03575351|532040267|FG001|Overall Study|Death|2|||
147515820|NCT03575351|532040266|FG000|Overall Study|Death due to the COVID-19 pandemic|0|||
147515821|NCT03575351|532040267|FG001|Overall Study|Death due to the COVID-19 pandemic|1|||
147515822|NCT03575351|532040266|FG000|Overall Study|Lack of Efficacy|28|||
147515823|NCT03575351|532040267|FG001|Overall Study|Lack of Efficacy|0|||
147515824|NCT03575351|532040266|FG000|Overall Study|Withdrawal by Subject|1|||
147515825|NCT03575351|532040267|FG001|Overall Study|Withdrawal by Subject|1|||
147515826|NCT03575351|532040266|FG000|Overall Study|Physician Decision|3|||
147515827|NCT03575351|532040267|FG001|Overall Study|Physician Decision|0|||
147515828|NCT03575351|532040266|FG000|Overall Study|Disease relapse|15|||
147515829|NCT03575351|532040267|FG001|Overall Study|Disease relapse|6|||
147515830|NCT03575351|532040266|FG000|Overall Study|Study drug manufacturing failure|0|||
147515831|NCT03575351|532040267|FG001|Overall Study|Study drug manufacturing failure|1|||
147515832|NCT03575351|532040266|FG000|Overall Study|other reasons|5|||
147515833|NCT03575351|532040267|FG001|Overall Study|other reasons|0|||
147515834|NCT00976963|532040268|FG000|Overall Study|medication not dispensed at the pharmacy due to contraindications to the assigned therapy|2|||
147515835|NCT00976963|532040269|FG001|Overall Study|medication not dispensed at the pharmacy due to contraindications to the assigned therapy|0|||
147515836|NCT00976963|532040268|FG000|Overall Study|administrative error|1|||
147515837|NCT00976963|532040269|FG001|Overall Study|administrative error|0|||
147515838|NCT00976963|532040268|FG000|Overall Study|allergic reaction due to previously unknown allergy|1|||
147515839|NCT00976963|532040269|FG001|Overall Study|allergic reaction due to previously unknown allergy|0|||
147515840|NCT01688999|532040272|FG000|Overall Study|Withdrawal by Subject|5|||
147515841|NCT01688999|532040273|FG001|Overall Study|Withdrawal by Subject|1|||
147515842|NCT01688999|532040274|FG002|Overall Study|Withdrawal by Subject|1|||
147515843|NCT01688999|532040272|FG000|Overall Study|Adverse Event|2|||
147515844|NCT01688999|532040273|FG001|Overall Study|Adverse Event|0|||
147515845|NCT01688999|532040274|FG002|Overall Study|Adverse Event|2|||
147515846|NCT01688999|532040272|FG000|Overall Study|Ineligible/Not treated|1|||
147515847|NCT01688999|532040273|FG001|Overall Study|Ineligible/Not treated|0|||
147515848|NCT01688999|532040274|FG002|Overall Study|Ineligible/Not treated|0|||
147515849|NCT02768103|532040275|FG000|Overall Study|1 participant did not fit in the fMRI|1|||
147515850|NCT03039790|532040292|FG000|Overall Study|Lost to Follow-up|2|||
147515851|NCT03039790|532040293|FG001|Overall Study|Lost to Follow-up|0|||
147515852|NCT03039790|532040294|FG002|Overall Study|Lost to Follow-up|1|||
147515853|NCT03039790|532040295|FG003|Overall Study|Lost to Follow-up|1|||
147515854|NCT03039790|532040296|FG004|Overall Study|Lost to Follow-up|0|||
147515855|NCT03039790|532040297|FG005|Overall Study|Lost to Follow-up|1|||
147515856|NCT03039790|532040298|FG006|Overall Study|Lost to Follow-up|1|||
147515857|NCT03039790|532040299|FG007|Overall Study|Lost to Follow-up|1|||
147515858|NCT03039790|532040300|FG008|Overall Study|Lost to Follow-up|0|||
147515859|NCT03039790|532040301|FG009|Overall Study|Lost to Follow-up|1|||
147515860|NCT03039790|532040302|FG010|Overall Study|Lost to Follow-up|1|||
147515861|NCT03039790|532040303|FG011|Overall Study|Lost to Follow-up|0|||
147515862|NCT03039790|532040304|FG012|Overall Study|Lost to Follow-up|1|||
147515863|NCT03039790|532040305|FG013|Overall Study|Lost to Follow-up|0|||
147515864|NCT03039790|532040306|FG014|Overall Study|Lost to Follow-up|3|||
147515865|NCT03039790|532040307|FG015|Overall Study|Lost to Follow-up|1|||
147515866|NCT03039790|532040308|FG016|Overall Study|Lost to Follow-up|2|||
147515867|NCT03039790|532040309|FG017|Overall Study|Lost to Follow-up|2|||
147515868|NCT03039790|532040310|FG018|Overall Study|Lost to Follow-up|1|||
147515869|NCT03039790|532040311|FG019|Overall Study|Lost to Follow-up|3|||
147515870|NCT03039790|532040292|FG000|Overall Study|Withdrawal of Consent|1|||
147515871|NCT03039790|532040293|FG001|Overall Study|Withdrawal of Consent|0|||
147515872|NCT03039790|532040294|FG002|Overall Study|Withdrawal of Consent|0|||
147515873|NCT03039790|532040295|FG003|Overall Study|Withdrawal of Consent|1|||
147515874|NCT03039790|532040296|FG004|Overall Study|Withdrawal of Consent|0|||
147515875|NCT03039790|532040297|FG005|Overall Study|Withdrawal of Consent|0|||
147515876|NCT03039790|532040298|FG006|Overall Study|Withdrawal of Consent|0|||
147515877|NCT03039790|532040299|FG007|Overall Study|Withdrawal of Consent|0|||
147515878|NCT03039790|532040300|FG008|Overall Study|Withdrawal of Consent|0|||
147515879|NCT03039790|532040301|FG009|Overall Study|Withdrawal of Consent|1|||
147515880|NCT03039790|532040302|FG010|Overall Study|Withdrawal of Consent|0|||
147515881|NCT03039790|532040303|FG011|Overall Study|Withdrawal of Consent|0|||
147515882|NCT03039790|532040304|FG012|Overall Study|Withdrawal of Consent|2|||
147515883|NCT03039790|532040305|FG013|Overall Study|Withdrawal of Consent|0|||
147515884|NCT03039790|532040306|FG014|Overall Study|Withdrawal of Consent|1|||
147515885|NCT03039790|532040307|FG015|Overall Study|Withdrawal of Consent|5|||
147515886|NCT03039790|532040308|FG016|Overall Study|Withdrawal of Consent|3|||
147515887|NCT03039790|532040309|FG017|Overall Study|Withdrawal of Consent|0|||
147515888|NCT03039790|532040310|FG018|Overall Study|Withdrawal of Consent|2|||
147515889|NCT03039790|532040311|FG019|Overall Study|Withdrawal of Consent|5|||
147515890|NCT03039790|532040292|FG000|Overall Study|Death|0|||
147515891|NCT03039790|532040293|FG001|Overall Study|Death|0|||
147515892|NCT03039790|532040294|FG002|Overall Study|Death|0|||
147515893|NCT03039790|532040295|FG003|Overall Study|Death|0|||
147515894|NCT03039790|532040296|FG004|Overall Study|Death|0|||
147515895|NCT03039790|532040297|FG005|Overall Study|Death|0|||
147515896|NCT03039790|532040298|FG006|Overall Study|Death|0|||
147515897|NCT03039790|532040299|FG007|Overall Study|Death|0|||
147515898|NCT03039790|532040300|FG008|Overall Study|Death|0|||
147515899|NCT03039790|532040301|FG009|Overall Study|Death|0|||
147515900|NCT03039790|532040302|FG010|Overall Study|Death|0|||
147515901|NCT03039790|532040303|FG011|Overall Study|Death|0|||
147515902|NCT03039790|532040304|FG012|Overall Study|Death|0|||
147515903|NCT03039790|532040305|FG013|Overall Study|Death|0|||
147515904|NCT03039790|532040306|FG014|Overall Study|Death|0|||
147515905|NCT03039790|532040307|FG015|Overall Study|Death|1|||
147515906|NCT03039790|532040308|FG016|Overall Study|Death|3|||
147515907|NCT03039790|532040309|FG017|Overall Study|Death|0|||
147515908|NCT03039790|532040310|FG018|Overall Study|Death|2|||
147515909|NCT03039790|532040311|FG019|Overall Study|Death|0|||
147515910|NCT03039790|532040292|FG000|Overall Study|Reason, not Specified|1|||
147515911|NCT03039790|532040293|FG001|Overall Study|Reason, not Specified|0|||
147515912|NCT03039790|532040294|FG002|Overall Study|Reason, not Specified|0|||
147515913|NCT03039790|532040295|FG003|Overall Study|Reason, not Specified|0|||
147515914|NCT03039790|532040296|FG004|Overall Study|Reason, not Specified|0|||
147515915|NCT03039790|532040297|FG005|Overall Study|Reason, not Specified|0|||
147515916|NCT03039790|532040298|FG006|Overall Study|Reason, not Specified|0|||
147515917|NCT03039790|532040299|FG007|Overall Study|Reason, not Specified|0|||
147515918|NCT03039790|532040300|FG008|Overall Study|Reason, not Specified|0|||
147515919|NCT03039790|532040301|FG009|Overall Study|Reason, not Specified|0|||
147515920|NCT03039790|532040302|FG010|Overall Study|Reason, not Specified|0|||
147515921|NCT03039790|532040303|FG011|Overall Study|Reason, not Specified|0|||
147515922|NCT03039790|532040304|FG012|Overall Study|Reason, not Specified|0|||
147515923|NCT03039790|532040305|FG013|Overall Study|Reason, not Specified|0|||
147515924|NCT03039790|532040306|FG014|Overall Study|Reason, not Specified|0|||
147515925|NCT03039790|532040307|FG015|Overall Study|Reason, not Specified|0|||
147515926|NCT03039790|532040308|FG016|Overall Study|Reason, not Specified|2|||
147515927|NCT03039790|532040309|FG017|Overall Study|Reason, not Specified|0|||
147515928|NCT03039790|532040310|FG018|Overall Study|Reason, not Specified|1|||
147515929|NCT03039790|532040311|FG019|Overall Study|Reason, not Specified|0|||
147515930|NCT01855425|532040316|FG000|Overall Study|Physician Decision|20|||
147515931|NCT01025232|532040324|FG000|Overall Study|Study drug no longer available|3|||
147515932|NCT01025232|532040325|FG001|Overall Study|Study drug no longer available|6|||
147515933|NCT01600105|532040326|FG000|Total Participants|Withdrawal by Subject|1|||
147515934|NCT01600105|532040327|FG001|Total Participants|Withdrawal by Subject|0|||
147515935|NCT01600105|532040326|FG000|Total Participants|No images in PACS|10|||
147515936|NCT01600105|532040327|FG001|Total Participants|No images in PACS|0|||
147515937|NCT01600105|532040326|FG000|Total Participants|Insufficient image quality|30|||
147515938|NCT01600105|532040327|FG001|Total Participants|Insufficient image quality|10|||
147515939|NCT01600105|532040326|FG000|Sub Study I|Insufficient image quality|0|||
147515940|NCT01600105|532040327|FG001|Sub Study I|Insufficient image quality|10|||
147515941|NCT01600105|532040326|FG000|Sub Study II|Withdrawal by Subject|1|||
147515942|NCT01600105|532040327|FG001|Sub Study II|Withdrawal by Subject|0|||
147515943|NCT01600105|532040326|FG000|Sub Study II|No images in PACS|1|||
147515944|NCT01600105|532040327|FG001|Sub Study II|No images in PACS|0|||
147515945|NCT01600105|532040326|FG000|Sub Study II|Insufficient image quality|3|||
147515946|NCT01600105|532040327|FG001|Sub Study II|Insufficient image quality|0|||
147515947|NCT01600105|532040326|FG000|Sub Study III|Insufficient image quality|5|||
147515948|NCT01600105|532040327|FG001|Sub Study III|Insufficient image quality|0|||
147515949|NCT01600105|532040326|FG000|Sub Study V|Poor Image Quality|2|||
147515950|NCT01600105|532040327|FG001|Sub Study V|Poor Image Quality|0|||
147515951|NCT03748420|532040328|FG000|Overall Study|No 12 month medication adherence data available|0|||
147515952|NCT03748420|532040329|FG001|Overall Study|No 12 month medication adherence data available|1|||
147515953|NCT03748420|532040328|FG000|Overall Study|Death|24|||
147515954|NCT03748420|532040329|FG001|Overall Study|Death|28|||
147515955|NCT03748420|532040328|FG000|Overall Study|Lost to Follow-up|231|||
147515956|NCT03748420|532040329|FG001|Overall Study|Lost to Follow-up|230|||
147515957|NCT01263444|532040330|FG000|Overall Study|Adverse Event|8|||
147515958|NCT01263444|532040330|FG000|Overall Study|Withdrawal by Subject|1|||
147515959|NCT01263444|532040330|FG000|Overall Study|Protocol Violation|1|||
147515960|NCT00372489|532040332|FG000|Overall Study|Adverse Event|18|||
147515961|NCT00372489|532040332|FG000|Overall Study|Lack of Efficacy|1|||
147515962|NCT00372489|532040332|FG000|Overall Study|Lost to Follow-up|3|||
147515963|NCT00372489|532040332|FG000|Overall Study|Physician Decision|3|||
147515964|NCT00372489|532040332|FG000|Overall Study|Withdrawal by Subject|5|||
147515965|NCT00372489|532040332|FG000|Overall Study|Patient Relocation|2|||
147515966|NCT00372489|532040332|FG000|Overall Study|Renal transplant|6|||
147515967|NCT00372489|532040332|FG000|Overall Study|Sponsor Decision to Terminate Study|41|||
147515968|NCT03330106|532040333|FG000|Part A|Withdrawal by Subject|1|||
147515969|NCT03330106|532040334|FG001|Part A|Withdrawal by Subject|1|||
147515970|NCT03330106|532040335|FG002|Part A|Withdrawal by Subject|0|||
147515971|NCT03330106|532040336|FG003|Part A|Withdrawal by Subject|0|||
147515972|NCT03330106|532040333|FG000|Part A|Death|2|||
147515973|NCT03330106|532040334|FG001|Part A|Death|1|||
147515974|NCT03330106|532040335|FG002|Part A|Death|0|||
147515975|NCT03330106|532040336|FG003|Part A|Death|0|||
147515976|NCT03330106|532040333|FG000|Part A|Adverse Event|0|||
147515977|NCT03330106|532040334|FG001|Part A|Adverse Event|1|||
147515978|NCT03330106|532040335|FG002|Part A|Adverse Event|0|||
147515979|NCT03330106|532040336|FG003|Part A|Adverse Event|0|||
147515980|NCT03330106|532040333|FG000|Part A|Subjects Outside Eligibility Window for Part B due to Serious Adverse Event (SAE)|0|||
147515981|NCT03330106|532040334|FG001|Part A|Subjects Outside Eligibility Window for Part B due to Serious Adverse Event (SAE)|1|||
147515982|NCT03330106|532040335|FG002|Part A|Subjects Outside Eligibility Window for Part B due to Serious Adverse Event (SAE)|0|||
147515983|NCT03330106|532040336|FG003|Part A|Subjects Outside Eligibility Window for Part B due to Serious Adverse Event (SAE)|0|||
147515984|NCT03330106|532040333|FG000|Part A|Worsening Creatinine Clearance and Thrombocytopenia|1|||
147515985|NCT03330106|532040334|FG001|Part A|Worsening Creatinine Clearance and Thrombocytopenia|0|||
147515986|NCT03330106|532040335|FG002|Part A|Worsening Creatinine Clearance and Thrombocytopenia|0|||
147515987|NCT03330106|532040336|FG003|Part A|Worsening Creatinine Clearance and Thrombocytopenia|0|||
147515988|NCT03330106|532040333|FG000|Part A|Progressive Disease|0|||
147515989|NCT03330106|532040334|FG001|Part A|Progressive Disease|1|||
147515990|NCT03330106|532040335|FG002|Part A|Progressive Disease|0|||
147515991|NCT03330106|532040336|FG003|Part A|Progressive Disease|0|||
147515992|NCT03330106|532040333|FG000|Part B|Lost to Follow-up|0|||
147515993|NCT03330106|532040334|FG001|Part B|Lost to Follow-up|0|||
147515994|NCT03330106|532040335|FG002|Part B|Lost to Follow-up|0|||
147515995|NCT03330106|532040336|FG003|Part B|Lost to Follow-up|1|||
147515996|NCT03330106|532040333|FG000|Part B|Withdrawal by Subject|0|||
147515997|NCT03330106|532040334|FG001|Part B|Withdrawal by Subject|0|||
147515998|NCT03330106|532040335|FG002|Part B|Withdrawal by Subject|4|||
147515999|NCT03330106|532040336|FG003|Part B|Withdrawal by Subject|0|||
147516000|NCT03330106|532040333|FG000|Part B|Death|0|||
147516001|NCT03330106|532040334|FG001|Part B|Death|0|||
147516002|NCT03330106|532040335|FG002|Part B|Death|2|||
147516003|NCT03330106|532040336|FG003|Part B|Death|0|||
147516004|NCT03330106|532040333|FG000|Part B|Clinical Progression|0|||
147516005|NCT03330106|532040334|FG001|Part B|Clinical Progression|0|||
147516006|NCT03330106|532040335|FG002|Part B|Clinical Progression|1|||
147516007|NCT03330106|532040336|FG003|Part B|Clinical Progression|1|||
147516008|NCT03330106|532040333|FG000|Part B|Symptomatic Deterioration|0|||
147516009|NCT03330106|532040334|FG001|Part B|Symptomatic Deterioration|0|||
147516010|NCT03330106|532040335|FG002|Part B|Symptomatic Deterioration|0|||
147516011|NCT03330106|532040336|FG003|Part B|Symptomatic Deterioration|1|||
147516012|NCT03330106|532040333|FG000|Part B|Symptomatic Deterioration, Participant Placed on Hospice|0|||
147516013|NCT03330106|532040334|FG001|Part B|Symptomatic Deterioration, Participant Placed on Hospice|0|||
147516014|NCT03330106|532040335|FG002|Part B|Symptomatic Deterioration, Participant Placed on Hospice|0|||
147516015|NCT03330106|532040336|FG003|Part B|Symptomatic Deterioration, Participant Placed on Hospice|1|||
147516016|NCT03330106|532040333|FG000|Part B|Progressive Disease|0|||
147516017|NCT03330106|532040334|FG001|Part B|Progressive Disease|0|||
147516018|NCT03330106|532040335|FG002|Part B|Progressive Disease|11|||
147516019|NCT03330106|532040336|FG003|Part B|Progressive Disease|4|||
147516020|NCT00623766|532040339|FG000|Induction Phase (Day 1 to Week 24)|Off treatment|36|||
147516021|NCT00623766|532040340|FG001|Induction Phase (Day 1 to Week 24)|Off treatment|16|||
147516022|NCT00623766|532040339|FG000|Maintenance Phase (Week 24 to Year 2)|Disease progression|4|||
147516023|NCT00623766|532040340|FG001|Maintenance Phase (Week 24 to Year 2)|Disease progression|0|||
147516024|NCT00623766|532040339|FG000|Maintenance Phase (Week 24 to Year 2)|Administrative reason by sponsor|4|||
147516025|NCT00623766|532040340|FG001|Maintenance Phase (Week 24 to Year 2)|Administrative reason by sponsor|0|||
147516026|NCT00623766|532040339|FG000|Maintenance Phase (Week 24 to Year 2)|Withdrawal by Subject|1|||
147516027|NCT00623766|532040340|FG001|Maintenance Phase (Week 24 to Year 2)|Withdrawal by Subject|2|||
147516028|NCT00623766|532040339|FG000|Maintenance Phase (Week 24 to Year 2)|Patient required surgery|1|||
147516029|NCT00623766|532040340|FG001|Maintenance Phase (Week 24 to Year 2)|Patient required surgery|0|||
147516030|NCT00486889|532040341|FG000|Overall Study|Death|3|||
147516031|NCT00486889|532040341|FG000|Overall Study|Non-compliant|2|||
147516032|NCT00486889|532040341|FG000|Overall Study|Withdrawal by Subject|6|||
147516033|NCT00893763|532040342|FG000|Overall Study|extubated|110|||
147516034|NCT00893763|532040343|FG001|Overall Study|extubated|110|||
147516035|NCT02324049|532040344|FG000|Part C|Study terminated|11|||
147516036|NCT02159365|532040345|FG000|Overall Study|Disease Progression|23|||
147516037|NCT02159365|532040345|FG000|Overall Study|Other reasons|11|||
147516038|NCT02159365|532040345|FG000|Overall Study|Administrative reason by Sponsor|9|||
147516039|NCT02159365|532040345|FG000|Overall Study|Adverse Event unrelated to study drug|9|||
147516040|NCT02159365|532040345|FG000|Overall Study|Study drug toxicity|7|||
147516041|NCT02159365|532040345|FG000|Overall Study|Maximum clinical benefit|3|||
147516042|NCT02159365|532040345|FG000|Overall Study|Subject request to discontinue treatment|3|||
147516043|NCT02159365|532040345|FG000|Overall Study|Subject withdrew consent|3|||
147516044|NCT02159365|532040345|FG000|Overall Study|Death|1|||
147516045|NCT02159365|532040345|FG000|Overall Study|Lost to Follow-up|1|||
147516046|NCT03198728|532040347|FG000|Overall Study|Adverse Event|10|||
147516047|NCT03198728|532040348|FG001|Overall Study|Adverse Event|5|||
147516048|NCT03198728|532040347|FG000|Overall Study|Lost to Follow-up|21|||
147516049|NCT03198728|532040348|FG001|Overall Study|Lost to Follow-up|7|||
147516050|NCT03198728|532040347|FG000|Overall Study|Physician Decision|7|||
147516051|NCT03198728|532040348|FG001|Overall Study|Physician Decision|2|||
147516052|NCT03198728|532040347|FG000|Overall Study|Withdrawal by Subject|14|||
147516053|NCT03198728|532040348|FG001|Overall Study|Withdrawal by Subject|10|||
147516054|NCT04051944|532040350|FG000|Overall Study|Study ending|1|||
147516055|NCT04051944|532040351|FG001|Overall Study|Study ending|1|||
147516056|NCT04051944|532040350|FG000|Overall Study|Early study termination by participant|1|||
147516057|NCT04051944|532040351|FG001|Overall Study|Early study termination by participant|0|||
147516058|NCT04051944|532040350|FG000|Overall Study|Withdrawal by Subject|2|||
147516059|NCT04051944|532040351|FG001|Overall Study|Withdrawal by Subject|2|||
147516060|NCT04051944|532040350|FG000|Overall Study|Lack of Efficacy|3|||
147516061|NCT04051944|532040351|FG001|Overall Study|Lack of Efficacy|0|||
147516062|NCT04051944|532040350|FG000|Overall Study|Adverse event, non- fatal|1|||
147516063|NCT04051944|532040351|FG001|Overall Study|Adverse event, non- fatal|1|||
147516064|NCT03083470|532040352|FG000|Overall Study|Lost to Follow-up|0|||
147516065|NCT03083470|532040353|FG001|Overall Study|Lost to Follow-up|0|||
147516066|NCT03083470|532040354|FG002|Overall Study|Lost to Follow-up|0|||
147516067|NCT03083470|532040355|FG003|Overall Study|Lost to Follow-up|0|||
147516068|NCT03083470|532040356|FG004|Overall Study|Lost to Follow-up|1|||
147516069|NCT03083470|532040352|FG000|Overall Study|Withdrawal by Subject|0|||
147516070|NCT03083470|532040353|FG001|Overall Study|Withdrawal by Subject|0|||
147516071|NCT03083470|532040354|FG002|Overall Study|Withdrawal by Subject|0|||
147516072|NCT03083470|532040355|FG003|Overall Study|Withdrawal by Subject|0|||
147516073|NCT03083470|532040356|FG004|Overall Study|Withdrawal by Subject|1|||
147516074|NCT03077711|532040357|FG000|Overall Study|Lost to Follow-up|2|||
147516075|NCT03077711|532040358|FG001|Overall Study|Lost to Follow-up|2|||
147516076|NCT03077711|532040357|FG000|Overall Study|noncompliant taking medication|2|||
147516077|NCT03077711|532040358|FG001|Overall Study|noncompliant taking medication|0|||
147516078|NCT01526928|532040359|FG000|Overall Study|Progressive Disease|35|||
147516079|NCT01526928|532040360|FG001|Overall Study|Progressive Disease|17|||
147516080|NCT01526928|532040361|FG002|Overall Study|Progressive Disease|150|||
147516081|NCT01526928|532040362|FG003|Overall Study|Progressive Disease|182|||
147516082|NCT01526928|532040363|FG004|Overall Study|Progressive Disease|76|||
147516083|NCT01526928|532040364|FG005|Overall Study|Progressive Disease|4|||
147516084|NCT01526928|532040359|FG000|Overall Study|Adverse Event|2|||
147516085|NCT01526928|532040360|FG001|Overall Study|Adverse Event|1|||
147516086|NCT01526928|532040361|FG002|Overall Study|Adverse Event|29|||
147516087|NCT01526928|532040362|FG003|Overall Study|Adverse Event|40|||
147516088|NCT01526928|532040363|FG004|Overall Study|Adverse Event|13|||
147516089|NCT01526928|532040364|FG005|Overall Study|Adverse Event|2|||
147516090|NCT01526928|532040359|FG000|Overall Study|Death|0|||
147516091|NCT01526928|532040360|FG001|Overall Study|Death|0|||
147516092|NCT01526928|532040361|FG002|Overall Study|Death|3|||
147516093|NCT01526928|532040362|FG003|Overall Study|Death|0|||
147516094|NCT01526928|532040363|FG004|Overall Study|Death|0|||
147516095|NCT01526928|532040364|FG005|Overall Study|Death|0|||
147516096|NCT01526928|532040359|FG000|Overall Study|Withdrawal by Subject|1|||
147516097|NCT01526928|532040360|FG001|Overall Study|Withdrawal by Subject|0|||
147516098|NCT01526928|532040361|FG002|Overall Study|Withdrawal by Subject|13|||
147516099|NCT01526928|532040362|FG003|Overall Study|Withdrawal by Subject|11|||
147516100|NCT01526928|532040363|FG004|Overall Study|Withdrawal by Subject|3|||
147516101|NCT01526928|532040364|FG005|Overall Study|Withdrawal by Subject|0|||
147516102|NCT01526928|532040359|FG000|Overall Study|Physician Decision|0|||
147516103|NCT01526928|532040360|FG001|Overall Study|Physician Decision|0|||
147516104|NCT01526928|532040361|FG002|Overall Study|Physician Decision|2|||
147516105|NCT01526928|532040362|FG003|Overall Study|Physician Decision|5|||
147516106|NCT01526928|532040363|FG004|Overall Study|Physician Decision|0|||
147516107|NCT01526928|532040364|FG005|Overall Study|Physician Decision|0|||
147516108|NCT01526928|532040359|FG000|Overall Study|Other Reason|0|||
147516109|NCT01526928|532040360|FG001|Overall Study|Other Reason|1|||
147516110|NCT01526928|532040361|FG002|Overall Study|Other Reason|11|||
147516111|NCT01526928|532040362|FG003|Overall Study|Other Reason|4|||
147516112|NCT01526928|532040363|FG004|Overall Study|Other Reason|1|||
147516113|NCT01526928|532040364|FG005|Overall Study|Other Reason|0|||
147516114|NCT01526928|532040359|FG000|Overall Study|Lost to Follow-up|0|||
147516115|NCT01526928|532040360|FG001|Overall Study|Lost to Follow-up|0|||
147516116|NCT01526928|532040361|FG002|Overall Study|Lost to Follow-up|0|||
147516117|NCT01526928|532040362|FG003|Overall Study|Lost to Follow-up|1|||
147516118|NCT01526928|532040363|FG004|Overall Study|Lost to Follow-up|0|||
147516119|NCT01526928|532040364|FG005|Overall Study|Lost to Follow-up|0|||
147516120|NCT01526928|532040359|FG000|Overall Study|Protocol Deviation|0|||
147516121|NCT01526928|532040360|FG001|Overall Study|Protocol Deviation|0|||
147516122|NCT01526928|532040361|FG002|Overall Study|Protocol Deviation|0|||
147516123|NCT01526928|532040362|FG003|Overall Study|Protocol Deviation|2|||
147516124|NCT01526928|532040363|FG004|Overall Study|Protocol Deviation|0|||
147516125|NCT01526928|532040364|FG005|Overall Study|Protocol Deviation|0|||
147516126|NCT01526928|532040359|FG000|Overall Study|Missing|0|||
147516127|NCT01526928|532040360|FG001|Overall Study|Missing|0|||
147516128|NCT01526928|532040361|FG002|Overall Study|Missing|1|||
147516129|NCT01526928|532040362|FG003|Overall Study|Missing|0|||
147516130|NCT01526928|532040363|FG004|Overall Study|Missing|2|||
147516131|NCT01526928|532040364|FG005|Overall Study|Missing|0|||
147516132|NCT00736450|532040365|FG000|Overall Study|Not ABC gene eligible|19|||
147516133|NCT00736450|532040365|FG000|Overall Study|Withdrawal by Subject|5|||
147516134|NCT00736450|532040365|FG000|Overall Study|Physician Decision|1|||
147516135|NCT04157751|532040366|FG000|Overall Study|Withdrawal by Subject|12|||
147516136|NCT04157751|532040367|FG001|Overall Study|Withdrawal by Subject|17|||
147516137|NCT04157751|532040366|FG000|Overall Study|Lost to Follow-up|6|||
147516138|NCT04157751|532040367|FG001|Overall Study|Lost to Follow-up|2|||
147516139|NCT04157751|532040366|FG000|Overall Study|Adverse Event|34|||
147516140|NCT04157751|532040367|FG001|Overall Study|Adverse Event|23|||
147516141|NCT04157751|532040366|FG000|Overall Study|Not treated|1|||
147516142|NCT04157751|532040367|FG001|Overall Study|Not treated|5|||
147516143|NCT04157751|532040366|FG000|Overall Study|Other reason not stated above|10|||
147516144|NCT04157751|532040367|FG001|Overall Study|Other reason not stated above|10|||
147516145|NCT03446612|532040373|FG000|Overall Study|Protocol defined stopping criteria|0|||
147516146|NCT03446612|532040374|FG001|Overall Study|Protocol defined stopping criteria|1|||
147516147|NCT00333970|532040376|FG000|Overall Study|Withdrawal by Subject|13|||
147516148|NCT00333970|532040377|FG001|Overall Study|Withdrawal by Subject|7|||
147516149|NCT00899678|532040379|FG000|Induction Period (Weeks 0 to 6)|Adverse Event|6|||
147516150|NCT00899678|532040380|FG001|Induction Period (Weeks 0 to 6)|Adverse Event|0|||
147516151|NCT00899678|532040381|FG002|Induction Period (Weeks 0 to 6)|Adverse Event|0|||
147516152|NCT00899678|532040379|FG000|Induction Period (Weeks 0 to 6)|Lack of Efficacy|17|||
147516153|NCT00899678|532040380|FG001|Induction Period (Weeks 0 to 6)|Lack of Efficacy|0|||
147516154|NCT00899678|532040381|FG002|Induction Period (Weeks 0 to 6)|Lack of Efficacy|0|||
147516155|NCT00899678|532040379|FG000|Induction Period (Weeks 0 to 6)|Protocol Violation|1|||
147516156|NCT00899678|532040380|FG001|Induction Period (Weeks 0 to 6)|Protocol Violation|0|||
147516157|NCT00899678|532040381|FG002|Induction Period (Weeks 0 to 6)|Protocol Violation|0|||
147516158|NCT00899678|532040379|FG000|Induction Period (Weeks 0 to 6)|Other reason|1|||
147516159|NCT00899678|532040380|FG001|Induction Period (Weeks 0 to 6)|Other reason|0|||
147516160|NCT00899678|532040381|FG002|Induction Period (Weeks 0 to 6)|Other reason|0|||
147516161|NCT00899678|532040379|FG000|Maintenance Period (Weeks 8 to 62)|Adverse Event|0|||
147516162|NCT00899678|532040380|FG001|Maintenance Period (Weeks 8 to 62)|Adverse Event|10|||
147516163|NCT00899678|532040381|FG002|Maintenance Period (Weeks 8 to 62)|Adverse Event|5|||
147516164|NCT00899678|532040379|FG000|Maintenance Period (Weeks 8 to 62)|Lack of Efficacy|0|||
147516165|NCT00899678|532040380|FG001|Maintenance Period (Weeks 8 to 62)|Lack of Efficacy|11|||
147516166|NCT00899678|532040381|FG002|Maintenance Period (Weeks 8 to 62)|Lack of Efficacy|18|||
147516167|NCT00899678|532040379|FG000|Maintenance Period (Weeks 8 to 62)|Protocol Violation|0|||
147516168|NCT00899678|532040380|FG001|Maintenance Period (Weeks 8 to 62)|Protocol Violation|1|||
147516169|NCT00899678|532040381|FG002|Maintenance Period (Weeks 8 to 62)|Protocol Violation|1|||
147516170|NCT00899678|532040379|FG000|Maintenance Period (Weeks 8 to 62)|Withdrawal by Subject|0|||
147516171|NCT00899678|532040380|FG001|Maintenance Period (Weeks 8 to 62)|Withdrawal by Subject|1|||
147516172|NCT00899678|532040381|FG002|Maintenance Period (Weeks 8 to 62)|Withdrawal by Subject|2|||
147516173|NCT00899678|532040379|FG000|Maintenance Period (Weeks 8 to 62)|Other reason|0|||
147516174|NCT00899678|532040380|FG001|Maintenance Period (Weeks 8 to 62)|Other reason|2|||
147516175|NCT00899678|532040381|FG002|Maintenance Period (Weeks 8 to 62)|Other reason|2|||
147516176|NCT03148795|532040386|FG000|Overall Study|Progressive Disease|1|||
147516177|NCT03924427|532040394|FG000|Overall Study|Adverse Event|4|||
147516178|NCT03924427|532040394|FG000|Overall Study|Lack of Efficacy|1|||
147516179|NCT03924427|532040394|FG000|Overall Study|Withdrawal by Subject|1|||
147516180|NCT00149890|532040402|FG000|Overall Study|Adverse Event|1|||
147516181|NCT00149890|532040403|FG001|Overall Study|Adverse Event|8|||
147516182|NCT00149890|532040402|FG000|Overall Study|Lack of Efficacy|8|||
147516183|NCT00149890|532040403|FG001|Overall Study|Lack of Efficacy|9|||
147516184|NCT00149890|532040402|FG000|Overall Study|Protocol Violation|1|||
147516185|NCT00149890|532040403|FG001|Overall Study|Protocol Violation|0|||
147516186|NCT00149890|532040402|FG000|Overall Study|Lost to Follow-up|1|||
147516187|NCT00149890|532040403|FG001|Overall Study|Lost to Follow-up|0|||
147516188|NCT00149890|532040402|FG000|Overall Study|Graft Loss|2|||
147516189|NCT00149890|532040403|FG001|Overall Study|Graft Loss|1|||
147516190|NCT01387594|532040404|FG000|Overall Study|Withdrawal by Subject|0|||
147516191|NCT01387594|532040405|FG001|Overall Study|Withdrawal by Subject|2|||
147516192|NCT01387594|532040404|FG000|Overall Study|Lost to Follow-up|0|||
147516193|NCT01387594|532040405|FG001|Overall Study|Lost to Follow-up|1|||
147516194|NCT01365091|532040406|FG000|Period 1|Adverse Event|1|||
147516195|NCT01365091|532040407|FG001|Period 1|Adverse Event|0|||
147516196|NCT01365091|532040408|FG002|Period 1|Adverse Event|2|||
147516197|NCT01365091|532040409|FG003|Period 1|Adverse Event|3|||
147516198|NCT01365091|532040406|FG000|Period 1|Positive test result for drugs of abuse|1|||
147516199|NCT01365091|532040407|FG001|Period 1|Positive test result for drugs of abuse|0|||
147516200|NCT01365091|532040408|FG002|Period 1|Positive test result for drugs of abuse|0|||
147516201|NCT01365091|532040409|FG003|Period 1|Positive test result for drugs of abuse|0|||
147516202|NCT01365091|532040406|FG000|Period 1|No longer met study criteria|0|||
147516203|NCT01365091|532040407|FG001|Period 1|No longer met study criteria|1|||
147516204|NCT01365091|532040408|FG002|Period 1|No longer met study criteria|0|||
147516205|NCT01365091|532040409|FG003|Period 1|No longer met study criteria|0|||
147516206|NCT01365091|532040406|FG000|Period 1|Withdrawal by Subject|0|||
147516207|NCT01365091|532040407|FG001|Period 1|Withdrawal by Subject|1|||
147516208|NCT01365091|532040408|FG002|Period 1|Withdrawal by Subject|0|||
147516209|NCT01365091|532040409|FG003|Period 1|Withdrawal by Subject|0|||
147516210|NCT01365091|532040406|FG000|Period 1|Personal reasons|0|||
147516211|NCT01365091|532040407|FG001|Period 1|Personal reasons|0|||
147516212|NCT01365091|532040408|FG002|Period 1|Personal reasons|1|||
147516213|NCT01365091|532040409|FG003|Period 1|Personal reasons|0|||
147516214|NCT01365091|532040406|FG000|Period 2|Withdrawal by Subject|1|||
147516215|NCT01365091|532040407|FG001|Period 2|Withdrawal by Subject|0|||
147516216|NCT01365091|532040408|FG002|Period 2|Withdrawal by Subject|0|||
147516217|NCT01365091|532040409|FG003|Period 2|Withdrawal by Subject|0|||
147516218|NCT01365091|532040406|FG000|Period 2|Adverse Event|0|||
147516219|NCT01365091|532040407|FG001|Period 2|Adverse Event|0|||
147516220|NCT01365091|532040408|FG002|Period 2|Adverse Event|1|||
147516221|NCT01365091|532040409|FG003|Period 2|Adverse Event|0|||
147516222|NCT01435122|532040414|FG000|Overall Study|Early withdrawal due to toxicity|8|||
147516223|NCT02406027|532040415|FG000|Double-blind Treatment Phase (Period 1)|Adverse Event|0|||
147516224|NCT02406027|532040416|FG001|Double-blind Treatment Phase (Period 1)|Adverse Event|2|||
147516225|NCT02406027|532040417|FG002|Double-blind Treatment Phase (Period 1)|Adverse Event|1|||
147516226|NCT02406027|532040418|FG003|Double-blind Treatment Phase (Period 1)|Adverse Event|0|||
147516227|NCT02406027|532040419|FG004|Double-blind Treatment Phase (Period 1)|Adverse Event|0|||
147516228|NCT02406027|532040420|FG005|Double-blind Treatment Phase (Period 1)|Adverse Event|0|||
147516229|NCT02406027|532040421|FG006|Double-blind Treatment Phase (Period 1)|Adverse Event|0|||
147516230|NCT02406027|532040415|FG000|Double-blind Treatment Phase (Period 1)|Physician Decision|3|||
147516231|NCT02406027|532040416|FG001|Double-blind Treatment Phase (Period 1)|Physician Decision|0|||
147516232|NCT02406027|532040417|FG002|Double-blind Treatment Phase (Period 1)|Physician Decision|1|||
147516233|NCT02406027|532040418|FG003|Double-blind Treatment Phase (Period 1)|Physician Decision|0|||
147516234|NCT02406027|532040419|FG004|Double-blind Treatment Phase (Period 1)|Physician Decision|0|||
147516235|NCT02406027|532040420|FG005|Double-blind Treatment Phase (Period 1)|Physician Decision|0|||
147516236|NCT02406027|532040421|FG006|Double-blind Treatment Phase (Period 1)|Physician Decision|0|||
147516237|NCT02406027|532040415|FG000|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|2|||
147516238|NCT02406027|532040416|FG001|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|1|||
147516239|NCT02406027|532040417|FG002|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|1|||
147516240|NCT02406027|532040418|FG003|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|0|||
147516241|NCT02406027|532040419|FG004|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|0|||
147516242|NCT02406027|532040420|FG005|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|0|||
147516243|NCT02406027|532040421|FG006|Double-blind Treatment Phase (Period 1)|Withdrawal by Subject|0|||
147516244|NCT02406027|532040415|FG000|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|1|||
147516245|NCT02406027|532040416|FG001|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0|||
147516246|NCT02406027|532040417|FG002|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|1|||
147516247|NCT02406027|532040418|FG003|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0|||
147516248|NCT02406027|532040419|FG004|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0|||
147516249|NCT02406027|532040420|FG005|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0|||
147516250|NCT02406027|532040421|FG006|Double-blind Treatment Phase (Period 1)|Subject Refused Further Study Treatment|0|||
147516251|NCT02406027|532040415|FG000|Open-label Phase (Period 2)|Adverse Event|0|||
147516252|NCT02406027|532040416|FG001|Open-label Phase (Period 2)|Adverse Event|0|||
147516253|NCT02406027|532040417|FG002|Open-label Phase (Period 2)|Adverse Event|0|||
147516254|NCT02406027|532040418|FG003|Open-label Phase (Period 2)|Adverse Event|2|||
147516255|NCT02406027|532040419|FG004|Open-label Phase (Period 2)|Adverse Event|2|||
147516256|NCT02406027|532040420|FG005|Open-label Phase (Period 2)|Adverse Event|0|||
147516257|NCT02406027|532040421|FG006|Open-label Phase (Period 2)|Adverse Event|0|||
147516258|NCT02406027|532040415|FG000|Open-label Phase (Period 2)|Physician Decision|0|||
147516259|NCT02406027|532040416|FG001|Open-label Phase (Period 2)|Physician Decision|0|||
147516260|NCT02406027|532040417|FG002|Open-label Phase (Period 2)|Physician Decision|0|||
147516261|NCT02406027|532040418|FG003|Open-label Phase (Period 2)|Physician Decision|0|||
147516262|NCT02406027|532040419|FG004|Open-label Phase (Period 2)|Physician Decision|0|||
147516263|NCT02406027|532040420|FG005|Open-label Phase (Period 2)|Physician Decision|1|||
147516264|NCT02406027|532040421|FG006|Open-label Phase (Period 2)|Physician Decision|1|||
147516265|NCT02406027|532040415|FG000|Open-label Phase (Period 2)|Withdrawal by Subject|0|||
147516266|NCT02406027|532040416|FG001|Open-label Phase (Period 2)|Withdrawal by Subject|0|||
147516267|NCT02406027|532040417|FG002|Open-label Phase (Period 2)|Withdrawal by Subject|0|||
147516268|NCT02406027|532040418|FG003|Open-label Phase (Period 2)|Withdrawal by Subject|2|||
147516269|NCT02406027|532040419|FG004|Open-label Phase (Period 2)|Withdrawal by Subject|4|||
147516270|NCT02406027|532040420|FG005|Open-label Phase (Period 2)|Withdrawal by Subject|0|||
147516271|NCT02406027|532040421|FG006|Open-label Phase (Period 2)|Withdrawal by Subject|2|||
147516272|NCT02406027|532040415|FG000|Open-label Phase (Period 2)|Study Terminated by Sponsor|0|||
147516273|NCT02406027|532040416|FG001|Open-label Phase (Period 2)|Study Terminated by Sponsor|0|||
147516274|NCT02406027|532040417|FG002|Open-label Phase (Period 2)|Study Terminated by Sponsor|0|||
147516275|NCT02406027|532040418|FG003|Open-label Phase (Period 2)|Study Terminated by Sponsor|11|||
147516276|NCT02406027|532040419|FG004|Open-label Phase (Period 2)|Study Terminated by Sponsor|7|||
147516277|NCT02406027|532040420|FG005|Open-label Phase (Period 2)|Study Terminated by Sponsor|24|||
147516278|NCT02406027|532040421|FG006|Open-label Phase (Period 2)|Study Terminated by Sponsor|19|||
147516279|NCT02406027|532040415|FG000|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
147516280|NCT02406027|532040416|FG001|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
147516281|NCT02406027|532040417|FG002|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
147516282|NCT02406027|532040418|FG003|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
147516283|NCT02406027|532040419|FG004|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
147516284|NCT02406027|532040420|FG005|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|1|||
147516285|NCT02406027|532040421|FG006|Open-label Phase (Period 2)|At Spouse Request With PI Agreement|0|||
147516286|NCT02406027|532040415|FG000|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
147516287|NCT02406027|532040416|FG001|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
147516288|NCT02406027|532040417|FG002|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
147516289|NCT02406027|532040418|FG003|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
147516290|NCT02406027|532040419|FG004|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|1|||
147516291|NCT02406027|532040420|FG005|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
147516292|NCT02406027|532040421|FG006|Open-label Phase (Period 2)|Subject not Compliant to Study Procedure|0|||
147516293|NCT03277794|532040424|FG000|Overall Study|Lost to Follow-up|2|||
147516294|NCT03277794|532040425|FG001|Overall Study|Lost to Follow-up|4|||
147516295|NCT03277794|532040424|FG000|Overall Study|Withdrew due to high acuity|1|||
147516296|NCT03277794|532040425|FG001|Overall Study|Withdrew due to high acuity|0|||
147516297|NCT03671148|532042505|FG000|Overall Study|Adverse Event|3|||
147516298|NCT03671148|532042506|FG001|Overall Study|Adverse Event|2|||
147516299|NCT03671148|532042505|FG000|Overall Study|Withdrawal by Subject|8|||
147516300|NCT03671148|532042506|FG001|Overall Study|Withdrawal by Subject|2|||
147516301|NCT03671148|532042505|FG000|Overall Study|Lost to Follow-up|1|||
147516302|NCT03671148|532042506|FG001|Overall Study|Lost to Follow-up|2|||
147516303|NCT03671148|532042505|FG000|Overall Study|Lack of Efficacy|7|||
147516304|NCT03671148|532042506|FG001|Overall Study|Lack of Efficacy|2|||
147516305|NCT03671148|532042505|FG000|Overall Study|COVID-19 Logistical Restrictions|0|||
147516306|NCT03671148|532042506|FG001|Overall Study|COVID-19 Logistical Restrictions|1|||
147516307|NCT03671148|532042505|FG000|Overall Study|Other|1|||
147516308|NCT03671148|532042506|FG001|Overall Study|Other|0|||
147516309|NCT03671148|532042505|FG000|Overall Study|Incomplete Randomization Visit|1|||
147516310|NCT03671148|532042506|FG001|Overall Study|Incomplete Randomization Visit|0|||
147516311|NCT03878160|532042510|FG000|Overall Study|Lost to Follow-up|1|||
147516312|NCT03878160|532042511|FG001|Overall Study|Lost to Follow-up|1|||
147516313|NCT03878160|532042512|FG002|Overall Study|Lost to Follow-up|1|||
147516314|NCT03878160|532042510|FG000|Overall Study|Did not meet eligibility criteria, withdrawn by PI|1|||
147516315|NCT03878160|532042511|FG001|Overall Study|Did not meet eligibility criteria, withdrawn by PI|0|||
147516316|NCT03878160|532042512|FG002|Overall Study|Did not meet eligibility criteria, withdrawn by PI|0|||
147516317|NCT03887052|532042514|FG000|Overall Study|Adverse Event|2|||
147516318|NCT03887052|532042514|FG000|Overall Study|Physician Decision|2|||
147516319|NCT03887052|532042514|FG000|Overall Study|Withdrawal by Subject|3|||
147516320|NCT03887052|532042514|FG000|Overall Study|Motor Vehicle Accident, unrelated to study participation|1|||
147516321|NCT03887052|532042514|FG000|Overall Study|Subject Hospitalized, unrelated to study participation|1|||
147516322|NCT02365506|532042515|FG000|Overall Study|Investigator's Discretion|0|||
147516323|NCT02365506|532042516|FG001|Overall Study|Investigator's Discretion|0|||
147516324|NCT02365506|532042517|FG002|Overall Study|Investigator's Discretion|1|||
147516325|NCT01058395|532042519|FG000|Overall Study|Death|2|||
147516326|NCT01058395|532042520|FG001|Overall Study|Death|1|||
147516327|NCT01058395|532042519|FG000|Overall Study|Lost to Follow-up|1|||
147516328|NCT01058395|532042520|FG001|Overall Study|Lost to Follow-up|0|||
147516329|NCT01266876|532042521|FG000|Overall Study|Adverse Event|0|||
147516330|NCT01266876|532042522|FG001|Overall Study|Adverse Event|0|||
147516331|NCT01266876|532042523|FG002|Overall Study|Adverse Event|0|||
147516332|NCT01266876|532042524|FG003|Overall Study|Adverse Event|1|||
147516333|NCT01266876|532042525|FG004|Overall Study|Adverse Event|0|||
147516334|NCT05016037|532042526|FG000|Overall Study|Lost to Follow-up|2|||
147516335|NCT01899768|532042527|FG000|Part A|Adverse Event|2|||
147516336|NCT01899768|532042527|FG000|Part A|Withdrawal by Subject|1|||
147516337|NCT01899768|532042527|FG000|Part B|Adverse Event|1|||
147516338|NCT01899768|532042527|FG000|Part B|Withdrawal by Subject|1|||
147516339|NCT04043416|532042528|FG000|Washout|Change in health condition|0|||
147516340|NCT04043416|532042529|FG001|Washout|Change in health condition|1|||
147516341|NCT01196091|532042531|FG000|Overall Study|Adverse Event|22|||
147516342|NCT01196091|532042532|FG001|Overall Study|Adverse Event|27|||
147516343|NCT01196091|532042533|FG002|Overall Study|Adverse Event|26|||
147516344|NCT01196091|532042531|FG000|Overall Study|Death|3|||
147516345|NCT01196091|532042532|FG001|Overall Study|Death|2|||
147516346|NCT01196091|532042533|FG002|Overall Study|Death|2|||
147516347|NCT01196091|532042531|FG000|Overall Study|Entry Criteria Not Met|11|||
147516348|NCT01196091|532042532|FG001|Overall Study|Entry Criteria Not Met|11|||
147516349|NCT01196091|532042533|FG002|Overall Study|Entry Criteria Not Met|10|||
147516350|NCT01196091|532042531|FG000|Overall Study|Lack of Efficacy|15|||
147516351|NCT01196091|532042532|FG001|Overall Study|Lack of Efficacy|12|||
147516352|NCT01196091|532042533|FG002|Overall Study|Lack of Efficacy|17|||
147516353|NCT01196091|532042531|FG000|Overall Study|Lost to Follow-up|5|||
147516354|NCT01196091|532042532|FG001|Overall Study|Lost to Follow-up|5|||
147516355|NCT01196091|532042533|FG002|Overall Study|Lost to Follow-up|6|||
147516356|NCT01196091|532042531|FG000|Overall Study|Parent/Caregiver Decision|0|||
147516357|NCT01196091|532042532|FG001|Overall Study|Parent/Caregiver Decision|0|||
147516358|NCT01196091|532042533|FG002|Overall Study|Parent/Caregiver Decision|1|||
147516359|NCT01196091|532042531|FG000|Overall Study|Withdrawal by Subject|16|||
147516360|NCT01196091|532042532|FG001|Overall Study|Withdrawal by Subject|19|||
147516361|NCT01196091|532042533|FG002|Overall Study|Withdrawal by Subject|22|||
147516362|NCT01196091|532042531|FG000|Overall Study|Physician Decision|3|||
147516363|NCT01196091|532042532|FG001|Overall Study|Physician Decision|3|||
147516364|NCT01196091|532042533|FG002|Overall Study|Physician Decision|4|||
147516365|NCT01196091|532042531|FG000|Overall Study|Protocol Violation|1|||
147516366|NCT01196091|532042532|FG001|Overall Study|Protocol Violation|3|||
147516367|NCT01196091|532042533|FG002|Overall Study|Protocol Violation|3|||
147516368|NCT01196091|532042531|FG000|Overall Study|Sponsor Decision|6|||
147516369|NCT01196091|532042532|FG001|Overall Study|Sponsor Decision|5|||
147516370|NCT01196091|532042533|FG002|Overall Study|Sponsor Decision|4|||
147516371|NCT01196091|532042531|FG000|Overall Study|Excluded Site|5|||
147516372|NCT01196091|532042532|FG001|Overall Study|Excluded Site|11|||
147516373|NCT01196091|532042533|FG002|Overall Study|Excluded Site|8|||
147516374|NCT01196091|532042531|FG000|Overall Study|Randomized, No Study Drug Received|1|||
147516375|NCT01196091|532042532|FG001|Overall Study|Randomized, No Study Drug Received|0|||
147516376|NCT01196091|532042533|FG002|Overall Study|Randomized, No Study Drug Received|1|||
147516377|NCT04476108|532042534|FG000|Overall Study|Adverse Event|4|||
147516378|NCT04476108|532042535|FG001|Overall Study|Adverse Event|1|||
147516379|NCT04476108|532042534|FG000|Overall Study|Lost to Follow-up|1|||
147516380|NCT04476108|532042535|FG001|Overall Study|Lost to Follow-up|0|||
147516381|NCT04476108|532042534|FG000|Overall Study|Inadvertent Enrollment|1|||
147516382|NCT04476108|532042535|FG001|Overall Study|Inadvertent Enrollment|0|||
147516383|NCT04476108|532042534|FG000|Overall Study|Protocol Violation|1|||
147516384|NCT04476108|532042535|FG001|Overall Study|Protocol Violation|1|||
147516385|NCT04476108|532042534|FG000|Overall Study|Withdrawal by Subject|1|||
147516386|NCT04476108|532042535|FG001|Overall Study|Withdrawal by Subject|1|||
147516387|NCT00355615|532042537|FG000|Randomized Double Blind Period|Adverse Event|1|||
147516388|NCT00355615|532042538|FG001|Randomized Double Blind Period|Adverse Event|0|||
147516389|NCT00355615|532042539|FG002|Randomized Double Blind Period|Adverse Event|0|||
147516390|NCT00355615|532042540|FG003|Randomized Double Blind Period|Adverse Event|0|||
147516391|NCT00355615|532042541|FG004|Randomized Double Blind Period|Adverse Event|0|||
147516392|NCT00355615|532042537|FG000|Randomized Double Blind Period|Protocol Violation|0|||
147516393|NCT00355615|532042538|FG001|Randomized Double Blind Period|Protocol Violation|0|||
147516394|NCT00355615|532042539|FG002|Randomized Double Blind Period|Protocol Violation|1|||
147516395|NCT00355615|532042540|FG003|Randomized Double Blind Period|Protocol Violation|1|||
147516396|NCT00355615|532042541|FG004|Randomized Double Blind Period|Protocol Violation|0|||
147516397|NCT00355615|532042537|FG000|40-week Rosuvastatin Open Label Period|Adverse Event|0|||
147516398|NCT00355615|532042538|FG001|40-week Rosuvastatin Open Label Period|Adverse Event|0|||
147516399|NCT00355615|532042539|FG002|40-week Rosuvastatin Open Label Period|Adverse Event|0|||
147516400|NCT00355615|532042540|FG003|40-week Rosuvastatin Open Label Period|Adverse Event|0|||
147516401|NCT00355615|532042541|FG004|40-week Rosuvastatin Open Label Period|Adverse Event|4|||
147516402|NCT00355615|532042537|FG000|40-week Rosuvastatin Open Label Period|Protocol Violation|0|||
147516403|NCT00355615|532042538|FG001|40-week Rosuvastatin Open Label Period|Protocol Violation|0|||
147516404|NCT00355615|532042539|FG002|40-week Rosuvastatin Open Label Period|Protocol Violation|0|||
147516405|NCT00355615|532042540|FG003|40-week Rosuvastatin Open Label Period|Protocol Violation|0|||
147516406|NCT00355615|532042541|FG004|40-week Rosuvastatin Open Label Period|Protocol Violation|1|||
147516407|NCT00355615|532042537|FG000|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0|||
147516408|NCT00355615|532042538|FG001|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0|||
147516409|NCT00355615|532042539|FG002|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0|||
147516410|NCT00355615|532042540|FG003|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|0|||
147516411|NCT00355615|532042541|FG004|40-week Rosuvastatin Open Label Period|Withdrawal by Subject|3|||
147516412|NCT00355615|532042537|FG000|40-week Rosuvastatin Open Label Period|investigational site closed|0|||
147516413|NCT00355615|532042538|FG001|40-week Rosuvastatin Open Label Period|investigational site closed|0|||
147516414|NCT00355615|532042539|FG002|40-week Rosuvastatin Open Label Period|investigational site closed|0|||
147516415|NCT00355615|532042540|FG003|40-week Rosuvastatin Open Label Period|investigational site closed|0|||
147516416|NCT00355615|532042541|FG004|40-week Rosuvastatin Open Label Period|investigational site closed|1|||
147516417|NCT04259346|532042542|FG000|Overall Study|Lost to Follow-up|1|||
147516418|NCT04259346|532042543|FG001|Overall Study|Lost to Follow-up|3|||
147516419|NCT04259346|532042542|FG000|Overall Study|Protocol Violation|1|||
147516420|NCT04259346|532042543|FG001|Overall Study|Protocol Violation|0|||
147516421|NCT04259346|532042542|FG000|Overall Study|Withdrawal by Subject|1|||
147516422|NCT04259346|532042543|FG001|Overall Study|Withdrawal by Subject|0|||
147516423|NCT04259346|532042542|FG000|Overall Study|Adverse Event|1|||
147516424|NCT04259346|532042543|FG001|Overall Study|Adverse Event|1|||
147516425|NCT00085644|532042544|FG000|Double-Blind Period|Adverse Event|5|||
147516426|NCT00085644|532042545|FG001|Double-Blind Period|Adverse Event|2|||
147516427|NCT00085644|532042546|FG002|Double-Blind Period|Adverse Event|0|||
147516428|NCT00085644|532042544|FG000|Double-Blind Period|Withdrawal by Subject|3|||
147516429|NCT00085644|532042545|FG001|Double-Blind Period|Withdrawal by Subject|0|||
147516430|NCT00085644|532042546|FG002|Double-Blind Period|Withdrawal by Subject|0|||
147516431|NCT00085644|532042544|FG000|Double-Blind Period|Lost to Follow-up|2|||
147516432|NCT00085644|532042545|FG001|Double-Blind Period|Lost to Follow-up|1|||
147516433|NCT00085644|532042546|FG002|Double-Blind Period|Lost to Follow-up|0|||
147516434|NCT00085644|532042544|FG000|Double-Blind Period|Lack/loss of efficacy|2|||
147516435|NCT00085644|532042545|FG001|Double-Blind Period|Lack/loss of efficacy|2|||
147516436|NCT00085644|532042546|FG002|Double-Blind Period|Lack/loss of efficacy|0|||
147516437|NCT00085644|532042544|FG000|Double-Blind Period|Contemplating pregnancy|1|||
147516438|NCT00085644|532042545|FG001|Double-Blind Period|Contemplating pregnancy|0|||
147516439|NCT00085644|532042546|FG002|Double-Blind Period|Contemplating pregnancy|0|||
147516440|NCT00085644|532042544|FG000|Double-Blind Period|Undiagnosed pre-existing condition|0|||
147516441|NCT00085644|532042545|FG001|Double-Blind Period|Undiagnosed pre-existing condition|1|||
147516442|NCT00085644|532042546|FG002|Double-Blind Period|Undiagnosed pre-existing condition|0|||
147516443|NCT00085644|532042544|FG000|Open-Label Period|Adverse Event|0|||
147516444|NCT00085644|532042545|FG001|Open-Label Period|Adverse Event|0|||
147516445|NCT00085644|532042546|FG002|Open-Label Period|Adverse Event|38|||
147516446|NCT00085644|532042544|FG000|Open-Label Period|Withdrawal by Subject|0|||
147516447|NCT00085644|532042545|FG001|Open-Label Period|Withdrawal by Subject|0|||
147516448|NCT00085644|532042546|FG002|Open-Label Period|Withdrawal by Subject|29|||
147516449|NCT00085644|532042544|FG000|Open-Label Period|Lost to Follow-up|0|||
147516450|NCT00085644|532042545|FG001|Open-Label Period|Lost to Follow-up|0|||
147516451|NCT00085644|532042546|FG002|Open-Label Period|Lost to Follow-up|13|||
147516452|NCT00085644|532042544|FG000|Open-Label Period|Lack of Efficacy|0|||
147516453|NCT00085644|532042545|FG001|Open-Label Period|Lack of Efficacy|0|||
147516454|NCT00085644|532042546|FG002|Open-Label Period|Lack of Efficacy|15|||
147516455|NCT00085644|532042544|FG000|Open-Label Period|Pregnancy|0|||
147516456|NCT00085644|532042545|FG001|Open-Label Period|Pregnancy|0|||
147516457|NCT00085644|532042546|FG002|Open-Label Period|Pregnancy|3|||
147516458|NCT00085644|532042544|FG000|Open-Label Period|Contemplating pregnancy|0|||
147516459|NCT00085644|532042545|FG001|Open-Label Period|Contemplating pregnancy|0|||
147516460|NCT00085644|532042546|FG002|Open-Label Period|Contemplating pregnancy|3|||
147516461|NCT00085644|532042544|FG000|Open-Label Period|Protocol Violation|0|||
147516462|NCT00085644|532042545|FG001|Open-Label Period|Protocol Violation|0|||
147516463|NCT00085644|532042546|FG002|Open-Label Period|Protocol Violation|4|||
147516464|NCT00085644|532042544|FG000|Open-Label Period|Personal reason|0|||
147516465|NCT00085644|532042545|FG001|Open-Label Period|Personal reason|0|||
147516466|NCT00085644|532042546|FG002|Open-Label Period|Personal reason|4|||
147516467|NCT01302691|532042547|FG000|Overall Study|Adverse Event|2|||
147516468|NCT01302691|532042548|FG001|Overall Study|Adverse Event|0|||
147516469|NCT01302691|532042547|FG000|Overall Study|Death|0|||
147516470|NCT01302691|532042548|FG001|Overall Study|Death|1|||
147516471|NCT01302691|532042547|FG000|Overall Study|Lost to Follow-up|1|||
147516472|NCT01302691|532042548|FG001|Overall Study|Lost to Follow-up|0|||
147516473|NCT01302691|532042547|FG000|Overall Study|Blood Pressure/Potassium Criteria Met|6|||
147516474|NCT01302691|532042548|FG001|Overall Study|Blood Pressure/Potassium Criteria Met|4|||
147516475|NCT01302691|532042547|FG000|Overall Study|Physician Decision|0|||
147516476|NCT01302691|532042548|FG001|Overall Study|Physician Decision|1|||
147516477|NCT01302691|532042547|FG000|Overall Study|Protocol Violation|1|||
147516478|NCT01302691|532042548|FG001|Overall Study|Protocol Violation|0|||
147516479|NCT02829775|532042549|FG000|Overall Study|Death|1|||
147516480|NCT02829775|532042549|FG000|Overall Study|Withdrawal by Subject|3|||
147516481|NCT02829775|532042549|FG000|Overall Study|Disease remission|1|||
147516482|NCT00062647|532042550|FG000|Overall Study|Death|2|||
147516483|NCT00062647|532042551|FG001|Overall Study|Death|2|||
147516484|NCT00062647|532042550|FG000|Overall Study|Adverse Event|1|||
147516485|NCT00062647|532042551|FG001|Overall Study|Adverse Event|1|||
147516486|NCT00062647|532042550|FG000|Overall Study|Withdrawal by Subject|2|||
147516487|NCT00062647|532042551|FG001|Overall Study|Withdrawal by Subject|1|||
147516488|NCT00062647|532042550|FG000|Overall Study|Protocol Violation|1|||
147516489|NCT00062647|532042551|FG001|Overall Study|Protocol Violation|0|||
147516490|NCT00062647|532042550|FG000|Overall Study|Lost to Follow-up|1|||
147516491|NCT00062647|532042551|FG001|Overall Study|Lost to Follow-up|2|||
147516492|NCT00062647|532042550|FG000|Overall Study|Failed continuation criteria|4|||
147516493|NCT00062647|532042551|FG001|Overall Study|Failed continuation criteria|2|||
147516494|NCT00062647|532042550|FG000|Overall Study|Other|4|||
147516495|NCT00062647|532042551|FG001|Overall Study|Other|4|||
147516496|NCT00062647|532042550|FG000|Overall Study|Never received study treatment|1|||
147516497|NCT00062647|532042551|FG001|Overall Study|Never received study treatment|1|||
147516498|NCT01039428|532042556|FG000|Overall Study|Protocol Violation|1|||
147516499|NCT01039428|532042557|FG001|Overall Study|Protocol Violation|0|||
147516500|NCT01039428|532042556|FG000|Overall Study|Withdrawal by Subject|1|||
147516501|NCT01039428|532042557|FG001|Overall Study|Withdrawal by Subject|0|||
147516502|NCT01313039|532042558|FG000|Overall Study|Physician Decision|1|||
147516503|NCT01313039|532042558|FG000|Overall Study|Adverse Event|1|||
147516504|NCT01678560|532042559|FG000|Overall Study|Physician Decision|4|||
147516505|NCT01678560|532042560|FG001|Overall Study|Physician Decision|4|||
147516506|NCT01678560|532042559|FG000|Overall Study|Death|0|||
147516507|NCT01678560|532042560|FG001|Overall Study|Death|1|||
147516508|NCT01678560|532042559|FG000|Overall Study|Withdrawal by Subject|0|||
147516509|NCT01678560|532042560|FG001|Overall Study|Withdrawal by Subject|1|||
147516510|NCT02201472|532042561|FG000|Overall Study|Lack of Efficacy|2|||
147516511|NCT01300767|532042562|FG000|Overall Study|Discomfort|2|||
147516512|NCT01300767|532042562|FG000|Overall Study|Biomicroscopy|1|||
147516513|NCT01300767|532042562|FG000|Overall Study|Unacceptable fit|1|||
147516514|NCT00117572|532042563|FG000|Overall Study|Site withdrew before starting treatment|2|||
147516515|NCT00117572|532042564|FG001|Overall Study|Site withdrew before starting treatment|3|||
147516516|NCT00117572|532042563|FG000|Overall Study|Withdrawal by Subject|3|||
147516517|NCT00117572|532042564|FG001|Overall Study|Withdrawal by Subject|3|||
147516518|NCT00117572|532042563|FG000|Overall Study|Protocol Violation|1|||
147516519|NCT00117572|532042564|FG001|Overall Study|Protocol Violation|0|||
147516520|NCT01188811|532042567|FG000|Overall Study|Withdrawal by Subject|0|||
147516521|NCT01188811|532042568|FG001|Overall Study|Withdrawal by Subject|2|||
147516522|NCT01188811|532042567|FG000|Overall Study|Adverse Event|6|||
147516523|NCT01188811|532042568|FG001|Overall Study|Adverse Event|0|||
147516524|NCT01602744|532042569|FG000|Overall Study|Death|17|||
147516525|NCT01602744|532042570|FG001|Overall Study|Death|15|||
147516526|NCT01602744|532042569|FG000|Overall Study|Lost to Follow-up|13|||
147516527|NCT01602744|532042570|FG001|Overall Study|Lost to Follow-up|8|||
147516528|NCT00654368|532042571|FG000|Overall Study|Ineligibility determined|6|||
147516529|NCT00654368|532042572|FG001|Overall Study|Ineligibility determined|0|||
147516530|NCT00654368|532042573|FG002|Overall Study|Ineligibility determined|0|||
147516531|NCT00654368|532042571|FG000|Overall Study|Protocol deviation|3|||
147516532|NCT00654368|532042572|FG001|Overall Study|Protocol deviation|2|||
147516533|NCT00654368|532042573|FG002|Overall Study|Protocol deviation|1|||
147516534|NCT00654368|532042571|FG000|Overall Study|Non-compliance|2|||
147516535|NCT00654368|532042572|FG001|Overall Study|Non-compliance|1|||
147516536|NCT00654368|532042573|FG002|Overall Study|Non-compliance|2|||
147516537|NCT00654368|532042571|FG000|Overall Study|Withdrawal by Subject|5|||
147516538|NCT00654368|532042572|FG001|Overall Study|Withdrawal by Subject|2|||
147516539|NCT00654368|532042573|FG002|Overall Study|Withdrawal by Subject|2|||
147516540|NCT00654368|532042571|FG000|Overall Study|Disease progression|21|||
147516541|NCT00654368|532042572|FG001|Overall Study|Disease progression|31|||
147516542|NCT00654368|532042573|FG002|Overall Study|Disease progression|13|||
147516543|NCT00654368|532042571|FG000|Overall Study|Requirement for alternative therapy|1|||
147516544|NCT00654368|532042572|FG001|Overall Study|Requirement for alternative therapy|1|||
147516545|NCT00654368|532042573|FG002|Overall Study|Requirement for alternative therapy|1|||
147516546|NCT00654368|532042571|FG000|Overall Study|Physician Decision|0|||
147516547|NCT00654368|532042572|FG001|Overall Study|Physician Decision|0|||
147516548|NCT00654368|532042573|FG002|Overall Study|Physician Decision|2|||
147516549|NCT00654368|532042571|FG000|Overall Study|Death|1|||
147516550|NCT00654368|532042572|FG001|Overall Study|Death|0|||
147516551|NCT00654368|532042573|FG002|Overall Study|Death|0|||
147516552|NCT00654368|532042571|FG000|Overall Study|Pregnancy|0|||
147516553|NCT00654368|532042572|FG001|Overall Study|Pregnancy|0|||
147516554|NCT00654368|532042573|FG002|Overall Study|Pregnancy|2|||
147516555|NCT00654368|532042571|FG000|Overall Study|Other|0|||
147516556|NCT00654368|532042572|FG001|Overall Study|Other|2|||
147516557|NCT00654368|532042573|FG002|Overall Study|Other|3|||
147516558|NCT00654368|532042571|FG000|Overall Study|Adverse Event|14|||
147516559|NCT00654368|532042572|FG001|Overall Study|Adverse Event|9|||
147516560|NCT00654368|532042573|FG002|Overall Study|Adverse Event|6|||
147516561|NCT04228445|532042575|FG000|Overall Study|Lost to Follow-up|1|||
147516562|NCT04228445|532042576|FG001|Overall Study|Lost to Follow-up|1|||
147516563|NCT04228445|532042575|FG000|Overall Study|Physician Decision|1|||
147516564|NCT04228445|532042576|FG001|Overall Study|Physician Decision|2|||
147516565|NCT04228445|532042575|FG000|Overall Study|Withdrawal by Subject|0|||
147516566|NCT04228445|532042576|FG001|Overall Study|Withdrawal by Subject|1|||
147516567|NCT04228445|532042575|FG000|Overall Study|Planned procedure not performed after randomization, study drug not administered|1|||
147516568|NCT04228445|532042576|FG001|Overall Study|Planned procedure not performed after randomization, study drug not administered|0|||
147516569|NCT00606294|532042579|FG000|Overall Study|Withdrawal by Subject|36|||
147516570|NCT00606294|532042580|FG001|Overall Study|Withdrawal by Subject|0|||
147516571|NCT03418376|532042581|FG000|Overall Study|Musculoskeletal injury|1|||
147516572|NCT03418376|532042582|FG001|Overall Study|Musculoskeletal injury|2|||
147516573|NCT03418376|532042583|FG002|Overall Study|Musculoskeletal injury|1|||
147516574|NCT03418376|532042584|FG003|Overall Study|Musculoskeletal injury|0|||
147516575|NCT03418376|532042581|FG000|Overall Study|Personal reasons|0|||
147516576|NCT03418376|532042582|FG001|Overall Study|Personal reasons|2|||
147516577|NCT03418376|532042583|FG002|Overall Study|Personal reasons|2|||
147516578|NCT03418376|532042584|FG003|Overall Study|Personal reasons|1|||
147516579|NCT03418376|532042581|FG000|Overall Study|Exacerbation|0|||
147516580|NCT03418376|532042582|FG001|Overall Study|Exacerbation|1|||
147516581|NCT03418376|532042583|FG002|Overall Study|Exacerbation|0|||
147516582|NCT03418376|532042584|FG003|Overall Study|Exacerbation|0|||
147516583|NCT01976624|532042585|FG000|Overall Study|Participants contraindicated|2|||
147516584|NCT01976624|532042585|FG000|Overall Study|Participants age less than 19 years|12|||
147516585|NCT02774291|532042586|FG000|Overall Study|Lost to Follow-up|1|||
147516586|NCT00471315|532042587|FG000|Overall Study|Adverse Event|7|||
147516587|NCT00471315|532042587|FG000|Overall Study|Withdrawal by Subject|1|||
147516588|NCT04757376|532042593|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Withdrawal by Subject|8|||
147516589|NCT04757376|532042594|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Withdrawal by Subject|24|||
147516590|NCT04757376|532042595|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Withdrawal by Subject|0|||
147516591|NCT04757376|532042596|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Withdrawal by Subject|0|||
147516592|NCT04757376|532042597|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Withdrawal by Subject|0|||
147516593|NCT04757376|532042593|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Adverse Event|4|||
147516594|NCT04757376|532042594|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Adverse Event|5|||
147516595|NCT04757376|532042595|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Adverse Event|0|||
147516596|NCT04757376|532042596|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Adverse Event|0|||
147516597|NCT04757376|532042597|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Adverse Event|0|||
147516598|NCT04757376|532042593|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Protocol Violation|5|||
147516599|NCT04757376|532042594|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Protocol Violation|4|||
147516600|NCT04757376|532042595|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Protocol Violation|0|||
147516601|NCT04757376|532042596|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Protocol Violation|0|||
147516602|NCT04757376|532042597|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Protocol Violation|0|||
147516603|NCT04757376|532042593|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Lost to Follow-up|0|||
147516604|NCT04757376|532042594|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Lost to Follow-up|3|||
147516605|NCT04757376|532042595|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Lost to Follow-up|0|||
147516606|NCT04757376|532042596|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Lost to Follow-up|0|||
147516607|NCT04757376|532042597|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Lost to Follow-up|0|||
147516608|NCT04757376|532042593|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Physician Decision|1|||
147516609|NCT04757376|532042594|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Physician Decision|0|||
147516610|NCT04757376|532042595|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Physician Decision|0|||
147516611|NCT04757376|532042596|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Physician Decision|0|||
147516612|NCT04757376|532042597|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Physician Decision|0|||
147516613|NCT04757376|532042593|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Disease progression|0|||
147516614|NCT04757376|532042594|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Disease progression|1|||
147516615|NCT04757376|532042595|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Disease progression|0|||
147516616|NCT04757376|532042596|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Disease progression|0|||
147516617|NCT04757376|532042597|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Disease progression|0|||
147516618|NCT04757376|532042593|FG000|TP I - Week 0, Day 1 to Week 52 Predose|Terminated the study before the initiation of the study treatment|1|||
147516619|NCT04757376|532042594|FG001|TP I - Week 0, Day 1 to Week 52 Predose|Terminated the study before the initiation of the study treatment|1|||
147516620|NCT04757376|532042595|FG002|TP I - Week 0, Day 1 to Week 52 Predose|Terminated the study before the initiation of the study treatment|0|||
147516621|NCT04757376|532042596|FG003|TP I - Week 0, Day 1 to Week 52 Predose|Terminated the study before the initiation of the study treatment|0|||
147516622|NCT04757376|532042597|FG004|TP I - Week 0, Day 1 to Week 52 Predose|Terminated the study before the initiation of the study treatment|0|||
147516623|NCT04757376|532042593|FG000|TP II - Week 52 to Week 78|Discontinued the study treatment before the study treatment initiation due to the adverse event|0|||
147516624|NCT04757376|532042594|FG001|TP II - Week 52 to Week 78|Discontinued the study treatment before the study treatment initiation due to the adverse event|0|||
147516625|NCT04757376|532042595|FG002|TP II - Week 52 to Week 78|Discontinued the study treatment before the study treatment initiation due to the adverse event|1|||
147516626|NCT04757376|532042596|FG003|TP II - Week 52 to Week 78|Discontinued the study treatment before the study treatment initiation due to the adverse event|0|||
147516627|NCT04757376|532042597|FG004|TP II - Week 52 to Week 78|Discontinued the study treatment before the study treatment initiation due to the adverse event|0|||
147516628|NCT01307046|532042598|FG000|Overall Study|Adverse Event|3|||
147516629|NCT01307046|532042599|FG001|Overall Study|Adverse Event|3|||
147516630|NCT01307046|532042598|FG000|Overall Study|Lack of Efficacy|0|||
147516631|NCT01307046|532042599|FG001|Overall Study|Lack of Efficacy|2|||
147516632|NCT01307046|532042598|FG000|Overall Study|Physician Decision|2|||
147516633|NCT01307046|532042599|FG001|Overall Study|Physician Decision|0|||
147516634|NCT01307046|532042598|FG000|Overall Study|Withdrawal by Subject|1|||
147516635|NCT01307046|532042599|FG001|Overall Study|Withdrawal by Subject|1|||
147516636|NCT01307046|532042598|FG000|Overall Study|Serum Potassium Withdrawal Criteria Met|4|||
147516637|NCT01307046|532042599|FG001|Overall Study|Serum Potassium Withdrawal Criteria Met|2|||
147516638|NCT01307046|532042598|FG000|Overall Study|Blood Pressure Withdrawal Criteria Met|2|||
147516639|NCT01307046|532042599|FG001|Overall Study|Blood Pressure Withdrawal Criteria Met|3|||
147516640|NCT00609167|532042600|FG000|Overall Study|Withdrawal by Subject|1|||
147516641|NCT00609167|532042601|FG001|Overall Study|Withdrawal by Subject|0|||
147516642|NCT00609167|532042600|FG000|Overall Study|Lack of Efficacy|1|||
147516643|NCT00609167|532042601|FG001|Overall Study|Lack of Efficacy|0|||
147516644|NCT00609167|532042600|FG000|Overall Study|Adverse Event|5|||
147516645|NCT00609167|532042601|FG001|Overall Study|Adverse Event|1|||
147516646|NCT00609167|532042600|FG000|Overall Study|Disease Progression|1|||
147516647|NCT00609167|532042601|FG001|Overall Study|Disease Progression|0|||
147516648|NCT00609167|532042600|FG000|Overall Study|Stem Cell Transplant|0|||
147516649|NCT00609167|532042601|FG001|Overall Study|Stem Cell Transplant|6|||
147516650|NCT03898323|532042602|FG000|Overall Study|Physician Decision|1|||
147516651|NCT00712270|532042604|FG000|Overall Study|Withdrawal by Subject|11|||
147516652|NCT00712270|532042604|FG000|Overall Study|Screen Failure|3|||
147516653|NCT02574520|532042605|FG000|Overall Study|Not dosed|2|||
147516654|NCT02574520|532042606|FG001|Overall Study|Not dosed|0|||
147516655|NCT02574520|532042607|FG002|Overall Study|Not dosed|5|||
147516656|NCT02574520|532042608|FG003|Overall Study|Not dosed|4|||
147516657|NCT02574520|532042605|FG000|Overall Study|Adverse Event|0|||
147516658|NCT02574520|532042606|FG001|Overall Study|Adverse Event|0|||
147516659|NCT02574520|532042607|FG002|Overall Study|Adverse Event|0|||
147516660|NCT02574520|532042608|FG003|Overall Study|Adverse Event|1|||
147516661|NCT02574520|532042605|FG000|Overall Study|Withdrawal by Subject|0|||
147516662|NCT02574520|532042606|FG001|Overall Study|Withdrawal by Subject|0|||
147516663|NCT02574520|532042607|FG002|Overall Study|Withdrawal by Subject|0|||
147516664|NCT02574520|532042608|FG003|Overall Study|Withdrawal by Subject|1|||
147516665|NCT02574520|532042605|FG000|Overall Study|Other|0|||
147516666|NCT02574520|532042606|FG001|Overall Study|Other|0|||
147516667|NCT02574520|532042607|FG002|Overall Study|Other|0|||
147516668|NCT02574520|532042608|FG003|Overall Study|Other|2|||
147516669|NCT03935594|532042625|FG000|Overall Study|Physician Decision|3|||
147516670|NCT03954704|532042626|FG000|Overall Study|Death|1|||
147516671|NCT03954704|532042627|FG001|Overall Study|Death|1|||
147516672|NCT03954704|532042628|FG002|Overall Study|Death|1|||
147516673|NCT03954704|532042629|FG003|Overall Study|Death|3|||
147516674|NCT03954704|532042630|FG004|Overall Study|Death|2|||
147516675|NCT03954704|532042631|FG005|Overall Study|Death|2|||
147516676|NCT03954704|532042632|FG006|Overall Study|Death|0|||
147516677|NCT03954704|532042626|FG000|Overall Study|Withdrew Consent|0|||
147516678|NCT03954704|532042627|FG001|Overall Study|Withdrew Consent|0|||
147516679|NCT03954704|532042628|FG002|Overall Study|Withdrew Consent|1|||
147516680|NCT03954704|532042629|FG003|Overall Study|Withdrew Consent|0|||
147516681|NCT03954704|532042630|FG004|Overall Study|Withdrew Consent|0|||
147516682|NCT03954704|532042631|FG005|Overall Study|Withdrew Consent|1|||
147516683|NCT03954704|532042632|FG006|Overall Study|Withdrew Consent|0|||
147516684|NCT03954704|532042626|FG000|Overall Study|Lost to Follow-up|0|||
147516685|NCT03954704|532042627|FG001|Overall Study|Lost to Follow-up|0|||
147516686|NCT03954704|532042628|FG002|Overall Study|Lost to Follow-up|0|||
147516687|NCT03954704|532042629|FG003|Overall Study|Lost to Follow-up|0|||
147516688|NCT03954704|532042630|FG004|Overall Study|Lost to Follow-up|0|||
147516689|NCT03954704|532042631|FG005|Overall Study|Lost to Follow-up|0|||
147516690|NCT03954704|532042632|FG006|Overall Study|Lost to Follow-up|1|||
147516691|NCT03954704|532042626|FG000|Overall Study|Study Terminated by Sponsor|0|||
147516692|NCT03954704|532042627|FG001|Overall Study|Study Terminated by Sponsor|0|||
147516693|NCT03954704|532042628|FG002|Overall Study|Study Terminated by Sponsor|1|||
147516694|NCT03954704|532042629|FG003|Overall Study|Study Terminated by Sponsor|0|||
147516695|NCT03954704|532042630|FG004|Overall Study|Study Terminated by Sponsor|1|||
147516696|NCT03954704|532042631|FG005|Overall Study|Study Terminated by Sponsor|4|||
147516697|NCT03954704|532042632|FG006|Overall Study|Study Terminated by Sponsor|2|||
147516698|NCT03954704|532042626|FG000|Overall Study|Enrolled but not Treated|0|||
147516699|NCT03954704|532042627|FG001|Overall Study|Enrolled but not Treated|0|||
147516700|NCT03954704|532042628|FG002|Overall Study|Enrolled but not Treated|0|||
147516701|NCT03954704|532042629|FG003|Overall Study|Enrolled but not Treated|0|||
147516702|NCT03954704|532042630|FG004|Overall Study|Enrolled but not Treated|0|||
147516703|NCT03954704|532042631|FG005|Overall Study|Enrolled but not Treated|1|||
147516704|NCT03954704|532042632|FG006|Overall Study|Enrolled but not Treated|0|||
147516705|NCT01388491|532042636|FG000|Overall Study|Adverse Event|10|||
147516706|NCT01388491|532042637|FG001|Overall Study|Adverse Event|9|||
147516707|NCT01388491|532042636|FG000|Overall Study|Sponsor Request|9|||
147516708|NCT01388491|532042637|FG001|Overall Study|Sponsor Request|7|||
147516709|NCT01388491|532042636|FG000|Overall Study|Withdrawal by Subject|6|||
147516710|NCT01388491|532042637|FG001|Overall Study|Withdrawal by Subject|10|||
147516711|NCT01388491|532042636|FG000|Overall Study|Lost to Follow-up|4|||
147516712|NCT01388491|532042637|FG001|Overall Study|Lost to Follow-up|3|||
147516713|NCT01388491|532042636|FG000|Overall Study|Protocol Violation|2|||
147516714|NCT01388491|532042637|FG001|Overall Study|Protocol Violation|0|||
147516715|NCT01388491|532042636|FG000|Overall Study|Noncompliance|2|||
147516716|NCT01388491|532042637|FG001|Overall Study|Noncompliance|0|||
147516717|NCT01388491|532042636|FG000|Overall Study|Pregnancy|1|||
147516718|NCT01388491|532042637|FG001|Overall Study|Pregnancy|0|||
147516719|NCT04035473|532042638|FG000|Screening/Baseline|Death|0|||
147516720|NCT04035473|532042639|FG001|Screening/Baseline|Death|1|||
147516721|NCT04035473|532042638|FG000|Screening/Baseline|Adverse Event|0|||
147516722|NCT04035473|532042639|FG001|Screening/Baseline|Adverse Event|1|||
147516723|NCT04035473|532042638|FG000|Follow-up Period|Adverse Event|2|||
147516724|NCT04035473|532042639|FG001|Follow-up Period|Adverse Event|0|||
147516725|NCT02735044|532042641|FG000|Overall Study|Adverse Event|3|||
147516726|NCT02735044|532042642|FG001|Overall Study|Adverse Event|3|||
147516727|NCT02735044|532042641|FG000|Overall Study|Lack of Efficacy|1|||
147516728|NCT02735044|532042642|FG001|Overall Study|Lack of Efficacy|0|||
147516729|NCT02735044|532042641|FG000|Overall Study|Poor compliance to protocol|7|||
147516730|NCT02735044|532042642|FG001|Overall Study|Poor compliance to protocol|7|||
147516731|NCT02735044|532042641|FG000|Overall Study|Randomized and not treated|0|||
147516732|NCT02735044|532042642|FG001|Overall Study|Randomized and not treated|2|||
147516733|NCT02735044|532042641|FG000|Overall Study|Other, not specified above|5|||
147516734|NCT02735044|532042642|FG001|Overall Study|Other, not specified above|11|||
147516735|NCT01682759|532042644|FG000|Overall Study|Death|2|||
147516736|NCT01682759|532042645|FG001|Overall Study|Death|1|||
147516737|NCT01682759|532042644|FG000|Overall Study|Lost to Follow-up|10|||
147516738|NCT01682759|532042645|FG001|Overall Study|Lost to Follow-up|13|||
147516739|NCT01682759|532042644|FG000|Overall Study|Physician Decision|1|||
147516740|NCT01682759|532042645|FG001|Overall Study|Physician Decision|1|||
147516741|NCT01682759|532042644|FG000|Overall Study|Withdrawal by Subject|56|||
147516742|NCT01682759|532042645|FG001|Overall Study|Withdrawal by Subject|55|||
147516743|NCT00397891|532042646|FG000|Overall Study|Withdrawal by Subject|1|||
147516744|NCT00397891|532042647|FG001|Overall Study|Withdrawal by Subject|0|||
147516745|NCT00397891|532042648|FG002|Overall Study|Withdrawal by Subject|0|||
147516746|NCT00397891|532042649|FG003|Overall Study|Withdrawal by Subject|0|||
147516747|NCT00397891|532042650|FG004|Overall Study|Withdrawal by Subject|1|||
147516748|NCT00412113|532042651|FG000|Overall Study|Adverse Event|11|||
147516749|NCT00412113|532042652|FG001|Overall Study|Adverse Event|15|||
147516750|NCT00412113|532042651|FG000|Overall Study|did not receive treatment|1|||
147516751|NCT00412113|532042652|FG001|Overall Study|did not receive treatment|0|||
147516752|NCT01190020|532042657|FG000|Overall Study|Adverse Event|2|||
147516753|NCT01190020|532042658|FG001|Overall Study|Adverse Event|0|||
147516754|NCT01190020|532042657|FG000|Overall Study|Lost to Follow-up|2|||
147516755|NCT01190020|532042658|FG001|Overall Study|Lost to Follow-up|0|||
147516756|NCT01190020|532042657|FG000|Overall Study|Withdrawal by Subject|3|||
147516757|NCT01190020|532042658|FG001|Overall Study|Withdrawal by Subject|0|||
147516758|NCT00796224|532042659|FG000|Overall Study|Adverse Event|1|||
147516759|NCT00796224|532042660|FG001|Overall Study|Adverse Event|0|||
147516760|NCT00796224|532042659|FG000|Overall Study|Protocol Violation|0|||
147516761|NCT00796224|532042660|FG001|Overall Study|Protocol Violation|1|||
147516762|NCT03227224|532042663|FG000|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|1|||
147516763|NCT03227224|532042664|FG001|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|0|||
147516764|NCT03227224|532042665|FG002|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|2|||
147516765|NCT03227224|532042666|FG003|Double-blind Treatment Period (6 Weeks)|Lost to Follow-up|0|||
147516766|NCT03227224|532042663|FG000|Double-blind Treatment Period (6 Weeks)|Protocol Violation|2|||
147516767|NCT03227224|532042664|FG001|Double-blind Treatment Period (6 Weeks)|Protocol Violation|2|||
147516768|NCT03227224|532042665|FG002|Double-blind Treatment Period (6 Weeks)|Protocol Violation|0|||
147516769|NCT03227224|532042666|FG003|Double-blind Treatment Period (6 Weeks)|Protocol Violation|0|||
147516770|NCT03227224|532042663|FG000|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|3|||
147516771|NCT03227224|532042664|FG001|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|2|||
147516772|NCT03227224|532042665|FG002|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|3|||
147516773|NCT03227224|532042666|FG003|Double-blind Treatment Period (6 Weeks)|Withdrawal by Subject|2|||
147516774|NCT03227224|532042663|FG000|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|1|||
147516775|NCT03227224|532042664|FG001|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
147516776|NCT03227224|532042665|FG002|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
147516777|NCT03227224|532042666|FG003|Double-blind Treatment Period (6 Weeks)|Lack of Efficacy|0|||
147516778|NCT03227224|532042663|FG000|Double-blind Treatment Period (6 Weeks)|Received a Disallowed Concomitant Treatment|0|||
147516779|NCT03227224|532042664|FG001|Double-blind Treatment Period (6 Weeks)|Received a Disallowed Concomitant Treatment|0|||
147516780|NCT03227224|532042665|FG002|Double-blind Treatment Period (6 Weeks)|Received a Disallowed Concomitant Treatment|1|||
147516781|NCT03227224|532042666|FG003|Double-blind Treatment Period (6 Weeks)|Received a Disallowed Concomitant Treatment|0|||
147516782|NCT03227224|532042663|FG000|Double-blind Treatment Period (6 Weeks)|Adverse Event|2|||
147516783|NCT03227224|532042664|FG001|Double-blind Treatment Period (6 Weeks)|Adverse Event|1|||
147516784|NCT03227224|532042665|FG002|Double-blind Treatment Period (6 Weeks)|Adverse Event|1|||
147516785|NCT03227224|532042666|FG003|Double-blind Treatment Period (6 Weeks)|Adverse Event|4|||
147516786|NCT03227224|532042663|FG000|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|2|||
147516787|NCT03227224|532042664|FG001|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|1|||
147516788|NCT03227224|532042665|FG002|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|0|||
147516789|NCT03227224|532042666|FG003|Double-blind Treatment Period (6 Weeks)|Non-Compliance with Study Drug|1|||
147516790|NCT03227224|532042663|FG000|Double-blind Treatment Period (6 Weeks)|Other|4|||
147516791|NCT03227224|532042664|FG001|Double-blind Treatment Period (6 Weeks)|Other|0|||
147516792|NCT03227224|532042665|FG002|Double-blind Treatment Period (6 Weeks)|Other|1|||
147516793|NCT03227224|532042666|FG003|Double-blind Treatment Period (6 Weeks)|Other|0|||
147516794|NCT03227224|532042663|FG000|Follow-up Phase (2 Weeks)|Other|4|||
147516795|NCT03227224|532042664|FG001|Follow-up Phase (2 Weeks)|Other|4|||
147516796|NCT03227224|532042665|FG002|Follow-up Phase (2 Weeks)|Other|6|||
147516797|NCT03227224|532042666|FG003|Follow-up Phase (2 Weeks)|Other|3|||
147516798|NCT04195750|532042667|FG000|Overall Study|Death|245|||
147516799|NCT04195750|532042668|FG001|Overall Study|Death|253|||
147516800|NCT04195750|532042669|FG002|Overall Study|Death|5|||
147516801|NCT04195750|532042667|FG000|Overall Study|Physician Decision|0|||
147516802|NCT04195750|532042668|FG001|Overall Study|Physician Decision|1|||
147516803|NCT04195750|532042669|FG002|Overall Study|Physician Decision|0|||
147516804|NCT04195750|532042667|FG000|Overall Study|Withdrawal by Subject|9|||
147516805|NCT04195750|532042668|FG001|Overall Study|Withdrawal by Subject|8|||
147516806|NCT04195750|532042669|FG002|Overall Study|Withdrawal by Subject|0|||
147516807|NCT04195750|532042667|FG000|Overall Study|Ongoing|120|||
147516808|NCT04195750|532042668|FG001|Overall Study|Ongoing|110|||
147516809|NCT04195750|532042669|FG002|Overall Study|Ongoing|4|||
147516810|NCT03782376|532042670|FG000|Overall Study|Lost to Follow-up|2|||
147516811|NCT03782376|532042671|FG001|Overall Study|Lost to Follow-up|2|||
147516812|NCT03782376|532042670|FG000|Overall Study|Withdrawal by Subject|7|||
147516813|NCT03782376|532042671|FG001|Overall Study|Withdrawal by Subject|11|||
147516814|NCT03782376|532042670|FG000|Overall Study|Death|1|||
147516815|NCT03782376|532042671|FG001|Overall Study|Death|0|||
147516816|NCT03782376|532042670|FG000|Overall Study|Other|16|||
147516817|NCT03782376|532042671|FG001|Overall Study|Other|17|||
147516818|NCT02254304|532042676|FG000|Overall Study|Adverse Event|2|||
147516819|NCT02254304|532042677|FG001|Overall Study|Adverse Event|1|||
147516820|NCT02254304|532042676|FG000|Overall Study|Lost to Follow-up|2|||
147516821|NCT02254304|532042677|FG001|Overall Study|Lost to Follow-up|2|||
147516822|NCT02254304|532042676|FG000|Overall Study|Protocol Violation|1|||
147516823|NCT02254304|532042677|FG001|Overall Study|Protocol Violation|0|||
147516824|NCT02254304|532042676|FG000|Overall Study|Withdrawal by Subject|3|||
147516825|NCT02254304|532042677|FG001|Overall Study|Withdrawal by Subject|0|||
147516826|NCT02254304|532042676|FG000|Overall Study|Injection site pain and Injection fear|1|||
147516827|NCT02254304|532042677|FG001|Overall Study|Injection site pain and Injection fear|0|||
147516828|NCT02254304|532042676|FG000|Overall Study|Personal causes|4|||
147516829|NCT02254304|532042677|FG001|Overall Study|Personal causes|1|||
147516830|NCT02254304|532042676|FG000|Overall Study|Personal decision|1|||
147516831|NCT02254304|532042677|FG001|Overall Study|Personal decision|0|||
147516832|NCT01226472|532042678|FG000|Overall Study|Progressive Disease|1|||
147516833|NCT05166603|532042679|FG000|Overall Study|Withdrawal by Subject|68|||
147516834|NCT05166603|532042680|FG001|Overall Study|Withdrawal by Subject|0|||
147516835|NCT02531633|532045145|FG000|Part A (52 Weeks)|Sponsor request|24|||
147516836|NCT02531633|532045146|FG001|Part A (52 Weeks)|Sponsor request|24|||
147516837|NCT02531633|532045147|FG002|Part A (52 Weeks)|Sponsor request|18|||
147516838|NCT02531633|532045148|FG003|Part A (52 Weeks)|Sponsor request|18|||
147516839|NCT02531633|532045149|FG004|Part A (52 Weeks)|Sponsor request|19|||
147516840|NCT02531633|532045150|FG005|Part A (52 Weeks)|Sponsor request|0|||
147516841|NCT02531633|532045151|FG006|Part A (52 Weeks)|Sponsor request|0|||
147516842|NCT02531633|532045152|FG007|Part A (52 Weeks)|Sponsor request|0|||
147516843|NCT02531633|532045153|FG008|Part A (52 Weeks)|Sponsor request|0|||
147516844|NCT02531633|532045154|FG009|Part A (52 Weeks)|Sponsor request|0|||
147516845|NCT02531633|532045145|FG000|Part A (52 Weeks)|Protocol Violation|1|||
147516846|NCT02531633|532045146|FG001|Part A (52 Weeks)|Protocol Violation|0|||
147516847|NCT02531633|532045147|FG002|Part A (52 Weeks)|Protocol Violation|0|||
147516848|NCT02531633|532045148|FG003|Part A (52 Weeks)|Protocol Violation|0|||
147516849|NCT02531633|532045149|FG004|Part A (52 Weeks)|Protocol Violation|0|||
147516850|NCT02531633|532045150|FG005|Part A (52 Weeks)|Protocol Violation|0|||
147516851|NCT02531633|532045151|FG006|Part A (52 Weeks)|Protocol Violation|0|||
147516852|NCT02531633|532045152|FG007|Part A (52 Weeks)|Protocol Violation|0|||
147516853|NCT02531633|532045153|FG008|Part A (52 Weeks)|Protocol Violation|0|||
147516854|NCT02531633|532045154|FG009|Part A (52 Weeks)|Protocol Violation|0|||
147516855|NCT02531633|532045145|FG000|Part A (52 Weeks)|Lost to Follow-up|0|||
147516856|NCT02531633|532045146|FG001|Part A (52 Weeks)|Lost to Follow-up|0|||
147516857|NCT02531633|532045147|FG002|Part A (52 Weeks)|Lost to Follow-up|0|||
147516858|NCT02531633|532045148|FG003|Part A (52 Weeks)|Lost to Follow-up|0|||
147516859|NCT02531633|532045149|FG004|Part A (52 Weeks)|Lost to Follow-up|1|||
147516860|NCT02531633|532045150|FG005|Part A (52 Weeks)|Lost to Follow-up|0|||
147516861|NCT02531633|532045151|FG006|Part A (52 Weeks)|Lost to Follow-up|0|||
147516862|NCT02531633|532045152|FG007|Part A (52 Weeks)|Lost to Follow-up|0|||
147516863|NCT02531633|532045153|FG008|Part A (52 Weeks)|Lost to Follow-up|0|||
147516864|NCT02531633|532045154|FG009|Part A (52 Weeks)|Lost to Follow-up|0|||
147516865|NCT02531633|532045145|FG000|Part A (52 Weeks)|Physician Decision|1|||
147516866|NCT02531633|532045146|FG001|Part A (52 Weeks)|Physician Decision|4|||
147516867|NCT02531633|532045147|FG002|Part A (52 Weeks)|Physician Decision|3|||
147516868|NCT02531633|532045148|FG003|Part A (52 Weeks)|Physician Decision|1|||
147516869|NCT02531633|532045149|FG004|Part A (52 Weeks)|Physician Decision|0|||
147516870|NCT02531633|532045150|FG005|Part A (52 Weeks)|Physician Decision|0|||
147516871|NCT02531633|532045151|FG006|Part A (52 Weeks)|Physician Decision|0|||
147516872|NCT02531633|532045152|FG007|Part A (52 Weeks)|Physician Decision|0|||
147516873|NCT02531633|532045153|FG008|Part A (52 Weeks)|Physician Decision|0|||
147516874|NCT02531633|532045154|FG009|Part A (52 Weeks)|Physician Decision|0|||
147516875|NCT02531633|532045145|FG000|Part A (52 Weeks)|Withdrawal by Subject|6|||
147516876|NCT02531633|532045146|FG001|Part A (52 Weeks)|Withdrawal by Subject|6|||
147516877|NCT02531633|532045147|FG002|Part A (52 Weeks)|Withdrawal by Subject|1|||
147516878|NCT02531633|532045148|FG003|Part A (52 Weeks)|Withdrawal by Subject|3|||
147516879|NCT02531633|532045149|FG004|Part A (52 Weeks)|Withdrawal by Subject|3|||
147516880|NCT02531633|532045150|FG005|Part A (52 Weeks)|Withdrawal by Subject|0|||
147516881|NCT02531633|532045151|FG006|Part A (52 Weeks)|Withdrawal by Subject|0|||
147516882|NCT02531633|532045152|FG007|Part A (52 Weeks)|Withdrawal by Subject|0|||
147516883|NCT02531633|532045153|FG008|Part A (52 Weeks)|Withdrawal by Subject|0|||
147516884|NCT02531633|532045154|FG009|Part A (52 Weeks)|Withdrawal by Subject|0|||
147516885|NCT02531633|532045145|FG000|Part A (52 Weeks)|Other|2|||
147516886|NCT02531633|532045146|FG001|Part A (52 Weeks)|Other|0|||
147516887|NCT02531633|532045147|FG002|Part A (52 Weeks)|Other|0|||
147516888|NCT02531633|532045148|FG003|Part A (52 Weeks)|Other|0|||
147516889|NCT02531633|532045149|FG004|Part A (52 Weeks)|Other|0|||
147516890|NCT02531633|532045150|FG005|Part A (52 Weeks)|Other|0|||
147516891|NCT02531633|532045151|FG006|Part A (52 Weeks)|Other|0|||
147516892|NCT02531633|532045152|FG007|Part A (52 Weeks)|Other|0|||
147516893|NCT02531633|532045153|FG008|Part A (52 Weeks)|Other|0|||
147516894|NCT02531633|532045154|FG009|Part A (52 Weeks)|Other|0|||
147516895|NCT02531633|532045145|FG000|Part B (104 Weeks)|Sponsor request|0|||
147516896|NCT02531633|532045146|FG001|Part B (104 Weeks)|Sponsor request|0|||
147516897|NCT02531633|532045147|FG002|Part B (104 Weeks)|Sponsor request|0|||
147516898|NCT02531633|532045148|FG003|Part B (104 Weeks)|Sponsor request|0|||
147516899|NCT02531633|532045149|FG004|Part B (104 Weeks)|Sponsor request|0|||
147516900|NCT02531633|532045150|FG005|Part B (104 Weeks)|Sponsor request|8|||
147516901|NCT02531633|532045151|FG006|Part B (104 Weeks)|Sponsor request|5|||
147516902|NCT02531633|532045152|FG007|Part B (104 Weeks)|Sponsor request|3|||
147516903|NCT02531633|532045153|FG008|Part B (104 Weeks)|Sponsor request|5|||
147516904|NCT02531633|532045154|FG009|Part B (104 Weeks)|Sponsor request|4|||
147516905|NCT02531633|532045145|FG000|Part B (104 Weeks)|Lost to Follow-up|0|||
147516906|NCT02531633|532045146|FG001|Part B (104 Weeks)|Lost to Follow-up|0|||
147516907|NCT02531633|532045147|FG002|Part B (104 Weeks)|Lost to Follow-up|0|||
147516908|NCT02531633|532045148|FG003|Part B (104 Weeks)|Lost to Follow-up|0|||
147516909|NCT02531633|532045149|FG004|Part B (104 Weeks)|Lost to Follow-up|0|||
147516910|NCT02531633|532045150|FG005|Part B (104 Weeks)|Lost to Follow-up|0|||
147516911|NCT02531633|532045151|FG006|Part B (104 Weeks)|Lost to Follow-up|0|||
147516912|NCT02531633|532045152|FG007|Part B (104 Weeks)|Lost to Follow-up|1|||
147516913|NCT02531633|532045153|FG008|Part B (104 Weeks)|Lost to Follow-up|0|||
147516914|NCT02531633|532045154|FG009|Part B (104 Weeks)|Lost to Follow-up|0|||
147516915|NCT04992507|532045157|FG000|Overall Study|Study terminated early due to principal investigator departing sponsoring organization|5|||
147516916|NCT04992507|532045158|FG001|Overall Study|Study terminated early due to principal investigator departing sponsoring organization|2|||
147516917|NCT04992507|532045157|FG000|Overall Study|Death|0|||
147516918|NCT04992507|532045158|FG001|Overall Study|Death|1|||
147516919|NCT01852591|532045159|FG000|Overall Study|Withdrawal by Subject|2|||
147516920|NCT01852591|532045159|FG000|Overall Study|Not Evaluable at Time of Analysis|1|||
147516921|NCT03728881|532045162|FG000|Enrolled and Received 1st Vaccination|Adverse Event|0|||
147516922|NCT03728881|532045163|FG001|Enrolled and Received 1st Vaccination|Adverse Event|1|||
147516923|NCT03728881|532045162|FG000|Enrolled and Received 1st Vaccination|Death|1|||
147516924|NCT03728881|532045163|FG001|Enrolled and Received 1st Vaccination|Death|1|||
147516925|NCT03728881|532045162|FG000|Enrolled and Received 1st Vaccination|Withdrawal by Subject|5|||
147516926|NCT03728881|532045163|FG001|Enrolled and Received 1st Vaccination|Withdrawal by Subject|8|||
147516927|NCT03728881|532045162|FG000|Enrolled and Received 1st Vaccination|Out of Country|1|||
147516928|NCT03728881|532045163|FG001|Enrolled and Received 1st Vaccination|Out of Country|3|||
147516929|NCT03728881|532045162|FG000|Enrolled and Received 1st Vaccination|No Show|0|||
147516930|NCT03728881|532045163|FG001|Enrolled and Received 1st Vaccination|No Show|1|||
147516931|NCT03728881|532045162|FG000|Enrolled and Received 1st Vaccination|Unable to appoint|3|||
147516932|NCT03728881|532045163|FG001|Enrolled and Received 1st Vaccination|Unable to appoint|12|||
147516933|NCT03728881|532045162|FG000|Enrolled and Received 1st Vaccination|Not fully vaccinated during ATP windows|0|||
147516934|NCT03728881|532045163|FG001|Enrolled and Received 1st Vaccination|Not fully vaccinated during ATP windows|49|||
147516935|NCT03728881|532045162|FG000|Enrolled and Received 1st Vaccination|Received HPV vaccination outside study (self-report)|25|||
147516936|NCT03728881|532045163|FG001|Enrolled and Received 1st Vaccination|Received HPV vaccination outside study (self-report)|0|||
147516937|NCT03728881|532045162|FG000|Enrolled and Received 1st Vaccination|HPV6/11 positive|10|||
147516938|NCT03728881|532045163|FG001|Enrolled and Received 1st Vaccination|HPV6/11 positive|0|||
147516939|NCT03728881|532045162|FG000|ATP Cohort for HPV16 at 36 Months|HPV16 seropositive at baseline|36|||
147516940|NCT03728881|532045163|FG001|ATP Cohort for HPV16 at 36 Months|HPV16 seropositive at baseline|179|||
147516941|NCT03728881|532045162|FG000|ATP Cohort for HPV18 at 36 Months|HPV18 seropositive at baseline|52|||
147516942|NCT03728881|532045163|FG001|ATP Cohort for HPV18 at 36 Months|HPV18 seropositive at baseline|172|||
147516943|NCT04517253|532045166|FG000|Primary Treatment Period|Adverse Event|1|||
147516944|NCT04517253|532045167|FG001|Primary Treatment Period|Adverse Event|0|||
147516945|NCT04517253|532045168|FG002|Primary Treatment Period|Adverse Event|0|||
147516946|NCT04517253|532045166|FG000|Primary Treatment Period|Death|0|||
147516947|NCT04517253|532045167|FG001|Primary Treatment Period|Death|1|||
147516948|NCT04517253|532045168|FG002|Primary Treatment Period|Death|0|||
147516949|NCT04517253|532045166|FG000|Maintenance Period|Withdrawal by Subject|1|||
147516950|NCT04517253|532045167|FG001|Maintenance Period|Withdrawal by Subject|0|||
147516951|NCT04517253|532045168|FG002|Maintenance Period|Withdrawal by Subject|0|||
147516952|NCT04517253|532045166|FG000|Maintenance Period|Study Terminated by Sponsor|3|||
147516953|NCT04517253|532045167|FG001|Maintenance Period|Study Terminated by Sponsor|2|||
147516954|NCT04517253|532045168|FG002|Maintenance Period|Study Terminated by Sponsor|2|||
147516955|NCT04651777|532045171|FG000|Overall Study|Adverse Event|1|||
147516956|NCT04651777|532045171|FG000|Overall Study|Withdrawal by Subject|2|||
147516957|NCT06048367|532045172|FG000|Overall Study|Withdrawal by Subject|0|||
147516958|NCT06048367|532045173|FG001|Overall Study|Withdrawal by Subject|1|||
147516959|NCT06048367|532045174|FG002|Overall Study|Withdrawal by Subject|0|||
147516960|NCT06048367|532045175|FG003|Overall Study|Withdrawal by Subject|0|||
147516961|NCT06048367|532045176|FG004|Overall Study|Withdrawal by Subject|0|||
147516962|NCT06048367|532045172|FG000|Overall Study|Withdrawal by Subject|0|||
147516963|NCT06048367|532045173|FG001|Overall Study|Withdrawal by Subject|0|||
147516964|NCT06048367|532045174|FG002|Overall Study|Withdrawal by Subject|1|||
147516965|NCT06048367|532045175|FG003|Overall Study|Withdrawal by Subject|0|||
147516966|NCT06048367|532045176|FG004|Overall Study|Withdrawal by Subject|0|||
147516967|NCT06048367|532045172|FG000|Overall Study|Withdrawal by Subject|0|||
147516968|NCT06048367|532045173|FG001|Overall Study|Withdrawal by Subject|0|||
147516969|NCT06048367|532045174|FG002|Overall Study|Withdrawal by Subject|0|||
147516970|NCT06048367|532045175|FG003|Overall Study|Withdrawal by Subject|1|||
147516971|NCT06048367|532045176|FG004|Overall Study|Withdrawal by Subject|0|||
147516972|NCT06048367|532045172|FG000|Overall Study|Withdrawal by Subject|0|||
147516973|NCT06048367|532045173|FG001|Overall Study|Withdrawal by Subject|0|||
147516974|NCT06048367|532045174|FG002|Overall Study|Withdrawal by Subject|0|||
147516975|NCT06048367|532045175|FG003|Overall Study|Withdrawal by Subject|1|||
147516976|NCT06048367|532045176|FG004|Overall Study|Withdrawal by Subject|0|||
147516977|NCT04088331|532045177|FG000|Overall Study|Lost to Follow-up|3|||
147516978|NCT04088331|532045177|FG000|Overall Study|Withdrawal by Subject|7|||
147516979|NCT04088331|532045177|FG000|Overall Study|Adverse Event|4|||
147516980|NCT02136134|532045183|FG000|Overall Study|Death|170|||
147516981|NCT02136134|532045184|FG001|Overall Study|Death|148|||
147516982|NCT02136134|532045183|FG000|Overall Study|Withdrawal by Subject|19|||
147516983|NCT02136134|532045184|FG001|Overall Study|Withdrawal by Subject|10|||
147516984|NCT02136134|532045183|FG000|Overall Study|Lost to Follow-up|3|||
147516985|NCT02136134|532045184|FG001|Overall Study|Lost to Follow-up|3|||
147516986|NCT02136134|532045183|FG000|Overall Study|Uspecified|55|||
147516987|NCT02136134|532045184|FG001|Overall Study|Uspecified|90|||
147516988|NCT03070119|532045187|FG000|Overall Study|Adverse Event|0|||
147516989|NCT03070119|532045188|FG001|Overall Study|Adverse Event|0|||
147516990|NCT03070119|532045189|FG002|Overall Study|Adverse Event|1|||
147516991|NCT03070119|532045187|FG000|Overall Study|Lost to Follow-up|0|||
147516992|NCT03070119|532045188|FG001|Overall Study|Lost to Follow-up|1|||
147516993|NCT03070119|532045189|FG002|Overall Study|Lost to Follow-up|0|||
147516994|NCT03070119|532045187|FG000|Overall Study|Consent Withdrawn|6|||
147516995|NCT03070119|532045188|FG001|Overall Study|Consent Withdrawn|5|||
147516996|NCT03070119|532045189|FG002|Overall Study|Consent Withdrawn|3|||
147516997|NCT03070119|532045187|FG000|Overall Study|Investigator Decision|0|||
147516998|NCT03070119|532045188|FG001|Overall Study|Investigator Decision|0|||
147516999|NCT03070119|532045189|FG002|Overall Study|Investigator Decision|1|||
147517000|NCT03070119|532045187|FG000|Overall Study|Death|7|||
147517001|NCT03070119|532045188|FG001|Overall Study|Death|14|||
147517002|NCT03070119|532045189|FG002|Overall Study|Death|5|||
147517003|NCT03070119|532045187|FG000|Overall Study|Disease Progression|5|||
147517004|NCT03070119|532045188|FG001|Overall Study|Disease Progression|7|||
147517005|NCT03070119|532045189|FG002|Overall Study|Disease Progression|7|||
147517006|NCT03070119|532045187|FG000|Overall Study|Reason not Specified|2|||
147517007|NCT03070119|532045188|FG001|Overall Study|Reason not Specified|2|||
147517008|NCT03070119|532045189|FG002|Overall Study|Reason not Specified|1|||
147517009|NCT02974621|532045191|FG000|Overall Study|Didn't receive study treatment|1|||
147517010|NCT02974621|532045192|FG001|Overall Study|Didn't receive study treatment|10|||
147517011|NCT00732472|532045193|FG000|Overall Study|Adverse Event|0|||
147517012|NCT00732472|532045194|FG001|Overall Study|Adverse Event|1|||
147517013|NCT00732472|532045195|FG002|Overall Study|Adverse Event|1|||
147517014|NCT00732472|532045196|FG003|Overall Study|Adverse Event|1|||
147517015|NCT00732472|532045193|FG000|Overall Study|Protocol Violation|0|||
147517016|NCT00732472|532045194|FG001|Overall Study|Protocol Violation|0|||
147517017|NCT00732472|532045195|FG002|Overall Study|Protocol Violation|0|||
147517018|NCT00732472|532045196|FG003|Overall Study|Protocol Violation|1|||
147517019|NCT00732472|532045193|FG000|Overall Study|Withdrawal by Subject|0|||
147517020|NCT00732472|532045194|FG001|Overall Study|Withdrawal by Subject|2|||
147517021|NCT00732472|532045195|FG002|Overall Study|Withdrawal by Subject|0|||
147517022|NCT00732472|532045196|FG003|Overall Study|Withdrawal by Subject|1|||
147517023|NCT03715205|532045199|FG000|Overall Study|Death|13|||
147517024|NCT03715205|532045199|FG000|Overall Study|Lost to Follow-up|2|||
147517025|NCT03715205|532045199|FG000|Overall Study|Physician Decision|93|||
147517026|NCT03715205|532045199|FG000|Overall Study|Withdrawal by Subject|26|||
147517027|NCT03342404|532045200|FG000|Blinded Treatment Phase|Withdrawal by Subject|17|||
147517028|NCT03342404|532045201|FG001|Blinded Treatment Phase|Withdrawal by Subject|10|||
147517029|NCT03342404|532045200|FG000|Blinded Treatment Phase|Lack of Efficacy|2|||
147517030|NCT03342404|532045201|FG001|Blinded Treatment Phase|Lack of Efficacy|17|||
147517031|NCT03342404|532045200|FG000|Blinded Treatment Phase|Adverse Event|5|||
147517032|NCT03342404|532045201|FG001|Blinded Treatment Phase|Adverse Event|4|||
147517033|NCT03342404|532045200|FG000|Blinded Treatment Phase|Noncompliance with study drug|1|||
147517034|NCT03342404|532045201|FG001|Blinded Treatment Phase|Noncompliance with study drug|0|||
147517035|NCT03342404|532045200|FG000|Blinded Treatment Phase|Other reasons|1|||
147517036|NCT03342404|532045201|FG001|Blinded Treatment Phase|Other reasons|0|||
147517037|NCT03342404|532045200|FG000|Blinded Treatment Phase|Physician Decision|1|||
147517038|NCT03342404|532045201|FG001|Blinded Treatment Phase|Physician Decision|0|||
147517039|NCT03342404|532045200|FG000|Blinded Treatment Phase|Death|1|||
147517040|NCT03342404|532045201|FG001|Blinded Treatment Phase|Death|0|||
147517041|NCT03342404|532045200|FG000|Open-Label Phase|Lost to Follow-up|0|||
147517042|NCT03342404|532045201|FG001|Open-Label Phase|Lost to Follow-up|1|||
147517043|NCT03342404|532045200|FG000|Open-Label Phase|Other reasons|0|||
147517044|NCT03342404|532045201|FG001|Open-Label Phase|Other reasons|1|||
147517045|NCT03342404|532045200|FG000|Open-Label Phase|Adverse Event|0|||
147517046|NCT03342404|532045201|FG001|Open-Label Phase|Adverse Event|3|||
147517047|NCT03342404|532045200|FG000|Open-Label Phase|Withdrawal by Subject|0|||
147517048|NCT03342404|532045201|FG001|Open-Label Phase|Withdrawal by Subject|6|||
147517049|NCT03733249|532045203|FG000|Overall Study|Death|7|||
147517050|NCT03733249|532045203|FG000|Overall Study|Disease relapse|16|||
147517051|NCT03733249|532045203|FG000|Overall Study|Lost to Follow-up|4|||
147517052|NCT03733249|532045203|FG000|Overall Study|No rivogenlecleucel cells infused (non-evaluable)|7|||
147517053|NCT03733249|532045203|FG000|Overall Study|Withdrawal by Subject|1|||
147517054|NCT00850135|532045204|FG000|Overall Study|Physician Decision|1|||
147517055|NCT02253992|532045205|FG000|Overall Study|Study drug toxicity|1|||
147517056|NCT02253992|532045206|FG001|Overall Study|Study drug toxicity|0|||
147517057|NCT02253992|532045207|FG002|Overall Study|Study drug toxicity|10|||
147517058|NCT02253992|532045205|FG000|Overall Study|Disease progression|4|||
147517059|NCT02253992|532045206|FG001|Overall Study|Disease progression|3|||
147517060|NCT02253992|532045207|FG002|Overall Study|Disease progression|98|||
147517061|NCT02253992|532045205|FG000|Overall Study|Withdrawal by Subject|0|||
147517062|NCT02253992|532045206|FG001|Overall Study|Withdrawal by Subject|0|||
147517063|NCT02253992|532045207|FG002|Overall Study|Withdrawal by Subject|3|||
147517064|NCT02253992|532045205|FG000|Overall Study|Adverse Event|0|||
147517065|NCT02253992|532045206|FG001|Overall Study|Adverse Event|0|||
147517066|NCT02253992|532045207|FG002|Overall Study|Adverse Event|8|||
147517067|NCT02253992|532045205|FG000|Overall Study|Death|0|||
147517068|NCT02253992|532045206|FG001|Overall Study|Death|0|||
147517069|NCT02253992|532045207|FG002|Overall Study|Death|1|||
147517070|NCT02253992|532045205|FG000|Overall Study|Subject discontinued study drug|1|||
147517071|NCT02253992|532045206|FG001|Overall Study|Subject discontinued study drug|0|||
147517072|NCT02253992|532045207|FG002|Overall Study|Subject discontinued study drug|1|||
147517073|NCT02253992|532045205|FG000|Overall Study|Completed treatment as per protocol|0|||
147517074|NCT02253992|532045206|FG001|Overall Study|Completed treatment as per protocol|1|||
147517075|NCT02253992|532045207|FG002|Overall Study|Completed treatment as per protocol|22|||
147517076|NCT02253992|532045205|FG000|Overall Study|Other|0|||
147517077|NCT02253992|532045206|FG001|Overall Study|Other|0|||
147517078|NCT02253992|532045207|FG002|Overall Study|Other|1|||
147517079|NCT03323086|532045208|FG000|Overall Study|Lost to Follow-up|3|||
147517080|NCT03323086|532045209|FG001|Overall Study|Lost to Follow-up|2|||
147517081|NCT00796549|532045221|FG000|Overall Study|Adverse Event|11|||
147517082|NCT00796549|532045221|FG000|Overall Study|not entered|149|||
147517083|NCT00796549|532045221|FG000|Overall Study|Other|2|||
147517084|NCT00796549|532045221|FG000|Overall Study|Progressive disease|56|||
147517085|NCT03523715|532045224|FG000|Overall Study|Lost to Follow-up|11|||
147517086|NCT03523715|532045225|FG001|Overall Study|Lost to Follow-up|14|||
147517087|NCT03523715|532045224|FG000|Overall Study|Did not meet inclusion criteria|1|||
147517088|NCT03523715|532045225|FG001|Overall Study|Did not meet inclusion criteria|0|||
147517089|NCT03523715|532045224|FG000|Overall Study|Internally inconsistent reporting|0|||
147517090|NCT03523715|532045225|FG001|Overall Study|Internally inconsistent reporting|2|||
147517091|NCT00606229|532045226|FG000|Overall Study|Adverse Event|11|||
147517092|NCT00606229|532045226|FG000|Overall Study|Lack of Efficacy|1|||
147517093|NCT00606229|532045226|FG000|Overall Study|Withdrawal by Subject|4|||
147517094|NCT00606229|532045226|FG000|Overall Study|does not meet inclusion criterion 1-3|4|||
147517095|NCT00606229|532045226|FG000|Overall Study|change of residence or other commitments|2|||
147517096|NCT02139280|532045227|FG000|Overall Study|No longer eligible|2|||
147517097|NCT02139280|532045228|FG001|Overall Study|No longer eligible|0|||
147517098|NCT01332851|532045229|FG000|Overall Study|Withdrawal by Subject|4|||
147517099|NCT01332851|532045230|FG001|Overall Study|Withdrawal by Subject|2|||
147517100|NCT01332851|532045229|FG000|Overall Study|Lost to Follow-up|7|||
147517101|NCT01332851|532045230|FG001|Overall Study|Lost to Follow-up|11|||
147517102|NCT03299166|532045231|FG000|Overall Study|Adverse Event|9|||
147517103|NCT03299166|532045232|FG001|Overall Study|Adverse Event|4|||
147517104|NCT03299166|532045231|FG000|Overall Study|Withdrawal by Subject|6|||
147517105|NCT03299166|532045232|FG001|Overall Study|Withdrawal by Subject|5|||
147517106|NCT03299166|532045231|FG000|Overall Study|Physician Decision|1|||
147517107|NCT03299166|532045232|FG001|Overall Study|Physician Decision|1|||
147517108|NCT03299166|532045231|FG000|Overall Study|Sponsor Decision|3|||
147517109|NCT03299166|532045232|FG001|Overall Study|Sponsor Decision|0|||
147517110|NCT03299166|532045231|FG000|Overall Study|Lost to Follow-up|2|||
147517111|NCT03299166|532045232|FG001|Overall Study|Lost to Follow-up|4|||
147517112|NCT03299166|532045231|FG000|Overall Study|Randomization Error|0|||
147517113|NCT03299166|532045232|FG001|Overall Study|Randomization Error|1|||
147517114|NCT03299166|532045231|FG000|Overall Study|Subject unable to return due to COVID|1|||
147517115|NCT03299166|532045232|FG001|Overall Study|Subject unable to return due to COVID|0|||
147517116|NCT03299166|532045231|FG000|Overall Study|Unable to complete Week 12 visit at site|1|||
147517117|NCT03299166|532045232|FG001|Overall Study|Unable to complete Week 12 visit at site|0|||
147517118|NCT00422903|532045235|FG000|Overall Study|Disease Progression|3|||
147517119|NCT00422903|532045236|FG001|Overall Study|Disease Progression|1|||
147517120|NCT00422903|532045235|FG000|Overall Study|Adverse Event|0|||
147517121|NCT00422903|532045236|FG001|Overall Study|Adverse Event|2|||
147517122|NCT00422903|532045235|FG000|Overall Study|Informed Consent Withdrawn|1|||
147517123|NCT00422903|532045236|FG001|Overall Study|Informed Consent Withdrawn|2|||
147517124|NCT01947894|532045241|FG000|Overall Study|Other|3|||
147517125|NCT01947894|532045242|FG001|Overall Study|Other|4|||
147517126|NCT01947894|532045243|FG002|Overall Study|Other|3|||
147517127|NCT01947894|532045241|FG000|Overall Study|Withdrawal by Subject|12|||
147517128|NCT01947894|532045242|FG001|Overall Study|Withdrawal by Subject|4|||
147517129|NCT01947894|532045243|FG002|Overall Study|Withdrawal by Subject|1|||
147517130|NCT01947894|532045241|FG000|Overall Study|Death|12|||
147517131|NCT01947894|532045242|FG001|Overall Study|Death|1|||
147517132|NCT01947894|532045243|FG002|Overall Study|Death|0|||
147517133|NCT01947894|532045241|FG000|Overall Study|Physician Decision|2|||
147517134|NCT01947894|532045242|FG001|Overall Study|Physician Decision|0|||
147517135|NCT01947894|532045243|FG002|Overall Study|Physician Decision|0|||
147517136|NCT01947894|532045241|FG000|Overall Study|Adverse Event|5|||
147517137|NCT01947894|532045242|FG001|Overall Study|Adverse Event|1|||
147517138|NCT01947894|532045243|FG002|Overall Study|Adverse Event|0|||
147517139|NCT01947894|532045241|FG000|Overall Study|Switched to other growth hormone brand|53|||
147517140|NCT01947894|532045242|FG001|Overall Study|Switched to other growth hormone brand|8|||
147517141|NCT01947894|532045243|FG002|Overall Study|Switched to other growth hormone brand|23|||
147517142|NCT01249157|532045244|FG000|Overall Study|Withdrawal by Subject|1|||
147517143|NCT03796195|532045245|FG000|Overall Study|Study closed early|1|||
147517144|NCT02392468|532045247|FG000|Overall Study|Adverse Event|0|||
147517145|NCT02392468|532045248|FG001|Overall Study|Adverse Event|1|||
147517146|NCT02392468|532045249|FG002|Overall Study|Adverse Event|0|||
147517147|NCT02392468|532045250|FG003|Overall Study|Adverse Event|0|||
147517148|NCT02392468|532045251|FG004|Overall Study|Adverse Event|0|||
147517149|NCT02392468|532045252|FG005|Overall Study|Adverse Event|1|||
147517150|NCT03630016|532045253|FG000|Overall Study|Poor Sensor Placement|1|||
147517151|NCT02470429|532045256|FG000|Overall Study|Adverse Event|1|||
147517152|NCT02470429|532045257|FG001|Overall Study|Adverse Event|0|||
147517153|NCT02470429|532045256|FG000|Overall Study|Withdrawal by Subject|1|||
147517154|NCT02470429|532045257|FG001|Overall Study|Withdrawal by Subject|0|||
147517155|NCT00090766|532045258|FG000|Overall Study|Nephrectomy Planned|0|||
147517156|NCT00090766|532045259|FG001|Overall Study|Nephrectomy Planned|0|||
147517157|NCT00090766|532045260|FG002|Overall Study|Nephrectomy Planned|1|||
147517158|NCT00090766|532045258|FG000|Overall Study|Death|1|||
147517159|NCT00090766|532045259|FG001|Overall Study|Death|0|||
147517160|NCT00090766|532045260|FG002|Overall Study|Death|0|||
147517161|NCT00090766|532045258|FG000|Overall Study|Admin|0|||
147517162|NCT00090766|532045259|FG001|Overall Study|Admin|2|||
147517163|NCT00090766|532045260|FG002|Overall Study|Admin|0|||
147517164|NCT00090766|532045258|FG000|Overall Study|Lost to Follow-up|2|||
147517165|NCT00090766|532045259|FG001|Overall Study|Lost to Follow-up|0|||
147517166|NCT00090766|532045260|FG002|Overall Study|Lost to Follow-up|2|||
147517167|NCT00804986|532045261|FG000|Overall Study|Adverse Event|0|||
147517168|NCT00804986|532045262|FG001|Overall Study|Adverse Event|1|||
147517169|NCT00804986|532045263|FG002|Overall Study|Adverse Event|2|||
147517170|NCT00804986|532045264|FG003|Overall Study|Adverse Event|1|||
147517171|NCT00804986|532045265|FG004|Overall Study|Adverse Event|3|||
147517172|NCT00804986|532045266|FG005|Overall Study|Adverse Event|0|||
147517173|NCT00804986|532045261|FG000|Overall Study|Lack of Efficacy|0|||
147517174|NCT00804986|532045262|FG001|Overall Study|Lack of Efficacy|0|||
147517175|NCT00804986|532045263|FG002|Overall Study|Lack of Efficacy|0|||
147517176|NCT00804986|532045264|FG003|Overall Study|Lack of Efficacy|1|||
147517177|NCT00804986|532045265|FG004|Overall Study|Lack of Efficacy|0|||
147517178|NCT00804986|532045266|FG005|Overall Study|Lack of Efficacy|3|||
147517179|NCT00804986|532045261|FG000|Overall Study|Lost to Follow-up|0|||
147517180|NCT00804986|532045262|FG001|Overall Study|Lost to Follow-up|0|||
147517181|NCT00804986|532045263|FG002|Overall Study|Lost to Follow-up|0|||
147517182|NCT00804986|532045264|FG003|Overall Study|Lost to Follow-up|1|||
147517183|NCT00804986|532045265|FG004|Overall Study|Lost to Follow-up|1|||
147517184|NCT00804986|532045266|FG005|Overall Study|Lost to Follow-up|3|||
147517185|NCT00804986|532045261|FG000|Overall Study|Protocol Violation|0|||
147517186|NCT00804986|532045262|FG001|Overall Study|Protocol Violation|1|||
147517187|NCT00804986|532045263|FG002|Overall Study|Protocol Violation|0|||
147517188|NCT00804986|532045264|FG003|Overall Study|Protocol Violation|1|||
147517189|NCT00804986|532045265|FG004|Overall Study|Protocol Violation|0|||
147517190|NCT00804986|532045266|FG005|Overall Study|Protocol Violation|0|||
147517191|NCT00804986|532045261|FG000|Overall Study|Withdrawal by Subject|0|||
147517192|NCT00804986|532045262|FG001|Overall Study|Withdrawal by Subject|3|||
147517193|NCT00804986|532045263|FG002|Overall Study|Withdrawal by Subject|0|||
147517194|NCT00804986|532045264|FG003|Overall Study|Withdrawal by Subject|3|||
147517195|NCT00804986|532045265|FG004|Overall Study|Withdrawal by Subject|5|||
147517196|NCT00804986|532045266|FG005|Overall Study|Withdrawal by Subject|3|||
147517197|NCT00804986|532045261|FG000|Overall Study|Inclusion/Exclusion criteria not met|0|||
147517198|NCT00804986|532045262|FG001|Overall Study|Inclusion/Exclusion criteria not met|2|||
147517199|NCT00804986|532045263|FG002|Overall Study|Inclusion/Exclusion criteria not met|0|||
147517200|NCT00804986|532045264|FG003|Overall Study|Inclusion/Exclusion criteria not met|1|||
147517201|NCT00804986|532045265|FG004|Overall Study|Inclusion/Exclusion criteria not met|0|||
147517202|NCT00804986|532045266|FG005|Overall Study|Inclusion/Exclusion criteria not met|1|||
147517203|NCT00804986|532045261|FG000|Overall Study|Sponsor Decision|0|||
147517204|NCT00804986|532045262|FG001|Overall Study|Sponsor Decision|1|||
147517205|NCT00804986|532045263|FG002|Overall Study|Sponsor Decision|0|||
147517206|NCT00804986|532045264|FG003|Overall Study|Sponsor Decision|0|||
147517207|NCT00804986|532045265|FG004|Overall Study|Sponsor Decision|0|||
147517208|NCT00804986|532045266|FG005|Overall Study|Sponsor Decision|0|||
147517209|NCT00804986|532045261|FG000|Overall Study|Physician Decision|1|||
147517210|NCT00804986|532045262|FG001|Overall Study|Physician Decision|0|||
147517211|NCT00804986|532045263|FG002|Overall Study|Physician Decision|0|||
147517212|NCT00804986|532045264|FG003|Overall Study|Physician Decision|0|||
147517213|NCT00804986|532045265|FG004|Overall Study|Physician Decision|0|||
147517214|NCT00804986|532045266|FG005|Overall Study|Physician Decision|0|||
147517215|NCT00959699|532045267|FG000|Treatment Period|Adverse Event|3|||
147517216|NCT00959699|532045268|FG001|Treatment Period|Adverse Event|13|||
147517217|NCT00959699|532045267|FG000|Treatment Period|Lack of Efficacy|15|||
147517218|NCT00959699|532045268|FG001|Treatment Period|Lack of Efficacy|6|||
147517219|NCT00959699|532045267|FG000|Treatment Period|Lost to Follow-up|0|||
147517220|NCT00959699|532045268|FG001|Treatment Period|Lost to Follow-up|1|||
147517221|NCT00959699|532045267|FG000|Treatment Period|Withdrawal by Subject|1|||
147517222|NCT00959699|532045268|FG001|Treatment Period|Withdrawal by Subject|3|||
147517223|NCT00959699|532045267|FG000|Treatment Period|Non-Compliance with Protocol|0|||
147517224|NCT00959699|532045268|FG001|Treatment Period|Non-Compliance with Protocol|1|||
147517225|NCT00959699|532045267|FG000|Treatment Period|Did not receive treatment|0|||
147517226|NCT00959699|532045268|FG001|Treatment Period|Did not receive treatment|1|||
147517227|NCT00959699|532045267|FG000|Treatment Period|Futility/crossover to boceprevir|4|||
147517228|NCT00959699|532045268|FG001|Treatment Period|Futility/crossover to boceprevir|0|||
147517229|NCT00959699|532045267|FG000|Follow-up Period|Lost to Follow-up|3|||
147517230|NCT00959699|532045268|FG001|Follow-up Period|Lost to Follow-up|2|||
147517231|NCT00959699|532045267|FG000|Follow-up Period|Withdrawal by Subject|3|||
147517232|NCT00959699|532045268|FG001|Follow-up Period|Withdrawal by Subject|4|||
147517233|NCT01885104|532045270|FG000|Overall Study|Withdrawal of Consent|1|||
147517234|NCT01885104|532045271|FG001|Overall Study|Withdrawal of Consent|0|||
147517235|NCT01885104|532045270|FG000|Overall Study|Lost to Follow-up|0|||
147517236|NCT01885104|532045271|FG001|Overall Study|Lost to Follow-up|1|||
147517237|NCT01885104|532045270|FG000|Overall Study|Physician Decision|1|||
147517238|NCT01885104|532045271|FG001|Overall Study|Physician Decision|0|||
147517239|NCT00126425|532045274|FG000|Overall Study|Withdrawal by Subject|17|||
147517240|NCT00126425|532045275|FG001|Overall Study|Withdrawal by Subject|1|||
147517241|NCT00126425|532045274|FG000|Overall Study|Lost to Follow-up|8|||
147517242|NCT00126425|532045275|FG001|Overall Study|Lost to Follow-up|4|||
147517243|NCT00126425|532045274|FG000|Overall Study|Protocol Violation|9|||
147517244|NCT00126425|532045275|FG001|Overall Study|Protocol Violation|6|||
147517245|NCT00126425|532045274|FG000|Overall Study|Adverse Event|1|||
147517246|NCT00126425|532045275|FG001|Overall Study|Adverse Event|0|||
147517247|NCT00126425|532045274|FG000|Overall Study|Failed Inclusion Exclusion Criteria|1|||
147517248|NCT00126425|532045275|FG001|Overall Study|Failed Inclusion Exclusion Criteria|0|||
147517249|NCT00126425|532045274|FG000|Overall Study|Other|5|||
147517250|NCT00126425|532045275|FG001|Overall Study|Other|0|||
147517251|NCT03325010|532045277|FG000|Overall Study|Adverse Event|3|||
147517252|NCT03325010|532045278|FG001|Overall Study|Adverse Event|8|||
147517253|NCT03325010|532045277|FG000|Overall Study|Protocol Violation|1|||
147517254|NCT03325010|532045278|FG001|Overall Study|Protocol Violation|8|||
147517255|NCT03325010|532045277|FG000|Overall Study|Withdrawal by Subject|1|||
147517256|NCT03325010|532045278|FG001|Overall Study|Withdrawal by Subject|3|||
147517257|NCT03325010|532045277|FG000|Overall Study|Lost to Follow-up|1|||
147517258|NCT03325010|532045278|FG001|Overall Study|Lost to Follow-up|0|||
147517259|NCT03325010|532045277|FG000|Overall Study|Physician Decision|1|||
147517260|NCT03325010|532045278|FG001|Overall Study|Physician Decision|1|||
147517261|NCT03325010|532045277|FG000|Overall Study|Lack of Efficacy|2|||
147517262|NCT03325010|532045278|FG001|Overall Study|Lack of Efficacy|0|||
147517263|NCT04350372|532045283|FG000|Overall Study|Death|1|||
147517264|NCT00113555|532045285|FG000|Overall Study|Baseline Failure|59|||
147517265|NCT00113555|532045285|FG000|Overall Study|Permanently Explanted|7|||
147517266|NCT00113555|532045285|FG000|Overall Study|Death|1|||
147517267|NCT00113555|532045285|FG000|Overall Study|Missed Followup|4|||
147517268|NCT00113555|532045285|FG000|Overall Study|Lost to Follow-up|8|||
147517269|NCT03864627|532045286|FG000|Overall Study|Adverse Event|0|||
147517270|NCT03864627|532045287|FG001|Overall Study|Adverse Event|1|||
147517271|NCT03864627|532045286|FG000|Overall Study|Lack of Efficacy|0|||
147517272|NCT03864627|532045287|FG001|Overall Study|Lack of Efficacy|1|||
147517273|NCT03864627|532045286|FG000|Overall Study|Lost to Follow-up|0|||
147517274|NCT03864627|532045287|FG001|Overall Study|Lost to Follow-up|1|||
147517275|NCT03864627|532045286|FG000|Overall Study|Withdrawal by Subject|4|||
147517276|NCT03864627|532045287|FG001|Overall Study|Withdrawal by Subject|8|||
147517277|NCT03864627|532045286|FG000|Overall Study|Study terminated by sponsor|0|||
147517278|NCT03864627|532045287|FG001|Overall Study|Study terminated by sponsor|1|||
147517279|NCT00112840|532045288|FG000|Overall Study|Physician Decision|1|||
147517280|NCT00112840|532045289|FG001|Overall Study|Physician Decision|0|||
147517281|NCT00112840|532045290|FG002|Overall Study|Physician Decision|0|||
147517282|NCT00112840|532045288|FG000|Overall Study|Withdrawal by Subject|1|||
147517283|NCT00112840|532045289|FG001|Overall Study|Withdrawal by Subject|0|||
147517284|NCT00112840|532045290|FG002|Overall Study|Withdrawal by Subject|1|||
147517285|NCT00112840|532045288|FG000|Overall Study|Protocol Violation|0|||
147517286|NCT00112840|532045289|FG001|Overall Study|Protocol Violation|0|||
147517287|NCT00112840|532045290|FG002|Overall Study|Protocol Violation|5|||
147517288|NCT00683774|532045291|FG000|Overall Study|Withdrawal by Subject|0|||
147517289|NCT00683774|532045292|FG001|Overall Study|Withdrawal by Subject|1|||
147517290|NCT00683774|532045291|FG000|Overall Study|Physician Decision|3|||
147517291|NCT00683774|532045292|FG001|Overall Study|Physician Decision|0|||
147517292|NCT02875366|532045293|FG000|Overall Study|Adverse Event|0|||
147517293|NCT02875366|532045294|FG001|Overall Study|Adverse Event|2|||
147517294|NCT02875366|532045293|FG000|Overall Study|Noncompliance|0|||
147517295|NCT02875366|532045294|FG001|Overall Study|Noncompliance|1|||
147517296|NCT03595176|532045295|FG000|Overall Study|Death|0|||
147517297|NCT03595176|532045296|FG001|Overall Study|Death|2|||
147517298|NCT03595176|532045295|FG000|Overall Study|Lost to Follow-up|0|||
147517299|NCT03595176|532045296|FG001|Overall Study|Lost to Follow-up|1|||
147517300|NCT01201967|532045299|FG000|Overall Study|Lost to Follow-up|6|||
147517301|NCT01201967|532045300|FG001|Overall Study|Lost to Follow-up|5|||
147517302|NCT02497287|532045301|FG000|Induction Phase (4 Weeks)|Did Not Met Criteria for OP/MA Phase|84|||
147517303|NCT02497287|532045301|FG000|Induction Phase (4 Weeks)|Adverse Event|52|||
147517304|NCT02497287|532045301|FG000|Induction Phase (4 Weeks)|Withdrawal by Subject|22|||
147517305|NCT02497287|532045301|FG000|Induction Phase (4 Weeks)|Lack of Efficacy|21|||
147517306|NCT02497287|532045301|FG000|Induction Phase (4 Weeks)|Other|13|||
147517307|NCT02497287|532045301|FG000|Induction Phase (4 Weeks)|Lost to Follow-up|5|||
147517308|NCT02497287|532045301|FG000|Induction Phase (4 Weeks)|Protocol Violation|1|||
147517309|NCT02497287|532045301|FG000|Induction Phase (4 Weeks)|Non-Compliance with Study Drug|1|||
147517310|NCT02497287|532045301|FG000|Optimization/Maintenance (48 Weeks)|Study Terminated by Sponsor|331|||
147517311|NCT02497287|532045301|FG000|Optimization/Maintenance (48 Weeks)|Withdrawal by Subject|30|||
147517312|NCT02497287|532045301|FG000|Optimization/Maintenance (48 Weeks)|Adverse Event|25|||
147517313|NCT02497287|532045301|FG000|Optimization/Maintenance (48 Weeks)|Lack of Efficacy|25|||
147517314|NCT02497287|532045301|FG000|Optimization/Maintenance (48 Weeks)|Other|21|||
147517315|NCT02497287|532045301|FG000|Optimization/Maintenance (48 Weeks)|Lost to Follow-up|10|||
147517316|NCT02497287|532045301|FG000|Optimization/Maintenance (48 Weeks)|Protocol Violation|3|||
147517317|NCT02497287|532045301|FG000|Optimization/Maintenance (48 Weeks)|Missed Assessment or Treatment Sessions|3|||
147517318|NCT02497287|532045301|FG000|Optimization/Maintenance (48 Weeks)|Pregnancy|2|||
147517319|NCT02497287|532045301|FG000|Optimization/Maintenance (48 Weeks)|Death|2|||
147517320|NCT02497287|532045301|FG000|Optimization/Maintenance (48 Weeks)|Non-Compliance with Study Drug|1|||
147517321|NCT02497287|532045301|FG000|Follow-up Phase (4 Week)|PI Decision|12|||
147517322|NCT02497287|532045301|FG000|Follow-up Phase (4 Week)|Withdrawal by Subject|10|||
147517323|NCT02497287|532045301|FG000|Follow-up Phase (4 Week)|Lost to Follow-up|5|||
147517324|NCT02497287|532045301|FG000|Follow-up Phase (4 Week)|Adverse Event|3|||
147517325|NCT02497287|532045301|FG000|Follow-up Phase (4 Week)|Other|1|||
147517326|NCT02422186|532045302|FG000|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|1|||
147517327|NCT02422186|532045303|FG001|Double-blind Induction Phase (4 Weeks)|Lost to Follow-up|0|||
147517328|NCT02422186|532045302|FG000|Double-blind Induction Phase (4 Weeks)|Protocol Violation|0|||
147517329|NCT02422186|532045303|FG001|Double-blind Induction Phase (4 Weeks)|Protocol Violation|1|||
147517330|NCT02422186|532045302|FG000|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|1|||
147517331|NCT02422186|532045303|FG001|Double-blind Induction Phase (4 Weeks)|Withdrawal by Subject|2|||
147517332|NCT02422186|532045302|FG000|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|3|||
147517333|NCT02422186|532045303|FG001|Double-blind Induction Phase (4 Weeks)|Lack of Efficacy|1|||
147517334|NCT02422186|532045302|FG000|Double-blind Induction Phase (4 Weeks)|Adverse Event|4|||
147517335|NCT02422186|532045303|FG001|Double-blind Induction Phase (4 Weeks)|Adverse Event|2|||
147517336|NCT02422186|532045302|FG000|Double-blind Induction Phase (4 Weeks)|Other|1|||
147517337|NCT02422186|532045303|FG001|Double-blind Induction Phase (4 Weeks)|Other|0|||
147517338|NCT02422186|532045302|FG000|Follow-up Phase (2 Weeks)|Withdrawal by Subject|1|||
147517339|NCT02422186|532045303|FG001|Follow-up Phase (2 Weeks)|Withdrawal by Subject|0|||
147517340|NCT02422186|532045302|FG000|Follow-up Phase (2 Weeks)|Other|3|||
147517341|NCT02422186|532045303|FG001|Follow-up Phase (2 Weeks)|Other|0|||
147517342|NCT03074318|532045304|FG000|Overall Study|Adverse Event|0|||
147517343|NCT03074318|532045305|FG001|Overall Study|Adverse Event|1|||
147517344|NCT03074318|532045306|FG002|Overall Study|Adverse Event|1|||
147517345|NCT03074318|532045307|FG003|Overall Study|Adverse Event|1|||
147517346|NCT03074318|532045304|FG000|Overall Study|Death|1|||
147517347|NCT03074318|532045305|FG001|Overall Study|Death|0|||
147517348|NCT03074318|532045306|FG002|Overall Study|Death|0|||
147517349|NCT03074318|532045307|FG003|Overall Study|Death|0|||
147517350|NCT03074318|532045304|FG000|Overall Study|Withdrawal by Subject|1|||
147517351|NCT03074318|532045305|FG001|Overall Study|Withdrawal by Subject|2|||
147517352|NCT03074318|532045306|FG002|Overall Study|Withdrawal by Subject|2|||
147517353|NCT03074318|532045307|FG003|Overall Study|Withdrawal by Subject|4|||
147517354|NCT03074318|532045304|FG000|Overall Study|Trial Closure|2|||
147517355|NCT03074318|532045305|FG001|Overall Study|Trial Closure|2|||
147517356|NCT03074318|532045306|FG002|Overall Study|Trial Closure|3|||
147517357|NCT03074318|532045307|FG003|Overall Study|Trial Closure|11|||
147517358|NCT01952041|532046677|FG000|Overall Study|Lost to Follow-up|9|||
147517359|NCT01952041|532046678|FG001|Overall Study|Lost to Follow-up|16|||
147517360|NCT01952041|532046677|FG000|Overall Study|Withdrawal by Subject|7|||
147517361|NCT01952041|532046678|FG001|Overall Study|Withdrawal by Subject|5|||
147517362|NCT01952041|532046677|FG000|Overall Study|Death|1|||
147517363|NCT01952041|532046678|FG001|Overall Study|Death|0|||
147517364|NCT03650387|532046679|FG000|Overall Study|Withdrawal by Subject|13|||
147517365|NCT03650387|532046679|FG000|Overall Study|Lost to Follow-up|12|||
147517366|NCT03650387|532046679|FG000|Overall Study|Adverse Event (Not related)|1|||
147517367|NCT03650387|532046679|FG000|Overall Study|Due to COVID-19 Pandemic|8|||
147517368|NCT01370499|532046680|FG000|Overall Study|Adverse Event|38|||
147517369|NCT01370499|532046681|FG001|Overall Study|Adverse Event|12|||
147517370|NCT01370499|532046680|FG000|Overall Study|Lack of Efficacy|4|||
147517371|NCT01370499|532046681|FG001|Overall Study|Lack of Efficacy|2|||
147517372|NCT01370499|532046680|FG000|Overall Study|Lost to Follow-up|2|||
147517373|NCT01370499|532046681|FG001|Overall Study|Lost to Follow-up|1|||
147517374|NCT01370499|532046680|FG000|Overall Study|Physician Decision|3|||
147517375|NCT01370499|532046681|FG001|Overall Study|Physician Decision|3|||
147517376|NCT01370499|532046680|FG000|Overall Study|Protocol Violation|5|||
147517377|NCT01370499|532046681|FG001|Overall Study|Protocol Violation|4|||
147517378|NCT01370499|532046680|FG000|Overall Study|Withdrawal by Subject|18|||
147517379|NCT01370499|532046681|FG001|Overall Study|Withdrawal by Subject|7|||
147517380|NCT01370499|532046680|FG000|Overall Study|Sponsor Decision|41|||
147517381|NCT01370499|532046681|FG001|Overall Study|Sponsor Decision|15|||
147517382|NCT00887822|532046682|FG000|Overall Study|Insufficient therapeutic response|53|||
147517383|NCT00887822|532046683|FG001|Overall Study|Insufficient therapeutic response|55|||
147517384|NCT00887822|532046682|FG000|Overall Study|Adverse Event|14|||
147517385|NCT00887822|532046683|FG001|Overall Study|Adverse Event|17|||
147517386|NCT00887822|532046682|FG000|Overall Study|Failure to return|11|||
147517387|NCT00887822|532046683|FG001|Overall Study|Failure to return|11|||
147517388|NCT00887822|532046682|FG000|Overall Study|Refused treatment/Did not cooperate|12|||
147517389|NCT00887822|532046683|FG001|Overall Study|Refused treatment/Did not cooperate|10|||
147517390|NCT00887822|532046682|FG000|Overall Study|Administrative/Other than specified|5|||
147517391|NCT00887822|532046683|FG001|Overall Study|Administrative/Other than specified|4|||
147517392|NCT00887822|532046682|FG000|Overall Study|Death|2|||
147517393|NCT00887822|532046683|FG001|Overall Study|Death|3|||
147517394|NCT00887822|532046682|FG000|Overall Study|Protocol Violation|0|||
147517395|NCT00887822|532046683|FG001|Overall Study|Protocol Violation|1|||
147517396|NCT00887822|532046682|FG000|Overall Study|Randomized but not treated|0|||
147517397|NCT00887822|532046683|FG001|Overall Study|Randomized but not treated|1|||
147517398|NCT05815758|532046684|FG000|Overall Study|Adverse Event|6|||
147517399|NCT05815758|532046685|FG001|Overall Study|Adverse Event|2|||
147517400|NCT05815758|532046684|FG000|Overall Study|Lost to Follow-up|14|||
147517401|NCT05815758|532046685|FG001|Overall Study|Lost to Follow-up|1|||
147517402|NCT05815758|532046684|FG000|Overall Study|Withdrawal by Subject|6|||
147517403|NCT05815758|532046685|FG001|Overall Study|Withdrawal by Subject|6|||
147517404|NCT05815758|532046684|FG000|Overall Study|Protocol Violation|1|||
147517405|NCT05815758|532046685|FG001|Overall Study|Protocol Violation|1|||
147517406|NCT05815758|532046684|FG000|Overall Study|Discontinued|4|||
147517407|NCT05815758|532046685|FG001|Overall Study|Discontinued|4|||
147517408|NCT03661983|532046686|FG000|Open Label Stabilization Phase|Adverse Event|5|||
147517409|NCT03661983|532046687|FG001|Open Label Stabilization Phase|Adverse Event|0|||
147517410|NCT03661983|532046688|FG002|Open Label Stabilization Phase|Adverse Event|0|||
147517411|NCT03661983|532046689|FG003|Open Label Stabilization Phase|Adverse Event|0|||
147517412|NCT03661983|532046686|FG000|Open Label Stabilization Phase|Lack of Efficacy|1|||
147517413|NCT03661983|532046687|FG001|Open Label Stabilization Phase|Lack of Efficacy|0|||
147517414|NCT03661983|532046688|FG002|Open Label Stabilization Phase|Lack of Efficacy|0|||
147517415|NCT03661983|532046689|FG003|Open Label Stabilization Phase|Lack of Efficacy|0|||
147517416|NCT03661983|532046686|FG000|Open Label Stabilization Phase|Withdrawal by Parent/Guardian|2|||
147517417|NCT03661983|532046687|FG001|Open Label Stabilization Phase|Withdrawal by Parent/Guardian|0|||
147517418|NCT03661983|532046688|FG002|Open Label Stabilization Phase|Withdrawal by Parent/Guardian|0|||
147517419|NCT03661983|532046689|FG003|Open Label Stabilization Phase|Withdrawal by Parent/Guardian|0|||
147517420|NCT03661983|532046686|FG000|Open Label Stabilization Phase|Study Terminated by Sponsor|3|||
147517421|NCT03661983|532046687|FG001|Open Label Stabilization Phase|Study Terminated by Sponsor|0|||
147517422|NCT03661983|532046688|FG002|Open Label Stabilization Phase|Study Terminated by Sponsor|0|||
147517423|NCT03661983|532046689|FG003|Open Label Stabilization Phase|Study Terminated by Sponsor|0|||
147517424|NCT03661983|532046686|FG000|Double-blind Randomized Phase|Adverse Event|0|||
147517425|NCT03661983|532046687|FG001|Double-blind Randomized Phase|Adverse Event|1|||
147517426|NCT03661983|532046688|FG002|Double-blind Randomized Phase|Adverse Event|0|||
147517427|NCT03661983|532046689|FG003|Double-blind Randomized Phase|Adverse Event|0|||
147517428|NCT03661983|532046686|FG000|Double-blind Randomized Phase|Disease Relapse|0|||
147517429|NCT03661983|532046687|FG001|Double-blind Randomized Phase|Disease Relapse|0|||
147517430|NCT03661983|532046688|FG002|Double-blind Randomized Phase|Disease Relapse|0|||
147517431|NCT03661983|532046689|FG003|Double-blind Randomized Phase|Disease Relapse|6|||
147517432|NCT03661983|532046686|FG000|Double-blind Randomized Phase|Withdrawal by Parent/Guardian|0|||
147517433|NCT03661983|532046687|FG001|Double-blind Randomized Phase|Withdrawal by Parent/Guardian|0|||
147517434|NCT03661983|532046688|FG002|Double-blind Randomized Phase|Withdrawal by Parent/Guardian|0|||
147517435|NCT03661983|532046689|FG003|Double-blind Randomized Phase|Withdrawal by Parent/Guardian|1|||
147517436|NCT03661983|532046686|FG000|Double-blind Randomized Phase|Study Terminated by Sponsor|0|||
147517437|NCT03661983|532046687|FG001|Double-blind Randomized Phase|Study Terminated by Sponsor|1|||
147517438|NCT03661983|532046688|FG002|Double-blind Randomized Phase|Study Terminated by Sponsor|1|||
147517439|NCT03661983|532046689|FG003|Double-blind Randomized Phase|Study Terminated by Sponsor|1|||
147517440|NCT02903966|532046690|FG000|Part A (Day 1 to 43)|Adverse Event|1|||
147517441|NCT02903966|532046691|FG001|Part A (Day 1 to 43)|Adverse Event|0|||
147517442|NCT02903966|532046690|FG000|Part B (Day 44 to 112)|Lack of Efficacy|0|||
147517443|NCT02903966|532046691|FG001|Part B (Day 44 to 112)|Lack of Efficacy|1|||
147517444|NCT02903966|532046690|FG000|Part B (Day 44 to 112)|Withdrawal by Subject|0|||
147517445|NCT02903966|532046691|FG001|Part B (Day 44 to 112)|Withdrawal by Subject|1|||
147517446|NCT01320033|532046692|FG000|Overall Study|Lack of Efficacy|0|||
147517447|NCT01320033|532046693|FG001|Overall Study|Lack of Efficacy|0|||
147517448|NCT01320033|532046694|FG002|Overall Study|Lack of Efficacy|1|||
147517449|NCT01320033|532046692|FG000|Overall Study|Adverse Event|9|||
147517450|NCT01320033|532046693|FG001|Overall Study|Adverse Event|7|||
147517451|NCT01320033|532046694|FG002|Overall Study|Adverse Event|8|||
147517452|NCT01320033|532046692|FG000|Overall Study|Withdrawal by Subject|22|||
147517453|NCT01320033|532046693|FG001|Overall Study|Withdrawal by Subject|23|||
147517454|NCT01320033|532046694|FG002|Overall Study|Withdrawal by Subject|23|||
147517455|NCT01320033|532046692|FG000|Overall Study|Protocol Violation|3|||
147517456|NCT01320033|532046693|FG001|Overall Study|Protocol Violation|5|||
147517457|NCT01320033|532046694|FG002|Overall Study|Protocol Violation|3|||
147517458|NCT01320033|532046692|FG000|Overall Study|Lost to Follow-up|22|||
147517459|NCT01320033|532046693|FG001|Overall Study|Lost to Follow-up|26|||
147517460|NCT01320033|532046694|FG002|Overall Study|Lost to Follow-up|17|||
147517461|NCT01320033|532046692|FG000|Overall Study|Other|2|||
147517462|NCT01320033|532046693|FG001|Overall Study|Other|3|||
147517463|NCT01320033|532046694|FG002|Overall Study|Other|1|||
147517464|NCT02045979|532046695|FG000|Overall Study|Informed Consent Withdrawn|2|||
147517465|NCT02045979|532046696|FG001|Overall Study|Informed Consent Withdrawn|0|||
147517466|NCT02045979|532046697|FG002|Overall Study|Informed Consent Withdrawn|1|||
147517467|NCT02045979|532046695|FG000|Overall Study|not specified above|0|||
147517468|NCT02045979|532046696|FG001|Overall Study|not specified above|1|||
147517469|NCT02045979|532046697|FG002|Overall Study|not specified above|0|||
147517470|NCT00963469|532046698|FG000|Overall Study|Adverse Event|15|||
147517471|NCT00963469|532046699|FG001|Overall Study|Adverse Event|11|||
147517472|NCT00963469|532046700|FG002|Overall Study|Adverse Event|1|||
147517473|NCT00963469|532046698|FG000|Overall Study|Lack of Efficacy|10|||
147517474|NCT00963469|532046699|FG001|Overall Study|Lack of Efficacy|7|||
147517475|NCT00963469|532046700|FG002|Overall Study|Lack of Efficacy|2|||
147517476|NCT00963469|532046698|FG000|Overall Study|Lost to Follow-up|1|||
147517477|NCT00963469|532046699|FG001|Overall Study|Lost to Follow-up|1|||
147517478|NCT00963469|532046700|FG002|Overall Study|Lost to Follow-up|0|||
147517479|NCT00963469|532046698|FG000|Overall Study|Protocol Violation|5|||
147517480|NCT00963469|532046699|FG001|Overall Study|Protocol Violation|5|||
147517481|NCT00963469|532046700|FG002|Overall Study|Protocol Violation|3|||
147517482|NCT00963469|532046698|FG000|Overall Study|Withdrawal by Subject|4|||
147517483|NCT00963469|532046699|FG001|Overall Study|Withdrawal by Subject|1|||
147517484|NCT00963469|532046700|FG002|Overall Study|Withdrawal by Subject|1|||
147517485|NCT00963469|532046698|FG000|Overall Study|Pre-randomization Adverse Event|1|||
147517486|NCT00963469|532046699|FG001|Overall Study|Pre-randomization Adverse Event|2|||
147517487|NCT00963469|532046700|FG002|Overall Study|Pre-randomization Adverse Event|0|||
147517488|NCT00963469|532046698|FG000|Overall Study|Moved|1|||
147517489|NCT00963469|532046699|FG001|Overall Study|Moved|0|||
147517490|NCT00963469|532046700|FG002|Overall Study|Moved|0|||
147517491|NCT00963469|532046698|FG000|Overall Study|Site closed (local pollen Season ended)|4|||
147517492|NCT00963469|532046699|FG001|Overall Study|Site closed (local pollen Season ended)|1|||
147517493|NCT00963469|532046700|FG002|Overall Study|Site closed (local pollen Season ended)|3|||
147517494|NCT00378534|532046709|FG000|Overall Study|Participants did not receive transplant|3|||
147517495|NCT00378534|532046710|FG001|Overall Study|Participants did not receive transplant|0|||
147517496|NCT04969900|532046711|FG000|Overall Study|Physician Decision|1|||
147517497|NCT04969900|532046712|FG001|Overall Study|Physician Decision|1|||
147517498|NCT04969900|532046711|FG000|Overall Study|Subjects excluded due to enrollment in study prior to registration on ClinicalTrials.gov.|15|||
147517499|NCT04969900|532046712|FG001|Overall Study|Subjects excluded due to enrollment in study prior to registration on ClinicalTrials.gov.|15|||
147517500|NCT04423718|532046718|FG000|Main Study|Adverse Event|9|||
147517501|NCT04423718|532046719|FG001|Main Study|Adverse Event|5|||
147517502|NCT04423718|532046720|FG002|Main Study|Adverse Event|8|||
147517503|NCT04423718|532046718|FG000|Main Study|Physician Decision|3|||
147517504|NCT04423718|532046719|FG001|Main Study|Physician Decision|3|||
147517505|NCT04423718|532046720|FG002|Main Study|Physician Decision|2|||
147517506|NCT04423718|532046718|FG000|Main Study|Protocol Violation|0|||
147517507|NCT04423718|532046719|FG001|Main Study|Protocol Violation|0|||
147517508|NCT04423718|532046720|FG002|Main Study|Protocol Violation|1|||
147517509|NCT04423718|532046718|FG000|Main Study|Lost to Follow-up|3|||
147517510|NCT04423718|532046719|FG001|Main Study|Lost to Follow-up|3|||
147517511|NCT04423718|532046720|FG002|Main Study|Lost to Follow-up|4|||
147517512|NCT04423718|532046718|FG000|Main Study|Lack of Efficacy|2|||
147517513|NCT04423718|532046719|FG001|Main Study|Lack of Efficacy|1|||
147517514|NCT04423718|532046720|FG002|Main Study|Lack of Efficacy|0|||
147517515|NCT04423718|532046718|FG000|Main Study|Withdrawal by Subject|14|||
147517516|NCT04423718|532046719|FG001|Main Study|Withdrawal by Subject|20|||
147517517|NCT04423718|532046720|FG002|Main Study|Withdrawal by Subject|20|||
147517518|NCT04423718|532046718|FG000|Main Study|Death|10|||
147517519|NCT04423718|532046719|FG001|Main Study|Death|7|||
147517520|NCT04423718|532046720|FG002|Main Study|Death|7|||
147517521|NCT04423718|532046718|FG000|Main Study|COVID-19 pandemic|2|||
147517522|NCT04423718|532046719|FG001|Main Study|COVID-19 pandemic|2|||
147517523|NCT04423718|532046720|FG002|Main Study|COVID-19 pandemic|2|||
147517524|NCT04423718|532046718|FG000|Main Study|Other|7|||
147517525|NCT04423718|532046719|FG001|Main Study|Other|3|||
147517526|NCT04423718|532046720|FG002|Main Study|Other|2|||
147517527|NCT04423718|532046718|FG000|Extension Phase|Other|1|||
147517528|NCT04423718|532046719|FG001|Extension Phase|Other|0|||
147517529|NCT04423718|532046720|FG002|Extension Phase|Other|0|||
147517530|NCT04423718|532046718|FG000|Extension Phase|Logistical problems|0|||
147517531|NCT04423718|532046719|FG001|Extension Phase|Logistical problems|1|||
147517532|NCT04423718|532046720|FG002|Extension Phase|Logistical problems|1|||
147517533|NCT04423718|532046718|FG000|Extension Phase|Physician Decision|1|||
147517534|NCT04423718|532046719|FG001|Extension Phase|Physician Decision|0|||
147517535|NCT04423718|532046720|FG002|Extension Phase|Physician Decision|1|||
147517536|NCT04423718|532046718|FG000|Extension Phase|Lack of Efficacy|2|||
147517537|NCT04423718|532046719|FG001|Extension Phase|Lack of Efficacy|0|||
147517538|NCT04423718|532046720|FG002|Extension Phase|Lack of Efficacy|1|||
147517539|NCT04423718|532046718|FG000|Extension Phase|Lost to Follow-up|0|||
147517540|NCT04423718|532046719|FG001|Extension Phase|Lost to Follow-up|2|||
147517541|NCT04423718|532046720|FG002|Extension Phase|Lost to Follow-up|3|||
147517542|NCT04423718|532046718|FG000|Extension Phase|Adverse Event|2|||
147517543|NCT04423718|532046719|FG001|Extension Phase|Adverse Event|3|||
147517544|NCT04423718|532046720|FG002|Extension Phase|Adverse Event|1|||
147517545|NCT04423718|532046718|FG000|Extension Phase|Death|4|||
147517546|NCT04423718|532046719|FG001|Extension Phase|Death|7|||
147517547|NCT04423718|532046720|FG002|Extension Phase|Death|2|||
147517548|NCT04423718|532046718|FG000|Extension Phase|Withdrawal by Subject|11|||
147517549|NCT04423718|532046719|FG001|Extension Phase|Withdrawal by Subject|11|||
147517550|NCT04423718|532046720|FG002|Extension Phase|Withdrawal by Subject|7|||
147517551|NCT00425945|532046721|FG000|Overall Study|Concern about Supplement|2|||
147517552|NCT00425945|532046722|FG001|Overall Study|Concern about Supplement|0|||
147517553|NCT00425945|532046721|FG000|Overall Study|Inconvenience|0|||
147517554|NCT00425945|532046722|FG001|Overall Study|Inconvenience|2|||
147517555|NCT00425945|532046721|FG000|Overall Study|Lost to Follow-up|0|||
147517556|NCT00425945|532046722|FG001|Overall Study|Lost to Follow-up|2|||
147517557|NCT00425945|532046721|FG000|Overall Study|Began hypertension medication|1|||
147517558|NCT00425945|532046722|FG001|Overall Study|Began hypertension medication|0|||
147517559|NCT00425945|532046721|FG000|Overall Study|Began cancer treatments|1|||
147517560|NCT00425945|532046722|FG001|Overall Study|Began cancer treatments|0|||
147517561|NCT00425945|532046721|FG000|Overall Study|Moved from area|0|||
147517562|NCT00425945|532046722|FG001|Overall Study|Moved from area|1|||
147517563|NCT02881151|532046723|FG000|Post-surgical Washout (65 to 93 Days)|Device explantation|1|||
147517564|NCT03258593|532046725|FG000|Run-In Maintenance Phase|Disease recurrence|4|||
147517565|NCT03258593|532046726|FG001|Run-In Maintenance Phase|Disease recurrence|0|||
147517566|NCT03258593|532046727|FG002|Run-In Maintenance Phase|Disease recurrence|0|||
147517567|NCT03258593|532046728|FG003|Run-In Maintenance Phase|Disease recurrence|0|||
147517568|NCT03258593|532046725|FG000|Run-In Maintenance Phase|Disease progression|3|||
147517569|NCT03258593|532046726|FG001|Run-In Maintenance Phase|Disease progression|0|||
147517570|NCT03258593|532046727|FG002|Run-In Maintenance Phase|Disease progression|0|||
147517571|NCT03258593|532046728|FG003|Run-In Maintenance Phase|Disease progression|0|||
147517572|NCT03258593|532046725|FG000|Expansion Maintenance Phase|Withdrawal by Subject|0|||
147517573|NCT03258593|532046726|FG001|Expansion Maintenance Phase|Withdrawal by Subject|1|||
147517574|NCT03258593|532046727|FG002|Expansion Maintenance Phase|Withdrawal by Subject|0|||
147517575|NCT03258593|532046728|FG003|Expansion Maintenance Phase|Withdrawal by Subject|0|||
147517576|NCT03258593|532046725|FG000|Expansion Maintenance Phase|Physician Decision|0|||
147517577|NCT03258593|532046726|FG001|Expansion Maintenance Phase|Physician Decision|1|||
147517578|NCT03258593|532046727|FG002|Expansion Maintenance Phase|Physician Decision|0|||
147517579|NCT03258593|532046728|FG003|Expansion Maintenance Phase|Physician Decision|0|||
147517580|NCT05618808|532046732|FG000|Overall Study|Withdrawal by Subject|3|||
147517581|NCT05618808|532046733|FG001|Overall Study|Withdrawal by Subject|1|||
147517582|NCT05618808|532046734|FG002|Overall Study|Withdrawal by Subject|3|||
147517583|NCT03381274|532046735|FG000|Overall Study|Death|2|||
147517584|NCT03381274|532046736|FG001|Overall Study|Death|9|||
147517585|NCT03381274|532046737|FG002|Overall Study|Death|3|||
147517586|NCT03381274|532046738|FG003|Overall Study|Death|2|||
147517587|NCT03381274|532046739|FG004|Overall Study|Death|3|||
147517588|NCT03381274|532046735|FG000|Overall Study|Lost to Follow-up|0|||
147517589|NCT03381274|532046736|FG001|Overall Study|Lost to Follow-up|0|||
147517590|NCT03381274|532046737|FG002|Overall Study|Lost to Follow-up|0|||
147517591|NCT03381274|532046738|FG003|Overall Study|Lost to Follow-up|1|||
147517592|NCT03381274|532046739|FG004|Overall Study|Lost to Follow-up|0|||
147517593|NCT03381274|532046735|FG000|Overall Study|Withdrawal by Subject|2|||
147517594|NCT03381274|532046736|FG001|Overall Study|Withdrawal by Subject|1|||
147517595|NCT03381274|532046737|FG002|Overall Study|Withdrawal by Subject|3|||
147517596|NCT03381274|532046738|FG003|Overall Study|Withdrawal by Subject|1|||
147517597|NCT03381274|532046739|FG004|Overall Study|Withdrawal by Subject|0|||
147517598|NCT03381274|532046735|FG000|Overall Study|Other|1|||
147517599|NCT03381274|532046736|FG001|Overall Study|Other|11|||
147517600|NCT03381274|532046737|FG002|Overall Study|Other|0|||
147517601|NCT03381274|532046738|FG003|Overall Study|Other|2|||
147517602|NCT03381274|532046739|FG004|Overall Study|Other|2|||
147517603|NCT04284787|532046740|FG000|Overall Study|Disease Progression|9|||
147517604|NCT04284787|532046741|FG001|Overall Study|Disease Progression|12|||
147517605|NCT04284787|532046740|FG000|Overall Study|Physician Decision|12|||
147517606|NCT04284787|532046741|FG001|Overall Study|Physician Decision|7|||
147517607|NCT04284787|532046740|FG000|Overall Study|Transplant|5|||
147517608|NCT04284787|532046741|FG001|Overall Study|Transplant|4|||
147517609|NCT04284787|532046740|FG000|Overall Study|Death|1|||
147517610|NCT04284787|532046741|FG001|Overall Study|Death|2|||
147517611|NCT04284787|532046740|FG000|Overall Study|Adverse Event|0|||
147517612|NCT04284787|532046741|FG001|Overall Study|Adverse Event|4|||
147517613|NCT04284787|532046740|FG000|Overall Study|Non-adherence|2|||
147517614|NCT04284787|532046741|FG001|Overall Study|Non-adherence|0|||
147517615|NCT04284787|532046740|FG000|Overall Study|Lack of Efficacy|2|||
147517616|NCT04284787|532046741|FG001|Overall Study|Lack of Efficacy|0|||
147517617|NCT01874353|532046742|FG000|Overall Study|One patient was unblinded and one patient was randomised in error|2|||
147517618|NCT01874353|532046743|FG001|Overall Study|One patient was unblinded and one patient was randomised in error|0|||
147517619|NCT01874353|532046744|FG002|Overall Study|One patient was unblinded and one patient was randomised in error|0|||
147517620|NCT01874353|532046745|FG003|Overall Study|One patient was unblinded and one patient was randomised in error|0|||
147517621|NCT01874353|532046742|FG000|Overall Study|Lost to Follow-up|2|||
147517622|NCT01874353|532046743|FG001|Overall Study|Lost to Follow-up|2|||
147517623|NCT01874353|532046744|FG002|Overall Study|Lost to Follow-up|2|||
147517624|NCT01874353|532046745|FG003|Overall Study|Lost to Follow-up|0|||
147517625|NCT01874353|532046742|FG000|Overall Study|Death|110|||
147517626|NCT01874353|532046743|FG001|Overall Study|Death|60|||
147517627|NCT01874353|532046744|FG002|Overall Study|Death|13|||
147517628|NCT01874353|532046745|FG003|Overall Study|Death|7|||
147517629|NCT01874353|532046742|FG000|Overall Study|Withdrawal by Subject|13|||
147517630|NCT01874353|532046743|FG001|Overall Study|Withdrawal by Subject|11|||
147517631|NCT01874353|532046744|FG002|Overall Study|Withdrawal by Subject|0|||
147517632|NCT01874353|532046745|FG003|Overall Study|Withdrawal by Subject|0|||
147517633|NCT02559115|532046754|FG000|Overall Study|Withdrawal by Subject|3|||
147517634|NCT02756845|532046759|FG000|Overall Study|Death|12|||
147517635|NCT02756845|532046760|FG001|Overall Study|Death|2|||
147517636|NCT02756845|532046759|FG000|Overall Study|Withdrawal by Subject|1|||
147517637|NCT02756845|532046760|FG001|Overall Study|Withdrawal by Subject|0|||
147517638|NCT00772889|532046762|FG000|Overall Study|Adverse Event|7|||
147517639|NCT00772889|532046763|FG001|Overall Study|Adverse Event|4|||
147517640|NCT00772889|532046764|FG002|Overall Study|Adverse Event|0|||
147517641|NCT00772889|532046762|FG000|Overall Study|Withdrawal by Subject|9|||
147517642|NCT00772889|532046763|FG001|Overall Study|Withdrawal by Subject|8|||
147517643|NCT00772889|532046764|FG002|Overall Study|Withdrawal by Subject|9|||
147517644|NCT00772889|532046762|FG000|Overall Study|Lost to Follow-up|6|||
147517645|NCT00772889|532046763|FG001|Overall Study|Lost to Follow-up|6|||
147517646|NCT00772889|532046764|FG002|Overall Study|Lost to Follow-up|7|||
147517647|NCT05559203|532046769|FG000|Overall Study|Intervention not implemented at their care home due to insufficient staff|14|||
147517648|NCT00255008|532046771|FG000|Overall Study|Adverse Event|1|||
147517649|NCT00255008|532046772|FG001|Overall Study|Adverse Event|1|||
147517650|NCT00255008|532046773|FG002|Overall Study|Adverse Event|2|||
147517651|NCT00255008|532046774|FG003|Overall Study|Adverse Event|0|||
147517652|NCT00255008|532046771|FG000|Overall Study|Lost to Follow-up|1|||
147517653|NCT00255008|532046772|FG001|Overall Study|Lost to Follow-up|0|||
147517654|NCT00255008|532046773|FG002|Overall Study|Lost to Follow-up|1|||
147517655|NCT00255008|532046774|FG003|Overall Study|Lost to Follow-up|2|||
147517656|NCT00255008|532046771|FG000|Overall Study|Did not meet viral reduction criteria|4|||
147517657|NCT00255008|532046772|FG001|Overall Study|Did not meet viral reduction criteria|5|||
147517658|NCT00255008|532046773|FG002|Overall Study|Did not meet viral reduction criteria|0|||
147517659|NCT00255008|532046774|FG003|Overall Study|Did not meet viral reduction criteria|1|||
147517660|NCT00255008|532046771|FG000|Overall Study|Withdrew consent|0|||
147517661|NCT00255008|532046772|FG001|Overall Study|Withdrew consent|0|||
147517662|NCT00255008|532046773|FG002|Overall Study|Withdrew consent|2|||
147517663|NCT00255008|532046774|FG003|Overall Study|Withdrew consent|0|||
147517664|NCT00255008|532046771|FG000|Overall Study|Sponsor request|18|||
147517665|NCT00255008|532046772|FG001|Overall Study|Sponsor request|3|||
147517666|NCT00255008|532046773|FG002|Overall Study|Sponsor request|8|||
147517667|NCT00255008|532046774|FG003|Overall Study|Sponsor request|17|||
147517668|NCT00255008|532046771|FG000|Overall Study|Adverse lab experience|1|||
147517669|NCT00255008|532046772|FG001|Overall Study|Adverse lab experience|0|||
147517670|NCT00255008|532046773|FG002|Overall Study|Adverse lab experience|0|||
147517671|NCT00255008|532046774|FG003|Overall Study|Adverse lab experience|0|||
147517672|NCT00255008|532046771|FG000|Overall Study|Other|7|||
147517673|NCT00255008|532046772|FG001|Overall Study|Other|0|||
147517674|NCT00255008|532046773|FG002|Overall Study|Other|3|||
147517675|NCT00255008|532046774|FG003|Overall Study|Other|2|||
147517676|NCT00707486|532046777|FG000|Overall Study|Withdrawal by Subject|1|||
147517677|NCT04474366|532046788|FG000|Overall Study|Lost to Follow-up|2|||
147517678|NCT04474366|532046789|FG001|Overall Study|Lost to Follow-up|5|||
147517679|NCT05307523|532046791|FG000|First Condition (3 Weeks)|Lost to Follow-up|1|||
147517680|NCT05307523|532046792|FG001|First Condition (3 Weeks)|Lost to Follow-up|0|||
147517681|NCT05307523|532046791|FG000|First Condition (3 Weeks)|Withdrawal by Subject|1|||
147517682|NCT05307523|532046792|FG001|First Condition (3 Weeks)|Withdrawal by Subject|0|||
147517683|NCT03858686|532046795|FG000|Period 1|Adverse Event|1|||
147517684|NCT03858686|532046796|FG001|Period 1|Adverse Event|1|||
147517685|NCT03858686|532046795|FG000|Period 1|Lack of compliance|0|||
147517686|NCT03858686|532046796|FG001|Period 1|Lack of compliance|1|||
147517687|NCT03858686|532046795|FG000|Period 1|Adverse Event|0|||
147517688|NCT03858686|532046796|FG001|Period 1|Adverse Event|1|||
147517689|NCT03858686|532046795|FG000|Period 2|Adverse Event|0|||
147517690|NCT03858686|532046796|FG001|Period 2|Adverse Event|1|||
147517691|NCT04412668|532046797|FG000|Overall Study|Death - multiple comorbidities|2|||
147517692|NCT04412668|532046798|FG001|Overall Study|Death - multiple comorbidities|0|||
147517693|NCT04412668|532046799|FG002|Overall Study|Death - multiple comorbidities|0|||
147517694|NCT04412668|532046797|FG000|Overall Study|Withdrawal by Subject|3|||
147517695|NCT04412668|532046798|FG001|Overall Study|Withdrawal by Subject|0|||
147517696|NCT04412668|532046799|FG002|Overall Study|Withdrawal by Subject|0|||
147517697|NCT04412668|532046797|FG000|Overall Study|Other than Specified|2|||
147517698|NCT04412668|532046798|FG001|Overall Study|Other than Specified|0|||
147517699|NCT04412668|532046799|FG002|Overall Study|Other than Specified|0|||
147517700|NCT01868594|532046800|FG000|Overall Study|Do not meet inclusion criteria|4|||
147517701|NCT01868594|532046801|FG001|Overall Study|Do not meet inclusion criteria|3|||
147517702|NCT02116361|532046806|FG000|Overall Study|Pregnancy|0|||
147517703|NCT02116361|532046807|FG001|Overall Study|Pregnancy|0|||
147517704|NCT02116361|532046808|FG002|Overall Study|Pregnancy|0|||
147517705|NCT02116361|532046809|FG003|Overall Study|Pregnancy|1|||
147517706|NCT02116361|532046806|FG000|Overall Study|Protocol Violation|1|||
147517707|NCT02116361|532046807|FG001|Overall Study|Protocol Violation|0|||
147517708|NCT02116361|532046808|FG002|Overall Study|Protocol Violation|0|||
147517709|NCT02116361|532046809|FG003|Overall Study|Protocol Violation|2|||
147517710|NCT02116361|532046806|FG000|Overall Study|Physician Decision|2|||
147517711|NCT02116361|532046807|FG001|Overall Study|Physician Decision|3|||
147517712|NCT02116361|532046808|FG002|Overall Study|Physician Decision|0|||
147517713|NCT02116361|532046809|FG003|Overall Study|Physician Decision|0|||
147517714|NCT02116361|532046806|FG000|Overall Study|Adverse Event|1|||
147517715|NCT02116361|532046807|FG001|Overall Study|Adverse Event|0|||
147517716|NCT02116361|532046808|FG002|Overall Study|Adverse Event|0|||
147517717|NCT02116361|532046809|FG003|Overall Study|Adverse Event|3|||
147517718|NCT02116361|532046806|FG000|Overall Study|Other Reasons|3|||
147517719|NCT02116361|532046807|FG001|Overall Study|Other Reasons|3|||
147517720|NCT02116361|532046808|FG002|Overall Study|Other Reasons|3|||
147517721|NCT02116361|532046809|FG003|Overall Study|Other Reasons|3|||
147517722|NCT02116361|532046806|FG000|Overall Study|Lack of Efficacy|5|||
147517723|NCT02116361|532046807|FG001|Overall Study|Lack of Efficacy|7|||
147517724|NCT02116361|532046808|FG002|Overall Study|Lack of Efficacy|4|||
147517725|NCT02116361|532046809|FG003|Overall Study|Lack of Efficacy|3|||
147517726|NCT02116361|532046806|FG000|Overall Study|Lost to Follow-up|4|||
147517727|NCT02116361|532046807|FG001|Overall Study|Lost to Follow-up|5|||
147517728|NCT02116361|532046808|FG002|Overall Study|Lost to Follow-up|7|||
147517729|NCT02116361|532046809|FG003|Overall Study|Lost to Follow-up|5|||
147517730|NCT02116361|532046806|FG000|Overall Study|Personal Reasons|6|||
147517731|NCT02116361|532046807|FG001|Overall Study|Personal Reasons|6|||
147517732|NCT02116361|532046808|FG002|Overall Study|Personal Reasons|4|||
147517733|NCT02116361|532046809|FG003|Overall Study|Personal Reasons|9|||
147517734|NCT02116361|532046806|FG000|Overall Study|Investigator Decision - Relapse|9|||
147517735|NCT02116361|532046807|FG001|Overall Study|Investigator Decision - Relapse|7|||
147517736|NCT02116361|532046808|FG002|Overall Study|Investigator Decision - Relapse|8|||
147517737|NCT02116361|532046809|FG003|Overall Study|Investigator Decision - Relapse|5|||
147517738|NCT02659098|532046810|FG000|Overall Study|Withdrawal by Subject|7|||
147517739|NCT04363944|532046811|FG000|Overall Study|Withdrawal by Subject|2|||
147517740|NCT04363944|532046812|FG001|Overall Study|Withdrawal by Subject|0|||
147517741|NCT03517722|532046813|FG000|Double Blind Period: Week 0-52|Adverse Event|9|||
147517742|NCT03517722|532046814|FG001|Double Blind Period: Week 0-52|Adverse Event|11|||
147517743|NCT03517722|532046813|FG000|Double Blind Period: Week 0-52|Death|0|||
147517744|NCT03517722|532046814|FG001|Double Blind Period: Week 0-52|Death|4|||
147517745|NCT03517722|532046813|FG000|Double Blind Period: Week 0-52|Lack of Efficacy|2|||
147517746|NCT03517722|532046814|FG001|Double Blind Period: Week 0-52|Lack of Efficacy|3|||
147517747|NCT03517722|532046813|FG000|Double Blind Period: Week 0-52|Pregnancy|0|||
147517748|NCT03517722|532046814|FG001|Double Blind Period: Week 0-52|Pregnancy|1|||
147517749|NCT03517722|532046813|FG000|Double Blind Period: Week 0-52|Protocol Violation|1|||
147517750|NCT03517722|532046814|FG001|Double Blind Period: Week 0-52|Protocol Violation|0|||
147517751|NCT03517722|532046813|FG000|Double Blind Period: Week 0-52|Withdrawal by Subject|11|||
147517752|NCT03517722|532046814|FG001|Double Blind Period: Week 0-52|Withdrawal by Subject|11|||
147517753|NCT03517722|532046813|FG000|Double Blind Period: Week 0-52|Study Terminated by Sponsor|76|||
147517754|NCT03517722|532046814|FG001|Double Blind Period: Week 0-52|Study Terminated by Sponsor|120|||
147517755|NCT03517722|532046813|FG000|Double Blind Period: Week 0-52|Other|4|||
147517756|NCT03517722|532046814|FG001|Double Blind Period: Week 0-52|Other|3|||
147517757|NCT03517722|532046813|FG000|Double Blind Period: Week 0-52|Initiated prohibited medication|0|||
147517758|NCT03517722|532046814|FG001|Double Blind Period: Week 0-52|Initiated prohibited medication|2|||
147517759|NCT03517722|532046813|FG000|Open-label Extension Period: Week 52-113|Adverse Event|0|||
147517760|NCT03517722|532046814|FG001|Open-label Extension Period: Week 52-113|Adverse Event|1|||
147517761|NCT03517722|532046813|FG000|Open-label Extension Period: Week 52-113|Lack of Efficacy|0|||
147517762|NCT03517722|532046814|FG001|Open-label Extension Period: Week 52-113|Lack of Efficacy|1|||
147517763|NCT03517722|532046813|FG000|Open-label Extension Period: Week 52-113|Withdrawal by Subject|1|||
147517764|NCT03517722|532046814|FG001|Open-label Extension Period: Week 52-113|Withdrawal by Subject|1|||
147517765|NCT03517722|532046813|FG000|Open-label Extension Period: Week 52-113|Study Terminated by Sponsor|87|||
147517766|NCT03517722|532046814|FG001|Open-label Extension Period: Week 52-113|Study Terminated by Sponsor|134|||
147517767|NCT03573804|532046815|FG000|Overall Study|claustrophobia or MRI table problems|10|||
147517768|NCT00952419|532046819|FG000|Overall Study|Adverse Event|2|||
147517769|NCT00952419|532046820|FG001|Overall Study|Adverse Event|0|||
147517770|NCT00952419|532046821|FG002|Overall Study|Adverse Event|0|||
147517771|NCT00952419|532046819|FG000|Overall Study|Protocol Violation|3|||
147517772|NCT00952419|532046820|FG001|Overall Study|Protocol Violation|7|||
147517773|NCT00952419|532046821|FG002|Overall Study|Protocol Violation|0|||
147517774|NCT00952419|532046819|FG000|Overall Study|Withdrawal by Subject|1|||
147517775|NCT00952419|532046820|FG001|Overall Study|Withdrawal by Subject|3|||
147517776|NCT00952419|532046821|FG002|Overall Study|Withdrawal by Subject|0|||
147517777|NCT01592773|532048047|FG000|Overall Study|Study Terminated by Sponsor|582|||
147517778|NCT01592773|532048047|FG000|Overall Study|Withdrawal by Subject|35|||
147517779|NCT01592773|532048047|FG000|Overall Study|Lost to Follow-up|19|||
147517780|NCT01592773|532048047|FG000|Overall Study|Adverse Event|17|||
147517781|NCT01592773|532048047|FG000|Overall Study|Lack of Efficacy|9|||
147517782|NCT01592773|532048047|FG000|Overall Study|Protocol Violation|2|||
147517783|NCT01592773|532048047|FG000|Overall Study|Inclusion/exclusion not meet|1|||
147517784|NCT01592773|532048047|FG000|Overall Study|Other Reason|1|||
147517785|NCT04418427|532048048|FG000|Overall Study|Death|0|||
147517786|NCT04418427|532048049|FG001|Overall Study|Death|1|||
147517787|NCT04418427|532048050|FG002|Overall Study|Death|0|||
147517788|NCT04418427|532048048|FG000|Overall Study|Lost to Follow-up|0|||
147517789|NCT04418427|532048049|FG001|Overall Study|Lost to Follow-up|2|||
147517790|NCT04418427|532048050|FG002|Overall Study|Lost to Follow-up|2|||
147517791|NCT04418427|532048048|FG000|Overall Study|Subject Discontinued by the Sponsor|1|||
147517792|NCT04418427|532048049|FG001|Overall Study|Subject Discontinued by the Sponsor|0|||
147517793|NCT04418427|532048050|FG002|Overall Study|Subject Discontinued by the Sponsor|1|||
147517794|NCT04418427|532048048|FG000|Overall Study|Pre-existing medical condition|0|||
147517795|NCT04418427|532048049|FG001|Overall Study|Pre-existing medical condition|1|||
147517796|NCT04418427|532048050|FG002|Overall Study|Pre-existing medical condition|0|||
147517797|NCT01293123|532048051|FG000|Overall Study|Lost to Follow-up|0|||
147517798|NCT01293123|532048052|FG001|Overall Study|Lost to Follow-up|1|||
147517799|NCT01888965|532048057|FG000|Overall Study|Adverse Event|5|||
147517800|NCT01888965|532048057|FG000|Overall Study|Lack of Efficacy|4|||
147517801|NCT04076579|532048058|FG000|Overall Study|Adverse Event|2|||
147517802|NCT04076579|532048059|FG001|Overall Study|Adverse Event|0|||
147517803|NCT04076579|532048058|FG000|Overall Study|discontinued due to toxicity|1|||
147517804|NCT04076579|532048059|FG001|Overall Study|discontinued due to toxicity|0|||
147517805|NCT04076579|532048058|FG000|Overall Study|Physician Decision|1|||
147517806|NCT04076579|532048059|FG001|Overall Study|Physician Decision|0|||
147517807|NCT04076579|532048058|FG000|Overall Study|Patient was deemed ineligible before starting study treatment|0|||
147517808|NCT04076579|532048059|FG001|Overall Study|Patient was deemed ineligible before starting study treatment|1|||
147517809|NCT04076579|532048058|FG000|Overall Study|Noncompliance|0|||
147517810|NCT04076579|532048059|FG001|Overall Study|Noncompliance|1|||
147517811|NCT04076579|532048058|FG000|Overall Study|Withdrawal by Subject|0|||
147517812|NCT04076579|532048059|FG001|Overall Study|Withdrawal by Subject|2|||
147517813|NCT03793010|532048060|FG000|Overall Study|Withdrawal by Subject|5|||
147517814|NCT03793010|532048061|FG001|Overall Study|Withdrawal by Subject|7|||
147517815|NCT03793010|532048060|FG000|Overall Study|Withdrawn by Investigator or Sponsor|19|||
147517816|NCT03793010|532048061|FG001|Overall Study|Withdrawn by Investigator or Sponsor|18|||
147517817|NCT03793010|532048060|FG000|Overall Study|Lost to Follow-up|1|||
147517818|NCT03793010|532048061|FG001|Overall Study|Lost to Follow-up|2|||
147517819|NCT03793010|532048060|FG000|Overall Study|Patient couldn't sit still for injection|1|||
147517820|NCT03793010|532048061|FG001|Overall Study|Patient couldn't sit still for injection|0|||
147517821|NCT03793010|532048060|FG000|Overall Study|Withdrew to pursue other treatment|1|||
147517822|NCT03793010|532048061|FG001|Overall Study|Withdrew to pursue other treatment|0|||
147517823|NCT03793010|532048060|FG000|Overall Study|Did not meet eligibility criteria|1|||
147517824|NCT03793010|532048061|FG001|Overall Study|Did not meet eligibility criteria|0|||
147517825|NCT01736176|532048069|FG000|Overall Study|Adverse Event|3|||
147517826|NCT01736176|532048069|FG000|Overall Study|Withdrawal by Subject|4|||
147517827|NCT01736176|532048069|FG000|Overall Study|Lack of Efficacy|3|||
147517828|NCT01736176|532048069|FG000|Overall Study|Unable to Complete PEG Placement|1|||
147517829|NCT00186121|532048070|FG000|Overall Study|Subject withdrawal (no treatment)|1|||
147517830|NCT00186121|532048070|FG000|Overall Study|Underwent oophorectomy (no treatment)|1|||
147517831|NCT00186121|532048070|FG000|Overall Study|Not eligible (no treatment)|1|||
147517832|NCT00417248|532048071|FG000|Overall Study|Study Terminated|6|||
147517833|NCT00417248|532048071|FG000|Overall Study|Death|1|||
147517834|NCT00417248|532048071|FG000|Overall Study|Lack of Efficacy|1|||
147517835|NCT01569568|532048072|FG000|Overall Study|Physician Decision|0|||
147517836|NCT01569568|532048073|FG001|Overall Study|Physician Decision|2|||
147517837|NCT00934791|532048074|FG000|Overall Study|Withdrawal by Subject|1|||
147517838|NCT00934791|532048075|FG001|Overall Study|Withdrawal by Subject|0|||
147517839|NCT02425891|532048077|FG000|Overall Study|Death|333|||
147517840|NCT02425891|532048078|FG001|Overall Study|Death|314|||
147517841|NCT02425891|532048077|FG000|Overall Study|Lost to Follow-up|4|||
147517842|NCT02425891|532048078|FG001|Overall Study|Lost to Follow-up|6|||
147517843|NCT02425891|532048077|FG000|Overall Study|Non-Compliance|1|||
147517844|NCT02425891|532048078|FG001|Overall Study|Non-Compliance|1|||
147517845|NCT02425891|532048077|FG000|Overall Study|Accidentally randomized screen failure participant|0|||
147517846|NCT02425891|532048078|FG001|Overall Study|Accidentally randomized screen failure participant|1|||
147517847|NCT02425891|532048077|FG000|Overall Study|Physician Decision|0|||
147517848|NCT02425891|532048078|FG001|Overall Study|Physician Decision|1|||
147517849|NCT02425891|532048077|FG000|Overall Study|Protocol Violation|1|||
147517850|NCT02425891|532048078|FG001|Overall Study|Protocol Violation|1|||
147517851|NCT02425891|532048077|FG000|Overall Study|Study Terminated By Sponsor|85|||
147517852|NCT02425891|532048078|FG001|Overall Study|Study Terminated By Sponsor|95|||
147517853|NCT02425891|532048077|FG000|Overall Study|Withdrawal by Subject|27|||
147517854|NCT02425891|532048078|FG001|Overall Study|Withdrawal by Subject|32|||
147517855|NCT04124952|532048079|FG000|Overall Study|Lost to Follow-up|1|||
147517856|NCT00166504|532048081|FG000|Overall Study|Adverse Event|3|||
147517857|NCT00166504|532048082|FG001|Overall Study|Adverse Event|3|||
147517858|NCT00166504|532048081|FG000|Overall Study|Lost to Follow-up|1|||
147517859|NCT00166504|532048082|FG001|Overall Study|Lost to Follow-up|1|||
147517860|NCT00166504|532048081|FG000|Overall Study|Withdrawal by Subject|1|||
147517861|NCT00166504|532048082|FG001|Overall Study|Withdrawal by Subject|0|||
147517862|NCT03261037|532048085|FG000|Overall Study|Withdrawal by Subject|2|||
147517863|NCT03261037|532048086|FG001|Overall Study|Withdrawal by Subject|13|||
147517864|NCT03261037|532048087|FG002|Overall Study|Withdrawal by Subject|0|||
147517865|NCT03261037|532048088|FG003|Overall Study|Withdrawal by Subject|18|||
147517866|NCT03261037|532048085|FG000|Overall Study|Non-compliance with study procedures|0|||
147517867|NCT03261037|532048086|FG001|Overall Study|Non-compliance with study procedures|2|||
147517868|NCT03261037|532048087|FG002|Overall Study|Non-compliance with study procedures|0|||
147517869|NCT03261037|532048088|FG003|Overall Study|Non-compliance with study procedures|6|||
147517870|NCT03261037|532048085|FG000|Overall Study|Participant moving away and can no longer be in study|0|||
147517871|NCT03261037|532048086|FG001|Overall Study|Participant moving away and can no longer be in study|1|||
147517872|NCT03261037|532048087|FG002|Overall Study|Participant moving away and can no longer be in study|0|||
147517873|NCT03261037|532048088|FG003|Overall Study|Participant moving away and can no longer be in study|0|||
147517874|NCT03261037|532048085|FG000|Overall Study|Participant came out of study due to investigator discretion|0|||
147517875|NCT03261037|532048086|FG001|Overall Study|Participant came out of study due to investigator discretion|2|||
147517876|NCT03261037|532048087|FG002|Overall Study|Participant came out of study due to investigator discretion|0|||
147517877|NCT03261037|532048088|FG003|Overall Study|Participant came out of study due to investigator discretion|0|||
147517878|NCT03261037|532048085|FG000|Overall Study|Diagnosed but protocol deviation|1|||
147517879|NCT03261037|532048086|FG001|Overall Study|Diagnosed but protocol deviation|0|||
147517880|NCT03261037|532048087|FG002|Overall Study|Diagnosed but protocol deviation|0|||
147517881|NCT03261037|532048088|FG003|Overall Study|Diagnosed but protocol deviation|0|||
147517882|NCT03261037|532048085|FG000|Overall Study|Participant did not want to continue the study|0|||
147517883|NCT03261037|532048086|FG001|Overall Study|Participant did not want to continue the study|1|||
147517884|NCT03261037|532048087|FG002|Overall Study|Participant did not want to continue the study|0|||
147517885|NCT03261037|532048088|FG003|Overall Study|Participant did not want to continue the study|0|||
147517886|NCT03261037|532048085|FG000|Overall Study|Participant did not want to continue the diagnostic procedures|0|||
147517887|NCT03261037|532048086|FG001|Overall Study|Participant did not want to continue the diagnostic procedures|0|||
147517888|NCT03261037|532048087|FG002|Overall Study|Participant did not want to continue the diagnostic procedures|0|||
147517889|NCT03261037|532048088|FG003|Overall Study|Participant did not want to continue the diagnostic procedures|1|||
147517890|NCT03261037|532048085|FG000|Overall Study|Participant presented clinical improvement|0|||
147517891|NCT03261037|532048086|FG001|Overall Study|Participant presented clinical improvement|2|||
147517892|NCT03261037|532048087|FG002|Overall Study|Participant presented clinical improvement|0|||
147517893|NCT03261037|532048088|FG003|Overall Study|Participant presented clinical improvement|0|||
147517894|NCT03261037|532048085|FG000|Overall Study|Technical difficulties|0|||
147517895|NCT03261037|532048086|FG001|Overall Study|Technical difficulties|0|||
147517896|NCT03261037|532048087|FG002|Overall Study|Technical difficulties|0|||
147517897|NCT03261037|532048088|FG003|Overall Study|Technical difficulties|1|||
147517898|NCT03261037|532048085|FG000|Overall Study|Equipment failed to work|0|||
147517899|NCT03261037|532048086|FG001|Overall Study|Equipment failed to work|0|||
147517900|NCT03261037|532048087|FG002|Overall Study|Equipment failed to work|0|||
147517901|NCT03261037|532048088|FG003|Overall Study|Equipment failed to work|1|||
147517902|NCT03261037|532048085|FG000|Overall Study|End of study for participant and no follow up|0|||
147517903|NCT03261037|532048086|FG001|Overall Study|End of study for participant and no follow up|0|||
147517904|NCT03261037|532048087|FG002|Overall Study|End of study for participant and no follow up|0|||
147517905|NCT03261037|532048088|FG003|Overall Study|End of study for participant and no follow up|1|||
147517906|NCT03261037|532048085|FG000|Overall Study|Participant was too weak to continue in study|1|||
147517907|NCT03261037|532048086|FG001|Overall Study|Participant was too weak to continue in study|0|||
147517908|NCT03261037|532048087|FG002|Overall Study|Participant was too weak to continue in study|0|||
147517909|NCT03261037|532048088|FG003|Overall Study|Participant was too weak to continue in study|0|||
147517910|NCT01944462|532048093|FG000|PPPP Educational Program|Lost to Follow-up|60|||
147517911|NCT01222767|532048094|FG000|Overall Study|Progressive disease|13|||
147517912|NCT01222767|532048094|FG000|Overall Study|Adverse Event|2|||
147517913|NCT01222767|532048094|FG000|Overall Study|Surgical resection|1|||
147517914|NCT01222767|532048094|FG000|Overall Study|Never treated|1|||
147517915|NCT00723489|532048095|FG000|Overall Study|Physician Decision|0|||
147517916|NCT00723489|532048096|FG001|Overall Study|Physician Decision|1|||
147517917|NCT00723489|532048097|FG002|Overall Study|Physician Decision|0|||
147517918|NCT00723489|532048098|FG003|Overall Study|Physician Decision|0|||
147517919|NCT00723489|532048095|FG000|Overall Study|Pregnancy|0|||
147517920|NCT00723489|532048096|FG001|Overall Study|Pregnancy|0|||
147517921|NCT00723489|532048097|FG002|Overall Study|Pregnancy|0|||
147517922|NCT00723489|532048098|FG003|Overall Study|Pregnancy|1|||
147517923|NCT00723489|532048095|FG000|Overall Study|Withdrawal by Subject|0|||
147517924|NCT00723489|532048096|FG001|Overall Study|Withdrawal by Subject|0|||
147517925|NCT00723489|532048097|FG002|Overall Study|Withdrawal by Subject|0|||
147517926|NCT00723489|532048098|FG003|Overall Study|Withdrawal by Subject|1|||
147517927|NCT00723489|532048095|FG000|Overall Study|Seropositive at baseline|1|||
147517928|NCT00723489|532048096|FG001|Overall Study|Seropositive at baseline|0|||
147517929|NCT00723489|532048097|FG002|Overall Study|Seropositive at baseline|0|||
147517930|NCT00723489|532048098|FG003|Overall Study|Seropositive at baseline|0|||
147517931|NCT00723489|532048095|FG000|Overall Study|Prohibited Medication|0|||
147517932|NCT00723489|532048096|FG001|Overall Study|Prohibited Medication|0|||
147517933|NCT00723489|532048097|FG002|Overall Study|Prohibited Medication|0|||
147517934|NCT00723489|532048098|FG003|Overall Study|Prohibited Medication|1|||
147517935|NCT00723489|532048095|FG000|Overall Study|Samples Collected Out of Window|0|||
147517936|NCT00723489|532048096|FG001|Overall Study|Samples Collected Out of Window|3|||
147517937|NCT00723489|532048097|FG002|Overall Study|Samples Collected Out of Window|0|||
147517938|NCT00723489|532048098|FG003|Overall Study|Samples Collected Out of Window|0|||
147517939|NCT03657576|532048099|FG000|Overall Study|Death|0|||
147517940|NCT03657576|532048100|FG001|Overall Study|Death|1|||
147517941|NCT03657576|532048101|FG002|Overall Study|Death|1|||
147517942|NCT03657576|532048102|FG003|Overall Study|Death|0|||
147517943|NCT03657576|532048103|FG004|Overall Study|Death|0|||
147517944|NCT03657576|532048104|FG005|Overall Study|Death|0|||
147517945|NCT03657576|532048099|FG000|Overall Study|Withdrawal by Subject|0|||
147517946|NCT03657576|532048100|FG001|Overall Study|Withdrawal by Subject|0|||
147517947|NCT03657576|532048101|FG002|Overall Study|Withdrawal by Subject|0|||
147517948|NCT03657576|532048102|FG003|Overall Study|Withdrawal by Subject|1|||
147517949|NCT03657576|532048103|FG004|Overall Study|Withdrawal by Subject|0|||
147517950|NCT03657576|532048104|FG005|Overall Study|Withdrawal by Subject|0|||
147517951|NCT03657576|532048099|FG000|Overall Study|Screen Fail|0|||
147517952|NCT03657576|532048100|FG001|Overall Study|Screen Fail|0|||
147517953|NCT03657576|532048101|FG002|Overall Study|Screen Fail|0|||
147517954|NCT03657576|532048102|FG003|Overall Study|Screen Fail|0|||
147517955|NCT03657576|532048103|FG004|Overall Study|Screen Fail|0|||
147517956|NCT03657576|532048104|FG005|Overall Study|Screen Fail|5|||
147517957|NCT03657576|532048099|FG000|Overall Study|Disease Progression|1|||
147517958|NCT03657576|532048100|FG001|Overall Study|Disease Progression|1|||
147517959|NCT03657576|532048101|FG002|Overall Study|Disease Progression|0|||
147517960|NCT03657576|532048102|FG003|Overall Study|Disease Progression|5|||
147517961|NCT03657576|532048103|FG004|Overall Study|Disease Progression|0|||
147517962|NCT03657576|532048104|FG005|Overall Study|Disease Progression|0|||
147517963|NCT03657576|532048099|FG000|Overall Study|Insurance Coverage|0|||
147517964|NCT03657576|532048100|FG001|Overall Study|Insurance Coverage|0|||
147517965|NCT03657576|532048101|FG002|Overall Study|Insurance Coverage|0|||
147517966|NCT03657576|532048102|FG003|Overall Study|Insurance Coverage|1|||
147517967|NCT03657576|532048103|FG004|Overall Study|Insurance Coverage|0|||
147517968|NCT03657576|532048104|FG005|Overall Study|Insurance Coverage|0|||
147517969|NCT04437511|532048105|FG000|Overall Study|Adverse Event|50|||
147517970|NCT04437511|532048106|FG001|Overall Study|Adverse Event|21|||
147517971|NCT04437511|532048105|FG000|Overall Study|Death|15|||
147517972|NCT04437511|532048106|FG001|Overall Study|Death|10|||
147517973|NCT04437511|532048105|FG000|Overall Study|Lost to Follow-up|11|||
147517974|NCT04437511|532048106|FG001|Overall Study|Lost to Follow-up|11|||
147517975|NCT04437511|532048105|FG000|Overall Study|Physician Decision|19|||
147517976|NCT04437511|532048106|FG001|Overall Study|Physician Decision|10|||
147517977|NCT04437511|532048105|FG000|Overall Study|Progressive Disease|4|||
147517978|NCT04437511|532048106|FG001|Overall Study|Progressive Disease|7|||
147517979|NCT04437511|532048105|FG000|Overall Study|Withdrawal by Subject|111|||
147517980|NCT04437511|532048106|FG001|Overall Study|Withdrawal by Subject|94|||
147517981|NCT04437511|532048105|FG000|Overall Study|Withdrawal due to Caregiver Circumstances|21|||
147517982|NCT04437511|532048106|FG001|Overall Study|Withdrawal due to Caregiver Circumstances|20|||
147517983|NCT04437511|532048105|FG000|Overall Study|Continuing Study|7|||
147517984|NCT04437511|532048106|FG001|Overall Study|Continuing Study|5|||
147517985|NCT05298774|532048111|FG000|Overall Study|Physician Decision|3|||
147517986|NCT05298774|532048111|FG000|Overall Study|Withdrawal by Subject|2|||
147517987|NCT05298774|532048111|FG000|Overall Study|Lost to Follow-up|3|||
147517988|NCT05298774|532048111|FG000|Overall Study|Screen failure|1|||
147517989|NCT00081263|532048113|FG000|Overall Study|clerical error|1|||
147517990|NCT00081263|532048114|FG001|Overall Study|clerical error|0|||
147517991|NCT00081263|532048113|FG000|Overall Study|wrong cell type|7|||
147517992|NCT00081263|532048114|FG001|Overall Study|wrong cell type|5|||
147517993|NCT00081263|532048113|FG000|Overall Study|improper pre-protocol therapy|0|||
147517994|NCT00081263|532048114|FG001|Overall Study|improper pre-protocol therapy|1|||
147517995|NCT00081263|532048113|FG000|Overall Study|Inadequate pathology|0|||
147517996|NCT00081263|532048114|FG001|Overall Study|Inadequate pathology|1|||
147517997|NCT00081263|532048113|FG000|Overall Study|Never treated|4|||
147517998|NCT00081263|532048114|FG001|Overall Study|Never treated|5|||
147517999|NCT00081263|532048113|FG000|Overall Study|Inadequate data|5|||
147518000|NCT00081263|532048114|FG001|Overall Study|Inadequate data|10|||
147518001|NCT01267955|532048115|FG000|Stage 1 (6 Months)|Death|3|||
147518002|NCT01267955|532048115|FG000|Stage 2 (6 Months)|Death|5|||
147518003|NCT01267955|532048115|FG000|Stage 2 (6 Months)|Protocol Violation|1|||
147518004|NCT03233308|532048116|FG000|Overall Study|Adverse Event|1|||
147518005|NCT03233308|532048116|FG000|Overall Study|Protocol Violation|1|||
147518006|NCT01996865|532048117|FG000|Induction Period|Protocol Violation|1|||
147518007|NCT01996865|532048118|FG001|Induction Period|Protocol Violation|0|||
147518008|NCT01996865|532048119|FG002|Induction Period|Protocol Violation|0|||
147518009|NCT01996865|532048117|FG000|Induction Period|Progressive Disease|4|||
147518010|NCT01996865|532048118|FG001|Induction Period|Progressive Disease|0|||
147518011|NCT01996865|532048119|FG002|Induction Period|Progressive Disease|0|||
147518012|NCT01996865|532048117|FG000|Induction Period|Lost to Follow-up|10|||
147518013|NCT01996865|532048118|FG001|Induction Period|Lost to Follow-up|0|||
147518014|NCT01996865|532048119|FG002|Induction Period|Lost to Follow-up|0|||
147518015|NCT01996865|532048117|FG000|Induction Period|Other Reasons|13|||
147518016|NCT01996865|532048118|FG001|Induction Period|Other Reasons|0|||
147518017|NCT01996865|532048119|FG002|Induction Period|Other Reasons|0|||
147518018|NCT01996865|532048117|FG000|Induction Period|Adverse Event|20|||
147518019|NCT01996865|532048118|FG001|Induction Period|Adverse Event|0|||
147518020|NCT01996865|532048119|FG002|Induction Period|Adverse Event|0|||
147518021|NCT01996865|532048117|FG000|Induction Period|Withdrawal by Subject|60|||
147518022|NCT01996865|532048118|FG001|Induction Period|Withdrawal by Subject|0|||
147518023|NCT01996865|532048119|FG002|Induction Period|Withdrawal by Subject|0|||
147518024|NCT01996865|532048117|FG000|Induction Period|Death|111|||
147518025|NCT01996865|532048118|FG001|Induction Period|Death|0|||
147518026|NCT01996865|532048119|FG002|Induction Period|Death|0|||
147518027|NCT01996865|532048117|FG000|Maintenance Period|Protocol Violation|0|||
147518028|NCT01996865|532048118|FG001|Maintenance Period|Protocol Violation|1|||
147518029|NCT01996865|532048119|FG002|Maintenance Period|Protocol Violation|1|||
147518030|NCT01996865|532048117|FG000|Maintenance Period|Other reasons|0|||
147518031|NCT01996865|532048118|FG001|Maintenance Period|Other reasons|8|||
147518032|NCT01996865|532048119|FG002|Maintenance Period|Other reasons|5|||
147518033|NCT01996865|532048117|FG000|Maintenance Period|Progressive Disease|0|||
147518034|NCT01996865|532048118|FG001|Maintenance Period|Progressive Disease|6|||
147518035|NCT01996865|532048119|FG002|Maintenance Period|Progressive Disease|23|||
147518036|NCT01996865|532048117|FG000|Maintenance Period|Withdrawal by Subject|0|||
147518037|NCT01996865|532048118|FG001|Maintenance Period|Withdrawal by Subject|18|||
147518038|NCT01996865|532048119|FG002|Maintenance Period|Withdrawal by Subject|4|||
147518039|NCT01996865|532048117|FG000|Maintenance Period|Adverse Event|0|||
147518040|NCT01996865|532048118|FG001|Maintenance Period|Adverse Event|7|||
147518041|NCT01996865|532048119|FG002|Maintenance Period|Adverse Event|7|||
147518042|NCT01996865|532048117|FG000|Maintenance Period|Death|0|||
147518043|NCT01996865|532048118|FG001|Maintenance Period|Death|15|||
147518044|NCT01996865|532048119|FG002|Maintenance Period|Death|3|||
147518045|NCT01996865|532048117|FG000|Maintenance Period|Lost to Follow-up|0|||
147518046|NCT01996865|532048118|FG001|Maintenance Period|Lost to Follow-up|2|||
147518047|NCT01996865|532048119|FG002|Maintenance Period|Lost to Follow-up|0|||
147518048|NCT04430036|532048122|FG000|Safety Run in Phase|Progression of disease|2|||
147518049|NCT01842334|532048123|FG000|Overall Study|Withdrawal by Subject|3|||
147518050|NCT01842334|532048124|FG001|Overall Study|Withdrawal by Subject|3|||
147518051|NCT01842334|532048123|FG000|Overall Study|Moved away mid-study|0|||
147518052|NCT01842334|532048124|FG001|Overall Study|Moved away mid-study|1|||
147518053|NCT00376675|532048125|FG000|Overall Study|Withdrawal by Subject|9|||
147518054|NCT00376675|532048126|FG001|Overall Study|Withdrawal by Subject|2|||
147518055|NCT00376675|532048125|FG000|Overall Study|Adverse Event|10|||
147518056|NCT00376675|532048126|FG001|Overall Study|Adverse Event|5|||
147518057|NCT00376675|532048125|FG000|Overall Study|Other Reason|1|||
147518058|NCT00376675|532048126|FG001|Overall Study|Other Reason|7|||
147518059|NCT00942422|532048130|FG000|Overall Study|Withdrawal by Subject|1|||
147518060|NCT00942422|532048130|FG000|Overall Study|Death|1|||
147518061|NCT00942422|532048130|FG000|Overall Study|Progressive diease|1|||
147518062|NCT00423592|532048133|FG000|Overall Study|Adverse Event (through Week 12)|2|||
147518063|NCT00423592|532048133|FG000|Overall Study|Adverse Event (post Week 12)|5|||
147518064|NCT00002981|532048138|FG000|Overall Study|Inevaluable|6|||
147518065|NCT01833806|532048142|FG000|Overall Study|Alternative treatment|2|||
147518066|NCT01833806|532048142|FG000|Overall Study|Death|5|||
147518067|NCT01833806|532048142|FG000|Overall Study|Physician Decision|1|||
147518068|NCT01833806|532048142|FG000|Overall Study|Lost to Follow-up|1|||
147518069|NCT05083949|532048143|FG000|Period 1|Positive doping for Tetrahydrocannabinol (THC)|2|||
147518070|NCT05083949|532048144|FG001|Period 1|Positive doping for Tetrahydrocannabinol (THC)|1|||
147518071|NCT05083949|532048143|FG000|Period 1|Adverse Event|1|||
147518072|NCT05083949|532048144|FG001|Period 1|Adverse Event|1|||
147518073|NCT05083949|532048143|FG000|Period 2|The patient was not able to eat the full content of the breakfast|1|||
147518074|NCT05083949|532048144|FG001|Period 2|The patient was not able to eat the full content of the breakfast|0|||
147518075|NCT05083949|532048143|FG000|Period 2|Adverse Event|0|||
147518076|NCT05083949|532048144|FG001|Period 2|Adverse Event|2|||
147518077|NCT00322387|532048146|FG000|Treatment Period|Adverse Event|0|||
147518078|NCT00322387|532048147|FG001|Treatment Period|Adverse Event|1|||
147518079|NCT00322387|532048146|FG000|Follow-up Period|Final assessment not done|1|||
147518080|NCT00322387|532048147|FG001|Follow-up Period|Final assessment not done|3|||
147518081|NCT00322387|532048146|FG000|Follow-up Period|Death|1|||
147518082|NCT00322387|532048147|FG001|Follow-up Period|Death|0|||
147518083|NCT01894776|532048150|FG000|Overall Study|Withdrawal by Subject|1|||
147640284|NCT02275780|532501492|FG001|Study Extension 2: Week 192 to Week 288|Lost to Follow-up|1|||
147640285|NCT02275780|532501491|FG000|Study Extension 2: Week 192 to Week 288|Non-compliance with study drug|2|||
147640286|NCT02275780|532501492|FG001|Study Extension 2: Week 192 to Week 288|Non-compliance with study drug|0|||
147640287|NCT02275780|532501491|FG000|Study Extension 2: Week 192 to Week 288|Physician Decision|1|||
147640288|NCT02275780|532501492|FG001|Study Extension 2: Week 192 to Week 288|Physician Decision|1|||
147640289|NCT02275780|532501491|FG000|Study Extension 2: Week 192 to Week 288|Withdrawal by Subject|4|||
147640290|NCT02275780|532501492|FG001|Study Extension 2: Week 192 to Week 288|Withdrawal by Subject|3|||
147640291|NCT02275780|532501491|FG000|Study Extension 3: Week 288 to Week 384|Availability of study medication locally|6|||
147640292|NCT02275780|532501492|FG001|Study Extension 3: Week 288 to Week 384|Availability of study medication locally|6|||
147640293|NCT02275780|532501491|FG000|Study Extension 3: Week 288 to Week 384|Death|0|||
147640294|NCT02275780|532501492|FG001|Study Extension 3: Week 288 to Week 384|Death|1|||
147640295|NCT02275780|532501491|FG000|Study Extension 3: Week 288 to Week 384|Lost to Follow-up|1|||
147640296|NCT02275780|532501492|FG001|Study Extension 3: Week 288 to Week 384|Lost to Follow-up|3|||
147640297|NCT02275780|532501491|FG000|Study Extension 3: Week 288 to Week 384|Non-compliance with study drug|1|||
147640298|NCT02275780|532501492|FG001|Study Extension 3: Week 288 to Week 384|Non-compliance with study drug|1|||
147640299|NCT02275780|532501491|FG000|Study Extension 3: Week 288 to Week 384|Physician Decision|1|||
147640300|NCT02275780|532501492|FG001|Study Extension 3: Week 288 to Week 384|Physician Decision|0|||
147640301|NCT02275780|532501491|FG000|Study Extension 3: Week 288 to Week 384|Withdrawal by Subject|5|||
147640302|NCT02275780|532501492|FG001|Study Extension 3: Week 288 to Week 384|Withdrawal by Subject|2|||
147640303|NCT01054300|532501495|FG000|Period 1|Adverse Event|1|||
147640304|NCT01054300|532501496|FG001|Period 1|Adverse Event|0|||
147640305|NCT01054300|532501497|FG002|Period 1|Adverse Event|0|||
147640306|NCT01054300|532501498|FG003|Period 1|Adverse Event|0|||
147640307|NCT01054300|532501495|FG000|Period 2|Withdrawal by Subject|0|||
147640308|NCT01054300|532501496|FG001|Period 2|Withdrawal by Subject|0|||
147640309|NCT01054300|532501497|FG002|Period 2|Withdrawal by Subject|1|||
147640310|NCT01054300|532501498|FG003|Period 2|Withdrawal by Subject|0|||
147640311|NCT00738881|532501502|FG000|Overall Study|Withdrawal by Subject|0|||
147640312|NCT00738881|532501503|FG001|Overall Study|Withdrawal by Subject|2|||
147640313|NCT01282164|532501504|FG000|Overall Study|Lack of hypoglycemia during ITT|1|||
147640314|NCT01282164|532501505|FG001|Overall Study|Lack of hypoglycemia during ITT|0|||
147640315|NCT03409107|532501508|FG000|Overall Study|Withdrawal by Subject|4|||
147640316|NCT03409107|532501509|FG001|Overall Study|Withdrawal by Subject|2|||
147640317|NCT03409107|532501508|FG000|Overall Study|Physician Decision|1|||
147640318|NCT03409107|532501509|FG001|Overall Study|Physician Decision|0|||
147640319|NCT03409107|532501508|FG000|Overall Study|Lost to Follow-up|7|||
147640320|NCT03409107|532501509|FG001|Overall Study|Lost to Follow-up|2|||
147640321|NCT03409107|532501508|FG000|Overall Study|Adverse Event|5|||
147640322|NCT03409107|532501509|FG001|Overall Study|Adverse Event|3|||
147640323|NCT01185509|532501510|FG000|Overall Study|Progression/Relapse|9|||
147640324|NCT01185509|532501511|FG001|Overall Study|Progression/Relapse|15|||
147640325|NCT01185509|532501510|FG000|Overall Study|Physician Decision|2|||
147640326|NCT01185509|532501511|FG001|Overall Study|Physician Decision|2|||
147640327|NCT01185509|532501510|FG000|Overall Study|Withdrawal by Subject|0|||
147640328|NCT01185509|532501511|FG001|Overall Study|Withdrawal by Subject|1|||
147640329|NCT01185509|532501510|FG000|Overall Study|Death|0|||
147640330|NCT01185509|532501511|FG001|Overall Study|Death|1|||
147640331|NCT01185509|532501510|FG000|Overall Study|Intercurrent Illness|0|||
147640332|NCT01185509|532501511|FG001|Overall Study|Intercurrent Illness|1|||
147640333|NCT00916344|532501512|FG000|Overall Study|Death|2|||
147640334|NCT00916344|532501512|FG000|Overall Study|ICD upgrade|1|||
147640335|NCT00916344|532501512|FG000|Overall Study|Drop-out|5|||
147640336|NCT00108485|532501524|FG000|Overall Study|Withdrawal by Subject|3|||
147640337|NCT00108485|532501525|FG001|Overall Study|Withdrawal by Subject|0|||
147640338|NCT00108485|532501524|FG000|Overall Study|Lost to Follow-up|0|||
147640339|NCT00108485|532501525|FG001|Overall Study|Lost to Follow-up|2|||
147640340|NCT01537068|532501532|FG000|Overall Study|Lost to Follow-up|2|||
147640341|NCT01537068|532501533|FG001|Overall Study|Lost to Follow-up|1|||
147640342|NCT01537068|532501532|FG000|Overall Study|Adverse Event|0|||
147640343|NCT01537068|532501533|FG001|Overall Study|Adverse Event|1|||
147640344|NCT01537068|532501532|FG000|Overall Study|Withdrawal by Subject|1|||
147640345|NCT01537068|532501533|FG001|Overall Study|Withdrawal by Subject|1|||
147640346|NCT01537068|532501532|FG000|Overall Study|Lack of Efficacy|1|||
147640347|NCT01537068|532501533|FG001|Overall Study|Lack of Efficacy|0|||
147640348|NCT03099694|532501534|FG000|Overall Study|Withdrawal by Subject|11|||
147640349|NCT03099694|532501535|FG001|Overall Study|Withdrawal by Subject|13|||
147640350|NCT03099694|532501534|FG000|Overall Study|Lost to Follow-up|9|||
147518084|NCT00320190|532048151|FG000|First 12 Months|Completed but did not enter extension|5|||
147640351|NCT03099694|532501535|FG001|Overall Study|Lost to Follow-up|5|||
147640352|NCT02537431|532501537|FG000|Open-Label Period (Week 0 to Week 48)|Withdrawal by Subject|1|||
147640353|NCT00794040|532501540|FG000|Overall Study|Withdrawal by Subject|3|||
147640354|NCT00794040|532501541|FG001|Overall Study|Withdrawal by Subject|4|||
147640355|NCT00794040|532501540|FG000|Overall Study|Physician Decision|0|||
147640356|NCT00794040|532501541|FG001|Overall Study|Physician Decision|1|||
147640357|NCT04696354|532501542|FG000|Overall Study|Study termination|6|||
147640358|NCT04696354|532501543|FG001|Overall Study|Study termination|6|||
147640359|NCT03005327|532501544|FG000|Initial Treatment Period (24 Weeks)|Adverse Event|0|||
147640360|NCT03005327|532501545|FG001|Initial Treatment Period (24 Weeks)|Adverse Event|0|||
147640361|NCT03005327|532501546|FG002|Initial Treatment Period (24 Weeks)|Adverse Event|1|||
147640362|NCT03005327|532501547|FG003|Initial Treatment Period (24 Weeks)|Adverse Event|0|||
147640363|NCT03005327|532501544|FG000|Initial Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
147640364|NCT03005327|532501545|FG001|Initial Treatment Period (24 Weeks)|Withdrawal by Subject|1|||
147640365|NCT03005327|532501546|FG002|Initial Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
147640366|NCT03005327|532501547|FG003|Initial Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
147640367|NCT04687072|532501548|FG000|Overall Study|Adverse Event|2|||
147640368|NCT04687072|532501549|FG001|Overall Study|Adverse Event|0|||
147640369|NCT04687072|532501548|FG000|Overall Study|Death|1|||
147640370|NCT04687072|532501549|FG001|Overall Study|Death|0|||
147640371|NCT04687072|532501548|FG000|Overall Study|Lack of Efficacy|2|||
147640372|NCT04687072|532501549|FG001|Overall Study|Lack of Efficacy|1|||
147640373|NCT04687072|532501548|FG000|Overall Study|Physician Decision|1|||
147640374|NCT04687072|532501549|FG001|Overall Study|Physician Decision|0|||
147640375|NCT04687072|532501548|FG000|Overall Study|Pregnancy|1|||
147640376|NCT04687072|532501549|FG001|Overall Study|Pregnancy|0|||
147640377|NCT04687072|532501548|FG000|Overall Study|Requires Prohibited Medication|2|||
147640378|NCT04687072|532501549|FG001|Overall Study|Requires Prohibited Medication|0|||
147640379|NCT04687072|532501548|FG000|Overall Study|Withdrawal of Consent|11|||
147640380|NCT04687072|532501549|FG001|Overall Study|Withdrawal of Consent|6|||
147640381|NCT04687072|532501548|FG000|Overall Study|Miscellaneous|4|||
147640382|NCT04687072|532501549|FG001|Overall Study|Miscellaneous|1|||
147640383|NCT01263782|532501550|FG000|Overall Study|Death|0|||
147640384|NCT01263782|532501551|FG001|Overall Study|Death|0|||
147640385|NCT01263782|532501552|FG002|Overall Study|Death|1|||
147640386|NCT01263782|532501553|FG003|Overall Study|Death|0|||
147640387|NCT01263782|532501550|FG000|Overall Study|Progressive disease|0|||
147640388|NCT01263782|532501551|FG001|Overall Study|Progressive disease|0|||
147640389|NCT01263782|532501552|FG002|Overall Study|Progressive disease|0|||
147640390|NCT01263782|532501553|FG003|Overall Study|Progressive disease|1|||
147640391|NCT01263782|532501550|FG000|Overall Study|Too early|0|||
147640392|NCT01263782|532501551|FG001|Overall Study|Too early|0|||
147640393|NCT01263782|532501552|FG002|Overall Study|Too early|1|||
147640394|NCT01263782|532501553|FG003|Overall Study|Too early|0|||
147640395|NCT01263782|532501550|FG000|Overall Study|Inevaluable|0|||
147640396|NCT01263782|532501551|FG001|Overall Study|Inevaluable|0|||
147640397|NCT01263782|532501552|FG002|Overall Study|Inevaluable|1|||
147640398|NCT01263782|532501553|FG003|Overall Study|Inevaluable|0|||
147640399|NCT00915876|532501554|FG000|Overall Study|Adverse Event|0|||
147640400|NCT00915876|532501555|FG001|Overall Study|Adverse Event|1|||
147640401|NCT04545567|532501557|FG000|Overall Study|tested positive for SARS-co-V2|1|||
147640402|NCT04545567|532501558|FG001|Overall Study|tested positive for SARS-co-V2|1|||
147640403|NCT04545567|532501557|FG000|Overall Study|Withdrawal by Subject|0|||
147640404|NCT04545567|532501558|FG001|Overall Study|Withdrawal by Subject|1|||
147640405|NCT02419612|532501562|FG000|Short-term Treatment Period|Adverse Event|1|||
147640406|NCT02419612|532501563|FG001|Short-term Treatment Period|Adverse Event|1|||
147640407|NCT02419612|532501562|FG000|Short-term Treatment Period|Death|0|||
147640408|NCT02419612|532501563|FG001|Short-term Treatment Period|Death|2|||
147640409|NCT02419612|532501562|FG000|Short-term Treatment Period|Lost to Follow-up|6|||
147640410|NCT02419612|532501563|FG001|Short-term Treatment Period|Lost to Follow-up|6|||
147640411|NCT02419612|532501562|FG000|Short-term Treatment Period|Withdrawal by Subject|9|||
147640412|NCT02419612|532501563|FG001|Short-term Treatment Period|Withdrawal by Subject|9|||
147640413|NCT02419612|532501562|FG000|Short-term Treatment Period|Subject Request To Discontinue Treatment|1|||
147640414|NCT02419612|532501563|FG001|Short-term Treatment Period|Subject Request To Discontinue Treatment|1|||
147640415|NCT02419612|532501562|FG000|Short-term Treatment Period|Non-compliance with Study Drug|0|||
147640416|NCT02419612|532501563|FG001|Short-term Treatment Period|Non-compliance with Study Drug|2|||
147640417|NCT02419612|532501562|FG000|Short-term Treatment Period|Worsening of liver function|0|||
147640418|NCT02419612|532501563|FG001|Short-term Treatment Period|Worsening of liver function|1|||
147640419|NCT02419612|532501562|FG000|Short-term Treatment Period|Subject moved out of state|0|||
147640420|NCT02419612|532501563|FG001|Short-term Treatment Period|Subject moved out of state|1|||
147640421|NCT02419612|532501562|FG000|Long-term Treatment Period|Non-compliance with Study Drug|1|||
147640422|NCT02419612|532501563|FG001|Long-term Treatment Period|Non-compliance with Study Drug|1|||
147640423|NCT02419612|532501562|FG000|Long-term Treatment Period|Lost to Follow-up|6|||
147640424|NCT02419612|532501563|FG001|Long-term Treatment Period|Lost to Follow-up|4|||
147640425|NCT02419612|532501562|FG000|Long-term Treatment Period|Lack of Efficacy|1|||
147640426|NCT02419612|532501563|FG001|Long-term Treatment Period|Lack of Efficacy|1|||
147640427|NCT02419612|532501562|FG000|Long-term Treatment Period|Death|0|||
147640428|NCT02419612|532501563|FG001|Long-term Treatment Period|Death|1|||
147640429|NCT02419612|532501562|FG000|Long-term Treatment Period|Adverse Event|0|||
147640430|NCT02419612|532501563|FG001|Long-term Treatment Period|Adverse Event|5|||
147518085|NCT00320190|532048152|FG001|First 12 Months|Completed but did not enter extension|3|||
147518086|NCT00320190|532048151|FG000|First 12 Months|Sponsor terminated study|2|||
147518087|NCT00320190|532048152|FG001|First 12 Months|Sponsor terminated study|2|||
147518088|NCT00320190|532048151|FG000|First 12 Months|Lost to Follow-up|0|||
147518089|NCT00320190|532048152|FG001|First 12 Months|Lost to Follow-up|1|||
147518090|NCT00320190|532048151|FG000|First 12 Months|Enrollment failure|0|||
147518091|NCT00320190|532048152|FG001|First 12 Months|Enrollment failure|1|||
147518092|NCT00320190|532048151|FG000|First 12 Months|Adverse event unrelated to study drug|1|||
147640431|NCT02419612|532501562|FG000|Long-term Treatment Period|Other|4|||
147640432|NCT02419612|532501563|FG001|Long-term Treatment Period|Other|4|||
147640433|NCT02419612|532501562|FG000|Long-term Treatment Period|Subject Decision|2|||
147640434|NCT02419612|532501563|FG001|Long-term Treatment Period|Subject Decision|4|||
147640435|NCT02419612|532501562|FG000|Long-term Treatment Period|Withdrawal by Subject|8|||
147640436|NCT02419612|532501563|FG001|Long-term Treatment Period|Withdrawal by Subject|2|||
147640437|NCT03626363|532501564|FG000|Overall Study|Protocol Violation|4|||
147640438|NCT03626363|532501565|FG001|Overall Study|Protocol Violation|0|||
147640439|NCT03626363|532501564|FG000|Overall Study|Lost to Follow-up|5|||
147640440|NCT03626363|532501565|FG001|Overall Study|Lost to Follow-up|7|||
147640441|NCT00533702|532501566|FG000|Overall Study|Withdrawal by Subject|3|||
147640442|NCT00533702|532501567|FG001|Overall Study|Withdrawal by Subject|1|||
147640443|NCT00533702|532501566|FG000|Overall Study|Found ineligible after randomization|2|||
147640444|NCT00533702|532501567|FG001|Overall Study|Found ineligible after randomization|1|||
147640445|NCT01095978|532501568|FG000|Overall Study|Did not take Klacid SR|2|||
147640446|NCT01095978|532501568|FG000|Overall Study|Adverse Event|1|||
147640447|NCT00960986|532501569|FG000|Period 1 (Screening and Washout)|Adverse Event|1|||
147640448|NCT00960986|532501570|FG001|Period 1 (Screening and Washout)|Adverse Event|2|||
147640449|NCT00960986|532501571|FG002|Period 1 (Screening and Washout)|Adverse Event|1|||
147640450|NCT00960986|532501572|FG003|Period 1 (Screening and Washout)|Adverse Event|1|||
147640451|NCT00960986|532501569|FG000|Period 1 (Screening and Washout)|Lost to Follow-up|0|||
147640452|NCT00960986|532501570|FG001|Period 1 (Screening and Washout)|Lost to Follow-up|0|||
147640453|NCT00960986|532501571|FG002|Period 1 (Screening and Washout)|Lost to Follow-up|2|||
147640454|NCT00960986|532501572|FG003|Period 1 (Screening and Washout)|Lost to Follow-up|1|||
147640455|NCT00960986|532501569|FG000|Period 1 (Screening and Washout)|Protocol Violation|1|||
147640456|NCT00960986|532501570|FG001|Period 1 (Screening and Washout)|Protocol Violation|0|||
147640457|NCT00960986|532501571|FG002|Period 1 (Screening and Washout)|Protocol Violation|0|||
147640458|NCT00960986|532501572|FG003|Period 1 (Screening and Washout)|Protocol Violation|0|||
147640459|NCT00960986|532501569|FG000|Period 1 (Screening and Washout)|Withdrawal by Subject|1|||
147640460|NCT00960986|532501570|FG001|Period 1 (Screening and Washout)|Withdrawal by Subject|2|||
147640461|NCT00960986|532501571|FG002|Period 1 (Screening and Washout)|Withdrawal by Subject|1|||
147640462|NCT00960986|532501572|FG003|Period 1 (Screening and Washout)|Withdrawal by Subject|1|||
147640463|NCT00960986|532501569|FG000|Period 3 (7-week Therapy Period)|Adverse Event|17|||
147640464|NCT00960986|532501570|FG001|Period 3 (7-week Therapy Period)|Adverse Event|15|||
147640465|NCT00960986|532501571|FG002|Period 3 (7-week Therapy Period)|Adverse Event|10|||
147640466|NCT00960986|532501572|FG003|Period 3 (7-week Therapy Period)|Adverse Event|12|||
147640467|NCT00960986|532501569|FG000|Period 3 (7-week Therapy Period)|Death|0|||
147640468|NCT00960986|532501570|FG001|Period 3 (7-week Therapy Period)|Death|0|||
147640469|NCT00960986|532501571|FG002|Period 3 (7-week Therapy Period)|Death|1|||
147640470|NCT00960986|532501572|FG003|Period 3 (7-week Therapy Period)|Death|0|||
147640471|NCT00960986|532501569|FG000|Period 3 (7-week Therapy Period)|Lost to Follow-up|0|||
147640472|NCT00960986|532501570|FG001|Period 3 (7-week Therapy Period)|Lost to Follow-up|0|||
147640473|NCT00960986|532501571|FG002|Period 3 (7-week Therapy Period)|Lost to Follow-up|1|||
147640474|NCT00960986|532501572|FG003|Period 3 (7-week Therapy Period)|Lost to Follow-up|0|||
147640475|NCT00960986|532501569|FG000|Period 3 (7-week Therapy Period)|Protocol Violation|10|||
147640476|NCT00960986|532501570|FG001|Period 3 (7-week Therapy Period)|Protocol Violation|4|||
147640477|NCT00960986|532501571|FG002|Period 3 (7-week Therapy Period)|Protocol Violation|3|||
147640478|NCT00960986|532501572|FG003|Period 3 (7-week Therapy Period)|Protocol Violation|11|||
147640479|NCT00960986|532501569|FG000|Period 3 (7-week Therapy Period)|Withdrawal by Subject|2|||
147640480|NCT00960986|532501570|FG001|Period 3 (7-week Therapy Period)|Withdrawal by Subject|2|||
147640481|NCT00960986|532501571|FG002|Period 3 (7-week Therapy Period)|Withdrawal by Subject|4|||
147640482|NCT00960986|532501572|FG003|Period 3 (7-week Therapy Period)|Withdrawal by Subject|2|||
147640483|NCT00960986|532501569|FG000|Period 3 (7-week Therapy Period)|Lack of Efficacy|1|||
147640484|NCT00960986|532501570|FG001|Period 3 (7-week Therapy Period)|Lack of Efficacy|2|||
147640485|NCT00960986|532501571|FG002|Period 3 (7-week Therapy Period)|Lack of Efficacy|1|||
147518093|NCT00320190|532048152|FG001|First 12 Months|Adverse event unrelated to study drug|0|||
147518094|NCT00320190|532048151|FG000|First 12 Months|Investigator request|0|||
147518095|NCT00320190|532048152|FG001|First 12 Months|Investigator request|1|||
147640486|NCT00960986|532501572|FG003|Period 3 (7-week Therapy Period)|Lack of Efficacy|0|||
147640487|NCT01984892|532501573|FG000|Overall Study|Progressive disease|7|||
147640488|NCT04464720|532501574|FG000|Pre-Intervention|Intervention (hood retrofit) beyond the scope available in the study, so participation ended.|1|||
147640489|NCT04413552|532501580|FG000|Overall Study|Adverse Event|0|||
147518096|NCT00320190|532048151|FG000|First 12 Months|Study drug toxicity|0|||
147518097|NCT00320190|532048152|FG001|First 12 Months|Study drug toxicity|1|||
147518098|NCT00320190|532048151|FG000|First 12 Months|Withdrawal by Subject|0|||
147518099|NCT00320190|532048152|FG001|First 12 Months|Withdrawal by Subject|1|||
147518100|NCT00320190|532048151|FG000|Long-term (12-month) Extension|Sponsor terminated study|7|||
147518101|NCT00320190|532048152|FG001|Long-term (12-month) Extension|Sponsor terminated study|0|||
147518102|NCT00320190|532048151|FG000|Long-term (12-month) Extension|Lack of major molecular response|1|||
147518103|NCT00320190|532048152|FG001|Long-term (12-month) Extension|Lack of major molecular response|2|||
147518104|NCT00320190|532048151|FG000|Long-term (12-month) Extension|Withdrawal by Subject|1|||
147518105|NCT00320190|532048152|FG001|Long-term (12-month) Extension|Withdrawal by Subject|0|||
147518106|NCT00102804|532048153|FG000|Overall Study|Progressive Disease (PD)|307|||
147518107|NCT00102804|532048154|FG001|Overall Study|Progressive Disease (PD)|196|||
147518108|NCT00102804|532048153|FG000|Overall Study|Withdrawal by Subject|46|||
147518109|NCT00102804|532048154|FG001|Overall Study|Withdrawal by Subject|7|||
147518110|NCT00102804|532048153|FG000|Overall Study|Adverse Event|37|||
147518111|NCT00102804|532048154|FG001|Overall Study|Adverse Event|3|||
147518112|NCT00102804|532048153|FG000|Overall Study|Physician Decision|24|||
147518113|NCT00102804|532048154|FG001|Overall Study|Physician Decision|6|||
147518114|NCT00102804|532048153|FG000|Overall Study|Death|5|||
147518115|NCT00102804|532048154|FG001|Overall Study|Death|6|||
147518116|NCT00102804|532048153|FG000|Overall Study|Enrollment Criteria Not Met|6|||
147518117|NCT00102804|532048154|FG001|Overall Study|Enrollment Criteria Not Met|0|||
147518118|NCT00102804|532048153|FG000|Overall Study|Lost to Follow-up|4|||
147518119|NCT00102804|532048154|FG001|Overall Study|Lost to Follow-up|1|||
147518120|NCT00102804|532048153|FG000|Overall Study|Protocol Violation|2|||
147518121|NCT00102804|532048154|FG001|Overall Study|Protocol Violation|1|||
147518122|NCT00102804|532048153|FG000|Overall Study|Satisfactory Response|2|||
147518123|NCT00102804|532048154|FG001|Overall Study|Satisfactory Response|0|||
147518124|NCT00102804|532048153|FG000|Overall Study|Sponsor Decision|1|||
147518125|NCT00102804|532048154|FG001|Overall Study|Sponsor Decision|0|||
147518126|NCT00102804|532048153|FG000|Overall Study|Alive, Receiving Treatment|7|||
147518127|NCT00102804|532048154|FG001|Overall Study|Alive, Receiving Treatment|2|||
147640490|NCT04413552|532501581|FG001|Overall Study|Adverse Event|0|||
147640491|NCT04413552|532501582|FG002|Overall Study|Adverse Event|0|||
147640492|NCT04413552|532501583|FG003|Overall Study|Adverse Event|0|||
147640493|NCT04413552|532501584|FG004|Overall Study|Adverse Event|0|||
147640494|NCT04413552|532501585|FG005|Overall Study|Adverse Event|0|||
147640495|NCT04413552|532501586|FG006|Overall Study|Adverse Event|1|||
147640496|NCT04413552|532501587|FG007|Overall Study|Adverse Event|0|||
147640497|NCT04413552|532501588|FG008|Overall Study|Adverse Event|0|||
147640498|NCT04413552|532501589|FG009|Overall Study|Adverse Event|0|||
147640499|NCT01794793|532501592|FG000|Treatment Period|Withdrawal by Subject|24|||
147640500|NCT01794793|532501592|FG000|Treatment Period|Lack of Efficacy|22|||
147640501|NCT01794793|532501592|FG000|Treatment Period|Adverse Event|17|||
147640502|NCT01794793|532501592|FG000|Treatment Period|Physician Decision|14|||
147640503|NCT01794793|532501592|FG000|Treatment Period|Lost to Follow-up|7|||
147640504|NCT01794793|532501592|FG000|Treatment Period|Death|6|||
147640505|NCT01794793|532501592|FG000|Treatment Period|Protocol Violation|5|||
147640506|NCT01794793|532501592|FG000|Treatment Period|administrative problem|3|||
147640507|NCT01794793|532501592|FG000|Post-treatment Follow-up|Lack of Efficacy|14|||
147640508|NCT01794793|532501592|FG000|Post-treatment Follow-up|Adverse Event|8|||
147640509|NCT01794793|532501592|FG000|Post-treatment Follow-up|Withdrawal by Subject|6|||
147640510|NCT01794793|532501592|FG000|Post-treatment Follow-up|administrative problem|5|||
147640511|NCT01794793|532501592|FG000|Post-treatment Follow-up|Lost to Follow-up|3|||
147640512|NCT01794793|532501592|FG000|Post-treatment Follow-up|Protocol Violation|3|||
147640513|NCT04852679|532501595|FG000|Main Intervention Period|Withdrawal by Subject|3|||
147640514|NCT04852679|532501595|FG000|Main Intervention Period|Adverse Event|1|||
147640515|NCT04852679|532501595|FG000|Main Intervention Period|Progressive Disease|16|||
147640516|NCT04852679|532501595|FG000|Main Intervention Period|Refused study visit|1|||
147640517|NCT04852679|532501595|FG000|Independent Injection Period|Missed study visit|1|||
147640518|NCT01294696|532501597|FG000|Overall Study|Screening failures|7|||
147640519|NCT01294696|532501597|FG000|Overall Study|Protocol Violation|8|||
147640520|NCT01294696|532501597|FG000|Overall Study|Missing BPI Response|7|||
147640521|NCT01294696|532501597|FG000|Overall Study|Site closure|52|||
147640522|NCT02417961|532503979|FG000|Overall Study|Adverse Event|1|||
147640523|NCT02417961|532503979|FG000|Overall Study|Lost to Follow-up|1|||
147640524|NCT02417961|532503979|FG000|Overall Study|Withdrawal by Subject|2|||
147640525|NCT05079750|532503980|FG000|Overall Study|Lost to Follow-up|0|||
147640526|NCT05079750|532503981|FG001|Overall Study|Lost to Follow-up|0|||
147640527|NCT05079750|532503982|FG002|Overall Study|Lost to Follow-up|1|||
147640528|NCT05091346|532503983|FG000|Overall Study|Survival follow-up ceased/discontinued by sponsor|0|||
147640529|NCT05091346|532503984|FG001|Overall Study|Survival follow-up ceased/discontinued by sponsor|0|||
147640530|NCT05091346|532503985|FG002|Overall Study|Survival follow-up ceased/discontinued by sponsor|7|||
147640531|NCT05091346|532503986|FG003|Overall Study|Survival follow-up ceased/discontinued by sponsor|10|||
147640532|NCT05091346|532503987|FG004|Overall Study|Survival follow-up ceased/discontinued by sponsor|4|||
147640533|NCT05091346|532503983|FG000|Overall Study|Death|6|||
147640534|NCT05091346|532503984|FG001|Overall Study|Death|5|||
147640535|NCT05091346|532503985|FG002|Overall Study|Death|8|||
147640536|NCT05091346|532503986|FG003|Overall Study|Death|16|||
147640537|NCT05091346|532503987|FG004|Overall Study|Death|26|||
147640538|NCT05091346|532503983|FG000|Overall Study|Lost to Follow-up|0|||
147640539|NCT05091346|532503984|FG001|Overall Study|Lost to Follow-up|0|||
147640540|NCT05091346|532503985|FG002|Overall Study|Lost to Follow-up|0|||
147640541|NCT05091346|532503986|FG003|Overall Study|Lost to Follow-up|1|||
147640542|NCT05091346|532503987|FG004|Overall Study|Lost to Follow-up|0|||
147640543|NCT05091346|532503983|FG000|Overall Study|Withdrawal by Subject|0|||
147640544|NCT05091346|532503984|FG001|Overall Study|Withdrawal by Subject|1|||
147640545|NCT05091346|532503985|FG002|Overall Study|Withdrawal by Subject|2|||
147640546|NCT05091346|532503986|FG003|Overall Study|Withdrawal by Subject|2|||
147518128|NCT02299206|532048161|FG000|Overall Study|Lost to Follow-up|1|||
147518129|NCT02299206|532048161|FG000|Overall Study|Withdrawal by Subject|1|||
147518130|NCT00691054|532048162|FG000|Overall Study|Withdrawal by Subject|1|||
147518131|NCT02141854|532048164|FG000|Run-In Period (Pre-assignment)|Inclusion criteria not met|25|||
147518132|NCT02141854|532048165|FG001|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
147518133|NCT02141854|532048166|FG002|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
147518134|NCT02141854|532048167|FG003|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
147518135|NCT02141854|532048168|FG004|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
147518136|NCT02141854|532048169|FG005|Run-In Period (Pre-assignment)|Inclusion criteria not met|0|||
147640547|NCT05091346|532503987|FG004|Overall Study|Withdrawal by Subject|1|||
147518137|NCT02141854|532048164|FG000|Run-In Period (Pre-assignment)|Randomization criteria not met|76|||
147640548|NCT00197002|532503988|FG000|Overall Study|Adverse Event|0|||
147640549|NCT00197002|532503989|FG001|Overall Study|Adverse Event|1|||
147640550|NCT00197002|532503990|FG002|Overall Study|Adverse Event|0|||
147640551|NCT00197002|532503988|FG000|Overall Study|Protocol Violation|1|||
147640552|NCT00197002|532503989|FG001|Overall Study|Protocol Violation|0|||
147640553|NCT00197002|532503990|FG002|Overall Study|Protocol Violation|2|||
147640554|NCT00197002|532503988|FG000|Overall Study|Withdrawal by Subject|9|||
147640555|NCT00197002|532503989|FG001|Overall Study|Withdrawal by Subject|5|||
147518138|NCT02141854|532048165|FG001|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
147518139|NCT02141854|532048166|FG002|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
147518140|NCT02141854|532048167|FG003|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
147518141|NCT02141854|532048168|FG004|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
147640556|NCT00197002|532503990|FG002|Overall Study|Withdrawal by Subject|7|||
147640557|NCT00197002|532503988|FG000|Overall Study|Migrated/moved from study area|3|||
147640558|NCT00197002|532503989|FG001|Overall Study|Migrated/moved from study area|5|||
147640559|NCT00197002|532503990|FG002|Overall Study|Migrated/moved from study area|1|||
147640560|NCT00197002|532503988|FG000|Overall Study|Lost to follow-up (incompl. vaccination)|4|||
147640561|NCT00197002|532503989|FG001|Overall Study|Lost to follow-up (incompl. vaccination)|4|||
147640562|NCT00197002|532503990|FG002|Overall Study|Lost to follow-up (incompl. vaccination)|5|||
147640563|NCT00197002|532503988|FG000|Overall Study|Lost to follow-up (compl. vaccination)|2|||
147640564|NCT00197002|532503989|FG001|Overall Study|Lost to follow-up (compl. vaccination)|2|||
147640565|NCT00197002|532503990|FG002|Overall Study|Lost to follow-up (compl. vaccination)|1|||
147640566|NCT00197002|532503988|FG000|Overall Study|Others|3|||
147640567|NCT00197002|532503989|FG001|Overall Study|Others|1|||
147640568|NCT00197002|532503990|FG002|Overall Study|Others|1|||
147640569|NCT03569293|532503993|FG000|Overall Study|Adverse Event|4|||
147640570|NCT03569293|532503994|FG001|Overall Study|Adverse Event|1|||
147640571|NCT03569293|532503995|FG002|Overall Study|Adverse Event|5|||
147640572|NCT03569293|532503996|FG003|Overall Study|Adverse Event|1|||
147640573|NCT03569293|532503997|FG004|Overall Study|Adverse Event|0|||
147640574|NCT03569293|532503998|FG005|Overall Study|Adverse Event|0|||
147640575|NCT03569293|532503993|FG000|Overall Study|Withdrawal by Subject|16|||
147640576|NCT03569293|532503994|FG001|Overall Study|Withdrawal by Subject|2|||
147640577|NCT03569293|532503995|FG002|Overall Study|Withdrawal by Subject|4|||
147640578|NCT03569293|532503996|FG003|Overall Study|Withdrawal by Subject|1|||
147640579|NCT03569293|532503997|FG004|Overall Study|Withdrawal by Subject|0|||
147640580|NCT03569293|532503998|FG005|Overall Study|Withdrawal by Subject|0|||
147640581|NCT03569293|532503993|FG000|Overall Study|Lost to Follow-up|1|||
147640582|NCT03569293|532503994|FG001|Overall Study|Lost to Follow-up|3|||
147640583|NCT03569293|532503995|FG002|Overall Study|Lost to Follow-up|1|||
147640584|NCT03569293|532503996|FG003|Overall Study|Lost to Follow-up|1|||
147640585|NCT03569293|532503997|FG004|Overall Study|Lost to Follow-up|0|||
147640586|NCT03569293|532503998|FG005|Overall Study|Lost to Follow-up|0|||
147640587|NCT03569293|532503993|FG000|Overall Study|Other|8|||
147640588|NCT03569293|532503994|FG001|Overall Study|Other|2|||
147640589|NCT03569293|532503995|FG002|Overall Study|Other|1|||
147640590|NCT03569293|532503996|FG003|Overall Study|Other|1|||
147640591|NCT03569293|532503997|FG004|Overall Study|Other|0|||
147640592|NCT03569293|532503998|FG005|Overall Study|Other|0|||
147640593|NCT03569293|532503993|FG000|Overall Study|Ongoing at Time of Analysis|8|||
147640594|NCT03569293|532503994|FG001|Overall Study|Ongoing at Time of Analysis|1|||
147640595|NCT03569293|532503995|FG002|Overall Study|Ongoing at Time of Analysis|3|||
147640596|NCT03569293|532503996|FG003|Overall Study|Ongoing at Time of Analysis|0|||
147640597|NCT03569293|532503997|FG004|Overall Study|Ongoing at Time of Analysis|0|||
147640598|NCT03569293|532503998|FG005|Overall Study|Ongoing at Time of Analysis|0|||
147640599|NCT04542499|532504011|FG000|Overall Study|Adverse Event|23|||
147640600|NCT04542499|532504012|FG001|Overall Study|Adverse Event|43|||
147640601|NCT04542499|532504011|FG000|Overall Study|Lack of Efficacy|5|||
147640602|NCT04542499|532504012|FG001|Overall Study|Lack of Efficacy|2|||
147518142|NCT02141854|532048169|FG005|Run-In Period (Pre-assignment)|Randomization criteria not met|0|||
147518143|NCT02141854|532048164|FG000|Run-In Period (Pre-assignment)|Exclusion criteria met|14|||
147518144|NCT02141854|532048165|FG001|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
147518145|NCT02141854|532048166|FG002|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
147518146|NCT02141854|532048167|FG003|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
147518147|NCT02141854|532048168|FG004|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
147518148|NCT02141854|532048169|FG005|Run-In Period (Pre-assignment)|Exclusion criteria met|0|||
147518149|NCT02141854|532048164|FG000|Run-In Period (Pre-assignment)|Other|14|||
147518150|NCT02141854|532048165|FG001|Run-In Period (Pre-assignment)|Other|0|||
147518151|NCT02141854|532048166|FG002|Run-In Period (Pre-assignment)|Other|0|||
147518152|NCT02141854|532048167|FG003|Run-In Period (Pre-assignment)|Other|0|||
147518153|NCT02141854|532048168|FG004|Run-In Period (Pre-assignment)|Other|0|||
147518154|NCT02141854|532048169|FG005|Run-In Period (Pre-assignment)|Other|0|||
147518155|NCT02141854|532048164|FG000|Run-In Period (Pre-assignment)|Adverse Event|10|||
147640603|NCT04542499|532504011|FG000|Overall Study|Lost to Follow-up|3|||
147640604|NCT04542499|532504012|FG001|Overall Study|Lost to Follow-up|4|||
147640605|NCT04542499|532504011|FG000|Overall Study|Failure to Meet Continuation Criteria|0|||
147640606|NCT04542499|532504012|FG001|Overall Study|Failure to Meet Continuation Criteria|1|||
147640607|NCT04542499|532504011|FG000|Overall Study|Treatment with Prohibited Concomitant Medications|1|||
147640608|NCT04542499|532504012|FG001|Overall Study|Treatment with Prohibited Concomitant Medications|0|||
147640609|NCT04542499|532504011|FG000|Overall Study|Non-Compliance with Study Drug|0|||
147640610|NCT04542499|532504012|FG001|Overall Study|Non-Compliance with Study Drug|2|||
147640611|NCT04542499|532504011|FG000|Overall Study|Physician Decision|0|||
147640612|NCT04542499|532504012|FG001|Overall Study|Physician Decision|1|||
147518156|NCT02141854|532048165|FG001|Run-In Period (Pre-assignment)|Adverse Event|0|||
147518157|NCT02141854|532048166|FG002|Run-In Period (Pre-assignment)|Adverse Event|0|||
147518158|NCT02141854|532048167|FG003|Run-In Period (Pre-assignment)|Adverse Event|0|||
147518159|NCT02141854|532048168|FG004|Run-In Period (Pre-assignment)|Adverse Event|0|||
147518160|NCT02141854|532048169|FG005|Run-In Period (Pre-assignment)|Adverse Event|0|||
147518161|NCT02141854|532048164|FG000|Run-In Period (Pre-assignment)|Withdrawal by Subject|9|||
147518162|NCT02141854|532048165|FG001|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
147518163|NCT02141854|532048166|FG002|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
147518164|NCT02141854|532048167|FG003|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
147518165|NCT02141854|532048168|FG004|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
147518166|NCT02141854|532048169|FG005|Run-In Period (Pre-assignment)|Withdrawal by Subject|0|||
147518167|NCT02141854|532048164|FG000|Run-In Period (Pre-assignment)|Lost to Follow-up|6|||
147518168|NCT02141854|532048165|FG001|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
147518169|NCT02141854|532048166|FG002|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
147518170|NCT02141854|532048167|FG003|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
147518171|NCT02141854|532048168|FG004|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
147518172|NCT02141854|532048169|FG005|Run-In Period (Pre-assignment)|Lost to Follow-up|0|||
147518173|NCT02141854|532048164|FG000|Treatment Period|Protocol Violation|0|||
147518174|NCT02141854|532048165|FG001|Treatment Period|Protocol Violation|1|||
147518175|NCT02141854|532048166|FG002|Treatment Period|Protocol Violation|0|||
147518176|NCT02141854|532048167|FG003|Treatment Period|Protocol Violation|2|||
147518177|NCT02141854|532048168|FG004|Treatment Period|Protocol Violation|2|||
147518178|NCT02141854|532048169|FG005|Treatment Period|Protocol Violation|1|||
147518179|NCT02141854|532048164|FG000|Treatment Period|Noncompliance|0|||
147518180|NCT02141854|532048165|FG001|Treatment Period|Noncompliance|0|||
147518181|NCT02141854|532048166|FG002|Treatment Period|Noncompliance|0|||
147518182|NCT02141854|532048167|FG003|Treatment Period|Noncompliance|1|||
147518183|NCT02141854|532048168|FG004|Treatment Period|Noncompliance|0|||
147518184|NCT02141854|532048169|FG005|Treatment Period|Noncompliance|0|||
147518185|NCT02141854|532048164|FG000|Treatment Period|Lack of Efficacy|0|||
147518186|NCT02141854|532048165|FG001|Treatment Period|Lack of Efficacy|0|||
147518187|NCT02141854|532048166|FG002|Treatment Period|Lack of Efficacy|0|||
147518188|NCT02141854|532048167|FG003|Treatment Period|Lack of Efficacy|1|||
147518189|NCT02141854|532048168|FG004|Treatment Period|Lack of Efficacy|1|||
147518190|NCT02141854|532048169|FG005|Treatment Period|Lack of Efficacy|7|||
147518191|NCT02141854|532048164|FG000|Treatment Period|Pregnancy|0|||
147518192|NCT02141854|532048165|FG001|Treatment Period|Pregnancy|1|||
147518193|NCT02141854|532048166|FG002|Treatment Period|Pregnancy|0|||
147518194|NCT02141854|532048167|FG003|Treatment Period|Pregnancy|0|||
147518195|NCT02141854|532048168|FG004|Treatment Period|Pregnancy|0|||
147518196|NCT02141854|532048169|FG005|Treatment Period|Pregnancy|0|||
147518197|NCT02141854|532048164|FG000|Treatment Period|Other|0|||
147518198|NCT02141854|532048165|FG001|Treatment Period|Other|1|||
147518199|NCT02141854|532048166|FG002|Treatment Period|Other|2|||
147518200|NCT02141854|532048167|FG003|Treatment Period|Other|0|||
147518201|NCT02141854|532048168|FG004|Treatment Period|Other|1|||
147518202|NCT02141854|532048169|FG005|Treatment Period|Other|2|||
147518203|NCT02141854|532048164|FG000|Treatment Period|Adverse Event|0|||
147518204|NCT02141854|532048165|FG001|Treatment Period|Adverse Event|2|||
147518205|NCT02141854|532048166|FG002|Treatment Period|Adverse Event|2|||
147518206|NCT02141854|532048167|FG003|Treatment Period|Adverse Event|0|||
147518207|NCT02141854|532048168|FG004|Treatment Period|Adverse Event|2|||
147518208|NCT02141854|532048169|FG005|Treatment Period|Adverse Event|2|||
147518209|NCT02141854|532048164|FG000|Treatment Period|Withdrawal by Subject|0|||
147518210|NCT02141854|532048165|FG001|Treatment Period|Withdrawal by Subject|2|||
147518211|NCT02141854|532048166|FG002|Treatment Period|Withdrawal by Subject|3|||
147518212|NCT02141854|532048167|FG003|Treatment Period|Withdrawal by Subject|3|||
147518213|NCT02141854|532048168|FG004|Treatment Period|Withdrawal by Subject|4|||
147518214|NCT02141854|532048169|FG005|Treatment Period|Withdrawal by Subject|7|||
147518215|NCT02141854|532048164|FG000|Treatment Period|Disease progression|0|||
147518216|NCT02141854|532048165|FG001|Treatment Period|Disease progression|2|||
147518217|NCT02141854|532048166|FG002|Treatment Period|Disease progression|1|||
147518218|NCT02141854|532048167|FG003|Treatment Period|Disease progression|3|||
147518219|NCT02141854|532048168|FG004|Treatment Period|Disease progression|0|||
147518220|NCT02141854|532048169|FG005|Treatment Period|Disease progression|18|||
147518221|NCT02141854|532048164|FG000|Treatment Period|Lost to Follow-up|0|||
147518222|NCT02141854|532048165|FG001|Treatment Period|Lost to Follow-up|1|||
147518223|NCT02141854|532048166|FG002|Treatment Period|Lost to Follow-up|1|||
147518224|NCT02141854|532048167|FG003|Treatment Period|Lost to Follow-up|1|||
147518225|NCT02141854|532048168|FG004|Treatment Period|Lost to Follow-up|0|||
147518226|NCT02141854|532048169|FG005|Treatment Period|Lost to Follow-up|1|||
147518227|NCT03128307|532048170|FG000|Overall Study|Lost to Follow-up|29|||
147518228|NCT03128307|532048170|FG000|Overall Study|Withdrawal by Subject|5|||
147518229|NCT00121485|532049780|FG000|Overall Study|Not implanted|1|||
147518230|NCT00121485|532049781|FG001|Overall Study|Not implanted|5|||
147518231|NCT00121485|532049780|FG000|Overall Study|Crossover|0|||
147640613|NCT04542499|532504011|FG000|Overall Study|Site Terminated by Sponsor|3|||
147640614|NCT04542499|532504012|FG001|Overall Study|Site Terminated by Sponsor|5|||
147640615|NCT04542499|532504011|FG000|Overall Study|Withdrawal by Subject|12|||
147640616|NCT04542499|532504012|FG001|Overall Study|Withdrawal by Subject|33|||
147640617|NCT04542499|532504011|FG000|Overall Study|Other|2|||
147640618|NCT04542499|532504012|FG001|Overall Study|Other|2|||
147640619|NCT04035434|532504018|FG000|Dose Escalation Phase (Up to 5 Years)|Withdrawal by Subject|0|||
147640620|NCT04035434|532504019|FG001|Dose Escalation Phase (Up to 5 Years)|Withdrawal by Subject|1|||
147640621|NCT04035434|532504020|FG002|Dose Escalation Phase (Up to 5 Years)|Withdrawal by Subject|0|||
147640622|NCT04035434|532504021|FG003|Dose Escalation Phase (Up to 5 Years)|Withdrawal by Subject|2|||
147640623|NCT04035434|532504022|FG004|Dose Escalation Phase (Up to 5 Years)|Withdrawal by Subject|1|||
147640624|NCT04035434|532504023|FG005|Dose Escalation Phase (Up to 5 Years)|Withdrawal by Subject|0|||
147640625|NCT04035434|532504024|FG006|Dose Escalation Phase (Up to 5 Years)|Withdrawal by Subject|0|||
147640626|NCT04035434|532504025|FG007|Dose Escalation Phase (Up to 5 Years)|Withdrawal by Subject|0|||
147640627|NCT04035434|532504026|FG008|Dose Escalation Phase (Up to 5 Years)|Withdrawal by Subject|0|||
147640628|NCT04035434|532504027|FG009|Dose Escalation Phase (Up to 5 Years)|Withdrawal by Subject|0|||
147640629|NCT04035434|532504028|FG010|Dose Escalation Phase (Up to 5 Years)|Withdrawal by Subject|1|||
147640630|NCT04035434|532504029|FG011|Dose Escalation Phase (Up to 5 Years)|Withdrawal by Subject|1|||
147640631|NCT04035434|532504030|FG012|Dose Escalation Phase (Up to 5 Years)|Withdrawal by Subject|0|||
147518232|NCT00121485|532049781|FG001|Overall Study|Crossover|2|||
147518233|NCT00908895|532049784|FG000|Overall Study|Lost to Follow-up|1|||
147518234|NCT00908895|532049785|FG001|Overall Study|Lost to Follow-up|3|||
147518235|NCT00908895|532049784|FG000|Overall Study|algodystrophy|2|||
147518236|NCT00908895|532049785|FG001|Overall Study|algodystrophy|2|||
147518237|NCT00908895|532049784|FG000|Overall Study|Adverse Event|1|||
147518238|NCT00908895|532049785|FG001|Overall Study|Adverse Event|1|||
147518239|NCT02710422|532049786|FG000|Overall Study|Termination of study|9|||
147518240|NCT02710422|532049787|FG001|Overall Study|Termination of study|9|||
147518241|NCT02608099|532049788|FG000|Overall Study|Ablation procedure not initiated|3|||
147518242|NCT02608099|532049789|FG001|Overall Study|Ablation procedure not initiated|2|||
147518243|NCT01654224|532049793|FG000|Overall Study|Lost to Follow-up|2|||
147640632|NCT04035434|532504018|FG000|Dose Escalation Phase (Up to 5 Years)|Death|3|||
147518244|NCT01654224|532049794|FG001|Overall Study|Lost to Follow-up|2|||
147518245|NCT01654224|532049793|FG000|Overall Study|Did not receive allocation|1|||
147518246|NCT01654224|532049794|FG001|Overall Study|Did not receive allocation|8|||
147518247|NCT01654224|532049793|FG000|Overall Study|Insufficient blood sample|3|||
147518248|NCT01654224|532049794|FG001|Overall Study|Insufficient blood sample|2|||
147518249|NCT03763942|532049795|FG000|Overall Study|Lost to Follow-up|114|||
147518250|NCT03763942|532049796|FG001|Overall Study|Lost to Follow-up|54|||
147518251|NCT03763942|532049795|FG000|Overall Study|Protocol Violation|1|||
147518252|NCT03763942|532049796|FG001|Overall Study|Protocol Violation|0|||
147518253|NCT03763942|532049795|FG000|Overall Study|Withdrawal by Subject|2|||
147518254|NCT03763942|532049796|FG001|Overall Study|Withdrawal by Subject|0|||
147640633|NCT04035434|532504019|FG001|Dose Escalation Phase (Up to 5 Years)|Death|1|||
147640634|NCT04035434|532504020|FG002|Dose Escalation Phase (Up to 5 Years)|Death|4|||
147640635|NCT04035434|532504021|FG003|Dose Escalation Phase (Up to 5 Years)|Death|3|||
147640636|NCT04035434|532504022|FG004|Dose Escalation Phase (Up to 5 Years)|Death|8|||
147640637|NCT04035434|532504023|FG005|Dose Escalation Phase (Up to 5 Years)|Death|3|||
147640638|NCT04035434|532504024|FG006|Dose Escalation Phase (Up to 5 Years)|Death|0|||
147640639|NCT04035434|532504025|FG007|Dose Escalation Phase (Up to 5 Years)|Death|1|||
147640640|NCT04035434|532504026|FG008|Dose Escalation Phase (Up to 5 Years)|Death|3|||
147640641|NCT04035434|532504027|FG009|Dose Escalation Phase (Up to 5 Years)|Death|4|||
147640642|NCT04035434|532504028|FG010|Dose Escalation Phase (Up to 5 Years)|Death|3|||
147640643|NCT04035434|532504029|FG011|Dose Escalation Phase (Up to 5 Years)|Death|2|||
147640644|NCT04035434|532504030|FG012|Dose Escalation Phase (Up to 5 Years)|Death|1|||
147640645|NCT04035434|532504018|FG000|Dose Escalation Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
147640646|NCT04035434|532504019|FG001|Dose Escalation Phase (Up to 5 Years)|Study terminated by the Sponsor|1|||
147640647|NCT04035434|532504020|FG002|Dose Escalation Phase (Up to 5 Years)|Study terminated by the Sponsor|2|||
147640648|NCT04035434|532504021|FG003|Dose Escalation Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
147640649|NCT04035434|532504022|FG004|Dose Escalation Phase (Up to 5 Years)|Study terminated by the Sponsor|1|||
147640650|NCT04035434|532504023|FG005|Dose Escalation Phase (Up to 5 Years)|Study terminated by the Sponsor|1|||
147640651|NCT04035434|532504024|FG006|Dose Escalation Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
147640652|NCT04035434|532504025|FG007|Dose Escalation Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
147640653|NCT04035434|532504026|FG008|Dose Escalation Phase (Up to 5 Years)|Study terminated by the Sponsor|2|||
147640654|NCT04035434|532504027|FG009|Dose Escalation Phase (Up to 5 Years)|Study terminated by the Sponsor|1|||
147640655|NCT04035434|532504028|FG010|Dose Escalation Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
147640656|NCT04035434|532504029|FG011|Dose Escalation Phase (Up to 5 Years)|Study terminated by the Sponsor|2|||
147640657|NCT04035434|532504030|FG012|Dose Escalation Phase (Up to 5 Years)|Study terminated by the Sponsor|6|||
147640658|NCT04035434|532504018|FG000|Dose Escalation Phase (Up to 5 Years)|Lost to Follow-up|0|||
147640659|NCT04035434|532504019|FG001|Dose Escalation Phase (Up to 5 Years)|Lost to Follow-up|0|||
147640660|NCT04035434|532504020|FG002|Dose Escalation Phase (Up to 5 Years)|Lost to Follow-up|0|||
147640661|NCT04035434|532504021|FG003|Dose Escalation Phase (Up to 5 Years)|Lost to Follow-up|1|||
147640662|NCT04035434|532504022|FG004|Dose Escalation Phase (Up to 5 Years)|Lost to Follow-up|0|||
147640663|NCT04035434|532504023|FG005|Dose Escalation Phase (Up to 5 Years)|Lost to Follow-up|0|||
147640664|NCT04035434|532504024|FG006|Dose Escalation Phase (Up to 5 Years)|Lost to Follow-up|0|||
147640665|NCT04035434|532504025|FG007|Dose Escalation Phase (Up to 5 Years)|Lost to Follow-up|0|||
147640666|NCT04035434|532504026|FG008|Dose Escalation Phase (Up to 5 Years)|Lost to Follow-up|0|||
147640667|NCT04035434|532504027|FG009|Dose Escalation Phase (Up to 5 Years)|Lost to Follow-up|0|||
147640668|NCT04035434|532504028|FG010|Dose Escalation Phase (Up to 5 Years)|Lost to Follow-up|0|||
147640669|NCT04035434|532504029|FG011|Dose Escalation Phase (Up to 5 Years)|Lost to Follow-up|0|||
147640670|NCT04035434|532504030|FG012|Dose Escalation Phase (Up to 5 Years)|Lost to Follow-up|0|||
147640671|NCT04035434|532504018|FG000|Dose Expansion Phase (Up to 5 Years)|Death|0|||
147640672|NCT04035434|532504019|FG001|Dose Expansion Phase (Up to 5 Years)|Death|0|||
147640673|NCT04035434|532504020|FG002|Dose Expansion Phase (Up to 5 Years)|Death|0|||
147640674|NCT04035434|532504021|FG003|Dose Expansion Phase (Up to 5 Years)|Death|0|||
147640675|NCT04035434|532504022|FG004|Dose Expansion Phase (Up to 5 Years)|Death|0|||
147640676|NCT04035434|532504023|FG005|Dose Expansion Phase (Up to 5 Years)|Death|14|||
147640677|NCT04035434|532504024|FG006|Dose Expansion Phase (Up to 5 Years)|Death|3|||
147640678|NCT04035434|532504025|FG007|Dose Expansion Phase (Up to 5 Years)|Death|0|||
147640679|NCT04035434|532504026|FG008|Dose Expansion Phase (Up to 5 Years)|Death|0|||
147640680|NCT04035434|532504027|FG009|Dose Expansion Phase (Up to 5 Years)|Death|0|||
147640681|NCT04035434|532504028|FG010|Dose Expansion Phase (Up to 5 Years)|Death|0|||
147640682|NCT04035434|532504029|FG011|Dose Expansion Phase (Up to 5 Years)|Death|0|||
147640683|NCT04035434|532504030|FG012|Dose Expansion Phase (Up to 5 Years)|Death|0|||
147640684|NCT04035434|532504018|FG000|Dose Expansion Phase (Up to 5 Years)|Withdrawal by Subject|0|||
147640685|NCT04035434|532504019|FG001|Dose Expansion Phase (Up to 5 Years)|Withdrawal by Subject|0|||
147640686|NCT04035434|532504020|FG002|Dose Expansion Phase (Up to 5 Years)|Withdrawal by Subject|0|||
147640687|NCT04035434|532504021|FG003|Dose Expansion Phase (Up to 5 Years)|Withdrawal by Subject|0|||
147518255|NCT03763942|532049795|FG000|Overall Study|Other|2|||
147518256|NCT03763942|532049796|FG001|Overall Study|Other|3|||
147640688|NCT04035434|532504022|FG004|Dose Expansion Phase (Up to 5 Years)|Withdrawal by Subject|0|||
147518257|NCT02145429|532049797|FG000|Overall Study|Death|4|||
147518258|NCT02145429|532049798|FG001|Overall Study|Death|5|||
147518259|NCT02145429|532049797|FG000|Overall Study|Lost to Follow-up|4|||
147518260|NCT02145429|532049798|FG001|Overall Study|Lost to Follow-up|3|||
147518261|NCT02145429|532049797|FG000|Overall Study|Withdrawal by Subject|8|||
147640689|NCT04035434|532504023|FG005|Dose Expansion Phase (Up to 5 Years)|Withdrawal by Subject|1|||
147640690|NCT04035434|532504024|FG006|Dose Expansion Phase (Up to 5 Years)|Withdrawal by Subject|1|||
147640691|NCT04035434|532504025|FG007|Dose Expansion Phase (Up to 5 Years)|Withdrawal by Subject|0|||
147640692|NCT04035434|532504026|FG008|Dose Expansion Phase (Up to 5 Years)|Withdrawal by Subject|0|||
147640693|NCT04035434|532504027|FG009|Dose Expansion Phase (Up to 5 Years)|Withdrawal by Subject|0|||
147640694|NCT04035434|532504028|FG010|Dose Expansion Phase (Up to 5 Years)|Withdrawal by Subject|0|||
147640695|NCT04035434|532504029|FG011|Dose Expansion Phase (Up to 5 Years)|Withdrawal by Subject|0|||
147640696|NCT04035434|532504030|FG012|Dose Expansion Phase (Up to 5 Years)|Withdrawal by Subject|0|||
147640697|NCT04035434|532504018|FG000|Dose Expansion Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
147640698|NCT04035434|532504019|FG001|Dose Expansion Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
147640699|NCT04035434|532504020|FG002|Dose Expansion Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
147640700|NCT04035434|532504021|FG003|Dose Expansion Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
147640701|NCT04035434|532504022|FG004|Dose Expansion Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
147640702|NCT04035434|532504023|FG005|Dose Expansion Phase (Up to 5 Years)|Study terminated by the Sponsor|8|||
147640703|NCT04035434|532504024|FG006|Dose Expansion Phase (Up to 5 Years)|Study terminated by the Sponsor|4|||
147640704|NCT04035434|532504025|FG007|Dose Expansion Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
147640705|NCT04035434|532504026|FG008|Dose Expansion Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
147640706|NCT04035434|532504027|FG009|Dose Expansion Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
147640707|NCT04035434|532504028|FG010|Dose Expansion Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
147640708|NCT04035434|532504029|FG011|Dose Expansion Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
147640709|NCT04035434|532504030|FG012|Dose Expansion Phase (Up to 5 Years)|Study terminated by the Sponsor|0|||
147640710|NCT04488497|532504031|FG000|Randomization/Baseline Assessment|Lost to Follow-up|2|||
147640711|NCT04488497|532504032|FG001|Randomization/Baseline Assessment|Lost to Follow-up|3|||
147640712|NCT04488497|532504031|FG000|Intervention|Physician Decision|2|||
147640713|NCT04488497|532504032|FG001|Intervention|Physician Decision|1|||
147640714|NCT04488497|532504031|FG000|Intervention|Withdrawal by Subject|5|||
147640715|NCT04488497|532504032|FG001|Intervention|Withdrawal by Subject|6|||
147640716|NCT04488497|532504031|FG000|Intervention|Lost to Follow-up|2|||
147640717|NCT04488497|532504032|FG001|Intervention|Lost to Follow-up|0|||
147640718|NCT04488497|532504031|FG000|1-Week Post-Intervention Data Collection|Lost to Follow-up|0|||
147640719|NCT04488497|532504032|FG001|1-Week Post-Intervention Data Collection|Lost to Follow-up|2|||
147640720|NCT04488497|532504031|FG000|3-Months Post-Intervention|Lost to Follow-up|0|||
147640721|NCT04488497|532504032|FG001|3-Months Post-Intervention|Lost to Follow-up|2|||
147640722|NCT02659514|532504044|FG000|Overall Study|Adverse Event|3|||
147640723|NCT02659514|532504045|FG001|Overall Study|Adverse Event|12|||
147640724|NCT02659514|532504044|FG000|Overall Study|Disease Progression|23|||
147640725|NCT02659514|532504045|FG001|Overall Study|Disease Progression|13|||
147640726|NCT02659514|532504044|FG000|Overall Study|Withdrawal by Subject|0|||
147640727|NCT02659514|532504045|FG001|Overall Study|Withdrawal by Subject|4|||
147640728|NCT02659514|532504044|FG000|Overall Study|Lost to Follow-up|0|||
147640729|NCT02659514|532504045|FG001|Overall Study|Lost to Follow-up|1|||
147640730|NCT02659514|532504044|FG000|Overall Study|Death|6|||
147640731|NCT02659514|532504045|FG001|Overall Study|Death|1|||
147640732|NCT02659514|532504044|FG000|Overall Study|Reason Unspecified|0|||
147640733|NCT02659514|532504045|FG001|Overall Study|Reason Unspecified|3|||
147640734|NCT00348790|532504048|FG000|Completed Treatment|Withdrawal by Subject|4|||
147640735|NCT00348790|532504048|FG000|Completed Treatment|Disease progression|14|||
147640736|NCT00348790|532504048|FG000|Completed Treatment|Adverse Event|4|||
147640737|NCT00348790|532504048|FG000|Completed Treatment|Required surgery|2|||
147640738|NCT00348790|532504048|FG000|Completed Treatment|Unable to travel to study site|1|||
147640739|NCT04186806|532504049|FG000|Period 1: 7 Days|Adverse Event|1|||
147640740|NCT04186806|532504050|FG001|Period 1: 7 Days|Adverse Event|0|||
147640741|NCT03687372|532504051|FG000|Overall Study|Lost to Follow-up|12|||
147640742|NCT03687372|532504052|FG001|Overall Study|Lost to Follow-up|21|||
147640743|NCT03687372|532504051|FG000|Overall Study|Withdrawal by Subject|4|||
147640744|NCT03687372|532504052|FG001|Overall Study|Withdrawal by Subject|17|||
147640745|NCT03687372|532504051|FG000|Overall Study|Investigator Decision|1|||
147640746|NCT03687372|532504052|FG001|Overall Study|Investigator Decision|1|||
147640747|NCT03602391|532504055|FG000|Overall Study|COVID-19|7|||
147640748|NCT03602391|532504056|FG001|Overall Study|COVID-19|6|||
147640749|NCT00878969|532504059|FG000|Overall Study|Physician Decision|5|||
147640750|NCT00878969|532504060|FG001|Overall Study|Physician Decision|3|||
147640751|NCT00878969|532504061|FG002|Overall Study|Physician Decision|2|||
147518262|NCT02145429|532049798|FG001|Overall Study|Withdrawal by Subject|3|||
147640752|NCT00878969|532504059|FG000|Overall Study|Withdrawal by Subject|1|||
147640753|NCT00878969|532504060|FG001|Overall Study|Withdrawal by Subject|6|||
147518263|NCT02200510|532049799|FG000|Overall Study|Death|1|||
147518264|NCT02200510|532049800|FG001|Overall Study|Death|1|||
147518265|NCT02200510|532049799|FG000|Overall Study|Protocol Violation|0|||
147518266|NCT02200510|532049800|FG001|Overall Study|Protocol Violation|1|||
147518267|NCT02200510|532049799|FG000|Overall Study|Lost to Follow-up|7|||
147518268|NCT02200510|532049800|FG001|Overall Study|Lost to Follow-up|1|||
147518269|NCT02200510|532049799|FG000|Overall Study|potential COI - joined study team|1|||
147518270|NCT02200510|532049800|FG001|Overall Study|potential COI - joined study team|0|||
147518271|NCT03662789|532049801|FG000|Overall Study|Lost to Follow-up|1|||
147518272|NCT03662789|532049802|FG001|Overall Study|Lost to Follow-up|2|||
147518273|NCT03662789|532049801|FG000|Overall Study|Could not perform treadmill test|4|||
147518274|NCT03662789|532049802|FG001|Overall Study|Could not perform treadmill test|4|||
147518275|NCT03662789|532049801|FG000|Overall Study|Death|0|||
147518276|NCT03662789|532049802|FG001|Overall Study|Death|1|||
147518277|NCT03598140|532049803|FG000|Overall Study|enrolled but didn't start|1|||
147518278|NCT03598140|532049804|FG001|Overall Study|enrolled but didn't start|0|||
147518279|NCT05304611|532049805|FG000|Pediatric Efficacy Study|Lost to Follow-up|0|||
147518280|NCT05304611|532049806|FG001|Pediatric Efficacy Study|Lost to Follow-up|0|||
147518281|NCT05304611|532049807|FG002|Pediatric Efficacy Study|Lost to Follow-up|0|||
147518282|NCT05304611|532049808|FG003|Pediatric Efficacy Study|Lost to Follow-up|0|||
147518283|NCT05304611|532049809|FG004|Pediatric Efficacy Study|Lost to Follow-up|0|||
147518284|NCT05304611|532049810|FG005|Pediatric Efficacy Study|Lost to Follow-up|0|||
147518285|NCT05304611|532049811|FG006|Pediatric Efficacy Study|Lost to Follow-up|1|||
147518286|NCT05304611|532049812|FG007|Pediatric Efficacy Study|Lost to Follow-up|0|||
147518287|NCT05304611|532049813|FG008|Pediatric Efficacy Study|Lost to Follow-up|1|||
147518288|NCT05304611|532049814|FG009|Pediatric Efficacy Study|Lost to Follow-up|0|||
147518289|NCT05304611|532049815|FG010|Pediatric Efficacy Study|Lost to Follow-up|0|||
147518290|NCT05304611|532049816|FG011|Pediatric Efficacy Study|Lost to Follow-up|0|||
147518291|NCT05304611|532049805|FG000|Pediatric Efficacy Study|Withdrew consent|0|||
147518292|NCT05304611|532049806|FG001|Pediatric Efficacy Study|Withdrew consent|0|||
147518293|NCT05304611|532049807|FG002|Pediatric Efficacy Study|Withdrew consent|0|||
147518294|NCT05304611|532049808|FG003|Pediatric Efficacy Study|Withdrew consent|0|||
147518295|NCT05304611|532049809|FG004|Pediatric Efficacy Study|Withdrew consent|0|||
147518296|NCT05304611|532049810|FG005|Pediatric Efficacy Study|Withdrew consent|0|||
147518297|NCT05304611|532049811|FG006|Pediatric Efficacy Study|Withdrew consent|1|||
147518298|NCT05304611|532049812|FG007|Pediatric Efficacy Study|Withdrew consent|1|||
147518299|NCT05304611|532049813|FG008|Pediatric Efficacy Study|Withdrew consent|2|||
147518300|NCT05304611|532049814|FG009|Pediatric Efficacy Study|Withdrew consent|0|||
147518301|NCT05304611|532049815|FG010|Pediatric Efficacy Study|Withdrew consent|0|||
147518302|NCT05304611|532049816|FG011|Pediatric Efficacy Study|Withdrew consent|0|||
147518303|NCT05304611|532049805|FG000|Pediatric Extension Study|Withdrawal by Subject|0|||
147518304|NCT05304611|532049806|FG001|Pediatric Extension Study|Withdrawal by Subject|0|||
147518305|NCT05304611|532049807|FG002|Pediatric Extension Study|Withdrawal by Subject|0|||
147518306|NCT05304611|532049808|FG003|Pediatric Extension Study|Withdrawal by Subject|0|||
147518307|NCT05304611|532049809|FG004|Pediatric Extension Study|Withdrawal by Subject|0|||
147518308|NCT05304611|532049810|FG005|Pediatric Extension Study|Withdrawal by Subject|0|||
147518309|NCT05304611|532049811|FG006|Pediatric Extension Study|Withdrawal by Subject|0|||
147518310|NCT05304611|532049812|FG007|Pediatric Extension Study|Withdrawal by Subject|0|||
147518311|NCT05304611|532049813|FG008|Pediatric Extension Study|Withdrawal by Subject|0|||
147518312|NCT05304611|532049814|FG009|Pediatric Extension Study|Withdrawal by Subject|0|||
147518313|NCT05304611|532049815|FG010|Pediatric Extension Study|Withdrawal by Subject|1|||
147518314|NCT05304611|532049816|FG011|Pediatric Extension Study|Withdrawal by Subject|2|||
147518315|NCT00963820|532049821|FG000|Dose Escalation Phase|Progressive Disease|3|||
147518316|NCT00963820|532049822|FG001|Dose Escalation Phase|Progressive Disease|3|||
147518317|NCT00963820|532049823|FG002|Dose Escalation Phase|Progressive Disease|3|||
147518318|NCT00963820|532049824|FG003|Dose Escalation Phase|Progressive Disease|3|||
147518319|NCT00963820|532049825|FG004|Dose Escalation Phase|Progressive Disease|4|||
147518320|NCT00963820|532049826|FG005|Dose Escalation Phase|Progressive Disease|3|||
147518321|NCT00963820|532049827|FG006|Dose Escalation Phase|Progressive Disease|3|||
147518322|NCT00963820|532049828|FG007|Dose Escalation Phase|Progressive Disease|2|||
147518323|NCT00963820|532049829|FG008|Dose Escalation Phase|Progressive Disease|0|||
147518324|NCT00963820|532049830|FG009|Dose Escalation Phase|Progressive Disease|0|||
147518325|NCT00963820|532049831|FG010|Dose Escalation Phase|Progressive Disease|0|||
147518326|NCT00963820|532049832|FG011|Dose Escalation Phase|Progressive Disease|0|||
147518327|NCT00963820|532049821|FG000|Dose Escalation Phase|Adverse Event|0|||
147518328|NCT00963820|532049822|FG001|Dose Escalation Phase|Adverse Event|0|||
147518329|NCT00963820|532049823|FG002|Dose Escalation Phase|Adverse Event|0|||
147518330|NCT00963820|532049824|FG003|Dose Escalation Phase|Adverse Event|0|||
147518331|NCT00963820|532049825|FG004|Dose Escalation Phase|Adverse Event|0|||
147518332|NCT00963820|532049826|FG005|Dose Escalation Phase|Adverse Event|0|||
147518333|NCT00963820|532049827|FG006|Dose Escalation Phase|Adverse Event|3|||
147518334|NCT00963820|532049828|FG007|Dose Escalation Phase|Adverse Event|1|||
147518335|NCT00963820|532049829|FG008|Dose Escalation Phase|Adverse Event|0|||
147518336|NCT00963820|532049830|FG009|Dose Escalation Phase|Adverse Event|0|||
147518337|NCT00963820|532049831|FG010|Dose Escalation Phase|Adverse Event|0|||
147518338|NCT00963820|532049832|FG011|Dose Escalation Phase|Adverse Event|0|||
147518339|NCT00963820|532049821|FG000|Dose Escalation Phase|Withdrawal by Subject|0|||
147518340|NCT00963820|532049822|FG001|Dose Escalation Phase|Withdrawal by Subject|0|||
147518341|NCT00963820|532049823|FG002|Dose Escalation Phase|Withdrawal by Subject|0|||
147518342|NCT00963820|532049824|FG003|Dose Escalation Phase|Withdrawal by Subject|0|||
147518343|NCT00963820|532049825|FG004|Dose Escalation Phase|Withdrawal by Subject|0|||
147518344|NCT00963820|532049826|FG005|Dose Escalation Phase|Withdrawal by Subject|0|||
147518345|NCT00963820|532049827|FG006|Dose Escalation Phase|Withdrawal by Subject|1|||
147518346|NCT00963820|532049828|FG007|Dose Escalation Phase|Withdrawal by Subject|2|||
147518347|NCT00963820|532049829|FG008|Dose Escalation Phase|Withdrawal by Subject|0|||
147518348|NCT00963820|532049830|FG009|Dose Escalation Phase|Withdrawal by Subject|0|||
147518349|NCT00963820|532049831|FG010|Dose Escalation Phase|Withdrawal by Subject|0|||
147518350|NCT00963820|532049832|FG011|Dose Escalation Phase|Withdrawal by Subject|0|||
147518351|NCT00963820|532049821|FG000|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
147518352|NCT00963820|532049822|FG001|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
147518353|NCT00963820|532049823|FG002|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
147518354|NCT00963820|532049824|FG003|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
147518355|NCT00963820|532049825|FG004|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
147640754|NCT00878969|532504061|FG002|Overall Study|Withdrawal by Subject|3|||
147640755|NCT00878969|532504059|FG000|Overall Study|kidney transplant|2|||
147640756|NCT00878969|532504060|FG001|Overall Study|kidney transplant|3|||
147640757|NCT00878969|532504061|FG002|Overall Study|kidney transplant|2|||
147640758|NCT00878969|532504059|FG000|Overall Study|Adverse Event|3|||
147640759|NCT00878969|532504060|FG001|Overall Study|Adverse Event|1|||
147640760|NCT00878969|532504061|FG002|Overall Study|Adverse Event|2|||
147640761|NCT00878969|532504059|FG000|Overall Study|Lost to Follow-up|2|||
147640762|NCT00878969|532504060|FG001|Overall Study|Lost to Follow-up|1|||
147640763|NCT00878969|532504061|FG002|Overall Study|Lost to Follow-up|0|||
147640764|NCT00878969|532504059|FG000|Overall Study|Protocol Violation|2|||
147640765|NCT00878969|532504060|FG001|Overall Study|Protocol Violation|0|||
147640766|NCT00878969|532504061|FG002|Overall Study|Protocol Violation|0|||
147640767|NCT00878969|532504059|FG000|Overall Study|Death|0|||
147640768|NCT00878969|532504060|FG001|Overall Study|Death|0|||
147640769|NCT00878969|532504061|FG002|Overall Study|Death|2|||
147640770|NCT00878969|532504059|FG000|Overall Study|Pregnancy|0|||
147640771|NCT00878969|532504060|FG001|Overall Study|Pregnancy|1|||
147640772|NCT00878969|532504061|FG002|Overall Study|Pregnancy|0|||
147640773|NCT00655733|532504062|FG000|Overall Study|Lost to Follow-up|2|||
147640774|NCT00655733|532504063|FG001|Overall Study|Lost to Follow-up|2|||
147640775|NCT00655733|532504062|FG000|Overall Study|Adverse Event|2|||
147640776|NCT00655733|532504063|FG001|Overall Study|Adverse Event|2|||
147640777|NCT00655733|532504062|FG000|Overall Study|Withdrawal by Subject|3|||
147640778|NCT00655733|532504063|FG001|Overall Study|Withdrawal by Subject|3|||
147640779|NCT00655733|532504062|FG000|Overall Study|Physician Decision|0|||
147640780|NCT00655733|532504063|FG001|Overall Study|Physician Decision|1|||
147640781|NCT02035748|532504064|FG000|Overall Study|Adverse Event|5|||
147640782|NCT02035748|532504064|FG000|Overall Study|Death|3|||
147640783|NCT02035748|532504064|FG000|Overall Study|Lost to Follow-up|2|||
147640784|NCT02035748|532504064|FG000|Overall Study|Physician Decision|3|||
147640785|NCT02035748|532504064|FG000|Overall Study|Withdrawal by Subject|6|||
147640786|NCT02035748|532504064|FG000|Overall Study|Progressive Disease|1|||
147640787|NCT01088243|532504066|FG000|Overall Study|Adverse Event|1|||
147640788|NCT01088243|532504067|FG001|Overall Study|Adverse Event|0|||
147640789|NCT02370667|532504077|FG000|Overall Study|Lost to Follow-up|0|||
147640790|NCT02370667|532504078|FG001|Overall Study|Lost to Follow-up|1|||
147640791|NCT02370667|532504079|FG002|Overall Study|Lost to Follow-up|0|||
147640792|NCT00705718|532504080|FG000|Overall Study|Death|6|||
147640793|NCT00705718|532504081|FG001|Overall Study|Death|6|||
147640794|NCT00705718|532504080|FG000|Overall Study|Not due for Visit|0|||
147640795|NCT00705718|532504081|FG001|Overall Study|Not due for Visit|12|||
147640796|NCT00705718|532504080|FG000|Overall Study|Follow up not done|1|||
147640797|NCT00705718|532504081|FG001|Overall Study|Follow up not done|4|||
147640798|NCT02954653|532504082|FG000|Overall Study|Death|3|||
147640799|NCT02954653|532504083|FG001|Overall Study|Death|1|||
147640800|NCT02954653|532504084|FG002|Overall Study|Death|0|||
147640801|NCT02954653|532504085|FG003|Overall Study|Death|0|||
147640802|NCT02954653|532504086|FG004|Overall Study|Death|0|||
147640803|NCT02954653|532504087|FG005|Overall Study|Death|0|||
147640804|NCT02954653|532504088|FG006|Overall Study|Death|0|||
147640805|NCT02954653|532504089|FG007|Overall Study|Death|0|||
147640806|NCT02954653|532504090|FG008|Overall Study|Death|0|||
147640807|NCT02954653|532504082|FG000|Overall Study|Randomized but did not receive treatment|1|||
147640808|NCT02954653|532504083|FG001|Overall Study|Randomized but did not receive treatment|0|||
147640809|NCT02954653|532504084|FG002|Overall Study|Randomized but did not receive treatment|0|||
147640810|NCT02954653|532504085|FG003|Overall Study|Randomized but did not receive treatment|0|||
147640811|NCT02954653|532504086|FG004|Overall Study|Randomized but did not receive treatment|0|||
147640812|NCT02954653|532504087|FG005|Overall Study|Randomized but did not receive treatment|0|||
147640813|NCT02954653|532504088|FG006|Overall Study|Randomized but did not receive treatment|0|||
147640814|NCT02954653|532504089|FG007|Overall Study|Randomized but did not receive treatment|0|||
147640815|NCT02954653|532504090|FG008|Overall Study|Randomized but did not receive treatment|0|||
147640816|NCT02954653|532504082|FG000|Overall Study|Started another anti-cancer therapy|0|||
147640817|NCT02954653|532504083|FG001|Overall Study|Started another anti-cancer therapy|1|||
147640818|NCT02954653|532504084|FG002|Overall Study|Started another anti-cancer therapy|0|||
147640819|NCT02954653|532504085|FG003|Overall Study|Started another anti-cancer therapy|0|||
147640820|NCT02954653|532504086|FG004|Overall Study|Started another anti-cancer therapy|0|||
147640821|NCT02954653|532504087|FG005|Overall Study|Started another anti-cancer therapy|0|||
147640822|NCT02954653|532504088|FG006|Overall Study|Started another anti-cancer therapy|0|||
147640823|NCT02954653|532504089|FG007|Overall Study|Started another anti-cancer therapy|0|||
147640824|NCT02954653|532504090|FG008|Overall Study|Started another anti-cancer therapy|0|||
147640825|NCT02954653|532504082|FG000|Overall Study|Treatment failure and consent withdrawal|0|||
147640826|NCT02954653|532504083|FG001|Overall Study|Treatment failure and consent withdrawal|1|||
147640827|NCT02954653|532504084|FG002|Overall Study|Treatment failure and consent withdrawal|0|||
147518356|NCT00963820|532049826|FG005|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
147640828|NCT02954653|532504085|FG003|Overall Study|Treatment failure and consent withdrawal|0|||
147640829|NCT02954653|532504086|FG004|Overall Study|Treatment failure and consent withdrawal|0|||
147640830|NCT02954653|532504087|FG005|Overall Study|Treatment failure and consent withdrawal|0|||
147640831|NCT02954653|532504088|FG006|Overall Study|Treatment failure and consent withdrawal|0|||
147640832|NCT02954653|532504089|FG007|Overall Study|Treatment failure and consent withdrawal|0|||
147640833|NCT02954653|532504090|FG008|Overall Study|Treatment failure and consent withdrawal|0|||
147640834|NCT03054064|532504091|FG000|Overall Study|Lower Extremity Deep Vein Thrombosis|1|||
147640835|NCT03054064|532504091|FG000|Overall Study|Investigator Decision|2|||
147640836|NCT03054064|532504091|FG000|Overall Study|Bladder Issue|1|||
147640837|NCT03054064|532504091|FG000|Overall Study|High Blood Pressure|1|||
147640838|NCT03054064|532504091|FG000|Overall Study|Change in Status|1|||
147640839|NCT01459718|532504094|FG000|Overall Study|Physician Decision|1|||
147640840|NCT01459718|532504094|FG000|Overall Study|Lost to Follow-up|1|||
147640841|NCT01459718|532504094|FG000|Overall Study|Adverse Event|1|||
147640842|NCT01500213|532504095|FG000|Overall Study|Adverse Event|35|||
147640843|NCT01500213|532504096|FG001|Overall Study|Adverse Event|35|||
147640844|NCT01500213|532504095|FG000|Overall Study|Chemo Completed or Change in Therapy|84|||
147640845|NCT01500213|532504096|FG001|Overall Study|Chemo Completed or Change in Therapy|81|||
147640846|NCT01500213|532504095|FG000|Overall Study|Withdrawal by Subject|28|||
147640847|NCT01500213|532504096|FG001|Overall Study|Withdrawal by Subject|37|||
147640848|NCT01500213|532504095|FG000|Overall Study|Death|7|||
147640849|NCT01500213|532504096|FG001|Overall Study|Death|3|||
147640850|NCT01500213|532504095|FG000|Overall Study|Disease Progression|13|||
147640851|NCT01500213|532504096|FG001|Overall Study|Disease Progression|21|||
147640852|NCT01500213|532504095|FG000|Overall Study|Protocol Violation|19|||
147640853|NCT01500213|532504096|FG001|Overall Study|Protocol Violation|19|||
147640854|NCT01500213|532504095|FG000|Overall Study|Physician Decision|12|||
147640855|NCT01500213|532504096|FG001|Overall Study|Physician Decision|10|||
147640856|NCT01500213|532504095|FG000|Overall Study|Lack of Efficacy|9|||
147640857|NCT01500213|532504096|FG001|Overall Study|Lack of Efficacy|7|||
147640858|NCT01500213|532504095|FG000|Overall Study|Lost to Follow-up|3|||
147640859|NCT01500213|532504096|FG001|Overall Study|Lost to Follow-up|6|||
147640860|NCT01500213|532504095|FG000|Overall Study|Other Reasons|7|||
147640861|NCT01500213|532504096|FG001|Overall Study|Other Reasons|5|||
147640862|NCT00785213|532504097|FG000|Quinine Sulfate Alone|Adverse Event|4|||
147640863|NCT00785213|532504097|FG000|Rosiglitazone With Quinine Sulfate|Adverse Event|1|||
147640864|NCT02386345|532504098|FG000|Overall Study|Not treated|14|||
147640865|NCT02386345|532504098|FG000|Overall Study|Lost to Follow-up|1|||
147640866|NCT02386345|532504098|FG000|Overall Study|Adverse Event|5|||
147640867|NCT02386345|532504098|FG000|Overall Study|Repeat Procedure|10|||
147640868|NCT02386345|532504098|FG000|Overall Study|Did not complete 12-month follow-up|72|||
147640869|NCT02612610|532504099|FG000|Overall Study|Withdrawal by Subject|1|||
147640870|NCT02612610|532504100|FG001|Overall Study|Withdrawal by Subject|1|||
147640871|NCT02612610|532504101|FG002|Overall Study|Withdrawal by Subject|0|||
147640872|NCT02612610|532504102|FG003|Overall Study|Withdrawal by Subject|2|||
147640873|NCT02612610|532504099|FG000|Overall Study|Adverse Event|2|||
147640874|NCT02612610|532504100|FG001|Overall Study|Adverse Event|2|||
147640875|NCT02612610|532504101|FG002|Overall Study|Adverse Event|3|||
147640876|NCT02612610|532504102|FG003|Overall Study|Adverse Event|10|||
147640877|NCT02612610|532504099|FG000|Overall Study|Lost to Follow-up|0|||
147640878|NCT02612610|532504100|FG001|Overall Study|Lost to Follow-up|1|||
147640879|NCT02612610|532504101|FG002|Overall Study|Lost to Follow-up|0|||
147640880|NCT02612610|532504102|FG003|Overall Study|Lost to Follow-up|0|||
147640881|NCT02612610|532504099|FG000|Overall Study|Protocol Violation|0|||
147640882|NCT02612610|532504100|FG001|Overall Study|Protocol Violation|1|||
147640883|NCT02612610|532504101|FG002|Overall Study|Protocol Violation|1|||
147640884|NCT02612610|532504102|FG003|Overall Study|Protocol Violation|0|||
147640885|NCT02612610|532504099|FG000|Overall Study|Lack of Efficacy|1|||
147640886|NCT02612610|532504100|FG001|Overall Study|Lack of Efficacy|2|||
147640887|NCT02612610|532504101|FG002|Overall Study|Lack of Efficacy|0|||
147640888|NCT02612610|532504102|FG003|Overall Study|Lack of Efficacy|1|||
147640889|NCT02612610|532504099|FG000|Overall Study|Physician Decision|0|||
147640890|NCT02612610|532504100|FG001|Overall Study|Physician Decision|1|||
147640891|NCT02612610|532504101|FG002|Overall Study|Physician Decision|0|||
147640892|NCT02612610|532504102|FG003|Overall Study|Physician Decision|0|||
147640893|NCT02612610|532504099|FG000|Overall Study|Noncompliance|1|||
147640894|NCT02612610|532504100|FG001|Overall Study|Noncompliance|0|||
147640895|NCT02612610|532504101|FG002|Overall Study|Noncompliance|0|||
147640896|NCT02612610|532504102|FG003|Overall Study|Noncompliance|0|||
147640897|NCT02612610|532504099|FG000|Overall Study|Cough Improvement|0|||
147640898|NCT02612610|532504100|FG001|Overall Study|Cough Improvement|0|||
147640899|NCT02612610|532504101|FG002|Overall Study|Cough Improvement|1|||
147640900|NCT02612610|532504102|FG003|Overall Study|Cough Improvement|0|||
147640901|NCT02003963|532504104|FG000|Overall Study|Lost to Follow-up|2|||
147640902|NCT02003963|532504105|FG001|Overall Study|Lost to Follow-up|1|||
147640903|NCT00176644|532504106|FG000|Overall Study|Withdrawal by Subject|1|||
147640904|NCT01801280|532504107|FG000|Period 1|Withdrawal by Subject|0|||
147518357|NCT00963820|532049827|FG006|Dose Escalation Phase|Unsatisfactory Therapeutic Response|1|||
147518358|NCT00963820|532049828|FG007|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
147518359|NCT00963820|532049829|FG008|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
147518360|NCT00963820|532049830|FG009|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
147518361|NCT00963820|532049831|FG010|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
147518362|NCT00963820|532049832|FG011|Dose Escalation Phase|Unsatisfactory Therapeutic Response|0|||
147640905|NCT01801280|532504108|FG001|Period 1|Withdrawal by Subject|1|||
147640906|NCT01801280|532504109|FG002|Period 1|Withdrawal by Subject|0|||
147640907|NCT01801280|532504110|FG003|Period 1|Withdrawal by Subject|0|||
147640908|NCT01801280|532504107|FG000|Period 2|Withdrawal by Subject|1|||
147640909|NCT01801280|532504108|FG001|Period 2|Withdrawal by Subject|0|||
147640910|NCT01801280|532504109|FG002|Period 2|Withdrawal by Subject|0|||
147640911|NCT01801280|532504110|FG003|Period 2|Withdrawal by Subject|0|||
147640912|NCT01801280|532504107|FG000|Period 4|Protocol Violation|0|||
147640913|NCT01801280|532504108|FG001|Period 4|Protocol Violation|0|||
147640914|NCT01801280|532504109|FG002|Period 4|Protocol Violation|1|||
147640915|NCT01801280|532504110|FG003|Period 4|Protocol Violation|0|||
147640916|NCT01546571|532504111|FG000|Overall Study|Adverse Event|1|||
147640917|NCT01546571|532504112|FG001|Overall Study|Adverse Event|0|||
147640918|NCT01546571|532504113|FG002|Overall Study|Adverse Event|0|||
147640919|NCT01546571|532504114|FG003|Overall Study|Adverse Event|1|||
147640920|NCT01546571|532504115|FG004|Overall Study|Adverse Event|0|||
147640921|NCT01546571|532504111|FG000|Overall Study|assigned placebo in Part A|0|||
147640922|NCT01546571|532504112|FG001|Overall Study|assigned placebo in Part A|0|||
147640923|NCT01546571|532504113|FG002|Overall Study|assigned placebo in Part A|22|||
147640924|NCT01546571|532504114|FG003|Overall Study|assigned placebo in Part A|0|||
147640925|NCT01546571|532504115|FG004|Overall Study|assigned placebo in Part A|0|||
147640926|NCT01546571|532504111|FG000|Overall Study|Death|0|||
147640927|NCT01546571|532504112|FG001|Overall Study|Death|1|||
147640928|NCT01546571|532504113|FG002|Overall Study|Death|0|||
147640929|NCT01546571|532504114|FG003|Overall Study|Death|0|||
147640930|NCT01546571|532504115|FG004|Overall Study|Death|0|||
147640931|NCT01546571|532504111|FG000|Overall Study|Lost to Follow-up|0|||
147640932|NCT01546571|532504112|FG001|Overall Study|Lost to Follow-up|0|||
147640933|NCT01546571|532504113|FG002|Overall Study|Lost to Follow-up|2|||
147640934|NCT01546571|532504114|FG003|Overall Study|Lost to Follow-up|2|||
147640935|NCT01546571|532504115|FG004|Overall Study|Lost to Follow-up|3|||
147640936|NCT01546571|532504111|FG000|Overall Study|Pregnancy|0|||
147640937|NCT01546571|532504112|FG001|Overall Study|Pregnancy|0|||
147640938|NCT01546571|532504113|FG002|Overall Study|Pregnancy|0|||
147640939|NCT01546571|532504114|FG003|Overall Study|Pregnancy|1|||
147640940|NCT01546571|532504115|FG004|Overall Study|Pregnancy|0|||
147640941|NCT01546571|532504111|FG000|Overall Study|Disease Progression|20|||
147640942|NCT01546571|532504112|FG001|Overall Study|Disease Progression|18|||
147640943|NCT01546571|532504113|FG002|Overall Study|Disease Progression|15|||
147640944|NCT01546571|532504114|FG003|Overall Study|Disease Progression|73|||
147640945|NCT01546571|532504115|FG004|Overall Study|Disease Progression|37|||
147640946|NCT01546571|532504111|FG000|Overall Study|Withdrawal by Subject|1|||
147640947|NCT01546571|532504112|FG001|Overall Study|Withdrawal by Subject|2|||
147640948|NCT01546571|532504113|FG002|Overall Study|Withdrawal by Subject|4|||
147640949|NCT01546571|532504114|FG003|Overall Study|Withdrawal by Subject|9|||
147640950|NCT01546571|532504115|FG004|Overall Study|Withdrawal by Subject|2|||
147640951|NCT01546571|532504111|FG000|Overall Study|Intercurrent Illness|1|||
147640952|NCT01546571|532504112|FG001|Overall Study|Intercurrent Illness|2|||
147640953|NCT01546571|532504113|FG002|Overall Study|Intercurrent Illness|0|||
147640954|NCT01546571|532504114|FG003|Overall Study|Intercurrent Illness|0|||
147640955|NCT01546571|532504115|FG004|Overall Study|Intercurrent Illness|0|||
147640956|NCT01546571|532504111|FG000|Overall Study|Other Cancers|0|||
147640957|NCT01546571|532504112|FG001|Overall Study|Other Cancers|0|||
147640958|NCT01546571|532504113|FG002|Overall Study|Other Cancers|0|||
147640959|NCT01546571|532504114|FG003|Overall Study|Other Cancers|3|||
147640960|NCT01546571|532504115|FG004|Overall Study|Other Cancers|1|||
147518363|NCT00963820|532049821|FG000|Expansion Phase|Progressive Disease|0|||
147640961|NCT01546571|532504111|FG000|Overall Study|Other|0|||
147640962|NCT01546571|532504112|FG001|Overall Study|Other|0|||
147640963|NCT01546571|532504113|FG002|Overall Study|Other|3|||
147640964|NCT01546571|532504114|FG003|Overall Study|Other|0|||
147518364|NCT00963820|532049822|FG001|Expansion Phase|Progressive Disease|0|||
147640965|NCT01546571|532504115|FG004|Overall Study|Other|0|||
147640966|NCT01866657|532504118|FG000|Overall Study|Surgery canceled|2|||
147640967|NCT01866657|532504119|FG001|Overall Study|Surgery canceled|0|||
147640968|NCT01880086|532504125|FG000|Overall Study|Lost to Follow-up|1|||
147640969|NCT01880086|532504126|FG001|Overall Study|Lost to Follow-up|1|||
147640970|NCT03973918|532504134|FG000|Overall Study|Adverse Event|0|||
147640971|NCT03973918|532504135|FG001|Overall Study|Adverse Event|0|||
147640972|NCT03973918|532504136|FG002|Overall Study|Adverse Event|0|||
147640973|NCT03973918|532504137|FG003|Overall Study|Adverse Event|1|||
147640974|NCT03973918|532504134|FG000|Overall Study|pt had to stop treatment on this study but continued treatment off this study|0|||
147644039|NCT00738062|532516706|FG002|Open Label Treatment|Withdrawal by Subject|0|||
147518365|NCT00963820|532049823|FG002|Expansion Phase|Progressive Disease|0|||
147518366|NCT00963820|532049824|FG003|Expansion Phase|Progressive Disease|0|||
147518367|NCT00963820|532049825|FG004|Expansion Phase|Progressive Disease|0|||
147518368|NCT00963820|532049826|FG005|Expansion Phase|Progressive Disease|0|||
147518369|NCT00963820|532049827|FG006|Expansion Phase|Progressive Disease|0|||
147518370|NCT00963820|532049828|FG007|Expansion Phase|Progressive Disease|0|||
147518371|NCT00963820|532049829|FG008|Expansion Phase|Progressive Disease|8|||
147640975|NCT03973918|532504135|FG001|Overall Study|pt had to stop treatment on this study but continued treatment off this study|1|||
147640976|NCT03973918|532504136|FG002|Overall Study|pt had to stop treatment on this study but continued treatment off this study|0|||
147640977|NCT03973918|532504137|FG003|Overall Study|pt had to stop treatment on this study but continued treatment off this study|0|||
147640978|NCT05174949|532504138|FG000|Overall Study|Physician Decision|1|||
147640979|NCT05174949|532504139|FG001|Overall Study|Physician Decision|2|||
147640980|NCT05174949|532504140|FG002|Overall Study|Physician Decision|0|||
147640981|NCT05174949|532504141|FG003|Overall Study|Physician Decision|1|||
147640982|NCT05174949|532504142|FG004|Overall Study|Physician Decision|0|||
147640983|NCT05174949|532504143|FG005|Overall Study|Physician Decision|0|||
147640984|NCT05174949|532504138|FG000|Overall Study|Withdrawal by Subject|0|||
147640985|NCT05174949|532504139|FG001|Overall Study|Withdrawal by Subject|1|||
147640986|NCT05174949|532504140|FG002|Overall Study|Withdrawal by Subject|0|||
147640987|NCT05174949|532504141|FG003|Overall Study|Withdrawal by Subject|0|||
147640988|NCT05174949|532504142|FG004|Overall Study|Withdrawal by Subject|0|||
147640989|NCT05174949|532504143|FG005|Overall Study|Withdrawal by Subject|0|||
147640990|NCT05174949|532504138|FG000|Overall Study|Lost to Follow-up|0|||
147640991|NCT05174949|532504139|FG001|Overall Study|Lost to Follow-up|0|||
147640992|NCT05174949|532504140|FG002|Overall Study|Lost to Follow-up|0|||
147640993|NCT05174949|532504141|FG003|Overall Study|Lost to Follow-up|1|||
147640994|NCT05174949|532504142|FG004|Overall Study|Lost to Follow-up|0|||
147640995|NCT05174949|532504143|FG005|Overall Study|Lost to Follow-up|0|||
147640996|NCT04351373|532504144|FG000|Overall Study|Intraoperative diagnosis of facial nerve schwannoma|1|||
147640997|NCT01123941|532504152|FG000|Overall Study|Lost to Follow-up|2|||
147640998|NCT01123941|532504153|FG001|Overall Study|Lost to Follow-up|1|||
147640999|NCT05083923|532504161|FG000|Overall Study|Adverse Event|2|||
147641000|NCT05083923|532504162|FG001|Overall Study|Adverse Event|0|||
147641001|NCT05083923|532504161|FG000|Overall Study|Lack of Efficacy|1|||
147641002|NCT05083923|532504162|FG001|Overall Study|Lack of Efficacy|3|||
147641003|NCT05083923|532504161|FG000|Overall Study|Withdrawal by Subject|2|||
147641004|NCT05083923|532504162|FG001|Overall Study|Withdrawal by Subject|6|||
147641005|NCT05083923|532504161|FG000|Overall Study|Reason Not Specified|0|||
147641006|NCT05083923|532504162|FG001|Overall Study|Reason Not Specified|1|||
147641007|NCT03802565|532504165|FG000|Overall Study|Adverse Event|0|||
147641008|NCT03802565|532504166|FG001|Overall Study|Adverse Event|1|||
147641009|NCT03802565|532504167|FG002|Overall Study|Adverse Event|2|||
147641010|NCT03802565|532504168|FG003|Overall Study|Adverse Event|1|||
147641011|NCT03802565|532504169|FG004|Overall Study|Adverse Event|1|||
147641012|NCT03802565|532504165|FG000|Overall Study|Withdrawal by Subject|2|||
147641013|NCT03802565|532504166|FG001|Overall Study|Withdrawal by Subject|2|||
147641014|NCT03802565|532504167|FG002|Overall Study|Withdrawal by Subject|2|||
147641015|NCT03802565|532504168|FG003|Overall Study|Withdrawal by Subject|0|||
147641016|NCT03802565|532504169|FG004|Overall Study|Withdrawal by Subject|1|||
147641017|NCT03802565|532504165|FG000|Overall Study|Protocol Violation|2|||
147641018|NCT03802565|532504166|FG001|Overall Study|Protocol Violation|1|||
147641019|NCT03802565|532504167|FG002|Overall Study|Protocol Violation|4|||
147641020|NCT03802565|532504168|FG003|Overall Study|Protocol Violation|5|||
147641021|NCT03802565|532504169|FG004|Overall Study|Protocol Violation|1|||
147641022|NCT03802565|532504165|FG000|Overall Study|Lost to Follow-up|0|||
147641023|NCT03802565|532504166|FG001|Overall Study|Lost to Follow-up|0|||
147641024|NCT03802565|532504167|FG002|Overall Study|Lost to Follow-up|1|||
147641025|NCT03802565|532504168|FG003|Overall Study|Lost to Follow-up|0|||
147641026|NCT03802565|532504169|FG004|Overall Study|Lost to Follow-up|0|||
147641027|NCT03802565|532504165|FG000|Overall Study|Subjects Related to Each Other|1|||
147641028|NCT03802565|532504166|FG001|Overall Study|Subjects Related to Each Other|0|||
147641029|NCT03802565|532504167|FG002|Overall Study|Subjects Related to Each Other|0|||
147641030|NCT03802565|532504168|FG003|Overall Study|Subjects Related to Each Other|2|||
147641031|NCT03802565|532504169|FG004|Overall Study|Subjects Related to Each Other|1|||
147641032|NCT03802565|532504165|FG000|Overall Study|Elevated Enzymes|0|||
147641033|NCT03802565|532504166|FG001|Overall Study|Elevated Enzymes|0|||
147641034|NCT03802565|532504167|FG002|Overall Study|Elevated Enzymes|0|||
147518372|NCT00963820|532049830|FG009|Expansion Phase|Progressive Disease|6|||
147641035|NCT03802565|532504168|FG003|Overall Study|Elevated Enzymes|0|||
147641036|NCT03802565|532504169|FG004|Overall Study|Elevated Enzymes|2|||
147518373|NCT00963820|532049831|FG010|Expansion Phase|Progressive Disease|4|||
147641037|NCT03839459|532505562|FG000|Overall Study|Withdrawal by Subject|2|||
147641038|NCT03839459|532505562|FG000|Overall Study|progression of disease|3|||
147641039|NCT03036098|532505563|FG000|Pre-Treatment|Other Reasons|1|||
147641040|NCT03036098|532505564|FG001|Pre-Treatment|Other Reasons|2|||
147641041|NCT03036098|532505565|FG002|Pre-Treatment|Other Reasons|0|||
147518374|NCT00963820|532049832|FG011|Expansion Phase|Progressive Disease|2|||
147518375|NCT00963820|532049821|FG000|Expansion Phase|Adverse Event|0|||
147518376|NCT00963820|532049822|FG001|Expansion Phase|Adverse Event|0|||
147518377|NCT00963820|532049823|FG002|Expansion Phase|Adverse Event|0|||
147518378|NCT00963820|532049824|FG003|Expansion Phase|Adverse Event|0|||
147518379|NCT00963820|532049825|FG004|Expansion Phase|Adverse Event|0|||
147518380|NCT00963820|532049826|FG005|Expansion Phase|Adverse Event|0|||
147518381|NCT00963820|532049827|FG006|Expansion Phase|Adverse Event|0|||
147518382|NCT00963820|532049828|FG007|Expansion Phase|Adverse Event|0|||
147518383|NCT00963820|532049829|FG008|Expansion Phase|Adverse Event|1|||
147518384|NCT00963820|532049830|FG009|Expansion Phase|Adverse Event|3|||
147518385|NCT00963820|532049831|FG010|Expansion Phase|Adverse Event|0|||
147518386|NCT00963820|532049832|FG011|Expansion Phase|Adverse Event|0|||
147518387|NCT00963820|532049821|FG000|Expansion Phase|Withdrawal by Subject|0|||
147518388|NCT00963820|532049822|FG001|Expansion Phase|Withdrawal by Subject|0|||
147518389|NCT00963820|532049823|FG002|Expansion Phase|Withdrawal by Subject|0|||
147518390|NCT00963820|532049824|FG003|Expansion Phase|Withdrawal by Subject|0|||
147518391|NCT00963820|532049825|FG004|Expansion Phase|Withdrawal by Subject|0|||
147518392|NCT00963820|532049826|FG005|Expansion Phase|Withdrawal by Subject|0|||
147518393|NCT00963820|532049827|FG006|Expansion Phase|Withdrawal by Subject|0|||
147518394|NCT00963820|532049828|FG007|Expansion Phase|Withdrawal by Subject|0|||
147518395|NCT00963820|532049829|FG008|Expansion Phase|Withdrawal by Subject|1|||
147518396|NCT00963820|532049830|FG009|Expansion Phase|Withdrawal by Subject|0|||
147518397|NCT00963820|532049831|FG010|Expansion Phase|Withdrawal by Subject|1|||
147518398|NCT00963820|532049832|FG011|Expansion Phase|Withdrawal by Subject|1|||
147518399|NCT00963820|532049821|FG000|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
147518400|NCT00963820|532049822|FG001|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
147518401|NCT00963820|532049823|FG002|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
147518402|NCT00963820|532049824|FG003|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
147518403|NCT00963820|532049825|FG004|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
147518404|NCT00963820|532049826|FG005|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
147518405|NCT00963820|532049827|FG006|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
147641042|NCT03036098|532505566|FG003|Pre-Treatment|Other Reasons|5|||
147641043|NCT03036098|532505563|FG000|Pre-Treatment|Participant No Longer Meets Study Criteria|2|||
147641044|NCT03036098|532505564|FG001|Pre-Treatment|Participant No Longer Meets Study Criteria|0|||
147641045|NCT03036098|532505565|FG002|Pre-Treatment|Participant No Longer Meets Study Criteria|0|||
147641046|NCT03036098|532505566|FG003|Pre-Treatment|Participant No Longer Meets Study Criteria|2|||
147641047|NCT03036098|532505563|FG000|Pre-Treatment|Withdrawal by Subject|1|||
147641048|NCT03036098|532505564|FG001|Pre-Treatment|Withdrawal by Subject|14|||
147641049|NCT03036098|532505565|FG002|Pre-Treatment|Withdrawal by Subject|0|||
147641050|NCT03036098|532505566|FG003|Pre-Treatment|Withdrawal by Subject|5|||
147641051|NCT03036098|532505563|FG000|Pre-Treatment|Participant Request to Discontinue Study Treatment|0|||
147641052|NCT03036098|532505564|FG001|Pre-Treatment|Participant Request to Discontinue Study Treatment|3|||
147641053|NCT03036098|532505565|FG002|Pre-Treatment|Participant Request to Discontinue Study Treatment|0|||
147641054|NCT03036098|532505566|FG003|Pre-Treatment|Participant Request to Discontinue Study Treatment|1|||
147641055|NCT03036098|532505563|FG000|Treatment|Disease Progression|130|||
147641056|NCT03036098|532505564|FG001|Treatment|Disease Progression|77|||
147641057|NCT03036098|532505565|FG002|Treatment|Disease Progression|168|||
147641058|NCT03036098|532505566|FG003|Treatment|Disease Progression|50|||
147641059|NCT03036098|532505563|FG000|Treatment|Study Drug Toxicity|95|||
147641060|NCT03036098|532505564|FG001|Treatment|Study Drug Toxicity|45|||
147641061|NCT03036098|532505565|FG002|Treatment|Study Drug Toxicity|26|||
147641062|NCT03036098|532505566|FG003|Treatment|Study Drug Toxicity|22|||
147641063|NCT03036098|532505563|FG000|Treatment|Death|9|||
147641064|NCT03036098|532505564|FG001|Treatment|Death|3|||
147641065|NCT03036098|532505565|FG002|Treatment|Death|1|||
147641066|NCT03036098|532505566|FG003|Treatment|Death|2|||
147641067|NCT03036098|532505563|FG000|Treatment|Adverse Event Unrelated to Study Drug|18|||
147641068|NCT03036098|532505564|FG001|Treatment|Adverse Event Unrelated to Study Drug|15|||
147641069|NCT03036098|532505565|FG002|Treatment|Adverse Event Unrelated to Study Drug|10|||
147641070|NCT03036098|532505566|FG003|Treatment|Adverse Event Unrelated to Study Drug|14|||
147641071|NCT03036098|532505563|FG000|Treatment|Participant Request to Discontinue Study Treatment|6|||
147641072|NCT03036098|532505564|FG001|Treatment|Participant Request to Discontinue Study Treatment|18|||
147641073|NCT03036098|532505565|FG002|Treatment|Participant Request to Discontinue Study Treatment|15|||
147641074|NCT03036098|532505566|FG003|Treatment|Participant Request to Discontinue Study Treatment|18|||
147641075|NCT03036098|532505563|FG000|Treatment|Withdrawal by Subject|2|||
147641076|NCT03036098|532505564|FG001|Treatment|Withdrawal by Subject|9|||
147641077|NCT03036098|532505565|FG002|Treatment|Withdrawal by Subject|2|||
147641078|NCT03036098|532505566|FG003|Treatment|Withdrawal by Subject|4|||
147641079|NCT03036098|532505563|FG000|Treatment|Maximum Clinical Benefit|6|||
147641080|NCT03036098|532505564|FG001|Treatment|Maximum Clinical Benefit|1|||
147641081|NCT03036098|532505565|FG002|Treatment|Maximum Clinical Benefit|6|||
147641082|NCT03036098|532505566|FG003|Treatment|Maximum Clinical Benefit|10|||
147641083|NCT03036098|532505563|FG000|Treatment|Poor/Non Compliance|1|||
147641084|NCT03036098|532505564|FG001|Treatment|Poor/Non Compliance|2|||
147641085|NCT03036098|532505565|FG002|Treatment|Poor/Non Compliance|0|||
147641086|NCT03036098|532505566|FG003|Treatment|Poor/Non Compliance|1|||
147641087|NCT03036098|532505563|FG000|Treatment|Participant No Longer Meets Study Criteria|0|||
147641088|NCT03036098|532505564|FG001|Treatment|Participant No Longer Meets Study Criteria|1|||
147641089|NCT03036098|532505565|FG002|Treatment|Participant No Longer Meets Study Criteria|1|||
147641090|NCT03036098|532505566|FG003|Treatment|Participant No Longer Meets Study Criteria|1|||
147641091|NCT03036098|532505563|FG000|Treatment|Administrative Reason by Sponsor|1|||
147641092|NCT03036098|532505564|FG001|Treatment|Administrative Reason by Sponsor|0|||
147641093|NCT03036098|532505565|FG002|Treatment|Administrative Reason by Sponsor|2|||
147641094|NCT03036098|532505566|FG003|Treatment|Administrative Reason by Sponsor|1|||
147641095|NCT03036098|532505563|FG000|Treatment|Other Reasons|31|||
147641096|NCT03036098|532505564|FG001|Treatment|Other Reasons|5|||
147641097|NCT03036098|532505565|FG002|Treatment|Other Reasons|21|||
147641098|NCT03036098|532505566|FG003|Treatment|Other Reasons|8|||
147641099|NCT03036098|532505563|FG000|Treatment|Ongoing Treatment|0|||
147641100|NCT03036098|532505564|FG001|Treatment|Ongoing Treatment|0|||
147641101|NCT03036098|532505565|FG002|Treatment|Ongoing Treatment|23|||
147641102|NCT03036098|532505566|FG003|Treatment|Ongoing Treatment|0|||
147641103|NCT02276053|532505567|FG000|Overall Study|Death|2|||
147641104|NCT02276053|532505567|FG000|Overall Study|Adverse Event|5|||
147641105|NCT02276053|532505567|FG000|Overall Study|Lack of Efficacy|2|||
147641106|NCT02276053|532505567|FG000|Overall Study|Withdrawal by Subject|1|||
147641107|NCT02276053|532505567|FG000|Overall Study|Patient does not meet selection criteria|3|||
147641108|NCT02276053|532505567|FG000|Overall Study|Patient needs to increase baseline AED|1|||
147641109|NCT01632904|532505568|FG000|Overall Study|Adverse Event|4|||
147641110|NCT01632904|532505569|FG001|Overall Study|Adverse Event|1|||
147641111|NCT01632904|532505568|FG000|Overall Study|Physician Decision|0|||
147641112|NCT01632904|532505569|FG001|Overall Study|Physician Decision|1|||
147641113|NCT01632904|532505568|FG000|Overall Study|Subject decision|3|||
147641114|NCT01632904|532505569|FG001|Overall Study|Subject decision|2|||
147641115|NCT01632904|532505568|FG000|Overall Study|Disease Progression|0|||
147641116|NCT01632904|532505569|FG001|Overall Study|Disease Progression|1|||
147641117|NCT01632904|532505568|FG000|Overall Study|Reason for discontinuation not available|0|||
147641118|NCT01632904|532505569|FG001|Overall Study|Reason for discontinuation not available|1|||
147641119|NCT02907593|532505575|FG000|Overall Study|Withdrawal by Subject|0|||
147641120|NCT02907593|532505576|FG001|Overall Study|Withdrawal by Subject|0|||
147641121|NCT02907593|532505577|FG002|Overall Study|Withdrawal by Subject|1|||
147641122|NCT02907593|532505578|FG003|Overall Study|Withdrawal by Subject|0|||
147641123|NCT05128773|532505582|FG000|Overall Study|Sponsor decision to terminate study|3|||
147641124|NCT04697056|532505583|FG000|Overall Study|Termination of the participant participation by the Investigator or Sponsor|4|||
147641125|NCT04697056|532505584|FG001|Overall Study|Termination of the participant participation by the Investigator or Sponsor|1|||
147641126|NCT01451164|532505585|FG000|Overall Study|Adverse Event|19|||
147641127|NCT01451164|532505586|FG001|Overall Study|Adverse Event|12|||
147641128|NCT01451164|532505587|FG002|Overall Study|Adverse Event|18|||
147641129|NCT01451164|532505588|FG003|Overall Study|Adverse Event|21|||
147641130|NCT01451164|532505585|FG000|Overall Study|Withdrawal Criteria|1|||
147641131|NCT01451164|532505586|FG001|Overall Study|Withdrawal Criteria|1|||
147641132|NCT01451164|532505587|FG002|Overall Study|Withdrawal Criteria|1|||
147641133|NCT01451164|532505588|FG003|Overall Study|Withdrawal Criteria|1|||
147641134|NCT01451164|532505585|FG000|Overall Study|Physician Decision|2|||
147641135|NCT01451164|532505586|FG001|Overall Study|Physician Decision|0|||
147641136|NCT01451164|532505587|FG002|Overall Study|Physician Decision|1|||
147641137|NCT01451164|532505588|FG003|Overall Study|Physician Decision|0|||
147641138|NCT01451164|532505585|FG000|Overall Study|Withdrawal by Subject|14|||
147641139|NCT01451164|532505586|FG001|Overall Study|Withdrawal by Subject|11|||
147641140|NCT01451164|532505587|FG002|Overall Study|Withdrawal by Subject|16|||
147641141|NCT01451164|532505588|FG003|Overall Study|Withdrawal by Subject|17|||
147641142|NCT01451164|532505585|FG000|Overall Study|Protocol Violation|0|||
147641143|NCT01451164|532505586|FG001|Overall Study|Protocol Violation|1|||
147641144|NCT01451164|532505587|FG002|Overall Study|Protocol Violation|0|||
147641145|NCT01451164|532505588|FG003|Overall Study|Protocol Violation|0|||
147641146|NCT01451164|532505585|FG000|Overall Study|Lack of Efficacy|7|||
147641147|NCT01451164|532505586|FG001|Overall Study|Lack of Efficacy|9|||
147641148|NCT01451164|532505587|FG002|Overall Study|Lack of Efficacy|9|||
147641149|NCT01451164|532505588|FG003|Overall Study|Lack of Efficacy|7|||
147641150|NCT01668966|532505589|FG000|Overall Study|Withdrawal by Subject|1|||
147641151|NCT01668966|532505589|FG000|Overall Study|Death|1|||
147641152|NCT01668966|532505589|FG000|Overall Study|Not treated|2|||
147641153|NCT04495816|532505590|FG000|Overall Study|Lost to Follow-up|10|||
147641154|NCT04495816|532505591|FG001|Overall Study|Lost to Follow-up|4|||
147641155|NCT04495816|532505590|FG000|Overall Study|Withdrawal by Subject|3|||
147641156|NCT04495816|532505591|FG001|Overall Study|Withdrawal by Subject|5|||
147641157|NCT06137703|532505593|FG000|Overall Study|Other|0|||
147641158|NCT06137703|532505594|FG001|Overall Study|Other|1|||
147641159|NCT06137703|532505595|FG002|Overall Study|Other|0|||
147641160|NCT06137703|532505596|FG003|Overall Study|Other|0|||
147641161|NCT06137703|532505593|FG000|Overall Study|Adverse Event|0|||
147641162|NCT06137703|532505594|FG001|Overall Study|Adverse Event|0|||
147641163|NCT06137703|532505595|FG002|Overall Study|Adverse Event|1|||
147641164|NCT06137703|532505596|FG003|Overall Study|Adverse Event|0|||
147641165|NCT01527487|532505597|FG000|Overall Study|MD Discretion/Lack of Efficacy|3|||
147641166|NCT01527487|532505598|FG001|Overall Study|MD Discretion/Lack of Efficacy|4|||
147641167|NCT01527487|532505597|FG000|Overall Study|Disease Progression|4|||
147641168|NCT01527487|532505598|FG001|Overall Study|Disease Progression|1|||
147641169|NCT01527487|532505597|FG000|Overall Study|Adverse Event|1|||
147641170|NCT01527487|532505598|FG001|Overall Study|Adverse Event|1|||
147641171|NCT01527487|532505597|FG000|Overall Study|Death|0|||
147641172|NCT01527487|532505598|FG001|Overall Study|Death|1|||
147641173|NCT01384019|532505599|FG000|Overall Study|Withdrawal by Subject|3|||
147641174|NCT01384019|532505600|FG001|Overall Study|Withdrawal by Subject|0|||
147641175|NCT01384019|532505599|FG000|Overall Study|Death|1|||
147641176|NCT01384019|532505600|FG001|Overall Study|Death|0|||
147641177|NCT01384019|532505599|FG000|Overall Study|MRI refusal|6|||
147641178|NCT01384019|532505600|FG001|Overall Study|MRI refusal|6|||
147641179|NCT00597506|532505608|FG000|Overall Study|Subject is being followed for survival|1|||
147641180|NCT03199612|532505611|FG000|Overall Study|Adverse Event|1|||
147641181|NCT03199612|532505612|FG001|Overall Study|Adverse Event|0|||
147641182|NCT00526331|532505617|FG000|Overall Study|Sponsor Termination|55|||
147641183|NCT01043705|532505618|FG000|Overall Study|Death|28|||
147641184|NCT01043705|532505619|FG001|Overall Study|Death|60|||
147641185|NCT01043705|532505620|FG002|Overall Study|Death|26|||
147641186|NCT01043705|532505618|FG000|Overall Study|Lost to Follow-up|27|||
147641187|NCT01043705|532505619|FG001|Overall Study|Lost to Follow-up|12|||
147641188|NCT01043705|532505620|FG002|Overall Study|Lost to Follow-up|0|||
147641189|NCT01043705|532505618|FG000|Overall Study|Multiple Reasons|4|||
147641190|NCT01043705|532505619|FG001|Overall Study|Multiple Reasons|7|||
147641191|NCT01043705|532505620|FG002|Overall Study|Multiple Reasons|0|||
147641192|NCT01043705|532505618|FG000|Overall Study|Protocol Violation|2|||
147641193|NCT01043705|532505619|FG001|Overall Study|Protocol Violation|1|||
147641194|NCT01043705|532505620|FG002|Overall Study|Protocol Violation|0|||
147641195|NCT01043705|532505618|FG000|Overall Study|Withdrawal by Subject|8|||
147518406|NCT00963820|532049828|FG007|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
147518407|NCT00963820|532049829|FG008|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
147518408|NCT00963820|532049830|FG009|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
147518409|NCT00963820|532049831|FG010|Expansion Phase|Unsatisfactory Therapeutic Response|0|||
147518410|NCT00963820|532049832|FG011|Expansion Phase|Unsatisfactory Therapeutic Response|1|||
147518411|NCT02354690|532049833|FG000|Overall Study|Physician Decision|1|||
147518412|NCT04556175|532049837|FG000|Overall Study|Study terminated due to COVID-19|8|||
147518413|NCT04556175|532049838|FG001|Overall Study|Study terminated due to COVID-19|8|||
147518414|NCT05549505|532049840|FG000|Overall Study|Lost to Follow-up|2|||
147518415|NCT05549505|532049841|FG001|Overall Study|Lost to Follow-up|0|||
147518416|NCT05549505|532049840|FG000|Overall Study|Withdrawal by Subject|3|||
147518417|NCT05549505|532049841|FG001|Overall Study|Withdrawal by Subject|3|||
147518418|NCT05549505|532049840|FG000|Overall Study|Other: Miscellaneous|3|||
147518419|NCT05549505|532049841|FG001|Overall Study|Other: Miscellaneous|6|||
147518420|NCT05492877|532049845|FG000|Overall Study|Adverse Event|11|||
147518421|NCT05492877|532049846|FG001|Overall Study|Adverse Event|7|||
147518422|NCT05492877|532049845|FG000|Overall Study|Death|1|||
147518423|NCT05492877|532049846|FG001|Overall Study|Death|0|||
147518424|NCT05492877|532049845|FG000|Overall Study|Lost to Follow-up|1|||
147518425|NCT05492877|532049846|FG001|Overall Study|Lost to Follow-up|1|||
147518426|NCT05492877|532049845|FG000|Overall Study|Physician Decision|1|||
147518427|NCT05492877|532049846|FG001|Overall Study|Physician Decision|2|||
147518428|NCT05492877|532049845|FG000|Overall Study|Protocol Violation|1|||
147518429|NCT05492877|532049846|FG001|Overall Study|Protocol Violation|1|||
147518430|NCT05492877|532049845|FG000|Overall Study|Withdrawal by Subject|3|||
147518431|NCT05492877|532049846|FG001|Overall Study|Withdrawal by Subject|7|||
147518432|NCT05492877|532049845|FG000|Overall Study|Reason not specified|6|||
147518433|NCT05492877|532049846|FG001|Overall Study|Reason not specified|4|||
147518434|NCT02871791|532049847|FG000|Phase 1b|Death|0|||
147518435|NCT02871791|532049848|FG001|Phase 1b|Death|1|||
147518436|NCT02871791|532049847|FG000|Phase 1b|progressive disease|6|||
147518437|NCT02871791|532049848|FG001|Phase 1b|progressive disease|2|||
147641196|NCT01043705|532505619|FG001|Overall Study|Withdrawal by Subject|6|||
147641197|NCT01043705|532505620|FG002|Overall Study|Withdrawal by Subject|0|||
147641198|NCT01043705|532505618|FG000|Overall Study|Site Closure|8|||
147641199|NCT01043705|532505619|FG001|Overall Study|Site Closure|0|||
147641200|NCT01043705|532505620|FG002|Overall Study|Site Closure|0|||
147641201|NCT01043705|532505618|FG000|Overall Study|Subsequent Procedure|9|||
147641202|NCT01043705|532505619|FG001|Overall Study|Subsequent Procedure|24|||
147641203|NCT01043705|532505620|FG002|Overall Study|Subsequent Procedure|29|||
147641204|NCT01043705|532505618|FG000|Overall Study|Adverse Event|0|||
147641205|NCT01043705|532505619|FG001|Overall Study|Adverse Event|2|||
147641206|NCT01043705|532505620|FG002|Overall Study|Adverse Event|0|||
147641207|NCT01043705|532505618|FG000|Overall Study|Screen Fail|21|||
147641208|NCT01043705|532505619|FG001|Overall Study|Screen Fail|0|||
147641209|NCT01043705|532505620|FG002|Overall Study|Screen Fail|0|||
147641210|NCT01043705|532505618|FG000|Overall Study|Other|0|||
147641211|NCT01043705|532505619|FG001|Overall Study|Other|19|||
147641212|NCT01043705|532505620|FG002|Overall Study|Other|25|||
147641213|NCT00581542|532505621|FG000|Overall Study|they met an exclusion criteria|2|||
147641214|NCT00581542|532505622|FG001|Overall Study|they met an exclusion criteria|2|||
147641215|NCT00581542|532505621|FG000|Overall Study|Lost to Follow-up|9|||
147641216|NCT00581542|532505622|FG001|Overall Study|Lost to Follow-up|21|||
147641217|NCT05020366|532505623|FG000|Overall Study|Lost to Follow-up|2|||
147641218|NCT05020366|532505624|FG001|Overall Study|Lost to Follow-up|0|||
147641219|NCT05020366|532505623|FG000|Overall Study|Withdrawal by Subject|2|||
147641220|NCT05020366|532505624|FG001|Overall Study|Withdrawal by Subject|0|||
147641221|NCT04050124|532505627|FG000|Overall Study|Death|1|||
147641222|NCT04050124|532505628|FG001|Overall Study|Death|0|||
147641223|NCT04601103|532505629|FG000|Overall Study|Needed crown & cleaning|0|||
147641224|NCT04601103|532505630|FG001|Overall Study|Needed crown & cleaning|0|||
147641225|NCT04601103|532505631|FG002|Overall Study|Needed crown & cleaning|1|||
147641226|NCT04601103|532505629|FG000|Overall Study|study was terminated|18|||
147641227|NCT04601103|532505630|FG001|Overall Study|study was terminated|18|||
147641228|NCT04601103|532505631|FG002|Overall Study|study was terminated|16|||
147641229|NCT06011161|532505634|FG000|Overall Study|Withdrawal by Subject|2|||
147641230|NCT06011161|532505634|FG000|Overall Study|Lost to Follow-up|5|||
147641231|NCT04442269|532505635|FG000|Overall Study|Adverse Event|1|||
147641232|NCT04442269|532505636|FG001|Overall Study|Adverse Event|0|||
147641233|NCT04442269|532505635|FG000|Overall Study|Death|0|||
147641234|NCT04442269|532505636|FG001|Overall Study|Death|1|||
147641235|NCT04442269|532505635|FG000|Overall Study|Decision by the Investigator/Sponsor|1|||
147641236|NCT04442269|532505636|FG001|Overall Study|Decision by the Investigator/Sponsor|1|||
147641237|NCT04442269|532505635|FG000|Overall Study|Lost to Follow-up|1|||
147518438|NCT02871791|532049847|FG000|Phase 2|Death|1|||
147641238|NCT04442269|532505636|FG001|Overall Study|Lost to Follow-up|0|||
147641239|NCT04442269|532505635|FG000|Overall Study|Withdrawal by Subject|3|||
147641240|NCT04442269|532505636|FG001|Overall Study|Withdrawal by Subject|2|||
147641241|NCT04442269|532505635|FG000|Overall Study|Protocol Deviation|0|||
147641242|NCT04442269|532505636|FG001|Overall Study|Protocol Deviation|1|||
147641243|NCT04442269|532505635|FG000|Overall Study|Travel Limitations|1|||
147641244|NCT04442269|532505636|FG001|Overall Study|Travel Limitations|1|||
147641245|NCT00430352|532505640|FG000|Overall Study|Disease progression|58|||
147641246|NCT00430352|532505640|FG000|Overall Study|Withdrawal by Subject|11|||
147641247|NCT00430352|532505640|FG000|Overall Study|Adverse Event|16|||
147641248|NCT00430352|532505640|FG000|Overall Study|Death|5|||
147641249|NCT00430352|532505640|FG000|Overall Study|Other|48|||
147641250|NCT04326439|532505641|FG000|Overall Study|Withdrawal by Subject|1|||
147641251|NCT04326439|532505642|FG001|Overall Study|Withdrawal by Subject|0|||
147641252|NCT04326439|532505641|FG000|Overall Study|Proceeded to HSCT after Induction 2|0|||
147641253|NCT04326439|532505642|FG001|Overall Study|Proceeded to HSCT after Induction 2|2|||
147641254|NCT04326439|532505641|FG000|Overall Study|Relapse after Induction 2|0|||
147641255|NCT04326439|532505642|FG001|Overall Study|Relapse after Induction 2|1|||
147641256|NCT04326439|532505641|FG000|Overall Study|Refractory CNS Leukemia after 6 doses IT cytarabine|1|||
147641257|NCT04326439|532505642|FG001|Overall Study|Refractory CNS Leukemia after 6 doses IT cytarabine|0|||
147641258|NCT02291601|532505645|FG000|Abdomen|Did not qualify|333|||
147641259|NCT02291601|532505646|FG001|Abdomen|Did not qualify|54|||
147641260|NCT02291601|532505647|FG002|Abdomen|Did not qualify|339|||
147641261|NCT02291601|532505645|FG000|Groin|Did not qualify|183|||
147641262|NCT02291601|532505646|FG001|Groin|Did not qualify|30|||
147641263|NCT02291601|532505647|FG002|Groin|Did not qualify|177|||
147641264|NCT00347919|532505653|FG000|Overall Study|Lost to Follow-up|11|||
147641265|NCT00347919|532505654|FG001|Overall Study|Lost to Follow-up|13|||
147641266|NCT00347919|532505655|FG002|Overall Study|Lost to Follow-up|0|||
147641267|NCT00347919|532505653|FG000|Overall Study|Withdrawal by Subject|6|||
147641268|NCT00347919|532505654|FG001|Overall Study|Withdrawal by Subject|8|||
147641269|NCT00347919|532505655|FG002|Overall Study|Withdrawal by Subject|0|||
147641270|NCT00347919|532505653|FG000|Overall Study|Physician Decision|1|||
147641271|NCT00347919|532505654|FG001|Overall Study|Physician Decision|1|||
147641272|NCT00347919|532505655|FG002|Overall Study|Physician Decision|0|||
147641273|NCT00347919|532505653|FG000|Overall Study|Sponsor terminated study|15|||
147641274|NCT00347919|532505654|FG001|Overall Study|Sponsor terminated study|10|||
147641275|NCT00347919|532505655|FG002|Overall Study|Sponsor terminated study|16|||
147641276|NCT00347919|532505653|FG000|Overall Study|Death|35|||
147641277|NCT00347919|532505654|FG001|Overall Study|Death|42|||
147641278|NCT00347919|532505655|FG002|Overall Study|Death|19|||
147641279|NCT00347919|532505653|FG000|Overall Study|Par. Started Other Treatment|1|||
147641280|NCT00347919|532505654|FG001|Overall Study|Par. Started Other Treatment|1|||
147641281|NCT00347919|532505655|FG002|Overall Study|Par. Started Other Treatment|1|||
147641282|NCT00347919|532505653|FG000|Overall Study|Missing|2|||
147641283|NCT00347919|532505654|FG001|Overall Study|Missing|1|||
147641284|NCT00347919|532505655|FG002|Overall Study|Missing|2|||
147641285|NCT01597375|532505656|FG000|First Intervention (4 Weeks)|Uncontrolled Asthma|1|||
147641286|NCT01597375|532505657|FG001|First Intervention (4 Weeks)|Uncontrolled Asthma|0|||
147641287|NCT01597375|532505656|FG000|First Intervention (4 Weeks)|Needed surgery|1|||
147641288|NCT01597375|532505657|FG001|First Intervention (4 Weeks)|Needed surgery|0|||
147641289|NCT01597375|532505656|FG000|First Intervention (4 Weeks)|Lost to Follow-up|0|||
147641290|NCT01597375|532505657|FG001|First Intervention (4 Weeks)|Lost to Follow-up|1|||
147641291|NCT01597375|532505656|FG000|Washout (2 Weeks)|Adverse Event|1|||
147641292|NCT01597375|532505657|FG001|Washout (2 Weeks)|Adverse Event|0|||
147641293|NCT01597375|532505656|FG000|Second Intervention|Failed to react at both Aspirin|1|||
147641294|NCT01597375|532505657|FG001|Second Intervention|Failed to react at both Aspirin|1|||
147641295|NCT03379753|532505658|FG000|Overall Study|Withdrawal by Subject|2|||
147641296|NCT03379753|532505659|FG001|Overall Study|Withdrawal by Subject|1|||
147641297|NCT03379753|532505658|FG000|Overall Study|not having correct procedure|1|||
147641298|NCT03379753|532505659|FG001|Overall Study|not having correct procedure|2|||
147641299|NCT03379753|532505658|FG000|Overall Study|No primary outcome|12|||
147641300|NCT03379753|532505659|FG001|Overall Study|No primary outcome|22|||
147641301|NCT01032239|532505660|FG000|Overall Study|Lost to Follow-up|3|||
147641302|NCT01032239|532505661|FG001|Overall Study|Lost to Follow-up|2|||
147641303|NCT01032239|532505660|FG000|Overall Study|Withdrawal by Subject|2|||
147641304|NCT01032239|532505661|FG001|Overall Study|Withdrawal by Subject|3|||
147641305|NCT01032239|532505660|FG000|Overall Study|Death|1|||
147641306|NCT01032239|532505661|FG001|Overall Study|Death|0|||
147641307|NCT01032239|532505660|FG000|Overall Study|Protocol Violation|1|||
147641308|NCT01032239|532505661|FG001|Overall Study|Protocol Violation|0|||
147641309|NCT04713592|532505670|FG000|Double-blind Period (Baseline - Week 16)|Adverse Event|0|||
147641310|NCT04713592|532505671|FG001|Double-blind Period (Baseline - Week 16)|Adverse Event|1|||
147641311|NCT04713592|532505672|FG002|Double-blind Period (Baseline - Week 16)|Adverse Event|0|||
147641312|NCT04713592|532505673|FG003|Double-blind Period (Baseline - Week 16)|Adverse Event|0|||
147641313|NCT04713592|532505670|FG000|Double-blind Period (Baseline - Week 16)|Withdrawal by Subject|6|||
147641314|NCT04713592|532505671|FG001|Double-blind Period (Baseline - Week 16)|Withdrawal by Subject|2|||
147641315|NCT04713592|532505672|FG002|Double-blind Period (Baseline - Week 16)|Withdrawal by Subject|0|||
147641316|NCT04713592|532505673|FG003|Double-blind Period (Baseline - Week 16)|Withdrawal by Subject|0|||
147641317|NCT04713592|532505670|FG000|Open-label Period (Week 16 - Week 52)|Adverse Event|0|||
147641318|NCT04713592|532505671|FG001|Open-label Period (Week 16 - Week 52)|Adverse Event|0|||
147641319|NCT04713592|532505672|FG002|Open-label Period (Week 16 - Week 52)|Adverse Event|1|||
147641320|NCT04713592|532505673|FG003|Open-label Period (Week 16 - Week 52)|Adverse Event|2|||
147641321|NCT04713592|532505670|FG000|Open-label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
147641322|NCT04713592|532505671|FG001|Open-label Period (Week 16 - Week 52)|Withdrawal by Subject|0|||
147641323|NCT04713592|532505672|FG002|Open-label Period (Week 16 - Week 52)|Withdrawal by Subject|3|||
147641324|NCT04713592|532505673|FG003|Open-label Period (Week 16 - Week 52)|Withdrawal by Subject|5|||
147641325|NCT04713592|532505670|FG000|Open-label Period (Week 16 - Week 52)|Lost to Follow-up|0|||
147641326|NCT04713592|532505671|FG001|Open-label Period (Week 16 - Week 52)|Lost to Follow-up|0|||
147641327|NCT04713592|532505672|FG002|Open-label Period (Week 16 - Week 52)|Lost to Follow-up|1|||
147641328|NCT04713592|532505673|FG003|Open-label Period (Week 16 - Week 52)|Lost to Follow-up|1|||
147641329|NCT04713592|532505670|FG000|Open-label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
147641330|NCT04713592|532505671|FG001|Open-label Period (Week 16 - Week 52)|Lack of Efficacy|0|||
147641331|NCT04713592|532505672|FG002|Open-label Period (Week 16 - Week 52)|Lack of Efficacy|1|||
147641332|NCT04713592|532505673|FG003|Open-label Period (Week 16 - Week 52)|Lack of Efficacy|1|||
147641333|NCT04713592|532505670|FG000|Open-label Period (Week 16 - Week 52)|Other, not specified|0|||
147641334|NCT04713592|532505671|FG001|Open-label Period (Week 16 - Week 52)|Other, not specified|0|||
147641335|NCT04713592|532505672|FG002|Open-label Period (Week 16 - Week 52)|Other, not specified|16|||
147641336|NCT04713592|532505673|FG003|Open-label Period (Week 16 - Week 52)|Other, not specified|14|||
147641337|NCT02225366|532505676|FG000|Overall Study|Lack of Efficacy|1|||
147641338|NCT02225366|532505677|FG001|Overall Study|Lack of Efficacy|0|||
147641339|NCT01190267|532505678|FG000|Overall Study|Adverse Event|10|||
147641340|NCT01190267|532505679|FG001|Overall Study|Adverse Event|0|||
147641341|NCT01190267|532505678|FG000|Overall Study|Treatment Failure|8|||
147641342|NCT01190267|532505679|FG001|Overall Study|Treatment Failure|2|||
147641343|NCT01190267|532505678|FG000|Overall Study|Lost to Follow-up|2|||
147641344|NCT01190267|532505679|FG001|Overall Study|Lost to Follow-up|0|||
147641345|NCT01190267|532505678|FG000|Overall Study|Withdrawal by Subject|13|||
147641346|NCT01190267|532505679|FG001|Overall Study|Withdrawal by Subject|1|||
147641347|NCT01190267|532505678|FG000|Overall Study|Protocol Violation|8|||
147641348|NCT01190267|532505679|FG001|Overall Study|Protocol Violation|1|||
147641349|NCT04017832|532505682|FG000|Overall Study|Withdrawal by Subject|13|||
147641350|NCT04017832|532505683|FG001|Overall Study|Withdrawal by Subject|12|||
147641351|NCT04017832|532505684|FG002|Overall Study|Withdrawal by Subject|21|||
147641352|NCT04017832|532505685|FG003|Overall Study|Withdrawal by Subject|7|||
147641353|NCT04017832|532505682|FG000|Overall Study|Lost to Follow-up|0|||
147641354|NCT04017832|532505683|FG001|Overall Study|Lost to Follow-up|3|||
147641355|NCT04017832|532505684|FG002|Overall Study|Lost to Follow-up|3|||
147641356|NCT04017832|532505685|FG003|Overall Study|Lost to Follow-up|1|||
147641357|NCT04017832|532505682|FG000|Overall Study|Physician Decision|1|||
147641358|NCT04017832|532505683|FG001|Overall Study|Physician Decision|1|||
147641359|NCT04017832|532505684|FG002|Overall Study|Physician Decision|1|||
147641360|NCT04017832|532505685|FG003|Overall Study|Physician Decision|1|||
147641361|NCT04017832|532505682|FG000|Overall Study|Death|2|||
147641362|NCT04017832|532505683|FG001|Overall Study|Death|2|||
147641363|NCT04017832|532505684|FG002|Overall Study|Death|1|||
147641364|NCT04017832|532505685|FG003|Overall Study|Death|0|||
147641365|NCT01382225|532505686|FG000|Overall Study|Adverse Event|3|||
147641366|NCT01382225|532505687|FG001|Overall Study|Adverse Event|2|||
147641367|NCT01382225|532505686|FG000|Overall Study|Protocol Violation|2|||
147641368|NCT01382225|532505687|FG001|Overall Study|Protocol Violation|1|||
147641369|NCT01382225|532505686|FG000|Overall Study|Subject Withdrew Consent|5|||
147641370|NCT01382225|532505687|FG001|Overall Study|Subject Withdrew Consent|2|||
147641371|NCT01382225|532505686|FG000|Overall Study|Other|4|||
147641372|NCT01382225|532505687|FG001|Overall Study|Other|2|||
147641373|NCT02484651|532505693|FG000|Overall Study|Patients' data files were corrupted.|1|||
147641374|NCT02484651|532505694|FG001|Overall Study|Patients' data files were corrupted.|1|||
147641375|NCT02484651|532505693|FG000|Overall Study|BIS monitoring failed.|1|||
147641376|NCT02484651|532505694|FG001|Overall Study|BIS monitoring failed.|1|||
147641377|NCT02484651|532505693|FG000|Overall Study|Time of the procedure less than 90 min.|1|||
147641378|NCT02484651|532505694|FG001|Overall Study|Time of the procedure less than 90 min.|2|||
147641379|NCT01419080|532505695|FG000|Overall Study|Withdrawal by Subject|75|||
147641380|NCT01419080|532505695|FG000|Overall Study|Death|30|||
147641381|NCT01419080|532505695|FG000|Overall Study|Lost to Follow-up|23|||
147641382|NCT01419080|532505695|FG000|Overall Study|Too Ill|3|||
147641383|NCT01077739|532505699|FG000|Overall Study|Premature withdrawal|1|||
147641384|NCT01077739|532505700|FG001|Overall Study|Premature withdrawal|3|||
147641385|NCT01077739|532505699|FG000|Overall Study|Withdrawal by Subject|1|||
147518439|NCT02871791|532049848|FG001|Phase 2|Death|0|||
147641386|NCT01077739|532505700|FG001|Overall Study|Withdrawal by Subject|0|||
147641387|NCT01077739|532505699|FG000|Overall Study|Death|0|||
147641388|NCT01077739|532505700|FG001|Overall Study|Death|3|||
147641389|NCT01077739|532505699|FG000|Overall Study|Unacceptable toxicity|1|||
147641390|NCT01077739|532505700|FG001|Overall Study|Unacceptable toxicity|2|||
147641391|NCT01077739|532505699|FG000|Overall Study|Other|2|||
147641392|NCT01077739|532505700|FG001|Overall Study|Other|2|||
147641393|NCT00877071|532505701|FG000|Overall Study|disease progression|2|||
147641394|NCT05723328|532505702|FG000|Overall Study|Investigator's Decision|5|||
147641395|NCT05723328|532505703|FG001|Overall Study|Investigator's Decision|2|||
147641396|NCT03495154|532505705|FG000|Overall Study|Screen Failures Pre-Operatively|4|||
147641397|NCT03495154|532505705|FG000|Overall Study|Withdrawn Prior to Surgery|10|||
147641398|NCT03495154|532505705|FG000|Overall Study|Screen Failures During Surgery|6|||
147641399|NCT03495154|532505705|FG000|Overall Study|Death|2|||
147641400|NCT03495154|532505705|FG000|Overall Study|Lost to Follow-up|16|||
147641401|NCT03495154|532505705|FG000|Overall Study|Withdrawal by Subject|2|||
147641402|NCT03495154|532505705|FG000|Overall Study|Unable to gather information from subject due to age and limited abilities|1|||
147641403|NCT05376241|532507620|FG000|Overall Study|did not meet eligibility criteria after consenting|22|||
147641404|NCT05376241|532507620|FG000|Overall Study|103 did not complete the survey|103|||
147641405|NCT05376241|532507620|FG000|Overall Study|17 failed 2 attention check questions|17|||
147641406|NCT02059434|532507623|FG000|Washout Between Periods 1 and 2|Physician Decision|0|||
147641407|NCT02059434|532507624|FG001|Washout Between Periods 1 and 2|Physician Decision|0|||
147641408|NCT02059434|532507625|FG002|Washout Between Periods 1 and 2|Physician Decision|0|||
147641409|NCT02059434|532507626|FG003|Washout Between Periods 1 and 2|Physician Decision|0|||
147641410|NCT02059434|532507627|FG004|Washout Between Periods 1 and 2|Physician Decision|0|||
147641411|NCT02059434|532507628|FG005|Washout Between Periods 1 and 2|Physician Decision|0|||
147641412|NCT02059434|532507629|FG006|Washout Between Periods 1 and 2|Physician Decision|0|||
147641413|NCT02059434|532507630|FG007|Washout Between Periods 1 and 2|Physician Decision|1|||
147641414|NCT02059434|532507631|FG008|Washout Between Periods 1 and 2|Physician Decision|0|||
147641415|NCT02059434|532507623|FG000|Washout Between Periods 4 and 5|Adverse Event|0|||
147641416|NCT02059434|532507624|FG001|Washout Between Periods 4 and 5|Adverse Event|0|||
147641417|NCT02059434|532507625|FG002|Washout Between Periods 4 and 5|Adverse Event|0|||
147641418|NCT02059434|532507626|FG003|Washout Between Periods 4 and 5|Adverse Event|0|||
147641419|NCT02059434|532507627|FG004|Washout Between Periods 4 and 5|Adverse Event|0|||
147641420|NCT02059434|532507628|FG005|Washout Between Periods 4 and 5|Adverse Event|0|||
147641421|NCT02059434|532507629|FG006|Washout Between Periods 4 and 5|Adverse Event|0|||
147641422|NCT02059434|532507630|FG007|Washout Between Periods 4 and 5|Adverse Event|0|||
147641423|NCT02059434|532507631|FG008|Washout Between Periods 4 and 5|Adverse Event|1|||
147641424|NCT02059434|532507623|FG000|Washout Between Periods 6 and 7|Physician Decision|0|||
147641425|NCT02059434|532507624|FG001|Washout Between Periods 6 and 7|Physician Decision|0|||
147641426|NCT02059434|532507625|FG002|Washout Between Periods 6 and 7|Physician Decision|0|||
147641427|NCT02059434|532507626|FG003|Washout Between Periods 6 and 7|Physician Decision|0|||
147641428|NCT02059434|532507627|FG004|Washout Between Periods 6 and 7|Physician Decision|0|||
147641429|NCT02059434|532507628|FG005|Washout Between Periods 6 and 7|Physician Decision|0|||
147641430|NCT02059434|532507629|FG006|Washout Between Periods 6 and 7|Physician Decision|0|||
147641431|NCT02059434|532507630|FG007|Washout Between Periods 6 and 7|Physician Decision|0|||
147641432|NCT02059434|532507631|FG008|Washout Between Periods 6 and 7|Physician Decision|1|||
147641433|NCT02059434|532507623|FG000|Washout Between Periods 7 and 8|Adverse Event|0|||
147641434|NCT02059434|532507624|FG001|Washout Between Periods 7 and 8|Adverse Event|0|||
147641435|NCT02059434|532507625|FG002|Washout Between Periods 7 and 8|Adverse Event|0|||
147641436|NCT02059434|532507626|FG003|Washout Between Periods 7 and 8|Adverse Event|0|||
147641437|NCT02059434|532507627|FG004|Washout Between Periods 7 and 8|Adverse Event|0|||
147641438|NCT02059434|532507628|FG005|Washout Between Periods 7 and 8|Adverse Event|0|||
147641439|NCT02059434|532507629|FG006|Washout Between Periods 7 and 8|Adverse Event|0|||
147641440|NCT02059434|532507630|FG007|Washout Between Periods 7 and 8|Adverse Event|0|||
147641441|NCT02059434|532507631|FG008|Washout Between Periods 7 and 8|Adverse Event|1|||
147641442|NCT02059434|532507623|FG000|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
147641443|NCT02059434|532507624|FG001|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
147641444|NCT02059434|532507625|FG002|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
147641445|NCT02059434|532507626|FG003|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
147641446|NCT02059434|532507627|FG004|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
147641447|NCT02059434|532507628|FG005|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
147641448|NCT02059434|532507629|FG006|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
147641449|NCT02059434|532507630|FG007|Washout Between Periods 7 and 8|Withdrawal by Subject|0|||
147518440|NCT02871791|532049847|FG000|Phase 2|Lost to Follow-up|2|||
147518441|NCT02871791|532049848|FG001|Phase 2|Lost to Follow-up|0|||
147518442|NCT00515099|532049854|FG000|Overall Study|Lost to Follow-up|0|||
147518443|NCT00515099|532049855|FG001|Overall Study|Lost to Follow-up|4|||
147518444|NCT00515099|532049854|FG000|Overall Study|Withdrawal by Subject|2|||
147518445|NCT00515099|532049855|FG001|Overall Study|Withdrawal by Subject|0|||
147518446|NCT00515099|532049854|FG000|Overall Study|IRB Recommendation|1|||
147518447|NCT00515099|532049855|FG001|Overall Study|IRB Recommendation|0|||
147518448|NCT00592072|532049856|FG000|Wash Out Period|Lost to Follow-up|1|||
147518449|NCT00592072|532049857|FG001|Wash Out Period|Lost to Follow-up|1|||
147518450|NCT03369704|532049858|FG000|Treatment Epoch|technical problems|1|||
147518451|NCT03369704|532049859|FG001|Treatment Epoch|technical problems|0|||
147518452|NCT03369704|532049858|FG000|Treatment Epoch|Protocol Violation|1|||
147518453|NCT03369704|532049859|FG001|Treatment Epoch|Protocol Violation|0|||
147518454|NCT03369704|532049858|FG000|Treatment Epoch|Lost to Follow-up|0|||
147518455|NCT03369704|532049859|FG001|Treatment Epoch|Lost to Follow-up|1|||
147518456|NCT03369704|532049858|FG000|Treatment Epoch|Lack of Efficacy|0|||
147518457|NCT03369704|532049859|FG001|Treatment Epoch|Lack of Efficacy|2|||
147518458|NCT03369704|532049858|FG000|Treatment Epoch|Adverse Event|2|||
147641450|NCT02059434|532507631|FG008|Washout Between Periods 7 and 8|Withdrawal by Subject|1|||
147641451|NCT03201874|532507634|FG000|Post-Treatment (12 Weeks)|Declined due to lack of time/interest or could not be reached|4|||
147641452|NCT03201874|532507635|FG001|Post-Treatment (12 Weeks)|Declined due to lack of time/interest or could not be reached|5|||
147641453|NCT03201874|532507634|FG000|Follow-up (26 Weeks)|Declined due to lack of time/interest or could not be reached|5|||
147641454|NCT03201874|532507635|FG001|Follow-up (26 Weeks)|Declined due to lack of time/interest or could not be reached|8|||
147641455|NCT01702532|532507642|FG000|Overall Study|Adverse Event|0|||
147641456|NCT01702532|532507643|FG001|Overall Study|Adverse Event|1|||
147641457|NCT00345878|532507652|FG000|Overall Study|Adverse Event|1|||
147641458|NCT00345878|532507653|FG001|Overall Study|Adverse Event|0|||
147641459|NCT00345878|532507652|FG000|Overall Study|Lost to Follow-up|2|||
147641460|NCT00345878|532507653|FG001|Overall Study|Lost to Follow-up|1|||
147641461|NCT00345878|532507652|FG000|Overall Study|Other|1|||
147641462|NCT00345878|532507653|FG001|Overall Study|Other|0|||
147641463|NCT04076059|532507656|FG000|Double Blind Phase|Progressive disease|22|||
147641464|NCT04076059|532507657|FG001|Double Blind Phase|Progressive disease|26|||
147641465|NCT04076059|532507658|FG002|Double Blind Phase|Progressive disease|0|||
147641466|NCT04076059|532507656|FG000|Double Blind Phase|Withdrawal by Subject|4|||
147641467|NCT04076059|532507657|FG001|Double Blind Phase|Withdrawal by Subject|11|||
147641468|NCT04076059|532507658|FG002|Double Blind Phase|Withdrawal by Subject|0|||
147641469|NCT04076059|532507656|FG000|Double Blind Phase|Death|1|||
147641470|NCT04076059|532507657|FG001|Double Blind Phase|Death|1|||
147641471|NCT04076059|532507658|FG002|Double Blind Phase|Death|0|||
147641472|NCT04076059|532507656|FG000|Double Blind Phase|Lost to Follow-up|1|||
147641473|NCT04076059|532507657|FG001|Double Blind Phase|Lost to Follow-up|0|||
147641474|NCT04076059|532507658|FG002|Double Blind Phase|Lost to Follow-up|0|||
147641475|NCT04076059|532507656|FG000|Double Blind Phase|Adverse Event|5|||
147641476|NCT04076059|532507657|FG001|Double Blind Phase|Adverse Event|1|||
147641477|NCT04076059|532507658|FG002|Double Blind Phase|Adverse Event|0|||
147641478|NCT04076059|532507656|FG000|Double Blind Phase|Ongoing Participants|82|||
147641479|NCT04076059|532507657|FG001|Double Blind Phase|Ongoing Participants|18|||
147641480|NCT04076059|532507658|FG002|Double Blind Phase|Ongoing Participants|0|||
147641481|NCT04076059|532507656|FG000|Double Blind Phase|Miscellaneous|3|||
147641482|NCT04076059|532507657|FG001|Double Blind Phase|Miscellaneous|1|||
147641483|NCT04076059|532507658|FG002|Double Blind Phase|Miscellaneous|0|||
147641484|NCT04076059|532507656|FG000|Double Blind Phase|Protocol Deviation|1|||
147641485|NCT04076059|532507657|FG001|Double Blind Phase|Protocol Deviation|1|||
147641486|NCT04076059|532507658|FG002|Double Blind Phase|Protocol Deviation|0|||
147641487|NCT04076059|532507656|FG000|Double Blind Phase|Did not take study drug|1|||
147641488|NCT04076059|532507657|FG001|Double Blind Phase|Did not take study drug|1|||
147641489|NCT04076059|532507658|FG002|Double Blind Phase|Did not take study drug|0|||
147641490|NCT04076059|532507656|FG000|Open Label Phase|Progressive disease|0|||
147641491|NCT04076059|532507657|FG001|Open Label Phase|Progressive disease|0|||
147641492|NCT04076059|532507658|FG002|Open Label Phase|Progressive disease|7|||
147641493|NCT04076059|532507656|FG000|Open Label Phase|Withdrawal by Subject|0|||
147641494|NCT04076059|532507657|FG001|Open Label Phase|Withdrawal by Subject|0|||
147641495|NCT04076059|532507658|FG002|Open Label Phase|Withdrawal by Subject|3|||
147641496|NCT04076059|532507656|FG000|Open Label Phase|Death|0|||
147641497|NCT04076059|532507657|FG001|Open Label Phase|Death|0|||
147518459|NCT03369704|532049859|FG001|Treatment Epoch|Adverse Event|0|||
147518460|NCT03369704|532049858|FG000|Follow-up Epoch|Lost to Follow-up|1|||
147518461|NCT03369704|532049859|FG001|Follow-up Epoch|Lost to Follow-up|0|||
147641498|NCT04076059|532507658|FG002|Open Label Phase|Death|2|||
147518462|NCT05333289|532049860|FG000|Overall Study|Other|1|||
147641499|NCT04076059|532507656|FG000|Open Label Phase|Ongoing Participants|0|||
147518463|NCT05333289|532049861|FG001|Overall Study|Other|0|||
147518464|NCT05333289|532049862|FG002|Overall Study|Other|0|||
147518465|NCT05333289|532049863|FG003|Overall Study|Other|1|||
147518466|NCT05333289|532049864|FG004|Overall Study|Other|1|||
147518467|NCT05333289|532049865|FG005|Overall Study|Other|2|||
147518468|NCT05333289|532049866|FG006|Overall Study|Other|2|||
147518469|NCT05333289|532049867|FG007|Overall Study|Other|0|||
147518470|NCT05333289|532049860|FG000|Overall Study|Withdrawal by Subject|1|||
147518471|NCT05333289|532049861|FG001|Overall Study|Withdrawal by Subject|2|||
147518472|NCT05333289|532049862|FG002|Overall Study|Withdrawal by Subject|2|||
147518473|NCT05333289|532049863|FG003|Overall Study|Withdrawal by Subject|1|||
147518474|NCT05333289|532049864|FG004|Overall Study|Withdrawal by Subject|1|||
147518475|NCT05333289|532049865|FG005|Overall Study|Withdrawal by Subject|2|||
147518476|NCT05333289|532049866|FG006|Overall Study|Withdrawal by Subject|1|||
147518477|NCT05333289|532049867|FG007|Overall Study|Withdrawal by Subject|3|||
147518478|NCT05333289|532049860|FG000|Overall Study|Protocol Violation|1|||
147518479|NCT05333289|532049861|FG001|Overall Study|Protocol Violation|0|||
147518480|NCT05333289|532049862|FG002|Overall Study|Protocol Violation|0|||
147518481|NCT05333289|532049863|FG003|Overall Study|Protocol Violation|0|||
147518482|NCT05333289|532049864|FG004|Overall Study|Protocol Violation|0|||
147518483|NCT05333289|532049865|FG005|Overall Study|Protocol Violation|0|||
147518484|NCT05333289|532049866|FG006|Overall Study|Protocol Violation|0|||
147518485|NCT05333289|532049867|FG007|Overall Study|Protocol Violation|0|||
147518486|NCT05333289|532049860|FG000|Overall Study|Physician Decision|0|||
147518487|NCT05333289|532049861|FG001|Overall Study|Physician Decision|0|||
147518488|NCT05333289|532049862|FG002|Overall Study|Physician Decision|1|||
147518489|NCT05333289|532049863|FG003|Overall Study|Physician Decision|0|||
147518490|NCT05333289|532049864|FG004|Overall Study|Physician Decision|0|||
147518491|NCT05333289|532049865|FG005|Overall Study|Physician Decision|2|||
147641500|NCT04076059|532507657|FG001|Open Label Phase|Ongoing Participants|0|||
147641501|NCT04076059|532507658|FG002|Open Label Phase|Ongoing Participants|11|||
147641502|NCT02677896|532507659|FG000|Double Blind Period (up to 35 Months)|Death|117|||
147641503|NCT02677896|532507660|FG001|Double Blind Period (up to 35 Months)|Death|197|||
147641504|NCT02677896|532507659|FG000|Double Blind Period (up to 35 Months)|Lost to Follow-up|12|||
147641505|NCT02677896|532507660|FG001|Double Blind Period (up to 35 Months)|Lost to Follow-up|15|||
147641506|NCT02677896|532507659|FG000|Double Blind Period (up to 35 Months)|Progressive disease|3|||
147641507|NCT02677896|532507660|FG001|Double Blind Period (up to 35 Months)|Progressive disease|6|||
147641508|NCT02677896|532507659|FG000|Double Blind Period (up to 35 Months)|Withdrawal by Subject|41|||
147641509|NCT02677896|532507660|FG001|Double Blind Period (up to 35 Months)|Withdrawal by Subject|71|||
147641510|NCT02677896|532507659|FG000|Double Blind Period (up to 35 Months)|Miscellaneous|30|||
147641511|NCT02677896|532507660|FG001|Double Blind Period (up to 35 Months)|Miscellaneous|99|||
147641512|NCT02677896|532507659|FG000|Double Blind Period (up to 35 Months)|Continued in OLE|370|||
147641513|NCT02677896|532507660|FG001|Double Blind Period (up to 35 Months)|Continued in OLE|182|||
147641514|NCT02677896|532507659|FG000|Double Blind Period (up to 35 Months)|Discontinued by Sponsor|1|||
147641515|NCT02677896|532507660|FG001|Double Blind Period (up to 35 Months)|Discontinued by Sponsor|4|||
147641516|NCT02677896|532507659|FG000|Double Blind Period (up to 35 Months)|Randomized, Not Treated|0|||
147641517|NCT02677896|532507660|FG001|Double Blind Period (up to 35 Months)|Randomized, Not Treated|2|||
147641518|NCT02677896|532507659|FG000|Open-Label Extension (Approx. 66 Months)|Death|73|||
147641519|NCT02677896|532507660|FG001|Open-Label Extension (Approx. 66 Months)|Death|26|||
147641520|NCT02677896|532507659|FG000|Open-Label Extension (Approx. 66 Months)|Lost to Follow-up|8|||
147641521|NCT02677896|532507660|FG001|Open-Label Extension (Approx. 66 Months)|Lost to Follow-up|3|||
147641522|NCT02677896|532507659|FG000|Open-Label Extension (Approx. 66 Months)|Progressive disease|22|||
147641523|NCT02677896|532507660|FG001|Open-Label Extension (Approx. 66 Months)|Progressive disease|10|||
147641524|NCT02677896|532507659|FG000|Open-Label Extension (Approx. 66 Months)|Withdrawal by Subject|16|||
147641525|NCT02677896|532507660|FG001|Open-Label Extension (Approx. 66 Months)|Withdrawal by Subject|13|||
147641526|NCT02677896|532507659|FG000|Open-Label Extension (Approx. 66 Months)|Miscellaneous|241|||
147641527|NCT02677896|532507660|FG001|Open-Label Extension (Approx. 66 Months)|Miscellaneous|125|||
147641528|NCT02677896|532507659|FG000|Open-Label Extension (Approx. 66 Months)|Discontinued by Sponsor|10|||
147641529|NCT02677896|532507660|FG001|Open-Label Extension (Approx. 66 Months)|Discontinued by Sponsor|5|||
147641530|NCT03536949|532507676|FG000|Overall Study|Adverse Event|4|||
147641531|NCT03536949|532507677|FG001|Overall Study|Adverse Event|0|||
147641532|NCT03536949|532507676|FG000|Overall Study|Lost to Follow-up|2|||
147641533|NCT03536949|532507677|FG001|Overall Study|Lost to Follow-up|1|||
147641534|NCT03536949|532507676|FG000|Overall Study|Withdrawal by Subject|6|||
147641535|NCT03536949|532507677|FG001|Overall Study|Withdrawal by Subject|0|||
147641536|NCT03536949|532507676|FG000|Overall Study|Non-compliance|2|||
147641537|NCT03536949|532507677|FG001|Overall Study|Non-compliance|1|||
147641538|NCT04329091|532507680|FG000|Overall Study|Physician Decision|5|||
147641539|NCT00741091|532507683|FG000|Overall Study|Death|13|||
147641540|NCT00741091|532507683|FG000|Overall Study|Lost to Follow-up|16|||
147641541|NCT00741091|532507683|FG000|Overall Study|Withdrawal by Subject|6|||
147641542|NCT00741091|532507683|FG000|Overall Study|Missed Visit|22|||
147641543|NCT01801358|532507684|FG000|Overall Study|Adverse Event|0|||
147641544|NCT01801358|532507685|FG001|Overall Study|Adverse Event|2|||
147641545|NCT01801358|532507686|FG002|Overall Study|Adverse Event|1|||
147641546|NCT01801358|532507687|FG003|Overall Study|Adverse Event|0|||
147641547|NCT01801358|532507688|FG004|Overall Study|Adverse Event|0|||
147641548|NCT01801358|532507689|FG005|Overall Study|Adverse Event|1|||
147641549|NCT01801358|532507684|FG000|Overall Study|Physician Decision|0|||
147641550|NCT01801358|532507685|FG001|Overall Study|Physician Decision|0|||
147641551|NCT01801358|532507686|FG002|Overall Study|Physician Decision|1|||
147641552|NCT01801358|532507687|FG003|Overall Study|Physician Decision|0|||
147641553|NCT01801358|532507688|FG004|Overall Study|Physician Decision|0|||
147641554|NCT01801358|532507689|FG005|Overall Study|Physician Decision|0|||
147641555|NCT01801358|532507684|FG000|Overall Study|Progressive Disease|6|||
147641556|NCT01801358|532507685|FG001|Overall Study|Progressive Disease|4|||
147641557|NCT01801358|532507686|FG002|Overall Study|Progressive Disease|4|||
147641558|NCT01801358|532507687|FG003|Overall Study|Progressive Disease|5|||
147641559|NCT01801358|532507688|FG004|Overall Study|Progressive Disease|6|||
147641560|NCT01801358|532507689|FG005|Overall Study|Progressive Disease|5|||
147641561|NCT01801358|532507684|FG000|Overall Study|Withdrawal by Subject|0|||
147641562|NCT01801358|532507685|FG001|Overall Study|Withdrawal by Subject|0|||
147641563|NCT01801358|532507686|FG002|Overall Study|Withdrawal by Subject|0|||
147641564|NCT01801358|532507687|FG003|Overall Study|Withdrawal by Subject|1|||
147641565|NCT01801358|532507688|FG004|Overall Study|Withdrawal by Subject|0|||
147641566|NCT01801358|532507689|FG005|Overall Study|Withdrawal by Subject|2|||
147641567|NCT03787303|532507690|FG000|Overall Study|Death|1|||
147641568|NCT03787303|532507690|FG000|Overall Study|Premature Termination of Study|1|||
147641569|NCT01210495|532507693|FG000|Overall Study|Participant Refused Further Follow-Up|1|||
147641570|NCT01210495|532507694|FG001|Overall Study|Participant Refused Further Follow-Up|0|||
147641571|NCT01210495|532507695|FG002|Overall Study|Participant Refused Further Follow-Up|11|||
147641572|NCT01210495|532507696|FG003|Overall Study|Participant Refused Further Follow-Up|2|||
147641573|NCT01210495|532507693|FG000|Overall Study|Death|14|||
147641574|NCT01210495|532507694|FG001|Overall Study|Death|7|||
147641575|NCT01210495|532507695|FG002|Overall Study|Death|112|||
147641576|NCT01210495|532507696|FG003|Overall Study|Death|54|||
147641577|NCT01210495|532507693|FG000|Overall Study|Study Terminated by Sponsor|0|||
147641578|NCT01210495|532507694|FG001|Overall Study|Study Terminated by Sponsor|0|||
147641579|NCT01210495|532507695|FG002|Overall Study|Study Terminated by Sponsor|4|||
147641580|NCT01210495|532507696|FG003|Overall Study|Study Terminated by Sponsor|11|||
147641581|NCT01210495|532507693|FG000|Overall Study|Lost to Follow-up|0|||
147641582|NCT01210495|532507694|FG001|Overall Study|Lost to Follow-up|0|||
147641583|NCT01210495|532507695|FG002|Overall Study|Lost to Follow-up|1|||
147641584|NCT01210495|532507696|FG003|Overall Study|Lost to Follow-up|1|||
147641585|NCT01210495|532507693|FG000|Overall Study|Other unspecified|0|||
147641586|NCT01210495|532507694|FG001|Overall Study|Other unspecified|0|||
147641587|NCT01210495|532507695|FG002|Overall Study|Other unspecified|6|||
147641588|NCT01210495|532507696|FG003|Overall Study|Other unspecified|0|||
147641589|NCT00767039|532507699|FG000|Overall Study|Death|5|||
147641590|NCT00767039|532507700|FG001|Overall Study|Death|2|||
147641591|NCT01826370|532507701|FG000|Overall Study|Protocol Violation|6|||
147641592|NCT01826370|532507701|FG000|Overall Study|Lost to Follow-up|12|||
147641593|NCT01826370|532507701|FG000|Overall Study|Other reason not defined above|2|||
147641594|NCT04416737|532507703|FG000|Week 1 (First Injection)|Physician Decision|0|||
147641595|NCT04416737|532507704|FG001|Week 1 (First Injection)|Physician Decision|1|||
147641596|NCT03332628|532507705|FG000|Overall Study|Physician Decision|2|||
147641597|NCT01472757|532507706|FG000|Overall Study|Withdrawal by Subject|1|||
147641598|NCT01472757|532507707|FG001|Overall Study|Withdrawal by Subject|2|||
147641599|NCT01472757|532507708|FG002|Overall Study|Withdrawal by Subject|2|||
147641600|NCT01472757|532507709|FG003|Overall Study|Withdrawal by Subject|0|||
147641601|NCT01472757|532507706|FG000|Overall Study|Asthma exacerbation|4|||
147641602|NCT01472757|532507707|FG001|Overall Study|Asthma exacerbation|1|||
147641603|NCT01472757|532507708|FG002|Overall Study|Asthma exacerbation|2|||
147641604|NCT01472757|532507709|FG003|Overall Study|Asthma exacerbation|1|||
147641605|NCT01472757|532507706|FG000|Overall Study|Treatment period withdrawal criteria met|21|||
147641606|NCT01472757|532507707|FG001|Overall Study|Treatment period withdrawal criteria met|8|||
147641607|NCT01472757|532507708|FG002|Overall Study|Treatment period withdrawal criteria met|9|||
147641608|NCT01472757|532507709|FG003|Overall Study|Treatment period withdrawal criteria met|12|||
147641609|NCT01472757|532507706|FG000|Overall Study|Protocol Violation|3|||
147641610|NCT01472757|532507707|FG001|Overall Study|Protocol Violation|2|||
147641611|NCT01472757|532507708|FG002|Overall Study|Protocol Violation|4|||
147641612|NCT01472757|532507709|FG003|Overall Study|Protocol Violation|4|||
147641613|NCT01472757|532507706|FG000|Overall Study|Other reasons|1|||
147641614|NCT01472757|532507707|FG001|Overall Study|Other reasons|0|||
147641615|NCT01472757|532507708|FG002|Overall Study|Other reasons|2|||
147641616|NCT01472757|532507709|FG003|Overall Study|Other reasons|2|||
147641617|NCT02505334|532507716|FG000|Main Treatment Period|Adverse Event|3|||
147641618|NCT02505334|532507717|FG001|Main Treatment Period|Adverse Event|3|||
147641619|NCT02505334|532507716|FG000|Main Treatment Period|Lack of Efficacy|7|||
147641620|NCT02505334|532507717|FG001|Main Treatment Period|Lack of Efficacy|17|||
147641621|NCT02505334|532507716|FG000|Main Treatment Period|Protocol Violation|0|||
147641622|NCT02505334|532507717|FG001|Main Treatment Period|Protocol Violation|1|||
147641623|NCT02505334|532507716|FG000|Main Treatment Period|Withdrawal by Subject|1|||
147641624|NCT02505334|532507717|FG001|Main Treatment Period|Withdrawal by Subject|8|||
147641625|NCT02505334|532507716|FG000|Main Treatment Period|Unclassified|4|||
147641626|NCT02505334|532507717|FG001|Main Treatment Period|Unclassified|10|||
147641627|NCT02505334|532507716|FG000|Extension Treatment Period|Adverse Event|5|||
147641628|NCT02505334|532507717|FG001|Extension Treatment Period|Adverse Event|0|||
147641629|NCT02505334|532507716|FG000|Extension Treatment Period|Lack of Efficacy|4|||
147641630|NCT02505334|532507717|FG001|Extension Treatment Period|Lack of Efficacy|0|||
147641631|NCT02505334|532507716|FG000|Extension Treatment Period|Withdrawal by Subject|6|||
147641632|NCT02505334|532507717|FG001|Extension Treatment Period|Withdrawal by Subject|0|||
147641633|NCT02505334|532507716|FG000|Extension Treatment Period|Unclassified|3|||
147641634|NCT02505334|532507717|FG001|Extension Treatment Period|Unclassified|0|||
147641635|NCT02543892|532507718|FG000|Received Vaccination 2|Withdrawal by Subject|1|||
147641636|NCT02543892|532507719|FG001|Received Vaccination 2|Withdrawal by Subject|0|||
147641637|NCT02543892|532507720|FG002|Received Vaccination 2|Withdrawal by Subject|0|||
147641638|NCT02543892|532507721|FG003|Received Vaccination 2|Withdrawal by Subject|0|||
147641639|NCT02543892|532507722|FG004|Received Vaccination 2|Withdrawal by Subject|0|||
147641640|NCT02543892|532507723|FG005|Received Vaccination 2|Withdrawal by Subject|0|||
147641641|NCT02543892|532507724|FG006|Received Vaccination 2|Withdrawal by Subject|0|||
147641642|NCT02543892|532507725|FG007|Received Vaccination 2|Withdrawal by Subject|1|||
147641643|NCT02543892|532507718|FG000|Received Vaccination 2|Physician Decision|0|||
147641644|NCT02543892|532507719|FG001|Received Vaccination 2|Physician Decision|0|||
147641645|NCT02543892|532507720|FG002|Received Vaccination 2|Physician Decision|0|||
147641646|NCT02543892|532507721|FG003|Received Vaccination 2|Physician Decision|0|||
147641647|NCT02543892|532507722|FG004|Received Vaccination 2|Physician Decision|0|||
147641648|NCT02543892|532507723|FG005|Received Vaccination 2|Physician Decision|1|||
147641649|NCT02543892|532507724|FG006|Received Vaccination 2|Physician Decision|0|||
147641650|NCT02543892|532507725|FG007|Received Vaccination 2|Physician Decision|0|||
147641651|NCT02543892|532507718|FG000|Received Vaccination 2|Adverse Event|0|||
147641652|NCT02543892|532507719|FG001|Received Vaccination 2|Adverse Event|1|||
147641653|NCT02543892|532507720|FG002|Received Vaccination 2|Adverse Event|0|||
147641654|NCT02543892|532507721|FG003|Received Vaccination 2|Adverse Event|0|||
147641655|NCT02543892|532507722|FG004|Received Vaccination 2|Adverse Event|0|||
147641656|NCT02543892|532507723|FG005|Received Vaccination 2|Adverse Event|0|||
147641657|NCT02543892|532507724|FG006|Received Vaccination 2|Adverse Event|0|||
147641658|NCT02543892|532507725|FG007|Received Vaccination 2|Adverse Event|0|||
147641659|NCT02543892|532507718|FG000|Had Immunology Data|Withdrawal by Subject|0|||
147641660|NCT02543892|532507719|FG001|Had Immunology Data|Withdrawal by Subject|0|||
147641661|NCT02543892|532507720|FG002|Had Immunology Data|Withdrawal by Subject|0|||
147641662|NCT02543892|532507721|FG003|Had Immunology Data|Withdrawal by Subject|0|||
147641663|NCT02543892|532507722|FG004|Had Immunology Data|Withdrawal by Subject|0|||
147641664|NCT02543892|532507723|FG005|Had Immunology Data|Withdrawal by Subject|0|||
147641665|NCT02543892|532507724|FG006|Had Immunology Data|Withdrawal by Subject|1|||
147641666|NCT02543892|532507725|FG007|Had Immunology Data|Withdrawal by Subject|0|||
147641667|NCT00081731|532507726|FG000|Overall Study|scientific integrity issue|8|||
147641668|NCT00081731|532507727|FG001|Overall Study|scientific integrity issue|8|||
147641669|NCT01259375|532507728|FG000|Overall Study|Adverse Event|1|||
147641670|NCT00628095|532507729|FG000|Overall Study|Adverse Event|5|||
147641671|NCT00628095|532507730|FG001|Overall Study|Adverse Event|3|||
147641672|NCT00628095|532507729|FG000|Overall Study|Lack of Efficacy|0|||
147641673|NCT00628095|532507730|FG001|Overall Study|Lack of Efficacy|3|||
147641674|NCT00628095|532507729|FG000|Overall Study|Withdrawal by Subject|2|||
147641675|NCT00628095|532507730|FG001|Overall Study|Withdrawal by Subject|0|||
147641676|NCT00628095|532507729|FG000|Overall Study|Other|0|||
147641677|NCT00628095|532507730|FG001|Overall Study|Other|1|||
147641678|NCT00478699|532507733|FG000|Overall Study|Inclusion Error|1|||
147641679|NCT00478699|532507734|FG001|Overall Study|Inclusion Error|7|||
147641680|NCT00478699|532507733|FG000|Overall Study|Not receive study treatment|6|||
147641681|NCT00478699|532507734|FG001|Overall Study|Not receive study treatment|30|||
147641682|NCT00656851|532507745|FG000|Overall Study|Withdrawal by Subject|0|||
147641683|NCT00656851|532507746|FG001|Overall Study|Withdrawal by Subject|4|||
147641684|NCT03932331|532507749|FG000|Overall Study|Death|0|||
147641685|NCT03932331|532507750|FG001|Overall Study|Death|7|||
147518492|NCT05333289|532049866|FG006|Overall Study|Physician Decision|0|||
147641686|NCT03932331|532507751|FG002|Overall Study|Death|2|||
147641687|NCT03932331|532507749|FG000|Overall Study|Withdrawal by Subject|0|||
147641688|NCT03932331|532507750|FG001|Overall Study|Withdrawal by Subject|3|||
147641689|NCT03932331|532507751|FG002|Overall Study|Withdrawal by Subject|0|||
147641690|NCT03932331|532507749|FG000|Overall Study|Meet the point of final analysis for this cohort|8|||
147641691|NCT03932331|532507750|FG001|Overall Study|Meet the point of final analysis for this cohort|23|||
147641692|NCT03932331|532507751|FG002|Overall Study|Meet the point of final analysis for this cohort|0|||
147641693|NCT03932331|532507749|FG000|Overall Study|Progressive disease|3|||
147641694|NCT03932331|532507750|FG001|Overall Study|Progressive disease|0|||
147641695|NCT03932331|532507751|FG002|Overall Study|Progressive disease|0|||
147641696|NCT03932331|532507749|FG000|Overall Study|Lung infection|1|||
147641697|NCT03932331|532507750|FG001|Overall Study|Lung infection|0|||
147641698|NCT03932331|532507751|FG002|Overall Study|Lung infection|0|||
147641699|NCT03932331|532507749|FG000|Overall Study|Other|0|||
147641700|NCT03932331|532507750|FG001|Overall Study|Other|0|||
147641701|NCT03932331|532507751|FG002|Overall Study|Other|58|||
147641702|NCT03782298|532507752|FG000|Overall Study|Protocol Deviation|4|||
147641703|NCT01797081|532507753|FG000|Overall Study|Adverse Event|1|||
147641704|NCT01797081|532507754|FG001|Overall Study|Adverse Event|0|||
147641705|NCT01797081|532507755|FG002|Overall Study|Adverse Event|1|||
147641706|NCT01797081|532507756|FG003|Overall Study|Adverse Event|0|||
147641707|NCT01797081|532507753|FG000|Overall Study|Pregnancy|1|||
147641708|NCT01797081|532507754|FG001|Overall Study|Pregnancy|0|||
147641709|NCT01797081|532507755|FG002|Overall Study|Pregnancy|0|||
147641710|NCT01797081|532507756|FG003|Overall Study|Pregnancy|0|||
147641711|NCT01797081|532507753|FG000|Overall Study|Personal Reasons|12|||
147518493|NCT05333289|532049867|FG007|Overall Study|Physician Decision|0|||
147518494|NCT05333289|532049860|FG000|Overall Study|Lost to Follow-up|6|||
147518495|NCT05333289|532049861|FG001|Overall Study|Lost to Follow-up|0|||
147518496|NCT05333289|532049862|FG002|Overall Study|Lost to Follow-up|1|||
147518497|NCT05333289|532049863|FG003|Overall Study|Lost to Follow-up|6|||
147518498|NCT05333289|532049864|FG004|Overall Study|Lost to Follow-up|3|||
147518499|NCT05333289|532049865|FG005|Overall Study|Lost to Follow-up|3|||
147518500|NCT05333289|532049866|FG006|Overall Study|Lost to Follow-up|2|||
147641712|NCT01797081|532507754|FG001|Overall Study|Personal Reasons|4|||
147641713|NCT01797081|532507755|FG002|Overall Study|Personal Reasons|4|||
147518501|NCT05333289|532049867|FG007|Overall Study|Lost to Follow-up|1|||
147641714|NCT01797081|532507756|FG003|Overall Study|Personal Reasons|8|||
147641715|NCT01797081|532507753|FG000|Overall Study|Protocol Violation|0|||
147641716|NCT01797081|532507754|FG001|Overall Study|Protocol Violation|0|||
147641717|NCT01797081|532507755|FG002|Overall Study|Protocol Violation|0|||
147641718|NCT01797081|532507756|FG003|Overall Study|Protocol Violation|1|||
147641719|NCT05513703|532507760|FG000|Overall Study|Death|4|||
147518502|NCT05333289|532049860|FG000|Overall Study|Death|1|||
147518503|NCT05333289|532049861|FG001|Overall Study|Death|0|||
147518504|NCT05333289|532049862|FG002|Overall Study|Death|0|||
147518505|NCT05333289|532049863|FG003|Overall Study|Death|0|||
147641720|NCT05513703|532507760|FG000|Overall Study|Study terminated by sponsor|5|||
147641721|NCT01793688|532507763|FG000|Overall Study|Protocol Violation|2|||
147641722|NCT03649178|532507764|FG000|Overall Study|Adverse Event|1|||
147641723|NCT03649178|532507765|FG001|Overall Study|Adverse Event|2|||
147641724|NCT03649178|532507764|FG000|Overall Study|Withdrawal by Subject|0|||
147641725|NCT03649178|532507765|FG001|Overall Study|Withdrawal by Subject|2|||
147641726|NCT03649178|532507764|FG000|Overall Study|COVID regulation required halt in protocol|1|||
147641727|NCT03649178|532507765|FG001|Overall Study|COVID regulation required halt in protocol|0|||
147641728|NCT03003494|532507766|FG000|Overall Study|Evaluable PF10 questionnaire at visit1|28|||
147641729|NCT05238025|532507767|FG000|Overall Study|Adverse Event|2|||
147641730|NCT05238025|532507768|FG001|Overall Study|Adverse Event|2|||
147641731|NCT05238025|532507767|FG000|Overall Study|Lost to Follow-up|334|||
147641732|NCT05238025|532507768|FG001|Overall Study|Lost to Follow-up|339|||
147641733|NCT05238025|532507767|FG000|Overall Study|Withdrawal by Subject|203|||
147641734|NCT05238025|532507768|FG001|Overall Study|Withdrawal by Subject|222|||
147641735|NCT05238025|532507767|FG000|Overall Study|Physician Decision|20|||
147641736|NCT05238025|532507768|FG001|Overall Study|Physician Decision|8|||
147641737|NCT05238025|532507767|FG000|Overall Study|Protocol Violation|6|||
147641738|NCT05238025|532507768|FG001|Overall Study|Protocol Violation|2|||
147641739|NCT05238025|532507767|FG000|Overall Study|Death|38|||
147641740|NCT05238025|532507768|FG001|Overall Study|Death|32|||
147641741|NCT05238025|532507767|FG000|Overall Study|Study terminated by Sponsor|6358|||
147641742|NCT05238025|532507768|FG001|Overall Study|Study terminated by Sponsor|6358|||
147641743|NCT05238025|532507767|FG000|Overall Study|Other Reason|669|||
147641744|NCT05238025|532507768|FG001|Overall Study|Other Reason|690|||
147641745|NCT02135107|532507773|FG000|Treatment Period|Withdrawal by Subject|11|||
147641746|NCT02135107|532507774|FG001|Treatment Period|Withdrawal by Subject|0|||
147641747|NCT02135107|532507775|FG002|Treatment Period|Withdrawal by Subject|0|||
147641748|NCT02135107|532507776|FG003|Treatment Period|Withdrawal by Subject|0|||
147641749|NCT02135107|532507773|FG000|Treatment Period|Adverse Event|5|||
147641750|NCT02135107|532507774|FG001|Treatment Period|Adverse Event|2|||
147641751|NCT02135107|532507775|FG002|Treatment Period|Adverse Event|0|||
147641752|NCT02135107|532507776|FG003|Treatment Period|Adverse Event|0|||
147641753|NCT02135107|532507773|FG000|Treatment Period|Pregnancy|1|||
147641754|NCT02135107|532507774|FG001|Treatment Period|Pregnancy|0|||
147641755|NCT02135107|532507775|FG002|Treatment Period|Pregnancy|0|||
147641756|NCT02135107|532507776|FG003|Treatment Period|Pregnancy|0|||
147641757|NCT02135107|532507773|FG000|Treatment Period|Other|115|||
147641758|NCT02135107|532507774|FG001|Treatment Period|Other|24|||
147641759|NCT02135107|532507775|FG002|Treatment Period|Other|0|||
147641760|NCT02135107|532507776|FG003|Treatment Period|Other|0|||
147641761|NCT02135107|532507773|FG000|Maintenance Therapy Period|Adverse Event|0|||
147641762|NCT02135107|532507774|FG001|Maintenance Therapy Period|Adverse Event|0|||
147641763|NCT02135107|532507775|FG002|Maintenance Therapy Period|Adverse Event|3|||
147641764|NCT02135107|532507776|FG003|Maintenance Therapy Period|Adverse Event|7|||
147641765|NCT02135107|532507773|FG000|Maintenance Therapy Period|Withdrawal by Subject|0|||
147641766|NCT02135107|532507774|FG001|Maintenance Therapy Period|Withdrawal by Subject|0|||
147641767|NCT02135107|532507775|FG002|Maintenance Therapy Period|Withdrawal by Subject|5|||
147641768|NCT02135107|532507776|FG003|Maintenance Therapy Period|Withdrawal by Subject|4|||
147641769|NCT02135107|532507773|FG000|Maintenance Therapy Period|Pregnancy|0|||
147641770|NCT02135107|532507774|FG001|Maintenance Therapy Period|Pregnancy|0|||
147641771|NCT02135107|532507775|FG002|Maintenance Therapy Period|Pregnancy|0|||
147641772|NCT02135107|532507776|FG003|Maintenance Therapy Period|Pregnancy|1|||
147641773|NCT02135107|532507773|FG000|Maintenance Therapy Period|Other|0|||
147641774|NCT02135107|532507774|FG001|Maintenance Therapy Period|Other|0|||
147641775|NCT02135107|532507775|FG002|Maintenance Therapy Period|Other|7|||
147641776|NCT02135107|532507776|FG003|Maintenance Therapy Period|Other|8|||
147641777|NCT02278120|532507784|FG000|Treatment Period|Progressive disease|234|||
147641778|NCT02278120|532507785|FG001|Treatment Period|Progressive disease|260|||
147641779|NCT02278120|532507784|FG000|Treatment Period|Subject/guardian decision|23|||
147641780|NCT02278120|532507785|FG001|Treatment Period|Subject/guardian decision|20|||
147641781|NCT02278120|532507784|FG000|Treatment Period|Adverse Event|16|||
147641782|NCT02278120|532507785|FG001|Treatment Period|Adverse Event|14|||
147641783|NCT02278120|532507784|FG000|Treatment Period|Physician Decision|14|||
147641784|NCT02278120|532507785|FG001|Treatment Period|Physician Decision|27|||
147641785|NCT02278120|532507784|FG000|Treatment Period|Death|3|||
147518506|NCT05333289|532049864|FG004|Overall Study|Death|0|||
147518507|NCT05333289|532049865|FG005|Overall Study|Death|0|||
147518508|NCT05333289|532049866|FG006|Overall Study|Death|0|||
147641786|NCT02278120|532507785|FG001|Treatment Period|Death|3|||
147641787|NCT02278120|532507784|FG000|Treatment Period|Lost to Follow-up|2|||
147641788|NCT02278120|532507785|FG001|Treatment Period|Lost to Follow-up|0|||
147641789|NCT02278120|532507784|FG000|Treatment Period|Protocol deviation|0|||
147641790|NCT02278120|532507785|FG001|Treatment Period|Protocol deviation|2|||
147641791|NCT02278120|532507784|FG000|Treatment Period|Study terminated as per protocol|43|||
147641792|NCT02278120|532507785|FG001|Treatment Period|Study terminated as per protocol|11|||
147641793|NCT02278120|532507784|FG000|Post-treatment Efficacy Follow-up|Death|0|||
147641794|NCT02278120|532507785|FG001|Post-treatment Efficacy Follow-up|Death|1|||
147641795|NCT02278120|532507784|FG000|Post-treatment Efficacy Follow-up|Subject/guardian decision|1|||
147641796|NCT02278120|532507785|FG001|Post-treatment Efficacy Follow-up|Subject/guardian decision|2|||
147641797|NCT02278120|532507784|FG000|Post-treatment Efficacy Follow-up|Study terminated as per protocol|8|||
147641798|NCT02278120|532507785|FG001|Post-treatment Efficacy Follow-up|Study terminated as per protocol|3|||
147641799|NCT02278120|532507784|FG000|Post-treatment Efficacy Follow-up|Progressive disease|12|||
147641800|NCT02278120|532507785|FG001|Post-treatment Efficacy Follow-up|Progressive disease|7|||
147641801|NCT02278120|532507784|FG000|Post-treatment Efficacy Follow-up|Physician Decision|1|||
147641802|NCT02278120|532507785|FG001|Post-treatment Efficacy Follow-up|Physician Decision|1|||
147641803|NCT03197324|532507786|FG000|Overall Study|Adverse Event|0|||
147641804|NCT03197324|532507787|FG001|Overall Study|Adverse Event|1|||
147641805|NCT00102531|532507788|FG000|Overall Study|Adverse Event|0|||
147641806|NCT00102531|532507789|FG001|Overall Study|Adverse Event|1|||
147641807|NCT00102531|532507788|FG000|Overall Study|Disease Progression|5|||
147641808|NCT00102531|532507789|FG001|Overall Study|Disease Progression|9|||
147641809|NCT00102531|532507788|FG000|Overall Study|Physician Decision|0|||
147641810|NCT00102531|532507789|FG001|Overall Study|Physician Decision|1|||
147641811|NCT00954512|532507791|FG000|Overall Study|Withdrawal by Subject|0|||
147641812|NCT00954512|532507792|FG001|Overall Study|Withdrawal by Subject|0|||
147641813|NCT00954512|532507793|FG002|Overall Study|Withdrawal by Subject|0|||
147641814|NCT00954512|532507794|FG003|Overall Study|Withdrawal by Subject|0|||
147641815|NCT00954512|532507795|FG004|Overall Study|Withdrawal by Subject|0|||
147641816|NCT00954512|532507796|FG005|Overall Study|Withdrawal by Subject|1|||
147641817|NCT00954512|532507791|FG000|Overall Study|Adverse Event|0|||
147641818|NCT00954512|532507792|FG001|Overall Study|Adverse Event|0|||
147641819|NCT00954512|532507793|FG002|Overall Study|Adverse Event|0|||
147641820|NCT00954512|532507794|FG003|Overall Study|Adverse Event|0|||
147641821|NCT00954512|532507795|FG004|Overall Study|Adverse Event|1|||
147641822|NCT00954512|532507796|FG005|Overall Study|Adverse Event|2|||
147641823|NCT00954512|532507791|FG000|Overall Study|Physician Decision|0|||
147641824|NCT00954512|532507792|FG001|Overall Study|Physician Decision|1|||
147641825|NCT00954512|532507793|FG002|Overall Study|Physician Decision|0|||
147641826|NCT00954512|532507794|FG003|Overall Study|Physician Decision|1|||
147641827|NCT00954512|532507795|FG004|Overall Study|Physician Decision|0|||
147641828|NCT00954512|532507796|FG005|Overall Study|Physician Decision|0|||
147641829|NCT00954512|532507791|FG000|Overall Study|Symptomatic Deterioration|0|||
147641830|NCT00954512|532507792|FG001|Overall Study|Symptomatic Deterioration|1|||
147641831|NCT00954512|532507793|FG002|Overall Study|Symptomatic Deterioration|0|||
147641832|NCT00954512|532507794|FG003|Overall Study|Symptomatic Deterioration|0|||
147641833|NCT00954512|532507795|FG004|Overall Study|Symptomatic Deterioration|2|||
147641834|NCT00954512|532507796|FG005|Overall Study|Symptomatic Deterioration|0|||
147641835|NCT00954512|532507791|FG000|Overall Study|Progression of Disease|2|||
147641836|NCT00954512|532507792|FG001|Overall Study|Progression of Disease|1|||
147641837|NCT00954512|532507793|FG002|Overall Study|Progression of Disease|0|||
147641838|NCT00954512|532507794|FG003|Overall Study|Progression of Disease|1|||
147641839|NCT00954512|532507795|FG004|Overall Study|Progression of Disease|1|||
147641840|NCT00954512|532507796|FG005|Overall Study|Progression of Disease|1|||
147641841|NCT05685732|532507797|FG000|Overall Study|Withdrawal by Subject|2|||
147641842|NCT05685732|532507798|FG001|Overall Study|Withdrawal by Subject|0|||
147641843|NCT05685732|532507799|FG002|Overall Study|Withdrawal by Subject|2|||
147641844|NCT05685732|532507800|FG003|Overall Study|Withdrawal by Subject|3|||
147641845|NCT05685732|532507797|FG000|Overall Study|Protocol Violation|1|||
147641846|NCT05685732|532507798|FG001|Overall Study|Protocol Violation|2|||
147641847|NCT05685732|532507799|FG002|Overall Study|Protocol Violation|4|||
147641848|NCT05685732|532507800|FG003|Overall Study|Protocol Violation|1|||
147641849|NCT05685732|532507797|FG000|Overall Study|Lost to Follow-up|5|||
147641850|NCT05685732|532507798|FG001|Overall Study|Lost to Follow-up|1|||
147641851|NCT05685732|532507799|FG002|Overall Study|Lost to Follow-up|3|||
147641852|NCT05685732|532507800|FG003|Overall Study|Lost to Follow-up|1|||
147641853|NCT05685732|532507797|FG000|Overall Study|Adverse Event|2|||
147641854|NCT05685732|532507798|FG001|Overall Study|Adverse Event|1|||
147641855|NCT05685732|532507799|FG002|Overall Study|Adverse Event|0|||
147641856|NCT05685732|532507800|FG003|Overall Study|Adverse Event|0|||
147641857|NCT05685732|532507797|FG000|Overall Study|Physician Decision|1|||
147641858|NCT05685732|532507798|FG001|Overall Study|Physician Decision|0|||
147641859|NCT05685732|532507799|FG002|Overall Study|Physician Decision|0|||
147641860|NCT05685732|532507800|FG003|Overall Study|Physician Decision|0|||
147641861|NCT02640404|532507801|FG000|Overall Study|Protocol Violation|1|||
147641862|NCT02640404|532507802|FG001|Overall Study|Protocol Violation|0|||
147641863|NCT02640404|532507801|FG000|Overall Study|Withdrawal by Subject|1|||
147641864|NCT02640404|532507802|FG001|Overall Study|Withdrawal by Subject|0|||
147641865|NCT04908202|532507804|FG000|Pre-Treatment Period|OTHER REASONS|3|||
147641866|NCT04908202|532507805|FG001|Pre-Treatment Period|OTHER REASONS|1|||
147518509|NCT05333289|532049867|FG007|Overall Study|Death|0|||
147518510|NCT02010567|532049870|FG000|Overall Study|Adverse Event|0|||
147518511|NCT02010567|532049871|FG001|Overall Study|Adverse Event|0|||
147641867|NCT04908202|532507806|FG002|Pre-Treatment Period|OTHER REASONS|0|||
147641868|NCT04908202|532507807|FG003|Pre-Treatment Period|OTHER REASONS|0|||
147641869|NCT04908202|532507804|FG000|Pre-Treatment Period|PARTICIPANT WITHDREW CONSENT|1|||
147641870|NCT04908202|532507805|FG001|Pre-Treatment Period|PARTICIPANT WITHDREW CONSENT|0|||
147641871|NCT04908202|532507806|FG002|Pre-Treatment Period|PARTICIPANT WITHDREW CONSENT|0|||
147641872|NCT04908202|532507807|FG003|Pre-Treatment Period|PARTICIPANT WITHDREW CONSENT|0|||
147641873|NCT04908202|532507804|FG000|Placebo-Controlled Treatment Period|Lack of Efficacy|1|||
147641874|NCT04908202|532507805|FG001|Placebo-Controlled Treatment Period|Lack of Efficacy|2|||
147641875|NCT04908202|532507806|FG002|Placebo-Controlled Treatment Period|Lack of Efficacy|0|||
147641876|NCT04908202|532507807|FG003|Placebo-Controlled Treatment Period|Lack of Efficacy|0|||
147641877|NCT04908202|532507804|FG000|Placebo-Controlled Treatment Period|Adverse Event|8|||
147641878|NCT04908202|532507805|FG001|Placebo-Controlled Treatment Period|Adverse Event|6|||
147641879|NCT04908202|532507806|FG002|Placebo-Controlled Treatment Period|Adverse Event|0|||
147641880|NCT04908202|532507807|FG003|Placebo-Controlled Treatment Period|Adverse Event|0|||
147641881|NCT04908202|532507804|FG000|Placebo-Controlled Treatment Period|PARTICIPANT REQUEST TO DISCONTINUE STUDY TREATMENT|2|||
147641882|NCT04908202|532507805|FG001|Placebo-Controlled Treatment Period|PARTICIPANT REQUEST TO DISCONTINUE STUDY TREATMENT|3|||
147641883|NCT04908202|532507806|FG002|Placebo-Controlled Treatment Period|PARTICIPANT REQUEST TO DISCONTINUE STUDY TREATMENT|0|||
147641884|NCT04908202|532507807|FG003|Placebo-Controlled Treatment Period|PARTICIPANT REQUEST TO DISCONTINUE STUDY TREATMENT|0|||
147641885|NCT04908202|532507804|FG000|Placebo-Controlled Treatment Period|PARTICIPANT WITHDREW CONSENT|4|||
147641886|NCT04908202|532507805|FG001|Placebo-Controlled Treatment Period|PARTICIPANT WITHDREW CONSENT|10|||
147641887|NCT04908202|532507806|FG002|Placebo-Controlled Treatment Period|PARTICIPANT WITHDREW CONSENT|0|||
147641888|NCT04908202|532507807|FG003|Placebo-Controlled Treatment Period|PARTICIPANT WITHDREW CONSENT|0|||
147641889|NCT04908202|532507804|FG000|Placebo-Controlled Treatment Period|Lost to Follow-up|0|||
147641890|NCT04908202|532507805|FG001|Placebo-Controlled Treatment Period|Lost to Follow-up|1|||
147518512|NCT02010567|532049872|FG002|Overall Study|Adverse Event|1|||
147518513|NCT02010567|532049873|FG003|Overall Study|Adverse Event|0|||
147518514|NCT02010567|532049874|FG004|Overall Study|Adverse Event|1|||
147518515|NCT00118040|532049875|FG000|Overall Study|Adverse Event|0|||
147518516|NCT00118040|532049876|FG001|Overall Study|Adverse Event|1|||
147518517|NCT00118040|532049877|FG002|Overall Study|Adverse Event|0|||
147518518|NCT00118040|532049875|FG000|Overall Study|Withdrawal by Subject|0|||
147641891|NCT04908202|532507806|FG002|Placebo-Controlled Treatment Period|Lost to Follow-up|0|||
147641892|NCT04908202|532507807|FG003|Placebo-Controlled Treatment Period|Lost to Follow-up|0|||
147641893|NCT04908202|532507804|FG000|Placebo-Controlled Treatment Period|ADMINISTRATIVE REASONS BY SPONSOR|0|||
147641894|NCT04908202|532507805|FG001|Placebo-Controlled Treatment Period|ADMINISTRATIVE REASONS BY SPONSOR|1|||
147641895|NCT04908202|532507806|FG002|Placebo-Controlled Treatment Period|ADMINISTRATIVE REASONS BY SPONSOR|0|||
147641896|NCT04908202|532507807|FG003|Placebo-Controlled Treatment Period|ADMINISTRATIVE REASONS BY SPONSOR|0|||
147641897|NCT04908202|532507804|FG000|Placebo-Controlled Treatment Period|Other reasons|8|||
147641898|NCT04908202|532507805|FG001|Placebo-Controlled Treatment Period|Other reasons|4|||
147641899|NCT04908202|532507806|FG002|Placebo-Controlled Treatment Period|Other reasons|0|||
147641900|NCT04908202|532507807|FG003|Placebo-Controlled Treatment Period|Other reasons|0|||
147641901|NCT04908202|532507804|FG000|Active Treatment Period|OTHER REASONS|0|||
147641902|NCT04908202|532507805|FG001|Active Treatment Period|OTHER REASONS|0|||
147641903|NCT04908202|532507806|FG002|Active Treatment Period|OTHER REASONS|1|||
147641904|NCT04908202|532507807|FG003|Active Treatment Period|OTHER REASONS|3|||
147641905|NCT04908202|532507804|FG000|Active Treatment Period|Lack of Efficacy|0|||
147641906|NCT04908202|532507805|FG001|Active Treatment Period|Lack of Efficacy|0|||
147641907|NCT04908202|532507806|FG002|Active Treatment Period|Lack of Efficacy|4|||
147641908|NCT04908202|532507807|FG003|Active Treatment Period|Lack of Efficacy|5|||
147641909|NCT04908202|532507804|FG000|Active Treatment Period|Adverse Event|0|||
147641910|NCT04908202|532507805|FG001|Active Treatment Period|Adverse Event|0|||
147641911|NCT04908202|532507806|FG002|Active Treatment Period|Adverse Event|5|||
147641912|NCT04908202|532507807|FG003|Active Treatment Period|Adverse Event|8|||
147641913|NCT04908202|532507804|FG000|Active Treatment Period|PARTICIPANT REQUEST TO DISCONTINUE STUDY TREATMENT|0|||
147641914|NCT04908202|532507805|FG001|Active Treatment Period|PARTICIPANT REQUEST TO DISCONTINUE STUDY TREATMENT|0|||
147641915|NCT04908202|532507806|FG002|Active Treatment Period|PARTICIPANT REQUEST TO DISCONTINUE STUDY TREATMENT|2|||
147641916|NCT04908202|532507807|FG003|Active Treatment Period|PARTICIPANT REQUEST TO DISCONTINUE STUDY TREATMENT|2|||
147641917|NCT04908202|532507804|FG000|Active Treatment Period|PARTICIPANT WITHDREW CONSENT|0|||
147641918|NCT04908202|532507805|FG001|Active Treatment Period|PARTICIPANT WITHDREW CONSENT|0|||
147641919|NCT04908202|532507806|FG002|Active Treatment Period|PARTICIPANT WITHDREW CONSENT|8|||
147641920|NCT04908202|532507807|FG003|Active Treatment Period|PARTICIPANT WITHDREW CONSENT|11|||
147641921|NCT04908202|532507804|FG000|Active Treatment Period|Lost to Follow-up|0|||
147641922|NCT04908202|532507805|FG001|Active Treatment Period|Lost to Follow-up|0|||
147641923|NCT04908202|532507806|FG002|Active Treatment Period|Lost to Follow-up|2|||
147641924|NCT04908202|532507807|FG003|Active Treatment Period|Lost to Follow-up|2|||
147641925|NCT04908202|532507804|FG000|Active Treatment Period|POOR/NON-COMPLIANCE|0|||
147641926|NCT04908202|532507805|FG001|Active Treatment Period|POOR/NON-COMPLIANCE|0|||
147641927|NCT04908202|532507806|FG002|Active Treatment Period|POOR/NON-COMPLIANCE|1|||
147641928|NCT04908202|532507807|FG003|Active Treatment Period|POOR/NON-COMPLIANCE|0|||
147641929|NCT04908202|532507804|FG000|Active Treatment Period|ADMINISTRATIVE REASONS BY SPONSOR|0|||
147641930|NCT04908202|532507805|FG001|Active Treatment Period|ADMINISTRATIVE REASONS BY SPONSOR|0|||
147641931|NCT04908202|532507806|FG002|Active Treatment Period|ADMINISTRATIVE REASONS BY SPONSOR|1|||
147641932|NCT04908202|532507807|FG003|Active Treatment Period|ADMINISTRATIVE REASONS BY SPONSOR|1|||
147641933|NCT04908202|532507804|FG000|Active Treatment Period|ONGOING Treatment|0|||
147641934|NCT04908202|532507805|FG001|Active Treatment Period|ONGOING Treatment|0|||
147641935|NCT04908202|532507806|FG002|Active Treatment Period|ONGOING Treatment|117|||
147641936|NCT04908202|532507807|FG003|Active Treatment Period|ONGOING Treatment|114|||
147641937|NCT05397171|532507808|FG000|Overall Study|Death|2|||
147641938|NCT05397171|532507809|FG001|Overall Study|Death|3|||
147641939|NCT05397171|532507810|FG002|Overall Study|Death|3|||
147641940|NCT05397171|532507808|FG000|Overall Study|Study Terminated By Sponsor|1|||
147641941|NCT05397171|532507809|FG001|Overall Study|Study Terminated By Sponsor|2|||
147641942|NCT05397171|532507810|FG002|Overall Study|Study Terminated By Sponsor|3|||
147641943|NCT05397171|532507808|FG000|Overall Study|Withdrawal by Subject|0|||
147641944|NCT05397171|532507809|FG001|Overall Study|Withdrawal by Subject|1|||
147641945|NCT05397171|532507810|FG002|Overall Study|Withdrawal by Subject|1|||
147641946|NCT02100670|532507811|FG000|Overall Study|Adverse Event|10|||
147641947|NCT02100670|532507812|FG001|Overall Study|Adverse Event|3|||
147641948|NCT02100670|532507813|FG002|Overall Study|Adverse Event|3|||
147641949|NCT02100670|532507814|FG003|Overall Study|Adverse Event|0|||
147641950|NCT02100670|532507811|FG000|Overall Study|Lost to Follow-up|1|||
147641951|NCT02100670|532507812|FG001|Overall Study|Lost to Follow-up|0|||
147641952|NCT02100670|532507813|FG002|Overall Study|Lost to Follow-up|0|||
147641953|NCT02100670|532507814|FG003|Overall Study|Lost to Follow-up|0|||
147641954|NCT02100670|532507811|FG000|Overall Study|Protocol Violation|0|||
147641955|NCT02100670|532507812|FG001|Overall Study|Protocol Violation|1|||
147641956|NCT02100670|532507813|FG002|Overall Study|Protocol Violation|0|||
147641957|NCT02100670|532507814|FG003|Overall Study|Protocol Violation|1|||
147641958|NCT02100670|532507811|FG000|Overall Study|Withdrawal of Consent|0|||
147641959|NCT02100670|532507812|FG001|Overall Study|Withdrawal of Consent|1|||
147641960|NCT02100670|532507813|FG002|Overall Study|Withdrawal of Consent|1|||
147641961|NCT02100670|532507814|FG003|Overall Study|Withdrawal of Consent|0|||
147641962|NCT02100670|532507811|FG000|Overall Study|No swelling no pain|1|||
147518519|NCT00118040|532049876|FG001|Overall Study|Withdrawal by Subject|0|||
147518520|NCT00118040|532049877|FG002|Overall Study|Withdrawal by Subject|2|||
147641963|NCT02100670|532507812|FG001|Overall Study|No swelling no pain|0|||
147641964|NCT02100670|532507813|FG002|Overall Study|No swelling no pain|0|||
147641965|NCT02100670|532507814|FG003|Overall Study|No swelling no pain|0|||
147641966|NCT02100670|532507811|FG000|Overall Study|Poor Efficacy|0|||
147641967|NCT02100670|532507812|FG001|Overall Study|Poor Efficacy|1|||
147641968|NCT02100670|532507813|FG002|Overall Study|Poor Efficacy|0|||
147641969|NCT02100670|532507814|FG003|Overall Study|Poor Efficacy|0|||
147641970|NCT02100670|532507811|FG000|Overall Study|Physician Decision|0|||
147641971|NCT02100670|532507812|FG001|Overall Study|Physician Decision|1|||
147641972|NCT02100670|532507813|FG002|Overall Study|Physician Decision|0|||
147641973|NCT02100670|532507814|FG003|Overall Study|Physician Decision|0|||
147641974|NCT02100670|532507811|FG000|Overall Study|Withdrawal by Subject|1|||
147641975|NCT02100670|532507812|FG001|Overall Study|Withdrawal by Subject|0|||
147641976|NCT02100670|532507813|FG002|Overall Study|Withdrawal by Subject|0|||
147641977|NCT02100670|532507814|FG003|Overall Study|Withdrawal by Subject|0|||
147641978|NCT01390428|532509098|FG000|Overall Study|Elective Surgery|0|||
147641979|NCT01390428|532509099|FG001|Overall Study|Elective Surgery|0|||
147641980|NCT01390428|532509100|FG002|Overall Study|Elective Surgery|0|||
147641981|NCT01390428|532509101|FG003|Overall Study|Elective Surgery|0|||
147641982|NCT01390428|532509102|FG004|Overall Study|Elective Surgery|1|||
147641983|NCT01390428|532509103|FG005|Overall Study|Elective Surgery|0|||
147641984|NCT01390428|532509098|FG000|Overall Study|Withdrawal by Subject|0|||
147641985|NCT01390428|532509099|FG001|Overall Study|Withdrawal by Subject|0|||
147641986|NCT01390428|532509100|FG002|Overall Study|Withdrawal by Subject|1|||
147641987|NCT01390428|532509101|FG003|Overall Study|Withdrawal by Subject|0|||
147641988|NCT01390428|532509102|FG004|Overall Study|Withdrawal by Subject|0|||
147641989|NCT01390428|532509103|FG005|Overall Study|Withdrawal by Subject|0|||
147641990|NCT05897827|532509106|FG000|Overall Study|Lost to Follow-up|33|||
147641991|NCT05897827|532509107|FG001|Overall Study|Lost to Follow-up|14|||
147641992|NCT05897827|532509106|FG000|Overall Study|Withdrawal by Subject|1|||
147641993|NCT05897827|532509107|FG001|Overall Study|Withdrawal by Subject|1|||
147641994|NCT01004406|532509108|FG000|Overall Study|Withdrawal by Subject|2|||
147641995|NCT01004406|532509109|FG001|Overall Study|Withdrawal by Subject|0|||
147641996|NCT01004406|532509108|FG000|Overall Study|Lost to Follow-up|1|||
147641997|NCT01004406|532509109|FG001|Overall Study|Lost to Follow-up|0|||
147641998|NCT02928770|532509110|FG000|Overall Study|Withdrawal by Subject|2|||
147641999|NCT01752634|532509111|FG000|Up to Week 24 (Primary Analysis)|Subject/guardian decision|1|||
147642000|NCT01752634|532509112|FG001|Up to Week 24 (Primary Analysis)|Subject/guardian decision|1|||
147642001|NCT01752634|532509113|FG002|Up to Week 24 (Primary Analysis)|Subject/guardian decision|1|||
147642002|NCT01752634|532509114|FG003|Up to Week 24 (Primary Analysis)|Subject/guardian decision|0|||
147642003|NCT01752634|532509115|FG004|Up to Week 24 (Primary Analysis)|Subject/guardian decision|0|||
147642004|NCT01752634|532509116|FG005|Up to Week 24 (Primary Analysis)|Subject/guardian decision|3|||
147642005|NCT01752634|532509111|FG000|Up to Week 24 (Primary Analysis)|Physician Decision|0|||
147642006|NCT01752634|532509112|FG001|Up to Week 24 (Primary Analysis)|Physician Decision|1|||
147642007|NCT01752634|532509113|FG002|Up to Week 24 (Primary Analysis)|Physician Decision|0|||
147642008|NCT01752634|532509114|FG003|Up to Week 24 (Primary Analysis)|Physician Decision|0|||
147642009|NCT01752634|532509115|FG004|Up to Week 24 (Primary Analysis)|Physician Decision|0|||
147642010|NCT01752634|532509116|FG005|Up to Week 24 (Primary Analysis)|Physician Decision|0|||
147642011|NCT01752634|532509111|FG000|Up to Week 24 (Primary Analysis)|Lack of Efficacy|2|||
147642012|NCT01752634|532509112|FG001|Up to Week 24 (Primary Analysis)|Lack of Efficacy|3|||
147642013|NCT01752634|532509113|FG002|Up to Week 24 (Primary Analysis)|Lack of Efficacy|0|||
147642014|NCT01752634|532509114|FG003|Up to Week 24 (Primary Analysis)|Lack of Efficacy|0|||
147642015|NCT01752634|532509115|FG004|Up to Week 24 (Primary Analysis)|Lack of Efficacy|0|||
147642016|NCT01752634|532509116|FG005|Up to Week 24 (Primary Analysis)|Lack of Efficacy|3|||
147642017|NCT01752634|532509111|FG000|Up to Week 24 (Primary Analysis)|Adverse Event|3|||
147642018|NCT01752634|532509112|FG001|Up to Week 24 (Primary Analysis)|Adverse Event|0|||
147642019|NCT01752634|532509113|FG002|Up to Week 24 (Primary Analysis)|Adverse Event|2|||
147642020|NCT01752634|532509114|FG003|Up to Week 24 (Primary Analysis)|Adverse Event|0|||
147642021|NCT01752634|532509115|FG004|Up to Week 24 (Primary Analysis)|Adverse Event|0|||
147642022|NCT01752634|532509116|FG005|Up to Week 24 (Primary Analysis)|Adverse Event|4|||
147642023|NCT01752634|532509111|FG000|Week 24 to Week 260|Lack of Efficacy|15|||
147642024|NCT01752634|532509112|FG001|Week 24 to Week 260|Lack of Efficacy|7|||
147642025|NCT01752634|532509113|FG002|Week 24 to Week 260|Lack of Efficacy|7|||
147642026|NCT01752634|532509114|FG003|Week 24 to Week 260|Lack of Efficacy|3|||
147642027|NCT01752634|532509115|FG004|Week 24 to Week 260|Lack of Efficacy|4|||
147642028|NCT01752634|532509116|FG005|Week 24 to Week 260|Lack of Efficacy|0|||
147642029|NCT01752634|532509111|FG000|Week 24 to Week 260|Subject/guardian decision|12|||
147642030|NCT01752634|532509112|FG001|Week 24 to Week 260|Subject/guardian decision|10|||
147642031|NCT01752634|532509113|FG002|Week 24 to Week 260|Subject/guardian decision|9|||
147642032|NCT01752634|532509114|FG003|Week 24 to Week 260|Subject/guardian decision|5|||
147642033|NCT01752634|532509115|FG004|Week 24 to Week 260|Subject/guardian decision|5|||
147518521|NCT00118040|532049875|FG000|Overall Study|Medical Contraindication|0|||
147518522|NCT00118040|532049876|FG001|Overall Study|Medical Contraindication|0|||
147518523|NCT00118040|532049877|FG002|Overall Study|Medical Contraindication|1|||
147518524|NCT00118040|532049875|FG000|Overall Study|Non-Compliant Participant|1|||
147518525|NCT00118040|532049876|FG001|Overall Study|Non-Compliant Participant|1|||
147518526|NCT00118040|532049877|FG002|Overall Study|Non-Compliant Participant|2|||
147518527|NCT00118040|532049875|FG000|Overall Study|Other|0|||
147518528|NCT00118040|532049876|FG001|Overall Study|Other|0|||
147518529|NCT00118040|532049877|FG002|Overall Study|Other|1|||
147518530|NCT02750501|532049878|FG000|Overall Study|Adverse Event|4|||
147518531|NCT02750501|532049878|FG000|Overall Study|Physician Decision|1|||
147518532|NCT02750501|532049878|FG000|Overall Study|Protocol Violation|1|||
147518533|NCT02750501|532049878|FG000|Overall Study|G-tube came out|1|||
147518534|NCT02750501|532049878|FG000|Overall Study|Non-compliant use of PERT|1|||
147518535|NCT03685643|532049879|FG000|Overall Study|Lost to Follow-up|14|||
147518536|NCT03685643|532049880|FG001|Overall Study|Lost to Follow-up|22|||
147518537|NCT01738594|532049881|FG000|Registration and Treatment Start|Adverse Event|0|||
147518538|NCT01738594|532049882|FG001|Registration and Treatment Start|Adverse Event|1|||
147518539|NCT01738594|532049883|FG002|Registration and Treatment Start|Adverse Event|0|||
147518540|NCT01738594|532049884|FG003|Registration and Treatment Start|Adverse Event|0|||
147518541|NCT01738594|532049885|FG004|Registration and Treatment Start|Adverse Event|0|||
147518542|NCT01738594|532049886|FG005|Registration and Treatment Start|Adverse Event|0|||
147518543|NCT01738594|532049887|FG006|Registration and Treatment Start|Adverse Event|0|||
147518544|NCT01738594|532049888|FG007|Registration and Treatment Start|Adverse Event|0|||
147518545|NCT01738594|532049881|FG000|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
147518546|NCT01738594|532049882|FG001|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
147518547|NCT01738594|532049883|FG002|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
147518548|NCT01738594|532049884|FG003|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
147518549|NCT01738594|532049885|FG004|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
147518550|NCT01738594|532049886|FG005|Completed 2 Cycles/Reached 1st Response|Physician Decision|1|||
147518551|NCT01738594|532049887|FG006|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
147518552|NCT01738594|532049888|FG007|Completed 2 Cycles/Reached 1st Response|Physician Decision|0|||
147518553|NCT01738594|532049881|FG000|Completed 4 Cycles of Treatment|Progressive disease|0|||
147518554|NCT01738594|532049882|FG001|Completed 4 Cycles of Treatment|Progressive disease|2|||
147518555|NCT01738594|532049883|FG002|Completed 4 Cycles of Treatment|Progressive disease|0|||
147518556|NCT01738594|532049884|FG003|Completed 4 Cycles of Treatment|Progressive disease|0|||
147518557|NCT01738594|532049885|FG004|Completed 4 Cycles of Treatment|Progressive disease|0|||
147518558|NCT01738594|532049886|FG005|Completed 4 Cycles of Treatment|Progressive disease|0|||
147518559|NCT01738594|532049887|FG006|Completed 4 Cycles of Treatment|Progressive disease|0|||
147518560|NCT01738594|532049888|FG007|Completed 4 Cycles of Treatment|Progressive disease|0|||
147518561|NCT01738594|532049881|FG000|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
147518562|NCT01738594|532049882|FG001|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
147518563|NCT01738594|532049883|FG002|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
147518564|NCT01738594|532049884|FG003|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
147518565|NCT01738594|532049885|FG004|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
147518566|NCT01738594|532049886|FG005|Completed 4 Cycles of Treatment|No response/patient benefit|1|||
147518567|NCT01738594|532049887|FG006|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
147518568|NCT01738594|532049888|FG007|Completed 4 Cycles of Treatment|No response/patient benefit|0|||
147518569|NCT01738594|532049881|FG000|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
147518570|NCT01738594|532049882|FG001|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
147518571|NCT01738594|532049883|FG002|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
147518572|NCT01738594|532049884|FG003|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
147518573|NCT01738594|532049885|FG004|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
147518574|NCT01738594|532049886|FG005|Went on to Continue Treatment Cycle 5|Progressive Disease|1|||
147518575|NCT01738594|532049887|FG006|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
147518576|NCT01738594|532049888|FG007|Went on to Continue Treatment Cycle 5|Progressive Disease|0|||
147518577|NCT01738594|532049881|FG000|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
147518578|NCT01738594|532049882|FG001|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
147518579|NCT01738594|532049883|FG002|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
147518580|NCT01738594|532049884|FG003|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
147518581|NCT01738594|532049885|FG004|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|1|||
147518582|NCT01738594|532049886|FG005|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
147518583|NCT01738594|532049887|FG006|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
147518584|NCT01738594|532049888|FG007|Went on to Continue Treatment Cycle 5|Withdrawal by Subject|0|||
147518585|NCT01738594|532049881|FG000|Follow up for 1 Year|Death|0|||
147518586|NCT01738594|532049882|FG001|Follow up for 1 Year|Death|0|||
147518587|NCT01738594|532049883|FG002|Follow up for 1 Year|Death|0|||
147518588|NCT01738594|532049884|FG003|Follow up for 1 Year|Death|0|||
147518589|NCT01738594|532049885|FG004|Follow up for 1 Year|Death|0|||
147518590|NCT01738594|532049886|FG005|Follow up for 1 Year|Death|1|||
147518591|NCT01738594|532049887|FG006|Follow up for 1 Year|Death|0|||
147518592|NCT01738594|532049888|FG007|Follow up for 1 Year|Death|0|||
147518593|NCT01738594|532049881|FG000|Follow up for 1 Year|Other|0|||
147518594|NCT01738594|532049882|FG001|Follow up for 1 Year|Other|0|||
147518595|NCT01738594|532049883|FG002|Follow up for 1 Year|Other|0|||
147518596|NCT01738594|532049884|FG003|Follow up for 1 Year|Other|0|||
147518597|NCT01738594|532049885|FG004|Follow up for 1 Year|Other|0|||
147518598|NCT01738594|532049886|FG005|Follow up for 1 Year|Other|2|||
147518599|NCT01738594|532049887|FG006|Follow up for 1 Year|Other|0|||
147518600|NCT01738594|532049888|FG007|Follow up for 1 Year|Other|0|||
147518601|NCT03797144|532049889|FG000|Enrollment|Protocol Violation|4|||
147518602|NCT03797144|532049890|FG001|Enrollment|Protocol Violation|1|||
147518603|NCT03797144|532049889|FG000|Surgery|Protocol Violation|1|||
147518604|NCT03797144|532049890|FG001|Surgery|Protocol Violation|0|||
147518605|NCT03797144|532049889|FG000|3 Month|Early termination cut-off date|2|||
147518606|NCT03797144|532049890|FG001|3 Month|Early termination cut-off date|0|||
147518607|NCT03797144|532049889|FG000|12 Month|Early termination cut-off date|8|||
147518608|NCT03797144|532049890|FG001|12 Month|Early termination cut-off date|9|||
147518609|NCT03797144|532049889|FG000|24 Month|Early termination cut-off date|1|||
147518610|NCT03797144|532049890|FG001|24 Month|Early termination cut-off date|1|||
147518611|NCT00403390|532049891|FG000|Overall Study|Withdrawal by Subject|1|||
147518612|NCT00403390|532049892|FG001|Overall Study|Withdrawal by Subject|0|||
147642034|NCT01752634|532509116|FG005|Week 24 to Week 260|Subject/guardian decision|0|||
147642035|NCT01752634|532509111|FG000|Week 24 to Week 260|Physician Decision|1|||
147642036|NCT01752634|532509112|FG001|Week 24 to Week 260|Physician Decision|2|||
147642037|NCT01752634|532509113|FG002|Week 24 to Week 260|Physician Decision|4|||
147642038|NCT01752634|532509114|FG003|Week 24 to Week 260|Physician Decision|2|||
147642039|NCT01752634|532509115|FG004|Week 24 to Week 260|Physician Decision|1|||
147642040|NCT01752634|532509116|FG005|Week 24 to Week 260|Physician Decision|0|||
147642041|NCT01752634|532509111|FG000|Week 24 to Week 260|Death|0|||
147642042|NCT01752634|532509112|FG001|Week 24 to Week 260|Death|1|||
147642043|NCT01752634|532509113|FG002|Week 24 to Week 260|Death|0|||
147642044|NCT01752634|532509114|FG003|Week 24 to Week 260|Death|0|||
147642045|NCT01752634|532509115|FG004|Week 24 to Week 260|Death|0|||
147642046|NCT01752634|532509116|FG005|Week 24 to Week 260|Death|0|||
147642047|NCT01752634|532509111|FG000|Week 24 to Week 260|Pregnancy|0|||
147642048|NCT01752634|532509112|FG001|Week 24 to Week 260|Pregnancy|0|||
147642049|NCT01752634|532509113|FG002|Week 24 to Week 260|Pregnancy|1|||
147642050|NCT01752634|532509114|FG003|Week 24 to Week 260|Pregnancy|0|||
147642051|NCT01752634|532509115|FG004|Week 24 to Week 260|Pregnancy|0|||
147642052|NCT01752634|532509116|FG005|Week 24 to Week 260|Pregnancy|0|||
147642053|NCT01752634|532509111|FG000|Week 24 to Week 260|Noncompliance with study treatment|0|||
147642054|NCT01752634|532509112|FG001|Week 24 to Week 260|Noncompliance with study treatment|0|||
147642055|NCT01752634|532509113|FG002|Week 24 to Week 260|Noncompliance with study treatment|1|||
147642056|NCT01752634|532509114|FG003|Week 24 to Week 260|Noncompliance with study treatment|0|||
147642057|NCT01752634|532509115|FG004|Week 24 to Week 260|Noncompliance with study treatment|0|||
147642058|NCT01752634|532509116|FG005|Week 24 to Week 260|Noncompliance with study treatment|0|||
147642059|NCT01752634|532509111|FG000|Week 24 to Week 260|Lost to Follow-up|2|||
147642060|NCT01752634|532509112|FG001|Week 24 to Week 260|Lost to Follow-up|2|||
147642061|NCT01752634|532509113|FG002|Week 24 to Week 260|Lost to Follow-up|3|||
147642062|NCT01752634|532509114|FG003|Week 24 to Week 260|Lost to Follow-up|0|||
147642063|NCT01752634|532509115|FG004|Week 24 to Week 260|Lost to Follow-up|2|||
147642064|NCT01752634|532509116|FG005|Week 24 to Week 260|Lost to Follow-up|0|||
147642065|NCT01752634|532509111|FG000|Week 24 to Week 260|Adverse Event|4|||
147642066|NCT01752634|532509112|FG001|Week 24 to Week 260|Adverse Event|8|||
147642067|NCT01752634|532509113|FG002|Week 24 to Week 260|Adverse Event|8|||
147642068|NCT01752634|532509114|FG003|Week 24 to Week 260|Adverse Event|4|||
147642069|NCT01752634|532509115|FG004|Week 24 to Week 260|Adverse Event|2|||
147642070|NCT01752634|532509116|FG005|Week 24 to Week 260|Adverse Event|0|||
147642071|NCT05562934|532509120|FG000|Overall Study|Adverse Event|0|||
147642072|NCT05562934|532509121|FG001|Overall Study|Adverse Event|2|||
147642073|NCT05562934|532509122|FG002|Overall Study|Adverse Event|0|||
147642074|NCT05562934|532509123|FG003|Overall Study|Adverse Event|0|||
147642075|NCT05562934|532509124|FG004|Overall Study|Adverse Event|2|||
147642076|NCT05562934|532509120|FG000|Overall Study|Lost to Follow-up|0|||
147642077|NCT05562934|532509121|FG001|Overall Study|Lost to Follow-up|0|||
147642078|NCT05562934|532509122|FG002|Overall Study|Lost to Follow-up|0|||
147642079|NCT05562934|532509123|FG003|Overall Study|Lost to Follow-up|0|||
147642080|NCT05562934|532509124|FG004|Overall Study|Lost to Follow-up|1|||
147642081|NCT05562934|532509120|FG000|Overall Study|Protocol Violation|0|||
147642082|NCT05562934|532509121|FG001|Overall Study|Protocol Violation|0|||
147642083|NCT05562934|532509122|FG002|Overall Study|Protocol Violation|0|||
147642084|NCT05562934|532509123|FG003|Overall Study|Protocol Violation|1|||
147642085|NCT05562934|532509124|FG004|Overall Study|Protocol Violation|1|||
147642086|NCT05562934|532509120|FG000|Overall Study|Withdrawal by Subject|0|||
147642087|NCT05562934|532509121|FG001|Overall Study|Withdrawal by Subject|0|||
147642088|NCT05562934|532509122|FG002|Overall Study|Withdrawal by Subject|1|||
147642089|NCT05562934|532509123|FG003|Overall Study|Withdrawal by Subject|1|||
147642090|NCT05562934|532509124|FG004|Overall Study|Withdrawal by Subject|0|||
147642091|NCT04250714|532509131|FG000|Overall Study|Treatment - withdrawal by subject|14|||
147642092|NCT04250714|532509131|FG000|Overall Study|Treatment - Lost to Follow-up|11|||
147642093|NCT04250714|532509131|FG000|Overall Study|Treatment - End of study due to logistical reasons|2|||
147642094|NCT04250714|532509131|FG000|Overall Study|Treatment - End of study due to refusing testing COVID|1|||
147642095|NCT04250714|532509131|FG000|Overall Study|Treatment - Death|1|||
147642096|NCT04250714|532509131|FG000|Overall Study|Treatment - Withdrawn due to unknown reason|2|||
147642097|NCT04250714|532509131|FG000|Overall Study|Consent Ineligible - Does not meet eligibility criteria|1|||
147642098|NCT04250714|532509131|FG000|Overall Study|Attempt|2|||
147642099|NCT04250714|532509131|FG000|Overall Study|Intent|7|||
147642100|NCT05741346|532509132|FG000|Overall Study|Withdrawn due to termination of study|28|||
147642101|NCT05906836|532509141|FG000|Overall Study|Unwilling to Make Travel Arrangements|1|||
147642102|NCT05906836|532509141|FG000|Overall Study|Lost to Follow-up|1|||
147642103|NCT04982575|532509142|FG000|Overall Study|Withdrawal by Subject|2|||
147642104|NCT04982575|532509143|FG001|Overall Study|Withdrawal by Subject|0|||
147518613|NCT00403390|532049891|FG000|Overall Study|samples lost|1|||
147518614|NCT00403390|532049892|FG001|Overall Study|samples lost|0|||
147518615|NCT00403390|532049891|FG000|Overall Study|non-compliant|1|||
147518616|NCT00403390|532049892|FG001|Overall Study|non-compliant|0|||
147518617|NCT02943668|532049893|FG000|Overall Study|Disease Progression|1|||
147518618|NCT02711553|532049894|FG000|Overall Study|Withdrawal by Subject|2|||
147518619|NCT02711553|532049895|FG001|Overall Study|Withdrawal by Subject|1|||
147518620|NCT02711553|532049896|FG002|Overall Study|Withdrawal by Subject|1|||
147642105|NCT04982575|532509144|FG002|Overall Study|Withdrawal by Subject|2|||
147642106|NCT04322539|532509149|FG000|Overall Study|Adverse Event|2|||
147642107|NCT04322539|532509150|FG001|Overall Study|Adverse Event|0|||
147642108|NCT04322539|532509149|FG000|Overall Study|Death|411|||
147642109|NCT04322539|532509150|FG001|Overall Study|Death|203|||
147642110|NCT04322539|532509149|FG000|Overall Study|Lost to Follow-up|3|||
147642111|NCT04322539|532509150|FG001|Overall Study|Lost to Follow-up|1|||
147642112|NCT04322539|532509149|FG000|Overall Study|Withdrawal of consent|14|||
147642113|NCT04322539|532509150|FG001|Overall Study|Withdrawal of consent|8|||
147642114|NCT04322539|532509149|FG000|Overall Study|Radiological Disease Progression|6|||
147642115|NCT04322539|532509150|FG001|Overall Study|Radiological Disease Progression|0|||
147642116|NCT04322539|532509149|FG000|Overall Study|Sponsor Decision|19|||
147642117|NCT04322539|532509150|FG001|Overall Study|Sponsor Decision|14|||
147642118|NCT04322539|532509149|FG000|Overall Study|Other|6|||
147642119|NCT04322539|532509150|FG001|Overall Study|Other|4|||
147642120|NCT03617861|532509151|FG000|Second Intervention (1 Day)|Adverse Event|0|||
147642121|NCT03617861|532509152|FG001|Second Intervention (1 Day)|Adverse Event|0|||
147642122|NCT03617861|532509153|FG002|Second Intervention (1 Day)|Adverse Event|1|||
147642123|NCT03617861|532509154|FG003|Second Intervention (1 Day)|Adverse Event|0|||
147642124|NCT00623597|532509155|FG000|Overall Study|Failed to return|1|||
147642125|NCT00623597|532509156|FG001|Overall Study|Failed to return|0|||
147642126|NCT01846221|532509157|FG000|Overall Study|Catheter Failure|2|||
147642127|NCT01846221|532509158|FG001|Overall Study|Catheter Failure|0|||
147642128|NCT01846221|532509157|FG000|Overall Study|Age Exclusion|1|||
147642129|NCT01846221|532509158|FG001|Overall Study|Age Exclusion|0|||
147642130|NCT04599933|532509159|FG000|Overall Study|Adverse Event|4|||
147642131|NCT04599933|532509160|FG001|Overall Study|Adverse Event|1|||
147642132|NCT04599933|532509159|FG000|Overall Study|Withdrawal by Subject|4|||
147642133|NCT04599933|532509160|FG001|Overall Study|Withdrawal by Subject|2|||
147642134|NCT04599933|532509159|FG000|Overall Study|Lost to Follow-up|0|||
147642135|NCT04599933|532509160|FG001|Overall Study|Lost to Follow-up|1|||
147642136|NCT04599933|532509159|FG000|Overall Study|Physician Decision|0|||
147642137|NCT04599933|532509160|FG001|Overall Study|Physician Decision|1|||
147642138|NCT04599933|532509159|FG000|Overall Study|Screen Failure|1|||
147642139|NCT04599933|532509160|FG001|Overall Study|Screen Failure|2|||
147642140|NCT02963558|532509163|FG000|Overall Study|Withdrawn by investigator|1|||
147642141|NCT02963558|532509164|FG001|Overall Study|Withdrawn by investigator|0|||
147642142|NCT02963558|532509163|FG000|Overall Study|Withdrawal by Subject|0|||
147642143|NCT02963558|532509164|FG001|Overall Study|Withdrawal by Subject|1|||
147642144|NCT02339155|532509165|FG000|Overall Study|Adverse Event|0|||
147642145|NCT02339155|532509166|FG001|Overall Study|Adverse Event|6|||
147642146|NCT02339155|532509165|FG000|Overall Study|Death|1|||
147642147|NCT02339155|532509166|FG001|Overall Study|Death|1|||
147642148|NCT02339155|532509165|FG000|Overall Study|Lost to Follow-up|8|||
147642149|NCT02339155|532509166|FG001|Overall Study|Lost to Follow-up|9|||
147642150|NCT02339155|532509165|FG000|Overall Study|Physician Decision|2|||
147642151|NCT02339155|532509166|FG001|Overall Study|Physician Decision|1|||
147642152|NCT02339155|532509165|FG000|Overall Study|Withdrawal by Subject|4|||
147642153|NCT02339155|532509166|FG001|Overall Study|Withdrawal by Subject|4|||
147642154|NCT03226678|532509169|FG000|Part A (Core Study Phase)|Adverse Event|0|||
147642155|NCT03226678|532509170|FG001|Part A (Core Study Phase)|Adverse Event|1|||
147642156|NCT03226678|532509171|FG002|Part A (Core Study Phase)|Adverse Event|0|||
147642157|NCT03226678|532509172|FG003|Part A (Core Study Phase)|Adverse Event|0|||
147642158|NCT03226678|532509173|FG004|Part A (Core Study Phase)|Adverse Event|0|||
147642159|NCT03226678|532509174|FG005|Part A (Core Study Phase)|Adverse Event|0|||
147642160|NCT03226678|532509169|FG000|Part A (Core Study Phase)|Death|0|||
147642161|NCT03226678|532509170|FG001|Part A (Core Study Phase)|Death|0|||
147642162|NCT03226678|532509171|FG002|Part A (Core Study Phase)|Death|1|||
147642163|NCT03226678|532509172|FG003|Part A (Core Study Phase)|Death|0|||
147642164|NCT03226678|532509173|FG004|Part A (Core Study Phase)|Death|0|||
147642165|NCT03226678|532509174|FG005|Part A (Core Study Phase)|Death|0|||
147518621|NCT02711553|532049897|FG003|Overall Study|Withdrawal by Subject|0|||
147642166|NCT03226678|532509169|FG000|Part A (Core Study Phase)|Lack of Efficacy|0|||
147642167|NCT03226678|532509170|FG001|Part A (Core Study Phase)|Lack of Efficacy|1|||
147518622|NCT02711553|532049894|FG000|Overall Study|Lost to Follow-up|3|||
147642168|NCT03226678|532509171|FG002|Part A (Core Study Phase)|Lack of Efficacy|0|||
147642169|NCT03226678|532509172|FG003|Part A (Core Study Phase)|Lack of Efficacy|0|||
147642170|NCT03226678|532509173|FG004|Part A (Core Study Phase)|Lack of Efficacy|0|||
147518623|NCT02711553|532049895|FG001|Overall Study|Lost to Follow-up|3|||
147518624|NCT02711553|532049896|FG002|Overall Study|Lost to Follow-up|6|||
147518625|NCT02711553|532049897|FG003|Overall Study|Lost to Follow-up|3|||
147518626|NCT02711553|532049894|FG000|Overall Study|On Study Treatment at Study Conclusion|1|||
147518627|NCT02711553|532049895|FG001|Overall Study|On Study Treatment at Study Conclusion|1|||
147518628|NCT02711553|532049896|FG002|Overall Study|On Study Treatment at Study Conclusion|3|||
147642171|NCT03226678|532509174|FG005|Part A (Core Study Phase)|Lack of Efficacy|0|||
147642172|NCT03226678|532509169|FG000|Part A (Core Study Phase)|Non-compliance with study drug|0|||
147642173|NCT03226678|532509170|FG001|Part A (Core Study Phase)|Non-compliance with study drug|0|||
147642174|NCT03226678|532509171|FG002|Part A (Core Study Phase)|Non-compliance with study drug|1|||
147642175|NCT03226678|532509172|FG003|Part A (Core Study Phase)|Non-compliance with study drug|0|||
147642176|NCT03226678|532509173|FG004|Part A (Core Study Phase)|Non-compliance with study drug|0|||
147642177|NCT03226678|532509174|FG005|Part A (Core Study Phase)|Non-compliance with study drug|0|||
147642178|NCT03226678|532509169|FG000|Part A (Core Study Phase)|Withdrawal by Subject|0|||
147642179|NCT03226678|532509170|FG001|Part A (Core Study Phase)|Withdrawal by Subject|0|||
147642180|NCT03226678|532509171|FG002|Part A (Core Study Phase)|Withdrawal by Subject|0|||
147642181|NCT03226678|532509172|FG003|Part A (Core Study Phase)|Withdrawal by Subject|1|||
147642182|NCT03226678|532509173|FG004|Part A (Core Study Phase)|Withdrawal by Subject|0|||
147642183|NCT03226678|532509174|FG005|Part A (Core Study Phase)|Withdrawal by Subject|0|||
147642184|NCT03226678|532509169|FG000|Part A (Core Study Phase)|Withdrew, per Investigator|2|||
147642185|NCT03226678|532509170|FG001|Part A (Core Study Phase)|Withdrew, per Investigator|1|||
147642186|NCT03226678|532509171|FG002|Part A (Core Study Phase)|Withdrew, per Investigator|0|||
147642187|NCT03226678|532509172|FG003|Part A (Core Study Phase)|Withdrew, per Investigator|0|||
147642188|NCT03226678|532509173|FG004|Part A (Core Study Phase)|Withdrew, per Investigator|0|||
147642189|NCT03226678|532509174|FG005|Part A (Core Study Phase)|Withdrew, per Investigator|0|||
147642190|NCT03226678|532509169|FG000|Part B (Long-Term Extension Phase)|Adverse Event|0|||
147642191|NCT03226678|532509170|FG001|Part B (Long-Term Extension Phase)|Adverse Event|0|||
147642192|NCT03226678|532509171|FG002|Part B (Long-Term Extension Phase)|Adverse Event|0|||
147642193|NCT03226678|532509172|FG003|Part B (Long-Term Extension Phase)|Adverse Event|0|||
147642194|NCT03226678|532509173|FG004|Part B (Long-Term Extension Phase)|Adverse Event|2|||
147642195|NCT03226678|532509174|FG005|Part B (Long-Term Extension Phase)|Adverse Event|1|||
147642196|NCT03226678|532509169|FG000|Part B (Long-Term Extension Phase)|Death|0|||
147642197|NCT03226678|532509170|FG001|Part B (Long-Term Extension Phase)|Death|0|||
147642198|NCT03226678|532509171|FG002|Part B (Long-Term Extension Phase)|Death|0|||
147642199|NCT03226678|532509172|FG003|Part B (Long-Term Extension Phase)|Death|0|||
147642200|NCT03226678|532509173|FG004|Part B (Long-Term Extension Phase)|Death|0|||
147642201|NCT03226678|532509174|FG005|Part B (Long-Term Extension Phase)|Death|1|||
147642202|NCT03226678|532509169|FG000|Part B (Long-Term Extension Phase)|Non-Compliance With Study Drug|0|||
147642203|NCT03226678|532509170|FG001|Part B (Long-Term Extension Phase)|Non-Compliance With Study Drug|0|||
147642204|NCT03226678|532509171|FG002|Part B (Long-Term Extension Phase)|Non-Compliance With Study Drug|0|||
147642205|NCT03226678|532509172|FG003|Part B (Long-Term Extension Phase)|Non-Compliance With Study Drug|0|||
147642206|NCT03226678|532509173|FG004|Part B (Long-Term Extension Phase)|Non-Compliance With Study Drug|0|||
147642207|NCT03226678|532509174|FG005|Part B (Long-Term Extension Phase)|Non-Compliance With Study Drug|1|||
147642208|NCT03226678|532509169|FG000|Part B (Long-Term Extension Phase)|Study Terminated By Sponsor|0|||
147642209|NCT03226678|532509170|FG001|Part B (Long-Term Extension Phase)|Study Terminated By Sponsor|0|||
147642210|NCT03226678|532509171|FG002|Part B (Long-Term Extension Phase)|Study Terminated By Sponsor|0|||
147642211|NCT03226678|532509172|FG003|Part B (Long-Term Extension Phase)|Study Terminated By Sponsor|0|||
147642212|NCT03226678|532509173|FG004|Part B (Long-Term Extension Phase)|Study Terminated By Sponsor|3|||
147642213|NCT03226678|532509174|FG005|Part B (Long-Term Extension Phase)|Study Terminated By Sponsor|5|||
147642214|NCT03226678|532509169|FG000|Part B (Long-Term Extension Phase)|Withdrew, Per Sponsor|0|||
147642215|NCT03226678|532509170|FG001|Part B (Long-Term Extension Phase)|Withdrew, Per Sponsor|0|||
147642216|NCT03226678|532509171|FG002|Part B (Long-Term Extension Phase)|Withdrew, Per Sponsor|0|||
147642217|NCT03226678|532509172|FG003|Part B (Long-Term Extension Phase)|Withdrew, Per Sponsor|0|||
147642218|NCT03226678|532509173|FG004|Part B (Long-Term Extension Phase)|Withdrew, Per Sponsor|0|||
147642219|NCT03226678|532509174|FG005|Part B (Long-Term Extension Phase)|Withdrew, Per Sponsor|1|||
147642220|NCT03427268|532509177|FG000|Overall Study|Progressive disease|25|||
147642221|NCT03427268|532509177|FG000|Overall Study|Never treated|2|||
147642222|NCT03427268|532509177|FG000|Overall Study|Compassionate use|1|||
147642223|NCT03427268|532509177|FG000|Overall Study|Withdrawal by Subject|1|||
147642224|NCT03427268|532509177|FG000|Overall Study|Adverse Event|3|||
147642225|NCT01643798|532509179|FG000|Pretreatment 1 and Stimulation|Withdrawal by Subject|1|||
147642226|NCT01643798|532509180|FG001|Pretreatment 1 and Stimulation|Withdrawal by Subject|0|||
147642227|NCT02045732|532509184|FG000|Overall Study|At the discretion of the investigator|1|||
147642228|NCT02045732|532509185|FG001|Overall Study|At the discretion of the investigator|1|||
147642229|NCT01349322|532509186|FG000|Overall Study|Protocol Violation|45|||
147518629|NCT02711553|532049897|FG003|Overall Study|On Study Treatment at Study Conclusion|1|||
147518630|NCT00572728|532049900|FG000|Overall Study|Withdrawal by Subject|10|||
147518631|NCT00572728|532049900|FG000|Overall Study|Ineligible|3|||
147518632|NCT00572728|532049900|FG000|Overall Study|Enrolled under Amendment 4|5|||
147518633|NCT00572728|532049900|FG000|Overall Study|Offstudy due to complicating disease|1|||
147642230|NCT01349322|532509187|FG001|Overall Study|Protocol Violation|47|||
147642231|NCT05014815|532509188|FG000|Overall Study|Death|63|||
147642232|NCT05014815|532509189|FG001|Overall Study|Death|70|||
147642233|NCT05014815|532509188|FG000|Overall Study|Withdrawal by Subject|10|||
147642234|NCT05014815|532509189|FG001|Overall Study|Withdrawal by Subject|10|||
147642235|NCT05014815|532509188|FG000|Overall Study|Lost to Follow-up|4|||
147642236|NCT05014815|532509189|FG001|Overall Study|Lost to Follow-up|2|||
147642237|NCT05014815|532509188|FG000|Overall Study|Physician Decision|2|||
147642238|NCT05014815|532509189|FG001|Overall Study|Physician Decision|4|||
147642239|NCT04247880|532509190|FG000|Overall Study|Lost to Follow-up|24|||
147642240|NCT04247880|532509191|FG001|Overall Study|Lost to Follow-up|17|||
147642241|NCT04247880|532509190|FG000|Overall Study|Withdrawal by Subject|3|||
147642242|NCT04247880|532509191|FG001|Overall Study|Withdrawal by Subject|0|||
147642243|NCT06303167|532509196|FG000|Overall Study|Ineligible|1|||
147642244|NCT06303167|532509196|FG000|Overall Study|Never start protocol therapy|2|||
147642245|NCT06303167|532509196|FG000|Overall Study|Disease progression|16|||
147642246|NCT03385304|532509199|FG000|Overall Study|Death|19|||
147642247|NCT03385304|532509200|FG001|Overall Study|Death|7|||
147642248|NCT03385304|532509199|FG000|Overall Study|Lost to Follow-up|17|||
147642249|NCT03385304|532509200|FG001|Overall Study|Lost to Follow-up|14|||
147642250|NCT03385304|532509199|FG000|Overall Study|Withdrawal by Subject|3|||
147642251|NCT03385304|532509200|FG001|Overall Study|Withdrawal by Subject|2|||
147642252|NCT03385304|532509199|FG000|Overall Study|Incarceration|2|||
147642253|NCT03385304|532509200|FG001|Overall Study|Incarceration|3|||
147642254|NCT01097421|532509201|FG000|Overall Study|Adverse Event|8|||
147642255|NCT01097421|532509201|FG000|Overall Study|Protocol Violation|2|||
147642256|NCT01097421|532509201|FG000|Overall Study|Lost to Follow-up|1|||
147642257|NCT01097421|532509201|FG000|Overall Study|Withdrawal by Subject|3|||
147642258|NCT01120249|532509204|FG000|Overall Study|No protocol treatment received|21|||
147642259|NCT01120249|532509205|FG001|Overall Study|No protocol treatment received|15|||
147642260|NCT01120249|532509204|FG000|Overall Study|Disease recurrence|107|||
147642261|NCT01120249|532509205|FG001|Overall Study|Disease recurrence|57|||
147642262|NCT01120249|532509204|FG000|Overall Study|Death|1|||
147642263|NCT01120249|532509205|FG001|Overall Study|Death|0|||
147642264|NCT01120249|532509204|FG000|Overall Study|Adverse Event|40|||
147642265|NCT01120249|532509205|FG001|Overall Study|Adverse Event|276|||
147642266|NCT01120249|532509204|FG000|Overall Study|Participant refusal|34|||
147642267|NCT01120249|532509205|FG001|Overall Study|Participant refusal|42|||
147642268|NCT01120249|532509204|FG000|Overall Study|Other reasons, not protocol specified|29|||
147642269|NCT01120249|532509205|FG001|Overall Study|Other reasons, not protocol specified|22|||
147642270|NCT01701193|532509206|FG000|Overall Study|Withdrawal by Subject|2|||
147642271|NCT01701193|532509207|FG001|Overall Study|Withdrawal by Subject|2|||
147642272|NCT01701193|532509208|FG002|Overall Study|Withdrawal by Subject|1|||
147642273|NCT01701193|532509209|FG003|Overall Study|Withdrawal by Subject|2|||
147642274|NCT01701193|532509206|FG000|Overall Study|Adverse Event|1|||
147642275|NCT01701193|532509207|FG001|Overall Study|Adverse Event|0|||
147642276|NCT01701193|532509208|FG002|Overall Study|Adverse Event|0|||
147642277|NCT01701193|532509209|FG003|Overall Study|Adverse Event|0|||
147642278|NCT02720744|532509210|FG000|Overall Study|Protocol Violation|0|||
147642279|NCT02720744|532509211|FG001|Overall Study|Protocol Violation|2|||
147642280|NCT02720744|532509210|FG000|Overall Study|Pregnancy|2|||
147642281|NCT02720744|532509211|FG001|Overall Study|Pregnancy|0|||
147642282|NCT02720744|532509210|FG000|Overall Study|Lack of Efficacy|2|||
147642283|NCT02720744|532509211|FG001|Overall Study|Lack of Efficacy|8|||
147642284|NCT02720744|532509210|FG000|Overall Study|Adverse Event|21|||
147642285|NCT02720744|532509211|FG001|Overall Study|Adverse Event|3|||
147642286|NCT02720744|532509210|FG000|Overall Study|Withdrawal by Subject|11|||
147642287|NCT02720744|532509211|FG001|Overall Study|Withdrawal by Subject|11|||
147642288|NCT02720744|532509210|FG000|Overall Study|Lost to follow up|2|||
147642289|NCT02720744|532509211|FG001|Overall Study|Lost to follow up|0|||
147642290|NCT02720744|532509210|FG000|Overall Study|Non Compliance with Investigational Product|0|||
147642291|NCT02720744|532509211|FG001|Overall Study|Non Compliance with Investigational Product|1|||
147642292|NCT02720744|532509210|FG000|Overall Study|Excluded Concomitant Medication|0|||
147642293|NCT02720744|532509211|FG001|Overall Study|Excluded Concomitant Medication|1|||
147642294|NCT01482962|532509212|FG000|Overall Study|Progressive Disease|65|||
147642295|NCT01482962|532509213|FG001|Overall Study|Progressive Disease|53|||
147642296|NCT01482962|532509212|FG000|Overall Study|Unsatisfactory Therapeutic Response|37|||
147642297|NCT01482962|532509213|FG001|Overall Study|Unsatisfactory Therapeutic Response|23|||
147642298|NCT01482962|532509212|FG000|Overall Study|Adverse Event|18|||
147642299|NCT01482962|532509213|FG001|Overall Study|Adverse Event|22|||
147642300|NCT01482962|532509212|FG000|Overall Study|Withdrawal by Participant|8|||
147642301|NCT01482962|532509213|FG001|Overall Study|Withdrawal by Participant|13|||
147642302|NCT01482962|532509212|FG000|Overall Study|Hematopoietic Stem Cell Transplant|3|||
147642303|NCT01482962|532509213|FG001|Overall Study|Hematopoietic Stem Cell Transplant|9|||
147642304|NCT01482962|532509212|FG000|Overall Study|Other Reason|1|||
147518634|NCT00572728|532049900|FG000|Overall Study|FLT1 not completed|4|||
147518635|NCT00572728|532049900|FG000|Overall Study|First Chemotherapy not initiated|2|||
147642305|NCT01482962|532509213|FG001|Overall Study|Other Reason|5|||
147642306|NCT01482962|532509212|FG000|Overall Study|Study Terminated by Sponsor|5|||
147642307|NCT01482962|532509213|FG001|Overall Study|Study Terminated by Sponsor|2|||
147642308|NCT01482962|532509212|FG000|Overall Study|Did not Receive Study Drug|1|||
147642309|NCT01482962|532509213|FG001|Overall Study|Did not Receive Study Drug|6|||
147642310|NCT02407457|532509214|FG000|1 Month|Death|3|||
147642311|NCT02407457|532509215|FG001|1 Month|Death|0|||
147642312|NCT02407457|532509214|FG000|1 Month|Lost to Follow-up|1|||
147642313|NCT02407457|532509215|FG001|1 Month|Lost to Follow-up|1|||
147642314|NCT02407457|532509214|FG000|1 Month|missed visit|2|||
147642315|NCT02407457|532509215|FG001|1 Month|missed visit|5|||
147642316|NCT02407457|532509214|FG000|6-Month|Death|2|||
147642317|NCT02407457|532509215|FG001|6-Month|Death|8|||
147642318|NCT02407457|532509214|FG000|6-Month|Lost to Follow-up|2|||
147642319|NCT02407457|532509215|FG001|6-Month|Lost to Follow-up|2|||
147642320|NCT02407457|532509214|FG000|6-Month|missed visit|16|||
147642321|NCT02407457|532509215|FG001|6-Month|missed visit|14|||
147642322|NCT02407457|532509214|FG000|6-Month|Open Repair|0|||
147642323|NCT02407457|532509215|FG001|6-Month|Open Repair|1|||
147642324|NCT02407457|532509214|FG000|1 Year|Death|6|||
147642325|NCT02407457|532509215|FG001|1 Year|Death|11|||
147642326|NCT02407457|532509214|FG000|1 Year|Lost to Follow-up|3|||
147642327|NCT02407457|532509215|FG001|1 Year|Lost to Follow-up|2|||
147642328|NCT02407457|532509214|FG000|1 Year|Missed Visit|24|||
147642329|NCT02407457|532509215|FG001|1 Year|Missed Visit|14|||
147642330|NCT02407457|532509214|FG000|1 Year|Open Repair|0|||
147642331|NCT02407457|532509215|FG001|1 Year|Open Repair|1|||
147642332|NCT02407457|532509214|FG000|2-year|Death|14|||
147642333|NCT02407457|532509215|FG001|2-year|Death|8|||
147642334|NCT02407457|532509214|FG000|2-year|Lost to Follow-up|7|||
147642335|NCT02407457|532509215|FG001|2-year|Lost to Follow-up|10|||
147642336|NCT02407457|532509214|FG000|2-year|Missed Visit|13|||
147642337|NCT02407457|532509215|FG001|2-year|Missed Visit|15|||
147642338|NCT02407457|532509214|FG000|2-year|Open Repair|0|||
147642339|NCT02407457|532509215|FG001|2-year|Open Repair|2|||
147642340|NCT02407457|532509214|FG000|3-year|Death|11|||
147642341|NCT02407457|532509215|FG001|3-year|Death|10|||
147642342|NCT02407457|532509214|FG000|3-year|Lost to Follow-up|9|||
147642343|NCT02407457|532509215|FG001|3-year|Lost to Follow-up|10|||
147642344|NCT02407457|532509214|FG000|3-year|Missed Visit|19|||
147642345|NCT02407457|532509215|FG001|3-year|Missed Visit|16|||
147642346|NCT02407457|532509214|FG000|4-year|Death|18|||
147642347|NCT02407457|532509215|FG001|4-year|Death|10|||
147642348|NCT02407457|532509214|FG000|4-year|Lost to Follow-up|10|||
147642349|NCT02407457|532509215|FG001|4-year|Lost to Follow-up|12|||
147642350|NCT02407457|532509214|FG000|4-year|Missed Visit|18|||
147642351|NCT02407457|532509215|FG001|4-year|Missed Visit|16|||
147642352|NCT02407457|532509214|FG000|5-year|Death|10|||
147642353|NCT02407457|532509215|FG001|5-year|Death|3|||
147642354|NCT02407457|532509214|FG000|5-year|Lost to Follow-up|22|||
147642355|NCT02407457|532509215|FG001|5-year|Lost to Follow-up|13|||
147642356|NCT02407457|532509214|FG000|5-year|Missed Visit|9|||
147642357|NCT02407457|532509215|FG001|5-year|Missed Visit|1|||
147642358|NCT04489381|532509222|FG000|Overall Study|Lost to Follow-up|2|||
147642359|NCT04489381|532509223|FG001|Overall Study|Lost to Follow-up|3|||
147642360|NCT04489381|532509222|FG000|Overall Study|Withdrawal by Subject|1|||
147642361|NCT04489381|532509223|FG001|Overall Study|Withdrawal by Subject|0|||
147642362|NCT01549041|532509226|FG000|Overall Study|Lack of Efficacy|2|||
147642363|NCT01549041|532509227|FG001|Overall Study|Lack of Efficacy|4|||
147642364|NCT01549041|532509226|FG000|Overall Study|Adverse Event|0|||
147642365|NCT01549041|532509227|FG001|Overall Study|Adverse Event|4|||
147642366|NCT03814720|532509229|FG000|Overall Study|Lost to Follow-up|0|||
147642367|NCT03814720|532509230|FG001|Overall Study|Lost to Follow-up|1|||
147642368|NCT03814720|532509231|FG002|Overall Study|Lost to Follow-up|0|||
147642369|NCT03814720|532509232|FG003|Overall Study|Lost to Follow-up|0|||
147642370|NCT03814720|532509233|FG004|Overall Study|Lost to Follow-up|0|||
147642371|NCT03117881|532510984|FG000|Baseline|Withdrawal by Subject|21|||
147642372|NCT03117881|532510985|FG001|Baseline|Withdrawal by Subject|10|||
147642373|NCT03117881|532510986|FG002|Baseline|Withdrawal by Subject|0|||
147642374|NCT03117881|532510984|FG000|Baseline|Lost to Follow-up|22|||
147642375|NCT03117881|532510985|FG001|Baseline|Lost to Follow-up|25|||
147518636|NCT00572728|532049900|FG000|Overall Study|FLT2 not completed|5|||
147642376|NCT03117881|532510986|FG002|Baseline|Lost to Follow-up|0|||
147642377|NCT03117881|532510984|FG000|Post-Intervention Follow-Up (3 Months)|Withdrawal by Subject|26|||
147642378|NCT03117881|532510985|FG001|Post-Intervention Follow-Up (3 Months)|Withdrawal by Subject|21|||
147642379|NCT03117881|532510986|FG002|Post-Intervention Follow-Up (3 Months)|Withdrawal by Subject|1|||
147642380|NCT03117881|532510984|FG000|Post-Intervention Follow-Up (3 Months)|Lost to Follow-up|34|||
147642381|NCT03117881|532510985|FG001|Post-Intervention Follow-Up (3 Months)|Lost to Follow-up|38|||
147642382|NCT03117881|532510986|FG002|Post-Intervention Follow-Up (3 Months)|Lost to Follow-up|4|||
147642383|NCT03117881|532510984|FG000|Post-Intervention Follow-Up (3 Months)|Did not complete test|33|||
147642384|NCT03117881|532510985|FG001|Post-Intervention Follow-Up (3 Months)|Did not complete test|22|||
147518637|NCT00572728|532049900|FG000|Overall Study|Second chemotherapy not initiated|1|||
147518638|NCT00572728|532049900|FG000|Overall Study|FLT2 after second chemotherapy initiated|7|||
147518639|NCT00572728|532049900|FG000|Overall Study|Pathology missing|1|||
147518640|NCT03457636|532049903|FG000|Overall Study|Lost to Follow-up|2|||
147518641|NCT02724111|532049904|FG000|Overall Study|Protocol Violation|2|||
147518642|NCT02724111|532049905|FG001|Overall Study|Protocol Violation|5|||
147518643|NCT01828567|532049908|FG000|Overall Study|Lost to Follow-up|27|||
147518644|NCT01828567|532049909|FG001|Overall Study|Lost to Follow-up|9|||
147518645|NCT01828567|532049908|FG000|Overall Study|Excluded - did not meet criteria|4|||
147518646|NCT01828567|532049909|FG001|Overall Study|Excluded - did not meet criteria|1|||
147518647|NCT02614261|532049910|FG000|Double-Blind Treatment Phase|Adverse Event|7|||
147518648|NCT02614261|532049911|FG001|Double-Blind Treatment Phase|Adverse Event|3|||
147518649|NCT02614261|532049912|FG002|Double-Blind Treatment Phase|Adverse Event|2|||
147518650|NCT02614261|532049913|FG003|Double-Blind Treatment Phase|Adverse Event|0|||
147518651|NCT02614261|532049910|FG000|Double-Blind Treatment Phase|Lack of Efficacy|4|||
147518652|NCT02614261|532049911|FG001|Double-Blind Treatment Phase|Lack of Efficacy|0|||
147518653|NCT02614261|532049912|FG002|Double-Blind Treatment Phase|Lack of Efficacy|0|||
147518654|NCT02614261|532049913|FG003|Double-Blind Treatment Phase|Lack of Efficacy|0|||
147518655|NCT02614261|532049910|FG000|Double-Blind Treatment Phase|Lost to Follow-up|9|||
147518656|NCT02614261|532049911|FG001|Double-Blind Treatment Phase|Lost to Follow-up|4|||
147518657|NCT02614261|532049912|FG002|Double-Blind Treatment Phase|Lost to Follow-up|1|||
147518658|NCT02614261|532049913|FG003|Double-Blind Treatment Phase|Lost to Follow-up|0|||
147518659|NCT02614261|532049910|FG000|Double-Blind Treatment Phase|Physician Decision|2|||
147518660|NCT02614261|532049911|FG001|Double-Blind Treatment Phase|Physician Decision|1|||
147518661|NCT02614261|532049912|FG002|Double-Blind Treatment Phase|Physician Decision|1|||
147518662|NCT02614261|532049913|FG003|Double-Blind Treatment Phase|Physician Decision|0|||
147518663|NCT02614261|532049910|FG000|Double-Blind Treatment Phase|Pregnancy|2|||
147518664|NCT02614261|532049911|FG001|Double-Blind Treatment Phase|Pregnancy|2|||
147518665|NCT02614261|532049912|FG002|Double-Blind Treatment Phase|Pregnancy|0|||
147518666|NCT02614261|532049913|FG003|Double-Blind Treatment Phase|Pregnancy|0|||
147518667|NCT02614261|532049910|FG000|Double-Blind Treatment Phase|Protocol Violation|6|||
147518668|NCT02614261|532049911|FG001|Double-Blind Treatment Phase|Protocol Violation|1|||
147642385|NCT03117881|532510986|FG002|Post-Intervention Follow-Up (3 Months)|Did not complete test|2|||
147642386|NCT03117881|532510984|FG000|6-Month Follow-Up|Withdrawal by Subject|4|||
147642387|NCT03117881|532510985|FG001|6-Month Follow-Up|Withdrawal by Subject|8|||
147642388|NCT03117881|532510986|FG002|6-Month Follow-Up|Withdrawal by Subject|0|||
147642389|NCT03117881|532510984|FG000|6-Month Follow-Up|Lost to Follow-up|18|||
147642390|NCT03117881|532510985|FG001|6-Month Follow-Up|Lost to Follow-up|8|||
147642391|NCT03117881|532510986|FG002|6-Month Follow-Up|Lost to Follow-up|2|||
147642392|NCT03117881|532510984|FG000|6-Month Follow-Up|Did not complete test|53|||
147642393|NCT03117881|532510985|FG001|6-Month Follow-Up|Did not complete test|25|||
147642394|NCT03117881|532510986|FG002|6-Month Follow-Up|Did not complete test|7|||
147642395|NCT03117881|532510984|FG000|12-Month Follow-Up|Withdrawal by Subject|3|||
147642396|NCT03117881|532510985|FG001|12-Month Follow-Up|Withdrawal by Subject|2|||
147642397|NCT03117881|532510986|FG002|12-Month Follow-Up|Withdrawal by Subject|0|||
147642398|NCT03117881|532510984|FG000|12-Month Follow-Up|Lost to Follow-up|18|||
147642399|NCT03117881|532510985|FG001|12-Month Follow-Up|Lost to Follow-up|22|||
147642400|NCT03117881|532510986|FG002|12-Month Follow-Up|Lost to Follow-up|0|||
147642401|NCT03117881|532510984|FG000|12-Month Follow-Up|Did not complete test|40|||
147642402|NCT03117881|532510985|FG001|12-Month Follow-Up|Did not complete test|0|||
147642403|NCT03117881|532510986|FG002|12-Month Follow-Up|Did not complete test|0|||
147642404|NCT00308750|532510989|FG000|Overall Study|Adverse Event|9|||
147642405|NCT00308750|532510990|FG001|Overall Study|Adverse Event|9|||
147642406|NCT00308750|532510991|FG002|Overall Study|Adverse Event|13|||
147642407|NCT00308750|532510989|FG000|Overall Study|Withdrawal by Subject|6|||
147642408|NCT00308750|532510990|FG001|Overall Study|Withdrawal by Subject|2|||
147642409|NCT00308750|532510991|FG002|Overall Study|Withdrawal by Subject|3|||
147642410|NCT00308750|532510989|FG000|Overall Study|Physician Decision|3|||
147642411|NCT00308750|532510990|FG001|Overall Study|Physician Decision|4|||
147642412|NCT00308750|532510991|FG002|Overall Study|Physician Decision|3|||
147642413|NCT00308750|532510989|FG000|Overall Study|Sponsor Decision|1|||
147642414|NCT00308750|532510990|FG001|Overall Study|Sponsor Decision|0|||
147642415|NCT00308750|532510991|FG002|Overall Study|Sponsor Decision|0|||
147642416|NCT00308750|532510989|FG000|Overall Study|Disease Progression|47|||
147642417|NCT00308750|532510990|FG001|Overall Study|Disease Progression|24|||
147518669|NCT02614261|532049912|FG002|Double-Blind Treatment Phase|Protocol Violation|0|||
147518670|NCT02614261|532049913|FG003|Double-Blind Treatment Phase|Protocol Violation|0|||
147518671|NCT02614261|532049910|FG000|Double-Blind Treatment Phase|Screen failure|0|||
147518672|NCT02614261|532049911|FG001|Double-Blind Treatment Phase|Screen failure|1|||
147642418|NCT00308750|532510991|FG002|Overall Study|Disease Progression|28|||
147642419|NCT00308750|532510989|FG000|Overall Study|Unrelated Complication|3|||
147642420|NCT00308750|532510990|FG001|Overall Study|Unrelated Complication|0|||
147642421|NCT00308750|532510991|FG002|Overall Study|Unrelated Complication|1|||
147642422|NCT00308750|532510989|FG000|Overall Study|Death|1|||
147642423|NCT00308750|532510990|FG001|Overall Study|Death|0|||
147518673|NCT02614261|532049912|FG002|Double-Blind Treatment Phase|Screen failure|2|||
147518674|NCT02614261|532049913|FG003|Double-Blind Treatment Phase|Screen failure|0|||
147518675|NCT02614261|532049910|FG000|Double-Blind Treatment Phase|Withdrawal by Subject|20|||
147518676|NCT02614261|532049911|FG001|Double-Blind Treatment Phase|Withdrawal by Subject|5|||
147518677|NCT02614261|532049912|FG002|Double-Blind Treatment Phase|Withdrawal by Subject|7|||
147518678|NCT02614261|532049913|FG003|Double-Blind Treatment Phase|Withdrawal by Subject|0|||
147518679|NCT02614261|532049910|FG000|Open-Label Extension Phase|Adverse Event|23|||
147518680|NCT02614261|532049911|FG001|Open-Label Extension Phase|Adverse Event|12|||
147518681|NCT02614261|532049912|FG002|Open-Label Extension Phase|Adverse Event|11|||
147518682|NCT02614261|532049913|FG003|Open-Label Extension Phase|Adverse Event|0|||
147518683|NCT02614261|532049910|FG000|Open-Label Extension Phase|Lack of Efficacy|14|||
147518684|NCT02614261|532049911|FG001|Open-Label Extension Phase|Lack of Efficacy|12|||
147642424|NCT00308750|532510991|FG002|Overall Study|Death|1|||
147642425|NCT00308750|532510989|FG000|Overall Study|Protocol Violation|1|||
147642426|NCT00308750|532510990|FG001|Overall Study|Protocol Violation|0|||
147642427|NCT00308750|532510991|FG002|Overall Study|Protocol Violation|0|||
147642428|NCT00308750|532510989|FG000|Overall Study|New Primary Disease Identified|1|||
147642429|NCT00308750|532510990|FG001|Overall Study|New Primary Disease Identified|1|||
147642430|NCT00308750|532510991|FG002|Overall Study|New Primary Disease Identified|0|||
147642431|NCT01358578|532510992|FG000|Induction Period|Adverse Event|2|||
147642432|NCT01358578|532510993|FG001|Induction Period|Adverse Event|4|||
147642433|NCT01358578|532510994|FG002|Induction Period|Adverse Event|2|||
147642434|NCT01358578|532510995|FG003|Induction Period|Adverse Event|6|||
147642435|NCT01358578|532510996|FG004|Induction Period|Adverse Event|0|||
147642436|NCT01358578|532510997|FG005|Induction Period|Adverse Event|0|||
147642437|NCT01358578|532510992|FG000|Induction Period|Lack of Efficacy|0|||
147642438|NCT01358578|532510993|FG001|Induction Period|Lack of Efficacy|0|||
147642439|NCT01358578|532510994|FG002|Induction Period|Lack of Efficacy|9|||
147642440|NCT01358578|532510995|FG003|Induction Period|Lack of Efficacy|1|||
147642441|NCT01358578|532510996|FG004|Induction Period|Lack of Efficacy|0|||
147642442|NCT01358578|532510997|FG005|Induction Period|Lack of Efficacy|0|||
147642443|NCT01358578|532510992|FG000|Induction Period|Lost to Follow-up|0|||
147642444|NCT01358578|532510993|FG001|Induction Period|Lost to Follow-up|0|||
147642445|NCT01358578|532510994|FG002|Induction Period|Lost to Follow-up|1|||
147642446|NCT01358578|532510995|FG003|Induction Period|Lost to Follow-up|4|||
147642447|NCT01358578|532510996|FG004|Induction Period|Lost to Follow-up|0|||
147642448|NCT01358578|532510997|FG005|Induction Period|Lost to Follow-up|0|||
147642449|NCT01358578|532510992|FG000|Induction Period|Physician Decision|2|||
147642450|NCT01358578|532510993|FG001|Induction Period|Physician Decision|1|||
147642451|NCT01358578|532510994|FG002|Induction Period|Physician Decision|2|||
147642452|NCT01358578|532510995|FG003|Induction Period|Physician Decision|0|||
147642453|NCT01358578|532510996|FG004|Induction Period|Physician Decision|0|||
147642454|NCT01358578|532510997|FG005|Induction Period|Physician Decision|0|||
147642455|NCT01358578|532510992|FG000|Induction Period|Protocol Deviation|3|||
147642456|NCT01358578|532510993|FG001|Induction Period|Protocol Deviation|5|||
147642457|NCT01358578|532510994|FG002|Induction Period|Protocol Deviation|0|||
147642458|NCT01358578|532510995|FG003|Induction Period|Protocol Deviation|3|||
147642459|NCT01358578|532510996|FG004|Induction Period|Protocol Deviation|0|||
147642460|NCT01358578|532510997|FG005|Induction Period|Protocol Deviation|0|||
147642461|NCT01358578|532510992|FG000|Induction Period|technical problems|0|||
147642462|NCT01358578|532510993|FG001|Induction Period|technical problems|0|||
147642463|NCT01358578|532510994|FG002|Induction Period|technical problems|1|||
147642464|NCT01358578|532510995|FG003|Induction Period|technical problems|1|||
147642465|NCT01358578|532510996|FG004|Induction Period|technical problems|0|||
147642466|NCT01358578|532510997|FG005|Induction Period|technical problems|0|||
147642467|NCT01358578|532510992|FG000|Induction Period|Withdrawal by Subject|5|||
147642468|NCT01358578|532510993|FG001|Induction Period|Withdrawal by Subject|5|||
147642469|NCT01358578|532510994|FG002|Induction Period|Withdrawal by Subject|10|||
147642470|NCT01358578|532510995|FG003|Induction Period|Withdrawal by Subject|6|||
147642471|NCT01358578|532510996|FG004|Induction Period|Withdrawal by Subject|0|||
147642472|NCT01358578|532510997|FG005|Induction Period|Withdrawal by Subject|0|||
147642473|NCT01358578|532510992|FG000|Maintenance Period|Adverse Event|2|||
147642474|NCT01358578|532510993|FG001|Maintenance Period|Adverse Event|7|||
147642475|NCT01358578|532510994|FG002|Maintenance Period|Adverse Event|0|||
147642476|NCT01358578|532510995|FG003|Maintenance Period|Adverse Event|6|||
147642477|NCT01358578|532510996|FG004|Maintenance Period|Adverse Event|4|||
147642478|NCT01358578|532510997|FG005|Maintenance Period|Adverse Event|3|||
147642479|NCT01358578|532510992|FG000|Maintenance Period|Lack of Efficacy|10|||
147642480|NCT01358578|532510993|FG001|Maintenance Period|Lack of Efficacy|2|||
147642481|NCT01358578|532510994|FG002|Maintenance Period|Lack of Efficacy|0|||
147642482|NCT01358578|532510995|FG003|Maintenance Period|Lack of Efficacy|11|||
147642483|NCT01358578|532510996|FG004|Maintenance Period|Lack of Efficacy|3|||
147642484|NCT01358578|532510997|FG005|Maintenance Period|Lack of Efficacy|0|||
147642485|NCT01358578|532510992|FG000|Maintenance Period|Lost to Follow-up|4|||
147642486|NCT01358578|532510993|FG001|Maintenance Period|Lost to Follow-up|0|||
147642487|NCT01358578|532510994|FG002|Maintenance Period|Lost to Follow-up|0|||
147642488|NCT01358578|532510995|FG003|Maintenance Period|Lost to Follow-up|5|||
147642489|NCT01358578|532510996|FG004|Maintenance Period|Lost to Follow-up|1|||
147642490|NCT01358578|532510997|FG005|Maintenance Period|Lost to Follow-up|1|||
147642491|NCT01358578|532510992|FG000|Maintenance Period|Non-compliance with study treatment|3|||
147642492|NCT01358578|532510993|FG001|Maintenance Period|Non-compliance with study treatment|1|||
147642493|NCT01358578|532510994|FG002|Maintenance Period|Non-compliance with study treatment|0|||
147642494|NCT01358578|532510995|FG003|Maintenance Period|Non-compliance with study treatment|2|||
147642495|NCT01358578|532510996|FG004|Maintenance Period|Non-compliance with study treatment|1|||
147642496|NCT01358578|532510997|FG005|Maintenance Period|Non-compliance with study treatment|2|||
147642497|NCT01358578|532510992|FG000|Maintenance Period|Physician Decision|0|||
147642498|NCT01358578|532510993|FG001|Maintenance Period|Physician Decision|1|||
147642499|NCT01358578|532510994|FG002|Maintenance Period|Physician Decision|0|||
147642500|NCT01358578|532510995|FG003|Maintenance Period|Physician Decision|1|||
147642501|NCT01358578|532510996|FG004|Maintenance Period|Physician Decision|0|||
147642502|NCT01358578|532510997|FG005|Maintenance Period|Physician Decision|0|||
147642503|NCT01358578|532510992|FG000|Maintenance Period|Pregnancy|1|||
147642504|NCT01358578|532510993|FG001|Maintenance Period|Pregnancy|0|||
147642505|NCT01358578|532510994|FG002|Maintenance Period|Pregnancy|0|||
147642506|NCT01358578|532510995|FG003|Maintenance Period|Pregnancy|0|||
147642507|NCT01358578|532510996|FG004|Maintenance Period|Pregnancy|0|||
147642508|NCT01358578|532510997|FG005|Maintenance Period|Pregnancy|0|||
147642509|NCT01358578|532510992|FG000|Maintenance Period|Protocol deviation|7|||
147642510|NCT01358578|532510993|FG001|Maintenance Period|Protocol deviation|4|||
147642511|NCT01358578|532510994|FG002|Maintenance Period|Protocol deviation|0|||
147642512|NCT01358578|532510995|FG003|Maintenance Period|Protocol deviation|2|||
147642513|NCT01358578|532510996|FG004|Maintenance Period|Protocol deviation|2|||
147642514|NCT01358578|532510997|FG005|Maintenance Period|Protocol deviation|2|||
147642515|NCT01358578|532510992|FG000|Maintenance Period|Withdrawal by Subject|12|||
147642516|NCT01358578|532510993|FG001|Maintenance Period|Withdrawal by Subject|7|||
147642517|NCT01358578|532510994|FG002|Maintenance Period|Withdrawal by Subject|2|||
147642518|NCT01358578|532510995|FG003|Maintenance Period|Withdrawal by Subject|15|||
147642519|NCT01358578|532510996|FG004|Maintenance Period|Withdrawal by Subject|6|||
147642520|NCT01358578|532510997|FG005|Maintenance Period|Withdrawal by Subject|3|||
147642521|NCT01358578|532510992|FG000|Follow-up Period|Adverse Event|1|||
147642522|NCT01358578|532510993|FG001|Follow-up Period|Adverse Event|1|||
147642523|NCT01358578|532510994|FG002|Follow-up Period|Adverse Event|0|||
147642524|NCT01358578|532510995|FG003|Follow-up Period|Adverse Event|0|||
147642525|NCT01358578|532510996|FG004|Follow-up Period|Adverse Event|0|||
147642526|NCT01358578|532510997|FG005|Follow-up Period|Adverse Event|0|||
147642527|NCT01358578|532510992|FG000|Follow-up Period|Lack of Efficacy|3|||
147642528|NCT01358578|532510993|FG001|Follow-up Period|Lack of Efficacy|0|||
147642529|NCT01358578|532510994|FG002|Follow-up Period|Lack of Efficacy|4|||
147642530|NCT01358578|532510995|FG003|Follow-up Period|Lack of Efficacy|1|||
147642531|NCT01358578|532510996|FG004|Follow-up Period|Lack of Efficacy|0|||
147642532|NCT01358578|532510997|FG005|Follow-up Period|Lack of Efficacy|0|||
147642533|NCT01358578|532510992|FG000|Follow-up Period|Lost to Follow-up|0|||
147642534|NCT01358578|532510993|FG001|Follow-up Period|Lost to Follow-up|1|||
147642535|NCT01358578|532510994|FG002|Follow-up Period|Lost to Follow-up|0|||
147642536|NCT01358578|532510995|FG003|Follow-up Period|Lost to Follow-up|4|||
147642537|NCT01358578|532510996|FG004|Follow-up Period|Lost to Follow-up|0|||
147642538|NCT01358578|532510997|FG005|Follow-up Period|Lost to Follow-up|0|||
147642539|NCT01358578|532510992|FG000|Follow-up Period|non- compliance with study treatment|1|||
147642540|NCT01358578|532510993|FG001|Follow-up Period|non- compliance with study treatment|0|||
147642541|NCT01358578|532510994|FG002|Follow-up Period|non- compliance with study treatment|0|||
147642542|NCT01358578|532510995|FG003|Follow-up Period|non- compliance with study treatment|0|||
147642543|NCT01358578|532510996|FG004|Follow-up Period|non- compliance with study treatment|0|||
147642544|NCT01358578|532510997|FG005|Follow-up Period|non- compliance with study treatment|0|||
147642545|NCT01358578|532510992|FG000|Follow-up Period|Pregnancy|1|||
147642546|NCT01358578|532510993|FG001|Follow-up Period|Pregnancy|0|||
147642547|NCT01358578|532510994|FG002|Follow-up Period|Pregnancy|0|||
147642548|NCT01358578|532510995|FG003|Follow-up Period|Pregnancy|0|||
147642549|NCT01358578|532510996|FG004|Follow-up Period|Pregnancy|0|||
147642550|NCT01358578|532510997|FG005|Follow-up Period|Pregnancy|0|||
147642551|NCT01358578|532510992|FG000|Follow-up Period|Withdrawal by Subject|3|||
147642552|NCT01358578|532510993|FG001|Follow-up Period|Withdrawal by Subject|3|||
147642553|NCT01358578|532510994|FG002|Follow-up Period|Withdrawal by Subject|1|||
147642554|NCT01358578|532510995|FG003|Follow-up Period|Withdrawal by Subject|12|||
147642555|NCT01358578|532510996|FG004|Follow-up Period|Withdrawal by Subject|0|||
147642556|NCT01358578|532510997|FG005|Follow-up Period|Withdrawal by Subject|0|||
147642557|NCT01358578|532510992|FG000|Follow-up Period|Physician Decision|1|||
147642558|NCT01358578|532510993|FG001|Follow-up Period|Physician Decision|1|||
147642559|NCT01358578|532510994|FG002|Follow-up Period|Physician Decision|0|||
147642560|NCT01358578|532510995|FG003|Follow-up Period|Physician Decision|2|||
147518685|NCT02614261|532049912|FG002|Open-Label Extension Phase|Lack of Efficacy|14|||
147518686|NCT02614261|532049913|FG003|Open-Label Extension Phase|Lack of Efficacy|0|||
147518687|NCT02614261|532049910|FG000|Open-Label Extension Phase|Lost to Follow-up|15|||
147518688|NCT02614261|532049911|FG001|Open-Label Extension Phase|Lost to Follow-up|7|||
147518689|NCT02614261|532049912|FG002|Open-Label Extension Phase|Lost to Follow-up|9|||
147518690|NCT02614261|532049913|FG003|Open-Label Extension Phase|Lost to Follow-up|0|||
147518691|NCT02614261|532049910|FG000|Open-Label Extension Phase|Physician Decision|2|||
147518692|NCT02614261|532049911|FG001|Open-Label Extension Phase|Physician Decision|0|||
147518693|NCT02614261|532049912|FG002|Open-Label Extension Phase|Physician Decision|0|||
147518694|NCT02614261|532049913|FG003|Open-Label Extension Phase|Physician Decision|0|||
147518695|NCT02614261|532049910|FG000|Open-Label Extension Phase|Pregnancy|1|||
147518696|NCT02614261|532049911|FG001|Open-Label Extension Phase|Pregnancy|2|||
147518697|NCT02614261|532049912|FG002|Open-Label Extension Phase|Pregnancy|1|||
147518698|NCT02614261|532049913|FG003|Open-Label Extension Phase|Pregnancy|0|||
147518699|NCT02614261|532049910|FG000|Open-Label Extension Phase|Protocol Violation|3|||
147518700|NCT02614261|532049911|FG001|Open-Label Extension Phase|Protocol Violation|4|||
147518701|NCT02614261|532049912|FG002|Open-Label Extension Phase|Protocol Violation|1|||
147518702|NCT02614261|532049913|FG003|Open-Label Extension Phase|Protocol Violation|0|||
147518703|NCT02614261|532049910|FG000|Open-Label Extension Phase|Withdrawal by Subject|30|||
147518704|NCT02614261|532049911|FG001|Open-Label Extension Phase|Withdrawal by Subject|18|||
147518705|NCT02614261|532049912|FG002|Open-Label Extension Phase|Withdrawal by Subject|18|||
147518706|NCT02614261|532049913|FG003|Open-Label Extension Phase|Withdrawal by Subject|0|||
147518707|NCT02614261|532049910|FG000|Follow-up Phase|Adverse Event|2|||
147518708|NCT02614261|532049911|FG001|Follow-up Phase|Adverse Event|0|||
147518709|NCT02614261|532049912|FG002|Follow-up Phase|Adverse Event|1|||
147518710|NCT02614261|532049913|FG003|Follow-up Phase|Adverse Event|0|||
147518711|NCT02614261|532049910|FG000|Follow-up Phase|Lost to Follow-up|12|||
147518712|NCT02614261|532049911|FG001|Follow-up Phase|Lost to Follow-up|5|||
147518713|NCT02614261|532049912|FG002|Follow-up Phase|Lost to Follow-up|2|||
147518714|NCT02614261|532049913|FG003|Follow-up Phase|Lost to Follow-up|0|||
147518715|NCT02614261|532049910|FG000|Follow-up Phase|Physician Decision|5|||
147518716|NCT02614261|532049911|FG001|Follow-up Phase|Physician Decision|1|||
147518717|NCT02614261|532049912|FG002|Follow-up Phase|Physician Decision|0|||
147642561|NCT01358578|532510996|FG004|Follow-up Period|Physician Decision|0|||
147642562|NCT01358578|532510997|FG005|Follow-up Period|Physician Decision|0|||
147642563|NCT03605849|532510998|FG000|Overall Study|Adverse Event|20|||
147642564|NCT03605849|532510999|FG001|Overall Study|Adverse Event|21|||
147642565|NCT03605849|532511000|FG002|Overall Study|Adverse Event|29|||
147642566|NCT03605849|532511001|FG003|Overall Study|Adverse Event|11|||
147642567|NCT03605849|532510998|FG000|Overall Study|Lack of Efficacy|4|||
147642568|NCT03605849|532510999|FG001|Overall Study|Lack of Efficacy|7|||
147642569|NCT03605849|532511000|FG002|Overall Study|Lack of Efficacy|9|||
147642570|NCT03605849|532511001|FG003|Overall Study|Lack of Efficacy|2|||
147642571|NCT03605849|532510998|FG000|Overall Study|Lost to Follow-up|8|||
147642572|NCT03605849|532510999|FG001|Overall Study|Lost to Follow-up|8|||
147642573|NCT03605849|532511000|FG002|Overall Study|Lost to Follow-up|14|||
147642574|NCT03605849|532511001|FG003|Overall Study|Lost to Follow-up|11|||
147642575|NCT03605849|532510998|FG000|Overall Study|Non-compliance With IMP|6|||
147642576|NCT03605849|532510999|FG001|Overall Study|Non-compliance With IMP|5|||
147642577|NCT03605849|532511000|FG002|Overall Study|Non-compliance With IMP|2|||
147642578|NCT03605849|532511001|FG003|Overall Study|Non-compliance With IMP|1|||
147642579|NCT03605849|532510998|FG000|Overall Study|Protocol Deviation|1|||
147642580|NCT03605849|532510999|FG001|Overall Study|Protocol Deviation|2|||
147642581|NCT03605849|532511000|FG002|Overall Study|Protocol Deviation|1|||
147642582|NCT03605849|532511001|FG003|Overall Study|Protocol Deviation|3|||
147642583|NCT03605849|532510998|FG000|Overall Study|Withdrawal by Subject|33|||
147642584|NCT03605849|532510999|FG001|Overall Study|Withdrawal by Subject|28|||
147642585|NCT03605849|532511000|FG002|Overall Study|Withdrawal by Subject|30|||
147642586|NCT03605849|532511001|FG003|Overall Study|Withdrawal by Subject|28|||
147642587|NCT03605849|532510998|FG000|Overall Study|Site Terminated by Sponsor|0|||
147518718|NCT02614261|532049913|FG003|Follow-up Phase|Physician Decision|0|||
147642588|NCT03605849|532510999|FG001|Overall Study|Site Terminated by Sponsor|0|||
147642589|NCT03605849|532511000|FG002|Overall Study|Site Terminated by Sponsor|0|||
147642590|NCT03605849|532511001|FG003|Overall Study|Site Terminated by Sponsor|1|||
147642591|NCT03605849|532510998|FG000|Overall Study|Physician Decision|2|||
147518719|NCT02614261|532049910|FG000|Follow-up Phase|Pregnancy|0|||
147642592|NCT03605849|532510999|FG001|Overall Study|Physician Decision|1|||
147518720|NCT02614261|532049911|FG001|Follow-up Phase|Pregnancy|1|||
147518721|NCT02614261|532049912|FG002|Follow-up Phase|Pregnancy|0|||
147518722|NCT02614261|532049913|FG003|Follow-up Phase|Pregnancy|0|||
147518723|NCT02614261|532049910|FG000|Follow-up Phase|Protocol Violation|1|||
147518724|NCT02614261|532049911|FG001|Follow-up Phase|Protocol Violation|0|||
147518725|NCT02614261|532049912|FG002|Follow-up Phase|Protocol Violation|0|||
147518726|NCT02614261|532049913|FG003|Follow-up Phase|Protocol Violation|0|||
147518727|NCT02614261|532049910|FG000|Follow-up Phase|Withdrawal by Subject|12|||
147518728|NCT02614261|532049911|FG001|Follow-up Phase|Withdrawal by Subject|4|||
147518729|NCT02614261|532049912|FG002|Follow-up Phase|Withdrawal by Subject|11|||
147518730|NCT02614261|532049913|FG003|Follow-up Phase|Withdrawal by Subject|0|||
147518731|NCT02614261|532049910|FG000|Israel Addendum|Withdrawal by Subject|0|||
147518732|NCT02614261|532049911|FG001|Israel Addendum|Withdrawal by Subject|0|||
147518733|NCT02614261|532049912|FG002|Israel Addendum|Withdrawal by Subject|0|||
147518734|NCT02614261|532049913|FG003|Israel Addendum|Withdrawal by Subject|4|||
147518735|NCT03512275|532049914|FG000|Overall Study|Withdrawal by Subject|1|||
147518736|NCT03512275|532049915|FG001|Overall Study|Withdrawal by Subject|3|||
147518737|NCT03512275|532049914|FG000|Overall Study|Physician Decision|0|||
147518738|NCT03512275|532049915|FG001|Overall Study|Physician Decision|1|||
147518739|NCT03512275|532049914|FG000|Overall Study|Lost to Follow-up|0|||
147518740|NCT03512275|532049915|FG001|Overall Study|Lost to Follow-up|3|||
147518741|NCT03512275|532049914|FG000|Overall Study|Other|1|||
147518742|NCT03512275|532049915|FG001|Overall Study|Other|0|||
147518743|NCT03399786|532049918|FG000|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|1|||
147518744|NCT03399786|532049919|FG001|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
147518745|NCT03399786|532049920|FG002|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
147518746|NCT03399786|532049921|FG003|Double-blind Treatment Period (DBTP)|Withdrawal by Subject|0|||
147518747|NCT03399786|532049918|FG000|Open-label Treatment Period (OLTP)|Noncompliance with protocol by the participant|0|||
147518748|NCT03399786|532049919|FG001|Open-label Treatment Period (OLTP)|Noncompliance with protocol by the participant|0|||
147518749|NCT03399786|532049920|FG002|Open-label Treatment Period (OLTP)|Noncompliance with protocol by the participant|1|||
147518750|NCT03399786|532049921|FG003|Open-label Treatment Period (OLTP)|Noncompliance with protocol by the participant|0|||
147518751|NCT03399786|532049918|FG000|Open-label Treatment Period (OLTP)|Pregnancy|0|||
147518752|NCT03399786|532049919|FG001|Open-label Treatment Period (OLTP)|Pregnancy|0|||
147518753|NCT03399786|532049920|FG002|Open-label Treatment Period (OLTP)|Pregnancy|0|||
147518754|NCT03399786|532049921|FG003|Open-label Treatment Period (OLTP)|Pregnancy|1|||
147518755|NCT01855919|532051962|FG000|Overall Study|Adverse Event|16|||
147518756|NCT01855919|532051963|FG001|Overall Study|Adverse Event|8|||
147518757|NCT01855919|532051962|FG000|Overall Study|Lack of Efficacy|1|||
147518758|NCT01855919|532051963|FG001|Overall Study|Lack of Efficacy|3|||
147518759|NCT01855919|532051962|FG000|Overall Study|Withdrawal by Subject|4|||
147518760|NCT01855919|532051963|FG001|Overall Study|Withdrawal by Subject|10|||
147518761|NCT01855919|532051962|FG000|Overall Study|Entry Criteria Not Met|1|||
147518762|NCT01855919|532051963|FG001|Overall Study|Entry Criteria Not Met|1|||
147518763|NCT01855919|532051962|FG000|Overall Study|Protocol Violation|1|||
147518764|NCT01855919|532051963|FG001|Overall Study|Protocol Violation|4|||
147518765|NCT03455530|532051964|FG000|Overall Study|Withdrawal by Subject|9|||
147518766|NCT03455530|532051965|FG001|Overall Study|Withdrawal by Subject|1|||
147518767|NCT03455530|532051966|FG002|Overall Study|Withdrawal by Subject|3|||
147518768|NCT03455530|532051967|FG003|Overall Study|Withdrawal by Subject|3|||
147518769|NCT00740116|532051976|FG000|Overall Study|Withdrawal by Subject|1|||
147518770|NCT00740116|532051977|FG001|Overall Study|Withdrawal by Subject|1|||
147518771|NCT00740116|532051976|FG000|Overall Study|Protocol Violation|1|||
147518772|NCT00740116|532051977|FG001|Overall Study|Protocol Violation|4|||
147518773|NCT03037489|532051978|FG000|Overall Study|Adverse Event|4|||
147518774|NCT03037489|532051979|FG001|Overall Study|Adverse Event|0|||
147518775|NCT03037489|532051978|FG000|Overall Study|Withdrawal by Subject|3|||
147518776|NCT03037489|532051979|FG001|Overall Study|Withdrawal by Subject|0|||
147518777|NCT02499172|532051980|FG000|Overall Study|Financial reason|0|||
147518778|NCT02499172|532051981|FG001|Overall Study|Financial reason|0|||
147518779|NCT02499172|532051982|FG002|Overall Study|Financial reason|523|||
147518780|NCT02499172|532051983|FG003|Overall Study|Financial reason|436|||
147518781|NCT02499172|532051980|FG000|Overall Study|Lost to Follow-up|65|||
147518782|NCT02499172|532051981|FG001|Overall Study|Lost to Follow-up|64|||
147518783|NCT02499172|532051982|FG002|Overall Study|Lost to Follow-up|0|||
147518784|NCT02499172|532051983|FG003|Overall Study|Lost to Follow-up|0|||
147518785|NCT00724243|532051986|FG000|Overall Study|Lack of Efficacy|10|||
147518786|NCT00724243|532051986|FG000|Overall Study|Adverse Event|5|||
147518787|NCT01997892|532051990|FG000|Overall Study|Physician Decision|2|||
147518788|NCT01997892|532051990|FG000|Overall Study|Lost to Follow-up|6|||
147518789|NCT01997892|532051990|FG000|Overall Study|Death|14|||
147518790|NCT01997892|532051990|FG000|Overall Study|Renal transplant|8|||
147518791|NCT01997892|532051990|FG000|Overall Study|Other|3|||
147518792|NCT01997892|532051990|FG000|Overall Study|Study completion data not recorded|35|||
147518793|NCT02943577|532052007|FG000|Overall Study|Protocol Violation|0|||
147518794|NCT02943577|532052008|FG001|Overall Study|Protocol Violation|1|||
147518795|NCT02943577|532052007|FG000|Overall Study|Adverse Event|3|||
147518796|NCT02943577|532052008|FG001|Overall Study|Adverse Event|2|||
147518797|NCT02943577|532052007|FG000|Overall Study|Lost to Follow-up|0|||
147518798|NCT02943577|532052008|FG001|Overall Study|Lost to Follow-up|1|||
147518799|NCT02943577|532052007|FG000|Overall Study|Withdrawal by Subject|1|||
147518800|NCT02943577|532052008|FG001|Overall Study|Withdrawal by Subject|1|||
147518801|NCT02943577|532052007|FG000|Overall Study|Pregnancy|1|||
147518802|NCT02943577|532052008|FG001|Overall Study|Pregnancy|0|||
147518803|NCT00939055|532052013|FG000|Overall Study|Discontinuation prior to procedure|4|||
147518804|NCT00939055|532052014|FG001|Overall Study|Discontinuation prior to procedure|0|||
147642593|NCT03605849|532511000|FG002|Overall Study|Physician Decision|2|||
147642594|NCT03605849|532511001|FG003|Overall Study|Physician Decision|1|||
147642595|NCT03605849|532510998|FG000|Overall Study|Enrolled, but not Treated|2|||
147642596|NCT03605849|532510999|FG001|Overall Study|Enrolled, but not Treated|2|||
147642597|NCT03605849|532511000|FG002|Overall Study|Enrolled, but not Treated|3|||
147642598|NCT03605849|532511001|FG003|Overall Study|Enrolled, but not Treated|2|||
147642599|NCT03605849|532510998|FG000|Overall Study|Other (COVID-19 Related)|0|||
147642600|NCT03605849|532510999|FG001|Overall Study|Other (COVID-19 Related)|1|||
147642601|NCT03605849|532511000|FG002|Overall Study|Other (COVID-19 Related)|1|||
147642602|NCT03605849|532511001|FG003|Overall Study|Other (COVID-19 Related)|0|||
147642603|NCT03605849|532510998|FG000|Overall Study|Other (Not Related to COVID-19)|2|||
147642604|NCT03605849|532510999|FG001|Overall Study|Other (Not Related to COVID-19)|4|||
147642605|NCT03605849|532511000|FG002|Overall Study|Other (Not Related to COVID-19)|4|||
147642606|NCT03605849|532511001|FG003|Overall Study|Other (Not Related to COVID-19)|5|||
147642607|NCT02304380|532511002|FG000|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0|||
147642608|NCT02304380|532511003|FG001|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0|||
147642609|NCT02304380|532511004|FG002|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0|||
147642610|NCT02304380|532511005|FG003|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|34|||
147642611|NCT02304380|532511006|FG004|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0|||
147642612|NCT02304380|532511007|FG005|Pediatric Adult Caregiver Survey (Aim 2)|Withdrawal by Subject|0|||
147642613|NCT00328094|532511008|FG000|Overall Study|Physician Decision|3|||
147642614|NCT00328094|532511009|FG001|Overall Study|Physician Decision|3|||
147642615|NCT01911780|532511010|FG000|Double-blind Period (8 Weeks)|Adverse Event|1|||
147642616|NCT01911780|532511011|FG001|Double-blind Period (8 Weeks)|Adverse Event|2|||
147642617|NCT01911780|532511010|FG000|Double-blind Period (8 Weeks)|Consent withdrawn not due to AEs|1|||
147642618|NCT01911780|532511011|FG001|Double-blind Period (8 Weeks)|Consent withdrawn not due to AEs|1|||
147642619|NCT01911780|532511010|FG000|Double-blind Period (8 Weeks)|Personal reason|1|||
147642620|NCT01911780|532511011|FG001|Double-blind Period (8 Weeks)|Personal reason|0|||
147642621|NCT01911780|532511010|FG000|Extension Period (52 Weeks)|Adverse Event|3|||
147642622|NCT01911780|532511011|FG001|Extension Period (52 Weeks)|Adverse Event|0|||
147642623|NCT01911780|532511010|FG000|Extension Period (52 Weeks)|Consent withdrawn not due to AEs|0|||
147642624|NCT01911780|532511011|FG001|Extension Period (52 Weeks)|Consent withdrawn not due to AEs|2|||
147642625|NCT01911780|532511010|FG000|Extension Period (52 Weeks)|Personal reason|1|||
147642626|NCT01911780|532511011|FG001|Extension Period (52 Weeks)|Personal reason|1|||
147642627|NCT00985426|532511012|FG000|Overall Study|Adverse Event|0|||
147642628|NCT00985426|532511013|FG001|Overall Study|Adverse Event|1|||
147642629|NCT00985426|532511012|FG000|Overall Study|Subject Non-Compliance|3|||
147642630|NCT00985426|532511013|FG001|Overall Study|Subject Non-Compliance|3|||
147642631|NCT00985426|532511012|FG000|Overall Study|Withdrawal by Subject|12|||
147642632|NCT00985426|532511013|FG001|Overall Study|Withdrawal by Subject|16|||
147642633|NCT00985426|532511012|FG000|Overall Study|Lost to Follow-up|8|||
147642634|NCT00985426|532511013|FG001|Overall Study|Lost to Follow-up|10|||
147642635|NCT00985426|532511012|FG000|Overall Study|Death|7|||
147642636|NCT00985426|532511013|FG001|Overall Study|Death|3|||
147642637|NCT00985426|532511012|FG000|Overall Study|Protocol Violation|2|||
147642638|NCT00985426|532511013|FG001|Overall Study|Protocol Violation|0|||
147518805|NCT00584987|532052015|FG000|Overall Study|Protocol Violation|1|||
147518806|NCT00584987|532052016|FG001|Overall Study|Protocol Violation|1|||
147518807|NCT00584987|532052017|FG002|Overall Study|Protocol Violation|1|||
147518808|NCT00584987|532052018|FG003|Overall Study|Protocol Violation|0|||
147518809|NCT00584987|532052015|FG000|Overall Study|Adverse Event|0|||
147642639|NCT00985426|532511012|FG000|Overall Study|Lack of seroprotection at protocol-specified timepoints|11|||
147642640|NCT00985426|532511013|FG001|Overall Study|Lack of seroprotection at protocol-specified timepoints|11|||
147642641|NCT02052596|532511014|FG000|Active Phase|Adverse Event|3|||
147642642|NCT02052596|532511015|FG001|Active Phase|Adverse Event|2|||
147518810|NCT00584987|532052016|FG001|Overall Study|Adverse Event|0|||
147518811|NCT00584987|532052017|FG002|Overall Study|Adverse Event|0|||
147518812|NCT00584987|532052018|FG003|Overall Study|Adverse Event|1|||
147518813|NCT03225833|532052022|FG000|Overall Study|Adverse Event|0|||
147518814|NCT03225833|532052023|FG001|Overall Study|Adverse Event|1|||
147518815|NCT03225833|532052024|FG002|Overall Study|Adverse Event|2|||
147518816|NCT03225833|532052025|FG003|Overall Study|Adverse Event|0|||
147518817|NCT03225833|532052026|FG004|Overall Study|Adverse Event|0|||
147518818|NCT03225833|532052027|FG005|Overall Study|Adverse Event|2|||
147518819|NCT03225833|532052022|FG000|Overall Study|Withdrawal by Subject|1|||
147518820|NCT03225833|532052023|FG001|Overall Study|Withdrawal by Subject|0|||
147518821|NCT03225833|532052024|FG002|Overall Study|Withdrawal by Subject|0|||
147518822|NCT03225833|532052025|FG003|Overall Study|Withdrawal by Subject|0|||
147518823|NCT03225833|532052026|FG004|Overall Study|Withdrawal by Subject|1|||
147518824|NCT03225833|532052027|FG005|Overall Study|Withdrawal by Subject|0|||
147518825|NCT03225833|532052022|FG000|Overall Study|Termination of Study by Sponsor|4|||
147518826|NCT03225833|532052023|FG001|Overall Study|Termination of Study by Sponsor|0|||
147518827|NCT03225833|532052024|FG002|Overall Study|Termination of Study by Sponsor|0|||
147518828|NCT03225833|532052025|FG003|Overall Study|Termination of Study by Sponsor|0|||
147518829|NCT03225833|532052026|FG004|Overall Study|Termination of Study by Sponsor|0|||
147518830|NCT03225833|532052027|FG005|Overall Study|Termination of Study by Sponsor|7|||
147518831|NCT03225833|532052022|FG000|Overall Study|Sponsor Decision|0|||
147518832|NCT03225833|532052023|FG001|Overall Study|Sponsor Decision|0|||
147518833|NCT03225833|532052024|FG002|Overall Study|Sponsor Decision|0|||
147518834|NCT03225833|532052025|FG003|Overall Study|Sponsor Decision|0|||
147518835|NCT03225833|532052026|FG004|Overall Study|Sponsor Decision|0|||
147518836|NCT03225833|532052027|FG005|Overall Study|Sponsor Decision|1|||
147518837|NCT00808028|532052028|FG000|Stage 1 (6 Months)|Withdrawal by Subject|3|||
147518838|NCT00808028|532052029|FG001|Stage 1 (6 Months)|Withdrawal by Subject|0|||
147518839|NCT00808028|532052030|FG002|Stage 1 (6 Months)|Withdrawal by Subject|2|||
147518840|NCT00808028|532052031|FG003|Stage 1 (6 Months)|Withdrawal by Subject|5|||
147518841|NCT00808028|532052028|FG000|Stage 1 (6 Months)|Other|1|||
147518842|NCT00808028|532052029|FG001|Stage 1 (6 Months)|Other|0|||
147518843|NCT00808028|532052030|FG002|Stage 1 (6 Months)|Other|2|||
147518844|NCT00808028|532052031|FG003|Stage 1 (6 Months)|Other|4|||
147518845|NCT00808028|532052028|FG000|Stage 1 (6 Months)|Parent/legal guardian request|0|||
147518846|NCT00808028|532052029|FG001|Stage 1 (6 Months)|Parent/legal guardian request|1|||
147518847|NCT00808028|532052030|FG002|Stage 1 (6 Months)|Parent/legal guardian request|1|||
147518848|NCT00808028|532052031|FG003|Stage 1 (6 Months)|Parent/legal guardian request|3|||
147518849|NCT00808028|532052028|FG000|Stage 1 (6 Months)|Adverse Event|0|||
147518850|NCT00808028|532052029|FG001|Stage 1 (6 Months)|Adverse Event|0|||
147518851|NCT00808028|532052030|FG002|Stage 1 (6 Months)|Adverse Event|1|||
147518852|NCT00808028|532052031|FG003|Stage 1 (6 Months)|Adverse Event|2|||
147518853|NCT00808028|532052028|FG000|Stage 1 (6 Months)|Lost to Follow-up|1|||
147518854|NCT00808028|532052029|FG001|Stage 1 (6 Months)|Lost to Follow-up|0|||
147518855|NCT00808028|532052030|FG002|Stage 1 (6 Months)|Lost to Follow-up|1|||
147518856|NCT00808028|532052031|FG003|Stage 1 (6 Months)|Lost to Follow-up|0|||
147518857|NCT00808028|532052028|FG000|Stage 1 (6 Months)|Protocol Violation|0|||
147518858|NCT00808028|532052029|FG001|Stage 1 (6 Months)|Protocol Violation|0|||
147518859|NCT00808028|532052030|FG002|Stage 1 (6 Months)|Protocol Violation|0|||
147518860|NCT00808028|532052031|FG003|Stage 1 (6 Months)|Protocol Violation|1|||
147518861|NCT00808028|532052028|FG000|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|6|||
147518862|NCT00808028|532052029|FG001|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|0|||
147518863|NCT00808028|532052030|FG002|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|9|||
147518864|NCT00808028|532052031|FG003|Stage 2 (Followed up to 48 Months )|Withdrawal by Subject|11|||
147518865|NCT00808028|532052028|FG000|Stage 2 (Followed up to 48 Months )|Protocol Violation|0|||
147518866|NCT00808028|532052029|FG001|Stage 2 (Followed up to 48 Months )|Protocol Violation|0|||
147518867|NCT00808028|532052030|FG002|Stage 2 (Followed up to 48 Months )|Protocol Violation|1|||
147518868|NCT00808028|532052031|FG003|Stage 2 (Followed up to 48 Months )|Protocol Violation|0|||
147518869|NCT00808028|532052028|FG000|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|2|||
147518870|NCT00808028|532052029|FG001|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|0|||
147518871|NCT00808028|532052030|FG002|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|8|||
147642643|NCT02052596|532511014|FG000|Active Phase|Lost to Follow-up|8|||
147642644|NCT02052596|532511015|FG001|Active Phase|Lost to Follow-up|11|||
147642645|NCT02052596|532511014|FG000|Active Phase|Protocol Violation|1|||
147642646|NCT02052596|532511015|FG001|Active Phase|Protocol Violation|2|||
147642647|NCT02052596|532511014|FG000|Active Phase|Withdrawal by Subject|3|||
147642648|NCT02052596|532511015|FG001|Active Phase|Withdrawal by Subject|4|||
147642649|NCT02052596|532511014|FG000|Active Phase|Enrolled in error|1|||
147642650|NCT02052596|532511015|FG001|Active Phase|Enrolled in error|0|||
147642651|NCT02052596|532511014|FG000|Active Phase|Lost due to Crohn's disease|0|||
147642652|NCT02052596|532511015|FG001|Active Phase|Lost due to Crohn's disease|1|||
147642653|NCT02052596|532511014|FG000|Safety Phase|Adverse Event|6|||
147642654|NCT02052596|532511015|FG001|Safety Phase|Adverse Event|3|||
147642655|NCT02052596|532511014|FG000|Safety Phase|Lost to Follow-up|11|||
147642656|NCT02052596|532511015|FG001|Safety Phase|Lost to Follow-up|18|||
147642657|NCT02052596|532511014|FG000|Safety Phase|Protocol Violation|1|||
147642658|NCT02052596|532511015|FG001|Safety Phase|Protocol Violation|2|||
147642659|NCT02052596|532511014|FG000|Safety Phase|Withdrawal by Subject|8|||
147642660|NCT02052596|532511015|FG001|Safety Phase|Withdrawal by Subject|11|||
147642661|NCT02052596|532511014|FG000|Safety Phase|Enrolled in error|1|||
147642662|NCT02052596|532511015|FG001|Safety Phase|Enrolled in error|0|||
147642663|NCT02052596|532511014|FG000|Safety Phase|Lost due to Crohn's disease|0|||
147642664|NCT02052596|532511015|FG001|Safety Phase|Lost due to Crohn's disease|1|||
147642665|NCT00558896|532511016|FG000|Overall Study|Adverse Event|1|||
147642666|NCT00558896|532511017|FG001|Overall Study|Adverse Event|1|||
147642667|NCT00558896|532511018|FG002|Overall Study|Adverse Event|1|||
147642668|NCT00558896|532511019|FG003|Overall Study|Adverse Event|3|||
147642669|NCT00558896|532511020|FG004|Overall Study|Adverse Event|4|||
147642670|NCT00558896|532511021|FG005|Overall Study|Adverse Event|10|||
147642671|NCT00558896|532511022|FG006|Overall Study|Adverse Event|3|||
147642672|NCT00558896|532511016|FG000|Overall Study|Death|3|||
147642673|NCT00558896|532511017|FG001|Overall Study|Death|0|||
147642674|NCT00558896|532511018|FG002|Overall Study|Death|2|||
147642675|NCT00558896|532511019|FG003|Overall Study|Death|3|||
147642676|NCT00558896|532511020|FG004|Overall Study|Death|2|||
147642677|NCT00558896|532511021|FG005|Overall Study|Death|2|||
147642678|NCT00558896|532511022|FG006|Overall Study|Death|6|||
147518872|NCT00808028|532052031|FG003|Stage 2 (Followed up to 48 Months )|Lost to Follow-up|7|||
147518873|NCT00808028|532052028|FG000|Stage 2 (Followed up to 48 Months )|Failed to return|2|||
147518874|NCT00808028|532052029|FG001|Stage 2 (Followed up to 48 Months )|Failed to return|0|||
147518875|NCT00808028|532052030|FG002|Stage 2 (Followed up to 48 Months )|Failed to return|5|||
147518876|NCT00808028|532052031|FG003|Stage 2 (Followed up to 48 Months )|Failed to return|4|||
147518877|NCT00808028|532052028|FG000|Stage 2 (Followed up to 48 Months )|Adverse Event|1|||
147518878|NCT00808028|532052029|FG001|Stage 2 (Followed up to 48 Months )|Adverse Event|0|||
147518879|NCT00808028|532052030|FG002|Stage 2 (Followed up to 48 Months )|Adverse Event|1|||
147518880|NCT00808028|532052031|FG003|Stage 2 (Followed up to 48 Months )|Adverse Event|0|||
147518881|NCT00808028|532052028|FG000|Stage 2 (Followed up to 48 Months )|Other|0|||
147518882|NCT00808028|532052029|FG001|Stage 2 (Followed up to 48 Months )|Other|0|||
147518883|NCT00808028|532052030|FG002|Stage 2 (Followed up to 48 Months )|Other|1|||
147518884|NCT00808028|532052031|FG003|Stage 2 (Followed up to 48 Months )|Other|1|||
147518885|NCT00808028|532052028|FG000|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|0|||
147518886|NCT00808028|532052029|FG001|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|0|||
147518887|NCT00808028|532052030|FG002|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|2|||
147518888|NCT00808028|532052031|FG003|Stage 2 (Followed up to 48 Months )|Parent's or guardian request|0|||
147518889|NCT00808028|532052028|FG000|Stage 2 (Followed up to 48 Months )|Death|0|||
147518890|NCT00808028|532052029|FG001|Stage 2 (Followed up to 48 Months )|Death|0|||
147518891|NCT00808028|532052030|FG002|Stage 2 (Followed up to 48 Months )|Death|1|||
147518892|NCT00808028|532052031|FG003|Stage 2 (Followed up to 48 Months )|Death|0|||
147518893|NCT00808028|532052028|FG000|Stage 2 (Followed up to 48 Months )|Non-compliance|0|||
147518894|NCT00808028|532052029|FG001|Stage 2 (Followed up to 48 Months )|Non-compliance|0|||
147518895|NCT00808028|532052030|FG002|Stage 2 (Followed up to 48 Months )|Non-compliance|1|||
147518896|NCT00808028|532052031|FG003|Stage 2 (Followed up to 48 Months )|Non-compliance|0|||
147518897|NCT02274311|532052034|FG000|Three Months of Clomiphene Wash-out|Lost to Follow-up|1|||
147518898|NCT00508001|532052035|FG000|Overall Study|Adverse Event|2|||
147518899|NCT00508001|532052036|FG001|Overall Study|Adverse Event|0|||
147518900|NCT00508001|532052037|FG002|Overall Study|Adverse Event|4|||
147518901|NCT00508001|532052035|FG000|Overall Study|condition under investigation worsened|13|||
147518902|NCT00508001|532052036|FG001|Overall Study|condition under investigation worsened|7|||
147518903|NCT00508001|532052037|FG002|Overall Study|condition under investigation worsened|1|||
147518904|NCT00508001|532052035|FG000|Overall Study|Death|0|||
147518905|NCT00508001|532052036|FG001|Overall Study|Death|1|||
147518906|NCT00508001|532052037|FG002|Overall Study|Death|1|||
147518907|NCT00508001|532052035|FG000|Overall Study|Withdrawal by Subject|4|||
147518908|NCT00508001|532052036|FG001|Overall Study|Withdrawal by Subject|4|||
147518909|NCT00508001|532052037|FG002|Overall Study|Withdrawal by Subject|1|||
147518910|NCT03093350|532052038|FG000|Overall Study|Death|1|||
147518911|NCT03093350|532052038|FG000|Overall Study|Signed consent, never began treartment|1|||
147518912|NCT00729560|532052045|FG000|Overall Study|Withdrawal by Subject|3|||
147518913|NCT00829010|532052046|FG000|Overall Study|Adverse Event|1|||
147518914|NCT00829010|532052047|FG001|Overall Study|Adverse Event|0|||
147518915|NCT00829010|532052048|FG002|Overall Study|Adverse Event|0|||
147518916|NCT00829010|532052049|FG003|Overall Study|Adverse Event|0|||
147518917|NCT00829010|532052050|FG004|Overall Study|Adverse Event|0|||
147518918|NCT00829010|532052046|FG000|Overall Study|Withdrawal by Subject|0|||
147518919|NCT00829010|532052047|FG001|Overall Study|Withdrawal by Subject|1|||
147518920|NCT00829010|532052048|FG002|Overall Study|Withdrawal by Subject|1|||
147518921|NCT00829010|532052049|FG003|Overall Study|Withdrawal by Subject|0|||
147518922|NCT00829010|532052050|FG004|Overall Study|Withdrawal by Subject|2|||
147518923|NCT00829010|532052046|FG000|Overall Study|Lost to Follow-up|1|||
147518924|NCT00829010|532052047|FG001|Overall Study|Lost to Follow-up|0|||
147518925|NCT00829010|532052048|FG002|Overall Study|Lost to Follow-up|2|||
147518926|NCT00829010|532052049|FG003|Overall Study|Lost to Follow-up|0|||
147518927|NCT00829010|532052050|FG004|Overall Study|Lost to Follow-up|0|||
147518928|NCT00829010|532052046|FG000|Overall Study|Fatality|5|||
147518929|NCT00829010|532052047|FG001|Overall Study|Fatality|4|||
147518930|NCT00829010|532052048|FG002|Overall Study|Fatality|0|||
147518931|NCT00829010|532052049|FG003|Overall Study|Fatality|3|||
147518932|NCT00829010|532052050|FG004|Overall Study|Fatality|0|||
147518933|NCT00829010|532052046|FG000|Overall Study|Migrated/Moved from study area|3|||
147518934|NCT00829010|532052047|FG001|Overall Study|Migrated/Moved from study area|4|||
147518935|NCT00829010|532052048|FG002|Overall Study|Migrated/Moved from study area|0|||
147518936|NCT00829010|532052049|FG003|Overall Study|Migrated/Moved from study area|5|||
147518937|NCT00829010|532052050|FG004|Overall Study|Migrated/Moved from study area|0|||
147518938|NCT01023516|532052052|FG000|Overall Study|Voluntary discontinuation|7|||
147518939|NCT01023516|532052053|FG001|Overall Study|Voluntary discontinuation|5|||
147518940|NCT01023516|532052052|FG000|Overall Study|Adverse Event|9|||
147518941|NCT01023516|532052053|FG001|Overall Study|Adverse Event|6|||
147518942|NCT01023516|532052052|FG000|Overall Study|Safety reason|0|||
147518943|NCT01023516|532052053|FG001|Overall Study|Safety reason|3|||
147518944|NCT01023516|532052052|FG000|Overall Study|Study-specific criteria|4|||
147518945|NCT01023516|532052053|FG001|Overall Study|Study-specific criteria|2|||
147518946|NCT01023516|532052052|FG000|Overall Study|Incorrect enrolment|4|||
147518947|NCT01023516|532052053|FG001|Overall Study|Incorrect enrolment|2|||
147518948|NCT02060903|532052056|FG000|Overall Study|Lost to Follow-up|4|||
147518949|NCT02060903|532052057|FG001|Overall Study|Lost to Follow-up|0|||
147518950|NCT02060903|532052056|FG000|Overall Study|Withdrawal by Subject|0|||
147518951|NCT02060903|532052057|FG001|Overall Study|Withdrawal by Subject|7|||
147518952|NCT00137267|532052058|FG000|Overall Study|Lost to Follow-up|15|||
147518953|NCT00137267|532052059|FG001|Overall Study|Lost to Follow-up|21|||
147518954|NCT00638989|532052060|FG000|Overall Study|Lost to Follow-up|0|||
147518955|NCT00638989|532052061|FG001|Overall Study|Lost to Follow-up|0|||
147518956|NCT00638989|532052062|FG002|Overall Study|Lost to Follow-up|1|||
147518957|NCT00853112|532052065|FG000|Overall Study|Randomized but not treated|0|||
147518958|NCT00853112|532052066|FG001|Overall Study|Randomized but not treated|1|||
147518959|NCT00853112|532052067|FG002|Overall Study|Randomized but not treated|0|||
147518960|NCT00853112|532052068|FG003|Overall Study|Randomized but not treated|2|||
147518961|NCT00853112|532052069|FG004|Overall Study|Randomized but not treated|0|||
147518962|NCT00853112|532052070|FG005|Overall Study|Randomized but not treated|0|||
147518963|NCT00853112|532052071|FG006|Overall Study|Randomized but not treated|1|||
147518964|NCT01553591|532052072|FG000|Overall Study|Voluntarily withdrew|94|||
147518965|NCT01553591|532052073|FG001|Overall Study|Voluntarily withdrew|79|||
147518966|NCT01553591|532052074|FG002|Overall Study|Voluntarily withdrew|96|||
147518967|NCT01553591|532052072|FG000|Overall Study|Adverse Event|36|||
147518968|NCT01553591|532052073|FG001|Overall Study|Adverse Event|45|||
147518969|NCT01553591|532052074|FG002|Overall Study|Adverse Event|16|||
147518970|NCT01553591|532052072|FG000|Overall Study|Lost to Follow-up|25|||
147642679|NCT00558896|532511016|FG000|Overall Study|Withdrawal by Subject|2|||
147642680|NCT00558896|532511017|FG001|Overall Study|Withdrawal by Subject|1|||
147642681|NCT00558896|532511018|FG002|Overall Study|Withdrawal by Subject|1|||
147642682|NCT00558896|532511019|FG003|Overall Study|Withdrawal by Subject|1|||
147642683|NCT00558896|532511020|FG004|Overall Study|Withdrawal by Subject|1|||
147642684|NCT00558896|532511021|FG005|Overall Study|Withdrawal by Subject|5|||
147642685|NCT00558896|532511022|FG006|Overall Study|Withdrawal by Subject|5|||
147642686|NCT00558896|532511016|FG000|Overall Study|Alternative Treatment|2|||
147642687|NCT00558896|532511017|FG001|Overall Study|Alternative Treatment|2|||
147642688|NCT00558896|532511018|FG002|Overall Study|Alternative Treatment|0|||
147642689|NCT00558896|532511019|FG003|Overall Study|Alternative Treatment|2|||
147642690|NCT00558896|532511020|FG004|Overall Study|Alternative Treatment|6|||
147642691|NCT00558896|532511021|FG005|Overall Study|Alternative Treatment|7|||
147642692|NCT00558896|532511022|FG006|Overall Study|Alternative Treatment|1|||
147642693|NCT00558896|532511016|FG000|Overall Study|Physician discretion|3|||
147642694|NCT00558896|532511017|FG001|Overall Study|Physician discretion|2|||
147642695|NCT00558896|532511018|FG002|Overall Study|Physician discretion|1|||
147642696|NCT00558896|532511019|FG003|Overall Study|Physician discretion|2|||
147642697|NCT00558896|532511020|FG004|Overall Study|Physician discretion|1|||
147642698|NCT00558896|532511021|FG005|Overall Study|Physician discretion|3|||
147642699|NCT00558896|532511022|FG006|Overall Study|Physician discretion|3|||
147642700|NCT00558896|532511016|FG000|Overall Study|Continues on treatment|10|||
147642701|NCT00558896|532511017|FG001|Overall Study|Continues on treatment|1|||
147642702|NCT00558896|532511018|FG002|Overall Study|Continues on treatment|0|||
147642703|NCT00558896|532511019|FG003|Overall Study|Continues on treatment|1|||
147642704|NCT00558896|532511020|FG004|Overall Study|Continues on treatment|9|||
147642705|NCT00558896|532511021|FG005|Overall Study|Continues on treatment|25|||
147642706|NCT00558896|532511022|FG006|Overall Study|Continues on treatment|6|||
147642707|NCT00250458|532511024|FG000|Overall Study|Lost to Follow-up|4|||
147642708|NCT00250458|532511025|FG001|Overall Study|Lost to Follow-up|2|||
147642709|NCT00250458|532511024|FG000|Overall Study|Protocol Violation|0|||
147642710|NCT00250458|532511025|FG001|Overall Study|Protocol Violation|1|||
147642711|NCT00250458|532511024|FG000|Overall Study|Withdrawal by Subject|4|||
147642712|NCT00250458|532511025|FG001|Overall Study|Withdrawal by Subject|2|||
147642713|NCT00250458|532511024|FG000|Overall Study|Lack of Migraine Attack|20|||
147642714|NCT00250458|532511025|FG001|Overall Study|Lack of Migraine Attack|9|||
147642715|NCT00250458|532511024|FG000|Overall Study|Qualifying migraine but did not treat|3|||
147642716|NCT00250458|532511025|FG001|Overall Study|Qualifying migraine but did not treat|3|||
147642717|NCT00250458|532511024|FG000|Overall Study|Other|1|||
147642718|NCT00250458|532511025|FG001|Overall Study|Other|0|||
147642719|NCT01629823|532511035|FG000|Trial Period|Missed visit|11|||
147642720|NCT01629823|532511036|FG001|Trial Period|Missed visit|9|||
147642721|NCT01629823|532511037|FG002|Trial Period|Missed visit|8|||
147642722|NCT01629823|532511035|FG000|Trial Period|Pre-diluent FEV₁ predicted <70%|1|||
147642723|NCT01629823|532511036|FG001|Trial Period|Pre-diluent FEV₁ predicted <70%|1|||
147642724|NCT01629823|532511037|FG002|Trial Period|Pre-diluent FEV₁ predicted <70%|1|||
147642725|NCT01629823|532511035|FG000|Trial Period|Pregnancy|1|||
147642726|NCT01629823|532511036|FG001|Trial Period|Pregnancy|0|||
147642727|NCT01629823|532511037|FG002|Trial Period|Pregnancy|0|||
147642728|NCT01629823|532511035|FG000|Trial Period|Adverse Event|0|||
147642729|NCT01629823|532511036|FG001|Trial Period|Adverse Event|1|||
147642730|NCT01629823|532511037|FG002|Trial Period|Adverse Event|0|||
147642731|NCT01629823|532511035|FG000|Trial Period|Out-of-window visit|0|||
147642732|NCT01629823|532511036|FG001|Trial Period|Out-of-window visit|2|||
147642733|NCT01629823|532511037|FG002|Trial Period|Out-of-window visit|0|||
147642734|NCT01629823|532511035|FG000|Trial Period|Failed to hold medication|0|||
147518971|NCT01553591|532052073|FG001|Overall Study|Lost to Follow-up|23|||
147518972|NCT01553591|532052074|FG002|Overall Study|Lost to Follow-up|16|||
147642735|NCT01629823|532511036|FG001|Trial Period|Failed to hold medication|0|||
147642736|NCT01629823|532511037|FG002|Trial Period|Failed to hold medication|1|||
147642737|NCT01629823|532511035|FG000|Washout Period|Safety|2|||
147642738|NCT01629823|532511036|FG001|Washout Period|Safety|5|||
147642739|NCT01629823|532511037|FG002|Washout Period|Safety|0|||
147518973|NCT01553591|532052072|FG000|Overall Study|Physician decision: other|11|||
147518974|NCT01553591|532052073|FG001|Overall Study|Physician decision: other|14|||
147642740|NCT01629823|532511035|FG000|Washout Period|Pregnancy|1|||
147642741|NCT01629823|532511036|FG001|Washout Period|Pregnancy|0|||
147642742|NCT01629823|532511037|FG002|Washout Period|Pregnancy|0|||
147642743|NCT01629823|532511035|FG000|Washout Period|Protocol Violation|0|||
147642744|NCT01629823|532511036|FG001|Washout Period|Protocol Violation|1|||
147642745|NCT01629823|532511037|FG002|Washout Period|Protocol Violation|0|||
147642746|NCT01199822|532511038|FG000|Overall Study|Investigator discontinued therapy|0|||
147642747|NCT01199822|532511039|FG001|Overall Study|Investigator discontinued therapy|1|||
147642748|NCT01199822|532511040|FG002|Overall Study|Investigator discontinued therapy|0|||
147642749|NCT00525902|532511041|FG000|Overall Study|Lack of Efficacy|1|||
147642750|NCT02258542|532511042|FG000|Overall Study|eg. not made to the visit|7|||
147642751|NCT02258542|532511043|FG001|Overall Study|eg. not made to the visit|4|||
147642752|NCT02258542|532511044|FG002|Overall Study|eg. not made to the visit|0|||
147642753|NCT02258542|532511045|FG003|Overall Study|eg. not made to the visit|1|||
147642754|NCT02258542|532511042|FG000|Overall Study|study specific discount. criteria|1|||
147642755|NCT02258542|532511043|FG001|Overall Study|study specific discount. criteria|1|||
147642756|NCT02258542|532511044|FG002|Overall Study|study specific discount. criteria|0|||
147642757|NCT02258542|532511045|FG003|Overall Study|study specific discount. criteria|0|||
147642758|NCT02258542|532511042|FG000|Overall Study|Withdrawal by Subject|20|||
147642759|NCT02258542|532511043|FG001|Overall Study|Withdrawal by Subject|20|||
147642760|NCT02258542|532511044|FG002|Overall Study|Withdrawal by Subject|7|||
147642761|NCT02258542|532511045|FG003|Overall Study|Withdrawal by Subject|1|||
147642762|NCT02258542|532511042|FG000|Overall Study|Lost to Follow-up|5|||
147642763|NCT02258542|532511043|FG001|Overall Study|Lost to Follow-up|12|||
147642764|NCT02258542|532511044|FG002|Overall Study|Lost to Follow-up|1|||
147642765|NCT02258542|532511045|FG003|Overall Study|Lost to Follow-up|2|||
147642766|NCT02258542|532511042|FG000|Overall Study|Death|5|||
147642767|NCT02258542|532511043|FG001|Overall Study|Death|4|||
147642768|NCT02258542|532511044|FG002|Overall Study|Death|0|||
147642769|NCT02258542|532511045|FG003|Overall Study|Death|1|||
147642770|NCT02258542|532511042|FG000|Overall Study|Adverse Event|3|||
147642771|NCT02258542|532511043|FG001|Overall Study|Adverse Event|4|||
147642772|NCT02258542|532511044|FG002|Overall Study|Adverse Event|0|||
147642773|NCT02258542|532511045|FG003|Overall Study|Adverse Event|0|||
147642774|NCT02258542|532511042|FG000|Overall Study|Protocol Violation|1|||
147642775|NCT02258542|532511043|FG001|Overall Study|Protocol Violation|2|||
147642776|NCT02258542|532511044|FG002|Overall Study|Protocol Violation|0|||
147642777|NCT02258542|532511045|FG003|Overall Study|Protocol Violation|0|||
147642778|NCT02258542|532511042|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
147642779|NCT02258542|532511043|FG001|Overall Study|Eligibility criteria not fulfilled|2|||
147642780|NCT02258542|532511044|FG002|Overall Study|Eligibility criteria not fulfilled|0|||
147642781|NCT02258542|532511045|FG003|Overall Study|Eligibility criteria not fulfilled|0|||
147642782|NCT00480493|532511046|FG000|Overall Study|moved|2|||
147642783|NCT00480493|532511047|FG001|Overall Study|moved|7|||
147642784|NCT04027075|532511048|FG000|Overall Study|Lost to Follow-up|41|||
147642785|NCT04027075|532511049|FG001|Overall Study|Lost to Follow-up|22|||
147642786|NCT02844907|532511050|FG000|With Dexamethasone|No IV access|1|||
147642787|NCT00550862|532511051|FG000|Double-Blind Phase (Day 1 to Day 85)|Adverse Event|5|||
147642788|NCT00550862|532511052|FG001|Double-Blind Phase (Day 1 to Day 85)|Adverse Event|5|||
147642789|NCT00550862|532511053|FG002|Double-Blind Phase (Day 1 to Day 85)|Adverse Event|12|||
147642790|NCT00550862|532511054|FG003|Double-Blind Phase (Day 1 to Day 85)|Adverse Event|1|||
147642791|NCT00550862|532511055|FG004|Double-Blind Phase (Day 1 to Day 85)|Adverse Event|0|||
147642792|NCT00550862|532511051|FG000|Double-Blind Phase (Day 1 to Day 85)|Elevated conjugated (direct) bilirubin|1|||
147642793|NCT00550862|532511052|FG001|Double-Blind Phase (Day 1 to Day 85)|Elevated conjugated (direct) bilirubin|0|||
147642794|NCT00550862|532511053|FG002|Double-Blind Phase (Day 1 to Day 85)|Elevated conjugated (direct) bilirubin|2|||
147642795|NCT00550862|532511054|FG003|Double-Blind Phase (Day 1 to Day 85)|Elevated conjugated (direct) bilirubin|0|||
147642796|NCT00550862|532511055|FG004|Double-Blind Phase (Day 1 to Day 85)|Elevated conjugated (direct) bilirubin|0|||
147642797|NCT00550862|532511051|FG000|Double-Blind Phase (Day 1 to Day 85)|Elevated aspartate transaminase (AST)/ alanine transaminase (ALT) levels|0|||
147642798|NCT00550862|532511052|FG001|Double-Blind Phase (Day 1 to Day 85)|Elevated aspartate transaminase (AST)/ alanine transaminase (ALT) levels|0|||
147642799|NCT00550862|532511053|FG002|Double-Blind Phase (Day 1 to Day 85)|Elevated aspartate transaminase (AST)/ alanine transaminase (ALT) levels|1|||
147642800|NCT00550862|532511054|FG003|Double-Blind Phase (Day 1 to Day 85)|Elevated aspartate transaminase (AST)/ alanine transaminase (ALT) levels|0|||
147642801|NCT00550862|532511055|FG004|Double-Blind Phase (Day 1 to Day 85)|Elevated aspartate transaminase (AST)/ alanine transaminase (ALT) levels|0|||
147642802|NCT00550862|532511051|FG000|Double-Blind Phase (Day 1 to Day 85)|Withdrawal by Subject|0|||
147642803|NCT00550862|532511052|FG001|Double-Blind Phase (Day 1 to Day 85)|Withdrawal by Subject|0|||
147642804|NCT00550862|532511053|FG002|Double-Blind Phase (Day 1 to Day 85)|Withdrawal by Subject|1|||
147642805|NCT00550862|532511054|FG003|Double-Blind Phase (Day 1 to Day 85)|Withdrawal by Subject|0|||
147518975|NCT01553591|532052074|FG002|Overall Study|Physician decision: other|16|||
147518976|NCT01553591|532052072|FG000|Overall Study|Physician decision: lack of efficacy|2|||
147518977|NCT01553591|532052073|FG001|Overall Study|Physician decision: lack of efficacy|3|||
147518978|NCT01553591|532052074|FG002|Overall Study|Physician decision: lack of efficacy|7|||
147518979|NCT01553591|532052072|FG000|Overall Study|Protocol Violation|3|||
147518980|NCT01553591|532052073|FG001|Overall Study|Protocol Violation|4|||
147518981|NCT01553591|532052074|FG002|Overall Study|Protocol Violation|4|||
147518982|NCT01553591|532052072|FG000|Overall Study|Sponsor decision|1|||
147518983|NCT01553591|532052073|FG001|Overall Study|Sponsor decision|0|||
147518984|NCT01553591|532052074|FG002|Overall Study|Sponsor decision|3|||
147518985|NCT01553591|532052072|FG000|Overall Study|Randomized and never dispensed drug|0|||
147518986|NCT01553591|532052073|FG001|Overall Study|Randomized and never dispensed drug|1|||
147518987|NCT01553591|532052074|FG002|Overall Study|Randomized and never dispensed drug|0|||
147518988|NCT01426009|532052075|FG000|Period 1-First Intervention (7 Days)|Adverse Event|1|||
147518989|NCT01426009|532052075|FG000|Period 1-First Intervention (7 Days)|Personal Reasons|1|||
147518990|NCT01426009|532052075|FG000|Washout 1|Withdrawal by Subject|1|||
147518991|NCT01426009|532052075|FG000|Washout 1|Personal Reasons|1|||
147518992|NCT01426009|532052075|FG000|Period 2-Second Intervention (7 Days)|Adverse Event|4|||
147518993|NCT01426009|532052075|FG000|Period 2-Second Intervention (7 Days)|personal reasons|1|||
147518994|NCT01426009|532052075|FG000|Washout 2|electrive surgery|1|||
147518995|NCT01426009|532052075|FG000|Washout 3|personal reasons|1|||
147518996|NCT01426009|532052075|FG000|Period 4-Fourth Intervention (7 Days)|personal reasons|1|||
147518997|NCT01426009|532052075|FG000|Washout 4|Lost to Follow-up|1|||
147518998|NCT00397631|532052087|FG000|Overall Study|Adverse Event|5|||
147518999|NCT00397631|532052088|FG001|Overall Study|Adverse Event|6|||
147519000|NCT00397631|532052087|FG000|Overall Study|Lack of Efficacy|7|||
147519001|NCT00397631|532052088|FG001|Overall Study|Lack of Efficacy|10|||
147519002|NCT00397631|532052087|FG000|Overall Study|Lost to Follow-up|8|||
147519003|NCT00397631|532052088|FG001|Overall Study|Lost to Follow-up|9|||
147519004|NCT00397631|532052087|FG000|Overall Study|Physician Decision|2|||
147519005|NCT00397631|532052088|FG001|Overall Study|Physician Decision|0|||
147519006|NCT00397631|532052087|FG000|Overall Study|Protocol Violation|0|||
147519007|NCT00397631|532052088|FG001|Overall Study|Protocol Violation|1|||
147519008|NCT00397631|532052087|FG000|Overall Study|Withdrawal by Subject|7|||
147519009|NCT00397631|532052088|FG001|Overall Study|Withdrawal by Subject|14|||
147519010|NCT00397631|532052087|FG000|Overall Study|protocol discontinuation criteria|1|||
147519011|NCT00397631|532052088|FG001|Overall Study|protocol discontinuation criteria|4|||
147519012|NCT01878175|532052090|FG000|Overall Study|Developed contraindicated health problem|2|||
147519013|NCT01796106|532052091|FG000|Overall Study|Study was terminated due to insufficient recruitment before follow ups could be completed|5|||
147519014|NCT01796106|532052092|FG001|Overall Study|Study was terminated due to insufficient recruitment before follow ups could be completed|7|||
147519015|NCT01108068|532052093|FG000|Overall Study|5 not started, 1 stop due to side effect|6|||
147519016|NCT01108068|532052094|FG001|Overall Study|5 not started, 1 stop due to side effect|0|||
147519017|NCT04107935|532052095|FG000|Overall Study|Death|1|||
147519018|NCT04107935|532052096|FG001|Overall Study|Death|0|||
147519019|NCT00836953|532052097|FG000|Overall Study|Withdrawal by Subject|1|||
147519020|NCT00836953|532052097|FG000|Overall Study|Lost to Follow-up|1|||
147519021|NCT02201251|532052099|FG000|Overall Study|Adverse Event|1|||
147519022|NCT02201251|532052100|FG001|Overall Study|Adverse Event|1|||
147519023|NCT02201251|532052099|FG000|Overall Study|Protocol Violation|1|||
147519024|NCT02201251|532052100|FG001|Overall Study|Protocol Violation|0|||
147519025|NCT02201251|532052099|FG000|Overall Study|Noncompliance with Study Drug|0|||
147519026|NCT02201251|532052100|FG001|Overall Study|Noncompliance with Study Drug|1|||
147519027|NCT02201251|532052099|FG000|Overall Study|Withdrawal by Subject|2|||
147519028|NCT02201251|532052100|FG001|Overall Study|Withdrawal by Subject|1|||
147519029|NCT04048876|532052106|FG000|Placebo Controlled Phase|Withdrawal by Subject|1|||
147519030|NCT04048876|532052107|FG001|Placebo Controlled Phase|Withdrawal by Subject|2|||
147519031|NCT04048876|532052108|FG002|Placebo Controlled Phase|Withdrawal by Subject|0|||
147519032|NCT04048876|532052109|FG003|Placebo Controlled Phase|Withdrawal by Subject|1|||
147519033|NCT04048876|532052106|FG000|Placebo Controlled Phase|Study Terminated by Sponsor|10|||
147519034|NCT04048876|532052107|FG001|Placebo Controlled Phase|Study Terminated by Sponsor|12|||
147519035|NCT04048876|532052108|FG002|Placebo Controlled Phase|Study Terminated by Sponsor|10|||
147519036|NCT04048876|532052109|FG003|Placebo Controlled Phase|Study Terminated by Sponsor|12|||
147519037|NCT04048876|532052106|FG000|Placebo Controlled Phase|Adverse Event|0|||
147519038|NCT04048876|532052107|FG001|Placebo Controlled Phase|Adverse Event|1|||
147519039|NCT04048876|532052108|FG002|Placebo Controlled Phase|Adverse Event|0|||
147519040|NCT04048876|532052109|FG003|Placebo Controlled Phase|Adverse Event|0|||
147519041|NCT04048876|532052106|FG000|Active Treatment Phase|Study Terminated by Sponsor|2|||
147519042|NCT04048876|532052107|FG001|Active Treatment Phase|Study Terminated by Sponsor|0|||
147519043|NCT04048876|532052108|FG002|Active Treatment Phase|Study Terminated by Sponsor|3|||
147519044|NCT04048876|532052109|FG003|Active Treatment Phase|Study Terminated by Sponsor|2|||
147519045|NCT02996500|532052110|FG000|Overall Study|Adverse Event|1|||
147519046|NCT02996500|532052111|FG001|Overall Study|Adverse Event|1|||
147519047|NCT02996500|532052112|FG002|Overall Study|Adverse Event|4|||
147519048|NCT02996500|532052113|FG003|Overall Study|Adverse Event|3|||
147519049|NCT02996500|532052114|FG004|Overall Study|Adverse Event|1|||
147519050|NCT02996500|532052115|FG005|Overall Study|Adverse Event|2|||
147519051|NCT02996500|532052110|FG000|Overall Study|Lack of Efficacy|0|||
147519052|NCT02996500|532052111|FG001|Overall Study|Lack of Efficacy|0|||
147519053|NCT02996500|532052112|FG002|Overall Study|Lack of Efficacy|0|||
147519054|NCT02996500|532052113|FG003|Overall Study|Lack of Efficacy|0|||
147519055|NCT02996500|532052114|FG004|Overall Study|Lack of Efficacy|2|||
147519056|NCT02996500|532052115|FG005|Overall Study|Lack of Efficacy|0|||
147519057|NCT02996500|532052110|FG000|Overall Study|Lost to Follow-up|1|||
147519058|NCT02996500|532052111|FG001|Overall Study|Lost to Follow-up|0|||
147519059|NCT02996500|532052112|FG002|Overall Study|Lost to Follow-up|0|||
147519060|NCT02996500|532052113|FG003|Overall Study|Lost to Follow-up|0|||
147519061|NCT02996500|532052114|FG004|Overall Study|Lost to Follow-up|0|||
147519062|NCT02996500|532052115|FG005|Overall Study|Lost to Follow-up|1|||
147519063|NCT02996500|532052110|FG000|Overall Study|No Longer Meets Eligibility Criteria|0|||
147519064|NCT02996500|532052111|FG001|Overall Study|No Longer Meets Eligibility Criteria|0|||
147519065|NCT02996500|532052112|FG002|Overall Study|No Longer Meets Eligibility Criteria|1|||
147519066|NCT02996500|532052113|FG003|Overall Study|No Longer Meets Eligibility Criteria|0|||
147519067|NCT02996500|532052114|FG004|Overall Study|No Longer Meets Eligibility Criteria|0|||
147519068|NCT02996500|532052115|FG005|Overall Study|No Longer Meets Eligibility Criteria|0|||
147519069|NCT02996500|532052110|FG000|Overall Study|Non-Compliance With Study Drug|0|||
147519070|NCT02996500|532052111|FG001|Overall Study|Non-Compliance With Study Drug|0|||
147519071|NCT02996500|532052112|FG002|Overall Study|Non-Compliance With Study Drug|0|||
147519072|NCT02996500|532052113|FG003|Overall Study|Non-Compliance With Study Drug|0|||
147519073|NCT02996500|532052114|FG004|Overall Study|Non-Compliance With Study Drug|0|||
147519074|NCT02996500|532052115|FG005|Overall Study|Non-Compliance With Study Drug|1|||
147519075|NCT02996500|532052110|FG000|Overall Study|Progressive Disease|1|||
147519076|NCT02996500|532052111|FG001|Overall Study|Progressive Disease|0|||
147519077|NCT02996500|532052112|FG002|Overall Study|Progressive Disease|0|||
147519078|NCT02996500|532052113|FG003|Overall Study|Progressive Disease|0|||
147519079|NCT02996500|532052114|FG004|Overall Study|Progressive Disease|0|||
147519080|NCT02996500|532052115|FG005|Overall Study|Progressive Disease|0|||
147519081|NCT02996500|532052110|FG000|Overall Study|Other|2|||
147519082|NCT02996500|532052111|FG001|Overall Study|Other|0|||
147519083|NCT02996500|532052112|FG002|Overall Study|Other|2|||
147519084|NCT02996500|532052113|FG003|Overall Study|Other|0|||
147519085|NCT02996500|532052114|FG004|Overall Study|Other|0|||
147519086|NCT02996500|532052115|FG005|Overall Study|Other|0|||
147519087|NCT02996500|532052110|FG000|Overall Study|Protocol Violation|0|||
147519088|NCT02996500|532052111|FG001|Overall Study|Protocol Violation|0|||
147519089|NCT02996500|532052112|FG002|Overall Study|Protocol Violation|0|||
147519090|NCT02996500|532052113|FG003|Overall Study|Protocol Violation|1|||
147519091|NCT02996500|532052114|FG004|Overall Study|Protocol Violation|0|||
147519092|NCT02996500|532052115|FG005|Overall Study|Protocol Violation|0|||
147519093|NCT02996500|532052110|FG000|Overall Study|Withdrawal by Subject|3|||
147519094|NCT02996500|532052111|FG001|Overall Study|Withdrawal by Subject|0|||
147519095|NCT02996500|532052112|FG002|Overall Study|Withdrawal by Subject|3|||
147519096|NCT02996500|532052113|FG003|Overall Study|Withdrawal by Subject|0|||
147519097|NCT02996500|532052114|FG004|Overall Study|Withdrawal by Subject|2|||
147519098|NCT02996500|532052115|FG005|Overall Study|Withdrawal by Subject|0|||
147519099|NCT02332876|532052116|FG000|Overall Study|Lost to Follow-up|1|||
147519100|NCT02332876|532052117|FG001|Overall Study|Lost to Follow-up|1|||
147519101|NCT02415595|532052118|FG000|Overall Study|Administrative reason by sponsor|39|||
147519102|NCT02415595|532052119|FG001|Overall Study|Administrative reason by sponsor|40|||
147519103|NCT02415595|532052120|FG002|Overall Study|Administrative reason by sponsor|41|||
147519104|NCT02415595|532052121|FG003|Overall Study|Administrative reason by sponsor|39|||
147519105|NCT02415595|532052118|FG000|Overall Study|Adverse Event|1|||
147519106|NCT02415595|532052119|FG001|Overall Study|Adverse Event|3|||
147519107|NCT02415595|532052120|FG002|Overall Study|Adverse Event|5|||
147519108|NCT02415595|532052121|FG003|Overall Study|Adverse Event|10|||
147519109|NCT02415595|532052118|FG000|Overall Study|Lack of Efficacy|4|||
147519110|NCT02415595|532052119|FG001|Overall Study|Lack of Efficacy|4|||
147519111|NCT02415595|532052120|FG002|Overall Study|Lack of Efficacy|0|||
147519112|NCT02415595|532052121|FG003|Overall Study|Lack of Efficacy|0|||
147519113|NCT02415595|532052118|FG000|Overall Study|Lost to Follow-up|1|||
147519114|NCT02415595|532052119|FG001|Overall Study|Lost to Follow-up|3|||
147519115|NCT02415595|532052120|FG002|Overall Study|Lost to Follow-up|1|||
147519116|NCT02415595|532052121|FG003|Overall Study|Lost to Follow-up|1|||
147519117|NCT02415595|532052118|FG000|Overall Study|Poor/Non-compliance|1|||
147519118|NCT02415595|532052119|FG001|Overall Study|Poor/Non-compliance|0|||
147519119|NCT02415595|532052120|FG002|Overall Study|Poor/Non-compliance|1|||
147519120|NCT02415595|532052121|FG003|Overall Study|Poor/Non-compliance|0|||
147519121|NCT02415595|532052118|FG000|Overall Study|Reached stopping criteria|0|||
147519122|NCT02415595|532052119|FG001|Overall Study|Reached stopping criteria|1|||
147519123|NCT02415595|532052120|FG002|Overall Study|Reached stopping criteria|1|||
147519124|NCT02415595|532052121|FG003|Overall Study|Reached stopping criteria|0|||
147519125|NCT02415595|532052118|FG000|Overall Study|Withdrawal by Subject|4|||
147519126|NCT02415595|532052119|FG001|Overall Study|Withdrawal by Subject|0|||
147519127|NCT02415595|532052120|FG002|Overall Study|Withdrawal by Subject|1|||
147519128|NCT02415595|532052121|FG003|Overall Study|Withdrawal by Subject|3|||
147519129|NCT02415595|532052118|FG000|Overall Study|Other|0|||
147519130|NCT02415595|532052119|FG001|Overall Study|Other|1|||
147519131|NCT02415595|532052120|FG002|Overall Study|Other|1|||
147519132|NCT02415595|532052121|FG003|Overall Study|Other|0|||
147519133|NCT04063865|532052124|FG000|Overall Study|Physician Decision|1|||
147519134|NCT04063865|532052125|FG001|Overall Study|Physician Decision|3|||
147519135|NCT04063865|532052124|FG000|Overall Study|Study Closed Prior to Completion|4|||
147519136|NCT04063865|532052125|FG001|Overall Study|Study Closed Prior to Completion|4|||
147519137|NCT04063865|532052124|FG000|Overall Study|Withdrawal by Subject|1|||
147519138|NCT04063865|532052125|FG001|Overall Study|Withdrawal by Subject|1|||
147519139|NCT01700140|532052126|FG000|Overall Study|Use of rescue drugs|3|||
147519140|NCT01700140|532052127|FG001|Overall Study|Use of rescue drugs|3|||
147519141|NCT01700140|532052128|FG002|Overall Study|Use of rescue drugs|1|||
147519142|NCT01700140|532052126|FG000|Overall Study|Discontinuation of radiotherapy|1|||
147519143|NCT01700140|532052127|FG001|Overall Study|Discontinuation of radiotherapy|0|||
147519144|NCT01700140|532052128|FG002|Overall Study|Discontinuation of radiotherapy|0|||
147519145|NCT01700140|532052126|FG000|Overall Study|Use of chemotherapy or surgical therapy|0|||
147519146|NCT01700140|532052127|FG001|Overall Study|Use of chemotherapy or surgical therapy|1|||
147519147|NCT01700140|532052128|FG002|Overall Study|Use of chemotherapy or surgical therapy|0|||
147519148|NCT01700140|532052126|FG000|Overall Study|Aggravation of symptoms|1|||
147519149|NCT01700140|532052127|FG001|Overall Study|Aggravation of symptoms|0|||
147519150|NCT01700140|532052128|FG002|Overall Study|Aggravation of symptoms|0|||
147519151|NCT01700140|532052126|FG000|Overall Study|Adverse Event|0|||
147519152|NCT01700140|532052127|FG001|Overall Study|Adverse Event|1|||
147519153|NCT01700140|532052128|FG002|Overall Study|Adverse Event|0|||
147519154|NCT01700140|532052126|FG000|Overall Study|Inclusion/exclusion criteria deviation|1|||
147519155|NCT01700140|532052127|FG001|Overall Study|Inclusion/exclusion criteria deviation|4|||
147519156|NCT01700140|532052128|FG002|Overall Study|Inclusion/exclusion criteria deviation|0|||
147519157|NCT01060124|532052129|FG000|Overall Study|Other|16|||
147519158|NCT01060124|532052129|FG000|Overall Study|Adverse Event|14|||
147519159|NCT01060124|532052129|FG000|Overall Study|Withdrawal by Subject|7|||
147519160|NCT01708915|532052131|FG000|Overall Study|Adverse Event|1|||
147519161|NCT01708915|532052132|FG001|Overall Study|Adverse Event|0|||
147519162|NCT01708915|532052133|FG002|Overall Study|Adverse Event|9|||
147519163|NCT01708915|532052134|FG003|Overall Study|Adverse Event|13|||
147519164|NCT01708915|532052131|FG000|Overall Study|Lack of Efficacy|84|||
147519165|NCT01708915|532052132|FG001|Overall Study|Lack of Efficacy|60|||
147519166|NCT01708915|532052133|FG002|Overall Study|Lack of Efficacy|35|||
147519167|NCT01708915|532052134|FG003|Overall Study|Lack of Efficacy|15|||
147519168|NCT01708915|532052131|FG000|Overall Study|Protocol Violation|0|||
147519169|NCT01708915|532052132|FG001|Overall Study|Protocol Violation|0|||
147519170|NCT01708915|532052133|FG002|Overall Study|Protocol Violation|0|||
147519171|NCT01708915|532052134|FG003|Overall Study|Protocol Violation|1|||
147519172|NCT01708915|532052131|FG000|Overall Study|Withdrawal by Subject|0|||
147519173|NCT01708915|532052132|FG001|Overall Study|Withdrawal by Subject|1|||
147519174|NCT01708915|532052133|FG002|Overall Study|Withdrawal by Subject|2|||
147519175|NCT01708915|532052134|FG003|Overall Study|Withdrawal by Subject|2|||
147519176|NCT01708915|532052131|FG000|Overall Study|Other reasons than stated above|1|||
147519177|NCT01708915|532052132|FG001|Overall Study|Other reasons than stated above|1|||
147519178|NCT01708915|532052133|FG002|Overall Study|Other reasons than stated above|0|||
147519179|NCT01708915|532052134|FG003|Overall Study|Other reasons than stated above|2|||
147519180|NCT03231228|532052136|FG000|Overall Study|Lost to Follow-up|2|||
147519181|NCT03231228|532052137|FG001|Overall Study|Lost to Follow-up|0|||
147519182|NCT03231228|532052136|FG000|Overall Study|Physician Decision|1|||
147519183|NCT03231228|532052137|FG001|Overall Study|Physician Decision|0|||
147519184|NCT01222416|532052138|FG000|Overall Study|ineligible;metastasis|3|||
147519185|NCT01222416|532052139|FG001|Overall Study|ineligible;metastasis|0|||
147519186|NCT01222416|532052138|FG000|Overall Study|Adverse Event|4|||
147642806|NCT00550862|532511055|FG004|Double-Blind Phase (Day 1 to Day 85)|Withdrawal by Subject|0|||
147642807|NCT00550862|532511051|FG000|Double-Blind Phase (Day 1 to Day 85)|Lost to Follow-up|0|||
147642808|NCT00550862|532511052|FG001|Double-Blind Phase (Day 1 to Day 85)|Lost to Follow-up|1|||
147642809|NCT00550862|532511053|FG002|Double-Blind Phase (Day 1 to Day 85)|Lost to Follow-up|0|||
147642810|NCT00550862|532511054|FG003|Double-Blind Phase (Day 1 to Day 85)|Lost to Follow-up|0|||
147642811|NCT00550862|532511055|FG004|Double-Blind Phase (Day 1 to Day 85)|Lost to Follow-up|0|||
147642812|NCT00550862|532511051|FG000|LTSE Phase (Up to 12 Months)|Adverse Event|0|||
147642813|NCT00550862|532511052|FG001|LTSE Phase (Up to 12 Months)|Adverse Event|0|||
147642814|NCT00550862|532511053|FG002|LTSE Phase (Up to 12 Months)|Adverse Event|0|||
147642815|NCT00550862|532511054|FG003|LTSE Phase (Up to 12 Months)|Adverse Event|0|||
147519187|NCT01222416|532052139|FG001|Overall Study|Adverse Event|0|||
147519188|NCT01222416|532052138|FG000|Overall Study|Withdrawal by Subject|5|||
147519189|NCT01222416|532052139|FG001|Overall Study|Withdrawal by Subject|0|||
147519190|NCT01222416|532052138|FG000|Overall Study|scheduling|6|||
147519191|NCT01222416|532052139|FG001|Overall Study|scheduling|0|||
147519192|NCT01222416|532052138|FG000|Overall Study|missed view/scan|1|||
147519193|NCT01222416|532052139|FG001|Overall Study|missed view/scan|0|||
147519194|NCT01222416|532052138|FG000|Overall Study|Death|1|||
147519195|NCT01222416|532052139|FG001|Overall Study|Death|0|||
147519196|NCT00518336|532052142|FG000|Year 7|Lost to Follow-up|2|||
147519197|NCT00518336|532052143|FG001|Year 7|Lost to Follow-up|0|||
147519198|NCT00518336|532052142|FG000|Year 7|Could not attend in time|0|||
147519199|NCT00518336|532052143|FG001|Year 7|Could not attend in time|3|||
147519200|NCT00518336|532052142|FG000|Year 8|Lost to Follow-up|1|||
147519201|NCT00518336|532052143|FG001|Year 8|Lost to Follow-up|1|||
147519202|NCT00518336|532052142|FG000|Year 8|Could not attend in time|0|||
147519203|NCT00518336|532052143|FG001|Year 8|Could not attend in time|1|||
147519204|NCT00518336|532052142|FG000|Year 9|Migrated/moved from study area|1|||
147519205|NCT00518336|532052143|FG001|Year 9|Migrated/moved from study area|1|||
147519206|NCT00518336|532052142|FG000|Year 9|Lost to Follow-up|3|||
147519207|NCT00518336|532052143|FG001|Year 9|Lost to Follow-up|0|||
147519208|NCT00518336|532052142|FG000|Year 9|Personal reasons|1|||
147519209|NCT00518336|532052143|FG001|Year 9|Personal reasons|0|||
147519210|NCT03031327|532054304|FG000|Overall Study|Withdrawal by Subject|0|||
147519211|NCT03031327|532054305|FG001|Overall Study|Withdrawal by Subject|1|||
147519212|NCT03031327|532054306|FG002|Overall Study|Withdrawal by Subject|1|||
147519213|NCT00669240|532054307|FG000|Overall Study|Lack of Efficacy|33|||
147519214|NCT00669240|532054307|FG000|Overall Study|Withdrawal by Subject|42|||
147519215|NCT00669240|532054307|FG000|Overall Study|Lost to Follow-up|34|||
147519216|NCT00669240|532054307|FG000|Overall Study|Adverse Event|21|||
147519217|NCT00669240|532054307|FG000|Overall Study|Other|19|||
147519218|NCT00669240|532054307|FG000|Overall Study|Enrolled but not treated|15|||
147519219|NCT00669240|532054307|FG000|Overall Study|Enrolled but no dosing record|1|||
147519220|NCT04610827|532054309|FG000|Overall Study|Withdrawal by Subject|1|||
147519221|NCT04610827|532054310|FG001|Overall Study|Withdrawal by Subject|1|||
147519222|NCT04610827|532054311|FG002|Overall Study|Withdrawal by Subject|0|||
147519223|NCT00364611|532054312|FG000|Overall Study|Did not receive study medication|0|||
147642816|NCT00550862|532511055|FG004|LTSE Phase (Up to 12 Months)|Adverse Event|14|||
147642817|NCT00550862|532511051|FG000|LTSE Phase (Up to 12 Months)|Withdrawal by Subject|0|||
147642818|NCT00550862|532511052|FG001|LTSE Phase (Up to 12 Months)|Withdrawal by Subject|0|||
147642819|NCT00550862|532511053|FG002|LTSE Phase (Up to 12 Months)|Withdrawal by Subject|0|||
147642820|NCT00550862|532511054|FG003|LTSE Phase (Up to 12 Months)|Withdrawal by Subject|0|||
147642821|NCT00550862|532511055|FG004|LTSE Phase (Up to 12 Months)|Withdrawal by Subject|2|||
147642822|NCT00550862|532511051|FG000|LTSE Phase (Up to 12 Months)|Protocol Violation|0|||
147642823|NCT00550862|532511052|FG001|LTSE Phase (Up to 12 Months)|Protocol Violation|0|||
147642824|NCT00550862|532511053|FG002|LTSE Phase (Up to 12 Months)|Protocol Violation|0|||
147642825|NCT00550862|532511054|FG003|LTSE Phase (Up to 12 Months)|Protocol Violation|0|||
147642826|NCT00550862|532511055|FG004|LTSE Phase (Up to 12 Months)|Protocol Violation|1|||
147642827|NCT00550862|532511051|FG000|LTSE Phase (Up to 12 Months)|Other|0|||
147642828|NCT00550862|532511052|FG001|LTSE Phase (Up to 12 Months)|Other|0|||
147642829|NCT00550862|532511053|FG002|LTSE Phase (Up to 12 Months)|Other|0|||
147642830|NCT00550862|532511054|FG003|LTSE Phase (Up to 12 Months)|Other|0|||
147642831|NCT00550862|532511055|FG004|LTSE Phase (Up to 12 Months)|Other|2|||
147642832|NCT00550862|532511051|FG000|LTSE Phase (Up to 12 Months)|Other: Study stopped by sponsor due to administrative reasons|0|||
147642833|NCT00550862|532511052|FG001|LTSE Phase (Up to 12 Months)|Other: Study stopped by sponsor due to administrative reasons|0|||
147642834|NCT00550862|532511053|FG002|LTSE Phase (Up to 12 Months)|Other: Study stopped by sponsor due to administrative reasons|0|||
147642835|NCT00550862|532511054|FG003|LTSE Phase (Up to 12 Months)|Other: Study stopped by sponsor due to administrative reasons|0|||
147642836|NCT00550862|532511055|FG004|LTSE Phase (Up to 12 Months)|Other: Study stopped by sponsor due to administrative reasons|59|||
147642837|NCT00455520|532511058|FG000|Open Label Tapentadol Extended Release|Withdrawal by Subject|24|||
147642838|NCT00455520|532511059|FG001|Open Label Tapentadol Extended Release|Withdrawal by Subject|0|||
147642839|NCT00455520|532511058|FG000|Open Label Tapentadol Extended Release|Lost to Follow-up|3|||
147519224|NCT00364611|532054313|FG001|Overall Study|Did not receive study medication|1|||
147519225|NCT00364611|532054312|FG000|Overall Study|Adverse Event|7|||
147519226|NCT00364611|532054313|FG001|Overall Study|Adverse Event|4|||
147519227|NCT00364611|532054312|FG000|Overall Study|Participant's Request|3|||
147519228|NCT00364611|532054313|FG001|Overall Study|Participant's Request|4|||
147519229|NCT00364611|532054312|FG000|Overall Study|Disease Progression|38|||
147519230|NCT00364611|532054313|FG001|Overall Study|Disease Progression|8|||
147519231|NCT00364611|532054312|FG000|Overall Study|Investigator decision|2|||
147519232|NCT00364611|532054313|FG001|Overall Study|Investigator decision|2|||
147519233|NCT00364611|532054312|FG000|Overall Study|Found Ineligible|1|||
147519234|NCT00364611|532054313|FG001|Overall Study|Found Ineligible|0|||
147519235|NCT00364611|532054312|FG000|Overall Study|Presumed CR on Study|0|||
147519236|NCT00364611|532054313|FG001|Overall Study|Presumed CR on Study|1|||
147519237|NCT00364611|532054312|FG000|Overall Study|Receiving Liver Ablation|0|||
147519238|NCT00364611|532054313|FG001|Overall Study|Receiving Liver Ablation|1|||
147519239|NCT04097925|532054326|FG000|Overall Study|Withdrawal by Subject|1|||
147519240|NCT02059174|532054329|FG000|Period 1|Withdrawal by Subject|0|||
147519241|NCT02059174|532054330|FG001|Period 1|Withdrawal by Subject|2|||
147519242|NCT02059174|532054329|FG000|Period 2|Withdrawal by Subject|0|||
147519243|NCT02059174|532054330|FG001|Period 2|Withdrawal by Subject|2|||
147519244|NCT02059174|532054329|FG000|Period 2|Protocol Violation|1|||
147519245|NCT02059174|532054330|FG001|Period 2|Protocol Violation|0|||
147519246|NCT02059174|532054329|FG000|Period 3|Physician Decision|1|||
147519247|NCT02059174|532054330|FG001|Period 3|Physician Decision|0|||
147519248|NCT02306148|532054331|FG000|Overall Study|Adverse Event|12|||
147519249|NCT02306148|532054332|FG001|Overall Study|Adverse Event|6|||
147519250|NCT02306148|532054331|FG000|Overall Study|Lost to Follow-up|1|||
147519251|NCT02306148|532054332|FG001|Overall Study|Lost to Follow-up|4|||
147519252|NCT04397757|532054333|FG000|Overall Study|Death|3|||
147519253|NCT04397757|532054334|FG001|Overall Study|Death|11|||
147519254|NCT04397757|532054333|FG000|Overall Study|Withdrawal by Subject|2|||
147519255|NCT04397757|532054334|FG001|Overall Study|Withdrawal by Subject|0|||
147519256|NCT04397757|532054333|FG000|Overall Study|Lost to Follow-up|4|||
147519257|NCT04397757|532054334|FG001|Overall Study|Lost to Follow-up|3|||
147519258|NCT04167514|532054341|FG000|Overall Study|Adverse event, not serious|0|||
147519259|NCT04167514|532054342|FG001|Overall Study|Adverse event, not serious|1|||
147519260|NCT04167514|532054341|FG000|Overall Study|Lost to Follow-up|1|||
147519261|NCT04167514|532054342|FG001|Overall Study|Lost to Follow-up|0|||
147519262|NCT04167514|532054341|FG000|Overall Study|Participant Decision|2|||
147519263|NCT04167514|532054342|FG001|Overall Study|Participant Decision|4|||
147519264|NCT04167514|532054341|FG000|Overall Study|Physician Decision|3|||
147519265|NCT04167514|532054342|FG001|Overall Study|Physician Decision|2|||
147519266|NCT04167514|532054341|FG000|Overall Study|Death|14|||
147519267|NCT04167514|532054342|FG001|Overall Study|Death|18|||
147519268|NCT04167514|532054341|FG000|Overall Study|Enrolled but treatment not administered|2|||
147519269|NCT04167514|532054342|FG001|Overall Study|Enrolled but treatment not administered|0|||
147519270|NCT04167514|532054341|FG000|Overall Study|Multiple reasons for study discontinuation documented; including death, primary reason not reported|3|||
147519271|NCT04167514|532054342|FG001|Overall Study|Multiple reasons for study discontinuation documented; including death, primary reason not reported|1|||
147519272|NCT04167514|532054341|FG000|Overall Study|Multiple reasons for study discontinuation documented; excluding death, primary reason not reported|2|||
147519273|NCT04167514|532054342|FG001|Overall Study|Multiple reasons for study discontinuation documented; excluding death, primary reason not reported|4|||
147519274|NCT00290355|532054343|FG000|Overall Study|Serious adverse event|7|||
147519275|NCT00290355|532054344|FG001|Overall Study|Serious adverse event|4|||
147519276|NCT00290355|532054343|FG000|Overall Study|Study product reactogenicity|1|||
147519277|NCT00290355|532054344|FG001|Overall Study|Study product reactogenicity|0|||
147519278|NCT00290355|532054343|FG000|Overall Study|Protocol Violation|1|||
147519279|NCT00290355|532054344|FG001|Overall Study|Protocol Violation|0|||
147519280|NCT00290355|532054343|FG000|Overall Study|Withdrawal by Subject|2|||
147519281|NCT00290355|532054344|FG001|Overall Study|Withdrawal by Subject|0|||
147519282|NCT00290355|532054343|FG000|Overall Study|Migrated / moved from the study area|1|||
147519283|NCT00290355|532054344|FG001|Overall Study|Migrated / moved from the study area|0|||
147519284|NCT00290355|532054343|FG000|Overall Study|Lost to Follow-up|3|||
147519285|NCT00290355|532054344|FG001|Overall Study|Lost to Follow-up|1|||
147519286|NCT00290355|532054343|FG000|Overall Study|Other|2|||
147519287|NCT00290355|532054344|FG001|Overall Study|Other|0|||
147519288|NCT03345849|532054345|FG000|Part 1: Induction Period (Weeks 1-12)|Adverse Event|8|||
147519289|NCT03345849|532054346|FG001|Part 1: Induction Period (Weeks 1-12)|Adverse Event|12|||
147519290|NCT03345849|532054347|FG002|Part 1: Induction Period (Weeks 1-12)|Adverse Event|0|||
147519291|NCT03345849|532054348|FG003|Part 1: Induction Period (Weeks 1-12)|Adverse Event|0|||
147519292|NCT03345849|532054345|FG000|Part 1: Induction Period (Weeks 1-12)|Withdrawal by Subject|6|||
147519293|NCT03345849|532054346|FG001|Part 1: Induction Period (Weeks 1-12)|Withdrawal by Subject|3|||
147519294|NCT03345849|532054347|FG002|Part 1: Induction Period (Weeks 1-12)|Withdrawal by Subject|0|||
147519295|NCT03345849|532054348|FG003|Part 1: Induction Period (Weeks 1-12)|Withdrawal by Subject|0|||
147519296|NCT03345849|532054345|FG000|Part 1: Induction Period (Weeks 1-12)|Lost to Follow-up|0|||
147519297|NCT03345849|532054346|FG001|Part 1: Induction Period (Weeks 1-12)|Lost to Follow-up|1|||
147519298|NCT03345849|532054347|FG002|Part 1: Induction Period (Weeks 1-12)|Lost to Follow-up|0|||
147519299|NCT03345849|532054348|FG003|Part 1: Induction Period (Weeks 1-12)|Lost to Follow-up|0|||
147519300|NCT03345849|532054345|FG000|Part 1: Induction Period (Weeks 1-12)|Lack of Efficacy|8|||
147519301|NCT03345849|532054346|FG001|Part 1: Induction Period (Weeks 1-12)|Lack of Efficacy|3|||
147519302|NCT03345849|532054347|FG002|Part 1: Induction Period (Weeks 1-12)|Lack of Efficacy|0|||
147519303|NCT03345849|532054348|FG003|Part 1: Induction Period (Weeks 1-12)|Lack of Efficacy|0|||
147519304|NCT03345849|532054345|FG000|Part 1: Induction Period (Weeks 1-12)|Other|0|||
147519305|NCT03345849|532054346|FG001|Part 1: Induction Period (Weeks 1-12)|Other|1|||
147519306|NCT03345849|532054347|FG002|Part 1: Induction Period (Weeks 1-12)|Other|0|||
147519307|NCT03345849|532054348|FG003|Part 1: Induction Period (Weeks 1-12)|Other|0|||
147519308|NCT03345849|532054345|FG000|Part 2: Extended Treatment (Weeks 12-24)|Adverse Event|0|||
147519309|NCT03345849|532054346|FG001|Part 2: Extended Treatment (Weeks 12-24)|Adverse Event|0|||
147519310|NCT03345849|532054347|FG002|Part 2: Extended Treatment (Weeks 12-24)|Adverse Event|2|||
147519311|NCT03345849|532054348|FG003|Part 2: Extended Treatment (Weeks 12-24)|Adverse Event|2|||
147519312|NCT03345849|532054345|FG000|Part 2: Extended Treatment (Weeks 12-24)|Withdrawal by Subject|0|||
147519313|NCT03345849|532054346|FG001|Part 2: Extended Treatment (Weeks 12-24)|Withdrawal by Subject|0|||
147519314|NCT03345849|532054347|FG002|Part 2: Extended Treatment (Weeks 12-24)|Withdrawal by Subject|3|||
147519315|NCT03345849|532054348|FG003|Part 2: Extended Treatment (Weeks 12-24)|Withdrawal by Subject|1|||
147519316|NCT03345849|532054345|FG000|Part 2: Extended Treatment (Weeks 12-24)|Lack of Efficacy|0|||
147519317|NCT03345849|532054346|FG001|Part 2: Extended Treatment (Weeks 12-24)|Lack of Efficacy|0|||
147519318|NCT03345849|532054347|FG002|Part 2: Extended Treatment (Weeks 12-24)|Lack of Efficacy|1|||
147519319|NCT03345849|532054348|FG003|Part 2: Extended Treatment (Weeks 12-24)|Lack of Efficacy|5|||
147519320|NCT03345849|532054345|FG000|Part 2: Extended Treatment (Weeks 12-24)|Coronavirus Disease-2019 (COVID-19) Infection|0|||
147519321|NCT03345849|532054346|FG001|Part 2: Extended Treatment (Weeks 12-24)|Coronavirus Disease-2019 (COVID-19) Infection|0|||
147519322|NCT03345849|532054347|FG002|Part 2: Extended Treatment (Weeks 12-24)|Coronavirus Disease-2019 (COVID-19) Infection|0|||
147519323|NCT03345849|532054348|FG003|Part 2: Extended Treatment (Weeks 12-24)|Coronavirus Disease-2019 (COVID-19) Infection|1|||
147519324|NCT03345849|532054345|FG000|Part 2: Extended Treatment (Weeks 12-24)|COVID-19 Logistical Restrictions|0|||
147519325|NCT03345849|532054346|FG001|Part 2: Extended Treatment (Weeks 12-24)|COVID-19 Logistical Restrictions|0|||
147642840|NCT00455520|532511059|FG001|Open Label Tapentadol Extended Release|Lost to Follow-up|0|||
147642841|NCT00455520|532511058|FG000|Open Label Tapentadol Extended Release|Adverse Event|100|||
147642842|NCT00455520|532511059|FG001|Open Label Tapentadol Extended Release|Adverse Event|0|||
147642843|NCT00455520|532511058|FG000|Open Label Tapentadol Extended Release|Lack of Efficacy|23|||
147642844|NCT00455520|532511059|FG001|Open Label Tapentadol Extended Release|Lack of Efficacy|0|||
147642845|NCT00455520|532511058|FG000|Open Label Tapentadol Extended Release|Study drug non-compliant|13|||
147642846|NCT00455520|532511059|FG001|Open Label Tapentadol Extended Release|Study drug non-compliant|0|||
147642847|NCT00455520|532511058|FG000|Open Label Tapentadol Extended Release|All other|33|||
147642848|NCT00455520|532511059|FG001|Open Label Tapentadol Extended Release|All other|0|||
147642849|NCT00455520|532511058|FG000|Double Blind Tapentadol ER vs Placebo|Adverse Event|29|||
147642850|NCT00455520|532511059|FG001|Double Blind Tapentadol ER vs Placebo|Adverse Event|15|||
147642851|NCT00455520|532511058|FG000|Double Blind Tapentadol ER vs Placebo|Lack of Efficacy|8|||
147642852|NCT00455520|532511059|FG001|Double Blind Tapentadol ER vs Placebo|Lack of Efficacy|29|||
147642853|NCT00455520|532511058|FG000|Double Blind Tapentadol ER vs Placebo|Withdrawal by Subject|15|||
147642854|NCT00455520|532511059|FG001|Double Blind Tapentadol ER vs Placebo|Withdrawal by Subject|7|||
147519326|NCT03345849|532054347|FG002|Part 2: Extended Treatment (Weeks 12-24)|COVID-19 Logistical Restrictions|1|||
147519327|NCT03345849|532054348|FG003|Part 2: Extended Treatment (Weeks 12-24)|COVID-19 Logistical Restrictions|0|||
147519328|NCT03345849|532054345|FG000|Part 2: Extended Treatment (Weeks 12-24)|Other|0|||
147519329|NCT03345849|532054346|FG001|Part 2: Extended Treatment (Weeks 12-24)|Other|0|||
147519330|NCT03345849|532054347|FG002|Part 2: Extended Treatment (Weeks 12-24)|Other|1|||
147519331|NCT03345849|532054348|FG003|Part 2: Extended Treatment (Weeks 12-24)|Other|1|||
147519332|NCT00033514|532054349|FG000|Overall Study|Lost to Follow-up|1|||
147519333|NCT00033514|532054350|FG001|Overall Study|Lost to Follow-up|1|||
147519334|NCT00033514|532054349|FG000|Overall Study|Withdrawal by Subject|0|||
147519335|NCT00033514|532054350|FG001|Overall Study|Withdrawal by Subject|3|||
147519336|NCT01599585|532054360|FG000|Overall Study|Withdrawal by Subject|16|||
147519337|NCT01599585|532054361|FG001|Overall Study|Withdrawal by Subject|9|||
147519338|NCT01599585|532054360|FG000|Overall Study|Lost to Follow-up|3|||
147519339|NCT01599585|532054361|FG001|Overall Study|Lost to Follow-up|5|||
147519340|NCT01599585|532054360|FG000|Overall Study|randomized did not start treatment|3|||
147519341|NCT01599585|532054361|FG001|Overall Study|randomized did not start treatment|3|||
147519342|NCT04564027|532054362|FG000|Overall Study|Ongoing treatment at Data cut off|0|||
147519343|NCT04564027|532054363|FG001|Overall Study|Ongoing treatment at Data cut off|3|||
147519344|NCT04564027|532054364|FG002|Overall Study|Ongoing treatment at Data cut off|0|||
147519345|NCT04564027|532054365|FG003|Overall Study|Ongoing treatment at Data cut off|0|||
147519346|NCT00777036|532054366|FG000|On Treatment|Reached 18 years of age and transitioned to commercial drug|13|||
147519347|NCT00777036|532054367|FG001|On Treatment|Reached 18 years of age and transitioned to commercial drug|7|||
147519348|NCT00777036|532054368|FG002|On Treatment|Reached 18 years of age and transitioned to commercial drug|42|||
147519349|NCT00777036|532054369|FG003|On Treatment|Reached 18 years of age and transitioned to commercial drug|0|||
147519350|NCT00777036|532054366|FG000|On Treatment|Administrative Reason By Sponsor|1|||
147519351|NCT00777036|532054367|FG001|On Treatment|Administrative Reason By Sponsor|0|||
147519352|NCT00777036|532054368|FG002|On Treatment|Administrative Reason By Sponsor|9|||
147519353|NCT00777036|532054369|FG003|On Treatment|Administrative Reason By Sponsor|0|||
147519354|NCT00777036|532054366|FG000|On Treatment|Failure to Meet Study Criteria|0|||
147519355|NCT00777036|532054367|FG001|On Treatment|Failure to Meet Study Criteria|1|||
147519356|NCT00777036|532054368|FG002|On Treatment|Failure to Meet Study Criteria|4|||
147519357|NCT00777036|532054369|FG003|On Treatment|Failure to Meet Study Criteria|0|||
147519358|NCT00777036|532054366|FG000|On Treatment|Pregnancy|1|||
147519359|NCT00777036|532054367|FG001|On Treatment|Pregnancy|0|||
147519360|NCT00777036|532054368|FG002|On Treatment|Pregnancy|1|||
147519361|NCT00777036|532054369|FG003|On Treatment|Pregnancy|0|||
147519362|NCT00777036|532054366|FG000|On Treatment|Non-compliance with Study Drug|1|||
147519363|NCT00777036|532054367|FG001|On Treatment|Non-compliance with Study Drug|0|||
147519364|NCT00777036|532054368|FG002|On Treatment|Non-compliance with Study Drug|1|||
147519365|NCT00777036|532054369|FG003|On Treatment|Non-compliance with Study Drug|0|||
147519366|NCT00777036|532054366|FG000|On Treatment|Maximum Clinical Benefit|2|||
147519367|NCT00777036|532054367|FG001|On Treatment|Maximum Clinical Benefit|0|||
147519368|NCT00777036|532054368|FG002|On Treatment|Maximum Clinical Benefit|5|||
147519369|NCT00777036|532054369|FG003|On Treatment|Maximum Clinical Benefit|0|||
147519370|NCT00777036|532054366|FG000|On Treatment|Withdrawal by Subject|0|||
147519371|NCT00777036|532054367|FG001|On Treatment|Withdrawal by Subject|2|||
147519372|NCT00777036|532054368|FG002|On Treatment|Withdrawal by Subject|2|||
147519373|NCT00777036|532054369|FG003|On Treatment|Withdrawal by Subject|0|||
147519374|NCT00777036|532054366|FG000|On Treatment|Participant Request to Discontinue Study Treatment|4|||
147519375|NCT00777036|532054367|FG001|On Treatment|Participant Request to Discontinue Study Treatment|0|||
147519376|NCT00777036|532054368|FG002|On Treatment|Participant Request to Discontinue Study Treatment|6|||
147519377|NCT00777036|532054369|FG003|On Treatment|Participant Request to Discontinue Study Treatment|0|||
147519378|NCT00777036|532054366|FG000|On Treatment|Death|0|||
147519379|NCT00777036|532054367|FG001|On Treatment|Death|2|||
147519380|NCT00777036|532054368|FG002|On Treatment|Death|0|||
147519381|NCT00777036|532054369|FG003|On Treatment|Death|0|||
147519382|NCT00777036|532054366|FG000|On Treatment|Study Drug Toxicity|1|||
147519383|NCT00777036|532054367|FG001|On Treatment|Study Drug Toxicity|0|||
147519384|NCT00777036|532054368|FG002|On Treatment|Study Drug Toxicity|4|||
147519385|NCT00777036|532054369|FG003|On Treatment|Study Drug Toxicity|0|||
147519386|NCT00777036|532054366|FG000|On Treatment|Progressive Disease|6|||
147519387|NCT00777036|532054367|FG001|On Treatment|Progressive Disease|4|||
147519388|NCT00777036|532054368|FG002|On Treatment|Progressive Disease|7|||
147519389|NCT00777036|532054369|FG003|On Treatment|Progressive Disease|0|||
147519390|NCT00777036|532054366|FG000|On Treatment|Not Reported|0|||
147519391|NCT00777036|532054367|FG001|On Treatment|Not Reported|0|||
147642855|NCT00455520|532511058|FG000|Double Blind Tapentadol ER vs Placebo|Lost to Follow-up|3|||
147519392|NCT00777036|532054368|FG002|On Treatment|Not Reported|2|||
147519393|NCT00777036|532054369|FG003|On Treatment|Not Reported|0|||
147519394|NCT00777036|532054366|FG000|On Treatment|Site Closed|0|||
147519395|NCT00777036|532054367|FG001|On Treatment|Site Closed|1|||
147519396|NCT00777036|532054368|FG002|On Treatment|Site Closed|1|||
147519397|NCT00777036|532054369|FG003|On Treatment|Site Closed|0|||
147519398|NCT00777036|532054366|FG000|Follow-Up|Withdrawal by Subject|0|||
147519399|NCT00777036|532054367|FG001|Follow-Up|Withdrawal by Subject|0|||
147519400|NCT00777036|532054368|FG002|Follow-Up|Withdrawal by Subject|5|||
147519401|NCT00777036|532054369|FG003|Follow-Up|Withdrawal by Subject|0|||
147519402|NCT00777036|532054366|FG000|Follow-Up|Death|1|||
147519403|NCT00777036|532054367|FG001|Follow-Up|Death|9|||
147519404|NCT00777036|532054368|FG002|Follow-Up|Death|0|||
147519405|NCT00777036|532054369|FG003|Follow-Up|Death|0|||
147519406|NCT00777036|532054366|FG000|Follow-Up|Lost to Follow-up|3|||
147519407|NCT00777036|532054367|FG001|Follow-Up|Lost to Follow-up|0|||
147519408|NCT00777036|532054368|FG002|Follow-Up|Lost to Follow-up|0|||
147519409|NCT00777036|532054369|FG003|Follow-Up|Lost to Follow-up|0|||
147519410|NCT00777036|532054366|FG000|Follow-Up|Reason Not Specified|4|||
147519411|NCT00777036|532054367|FG001|Follow-Up|Reason Not Specified|0|||
147519412|NCT00777036|532054368|FG002|Follow-Up|Reason Not Specified|13|||
147519413|NCT00777036|532054369|FG003|Follow-Up|Reason Not Specified|0|||
147519414|NCT00777036|532054366|FG000|Follow-Up|Missing - Administrative Reasons in Russia|1|||
147519415|NCT00777036|532054367|FG001|Follow-Up|Missing - Administrative Reasons in Russia|0|||
147519416|NCT00777036|532054368|FG002|Follow-Up|Missing - Administrative Reasons in Russia|4|||
147519417|NCT00777036|532054369|FG003|Follow-Up|Missing - Administrative Reasons in Russia|0|||
147519418|NCT05827978|532054372|FG000|Overall Study|Adverse Event|1|||
147519419|NCT05827978|532054373|FG001|Overall Study|Adverse Event|0|||
147519420|NCT05827978|532054374|FG002|Overall Study|Adverse Event|0|||
147519421|NCT05827978|532054375|FG003|Overall Study|Adverse Event|1|||
147519422|NCT05827978|532054376|FG004|Overall Study|Adverse Event|0|||
147519423|NCT05827978|532054377|FG005|Overall Study|Adverse Event|0|||
147519424|NCT05827978|532054372|FG000|Overall Study|Death|1|||
147519425|NCT05827978|532054373|FG001|Overall Study|Death|5|||
147519426|NCT05827978|532054374|FG002|Overall Study|Death|2|||
147519427|NCT05827978|532054375|FG003|Overall Study|Death|3|||
147519428|NCT05827978|532054376|FG004|Overall Study|Death|1|||
147519429|NCT05827978|532054377|FG005|Overall Study|Death|3|||
147519430|NCT05827978|532054372|FG000|Overall Study|Lost to Follow-up|57|||
147519431|NCT05827978|532054373|FG001|Overall Study|Lost to Follow-up|88|||
147519432|NCT05827978|532054374|FG002|Overall Study|Lost to Follow-up|54|||
147519433|NCT05827978|532054375|FG003|Overall Study|Lost to Follow-up|47|||
147519434|NCT05827978|532054376|FG004|Overall Study|Lost to Follow-up|25|||
147519435|NCT05827978|532054377|FG005|Overall Study|Lost to Follow-up|10|||
147519436|NCT05827978|532054372|FG000|Overall Study|Noncompliance with Study Procedures|0|||
147519437|NCT05827978|532054373|FG001|Overall Study|Noncompliance with Study Procedures|1|||
147519438|NCT05827978|532054374|FG002|Overall Study|Noncompliance with Study Procedures|1|||
147519439|NCT05827978|532054375|FG003|Overall Study|Noncompliance with Study Procedures|1|||
147519440|NCT05827978|532054376|FG004|Overall Study|Noncompliance with Study Procedures|1|||
147519441|NCT05827978|532054377|FG005|Overall Study|Noncompliance with Study Procedures|0|||
147519442|NCT05827978|532054372|FG000|Overall Study|Physician Decision|2|||
147519443|NCT05827978|532054373|FG001|Overall Study|Physician Decision|0|||
147519444|NCT05827978|532054374|FG002|Overall Study|Physician Decision|1|||
147519445|NCT05827978|532054375|FG003|Overall Study|Physician Decision|2|||
147519446|NCT05827978|532054376|FG004|Overall Study|Physician Decision|1|||
147519447|NCT05827978|532054377|FG005|Overall Study|Physician Decision|1|||
147519448|NCT05827978|532054372|FG000|Overall Study|Protocol Violation|5|||
147519449|NCT05827978|532054373|FG001|Overall Study|Protocol Violation|2|||
147519450|NCT05827978|532054374|FG002|Overall Study|Protocol Violation|0|||
147519451|NCT05827978|532054375|FG003|Overall Study|Protocol Violation|0|||
147519452|NCT05827978|532054376|FG004|Overall Study|Protocol Violation|0|||
147519453|NCT05827978|532054377|FG005|Overall Study|Protocol Violation|0|||
147519454|NCT05827978|532054372|FG000|Overall Study|Withdrawal by Subject|17|||
147519455|NCT05827978|532054373|FG001|Overall Study|Withdrawal by Subject|16|||
147519456|NCT05827978|532054374|FG002|Overall Study|Withdrawal by Subject|10|||
147519457|NCT05827978|532054375|FG003|Overall Study|Withdrawal by Subject|12|||
147519458|NCT05827978|532054376|FG004|Overall Study|Withdrawal by Subject|10|||
147519459|NCT05827978|532054377|FG005|Overall Study|Withdrawal by Subject|9|||
147519460|NCT05827978|532054372|FG000|Overall Study|Other Than Specified|0|||
147519461|NCT05827978|532054373|FG001|Overall Study|Other Than Specified|0|||
147642856|NCT00455520|532511059|FG001|Double Blind Tapentadol ER vs Placebo|Lost to Follow-up|3|||
147642857|NCT00455520|532511058|FG000|Double Blind Tapentadol ER vs Placebo|Study drug non compliant|4|||
147642858|NCT00455520|532511059|FG001|Double Blind Tapentadol ER vs Placebo|Study drug non compliant|2|||
147519462|NCT05827978|532054374|FG002|Overall Study|Other Than Specified|1|||
147519463|NCT05827978|532054375|FG003|Overall Study|Other Than Specified|0|||
147519464|NCT05827978|532054376|FG004|Overall Study|Other Than Specified|2|||
147519465|NCT05827978|532054377|FG005|Overall Study|Other Than Specified|0|||
147519466|NCT05564039|532054378|FG000|Overall Study|Adverse Event|1|||
147519467|NCT05564039|532054379|FG001|Overall Study|Adverse Event|0|||
147519468|NCT05564039|532054378|FG000|Overall Study|Death|1|||
147519469|NCT05564039|532054379|FG001|Overall Study|Death|1|||
147519470|NCT05564039|532054378|FG000|Overall Study|Lost to Follow-up|3|||
147519471|NCT05564039|532054379|FG001|Overall Study|Lost to Follow-up|2|||
147519472|NCT05564039|532054378|FG000|Overall Study|Withdrawal by Subject|2|||
147519473|NCT05564039|532054379|FG001|Overall Study|Withdrawal by Subject|0|||
147519474|NCT05564039|532054378|FG000|Overall Study|Inadvertent enrollment|3|||
147519475|NCT05564039|532054379|FG001|Overall Study|Inadvertent enrollment|6|||
147519476|NCT04566445|532054380|FG000|Overall Study|Death|4|||
147519477|NCT04566445|532054381|FG001|Overall Study|Death|1|||
147519478|NCT04566445|532054382|FG002|Overall Study|Death|1|||
147519479|NCT04566445|532054380|FG000|Overall Study|Lost to Follow-up|3|||
147519480|NCT04566445|532054381|FG001|Overall Study|Lost to Follow-up|1|||
147519481|NCT04566445|532054382|FG002|Overall Study|Lost to Follow-up|1|||
147519482|NCT04566445|532054380|FG000|Overall Study|Study terminated by sponsor|11|||
147519483|NCT04566445|532054381|FG001|Overall Study|Study terminated by sponsor|17|||
147519484|NCT04566445|532054382|FG002|Overall Study|Study terminated by sponsor|32|||
147519485|NCT04566445|532054380|FG000|Overall Study|Withdrawal by Subject|12|||
147519486|NCT04566445|532054381|FG001|Overall Study|Withdrawal by Subject|14|||
147519487|NCT04566445|532054382|FG002|Overall Study|Withdrawal by Subject|13|||
147519488|NCT04566445|532054380|FG000|Overall Study|Randomized but not treated due to AE|2|||
147519489|NCT04566445|532054381|FG001|Overall Study|Randomized but not treated due to AE|1|||
147519490|NCT04566445|532054382|FG002|Overall Study|Randomized but not treated due to AE|0|||
147519491|NCT04566445|532054380|FG000|Overall Study|Adverse Event|1|||
147519492|NCT04566445|532054381|FG001|Overall Study|Adverse Event|1|||
147519493|NCT04566445|532054382|FG002|Overall Study|Adverse Event|0|||
147519494|NCT04785144|532054383|FG000|Overall Study|Withdrawal by Subject|4|||
147519495|NCT04785144|532054384|FG001|Overall Study|Withdrawal by Subject|1|||
147519496|NCT04785144|532054385|FG002|Overall Study|Withdrawal by Subject|0|||
147519497|NCT04785144|532054386|FG003|Overall Study|Withdrawal by Subject|0|||
147519498|NCT04785144|532054387|FG004|Overall Study|Withdrawal by Subject|0|||
147519499|NCT04785144|532054388|FG005|Overall Study|Withdrawal by Subject|2|||
147519500|NCT04785144|532054389|FG006|Overall Study|Withdrawal by Subject|2|||
147519501|NCT04785144|532054390|FG007|Overall Study|Withdrawal by Subject|0|||
147519502|NCT04785144|532054391|FG008|Overall Study|Withdrawal by Subject|1|||
147519503|NCT04785144|532054392|FG009|Overall Study|Withdrawal by Subject|0|||
147519504|NCT04785144|532054383|FG000|Overall Study|Lost to Follow-up|1|||
147519505|NCT04785144|532054384|FG001|Overall Study|Lost to Follow-up|0|||
147519506|NCT04785144|532054385|FG002|Overall Study|Lost to Follow-up|0|||
147519507|NCT04785144|532054386|FG003|Overall Study|Lost to Follow-up|0|||
147519508|NCT04785144|532054387|FG004|Overall Study|Lost to Follow-up|1|||
147519509|NCT04785144|532054388|FG005|Overall Study|Lost to Follow-up|2|||
147519510|NCT04785144|532054389|FG006|Overall Study|Lost to Follow-up|1|||
147519511|NCT04785144|532054390|FG007|Overall Study|Lost to Follow-up|2|||
147519512|NCT04785144|532054391|FG008|Overall Study|Lost to Follow-up|4|||
147519513|NCT04785144|532054392|FG009|Overall Study|Lost to Follow-up|1|||
147519514|NCT04785144|532054383|FG000|Overall Study|Protocol Violation|0|||
147519515|NCT04785144|532054384|FG001|Overall Study|Protocol Violation|0|||
147519516|NCT04785144|532054385|FG002|Overall Study|Protocol Violation|0|||
147519517|NCT04785144|532054386|FG003|Overall Study|Protocol Violation|0|||
147519518|NCT04785144|532054387|FG004|Overall Study|Protocol Violation|0|||
147519519|NCT04785144|532054388|FG005|Overall Study|Protocol Violation|0|||
147519520|NCT04785144|532054389|FG006|Overall Study|Protocol Violation|1|||
147519521|NCT04785144|532054390|FG007|Overall Study|Protocol Violation|0|||
147519522|NCT04785144|532054391|FG008|Overall Study|Protocol Violation|0|||
147519523|NCT04785144|532054392|FG009|Overall Study|Protocol Violation|0|||
147519524|NCT04785144|532054383|FG000|Overall Study|Physician Decision|0|||
147519525|NCT04785144|532054384|FG001|Overall Study|Physician Decision|0|||
147519526|NCT04785144|532054385|FG002|Overall Study|Physician Decision|0|||
147519527|NCT04785144|532054386|FG003|Overall Study|Physician Decision|0|||
147519528|NCT04785144|532054387|FG004|Overall Study|Physician Decision|0|||
147519529|NCT04785144|532054388|FG005|Overall Study|Physician Decision|0|||
147519530|NCT04785144|532054389|FG006|Overall Study|Physician Decision|0|||
147519531|NCT04785144|532054390|FG007|Overall Study|Physician Decision|0|||
147519532|NCT04785144|532054391|FG008|Overall Study|Physician Decision|0|||
147519533|NCT04785144|532054392|FG009|Overall Study|Physician Decision|1|||
147519534|NCT04785144|532054383|FG000|Overall Study|Unable to continue due to work schedule|0|||
147519535|NCT04785144|532054384|FG001|Overall Study|Unable to continue due to work schedule|0|||
147519536|NCT04785144|532054385|FG002|Overall Study|Unable to continue due to work schedule|0|||
147519537|NCT04785144|532054386|FG003|Overall Study|Unable to continue due to work schedule|0|||
147519538|NCT04785144|532054387|FG004|Overall Study|Unable to continue due to work schedule|0|||
147519539|NCT04785144|532054388|FG005|Overall Study|Unable to continue due to work schedule|0|||
147519540|NCT04785144|532054389|FG006|Overall Study|Unable to continue due to work schedule|0|||
147519541|NCT04785144|532054390|FG007|Overall Study|Unable to continue due to work schedule|0|||
147519542|NCT04785144|532054391|FG008|Overall Study|Unable to continue due to work schedule|0|||
147519543|NCT04785144|532054392|FG009|Overall Study|Unable to continue due to work schedule|1|||
147519544|NCT01263470|532054395|FG000|Overall Study|Adverse Event|2|||
147519545|NCT01263470|532054396|FG001|Overall Study|Adverse Event|2|||
147519546|NCT01263470|532054397|FG002|Overall Study|Adverse Event|1|||
147519547|NCT01263470|532054398|FG003|Overall Study|Adverse Event|1|||
147519548|NCT01263470|532054399|FG004|Overall Study|Adverse Event|2|||
147519549|NCT01263470|532054400|FG005|Overall Study|Adverse Event|2|||
147519550|NCT01263470|532054395|FG000|Overall Study|Protocol Violation|0|||
147519551|NCT01263470|532054396|FG001|Overall Study|Protocol Violation|1|||
147519552|NCT01263470|532054397|FG002|Overall Study|Protocol Violation|0|||
147519553|NCT01263470|532054398|FG003|Overall Study|Protocol Violation|0|||
147519554|NCT01263470|532054399|FG004|Overall Study|Protocol Violation|0|||
147519555|NCT01263470|532054400|FG005|Overall Study|Protocol Violation|1|||
147519556|NCT01263470|532054395|FG000|Overall Study|Withdrawal by Subject|0|||
147519557|NCT01263470|532054396|FG001|Overall Study|Withdrawal by Subject|1|||
147519558|NCT01263470|532054397|FG002|Overall Study|Withdrawal by Subject|1|||
147519559|NCT01263470|532054398|FG003|Overall Study|Withdrawal by Subject|2|||
147519560|NCT01263470|532054399|FG004|Overall Study|Withdrawal by Subject|0|||
147519561|NCT01263470|532054400|FG005|Overall Study|Withdrawal by Subject|2|||
147519562|NCT01263470|532054395|FG000|Overall Study|Lack of Efficacy|0|||
147519563|NCT01263470|532054396|FG001|Overall Study|Lack of Efficacy|0|||
147519564|NCT01263470|532054397|FG002|Overall Study|Lack of Efficacy|2|||
147519565|NCT01263470|532054398|FG003|Overall Study|Lack of Efficacy|0|||
147519566|NCT01263470|532054399|FG004|Overall Study|Lack of Efficacy|0|||
147519567|NCT01263470|532054400|FG005|Overall Study|Lack of Efficacy|0|||
147519568|NCT01263470|532054395|FG000|Overall Study|Participant Unavailability|0|||
147519569|NCT01263470|532054396|FG001|Overall Study|Participant Unavailability|1|||
147519570|NCT01263470|532054397|FG002|Overall Study|Participant Unavailability|0|||
147519571|NCT01263470|532054398|FG003|Overall Study|Participant Unavailability|0|||
147519572|NCT01263470|532054399|FG004|Overall Study|Participant Unavailability|0|||
147519573|NCT01263470|532054400|FG005|Overall Study|Participant Unavailability|0|||
147519574|NCT01263470|532054395|FG000|Overall Study|Study Drug Non-compliance|0|||
147519575|NCT01263470|532054396|FG001|Overall Study|Study Drug Non-compliance|0|||
147519576|NCT01263470|532054397|FG002|Overall Study|Study Drug Non-compliance|0|||
147519577|NCT01263470|532054398|FG003|Overall Study|Study Drug Non-compliance|0|||
147519578|NCT01263470|532054399|FG004|Overall Study|Study Drug Non-compliance|1|||
147519579|NCT01263470|532054400|FG005|Overall Study|Study Drug Non-compliance|0|||
147519580|NCT00610714|532054401|FG000|Overall Study|Adverse Event|3|||
147519581|NCT00610714|532054402|FG001|Overall Study|Adverse Event|1|||
147519582|NCT00610714|532054401|FG000|Overall Study|Death|12|||
147519583|NCT00610714|532054402|FG001|Overall Study|Death|18|||
147519584|NCT00610714|532054401|FG000|Overall Study|Withdrawal by Subject|9|||
147519585|NCT00610714|532054402|FG001|Overall Study|Withdrawal by Subject|3|||
147519586|NCT00610714|532054401|FG000|Overall Study|Study completion at 120 PFS events|2|||
147519587|NCT00610714|532054402|FG001|Overall Study|Study completion at 120 PFS events|2|||
147519588|NCT01327573|532054403|FG000|Overall Study|Physician Decision|3|||
147519589|NCT01327573|532054404|FG001|Overall Study|Physician Decision|1|||
147519590|NCT01108263|532054405|FG000|Overall Study|Adverse Event|0|||
147519591|NCT01108263|532054406|FG001|Overall Study|Adverse Event|1|||
147519592|NCT00712712|532054407|FG000|Overall Study|Protocol Violation|11|||
147519593|NCT00712712|532054407|FG000|Overall Study|Radiofrequency not done|3|||
147519594|NCT00712712|532054407|FG000|Overall Study|Death|8|||
147519595|NCT00712712|532054407|FG000|Overall Study|Withdrawal by Subject|1|||
147519596|NCT01029691|532054410|FG000|Continued APAP to Delivery|Death|0|||
147519597|NCT01029691|532054411|FG001|Continued APAP to Delivery|Death|0|||
147519598|NCT01029691|532054412|FG002|Continued APAP to Delivery|Death|1|||
147519599|NCT05245071|532054417|FG000|Overall Study|Progressive disease|18|||
147519600|NCT05245071|532054417|FG000|Overall Study|Adverse event not related to Coronavirus Disease 2019|2|||
147519601|NCT05245071|532054417|FG000|Overall Study|Not related to Coronavirus Disease 2019|2|||
147519602|NCT01602822|532054418|FG000|Overall Study|Adverse Event|11|||
147519603|NCT04005755|532054428|FG000|Overall Study|Adverse Event|6|||
147519604|NCT04005755|532054428|FG000|Overall Study|Physician Decision|3|||
147519605|NCT04005755|532054428|FG000|Overall Study|Administrative reason, temporary site closure due to COVID-19|4|||
147519606|NCT04005755|532054428|FG000|Overall Study|Withdrawal by Subject|3|||
147519607|NCT04005755|532054428|FG000|Overall Study|Lost to Follow-up|1|||
147519608|NCT02005211|532054432|FG000|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
147519609|NCT02005211|532054433|FG001|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
147519610|NCT02005211|532054434|FG002|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
147519611|NCT02005211|532054435|FG003|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
147519612|NCT02005211|532054436|FG004|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|1|||
147519613|NCT02005211|532054437|FG005|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
147519614|NCT02005211|532054438|FG006|Part 2 - Elderly Subjects Cohorts 4 & 5|Withdrawal by Subject|0|||
147519615|NCT02202161|532054441|FG000|Overall Study|Adverse Event|1|||
147642859|NCT00455520|532511058|FG000|Double Blind Tapentadol ER vs Placebo|All other|4|||
147642860|NCT00455520|532511059|FG001|Double Blind Tapentadol ER vs Placebo|All other|6|||
147642861|NCT00986986|532511062|FG000|Overall Study|Lost to Follow-up|0|||
147519616|NCT02202161|532054442|FG001|Overall Study|Adverse Event|1|||
147519617|NCT02202161|532054443|FG002|Overall Study|Adverse Event|0|||
147519618|NCT02202161|532054444|FG003|Overall Study|Adverse Event|0|||
147519619|NCT02202161|532054445|FG004|Overall Study|Adverse Event|0|||
147519620|NCT02202161|532054446|FG005|Overall Study|Adverse Event|1|||
147519621|NCT02202161|532054447|FG006|Overall Study|Adverse Event|0|||
147519622|NCT02202161|532054448|FG007|Overall Study|Adverse Event|0|||
147519623|NCT02202161|532054441|FG000|Overall Study|Did not meet continuation criteria|0|||
147519624|NCT02202161|532054442|FG001|Overall Study|Did not meet continuation criteria|0|||
147519625|NCT02202161|532054443|FG002|Overall Study|Did not meet continuation criteria|0|||
147519626|NCT02202161|532054444|FG003|Overall Study|Did not meet continuation criteria|0|||
147519627|NCT02202161|532054445|FG004|Overall Study|Did not meet continuation criteria|0|||
147519628|NCT02202161|532054446|FG005|Overall Study|Did not meet continuation criteria|0|||
147519629|NCT02202161|532054447|FG006|Overall Study|Did not meet continuation criteria|0|||
147519630|NCT02202161|532054448|FG007|Overall Study|Did not meet continuation criteria|3|||
147519631|NCT02202161|532054441|FG000|Overall Study|Physician Decision|0|||
147519632|NCT02202161|532054442|FG001|Overall Study|Physician Decision|0|||
147519633|NCT02202161|532054443|FG002|Overall Study|Physician Decision|0|||
147519634|NCT02202161|532054444|FG003|Overall Study|Physician Decision|0|||
147519635|NCT02202161|532054445|FG004|Overall Study|Physician Decision|0|||
147519636|NCT02202161|532054446|FG005|Overall Study|Physician Decision|0|||
147519637|NCT02202161|532054447|FG006|Overall Study|Physician Decision|0|||
147519638|NCT02202161|532054448|FG007|Overall Study|Physician Decision|3|||
147519639|NCT02202161|532054441|FG000|Overall Study|Withdrawal by Subject|0|||
147519640|NCT02202161|532054442|FG001|Overall Study|Withdrawal by Subject|0|||
147519641|NCT02202161|532054443|FG002|Overall Study|Withdrawal by Subject|0|||
147519642|NCT02202161|532054444|FG003|Overall Study|Withdrawal by Subject|0|||
147519643|NCT02202161|532054445|FG004|Overall Study|Withdrawal by Subject|1|||
147519644|NCT02202161|532054446|FG005|Overall Study|Withdrawal by Subject|0|||
147519645|NCT02202161|532054447|FG006|Overall Study|Withdrawal by Subject|0|||
147519646|NCT02202161|532054448|FG007|Overall Study|Withdrawal by Subject|0|||
147519647|NCT00832091|532054449|FG000|Overall Study|Adverse Event|1|||
147519648|NCT00832091|532054450|FG001|Overall Study|Adverse Event|1|||
147519649|NCT00832091|532054449|FG000|Overall Study|Protocol Violation|1|||
147519650|NCT00832091|532054450|FG001|Overall Study|Protocol Violation|0|||
147519651|NCT00832091|532054449|FG000|Overall Study|Withdrawal by Subject|2|||
147519652|NCT00832091|532054450|FG001|Overall Study|Withdrawal by Subject|1|||
147519653|NCT00832091|532054449|FG000|Overall Study|Prohibited Medication|1|||
147519654|NCT00832091|532054450|FG001|Overall Study|Prohibited Medication|0|||
147519655|NCT00952588|532054451|FG000|Overall Study|Death|28|||
147519656|NCT00952588|532054452|FG001|Overall Study|Death|13|||
147519657|NCT00952588|532054451|FG000|Overall Study|Withdrawal by Subject|2|||
147519658|NCT00952588|532054452|FG001|Overall Study|Withdrawal by Subject|5|||
147519659|NCT00952588|532054451|FG000|Overall Study|Adverse Event|2|||
147519660|NCT00952588|532054452|FG001|Overall Study|Adverse Event|3|||
147519661|NCT00952588|532054451|FG000|Overall Study|Lost to Follow-up|2|||
147519662|NCT00952588|532054452|FG001|Overall Study|Lost to Follow-up|0|||
147519663|NCT00952588|532054451|FG000|Overall Study|Physician Decision|0|||
147519664|NCT00952588|532054452|FG001|Overall Study|Physician Decision|1|||
147519665|NCT00952588|532054451|FG000|Overall Study|Lack of Efficacy|2|||
147519666|NCT00952588|532054452|FG001|Overall Study|Lack of Efficacy|2|||
147519667|NCT04554394|532054453|FG000|Overall Study|Clinical Site Closed due to COVID-19 Restrictions|4|||
147519668|NCT04554394|532054454|FG001|Overall Study|Clinical Site Closed due to COVID-19 Restrictions|4|||
147519669|NCT04554394|532054453|FG000|Overall Study|Withdrawal by Subject|2|||
147519670|NCT04554394|532054454|FG001|Overall Study|Withdrawal by Subject|2|||
147519671|NCT04554394|532054453|FG000|Overall Study|Lost to Follow-up|2|||
147519672|NCT04554394|532054454|FG001|Overall Study|Lost to Follow-up|2|||
147519673|NCT04554394|532054453|FG000|Overall Study|Physician Decision|1|||
147519674|NCT04554394|532054454|FG001|Overall Study|Physician Decision|1|||
147519675|NCT01766401|532054455|FG000|Overall Study|Adverse Event|7|||
147519676|NCT01766401|532054456|FG001|Overall Study|Adverse Event|22|||
147519677|NCT01766401|532054455|FG000|Overall Study|Lack of Efficacy|1|||
147519678|NCT01766401|532054456|FG001|Overall Study|Lack of Efficacy|2|||
147519679|NCT01766401|532054455|FG000|Overall Study|Protocol Violation|3|||
147519680|NCT01766401|532054456|FG001|Overall Study|Protocol Violation|8|||
147519681|NCT01766401|532054455|FG000|Overall Study|Withdrawal by Subject|15|||
147519682|NCT01766401|532054456|FG001|Overall Study|Withdrawal by Subject|12|||
147519683|NCT01766401|532054455|FG000|Overall Study|Lost to Follow-up|10|||
147519684|NCT01766401|532054456|FG001|Overall Study|Lost to Follow-up|11|||
147519685|NCT01766401|532054455|FG000|Overall Study|Pregnancy|1|||
147519686|NCT01766401|532054456|FG001|Overall Study|Pregnancy|1|||
147519687|NCT01021553|532054457|FG000|Overall Study|Adverse Event|1|||
147519688|NCT01021553|532054458|FG001|Overall Study|Adverse Event|0|||
147519689|NCT01021553|532054459|FG002|Overall Study|Adverse Event|0|||
147519690|NCT01021553|532054457|FG000|Overall Study|Lack of Efficacy|2|||
147519691|NCT01021553|532054458|FG001|Overall Study|Lack of Efficacy|2|||
147519692|NCT01021553|532054459|FG002|Overall Study|Lack of Efficacy|0|||
147519693|NCT01021553|532054457|FG000|Overall Study|Protocol Violation|0|||
147519694|NCT01021553|532054458|FG001|Overall Study|Protocol Violation|2|||
147519695|NCT01021553|532054459|FG002|Overall Study|Protocol Violation|2|||
147519696|NCT01021553|532054457|FG000|Overall Study|Lost to Follow-up|0|||
147519697|NCT01021553|532054458|FG001|Overall Study|Lost to Follow-up|0|||
147519698|NCT01021553|532054459|FG002|Overall Study|Lost to Follow-up|1|||
147519699|NCT01021553|532054457|FG000|Overall Study|Withdrawal by Subject|1|||
147519700|NCT01021553|532054458|FG001|Overall Study|Withdrawal by Subject|1|||
147519701|NCT01021553|532054459|FG002|Overall Study|Withdrawal by Subject|0|||
147519702|NCT01950364|532054460|FG000|Overall Study|Adverse Event|3|||
147519703|NCT01950364|532054461|FG001|Overall Study|Adverse Event|0|||
147519704|NCT01950364|532054460|FG000|Overall Study|Stem Cell Transplant|2|||
147519705|NCT01950364|532054461|FG001|Overall Study|Stem Cell Transplant|6|||
147519706|NCT01950364|532054460|FG000|Overall Study|Disease Progression|5|||
147519707|NCT01950364|532054461|FG001|Overall Study|Disease Progression|2|||
147519708|NCT01950364|532054460|FG000|Overall Study|Withdrawal by Subject|0|||
147519709|NCT01950364|532054461|FG001|Overall Study|Withdrawal by Subject|1|||
147519710|NCT01950364|532054460|FG000|Overall Study|Protocol Violation|0|||
147519711|NCT01950364|532054461|FG001|Overall Study|Protocol Violation|1|||
147519712|NCT00935701|532054462|FG000|Overall Study|Failure to Transition to Acupuncture|1|||
147519713|NCT04055844|532054463|FG000|Overall Study|Adverse Event|12|||
147519714|NCT04055844|532054463|FG000|Overall Study|Poor Performance|1|||
147519715|NCT04055844|532054463|FG000|Overall Study|Death|1|||
147519716|NCT01347840|532054476|FG000|Overall Study|Withdrawal by Subject|1|||
147519717|NCT04223778|532054480|FG000|Overall Study|Death|1|||
147519718|NCT04223778|532054481|FG001|Overall Study|Death|1|||
147519719|NCT04223778|532054480|FG000|Overall Study|Lost to Follow-up|4|||
147519720|NCT04223778|532054481|FG001|Overall Study|Lost to Follow-up|5|||
147519721|NCT04223778|532054480|FG000|Overall Study|Physician Decision|10|||
147519722|NCT04223778|532054481|FG001|Overall Study|Physician Decision|6|||
147519723|NCT04223778|532054480|FG000|Overall Study|Withdrawal by Subject|35|||
147519724|NCT04223778|532054481|FG001|Overall Study|Withdrawal by Subject|17|||
147519725|NCT04223778|532054480|FG000|Overall Study|Not Reported|7|||
147519726|NCT04223778|532054481|FG001|Overall Study|Not Reported|8|||
147519727|NCT03053180|532056271|FG000|Overall Study|Failure to Return|1|||
147519728|NCT02972658|532056275|FG000|Overall Study|Adverse Event|0|||
147519729|NCT02972658|532056276|FG001|Overall Study|Adverse Event|3|||
147519730|NCT02972658|532056277|FG002|Overall Study|Adverse Event|0|||
147519731|NCT02972658|532056278|FG003|Overall Study|Adverse Event|2|||
147519732|NCT02972658|532056275|FG000|Overall Study|Other-determined by Investigator|1|||
147519733|NCT02972658|532056276|FG001|Overall Study|Other-determined by Investigator|1|||
147519734|NCT02972658|532056277|FG002|Overall Study|Other-determined by Investigator|0|||
147519735|NCT02972658|532056278|FG003|Overall Study|Other-determined by Investigator|0|||
147519736|NCT02972658|532056275|FG000|Overall Study|Death|0|||
147519737|NCT02972658|532056276|FG001|Overall Study|Death|0|||
147519738|NCT02972658|532056277|FG002|Overall Study|Death|0|||
147519739|NCT02972658|532056278|FG003|Overall Study|Death|1|||
147519740|NCT02972658|532056275|FG000|Overall Study|Lost to Follow-up|0|||
147519741|NCT02972658|532056276|FG001|Overall Study|Lost to Follow-up|1|||
147519742|NCT02972658|532056277|FG002|Overall Study|Lost to Follow-up|1|||
147519743|NCT02972658|532056278|FG003|Overall Study|Lost to Follow-up|2|||
147519744|NCT02972658|532056275|FG000|Overall Study|Progressive Disease|0|||
147519745|NCT02972658|532056276|FG001|Overall Study|Progressive Disease|1|||
147519746|NCT02972658|532056277|FG002|Overall Study|Progressive Disease|0|||
147519747|NCT02972658|532056278|FG003|Overall Study|Progressive Disease|1|||
147519748|NCT02972658|532056275|FG000|Overall Study|Withdrawal by Subject|4|||
147519749|NCT02972658|532056276|FG001|Overall Study|Withdrawal by Subject|4|||
147519750|NCT02972658|532056277|FG002|Overall Study|Withdrawal by Subject|1|||
147519751|NCT02972658|532056278|FG003|Overall Study|Withdrawal by Subject|6|||
147519752|NCT02972658|532056275|FG000|Overall Study|Withdrawal due to Caregiver Circumstance|1|||
147519753|NCT02972658|532056276|FG001|Overall Study|Withdrawal due to Caregiver Circumstance|1|||
147519754|NCT02972658|532056277|FG002|Overall Study|Withdrawal due to Caregiver Circumstance|1|||
147519755|NCT02972658|532056278|FG003|Overall Study|Withdrawal due to Caregiver Circumstance|0|||
147519756|NCT02972658|532056275|FG000|Overall Study|Sponsor Decision|70|||
147519757|NCT02972658|532056276|FG001|Overall Study|Sponsor Decision|127|||
147519758|NCT02972658|532056277|FG002|Overall Study|Sponsor Decision|72|||
147519759|NCT02972658|532056278|FG003|Overall Study|Sponsor Decision|119|||
147519760|NCT03958149|532056279|FG000|Overall Study|Withdrawal by Subject|0|||
147519761|NCT03958149|532056280|FG001|Overall Study|Withdrawal by Subject|1|||
147642862|NCT00986986|532511063|FG001|Overall Study|Lost to Follow-up|1|||
147642863|NCT03235115|532511065|FG000|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0|||
147642864|NCT03235115|532511066|FG001|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0|||
147642865|NCT03235115|532511067|FG002|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0|||
147642866|NCT03235115|532511068|FG003|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0|||
147642867|NCT03235115|532511069|FG004|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|0|||
147642868|NCT03235115|532511070|FG005|First Intervention (1 Hour, Visit 2)|Lost to Follow-up|1|||
147642869|NCT00955968|532511074|FG000|Overall Study|Death|2|||
147519762|NCT00621764|532056281|FG000|Overall Study|Protocol Violation|0|||
147519763|NCT00621764|532056282|FG001|Overall Study|Protocol Violation|0|||
147519764|NCT00621764|532056283|FG002|Overall Study|Protocol Violation|0|||
147519765|NCT00621764|532056284|FG003|Overall Study|Protocol Violation|1|||
147519766|NCT02583399|532056285|FG000|Overall Study|Able to be discharged|3|||
147519767|NCT02583399|532056285|FG000|Overall Study|Wanted to use a restricted medication|3|||
147519768|NCT00686699|532056286|FG000|Treatment Period 1|Adverse Event|0|||
147519769|NCT00686699|532056287|FG001|Treatment Period 1|Adverse Event|2|||
147519770|NCT01693562|532056288|FG000|Escalation Phase|Withdrawal by Subject|0|||
147519771|NCT01693562|532056289|FG001|Escalation Phase|Withdrawal by Subject|1|||
147519772|NCT01693562|532056290|FG002|Escalation Phase|Withdrawal by Subject|0|||
147519773|NCT01693562|532056291|FG003|Escalation Phase|Withdrawal by Subject|0|||
147519774|NCT01693562|532056292|FG004|Escalation Phase|Withdrawal by Subject|0|||
147519775|NCT01693562|532056293|FG005|Escalation Phase|Withdrawal by Subject|2|||
147519776|NCT01693562|532056294|FG006|Escalation Phase|Withdrawal by Subject|0|||
147519777|NCT01693562|532056295|FG007|Escalation Phase|Withdrawal by Subject|0|||
147519778|NCT01693562|532056296|FG008|Escalation Phase|Withdrawal by Subject|0|||
147519779|NCT01693562|532056297|FG009|Escalation Phase|Withdrawal by Subject|0|||
147519780|NCT01693562|532056298|FG010|Escalation Phase|Withdrawal by Subject|0|||
147519781|NCT01693562|532056299|FG011|Escalation Phase|Withdrawal by Subject|0|||
147519782|NCT01693562|532056300|FG012|Escalation Phase|Withdrawal by Subject|0|||
147519783|NCT01693562|532056301|FG013|Escalation Phase|Withdrawal by Subject|0|||
147519784|NCT01693562|532056302|FG014|Escalation Phase|Withdrawal by Subject|0|||
147519785|NCT01693562|532056303|FG015|Escalation Phase|Withdrawal by Subject|0|||
147519786|NCT01693562|532056304|FG016|Escalation Phase|Withdrawal by Subject|0|||
147519787|NCT01693562|532056305|FG017|Escalation Phase|Withdrawal by Subject|0|||
147519788|NCT01693562|532056306|FG018|Escalation Phase|Withdrawal by Subject|0|||
147519789|NCT01693562|532056307|FG019|Escalation Phase|Withdrawal by Subject|0|||
147519790|NCT01693562|532056308|FG020|Escalation Phase|Withdrawal by Subject|0|||
147519791|NCT01693562|532056309|FG021|Escalation Phase|Withdrawal by Subject|0|||
147519792|NCT01693562|532056310|FG022|Escalation Phase|Withdrawal by Subject|0|||
147519793|NCT01693562|532056288|FG000|Escalation Phase|Death|4|||
147519794|NCT01693562|532056289|FG001|Escalation Phase|Death|2|||
147519795|NCT01693562|532056290|FG002|Escalation Phase|Death|0|||
147519796|NCT01693562|532056291|FG003|Escalation Phase|Death|3|||
147519797|NCT01693562|532056292|FG004|Escalation Phase|Death|6|||
147519798|NCT01693562|532056293|FG005|Escalation Phase|Death|4|||
147519799|NCT01693562|532056294|FG006|Escalation Phase|Death|0|||
147519800|NCT01693562|532056295|FG007|Escalation Phase|Death|0|||
147519801|NCT01693562|532056296|FG008|Escalation Phase|Death|0|||
147519802|NCT01693562|532056297|FG009|Escalation Phase|Death|0|||
147519803|NCT01693562|532056298|FG010|Escalation Phase|Death|0|||
147519804|NCT01693562|532056299|FG011|Escalation Phase|Death|0|||
147519805|NCT01693562|532056300|FG012|Escalation Phase|Death|0|||
147519806|NCT01693562|532056301|FG013|Escalation Phase|Death|0|||
147519807|NCT01693562|532056302|FG014|Escalation Phase|Death|0|||
147519808|NCT01693562|532056303|FG015|Escalation Phase|Death|0|||
147519809|NCT01693562|532056304|FG016|Escalation Phase|Death|0|||
147519810|NCT01693562|532056305|FG017|Escalation Phase|Death|0|||
147519811|NCT01693562|532056306|FG018|Escalation Phase|Death|0|||
147519812|NCT01693562|532056307|FG019|Escalation Phase|Death|0|||
147519813|NCT01693562|532056308|FG020|Escalation Phase|Death|0|||
147519814|NCT01693562|532056309|FG021|Escalation Phase|Death|0|||
147519815|NCT01693562|532056310|FG022|Escalation Phase|Death|0|||
147519816|NCT01693562|532056288|FG000|Escalation Phase|Lost to Follow-up|0|||
147519817|NCT01693562|532056289|FG001|Escalation Phase|Lost to Follow-up|1|||
147519818|NCT01693562|532056290|FG002|Escalation Phase|Lost to Follow-up|1|||
147519819|NCT01693562|532056291|FG003|Escalation Phase|Lost to Follow-up|0|||
147519820|NCT01693562|532056292|FG004|Escalation Phase|Lost to Follow-up|0|||
147519821|NCT01693562|532056293|FG005|Escalation Phase|Lost to Follow-up|0|||
147519822|NCT01693562|532056294|FG006|Escalation Phase|Lost to Follow-up|0|||
147519823|NCT01693562|532056295|FG007|Escalation Phase|Lost to Follow-up|0|||
147519824|NCT01693562|532056296|FG008|Escalation Phase|Lost to Follow-up|0|||
147519825|NCT01693562|532056297|FG009|Escalation Phase|Lost to Follow-up|0|||
147519826|NCT01693562|532056298|FG010|Escalation Phase|Lost to Follow-up|0|||
147519827|NCT01693562|532056299|FG011|Escalation Phase|Lost to Follow-up|0|||
147519828|NCT01693562|532056300|FG012|Escalation Phase|Lost to Follow-up|0|||
147519829|NCT01693562|532056301|FG013|Escalation Phase|Lost to Follow-up|0|||
147519830|NCT01693562|532056302|FG014|Escalation Phase|Lost to Follow-up|0|||
147519831|NCT01693562|532056303|FG015|Escalation Phase|Lost to Follow-up|0|||
147519832|NCT01693562|532056304|FG016|Escalation Phase|Lost to Follow-up|0|||
147642870|NCT00955968|532511075|FG001|Overall Study|Death|4|||
147642871|NCT00955968|532511074|FG000|Overall Study|Withdrawal by Subject|35|||
147642872|NCT00955968|532511075|FG001|Overall Study|Withdrawal by Subject|31|||
147642873|NCT00955968|532511074|FG000|Overall Study|Lost to Follow-up|45|||
147642874|NCT00955968|532511075|FG001|Overall Study|Lost to Follow-up|39|||
147642875|NCT00955968|532511074|FG000|Overall Study|Site closed|55|||
147519833|NCT01693562|532056305|FG017|Escalation Phase|Lost to Follow-up|0|||
147519834|NCT01693562|532056306|FG018|Escalation Phase|Lost to Follow-up|0|||
147519835|NCT01693562|532056307|FG019|Escalation Phase|Lost to Follow-up|0|||
147519836|NCT01693562|532056308|FG020|Escalation Phase|Lost to Follow-up|0|||
147519837|NCT01693562|532056309|FG021|Escalation Phase|Lost to Follow-up|0|||
147519838|NCT01693562|532056310|FG022|Escalation Phase|Lost to Follow-up|0|||
147519839|NCT01693562|532056288|FG000|Escalation Phase|Other|0|||
147519840|NCT01693562|532056289|FG001|Escalation Phase|Other|0|||
147519841|NCT01693562|532056290|FG002|Escalation Phase|Other|2|||
147519842|NCT01693562|532056291|FG003|Escalation Phase|Other|0|||
147519843|NCT01693562|532056292|FG004|Escalation Phase|Other|0|||
147519844|NCT01693562|532056293|FG005|Escalation Phase|Other|1|||
147642876|NCT00955968|532511075|FG001|Overall Study|Site closed|52|||
147519845|NCT01693562|532056294|FG006|Escalation Phase|Other|0|||
147519846|NCT01693562|532056295|FG007|Escalation Phase|Other|0|||
147519847|NCT01693562|532056296|FG008|Escalation Phase|Other|0|||
147519848|NCT01693562|532056297|FG009|Escalation Phase|Other|0|||
147519849|NCT01693562|532056298|FG010|Escalation Phase|Other|0|||
147519850|NCT01693562|532056299|FG011|Escalation Phase|Other|0|||
147519851|NCT01693562|532056300|FG012|Escalation Phase|Other|0|||
147519852|NCT01693562|532056301|FG013|Escalation Phase|Other|0|||
147519853|NCT01693562|532056302|FG014|Escalation Phase|Other|0|||
147519854|NCT01693562|532056303|FG015|Escalation Phase|Other|0|||
147519855|NCT01693562|532056304|FG016|Escalation Phase|Other|0|||
147519856|NCT01693562|532056305|FG017|Escalation Phase|Other|0|||
147519857|NCT01693562|532056306|FG018|Escalation Phase|Other|0|||
147519858|NCT01693562|532056307|FG019|Escalation Phase|Other|0|||
147519859|NCT01693562|532056308|FG020|Escalation Phase|Other|0|||
147519860|NCT01693562|532056309|FG021|Escalation Phase|Other|0|||
147519861|NCT01693562|532056310|FG022|Escalation Phase|Other|0|||
147519862|NCT01693562|532056288|FG000|Exploration Phase|Withdrawal by Subject|0|||
147519863|NCT01693562|532056289|FG001|Exploration Phase|Withdrawal by Subject|0|||
147519864|NCT01693562|532056290|FG002|Exploration Phase|Withdrawal by Subject|0|||
147519865|NCT01693562|532056291|FG003|Exploration Phase|Withdrawal by Subject|0|||
147519866|NCT01693562|532056292|FG004|Exploration Phase|Withdrawal by Subject|0|||
147519867|NCT01693562|532056293|FG005|Exploration Phase|Withdrawal by Subject|0|||
147519868|NCT01693562|532056294|FG006|Exploration Phase|Withdrawal by Subject|2|||
147519869|NCT01693562|532056295|FG007|Exploration Phase|Withdrawal by Subject|0|||
147519870|NCT01693562|532056296|FG008|Exploration Phase|Withdrawal by Subject|0|||
147519871|NCT01693562|532056297|FG009|Exploration Phase|Withdrawal by Subject|0|||
147519872|NCT01693562|532056298|FG010|Exploration Phase|Withdrawal by Subject|0|||
147519873|NCT01693562|532056299|FG011|Exploration Phase|Withdrawal by Subject|0|||
147519874|NCT01693562|532056300|FG012|Exploration Phase|Withdrawal by Subject|0|||
147519875|NCT01693562|532056301|FG013|Exploration Phase|Withdrawal by Subject|0|||
147519876|NCT01693562|532056302|FG014|Exploration Phase|Withdrawal by Subject|0|||
147519877|NCT01693562|532056303|FG015|Exploration Phase|Withdrawal by Subject|0|||
147519878|NCT01693562|532056304|FG016|Exploration Phase|Withdrawal by Subject|0|||
147519879|NCT01693562|532056305|FG017|Exploration Phase|Withdrawal by Subject|0|||
147519880|NCT01693562|532056306|FG018|Exploration Phase|Withdrawal by Subject|0|||
147519881|NCT01693562|532056307|FG019|Exploration Phase|Withdrawal by Subject|0|||
147519882|NCT01693562|532056308|FG020|Exploration Phase|Withdrawal by Subject|0|||
147519883|NCT01693562|532056309|FG021|Exploration Phase|Withdrawal by Subject|0|||
147519884|NCT01693562|532056310|FG022|Exploration Phase|Withdrawal by Subject|0|||
147519885|NCT01693562|532056288|FG000|Exploration Phase|Death|0|||
147519886|NCT01693562|532056289|FG001|Exploration Phase|Death|0|||
147519887|NCT01693562|532056290|FG002|Exploration Phase|Death|0|||
147519888|NCT01693562|532056291|FG003|Exploration Phase|Death|0|||
147519889|NCT01693562|532056292|FG004|Exploration Phase|Death|0|||
147519890|NCT01693562|532056293|FG005|Exploration Phase|Death|0|||
147519891|NCT01693562|532056294|FG006|Exploration Phase|Death|17|||
147519892|NCT01693562|532056295|FG007|Exploration Phase|Death|0|||
147519893|NCT01693562|532056296|FG008|Exploration Phase|Death|0|||
147519894|NCT01693562|532056297|FG009|Exploration Phase|Death|0|||
147519895|NCT01693562|532056298|FG010|Exploration Phase|Death|0|||
147519896|NCT01693562|532056299|FG011|Exploration Phase|Death|0|||
147519897|NCT01693562|532056300|FG012|Exploration Phase|Death|0|||
147519898|NCT01693562|532056301|FG013|Exploration Phase|Death|0|||
147519899|NCT01693562|532056302|FG014|Exploration Phase|Death|0|||
147519900|NCT01693562|532056303|FG015|Exploration Phase|Death|0|||
147519901|NCT01693562|532056304|FG016|Exploration Phase|Death|0|||
147642877|NCT05020899|532511077|FG000|8 Week Follow-up|Lost to Follow-up|3|||
147642878|NCT05020899|532511078|FG001|8 Week Follow-up|Lost to Follow-up|6|||
147642879|NCT05020899|532511077|FG000|12 Week Follow-up|Lost to Follow-up|1|||
147642880|NCT05020899|532511078|FG001|12 Week Follow-up|Lost to Follow-up|0|||
147642881|NCT05020899|532511077|FG000|12 Week Follow-up|Death|0|||
147642882|NCT05020899|532511078|FG001|12 Week Follow-up|Death|1|||
147642883|NCT01068626|532511081|FG000|Overall Study|Adverse Event|3|||
147519902|NCT01693562|532056305|FG017|Exploration Phase|Death|0|||
147519903|NCT01693562|532056306|FG018|Exploration Phase|Death|0|||
147519904|NCT01693562|532056307|FG019|Exploration Phase|Death|0|||
147519905|NCT01693562|532056308|FG020|Exploration Phase|Death|0|||
147519906|NCT01693562|532056309|FG021|Exploration Phase|Death|0|||
147642884|NCT01068626|532511082|FG001|Overall Study|Adverse Event|0|||
147519907|NCT01693562|532056310|FG022|Exploration Phase|Death|0|||
147519908|NCT01693562|532056288|FG000|Exploration Phase|Other|0|||
147519909|NCT01693562|532056289|FG001|Exploration Phase|Other|0|||
147519910|NCT01693562|532056290|FG002|Exploration Phase|Other|0|||
147519911|NCT01693562|532056291|FG003|Exploration Phase|Other|0|||
147519912|NCT01693562|532056292|FG004|Exploration Phase|Other|0|||
147519913|NCT01693562|532056293|FG005|Exploration Phase|Other|0|||
147519914|NCT01693562|532056294|FG006|Exploration Phase|Other|2|||
147519915|NCT01693562|532056295|FG007|Exploration Phase|Other|0|||
147519916|NCT01693562|532056296|FG008|Exploration Phase|Other|0|||
147642885|NCT01068626|532511081|FG000|Overall Study|Withdrawal by Subject|0|||
147519917|NCT01693562|532056297|FG009|Exploration Phase|Other|0|||
147519918|NCT01693562|532056298|FG010|Exploration Phase|Other|0|||
147519919|NCT01693562|532056299|FG011|Exploration Phase|Other|0|||
147519920|NCT01693562|532056300|FG012|Exploration Phase|Other|0|||
147519921|NCT01693562|532056301|FG013|Exploration Phase|Other|0|||
147519922|NCT01693562|532056302|FG014|Exploration Phase|Other|0|||
147519923|NCT01693562|532056303|FG015|Exploration Phase|Other|0|||
147519924|NCT01693562|532056304|FG016|Exploration Phase|Other|0|||
147519925|NCT01693562|532056305|FG017|Exploration Phase|Other|0|||
147519926|NCT01693562|532056306|FG018|Exploration Phase|Other|0|||
147519927|NCT01693562|532056307|FG019|Exploration Phase|Other|0|||
147519928|NCT01693562|532056308|FG020|Exploration Phase|Other|0|||
147519929|NCT01693562|532056309|FG021|Exploration Phase|Other|0|||
147519930|NCT01693562|532056310|FG022|Exploration Phase|Other|0|||
147519931|NCT01693562|532056288|FG000|Expansion Phase|Withdrawal by Subject|0|||
147519932|NCT01693562|532056289|FG001|Expansion Phase|Withdrawal by Subject|0|||
147519933|NCT01693562|532056290|FG002|Expansion Phase|Withdrawal by Subject|0|||
147519934|NCT01693562|532056291|FG003|Expansion Phase|Withdrawal by Subject|0|||
147519935|NCT01693562|532056292|FG004|Expansion Phase|Withdrawal by Subject|0|||
147519936|NCT01693562|532056293|FG005|Expansion Phase|Withdrawal by Subject|0|||
147519937|NCT01693562|532056294|FG006|Expansion Phase|Withdrawal by Subject|0|||
147519938|NCT01693562|532056295|FG007|Expansion Phase|Withdrawal by Subject|16|||
147519939|NCT01693562|532056296|FG008|Expansion Phase|Withdrawal by Subject|2|||
147519940|NCT01693562|532056297|FG009|Expansion Phase|Withdrawal by Subject|54|||
147519941|NCT01693562|532056298|FG010|Expansion Phase|Withdrawal by Subject|2|||
147519942|NCT01693562|532056299|FG011|Expansion Phase|Withdrawal by Subject|2|||
147519943|NCT01693562|532056300|FG012|Expansion Phase|Withdrawal by Subject|3|||
147519944|NCT01693562|532056301|FG013|Expansion Phase|Withdrawal by Subject|5|||
147519945|NCT01693562|532056302|FG014|Expansion Phase|Withdrawal by Subject|16|||
147519946|NCT01693562|532056303|FG015|Expansion Phase|Withdrawal by Subject|7|||
147519947|NCT01693562|532056304|FG016|Expansion Phase|Withdrawal by Subject|40|||
147519948|NCT01693562|532056305|FG017|Expansion Phase|Withdrawal by Subject|4|||
147519949|NCT01693562|532056306|FG018|Expansion Phase|Withdrawal by Subject|8|||
147519950|NCT01693562|532056307|FG019|Expansion Phase|Withdrawal by Subject|3|||
147519951|NCT01693562|532056308|FG020|Expansion Phase|Withdrawal by Subject|1|||
147519952|NCT01693562|532056309|FG021|Expansion Phase|Withdrawal by Subject|8|||
147519953|NCT01693562|532056310|FG022|Expansion Phase|Withdrawal by Subject|1|||
147519954|NCT01693562|532056288|FG000|Expansion Phase|Death|0|||
147519955|NCT01693562|532056289|FG001|Expansion Phase|Death|0|||
147519956|NCT01693562|532056290|FG002|Expansion Phase|Death|0|||
147519957|NCT01693562|532056291|FG003|Expansion Phase|Death|0|||
147519958|NCT01693562|532056292|FG004|Expansion Phase|Death|0|||
147519959|NCT01693562|532056293|FG005|Expansion Phase|Death|0|||
147519960|NCT01693562|532056294|FG006|Expansion Phase|Death|0|||
147519961|NCT01693562|532056295|FG007|Expansion Phase|Death|42|||
147519962|NCT01693562|532056296|FG008|Expansion Phase|Death|17|||
147519963|NCT01693562|532056297|FG009|Expansion Phase|Death|208|||
147519964|NCT01693562|532056298|FG010|Expansion Phase|Death|30|||
147519965|NCT01693562|532056299|FG011|Expansion Phase|Death|8|||
147519966|NCT01693562|532056300|FG012|Expansion Phase|Death|19|||
147519967|NCT01693562|532056301|FG013|Expansion Phase|Death|42|||
147519968|NCT01693562|532056302|FG014|Expansion Phase|Death|23|||
147519969|NCT01693562|532056303|FG015|Expansion Phase|Death|23|||
147519970|NCT01693562|532056304|FG016|Expansion Phase|Death|128|||
147519971|NCT01693562|532056305|FG017|Expansion Phase|Death|16|||
147519972|NCT01693562|532056306|FG018|Expansion Phase|Death|36|||
147519973|NCT01693562|532056307|FG019|Expansion Phase|Death|16|||
147519974|NCT01693562|532056308|FG020|Expansion Phase|Death|17|||
147519975|NCT01693562|532056309|FG021|Expansion Phase|Death|35|||
147519976|NCT01693562|532056310|FG022|Expansion Phase|Death|7|||
147519977|NCT01693562|532056288|FG000|Expansion Phase|Lost to Follow-up|0|||
147519978|NCT01693562|532056289|FG001|Expansion Phase|Lost to Follow-up|0|||
147519979|NCT01693562|532056290|FG002|Expansion Phase|Lost to Follow-up|0|||
147519980|NCT01693562|532056291|FG003|Expansion Phase|Lost to Follow-up|0|||
147519981|NCT01693562|532056292|FG004|Expansion Phase|Lost to Follow-up|0|||
147519982|NCT01693562|532056293|FG005|Expansion Phase|Lost to Follow-up|0|||
147519983|NCT01693562|532056294|FG006|Expansion Phase|Lost to Follow-up|0|||
147519984|NCT01693562|532056295|FG007|Expansion Phase|Lost to Follow-up|1|||
147519985|NCT01693562|532056296|FG008|Expansion Phase|Lost to Follow-up|2|||
147519986|NCT01693562|532056297|FG009|Expansion Phase|Lost to Follow-up|10|||
147519987|NCT01693562|532056298|FG010|Expansion Phase|Lost to Follow-up|4|||
147519988|NCT01693562|532056299|FG011|Expansion Phase|Lost to Follow-up|4|||
147519989|NCT01693562|532056300|FG012|Expansion Phase|Lost to Follow-up|1|||
147519990|NCT01693562|532056301|FG013|Expansion Phase|Lost to Follow-up|3|||
147519991|NCT01693562|532056302|FG014|Expansion Phase|Lost to Follow-up|0|||
147519992|NCT01693562|532056303|FG015|Expansion Phase|Lost to Follow-up|1|||
147519993|NCT01693562|532056304|FG016|Expansion Phase|Lost to Follow-up|1|||
147519994|NCT01693562|532056305|FG017|Expansion Phase|Lost to Follow-up|0|||
147519995|NCT01693562|532056306|FG018|Expansion Phase|Lost to Follow-up|2|||
147519996|NCT01693562|532056307|FG019|Expansion Phase|Lost to Follow-up|1|||
147519997|NCT01693562|532056308|FG020|Expansion Phase|Lost to Follow-up|2|||
147519998|NCT01693562|532056309|FG021|Expansion Phase|Lost to Follow-up|2|||
147519999|NCT01693562|532056310|FG022|Expansion Phase|Lost to Follow-up|1|||
147520000|NCT01693562|532056288|FG000|Expansion Phase|Other|0|||
147520001|NCT01693562|532056289|FG001|Expansion Phase|Other|0|||
147520002|NCT01693562|532056290|FG002|Expansion Phase|Other|0|||
147520003|NCT01693562|532056291|FG003|Expansion Phase|Other|0|||
147520004|NCT01693562|532056292|FG004|Expansion Phase|Other|0|||
147520005|NCT01693562|532056293|FG005|Expansion Phase|Other|0|||
147520006|NCT01693562|532056294|FG006|Expansion Phase|Other|0|||
147520007|NCT01693562|532056295|FG007|Expansion Phase|Other|3|||
147520008|NCT01693562|532056296|FG008|Expansion Phase|Other|1|||
147520009|NCT01693562|532056297|FG009|Expansion Phase|Other|28|||
147520010|NCT01693562|532056298|FG010|Expansion Phase|Other|4|||
147520011|NCT01693562|532056299|FG011|Expansion Phase|Other|7|||
147520012|NCT01693562|532056300|FG012|Expansion Phase|Other|0|||
147520013|NCT01693562|532056301|FG013|Expansion Phase|Other|1|||
147520014|NCT01693562|532056302|FG014|Expansion Phase|Other|1|||
147520015|NCT01693562|532056303|FG015|Expansion Phase|Other|0|||
147520016|NCT01693562|532056304|FG016|Expansion Phase|Other|28|||
147520017|NCT01693562|532056305|FG017|Expansion Phase|Other|0|||
147520018|NCT01693562|532056306|FG018|Expansion Phase|Other|1|||
147520019|NCT01693562|532056307|FG019|Expansion Phase|Other|0|||
147520020|NCT01693562|532056308|FG020|Expansion Phase|Other|1|||
147520021|NCT01693562|532056309|FG021|Expansion Phase|Other|17|||
147520022|NCT01693562|532056310|FG022|Expansion Phase|Other|1|||
147520023|NCT02759939|532056311|FG000|Overall Study|Missing data on first outcome assessed|11|||
147520024|NCT02759939|532056312|FG001|Overall Study|Missing data on first outcome assessed|2|||
147520025|NCT02759939|532056313|FG002|Overall Study|Missing data on first outcome assessed|5|||
147520026|NCT02759939|532056314|FG003|Overall Study|Missing data on first outcome assessed|2|||
147520027|NCT02759939|532056311|FG000|Overall Study|Ineligible for T2 and T3|310|||
147520028|NCT02759939|532056312|FG001|Overall Study|Ineligible for T2 and T3|179|||
147520029|NCT02759939|532056313|FG002|Overall Study|Ineligible for T2 and T3|366|||
147520030|NCT02759939|532056314|FG003|Overall Study|Ineligible for T2 and T3|391|||
147520031|NCT02759939|532056311|FG000|Overall Study|Lost to Follow-up|735|||
147520032|NCT02759939|532056312|FG001|Overall Study|Lost to Follow-up|791|||
147520033|NCT02759939|532056313|FG002|Overall Study|Lost to Follow-up|783|||
147520034|NCT02759939|532056314|FG003|Overall Study|Lost to Follow-up|650|||
147520035|NCT00087594|532056315|FG000|Overall Study|Adverse Event|2|||
147520036|NCT00087594|532056316|FG001|Overall Study|Adverse Event|3|||
147520037|NCT00087594|532056315|FG000|Overall Study|Lost to Follow-up|0|||
147520038|NCT00087594|532056316|FG001|Overall Study|Lost to Follow-up|2|||
147520039|NCT00087594|532056315|FG000|Overall Study|Withdrawal by Subject|4|||
147520040|NCT00087594|532056316|FG001|Overall Study|Withdrawal by Subject|2|||
147520041|NCT00087594|532056315|FG000|Overall Study|Lack of Efficacy|2|||
147520042|NCT00087594|532056316|FG001|Overall Study|Lack of Efficacy|5|||
147520043|NCT00768040|532056317|FG000|Overall Study|Adverse Event|3|||
147520044|NCT00768040|532056318|FG001|Overall Study|Adverse Event|2|||
147520045|NCT00768040|532056317|FG000|Overall Study|Abnormal laboratory value|1|||
147520046|NCT00768040|532056318|FG001|Overall Study|Abnormal laboratory value|1|||
147520047|NCT03347279|532056320|FG000|Overall Study|Withdrawal by Subject|8|||
147520048|NCT03347279|532056321|FG001|Overall Study|Withdrawal by Subject|15|||
147520049|NCT03347279|532056320|FG000|Overall Study|Death|0|||
147520050|NCT03347279|532056321|FG001|Overall Study|Death|2|||
147520051|NCT03347279|532056320|FG000|Overall Study|Lost to Follow-up|5|||
147520052|NCT03347279|532056321|FG001|Overall Study|Lost to Follow-up|2|||
147520053|NCT03347279|532056320|FG000|Overall Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|3|||
147520054|NCT03347279|532056321|FG001|Overall Study|Did not receive treatment / Non-compliance with protocol / did not complete safety follow-up visits|4|||
147520055|NCT03558503|532056325|FG000|Overall Study|Adverse Event|1|||
147520056|NCT03558503|532056325|FG000|Overall Study|Death|1|||
147520057|NCT03558503|532056325|FG000|Overall Study|Refused to come in for the final 12-month assessment due to COVID-19|1|||
147520058|NCT02094612|532056326|FG000|Overall Study|Lost to Follow-up|47|||
147520059|NCT02094612|532056327|FG001|Overall Study|Lost to Follow-up|47|||
147520060|NCT02094612|532056326|FG000|Overall Study|Never started ADHD medication|32|||
147520061|NCT02094612|532056327|FG001|Overall Study|Never started ADHD medication|23|||
147520062|NCT01542632|532056328|FG000|Overall Study|Withdrawal of Consent|0|||
147520063|NCT01542632|532056329|FG001|Overall Study|Withdrawal of Consent|0|||
147520064|NCT01542632|532056330|FG002|Overall Study|Withdrawal of Consent|0|||
147520065|NCT01542632|532056331|FG003|Overall Study|Withdrawal of Consent|2|||
147520066|NCT01542632|532056332|FG004|Overall Study|Withdrawal of Consent|3|||
147520067|NCT01542632|532056333|FG005|Overall Study|Withdrawal of Consent|0|||
147520068|NCT01542632|532056328|FG000|Overall Study|Adverse Event|0|||
147520069|NCT01542632|532056329|FG001|Overall Study|Adverse Event|0|||
147520070|NCT01542632|532056330|FG002|Overall Study|Adverse Event|1|||
147520071|NCT01542632|532056331|FG003|Overall Study|Adverse Event|0|||
147520072|NCT01542632|532056332|FG004|Overall Study|Adverse Event|0|||
147520073|NCT01542632|532056333|FG005|Overall Study|Adverse Event|0|||
147520074|NCT01542632|532056328|FG000|Overall Study|Lost to Follow-up|0|||
147520075|NCT01542632|532056329|FG001|Overall Study|Lost to Follow-up|1|||
147520076|NCT01542632|532056330|FG002|Overall Study|Lost to Follow-up|0|||
147520077|NCT01542632|532056331|FG003|Overall Study|Lost to Follow-up|0|||
147520078|NCT01542632|532056332|FG004|Overall Study|Lost to Follow-up|0|||
147520079|NCT01542632|532056333|FG005|Overall Study|Lost to Follow-up|0|||
147520080|NCT01542632|532056328|FG000|Overall Study|Sponsor/Investigator Decision|0|||
147520081|NCT01542632|532056329|FG001|Overall Study|Sponsor/Investigator Decision|0|||
147520082|NCT01542632|532056330|FG002|Overall Study|Sponsor/Investigator Decision|0|||
147520083|NCT01542632|532056331|FG003|Overall Study|Sponsor/Investigator Decision|0|||
147520084|NCT01542632|532056332|FG004|Overall Study|Sponsor/Investigator Decision|1|||
147520085|NCT01542632|532056333|FG005|Overall Study|Sponsor/Investigator Decision|0|||
147520086|NCT03991936|532056334|FG000|Overall Study|Lost to Follow-up|1|||
147520087|NCT03991936|532056335|FG001|Overall Study|Lost to Follow-up|1|||
147520088|NCT03991936|532056336|FG002|Overall Study|Lost to Follow-up|1|||
147520089|NCT03991936|532056337|FG003|Overall Study|Lost to Follow-up|1|||
147520090|NCT03991936|532056338|FG004|Overall Study|Lost to Follow-up|1|||
147520091|NCT02773849|532056340|FG000|Overall Study|Lost to Follow-up|11|||
147520092|NCT02773849|532056340|FG000|Overall Study|Death|26|||
147520093|NCT02773849|532056340|FG000|Overall Study|Withdrawal by Subject|5|||
147520094|NCT02773849|532056340|FG000|Overall Study|Withdrawal of Consent|9|||
147520095|NCT02773849|532056340|FG000|Overall Study|Other: not due to lack of tolerability|11|||
147520096|NCT01685372|532056351|FG000|Timepoint 3 (T3): 3rd Blood Draw|Lost to Follow-up|3|||
147520097|NCT01685372|532056352|FG001|Timepoint 3 (T3): 3rd Blood Draw|Lost to Follow-up|4|||
147520098|NCT02477800|532056353|FG000|Placebo-Controlled Period|Adverse Event|16|||
147520099|NCT02477800|532056354|FG001|Placebo-Controlled Period|Adverse Event|25|||
147520100|NCT02477800|532056355|FG002|Placebo-Controlled Period|Adverse Event|28|||
147520101|NCT02477800|532056356|FG003|Placebo-Controlled Period|Adverse Event|0|||
147520102|NCT02477800|532056357|FG004|Placebo-Controlled Period|Adverse Event|0|||
147642886|NCT01068626|532511082|FG001|Overall Study|Withdrawal by Subject|2|||
147642887|NCT01785849|532511083|FG000|Overall Study|Death|7|||
147642888|NCT01785849|532511084|FG001|Overall Study|Death|9|||
147642889|NCT01785849|532511083|FG000|Overall Study|Protocol Specified Criteria|29|||
147642890|NCT01785849|532511084|FG001|Overall Study|Protocol Specified Criteria|1|||
147642891|NCT01785849|532511083|FG000|Overall Study|Withdrawal by Subject|15|||
147642892|NCT01785849|532511084|FG001|Overall Study|Withdrawal by Subject|12|||
147642893|NCT01785849|532511083|FG000|Overall Study|Sponsor Decision|0|||
147642894|NCT01785849|532511084|FG001|Overall Study|Sponsor Decision|1|||
147642895|NCT01785849|532511083|FG000|Overall Study|Lost to Follow-up|10|||
147642896|NCT01785849|532511084|FG001|Overall Study|Lost to Follow-up|11|||
147642897|NCT01940900|532511085|FG000|Overall Study|Physician Decision|4|||
147642898|NCT01940900|532511086|FG001|Overall Study|Physician Decision|0|||
147642899|NCT01940900|532511085|FG000|Overall Study|Adverse Event|10|||
147642900|NCT01940900|532511086|FG001|Overall Study|Adverse Event|15|||
147642901|NCT01940900|532511085|FG000|Overall Study|Withdrawal by Subject|11|||
147642902|NCT01940900|532511086|FG001|Overall Study|Withdrawal by Subject|15|||
147642903|NCT01940900|532511085|FG000|Overall Study|Lost to Follow-up|1|||
147642904|NCT01940900|532511086|FG001|Overall Study|Lost to Follow-up|0|||
147642905|NCT01940900|532511085|FG000|Overall Study|Sponsor Decision|1|||
147520103|NCT02477800|532056358|FG005|Placebo-Controlled Period|Adverse Event|0|||
147520104|NCT02477800|532056359|FG006|Placebo-Controlled Period|Adverse Event|0|||
147642906|NCT01940900|532511086|FG001|Overall Study|Sponsor Decision|0|||
147642907|NCT01940900|532511085|FG000|Overall Study|subject non-compliance|1|||
147642908|NCT01940900|532511086|FG001|Overall Study|subject non-compliance|1|||
147642909|NCT01940900|532511085|FG000|Overall Study|other|1|||
147642910|NCT01940900|532511086|FG001|Overall Study|other|0|||
147520105|NCT02477800|532056353|FG000|Placebo-Controlled Period|Change of Treatment|1|||
147520106|NCT02477800|532056354|FG001|Placebo-Controlled Period|Change of Treatment|2|||
147520107|NCT02477800|532056355|FG002|Placebo-Controlled Period|Change of Treatment|1|||
147520108|NCT02477800|532056356|FG003|Placebo-Controlled Period|Change of Treatment|0|||
147520109|NCT02477800|532056357|FG004|Placebo-Controlled Period|Change of Treatment|0|||
147520110|NCT02477800|532056358|FG005|Placebo-Controlled Period|Change of Treatment|0|||
147520111|NCT02477800|532056359|FG006|Placebo-Controlled Period|Change of Treatment|0|||
147520112|NCT02477800|532056353|FG000|Placebo-Controlled Period|Consent Withdrawn|26|||
147520113|NCT02477800|532056354|FG001|Placebo-Controlled Period|Consent Withdrawn|16|||
147520114|NCT02477800|532056355|FG002|Placebo-Controlled Period|Consent Withdrawn|27|||
147520115|NCT02477800|532056356|FG003|Placebo-Controlled Period|Consent Withdrawn|0|||
147520116|NCT02477800|532056357|FG004|Placebo-Controlled Period|Consent Withdrawn|0|||
147520117|NCT02477800|532056358|FG005|Placebo-Controlled Period|Consent Withdrawn|0|||
147520118|NCT02477800|532056359|FG006|Placebo-Controlled Period|Consent Withdrawn|0|||
147520119|NCT02477800|532056353|FG000|Placebo-Controlled Period|Death|0|||
147520120|NCT02477800|532056354|FG001|Placebo-Controlled Period|Death|3|||
147520121|NCT02477800|532056355|FG002|Placebo-Controlled Period|Death|2|||
147520122|NCT02477800|532056356|FG003|Placebo-Controlled Period|Death|0|||
147520123|NCT02477800|532056357|FG004|Placebo-Controlled Period|Death|0|||
147520124|NCT02477800|532056358|FG005|Placebo-Controlled Period|Death|0|||
147520125|NCT02477800|532056359|FG006|Placebo-Controlled Period|Death|0|||
147520126|NCT02477800|532056353|FG000|Placebo-Controlled Period|Disease Progression|1|||
147520127|NCT02477800|532056354|FG001|Placebo-Controlled Period|Disease Progression|0|||
147520128|NCT02477800|532056355|FG002|Placebo-Controlled Period|Disease Progression|1|||
147520129|NCT02477800|532056356|FG003|Placebo-Controlled Period|Disease Progression|0|||
147520130|NCT02477800|532056357|FG004|Placebo-Controlled Period|Disease Progression|0|||
147520131|NCT02477800|532056358|FG005|Placebo-Controlled Period|Disease Progression|0|||
147520132|NCT02477800|532056359|FG006|Placebo-Controlled Period|Disease Progression|0|||
147520133|NCT02477800|532056353|FG000|Placebo-Controlled Period|Investigator Decision|3|||
147520134|NCT02477800|532056354|FG001|Placebo-Controlled Period|Investigator Decision|2|||
147520135|NCT02477800|532056355|FG002|Placebo-Controlled Period|Investigator Decision|1|||
147520136|NCT02477800|532056356|FG003|Placebo-Controlled Period|Investigator Decision|0|||
147520137|NCT02477800|532056357|FG004|Placebo-Controlled Period|Investigator Decision|0|||
147520138|NCT02477800|532056358|FG005|Placebo-Controlled Period|Investigator Decision|0|||
147520139|NCT02477800|532056359|FG006|Placebo-Controlled Period|Investigator Decision|0|||
147520140|NCT02477800|532056353|FG000|Placebo-Controlled Period|Lost to Follow-up|1|||
147520141|NCT02477800|532056354|FG001|Placebo-Controlled Period|Lost to Follow-up|3|||
147520142|NCT02477800|532056355|FG002|Placebo-Controlled Period|Lost to Follow-up|3|||
147520143|NCT02477800|532056356|FG003|Placebo-Controlled Period|Lost to Follow-up|0|||
147520144|NCT02477800|532056357|FG004|Placebo-Controlled Period|Lost to Follow-up|0|||
147520145|NCT02477800|532056358|FG005|Placebo-Controlled Period|Lost to Follow-up|0|||
147520146|NCT02477800|532056359|FG006|Placebo-Controlled Period|Lost to Follow-up|0|||
147520147|NCT02477800|532056353|FG000|Placebo-Controlled Period|Relocation|2|||
147520148|NCT02477800|532056354|FG001|Placebo-Controlled Period|Relocation|0|||
147520149|NCT02477800|532056355|FG002|Placebo-Controlled Period|Relocation|0|||
147520150|NCT02477800|532056356|FG003|Placebo-Controlled Period|Relocation|0|||
147520151|NCT02477800|532056357|FG004|Placebo-Controlled Period|Relocation|0|||
147520152|NCT02477800|532056358|FG005|Placebo-Controlled Period|Relocation|0|||
147520153|NCT02477800|532056359|FG006|Placebo-Controlled Period|Relocation|0|||
147520154|NCT02477800|532056353|FG000|Placebo-Controlled Period|Site Terminated by Investigator|1|||
147520155|NCT02477800|532056354|FG001|Placebo-Controlled Period|Site Terminated by Investigator|1|||
147520156|NCT02477800|532056355|FG002|Placebo-Controlled Period|Site Terminated by Investigator|1|||
147520157|NCT02477800|532056356|FG003|Placebo-Controlled Period|Site Terminated by Investigator|0|||
147520158|NCT02477800|532056357|FG004|Placebo-Controlled Period|Site Terminated by Investigator|0|||
147520159|NCT02477800|532056358|FG005|Placebo-Controlled Period|Site Terminated by Investigator|0|||
147520160|NCT02477800|532056359|FG006|Placebo-Controlled Period|Site Terminated by Investigator|0|||
147520161|NCT02477800|532056353|FG000|Placebo-Controlled Period|Site Terminated by Sponsor|2|||
147520162|NCT02477800|532056354|FG001|Placebo-Controlled Period|Site Terminated by Sponsor|1|||
147520163|NCT02477800|532056355|FG002|Placebo-Controlled Period|Site Terminated by Sponsor|0|||
147520164|NCT02477800|532056356|FG003|Placebo-Controlled Period|Site Terminated by Sponsor|0|||
147520165|NCT02477800|532056357|FG004|Placebo-Controlled Period|Site Terminated by Sponsor|0|||
147520166|NCT02477800|532056358|FG005|Placebo-Controlled Period|Site Terminated by Sponsor|0|||
147520167|NCT02477800|532056359|FG006|Placebo-Controlled Period|Site Terminated by Sponsor|0|||
147520168|NCT02477800|532056353|FG000|Placebo-Controlled Period|Study Visit Burden|5|||
147642911|NCT02431806|532511089|FG000|Double-blind Treatment Period|Did not Receive Treatment|1|||
147642912|NCT02431806|532511090|FG001|Double-blind Treatment Period|Did not Receive Treatment|2|||
147642913|NCT02431806|532511091|FG002|Double-blind Treatment Period|Did not Receive Treatment|1|||
147642914|NCT02431806|532511092|FG003|Double-blind Treatment Period|Did not Receive Treatment|1|||
147642915|NCT02431806|532511089|FG000|Double-blind Treatment Period|Adverse Event|4|||
147642916|NCT02431806|532511090|FG001|Double-blind Treatment Period|Adverse Event|7|||
147520169|NCT02477800|532056354|FG001|Placebo-Controlled Period|Study Visit Burden|3|||
147520170|NCT02477800|532056355|FG002|Placebo-Controlled Period|Study Visit Burden|11|||
147520171|NCT02477800|532056356|FG003|Placebo-Controlled Period|Study Visit Burden|0|||
147520172|NCT02477800|532056357|FG004|Placebo-Controlled Period|Study Visit Burden|0|||
147520173|NCT02477800|532056358|FG005|Placebo-Controlled Period|Study Visit Burden|0|||
147520174|NCT02477800|532056359|FG006|Placebo-Controlled Period|Study Visit Burden|0|||
147520175|NCT02477800|532056353|FG000|Placebo-Controlled Period|Withdrawal by Parent/Guardian|1|||
147520176|NCT02477800|532056354|FG001|Placebo-Controlled Period|Withdrawal by Parent/Guardian|5|||
147520177|NCT02477800|532056355|FG002|Placebo-Controlled Period|Withdrawal by Parent/Guardian|3|||
147520178|NCT02477800|532056356|FG003|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
147520179|NCT02477800|532056357|FG004|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
147520180|NCT02477800|532056358|FG005|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
147520181|NCT02477800|532056359|FG006|Placebo-Controlled Period|Withdrawal by Parent/Guardian|0|||
147520182|NCT02477800|532056353|FG000|Placebo-Controlled Period|Reason not Specified|161|||
147520183|NCT02477800|532056354|FG001|Placebo-Controlled Period|Reason not Specified|161|||
147520184|NCT02477800|532056355|FG002|Placebo-Controlled Period|Reason not Specified|189|||
147520185|NCT02477800|532056356|FG003|Placebo-Controlled Period|Reason not Specified|0|||
147520186|NCT02477800|532056357|FG004|Placebo-Controlled Period|Reason not Specified|0|||
147520187|NCT02477800|532056358|FG005|Placebo-Controlled Period|Reason not Specified|0|||
147520188|NCT02477800|532056359|FG006|Placebo-Controlled Period|Reason not Specified|0|||
147520189|NCT02477800|532056353|FG000|Long Term Extension Period|Adverse Event|0|||
147520190|NCT02477800|532056354|FG001|Long Term Extension Period|Adverse Event|0|||
147520191|NCT02477800|532056355|FG002|Long Term Extension Period|Adverse Event|0|||
147520192|NCT02477800|532056356|FG003|Long Term Extension Period|Adverse Event|6|||
147520193|NCT02477800|532056357|FG004|Long Term Extension Period|Adverse Event|2|||
147520194|NCT02477800|532056358|FG005|Long Term Extension Period|Adverse Event|4|||
147520195|NCT02477800|532056359|FG006|Long Term Extension Period|Adverse Event|3|||
147520196|NCT02477800|532056353|FG000|Long Term Extension Period|Death|0|||
147520197|NCT02477800|532056354|FG001|Long Term Extension Period|Death|0|||
147520198|NCT02477800|532056355|FG002|Long Term Extension Period|Death|0|||
147520199|NCT02477800|532056356|FG003|Long Term Extension Period|Death|1|||
147520200|NCT02477800|532056357|FG004|Long Term Extension Period|Death|1|||
147520201|NCT02477800|532056358|FG005|Long Term Extension Period|Death|1|||
147520202|NCT02477800|532056359|FG006|Long Term Extension Period|Death|2|||
147520203|NCT02477800|532056353|FG000|Long Term Extension Period|Consent Withdrawn|0|||
147520204|NCT02477800|532056354|FG001|Long Term Extension Period|Consent Withdrawn|0|||
147520205|NCT02477800|532056355|FG002|Long Term Extension Period|Consent Withdrawn|0|||
147520206|NCT02477800|532056356|FG003|Long Term Extension Period|Consent Withdrawn|10|||
147520207|NCT02477800|532056357|FG004|Long Term Extension Period|Consent Withdrawn|4|||
147520208|NCT02477800|532056358|FG005|Long Term Extension Period|Consent Withdrawn|13|||
147520209|NCT02477800|532056359|FG006|Long Term Extension Period|Consent Withdrawn|16|||
147520210|NCT02477800|532056353|FG000|Long Term Extension Period|Disease Progression|0|||
147520211|NCT02477800|532056354|FG001|Long Term Extension Period|Disease Progression|0|||
147520212|NCT02477800|532056355|FG002|Long Term Extension Period|Disease Progression|0|||
147520213|NCT02477800|532056356|FG003|Long Term Extension Period|Disease Progression|3|||
147520214|NCT02477800|532056357|FG004|Long Term Extension Period|Disease Progression|1|||
147520215|NCT02477800|532056358|FG005|Long Term Extension Period|Disease Progression|1|||
147520216|NCT02477800|532056359|FG006|Long Term Extension Period|Disease Progression|0|||
147520217|NCT02477800|532056353|FG000|Long Term Extension Period|Investigator Decision|0|||
147520218|NCT02477800|532056354|FG001|Long Term Extension Period|Investigator Decision|0|||
147520219|NCT02477800|532056355|FG002|Long Term Extension Period|Investigator Decision|0|||
147520220|NCT02477800|532056356|FG003|Long Term Extension Period|Investigator Decision|0|||
147520221|NCT02477800|532056357|FG004|Long Term Extension Period|Investigator Decision|0|||
147520222|NCT02477800|532056358|FG005|Long Term Extension Period|Investigator Decision|0|||
147520223|NCT02477800|532056359|FG006|Long Term Extension Period|Investigator Decision|2|||
147520224|NCT02477800|532056353|FG000|Long Term Extension Period|Lost to Follow-up|0|||
147520225|NCT02477800|532056354|FG001|Long Term Extension Period|Lost to Follow-up|0|||
147520226|NCT02477800|532056355|FG002|Long Term Extension Period|Lost to Follow-up|0|||
147520227|NCT02477800|532056356|FG003|Long Term Extension Period|Lost to Follow-up|0|||
147520228|NCT02477800|532056357|FG004|Long Term Extension Period|Lost to Follow-up|1|||
147520229|NCT02477800|532056358|FG005|Long Term Extension Period|Lost to Follow-up|3|||
147520230|NCT02477800|532056359|FG006|Long Term Extension Period|Lost to Follow-up|0|||
147520231|NCT02477800|532056353|FG000|Long Term Extension Period|Site Terminated By Sponsor|0|||
147520232|NCT02477800|532056354|FG001|Long Term Extension Period|Site Terminated By Sponsor|0|||
147520233|NCT02477800|532056355|FG002|Long Term Extension Period|Site Terminated By Sponsor|0|||
147520234|NCT02477800|532056356|FG003|Long Term Extension Period|Site Terminated By Sponsor|0|||
147520235|NCT02477800|532056357|FG004|Long Term Extension Period|Site Terminated By Sponsor|0|||
147520236|NCT02477800|532056358|FG005|Long Term Extension Period|Site Terminated By Sponsor|2|||
147520237|NCT02477800|532056359|FG006|Long Term Extension Period|Site Terminated By Sponsor|1|||
147520238|NCT02477800|532056353|FG000|Long Term Extension Period|Study Visit Burden|0|||
147520239|NCT02477800|532056354|FG001|Long Term Extension Period|Study Visit Burden|0|||
147520240|NCT02477800|532056355|FG002|Long Term Extension Period|Study Visit Burden|0|||
147520241|NCT02477800|532056356|FG003|Long Term Extension Period|Study Visit Burden|3|||
147520242|NCT02477800|532056357|FG004|Long Term Extension Period|Study Visit Burden|0|||
147520243|NCT02477800|532056358|FG005|Long Term Extension Period|Study Visit Burden|2|||
147520244|NCT02477800|532056359|FG006|Long Term Extension Period|Study Visit Burden|2|||
147520245|NCT02477800|532056353|FG000|Long Term Extension Period|Withdrawal by Parent/Guardian|0|||
147520246|NCT02477800|532056354|FG001|Long Term Extension Period|Withdrawal by Parent/Guardian|0|||
147520247|NCT02477800|532056355|FG002|Long Term Extension Period|Withdrawal by Parent/Guardian|0|||
147520248|NCT02477800|532056356|FG003|Long Term Extension Period|Withdrawal by Parent/Guardian|1|||
147520249|NCT02477800|532056357|FG004|Long Term Extension Period|Withdrawal by Parent/Guardian|3|||
147520250|NCT02477800|532056358|FG005|Long Term Extension Period|Withdrawal by Parent/Guardian|3|||
147520251|NCT02477800|532056359|FG006|Long Term Extension Period|Withdrawal by Parent/Guardian|1|||
147520252|NCT02477800|532056353|FG000|Long Term Extension Period|Reason not Specified|0|||
147520253|NCT02477800|532056354|FG001|Long Term Extension Period|Reason not Specified|0|||
147520254|NCT02477800|532056355|FG002|Long Term Extension Period|Reason not Specified|0|||
147520255|NCT02477800|532056356|FG003|Long Term Extension Period|Reason not Specified|126|||
147520256|NCT02477800|532056357|FG004|Long Term Extension Period|Reason not Specified|140|||
147520257|NCT02477800|532056358|FG005|Long Term Extension Period|Reason not Specified|270|||
147520258|NCT02477800|532056359|FG006|Long Term Extension Period|Reason not Specified|224|||
147520259|NCT00129376|532056360|FG000|Overall Study|Adverse Event|1|||
147520260|NCT00129376|532056360|FG000|Overall Study|Lack of Efficacy|1|||
147520261|NCT02061540|532056361|FG000|Overall Study|Adverse Event|2|||
147520262|NCT02061540|532056361|FG000|Overall Study|Withdrawal by Subject|2|||
147520263|NCT02289833|532056363|FG000|Overall Study|Study discontinuation|0|||
147520264|NCT02289833|532056364|FG001|Overall Study|Study discontinuation|1|||
147520265|NCT02289833|532056363|FG000|Overall Study|Lost to Follow-up|4|||
147520266|NCT02289833|532056364|FG001|Overall Study|Lost to Follow-up|0|||
147520267|NCT02289833|532056363|FG000|Overall Study|Death|23|||
147520268|NCT02289833|532056364|FG001|Overall Study|Death|16|||
147520269|NCT02561273|532056371|FG000|Overall Study|Protocol Violation|1|||
147520270|NCT02561273|532056372|FG001|Overall Study|Protocol Violation|0|||
147520271|NCT02723019|532056373|FG000|Overall Study|Death|17|||
147520272|NCT02723019|532056374|FG001|Overall Study|Death|13|||
147520273|NCT02723019|532056373|FG000|Overall Study|Withdrawal by Subject|11|||
147520274|NCT02723019|532056374|FG001|Overall Study|Withdrawal by Subject|7|||
147520275|NCT02723019|532056373|FG000|Overall Study|Lost to Follow-up|57|||
147520276|NCT02723019|532056374|FG001|Overall Study|Lost to Follow-up|70|||
147520277|NCT00958191|532056376|FG000|Overall Study|Death|4|||
147520278|NCT00958191|532056376|FG000|Overall Study|Lost to Follow-up|5|||
147520279|NCT00958191|532056376|FG000|Overall Study|Inadequate 5 yr x-ray quality|10|||
147520280|NCT00958191|532056376|FG000|Overall Study|Unable/Unwilling to Return/Withdrawal|21|||
147520281|NCT00958191|532056376|FG000|Overall Study|Revision of study device|4|||
147520282|NCT00958191|532056376|FG000|Overall Study|Site termination|11|||
147520283|NCT00958191|532056376|FG000|Overall Study|No 5 yr x-rays|56|||
147520284|NCT00611767|532056377|FG000|Overall Study|Withdrawal by Subject|4|||
147520285|NCT00611767|532056378|FG001|Overall Study|Withdrawal by Subject|1|||
147520286|NCT00611767|532056377|FG000|Overall Study|Thiopental not available|3|||
147520287|NCT00611767|532056378|FG001|Overall Study|Thiopental not available|0|||
147520288|NCT00611767|532056377|FG000|Overall Study|didn't like the medication|1|||
147520289|NCT00611767|532056378|FG001|Overall Study|didn't like the medication|1|||
147520290|NCT00611767|532056377|FG000|Overall Study|Physician Decision|1|||
147520291|NCT00611767|532056378|FG001|Overall Study|Physician Decision|0|||
147520292|NCT01642004|532056379|FG000|Randomization|Adverse Event unrelated to study drug|1|||
147520293|NCT01642004|532056380|FG001|Randomization|Adverse Event unrelated to study drug|0|||
147520294|NCT01642004|532056379|FG000|Randomization|Participant withdrew consent|1|||
147520295|NCT01642004|532056380|FG001|Randomization|Participant withdrew consent|6|||
147520296|NCT01642004|532056379|FG000|Randomization|No longer meets study criteria|2|||
147520297|NCT01642004|532056380|FG001|Randomization|No longer meets study criteria|2|||
147520298|NCT01642004|532056379|FG000|Treatment|Disease progression|95|||
147520299|NCT01642004|532056380|FG001|Treatment|Disease progression|79|||
147520300|NCT01642004|532056379|FG000|Treatment|Study drug toxicity|10|||
147520301|NCT01642004|532056380|FG001|Treatment|Study drug toxicity|13|||
147520302|NCT01642004|532056379|FG000|Treatment|Death|1|||
147520303|NCT01642004|532056380|FG001|Treatment|Death|1|||
147520304|NCT01642004|532056379|FG000|Treatment|Adverse event unrelated to study drug|9|||
147520305|NCT01642004|532056380|FG001|Treatment|Adverse event unrelated to study drug|13|||
147520306|NCT01642004|532056379|FG000|Treatment|Maximum clinical benefit|1|||
147520307|NCT01642004|532056380|FG001|Treatment|Maximum clinical benefit|9|||
147520308|NCT01642004|532056379|FG000|Treatment|Poor/non-compliance|1|||
147520309|NCT01642004|532056380|FG001|Treatment|Poor/non-compliance|0|||
147520310|NCT01642004|532056379|FG000|Treatment|No longer meets study criteria|1|||
147520311|NCT01642004|532056380|FG001|Treatment|No longer meets study criteria|2|||
147520312|NCT01642004|532056379|FG000|Treatment|Other reasons|2|||
147520313|NCT01642004|532056380|FG001|Treatment|Other reasons|0|||
147418036|NCT00506441|531694577|FG001|Period 1; Open-label Period|Lack of Efficacy|0|||
147418037|NCT00506441|531694576|FG000|Period 1; Open-label Period|Lost to Follow-up|2|||
147418038|NCT00506441|531694577|FG001|Period 1; Open-label Period|Lost to Follow-up|0|||
147418039|NCT00506441|531694576|FG000|Period 1; Open-label Period|Physician Decision|5|||
147418040|NCT00506441|531694577|FG001|Period 1; Open-label Period|Physician Decision|0|||
147418041|NCT00506441|531694576|FG000|Period 1; Open-label Period|Protocol Violation|9|||
147418042|NCT00506441|531694577|FG001|Period 1; Open-label Period|Protocol Violation|0|||
147418043|NCT00506441|531694576|FG000|Period 1; Open-label Period|Withdrawal by Subject|13|||
147418044|NCT00506441|531694577|FG001|Period 1; Open-label Period|Withdrawal by Subject|0|||
147418045|NCT00506441|531694576|FG000|Period 1; Open-label Period|Other Reasons|13|||
147418046|NCT00506441|531694577|FG001|Period 1; Open-label Period|Other Reasons|0|||
147418047|NCT00506441|531694576|FG000|Period 2; Double-blind Period|Adverse Event|0|||
147418048|NCT00506441|531694577|FG001|Period 2; Double-blind Period|Adverse Event|1|||
147418049|NCT00506441|531694576|FG000|Period 2; Double-blind Period|Lack of Efficacy|0|||
147418050|NCT00506441|531694577|FG001|Period 2; Double-blind Period|Lack of Efficacy|2|||
147418051|NCT00506441|531694576|FG000|Period 2; Double-blind Period|Physician Decision|1|||
147418052|NCT00506441|531694577|FG001|Period 2; Double-blind Period|Physician Decision|1|||
147418053|NCT00506441|531694576|FG000|Period 2; Double-blind Period|Withdrawal by Subject|1|||
147418054|NCT00506441|531694577|FG001|Period 2; Double-blind Period|Withdrawal by Subject|0|||
147418055|NCT00506441|531694576|FG000|Period 2; Double-blind Period|Other Reason|1|||
147418056|NCT00506441|531694577|FG001|Period 2; Double-blind Period|Other Reason|1|||
147418057|NCT01151410|531694579|FG000|Overall Study|Withdrawal by Subject|3|||
147418058|NCT01151410|531694580|FG001|Overall Study|Withdrawal by Subject|5|||
147418059|NCT01151410|531694579|FG000|Overall Study|Lost to Follow-up|3|||
147418060|NCT01151410|531694580|FG001|Overall Study|Lost to Follow-up|4|||
147418061|NCT01151410|531694579|FG000|Overall Study|Adverse Event|1|||
147418062|NCT01151410|531694580|FG001|Overall Study|Adverse Event|2|||
147418063|NCT01151410|531694579|FG000|Overall Study|Protocol deviation|2|||
147418064|NCT01151410|531694580|FG001|Overall Study|Protocol deviation|1|||
147418065|NCT01151410|531694579|FG000|Overall Study|Administrative problems|1|||
147418066|NCT01151410|531694580|FG001|Overall Study|Administrative problems|1|||
147418067|NCT01151410|531694579|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
147418068|NCT01151410|531694580|FG001|Overall Study|Unsatisfactory therapeutic effect|1|||
147418069|NCT01151410|531694579|FG000|Overall Study|Abnormal laboratory value(s)|0|||
147418070|NCT01151410|531694580|FG001|Overall Study|Abnormal laboratory value(s)|1|||
147418071|NCT01820585|531694581|FG000|Overall Study|Adverse Event|9|||
147418072|NCT01820585|531694582|FG001|Overall Study|Adverse Event|13|||
147418073|NCT01820585|531694583|FG002|Overall Study|Adverse Event|23|||
147418074|NCT01820585|531694584|FG003|Overall Study|Adverse Event|34|||
147418075|NCT01820585|531694581|FG000|Overall Study|Lack of Efficacy|9|||
147418076|NCT01820585|531694582|FG001|Overall Study|Lack of Efficacy|7|||
147418077|NCT01820585|531694583|FG002|Overall Study|Lack of Efficacy|5|||
147418078|NCT01820585|531694584|FG003|Overall Study|Lack of Efficacy|1|||
147418079|NCT01820585|531694581|FG000|Overall Study|Withdrawal by Subject|3|||
147418080|NCT01820585|531694582|FG001|Overall Study|Withdrawal by Subject|7|||
147418081|NCT01820585|531694583|FG002|Overall Study|Withdrawal by Subject|3|||
147418082|NCT01820585|531694584|FG003|Overall Study|Withdrawal by Subject|8|||
147418083|NCT01820585|531694581|FG000|Overall Study|Lost to Follow-up|3|||
147418084|NCT01820585|531694582|FG001|Overall Study|Lost to Follow-up|3|||
147418085|NCT01820585|531694583|FG002|Overall Study|Lost to Follow-up|0|||
147418086|NCT01820585|531694584|FG003|Overall Study|Lost to Follow-up|3|||
147418087|NCT01820585|531694581|FG000|Overall Study|Protocol Violation|3|||
147418088|NCT01820585|531694582|FG001|Overall Study|Protocol Violation|1|||
147418089|NCT01820585|531694583|FG002|Overall Study|Protocol Violation|1|||
147418090|NCT01820585|531694584|FG003|Overall Study|Protocol Violation|1|||
147418091|NCT01820585|531694581|FG000|Overall Study|Subject non-compliance|0|||
147418092|NCT01820585|531694582|FG001|Overall Study|Subject non-compliance|0|||
147418093|NCT01820585|531694583|FG002|Overall Study|Subject non-compliance|1|||
147418094|NCT01820585|531694584|FG003|Overall Study|Subject non-compliance|2|||
147418095|NCT01820585|531694581|FG000|Overall Study|at sponsor request|0|||
147418096|NCT01820585|531694582|FG001|Overall Study|at sponsor request|0|||
147418097|NCT01820585|531694583|FG002|Overall Study|at sponsor request|1|||
147418098|NCT01820585|531694584|FG003|Overall Study|at sponsor request|0|||
147418099|NCT01820585|531694581|FG000|Overall Study|Pregnancy|0|||
147418100|NCT01820585|531694582|FG001|Overall Study|Pregnancy|1|||
147418101|NCT01820585|531694583|FG002|Overall Study|Pregnancy|0|||
147418102|NCT01820585|531694584|FG003|Overall Study|Pregnancy|0|||
147418103|NCT02544451|531694585|FG000|Treatment Period 1 (96 Weeks)|Adverse Event|1|||
147418104|NCT02544451|531694586|FG001|Treatment Period 1 (96 Weeks)|Adverse Event|6|||
147418105|NCT02544451|531694587|FG002|Treatment Period 1 (96 Weeks)|Adverse Event|0|||
147418106|NCT02544451|531694588|FG003|Treatment Period 1 (96 Weeks)|Adverse Event|0|||
147418107|NCT02544451|531694585|FG000|Treatment Period 1 (96 Weeks)|Withdrawal of consent (not due to AE)|3|||
147418108|NCT02544451|531694586|FG001|Treatment Period 1 (96 Weeks)|Withdrawal of consent (not due to AE)|2|||
147418109|NCT02544451|531694587|FG002|Treatment Period 1 (96 Weeks)|Withdrawal of consent (not due to AE)|1|||
147520314|NCT01642004|532056379|FG000|Treatment|Not reported|0|||
147418110|NCT02544451|531694588|FG003|Treatment Period 1 (96 Weeks)|Withdrawal of consent (not due to AE)|0|||
147418111|NCT02544451|531694585|FG000|Treatment Period 1 (96 Weeks)|Lost to Follow-up|2|||
147418112|NCT02544451|531694586|FG001|Treatment Period 1 (96 Weeks)|Lost to Follow-up|0|||
147418113|NCT02544451|531694587|FG002|Treatment Period 1 (96 Weeks)|Lost to Follow-up|0|||
147418114|NCT02544451|531694588|FG003|Treatment Period 1 (96 Weeks)|Lost to Follow-up|0|||
147418115|NCT02544451|531694585|FG000|Treatment Period 1 (96 Weeks)|Physician Decision|4|||
147418116|NCT02544451|531694586|FG001|Treatment Period 1 (96 Weeks)|Physician Decision|0|||
147418117|NCT02544451|531694587|FG002|Treatment Period 1 (96 Weeks)|Physician Decision|0|||
147418118|NCT02544451|531694588|FG003|Treatment Period 1 (96 Weeks)|Physician Decision|0|||
147418119|NCT02544451|531694585|FG000|Treatment Period 1 (96 Weeks)|Other|4|||
147418120|NCT02544451|531694586|FG001|Treatment Period 1 (96 Weeks)|Other|4|||
147418121|NCT02544451|531694587|FG002|Treatment Period 1 (96 Weeks)|Other|0|||
147418122|NCT02544451|531694588|FG003|Treatment Period 1 (96 Weeks)|Other|0|||
147418123|NCT02544451|531694585|FG000|Treatment Period 2 (168 Weeks)|Commercial drug is available for subject|0|||
147418124|NCT02544451|531694586|FG001|Treatment Period 2 (168 Weeks)|Commercial drug is available for subject|0|||
147418125|NCT02544451|531694587|FG002|Treatment Period 2 (168 Weeks)|Commercial drug is available for subject|0|||
147418126|NCT02544451|531694588|FG003|Treatment Period 2 (168 Weeks)|Commercial drug is available for subject|10|||
147418127|NCT02656329|531694590|FG000|Overall Study|Lost to Follow-up|2|||
147418128|NCT02656329|531694591|FG001|Overall Study|Lost to Follow-up|3|||
147418129|NCT02656329|531694590|FG000|Overall Study|Withdrawal by Subject|7|||
147418130|NCT02656329|531694591|FG001|Overall Study|Withdrawal by Subject|6|||
147418131|NCT02656329|531694590|FG000|Overall Study|Study termination by Sponsor|150|||
147418132|NCT02656329|531694591|FG001|Overall Study|Study termination by Sponsor|142|||
147418133|NCT02656329|531694590|FG000|Overall Study|Other than specified above|5|||
147418134|NCT02656329|531694591|FG001|Overall Study|Other than specified above|6|||
147418135|NCT01081665|531694592|FG000|Overall Study|Death|41|||
147418136|NCT01081665|531694592|FG000|Overall Study|Lost to Follow-up|18|||
147418137|NCT01081665|531694592|FG000|Overall Study|Withdrawal by Subject|17|||
147418138|NCT01081665|531694592|FG000|Overall Study|Change of dialysis unit|10|||
147418139|NCT01081665|531694592|FG000|Overall Study|Regulation of iPTH|5|||
147418140|NCT01081665|531694592|FG000|Overall Study|Change in renal replacement therapy|2|||
147418141|NCT01081665|531694592|FG000|Overall Study|Adverse Event|1|||
147418142|NCT01081665|531694592|FG000|Overall Study|Lack of Efficacy|1|||
147418143|NCT03117998|531694595|FG000|Overall Study|Adverse Event|1|||
147418144|NCT03117998|531694596|FG001|Overall Study|Adverse Event|0|||
147418145|NCT03117998|531694597|FG002|Overall Study|Adverse Event|0|||
147418146|NCT03117998|531694598|FG003|Overall Study|Adverse Event|0|||
147418147|NCT03117998|531694599|FG004|Overall Study|Adverse Event|0|||
147418148|NCT03117998|531694600|FG005|Overall Study|Adverse Event|0|||
147418149|NCT03117998|531694595|FG000|Overall Study|Withdrawal by Subject|0|||
147418150|NCT03117998|531694596|FG001|Overall Study|Withdrawal by Subject|0|||
147418151|NCT03117998|531694597|FG002|Overall Study|Withdrawal by Subject|2|||
147418152|NCT03117998|531694598|FG003|Overall Study|Withdrawal by Subject|3|||
147418153|NCT03117998|531694599|FG004|Overall Study|Withdrawal by Subject|3|||
147418154|NCT03117998|531694600|FG005|Overall Study|Withdrawal by Subject|0|||
147418155|NCT03117998|531694595|FG000|Overall Study|Physician Decision|0|||
147418156|NCT03117998|531694596|FG001|Overall Study|Physician Decision|1|||
147418157|NCT03117998|531694597|FG002|Overall Study|Physician Decision|1|||
147418158|NCT03117998|531694598|FG003|Overall Study|Physician Decision|0|||
147418159|NCT03117998|531694599|FG004|Overall Study|Physician Decision|0|||
147418160|NCT03117998|531694600|FG005|Overall Study|Physician Decision|0|||
147418161|NCT03117998|531694595|FG000|Overall Study|Lost to Follow-up|0|||
147418162|NCT03117998|531694596|FG001|Overall Study|Lost to Follow-up|0|||
147418163|NCT03117998|531694597|FG002|Overall Study|Lost to Follow-up|0|||
147418164|NCT03117998|531694598|FG003|Overall Study|Lost to Follow-up|1|||
147418165|NCT03117998|531694599|FG004|Overall Study|Lost to Follow-up|4|||
147418166|NCT03117998|531694600|FG005|Overall Study|Lost to Follow-up|0|||
147418167|NCT03117998|531694595|FG000|Overall Study|Subject noncompliance|0|||
147418168|NCT03117998|531694596|FG001|Overall Study|Subject noncompliance|0|||
147418169|NCT03117998|531694597|FG002|Overall Study|Subject noncompliance|1|||
147418170|NCT03117998|531694598|FG003|Overall Study|Subject noncompliance|0|||
147418171|NCT03117998|531694599|FG004|Overall Study|Subject noncompliance|0|||
147418172|NCT03117998|531694600|FG005|Overall Study|Subject noncompliance|2|||
147418173|NCT03117998|531694595|FG000|Overall Study|Protocol Violation|0|||
147418174|NCT03117998|531694596|FG001|Overall Study|Protocol Violation|0|||
147418175|NCT03117998|531694597|FG002|Overall Study|Protocol Violation|0|||
147418176|NCT03117998|531694598|FG003|Overall Study|Protocol Violation|0|||
147418177|NCT03117998|531694599|FG004|Overall Study|Protocol Violation|0|||
147418178|NCT03117998|531694600|FG005|Overall Study|Protocol Violation|1|||
147418179|NCT01468181|531694601|FG000|Overall Study|Adverse Event|8|||
147418180|NCT01468181|531694602|FG001|Overall Study|Adverse Event|1|||
147418181|NCT01468181|531694603|FG002|Overall Study|Adverse Event|6|||
147418182|NCT01468181|531694604|FG003|Overall Study|Adverse Event|2|||
147418183|NCT01468181|531694605|FG004|Overall Study|Adverse Event|2|||
147418184|NCT01468181|531694601|FG000|Overall Study|Protocol Violation|2|||
147418185|NCT01468181|531694602|FG001|Overall Study|Protocol Violation|0|||
147520315|NCT01642004|532056380|FG001|Treatment|Not reported|3|||
147520316|NCT01642004|532056379|FG000|Treatment|Participant request to discontinue study treatment|6|||
147520317|NCT01642004|532056380|FG001|Treatment|Participant request to discontinue study treatment|4|||
147520318|NCT01642004|532056379|FG000|Treatment|Participant withdrew consent|5|||
147520319|NCT01642004|532056380|FG001|Treatment|Participant withdrew consent|5|||
147520320|NCT02718625|532056381|FG000|Overall Study|Adverse Event|0|||
147520321|NCT02718625|532056382|FG001|Overall Study|Adverse Event|1|||
147520322|NCT02718625|532056381|FG000|Overall Study|Termination of Study by Sponsor|0|||
147520323|NCT02718625|532056382|FG001|Overall Study|Termination of Study by Sponsor|1|||
147520324|NCT01818765|532056385|FG000|Overall Study|Death|2|||
147520325|NCT01603628|532056390|FG000|Overall Study|Personal Reasons|1|||
147520326|NCT01603628|532056391|FG001|Overall Study|Personal Reasons|1|||
147520327|NCT01603628|532056392|FG002|Overall Study|Personal Reasons|2|||
147520328|NCT01603628|532056390|FG000|Overall Study|Protocol Violation|1|||
147520329|NCT01603628|532056391|FG001|Overall Study|Protocol Violation|1|||
147520330|NCT01603628|532056392|FG002|Overall Study|Protocol Violation|0|||
147520331|NCT01603628|532056390|FG000|Overall Study|Lost to Follow-up|0|||
147520332|NCT01603628|532056391|FG001|Overall Study|Lost to Follow-up|1|||
147520333|NCT01603628|532056392|FG002|Overall Study|Lost to Follow-up|0|||
147520334|NCT01603628|532056390|FG000|Overall Study|Other Miscellaneous Reason|1|||
147520335|NCT01603628|532056391|FG001|Overall Study|Other Miscellaneous Reason|0|||
147520336|NCT01603628|532056392|FG002|Overall Study|Other Miscellaneous Reason|0|||
147520337|NCT01969565|532056393|FG000|Overall Study|Withdrawal by Subject|1|||
147520338|NCT02877134|532056398|FG000|Main Study (Parts I,II): Up to Week 38|Death|0|||
147520339|NCT02877134|532056399|FG001|Main Study (Parts I,II): Up to Week 38|Death|1|||
147520340|NCT02877134|532056400|FG002|Main Study (Parts I,II): Up to Week 38|Death|0|||
147520341|NCT02877134|532056401|FG003|Main Study (Parts I,II): Up to Week 38|Death|0|||
147520342|NCT02877134|532056402|FG004|Main Study (Parts I,II): Up to Week 38|Death|0|||
147520343|NCT02877134|532056403|FG005|Main Study (Parts I,II): Up to Week 38|Death|1|||
147520344|NCT02877134|532056404|FG006|Main Study (Parts I,II): Up to Week 38|Death|0|||
147520345|NCT02877134|532056405|FG007|Main Study (Parts I,II): Up to Week 38|Death|0|||
147520346|NCT02877134|532056406|FG008|Main Study (Parts I,II): Up to Week 38|Death|0|||
147520347|NCT02877134|532056407|FG009|Main Study (Parts I,II): Up to Week 38|Death|0|||
147520348|NCT02877134|532056408|FG010|Main Study (Parts I,II): Up to Week 38|Death|0|||
147520349|NCT02877134|532056409|FG011|Main Study (Parts I,II): Up to Week 38|Death|0|||
147520350|NCT02877134|532056398|FG000|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
147520351|NCT02877134|532056399|FG001|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|4|||
147520352|NCT02877134|532056400|FG002|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
147520353|NCT02877134|532056401|FG003|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|1|||
147520354|NCT02877134|532056402|FG004|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
147520355|NCT02877134|532056403|FG005|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
147520356|NCT02877134|532056404|FG006|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|1|||
147520357|NCT02877134|532056405|FG007|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
147520358|NCT02877134|532056406|FG008|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
147520359|NCT02877134|532056407|FG009|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
147520360|NCT02877134|532056408|FG010|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
147520361|NCT02877134|532056409|FG011|Main Study (Parts I,II): Up to Week 38|Lost to Follow-up|0|||
147520362|NCT02877134|532056398|FG000|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|13|||
147520363|NCT02877134|532056399|FG001|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|19|||
147520364|NCT02877134|532056400|FG002|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|5|||
147520365|NCT02877134|532056401|FG003|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|8|||
147520366|NCT02877134|532056402|FG004|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|3|||
147520367|NCT02877134|532056403|FG005|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|6|||
147418186|NCT01468181|531694603|FG002|Overall Study|Protocol Violation|1|||
147418187|NCT01468181|531694604|FG003|Overall Study|Protocol Violation|0|||
147418188|NCT01468181|531694605|FG004|Overall Study|Protocol Violation|1|||
147418189|NCT01468181|531694601|FG000|Overall Study|Physician Decision|0|||
147418190|NCT01468181|531694602|FG001|Overall Study|Physician Decision|0|||
147418191|NCT01468181|531694603|FG002|Overall Study|Physician Decision|0|||
147418192|NCT01468181|531694604|FG003|Overall Study|Physician Decision|1|||
147418193|NCT01468181|531694605|FG004|Overall Study|Physician Decision|1|||
147418194|NCT01468181|531694601|FG000|Overall Study|Lost to Follow-up|0|||
147418195|NCT01468181|531694602|FG001|Overall Study|Lost to Follow-up|0|||
147418196|NCT01468181|531694603|FG002|Overall Study|Lost to Follow-up|1|||
147418197|NCT01468181|531694604|FG003|Overall Study|Lost to Follow-up|0|||
147418198|NCT01468181|531694605|FG004|Overall Study|Lost to Follow-up|1|||
147418199|NCT01468181|531694601|FG000|Overall Study|Withdrawal by Subject|0|||
147418200|NCT01468181|531694602|FG001|Overall Study|Withdrawal by Subject|1|||
147418201|NCT01468181|531694603|FG002|Overall Study|Withdrawal by Subject|0|||
147418202|NCT01468181|531694604|FG003|Overall Study|Withdrawal by Subject|0|||
147418203|NCT01468181|531694605|FG004|Overall Study|Withdrawal by Subject|0|||
147418204|NCT04664400|531694606|FG000|Overall Study|Withdrawal by Subject|2|||
147418205|NCT01011153|531694609|FG000|Overall Study|Less than 78 cases completed|8|||
147418206|NCT01011153|531694610|FG001|Overall Study|Less than 78 cases completed|11|||
147418207|NCT01011153|531694611|FG002|Overall Study|Less than 78 cases completed|9|||
147418208|NCT01081132|531694614|FG000|Overall Study|Lack of Efficacy|25|||
147418209|NCT01081132|531694615|FG001|Overall Study|Lack of Efficacy|9|||
147418210|NCT01081132|531694614|FG000|Overall Study|Withdrawal by Subject|13|||
147418211|NCT01081132|531694615|FG001|Overall Study|Withdrawal by Subject|16|||
147418212|NCT01081132|531694614|FG000|Overall Study|Lost to Follow-up|4|||
147418213|NCT01081132|531694615|FG001|Overall Study|Lost to Follow-up|11|||
147418214|NCT01081132|531694614|FG000|Overall Study|Adverse Event|3|||
147418215|NCT01081132|531694615|FG001|Overall Study|Adverse Event|9|||
147418216|NCT01081132|531694614|FG000|Overall Study|Non Compliance|4|||
147418217|NCT01081132|531694615|FG001|Overall Study|Non Compliance|2|||
147418218|NCT01081132|531694614|FG000|Overall Study|Lack Of Compliance|0|||
147418219|NCT01081132|531694615|FG001|Overall Study|Lack Of Compliance|1|||
147418220|NCT01081132|531694614|FG000|Overall Study|Missed Visits|1|||
147418221|NCT01081132|531694615|FG001|Overall Study|Missed Visits|1|||
147418222|NCT01081132|531694614|FG000|Overall Study|Stopped Taking Meds|2|||
147418223|NCT01081132|531694615|FG001|Overall Study|Stopped Taking Meds|0|||
147418224|NCT01081132|531694614|FG000|Overall Study|Patient Did Not Complete Wk14 and 15|0|||
147418225|NCT01081132|531694615|FG001|Overall Study|Patient Did Not Complete Wk14 and 15|1|||
147418226|NCT01081132|531694614|FG000|Overall Study|Declined Taper Phase|0|||
147418227|NCT01081132|531694615|FG001|Overall Study|Declined Taper Phase|1|||
147418228|NCT01081132|531694614|FG000|Overall Study|Protocol Violation|3|||
147418229|NCT01081132|531694615|FG001|Overall Study|Protocol Violation|1|||
147418230|NCT02297139|531694616|FG000|Overall Study|Disease progression|0|||
147418231|NCT02297139|531694617|FG001|Overall Study|Disease progression|1|||
147418232|NCT02297139|531694616|FG000|Overall Study|Study drug toxicity|0|||
147418233|NCT02297139|531694617|FG001|Overall Study|Study drug toxicity|4|||
147418234|NCT02297139|531694616|FG000|Overall Study|Participant request to discontinue study treatment|0|||
147418235|NCT02297139|531694617|FG001|Overall Study|Participant request to discontinue study treatment|1|||
147520368|NCT02877134|532056404|FG006|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|2|||
147520369|NCT02877134|532056405|FG007|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|0|||
147520370|NCT02877134|532056406|FG008|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|0|||
147520371|NCT02877134|532056407|FG009|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|0|||
147520372|NCT02877134|532056408|FG010|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|0|||
147520373|NCT02877134|532056409|FG011|Main Study (Parts I,II): Up to Week 38|Withdrawal by Subject|0|||
147520374|NCT02877134|532056398|FG000|Main Study (Parts I,II): Up to Week 38|Other|1|||
147520375|NCT02877134|532056399|FG001|Main Study (Parts I,II): Up to Week 38|Other|1|||
147520376|NCT02877134|532056400|FG002|Main Study (Parts I,II): Up to Week 38|Other|3|||
147520377|NCT02877134|532056401|FG003|Main Study (Parts I,II): Up to Week 38|Other|6|||
147520378|NCT02877134|532056402|FG004|Main Study (Parts I,II): Up to Week 38|Other|4|||
147520379|NCT02877134|532056403|FG005|Main Study (Parts I,II): Up to Week 38|Other|3|||
147520380|NCT02877134|532056404|FG006|Main Study (Parts I,II): Up to Week 38|Other|2|||
147520381|NCT02877134|532056405|FG007|Main Study (Parts I,II): Up to Week 38|Other|0|||
147520382|NCT02877134|532056406|FG008|Main Study (Parts I,II): Up to Week 38|Other|0|||
147520383|NCT02877134|532056407|FG009|Main Study (Parts I,II): Up to Week 38|Other|0|||
147520384|NCT02877134|532056408|FG010|Main Study (Parts I,II): Up to Week 38|Other|0|||
147520385|NCT02877134|532056409|FG011|Main Study (Parts I,II): Up to Week 38|Other|0|||
147520386|NCT02877134|532056398|FG000|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
147520387|NCT02877134|532056399|FG001|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
147520388|NCT02877134|532056400|FG002|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
147520389|NCT02877134|532056401|FG003|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
147520390|NCT02877134|532056402|FG004|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
147520391|NCT02877134|532056403|FG005|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
147520392|NCT02877134|532056404|FG006|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
147520393|NCT02877134|532056405|FG007|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
147520394|NCT02877134|532056406|FG008|Part II LTE Phase: From Week 24-88|Lost to Follow-up|1|||
147520395|NCT02877134|532056407|FG009|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
147520396|NCT02877134|532056408|FG010|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
147520397|NCT02877134|532056409|FG011|Part II LTE Phase: From Week 24-88|Lost to Follow-up|0|||
147520398|NCT02877134|532056398|FG000|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
147520399|NCT02877134|532056399|FG001|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
147520400|NCT02877134|532056400|FG002|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
147520401|NCT02877134|532056401|FG003|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
147520402|NCT02877134|532056402|FG004|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
147520403|NCT02877134|532056403|FG005|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
147520404|NCT02877134|532056404|FG006|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|0|||
147520405|NCT02877134|532056405|FG007|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|1|||
147520406|NCT02877134|532056406|FG008|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|2|||
147520407|NCT02877134|532056407|FG009|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|3|||
147520408|NCT02877134|532056408|FG010|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|9|||
147520409|NCT02877134|532056409|FG011|Part II LTE Phase: From Week 24-88|Withdrawal by Subject|3|||
147520410|NCT02877134|532056398|FG000|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
147520411|NCT02877134|532056399|FG001|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
147520412|NCT02877134|532056400|FG002|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
147520413|NCT02877134|532056401|FG003|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
147520414|NCT02877134|532056402|FG004|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
147520415|NCT02877134|532056403|FG005|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
147520416|NCT02877134|532056404|FG006|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
147520417|NCT02877134|532056405|FG007|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|1|||
147520418|NCT02877134|532056406|FG008|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|1|||
147520419|NCT02877134|532056407|FG009|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|1|||
147520420|NCT02877134|532056408|FG010|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
147520421|NCT02877134|532056409|FG011|Part II LTE Phase: From Week 24-88|Study Terminated by Sponsor|0|||
147520422|NCT02877134|532056398|FG000|Part II LTE Phase: From Week 24-88|Other|0|||
147520423|NCT02877134|532056399|FG001|Part II LTE Phase: From Week 24-88|Other|0|||
147520424|NCT02877134|532056400|FG002|Part II LTE Phase: From Week 24-88|Other|0|||
147520425|NCT02877134|532056401|FG003|Part II LTE Phase: From Week 24-88|Other|0|||
147520426|NCT02877134|532056402|FG004|Part II LTE Phase: From Week 24-88|Other|0|||
147520427|NCT02877134|532056403|FG005|Part II LTE Phase: From Week 24-88|Other|0|||
147520428|NCT02877134|532056404|FG006|Part II LTE Phase: From Week 24-88|Other|0|||
147520429|NCT02877134|532056405|FG007|Part II LTE Phase: From Week 24-88|Other|0|||
147520430|NCT02877134|532056406|FG008|Part II LTE Phase: From Week 24-88|Other|0|||
147520431|NCT02877134|532056407|FG009|Part II LTE Phase: From Week 24-88|Other|3|||
147520432|NCT02877134|532056408|FG010|Part II LTE Phase: From Week 24-88|Other|1|||
147520433|NCT02877134|532056409|FG011|Part II LTE Phase: From Week 24-88|Other|1|||
147520434|NCT01197794|532056410|FG000|Overall Study|Adverse Event|3|||
147520435|NCT01197794|532056411|FG001|Overall Study|Adverse Event|2|||
147520436|NCT01197794|532056412|FG002|Overall Study|Adverse Event|4|||
147520437|NCT01197794|532056413|FG003|Overall Study|Adverse Event|4|||
147520438|NCT01197794|532056414|FG004|Overall Study|Adverse Event|4|||
147520439|NCT01197794|532056415|FG005|Overall Study|Adverse Event|2|||
147520440|NCT01197794|532056416|FG006|Overall Study|Adverse Event|3|||
147520441|NCT01197794|532056410|FG000|Overall Study|Protocol Violation|0|||
147520442|NCT01197794|532056411|FG001|Overall Study|Protocol Violation|0|||
147520443|NCT01197794|532056412|FG002|Overall Study|Protocol Violation|0|||
147520444|NCT01197794|532056413|FG003|Overall Study|Protocol Violation|0|||
147520445|NCT01197794|532056414|FG004|Overall Study|Protocol Violation|2|||
147520446|NCT01197794|532056415|FG005|Overall Study|Protocol Violation|0|||
147520447|NCT01197794|532056416|FG006|Overall Study|Protocol Violation|1|||
147520448|NCT01197794|532056410|FG000|Overall Study|Development of study withdrawal criteria|3|||
147520449|NCT01197794|532056411|FG001|Overall Study|Development of study withdrawal criteria|0|||
147520450|NCT01197794|532056412|FG002|Overall Study|Development of study withdrawal criteria|0|||
147520451|NCT01197794|532056413|FG003|Overall Study|Development of study withdrawal criteria|1|||
147520452|NCT01197794|532056414|FG004|Overall Study|Development of study withdrawal criteria|0|||
147520453|NCT01197794|532056415|FG005|Overall Study|Development of study withdrawal criteria|0|||
147520454|NCT01197794|532056416|FG006|Overall Study|Development of study withdrawal criteria|1|||
147520455|NCT01197794|532056410|FG000|Overall Study|Eligibility criteria not fulfilled|5|||
147520456|NCT01197794|532056411|FG001|Overall Study|Eligibility criteria not fulfilled|8|||
147520457|NCT01197794|532056412|FG002|Overall Study|Eligibility criteria not fulfilled|2|||
147520458|NCT01197794|532056413|FG003|Overall Study|Eligibility criteria not fulfilled|5|||
147520459|NCT01197794|532056414|FG004|Overall Study|Eligibility criteria not fulfilled|5|||
147520460|NCT01197794|532056415|FG005|Overall Study|Eligibility criteria not fulfilled|9|||
147520461|NCT01197794|532056416|FG006|Overall Study|Eligibility criteria not fulfilled|6|||
147520462|NCT01197794|532056410|FG000|Overall Study|Withdrawal by Subject|3|||
147520463|NCT01197794|532056411|FG001|Overall Study|Withdrawal by Subject|3|||
147520464|NCT01197794|532056412|FG002|Overall Study|Withdrawal by Subject|4|||
147520465|NCT01197794|532056413|FG003|Overall Study|Withdrawal by Subject|1|||
147520466|NCT01197794|532056414|FG004|Overall Study|Withdrawal by Subject|1|||
147520467|NCT01197794|532056415|FG005|Overall Study|Withdrawal by Subject|5|||
147520468|NCT01197794|532056416|FG006|Overall Study|Withdrawal by Subject|6|||
147520469|NCT01197794|532056410|FG000|Overall Study|Lost to Follow-up|1|||
147520470|NCT01197794|532056411|FG001|Overall Study|Lost to Follow-up|1|||
147520471|NCT01197794|532056412|FG002|Overall Study|Lost to Follow-up|0|||
147520472|NCT01197794|532056413|FG003|Overall Study|Lost to Follow-up|1|||
147520473|NCT01197794|532056414|FG004|Overall Study|Lost to Follow-up|0|||
147520474|NCT01197794|532056415|FG005|Overall Study|Lost to Follow-up|1|||
147520475|NCT01197794|532056416|FG006|Overall Study|Lost to Follow-up|0|||
147520476|NCT01197794|532056410|FG000|Overall Study|Other|1|||
147520477|NCT01197794|532056411|FG001|Overall Study|Other|1|||
147520478|NCT01197794|532056412|FG002|Overall Study|Other|3|||
147520479|NCT01197794|532056413|FG003|Overall Study|Other|0|||
147520480|NCT01197794|532056414|FG004|Overall Study|Other|2|||
147520481|NCT01197794|532056415|FG005|Overall Study|Other|2|||
147520482|NCT01197794|532056416|FG006|Overall Study|Other|4|||
147520483|NCT01055457|532056417|FG000|Overall Study|Lost to Follow-up|0|||
147520484|NCT01055457|532056418|FG001|Overall Study|Lost to Follow-up|1|||
147520485|NCT01055457|532056419|FG002|Overall Study|Lost to Follow-up|0|||
147520486|NCT01055457|532056420|FG003|Overall Study|Lost to Follow-up|0|||
147520487|NCT01055457|532056421|FG004|Overall Study|Lost to Follow-up|0|||
147520488|NCT01055457|532056422|FG005|Overall Study|Lost to Follow-up|1|||
147520489|NCT01055457|532056423|FG006|Overall Study|Lost to Follow-up|0|||
147642917|NCT02431806|532511091|FG002|Double-blind Treatment Period|Adverse Event|11|||
147642918|NCT02431806|532511092|FG003|Double-blind Treatment Period|Adverse Event|7|||
147642919|NCT02431806|532511089|FG000|Double-blind Treatment Period|Lack of Efficacy|2|||
147642920|NCT02431806|532511090|FG001|Double-blind Treatment Period|Lack of Efficacy|0|||
147642921|NCT02431806|532511091|FG002|Double-blind Treatment Period|Lack of Efficacy|2|||
147642922|NCT02431806|532511092|FG003|Double-blind Treatment Period|Lack of Efficacy|2|||
147642923|NCT02431806|532511089|FG000|Double-blind Treatment Period|Withdrawal of Consent|10|||
147642924|NCT02431806|532511090|FG001|Double-blind Treatment Period|Withdrawal of Consent|7|||
147642925|NCT02431806|532511091|FG002|Double-blind Treatment Period|Withdrawal of Consent|5|||
147642926|NCT02431806|532511092|FG003|Double-blind Treatment Period|Withdrawal of Consent|5|||
147642927|NCT02431806|532511089|FG000|Double-blind Treatment Period|Lost to Follow-up|7|||
147642928|NCT02431806|532511090|FG001|Double-blind Treatment Period|Lost to Follow-up|4|||
147642929|NCT02431806|532511091|FG002|Double-blind Treatment Period|Lost to Follow-up|5|||
147642930|NCT02431806|532511092|FG003|Double-blind Treatment Period|Lost to Follow-up|8|||
147520490|NCT01055457|532056424|FG007|Overall Study|Lost to Follow-up|0|||
147642931|NCT02431806|532511089|FG000|Double-blind Treatment Period|Investigational Product Non-compliance|1|||
147642932|NCT02431806|532511090|FG001|Double-blind Treatment Period|Investigational Product Non-compliance|0|||
147644040|NCT00738062|532516704|FG000|Open Label Treatment|Investigator Decision|1|||
147644041|NCT00738062|532516705|FG001|Open Label Treatment|Investigator Decision|0|||
147520491|NCT01055457|532056425|FG008|Overall Study|Lost to Follow-up|0|||
147520492|NCT01055457|532056426|FG009|Overall Study|Lost to Follow-up|0|||
147520493|NCT01055457|532056417|FG000|Overall Study|Protocol Violation|0|||
147520494|NCT01055457|532056418|FG001|Overall Study|Protocol Violation|0|||
147520495|NCT01055457|532056419|FG002|Overall Study|Protocol Violation|1|||
147520496|NCT01055457|532056420|FG003|Overall Study|Protocol Violation|1|||
147520497|NCT01055457|532056421|FG004|Overall Study|Protocol Violation|1|||
147520498|NCT01055457|532056422|FG005|Overall Study|Protocol Violation|2|||
147520499|NCT01055457|532056423|FG006|Overall Study|Protocol Violation|1|||
147520500|NCT01055457|532056424|FG007|Overall Study|Protocol Violation|0|||
147520501|NCT01055457|532056425|FG008|Overall Study|Protocol Violation|0|||
147520502|NCT01055457|532056426|FG009|Overall Study|Protocol Violation|1|||
147520503|NCT01055457|532056417|FG000|Overall Study|Subject Disinterest|0|||
147520504|NCT01055457|532056418|FG001|Overall Study|Subject Disinterest|0|||
147520505|NCT01055457|532056419|FG002|Overall Study|Subject Disinterest|0|||
147520506|NCT01055457|532056420|FG003|Overall Study|Subject Disinterest|0|||
147520507|NCT01055457|532056421|FG004|Overall Study|Subject Disinterest|0|||
147520508|NCT01055457|532056422|FG005|Overall Study|Subject Disinterest|0|||
147520509|NCT01055457|532056423|FG006|Overall Study|Subject Disinterest|0|||
147520510|NCT01055457|532056424|FG007|Overall Study|Subject Disinterest|1|||
147520511|NCT01055457|532056425|FG008|Overall Study|Subject Disinterest|0|||
147520512|NCT01055457|532056426|FG009|Overall Study|Subject Disinterest|0|||
147520513|NCT01055457|532056417|FG000|Overall Study|Subject Ineligible|1|||
147520514|NCT01055457|532056418|FG001|Overall Study|Subject Ineligible|0|||
147520515|NCT01055457|532056419|FG002|Overall Study|Subject Ineligible|1|||
147520516|NCT01055457|532056420|FG003|Overall Study|Subject Ineligible|0|||
147520517|NCT01055457|532056421|FG004|Overall Study|Subject Ineligible|1|||
147520518|NCT01055457|532056422|FG005|Overall Study|Subject Ineligible|0|||
147520519|NCT01055457|532056423|FG006|Overall Study|Subject Ineligible|0|||
147520520|NCT01055457|532056424|FG007|Overall Study|Subject Ineligible|0|||
147520521|NCT01055457|532056425|FG008|Overall Study|Subject Ineligible|0|||
147520522|NCT01055457|532056426|FG009|Overall Study|Subject Ineligible|0|||
147520523|NCT01055457|532056417|FG000|Overall Study|Discomfort|0|||
147520524|NCT01055457|532056418|FG001|Overall Study|Discomfort|0|||
147520525|NCT01055457|532056419|FG002|Overall Study|Discomfort|0|||
147520526|NCT01055457|532056420|FG003|Overall Study|Discomfort|0|||
147520527|NCT01055457|532056421|FG004|Overall Study|Discomfort|1|||
147520528|NCT01055457|532056422|FG005|Overall Study|Discomfort|0|||
147520529|NCT01055457|532056423|FG006|Overall Study|Discomfort|0|||
147520530|NCT01055457|532056424|FG007|Overall Study|Discomfort|0|||
147520531|NCT01055457|532056425|FG008|Overall Study|Discomfort|0|||
147520532|NCT01055457|532056426|FG009|Overall Study|Discomfort|0|||
147520533|NCT01055457|532056417|FG000|Overall Study|Pregnancy|0|||
147520534|NCT01055457|532056418|FG001|Overall Study|Pregnancy|0|||
147520535|NCT01055457|532056419|FG002|Overall Study|Pregnancy|0|||
147520536|NCT01055457|532056420|FG003|Overall Study|Pregnancy|1|||
147520537|NCT01055457|532056421|FG004|Overall Study|Pregnancy|0|||
147520538|NCT01055457|532056422|FG005|Overall Study|Pregnancy|0|||
147520539|NCT01055457|532056423|FG006|Overall Study|Pregnancy|0|||
147520540|NCT01055457|532056424|FG007|Overall Study|Pregnancy|0|||
147520541|NCT01055457|532056425|FG008|Overall Study|Pregnancy|0|||
147520542|NCT01055457|532056426|FG009|Overall Study|Pregnancy|0|||
147520543|NCT01055457|532056417|FG000|Overall Study|Adverse Event|0|||
147520544|NCT01055457|532056418|FG001|Overall Study|Adverse Event|0|||
147520545|NCT01055457|532056419|FG002|Overall Study|Adverse Event|0|||
147520546|NCT01055457|532056420|FG003|Overall Study|Adverse Event|1|||
147520547|NCT01055457|532056421|FG004|Overall Study|Adverse Event|0|||
147520548|NCT01055457|532056422|FG005|Overall Study|Adverse Event|0|||
147520549|NCT01055457|532056423|FG006|Overall Study|Adverse Event|0|||
147520550|NCT01055457|532056424|FG007|Overall Study|Adverse Event|0|||
147520551|NCT01055457|532056425|FG008|Overall Study|Adverse Event|0|||
147520552|NCT01055457|532056426|FG009|Overall Study|Adverse Event|0|||
147520553|NCT02187224|532056427|FG000|Overall Study|Did not show up for test day|1|||
147520554|NCT02187224|532056428|FG001|Overall Study|Did not show up for test day|0|||
147520555|NCT01010776|532056432|FG000|Main Phase|Withdrawal by Subject|14|||
147520556|NCT01010776|532056432|FG000|Main Phase|Lack of Efficacy|8|||
147520557|NCT01010776|532056432|FG000|Main Phase|Adverse Event|7|||
147520558|NCT01010776|532056432|FG000|Main Phase|Lost to Follow-up|6|||
147520559|NCT01010776|532056432|FG000|Main Phase|Non-compliance to study medication|5|||
147520560|NCT01010776|532056432|FG000|Main Phase|Selection failure|2|||
147520561|NCT01010776|532056432|FG000|Main Phase|Inform consent withdrawal|1|||
147520562|NCT01010776|532056432|FG000|Main Phase|Other|1|||
147520563|NCT01010776|532056432|FG000|Main Phase|Did not received study medication|5|||
147520564|NCT01010776|532056432|FG000|In-Between Main Phase & Extension Phase|Extension phase was optional|15|||
147520565|NCT01010776|532056432|FG000|Extension Phase|Other|3|||
147520566|NCT00374127|532056439|FG000|Overall Study|Did not inhale during smoking procedure.|3|||
147520567|NCT00374127|532056439|FG000|Overall Study|Blood could not be drawn.|2|||
147520568|NCT00374127|532056439|FG000|Overall Study|Protocol Violation|5|||
147520569|NCT00374127|532056439|FG000|Overall Study|Pregnancy|1|||
147520570|NCT00703781|532056442|FG000|Overall Study|Withdrawal by Subject|1|||
147520571|NCT00703781|532056443|FG001|Overall Study|Withdrawal by Subject|2|||
147520572|NCT00703781|532056442|FG000|Overall Study|Cancelled surgery|1|||
147520573|NCT00703781|532056443|FG001|Overall Study|Cancelled surgery|0|||
147520574|NCT03893630|532056447|FG000|Overall Study|Lost to Follow-up|5|||
147520575|NCT03893630|532056448|FG001|Overall Study|Lost to Follow-up|4|||
147520576|NCT03893630|532056449|FG002|Overall Study|Lost to Follow-up|2|||
147520577|NCT03893630|532056447|FG000|Overall Study|Withdrawal by Subject|3|||
147520578|NCT03893630|532056448|FG001|Overall Study|Withdrawal by Subject|6|||
147520579|NCT03893630|532056449|FG002|Overall Study|Withdrawal by Subject|3|||
147520580|NCT03893630|532056447|FG000|Overall Study|Discontinued Intervention|0|||
147520581|NCT03893630|532056448|FG001|Overall Study|Discontinued Intervention|4|||
147520582|NCT03893630|532056449|FG002|Overall Study|Discontinued Intervention|2|||
147520583|NCT01465958|532057873|FG000|Run-in Phase|Protocol Violation|1|||
147520584|NCT01465958|532057874|FG001|Run-in Phase|Protocol Violation|0|||
147520585|NCT01465958|532057873|FG000|Subcutaneous (SC) Phase|Adverse Event|0|||
147520586|NCT01465958|532057874|FG001|Subcutaneous (SC) Phase|Adverse Event|1|||
147520587|NCT02785588|532057879|FG000|Phase 1: Initial Feasibility Assessment|Breakdown of investigational device|1|||
147520588|NCT02785588|532057879|FG000|Phase 1: Initial Feasibility Assessment|Withdrawal by Subject|1|||
147520589|NCT00211536|532057882|FG000|Overall Study|Withdrawal by Subject|2|||
147520590|NCT00211536|532057883|FG001|Overall Study|Withdrawal by Subject|2|||
147520591|NCT00211536|532057882|FG000|Overall Study|Physician Decision|0|||
147520592|NCT00211536|532057883|FG001|Overall Study|Physician Decision|5|||
147520593|NCT00211536|532057882|FG000|Overall Study|Adverse Event|2|||
147520594|NCT00211536|532057883|FG001|Overall Study|Adverse Event|0|||
147520595|NCT01004861|532057884|FG000|Overall Study|Disease progression|3|||
147520596|NCT01004861|532057885|FG001|Overall Study|Disease progression|4|||
147520597|NCT01004861|532057886|FG002|Overall Study|Disease progression|5|||
147520598|NCT01004861|532057887|FG003|Overall Study|Disease progression|4|||
147520599|NCT01004861|532057888|FG004|Overall Study|Disease progression|4|||
147520600|NCT01004861|532057889|FG005|Overall Study|Disease progression|4|||
147520601|NCT01004861|532057890|FG006|Overall Study|Disease progression|5|||
147520602|NCT01004861|532057891|FG007|Overall Study|Disease progression|1|||
147520603|NCT01004861|532057892|FG008|Overall Study|Disease progression|4|||
147520604|NCT01004861|532057893|FG009|Overall Study|Disease progression|7|||
147520605|NCT01004861|532057894|FG010|Overall Study|Disease progression|6|||
147520606|NCT01004861|532057895|FG011|Overall Study|Disease progression|3|||
147520607|NCT01004861|532057896|FG012|Overall Study|Disease progression|8|||
147520608|NCT01004861|532057884|FG000|Overall Study|Physician Decision|0|||
147520609|NCT01004861|532057885|FG001|Overall Study|Physician Decision|2|||
147520610|NCT01004861|532057886|FG002|Overall Study|Physician Decision|1|||
147520611|NCT01004861|532057887|FG003|Overall Study|Physician Decision|1|||
147520612|NCT01004861|532057888|FG004|Overall Study|Physician Decision|1|||
147520613|NCT01004861|532057889|FG005|Overall Study|Physician Decision|0|||
147520614|NCT01004861|532057890|FG006|Overall Study|Physician Decision|0|||
147520615|NCT01004861|532057891|FG007|Overall Study|Physician Decision|1|||
147520616|NCT01004861|532057892|FG008|Overall Study|Physician Decision|0|||
147520617|NCT01004861|532057893|FG009|Overall Study|Physician Decision|0|||
147520618|NCT01004861|532057894|FG010|Overall Study|Physician Decision|0|||
147520619|NCT01004861|532057895|FG011|Overall Study|Physician Decision|0|||
147520620|NCT01004861|532057896|FG012|Overall Study|Physician Decision|3|||
147520621|NCT01004861|532057884|FG000|Overall Study|Adverse Event|0|||
147520622|NCT01004861|532057885|FG001|Overall Study|Adverse Event|0|||
147520623|NCT01004861|532057886|FG002|Overall Study|Adverse Event|0|||
147520624|NCT01004861|532057887|FG003|Overall Study|Adverse Event|1|||
147520625|NCT01004861|532057888|FG004|Overall Study|Adverse Event|0|||
147520626|NCT01004861|532057889|FG005|Overall Study|Adverse Event|2|||
147520627|NCT01004861|532057890|FG006|Overall Study|Adverse Event|1|||
147520628|NCT01004861|532057891|FG007|Overall Study|Adverse Event|1|||
147520629|NCT01004861|532057892|FG008|Overall Study|Adverse Event|13|||
147642933|NCT02431806|532511091|FG002|Double-blind Treatment Period|Investigational Product Non-compliance|3|||
147642934|NCT02431806|532511092|FG003|Double-blind Treatment Period|Investigational Product Non-compliance|1|||
147642935|NCT02431806|532511089|FG000|Double-blind Treatment Period|Reason Not Specified|0|||
147642936|NCT02431806|532511090|FG001|Double-blind Treatment Period|Reason Not Specified|1|||
147642937|NCT02431806|532511091|FG002|Double-blind Treatment Period|Reason Not Specified|5|||
147520630|NCT01004861|532057893|FG009|Overall Study|Adverse Event|1|||
147520631|NCT01004861|532057894|FG010|Overall Study|Adverse Event|1|||
147520632|NCT01004861|532057895|FG011|Overall Study|Adverse Event|0|||
147520633|NCT01004861|532057896|FG012|Overall Study|Adverse Event|2|||
147520634|NCT01004861|532057884|FG000|Overall Study|Protocol Violation|0|||
147642938|NCT02431806|532511092|FG003|Double-blind Treatment Period|Reason Not Specified|2|||
147642939|NCT00742508|532511093|FG000|8-Week Primary Evaluation Period|Adverse Event|2|||
147520635|NCT01004861|532057885|FG001|Overall Study|Protocol Violation|0|||
147520636|NCT01004861|532057886|FG002|Overall Study|Protocol Violation|0|||
147520637|NCT01004861|532057887|FG003|Overall Study|Protocol Violation|0|||
147520638|NCT01004861|532057888|FG004|Overall Study|Protocol Violation|1|||
147520639|NCT01004861|532057889|FG005|Overall Study|Protocol Violation|0|||
147520640|NCT01004861|532057890|FG006|Overall Study|Protocol Violation|0|||
147520641|NCT01004861|532057891|FG007|Overall Study|Protocol Violation|0|||
147520642|NCT01004861|532057892|FG008|Overall Study|Protocol Violation|0|||
147520643|NCT01004861|532057893|FG009|Overall Study|Protocol Violation|0|||
147520644|NCT01004861|532057894|FG010|Overall Study|Protocol Violation|0|||
147520645|NCT01004861|532057895|FG011|Overall Study|Protocol Violation|0|||
147520646|NCT01004861|532057896|FG012|Overall Study|Protocol Violation|0|||
147520647|NCT01004861|532057884|FG000|Overall Study|Lost to Follow-up|0|||
147520648|NCT01004861|532057885|FG001|Overall Study|Lost to Follow-up|0|||
147520649|NCT01004861|532057886|FG002|Overall Study|Lost to Follow-up|0|||
147520650|NCT01004861|532057887|FG003|Overall Study|Lost to Follow-up|0|||
147520651|NCT01004861|532057888|FG004|Overall Study|Lost to Follow-up|0|||
147520652|NCT01004861|532057889|FG005|Overall Study|Lost to Follow-up|0|||
147520653|NCT01004861|532057890|FG006|Overall Study|Lost to Follow-up|0|||
147520654|NCT01004861|532057891|FG007|Overall Study|Lost to Follow-up|1|||
147520655|NCT01004861|532057892|FG008|Overall Study|Lost to Follow-up|3|||
147520656|NCT01004861|532057893|FG009|Overall Study|Lost to Follow-up|0|||
147520657|NCT01004861|532057894|FG010|Overall Study|Lost to Follow-up|0|||
147520658|NCT01004861|532057895|FG011|Overall Study|Lost to Follow-up|1|||
147520659|NCT01004861|532057896|FG012|Overall Study|Lost to Follow-up|0|||
147520660|NCT01004861|532057884|FG000|Overall Study|Non-compliance|0|||
147520661|NCT01004861|532057885|FG001|Overall Study|Non-compliance|0|||
147520662|NCT01004861|532057886|FG002|Overall Study|Non-compliance|0|||
147520663|NCT01004861|532057887|FG003|Overall Study|Non-compliance|0|||
147520664|NCT01004861|532057888|FG004|Overall Study|Non-compliance|0|||
147520665|NCT01004861|532057889|FG005|Overall Study|Non-compliance|0|||
147520666|NCT01004861|532057890|FG006|Overall Study|Non-compliance|0|||
147520667|NCT01004861|532057891|FG007|Overall Study|Non-compliance|0|||
147520668|NCT01004861|532057892|FG008|Overall Study|Non-compliance|5|||
147520669|NCT01004861|532057893|FG009|Overall Study|Non-compliance|0|||
147520670|NCT01004861|532057894|FG010|Overall Study|Non-compliance|0|||
147520671|NCT01004861|532057895|FG011|Overall Study|Non-compliance|0|||
147520672|NCT01004861|532057896|FG012|Overall Study|Non-compliance|1|||
147520673|NCT01004861|532057884|FG000|Overall Study|Other|0|||
147520674|NCT01004861|532057885|FG001|Overall Study|Other|0|||
147520675|NCT01004861|532057886|FG002|Overall Study|Other|0|||
147520676|NCT01004861|532057887|FG003|Overall Study|Other|0|||
147520677|NCT01004861|532057888|FG004|Overall Study|Other|0|||
147520678|NCT01004861|532057889|FG005|Overall Study|Other|0|||
147520679|NCT01004861|532057890|FG006|Overall Study|Other|0|||
147520680|NCT01004861|532057891|FG007|Overall Study|Other|0|||
147520681|NCT01004861|532057892|FG008|Overall Study|Other|0|||
147520682|NCT01004861|532057893|FG009|Overall Study|Other|2|||
147520683|NCT01004861|532057894|FG010|Overall Study|Other|1|||
147520684|NCT01004861|532057895|FG011|Overall Study|Other|2|||
147520685|NCT01004861|532057896|FG012|Overall Study|Other|3|||
147520686|NCT01004861|532057884|FG000|Overall Study|Patient decision|0|||
147520687|NCT01004861|532057885|FG001|Overall Study|Patient decision|0|||
147520688|NCT01004861|532057886|FG002|Overall Study|Patient decision|0|||
147520689|NCT01004861|532057887|FG003|Overall Study|Patient decision|0|||
147520690|NCT01004861|532057888|FG004|Overall Study|Patient decision|1|||
147520691|NCT01004861|532057889|FG005|Overall Study|Patient decision|0|||
147520692|NCT01004861|532057890|FG006|Overall Study|Patient decision|1|||
147520693|NCT01004861|532057891|FG007|Overall Study|Patient decision|0|||
147520694|NCT01004861|532057892|FG008|Overall Study|Patient decision|7|||
147520695|NCT01004861|532057893|FG009|Overall Study|Patient decision|1|||
147520696|NCT01004861|532057894|FG010|Overall Study|Patient decision|1|||
147520697|NCT01004861|532057895|FG011|Overall Study|Patient decision|2|||
147520698|NCT01004861|532057896|FG012|Overall Study|Patient decision|3|||
147520699|NCT01004861|532057884|FG000|Overall Study|Transitioned to Phase 4 study|0|||
147520700|NCT01004861|532057885|FG001|Overall Study|Transitioned to Phase 4 study|0|||
147520701|NCT01004861|532057886|FG002|Overall Study|Transitioned to Phase 4 study|0|||
147520702|NCT01004861|532057887|FG003|Overall Study|Transitioned to Phase 4 study|0|||
147520703|NCT01004861|532057888|FG004|Overall Study|Transitioned to Phase 4 study|0|||
147520704|NCT01004861|532057889|FG005|Overall Study|Transitioned to Phase 4 study|0|||
147520705|NCT01004861|532057890|FG006|Overall Study|Transitioned to Phase 4 study|0|||
147520706|NCT01004861|532057891|FG007|Overall Study|Transitioned to Phase 4 study|0|||
147520707|NCT01004861|532057892|FG008|Overall Study|Transitioned to Phase 4 study|2|||
147520708|NCT01004861|532057893|FG009|Overall Study|Transitioned to Phase 4 study|0|||
147520709|NCT01004861|532057894|FG010|Overall Study|Transitioned to Phase 4 study|0|||
147520710|NCT01004861|532057895|FG011|Overall Study|Transitioned to Phase 4 study|0|||
147520711|NCT01004861|532057896|FG012|Overall Study|Transitioned to Phase 4 study|0|||
147520712|NCT01004861|532057884|FG000|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
147520713|NCT01004861|532057885|FG001|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
147520714|NCT01004861|532057886|FG002|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
147520715|NCT01004861|532057887|FG003|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
147520716|NCT01004861|532057888|FG004|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
147520717|NCT01004861|532057889|FG005|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
147520718|NCT01004861|532057890|FG006|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
147520719|NCT01004861|532057891|FG007|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
147520720|NCT01004861|532057892|FG008|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|1|||
147520721|NCT01004861|532057893|FG009|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
147520722|NCT01004861|532057894|FG010|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
147520723|NCT01004861|532057895|FG011|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
147520724|NCT01004861|532057896|FG012|Overall Study|Patient completed 12-week follow-up and continued on commercially approved drug|0|||
147520725|NCT01004861|532057884|FG000|Overall Study|Patient withdrew|0|||
147520726|NCT01004861|532057885|FG001|Overall Study|Patient withdrew|0|||
147520727|NCT01004861|532057886|FG002|Overall Study|Patient withdrew|0|||
147520728|NCT01004861|532057887|FG003|Overall Study|Patient withdrew|0|||
147520729|NCT01004861|532057888|FG004|Overall Study|Patient withdrew|0|||
147520730|NCT01004861|532057889|FG005|Overall Study|Patient withdrew|0|||
147520731|NCT01004861|532057890|FG006|Overall Study|Patient withdrew|0|||
147520732|NCT01004861|532057891|FG007|Overall Study|Patient withdrew|0|||
147520733|NCT01004861|532057892|FG008|Overall Study|Patient withdrew|1|||
147520734|NCT01004861|532057893|FG009|Overall Study|Patient withdrew|0|||
147520735|NCT01004861|532057894|FG010|Overall Study|Patient withdrew|0|||
147520736|NCT01004861|532057895|FG011|Overall Study|Patient withdrew|0|||
147520737|NCT01004861|532057896|FG012|Overall Study|Patient withdrew|0|||
147520738|NCT01004861|532057884|FG000|Overall Study|Surgical resection|0|||
147520739|NCT01004861|532057885|FG001|Overall Study|Surgical resection|0|||
147520740|NCT01004861|532057886|FG002|Overall Study|Surgical resection|0|||
147520741|NCT01004861|532057887|FG003|Overall Study|Surgical resection|0|||
147520742|NCT01004861|532057888|FG004|Overall Study|Surgical resection|0|||
147520743|NCT01004861|532057889|FG005|Overall Study|Surgical resection|0|||
147520744|NCT01004861|532057890|FG006|Overall Study|Surgical resection|0|||
147520745|NCT01004861|532057891|FG007|Overall Study|Surgical resection|0|||
147520746|NCT01004861|532057892|FG008|Overall Study|Surgical resection|1|||
147520747|NCT01004861|532057893|FG009|Overall Study|Surgical resection|0|||
147520748|NCT01004861|532057894|FG010|Overall Study|Surgical resection|0|||
147520749|NCT01004861|532057895|FG011|Overall Study|Surgical resection|0|||
147520750|NCT01004861|532057896|FG012|Overall Study|Surgical resection|0|||
147520751|NCT01004861|532057884|FG000|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
147520752|NCT01004861|532057885|FG001|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
147520753|NCT01004861|532057886|FG002|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
147520754|NCT01004861|532057887|FG003|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
147520755|NCT01004861|532057888|FG004|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
147520756|NCT01004861|532057889|FG005|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
147520757|NCT01004861|532057890|FG006|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
147520758|NCT01004861|532057891|FG007|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
147520759|NCT01004861|532057892|FG008|Overall Study|Patient maintained complete response status throughout drug holiday|1|||
147520760|NCT01004861|532057893|FG009|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
147520761|NCT01004861|532057894|FG010|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
147520762|NCT01004861|532057895|FG011|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
147520763|NCT01004861|532057896|FG012|Overall Study|Patient maintained complete response status throughout drug holiday|0|||
147520764|NCT01004861|532057884|FG000|Overall Study|Study termination by Sponsor|0|||
147520765|NCT01004861|532057885|FG001|Overall Study|Study termination by Sponsor|0|||
147520766|NCT01004861|532057886|FG002|Overall Study|Study termination by Sponsor|0|||
147520767|NCT01004861|532057887|FG003|Overall Study|Study termination by Sponsor|0|||
147520768|NCT01004861|532057888|FG004|Overall Study|Study termination by Sponsor|0|||
147520769|NCT01004861|532057889|FG005|Overall Study|Study termination by Sponsor|0|||
147520770|NCT01004861|532057890|FG006|Overall Study|Study termination by Sponsor|0|||
147520771|NCT01004861|532057891|FG007|Overall Study|Study termination by Sponsor|0|||
147520772|NCT01004861|532057892|FG008|Overall Study|Study termination by Sponsor|1|||
147520773|NCT01004861|532057893|FG009|Overall Study|Study termination by Sponsor|0|||
147520774|NCT01004861|532057894|FG010|Overall Study|Study termination by Sponsor|0|||
147520775|NCT01004861|532057895|FG011|Overall Study|Study termination by Sponsor|0|||
147520776|NCT01004861|532057896|FG012|Overall Study|Study termination by Sponsor|0|||
147520777|NCT00003389|532057897|FG000|Overall Study|Disease progression|6|||
147520778|NCT00003389|532057898|FG001|Overall Study|Disease progression|1|||
147520779|NCT00003389|532057897|FG000|Overall Study|Adverse Event|13|||
147520780|NCT00003389|532057898|FG001|Overall Study|Adverse Event|2|||
147520781|NCT00003389|532057897|FG000|Overall Study|Death|0|||
147520782|NCT00003389|532057898|FG001|Overall Study|Death|3|||
147520783|NCT00003389|532057897|FG000|Overall Study|Withdrawal by Subject|12|||
147520784|NCT00003389|532057898|FG001|Overall Study|Withdrawal by Subject|5|||
147520785|NCT00003389|532057897|FG000|Overall Study|Alternative therapy|2|||
147520786|NCT00003389|532057898|FG001|Overall Study|Alternative therapy|1|||
147520787|NCT00003389|532057897|FG000|Overall Study|Complicating disease|1|||
147520788|NCT00003389|532057898|FG001|Overall Study|Complicating disease|0|||
147520789|NCT00003389|532057897|FG000|Overall Study|Off-treatment reason missing|31|||
147642940|NCT00742508|532511094|FG001|8-Week Primary Evaluation Period|Adverse Event|4|||
147520790|NCT00003389|532057898|FG001|Overall Study|Off-treatment reason missing|21|||
147520791|NCT00003389|532057897|FG000|Overall Study|Ineligible|33|||
147520792|NCT00003389|532057898|FG001|Overall Study|Ineligible|27|||
147520793|NCT02554721|532057899|FG000|Overall Study|Adverse Event|1|||
147520794|NCT02554721|532057900|FG001|Overall Study|Adverse Event|0|||
147520795|NCT02554721|532057901|FG002|Overall Study|Adverse Event|0|||
147520796|NCT02554721|532057902|FG003|Overall Study|Adverse Event|0|||
147520797|NCT02554721|532057903|FG004|Overall Study|Adverse Event|1|||
147520798|NCT02554721|532057899|FG000|Overall Study|Noncompliance|0|||
147520799|NCT02554721|532057900|FG001|Overall Study|Noncompliance|0|||
147520800|NCT02554721|532057901|FG002|Overall Study|Noncompliance|0|||
147520801|NCT02554721|532057902|FG003|Overall Study|Noncompliance|0|||
147520802|NCT02554721|532057903|FG004|Overall Study|Noncompliance|1|||
147520803|NCT04657003|532057905|FG000|Overall Study|Adverse Event|5|||
147520804|NCT04657003|532057906|FG001|Overall Study|Adverse Event|1|||
147520805|NCT04657003|532057907|FG002|Overall Study|Adverse Event|5|||
147520806|NCT04657003|532057905|FG000|Overall Study|Death|0|||
147520807|NCT04657003|532057906|FG001|Overall Study|Death|2|||
147520808|NCT04657003|532057907|FG002|Overall Study|Death|0|||
147520809|NCT04657003|532057905|FG000|Overall Study|Lost to Follow-up|8|||
147520810|NCT04657003|532057906|FG001|Overall Study|Lost to Follow-up|4|||
147520811|NCT04657003|532057907|FG002|Overall Study|Lost to Follow-up|10|||
147520812|NCT04657003|532057905|FG000|Overall Study|Other - As Reported by Investigator|3|||
147520813|NCT04657003|532057906|FG001|Overall Study|Other - As Reported by Investigator|2|||
147520814|NCT04657003|532057907|FG002|Overall Study|Other - As Reported by Investigator|2|||
147520815|NCT04657003|532057905|FG000|Overall Study|Pregnancy|2|||
147520816|NCT04657003|532057906|FG001|Overall Study|Pregnancy|0|||
147520817|NCT04657003|532057907|FG002|Overall Study|Pregnancy|2|||
147520818|NCT04657003|532057905|FG000|Overall Study|Withdrawal by Subject|16|||
147520819|NCT04657003|532057906|FG001|Overall Study|Withdrawal by Subject|7|||
147520820|NCT04657003|532057907|FG002|Overall Study|Withdrawal by Subject|10|||
147520821|NCT01823991|532057910|FG000|Overall Study|Withdrawal by Subject|8|||
147520822|NCT01823991|532057911|FG001|Overall Study|Withdrawal by Subject|5|||
147520823|NCT05158244|532057912|FG000|Overall Study|Withdrawal by principal investigator due to protocol deviation|1|||
147520824|NCT05158244|532057913|FG001|Overall Study|Withdrawal by principal investigator due to protocol deviation|0|||
147520825|NCT05158244|532057914|FG002|Overall Study|Withdrawal by principal investigator due to protocol deviation|0|||
147520826|NCT05158244|532057915|FG003|Overall Study|Withdrawal by principal investigator due to protocol deviation|0|||
147520827|NCT05158244|532057916|FG004|Overall Study|Withdrawal by principal investigator due to protocol deviation|0|||
147520828|NCT05158244|532057912|FG000|Overall Study|Withdrawal by Subject|0|||
147520829|NCT05158244|532057913|FG001|Overall Study|Withdrawal by Subject|0|||
147520830|NCT05158244|532057914|FG002|Overall Study|Withdrawal by Subject|1|||
147520831|NCT05158244|532057915|FG003|Overall Study|Withdrawal by Subject|0|||
147520832|NCT05158244|532057916|FG004|Overall Study|Withdrawal by Subject|0|||
147520833|NCT02185040|532057920|FG000|Part 1 Treatment Phase|Miscellaneous|0|||
147520834|NCT02185040|532057921|FG001|Part 1 Treatment Phase|Miscellaneous|0|||
147520835|NCT02185040|532057922|FG002|Part 1 Treatment Phase|Miscellaneous|1|||
147520836|NCT02185040|532057923|FG003|Part 1 Treatment Phase|Miscellaneous|0|||
147520837|NCT02185040|532057924|FG004|Part 1 Treatment Phase|Miscellaneous|0|||
147520838|NCT02185040|532057925|FG005|Part 1 Treatment Phase|Miscellaneous|0|||
147520839|NCT02185040|532057926|FG006|Part 1 Treatment Phase|Miscellaneous|0|||
147520840|NCT02185040|532057920|FG000|Part 1 Treatment Phase|Adverse Event|1|||
147520841|NCT02185040|532057921|FG001|Part 1 Treatment Phase|Adverse Event|0|||
147520842|NCT02185040|532057922|FG002|Part 1 Treatment Phase|Adverse Event|0|||
147520843|NCT02185040|532057923|FG003|Part 1 Treatment Phase|Adverse Event|2|||
147520844|NCT02185040|532057924|FG004|Part 1 Treatment Phase|Adverse Event|3|||
147520845|NCT02185040|532057925|FG005|Part 1 Treatment Phase|Adverse Event|0|||
147520846|NCT02185040|532057926|FG006|Part 1 Treatment Phase|Adverse Event|0|||
147520847|NCT02185040|532057920|FG000|Part 1 Treatment Phase|Withdrawal by Subject|0|||
147520848|NCT02185040|532057921|FG001|Part 1 Treatment Phase|Withdrawal by Subject|1|||
147520849|NCT02185040|532057922|FG002|Part 1 Treatment Phase|Withdrawal by Subject|0|||
147520850|NCT02185040|532057923|FG003|Part 1 Treatment Phase|Withdrawal by Subject|0|||
147520851|NCT02185040|532057924|FG004|Part 1 Treatment Phase|Withdrawal by Subject|0|||
147520852|NCT02185040|532057925|FG005|Part 1 Treatment Phase|Withdrawal by Subject|0|||
147520853|NCT02185040|532057926|FG006|Part 1 Treatment Phase|Withdrawal by Subject|0|||
147520854|NCT02185040|532057920|FG000|Part 1 Treatment Phase|Lost to Follow-up|0|||
147520855|NCT02185040|532057921|FG001|Part 1 Treatment Phase|Lost to Follow-up|1|||
147520856|NCT02185040|532057922|FG002|Part 1 Treatment Phase|Lost to Follow-up|0|||
147520857|NCT02185040|532057923|FG003|Part 1 Treatment Phase|Lost to Follow-up|0|||
147520858|NCT02185040|532057924|FG004|Part 1 Treatment Phase|Lost to Follow-up|0|||
147520859|NCT02185040|532057925|FG005|Part 1 Treatment Phase|Lost to Follow-up|0|||
147520860|NCT02185040|532057926|FG006|Part 1 Treatment Phase|Lost to Follow-up|0|||
147520861|NCT02185040|532057920|FG000|Active Treatment Extension Phase|Miscellaneous|0|||
147520862|NCT02185040|532057921|FG001|Active Treatment Extension Phase|Miscellaneous|0|||
147520863|NCT02185040|532057922|FG002|Active Treatment Extension Phase|Miscellaneous|0|||
147520864|NCT02185040|532057923|FG003|Active Treatment Extension Phase|Miscellaneous|0|||
147520865|NCT02185040|532057924|FG004|Active Treatment Extension Phase|Miscellaneous|0|||
147520866|NCT02185040|532057925|FG005|Active Treatment Extension Phase|Miscellaneous|1|||
147520867|NCT02185040|532057926|FG006|Active Treatment Extension Phase|Miscellaneous|0|||
147520868|NCT02185040|532057920|FG000|Active Treatment Extension Phase|Adverse Event|0|||
147520869|NCT02185040|532057921|FG001|Active Treatment Extension Phase|Adverse Event|0|||
147520870|NCT02185040|532057922|FG002|Active Treatment Extension Phase|Adverse Event|0|||
147520871|NCT02185040|532057923|FG003|Active Treatment Extension Phase|Adverse Event|0|||
147520872|NCT02185040|532057924|FG004|Active Treatment Extension Phase|Adverse Event|0|||
147520873|NCT02185040|532057925|FG005|Active Treatment Extension Phase|Adverse Event|1|||
147520874|NCT02185040|532057926|FG006|Active Treatment Extension Phase|Adverse Event|4|||
147520875|NCT02185040|532057920|FG000|Active Treatment Extension Phase|Withdrawal by Subject|0|||
147520876|NCT02185040|532057921|FG001|Active Treatment Extension Phase|Withdrawal by Subject|0|||
147520877|NCT02185040|532057922|FG002|Active Treatment Extension Phase|Withdrawal by Subject|0|||
147520878|NCT02185040|532057923|FG003|Active Treatment Extension Phase|Withdrawal by Subject|0|||
147520879|NCT02185040|532057924|FG004|Active Treatment Extension Phase|Withdrawal by Subject|0|||
147520880|NCT02185040|532057925|FG005|Active Treatment Extension Phase|Withdrawal by Subject|1|||
147520881|NCT02185040|532057926|FG006|Active Treatment Extension Phase|Withdrawal by Subject|1|||
147520882|NCT02185040|532057920|FG000|Active Treatment Extension Phase|Lost to Follow-up|0|||
147520883|NCT02185040|532057921|FG001|Active Treatment Extension Phase|Lost to Follow-up|0|||
147520884|NCT02185040|532057922|FG002|Active Treatment Extension Phase|Lost to Follow-up|0|||
147520885|NCT02185040|532057923|FG003|Active Treatment Extension Phase|Lost to Follow-up|0|||
147520886|NCT02185040|532057924|FG004|Active Treatment Extension Phase|Lost to Follow-up|0|||
147520887|NCT02185040|532057925|FG005|Active Treatment Extension Phase|Lost to Follow-up|0|||
147520888|NCT02185040|532057926|FG006|Active Treatment Extension Phase|Lost to Follow-up|2|||
147520889|NCT00811395|532057928|FG000|Extension Treatment|Adverse Event|1|||
147520890|NCT00811395|532057929|FG001|Extension Treatment|Adverse Event|2|||
147520891|NCT00811395|532057930|FG002|Extension Treatment|Adverse Event|2|||
147520892|NCT00811395|532057931|FG003|Extension Treatment|Adverse Event|2|||
147520893|NCT00811395|532057932|FG004|Extension Treatment|Adverse Event|0|||
147520894|NCT00811395|532057933|FG005|Extension Treatment|Adverse Event|1|||
147520895|NCT00811395|532057928|FG000|Extension Treatment|Progressive disease|1|||
147520896|NCT00811395|532057929|FG001|Extension Treatment|Progressive disease|1|||
147520897|NCT00811395|532057930|FG002|Extension Treatment|Progressive disease|0|||
147520898|NCT00811395|532057931|FG003|Extension Treatment|Progressive disease|0|||
147520899|NCT00811395|532057932|FG004|Extension Treatment|Progressive disease|0|||
147520900|NCT00811395|532057933|FG005|Extension Treatment|Progressive disease|0|||
147520901|NCT00811395|532057928|FG000|Extension Treatment|Participant did not wish to continue|0|||
147520902|NCT00811395|532057929|FG001|Extension Treatment|Participant did not wish to continue|3|||
147520903|NCT00811395|532057930|FG002|Extension Treatment|Participant did not wish to continue|0|||
147520904|NCT00811395|532057931|FG003|Extension Treatment|Participant did not wish to continue|1|||
147520905|NCT00811395|532057932|FG004|Extension Treatment|Participant did not wish to continue|0|||
147520906|NCT00811395|532057933|FG005|Extension Treatment|Participant did not wish to continue|1|||
147520907|NCT00811395|532057928|FG000|Extension Treatment|Other than above|0|||
147520908|NCT00811395|532057929|FG001|Extension Treatment|Other than above|0|||
147520909|NCT00811395|532057930|FG002|Extension Treatment|Other than above|1|||
147520910|NCT00811395|532057931|FG003|Extension Treatment|Other than above|0|||
147520911|NCT00811395|532057932|FG004|Extension Treatment|Other than above|0|||
147520912|NCT00811395|532057933|FG005|Extension Treatment|Other than above|0|||
147520913|NCT00170846|532057934|FG000|Overall Study|Subject withdrew Informed Consent|5|||
147520914|NCT00170846|532057935|FG001|Overall Study|Subject withdrew Informed Consent|12|||
147520915|NCT00170846|532057936|FG002|Overall Study|Subject withdrew Informed Consent|8|||
147520916|NCT00170846|532057934|FG000|Overall Study|Lost to Follow-up|6|||
147520917|NCT00170846|532057935|FG001|Overall Study|Lost to Follow-up|3|||
147520918|NCT00170846|532057936|FG002|Overall Study|Lost to Follow-up|2|||
147520919|NCT00170846|532057934|FG000|Overall Study|Death|0|||
147520920|NCT00170846|532057935|FG001|Overall Study|Death|3|||
147520921|NCT00170846|532057936|FG002|Overall Study|Death|3|||
147520922|NCT00170846|532057934|FG000|Overall Study|Reason Missing|0|||
147520923|NCT00170846|532057935|FG001|Overall Study|Reason Missing|1|||
147520924|NCT00170846|532057936|FG002|Overall Study|Reason Missing|0|||
147520925|NCT00528840|532057937|FG000|Overall Study|Lost to Follow-up|10|||
147520926|NCT00528840|532057937|FG000|Overall Study|Adverse Event|1|||
147520927|NCT00528840|532057937|FG000|Overall Study|Withdrawal by Subject|17|||
147520928|NCT00528840|532057937|FG000|Overall Study|Death|2|||
147520929|NCT00528840|532057937|FG000|Overall Study|Administrative Reasons|1|||
147520930|NCT00528840|532057937|FG000|Overall Study|Other|2|||
147520931|NCT01756833|532057943|FG000|Overall Study|Withdrawal by Subject|4|||
147520932|NCT01756833|532057944|FG001|Overall Study|Withdrawal by Subject|3|||
147520933|NCT00808132|532057948|FG000|Overall Study|Adverse Event|34|||
147520934|NCT00808132|532057949|FG001|Overall Study|Adverse Event|33|||
147520935|NCT00808132|532057950|FG002|Overall Study|Adverse Event|16|||
147520936|NCT00808132|532057951|FG003|Overall Study|Adverse Event|31|||
147520937|NCT00808132|532057952|FG004|Overall Study|Adverse Event|33|||
147520938|NCT00808132|532057948|FG000|Overall Study|Death|0|||
147520939|NCT00808132|532057949|FG001|Overall Study|Death|0|||
147520940|NCT00808132|532057950|FG002|Overall Study|Death|0|||
147520941|NCT00808132|532057951|FG003|Overall Study|Death|0|||
147520942|NCT00808132|532057952|FG004|Overall Study|Death|1|||
147520943|NCT00808132|532057948|FG000|Overall Study|Physician Decision|0|||
147520944|NCT00808132|532057949|FG001|Overall Study|Physician Decision|1|||
147520945|NCT00808132|532057950|FG002|Overall Study|Physician Decision|0|||
147520946|NCT00808132|532057951|FG003|Overall Study|Physician Decision|0|||
147520947|NCT00808132|532057952|FG004|Overall Study|Physician Decision|0|||
147520948|NCT00808132|532057948|FG000|Overall Study|Lost to Follow-up|8|||
147520949|NCT00808132|532057949|FG001|Overall Study|Lost to Follow-up|10|||
147520950|NCT00808132|532057950|FG002|Overall Study|Lost to Follow-up|11|||
147520951|NCT00808132|532057951|FG003|Overall Study|Lost to Follow-up|8|||
147520952|NCT00808132|532057952|FG004|Overall Study|Lost to Follow-up|9|||
147520953|NCT00808132|532057948|FG000|Overall Study|Protocol Violation|8|||
147520954|NCT00808132|532057949|FG001|Overall Study|Protocol Violation|9|||
147520955|NCT00808132|532057950|FG002|Overall Study|Protocol Violation|4|||
147520956|NCT00808132|532057951|FG003|Overall Study|Protocol Violation|9|||
147520957|NCT00808132|532057952|FG004|Overall Study|Protocol Violation|5|||
147520958|NCT00808132|532057948|FG000|Overall Study|Withdrawal by Subject|27|||
147520959|NCT00808132|532057949|FG001|Overall Study|Withdrawal by Subject|18|||
147642941|NCT00742508|532511093|FG000|8-Week Primary Evaluation Period|Protocol Violation|1|||
147642942|NCT00742508|532511094|FG001|8-Week Primary Evaluation Period|Protocol Violation|0|||
147642943|NCT00742508|532511093|FG000|8-Week Primary Evaluation Period|Met Protocol-defined Stopping Criteria|8|||
147642944|NCT00742508|532511094|FG001|8-Week Primary Evaluation Period|Met Protocol-defined Stopping Criteria|5|||
147642945|NCT00742508|532511093|FG000|8-Week Primary Evaluation Period|Withdrawal by Subject|0|||
147642946|NCT00742508|532511094|FG001|8-Week Primary Evaluation Period|Withdrawal by Subject|2|||
147642947|NCT00742508|532511093|FG000|4-Week Exploratory Evaluation Period|Met Protocol-defined Stopping Criteria|0|||
147642948|NCT00742508|532511094|FG001|4-Week Exploratory Evaluation Period|Met Protocol-defined Stopping Criteria|1|||
147642949|NCT04972968|532511096|FG000|Overall Study|Adverse Event|3|||
147642950|NCT04972968|532511097|FG001|Overall Study|Adverse Event|1|||
147642951|NCT04972968|532511098|FG002|Overall Study|Adverse Event|1|||
147642952|NCT04972968|532511099|FG003|Overall Study|Adverse Event|7|||
147642953|NCT04972968|532511096|FG000|Overall Study|Lack of Efficacy|2|||
147642954|NCT04972968|532511097|FG001|Overall Study|Lack of Efficacy|1|||
147642955|NCT04972968|532511098|FG002|Overall Study|Lack of Efficacy|0|||
147642956|NCT04972968|532511099|FG003|Overall Study|Lack of Efficacy|0|||
147642957|NCT04972968|532511096|FG000|Overall Study|Withdrawal by Subject|7|||
147642958|NCT04972968|532511097|FG001|Overall Study|Withdrawal by Subject|4|||
147642959|NCT04972968|532511098|FG002|Overall Study|Withdrawal by Subject|3|||
147642960|NCT04972968|532511099|FG003|Overall Study|Withdrawal by Subject|2|||
147642961|NCT04972968|532511096|FG000|Overall Study|Study Terminated by Sponsor|25|||
147642962|NCT04972968|532511097|FG001|Overall Study|Study Terminated by Sponsor|28|||
147642963|NCT04972968|532511098|FG002|Overall Study|Study Terminated by Sponsor|32|||
147642964|NCT04972968|532511099|FG003|Overall Study|Study Terminated by Sponsor|27|||
147642965|NCT04972968|532511096|FG000|Overall Study|Other|1|||
147642966|NCT04972968|532511097|FG001|Overall Study|Other|0|||
147642967|NCT04972968|532511098|FG002|Overall Study|Other|1|||
147642968|NCT04972968|532511099|FG003|Overall Study|Other|1|||
147642969|NCT01698879|532511100|FG000|Overall Study|Withdrawal by Subject|1|||
147642970|NCT01698879|532511101|FG001|Overall Study|Withdrawal by Subject|0|||
147642971|NCT01698879|532511102|FG002|Overall Study|Withdrawal by Subject|0|||
147642972|NCT03619902|532511104|FG000|Overall Study|Termination of Study by Investigator|1|||
147642973|NCT03619902|532511104|FG000|Overall Study|Use of Excluded/Prohibited Medication|1|||
147642974|NCT04450407|532511105|FG000|Overall Study|Withdrawal by Subject|10|||
147642975|NCT04450407|532511106|FG001|Overall Study|Withdrawal by Subject|1|||
147642976|NCT04450407|532511107|FG002|Overall Study|Withdrawal by Subject|4|||
147642977|NCT04450407|532511105|FG000|Overall Study|Adverse Event|0|||
147642978|NCT04450407|532511106|FG001|Overall Study|Adverse Event|0|||
147642979|NCT04450407|532511107|FG002|Overall Study|Adverse Event|1|||
147642980|NCT04450407|532511105|FG000|Overall Study|Lost to Follow-up|1|||
147642981|NCT04450407|532511106|FG001|Overall Study|Lost to Follow-up|0|||
147642982|NCT04450407|532511107|FG002|Overall Study|Lost to Follow-up|0|||
147642983|NCT04450407|532511105|FG000|Overall Study|Physician Decision|0|||
147642984|NCT04450407|532511106|FG001|Overall Study|Physician Decision|0|||
147642985|NCT04450407|532511107|FG002|Overall Study|Physician Decision|1|||
147642986|NCT04450407|532511105|FG000|Overall Study|Pregnancy|1|||
147642987|NCT04450407|532511106|FG001|Overall Study|Pregnancy|0|||
147642988|NCT04450407|532511107|FG002|Overall Study|Pregnancy|0|||
147642989|NCT04450407|532511105|FG000|Overall Study|Protocol Violation|2|||
147520960|NCT00808132|532057950|FG002|Overall Study|Withdrawal by Subject|2|||
147520961|NCT00808132|532057951|FG003|Overall Study|Withdrawal by Subject|7|||
147520962|NCT00808132|532057952|FG004|Overall Study|Withdrawal by Subject|16|||
147520963|NCT00808132|532057948|FG000|Overall Study|Other|6|||
147520964|NCT00808132|532057949|FG001|Overall Study|Other|4|||
147520965|NCT00808132|532057950|FG002|Overall Study|Other|6|||
147520966|NCT00808132|532057951|FG003|Overall Study|Other|2|||
147520967|NCT00808132|532057952|FG004|Overall Study|Other|15|||
147642990|NCT04450407|532511106|FG001|Overall Study|Protocol Violation|0|||
147642991|NCT04450407|532511107|FG002|Overall Study|Protocol Violation|0|||
147642992|NCT04450407|532511105|FG000|Overall Study|Investigational site terminated by sponsor|3|||
147642993|NCT04450407|532511106|FG001|Overall Study|Investigational site terminated by sponsor|0|||
147642994|NCT04450407|532511107|FG002|Overall Study|Investigational site terminated by sponsor|2|||
147642995|NCT00474045|532511110|FG000|Overall Study|Adverse Event|18|||
147642996|NCT00474045|532511111|FG001|Overall Study|Adverse Event|8|||
147642997|NCT00474045|532511110|FG000|Overall Study|Unclassified|1|||
147642998|NCT00474045|532511111|FG001|Overall Study|Unclassified|3|||
147642999|NCT00474045|532511110|FG000|Overall Study|Lack of Efficacy|0|||
147643000|NCT00474045|532511111|FG001|Overall Study|Lack of Efficacy|9|||
147643001|NCT00474045|532511110|FG000|Overall Study|Lost to Follow-up|1|||
147643002|NCT00474045|532511111|FG001|Overall Study|Lost to Follow-up|1|||
147643003|NCT00474045|532511110|FG000|Overall Study|Protocol Violation|10|||
147643004|NCT00474045|532511111|FG001|Overall Study|Protocol Violation|12|||
147643005|NCT00474045|532511110|FG000|Overall Study|Withdrawal by Subject|16|||
147643006|NCT00474045|532511111|FG001|Overall Study|Withdrawal by Subject|18|||
147643007|NCT00474045|532511110|FG000|Overall Study|Withdrawal criteria|60|||
147643008|NCT00474045|532511111|FG001|Overall Study|Withdrawal criteria|50|||
147643009|NCT02009397|532511112|FG000|Overall Study|Protocol Violation|6|||
147643010|NCT02009397|532511112|FG000|Overall Study|Death|8|||
147643011|NCT02009397|532511112|FG000|Overall Study|Lost to Follow-up|6|||
147643012|NCT00808639|532511119|FG000|Overall Study|Disease progression before surgery.|1|||
147643013|NCT00710684|532511122|FG000|Overall Study|Adverse Event|11|||
147643014|NCT00710684|532511123|FG001|Overall Study|Adverse Event|19|||
147643015|NCT00710684|532511124|FG002|Overall Study|Adverse Event|16|||
147643016|NCT00710684|532511122|FG000|Overall Study|Lack of Efficacy|4|||
147643017|NCT00710684|532511123|FG001|Overall Study|Lack of Efficacy|3|||
147643018|NCT00710684|532511124|FG002|Overall Study|Lack of Efficacy|5|||
147643019|NCT00710684|532511122|FG000|Overall Study|Protocol Violation|5|||
147643020|NCT00710684|532511123|FG001|Overall Study|Protocol Violation|5|||
147643021|NCT00710684|532511124|FG002|Overall Study|Protocol Violation|5|||
147643022|NCT00710684|532511122|FG000|Overall Study|Lost to Follow-up|4|||
147643023|NCT00710684|532511123|FG001|Overall Study|Lost to Follow-up|6|||
147643024|NCT00710684|532511124|FG002|Overall Study|Lost to Follow-up|7|||
147643025|NCT00710684|532511122|FG000|Overall Study|Physician Decision|0|||
147643026|NCT00710684|532511123|FG001|Overall Study|Physician Decision|2|||
147643027|NCT00710684|532511124|FG002|Overall Study|Physician Decision|4|||
147643028|NCT00710684|532511122|FG000|Overall Study|Withdrawal by Subject|24|||
147643029|NCT00710684|532511123|FG001|Overall Study|Withdrawal by Subject|18|||
147643030|NCT00710684|532511124|FG002|Overall Study|Withdrawal by Subject|11|||
147643031|NCT00710684|532511122|FG000|Overall Study|Missing|1|||
147643032|NCT00710684|532511123|FG001|Overall Study|Missing|0|||
147643033|NCT00710684|532511124|FG002|Overall Study|Missing|0|||
147643034|NCT00710684|532511122|FG000|Overall Study|Did not continue after week 24|25|||
147643035|NCT00710684|532511123|FG001|Overall Study|Did not continue after week 24|21|||
147643036|NCT00710684|532511124|FG002|Overall Study|Did not continue after week 24|16|||
147643037|NCT00514904|532511125|FG000|Overall Study|Withdrawal by Subject|3|||
147643038|NCT00514904|532511126|FG001|Overall Study|Withdrawal by Subject|2|||
147643039|NCT00514904|532511125|FG000|Overall Study|Lost to Follow-up|21|||
147643040|NCT00514904|532511126|FG001|Overall Study|Lost to Follow-up|3|||
147643041|NCT01317797|532511127|FG000|Overall Study|Other|0|||
147643042|NCT01317797|532511128|FG001|Overall Study|Other|1|||
147643043|NCT01317797|532511129|FG002|Overall Study|Other|0|||
147643044|NCT01317797|532511127|FG000|Overall Study|Withdrawal of Patient|0|||
147643045|NCT01317797|532511128|FG001|Overall Study|Withdrawal of Patient|0|||
147643046|NCT01317797|532511129|FG002|Overall Study|Withdrawal of Patient|1|||
147643047|NCT01306045|532511133|FG000|Met General Eligibility Criteria|Screen failures|193|||
147643048|NCT01306045|532511134|FG001|Met General Eligibility Criteria|Screen failures|11|||
147643049|NCT01306045|532511135|FG002|Met General Eligibility Criteria|Screen failures|8|||
147643050|NCT04550832|532512651|FG000|Overall Study|Adverse Event|0|||
147643051|NCT04550832|532512652|FG001|Overall Study|Adverse Event|0|||
147520968|NCT00808132|532057948|FG000|Overall Study|Randomized, but not treated|10|||
147520969|NCT00808132|532057949|FG001|Overall Study|Randomized, but not treated|7|||
147643052|NCT04550832|532512653|FG002|Overall Study|Adverse Event|2|||
147643053|NCT04550832|532512654|FG003|Overall Study|Adverse Event|0|||
147643054|NCT04550832|532512655|FG004|Overall Study|Adverse Event|1|||
147643055|NCT04823130|532512656|FG000|Overall Study|Withdrawal by Subject|2|||
147520970|NCT00808132|532057950|FG002|Overall Study|Randomized, but not treated|9|||
147643056|NCT04823130|532512657|FG001|Overall Study|Withdrawal by Subject|3|||
147643057|NCT04823130|532512656|FG000|Overall Study|Failure to meet inclusion criteria|6|||
147643058|NCT04823130|532512657|FG001|Overall Study|Failure to meet inclusion criteria|4|||
147643059|NCT04823130|532512656|FG000|Overall Study|Other-unspecified|1|||
147643060|NCT04823130|532512657|FG001|Overall Study|Other-unspecified|0|||
147643061|NCT03315455|532512659|FG000|Overall Study|Ongoing in the Study|13|||
147643062|NCT03315455|532512660|FG001|Overall Study|Ongoing in the Study|24|||
147520971|NCT00808132|532057951|FG003|Overall Study|Randomized, but not treated|8|||
147520972|NCT00808132|532057952|FG004|Overall Study|Randomized, but not treated|9|||
147643063|NCT03315455|532512661|FG002|Overall Study|Ongoing in the Study|17|||
147643064|NCT03315455|532512662|FG003|Overall Study|Ongoing in the Study|15|||
147643065|NCT03315455|532512659|FG000|Overall Study|Withdrawal by Subject|0|||
147643066|NCT03315455|532512660|FG001|Overall Study|Withdrawal by Subject|1|||
147643067|NCT03315455|532512661|FG002|Overall Study|Withdrawal by Subject|0|||
147643068|NCT03315455|532512662|FG003|Overall Study|Withdrawal by Subject|0|||
147643069|NCT04439357|532512663|FG000|Overall Study|Disease Progression|4|||
147643070|NCT01458951|532512671|FG000|Overall Study|Other|1|||
147643071|NCT01458951|532512672|FG001|Overall Study|Other|0|||
147643072|NCT01458951|532512673|FG002|Overall Study|Other|0|||
147643073|NCT01458951|532512671|FG000|Overall Study|Protocol Violation|5|||
147643074|NCT01458951|532512672|FG001|Overall Study|Protocol Violation|1|||
147643075|NCT01458951|532512673|FG002|Overall Study|Protocol Violation|0|||
147643076|NCT01458951|532512671|FG000|Overall Study|Withdrawal by Subject|2|||
147643077|NCT01458951|532512672|FG001|Overall Study|Withdrawal by Subject|0|||
147643078|NCT01458951|532512673|FG002|Overall Study|Withdrawal by Subject|2|||
147643079|NCT01458951|532512671|FG000|Overall Study|Adverse Event|7|||
147643080|NCT01458951|532512672|FG001|Overall Study|Adverse Event|0|||
147643081|NCT01458951|532512673|FG002|Overall Study|Adverse Event|2|||
147643082|NCT01458951|532512671|FG000|Overall Study|Insufficient Clinical Response|17|||
147643083|NCT01458951|532512672|FG001|Overall Study|Insufficient Clinical Response|0|||
147643084|NCT01458951|532512673|FG002|Overall Study|Insufficient Clinical Response|11|||
147643085|NCT04392167|532512678|FG000|Overall Study|unable to swallow a/LCI-OCT probe|6|||
147643086|NCT01573767|532512679|FG000|Overall Study|Adverse Event|0|||
147643087|NCT01573767|532512680|FG001|Overall Study|Adverse Event|1|||
147643088|NCT01573767|532512681|FG002|Overall Study|Adverse Event|0|||
147643089|NCT01573767|532512682|FG003|Overall Study|Adverse Event|1|||
147643090|NCT01573767|532512679|FG000|Overall Study|Lack of Efficacy|18|||
147643091|NCT01573767|532512680|FG001|Overall Study|Lack of Efficacy|15|||
147643092|NCT01573767|532512681|FG002|Overall Study|Lack of Efficacy|12|||
147643093|NCT01573767|532512682|FG003|Overall Study|Lack of Efficacy|17|||
147643094|NCT01573767|532512679|FG000|Overall Study|Protocol Violation|3|||
147643095|NCT01573767|532512680|FG001|Overall Study|Protocol Violation|1|||
147643096|NCT01573767|532512681|FG002|Overall Study|Protocol Violation|1|||
147643097|NCT01573767|532512682|FG003|Overall Study|Protocol Violation|3|||
147643098|NCT01573767|532512679|FG000|Overall Study|Lost to Follow-up|0|||
147643099|NCT01573767|532512680|FG001|Overall Study|Lost to Follow-up|1|||
147643100|NCT01573767|532512681|FG002|Overall Study|Lost to Follow-up|1|||
147643101|NCT01573767|532512682|FG003|Overall Study|Lost to Follow-up|1|||
147643102|NCT01573767|532512679|FG000|Overall Study|Physician Decision|1|||
147643103|NCT01573767|532512680|FG001|Overall Study|Physician Decision|2|||
147643104|NCT01573767|532512681|FG002|Overall Study|Physician Decision|0|||
147643105|NCT01573767|532512682|FG003|Overall Study|Physician Decision|2|||
147643106|NCT01573767|532512679|FG000|Overall Study|Withdrawal by Subject|0|||
147643107|NCT01573767|532512680|FG001|Overall Study|Withdrawal by Subject|1|||
147643108|NCT01573767|532512681|FG002|Overall Study|Withdrawal by Subject|0|||
147643109|NCT01573767|532512682|FG003|Overall Study|Withdrawal by Subject|0|||
147643110|NCT00473824|532512683|FG000|Overall Study|Virologic Breakthrough|1|||
147643111|NCT00473824|532512684|FG001|Overall Study|Virologic Breakthrough|0|||
147643112|NCT00473824|532512683|FG000|Overall Study|Adverse Event|1|||
147643113|NCT00473824|532512684|FG001|Overall Study|Adverse Event|0|||
147643114|NCT00473824|532512683|FG000|Overall Study|Death|1|||
147643115|NCT00473824|532512684|FG001|Overall Study|Death|0|||
147643116|NCT00473824|532512683|FG000|Overall Study|Lost to Follow-up|1|||
147643117|NCT00473824|532512684|FG001|Overall Study|Lost to Follow-up|0|||
147643118|NCT00473824|532512683|FG000|Overall Study|Withdrawal by physician|1|||
147643119|NCT00473824|532512684|FG001|Overall Study|Withdrawal by physician|0|||
147643120|NCT02560623|532512685|FG000|Overall Study|Unable to swallow sponge|0|||
147643121|NCT02560623|532512686|FG001|Overall Study|Unable to swallow sponge|1|||
147643122|NCT02560623|532512687|FG002|Overall Study|Unable to swallow sponge|0|||
147643123|NCT02560623|532512688|FG003|Overall Study|Unable to swallow sponge|0|||
147520973|NCT00808132|532057948|FG000|Overall Study|Unsatisfactory response|5|||
147643124|NCT02560623|532512685|FG000|Overall Study|Intervention prior to sponge administration|0|||
147643125|NCT02560623|532512686|FG001|Overall Study|Intervention prior to sponge administration|1|||
147643126|NCT02560623|532512687|FG002|Overall Study|Intervention prior to sponge administration|0|||
147643127|NCT02560623|532512688|FG003|Overall Study|Intervention prior to sponge administration|0|||
147643128|NCT01661933|532512691|FG000|Low-dose Gluten Challenge|Physician Decision|2|||
147643129|NCT01661933|532512691|FG000|High-dose Gluten Challenge|Withdrawal by Subject|2|||
147643130|NCT00723190|532512697|FG000|Overall Study|Withdrawal by Subject|45|||
147643131|NCT00723190|532512697|FG000|Overall Study|Lost to Follow-up|37|||
147643132|NCT00723190|532512697|FG000|Overall Study|Adverse Event|18|||
147643133|NCT00723190|532512697|FG000|Overall Study|Lack of Efficacy|16|||
147643134|NCT00723190|532512697|FG000|Overall Study|Protocol Violation|15|||
147643135|NCT00723190|532512697|FG000|Overall Study|Other-Premature Discontinuation|9|||
147643136|NCT00723190|532512697|FG000|Overall Study|Other-Not included in safety population|2|||
147520974|NCT00808132|532057949|FG001|Overall Study|Unsatisfactory response|6|||
147520975|NCT00808132|532057950|FG002|Overall Study|Unsatisfactory response|6|||
147520976|NCT00808132|532057951|FG003|Overall Study|Unsatisfactory response|4|||
147520977|NCT00808132|532057952|FG004|Overall Study|Unsatisfactory response|12|||
147520978|NCT02795182|532057953|FG000|Overall Study|Death|5|||
147520979|NCT02795182|532057954|FG001|Overall Study|Death|4|||
147520980|NCT02795182|532057955|FG002|Overall Study|Death|4|||
147520981|NCT02795182|532057956|FG003|Overall Study|Death|18|||
147520982|NCT02795182|532057953|FG000|Overall Study|Sponsor's Decision at Discontinuation and Death at End of Trial|0|||
147520983|NCT02795182|532057954|FG001|Overall Study|Sponsor's Decision at Discontinuation and Death at End of Trial|0|||
147520984|NCT02795182|532057955|FG002|Overall Study|Sponsor's Decision at Discontinuation and Death at End of Trial|0|||
147520985|NCT02795182|532057956|FG003|Overall Study|Sponsor's Decision at Discontinuation and Death at End of Trial|1|||
147520986|NCT02795182|532057953|FG000|Overall Study|Physician's decision at Discontinuation and Death at End of Trial|0|||
147520987|NCT02795182|532057954|FG001|Overall Study|Physician's decision at Discontinuation and Death at End of Trial|0|||
147520988|NCT02795182|532057955|FG002|Overall Study|Physician's decision at Discontinuation and Death at End of Trial|0|||
147520989|NCT02795182|532057956|FG003|Overall Study|Physician's decision at Discontinuation and Death at End of Trial|2|||
147520990|NCT02795182|532057953|FG000|Overall Study|Study Ended by Sponsor Once Primary and Secondary Objectives Were Met|3|||
147520991|NCT02795182|532057954|FG001|Overall Study|Study Ended by Sponsor Once Primary and Secondary Objectives Were Met|2|||
147520992|NCT02795182|532057955|FG002|Overall Study|Study Ended by Sponsor Once Primary and Secondary Objectives Were Met|0|||
147520993|NCT02795182|532057956|FG003|Overall Study|Study Ended by Sponsor Once Primary and Secondary Objectives Were Met|8|||
147520994|NCT02795182|532057953|FG000|Overall Study|Withdrawal by Subject|4|||
147520995|NCT02795182|532057954|FG001|Overall Study|Withdrawal by Subject|0|||
147520996|NCT02795182|532057955|FG002|Overall Study|Withdrawal by Subject|0|||
147520997|NCT02795182|532057956|FG003|Overall Study|Withdrawal by Subject|3|||
147520998|NCT02795182|532057953|FG000|Overall Study|Lost to Follow-up|0|||
147520999|NCT02795182|532057954|FG001|Overall Study|Lost to Follow-up|0|||
147521000|NCT02795182|532057955|FG002|Overall Study|Lost to Follow-up|1|||
147521001|NCT02795182|532057956|FG003|Overall Study|Lost to Follow-up|1|||
147521002|NCT02795182|532057953|FG000|Overall Study|Roll Over to Long Term Extension|3|||
147521003|NCT02795182|532057954|FG001|Overall Study|Roll Over to Long Term Extension|3|||
147521004|NCT02795182|532057955|FG002|Overall Study|Roll Over to Long Term Extension|2|||
147521005|NCT02795182|532057956|FG003|Overall Study|Roll Over to Long Term Extension|5|||
147521006|NCT02795182|532057953|FG000|Overall Study|Progressive Disease|0|||
147521007|NCT02795182|532057954|FG001|Overall Study|Progressive Disease|1|||
147521008|NCT02795182|532057955|FG002|Overall Study|Progressive Disease|0|||
147521009|NCT02795182|532057956|FG003|Overall Study|Progressive Disease|4|||
147521010|NCT02795182|532057953|FG000|Overall Study|Physician Decision|0|||
147521011|NCT02795182|532057954|FG001|Overall Study|Physician Decision|0|||
147521012|NCT02795182|532057955|FG002|Overall Study|Physician Decision|0|||
147521013|NCT02795182|532057956|FG003|Overall Study|Physician Decision|1|||
147521014|NCT00398086|532057959|FG000|Overall Study|Unacceptable Toxicity|2|||
147521015|NCT00398086|532057960|FG001|Overall Study|Unacceptable Toxicity|8|||
147521016|NCT00398086|532057961|FG002|Overall Study|Unacceptable Toxicity|2|||
147521017|NCT00398086|532057959|FG000|Overall Study|Adverse Event|1|||
147521018|NCT00398086|532057960|FG001|Overall Study|Adverse Event|4|||
147521019|NCT00398086|532057961|FG002|Overall Study|Adverse Event|0|||
147521020|NCT00398086|532057959|FG000|Overall Study|Physician Decision|1|||
147521021|NCT00398086|532057960|FG001|Overall Study|Physician Decision|4|||
147521022|NCT00398086|532057961|FG002|Overall Study|Physician Decision|0|||
147643137|NCT00454818|532512698|FG000|Phase I: Open-label Dose-escalation|Received heart transplant|1|||
147643138|NCT00454818|532512699|FG001|Phase I: Open-label Dose-escalation|Received heart transplant|0|||
147643139|NCT00454818|532512700|FG002|Phase I: Open-label Dose-escalation|Received heart transplant|0|||
147643140|NCT00454818|532512701|FG003|Phase I: Open-label Dose-escalation|Received heart transplant|0|||
147643141|NCT00454818|532512702|FG004|Phase I: Open-label Dose-escalation|Received heart transplant|0|||
147643142|NCT00454818|532512698|FG000|Phase I: Open-label Dose-escalation|Death|0|||
147643143|NCT00454818|532512699|FG001|Phase I: Open-label Dose-escalation|Death|1|||
147643144|NCT00454818|532512700|FG002|Phase I: Open-label Dose-escalation|Death|0|||
147643145|NCT00454818|532512701|FG003|Phase I: Open-label Dose-escalation|Death|0|||
147643146|NCT00454818|532512702|FG004|Phase I: Open-label Dose-escalation|Death|0|||
147643147|NCT00454818|532512698|FG000|Phase I: Open-label Dose-escalation|Received left ventricular assist device|0|||
147643148|NCT00454818|532512699|FG001|Phase I: Open-label Dose-escalation|Received left ventricular assist device|0|||
147643149|NCT00454818|532512700|FG002|Phase I: Open-label Dose-escalation|Received left ventricular assist device|1|||
147643150|NCT00454818|532512701|FG003|Phase I: Open-label Dose-escalation|Received left ventricular assist device|1|||
147643151|NCT00454818|532512702|FG004|Phase I: Open-label Dose-escalation|Received left ventricular assist device|0|||
147643152|NCT00454818|532512698|FG000|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|0|||
147643153|NCT00454818|532512699|FG001|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|1|||
147643154|NCT00454818|532512700|FG002|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|0|||
147643155|NCT00454818|532512701|FG003|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|1|||
147643156|NCT00454818|532512702|FG004|Phase 2: Randomized Double-blind|Received milrinone or dobutamine|0|||
147643157|NCT00454818|532512698|FG000|Phase 2: Randomized Double-blind|Death|0|||
147643158|NCT00454818|532512699|FG001|Phase 2: Randomized Double-blind|Death|1|||
147643159|NCT00454818|532512700|FG002|Phase 2: Randomized Double-blind|Death|0|||
147643160|NCT00454818|532512701|FG003|Phase 2: Randomized Double-blind|Death|0|||
147643161|NCT00454818|532512702|FG004|Phase 2: Randomized Double-blind|Death|1|||
147643162|NCT00454818|532512698|FG000|Phase 2: Randomized Double-blind|Received a heart transplant|0|||
147643163|NCT00454818|532512699|FG001|Phase 2: Randomized Double-blind|Received a heart transplant|0|||
147643164|NCT00454818|532512700|FG002|Phase 2: Randomized Double-blind|Received a heart transplant|2|||
147643165|NCT00454818|532512701|FG003|Phase 2: Randomized Double-blind|Received a heart transplant|0|||
147643166|NCT00454818|532512702|FG004|Phase 2: Randomized Double-blind|Received a heart transplant|1|||
147643167|NCT00454818|532512698|FG000|Phase 2: Randomized Double-blind|Received left ventricular assist device|0|||
147643168|NCT00454818|532512699|FG001|Phase 2: Randomized Double-blind|Received left ventricular assist device|0|||
147643169|NCT00454818|532512700|FG002|Phase 2: Randomized Double-blind|Received left ventricular assist device|1|||
147643170|NCT00454818|532512701|FG003|Phase 2: Randomized Double-blind|Received left ventricular assist device|0|||
147643171|NCT00454818|532512702|FG004|Phase 2: Randomized Double-blind|Received left ventricular assist device|2|||
147643172|NCT03181503|532512703|FG000|Overall Study|Adverse Event|2|||
147643173|NCT03181503|532512704|FG001|Overall Study|Adverse Event|2|||
147643174|NCT03181503|532512703|FG000|Overall Study|Protocol Violation|1|||
147643175|NCT03181503|532512704|FG001|Overall Study|Protocol Violation|0|||
147643176|NCT03181503|532512703|FG000|Overall Study|Withdrawal by Subject|3|||
147643177|NCT03181503|532512704|FG001|Overall Study|Withdrawal by Subject|0|||
147643178|NCT03181503|532512703|FG000|Overall Study|Lost to Follow-up|1|||
147643179|NCT03181503|532512704|FG001|Overall Study|Lost to Follow-up|1|||
147643180|NCT01892085|532512705|FG000|Overall Study|Death|4|||
147643181|NCT01892085|532512706|FG001|Overall Study|Death|1|||
147643182|NCT01892085|532512707|FG002|Overall Study|Death|3|||
147643183|NCT01892085|532512705|FG000|Overall Study|Withdrawal by Subject|2|||
147643184|NCT01892085|532512706|FG001|Overall Study|Withdrawal by Subject|0|||
147643185|NCT01892085|532512707|FG002|Overall Study|Withdrawal by Subject|2|||
147643186|NCT03448939|532512709|FG000|Overall Study|Adverse Event|5|||
147643187|NCT03448939|532512710|FG001|Overall Study|Adverse Event|1|||
147643188|NCT03448939|532512709|FG000|Overall Study|Lost to Follow-up|6|||
147643189|NCT03448939|532512710|FG001|Overall Study|Lost to Follow-up|6|||
147643190|NCT03448939|532512709|FG000|Overall Study|Pregnancy|1|||
147643191|NCT03448939|532512710|FG001|Overall Study|Pregnancy|1|||
147643192|NCT03448939|532512709|FG000|Overall Study|Withdrawal by Subject|9|||
147643193|NCT03448939|532512710|FG001|Overall Study|Withdrawal by Subject|3|||
147643194|NCT03488225|532512713|FG000|Overall Study|Off Protocol Therapy|2|||
147643195|NCT03488225|532512713|FG000|Overall Study|Stem Cell Transplant|2|||
147643196|NCT01472965|532512714|FG000|Overall Study|Withdrawal by Subject|1|||
147521023|NCT00398086|532057959|FG000|Overall Study|Withdrawal by Subject|5|||
147521024|NCT00398086|532057960|FG001|Overall Study|Withdrawal by Subject|7|||
147521025|NCT00398086|532057961|FG002|Overall Study|Withdrawal by Subject|0|||
147521026|NCT00696774|532057962|FG000|Period II|Adverse Event|0|||
147521027|NCT00696774|532057963|FG001|Period II|Adverse Event|0|||
147521028|NCT00696774|532057964|FG002|Period II|Adverse Event|15|||
147521029|NCT00696774|532057962|FG000|Period II|Lost to Follow-up|0|||
147521030|NCT00696774|532057963|FG001|Period II|Lost to Follow-up|0|||
147521031|NCT00696774|532057964|FG002|Period II|Lost to Follow-up|4|||
147521032|NCT00696774|532057962|FG000|Period II|Protocol Violation|0|||
147521033|NCT00696774|532057963|FG001|Period II|Protocol Violation|0|||
147521034|NCT00696774|532057964|FG002|Period II|Protocol Violation|11|||
147521035|NCT00696774|532057962|FG000|Period II|Withdrawal by Subject|0|||
147521036|NCT00696774|532057963|FG001|Period II|Withdrawal by Subject|0|||
147521037|NCT00696774|532057964|FG002|Period II|Withdrawal by Subject|4|||
147521038|NCT00696774|532057962|FG000|Period II|Sponsor Decision|0|||
147521039|NCT00696774|532057963|FG001|Period II|Sponsor Decision|0|||
147521040|NCT00696774|532057964|FG002|Period II|Sponsor Decision|0|||
147521041|NCT00696774|532057962|FG000|Period II|Lack of Efficacy|0|||
147521042|NCT00696774|532057963|FG001|Period II|Lack of Efficacy|0|||
147521043|NCT00696774|532057964|FG002|Period II|Lack of Efficacy|2|||
147521044|NCT00696774|532057962|FG000|Period III|Adverse Event|1|||
147521045|NCT00696774|532057963|FG001|Period III|Adverse Event|1|||
147521046|NCT00696774|532057964|FG002|Period III|Adverse Event|0|||
147521047|NCT00696774|532057962|FG000|Period III|Lost to Follow-up|2|||
147521048|NCT00696774|532057963|FG001|Period III|Lost to Follow-up|1|||
147521049|NCT00696774|532057964|FG002|Period III|Lost to Follow-up|0|||
147521050|NCT00696774|532057962|FG000|Period III|Protocol Violation|1|||
147521051|NCT00696774|532057963|FG001|Period III|Protocol Violation|1|||
147521052|NCT00696774|532057964|FG002|Period III|Protocol Violation|0|||
147521053|NCT00696774|532057962|FG000|Period III|Withdrawal by Subject|1|||
147521054|NCT00696774|532057963|FG001|Period III|Withdrawal by Subject|2|||
147521055|NCT00696774|532057964|FG002|Period III|Withdrawal by Subject|0|||
147521056|NCT00696774|532057962|FG000|Period III|Sponsor Decision|2|||
147521057|NCT00696774|532057963|FG001|Period III|Sponsor Decision|0|||
147521058|NCT00696774|532057964|FG002|Period III|Sponsor Decision|0|||
147521059|NCT00696774|532057962|FG000|Period III|Lack of Efficacy|0|||
147521060|NCT00696774|532057963|FG001|Period III|Lack of Efficacy|2|||
147521061|NCT00696774|532057964|FG002|Period III|Lack of Efficacy|0|||
147521062|NCT00890201|532057965|FG000|Overall Study|Protocol Violation|5|||
147521063|NCT00890201|532057966|FG001|Overall Study|Protocol Violation|56|||
147521064|NCT00033293|532057967|FG000|Overall Study|Death|0|||
147521065|NCT00033293|532057968|FG001|Overall Study|Death|1|||
147521066|NCT00033293|532057967|FG000|Overall Study|Lack of Efficacy|5|||
147643197|NCT01472965|532512715|FG001|Overall Study|Withdrawal by Subject|0|||
147643198|NCT04631107|532512718|FG000|First Intervention (1 Night)|ineligible participant was inadvertently randomized but not treated|1|||
147643199|NCT04631107|532512718|FG000|Second Intervention (1 Night)|Adverse Event|1|||
147643200|NCT04631107|532512718|FG000|Second Intervention (1 Night)|Withdrawal by Subject|1|||
147643201|NCT04631107|532512718|FG000|Third Intervention (1 Night)|Withdrawal by Subject|2|||
147643202|NCT00096993|532512725|FG000|Overall Study|Death|1|||
147643203|NCT00096993|532512726|FG001|Overall Study|Death|0|||
147643204|NCT00096993|532512725|FG000|Overall Study|Disease progression|56|||
147643205|NCT00096993|532512726|FG001|Overall Study|Disease progression|53|||
147643206|NCT00096993|532512725|FG000|Overall Study|Adverse Event|2|||
147643207|NCT00096993|532512726|FG001|Overall Study|Adverse Event|8|||
147643208|NCT00096993|532512725|FG000|Overall Study|Subject's decision|3|||
147643209|NCT00096993|532512726|FG001|Overall Study|Subject's decision|1|||
147643210|NCT00096993|532512725|FG000|Overall Study|Physician Decision|2|||
147643211|NCT00096993|532512726|FG001|Overall Study|Physician Decision|1|||
147643212|NCT00096993|532512725|FG000|Overall Study|Non-compliance|0|||
147643213|NCT00096993|532512726|FG001|Overall Study|Non-compliance|1|||
147643214|NCT00096993|532512725|FG000|Overall Study|Other unspecified|1|||
147643215|NCT00096993|532512726|FG001|Overall Study|Other unspecified|1|||
147643216|NCT00435487|532512729|FG000|Overall Study|Death|3|||
147643217|NCT00435487|532512730|FG001|Overall Study|Death|4|||
147643218|NCT00435487|532512729|FG000|Overall Study|Adverse Event|0|||
147643219|NCT00435487|532512730|FG001|Overall Study|Adverse Event|3|||
147643220|NCT00435487|532512729|FG000|Overall Study|Lost to Follow-up|2|||
147643221|NCT00435487|532512730|FG001|Overall Study|Lost to Follow-up|2|||
147643222|NCT00435487|532512729|FG000|Overall Study|Other|5|||
147643223|NCT00435487|532512730|FG001|Overall Study|Other|2|||
147643224|NCT00435487|532512729|FG000|Overall Study|Withdrawal by Subject|2|||
147643225|NCT00435487|532512730|FG001|Overall Study|Withdrawal by Subject|1|||
147643226|NCT00435487|532512729|FG000|Overall Study|Withdrawal by Subject Prior to Treatment|0|||
147643227|NCT00435487|532512730|FG001|Overall Study|Withdrawal by Subject Prior to Treatment|2|||
147643228|NCT00435487|532512729|FG000|Overall Study|Received Drug in Other Treatment Group|0|||
147643229|NCT00435487|532512730|FG001|Overall Study|Received Drug in Other Treatment Group|1|||
147643230|NCT00835679|532512731|FG000|Overall Study|Withdrawal by Subject|1|||
147643231|NCT00835679|532512732|FG001|Overall Study|Withdrawal by Subject|0|||
147643232|NCT00835679|532512733|FG002|Overall Study|Withdrawal by Subject|0|||
147643233|NCT00835679|532512734|FG003|Overall Study|Withdrawal by Subject|0|||
147643234|NCT00191282|532512739|FG000|Overall Study|Adverse Event|5|||
147643235|NCT00191282|532512740|FG001|Overall Study|Adverse Event|6|||
147643236|NCT00191282|532512739|FG000|Overall Study|Death|51|||
147643237|NCT00191282|532512740|FG001|Overall Study|Death|51|||
147643238|NCT00191282|532512739|FG000|Overall Study|Lack of Efficacy|11|||
147643239|NCT00191282|532512740|FG001|Overall Study|Lack of Efficacy|6|||
147643240|NCT00191282|532512739|FG000|Overall Study|Noncompliance|14|||
147643241|NCT00191282|532512740|FG001|Overall Study|Noncompliance|17|||
147643242|NCT00191282|532512739|FG000|Overall Study|Patient moved|11|||
147643243|NCT00191282|532512740|FG001|Overall Study|Patient moved|14|||
147643244|NCT00191282|532512739|FG000|Overall Study|Withdrawal by Subject|59|||
147643245|NCT00191282|532512740|FG001|Overall Study|Withdrawal by Subject|44|||
147643246|NCT00191282|532512739|FG000|Overall Study|Physician Decision|18|||
147643247|NCT00191282|532512740|FG001|Overall Study|Physician Decision|15|||
147643248|NCT00191282|532512739|FG000|Overall Study|Protocol entry criteria not met|14|||
147643249|NCT00191282|532512740|FG001|Overall Study|Protocol entry criteria not met|9|||
147643250|NCT00191282|532512739|FG000|Overall Study|Protocol Violation|9|||
147643251|NCT00191282|532512740|FG001|Overall Study|Protocol Violation|12|||
147643252|NCT00191282|532512739|FG000|Overall Study|Severity of outcome|2|||
147643253|NCT00191282|532512740|FG001|Overall Study|Severity of outcome|5|||
147643254|NCT00191282|532512739|FG000|Overall Study|Sponsor's decision|2|||
147643255|NCT00191282|532512740|FG001|Overall Study|Sponsor's decision|2|||
147643256|NCT00191282|532512739|FG000|Overall Study|Lost to Follow-up|24|||
147643257|NCT00191282|532512740|FG001|Overall Study|Lost to Follow-up|31|||
147643258|NCT04756154|532512743|FG000|Overall Study|Did not meet treatment day baseline|30|||
147643259|NCT04756154|532512744|FG001|Overall Study|Did not meet treatment day baseline|28|||
147643260|NCT04756154|532512745|FG002|Overall Study|Did not meet treatment day baseline|7|||
147643261|NCT04756154|532512743|FG000|Overall Study|Did not return for final sample collection|1|||
147643262|NCT04756154|532512744|FG001|Overall Study|Did not return for final sample collection|1|||
147643263|NCT04756154|532512745|FG002|Overall Study|Did not return for final sample collection|0|||
147521067|NCT00033293|532057968|FG001|Overall Study|Lack of Efficacy|8|||
147643264|NCT03589976|532512746|FG000|Overall Study|Death|5|||
147643265|NCT03589976|532512747|FG001|Overall Study|Death|1|||
147643266|NCT03589976|532512746|FG000|Overall Study|Adverse Event|5|||
147643267|NCT03589976|532512747|FG001|Overall Study|Adverse Event|1|||
147643268|NCT03589976|532512746|FG000|Overall Study|Withdrawal by Subject|4|||
147521068|NCT00033293|532057967|FG000|Overall Study|Lost to Follow-up|0|||
147521069|NCT00033293|532057968|FG001|Overall Study|Lost to Follow-up|1|||
147521070|NCT00033293|532057967|FG000|Overall Study|Physician Decision|3|||
147521071|NCT00033293|532057968|FG001|Overall Study|Physician Decision|1|||
147521072|NCT00033293|532057967|FG000|Overall Study|Withdrawal by Subject|1|||
147521073|NCT00033293|532057968|FG001|Overall Study|Withdrawal by Subject|0|||
147521074|NCT00033293|532057967|FG000|Overall Study|Could not be weaned from steroid therapy|1|||
147521075|NCT00033293|532057968|FG001|Overall Study|Could not be weaned from steroid therapy|1|||
147521076|NCT00033293|532057967|FG000|Overall Study|Treatment refused|0|||
147521077|NCT00033293|532057968|FG001|Overall Study|Treatment refused|6|||
147521078|NCT02087241|532057969|FG000|Overall Study|Death|2|||
147521079|NCT02087241|532057970|FG001|Overall Study|Death|1|||
147521080|NCT02087241|532057971|FG002|Overall Study|Death|1|||
147521081|NCT02087241|532057972|FG003|Overall Study|Death|1|||
147521082|NCT02087241|532057969|FG000|Overall Study|Withdrawal by Subject|1|||
147521083|NCT02087241|532057970|FG001|Overall Study|Withdrawal by Subject|0|||
147521084|NCT02087241|532057971|FG002|Overall Study|Withdrawal by Subject|0|||
147521085|NCT02087241|532057972|FG003|Overall Study|Withdrawal by Subject|1|||
147521086|NCT02087241|532057969|FG000|Overall Study|Progressive Disease|0|||
147521087|NCT02087241|532057970|FG001|Overall Study|Progressive Disease|0|||
147521088|NCT02087241|532057971|FG002|Overall Study|Progressive Disease|0|||
147521089|NCT02087241|532057972|FG003|Overall Study|Progressive Disease|1|||
147521090|NCT02087241|532057969|FG000|Overall Study|Study Terminated by Sponsor|0|||
147521091|NCT02087241|532057970|FG001|Overall Study|Study Terminated by Sponsor|2|||
147521092|NCT02087241|532057971|FG002|Overall Study|Study Terminated by Sponsor|0|||
147521093|NCT02087241|532057972|FG003|Overall Study|Study Terminated by Sponsor|4|||
147643269|NCT03589976|532512747|FG001|Overall Study|Withdrawal by Subject|1|||
147643270|NCT03589976|532512746|FG000|Overall Study|Lost to Follow-up|1|||
147643271|NCT03589976|532512747|FG001|Overall Study|Lost to Follow-up|0|||
147643272|NCT03589976|532512746|FG000|Overall Study|Other|4|||
147643273|NCT03589976|532512747|FG001|Overall Study|Other|3|||
147643274|NCT02089334|532512750|FG000|Overall Study|Withdrawal by Subject|0|||
147643275|NCT02089334|532512751|FG001|Overall Study|Withdrawal by Subject|0|||
147643276|NCT02089334|532512752|FG002|Overall Study|Withdrawal by Subject|0|||
147643277|NCT02089334|532512753|FG003|Overall Study|Withdrawal by Subject|2|||
147643278|NCT02089334|532512750|FG000|Overall Study|Adverse Event|0|||
147643279|NCT02089334|532512751|FG001|Overall Study|Adverse Event|0|||
147643280|NCT02089334|532512752|FG002|Overall Study|Adverse Event|0|||
147643281|NCT02089334|532512753|FG003|Overall Study|Adverse Event|2|||
147643282|NCT02089334|532512750|FG000|Overall Study|Progressive disease|0|||
147643283|NCT02089334|532512751|FG001|Overall Study|Progressive disease|0|||
147643284|NCT02089334|532512752|FG002|Overall Study|Progressive disease|0|||
147643285|NCT02089334|532512753|FG003|Overall Study|Progressive disease|2|||
147643286|NCT02089334|532512750|FG000|Overall Study|Physician Decision|0|||
147643287|NCT02089334|532512751|FG001|Overall Study|Physician Decision|0|||
147643288|NCT02089334|532512752|FG002|Overall Study|Physician Decision|1|||
147643289|NCT02089334|532512753|FG003|Overall Study|Physician Decision|1|||
147643290|NCT04778059|532512754|FG000|Overall Study|Death|2|||
147643291|NCT04778059|532512755|FG001|Overall Study|Death|2|||
147643292|NCT04778059|532512756|FG002|Overall Study|Death|1|||
147643293|NCT04778059|532512757|FG003|Overall Study|Death|1|||
147643294|NCT04778059|532512758|FG004|Overall Study|Death|1|||
147643295|NCT04778059|532512754|FG000|Overall Study|Lost to Follow-up|0|||
147643296|NCT04778059|532512755|FG001|Overall Study|Lost to Follow-up|0|||
147643297|NCT04778059|532512756|FG002|Overall Study|Lost to Follow-up|0|||
147643298|NCT04778059|532512757|FG003|Overall Study|Lost to Follow-up|0|||
147643299|NCT04778059|532512758|FG004|Overall Study|Lost to Follow-up|1|||
147643300|NCT04778059|532512754|FG000|Overall Study|Telemed not done due to internal miscommunication.|0|||
147643301|NCT04778059|532512755|FG001|Overall Study|Telemed not done due to internal miscommunication.|0|||
147643302|NCT04778059|532512756|FG002|Overall Study|Telemed not done due to internal miscommunication.|0|||
147643303|NCT04778059|532512757|FG003|Overall Study|Telemed not done due to internal miscommunication.|0|||
147643304|NCT04778059|532512758|FG004|Overall Study|Telemed not done due to internal miscommunication.|1|||
147643305|NCT02832375|532512759|FG000|Overall Study|Lost to Follow-up|1|||
147643306|NCT02832375|532512760|FG001|Overall Study|Lost to Follow-up|0|||
147643307|NCT02832375|532512759|FG000|Overall Study|Withdrawal of Consent|1|||
147643308|NCT02832375|532512760|FG001|Overall Study|Withdrawal of Consent|0|||
147643309|NCT03430895|532512766|FG000|Overall Study|Not Treated|2|||
147643310|NCT00084318|532512767|FG000|Overall Study|Withdrawal by Subject|5|||
147643311|NCT00084318|532512768|FG001|Overall Study|Withdrawal by Subject|2|||
147643312|NCT00084318|532512767|FG000|Overall Study|Protocol Violation|15|||
147643313|NCT00084318|532512768|FG001|Overall Study|Protocol Violation|11|||
147643314|NCT00084318|532512767|FG000|Overall Study|No protocol treatment|2|||
147643315|NCT00084318|532512768|FG001|Overall Study|No protocol treatment|0|||
147643316|NCT01645891|532512774|FG000|Overall Study|Adverse Event|6|||
147643317|NCT01645891|532512775|FG001|Overall Study|Adverse Event|10|||
147643318|NCT01645891|532512774|FG000|Overall Study|Adverse Event Unrelated to Wound|5|||
147643319|NCT01645891|532512775|FG001|Overall Study|Adverse Event Unrelated to Wound|3|||
147643320|NCT01645891|532512774|FG000|Overall Study|Withdrawal by Subject|3|||
147643321|NCT01645891|532512775|FG001|Overall Study|Withdrawal by Subject|3|||
147643322|NCT01645891|532512774|FG000|Overall Study|Protocol Violation|4|||
147643323|NCT01645891|532512775|FG001|Overall Study|Protocol Violation|0|||
147643324|NCT01645891|532512774|FG000|Overall Study|Lost to Follow-up|4|||
147643325|NCT01645891|532512775|FG001|Overall Study|Lost to Follow-up|1|||
147643326|NCT01645891|532512774|FG000|Overall Study|Death|0|||
147643327|NCT01645891|532512775|FG001|Overall Study|Death|2|||
147643328|NCT00138073|532512778|FG000|Overall Study|lack of resources|55|||
147643329|NCT03026530|532512779|FG000|Overall Study|Lost to Follow-up|19|||
147643330|NCT03026530|532512780|FG001|Overall Study|Lost to Follow-up|24|||
147643331|NCT03026530|532512779|FG000|Overall Study|Protocol Violation|2|||
147643332|NCT03026530|532512780|FG001|Overall Study|Protocol Violation|5|||
147643333|NCT03301740|532512781|FG000|Phase 2 Intervention (3 Weeks)|Kidney Transplant|1|||
147643334|NCT03301740|532512782|FG001|Phase 2 Intervention (3 Weeks)|Kidney Transplant|0|||
147643335|NCT03301740|532512781|FG000|Phase 4 Intervention (3 Weeks)|Prolonged Hospitalization|1|||
147521094|NCT02181504|532057973|FG000|Overall Study|Adverse Event|1|||
147643336|NCT03301740|532512782|FG001|Phase 4 Intervention (3 Weeks)|Prolonged Hospitalization|0|||
147643337|NCT01173055|532512786|FG000|Period 1 - Day 1 to 49|Withdrawal by Subject|2|||
147643338|NCT01173055|532512787|FG001|Period 1 - Day 1 to 49|Withdrawal by Subject|2|||
147643339|NCT01173055|532512786|FG000|Period 2 - Day 64 to 112|Adverse Event|0|||
147643340|NCT01173055|532512787|FG001|Period 2 - Day 64 to 112|Adverse Event|1|||
147643341|NCT04814368|532512789|FG000|Overall Study|Study Terminated by Sponsor|0|||
147521095|NCT02181504|532057974|FG001|Overall Study|Adverse Event|1|||
147521096|NCT02181504|532057975|FG002|Overall Study|Adverse Event|1|||
147521097|NCT00887913|532057978|FG000|Overall Study|Withdrawal by Subject|6|||
147521098|NCT00598585|532057979|FG000|Overall Study|Lost to Follow-up|1|||
147521099|NCT00598585|532057980|FG001|Overall Study|Lost to Follow-up|0|||
147521100|NCT01200758|532057981|FG000|Stage I|Death|0|||
147521101|NCT01200758|532057982|FG001|Stage I|Death|1|||
147521102|NCT01200758|532057983|FG002|Stage I|Death|0|||
147521103|NCT01200758|532057984|FG003|Stage I|Death|0|||
147521104|NCT01200758|532057981|FG000|Stage I|Physician Decision|1|||
147521105|NCT01200758|532057982|FG001|Stage I|Physician Decision|1|||
147521106|NCT01200758|532057983|FG002|Stage I|Physician Decision|0|||
147521107|NCT01200758|532057984|FG003|Stage I|Physician Decision|0|||
147521108|NCT01200758|532057981|FG000|Stage I|Lack of Efficacy|2|||
147521109|NCT01200758|532057982|FG001|Stage I|Lack of Efficacy|1|||
147521110|NCT01200758|532057983|FG002|Stage I|Lack of Efficacy|0|||
147521111|NCT01200758|532057984|FG003|Stage I|Lack of Efficacy|0|||
147521112|NCT01200758|532057981|FG000|Stage I|Adverse Event|5|||
147521113|NCT01200758|532057982|FG001|Stage I|Adverse Event|5|||
147521114|NCT01200758|532057983|FG002|Stage I|Adverse Event|0|||
147521115|NCT01200758|532057984|FG003|Stage I|Adverse Event|0|||
147521116|NCT01200758|532057981|FG000|Stage I|Withdrawal by Subject|1|||
147521117|NCT01200758|532057982|FG001|Stage I|Withdrawal by Subject|2|||
147643342|NCT04814368|532512790|FG001|Overall Study|Study Terminated by Sponsor|3|||
147643343|NCT04814368|532512791|FG002|Overall Study|Study Terminated by Sponsor|0|||
147643344|NCT04814368|532512792|FG003|Overall Study|Study Terminated by Sponsor|2|||
147643345|NCT04814368|532512789|FG000|Overall Study|Subject Decision|1|||
147643346|NCT04814368|532512790|FG001|Overall Study|Subject Decision|2|||
147643347|NCT04814368|532512791|FG002|Overall Study|Subject Decision|0|||
147643348|NCT04814368|532512792|FG003|Overall Study|Subject Decision|0|||
147643349|NCT04216589|532512794|FG000|Overall Study|Withdrawal by Subject|2|||
147643350|NCT04216589|532512794|FG000|Overall Study|Protocol Violation|1|||
147643351|NCT04216589|532512794|FG000|Overall Study|Incarceration|1|||
147643352|NCT03721835|532512795|FG000|Overall Study|Participant not able to return|1|||
147643353|NCT03721835|532512795|FG000|Overall Study|Lost to Follow-up|1|||
147643354|NCT03721835|532512795|FG000|Overall Study|Revision of the components of the study device|2|||
147643355|NCT03721835|532512795|FG000|Overall Study|Sponsor terminated study|6|||
147643356|NCT03721835|532512795|FG000|Overall Study|Death|1|||
147643357|NCT03721835|532512795|FG000|Overall Study|Sponsor decision|1|||
147643358|NCT02294461|532512800|FG000|Double-blind Period (up to 29.4 Months)|Death|6|||
147643359|NCT02294461|532512801|FG001|Double-blind Period (up to 29.4 Months)|Death|4|||
147643360|NCT02294461|532512802|FG002|Double-blind Period (up to 29.4 Months)|Death|0|||
147643361|NCT02294461|532512800|FG000|Double-blind Period (up to 29.4 Months)|Miscellaneous|30|||
147643362|NCT02294461|532512801|FG001|Double-blind Period (up to 29.4 Months)|Miscellaneous|66|||
147643363|NCT02294461|532512802|FG002|Double-blind Period (up to 29.4 Months)|Miscellaneous|0|||
147643364|NCT02294461|532512800|FG000|Double-blind Period (up to 29.4 Months)|Withdrawal by Subject|27|||
147643365|NCT02294461|532512801|FG001|Double-blind Period (up to 29.4 Months)|Withdrawal by Subject|54|||
147643366|NCT02294461|532512802|FG002|Double-blind Period (up to 29.4 Months)|Withdrawal by Subject|0|||
147643367|NCT02294461|532512800|FG000|Double-blind Period (up to 29.4 Months)|Protocol Deviation|0|||
147643368|NCT02294461|532512801|FG001|Double-blind Period (up to 29.4 Months)|Protocol Deviation|2|||
147643369|NCT02294461|532512802|FG002|Double-blind Period (up to 29.4 Months)|Protocol Deviation|0|||
147643370|NCT02294461|532512800|FG000|Double-blind Period (up to 29.4 Months)|Lost to Follow-up|1|||
147643371|NCT02294461|532512801|FG001|Double-blind Period (up to 29.4 Months)|Lost to Follow-up|0|||
147643372|NCT02294461|532512802|FG002|Double-blind Period (up to 29.4 Months)|Lost to Follow-up|0|||
147643373|NCT02294461|532512800|FG000|Double-blind Period (up to 29.4 Months)|Progressive Disease|38|||
147643374|NCT02294461|532512801|FG001|Double-blind Period (up to 29.4 Months)|Progressive Disease|51|||
147643375|NCT02294461|532512802|FG002|Double-blind Period (up to 29.4 Months)|Progressive Disease|0|||
147643376|NCT02294461|532512800|FG000|Double-blind Period (up to 29.4 Months)|Adverse Event|16|||
147643377|NCT02294461|532512801|FG001|Double-blind Period (up to 29.4 Months)|Adverse Event|15|||
147643378|NCT02294461|532512802|FG002|Double-blind Period (up to 29.4 Months)|Adverse Event|0|||
147643379|NCT02294461|532512800|FG000|Open-label Period (up to 54.3 Months)|Miscellaneous|28|||
147643380|NCT02294461|532512801|FG001|Open-label Period (up to 54.3 Months)|Miscellaneous|0|||
147643381|NCT02294461|532512802|FG002|Open-label Period (up to 54.3 Months)|Miscellaneous|16|||
147643382|NCT02294461|532512800|FG000|Open-label Period (up to 54.3 Months)|Withdrawal by Subject|19|||
147643383|NCT02294461|532512801|FG001|Open-label Period (up to 54.3 Months)|Withdrawal by Subject|0|||
147643384|NCT02294461|532512802|FG002|Open-label Period (up to 54.3 Months)|Withdrawal by Subject|10|||
147643385|NCT02294461|532512800|FG000|Open-label Period (up to 54.3 Months)|Protocol Deviation|2|||
147521118|NCT01200758|532057983|FG002|Stage I|Withdrawal by Subject|0|||
147521119|NCT01200758|532057984|FG003|Stage I|Withdrawal by Subject|0|||
147521120|NCT01200758|532057981|FG000|Stage I|Disease Progression|9|||
147521121|NCT01200758|532057982|FG001|Stage I|Disease Progression|7|||
147521122|NCT01200758|532057983|FG002|Stage I|Disease Progression|0|||
147521123|NCT01200758|532057984|FG003|Stage I|Disease Progression|0|||
147521124|NCT01200758|532057981|FG000|Stage 2|Disease Progression|0|||
147521125|NCT01200758|532057982|FG001|Stage 2|Disease Progression|0|||
147521126|NCT01200758|532057983|FG002|Stage 2|Disease Progression|16|||
147521127|NCT01200758|532057984|FG003|Stage 2|Disease Progression|21|||
147521128|NCT01200758|532057981|FG000|Stage 2|Lack of Efficacy|0|||
147521129|NCT01200758|532057982|FG001|Stage 2|Lack of Efficacy|0|||
147521130|NCT01200758|532057983|FG002|Stage 2|Lack of Efficacy|4|||
147521131|NCT01200758|532057984|FG003|Stage 2|Lack of Efficacy|2|||
147521132|NCT01200758|532057981|FG000|Stage 2|Physician Decision|0|||
147521133|NCT01200758|532057982|FG001|Stage 2|Physician Decision|0|||
147521134|NCT01200758|532057983|FG002|Stage 2|Physician Decision|5|||
147521135|NCT01200758|532057984|FG003|Stage 2|Physician Decision|7|||
147521136|NCT01200758|532057981|FG000|Stage 2|Adverse Event|0|||
147521137|NCT01200758|532057982|FG001|Stage 2|Adverse Event|0|||
147521138|NCT01200758|532057983|FG002|Stage 2|Adverse Event|5|||
147521139|NCT01200758|532057984|FG003|Stage 2|Adverse Event|9|||
147521140|NCT01200758|532057981|FG000|Stage 2|Withdrawal by Subject|0|||
147521141|NCT01200758|532057982|FG001|Stage 2|Withdrawal by Subject|0|||
147521142|NCT01200758|532057983|FG002|Stage 2|Withdrawal by Subject|4|||
147521143|NCT01200758|532057984|FG003|Stage 2|Withdrawal by Subject|1|||
147521144|NCT01200758|532057981|FG000|Stage 2|Lost to Follow-up|0|||
147521145|NCT01200758|532057982|FG001|Stage 2|Lost to Follow-up|0|||
147521146|NCT01200758|532057983|FG002|Stage 2|Lost to Follow-up|3|||
147521147|NCT01200758|532057984|FG003|Stage 2|Lost to Follow-up|1|||
147521148|NCT01200758|532057981|FG000|Stage 2|Protocol Violation|0|||
147521149|NCT01200758|532057982|FG001|Stage 2|Protocol Violation|0|||
147521150|NCT01200758|532057983|FG002|Stage 2|Protocol Violation|1|||
147521151|NCT01200758|532057984|FG003|Stage 2|Protocol Violation|4|||
147521152|NCT01200758|532057981|FG000|Stage 2|Death|0|||
147521153|NCT01200758|532057982|FG001|Stage 2|Death|0|||
147521154|NCT01200758|532057983|FG002|Stage 2|Death|3|||
147521155|NCT01200758|532057984|FG003|Stage 2|Death|5|||
147521156|NCT00461552|532057987|FG000|Overall Study|Drug Dispensing error|0|||
147521157|NCT00461552|532057988|FG001|Overall Study|Drug Dispensing error|2|||
147521158|NCT01289028|532057989|FG000|Overall Study|Progressive Disease|49|||
147521159|NCT01289028|532057989|FG000|Overall Study|Adverse Event|14|||
147521160|NCT01289028|532057989|FG000|Overall Study|Withdrawal by Subject|6|||
147521161|NCT01289028|532057989|FG000|Overall Study|Death|4|||
147521162|NCT01289028|532057989|FG000|Overall Study|Lack of Efficacy|2|||
147521163|NCT01289028|532057989|FG000|Overall Study|No longer required|2|||
147521164|NCT01289028|532057989|FG000|Overall Study|Lost to Follow-up|2|||
147521165|NCT01289028|532057989|FG000|Overall Study|New Cancer Therapy|2|||
147521166|NCT01289028|532057989|FG000|Overall Study|Abnormal Lab Value|1|||
147521167|NCT01289028|532057989|FG000|Overall Study|Missing reason for discon|1|||
147521168|NCT03267576|532058000|FG000|Period 2: Day 44 to 71|Lost to Follow-up|0|||
147521169|NCT03267576|532058001|FG001|Period 2: Day 44 to 71|Lost to Follow-up|1|||
147521170|NCT03267576|532058000|FG000|Period 2: Day 44 to 71|Withdrawal by Subject|1|||
147521171|NCT03267576|532058001|FG001|Period 2: Day 44 to 71|Withdrawal by Subject|1|||
147521172|NCT01846208|532058002|FG000|Overall Study|Withdrew prior to treatment|1|||
147521173|NCT01846208|532058003|FG001|Overall Study|Withdrew prior to treatment|1|||
147521174|NCT01846208|532058004|FG002|Overall Study|Withdrew prior to treatment|1|||
147521175|NCT01846208|532058002|FG000|Overall Study|Dosing Symptoms|1|||
147521176|NCT01846208|532058003|FG001|Overall Study|Dosing Symptoms|2|||
147521177|NCT01846208|532058004|FG002|Overall Study|Dosing Symptoms|6|||
147521178|NCT01846208|532058002|FG000|Overall Study|Withdrawal by Subject|5|||
147521179|NCT01846208|532058003|FG001|Overall Study|Withdrawal by Subject|0|||
147521180|NCT01846208|532058004|FG002|Overall Study|Withdrawal by Subject|0|||
147521181|NCT01846208|532058002|FG000|Overall Study|Non-compliance|1|||
147521182|NCT01846208|532058003|FG001|Overall Study|Non-compliance|1|||
147521183|NCT01846208|532058004|FG002|Overall Study|Non-compliance|0|||
147521184|NCT01846208|532058002|FG000|Overall Study|Developed Eosinophilic Esophagitis (EoE)|1|||
147521185|NCT01846208|532058003|FG001|Overall Study|Developed Eosinophilic Esophagitis (EoE)|0|||
147521186|NCT01846208|532058004|FG002|Overall Study|Developed Eosinophilic Esophagitis (EoE)|0|||
147521187|NCT01846208|532058002|FG000|Overall Study|Refused SU OFC|0|||
147521188|NCT01846208|532058003|FG001|Overall Study|Refused SU OFC|0|||
147521189|NCT01846208|532058004|FG002|Overall Study|Refused SU OFC|1|||
147521190|NCT01268514|532058005|FG000|Overall Study|Adverse Event|20|||
147521191|NCT01268514|532058005|FG000|Overall Study|Death|8|||
147521192|NCT01268514|532058005|FG000|Overall Study|Lost to Follow-up|5|||
147521193|NCT01268514|532058005|FG000|Overall Study|Withdrawal by Subject|3|||
147521194|NCT01268514|532058005|FG000|Overall Study|Withdrawal by Surgeon|5|||
147521195|NCT01432938|532058006|FG000|First Intervention|Protocol Violation|1|||
147521196|NCT01432938|532058007|FG001|First Intervention|Protocol Violation|0|||
147521197|NCT01432938|532058006|FG000|First Intervention|Physician Decision|1|||
147521198|NCT01432938|532058007|FG001|First Intervention|Physician Decision|0|||
147521199|NCT01432938|532058006|FG000|Second Intervention|Adverse Event|1|||
147521200|NCT01432938|532058007|FG001|Second Intervention|Adverse Event|0|||
147521201|NCT01424306|532058008|FG000|Overall Study|Protocol Violation|0|||
147521202|NCT01424306|532058009|FG001|Overall Study|Protocol Violation|0|||
147521203|NCT01424306|532058010|FG002|Overall Study|Protocol Violation|0|||
147521204|NCT01424306|532058011|FG003|Overall Study|Protocol Violation|0|||
147521205|NCT01424306|532058012|FG004|Overall Study|Protocol Violation|1|||
147521206|NCT01424306|532058013|FG005|Overall Study|Protocol Violation|0|||
147521207|NCT01875874|532058017|FG000|Overall Study|Death|3|||
147521208|NCT03344562|532058020|FG000|Overall Study|Withdrawal by Subject|2|||
147521209|NCT03344562|532058021|FG001|Overall Study|Withdrawal by Subject|0|||
147521210|NCT02736474|532058022|FG000|Overall Study|Lost to Follow-up|0|||
147521211|NCT02736474|532058023|FG001|Overall Study|Lost to Follow-up|1|||
147521212|NCT02463331|532058024|FG000|Overall Study|Adverse Event|4|||
147521213|NCT02463331|532058025|FG001|Overall Study|Adverse Event|2|||
147521214|NCT02463331|532058024|FG000|Overall Study|Lost to Follow-up|1|||
147521215|NCT02463331|532058025|FG001|Overall Study|Lost to Follow-up|1|||
147521216|NCT02463331|532058024|FG000|Overall Study|Pregnancy|2|||
147521217|NCT02463331|532058025|FG001|Overall Study|Pregnancy|3|||
147521218|NCT02463331|532058024|FG000|Overall Study|Lack of Efficacy|6|||
147521219|NCT02463331|532058025|FG001|Overall Study|Lack of Efficacy|0|||
147521220|NCT02463331|532058024|FG000|Overall Study|Physician Decision|3|||
147521221|NCT02463331|532058025|FG001|Overall Study|Physician Decision|0|||
147521222|NCT02382276|532058026|FG000|Overall Study|Withdrawal by Subject|4|||
147521223|NCT02382276|532058027|FG001|Overall Study|Withdrawal by Subject|8|||
147521224|NCT02382276|532058028|FG002|Overall Study|Withdrawal by Subject|5|||
147521225|NCT02382276|532058026|FG000|Overall Study|Adverse Event|7|||
147521226|NCT02382276|532058027|FG001|Overall Study|Adverse Event|2|||
147521227|NCT02382276|532058028|FG002|Overall Study|Adverse Event|32|||
147521228|NCT02382276|532058026|FG000|Overall Study|Physician Decision|0|||
147521229|NCT02382276|532058027|FG001|Overall Study|Physician Decision|0|||
147521230|NCT02382276|532058028|FG002|Overall Study|Physician Decision|2|||
147521231|NCT04191096|532058031|FG000|Overall Study|Death|102|||
147521232|NCT04191096|532058032|FG001|Overall Study|Death|89|||
147521233|NCT04191096|532058031|FG000|Overall Study|Lost to Follow-up|1|||
147521234|NCT04191096|532058032|FG001|Overall Study|Lost to Follow-up|1|||
147521235|NCT04191096|532058031|FG000|Overall Study|Withdrawal by Subject|5|||
147521236|NCT04191096|532058032|FG001|Overall Study|Withdrawal by Subject|5|||
147521237|NCT04191096|532058031|FG000|Overall Study|Participants Ongoing|518|||
147521238|NCT04191096|532058032|FG001|Overall Study|Participants Ongoing|530|||
147521239|NCT02683668|532058035|FG000|Period 2|Withdrawal by Subject|0|||
147521240|NCT02683668|532058036|FG001|Period 2|Withdrawal by Subject|1|||
147521241|NCT02683668|532058037|FG002|Period 2|Withdrawal by Subject|0|||
147521242|NCT02442765|532059658|FG000|Stage 2- (Days 43 to 85)|Adverse Event|0|||
147521243|NCT02442765|532059659|FG001|Stage 2- (Days 43 to 85)|Adverse Event|0|||
147521244|NCT02442765|532059660|FG002|Stage 2- (Days 43 to 85)|Adverse Event|0|||
147521245|NCT02442765|532059661|FG003|Stage 2- (Days 43 to 85)|Adverse Event|2|||
147521246|NCT02442765|532059662|FG004|Stage 2- (Days 43 to 85)|Adverse Event|6|||
147521247|NCT02442765|532059663|FG005|Stage 2- (Days 43 to 85)|Adverse Event|1|||
147521248|NCT02442765|532059664|FG006|Stage 2- (Days 43 to 85)|Adverse Event|1|||
147521249|NCT02442765|532059665|FG007|Stage 2- (Days 43 to 85)|Adverse Event|5|||
147521250|NCT02442765|532059658|FG000|Stage 2- (Days 43 to 85)|Death|0|||
147521251|NCT02442765|532059659|FG001|Stage 2- (Days 43 to 85)|Death|0|||
147521252|NCT02442765|532059660|FG002|Stage 2- (Days 43 to 85)|Death|0|||
147521253|NCT02442765|532059661|FG003|Stage 2- (Days 43 to 85)|Death|1|||
147521254|NCT02442765|532059662|FG004|Stage 2- (Days 43 to 85)|Death|1|||
147521255|NCT02442765|532059663|FG005|Stage 2- (Days 43 to 85)|Death|0|||
147521256|NCT02442765|532059664|FG006|Stage 2- (Days 43 to 85)|Death|2|||
147521257|NCT02442765|532059665|FG007|Stage 2- (Days 43 to 85)|Death|0|||
147521258|NCT02442765|532059658|FG000|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
147521259|NCT02442765|532059659|FG001|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
147521260|NCT02442765|532059660|FG002|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
147521261|NCT02442765|532059661|FG003|Stage 2- (Days 43 to 85)|Lack of Efficacy|1|||
147521262|NCT02442765|532059662|FG004|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
147521263|NCT02442765|532059663|FG005|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
147521264|NCT02442765|532059664|FG006|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
147521265|NCT02442765|532059665|FG007|Stage 2- (Days 43 to 85)|Lack of Efficacy|0|||
147521266|NCT02442765|532059658|FG000|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
147521267|NCT02442765|532059659|FG001|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
147521268|NCT02442765|532059660|FG002|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
147521269|NCT02442765|532059661|FG003|Stage 2- (Days 43 to 85)|Protocol Deviation|1|||
147521270|NCT02442765|532059662|FG004|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
147521271|NCT02442765|532059663|FG005|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
147521272|NCT02442765|532059664|FG006|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
147521273|NCT02442765|532059665|FG007|Stage 2- (Days 43 to 85)|Protocol Deviation|0|||
147521274|NCT02442765|532059658|FG000|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|0|||
147521275|NCT02442765|532059659|FG001|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|0|||
147521276|NCT02442765|532059660|FG002|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|0|||
147521277|NCT02442765|532059661|FG003|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|1|||
147521278|NCT02442765|532059662|FG004|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|0|||
147521279|NCT02442765|532059663|FG005|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|1|||
147521280|NCT02442765|532059664|FG006|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|0|||
147521281|NCT02442765|532059665|FG007|Stage 2- (Days 43 to 85)|Study Participant Withdrawal by Parent or Guardian|4|||
147521282|NCT02442765|532059658|FG000|Stage 2- (Days 43 to 85)|Lost to Follow-up|0|||
147521283|NCT02442765|532059659|FG001|Stage 2- (Days 43 to 85)|Lost to Follow-up|0|||
147521284|NCT02442765|532059660|FG002|Stage 2- (Days 43 to 85)|Lost to Follow-up|0|||
147521285|NCT02442765|532059661|FG003|Stage 2- (Days 43 to 85)|Lost to Follow-up|1|||
147521286|NCT02442765|532059662|FG004|Stage 2- (Days 43 to 85)|Lost to Follow-up|0|||
147521287|NCT02442765|532059663|FG005|Stage 2- (Days 43 to 85)|Lost to Follow-up|3|||
147521288|NCT02442765|532059664|FG006|Stage 2- (Days 43 to 85)|Lost to Follow-up|1|||
147521289|NCT02442765|532059665|FG007|Stage 2- (Days 43 to 85)|Lost to Follow-up|0|||
147521290|NCT02442765|532059658|FG000|Stage 2- (Days 43 to 85)|Withdrawal by Subject|0|||
147521291|NCT02442765|532059659|FG001|Stage 2- (Days 43 to 85)|Withdrawal by Subject|0|||
147521292|NCT02442765|532059660|FG002|Stage 2- (Days 43 to 85)|Withdrawal by Subject|0|||
147521293|NCT02442765|532059661|FG003|Stage 2- (Days 43 to 85)|Withdrawal by Subject|0|||
147521294|NCT02442765|532059662|FG004|Stage 2- (Days 43 to 85)|Withdrawal by Subject|2|||
147521295|NCT02442765|532059663|FG005|Stage 2- (Days 43 to 85)|Withdrawal by Subject|0|||
147521296|NCT02442765|532059664|FG006|Stage 2- (Days 43 to 85)|Withdrawal by Subject|2|||
147521297|NCT02442765|532059665|FG007|Stage 2- (Days 43 to 85)|Withdrawal by Subject|1|||
147521298|NCT02442765|532059658|FG000|Stage 2- (Days 43 to 85)|Reason not specified|0|||
147521299|NCT02442765|532059659|FG001|Stage 2- (Days 43 to 85)|Reason not specified|0|||
147521300|NCT02442765|532059660|FG002|Stage 2- (Days 43 to 85)|Reason not specified|0|||
147521301|NCT02442765|532059661|FG003|Stage 2- (Days 43 to 85)|Reason not specified|0|||
147521302|NCT02442765|532059662|FG004|Stage 2- (Days 43 to 85)|Reason not specified|1|||
147521303|NCT02442765|532059663|FG005|Stage 2- (Days 43 to 85)|Reason not specified|0|||
147521304|NCT02442765|532059664|FG006|Stage 2- (Days 43 to 85)|Reason not specified|0|||
147521305|NCT02442765|532059665|FG007|Stage 2- (Days 43 to 85)|Reason not specified|1|||
147521306|NCT03818399|532059668|FG000|Overall Study|Lost to Follow-up|11|||
147521307|NCT03818399|532059668|FG000|Overall Study|Withdrawal by Subject|1|||
147521308|NCT03818399|532059668|FG000|Overall Study|Protocol Violation|2|||
147521309|NCT00141297|532059669|FG000|Overall Study|Adverse Event|0|||
147521310|NCT00141297|532059670|FG001|Overall Study|Adverse Event|0|||
147521311|NCT00141297|532059671|FG002|Overall Study|Adverse Event|1|||
147521312|NCT00141297|532059672|FG003|Overall Study|Adverse Event|0|||
147521313|NCT00141297|532059673|FG004|Overall Study|Adverse Event|1|||
147521314|NCT00141297|532059674|FG005|Overall Study|Adverse Event|1|||
147521315|NCT00141297|532059675|FG006|Overall Study|Adverse Event|0|||
147521316|NCT00141297|532059676|FG007|Overall Study|Adverse Event|1|||
147521317|NCT00141297|532059677|FG008|Overall Study|Adverse Event|1|||
147521318|NCT00141297|532059678|FG009|Overall Study|Adverse Event|0|||
147521319|NCT00141297|532059669|FG000|Overall Study|Death|1|||
147521320|NCT00141297|532059670|FG001|Overall Study|Death|0|||
147521321|NCT00141297|532059671|FG002|Overall Study|Death|0|||
147521322|NCT00141297|532059672|FG003|Overall Study|Death|0|||
147521323|NCT00141297|532059673|FG004|Overall Study|Death|0|||
147521324|NCT00141297|532059674|FG005|Overall Study|Death|0|||
147521325|NCT00141297|532059675|FG006|Overall Study|Death|0|||
147521326|NCT00141297|532059676|FG007|Overall Study|Death|0|||
147521327|NCT00141297|532059677|FG008|Overall Study|Death|1|||
147521328|NCT00141297|532059678|FG009|Overall Study|Death|0|||
147521329|NCT00141297|532059669|FG000|Overall Study|Withdrawal by Subject|0|||
147521330|NCT00141297|532059670|FG001|Overall Study|Withdrawal by Subject|0|||
147521331|NCT00141297|532059671|FG002|Overall Study|Withdrawal by Subject|0|||
147521332|NCT00141297|532059672|FG003|Overall Study|Withdrawal by Subject|0|||
147521333|NCT00141297|532059673|FG004|Overall Study|Withdrawal by Subject|0|||
147521334|NCT00141297|532059674|FG005|Overall Study|Withdrawal by Subject|0|||
147521335|NCT00141297|532059675|FG006|Overall Study|Withdrawal by Subject|0|||
147521336|NCT00141297|532059676|FG007|Overall Study|Withdrawal by Subject|0|||
147521337|NCT00141297|532059677|FG008|Overall Study|Withdrawal by Subject|1|||
147521338|NCT00141297|532059678|FG009|Overall Study|Withdrawal by Subject|0|||
147521339|NCT00141297|532059669|FG000|Overall Study|Other|0|||
147521340|NCT00141297|532059670|FG001|Overall Study|Other|0|||
147521341|NCT00141297|532059671|FG002|Overall Study|Other|0|||
147521342|NCT00141297|532059672|FG003|Overall Study|Other|1|||
147521343|NCT00141297|532059673|FG004|Overall Study|Other|5|||
147521344|NCT00141297|532059674|FG005|Overall Study|Other|0|||
147521345|NCT00141297|532059675|FG006|Overall Study|Other|0|||
147521346|NCT00141297|532059676|FG007|Overall Study|Other|0|||
147521347|NCT00141297|532059677|FG008|Overall Study|Other|2|||
147521348|NCT00141297|532059678|FG009|Overall Study|Other|0|||
147521349|NCT00141297|532059669|FG000|Overall Study|Progressive Disease|2|||
147521350|NCT00141297|532059670|FG001|Overall Study|Progressive Disease|3|||
147521351|NCT00141297|532059671|FG002|Overall Study|Progressive Disease|6|||
147521352|NCT00141297|532059672|FG003|Overall Study|Progressive Disease|2|||
147521353|NCT00141297|532059673|FG004|Overall Study|Progressive Disease|15|||
147521354|NCT00141297|532059674|FG005|Overall Study|Progressive Disease|2|||
147521355|NCT00141297|532059675|FG006|Overall Study|Progressive Disease|3|||
147521356|NCT00141297|532059676|FG007|Overall Study|Progressive Disease|3|||
147521357|NCT00141297|532059677|FG008|Overall Study|Progressive Disease|15|||
147521358|NCT00141297|532059678|FG009|Overall Study|Progressive Disease|6|||
147521359|NCT00141297|532059669|FG000|Overall Study|Transitioned|0|||
147521360|NCT00141297|532059670|FG001|Overall Study|Transitioned|0|||
147521361|NCT00141297|532059671|FG002|Overall Study|Transitioned|0|||
147521362|NCT00141297|532059672|FG003|Overall Study|Transitioned|0|||
147521363|NCT00141297|532059673|FG004|Overall Study|Transitioned|1|||
147521364|NCT00141297|532059674|FG005|Overall Study|Transitioned|0|||
147521365|NCT00141297|532059675|FG006|Overall Study|Transitioned|0|||
147521366|NCT00141297|532059676|FG007|Overall Study|Transitioned|0|||
147521367|NCT00141297|532059677|FG008|Overall Study|Transitioned|0|||
147521368|NCT00141297|532059678|FG009|Overall Study|Transitioned|0|||
147521369|NCT02987205|532059679|FG000|Overall Study|Adverse Event|1|||
147521370|NCT02987205|532059679|FG000|Overall Study|Withdrawal by Subject|3|||
147521371|NCT02646891|532059680|FG000|Overall Study|Adverse Event|0|||
147521372|NCT02646891|532059681|FG001|Overall Study|Adverse Event|1|||
147521373|NCT02646891|532059682|FG002|Overall Study|Adverse Event|0|||
147521374|NCT02646891|532059683|FG003|Overall Study|Adverse Event|0|||
147521375|NCT02646891|532059684|FG004|Overall Study|Adverse Event|0|||
147521376|NCT02646891|532059685|FG005|Overall Study|Adverse Event|0|||
147521377|NCT02646891|532059686|FG006|Overall Study|Adverse Event|0|||
147521378|NCT02646891|532059687|FG007|Overall Study|Adverse Event|0|||
147521379|NCT02646891|532059688|FG008|Overall Study|Adverse Event|0|||
147521380|NCT02646891|532059689|FG009|Overall Study|Adverse Event|0|||
147521381|NCT02646891|532059680|FG000|Overall Study|Lost to Follow-up|0|||
147521382|NCT02646891|532059681|FG001|Overall Study|Lost to Follow-up|0|||
147521383|NCT02646891|532059682|FG002|Overall Study|Lost to Follow-up|0|||
147521384|NCT02646891|532059683|FG003|Overall Study|Lost to Follow-up|0|||
147521385|NCT02646891|532059684|FG004|Overall Study|Lost to Follow-up|0|||
147521386|NCT02646891|532059685|FG005|Overall Study|Lost to Follow-up|0|||
147521387|NCT02646891|532059686|FG006|Overall Study|Lost to Follow-up|2|||
147521388|NCT02646891|532059687|FG007|Overall Study|Lost to Follow-up|2|||
147521389|NCT02646891|532059688|FG008|Overall Study|Lost to Follow-up|2|||
147521390|NCT02646891|532059689|FG009|Overall Study|Lost to Follow-up|2|||
147521391|NCT02646891|532059680|FG000|Overall Study|Protocol Violation|0|||
147521392|NCT02646891|532059681|FG001|Overall Study|Protocol Violation|0|||
147521393|NCT02646891|532059682|FG002|Overall Study|Protocol Violation|0|||
147521394|NCT02646891|532059683|FG003|Overall Study|Protocol Violation|0|||
147521395|NCT02646891|532059684|FG004|Overall Study|Protocol Violation|0|||
147521396|NCT02646891|532059685|FG005|Overall Study|Protocol Violation|0|||
147521397|NCT02646891|532059686|FG006|Overall Study|Protocol Violation|1|||
147521398|NCT02646891|532059687|FG007|Overall Study|Protocol Violation|1|||
147521399|NCT02646891|532059688|FG008|Overall Study|Protocol Violation|0|||
147521400|NCT02646891|532059689|FG009|Overall Study|Protocol Violation|0|||
147521401|NCT02646891|532059680|FG000|Overall Study|Withdrawal by Subject|2|||
147521402|NCT02646891|532059681|FG001|Overall Study|Withdrawal by Subject|0|||
147521403|NCT02646891|532059682|FG002|Overall Study|Withdrawal by Subject|1|||
147521404|NCT02646891|532059683|FG003|Overall Study|Withdrawal by Subject|0|||
147521405|NCT02646891|532059684|FG004|Overall Study|Withdrawal by Subject|0|||
147521406|NCT02646891|532059685|FG005|Overall Study|Withdrawal by Subject|0|||
147521407|NCT02646891|532059686|FG006|Overall Study|Withdrawal by Subject|5|||
147521408|NCT02646891|532059687|FG007|Overall Study|Withdrawal by Subject|9|||
147521409|NCT02646891|532059688|FG008|Overall Study|Withdrawal by Subject|7|||
147521410|NCT02646891|532059689|FG009|Overall Study|Withdrawal by Subject|3|||
147521411|NCT02646891|532059680|FG000|Overall Study|Death|0|||
147521412|NCT02646891|532059681|FG001|Overall Study|Death|0|||
147521413|NCT02646891|532059682|FG002|Overall Study|Death|0|||
147521414|NCT02646891|532059683|FG003|Overall Study|Death|0|||
147521415|NCT02646891|532059684|FG004|Overall Study|Death|0|||
147521416|NCT02646891|532059685|FG005|Overall Study|Death|0|||
147521417|NCT02646891|532059686|FG006|Overall Study|Death|1|||
147521418|NCT02646891|532059687|FG007|Overall Study|Death|1|||
147521419|NCT02646891|532059688|FG008|Overall Study|Death|1|||
147521420|NCT02646891|532059689|FG009|Overall Study|Death|0|||
147521421|NCT00103207|532059692|FG000|Overall Study|Adverse Event|3|||
147521422|NCT00103207|532059692|FG000|Overall Study|Death|1|||
147521423|NCT00103207|532059692|FG000|Overall Study|Withdrawal by Subject|2|||
147521424|NCT00103207|532059692|FG000|Overall Study|Other complicating disease|1|||
147521425|NCT00103207|532059692|FG000|Overall Study|Ineligible|4|||
147521426|NCT00103207|532059692|FG000|Overall Study|Diagnosis of BAC not confirmed|27|||
147521427|NCT03442595|532059693|FG000|Overall Study|Lost to Follow-up|94|||
147521428|NCT03442595|532059694|FG001|Overall Study|Lost to Follow-up|0|||
147521429|NCT01947127|532059697|FG000|Overall Study|Protocol Violation|18|||
147521430|NCT01947127|532059698|FG001|Overall Study|Protocol Violation|38|||
147521431|NCT01947127|532059697|FG000|Overall Study|Withdrawal by Subject|1|||
147521432|NCT01947127|532059698|FG001|Overall Study|Withdrawal by Subject|1|||
147521433|NCT01947127|532059697|FG000|Overall Study|Data loss|4|||
147521434|NCT01947127|532059698|FG001|Overall Study|Data loss|4|||
147521435|NCT01562327|532059699|FG000|Overall Study|Adverse Event|2|||
147521436|NCT01562327|532059699|FG000|Overall Study|Lack of Efficacy|1|||
147521437|NCT01562327|532059699|FG000|Overall Study|Participant drop-out|1|||
147521438|NCT01562327|532059699|FG000|Overall Study|Infusion not received at 6 month window|4|||
147521439|NCT02447952|532059702|FG000|Overall Study|Adverse Event|2|||
147521440|NCT02447952|532059702|FG000|Overall Study|Physician Decision|1|||
147521441|NCT02447952|532059702|FG000|Overall Study|Withdrawal by Subject|4|||
147521442|NCT00998985|532059713|FG000|Overall Study|Withdrawal by Subject|0|||
147521443|NCT00998985|532059714|FG001|Overall Study|Withdrawal by Subject|0|||
147521444|NCT00998985|532059715|FG002|Overall Study|Withdrawal by Subject|0|||
147521445|NCT00998985|532059716|FG003|Overall Study|Withdrawal by Subject|0|||
147521446|NCT00998985|532059717|FG004|Overall Study|Withdrawal by Subject|0|||
147521447|NCT00998985|532059718|FG005|Overall Study|Withdrawal by Subject|0|||
147521448|NCT00998985|532059719|FG006|Overall Study|Withdrawal by Subject|0|||
147521449|NCT00998985|532059720|FG007|Overall Study|Withdrawal by Subject|0|||
147521450|NCT00998985|532059721|FG008|Overall Study|Withdrawal by Subject|1|||
147521451|NCT00998985|532059722|FG009|Overall Study|Withdrawal by Subject|0|||
147521452|NCT00998985|532059723|FG010|Overall Study|Withdrawal by Subject|0|||
147521453|NCT00998985|532059724|FG011|Overall Study|Withdrawal by Subject|0|||
147521454|NCT00998985|532059725|FG012|Overall Study|Withdrawal by Subject|0|||
147521455|NCT00998985|532059726|FG013|Overall Study|Withdrawal by Subject|0|||
147521456|NCT00998985|532059713|FG000|Overall Study|Protocol Violation|0|||
147521457|NCT00998985|532059714|FG001|Overall Study|Protocol Violation|0|||
147521458|NCT00998985|532059715|FG002|Overall Study|Protocol Violation|0|||
147521459|NCT00998985|532059716|FG003|Overall Study|Protocol Violation|0|||
147521460|NCT00998985|532059717|FG004|Overall Study|Protocol Violation|0|||
147521461|NCT00998985|532059718|FG005|Overall Study|Protocol Violation|1|||
147521462|NCT00998985|532059719|FG006|Overall Study|Protocol Violation|0|||
147521463|NCT00998985|532059720|FG007|Overall Study|Protocol Violation|0|||
147521464|NCT00998985|532059721|FG008|Overall Study|Protocol Violation|0|||
147521465|NCT00998985|532059722|FG009|Overall Study|Protocol Violation|0|||
147521466|NCT00998985|532059723|FG010|Overall Study|Protocol Violation|0|||
147521467|NCT00998985|532059724|FG011|Overall Study|Protocol Violation|0|||
147521468|NCT00998985|532059725|FG012|Overall Study|Protocol Violation|0|||
147521469|NCT00998985|532059726|FG013|Overall Study|Protocol Violation|0|||
147521470|NCT01012037|532059730|FG000|Overall Study|Adverse Event|0|||
147521471|NCT01012037|532059731|FG001|Overall Study|Adverse Event|8|||
147521472|NCT01012037|532059732|FG002|Overall Study|Adverse Event|3|||
147521473|NCT01012037|532059730|FG000|Overall Study|Protocol Violation|0|||
147521474|NCT01012037|532059731|FG001|Overall Study|Protocol Violation|3|||
147643386|NCT02294461|532512801|FG001|Open-label Period (up to 54.3 Months)|Protocol Deviation|0|||
147643387|NCT02294461|532512802|FG002|Open-label Period (up to 54.3 Months)|Protocol Deviation|0|||
147643388|NCT02294461|532512800|FG000|Open-label Period (up to 54.3 Months)|Lost to Follow-up|4|||
147643389|NCT02294461|532512801|FG001|Open-label Period (up to 54.3 Months)|Lost to Follow-up|0|||
147643390|NCT02294461|532512802|FG002|Open-label Period (up to 54.3 Months)|Lost to Follow-up|2|||
147643391|NCT02294461|532512800|FG000|Open-label Period (up to 54.3 Months)|Progressive Disease|20|||
147643392|NCT02294461|532512801|FG001|Open-label Period (up to 54.3 Months)|Progressive Disease|0|||
147643393|NCT02294461|532512802|FG002|Open-label Period (up to 54.3 Months)|Progressive Disease|12|||
147643394|NCT02294461|532512800|FG000|Open-label Period (up to 54.3 Months)|Death|6|||
147643395|NCT02294461|532512801|FG001|Open-label Period (up to 54.3 Months)|Death|0|||
147643396|NCT02294461|532512802|FG002|Open-label Period (up to 54.3 Months)|Death|5|||
147643397|NCT02294461|532512800|FG000|Open-label Period (up to 54.3 Months)|Adverse Event|6|||
147643398|NCT02294461|532512801|FG001|Open-label Period (up to 54.3 Months)|Adverse Event|0|||
147643399|NCT02294461|532512802|FG002|Open-label Period (up to 54.3 Months)|Adverse Event|6|||
147643400|NCT04676412|532514029|FG000|Overall Study|Death|28|||
147643401|NCT04676412|532514030|FG001|Overall Study|Death|31|||
147643402|NCT04676412|532514029|FG000|Overall Study|Lost to Follow-up|1|||
147643403|NCT04676412|532514030|FG001|Overall Study|Lost to Follow-up|2|||
147643404|NCT04676412|532514029|FG000|Overall Study|Sponsor Decision|20|||
147643405|NCT04676412|532514030|FG001|Overall Study|Sponsor Decision|23|||
147643406|NCT04676412|532514029|FG000|Overall Study|Withdrawal by Subject|0|||
147643407|NCT04676412|532514030|FG001|Overall Study|Withdrawal by Subject|2|||
147643408|NCT01371877|532514031|FG000|Overall Study|3 for unknown reasons and 1 pregnant|0|||
147643409|NCT01371877|532514032|FG001|Overall Study|3 for unknown reasons and 1 pregnant|4|||
147643410|NCT05932225|532514033|FG000|Overall Study|Lost to Follow-up|0|||
147643411|NCT05932225|532514034|FG001|Overall Study|Lost to Follow-up|1|||
147643412|NCT05932225|532514035|FG002|Overall Study|Lost to Follow-up|0|||
147521475|NCT01012037|532059732|FG002|Overall Study|Protocol Violation|5|||
147521476|NCT01012037|532059730|FG000|Overall Study|Withdrawal by Subject|0|||
147521477|NCT01012037|532059731|FG001|Overall Study|Withdrawal by Subject|4|||
147521478|NCT01012037|532059732|FG002|Overall Study|Withdrawal by Subject|1|||
147521479|NCT01012037|532059730|FG000|Overall Study|Other reason (not specified)|1|||
147643413|NCT05932225|532514033|FG000|Overall Study|Withdrawal by Subject|1|||
147521480|NCT01012037|532059731|FG001|Overall Study|Other reason (not specified)|1|||
147521481|NCT01012037|532059732|FG002|Overall Study|Other reason (not specified)|1|||
147521482|NCT00415623|532059733|FG000|Overall Study|Adverse Event|3|||
147521483|NCT00415623|532059734|FG001|Overall Study|Adverse Event|4|||
147521484|NCT00415623|532059733|FG000|Overall Study|Death|1|||
147521485|NCT00415623|532059734|FG001|Overall Study|Death|0|||
147521486|NCT00415623|532059733|FG000|Overall Study|Withdrawal by Subject|1|||
147521487|NCT00415623|532059734|FG001|Overall Study|Withdrawal by Subject|1|||
147521488|NCT01369069|532059735|FG000|Overall Study|Lost to Follow-up|8|||
147521489|NCT01369069|532059736|FG001|Overall Study|Lost to Follow-up|9|||
147521490|NCT01369069|532059735|FG000|Overall Study|Withdrawal by Subject|9|||
147521491|NCT01369069|532059736|FG001|Overall Study|Withdrawal by Subject|7|||
147521492|NCT02573012|532059737|FG000|Overall Study|Adverse Event|5|||
147521493|NCT02573012|532059738|FG001|Overall Study|Adverse Event|5|||
147521494|NCT02573012|532059737|FG000|Overall Study|Lack of Efficacy|5|||
147521495|NCT02573012|532059738|FG001|Overall Study|Lack of Efficacy|4|||
147521496|NCT02573012|532059737|FG000|Overall Study|Non-compliance|1|||
147521497|NCT02573012|532059738|FG001|Overall Study|Non-compliance|2|||
147521498|NCT02573012|532059737|FG000|Overall Study|Withdrawal by Subject|2|||
147521499|NCT02573012|532059738|FG001|Overall Study|Withdrawal by Subject|2|||
147521500|NCT02573012|532059737|FG000|Overall Study|Study Ended per Protocol|1|||
147521501|NCT02573012|532059738|FG001|Overall Study|Study Ended per Protocol|0|||
147521502|NCT02573012|532059737|FG000|Overall Study|Physician Decision|1|||
147521503|NCT02573012|532059738|FG001|Overall Study|Physician Decision|2|||
147521504|NCT00882362|532059739|FG000|Overall Study|Adverse Event|13|||
147521505|NCT00882362|532059740|FG001|Overall Study|Adverse Event|10|||
147521506|NCT00882362|532059739|FG000|Overall Study|Withdrawal by Subject|13|||
147521507|NCT00882362|532059740|FG001|Overall Study|Withdrawal by Subject|10|||
147521508|NCT00882362|532059739|FG000|Overall Study|Lack of Efficacy|3|||
147521509|NCT00882362|532059740|FG001|Overall Study|Lack of Efficacy|0|||
147521510|NCT00882362|532059739|FG000|Overall Study|Protocol Violation|7|||
147521511|NCT00882362|532059740|FG001|Overall Study|Protocol Violation|2|||
147521512|NCT00882362|532059739|FG000|Overall Study|Pregnancy|1|||
147521513|NCT00882362|532059740|FG001|Overall Study|Pregnancy|0|||
147521514|NCT00882362|532059739|FG000|Overall Study|Physician Decision|5|||
147521515|NCT00882362|532059740|FG001|Overall Study|Physician Decision|1|||
147521516|NCT00882362|532059739|FG000|Overall Study|Diabetic glucose level or HbA1C>=6.5%|2|||
147521517|NCT00882362|532059740|FG001|Overall Study|Diabetic glucose level or HbA1C>=6.5%|0|||
147521518|NCT00882362|532059739|FG000|Overall Study|change of residence or other commitments|5|||
147521519|NCT00882362|532059740|FG001|Overall Study|change of residence or other commitments|0|||
147521520|NCT02096471|532059741|FG000|Overall Study|Adverse Event|1|||
147521521|NCT02096471|532059741|FG000|Overall Study|Lack of Efficacy|7|||
147521522|NCT02096471|532059741|FG000|Overall Study|Withdrawal by Subject|3|||
147521523|NCT02096471|532059741|FG000|Overall Study|Non-Compliant|2|||
147521524|NCT01809327|532059742|FG000|Overall Study|Lost to Follow-up|5|||
147521525|NCT01809327|532059743|FG001|Overall Study|Lost to Follow-up|2|||
147521526|NCT01809327|532059744|FG002|Overall Study|Lost to Follow-up|4|||
147521527|NCT01809327|532059745|FG003|Overall Study|Lost to Follow-up|2|||
147521528|NCT01809327|532059746|FG004|Overall Study|Lost to Follow-up|3|||
147521529|NCT01809327|532059742|FG000|Overall Study|Withdrawal by Subject|6|||
147521530|NCT01809327|532059743|FG001|Overall Study|Withdrawal by Subject|4|||
147521531|NCT01809327|532059744|FG002|Overall Study|Withdrawal by Subject|4|||
147521532|NCT01809327|532059745|FG003|Overall Study|Withdrawal by Subject|2|||
147521533|NCT01809327|532059746|FG004|Overall Study|Withdrawal by Subject|5|||
147521534|NCT01809327|532059742|FG000|Overall Study|Adverse Event|4|||
147521535|NCT01809327|532059743|FG001|Overall Study|Adverse Event|3|||
147521536|NCT01809327|532059744|FG002|Overall Study|Adverse Event|7|||
147521537|NCT01809327|532059745|FG003|Overall Study|Adverse Event|4|||
147521538|NCT01809327|532059746|FG004|Overall Study|Adverse Event|8|||
147521539|NCT01809327|532059742|FG000|Overall Study|Death|1|||
147521540|NCT01809327|532059743|FG001|Overall Study|Death|0|||
147521541|NCT01809327|532059744|FG002|Overall Study|Death|0|||
147521542|NCT01809327|532059745|FG003|Overall Study|Death|0|||
147521543|NCT01809327|532059746|FG004|Overall Study|Death|0|||
147521544|NCT01809327|532059742|FG000|Overall Study|Protocol Violation|0|||
147521545|NCT01809327|532059743|FG001|Overall Study|Protocol Violation|1|||
147521546|NCT01809327|532059744|FG002|Overall Study|Protocol Violation|0|||
147521547|NCT01809327|532059745|FG003|Overall Study|Protocol Violation|0|||
147521548|NCT01809327|532059746|FG004|Overall Study|Protocol Violation|0|||
147521549|NCT01809327|532059742|FG000|Overall Study|Physician Decision|1|||
147521550|NCT01809327|532059743|FG001|Overall Study|Physician Decision|1|||
147521551|NCT01809327|532059744|FG002|Overall Study|Physician Decision|0|||
147521552|NCT01809327|532059745|FG003|Overall Study|Physician Decision|0|||
147521553|NCT01809327|532059746|FG004|Overall Study|Physician Decision|0|||
147521554|NCT01809327|532059742|FG000|Overall Study|Pregnancy|1|||
147521555|NCT01809327|532059743|FG001|Overall Study|Pregnancy|0|||
147521556|NCT01809327|532059744|FG002|Overall Study|Pregnancy|0|||
147521557|NCT01809327|532059745|FG003|Overall Study|Pregnancy|0|||
147521558|NCT01809327|532059746|FG004|Overall Study|Pregnancy|0|||
147521559|NCT01809327|532059742|FG000|Overall Study|Other|14|||
147521560|NCT01809327|532059743|FG001|Overall Study|Other|15|||
147521561|NCT01809327|532059744|FG002|Overall Study|Other|7|||
147521562|NCT01809327|532059745|FG003|Overall Study|Other|4|||
147521563|NCT01809327|532059746|FG004|Overall Study|Other|9|||
147521564|NCT02520141|532059759|FG000|Overall Study|Rapid decline clinically and thus unable to enroll|1|||
147521565|NCT02168816|532059764|FG000|Overall Study|Lost to Follow-up|2|||
147521566|NCT02168816|532059765|FG001|Overall Study|Lost to Follow-up|2|||
147521567|NCT01066546|532059770|FG000|Overall Study|Study terminated by sponsor|5|||
147521568|NCT03258762|532059775|FG000|Overall Study|Lost to Follow-up|0|||
147521569|NCT03258762|532059776|FG001|Overall Study|Lost to Follow-up|1|||
147521570|NCT02545049|532059778|FG000|Overall Study|Withdrawal by Subject|1|||
147521571|NCT02545049|532059779|FG001|Overall Study|Withdrawal by Subject|7|||
147521572|NCT02545049|532059778|FG000|Overall Study|Lost to Follow-up|4|||
147521573|NCT02545049|532059779|FG001|Overall Study|Lost to Follow-up|6|||
147521574|NCT02545049|532059778|FG000|Overall Study|GCP violations|37|||
147521575|NCT02545049|532059779|FG001|Overall Study|GCP violations|48|||
147521576|NCT04144140|532061150|FG000|Overall Study|Other|0|||
147521577|NCT04144140|532061151|FG001|Overall Study|Other|0|||
147521578|NCT04144140|532061152|FG002|Overall Study|Other|0|||
147521579|NCT04144140|532061153|FG003|Overall Study|Other|0|||
147521580|NCT04144140|532061154|FG004|Overall Study|Other|0|||
147521581|NCT04144140|532061155|FG005|Overall Study|Other|1|||
147521582|NCT04144140|532061156|FG006|Overall Study|Other|0|||
147521583|NCT04735432|532061159|FG000|Overall Study|Other - due to personal reason|1|||
147521584|NCT04735432|532061160|FG001|Overall Study|Other - due to personal reason|0|||
147521585|NCT04735432|532061159|FG000|Overall Study|Adverse Event|2|||
147521586|NCT04735432|532061160|FG001|Overall Study|Adverse Event|0|||
147521587|NCT01066819|532061161|FG000|Overall Study|Adverse Event|18|||
147521588|NCT01066819|532061162|FG001|Overall Study|Adverse Event|1|||
147521589|NCT01066819|532061163|FG002|Overall Study|Adverse Event|6|||
147521590|NCT01066819|532061164|FG003|Overall Study|Adverse Event|0|||
147521591|NCT01066819|532061165|FG004|Overall Study|Adverse Event|0|||
147521592|NCT01066819|532061166|FG005|Overall Study|Adverse Event|0|||
147521593|NCT01066819|532061161|FG000|Overall Study|Death|5|||
147521594|NCT01066819|532061162|FG001|Overall Study|Death|0|||
147521595|NCT01066819|532061163|FG002|Overall Study|Death|1|||
147521596|NCT01066819|532061164|FG003|Overall Study|Death|0|||
147521597|NCT01066819|532061165|FG004|Overall Study|Death|0|||
147521598|NCT01066819|532061166|FG005|Overall Study|Death|0|||
147521599|NCT01066819|532061161|FG000|Overall Study|Lack of Efficacy|22|||
147521600|NCT01066819|532061162|FG001|Overall Study|Lack of Efficacy|1|||
147521601|NCT01066819|532061163|FG002|Overall Study|Lack of Efficacy|2|||
147521602|NCT01066819|532061164|FG003|Overall Study|Lack of Efficacy|1|||
147521603|NCT01066819|532061165|FG004|Overall Study|Lack of Efficacy|0|||
147521604|NCT01066819|532061166|FG005|Overall Study|Lack of Efficacy|0|||
147521605|NCT01066819|532061161|FG000|Overall Study|Physician Decision|6|||
147521606|NCT01066819|532061162|FG001|Overall Study|Physician Decision|2|||
147521607|NCT01066819|532061163|FG002|Overall Study|Physician Decision|3|||
147521608|NCT01066819|532061164|FG003|Overall Study|Physician Decision|0|||
147521609|NCT01066819|532061165|FG004|Overall Study|Physician Decision|0|||
147521610|NCT01066819|532061166|FG005|Overall Study|Physician Decision|0|||
147521611|NCT01066819|532061161|FG000|Overall Study|Protocol Violation|12|||
147521612|NCT01066819|532061162|FG001|Overall Study|Protocol Violation|6|||
147521613|NCT01066819|532061163|FG002|Overall Study|Protocol Violation|0|||
147521614|NCT01066819|532061164|FG003|Overall Study|Protocol Violation|0|||
147521615|NCT01066819|532061165|FG004|Overall Study|Protocol Violation|0|||
147521616|NCT01066819|532061166|FG005|Overall Study|Protocol Violation|0|||
147521617|NCT01066819|532061161|FG000|Overall Study|Withdrawal by Subject|29|||
147521618|NCT01066819|532061162|FG001|Overall Study|Withdrawal by Subject|11|||
147521619|NCT01066819|532061163|FG002|Overall Study|Withdrawal by Subject|6|||
147521620|NCT01066819|532061164|FG003|Overall Study|Withdrawal by Subject|0|||
147521621|NCT01066819|532061165|FG004|Overall Study|Withdrawal by Subject|0|||
147521622|NCT01066819|532061166|FG005|Overall Study|Withdrawal by Subject|0|||
147521623|NCT01066819|532061161|FG000|Overall Study|Administrative|6|||
147521624|NCT01066819|532061162|FG001|Overall Study|Administrative|4|||
147521625|NCT01066819|532061163|FG002|Overall Study|Administrative|2|||
147521626|NCT01066819|532061164|FG003|Overall Study|Administrative|0|||
147521627|NCT01066819|532061165|FG004|Overall Study|Administrative|0|||
147521628|NCT01066819|532061166|FG005|Overall Study|Administrative|0|||
147521629|NCT01066819|532061161|FG000|Overall Study|Not met inclusion/exclusion criteria|1|||
147521630|NCT01066819|532061162|FG001|Overall Study|Not met inclusion/exclusion criteria|0|||
147521631|NCT01066819|532061163|FG002|Overall Study|Not met inclusion/exclusion criteria|0|||
147521632|NCT01066819|532061164|FG003|Overall Study|Not met inclusion/exclusion criteria|0|||
147521633|NCT01066819|532061165|FG004|Overall Study|Not met inclusion/exclusion criteria|0|||
147521634|NCT01066819|532061166|FG005|Overall Study|Not met inclusion/exclusion criteria|0|||
147521635|NCT01066819|532061161|FG000|Overall Study|Early termination|2|||
147521636|NCT01066819|532061162|FG001|Overall Study|Early termination|0|||
147521637|NCT01066819|532061163|FG002|Overall Study|Early termination|0|||
147521638|NCT01066819|532061164|FG003|Overall Study|Early termination|0|||
147521639|NCT01066819|532061165|FG004|Overall Study|Early termination|0|||
147521640|NCT01066819|532061166|FG005|Overall Study|Early termination|0|||
147521641|NCT01066819|532061161|FG000|Overall Study|Failed to return|298|||
147521642|NCT01066819|532061162|FG001|Overall Study|Failed to return|107|||
147521643|NCT01066819|532061163|FG002|Overall Study|Failed to return|68|||
147521644|NCT01066819|532061164|FG003|Overall Study|Failed to return|7|||
147521645|NCT01066819|532061165|FG004|Overall Study|Failed to return|2|||
147521646|NCT01066819|532061166|FG005|Overall Study|Failed to return|3|||
147521647|NCT01066819|532061161|FG000|Overall Study|Lab test not done|9|||
147521648|NCT01066819|532061162|FG001|Overall Study|Lab test not done|0|||
147521649|NCT01066819|532061163|FG002|Overall Study|Lab test not done|2|||
147521650|NCT01066819|532061164|FG003|Overall Study|Lab test not done|1|||
147521651|NCT01066819|532061165|FG004|Overall Study|Lab test not done|0|||
147521652|NCT01066819|532061166|FG005|Overall Study|Lab test not done|0|||
147521653|NCT01066819|532061161|FG000|Overall Study|Miscellaneous|28|||
147521654|NCT01066819|532061162|FG001|Overall Study|Miscellaneous|10|||
147521655|NCT01066819|532061163|FG002|Overall Study|Miscellaneous|18|||
147521656|NCT01066819|532061164|FG003|Overall Study|Miscellaneous|1|||
147521657|NCT01066819|532061165|FG004|Overall Study|Miscellaneous|0|||
147521658|NCT01066819|532061166|FG005|Overall Study|Miscellaneous|0|||
147521659|NCT01066819|532061161|FG000|Overall Study|Non responders|123|||
147521660|NCT01066819|532061162|FG001|Overall Study|Non responders|2|||
147521661|NCT01066819|532061163|FG002|Overall Study|Non responders|7|||
147521662|NCT01066819|532061164|FG003|Overall Study|Non responders|2|||
147521663|NCT01066819|532061165|FG004|Overall Study|Non responders|0|||
147521664|NCT01066819|532061166|FG005|Overall Study|Non responders|1|||
147643414|NCT05932225|532514034|FG001|Overall Study|Withdrawal by Subject|0|||
147643415|NCT05932225|532514035|FG002|Overall Study|Withdrawal by Subject|0|||
147643416|NCT05932225|532514033|FG000|Overall Study|As detailed in the Clinical Study Report|0|||
147643417|NCT05932225|532514034|FG001|Overall Study|As detailed in the Clinical Study Report|2|||
147643418|NCT05932225|532514035|FG002|Overall Study|As detailed in the Clinical Study Report|0|||
147643419|NCT01027897|532514036|FG000|Overall Study|Protocol Violation|1|||
147643420|NCT01027897|532514036|FG000|Overall Study|Withdrawal by Subject|1|||
147643421|NCT02667626|532514037|FG000|Overall Study|Withdrawal by Subject|0|||
147643422|NCT02667626|532514038|FG001|Overall Study|Withdrawal by Subject|1|||
147643423|NCT00033657|532514042|FG000|Neoadjuvant Chemotherapy|Lack of Efficacy|1|||
147643424|NCT00033657|532514043|FG001|Neoadjuvant Chemotherapy|Lack of Efficacy|2|||
147643425|NCT00033657|532514042|FG000|Neoadjuvant Chemotherapy|Adverse Event|0|||
147643426|NCT00033657|532514043|FG001|Neoadjuvant Chemotherapy|Adverse Event|2|||
147643427|NCT00033657|532514042|FG000|Neoadjuvant Chemotherapy|Death|1|||
147643428|NCT00033657|532514043|FG001|Neoadjuvant Chemotherapy|Death|1|||
147643429|NCT00033657|532514042|FG000|Neoadjuvant Chemotherapy|Withdrawal by Subject|1|||
147643430|NCT00033657|532514043|FG001|Neoadjuvant Chemotherapy|Withdrawal by Subject|0|||
147643431|NCT00033657|532514042|FG000|Neoadjuvant Chemotherapy|other complicating disease|0|||
147643432|NCT00033657|532514043|FG001|Neoadjuvant Chemotherapy|other complicating disease|1|||
147643433|NCT00033657|532514042|FG000|Neoadjuvant Chemotherapy|Ineligible|8|||
147643434|NCT00033657|532514043|FG001|Neoadjuvant Chemotherapy|Ineligible|4|||
147643435|NCT00033657|532514042|FG000|Neoadjuvant Chemotherapy|Not started protocol therapy|3|||
147643436|NCT00033657|532514043|FG001|Neoadjuvant Chemotherapy|Not started protocol therapy|1|||
147643437|NCT00033657|532514042|FG000|Surgical Resection|not complete resection|0|||
147643438|NCT00033657|532514043|FG001|Surgical Resection|not complete resection|3|||
147643439|NCT00033657|532514042|FG000|Adjuvant Chemotherapy|Lack of Efficacy|3|||
147643440|NCT00033657|532514043|FG001|Adjuvant Chemotherapy|Lack of Efficacy|1|||
147643441|NCT00033657|532514042|FG000|Adjuvant Chemotherapy|Adverse Event|7|||
147643442|NCT00033657|532514043|FG001|Adjuvant Chemotherapy|Adverse Event|10|||
147643443|NCT00033657|532514042|FG000|Adjuvant Chemotherapy|Death|2|||
147643444|NCT00033657|532514043|FG001|Adjuvant Chemotherapy|Death|1|||
147643445|NCT00033657|532514042|FG000|Adjuvant Chemotherapy|Withdrawal by Subject|5|||
147643446|NCT00033657|532514043|FG001|Adjuvant Chemotherapy|Withdrawal by Subject|3|||
147643447|NCT00033657|532514042|FG000|Adjuvant Chemotherapy|alternative therapy|1|||
147643448|NCT00033657|532514043|FG001|Adjuvant Chemotherapy|alternative therapy|0|||
147643449|NCT00033657|532514042|FG000|Adjuvant Chemotherapy|Other|0|||
147643450|NCT00033657|532514043|FG001|Adjuvant Chemotherapy|Other|2|||
147643451|NCT02332239|532514044|FG000|Overall Study|Lost to Follow-up|4|||
147643452|NCT02332239|532514045|FG001|Overall Study|Lost to Follow-up|6|||
147643453|NCT01440569|532514052|FG000|Main Study|Enrolled but not treated|1|||
147643454|NCT01440569|532514053|FG001|Main Study|Enrolled but not treated|0|||
147643455|NCT01440569|532514052|FG000|Main Study|Adverse Event|9|||
147643456|NCT01440569|532514053|FG001|Main Study|Adverse Event|0|||
147643457|NCT01440569|532514052|FG000|Main Study|Pregnancy|1|||
147643458|NCT01440569|532514053|FG001|Main Study|Pregnancy|0|||
147643459|NCT01440569|532514052|FG000|Main Study|Investigator's Discretion|1|||
147643460|NCT01440569|532514053|FG001|Main Study|Investigator's Discretion|1|||
147643461|NCT01440569|532514052|FG000|Main Study|Withdrew Consent|7|||
147643462|NCT01440569|532514053|FG001|Main Study|Withdrew Consent|1|||
147643463|NCT01440569|532514052|FG000|Main Study|Lost to Follow-up|13|||
147643464|NCT01440569|532514053|FG001|Main Study|Lost to Follow-up|2|||
147643465|NCT01440569|532514052|FG000|Main Study|Subject Non-Compliance|3|||
147643466|NCT01440569|532514053|FG001|Main Study|Subject Non-Compliance|0|||
147643467|NCT01440569|532514052|FG000|Main Study|Protocol Violation|1|||
147643468|NCT01440569|532514053|FG001|Main Study|Protocol Violation|0|||
147643469|NCT01440569|532514052|FG000|Open-Label Rollover Phase|Adverse Event|3|||
147521665|NCT01066819|532061161|FG000|Overall Study|Not categorised|9|||
147521666|NCT01066819|532061162|FG001|Overall Study|Not categorised|2|||
147521667|NCT01066819|532061163|FG002|Overall Study|Not categorised|6|||
147643470|NCT01440569|532514053|FG001|Open-Label Rollover Phase|Adverse Event|0|||
147643471|NCT01440569|532514052|FG000|Open-Label Rollover Phase|Pregnancy|1|||
147643472|NCT01440569|532514053|FG001|Open-Label Rollover Phase|Pregnancy|0|||
147643473|NCT01440569|532514052|FG000|Open-Label Rollover Phase|Lack of Efficacy|2|||
147643474|NCT01440569|532514053|FG001|Open-Label Rollover Phase|Lack of Efficacy|0|||
147643475|NCT01440569|532514052|FG000|Open-Label Rollover Phase|Investigator's Discretion|3|||
147643476|NCT01440569|532514053|FG001|Open-Label Rollover Phase|Investigator's Discretion|1|||
147643477|NCT01440569|532514052|FG000|Open-Label Rollover Phase|Withdrew Consent|11|||
147643478|NCT01440569|532514053|FG001|Open-Label Rollover Phase|Withdrew Consent|1|||
147643479|NCT01440569|532514052|FG000|Open-Label Rollover Phase|Lost to Follow-up|26|||
147643480|NCT01440569|532514053|FG001|Open-Label Rollover Phase|Lost to Follow-up|3|||
147643481|NCT01440569|532514052|FG000|Open-Label Rollover Phase|Subject Non-Compliance|1|||
147643482|NCT01440569|532514053|FG001|Open-Label Rollover Phase|Subject Non-Compliance|1|||
147643483|NCT02584959|532514061|FG000|Period 1|Withdrawn from study|3|||
147643484|NCT02584959|532514062|FG001|Period 1|Withdrawn from study|4|||
147643485|NCT02584959|532514063|FG002|Period 1|Withdrawn from study|0|||
147643486|NCT02584959|532514061|FG000|Period 2|Withdrawn from study|6|||
147643487|NCT02584959|532514062|FG001|Period 2|Withdrawn from study|1|||
147643488|NCT02584959|532514063|FG002|Period 2|Withdrawn from study|2|||
147643489|NCT00204477|532514064|FG000|One Year After Diet|Did not complete 1 year of diet|42|||
147643490|NCT00204477|532514065|FG001|One Year After Diet|Did not complete 1 year of diet|38|||
147643491|NCT00204477|532514064|FG000|Two Years After Diet|Did not complete the 2nd year of diet|16|||
147643492|NCT00204477|532514065|FG001|Two Years After Diet|Did not complete the 2nd year of diet|13|||
147643493|NCT01966068|532514068|FG000|Overall Study|Withdrawal by Subject|57|||
147643494|NCT01966068|532514068|FG000|Overall Study|Lost to Follow-up|81|||
147643495|NCT01037127|532514073|FG000|Overall Study|Lost to Follow-up|2|||
147643496|NCT01037127|532514074|FG001|Overall Study|Lost to Follow-up|4|||
147643497|NCT01037127|532514073|FG000|Overall Study|Physician Decision|1|||
147643498|NCT01037127|532514074|FG001|Overall Study|Physician Decision|0|||
147643499|NCT01037127|532514073|FG000|Overall Study|Study Closed Terminated|2|||
147643500|NCT01037127|532514074|FG001|Overall Study|Study Closed Terminated|17|||
147643501|NCT02637713|532514078|FG000|Overall Study|Screen Failure|2|||
147643502|NCT02847182|532514079|FG000|Overall Study|Withdrawal by Subject|0|||
147643503|NCT02847182|532514080|FG001|Overall Study|Withdrawal by Subject|1|||
147643504|NCT02345889|532514081|FG000|Overall Study|Inadequate Bowel Prep|17|||
147643505|NCT02345889|532514082|FG001|Overall Study|Inadequate Bowel Prep|16|||
147643506|NCT02345889|532514083|FG002|Overall Study|Inadequate Bowel Prep|18|||
147643507|NCT02345889|532514084|FG003|Overall Study|Inadequate Bowel Prep|14|||
147643508|NCT02345889|532514081|FG000|Overall Study|Polyposis identified during procedure|1|||
147643509|NCT02345889|532514082|FG001|Overall Study|Polyposis identified during procedure|1|||
147643510|NCT02345889|532514083|FG002|Overall Study|Polyposis identified during procedure|0|||
147643511|NCT02345889|532514084|FG003|Overall Study|Polyposis identified during procedure|1|||
147643512|NCT02345889|532514081|FG000|Overall Study|Recognized ineligible post-randomization|1|||
147643513|NCT02345889|532514082|FG001|Overall Study|Recognized ineligible post-randomization|0|||
147643514|NCT02345889|532514083|FG002|Overall Study|Recognized ineligible post-randomization|2|||
147643515|NCT02345889|532514084|FG003|Overall Study|Recognized ineligible post-randomization|1|||
147643516|NCT02345889|532514081|FG000|Overall Study|Ulcerative Colitis identified|1|||
147643517|NCT02345889|532514082|FG001|Overall Study|Ulcerative Colitis identified|0|||
147643518|NCT02345889|532514083|FG002|Overall Study|Ulcerative Colitis identified|0|||
147643519|NCT02345889|532514084|FG003|Overall Study|Ulcerative Colitis identified|0|||
147643520|NCT02345889|532514081|FG000|Overall Study|Cecum not intubated|1|||
147643521|NCT02345889|532514082|FG001|Overall Study|Cecum not intubated|0|||
147643522|NCT02345889|532514083|FG002|Overall Study|Cecum not intubated|0|||
147643523|NCT02345889|532514084|FG003|Overall Study|Cecum not intubated|0|||
147643524|NCT04325698|532514085|FG000|Overall Study|Study Terminated By Sponsor|1|||
147643525|NCT04325698|532514086|FG001|Overall Study|Study Terminated By Sponsor|1|||
147643526|NCT04325698|532514085|FG000|Overall Study|Withdrawal by Subject|0|||
147643527|NCT04325698|532514086|FG001|Overall Study|Withdrawal by Subject|2|||
147643528|NCT04253782|532514087|FG000|Overall Study|Death|2|||
147643529|NCT04253782|532514088|FG001|Overall Study|Death|0|||
147643530|NCT00962091|532514089|FG000|Overall Study|Withdrawal by Subject|1|||
147643531|NCT00962091|532514090|FG001|Overall Study|Withdrawal by Subject|2|||
147643532|NCT00962091|532514091|FG002|Overall Study|Withdrawal by Subject|1|||
147643533|NCT00962091|532514092|FG003|Overall Study|Withdrawal by Subject|1|||
147643534|NCT00962091|532514093|FG004|Overall Study|Withdrawal by Subject|0|||
147643535|NCT00962091|532514094|FG005|Overall Study|Withdrawal by Subject|1|||
147643536|NCT00962091|532514095|FG006|Overall Study|Withdrawal by Subject|0|||
147643537|NCT00962091|532514089|FG000|Overall Study|Adverse Event|0|||
147643538|NCT00962091|532514090|FG001|Overall Study|Adverse Event|0|||
147643539|NCT00962091|532514091|FG002|Overall Study|Adverse Event|0|||
147643540|NCT00962091|532514092|FG003|Overall Study|Adverse Event|0|||
147643541|NCT00962091|532514093|FG004|Overall Study|Adverse Event|0|||
147643542|NCT00962091|532514094|FG005|Overall Study|Adverse Event|0|||
147643543|NCT00962091|532514095|FG006|Overall Study|Adverse Event|1|||
147643544|NCT02044874|532514100|FG000|Overall Study|Adverse Event|5|||
147643545|NCT02044874|532514101|FG001|Overall Study|Adverse Event|6|||
147643546|NCT02044874|532514102|FG002|Overall Study|Adverse Event|6|||
147643547|NCT02044874|532514100|FG000|Overall Study|Withdrawal by Subject|8|||
147643548|NCT02044874|532514101|FG001|Overall Study|Withdrawal by Subject|16|||
147643549|NCT02044874|532514102|FG002|Overall Study|Withdrawal by Subject|23|||
147643550|NCT02044874|532514100|FG000|Overall Study|Physician Decision|0|||
147643551|NCT02044874|532514101|FG001|Overall Study|Physician Decision|2|||
147643552|NCT02044874|532514102|FG002|Overall Study|Physician Decision|1|||
147643553|NCT02044874|532514100|FG000|Overall Study|Lost to Follow-up|10|||
147643554|NCT02044874|532514101|FG001|Overall Study|Lost to Follow-up|27|||
147643555|NCT02044874|532514102|FG002|Overall Study|Lost to Follow-up|21|||
147643556|NCT02044874|532514100|FG000|Overall Study|Sponsor Decision|0|||
147643557|NCT02044874|532514101|FG001|Overall Study|Sponsor Decision|1|||
147643558|NCT02044874|532514102|FG002|Overall Study|Sponsor Decision|1|||
147643559|NCT02044874|532514100|FG000|Overall Study|Other|7|||
147643560|NCT02044874|532514101|FG001|Overall Study|Other|3|||
147643561|NCT02044874|532514102|FG002|Overall Study|Other|8|||
147643562|NCT02889835|532514103|FG000|Overall Study|Lost to Follow-up|13|||
147643563|NCT02889835|532514104|FG001|Overall Study|Lost to Follow-up|13|||
147643564|NCT02889835|532514105|FG002|Overall Study|Lost to Follow-up|13|||
147643565|NCT02889835|532514103|FG000|Overall Study|Withdrawal by Subject|2|||
147643566|NCT02889835|532514104|FG001|Overall Study|Withdrawal by Subject|2|||
147643567|NCT02889835|532514105|FG002|Overall Study|Withdrawal by Subject|2|||
147643568|NCT02889835|532514103|FG000|Overall Study|Protocol Violation|1|||
147643569|NCT02889835|532514104|FG001|Overall Study|Protocol Violation|1|||
147643570|NCT02889835|532514105|FG002|Overall Study|Protocol Violation|1|||
147643571|NCT02889835|532514103|FG000|Overall Study|Exclusion Criteria -change in oral status|1|||
147643572|NCT02889835|532514104|FG001|Overall Study|Exclusion Criteria -change in oral status|1|||
147521668|NCT01066819|532061164|FG003|Overall Study|Not categorised|1|||
147521669|NCT01066819|532061165|FG004|Overall Study|Not categorised|0|||
147521670|NCT01066819|532061166|FG005|Overall Study|Not categorised|0|||
147521671|NCT01066819|532061161|FG000|Overall Study|Relapse|16|||
147521672|NCT01066819|532061162|FG001|Overall Study|Relapse|4|||
147521673|NCT01066819|532061163|FG002|Overall Study|Relapse|3|||
147521674|NCT01066819|532061164|FG003|Overall Study|Relapse|0|||
147521675|NCT01066819|532061165|FG004|Overall Study|Relapse|0|||
147521676|NCT01066819|532061166|FG005|Overall Study|Relapse|0|||
147521677|NCT01066819|532061161|FG000|Overall Study|Results not available|1|||
147521678|NCT01066819|532061162|FG001|Overall Study|Results not available|0|||
147521679|NCT01066819|532061163|FG002|Overall Study|Results not available|0|||
147521680|NCT01066819|532061164|FG003|Overall Study|Results not available|0|||
147521681|NCT01066819|532061165|FG004|Overall Study|Results not available|0|||
147521682|NCT01066819|532061166|FG005|Overall Study|Results not available|0|||
147521683|NCT01066819|532061161|FG000|Overall Study|Screen failure|1|||
147521684|NCT01066819|532061162|FG001|Overall Study|Screen failure|0|||
147521685|NCT01066819|532061163|FG002|Overall Study|Screen failure|0|||
147521686|NCT01066819|532061164|FG003|Overall Study|Screen failure|0|||
147521687|NCT01066819|532061165|FG004|Overall Study|Screen failure|0|||
147521688|NCT01066819|532061166|FG005|Overall Study|Screen failure|0|||
147521689|NCT01066819|532061161|FG000|Overall Study|Spontaneous cure|1|||
147521690|NCT01066819|532061162|FG001|Overall Study|Spontaneous cure|0|||
147521691|NCT01066819|532061163|FG002|Overall Study|Spontaneous cure|0|||
147521692|NCT01066819|532061164|FG003|Overall Study|Spontaneous cure|0|||
147521693|NCT01066819|532061165|FG004|Overall Study|Spontaneous cure|0|||
147521694|NCT01066819|532061166|FG005|Overall Study|Spontaneous cure|0|||
147521695|NCT01066819|532061161|FG000|Overall Study|Treatment never started|85|||
147521696|NCT01066819|532061162|FG001|Overall Study|Treatment never started|19|||
147521697|NCT01066819|532061163|FG002|Overall Study|Treatment never started|19|||
147521698|NCT01066819|532061164|FG003|Overall Study|Treatment never started|3|||
147521699|NCT01066819|532061165|FG004|Overall Study|Treatment never started|2|||
147521700|NCT01066819|532061166|FG005|Overall Study|Treatment never started|2|||
147521701|NCT01066819|532061161|FG000|Overall Study|Treatment stopped|12|||
147521702|NCT01066819|532061162|FG001|Overall Study|Treatment stopped|1|||
147521703|NCT01066819|532061163|FG002|Overall Study|Treatment stopped|2|||
147521704|NCT01066819|532061164|FG003|Overall Study|Treatment stopped|1|||
147521705|NCT01066819|532061165|FG004|Overall Study|Treatment stopped|0|||
147521706|NCT01066819|532061166|FG005|Overall Study|Treatment stopped|0|||
147521707|NCT01066819|532061161|FG000|Overall Study|Other|5|||
147521708|NCT01066819|532061162|FG001|Overall Study|Other|1|||
147521709|NCT01066819|532061163|FG002|Overall Study|Other|1|||
147521710|NCT01066819|532061164|FG003|Overall Study|Other|0|||
147521711|NCT01066819|532061165|FG004|Overall Study|Other|0|||
147521712|NCT01066819|532061166|FG005|Overall Study|Other|0|||
147521713|NCT02408016|532061167|FG000|Overall Study|Death|6|||
147521714|NCT02408016|532061168|FG001|Overall Study|Death|1|||
147521715|NCT02408016|532061169|FG002|Overall Study|Death|0|||
147521716|NCT02408016|532061167|FG000|Overall Study|Physician Decision|0|||
147521717|NCT02408016|532061168|FG001|Overall Study|Physician Decision|2|||
147521718|NCT02408016|532061169|FG002|Overall Study|Physician Decision|0|||
147521719|NCT00718887|532061171|FG000|Overall Study|Withdrawal by Subject|3|||
147521720|NCT00718887|532061172|FG001|Overall Study|Withdrawal by Subject|2|||
147521721|NCT00718887|532061171|FG000|Overall Study|Not identified|2|||
147521722|NCT00718887|532061172|FG001|Overall Study|Not identified|7|||
147521723|NCT00775138|532061173|FG000|Overall Study|Withdrawal by Subject|0|||
147521724|NCT00775138|532061174|FG001|Overall Study|Withdrawal by Subject|0|||
147521725|NCT00775138|532061175|FG002|Overall Study|Withdrawal by Subject|2|||
147521726|NCT00775138|532061176|FG003|Overall Study|Withdrawal by Subject|2|||
147521727|NCT00775138|532061173|FG000|Overall Study|Adverse Event|0|||
147521728|NCT00775138|532061174|FG001|Overall Study|Adverse Event|0|||
147521729|NCT00775138|532061175|FG002|Overall Study|Adverse Event|1|||
147521730|NCT00775138|532061176|FG003|Overall Study|Adverse Event|0|||
147521731|NCT03557801|532061177|FG000|Overall Study|Protocol Violation|1|||
147521732|NCT03557801|532061178|FG001|Overall Study|Protocol Violation|0|||
147643573|NCT02889835|532514105|FG002|Overall Study|Exclusion Criteria -change in oral status|1|||
147643574|NCT02889835|532514103|FG000|Overall Study|Death|1|||
147643575|NCT02889835|532514104|FG001|Overall Study|Death|1|||
147643576|NCT02889835|532514105|FG002|Overall Study|Death|1|||
147643577|NCT05072964|532514108|FG000|Overall Study|Withdrawal by Subject|4|||
147643578|NCT05072964|532514108|FG000|Overall Study|Death|1|||
147643579|NCT02987972|532514109|FG000|Overall Study|Adverse Event|1|||
147643580|NCT02987972|532514110|FG001|Overall Study|Adverse Event|1|||
147643581|NCT02987972|532514111|FG002|Overall Study|Adverse Event|0|||
147643582|NCT02987972|532514109|FG000|Overall Study|Death|1|||
147643583|NCT02987972|532514110|FG001|Overall Study|Death|0|||
147643584|NCT02987972|532514111|FG002|Overall Study|Death|0|||
147643585|NCT02987972|532514109|FG000|Overall Study|Lack of Efficacy|9|||
147643586|NCT02987972|532514110|FG001|Overall Study|Lack of Efficacy|12|||
147643587|NCT02987972|532514111|FG002|Overall Study|Lack of Efficacy|12|||
147643588|NCT02987972|532514109|FG000|Overall Study|Lost to Follow-up|7|||
147643589|NCT02987972|532514110|FG001|Overall Study|Lost to Follow-up|8|||
147643590|NCT02987972|532514111|FG002|Overall Study|Lost to Follow-up|4|||
147643591|NCT02987972|532514109|FG000|Overall Study|Physician Decision|1|||
147643592|NCT02987972|532514110|FG001|Overall Study|Physician Decision|6|||
147643593|NCT02987972|532514111|FG002|Overall Study|Physician Decision|0|||
147643594|NCT02987972|532514109|FG000|Overall Study|Protocol Violation|2|||
147643595|NCT02987972|532514110|FG001|Overall Study|Protocol Violation|1|||
147521733|NCT03557801|532061179|FG002|Overall Study|Protocol Violation|0|||
147521734|NCT03557801|532061177|FG000|Overall Study|Withdrawal by Subject|1|||
147521735|NCT03557801|532061178|FG001|Overall Study|Withdrawal by Subject|0|||
147521736|NCT03557801|532061179|FG002|Overall Study|Withdrawal by Subject|3|||
147521737|NCT03557801|532061177|FG000|Overall Study|Lost to Follow-up|0|||
147521738|NCT03557801|532061178|FG001|Overall Study|Lost to Follow-up|1|||
147521739|NCT03557801|532061179|FG002|Overall Study|Lost to Follow-up|0|||
147521740|NCT00535236|532061180|FG000|Overall Study|Adverse Event|1|||
147521741|NCT00535236|532061181|FG001|Overall Study|Adverse Event|0|||
147521742|NCT00535236|532061182|FG002|Overall Study|Adverse Event|9|||
147521743|NCT00535236|532061183|FG003|Overall Study|Adverse Event|3|||
147521744|NCT00535236|532061184|FG004|Overall Study|Adverse Event|3|||
147521745|NCT00535236|532061185|FG005|Overall Study|Adverse Event|0|||
147521746|NCT00535236|532061186|FG006|Overall Study|Adverse Event|5|||
147521747|NCT00535236|532061187|FG007|Overall Study|Adverse Event|1|||
147521748|NCT00535236|532061188|FG008|Overall Study|Adverse Event|2|||
147521749|NCT00535236|532061189|FG009|Overall Study|Adverse Event|1|||
147521750|NCT00535236|532061180|FG000|Overall Study|Lost to Follow-up|1|||
147521751|NCT00535236|532061181|FG001|Overall Study|Lost to Follow-up|2|||
147521752|NCT00535236|532061182|FG002|Overall Study|Lost to Follow-up|0|||
147521753|NCT00535236|532061183|FG003|Overall Study|Lost to Follow-up|0|||
147521754|NCT00535236|532061184|FG004|Overall Study|Lost to Follow-up|2|||
147521755|NCT00535236|532061185|FG005|Overall Study|Lost to Follow-up|0|||
147521756|NCT00535236|532061186|FG006|Overall Study|Lost to Follow-up|0|||
147521757|NCT00535236|532061187|FG007|Overall Study|Lost to Follow-up|0|||
147521758|NCT00535236|532061188|FG008|Overall Study|Lost to Follow-up|6|||
147521759|NCT00535236|532061189|FG009|Overall Study|Lost to Follow-up|1|||
147521760|NCT00535236|532061180|FG000|Overall Study|Physician Decision|0|||
147521761|NCT00535236|532061181|FG001|Overall Study|Physician Decision|0|||
147521762|NCT00535236|532061182|FG002|Overall Study|Physician Decision|0|||
147521763|NCT00535236|532061183|FG003|Overall Study|Physician Decision|0|||
147521764|NCT00535236|532061184|FG004|Overall Study|Physician Decision|1|||
147521765|NCT00535236|532061185|FG005|Overall Study|Physician Decision|0|||
147521766|NCT00535236|532061186|FG006|Overall Study|Physician Decision|1|||
147521767|NCT00535236|532061187|FG007|Overall Study|Physician Decision|0|||
147521768|NCT00535236|532061188|FG008|Overall Study|Physician Decision|0|||
147521769|NCT00535236|532061189|FG009|Overall Study|Physician Decision|0|||
147521770|NCT00535236|532061180|FG000|Overall Study|Protocol Violation|2|||
147521771|NCT00535236|532061181|FG001|Overall Study|Protocol Violation|0|||
147521772|NCT00535236|532061182|FG002|Overall Study|Protocol Violation|1|||
147521773|NCT00535236|532061183|FG003|Overall Study|Protocol Violation|0|||
147521774|NCT00535236|532061184|FG004|Overall Study|Protocol Violation|0|||
147521775|NCT00535236|532061185|FG005|Overall Study|Protocol Violation|0|||
147521776|NCT00535236|532061186|FG006|Overall Study|Protocol Violation|0|||
147521777|NCT00535236|532061187|FG007|Overall Study|Protocol Violation|0|||
147521778|NCT00535236|532061188|FG008|Overall Study|Protocol Violation|1|||
147521779|NCT00535236|532061189|FG009|Overall Study|Protocol Violation|0|||
147521780|NCT00535236|532061180|FG000|Overall Study|Withdrawal by Subject|3|||
147521781|NCT00535236|532061181|FG001|Overall Study|Withdrawal by Subject|0|||
147521782|NCT00535236|532061182|FG002|Overall Study|Withdrawal by Subject|2|||
147521783|NCT00535236|532061183|FG003|Overall Study|Withdrawal by Subject|1|||
147521784|NCT00535236|532061184|FG004|Overall Study|Withdrawal by Subject|6|||
147521785|NCT00535236|532061185|FG005|Overall Study|Withdrawal by Subject|1|||
147521786|NCT00535236|532061186|FG006|Overall Study|Withdrawal by Subject|5|||
147521787|NCT00535236|532061187|FG007|Overall Study|Withdrawal by Subject|0|||
147521788|NCT00535236|532061188|FG008|Overall Study|Withdrawal by Subject|4|||
147521789|NCT00535236|532061189|FG009|Overall Study|Withdrawal by Subject|2|||
147521790|NCT04880642|532061190|FG000|Randomization|Withdrawal by Subject|2|||
147521791|NCT04880642|532061191|FG001|Randomization|Withdrawal by Subject|3|||
147521792|NCT04880642|532061190|FG000|Treatment Period|Adverse Event|0|||
147521793|NCT04880642|532061191|FG001|Treatment Period|Adverse Event|1|||
147521794|NCT04880642|532061190|FG000|Treatment Period|Death|6|||
147521795|NCT04880642|532061191|FG001|Treatment Period|Death|6|||
147521796|NCT04880642|532061190|FG000|Treatment Period|Lost to Follow-up|1|||
147521797|NCT04880642|532061191|FG001|Treatment Period|Lost to Follow-up|0|||
147521798|NCT04880642|532061190|FG000|Treatment Period|Protocol Violation|0|||
147521799|NCT04880642|532061191|FG001|Treatment Period|Protocol Violation|1|||
147521800|NCT04880642|532061190|FG000|Treatment Period|Withdrawal by Subject|5|||
147521801|NCT04880642|532061191|FG001|Treatment Period|Withdrawal by Subject|3|||
147521802|NCT04880642|532061190|FG000|Treatment Period|Discontinuation criteria of eGFR|0|||
147521803|NCT04880642|532061191|FG001|Treatment Period|Discontinuation criteria of eGFR|1|||
147521804|NCT04880642|532061190|FG000|Follow-up|Death|4|||
147521805|NCT04880642|532061191|FG001|Follow-up|Death|3|||
147521806|NCT04880642|532061190|FG000|Follow-up|Withdrawal by Subject|1|||
147521807|NCT04880642|532061191|FG001|Follow-up|Withdrawal by Subject|0|||
147521808|NCT02275052|532061194|FG000|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
147521809|NCT02275052|532061195|FG001|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|1|||
147521810|NCT02275052|532061196|FG002|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
147521811|NCT02275052|532061197|FG003|Period 1: Treatment Period 1 (12 Weeks)|Lost to Follow-up|0|||
147521812|NCT02275052|532061194|FG000|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|0|||
147521813|NCT02275052|532061195|FG001|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|1|||
147521814|NCT02275052|532061196|FG002|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|0|||
147521815|NCT02275052|532061197|FG003|Period 1: Treatment Period 1 (12 Weeks)|Met protocol-defined stopping criteria|0|||
147521816|NCT02275052|532061194|FG000|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|6|||
147521817|NCT02275052|532061195|FG001|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|4|||
147521818|NCT02275052|532061196|FG002|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
147521819|NCT02275052|532061197|FG003|Period 1: Treatment Period 1 (12 Weeks)|Withdrawal by Subject|0|||
147521820|NCT02275052|532061194|FG000|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|1|||
147521821|NCT02275052|532061195|FG001|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|0|||
147521822|NCT02275052|532061196|FG002|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|0|||
147521823|NCT02275052|532061197|FG003|Period 1: Treatment Period 1 (12 Weeks)|Physician Decision|0|||
147521824|NCT02275052|532061194|FG000|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|2|||
147521825|NCT02275052|532061195|FG001|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|0|||
147521826|NCT02275052|532061196|FG002|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|0|||
147521827|NCT02275052|532061197|FG003|Period 1: Treatment Period 1 (12 Weeks)|Adverse Event|0|||
147521828|NCT02275052|532061194|FG000|Washout Period (12-17 Days)|Withdrawal by Subject|3|||
147521829|NCT02275052|532061195|FG001|Washout Period (12-17 Days)|Withdrawal by Subject|0|||
147521830|NCT02275052|532061196|FG002|Washout Period (12-17 Days)|Withdrawal by Subject|0|||
147521831|NCT02275052|532061197|FG003|Washout Period (12-17 Days)|Withdrawal by Subject|0|||
147521832|NCT02275052|532061194|FG000|Washout Period (12-17 Days)|Lack of Efficacy|1|||
147521833|NCT02275052|532061195|FG001|Washout Period (12-17 Days)|Lack of Efficacy|0|||
147521834|NCT02275052|532061196|FG002|Washout Period (12-17 Days)|Lack of Efficacy|0|||
147521835|NCT02275052|532061197|FG003|Washout Period (12-17 Days)|Lack of Efficacy|0|||
147521836|NCT02275052|532061194|FG000|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|0|||
147521837|NCT02275052|532061195|FG001|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|0|||
147521838|NCT02275052|532061196|FG002|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|3|||
147521839|NCT02275052|532061197|FG003|Period 2: Treatment Period 2 (12 Weeks)|Adverse Event|2|||
147521840|NCT02275052|532061194|FG000|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
147521841|NCT02275052|532061195|FG001|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|0|||
147521842|NCT02275052|532061196|FG002|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|1|||
147521843|NCT02275052|532061197|FG003|Period 2: Treatment Period 2 (12 Weeks)|Withdrawal by Subject|4|||
147521844|NCT02275052|532061194|FG000|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|0|||
147521845|NCT02275052|532061195|FG001|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|0|||
147521846|NCT02275052|532061196|FG002|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|1|||
147521847|NCT02275052|532061197|FG003|Period 2: Treatment Period 2 (12 Weeks)|Lack of Efficacy|6|||
147521848|NCT02275052|532061194|FG000|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
147521849|NCT02275052|532061195|FG001|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
147521850|NCT02275052|532061196|FG002|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|0|||
147521851|NCT02275052|532061197|FG003|Period 2: Treatment Period 2 (12 Weeks)|Met Protocol-defined Stopping Criteria|2|||
147521852|NCT00561795|532061198|FG000|Overall Study|Adverse Event|3|||
147521853|NCT00561795|532061199|FG001|Overall Study|Adverse Event|3|||
147521854|NCT00561795|532061200|FG002|Overall Study|Adverse Event|0|||
147521855|NCT00561795|532061201|FG003|Overall Study|Adverse Event|0|||
147521856|NCT00561795|532061198|FG000|Overall Study|Study Closed/Terminated|0|||
147521857|NCT00561795|532061199|FG001|Overall Study|Study Closed/Terminated|3|||
147521858|NCT00561795|532061200|FG002|Overall Study|Study Closed/Terminated|0|||
147521859|NCT00561795|532061201|FG003|Overall Study|Study Closed/Terminated|0|||
147521860|NCT00561795|532061198|FG000|Overall Study|Physician Decision|1|||
147521861|NCT00561795|532061199|FG001|Overall Study|Physician Decision|0|||
147521862|NCT00561795|532061200|FG002|Overall Study|Physician Decision|0|||
147521863|NCT00561795|532061201|FG003|Overall Study|Physician Decision|0|||
147521864|NCT02807376|532061202|FG000|Overall Study|Intra-operative exclusion criteria|3|||
147521865|NCT02807376|532061203|FG001|Overall Study|Intra-operative exclusion criteria|0|||
147521866|NCT02807376|532061202|FG000|Overall Study|Lost to Follow-up|0|||
147521867|NCT02807376|532061203|FG001|Overall Study|Lost to Follow-up|1|||
147521868|NCT00846027|532061204|FG000|Overall Study|Death|3|||
147521869|NCT00846027|532061204|FG000|Overall Study|Disease Progression|30|||
147521870|NCT00846027|532061204|FG000|Overall Study|Toxicity|12|||
147521871|NCT00846027|532061204|FG000|Overall Study|Patient Decision|7|||
147521872|NCT00846027|532061204|FG000|Overall Study|Investigator Discretion|29|||
147521873|NCT00846027|532061204|FG000|Overall Study|Protocol Violation|2|||
147521874|NCT00846027|532061204|FG000|Overall Study|Subject Not Treated|7|||
147521875|NCT03228836|532061209|FG000|Overall Study|Adverse Event|3|||
147521876|NCT03228836|532061209|FG000|Overall Study|Withdrawal by Subject|1|||
147521877|NCT03228836|532061209|FG000|Overall Study|Death|1|||
147521878|NCT03228836|532061209|FG000|Overall Study|Physician Decision|1|||
147521879|NCT03228836|532061209|FG000|Overall Study|Disease Progression|7|||
147521880|NCT03228836|532061209|FG000|Overall Study|Other|4|||
147521881|NCT00948389|532061210|FG000|Overall Study|Disease Progression/Relapse/Death|3|||
147521882|NCT00948389|532061211|FG001|Overall Study|Disease Progression/Relapse/Death|3|||
147521883|NCT00948389|532061212|FG002|Overall Study|Disease Progression/Relapse/Death|7|||
147521884|NCT00948389|532061213|FG003|Overall Study|Disease Progression/Relapse/Death|8|||
147521885|NCT00948389|532061214|FG004|Overall Study|Disease Progression/Relapse/Death|1|||
147521886|NCT00948389|532061210|FG000|Overall Study|Thrombocytopenia, Grade 4|2|||
147521887|NCT00948389|532061211|FG001|Overall Study|Thrombocytopenia, Grade 4|0|||
147521888|NCT00948389|532061212|FG002|Overall Study|Thrombocytopenia, Grade 4|0|||
147521889|NCT00948389|532061213|FG003|Overall Study|Thrombocytopenia, Grade 4|1|||
147521890|NCT00948389|532061214|FG004|Overall Study|Thrombocytopenia, Grade 4|0|||
147521891|NCT00948389|532061210|FG000|Overall Study|Both Progression and Toxicity|1|||
147521892|NCT00948389|532061211|FG001|Overall Study|Both Progression and Toxicity|0|||
147521893|NCT00948389|532061212|FG002|Overall Study|Both Progression and Toxicity|0|||
147521894|NCT00948389|532061213|FG003|Overall Study|Both Progression and Toxicity|0|||
147521895|NCT00948389|532061214|FG004|Overall Study|Both Progression and Toxicity|0|||
147521896|NCT02967562|532061217|FG000|Overall Study|Consent not obtained|1|||
147521897|NCT02967562|532061218|FG001|Overall Study|Consent not obtained|0|||
147521898|NCT02967562|532061217|FG000|Overall Study|High leak precluding analysis|1|||
147521899|NCT02967562|532061218|FG001|Overall Study|High leak precluding analysis|1|||
147521900|NCT04652102|532061219|FG000|Overall Study|Adverse Event|14|||
147521901|NCT04652102|532061220|FG001|Overall Study|Adverse Event|13|||
147521902|NCT04652102|532061219|FG000|Overall Study|Subject Received Alternative Authorised Vaccine|1407|||
147521903|NCT04652102|532061220|FG001|Overall Study|Subject Received Alternative Authorised Vaccine|6552|||
147521904|NCT04652102|532061219|FG000|Overall Study|Physician Decision|78|||
147521905|NCT04652102|532061220|FG001|Overall Study|Physician Decision|40|||
147521906|NCT04652102|532061219|FG000|Overall Study|Study Ended by Sponsor|64|||
147521907|NCT04652102|532061220|FG001|Overall Study|Study Ended by Sponsor|17|||
147521908|NCT04652102|532061219|FG000|Overall Study|Withdrawal by Subject|4625|||
147521909|NCT04652102|532061220|FG001|Overall Study|Withdrawal by Subject|5594|||
147521910|NCT04652102|532061219|FG000|Overall Study|Lost to Follow-up|2019|||
147521911|NCT04652102|532061220|FG001|Overall Study|Lost to Follow-up|1082|||
147521912|NCT04652102|532061219|FG000|Overall Study|Protocol Specified Withdrawal Criterion Met|49|||
147521913|NCT04652102|532061220|FG001|Overall Study|Protocol Specified Withdrawal Criterion Met|2230|||
147521914|NCT04652102|532061219|FG000|Overall Study|Miscellaneous|80|||
147521915|NCT04652102|532061220|FG001|Overall Study|Miscellaneous|64|||
147521916|NCT00886587|532061221|FG000|Overall Study|Adverse Event|2|||
147521917|NCT00886587|532061222|FG001|Overall Study|Adverse Event|1|||
147521918|NCT00886587|532061221|FG000|Overall Study|Protocol Violation|2|||
147521919|NCT00886587|532061222|FG001|Overall Study|Protocol Violation|0|||
147521920|NCT00886587|532061221|FG000|Overall Study|Withdrawal by Subject|0|||
147521921|NCT00886587|532061222|FG001|Overall Study|Withdrawal by Subject|1|||
147521922|NCT02405091|532061225|FG000|Overall Study|Adverse Event|16|||
147521923|NCT02405091|532061226|FG001|Overall Study|Adverse Event|10|||
147521924|NCT02405091|532061227|FG002|Overall Study|Adverse Event|0|||
147521925|NCT02405091|532061225|FG000|Overall Study|Protocol Violation|1|||
147521926|NCT02405091|532061226|FG001|Overall Study|Protocol Violation|0|||
147521927|NCT02405091|532061227|FG002|Overall Study|Protocol Violation|0|||
147521928|NCT02405091|532061225|FG000|Overall Study|Noncompliance|1|||
147521929|NCT02405091|532061226|FG001|Overall Study|Noncompliance|6|||
147521930|NCT02405091|532061227|FG002|Overall Study|Noncompliance|2|||
147521931|NCT02405091|532061225|FG000|Overall Study|Withdrawal by Subject|4|||
147521932|NCT02405091|532061226|FG001|Overall Study|Withdrawal by Subject|8|||
147521933|NCT02405091|532061227|FG002|Overall Study|Withdrawal by Subject|0|||
147521934|NCT02405091|532061225|FG000|Overall Study|Death|0|||
147521935|NCT02405091|532061226|FG001|Overall Study|Death|1|||
147521936|NCT02405091|532061227|FG002|Overall Study|Death|0|||
147521937|NCT02405091|532061225|FG000|Overall Study|Lost to Follow-up|5|||
147521938|NCT02405091|532061226|FG001|Overall Study|Lost to Follow-up|6|||
147521939|NCT02405091|532061227|FG002|Overall Study|Lost to Follow-up|0|||
147521940|NCT02405091|532061225|FG000|Overall Study|Physician Decision|2|||
147521941|NCT02405091|532061226|FG001|Overall Study|Physician Decision|2|||
147521942|NCT02405091|532061227|FG002|Overall Study|Physician Decision|0|||
147521943|NCT00247962|532061237|FG000|Overall Study|Adverse Event|15|||
147521944|NCT00247962|532061238|FG001|Overall Study|Adverse Event|12|||
147521945|NCT00247962|532061237|FG000|Overall Study|Lost to Follow-up|3|||
147521946|NCT00247962|532061238|FG001|Overall Study|Lost to Follow-up|1|||
147521947|NCT00247962|532061237|FG000|Overall Study|Physician Decision|0|||
147521948|NCT00247962|532061238|FG001|Overall Study|Physician Decision|1|||
147521949|NCT00247962|532061237|FG000|Overall Study|Protocol Violation|1|||
147521950|NCT00247962|532061238|FG001|Overall Study|Protocol Violation|1|||
147521951|NCT00247962|532061237|FG000|Overall Study|Withdrawal by Subject|3|||
147521952|NCT00247962|532061238|FG001|Overall Study|Withdrawal by Subject|2|||
147521953|NCT00247962|532061237|FG000|Overall Study|Lack of Efficacy|4|||
147521954|NCT00247962|532061238|FG001|Overall Study|Lack of Efficacy|2|||
147521955|NCT01955005|532061239|FG000|Overall Study|Withdrawal by Subject|3|||
147521956|NCT01955005|532061240|FG001|Overall Study|Withdrawal by Subject|5|||
147521957|NCT01469637|532061245|FG000|First Intervention|Unacceptable behavior|0|||
147521958|NCT01469637|532061246|FG001|First Intervention|Unacceptable behavior|1|||
147521959|NCT01469637|532061245|FG000|Second Intervention|Incarcerated|1|||
147521960|NCT01469637|532061246|FG001|Second Intervention|Incarcerated|0|||
147521961|NCT01371721|532061247|FG000|Overall Study|Adverse Event|5|||
147521962|NCT01371721|532061248|FG001|Overall Study|Adverse Event|4|||
147521963|NCT01371721|532061249|FG002|Overall Study|Adverse Event|5|||
147521964|NCT01371721|532061247|FG000|Overall Study|Protocol Violation|6|||
147521965|NCT01371721|532061248|FG001|Overall Study|Protocol Violation|4|||
147521966|NCT01371721|532061249|FG002|Overall Study|Protocol Violation|5|||
147521967|NCT01371721|532061247|FG000|Overall Study|Lost to Follow-up|8|||
147521968|NCT01371721|532061248|FG001|Overall Study|Lost to Follow-up|2|||
147521969|NCT01371721|532061249|FG002|Overall Study|Lost to Follow-up|6|||
147521970|NCT01371721|532061247|FG000|Overall Study|Withdrawal by Subject|5|||
147521971|NCT01371721|532061248|FG001|Overall Study|Withdrawal by Subject|7|||
147521972|NCT01371721|532061249|FG002|Overall Study|Withdrawal by Subject|11|||
147521973|NCT01371721|532061247|FG000|Overall Study|Other|2|||
147521974|NCT01371721|532061248|FG001|Overall Study|Other|3|||
147521975|NCT01371721|532061249|FG002|Overall Study|Other|0|||
147521976|NCT01371721|532061247|FG000|Overall Study|Lack of Efficacy|2|||
147521977|NCT01371721|532061248|FG001|Overall Study|Lack of Efficacy|4|||
147521978|NCT01371721|532061249|FG002|Overall Study|Lack of Efficacy|3|||
147521979|NCT01371721|532061247|FG000|Overall Study|Randomized but not treated|1|||
147521980|NCT01371721|532061248|FG001|Overall Study|Randomized but not treated|0|||
147521981|NCT01371721|532061249|FG002|Overall Study|Randomized but not treated|0|||
147521982|NCT00545584|532061250|FG000|Overall Study|Only one reason for discontinuation|62|||
147521983|NCT00545584|532061251|FG001|Overall Study|Only one reason for discontinuation|61|||
147521984|NCT00545584|532061252|FG002|Overall Study|Only one reason for discontinuation|48|||
147521985|NCT00545584|532061250|FG000|Overall Study|Two or more reasons for discontinuation|17|||
147521986|NCT00545584|532061251|FG001|Overall Study|Two or more reasons for discontinuation|19|||
147521987|NCT00545584|532061252|FG002|Overall Study|Two or more reasons for discontinuation|8|||
147521988|NCT00135694|532061256|FG000|Overall Study|Adverse Event|17|||
147521989|NCT00135694|532061257|FG001|Overall Study|Adverse Event|4|||
147521990|NCT00135694|532061258|FG002|Overall Study|Adverse Event|0|||
147521991|NCT00135694|532061256|FG000|Overall Study|Death|14|||
147521992|NCT00135694|532061257|FG001|Overall Study|Death|1|||
147521993|NCT00135694|532061258|FG002|Overall Study|Death|2|||
147521994|NCT00135694|532061256|FG000|Overall Study|Lost to Follow-up|8|||
147521995|NCT00135694|532061257|FG001|Overall Study|Lost to Follow-up|7|||
147521996|NCT00135694|532061258|FG002|Overall Study|Lost to Follow-up|1|||
147521997|NCT00135694|532061256|FG000|Overall Study|Withdrawal by Subject|41|||
147521998|NCT00135694|532061257|FG001|Overall Study|Withdrawal by Subject|7|||
147521999|NCT00135694|532061258|FG002|Overall Study|Withdrawal by Subject|4|||
147522000|NCT00135694|532061256|FG000|Overall Study|Protocol Violation|19|||
147522001|NCT00135694|532061257|FG001|Overall Study|Protocol Violation|1|||
147522002|NCT00135694|532061258|FG002|Overall Study|Protocol Violation|0|||
147522003|NCT00135694|532061256|FG000|Overall Study|Hepatitis C related reasons|39|||
147522004|NCT00135694|532061257|FG001|Overall Study|Hepatitis C related reasons|1|||
147522005|NCT00135694|532061258|FG002|Overall Study|Hepatitis C related reasons|0|||
147522006|NCT00135694|532061256|FG000|Overall Study|Ineligible for Random assignment|42|||
147522007|NCT00135694|532061257|FG001|Overall Study|Ineligible for Random assignment|0|||
147643596|NCT02987972|532514111|FG002|Overall Study|Protocol Violation|5|||
147643597|NCT02987972|532514109|FG000|Overall Study|Withdrawal by Subject|22|||
147643598|NCT02987972|532514110|FG001|Overall Study|Withdrawal by Subject|17|||
147643599|NCT02987972|532514111|FG002|Overall Study|Withdrawal by Subject|21|||
147643600|NCT01047332|532514114|FG000|Overall Study|SEMS Obstruction|11|||
147643601|NCT01047332|532514115|FG001|Overall Study|SEMS Obstruction|20|||
147643602|NCT01047332|532514114|FG000|Overall Study|Died Unobstructed|38|||
147522008|NCT00135694|532061258|FG002|Overall Study|Ineligible for Random assignment|0|||
147522009|NCT02584660|532061259|FG000|Overall Study|Adverse Event|4|||
147522010|NCT02584660|532061260|FG001|Overall Study|Adverse Event|0|||
147522011|NCT02584660|532061259|FG000|Overall Study|Lost to Follow-up|3|||
147522012|NCT02584660|532061260|FG001|Overall Study|Lost to Follow-up|4|||
147522013|NCT02584660|532061259|FG000|Overall Study|Protocol Violation|0|||
147522014|NCT02584660|532061260|FG001|Overall Study|Protocol Violation|1|||
147522015|NCT02584660|532061259|FG000|Overall Study|Withdrawal by Subject|0|||
147522016|NCT02584660|532061260|FG001|Overall Study|Withdrawal by Subject|2|||
147522017|NCT02584660|532061259|FG000|Overall Study|Other|0|||
147522018|NCT02584660|532061260|FG001|Overall Study|Other|1|||
147522019|NCT02120469|532061263|FG000|Overall Study|HER-2/neu-amplified|1|||
147522020|NCT02120469|532061264|FG001|Overall Study|HER-2/neu-amplified|0|||
147522021|NCT02120469|532061265|FG002|Overall Study|HER-2/neu-amplified|1|||
147522022|NCT01040728|532061266|FG000|Overall Study|Adverse Event|4|||
147522023|NCT01040728|532061267|FG001|Overall Study|Adverse Event|8|||
147522024|NCT01040728|532061268|FG002|Overall Study|Adverse Event|0|||
147522025|NCT01040728|532061269|FG003|Overall Study|Adverse Event|4|||
147522026|NCT01040728|532061266|FG000|Overall Study|Withdrawal by Subject|0|||
147522027|NCT01040728|532061267|FG001|Overall Study|Withdrawal by Subject|1|||
147522028|NCT01040728|532061268|FG002|Overall Study|Withdrawal by Subject|1|||
147522029|NCT01040728|532061269|FG003|Overall Study|Withdrawal by Subject|0|||
147522030|NCT01040728|532061266|FG000|Overall Study|Protocol Violation|0|||
147522031|NCT01040728|532061267|FG001|Overall Study|Protocol Violation|0|||
147522032|NCT01040728|532061268|FG002|Overall Study|Protocol Violation|0|||
147522033|NCT01040728|532061269|FG003|Overall Study|Protocol Violation|1|||
147522034|NCT01040728|532061266|FG000|Overall Study|Lack of Efficacy|0|||
147522035|NCT01040728|532061267|FG001|Overall Study|Lack of Efficacy|1|||
147522036|NCT01040728|532061268|FG002|Overall Study|Lack of Efficacy|0|||
147522037|NCT01040728|532061269|FG003|Overall Study|Lack of Efficacy|1|||
147522038|NCT01040728|532061266|FG000|Overall Study|Other reasons not listed above|0|||
147522039|NCT01040728|532061267|FG001|Overall Study|Other reasons not listed above|1|||
147522040|NCT01040728|532061268|FG002|Overall Study|Other reasons not listed above|0|||
147522041|NCT01040728|532061269|FG003|Overall Study|Other reasons not listed above|0|||
147522042|NCT02583711|532061270|FG000|Overall Study|Withdrawal by Subject|0|||
147522043|NCT02583711|532061271|FG001|Overall Study|Withdrawal by Subject|10|||
147522044|NCT02583711|532061272|FG002|Overall Study|Withdrawal by Subject|0|||
147522045|NCT01601873|532061276|FG000|Overall Study|Lost to Follow-up|2|||
147522046|NCT01601873|532061277|FG001|Overall Study|Lost to Follow-up|3|||
147522047|NCT03196973|532061278|FG000|Overall Study|Adverse Event|1|||
147522048|NCT03196973|532061279|FG001|Overall Study|Adverse Event|1|||
147522049|NCT03196973|532061280|FG002|Overall Study|Adverse Event|2|||
147522050|NCT03196973|532061278|FG000|Overall Study|Lack of Efficacy|2|||
147522051|NCT03196973|532061279|FG001|Overall Study|Lack of Efficacy|6|||
147522052|NCT03196973|532061280|FG002|Overall Study|Lack of Efficacy|1|||
147522053|NCT03196973|532061278|FG000|Overall Study|Lost to Follow-up|4|||
147522054|NCT03196973|532061279|FG001|Overall Study|Lost to Follow-up|3|||
147522055|NCT03196973|532061280|FG002|Overall Study|Lost to Follow-up|2|||
147522056|NCT03196973|532061278|FG000|Overall Study|Consent withdrawn|2|||
147522057|NCT03196973|532061279|FG001|Overall Study|Consent withdrawn|1|||
147522058|NCT03196973|532061280|FG002|Overall Study|Consent withdrawn|0|||
147522059|NCT03196973|532061278|FG000|Overall Study|Administration of a wrong kit of study medication|0|||
147522060|NCT03196973|532061279|FG001|Overall Study|Administration of a wrong kit of study medication|1|||
147522061|NCT03196973|532061280|FG002|Overall Study|Administration of a wrong kit of study medication|0|||
147522062|NCT00125268|532061283|FG000|Overall Study|Withdrawal by Subject|1|||
147522063|NCT00125268|532061284|FG001|Overall Study|Withdrawal by Subject|1|||
147522064|NCT00925522|532061285|FG000|Overall Study|study closed -- business decision|20|||
147522065|NCT02985684|532061287|FG000|6-Month Clinical Success Evaluation|Missed Echocardiograph|5|||
147522066|NCT02985684|532061287|FG000|6-Month Closure Success Evaluation|Technical Failure (No Device)|5|||
147522067|NCT02985684|532061287|FG000|6-Month Closure Success Evaluation|Device Removal|3|||
147522068|NCT02449915|532061288|FG000|Overall Study|Exclusion criteria - drug use|1|||
147522069|NCT02449915|532061289|FG001|Overall Study|Exclusion criteria - drug use|0|||
147522070|NCT02449915|532061288|FG000|Overall Study|Withdrawal by Subject|0|||
147522071|NCT02449915|532061289|FG001|Overall Study|Withdrawal by Subject|2|||
147522072|NCT02449915|532061288|FG000|Overall Study|Intraoperative surgical findings|1|||
147522073|NCT02449915|532061289|FG001|Overall Study|Intraoperative surgical findings|1|||
147522074|NCT02449915|532061288|FG000|Overall Study|Abnormal preop lab|0|||
147522075|NCT02449915|532061289|FG001|Overall Study|Abnormal preop lab|1|||
147522076|NCT01436357|532061290|FG000|Overall Study|Death|5|||
147522077|NCT01436357|532061291|FG001|Overall Study|Death|1|||
147522078|NCT01436357|532061290|FG000|Overall Study|Enrolled but not vaccinated|1|||
147522079|NCT01436357|532061291|FG001|Overall Study|Enrolled but not vaccinated|1|||
147522080|NCT01436357|532061290|FG000|Overall Study|Incarceration|18|||
147522081|NCT01436357|532061291|FG001|Overall Study|Incarceration|20|||
147522082|NCT01436357|532061290|FG000|Overall Study|Lost to Follow-up|67|||
147522083|NCT01436357|532061291|FG001|Overall Study|Lost to Follow-up|61|||
147522084|NCT01436357|532061290|FG000|Overall Study|Protocol Violation|1|||
147522085|NCT01436357|532061291|FG001|Overall Study|Protocol Violation|0|||
147522086|NCT01436357|532061290|FG000|Overall Study|Withdrawal by Subject|26|||
147522087|NCT01436357|532061291|FG001|Overall Study|Withdrawal by Subject|38|||
147522088|NCT01436357|532061290|FG000|Overall Study|Physician Decision|3|||
147522089|NCT01436357|532061291|FG001|Overall Study|Physician Decision|4|||
147522090|NCT01436357|532061290|FG000|Overall Study|Moved out of area|1|||
147522091|NCT01436357|532061291|FG001|Overall Study|Moved out of area|2|||
147522092|NCT01436357|532061290|FG000|Overall Study|Subject in rehab|0|||
147522093|NCT01436357|532061291|FG001|Overall Study|Subject in rehab|1|||
147522094|NCT00656799|532061292|FG000|Overall Study|Death|2|||
147522095|NCT05281094|532061293|FG000|Overall Study|Adverse Event|1|||
147522096|NCT05281094|532061294|FG001|Overall Study|Adverse Event|0|||
147522097|NCT05281094|532061293|FG000|Overall Study|Lost to Follow-up|29|||
147522098|NCT05281094|532061294|FG001|Overall Study|Lost to Follow-up|22|||
147522099|NCT05281094|532061293|FG000|Overall Study|Withdrawal by Legally Authorized Representative|122|||
147522100|NCT05281094|532061294|FG001|Overall Study|Withdrawal by Legally Authorized Representative|103|||
147522101|NCT05281094|532061293|FG000|Overall Study|Death|1|||
147522102|NCT05281094|532061294|FG001|Overall Study|Death|2|||
147522103|NCT05281094|532061293|FG000|Overall Study|Not pre-specified reason|8|||
147522104|NCT05281094|532061294|FG001|Overall Study|Not pre-specified reason|5|||
147522105|NCT00631969|532061295|FG000|Overall Study|Adverse Event|3|||
147522106|NCT00631969|532061296|FG001|Overall Study|Adverse Event|1|||
147522107|NCT00631969|532061295|FG000|Overall Study|Lack of Efficacy|2|||
147522108|NCT00631969|532061296|FG001|Overall Study|Lack of Efficacy|8|||
147522109|NCT00631969|532061295|FG000|Overall Study|Lost to Follow-up|2|||
147522110|NCT00631969|532061296|FG001|Overall Study|Lost to Follow-up|1|||
147522111|NCT00631969|532061295|FG000|Overall Study|Protocol Violation|1|||
147522112|NCT00631969|532061296|FG001|Overall Study|Protocol Violation|1|||
147522113|NCT00631969|532061295|FG000|Overall Study|Consent Withdrawn|5|||
147522114|NCT00631969|532061296|FG001|Overall Study|Consent Withdrawn|7|||
147522115|NCT00631969|532061295|FG000|Overall Study|Noncompliant With Study Medication|0|||
147522116|NCT00631969|532061296|FG001|Overall Study|Noncompliant With Study Medication|1|||
147522117|NCT00631969|532061295|FG000|Overall Study|No Drug Exposure|2|||
147522118|NCT00631969|532061296|FG001|Overall Study|No Drug Exposure|2|||
147522119|NCT00957034|532061297|FG000|Overall Study|Adverse Event|0|||
147522120|NCT00957034|532061298|FG001|Overall Study|Adverse Event|1|||
147522121|NCT00957034|532061299|FG002|Overall Study|Adverse Event|1|||
147522122|NCT00957034|532061297|FG000|Overall Study|Sponsor Terminated Study|6|||
147522123|NCT00957034|532061298|FG001|Overall Study|Sponsor Terminated Study|1|||
147522124|NCT00957034|532061299|FG002|Overall Study|Sponsor Terminated Study|5|||
147522125|NCT00957034|532061297|FG000|Overall Study|Withdrawal by Subject|0|||
147522126|NCT00957034|532061298|FG001|Overall Study|Withdrawal by Subject|2|||
147522127|NCT00957034|532061299|FG002|Overall Study|Withdrawal by Subject|0|||
147522128|NCT02390167|532063895|FG000|Overall Study|Lost to Follow-up|1|||
147522129|NCT00805194|532063896|FG000|Overall Study|Progressive disease (modified RECIST)|404|||
147522130|NCT00805194|532063897|FG001|Overall Study|Progressive disease (modified RECIST)|435|||
147522131|NCT00805194|532063896|FG000|Overall Study|Worsening or AE of underlying disease|64|||
147522132|NCT00805194|532063897|FG001|Overall Study|Worsening or AE of underlying disease|70|||
147522133|NCT00805194|532063896|FG000|Overall Study|Other AE|84|||
147522134|NCT00805194|532063897|FG001|Overall Study|Other AE|73|||
147522135|NCT00805194|532063896|FG000|Overall Study|Protocol Violation|9|||
147522136|NCT00805194|532063897|FG001|Overall Study|Protocol Violation|9|||
147522137|NCT00805194|532063896|FG000|Overall Study|Lost to Follow-up|5|||
147522138|NCT00805194|532063897|FG001|Overall Study|Lost to Follow-up|5|||
147522139|NCT00805194|532063896|FG000|Overall Study|Withdrawal by Subject|60|||
147522140|NCT00805194|532063897|FG001|Overall Study|Withdrawal by Subject|42|||
147522141|NCT00805194|532063896|FG000|Overall Study|Not treated|3|||
147522142|NCT00805194|532063897|FG001|Overall Study|Not treated|4|||
147522143|NCT00805194|532063896|FG000|Overall Study|Reasons other than stated above|20|||
147522144|NCT00805194|532063897|FG001|Overall Study|Reasons other than stated above|16|||
147522145|NCT01488994|532063901|FG000|Overall Study|Withdrawal by Subject|0|||
147522146|NCT01488994|532063902|FG001|Overall Study|Withdrawal by Subject|1|||
147522147|NCT01072500|532063903|FG000|Overall Study|Death|2|||
147522148|NCT01072500|532063904|FG001|Overall Study|Death|2|||
147522149|NCT01072500|532063903|FG000|Overall Study|Lost to Follow-up|5|||
147522150|NCT01072500|532063904|FG001|Overall Study|Lost to Follow-up|2|||
147522151|NCT01072500|532063903|FG000|Overall Study|Withdrawal by Subject|17|||
147522152|NCT01072500|532063904|FG001|Overall Study|Withdrawal by Subject|10|||
147522153|NCT02908841|532063905|FG000|Overall Study|Physician Decision|4|||
147522154|NCT02908841|532063906|FG001|Overall Study|Physician Decision|0|||
147522155|NCT01611558|532063907|FG000|Induction Phase|Study drug toxicity|15|||
147522156|NCT01611558|532063907|FG000|Induction Phase|Disease progression|18|||
147522157|NCT01611558|532063907|FG000|Induction Phase|Heart arrest,urosepsis,respiratory fail|1|||
147522158|NCT01611558|532063907|FG000|Induction Phase|Adverse event unrelated to study drug|3|||
147522159|NCT01611558|532063907|FG000|Induction Phase|Death|1|||
147522160|NCT01611558|532063907|FG000|Maintenance Phase|Withdrawal by Subject|1|||
147522161|NCT01611558|532063907|FG000|Maintenance Phase|Elevated Uric acid|1|||
147522162|NCT03798366|532063919|FG000|Overall Study|Lost to Follow-up|0|||
147522163|NCT03798366|532063920|FG001|Overall Study|Lost to Follow-up|1|||
147522164|NCT04005885|532063924|FG000|First Intervention|Withdrawal by Subject|1|||
147522165|NCT04005885|532063925|FG001|First Intervention|Withdrawal by Subject|1|||
147522166|NCT04005885|532063924|FG000|Second Intervention|Withdrawal by Subject|0|||
147522167|NCT04005885|532063925|FG001|Second Intervention|Withdrawal by Subject|2|||
147522168|NCT01412333|532063926|FG000|Overall Study|Adverse Event|40|||
147522169|NCT01412333|532063927|FG001|Overall Study|Adverse Event|42|||
147522170|NCT01412333|532063926|FG000|Overall Study|Death|5|||
147522171|NCT01412333|532063927|FG001|Overall Study|Death|6|||
147522172|NCT01412333|532063926|FG000|Overall Study|Lack of Efficacy|22|||
147522173|NCT01412333|532063927|FG001|Overall Study|Lack of Efficacy|10|||
147522174|NCT01412333|532063926|FG000|Overall Study|Lost to Follow-up|15|||
147522175|NCT01412333|532063927|FG001|Overall Study|Lost to Follow-up|12|||
147522176|NCT01412333|532063926|FG000|Overall Study|Non-Compliance|3|||
147522177|NCT01412333|532063927|FG001|Overall Study|Non-Compliance|7|||
147522178|NCT01412333|532063926|FG000|Overall Study|Non-Compliance With Study Drug|1|||
147522179|NCT01412333|532063927|FG001|Overall Study|Non-Compliance With Study Drug|1|||
147522180|NCT01412333|532063926|FG000|Overall Study|Other|30|||
147522181|NCT01412333|532063927|FG001|Overall Study|Other|33|||
147522182|NCT01412333|532063926|FG000|Overall Study|Physician Decision|11|||
147522183|NCT01412333|532063927|FG001|Overall Study|Physician Decision|16|||
147522184|NCT01412333|532063926|FG000|Overall Study|Pregnancy|6|||
147522185|NCT01412333|532063927|FG001|Overall Study|Pregnancy|4|||
147522186|NCT01412333|532063926|FG000|Overall Study|Protocol Violation|1|||
147522187|NCT01412333|532063927|FG001|Overall Study|Protocol Violation|2|||
147522188|NCT01412333|532063926|FG000|Overall Study|Study Terminated By Sponsor|3|||
147522189|NCT01412333|532063927|FG001|Overall Study|Study Terminated By Sponsor|2|||
147522190|NCT01412333|532063926|FG000|Overall Study|Withdrawal by Subject|51|||
147522191|NCT01412333|532063927|FG001|Overall Study|Withdrawal by Subject|54|||
147522192|NCT01412333|532063926|FG000|Overall Study|Missing|1|||
147522193|NCT01412333|532063927|FG001|Overall Study|Missing|3|||
147522194|NCT00750867|532063929|FG000|Overall Study|Adverse Event|2|||
147522195|NCT00474539|532063930|FG000|Infant Series|Withdrawal by Subject|3|||
147522196|NCT00474539|532063931|FG001|Infant Series|Withdrawal by Subject|4|||
147522197|NCT00474539|532063930|FG000|Infant Series|Randomization error|5|||
147522198|NCT00474539|532063931|FG001|Infant Series|Randomization error|0|||
147522199|NCT00474539|532063930|FG000|Infant Series|Lost to Follow-up|2|||
147522200|NCT00474539|532063931|FG001|Infant Series|Lost to Follow-up|1|||
147522201|NCT00474539|532063930|FG000|Infant Series|Protocol Violation|0|||
147522202|NCT00474539|532063931|FG001|Infant Series|Protocol Violation|1|||
147522203|NCT00474539|532063930|FG000|After Infant Series|Lost to Follow-up|3|||
147522204|NCT00474539|532063931|FG001|After Infant Series|Lost to Follow-up|0|||
147522205|NCT00474539|532063930|FG000|After Infant Series|Withdrawal by Subject|1|||
147522206|NCT00474539|532063931|FG001|After Infant Series|Withdrawal by Subject|0|||
147522207|NCT00474539|532063930|FG000|Toddler Dose|Protocol Violation|1|||
147522208|NCT00474539|532063931|FG001|Toddler Dose|Protocol Violation|0|||
147522209|NCT03018340|532063932|FG000|Overall Study|Adverse Event|1|||
147522210|NCT03018340|532063933|FG001|Overall Study|Adverse Event|2|||
147522211|NCT03018340|532063932|FG000|Overall Study|Withdrawal by Subject|0|||
147522212|NCT03018340|532063933|FG001|Overall Study|Withdrawal by Subject|8|||
147522213|NCT03018340|532063932|FG000|Overall Study|Lack of Efficacy|0|||
147522214|NCT03018340|532063933|FG001|Overall Study|Lack of Efficacy|1|||
147522215|NCT03018340|532063932|FG000|Overall Study|Non-compliance with study drug/procedure|3|||
147522216|NCT03018340|532063933|FG001|Overall Study|Non-compliance with study drug/procedure|4|||
147522217|NCT03018340|532063932|FG000|Overall Study|Lost to Follow-up|1|||
147522218|NCT03018340|532063933|FG001|Overall Study|Lost to Follow-up|7|||
147522219|NCT03018340|532063932|FG000|Overall Study|Protocol Violation|3|||
147522220|NCT03018340|532063933|FG001|Overall Study|Protocol Violation|7|||
147522221|NCT03018340|532063932|FG000|Overall Study|Not further specified|0|||
147522222|NCT03018340|532063933|FG001|Overall Study|Not further specified|1|||
147522223|NCT01836549|532063934|FG000|Overall Study|Did not receive study drug|0|||
147522224|NCT01836549|532063935|FG001|Overall Study|Did not receive study drug|0|||
147522225|NCT01836549|532063936|FG002|Overall Study|Did not receive study drug|1|||
147522226|NCT01836549|532063937|FG003|Overall Study|Did not receive study drug|0|||
147522227|NCT01836549|532063938|FG004|Overall Study|Did not receive study drug|0|||
147522228|NCT01836549|532063939|FG005|Overall Study|Did not receive study drug|0|||
147522229|NCT01836549|532063940|FG006|Overall Study|Did not receive study drug|0|||
147522230|NCT01836549|532063934|FG000|Overall Study|Patient declared ineligible|0|||
147522231|NCT01836549|532063935|FG001|Overall Study|Patient declared ineligible|0|||
147522232|NCT01836549|532063936|FG002|Overall Study|Patient declared ineligible|0|||
147522233|NCT01836549|532063937|FG003|Overall Study|Patient declared ineligible|1|||
147522234|NCT01836549|532063938|FG004|Overall Study|Patient declared ineligible|0|||
147522235|NCT01836549|532063939|FG005|Overall Study|Patient declared ineligible|0|||
147522236|NCT01836549|532063940|FG006|Overall Study|Patient declared ineligible|0|||
147522237|NCT01836549|532063934|FG000|Overall Study|Patient inevaluable to start therapy|0|||
147522238|NCT01836549|532063935|FG001|Overall Study|Patient inevaluable to start therapy|0|||
147522239|NCT01836549|532063936|FG002|Overall Study|Patient inevaluable to start therapy|0|||
147522240|NCT01836549|532063937|FG003|Overall Study|Patient inevaluable to start therapy|0|||
147522241|NCT01836549|532063938|FG004|Overall Study|Patient inevaluable to start therapy|0|||
147522242|NCT01836549|532063939|FG005|Overall Study|Patient inevaluable to start therapy|0|||
147522243|NCT01836549|532063940|FG006|Overall Study|Patient inevaluable to start therapy|1|||
147522244|NCT02192190|532063945|FG000|Overall Study|Adverse Event|1|||
147522245|NCT02192190|532063946|FG001|Overall Study|Adverse Event|1|||
147522246|NCT02192190|532063947|FG002|Overall Study|Adverse Event|0|||
147522247|NCT02192190|532063948|FG003|Overall Study|Adverse Event|0|||
147522248|NCT02192190|532063949|FG004|Overall Study|Adverse Event|0|||
147522249|NCT02192190|532063950|FG005|Overall Study|Adverse Event|0|||
147522250|NCT02192190|532063945|FG000|Overall Study|Lost to Follow-up|3|||
147522251|NCT02192190|532063946|FG001|Overall Study|Lost to Follow-up|3|||
147522252|NCT02192190|532063947|FG002|Overall Study|Lost to Follow-up|2|||
147522253|NCT02192190|532063948|FG003|Overall Study|Lost to Follow-up|1|||
147522254|NCT02192190|532063949|FG004|Overall Study|Lost to Follow-up|4|||
147522255|NCT02192190|532063950|FG005|Overall Study|Lost to Follow-up|3|||
147522256|NCT02192190|532063945|FG000|Overall Study|Physician Decision|2|||
147522257|NCT02192190|532063946|FG001|Overall Study|Physician Decision|0|||
147522258|NCT02192190|532063947|FG002|Overall Study|Physician Decision|0|||
147522259|NCT02192190|532063948|FG003|Overall Study|Physician Decision|0|||
147522260|NCT02192190|532063949|FG004|Overall Study|Physician Decision|0|||
147522261|NCT02192190|532063950|FG005|Overall Study|Physician Decision|0|||
147522262|NCT02192190|532063945|FG000|Overall Study|Terminated by Sponsor|43|||
147522263|NCT02192190|532063946|FG001|Overall Study|Terminated by Sponsor|23|||
147522264|NCT02192190|532063947|FG002|Overall Study|Terminated by Sponsor|20|||
147522265|NCT02192190|532063948|FG003|Overall Study|Terminated by Sponsor|23|||
147522266|NCT02192190|532063949|FG004|Overall Study|Terminated by Sponsor|21|||
147522267|NCT02192190|532063950|FG005|Overall Study|Terminated by Sponsor|23|||
147522268|NCT02192190|532063945|FG000|Overall Study|Withdrawal by Subject|4|||
147522269|NCT02192190|532063946|FG001|Overall Study|Withdrawal by Subject|1|||
147522270|NCT02192190|532063947|FG002|Overall Study|Withdrawal by Subject|2|||
147522271|NCT02192190|532063948|FG003|Overall Study|Withdrawal by Subject|1|||
147522272|NCT02192190|532063949|FG004|Overall Study|Withdrawal by Subject|5|||
147522273|NCT02192190|532063950|FG005|Overall Study|Withdrawal by Subject|3|||
147522274|NCT02192190|532063945|FG000|Overall Study|Could not Keep Visit Schedule|1|||
147522275|NCT02192190|532063946|FG001|Overall Study|Could not Keep Visit Schedule|0|||
147522276|NCT02192190|532063947|FG002|Overall Study|Could not Keep Visit Schedule|0|||
147522277|NCT02192190|532063948|FG003|Overall Study|Could not Keep Visit Schedule|0|||
147522278|NCT02192190|532063949|FG004|Overall Study|Could not Keep Visit Schedule|0|||
147522279|NCT02192190|532063950|FG005|Overall Study|Could not Keep Visit Schedule|0|||
147522280|NCT02192190|532063945|FG000|Overall Study|Positive Drug Screen|0|||
147522281|NCT02192190|532063946|FG001|Overall Study|Positive Drug Screen|0|||
147522282|NCT02192190|532063947|FG002|Overall Study|Positive Drug Screen|0|||
147522283|NCT02192190|532063948|FG003|Overall Study|Positive Drug Screen|1|||
147522284|NCT02192190|532063949|FG004|Overall Study|Positive Drug Screen|0|||
147522285|NCT02192190|532063950|FG005|Overall Study|Positive Drug Screen|0|||
147522286|NCT02192190|532063945|FG000|Overall Study|Inadequate Pain Relief|0|||
147522287|NCT02192190|532063946|FG001|Overall Study|Inadequate Pain Relief|1|||
147522288|NCT02192190|532063947|FG002|Overall Study|Inadequate Pain Relief|1|||
147522289|NCT02192190|532063948|FG003|Overall Study|Inadequate Pain Relief|0|||
147522290|NCT02192190|532063949|FG004|Overall Study|Inadequate Pain Relief|0|||
147522291|NCT02192190|532063950|FG005|Overall Study|Inadequate Pain Relief|0|||
147522292|NCT02607865|532063951|FG000|Overall Study|Lost to Follow-up|9|||
147522293|NCT02607865|532063952|FG001|Overall Study|Lost to Follow-up|7|||
147522294|NCT02607865|532063953|FG002|Overall Study|Lost to Follow-up|7|||
147522295|NCT02607865|532063954|FG003|Overall Study|Lost to Follow-up|5|||
147522296|NCT02607865|532063951|FG000|Overall Study|Withdrawal by Subject|18|||
147522297|NCT02607865|532063952|FG001|Overall Study|Withdrawal by Subject|18|||
147522298|NCT02607865|532063953|FG002|Overall Study|Withdrawal by Subject|17|||
147522299|NCT02607865|532063954|FG003|Overall Study|Withdrawal by Subject|8|||
147522300|NCT02607865|532063951|FG000|Overall Study|Death|5|||
147522301|NCT02607865|532063952|FG001|Overall Study|Death|4|||
147522302|NCT02607865|532063953|FG002|Overall Study|Death|1|||
147522303|NCT02607865|532063954|FG003|Overall Study|Death|3|||
147522304|NCT02607865|532063951|FG000|Overall Study|Unclassified|1|||
147522305|NCT02607865|532063952|FG001|Overall Study|Unclassified|1|||
147522306|NCT02607865|532063953|FG002|Overall Study|Unclassified|2|||
147522307|NCT02607865|532063954|FG003|Overall Study|Unclassified|0|||
147522308|NCT03227692|532063955|FG000|Overall Study|Protocol Violation|1|||
147522309|NCT03227692|532063956|FG001|Overall Study|Protocol Violation|1|||
147522310|NCT03227692|532063955|FG000|Overall Study|Lost to Follow-up|4|||
147522311|NCT03227692|532063956|FG001|Overall Study|Lost to Follow-up|2|||
147522312|NCT03227692|532063955|FG000|Overall Study|Adverse Event|0|||
147522313|NCT03227692|532063956|FG001|Overall Study|Adverse Event|2|||
147522314|NCT01657253|532063957|FG000|Overall Study|Lost to Follow-up|6|||
147522315|NCT01657253|532063958|FG001|Overall Study|Lost to Follow-up|5|||
147522316|NCT01657253|532063957|FG000|Overall Study|Withdrawal by Subject|11|||
147522317|NCT01657253|532063958|FG001|Overall Study|Withdrawal by Subject|12|||
147522318|NCT01657253|532063957|FG000|Overall Study|Adverse Event|0|||
147522319|NCT01657253|532063958|FG001|Overall Study|Adverse Event|1|||
147522320|NCT01970540|532063959|FG000|Overall Study|Non-treatment-related AE|0|||
147522321|NCT01970540|532063960|FG001|Overall Study|Non-treatment-related AE|0|||
147522322|NCT01970540|532063961|FG002|Overall Study|Non-treatment-related AE|1|||
147522323|NCT01970540|532063959|FG000|Overall Study|Progressive disease|55|||
147522324|NCT01970540|532063960|FG001|Overall Study|Progressive disease|23|||
147522325|NCT01970540|532063961|FG002|Overall Study|Progressive disease|10|||
147522326|NCT01970540|532063959|FG000|Overall Study|Treatment delay over protocol|0|||
147522327|NCT01970540|532063960|FG001|Overall Study|Treatment delay over protocol|0|||
147522328|NCT01970540|532063961|FG002|Overall Study|Treatment delay over protocol|1|||
147522329|NCT01970540|532063959|FG000|Overall Study|Physician Decision|7|||
147522330|NCT01970540|532063960|FG001|Overall Study|Physician Decision|2|||
147522331|NCT01970540|532063961|FG002|Overall Study|Physician Decision|0|||
147522332|NCT01970540|532063959|FG000|Overall Study|Clinical progression|0|||
147522333|NCT01970540|532063960|FG001|Overall Study|Clinical progression|1|||
147522334|NCT01970540|532063961|FG002|Overall Study|Clinical progression|1|||
147522335|NCT01970540|532063959|FG000|Overall Study|End of study|2|||
147522336|NCT01970540|532063960|FG001|Overall Study|End of study|0|||
147522337|NCT01970540|532063961|FG002|Overall Study|End of study|2|||
147522338|NCT01970540|532063959|FG000|Overall Study|Adverse Event|0|||
147522339|NCT01970540|532063960|FG001|Overall Study|Adverse Event|2|||
147522340|NCT01970540|532063961|FG002|Overall Study|Adverse Event|1|||
147522341|NCT01970540|532063959|FG000|Overall Study|Treatment-related AE|4|||
147522342|NCT01970540|532063960|FG001|Overall Study|Treatment-related AE|0|||
147522343|NCT01970540|532063961|FG002|Overall Study|Treatment-related AE|2|||
147522344|NCT01970540|532063959|FG000|Overall Study|Withdrawal by Subject|4|||
147522345|NCT01970540|532063960|FG001|Overall Study|Withdrawal by Subject|0|||
147522346|NCT01970540|532063961|FG002|Overall Study|Withdrawal by Subject|1|||
147522347|NCT01970540|532063959|FG000|Overall Study|Clinical deterioration|1|||
147522348|NCT01970540|532063960|FG001|Overall Study|Clinical deterioration|0|||
147522349|NCT01970540|532063961|FG002|Overall Study|Clinical deterioration|0|||
147522350|NCT00242710|532063962|FG000|Core Study (up to Year 1)|Adverse Event|30|||
147522351|NCT00242710|532063963|FG001|Core Study (up to Year 1)|Adverse Event|25|||
147522352|NCT00242710|532063964|FG002|Core Study (up to Year 1)|Adverse Event|23|||
147522353|NCT00242710|532063965|FG003|Core Study (up to Year 1)|Adverse Event|14|||
147522354|NCT00242710|532063962|FG000|Core Study (up to Year 1)|Death|0|||
147522355|NCT00242710|532063963|FG001|Core Study (up to Year 1)|Death|0|||
147522356|NCT00242710|532063964|FG002|Core Study (up to Year 1)|Death|1|||
147522357|NCT00242710|532063965|FG003|Core Study (up to Year 1)|Death|0|||
147522358|NCT00242710|532063962|FG000|Core Study (up to Year 1)|Physician Decision|0|||
147522359|NCT00242710|532063963|FG001|Core Study (up to Year 1)|Physician Decision|1|||
147522360|NCT00242710|532063964|FG002|Core Study (up to Year 1)|Physician Decision|0|||
147522361|NCT00242710|532063965|FG003|Core Study (up to Year 1)|Physician Decision|1|||
147522362|NCT00242710|532063962|FG000|Core Study (up to Year 1)|Lost to Follow-up|8|||
147522363|NCT00242710|532063963|FG001|Core Study (up to Year 1)|Lost to Follow-up|8|||
147522364|NCT00242710|532063964|FG002|Core Study (up to Year 1)|Lost to Follow-up|7|||
147522365|NCT00242710|532063965|FG003|Core Study (up to Year 1)|Lost to Follow-up|3|||
147522366|NCT00242710|532063962|FG000|Core Study (up to Year 1)|Other|6|||
147522367|NCT00242710|532063963|FG001|Core Study (up to Year 1)|Other|1|||
147522368|NCT00242710|532063964|FG002|Core Study (up to Year 1)|Other|0|||
147522369|NCT00242710|532063965|FG003|Core Study (up to Year 1)|Other|2|||
147522370|NCT00242710|532063962|FG000|Core Study (up to Year 1)|Protocol Violation|2|||
147522371|NCT00242710|532063963|FG001|Core Study (up to Year 1)|Protocol Violation|9|||
147522372|NCT00242710|532063964|FG002|Core Study (up to Year 1)|Protocol Violation|1|||
147522373|NCT00242710|532063965|FG003|Core Study (up to Year 1)|Protocol Violation|3|||
147522374|NCT00242710|532063962|FG000|Core Study (up to Year 1)|Withdrawal by Subject|27|||
147522375|NCT00242710|532063963|FG001|Core Study (up to Year 1)|Withdrawal by Subject|16|||
147522376|NCT00242710|532063964|FG002|Core Study (up to Year 1)|Withdrawal by Subject|15|||
147522377|NCT00242710|532063965|FG003|Core Study (up to Year 1)|Withdrawal by Subject|6|||
147522378|NCT00242710|532063962|FG000|Core Study (up to Year 1)|Lack of Efficacy|1|||
147522379|NCT00242710|532063963|FG001|Core Study (up to Year 1)|Lack of Efficacy|0|||
147522380|NCT00242710|532063964|FG002|Core Study (up to Year 1)|Lack of Efficacy|0|||
147522381|NCT00242710|532063965|FG003|Core Study (up to Year 1)|Lack of Efficacy|0|||
147522382|NCT00242710|532063962|FG000|Core Study (up to Year 1)|Randomized but not Treated|12|||
147522383|NCT00242710|532063963|FG001|Core Study (up to Year 1)|Randomized but not Treated|4|||
147522384|NCT00242710|532063964|FG002|Core Study (up to Year 1)|Randomized but not Treated|4|||
147522385|NCT00242710|532063965|FG003|Core Study (up to Year 1)|Randomized but not Treated|2|||
147522386|NCT00242710|532063962|FG000|Period Between Core Study and Extension|Adverse Event|2|||
147522387|NCT00242710|532063963|FG001|Period Between Core Study and Extension|Adverse Event|3|||
147522388|NCT00242710|532063964|FG002|Period Between Core Study and Extension|Adverse Event|5|||
147522389|NCT00242710|532063965|FG003|Period Between Core Study and Extension|Adverse Event|2|||
147522390|NCT00242710|532063962|FG000|Period Between Core Study and Extension|Physician Decision|1|||
147522391|NCT00242710|532063963|FG001|Period Between Core Study and Extension|Physician Decision|1|||
147522392|NCT00242710|532063964|FG002|Period Between Core Study and Extension|Physician Decision|0|||
147522393|NCT00242710|532063965|FG003|Period Between Core Study and Extension|Physician Decision|0|||
147522394|NCT00242710|532063962|FG000|Period Between Core Study and Extension|Other|24|||
147522395|NCT00242710|532063963|FG001|Period Between Core Study and Extension|Other|24|||
147522396|NCT00242710|532063964|FG002|Period Between Core Study and Extension|Other|9|||
147522397|NCT00242710|532063965|FG003|Period Between Core Study and Extension|Other|11|||
147522398|NCT00242710|532063962|FG000|Period Between Core Study and Extension|Extension not Available|17|||
147522399|NCT00242710|532063963|FG001|Period Between Core Study and Extension|Extension not Available|21|||
147522400|NCT00242710|532063964|FG002|Period Between Core Study and Extension|Extension not Available|8|||
147522401|NCT00242710|532063965|FG003|Period Between Core Study and Extension|Extension not Available|7|||
147522402|NCT00242710|532063962|FG000|Period Between Core Study and Extension|Protocol Violation|0|||
147522403|NCT00242710|532063963|FG001|Period Between Core Study and Extension|Protocol Violation|0|||
147522404|NCT00242710|532063964|FG002|Period Between Core Study and Extension|Protocol Violation|2|||
147522405|NCT00242710|532063965|FG003|Period Between Core Study and Extension|Protocol Violation|1|||
147522406|NCT00242710|532063962|FG000|Period Between Core Study and Extension|Withdrawal by Subject|75|||
147522407|NCT00242710|532063963|FG001|Period Between Core Study and Extension|Withdrawal by Subject|63|||
147522408|NCT00242710|532063964|FG002|Period Between Core Study and Extension|Withdrawal by Subject|24|||
147522409|NCT00242710|532063965|FG003|Period Between Core Study and Extension|Withdrawal by Subject|28|||
147522410|NCT00242710|532063962|FG000|Study Extension (up to Year 2)|Adverse Event|7|||
147522411|NCT00242710|532063963|FG001|Study Extension (up to Year 2)|Adverse Event|9|||
147522412|NCT00242710|532063964|FG002|Study Extension (up to Year 2)|Adverse Event|2|||
147522413|NCT00242710|532063965|FG003|Study Extension (up to Year 2)|Adverse Event|4|||
147522414|NCT00242710|532063962|FG000|Study Extension (up to Year 2)|Death|0|||
147522415|NCT00242710|532063963|FG001|Study Extension (up to Year 2)|Death|0|||
147522416|NCT00242710|532063964|FG002|Study Extension (up to Year 2)|Death|0|||
147522417|NCT00242710|532063965|FG003|Study Extension (up to Year 2)|Death|1|||
147522418|NCT00242710|532063962|FG000|Study Extension (up to Year 2)|Lost to Follow-up|7|||
147522419|NCT00242710|532063963|FG001|Study Extension (up to Year 2)|Lost to Follow-up|7|||
147522420|NCT00242710|532063964|FG002|Study Extension (up to Year 2)|Lost to Follow-up|5|||
147522421|NCT00242710|532063965|FG003|Study Extension (up to Year 2)|Lost to Follow-up|0|||
147522422|NCT00242710|532063962|FG000|Study Extension (up to Year 2)|Other|3|||
147522423|NCT00242710|532063963|FG001|Study Extension (up to Year 2)|Other|5|||
147522424|NCT00242710|532063964|FG002|Study Extension (up to Year 2)|Other|4|||
147522425|NCT00242710|532063965|FG003|Study Extension (up to Year 2)|Other|3|||
147522426|NCT00242710|532063962|FG000|Study Extension (up to Year 2)|Protocol Violation|0|||
147522427|NCT00242710|532063963|FG001|Study Extension (up to Year 2)|Protocol Violation|2|||
147522428|NCT00242710|532063964|FG002|Study Extension (up to Year 2)|Protocol Violation|0|||
147522429|NCT00242710|532063965|FG003|Study Extension (up to Year 2)|Protocol Violation|1|||
147522430|NCT00242710|532063962|FG000|Study Extension (up to Year 2)|Withdrawal by Subject|10|||
147522431|NCT00242710|532063963|FG001|Study Extension (up to Year 2)|Withdrawal by Subject|6|||
147522432|NCT00242710|532063964|FG002|Study Extension (up to Year 2)|Withdrawal by Subject|4|||
147522433|NCT00242710|532063965|FG003|Study Extension (up to Year 2)|Withdrawal by Subject|1|||
147522434|NCT00579527|532063966|FG000|Overall Study|Death|4|||
147522435|NCT00381706|532063967|FG000|Overall Study|Never treated|7|||
147522436|NCT00381706|532063968|FG001|Overall Study|Never treated|2|||
147522437|NCT00381706|532063969|FG002|Overall Study|Never treated|1|||
147522438|NCT00203294|532063970|FG000|Overall Study|Withdrawal by Subject|8|||
147522439|NCT00203294|532063971|FG001|Overall Study|Withdrawal by Subject|13|||
147522440|NCT02364999|532063972|FG000|Overall Study|Death|136|||
147522441|NCT02364999|532063973|FG001|Overall Study|Death|138|||
147522442|NCT02364999|532063972|FG000|Overall Study|Lost to Follow-up|10|||
147522443|NCT02364999|532063973|FG001|Overall Study|Lost to Follow-up|15|||
147522444|NCT02364999|532063972|FG000|Overall Study|Protocol Violation|3|||
147522445|NCT02364999|532063973|FG001|Overall Study|Protocol Violation|2|||
147522446|NCT02364999|532063972|FG000|Overall Study|Withdrawal by Subject|14|||
147522447|NCT02364999|532063973|FG001|Overall Study|Withdrawal by Subject|14|||
147522448|NCT02364999|532063972|FG000|Overall Study|Other|0|||
147522449|NCT02364999|532063973|FG001|Overall Study|Other|1|||
147522450|NCT02364999|532063972|FG000|Overall Study|Randomized but did not receive treatment|2|||
147522451|NCT02364999|532063973|FG001|Overall Study|Randomized but did not receive treatment|3|||
147522452|NCT00550615|532063977|FG000|Overall Study|Withdrawal by Subject|0|||
147522453|NCT00550615|532063978|FG001|Overall Study|Withdrawal by Subject|0|||
147522454|NCT00550615|532063979|FG002|Overall Study|Withdrawal by Subject|2|||
147522455|NCT00550615|532063980|FG003|Overall Study|Withdrawal by Subject|3|||
147522456|NCT00550615|532063977|FG000|Overall Study|Not evaluable|0|||
147522457|NCT00550615|532063978|FG001|Overall Study|Not evaluable|0|||
147522458|NCT00550615|532063979|FG002|Overall Study|Not evaluable|2|||
147522459|NCT00550615|532063980|FG003|Overall Study|Not evaluable|7|||
147522460|NCT01948791|532063982|FG000|Overall Study|Adverse Event|12|||
147522461|NCT01948791|532063982|FG000|Overall Study|Lack of Efficacy|3|||
147522462|NCT01948791|532063982|FG000|Overall Study|Protocol Violation|2|||
147522463|NCT01948791|532063982|FG000|Overall Study|Withdrawal by Subject|5|||
147522464|NCT01948791|532063982|FG000|Overall Study|Lost to Follow-up|6|||
147522465|NCT01948791|532063982|FG000|Overall Study|Management issues|1|||
147522466|NCT01948791|532063982|FG000|Overall Study|Others|7|||
147522467|NCT01948791|532063982|FG000|Overall Study|Screening failure|35|||
147522468|NCT02555722|532063983|FG000|Week 2|Adverse Event|0|||
147522469|NCT02555722|532063984|FG001|Week 2|Adverse Event|1|||
147522470|NCT02555722|532063983|FG000|Week 2|Withdrawal by Subject|1|||
147522471|NCT02555722|532063984|FG001|Week 2|Withdrawal by Subject|0|||
147522472|NCT02555722|532063983|FG000|Month 1|Lens Discomfort|1|||
147522473|NCT02555722|532063984|FG001|Month 1|Lens Discomfort|0|||
147522474|NCT02555722|532063983|FG000|Month 2|Withdrawal by Subject|3|||
147522475|NCT02555722|532063984|FG001|Month 2|Withdrawal by Subject|0|||
147522476|NCT02555722|532063983|FG000|Month 2|Lost to Follow-up|1|||
147522477|NCT02555722|532063984|FG001|Month 2|Lost to Follow-up|0|||
147522478|NCT00702949|532063985|FG000|Overall Study|Refusal|3|||
147522479|NCT00702949|532063986|FG001|Overall Study|Refusal|2|||
147522480|NCT00702949|532063987|FG002|Overall Study|Refusal|2|||
147522481|NCT00702949|532063985|FG000|Overall Study|Adverse Event|1|||
147522482|NCT00702949|532063986|FG001|Overall Study|Adverse Event|6|||
147522483|NCT00702949|532063987|FG002|Overall Study|Adverse Event|3|||
147522484|NCT00702949|532063985|FG000|Overall Study|Other Medical Reason/unknown|1|||
147522485|NCT00702949|532063986|FG001|Overall Study|Other Medical Reason/unknown|1|||
147522486|NCT00702949|532063987|FG002|Overall Study|Other Medical Reason/unknown|3|||
147522487|NCT03525613|532063988|FG000|Overall Study|Adverse Event|11|||
147522488|NCT03525613|532063989|FG001|Overall Study|Adverse Event|8|||
147522489|NCT03525613|532063990|FG002|Overall Study|Adverse Event|3|||
147522490|NCT03525613|532063991|FG003|Overall Study|Adverse Event|3|||
147522491|NCT03525613|532063988|FG000|Overall Study|Lost to Follow-up|4|||
147522492|NCT03525613|532063989|FG001|Overall Study|Lost to Follow-up|5|||
147522493|NCT03525613|532063990|FG002|Overall Study|Lost to Follow-up|3|||
147522494|NCT03525613|532063991|FG003|Overall Study|Lost to Follow-up|2|||
147522495|NCT03525613|532063988|FG000|Overall Study|Physician Decision|0|||
147522496|NCT03525613|532063989|FG001|Overall Study|Physician Decision|1|||
147522497|NCT03525613|532063990|FG002|Overall Study|Physician Decision|0|||
147522498|NCT03525613|532063991|FG003|Overall Study|Physician Decision|1|||
147522499|NCT03525613|532063988|FG000|Overall Study|Consent Withdrawal|25|||
147522500|NCT03525613|532063989|FG001|Overall Study|Consent Withdrawal|16|||
147522501|NCT03525613|532063990|FG002|Overall Study|Consent Withdrawal|12|||
147522502|NCT03525613|532063991|FG003|Overall Study|Consent Withdrawal|9|||
147522503|NCT03525613|532063988|FG000|Overall Study|Death|20|||
147522504|NCT03525613|532063989|FG001|Overall Study|Death|9|||
147522505|NCT03525613|532063990|FG002|Overall Study|Death|7|||
147522506|NCT03525613|532063991|FG003|Overall Study|Death|1|||
147522507|NCT03525613|532063988|FG000|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|9|||
147522508|NCT03525613|532063989|FG001|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|4|||
147522509|NCT03525613|532063990|FG002|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|5|||
147522510|NCT03525613|532063991|FG003|Overall Study|Due to Coronavirus Disease-2019 (COVID-19) impact|8|||
147522511|NCT00374452|532063992|FG000|Overall Study|Left clinic before intervention started|4|||
147522512|NCT00374452|532063993|FG001|Overall Study|Left clinic before intervention started|1|||
147522513|NCT00374452|532063992|FG000|Overall Study|Change in job role before intervention|0|||
147522514|NCT00374452|532063993|FG001|Overall Study|Change in job role before intervention|1|||
147522515|NCT00374452|532063992|FG000|Overall Study|Left clinic after intervention started|1|||
147522516|NCT00374452|532063993|FG001|Overall Study|Left clinic after intervention started|1|||
147522517|NCT00374452|532063992|FG000|Overall Study|Withdrawal by Subject|0|||
147522518|NCT00374452|532063993|FG001|Overall Study|Withdrawal by Subject|2|||
147522519|NCT00523744|532063998|FG000|Phase 1 - Amlodipine+Olmesartan|Adverse Event|2|||
147522520|NCT00523744|532063998|FG000|Phase 1 - Amlodipine+Olmesartan|Withdrawal by Subject|1|||
147522521|NCT00523744|532063998|FG000|Phase 1 - Amlodipine+Olmesartan|Lost to Follow-up|2|||
147522522|NCT00523744|532063998|FG000|Phase 1 - Amlodipine+Olmesartan|Administrative problems|1|||
147522523|NCT00523744|532063998|FG000|Phase 2 - Amlodipine+Valsartan|Adverse Event|2|||
147522524|NCT00523744|532063998|FG000|Phase 2 - Amlodipine+Valsartan|Lost to Follow-up|1|||
147522525|NCT03117309|532063999|FG000|Overall Study|Not meeting inclusion criteria|0|||
147522526|NCT03117309|532064000|FG001|Overall Study|Not meeting inclusion criteria|1|||
147522527|NCT00542425|532064004|FG000|Initial 24 Weeks|Administrative reasons|0|||
147522528|NCT00542425|532064005|FG001|Initial 24 Weeks|Administrative reasons|0|||
147522529|NCT00542425|532064006|FG002|Initial 24 Weeks|Administrative reasons|1|||
147522530|NCT00542425|532064007|FG003|Initial 24 Weeks|Administrative reasons|1|||
147522531|NCT00542425|532064008|FG004|Initial 24 Weeks|Administrative reasons|0|||
147522532|NCT00542425|532064004|FG000|Initial 24 Weeks|Adverse Event|0|||
147522533|NCT00542425|532064005|FG001|Initial 24 Weeks|Adverse Event|1|||
147522534|NCT00542425|532064006|FG002|Initial 24 Weeks|Adverse Event|1|||
147522535|NCT00542425|532064007|FG003|Initial 24 Weeks|Adverse Event|3|||
147522536|NCT00542425|532064008|FG004|Initial 24 Weeks|Adverse Event|2|||
147522537|NCT00542425|532064004|FG000|Initial 24 Weeks|Inability to complete procedures|0|||
147522538|NCT00542425|532064005|FG001|Initial 24 Weeks|Inability to complete procedures|3|||
147522539|NCT00542425|532064006|FG002|Initial 24 Weeks|Inability to complete procedures|2|||
147522540|NCT00542425|532064007|FG003|Initial 24 Weeks|Inability to complete procedures|1|||
147522541|NCT00542425|532064008|FG004|Initial 24 Weeks|Inability to complete procedures|2|||
147522542|NCT00542425|532064004|FG000|Initial 24 Weeks|Lost to Follow-up|2|||
147522543|NCT00542425|532064005|FG001|Initial 24 Weeks|Lost to Follow-up|2|||
147522544|NCT00542425|532064006|FG002|Initial 24 Weeks|Lost to Follow-up|1|||
147522545|NCT00542425|532064007|FG003|Initial 24 Weeks|Lost to Follow-up|0|||
147522546|NCT00542425|532064008|FG004|Initial 24 Weeks|Lost to Follow-up|0|||
147522547|NCT00542425|532064004|FG000|Initial 24 Weeks|Non-compliance|0|||
147522548|NCT00542425|532064005|FG001|Initial 24 Weeks|Non-compliance|0|||
147522549|NCT00542425|532064006|FG002|Initial 24 Weeks|Non-compliance|0|||
147522550|NCT00542425|532064007|FG003|Initial 24 Weeks|Non-compliance|1|||
147522551|NCT00542425|532064008|FG004|Initial 24 Weeks|Non-compliance|1|||
147522552|NCT00542425|532064004|FG000|Initial 24 Weeks|Protocol Violation|0|||
147522553|NCT00542425|532064005|FG001|Initial 24 Weeks|Protocol Violation|0|||
147522554|NCT00542425|532064006|FG002|Initial 24 Weeks|Protocol Violation|0|||
147522555|NCT00542425|532064007|FG003|Initial 24 Weeks|Protocol Violation|1|||
147522556|NCT00542425|532064008|FG004|Initial 24 Weeks|Protocol Violation|0|||
147522557|NCT00542425|532064004|FG000|Initial 24 Weeks|Refusal of treatment|2|||
147522558|NCT00542425|532064005|FG001|Initial 24 Weeks|Refusal of treatment|2|||
147522559|NCT00542425|532064006|FG002|Initial 24 Weeks|Refusal of treatment|1|||
147522560|NCT00542425|532064007|FG003|Initial 24 Weeks|Refusal of treatment|4|||
147522561|NCT00542425|532064008|FG004|Initial 24 Weeks|Refusal of treatment|1|||
147522562|NCT00542425|532064004|FG000|Initial 24 Weeks|Other|0|||
147522563|NCT00542425|532064005|FG001|Initial 24 Weeks|Other|2|||
147522564|NCT00542425|532064006|FG002|Initial 24 Weeks|Other|1|||
147522565|NCT00542425|532064007|FG003|Initial 24 Weeks|Other|0|||
147522566|NCT00542425|532064008|FG004|Initial 24 Weeks|Other|0|||
147522567|NCT00542425|532064004|FG000|Extended 24 Weeks of Treatment|Adverse Event|0|||
147522568|NCT00542425|532064005|FG001|Extended 24 Weeks of Treatment|Adverse Event|0|||
147522569|NCT00542425|532064006|FG002|Extended 24 Weeks of Treatment|Adverse Event|1|||
147522570|NCT00542425|532064007|FG003|Extended 24 Weeks of Treatment|Adverse Event|1|||
147522571|NCT00542425|532064008|FG004|Extended 24 Weeks of Treatment|Adverse Event|0|||
147522572|NCT00542425|532064004|FG000|Extended 24 Weeks of Treatment|Protocol Violation|0|||
147522573|NCT00542425|532064005|FG001|Extended 24 Weeks of Treatment|Protocol Violation|0|||
147522574|NCT00542425|532064006|FG002|Extended 24 Weeks of Treatment|Protocol Violation|1|||
147522575|NCT00542425|532064007|FG003|Extended 24 Weeks of Treatment|Protocol Violation|0|||
147522576|NCT00542425|532064008|FG004|Extended 24 Weeks of Treatment|Protocol Violation|0|||
147522577|NCT00542425|532064004|FG000|Extended 24 Weeks of Treatment|Refusal of treatment|0|||
147522578|NCT00542425|532064005|FG001|Extended 24 Weeks of Treatment|Refusal of treatment|1|||
147522579|NCT00542425|532064006|FG002|Extended 24 Weeks of Treatment|Refusal of treatment|0|||
147522580|NCT00542425|532064007|FG003|Extended 24 Weeks of Treatment|Refusal of treatment|0|||
147522581|NCT00542425|532064008|FG004|Extended 24 Weeks of Treatment|Refusal of treatment|0|||
147522582|NCT00542425|532064004|FG000|Extended 24 Weeks of Treatment|Other|1|||
147522583|NCT00542425|532064005|FG001|Extended 24 Weeks of Treatment|Other|1|||
147522584|NCT00542425|532064006|FG002|Extended 24 Weeks of Treatment|Other|0|||
147522585|NCT00542425|532064007|FG003|Extended 24 Weeks of Treatment|Other|0|||
147522586|NCT00542425|532064008|FG004|Extended 24 Weeks of Treatment|Other|1|||
147522587|NCT00590031|532064011|FG000|Overall Study|Adverse Event|3|||
147522588|NCT00590031|532064011|FG000|Overall Study|Withdrawal by Subject|1|||
147522589|NCT00590031|532064011|FG000|Overall Study|Metastatic Disease|1|||
147522590|NCT00590031|532064011|FG000|Overall Study|Admin Hold|1|||
147522591|NCT01610414|532064012|FG000|Study Start - Month 13|Serious Adverse Event|65|||
147522592|NCT01610414|532064013|FG001|Study Start - Month 13|Serious Adverse Event|67|||
147522593|NCT01610414|532064012|FG000|Study Start - Month 13|Adverse Event|14|||
147522594|NCT01610414|532064013|FG001|Study Start - Month 13|Adverse Event|14|||
147522595|NCT01610414|532064012|FG000|Study Start - Month 13|Protocol Violation|3|||
147522596|NCT01610414|532064013|FG001|Study Start - Month 13|Protocol Violation|1|||
147522597|NCT01610414|532064012|FG000|Study Start - Month 13|Withdrawal by Subject|23|||
147522598|NCT01610414|532064013|FG001|Study Start - Month 13|Withdrawal by Subject|30|||
147522599|NCT01610414|532064012|FG000|Study Start - Month 13|Migrated/moved from study area|2|||
147522600|NCT01610414|532064013|FG001|Study Start - Month 13|Migrated/moved from study area|4|||
147522601|NCT01610414|532064012|FG000|Study Start - Month 13|Lost to Follow-up|4|||
147522602|NCT01610414|532064013|FG001|Study Start - Month 13|Lost to Follow-up|6|||
147522603|NCT01610414|532064012|FG000|Study Start - Month 13|Suspected HZ episode|1|||
147522604|NCT01610414|532064013|FG001|Study Start - Month 13|Suspected HZ episode|3|||
147522605|NCT01610414|532064012|FG000|Study Start - Month 13|Other reasons for withdrawal|3|||
147522606|NCT01610414|532064013|FG001|Study Start - Month 13|Other reasons for withdrawal|4|||
147522607|NCT01610414|532064012|FG000|Month 13 - Month 25|Serious Adverse Event|35|||
147522608|NCT01610414|532064013|FG001|Month 13 - Month 25|Serious Adverse Event|38|||
147522609|NCT01610414|532064012|FG000|Month 13 - Month 25|Adverse Event|8|||
147522610|NCT01610414|532064013|FG001|Month 13 - Month 25|Adverse Event|4|||
147522611|NCT01610414|532064012|FG000|Month 13 - Month 25|Withdrawal by Subject|7|||
147522612|NCT01610414|532064013|FG001|Month 13 - Month 25|Withdrawal by Subject|8|||
147522613|NCT01610414|532064012|FG000|Month 13 - Month 25|Migrated/moved from study area|4|||
147522614|NCT01610414|532064013|FG001|Month 13 - Month 25|Migrated/moved from study area|2|||
147522615|NCT01610414|532064012|FG000|Month 13 - Month 25|Protocol Violation|0|||
147522616|NCT01610414|532064013|FG001|Month 13 - Month 25|Protocol Violation|2|||
147522617|NCT01610414|532064012|FG000|Month 13 - Month 25|Lost to Follow-up|5|||
147522618|NCT01610414|532064013|FG001|Month 13 - Month 25|Lost to Follow-up|9|||
147522619|NCT01610414|532064012|FG000|Month 13 - Month 25|Other reasons for withdrawal|6|||
147522620|NCT01610414|532064013|FG001|Month 13 - Month 25|Other reasons for withdrawal|7|||
147522621|NCT01610414|532064012|FG000|After Month 25|Study end not reached|48|||
147522622|NCT01610414|532064013|FG001|After Month 25|Study end not reached|53|||
147522623|NCT00826540|532064026|FG000|Overall Study|ineligible|3|||
147522624|NCT00826540|532064026|FG000|Overall Study|Withdrawal by Subject|1|||
147522625|NCT02802735|532064027|FG000|Overall Study|Withdrawal by Subject|0|||
147522626|NCT02802735|532064028|FG001|Overall Study|Withdrawal by Subject|1|||
147522627|NCT02802735|532064029|FG002|Overall Study|Withdrawal by Subject|0|||
147522628|NCT02802735|532064030|FG003|Overall Study|Withdrawal by Subject|0|||
147522629|NCT02802735|532064031|FG004|Overall Study|Withdrawal by Subject|0|||
147522630|NCT01166386|532064032|FG000|Overall Study|Withdrawal by Subject|3|||
147522631|NCT01166386|532064033|FG001|Overall Study|Withdrawal by Subject|5|||
147522632|NCT03922711|532064038|FG000|Overall Study|Adverse Event|3|||
147522633|NCT03922711|532064039|FG001|Overall Study|Adverse Event|2|||
147522634|NCT03922711|532064040|FG002|Overall Study|Adverse Event|2|||
147522635|NCT03922711|532064038|FG000|Overall Study|Protocol Violation|1|||
147522636|NCT03922711|532064039|FG001|Overall Study|Protocol Violation|0|||
147522637|NCT03922711|532064040|FG002|Overall Study|Protocol Violation|0|||
147522638|NCT03922711|532064038|FG000|Overall Study|Withdrawal by Subject|0|||
147522639|NCT03922711|532064039|FG001|Overall Study|Withdrawal by Subject|3|||
147522640|NCT03922711|532064040|FG002|Overall Study|Withdrawal by Subject|1|||
147522641|NCT03922711|532064038|FG000|Overall Study|Not further specified|0|||
147522642|NCT03922711|532064039|FG001|Overall Study|Not further specified|0|||
147522643|NCT03922711|532064040|FG002|Overall Study|Not further specified|1|||
147522644|NCT02390362|532064041|FG000|Overall Study|Withdrawal by Subject|0|||
147522645|NCT02390362|532064042|FG001|Overall Study|Withdrawal by Subject|1|||
147522646|NCT04009824|532064043|FG000|Overall Study|COVID-19 pandemic restriction/closure|2|||
147522647|NCT04009824|532064044|FG001|Overall Study|COVID-19 pandemic restriction/closure|3|||
147522648|NCT04009824|532064045|FG002|Overall Study|COVID-19 pandemic restriction/closure|5|||
147522649|NCT04009824|532064046|FG003|Overall Study|COVID-19 pandemic restriction/closure|2|||
147522650|NCT04009824|532064047|FG004|Overall Study|COVID-19 pandemic restriction/closure|3|||
147522651|NCT01024946|532064048|FG000|Overall Study|Screen Failure|3|||
147522652|NCT01024946|532064048|FG000|Overall Study|Withdrawal by Subject|1|||
147522653|NCT01024946|532064048|FG000|Overall Study|Adverse Event|1|||
147522654|NCT03147495|532064049|FG000|Overall Study|Physician Decision|0|||
147522655|NCT03147495|532064050|FG001|Overall Study|Physician Decision|6|||
147522656|NCT02483611|532064051|FG000|Overall Study|Protocol Violation|0|||
147522657|NCT02483611|532064052|FG001|Overall Study|Protocol Violation|0|||
147522658|NCT02483611|532064053|FG002|Overall Study|Protocol Violation|1|||
147522659|NCT02608892|532064054|FG000|Overall Study|Lost to Follow-up|1|||
147522660|NCT02608892|532064055|FG001|Overall Study|Lost to Follow-up|0|||
147522661|NCT03032523|532064056|FG000|Overall Study|Withdrawal by Subject|2|||
147522662|NCT03032523|532064057|FG001|Overall Study|Withdrawal by Subject|2|||
147522663|NCT03032523|532064056|FG000|Overall Study|Physician Decision|1|||
147522664|NCT03032523|532064057|FG001|Overall Study|Physician Decision|0|||
147522665|NCT02590406|532064060|FG000|Overall Study|Adverse Event|1|||
147522666|NCT02590406|532064061|FG001|Overall Study|Adverse Event|0|||
147522667|NCT02590406|532064060|FG000|Overall Study|Saturometer malfunction|0|||
147522668|NCT02590406|532064061|FG001|Overall Study|Saturometer malfunction|1|||
147522669|NCT00957723|532064062|FG000|Overall Study|Death|3|||
147522670|NCT00957723|532064062|FG000|Overall Study|Revision/ Removal of Study Implant|3|||
147522671|NCT00957723|532064062|FG000|Overall Study|Lost to Follow-up|8|||
147522672|NCT00957723|532064062|FG000|Overall Study|Withdrawal by Subject|24|||
147522673|NCT00957723|532064062|FG000|Overall Study|Investigative Site Terminated|61|||
147522674|NCT00957723|532064062|FG000|Overall Study|Intercurrent Illness|2|||
147522675|NCT00957723|532064062|FG000|Overall Study|2yr ROM Data Not Evaluable|12|||
147522676|NCT00877890|532064063|FG000|Overall Study|Adverse Event|6|||
147522677|NCT00877890|532064064|FG001|Overall Study|Adverse Event|6|||
147522678|NCT00877890|532064063|FG000|Overall Study|Lost to Follow-up|5|||
147522679|NCT00877890|532064064|FG001|Overall Study|Lost to Follow-up|5|||
147522680|NCT00877890|532064063|FG000|Overall Study|Protocol Violation|0|||
147522681|NCT00877890|532064064|FG001|Overall Study|Protocol Violation|1|||
147522682|NCT00877890|532064063|FG000|Overall Study|Withdrawal of Consent|6|||
147522683|NCT00877890|532064064|FG001|Overall Study|Withdrawal of Consent|12|||
147522684|NCT00877890|532064063|FG000|Overall Study|Investigator Decision|0|||
147522685|NCT00877890|532064064|FG001|Overall Study|Investigator Decision|2|||
147522686|NCT00877890|532064063|FG000|Overall Study|Loss of Glucose Control|3|||
147522687|NCT00877890|532064064|FG001|Overall Study|Loss of Glucose Control|4|||
147522688|NCT00984009|532064065|FG000|Grapefruit Juice Alone|missed serving of grapefruit juice|1|||
147522689|NCT00281528|532064066|FG000|Overall Study|Progressive Disease|28|||
147522690|NCT00281528|532064067|FG001|Overall Study|Progressive Disease|18|||
147522691|NCT00281528|532064068|FG002|Overall Study|Progressive Disease|27|||
147522692|NCT00281528|532064066|FG000|Overall Study|Unacceptable Toxicity-related to trt|21|||
147522693|NCT00281528|532064067|FG001|Overall Study|Unacceptable Toxicity-related to trt|24|||
147522694|NCT00281528|532064068|FG002|Overall Study|Unacceptable Toxicity-related to trt|32|||
147522695|NCT00281528|532064066|FG000|Overall Study|Adverse Event-unrelated to treatment|3|||
147522696|NCT00281528|532064067|FG001|Overall Study|Adverse Event-unrelated to treatment|0|||
147522697|NCT00281528|532064068|FG002|Overall Study|Adverse Event-unrelated to treatment|2|||
147522698|NCT00281528|532064066|FG000|Overall Study|Physician Decision|11|||
147522699|NCT00281528|532064067|FG001|Overall Study|Physician Decision|4|||
147522700|NCT00281528|532064068|FG002|Overall Study|Physician Decision|5|||
147522701|NCT00281528|532064066|FG000|Overall Study|Protocol Violation|1|||
147522702|NCT00281528|532064067|FG001|Overall Study|Protocol Violation|0|||
147522703|NCT00281528|532064068|FG002|Overall Study|Protocol Violation|1|||
147522704|NCT00281528|532064066|FG000|Overall Study|Withdrawal by Subject|5|||
147522705|NCT00281528|532064067|FG001|Overall Study|Withdrawal by Subject|5|||
147522706|NCT00281528|532064068|FG002|Overall Study|Withdrawal by Subject|7|||
147522707|NCT00281528|532064066|FG000|Overall Study|Other|6|||
147522708|NCT00281528|532064067|FG001|Overall Study|Other|3|||
147522709|NCT00281528|532064068|FG002|Overall Study|Other|5|||
147522710|NCT02178592|532064069|FG000|Randomized Phase (Up to Week 52)|Adverse Event|0|||
147522711|NCT02178592|532064070|FG001|Randomized Phase (Up to Week 52)|Adverse Event|2|||
147522712|NCT02178592|532064069|FG000|Randomized Phase (Up to Week 52)|Lack of Efficacy|1|||
147522713|NCT02178592|532064070|FG001|Randomized Phase (Up to Week 52)|Lack of Efficacy|1|||
147522714|NCT02178592|532064069|FG000|Randomized Phase (Up to Week 52)|Protocol Violation|3|||
147522715|NCT02178592|532064070|FG001|Randomized Phase (Up to Week 52)|Protocol Violation|2|||
147522716|NCT02178592|532064069|FG000|Randomized Phase (Up to Week 52)|Withdrawal by Subject|3|||
147522717|NCT02178592|532064070|FG001|Randomized Phase (Up to Week 52)|Withdrawal by Subject|1|||
147522718|NCT02178592|532064069|FG000|Randomized Phase (Up to Week 52)|Lost to Follow-up|11|||
147522719|NCT02178592|532064070|FG001|Randomized Phase (Up to Week 52)|Lost to Follow-up|3|||
147522720|NCT02178592|532064069|FG000|Randomized Phase (Up to Week 52)|Physician Decision|1|||
147522721|NCT02178592|532064070|FG001|Randomized Phase (Up to Week 52)|Physician Decision|0|||
147522722|NCT02178592|532064069|FG000|OLE Phase (Week 52 to Week 252)|Adverse Event|1|||
147522723|NCT02178592|532064070|FG001|OLE Phase (Week 52 to Week 252)|Adverse Event|0|||
147522724|NCT02178592|532064069|FG000|OLE Phase (Week 52 to Week 252)|Lack of Efficacy|0|||
147522725|NCT02178592|532064070|FG001|OLE Phase (Week 52 to Week 252)|Lack of Efficacy|1|||
147522726|NCT02178592|532064069|FG000|OLE Phase (Week 52 to Week 252)|Protocol Violation|2|||
147522727|NCT02178592|532064070|FG001|OLE Phase (Week 52 to Week 252)|Protocol Violation|0|||
147522728|NCT02178592|532064069|FG000|OLE Phase (Week 52 to Week 252)|Withdrawal by Subject|4|||
147522729|NCT02178592|532064070|FG001|OLE Phase (Week 52 to Week 252)|Withdrawal by Subject|1|||
147522730|NCT02178592|532064069|FG000|OLE Phase (Week 52 to Week 252)|Reached Protocol defined stopping criteria|2|||
147522731|NCT02178592|532064070|FG001|OLE Phase (Week 52 to Week 252)|Reached Protocol defined stopping criteria|0|||
147522732|NCT02178592|532064069|FG000|OLE Phase (Week 52 to Week 252)|Lost to Follow-up|3|||
147522733|NCT02178592|532064070|FG001|OLE Phase (Week 52 to Week 252)|Lost to Follow-up|1|||
147522734|NCT02036476|532064072|FG000|Overall Study|Withdrawal by Subject|2|||
147522735|NCT02036476|532064072|FG000|Overall Study|Progressive Disease|4|||
147522736|NCT02036476|532064072|FG000|Overall Study|Unacceptable Toxicity|2|||
147522737|NCT01984294|532064080|FG000|Overall Study|Randomized but Never Treated|0|||
147522738|NCT01984294|532064081|FG001|Overall Study|Randomized but Never Treated|0|||
147522739|NCT01984294|532064082|FG002|Overall Study|Randomized but Never Treated|1|||
147522740|NCT01984294|532064080|FG000|Overall Study|Lack of Efficacy|4|||
147522741|NCT01984294|532064081|FG001|Overall Study|Lack of Efficacy|2|||
147522742|NCT01984294|532064082|FG002|Overall Study|Lack of Efficacy|6|||
147522743|NCT01984294|532064080|FG000|Overall Study|Adverse Event|0|||
147522744|NCT01984294|532064081|FG001|Overall Study|Adverse Event|1|||
147522745|NCT01984294|532064082|FG002|Overall Study|Adverse Event|0|||
147522746|NCT03049852|532064085|FG000|Overall Study|Lost to Follow-up|0|||
147522747|NCT03049852|532064086|FG001|Overall Study|Lost to Follow-up|1|||
147522748|NCT03049852|532064087|FG002|Overall Study|Lost to Follow-up|0|||
147522749|NCT02610231|532064088|FG000|Overall Study|Withdrawal by Subject|27|||
147522750|NCT02610231|532064088|FG000|Overall Study|Adverse Event|20|||
147522751|NCT02610231|532064088|FG000|Overall Study|Death|5|||
147522752|NCT02610231|532064088|FG000|Overall Study|Surgery|2|||
147522753|NCT02610231|532064088|FG000|Overall Study|Physician Decision|1|||
147522754|NCT02610231|532064088|FG000|Overall Study|Non Compliance|2|||
147522755|NCT02610231|532064088|FG000|Overall Study|Other|3|||
147522756|NCT02140762|532064098|FG000|Overall Study|Adverse Event|1|||
147522757|NCT02140762|532064099|FG001|Overall Study|Adverse Event|1|||
147522758|NCT02140762|532064098|FG000|Overall Study|Lost to Follow-up|9|||
147522759|NCT02140762|532064099|FG001|Overall Study|Lost to Follow-up|5|||
147522760|NCT02140762|532064098|FG000|Overall Study|Protocol Violation|1|||
147522761|NCT02140762|532064099|FG001|Overall Study|Protocol Violation|1|||
147522762|NCT02140762|532064098|FG000|Overall Study|Withdrawal by Subject|6|||
147522763|NCT02140762|532064099|FG001|Overall Study|Withdrawal by Subject|4|||
147522764|NCT02140762|532064098|FG000|Overall Study|Other|0|||
147522765|NCT02140762|532064099|FG001|Overall Study|Other|1|||
147522766|NCT02709889|532064100|FG000|Overall Study|Withdrawal by Subject|11|||
147522767|NCT02709889|532064101|FG001|Overall Study|Withdrawal by Subject|10|||
147522768|NCT02709889|532064102|FG002|Overall Study|Withdrawal by Subject|2|||
147522769|NCT02709889|532064103|FG003|Overall Study|Withdrawal by Subject|12|||
147522770|NCT02709889|532064100|FG000|Overall Study|Death|25|||
147522771|NCT02709889|532064101|FG001|Overall Study|Death|38|||
147522772|NCT02709889|532064102|FG002|Overall Study|Death|4|||
147522773|NCT02709889|532064103|FG003|Overall Study|Death|44|||
147522774|NCT02709889|532064100|FG000|Overall Study|Physician Decision|1|||
147522775|NCT02709889|532064101|FG001|Overall Study|Physician Decision|2|||
147522776|NCT02709889|532064102|FG002|Overall Study|Physician Decision|3|||
147522777|NCT02709889|532064103|FG003|Overall Study|Physician Decision|5|||
147522778|NCT02709889|532064100|FG000|Overall Study|Lost to Follow-up|2|||
147522779|NCT02709889|532064101|FG001|Overall Study|Lost to Follow-up|0|||
147522780|NCT02709889|532064102|FG002|Overall Study|Lost to Follow-up|0|||
147522781|NCT02709889|532064103|FG003|Overall Study|Lost to Follow-up|4|||
147522782|NCT02709889|532064100|FG000|Overall Study|Study Terminated by Sponsor|4|||
147522783|NCT02709889|532064101|FG001|Overall Study|Study Terminated by Sponsor|6|||
147522784|NCT02709889|532064102|FG002|Overall Study|Study Terminated by Sponsor|2|||
147522785|NCT02709889|532064103|FG003|Overall Study|Study Terminated by Sponsor|17|||
147522786|NCT02709889|532064100|FG000|Overall Study|Other, Not Specified|0|||
147522787|NCT02709889|532064101|FG001|Overall Study|Other, Not Specified|1|||
147522788|NCT02709889|532064102|FG002|Overall Study|Other, Not Specified|1|||
147522789|NCT02709889|532064103|FG003|Overall Study|Other, Not Specified|6|||
147522790|NCT00537810|532064104|FG000|Overall Study|Withdrawal by Subject|4|||
147522791|NCT00537810|532064105|FG001|Overall Study|Withdrawal by Subject|11|||
147522792|NCT00537810|532064106|FG002|Overall Study|Withdrawal by Subject|4|||
147522793|NCT00537810|532064107|FG003|Overall Study|Withdrawal by Subject|3|||
147522794|NCT00537810|532064104|FG000|Overall Study|Medically withdrawn|2|||
147522795|NCT00537810|532064105|FG001|Overall Study|Medically withdrawn|2|||
147522796|NCT00537810|532064106|FG002|Overall Study|Medically withdrawn|0|||
147522797|NCT00537810|532064107|FG003|Overall Study|Medically withdrawn|1|||
147522798|NCT03452397|532064108|FG000|Overall Study|Adverse Event|1|||
147522799|NCT03452397|532064109|FG001|Overall Study|Adverse Event|0|||
147522800|NCT03452397|532064110|FG002|Overall Study|Adverse Event|0|||
147522801|NCT03452397|532064111|FG003|Overall Study|Adverse Event|0|||
147522802|NCT03452397|532064108|FG000|Overall Study|Administrative reason|0|||
147522803|NCT03452397|532064109|FG001|Overall Study|Administrative reason|0|||
147522804|NCT03452397|532064110|FG002|Overall Study|Administrative reason|1|||
147522805|NCT03452397|532064111|FG003|Overall Study|Administrative reason|1|||
147522806|NCT03452397|532064108|FG000|Overall Study|Withdrawal by Subject|0|||
147522807|NCT03452397|532064109|FG001|Overall Study|Withdrawal by Subject|0|||
147522808|NCT03452397|532064110|FG002|Overall Study|Withdrawal by Subject|1|||
147522809|NCT03452397|532064111|FG003|Overall Study|Withdrawal by Subject|0|||
147522810|NCT01711359|532064112|FG000|Treatment Period|Withdrawal by Subject|18|||
147522811|NCT01711359|532064113|FG001|Treatment Period|Withdrawal by Subject|7|||
147522812|NCT01711359|532064114|FG002|Treatment Period|Withdrawal by Subject|13|||
147522813|NCT01711359|532064112|FG000|Treatment Period|Lack of Efficacy|13|||
147522814|NCT01711359|532064113|FG001|Treatment Period|Lack of Efficacy|2|||
147522815|NCT01711359|532064114|FG002|Treatment Period|Lack of Efficacy|2|||
147522816|NCT01711359|532064112|FG000|Treatment Period|Adverse Event|8|||
147522817|NCT01711359|532064113|FG001|Treatment Period|Adverse Event|10|||
147522818|NCT01711359|532064114|FG002|Treatment Period|Adverse Event|24|||
147522819|NCT01711359|532064112|FG000|Treatment Period|Physician Decision|4|||
147522820|NCT01711359|532064113|FG001|Treatment Period|Physician Decision|3|||
147522821|NCT01711359|532064114|FG002|Treatment Period|Physician Decision|2|||
147522822|NCT01711359|532064112|FG000|Treatment Period|Death|3|||
147522823|NCT01711359|532064113|FG001|Treatment Period|Death|0|||
147522824|NCT01711359|532064114|FG002|Treatment Period|Death|0|||
147522825|NCT01711359|532064112|FG000|Treatment Period|Entry Criteria Not Met|1|||
147522826|NCT01711359|532064113|FG001|Treatment Period|Entry Criteria Not Met|0|||
147522827|NCT01711359|532064114|FG002|Treatment Period|Entry Criteria Not Met|0|||
147522828|NCT01711359|532064112|FG000|Treatment Period|Sponsor Decision|1|||
147522829|NCT01711359|532064113|FG001|Treatment Period|Sponsor Decision|0|||
147522830|NCT01711359|532064114|FG002|Treatment Period|Sponsor Decision|0|||
147522831|NCT01711359|532064112|FG000|Treatment Period|Lost to Follow-up|1|||
147522832|NCT01711359|532064113|FG001|Treatment Period|Lost to Follow-up|1|||
147522833|NCT01711359|532064114|FG002|Treatment Period|Lost to Follow-up|1|||
147522834|NCT01711359|532064112|FG000|Treatment Period|Randomized, Not Treated|3|||
147522835|NCT01711359|532064113|FG001|Treatment Period|Randomized, Not Treated|1|||
147522836|NCT01711359|532064114|FG002|Treatment Period|Randomized, Not Treated|0|||
147522837|NCT02698176|532064115|FG000|Overall Study|Progressive disease|4|||
147522838|NCT02698176|532064116|FG001|Overall Study|Progressive disease|3|||
147522839|NCT02698176|532064117|FG002|Overall Study|Progressive disease|1|||
147522840|NCT02698176|532064118|FG003|Overall Study|Progressive disease|0|||
147522841|NCT02698176|532064115|FG000|Overall Study|Adverse Event|2|||
147522842|NCT02698176|532064116|FG001|Overall Study|Adverse Event|0|||
147522843|NCT02698176|532064117|FG002|Overall Study|Adverse Event|0|||
147522844|NCT02698176|532064118|FG003|Overall Study|Adverse Event|0|||
147522845|NCT02698176|532064115|FG000|Overall Study|Clinical progression|3|||
147522846|NCT02698176|532064116|FG001|Overall Study|Clinical progression|0|||
147522847|NCT02698176|532064117|FG002|Overall Study|Clinical progression|0|||
147522848|NCT02698176|532064118|FG003|Overall Study|Clinical progression|0|||
147643603|NCT01047332|532514115|FG001|Overall Study|Died Unobstructed|41|||
147643604|NCT01047332|532514114|FG000|Overall Study|Lost to Follow-up|8|||
147643605|NCT01047332|532514115|FG001|Overall Study|Lost to Follow-up|3|||
147643606|NCT03521817|532514120|FG000|Overall Study|Protocol Violation|0|||
147643607|NCT03521817|532514121|FG001|Overall Study|Protocol Violation|1|||
147643608|NCT00778102|532514123|FG000|Overall Study|Adverse Event|8|||
147643609|NCT00778102|532514124|FG001|Overall Study|Adverse Event|5|||
147643610|NCT00778102|532514123|FG000|Overall Study|Death|1|||
147643611|NCT00778102|532514124|FG001|Overall Study|Death|1|||
147643612|NCT00778102|532514123|FG000|Overall Study|Lost to Follow-up|1|||
147643613|NCT00778102|532514124|FG001|Overall Study|Lost to Follow-up|0|||
147522849|NCT02561572|532064123|FG000|Overall Study|Inadequate time before surgery|2|||
147522850|NCT02561572|532064124|FG001|Overall Study|Inadequate time before surgery|1|||
147522851|NCT02561572|532064123|FG000|Overall Study|Protocol Violation|0|||
147522852|NCT02561572|532064124|FG001|Overall Study|Protocol Violation|1|||
147522853|NCT00805142|532064125|FG000|Titration Period|Adverse Event|3|||
147522854|NCT00805142|532064126|FG001|Titration Period|Adverse Event|3|||
147522855|NCT00805142|532064125|FG000|Titration Period|Lack of Efficacy|1|||
147522856|NCT00805142|532064126|FG001|Titration Period|Lack of Efficacy|1|||
147522857|NCT00805142|532064125|FG000|Titration Period|Lost to Follow-up|0|||
147522858|NCT00805142|532064126|FG001|Titration Period|Lost to Follow-up|1|||
147522859|NCT00805142|532064125|FG000|Titration Period|Disease Progression|2|||
147522860|NCT00805142|532064126|FG001|Titration Period|Disease Progression|1|||
147522861|NCT00805142|532064125|FG000|Titration Period|Withdrawal of consent|0|||
147522862|NCT00805142|532064126|FG001|Titration Period|Withdrawal of consent|1|||
147522863|NCT00805142|532064125|FG000|Titration Period|Other|0|||
147522864|NCT00805142|532064126|FG001|Titration Period|Other|3|||
147522865|NCT00805142|532064125|FG000|Maintenance Period|Adverse Event|0|||
147522866|NCT00805142|532064126|FG001|Maintenance Period|Adverse Event|1|||
147522867|NCT00805142|532064125|FG000|Maintenance Period|Other|0|||
147522868|NCT00805142|532064126|FG001|Maintenance Period|Other|1|||
147522869|NCT00424463|532064127|FG000|Overall Study|Adverse Event|2|||
147522870|NCT00424463|532064128|FG001|Overall Study|Adverse Event|3|||
147522871|NCT00424463|532064129|FG002|Overall Study|Adverse Event|2|||
147522872|NCT00424463|532064127|FG000|Overall Study|Physician Decision|0|||
147522873|NCT00424463|532064128|FG001|Overall Study|Physician Decision|2|||
147522874|NCT00424463|532064129|FG002|Overall Study|Physician Decision|2|||
147522875|NCT00424463|532064127|FG000|Overall Study|Withdrawal by Subject|4|||
147522876|NCT00424463|532064128|FG001|Overall Study|Withdrawal by Subject|2|||
147522877|NCT00424463|532064129|FG002|Overall Study|Withdrawal by Subject|5|||
147522878|NCT00424463|532064127|FG000|Overall Study|Tracheotomy due to worsening of ALS|1|||
147522879|NCT00424463|532064128|FG001|Overall Study|Tracheotomy due to worsening of ALS|7|||
147522880|NCT00424463|532064129|FG002|Overall Study|Tracheotomy due to worsening of ALS|6|||
147522881|NCT00424463|532064127|FG000|Overall Study|Patient's convenience|0|||
147522882|NCT00424463|532064128|FG001|Overall Study|Patient's convenience|0|||
147522883|NCT00424463|532064129|FG002|Overall Study|Patient's convenience|1|||
147522884|NCT01265719|532065550|FG000|Overall Study|Does not meet entrance criteria|0|||
147522885|NCT01265719|532065551|FG001|Overall Study|Does not meet entrance criteria|3|||
147522886|NCT01265719|532065550|FG000|Overall Study|Other reasons|2|||
147522887|NCT01265719|532065551|FG001|Overall Study|Other reasons|0|||
147522888|NCT01265719|532065550|FG000|Overall Study|Withdrawal by Subject|8|||
147522889|NCT01265719|532065551|FG001|Overall Study|Withdrawal by Subject|3|||
147522890|NCT01265719|532065550|FG000|Overall Study|Lost to Follow-up|2|||
147522891|NCT01265719|532065551|FG001|Overall Study|Lost to Follow-up|7|||
147522892|NCT01265719|532065550|FG000|Overall Study|Adverse Event|2|||
147522893|NCT01265719|532065551|FG001|Overall Study|Adverse Event|0|||
147522894|NCT00027027|532065552|FG000|Overall Study|Adverse Event|0|||
147522895|NCT00027027|532065553|FG001|Overall Study|Adverse Event|0|||
147522896|NCT00027027|532065554|FG002|Overall Study|Adverse Event|1|||
147522897|NCT00027027|532065555|FG003|Overall Study|Adverse Event|0|||
147522898|NCT00027027|532065556|FG004|Overall Study|Adverse Event|1|||
147522899|NCT00027027|532065552|FG000|Overall Study|Admitted for Signs of PD|0|||
147522900|NCT00027027|532065553|FG001|Overall Study|Admitted for Signs of PD|0|||
147522901|NCT00027027|532065554|FG002|Overall Study|Admitted for Signs of PD|0|||
147522902|NCT00027027|532065555|FG003|Overall Study|Admitted for Signs of PD|0|||
147522903|NCT00027027|532065556|FG004|Overall Study|Admitted for Signs of PD|1|||
147522904|NCT00027027|532065552|FG000|Overall Study|Clinical Symptoms Progression not PD|1|||
147522905|NCT00027027|532065553|FG001|Overall Study|Clinical Symptoms Progression not PD|0|||
147522906|NCT00027027|532065554|FG002|Overall Study|Clinical Symptoms Progression not PD|0|||
147522907|NCT00027027|532065555|FG003|Overall Study|Clinical Symptoms Progression not PD|0|||
147522908|NCT00027027|532065556|FG004|Overall Study|Clinical Symptoms Progression not PD|0|||
147522909|NCT00027027|532065552|FG000|Overall Study|PD Requiring Surgery|0|||
147522910|NCT00027027|532065553|FG001|Overall Study|PD Requiring Surgery|0|||
147522911|NCT00027027|532065554|FG002|Overall Study|PD Requiring Surgery|1|||
147522912|NCT00027027|532065555|FG003|Overall Study|PD Requiring Surgery|0|||
147522913|NCT00027027|532065556|FG004|Overall Study|PD Requiring Surgery|0|||
147522914|NCT00027027|532065552|FG000|Overall Study|Physician Decision Due To PD|2|||
147522915|NCT00027027|532065553|FG001|Overall Study|Physician Decision Due To PD|3|||
147522916|NCT00027027|532065554|FG002|Overall Study|Physician Decision Due To PD|2|||
147522917|NCT00027027|532065555|FG003|Overall Study|Physician Decision Due To PD|3|||
147522918|NCT00027027|532065556|FG004|Overall Study|Physician Decision Due To PD|5|||
147522919|NCT00027027|532065552|FG000|Overall Study|Withdrawal by Subject|0|||
147522920|NCT00027027|532065553|FG001|Overall Study|Withdrawal by Subject|0|||
147522921|NCT00027027|532065554|FG002|Overall Study|Withdrawal by Subject|0|||
147522922|NCT00027027|532065555|FG003|Overall Study|Withdrawal by Subject|0|||
147522923|NCT00027027|532065556|FG004|Overall Study|Withdrawal by Subject|1|||
147522924|NCT00959192|532065562|FG000|Overall Study|Adverse Event|1|||
147522925|NCT00959192|532065563|FG001|Overall Study|Adverse Event|1|||
147522926|NCT00959192|532065564|FG002|Overall Study|Adverse Event|1|||
147522927|NCT00959192|532065565|FG003|Overall Study|Adverse Event|0|||
147522928|NCT00959192|532065562|FG000|Overall Study|Investigator Request|1|||
147522929|NCT00959192|532065563|FG001|Overall Study|Investigator Request|0|||
147522930|NCT00959192|532065564|FG002|Overall Study|Investigator Request|0|||
147522931|NCT00959192|532065565|FG003|Overall Study|Investigator Request|0|||
147522932|NCT00959192|532065562|FG000|Overall Study|Caregiver Request|0|||
147522933|NCT00959192|532065563|FG001|Overall Study|Caregiver Request|0|||
147522934|NCT00959192|532065564|FG002|Overall Study|Caregiver Request|2|||
147522935|NCT00959192|532065565|FG003|Overall Study|Caregiver Request|1|||
147522936|NCT01967134|532065566|FG000|Overall Study|Lost to Follow-up|0|||
147522937|NCT01967134|532065567|FG001|Overall Study|Lost to Follow-up|1|||
147522938|NCT01967134|532065568|FG002|Overall Study|Lost to Follow-up|0|||
147522939|NCT00305773|532065570|FG000|Overall Study|Death|3|||
147522940|NCT00305773|532065571|FG001|Overall Study|Death|2|||
147522941|NCT00305773|532065570|FG000|Overall Study|Adverse Event|1|||
147522942|NCT00305773|532065571|FG001|Overall Study|Adverse Event|2|||
147522943|NCT00305773|532065570|FG000|Overall Study|Alternative Treatment|4|||
147522944|NCT00305773|532065571|FG001|Overall Study|Alternative Treatment|4|||
147522945|NCT00305773|532065570|FG000|Overall Study|Physician Decision|1|||
147522946|NCT00305773|532065571|FG001|Overall Study|Physician Decision|1|||
147522947|NCT00305773|532065570|FG000|Overall Study|Withdrawal by Subject|1|||
147522948|NCT00305773|532065571|FG001|Overall Study|Withdrawal by Subject|4|||
147522949|NCT00305773|532065570|FG000|Overall Study|Disease Progression|1|||
147522950|NCT00305773|532065571|FG001|Overall Study|Disease Progression|3|||
147522951|NCT00305773|532065570|FG000|Overall Study|All other reasons|3|||
147522952|NCT00305773|532065571|FG001|Overall Study|All other reasons|2|||
147522953|NCT02679222|532065572|FG000|Overall Study|No time for project|1|||
147522954|NCT00945945|532065575|FG000|Overall Study|Adverse Event|15|||
147522955|NCT00945945|532065576|FG001|Overall Study|Adverse Event|35|||
147522956|NCT00945945|532065575|FG000|Overall Study|Withdrawal by Subject|7|||
147522957|NCT00945945|532065576|FG001|Overall Study|Withdrawal by Subject|10|||
147522958|NCT00945945|532065575|FG000|Overall Study|Lost to Follow-up|4|||
147522959|NCT00945945|532065576|FG001|Overall Study|Lost to Follow-up|5|||
147522960|NCT00945945|532065575|FG000|Overall Study|Lack of Efficacy|6|||
147522961|NCT00945945|532065576|FG001|Overall Study|Lack of Efficacy|2|||
147522962|NCT00945945|532065575|FG000|Overall Study|Protocol Violation|4|||
147522963|NCT00945945|532065576|FG001|Overall Study|Protocol Violation|2|||
147522964|NCT00945945|532065575|FG000|Overall Study|Entry Criteria Not Met|0|||
147522965|NCT00945945|532065576|FG001|Overall Study|Entry Criteria Not Met|1|||
147522966|NCT01716585|532065578|FG000|Double-blind Treatment|Did Not Receive Study Drug|4|||
147522967|NCT01716585|532065579|FG001|Double-blind Treatment|Did Not Receive Study Drug|1|||
147522968|NCT01716585|532065578|FG000|Double-blind Treatment|Adverse Event|2|||
147522969|NCT01716585|532065579|FG001|Double-blind Treatment|Adverse Event|1|||
147522970|NCT01716585|532065578|FG000|Double-blind Treatment|Withdrawal by Subject|3|||
147522971|NCT01716585|532065579|FG001|Double-blind Treatment|Withdrawal by Subject|0|||
147522972|NCT01716585|532065578|FG000|Double-blind Treatment|Lost to Follow-up|2|||
147522973|NCT01716585|532065579|FG001|Double-blind Treatment|Lost to Follow-up|0|||
147522974|NCT01716585|532065578|FG000|Double-blind Treatment|Subject Noncompliant|1|||
147522975|NCT01716585|532065579|FG001|Double-blind Treatment|Subject Noncompliant|0|||
147522976|NCT01716585|532065578|FG000|Double-blind Treatment|Other|1|||
147522977|NCT01716585|532065579|FG001|Double-blind Treatment|Other|0|||
147522978|NCT01716585|532065578|FG000|Open-label Treatment|Adverse Event|0|||
147522979|NCT01716585|532065579|FG001|Open-label Treatment|Adverse Event|2|||
147522980|NCT01716585|532065578|FG000|Open-label Treatment|Virologic Failure|0|||
147522981|NCT01716585|532065579|FG001|Open-label Treatment|Virologic Failure|2|||
147522982|NCT01716585|532065578|FG000|Open-label Treatment|Withdrawal by Subject|0|||
147522983|NCT01716585|532065579|FG001|Open-label Treatment|Withdrawal by Subject|3|||
147522984|NCT03288987|532065581|FG000|Overall Study|Protocol Violation|10|||
147522985|NCT03288987|532065582|FG001|Overall Study|Protocol Violation|4|||
147522986|NCT04235959|532065583|FG000|Overall Study|Protocol Violation|0|||
147522987|NCT04235959|532065584|FG001|Overall Study|Protocol Violation|1|||
147522988|NCT04235959|532065585|FG002|Overall Study|Protocol Violation|0|||
147522989|NCT04235959|532065583|FG000|Overall Study|Adverse Event|1|||
147522990|NCT04235959|532065584|FG001|Overall Study|Adverse Event|0|||
147522991|NCT04235959|532065585|FG002|Overall Study|Adverse Event|0|||
147522992|NCT03055806|532065588|FG000|Overall Study|Adverse Event|0|||
147522993|NCT03055806|532065589|FG001|Overall Study|Adverse Event|0|||
147522994|NCT03055806|532065590|FG002|Overall Study|Adverse Event|1|||
147522995|NCT03055806|532065591|FG003|Overall Study|Adverse Event|1|||
147522996|NCT03055806|532065588|FG000|Overall Study|Lost to Follow-up|0|||
147522997|NCT03055806|532065589|FG001|Overall Study|Lost to Follow-up|3|||
147522998|NCT03055806|532065590|FG002|Overall Study|Lost to Follow-up|6|||
147522999|NCT03055806|532065591|FG003|Overall Study|Lost to Follow-up|7|||
147523000|NCT03055806|532065588|FG000|Overall Study|Physician Decision|1|||
147523001|NCT03055806|532065589|FG001|Overall Study|Physician Decision|0|||
147523002|NCT03055806|532065590|FG002|Overall Study|Physician Decision|0|||
147523003|NCT03055806|532065591|FG003|Overall Study|Physician Decision|1|||
147523004|NCT03055806|532065588|FG000|Overall Study|Protocol Violation|1|||
147523005|NCT03055806|532065589|FG001|Overall Study|Protocol Violation|0|||
147523006|NCT03055806|532065590|FG002|Overall Study|Protocol Violation|0|||
147523007|NCT03055806|532065591|FG003|Overall Study|Protocol Violation|0|||
147523008|NCT03055806|532065588|FG000|Overall Study|Withdrawal of consent to continue drug|1|||
147523009|NCT03055806|532065589|FG001|Overall Study|Withdrawal of consent to continue drug|1|||
147523010|NCT03055806|532065590|FG002|Overall Study|Withdrawal of consent to continue drug|2|||
147523011|NCT03055806|532065591|FG003|Overall Study|Withdrawal of consent to continue drug|0|||
147523012|NCT03055806|532065588|FG000|Overall Study|Withdrawal of consent to continue study|2|||
147523013|NCT03055806|532065589|FG001|Overall Study|Withdrawal of consent to continue study|3|||
147523014|NCT03055806|532065590|FG002|Overall Study|Withdrawal of consent to continue study|4|||
147523015|NCT03055806|532065591|FG003|Overall Study|Withdrawal of consent to continue study|6|||
147523016|NCT03055806|532065588|FG000|Overall Study|Partner not willing to try intercourse|1|||
147523017|NCT03055806|532065589|FG001|Overall Study|Partner not willing to try intercourse|0|||
147523018|NCT03055806|532065590|FG002|Overall Study|Partner not willing to try intercourse|0|||
147523019|NCT03055806|532065591|FG003|Overall Study|Partner not willing to try intercourse|0|||
147523020|NCT04601194|532065592|FG000|Overall Study|Lost to Follow-up|7|||
147523021|NCT04905563|532065593|FG000|Overall Study|Withdrawal by Subject|1|||
147523022|NCT04905563|532065594|FG001|Overall Study|Withdrawal by Subject|0|||
147523023|NCT04905563|532065593|FG000|Overall Study|Standard of care orders entered by resident|1|||
147523024|NCT04905563|532065594|FG001|Overall Study|Standard of care orders entered by resident|0|||
147523025|NCT04905563|532065593|FG000|Overall Study|Patient discharged from PACU. No study meds adinistered|0|||
147523026|NCT04905563|532065594|FG001|Overall Study|Patient discharged from PACU. No study meds adinistered|1|||
147523027|NCT04905563|532065593|FG000|Overall Study|Withdrawal by Subject|0|||
147523028|NCT04905563|532065594|FG001|Overall Study|Withdrawal by Subject|1|||
147523029|NCT01797302|532065595|FG000|Overall Study|Lost to Follow-up|16|||
147523030|NCT01797302|532065596|FG001|Overall Study|Lost to Follow-up|23|||
147523031|NCT01797302|532065597|FG002|Overall Study|Lost to Follow-up|22|||
147523032|NCT01797302|532065595|FG000|Overall Study|Withdrawal by Subject|1|||
147523033|NCT01797302|532065596|FG001|Overall Study|Withdrawal by Subject|3|||
147523034|NCT01797302|532065597|FG002|Overall Study|Withdrawal by Subject|4|||
147523035|NCT00568399|532065598|FG000|Overall Study|Death|2|||
147523036|NCT00568399|532065598|FG000|Overall Study|Adverse Event|5|||
147523037|NCT00568399|532065598|FG000|Overall Study|Withdrawal by Subject|8|||
147523038|NCT02381795|532065603|FG000|Overall Study|Withdrawal by Subject|1|||
147523039|NCT02381795|532065603|FG000|Overall Study|Study Terminated|2|||
147523040|NCT02176226|532065606|FG000|Overall Study|Lost to Follow-up|3|||
147523041|NCT02176226|532065606|FG000|Overall Study|Withdrew prior to treatment|6|||
147523042|NCT01038635|532065613|FG000|Overall Study|Disease Progression|2|||
147523043|NCT01038635|532065614|FG001|Overall Study|Disease Progression|0|||
147523044|NCT01038635|532065615|FG002|Overall Study|Disease Progression|0|||
147523045|NCT01038635|532065616|FG003|Overall Study|Disease Progression|0|||
147523046|NCT01038635|532065617|FG004|Overall Study|Disease Progression|0|||
147523047|NCT01038635|532065618|FG005|Overall Study|Disease Progression|0|||
147523048|NCT01038635|532065619|FG006|Overall Study|Disease Progression|1|||
147523049|NCT01038635|532065620|FG007|Overall Study|Disease Progression|4|||
147523050|NCT01038635|532065621|FG008|Overall Study|Disease Progression|0|||
147523051|NCT01038635|532065613|FG000|Overall Study|Death|0|||
147523052|NCT01038635|532065614|FG001|Overall Study|Death|0|||
147523053|NCT01038635|532065615|FG002|Overall Study|Death|0|||
147523054|NCT01038635|532065616|FG003|Overall Study|Death|0|||
147523055|NCT01038635|532065617|FG004|Overall Study|Death|1|||
147523056|NCT01038635|532065618|FG005|Overall Study|Death|0|||
147523057|NCT01038635|532065619|FG006|Overall Study|Death|1|||
147523058|NCT01038635|532065620|FG007|Overall Study|Death|1|||
147523059|NCT01038635|532065621|FG008|Overall Study|Death|2|||
147523060|NCT01227252|532065622|FG000|Overall Study|Sponsor Decision|0|||
147523061|NCT01227252|532065623|FG001|Overall Study|Sponsor Decision|1|||
147523062|NCT01227252|532065624|FG002|Overall Study|Sponsor Decision|0|||
147523063|NCT01227252|532065625|FG003|Overall Study|Sponsor Decision|0|||
147523064|NCT01227252|532065622|FG000|Overall Study|Lost to Follow-up|0|||
147523065|NCT01227252|532065623|FG001|Overall Study|Lost to Follow-up|1|||
147523066|NCT01227252|532065624|FG002|Overall Study|Lost to Follow-up|0|||
147523067|NCT01227252|532065625|FG003|Overall Study|Lost to Follow-up|0|||
147523068|NCT01227252|532065622|FG000|Overall Study|Withdrawal by Subject|0|||
147523069|NCT01227252|532065623|FG001|Overall Study|Withdrawal by Subject|1|||
147523070|NCT01227252|532065624|FG002|Overall Study|Withdrawal by Subject|0|||
147523071|NCT01227252|532065625|FG003|Overall Study|Withdrawal by Subject|0|||
147523072|NCT01034709|532065627|FG000|Overall Study|Protocol Violation|9|||
147523073|NCT01034709|532065628|FG001|Overall Study|Protocol Violation|16|||
147523074|NCT01060150|532065631|FG000|Overall Study|Adverse Event|6|||
147523075|NCT01060150|532065631|FG000|Overall Study|Lost to Follow-up|1|||
147523076|NCT01060150|532065631|FG000|Overall Study|Protocol Violation|6|||
147523077|NCT01060150|532065631|FG000|Overall Study|Withdrawal by Subject|8|||
147523078|NCT01060150|532065631|FG000|Overall Study|Enrolled, but not treated|2|||
147523079|NCT02516306|532065632|FG000|Period 2: Day 8 - 91|Protocol Violation|1|||
147523080|NCT02516306|532065633|FG001|Period 2: Day 8 - 91|Protocol Violation|2|||
147523081|NCT01566981|532065635|FG000|Overall Study|Lost to Follow-up|5|||
147523082|NCT01566981|532065636|FG001|Overall Study|Lost to Follow-up|8|||
147523083|NCT01351415|532065637|FG000|Overall Study|Withdrawal by Subject|15|||
147523084|NCT01351415|532065638|FG001|Overall Study|Withdrawal by Subject|17|||
147523085|NCT01351415|532065637|FG000|Overall Study|Trial termination by the Sponsor|28|||
147523086|NCT01351415|532065638|FG001|Overall Study|Trial termination by the Sponsor|19|||
147523087|NCT01351415|532065637|FG000|Overall Study|Lost to Follow-up|5|||
147523088|NCT01351415|532065638|FG001|Overall Study|Lost to Follow-up|7|||
147523089|NCT01351415|532065637|FG000|Overall Study|Death|190|||
147523090|NCT01351415|532065638|FG001|Overall Study|Death|187|||
147523091|NCT01351415|532065637|FG000|Overall Study|Physician Decision|2|||
147523092|NCT01351415|532065638|FG001|Overall Study|Physician Decision|3|||
147523093|NCT01351415|532065637|FG000|Overall Study|Reason unknown|0|||
147523094|NCT01351415|532065638|FG001|Overall Study|Reason unknown|2|||
147523095|NCT01351415|532065637|FG000|Overall Study|Never Started|5|||
147523096|NCT01351415|532065638|FG001|Overall Study|Never Started|5|||
147523097|NCT03480360|532065643|FG000|Overall Study|Death|2|||
147523098|NCT00472043|532065644|FG000|Overall Study|Withdrawal by Subject|1|||
147523099|NCT00472043|532065645|FG001|Overall Study|Withdrawal by Subject|0|||
147523100|NCT00472043|532065644|FG000|Overall Study|Death|1|||
147523101|NCT00472043|532065645|FG001|Overall Study|Death|0|||
147523102|NCT02975206|532065646|FG000|Overall Study|Withdrawal by Subject|14|||
147523103|NCT02975206|532065647|FG001|Overall Study|Withdrawal by Subject|11|||
147523104|NCT02975206|532065648|FG002|Overall Study|Withdrawal by Subject|11|||
147523105|NCT02975206|532065646|FG000|Overall Study|Other (e.g., lost to follow up)|13|||
147523106|NCT02975206|532065647|FG001|Overall Study|Other (e.g., lost to follow up)|6|||
147523107|NCT02975206|532065648|FG002|Overall Study|Other (e.g., lost to follow up)|6|||
147523108|NCT01981096|532065649|FG000|Overall Study|Parent illness|1|||
147523109|NCT01981096|532065650|FG001|Overall Study|Parent illness|0|||
147523110|NCT01981096|532065649|FG000|Overall Study|Withdrawal by Subject|0|||
147523111|NCT01981096|532065650|FG001|Overall Study|Withdrawal by Subject|1|||
147523112|NCT01981096|532065649|FG000|Overall Study|Lost to Follow-up|2|||
147523113|NCT01981096|532065650|FG001|Overall Study|Lost to Follow-up|0|||
147523114|NCT01225211|532065651|FG000|Overall Study|Adverse Event|0|||
147523115|NCT01225211|532065652|FG001|Overall Study|Adverse Event|0|||
147523116|NCT01225211|532065653|FG002|Overall Study|Adverse Event|1|||
147523117|NCT01225211|532065654|FG003|Overall Study|Adverse Event|0|||
147523118|NCT01225211|532065655|FG004|Overall Study|Adverse Event|0|||
147523119|NCT01225211|532065656|FG005|Overall Study|Adverse Event|0|||
147523120|NCT01225211|532065657|FG006|Overall Study|Adverse Event|0|||
147523121|NCT01225211|532065658|FG007|Overall Study|Adverse Event|0|||
147523122|NCT01225211|532065659|FG008|Overall Study|Adverse Event|0|||
147523123|NCT01225211|532065660|FG009|Overall Study|Adverse Event|1|||
147523124|NCT01225211|532065651|FG000|Overall Study|Withdrawal by Subject|0|||
147523125|NCT01225211|532065652|FG001|Overall Study|Withdrawal by Subject|0|||
147523126|NCT01225211|532065653|FG002|Overall Study|Withdrawal by Subject|0|||
147523127|NCT01225211|532065654|FG003|Overall Study|Withdrawal by Subject|0|||
147523128|NCT01225211|532065655|FG004|Overall Study|Withdrawal by Subject|0|||
147523129|NCT01225211|532065656|FG005|Overall Study|Withdrawal by Subject|0|||
147523130|NCT01225211|532065657|FG006|Overall Study|Withdrawal by Subject|1|||
147523131|NCT01225211|532065658|FG007|Overall Study|Withdrawal by Subject|0|||
147523132|NCT01225211|532065659|FG008|Overall Study|Withdrawal by Subject|1|||
147523133|NCT01225211|532065660|FG009|Overall Study|Withdrawal by Subject|3|||
147523134|NCT01225211|532065651|FG000|Overall Study|Other|0|||
147523135|NCT01225211|532065652|FG001|Overall Study|Other|0|||
147523136|NCT01225211|532065653|FG002|Overall Study|Other|0|||
147523137|NCT01225211|532065654|FG003|Overall Study|Other|0|||
147523138|NCT01225211|532065655|FG004|Overall Study|Other|0|||
147523139|NCT01225211|532065656|FG005|Overall Study|Other|0|||
147523140|NCT01225211|532065657|FG006|Overall Study|Other|0|||
147523141|NCT01225211|532065658|FG007|Overall Study|Other|0|||
147523142|NCT01225211|532065659|FG008|Overall Study|Other|0|||
147523143|NCT01225211|532065660|FG009|Overall Study|Other|1|||
147523144|NCT02067104|532065661|FG000|Overall Study|Study termination due to low accrual|4|||
147523145|NCT02067104|532065662|FG001|Overall Study|Study termination due to low accrual|5|||
147523146|NCT00806494|532065663|FG000|Overall Study|Adverse Event|29|||
147523147|NCT00806494|532065663|FG000|Overall Study|Lack of Efficacy|6|||
147523148|NCT00806494|532065663|FG000|Overall Study|Lost to Follow-up|10|||
147523149|NCT00806494|532065663|FG000|Overall Study|Other|30|||
147523150|NCT00806494|532065663|FG000|Overall Study|Withdrawal by Subject|5|||
147523151|NCT00554840|532065669|FG000|Overall Study|Physician Decision|0|||
147523152|NCT00554840|532065670|FG001|Overall Study|Physician Decision|1|||
147523153|NCT00795717|532065673|FG000|Phase I Followed by Wash Out x 4 Weeks|alcohol treatment|1|||
147523154|NCT00795717|532065674|FG001|Phase I Followed by Wash Out x 4 Weeks|alcohol treatment|0|||
147523155|NCT00795717|532065673|FG000|Phase I Followed by Wash Out x 4 Weeks|Adverse Event|1|||
147523156|NCT00795717|532065674|FG001|Phase I Followed by Wash Out x 4 Weeks|Adverse Event|1|||
147523157|NCT00795717|532065673|FG000|Phase I Followed by Wash Out x 4 Weeks|Lost to Follow-up|0|||
147523158|NCT00795717|532065674|FG001|Phase I Followed by Wash Out x 4 Weeks|Lost to Follow-up|1|||
147523159|NCT00795717|532065673|FG000|Phase II|too busy|0|||
147523160|NCT00795717|532065674|FG001|Phase II|too busy|1|||
147523161|NCT00410514|532065677|FG000|Overall Study|Adverse Event|2|||
147523162|NCT00410514|532065678|FG001|Overall Study|Adverse Event|2|||
147523163|NCT00410514|532065679|FG002|Overall Study|Adverse Event|2|||
147523164|NCT00410514|532065677|FG000|Overall Study|Protocol Violation|0|||
147523165|NCT00410514|532065678|FG001|Overall Study|Protocol Violation|1|||
147523166|NCT00410514|532065679|FG002|Overall Study|Protocol Violation|1|||
147523167|NCT00410514|532065677|FG000|Overall Study|Lost to Follow-up|0|||
147523168|NCT00410514|532065678|FG001|Overall Study|Lost to Follow-up|0|||
147523169|NCT00410514|532065679|FG002|Overall Study|Lost to Follow-up|2|||
147523170|NCT00410514|532065677|FG000|Overall Study|Non-compliant with study procedures|0|||
147523171|NCT00410514|532065678|FG001|Overall Study|Non-compliant with study procedures|0|||
147523172|NCT00410514|532065679|FG002|Overall Study|Non-compliant with study procedures|2|||
147523173|NCT02691468|532065680|FG000|Overall Study|Bronchial blocker use|2|||
147523174|NCT02691468|532065681|FG001|Overall Study|Bronchial blocker use|1|||
147523175|NCT02691468|532065680|FG000|Overall Study|Lost to Follow-up|2|||
147523176|NCT02691468|532065681|FG001|Overall Study|Lost to Follow-up|1|||
147523177|NCT02691468|532065680|FG000|Overall Study|Failure to advance FOB|2|||
147523178|NCT02691468|532065681|FG001|Overall Study|Failure to advance FOB|0|||
147523179|NCT01021423|532065683|FG000|Overall Study|Study terminated|4|||
147523180|NCT01021423|532065684|FG001|Overall Study|Study terminated|5|||
147523181|NCT02886338|532065685|FG000|Overall Study|Withdrawal by Subject|1|||
147523182|NCT00394654|532065686|FG000|Overall Study|Lost to Follow-up|1|||
147523183|NCT00394654|532065687|FG001|Overall Study|Lost to Follow-up|0|||
147523184|NCT00394654|532065686|FG000|Overall Study|PARTICIPANT LEFT STDUY REGION|1|||
147523185|NCT00394654|532065687|FG001|Overall Study|PARTICIPANT LEFT STDUY REGION|0|||
147523186|NCT03756285|532065688|FG000|Overall Study|Lost to Follow-up|0|||
147523187|NCT03756285|532065689|FG001|Overall Study|Lost to Follow-up|1|||
147523188|NCT03756285|532065688|FG000|Overall Study|Study discontinued due to Other (Protocol deviation:subject meets exclusion criteria 20.)|0|||
147523189|NCT03756285|532065689|FG001|Overall Study|Study discontinued due to Other (Protocol deviation:subject meets exclusion criteria 20.)|1|||
147523190|NCT03756285|532065688|FG000|Overall Study|Study discontinued due to Other (Dosing discontinued due to COVID-19)|3|||
147523191|NCT03756285|532065689|FG001|Overall Study|Study discontinued due to Other (Dosing discontinued due to COVID-19)|3|||
147523192|NCT00286156|532065694|FG000|Overall Study|Missed 12 month visit|0|||
147523193|NCT00286156|532065695|FG001|Overall Study|Missed 12 month visit|0|||
147523194|NCT00286156|532065696|FG002|Overall Study|Missed 12 month visit|1|||
147523195|NCT00286156|532065694|FG000|Overall Study|AE: pulmonary embolus|0|||
147523196|NCT00286156|532065695|FG001|Overall Study|AE: pulmonary embolus|1|||
147523197|NCT00286156|532065696|FG002|Overall Study|AE: pulmonary embolus|0|||
147523198|NCT00286156|532065694|FG000|Overall Study|AE: nephrotic-range proteinuruia|1|||
147523199|NCT00286156|532065695|FG001|Overall Study|AE: nephrotic-range proteinuruia|0|||
147523200|NCT00286156|532065696|FG002|Overall Study|AE: nephrotic-range proteinuruia|0|||
147523201|NCT00286156|532065694|FG000|Overall Study|AE: pneumonia|1|||
147523202|NCT00286156|532065695|FG001|Overall Study|AE: pneumonia|0|||
147523203|NCT00286156|532065696|FG002|Overall Study|AE: pneumonia|0|||
147523204|NCT06334055|532065697|FG000|Overall Study|Adverse Event|4|||
147523205|NCT06334055|532065697|FG000|Overall Study|Disqualified|72|||
147523206|NCT03458234|532065698|FG000|Overall Study|Withdrawal by Subject|1|||
147523207|NCT01021293|532065704|FG000|Overall Study|Serious Adverse Event|2|||
147523208|NCT01021293|532065705|FG001|Overall Study|Serious Adverse Event|1|||
147523209|NCT01021293|532065704|FG000|Overall Study|Adverse Event|2|||
147523210|NCT01021293|532065705|FG001|Overall Study|Adverse Event|1|||
147523211|NCT01021293|532065704|FG000|Overall Study|Withdrawal by Subject|1|||
147523212|NCT01021293|532065705|FG001|Overall Study|Withdrawal by Subject|3|||
147523213|NCT01021293|532065704|FG000|Overall Study|Migrated/moved from study area|6|||
147523214|NCT01021293|532065705|FG001|Overall Study|Migrated/moved from study area|18|||
147523215|NCT01021293|532065704|FG000|Overall Study|Lost to Follow-up|1|||
147523216|NCT01021293|532065705|FG001|Overall Study|Lost to Follow-up|1|||
147523217|NCT04728815|532065706|FG000|Overall Study|Lost to Follow-up|3|||
147523218|NCT04728815|532065707|FG001|Overall Study|Lost to Follow-up|0|||
147523219|NCT04728815|532065708|FG002|Overall Study|Lost to Follow-up|0|||
147523220|NCT04728815|532065709|FG003|Overall Study|Lost to Follow-up|1|||
147523221|NCT04728815|532065710|FG004|Overall Study|Lost to Follow-up|1|||
147523222|NCT04728815|532065711|FG005|Overall Study|Lost to Follow-up|0|||
147523223|NCT04728815|532065712|FG006|Overall Study|Lost to Follow-up|2|||
147523224|NCT04728815|532065713|FG007|Overall Study|Lost to Follow-up|0|||
147523225|NCT04728815|532065706|FG000|Overall Study|Physician Decision|0|||
147523226|NCT04728815|532065707|FG001|Overall Study|Physician Decision|0|||
147523227|NCT04728815|532065708|FG002|Overall Study|Physician Decision|1|||
147523228|NCT04728815|532065709|FG003|Overall Study|Physician Decision|0|||
147523229|NCT04728815|532065710|FG004|Overall Study|Physician Decision|0|||
147523230|NCT04728815|532065711|FG005|Overall Study|Physician Decision|0|||
147523231|NCT04728815|532065712|FG006|Overall Study|Physician Decision|0|||
147523232|NCT04728815|532065713|FG007|Overall Study|Physician Decision|0|||
147523233|NCT04728815|532065706|FG000|Overall Study|Treatment drop|0|||
147523234|NCT04728815|532065707|FG001|Overall Study|Treatment drop|2|||
147523235|NCT04728815|532065708|FG002|Overall Study|Treatment drop|1|||
147523236|NCT04728815|532065709|FG003|Overall Study|Treatment drop|0|||
147523237|NCT04728815|532065710|FG004|Overall Study|Treatment drop|3|||
147523238|NCT04728815|532065711|FG005|Overall Study|Treatment drop|1|||
147523239|NCT04728815|532065712|FG006|Overall Study|Treatment drop|3|||
147523240|NCT04728815|532065713|FG007|Overall Study|Treatment drop|0|||
147523241|NCT04728815|532065706|FG000|Overall Study|Study drop|0|||
147523242|NCT04728815|532065707|FG001|Overall Study|Study drop|3|||
147523243|NCT04728815|532065708|FG002|Overall Study|Study drop|3|||
147523244|NCT04728815|532065709|FG003|Overall Study|Study drop|0|||
147523245|NCT04728815|532065710|FG004|Overall Study|Study drop|0|||
147523246|NCT04728815|532065711|FG005|Overall Study|Study drop|0|||
147523247|NCT04728815|532065712|FG006|Overall Study|Study drop|7|||
147523248|NCT04728815|532065713|FG007|Overall Study|Study drop|0|||
147523249|NCT05315297|532065714|FG000|Overall Study|Lost to Follow-up|6|||
147523250|NCT05315297|532065715|FG001|Overall Study|Lost to Follow-up|4|||
147523251|NCT05315297|532065714|FG000|Overall Study|Withdrawal by Subject|0|||
147523252|NCT05315297|532065715|FG001|Overall Study|Withdrawal by Subject|1|||
147523253|NCT02033369|532066941|FG000|Overall Study|Physician Decision|1|||
147523254|NCT02033369|532066942|FG001|Overall Study|Physician Decision|2|||
147523255|NCT02033369|532066941|FG000|Overall Study|Not a good demographic match|0|||
147523256|NCT02033369|532066942|FG001|Overall Study|Not a good demographic match|2|||
147523257|NCT02033369|532066941|FG000|Overall Study|Withdrawal by Subject|1|||
147523258|NCT02033369|532066942|FG001|Overall Study|Withdrawal by Subject|1|||
147523259|NCT02033369|532066941|FG000|Overall Study|Lost to Follow-up|1|||
147523260|NCT02033369|532066942|FG001|Overall Study|Lost to Follow-up|0|||
147523261|NCT02033369|532066941|FG000|Overall Study|Protocol Violation|2|||
147523262|NCT02033369|532066942|FG001|Overall Study|Protocol Violation|0|||
147523263|NCT01503229|532066943|FG000|Overall Study|Withdrew consent|1|||
147523264|NCT04335929|532066944|FG000|Overall Study|Lost to Follow-up|10|||
147523265|NCT02534324|532066950|FG000|Overall Study|Protocol Violation|4|||
147523266|NCT02534324|532066951|FG001|Overall Study|Protocol Violation|1|||
147523267|NCT02534324|532066950|FG000|Overall Study|Lost to Follow-up|20|||
147523268|NCT02534324|532066951|FG001|Overall Study|Lost to Follow-up|7|||
147523269|NCT02534324|532066950|FG000|Overall Study|Adverse Event|1|||
147523270|NCT02534324|532066951|FG001|Overall Study|Adverse Event|0|||
147523271|NCT02889861|532066954|FG000|Overall Study|Ongoing in Survival Follow-up|2|||
147523272|NCT01041027|532066957|FG000|Overall Study|Withdrawal by Subject|2|||
147523273|NCT01041027|532066957|FG000|Overall Study|Protocol Violation|1|||
147523274|NCT01041027|532066957|FG000|Overall Study|Delayed Radiation Therapy|1|||
147523275|NCT01041027|532066957|FG000|Overall Study|Adverse Event|4|||
147523276|NCT02146274|532066959|FG000|Overall Study|Protocol Violation|73|||
147523277|NCT02039687|532066962|FG000|Overall Study|Adverse Event|0|||
147523278|NCT02039687|532066963|FG001|Overall Study|Adverse Event|0|||
147523279|NCT02039687|532066964|FG002|Overall Study|Adverse Event|1|||
147523280|NCT02039687|532066965|FG003|Overall Study|Adverse Event|0|||
147523281|NCT02039687|532066962|FG000|Overall Study|Withdrawal by Subject|0|||
147523282|NCT02039687|532066963|FG001|Overall Study|Withdrawal by Subject|1|||
147523283|NCT02039687|532066964|FG002|Overall Study|Withdrawal by Subject|0|||
147523284|NCT02039687|532066965|FG003|Overall Study|Withdrawal by Subject|0|||
147523285|NCT02039687|532066962|FG000|Overall Study|treatment assignment could not be confir|0|||
147523286|NCT02039687|532066963|FG001|Overall Study|treatment assignment could not be confir|0|||
147523287|NCT02039687|532066964|FG002|Overall Study|treatment assignment could not be confir|2|||
147523288|NCT02039687|532066965|FG003|Overall Study|treatment assignment could not be confir|0|||
147523289|NCT00532441|532066974|FG000|Overall Study|Death|1|||
147523290|NCT00532441|532066975|FG001|Overall Study|Death|0|||
147523291|NCT00443534|532066976|FG000|Overall Study|Lack of Efficacy|67|||
147523292|NCT00443534|532066976|FG000|Overall Study|Adverse Event|16|||
147523293|NCT00443534|532066976|FG000|Overall Study|Death|9|||
147523294|NCT00443534|532066976|FG000|Overall Study|Withdrawal by Subject|8|||
147523295|NCT00443534|532066976|FG000|Overall Study|Study Terminated by Sponsor|12|||
147523296|NCT00443534|532066976|FG000|Overall Study|Other|10|||
147523297|NCT00443534|532066976|FG000|Overall Study|Enrolled, Not Treated|1|||
147523298|NCT05466240|532066977|FG000|Overall Study|Adverse Event|1|||
147523299|NCT05466240|532066978|FG001|Overall Study|Adverse Event|0|||
147523300|NCT05466240|532066977|FG000|Overall Study|Withdrawal by Subject|1|||
147523301|NCT05466240|532066978|FG001|Overall Study|Withdrawal by Subject|0|||
147523302|NCT00303329|532066979|FG000|Overall Study|Adverse Event|7|||
147523303|NCT00303329|532066980|FG001|Overall Study|Adverse Event|14|||
147523304|NCT00303329|532066979|FG000|Overall Study|Abnormal Laboratory Values|0|||
147523305|NCT00303329|532066980|FG001|Overall Study|Abnormal Laboratory Values|1|||
147523306|NCT00303329|532066979|FG000|Overall Study|Unsatisfactory therapeutic effect|9|||
147523307|NCT00303329|532066980|FG001|Overall Study|Unsatisfactory therapeutic effect|2|||
147523308|NCT00303329|532066979|FG000|Overall Study|Condition no longer requires study drug|0|||
147523309|NCT00303329|532066980|FG001|Overall Study|Condition no longer requires study drug|8|||
147523310|NCT00303329|532066979|FG000|Overall Study|Protocol Violation|3|||
147523311|NCT00303329|532066980|FG001|Overall Study|Protocol Violation|0|||
147523312|NCT00303329|532066979|FG000|Overall Study|Withdrawal by Subject|9|||
147523313|NCT00303329|532066980|FG001|Overall Study|Withdrawal by Subject|15|||
147523314|NCT00303329|532066979|FG000|Overall Study|Lost to Follow-up|0|||
147523315|NCT00303329|532066980|FG001|Overall Study|Lost to Follow-up|1|||
147523316|NCT00303329|532066979|FG000|Overall Study|Administrative problems|1|||
147523317|NCT00303329|532066980|FG001|Overall Study|Administrative problems|0|||
147523318|NCT00303329|532066979|FG000|Overall Study|Death|2|||
147523319|NCT00303329|532066980|FG001|Overall Study|Death|12|||
147523320|NCT00303329|532066979|FG000|Overall Study|Stopped at end of core|3|||
147523321|NCT00303329|532066980|FG001|Overall Study|Stopped at end of core|9|||
147523322|NCT00303329|532066979|FG000|Overall Study|Stopped at end of extension 1|1|||
147523323|NCT00303329|532066980|FG001|Overall Study|Stopped at end of extension 1|0|||
147523324|NCT00413231|532066981|FG000|0 to 30-day Post Treatment|Death|5|||
147523325|NCT00413231|532066981|FG000|0 to 30-day Post Treatment|Intend to treat, but not implanted|3|||
147523326|NCT00413231|532066981|FG000|30-day to 365-day Post Treatment|Death|13|||
147523327|NCT00413231|532066981|FG000|365-day to 60-month Post Treatment|Death|36|||
147523328|NCT00413231|532066981|FG000|365-day to 60-month Post Treatment|Withdrawal by Subject|5|||
147523329|NCT00413231|532066981|FG000|365-day to 60-month Post Treatment|Lost to Follow-up|4|||
147523330|NCT00413231|532066981|FG000|365-day to 60-month Post Treatment|Exited after surgical conversion|1|||
147523331|NCT00626327|532066986|FG000|Overall Study|Withdrawal by Subject|21|||
147523332|NCT00626327|532066987|FG001|Overall Study|Withdrawal by Subject|29|||
147523333|NCT00626327|532066988|FG002|Overall Study|Withdrawal by Subject|30|||
147523334|NCT00626327|532066986|FG000|Overall Study|Adverse Event|1|||
147523335|NCT00626327|532066987|FG001|Overall Study|Adverse Event|0|||
147523336|NCT00626327|532066988|FG002|Overall Study|Adverse Event|0|||
147523337|NCT00626327|532066986|FG000|Overall Study|Lost to Follow-up|24|||
147523338|NCT00626327|532066987|FG001|Overall Study|Lost to Follow-up|21|||
147523339|NCT00626327|532066988|FG002|Overall Study|Lost to Follow-up|23|||
147523340|NCT00626327|532066986|FG000|Overall Study|Inappropriate enrollment|4|||
147523341|NCT00626327|532066987|FG001|Overall Study|Inappropriate enrollment|5|||
147523342|NCT00626327|532066988|FG002|Overall Study|Inappropriate enrollment|3|||
147523343|NCT00626327|532066986|FG000|Overall Study|Administrative Reason|2|||
147523344|NCT00626327|532066987|FG001|Overall Study|Administrative Reason|0|||
147523345|NCT00626327|532066988|FG002|Overall Study|Administrative Reason|6|||
147523346|NCT00626327|532066986|FG000|Overall Study|Protocol Violation|26|||
147523347|NCT00626327|532066987|FG001|Overall Study|Protocol Violation|4|||
147523348|NCT00626327|532066988|FG002|Overall Study|Protocol Violation|26|||
147523349|NCT01710709|532066989|FG000|Overall Study|Lost to Follow-up|29|||
147523350|NCT01710709|532066989|FG000|Overall Study|Adverse Event|48|||
147523351|NCT01710709|532066989|FG000|Overall Study|Participant met withdrawal criteria|33|||
147523352|NCT01710709|532066989|FG000|Overall Study|Participant withdrawn by investigator|2|||
147523353|NCT01710709|532066989|FG000|Overall Study|Withdrawal by Subject|53|||
147523354|NCT01710709|532066989|FG000|Overall Study|Protocol Violation|5|||
147523355|NCT01710709|532066989|FG000|Overall Study|Lack of Efficacy|3|||
147523356|NCT00542321|532066991|FG000|Overall Study|Death|0|||
147523357|NCT00542321|532066992|FG001|Overall Study|Death|1|||
147523358|NCT01731951|532066993|FG000|Overall Study|Documented Disease Progression|1|||
147523359|NCT01731951|532066994|FG001|Overall Study|Documented Disease Progression|0|||
147523360|NCT01731951|532066995|FG002|Overall Study|Documented Disease Progression|0|||
147523361|NCT01731951|532066996|FG003|Overall Study|Documented Disease Progression|0|||
147523362|NCT01731951|532066997|FG004|Overall Study|Documented Disease Progression|0|||
147523363|NCT01731951|532066998|FG005|Overall Study|Documented Disease Progression|0|||
147523364|NCT01731951|532066993|FG000|Overall Study|Lost to Follow-up|2|||
147523365|NCT01731951|532066994|FG001|Overall Study|Lost to Follow-up|0|||
147523366|NCT01731951|532066995|FG002|Overall Study|Lost to Follow-up|0|||
147523367|NCT01731951|532066996|FG003|Overall Study|Lost to Follow-up|1|||
147523368|NCT01731951|532066997|FG004|Overall Study|Lost to Follow-up|3|||
147523369|NCT01731951|532066998|FG005|Overall Study|Lost to Follow-up|1|||
147523370|NCT01731951|532066993|FG000|Overall Study|Withdrawal of Consent|1|||
147523371|NCT01731951|532066994|FG001|Overall Study|Withdrawal of Consent|0|||
147523372|NCT01731951|532066995|FG002|Overall Study|Withdrawal of Consent|0|||
147523373|NCT01731951|532066996|FG003|Overall Study|Withdrawal of Consent|0|||
147523374|NCT01731951|532066997|FG004|Overall Study|Withdrawal of Consent|0|||
147523375|NCT01731951|532066998|FG005|Overall Study|Withdrawal of Consent|2|||
147523376|NCT01731951|532066993|FG000|Overall Study|Death|13|||
147523377|NCT01731951|532066994|FG001|Overall Study|Death|15|||
147523378|NCT01731951|532066995|FG002|Overall Study|Death|9|||
147523379|NCT01731951|532066996|FG003|Overall Study|Death|8|||
147523380|NCT01731951|532066997|FG004|Overall Study|Death|9|||
147523381|NCT01731951|532066998|FG005|Overall Study|Death|6|||
147523382|NCT00253747|532066999|FG000|Overall Study|Lost to Follow-up|13|||
147523383|NCT00253747|532067000|FG001|Overall Study|Lost to Follow-up|14|||
147523384|NCT00253747|532066999|FG000|Overall Study|Withdrawal by Subject|10|||
147523385|NCT00253747|532067000|FG001|Overall Study|Withdrawal by Subject|11|||
147523386|NCT00253747|532066999|FG000|Overall Study|Administrative Discharge (1), Other (2)|1|||
147523387|NCT00253747|532067000|FG001|Overall Study|Administrative Discharge (1), Other (2)|2|||
147523388|NCT02452034|532067001|FG000|Overall Study|Adverse Event|0|||
147523389|NCT02452034|532067002|FG001|Overall Study|Adverse Event|0|||
147523390|NCT02452034|532067003|FG002|Overall Study|Adverse Event|0|||
147523391|NCT02452034|532067004|FG003|Overall Study|Adverse Event|0|||
147523392|NCT02452034|532067005|FG004|Overall Study|Adverse Event|0|||
147523393|NCT02452034|532067006|FG005|Overall Study|Adverse Event|1|||
147523394|NCT02452034|532067001|FG000|Overall Study|Death|0|||
147523395|NCT02452034|532067002|FG001|Overall Study|Death|0|||
147523396|NCT02452034|532067003|FG002|Overall Study|Death|0|||
147523397|NCT02452034|532067004|FG003|Overall Study|Death|0|||
147523398|NCT02452034|532067005|FG004|Overall Study|Death|1|||
147523399|NCT02452034|532067006|FG005|Overall Study|Death|1|||
147523400|NCT02452034|532067001|FG000|Overall Study|Physician Decision|0|||
147523401|NCT02452034|532067002|FG001|Overall Study|Physician Decision|1|||
147523402|NCT02452034|532067003|FG002|Overall Study|Physician Decision|1|||
147523403|NCT02452034|532067004|FG003|Overall Study|Physician Decision|0|||
147523404|NCT02452034|532067005|FG004|Overall Study|Physician Decision|0|||
147523405|NCT02452034|532067006|FG005|Overall Study|Physician Decision|0|||
147523406|NCT02452034|532067001|FG000|Overall Study|Protocol Violation|0|||
147523407|NCT02452034|532067002|FG001|Overall Study|Protocol Violation|0|||
147523408|NCT02452034|532067003|FG002|Overall Study|Protocol Violation|0|||
147523409|NCT02452034|532067004|FG003|Overall Study|Protocol Violation|0|||
147523410|NCT02452034|532067005|FG004|Overall Study|Protocol Violation|0|||
147523411|NCT02452034|532067006|FG005|Overall Study|Protocol Violation|1|||
147523412|NCT02452034|532067001|FG000|Overall Study|Screen Failure|1|||
147523413|NCT02452034|532067002|FG001|Overall Study|Screen Failure|0|||
147523414|NCT02452034|532067003|FG002|Overall Study|Screen Failure|0|||
147523415|NCT02452034|532067004|FG003|Overall Study|Screen Failure|1|||
147523416|NCT02452034|532067005|FG004|Overall Study|Screen Failure|0|||
147523417|NCT02452034|532067006|FG005|Overall Study|Screen Failure|0|||
147523418|NCT02452034|532067001|FG000|Overall Study|Withdrawn by Parent/Guardian|1|||
147523419|NCT02452034|532067002|FG001|Overall Study|Withdrawn by Parent/Guardian|0|||
147523420|NCT02452034|532067003|FG002|Overall Study|Withdrawn by Parent/Guardian|0|||
147523421|NCT02452034|532067004|FG003|Overall Study|Withdrawn by Parent/Guardian|0|||
147523422|NCT02452034|532067005|FG004|Overall Study|Withdrawn by Parent/Guardian|0|||
147523423|NCT02452034|532067006|FG005|Overall Study|Withdrawn by Parent/Guardian|0|||
147523424|NCT00672139|532067008|FG000|Overall Study|Death|14|||
147523425|NCT00672139|532067009|FG001|Overall Study|Death|23|||
147523426|NCT00672139|532067008|FG000|Overall Study|Withdrawal by Subject|2|||
147523427|NCT00672139|532067009|FG001|Overall Study|Withdrawal by Subject|11|||
147523428|NCT00672139|532067008|FG000|Overall Study|Adverse Event|4|||
147523429|NCT00672139|532067009|FG001|Overall Study|Adverse Event|7|||
147523430|NCT00672139|532067008|FG000|Overall Study|Physician Decision|2|||
147523431|NCT00672139|532067009|FG001|Overall Study|Physician Decision|0|||
147523432|NCT00672139|532067008|FG000|Overall Study|Lack of Efficacy|4|||
147523433|NCT00672139|532067009|FG001|Overall Study|Lack of Efficacy|1|||
147523434|NCT00672139|532067008|FG000|Overall Study|Protocol Violation|1|||
147523435|NCT00672139|532067009|FG001|Overall Study|Protocol Violation|1|||
147523436|NCT00672139|532067008|FG000|Overall Study|hospice discharge, caregiver requests|3|||
147523437|NCT00672139|532067009|FG001|Overall Study|hospice discharge, caregiver requests|2|||
147523438|NCT00256204|532067019|FG000|Overall Study|Adverse Event|10|||
147523439|NCT00256204|532067020|FG001|Overall Study|Adverse Event|14|||
147523440|NCT00256204|532067021|FG002|Overall Study|Adverse Event|16|||
147523441|NCT00256204|532067022|FG003|Overall Study|Adverse Event|14|||
147523442|NCT00256204|532067019|FG000|Overall Study|Death|0|||
147523443|NCT00256204|532067020|FG001|Overall Study|Death|1|||
147523444|NCT00256204|532067021|FG002|Overall Study|Death|0|||
147523445|NCT00256204|532067022|FG003|Overall Study|Death|0|||
147523446|NCT00256204|532067019|FG000|Overall Study|Lost to Follow-up|1|||
147523447|NCT00256204|532067020|FG001|Overall Study|Lost to Follow-up|1|||
147523448|NCT00256204|532067021|FG002|Overall Study|Lost to Follow-up|1|||
147523449|NCT00256204|532067022|FG003|Overall Study|Lost to Follow-up|2|||
147523450|NCT00256204|532067019|FG000|Overall Study|Protocol Violation|1|||
147523451|NCT00256204|532067020|FG001|Overall Study|Protocol Violation|0|||
147523452|NCT00256204|532067021|FG002|Overall Study|Protocol Violation|2|||
147523453|NCT00256204|532067022|FG003|Overall Study|Protocol Violation|1|||
147523454|NCT00256204|532067019|FG000|Overall Study|Physician Decision|0|||
147523455|NCT00256204|532067020|FG001|Overall Study|Physician Decision|0|||
147523456|NCT00256204|532067021|FG002|Overall Study|Physician Decision|1|||
147523457|NCT00256204|532067022|FG003|Overall Study|Physician Decision|2|||
147523458|NCT00256204|532067019|FG000|Overall Study|Withdrawal by Subject|17|||
147523459|NCT00256204|532067020|FG001|Overall Study|Withdrawal by Subject|6|||
147523460|NCT00256204|532067021|FG002|Overall Study|Withdrawal by Subject|7|||
147523461|NCT00256204|532067022|FG003|Overall Study|Withdrawal by Subject|5|||
147523462|NCT00256204|532067019|FG000|Overall Study|Need for additional prohibited treatment|38|||
147523463|NCT00256204|532067020|FG001|Overall Study|Need for additional prohibited treatment|28|||
147523464|NCT00256204|532067021|FG002|Overall Study|Need for additional prohibited treatment|27|||
147523465|NCT00256204|532067022|FG003|Overall Study|Need for additional prohibited treatment|25|||
147523466|NCT02177942|532067023|FG000|Overall Study|Adverse Event|1|||
147523467|NCT02177942|532067024|FG001|Overall Study|Adverse Event|0|||
147523468|NCT02177942|532067023|FG000|Overall Study|Lost to Follow-up|1|||
147523469|NCT02177942|532067024|FG001|Overall Study|Lost to Follow-up|1|||
147523470|NCT02177942|532067023|FG000|Overall Study|Protocol Violation|4|||
147523471|NCT02177942|532067024|FG001|Overall Study|Protocol Violation|6|||
147523472|NCT02177942|532067023|FG000|Overall Study|Withdrawal by Subject|71|||
147523473|NCT02177942|532067024|FG001|Overall Study|Withdrawal by Subject|81|||
147523474|NCT01234337|532067025|FG000|Overall Study|Adverse Event|58|||
147523475|NCT01234337|532067026|FG001|Overall Study|Adverse Event|21|||
147523476|NCT01234337|532067025|FG000|Overall Study|Disease progression/recurrence/relapse|181|||
147523477|NCT01234337|532067026|FG001|Overall Study|Disease progression/recurrence/relapse|223|||
147523478|NCT01234337|532067025|FG000|Overall Study|Investi. decision not protocol driven|5|||
147523479|NCT01234337|532067026|FG001|Overall Study|Investi. decision not protocol driven|6|||
147523480|NCT01234337|532067025|FG000|Overall Study|Non-compliant with study medication|3|||
147523481|NCT01234337|532067026|FG001|Overall Study|Non-compliant with study medication|2|||
147523482|NCT01234337|532067025|FG000|Overall Study|Randomized but not treated|6|||
147523483|NCT01234337|532067026|FG001|Overall Study|Randomized but not treated|4|||
147523484|NCT01234337|532067025|FG000|Overall Study|Lost to Follow-up|0|||
147523485|NCT01234337|532067026|FG001|Overall Study|Lost to Follow-up|1|||
147523486|NCT01234337|532067025|FG000|Overall Study|Protocol Violation|2|||
147523487|NCT01234337|532067026|FG001|Overall Study|Protocol Violation|3|||
147523488|NCT01234337|532067025|FG000|Overall Study|Withdrawal by Subject|11|||
147523489|NCT01234337|532067026|FG001|Overall Study|Withdrawal by Subject|9|||
147523490|NCT01234337|532067025|FG000|Overall Study|Death|0|||
147523491|NCT01234337|532067026|FG001|Overall Study|Death|1|||
147523492|NCT01234337|532067025|FG000|Overall Study|Switch to commercial drug|0|||
147523493|NCT01234337|532067026|FG001|Overall Study|Switch to commercial drug|1|||
147523494|NCT01142791|532067041|FG000|Overall Study|Alternative Treatment|1|||
147523495|NCT01142791|532067042|FG001|Overall Study|Alternative Treatment|0|||
147523496|NCT01142791|532067041|FG000|Overall Study|Lost to Follow-up|1|||
147523497|NCT01142791|532067042|FG001|Overall Study|Lost to Follow-up|0|||
147523498|NCT01142791|532067041|FG000|Overall Study|Withdrawal by Subject|5|||
147523499|NCT01142791|532067042|FG001|Overall Study|Withdrawal by Subject|0|||
147523500|NCT01142791|532067041|FG000|Overall Study|Received only 1 sonication|0|||
147523501|NCT01142791|532067042|FG001|Overall Study|Received only 1 sonication|6|||
147523502|NCT05375838|532067045|FG000|Overall Study|Other|0|||
147523503|NCT05375838|532067046|FG001|Overall Study|Other|0|||
147523504|NCT05375838|532067047|FG002|Overall Study|Other|0|||
147523505|NCT05375838|532067048|FG003|Overall Study|Other|1|||
147523506|NCT05375838|532067049|FG004|Overall Study|Other|1|||
147523507|NCT05375838|532067050|FG005|Overall Study|Other|0|||
147523508|NCT05375838|532067045|FG000|Overall Study|Withdrawal by Subject|2|||
147523509|NCT05375838|532067046|FG001|Overall Study|Withdrawal by Subject|1|||
147523510|NCT05375838|532067047|FG002|Overall Study|Withdrawal by Subject|3|||
147523511|NCT05375838|532067048|FG003|Overall Study|Withdrawal by Subject|2|||
147523512|NCT05375838|532067049|FG004|Overall Study|Withdrawal by Subject|2|||
147523513|NCT05375838|532067050|FG005|Overall Study|Withdrawal by Subject|0|||
147523514|NCT05375838|532067045|FG000|Overall Study|Protocol Violation|0|||
147523515|NCT05375838|532067046|FG001|Overall Study|Protocol Violation|0|||
147523516|NCT05375838|532067047|FG002|Overall Study|Protocol Violation|0|||
147523517|NCT05375838|532067048|FG003|Overall Study|Protocol Violation|0|||
147523518|NCT05375838|532067049|FG004|Overall Study|Protocol Violation|1|||
147523519|NCT05375838|532067050|FG005|Overall Study|Protocol Violation|0|||
147523520|NCT05375838|532067045|FG000|Overall Study|Physician Decision|0|||
147523521|NCT05375838|532067046|FG001|Overall Study|Physician Decision|1|||
147523522|NCT05375838|532067047|FG002|Overall Study|Physician Decision|0|||
147523523|NCT05375838|532067048|FG003|Overall Study|Physician Decision|0|||
147523524|NCT05375838|532067049|FG004|Overall Study|Physician Decision|0|||
147523525|NCT05375838|532067050|FG005|Overall Study|Physician Decision|1|||
147523526|NCT05375838|532067045|FG000|Overall Study|Lost to Follow-up|2|||
147523527|NCT05375838|532067046|FG001|Overall Study|Lost to Follow-up|7|||
147523528|NCT05375838|532067047|FG002|Overall Study|Lost to Follow-up|0|||
147523529|NCT05375838|532067048|FG003|Overall Study|Lost to Follow-up|4|||
147523530|NCT05375838|532067049|FG004|Overall Study|Lost to Follow-up|2|||
147523531|NCT05375838|532067050|FG005|Overall Study|Lost to Follow-up|3|||
147523532|NCT00866606|532067051|FG000|Overall Study|Lost to Follow-up|3|||
147523533|NCT00866606|532067051|FG000|Overall Study|Adverse Event|1|||
147523534|NCT00392210|532067055|FG000|First Voiding Trial|Physician Decision|2|||
147523535|NCT00392210|532067056|FG001|First Voiding Trial|Physician Decision|2|||
147523536|NCT01987609|532067057|FG000|Overall Study|Adverse Event|1|||
147523537|NCT01279954|532067058|FG000|Overall Study|Lack of Efficacy|3|||
147523538|NCT01279954|532067059|FG001|Overall Study|Lack of Efficacy|4|||
147523539|NCT01385098|532067064|FG000|Overall Study|Adverse Event|10|||
147523540|NCT01385098|532067064|FG000|Overall Study|Lost to Follow-up|4|||
147523541|NCT00122317|532067065|FG000|Overall Study|Death|3|||
147523542|NCT00122317|532067065|FG000|Overall Study|Adverse Event|4|||
147523543|NCT00122317|532067065|FG000|Overall Study|Physician Decision|2|||
147523544|NCT00122317|532067065|FG000|Overall Study|patient non-compliance|1|||
147523545|NCT00122317|532067065|FG000|Overall Study|Withdrawal by Subject|1|||
147523546|NCT01084096|532069688|FG000|Overall Study|Lost to Follow-up|1501|||
147523547|NCT01084096|532069689|FG001|Overall Study|Lost to Follow-up|1833|||
147523548|NCT01084096|532069688|FG000|Overall Study|Withdrawal by Subject|3|||
147523549|NCT01084096|532069689|FG001|Overall Study|Withdrawal by Subject|0|||
147523550|NCT01084096|532069688|FG000|Overall Study|Woman had a miscarriage|21|||
147523551|NCT01084096|532069689|FG001|Overall Study|Woman had a miscarriage|17|||
147523552|NCT05604781|532069690|FG000|Overall Study|Lost to Follow-up|3|||
147523553|NCT05604781|532069690|FG000|Overall Study|Adverse Event|1|||
147523554|NCT01864746|532069701|FG000|Overall Study|Disease recurrence|25|||
147523555|NCT01864746|532069702|FG001|Overall Study|Disease recurrence|40|||
147523556|NCT01864746|532069701|FG000|Overall Study|Second primary invasive nonbreast|2|||
147523557|NCT01864746|532069702|FG001|Overall Study|Second primary invasive nonbreast|3|||
147523558|NCT01864746|532069701|FG000|Overall Study|Death|2|||
147523559|NCT01864746|532069702|FG001|Overall Study|Death|1|||
147523560|NCT01864746|532069701|FG000|Overall Study|Adverse Event|33|||
147523561|NCT01864746|532069702|FG001|Overall Study|Adverse Event|5|||
147523562|NCT01864746|532069701|FG000|Overall Study|Withdrawal by Subject|56|||
147523563|NCT01864746|532069702|FG001|Overall Study|Withdrawal by Subject|41|||
147523564|NCT01864746|532069701|FG000|Overall Study|Physician Decision|5|||
147523565|NCT01864746|532069702|FG001|Overall Study|Physician Decision|6|||
147523566|NCT01005966|532069703|FG000|Treatment Period 1 (14 Days)|Adverse Event|1|||
147523567|NCT01005966|532069704|FG001|Treatment Period 1 (14 Days)|Adverse Event|0|||
147523568|NCT01005966|532069705|FG002|Treatment Period 1 (14 Days)|Adverse Event|0|||
147523569|NCT01005966|532069706|FG003|Treatment Period 1 (14 Days)|Adverse Event|0|||
147523570|NCT01005966|532069707|FG004|Treatment Period 1 (14 Days)|Adverse Event|0|||
147523571|NCT01005966|532069703|FG000|Treatment Period 1 (14 Days)|Protocol Violation|1|||
147523572|NCT01005966|532069704|FG001|Treatment Period 1 (14 Days)|Protocol Violation|0|||
147523573|NCT01005966|532069705|FG002|Treatment Period 1 (14 Days)|Protocol Violation|1|||
147523574|NCT01005966|532069706|FG003|Treatment Period 1 (14 Days)|Protocol Violation|0|||
147523575|NCT01005966|532069707|FG004|Treatment Period 1 (14 Days)|Protocol Violation|0|||
147523576|NCT01005966|532069703|FG000|Washout Period 1 (4 Days)|Withdrawal by Subject|0|||
147523577|NCT01005966|532069704|FG001|Washout Period 1 (4 Days)|Withdrawal by Subject|0|||
147523578|NCT01005966|532069705|FG002|Washout Period 1 (4 Days)|Withdrawal by Subject|0|||
147523579|NCT01005966|532069706|FG003|Washout Period 1 (4 Days)|Withdrawal by Subject|1|||
147523580|NCT01005966|532069707|FG004|Washout Period 1 (4 Days)|Withdrawal by Subject|0|||
147523581|NCT01005966|532069703|FG000|Treatment Period 2 (14 Days)|Adverse Event|0|||
147523582|NCT01005966|532069704|FG001|Treatment Period 2 (14 Days)|Adverse Event|1|||
147523583|NCT01005966|532069705|FG002|Treatment Period 2 (14 Days)|Adverse Event|1|||
147523584|NCT01005966|532069706|FG003|Treatment Period 2 (14 Days)|Adverse Event|0|||
147523585|NCT01005966|532069707|FG004|Treatment Period 2 (14 Days)|Adverse Event|0|||
147523586|NCT01005966|532069703|FG000|Treatment Period 2 (14 Days)|Protocol Violation|0|||
147523587|NCT01005966|532069704|FG001|Treatment Period 2 (14 Days)|Protocol Violation|0|||
147523588|NCT01005966|532069705|FG002|Treatment Period 2 (14 Days)|Protocol Violation|0|||
147523589|NCT01005966|532069706|FG003|Treatment Period 2 (14 Days)|Protocol Violation|1|||
147523590|NCT01005966|532069707|FG004|Treatment Period 2 (14 Days)|Protocol Violation|0|||
147523591|NCT01005966|532069703|FG000|Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
147523592|NCT01005966|532069704|FG001|Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
147523593|NCT01005966|532069705|FG002|Treatment Period 2 (14 Days)|Withdrawal by Subject|1|||
147523594|NCT01005966|532069706|FG003|Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
147523595|NCT01005966|532069707|FG004|Treatment Period 2 (14 Days)|Withdrawal by Subject|0|||
147523596|NCT01005966|532069703|FG000|Treatment Period 3 (14 Days)|Protocol Violation|0|||
147523597|NCT01005966|532069704|FG001|Treatment Period 3 (14 Days)|Protocol Violation|1|||
147523598|NCT01005966|532069705|FG002|Treatment Period 3 (14 Days)|Protocol Violation|0|||
147523599|NCT01005966|532069706|FG003|Treatment Period 3 (14 Days)|Protocol Violation|0|||
147523600|NCT01005966|532069707|FG004|Treatment Period 3 (14 Days)|Protocol Violation|1|||
147523601|NCT01005966|532069703|FG000|Treatment Period 4 (14 Days)|Protocol Violation|0|||
147523602|NCT01005966|532069704|FG001|Treatment Period 4 (14 Days)|Protocol Violation|1|||
147523603|NCT01005966|532069705|FG002|Treatment Period 4 (14 Days)|Protocol Violation|0|||
147523604|NCT01005966|532069706|FG003|Treatment Period 4 (14 Days)|Protocol Violation|0|||
147523605|NCT01005966|532069707|FG004|Treatment Period 4 (14 Days)|Protocol Violation|0|||
147523606|NCT01005966|532069703|FG000|Treatment Period 4 (14 Days)|Other Reason|0|||
147523607|NCT01005966|532069704|FG001|Treatment Period 4 (14 Days)|Other Reason|0|||
147523608|NCT01005966|532069705|FG002|Treatment Period 4 (14 Days)|Other Reason|0|||
147523609|NCT01005966|532069706|FG003|Treatment Period 4 (14 Days)|Other Reason|0|||
147523610|NCT01005966|532069707|FG004|Treatment Period 4 (14 Days)|Other Reason|1|||
147523611|NCT01451203|532069708|FG000|Double-blind Treatment Period|Did not receive treatment|1|||
147523612|NCT01451203|532069709|FG001|Double-blind Treatment Period|Did not receive treatment|2|||
147523613|NCT01451203|532069708|FG000|Double-blind Treatment Period|Consent Withdrawn|3|||
147523614|NCT01451203|532069709|FG001|Double-blind Treatment Period|Consent Withdrawn|2|||
147523615|NCT01451203|532069708|FG000|Double-blind Treatment Period|Lack of Efficacy|71|||
147523616|NCT01451203|532069709|FG001|Double-blind Treatment Period|Lack of Efficacy|36|||
147523617|NCT01451203|532069708|FG000|Double-blind Treatment Period|HBV-DNA positive (during the DB Period)|0|||
147523618|NCT01451203|532069709|FG001|Double-blind Treatment Period|HBV-DNA positive (during the DB Period)|1|||
147523619|NCT01451203|532069708|FG000|Double-blind Treatment Period|Adverse Event|6|||
147523620|NCT01451203|532069709|FG001|Double-blind Treatment Period|Adverse Event|9|||
147523621|NCT01451203|532069708|FG000|Double-blind Treatment Period|Missing study medication ≥6 times|1|||
147523622|NCT01451203|532069709|FG001|Double-blind Treatment Period|Missing study medication ≥6 times|0|||
147523623|NCT01451203|532069708|FG000|Double-blind Treatment Period|Violation of eligibility criteria|1|||
147523624|NCT01451203|532069709|FG001|Double-blind Treatment Period|Violation of eligibility criteria|0|||
147418236|NCT02297139|531694616|FG000|Overall Study|Maximum clinical benefit|1|||
147418237|NCT02297139|531694617|FG001|Overall Study|Maximum clinical benefit|0|||
147523625|NCT01451203|532069708|FG000|Double-blind Treatment Period|Investigator decision|2|||
147418238|NCT02297139|531694616|FG000|Overall Study|Administrative reason by sponsor|0|||
147418239|NCT02297139|531694617|FG001|Overall Study|Administrative reason by sponsor|2|||
147418240|NCT02297139|531694616|FG000|Overall Study|Other reasons|0|||
147418241|NCT02297139|531694617|FG001|Overall Study|Other reasons|8|||
147418242|NCT02101385|531694620|FG000|Study Treatment|Disease Progression|9|||
147418243|NCT02101385|531694621|FG001|Study Treatment|Disease Progression|3|||
147418244|NCT02101385|531694620|FG000|Study Treatment|Alternative therapy|0|||
147418245|NCT02101385|531694621|FG001|Study Treatment|Alternative therapy|1|||
147523626|NCT01451203|532069709|FG001|Double-blind Treatment Period|Investigator decision|0|||
147523627|NCT01451203|532069708|FG000|Post-treatment Period|Consent withdrawn|2|||
147523628|NCT01451203|532069709|FG001|Post-treatment Period|Consent withdrawn|4|||
147523629|NCT01451203|532069708|FG000|Post-treatment Period|Lack of Efficacy|12|||
147523630|NCT01451203|532069709|FG001|Post-treatment Period|Lack of Efficacy|28|||
147523631|NCT01451203|532069708|FG000|Post-treatment Period|Adverse Event|0|||
147523632|NCT01451203|532069709|FG001|Post-treatment Period|Adverse Event|1|||
147523633|NCT01451203|532069708|FG000|Post-treatment Period|Investigator decision|0|||
147523634|NCT01451203|532069709|FG001|Post-treatment Period|Investigator decision|1|||
147523635|NCT02493712|532069710|FG000|Overall Study|Withdrawal by Subject|1|||
147523636|NCT02493712|532069711|FG001|Overall Study|Withdrawal by Subject|0|||
147523637|NCT02493712|532069712|FG002|Overall Study|Withdrawal by Subject|2|||
147523638|NCT02493712|532069710|FG000|Overall Study|Protocol Violation|0|||
147523639|NCT02493712|532069711|FG001|Overall Study|Protocol Violation|0|||
147523640|NCT02493712|532069712|FG002|Overall Study|Protocol Violation|1|||
147523641|NCT02493712|532069710|FG000|Overall Study|Lost to Follow-up|1|||
147523642|NCT02493712|532069711|FG001|Overall Study|Lost to Follow-up|0|||
147523643|NCT02493712|532069712|FG002|Overall Study|Lost to Follow-up|0|||
147523644|NCT02493712|532069710|FG000|Overall Study|Physician Decision|0|||
147523645|NCT02493712|532069711|FG001|Overall Study|Physician Decision|1|||
147523646|NCT02493712|532069712|FG002|Overall Study|Physician Decision|0|||
147523647|NCT02493712|532069710|FG000|Overall Study|Lack of Efficacy|0|||
147523648|NCT02493712|532069711|FG001|Overall Study|Lack of Efficacy|5|||
147523649|NCT02493712|532069712|FG002|Overall Study|Lack of Efficacy|3|||
147523650|NCT02528643|532069713|FG000|DB (Median Duration up to 14.65 Months)|Adverse Event|5|||
147523651|NCT02528643|532069714|FG001|DB (Median Duration up to 14.65 Months)|Adverse Event|8|||
147523652|NCT02528643|532069713|FG000|DB (Median Duration up to 14.65 Months)|Death|1|||
147523653|NCT02528643|532069714|FG001|DB (Median Duration up to 14.65 Months)|Death|6|||
147523654|NCT02528643|532069713|FG000|DB (Median Duration up to 14.65 Months)|Lost to Follow-up|0|||
147523655|NCT02528643|532069714|FG001|DB (Median Duration up to 14.65 Months)|Lost to Follow-up|1|||
147523656|NCT02528643|532069713|FG000|DB (Median Duration up to 14.65 Months)|Progressive Disease|44|||
147523657|NCT02528643|532069714|FG001|DB (Median Duration up to 14.65 Months)|Progressive Disease|82|||
147523658|NCT02528643|532069713|FG000|DB (Median Duration up to 14.65 Months)|Withdrawal by Subject|2|||
147523659|NCT02528643|532069714|FG001|DB (Median Duration up to 14.65 Months)|Withdrawal by Subject|8|||
147523660|NCT02528643|532069713|FG000|DB (Median Duration up to 14.65 Months)|Miscellaneous|3|||
147523661|NCT02528643|532069714|FG001|DB (Median Duration up to 14.65 Months)|Miscellaneous|5|||
147523662|NCT02528643|532069713|FG000|OL (Median Duration up to 27.56 Months)|Progressive Disease|0|||
147523663|NCT02528643|532069714|FG001|OL (Median Duration up to 27.56 Months)|Progressive Disease|1|||
147523664|NCT01640353|532069717|FG000|Overall Study|Withdrew prior to treatment|10|||
147418246|NCT02101385|531694620|FG000|Study Treatment|No treatment, per protocol criteria|0|||
147523665|NCT01640353|532069717|FG000|Overall Study|Withdrawn from analysis at term site|12|||
147523666|NCT01640353|532069717|FG000|Overall Study|Withdrawal by Subject|5|||
147523667|NCT01640353|532069717|FG000|Overall Study|Death|2|||
147523668|NCT01640353|532069717|FG000|Overall Study|Early site termination|3|||
147523669|NCT01640353|532069717|FG000|Overall Study|Lost to Follow-up|12|||
147523670|NCT01640353|532069717|FG000|Overall Study|Physician Decision|1|||
147523671|NCT01524900|532069718|FG000|Overall Study|Lost to Follow-up|3|||
147523672|NCT01524900|532069719|FG001|Overall Study|Lost to Follow-up|12|||
147523673|NCT01524900|532069720|FG002|Overall Study|Lost to Follow-up|1|||
147523674|NCT01524900|532069721|FG003|Overall Study|Lost to Follow-up|0|||
147523675|NCT01524900|532069722|FG004|Overall Study|Lost to Follow-up|0|||
147523676|NCT01524900|532069718|FG000|Overall Study|Other reason than stated above|1|||
147523677|NCT01524900|532069719|FG001|Overall Study|Other reason than stated above|1|||
147523678|NCT01524900|532069720|FG002|Overall Study|Other reason than stated above|0|||
147523679|NCT01524900|532069721|FG003|Overall Study|Other reason than stated above|0|||
147523680|NCT01524900|532069722|FG004|Overall Study|Other reason than stated above|0|||
147523681|NCT01524900|532069718|FG000|Overall Study|No reason documented|2|||
147523682|NCT01524900|532069719|FG001|Overall Study|No reason documented|1|||
147523683|NCT01524900|532069720|FG002|Overall Study|No reason documented|0|||
147523684|NCT01524900|532069721|FG003|Overall Study|No reason documented|1|||
147523685|NCT01524900|532069722|FG004|Overall Study|No reason documented|0|||
147523686|NCT03758612|532069723|FG000|Washout Period|Withdrawal by Subject|0|||
147523687|NCT03758612|532069724|FG001|Washout Period|Withdrawal by Subject|0|||
147523688|NCT03758612|532069725|FG002|Washout Period|Withdrawal by Subject|2|||
147523689|NCT03758612|532069726|FG003|Washout Period|Withdrawal by Subject|0|||
147523690|NCT03758612|532069727|FG004|Washout Period|Withdrawal by Subject|0|||
147523691|NCT03758612|532069728|FG005|Washout Period|Withdrawal by Subject|0|||
147523692|NCT03758612|532069729|FG006|Washout Period|Withdrawal by Subject|0|||
147523693|NCT03758612|532069730|FG007|Washout Period|Withdrawal by Subject|0|||
147523694|NCT03758612|532069731|FG008|Washout Period|Withdrawal by Subject|0|||
147523695|NCT03758612|532069732|FG009|Washout Period|Withdrawal by Subject|0|||
147523696|NCT03758612|532069733|FG010|Washout Period|Withdrawal by Subject|0|||
147523697|NCT03758612|532069734|FG011|Washout Period|Withdrawal by Subject|0|||
147418247|NCT02101385|531694621|FG001|Study Treatment|No treatment, per protocol criteria|4|||
147418248|NCT02101385|531694620|FG000|Study Treatment|Patient Non compliance|0|||
147418249|NCT02101385|531694621|FG001|Study Treatment|Patient Non compliance|2|||
147418250|NCT02101385|531694620|FG000|Study Treatment|Withdrawal by Subject|5|||
147418251|NCT02101385|531694621|FG001|Study Treatment|Withdrawal by Subject|2|||
147418252|NCT02101385|531694620|FG000|Study Treatment|screen failure|1|||
147418253|NCT02101385|531694621|FG001|Study Treatment|screen failure|0|||
147418254|NCT02101385|531694620|FG000|Study Treatment|AE/Side Effects/Complications|8|||
147418255|NCT02101385|531694621|FG001|Study Treatment|AE/Side Effects/Complications|0|||
147418256|NCT02101385|531694620|FG000|Study Treatment|Lost to Follow-up|1|||
147418257|NCT02101385|531694621|FG001|Study Treatment|Lost to Follow-up|0|||
147523698|NCT03758612|532069723|FG000|Period 2|Protocol Violation|0|||
147523699|NCT03758612|532069724|FG001|Period 2|Protocol Violation|0|||
147523700|NCT03758612|532069725|FG002|Period 2|Protocol Violation|0|||
147523701|NCT03758612|532069726|FG003|Period 2|Protocol Violation|0|||
147523702|NCT03758612|532069727|FG004|Period 2|Protocol Violation|1|||
147523703|NCT03758612|532069728|FG005|Period 2|Protocol Violation|0|||
147523704|NCT03758612|532069729|FG006|Period 2|Protocol Violation|0|||
147523705|NCT03758612|532069730|FG007|Period 2|Protocol Violation|0|||
147523706|NCT03758612|532069731|FG008|Period 2|Protocol Violation|0|||
147523707|NCT03758612|532069732|FG009|Period 2|Protocol Violation|0|||
147523708|NCT03758612|532069733|FG010|Period 2|Protocol Violation|0|||
147523709|NCT03758612|532069734|FG011|Period 2|Protocol Violation|0|||
147523710|NCT04450394|532069735|FG000|Overall Study|Adverse Event|2|||
147523711|NCT04450394|532069736|FG001|Overall Study|Adverse Event|0|||
147523712|NCT04450394|532069737|FG002|Overall Study|Adverse Event|0|||
147523713|NCT04450394|532069735|FG000|Overall Study|Death|0|||
147523714|NCT04450394|532069736|FG001|Overall Study|Death|1|||
147523715|NCT04450394|532069737|FG002|Overall Study|Death|0|||
147523716|NCT04450394|532069735|FG000|Overall Study|Lost to Follow-up|0|||
147523717|NCT04450394|532069736|FG001|Overall Study|Lost to Follow-up|3|||
147523718|NCT04450394|532069737|FG002|Overall Study|Lost to Follow-up|0|||
147523719|NCT04450394|532069735|FG000|Overall Study|Physician Decision|0|||
147523720|NCT04450394|532069736|FG001|Overall Study|Physician Decision|1|||
147523721|NCT04450394|532069737|FG002|Overall Study|Physician Decision|0|||
147523722|NCT04450394|532069735|FG000|Overall Study|Protocol Violation|2|||
147523723|NCT04450394|532069736|FG001|Overall Study|Protocol Violation|0|||
147523724|NCT04450394|532069737|FG002|Overall Study|Protocol Violation|0|||
147523725|NCT04450394|532069735|FG000|Overall Study|Withdrawal by Subject|6|||
147523726|NCT04450394|532069736|FG001|Overall Study|Withdrawal by Subject|9|||
147523727|NCT04450394|532069737|FG002|Overall Study|Withdrawal by Subject|0|||
147523728|NCT03812224|532069747|FG000|Double-blind Treatment Period|Withdrawal by Subject|4|||
147523729|NCT03812224|532069748|FG001|Double-blind Treatment Period|Withdrawal by Subject|2|||
147523730|NCT03812224|532069747|FG000|Double-blind Treatment Period|Decision by Sponsor|0|||
147523731|NCT03812224|532069748|FG001|Double-blind Treatment Period|Decision by Sponsor|1|||
147523732|NCT03812224|532069747|FG000|Open-label Treatment Period|Withdrawal by Subject|2|||
147523733|NCT03812224|532069748|FG001|Open-label Treatment Period|Withdrawal by Subject|2|||
147523734|NCT03812224|532069747|FG000|Open-label Treatment Period|Decision by Sponsor|0|||
147523735|NCT03812224|532069748|FG001|Open-label Treatment Period|Decision by Sponsor|1|||
147523736|NCT00303719|532069749|FG000|Overall Study|Not evaluable, prior therapies|0|||
147523737|NCT00303719|532069750|FG001|Overall Study|Not evaluable, prior therapies|30|||
147523738|NCT00303719|532069749|FG000|Overall Study|Lost to Follow-up|0|||
147523739|NCT00303719|532069750|FG001|Overall Study|Lost to Follow-up|7|||
147523740|NCT01641952|532069751|FG000|Overall Study|Lost to Follow-up|28|||
147523741|NCT01641952|532069751|FG000|Overall Study|Adverse Event|6|||
147523742|NCT03633461|532069765|FG000|Overall Study|Lost to Follow-up|0|||
147523743|NCT03633461|532069766|FG001|Overall Study|Lost to Follow-up|1|||
147523744|NCT03938857|532069773|FG000|Overall Study|Physician Decision|1|||
147523745|NCT03938857|532069774|FG001|Overall Study|Physician Decision|0|||
147523746|NCT03938857|532069775|FG002|Overall Study|Physician Decision|0|||
147523747|NCT03938857|532069776|FG003|Overall Study|Physician Decision|0|||
147523748|NCT02516605|532069777|FG000|Overall Study|Protocol Violation|0|||
147523749|NCT02516605|532069778|FG001|Overall Study|Protocol Violation|0|||
147523750|NCT02516605|532069779|FG002|Overall Study|Protocol Violation|0|||
147523751|NCT02516605|532069780|FG003|Overall Study|Protocol Violation|0|||
147523752|NCT02516605|532069781|FG004|Overall Study|Protocol Violation|1|||
147523753|NCT02516605|532069777|FG000|Overall Study|Withdrawal by Subject|0|||
147523754|NCT02516605|532069778|FG001|Overall Study|Withdrawal by Subject|0|||
147523755|NCT02516605|532069779|FG002|Overall Study|Withdrawal by Subject|0|||
147523756|NCT02516605|532069780|FG003|Overall Study|Withdrawal by Subject|1|||
147523757|NCT02516605|532069781|FG004|Overall Study|Withdrawal by Subject|0|||
147523758|NCT02643420|532069782|FG000|Overall Study|Initiation of Non-Protocol Therapy for Breast Cancer|6|||
147523759|NCT02643420|532069783|FG001|Overall Study|Initiation of Non-Protocol Therapy for Breast Cancer|12|||
147523760|NCT02643420|532069782|FG000|Overall Study|Withdrawal by Subject|25|||
147523761|NCT02643420|532069783|FG001|Overall Study|Withdrawal by Subject|19|||
147523762|NCT02643420|532069782|FG000|Overall Study|Treatment with Additional Myeloid Growth Factors During Follow-up|6|||
147523763|NCT02643420|532069783|FG001|Overall Study|Treatment with Additional Myeloid Growth Factors During Follow-up|10|||
147523764|NCT02643420|532069782|FG000|Overall Study|Lost to Follow-up|6|||
147523765|NCT02643420|532069783|FG001|Overall Study|Lost to Follow-up|10|||
147523766|NCT02643420|532069782|FG000|Overall Study|Investigator Decision|2|||
147523767|NCT02643420|532069783|FG001|Overall Study|Investigator Decision|4|||
147523768|NCT02643420|532069782|FG000|Overall Study|Sponsor decision|1|||
147523769|NCT02643420|532069783|FG001|Overall Study|Sponsor decision|1|||
147523770|NCT02643420|532069782|FG000|Overall Study|Death|0|||
147523771|NCT02643420|532069783|FG001|Overall Study|Death|2|||
147523772|NCT02643420|532069782|FG000|Overall Study|Reason not Specified|8|||
147523773|NCT02643420|532069783|FG001|Overall Study|Reason not Specified|7|||
147523774|NCT02127970|532069784|FG000|Overall Study|Adverse Event|2|||
147523775|NCT02127970|532069785|FG001|Overall Study|Adverse Event|1|||
147418258|NCT02101385|531694620|FG000|Study Treatment|Disease Progression before treatment|1|||
147418259|NCT02101385|531694621|FG001|Study Treatment|Disease Progression before treatment|0|||
147523776|NCT02127970|532069784|FG000|Overall Study|Death|1|||
147523777|NCT02127970|532069785|FG001|Overall Study|Death|1|||
147523778|NCT02127970|532069784|FG000|Overall Study|Lost to Follow-up|14|||
147523779|NCT02127970|532069785|FG001|Overall Study|Lost to Follow-up|14|||
147523780|NCT02127970|532069784|FG000|Overall Study|Reason not Specified|4|||
147523781|NCT02127970|532069785|FG001|Overall Study|Reason not Specified|7|||
147523782|NCT02127970|532069784|FG000|Overall Study|Pregnancy|0|||
147523783|NCT02127970|532069785|FG001|Overall Study|Pregnancy|1|||
147418260|NCT02101385|531694620|FG000|Study Treatment|Death|1|||
147418261|NCT02101385|531694621|FG001|Study Treatment|Death|0|||
147418262|NCT02101385|531694620|FG000|Follow up|Lost to Follow-up|4|||
147418263|NCT02101385|531694621|FG001|Follow up|Lost to Follow-up|9|||
147418264|NCT02101385|531694620|FG000|Follow up|Refused to follow up|5|||
147418265|NCT02101385|531694621|FG001|Follow up|Refused to follow up|4|||
147418266|NCT02101385|531694620|FG000|Follow up|Death|21|||
147418267|NCT02101385|531694621|FG001|Follow up|Death|39|||
147418268|NCT02101385|531694620|FG000|Follow up|study completed|33|||
147523784|NCT02127970|532069784|FG000|Overall Study|Subject Withdrew Consent|5|||
147523785|NCT02127970|532069785|FG001|Overall Study|Subject Withdrew Consent|3|||
147523786|NCT02988115|532069792|FG000|Overall Study|Adverse Event|6|||
147523787|NCT02988115|532069793|FG001|Overall Study|Adverse Event|1|||
147523788|NCT02988115|532069792|FG000|Overall Study|Sponsor Decision|5|||
147523789|NCT02988115|532069793|FG001|Overall Study|Sponsor Decision|2|||
147523790|NCT02988115|532069792|FG000|Overall Study|Withdrawal by Subject|1|||
147523791|NCT02988115|532069793|FG001|Overall Study|Withdrawal by Subject|1|||
147523792|NCT02988115|532069792|FG000|Overall Study|Withdrawn by Mistake|1|||
147523793|NCT02988115|532069793|FG001|Overall Study|Withdrawn by Mistake|0|||
147523794|NCT02988115|532069792|FG000|Overall Study|Lost to Follow-up|1|||
147523795|NCT02988115|532069793|FG001|Overall Study|Lost to Follow-up|0|||
147523796|NCT00104299|532069794|FG000|Overall Study|Adverse Event|3|||
147523797|NCT00104299|532069795|FG001|Overall Study|Adverse Event|1|||
147523798|NCT00104299|532069794|FG000|Overall Study|Death|2|||
147523799|NCT00104299|532069795|FG001|Overall Study|Death|2|||
147523800|NCT00104299|532069794|FG000|Overall Study|Withdrawal by Subject|2|||
147523801|NCT00104299|532069795|FG001|Overall Study|Withdrawal by Subject|6|||
147418269|NCT02101385|531694621|FG001|Follow up|study completed|52|||
147523802|NCT00104299|532069794|FG000|Overall Study|Physician Decision|1|||
147418270|NCT02101385|531694620|FG000|Follow up|screen failure|2|||
147418271|NCT02101385|531694621|FG001|Follow up|screen failure|0|||
147418272|NCT02101385|531694620|FG000|Follow up|Pt. moved tx to Cancer Treatment Centers of America (Georgia). last contact was verbal on 3/10/16|0|||
147418273|NCT02101385|531694621|FG001|Follow up|Pt. moved tx to Cancer Treatment Centers of America (Georgia). last contact was verbal on 3/10/16|1|||
147523803|NCT00104299|532069795|FG001|Overall Study|Physician Decision|1|||
147523804|NCT00104299|532069794|FG000|Overall Study|To have renal transplant|1|||
147523805|NCT00104299|532069795|FG001|Overall Study|To have renal transplant|0|||
147523806|NCT05102734|532069796|FG000|Overall Study|Did not require vasopressors|1|||
147523807|NCT05102734|532069797|FG001|Overall Study|Did not require vasopressors|0|||
147523808|NCT05102734|532069796|FG000|Overall Study|Did not have functioning PA catheter|1|||
147418274|NCT02101385|531694620|FG000|Follow up|Disease progression - elected to participate in another clinical trial with no more follow up|0|||
147523809|NCT05102734|532069797|FG001|Overall Study|Did not have functioning PA catheter|0|||
147523810|NCT05102734|532069796|FG000|Overall Study|Inadequate video quality|2|||
147523811|NCT05102734|532069797|FG001|Overall Study|Inadequate video quality|0|||
147523812|NCT02630459|532069801|FG000|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
147523813|NCT02630459|532069802|FG001|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|1|||
147523814|NCT02630459|532069803|FG002|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
147523815|NCT02630459|532069804|FG003|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|2|||
147418275|NCT02101385|531694621|FG001|Follow up|Disease progression - elected to participate in another clinical trial with no more follow up|1|||
147418276|NCT02101385|531694620|FG000|Follow up|Withdrawal by Subject|2|||
147418277|NCT02101385|531694621|FG001|Follow up|Withdrawal by Subject|2|||
147418278|NCT02101385|531694620|FG000|Follow up|PI requested closure of site|0|||
147418279|NCT02101385|531694621|FG001|Follow up|PI requested closure of site|5|||
147523816|NCT02630459|532069805|FG004|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
147523817|NCT02630459|532069806|FG005|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
147523818|NCT02630459|532069807|FG006|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
147523819|NCT02630459|532069808|FG007|Double-Blind Treatment Phase (DBTP)|Protocol-specified criteria|0|||
147523820|NCT02630459|532069801|FG000|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
147523821|NCT02630459|532069802|FG001|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
147523822|NCT02630459|532069803|FG002|Double-Blind Treatment Phase (DBTP)|Sponsor decision|1|||
147523823|NCT02630459|532069804|FG003|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
147523824|NCT02630459|532069805|FG004|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
147523825|NCT02630459|532069806|FG005|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
147523826|NCT02630459|532069807|FG006|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
147523827|NCT02630459|532069808|FG007|Double-Blind Treatment Phase (DBTP)|Sponsor decision|0|||
147523828|NCT02630459|532069801|FG000|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|2|||
147523829|NCT02630459|532069802|FG001|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|1|||
147523830|NCT02630459|532069803|FG002|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|4|||
147523831|NCT02630459|532069804|FG003|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|1|||
147523832|NCT02630459|532069805|FG004|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|0|||
147523833|NCT02630459|532069806|FG005|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|0|||
147523834|NCT02630459|532069807|FG006|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|0|||
147523835|NCT02630459|532069808|FG007|Double-Blind Treatment Phase (DBTP)|Withdrawal by Subject|0|||
147523836|NCT02630459|532069801|FG000|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|1|||
147523837|NCT02630459|532069802|FG001|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
147523838|NCT02630459|532069803|FG002|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
147523839|NCT02630459|532069804|FG003|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
147523840|NCT02630459|532069805|FG004|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
147523841|NCT02630459|532069806|FG005|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
147523842|NCT02630459|532069807|FG006|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
147523843|NCT02630459|532069808|FG007|Double-Blind Treatment Phase (DBTP)|Subject missed week 24 assessment|0|||
147523844|NCT02630459|532069801|FG000|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
147523845|NCT02630459|532069802|FG001|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
147523846|NCT02630459|532069803|FG002|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
147523847|NCT02630459|532069804|FG003|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
147523848|NCT02630459|532069805|FG004|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|4|||
147523849|NCT02630459|532069806|FG005|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|1|||
147523850|NCT02630459|532069807|FG006|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
147523851|NCT02630459|532069808|FG007|Open-Label Treatment Phase (OLTP)|Protocol-Specified Criteria|0|||
147523852|NCT02630459|532069801|FG000|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
147523853|NCT02630459|532069802|FG001|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
147523854|NCT02630459|532069803|FG002|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
147523855|NCT02630459|532069804|FG003|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
147523856|NCT02630459|532069805|FG004|Open-Label Treatment Phase (OLTP)|Subject Request|24|||
147523857|NCT02630459|532069806|FG005|Open-Label Treatment Phase (OLTP)|Subject Request|3|||
147523858|NCT02630459|532069807|FG006|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
147523859|NCT02630459|532069808|FG007|Open-Label Treatment Phase (OLTP)|Subject Request|0|||
147523860|NCT02630459|532069801|FG000|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
147523861|NCT02630459|532069802|FG001|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
147523862|NCT02630459|532069803|FG002|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
147523863|NCT02630459|532069804|FG003|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
147523864|NCT02630459|532069805|FG004|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|1|||
147523865|NCT02630459|532069806|FG005|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
147523866|NCT02630459|532069807|FG006|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
147523867|NCT02630459|532069808|FG007|Open-Label Treatment Phase (OLTP)|Decision by Sponsor|0|||
147523868|NCT00125138|532069809|FG000|Overall Study|Adverse Event|1|||
147523869|NCT00125138|532069810|FG001|Overall Study|Adverse Event|0|||
147523870|NCT00125138|532069811|FG002|Overall Study|Adverse Event|3|||
147523871|NCT00125138|532069812|FG003|Overall Study|Adverse Event|2|||
147523872|NCT00125138|532069809|FG000|Overall Study|Withdrawal by Subject|2|||
147523873|NCT00125138|532069810|FG001|Overall Study|Withdrawal by Subject|3|||
147523874|NCT00125138|532069811|FG002|Overall Study|Withdrawal by Subject|1|||
147418280|NCT03738423|531694627|FG000|Overall Study|Withdrawal by Subject|9|||
147418281|NCT03738423|531694628|FG001|Overall Study|Withdrawal by Subject|12|||
147418282|NCT03738423|531694629|FG002|Overall Study|Withdrawal by Subject|9|||
147418283|NCT03738423|531694630|FG003|Overall Study|Withdrawal by Subject|12|||
147418284|NCT03738423|531694631|FG004|Overall Study|Withdrawal by Subject|10|||
147418285|NCT03738423|531694627|FG000|Overall Study|Lack of Efficacy|3|||
147418286|NCT03738423|531694628|FG001|Overall Study|Lack of Efficacy|1|||
147418287|NCT03738423|531694629|FG002|Overall Study|Lack of Efficacy|1|||
147418288|NCT03738423|531694630|FG003|Overall Study|Lack of Efficacy|1|||
147418289|NCT03738423|531694631|FG004|Overall Study|Lack of Efficacy|2|||
147523875|NCT00125138|532069812|FG003|Overall Study|Withdrawal by Subject|1|||
147523876|NCT00125138|532069809|FG000|Overall Study|Lack of Efficacy|0|||
147523877|NCT00125138|532069810|FG001|Overall Study|Lack of Efficacy|0|||
147523878|NCT00125138|532069811|FG002|Overall Study|Lack of Efficacy|0|||
147523879|NCT00125138|532069812|FG003|Overall Study|Lack of Efficacy|1|||
147523880|NCT00125138|532069809|FG000|Overall Study|Sponsor decision-pt moved to assist care|0|||
147523881|NCT00125138|532069810|FG001|Overall Study|Sponsor decision-pt moved to assist care|0|||
147523882|NCT00125138|532069811|FG002|Overall Study|Sponsor decision-pt moved to assist care|0|||
147523883|NCT00125138|532069812|FG003|Overall Study|Sponsor decision-pt moved to assist care|1|||
147523884|NCT00348686|532069815|FG000|Overall Study|Withdrawal by Subject|45|||
147523885|NCT00348686|532069815|FG000|Overall Study|Adverse Event|5|||
147523886|NCT00348686|532069815|FG000|Overall Study|Protocol Violation|6|||
147523887|NCT00348686|532069815|FG000|Overall Study|Lost to Follow-up|2|||
147523888|NCT00348686|532069815|FG000|Overall Study|Multiple Reasons|8|||
147523889|NCT01258738|532069818|FG000|Double-blind Period|Did not meet inclusion criteria|3|||
147523890|NCT01258738|532069819|FG001|Double-blind Period|Did not meet inclusion criteria|3|||
147523891|NCT01258738|532069818|FG000|Double-blind Period|Withdrawal by Subject|2|||
147523892|NCT01258738|532069819|FG001|Double-blind Period|Withdrawal by Subject|2|||
147523893|NCT01258738|532069818|FG000|Double-blind Period|Protocol Violation|1|||
147523894|NCT01258738|532069819|FG001|Double-blind Period|Protocol Violation|1|||
147523895|NCT01258738|532069818|FG000|Double-blind Period|Adverse Event|3|||
147523896|NCT01258738|532069819|FG001|Double-blind Period|Adverse Event|1|||
147523897|NCT01258738|532069818|FG000|Open-label Period|Did not meet inclusion criteria|0|||
147523898|NCT01258738|532069819|FG001|Open-label Period|Did not meet inclusion criteria|1|||
147523899|NCT01258738|532069818|FG000|Open-label Period|Insufficient clinical response|5|||
147523900|NCT01258738|532069819|FG001|Open-label Period|Insufficient clinical response|3|||
147523901|NCT01258738|532069818|FG000|Open-label Period|Lost to Follow-up|0|||
147523902|NCT01258738|532069819|FG001|Open-label Period|Lost to Follow-up|2|||
147523903|NCT01258738|532069818|FG000|Open-label Period|Withdrawal by Subject|5|||
147523904|NCT01258738|532069819|FG001|Open-label Period|Withdrawal by Subject|6|||
147523905|NCT01258738|532069818|FG000|Open-label Period|Protocol Violation|2|||
147523906|NCT01258738|532069819|FG001|Open-label Period|Protocol Violation|2|||
147523907|NCT01258738|532069818|FG000|Open-label Period|Adverse Event|4|||
147523908|NCT01258738|532069819|FG001|Open-label Period|Adverse Event|5|||
147523909|NCT01258738|532069818|FG000|Open-label Period|Other Reasons|0|||
147523910|NCT01258738|532069819|FG001|Open-label Period|Other Reasons|1|||
147523911|NCT01258738|532069818|FG000|Open-label Period|Withdrawn due to pregnancy|1|||
147523912|NCT01258738|532069819|FG001|Open-label Period|Withdrawn due to pregnancy|1|||
147523913|NCT02418000|532069820|FG000|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|2|||
147523914|NCT02418000|532069821|FG001|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|0|||
147523915|NCT02418000|532069822|FG002|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|0|||
147418290|NCT03738423|531694627|FG000|Overall Study|Lost to Follow-up|1|||
147418291|NCT03738423|531694628|FG001|Overall Study|Lost to Follow-up|0|||
147418292|NCT03738423|531694629|FG002|Overall Study|Lost to Follow-up|1|||
147418293|NCT03738423|531694630|FG003|Overall Study|Lost to Follow-up|1|||
147418294|NCT03738423|531694631|FG004|Overall Study|Lost to Follow-up|0|||
147418295|NCT03738423|531694627|FG000|Overall Study|Protocol Violation|1|||
147418296|NCT03738423|531694628|FG001|Overall Study|Protocol Violation|0|||
147418297|NCT03738423|531694629|FG002|Overall Study|Protocol Violation|0|||
147418298|NCT03738423|531694630|FG003|Overall Study|Protocol Violation|0|||
147418299|NCT03738423|531694631|FG004|Overall Study|Protocol Violation|1|||
147418300|NCT03738423|531694627|FG000|Overall Study|Physician Decision|0|||
147418301|NCT03738423|531694628|FG001|Overall Study|Physician Decision|0|||
147418302|NCT03738423|531694629|FG002|Overall Study|Physician Decision|1|||
147418303|NCT03738423|531694630|FG003|Overall Study|Physician Decision|0|||
147418304|NCT03738423|531694631|FG004|Overall Study|Physician Decision|1|||
147418305|NCT03738423|531694627|FG000|Overall Study|Death|0|||
147418306|NCT03738423|531694628|FG001|Overall Study|Death|0|||
147418307|NCT03738423|531694629|FG002|Overall Study|Death|0|||
147418308|NCT03738423|531694630|FG003|Overall Study|Death|0|||
147418309|NCT03738423|531694631|FG004|Overall Study|Death|1|||
147418310|NCT03738423|531694627|FG000|Overall Study|Randomized but never treated|0|||
147418311|NCT03738423|531694628|FG001|Overall Study|Randomized but never treated|0|||
147418312|NCT03738423|531694629|FG002|Overall Study|Randomized but never treated|1|||
147418313|NCT03738423|531694630|FG003|Overall Study|Randomized but never treated|1|||
147418314|NCT03738423|531694631|FG004|Overall Study|Randomized but never treated|0|||
147418315|NCT01865747|531694638|FG000|Overall Study (ITT)|Adverse Event|32|||
147418316|NCT01865747|531694639|FG001|Overall Study (ITT)|Adverse Event|31|||
147418317|NCT01865747|531694638|FG000|Overall Study (ITT)|Clinical Deterioration|29|||
147418318|NCT01865747|531694639|FG001|Overall Study (ITT)|Clinical Deterioration|50|||
147418319|NCT01865747|531694638|FG000|Overall Study (ITT)|Lack of Efficacy|3|||
147418320|NCT01865747|531694639|FG001|Overall Study (ITT)|Lack of Efficacy|0|||
147418321|NCT01865747|531694638|FG000|Overall Study (ITT)|Protocol Violation|1|||
147418322|NCT01865747|531694639|FG001|Overall Study (ITT)|Protocol Violation|1|||
147418323|NCT01865747|531694638|FG000|Overall Study (ITT)|Physician Decision|5|||
147418324|NCT01865747|531694639|FG001|Overall Study (ITT)|Physician Decision|2|||
147418325|NCT01865747|531694638|FG000|Overall Study (ITT)|Withdrawal by Subject|6|||
147418326|NCT01865747|531694639|FG001|Overall Study (ITT)|Withdrawal by Subject|11|||
147418327|NCT01865747|531694638|FG000|Overall Study (ITT)|Sponsor Decision|0|||
147418328|NCT01865747|531694639|FG001|Overall Study (ITT)|Sponsor Decision|1|||
147418329|NCT01865747|531694638|FG000|Overall Study (ITT)|Progressive Disease|122|||
147418330|NCT01865747|531694639|FG001|Overall Study (ITT)|Progressive Disease|158|||
147418331|NCT01865747|531694638|FG000|Overall Study (ITT)|Reason Not Provided|0|||
147418332|NCT01865747|531694639|FG001|Overall Study (ITT)|Reason Not Provided|1|||
147418333|NCT01865747|531694638|FG000|Primary Intent to Treat (PITT)|Adverse Event|21|||
147523916|NCT02418000|532069823|FG003|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|0|||
147523917|NCT02418000|532069824|FG004|Cohort 1: E6201 240 mg/m^2 Weekly|Withdrawal by Subject|0|||
147523918|NCT02418000|532069820|FG000|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|4|||
147523919|NCT02418000|532069821|FG001|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|0|||
147523920|NCT02418000|532069822|FG002|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|0|||
147523921|NCT02418000|532069823|FG003|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|0|||
147523922|NCT02418000|532069824|FG004|Cohort 1: E6201 240 mg/m^2 Weekly|Lack of Efficacy|0|||
147523923|NCT02418000|532069820|FG000|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|1|||
147523924|NCT02418000|532069821|FG001|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|0|||
147523925|NCT02418000|532069822|FG002|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|0|||
147523926|NCT02418000|532069823|FG003|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|0|||
147523927|NCT02418000|532069824|FG004|Cohort 1: E6201 240 mg/m^2 Weekly|Prepare for HSCT|0|||
147523928|NCT02418000|532069820|FG000|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|0|||
147523929|NCT02418000|532069821|FG001|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|1|||
147523930|NCT02418000|532069822|FG002|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|0|||
147523931|NCT02418000|532069823|FG003|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|0|||
147523932|NCT02418000|532069824|FG004|Cohort 2: E6201 320 mg/m^2 Weekly|Withdrawal by Subject|0|||
147523933|NCT02418000|532069820|FG000|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|0|||
147523934|NCT02418000|532069821|FG001|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|9|||
147523935|NCT02418000|532069822|FG002|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|0|||
147418334|NCT01865747|531694639|FG001|Primary Intent to Treat (PITT)|Adverse Event|20|||
147418335|NCT01865747|531694638|FG000|Primary Intent to Treat (PITT)|Clinical Deterioration|18|||
147418336|NCT01865747|531694639|FG001|Primary Intent to Treat (PITT)|Clinical Deterioration|29|||
147418337|NCT01865747|531694638|FG000|Primary Intent to Treat (PITT)|Lack of Efficacy|2|||
147418338|NCT01865747|531694639|FG001|Primary Intent to Treat (PITT)|Lack of Efficacy|0|||
147418339|NCT01865747|531694638|FG000|Primary Intent to Treat (PITT)|Protocol Violation|1|||
147418340|NCT01865747|531694639|FG001|Primary Intent to Treat (PITT)|Protocol Violation|1|||
147418341|NCT01865747|531694638|FG000|Primary Intent to Treat (PITT)|Physician Decision|4|||
147418342|NCT01865747|531694639|FG001|Primary Intent to Treat (PITT)|Physician Decision|2|||
147418343|NCT01865747|531694638|FG000|Primary Intent to Treat (PITT)|Withdrawal by Subject|3|||
147418344|NCT01865747|531694639|FG001|Primary Intent to Treat (PITT)|Withdrawal by Subject|7|||
147418345|NCT01865747|531694638|FG000|Primary Intent to Treat (PITT)|Progressive Disease|82|||
147418346|NCT01865747|531694639|FG001|Primary Intent to Treat (PITT)|Progressive Disease|92|||
147418347|NCT01865747|531694638|FG000|Primary Intent to Treat (PITT)|Other|0|||
147418348|NCT01865747|531694639|FG001|Primary Intent to Treat (PITT)|Other|1|||
147418349|NCT00925353|531694640|FG000|Overall Study|Failed preliminary EKG or lab criteria.|3|||
147523936|NCT02418000|532069823|FG003|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|0|||
147523937|NCT02418000|532069824|FG004|Cohort 2: E6201 320 mg/m^2 Weekly|Lack of Efficacy|0|||
147523938|NCT02418000|532069820|FG000|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
147523939|NCT02418000|532069821|FG001|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
147523940|NCT02418000|532069822|FG002|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|3|||
147523941|NCT02418000|532069823|FG003|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
147523942|NCT02418000|532069824|FG004|Cohort 3: 160 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
147523943|NCT02418000|532069820|FG000|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
147523944|NCT02418000|532069821|FG001|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
147523945|NCT02418000|532069822|FG002|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
147523946|NCT02418000|532069823|FG003|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|3|||
147523947|NCT02418000|532069824|FG004|Cohort 4: 240 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
147523948|NCT02418000|532069820|FG000|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|0|||
147523949|NCT02418000|532069821|FG001|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|0|||
147523950|NCT02418000|532069822|FG002|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|0|||
147523951|NCT02418000|532069823|FG003|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|0|||
147523952|NCT02418000|532069824|FG004|Cohort 5: 320 mg/m^2 Twice Weekly|Withdrawal by Subject|1|||
147523953|NCT02418000|532069820|FG000|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
147523954|NCT02418000|532069821|FG001|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
147523955|NCT02418000|532069822|FG002|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
147523956|NCT02418000|532069823|FG003|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|0|||
147523957|NCT02418000|532069824|FG004|Cohort 5: 320 mg/m^2 Twice Weekly|Lack of Efficacy|3|||
147523958|NCT00689611|532069825|FG000|Overall Study|Death|6|||
147523959|NCT00689611|532069826|FG001|Overall Study|Death|9|||
147523960|NCT00689611|532069825|FG000|Overall Study|Withdrawal by Subject|8|||
147523961|NCT00689611|532069826|FG001|Overall Study|Withdrawal by Subject|9|||
147523962|NCT00689611|532069825|FG000|Overall Study|Lost to Follow-up|27|||
147523963|NCT00689611|532069826|FG001|Overall Study|Lost to Follow-up|28|||
147523964|NCT00490815|532069831|FG000|Overall Study|Adverse Event|2|||
147523965|NCT00490815|532069832|FG001|Overall Study|Adverse Event|3|||
147523966|NCT00490815|532069831|FG000|Overall Study|Withdrawal by Subject|4|||
147523967|NCT00490815|532069832|FG001|Overall Study|Withdrawal by Subject|0|||
147523968|NCT00490815|532069831|FG000|Overall Study|Lost to Follow-up|1|||
147523969|NCT00490815|532069832|FG001|Overall Study|Lost to Follow-up|3|||
147523970|NCT00490815|532069831|FG000|Overall Study|Death|1|||
147523971|NCT00490815|532069832|FG001|Overall Study|Death|3|||
147523972|NCT01904760|532069840|FG000|Overall Study|Protocol Violation|1|||
147523973|NCT01904760|532069841|FG001|Overall Study|Protocol Violation|0|||
147523974|NCT04249076|532069852|FG000|Overall Study|Adverse Event|1|||
147523975|NCT04249076|532069853|FG001|Overall Study|Adverse Event|1|||
147523976|NCT04249076|532069852|FG000|Overall Study|Protocol Violation|1|||
147523977|NCT04249076|532069853|FG001|Overall Study|Protocol Violation|2|||
147523978|NCT04249076|532069852|FG000|Overall Study|Lack of Efficacy|0|||
147523979|NCT04249076|532069853|FG001|Overall Study|Lack of Efficacy|1|||
147523980|NCT04249076|532069852|FG000|Overall Study|Withdrawal by Subject|0|||
147523981|NCT04249076|532069853|FG001|Overall Study|Withdrawal by Subject|1|||
147523982|NCT00783263|532069854|FG000|Overall Study|Adverse Event|3|||
147523983|NCT00783263|532069855|FG001|Overall Study|Adverse Event|0|||
147523984|NCT00783263|532069856|FG002|Overall Study|Adverse Event|2|||
147523985|NCT00783263|532069857|FG003|Overall Study|Adverse Event|1|||
147523986|NCT00783263|532069854|FG000|Overall Study|Lost to Follow-up|1|||
147523987|NCT00783263|532069855|FG001|Overall Study|Lost to Follow-up|1|||
147523988|NCT00783263|532069856|FG002|Overall Study|Lost to Follow-up|0|||
147523989|NCT00783263|532069857|FG003|Overall Study|Lost to Follow-up|0|||
147523990|NCT00783263|532069854|FG000|Overall Study|Withdrawal by Subject|0|||
147523991|NCT00783263|532069855|FG001|Overall Study|Withdrawal by Subject|1|||
147523992|NCT00783263|532069856|FG002|Overall Study|Withdrawal by Subject|1|||
147523993|NCT00783263|532069857|FG003|Overall Study|Withdrawal by Subject|2|||
147523994|NCT00106626|532069858|FG000|Overall Study|Adverse Event|5|||
147523995|NCT00106626|532069859|FG001|Overall Study|Adverse Event|4|||
147523996|NCT00106626|532069860|FG002|Overall Study|Adverse Event|3|||
147523997|NCT00106626|532069861|FG003|Overall Study|Adverse Event|3|||
147523998|NCT00106626|532069858|FG000|Overall Study|Progressive Disease|4|||
147523999|NCT00106626|532069859|FG001|Overall Study|Progressive Disease|1|||
147524000|NCT00106626|532069860|FG002|Overall Study|Progressive Disease|9|||
147524001|NCT00106626|532069861|FG003|Overall Study|Progressive Disease|10|||
147524002|NCT00106626|532069858|FG000|Overall Study|Received radiation on new therapy|1|||
147524003|NCT00106626|532069859|FG001|Overall Study|Received radiation on new therapy|0|||
147524004|NCT00106626|532069860|FG002|Overall Study|Received radiation on new therapy|0|||
147524005|NCT00106626|532069861|FG003|Overall Study|Received radiation on new therapy|0|||
147524006|NCT00106626|532069858|FG000|Overall Study|> 14 day delay in therapy start|0|||
147524007|NCT00106626|532069859|FG001|Overall Study|> 14 day delay in therapy start|1|||
147524008|NCT00106626|532069860|FG002|Overall Study|> 14 day delay in therapy start|0|||
147524009|NCT00106626|532069861|FG003|Overall Study|> 14 day delay in therapy start|0|||
147524010|NCT00732199|532069866|FG000|Overall Study|Withdrawal by Subject|25|||
147524011|NCT00732199|532069867|FG001|Overall Study|Withdrawal by Subject|18|||
147524012|NCT00732199|532069866|FG000|Overall Study|sleep apnea, inadequate signals/sleep|9|||
147524013|NCT00732199|532069867|FG001|Overall Study|sleep apnea, inadequate signals/sleep|8|||
147524014|NCT00405756|532069880|FG000|Double-blind Treatment|Ongoing in Double-blind Treatment|45|||
147524015|NCT00405756|532069881|FG001|Double-blind Treatment|Ongoing in Double-blind Treatment|24|||
147524016|NCT00405756|532069882|FG002|Double-blind Treatment|Ongoing in Double-blind Treatment|18|||
147524017|NCT00405756|532069880|FG000|Double-blind Treatment|Adverse Event|31|||
147524018|NCT00405756|532069881|FG001|Double-blind Treatment|Adverse Event|27|||
147524019|NCT00405756|532069882|FG002|Double-blind Treatment|Adverse Event|12|||
147524020|NCT00405756|532069880|FG000|Double-blind Treatment|Disease Progression|47|||
147524021|NCT00405756|532069881|FG001|Double-blind Treatment|Disease Progression|81|||
147524022|NCT00405756|532069882|FG002|Double-blind Treatment|Disease Progression|102|||
147524023|NCT00405756|532069880|FG000|Double-blind Treatment|Lack of Efficacy|1|||
147524024|NCT00405756|532069881|FG001|Double-blind Treatment|Lack of Efficacy|4|||
147524025|NCT00405756|532069882|FG002|Double-blind Treatment|Lack of Efficacy|2|||
147524026|NCT00405756|532069880|FG000|Double-blind Treatment|Withdrawal by Subject|15|||
147524027|NCT00405756|532069881|FG001|Double-blind Treatment|Withdrawal by Subject|9|||
147524028|NCT00405756|532069882|FG002|Double-blind Treatment|Withdrawal by Subject|10|||
147524029|NCT00405756|532069880|FG000|Double-blind Treatment|Lost to Follow-up|1|||
147524030|NCT00405756|532069881|FG001|Double-blind Treatment|Lost to Follow-up|0|||
147524031|NCT00405756|532069882|FG002|Double-blind Treatment|Lost to Follow-up|0|||
147524032|NCT00405756|532069880|FG000|Double-blind Treatment|Death|4|||
147524033|NCT00405756|532069881|FG001|Double-blind Treatment|Death|4|||
147524034|NCT00405756|532069882|FG002|Double-blind Treatment|Death|4|||
147524035|NCT00405756|532069880|FG000|Double-blind Treatment|Protocol Violation|1|||
147524036|NCT00405756|532069881|FG001|Double-blind Treatment|Protocol Violation|0|||
147524037|NCT00405756|532069882|FG002|Double-blind Treatment|Protocol Violation|2|||
147524038|NCT00405756|532069880|FG000|Double-blind Treatment|Other|7|||
147524039|NCT00405756|532069881|FG001|Double-blind Treatment|Other|4|||
147524040|NCT00405756|532069882|FG002|Double-blind Treatment|Other|4|||
147524041|NCT00405756|532069880|FG000|Open-label Extension|Ongoing in Open Label Period|7|||
147524042|NCT00405756|532069881|FG001|Open-label Extension|Ongoing in Open Label Period|15|||
147524043|NCT00405756|532069882|FG002|Open-label Extension|Ongoing in Open Label Period|25|||
147524044|NCT00405756|532069880|FG000|Open-label Extension|Adverse Event|1|||
147524045|NCT00405756|532069881|FG001|Open-label Extension|Adverse Event|3|||
147524046|NCT00405756|532069882|FG002|Open-label Extension|Adverse Event|7|||
147524047|NCT00405756|532069880|FG000|Open-label Extension|Disease Progression|8|||
147524048|NCT00405756|532069881|FG001|Open-label Extension|Disease Progression|23|||
147524049|NCT00405756|532069882|FG002|Open-label Extension|Disease Progression|26|||
147524050|NCT00405756|532069880|FG000|Open-label Extension|Withdrawal by Subject|2|||
147524051|NCT00405756|532069881|FG001|Open-label Extension|Withdrawal by Subject|3|||
147524052|NCT00405756|532069882|FG002|Open-label Extension|Withdrawal by Subject|3|||
147524053|NCT00405756|532069880|FG000|Open-label Extension|Death|1|||
147524054|NCT00405756|532069881|FG001|Open-label Extension|Death|2|||
147524055|NCT00405756|532069882|FG002|Open-label Extension|Death|4|||
147524056|NCT00405756|532069880|FG000|Open-label Extension|Other|0|||
147524057|NCT00405756|532069881|FG001|Open-label Extension|Other|1|||
147524058|NCT00405756|532069882|FG002|Open-label Extension|Other|7|||
147524059|NCT00405756|532069880|FG000|Follow-up|Ongoing in Follow-up Period|52|||
147524060|NCT00405756|532069881|FG001|Follow-up|Ongoing in Follow-up Period|51|||
147524061|NCT00405756|532069882|FG002|Follow-up|Ongoing in Follow-up Period|60|||
147643614|NCT00778102|532514123|FG000|Overall Study|Violation of Selection Criteria|1|||
147643615|NCT00778102|532514124|FG001|Overall Study|Violation of Selection Criteria|1|||
147643616|NCT00778102|532514123|FG000|Overall Study|Protocol Violation|0|||
147643617|NCT00778102|532514124|FG001|Overall Study|Protocol Violation|1|||
147643618|NCT00778102|532514123|FG000|Overall Study|Refused Treatment|2|||
147643619|NCT00778102|532514124|FG001|Overall Study|Refused Treatment|3|||
147643620|NCT00778102|532514123|FG000|Overall Study|Withdrawal by Subject|1|||
147643621|NCT00778102|532514124|FG001|Overall Study|Withdrawal by Subject|1|||
147643622|NCT00778102|532514123|FG000|Overall Study|Administrative Reason|7|||
147643623|NCT00778102|532514124|FG001|Overall Study|Administrative Reason|10|||
147643624|NCT01328548|532514125|FG000|Overall Study|Death|3|||
147643625|NCT01328548|532514126|FG001|Overall Study|Death|0|||
147643626|NCT01328548|532514125|FG000|Overall Study|Protocol Violation|1|||
147643627|NCT01328548|532514126|FG001|Overall Study|Protocol Violation|0|||
147643628|NCT04506905|532514129|FG000|Overall Study|Lost to Follow-up|1|||
147643629|NCT04506905|532514130|FG001|Overall Study|Lost to Follow-up|0|||
147643630|NCT04506905|532514131|FG002|Overall Study|Lost to Follow-up|0|||
147643631|NCT04506905|532514132|FG003|Overall Study|Lost to Follow-up|1|||
147643632|NCT04506905|532514133|FG004|Overall Study|Lost to Follow-up|0|||
147643633|NCT04506905|532514134|FG005|Overall Study|Lost to Follow-up|0|||
147643634|NCT04506905|532514135|FG006|Overall Study|Lost to Follow-up|0|||
147643635|NCT04506905|532514136|FG007|Overall Study|Lost to Follow-up|0|||
147643636|NCT04506905|532514137|FG008|Overall Study|Lost to Follow-up|0|||
147643637|NCT04506905|532514129|FG000|Overall Study|Withdrawal by Subject|0|||
147643638|NCT04506905|532514130|FG001|Overall Study|Withdrawal by Subject|0|||
147643639|NCT04506905|532514131|FG002|Overall Study|Withdrawal by Subject|0|||
147643640|NCT04506905|532514132|FG003|Overall Study|Withdrawal by Subject|2|||
147643641|NCT04506905|532514133|FG004|Overall Study|Withdrawal by Subject|0|||
147643642|NCT04506905|532514134|FG005|Overall Study|Withdrawal by Subject|0|||
147643643|NCT04506905|532514135|FG006|Overall Study|Withdrawal by Subject|0|||
147643644|NCT04506905|532514136|FG007|Overall Study|Withdrawal by Subject|0|||
147643645|NCT04506905|532514137|FG008|Overall Study|Withdrawal by Subject|0|||
147643646|NCT00073983|532514138|FG000|Overall Study|not evaluable|1|||
147643647|NCT03976323|532514141|FG000|Induction Phase|Failure to Meet Maintenance Randomization Criteria|251|||
147643648|NCT03976323|532514142|FG001|Induction Phase|Failure to Meet Maintenance Randomization Criteria|0|||
147643649|NCT03976323|532514143|FG002|Induction Phase|Failure to Meet Maintenance Randomization Criteria|0|||
147643650|NCT03976323|532514141|FG000|Induction Phase|Death|80|||
147643651|NCT03976323|532514142|FG001|Induction Phase|Death|0|||
147643652|NCT03976323|532514143|FG002|Induction Phase|Death|0|||
147643653|NCT03976323|532514141|FG000|Maintenance Phase|Participant Ongoing in Study|0|||
147643654|NCT03976323|532514142|FG001|Maintenance Phase|Participant Ongoing in Study|100|||
147643655|NCT03976323|532514143|FG002|Maintenance Phase|Participant Ongoing in Study|97|||
147643656|NCT03976323|532514141|FG000|Maintenance Phase|Withdrawal by Subject|0|||
147643657|NCT03976323|532514142|FG001|Maintenance Phase|Withdrawal by Subject|9|||
147643658|NCT03976323|532514143|FG002|Maintenance Phase|Withdrawal by Subject|3|||
147643659|NCT03976323|532514141|FG000|Maintenance Phase|Physician Decision|0|||
147643660|NCT03976323|532514142|FG001|Maintenance Phase|Physician Decision|0|||
147643661|NCT03976323|532514143|FG002|Maintenance Phase|Physician Decision|1|||
147643662|NCT03976323|532514141|FG000|Maintenance Phase|Death|0|||
147643663|NCT03976323|532514142|FG001|Maintenance Phase|Death|228|||
147643664|NCT03976323|532514143|FG002|Maintenance Phase|Death|234|||
147643665|NCT03800836|532514145|FG000|Overall Study|Other|2|||
147643666|NCT03800836|532514146|FG001|Overall Study|Other|1|||
147524062|NCT00405756|532069880|FG000|Follow-up|Death|21|||
147524063|NCT00405756|532069881|FG001|Follow-up|Death|31|||
147524064|NCT00405756|532069882|FG002|Follow-up|Death|24|||
147524065|NCT00405756|532069880|FG000|Follow-up|Lost to Follow-up|2|||
147524066|NCT00405756|532069881|FG001|Follow-up|Lost to Follow-up|8|||
147524067|NCT00405756|532069882|FG002|Follow-up|Lost to Follow-up|4|||
147524068|NCT02870348|532069885|FG000|Overall Study|Participants were discontinued and assessed for entry into post-marketing study (GTI1401-EXP)|4|||
147524069|NCT01051856|532069886|FG000|Overall Study|Withdrawal by Subject|1|||
147524070|NCT01051856|532069887|FG001|Overall Study|Withdrawal by Subject|0|||
147524071|NCT01117428|532069889|FG000|Overall Study|Lack of Efficacy|1|||
147524072|NCT01117428|532069890|FG001|Overall Study|Lack of Efficacy|0|||
147524073|NCT01117428|532069891|FG002|Overall Study|Lack of Efficacy|0|||
147524074|NCT01117428|532069892|FG003|Overall Study|Lack of Efficacy|0|||
147524075|NCT01117428|532069893|FG004|Overall Study|Lack of Efficacy|0|||
147524076|NCT01117428|532069894|FG005|Overall Study|Lack of Efficacy|0|||
147524077|NCT01117428|532069889|FG000|Overall Study|Adverse Event|4|||
147524078|NCT01117428|532069890|FG001|Overall Study|Adverse Event|0|||
147524079|NCT01117428|532069891|FG002|Overall Study|Adverse Event|0|||
147524080|NCT01117428|532069892|FG003|Overall Study|Adverse Event|0|||
147524081|NCT01117428|532069893|FG004|Overall Study|Adverse Event|1|||
147524082|NCT01117428|532069894|FG005|Overall Study|Adverse Event|2|||
147524083|NCT01117428|532069889|FG000|Overall Study|Death|0|||
147524084|NCT01117428|532069890|FG001|Overall Study|Death|1|||
147524085|NCT01117428|532069891|FG002|Overall Study|Death|2|||
147524086|NCT01117428|532069892|FG003|Overall Study|Death|0|||
147524087|NCT01117428|532069893|FG004|Overall Study|Death|0|||
147524088|NCT01117428|532069894|FG005|Overall Study|Death|1|||
147524089|NCT01117428|532069889|FG000|Overall Study|Physician Decision|0|||
147524090|NCT01117428|532069890|FG001|Overall Study|Physician Decision|1|||
147524091|NCT01117428|532069891|FG002|Overall Study|Physician Decision|0|||
147524092|NCT01117428|532069892|FG003|Overall Study|Physician Decision|0|||
147524093|NCT01117428|532069893|FG004|Overall Study|Physician Decision|0|||
147524094|NCT01117428|532069894|FG005|Overall Study|Physician Decision|0|||
147524095|NCT01117428|532069889|FG000|Overall Study|Withdrawal by Subject|0|||
147524096|NCT01117428|532069890|FG001|Overall Study|Withdrawal by Subject|0|||
147524097|NCT01117428|532069891|FG002|Overall Study|Withdrawal by Subject|1|||
147524098|NCT01117428|532069892|FG003|Overall Study|Withdrawal by Subject|0|||
147524099|NCT01117428|532069893|FG004|Overall Study|Withdrawal by Subject|0|||
147524100|NCT01117428|532069894|FG005|Overall Study|Withdrawal by Subject|0|||
147524101|NCT01117428|532069889|FG000|Overall Study|Progressive disease|15|||
147524102|NCT01117428|532069890|FG001|Overall Study|Progressive disease|27|||
147524103|NCT01117428|532069891|FG002|Overall Study|Progressive disease|10|||
147524104|NCT01117428|532069892|FG003|Overall Study|Progressive disease|12|||
147524105|NCT01117428|532069893|FG004|Overall Study|Progressive disease|16|||
147524106|NCT01117428|532069894|FG005|Overall Study|Progressive disease|17|||
147524107|NCT02519777|532069895|FG000|Overall Study|Death|1|||
147524108|NCT02519777|532069896|FG001|Overall Study|Death|0|||
147524109|NCT02519777|532069897|FG002|Overall Study|Death|0|||
147524110|NCT02519777|532069895|FG000|Overall Study|Lost to Follow-up|0|||
147524111|NCT02519777|532069896|FG001|Overall Study|Lost to Follow-up|4|||
147524112|NCT02519777|532069897|FG002|Overall Study|Lost to Follow-up|2|||
147524113|NCT02519777|532069895|FG000|Overall Study|Withdrawal by Subject|3|||
147524114|NCT02519777|532069896|FG001|Overall Study|Withdrawal by Subject|1|||
147524115|NCT02519777|532069897|FG002|Overall Study|Withdrawal by Subject|0|||
147524116|NCT02519777|532069895|FG000|Overall Study|Severe Debilitation|1|||
147524117|NCT02519777|532069896|FG001|Overall Study|Severe Debilitation|1|||
147524118|NCT02519777|532069897|FG002|Overall Study|Severe Debilitation|1|||
147524119|NCT02519777|532069895|FG000|Overall Study|Not able to get to clinic|1|||
147524120|NCT02519777|532069896|FG001|Overall Study|Not able to get to clinic|2|||
147524121|NCT02519777|532069897|FG002|Overall Study|Not able to get to clinic|1|||
147524122|NCT02195531|532069898|FG000|Overall Study|Withdrawal by Subject|1|||
147524123|NCT02195531|532069899|FG001|Overall Study|Withdrawal by Subject|1|||
147524124|NCT02195531|532069900|FG002|Overall Study|Withdrawal by Subject|1|||
147524125|NCT01284127|532069904|FG000|Overall Study|Adverse Event|2|||
147524126|NCT01284127|532069904|FG000|Overall Study|Withdrawal by Subject|4|||
147524127|NCT01284127|532069904|FG000|Overall Study|Physician Decision|1|||
147524128|NCT01683058|532069908|FG000|Overall Study|Lost to Follow-up|9|||
147524129|NCT01683058|532069908|FG000|Overall Study|Adverse Event|6|||
147524130|NCT01683058|532069908|FG000|Overall Study|Subject Met Withdrawal Criteria|5|||
147524131|NCT01683058|532069908|FG000|Overall Study|Withdrawal by Subject|7|||
147524132|NCT01683058|532069908|FG000|Overall Study|Lack of Efficacy|2|||
147524133|NCT04062240|532069909|FG000|Overall Study|equipment malfunction|1|||
147524134|NCT01057394|532069910|FG000|Overall Study|Not eligible|0|||
147524135|NCT01057394|532069911|FG001|Overall Study|Not eligible|2|||
147524136|NCT01195636|532069912|FG000|First Intervention (3 Weeks)|Adverse Event|2|||
147524137|NCT01195636|532069913|FG001|First Intervention (3 Weeks)|Adverse Event|3|||
147524138|NCT01195636|532069912|FG000|First Intervention (3 Weeks)|Protocol Violation|1|||
147524139|NCT01195636|532069913|FG001|First Intervention (3 Weeks)|Protocol Violation|0|||
147524140|NCT01195636|532069912|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
147524141|NCT01195636|532069913|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|0|||
147524142|NCT01195636|532069912|FG000|First Intervention (3 Weeks)|Lost to Follow-up|1|||
147524143|NCT01195636|532069913|FG001|First Intervention (3 Weeks)|Lost to Follow-up|0|||
147524144|NCT01195636|532069912|FG000|Washout Period (2 Weeks)|Adverse Event|1|||
147524145|NCT01195636|532069913|FG001|Washout Period (2 Weeks)|Adverse Event|1|||
147524146|NCT01195636|532069912|FG000|Washout Period (2 Weeks)|Withdrawal by Subject|1|||
147524147|NCT01195636|532069913|FG001|Washout Period (2 Weeks)|Withdrawal by Subject|2|||
147524148|NCT01195636|532069912|FG000|Second Intervention (3 Weeks)|Adverse Event|1|||
147524149|NCT01195636|532069913|FG001|Second Intervention (3 Weeks)|Adverse Event|1|||
147524150|NCT01195636|532069912|FG000|Second Intervention (3 Weeks)|Withdrawal by Subject|0|||
147524151|NCT01195636|532069913|FG001|Second Intervention (3 Weeks)|Withdrawal by Subject|1|||
147524152|NCT03961529|532069914|FG000|Overall Study|Adverse Event|13|||
147524153|NCT03961529|532069915|FG001|Overall Study|Adverse Event|5|||
147524154|NCT03961529|532069916|FG002|Overall Study|Adverse Event|2|||
147524155|NCT03961529|532069914|FG000|Overall Study|Withdrawal by Subject|17|||
147524156|NCT03961529|532069915|FG001|Overall Study|Withdrawal by Subject|2|||
147524157|NCT03961529|532069916|FG002|Overall Study|Withdrawal by Subject|1|||
147524158|NCT03961529|532069914|FG000|Overall Study|Withdrawal by parent/guardian|0|||
147524159|NCT03961529|532069915|FG001|Overall Study|Withdrawal by parent/guardian|7|||
147524160|NCT03961529|532069916|FG002|Overall Study|Withdrawal by parent/guardian|0|||
147524161|NCT03961529|532069914|FG000|Overall Study|Physician Decision|2|||
147524162|NCT03961529|532069915|FG001|Overall Study|Physician Decision|1|||
147524163|NCT03961529|532069916|FG002|Overall Study|Physician Decision|1|||
147524164|NCT03961529|532069914|FG000|Overall Study|Lost to Follow-up|2|||
147524165|NCT03961529|532069915|FG001|Overall Study|Lost to Follow-up|1|||
147524166|NCT03961529|532069916|FG002|Overall Study|Lost to Follow-up|0|||
147524167|NCT03961529|532069914|FG000|Overall Study|Lack of Efficacy|2|||
147524168|NCT03961529|532069915|FG001|Overall Study|Lack of Efficacy|0|||
147524169|NCT03961529|532069916|FG002|Overall Study|Lack of Efficacy|1|||
147524170|NCT03961529|532069914|FG000|Overall Study|Other|6|||
147524171|NCT03961529|532069915|FG001|Overall Study|Other|1|||
147524172|NCT03961529|532069916|FG002|Overall Study|Other|0|||
147524173|NCT03481634|532069921|FG000|Overall Study|Withdrawal by Subject|16|||
147524174|NCT03481634|532069922|FG001|Overall Study|Withdrawal by Subject|19|||
147524175|NCT03481634|532069923|FG002|Overall Study|Withdrawal by Subject|14|||
147524176|NCT03481634|532069921|FG000|Overall Study|Protocol Violation|1|||
147524177|NCT03481634|532069922|FG001|Overall Study|Protocol Violation|0|||
147524178|NCT03481634|532069923|FG002|Overall Study|Protocol Violation|1|||
147524179|NCT03481634|532069921|FG000|Overall Study|Progressive disease|0|||
147524180|NCT03481634|532069922|FG001|Overall Study|Progressive disease|1|||
147524181|NCT03481634|532069923|FG002|Overall Study|Progressive disease|0|||
147524182|NCT03481634|532069921|FG000|Overall Study|Physician Decision|3|||
147524183|NCT03481634|532069922|FG001|Overall Study|Physician Decision|0|||
147524184|NCT03481634|532069923|FG002|Overall Study|Physician Decision|1|||
147524185|NCT03481634|532069921|FG000|Overall Study|Lost to Follow-up|3|||
147524186|NCT03481634|532069922|FG001|Overall Study|Lost to Follow-up|4|||
147524187|NCT03481634|532069923|FG002|Overall Study|Lost to Follow-up|4|||
147524188|NCT03481634|532069921|FG000|Overall Study|Death|4|||
147524189|NCT03481634|532069922|FG001|Overall Study|Death|8|||
147524190|NCT03481634|532069923|FG002|Overall Study|Death|7|||
147524191|NCT03481634|532069921|FG000|Overall Study|Adverse Event|6|||
147524192|NCT03481634|532069922|FG001|Overall Study|Adverse Event|3|||
147524193|NCT03481634|532069923|FG002|Overall Study|Adverse Event|7|||
147524194|NCT03490734|532069928|FG000|Pre-intervention Scan Visit|fMRI contraindications|2|||
147524195|NCT03490734|532069929|FG001|Pre-intervention Scan Visit|fMRI contraindications|1|||
147524196|NCT03490734|532069930|FG002|Pre-intervention Scan Visit|fMRI contraindications|0|||
147524197|NCT03490734|532069931|FG003|Pre-intervention Scan Visit|fMRI contraindications|2|||
147524198|NCT03490734|532069928|FG000|Pre-intervention Scan Visit|Lost to Follow-up|0|||
147643667|NCT03800836|532514147|FG002|Overall Study|Other|0|||
147643668|NCT03800836|532514148|FG003|Overall Study|Other|2|||
147643669|NCT03800836|532514149|FG004|Overall Study|Other|0|||
147643670|NCT03800836|532514150|FG005|Overall Study|Other|1|||
147643671|NCT03800836|532514145|FG000|Overall Study|Lost to Follow-up|2|||
147643672|NCT03800836|532514146|FG001|Overall Study|Lost to Follow-up|0|||
147643673|NCT03800836|532514147|FG002|Overall Study|Lost to Follow-up|1|||
147643674|NCT03800836|532514148|FG003|Overall Study|Lost to Follow-up|1|||
147643675|NCT03800836|532514149|FG004|Overall Study|Lost to Follow-up|3|||
147643676|NCT03800836|532514150|FG005|Overall Study|Lost to Follow-up|0|||
147643677|NCT03800836|532514145|FG000|Overall Study|Withdrawal by Subject|1|||
147643678|NCT03800836|532514146|FG001|Overall Study|Withdrawal by Subject|0|||
147643679|NCT03800836|532514147|FG002|Overall Study|Withdrawal by Subject|0|||
147643680|NCT03800836|532514148|FG003|Overall Study|Withdrawal by Subject|0|||
147643681|NCT03800836|532514149|FG004|Overall Study|Withdrawal by Subject|0|||
147643682|NCT03800836|532514150|FG005|Overall Study|Withdrawal by Subject|0|||
147643683|NCT03800836|532514145|FG000|Overall Study|Physician Decision|31|||
147643684|NCT03800836|532514146|FG001|Overall Study|Physician Decision|3|||
147643685|NCT03800836|532514147|FG002|Overall Study|Physician Decision|6|||
147643686|NCT03800836|532514148|FG003|Overall Study|Physician Decision|4|||
147643687|NCT03800836|532514149|FG004|Overall Study|Physician Decision|4|||
147643688|NCT03800836|532514150|FG005|Overall Study|Physician Decision|5|||
147643689|NCT03800836|532514145|FG000|Overall Study|Death|34|||
147643690|NCT03800836|532514146|FG001|Overall Study|Death|16|||
147643691|NCT03800836|532514147|FG002|Overall Study|Death|5|||
147643692|NCT03800836|532514148|FG003|Overall Study|Death|5|||
147643693|NCT03800836|532514149|FG004|Overall Study|Death|10|||
147643694|NCT03800836|532514150|FG005|Overall Study|Death|0|||
147643695|NCT03800836|532514145|FG000|Overall Study|Symptomatic Deterioration|1|||
147643696|NCT03800836|532514146|FG001|Overall Study|Symptomatic Deterioration|0|||
147643697|NCT03800836|532514147|FG002|Overall Study|Symptomatic Deterioration|1|||
147643698|NCT03800836|532514148|FG003|Overall Study|Symptomatic Deterioration|0|||
147643699|NCT03800836|532514149|FG004|Overall Study|Symptomatic Deterioration|0|||
147643700|NCT03800836|532514150|FG005|Overall Study|Symptomatic Deterioration|0|||
147643701|NCT02000882|532516609|FG000|Overall Study|Adverse Event|3|||
147643702|NCT02000882|532516609|FG000|Overall Study|Physician Decision|2|||
147643703|NCT02000882|532516609|FG000|Overall Study|Withdrawal by Subject|1|||
147643704|NCT00549601|532516610|FG000|Randomized|Protocol Violation|0|||
147643705|NCT00549601|532516611|FG001|Randomized|Protocol Violation|0|||
147643706|NCT00549601|532516612|FG002|Randomized|Protocol Violation|1|||
147643707|NCT00549601|532516610|FG000|Randomized|Withdrawal by Subject|0|||
147643708|NCT00549601|532516611|FG001|Randomized|Withdrawal by Subject|1|||
147643709|NCT00549601|532516612|FG002|Randomized|Withdrawal by Subject|1|||
147643710|NCT00549601|532516610|FG000|Received Study Drug|Adverse Event|2|||
147643711|NCT00549601|532516611|FG001|Received Study Drug|Adverse Event|5|||
147643712|NCT00549601|532516612|FG002|Received Study Drug|Adverse Event|1|||
147643713|NCT00549601|532516610|FG000|Received Study Drug|Death|0|||
147643714|NCT00549601|532516611|FG001|Received Study Drug|Death|1|||
147643715|NCT00549601|532516612|FG002|Received Study Drug|Death|0|||
147643716|NCT00549601|532516610|FG000|Received Study Drug|Lost to Follow-up|0|||
147643717|NCT00549601|532516611|FG001|Received Study Drug|Lost to Follow-up|1|||
147643718|NCT00549601|532516612|FG002|Received Study Drug|Lost to Follow-up|1|||
147643719|NCT00549601|532516610|FG000|Received Study Drug|Protocol Violation|3|||
147643720|NCT00549601|532516611|FG001|Received Study Drug|Protocol Violation|4|||
147643721|NCT00549601|532516612|FG002|Received Study Drug|Protocol Violation|1|||
147643722|NCT00549601|532516610|FG000|Received Study Drug|Withdrawal by Subject|2|||
147643723|NCT00549601|532516611|FG001|Received Study Drug|Withdrawal by Subject|0|||
147643724|NCT00549601|532516612|FG002|Received Study Drug|Withdrawal by Subject|1|||
147643725|NCT00908596|532516616|FG000|Overall Study|Other reasons|46|||
147643726|NCT00908596|532516617|FG001|Overall Study|Other reasons|6|||
147643727|NCT00908596|532516618|FG002|Overall Study|Other reasons|2|||
147643728|NCT00908596|532516619|FG003|Overall Study|Other reasons|0|||
147643729|NCT00908596|532516616|FG000|Overall Study|Lost to Follow-up|0|||
147643730|NCT00908596|532516617|FG001|Overall Study|Lost to Follow-up|1|||
147643731|NCT00908596|532516618|FG002|Overall Study|Lost to Follow-up|12|||
147643732|NCT00908596|532516619|FG003|Overall Study|Lost to Follow-up|4|||
147643733|NCT00908596|532516616|FG000|Overall Study|Death|0|||
147643734|NCT00908596|532516617|FG001|Overall Study|Death|5|||
147524199|NCT03490734|532069929|FG001|Pre-intervention Scan Visit|Lost to Follow-up|0|||
147524200|NCT03490734|532069930|FG002|Pre-intervention Scan Visit|Lost to Follow-up|0|||
147524201|NCT03490734|532069931|FG003|Pre-intervention Scan Visit|Lost to Follow-up|1|||
147524202|NCT03490734|532069928|FG000|Pre-intervention Scan Visit|Withdrawal by Subject|0|||
147524203|NCT03490734|532069929|FG001|Pre-intervention Scan Visit|Withdrawal by Subject|0|||
147524204|NCT03490734|532069930|FG002|Pre-intervention Scan Visit|Withdrawal by Subject|0|||
147524205|NCT03490734|532069931|FG003|Pre-intervention Scan Visit|Withdrawal by Subject|1|||
147524206|NCT03490734|532069928|FG000|Post-intervention Scan Visit|Adverse Event|2|||
147524207|NCT03490734|532069929|FG001|Post-intervention Scan Visit|Adverse Event|0|||
147524208|NCT03490734|532069930|FG002|Post-intervention Scan Visit|Adverse Event|0|||
147524209|NCT03490734|532069931|FG003|Post-intervention Scan Visit|Adverse Event|0|||
147643735|NCT00908596|532516618|FG002|Overall Study|Death|57|||
147643736|NCT00908596|532516619|FG003|Overall Study|Death|32|||
147643737|NCT00908596|532516616|FG000|Overall Study|Protocol Violation|1|||
147643738|NCT00908596|532516617|FG001|Overall Study|Protocol Violation|0|||
147643739|NCT00908596|532516618|FG002|Overall Study|Protocol Violation|0|||
147643740|NCT00908596|532516619|FG003|Overall Study|Protocol Violation|0|||
147643741|NCT00908596|532516616|FG000|Overall Study|Withdrawal by Subject|0|||
147643742|NCT00908596|532516617|FG001|Overall Study|Withdrawal by Subject|1|||
147643743|NCT00908596|532516618|FG002|Overall Study|Withdrawal by Subject|3|||
147643744|NCT00908596|532516619|FG003|Overall Study|Withdrawal by Subject|1|||
147643745|NCT00224406|532516620|FG000|Overall Study|Re-transplant|0|||
147643746|NCT00224406|532516621|FG001|Overall Study|Re-transplant|2|||
147643747|NCT00224406|532516620|FG000|Overall Study|Death|0|||
147643748|NCT00224406|532516621|FG001|Overall Study|Death|1|||
147643749|NCT00224406|532516620|FG000|Overall Study|Transplant cancelled|0|||
147643750|NCT00224406|532516621|FG001|Overall Study|Transplant cancelled|4|||
147643751|NCT00224406|532516620|FG000|Overall Study|Drug not delivered|2|||
147643752|NCT00224406|532516621|FG001|Overall Study|Drug not delivered|0|||
147643753|NCT00224406|532516620|FG000|Overall Study|Other|4|||
147643754|NCT00224406|532516621|FG001|Overall Study|Other|0|||
147643755|NCT00224406|532516620|FG000|Overall Study|Transplant cancelled|3|||
147643756|NCT00224406|532516621|FG001|Overall Study|Transplant cancelled|0|||
147643757|NCT01556997|532516624|FG000|Overall Study|Adverse Event|10|||
147643758|NCT01556997|532516625|FG001|Overall Study|Adverse Event|12|||
147643759|NCT01556997|532516626|FG002|Overall Study|Adverse Event|12|||
147643760|NCT01556997|532516624|FG000|Overall Study|Lost to Follow-up|6|||
147643761|NCT01556997|532516625|FG001|Overall Study|Lost to Follow-up|6|||
147643762|NCT01556997|532516626|FG002|Overall Study|Lost to Follow-up|4|||
147643763|NCT01556997|532516624|FG000|Overall Study|Physician Decision|1|||
147643764|NCT01556997|532516625|FG001|Overall Study|Physician Decision|1|||
147643765|NCT01556997|532516626|FG002|Overall Study|Physician Decision|1|||
147643766|NCT01556997|532516624|FG000|Overall Study|Withdrawal by Subject|7|||
147643767|NCT01556997|532516625|FG001|Overall Study|Withdrawal by Subject|6|||
147643768|NCT01556997|532516626|FG002|Overall Study|Withdrawal by Subject|8|||
147643769|NCT01556997|532516624|FG000|Overall Study|Other|2|||
147643770|NCT01556997|532516625|FG001|Overall Study|Other|3|||
147643771|NCT01556997|532516626|FG002|Overall Study|Other|7|||
147643772|NCT01250171|532516631|FG000|Overall Study|Administrative reasons|1|||
147643773|NCT01250171|532516632|FG001|Overall Study|Administrative reasons|0|||
147643774|NCT01250171|532516633|FG002|Overall Study|Administrative reasons|0|||
147643775|NCT03309696|532516634|FG000|Overall Study|Analysis of TEP data could not be completed|0|||
147643776|NCT03309696|532516635|FG001|Overall Study|Analysis of TEP data could not be completed|5|||
147643777|NCT03309696|532516636|FG002|Overall Study|Analysis of TEP data could not be completed|0|||
147643778|NCT03309696|532516637|FG003|Overall Study|Analysis of TEP data could not be completed|0|||
147643779|NCT02949908|532516638|FG000|Overall Study|Study termination|2|||
147643780|NCT02607280|532516641|FG000|Overall Study|Adverse Event|4|||
147643781|NCT02607280|532516642|FG001|Overall Study|Adverse Event|0|||
147643782|NCT02607280|532516641|FG000|Overall Study|Decrease in CrCl <15|0|||
147643783|NCT02607280|532516642|FG001|Overall Study|Decrease in CrCl <15|1|||
147643784|NCT00078949|532516643|FG000|Overall Study|No treated|4|||
147643785|NCT00078949|532516644|FG001|Overall Study|No treated|5|||
147643786|NCT00078949|532516645|FG002|Overall Study|No treated|3|||
147643787|NCT00078949|532516646|FG003|Overall Study|No treated|3|||
147643788|NCT00577005|532516647|FG000|Overall Study|Lost to Follow-up|3|||
147643789|NCT00577005|532516648|FG001|Overall Study|Lost to Follow-up|2|||
147643790|NCT00577005|532516647|FG000|Overall Study|Withdrawal by Subject|2|||
147643791|NCT00577005|532516648|FG001|Overall Study|Withdrawal by Subject|1|||
147643792|NCT01004432|532516649|FG000|Open-label (OL) Period (Week 0 - 16)|Adverse Event|20|||
147643793|NCT01004432|532516650|FG001|Open-label (OL) Period (Week 0 - 16)|Adverse Event|0|||
147643794|NCT01004432|532516651|FG002|Open-label (OL) Period (Week 0 - 16)|Adverse Event|0|||
147643795|NCT01004432|532516652|FG003|Open-label (OL) Period (Week 0 - 16)|Adverse Event|0|||
147643796|NCT01004432|532516653|FG004|Open-label (OL) Period (Week 0 - 16)|Adverse Event|0|||
147643797|NCT01004432|532516649|FG000|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|29|||
147643798|NCT01004432|532516650|FG001|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|0|||
147643799|NCT01004432|532516651|FG002|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|0|||
147643800|NCT01004432|532516652|FG003|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|0|||
147643801|NCT01004432|532516653|FG004|Open-label (OL) Period (Week 0 - 16)|Protocol Violation|0|||
147643802|NCT01004432|532516649|FG000|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|17|||
147643803|NCT01004432|532516650|FG001|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|0|||
147643804|NCT01004432|532516651|FG002|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|0|||
147524210|NCT03490734|532069928|FG000|Post-intervention Scan Visit|Lost to Follow-up|0|||
147524211|NCT03490734|532069929|FG001|Post-intervention Scan Visit|Lost to Follow-up|1|||
147524212|NCT03490734|532069930|FG002|Post-intervention Scan Visit|Lost to Follow-up|0|||
147524213|NCT03490734|532069931|FG003|Post-intervention Scan Visit|Lost to Follow-up|0|||
147524214|NCT03490734|532069928|FG000|Post-intervention Scan Visit|Withdrawal by Subject|0|||
147524215|NCT03490734|532069929|FG001|Post-intervention Scan Visit|Withdrawal by Subject|2|||
147524216|NCT03490734|532069930|FG002|Post-intervention Scan Visit|Withdrawal by Subject|0|||
147524217|NCT03490734|532069931|FG003|Post-intervention Scan Visit|Withdrawal by Subject|3|||
147524218|NCT01849289|532069934|FG000|Overall Study|Adverse Event|3|||
147524219|NCT01849289|532069935|FG001|Overall Study|Adverse Event|3|||
147524220|NCT01849289|532069934|FG000|Overall Study|Protocol Violation|3|||
147524221|NCT01849289|532069935|FG001|Overall Study|Protocol Violation|3|||
147524222|NCT01849289|532069934|FG000|Overall Study|Withdrawal criteria|1|||
147524223|NCT01849289|532069935|FG001|Overall Study|Withdrawal criteria|0|||
147524224|NCT01849289|532069934|FG000|Overall Study|Unclassified|25|||
147524225|NCT01849289|532069935|FG001|Overall Study|Unclassified|18|||
147524226|NCT00660816|532069936|FG000|Overall Study|Adverse Event|1|||
147524227|NCT00660816|532069937|FG001|Overall Study|Adverse Event|2|||
147524228|NCT00660816|532069936|FG000|Overall Study|Withdrawal by Subject|1|||
147524229|NCT00660816|532069937|FG001|Overall Study|Withdrawal by Subject|0|||
147524230|NCT00660816|532069936|FG000|Overall Study|Death|0|||
147524231|NCT00660816|532069937|FG001|Overall Study|Death|2|||
147524232|NCT00660816|532069936|FG000|Overall Study|Lack of Efficacy|1|||
147524233|NCT00660816|532069937|FG001|Overall Study|Lack of Efficacy|0|||
147524234|NCT00660816|532069936|FG000|Overall Study|Physician Decision|0|||
147524235|NCT00660816|532069937|FG001|Overall Study|Physician Decision|2|||
147524236|NCT00660816|532069936|FG000|Overall Study|Protocol Violation|1|||
147524237|NCT00660816|532069937|FG001|Overall Study|Protocol Violation|0|||
147524238|NCT00660816|532069936|FG000|Overall Study|Disease Progression|16|||
147524239|NCT00660816|532069937|FG001|Overall Study|Disease Progression|12|||
147524240|NCT00660816|532069936|FG000|Overall Study|Complicating Disease|0|||
147524241|NCT00660816|532069937|FG001|Overall Study|Complicating Disease|1|||
147524242|NCT01058356|532069952|FG000|Overall Study|Adverse Event|5|||
147524243|NCT01058356|532069952|FG000|Overall Study|Administration of contraindicated drugs|12|||
147524244|NCT01058356|532069952|FG000|Overall Study|Withdrawal by Subject|21|||
147524245|NCT01058356|532069952|FG000|Overall Study|Lost to Follow-up|4|||
147524246|NCT02993783|532069953|FG000|Overall Study|Reason not Specified|6|||
147524247|NCT02993783|532069954|FG001|Overall Study|Reason not Specified|9|||
147524248|NCT01899729|532069959|FG000|Overall Study|Adverse Event|1|||
147524249|NCT01899729|532069960|FG001|Overall Study|Adverse Event|0|||
147524250|NCT01899729|532069961|FG002|Overall Study|Adverse Event|0|||
147524251|NCT01899729|532069962|FG003|Overall Study|Adverse Event|0|||
147524252|NCT01899729|532069963|FG004|Overall Study|Adverse Event|1|||
147524253|NCT01899729|532069959|FG000|Overall Study|Withdrawal by Subject|1|||
147524254|NCT01899729|532069960|FG001|Overall Study|Withdrawal by Subject|2|||
147524255|NCT01899729|532069961|FG002|Overall Study|Withdrawal by Subject|0|||
147524256|NCT01899729|532069962|FG003|Overall Study|Withdrawal by Subject|0|||
147524257|NCT01899729|532069963|FG004|Overall Study|Withdrawal by Subject|0|||
147524258|NCT01899729|532069959|FG000|Overall Study|Lack of Efficacy|0|||
147524259|NCT01899729|532069960|FG001|Overall Study|Lack of Efficacy|0|||
147524260|NCT01899729|532069961|FG002|Overall Study|Lack of Efficacy|2|||
147524261|NCT01899729|532069962|FG003|Overall Study|Lack of Efficacy|0|||
147524262|NCT01899729|532069963|FG004|Overall Study|Lack of Efficacy|1|||
147524263|NCT01454531|532069964|FG000|Overall Study|Adverse Event|14|||
147524264|NCT01454531|532069964|FG000|Overall Study|Withdrawal by Subject|5|||
147524265|NCT01454531|532069964|FG000|Overall Study|Lost to Follow-up|1|||
147524266|NCT01454531|532069964|FG000|Overall Study|Physician Decision|1|||
147524267|NCT01454531|532069964|FG000|Overall Study|Delay in IMP administration|1|||
147524268|NCT01454531|532069964|FG000|Overall Study|Other|1|||
147524269|NCT01277666|532069966|FG000|Overall Study|Adverse Event|26|||
147524270|NCT01277666|532069967|FG001|Overall Study|Adverse Event|25|||
147524271|NCT01277666|532069968|FG002|Overall Study|Adverse Event|20|||
147524272|NCT01277666|532069966|FG000|Overall Study|Lack of Efficacy|8|||
147524273|NCT01277666|532069967|FG001|Overall Study|Lack of Efficacy|20|||
147524274|NCT01277666|532069968|FG002|Overall Study|Lack of Efficacy|12|||
147524275|NCT01277666|532069966|FG000|Overall Study|Protocol Violation|2|||
147524276|NCT01277666|532069967|FG001|Overall Study|Protocol Violation|3|||
147524277|NCT01277666|532069968|FG002|Overall Study|Protocol Violation|2|||
147524278|NCT01277666|532069966|FG000|Overall Study|Protocol Defined Stopping criteria|1|||
147524279|NCT01277666|532069967|FG001|Overall Study|Protocol Defined Stopping criteria|2|||
147524280|NCT01277666|532069968|FG002|Overall Study|Protocol Defined Stopping criteria|6|||
147524281|NCT01277666|532069966|FG000|Overall Study|Lost to Follow-up|1|||
147524282|NCT01277666|532069967|FG001|Overall Study|Lost to Follow-up|1|||
147524283|NCT01277666|532069968|FG002|Overall Study|Lost to Follow-up|2|||
147524284|NCT01277666|532069966|FG000|Overall Study|Withdrawal by Subject|7|||
147524285|NCT01277666|532069967|FG001|Overall Study|Withdrawal by Subject|8|||
147524286|NCT01277666|532069968|FG002|Overall Study|Withdrawal by Subject|6|||
147524287|NCT01277666|532069966|FG000|Overall Study|Death|0|||
147524288|NCT01277666|532069967|FG001|Overall Study|Death|0|||
147524289|NCT01277666|532069968|FG002|Overall Study|Death|1|||
147524290|NCT00027846|532072616|FG000|Overall Study|Lost to Follow-up|0|||
147524291|NCT00027846|532072617|FG001|Overall Study|Lost to Follow-up|41|||
147524292|NCT00027846|532072618|FG002|Overall Study|Lost to Follow-up|9|||
147524293|NCT00027846|532072616|FG000|Overall Study|Withdrawal by Subject|0|||
147524294|NCT00027846|532072617|FG001|Overall Study|Withdrawal by Subject|14|||
147524295|NCT00027846|532072618|FG002|Overall Study|Withdrawal by Subject|7|||
147524296|NCT00027846|532072616|FG000|Overall Study|Ineligible for study|2|||
147524297|NCT00027846|532072617|FG001|Overall Study|Ineligible for study|6|||
147524298|NCT00027846|532072618|FG002|Overall Study|Ineligible for study|14|||
147524299|NCT00027846|532072616|FG000|Overall Study|Entry into another COG therapeutic study|0|||
147524300|NCT00027846|532072617|FG001|Overall Study|Entry into another COG therapeutic study|5|||
147524301|NCT00027846|532072618|FG002|Overall Study|Entry into another COG therapeutic study|2|||
147524302|NCT00027846|532072616|FG000|Overall Study|Neuraxis dissemination during/after ther|0|||
147524303|NCT00027846|532072617|FG001|Overall Study|Neuraxis dissemination during/after ther|2|||
147524304|NCT00027846|532072618|FG002|Overall Study|Neuraxis dissemination during/after ther|5|||
147524305|NCT01354964|532072619|FG000|Overall Study|Lost to Follow-up|2|||
147524306|NCT01354964|532072620|FG001|Overall Study|Lost to Follow-up|0|||
147524307|NCT01354964|532072619|FG000|Overall Study|IV access issues|1|||
147524308|NCT01354964|532072620|FG001|Overall Study|IV access issues|1|||
147524309|NCT01354964|532072619|FG000|Overall Study|Physician Decision|1|||
147524310|NCT01354964|532072620|FG001|Overall Study|Physician Decision|0|||
147524311|NCT00711009|532072621|FG000|Overall Study|Adverse Event/HIV-Related Event|4|||
147524312|NCT00711009|532072622|FG001|Overall Study|Adverse Event/HIV-Related Event|5|||
147524313|NCT00711009|532072621|FG000|Overall Study|Withdrawal by Subject|4|||
147524314|NCT00711009|532072622|FG001|Overall Study|Withdrawal by Subject|2|||
147524315|NCT00711009|532072621|FG000|Overall Study|Lost to Follow-up|3|||
147524316|NCT00711009|532072622|FG001|Overall Study|Lost to Follow-up|9|||
147524317|NCT00711009|532072621|FG000|Overall Study|Participant Noncompliant|0|||
147524318|NCT00711009|532072622|FG001|Overall Study|Participant Noncompliant|1|||
147524319|NCT00711009|532072621|FG000|Overall Study|Virologic Failure|2|||
147524320|NCT00711009|532072622|FG001|Overall Study|Virologic Failure|1|||
147524321|NCT00711009|532072621|FG000|Overall Study|Pregnancy|1|||
147524322|NCT00711009|532072622|FG001|Overall Study|Pregnancy|0|||
147524323|NCT00711009|532072621|FG000|Overall Study|Site closing|0|||
147524324|NCT00711009|532072622|FG001|Overall Study|Site closing|1|||
147524325|NCT00711009|532072621|FG000|Overall Study|Dose adjustment|1|||
147524326|NCT00711009|532072622|FG001|Overall Study|Dose adjustment|0|||
147524327|NCT01459016|532072624|FG000|Overall Study|Withdrawal by Subject|11|||
147524328|NCT01459016|532072624|FG000|Overall Study|Amendment Discontinuation Criteria|4|||
147524329|NCT00303602|532072628|FG000|Overall Study|Adverse Event|2|||
147524330|NCT00303602|532072629|FG001|Overall Study|Adverse Event|2|||
147524331|NCT00303602|532072628|FG000|Overall Study|Withdrawal by Subject|5|||
147524332|NCT00303602|532072629|FG001|Overall Study|Withdrawal by Subject|6|||
147524333|NCT00303602|532072628|FG000|Overall Study|Lost to Follow-up|5|||
147524334|NCT00303602|532072629|FG001|Overall Study|Lost to Follow-up|2|||
147524335|NCT00303602|532072628|FG000|Overall Study|Protocol entry criteria not met|2|||
147524336|NCT00303602|532072629|FG001|Overall Study|Protocol entry criteria not met|2|||
147524337|NCT00303602|532072628|FG000|Overall Study|Physician Decision|2|||
147524338|NCT00303602|532072629|FG001|Overall Study|Physician Decision|1|||
147524339|NCT00303602|532072628|FG000|Overall Study|Noncompliance|2|||
147524340|NCT00303602|532072629|FG001|Overall Study|Noncompliance|2|||
147524341|NCT00303602|532072628|FG000|Overall Study|Protocol Violation|1|||
147524342|NCT00303602|532072629|FG001|Overall Study|Protocol Violation|0|||
147524343|NCT02551874|532072636|FG000|Overall Study|Lost to Follow-up|0|||
147524344|NCT02551874|532072637|FG001|Overall Study|Lost to Follow-up|2|||
147524345|NCT02551874|532072636|FG000|Overall Study|Pregnancy|0|||
147524346|NCT02551874|532072637|FG001|Overall Study|Pregnancy|1|||
147524347|NCT02551874|532072636|FG000|Overall Study|Reason not reported|10|||
147524348|NCT02551874|532072637|FG001|Overall Study|Reason not reported|4|||
147524349|NCT02551874|532072636|FG000|Overall Study|Did not receive randomized treatment|0|||
147524350|NCT02551874|532072637|FG001|Overall Study|Did not receive randomized treatment|7|||
147524351|NCT02551874|532072636|FG000|Overall Study|Did not enter long-term study|18|||
147524352|NCT02551874|532072637|FG001|Overall Study|Did not enter long-term study|25|||
147524353|NCT00313716|532072638|FG000|Overall Study|Death|3|||
147524354|NCT00313716|532072639|FG001|Overall Study|Death|2|||
147524355|NCT00313716|532072640|FG002|Overall Study|Death|9|||
147524356|NCT00313716|532072641|FG003|Overall Study|Death|3|||
147524357|NCT00313716|532072642|FG004|Overall Study|Death|5|||
147524358|NCT00313716|532072643|FG005|Overall Study|Death|9|||
147524359|NCT00313716|532072638|FG000|Overall Study|Lost to Follow-up|2|||
147524360|NCT00313716|532072639|FG001|Overall Study|Lost to Follow-up|5|||
147524361|NCT00313716|532072640|FG002|Overall Study|Lost to Follow-up|2|||
147524362|NCT00313716|532072641|FG003|Overall Study|Lost to Follow-up|1|||
147524363|NCT00313716|532072642|FG004|Overall Study|Lost to Follow-up|0|||
147524364|NCT00313716|532072643|FG005|Overall Study|Lost to Follow-up|4|||
147524365|NCT00313716|532072638|FG000|Overall Study|Withdrawal by Subject|0|||
147524366|NCT00313716|532072639|FG001|Overall Study|Withdrawal by Subject|1|||
147524367|NCT00313716|532072640|FG002|Overall Study|Withdrawal by Subject|1|||
147524368|NCT00313716|532072641|FG003|Overall Study|Withdrawal by Subject|0|||
147524369|NCT00313716|532072642|FG004|Overall Study|Withdrawal by Subject|1|||
147524370|NCT00313716|532072643|FG005|Overall Study|Withdrawal by Subject|0|||
147524371|NCT02491463|532072644|FG000|Overall Study|Withdrawal by Subject|1|||
147524372|NCT02491463|532072645|FG001|Overall Study|Withdrawal by Subject|2|||
147524373|NCT02491463|532072646|FG002|Overall Study|Withdrawal by Subject|0|||
147524374|NCT02491463|532072647|FG003|Overall Study|Withdrawal by Subject|0|||
147524375|NCT02491463|532072644|FG000|Overall Study|Migrated/moved from study area|1|||
147524376|NCT02491463|532072645|FG001|Overall Study|Migrated/moved from study area|5|||
147524377|NCT02491463|532072646|FG002|Overall Study|Migrated/moved from study area|1|||
147524378|NCT02491463|532072647|FG003|Overall Study|Migrated/moved from study area|1|||
147524379|NCT02491463|532072644|FG000|Overall Study|Lost to Follow-up|0|||
147524380|NCT02491463|532072645|FG001|Overall Study|Lost to Follow-up|3|||
147524381|NCT02491463|532072646|FG002|Overall Study|Lost to Follow-up|3|||
147524382|NCT02491463|532072647|FG003|Overall Study|Lost to Follow-up|0|||
147524383|NCT01491802|532072648|FG000|Overall Study|Adverse Event|1|||
147524384|NCT01491802|532072649|FG001|Overall Study|Adverse Event|1|||
147524385|NCT01491802|532072648|FG000|Overall Study|Withdrawal by Subject|0|||
147524386|NCT01491802|532072649|FG001|Overall Study|Withdrawal by Subject|1|||
147524387|NCT00663208|532072650|FG000|Treatment Period|Lost to Follow-up|0|||
147524388|NCT00663208|532072651|FG001|Treatment Period|Lost to Follow-up|1|||
147524389|NCT00663208|532072652|FG002|Treatment Period|Lost to Follow-up|0|||
147524390|NCT00663208|532072653|FG003|Treatment Period|Lost to Follow-up|0|||
147524391|NCT00663208|532072654|FG004|Treatment Period|Lost to Follow-up|0|||
147524392|NCT00663208|532072655|FG005|Treatment Period|Lost to Follow-up|0|||
147524393|NCT00663208|532072656|FG006|Treatment Period|Lost to Follow-up|0|||
147524394|NCT00663208|532072650|FG000|Follow-up Period|Lost to Follow-up|2|||
147524395|NCT00663208|532072651|FG001|Follow-up Period|Lost to Follow-up|0|||
147524396|NCT00663208|532072652|FG002|Follow-up Period|Lost to Follow-up|3|||
147524397|NCT00663208|532072653|FG003|Follow-up Period|Lost to Follow-up|2|||
147524398|NCT00663208|532072654|FG004|Follow-up Period|Lost to Follow-up|0|||
147524399|NCT00663208|532072655|FG005|Follow-up Period|Lost to Follow-up|0|||
147524400|NCT00663208|532072656|FG006|Follow-up Period|Lost to Follow-up|0|||
147524401|NCT00663208|532072650|FG000|Follow-up Period|Other reason|1|||
147524402|NCT00663208|532072651|FG001|Follow-up Period|Other reason|0|||
147524403|NCT00663208|532072652|FG002|Follow-up Period|Other reason|0|||
147524404|NCT00663208|532072653|FG003|Follow-up Period|Other reason|0|||
147524405|NCT00663208|532072654|FG004|Follow-up Period|Other reason|0|||
147524406|NCT00663208|532072655|FG005|Follow-up Period|Other reason|0|||
147524407|NCT00663208|532072656|FG006|Follow-up Period|Other reason|1|||
147524408|NCT00039377|532072659|FG000|Initial Registration|Adverse Event|2|||
147524409|NCT00039377|532072660|FG001|Initial Registration|Adverse Event|0|||
147524410|NCT00039377|532072661|FG002|Initial Registration|Adverse Event|0|||
147524411|NCT00039377|532072662|FG003|Initial Registration|Adverse Event|0|||
147524412|NCT00039377|532072659|FG000|Initial Registration|Relapsed|6|||
147524413|NCT00039377|532072660|FG001|Initial Registration|Relapsed|0|||
147524414|NCT00039377|532072661|FG002|Initial Registration|Relapsed|0|||
147524415|NCT00039377|532072662|FG003|Initial Registration|Relapsed|0|||
147524416|NCT00039377|532072659|FG000|Initial Registration|Received non-protocol therapy|11|||
147524417|NCT00039377|532072660|FG001|Initial Registration|Received non-protocol therapy|0|||
147524418|NCT00039377|532072661|FG002|Initial Registration|Received non-protocol therapy|0|||
147524419|NCT00039377|532072662|FG003|Initial Registration|Received non-protocol therapy|0|||
147524420|NCT00039377|532072659|FG000|Initial Registration|Withdrawal by Subject|3|||
147524421|NCT00039377|532072660|FG001|Initial Registration|Withdrawal by Subject|0|||
147524422|NCT00039377|532072661|FG002|Initial Registration|Withdrawal by Subject|0|||
147524423|NCT00039377|532072662|FG003|Initial Registration|Withdrawal by Subject|0|||
147524424|NCT04067310|532072666|FG000|Overall Study|Physician Decision|2|||
147524425|NCT04067310|532072667|FG001|Overall Study|Physician Decision|6|||
147524426|NCT04067310|532072666|FG000|Overall Study|Lost to Follow-up|0|||
147524427|NCT04067310|532072667|FG001|Overall Study|Lost to Follow-up|1|||
147524428|NCT04067310|532072666|FG000|Overall Study|Withdrawal by Subject|3|||
147524429|NCT04067310|532072667|FG001|Overall Study|Withdrawal by Subject|0|||
147524430|NCT01249404|532072668|FG000|Overall Study|Study treatment not received|0|||
147524431|NCT01249404|532072669|FG001|Overall Study|Study treatment not received|1|||
147524432|NCT01249404|532072670|FG002|Overall Study|Study treatment not received|2|||
147524433|NCT01249404|532072668|FG000|Overall Study|No MAS Score at baseline and/or Week 4|2|||
147524434|NCT01249404|532072669|FG001|Overall Study|No MAS Score at baseline and/or Week 4|0|||
147524435|NCT01249404|532072670|FG002|Overall Study|No MAS Score at baseline and/or Week 4|2|||
147524436|NCT01249404|532072668|FG000|Overall Study|Adverse Event|2|||
147524437|NCT01249404|532072669|FG001|Overall Study|Adverse Event|2|||
147524438|NCT01249404|532072670|FG002|Overall Study|Adverse Event|2|||
147524439|NCT01249404|532072668|FG000|Overall Study|Withdrawal by Subject|2|||
147524440|NCT01249404|532072669|FG001|Overall Study|Withdrawal by Subject|2|||
147524441|NCT01249404|532072670|FG002|Overall Study|Withdrawal by Subject|0|||
147524442|NCT01249404|532072668|FG000|Overall Study|Botulinum toxin (BTX) in upper limb|1|||
147524443|NCT01249404|532072669|FG001|Overall Study|Botulinum toxin (BTX) in upper limb|2|||
147524444|NCT01249404|532072670|FG002|Overall Study|Botulinum toxin (BTX) in upper limb|1|||
147524445|NCT01249404|532072668|FG000|Overall Study|Non compliance to visit schedule|0|||
147524446|NCT01249404|532072669|FG001|Overall Study|Non compliance to visit schedule|1|||
147524447|NCT01249404|532072670|FG002|Overall Study|Non compliance to visit schedule|0|||
147524448|NCT03890731|532072671|FG000|Overall Study|Progressive disease|1|||
147524449|NCT03890731|532072671|FG000|Overall Study|Patient's decision|1|||
147524450|NCT03890731|532072671|FG000|Overall Study|Adverse Event|4|||
147524451|NCT02058940|532072672|FG000|Overall Study|Discharged from Critical Care Unit|1|||
147524452|NCT01539720|532072683|FG000|Overall Study|Screen Fail|15|||
147524453|NCT01539720|532072684|FG001|Overall Study|Screen Fail|3|||
147524454|NCT01539720|532072683|FG000|Overall Study|Lost to Follow-up|14|||
147524455|NCT01539720|532072684|FG001|Overall Study|Lost to Follow-up|7|||
147524456|NCT00298766|532072685|FG000|Overall Study|Adverse Event|18|||
147524457|NCT00298766|532072685|FG000|Overall Study|Death|2|||
147524458|NCT00298766|532072685|FG000|Overall Study|Withdrawal by Subject|9|||
147524459|NCT00298766|532072685|FG000|Overall Study|Treatment ongoing|4|||
147524460|NCT00298766|532072685|FG000|Overall Study|Progression of amyloid markers|4|||
147524461|NCT00298766|532072685|FG000|Overall Study|Deterioration in KPS and organ function|1|||
147524462|NCT00298766|532072685|FG000|Overall Study|Subjects overall condition deterioration|4|||
147524463|NCT00298766|532072685|FG000|Overall Study|Other|4|||
147524464|NCT02500901|532072688|FG000|Overall Study|Disease ProgressionDD|2|||
147524465|NCT00656136|532072689|FG000|Overall Study|Progressive disease|177|||
147524466|NCT00656136|532072690|FG001|Overall Study|Progressive disease|322|||
147524467|NCT00656136|532072689|FG000|Overall Study|Other Adverse Event|5|||
147524468|NCT00656136|532072690|FG001|Overall Study|Other Adverse Event|51|||
147524469|NCT00656136|532072689|FG000|Overall Study|Protocol Violation|2|||
147524470|NCT00656136|532072690|FG001|Overall Study|Protocol Violation|3|||
147524471|NCT00656136|532072689|FG000|Overall Study|Patient refused to take study medication|7|||
147524472|NCT00656136|532072690|FG001|Overall Study|Patient refused to take study medication|10|||
147524473|NCT00656136|532072689|FG000|Overall Study|Unknown and others|4|||
147524474|NCT00656136|532072690|FG001|Overall Study|Unknown and others|4|||
147524475|NCT01345162|532072696|FG000|Overall Study|Protocol Violation|2|||
147524476|NCT01345162|532072697|FG001|Overall Study|Protocol Violation|4|||
147524477|NCT02242305|532072698|FG000|Overall Study|Without spasm-like pain during 3 weeks|1|||
147524478|NCT02242305|532072699|FG001|Overall Study|Without spasm-like pain during 3 weeks|4|||
147524479|NCT02242305|532072698|FG000|Overall Study|Adverse Event|1|||
147524480|NCT02242305|532072699|FG001|Overall Study|Adverse Event|0|||
147524481|NCT02242305|532072698|FG000|Overall Study|Non-compliance dosing regimen or visit|2|||
147524482|NCT02242305|532072699|FG001|Overall Study|Non-compliance dosing regimen or visit|2|||
147524483|NCT02242305|532072698|FG000|Overall Study|Subject withdraws inform consent|0|||
147524484|NCT02242305|532072699|FG001|Overall Study|Subject withdraws inform consent|4|||
147524485|NCT02242305|532072698|FG000|Overall Study|Lost to Follow-up|2|||
147524486|NCT02242305|532072699|FG001|Overall Study|Lost to Follow-up|0|||
147524487|NCT03018028|532072703|FG000|Overall Study|Withdrawal by Subject|3|||
147524488|NCT03018028|532072704|FG001|Overall Study|Withdrawal by Subject|0|||
147524489|NCT03018028|532072705|FG002|Overall Study|Withdrawal by Subject|1|||
147524490|NCT03018028|532072706|FG003|Overall Study|Withdrawal by Subject|2|||
147524491|NCT03018028|532072707|FG004|Overall Study|Withdrawal by Subject|0|||
147524492|NCT01957111|532072716|FG000|Overall Study|Withdrawal by Subject|1|||
147524493|NCT01957111|532072717|FG001|Overall Study|Withdrawal by Subject|1|||
147524494|NCT03644173|532072720|FG000|Participants at Last Visit (Pre-surveys)|Lost to Follow-up|21|||
147524495|NCT03644173|532072720|FG000|Participants at the 1-month Follow up|Lost to Follow-up|2|||
147524496|NCT03644173|532072720|FG000|Participants at the 1-month Follow up|Death|2|||
147524497|NCT03644173|532072720|FG000|Participants at the 3-month Follow up|Lost to Follow-up|2|||
147524498|NCT03500419|532072721|FG000|Overall Study|Withdrawal by Subject|2|||
147524499|NCT03500419|532072722|FG001|Overall Study|Withdrawal by Subject|25|||
147524500|NCT00082628|532072729|FG000|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0|||
147524501|NCT00082628|532072730|FG001|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|1|||
147524502|NCT00082628|532072731|FG002|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0|||
147524503|NCT00082628|532072732|FG003|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0|||
147524504|NCT00082628|532072733|FG004|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Receive Study Drug|0|||
147524505|NCT00082628|532072729|FG000|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|2|||
147524506|NCT00082628|532072730|FG001|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|1|||
147524507|NCT00082628|532072731|FG002|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|0|||
147524508|NCT00082628|532072732|FG003|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|0|||
147524509|NCT00082628|532072733|FG004|Treatment Period I (Week 1 to Week 12)|Subjects Without Post-Baseline Assessmen|0|||
147524510|NCT00082628|532072729|FG000|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|5|||
147524511|NCT00082628|532072730|FG001|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|43|||
147524512|NCT00082628|532072731|FG002|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|0|||
147524513|NCT00082628|532072732|FG003|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|0|||
147524514|NCT00082628|532072733|FG004|Treatment Period I (Week 1 to Week 12)|Subjects Did Not Complete Week 12|0|||
147524515|NCT00082628|532072729|FG000|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|1|||
147524516|NCT00082628|532072730|FG001|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|15|||
147524517|NCT00082628|532072731|FG002|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|0|||
147524518|NCT00082628|532072732|FG003|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|0|||
147524519|NCT00082628|532072733|FG004|Treatment Period I (Week 1 to Week 12)|Did not continue to Period II|0|||
147524520|NCT00082628|532072729|FG000|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0|||
147524521|NCT00082628|532072730|FG001|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0|||
147524522|NCT00082628|532072731|FG002|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0|||
147524523|NCT00082628|532072732|FG003|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|0|||
147524524|NCT00082628|532072733|FG004|Treatment Period II: Week 12 to Week 36|Lost to Follow-up|1|||
147524525|NCT00082628|532072729|FG000|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0|||
147524526|NCT00082628|532072730|FG001|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0|||
147524527|NCT00082628|532072731|FG002|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0|||
147524528|NCT00082628|532072732|FG003|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|1|||
147524529|NCT00082628|532072733|FG004|Treatment Period II: Week 12 to Week 36|Withdrawal by Subject|0|||
147524530|NCT00082628|532072729|FG000|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|0|||
147524531|NCT00082628|532072730|FG001|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|0|||
147524532|NCT00082628|532072731|FG002|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|15|||
147524533|NCT00082628|532072732|FG003|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|15|||
147524534|NCT00082628|532072733|FG004|Treatment Period II: Week 12 to Week 36|Subjects Did Not Complete Week 36|17|||
147524535|NCT00994890|532072742|FG000|Overall Study|Adverse Event|13|||
147524536|NCT00994890|532072743|FG001|Overall Study|Adverse Event|9|||
147524537|NCT00994890|532072744|FG002|Overall Study|Adverse Event|11|||
147524538|NCT00994890|532072742|FG000|Overall Study|Lack of Efficacy|0|||
147524539|NCT00994890|532072743|FG001|Overall Study|Lack of Efficacy|0|||
147524540|NCT00994890|532072744|FG002|Overall Study|Lack of Efficacy|1|||
147524541|NCT00994890|532072742|FG000|Overall Study|Lost to Follow-up|6|||
147524542|NCT00994890|532072743|FG001|Overall Study|Lost to Follow-up|1|||
147524543|NCT00994890|532072744|FG002|Overall Study|Lost to Follow-up|3|||
147524544|NCT00994890|532072742|FG000|Overall Study|No longer willing to participate|8|||
147524545|NCT00994890|532072743|FG001|Overall Study|No longer willing to participate|5|||
147524546|NCT00994890|532072744|FG002|Overall Study|No longer willing to participate|13|||
147524547|NCT00994890|532072742|FG000|Overall Study|Protocol Violation|2|||
147524548|NCT00994890|532072743|FG001|Overall Study|Protocol Violation|4|||
147524549|NCT00994890|532072744|FG002|Overall Study|Protocol Violation|0|||
147524550|NCT00994890|532072742|FG000|Overall Study|Study terminated by sponsor|199|||
147524551|NCT00994890|532072743|FG001|Overall Study|Study terminated by sponsor|201|||
147524552|NCT00994890|532072744|FG002|Overall Study|Study terminated by sponsor|197|||
147524553|NCT00994890|532072742|FG000|Overall Study|Randomized, but not treated|1|||
147524554|NCT00994890|532072743|FG001|Overall Study|Randomized, but not treated|0|||
147524555|NCT00994890|532072744|FG002|Overall Study|Randomized, but not treated|0|||
147524556|NCT00994890|532072742|FG000|Overall Study|Other|2|||
147524557|NCT00994890|532072743|FG001|Overall Study|Other|2|||
147524558|NCT00994890|532072744|FG002|Overall Study|Other|1|||
147524559|NCT03323385|532072749|FG000|Overall Study|Withdrawal by Subject|1|||
147524560|NCT03323385|532072750|FG001|Overall Study|Withdrawal by Subject|2|||
147524561|NCT03323385|532072749|FG000|Overall Study|Noncompliance|0|||
147524562|NCT03323385|532072750|FG001|Overall Study|Noncompliance|1|||
147524563|NCT00699582|532072751|FG000|Overall Study|Adverse Event|4|||
147524564|NCT00699582|532072752|FG001|Overall Study|Adverse Event|11|||
147524565|NCT00699582|532072753|FG002|Overall Study|Adverse Event|23|||
147524566|NCT00699582|532072751|FG000|Overall Study|Withdrawal by Subject|6|||
147524567|NCT00699582|532072752|FG001|Overall Study|Withdrawal by Subject|7|||
147524568|NCT00699582|532072753|FG002|Overall Study|Withdrawal by Subject|4|||
147524569|NCT00699582|532072751|FG000|Overall Study|Lack of Efficacy|1|||
147524570|NCT00699582|532072752|FG001|Overall Study|Lack of Efficacy|0|||
147524571|NCT00699582|532072753|FG002|Overall Study|Lack of Efficacy|1|||
147524572|NCT00699582|532072751|FG000|Overall Study|Progressive Disease|1|||
147524573|NCT00699582|532072752|FG001|Overall Study|Progressive Disease|0|||
147524574|NCT00699582|532072753|FG002|Overall Study|Progressive Disease|0|||
147524575|NCT00699582|532072751|FG000|Overall Study|Administrative/Other|4|||
147524576|NCT00699582|532072752|FG001|Overall Study|Administrative/Other|3|||
147524577|NCT00699582|532072753|FG002|Overall Study|Administrative/Other|0|||
147524578|NCT00699582|532072751|FG000|Overall Study|Randomized, Not Treated|2|||
147524579|NCT00699582|532072752|FG001|Overall Study|Randomized, Not Treated|1|||
147524580|NCT00699582|532072753|FG002|Overall Study|Randomized, Not Treated|0|||
147524581|NCT00352027|532072756|FG000|Overall Study|Progressive disease|3|||
147524582|NCT04491591|532072757|FG000|Overall Study|Accidently randomized|3|||
147524583|NCT04491591|532072758|FG001|Overall Study|Accidently randomized|1|||
147524584|NCT04491591|532072759|FG002|Overall Study|Accidently randomized|0|||
147524585|NCT04491591|532072757|FG000|Overall Study|Did not complete survey|28|||
147524586|NCT04491591|532072758|FG001|Overall Study|Did not complete survey|20|||
147524587|NCT04491591|532072759|FG002|Overall Study|Did not complete survey|3|||
147524588|NCT03099304|532072763|FG000|DB Period: Day 1 to Week 24|Adverse Event|1|||
147524589|NCT03099304|532072764|FG001|DB Period: Day 1 to Week 24|Adverse Event|1|||
147524590|NCT03099304|532072765|FG002|DB Period: Day 1 to Week 24|Adverse Event|0|||
147524591|NCT03099304|532072766|FG003|DB Period: Day 1 to Week 24|Adverse Event|0|||
147524592|NCT03099304|532072767|FG004|DB Period: Day 1 to Week 24|Adverse Event|1|||
147524593|NCT03099304|532072768|FG005|DB Period: Day 1 to Week 24|Adverse Event|0|||
147524594|NCT03099304|532072763|FG000|DB Period: Day 1 to Week 24|Lost to Follow-up|1|||
147524595|NCT03099304|532072764|FG001|DB Period: Day 1 to Week 24|Lost to Follow-up|1|||
147524596|NCT03099304|532072765|FG002|DB Period: Day 1 to Week 24|Lost to Follow-up|0|||
147524597|NCT03099304|532072766|FG003|DB Period: Day 1 to Week 24|Lost to Follow-up|0|||
147524598|NCT03099304|532072767|FG004|DB Period: Day 1 to Week 24|Lost to Follow-up|0|||
147524599|NCT03099304|532072768|FG005|DB Period: Day 1 to Week 24|Lost to Follow-up|0|||
147524600|NCT03099304|532072763|FG000|DB Period: Day 1 to Week 24|Reason not specified|0|||
147524601|NCT03099304|532072764|FG001|DB Period: Day 1 to Week 24|Reason not specified|0|||
147524602|NCT03099304|532072765|FG002|DB Period: Day 1 to Week 24|Reason not specified|0|||
147524603|NCT03099304|532072766|FG003|DB Period: Day 1 to Week 24|Reason not specified|1|||
147524604|NCT03099304|532072767|FG004|DB Period: Day 1 to Week 24|Reason not specified|0|||
147524605|NCT03099304|532072768|FG005|DB Period: Day 1 to Week 24|Reason not specified|0|||
147524606|NCT03099304|532072763|FG000|DB Period: Day 1 to Week 24|Withdrawal by Subject|3|||
147524607|NCT03099304|532072764|FG001|DB Period: Day 1 to Week 24|Withdrawal by Subject|3|||
147524608|NCT03099304|532072765|FG002|DB Period: Day 1 to Week 24|Withdrawal by Subject|0|||
147524609|NCT03099304|532072766|FG003|DB Period: Day 1 to Week 24|Withdrawal by Subject|2|||
147524610|NCT03099304|532072767|FG004|DB Period: Day 1 to Week 24|Withdrawal by Subject|2|||
147524611|NCT03099304|532072768|FG005|DB Period: Day 1 to Week 24|Withdrawal by Subject|0|||
147524612|NCT03099304|532072763|FG000|DB Period: Day 1 to Week 24|Protocol Violation|0|||
147524613|NCT03099304|532072764|FG001|DB Period: Day 1 to Week 24|Protocol Violation|0|||
147524614|NCT03099304|532072765|FG002|DB Period: Day 1 to Week 24|Protocol Violation|1|||
147524615|NCT03099304|532072766|FG003|DB Period: Day 1 to Week 24|Protocol Violation|1|||
147524616|NCT03099304|532072767|FG004|DB Period: Day 1 to Week 24|Protocol Violation|0|||
147524617|NCT03099304|532072768|FG005|DB Period: Day 1 to Week 24|Protocol Violation|0|||
147524618|NCT03099304|532072763|FG000|DB Period: Weeks 24 to 52|Protocol Violation|0|||
147524619|NCT03099304|532072764|FG001|DB Period: Weeks 24 to 52|Protocol Violation|0|||
147524620|NCT03099304|532072765|FG002|DB Period: Weeks 24 to 52|Protocol Violation|1|||
147524621|NCT03099304|532072766|FG003|DB Period: Weeks 24 to 52|Protocol Violation|0|||
147524622|NCT03099304|532072767|FG004|DB Period: Weeks 24 to 52|Protocol Violation|0|||
147524623|NCT03099304|532072768|FG005|DB Period: Weeks 24 to 52|Protocol Violation|0|||
147524624|NCT03099304|532072763|FG000|DB Period: Weeks 24 to 52|Lost to Follow-up|0|||
147524625|NCT03099304|532072764|FG001|DB Period: Weeks 24 to 52|Lost to Follow-up|1|||
147524626|NCT03099304|532072765|FG002|DB Period: Weeks 24 to 52|Lost to Follow-up|1|||
147524627|NCT03099304|532072766|FG003|DB Period: Weeks 24 to 52|Lost to Follow-up|1|||
147524628|NCT03099304|532072767|FG004|DB Period: Weeks 24 to 52|Lost to Follow-up|0|||
147524629|NCT03099304|532072768|FG005|DB Period: Weeks 24 to 52|Lost to Follow-up|0|||
147524630|NCT03099304|532072763|FG000|DB Period: Weeks 24 to 52|Adverse Event|0|||
147524631|NCT03099304|532072764|FG001|DB Period: Weeks 24 to 52|Adverse Event|0|||
147524632|NCT03099304|532072765|FG002|DB Period: Weeks 24 to 52|Adverse Event|0|||
147524633|NCT03099304|532072766|FG003|DB Period: Weeks 24 to 52|Adverse Event|1|||
147524634|NCT03099304|532072767|FG004|DB Period: Weeks 24 to 52|Adverse Event|1|||
147524635|NCT03099304|532072768|FG005|DB Period: Weeks 24 to 52|Adverse Event|0|||
147524636|NCT03099304|532072763|FG000|DB Period: Weeks 24 to 52|Withdrawal by Subject|0|||
147524637|NCT03099304|532072764|FG001|DB Period: Weeks 24 to 52|Withdrawal by Subject|0|||
147524638|NCT03099304|532072765|FG002|DB Period: Weeks 24 to 52|Withdrawal by Subject|0|||
147524639|NCT03099304|532072766|FG003|DB Period: Weeks 24 to 52|Withdrawal by Subject|4|||
147524640|NCT03099304|532072767|FG004|DB Period: Weeks 24 to 52|Withdrawal by Subject|1|||
147524641|NCT03099304|532072768|FG005|DB Period: Weeks 24 to 52|Withdrawal by Subject|0|||
147524642|NCT03099304|532072763|FG000|DB Period: Weeks 24 to 52|Reason not specified|0|||
147524643|NCT03099304|532072764|FG001|DB Period: Weeks 24 to 52|Reason not specified|0|||
147524644|NCT03099304|532072765|FG002|DB Period: Weeks 24 to 52|Reason not specified|0|||
147524645|NCT03099304|532072766|FG003|DB Period: Weeks 24 to 52|Reason not specified|1|||
147524646|NCT03099304|532072767|FG004|DB Period: Weeks 24 to 52|Reason not specified|0|||
147524647|NCT03099304|532072768|FG005|DB Period: Weeks 24 to 52|Reason not specified|0|||
147524648|NCT03099304|532072763|FG000|104-week Open-Label Extension Period|Adverse Event|0|||
147524649|NCT03099304|532072764|FG001|104-week Open-Label Extension Period|Adverse Event|0|||
147524650|NCT03099304|532072765|FG002|104-week Open-Label Extension Period|Adverse Event|1|||
147524651|NCT03099304|532072766|FG003|104-week Open-Label Extension Period|Adverse Event|0|||
147524652|NCT03099304|532072767|FG004|104-week Open-Label Extension Period|Adverse Event|0|||
147524653|NCT03099304|532072768|FG005|104-week Open-Label Extension Period|Adverse Event|0|||
147524654|NCT03099304|532072763|FG000|104-week Open-Label Extension Period|Lost to Follow-up|0|||
147524655|NCT03099304|532072764|FG001|104-week Open-Label Extension Period|Lost to Follow-up|0|||
147524656|NCT03099304|532072765|FG002|104-week Open-Label Extension Period|Lost to Follow-up|3|||
147524657|NCT03099304|532072766|FG003|104-week Open-Label Extension Period|Lost to Follow-up|2|||
147524658|NCT03099304|532072767|FG004|104-week Open-Label Extension Period|Lost to Follow-up|1|||
147524659|NCT03099304|532072768|FG005|104-week Open-Label Extension Period|Lost to Follow-up|6|||
147524660|NCT03099304|532072763|FG000|104-week Open-Label Extension Period|Physician Decision|0|||
147524661|NCT03099304|532072764|FG001|104-week Open-Label Extension Period|Physician Decision|0|||
147524662|NCT03099304|532072765|FG002|104-week Open-Label Extension Period|Physician Decision|0|||
147524663|NCT03099304|532072766|FG003|104-week Open-Label Extension Period|Physician Decision|0|||
147524664|NCT03099304|532072767|FG004|104-week Open-Label Extension Period|Physician Decision|1|||
147524665|NCT03099304|532072768|FG005|104-week Open-Label Extension Period|Physician Decision|0|||
147524666|NCT03099304|532072763|FG000|104-week Open-Label Extension Period|Pregnancy|0|||
147524667|NCT03099304|532072764|FG001|104-week Open-Label Extension Period|Pregnancy|0|||
147524668|NCT03099304|532072765|FG002|104-week Open-Label Extension Period|Pregnancy|0|||
147524669|NCT03099304|532072766|FG003|104-week Open-Label Extension Period|Pregnancy|0|||
147524670|NCT03099304|532072767|FG004|104-week Open-Label Extension Period|Pregnancy|0|||
147524671|NCT03099304|532072768|FG005|104-week Open-Label Extension Period|Pregnancy|1|||
147524672|NCT03099304|532072763|FG000|104-week Open-Label Extension Period|Protocol Violation|0|||
147524673|NCT03099304|532072764|FG001|104-week Open-Label Extension Period|Protocol Violation|0|||
147524674|NCT03099304|532072765|FG002|104-week Open-Label Extension Period|Protocol Violation|0|||
147524675|NCT03099304|532072766|FG003|104-week Open-Label Extension Period|Protocol Violation|0|||
147524676|NCT03099304|532072767|FG004|104-week Open-Label Extension Period|Protocol Violation|0|||
147524677|NCT03099304|532072768|FG005|104-week Open-Label Extension Period|Protocol Violation|1|||
147524678|NCT03099304|532072763|FG000|104-week Open-Label Extension Period|Withdrawal by Subject|0|||
147524679|NCT03099304|532072764|FG001|104-week Open-Label Extension Period|Withdrawal by Subject|0|||
147524680|NCT03099304|532072765|FG002|104-week Open-Label Extension Period|Withdrawal by Subject|9|||
147524681|NCT03099304|532072766|FG003|104-week Open-Label Extension Period|Withdrawal by Subject|10|||
147524682|NCT03099304|532072767|FG004|104-week Open-Label Extension Period|Withdrawal by Subject|13|||
147524683|NCT03099304|532072768|FG005|104-week Open-Label Extension Period|Withdrawal by Subject|15|||
147524684|NCT03099304|532072763|FG000|104-week Open-Label Extension Period|Other Reason not specified|0|||
147524685|NCT03099304|532072764|FG001|104-week Open-Label Extension Period|Other Reason not specified|0|||
147524686|NCT03099304|532072765|FG002|104-week Open-Label Extension Period|Other Reason not specified|4|||
147524687|NCT03099304|532072766|FG003|104-week Open-Label Extension Period|Other Reason not specified|1|||
147524688|NCT03099304|532072767|FG004|104-week Open-Label Extension Period|Other Reason not specified|1|||
147524689|NCT03099304|532072768|FG005|104-week Open-Label Extension Period|Other Reason not specified|0|||
147524690|NCT02692560|532072769|FG000|Overall Study|Withdrawal by Subject|0|||
147524691|NCT02692560|532072770|FG001|Overall Study|Withdrawal by Subject|6|||
147524692|NCT00715949|532072773|FG000|Overall Study|could not finish first test|4|||
147524693|NCT00420212|532072774|FG000|Overall Study|Adverse Event|22|||
147524694|NCT00420212|532072775|FG001|Overall Study|Adverse Event|40|||
147524695|NCT00420212|532072776|FG002|Overall Study|Adverse Event|36|||
147524696|NCT00420212|532072774|FG000|Overall Study|Lost to Follow-up|9|||
147524697|NCT00420212|532072775|FG001|Overall Study|Lost to Follow-up|11|||
147524698|NCT00420212|532072776|FG002|Overall Study|Lost to Follow-up|11|||
147524699|NCT00420212|532072774|FG000|Overall Study|Withdrawal by Subject|31|||
147524700|NCT00420212|532072775|FG001|Overall Study|Withdrawal by Subject|22|||
147524701|NCT00420212|532072776|FG002|Overall Study|Withdrawal by Subject|19|||
147524702|NCT00420212|532072774|FG000|Overall Study|Physician Decision|4|||
147524703|NCT00420212|532072775|FG001|Overall Study|Physician Decision|4|||
147524704|NCT00420212|532072776|FG002|Overall Study|Physician Decision|3|||
147524705|NCT00420212|532072774|FG000|Overall Study|Protocol Violation|4|||
147524706|NCT00420212|532072775|FG001|Overall Study|Protocol Violation|4|||
147524707|NCT00420212|532072776|FG002|Overall Study|Protocol Violation|8|||
147524708|NCT00420212|532072774|FG000|Overall Study|Death|0|||
147524709|NCT00420212|532072775|FG001|Overall Study|Death|0|||
147524710|NCT00420212|532072776|FG002|Overall Study|Death|1|||
147524711|NCT00420212|532072774|FG000|Overall Study|Other-Unspecified|21|||
147524712|NCT00420212|532072775|FG001|Overall Study|Other-Unspecified|14|||
147524713|NCT00420212|532072776|FG002|Overall Study|Other-Unspecified|18|||
147524714|NCT01326910|532072777|FG000|Overall Study|Withdrawal by Subject|3|||
147524715|NCT01326910|532072778|FG001|Overall Study|Withdrawal by Subject|2|||
147524716|NCT01326910|532072777|FG000|Overall Study|Protocol Violation|1|||
147524717|NCT01326910|532072778|FG001|Overall Study|Protocol Violation|1|||
147524718|NCT02274766|532072781|FG000|Overall Study|Withdrawal by Subject|3|||
147524719|NCT02274766|532072782|FG001|Overall Study|Withdrawal by Subject|6|||
147524720|NCT02274766|532072781|FG000|Overall Study|Did Not Receive Study Drug|1|||
147524721|NCT02274766|532072782|FG001|Overall Study|Did Not Receive Study Drug|1|||
147524722|NCT02274766|532072781|FG000|Overall Study|Subject Unwilling to Proceed|0|||
147524723|NCT02274766|532072782|FG001|Overall Study|Subject Unwilling to Proceed|1|||
147524724|NCT02274766|532072781|FG000|Overall Study|Adverse Event|0|||
147524725|NCT02274766|532072782|FG001|Overall Study|Adverse Event|1|||
147524726|NCT02607735|532072783|FG000|Primary Study|Randomized but Never Treated|1|||
147524727|NCT02607735|532072784|FG001|Primary Study|Randomized but Never Treated|0|||
147524728|NCT02607735|532072785|FG002|Primary Study|Randomized but Never Treated|0|||
147524729|NCT02607735|532072783|FG000|Primary Study|Lost to Follow-up|4|||
147524730|NCT02607735|532072784|FG001|Primary Study|Lost to Follow-up|0|||
147524731|NCT02607735|532072785|FG002|Primary Study|Lost to Follow-up|0|||
147524732|NCT02607735|532072783|FG000|Primary Study|Withdrew Consent|2|||
147524733|NCT02607735|532072784|FG001|Primary Study|Withdrew Consent|0|||
147524734|NCT02607735|532072785|FG002|Primary Study|Withdrew Consent|0|||
147524735|NCT02607735|532072783|FG000|Deferred Treatment Substudy|Lost to Follow-up|0|||
147524736|NCT02607735|532072784|FG001|Deferred Treatment Substudy|Lost to Follow-up|0|||
147524737|NCT02607735|532072785|FG002|Deferred Treatment Substudy|Lost to Follow-up|4|||
147524738|NCT02607735|532072783|FG000|Deferred Treatment Substudy|Withdrew Consent|0|||
147524739|NCT02607735|532072784|FG001|Deferred Treatment Substudy|Withdrew Consent|0|||
147524740|NCT02607735|532072785|FG002|Deferred Treatment Substudy|Withdrew Consent|1|||
147524741|NCT00606021|532072788|FG000|Induction Phase|Death|73|||
147524742|NCT00606021|532072789|FG001|Induction Phase|Death|0|||
147524743|NCT00606021|532072790|FG002|Induction Phase|Death|0|||
147524744|NCT00606021|532072788|FG000|Induction Phase|Physician Decision|2|||
147524745|NCT00606021|532072789|FG001|Induction Phase|Physician Decision|0|||
147524746|NCT00606021|532072790|FG002|Induction Phase|Physician Decision|0|||
147524747|NCT00606021|532072788|FG000|Induction Phase|Withdrawal by Subject|2|||
147524748|NCT00606021|532072789|FG001|Induction Phase|Withdrawal by Subject|0|||
147524749|NCT00606021|532072790|FG002|Induction Phase|Withdrawal by Subject|0|||
147524750|NCT00606021|532072788|FG000|Induction Phase|Lost to Follow-up|10|||
147524751|NCT00606021|532072789|FG001|Induction Phase|Lost to Follow-up|0|||
147524752|NCT00606021|532072790|FG002|Induction Phase|Lost to Follow-up|0|||
147524753|NCT00606021|532072788|FG000|Maintenance Phase|Death|0|||
147524754|NCT00606021|532072789|FG001|Maintenance Phase|Death|17|||
147524755|NCT00606021|532072790|FG002|Maintenance Phase|Death|15|||
147524756|NCT00606021|532072788|FG000|Maintenance Phase|Physician Decision|0|||
147524757|NCT00606021|532072789|FG001|Maintenance Phase|Physician Decision|1|||
147524758|NCT00606021|532072790|FG002|Maintenance Phase|Physician Decision|0|||
147524759|NCT00606021|532072788|FG000|Maintenance Phase|Lost to Follow-up|0|||
147524760|NCT00606021|532072789|FG001|Maintenance Phase|Lost to Follow-up|5|||
147524761|NCT00606021|532072790|FG002|Maintenance Phase|Lost to Follow-up|2|||
147524762|NCT01347931|532074667|FG000|Standard Oxygen Therapy|Withdrawal by Subject|1|||
147524763|NCT01603615|532074672|FG000|Overall Study|Did not Receive Treatment|7|||
147524764|NCT01603615|532074672|FG000|Overall Study|Lost to Follow-up|9|||
147524765|NCT01603615|532074672|FG000|Overall Study|Personal Reasons|17|||
147524766|NCT01603615|532074672|FG000|Overall Study|Other Miscellaneous|1|||
147524767|NCT03287960|532074676|FG000|Open-Label Period (10 Weeks)|Adverse Event|1|||
147524768|NCT03287960|532074676|FG000|Open-Label Period (32 Weeks)|Serious Adverse Event|1|||
147524769|NCT01398176|532074679|FG000|Overall Study|Lost to Follow-up|1|||
147524770|NCT01398176|532074680|FG001|Overall Study|Lost to Follow-up|3|||
147524771|NCT01398176|532074679|FG000|Overall Study|Physician Decision|2|||
147524772|NCT01398176|532074680|FG001|Overall Study|Physician Decision|3|||
147524773|NCT01871870|532074681|FG000|Overall Study|Hardware issues|7|||
147524774|NCT01871870|532074681|FG000|Overall Study|hyperglycemia|2|||
147524775|NCT01977651|532074684|FG000|4 Month Treatment Period|Adverse Event|34|||
147524776|NCT01977651|532074684|FG000|4 Month Treatment Period|Death|3|||
147524777|NCT01977651|532074684|FG000|4 Month Treatment Period|Progressive Disease|43|||
147524778|NCT01977651|532074684|FG000|4 Month Treatment Period|Withdrawal by Subject|17|||
147524779|NCT01977651|532074684|FG000|4 Month Treatment Period|Physician Decision|4|||
147524780|NCT01977651|532074684|FG000|1 Year Extension Period|Adverse Event|14|||
147524781|NCT01977651|532074684|FG000|1 Year Extension Period|Death|10|||
147524782|NCT01977651|532074684|FG000|1 Year Extension Period|Lost to Follow-up|2|||
147524783|NCT01977651|532074684|FG000|1 Year Extension Period|Progressive Disease|86|||
147524784|NCT01977651|532074684|FG000|1 Year Extension Period|Withdrawal by Subject|11|||
147524785|NCT01977651|532074684|FG000|1 Year Extension Period|Physician Decision|6|||
147524786|NCT01977651|532074684|FG000|1 Year Extension Period|Miscellaneous|1|||
147524787|NCT01977651|532074684|FG000|Post 1 Year Extension Period|Adverse Event|5|||
147524788|NCT01977651|532074684|FG000|Post 1 Year Extension Period|Death|13|||
147524789|NCT01977651|532074684|FG000|Post 1 Year Extension Period|Progressive Disease|60|||
147524790|NCT01977651|532074684|FG000|Post 1 Year Extension Period|Withdrawal by Subject|13|||
147524791|NCT01977651|532074684|FG000|Post 1 Year Extension Period|Physician Decision|4|||
147524792|NCT01977651|532074684|FG000|Post 1 Year Extension Period|Miscellaneous|49|||
147524793|NCT03287089|532074685|FG000|Overall Study|Lost to Follow-up|0|||
147524794|NCT03287089|532074686|FG001|Overall Study|Lost to Follow-up|2|||
147524795|NCT03287089|532074685|FG000|Overall Study|Physician Decision|0|||
147524796|NCT03287089|532074686|FG001|Overall Study|Physician Decision|2|||
147524797|NCT03287089|532074685|FG000|Overall Study|Withdrawal by Subject|0|||
147524798|NCT03287089|532074686|FG001|Overall Study|Withdrawal by Subject|2|||
147524799|NCT01646255|532074689|FG000|Overall Study|Adverse Event|7|||
147524800|NCT01646255|532074690|FG001|Overall Study|Adverse Event|8|||
147524801|NCT01646255|532074689|FG000|Overall Study|Lack of Efficacy|2|||
147524802|NCT01646255|532074690|FG001|Overall Study|Lack of Efficacy|0|||
147524803|NCT01646255|532074689|FG000|Overall Study|Withdrawal by Subject|10|||
147524804|NCT01646255|532074690|FG001|Overall Study|Withdrawal by Subject|6|||
147524805|NCT01646255|532074689|FG000|Overall Study|Compliance is not well|1|||
147524806|NCT01646255|532074690|FG001|Overall Study|Compliance is not well|0|||
147524807|NCT01646255|532074689|FG000|Overall Study|Inclusion Criteria Deviation|1|||
147524808|NCT01646255|532074690|FG001|Overall Study|Inclusion Criteria Deviation|0|||
147524809|NCT01681836|532074695|FG000|Second Intervention|Withdrawal by Subject|0|||
147524810|NCT01681836|532074696|FG001|Second Intervention|Withdrawal by Subject|1|||
147524811|NCT00742391|532074697|FG000|Overall Study|Adverse Event|2|||
147524812|NCT00742391|532074698|FG001|Overall Study|Adverse Event|1|||
147524813|NCT00742391|532074697|FG000|Overall Study|Lost to Follow-up|1|||
147524814|NCT00742391|532074698|FG001|Overall Study|Lost to Follow-up|0|||
147524815|NCT00742391|532074697|FG000|Overall Study|Protocol Violation|1|||
147524816|NCT00742391|532074698|FG001|Overall Study|Protocol Violation|0|||
147524817|NCT02394028|532074699|FG000|Induction Phase|Adverse Event|2|||
147524818|NCT02394028|532074700|FG001|Induction Phase|Adverse Event|4|||
147524819|NCT02394028|532074701|FG002|Induction Phase|Adverse Event|1|||
147524820|NCT02394028|532074702|FG003|Induction Phase|Adverse Event|2|||
147524821|NCT02394028|532074703|FG004|Induction Phase|Adverse Event|5|||
147524822|NCT02394028|532074704|FG005|Induction Phase|Adverse Event|2|||
147524823|NCT02394028|532074705|FG006|Induction Phase|Adverse Event|0|||
147524824|NCT02394028|532074706|FG007|Induction Phase|Adverse Event|0|||
147524825|NCT02394028|532074707|FG008|Induction Phase|Adverse Event|0|||
147524826|NCT02394028|532074708|FG009|Induction Phase|Adverse Event|0|||
147524827|NCT02394028|532074709|FG010|Induction Phase|Adverse Event|0|||
147524828|NCT02394028|532074699|FG000|Induction Phase|Lack of Efficacy|3|||
147524829|NCT02394028|532074700|FG001|Induction Phase|Lack of Efficacy|6|||
147524830|NCT02394028|532074701|FG002|Induction Phase|Lack of Efficacy|2|||
147524831|NCT02394028|532074702|FG003|Induction Phase|Lack of Efficacy|17|||
147524832|NCT02394028|532074703|FG004|Induction Phase|Lack of Efficacy|14|||
147524833|NCT02394028|532074704|FG005|Induction Phase|Lack of Efficacy|8|||
147524834|NCT02394028|532074705|FG006|Induction Phase|Lack of Efficacy|17|||
147524835|NCT02394028|532074706|FG007|Induction Phase|Lack of Efficacy|23|||
147524836|NCT02394028|532074707|FG008|Induction Phase|Lack of Efficacy|0|||
147524837|NCT02394028|532074708|FG009|Induction Phase|Lack of Efficacy|0|||
147524838|NCT02394028|532074709|FG010|Induction Phase|Lack of Efficacy|0|||
147524839|NCT02394028|532074699|FG000|Induction Phase|Lost to Follow-up|1|||
147524840|NCT02394028|532074700|FG001|Induction Phase|Lost to Follow-up|0|||
147524841|NCT02394028|532074701|FG002|Induction Phase|Lost to Follow-up|0|||
147524842|NCT02394028|532074702|FG003|Induction Phase|Lost to Follow-up|1|||
147524843|NCT02394028|532074703|FG004|Induction Phase|Lost to Follow-up|0|||
147524844|NCT02394028|532074704|FG005|Induction Phase|Lost to Follow-up|0|||
147524845|NCT02394028|532074705|FG006|Induction Phase|Lost to Follow-up|1|||
147524846|NCT02394028|532074706|FG007|Induction Phase|Lost to Follow-up|0|||
147524847|NCT02394028|532074707|FG008|Induction Phase|Lost to Follow-up|0|||
147524848|NCT02394028|532074708|FG009|Induction Phase|Lost to Follow-up|0|||
147524849|NCT02394028|532074709|FG010|Induction Phase|Lost to Follow-up|0|||
147524850|NCT02394028|532074699|FG000|Induction Phase|Non-compliance|0|||
147524851|NCT02394028|532074700|FG001|Induction Phase|Non-compliance|1|||
147524852|NCT02394028|532074701|FG002|Induction Phase|Non-compliance|3|||
147524853|NCT02394028|532074702|FG003|Induction Phase|Non-compliance|1|||
147524854|NCT02394028|532074703|FG004|Induction Phase|Non-compliance|3|||
147524855|NCT02394028|532074704|FG005|Induction Phase|Non-compliance|0|||
147524856|NCT02394028|532074705|FG006|Induction Phase|Non-compliance|1|||
147524857|NCT02394028|532074706|FG007|Induction Phase|Non-compliance|1|||
147524858|NCT02394028|532074707|FG008|Induction Phase|Non-compliance|0|||
147524859|NCT02394028|532074708|FG009|Induction Phase|Non-compliance|0|||
147524860|NCT02394028|532074709|FG010|Induction Phase|Non-compliance|0|||
147524861|NCT02394028|532074699|FG000|Induction Phase|Physician Decision|0|||
147524862|NCT02394028|532074700|FG001|Induction Phase|Physician Decision|0|||
147524863|NCT02394028|532074701|FG002|Induction Phase|Physician Decision|1|||
147524864|NCT02394028|532074702|FG003|Induction Phase|Physician Decision|4|||
147524865|NCT02394028|532074703|FG004|Induction Phase|Physician Decision|0|||
147524866|NCT02394028|532074704|FG005|Induction Phase|Physician Decision|2|||
147524867|NCT02394028|532074705|FG006|Induction Phase|Physician Decision|1|||
147524868|NCT02394028|532074706|FG007|Induction Phase|Physician Decision|0|||
147524869|NCT02394028|532074707|FG008|Induction Phase|Physician Decision|0|||
147524870|NCT02394028|532074708|FG009|Induction Phase|Physician Decision|0|||
147524871|NCT02394028|532074709|FG010|Induction Phase|Physician Decision|0|||
147524872|NCT02394028|532074699|FG000|Induction Phase|Protocol Violation|0|||
147524873|NCT02394028|532074700|FG001|Induction Phase|Protocol Violation|2|||
147524874|NCT02394028|532074701|FG002|Induction Phase|Protocol Violation|0|||
147524875|NCT02394028|532074702|FG003|Induction Phase|Protocol Violation|3|||
147524876|NCT02394028|532074703|FG004|Induction Phase|Protocol Violation|0|||
147524877|NCT02394028|532074704|FG005|Induction Phase|Protocol Violation|1|||
147524878|NCT02394028|532074705|FG006|Induction Phase|Protocol Violation|1|||
147524879|NCT02394028|532074706|FG007|Induction Phase|Protocol Violation|0|||
147524880|NCT02394028|532074707|FG008|Induction Phase|Protocol Violation|0|||
147524881|NCT02394028|532074708|FG009|Induction Phase|Protocol Violation|0|||
147524882|NCT02394028|532074709|FG010|Induction Phase|Protocol Violation|0|||
147524883|NCT02394028|532074699|FG000|Induction Phase|Withdrawal by Subject|1|||
147524884|NCT02394028|532074700|FG001|Induction Phase|Withdrawal by Subject|2|||
147524885|NCT02394028|532074701|FG002|Induction Phase|Withdrawal by Subject|4|||
147524886|NCT02394028|532074702|FG003|Induction Phase|Withdrawal by Subject|6|||
147524887|NCT02394028|532074703|FG004|Induction Phase|Withdrawal by Subject|7|||
147524888|NCT02394028|532074704|FG005|Induction Phase|Withdrawal by Subject|4|||
147524889|NCT02394028|532074705|FG006|Induction Phase|Withdrawal by Subject|3|||
147524890|NCT02394028|532074706|FG007|Induction Phase|Withdrawal by Subject|6|||
147524891|NCT02394028|532074707|FG008|Induction Phase|Withdrawal by Subject|0|||
147524892|NCT02394028|532074708|FG009|Induction Phase|Withdrawal by Subject|0|||
147524893|NCT02394028|532074709|FG010|Induction Phase|Withdrawal by Subject|0|||
147524894|NCT02394028|532074699|FG000|Induction Phase|Early withdrawal and roll over to a different study|0|||
147524895|NCT02394028|532074700|FG001|Induction Phase|Early withdrawal and roll over to a different study|0|||
147524896|NCT02394028|532074701|FG002|Induction Phase|Early withdrawal and roll over to a different study|0|||
147524897|NCT02394028|532074702|FG003|Induction Phase|Early withdrawal and roll over to a different study|0|||
147524898|NCT02394028|532074703|FG004|Induction Phase|Early withdrawal and roll over to a different study|0|||
147524899|NCT02394028|532074704|FG005|Induction Phase|Early withdrawal and roll over to a different study|0|||
147524900|NCT02394028|532074705|FG006|Induction Phase|Early withdrawal and roll over to a different study|1|||
147524901|NCT02394028|532074706|FG007|Induction Phase|Early withdrawal and roll over to a different study|0|||
147524902|NCT02394028|532074707|FG008|Induction Phase|Early withdrawal and roll over to a different study|0|||
147524903|NCT02394028|532074708|FG009|Induction Phase|Early withdrawal and roll over to a different study|0|||
147524904|NCT02394028|532074709|FG010|Induction Phase|Early withdrawal and roll over to a different study|0|||
147524905|NCT02394028|532074699|FG000|Induction Phase|Sponsor decision|0|||
147524906|NCT02394028|532074700|FG001|Induction Phase|Sponsor decision|1|||
147524907|NCT02394028|532074701|FG002|Induction Phase|Sponsor decision|2|||
147524908|NCT02394028|532074702|FG003|Induction Phase|Sponsor decision|0|||
147524909|NCT02394028|532074703|FG004|Induction Phase|Sponsor decision|0|||
147524910|NCT02394028|532074704|FG005|Induction Phase|Sponsor decision|0|||
147524911|NCT02394028|532074705|FG006|Induction Phase|Sponsor decision|0|||
147524912|NCT02394028|532074706|FG007|Induction Phase|Sponsor decision|0|||
147524913|NCT02394028|532074707|FG008|Induction Phase|Sponsor decision|0|||
147524914|NCT02394028|532074708|FG009|Induction Phase|Sponsor decision|0|||
147524915|NCT02394028|532074709|FG010|Induction Phase|Sponsor decision|0|||
147524916|NCT02394028|532074699|FG000|Induction Phase|Technical reason|0|||
147524917|NCT02394028|532074700|FG001|Induction Phase|Technical reason|0|||
147524918|NCT02394028|532074701|FG002|Induction Phase|Technical reason|0|||
147524919|NCT02394028|532074702|FG003|Induction Phase|Technical reason|1|||
147524920|NCT02394028|532074703|FG004|Induction Phase|Technical reason|0|||
147524921|NCT02394028|532074704|FG005|Induction Phase|Technical reason|0|||
147524922|NCT02394028|532074705|FG006|Induction Phase|Technical reason|0|||
147524923|NCT02394028|532074706|FG007|Induction Phase|Technical reason|0|||
147524924|NCT02394028|532074707|FG008|Induction Phase|Technical reason|0|||
147524925|NCT02394028|532074708|FG009|Induction Phase|Technical reason|0|||
147524926|NCT02394028|532074709|FG010|Induction Phase|Technical reason|0|||
147524927|NCT02394028|532074699|FG000|Induction Phase|:ack of calculation|0|||
147524928|NCT02394028|532074700|FG001|Induction Phase|:ack of calculation|0|||
147524929|NCT02394028|532074701|FG002|Induction Phase|:ack of calculation|0|||
147524930|NCT02394028|532074702|FG003|Induction Phase|:ack of calculation|0|||
147524931|NCT02394028|532074703|FG004|Induction Phase|:ack of calculation|0|||
147524932|NCT02394028|532074704|FG005|Induction Phase|:ack of calculation|0|||
147524933|NCT02394028|532074705|FG006|Induction Phase|:ack of calculation|0|||
147524934|NCT02394028|532074706|FG007|Induction Phase|:ack of calculation|1|||
147524935|NCT02394028|532074707|FG008|Induction Phase|:ack of calculation|0|||
147524936|NCT02394028|532074708|FG009|Induction Phase|:ack of calculation|0|||
147524937|NCT02394028|532074709|FG010|Induction Phase|:ack of calculation|0|||
147524938|NCT02394028|532074699|FG000|Maintenance Phase|Protocol Violation|0|||
147524939|NCT02394028|532074700|FG001|Maintenance Phase|Protocol Violation|0|||
147524940|NCT02394028|532074701|FG002|Maintenance Phase|Protocol Violation|0|||
147524941|NCT02394028|532074702|FG003|Maintenance Phase|Protocol Violation|0|||
147524942|NCT02394028|532074703|FG004|Maintenance Phase|Protocol Violation|0|||
147524943|NCT02394028|532074704|FG005|Maintenance Phase|Protocol Violation|0|||
147524944|NCT02394028|532074705|FG006|Maintenance Phase|Protocol Violation|0|||
147524945|NCT02394028|532074706|FG007|Maintenance Phase|Protocol Violation|0|||
147524946|NCT02394028|532074707|FG008|Maintenance Phase|Protocol Violation|0|||
147524947|NCT02394028|532074708|FG009|Maintenance Phase|Protocol Violation|0|||
147524948|NCT02394028|532074709|FG010|Maintenance Phase|Protocol Violation|1|||
147524949|NCT02394028|532074699|FG000|Maintenance Phase|Physician Decision|0|||
147524950|NCT02394028|532074700|FG001|Maintenance Phase|Physician Decision|0|||
147524951|NCT02394028|532074701|FG002|Maintenance Phase|Physician Decision|0|||
147524952|NCT02394028|532074702|FG003|Maintenance Phase|Physician Decision|0|||
147524953|NCT02394028|532074703|FG004|Maintenance Phase|Physician Decision|0|||
147524954|NCT02394028|532074704|FG005|Maintenance Phase|Physician Decision|0|||
147524955|NCT02394028|532074705|FG006|Maintenance Phase|Physician Decision|0|||
147524956|NCT02394028|532074706|FG007|Maintenance Phase|Physician Decision|0|||
147524957|NCT02394028|532074707|FG008|Maintenance Phase|Physician Decision|1|||
147524958|NCT02394028|532074708|FG009|Maintenance Phase|Physician Decision|3|||
147524959|NCT02394028|532074709|FG010|Maintenance Phase|Physician Decision|2|||
147524960|NCT02394028|532074699|FG000|Maintenance Phase|Lack of Efficacy|0|||
147524961|NCT02394028|532074700|FG001|Maintenance Phase|Lack of Efficacy|0|||
147524962|NCT02394028|532074701|FG002|Maintenance Phase|Lack of Efficacy|0|||
147524963|NCT02394028|532074702|FG003|Maintenance Phase|Lack of Efficacy|0|||
147524964|NCT02394028|532074703|FG004|Maintenance Phase|Lack of Efficacy|0|||
147524965|NCT02394028|532074704|FG005|Maintenance Phase|Lack of Efficacy|0|||
147524966|NCT02394028|532074705|FG006|Maintenance Phase|Lack of Efficacy|0|||
147524967|NCT02394028|532074706|FG007|Maintenance Phase|Lack of Efficacy|0|||
147524968|NCT02394028|532074707|FG008|Maintenance Phase|Lack of Efficacy|7|||
147524969|NCT02394028|532074708|FG009|Maintenance Phase|Lack of Efficacy|25|||
147524970|NCT02394028|532074709|FG010|Maintenance Phase|Lack of Efficacy|33|||
147524971|NCT02394028|532074699|FG000|Maintenance Phase|Death|0|||
147524972|NCT02394028|532074700|FG001|Maintenance Phase|Death|0|||
147524973|NCT02394028|532074701|FG002|Maintenance Phase|Death|0|||
147524974|NCT02394028|532074702|FG003|Maintenance Phase|Death|0|||
147524975|NCT02394028|532074703|FG004|Maintenance Phase|Death|0|||
147524976|NCT02394028|532074704|FG005|Maintenance Phase|Death|0|||
147524977|NCT02394028|532074705|FG006|Maintenance Phase|Death|0|||
147524978|NCT02394028|532074706|FG007|Maintenance Phase|Death|0|||
147524979|NCT02394028|532074707|FG008|Maintenance Phase|Death|0|||
147524980|NCT02394028|532074708|FG009|Maintenance Phase|Death|0|||
147524981|NCT02394028|532074709|FG010|Maintenance Phase|Death|1|||
147524982|NCT02394028|532074699|FG000|Maintenance Phase|Adverse Event|0|||
147524983|NCT02394028|532074700|FG001|Maintenance Phase|Adverse Event|0|||
147524984|NCT02394028|532074701|FG002|Maintenance Phase|Adverse Event|0|||
147524985|NCT02394028|532074702|FG003|Maintenance Phase|Adverse Event|0|||
147524986|NCT02394028|532074703|FG004|Maintenance Phase|Adverse Event|0|||
147524987|NCT02394028|532074704|FG005|Maintenance Phase|Adverse Event|0|||
147643805|NCT01004432|532516652|FG003|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|0|||
147643806|NCT01004432|532516653|FG004|Open-label (OL) Period (Week 0 - 16)|Withdrawal by Subject|0|||
147524988|NCT02394028|532074705|FG006|Maintenance Phase|Adverse Event|0|||
147524989|NCT02394028|532074706|FG007|Maintenance Phase|Adverse Event|0|||
147643807|NCT01004432|532516649|FG000|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|15|||
147643808|NCT01004432|532516650|FG001|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|0|||
147643809|NCT01004432|532516651|FG002|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|0|||
147643810|NCT01004432|532516652|FG003|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|0|||
147643811|NCT01004432|532516653|FG004|Open-label (OL) Period (Week 0 - 16)|Lack of Efficacy|0|||
147524990|NCT02394028|532074707|FG008|Maintenance Phase|Adverse Event|1|||
147524991|NCT02394028|532074708|FG009|Maintenance Phase|Adverse Event|1|||
147524992|NCT02394028|532074709|FG010|Maintenance Phase|Adverse Event|3|||
147524993|NCT02394028|532074699|FG000|Maintenance Phase|Site closure|0|||
147524994|NCT02394028|532074700|FG001|Maintenance Phase|Site closure|0|||
147524995|NCT02394028|532074701|FG002|Maintenance Phase|Site closure|0|||
147643812|NCT01004432|532516649|FG000|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|2|||
147524996|NCT02394028|532074702|FG003|Maintenance Phase|Site closure|0|||
147643813|NCT01004432|532516650|FG001|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|0|||
147643814|NCT01004432|532516651|FG002|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|0|||
147643815|NCT01004432|532516652|FG003|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|0|||
147643816|NCT01004432|532516653|FG004|Open-label (OL) Period (Week 0 - 16)|Lost to Follow-up|0|||
147643817|NCT01004432|532516649|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|0|||
147643818|NCT01004432|532516650|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|1|||
147643819|NCT01004432|532516651|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|5|||
147643820|NCT01004432|532516652|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|6|||
147643821|NCT01004432|532516653|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Adverse Event|0|||
147643822|NCT01004432|532516649|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|0|||
147643823|NCT01004432|532516650|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|3|||
147643824|NCT01004432|532516651|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|3|||
147643825|NCT01004432|532516652|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|4|||
147643826|NCT01004432|532516653|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Protocol Violation|0|||
147643827|NCT01004432|532516649|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|0|||
147643828|NCT01004432|532516650|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|1|||
147524997|NCT02394028|532074703|FG004|Maintenance Phase|Site closure|0|||
147524998|NCT02394028|532074704|FG005|Maintenance Phase|Site closure|0|||
147524999|NCT02394028|532074705|FG006|Maintenance Phase|Site closure|0|||
147525000|NCT02394028|532074706|FG007|Maintenance Phase|Site closure|0|||
147525001|NCT02394028|532074707|FG008|Maintenance Phase|Site closure|0|||
147525002|NCT02394028|532074708|FG009|Maintenance Phase|Site closure|1|||
147525003|NCT02394028|532074709|FG010|Maintenance Phase|Site closure|0|||
147525004|NCT02394028|532074699|FG000|Maintenance Phase|Withdrawal by Subject|0|||
147525005|NCT02394028|532074700|FG001|Maintenance Phase|Withdrawal by Subject|0|||
147525006|NCT02394028|532074701|FG002|Maintenance Phase|Withdrawal by Subject|0|||
147525007|NCT02394028|532074702|FG003|Maintenance Phase|Withdrawal by Subject|0|||
147525008|NCT02394028|532074703|FG004|Maintenance Phase|Withdrawal by Subject|0|||
147525009|NCT02394028|532074704|FG005|Maintenance Phase|Withdrawal by Subject|0|||
147525010|NCT02394028|532074705|FG006|Maintenance Phase|Withdrawal by Subject|0|||
147525011|NCT02394028|532074706|FG007|Maintenance Phase|Withdrawal by Subject|0|||
147525012|NCT02394028|532074707|FG008|Maintenance Phase|Withdrawal by Subject|3|||
147525013|NCT02394028|532074708|FG009|Maintenance Phase|Withdrawal by Subject|12|||
147525014|NCT02394028|532074709|FG010|Maintenance Phase|Withdrawal by Subject|12|||
147525015|NCT01241318|532074719|FG000|Overall Study|Woman: false pregnancies|27|||
147525016|NCT01241318|532074720|FG001|Overall Study|Woman: false pregnancies|15|||
147525017|NCT01241318|532074719|FG000|Overall Study|Woman: miscarriage/abortion|46|||
147525018|NCT01241318|532074720|FG001|Overall Study|Woman: miscarriage/abortion|38|||
147525019|NCT01241318|532074719|FG000|Overall Study|Withdrawal by Subject|175|||
147525020|NCT01241318|532074720|FG001|Overall Study|Withdrawal by Subject|46|||
147525021|NCT01241318|532074719|FG000|Overall Study|Lost to Follow-up|740|||
147525022|NCT01241318|532074720|FG001|Overall Study|Lost to Follow-up|455|||
147525023|NCT01241318|532074719|FG000|Overall Study|Death|2|||
147525024|NCT01241318|532074720|FG001|Overall Study|Death|4|||
147525025|NCT01241318|532074719|FG000|Overall Study|Withdrew/Lost to Follow after delivery|60|||
147525026|NCT01241318|532074720|FG001|Overall Study|Withdrew/Lost to Follow after delivery|38|||
147525027|NCT01241318|532074719|FG000|Overall Study|Woman: Stillborn infant|129|||
147525028|NCT01241318|532074720|FG001|Overall Study|Woman: Stillborn infant|146|||
147525029|NCT02355665|532074721|FG000|Overall Study|Adverse Event|16|||
147525030|NCT02355665|532074722|FG001|Overall Study|Adverse Event|24|||
147525031|NCT02355665|532074721|FG000|Overall Study|Protocol Violation|2|||
147525032|NCT02355665|532074722|FG001|Overall Study|Protocol Violation|0|||
147525033|NCT02355665|532074721|FG000|Overall Study|Withdrawal by Subject|90|||
147525034|NCT02355665|532074722|FG001|Overall Study|Withdrawal by Subject|100|||
147525035|NCT02355665|532074721|FG000|Overall Study|Lost to Follow-up|131|||
147525036|NCT02355665|532074722|FG001|Overall Study|Lost to Follow-up|103|||
147525037|NCT02355665|532074721|FG000|Overall Study|Death|4|||
147525038|NCT02355665|532074722|FG001|Overall Study|Death|2|||
147525039|NCT02355665|532074721|FG000|Overall Study|Compliance, PI decision, move, eligible|6|||
147525040|NCT02355665|532074722|FG001|Overall Study|Compliance, PI decision, move, eligible|3|||
147525041|NCT04129242|532074723|FG000|Overall Study|Physician Decision|1|||
147525042|NCT04129242|532074724|FG001|Overall Study|Physician Decision|1|||
147525043|NCT04129242|532074723|FG000|Overall Study|Protocol Violation|0|||
147525044|NCT04129242|532074724|FG001|Overall Study|Protocol Violation|1|||
147525045|NCT03480841|532074727|FG000|Overall Study|Lost to Follow-up|2|||
147525046|NCT01362049|532074728|FG000|Follow-Up at 7 Weeks|Lost to Follow-up|3|||
147525047|NCT01362049|532074729|FG001|Follow-Up at 7 Weeks|Lost to Follow-up|3|||
147525048|NCT01362049|532074730|FG002|Follow-Up at 7 Weeks|Lost to Follow-up|2|||
147525049|NCT01362049|532074731|FG003|Follow-Up at 7 Weeks|Lost to Follow-up|1|||
147525050|NCT01362049|532074728|FG000|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|5|||
147525051|NCT01362049|532074729|FG001|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|3|||
147525052|NCT01362049|532074730|FG002|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|2|||
147525053|NCT01362049|532074731|FG003|Follow-Up at 52 Weeks (12 Months)|Lost to Follow-up|3|||
147525054|NCT02417935|532074735|FG000|Treatment Period|Adverse Event|12|||
147525055|NCT02417935|532074736|FG001|Treatment Period|Adverse Event|10|||
147525056|NCT02417935|532074735|FG000|Treatment Period|Lost to Follow-up|1|||
147525057|NCT02417935|532074736|FG001|Treatment Period|Lost to Follow-up|0|||
147525058|NCT02417935|532074735|FG000|Treatment Period|Entry Criteria not met|0|||
147525059|NCT02417935|532074736|FG001|Treatment Period|Entry Criteria not met|1|||
147525060|NCT02417935|532074735|FG000|Treatment Period|Protocol Violation|2|||
147525061|NCT02417935|532074736|FG001|Treatment Period|Protocol Violation|1|||
147525062|NCT02417935|532074735|FG000|Treatment Period|Withdrawal by Subject|3|||
147525063|NCT02417935|532074736|FG001|Treatment Period|Withdrawal by Subject|3|||
147525064|NCT02417935|532074735|FG000|Treatment Period|Physician Decision|3|||
147525065|NCT02417935|532074736|FG001|Treatment Period|Physician Decision|1|||
147525066|NCT02850276|532074739|FG000|Overall Study|screen failure|43|||
147525067|NCT02850276|532074739|FG000|Overall Study|Withdrawal by Subject|14|||
147525068|NCT02850276|532074739|FG000|Overall Study|Physician Decision|2|||
147525069|NCT02850276|532074739|FG000|Overall Study|Lost to Follow-up|2|||
147525070|NCT04815291|532074740|FG000|Overall Study|Lost to Follow-up|1|||
147525071|NCT04815291|532074740|FG000|Overall Study|Physician Decision|4|||
147525072|NCT04815291|532074740|FG000|Overall Study|Surgery not planned and subject not operated.|3|||
147525073|NCT00989664|532074744|FG000|Dosimetric and Therapeutic Treatment|Non-compliant or Uncooperative|1|||
147525074|NCT00989664|532074744|FG000|Dosimetric and Therapeutic Treatment|Condition/Illness; Study Drug Unrelated|2|||
147525075|NCT00989664|532074744|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|49|||
147525076|NCT00989664|532074744|FG000|Dosimetric and Therapeutic Treatment|Death|1|||
147525077|NCT00989664|532074744|FG000|Dosimetric and Therapeutic Treatment|Enrolled into Study BEX104526|7|||
147525078|NCT00989664|532074744|FG000|Dosimetric and Therapeutic Treatment|Did Not Receive Study Drug|1|||
147525079|NCT00989664|532074744|FG000|Long-Term Follow-Up|Death|3|||
147525080|NCT00095836|532074747|FG000|Overall Study|Lost to Follow-up|1|||
147525081|NCT00095836|532074747|FG000|Overall Study|Adverse Event|1|||
147525082|NCT00095836|532074747|FG000|Overall Study|Death|2|||
147525083|NCT00962780|532074749|FG000|Overall Study|Death|0|||
147525084|NCT00962780|532074750|FG001|Overall Study|Death|1|||
147525085|NCT00962780|532074749|FG000|Overall Study|Protocol Violation|9|||
147525086|NCT00962780|532074750|FG001|Overall Study|Protocol Violation|4|||
147525087|NCT00962780|532074749|FG000|Overall Study|Withdrawal by Subject|1|||
147525088|NCT00962780|532074750|FG001|Overall Study|Withdrawal by Subject|8|||
147525089|NCT00962780|532074749|FG000|Overall Study|Other|0|||
147525090|NCT00962780|532074750|FG001|Overall Study|Other|1|||
147525091|NCT02363322|532074753|FG000|Overall Study|Lost to Follow-up|1|||
147525092|NCT02363322|532074754|FG001|Overall Study|Lost to Follow-up|0|||
147525093|NCT02269709|532074755|FG000|Time of Enrollment|Withdrawal by Subject|3|||
147525094|NCT02269709|532074755|FG000|Follow-up #1 (24-72 Hours Post-surgery)|Lost to Follow-up|1|||
147525095|NCT02269709|532074755|FG000|Six Month Follow-up|Lost to Follow-up|12|||
147525096|NCT02504424|532074756|FG000|Overall Study|Withdrawal by Subject|2|||
147525097|NCT00426842|532074758|FG000|Overall Study|Lost to Follow-up|1|||
147525098|NCT00982111|532074761|FG000|Overall Study|Adverse Event|1|||
147525099|NCT00982111|532074762|FG001|Overall Study|Adverse Event|1|||
147525100|NCT00982111|532074761|FG000|Overall Study|Progressive Disease|46|||
147643829|NCT01004432|532516651|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|4|||
147643830|NCT01004432|532516652|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|7|||
147643831|NCT01004432|532516653|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Withdrawal by Subject|0|||
147643832|NCT01004432|532516649|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Death|0|||
147643833|NCT01004432|532516650|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Death|0|||
147643834|NCT01004432|532516651|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Death|0|||
147643835|NCT01004432|532516652|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Death|1|||
147643836|NCT01004432|532516653|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Death|0|||
147643837|NCT01004432|532516649|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|0|||
147643838|NCT01004432|532516650|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|2|||
147643839|NCT01004432|532516651|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|24|||
147643840|NCT01004432|532516652|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|37|||
147643841|NCT01004432|532516653|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Lack of Efficacy|0|||
147643842|NCT01004432|532516649|FG000|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|0|||
147643843|NCT01004432|532516650|FG001|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|3|||
147643844|NCT01004432|532516651|FG002|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|1|||
147643845|NCT01004432|532516652|FG003|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|3|||
147643846|NCT01004432|532516653|FG004|OL/Double-Blind (DB) Period (Week 16-52)|Lost to Follow-up|0|||
147643847|NCT01004432|532516649|FG000|OL Study Extension (Week 52 - 76)|Adverse Event|0|||
147643848|NCT01004432|532516650|FG001|OL Study Extension (Week 52 - 76)|Adverse Event|0|||
147643849|NCT01004432|532516651|FG002|OL Study Extension (Week 52 - 76)|Adverse Event|0|||
147643850|NCT01004432|532516652|FG003|OL Study Extension (Week 52 - 76)|Adverse Event|0|||
147643851|NCT01004432|532516653|FG004|OL Study Extension (Week 52 - 76)|Adverse Event|2|||
147643852|NCT01004432|532516649|FG000|OL Study Extension (Week 52 - 76)|Protocol Violation|0|||
147643853|NCT01004432|532516650|FG001|OL Study Extension (Week 52 - 76)|Protocol Violation|0|||
147643854|NCT01004432|532516651|FG002|OL Study Extension (Week 52 - 76)|Protocol Violation|0|||
147643855|NCT01004432|532516652|FG003|OL Study Extension (Week 52 - 76)|Protocol Violation|0|||
147643856|NCT01004432|532516653|FG004|OL Study Extension (Week 52 - 76)|Protocol Violation|4|||
147643857|NCT01004432|532516649|FG000|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0|||
147643858|NCT01004432|532516650|FG001|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0|||
147643859|NCT01004432|532516651|FG002|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0|||
147643860|NCT01004432|532516652|FG003|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|0|||
147643861|NCT01004432|532516653|FG004|OL Study Extension (Week 52 - 76)|Withdrawal by Subject|2|||
147643862|NCT01004432|532516649|FG000|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0|||
147643863|NCT01004432|532516650|FG001|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0|||
147643864|NCT01004432|532516651|FG002|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0|||
147643865|NCT01004432|532516652|FG003|OL Study Extension (Week 52 - 76)|Lack of Efficacy|0|||
147525101|NCT00982111|532074762|FG001|Overall Study|Progressive Disease|39|||
147525102|NCT00982111|532074761|FG000|Overall Study|Lost to Follow-up|9|||
147525103|NCT00982111|532074762|FG001|Overall Study|Lost to Follow-up|6|||
147525104|NCT00982111|532074761|FG000|Overall Study|New Anti-Cancer Therapy|5|||
147525105|NCT00982111|532074762|FG001|Overall Study|New Anti-Cancer Therapy|5|||
147525106|NCT00982111|532074761|FG000|Overall Study|Medical Decision|1|||
147525107|NCT00982111|532074762|FG001|Overall Study|Medical Decision|0|||
147525108|NCT00982111|532074761|FG000|Overall Study|Withdrawal by Subject|17|||
147525109|NCT00982111|532074762|FG001|Overall Study|Withdrawal by Subject|19|||
147525110|NCT00982111|532074761|FG000|Overall Study|Global Study End|0|||
147525111|NCT00982111|532074762|FG001|Overall Study|Global Study End|1|||
147525112|NCT00982111|532074761|FG000|Overall Study|Sponsor's Decision|0|||
147525113|NCT00982111|532074762|FG001|Overall Study|Sponsor's Decision|1|||
147525114|NCT01070381|532074763|FG000|Period 2, 1 Week of Wear|Handling|0|||
147525115|NCT01070381|532074764|FG001|Period 2, 1 Week of Wear|Handling|1|||
147525116|NCT01070381|532074763|FG000|Period 2, 1 Week of Wear|Unacceptable Vision|1|||
147525117|NCT01070381|532074764|FG001|Period 2, 1 Week of Wear|Unacceptable Vision|0|||
147525118|NCT01230827|532074765|FG000|Overall Study|Lost to Follow-up|0|||
147525119|NCT01230827|532074766|FG001|Overall Study|Lost to Follow-up|0|||
147525120|NCT01230827|532074767|FG002|Overall Study|Lost to Follow-up|1|||
147525121|NCT01230827|532074768|FG003|Overall Study|Lost to Follow-up|3|||
147525122|NCT01230827|532074765|FG000|Overall Study|Withdrawal by Subject|1|||
147525123|NCT01230827|532074766|FG001|Overall Study|Withdrawal by Subject|0|||
147525124|NCT01230827|532074767|FG002|Overall Study|Withdrawal by Subject|3|||
147525125|NCT01230827|532074768|FG003|Overall Study|Withdrawal by Subject|2|||
147525126|NCT01230827|532074765|FG000|Overall Study|Lack of Efficacy|14|||
147525127|NCT01230827|532074766|FG001|Overall Study|Lack of Efficacy|1|||
147525128|NCT01230827|532074767|FG002|Overall Study|Lack of Efficacy|2|||
147525129|NCT01230827|532074768|FG003|Overall Study|Lack of Efficacy|3|||
147525130|NCT01230827|532074765|FG000|Overall Study|Adverse Event|4|||
147525131|NCT01230827|532074766|FG001|Overall Study|Adverse Event|2|||
147525132|NCT01230827|532074767|FG002|Overall Study|Adverse Event|3|||
147525133|NCT01230827|532074768|FG003|Overall Study|Adverse Event|7|||
147525134|NCT01230827|532074765|FG000|Overall Study|Recovery|0|||
147525135|NCT01230827|532074766|FG001|Overall Study|Recovery|6|||
147525136|NCT01230827|532074767|FG002|Overall Study|Recovery|0|||
147525137|NCT01230827|532074768|FG003|Overall Study|Recovery|0|||
147525138|NCT01230827|532074765|FG000|Overall Study|Study terminated by Sponsor|0|||
147525139|NCT01230827|532074766|FG001|Overall Study|Study terminated by Sponsor|2|||
147525140|NCT01230827|532074767|FG002|Overall Study|Study terminated by Sponsor|56|||
147525141|NCT01230827|532074768|FG003|Overall Study|Study terminated by Sponsor|63|||
147525142|NCT01854918|532074771|FG000|SOC-controlled Period (Year 1)|Withdrawal by Subject|20|||
147525143|NCT01854918|532074772|FG001|SOC-controlled Period (Year 1)|Withdrawal by Subject|49|||
147525144|NCT01854918|532074771|FG000|SOC-controlled Period (Year 1)|Decision by Sponsor|2|||
147525145|NCT01854918|532074772|FG001|SOC-controlled Period (Year 1)|Decision by Sponsor|1|||
147525146|NCT01854918|532074771|FG000|SOC-controlled Period (Year 1)|Lost to Follow-up|3|||
147525147|NCT01854918|532074772|FG001|SOC-controlled Period (Year 1)|Lost to Follow-up|8|||
147525148|NCT01854918|532074771|FG000|SOC-controlled Period (Year 1)|Death|5|||
147525149|NCT01854918|532074772|FG001|SOC-controlled Period (Year 1)|Death|5|||
147525150|NCT01854918|532074771|FG000|All-IP Period (Years 2 and 3)|Withdrawal by Subject|78|||
147525151|NCT01854918|532074772|FG001|All-IP Period (Years 2 and 3)|Withdrawal by Subject|117|||
147525152|NCT01854918|532074771|FG000|All-IP Period (Years 2 and 3)|Decision by Sponsor|8|||
147525153|NCT01854918|532074772|FG001|All-IP Period (Years 2 and 3)|Decision by Sponsor|11|||
147525154|NCT01854918|532074771|FG000|All-IP Period (Years 2 and 3)|Lost to Follow-up|27|||
147525155|NCT01854918|532074772|FG001|All-IP Period (Years 2 and 3)|Lost to Follow-up|51|||
147525156|NCT01854918|532074771|FG000|All-IP Period (Years 2 and 3)|Death|5|||
147525157|NCT01854918|532074772|FG001|All-IP Period (Years 2 and 3)|Death|16|||
147525158|NCT02146352|532074777|FG000|Overall Study|Death|1|||
147525159|NCT02146352|532074777|FG000|Overall Study|Patient entered hospice care|1|||
147525160|NCT02918006|532074778|FG000|Allocation and Follow-Up|Lost to Follow-up|1|||
147525161|NCT02918006|532074779|FG001|Allocation and Follow-Up|Lost to Follow-up|2|||
147643866|NCT01004432|532516653|FG004|OL Study Extension (Week 52 - 76)|Lack of Efficacy|10|||
147643867|NCT00590538|532516654|FG000|Overall Study|Study terminated before completed|2|||
147643868|NCT02309723|532516655|FG000|Overall Study|Withdrawal by Subject|24|||
147643869|NCT02309723|532516656|FG001|Overall Study|Withdrawal by Subject|23|||
147525162|NCT02918006|532074780|FG002|Allocation and Follow-Up|Lost to Follow-up|1|||
147525163|NCT02918006|532074778|FG000|Allocation and Follow-Up|Withdrawal by Subject|1|||
147525164|NCT02918006|532074779|FG001|Allocation and Follow-Up|Withdrawal by Subject|0|||
147525165|NCT02918006|532074780|FG002|Allocation and Follow-Up|Withdrawal by Subject|0|||
147525166|NCT02918006|532074778|FG000|Vaccination Phase Analysis|Withdrawal by Subject|3|||
147525167|NCT02918006|532074779|FG001|Vaccination Phase Analysis|Withdrawal by Subject|7|||
147525168|NCT02918006|532074780|FG002|Vaccination Phase Analysis|Withdrawal by Subject|2|||
147525169|NCT02918006|532074778|FG000|Vaccination Phase Analysis|Biofire Positive|5|||
147525170|NCT02918006|532074779|FG001|Vaccination Phase Analysis|Biofire Positive|5|||
147525171|NCT02918006|532074780|FG002|Vaccination Phase Analysis|Biofire Positive|0|||
147643870|NCT02309723|532516657|FG002|Overall Study|Withdrawal by Subject|24|||
147643871|NCT01125813|532516658|FG000|Overall Study|Death|1|||
147643872|NCT01125813|532516658|FG000|Overall Study|Withdrawal by Subject|1|||
147643873|NCT01125813|532516658|FG000|Overall Study|Screen Failures|4|||
147643874|NCT02539134|532516659|FG000|Overall Study|Lost to Follow-up|1|||
147525172|NCT02918006|532074778|FG000|Vaccination Phase Analysis|Symptoms of Sinusitis|1|||
147525173|NCT02918006|532074779|FG001|Vaccination Phase Analysis|Symptoms of Sinusitis|0|||
147525174|NCT02918006|532074780|FG002|Vaccination Phase Analysis|Symptoms of Sinusitis|0|||
147525175|NCT02918006|532074778|FG000|Vaccination Phase Analysis|Exlcuded by Investigator for Safety of Compliance|2|||
147525176|NCT02918006|532074779|FG001|Vaccination Phase Analysis|Exlcuded by Investigator for Safety of Compliance|3|||
147525177|NCT02918006|532074780|FG002|Vaccination Phase Analysis|Exlcuded by Investigator for Safety of Compliance|2|||
147525178|NCT02918006|532074778|FG000|Vaccination Phase Analysis|Seasonal allergies|0|||
147525179|NCT02918006|532074779|FG001|Vaccination Phase Analysis|Seasonal allergies|1|||
147525180|NCT02918006|532074780|FG002|Vaccination Phase Analysis|Seasonal allergies|0|||
147525181|NCT02918006|532074778|FG000|Challenge Phase Analysis|Withdrawal by Subject|0|||
147525182|NCT02918006|532074779|FG001|Challenge Phase Analysis|Withdrawal by Subject|0|||
147525183|NCT02918006|532074780|FG002|Challenge Phase Analysis|Withdrawal by Subject|1|||
147525184|NCT02918006|532074778|FG000|Challenge Phase Analysis|Lost to Follow-up|0|||
147525185|NCT02918006|532074779|FG001|Challenge Phase Analysis|Lost to Follow-up|0|||
147525186|NCT02918006|532074780|FG002|Challenge Phase Analysis|Lost to Follow-up|1|||
147525187|NCT03091920|532074784|FG000|Overall Study|Adverse Event|0|||
147525188|NCT03091920|532074785|FG001|Overall Study|Adverse Event|1|||
147525189|NCT03091920|532074786|FG002|Overall Study|Adverse Event|0|||
147525190|NCT00453349|532074787|FG000|Randomized|Adverse Event|12|||
147525191|NCT00453349|532074788|FG001|Randomized|Adverse Event|11|||
147525192|NCT00453349|532074787|FG000|Randomized|Lack of Efficacy|2|||
147525193|NCT00453349|532074788|FG001|Randomized|Lack of Efficacy|1|||
147525194|NCT00453349|532074787|FG000|Randomized|Lost to Follow-up|7|||
147525195|NCT00453349|532074788|FG001|Randomized|Lost to Follow-up|5|||
147525196|NCT00453349|532074787|FG000|Randomized|Protocol Violation|1|||
147525197|NCT00453349|532074788|FG001|Randomized|Protocol Violation|1|||
147525198|NCT00453349|532074787|FG000|Randomized|Withdrawal by Subject|3|||
147525199|NCT00453349|532074788|FG001|Randomized|Withdrawal by Subject|5|||
147525200|NCT00453349|532074787|FG000|Reaching of Primary Endpoint (TOC)|Missing information|10|||
147525201|NCT00453349|532074788|FG001|Reaching of Primary Endpoint (TOC)|Missing information|11|||
147525202|NCT00453349|532074787|FG000|Completed Study|Adverse Event|12|||
147525203|NCT00453349|532074788|FG001|Completed Study|Adverse Event|11|||
147525204|NCT00453349|532074787|FG000|Completed Study|Lack of Efficacy|2|||
147525205|NCT00453349|532074788|FG001|Completed Study|Lack of Efficacy|1|||
147525206|NCT00453349|532074787|FG000|Completed Study|Lost to Follow-up|7|||
147525207|NCT00453349|532074788|FG001|Completed Study|Lost to Follow-up|5|||
147525208|NCT00453349|532074787|FG000|Completed Study|Protocol Violation|1|||
147525209|NCT00453349|532074788|FG001|Completed Study|Protocol Violation|1|||
147525210|NCT00453349|532074787|FG000|Completed Study|Withdrawal by Subject|3|||
147525211|NCT00453349|532074788|FG001|Completed Study|Withdrawal by Subject|5|||
147525212|NCT00453349|532074787|FG000|Completed Study|Lost to follow up after study treatment|2|||
147525213|NCT00453349|532074788|FG001|Completed Study|Lost to follow up after study treatment|11|||
147525214|NCT01513460|532074791|FG000|Overall Study|Death|0|||
147525215|NCT01513460|532074792|FG001|Overall Study|Death|0|||
147525216|NCT01513460|532074793|FG002|Overall Study|Death|1|||
147525217|NCT01513460|532074791|FG000|Overall Study|Lost to Follow-up|0|||
147525218|NCT01513460|532074792|FG001|Overall Study|Lost to Follow-up|0|||
147525219|NCT01513460|532074793|FG002|Overall Study|Lost to Follow-up|2|||
147525220|NCT01513460|532074791|FG000|Overall Study|Abnormal laboratory value|1|||
147525221|NCT01513460|532074792|FG001|Overall Study|Abnormal laboratory value|0|||
147525222|NCT01513460|532074793|FG002|Overall Study|Abnormal laboratory value|1|||
147525223|NCT01513460|532074791|FG000|Overall Study|Lack of Efficacy|1|||
147525224|NCT01513460|532074792|FG001|Overall Study|Lack of Efficacy|2|||
147525225|NCT01513460|532074793|FG002|Overall Study|Lack of Efficacy|5|||
147525226|NCT01513460|532074791|FG000|Overall Study|Protocol deviations|3|||
147525227|NCT01513460|532074792|FG001|Overall Study|Protocol deviations|4|||
147525228|NCT01513460|532074793|FG002|Overall Study|Protocol deviations|3|||
147525229|NCT01513460|532074791|FG000|Overall Study|Withdrawal by Subject|7|||
147525230|NCT01513460|532074792|FG001|Overall Study|Withdrawal by Subject|8|||
147525231|NCT01513460|532074793|FG002|Overall Study|Withdrawal by Subject|21|||
147525232|NCT01513460|532074791|FG000|Overall Study|Adverse Event|16|||
147525233|NCT01513460|532074792|FG001|Overall Study|Adverse Event|18|||
147525234|NCT01513460|532074793|FG002|Overall Study|Adverse Event|23|||
147525235|NCT01513460|532074791|FG000|Overall Study|Abnormal test procedure|1|||
147525236|NCT01513460|532074792|FG001|Overall Study|Abnormal test procedure|0|||
147525237|NCT01513460|532074793|FG002|Overall Study|Abnormal test procedure|0|||
147525238|NCT00489216|532074797|FG000|Overall Study|Adverse Event|1|||
147525239|NCT02828982|532074800|FG000|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
147525240|NCT02828982|532074801|FG001|First Intervention (3 Weeks)|Withdrawal by Subject|1|||
147525241|NCT02312934|532074802|FG000|Overall Study|Lost to Follow-up|1|||
147525242|NCT02312934|532074803|FG001|Overall Study|Lost to Follow-up|0|||
147525243|NCT02312934|532074802|FG000|Overall Study|Physician Decision|1|||
147525244|NCT02312934|532074803|FG001|Overall Study|Physician Decision|0|||
147525245|NCT00701064|532074804|FG000|Overall Study|Protocol Violation|1|||
147525246|NCT00701064|532074805|FG001|Overall Study|Protocol Violation|1|||
147525247|NCT00701064|532074804|FG000|Overall Study|Withdrawal by Subject|1|||
147525248|NCT00701064|532074805|FG001|Overall Study|Withdrawal by Subject|1|||
147525249|NCT00701064|532074804|FG000|Overall Study|initiated other PTSD treatment|2|||
147525250|NCT00701064|532074805|FG001|Overall Study|initiated other PTSD treatment|2|||
147525251|NCT02475564|532074806|FG000|Overall Study|Withdrawal by Subject|1|||
147525252|NCT02475564|532074807|FG001|Overall Study|Withdrawal by Subject|0|||
147525253|NCT02475564|532074806|FG000|Overall Study|Lost to Follow-up|2|||
147525254|NCT02475564|532074807|FG001|Overall Study|Lost to Follow-up|1|||
147525255|NCT02475564|532074806|FG000|Overall Study|Intense Menstrual bleeding|1|||
147525256|NCT02475564|532074807|FG001|Overall Study|Intense Menstrual bleeding|0|||
147525257|NCT03395704|532074808|FG000|Overall Study|Adverse Event|2|||
147525258|NCT03395704|532074809|FG001|Overall Study|Adverse Event|1|||
147525259|NCT03395704|532074808|FG000|Overall Study|Withdrawal by Subject|2|||
147525260|NCT03395704|532074809|FG001|Overall Study|Withdrawal by Subject|1|||
147525261|NCT03395704|532074808|FG000|Overall Study|Physician Decision|0|||
147525262|NCT03395704|532074809|FG001|Overall Study|Physician Decision|1|||
147525263|NCT01156012|532074810|FG000|Overall Study|Adverse Event|3|||
147525264|NCT01156012|532074811|FG001|Overall Study|Adverse Event|1|||
147525265|NCT01156012|532074810|FG000|Overall Study|Lost to Follow-up|1|||
147525266|NCT01156012|532074811|FG001|Overall Study|Lost to Follow-up|0|||
147525267|NCT01156012|532074810|FG000|Overall Study|Withdrawal by Subject|1|||
147525268|NCT01156012|532074811|FG001|Overall Study|Withdrawal by Subject|0|||
147525269|NCT01156012|532074810|FG000|Overall Study|use of commercial drug instead of study|0|||
147525270|NCT01156012|532074811|FG001|Overall Study|use of commercial drug instead of study|1|||
147525271|NCT01156012|532074810|FG000|Overall Study|Non respect of one of inclusion criteria|2|||
147525272|NCT01156012|532074811|FG001|Overall Study|Non respect of one of inclusion criteria|1|||
147525273|NCT03922945|532076744|FG000|Overall Study|Adverse Event|1|||
147525274|NCT03922945|532076745|FG001|Overall Study|Adverse Event|1|||
147525275|NCT03922945|532076746|FG002|Overall Study|Adverse Event|2|||
147525276|NCT03922945|532076744|FG000|Overall Study|Lost to Follow-up|13|||
147525277|NCT03922945|532076745|FG001|Overall Study|Lost to Follow-up|9|||
147525278|NCT03922945|532076746|FG002|Overall Study|Lost to Follow-up|20|||
147525279|NCT03922945|532076744|FG000|Overall Study|Lack of Efficacy|2|||
147525280|NCT03922945|532076745|FG001|Overall Study|Lack of Efficacy|0|||
147525281|NCT03922945|532076746|FG002|Overall Study|Lack of Efficacy|1|||
147525282|NCT03922945|532076744|FG000|Overall Study|Protocol Non-Compliance|0|||
147525283|NCT03922945|532076745|FG001|Overall Study|Protocol Non-Compliance|0|||
147525284|NCT03922945|532076746|FG002|Overall Study|Protocol Non-Compliance|1|||
147525285|NCT03922945|532076744|FG000|Overall Study|Withdrawal by Subject / Parent / Legal Guardian|10|||
147525286|NCT03922945|532076745|FG001|Overall Study|Withdrawal by Subject / Parent / Legal Guardian|6|||
147525287|NCT03922945|532076746|FG002|Overall Study|Withdrawal by Subject / Parent / Legal Guardian|14|||
147525288|NCT03922945|532076744|FG000|Overall Study|All Other Personal Reasons|1|||
147525289|NCT03922945|532076745|FG001|Overall Study|All Other Personal Reasons|1|||
147525290|NCT03922945|532076746|FG002|Overall Study|All Other Personal Reasons|2|||
147525291|NCT00772031|532076753|FG000|Overall Study|Early termination of trial|12|||
147525292|NCT00772031|532076754|FG001|Overall Study|Early termination of trial|10|||
147525293|NCT00772031|532076753|FG000|Overall Study|Lost to Follow-up|20|||
147525294|NCT00772031|532076754|FG001|Overall Study|Lost to Follow-up|33|||
147525295|NCT03419741|532076755|FG000|Overall Study|Adverse Event|1|||
147525296|NCT03419741|532076756|FG001|Overall Study|Adverse Event|0|||
147525297|NCT03419741|532076755|FG000|Overall Study|Withdrawal by Subject|1|||
147525298|NCT03419741|532076756|FG001|Overall Study|Withdrawal by Subject|2|||
147525299|NCT04354870|532076757|FG000|Overall Study|Lost to Follow-up|32|||
147525300|NCT04354870|532076758|FG001|Overall Study|Lost to Follow-up|12|||
147525301|NCT04354870|532076757|FG000|Overall Study|Withdrawal by Subject|10|||
147525302|NCT04354870|532076758|FG001|Overall Study|Withdrawal by Subject|16|||
147525303|NCT04354870|532076757|FG000|Overall Study|Did not complete all study visits|6|||
147525304|NCT04354870|532076758|FG001|Overall Study|Did not complete all study visits|5|||
147525305|NCT03384316|532076759|FG000|Overall Study|Screen failure|0|||
147525306|NCT03384316|532076760|FG001|Overall Study|Screen failure|1|||
147525307|NCT02194699|532076765|FG000|Randomised|Did not receive treatment|1|||
147525308|NCT02194699|532076766|FG001|Randomised|Did not receive treatment|5|||
147525309|NCT02194699|532076765|FG000|Randomised|Without potential for 52 weeks of IP|5|||
147525310|NCT02194699|532076766|FG001|Randomised|Without potential for 52 weeks of IP|5|||
147525311|NCT02194699|532076765|FG000|Randomised|Duplicate patient|2|||
147525312|NCT02194699|532076766|FG001|Randomised|Duplicate patient|1|||
147525313|NCT02194699|532076765|FG000|With Potential to Receive 52 Weeks of IP|Adverse Event|4|||
147525314|NCT02194699|532076766|FG001|With Potential to Receive 52 Weeks of IP|Adverse Event|3|||
147525315|NCT02194699|532076765|FG000|With Potential to Receive 52 Weeks of IP|Death|1|||
147525316|NCT02194699|532076766|FG001|With Potential to Receive 52 Weeks of IP|Death|3|||
147525317|NCT02194699|532076765|FG000|With Potential to Receive 52 Weeks of IP|Lost to Follow-up|5|||
147525318|NCT02194699|532076766|FG001|With Potential to Receive 52 Weeks of IP|Lost to Follow-up|8|||
147525319|NCT02194699|532076765|FG000|With Potential to Receive 52 Weeks of IP|Protocol Violation|2|||
147525320|NCT02194699|532076766|FG001|With Potential to Receive 52 Weeks of IP|Protocol Violation|2|||
147525321|NCT02194699|532076765|FG000|With Potential to Receive 52 Weeks of IP|Withdrawal by Subject|14|||
147525322|NCT02194699|532076766|FG001|With Potential to Receive 52 Weeks of IP|Withdrawal by Subject|20|||
147525323|NCT02194699|532076765|FG000|With Potential to Receive 52 Weeks of IP|Other|24|||
147525324|NCT02194699|532076766|FG001|With Potential to Receive 52 Weeks of IP|Other|16|||
147525325|NCT02719028|532076767|FG000|Overall Study|Adverse Event|2|||
147525326|NCT02719028|532076768|FG001|Overall Study|Adverse Event|1|||
147525327|NCT02719028|532076769|FG002|Overall Study|Adverse Event|4|||
147525328|NCT02719028|532076770|FG003|Overall Study|Adverse Event|8|||
147525329|NCT02719028|532076767|FG000|Overall Study|Physician Decision|0|||
147525330|NCT02719028|532076768|FG001|Overall Study|Physician Decision|1|||
147525331|NCT02719028|532076769|FG002|Overall Study|Physician Decision|1|||
147525332|NCT02719028|532076770|FG003|Overall Study|Physician Decision|1|||
147525333|NCT02719028|532076767|FG000|Overall Study|Use of prohibited medication|0|||
147525334|NCT02719028|532076768|FG001|Overall Study|Use of prohibited medication|0|||
147525335|NCT02719028|532076769|FG002|Overall Study|Use of prohibited medication|1|||
147525336|NCT02719028|532076770|FG003|Overall Study|Use of prohibited medication|0|||
147525337|NCT02719028|532076767|FG000|Overall Study|Protocol Violation|0|||
147525338|NCT02719028|532076768|FG001|Overall Study|Protocol Violation|0|||
147525339|NCT02719028|532076769|FG002|Overall Study|Protocol Violation|0|||
147525340|NCT02719028|532076770|FG003|Overall Study|Protocol Violation|1|||
147525341|NCT01191190|532076771|FG000|Overall Study|Withdrawal by Subject|1|||
147525342|NCT01667731|532076773|FG000|Overall Study|Enrolled but not treated|0|||
147525343|NCT01667731|532076774|FG001|Overall Study|Enrolled but not treated|0|||
147525344|NCT01667731|532076775|FG002|Overall Study|Enrolled but not treated|0|||
147525345|NCT01667731|532076776|FG003|Overall Study|Enrolled but not treated|0|||
147525346|NCT01667731|532076777|FG004|Overall Study|Enrolled but not treated|1|||
147525347|NCT01667731|532076773|FG000|Overall Study|Efficacy Failure|1|||
147525348|NCT01667731|532076774|FG001|Overall Study|Efficacy Failure|12|||
147525349|NCT01667731|532076775|FG002|Overall Study|Efficacy Failure|0|||
147525350|NCT01667731|532076776|FG003|Overall Study|Efficacy Failure|1|||
147525351|NCT01667731|532076777|FG004|Overall Study|Efficacy Failure|24|||
147525352|NCT01667731|532076773|FG000|Overall Study|Lost to Follow-up|2|||
147525353|NCT01667731|532076774|FG001|Overall Study|Lost to Follow-up|3|||
147525354|NCT01667731|532076775|FG002|Overall Study|Lost to Follow-up|1|||
147525355|NCT01667731|532076776|FG003|Overall Study|Lost to Follow-up|1|||
147525356|NCT01667731|532076777|FG004|Overall Study|Lost to Follow-up|2|||
147525357|NCT01667731|532076773|FG000|Overall Study|Subject Withdrew Consent|2|||
147525358|NCT01667731|532076774|FG001|Overall Study|Subject Withdrew Consent|0|||
147525359|NCT01667731|532076775|FG002|Overall Study|Subject Withdrew Consent|1|||
147525360|NCT01667731|532076776|FG003|Overall Study|Subject Withdrew Consent|0|||
147525361|NCT01667731|532076777|FG004|Overall Study|Subject Withdrew Consent|1|||
147525362|NCT01667731|532076773|FG000|Overall Study|Death|0|||
147525363|NCT01667731|532076774|FG001|Overall Study|Death|1|||
147525364|NCT01667731|532076775|FG002|Overall Study|Death|0|||
147525365|NCT01667731|532076776|FG003|Overall Study|Death|0|||
147525366|NCT01667731|532076777|FG004|Overall Study|Death|0|||
147525367|NCT00561912|532076778|FG000|Overall Study|ineligible|1|||
147525368|NCT00577382|532076779|FG000|Overall Study|Adverse Event|0|||
147525369|NCT00577382|532076780|FG001|Overall Study|Adverse Event|6|||
147525370|NCT00577382|532076779|FG000|Overall Study|Withdrawal by Subject|0|||
147525371|NCT00577382|532076780|FG001|Overall Study|Withdrawal by Subject|1|||
147525372|NCT00577382|532076779|FG000|Overall Study|Progressive Disease|17|||
147525373|NCT00577382|532076780|FG001|Overall Study|Progressive Disease|19|||
147525374|NCT00577382|532076779|FG000|Overall Study|Intercurrent Illness|1|||
147525375|NCT00577382|532076780|FG001|Overall Study|Intercurrent Illness|2|||
147525376|NCT00577382|532076779|FG000|Overall Study|Death|1|||
147525377|NCT00577382|532076780|FG001|Overall Study|Death|1|||
147525378|NCT00577382|532076779|FG000|Overall Study|Lost to Follow-up|2|||
147525379|NCT00577382|532076780|FG001|Overall Study|Lost to Follow-up|2|||
147525380|NCT03007472|532076782|FG000|Overall Study|Did not have aidable contralateral thresholds at the time|2|||
147525381|NCT03007472|532076782|FG000|Overall Study|Death|2|||
147525382|NCT03007472|532076782|FG000|Overall Study|Loss to Follow Up|1|||
147525383|NCT00649220|532076783|FG000|Overall Study|Adverse Event|2|||
147525384|NCT00649220|532076783|FG000|Overall Study|Withdrawal by Subject|1|||
147525385|NCT00525499|532076784|FG000|Overall Study|Lost to Follow-up|2|||
147525386|NCT00525499|532076785|FG001|Overall Study|Lost to Follow-up|4|||
147525387|NCT00525499|532076786|FG002|Overall Study|Lost to Follow-up|1|||
147525388|NCT00525499|532076787|FG003|Overall Study|Lost to Follow-up|4|||
147525389|NCT00525499|532076784|FG000|Overall Study|Adverse Event|0|||
147525390|NCT00525499|532076785|FG001|Overall Study|Adverse Event|1|||
147525391|NCT00525499|532076786|FG002|Overall Study|Adverse Event|0|||
147525392|NCT00525499|532076787|FG003|Overall Study|Adverse Event|1|||
147525393|NCT00525499|532076784|FG000|Overall Study|Withdrawal by Subject|5|||
147525394|NCT00525499|532076785|FG001|Overall Study|Withdrawal by Subject|1|||
147525395|NCT00525499|532076786|FG002|Overall Study|Withdrawal by Subject|5|||
147525396|NCT00525499|532076787|FG003|Overall Study|Withdrawal by Subject|2|||
147525397|NCT00525499|532076784|FG000|Overall Study|Protocol Violation|0|||
147525398|NCT00525499|532076785|FG001|Overall Study|Protocol Violation|1|||
147525399|NCT00525499|532076786|FG002|Overall Study|Protocol Violation|1|||
147525400|NCT00525499|532076787|FG003|Overall Study|Protocol Violation|0|||
147525401|NCT01729559|532076792|FG000|Overall Study|Protocol Violation|31|||
147525402|NCT01729559|532076793|FG001|Overall Study|Protocol Violation|28|||
147525403|NCT02906644|532076798|FG000|First 2 Weeks|Withdrawal by Subject|0|||
147525404|NCT02906644|532076799|FG001|First 2 Weeks|Withdrawal by Subject|2|||
147525405|NCT02906644|532076798|FG000|First 2 Weeks|Physician Decision|1|||
147525406|NCT02906644|532076799|FG001|First 2 Weeks|Physician Decision|1|||
147525407|NCT02906644|532076798|FG000|Weeks 3 to 14|Withdrawal by Subject|13|||
147525408|NCT02906644|532076799|FG001|Weeks 3 to 14|Withdrawal by Subject|7|||
147525409|NCT02906644|532076798|FG000|Weeks 3 to 14|Lost to Follow-up|3|||
147525410|NCT02906644|532076799|FG001|Weeks 3 to 14|Lost to Follow-up|4|||
147525411|NCT03672006|532076802|FG000|Overall Study|exclusion criteria met|0|||
147525412|NCT03672006|532076803|FG001|Overall Study|exclusion criteria met|1|||
147525413|NCT00608426|532076804|FG000|Overall Study|Death|32|||
147525414|NCT00608426|532076805|FG001|Overall Study|Death|36|||
147525415|NCT00608426|532076804|FG000|Overall Study|Lost to Follow-up|485|||
147525416|NCT00608426|532076805|FG001|Overall Study|Lost to Follow-up|521|||
147525417|NCT00608426|532076804|FG000|Overall Study|refused, health issues, wrong address|319|||
147525418|NCT00608426|532076805|FG001|Overall Study|refused, health issues, wrong address|348|||
147525419|NCT00761891|532076806|FG000|Overall Study|Withdrawal by Subject|10|||
147525420|NCT01453439|532076810|FG000|Treatment Phase|Withdrawal by Subject|13|||
147525421|NCT01453439|532076811|FG001|Treatment Phase|Withdrawal by Subject|10|||
147525422|NCT01453439|532076810|FG000|Treatment Phase|Suicidal Ideation|2|||
147525423|NCT01453439|532076811|FG001|Treatment Phase|Suicidal Ideation|0|||
147525424|NCT01453439|532076810|FG000|Treatment Phase|Need for higher level of care|1|||
147525425|NCT01453439|532076811|FG001|Treatment Phase|Need for higher level of care|1|||
147525426|NCT01453439|532076810|FG000|Treatment Phase|Therapist conflict of interest|1|||
147525427|NCT01453439|532076811|FG001|Treatment Phase|Therapist conflict of interest|0|||
147525428|NCT01453439|532076810|FG000|Follow-up|Withdrawal by Subject|0|||
147525429|NCT01453439|532076811|FG001|Follow-up|Withdrawal by Subject|1|||
147525430|NCT01453439|532076810|FG000|Follow-up|Lost to Follow-up|5|||
147525431|NCT01453439|532076811|FG001|Follow-up|Lost to Follow-up|10|||
147525432|NCT01014442|532076812|FG000|Overall Study|Adverse Event|0|||
147525433|NCT01014442|532076813|FG001|Overall Study|Adverse Event|8|||
147525434|NCT01014442|532076812|FG000|Overall Study|Withdrawal by Subject|4|||
147525435|NCT01014442|532076813|FG001|Overall Study|Withdrawal by Subject|4|||
147525436|NCT01014442|532076812|FG000|Overall Study|Protocol Violation|2|||
147525437|NCT01014442|532076813|FG001|Overall Study|Protocol Violation|5|||
147525438|NCT01014442|532076812|FG000|Overall Study|Lack of Compliance|0|||
147525439|NCT01014442|532076813|FG001|Overall Study|Lack of Compliance|1|||
147525440|NCT01014442|532076812|FG000|Overall Study|Unspecified Reason|1|||
147525441|NCT01014442|532076813|FG001|Overall Study|Unspecified Reason|1|||
147525442|NCT02074059|532076814|FG000|Overall Study|Death|0|||
147525443|NCT02074059|532076815|FG001|Overall Study|Death|0|||
147525444|NCT02074059|532076816|FG002|Overall Study|Death|0|||
147525445|NCT02074059|532076817|FG003|Overall Study|Death|0|||
147525446|NCT02074059|532076818|FG004|Overall Study|Death|1|||
147525447|NCT02074059|532076819|FG005|Overall Study|Death|1|||
147525448|NCT02764229|532076822|FG000|Overall Study|Withdrawal by Subject|15|||
147525449|NCT02764229|532076822|FG000|Overall Study|Adverse Event|9|||
147525450|NCT02764229|532076822|FG000|Overall Study|Physician Decision|5|||
147525451|NCT02764229|532076822|FG000|Overall Study|Lost to Follow-up|3|||
147525452|NCT02764229|532076822|FG000|Overall Study|Lack of Efficacy|1|||
147525453|NCT02764229|532076822|FG000|Overall Study|Study Stopped by Sponsor|69|||
147525454|NCT02135848|532076826|FG000|Overall Study|Adverse Event|2|||
147525455|NCT02135848|532076827|FG001|Overall Study|Adverse Event|0|||
147525456|NCT02135848|532076826|FG000|Overall Study|Withdrawal by Subject|1|||
147525457|NCT02135848|532076827|FG001|Overall Study|Withdrawal by Subject|1|||
147525458|NCT02030067|532076831|FG000|Overall Study|Disease Progression|1|||
147525459|NCT02030067|532076832|FG001|Overall Study|Disease Progression|1|||
147525460|NCT02030067|532076833|FG002|Overall Study|Disease Progression|2|||
147525461|NCT02030067|532076834|FG003|Overall Study|Disease Progression|2|||
147525462|NCT02030067|532076835|FG004|Overall Study|Disease Progression|3|||
147525463|NCT02030067|532076836|FG005|Overall Study|Disease Progression|2|||
147525464|NCT02030067|532076837|FG006|Overall Study|Disease Progression|3|||
147525465|NCT02030067|532076838|FG007|Overall Study|Disease Progression|3|||
147525466|NCT02030067|532076839|FG008|Overall Study|Disease Progression|4|||
147525467|NCT02030067|532076840|FG009|Overall Study|Disease Progression|3|||
147525468|NCT02030067|532076841|FG010|Overall Study|Disease Progression|7|||
147525469|NCT02030067|532076842|FG011|Overall Study|Disease Progression|2|||
147525470|NCT02030067|532076843|FG012|Overall Study|Disease Progression|59|||
147525471|NCT02030067|532076831|FG000|Overall Study|Withdrawal by Subject|0|||
147525472|NCT02030067|532076832|FG001|Overall Study|Withdrawal by Subject|0|||
147525473|NCT02030067|532076833|FG002|Overall Study|Withdrawal by Subject|0|||
147525474|NCT02030067|532076834|FG003|Overall Study|Withdrawal by Subject|1|||
147525475|NCT02030067|532076835|FG004|Overall Study|Withdrawal by Subject|0|||
147525476|NCT02030067|532076836|FG005|Overall Study|Withdrawal by Subject|0|||
147525477|NCT02030067|532076837|FG006|Overall Study|Withdrawal by Subject|0|||
147525478|NCT02030067|532076838|FG007|Overall Study|Withdrawal by Subject|1|||
147525479|NCT02030067|532076839|FG008|Overall Study|Withdrawal by Subject|0|||
147525480|NCT02030067|532076840|FG009|Overall Study|Withdrawal by Subject|0|||
147525481|NCT02030067|532076841|FG010|Overall Study|Withdrawal by Subject|3|||
147525482|NCT02030067|532076842|FG011|Overall Study|Withdrawal by Subject|0|||
147525483|NCT02030067|532076843|FG012|Overall Study|Withdrawal by Subject|6|||
147525484|NCT02030067|532076831|FG000|Overall Study|Physician Decision|0|||
147525485|NCT02030067|532076832|FG001|Overall Study|Physician Decision|0|||
147525486|NCT02030067|532076833|FG002|Overall Study|Physician Decision|0|||
147525487|NCT02030067|532076834|FG003|Overall Study|Physician Decision|0|||
147525488|NCT02030067|532076835|FG004|Overall Study|Physician Decision|0|||
147525489|NCT02030067|532076836|FG005|Overall Study|Physician Decision|0|||
147525490|NCT02030067|532076837|FG006|Overall Study|Physician Decision|0|||
147525491|NCT02030067|532076838|FG007|Overall Study|Physician Decision|0|||
147525492|NCT02030067|532076839|FG008|Overall Study|Physician Decision|0|||
147525493|NCT02030067|532076840|FG009|Overall Study|Physician Decision|0|||
147525494|NCT02030067|532076841|FG010|Overall Study|Physician Decision|1|||
147525495|NCT02030067|532076842|FG011|Overall Study|Physician Decision|0|||
147525496|NCT02030067|532076843|FG012|Overall Study|Physician Decision|3|||
147525497|NCT02030067|532076831|FG000|Overall Study|other reasons|0|||
147525498|NCT02030067|532076832|FG001|Overall Study|other reasons|0|||
147525499|NCT02030067|532076833|FG002|Overall Study|other reasons|0|||
147525500|NCT02030067|532076834|FG003|Overall Study|other reasons|0|||
147525501|NCT02030067|532076835|FG004|Overall Study|other reasons|0|||
147525502|NCT02030067|532076836|FG005|Overall Study|other reasons|1|||
147525503|NCT02030067|532076837|FG006|Overall Study|other reasons|0|||
147525504|NCT02030067|532076838|FG007|Overall Study|other reasons|0|||
147525505|NCT02030067|532076839|FG008|Overall Study|other reasons|2|||
147525506|NCT02030067|532076840|FG009|Overall Study|other reasons|0|||
147525507|NCT02030067|532076841|FG010|Overall Study|other reasons|0|||
147525508|NCT02030067|532076842|FG011|Overall Study|other reasons|0|||
147525509|NCT02030067|532076843|FG012|Overall Study|other reasons|4|||
147525510|NCT02030067|532076831|FG000|Overall Study|Adverse Event|0|||
147525511|NCT02030067|532076832|FG001|Overall Study|Adverse Event|0|||
147525512|NCT02030067|532076833|FG002|Overall Study|Adverse Event|0|||
147525513|NCT02030067|532076834|FG003|Overall Study|Adverse Event|0|||
147525514|NCT02030067|532076835|FG004|Overall Study|Adverse Event|0|||
147525515|NCT02030067|532076836|FG005|Overall Study|Adverse Event|0|||
147525516|NCT02030067|532076837|FG006|Overall Study|Adverse Event|0|||
147525517|NCT02030067|532076838|FG007|Overall Study|Adverse Event|0|||
147525518|NCT02030067|532076839|FG008|Overall Study|Adverse Event|0|||
147525519|NCT02030067|532076840|FG009|Overall Study|Adverse Event|0|||
147525520|NCT02030067|532076841|FG010|Overall Study|Adverse Event|0|||
147525521|NCT02030067|532076842|FG011|Overall Study|Adverse Event|1|||
147525522|NCT02030067|532076843|FG012|Overall Study|Adverse Event|8|||
147525523|NCT00265382|532076844|FG000|Overall Study|Adverse Event|21|||
147525524|NCT00265382|532076844|FG000|Overall Study|Laboratory Abnormality|1|||
147525525|NCT00265382|532076844|FG000|Overall Study|Lost to Follow-up|3|||
147525526|NCT00265382|532076844|FG000|Overall Study|Lack of Efficacy|6|||
147525527|NCT00265382|532076844|FG000|Overall Study|Miscellaneous|6|||
147525528|NCT00265382|532076844|FG000|Overall Study|Withdrawal by Subject|13|||
147525529|NCT00265382|532076844|FG000|Overall Study|Study terminated by sponsor|94|||
147525530|NCT00265382|532076844|FG000|Overall Study|Death|1|||
147525531|NCT02543801|532076845|FG000|Overall Study|Protocol Violation|1|||
147525532|NCT02543801|532076846|FG001|Overall Study|Protocol Violation|2|||
147525533|NCT02543801|532076847|FG002|Overall Study|Protocol Violation|0|||
147525534|NCT02543801|532076848|FG003|Overall Study|Protocol Violation|0|||
147525535|NCT04118127|532076854|FG000|Overall Study|Trial terminated by sponsor|0|||
147525536|NCT04118127|532076855|FG001|Overall Study|Trial terminated by sponsor|12|||
147525537|NCT04118127|532076854|FG000|Overall Study|Adverse Event|1|||
147525538|NCT04118127|532076855|FG001|Overall Study|Adverse Event|2|||
147525539|NCT04118127|532076854|FG000|Overall Study|Physician Decision|0|||
147525540|NCT04118127|532076855|FG001|Overall Study|Physician Decision|1|||
147525541|NCT04118127|532076854|FG000|Overall Study|Withdrawal by Subject|2|||
147525542|NCT04118127|532076855|FG001|Overall Study|Withdrawal by Subject|1|||
147525543|NCT01376908|532076856|FG000|Overall Study|Protocol Violation|1|||
147525544|NCT01376908|532076857|FG001|Overall Study|Protocol Violation|1|||
147525545|NCT01376908|532076856|FG000|Overall Study|Withdrawal by Subject|1|||
147525546|NCT01376908|532076857|FG001|Overall Study|Withdrawal by Subject|2|||
147525547|NCT02142712|532076858|FG000|Overall Study|Lost to Follow-up|1|||
147525548|NCT02142712|532076859|FG001|Overall Study|Lost to Follow-up|1|||
147525549|NCT02142712|532076860|FG002|Overall Study|Lost to Follow-up|1|||
147525550|NCT02142712|532076861|FG003|Overall Study|Lost to Follow-up|0|||
147525551|NCT02853318|532076862|FG000|Overall Study|Withdrawal by Subject|1|||
147525552|NCT02646332|532076863|FG000|Overall Study|Lost to Follow-up|0|||
147525553|NCT02646332|532076864|FG001|Overall Study|Lost to Follow-up|3|||
147525554|NCT01882439|532076870|FG000|Overall Study|Adverse event related to study drug|3|||
147525555|NCT01882439|532076871|FG001|Overall Study|Adverse event related to study drug|8|||
147525556|NCT01882439|532076872|FG002|Overall Study|Adverse event related to study drug|1|||
147525557|NCT01882439|532076873|FG003|Overall Study|Adverse event related to study drug|2|||
147525558|NCT01882439|532076870|FG000|Overall Study|Pregnancy|0|||
147525559|NCT01882439|532076871|FG001|Overall Study|Pregnancy|1|||
147525560|NCT01882439|532076872|FG002|Overall Study|Pregnancy|0|||
147525561|NCT01882439|532076873|FG003|Overall Study|Pregnancy|0|||
147525562|NCT01882439|532076870|FG000|Overall Study|Protocol Violation|2|||
147525563|NCT01882439|532076871|FG001|Overall Study|Protocol Violation|2|||
147525564|NCT01882439|532076872|FG002|Overall Study|Protocol Violation|0|||
147525565|NCT01882439|532076873|FG003|Overall Study|Protocol Violation|1|||
147525566|NCT01882439|532076870|FG000|Overall Study|No longer willing to participate|1|||
147525567|NCT01882439|532076871|FG001|Overall Study|No longer willing to participate|4|||
147525568|NCT01882439|532076872|FG002|Overall Study|No longer willing to participate|2|||
147525569|NCT01882439|532076873|FG003|Overall Study|No longer willing to participate|3|||
147525570|NCT01882439|532076870|FG000|Overall Study|Medication error with no associated AE|0|||
147525571|NCT01882439|532076871|FG001|Overall Study|Medication error with no associated AE|0|||
147525572|NCT01882439|532076872|FG002|Overall Study|Medication error with no associated AE|2|||
147525573|NCT01882439|532076873|FG003|Overall Study|Medication error with no associated AE|0|||
147525574|NCT01882439|532076870|FG000|Overall Study|Insufficient clinical response|1|||
147525575|NCT01882439|532076871|FG001|Overall Study|Insufficient clinical response|4|||
147525576|NCT01882439|532076872|FG002|Overall Study|Insufficient clinical response|4|||
147525577|NCT01882439|532076873|FG003|Overall Study|Insufficient clinical response|2|||
147525578|NCT01882439|532076870|FG000|Overall Study|Adverse event unrelated to study drug|2|||
147525579|NCT01882439|532076871|FG001|Overall Study|Adverse event unrelated to study drug|2|||
147525580|NCT01882439|532076872|FG002|Overall Study|Adverse event unrelated to study drug|1|||
147525581|NCT01882439|532076873|FG003|Overall Study|Adverse event unrelated to study drug|1|||
147525582|NCT02909504|532076876|FG000|Overall Study|Adverse Event|2|||
147525583|NCT02909504|532076876|FG000|Overall Study|Lack of Efficacy|3|||
147525584|NCT02909504|532076876|FG000|Overall Study|Withdrawal by Subject|4|||
147525585|NCT02909504|532076876|FG000|Overall Study|Pregnancy|1|||
147525586|NCT02909504|532076876|FG000|Overall Study|Subject moved|1|||
147525587|NCT02909504|532076876|FG000|Overall Study|Lost to Follow-up|1|||
147525588|NCT02055976|532076877|FG000|Overall Study|Other|0|||
147525589|NCT02055976|532076878|FG001|Overall Study|Other|0|||
147525590|NCT02055976|532076879|FG002|Overall Study|Other|1|||
147525591|NCT02055976|532076880|FG003|Overall Study|Other|0|||
147525592|NCT02055976|532076881|FG004|Overall Study|Other|0|||
147525593|NCT02055976|532076882|FG005|Overall Study|Other|0|||
147525594|NCT02055976|532076883|FG006|Overall Study|Other|0|||
147525595|NCT02055976|532076884|FG007|Overall Study|Other|0|||
147525596|NCT02055976|532076885|FG008|Overall Study|Other|0|||
147525597|NCT02055976|532076877|FG000|Overall Study|Adverse Event|0|||
147525598|NCT02055976|532076878|FG001|Overall Study|Adverse Event|0|||
147525599|NCT02055976|532076879|FG002|Overall Study|Adverse Event|0|||
147525600|NCT02055976|532076880|FG003|Overall Study|Adverse Event|0|||
147525601|NCT02055976|532076881|FG004|Overall Study|Adverse Event|0|||
147525602|NCT02055976|532076882|FG005|Overall Study|Adverse Event|1|||
147525603|NCT02055976|532076883|FG006|Overall Study|Adverse Event|1|||
147525604|NCT02055976|532076884|FG007|Overall Study|Adverse Event|0|||
147525605|NCT02055976|532076885|FG008|Overall Study|Adverse Event|0|||
147525606|NCT02055976|532076877|FG000|Overall Study|Does not meet entrance criteria|0|||
147525607|NCT02055976|532076878|FG001|Overall Study|Does not meet entrance criteria|0|||
147525608|NCT02055976|532076879|FG002|Overall Study|Does not meet entrance criteria|0|||
147525609|NCT02055976|532076880|FG003|Overall Study|Does not meet entrance criteria|0|||
147525610|NCT02055976|532076881|FG004|Overall Study|Does not meet entrance criteria|0|||
147525611|NCT02055976|532076882|FG005|Overall Study|Does not meet entrance criteria|0|||
147525612|NCT02055976|532076883|FG006|Overall Study|Does not meet entrance criteria|1|||
147525613|NCT02055976|532076884|FG007|Overall Study|Does not meet entrance criteria|0|||
147525614|NCT02055976|532076885|FG008|Overall Study|Does not meet entrance criteria|0|||
147525615|NCT02055976|532076877|FG000|Overall Study|Lost to Follow-up|0|||
147525616|NCT02055976|532076878|FG001|Overall Study|Lost to Follow-up|0|||
147525617|NCT02055976|532076879|FG002|Overall Study|Lost to Follow-up|0|||
147525618|NCT02055976|532076880|FG003|Overall Study|Lost to Follow-up|1|||
147525619|NCT02055976|532076881|FG004|Overall Study|Lost to Follow-up|0|||
147525620|NCT02055976|532076882|FG005|Overall Study|Lost to Follow-up|0|||
147525621|NCT02055976|532076883|FG006|Overall Study|Lost to Follow-up|0|||
147525622|NCT02055976|532076884|FG007|Overall Study|Lost to Follow-up|0|||
147525623|NCT02055976|532076885|FG008|Overall Study|Lost to Follow-up|0|||
147525624|NCT00362297|532076888|FG000|Treatment 1 (Initial Drug Assignment)|Lost to Follow-up|0|||
147525625|NCT00362297|532076889|FG001|Treatment 1 (Initial Drug Assignment)|Lost to Follow-up|4|||
147525626|NCT00684073|532076890|FG000|Selection|Selection/non-selection criteria|3|||
147525627|NCT00684073|532076890|FG000|Selection|Death|1|||
147525628|NCT00684073|532076890|FG000|Selection|noncompliance|1|||
147525629|NCT00684073|532076890|FG000|Selection|Lost to Follow-up|1|||
147525630|NCT00684073|532076890|FG000|Selection|request of the sponsor|1|||
147525631|NCT00684073|532076890|FG000|Treatment (Days 1 Through 5)|non-respect of eligibility criteria|1|||
147525632|NCT03512028|532076892|FG000|Overall Study|Withdrawal by Subject|2|||
147525633|NCT03512028|532076893|FG001|Overall Study|Withdrawal by Subject|0|||
147525634|NCT03512028|532076892|FG000|Overall Study|Protocol Violation|2|||
147525635|NCT03512028|532076893|FG001|Overall Study|Protocol Violation|0|||
147525636|NCT00983827|532076894|FG000|Overall Study|Withdrawal by Subject|1|||
147525637|NCT02728804|532076898|FG000|Overall Study|Ineligible|3|||
147525638|NCT02728804|532076898|FG000|Overall Study|Did not complete baseline questionnaire|9|||
147525639|NCT02728804|532076898|FG000|Overall Study|Death|99|||
147525640|NCT02098733|532076900|FG000|Overall Study|Data Not Available|5|||
147525641|NCT02098733|532076900|FG000|Overall Study|Lost to Follow-up|5|||
147525642|NCT01078389|532078591|FG000|Overall Study|Adverse Event|10|||
147525643|NCT01078389|532078592|FG001|Overall Study|Adverse Event|6|||
147525644|NCT01078389|532078591|FG000|Overall Study|Major Protocol Deviation|2|||
147525645|NCT01078389|532078592|FG001|Overall Study|Major Protocol Deviation|0|||
147525646|NCT01078389|532078591|FG000|Overall Study|Lost to Follow-up|23|||
147525647|NCT01078389|532078592|FG001|Overall Study|Lost to Follow-up|23|||
147525648|NCT01078389|532078591|FG000|Overall Study|Voluntary Withdrawal|20|||
147525649|NCT01078389|532078592|FG001|Overall Study|Voluntary Withdrawal|36|||
147525650|NCT01078389|532078591|FG000|Overall Study|Other|9|||
147525651|NCT01078389|532078592|FG001|Overall Study|Other|2|||
147525652|NCT02927990|532078596|FG000|Overall Study|Protocol Violation|4|||
147525653|NCT02927990|532078596|FG000|Overall Study|Physician Decision|9|||
147525654|NCT02927990|532078596|FG000|Overall Study|Room switched and therefore no study device available|15|||
147525655|NCT02927990|532078596|FG000|Overall Study|No procedure performed, only diagnostic catheterization|28|||
147525656|NCT02155660|532078604|FG000|Overall Study|Other Reason|8|||
147525657|NCT02155660|532078605|FG001|Overall Study|Other Reason|6|||
147525658|NCT02155660|532078606|FG002|Overall Study|Other Reason|10|||
147525659|NCT02155660|532078607|FG003|Overall Study|Other Reason|10|||
147525660|NCT02155660|532078604|FG000|Overall Study|Study-specific withdrawal criteria|0|||
147525661|NCT02155660|532078605|FG001|Overall Study|Study-specific withdrawal criteria|1|||
147525662|NCT02155660|532078606|FG002|Overall Study|Study-specific withdrawal criteria|1|||
147525663|NCT02155660|532078607|FG003|Overall Study|Study-specific withdrawal criteria|1|||
147525664|NCT02155660|532078604|FG000|Overall Study|Severe non-compliance|0|||
147525665|NCT02155660|532078605|FG001|Overall Study|Severe non-compliance|4|||
147525666|NCT02155660|532078606|FG002|Overall Study|Severe non-compliance|0|||
147525667|NCT02155660|532078607|FG003|Overall Study|Severe non-compliance|1|||
147525668|NCT02155660|532078604|FG000|Overall Study|Adverse Event|2|||
147525669|NCT02155660|532078605|FG001|Overall Study|Adverse Event|6|||
147525670|NCT02155660|532078606|FG002|Overall Study|Adverse Event|3|||
147525671|NCT02155660|532078607|FG003|Overall Study|Adverse Event|1|||
147525672|NCT02155660|532078604|FG000|Overall Study|Lost to Follow-up|3|||
147525673|NCT02155660|532078605|FG001|Overall Study|Lost to Follow-up|6|||
147525674|NCT02155660|532078606|FG002|Overall Study|Lost to Follow-up|5|||
147525675|NCT02155660|532078607|FG003|Overall Study|Lost to Follow-up|8|||
147525676|NCT02155660|532078604|FG000|Overall Study|Death|17|||
147525677|NCT02155660|532078605|FG001|Overall Study|Death|19|||
147525678|NCT02155660|532078606|FG002|Overall Study|Death|17|||
147525679|NCT02155660|532078607|FG003|Overall Study|Death|19|||
147525680|NCT02155660|532078604|FG000|Overall Study|Withdrawal by Subject|28|||
147525681|NCT02155660|532078605|FG001|Overall Study|Withdrawal by Subject|31|||
147525682|NCT02155660|532078606|FG002|Overall Study|Withdrawal by Subject|24|||
147525683|NCT02155660|532078607|FG003|Overall Study|Withdrawal by Subject|21|||
147525684|NCT03730987|532078608|FG000|Overall Study|Lost to Follow-up|2|||
147525685|NCT03730987|532078609|FG001|Overall Study|Lost to Follow-up|0|||
147525686|NCT03730987|532078610|FG002|Overall Study|Lost to Follow-up|2|||
147525687|NCT03730987|532078611|FG003|Overall Study|Lost to Follow-up|0|||
147525688|NCT02505945|532078612|FG000|Overall Study|Withdrawal by Subject|13|||
147525689|NCT02505945|532078613|FG001|Overall Study|Withdrawal by Subject|2|||
147525690|NCT02505945|532078612|FG000|Overall Study|Adverse Event|1|||
147525691|NCT02505945|532078613|FG001|Overall Study|Adverse Event|0|||
147525692|NCT02505945|532078612|FG000|Overall Study|Physician Decision|2|||
147525693|NCT02505945|532078613|FG001|Overall Study|Physician Decision|1|||
147525694|NCT02505945|532078612|FG000|Overall Study|Lost to Follow-up|6|||
147525695|NCT02505945|532078613|FG001|Overall Study|Lost to Follow-up|1|||
147525696|NCT00386152|532078614|FG000|Overall Study|Adverse Event|6|||
147525697|NCT00386152|532078615|FG001|Overall Study|Adverse Event|5|||
147525698|NCT00386152|532078616|FG002|Overall Study|Adverse Event|4|||
147525699|NCT00386152|532078614|FG000|Overall Study|Chang from original chemo stratification|4|||
147525700|NCT00386152|532078615|FG001|Overall Study|Chang from original chemo stratification|5|||
147525701|NCT00386152|532078616|FG002|Overall Study|Chang from original chemo stratification|6|||
147525702|NCT00386152|532078614|FG000|Overall Study|Death|3|||
147525703|NCT00386152|532078615|FG001|Overall Study|Death|0|||
147525704|NCT00386152|532078616|FG002|Overall Study|Death|1|||
147525705|NCT00386152|532078614|FG000|Overall Study|Disease progression|7|||
147525706|NCT00386152|532078615|FG001|Overall Study|Disease progression|4|||
147525707|NCT00386152|532078616|FG002|Overall Study|Disease progression|5|||
147525708|NCT00386152|532078614|FG000|Overall Study|Physician Decision|13|||
147525709|NCT00386152|532078615|FG001|Overall Study|Physician Decision|10|||
147525710|NCT00386152|532078616|FG002|Overall Study|Physician Decision|4|||
147525711|NCT00386152|532078614|FG000|Overall Study|Lost to Follow-up|1|||
147525712|NCT00386152|532078615|FG001|Overall Study|Lost to Follow-up|0|||
147525713|NCT00386152|532078616|FG002|Overall Study|Lost to Follow-up|0|||
147525714|NCT00386152|532078614|FG000|Overall Study|Completed chemotherapy|4|||
147525715|NCT00386152|532078615|FG001|Overall Study|Completed chemotherapy|5|||
147525716|NCT00386152|532078616|FG002|Overall Study|Completed chemotherapy|1|||
147525717|NCT00386152|532078614|FG000|Overall Study|Protocol Violation|3|||
147525718|NCT00386152|532078615|FG001|Overall Study|Protocol Violation|5|||
147525719|NCT00386152|532078616|FG002|Overall Study|Protocol Violation|2|||
147525720|NCT00386152|532078614|FG000|Overall Study|Withdrawal by Subject|3|||
147525721|NCT00386152|532078615|FG001|Overall Study|Withdrawal by Subject|6|||
147525722|NCT00386152|532078616|FG002|Overall Study|Withdrawal by Subject|10|||
147525723|NCT03258710|532078619|FG000|Overall Study|Adverse Event|1|||
147525724|NCT03258710|532078619|FG000|Overall Study|Protocol-defined stopping criteria|1|||
147525725|NCT03258710|532078619|FG000|Overall Study|Physician Decision|1|||
147525726|NCT03451630|532078620|FG000|Overall Study|Death|15|||
147525727|NCT03451630|532078621|FG001|Overall Study|Death|16|||
147525728|NCT03451630|532078622|FG002|Overall Study|Death|11|||
147525729|NCT03451630|532078620|FG000|Overall Study|Lost to Follow-up|9|||
147525730|NCT03451630|532078621|FG001|Overall Study|Lost to Follow-up|0|||
147525731|NCT03451630|532078622|FG002|Overall Study|Lost to Follow-up|4|||
147525732|NCT03451630|532078620|FG000|Overall Study|Withdrawal by Subject|0|||
147525733|NCT03451630|532078621|FG001|Overall Study|Withdrawal by Subject|3|||
147525734|NCT03451630|532078622|FG002|Overall Study|Withdrawal by Subject|0|||
147525735|NCT03451630|532078620|FG000|Overall Study|Unable to confirm accurate eligibility criteria after randomization and intervention completion.|3|||
147525736|NCT03451630|532078621|FG001|Overall Study|Unable to confirm accurate eligibility criteria after randomization and intervention completion.|4|||
147525737|NCT03451630|532078622|FG002|Overall Study|Unable to confirm accurate eligibility criteria after randomization and intervention completion.|3|||
147525738|NCT01756846|532078623|FG000|Overall Study|Lost to Follow-up|5|||
147525739|NCT01756846|532078624|FG001|Overall Study|Lost to Follow-up|10|||
147525740|NCT01756846|532078623|FG000|Overall Study|Withdrawal by Subject|1|||
147525741|NCT01756846|532078624|FG001|Overall Study|Withdrawal by Subject|2|||
147525742|NCT00565721|532078627|FG000|Overall Study|Screen Failure|2|||
147525743|NCT00565721|532078627|FG000|Overall Study|Lost to Follow-up|6|||
147525744|NCT00565721|532078627|FG000|Overall Study|Technical Problems|1|||
147525745|NCT00565721|532078627|FG000|Overall Study|Physician Decision|2|||
147525746|NCT00565721|532078627|FG000|Overall Study|Other reasons|6|||
147525747|NCT02813681|532078628|FG000|Overall Study|Physician Decision|5|||
147525748|NCT02813681|532078629|FG001|Overall Study|Physician Decision|5|||
147525749|NCT02813681|532078630|FG002|Overall Study|Physician Decision|0|||
147525750|NCT02813681|532078628|FG000|Overall Study|Lost to Follow-up|0|||
147525751|NCT02813681|532078629|FG001|Overall Study|Lost to Follow-up|1|||
147525752|NCT02813681|532078630|FG002|Overall Study|Lost to Follow-up|0|||
147525753|NCT02500706|532078631|FG000|Overall Study|Adverse Event|0|||
147525754|NCT02500706|532078632|FG001|Overall Study|Adverse Event|0|||
147525755|NCT02500706|532078633|FG002|Overall Study|Adverse Event|1|||
147525756|NCT02500706|532078631|FG000|Overall Study|Lost to Follow-up|0|||
147525757|NCT02500706|532078632|FG001|Overall Study|Lost to Follow-up|1|||
147525758|NCT02500706|532078633|FG002|Overall Study|Lost to Follow-up|1|||
147525759|NCT02500706|532078631|FG000|Overall Study|Withdrawal by Subject|4|||
147525760|NCT02500706|532078632|FG001|Overall Study|Withdrawal by Subject|6|||
147525761|NCT02500706|532078633|FG002|Overall Study|Withdrawal by Subject|4|||
147525762|NCT02500706|532078631|FG000|Overall Study|Unclassified|0|||
147525763|NCT02500706|532078632|FG001|Overall Study|Unclassified|0|||
147525764|NCT02500706|532078633|FG002|Overall Study|Unclassified|1|||
147525765|NCT00529152|532078634|FG000|Overall Study|Adverse Event|2|||
147525766|NCT00529152|532078634|FG000|Overall Study|Withdrawal by Subject|2|||
147525767|NCT00529152|532078634|FG000|Overall Study|Lost to Follow-up|1|||
147525768|NCT01497899|532078635|FG000|Double-Blind Phase|Randomized but not Treated|1|||
147525769|NCT01497899|532078636|FG001|Double-Blind Phase|Randomized but not Treated|0|||
147525770|NCT01497899|532078637|FG002|Double-Blind Phase|Randomized but not Treated|0|||
147525771|NCT01497899|532078638|FG003|Double-Blind Phase|Randomized but not Treated|0|||
147525772|NCT01497899|532078635|FG000|Double-Blind Phase|Adverse Event|1|||
147525773|NCT01497899|532078636|FG001|Double-Blind Phase|Adverse Event|0|||
147525774|NCT01497899|532078637|FG002|Double-Blind Phase|Adverse Event|0|||
147525775|NCT01497899|532078638|FG003|Double-Blind Phase|Adverse Event|0|||
147525776|NCT01497899|532078635|FG000|Double-Blind Phase|Lack of Efficacy|0|||
147525777|NCT01497899|532078636|FG001|Double-Blind Phase|Lack of Efficacy|1|||
147525778|NCT01497899|532078637|FG002|Double-Blind Phase|Lack of Efficacy|0|||
147525779|NCT01497899|532078638|FG003|Double-Blind Phase|Lack of Efficacy|0|||
147643875|NCT02539134|532516660|FG001|Overall Study|Lost to Follow-up|0|||
147643876|NCT02539134|532516661|FG002|Overall Study|Lost to Follow-up|0|||
147525780|NCT01497899|532078635|FG000|Double-Blind Phase|Investigator's Discretion|1|||
147525781|NCT01497899|532078636|FG001|Double-Blind Phase|Investigator's Discretion|0|||
147525782|NCT01497899|532078637|FG002|Double-Blind Phase|Investigator's Discretion|0|||
147525783|NCT01497899|532078638|FG003|Double-Blind Phase|Investigator's Discretion|0|||
147525784|NCT01497899|532078635|FG000|Double-Blind Phase|Withdrew Consent|0|||
147525785|NCT01497899|532078636|FG001|Double-Blind Phase|Withdrew Consent|1|||
147525786|NCT01497899|532078637|FG002|Double-Blind Phase|Withdrew Consent|0|||
147525787|NCT01497899|532078638|FG003|Double-Blind Phase|Withdrew Consent|0|||
147525788|NCT01497899|532078635|FG000|Double-Blind Phase|Lost to Follow-up|3|||
147525789|NCT01497899|532078636|FG001|Double-Blind Phase|Lost to Follow-up|2|||
147525790|NCT01497899|532078637|FG002|Double-Blind Phase|Lost to Follow-up|0|||
147525791|NCT01497899|532078638|FG003|Double-Blind Phase|Lost to Follow-up|0|||
147525792|NCT01497899|532078635|FG000|Double-Blind Phase|Subject Non-Compliance|0|||
147525793|NCT01497899|532078636|FG001|Double-Blind Phase|Subject Non-Compliance|1|||
147525794|NCT01497899|532078637|FG002|Double-Blind Phase|Subject Non-Compliance|0|||
147525795|NCT01497899|532078638|FG003|Double-Blind Phase|Subject Non-Compliance|0|||
147525796|NCT01497899|532078635|FG000|Open-Label Extension Phase|Adverse Event|1|||
147525797|NCT01497899|532078636|FG001|Open-Label Extension Phase|Adverse Event|0|||
147525798|NCT01497899|532078637|FG002|Open-Label Extension Phase|Adverse Event|0|||
147525799|NCT01497899|532078638|FG003|Open-Label Extension Phase|Adverse Event|0|||
147525800|NCT01497899|532078635|FG000|Open-Label Extension Phase|Death|1|||
147525801|NCT01497899|532078636|FG001|Open-Label Extension Phase|Death|0|||
147525802|NCT01497899|532078637|FG002|Open-Label Extension Phase|Death|0|||
147525803|NCT01497899|532078638|FG003|Open-Label Extension Phase|Death|0|||
147525804|NCT01497899|532078635|FG000|Open-Label Extension Phase|Withdrew Consent|8|||
147525805|NCT01497899|532078636|FG001|Open-Label Extension Phase|Withdrew Consent|3|||
147525806|NCT01497899|532078637|FG002|Open-Label Extension Phase|Withdrew Consent|2|||
147525807|NCT01497899|532078638|FG003|Open-Label Extension Phase|Withdrew Consent|0|||
147525808|NCT01497899|532078635|FG000|Open-Label Extension Phase|Pregnancy|0|||
147525809|NCT01497899|532078636|FG001|Open-Label Extension Phase|Pregnancy|1|||
147525810|NCT01497899|532078637|FG002|Open-Label Extension Phase|Pregnancy|1|||
147525811|NCT01497899|532078638|FG003|Open-Label Extension Phase|Pregnancy|0|||
147525812|NCT01497899|532078635|FG000|Open-Label Extension Phase|Protocol Violation|0|||
147525813|NCT01497899|532078636|FG001|Open-Label Extension Phase|Protocol Violation|0|||
147525814|NCT01497899|532078637|FG002|Open-Label Extension Phase|Protocol Violation|1|||
147525815|NCT01497899|532078638|FG003|Open-Label Extension Phase|Protocol Violation|0|||
147525816|NCT01497899|532078635|FG000|Open-Label Extension Phase|Lost to Follow-up|9|||
147525817|NCT01497899|532078636|FG001|Open-Label Extension Phase|Lost to Follow-up|3|||
147525818|NCT01497899|532078637|FG002|Open-Label Extension Phase|Lost to Follow-up|5|||
147525819|NCT01497899|532078638|FG003|Open-Label Extension Phase|Lost to Follow-up|5|||
147525820|NCT01874288|532078642|FG000|Overall Study|Withdrawal by Subject|1|||
147525821|NCT01874288|532078643|FG001|Overall Study|Withdrawal by Subject|0|||
147525822|NCT01874288|532078644|FG002|Overall Study|Withdrawal by Subject|2|||
147525823|NCT01874288|532078645|FG003|Overall Study|Withdrawal by Subject|1|||
147525824|NCT01874288|532078646|FG004|Overall Study|Withdrawal by Subject|1|||
147525825|NCT01874288|532078642|FG000|Overall Study|Physician Decision|0|||
147525826|NCT01874288|532078643|FG001|Overall Study|Physician Decision|0|||
147525827|NCT01874288|532078644|FG002|Overall Study|Physician Decision|0|||
147525828|NCT01874288|532078645|FG003|Overall Study|Physician Decision|1|||
147525829|NCT01874288|532078646|FG004|Overall Study|Physician Decision|0|||
147525830|NCT01874288|532078642|FG000|Overall Study|Progressive disease|2|||
147525831|NCT01874288|532078643|FG001|Overall Study|Progressive disease|0|||
147525832|NCT01874288|532078644|FG002|Overall Study|Progressive disease|3|||
147525833|NCT01874288|532078645|FG003|Overall Study|Progressive disease|5|||
147525834|NCT01874288|532078646|FG004|Overall Study|Progressive disease|1|||
147525835|NCT04212221|532078647|FG000|Overall Study|Remained on Treatment|0|||
147525836|NCT04212221|532078648|FG001|Overall Study|Remained on Treatment|0|||
147525837|NCT04212221|532078649|FG002|Overall Study|Remained on Treatment|0|||
147525838|NCT04212221|532078650|FG003|Overall Study|Remained on Treatment|1|||
147525839|NCT04212221|532078651|FG004|Overall Study|Remained on Treatment|0|||
147525840|NCT04212221|532078652|FG005|Overall Study|Remained on Treatment|0|||
147525841|NCT04212221|532078653|FG006|Overall Study|Remained on Treatment|3|||
147525842|NCT04212221|532078654|FG007|Overall Study|Remained on Treatment|9|||
147525843|NCT04212221|532078647|FG000|Overall Study|Adverse Event|0|||
147525844|NCT04212221|532078648|FG001|Overall Study|Adverse Event|0|||
147525845|NCT04212221|532078649|FG002|Overall Study|Adverse Event|0|||
147525846|NCT04212221|532078650|FG003|Overall Study|Adverse Event|0|||
147525847|NCT04212221|532078651|FG004|Overall Study|Adverse Event|0|||
147525848|NCT04212221|532078652|FG005|Overall Study|Adverse Event|0|||
147525849|NCT04212221|532078653|FG006|Overall Study|Adverse Event|2|||
147525850|NCT04212221|532078654|FG007|Overall Study|Adverse Event|3|||
147525851|NCT04212221|532078647|FG000|Overall Study|Death|0|||
147525852|NCT04212221|532078648|FG001|Overall Study|Death|0|||
147525853|NCT04212221|532078649|FG002|Overall Study|Death|0|||
147525854|NCT04212221|532078650|FG003|Overall Study|Death|0|||
147525855|NCT04212221|532078651|FG004|Overall Study|Death|0|||
147525856|NCT04212221|532078652|FG005|Overall Study|Death|0|||
147525857|NCT04212221|532078653|FG006|Overall Study|Death|0|||
147525858|NCT04212221|532078654|FG007|Overall Study|Death|2|||
147643877|NCT02539134|532516662|FG003|Overall Study|Lost to Follow-up|0|||
147643878|NCT02539134|532516663|FG004|Overall Study|Lost to Follow-up|0|||
147643879|NCT02539134|532516664|FG005|Overall Study|Lost to Follow-up|0|||
147643880|NCT01143064|532516665|FG000|Overall Study|Death|109|||
147643881|NCT01143064|532516666|FG001|Overall Study|Death|91|||
147643882|NCT01143064|532516665|FG000|Overall Study|Adverse Event|0|||
147643883|NCT01143064|532516666|FG001|Overall Study|Adverse Event|1|||
147643884|NCT01143064|532516665|FG000|Overall Study|Withdrawal by Subject|7|||
147643885|NCT01143064|532516666|FG001|Overall Study|Withdrawal by Subject|5|||
147643886|NCT01143064|532516665|FG000|Overall Study|Lost to Follow-up|17|||
147643887|NCT01143064|532516666|FG001|Overall Study|Lost to Follow-up|14|||
147643888|NCT01143064|532516665|FG000|Overall Study|Physician Decision|0|||
147643889|NCT01143064|532516666|FG001|Overall Study|Physician Decision|4|||
147643890|NCT02453282|532516667|FG000|Overall Study|Death|275|||
147643891|NCT02453282|532516668|FG001|Overall Study|Death|277|||
147643892|NCT02453282|532516669|FG002|Overall Study|Death|296|||
147643893|NCT02453282|532516667|FG000|Overall Study|Lost to Follow-up|1|||
147643894|NCT02453282|532516668|FG001|Overall Study|Lost to Follow-up|0|||
147643895|NCT02453282|532516669|FG002|Overall Study|Lost to Follow-up|2|||
147643896|NCT02453282|532516667|FG000|Overall Study|Withdrawal by Subject|12|||
147643897|NCT02453282|532516668|FG001|Overall Study|Withdrawal by Subject|10|||
147643898|NCT02453282|532516669|FG002|Overall Study|Withdrawal by Subject|11|||
147643899|NCT02453282|532516667|FG000|Overall Study|Participants ongoing at data cut-off|85|||
147643900|NCT02453282|532516668|FG001|Overall Study|Participants ongoing at data cut-off|84|||
147643901|NCT02453282|532516669|FG002|Overall Study|Participants ongoing at data cut-off|62|||
147643902|NCT02453282|532516667|FG000|Overall Study|Other|1|||
147643903|NCT02453282|532516668|FG001|Overall Study|Other|1|||
147643904|NCT02453282|532516669|FG002|Overall Study|Other|1|||
147643905|NCT02327013|532516672|FG000|Overall Study|Adverse Event|4|||
147643906|NCT02327013|532516673|FG001|Overall Study|Adverse Event|4|||
147643907|NCT02327013|532516674|FG002|Overall Study|Adverse Event|3|||
147643908|NCT02327013|532516675|FG003|Overall Study|Adverse Event|0|||
147643909|NCT02327013|532516676|FG004|Overall Study|Adverse Event|1|||
147643910|NCT02327013|532516672|FG000|Overall Study|Lack of Efficacy|2|||
147643911|NCT02327013|532516673|FG001|Overall Study|Lack of Efficacy|0|||
147643912|NCT02327013|532516674|FG002|Overall Study|Lack of Efficacy|5|||
147525859|NCT04212221|532078647|FG000|Overall Study|Disease progression according to irRECIST|1|||
147525860|NCT04212221|532078648|FG001|Overall Study|Disease progression according to irRECIST|2|||
147525861|NCT04212221|532078649|FG002|Overall Study|Disease progression according to irRECIST|3|||
147525862|NCT04212221|532078650|FG003|Overall Study|Disease progression according to irRECIST|3|||
147525863|NCT04212221|532078651|FG004|Overall Study|Disease progression according to irRECIST|2|||
147525864|NCT04212221|532078652|FG005|Overall Study|Disease progression according to irRECIST|2|||
147525865|NCT04212221|532078653|FG006|Overall Study|Disease progression according to irRECIST|21|||
147525866|NCT04212221|532078654|FG007|Overall Study|Disease progression according to irRECIST|17|||
147525867|NCT04212221|532078647|FG000|Overall Study|Global Deterioration of Health Status|0|||
147525868|NCT04212221|532078648|FG001|Overall Study|Global Deterioration of Health Status|0|||
147525869|NCT04212221|532078649|FG002|Overall Study|Global Deterioration of Health Status|0|||
147525870|NCT04212221|532078650|FG003|Overall Study|Global Deterioration of Health Status|0|||
147525871|NCT04212221|532078651|FG004|Overall Study|Global Deterioration of Health Status|0|||
147525872|NCT04212221|532078652|FG005|Overall Study|Global Deterioration of Health Status|0|||
147525873|NCT04212221|532078653|FG006|Overall Study|Global Deterioration of Health Status|0|||
147525874|NCT04212221|532078654|FG007|Overall Study|Global Deterioration of Health Status|2|||
147525875|NCT04212221|532078647|FG000|Overall Study|Investigator's Decision|0|||
147525876|NCT04212221|532078648|FG001|Overall Study|Investigator's Decision|0|||
147525877|NCT04212221|532078649|FG002|Overall Study|Investigator's Decision|0|||
147525878|NCT04212221|532078650|FG003|Overall Study|Investigator's Decision|1|||
147525879|NCT04212221|532078651|FG004|Overall Study|Investigator's Decision|0|||
147525880|NCT04212221|532078652|FG005|Overall Study|Investigator's Decision|0|||
147525881|NCT04212221|532078653|FG006|Overall Study|Investigator's Decision|3|||
147525882|NCT04212221|532078654|FG007|Overall Study|Investigator's Decision|0|||
147525883|NCT04212221|532078647|FG000|Overall Study|Participant refused to continue treatment|0|||
147525884|NCT04212221|532078648|FG001|Overall Study|Participant refused to continue treatment|1|||
147525885|NCT04212221|532078649|FG002|Overall Study|Participant refused to continue treatment|0|||
147525886|NCT04212221|532078650|FG003|Overall Study|Participant refused to continue treatment|1|||
147525887|NCT04212221|532078651|FG004|Overall Study|Participant refused to continue treatment|1|||
147525888|NCT04212221|532078652|FG005|Overall Study|Participant refused to continue treatment|2|||
147525889|NCT04212221|532078653|FG006|Overall Study|Participant refused to continue treatment|4|||
147525890|NCT04212221|532078654|FG007|Overall Study|Participant refused to continue treatment|2|||
147525891|NCT04212221|532078647|FG000|Overall Study|Protocol Violation|0|||
147525892|NCT04212221|532078648|FG001|Overall Study|Protocol Violation|0|||
147525893|NCT04212221|532078649|FG002|Overall Study|Protocol Violation|0|||
147525894|NCT04212221|532078650|FG003|Overall Study|Protocol Violation|0|||
147525895|NCT04212221|532078651|FG004|Overall Study|Protocol Violation|0|||
147525896|NCT04212221|532078652|FG005|Overall Study|Protocol Violation|0|||
147525897|NCT04212221|532078653|FG006|Overall Study|Protocol Violation|0|||
147525898|NCT04212221|532078654|FG007|Overall Study|Protocol Violation|1|||
147525899|NCT03370133|532078662|FG000|Initial Treatment Period (WK 16)|Adverse Event|5|||
147525900|NCT03370133|532078663|FG001|Initial Treatment Period (WK 16)|Adverse Event|5|||
147525901|NCT03370133|532078664|FG002|Initial Treatment Period (WK 16)|Adverse Event|2|||
147525902|NCT03370133|532078665|FG003|Initial Treatment Period (WK 16)|Adverse Event|0|||
147525903|NCT03370133|532078666|FG004|Initial Treatment Period (WK 16)|Adverse Event|0|||
147525904|NCT03370133|532078667|FG005|Initial Treatment Period (WK 16)|Adverse Event|0|||
147525905|NCT03370133|532078662|FG000|Initial Treatment Period (WK 16)|Death|1|||
147525906|NCT03370133|532078663|FG001|Initial Treatment Period (WK 16)|Death|1|||
147525907|NCT03370133|532078664|FG002|Initial Treatment Period (WK 16)|Death|1|||
147525908|NCT03370133|532078665|FG003|Initial Treatment Period (WK 16)|Death|0|||
147525909|NCT03370133|532078666|FG004|Initial Treatment Period (WK 16)|Death|0|||
147525910|NCT03370133|532078667|FG005|Initial Treatment Period (WK 16)|Death|0|||
147525911|NCT03370133|532078662|FG000|Initial Treatment Period (WK 16)|Lack of Efficacy|2|||
147525912|NCT03370133|532078663|FG001|Initial Treatment Period (WK 16)|Lack of Efficacy|1|||
147525913|NCT03370133|532078664|FG002|Initial Treatment Period (WK 16)|Lack of Efficacy|0|||
147525914|NCT03370133|532078665|FG003|Initial Treatment Period (WK 16)|Lack of Efficacy|0|||
147525915|NCT03370133|532078666|FG004|Initial Treatment Period (WK 16)|Lack of Efficacy|0|||
147525916|NCT03370133|532078667|FG005|Initial Treatment Period (WK 16)|Lack of Efficacy|0|||
147525917|NCT03370133|532078662|FG000|Initial Treatment Period (WK 16)|Protocol Violation|0|||
147525918|NCT03370133|532078663|FG001|Initial Treatment Period (WK 16)|Protocol Violation|0|||
147525919|NCT03370133|532078664|FG002|Initial Treatment Period (WK 16)|Protocol Violation|2|||
147525920|NCT03370133|532078665|FG003|Initial Treatment Period (WK 16)|Protocol Violation|0|||
147525921|NCT03370133|532078666|FG004|Initial Treatment Period (WK 16)|Protocol Violation|0|||
147525922|NCT03370133|532078667|FG005|Initial Treatment Period (WK 16)|Protocol Violation|0|||
147525923|NCT03370133|532078662|FG000|Initial Treatment Period (WK 16)|Lost to Follow-up|0|||
147525924|NCT03370133|532078663|FG001|Initial Treatment Period (WK 16)|Lost to Follow-up|3|||
147525925|NCT03370133|532078664|FG002|Initial Treatment Period (WK 16)|Lost to Follow-up|0|||
147525926|NCT03370133|532078665|FG003|Initial Treatment Period (WK 16)|Lost to Follow-up|0|||
147525927|NCT03370133|532078666|FG004|Initial Treatment Period (WK 16)|Lost to Follow-up|0|||
147525928|NCT03370133|532078667|FG005|Initial Treatment Period (WK 16)|Lost to Follow-up|0|||
147525929|NCT03370133|532078662|FG000|Initial Treatment Period (WK 16)|Withdrawal by Subject|1|||
147525930|NCT03370133|532078663|FG001|Initial Treatment Period (WK 16)|Withdrawal by Subject|2|||
147525931|NCT03370133|532078664|FG002|Initial Treatment Period (WK 16)|Withdrawal by Subject|1|||
147525932|NCT03370133|532078665|FG003|Initial Treatment Period (WK 16)|Withdrawal by Subject|0|||
147525933|NCT03370133|532078666|FG004|Initial Treatment Period (WK 16)|Withdrawal by Subject|0|||
147525934|NCT03370133|532078667|FG005|Initial Treatment Period (WK 16)|Withdrawal by Subject|0|||
147525935|NCT03370133|532078662|FG000|Initial Treatment Period (WK 16)|Non-compliance|0|||
147525936|NCT03370133|532078663|FG001|Initial Treatment Period (WK 16)|Non-compliance|1|||
147525937|NCT03370133|532078664|FG002|Initial Treatment Period (WK 16)|Non-compliance|0|||
147525938|NCT03370133|532078665|FG003|Initial Treatment Period (WK 16)|Non-compliance|0|||
147525939|NCT03370133|532078666|FG004|Initial Treatment Period (WK 16)|Non-compliance|0|||
147525940|NCT03370133|532078667|FG005|Initial Treatment Period (WK 16)|Non-compliance|0|||
147525941|NCT03370133|532078662|FG000|Initial Treatment Period (WK 16)|Site closed|0|||
147525942|NCT03370133|532078663|FG001|Initial Treatment Period (WK 16)|Site closed|2|||
147525943|NCT03370133|532078664|FG002|Initial Treatment Period (WK 16)|Site closed|0|||
147525944|NCT03370133|532078665|FG003|Initial Treatment Period (WK 16)|Site closed|0|||
147525945|NCT03370133|532078666|FG004|Initial Treatment Period (WK 16)|Site closed|0|||
147525946|NCT03370133|532078667|FG005|Initial Treatment Period (WK 16)|Site closed|0|||
147525947|NCT03370133|532078662|FG000|Maintenance Treatment Period (WK 52)|Adverse Event|0|||
147525948|NCT03370133|532078663|FG001|Maintenance Treatment Period (WK 52)|Adverse Event|0|||
147525949|NCT03370133|532078664|FG002|Maintenance Treatment Period (WK 52)|Adverse Event|0|||
147525950|NCT03370133|532078665|FG003|Maintenance Treatment Period (WK 52)|Adverse Event|3|||
147525951|NCT03370133|532078666|FG004|Maintenance Treatment Period (WK 52)|Adverse Event|12|||
147525952|NCT03370133|532078667|FG005|Maintenance Treatment Period (WK 52)|Adverse Event|4|||
147525953|NCT03370133|532078662|FG000|Maintenance Treatment Period (WK 52)|Lack of Efficacy|0|||
147525954|NCT03370133|532078663|FG001|Maintenance Treatment Period (WK 52)|Lack of Efficacy|0|||
147525955|NCT03370133|532078664|FG002|Maintenance Treatment Period (WK 52)|Lack of Efficacy|0|||
147525956|NCT03370133|532078665|FG003|Maintenance Treatment Period (WK 52)|Lack of Efficacy|0|||
147525957|NCT03370133|532078666|FG004|Maintenance Treatment Period (WK 52)|Lack of Efficacy|1|||
147525958|NCT03370133|532078667|FG005|Maintenance Treatment Period (WK 52)|Lack of Efficacy|4|||
147525959|NCT03370133|532078662|FG000|Maintenance Treatment Period (WK 52)|Protocol Violation|0|||
147525960|NCT03370133|532078663|FG001|Maintenance Treatment Period (WK 52)|Protocol Violation|0|||
147525961|NCT03370133|532078664|FG002|Maintenance Treatment Period (WK 52)|Protocol Violation|0|||
147525962|NCT03370133|532078665|FG003|Maintenance Treatment Period (WK 52)|Protocol Violation|1|||
147525963|NCT03370133|532078666|FG004|Maintenance Treatment Period (WK 52)|Protocol Violation|1|||
147525964|NCT03370133|532078667|FG005|Maintenance Treatment Period (WK 52)|Protocol Violation|0|||
147525965|NCT03370133|532078662|FG000|Maintenance Treatment Period (WK 52)|Lost to Follow-up|0|||
147525966|NCT03370133|532078663|FG001|Maintenance Treatment Period (WK 52)|Lost to Follow-up|0|||
147525967|NCT03370133|532078664|FG002|Maintenance Treatment Period (WK 52)|Lost to Follow-up|0|||
147525968|NCT03370133|532078665|FG003|Maintenance Treatment Period (WK 52)|Lost to Follow-up|0|||
147525969|NCT03370133|532078666|FG004|Maintenance Treatment Period (WK 52)|Lost to Follow-up|4|||
147525970|NCT03370133|532078667|FG005|Maintenance Treatment Period (WK 52)|Lost to Follow-up|3|||
147525971|NCT03370133|532078662|FG000|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|0|||
147525972|NCT03370133|532078663|FG001|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|0|||
147525973|NCT03370133|532078664|FG002|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|0|||
147525974|NCT03370133|532078665|FG003|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|1|||
147525975|NCT03370133|532078666|FG004|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|4|||
147525976|NCT03370133|532078667|FG005|Maintenance Treatment Period (WK 52)|Withdrawal by Subject|4|||
147525977|NCT03370133|532078662|FG000|Maintenance Treatment Period (WK 52)|Non-compliance|0|||
147525978|NCT03370133|532078663|FG001|Maintenance Treatment Period (WK 52)|Non-compliance|0|||
147525979|NCT03370133|532078664|FG002|Maintenance Treatment Period (WK 52)|Non-compliance|0|||
147525980|NCT03370133|532078665|FG003|Maintenance Treatment Period (WK 52)|Non-compliance|0|||
147643913|NCT02327013|532516675|FG003|Overall Study|Lack of Efficacy|0|||
147643914|NCT02327013|532516676|FG004|Overall Study|Lack of Efficacy|1|||
147643915|NCT02327013|532516672|FG000|Overall Study|Non-compliance with IMP|1|||
147643916|NCT02327013|532516673|FG001|Overall Study|Non-compliance with IMP|2|||
147643917|NCT02327013|532516674|FG002|Overall Study|Non-compliance with IMP|7|||
147643918|NCT02327013|532516675|FG003|Overall Study|Non-compliance with IMP|0|||
147643919|NCT02327013|532516676|FG004|Overall Study|Non-compliance with IMP|0|||
147643920|NCT02327013|532516672|FG000|Overall Study|Withdrawal of Consent|1|||
147643921|NCT02327013|532516673|FG001|Overall Study|Withdrawal of Consent|0|||
147643922|NCT02327013|532516674|FG002|Overall Study|Withdrawal of Consent|3|||
147643923|NCT02327013|532516675|FG003|Overall Study|Withdrawal of Consent|0|||
147643924|NCT02327013|532516676|FG004|Overall Study|Withdrawal of Consent|0|||
147643925|NCT02327013|532516672|FG000|Overall Study|Lost to Follow-up|2|||
147643926|NCT02327013|532516673|FG001|Overall Study|Lost to Follow-up|4|||
147643927|NCT02327013|532516674|FG002|Overall Study|Lost to Follow-up|5|||
147643928|NCT02327013|532516675|FG003|Overall Study|Lost to Follow-up|0|||
147643929|NCT02327013|532516676|FG004|Overall Study|Lost to Follow-up|0|||
147643930|NCT02327013|532516672|FG000|Overall Study|Administrative or other reason(s)|1|||
147643931|NCT02327013|532516673|FG001|Overall Study|Administrative or other reason(s)|5|||
147643932|NCT02327013|532516674|FG002|Overall Study|Administrative or other reason(s)|11|||
147643933|NCT02327013|532516675|FG003|Overall Study|Administrative or other reason(s)|1|||
147643934|NCT02327013|532516676|FG004|Overall Study|Administrative or other reason(s)|1|||
147643935|NCT02327013|532516672|FG000|Overall Study|Protocol Violation|0|||
147643936|NCT02327013|532516673|FG001|Overall Study|Protocol Violation|0|||
147643937|NCT02327013|532516674|FG002|Overall Study|Protocol Violation|3|||
147643938|NCT02327013|532516675|FG003|Overall Study|Protocol Violation|0|||
147643939|NCT02327013|532516676|FG004|Overall Study|Protocol Violation|1|||
147643940|NCT02327013|532516672|FG000|Overall Study|Withdrawal before treatment|2|||
147643941|NCT02327013|532516673|FG001|Overall Study|Withdrawal before treatment|1|||
147643942|NCT02327013|532516674|FG002|Overall Study|Withdrawal before treatment|5|||
147643943|NCT02327013|532516675|FG003|Overall Study|Withdrawal before treatment|0|||
147643944|NCT02327013|532516676|FG004|Overall Study|Withdrawal before treatment|0|||
147643945|NCT02380859|532516677|FG000|Overall Study|Withdrawal by Subject|2|||
147643946|NCT02380859|532516678|FG001|Overall Study|Withdrawal by Subject|0|||
147643947|NCT01565668|532516679|FG000|Overall Study|Death|2|||
147643948|NCT01565668|532516680|FG001|Overall Study|Death|1|||
147643949|NCT01565668|532516679|FG000|Overall Study|Lack of Efficacy|4|||
147643950|NCT01565668|532516680|FG001|Overall Study|Lack of Efficacy|2|||
147643951|NCT01565668|532516679|FG000|Overall Study|Participant went on Hospice Care|1|||
147643952|NCT01565668|532516680|FG001|Overall Study|Participant went on Hospice Care|0|||
147643953|NCT01565668|532516679|FG000|Overall Study|Adverse Event|6|||
147643954|NCT01565668|532516680|FG001|Overall Study|Adverse Event|1|||
147643955|NCT01565668|532516679|FG000|Overall Study|Randomized, but never received drug|0|||
147643956|NCT01565668|532516680|FG001|Overall Study|Randomized, but never received drug|2|||
147643957|NCT01565668|532516679|FG000|Overall Study|Progressive disease|13|||
147643958|NCT01565668|532516680|FG001|Overall Study|Progressive disease|14|||
147643959|NCT01565668|532516679|FG000|Overall Study|Withdrawal by Subject|1|||
147643960|NCT01565668|532516680|FG001|Overall Study|Withdrawal by Subject|3|||
147643961|NCT01565668|532516679|FG000|Overall Study|HSCT Transplant|11|||
147643962|NCT01565668|532516680|FG001|Overall Study|HSCT Transplant|15|||
147643963|NCT04258254|532516681|FG000|Overall Study|Withdrawal by Subject|0|||
147643964|NCT04258254|532516682|FG001|Overall Study|Withdrawal by Subject|1|||
147643965|NCT04258254|532516683|FG002|Overall Study|Withdrawal by Subject|0|||
147643966|NCT02255552|532516684|FG000|Overall Study|Participants enrolled into another study|0|||
147643967|NCT02255552|532516685|FG001|Overall Study|Participants enrolled into another study|11|||
147525981|NCT03370133|532078666|FG004|Maintenance Treatment Period (WK 52)|Non-compliance|1|||
147525982|NCT03370133|532078667|FG005|Maintenance Treatment Period (WK 52)|Non-compliance|0|||
147525983|NCT03370133|532078662|FG000|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0|||
147525984|NCT03370133|532078663|FG001|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0|||
147525985|NCT03370133|532078664|FG002|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0|||
147525986|NCT03370133|532078665|FG003|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0|||
147525987|NCT03370133|532078666|FG004|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|0|||
147525988|NCT03370133|532078667|FG005|Maintenance Treatment Period (WK 52)|Consent Withdrawn for IMP Not Procedures|1|||
147525989|NCT00636506|532078668|FG000|Overall Study|Lost to Follow-up|8|||
147525990|NCT00636506|532078668|FG000|Overall Study|Explanted|1|||
147525991|NCT00636506|532078668|FG000|Overall Study|Withdrawal by Subject|6|||
147525992|NCT00636506|532078668|FG000|Overall Study|Procedure aborted|1|||
147525993|NCT03742271|532078669|FG000|Overall Study|Unsatisfactory Visual Response|1|||
147525994|NCT03742271|532078669|FG000|Overall Study|Withdrawal by Subject|3|||
147525995|NCT03742271|532078669|FG000|Overall Study|Lost to Follow-up|4|||
147525996|NCT03742271|532078669|FG000|Overall Study|Failed Insertion & removal|3|||
147525997|NCT03742271|532078669|FG000|Overall Study|Protocol Violation|1|||
147525998|NCT01624974|532078670|FG000|Period III of Treatment (4 Weeks)|Lack of Efficacy|0|||
147525999|NCT01624974|532078671|FG001|Period III of Treatment (4 Weeks)|Lack of Efficacy|2|||
147526000|NCT01624974|532078670|FG000|Period III of Treatment (4 Weeks)|Non-Compliance with Protocol|1|||
147526001|NCT01624974|532078671|FG001|Period III of Treatment (4 Weeks)|Non-Compliance with Protocol|2|||
147526002|NCT01624974|532078670|FG000|Period III of Treatment (4 Weeks)|Physician Decision|5|||
147526003|NCT01624974|532078671|FG001|Period III of Treatment (4 Weeks)|Physician Decision|3|||
147526004|NCT01624974|532078670|FG000|Period III of Treatment (4 Weeks)|Protocol Violation|1|||
147526005|NCT01624974|532078671|FG001|Period III of Treatment (4 Weeks)|Protocol Violation|0|||
147526006|NCT01624974|532078670|FG000|Period III of Treatment (4 Weeks)|Adverse Event|0|||
147526007|NCT01624974|532078671|FG001|Period III of Treatment (4 Weeks)|Adverse Event|1|||
147526008|NCT01624974|532078670|FG000|Period IV Washout (4 Weeks)|Lack of Efficacy|1|||
147526009|NCT01624974|532078671|FG001|Period IV Washout (4 Weeks)|Lack of Efficacy|1|||
147526010|NCT01624974|532078670|FG000|Period IV Washout (4 Weeks)|Withdrawal by Subject|0|||
147526011|NCT01624974|532078671|FG001|Period IV Washout (4 Weeks)|Withdrawal by Subject|1|||
147526012|NCT01624974|532078670|FG000|Period IV Washout (4 Weeks)|Adverse Event|2|||
147526013|NCT01624974|532078671|FG001|Period IV Washout (4 Weeks)|Adverse Event|0|||
147526014|NCT01624974|532078670|FG000|Period IV Washout (4 Weeks)|Non-Compliance with Study Drug|0|||
147526015|NCT01624974|532078671|FG001|Period IV Washout (4 Weeks)|Non-Compliance with Study Drug|1|||
147526016|NCT01624974|532078670|FG000|Period V of Treatment (4 Weeks)|Lack of Efficacy|1|||
147526017|NCT01624974|532078671|FG001|Period V of Treatment (4 Weeks)|Lack of Efficacy|0|||
147526018|NCT01624974|532078670|FG000|Period V of Treatment (4 Weeks)|Physician Decision|3|||
147526019|NCT01624974|532078671|FG001|Period V of Treatment (4 Weeks)|Physician Decision|0|||
147526020|NCT01624974|532078670|FG000|Period V of Treatment (4 Weeks)|Adverse Event|1|||
147526021|NCT01624974|532078671|FG001|Period V of Treatment (4 Weeks)|Adverse Event|0|||
147526022|NCT03607994|532078672|FG000|Overall Study|Discontinued intervention (started sessions and dropped out due to time commitment and schedule)|1|||
147526023|NCT03607994|532078673|FG001|Overall Study|Discontinued intervention (started sessions and dropped out due to time commitment and schedule)|1|||
147526024|NCT03125902|532078676|FG000|Overall Study|Adverse Event|0|||
147526025|NCT03125902|532078677|FG001|Overall Study|Adverse Event|1|||
147526026|NCT03125902|532078676|FG000|Overall Study|Death|119|||
147526027|NCT03125902|532078677|FG001|Overall Study|Death|229|||
147526028|NCT03125902|532078676|FG000|Overall Study|Lost to Follow-up|4|||
147526029|NCT03125902|532078677|FG001|Overall Study|Lost to Follow-up|13|||
147526030|NCT03125902|532078676|FG000|Overall Study|Other|0|||
147526031|NCT03125902|532078677|FG001|Overall Study|Other|4|||
147526032|NCT03125902|532078676|FG000|Overall Study|Physician Decision|2|||
147526033|NCT03125902|532078677|FG001|Overall Study|Physician Decision|1|||
147526034|NCT03125902|532078676|FG000|Overall Study|Progressive Disease|0|||
147526035|NCT03125902|532078677|FG001|Overall Study|Progressive Disease|3|||
147526036|NCT03125902|532078676|FG000|Overall Study|Study Terminated By Sponsor|74|||
147526037|NCT03125902|532078677|FG001|Overall Study|Study Terminated By Sponsor|143|||
147526038|NCT03125902|532078676|FG000|Overall Study|Withdrawal by Subject|21|||
147526039|NCT03125902|532078677|FG001|Overall Study|Withdrawal by Subject|37|||
147526040|NCT01775995|532078678|FG000|Overall Study|Lost to Follow-up|1|||
147526041|NCT01775995|532078679|FG001|Overall Study|Lost to Follow-up|1|||
147526042|NCT01997333|532078680|FG000|Randomization and Treatment|Disease Progression|70|||
147526043|NCT01997333|532078681|FG001|Randomization and Treatment|Disease Progression|159|||
147526044|NCT01997333|532078680|FG000|Randomization and Treatment|Adverse Event|10|||
147526045|NCT01997333|532078681|FG001|Randomization and Treatment|Adverse Event|32|||
147526046|NCT01997333|532078680|FG000|Randomization and Treatment|Physician Decision|0|||
147526047|NCT01997333|532078681|FG001|Randomization and Treatment|Physician Decision|4|||
147526048|NCT01997333|532078680|FG000|Randomization and Treatment|Withdrawal by Subject|6|||
147526049|NCT01997333|532078681|FG001|Randomization and Treatment|Withdrawal by Subject|3|||
147526050|NCT01997333|532078680|FG000|Randomization and Treatment|Did not receive treatment|17|||
147526051|NCT01997333|532078681|FG001|Randomization and Treatment|Did not receive treatment|5|||
147526052|NCT01997333|532078680|FG000|Survival Follow up|Withdrawal by Subject|15|||
147526053|NCT01997333|532078681|FG001|Survival Follow up|Withdrawal by Subject|6|||
147526054|NCT01997333|532078680|FG000|Survival Follow up|Lost to Follow-up|0|||
147526055|NCT01997333|532078681|FG001|Survival Follow up|Lost to Follow-up|6|||
147526056|NCT01997333|532078680|FG000|Survival Follow up|Various|1|||
147526057|NCT01997333|532078681|FG001|Survival Follow up|Various|2|||
147526058|NCT04411472|532078684|FG000|Overall Study|Adverse Event|5|||
147526059|NCT04411472|532078685|FG001|Overall Study|Adverse Event|10|||
147526060|NCT04411472|532078686|FG002|Overall Study|Adverse Event|1|||
147526061|NCT04411472|532078687|FG003|Overall Study|Adverse Event|0|||
147526062|NCT04411472|532078688|FG004|Overall Study|Adverse Event|0|||
147526063|NCT04411472|532078689|FG005|Overall Study|Adverse Event|0|||
147526064|NCT04411472|532078684|FG000|Overall Study|Protocol Violation|1|||
147526065|NCT04411472|532078685|FG001|Overall Study|Protocol Violation|0|||
147526066|NCT04411472|532078686|FG002|Overall Study|Protocol Violation|0|||
147526067|NCT04411472|532078687|FG003|Overall Study|Protocol Violation|0|||
147526068|NCT04411472|532078688|FG004|Overall Study|Protocol Violation|0|||
147526069|NCT04411472|532078689|FG005|Overall Study|Protocol Violation|0|||
147526070|NCT04411472|532078684|FG000|Overall Study|Withdrawal by Subject|0|||
147526071|NCT04411472|532078685|FG001|Overall Study|Withdrawal by Subject|1|||
147526072|NCT04411472|532078686|FG002|Overall Study|Withdrawal by Subject|0|||
147526073|NCT04411472|532078687|FG003|Overall Study|Withdrawal by Subject|1|||
147526074|NCT04411472|532078688|FG004|Overall Study|Withdrawal by Subject|0|||
147526075|NCT04411472|532078689|FG005|Overall Study|Withdrawal by Subject|0|||
147526076|NCT04411472|532078684|FG000|Overall Study|Physician Decision|1|||
147526077|NCT04411472|532078685|FG001|Overall Study|Physician Decision|0|||
147526078|NCT04411472|532078686|FG002|Overall Study|Physician Decision|0|||
147526079|NCT04411472|532078687|FG003|Overall Study|Physician Decision|0|||
147526080|NCT04411472|532078688|FG004|Overall Study|Physician Decision|0|||
147526081|NCT04411472|532078689|FG005|Overall Study|Physician Decision|0|||
147526082|NCT04411472|532078684|FG000|Overall Study|Study terminated by sponsor|17|||
147526083|NCT04411472|532078685|FG001|Overall Study|Study terminated by sponsor|20|||
147526084|NCT04411472|532078686|FG002|Overall Study|Study terminated by sponsor|3|||
147526085|NCT04411472|532078687|FG003|Overall Study|Study terminated by sponsor|0|||
147526086|NCT04411472|532078688|FG004|Overall Study|Study terminated by sponsor|0|||
147526087|NCT04411472|532078689|FG005|Overall Study|Study terminated by sponsor|0|||
147526088|NCT05060003|532078690|FG000|Overall Study|ctDNA negative|7|||
147526089|NCT00440232|532078691|FG000|Overall Study|Lost to Follow-up|1|||
147526090|NCT00440232|532078692|FG001|Overall Study|Lost to Follow-up|1|||
147526091|NCT00440232|532078691|FG000|Overall Study|Unable to treat within allowed time|0|||
147526092|NCT00440232|532078692|FG001|Overall Study|Unable to treat within allowed time|1|||
147526093|NCT00440232|532078691|FG000|Overall Study|Onset of headache within 4 hours of fast|2|||
147526094|NCT00440232|532078692|FG001|Overall Study|Onset of headache within 4 hours of fast|2|||
147526095|NCT01747655|532078695|FG000|PEG-J Period (Duodopa Treatment)|Investigator Decision (Medical Event)|5|||
147526096|NCT01747655|532078696|FG001|PEG-J Period (Duodopa Treatment)|Investigator Decision (Medical Event)|0|||
147526097|NCT01747655|532078695|FG000|PEG-J Period (Duodopa Treatment)|Patient Decision|8|||
147526098|NCT01747655|532078696|FG001|PEG-J Period (Duodopa Treatment)|Patient Decision|0|||
147526099|NCT01747655|532078695|FG000|PEG-J Period (Duodopa Treatment)|Lost to Follow-up|1|||
147526100|NCT01747655|532078696|FG001|PEG-J Period (Duodopa Treatment)|Lost to Follow-up|0|||
147526101|NCT03769753|532078699|FG000|Overall Study|Not Treated|6|||
147526102|NCT03769753|532078699|FG000|Overall Study|Inevaluable - No Evidence of Disease|1|||
147526103|NCT01657903|532078701|FG000|Overall Study|Lost to Follow-up|1|||
147526104|NCT01657903|532078701|FG000|Overall Study|Withdrawal by Subject|1|||
147526105|NCT01259388|532078702|FG000|Overall Study|Adverse Event|3|||
147526106|NCT01259388|532078703|FG001|Overall Study|Adverse Event|0|||
147526107|NCT01259388|532078702|FG000|Overall Study|Withdrawal by Subject|1|||
147526108|NCT01259388|532078703|FG001|Overall Study|Withdrawal by Subject|1|||
147526109|NCT01259388|532078702|FG000|Overall Study|Physician Decision|1|||
147526110|NCT01259388|532078703|FG001|Overall Study|Physician Decision|0|||
147526111|NCT03529162|532078704|FG000|Overall Study|Lost to Follow-up|2|||
147526112|NCT03529162|532078705|FG001|Overall Study|Lost to Follow-up|2|||
147526113|NCT00620815|532078706|FG000|Overall Study|Adverse Event|1|||
147526114|NCT00620815|532078707|FG001|Overall Study|Adverse Event|1|||
147526115|NCT00620815|532078708|FG002|Overall Study|Adverse Event|2|||
147526116|NCT00620815|532078706|FG000|Overall Study|Withdrawal by Subject|1|||
147526117|NCT00620815|532078707|FG001|Overall Study|Withdrawal by Subject|2|||
147526118|NCT00620815|532078708|FG002|Overall Study|Withdrawal by Subject|0|||
147526119|NCT00620815|532078706|FG000|Overall Study|Lost to Follow-up|1|||
147526120|NCT00620815|532078707|FG001|Overall Study|Lost to Follow-up|6|||
147526121|NCT00620815|532078708|FG002|Overall Study|Lost to Follow-up|3|||
147526122|NCT00620815|532078706|FG000|Overall Study|Inappropriate enrolment|0|||
147526123|NCT00620815|532078707|FG001|Overall Study|Inappropriate enrolment|0|||
147526124|NCT00620815|532078708|FG002|Overall Study|Inappropriate enrolment|1|||
147526125|NCT00620815|532078706|FG000|Overall Study|Protocol Violation|1|||
147526126|NCT00620815|532078707|FG001|Overall Study|Protocol Violation|2|||
147526127|NCT00620815|532078708|FG002|Overall Study|Protocol Violation|1|||
147526128|NCT01888367|532078709|FG000|Overall Study|Physician Decision|3|||
147526129|NCT01888367|532078710|FG001|Overall Study|Physician Decision|4|||
147526130|NCT01888367|532078711|FG002|Overall Study|Physician Decision|2|||
147526131|NCT01888367|532078709|FG000|Overall Study|Death|2|||
147526132|NCT01888367|532078710|FG001|Overall Study|Death|0|||
147526133|NCT01888367|532078711|FG002|Overall Study|Death|1|||
147526134|NCT01888367|532078709|FG000|Overall Study|Withdrawal by Subject|1|||
147526135|NCT01888367|532078710|FG001|Overall Study|Withdrawal by Subject|0|||
147526136|NCT01888367|532078711|FG002|Overall Study|Withdrawal by Subject|1|||
147526137|NCT01888367|532078709|FG000|Overall Study|Lost to Follow-up|1|||
147526138|NCT01888367|532078710|FG001|Overall Study|Lost to Follow-up|1|||
147526139|NCT01888367|532078711|FG002|Overall Study|Lost to Follow-up|0|||
147526140|NCT01888367|532078709|FG000|Overall Study|Protocol Violation|0|||
147526141|NCT01888367|532078710|FG001|Overall Study|Protocol Violation|0|||
147526142|NCT01888367|532078711|FG002|Overall Study|Protocol Violation|1|||
147526143|NCT01888367|532078709|FG000|Overall Study|30-Day Visit Too Early (< 28 Days)|1|||
147526144|NCT01888367|532078710|FG001|Overall Study|30-Day Visit Too Early (< 28 Days)|0|||
147526145|NCT01888367|532078711|FG002|Overall Study|30-Day Visit Too Early (< 28 Days)|0|||
147526146|NCT00591786|532078712|FG000|Overall Study|Withdrawal of Informed Consent|0|||
147526147|NCT00591786|532078713|FG001|Overall Study|Withdrawal of Informed Consent|0|||
147526148|NCT00591786|532078714|FG002|Overall Study|Withdrawal of Informed Consent|1|||
147526149|NCT00591786|532078715|FG003|Overall Study|Withdrawal of Informed Consent|0|||
147526150|NCT00591786|532078716|FG004|Overall Study|Withdrawal of Informed Consent|0|||
147526151|NCT00591786|532078717|FG005|Overall Study|Withdrawal of Informed Consent|0|||
147526152|NCT00591786|532078718|FG006|Overall Study|Withdrawal of Informed Consent|0|||
147526153|NCT00591786|532078719|FG007|Overall Study|Withdrawal of Informed Consent|0|||
147526154|NCT00591786|532078720|FG008|Overall Study|Withdrawal of Informed Consent|0|||
147526155|NCT00591786|532078721|FG009|Overall Study|Withdrawal of Informed Consent|0|||
147526156|NCT03969589|532078722|FG000|Overall Study|Lost to Follow-up|3|||
147526157|NCT03969589|532078723|FG001|Overall Study|Lost to Follow-up|2|||
147526158|NCT03969589|532078722|FG000|Overall Study|Declined Follow-Up|0|||
147526159|NCT03969589|532078723|FG001|Overall Study|Declined Follow-Up|1|||
147526160|NCT00517634|532078724|FG000|Second Treatment Period|Withdrawal by Subject|0|||
147526161|NCT00517634|532078725|FG001|Second Treatment Period|Withdrawal by Subject|0|||
147526162|NCT00517634|532078726|FG002|Second Treatment Period|Withdrawal by Subject|0|||
147526163|NCT00517634|532078727|FG003|Second Treatment Period|Withdrawal by Subject|0|||
147526164|NCT00517634|532078728|FG004|Second Treatment Period|Withdrawal by Subject|1|||
147526165|NCT00517634|532078729|FG005|Second Treatment Period|Withdrawal by Subject|0|||
147526166|NCT03143855|532078730|FG000|Overall Study|Withdrawal by Subject|4|||
147526167|NCT03143855|532078731|FG001|Overall Study|Withdrawal by Subject|3|||
147526168|NCT03143855|532078730|FG000|Overall Study|Protocol Violation|1|||
147526169|NCT03143855|532078731|FG001|Overall Study|Protocol Violation|0|||
147526170|NCT03143855|532078730|FG000|Overall Study|Participant experienced withdrawal|0|||
147526171|NCT03143855|532078731|FG001|Overall Study|Participant experienced withdrawal|1|||
147526172|NCT03417999|532078732|FG000|Overall Study|Withdrawal by Subject|1|||
147526173|NCT03417999|532078733|FG001|Overall Study|Withdrawal by Subject|0|||
147526174|NCT03417999|532078734|FG002|Overall Study|Withdrawal by Subject|0|||
147526175|NCT03417999|532078732|FG000|Overall Study|Procedure cancelled; subject did not receive study drug|2|||
147526176|NCT03417999|532078733|FG001|Overall Study|Procedure cancelled; subject did not receive study drug|0|||
147526177|NCT03417999|532078734|FG002|Overall Study|Procedure cancelled; subject did not receive study drug|2|||
147526178|NCT03417999|532078732|FG000|Overall Study|Met exclusion criteria after obtaining consent|0|||
147526179|NCT03417999|532078733|FG001|Overall Study|Met exclusion criteria after obtaining consent|0|||
147526180|NCT03417999|532078734|FG002|Overall Study|Met exclusion criteria after obtaining consent|1|||
147526181|NCT03417999|532078732|FG000|Overall Study|Inadequate study staff available to process samples|0|||
147526182|NCT03417999|532078733|FG001|Overall Study|Inadequate study staff available to process samples|0|||
147526183|NCT03417999|532078734|FG002|Overall Study|Inadequate study staff available to process samples|1|||
147526184|NCT00422942|532078740|FG000|Overall Study|Study terminated by Sponsor|3|||
147526185|NCT00695318|532078742|FG000|Overall Study|Lost to Follow-up|1|||
147526186|NCT00695318|532078743|FG001|Overall Study|Lost to Follow-up|0|||
147526187|NCT00695318|532078742|FG000|Overall Study|Withdrawal by Subject|2|||
147526188|NCT00695318|532078743|FG001|Overall Study|Withdrawal by Subject|0|||
147526189|NCT00695318|532078742|FG000|Overall Study|Death|1|||
147526190|NCT00695318|532078743|FG001|Overall Study|Death|1|||
147526191|NCT00695318|532078742|FG000|Overall Study|Study Terminated|1|||
147526192|NCT00695318|532078743|FG001|Overall Study|Study Terminated|0|||
147526193|NCT00939094|532078744|FG000|Overall Study|Adverse Event|9|||
147526194|NCT00939094|532078745|FG001|Overall Study|Adverse Event|0|||
147526195|NCT00939094|532078744|FG000|Overall Study|Withdrawal by Subject|1|||
147526196|NCT00939094|532078745|FG001|Overall Study|Withdrawal by Subject|6|||
147526197|NCT00939094|532078744|FG000|Overall Study|Lost to Follow-up|1|||
147526198|NCT00939094|532078745|FG001|Overall Study|Lost to Follow-up|1|||
147526199|NCT00939094|532078744|FG000|Overall Study|Eligibility criteria not fulfilled|2|||
147526200|NCT00939094|532078745|FG001|Overall Study|Eligibility criteria not fulfilled|0|||
147526201|NCT00939094|532078744|FG000|Overall Study|Severe non-compliance to protocol|0|||
147526202|NCT00939094|532078745|FG001|Overall Study|Severe non-compliance to protocol|1|||
147526203|NCT00939094|532078744|FG000|Overall Study|Study stopped by sponsor|0|||
147526204|NCT00939094|532078745|FG001|Overall Study|Study stopped by sponsor|2|||
147526205|NCT00939094|532078744|FG000|Overall Study|Abnormal ECG findings|1|||
147526206|NCT00939094|532078745|FG001|Overall Study|Abnormal ECG findings|0|||
147526207|NCT02705755|532078746|FG000|Part A (6 Days)|Adverse Event|1|||
147526208|NCT02705755|532078747|FG001|Part A (6 Days)|Adverse Event|0|||
147526209|NCT02705755|532078748|FG002|Part A (6 Days)|Adverse Event|0|||
147526210|NCT02705755|532078749|FG003|Part A (6 Days)|Adverse Event|0|||
147526211|NCT02705755|532078746|FG000|Part A (6 Days)|Physician Decision|3|||
147526212|NCT02705755|532078747|FG001|Part A (6 Days)|Physician Decision|0|||
147526213|NCT02705755|532078748|FG002|Part A (6 Days)|Physician Decision|0|||
147526214|NCT02705755|532078749|FG003|Part A (6 Days)|Physician Decision|0|||
147526215|NCT02705755|532078746|FG000|Part A (6 Days)|Withdrawal by Subject|1|||
147526216|NCT02705755|532078747|FG001|Part A (6 Days)|Withdrawal by Subject|0|||
147526217|NCT02705755|532078748|FG002|Part A (6 Days)|Withdrawal by Subject|0|||
147526218|NCT02705755|532078749|FG003|Part A (6 Days)|Withdrawal by Subject|0|||
147526219|NCT02705755|532078746|FG000|Part C (20 Weeks)|Physician Decision|0|||
147526220|NCT02705755|532078747|FG001|Part C (20 Weeks)|Physician Decision|0|||
147526221|NCT02705755|532078748|FG002|Part C (20 Weeks)|Physician Decision|0|||
147526222|NCT02705755|532078749|FG003|Part C (20 Weeks)|Physician Decision|2|||
147526223|NCT02705755|532078746|FG000|Part C (20 Weeks)|Adverse Event|0|||
147526224|NCT02705755|532078747|FG001|Part C (20 Weeks)|Adverse Event|0|||
147526225|NCT02705755|532078748|FG002|Part C (20 Weeks)|Adverse Event|0|||
147526226|NCT02705755|532078749|FG003|Part C (20 Weeks)|Adverse Event|6|||
147526227|NCT02705755|532078746|FG000|Part C (20 Weeks)|Withdrawal by Subject|0|||
147526228|NCT02705755|532078747|FG001|Part C (20 Weeks)|Withdrawal by Subject|0|||
147526229|NCT02705755|532078748|FG002|Part C (20 Weeks)|Withdrawal by Subject|0|||
147526230|NCT02705755|532078749|FG003|Part C (20 Weeks)|Withdrawal by Subject|2|||
147526231|NCT01906489|532078752|FG000|Overall Study|Adverse Event|10|||
147526232|NCT01906489|532078753|FG001|Overall Study|Adverse Event|3|||
147526233|NCT01906489|532078752|FG000|Overall Study|Worsening of CKD|6|||
147526234|NCT01906489|532078753|FG001|Overall Study|Worsening of CKD|4|||
147526235|NCT01906489|532078752|FG000|Overall Study|Withdrawal by Subject|5|||
147526236|NCT01906489|532078753|FG001|Overall Study|Withdrawal by Subject|0|||
147526237|NCT01906489|532078752|FG000|Overall Study|Worsening of Anemia|1|||
147526238|NCT01906489|532078753|FG001|Overall Study|Worsening of Anemia|0|||
147526239|NCT01906489|532078752|FG000|Overall Study|Protocol Violation|0|||
147526240|NCT01906489|532078753|FG001|Overall Study|Protocol Violation|1|||
147526241|NCT01906489|532078752|FG000|Overall Study|Non- Compliance|1|||
147526242|NCT01906489|532078753|FG001|Overall Study|Non- Compliance|0|||
147526243|NCT01906489|532078752|FG000|Overall Study|Sponsor Decision|1|||
147526244|NCT01906489|532078753|FG001|Overall Study|Sponsor Decision|0|||
147526245|NCT01906489|532078752|FG000|Overall Study|Lost to Follow-up|1|||
147526246|NCT01906489|532078753|FG001|Overall Study|Lost to Follow-up|1|||
147526247|NCT01906489|532078752|FG000|Overall Study|Other|1|||
147526248|NCT01906489|532078753|FG001|Overall Study|Other|0|||
147526249|NCT04823494|532081061|FG000|Overall Study|Programming software malfunction.|1|||
147526250|NCT04823494|532081062|FG001|Overall Study|Programming software malfunction.|0|||
147526251|NCT04823494|532081061|FG000|Overall Study|Withdrawal by Subject|1|||
147526252|NCT04823494|532081062|FG001|Overall Study|Withdrawal by Subject|0|||
147526253|NCT04823494|532081061|FG000|Overall Study|Devices lost|0|||
147526254|NCT04823494|532081062|FG001|Overall Study|Devices lost|1|||
147526255|NCT03691831|532081063|FG000|Overall Study|Lost to Follow-up|16|||
147526256|NCT03691831|532081064|FG001|Overall Study|Lost to Follow-up|12|||
147526257|NCT03691831|532081063|FG000|Overall Study|Withdrawal by Subject|9|||
147526258|NCT03691831|532081064|FG001|Overall Study|Withdrawal by Subject|17|||
147526259|NCT03691831|532081063|FG000|Overall Study|Investigator Decision|2|||
147526260|NCT03691831|532081064|FG001|Overall Study|Investigator Decision|2|||
147526261|NCT02198040|532081065|FG000|Overall Study|Work reasons|0|||
147526262|NCT02198040|532081066|FG001|Overall Study|Work reasons|1|||
147526263|NCT02198040|532081067|FG002|Overall Study|Work reasons|0|||
147526264|NCT02198040|532081065|FG000|Overall Study|Withdrawal by Subject|0|||
147526265|NCT02198040|532081066|FG001|Overall Study|Withdrawal by Subject|0|||
147526266|NCT02198040|532081067|FG002|Overall Study|Withdrawal by Subject|1|||
147526267|NCT04524663|532081068|FG000|Overall Study|Withdrawal by Subject|0|||
147526268|NCT04524663|532081069|FG001|Overall Study|Withdrawal by Subject|2|||
147526269|NCT03359811|532081070|FG000|Overall Study|Protocol Violation|2|||
147526270|NCT03359811|532081071|FG001|Overall Study|Protocol Violation|0|||
147526271|NCT01189201|532081076|FG000|Overall Study|Adverse Event|1|||
147526272|NCT01682876|532081077|FG000|Overall Study|Administrative reason|4|||
147526273|NCT01682876|532081078|FG001|Overall Study|Administrative reason|4|||
147526274|NCT01682876|532081079|FG002|Overall Study|Administrative reason|0|||
147526275|NCT01682876|532081080|FG003|Overall Study|Administrative reason|3|||
147526276|NCT01682876|532081077|FG000|Overall Study|Adverse Event|0|||
147526277|NCT01682876|532081078|FG001|Overall Study|Adverse Event|0|||
147526278|NCT01682876|532081079|FG002|Overall Study|Adverse Event|0|||
147526279|NCT01682876|532081080|FG003|Overall Study|Adverse Event|1|||
147526280|NCT01682876|532081077|FG000|Overall Study|Lost to Follow-up|11|||
147526281|NCT01682876|532081078|FG001|Overall Study|Lost to Follow-up|15|||
147526282|NCT01682876|532081079|FG002|Overall Study|Lost to Follow-up|9|||
147526283|NCT01682876|532081080|FG003|Overall Study|Lost to Follow-up|11|||
147526284|NCT01682876|532081077|FG000|Overall Study|Protocol Violation|1|||
147526285|NCT01682876|532081078|FG001|Overall Study|Protocol Violation|1|||
147526286|NCT01682876|532081079|FG002|Overall Study|Protocol Violation|1|||
147526287|NCT01682876|532081080|FG003|Overall Study|Protocol Violation|1|||
147526288|NCT01682876|532081077|FG000|Overall Study|Withdrawal by Subject|4|||
147526289|NCT01682876|532081078|FG001|Overall Study|Withdrawal by Subject|0|||
147526290|NCT01682876|532081079|FG002|Overall Study|Withdrawal by Subject|0|||
147526291|NCT01682876|532081080|FG003|Overall Study|Withdrawal by Subject|2|||
147526292|NCT01682876|532081077|FG000|Overall Study|Other|1|||
147526293|NCT01682876|532081078|FG001|Overall Study|Other|0|||
147526294|NCT01682876|532081079|FG002|Overall Study|Other|1|||
147526295|NCT01682876|532081080|FG003|Overall Study|Other|1|||
147526296|NCT00911508|532081084|FG000|Overall Study|Lost to Follow-up|27|||
147526297|NCT00911508|532081085|FG001|Overall Study|Lost to Follow-up|18|||
147526298|NCT00911508|532081084|FG000|Overall Study|Withdrawal by Subject|79|||
147526299|NCT00911508|532081085|FG001|Overall Study|Withdrawal by Subject|112|||
147526300|NCT00240331|532081088|FG000|Overall Study|Withdrawal by Subject|125|||
147526301|NCT00240331|532081089|FG001|Overall Study|Withdrawal by Subject|132|||
147526302|NCT00240331|532081088|FG000|Overall Study|Option selected by investigator|1|||
147526303|NCT00240331|532081089|FG001|Overall Study|Option selected by investigator|2|||
147526304|NCT01409382|532081090|FG000|Overall Study|Lost to Follow-up|1|||
147526305|NCT01409382|532081091|FG001|Overall Study|Lost to Follow-up|1|||
147526306|NCT01409382|532081090|FG000|Overall Study|Protocol Violation|0|||
147526307|NCT01409382|532081091|FG001|Overall Study|Protocol Violation|3|||
147526308|NCT01409382|532081090|FG000|Overall Study|Multiple pregnancy|2|||
147526309|NCT01409382|532081091|FG001|Overall Study|Multiple pregnancy|4|||
147526310|NCT01409382|532081090|FG000|Overall Study|Still pregnant when study ended|13|||
147526311|NCT01409382|532081091|FG001|Overall Study|Still pregnant when study ended|2|||
147526312|NCT01409382|532081090|FG000|Overall Study|Did not manage to get pregnant|64|||
147526313|NCT01409382|532081091|FG001|Overall Study|Did not manage to get pregnant|70|||
147526314|NCT01409382|532081090|FG000|Overall Study|Had a 2nd trimester loss after accident|1|||
147526315|NCT01409382|532081091|FG001|Overall Study|Had a 2nd trimester loss after accident|0|||
147526316|NCT01233076|532081092|FG000|Period 2, One Week|Lost to Follow-up|1|||
147526317|NCT01233076|532081093|FG001|Period 2, One Week|Lost to Follow-up|0|||
147526318|NCT04308668|532081094|FG000|Overall Study|Lost to Follow-up|32|||
147526319|NCT04308668|532081095|FG001|Overall Study|Lost to Follow-up|38|||
147526320|NCT04308668|532081094|FG000|Overall Study|Withdrawal by Subject|4|||
147526321|NCT04308668|532081095|FG001|Overall Study|Withdrawal by Subject|4|||
147526322|NCT01266967|532081096|FG000|Overall Study|Death|69|||
147526323|NCT01266967|532081097|FG001|Overall Study|Death|61|||
147526324|NCT01266967|532081096|FG000|Overall Study|Study Closed/Terminated|15|||
147526325|NCT01266967|532081097|FG001|Overall Study|Study Closed/Terminated|17|||
147526326|NCT01266967|532081096|FG000|Overall Study|Lost to Follow-up|2|||
147526327|NCT01266967|532081097|FG001|Overall Study|Lost to Follow-up|1|||
147526328|NCT01266967|532081096|FG000|Overall Study|Physician Decision|0|||
147526329|NCT01266967|532081097|FG001|Overall Study|Physician Decision|1|||
147526330|NCT01266967|532081096|FG000|Overall Study|Withdrawal by Subject|3|||
147526331|NCT01266967|532081097|FG001|Overall Study|Withdrawal by Subject|3|||
147526332|NCT04563845|532081098|FG000|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
147526333|NCT04563845|532081099|FG001|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
147526334|NCT04563845|532081100|FG002|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
147526335|NCT04563845|532081101|FG003|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
147526336|NCT04563845|532081102|FG004|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
147526337|NCT04563845|532081103|FG005|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
147526338|NCT04563845|532081104|FG006|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
147526339|NCT04563845|532081105|FG007|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|1|||
147526340|NCT04563845|532081106|FG008|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
147526341|NCT04563845|532081107|FG009|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
147526342|NCT04563845|532081108|FG010|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
147526343|NCT04563845|532081109|FG011|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
147526344|NCT04563845|532081110|FG012|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
147526345|NCT04563845|532081111|FG013|Part 2:Treatment Period 1(Up to 7 Days)|Adverse Event|0|||
147526346|NCT04563845|532081098|FG000|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
147526347|NCT04563845|532081099|FG001|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
147526348|NCT04563845|532081100|FG002|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
147526349|NCT04563845|532081101|FG003|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
147526350|NCT04563845|532081102|FG004|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|1|||
147526351|NCT04563845|532081103|FG005|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
147526352|NCT04563845|532081104|FG006|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
147526353|NCT04563845|532081105|FG007|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
147526354|NCT04563845|532081106|FG008|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
147526355|NCT04563845|532081107|FG009|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
147526356|NCT04563845|532081108|FG010|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
147526357|NCT04563845|532081109|FG011|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
147526358|NCT04563845|532081110|FG012|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
147526359|NCT04563845|532081111|FG013|Part 2:Washout Period 1(Up to 7 Days)|Withdrawal by Subject|0|||
147526360|NCT01020812|532081112|FG000|Overall Study|Physician Decision|1|||
147526361|NCT01020812|532081112|FG000|Overall Study|Withdrawal by Subject|1|||
147526362|NCT01020812|532081112|FG000|Overall Study|Protocol Violation|1|||
147526363|NCT01519700|532081113|FG000|Overall Study|Death|1|||
147526364|NCT01519700|532081114|FG001|Overall Study|Death|0|||
147526365|NCT01519700|532081115|FG002|Overall Study|Death|0|||
147526366|NCT01519700|532081116|FG003|Overall Study|Death|0|||
147526367|NCT01519700|532081113|FG000|Overall Study|Lost to Follow-up|0|||
147526368|NCT01519700|532081114|FG001|Overall Study|Lost to Follow-up|0|||
147526369|NCT01519700|532081115|FG002|Overall Study|Lost to Follow-up|1|||
147526370|NCT01519700|532081116|FG003|Overall Study|Lost to Follow-up|1|||
147526371|NCT01519700|532081113|FG000|Overall Study|Physician Decision|1|||
147526372|NCT01519700|532081114|FG001|Overall Study|Physician Decision|1|||
147526373|NCT01519700|532081115|FG002|Overall Study|Physician Decision|3|||
147526374|NCT01519700|532081116|FG003|Overall Study|Physician Decision|0|||
147526375|NCT01519700|532081113|FG000|Overall Study|Withdrawal by Subject|5|||
147526376|NCT01519700|532081114|FG001|Overall Study|Withdrawal by Subject|3|||
147526377|NCT01519700|532081115|FG002|Overall Study|Withdrawal by Subject|3|||
147526378|NCT01519700|532081116|FG003|Overall Study|Withdrawal by Subject|2|||
147526379|NCT01519700|532081113|FG000|Overall Study|Other Reason|2|||
147526380|NCT01519700|532081114|FG001|Overall Study|Other Reason|2|||
147526381|NCT01519700|532081115|FG002|Overall Study|Other Reason|0|||
147526382|NCT01519700|532081116|FG003|Overall Study|Other Reason|4|||
147526383|NCT00960323|532081117|FG000|Atorvastatin Alone|Withdrawal by Subject|1|||
147526384|NCT03824704|532081122|FG000|Overall Study|Study Terminated by Sponsor|1|||
147526385|NCT02577107|532081126|FG000|Overall Study|Protocol deviation|0|||
147526386|NCT02577107|532081127|FG001|Overall Study|Protocol deviation|1|||
147526387|NCT00883896|532081130|FG000|Overall Study|Lost to Follow-up|0|||
147526388|NCT00883896|532081131|FG001|Overall Study|Lost to Follow-up|0|||
147526389|NCT00883896|532081132|FG002|Overall Study|Lost to Follow-up|0|||
147526390|NCT00883896|532081133|FG003|Overall Study|Lost to Follow-up|2|||
147526391|NCT00883896|532081130|FG000|Overall Study|Withdrawal by Subject|5|||
147526392|NCT00883896|532081131|FG001|Overall Study|Withdrawal by Subject|0|||
147526393|NCT00883896|532081132|FG002|Overall Study|Withdrawal by Subject|1|||
147526394|NCT00883896|532081133|FG003|Overall Study|Withdrawal by Subject|3|||
147526395|NCT00883896|532081130|FG000|Overall Study|Lack of Efficacy|0|||
147526396|NCT00883896|532081131|FG001|Overall Study|Lack of Efficacy|0|||
147526397|NCT00883896|532081132|FG002|Overall Study|Lack of Efficacy|0|||
147526398|NCT00883896|532081133|FG003|Overall Study|Lack of Efficacy|2|||
147526399|NCT00883896|532081130|FG000|Overall Study|Other|1|||
147526400|NCT00883896|532081131|FG001|Overall Study|Other|0|||
147526401|NCT00883896|532081132|FG002|Overall Study|Other|0|||
147526402|NCT00883896|532081133|FG003|Overall Study|Other|0|||
147526403|NCT03380091|532081145|FG000|Overall Study|Withdrawal by Subject|2|||
147526404|NCT03380091|532081146|FG001|Overall Study|Withdrawal by Subject|1|||
147526405|NCT01980056|532081148|FG000|Overall Study|Death|1|||
147526406|NCT01980056|532081149|FG001|Overall Study|Death|1|||
147526407|NCT01980056|532081150|FG002|Overall Study|Death|0|||
147526408|NCT00535262|532081151|FG000|Overall Study|No funding|3|||
147526409|NCT01707667|532081152|FG000|Period 1|expulsion of colonic sensor catheter|1|||
147526410|NCT01707667|532081153|FG001|Period 1|expulsion of colonic sensor catheter|0|||
147526411|NCT03802331|532081154|FG000|Treatment Period 1 (P1) + Washout|Adverse Event|1|||
147526412|NCT03802331|532081155|FG001|Treatment Period 1 (P1) + Washout|Adverse Event|0|||
147526413|NCT00368069|532081157|FG000|Overall Study|Adverse Event|5|||
147526414|NCT00368069|532081158|FG001|Overall Study|Adverse Event|2|||
147526415|NCT00368069|532081157|FG000|Overall Study|Lack of Efficacy|0|||
147526416|NCT00368069|532081158|FG001|Overall Study|Lack of Efficacy|1|||
147526417|NCT00368069|532081157|FG000|Overall Study|Lost to Follow-up|1|||
147526418|NCT00368069|532081158|FG001|Overall Study|Lost to Follow-up|0|||
147526419|NCT00368069|532081157|FG000|Overall Study|Protocol Violation|0|||
147526420|NCT00368069|532081158|FG001|Overall Study|Protocol Violation|2|||
147526421|NCT00368069|532081157|FG000|Overall Study|Withdrawal of Consent|2|||
147526422|NCT00368069|532081158|FG001|Overall Study|Withdrawal of Consent|1|||
147526423|NCT00368069|532081157|FG000|Overall Study|no blood sampling possible|0|||
147526424|NCT00368069|532081158|FG001|Overall Study|no blood sampling possible|1|||
147526425|NCT01220024|532081167|FG000|Overall Study|Lost to Follow-up|1|||
147526426|NCT01220024|532081168|FG001|Overall Study|Lost to Follow-up|1|||
147526427|NCT00174460|532081169|FG000|Overall Study|Withdrawal by Subject|0|||
147526428|NCT00174460|532081170|FG001|Overall Study|Withdrawal by Subject|1|||
147526429|NCT00083616|532081173|FG000|Overall Study|Disease Progression|16|||
147526430|NCT00083616|532081173|FG000|Overall Study|Lost to Follow-up|1|||
147526431|NCT00083616|532081173|FG000|Overall Study|Physician Decision|2|||
147526432|NCT00083616|532081173|FG000|Overall Study|Withdrawal by Subject|3|||
147526433|NCT00083616|532081173|FG000|Overall Study|Ineligibility determined|2|||
147526434|NCT00083616|532081173|FG000|Overall Study|Non-compliance|1|||
147526435|NCT00083616|532081173|FG000|Overall Study|Other|6|||
147526436|NCT01474993|532081176|FG000|Overall Study|Lost to Follow-up|1|||
147526437|NCT01474993|532081177|FG001|Overall Study|Lost to Follow-up|2|||
147526438|NCT01474993|532081176|FG000|Overall Study|Adverse Event|0|||
147526439|NCT01474993|532081177|FG001|Overall Study|Adverse Event|1|||
147526440|NCT01853397|532081178|FG000|Overall Study|Withdrawal by Subject|0|||
147526441|NCT01853397|532081179|FG001|Overall Study|Withdrawal by Subject|0|||
147526442|NCT01853397|532081180|FG002|Overall Study|Withdrawal by Subject|0|||
147526443|NCT01853397|532081181|FG003|Overall Study|Withdrawal by Subject|1|||
147526444|NCT01853397|532081178|FG000|Overall Study|Subject Noncompliance|0|||
147526445|NCT01853397|532081179|FG001|Overall Study|Subject Noncompliance|0|||
147526446|NCT01853397|532081180|FG002|Overall Study|Subject Noncompliance|0|||
147526447|NCT01853397|532081181|FG003|Overall Study|Subject Noncompliance|1|||
147526448|NCT02132312|532081182|FG000|Overall Study|Adverse Event|2|||
147526449|NCT02132312|532081183|FG001|Overall Study|Adverse Event|0|||
147526450|NCT02132312|532081182|FG000|Overall Study|Physician Decision|1|||
147526451|NCT02132312|532081183|FG001|Overall Study|Physician Decision|1|||
147526452|NCT02132312|532081182|FG000|Overall Study|Protocol Violation|0|||
147526453|NCT02132312|532081183|FG001|Overall Study|Protocol Violation|1|||
147526454|NCT02132312|532081182|FG000|Overall Study|Withdrawal by Subject|1|||
147526455|NCT02132312|532081183|FG001|Overall Study|Withdrawal by Subject|0|||
147526456|NCT02132312|532081182|FG000|Overall Study|Lost to Follow-up|2|||
147526457|NCT02132312|532081183|FG001|Overall Study|Lost to Follow-up|1|||
147526458|NCT01632345|532081184|FG000|Treatment: Part I|Adverse Event|1|||
147526459|NCT01632345|532081185|FG001|Treatment: Part I|Adverse Event|4|||
147526460|NCT01632345|532081186|FG002|Treatment: Part I|Adverse Event|2|||
147526461|NCT01632345|532081187|FG003|Treatment: Part I|Adverse Event|1|||
147526462|NCT01632345|532081188|FG004|Treatment: Part I|Adverse Event|3|||
147526463|NCT01632345|532081189|FG005|Treatment: Part I|Adverse Event|0|||
147526464|NCT01632345|532081190|FG006|Treatment: Part I|Adverse Event|0|||
147526465|NCT01632345|532081184|FG000|Treatment: Part I|Lack of Efficacy|0|||
147526466|NCT01632345|532081185|FG001|Treatment: Part I|Lack of Efficacy|1|||
147526467|NCT01632345|532081186|FG002|Treatment: Part I|Lack of Efficacy|0|||
147526468|NCT01632345|532081187|FG003|Treatment: Part I|Lack of Efficacy|1|||
147526469|NCT01632345|532081188|FG004|Treatment: Part I|Lack of Efficacy|1|||
147526470|NCT01632345|532081189|FG005|Treatment: Part I|Lack of Efficacy|0|||
147526471|NCT01632345|532081190|FG006|Treatment: Part I|Lack of Efficacy|0|||
147526472|NCT01632345|532081184|FG000|Treatment: Part I|Lost to Follow-up|3|||
147526473|NCT01632345|532081185|FG001|Treatment: Part I|Lost to Follow-up|2|||
147526474|NCT01632345|532081186|FG002|Treatment: Part I|Lost to Follow-up|1|||
147526475|NCT01632345|532081187|FG003|Treatment: Part I|Lost to Follow-up|3|||
147526476|NCT01632345|532081188|FG004|Treatment: Part I|Lost to Follow-up|4|||
147526477|NCT01632345|532081189|FG005|Treatment: Part I|Lost to Follow-up|0|||
147526478|NCT01632345|532081190|FG006|Treatment: Part I|Lost to Follow-up|0|||
147526479|NCT01632345|532081184|FG000|Treatment: Part I|Non-Compliance with Study Drug|3|||
147526480|NCT01632345|532081185|FG001|Treatment: Part I|Non-Compliance with Study Drug|2|||
147526481|NCT01632345|532081186|FG002|Treatment: Part I|Non-Compliance with Study Drug|2|||
147526482|NCT01632345|532081187|FG003|Treatment: Part I|Non-Compliance with Study Drug|1|||
147526483|NCT01632345|532081188|FG004|Treatment: Part I|Non-Compliance with Study Drug|0|||
147526484|NCT01632345|532081189|FG005|Treatment: Part I|Non-Compliance with Study Drug|0|||
147526485|NCT01632345|532081190|FG006|Treatment: Part I|Non-Compliance with Study Drug|0|||
147526486|NCT01632345|532081184|FG000|Treatment: Part I|Physician Decision|2|||
147526487|NCT01632345|532081185|FG001|Treatment: Part I|Physician Decision|1|||
147526488|NCT01632345|532081186|FG002|Treatment: Part I|Physician Decision|0|||
147526489|NCT01632345|532081187|FG003|Treatment: Part I|Physician Decision|0|||
147526490|NCT01632345|532081188|FG004|Treatment: Part I|Physician Decision|1|||
147526491|NCT01632345|532081189|FG005|Treatment: Part I|Physician Decision|0|||
147526492|NCT01632345|532081190|FG006|Treatment: Part I|Physician Decision|0|||
147526493|NCT01632345|532081184|FG000|Treatment: Part I|Pregnancy|0|||
147526494|NCT01632345|532081185|FG001|Treatment: Part I|Pregnancy|1|||
147526495|NCT01632345|532081186|FG002|Treatment: Part I|Pregnancy|0|||
147526496|NCT01632345|532081187|FG003|Treatment: Part I|Pregnancy|0|||
147526497|NCT01632345|532081188|FG004|Treatment: Part I|Pregnancy|0|||
147526498|NCT01632345|532081189|FG005|Treatment: Part I|Pregnancy|0|||
147526499|NCT01632345|532081190|FG006|Treatment: Part I|Pregnancy|0|||
147526500|NCT01632345|532081184|FG000|Treatment: Part I|Protocol Deviation|0|||
147526501|NCT01632345|532081185|FG001|Treatment: Part I|Protocol Deviation|0|||
147526502|NCT01632345|532081186|FG002|Treatment: Part I|Protocol Deviation|1|||
147526503|NCT01632345|532081187|FG003|Treatment: Part I|Protocol Deviation|1|||
147526504|NCT01632345|532081188|FG004|Treatment: Part I|Protocol Deviation|0|||
147526505|NCT01632345|532081189|FG005|Treatment: Part I|Protocol Deviation|0|||
147526506|NCT01632345|532081190|FG006|Treatment: Part I|Protocol Deviation|0|||
147526507|NCT01632345|532081184|FG000|Treatment: Part I|Withdrawal by Subject|3|||
147526508|NCT01632345|532081185|FG001|Treatment: Part I|Withdrawal by Subject|4|||
147526509|NCT01632345|532081186|FG002|Treatment: Part I|Withdrawal by Subject|4|||
147526510|NCT01632345|532081187|FG003|Treatment: Part I|Withdrawal by Subject|1|||
147526511|NCT01632345|532081188|FG004|Treatment: Part I|Withdrawal by Subject|4|||
147526512|NCT01632345|532081189|FG005|Treatment: Part I|Withdrawal by Subject|0|||
147526513|NCT01632345|532081190|FG006|Treatment: Part I|Withdrawal by Subject|0|||
147526514|NCT01632345|532081184|FG000|Treatment: Part II|Adverse Event|0|||
147526515|NCT01632345|532081185|FG001|Treatment: Part II|Adverse Event|0|||
147526516|NCT01632345|532081186|FG002|Treatment: Part II|Adverse Event|0|||
147526517|NCT01632345|532081187|FG003|Treatment: Part II|Adverse Event|0|||
147526518|NCT01632345|532081188|FG004|Treatment: Part II|Adverse Event|0|||
147526519|NCT01632345|532081189|FG005|Treatment: Part II|Adverse Event|3|||
147526520|NCT01632345|532081190|FG006|Treatment: Part II|Adverse Event|8|||
147526521|NCT01632345|532081184|FG000|Treatment: Part II|Lost to Follow-up|0|||
147526522|NCT01632345|532081185|FG001|Treatment: Part II|Lost to Follow-up|0|||
147526523|NCT01632345|532081186|FG002|Treatment: Part II|Lost to Follow-up|0|||
147526524|NCT01632345|532081187|FG003|Treatment: Part II|Lost to Follow-up|0|||
147526525|NCT01632345|532081188|FG004|Treatment: Part II|Lost to Follow-up|0|||
147526526|NCT01632345|532081189|FG005|Treatment: Part II|Lost to Follow-up|3|||
147526527|NCT01632345|532081190|FG006|Treatment: Part II|Lost to Follow-up|1|||
147526528|NCT01632345|532081184|FG000|Treatment: Part II|Non-Compliance with Study Drug|0|||
147526529|NCT01632345|532081185|FG001|Treatment: Part II|Non-Compliance with Study Drug|0|||
147526530|NCT01632345|532081186|FG002|Treatment: Part II|Non-Compliance with Study Drug|0|||
147526531|NCT01632345|532081187|FG003|Treatment: Part II|Non-Compliance with Study Drug|0|||
147526532|NCT01632345|532081188|FG004|Treatment: Part II|Non-Compliance with Study Drug|0|||
147526533|NCT01632345|532081189|FG005|Treatment: Part II|Non-Compliance with Study Drug|3|||
147526534|NCT01632345|532081190|FG006|Treatment: Part II|Non-Compliance with Study Drug|0|||
147526535|NCT01632345|532081184|FG000|Treatment: Part II|Withdrawal by Subject|0|||
147526536|NCT01632345|532081185|FG001|Treatment: Part II|Withdrawal by Subject|0|||
147526537|NCT01632345|532081186|FG002|Treatment: Part II|Withdrawal by Subject|0|||
147526538|NCT01632345|532081187|FG003|Treatment: Part II|Withdrawal by Subject|0|||
147526539|NCT01632345|532081188|FG004|Treatment: Part II|Withdrawal by Subject|0|||
147526540|NCT01632345|532081189|FG005|Treatment: Part II|Withdrawal by Subject|2|||
147526541|NCT01632345|532081190|FG006|Treatment: Part II|Withdrawal by Subject|2|||
147526542|NCT00089505|532081191|FG000|Overall Study|Death|4|||
147526543|NCT00089505|532081192|FG001|Overall Study|Death|1|||
147526544|NCT00089505|532081193|FG002|Overall Study|Death|5|||
147526545|NCT00089505|532081194|FG003|Overall Study|Death|8|||
147526546|NCT00089505|532081191|FG000|Overall Study|Withdrawal by Subject|3|||
147526547|NCT00089505|532081192|FG001|Overall Study|Withdrawal by Subject|0|||
147526548|NCT00089505|532081193|FG002|Overall Study|Withdrawal by Subject|6|||
147526549|NCT00089505|532081194|FG003|Overall Study|Withdrawal by Subject|6|||
147526550|NCT00089505|532081191|FG000|Overall Study|Lost to Follow-up|1|||
147526551|NCT00089505|532081192|FG001|Overall Study|Lost to Follow-up|1|||
147526552|NCT00089505|532081193|FG002|Overall Study|Lost to Follow-up|9|||
147526553|NCT00089505|532081194|FG003|Overall Study|Lost to Follow-up|7|||
147526554|NCT00089505|532081191|FG000|Overall Study|Physician Decision|1|||
147526555|NCT00089505|532081192|FG001|Overall Study|Physician Decision|0|||
147526556|NCT00089505|532081193|FG002|Overall Study|Physician Decision|0|||
147526557|NCT00089505|532081194|FG003|Overall Study|Physician Decision|0|||
147526558|NCT00089505|532081191|FG000|Overall Study|Protocol Violation|0|||
147526559|NCT00089505|532081192|FG001|Overall Study|Protocol Violation|0|||
147526560|NCT00089505|532081193|FG002|Overall Study|Protocol Violation|1|||
147526561|NCT00089505|532081194|FG003|Overall Study|Protocol Violation|0|||
147526562|NCT01724021|532081195|FG000|Overall Study|Adverse Event|11|||
147526563|NCT01724021|532081196|FG001|Overall Study|Adverse Event|6|||
147526564|NCT01724021|532081195|FG000|Overall Study|Death|46|||
147526565|NCT01724021|532081196|FG001|Overall Study|Death|58|||
147526566|NCT01724021|532081195|FG000|Overall Study|Participant request/ Withdrew consent|18|||
147526567|NCT01724021|532081196|FG001|Overall Study|Participant request/ Withdrew consent|14|||
147526568|NCT01724021|532081195|FG000|Overall Study|Lost to Follow-up|15|||
147526569|NCT01724021|532081196|FG001|Overall Study|Lost to Follow-up|15|||
147526570|NCT01724021|532081195|FG000|Overall Study|Reason Not Specified|36|||
147526571|NCT01724021|532081196|FG001|Overall Study|Reason Not Specified|39|||
147526572|NCT01724021|532081195|FG000|Overall Study|Missing|1|||
147526573|NCT01724021|532081196|FG001|Overall Study|Missing|1|||
147526574|NCT02543918|532081197|FG000|Overall Study|Never treated|0|||
147526575|NCT02543918|532081198|FG001|Overall Study|Never treated|1|||
147526576|NCT02543918|532081197|FG000|Overall Study|Lost to Follow-up|1|||
147526577|NCT02543918|532081198|FG001|Overall Study|Lost to Follow-up|1|||
147526578|NCT02543918|532081197|FG000|Overall Study|Withdrawal by Subject|1|||
147526579|NCT02543918|532081198|FG001|Overall Study|Withdrawal by Subject|1|||
147526580|NCT02543918|532081197|FG000|Overall Study|Adverse Event|1|||
147526581|NCT02543918|532081198|FG001|Overall Study|Adverse Event|1|||
147526582|NCT02041533|532081202|FG000|Pre-Treatment Period|Disease Progression|1|||
147526583|NCT02041533|532081203|FG001|Pre-Treatment Period|Disease Progression|1|||
147526584|NCT02041533|532081202|FG000|Pre-Treatment Period|Participant Withdrew Consent|0|||
147526585|NCT02041533|532081203|FG001|Pre-Treatment Period|Participant Withdrew Consent|5|||
147526586|NCT02041533|532081202|FG000|Pre-Treatment Period|Participant no Longer Meets Study Criteria|3|||
147526587|NCT02041533|532081203|FG001|Pre-Treatment Period|Participant no Longer Meets Study Criteria|1|||
147526588|NCT02041533|532081202|FG000|Treatment Period|Disease progression|189|||
147526589|NCT02041533|532081203|FG001|Treatment Period|Disease progression|146|||
147526590|NCT02041533|532081202|FG000|Treatment Period|Study drug toxicity|30|||
147526591|NCT02041533|532081203|FG001|Treatment Period|Study drug toxicity|34|||
147526592|NCT02041533|532081202|FG000|Treatment Period|Death|1|||
147526593|NCT02041533|532081203|FG001|Treatment Period|Death|0|||
147526594|NCT02041533|532081202|FG000|Treatment Period|Adverse event unrelated to study drug|22|||
147526595|NCT02041533|532081203|FG001|Treatment Period|Adverse event unrelated to study drug|23|||
147526596|NCT02041533|532081202|FG000|Treatment Period|Participant request to discontinue study treatment|12|||
147526597|NCT02041533|532081203|FG001|Treatment Period|Participant request to discontinue study treatment|9|||
147526598|NCT02041533|532081202|FG000|Treatment Period|Participant withdrew consent|2|||
147526599|NCT02041533|532081203|FG001|Treatment Period|Participant withdrew consent|2|||
147526600|NCT02041533|532081202|FG000|Treatment Period|Maximum clinical benefit|0|||
147526601|NCT02041533|532081203|FG001|Treatment Period|Maximum clinical benefit|18|||
147526602|NCT02041533|532081202|FG000|Treatment Period|Poor/Non-compliance|1|||
147526603|NCT02041533|532081203|FG001|Treatment Period|Poor/Non-compliance|0|||
147526604|NCT02041533|532081202|FG000|Treatment Period|Administrative reason by sponsor|1|||
147526605|NCT02041533|532081203|FG001|Treatment Period|Administrative reason by sponsor|0|||
147526606|NCT02041533|532081202|FG000|Treatment Period|Other reasons|9|||
147526607|NCT02041533|532081203|FG001|Treatment Period|Other reasons|2|||
147526608|NCT02041533|532081202|FG000|Treatment Period|Not Reported|0|||
147526609|NCT02041533|532081203|FG001|Treatment Period|Not Reported|1|||
147526610|NCT00545740|532081204|FG000|Overall Study|Lack of Efficacy|34|||
147526611|NCT00545740|532081205|FG001|Overall Study|Lack of Efficacy|35|||
147526612|NCT00545740|532081206|FG002|Overall Study|Lack of Efficacy|47|||
147526613|NCT00545740|532081207|FG003|Overall Study|Lack of Efficacy|36|||
147526614|NCT00545740|532081204|FG000|Overall Study|Withdrawal by Subject|17|||
147526615|NCT00545740|532081205|FG001|Overall Study|Withdrawal by Subject|15|||
147526616|NCT00545740|532081206|FG002|Overall Study|Withdrawal by Subject|16|||
147526617|NCT00545740|532081207|FG003|Overall Study|Withdrawal by Subject|18|||
147526618|NCT00545740|532081204|FG000|Overall Study|Adverse Event|10|||
147526619|NCT00545740|532081205|FG001|Overall Study|Adverse Event|18|||
147526620|NCT00545740|532081206|FG002|Overall Study|Adverse Event|19|||
147526621|NCT00545740|532081207|FG003|Overall Study|Adverse Event|9|||
147526622|NCT00545740|532081204|FG000|Overall Study|Lost to Follow-up|7|||
147526623|NCT00545740|532081205|FG001|Overall Study|Lost to Follow-up|5|||
147526624|NCT00545740|532081206|FG002|Overall Study|Lost to Follow-up|5|||
147526625|NCT00545740|532081207|FG003|Overall Study|Lost to Follow-up|6|||
147526626|NCT00545740|532081204|FG000|Overall Study|Protocol Violation|1|||
147526627|NCT00545740|532081205|FG001|Overall Study|Protocol Violation|3|||
147526628|NCT00545740|532081206|FG002|Overall Study|Protocol Violation|1|||
147526629|NCT00545740|532081207|FG003|Overall Study|Protocol Violation|0|||
147526630|NCT00545740|532081204|FG000|Overall Study|Non-compliance|0|||
147526631|NCT00545740|532081205|FG001|Overall Study|Non-compliance|2|||
147526632|NCT00545740|532081206|FG002|Overall Study|Non-compliance|1|||
147526633|NCT00545740|532081207|FG003|Overall Study|Non-compliance|0|||
147526634|NCT00545740|532081204|FG000|Overall Study|Moved|2|||
147526635|NCT00545740|532081205|FG001|Overall Study|Moved|0|||
147526636|NCT00545740|532081206|FG002|Overall Study|Moved|1|||
147526637|NCT00545740|532081207|FG003|Overall Study|Moved|0|||
147526638|NCT00545740|532081204|FG000|Overall Study|Diverticulitis attack|0|||
147526639|NCT00545740|532081205|FG001|Overall Study|Diverticulitis attack|0|||
147526640|NCT00545740|532081206|FG002|Overall Study|Diverticulitis attack|1|||
147526641|NCT00545740|532081207|FG003|Overall Study|Diverticulitis attack|1|||
147526642|NCT00545740|532081204|FG000|Overall Study|Suspected Diverticulitis Recurrence|1|||
147526643|NCT00545740|532081205|FG001|Overall Study|Suspected Diverticulitis Recurrence|1|||
147526644|NCT00545740|532081206|FG002|Overall Study|Suspected Diverticulitis Recurrence|1|||
147526645|NCT00545740|532081207|FG003|Overall Study|Suspected Diverticulitis Recurrence|1|||
147526646|NCT00545740|532081204|FG000|Overall Study|Site closure|1|||
147526647|NCT00545740|532081205|FG001|Overall Study|Site closure|0|||
147526648|NCT00545740|532081206|FG002|Overall Study|Site closure|0|||
147526649|NCT00545740|532081207|FG003|Overall Study|Site closure|0|||
147526650|NCT00545740|532081204|FG000|Overall Study|Missed visit|1|||
147526651|NCT00545740|532081205|FG001|Overall Study|Missed visit|0|||
147526652|NCT00545740|532081206|FG002|Overall Study|Missed visit|0|||
147526653|NCT00545740|532081207|FG003|Overall Study|Missed visit|0|||
147526654|NCT00545740|532081204|FG000|Overall Study|Physician Decision|0|||
147526655|NCT00545740|532081205|FG001|Overall Study|Physician Decision|0|||
147526656|NCT00545740|532081206|FG002|Overall Study|Physician Decision|3|||
147526657|NCT00545740|532081207|FG003|Overall Study|Physician Decision|0|||
147526658|NCT00545740|532081204|FG000|Overall Study|Accepted only monthly telephone calls|1|||
147526659|NCT00545740|532081205|FG001|Overall Study|Accepted only monthly telephone calls|0|||
147526660|NCT00545740|532081206|FG002|Overall Study|Accepted only monthly telephone calls|0|||
147526661|NCT00545740|532081207|FG003|Overall Study|Accepted only monthly telephone calls|0|||
147526662|NCT00545740|532081204|FG000|Overall Study|Sponsor decision|0|||
147526663|NCT00545740|532081205|FG001|Overall Study|Sponsor decision|1|||
147526664|NCT00545740|532081206|FG002|Overall Study|Sponsor decision|0|||
147526665|NCT00545740|532081207|FG003|Overall Study|Sponsor decision|0|||
147526666|NCT00545740|532081204|FG000|Overall Study|Lack of time|0|||
147526667|NCT00545740|532081205|FG001|Overall Study|Lack of time|1|||
147526668|NCT00545740|532081206|FG002|Overall Study|Lack of time|0|||
147526669|NCT00545740|532081207|FG003|Overall Study|Lack of time|0|||
147526670|NCT00545740|532081204|FG000|Overall Study|Non-adherence to visits|0|||
147526671|NCT00545740|532081205|FG001|Overall Study|Non-adherence to visits|1|||
147526672|NCT00545740|532081206|FG002|Overall Study|Non-adherence to visits|0|||
147526673|NCT00545740|532081207|FG003|Overall Study|Non-adherence to visits|0|||
147526674|NCT00545740|532081204|FG000|Overall Study|Patient difficulties|0|||
147526675|NCT00545740|532081205|FG001|Overall Study|Patient difficulties|1|||
147526676|NCT00545740|532081206|FG002|Overall Study|Patient difficulties|0|||
147526677|NCT00545740|532081207|FG003|Overall Study|Patient difficulties|0|||
147526678|NCT00545740|532081204|FG000|Overall Study|Husband against study|0|||
147526679|NCT00545740|532081205|FG001|Overall Study|Husband against study|0|||
147526680|NCT00545740|532081206|FG002|Overall Study|Husband against study|1|||
147526681|NCT00545740|532081207|FG003|Overall Study|Husband against study|0|||
147526682|NCT02117024|532081208|FG000|Overall Study|Progressive Disease|26|||
147526683|NCT02117024|532081209|FG001|Overall Study|Progressive Disease|9|||
147526684|NCT02117024|532081208|FG000|Overall Study|Significant Clinical Progression|7|||
147526685|NCT02117024|532081209|FG001|Overall Study|Significant Clinical Progression|4|||
147526686|NCT02117024|532081208|FG000|Overall Study|Death|5|||
147526687|NCT02117024|532081209|FG001|Overall Study|Death|0|||
147526688|NCT02117024|532081208|FG000|Overall Study|Withdrawal by Subject|3|||
147526689|NCT02117024|532081209|FG001|Overall Study|Withdrawal by Subject|1|||
147526690|NCT02117024|532081208|FG000|Overall Study|Protocol Violation|1|||
147526691|NCT02117024|532081209|FG001|Overall Study|Protocol Violation|0|||
147526692|NCT02117024|532081208|FG000|Overall Study|Adverse Event|1|||
147526693|NCT02117024|532081209|FG001|Overall Study|Adverse Event|2|||
147526694|NCT02117024|532081208|FG000|Overall Study|Randomized in Error|1|||
147526695|NCT02117024|532081209|FG001|Overall Study|Randomized in Error|0|||
147526696|NCT02117024|532081208|FG000|Overall Study|Patient returned to primary oncologist|0|||
147526697|NCT02117024|532081209|FG001|Overall Study|Patient returned to primary oncologist|1|||
147526698|NCT02117024|532081208|FG000|Overall Study|Patient took treatment break|0|||
147526699|NCT02117024|532081209|FG001|Overall Study|Patient took treatment break|1|||
147526700|NCT02117024|532081208|FG000|Overall Study|Physician Decision|0|||
147526701|NCT02117024|532081209|FG001|Overall Study|Physician Decision|2|||
147526702|NCT02380703|532081212|FG000|Overall Study|Withdrawal by Subject|12|||
147526703|NCT02380703|532081213|FG001|Overall Study|Withdrawal by Subject|9|||
147526704|NCT02380703|532081212|FG000|Overall Study|Lost to Follow-up|12|||
147526705|NCT02380703|532081213|FG001|Overall Study|Lost to Follow-up|12|||
147526706|NCT02380703|532081212|FG000|Overall Study|Caregiver death|1|||
147526707|NCT02380703|532081213|FG001|Overall Study|Caregiver death|0|||
147526708|NCT02380703|532081212|FG000|Overall Study|Person with dementia (PWD) death|7|||
147526709|NCT02380703|532081213|FG001|Overall Study|Person with dementia (PWD) death|8|||
147526710|NCT02380703|532081212|FG000|Overall Study|Entered Long-term Care|4|||
147526711|NCT02380703|532081213|FG001|Overall Study|Entered Long-term Care|7|||
147526712|NCT00266695|532081214|FG000|Overall Study|Adverse Event|1|||
147526713|NCT00266695|532081214|FG000|Overall Study|Death|9|||
147526714|NCT00266695|532081214|FG000|Overall Study|Physician Decision|1|||
147526715|NCT00266695|532081214|FG000|Overall Study|Lost to Follow-up|3|||
147526716|NCT00266695|532081214|FG000|Overall Study|Withdrawal by Subject|15|||
147526717|NCT01373294|532081217|FG000|Overall Study|Adverse Event|1|||
147526718|NCT01373294|532081218|FG001|Overall Study|Adverse Event|0|||
147526719|NCT01920061|532081219|FG000|Overall Study|Death|1|||
147526720|NCT01920061|532081220|FG001|Overall Study|Death|1|||
147526721|NCT01920061|532081221|FG002|Overall Study|Death|0|||
147526722|NCT01920061|532081222|FG003|Overall Study|Death|1|||
147526723|NCT01920061|532081223|FG004|Overall Study|Death|1|||
147526724|NCT01920061|532081224|FG005|Overall Study|Death|0|||
147526725|NCT01920061|532081225|FG006|Overall Study|Death|0|||
147526726|NCT01920061|532081226|FG007|Overall Study|Death|1|||
147526727|NCT01920061|532081227|FG008|Overall Study|Death|0|||
147526728|NCT01920061|532081228|FG009|Overall Study|Death|1|||
147526729|NCT01920061|532081229|FG010|Overall Study|Death|0|||
147526730|NCT01920061|532081230|FG011|Overall Study|Death|1|||
147526731|NCT01920061|532081231|FG012|Overall Study|Death|0|||
147526732|NCT01920061|532081232|FG013|Overall Study|Death|2|||
147526733|NCT01920061|532081233|FG014|Overall Study|Death|0|||
147526734|NCT01920061|532081234|FG015|Overall Study|Death|0|||
147526735|NCT01920061|532081235|FG016|Overall Study|Death|0|||
147526736|NCT01920061|532081236|FG017|Overall Study|Death|0|||
147526737|NCT01920061|532081237|FG018|Overall Study|Death|1|||
147526738|NCT01920061|532081238|FG019|Overall Study|Death|0|||
147526739|NCT01920061|532081219|FG000|Overall Study|Lost to Follow-up|0|||
147526740|NCT01920061|532081220|FG001|Overall Study|Lost to Follow-up|2|||
147526741|NCT01920061|532081221|FG002|Overall Study|Lost to Follow-up|0|||
147526742|NCT01920061|532081222|FG003|Overall Study|Lost to Follow-up|0|||
147526743|NCT01920061|532081223|FG004|Overall Study|Lost to Follow-up|0|||
147526744|NCT01920061|532081224|FG005|Overall Study|Lost to Follow-up|0|||
147526745|NCT01920061|532081225|FG006|Overall Study|Lost to Follow-up|1|||
147526746|NCT01920061|532081226|FG007|Overall Study|Lost to Follow-up|0|||
147526747|NCT01920061|532081227|FG008|Overall Study|Lost to Follow-up|0|||
147526748|NCT01920061|532081228|FG009|Overall Study|Lost to Follow-up|0|||
147526749|NCT01920061|532081229|FG010|Overall Study|Lost to Follow-up|3|||
147526750|NCT01920061|532081230|FG011|Overall Study|Lost to Follow-up|0|||
147526751|NCT01920061|532081231|FG012|Overall Study|Lost to Follow-up|0|||
147526752|NCT01920061|532081232|FG013|Overall Study|Lost to Follow-up|0|||
147526753|NCT01920061|532081233|FG014|Overall Study|Lost to Follow-up|0|||
147526754|NCT01920061|532081234|FG015|Overall Study|Lost to Follow-up|0|||
147526755|NCT01920061|532081235|FG016|Overall Study|Lost to Follow-up|0|||
147526756|NCT01920061|532081236|FG017|Overall Study|Lost to Follow-up|1|||
147526757|NCT01920061|532081237|FG018|Overall Study|Lost to Follow-up|4|||
147526758|NCT01920061|532081238|FG019|Overall Study|Lost to Follow-up|3|||
147526759|NCT01920061|532081219|FG000|Overall Study|Other|1|||
147526760|NCT01920061|532081220|FG001|Overall Study|Other|1|||
147526761|NCT01920061|532081221|FG002|Overall Study|Other|2|||
147526762|NCT01920061|532081222|FG003|Overall Study|Other|1|||
147526763|NCT01920061|532081223|FG004|Overall Study|Other|0|||
147526764|NCT01920061|532081224|FG005|Overall Study|Other|1|||
147526765|NCT01920061|532081225|FG006|Overall Study|Other|0|||
147526766|NCT01920061|532081226|FG007|Overall Study|Other|0|||
147526767|NCT01920061|532081227|FG008|Overall Study|Other|0|||
147526768|NCT01920061|532081228|FG009|Overall Study|Other|1|||
147526769|NCT01920061|532081229|FG010|Overall Study|Other|1|||
147526770|NCT01920061|532081230|FG011|Overall Study|Other|2|||
147526771|NCT01920061|532081231|FG012|Overall Study|Other|1|||
147526772|NCT01920061|532081232|FG013|Overall Study|Other|4|||
147526773|NCT01920061|532081233|FG014|Overall Study|Other|0|||
147526774|NCT01920061|532081234|FG015|Overall Study|Other|1|||
147526775|NCT01920061|532081235|FG016|Overall Study|Other|1|||
147526776|NCT01920061|532081236|FG017|Overall Study|Other|0|||
147526777|NCT01920061|532081237|FG018|Overall Study|Other|1|||
147526778|NCT01920061|532081238|FG019|Overall Study|Other|1|||
147526779|NCT01920061|532081219|FG000|Overall Study|Participant refused further follow-up|0|||
147526780|NCT01920061|532081220|FG001|Overall Study|Participant refused further follow-up|0|||
147526781|NCT01920061|532081221|FG002|Overall Study|Participant refused further follow-up|0|||
147526782|NCT01920061|532081222|FG003|Overall Study|Participant refused further follow-up|0|||
147526783|NCT01920061|532081223|FG004|Overall Study|Participant refused further follow-up|1|||
147526784|NCT01920061|532081224|FG005|Overall Study|Participant refused further follow-up|1|||
147526785|NCT01920061|532081225|FG006|Overall Study|Participant refused further follow-up|0|||
147526786|NCT01920061|532081226|FG007|Overall Study|Participant refused further follow-up|0|||
147526787|NCT01920061|532081227|FG008|Overall Study|Participant refused further follow-up|1|||
147526788|NCT01920061|532081228|FG009|Overall Study|Participant refused further follow-up|0|||
147526789|NCT01920061|532081229|FG010|Overall Study|Participant refused further follow-up|1|||
147526790|NCT01920061|532081230|FG011|Overall Study|Participant refused further follow-up|0|||
147526791|NCT01920061|532081231|FG012|Overall Study|Participant refused further follow-up|1|||
147526792|NCT01920061|532081232|FG013|Overall Study|Participant refused further follow-up|0|||
147526793|NCT01920061|532081233|FG014|Overall Study|Participant refused further follow-up|1|||
147526794|NCT01920061|532081234|FG015|Overall Study|Participant refused further follow-up|2|||
147526795|NCT01920061|532081235|FG016|Overall Study|Participant refused further follow-up|1|||
147526796|NCT01920061|532081236|FG017|Overall Study|Participant refused further follow-up|1|||
147526797|NCT01920061|532081237|FG018|Overall Study|Participant refused further follow-up|0|||
147526798|NCT01920061|532081238|FG019|Overall Study|Participant refused further follow-up|0|||
147526799|NCT00877929|532081239|FG000|Overall Study|Adverse Event|11|||
147526800|NCT00877929|532081240|FG001|Overall Study|Adverse Event|20|||
147526801|NCT00877929|532081239|FG000|Overall Study|Protocol Violation|3|||
147526802|NCT00877929|532081240|FG001|Overall Study|Protocol Violation|3|||
147526803|NCT00877929|532081239|FG000|Overall Study|Lost to Follow-up|0|||
147526804|NCT00877929|532081240|FG001|Overall Study|Lost to Follow-up|1|||
147526805|NCT00877929|532081239|FG000|Overall Study|Withdrawal by Subject|4|||
147526806|NCT00877929|532081240|FG001|Overall Study|Withdrawal by Subject|4|||
147526807|NCT00877929|532081239|FG000|Overall Study|Lack of Efficacy|0|||
147526808|NCT00877929|532081240|FG001|Overall Study|Lack of Efficacy|1|||
147526809|NCT00877929|532081239|FG000|Overall Study|Other reason (not specified)|2|||
147526810|NCT00877929|532081240|FG001|Overall Study|Other reason (not specified)|6|||
147526811|NCT00337935|532082782|FG000|Overall Study|Adverse Event|2|||
147526812|NCT00337935|532082783|FG001|Overall Study|Adverse Event|5|||
147526813|NCT00337935|532082782|FG000|Overall Study|Death|2|||
147526814|NCT00337935|532082783|FG001|Overall Study|Death|8|||
147526815|NCT00337935|532082782|FG000|Overall Study|Physician Decision|1|||
147526816|NCT00337935|532082783|FG001|Overall Study|Physician Decision|1|||
147526817|NCT00337935|532082782|FG000|Overall Study|Lost to Follow-up|0|||
147526818|NCT00337935|532082783|FG001|Overall Study|Lost to Follow-up|1|||
147526819|NCT00337935|532082782|FG000|Overall Study|Protocol Violation|4|||
147526820|NCT00337935|532082783|FG001|Overall Study|Protocol Violation|3|||
147526821|NCT00337935|532082782|FG000|Overall Study|Withdrawal by Subject|1|||
147526822|NCT00337935|532082783|FG001|Overall Study|Withdrawal by Subject|7|||
147526823|NCT00337935|532082782|FG000|Overall Study|Other|0|||
147526824|NCT00337935|532082783|FG001|Overall Study|Other|1|||
147526825|NCT00337935|532082782|FG000|Overall Study|Lack of Efficacy|0|||
147526826|NCT00337935|532082783|FG001|Overall Study|Lack of Efficacy|1|||
147526827|NCT01884675|532082784|FG000|Overall Study|Study closed/terminated|3|||
147526828|NCT01884675|532082785|FG001|Overall Study|Study closed/terminated|2|||
147526829|NCT02361307|532082786|FG000|Overall Study|Unstable medical condition.|0|||
147526830|NCT02361307|532082787|FG001|Overall Study|Unstable medical condition.|1|||
147526831|NCT01336647|532082790|FG000|Overall Study|Lost to Follow-up|4|||
147526832|NCT01336647|532082791|FG001|Overall Study|Lost to Follow-up|1|||
147526833|NCT01336647|532082792|FG002|Overall Study|Lost to Follow-up|3|||
147526834|NCT03233009|532082803|FG000|Overall Study|Lost to Follow-up|1|||
147526835|NCT01101321|532082804|FG000|Period 1|Withdrawal by Subject|1|||
147526836|NCT01101321|532082805|FG001|Period 1|Withdrawal by Subject|1|||
147526837|NCT01101321|532082804|FG000|Period 1|Adverse Event|3|||
147526838|NCT01101321|532082805|FG001|Period 1|Adverse Event|3|||
147526839|NCT00134563|532082806|FG000|Overall Study|Not treated due to protocol violation|0|||
147526840|NCT00134563|532082807|FG001|Overall Study|Not treated due to protocol violation|1|||
147526841|NCT00134563|532082808|FG002|Overall Study|Not treated due to protocol violation|1|||
147526842|NCT00134563|532082806|FG000|Overall Study|Adverse Event|29|||
147526843|NCT00134563|532082807|FG001|Overall Study|Adverse Event|37|||
147526844|NCT00134563|532082808|FG002|Overall Study|Adverse Event|38|||
147526845|NCT00134563|532082806|FG000|Overall Study|Lack of Efficacy|24|||
147526846|NCT00134563|532082807|FG001|Overall Study|Lack of Efficacy|14|||
147526847|NCT00134563|532082808|FG002|Overall Study|Lack of Efficacy|17|||
147526848|NCT00134563|532082806|FG000|Overall Study|Protocol Violation|3|||
147526849|NCT00134563|532082807|FG001|Overall Study|Protocol Violation|2|||
147526850|NCT00134563|532082808|FG002|Overall Study|Protocol Violation|5|||
147526851|NCT00134563|532082806|FG000|Overall Study|Lost to Follow-up|4|||
147526852|NCT00134563|532082807|FG001|Overall Study|Lost to Follow-up|0|||
147526853|NCT00134563|532082808|FG002|Overall Study|Lost to Follow-up|2|||
147526854|NCT00134563|532082806|FG000|Overall Study|progressive disease|11|||
147526855|NCT00134563|532082807|FG001|Overall Study|progressive disease|4|||
147526856|NCT00134563|532082808|FG002|Overall Study|progressive disease|2|||
147526857|NCT00134563|532082806|FG000|Overall Study|did not wish to continue|33|||
147526858|NCT00134563|532082807|FG001|Overall Study|did not wish to continue|32|||
147526859|NCT00134563|532082808|FG002|Overall Study|did not wish to continue|26|||
147526860|NCT00134563|532082806|FG000|Overall Study|Reason other than above|0|||
147526861|NCT00134563|532082807|FG001|Overall Study|Reason other than above|2|||
147526862|NCT00134563|532082808|FG002|Overall Study|Reason other than above|5|||
147526863|NCT02406586|532082809|FG000|Overall Study|Lost to Follow-up|0|||
147526864|NCT02406586|532082810|FG001|Overall Study|Lost to Follow-up|4|||
147526865|NCT02406586|532082811|FG002|Overall Study|Lost to Follow-up|2|||
147526866|NCT02406586|532082809|FG000|Overall Study|Withdrawal by Subject|1|||
147526867|NCT02406586|532082810|FG001|Overall Study|Withdrawal by Subject|0|||
147526868|NCT02406586|532082811|FG002|Overall Study|Withdrawal by Subject|0|||
147526869|NCT02839330|532082812|FG000|Overall Study|Adverse Event|0|||
147526870|NCT02839330|532082813|FG001|Overall Study|Adverse Event|1|||
147526871|NCT02839330|532082814|FG002|Overall Study|Adverse Event|2|||
147526872|NCT02839330|532082815|FG003|Overall Study|Adverse Event|2|||
147526873|NCT02839330|532082812|FG000|Overall Study|Death|4|||
147526874|NCT02839330|532082813|FG001|Overall Study|Death|6|||
147526875|NCT02839330|532082814|FG002|Overall Study|Death|1|||
147526876|NCT02839330|532082815|FG003|Overall Study|Death|1|||
147526877|NCT02839330|532082812|FG000|Overall Study|Withdrawal by Subject|27|||
147526878|NCT02839330|532082813|FG001|Overall Study|Withdrawal by Subject|19|||
147526879|NCT02839330|532082814|FG002|Overall Study|Withdrawal by Subject|11|||
147526880|NCT02839330|532082815|FG003|Overall Study|Withdrawal by Subject|13|||
147526881|NCT02839330|532082812|FG000|Overall Study|Lost to Follow-up|22|||
147526882|NCT02839330|532082813|FG001|Overall Study|Lost to Follow-up|27|||
147526883|NCT02839330|532082814|FG002|Overall Study|Lost to Follow-up|29|||
147526884|NCT02839330|532082815|FG003|Overall Study|Lost to Follow-up|25|||
147526885|NCT02839330|532082812|FG000|Overall Study|Administrative Reason|0|||
147526886|NCT02839330|532082813|FG001|Overall Study|Administrative Reason|0|||
147526887|NCT02839330|532082814|FG002|Overall Study|Administrative Reason|0|||
147526888|NCT02839330|532082815|FG003|Overall Study|Administrative Reason|1|||
147526889|NCT02839330|532082812|FG000|Overall Study|Protocol Violation|1|||
147526890|NCT02839330|532082813|FG001|Overall Study|Protocol Violation|2|||
147526891|NCT02839330|532082814|FG002|Overall Study|Protocol Violation|2|||
147526892|NCT02839330|532082815|FG003|Overall Study|Protocol Violation|3|||
147526893|NCT02839330|532082812|FG000|Overall Study|Other reason, not specified|4|||
147526894|NCT02839330|532082813|FG001|Overall Study|Other reason, not specified|3|||
147526895|NCT02839330|532082814|FG002|Overall Study|Other reason, not specified|3|||
147526896|NCT02839330|532082815|FG003|Overall Study|Other reason, not specified|6|||
147526897|NCT03339999|532082821|FG000|Overall Study|Adverse Event|1|||
147526898|NCT03339999|532082822|FG001|Overall Study|Adverse Event|2|||
147526899|NCT03339999|532082823|FG002|Overall Study|Adverse Event|2|||
147526900|NCT03339999|532082824|FG003|Overall Study|Adverse Event|1|||
147526901|NCT03339999|532082821|FG000|Overall Study|Lack of Efficacy|0|||
147526902|NCT03339999|532082822|FG001|Overall Study|Lack of Efficacy|1|||
147526903|NCT03339999|532082823|FG002|Overall Study|Lack of Efficacy|0|||
147526904|NCT03339999|532082824|FG003|Overall Study|Lack of Efficacy|0|||
147526905|NCT03339999|532082821|FG000|Overall Study|Lost to Follow-up|0|||
147526906|NCT03339999|532082822|FG001|Overall Study|Lost to Follow-up|0|||
147526907|NCT03339999|532082823|FG002|Overall Study|Lost to Follow-up|0|||
147526908|NCT03339999|532082824|FG003|Overall Study|Lost to Follow-up|1|||
147526909|NCT03339999|532082821|FG000|Overall Study|Study Terminated by Sponsor|6|||
147526910|NCT03339999|532082822|FG001|Overall Study|Study Terminated by Sponsor|3|||
147526911|NCT03339999|532082823|FG002|Overall Study|Study Terminated by Sponsor|4|||
147526912|NCT03339999|532082824|FG003|Overall Study|Study Terminated by Sponsor|3|||
147526913|NCT01856920|532082825|FG000|Overall Study|Disease Progression On Study|3|||
147526914|NCT01856920|532082826|FG001|Overall Study|Disease Progression On Study|4|||
147526915|NCT01856920|532082825|FG000|Overall Study|Disease Progression before Treatment|1|||
147526916|NCT01856920|532082826|FG001|Overall Study|Disease Progression before Treatment|0|||
147526917|NCT01856920|532082825|FG000|Overall Study|Ineligible|0|||
147526918|NCT01856920|532082826|FG001|Overall Study|Ineligible|1|||
147526919|NCT01856920|532082825|FG000|Overall Study|Patient Declined to Participate (before treatment started.)|1|||
147526920|NCT01856920|532082826|FG001|Overall Study|Patient Declined to Participate (before treatment started.)|0|||
147526921|NCT01856920|532082825|FG000|Overall Study|Refused further Treatment|5|||
147526922|NCT01856920|532082826|FG001|Overall Study|Refused further Treatment|1|||
147526923|NCT01856920|532082825|FG000|Overall Study|Other Reasons|0|||
147526924|NCT01856920|532082826|FG001|Overall Study|Other Reasons|1|||
147526925|NCT01856920|532082825|FG000|Overall Study|Completed treatment phase but refused the Protocol-Specified|0|||
147526926|NCT01856920|532082826|FG001|Overall Study|Completed treatment phase but refused the Protocol-Specified|2|||
147526927|NCT02545270|532082828|FG000|Overall Study|technical difficulties|0|||
147526928|NCT02545270|532082829|FG001|Overall Study|technical difficulties|1|||
147526929|NCT02545270|532082830|FG002|Overall Study|technical difficulties|0|||
147526930|NCT02545270|532082828|FG000|Overall Study|Videos being too similar to other|0|||
147526931|NCT02545270|532082829|FG001|Overall Study|Videos being too similar to other|0|||
147526932|NCT02545270|532082830|FG002|Overall Study|Videos being too similar to other|2|||
147526933|NCT00661362|532082836|FG000|Overall Study|Adverse Event|5|||
147526934|NCT00661362|532082837|FG001|Overall Study|Adverse Event|4|||
147526935|NCT00661362|532082836|FG000|Overall Study|Incorrect enrollment|2|||
147526936|NCT00661362|532082837|FG001|Overall Study|Incorrect enrollment|0|||
147526937|NCT00661362|532082836|FG000|Overall Study|Study specific discontinuation criteria|4|||
147526938|NCT00661362|532082837|FG001|Overall Study|Study specific discontinuation criteria|11|||
147526939|NCT00661362|532082836|FG000|Overall Study|Withdrawal by Subject|13|||
147526940|NCT00661362|532082837|FG001|Overall Study|Withdrawal by Subject|23|||
147526941|NCT00661362|532082836|FG000|Overall Study|Lost to Follow-up|3|||
147526942|NCT00661362|532082837|FG001|Overall Study|Lost to Follow-up|1|||
147526943|NCT00661362|532082836|FG000|Overall Study|Severe non-compliance to protocol|0|||
147526944|NCT00661362|532082837|FG001|Overall Study|Severe non-compliance to protocol|1|||
147526945|NCT00661362|532082836|FG000|Overall Study|Safety reasons|1|||
147526946|NCT00661362|532082837|FG001|Overall Study|Safety reasons|0|||
147526947|NCT00661362|532082836|FG000|Overall Study|Metformin dose haven't decreasd to 2.5 g|1|||
147526948|NCT00661362|532082837|FG001|Overall Study|Metformin dose haven't decreasd to 2.5 g|0|||
147526949|NCT01654666|532082838|FG000|Overall Study|Protocol Violation|7|||
147526950|NCT01654666|532082839|FG001|Overall Study|Protocol Violation|4|||
147526951|NCT01654666|532082840|FG002|Overall Study|Protocol Violation|8|||
147526952|NCT01654666|532082838|FG000|Overall Study|Lost to Follow-up|4|||
147526953|NCT01654666|532082839|FG001|Overall Study|Lost to Follow-up|5|||
147526954|NCT01654666|532082840|FG002|Overall Study|Lost to Follow-up|5|||
147526955|NCT01654666|532082838|FG000|Overall Study|Withdrawal by Subject|4|||
147526956|NCT01654666|532082839|FG001|Overall Study|Withdrawal by Subject|4|||
147526957|NCT01654666|532082840|FG002|Overall Study|Withdrawal by Subject|1|||
147526958|NCT03432819|532082844|FG000|Overall Study|Lost to Follow-up|2|||
147526959|NCT03432819|532082845|FG001|Overall Study|Lost to Follow-up|2|||
147526960|NCT03432819|532082844|FG000|Overall Study|Withdrawal by Subject|5|||
147526961|NCT03432819|532082845|FG001|Overall Study|Withdrawal by Subject|3|||
147526962|NCT04382066|532082846|FG000|Overall Study|Adverse Event|1|||
147526963|NCT04382066|532082847|FG001|Overall Study|Adverse Event|0|||
147526964|NCT04382066|532082848|FG002|Overall Study|Adverse Event|0|||
147526965|NCT04382066|532082846|FG000|Overall Study|Death|1|||
147526966|NCT04382066|532082847|FG001|Overall Study|Death|0|||
147526967|NCT04382066|532082848|FG002|Overall Study|Death|1|||
147526968|NCT01430559|532082849|FG000|Overall Study|Adverse Event|7|||
147526969|NCT01430559|532082850|FG001|Overall Study|Adverse Event|3|||
147526970|NCT01430559|532082849|FG000|Overall Study|Entry criteria not met|1|||
147526971|NCT01430559|532082850|FG001|Overall Study|Entry criteria not met|1|||
147526972|NCT01430559|532082849|FG000|Overall Study|Lost to Follow-up|1|||
147526973|NCT01430559|532082850|FG001|Overall Study|Lost to Follow-up|0|||
147526974|NCT01430559|532082849|FG000|Overall Study|Medication error|1|||
147526975|NCT01430559|532082850|FG001|Overall Study|Medication error|0|||
147526976|NCT01430559|532082849|FG000|Overall Study|Withdrawal by Subject|3|||
147526977|NCT01430559|532082850|FG001|Overall Study|Withdrawal by Subject|2|||
147526978|NCT01430559|532082849|FG000|Overall Study|Protocol Violation|1|||
147526979|NCT01430559|532082850|FG001|Overall Study|Protocol Violation|0|||
147526980|NCT01430559|532082849|FG000|Overall Study|Other|3|||
147526981|NCT01430559|532082850|FG001|Overall Study|Other|3|||
147526982|NCT01430559|532082849|FG000|Overall Study|Randomized, Not Treated|3|||
147526983|NCT01430559|532082850|FG001|Overall Study|Randomized, Not Treated|3|||
147526984|NCT04225026|532082851|FG000|Overall Study|Withdrawal by Subject|4|||
147526985|NCT04225026|532082851|FG000|Overall Study|Adverse Event|1|||
147526986|NCT04225026|532082851|FG000|Overall Study|Other|1|||
147526987|NCT04225026|532082851|FG000|Overall Study|Death|11|||
147526988|NCT04225026|532082851|FG000|Overall Study|Study Terminated Early By Sponsor|7|||
147526989|NCT00579059|532082852|FG000|Overall Study|Study Canceled at 1 Year|21|||
147526990|NCT00579059|532082853|FG001|Overall Study|Study Canceled at 1 Year|10|||
147526991|NCT00779506|532082854|FG000|Overall Study|Screening Failed|2|||
147526992|NCT00779506|532082854|FG000|Overall Study|Adverse Event|4|||
147526993|NCT00779506|532082854|FG000|Overall Study|Lack of Efficacy|11|||
147526994|NCT00779506|532082854|FG000|Overall Study|Protocol Violation|5|||
147526995|NCT00779506|532082854|FG000|Overall Study|Withdrawal by Subject|6|||
147526996|NCT00779506|532082854|FG000|Overall Study|Lost to Follow-up|1|||
147526997|NCT03982069|532082855|FG000|Overall Study|Lost to Follow-up|5|||
147526998|NCT03982069|532082856|FG001|Overall Study|Lost to Follow-up|5|||
147526999|NCT03982069|532082857|FG002|Overall Study|Lost to Follow-up|3|||
147527000|NCT03982069|532082858|FG003|Overall Study|Lost to Follow-up|5|||
147527001|NCT03982069|532082855|FG000|Overall Study|Physician Decision|0|||
147527002|NCT03982069|532082856|FG001|Overall Study|Physician Decision|1|||
147527003|NCT03982069|532082857|FG002|Overall Study|Physician Decision|0|||
147527004|NCT03982069|532082858|FG003|Overall Study|Physician Decision|0|||
147527005|NCT03982069|532082855|FG000|Overall Study|Withdrawal by Subject|2|||
147527006|NCT03982069|532082856|FG001|Overall Study|Withdrawal by Subject|1|||
147527007|NCT03982069|532082857|FG002|Overall Study|Withdrawal by Subject|5|||
147527008|NCT03982069|532082858|FG003|Overall Study|Withdrawal by Subject|2|||
147527009|NCT03982069|532082855|FG000|Overall Study|Specimen loss|3|||
147527010|NCT03982069|532082856|FG001|Overall Study|Specimen loss|3|||
147527011|NCT03982069|532082857|FG002|Overall Study|Specimen loss|1|||
147527012|NCT03982069|532082858|FG003|Overall Study|Specimen loss|1|||
147527013|NCT01218477|532082859|FG000|Overall Study|Disease progression|2|||
147527014|NCT01218477|532082860|FG001|Overall Study|Disease progression|3|||
147527015|NCT01218477|532082861|FG002|Overall Study|Disease progression|6|||
147527016|NCT01218477|532082862|FG003|Overall Study|Disease progression|2|||
147527017|NCT01218477|532082859|FG000|Overall Study|Study drug toxicity|0|||
147527018|NCT01218477|532082860|FG001|Overall Study|Study drug toxicity|2|||
147527019|NCT01218477|532082861|FG002|Overall Study|Study drug toxicity|5|||
147527020|NCT01218477|532082862|FG003|Overall Study|Study drug toxicity|0|||
147527021|NCT01218477|532082859|FG000|Overall Study|No longer meets study criteria|1|||
147527022|NCT01218477|532082860|FG001|Overall Study|No longer meets study criteria|0|||
147527023|NCT01218477|532082861|FG002|Overall Study|No longer meets study criteria|0|||
147527024|NCT01218477|532082862|FG003|Overall Study|No longer meets study criteria|0|||
147527025|NCT01218477|532082859|FG000|Overall Study|Withdrawal by Subject|0|||
147527026|NCT01218477|532082860|FG001|Overall Study|Withdrawal by Subject|0|||
147527027|NCT01218477|532082861|FG002|Overall Study|Withdrawal by Subject|1|||
147527028|NCT01218477|532082862|FG003|Overall Study|Withdrawal by Subject|0|||
147527029|NCT01218477|532082859|FG000|Overall Study|Prepared for cell transplantation|0|||
147527030|NCT01218477|532082860|FG001|Overall Study|Prepared for cell transplantation|1|||
147527031|NCT01218477|532082861|FG002|Overall Study|Prepared for cell transplantation|1|||
147527032|NCT01218477|532082862|FG003|Overall Study|Prepared for cell transplantation|0|||
147527033|NCT01218477|532082859|FG000|Overall Study|Administrative reason by sponsor|0|||
147527034|NCT01218477|532082860|FG001|Overall Study|Administrative reason by sponsor|0|||
147527035|NCT01218477|532082861|FG002|Overall Study|Administrative reason by sponsor|1|||
147527036|NCT01218477|532082862|FG003|Overall Study|Administrative reason by sponsor|0|||
147527037|NCT01218477|532082859|FG000|Overall Study|Maximum clinical benefit|0|||
147527038|NCT01218477|532082860|FG001|Overall Study|Maximum clinical benefit|2|||
147527039|NCT01218477|532082861|FG002|Overall Study|Maximum clinical benefit|0|||
147527040|NCT01218477|532082862|FG003|Overall Study|Maximum clinical benefit|0|||
147527041|NCT00787527|532082863|FG000|Overall Study|Toxicity|3|||
147527042|NCT03137433|532082866|FG000|Overall Study|Withdrawal by Subject|11|||
147527043|NCT03137433|532082867|FG001|Overall Study|Withdrawal by Subject|11|||
147527044|NCT03137433|532082866|FG000|Overall Study|Lost to Follow-up|5|||
147527045|NCT03137433|532082867|FG001|Overall Study|Lost to Follow-up|6|||
147527046|NCT03137433|532082866|FG000|Overall Study|Physician Decision|2|||
147527047|NCT03137433|532082867|FG001|Overall Study|Physician Decision|0|||
147527048|NCT03137433|532082866|FG000|Overall Study|Moved out of study area|1|||
147527049|NCT03137433|532082867|FG001|Overall Study|Moved out of study area|0|||
147527050|NCT03137433|532082866|FG000|Overall Study|Too far out of window due to COVID|0|||
147527051|NCT03137433|532082867|FG001|Overall Study|Too far out of window due to COVID|1|||
147527052|NCT02452892|532082871|FG000|Week 1 Initial Randommization|Adverse Event|1|||
147527053|NCT02452892|532082872|FG001|Week 1 Initial Randommization|Adverse Event|0|||
147527054|NCT02452892|532082873|FG002|Week 1 Initial Randommization|Adverse Event|0|||
147527055|NCT02452892|532082874|FG003|Week 1 Initial Randommization|Adverse Event|0|||
147527056|NCT02452892|532082871|FG000|Week 1 Initial Randommization|Lost to Follow-up|0|||
147527057|NCT02452892|532082872|FG001|Week 1 Initial Randommization|Lost to Follow-up|0|||
147527058|NCT02452892|532082873|FG002|Week 1 Initial Randommization|Lost to Follow-up|1|||
147527059|NCT02452892|532082874|FG003|Week 1 Initial Randommization|Lost to Follow-up|0|||
147527060|NCT02452892|532082871|FG000|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|0|||
147527061|NCT02452892|532082872|FG001|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|0|||
147527062|NCT02452892|532082873|FG002|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|0|||
147527063|NCT02452892|532082874|FG003|Week 2 Stratification & Re-Randomization|Withdrawal by Subject|2|||
147527064|NCT02452892|532082871|FG000|Week 2 Stratification & Re-Randomization|Lost to Follow-up|2|||
147527065|NCT02452892|532082872|FG001|Week 2 Stratification & Re-Randomization|Lost to Follow-up|0|||
147527066|NCT02452892|532082873|FG002|Week 2 Stratification & Re-Randomization|Lost to Follow-up|0|||
147527067|NCT02452892|532082874|FG003|Week 2 Stratification & Re-Randomization|Lost to Follow-up|0|||
147527068|NCT02452892|532082871|FG000|Follow-up|Withdrawal by Subject|0|||
147527069|NCT02452892|532082872|FG001|Follow-up|Withdrawal by Subject|0|||
147527070|NCT02452892|532082873|FG002|Follow-up|Withdrawal by Subject|0|||
147527071|NCT02452892|532082874|FG003|Follow-up|Withdrawal by Subject|1|||
147527072|NCT02452892|532082871|FG000|Follow-up|Subject left town on Day 42|1|||
147527073|NCT02452892|532082872|FG001|Follow-up|Subject left town on Day 42|0|||
147527074|NCT02452892|532082873|FG002|Follow-up|Subject left town on Day 42|0|||
147527075|NCT02452892|532082874|FG003|Follow-up|Subject left town on Day 42|0|||
147527076|NCT01005875|532082875|FG000|Overall Study|Death|3|||
147527077|NCT00606931|532082878|FG000|Overall Study|Withdrawal by Subject|3|||
147527078|NCT00286234|532082879|FG000|Overall Study|Protocol Violation|1|||
147527079|NCT00286234|532082880|FG001|Overall Study|Protocol Violation|2|||
147527080|NCT00286234|532082881|FG002|Overall Study|Protocol Violation|0|||
147527081|NCT00286234|532082882|FG003|Overall Study|Protocol Violation|1|||
147527082|NCT00286234|532082879|FG000|Overall Study|Physician Decision|1|||
147527083|NCT00286234|532082880|FG001|Overall Study|Physician Decision|0|||
147527084|NCT00286234|532082881|FG002|Overall Study|Physician Decision|0|||
147527085|NCT00286234|532082882|FG003|Overall Study|Physician Decision|1|||
147527086|NCT00286234|532082879|FG000|Overall Study|Adverse Event|0|||
147527087|NCT00286234|532082880|FG001|Overall Study|Adverse Event|0|||
147527088|NCT00286234|532082881|FG002|Overall Study|Adverse Event|0|||
147527089|NCT00286234|532082882|FG003|Overall Study|Adverse Event|1|||
147527090|NCT00286234|532082879|FG000|Overall Study|Adverse Event|0|||
147527091|NCT00286234|532082880|FG001|Overall Study|Adverse Event|0|||
147527092|NCT00286234|532082881|FG002|Overall Study|Adverse Event|0|||
147527093|NCT00286234|532082882|FG003|Overall Study|Adverse Event|1|||
147527094|NCT01468844|532082887|FG000|Overall Study|Adverse Event|1|||
147527095|NCT01468844|532082888|FG001|Overall Study|Adverse Event|0|||
147527096|NCT01468844|532082887|FG000|Overall Study|Withdrawal by Subject|1|||
147527097|NCT01468844|532082888|FG001|Overall Study|Withdrawal by Subject|0|||
147527098|NCT04490499|532082891|FG000|Overall Study|Withdrawal by Subject|2|||
147527099|NCT01843933|532082892|FG000|Overall Study|Data lost|6|||
147527100|NCT01843933|532082893|FG001|Overall Study|Data lost|4|||
147527101|NCT00819052|532082894|FG000|Overall Study|Adverse Event|0|||
147527102|NCT00819052|532082895|FG001|Overall Study|Adverse Event|5|||
147527103|NCT00819052|532082894|FG000|Overall Study|Protocol Violation|1|||
147527104|NCT00819052|532082895|FG001|Overall Study|Protocol Violation|2|||
147527105|NCT00819052|532082894|FG000|Overall Study|Lost to Follow-up|1|||
147527106|NCT00819052|532082895|FG001|Overall Study|Lost to Follow-up|2|||
147527107|NCT00819052|532082894|FG000|Overall Study|Withdrawal by Subject|1|||
147527108|NCT00819052|532082895|FG001|Overall Study|Withdrawal by Subject|2|||
147527109|NCT00819052|532082894|FG000|Overall Study|Lack of Efficacy|1|||
147527110|NCT00819052|532082895|FG001|Overall Study|Lack of Efficacy|1|||
147527111|NCT00819052|532082894|FG000|Overall Study|Pregnancy|1|||
147527112|NCT00819052|532082895|FG001|Overall Study|Pregnancy|2|||
147527113|NCT00819052|532082894|FG000|Overall Study|Death or events leading to death|1|||
147527114|NCT00819052|532082895|FG001|Overall Study|Death or events leading to death|0|||
147527115|NCT03524664|532082896|FG000|Overall Study|Withdrawal by Subject|1|||
147527116|NCT03524664|532082897|FG001|Overall Study|Withdrawal by Subject|2|||
147527117|NCT03524664|532082896|FG000|Overall Study|Lost to Follow-up|4|||
147527118|NCT03524664|532082897|FG001|Overall Study|Lost to Follow-up|13|||
147527119|NCT02694562|532082898|FG000|Overall Study|Death|8|||
147527120|NCT02694562|532082898|FG000|Overall Study|Protocol Violation|4|||
147527121|NCT02694562|532082898|FG000|Overall Study|Lost to Follow-up|3|||
147527122|NCT02694562|532082898|FG000|Overall Study|Screen Failure|2|||
147527123|NCT02694562|532082898|FG000|Overall Study|Physician Decision|1|||
147527124|NCT01140646|532082906|FG000|Overall Study|Adverse Event|4|||
147527125|NCT01140646|532082906|FG000|Overall Study|Refused Further Treatment|5|||
147527126|NCT02612194|532082913|FG000|Overall Study|Death|5|||
147527127|NCT02612194|532082914|FG001|Overall Study|Death|0|||
147527128|NCT02612194|532082915|FG002|Overall Study|Death|2|||
147527129|NCT02612194|532082913|FG000|Overall Study|Early Study Termination|1|||
147527130|NCT02612194|532082914|FG001|Overall Study|Early Study Termination|0|||
147527131|NCT02612194|532082915|FG002|Overall Study|Early Study Termination|0|||
147527132|NCT02539160|532082916|FG000|Phase 1 Pre-crossover|Adverse Event|3|||
147527133|NCT02539160|532082917|FG001|Phase 1 Pre-crossover|Adverse Event|3|||
147527134|NCT02539160|532082918|FG002|Phase 1 Pre-crossover|Adverse Event|2|||
147527135|NCT02539160|532082919|FG003|Phase 1 Pre-crossover|Adverse Event|1|||
147527136|NCT02539160|532082916|FG000|Phase 1 Pre-crossover|Withdrawal by Subject|2|||
147527137|NCT02539160|532082917|FG001|Phase 1 Pre-crossover|Withdrawal by Subject|1|||
147527138|NCT02539160|532082918|FG002|Phase 1 Pre-crossover|Withdrawal by Subject|1|||
147527139|NCT02539160|532082919|FG003|Phase 1 Pre-crossover|Withdrawal by Subject|0|||
147527140|NCT02539160|532082916|FG000|Phase 1 Pre-crossover|Protocol Violation|0|||
147527141|NCT02539160|532082917|FG001|Phase 1 Pre-crossover|Protocol Violation|0|||
147527142|NCT02539160|532082918|FG002|Phase 1 Pre-crossover|Protocol Violation|0|||
147527143|NCT02539160|532082919|FG003|Phase 1 Pre-crossover|Protocol Violation|2|||
147527144|NCT01681004|532082920|FG000|Primary Endpoint: 6 Months|Withdrawal by Subject|1|||
147527145|NCT01681004|532082921|FG001|Primary Endpoint: 6 Months|Withdrawal by Subject|2|||
147527146|NCT01681004|532082920|FG000|Study Completion|Lost to Follow-up|8|||
147527147|NCT01681004|532082921|FG001|Study Completion|Lost to Follow-up|3|||
147527148|NCT01681004|532082920|FG000|Study Completion|Physician Decision|1|||
147527149|NCT01681004|532082921|FG001|Study Completion|Physician Decision|3|||
147527150|NCT01681004|532082920|FG000|Study Completion|Site Termination|2|||
147527151|NCT01681004|532082921|FG001|Study Completion|Site Termination|1|||
147527152|NCT01681004|532082920|FG000|Study Completion|Death|1|||
147527153|NCT01681004|532082921|FG001|Study Completion|Death|1|||
147527154|NCT00372905|532082922|FG000|Cohort 1: Dose Level 1.0mg/m2|Progressive Disease|2|||
147527155|NCT00372905|532082923|FG001|Cohort 1: Dose Level 1.0mg/m2|Progressive Disease|0|||
147527156|NCT00372905|532082924|FG002|Cohort 1: Dose Level 1.0mg/m2|Progressive Disease|0|||
147527157|NCT00372905|532082925|FG003|Cohort 1: Dose Level 1.0mg/m2|Progressive Disease|0|||
147527158|NCT00372905|532082922|FG000|Cohort 3: Dose Level 1.6mg/m2|Adverse Event|0|||
147527159|NCT00372905|532082923|FG001|Cohort 3: Dose Level 1.6mg/m2|Adverse Event|0|||
147527160|NCT00372905|532082924|FG002|Cohort 3: Dose Level 1.6mg/m2|Adverse Event|2|||
147527161|NCT00372905|532082925|FG003|Cohort 3: Dose Level 1.6mg/m2|Adverse Event|0|||
147527162|NCT00372905|532082922|FG000|Cohort 3: Dose Level 1.6mg/m2|Withdrawal by Subject|0|||
147527163|NCT00372905|532082923|FG001|Cohort 3: Dose Level 1.6mg/m2|Withdrawal by Subject|0|||
147527164|NCT00372905|532082924|FG002|Cohort 3: Dose Level 1.6mg/m2|Withdrawal by Subject|1|||
147527165|NCT00372905|532082925|FG003|Cohort 3: Dose Level 1.6mg/m2|Withdrawal by Subject|0|||
147527166|NCT00372905|532082922|FG000|Expansion Phase at Dose 1.3mg/m2|Adverse Event|0|||
147527167|NCT00372905|532082923|FG001|Expansion Phase at Dose 1.3mg/m2|Adverse Event|0|||
147527168|NCT00372905|532082924|FG002|Expansion Phase at Dose 1.3mg/m2|Adverse Event|0|||
147527169|NCT00372905|532082925|FG003|Expansion Phase at Dose 1.3mg/m2|Adverse Event|2|||
147527170|NCT00372905|532082922|FG000|Follow up Until Relapse or Progression|Study closed|0|||
147527171|NCT00372905|532082923|FG001|Follow up Until Relapse or Progression|Study closed|0|||
147527172|NCT00372905|532082924|FG002|Follow up Until Relapse or Progression|Study closed|0|||
147527173|NCT00372905|532082925|FG003|Follow up Until Relapse or Progression|Study closed|3|||
147527174|NCT00372905|532082922|FG000|Follow up Until Relapse or Progression|Other|0|||
147527175|NCT00372905|532082923|FG001|Follow up Until Relapse or Progression|Other|1|||
147527176|NCT00372905|532082924|FG002|Follow up Until Relapse or Progression|Other|0|||
147527177|NCT00372905|532082925|FG003|Follow up Until Relapse or Progression|Other|0|||
147527178|NCT03726320|532084155|FG000|Overall Study|Lost to Follow-up|2|||
147527364|NCT04594213|532084253|FG000|Main Period (Up to 22 Weeks)|Withdrawal by Subject|2|||
147527365|NCT04594213|532084254|FG001|Main Period (Up to 22 Weeks)|Withdrawal by Subject|6|||
147527366|NCT04594213|532084255|FG002|Main Period (Up to 22 Weeks)|Withdrawal by Subject|1|||
147527367|NCT04594213|532084256|FG003|Main Period (Up to 22 Weeks)|Withdrawal by Subject|0|||
147527368|NCT04594213|532084257|FG004|Main Period (Up to 22 Weeks)|Withdrawal by Subject|0|||
147527369|NCT04594213|532084258|FG005|Main Period (Up to 22 Weeks)|Withdrawal by Subject|0|||
147527370|NCT04594213|532084253|FG000|Main Period (Up to 22 Weeks)|Physician Decision|0|||
147527371|NCT04594213|532084254|FG001|Main Period (Up to 22 Weeks)|Physician Decision|1|||
147527372|NCT04594213|532084255|FG002|Main Period (Up to 22 Weeks)|Physician Decision|0|||
147527373|NCT04594213|532084256|FG003|Main Period (Up to 22 Weeks)|Physician Decision|0|||
147527374|NCT04594213|532084257|FG004|Main Period (Up to 22 Weeks)|Physician Decision|0|||
147527375|NCT04594213|532084258|FG005|Main Period (Up to 22 Weeks)|Physician Decision|0|||
147527376|NCT04594213|532084253|FG000|Main Period (Up to 22 Weeks)|Lost to Follow-up|1|||
147527377|NCT04594213|532084254|FG001|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
147527378|NCT04594213|532084255|FG002|Main Period (Up to 22 Weeks)|Lost to Follow-up|1|||
147527379|NCT04594213|532084256|FG003|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
147527380|NCT04594213|532084257|FG004|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
147527381|NCT04594213|532084258|FG005|Main Period (Up to 22 Weeks)|Lost to Follow-up|0|||
147527382|NCT04594213|532084253|FG000|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
147527383|NCT04594213|532084254|FG001|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
147527384|NCT04594213|532084255|FG002|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
147527385|NCT04594213|532084256|FG003|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
147527386|NCT04594213|532084257|FG004|OLEX Period (Up to 39 Weeks)|Adverse Event|2|||
147527387|NCT04594213|532084258|FG005|OLEX Period (Up to 39 Weeks)|Adverse Event|0|||
147527388|NCT04594213|532084253|FG000|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
147527389|NCT04594213|532084254|FG001|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
147527390|NCT04594213|532084255|FG002|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|0|||
147527391|NCT04594213|532084256|FG003|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|4|||
147527392|NCT04594213|532084257|FG004|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|6|||
147527393|NCT04594213|532084258|FG005|OLEX Period (Up to 39 Weeks)|Lost to Follow-up|2|||
147527394|NCT04594213|532084253|FG000|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
147527395|NCT04594213|532084254|FG001|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
147527396|NCT04594213|532084255|FG002|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
147527397|NCT04594213|532084256|FG003|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
147527398|NCT04594213|532084257|FG004|OLEX Period (Up to 39 Weeks)|Pregnancy|0|||
147527399|NCT04594213|532084258|FG005|OLEX Period (Up to 39 Weeks)|Pregnancy|1|||
147527400|NCT04594213|532084253|FG000|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
147527401|NCT04594213|532084254|FG001|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
147527402|NCT04594213|532084255|FG002|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
147527403|NCT04594213|532084256|FG003|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|1|||
147527404|NCT04594213|532084257|FG004|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
147527405|NCT04594213|532084258|FG005|OLEX Period (Up to 39 Weeks)|Other eligibility criteria for re-injection not met|0|||
147527406|NCT04594213|532084253|FG000|OLEX Period (Up to 39 Weeks)|Protocol Violation|0|||
147527407|NCT04594213|532084254|FG001|OLEX Period (Up to 39 Weeks)|Protocol Violation|0|||
147527408|NCT04594213|532084255|FG002|OLEX Period (Up to 39 Weeks)|Protocol Violation|0|||
147527409|NCT04594213|532084256|FG003|OLEX Period (Up to 39 Weeks)|Protocol Violation|1|||
147527410|NCT04594213|532084257|FG004|OLEX Period (Up to 39 Weeks)|Protocol Violation|0|||
147527411|NCT04594213|532084258|FG005|OLEX Period (Up to 39 Weeks)|Protocol Violation|0|||
147527412|NCT04594213|532084253|FG000|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|0|||
147527413|NCT04594213|532084254|FG001|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|0|||
147527414|NCT04594213|532084255|FG002|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|0|||
147527415|NCT04594213|532084256|FG003|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|6|||
147527416|NCT04594213|532084257|FG004|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|11|||
147527417|NCT04594213|532084258|FG005|OLEX Period (Up to 39 Weeks)|Withdrawal by Subject|4|||
147527418|NCT04594213|532084253|FG000|OLEX Period (Up to 39 Weeks)|No need for re-injection|0|||
147527419|NCT04594213|532084254|FG001|OLEX Period (Up to 39 Weeks)|No need for re-injection|0|||
147527420|NCT04594213|532084255|FG002|OLEX Period (Up to 39 Weeks)|No need for re-injection|0|||
147527421|NCT04594213|532084256|FG003|OLEX Period (Up to 39 Weeks)|No need for re-injection|7|||
147527422|NCT04594213|532084257|FG004|OLEX Period (Up to 39 Weeks)|No need for re-injection|22|||
147527423|NCT04594213|532084258|FG005|OLEX Period (Up to 39 Weeks)|No need for re-injection|5|||
147527424|NCT04594213|532084253|FG000|OLEX Period (Up to 39 Weeks)|Other|0|||
147527425|NCT04594213|532084254|FG001|OLEX Period (Up to 39 Weeks)|Other|0|||
147527426|NCT04594213|532084255|FG002|OLEX Period (Up to 39 Weeks)|Other|0|||
147527427|NCT04594213|532084256|FG003|OLEX Period (Up to 39 Weeks)|Other|1|||
147527428|NCT04594213|532084257|FG004|OLEX Period (Up to 39 Weeks)|Other|3|||
147527429|NCT04594213|532084258|FG005|OLEX Period (Up to 39 Weeks)|Other|1|||
147527430|NCT03764813|532084259|FG000|From Enrollment to the Age of 32 Weeks|Death before the age of 32 weeks|0|||
147527431|NCT03764813|532084260|FG001|From Enrollment to the Age of 32 Weeks|Death before the age of 32 weeks|1|||
147527432|NCT03764813|532084261|FG002|From Enrollment to the Age of 32 Weeks|Death before the age of 32 weeks|1|||
147527433|NCT03764813|532084262|FG003|From Enrollment to the Age of 32 Weeks|Death before the age of 32 weeks|0|||
147527434|NCT02898662|532084265|FG000|Overall Study|Adverse Event|1|||
147527435|NCT02898662|532084266|FG001|Overall Study|Adverse Event|0|||
147527436|NCT02898662|532084265|FG000|Overall Study|Loss of asthma control|23|||
147527437|NCT02898662|532084266|FG001|Overall Study|Loss of asthma control|24|||
147527438|NCT02898662|532084265|FG000|Overall Study|Withdrawal by Subject|4|||
147527439|NCT02898662|532084266|FG001|Overall Study|Withdrawal by Subject|1|||
147527440|NCT02898662|532084265|FG000|Overall Study|Technical issue|0|||
147527441|NCT02898662|532084266|FG001|Overall Study|Technical issue|1|||
147527442|NCT02898662|532084265|FG000|Overall Study|Randomized in error|0|||
147527443|NCT02898662|532084266|FG001|Overall Study|Randomized in error|1|||
147527444|NCT02898662|532084265|FG000|Overall Study|Subject decision|1|||
147527445|NCT02898662|532084266|FG001|Overall Study|Subject decision|0|||
147527446|NCT02898662|532084265|FG000|Overall Study|Other|0|||
147527447|NCT02898662|532084266|FG001|Overall Study|Other|1|||
147527448|NCT00779142|532084270|FG000|Overall Study|Screen Failures|3|||
147527449|NCT00672490|532084271|FG000|Overall Study|Withdrawal by Subject|8|||
147527450|NCT00672490|532084272|FG001|Overall Study|Withdrawal by Subject|8|||
147527451|NCT00672490|532084271|FG000|Overall Study|Lack of Compliance|2|||
147527452|NCT00672490|532084272|FG001|Overall Study|Lack of Compliance|7|||
147527453|NCT00672490|532084271|FG000|Overall Study|Mismatch Include/Exclude Criteria|1|||
147527454|NCT00672490|532084272|FG001|Overall Study|Mismatch Include/Exclude Criteria|0|||
147527455|NCT00672490|532084271|FG000|Overall Study|Adverse Event|5|||
147527456|NCT00672490|532084272|FG001|Overall Study|Adverse Event|8|||
147527457|NCT00672490|532084271|FG000|Overall Study|Violation of Concomitant Medicine|1|||
147527458|NCT00672490|532084272|FG001|Overall Study|Violation of Concomitant Medicine|0|||
147527459|NCT00672490|532084271|FG000|Overall Study|Intolerance|0|||
147527460|NCT00672490|532084272|FG001|Overall Study|Intolerance|2|||
147527461|NCT00672490|532084271|FG000|Overall Study|Lost to Follow-up|1|||
147527462|NCT00672490|532084272|FG001|Overall Study|Lost to Follow-up|5|||
147527463|NCT00672490|532084271|FG000|Overall Study|No reason was provided|6|||
147527464|NCT00672490|532084272|FG001|Overall Study|No reason was provided|2|||
147527465|NCT04738123|532084275|FG000|Overall Study|Changes in condition making participant ineligible for further treatment|1|||
147527466|NCT04738123|532084276|FG001|Overall Study|Changes in condition making participant ineligible for further treatment|0|||
147527467|NCT04738123|532084275|FG000|Overall Study|Progressive Disease|0|||
147527468|NCT04738123|532084276|FG001|Overall Study|Progressive Disease|4|||
147527469|NCT04738123|532084275|FG000|Overall Study|Adverse Event|8|||
147527470|NCT04738123|532084276|FG001|Overall Study|Adverse Event|7|||
147527471|NCT04738123|532084275|FG000|Overall Study|Other Reasons|0|||
147527472|NCT04738123|532084276|FG001|Overall Study|Other Reasons|1|||
147527473|NCT04738123|532084275|FG000|Overall Study|Suicidal or assaultive behavior|0|||
147527474|NCT04738123|532084276|FG001|Overall Study|Suicidal or assaultive behavior|2|||
147527475|NCT04738123|532084275|FG000|Overall Study|Protocol Violation|2|||
147527476|NCT04738123|532084276|FG001|Overall Study|Protocol Violation|2|||
147527477|NCT04738123|532084275|FG000|Overall Study|Consent Withdrawn|35|||
147527478|NCT04738123|532084276|FG001|Overall Study|Consent Withdrawn|22|||
147527479|NCT00486720|532084277|FG000|Overall Study|Adverse Event|1|||
147527480|NCT00486720|532084278|FG001|Overall Study|Adverse Event|2|||
147527481|NCT00486720|532084277|FG000|Overall Study|Lack of Efficacy|4|||
147527482|NCT00486720|532084278|FG001|Overall Study|Lack of Efficacy|6|||
147527483|NCT00486720|532084277|FG000|Overall Study|Physician Decision|1|||
147527484|NCT00486720|532084278|FG001|Overall Study|Physician Decision|2|||
147527485|NCT00486720|532084277|FG000|Overall Study|Protocol Violation|1|||
147527486|NCT00486720|532084278|FG001|Overall Study|Protocol Violation|0|||
147527487|NCT00486720|532084277|FG000|Overall Study|Withdrawal by Subject|3|||
147527488|NCT00486720|532084278|FG001|Overall Study|Withdrawal by Subject|1|||
147527489|NCT00486720|532084277|FG000|Overall Study|Progressive Disease|0|||
147527490|NCT00486720|532084278|FG001|Overall Study|Progressive Disease|1|||
147527491|NCT00302731|532084287|FG000|Overall Study|Lost to Follow-up|1|||
147527492|NCT00302731|532084288|FG001|Overall Study|Lost to Follow-up|2|||
147527493|NCT00302731|532084289|FG002|Overall Study|Lost to Follow-up|0|||
147527494|NCT00302731|532084290|FG003|Overall Study|Lost to Follow-up|0|||
147527495|NCT00302731|532084287|FG000|Overall Study|Adverse Event|0|||
147527496|NCT00302731|532084288|FG001|Overall Study|Adverse Event|2|||
147527497|NCT00302731|532084289|FG002|Overall Study|Adverse Event|2|||
147527498|NCT00302731|532084290|FG003|Overall Study|Adverse Event|0|||
147527499|NCT00302731|532084287|FG000|Overall Study|Withdrawal by Subject|1|||
147527500|NCT00302731|532084288|FG001|Overall Study|Withdrawal by Subject|1|||
147527501|NCT00302731|532084289|FG002|Overall Study|Withdrawal by Subject|0|||
147527502|NCT00302731|532084290|FG003|Overall Study|Withdrawal by Subject|0|||
147527503|NCT00302731|532084287|FG000|Overall Study|Protocol Violation|1|||
147527504|NCT00302731|532084288|FG001|Overall Study|Protocol Violation|0|||
147527505|NCT00302731|532084289|FG002|Overall Study|Protocol Violation|0|||
147527506|NCT00302731|532084290|FG003|Overall Study|Protocol Violation|0|||
147527507|NCT00302731|532084287|FG000|Overall Study|cancer unrelated to study discovered|1|||
147527508|NCT00302731|532084288|FG001|Overall Study|cancer unrelated to study discovered|0|||
147527509|NCT00302731|532084289|FG002|Overall Study|cancer unrelated to study discovered|1|||
147527510|NCT00302731|532084290|FG003|Overall Study|cancer unrelated to study discovered|0|||
147527511|NCT01610752|532084293|FG000|Overall Study|Miscarriage/Pregnancy loss|0|||
147527512|NCT01610752|532084294|FG001|Overall Study|Miscarriage/Pregnancy loss|0|||
147527513|NCT01610752|532084295|FG002|Overall Study|Miscarriage/Pregnancy loss|4|||
147527514|NCT00283062|532084299|FG000|Overall Study|Did not receive any study medication|5|||
147527515|NCT00283062|532084300|FG001|Overall Study|Did not receive any study medication|4|||
147527516|NCT00283062|532084301|FG002|Overall Study|Did not receive any study medication|36|||
147527517|NCT00283062|532084302|FG003|Overall Study|Did not receive any study medication|45|||
147527518|NCT00283062|532084299|FG000|Overall Study|Adverse Event|2|||
147527519|NCT00283062|532084300|FG001|Overall Study|Adverse Event|0|||
147527520|NCT00283062|532084301|FG002|Overall Study|Adverse Event|1|||
147527521|NCT00283062|532084302|FG003|Overall Study|Adverse Event|0|||
147527522|NCT00283062|532084299|FG000|Overall Study|Lost to Follow-up|1|||
147527523|NCT00283062|532084300|FG001|Overall Study|Lost to Follow-up|0|||
147527524|NCT00283062|532084301|FG002|Overall Study|Lost to Follow-up|1|||
147527525|NCT00283062|532084302|FG003|Overall Study|Lost to Follow-up|0|||
147527526|NCT00283062|532084299|FG000|Overall Study|Progressive disease|0|||
147527527|NCT00283062|532084300|FG001|Overall Study|Progressive disease|0|||
147527528|NCT00283062|532084301|FG002|Overall Study|Progressive disease|1|||
147527529|NCT00283062|532084302|FG003|Overall Study|Progressive disease|0|||
147527530|NCT00283062|532084299|FG000|Overall Study|Participant did not wish to continue|3|||
147527531|NCT00283062|532084300|FG001|Overall Study|Participant did not wish to continue|2|||
147527532|NCT00283062|532084301|FG002|Overall Study|Participant did not wish to continue|1|||
147527533|NCT00283062|532084302|FG003|Overall Study|Participant did not wish to continue|0|||
147527534|NCT00283062|532084299|FG000|Overall Study|Undefined|0|||
147527535|NCT00283062|532084300|FG001|Overall Study|Undefined|1|||
147527536|NCT00283062|532084301|FG002|Overall Study|Undefined|1|||
147527537|NCT00283062|532084302|FG003|Overall Study|Undefined|4|||
147527538|NCT00283062|532084299|FG000|Overall Study|chemotherapy not completed (cycle 6)|1|||
147527539|NCT00283062|532084300|FG001|Overall Study|chemotherapy not completed (cycle 6)|0|||
147527540|NCT00283062|532084301|FG002|Overall Study|chemotherapy not completed (cycle 6)|0|||
147527541|NCT00283062|532084302|FG003|Overall Study|chemotherapy not completed (cycle 6)|0|||
147527542|NCT03702166|532084303|FG000|Overall Study|Lost to Follow-up|1|||
147527543|NCT03702166|532084303|FG000|Overall Study|Withdrawal by Subject|1|||
147527544|NCT01333865|532084304|FG000|Overall Study|Adverse Event|2|||
147527545|NCT00554229|532084305|FG000|Overall Study|Lost to Follow-up|3|||
147527546|NCT00554229|532084306|FG001|Overall Study|Lost to Follow-up|6|||
147527547|NCT00554229|532084305|FG000|Overall Study|Withdrawal by Subject|29|||
147527548|NCT00554229|532084306|FG001|Overall Study|Withdrawal by Subject|37|||
147527549|NCT00554229|532084305|FG000|Overall Study|Adverse Event|71|||
147527550|NCT00554229|532084306|FG001|Overall Study|Adverse Event|39|||
147527551|NCT00554229|532084305|FG000|Overall Study|Protocol Violation|3|||
147527552|NCT00554229|532084306|FG001|Overall Study|Protocol Violation|3|||
147527553|NCT00554229|532084305|FG000|Overall Study|Reason not otherwise captured, eg; death|119|||
147527554|NCT00554229|532084306|FG001|Overall Study|Reason not otherwise captured, eg; death|140|||
147527555|NCT00554229|532084305|FG000|Overall Study|Randomised but no treatment received|1|||
147527556|NCT00554229|532084306|FG001|Overall Study|Randomised but no treatment received|0|||
147527557|NCT00784836|532084307|FG000|Overall Study|Early Study Termination|3|||
147527558|NCT02613910|532084308|FG000|Overall Study|Termination of study|1|||
147527559|NCT00434876|532084309|FG000|Overall Study|Lost to Follow-up|1|||
147527560|NCT00434876|532084310|FG001|Overall Study|Lost to Follow-up|1|||
147527561|NCT02681094|532086162|FG000|1 -Modified Enrolled Participants Set|Participant decision|7|||
147527562|NCT02681094|532086163|FG001|1 -Modified Enrolled Participants Set|Participant decision|10|||
147527563|NCT02681094|532086164|FG002|1 -Modified Enrolled Participants Set|Participant decision|9|||
147527564|NCT02681094|532086162|FG000|1 -Modified Enrolled Participants Set|Adverse Event|10|||
147527565|NCT02681094|532086163|FG001|1 -Modified Enrolled Participants Set|Adverse Event|4|||
147527566|NCT02681094|532086164|FG002|1 -Modified Enrolled Participants Set|Adverse Event|1|||
147527567|NCT02681094|532086162|FG000|1 -Modified Enrolled Participants Set|Severe non-compliance to protocol|2|||
147527568|NCT02681094|532086163|FG001|1 -Modified Enrolled Participants Set|Severe non-compliance to protocol|0|||
147527569|NCT02681094|532086164|FG002|1 -Modified Enrolled Participants Set|Severe non-compliance to protocol|1|||
147527570|NCT02681094|532086162|FG000|1 -Modified Enrolled Participants Set|Lack of therapeutic response|1|||
147527571|NCT02681094|532086163|FG001|1 -Modified Enrolled Participants Set|Lack of therapeutic response|5|||
147527572|NCT02681094|532086164|FG002|1 -Modified Enrolled Participants Set|Lack of therapeutic response|14|||
147527573|NCT02681094|532086162|FG000|1 -Modified Enrolled Participants Set|Study-specific discontinuation criteria|11|||
147527574|NCT02681094|532086163|FG001|1 -Modified Enrolled Participants Set|Study-specific discontinuation criteria|13|||
147527575|NCT02681094|532086164|FG002|1 -Modified Enrolled Participants Set|Study-specific discontinuation criteria|20|||
147527576|NCT02681094|532086162|FG000|1 -Modified Enrolled Participants Set|Other|6|||
147527577|NCT02681094|532086163|FG001|1 -Modified Enrolled Participants Set|Other|6|||
147527578|NCT02681094|532086164|FG002|1 -Modified Enrolled Participants Set|Other|7|||
147527579|NCT02681094|532086162|FG000|1 -Modified Enrolled Participants Set|No treatment given|0|||
147527580|NCT02681094|532086163|FG001|1 -Modified Enrolled Participants Set|No treatment given|1|||
147527581|NCT02681094|532086164|FG002|1 -Modified Enrolled Participants Set|No treatment given|1|||
147527582|NCT02681094|532086162|FG000|2 - Enrolled Participants Set|Participant decision|7|||
147527583|NCT02681094|532086163|FG001|2 - Enrolled Participants Set|Participant decision|10|||
147527584|NCT02681094|532086164|FG002|2 - Enrolled Participants Set|Participant decision|9|||
147527585|NCT02681094|532086162|FG000|2 - Enrolled Participants Set|Adverse Event|10|||
147527586|NCT02681094|532086163|FG001|2 - Enrolled Participants Set|Adverse Event|4|||
147527587|NCT02681094|532086164|FG002|2 - Enrolled Participants Set|Adverse Event|1|||
147527588|NCT02681094|532086162|FG000|2 - Enrolled Participants Set|Severe non-compliance to protocol|2|||
147527589|NCT02681094|532086163|FG001|2 - Enrolled Participants Set|Severe non-compliance to protocol|0|||
147527590|NCT02681094|532086164|FG002|2 - Enrolled Participants Set|Severe non-compliance to protocol|1|||
147527591|NCT02681094|532086162|FG000|2 - Enrolled Participants Set|Lack of therapeutic response|1|||
147527592|NCT02681094|532086163|FG001|2 - Enrolled Participants Set|Lack of therapeutic response|5|||
147527593|NCT02681094|532086164|FG002|2 - Enrolled Participants Set|Lack of therapeutic response|14|||
147527594|NCT02681094|532086162|FG000|2 - Enrolled Participants Set|Study specific discontinuation criteria|14|||
147527595|NCT02681094|532086163|FG001|2 - Enrolled Participants Set|Study specific discontinuation criteria|15|||
147527596|NCT02681094|532086164|FG002|2 - Enrolled Participants Set|Study specific discontinuation criteria|21|||
147527597|NCT02681094|532086162|FG000|2 - Enrolled Participants Set|Other|6|||
147527598|NCT02681094|532086163|FG001|2 - Enrolled Participants Set|Other|6|||
147527599|NCT02681094|532086164|FG002|2 - Enrolled Participants Set|Other|7|||
147527600|NCT02681094|532086162|FG000|2 - Enrolled Participants Set|No treatment given|0|||
147527601|NCT02681094|532086163|FG001|2 - Enrolled Participants Set|No treatment given|1|||
147527602|NCT02681094|532086164|FG002|2 - Enrolled Participants Set|No treatment given|1|||
147527603|NCT02210559|532086167|FG000|Overall Study|Progressive Disease|3|||
147527604|NCT02210559|532086168|FG001|Overall Study|Progressive Disease|2|||
147527605|NCT02210559|532086167|FG000|Overall Study|Adverse Event|2|||
147527606|NCT02210559|532086168|FG001|Overall Study|Adverse Event|2|||
147527607|NCT02210559|532086167|FG000|Overall Study|Physician Decision|1|||
147527608|NCT02210559|532086168|FG001|Overall Study|Physician Decision|0|||
147527609|NCT02210559|532086167|FG000|Overall Study|Withdrawal by Subject|0|||
147527610|NCT02210559|532086168|FG001|Overall Study|Withdrawal by Subject|1|||
147527611|NCT02210559|532086167|FG000|Overall Study|Other than specified|0|||
147527612|NCT02210559|532086168|FG001|Overall Study|Other than specified|1|||
147527613|NCT02546193|532086169|FG000|Overall Study|Withdrawal by Subject|2|||
147527614|NCT02546193|532086170|FG001|Overall Study|Withdrawal by Subject|0|||
147527615|NCT02546193|532086171|FG002|Overall Study|Withdrawal by Subject|1|||
147527616|NCT02546193|532086172|FG003|Overall Study|Withdrawal by Subject|0|||
147527617|NCT02546193|532086169|FG000|Overall Study|Not eligible at time of induction|4|||
147527618|NCT02546193|532086170|FG001|Overall Study|Not eligible at time of induction|6|||
147527619|NCT02546193|532086171|FG002|Overall Study|Not eligible at time of induction|1|||
147527620|NCT02546193|532086172|FG003|Overall Study|Not eligible at time of induction|0|||
147527621|NCT00310440|532086173|FG000|Overall Study|Lost to Follow-up|17|||
147527622|NCT00310440|532086174|FG001|Overall Study|Lost to Follow-up|8|||
147527623|NCT00310440|532086173|FG000|Overall Study|Withdrawal by Subject|2|||
147527624|NCT00310440|532086174|FG001|Overall Study|Withdrawal by Subject|1|||
147527625|NCT00310440|532086173|FG000|Overall Study|Missed 12 Month Visit|7|||
147527626|NCT00310440|532086174|FG001|Overall Study|Missed 12 Month Visit|4|||
147527627|NCT01287403|532086175|FG000|1st Intervention (1 Day)|Adverse Event|1|||
147527628|NCT00148109|532086176|FG000|Overall Study|Lack of Efficacy|10|||
147527629|NCT00148109|532086177|FG001|Overall Study|Lack of Efficacy|18|||
147527630|NCT00148109|532086176|FG000|Overall Study|Adverse Event|0|||
147527631|NCT00148109|532086177|FG001|Overall Study|Adverse Event|2|||
147527632|NCT00148109|532086176|FG000|Overall Study|Withdrawal by Subject|2|||
147527633|NCT00148109|532086177|FG001|Overall Study|Withdrawal by Subject|0|||
147527634|NCT01098266|532086178|FG000|Overall Study|Physician Decision|1|||
147527635|NCT01098266|532086179|FG001|Overall Study|Physician Decision|0|||
147527636|NCT01098266|532086178|FG000|Overall Study|Death|3|||
147527637|NCT01098266|532086179|FG001|Overall Study|Death|2|||
147527638|NCT01098266|532086178|FG000|Overall Study|Withdrawal by Subject|3|||
147527639|NCT01098266|532086179|FG001|Overall Study|Withdrawal by Subject|5|||
147527640|NCT01733758|532086180|FG000|Overall Study|Adverse Event|5|||
147527641|NCT01733758|532086181|FG001|Overall Study|Adverse Event|7|||
147527642|NCT01733758|532086182|FG002|Overall Study|Adverse Event|8|||
147527643|NCT01733758|532086183|FG003|Overall Study|Adverse Event|1|||
147527644|NCT01733758|532086180|FG000|Overall Study|Withdrawal by Subject|1|||
147527645|NCT01733758|532086181|FG001|Overall Study|Withdrawal by Subject|1|||
147527646|NCT01733758|532086182|FG002|Overall Study|Withdrawal by Subject|5|||
147527647|NCT01733758|532086183|FG003|Overall Study|Withdrawal by Subject|3|||
147527648|NCT01733758|532086180|FG000|Overall Study|Persistent Hyperglycemia|3|||
147527649|NCT01733758|532086181|FG001|Overall Study|Persistent Hyperglycemia|2|||
147527650|NCT01733758|532086182|FG002|Overall Study|Persistent Hyperglycemia|0|||
147527651|NCT01733758|532086183|FG003|Overall Study|Persistent Hyperglycemia|0|||
147527652|NCT01733758|532086180|FG000|Overall Study|Protocol Violation|0|||
147527653|NCT01733758|532086181|FG001|Overall Study|Protocol Violation|1|||
147527654|NCT01733758|532086182|FG002|Overall Study|Protocol Violation|2|||
147527655|NCT01733758|532086183|FG003|Overall Study|Protocol Violation|2|||
147527656|NCT01733758|532086180|FG000|Overall Study|Non-compliance|1|||
147527657|NCT01733758|532086181|FG001|Overall Study|Non-compliance|0|||
147527658|NCT01733758|532086182|FG002|Overall Study|Non-compliance|0|||
147527659|NCT01733758|532086183|FG003|Overall Study|Non-compliance|0|||
147527660|NCT01733758|532086180|FG000|Overall Study|Intro of New Anti-Diabetic Medication|4|||
147527661|NCT01733758|532086181|FG001|Overall Study|Intro of New Anti-Diabetic Medication|0|||
147527662|NCT01733758|532086182|FG002|Overall Study|Intro of New Anti-Diabetic Medication|0|||
147527663|NCT01733758|532086183|FG003|Overall Study|Intro of New Anti-Diabetic Medication|1|||
147527664|NCT01733758|532086180|FG000|Overall Study|Inv Decision, HbA1c not controlled|1|||
147527665|NCT01733758|532086181|FG001|Overall Study|Inv Decision, HbA1c not controlled|1|||
147527666|NCT01733758|532086182|FG002|Overall Study|Inv Decision, HbA1c not controlled|0|||
147527667|NCT01733758|532086183|FG003|Overall Study|Inv Decision, HbA1c not controlled|1|||
147527668|NCT02557308|532086184|FG000|Overall Study|Withdrawal by Subject|11|||
147527669|NCT02557308|532086185|FG001|Overall Study|Withdrawal by Subject|3|||
147527670|NCT02557308|532086186|FG002|Overall Study|Withdrawal by Subject|2|||
147527671|NCT02557308|532086187|FG003|Overall Study|Withdrawal by Subject|0|||
147527672|NCT02557308|532086188|FG004|Overall Study|Withdrawal by Subject|1|||
147527673|NCT02557308|532086189|FG005|Overall Study|Withdrawal by Subject|0|||
147527674|NCT02557308|532086190|FG006|Overall Study|Withdrawal by Subject|10|||
147527675|NCT02557308|532086191|FG007|Overall Study|Withdrawal by Subject|1|||
147527676|NCT02557308|532086184|FG000|Overall Study|Disease Progression|0|||
147527677|NCT02557308|532086185|FG001|Overall Study|Disease Progression|1|||
147527678|NCT02557308|532086186|FG002|Overall Study|Disease Progression|0|||
147527679|NCT02557308|532086187|FG003|Overall Study|Disease Progression|0|||
147527680|NCT02557308|532086188|FG004|Overall Study|Disease Progression|0|||
147527681|NCT02557308|532086189|FG005|Overall Study|Disease Progression|0|||
147527682|NCT02557308|532086190|FG006|Overall Study|Disease Progression|0|||
147527683|NCT02557308|532086191|FG007|Overall Study|Disease Progression|0|||
147527684|NCT02557308|532086184|FG000|Overall Study|Lack of Efficacy|3|||
147527685|NCT02557308|532086185|FG001|Overall Study|Lack of Efficacy|0|||
147527686|NCT02557308|532086186|FG002|Overall Study|Lack of Efficacy|0|||
147527687|NCT02557308|532086187|FG003|Overall Study|Lack of Efficacy|0|||
147527688|NCT02557308|532086188|FG004|Overall Study|Lack of Efficacy|0|||
147527689|NCT02557308|532086189|FG005|Overall Study|Lack of Efficacy|0|||
147527690|NCT02557308|532086190|FG006|Overall Study|Lack of Efficacy|1|||
147527691|NCT02557308|532086191|FG007|Overall Study|Lack of Efficacy|0|||
147527692|NCT02557308|532086184|FG000|Overall Study|Adverse Event|4|||
147527693|NCT02557308|532086185|FG001|Overall Study|Adverse Event|1|||
147527694|NCT02557308|532086186|FG002|Overall Study|Adverse Event|2|||
147527695|NCT02557308|532086187|FG003|Overall Study|Adverse Event|0|||
147527696|NCT02557308|532086188|FG004|Overall Study|Adverse Event|0|||
147527697|NCT02557308|532086189|FG005|Overall Study|Adverse Event|0|||
147527698|NCT02557308|532086190|FG006|Overall Study|Adverse Event|4|||
147527699|NCT02557308|532086191|FG007|Overall Study|Adverse Event|1|||
147527700|NCT02557308|532086184|FG000|Overall Study|Lost to Follow-up|2|||
147527701|NCT02557308|532086185|FG001|Overall Study|Lost to Follow-up|0|||
147527702|NCT02557308|532086186|FG002|Overall Study|Lost to Follow-up|1|||
147527703|NCT02557308|532086187|FG003|Overall Study|Lost to Follow-up|0|||
147527704|NCT02557308|532086188|FG004|Overall Study|Lost to Follow-up|0|||
147527705|NCT02557308|532086189|FG005|Overall Study|Lost to Follow-up|0|||
147527706|NCT02557308|532086190|FG006|Overall Study|Lost to Follow-up|2|||
147527707|NCT02557308|532086191|FG007|Overall Study|Lost to Follow-up|0|||
147527708|NCT02557308|532086184|FG000|Overall Study|Death|1|||
147527709|NCT02557308|532086185|FG001|Overall Study|Death|0|||
147527710|NCT02557308|532086186|FG002|Overall Study|Death|0|||
147527711|NCT02557308|532086187|FG003|Overall Study|Death|0|||
147527712|NCT02557308|532086188|FG004|Overall Study|Death|0|||
147527713|NCT02557308|532086189|FG005|Overall Study|Death|0|||
147527714|NCT02557308|532086190|FG006|Overall Study|Death|0|||
147527715|NCT02557308|532086191|FG007|Overall Study|Death|0|||
147527716|NCT02557308|532086184|FG000|Overall Study|Study Close|98|||
147527717|NCT02557308|532086185|FG001|Overall Study|Study Close|18|||
147527718|NCT02557308|532086186|FG002|Overall Study|Study Close|5|||
147527719|NCT02557308|532086187|FG003|Overall Study|Study Close|3|||
147527720|NCT02557308|532086188|FG004|Overall Study|Study Close|1|||
147527721|NCT02557308|532086189|FG005|Overall Study|Study Close|0|||
147527722|NCT02557308|532086190|FG006|Overall Study|Study Close|123|||
147527723|NCT02557308|532086191|FG007|Overall Study|Study Close|5|||
147527724|NCT02557308|532086184|FG000|Overall Study|Except for study close|5|||
147527725|NCT02557308|532086185|FG001|Overall Study|Except for study close|0|||
147527726|NCT02557308|532086186|FG002|Overall Study|Except for study close|0|||
147527727|NCT02557308|532086187|FG003|Overall Study|Except for study close|0|||
147527728|NCT02557308|532086188|FG004|Overall Study|Except for study close|3|||
147527729|NCT02557308|532086189|FG005|Overall Study|Except for study close|0|||
147527730|NCT02557308|532086190|FG006|Overall Study|Except for study close|6|||
147527731|NCT02557308|532086191|FG007|Overall Study|Except for study close|10|||
147527732|NCT03911401|532086194|FG000|Overall Study|Adverse Event|1|||
147527733|NCT03911401|532086195|FG001|Overall Study|Adverse Event|2|||
147527734|NCT03911401|532086196|FG002|Overall Study|Adverse Event|5|||
147527735|NCT03911401|532086194|FG000|Overall Study|Lack of Efficacy|1|||
147527736|NCT03911401|532086195|FG001|Overall Study|Lack of Efficacy|1|||
147527737|NCT03911401|532086196|FG002|Overall Study|Lack of Efficacy|8|||
147527738|NCT03911401|532086194|FG000|Overall Study|Physician Decision|0|||
147527739|NCT03911401|532086195|FG001|Overall Study|Physician Decision|0|||
147527740|NCT03911401|532086196|FG002|Overall Study|Physician Decision|1|||
147527741|NCT03911401|532086194|FG000|Overall Study|Withdrawal by Subject|1|||
147527742|NCT03911401|532086195|FG001|Overall Study|Withdrawal by Subject|2|||
147527743|NCT03911401|532086196|FG002|Overall Study|Withdrawal by Subject|0|||
147527744|NCT03911401|532086194|FG000|Overall Study|Withdrawal by parent/guardian|4|||
147527745|NCT03911401|532086195|FG001|Overall Study|Withdrawal by parent/guardian|4|||
147527746|NCT03911401|532086196|FG002|Overall Study|Withdrawal by parent/guardian|11|||
147527747|NCT02918968|532086197|FG000|1st Line AAT|Progressive disease|9|||
147527748|NCT02918968|532086198|FG001|1st Line AAT|Progressive disease|4|||
147527749|NCT02918968|532086197|FG000|1st Line AAT|Adverse Event|12|||
147527750|NCT02918968|532086198|FG001|1st Line AAT|Adverse Event|3|||
147527751|NCT02918968|532086197|FG000|1st Line AAT|Physician Decision|4|||
147527752|NCT02918968|532086198|FG001|1st Line AAT|Physician Decision|2|||
147527753|NCT02918968|532086197|FG000|1st Line AAT|Withdrawal by Subject|2|||
147527754|NCT02918968|532086198|FG001|1st Line AAT|Withdrawal by Subject|1|||
147527755|NCT02918968|532086197|FG000|1st Line AAT|Lost to Follow-up|0|||
147527756|NCT02918968|532086198|FG001|1st Line AAT|Lost to Follow-up|1|||
147527757|NCT02918968|532086197|FG000|1st Line AAT|Death|1|||
147527758|NCT02918968|532086198|FG001|1st Line AAT|Death|0|||
147527759|NCT02918968|532086197|FG000|1st Line AAT|Miscellaneous|1|||
147527760|NCT02918968|532086198|FG001|1st Line AAT|Miscellaneous|0|||
147527761|NCT02918968|532086197|FG000|2nd Line AAT|Progressive disease|21|||
147527762|NCT02918968|532086198|FG001|2nd Line AAT|Progressive disease|3|||
147527763|NCT02918968|532086197|FG000|2nd Line AAT|Adverse Event|2|||
147527764|NCT02918968|532086198|FG001|2nd Line AAT|Adverse Event|5|||
147527765|NCT02918968|532086197|FG000|2nd Line AAT|Physician Decision|0|||
147527766|NCT02918968|532086198|FG001|2nd Line AAT|Physician Decision|1|||
147527767|NCT02918968|532086197|FG000|2nd Line AAT|Withdrawal by Subject|2|||
147527768|NCT02918968|532086198|FG001|2nd Line AAT|Withdrawal by Subject|2|||
147527769|NCT02918968|532086197|FG000|2nd Line AAT|Death|0|||
147527770|NCT02918968|532086198|FG001|2nd Line AAT|Death|1|||
147527771|NCT01589185|532086199|FG000|Overall Study|Death|1|||
147527772|NCT01589185|532086200|FG001|Overall Study|Death|2|||
147527773|NCT01589185|532086201|FG002|Overall Study|Death|2|||
147527774|NCT01589185|532086202|FG003|Overall Study|Death|0|||
147527775|NCT01589185|532086203|FG004|Overall Study|Death|1|||
147527776|NCT01589185|532086199|FG000|Overall Study|Lost to Follow-up|1|||
147527777|NCT01589185|532086200|FG001|Overall Study|Lost to Follow-up|0|||
147527778|NCT01589185|532086201|FG002|Overall Study|Lost to Follow-up|2|||
147527779|NCT01589185|532086202|FG003|Overall Study|Lost to Follow-up|3|||
147527780|NCT01589185|532086203|FG004|Overall Study|Lost to Follow-up|0|||
147527781|NCT00917553|532086206|FG000|Overall Study|Lost to Follow-up|2|||
147527782|NCT00917553|532086207|FG001|Overall Study|Lost to Follow-up|1|||
147527783|NCT01616173|532086208|FG000|Overall Study|Lost to Follow-up|0|||
147527784|NCT01616173|532086209|FG001|Overall Study|Lost to Follow-up|2|||
147527785|NCT01616173|532086210|FG002|Overall Study|Lost to Follow-up|0|||
147527786|NCT03172026|532086215|FG000|Overall Study|Withdrawal by Subject|1|||
147527787|NCT03172026|532086216|FG001|Overall Study|Withdrawal by Subject|0|||
147527788|NCT03172026|532086215|FG000|Overall Study|COVID restrictions|1|||
147527789|NCT03172026|532086216|FG001|Overall Study|COVID restrictions|0|||
147527790|NCT00504595|532086218|FG000|Overall Study|Lack of Efficacy|1|||
147527791|NCT00504595|532086219|FG001|Overall Study|Lack of Efficacy|0|||
147527792|NCT00504595|532086220|FG002|Overall Study|Lack of Efficacy|0|||
147527793|NCT00504595|532086221|FG003|Overall Study|Lack of Efficacy|0|||
147527794|NCT00504595|532086218|FG000|Overall Study|Other|0|||
147527795|NCT00504595|532086219|FG001|Overall Study|Other|0|||
147527796|NCT00504595|532086220|FG002|Overall Study|Other|2|||
147527797|NCT00504595|532086221|FG003|Overall Study|Other|0|||
147527798|NCT01177943|532086222|FG000|First Intervention|Withdrawal by Subject|2|||
147527799|NCT01177943|532086223|FG001|First Intervention|Withdrawal by Subject|0|||
147527800|NCT04652245|532086224|FG000|Wash-Out Period|Adverse Event|0|||
147527801|NCT04652245|532086225|FG001|Wash-Out Period|Adverse Event|2|||
147527802|NCT04652245|532086224|FG000|Wash-Out Period|Withdrawal by Subject|0|||
147527803|NCT04652245|532086225|FG001|Wash-Out Period|Withdrawal by Subject|2|||
147527804|NCT04047472|532086230|FG000|Overall Study|Adverse Event|3|||
147527805|NCT04047472|532086231|FG001|Overall Study|Adverse Event|3|||
147527806|NCT04047472|532086230|FG000|Overall Study|Death|0|||
147527807|NCT04047472|532086231|FG001|Overall Study|Death|1|||
147527808|NCT04047472|532086230|FG000|Overall Study|Lost to Follow-up|1|||
147527809|NCT04047472|532086231|FG001|Overall Study|Lost to Follow-up|0|||
147527810|NCT04047472|532086230|FG000|Overall Study|Physician Decision|1|||
147527811|NCT04047472|532086231|FG001|Overall Study|Physician Decision|2|||
147527812|NCT04047472|532086230|FG000|Overall Study|Protocol Violation|1|||
147527813|NCT04047472|532086231|FG001|Overall Study|Protocol Violation|0|||
147527814|NCT04047472|532086230|FG000|Overall Study|Withdrawal by Subject|10|||
147527815|NCT04047472|532086231|FG001|Overall Study|Withdrawal by Subject|10|||
147527816|NCT01303159|532086232|FG000|Overall Study|Death|16|||
147527817|NCT01303159|532086232|FG000|Overall Study|Study Termination|7|||
147527818|NCT01016912|532086233|FG000|End of Treatment Period|Lack of Efficacy|0|||
147527819|NCT01016912|532086234|FG001|End of Treatment Period|Lack of Efficacy|1|||
147527820|NCT01016912|532086235|FG002|End of Treatment Period|Lack of Efficacy|0|||
147527821|NCT01016912|532086236|FG003|End of Treatment Period|Lack of Efficacy|4|||
147527822|NCT01016912|532086237|FG004|End of Treatment Period|Lack of Efficacy|4|||
147527823|NCT01016912|532086233|FG000|End of Treatment Period|Adverse Event|0|||
147527824|NCT01016912|532086234|FG001|End of Treatment Period|Adverse Event|1|||
147527825|NCT01016912|532086235|FG002|End of Treatment Period|Adverse Event|1|||
147527826|NCT01016912|532086236|FG003|End of Treatment Period|Adverse Event|0|||
147527827|NCT01016912|532086237|FG004|End of Treatment Period|Adverse Event|0|||
147527828|NCT01016912|532086233|FG000|End of Treatment Period|Completed double-blind period only|0|||
147527829|NCT01016912|532086234|FG001|End of Treatment Period|Completed double-blind period only|1|||
147527830|NCT01016912|532086235|FG002|End of Treatment Period|Completed double-blind period only|0|||
147527831|NCT01016912|532086236|FG003|End of Treatment Period|Completed double-blind period only|0|||
147527832|NCT01016912|532086237|FG004|End of Treatment Period|Completed double-blind period only|0|||
147527833|NCT01016912|532086233|FG000|Follow-up Period|Other reason|0|||
147527834|NCT01016912|532086234|FG001|Follow-up Period|Other reason|0|||
147527835|NCT01016912|532086235|FG002|Follow-up Period|Other reason|1|||
147527836|NCT01016912|532086236|FG003|Follow-up Period|Other reason|1|||
147527837|NCT01016912|532086237|FG004|Follow-up Period|Other reason|0|||
147527838|NCT00914940|532086241|FG000|D0 to D100 Post-transplant|Death|2|||
147527839|NCT00914940|532086241|FG000|D101 to 2 Years Post-transplant|Death|8|||
147527840|NCT00914940|532086241|FG000|2 Years to 5 Years Post-transplant|Death|3|||
147527841|NCT00496782|532086242|FG000|Overall Study|Protocol Violation|1|||
147527842|NCT00496782|532086243|FG001|Overall Study|Protocol Violation|2|||
147527843|NCT00760994|532086248|FG000|Overall Study|Lost to Follow-up|4|||
147527844|NCT00760994|532086249|FG001|Overall Study|Lost to Follow-up|4|||
147527845|NCT00760994|532086250|FG002|Overall Study|Lost to Follow-up|3|||
147527846|NCT01288911|532086251|FG000|Double-blind Period|Death|11|||
147527847|NCT01288911|532086252|FG001|Double-blind Period|Death|7|||
147527848|NCT01288911|532086251|FG000|Double-blind Period|Lost to Follow-up|0|||
147527849|NCT01288911|532086252|FG001|Double-blind Period|Lost to Follow-up|2|||
147527850|NCT01288911|532086251|FG000|Double-blind Period|Progressive Disease|75|||
147527851|NCT01288911|532086252|FG001|Double-blind Period|Progressive Disease|103|||
147527852|NCT01288911|532086251|FG000|Double-blind Period|Protocol Violation|1|||
147527853|NCT01288911|532086252|FG001|Double-blind Period|Protocol Violation|0|||
147527854|NCT01288911|532086251|FG000|Double-blind Period|Withdrawal by Subject|25|||
147527855|NCT01288911|532086252|FG001|Double-blind Period|Withdrawal by Subject|26|||
147527856|NCT01288911|532086251|FG000|Double-blind Period|Miscellaneous Reason|29|||
147527857|NCT01288911|532086252|FG001|Double-blind Period|Miscellaneous Reason|42|||
147527858|NCT01288911|532086251|FG000|Double-blind Period|Randomized but never received study drug|1|||
147527859|NCT01288911|532086252|FG001|Double-blind Period|Randomized but never received study drug|2|||
147527860|NCT01288911|532086251|FG000|Open-label Period (All Enzalutamide)|Death|0|||
147527861|NCT01288911|532086252|FG001|Open-label Period (All Enzalutamide)|Death|1|||
147527862|NCT01288911|532086251|FG000|Open-label Period (All Enzalutamide)|Lost to Follow-up|1|||
147527863|NCT01288911|532086252|FG001|Open-label Period (All Enzalutamide)|Lost to Follow-up|0|||
147527864|NCT01288911|532086251|FG000|Open-label Period (All Enzalutamide)|Progressive disease|18|||
147527865|NCT01288911|532086252|FG001|Open-label Period (All Enzalutamide)|Progressive disease|3|||
147527866|NCT01288911|532086251|FG000|Open-label Period (All Enzalutamide)|Withdrawal by Subject|1|||
147527867|NCT01288911|532086252|FG001|Open-label Period (All Enzalutamide)|Withdrawal by Subject|0|||
147527868|NCT01288911|532086251|FG000|Open-label Period (All Enzalutamide)|Miscellaneous Reason|5|||
147527869|NCT01288911|532086252|FG001|Open-label Period (All Enzalutamide)|Miscellaneous Reason|0|||
147527870|NCT01288911|532086251|FG000|Open-label Period (All Enzalutamide)|Transitioned to 9785-CL-0123 NCT02960022|17|||
147527871|NCT01288911|532086252|FG001|Open-label Period (All Enzalutamide)|Transitioned to 9785-CL-0123 NCT02960022|5|||
147527872|NCT02431559|532086253|FG000|Overall Study|Adverse Event|0|||
147527873|NCT02431559|532086254|FG001|Overall Study|Adverse Event|1|||
147527874|NCT02431559|532086255|FG002|Overall Study|Adverse Event|0|||
147527875|NCT02431559|532086256|FG003|Overall Study|Adverse Event|4|||
147527876|NCT02431559|532086253|FG000|Overall Study|Progressive disease|2|||
147527877|NCT02431559|532086254|FG001|Overall Study|Progressive disease|1|||
147527878|NCT02431559|532086255|FG002|Overall Study|Progressive disease|4|||
147527879|NCT02431559|532086256|FG003|Overall Study|Progressive disease|22|||
147527880|NCT02431559|532086253|FG000|Overall Study|Withdrawal by Subject|0|||
147527881|NCT02431559|532086254|FG001|Overall Study|Withdrawal by Subject|1|||
147527882|NCT02431559|532086255|FG002|Overall Study|Withdrawal by Subject|0|||
147527883|NCT02431559|532086256|FG003|Overall Study|Withdrawal by Subject|4|||
147527884|NCT02431559|532086253|FG000|Overall Study|Physician Decision|0|||
147527885|NCT02431559|532086254|FG001|Overall Study|Physician Decision|0|||
147527886|NCT02431559|532086255|FG002|Overall Study|Physician Decision|0|||
147527887|NCT02431559|532086256|FG003|Overall Study|Physician Decision|1|||
147527888|NCT00955682|532086259|FG000|Booster Period (Month 48- 49)|Lost to Follow-up|1|||
147527889|NCT00955682|532086260|FG001|Booster Period (Month 48- 49)|Lost to Follow-up|1|||
147527890|NCT02260791|532086270|FG000|Overall Study|Lost to Follow-up|4|||
147527891|NCT02260791|532086271|FG001|Overall Study|Lost to Follow-up|4|||
147527892|NCT02260791|532086270|FG000|Overall Study|Lack of Efficacy|2|||
147527893|NCT02260791|532086271|FG001|Overall Study|Lack of Efficacy|1|||
147527894|NCT02260791|532086270|FG000|Overall Study|Adverse Event|13|||
147527895|NCT02260791|532086271|FG001|Overall Study|Adverse Event|9|||
147527896|NCT02260791|532086270|FG000|Overall Study|Death|1|||
147527897|NCT02260791|532086271|FG001|Overall Study|Death|0|||
147527898|NCT02260791|532086270|FG000|Overall Study|Withdrawal by Subject|11|||
147527899|NCT02260791|532086271|FG001|Overall Study|Withdrawal by Subject|16|||
147527900|NCT02260791|532086270|FG000|Overall Study|Screen failure|0|||
147527901|NCT02260791|532086271|FG001|Overall Study|Screen failure|1|||
147527902|NCT02260791|532086270|FG000|Overall Study|Protocol deviation|2|||
147527903|NCT02260791|532086271|FG001|Overall Study|Protocol deviation|3|||
147527904|NCT05047601|532086273|FG000|Overall Study|Lost to Follow-up|9|||
147527905|NCT05047601|532086274|FG001|Overall Study|Lost to Follow-up|11|||
147527906|NCT05047601|532086275|FG002|Overall Study|Lost to Follow-up|7|||
147527907|NCT05047601|532086273|FG000|Overall Study|Withdrawal by Subject|25|||
147527908|NCT05047601|532086274|FG001|Overall Study|Withdrawal by Subject|36|||
147527909|NCT05047601|532086275|FG002|Overall Study|Withdrawal by Subject|23|||
147527910|NCT05047601|532086273|FG000|Overall Study|Other|10|||
147527911|NCT05047601|532086274|FG001|Overall Study|Other|6|||
147527912|NCT05047601|532086275|FG002|Overall Study|Other|5|||
147527913|NCT02924129|532086281|FG000|Overall Study|Adverse Event Unrelated to Device or Stimulation|2|||
147527914|NCT02924129|532086282|FG001|Overall Study|Adverse Event Unrelated to Device or Stimulation|1|||
147527915|NCT02924129|532086281|FG000|Overall Study|Withdrawal by Subject|2|||
147527916|NCT02924129|532086282|FG001|Overall Study|Withdrawal by Subject|2|||
147527917|NCT02924129|532086281|FG000|Overall Study|Physician Decision|1|||
147527918|NCT02924129|532086282|FG001|Overall Study|Physician Decision|0|||
147527919|NCT02924129|532086281|FG000|Overall Study|Missed Visit|0|||
147527920|NCT02924129|532086282|FG001|Overall Study|Missed Visit|1|||
147527921|NCT01000311|532086288|FG000|Overall Study|Adverse Event|2|||
147527922|NCT01000311|532086289|FG001|Overall Study|Adverse Event|5|||
147527923|NCT01000311|532086288|FG000|Overall Study|Withdrawal by Subject|16|||
147527924|NCT01000311|532086289|FG001|Overall Study|Withdrawal by Subject|24|||
147527925|NCT01000311|532086288|FG000|Overall Study|Lost to Follow-up|15|||
147527926|NCT01000311|532086289|FG001|Overall Study|Lost to Follow-up|24|||
147527927|NCT01000311|532086288|FG000|Overall Study|Protocol Violation|1|||
147527928|NCT01000311|532086289|FG001|Overall Study|Protocol Violation|2|||
147527929|NCT01000311|532086288|FG000|Overall Study|Inappropriate enrollment|2|||
147527930|NCT01000311|532086289|FG001|Overall Study|Inappropriate enrollment|0|||
147527931|NCT01000311|532086288|FG000|Overall Study|Administrative reason|9|||
147527932|NCT01000311|532086289|FG001|Overall Study|Administrative reason|15|||
147527933|NCT00252499|532086290|FG000|Overall Study|Lost to Follow-up|1|||
147527934|NCT00252499|532086291|FG001|Overall Study|Lost to Follow-up|0|||
147527935|NCT00252499|532086292|FG002|Overall Study|Lost to Follow-up|0|||
147527936|NCT01535638|532086293|FG000|Treatment 1 (Single Dose)|Protocol Violation|0|||
147527937|NCT01535638|532086294|FG001|Treatment 1 (Single Dose)|Protocol Violation|0|||
147527938|NCT01535638|532086295|FG002|Treatment 1 (Single Dose)|Protocol Violation|0|||
147527939|NCT01535638|532086296|FG003|Treatment 1 (Single Dose)|Protocol Violation|0|||
147527940|NCT01535638|532086297|FG004|Treatment 1 (Single Dose)|Protocol Violation|0|||
147527941|NCT01535638|532086298|FG005|Treatment 1 (Single Dose)|Protocol Violation|1|||
147527942|NCT01535638|532086293|FG000|Treatment 3 (Single Dose)|Protocol Violation|0|||
147527943|NCT01535638|532086294|FG001|Treatment 3 (Single Dose)|Protocol Violation|0|||
147527944|NCT01535638|532086295|FG002|Treatment 3 (Single Dose)|Protocol Violation|0|||
147527945|NCT01535638|532086296|FG003|Treatment 3 (Single Dose)|Protocol Violation|1|||
147527946|NCT01535638|532086297|FG004|Treatment 3 (Single Dose)|Protocol Violation|0|||
147527947|NCT01535638|532086298|FG005|Treatment 3 (Single Dose)|Protocol Violation|0|||
147527948|NCT01365468|532086299|FG000|Overall Study|Physician Decision|1|||
147527949|NCT01365468|532086300|FG001|Overall Study|Physician Decision|0|||
147527950|NCT01365468|532086299|FG000|Overall Study|Disease progression|1|||
147527951|NCT01365468|532086300|FG001|Overall Study|Disease progression|0|||
147527952|NCT01365468|532086299|FG000|Overall Study|Lost to Follow-up|2|||
147527953|NCT01365468|532086300|FG001|Overall Study|Lost to Follow-up|0|||
147527954|NCT01482598|532086301|FG000|Overall Study|Death|7|||
147527955|NCT01482598|532086302|FG001|Overall Study|Death|10|||
147527956|NCT01482598|532086301|FG000|Overall Study|Physician Decision|0|||
147527957|NCT01482598|532086302|FG001|Overall Study|Physician Decision|3|||
147527958|NCT01482598|532086301|FG000|Overall Study|Withdrawal by Subject|4|||
147527959|NCT01482598|532086302|FG001|Overall Study|Withdrawal by Subject|5|||
147527960|NCT01482598|532086301|FG000|Overall Study|Lost to Follow-up|5|||
147527961|NCT01482598|532086302|FG001|Overall Study|Lost to Follow-up|4|||
147527962|NCT00423267|532086303|FG000|Period A|Withdrawal by Subject|0|||
147527963|NCT00423267|532086304|FG001|Period A|Withdrawal by Subject|1|||
147527964|NCT00423267|532086303|FG000|Period A|Non-compliance with protocol|1|||
147527965|NCT00423267|532086304|FG001|Period A|Non-compliance with protocol|0|||
147527966|NCT00423267|532086303|FG000|Period A|Administrative|1|||
147527967|NCT00423267|532086304|FG001|Period A|Administrative|0|||
147527968|NCT00827112|532086305|FG000|Overall Study|Adverse Event|2|||
147527969|NCT00827112|532086306|FG001|Overall Study|Adverse Event|0|||
147527970|NCT00827112|532086305|FG000|Overall Study|Lack of Efficacy|2|||
147527971|NCT00827112|532086306|FG001|Overall Study|Lack of Efficacy|0|||
147527972|NCT00827112|532086305|FG000|Overall Study|Lost to Follow-up|3|||
147527973|NCT00827112|532086306|FG001|Overall Study|Lost to Follow-up|2|||
147527974|NCT00827112|532086305|FG000|Overall Study|Pregnancy|0|||
147527975|NCT00827112|532086306|FG001|Overall Study|Pregnancy|1|||
147527976|NCT00827112|532086305|FG000|Overall Study|Protocol Violation|0|||
147527977|NCT00827112|532086306|FG001|Overall Study|Protocol Violation|2|||
147527978|NCT00827112|532086305|FG000|Overall Study|Withdrawal by Subject|2|||
147527979|NCT00827112|532086306|FG001|Overall Study|Withdrawal by Subject|1|||
147527980|NCT00827112|532086305|FG000|Overall Study|Randomized but not treated|5|||
147527981|NCT00827112|532086306|FG001|Overall Study|Randomized but not treated|3|||
147527982|NCT00827112|532086305|FG000|Overall Study|Other|1|||
147527983|NCT00827112|532086306|FG001|Overall Study|Other|3|||
147527984|NCT01521494|532086311|FG000|Overall Study|Adverse Event|1|||
147527985|NCT01521494|532086312|FG001|Overall Study|Adverse Event|2|||
147527986|NCT01521494|532086313|FG002|Overall Study|Adverse Event|9|||
147527987|NCT01521494|532086314|FG003|Overall Study|Adverse Event|6|||
147527988|NCT01521494|532086315|FG004|Overall Study|Adverse Event|2|||
147527989|NCT01521494|532086311|FG000|Overall Study|Lack of Efficacy|0|||
147527990|NCT01521494|532086312|FG001|Overall Study|Lack of Efficacy|0|||
147527991|NCT01521494|532086313|FG002|Overall Study|Lack of Efficacy|0|||
147527992|NCT01521494|532086314|FG003|Overall Study|Lack of Efficacy|0|||
147527993|NCT01521494|532086315|FG004|Overall Study|Lack of Efficacy|2|||
147527994|NCT01521494|532086311|FG000|Overall Study|Withdrawal by Subject|1|||
147527995|NCT01521494|532086312|FG001|Overall Study|Withdrawal by Subject|1|||
147527996|NCT01521494|532086313|FG002|Overall Study|Withdrawal by Subject|0|||
147527997|NCT01521494|532086314|FG003|Overall Study|Withdrawal by Subject|2|||
147527998|NCT01521494|532086315|FG004|Overall Study|Withdrawal by Subject|0|||
147527999|NCT01521494|532086311|FG000|Overall Study|Decrease in serum phosphate|0|||
147528000|NCT01521494|532086312|FG001|Overall Study|Decrease in serum phosphate|2|||
147528001|NCT01521494|532086313|FG002|Overall Study|Decrease in serum phosphate|3|||
147528002|NCT01521494|532086314|FG003|Overall Study|Decrease in serum phosphate|12|||
147528003|NCT01521494|532086315|FG004|Overall Study|Decrease in serum phosphate|0|||
147528004|NCT01521494|532086311|FG000|Overall Study|Decrease in serum calcium|0|||
147528005|NCT01521494|532086312|FG001|Overall Study|Decrease in serum calcium|0|||
147528006|NCT01521494|532086313|FG002|Overall Study|Decrease in serum calcium|0|||
147528007|NCT01521494|532086314|FG003|Overall Study|Decrease in serum calcium|1|||
147528008|NCT01521494|532086315|FG004|Overall Study|Decrease in serum calcium|1|||
147528009|NCT01521494|532086311|FG000|Overall Study|Physician Decision|0|||
147528010|NCT01521494|532086312|FG001|Overall Study|Physician Decision|0|||
147528011|NCT01521494|532086313|FG002|Overall Study|Physician Decision|0|||
147528012|NCT01521494|532086314|FG003|Overall Study|Physician Decision|0|||
147528013|NCT01521494|532086315|FG004|Overall Study|Physician Decision|2|||
147528014|NCT00689728|532086316|FG000|Double-Blind Treatment|Adverse Event|1|||
147528015|NCT00689728|532086317|FG001|Double-Blind Treatment|Adverse Event|0|||
147528016|NCT00689728|532086318|FG002|Double-Blind Treatment|Adverse Event|0|||
147528017|NCT00689728|532086316|FG000|Double-Blind Treatment|Protocol Violation|0|||
147528018|NCT00689728|532086317|FG001|Double-Blind Treatment|Protocol Violation|0|||
147528019|NCT00689728|532086318|FG002|Double-Blind Treatment|Protocol Violation|1|||
147528020|NCT00689728|532086316|FG000|Double-Blind Treatment|Withdrawal by Subject|3|||
147528021|NCT00689728|532086317|FG001|Double-Blind Treatment|Withdrawal by Subject|3|||
147528022|NCT00689728|532086318|FG002|Double-Blind Treatment|Withdrawal by Subject|2|||
147528023|NCT00689728|532086316|FG000|Double-Blind Treatment|Lack of Efficacy|0|||
147528024|NCT00689728|532086317|FG001|Double-Blind Treatment|Lack of Efficacy|1|||
147528025|NCT00689728|532086318|FG002|Double-Blind Treatment|Lack of Efficacy|2|||
147528026|NCT00689728|532086316|FG000|Rescue|Adverse Event|0|||
147528027|NCT00689728|532086317|FG001|Rescue|Adverse Event|1|||
147528028|NCT00689728|532086318|FG002|Rescue|Adverse Event|0|||
147528029|NCT00689728|532086316|FG000|Rescue|Withdrawal by Subject|1|||
147528030|NCT00689728|532086317|FG001|Rescue|Withdrawal by Subject|1|||
147528031|NCT00689728|532086318|FG002|Rescue|Withdrawal by Subject|1|||
147528032|NCT00689728|532086316|FG000|Optional Follow-Up|Adverse Event|1|||
147528033|NCT00689728|532086317|FG001|Optional Follow-Up|Adverse Event|0|||
147528034|NCT00689728|532086318|FG002|Optional Follow-Up|Adverse Event|0|||
147528035|NCT00689728|532086316|FG000|Optional Follow-Up|Lack of Efficacy|0|||
147528036|NCT00689728|532086317|FG001|Optional Follow-Up|Lack of Efficacy|1|||
147528037|NCT00689728|532086318|FG002|Optional Follow-Up|Lack of Efficacy|1|||
147528038|NCT00689728|532086316|FG000|Optional Follow-Up|Lost to Follow-up|0|||
147528039|NCT00689728|532086317|FG001|Optional Follow-Up|Lost to Follow-up|1|||
147528040|NCT00689728|532086318|FG002|Optional Follow-Up|Lost to Follow-up|1|||
147528041|NCT00689728|532086316|FG000|Optional Follow-Up|Protocol Violation|0|||
147528042|NCT00689728|532086317|FG001|Optional Follow-Up|Protocol Violation|0|||
147528043|NCT00689728|532086318|FG002|Optional Follow-Up|Protocol Violation|1|||
147528044|NCT00689728|532086316|FG000|Optional Follow-Up|Withdrawal by Subject|2|||
147528045|NCT00689728|532086317|FG001|Optional Follow-Up|Withdrawal by Subject|4|||
147528046|NCT00689728|532086318|FG002|Optional Follow-Up|Withdrawal by Subject|3|||
147528047|NCT00689299|532086321|FG000|Overall Study|Adverse Event|2|||
147528048|NCT00689299|532086322|FG001|Overall Study|Adverse Event|1|||
147528049|NCT00689299|532086323|FG002|Overall Study|Adverse Event|1|||
147528050|NCT00689299|532086321|FG000|Overall Study|Lost to Follow-up|0|||
147528051|NCT00689299|532086322|FG001|Overall Study|Lost to Follow-up|1|||
147528052|NCT00689299|532086323|FG002|Overall Study|Lost to Follow-up|1|||
147528053|NCT00689299|532086321|FG000|Overall Study|Withdrawal by Subject|4|||
147528054|NCT00689299|532086322|FG001|Overall Study|Withdrawal by Subject|1|||
147528055|NCT00689299|532086323|FG002|Overall Study|Withdrawal by Subject|3|||
147528056|NCT00689299|532086321|FG000|Overall Study|Protocol Violation|1|||
147528057|NCT00689299|532086322|FG001|Overall Study|Protocol Violation|0|||
147528058|NCT00689299|532086323|FG002|Overall Study|Protocol Violation|0|||
147528059|NCT00758394|532086324|FG000|2nd Intervention Order|Lost to Follow-up|0|||
147528060|NCT00758394|532086325|FG001|2nd Intervention Order|Lost to Follow-up|1|||
147528061|NCT00758394|532086326|FG002|2nd Intervention Order|Lost to Follow-up|0|||
147528062|NCT00758394|532086327|FG003|2nd Intervention Order|Lost to Follow-up|0|||
147528063|NCT00758394|532086324|FG000|3rd Intervention|Lost to Follow-up|1|||
147528064|NCT00758394|532086325|FG001|3rd Intervention|Lost to Follow-up|0|||
147528065|NCT00758394|532086326|FG002|3rd Intervention|Lost to Follow-up|0|||
147528066|NCT00758394|532086327|FG003|3rd Intervention|Lost to Follow-up|1|||
147528067|NCT01002573|532088531|FG000|Overall Study|Subject did not receive at least 1 dose|11|||
147528068|NCT01002573|532088532|FG001|Overall Study|Subject did not receive at least 1 dose|7|||
147528069|NCT00690612|532088538|FG000|Overall Study|Adverse Event|1|||
147528070|NCT00690612|532088538|FG000|Overall Study|Withdrawal by Subject|2|||
147528071|NCT02926833|532088539|FG000|Overall Study|Death|1|||
147528072|NCT02926833|532088540|FG001|Overall Study|Death|1|||
147528073|NCT02926833|532088541|FG002|Overall Study|Death|2|||
147528074|NCT02926833|532088542|FG003|Overall Study|Death|13|||
147528075|NCT02926833|532088539|FG000|Overall Study|Lost to Follow-up|1|||
147528076|NCT02926833|532088540|FG001|Overall Study|Lost to Follow-up|2|||
147528077|NCT02926833|532088541|FG002|Overall Study|Lost to Follow-up|0|||
147528078|NCT02926833|532088542|FG003|Overall Study|Lost to Follow-up|3|||
147528079|NCT02926833|532088539|FG000|Overall Study|Full Consent Withdrawal|0|||
147528080|NCT02926833|532088540|FG001|Overall Study|Full Consent Withdrawal|0|||
147528081|NCT02926833|532088541|FG002|Overall Study|Full Consent Withdrawal|0|||
147528082|NCT02926833|532088542|FG003|Overall Study|Full Consent Withdrawal|2|||
147528083|NCT02926833|532088539|FG000|Overall Study|Rolled Over to Long-term Follow-up Study|0|||
147528084|NCT02926833|532088540|FG001|Overall Study|Rolled Over to Long-term Follow-up Study|0|||
147528085|NCT02926833|532088541|FG002|Overall Study|Rolled Over to Long-term Follow-up Study|3|||
147528086|NCT02926833|532088542|FG003|Overall Study|Rolled Over to Long-term Follow-up Study|4|||
147528087|NCT02926833|532088539|FG000|Overall Study|Investigator Decision|0|||
147528088|NCT02926833|532088540|FG001|Overall Study|Investigator Decision|1|||
147644042|NCT00738062|532516706|FG002|Open Label Treatment|Investigator Decision|0|||
147644043|NCT00738062|532516704|FG000|Open-Label Extension|Adverse Event|5|||
147644044|NCT00738062|532516705|FG001|Open-Label Extension|Adverse Event|0|||
147644045|NCT00738062|532516706|FG002|Open-Label Extension|Adverse Event|0|||
147644046|NCT00738062|532516704|FG000|Open-Label Extension|Physician Decision|1|||
147644047|NCT00738062|532516705|FG001|Open-Label Extension|Physician Decision|0|||
147644048|NCT00738062|532516706|FG002|Open-Label Extension|Physician Decision|0|||
147644049|NCT00738062|532516704|FG000|Open-Label Extension|Lack of Efficacy|2|||
147644050|NCT00738062|532516705|FG001|Open-Label Extension|Lack of Efficacy|0|||
147644051|NCT00738062|532516706|FG002|Open-Label Extension|Lack of Efficacy|0|||
147644052|NCT00738062|532516704|FG000|Open-Label Extension|Withdrawal by Subject|6|||
147644053|NCT00738062|532516705|FG001|Open-Label Extension|Withdrawal by Subject|0|||
147644054|NCT00738062|532516706|FG002|Open-Label Extension|Withdrawal by Subject|0|||
147528089|NCT02926833|532088541|FG002|Overall Study|Investigator Decision|0|||
147528090|NCT02926833|532088542|FG003|Overall Study|Investigator Decision|0|||
147644055|NCT00738062|532516704|FG000|Open-Label Extension|Protocol Violation|1|||
147644056|NCT00738062|532516705|FG001|Open-Label Extension|Protocol Violation|0|||
147644057|NCT00738062|532516706|FG002|Open-Label Extension|Protocol Violation|0|||
147644058|NCT00738062|532516704|FG000|Open-Label Extension|Study Terminated|2|||
147644059|NCT00738062|532516705|FG001|Open-Label Extension|Study Terminated|0|||
147644060|NCT00738062|532516706|FG002|Open-Label Extension|Study Terminated|0|||
147644061|NCT02772276|532516707|FG000|Overall Study|Lost to Follow-up|0|||
147644062|NCT02772276|532516708|FG001|Overall Study|Lost to Follow-up|0|||
147644063|NCT02772276|532516709|FG002|Overall Study|Lost to Follow-up|0|||
147644064|NCT02772276|532516710|FG003|Overall Study|Lost to Follow-up|0|||
147644065|NCT02772276|532516711|FG004|Overall Study|Lost to Follow-up|0|||
147644066|NCT02772276|532516712|FG005|Overall Study|Lost to Follow-up|0|||
147644067|NCT02772276|532516713|FG006|Overall Study|Lost to Follow-up|1|||
147644068|NCT02772276|532516714|FG007|Overall Study|Lost to Follow-up|0|||
147644069|NCT02772276|532516715|FG008|Overall Study|Lost to Follow-up|0|||
147644070|NCT02772276|532516716|FG009|Overall Study|Lost to Follow-up|0|||
147644071|NCT02772276|532516717|FG010|Overall Study|Lost to Follow-up|0|||
147644072|NCT02772276|532516718|FG011|Overall Study|Lost to Follow-up|0|||
147644073|NCT02772276|532516719|FG012|Overall Study|Lost to Follow-up|0|||
147644074|NCT02772276|532516707|FG000|Overall Study|Withdrew consent|0|||
147644075|NCT02772276|532516708|FG001|Overall Study|Withdrew consent|0|||
147644076|NCT02772276|532516709|FG002|Overall Study|Withdrew consent|0|||
147644077|NCT02772276|532516710|FG003|Overall Study|Withdrew consent|0|||
147644078|NCT02772276|532516711|FG004|Overall Study|Withdrew consent|0|||
147644079|NCT02772276|532516712|FG005|Overall Study|Withdrew consent|0|||
147644080|NCT02772276|532516713|FG006|Overall Study|Withdrew consent|0|||
147644081|NCT02772276|532516714|FG007|Overall Study|Withdrew consent|1|||
147644082|NCT02772276|532516715|FG008|Overall Study|Withdrew consent|0|||
147644083|NCT02772276|532516716|FG009|Overall Study|Withdrew consent|0|||
147644084|NCT02772276|532516717|FG010|Overall Study|Withdrew consent|0|||
147644085|NCT02772276|532516718|FG011|Overall Study|Withdrew consent|0|||
147644086|NCT02772276|532516719|FG012|Overall Study|Withdrew consent|0|||
147644087|NCT02248974|532516720|FG000|1-Day Follow-Up|Lost to Follow-up|4|||
147644088|NCT02248974|532516721|FG001|1-Day Follow-Up|Lost to Follow-up|0|||
147644089|NCT02248974|532516720|FG000|1-Day Follow-Up|Withdrawal by Subject|5|||
147644090|NCT02248974|532516721|FG001|1-Day Follow-Up|Withdrawal by Subject|0|||
147644091|NCT02248974|532516720|FG000|1-Day Follow-Up|Enrolled in another study|1|||
147644092|NCT02248974|532516721|FG001|1-Day Follow-Up|Enrolled in another study|0|||
147644093|NCT02248974|532516720|FG000|1-Week Follow-Up|Became ineligible for LVAD|4|||
147644094|NCT02248974|532516721|FG001|1-Week Follow-Up|Became ineligible for LVAD|1|||
147644095|NCT02248974|532516720|FG000|1-Week Follow-Up|Enrolled in another study|1|||
147644096|NCT02248974|532516721|FG001|1-Week Follow-Up|Enrolled in another study|1|||
147644097|NCT02248974|532516720|FG000|1-Week Follow-Up|Transferred to another facility|1|||
147644098|NCT02248974|532516721|FG001|1-Week Follow-Up|Transferred to another facility|0|||
147644099|NCT02248974|532516720|FG000|1-Week Follow-Up|Cognitive Difficulty|1|||
147644100|NCT02248974|532516721|FG001|1-Week Follow-Up|Cognitive Difficulty|0|||
147644101|NCT02248974|532516720|FG000|1-Week Follow-Up|Death|1|||
147644102|NCT02248974|532516721|FG001|1-Week Follow-Up|Death|1|||
147644103|NCT02248974|532516720|FG000|1-Week Follow-Up|Excluded because of age|0|||
147644104|NCT02248974|532516721|FG001|1-Week Follow-Up|Excluded because of age|1|||
147644105|NCT02248974|532516720|FG000|1-Week Follow-Up|Noncompliant with terms of participation|0|||
147644106|NCT02248974|532516721|FG001|1-Week Follow-Up|Noncompliant with terms of participation|1|||
147644107|NCT02248974|532516720|FG000|1-Week Follow-Up|Timing: implanted before survey|0|||
147644108|NCT02248974|532516721|FG001|1-Week Follow-Up|Timing: implanted before survey|2|||
147644109|NCT02248974|532516720|FG000|1-Week Follow-Up|Withdrawal by Subject|0|||
147644110|NCT02248974|532516721|FG001|1-Week Follow-Up|Withdrawal by Subject|2|||
147644111|NCT02248974|532516720|FG000|1-Week Follow-Up|Lost to Follow-up|0|||
147644112|NCT02248974|532516721|FG001|1-Week Follow-Up|Lost to Follow-up|8|||
147644113|NCT02248974|532516720|FG000|1-Month Follow-Up|Lost to Follow-up|2|||
147644114|NCT02248974|532516721|FG001|1-Month Follow-Up|Lost to Follow-up|3|||
147644115|NCT00894790|532516722|FG000|Overall Study|Protocol Violation|0|||
147528091|NCT02926833|532088539|FG000|Overall Study|Adverse Event|0|||
147528092|NCT02926833|532088540|FG001|Overall Study|Adverse Event|0|||
147528093|NCT02926833|532088541|FG002|Overall Study|Adverse Event|1|||
147644116|NCT00894790|532516723|FG001|Overall Study|Protocol Violation|1|||
147644117|NCT00894790|532516722|FG000|Overall Study|Lost to Follow-up|0|||
147644118|NCT00894790|532516723|FG001|Overall Study|Lost to Follow-up|1|||
147644119|NCT00894790|532516722|FG000|Overall Study|Did not meet entrance criteria|1|||
147644120|NCT00894790|532516723|FG001|Overall Study|Did not meet entrance criteria|0|||
147644121|NCT04093492|532516724|FG000|25 Weeks Gestational Age (GA)|Delivered before assessment|1|||
147644122|NCT04093492|532516725|FG001|25 Weeks Gestational Age (GA)|Delivered before assessment|2|||
147644123|NCT04093492|532516726|FG002|25 Weeks Gestational Age (GA)|Delivered before assessment|0|||
147644124|NCT04093492|532516727|FG003|25 Weeks Gestational Age (GA)|Delivered before assessment|0|||
147644125|NCT04093492|532516724|FG000|25 Weeks Gestational Age (GA)|No response|5|||
147644126|NCT04093492|532516725|FG001|25 Weeks Gestational Age (GA)|No response|5|||
147644127|NCT04093492|532516726|FG002|25 Weeks Gestational Age (GA)|No response|5|||
147644128|NCT04093492|532516727|FG003|25 Weeks Gestational Age (GA)|No response|2|||
147644129|NCT04093492|532516724|FG000|25 Weeks Gestational Age (GA)|Withdrawal by Subject|0|||
147644130|NCT04093492|532516725|FG001|25 Weeks Gestational Age (GA)|Withdrawal by Subject|0|||
147644131|NCT04093492|532516726|FG002|25 Weeks Gestational Age (GA)|Withdrawal by Subject|0|||
147644132|NCT04093492|532516727|FG003|25 Weeks Gestational Age (GA)|Withdrawal by Subject|1|||
147644133|NCT04093492|532516724|FG000|30 Weeks GA|Delivered before assessment|1|||
147644134|NCT04093492|532516725|FG001|30 Weeks GA|Delivered before assessment|2|||
147644135|NCT04093492|532516726|FG002|30 Weeks GA|Delivered before assessment|0|||
147644136|NCT04093492|532516727|FG003|30 Weeks GA|Delivered before assessment|0|||
147644137|NCT04093492|532516724|FG000|30 Weeks GA|No response|7|||
147644138|NCT04093492|532516725|FG001|30 Weeks GA|No response|5|||
147644139|NCT04093492|532516726|FG002|30 Weeks GA|No response|5|||
147644140|NCT04093492|532516727|FG003|30 Weeks GA|No response|2|||
147644141|NCT04093492|532516724|FG000|30 Weeks GA|Lost to Follow-up|0|||
147644142|NCT04093492|532516725|FG001|30 Weeks GA|Lost to Follow-up|1|||
147644143|NCT04093492|532516726|FG002|30 Weeks GA|Lost to Follow-up|0|||
147644144|NCT04093492|532516727|FG003|30 Weeks GA|Lost to Follow-up|0|||
147528094|NCT02926833|532088542|FG003|Overall Study|Adverse Event|0|||
147644145|NCT04093492|532516724|FG000|34 Weeks GA|Delivered before assessment|6|||
147644146|NCT04093492|532516725|FG001|34 Weeks GA|Delivered before assessment|3|||
147644147|NCT04093492|532516726|FG002|34 Weeks GA|Delivered before assessment|0|||
147644148|NCT04093492|532516727|FG003|34 Weeks GA|Delivered before assessment|0|||
147644149|NCT04093492|532516724|FG000|34 Weeks GA|No response|0|||
147644150|NCT04093492|532516725|FG001|34 Weeks GA|No response|7|||
147644151|NCT04093492|532516726|FG002|34 Weeks GA|No response|5|||
147644152|NCT04093492|532516727|FG003|34 Weeks GA|No response|3|||
147644153|NCT04093492|532516724|FG000|34 Weeks GA|Lost to Follow-up|0|||
147644154|NCT04093492|532516725|FG001|34 Weeks GA|Lost to Follow-up|1|||
147644155|NCT04093492|532516726|FG002|34 Weeks GA|Lost to Follow-up|0|||
147644156|NCT04093492|532516727|FG003|34 Weeks GA|Lost to Follow-up|0|||
147644157|NCT00087126|532516731|FG000|Overall Study|Ineligible - second primary|1|||
147644158|NCT00087126|532516731|FG000|Overall Study|Never treated|1|||
147644159|NCT01432275|532516732|FG000|First BG Meter System (7 Days)|Adverse Event|0|||
147644160|NCT01432275|532516733|FG001|First BG Meter System (7 Days)|Adverse Event|2|||
147644161|NCT01432275|532516732|FG000|First BG Meter System (7 Days)|Withdrawal by Subject|0|||
147644162|NCT01432275|532516733|FG001|First BG Meter System (7 Days)|Withdrawal by Subject|1|||
147644163|NCT01432275|532516732|FG000|Second BG Meter System (7 Days)|Adverse Event|1|||
147644164|NCT01432275|532516733|FG001|Second BG Meter System (7 Days)|Adverse Event|1|||
147644165|NCT01432275|532516732|FG000|Second BG Meter System (7 Days)|Lost to Follow-up|1|||
147644166|NCT01432275|532516733|FG001|Second BG Meter System (7 Days)|Lost to Follow-up|0|||
147644167|NCT01432275|532516732|FG000|Second BG Meter System (7 Days)|Physician Decision|0|||
147644168|NCT01432275|532516733|FG001|Second BG Meter System (7 Days)|Physician Decision|1|||
147644169|NCT01432275|532516732|FG000|Second BG Meter System (7 Days)|Withdrawal by Subject|0|||
147644170|NCT01432275|532516733|FG001|Second BG Meter System (7 Days)|Withdrawal by Subject|1|||
147644171|NCT01432275|532516732|FG000|ADC With Calculator (10 Days)|Physician Decision|1|||
147644172|NCT01432275|532516733|FG001|ADC With Calculator (10 Days)|Physician Decision|1|||
147644173|NCT01432275|532516732|FG000|ADC With Calculator (10 Days)|Withdrawal by Subject|2|||
147644174|NCT01432275|532516733|FG001|ADC With Calculator (10 Days)|Withdrawal by Subject|0|||
147644175|NCT01432275|532516732|FG000|ADC With Calculator (10 Days)|Protocol Violation|0|||
147644176|NCT01432275|532516733|FG001|ADC With Calculator (10 Days)|Protocol Violation|1|||
147644177|NCT01935700|532516740|FG000|Overall Study|Withdrawal by Subject|1|||
147644178|NCT01935700|532516741|FG001|Overall Study|Withdrawal by Subject|0|||
147644179|NCT01935700|532516740|FG000|Overall Study|Physician Decision|4|||
147644180|NCT01935700|532516741|FG001|Overall Study|Physician Decision|0|||
147644181|NCT01935128|532516742|FG000|Overall Study|Death|1|||
147644182|NCT01935128|532516742|FG000|Overall Study|Adverse Event|6|||
147644183|NCT00772005|532516744|FG000|Overall Study|Adverse Event|9|||
147644184|NCT00772005|532516745|FG001|Overall Study|Adverse Event|14|||
147644185|NCT00772005|532516746|FG002|Overall Study|Adverse Event|10|||
147644186|NCT00772005|532516747|FG003|Overall Study|Adverse Event|13|||
147644187|NCT00772005|532516744|FG000|Overall Study|Lack of Efficacy|0|||
147644188|NCT00772005|532516745|FG001|Overall Study|Lack of Efficacy|1|||
147644189|NCT00772005|532516746|FG002|Overall Study|Lack of Efficacy|0|||
147644190|NCT00772005|532516747|FG003|Overall Study|Lack of Efficacy|0|||
147644191|NCT00772005|532516744|FG000|Overall Study|Withdrawal by Subject|3|||
147644192|NCT00772005|532516745|FG001|Overall Study|Withdrawal by Subject|7|||
147644193|NCT00772005|532516746|FG002|Overall Study|Withdrawal by Subject|10|||
147644194|NCT00772005|532516747|FG003|Overall Study|Withdrawal by Subject|2|||
147644195|NCT00772005|532516744|FG000|Overall Study|Protocol Violation|2|||
147644196|NCT00772005|532516745|FG001|Overall Study|Protocol Violation|4|||
147644197|NCT00772005|532516746|FG002|Overall Study|Protocol Violation|1|||
147644198|NCT00772005|532516747|FG003|Overall Study|Protocol Violation|6|||
147644199|NCT00772005|532516744|FG000|Overall Study|Lost to Follow-up|7|||
147644200|NCT00772005|532516745|FG001|Overall Study|Lost to Follow-up|3|||
147644201|NCT00772005|532516746|FG002|Overall Study|Lost to Follow-up|6|||
147644202|NCT00772005|532516747|FG003|Overall Study|Lost to Follow-up|3|||
147644203|NCT00772005|532516744|FG000|Overall Study|Non-compliance with study procedures|1|||
147644204|NCT00772005|532516745|FG001|Overall Study|Non-compliance with study procedures|1|||
147644205|NCT00772005|532516746|FG002|Overall Study|Non-compliance with study procedures|0|||
147644206|NCT00772005|532516747|FG003|Overall Study|Non-compliance with study procedures|1|||
147644207|NCT00772005|532516744|FG000|Overall Study|Non-compliance with drug administration|3|||
147644208|NCT00772005|532516745|FG001|Overall Study|Non-compliance with drug administration|0|||
147644209|NCT00772005|532516746|FG002|Overall Study|Non-compliance with drug administration|1|||
147644210|NCT00772005|532516747|FG003|Overall Study|Non-compliance with drug administration|1|||
147644211|NCT01162122|532516758|FG000|Overall Study|Withdrawal by Subject|52|||
147644212|NCT01162122|532516759|FG001|Overall Study|Withdrawal by Subject|43|||
147644213|NCT01162122|532516758|FG000|Overall Study|Lost to Follow-up|73|||
147644214|NCT01162122|532516759|FG001|Overall Study|Lost to Follow-up|91|||
147644215|NCT01162122|532516758|FG000|Overall Study|Adverse Event|3|||
147644216|NCT01162122|532516759|FG001|Overall Study|Adverse Event|2|||
147644217|NCT01162122|532516758|FG000|Overall Study|Death|51|||
147644218|NCT01162122|532516759|FG001|Overall Study|Death|46|||
147644219|NCT01162122|532516758|FG000|Overall Study|Protocol Violation|2|||
147528095|NCT02926833|532088539|FG000|Overall Study|Partial Withdrawal of Consent|0|||
147528096|NCT02926833|532088540|FG001|Overall Study|Partial Withdrawal of Consent|0|||
147528097|NCT02926833|532088541|FG002|Overall Study|Partial Withdrawal of Consent|0|||
147528098|NCT02926833|532088542|FG003|Overall Study|Partial Withdrawal of Consent|1|||
147528099|NCT01945866|532088543|FG000|Overall Study|Eyes did not complete or were dropped|2|||
147528100|NCT01945866|532088544|FG001|Overall Study|Eyes did not complete or were dropped|0|||
147528101|NCT00346775|532088549|FG000|Period 1: Intervention Period 1|Lost to Follow-up|1|||
147528102|NCT00346775|532088550|FG001|Period 1: Intervention Period 1|Lost to Follow-up|1|||
147528103|NCT00346775|532088549|FG000|Period 1: Intervention Period 1|Protocol Violation|3|||
147528104|NCT00346775|532088550|FG001|Period 1: Intervention Period 1|Protocol Violation|2|||
147528105|NCT00346775|532088549|FG000|Period 1: Intervention Period 1|Participant had nasal congestion score<2|1|||
147528106|NCT00346775|532088550|FG001|Period 1: Intervention Period 1|Participant had nasal congestion score<2|0|||
147528107|NCT02946515|532088551|FG000|Overall Study|Lost to Follow-up|2|||
147528108|NCT02946515|532088552|FG001|Overall Study|Lost to Follow-up|1|||
147528109|NCT03039686|532088557|FG000|Double-blind Period|Administrative Reason by Sponsor|24|||
147528110|NCT03039686|532088558|FG001|Double-blind Period|Administrative Reason by Sponsor|25|||
147528111|NCT03039686|532088559|FG002|Double-blind Period|Administrative Reason by Sponsor|21|||
147528112|NCT03039686|532088557|FG000|Double-blind Period|Subject Request to Discontinue Study Treatment|1|||
147528113|NCT03039686|532088558|FG001|Double-blind Period|Subject Request to Discontinue Study Treatment|2|||
147528114|NCT03039686|532088559|FG002|Double-blind Period|Subject Request to Discontinue Study Treatment|0|||
147528115|NCT03039686|532088557|FG000|Double-blind Period|Withdrawal by Subject|2|||
147528116|NCT03039686|532088558|FG001|Double-blind Period|Withdrawal by Subject|2|||
147528117|NCT03039686|532088559|FG002|Double-blind Period|Withdrawal by Subject|1|||
147528118|NCT03039686|532088557|FG000|Double-blind Period|Death|0|||
147644220|NCT01162122|532516759|FG001|Overall Study|Protocol Violation|2|||
147644221|NCT01162122|532516758|FG000|Overall Study|Inappropriate enrollment|5|||
147644222|NCT01162122|532516759|FG001|Overall Study|Inappropriate enrollment|4|||
147644223|NCT01162122|532516758|FG000|Overall Study|Administrative reason|1|||
147644224|NCT01162122|532516759|FG001|Overall Study|Administrative reason|1|||
147644225|NCT01162122|532516758|FG000|Overall Study|Unable to classify|3|||
147644226|NCT01162122|532516759|FG001|Overall Study|Unable to classify|7|||
147644227|NCT01162122|532516758|FG000|Overall Study|Missing primary reason|1|||
147644228|NCT01162122|532516759|FG001|Overall Study|Missing primary reason|0|||
147644229|NCT00150800|532516774|FG000|Overall Study|Adverse Event|89|||
147644230|NCT00150800|532516774|FG000|Overall Study|Death|18|||
147644231|NCT00150800|532516774|FG000|Overall Study|Lack of Efficacy|166|||
147644232|NCT00150800|532516774|FG000|Overall Study|Lost to Follow-up|58|||
147644233|NCT00150800|532516774|FG000|Overall Study|Subject's choice|90|||
147644234|NCT00150800|532516774|FG000|Overall Study|No compliance|18|||
147644235|NCT00150800|532516774|FG000|Overall Study|IP misshandling|1|||
147644236|NCT00150800|532516774|FG000|Overall Study|Site closure|24|||
147644237|NCT00150800|532516774|FG000|Overall Study|Protocol non-adherence|2|||
147644238|NCT00150800|532516774|FG000|Overall Study|Nobody to accompany patient|1|||
147644239|NCT00150800|532516774|FG000|Overall Study|Distance too long for patient|1|||
147644240|NCT00150800|532516774|FG000|Overall Study|Neurosurgery|2|||
147644241|NCT00150800|532516774|FG000|Overall Study|BRV monotherapy|1|||
147644242|NCT00150800|532516774|FG000|Overall Study|Visit refusal|3|||
147644243|NCT00150800|532516774|FG000|Overall Study|Sponsor's request|2|||
147644244|NCT00150800|532516774|FG000|Overall Study|Generalized Epilepsy|1|||
147644245|NCT00150800|532516774|FG000|Overall Study|Moved from area/country|8|||
147644246|NCT00150800|532516774|FG000|Overall Study|PI retiring|2|||
147644247|NCT00150800|532516774|FG000|Overall Study|PI leaving site|2|||
147644248|NCT00150800|532516774|FG000|Overall Study|Patient insurance|1|||
147644249|NCT00150800|532516774|FG000|Overall Study|Surgical intervention|4|||
147644250|NCT00150800|532516774|FG000|Overall Study|Pregnancy planned|1|||
147644251|NCT00150800|532516774|FG000|Overall Study|PI discontinuation request|1|||
147644252|NCT01790828|532516775|FG000|Overall Study|Other|34|||
147644253|NCT02326298|532516777|FG000|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
147644254|NCT02326298|532516778|FG001|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
147644255|NCT02326298|532516779|FG002|Initial Period (Week 0 to Week 16)|Adverse Event|1|||
147644256|NCT02326298|532516780|FG003|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
147644257|NCT02326298|532516781|FG004|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
147644258|NCT02326298|532516782|FG005|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
147644259|NCT02326298|532516783|FG006|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
147644260|NCT02326298|532516784|FG007|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
147644261|NCT02326298|532516785|FG008|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
147644262|NCT02326298|532516786|FG009|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
147644263|NCT02326298|532516787|FG010|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
147644264|NCT02326298|532516788|FG011|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
147644265|NCT02326298|532516789|FG012|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
147644266|NCT02326298|532516790|FG013|Initial Period (Week 0 to Week 16)|Adverse Event|0|||
147644267|NCT02326298|532516777|FG000|Initial Period (Week 0 to Week 16)|Lack of Efficacy|1|||
147644268|NCT02326298|532516778|FG001|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
147644269|NCT02326298|532516779|FG002|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
147644270|NCT02326298|532516780|FG003|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
147644271|NCT02326298|532516781|FG004|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
147644272|NCT02326298|532516782|FG005|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
147644273|NCT02326298|532516783|FG006|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
147644274|NCT02326298|532516784|FG007|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
147644275|NCT02326298|532516785|FG008|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
147644276|NCT02326298|532516786|FG009|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
147644277|NCT02326298|532516787|FG010|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
147644278|NCT02326298|532516788|FG011|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
147644279|NCT02326298|532516789|FG012|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
147644280|NCT02326298|532516790|FG013|Initial Period (Week 0 to Week 16)|Lack of Efficacy|0|||
147644281|NCT02326298|532516777|FG000|Initial Period (Week 0 to Week 16)|Lost to Follow-up|1|||
147644282|NCT02326298|532516778|FG001|Initial Period (Week 0 to Week 16)|Lost to Follow-up|1|||
147644283|NCT02326298|532516779|FG002|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
147644284|NCT02326298|532516780|FG003|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
147644285|NCT02326298|532516781|FG004|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
147644286|NCT02326298|532516782|FG005|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
147644287|NCT02326298|532516783|FG006|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
147644288|NCT02326298|532516784|FG007|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
147644289|NCT02326298|532516785|FG008|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
147644290|NCT02326298|532516786|FG009|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
147644291|NCT02326298|532516787|FG010|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
147528119|NCT03039686|532088558|FG001|Double-blind Period|Death|0|||
147528120|NCT03039686|532088559|FG002|Double-blind Period|Death|1|||
147528121|NCT03039686|532088557|FG000|Open Label Period|Administrative Reason by Sponsor|0|||
147528122|NCT03039686|532088558|FG001|Open Label Period|Administrative Reason by Sponsor|34|||
147528123|NCT03039686|532088559|FG002|Open Label Period|Administrative Reason by Sponsor|41|||
147528124|NCT03039686|532088557|FG000|Open Label Period|Subject Request to Discontinue Study Treatment|0|||
147528125|NCT03039686|532088558|FG001|Open Label Period|Subject Request to Discontinue Study Treatment|1|||
147528126|NCT03039686|532088559|FG002|Open Label Period|Subject Request to Discontinue Study Treatment|0|||
147528127|NCT03039686|532088557|FG000|Open Label Period|Withdrawal by Subject|0|||
147528128|NCT03039686|532088558|FG001|Open Label Period|Withdrawal by Subject|3|||
147528129|NCT03039686|532088559|FG002|Open Label Period|Withdrawal by Subject|1|||
147528130|NCT02087085|532088562|FG000|Overall Study|Adverse Event|10|||
147528131|NCT02087085|532088563|FG001|Overall Study|Adverse Event|14|||
147528132|NCT02087085|532088562|FG000|Overall Study|Lack of Efficacy|4|||
147528133|NCT02087085|532088563|FG001|Overall Study|Lack of Efficacy|3|||
147528134|NCT02087085|532088562|FG000|Overall Study|Lost to Follow-up|6|||
147528135|NCT02087085|532088563|FG001|Overall Study|Lost to Follow-up|4|||
147528136|NCT02087085|532088562|FG000|Overall Study|Withdrawal by Subject|9|||
147528137|NCT02087085|532088563|FG001|Overall Study|Withdrawal by Subject|11|||
147528138|NCT02087085|532088562|FG000|Overall Study|Protocol Violation|1|||
147528139|NCT02087085|532088563|FG001|Overall Study|Protocol Violation|0|||
147528140|NCT02087085|532088562|FG000|Overall Study|Study Terminated by Sponsor|87|||
147528141|NCT02087085|532088563|FG001|Overall Study|Study Terminated by Sponsor|80|||
147528142|NCT02087085|532088562|FG000|Overall Study|Other Miscellaneous Reasons|3|||
147528143|NCT02087085|532088563|FG001|Overall Study|Other Miscellaneous Reasons|4|||
147528144|NCT00635804|532088564|FG000|Overall Study|Adverse Event|0|||
147528145|NCT00635804|532088565|FG001|Overall Study|Adverse Event|0|||
147528146|NCT00635804|532088566|FG002|Overall Study|Adverse Event|0|||
147528147|NCT00635804|532088567|FG003|Overall Study|Adverse Event|0|||
147528148|NCT00635804|532088568|FG004|Overall Study|Adverse Event|0|||
147528149|NCT00635804|532088569|FG005|Overall Study|Adverse Event|1|||
147528150|NCT00635804|532088570|FG006|Overall Study|Adverse Event|0|||
147528151|NCT00635804|532088571|FG007|Overall Study|Adverse Event|0|||
147528152|NCT00635804|532088564|FG000|Overall Study|Withdrawal by Subject|1|||
147528153|NCT00635804|532088565|FG001|Overall Study|Withdrawal by Subject|0|||
147528154|NCT00635804|532088566|FG002|Overall Study|Withdrawal by Subject|0|||
147528155|NCT00635804|532088567|FG003|Overall Study|Withdrawal by Subject|0|||
147528156|NCT00635804|532088568|FG004|Overall Study|Withdrawal by Subject|0|||
147528157|NCT00635804|532088569|FG005|Overall Study|Withdrawal by Subject|0|||
147528158|NCT00635804|532088570|FG006|Overall Study|Withdrawal by Subject|0|||
147528159|NCT00635804|532088571|FG007|Overall Study|Withdrawal by Subject|0|||
147528160|NCT01270139|532088581|FG000|Overall Study|Adverse Event|8|||
147528161|NCT01270139|532088582|FG001|Overall Study|Adverse Event|17|||
147528162|NCT01270139|532088583|FG002|Overall Study|Adverse Event|18|||
147528163|NCT01270139|532088581|FG000|Overall Study|Lost to Follow-up|10|||
147528164|NCT01270139|532088582|FG001|Overall Study|Lost to Follow-up|9|||
147528165|NCT01270139|532088583|FG002|Overall Study|Lost to Follow-up|2|||
147528166|NCT02452320|532088584|FG000|Overall Study|Adverse Event|0|||
147528167|NCT02452320|532088585|FG001|Overall Study|Adverse Event|1|||
147528168|NCT03382639|532088586|FG000|Overall Study|Adverse Event|2|||
147528169|NCT03382639|532088587|FG001|Overall Study|Adverse Event|0|||
147528170|NCT03382639|532088588|FG002|Overall Study|Adverse Event|1|||
147528171|NCT03382639|532088589|FG003|Overall Study|Adverse Event|1|||
147528172|NCT03382639|532088586|FG000|Overall Study|Lost to Follow-up|1|||
147528173|NCT03382639|532088587|FG001|Overall Study|Lost to Follow-up|0|||
147528174|NCT03382639|532088588|FG002|Overall Study|Lost to Follow-up|0|||
147528175|NCT03382639|532088589|FG003|Overall Study|Lost to Follow-up|0|||
147528176|NCT03382639|532088586|FG000|Overall Study|Withdrawal by Subject|4|||
147528177|NCT03382639|532088587|FG001|Overall Study|Withdrawal by Subject|3|||
147528178|NCT03382639|532088588|FG002|Overall Study|Withdrawal by Subject|2|||
147528179|NCT03382639|532088589|FG003|Overall Study|Withdrawal by Subject|3|||
147528180|NCT03382639|532088586|FG000|Overall Study|Unsatisfactory therapeutic response|1|||
147528181|NCT03382639|532088587|FG001|Overall Study|Unsatisfactory therapeutic response|0|||
147528182|NCT03382639|532088588|FG002|Overall Study|Unsatisfactory therapeutic response|0|||
147528183|NCT03382639|532088589|FG003|Overall Study|Unsatisfactory therapeutic response|0|||
147528184|NCT03382639|532088586|FG000|Overall Study|Noncompliance with study drug during the DBTP|1|||
147528185|NCT03382639|532088587|FG001|Overall Study|Noncompliance with study drug during the DBTP|2|||
147528186|NCT03382639|532088588|FG002|Overall Study|Noncompliance with study drug during the DBTP|1|||
147528187|NCT03382639|532088589|FG003|Overall Study|Noncompliance with study drug during the DBTP|1|||
147528188|NCT03382639|532088586|FG000|Overall Study|Other|2|||
147528189|NCT03382639|532088587|FG001|Overall Study|Other|0|||
147528190|NCT03382639|532088588|FG002|Overall Study|Other|0|||
147528191|NCT03382639|532088589|FG003|Overall Study|Other|3|||
147528192|NCT01072175|532088590|FG000|Part A (Drug-Drug Interaction)|Death|1|||
147528193|NCT01072175|532088591|FG001|Part A (Drug-Drug Interaction)|Death|0|||
147528194|NCT01072175|532088592|FG002|Part A (Drug-Drug Interaction)|Death|0|||
147528195|NCT01072175|532088593|FG003|Part A (Drug-Drug Interaction)|Death|0|||
147528196|NCT01072175|532088594|FG004|Part A (Drug-Drug Interaction)|Death|0|||
147528197|NCT01072175|532088595|FG005|Part A (Drug-Drug Interaction)|Death|0|||
147528198|NCT01072175|532088596|FG006|Part A (Drug-Drug Interaction)|Death|0|||
147528199|NCT01072175|532088597|FG007|Part A (Drug-Drug Interaction)|Death|0|||
147528200|NCT01072175|532088598|FG008|Part A (Drug-Drug Interaction)|Death|0|||
147528201|NCT01072175|532088599|FG009|Part A (Drug-Drug Interaction)|Death|0|||
147528202|NCT01072175|532088600|FG010|Part A (Drug-Drug Interaction)|Death|0|||
147528203|NCT01072175|532088601|FG011|Part A (Drug-Drug Interaction)|Death|0|||
147528204|NCT01072175|532088602|FG012|Part A (Drug-Drug Interaction)|Death|0|||
147528205|NCT01072175|532088590|FG000|Part A (Drug-Drug Interaction)|Physician Decision|6|||
147528206|NCT01072175|532088591|FG001|Part A (Drug-Drug Interaction)|Physician Decision|0|||
147528207|NCT01072175|532088592|FG002|Part A (Drug-Drug Interaction)|Physician Decision|0|||
147528208|NCT01072175|532088593|FG003|Part A (Drug-Drug Interaction)|Physician Decision|0|||
147528209|NCT01072175|532088594|FG004|Part A (Drug-Drug Interaction)|Physician Decision|0|||
147528210|NCT01072175|532088595|FG005|Part A (Drug-Drug Interaction)|Physician Decision|0|||
147528211|NCT01072175|532088596|FG006|Part A (Drug-Drug Interaction)|Physician Decision|0|||
147528212|NCT01072175|532088597|FG007|Part A (Drug-Drug Interaction)|Physician Decision|0|||
147528213|NCT01072175|532088598|FG008|Part A (Drug-Drug Interaction)|Physician Decision|0|||
147528214|NCT01072175|532088599|FG009|Part A (Drug-Drug Interaction)|Physician Decision|0|||
147528215|NCT01072175|532088600|FG010|Part A (Drug-Drug Interaction)|Physician Decision|0|||
147528216|NCT01072175|532088601|FG011|Part A (Drug-Drug Interaction)|Physician Decision|0|||
147528217|NCT01072175|532088602|FG012|Part A (Drug-Drug Interaction)|Physician Decision|0|||
147528218|NCT01072175|532088590|FG000|Part A (Drug-Drug Interaction)|Withdrawal by Subject|1|||
147528219|NCT01072175|532088591|FG001|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
147528220|NCT01072175|532088592|FG002|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
147528221|NCT01072175|532088593|FG003|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
147528222|NCT01072175|532088594|FG004|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
147528223|NCT01072175|532088595|FG005|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
147528224|NCT01072175|532088596|FG006|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
147528225|NCT01072175|532088597|FG007|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
147528226|NCT01072175|532088598|FG008|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
147528227|NCT01072175|532088599|FG009|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
147528228|NCT01072175|532088600|FG010|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
147528229|NCT01072175|532088601|FG011|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
147528230|NCT01072175|532088602|FG012|Part A (Drug-Drug Interaction)|Withdrawal by Subject|0|||
147528231|NCT01072175|532088590|FG000|Part B (Dose Escalation and Expansion)|Death|0|||
147528232|NCT01072175|532088591|FG001|Part B (Dose Escalation and Expansion)|Death|4|||
147528233|NCT01072175|532088592|FG002|Part B (Dose Escalation and Expansion)|Death|18|||
147528234|NCT01072175|532088593|FG003|Part B (Dose Escalation and Expansion)|Death|21|||
147528235|NCT01072175|532088594|FG004|Part B (Dose Escalation and Expansion)|Death|68|||
147528236|NCT01072175|532088595|FG005|Part B (Dose Escalation and Expansion)|Death|0|||
147528237|NCT01072175|532088596|FG006|Part B (Dose Escalation and Expansion)|Death|0|||
147528238|NCT01072175|532088597|FG007|Part B (Dose Escalation and Expansion)|Death|0|||
147528239|NCT01072175|532088598|FG008|Part B (Dose Escalation and Expansion)|Death|0|||
147528240|NCT01072175|532088599|FG009|Part B (Dose Escalation and Expansion)|Death|0|||
147528241|NCT01072175|532088600|FG010|Part B (Dose Escalation and Expansion)|Death|0|||
147528242|NCT01072175|532088601|FG011|Part B (Dose Escalation and Expansion)|Death|0|||
147528243|NCT01072175|532088602|FG012|Part B (Dose Escalation and Expansion)|Death|0|||
147528244|NCT01072175|532088590|FG000|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
147528245|NCT01072175|532088591|FG001|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
147528246|NCT01072175|532088592|FG002|Part B (Dose Escalation and Expansion)|Physician Decision|2|||
147528247|NCT01072175|532088593|FG003|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
147528248|NCT01072175|532088594|FG004|Part B (Dose Escalation and Expansion)|Physician Decision|4|||
147528249|NCT01072175|532088595|FG005|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
147528250|NCT01072175|532088596|FG006|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
147528251|NCT01072175|532088597|FG007|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
147528252|NCT01072175|532088598|FG008|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
147528253|NCT01072175|532088599|FG009|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
147528254|NCT01072175|532088600|FG010|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
147528255|NCT01072175|532088601|FG011|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
147528256|NCT01072175|532088602|FG012|Part B (Dose Escalation and Expansion)|Physician Decision|0|||
147528257|NCT01072175|532088590|FG000|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
147528258|NCT01072175|532088591|FG001|Part B (Dose Escalation and Expansion)|Lost to Follow-up|1|||
147528259|NCT01072175|532088592|FG002|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
147528260|NCT01072175|532088593|FG003|Part B (Dose Escalation and Expansion)|Lost to Follow-up|1|||
147528261|NCT01072175|532088594|FG004|Part B (Dose Escalation and Expansion)|Lost to Follow-up|6|||
147528262|NCT01072175|532088595|FG005|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
147528263|NCT01072175|532088596|FG006|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
147528264|NCT01072175|532088597|FG007|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
147528265|NCT01072175|532088598|FG008|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
147528266|NCT01072175|532088599|FG009|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
147528267|NCT01072175|532088600|FG010|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
147528268|NCT01072175|532088601|FG011|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
147528269|NCT01072175|532088602|FG012|Part B (Dose Escalation and Expansion)|Lost to Follow-up|0|||
147528270|NCT01072175|532088590|FG000|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
147528271|NCT01072175|532088591|FG001|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
147528272|NCT01072175|532088592|FG002|Part B (Dose Escalation and Expansion)|Study closed/terminated|3|||
147528273|NCT01072175|532088593|FG003|Part B (Dose Escalation and Expansion)|Study closed/terminated|2|||
147528274|NCT01072175|532088594|FG004|Part B (Dose Escalation and Expansion)|Study closed/terminated|10|||
147528275|NCT01072175|532088595|FG005|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
147528276|NCT01072175|532088596|FG006|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
147528277|NCT01072175|532088597|FG007|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
147528278|NCT01072175|532088598|FG008|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
147528279|NCT01072175|532088599|FG009|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
147528280|NCT01072175|532088600|FG010|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
147528281|NCT01072175|532088601|FG011|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
147528282|NCT01072175|532088602|FG012|Part B (Dose Escalation and Expansion)|Study closed/terminated|0|||
147528283|NCT01072175|532088590|FG000|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
147528284|NCT01072175|532088591|FG001|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|1|||
147528285|NCT01072175|532088592|FG002|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
147528286|NCT01072175|532088593|FG003|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|3|||
147528287|NCT01072175|532088594|FG004|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|6|||
147528288|NCT01072175|532088595|FG005|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
147528289|NCT01072175|532088596|FG006|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
147528290|NCT01072175|532088597|FG007|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
147528291|NCT01072175|532088598|FG008|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
147528292|NCT01072175|532088599|FG009|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
147528293|NCT01072175|532088600|FG010|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
147528294|NCT01072175|532088601|FG011|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
147528295|NCT01072175|532088602|FG012|Part B (Dose Escalation and Expansion)|Withdrawal by Subject|0|||
147528296|NCT01072175|532088590|FG000|Part C (Phase II: Randomized Phase)|Death|0|||
147528297|NCT01072175|532088591|FG001|Part C (Phase II: Randomized Phase)|Death|0|||
147528298|NCT01072175|532088592|FG002|Part C (Phase II: Randomized Phase)|Death|0|||
147528299|NCT01072175|532088593|FG003|Part C (Phase II: Randomized Phase)|Death|0|||
147528300|NCT01072175|532088594|FG004|Part C (Phase II: Randomized Phase)|Death|0|||
147528301|NCT01072175|532088595|FG005|Part C (Phase II: Randomized Phase)|Death|44|||
147528302|NCT01072175|532088596|FG006|Part C (Phase II: Randomized Phase)|Death|34|||
147528303|NCT01072175|532088597|FG007|Part C (Phase II: Randomized Phase)|Death|39|||
147528304|NCT01072175|532088598|FG008|Part C (Phase II: Randomized Phase)|Death|0|||
147528305|NCT01072175|532088599|FG009|Part C (Phase II: Randomized Phase)|Death|0|||
147528306|NCT01072175|532088600|FG010|Part C (Phase II: Randomized Phase)|Death|0|||
147528307|NCT01072175|532088601|FG011|Part C (Phase II: Randomized Phase)|Death|0|||
147528308|NCT01072175|532088602|FG012|Part C (Phase II: Randomized Phase)|Death|0|||
147528309|NCT01072175|532088590|FG000|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
147528310|NCT01072175|532088591|FG001|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
147528311|NCT01072175|532088592|FG002|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
147528312|NCT01072175|532088593|FG003|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
147528313|NCT01072175|532088594|FG004|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
147528314|NCT01072175|532088595|FG005|Part C (Phase II: Randomized Phase)|Physician Decision|1|||
147528315|NCT01072175|532088596|FG006|Part C (Phase II: Randomized Phase)|Physician Decision|1|||
147528316|NCT01072175|532088597|FG007|Part C (Phase II: Randomized Phase)|Physician Decision|1|||
147528317|NCT01072175|532088598|FG008|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
147528318|NCT01072175|532088599|FG009|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
147528319|NCT01072175|532088600|FG010|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
147528320|NCT01072175|532088601|FG011|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
147528321|NCT01072175|532088602|FG012|Part C (Phase II: Randomized Phase)|Physician Decision|0|||
147528322|NCT01072175|532088590|FG000|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
147528323|NCT01072175|532088591|FG001|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
147528324|NCT01072175|532088592|FG002|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
147528325|NCT01072175|532088593|FG003|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
147528326|NCT01072175|532088594|FG004|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
147528327|NCT01072175|532088595|FG005|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
147528328|NCT01072175|532088596|FG006|Part C (Phase II: Randomized Phase)|Lost to Follow-up|3|||
147528329|NCT01072175|532088597|FG007|Part C (Phase II: Randomized Phase)|Lost to Follow-up|3|||
147528330|NCT01072175|532088598|FG008|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
147528331|NCT01072175|532088599|FG009|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
147528332|NCT01072175|532088600|FG010|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
147528333|NCT01072175|532088601|FG011|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
147528334|NCT01072175|532088602|FG012|Part C (Phase II: Randomized Phase)|Lost to Follow-up|0|||
147528335|NCT01072175|532088590|FG000|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
147528336|NCT01072175|532088591|FG001|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
147528337|NCT01072175|532088592|FG002|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
147528338|NCT01072175|532088593|FG003|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
147528339|NCT01072175|532088594|FG004|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
147528340|NCT01072175|532088595|FG005|Part C (Phase II: Randomized Phase)|Study closed/terminated|6|||
147528341|NCT01072175|532088596|FG006|Part C (Phase II: Randomized Phase)|Study closed/terminated|9|||
147528342|NCT01072175|532088597|FG007|Part C (Phase II: Randomized Phase)|Study closed/terminated|11|||
147528343|NCT01072175|532088598|FG008|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
147528344|NCT01072175|532088599|FG009|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
147528345|NCT01072175|532088600|FG010|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
147528346|NCT01072175|532088601|FG011|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
147528347|NCT01072175|532088602|FG012|Part C (Phase II: Randomized Phase)|Study closed/terminated|0|||
147528348|NCT01072175|532088590|FG000|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
147528349|NCT01072175|532088591|FG001|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
147528350|NCT01072175|532088592|FG002|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
147528351|NCT01072175|532088593|FG003|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
147528352|NCT01072175|532088594|FG004|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
147528353|NCT01072175|532088595|FG005|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|3|||
147528354|NCT01072175|532088596|FG006|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|7|||
147528355|NCT01072175|532088597|FG007|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
147528356|NCT01072175|532088598|FG008|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
147528357|NCT01072175|532088599|FG009|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
147528358|NCT01072175|532088600|FG010|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
147528359|NCT01072175|532088601|FG011|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
147528360|NCT01072175|532088602|FG012|Part C (Phase II: Randomized Phase)|Withdrawal by Subject|0|||
147528361|NCT01072175|532088590|FG000|Part C (Phase II: Crossover Phase [CP])|Death|0|||
147528362|NCT01072175|532088591|FG001|Part C (Phase II: Crossover Phase [CP])|Death|0|||
147528363|NCT01072175|532088592|FG002|Part C (Phase II: Crossover Phase [CP])|Death|0|||
147528364|NCT01072175|532088593|FG003|Part C (Phase II: Crossover Phase [CP])|Death|0|||
147528365|NCT01072175|532088594|FG004|Part C (Phase II: Crossover Phase [CP])|Death|0|||
147528366|NCT01072175|532088595|FG005|Part C (Phase II: Crossover Phase [CP])|Death|0|||
147528367|NCT01072175|532088596|FG006|Part C (Phase II: Crossover Phase [CP])|Death|0|||
147528368|NCT01072175|532088597|FG007|Part C (Phase II: Crossover Phase [CP])|Death|0|||
147528369|NCT01072175|532088598|FG008|Part C (Phase II: Crossover Phase [CP])|Death|37|||
147528370|NCT01072175|532088599|FG009|Part C (Phase II: Crossover Phase [CP])|Death|0|||
147528371|NCT01072175|532088600|FG010|Part C (Phase II: Crossover Phase [CP])|Death|0|||
147528372|NCT01072175|532088601|FG011|Part C (Phase II: Crossover Phase [CP])|Death|0|||
147528373|NCT01072175|532088602|FG012|Part C (Phase II: Crossover Phase [CP])|Death|0|||
147528374|NCT01072175|532088590|FG000|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
147528375|NCT01072175|532088591|FG001|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
147528376|NCT01072175|532088592|FG002|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
147528377|NCT01072175|532088593|FG003|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
147528378|NCT01072175|532088594|FG004|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
147528379|NCT01072175|532088595|FG005|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
147528380|NCT01072175|532088596|FG006|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
147528381|NCT01072175|532088597|FG007|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
147528382|NCT01072175|532088598|FG008|Part C (Phase II: Crossover Phase [CP])|Physician Decision|1|||
147528383|NCT01072175|532088599|FG009|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
147528384|NCT01072175|532088600|FG010|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
147528385|NCT01072175|532088601|FG011|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
147528386|NCT01072175|532088602|FG012|Part C (Phase II: Crossover Phase [CP])|Physician Decision|0|||
147528387|NCT01072175|532088590|FG000|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
147528388|NCT01072175|532088591|FG001|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
147528389|NCT01072175|532088592|FG002|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
147528390|NCT01072175|532088593|FG003|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
147528391|NCT01072175|532088594|FG004|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
147528392|NCT01072175|532088595|FG005|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
147528393|NCT01072175|532088596|FG006|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
147528394|NCT01072175|532088597|FG007|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
147528395|NCT01072175|532088598|FG008|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|4|||
147528396|NCT01072175|532088599|FG009|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
147528397|NCT01072175|532088600|FG010|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
147528398|NCT01072175|532088601|FG011|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
147528399|NCT01072175|532088602|FG012|Part C (Phase II: Crossover Phase [CP])|Study closed/terminated|0|||
147528400|NCT01072175|532088590|FG000|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
147528401|NCT01072175|532088591|FG001|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
147528402|NCT01072175|532088592|FG002|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
147528403|NCT01072175|532088593|FG003|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
147528404|NCT01072175|532088594|FG004|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
147528405|NCT01072175|532088595|FG005|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
147528406|NCT01072175|532088596|FG006|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
147528407|NCT01072175|532088597|FG007|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
147528408|NCT01072175|532088598|FG008|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|3|||
147528409|NCT01072175|532088599|FG009|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
147528410|NCT01072175|532088600|FG010|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
147528411|NCT01072175|532088601|FG011|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
147528412|NCT01072175|532088602|FG012|Part C (Phase II: Crossover Phase [CP])|Withdrawal by Subject|0|||
147528413|NCT01072175|532088590|FG000|Part D (HPMC Capsules)|Death|0|||
147528414|NCT01072175|532088591|FG001|Part D (HPMC Capsules)|Death|0|||
147528415|NCT01072175|532088592|FG002|Part D (HPMC Capsules)|Death|0|||
147528416|NCT01072175|532088593|FG003|Part D (HPMC Capsules)|Death|0|||
147528417|NCT01072175|532088594|FG004|Part D (HPMC Capsules)|Death|0|||
147528418|NCT01072175|532088595|FG005|Part D (HPMC Capsules)|Death|0|||
147528419|NCT01072175|532088596|FG006|Part D (HPMC Capsules)|Death|0|||
147528420|NCT01072175|532088597|FG007|Part D (HPMC Capsules)|Death|0|||
147528421|NCT01072175|532088598|FG008|Part D (HPMC Capsules)|Death|0|||
147528422|NCT01072175|532088599|FG009|Part D (HPMC Capsules)|Death|10|||
147528423|NCT01072175|532088600|FG010|Part D (HPMC Capsules)|Death|12|||
147528424|NCT01072175|532088601|FG011|Part D (HPMC Capsules)|Death|28|||
147528425|NCT01072175|532088602|FG012|Part D (HPMC Capsules)|Death|26|||
147528426|NCT01072175|532088590|FG000|Part D (HPMC Capsules)|Physician Decision|0|||
147528427|NCT01072175|532088591|FG001|Part D (HPMC Capsules)|Physician Decision|0|||
147528428|NCT01072175|532088592|FG002|Part D (HPMC Capsules)|Physician Decision|0|||
147528429|NCT01072175|532088593|FG003|Part D (HPMC Capsules)|Physician Decision|0|||
147528430|NCT01072175|532088594|FG004|Part D (HPMC Capsules)|Physician Decision|0|||
147528431|NCT01072175|532088595|FG005|Part D (HPMC Capsules)|Physician Decision|0|||
147528432|NCT01072175|532088596|FG006|Part D (HPMC Capsules)|Physician Decision|0|||
147528433|NCT01072175|532088597|FG007|Part D (HPMC Capsules)|Physician Decision|0|||
147528434|NCT01072175|532088598|FG008|Part D (HPMC Capsules)|Physician Decision|0|||
147528435|NCT01072175|532088599|FG009|Part D (HPMC Capsules)|Physician Decision|0|||
147528436|NCT01072175|532088600|FG010|Part D (HPMC Capsules)|Physician Decision|1|||
147528437|NCT01072175|532088601|FG011|Part D (HPMC Capsules)|Physician Decision|1|||
147528438|NCT01072175|532088602|FG012|Part D (HPMC Capsules)|Physician Decision|1|||
147528439|NCT01072175|532088590|FG000|Part D (HPMC Capsules)|Lost to Follow-up|0|||
147528440|NCT01072175|532088591|FG001|Part D (HPMC Capsules)|Lost to Follow-up|0|||
147528441|NCT01072175|532088592|FG002|Part D (HPMC Capsules)|Lost to Follow-up|0|||
147528442|NCT01072175|532088593|FG003|Part D (HPMC Capsules)|Lost to Follow-up|0|||
147528443|NCT01072175|532088594|FG004|Part D (HPMC Capsules)|Lost to Follow-up|0|||
147528444|NCT01072175|532088595|FG005|Part D (HPMC Capsules)|Lost to Follow-up|0|||
147528445|NCT01072175|532088596|FG006|Part D (HPMC Capsules)|Lost to Follow-up|0|||
147528446|NCT01072175|532088597|FG007|Part D (HPMC Capsules)|Lost to Follow-up|0|||
147528447|NCT01072175|532088598|FG008|Part D (HPMC Capsules)|Lost to Follow-up|0|||
147528448|NCT01072175|532088599|FG009|Part D (HPMC Capsules)|Lost to Follow-up|0|||
147528449|NCT01072175|532088600|FG010|Part D (HPMC Capsules)|Lost to Follow-up|1|||
147528450|NCT01072175|532088601|FG011|Part D (HPMC Capsules)|Lost to Follow-up|1|||
147528451|NCT01072175|532088602|FG012|Part D (HPMC Capsules)|Lost to Follow-up|3|||
147528452|NCT01072175|532088590|FG000|Part D (HPMC Capsules)|Study closed/terminated|0|||
147528453|NCT01072175|532088591|FG001|Part D (HPMC Capsules)|Study closed/terminated|0|||
147528454|NCT01072175|532088592|FG002|Part D (HPMC Capsules)|Study closed/terminated|0|||
147528455|NCT01072175|532088593|FG003|Part D (HPMC Capsules)|Study closed/terminated|0|||
147528456|NCT01072175|532088594|FG004|Part D (HPMC Capsules)|Study closed/terminated|0|||
147528457|NCT01072175|532088595|FG005|Part D (HPMC Capsules)|Study closed/terminated|0|||
147528458|NCT01072175|532088596|FG006|Part D (HPMC Capsules)|Study closed/terminated|0|||
147528459|NCT01072175|532088597|FG007|Part D (HPMC Capsules)|Study closed/terminated|0|||
147528460|NCT01072175|532088598|FG008|Part D (HPMC Capsules)|Study closed/terminated|0|||
147528461|NCT01072175|532088599|FG009|Part D (HPMC Capsules)|Study closed/terminated|2|||
147528462|NCT01072175|532088600|FG010|Part D (HPMC Capsules)|Study closed/terminated|1|||
147528463|NCT01072175|532088601|FG011|Part D (HPMC Capsules)|Study closed/terminated|10|||
147528464|NCT01072175|532088602|FG012|Part D (HPMC Capsules)|Study closed/terminated|9|||
147528465|NCT01072175|532088590|FG000|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
147528466|NCT01072175|532088591|FG001|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
147528467|NCT01072175|532088592|FG002|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
147528468|NCT01072175|532088593|FG003|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
147528469|NCT01072175|532088594|FG004|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
147528470|NCT01072175|532088595|FG005|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
147528471|NCT01072175|532088596|FG006|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
147528472|NCT01072175|532088597|FG007|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
147528473|NCT01072175|532088598|FG008|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
147528474|NCT01072175|532088599|FG009|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
147528475|NCT01072175|532088600|FG010|Part D (HPMC Capsules)|Withdrawal by Subject|1|||
147528476|NCT01072175|532088601|FG011|Part D (HPMC Capsules)|Withdrawal by Subject|3|||
147528477|NCT01072175|532088602|FG012|Part D (HPMC Capsules)|Withdrawal by Subject|0|||
147528478|NCT02477215|532088603|FG000|Dose Escalation Phase|Physician Decision|1|||
147528479|NCT02477215|532088604|FG001|Dose Escalation Phase|Physician Decision|2|||
147528480|NCT02477215|532088605|FG002|Dose Escalation Phase|Physician Decision|0|||
147528481|NCT02477215|532088603|FG000|Fixed Dose Phase|Physician Decision|0|||
147528482|NCT02477215|532088604|FG001|Fixed Dose Phase|Physician Decision|7|||
147528483|NCT02477215|532088605|FG002|Fixed Dose Phase|Physician Decision|0|||
147528484|NCT00285857|532088606|FG000|Overall Study|Withdrawal by Subject|2|||
147528485|NCT00285857|532088606|FG000|Overall Study|Inadequate initial breast cytology|1|||
147528486|NCT00285857|532088606|FG000|Overall Study|Adverse Event|1|||
147528487|NCT00438815|532088607|FG000|Overall Study|Transferred to LEVP2006-4 (NCT00462709)|30|||
147528488|NCT00438815|532088607|FG000|Overall Study|3-month follow-up no longer required|12|||
147528489|NCT00438815|532088607|FG000|Overall Study|Noncompliance with protocol requirements|9|||
147528490|NCT00438815|532088607|FG000|Overall Study|Transitioned to commercial C1INH-nf|6|||
147528491|NCT00438815|532088607|FG000|Overall Study|Lost to Follow-up|6|||
147528492|NCT00438815|532088607|FG000|Overall Study|Withdrawal by Subject|6|||
147528493|NCT00438815|532088607|FG000|Overall Study|Death|1|||
147528494|NCT06104423|532088612|FG000|MONOTHERAPY Period 1 RunIn (-4W to W0)|Not compliant with eligibility criteria|3|||
147528495|NCT06104423|532088613|FG001|MONOTHERAPY Period 1 RunIn (-4W to W0)|Not compliant with eligibility criteria|6|||
147528496|NCT06104423|532088614|FG002|MONOTHERAPY Period 1 RunIn (-4W to W0)|Not compliant with eligibility criteria|0|||
147528497|NCT06104423|532088612|FG000|MONOTHERAPY Period 1 RunIn (-4W to W0)|Lab abnormal results|1|||
147528498|NCT06104423|532088613|FG001|MONOTHERAPY Period 1 RunIn (-4W to W0)|Lab abnormal results|1|||
147528499|NCT06104423|532088614|FG002|MONOTHERAPY Period 1 RunIn (-4W to W0)|Lab abnormal results|0|||
147528500|NCT05602818|532088615|FG000|Qualification Phase (3 Days)|Adverse Event|1|||
147528501|NCT05602818|532088616|FG001|Qualification Phase (3 Days)|Adverse Event|0|||
147528502|NCT05602818|532088617|FG002|Qualification Phase (3 Days)|Adverse Event|0|||
147528503|NCT05602818|532088618|FG003|Qualification Phase (3 Days)|Adverse Event|0|||
147528504|NCT05602818|532088619|FG004|Qualification Phase (3 Days)|Adverse Event|0|||
147528505|NCT05602818|532088620|FG005|Qualification Phase (3 Days)|Adverse Event|0|||
147528506|NCT05602818|532088621|FG006|Qualification Phase (3 Days)|Adverse Event|0|||
147528507|NCT05602818|532088622|FG007|Qualification Phase (3 Days)|Adverse Event|0|||
147528508|NCT05602818|532088623|FG008|Qualification Phase (3 Days)|Adverse Event|0|||
147528509|NCT05602818|532088624|FG009|Qualification Phase (3 Days)|Adverse Event|0|||
147528510|NCT05602818|532088625|FG010|Qualification Phase (3 Days)|Adverse Event|0|||
147528511|NCT05602818|532088626|FG011|Qualification Phase (3 Days)|Adverse Event|0|||
147528512|NCT05602818|532088615|FG000|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|13|||
147528513|NCT05602818|532088616|FG001|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|13|||
147528514|NCT05602818|532088617|FG002|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
147528515|NCT05602818|532088618|FG003|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
147528516|NCT05602818|532088619|FG004|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
147528517|NCT05602818|532088620|FG005|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
147528518|NCT05602818|532088621|FG006|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
147528519|NCT05602818|532088622|FG007|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
147528520|NCT05602818|532088623|FG008|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
147528521|NCT05602818|532088624|FG009|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
147528522|NCT05602818|532088625|FG010|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
147528523|NCT05602818|532088626|FG011|Qualification Phase (3 Days)|Did Not Meet Qualification Criteria|0|||
147528524|NCT05602818|532088615|FG000|Qualification Phase (3 Days)|Withdrawal by Subject|2|||
147528525|NCT05602818|532088616|FG001|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
147528526|NCT05602818|532088617|FG002|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
147528527|NCT05602818|532088618|FG003|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
147528528|NCT05602818|532088619|FG004|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
147528529|NCT05602818|532088620|FG005|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
147528530|NCT05602818|532088621|FG006|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
147528531|NCT05602818|532088622|FG007|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
147528532|NCT05602818|532088623|FG008|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
147528533|NCT05602818|532088624|FG009|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
147528534|NCT05602818|532088625|FG010|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
147528535|NCT05602818|532088626|FG011|Qualification Phase (3 Days)|Withdrawal by Subject|0|||
147528536|NCT05602818|532088615|FG000|Qualification Phase (3 Days)|Other|1|||
147528537|NCT05602818|532088616|FG001|Qualification Phase (3 Days)|Other|0|||
147528538|NCT05602818|532088617|FG002|Qualification Phase (3 Days)|Other|0|||
147528539|NCT05602818|532088618|FG003|Qualification Phase (3 Days)|Other|0|||
147528540|NCT05602818|532088619|FG004|Qualification Phase (3 Days)|Other|0|||
147528541|NCT05602818|532088620|FG005|Qualification Phase (3 Days)|Other|0|||
147528542|NCT05602818|532088621|FG006|Qualification Phase (3 Days)|Other|0|||
147528543|NCT05602818|532088622|FG007|Qualification Phase (3 Days)|Other|0|||
147528544|NCT05602818|532088623|FG008|Qualification Phase (3 Days)|Other|0|||
147528545|NCT05602818|532088624|FG009|Qualification Phase (3 Days)|Other|0|||
147528546|NCT05602818|532088625|FG010|Qualification Phase (3 Days)|Other|0|||
147528547|NCT05602818|532088626|FG011|Qualification Phase (3 Days)|Other|0|||
147528548|NCT05602818|532088615|FG000|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
147528549|NCT05602818|532088616|FG001|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|1|||
147531981|NCT00570492|532101896|FG002|52-week Double-blind Treatment Period|Protocol Violation|15|||
147528550|NCT05602818|532088617|FG002|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
147528551|NCT05602818|532088618|FG003|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
147528552|NCT05602818|532088619|FG004|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
147528553|NCT05602818|532088620|FG005|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
147528554|NCT05602818|532088621|FG006|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
147528555|NCT05602818|532088622|FG007|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
147528556|NCT05602818|532088623|FG008|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
147528557|NCT05602818|532088624|FG009|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
147528558|NCT05602818|532088625|FG010|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
147531982|NCT00570492|532101894|FG000|52-week Double-blind Treatment Period|Lost to Follow-up|0|||
147528559|NCT05602818|532088626|FG011|Qualification Phase (3 Days)|Failure to Meet Continuation Criteria|0|||
147528560|NCT05602818|532088615|FG000|Treatment Phase (29 Days)|Protocol Violation|0|||
147528561|NCT05602818|532088616|FG001|Treatment Phase (29 Days)|Protocol Violation|0|||
147528562|NCT05602818|532088617|FG002|Treatment Phase (29 Days)|Protocol Violation|2|||
147528563|NCT05602818|532088618|FG003|Treatment Phase (29 Days)|Protocol Violation|1|||
147528564|NCT05602818|532088619|FG004|Treatment Phase (29 Days)|Protocol Violation|1|||
147532057|NCT05966129|532101924|FG001|Overall Study|Lost to Follow-up|66|||
147528565|NCT05602818|532088620|FG005|Treatment Phase (29 Days)|Protocol Violation|1|||
147528566|NCT05602818|532088621|FG006|Treatment Phase (29 Days)|Protocol Violation|2|||
147528567|NCT05602818|532088622|FG007|Treatment Phase (29 Days)|Protocol Violation|2|||
147528568|NCT05602818|532088623|FG008|Treatment Phase (29 Days)|Protocol Violation|1|||
147528569|NCT05602818|532088624|FG009|Treatment Phase (29 Days)|Protocol Violation|1|||
147528570|NCT05602818|532088625|FG010|Treatment Phase (29 Days)|Protocol Violation|2|||
147528571|NCT05602818|532088626|FG011|Treatment Phase (29 Days)|Protocol Violation|1|||
147528572|NCT05602818|532088615|FG000|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
147528573|NCT05602818|532088616|FG001|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
147528574|NCT05602818|532088617|FG002|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
147528575|NCT05602818|532088618|FG003|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
147528576|NCT05602818|532088619|FG004|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
147528577|NCT05602818|532088620|FG005|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
147528578|NCT05602818|532088621|FG006|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
147528579|NCT05602818|532088622|FG007|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
147528580|NCT05602818|532088623|FG008|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
147528581|NCT05602818|532088624|FG009|Treatment Phase (29 Days)|Withdrawal by Subject|0|||
147528582|NCT05602818|532088625|FG010|Treatment Phase (29 Days)|Withdrawal by Subject|1|||
147528583|NCT05602818|532088626|FG011|Treatment Phase (29 Days)|Withdrawal by Subject|1|||
147528584|NCT05602818|532088615|FG000|Treatment Phase (29 Days)|Physician Decision|0|||
147528585|NCT05602818|532088616|FG001|Treatment Phase (29 Days)|Physician Decision|0|||
147528586|NCT05602818|532088617|FG002|Treatment Phase (29 Days)|Physician Decision|1|||
147528587|NCT05602818|532088618|FG003|Treatment Phase (29 Days)|Physician Decision|0|||
147532058|NCT05966129|532101923|FG000|Overall Study|Protocol Violation|1|||
147528588|NCT05602818|532088619|FG004|Treatment Phase (29 Days)|Physician Decision|0|||
147528589|NCT05602818|532088620|FG005|Treatment Phase (29 Days)|Physician Decision|0|||
147528590|NCT05602818|532088621|FG006|Treatment Phase (29 Days)|Physician Decision|1|||
147528591|NCT05602818|532088622|FG007|Treatment Phase (29 Days)|Physician Decision|0|||
147528592|NCT05602818|532088623|FG008|Treatment Phase (29 Days)|Physician Decision|0|||
147528593|NCT05602818|532088624|FG009|Treatment Phase (29 Days)|Physician Decision|0|||
147528594|NCT05602818|532088625|FG010|Treatment Phase (29 Days)|Physician Decision|1|||
147532059|NCT05966129|532101924|FG001|Overall Study|Protocol Violation|0|||
147528595|NCT05602818|532088626|FG011|Treatment Phase (29 Days)|Physician Decision|0|||
147528596|NCT00727246|532088627|FG000|Overall Study|could not complete MRI|0|||
147528597|NCT00727246|532088628|FG001|Overall Study|could not complete MRI|1|||
147528598|NCT00727246|532088629|FG002|Overall Study|could not complete MRI|0|||
147528599|NCT00727246|532088630|FG003|Overall Study|could not complete MRI|1|||
147528600|NCT00727246|532088627|FG000|Overall Study|incidental finding|0|||
147528601|NCT00727246|532088628|FG001|Overall Study|incidental finding|0|||
147528602|NCT00727246|532088629|FG002|Overall Study|incidental finding|0|||
147528603|NCT00727246|532088630|FG003|Overall Study|incidental finding|1|||
147528604|NCT00727246|532088627|FG000|Overall Study|withdrawn|0|||
147528605|NCT00727246|532088628|FG001|Overall Study|withdrawn|0|||
147528606|NCT00727246|532088629|FG002|Overall Study|withdrawn|1|||
147528607|NCT00727246|532088630|FG003|Overall Study|withdrawn|0|||
147528608|NCT03814499|532088631|FG000|Overall Study|Lost to Follow-up|3|||
147528609|NCT00334893|532088632|FG000|Overall Study|Not Treated|1|||
147528610|NCT00334893|532088633|FG001|Overall Study|Not Treated|0|||
147528611|NCT01552408|532088634|FG000|Overall Study|Lost to Follow-up|2|||
147528612|NCT01552408|532088635|FG001|Overall Study|Lost to Follow-up|0|||
147528613|NCT01552408|532088634|FG000|Overall Study|Relocation|0|||
147528614|NCT01552408|532088635|FG001|Overall Study|Relocation|1|||
147528615|NCT01552408|532088634|FG000|Overall Study|Withdrawal by Subject|2|||
147528616|NCT01552408|532088635|FG001|Overall Study|Withdrawal by Subject|1|||
147528617|NCT01348828|532088642|FG000|Overall Study|Death|20|||
147528618|NCT01348828|532088642|FG000|Overall Study|Withdrawals/Lost to Follow-up|10|||
147528619|NCT01348828|532088642|FG000|Overall Study|Conversion|2|||
147528620|NCT01348828|532088642|FG000|Overall Study|missed visit|1|||
147528621|NCT02442284|532088645|FG000|Overall Study|Adverse Event|1|||
147528622|NCT02442284|532088645|FG000|Overall Study|Withdrew Consent|2|||
147528623|NCT02442284|532088645|FG000|Overall Study|Lost to Follow-up|3|||
147528624|NCT02442284|532088645|FG000|Overall Study|Other|1|||
147528625|NCT02815670|532088646|FG000|Overall Study|Prematurely discontinued of the trial|1|||
147528626|NCT03137173|532088647|FG000|Overall Study|Withdrawal by Subject|8|||
147528627|NCT03137173|532088648|FG001|Overall Study|Withdrawal by Subject|13|||
147528628|NCT03137173|532088647|FG000|Overall Study|Death|1|||
147528629|NCT03137173|532088648|FG001|Overall Study|Death|3|||
147528630|NCT03137173|532088647|FG000|Overall Study|Physician Decision|1|||
147528631|NCT03137173|532088648|FG001|Overall Study|Physician Decision|0|||
147528632|NCT03137173|532088647|FG000|Overall Study|Lost to Follow-up|13|||
147528633|NCT03137173|532088648|FG001|Overall Study|Lost to Follow-up|18|||
147528634|NCT03137173|532088647|FG000|Overall Study|Other reasons|3|||
147528635|NCT03137173|532088648|FG001|Overall Study|Other reasons|2|||
147528636|NCT00842829|532088649|FG000|Dose Titration Period|Adverse Event|11|||
147528637|NCT00842829|532088650|FG001|Dose Titration Period|Adverse Event|10|||
147528638|NCT00842829|532088651|FG002|Dose Titration Period|Adverse Event|0|||
147528639|NCT00842829|532088649|FG000|Dose Titration Period|Lack of Efficacy|4|||
147528640|NCT00842829|532088650|FG001|Dose Titration Period|Lack of Efficacy|1|||
147528641|NCT00842829|532088651|FG002|Dose Titration Period|Lack of Efficacy|0|||
147528642|NCT00842829|532088649|FG000|Dose Titration Period|Unstable persistent cancer pain|1|||
147528643|NCT00842829|532088650|FG001|Dose Titration Period|Unstable persistent cancer pain|0|||
147528644|NCT00842829|532088651|FG002|Dose Titration Period|Unstable persistent cancer pain|0|||
147528645|NCT00842829|532088649|FG000|Dose Titration Period|Withdrawal by Subject|2|||
147528646|NCT00842829|532088650|FG001|Dose Titration Period|Withdrawal by Subject|6|||
147528647|NCT00842829|532088651|FG002|Dose Titration Period|Withdrawal by Subject|0|||
147528648|NCT00842829|532088649|FG000|Dose Titration Period|Other|5|||
147528649|NCT00842829|532088650|FG001|Dose Titration Period|Other|4|||
147528650|NCT00842829|532088651|FG002|Dose Titration Period|Other|0|||
147528651|NCT00842829|532088649|FG000|Dose Titration Period|Non-compliance to study procedures|1|||
147528652|NCT00842829|532088650|FG001|Dose Titration Period|Non-compliance to study procedures|1|||
147528653|NCT00842829|532088651|FG002|Dose Titration Period|Non-compliance to study procedures|0|||
147528654|NCT00842829|532088649|FG000|Dose Titration Period|Non-compliance to study drug|2|||
147528655|NCT00842829|532088650|FG001|Dose Titration Period|Non-compliance to study drug|1|||
147528656|NCT00842829|532088651|FG002|Dose Titration Period|Non-compliance to study drug|0|||
147528657|NCT00842829|532088649|FG000|Treatment Period|Adverse Event|0|||
147528658|NCT00842829|532088650|FG001|Treatment Period|Adverse Event|0|||
147528659|NCT00842829|532088651|FG002|Treatment Period|Adverse Event|15|||
147528660|NCT00842829|532088649|FG000|Treatment Period|Lack of Efficacy|0|||
147528661|NCT00842829|532088650|FG001|Treatment Period|Lack of Efficacy|0|||
147528662|NCT00842829|532088651|FG002|Treatment Period|Lack of Efficacy|6|||
147528663|NCT00842829|532088649|FG000|Treatment Period|Unstable persistent cancer pain|0|||
147528664|NCT00842829|532088650|FG001|Treatment Period|Unstable persistent cancer pain|0|||
147528665|NCT00842829|532088651|FG002|Treatment Period|Unstable persistent cancer pain|5|||
147528666|NCT00842829|532088649|FG000|Treatment Period|Withdrawal by Subject|0|||
147528667|NCT00842829|532088650|FG001|Treatment Period|Withdrawal by Subject|0|||
147528668|NCT00842829|532088651|FG002|Treatment Period|Withdrawal by Subject|11|||
147528669|NCT00842829|532088649|FG000|Treatment Period|Consistently >4 BTP episodes daily|0|||
147528670|NCT00842829|532088650|FG001|Treatment Period|Consistently >4 BTP episodes daily|0|||
147528671|NCT00842829|532088651|FG002|Treatment Period|Consistently >4 BTP episodes daily|1|||
147528672|NCT00842829|532088649|FG000|Treatment Period|Protocol Violation|0|||
147528673|NCT00842829|532088650|FG001|Treatment Period|Protocol Violation|0|||
147528674|NCT00842829|532088651|FG002|Treatment Period|Protocol Violation|2|||
147528675|NCT00842829|532088649|FG000|Treatment Period|Other|0|||
147528676|NCT00842829|532088650|FG001|Treatment Period|Other|0|||
147528677|NCT00842829|532088651|FG002|Treatment Period|Other|18|||
147528678|NCT00842829|532088649|FG000|Treatment Period|Non-compliance to study procedures|0|||
147528679|NCT00842829|532088650|FG001|Treatment Period|Non-compliance to study procedures|0|||
147528680|NCT00842829|532088651|FG002|Treatment Period|Non-compliance to study procedures|4|||
147528681|NCT00842829|532088649|FG000|Treatment Period|Unclear completion status|0|||
147528682|NCT00842829|532088650|FG001|Treatment Period|Unclear completion status|0|||
147528683|NCT00842829|532088651|FG002|Treatment Period|Unclear completion status|1|||
147528684|NCT00842829|532088649|FG000|Continuation Period|Adverse Event|0|||
147528685|NCT00842829|532088650|FG001|Continuation Period|Adverse Event|0|||
147528686|NCT00842829|532088651|FG002|Continuation Period|Adverse Event|32|||
147528687|NCT00842829|532088649|FG000|Continuation Period|Lack of Efficacy|0|||
147528688|NCT00842829|532088650|FG001|Continuation Period|Lack of Efficacy|0|||
147528689|NCT00842829|532088651|FG002|Continuation Period|Lack of Efficacy|6|||
147528690|NCT00842829|532088649|FG000|Continuation Period|Unstable persistent cancer pain|0|||
147528691|NCT00842829|532088650|FG001|Continuation Period|Unstable persistent cancer pain|0|||
147528692|NCT00842829|532088651|FG002|Continuation Period|Unstable persistent cancer pain|3|||
147528693|NCT00842829|532088649|FG000|Continuation Period|Withdrawal by Subject|0|||
147528694|NCT00842829|532088650|FG001|Continuation Period|Withdrawal by Subject|0|||
147528695|NCT00842829|532088651|FG002|Continuation Period|Withdrawal by Subject|10|||
147528696|NCT00842829|532088649|FG000|Continuation Period|Other|0|||
147528697|NCT00842829|532088650|FG001|Continuation Period|Other|0|||
147528698|NCT00842829|532088651|FG002|Continuation Period|Other|7|||
147528699|NCT00842829|532088649|FG000|Continuation Period|Non-compliance to study procedures|0|||
147528700|NCT00842829|532088650|FG001|Continuation Period|Non-compliance to study procedures|0|||
147528701|NCT00842829|532088651|FG002|Continuation Period|Non-compliance to study procedures|2|||
147528702|NCT00842829|532088649|FG000|Continuation Period|Non-compliance to study drug|0|||
147528703|NCT00842829|532088650|FG001|Continuation Period|Non-compliance to study drug|0|||
147528704|NCT00842829|532088651|FG002|Continuation Period|Non-compliance to study drug|1|||
147528705|NCT02127931|532088652|FG000|Overall Study|Glitch in Game|1|||
147528706|NCT01377194|532088653|FG000|Overall Study|Adverse Event|3|||
147528707|NCT01377194|532088654|FG001|Overall Study|Adverse Event|12|||
147528708|NCT01377194|532088655|FG002|Overall Study|Adverse Event|19|||
147528709|NCT01377194|532088653|FG000|Overall Study|Lack of Efficacy|3|||
147528710|NCT01377194|532088654|FG001|Overall Study|Lack of Efficacy|3|||
147528711|NCT01377194|532088655|FG002|Overall Study|Lack of Efficacy|3|||
147528712|NCT01377194|532088653|FG000|Overall Study|Protocol Violation|4|||
147528713|NCT01377194|532088654|FG001|Overall Study|Protocol Violation|10|||
147528714|NCT01377194|532088655|FG002|Overall Study|Protocol Violation|6|||
147528715|NCT01377194|532088653|FG000|Overall Study|Withdrawal by Subject|8|||
147528716|NCT01377194|532088654|FG001|Overall Study|Withdrawal by Subject|10|||
147528717|NCT01377194|532088655|FG002|Overall Study|Withdrawal by Subject|7|||
147528718|NCT01377194|532088653|FG000|Overall Study|Lost to Follow-up|14|||
147528719|NCT01377194|532088654|FG001|Overall Study|Lost to Follow-up|8|||
147528720|NCT01377194|532088655|FG002|Overall Study|Lost to Follow-up|11|||
147528721|NCT01190839|532088658|FG000|Overall Study|Adverse Event|32|||
147528722|NCT01190839|532088659|FG001|Overall Study|Adverse Event|41|||
147528723|NCT01190839|532088658|FG000|Overall Study|Protocol Violation|2|||
147528724|NCT01190839|532088659|FG001|Overall Study|Protocol Violation|2|||
147528725|NCT01190839|532088658|FG000|Overall Study|Lost to Follow-up|7|||
147528726|NCT01190839|532088659|FG001|Overall Study|Lost to Follow-up|1|||
147528727|NCT01190839|532088658|FG000|Overall Study|Death|1|||
147528728|NCT01190839|532088659|FG001|Overall Study|Death|0|||
147528729|NCT01190839|532088658|FG000|Overall Study|Trial stopped by Sponsor|71|||
147528730|NCT01190839|532088659|FG001|Overall Study|Trial stopped by Sponsor|68|||
147528731|NCT01190839|532088658|FG000|Overall Study|Undefined|35|||
147528732|NCT01190839|532088659|FG001|Overall Study|Undefined|31|||
147528733|NCT01190839|532088658|FG000|Overall Study|Randomized but not treated|2|||
147528734|NCT01190839|532088659|FG001|Overall Study|Randomized but not treated|4|||
147528735|NCT02993731|532088661|FG000|Overall Study|Study Termination|101|||
147528736|NCT02993731|532088662|FG001|Overall Study|Study Termination|105|||
147528737|NCT00323479|532088663|FG000|Overall Study|Adverse Event|2|||
147528738|NCT00323479|532088663|FG000|Overall Study|Withdrawal by Subject|2|||
147528739|NCT00323479|532088663|FG000|Overall Study|Protocol Violation|3|||
147528740|NCT00323479|532088663|FG000|Overall Study|house moving|1|||
147528741|NCT01362062|532088664|FG000|Overall Study|Adverse Event|1|||
147528742|NCT01362062|532088665|FG001|Overall Study|Adverse Event|0|||
147528743|NCT01362062|532088664|FG000|Overall Study|Lost to Follow-up|11|||
147528744|NCT01362062|532088665|FG001|Overall Study|Lost to Follow-up|0|||
147528745|NCT01362062|532088664|FG000|Overall Study|Withdrawal by Subject|2|||
147528746|NCT01362062|532088665|FG001|Overall Study|Withdrawal by Subject|0|||
147528747|NCT01362062|532088664|FG000|Overall Study|Non-compliant participant|2|||
147528748|NCT01362062|532088665|FG001|Overall Study|Non-compliant participant|0|||
147528749|NCT01362062|532088664|FG000|Overall Study|Detected with Spondylo-arthritis|1|||
147528750|NCT01362062|532088665|FG001|Overall Study|Detected with Spondylo-arthritis|0|||
147528751|NCT01362062|532088664|FG000|Overall Study|Had significant improvement|9|||
147528752|NCT01362062|532088665|FG001|Overall Study|Had significant improvement|0|||
147528753|NCT02545504|532088667|FG000|Overall Study|Death|174|||
147528754|NCT02545504|532088668|FG001|Overall Study|Death|168|||
147528755|NCT02545504|532088667|FG000|Overall Study|Unknown reason|30|||
147528756|NCT02545504|532088668|FG001|Overall Study|Unknown reason|32|||
147528757|NCT02545504|532088667|FG000|Overall Study|Withdrew consent|9|||
147528758|NCT02545504|532088668|FG001|Overall Study|Withdrew consent|11|||
147528759|NCT02545504|532088667|FG000|Overall Study|Investigator's discretion|3|||
147528760|NCT02545504|532088668|FG001|Overall Study|Investigator's discretion|1|||
147528761|NCT02545504|532088667|FG000|Overall Study|Lost to Follow-up|2|||
147528762|NCT02545504|532088668|FG001|Overall Study|Lost to Follow-up|2|||
147528763|NCT00967343|532088669|FG000|Overall Study|Study termination by sponsor|12|||
147528764|NCT00967343|532088669|FG000|Overall Study|Death|24|||
147528765|NCT00967343|532088669|FG000|Overall Study|Relapse|1|||
147528766|NCT00967343|532088669|FG000|Overall Study|Lost to Follow-up|1|||
147528767|NCT00950755|532088670|FG000|Dosimetric and Therapeutic Treatment|Lost to Follow-up|3|||
147528768|NCT00950755|532088670|FG000|Dosimetric and Therapeutic Treatment|Received Alternative Therapy|1|||
147528769|NCT00950755|532088670|FG000|Dosimetric and Therapeutic Treatment|Progressive Disease|27|||
147528770|NCT00950755|532088670|FG000|Dosimetric and Therapeutic Treatment|Death|1|||
147528771|NCT00950755|532088670|FG000|Dosimetric and Therapeutic Treatment|Stroke; Difficult to Attend Study Visits|1|||
147528772|NCT00950755|532088670|FG000|Dosimetric and Therapeutic Treatment|Participant Moved; Unable to Follow Up|1|||
147528773|NCT00950755|532088670|FG000|Dosimetric and Therapeutic Treatment|Rolled Over to Study BEX104528|6|||
147528774|NCT00950755|532088670|FG000|Dosimetric and Therapeutic Treatment|Investigator Discretion|1|||
147528775|NCT00950755|532088670|FG000|Long-Term Follow-Up|Lost to Follow-up|1|||
147528776|NCT00950755|532088670|FG000|Long-Term Follow-Up|Death|8|||
147528777|NCT00508820|532088672|FG000|Overall Study|Adverse Event|6|||
147528778|NCT00508820|532088673|FG001|Overall Study|Adverse Event|10|||
147528779|NCT00508820|532088672|FG000|Overall Study|Death|6|||
147528780|NCT00508820|532088673|FG001|Overall Study|Death|8|||
147528781|NCT00508820|532088672|FG000|Overall Study|Lost to Follow-up|1|||
147528782|NCT00508820|532088673|FG001|Overall Study|Lost to Follow-up|1|||
147528783|NCT00508820|532088672|FG000|Overall Study|Physician Decision|8|||
147528784|NCT00508820|532088673|FG001|Overall Study|Physician Decision|2|||
147528785|NCT00508820|532088672|FG000|Overall Study|Pregnancy|0|||
147528786|NCT00508820|532088673|FG001|Overall Study|Pregnancy|2|||
147528787|NCT00508820|532088672|FG000|Overall Study|Protocol Violation|2|||
147528788|NCT00508820|532088673|FG001|Overall Study|Protocol Violation|0|||
147528789|NCT00508820|532088672|FG000|Overall Study|Withdrawal by Subject|10|||
147528790|NCT00508820|532088673|FG001|Overall Study|Withdrawal by Subject|12|||
147528791|NCT00508820|532088672|FG000|Overall Study|Other|11|||
147528792|NCT00508820|532088673|FG001|Overall Study|Other|2|||
147528793|NCT00508820|532088672|FG000|Overall Study|Noncompliance|1|||
147528794|NCT00508820|532088673|FG001|Overall Study|Noncompliance|0|||
147528795|NCT00508820|532088672|FG000|Overall Study|Requirement for alternative therapy|7|||
147528796|NCT00508820|532088673|FG001|Overall Study|Requirement for alternative therapy|15|||
147528797|NCT00508820|532088672|FG000|Overall Study|Protocol-specified Criteria|3|||
147528798|NCT00508820|532088673|FG001|Overall Study|Protocol-specified Criteria|12|||
147528799|NCT04398030|532090503|FG000|Treatment Period 1 (1 Week)|Withdrawal by Subject|0|||
147528800|NCT04398030|532090504|FG001|Treatment Period 1 (1 Week)|Withdrawal by Subject|1|||
147528801|NCT04398030|532090503|FG000|Treatment Period 2 (1 Week)|Physician Decision|1|||
147528802|NCT04398030|532090504|FG001|Treatment Period 2 (1 Week)|Physician Decision|0|||
147528803|NCT02713490|532090507|FG000|Overall Study|Withdrawal by Subject|2|||
147528804|NCT02713490|532090508|FG001|Overall Study|Withdrawal by Subject|1|||
147528805|NCT02713490|532090507|FG000|Overall Study|Did not receive study drug|1|||
147528806|NCT02713490|532090508|FG001|Overall Study|Did not receive study drug|0|||
147528807|NCT02713490|532090507|FG000|Overall Study|Met exclusion criteria|0|||
147528808|NCT02713490|532090508|FG001|Overall Study|Met exclusion criteria|1|||
147528809|NCT00548340|532090513|FG000|Overall Study|Protocol Violation|2|||
147528810|NCT00548340|532090514|FG001|Overall Study|Protocol Violation|3|||
147528811|NCT00548340|532090515|FG002|Overall Study|Protocol Violation|3|||
147528812|NCT00548340|532090513|FG000|Overall Study|Adverse Event|2|||
147528813|NCT00548340|532090514|FG001|Overall Study|Adverse Event|2|||
147528814|NCT00548340|532090515|FG002|Overall Study|Adverse Event|2|||
147528815|NCT00548340|532090513|FG000|Overall Study|Lost to Follow-up|1|||
147528816|NCT00548340|532090514|FG001|Overall Study|Lost to Follow-up|1|||
147528817|NCT00548340|532090515|FG002|Overall Study|Lost to Follow-up|0|||
147528818|NCT00548340|532090513|FG000|Overall Study|Withdrawal by Subject|2|||
147528819|NCT00548340|532090514|FG001|Overall Study|Withdrawal by Subject|4|||
147528820|NCT00548340|532090515|FG002|Overall Study|Withdrawal by Subject|3|||
147528821|NCT00548340|532090513|FG000|Overall Study|Other|1|||
147528822|NCT00548340|532090514|FG001|Overall Study|Other|1|||
147528823|NCT00548340|532090515|FG002|Overall Study|Other|1|||
147528824|NCT01096017|532090516|FG000|Treatment Period 2|Eligibility criteria not fulfilled|1|||
147528825|NCT01096017|532090517|FG001|Treatment Period 2|Eligibility criteria not fulfilled|1|||
147528826|NCT02600559|532090518|FG000|Overall Study|Withdrawal by Subject|3|||
147528827|NCT02600559|532090518|FG000|Overall Study|Lost to Follow-up|20|||
147528828|NCT03410693|532090519|FG000|Overall Study|Disc trt: Withdrawal by participant|6|||
147528829|NCT03410693|532090520|FG001|Overall Study|Disc trt: Withdrawal by participant|4|||
147528830|NCT03410693|532090519|FG000|Overall Study|Disc trt: Lost to follow up|0|||
147528831|NCT03410693|532090520|FG001|Overall Study|Disc trt: Lost to follow up|1|||
147528832|NCT03410693|532090519|FG000|Overall Study|Disc trt: radiological progression|58|||
147528833|NCT03410693|532090520|FG001|Overall Study|Disc trt: radiological progression|50|||
147528834|NCT03410693|532090519|FG000|Overall Study|Disc trt: Other|1|||
147528835|NCT03410693|532090520|FG001|Overall Study|Disc trt: Other|0|||
147528836|NCT03410693|532090519|FG000|Overall Study|Study drug never administered|1|||
147528837|NCT03410693|532090520|FG001|Overall Study|Study drug never administered|6|||
147528838|NCT03410693|532090519|FG000|Overall Study|Discontinued (disc) treatment (trt): Death|6|||
147528839|NCT03410693|532090520|FG001|Overall Study|Discontinued (disc) treatment (trt): Death|4|||
147528840|NCT03410693|532090519|FG000|Overall Study|Disc trt: Adverse Event (AE)|13|||
147528841|NCT03410693|532090520|FG001|Overall Study|Disc trt: Adverse Event (AE)|9|||
147528842|NCT03410693|532090519|FG000|Overall Study|Disc trt: Physician decision|0|||
147528843|NCT03410693|532090520|FG001|Overall Study|Disc trt: Physician decision|5|||
147528844|NCT03410693|532090519|FG000|Overall Study|Disc trt: clinical progression|1|||
147528845|NCT03410693|532090520|FG001|Overall Study|Disc trt: clinical progression|5|||
147528846|NCT03410693|532090519|FG000|Overall Study|Disc trt:AE not asso. w/ clinical disease progress|1|||
147528847|NCT03410693|532090520|FG001|Overall Study|Disc trt:AE not asso. w/ clinical disease progress|4|||
147528848|NCT01789476|532090521|FG000|Overall Study|Lack of Efficacy|6|||
147528849|NCT01789476|532090522|FG001|Overall Study|Lack of Efficacy|2|||
147528850|NCT01789476|532090521|FG000|Overall Study|Adverse Event|1|||
147528851|NCT01789476|532090522|FG001|Overall Study|Adverse Event|0|||
147528852|NCT01789476|532090521|FG000|Overall Study|Unable to get IV access|1|||
147528853|NCT01789476|532090522|FG001|Overall Study|Unable to get IV access|0|||
147528854|NCT00953576|532090523|FG000|Overall Study|Adverse Event|0|||
147528855|NCT00953576|532090524|FG001|Overall Study|Adverse Event|1|||
147528856|NCT00953576|532090523|FG000|Overall Study|Ineligible after Consent|2|||
147528857|NCT00953576|532090524|FG001|Overall Study|Ineligible after Consent|0|||
147528858|NCT00501969|532090525|FG000|Overall Study|Major Protocol Violation|4|||
147528859|NCT00501969|532090525|FG000|Overall Study|Lack of Efficacy|29|||
147528860|NCT00501969|532090525|FG000|Overall Study|Adverse Event|76|||
147528861|NCT00501969|532090525|FG000|Overall Study|Unsatisfactory compliance of subject|7|||
147528862|NCT00501969|532090525|FG000|Overall Study|Subject withdrew consent|51|||
147528863|NCT00501969|532090525|FG000|Overall Study|Lost to Follow-up|4|||
147528864|NCT00501969|532090525|FG000|Overall Study|Other: Tired Of Clinical Trial Process|1|||
147528865|NCT00501969|532090525|FG000|Overall Study|Other: Sponsors Request|10|||
147528866|NCT00501969|532090525|FG000|Overall Study|Other: Sponsor Termination at Site|1|||
147528867|NCT00501969|532090525|FG000|Overall Study|Other: Sponsor Stopped Study|12|||
147528868|NCT00501969|532090525|FG000|Overall Study|Other: Severe Dementia Unable Sign PIC|1|||
147528869|NCT00501969|532090525|FG000|Overall Study|Other: Patients + Investigator Agreement|1|||
147528870|NCT00501969|532090525|FG000|Overall Study|Other: Patient is Going to Have DBS|1|||
147528871|NCT00501969|532090525|FG000|Overall Study|Other: Pat Pending Surgery for PD|1|||
147528872|NCT00501969|532090525|FG000|Overall Study|Other: DX Changed - Parkinsons to PSNP|1|||
147528873|NCT00501969|532090525|FG000|Overall Study|Other: As Required by Local EC|2|||
147528874|NCT00501969|532090525|FG000|Overall Study|Other: Admin Request from the Sponsor|3|||
147528875|NCT00501969|532090525|FG000|Overall Study|Other: Sponsor Termination/Commercial RX|1|||
147528876|NCT00665366|532090528|FG000|Overall Study|Lack of Efficacy|11|||
147528877|NCT00665366|532090529|FG001|Overall Study|Lack of Efficacy|10|||
147528878|NCT00665366|532090528|FG000|Overall Study|Adverse Event|25|||
147528879|NCT00665366|532090529|FG001|Overall Study|Adverse Event|23|||
147528880|NCT00665366|532090528|FG000|Overall Study|Withdrawal by Subject|11|||
147528881|NCT00665366|532090529|FG001|Overall Study|Withdrawal by Subject|14|||
147528882|NCT00665366|532090528|FG000|Overall Study|Lost to Follow-up|3|||
147528883|NCT00665366|532090529|FG001|Overall Study|Lost to Follow-up|5|||
147528884|NCT00665366|532090528|FG000|Overall Study|Poor compliance/noncompliance|3|||
147528885|NCT00665366|532090529|FG001|Overall Study|Poor compliance/noncompliance|5|||
147528886|NCT00665366|532090528|FG000|Overall Study|Pregnancy|1|||
147528887|NCT00665366|532090529|FG001|Overall Study|Pregnancy|0|||
147528888|NCT00665366|532090528|FG000|Overall Study|No longer meets study criteria|0|||
147528889|NCT00665366|532090529|FG001|Overall Study|No longer meets study criteria|1|||
147528890|NCT00665366|532090528|FG000|Overall Study|Other reasons|4|||
147528891|NCT00665366|532090529|FG001|Overall Study|Other reasons|1|||
147528892|NCT03778021|532090531|FG000|Overall Study|Student failed to respond to follow-up survey|28|||
147528893|NCT03778021|532090532|FG001|Overall Study|Student failed to respond to follow-up survey|53|||
147528894|NCT01545375|532090533|FG000|Overall Study|Adverse Event|2|||
147528895|NCT01545375|532090534|FG001|Overall Study|Adverse Event|1|||
147528896|NCT01545375|532090533|FG000|Overall Study|Lost to Follow-up|34|||
147528897|NCT01545375|532090534|FG001|Overall Study|Lost to Follow-up|31|||
147528898|NCT01545375|532090533|FG000|Overall Study|Protocol Violation|3|||
147528899|NCT01545375|532090534|FG001|Overall Study|Protocol Violation|3|||
147528900|NCT01545375|532090533|FG000|Overall Study|Withdrawal by Subject|58|||
147528901|NCT01545375|532090534|FG001|Overall Study|Withdrawal by Subject|55|||
147528902|NCT02687815|532090535|FG000|Overall Study|Lost to Follow-up|2|||
147528903|NCT02687815|532090536|FG001|Overall Study|Lost to Follow-up|4|||
147528904|NCT02687815|532090535|FG000|Overall Study|Withdrawal by Subject|2|||
147528905|NCT02687815|532090536|FG001|Overall Study|Withdrawal by Subject|4|||
147528906|NCT04177862|532090537|FG000|Overall Study|Protocol Violation|2|||
147528907|NCT04177862|532090538|FG001|Overall Study|Protocol Violation|7|||
147528908|NCT05637515|532090543|FG000|Overall Study|Withdrawal by Subject|17|||
147528909|NCT05637515|532090544|FG001|Overall Study|Withdrawal by Subject|17|||
147528910|NCT00151775|532090545|FG000|Period 2 - Double-Blind Dose Response|Adverse Event|1|||
147528911|NCT00151775|532090546|FG001|Period 2 - Double-Blind Dose Response|Adverse Event|2|||
147528912|NCT00151775|532090547|FG002|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
147528913|NCT00151775|532090548|FG003|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
147528914|NCT00151775|532090549|FG004|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
147528915|NCT00151775|532090550|FG005|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
147528916|NCT00151775|532090551|FG006|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
147528917|NCT00151775|532090552|FG007|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
147528918|NCT00151775|532090553|FG008|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
147528919|NCT00151775|532090554|FG009|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
147528920|NCT00151775|532090555|FG010|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
147528921|NCT00151775|532090556|FG011|Period 2 - Double-Blind Dose Response|Adverse Event|0|||
147528922|NCT00151775|532090545|FG000|Period 2 - Double-Blind Dose Response|Lost to Follow-up|1|||
147528923|NCT00151775|532090546|FG001|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
147528924|NCT00151775|532090547|FG002|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
147528925|NCT00151775|532090548|FG003|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
147528926|NCT00151775|532090549|FG004|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
147528927|NCT00151775|532090550|FG005|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
147528928|NCT00151775|532090551|FG006|Period 2 - Double-Blind Dose Response|Lost to Follow-up|1|||
147528929|NCT00151775|532090552|FG007|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
147528930|NCT00151775|532090553|FG008|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
147528931|NCT00151775|532090554|FG009|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
147528932|NCT00151775|532090555|FG010|Period 2 - Double-Blind Dose Response|Lost to Follow-up|1|||
147528933|NCT00151775|532090556|FG011|Period 2 - Double-Blind Dose Response|Lost to Follow-up|0|||
147528934|NCT00151775|532090545|FG000|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
147528935|NCT00151775|532090546|FG001|Period 2 - Double-Blind Dose Response|Protocol Violation|4|||
147528936|NCT00151775|532090547|FG002|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
147528937|NCT00151775|532090548|FG003|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
147528938|NCT00151775|532090549|FG004|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
147528939|NCT00151775|532090550|FG005|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
147528940|NCT00151775|532090551|FG006|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
147528941|NCT00151775|532090552|FG007|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
147528942|NCT00151775|532090553|FG008|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
147528943|NCT00151775|532090554|FG009|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
147528944|NCT00151775|532090555|FG010|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
147528945|NCT00151775|532090556|FG011|Period 2 - Double-Blind Dose Response|Protocol Violation|0|||
147528946|NCT00151775|532090545|FG000|Period 2 - Double-Blind Dose Response|Other|0|||
147528947|NCT00151775|532090546|FG001|Period 2 - Double-Blind Dose Response|Other|0|||
147528948|NCT00151775|532090547|FG002|Period 2 - Double-Blind Dose Response|Other|0|||
147528949|NCT00151775|532090548|FG003|Period 2 - Double-Blind Dose Response|Other|0|||
147528950|NCT00151775|532090549|FG004|Period 2 - Double-Blind Dose Response|Other|0|||
147644292|NCT02326298|532516788|FG011|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
147644293|NCT02326298|532516789|FG012|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
147644294|NCT02326298|532516790|FG013|Initial Period (Week 0 to Week 16)|Lost to Follow-up|0|||
147644295|NCT02326298|532516777|FG000|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|3|||
147644296|NCT02326298|532516778|FG001|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|2|||
147644297|NCT02326298|532516779|FG002|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
147644298|NCT02326298|532516780|FG003|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
147644299|NCT02326298|532516781|FG004|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
147644300|NCT02326298|532516782|FG005|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
147644301|NCT02326298|532516783|FG006|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
147644302|NCT02326298|532516784|FG007|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
147644303|NCT02326298|532516785|FG008|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
147644304|NCT02326298|532516786|FG009|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
147644305|NCT02326298|532516787|FG010|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
147644306|NCT02326298|532516788|FG011|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
147644307|NCT02326298|532516789|FG012|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
147644308|NCT02326298|532516790|FG013|Initial Period (Week 0 to Week 16)|Withdrawal by Subject|0|||
147644309|NCT02326298|532516777|FG000|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
147644310|NCT02326298|532516778|FG001|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
147644311|NCT02326298|532516779|FG002|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|2|||
147644312|NCT02326298|532516780|FG003|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
147644313|NCT02326298|532516781|FG004|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
147644314|NCT02326298|532516782|FG005|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
147644315|NCT02326298|532516783|FG006|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
147644316|NCT02326298|532516784|FG007|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
147644317|NCT02326298|532516785|FG008|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
147644318|NCT02326298|532516786|FG009|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
147644319|NCT02326298|532516787|FG010|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
147644320|NCT02326298|532516788|FG011|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
147644321|NCT02326298|532516789|FG012|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
147644322|NCT02326298|532516790|FG013|Initial Period (Week 0 to Week 16)|Adverse event after completing wk16|0|||
147644323|NCT02326298|532516777|FG000|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
147644324|NCT02326298|532516778|FG001|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
147644325|NCT02326298|532516779|FG002|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
147644326|NCT02326298|532516780|FG003|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
147644327|NCT02326298|532516781|FG004|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
147644328|NCT02326298|532516782|FG005|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
147644329|NCT02326298|532516783|FG006|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|3|||
147644330|NCT02326298|532516784|FG007|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
147644331|NCT02326298|532516785|FG008|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
147644332|NCT02326298|532516786|FG009|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|1|||
147644333|NCT02326298|532516787|FG010|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
147644334|NCT02326298|532516788|FG011|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
147644335|NCT02326298|532516789|FG012|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
147644336|NCT02326298|532516790|FG013|Maintenance Period (Week 16 to Week 48)|Withdrawal by Subject|0|||
147644337|NCT02326298|532516777|FG000|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
147644338|NCT02326298|532516778|FG001|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
147644339|NCT02326298|532516779|FG002|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
147644340|NCT02326298|532516780|FG003|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
147644341|NCT02326298|532516781|FG004|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
147644342|NCT02326298|532516782|FG005|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|1|||
147644343|NCT02326298|532516783|FG006|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|2|||
147644344|NCT02326298|532516784|FG007|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
147644345|NCT02326298|532516785|FG008|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|4|||
147644346|NCT02326298|532516786|FG009|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
147644347|NCT02326298|532516787|FG010|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
147644348|NCT02326298|532516788|FG011|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
147644349|NCT02326298|532516789|FG012|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
147644350|NCT02326298|532516790|FG013|Maintenance Period (Week 16 to Week 48)|Patient did not achieve PASI50 response|0|||
147644351|NCT02326298|532516777|FG000|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
147644352|NCT02326298|532516778|FG001|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
147644353|NCT02326298|532516779|FG002|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
147644354|NCT02326298|532516780|FG003|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
147644355|NCT02326298|532516781|FG004|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
147644356|NCT02326298|532516782|FG005|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|1|||
147644357|NCT02326298|532516783|FG006|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
147644358|NCT02326298|532516784|FG007|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
147644359|NCT02326298|532516785|FG008|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
147644360|NCT02326298|532516786|FG009|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
147644361|NCT02326298|532516787|FG010|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
147644362|NCT02326298|532516788|FG011|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
147644363|NCT02326298|532516789|FG012|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
147644364|NCT02326298|532516790|FG013|Maintenance Period (Week 16 to Week 48)|Patient cannot attend visits|0|||
147644365|NCT02326298|532516777|FG000|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
147644366|NCT02326298|532516778|FG001|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
147644367|NCT02326298|532516779|FG002|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
147644368|NCT02326298|532516780|FG003|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
147644369|NCT02326298|532516781|FG004|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
147644370|NCT02326298|532516782|FG005|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
147644371|NCT02326298|532516783|FG006|Maintenance Period (Week 16 to Week 48)|Pregnancy|1|||
147644372|NCT02326298|532516784|FG007|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
147644373|NCT02326298|532516785|FG008|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
147644374|NCT02326298|532516786|FG009|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
147644375|NCT02326298|532516787|FG010|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
147644376|NCT02326298|532516788|FG011|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
147644377|NCT02326298|532516789|FG012|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
147644378|NCT02326298|532516790|FG013|Maintenance Period (Week 16 to Week 48)|Pregnancy|0|||
147644379|NCT02326298|532516777|FG000|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
147644380|NCT02326298|532516778|FG001|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
147644381|NCT02326298|532516779|FG002|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
147644382|NCT02326298|532516780|FG003|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
147644383|NCT02326298|532516781|FG004|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
147644384|NCT02326298|532516782|FG005|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
147644385|NCT02326298|532516783|FG006|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
147644386|NCT02326298|532516784|FG007|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|1|||
147644387|NCT02326298|532516785|FG008|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
147644388|NCT02326298|532516786|FG009|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
147644389|NCT02326298|532516787|FG010|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
147644390|NCT02326298|532516788|FG011|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
147644391|NCT02326298|532516789|FG012|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
147644392|NCT02326298|532516790|FG013|Maintenance Period (Week 16 to Week 48)|No valid reason stated by patient|0|||
147644393|NCT02326298|532516777|FG000|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
147644394|NCT02326298|532516778|FG001|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
147644395|NCT02326298|532516779|FG002|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
147644396|NCT02326298|532516780|FG003|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
147644397|NCT02326298|532516781|FG004|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
147644398|NCT02326298|532516782|FG005|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
147644399|NCT02326298|532516783|FG006|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|1|||
147644400|NCT02326298|532516784|FG007|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|2|||
147644401|NCT02326298|532516785|FG008|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
147644402|NCT02326298|532516786|FG009|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
147644403|NCT02326298|532516787|FG010|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
147644404|NCT02326298|532516788|FG011|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
147644405|NCT02326298|532516789|FG012|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
147644406|NCT02326298|532516790|FG013|Maintenance Period (Week 16 to Week 48)|Lost to Follow-up|0|||
147644407|NCT02326298|532516777|FG000|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
147644408|NCT02326298|532516778|FG001|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
147644409|NCT02326298|532516779|FG002|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
147644410|NCT02326298|532516780|FG003|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
147644411|NCT02326298|532516781|FG004|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
147644412|NCT02326298|532516782|FG005|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
147644413|NCT02326298|532516783|FG006|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
147644414|NCT02326298|532516784|FG007|Maintenance Period (Week 16 to Week 48)|Adverse Event|1|||
147644415|NCT02326298|532516785|FG008|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
147644416|NCT02326298|532516786|FG009|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
147644417|NCT02326298|532516787|FG010|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
147644418|NCT02326298|532516788|FG011|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
147644419|NCT02326298|532516789|FG012|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
147644420|NCT02326298|532516790|FG013|Maintenance Period (Week 16 to Week 48)|Adverse Event|0|||
147644421|NCT02326298|532516777|FG000|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
147644422|NCT02326298|532516778|FG001|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
147644423|NCT02326298|532516779|FG002|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
147644424|NCT02326298|532516780|FG003|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
147644425|NCT02326298|532516781|FG004|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
147644426|NCT02326298|532516782|FG005|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|2|||
147644427|NCT02326298|532516783|FG006|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
147644428|NCT02326298|532516784|FG007|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
147644429|NCT02326298|532516785|FG008|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
147644430|NCT02326298|532516786|FG009|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
147644431|NCT02326298|532516787|FG010|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
147644432|NCT02326298|532516788|FG011|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
147644433|NCT02326298|532516789|FG012|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
147644434|NCT02326298|532516790|FG013|Maintenance Period (Week 16 to Week 48)|Did not achieve PASI50 after week 48|0|||
147644435|NCT02326298|532516777|FG000|Open-label Period (Week 48 to Week 144)|Death|0|||
147644436|NCT02326298|532516778|FG001|Open-label Period (Week 48 to Week 144)|Death|0|||
147644437|NCT02326298|532516779|FG002|Open-label Period (Week 48 to Week 144)|Death|0|||
147644438|NCT02326298|532516780|FG003|Open-label Period (Week 48 to Week 144)|Death|0|||
147644439|NCT02326298|532516781|FG004|Open-label Period (Week 48 to Week 144)|Death|0|||
147644440|NCT02326298|532516782|FG005|Open-label Period (Week 48 to Week 144)|Death|0|||
147644441|NCT02326298|532516783|FG006|Open-label Period (Week 48 to Week 144)|Death|0|||
147644442|NCT02326298|532516784|FG007|Open-label Period (Week 48 to Week 144)|Death|0|||
147644443|NCT02326298|532516785|FG008|Open-label Period (Week 48 to Week 144)|Death|0|||
147644444|NCT02326298|532516786|FG009|Open-label Period (Week 48 to Week 144)|Death|0|||
147644445|NCT02326298|532516787|FG010|Open-label Period (Week 48 to Week 144)|Death|0|||
147644446|NCT02326298|532516788|FG011|Open-label Period (Week 48 to Week 144)|Death|1|||
147644447|NCT02326298|532516789|FG012|Open-label Period (Week 48 to Week 144)|Death|0|||
147644448|NCT02326298|532516790|FG013|Open-label Period (Week 48 to Week 144)|Death|0|||
147644449|NCT02326298|532516777|FG000|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
147644450|NCT02326298|532516778|FG001|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
147644451|NCT02326298|532516779|FG002|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
147644452|NCT02326298|532516780|FG003|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
147644453|NCT02326298|532516781|FG004|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
147644454|NCT02326298|532516782|FG005|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
147644455|NCT02326298|532516783|FG006|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
147644456|NCT02326298|532516784|FG007|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
147644457|NCT02326298|532516785|FG008|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
147644458|NCT02326298|532516786|FG009|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
147644459|NCT02326298|532516787|FG010|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
147644460|NCT02326298|532516788|FG011|Open-label Period (Week 48 to Week 144)|Adverse Event|3|||
147644461|NCT02326298|532516789|FG012|Open-label Period (Week 48 to Week 144)|Adverse Event|3|||
147644462|NCT02326298|532516790|FG013|Open-label Period (Week 48 to Week 144)|Adverse Event|0|||
147644463|NCT02326298|532516777|FG000|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
147644464|NCT02326298|532516778|FG001|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
147644465|NCT02326298|532516779|FG002|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
147644466|NCT02326298|532516780|FG003|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
147644467|NCT02326298|532516781|FG004|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
147644468|NCT02326298|532516782|FG005|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
147644469|NCT02326298|532516783|FG006|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
147644470|NCT02326298|532516784|FG007|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
147644471|NCT02326298|532516785|FG008|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
147644472|NCT02326298|532516786|FG009|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
147644473|NCT02326298|532516787|FG010|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
147644474|NCT02326298|532516788|FG011|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
147644475|NCT02326298|532516789|FG012|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|1|||
147644476|NCT02326298|532516790|FG013|Open-label Period (Week 48 to Week 144)|Lack of Efficacy|0|||
147644477|NCT02326298|532516777|FG000|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
147644478|NCT02326298|532516778|FG001|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
147644479|NCT02326298|532516779|FG002|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
147644480|NCT02326298|532516780|FG003|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
147644481|NCT02326298|532516781|FG004|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
147644482|NCT02326298|532516782|FG005|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
147644483|NCT02326298|532516783|FG006|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
147644484|NCT02326298|532516784|FG007|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
147644485|NCT02326298|532516785|FG008|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
147644486|NCT02326298|532516786|FG009|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
147644487|NCT02326298|532516787|FG010|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
147644488|NCT02326298|532516788|FG011|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
147644489|NCT02326298|532516789|FG012|Open-label Period (Week 48 to Week 144)|Protocol Violation|0|||
147644490|NCT02326298|532516790|FG013|Open-label Period (Week 48 to Week 144)|Protocol Violation|2|||
147644491|NCT02326298|532516777|FG000|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
147644492|NCT02326298|532516778|FG001|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
147528951|NCT00151775|532090550|FG005|Period 2 - Double-Blind Dose Response|Other|0|||
147528952|NCT00151775|532090551|FG006|Period 2 - Double-Blind Dose Response|Other|1|||
147528953|NCT00151775|532090552|FG007|Period 2 - Double-Blind Dose Response|Other|0|||
147528954|NCT00151775|532090553|FG008|Period 2 - Double-Blind Dose Response|Other|0|||
147528955|NCT00151775|532090554|FG009|Period 2 - Double-Blind Dose Response|Other|0|||
147528956|NCT00151775|532090555|FG010|Period 2 - Double-Blind Dose Response|Other|0|||
147528957|NCT00151775|532090556|FG011|Period 2 - Double-Blind Dose Response|Other|0|||
147528958|NCT00151775|532090545|FG000|Period 2 - Double-Blind Dose Response|non-compliance|0|||
147528959|NCT00151775|532090546|FG001|Period 2 - Double-Blind Dose Response|non-compliance|0|||
147528960|NCT00151775|532090547|FG002|Period 2 - Double-Blind Dose Response|non-compliance|0|||
147528961|NCT00151775|532090548|FG003|Period 2 - Double-Blind Dose Response|non-compliance|0|||
147644493|NCT02326298|532516779|FG002|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
147644494|NCT02326298|532516780|FG003|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
147644495|NCT02326298|532516781|FG004|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
147644496|NCT02326298|532516782|FG005|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
147644497|NCT02326298|532516783|FG006|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
147644498|NCT02326298|532516784|FG007|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
147644499|NCT02326298|532516785|FG008|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
147644500|NCT02326298|532516786|FG009|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
147644501|NCT02326298|532516787|FG010|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|0|||
147644502|NCT02326298|532516788|FG011|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|7|||
147644503|NCT02326298|532516789|FG012|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|2|||
147644504|NCT02326298|532516790|FG013|Open-label Period (Week 48 to Week 144)|Withdrawal by Subject|1|||
147644505|NCT02326298|532516777|FG000|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
147644506|NCT02326298|532516778|FG001|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
147644507|NCT02326298|532516779|FG002|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
147644508|NCT02326298|532516780|FG003|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
147644509|NCT02326298|532516781|FG004|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
147644510|NCT02326298|532516782|FG005|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
147644511|NCT02326298|532516783|FG006|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
147644512|NCT02326298|532516784|FG007|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
147644513|NCT02326298|532516785|FG008|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
147644514|NCT02326298|532516786|FG009|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
147644515|NCT02326298|532516787|FG010|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|0|||
147644516|NCT02326298|532516788|FG011|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|2|||
147644517|NCT02326298|532516789|FG012|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|7|||
147644518|NCT02326298|532516790|FG013|Open-label Period (Week 48 to Week 144)|Did not achieve PASI50|3|||
147644519|NCT02326298|532516777|FG000|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
147644520|NCT02326298|532516778|FG001|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
147644521|NCT02326298|532516779|FG002|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
147644522|NCT02326298|532516780|FG003|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
147644523|NCT02326298|532516781|FG004|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
147644524|NCT02326298|532516782|FG005|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
147644525|NCT02326298|532516783|FG006|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
147644526|NCT02326298|532516784|FG007|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
147644527|NCT02326298|532516785|FG008|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
147644528|NCT02326298|532516786|FG009|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
147644529|NCT02326298|532516787|FG010|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|0|||
147644530|NCT02326298|532516788|FG011|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|6|||
147644531|NCT02326298|532516789|FG012|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|6|||
147644532|NCT02326298|532516790|FG013|Open-label Period (Week 48 to Week 144)|Lost to Follow-up|3|||
147644533|NCT01472939|532518837|FG000|Overall Study|Adverse Event|3|||
147644534|NCT01472939|532518838|FG001|Overall Study|Adverse Event|7|||
147644535|NCT01472939|532518839|FG002|Overall Study|Adverse Event|7|||
147644536|NCT01472939|532518840|FG003|Overall Study|Adverse Event|14|||
147644537|NCT01472939|532518837|FG000|Overall Study|Lack of Efficacy|1|||
147644538|NCT01472939|532518838|FG001|Overall Study|Lack of Efficacy|0|||
147644539|NCT01472939|532518839|FG002|Overall Study|Lack of Efficacy|0|||
147644540|NCT01472939|532518840|FG003|Overall Study|Lack of Efficacy|1|||
147644541|NCT01472939|532518837|FG000|Overall Study|Lost to Follow-up|3|||
147644542|NCT01472939|532518838|FG001|Overall Study|Lost to Follow-up|0|||
147644543|NCT01472939|532518839|FG002|Overall Study|Lost to Follow-up|2|||
147644544|NCT01472939|532518840|FG003|Overall Study|Lost to Follow-up|0|||
147644545|NCT01472939|532518837|FG000|Overall Study|Clinically Significant Pre-Dose ECG|0|||
147644546|NCT01472939|532518838|FG001|Overall Study|Clinically Significant Pre-Dose ECG|0|||
147644547|NCT01472939|532518839|FG002|Overall Study|Clinically Significant Pre-Dose ECG|1|||
147644548|NCT01472939|532518840|FG003|Overall Study|Clinically Significant Pre-Dose ECG|0|||
147644549|NCT01472939|532518837|FG000|Overall Study|Prohibited Medication|0|||
147644550|NCT01472939|532518838|FG001|Overall Study|Prohibited Medication|1|||
147644551|NCT01472939|532518839|FG002|Overall Study|Prohibited Medication|0|||
147644552|NCT01472939|532518840|FG003|Overall Study|Prohibited Medication|0|||
147644553|NCT01472939|532518837|FG000|Overall Study|Withdrawal By PI|1|||
147644554|NCT01472939|532518838|FG001|Overall Study|Withdrawal By PI|0|||
147644555|NCT01472939|532518839|FG002|Overall Study|Withdrawal By PI|0|||
147644556|NCT01472939|532518840|FG003|Overall Study|Withdrawal By PI|0|||
147644557|NCT01472939|532518837|FG000|Overall Study|Protocol Violation|3|||
147644558|NCT01472939|532518838|FG001|Overall Study|Protocol Violation|3|||
147644559|NCT01472939|532518839|FG002|Overall Study|Protocol Violation|0|||
147644560|NCT01472939|532518840|FG003|Overall Study|Protocol Violation|1|||
147644561|NCT01472939|532518837|FG000|Overall Study|Withdrawal by Subject|9|||
147644562|NCT01472939|532518838|FG001|Overall Study|Withdrawal by Subject|3|||
147644563|NCT01472939|532518839|FG002|Overall Study|Withdrawal by Subject|1|||
147644564|NCT01472939|532518840|FG003|Overall Study|Withdrawal by Subject|4|||
147644565|NCT02604550|532518845|FG000|Overall Study|Lost to Follow-up|7|||
147644566|NCT02604550|532518846|FG001|Overall Study|Lost to Follow-up|6|||
147644567|NCT02604550|532518845|FG000|Overall Study|Withdrawal by Subject|0|||
147644568|NCT02604550|532518846|FG001|Overall Study|Withdrawal by Subject|1|||
147644569|NCT02604550|532518845|FG000|Overall Study|Incomplete data using paper journal|18|||
147644570|NCT02604550|532518846|FG001|Overall Study|Incomplete data using paper journal|19|||
147644571|NCT01404208|532518847|FG000|Overall Study|Discontinued|3|||
147644572|NCT01404208|532518848|FG001|Overall Study|Discontinued|0|||
147644573|NCT00908076|532518851|FG000|Overall Study|Lack of Efficacy|1|||
147644574|NCT00908076|532518852|FG001|Overall Study|Lack of Efficacy|1|||
147644575|NCT02609724|532518853|FG000|Overall Study|Death|2|||
147644576|NCT02609724|532518854|FG001|Overall Study|Death|0|||
147644577|NCT02609724|532518855|FG002|Overall Study|Death|1|||
147644578|NCT02609724|532518853|FG000|Overall Study|Withdrawal by Subject|1|||
147644579|NCT02609724|532518854|FG001|Overall Study|Withdrawal by Subject|2|||
147644580|NCT02609724|532518855|FG002|Overall Study|Withdrawal by Subject|3|||
147644581|NCT02609724|532518853|FG000|Overall Study|Illness|2|||
147644582|NCT02609724|532518854|FG001|Overall Study|Illness|1|||
147644583|NCT02609724|532518855|FG002|Overall Study|Illness|0|||
147644584|NCT03077659|532518856|FG000|Overall Study|Withdrawal by Subject|0|||
147644585|NCT03077659|532518857|FG001|Overall Study|Withdrawal by Subject|0|||
147644586|NCT03077659|532518858|FG002|Overall Study|Withdrawal by Subject|1|||
147644587|NCT03769675|532518859|FG000|Overall Study|Lost to Follow-up|1|||
147644588|NCT04068688|532518860|FG000|Overall Study|Lost to Follow-up|1|||
147644589|NCT04068688|532518861|FG001|Overall Study|Lost to Follow-up|1|||
147644590|NCT04068688|532518862|FG002|Overall Study|Lost to Follow-up|0|||
147644591|NCT04068688|532518863|FG003|Overall Study|Lost to Follow-up|0|||
147644592|NCT04068688|532518864|FG004|Overall Study|Lost to Follow-up|5|||
147644593|NCT04068688|532518865|FG005|Overall Study|Lost to Follow-up|5|||
147644594|NCT04068688|532518866|FG006|Overall Study|Lost to Follow-up|0|||
147644595|NCT04068688|532518867|FG007|Overall Study|Lost to Follow-up|0|||
147644596|NCT04068688|532518868|FG008|Overall Study|Lost to Follow-up|1|||
147644597|NCT04068688|532518869|FG009|Overall Study|Lost to Follow-up|0|||
147644598|NCT04068688|532518860|FG000|Overall Study|Withdrawal by Subject|1|||
147644599|NCT04068688|532518861|FG001|Overall Study|Withdrawal by Subject|1|||
147644600|NCT04068688|532518862|FG002|Overall Study|Withdrawal by Subject|0|||
147644601|NCT04068688|532518863|FG003|Overall Study|Withdrawal by Subject|0|||
147644602|NCT04068688|532518864|FG004|Overall Study|Withdrawal by Subject|0|||
147644603|NCT04068688|532518865|FG005|Overall Study|Withdrawal by Subject|0|||
147644604|NCT04068688|532518866|FG006|Overall Study|Withdrawal by Subject|0|||
147644605|NCT04068688|532518867|FG007|Overall Study|Withdrawal by Subject|0|||
147644606|NCT04068688|532518868|FG008|Overall Study|Withdrawal by Subject|0|||
147644607|NCT04068688|532518869|FG009|Overall Study|Withdrawal by Subject|0|||
147644608|NCT04068688|532518860|FG000|Overall Study|Unable to complete intervention due to COVID-19 restrictions|7|||
147644609|NCT04068688|532518861|FG001|Overall Study|Unable to complete intervention due to COVID-19 restrictions|7|||
147644610|NCT04068688|532518862|FG002|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
147644611|NCT04068688|532518863|FG003|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
147644612|NCT04068688|532518864|FG004|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
147644613|NCT04068688|532518865|FG005|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
147644614|NCT04068688|532518866|FG006|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
147644615|NCT04068688|532518867|FG007|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
147644616|NCT04068688|532518868|FG008|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
147644617|NCT04068688|532518869|FG009|Overall Study|Unable to complete intervention due to COVID-19 restrictions|0|||
147644618|NCT02554318|532518872|FG000|Overall Study|Withdrawal by Subject|10|||
147644619|NCT02554318|532518873|FG001|Overall Study|Withdrawal by Subject|8|||
147644620|NCT00006305|532518874|FG000|Overall Study|Withdrawal by Subject|17|||
147644621|NCT00006305|532518875|FG001|Overall Study|Withdrawal by Subject|10|||
147644622|NCT00006305|532518876|FG002|Overall Study|Withdrawal by Subject|15|||
147644623|NCT00006305|532518877|FG003|Overall Study|Withdrawal by Subject|14|||
147644624|NCT00662558|532518878|FG000|Overall Study|Adverse Event|21|||
147644625|NCT00662558|532518879|FG001|Overall Study|Adverse Event|59|||
147644626|NCT00662558|532518878|FG000|Overall Study|Lack of Efficacy|4|||
147644627|NCT00662558|532518879|FG001|Overall Study|Lack of Efficacy|7|||
147644628|NCT00662558|532518878|FG000|Overall Study|Lost to Follow-up|13|||
147644629|NCT00662558|532518879|FG001|Overall Study|Lost to Follow-up|10|||
147644630|NCT00662558|532518878|FG000|Overall Study|Other|9|||
147644631|NCT00662558|532518879|FG001|Overall Study|Other|14|||
147644632|NCT00662558|532518878|FG000|Overall Study|Withdrawal by Subject|7|||
147644633|NCT00662558|532518879|FG001|Overall Study|Withdrawal by Subject|12|||
147644634|NCT00662558|532518878|FG000|Overall Study|Randomized But Did Not Receive Treatment|2|||
147644635|NCT00662558|532518879|FG001|Overall Study|Randomized But Did Not Receive Treatment|8|||
147644636|NCT00396877|532518882|FG000|Overall Study|Lost to Follow-up|2|||
147644637|NCT00396877|532518883|FG001|Overall Study|Lost to Follow-up|1|||
147644638|NCT00396877|532518882|FG000|Overall Study|Parent(s)/guardian(s)'s request|4|||
147644639|NCT00396877|532518883|FG001|Overall Study|Parent(s)/guardian(s)'s request|7|||
147644640|NCT02945254|532518884|FG000|Overall Study|Lost to Follow-up|1|||
147644641|NCT02945254|532518885|FG001|Overall Study|Lost to Follow-up|0|||
147644642|NCT02945254|532518884|FG000|Overall Study|Withdrawal by Subject|1|||
147644643|NCT02945254|532518885|FG001|Overall Study|Withdrawal by Subject|0|||
147644644|NCT00783224|532518886|FG000|Overall Study|Adverse Event|0|||
147644645|NCT00783224|532518887|FG001|Overall Study|Adverse Event|0|||
147644646|NCT00783224|532518888|FG002|Overall Study|Adverse Event|1|||
147644647|NCT00783224|532518889|FG003|Overall Study|Adverse Event|0|||
147644648|NCT00783224|532518886|FG000|Overall Study|Discarded the Investigational Drug Used|0|||
147644649|NCT00783224|532518887|FG001|Overall Study|Discarded the Investigational Drug Used|0|||
147644650|NCT00783224|532518888|FG002|Overall Study|Discarded the Investigational Drug Used|0|||
147644651|NCT00783224|532518889|FG003|Overall Study|Discarded the Investigational Drug Used|1|||
147644652|NCT00783224|532518886|FG000|Overall Study|Inappropriate as a study subject|0|||
147644653|NCT00783224|532518887|FG001|Overall Study|Inappropriate as a study subject|0|||
147644654|NCT00783224|532518888|FG002|Overall Study|Inappropriate as a study subject|0|||
147644655|NCT00783224|532518889|FG003|Overall Study|Inappropriate as a study subject|1|||
147644656|NCT01711619|532518890|FG000|Overall Study|Early study termination|10|||
147644657|NCT01711619|532518891|FG001|Overall Study|Early study termination|14|||
147644658|NCT01711619|532518890|FG000|Overall Study|Withdrawal by Subject|3|||
147644659|NCT01711619|532518891|FG001|Overall Study|Withdrawal by Subject|7|||
147644660|NCT01711619|532518890|FG000|Overall Study|Protocol Violation|2|||
147644661|NCT01711619|532518891|FG001|Overall Study|Protocol Violation|3|||
147644662|NCT01711619|532518890|FG000|Overall Study|Adverse Event|2|||
147644663|NCT01711619|532518891|FG001|Overall Study|Adverse Event|0|||
147644664|NCT01711619|532518890|FG000|Overall Study|Lost to Follow-up|1|||
147644665|NCT01711619|532518891|FG001|Overall Study|Lost to Follow-up|0|||
147644666|NCT00334802|532518892|FG000|Overall Study|Progressive Disease|2|||
147644667|NCT00334802|532518893|FG001|Overall Study|Progressive Disease|24|||
147644668|NCT00334802|532518892|FG000|Overall Study|Toxicity|1|||
147644669|NCT00334802|532518893|FG001|Overall Study|Toxicity|5|||
147644670|NCT00334802|532518892|FG000|Overall Study|Lack of Efficacy|1|||
147644671|NCT00334802|532518893|FG001|Overall Study|Lack of Efficacy|3|||
147644672|NCT00334802|532518892|FG000|Overall Study|Patient Condition Aggrevated|1|||
147644673|NCT00334802|532518893|FG001|Overall Study|Patient Condition Aggrevated|0|||
147644674|NCT00334802|532518892|FG000|Overall Study|Physician Decision|1|||
147644675|NCT00334802|532518893|FG001|Overall Study|Physician Decision|0|||
147644676|NCT00334802|532518892|FG000|Overall Study|Withdrawal by Subject|0|||
147644677|NCT00334802|532518893|FG001|Overall Study|Withdrawal by Subject|4|||
147644678|NCT00334802|532518892|FG000|Overall Study|Adverse Event|0|||
147644679|NCT00334802|532518893|FG001|Overall Study|Adverse Event|3|||
147644680|NCT00334802|532518892|FG000|Overall Study|Criteria for Starting Next Cycle Not Met|0|||
147644681|NCT00334802|532518893|FG001|Overall Study|Criteria for Starting Next Cycle Not Met|1|||
147644682|NCT02470403|532518894|FG000|Overall Study|Adverse Event|1|||
147644683|NCT02470403|532518895|FG001|Overall Study|Adverse Event|0|||
147644684|NCT02470403|532518896|FG002|Overall Study|Adverse Event|0|||
147644685|NCT02470403|532518897|FG003|Overall Study|Adverse Event|0|||
147644686|NCT02470403|532518898|FG004|Overall Study|Adverse Event|0|||
147644687|NCT02470403|532518894|FG000|Overall Study|Lost to Follow-up|0|||
147644688|NCT02470403|532518895|FG001|Overall Study|Lost to Follow-up|1|||
147644689|NCT02470403|532518896|FG002|Overall Study|Lost to Follow-up|0|||
147644690|NCT02470403|532518897|FG003|Overall Study|Lost to Follow-up|0|||
147644691|NCT02470403|532518898|FG004|Overall Study|Lost to Follow-up|0|||
147644692|NCT02470403|532518894|FG000|Overall Study|Subject/guardian decision|1|||
147644693|NCT02470403|532518895|FG001|Overall Study|Subject/guardian decision|0|||
147644694|NCT02470403|532518896|FG002|Overall Study|Subject/guardian decision|0|||
147644695|NCT02470403|532518897|FG003|Overall Study|Subject/guardian decision|4|||
147644696|NCT02470403|532518898|FG004|Overall Study|Subject/guardian decision|0|||
147644697|NCT03422159|532518899|FG000|Overall Study|Exclusion due to terminal disease|2|||
147644698|NCT03422159|532518900|FG001|Overall Study|Exclusion due to terminal disease|1|||
147644699|NCT03436199|532518905|FG000|Overall Study|Adverse Event|15|||
147644700|NCT03436199|532518906|FG001|Overall Study|Adverse Event|40|||
147644701|NCT03436199|532518907|FG002|Overall Study|Adverse Event|7|||
147644702|NCT03436199|532518905|FG000|Overall Study|Withdrawal by Subject|4|||
147644703|NCT03436199|532518906|FG001|Overall Study|Withdrawal by Subject|10|||
147644704|NCT03436199|532518907|FG002|Overall Study|Withdrawal by Subject|3|||
147644705|NCT03436199|532518905|FG000|Overall Study|Lost to Follow-up|1|||
147644706|NCT03436199|532518906|FG001|Overall Study|Lost to Follow-up|0|||
147644707|NCT03436199|532518907|FG002|Overall Study|Lost to Follow-up|2|||
147644708|NCT03436199|532518905|FG000|Overall Study|Protocol Violation|1|||
147644709|NCT03436199|532518906|FG001|Overall Study|Protocol Violation|1|||
147644710|NCT03436199|532518907|FG002|Overall Study|Protocol Violation|0|||
147644711|NCT03436199|532518905|FG000|Overall Study|Physician Decision|0|||
147644712|NCT03436199|532518906|FG001|Overall Study|Physician Decision|1|||
147644713|NCT03436199|532518907|FG002|Overall Study|Physician Decision|0|||
147644714|NCT03436199|532518905|FG000|Overall Study|Could not return to clinic|1|||
147644715|NCT03436199|532518906|FG001|Overall Study|Could not return to clinic|0|||
147644716|NCT03436199|532518907|FG002|Overall Study|Could not return to clinic|0|||
147644717|NCT03436199|532518905|FG000|Overall Study|Withdrawn per physician|0|||
147644718|NCT03436199|532518906|FG001|Overall Study|Withdrawn per physician|1|||
147644719|NCT03436199|532518907|FG002|Overall Study|Withdrawn per physician|0|||
147644720|NCT02631070|532518911|FG000|Overall Study|Withdrawal by Subject|35|||
147644721|NCT02631070|532518912|FG001|Overall Study|Withdrawal by Subject|13|||
147644722|NCT02631070|532518911|FG000|Overall Study|Death|45|||
147644723|NCT02631070|532518912|FG001|Overall Study|Death|24|||
147644724|NCT02631070|532518911|FG000|Overall Study|Lost to Follow-up|5|||
147644725|NCT02631070|532518912|FG001|Overall Study|Lost to Follow-up|1|||
147644726|NCT02631070|532518911|FG000|Overall Study|Transition to rollover protocol|52|||
147644727|NCT02631070|532518912|FG001|Overall Study|Transition to rollover protocol|21|||
147644728|NCT02631070|532518911|FG000|Overall Study|Other reasons|12|||
147644729|NCT02631070|532518912|FG001|Overall Study|Other reasons|5|||
147644730|NCT00503997|532518918|FG000|Overall Study|disease progression|1|||
147644731|NCT00503997|532518918|FG000|Overall Study|Adverse Event|5|||
147644732|NCT00503997|532518918|FG000|Overall Study|Death|1|||
147644733|NCT00503997|532518918|FG000|Overall Study|Withdrawal by Subject|1|||
147644734|NCT00085098|532518919|FG000|Overall Study|Withdrawal by Subject|0|||
147644735|NCT00085098|532518920|FG001|Overall Study|Withdrawal by Subject|1|||
147644736|NCT00085098|532518919|FG000|Overall Study|Ineligible|1|||
147644737|NCT00085098|532518920|FG001|Overall Study|Ineligible|1|||
147644738|NCT01195844|532518921|FG000|Overall Study|Fecal sample not collected|40|||
147644739|NCT00980018|532518926|FG000|Overall Study|Adverse Event|8|||
147644740|NCT00980018|532518926|FG000|Overall Study|Patient withdrew consent|3|||
147644741|NCT00980018|532518926|FG000|Overall Study|Lost to Follow-up|1|||
147644742|NCT02565706|532518927|FG000|Overall Study|Withdrawal by Subject|5|||
147644743|NCT02565706|532518928|FG001|Overall Study|Withdrawal by Subject|7|||
147644744|NCT02565706|532518929|FG002|Overall Study|Withdrawal by Subject|7|||
147644745|NCT02565706|532518930|FG003|Overall Study|Withdrawal by Subject|11|||
147644746|NCT02565706|532518927|FG000|Overall Study|Lost to Follow-up|72|||
147644747|NCT02565706|532518928|FG001|Overall Study|Lost to Follow-up|75|||
147644748|NCT02565706|532518929|FG002|Overall Study|Lost to Follow-up|82|||
147644749|NCT02565706|532518930|FG003|Overall Study|Lost to Follow-up|74|||
147644750|NCT03887117|532518931|FG000|Overall Study|Discontinued prematurely|0|||
147644751|NCT03887117|532518932|FG001|Overall Study|Discontinued prematurely|1|||
147644752|NCT03887117|532518933|FG002|Overall Study|Discontinued prematurely|1|||
147644753|NCT03887117|532518934|FG003|Overall Study|Discontinued prematurely|2|||
147644754|NCT02020512|532518935|FG000|Overall Study|Adverse Event|1|||
147644755|NCT02020512|532518935|FG000|Overall Study|Lost to Follow-up|3|||
147644756|NCT02020512|532518935|FG000|Overall Study|Protocol Violation|4|||
147644757|NCT00483704|532518936|FG000|Randomization|Withdrawal by Subject|19|||
147644758|NCT00483704|532518937|FG001|Randomization|Withdrawal by Subject|28|||
147644759|NCT00483704|532518938|FG002|Randomization|Withdrawal by Subject|18|||
147644760|NCT00483704|532518936|FG000|Randomization|Protocol Violation|14|||
147644761|NCT00483704|532518937|FG001|Randomization|Protocol Violation|25|||
147644762|NCT00483704|532518938|FG002|Randomization|Protocol Violation|22|||
147644763|NCT00483704|532518936|FG000|Randomization|Lost to Follow-up|14|||
147644764|NCT00483704|532518937|FG001|Randomization|Lost to Follow-up|14|||
147644765|NCT00483704|532518938|FG002|Randomization|Lost to Follow-up|19|||
147644766|NCT00483704|532518936|FG000|Randomization|Pregnancy|1|||
147644767|NCT00483704|532518937|FG001|Randomization|Pregnancy|0|||
147644768|NCT00483704|532518938|FG002|Randomization|Pregnancy|0|||
147644769|NCT00483704|532518936|FG000|Randomization|Physician Decision|2|||
147644770|NCT00483704|532518937|FG001|Randomization|Physician Decision|4|||
147644771|NCT00483704|532518938|FG002|Randomization|Physician Decision|0|||
147644772|NCT00483704|532518936|FG000|Randomization|Progressive disease|0|||
147644773|NCT00483704|532518937|FG001|Randomization|Progressive disease|0|||
147644774|NCT00483704|532518938|FG002|Randomization|Progressive disease|1|||
147644775|NCT00483704|532518936|FG000|Randomization|Lack of qualifying migraines|21|||
147644776|NCT00483704|532518937|FG001|Randomization|Lack of qualifying migraines|25|||
147644777|NCT00483704|532518938|FG002|Randomization|Lack of qualifying migraines|31|||
147644778|NCT00483704|532518936|FG000|Treatment|Lack of qualifying migraines|101|||
147644779|NCT00483704|532518937|FG001|Treatment|Lack of qualifying migraines|99|||
147644780|NCT00483704|532518938|FG002|Treatment|Lack of qualifying migraines|116|||
147644781|NCT00483704|532518936|FG000|Treatment|Adverse Event|3|||
147644782|NCT00483704|532518937|FG001|Treatment|Adverse Event|5|||
147644783|NCT00483704|532518938|FG002|Treatment|Adverse Event|4|||
147644784|NCT00483704|532518936|FG000|Treatment|Withdrawal by Subject|16|||
147644785|NCT00483704|532518937|FG001|Treatment|Withdrawal by Subject|12|||
147644786|NCT00483704|532518938|FG002|Treatment|Withdrawal by Subject|21|||
147644787|NCT00483704|532518936|FG000|Treatment|Protocol Violation|6|||
147644788|NCT00483704|532518937|FG001|Treatment|Protocol Violation|3|||
147644789|NCT00483704|532518938|FG002|Treatment|Protocol Violation|5|||
147644790|NCT00483704|532518936|FG000|Treatment|Lost to Follow-up|2|||
147644791|NCT00483704|532518937|FG001|Treatment|Lost to Follow-up|7|||
147644792|NCT00483704|532518938|FG002|Treatment|Lost to Follow-up|5|||
147644793|NCT00483704|532518936|FG000|Treatment|Lack of Efficacy|1|||
147644794|NCT00483704|532518937|FG001|Treatment|Lack of Efficacy|1|||
147644795|NCT00483704|532518938|FG002|Treatment|Lack of Efficacy|1|||
147644796|NCT00483704|532518936|FG000|Treatment|Pregnancy|0|||
147644797|NCT00483704|532518937|FG001|Treatment|Pregnancy|1|||
147644798|NCT00483704|532518938|FG002|Treatment|Pregnancy|0|||
147644799|NCT00483704|532518936|FG000|Treatment|Physician Decision|0|||
147644800|NCT00483704|532518937|FG001|Treatment|Physician Decision|1|||
147644801|NCT00483704|532518938|FG002|Treatment|Physician Decision|4|||
147644802|NCT03627416|532518939|FG000|Overall Study|Adverse Event|0|||
147644803|NCT03627416|532518940|FG001|Overall Study|Adverse Event|1|||
147644804|NCT00948506|532518943|FG000|Overall Study|Withdrawal by Subject|3|||
147644805|NCT00948506|532518944|FG001|Overall Study|Withdrawal by Subject|1|||
147644806|NCT03912428|532518945|FG000|Phase 2: Whole Body PET/CT Scans|Physician Decision|0|||
147644807|NCT03912428|532518946|FG001|Phase 2: Whole Body PET/CT Scans|Physician Decision|2|||
147644808|NCT03912428|532518947|FG002|Phase 2: Whole Body PET/CT Scans|Physician Decision|0|||
147644809|NCT03912428|532518948|FG003|Phase 2: Whole Body PET/CT Scans|Physician Decision|0|||
147644810|NCT03912428|532518945|FG000|Phase 2: Whole Body PET/CT Scans|Withdrawal by Subject|0|||
147644811|NCT03912428|532518946|FG001|Phase 2: Whole Body PET/CT Scans|Withdrawal by Subject|3|||
147644812|NCT03912428|532518947|FG002|Phase 2: Whole Body PET/CT Scans|Withdrawal by Subject|1|||
147644813|NCT03912428|532518948|FG003|Phase 2: Whole Body PET/CT Scans|Withdrawal by Subject|0|||
147644814|NCT03912428|532518945|FG000|Phase 3: Brain PET/CT Scans|Withdrawal by Subject|0|||
147644815|NCT03912428|532518946|FG001|Phase 3: Brain PET/CT Scans|Withdrawal by Subject|0|||
147644816|NCT03912428|532518947|FG002|Phase 3: Brain PET/CT Scans|Withdrawal by Subject|0|||
147644817|NCT03912428|532518948|FG003|Phase 3: Brain PET/CT Scans|Withdrawal by Subject|2|||
147644818|NCT03233204|532518949|FG000|Overall Study|Adverse Event|1|||
147644819|NCT03233204|532518949|FG000|Overall Study|Death|1|||
147644820|NCT03233204|532518949|FG000|Overall Study|Withdrawal by Subject|1|||
147644821|NCT03233204|532518949|FG000|Overall Study|Progressive Disease|3|||
147644822|NCT02520427|532518951|FG000|Overall Study|Decision by sponsor|0|||
147644823|NCT02520427|532518952|FG001|Overall Study|Decision by sponsor|0|||
147644824|NCT02520427|532518953|FG002|Overall Study|Decision by sponsor|0|||
147644825|NCT02520427|532518954|FG003|Overall Study|Decision by sponsor|0|||
147644826|NCT02520427|532518955|FG004|Overall Study|Decision by sponsor|0|||
147644827|NCT02520427|532518956|FG005|Overall Study|Decision by sponsor|0|||
147644828|NCT02520427|532518957|FG006|Overall Study|Decision by sponsor|0|||
147644829|NCT02520427|532518958|FG007|Overall Study|Decision by sponsor|0|||
147644830|NCT02520427|532518959|FG008|Overall Study|Decision by sponsor|1|||
147644831|NCT02520427|532518960|FG009|Overall Study|Decision by sponsor|1|||
147644832|NCT02520427|532518961|FG010|Overall Study|Decision by sponsor|0|||
147644833|NCT02520427|532518962|FG011|Overall Study|Decision by sponsor|0|||
147644834|NCT02520427|532518963|FG012|Overall Study|Decision by sponsor|0|||
147644835|NCT02520427|532518964|FG013|Overall Study|Decision by sponsor|0|||
147644836|NCT02520427|532518965|FG014|Overall Study|Decision by sponsor|0|||
147644837|NCT02520427|532518966|FG015|Overall Study|Decision by sponsor|0|||
147644838|NCT02520427|532518967|FG016|Overall Study|Decision by sponsor|0|||
147644839|NCT02520427|532518968|FG017|Overall Study|Decision by sponsor|0|||
147644840|NCT02520427|532518969|FG018|Overall Study|Decision by sponsor|0|||
147644841|NCT02520427|532518970|FG019|Overall Study|Decision by sponsor|0|||
147644842|NCT02520427|532518971|FG020|Overall Study|Decision by sponsor|0|||
147644843|NCT02520427|532518972|FG021|Overall Study|Decision by sponsor|0|||
147644844|NCT02520427|532518973|FG022|Overall Study|Decision by sponsor|0|||
147644845|NCT02520427|532518974|FG023|Overall Study|Decision by sponsor|0|||
147644846|NCT02520427|532518975|FG024|Overall Study|Decision by sponsor|0|||
147644847|NCT02520427|532518976|FG025|Overall Study|Decision by sponsor|0|||
147644848|NCT02520427|532518951|FG000|Overall Study|Withdrawal by Subject|0|||
147644849|NCT02520427|532518952|FG001|Overall Study|Withdrawal by Subject|0|||
147644850|NCT02520427|532518953|FG002|Overall Study|Withdrawal by Subject|1|||
147644851|NCT02520427|532518954|FG003|Overall Study|Withdrawal by Subject|0|||
147644852|NCT02520427|532518955|FG004|Overall Study|Withdrawal by Subject|0|||
147644853|NCT02520427|532518956|FG005|Overall Study|Withdrawal by Subject|0|||
147644854|NCT02520427|532518957|FG006|Overall Study|Withdrawal by Subject|0|||
147644855|NCT02520427|532518958|FG007|Overall Study|Withdrawal by Subject|0|||
147644856|NCT02520427|532518959|FG008|Overall Study|Withdrawal by Subject|0|||
147644857|NCT02520427|532518960|FG009|Overall Study|Withdrawal by Subject|0|||
147644858|NCT02520427|532518961|FG010|Overall Study|Withdrawal by Subject|0|||
147644859|NCT02520427|532518962|FG011|Overall Study|Withdrawal by Subject|0|||
147644860|NCT02520427|532518963|FG012|Overall Study|Withdrawal by Subject|1|||
147644861|NCT02520427|532518964|FG013|Overall Study|Withdrawal by Subject|1|||
147644862|NCT02520427|532518965|FG014|Overall Study|Withdrawal by Subject|1|||
147644863|NCT02520427|532518966|FG015|Overall Study|Withdrawal by Subject|0|||
147644864|NCT02520427|532518967|FG016|Overall Study|Withdrawal by Subject|1|||
147644865|NCT02520427|532518968|FG017|Overall Study|Withdrawal by Subject|0|||
147644866|NCT02520427|532518969|FG018|Overall Study|Withdrawal by Subject|0|||
147528962|NCT00151775|532090549|FG004|Period 2 - Double-Blind Dose Response|non-compliance|0|||
147528963|NCT00151775|532090550|FG005|Period 2 - Double-Blind Dose Response|non-compliance|1|||
147528964|NCT00151775|532090551|FG006|Period 2 - Double-Blind Dose Response|non-compliance|0|||
147528965|NCT00151775|532090552|FG007|Period 2 - Double-Blind Dose Response|non-compliance|0|||
147528966|NCT00151775|532090553|FG008|Period 2 - Double-Blind Dose Response|non-compliance|0|||
147528967|NCT00151775|532090554|FG009|Period 2 - Double-Blind Dose Response|non-compliance|0|||
147528968|NCT00151775|532090555|FG010|Period 2 - Double-Blind Dose Response|non-compliance|0|||
147528969|NCT00151775|532090556|FG011|Period 2 - Double-Blind Dose Response|non-compliance|0|||
147528970|NCT00151775|532090545|FG000|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
147528971|NCT00151775|532090546|FG001|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
147528972|NCT00151775|532090547|FG002|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
147528973|NCT00151775|532090548|FG003|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
147528974|NCT00151775|532090549|FG004|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
147528975|NCT00151775|532090550|FG005|Period 2 - Double-Blind Dose Response|Physician Decision|1|||
147528976|NCT00151775|532090551|FG006|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
147528977|NCT00151775|532090552|FG007|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
147528978|NCT00151775|532090553|FG008|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
147528979|NCT00151775|532090554|FG009|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
147528980|NCT00151775|532090555|FG010|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
147528981|NCT00151775|532090556|FG011|Period 2 - Double-Blind Dose Response|Physician Decision|0|||
147528982|NCT00151775|532090545|FG000|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
147528983|NCT00151775|532090546|FG001|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
147644867|NCT02520427|532518970|FG019|Overall Study|Withdrawal by Subject|3|||
147644868|NCT02520427|532518971|FG020|Overall Study|Withdrawal by Subject|2|||
147644869|NCT02520427|532518972|FG021|Overall Study|Withdrawal by Subject|0|||
147644870|NCT02520427|532518973|FG022|Overall Study|Withdrawal by Subject|0|||
147644871|NCT02520427|532518974|FG023|Overall Study|Withdrawal by Subject|0|||
147644872|NCT02520427|532518975|FG024|Overall Study|Withdrawal by Subject|0|||
147644873|NCT02520427|532518976|FG025|Overall Study|Withdrawal by Subject|0|||
147644874|NCT02520427|532518951|FG000|Overall Study|Death|1|||
147644875|NCT02520427|532518952|FG001|Overall Study|Death|0|||
147644876|NCT02520427|532518953|FG002|Overall Study|Death|0|||
147644877|NCT02520427|532518954|FG003|Overall Study|Death|0|||
147644878|NCT02520427|532518955|FG004|Overall Study|Death|0|||
147644879|NCT02520427|532518956|FG005|Overall Study|Death|0|||
147644880|NCT02520427|532518957|FG006|Overall Study|Death|0|||
147644881|NCT02520427|532518958|FG007|Overall Study|Death|0|||
147644882|NCT02520427|532518959|FG008|Overall Study|Death|0|||
147644883|NCT02520427|532518960|FG009|Overall Study|Death|0|||
147644884|NCT02520427|532518961|FG010|Overall Study|Death|0|||
147644885|NCT02520427|532518962|FG011|Overall Study|Death|0|||
147644886|NCT02520427|532518963|FG012|Overall Study|Death|0|||
147644887|NCT02520427|532518964|FG013|Overall Study|Death|0|||
147644888|NCT02520427|532518965|FG014|Overall Study|Death|0|||
147644889|NCT02520427|532518966|FG015|Overall Study|Death|0|||
147644890|NCT02520427|532518967|FG016|Overall Study|Death|2|||
147644891|NCT02520427|532518968|FG017|Overall Study|Death|1|||
147644892|NCT02520427|532518969|FG018|Overall Study|Death|3|||
147644893|NCT02520427|532518970|FG019|Overall Study|Death|2|||
147644894|NCT02520427|532518971|FG020|Overall Study|Death|0|||
147644895|NCT02520427|532518972|FG021|Overall Study|Death|0|||
147644896|NCT02520427|532518973|FG022|Overall Study|Death|1|||
147644897|NCT02520427|532518974|FG023|Overall Study|Death|0|||
147644898|NCT02520427|532518975|FG024|Overall Study|Death|1|||
147644899|NCT02520427|532518976|FG025|Overall Study|Death|0|||
147644900|NCT00793624|532518977|FG000|Overall Study|Adverse Event|18|||
147644901|NCT00793624|532518978|FG001|Overall Study|Adverse Event|16|||
147644902|NCT00793624|532518979|FG002|Overall Study|Adverse Event|15|||
147644903|NCT00793624|532518980|FG003|Overall Study|Adverse Event|20|||
147644904|NCT00793624|532518977|FG000|Overall Study|Lost to Follow-up|2|||
147644905|NCT00793624|532518978|FG001|Overall Study|Lost to Follow-up|2|||
147644906|NCT00793624|532518979|FG002|Overall Study|Lost to Follow-up|4|||
147644907|NCT00793624|532518980|FG003|Overall Study|Lost to Follow-up|0|||
147644908|NCT00793624|532518977|FG000|Overall Study|Withdrawal by Subject|20|||
147644909|NCT00793624|532518978|FG001|Overall Study|Withdrawal by Subject|9|||
147644910|NCT00793624|532518979|FG002|Overall Study|Withdrawal by Subject|11|||
147644911|NCT00793624|532518980|FG003|Overall Study|Withdrawal by Subject|14|||
147644912|NCT00793624|532518977|FG000|Overall Study|Lack of Efficacy|9|||
147644913|NCT00793624|532518978|FG001|Overall Study|Lack of Efficacy|2|||
147644914|NCT00793624|532518979|FG002|Overall Study|Lack of Efficacy|1|||
147644915|NCT00793624|532518980|FG003|Overall Study|Lack of Efficacy|3|||
147644916|NCT00793624|532518977|FG000|Overall Study|Non compliance with protocol|2|||
147644917|NCT00793624|532518978|FG001|Overall Study|Non compliance with protocol|3|||
147644918|NCT00793624|532518979|FG002|Overall Study|Non compliance with protocol|2|||
147644919|NCT00793624|532518980|FG003|Overall Study|Non compliance with protocol|3|||
147644920|NCT00793624|532518977|FG000|Overall Study|Other reason not described above|6|||
147644921|NCT00793624|532518978|FG001|Overall Study|Other reason not described above|4|||
147644922|NCT00793624|532518979|FG002|Overall Study|Other reason not described above|6|||
147644923|NCT00793624|532518980|FG003|Overall Study|Other reason not described above|3|||
147644924|NCT00157248|532518981|FG000|Overall Study|Adverse Event|36|||
147644925|NCT00157248|532518982|FG001|Overall Study|Adverse Event|25|||
147644926|NCT00157248|532518983|FG002|Overall Study|Adverse Event|13|||
147644927|NCT00157248|532518984|FG003|Overall Study|Adverse Event|33|||
147644928|NCT00157248|532518981|FG000|Overall Study|Protocol Violation|4|||
147644929|NCT00157248|532518982|FG001|Overall Study|Protocol Violation|0|||
147644930|NCT00157248|532518983|FG002|Overall Study|Protocol Violation|2|||
147644931|NCT00157248|532518984|FG003|Overall Study|Protocol Violation|2|||
147644932|NCT00157248|532518981|FG000|Overall Study|Lost to Follow-up|0|||
147644933|NCT00157248|532518982|FG001|Overall Study|Lost to Follow-up|1|||
147644934|NCT00157248|532518983|FG002|Overall Study|Lost to Follow-up|0|||
147644935|NCT00157248|532518984|FG003|Overall Study|Lost to Follow-up|0|||
147644936|NCT00157248|532518981|FG000|Overall Study|Withdrawal by Subject|1|||
147644937|NCT00157248|532518982|FG001|Overall Study|Withdrawal by Subject|4|||
147644938|NCT00157248|532518983|FG002|Overall Study|Withdrawal by Subject|3|||
147644939|NCT00157248|532518984|FG003|Overall Study|Withdrawal by Subject|3|||
147644940|NCT00157248|532518981|FG000|Overall Study|site closures, subject moving|7|||
147644941|NCT00157248|532518982|FG001|Overall Study|site closures, subject moving|7|||
147644942|NCT00157248|532518983|FG002|Overall Study|site closures, subject moving|3|||
147644943|NCT00157248|532518984|FG003|Overall Study|site closures, subject moving|9|||
147644944|NCT03191864|532518985|FG000|Baseline Symptom Assessment|Lost to Follow-up|0|||
147644945|NCT03191864|532518986|FG001|Baseline Symptom Assessment|Lost to Follow-up|0|||
147644946|NCT03191864|532518987|FG002|Baseline Symptom Assessment|Lost to Follow-up|0|||
147644947|NCT03191864|532518988|FG003|Baseline Symptom Assessment|Lost to Follow-up|0|||
147644948|NCT03191864|532518989|FG004|Baseline Symptom Assessment|Lost to Follow-up|0|||
147644949|NCT03191864|532518990|FG005|Baseline Symptom Assessment|Lost to Follow-up|1|||
147644950|NCT03191864|532518985|FG000|Baseline Symptom Assessment|Patient Diary Unavailable at Site|0|||
147644951|NCT03191864|532518986|FG001|Baseline Symptom Assessment|Patient Diary Unavailable at Site|0|||
147644952|NCT03191864|532518987|FG002|Baseline Symptom Assessment|Patient Diary Unavailable at Site|0|||
147644953|NCT03191864|532518988|FG003|Baseline Symptom Assessment|Patient Diary Unavailable at Site|0|||
147644954|NCT03191864|532518989|FG004|Baseline Symptom Assessment|Patient Diary Unavailable at Site|0|||
147644955|NCT03191864|532518990|FG005|Baseline Symptom Assessment|Patient Diary Unavailable at Site|1|||
147644956|NCT03191864|532518985|FG000|Baseline Symptom Assessment|Adverse Event|0|||
147644957|NCT03191864|532518986|FG001|Baseline Symptom Assessment|Adverse Event|0|||
147644958|NCT03191864|532518987|FG002|Baseline Symptom Assessment|Adverse Event|0|||
147644959|NCT03191864|532518988|FG003|Baseline Symptom Assessment|Adverse Event|0|||
147644960|NCT03191864|532518989|FG004|Baseline Symptom Assessment|Adverse Event|0|||
147644961|NCT03191864|532518990|FG005|Baseline Symptom Assessment|Adverse Event|2|||
147644962|NCT03191864|532518985|FG000|Baseline Symptom Assessment|Withdrawal by Subject|0|||
147644963|NCT03191864|532518986|FG001|Baseline Symptom Assessment|Withdrawal by Subject|0|||
147644964|NCT03191864|532518987|FG002|Baseline Symptom Assessment|Withdrawal by Subject|0|||
147644965|NCT03191864|532518988|FG003|Baseline Symptom Assessment|Withdrawal by Subject|0|||
147644966|NCT03191864|532518989|FG004|Baseline Symptom Assessment|Withdrawal by Subject|0|||
147644967|NCT03191864|532518990|FG005|Baseline Symptom Assessment|Withdrawal by Subject|19|||
147644968|NCT03191864|532518985|FG000|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|0|||
147644969|NCT03191864|532518986|FG001|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|0|||
147644970|NCT03191864|532518987|FG002|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|0|||
147644971|NCT03191864|532518988|FG003|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|0|||
147644972|NCT03191864|532518989|FG004|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|0|||
147644973|NCT03191864|532518990|FG005|Baseline Symptom Assessment|Violation of inclusion/exclusion criteria|179|||
147644974|NCT03191864|532518985|FG000|Part 1 - Induction|Violation of inclusion/exclusion criteria|0|||
147644975|NCT03191864|532518986|FG001|Part 1 - Induction|Violation of inclusion/exclusion criteria|0|||
147644976|NCT03191864|532518987|FG002|Part 1 - Induction|Violation of inclusion/exclusion criteria|1|||
147644977|NCT03191864|532518988|FG003|Part 1 - Induction|Violation of inclusion/exclusion criteria|0|||
147644978|NCT03191864|532518989|FG004|Part 1 - Induction|Violation of inclusion/exclusion criteria|0|||
147644979|NCT03191864|532518990|FG005|Part 1 - Induction|Violation of inclusion/exclusion criteria|1|||
147644980|NCT03191864|532518985|FG000|Part 1 - Induction|Adverse Event|0|||
147644981|NCT03191864|532518986|FG001|Part 1 - Induction|Adverse Event|2|||
147644982|NCT03191864|532518987|FG002|Part 1 - Induction|Adverse Event|0|||
147644983|NCT03191864|532518988|FG003|Part 1 - Induction|Adverse Event|1|||
147644984|NCT03191864|532518989|FG004|Part 1 - Induction|Adverse Event|0|||
147644985|NCT03191864|532518990|FG005|Part 1 - Induction|Adverse Event|2|||
147644986|NCT03191864|532518985|FG000|Part 1 - Induction|Randomized but never dosed|0|||
147644987|NCT03191864|532518986|FG001|Part 1 - Induction|Randomized but never dosed|0|||
147528984|NCT00151775|532090547|FG002|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
147528985|NCT00151775|532090548|FG003|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
147528986|NCT00151775|532090549|FG004|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
147528987|NCT00151775|532090550|FG005|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
147528988|NCT00151775|532090551|FG006|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|1|||
147528989|NCT00151775|532090552|FG007|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
147528990|NCT00151775|532090553|FG008|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
147528991|NCT00151775|532090554|FG009|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
147528992|NCT00151775|532090555|FG010|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
147528993|NCT00151775|532090556|FG011|Period 2 - Double-Blind Dose Response|The blood pressure goal was met|0|||
147528994|NCT00151775|532090545|FG000|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
147528995|NCT00151775|532090546|FG001|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
147528996|NCT00151775|532090547|FG002|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
147528997|NCT00151775|532090548|FG003|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
147528998|NCT00151775|532090549|FG004|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
147528999|NCT00151775|532090550|FG005|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|1|||
147529000|NCT00151775|532090551|FG006|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
147529001|NCT00151775|532090552|FG007|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
147529002|NCT00151775|532090553|FG008|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
147529003|NCT00151775|532090554|FG009|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
147529004|NCT00151775|532090555|FG010|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
147529005|NCT00151775|532090556|FG011|Period 3: Double-blind, Withdrawal|Withdrawal by Subject|0|||
147529006|NCT00151775|532090545|FG000|Period 3: Double-blind, Withdrawal|Other|0|||
147529007|NCT00151775|532090546|FG001|Period 3: Double-blind, Withdrawal|Other|0|||
147529008|NCT00151775|532090547|FG002|Period 3: Double-blind, Withdrawal|Other|1|||
147529009|NCT00151775|532090548|FG003|Period 3: Double-blind, Withdrawal|Other|0|||
147529010|NCT00151775|532090549|FG004|Period 3: Double-blind, Withdrawal|Other|0|||
147529011|NCT00151775|532090550|FG005|Period 3: Double-blind, Withdrawal|Other|0|||
147529012|NCT00151775|532090551|FG006|Period 3: Double-blind, Withdrawal|Other|0|||
147529013|NCT00151775|532090552|FG007|Period 3: Double-blind, Withdrawal|Other|1|||
147529014|NCT00151775|532090553|FG008|Period 3: Double-blind, Withdrawal|Other|0|||
147529015|NCT00151775|532090554|FG009|Period 3: Double-blind, Withdrawal|Other|0|||
147529016|NCT00151775|532090555|FG010|Period 3: Double-blind, Withdrawal|Other|0|||
147529017|NCT00151775|532090556|FG011|Period 3: Double-blind, Withdrawal|Other|0|||
147529018|NCT00151775|532090545|FG000|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
147529019|NCT00151775|532090546|FG001|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
147529020|NCT00151775|532090547|FG002|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
147529021|NCT00151775|532090548|FG003|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
147529022|NCT00151775|532090549|FG004|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
147529023|NCT00151775|532090550|FG005|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
147529024|NCT00151775|532090551|FG006|Period 3: Double-blind, Withdrawal|Met blood pressure goal|1|||
147529025|NCT00151775|532090552|FG007|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
147529026|NCT00151775|532090553|FG008|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
147529027|NCT00151775|532090554|FG009|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
147644988|NCT03191864|532518987|FG002|Part 1 - Induction|Randomized but never dosed|1|||
147644989|NCT03191864|532518988|FG003|Part 1 - Induction|Randomized but never dosed|0|||
147644990|NCT03191864|532518989|FG004|Part 1 - Induction|Randomized but never dosed|0|||
147644991|NCT03191864|532518990|FG005|Part 1 - Induction|Randomized but never dosed|0|||
147644992|NCT03191864|532518985|FG000|Part 1 - Induction|Withdrawal by Subject|3|||
147644993|NCT03191864|532518986|FG001|Part 1 - Induction|Withdrawal by Subject|1|||
147644994|NCT03191864|532518987|FG002|Part 1 - Induction|Withdrawal by Subject|0|||
147644995|NCT03191864|532518988|FG003|Part 1 - Induction|Withdrawal by Subject|0|||
147644996|NCT03191864|532518989|FG004|Part 1 - Induction|Withdrawal by Subject|0|||
147644997|NCT03191864|532518990|FG005|Part 1 - Induction|Withdrawal by Subject|2|||
147644998|NCT03191864|532518985|FG000|Part 2 - Maintenance|Refused EGD at Week 26|0|||
147644999|NCT03191864|532518986|FG001|Part 2 - Maintenance|Refused EGD at Week 26|0|||
147645000|NCT03191864|532518987|FG002|Part 2 - Maintenance|Refused EGD at Week 26|1|||
147645001|NCT03191864|532518988|FG003|Part 2 - Maintenance|Refused EGD at Week 26|0|||
147645002|NCT03191864|532518989|FG004|Part 2 - Maintenance|Refused EGD at Week 26|0|||
147529028|NCT00151775|532090555|FG010|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
147529029|NCT00151775|532090556|FG011|Period 3: Double-blind, Withdrawal|Met blood pressure goal|0|||
147529030|NCT00151775|532090545|FG000|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
147529031|NCT00151775|532090546|FG001|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
147529032|NCT00151775|532090547|FG002|Period 3: Double-blind, Withdrawal|Adverse Event|1|||
147529033|NCT00151775|532090548|FG003|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
147529034|NCT00151775|532090549|FG004|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
147529035|NCT00151775|532090550|FG005|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
147645003|NCT03191864|532518990|FG005|Part 2 - Maintenance|Refused EGD at Week 26|0|||
147645004|NCT03191864|532518985|FG000|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|1|||
147645005|NCT03191864|532518986|FG001|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|0|||
147645006|NCT03191864|532518987|FG002|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|0|||
147645007|NCT03191864|532518988|FG003|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|0|||
147645008|NCT03191864|532518989|FG004|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|0|||
147645009|NCT03191864|532518990|FG005|Part 2 - Maintenance|Subject Could Not Transfer Site to Complete the Study|0|||
147645010|NCT03191864|532518985|FG000|Part 2 - Maintenance|Physician Decision|1|||
147645011|NCT03191864|532518986|FG001|Part 2 - Maintenance|Physician Decision|0|||
147645012|NCT03191864|532518987|FG002|Part 2 - Maintenance|Physician Decision|0|||
147645013|NCT03191864|532518988|FG003|Part 2 - Maintenance|Physician Decision|0|||
147645014|NCT03191864|532518989|FG004|Part 2 - Maintenance|Physician Decision|0|||
147645015|NCT03191864|532518990|FG005|Part 2 - Maintenance|Physician Decision|0|||
147645016|NCT03191864|532518985|FG000|Part 2 - Maintenance|Lack of Efficacy|1|||
147645017|NCT03191864|532518986|FG001|Part 2 - Maintenance|Lack of Efficacy|2|||
147645018|NCT03191864|532518987|FG002|Part 2 - Maintenance|Lack of Efficacy|2|||
147645019|NCT03191864|532518988|FG003|Part 2 - Maintenance|Lack of Efficacy|2|||
147645020|NCT03191864|532518989|FG004|Part 2 - Maintenance|Lack of Efficacy|10|||
147645021|NCT03191864|532518990|FG005|Part 2 - Maintenance|Lack of Efficacy|0|||
147645022|NCT03191864|532518985|FG000|Part 2 - Maintenance|Adverse Event|0|||
147645023|NCT03191864|532518986|FG001|Part 2 - Maintenance|Adverse Event|0|||
147645024|NCT03191864|532518987|FG002|Part 2 - Maintenance|Adverse Event|0|||
147645025|NCT03191864|532518988|FG003|Part 2 - Maintenance|Adverse Event|0|||
147645026|NCT03191864|532518989|FG004|Part 2 - Maintenance|Adverse Event|1|||
147645027|NCT03191864|532518990|FG005|Part 2 - Maintenance|Adverse Event|0|||
147645028|NCT03191864|532518985|FG000|Part 2 - Maintenance|Withdrawal by Subject|2|||
147645029|NCT03191864|532518986|FG001|Part 2 - Maintenance|Withdrawal by Subject|0|||
147645030|NCT03191864|532518987|FG002|Part 2 - Maintenance|Withdrawal by Subject|0|||
147645031|NCT03191864|532518988|FG003|Part 2 - Maintenance|Withdrawal by Subject|0|||
147645032|NCT03191864|532518989|FG004|Part 2 - Maintenance|Withdrawal by Subject|3|||
147645033|NCT03191864|532518990|FG005|Part 2 - Maintenance|Withdrawal by Subject|0|||
147645034|NCT03191864|532518985|FG000|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|0|||
147645035|NCT03191864|532518986|FG001|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|0|||
147645036|NCT03191864|532518987|FG002|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|0|||
147645037|NCT03191864|532518988|FG003|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|0|||
147645038|NCT03191864|532518989|FG004|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|1|||
147645039|NCT03191864|532518990|FG005|Part 2 - Maintenance|Unresponsive - Patient missed multiple appointments|0|||
147645040|NCT01447927|532518991|FG000|Overall Study|Adverse Event|4|||
147645041|NCT01447927|532518992|FG001|Overall Study|Adverse Event|3|||
147645042|NCT01447927|532518991|FG000|Overall Study|Withdrawal by Subject|1|||
147645043|NCT01447927|532518992|FG001|Overall Study|Withdrawal by Subject|0|||
147645044|NCT02342548|532518993|FG000|Overall Study|Adverse Event|12|||
147645045|NCT02342548|532518994|FG001|Overall Study|Adverse Event|17|||
147645046|NCT02342548|532518995|FG002|Overall Study|Adverse Event|13|||
147645047|NCT02342548|532518993|FG000|Overall Study|Lost to Follow-up|0|||
147645048|NCT02342548|532518994|FG001|Overall Study|Lost to Follow-up|1|||
147645049|NCT02342548|532518995|FG002|Overall Study|Lost to Follow-up|0|||
147645050|NCT02342548|532518993|FG000|Overall Study|Study terminated by sponsor|20|||
147645051|NCT02342548|532518994|FG001|Overall Study|Study terminated by sponsor|39|||
147645052|NCT02342548|532518995|FG002|Overall Study|Study terminated by sponsor|25|||
147645053|NCT02342548|532518993|FG000|Overall Study|Protocol Violation|0|||
147645054|NCT02342548|532518994|FG001|Overall Study|Protocol Violation|1|||
147645055|NCT02342548|532518995|FG002|Overall Study|Protocol Violation|0|||
147645056|NCT02342548|532518993|FG000|Overall Study|Withdrawal by Subject|1|||
147645057|NCT02342548|532518994|FG001|Overall Study|Withdrawal by Subject|3|||
147645058|NCT02342548|532518995|FG002|Overall Study|Withdrawal by Subject|4|||
147645059|NCT02342548|532518993|FG000|Overall Study|Other|1|||
147645060|NCT02342548|532518994|FG001|Overall Study|Other|1|||
147645061|NCT02342548|532518995|FG002|Overall Study|Other|1|||
147645062|NCT00616603|532520170|FG000|Overall Study|Physician Decision|2|||
147645063|NCT00616603|532520171|FG001|Overall Study|Physician Decision|0|||
147645064|NCT00616603|532520172|FG002|Overall Study|Physician Decision|2|||
147645065|NCT04679051|532520181|FG000|Overall Study|felt tired after restricted time in bed|3|||
147645066|NCT04679051|532520182|FG001|Overall Study|felt tired after restricted time in bed|0|||
147645067|NCT04679051|532520181|FG000|Overall Study|discomfort with blood pressure cuff|2|||
147645068|NCT04679051|532520182|FG001|Overall Study|discomfort with blood pressure cuff|0|||
147645069|NCT04679051|532520181|FG000|Overall Study|scheduling conflict|1|||
147645070|NCT04679051|532520182|FG001|Overall Study|scheduling conflict|1|||
147645071|NCT04679051|532520181|FG000|Overall Study|Protocol Violation|0|||
147645072|NCT04679051|532520182|FG001|Overall Study|Protocol Violation|4|||
147645073|NCT01886781|532520183|FG000|Overall Study|Protocol Violation|5|||
147645074|NCT01886781|532520184|FG001|Overall Study|Protocol Violation|0|||
147645075|NCT01886781|532520183|FG000|Overall Study|Adverse Event|1|||
147645076|NCT01886781|532520184|FG001|Overall Study|Adverse Event|0|||
147645077|NCT01886781|532520183|FG000|Overall Study|Lost to Follow-up|5|||
147645078|NCT01886781|532520184|FG001|Overall Study|Lost to Follow-up|0|||
147645079|NCT01886781|532520183|FG000|Overall Study|Withdrawal by Subject|2|||
147645080|NCT01886781|532520184|FG001|Overall Study|Withdrawal by Subject|1|||
147645081|NCT01886781|532520183|FG000|Overall Study|Worsening of symptoms|1|||
147645082|NCT01886781|532520184|FG001|Overall Study|Worsening of symptoms|1|||
147645083|NCT01522235|532520185|FG000|Overall Study|Physician Decision|1|||
147645084|NCT01522235|532520186|FG001|Overall Study|Physician Decision|1|||
147645085|NCT00934856|532520188|FG000|Feasibility Part|Progressive disease|4|||
147645086|NCT00934856|532520189|FG001|Feasibility Part|Progressive disease|4|||
147645087|NCT00934856|532520190|FG002|Feasibility Part|Progressive disease|2|||
147645088|NCT00934856|532520191|FG003|Feasibility Part|Progressive disease|3|||
147645089|NCT00934856|532520192|FG004|Feasibility Part|Progressive disease|0|||
147645090|NCT00934856|532520193|FG005|Feasibility Part|Progressive disease|0|||
147645091|NCT00934856|532520188|FG000|Feasibility Part|Physician Decision|0|||
147645092|NCT00934856|532520189|FG001|Feasibility Part|Physician Decision|0|||
147645093|NCT00934856|532520190|FG002|Feasibility Part|Physician Decision|1|||
147645094|NCT00934856|532520191|FG003|Feasibility Part|Physician Decision|0|||
147645095|NCT00934856|532520192|FG004|Feasibility Part|Physician Decision|0|||
147645096|NCT00934856|532520193|FG005|Feasibility Part|Physician Decision|0|||
147645097|NCT00934856|532520188|FG000|Feasibility Part|Adverse Event|1|||
147645098|NCT00934856|532520189|FG001|Feasibility Part|Adverse Event|1|||
147645099|NCT00934856|532520190|FG002|Feasibility Part|Adverse Event|0|||
147645100|NCT00934856|532520191|FG003|Feasibility Part|Adverse Event|1|||
147645101|NCT00934856|532520192|FG004|Feasibility Part|Adverse Event|0|||
147645102|NCT00934856|532520193|FG005|Feasibility Part|Adverse Event|2|||
147645103|NCT00934856|532520188|FG000|Feasibility Part|Withdrawal by Subject|0|||
147645104|NCT00934856|532520189|FG001|Feasibility Part|Withdrawal by Subject|0|||
147645105|NCT00934856|532520190|FG002|Feasibility Part|Withdrawal by Subject|0|||
147645106|NCT00934856|532520191|FG003|Feasibility Part|Withdrawal by Subject|1|||
147645107|NCT00934856|532520192|FG004|Feasibility Part|Withdrawal by Subject|0|||
147645108|NCT00934856|532520193|FG005|Feasibility Part|Withdrawal by Subject|1|||
147645109|NCT00934856|532520188|FG000|Extension Part|Adverse Event|0|||
147645110|NCT00934856|532520189|FG001|Extension Part|Adverse Event|0|||
147645111|NCT00934856|532520190|FG002|Extension Part|Adverse Event|0|||
147645112|NCT00934856|532520191|FG003|Extension Part|Adverse Event|1|||
147645113|NCT00934856|532520192|FG004|Extension Part|Adverse Event|4|||
147645114|NCT00934856|532520193|FG005|Extension Part|Adverse Event|4|||
147645115|NCT00934856|532520188|FG000|Extension Part|Progressive disease|0|||
147645116|NCT00934856|532520189|FG001|Extension Part|Progressive disease|0|||
147645117|NCT00934856|532520190|FG002|Extension Part|Progressive disease|0|||
147645118|NCT00934856|532520191|FG003|Extension Part|Progressive disease|1|||
147645119|NCT00934856|532520192|FG004|Extension Part|Progressive disease|0|||
147645120|NCT00934856|532520193|FG005|Extension Part|Progressive disease|0|||
147645121|NCT00934856|532520188|FG000|Extension Part|Non-compliance with drug|0|||
147645122|NCT00934856|532520189|FG001|Extension Part|Non-compliance with drug|0|||
147645123|NCT00934856|532520190|FG002|Extension Part|Non-compliance with drug|0|||
147645124|NCT00934856|532520191|FG003|Extension Part|Non-compliance with drug|0|||
147645125|NCT00934856|532520192|FG004|Extension Part|Non-compliance with drug|0|||
147645126|NCT00934856|532520193|FG005|Extension Part|Non-compliance with drug|1|||
147645127|NCT00195494|532520194|FG000|Year 1|Adverse Event|0|||
147645128|NCT00195494|532520195|FG001|Year 1|Adverse Event|0|||
147645129|NCT00195494|532520196|FG002|Year 1|Adverse Event|0|||
147645130|NCT00195494|532520197|FG003|Year 1|Adverse Event|0|||
147645131|NCT00195494|532520198|FG004|Year 1|Adverse Event|34|||
147645132|NCT00195494|532520199|FG005|Year 1|Adverse Event|27|||
147645133|NCT00195494|532520194|FG000|Year 1|System Toxicity|0|||
147645134|NCT00195494|532520195|FG001|Year 1|System Toxicity|0|||
147645135|NCT00195494|532520196|FG002|Year 1|System Toxicity|0|||
147645136|NCT00195494|532520197|FG003|Year 1|System Toxicity|0|||
147645137|NCT00195494|532520198|FG004|Year 1|System Toxicity|0|||
147645138|NCT00195494|532520199|FG005|Year 1|System Toxicity|1|||
147645139|NCT00195494|532520194|FG000|Year 1|Lack of Efficacy|0|||
147645140|NCT00195494|532520195|FG001|Year 1|Lack of Efficacy|0|||
147645141|NCT00195494|532520196|FG002|Year 1|Lack of Efficacy|0|||
147645142|NCT00195494|532520197|FG003|Year 1|Lack of Efficacy|0|||
147645143|NCT00195494|532520198|FG004|Year 1|Lack of Efficacy|24|||
147645144|NCT00195494|532520199|FG005|Year 1|Lack of Efficacy|9|||
147645145|NCT00195494|532520194|FG000|Year 1|Compliance|0|||
147645146|NCT00195494|532520195|FG001|Year 1|Compliance|0|||
147645147|NCT00195494|532520196|FG002|Year 1|Compliance|0|||
147645148|NCT00195494|532520197|FG003|Year 1|Compliance|0|||
147645149|NCT00195494|532520198|FG004|Year 1|Compliance|5|||
147645150|NCT00195494|532520199|FG005|Year 1|Compliance|1|||
147645151|NCT00195494|532520194|FG000|Year 1|Lost to Follow-up|0|||
147645152|NCT00195494|532520195|FG001|Year 1|Lost to Follow-up|0|||
147645153|NCT00195494|532520196|FG002|Year 1|Lost to Follow-up|0|||
147645154|NCT00195494|532520197|FG003|Year 1|Lost to Follow-up|0|||
147645155|NCT00195494|532520198|FG004|Year 1|Lost to Follow-up|1|||
147645156|NCT00195494|532520199|FG005|Year 1|Lost to Follow-up|0|||
147645157|NCT00195494|532520194|FG000|Year 1|Missed >4 consecutive doses|0|||
147645158|NCT00195494|532520195|FG001|Year 1|Missed >4 consecutive doses|0|||
147645159|NCT00195494|532520196|FG002|Year 1|Missed >4 consecutive doses|0|||
147645160|NCT00195494|532520197|FG003|Year 1|Missed >4 consecutive doses|0|||
147645161|NCT00195494|532520198|FG004|Year 1|Missed >4 consecutive doses|3|||
147645162|NCT00195494|532520199|FG005|Year 1|Missed >4 consecutive doses|2|||
147645163|NCT00195494|532520194|FG000|Year 1|Protocol deviation|0|||
147645164|NCT00195494|532520195|FG001|Year 1|Protocol deviation|0|||
147645165|NCT00195494|532520196|FG002|Year 1|Protocol deviation|0|||
147645166|NCT00195494|532520197|FG003|Year 1|Protocol deviation|0|||
147645167|NCT00195494|532520198|FG004|Year 1|Protocol deviation|2|||
147645168|NCT00195494|532520199|FG005|Year 1|Protocol deviation|3|||
147645169|NCT00195494|532520194|FG000|Year 1|Physician Decision|0|||
147645170|NCT00195494|532520195|FG001|Year 1|Physician Decision|0|||
147645171|NCT00195494|532520196|FG002|Year 1|Physician Decision|0|||
147645172|NCT00195494|532520197|FG003|Year 1|Physician Decision|0|||
147645173|NCT00195494|532520198|FG004|Year 1|Physician Decision|1|||
147645174|NCT00195494|532520199|FG005|Year 1|Physician Decision|0|||
147645175|NCT00195494|532520194|FG000|Year 1|Withdrawal by Subject|0|||
147645176|NCT00195494|532520195|FG001|Year 1|Withdrawal by Subject|0|||
147645177|NCT00195494|532520196|FG002|Year 1|Withdrawal by Subject|0|||
147645178|NCT00195494|532520197|FG003|Year 1|Withdrawal by Subject|0|||
147645179|NCT00195494|532520198|FG004|Year 1|Withdrawal by Subject|8|||
147645180|NCT00195494|532520199|FG005|Year 1|Withdrawal by Subject|9|||
147645181|NCT00195494|532520194|FG000|Year 1|Protocol Violation|0|||
147645182|NCT00195494|532520195|FG001|Year 1|Protocol Violation|0|||
147645183|NCT00195494|532520196|FG002|Year 1|Protocol Violation|0|||
147645184|NCT00195494|532520197|FG003|Year 1|Protocol Violation|0|||
147645185|NCT00195494|532520198|FG004|Year 1|Protocol Violation|1|||
147645186|NCT00195494|532520199|FG005|Year 1|Protocol Violation|1|||
147645187|NCT00195494|532520194|FG000|Year 2|Adverse Event|3|||
147645188|NCT00195494|532520195|FG001|Year 2|Adverse Event|7|||
147645189|NCT00195494|532520196|FG002|Year 2|Adverse Event|5|||
147645190|NCT00195494|532520197|FG003|Year 2|Adverse Event|9|||
147645191|NCT00195494|532520198|FG004|Year 2|Adverse Event|0|||
147645192|NCT00195494|532520199|FG005|Year 2|Adverse Event|0|||
147645193|NCT00195494|532520194|FG000|Year 2|Lack of Efficacy|0|||
147645194|NCT00195494|532520195|FG001|Year 2|Lack of Efficacy|1|||
147645195|NCT00195494|532520196|FG002|Year 2|Lack of Efficacy|7|||
147645196|NCT00195494|532520197|FG003|Year 2|Lack of Efficacy|7|||
147645197|NCT00195494|532520198|FG004|Year 2|Lack of Efficacy|0|||
147645198|NCT00195494|532520199|FG005|Year 2|Lack of Efficacy|0|||
147645199|NCT00195494|532520194|FG000|Year 2|Compliance|1|||
147645200|NCT00195494|532520195|FG001|Year 2|Compliance|0|||
147645201|NCT00195494|532520196|FG002|Year 2|Compliance|0|||
147645202|NCT00195494|532520197|FG003|Year 2|Compliance|2|||
147645203|NCT00195494|532520198|FG004|Year 2|Compliance|0|||
147645204|NCT00195494|532520199|FG005|Year 2|Compliance|0|||
147645205|NCT00195494|532520194|FG000|Year 2|Lost to Follow-up|0|||
147645206|NCT00195494|532520195|FG001|Year 2|Lost to Follow-up|0|||
147645207|NCT00195494|532520196|FG002|Year 2|Lost to Follow-up|1|||
147645208|NCT00195494|532520197|FG003|Year 2|Lost to Follow-up|1|||
147645209|NCT00195494|532520198|FG004|Year 2|Lost to Follow-up|0|||
147645210|NCT00195494|532520199|FG005|Year 2|Lost to Follow-up|0|||
147645211|NCT00195494|532520194|FG000|Year 2|Missed >4 consecutive doses|1|||
147645212|NCT00195494|532520195|FG001|Year 2|Missed >4 consecutive doses|1|||
147645213|NCT00195494|532520196|FG002|Year 2|Missed >4 consecutive doses|1|||
147645214|NCT00195494|532520197|FG003|Year 2|Missed >4 consecutive doses|0|||
147645215|NCT00195494|532520198|FG004|Year 2|Missed >4 consecutive doses|0|||
147645216|NCT00195494|532520199|FG005|Year 2|Missed >4 consecutive doses|0|||
147645217|NCT00195494|532520194|FG000|Year 2|Protocol deviation|0|||
147645218|NCT00195494|532520195|FG001|Year 2|Protocol deviation|1|||
147645219|NCT00195494|532520196|FG002|Year 2|Protocol deviation|0|||
147645220|NCT00195494|532520197|FG003|Year 2|Protocol deviation|0|||
147645221|NCT00195494|532520198|FG004|Year 2|Protocol deviation|0|||
147645222|NCT00195494|532520199|FG005|Year 2|Protocol deviation|0|||
147645223|NCT00195494|532520194|FG000|Year 2|Physician Decision|1|||
147645224|NCT00195494|532520195|FG001|Year 2|Physician Decision|1|||
147645225|NCT00195494|532520196|FG002|Year 2|Physician Decision|0|||
147645226|NCT00195494|532520197|FG003|Year 2|Physician Decision|0|||
147645227|NCT00195494|532520198|FG004|Year 2|Physician Decision|0|||
147645228|NCT00195494|532520199|FG005|Year 2|Physician Decision|0|||
147645229|NCT00195494|532520194|FG000|Year 2|Withdrawal by Subject|1|||
147645230|NCT00195494|532520195|FG001|Year 2|Withdrawal by Subject|5|||
147645231|NCT00195494|532520196|FG002|Year 2|Withdrawal by Subject|4|||
147645232|NCT00195494|532520197|FG003|Year 2|Withdrawal by Subject|3|||
147645233|NCT00195494|532520198|FG004|Year 2|Withdrawal by Subject|0|||
147645234|NCT00195494|532520199|FG005|Year 2|Withdrawal by Subject|0|||
147645235|NCT00195494|532520194|FG000|Year 2|System toxicity|0|||
147645236|NCT00195494|532520195|FG001|Year 2|System toxicity|0|||
147645237|NCT00195494|532520196|FG002|Year 2|System toxicity|0|||
147645238|NCT00195494|532520197|FG003|Year 2|System toxicity|1|||
147645239|NCT00195494|532520198|FG004|Year 2|System toxicity|0|||
147645240|NCT00195494|532520199|FG005|Year 2|System toxicity|0|||
147645241|NCT00513357|532520200|FG000|Overall Study|did not receive allocated placebo|2|||
147645242|NCT00513357|532520201|FG001|Overall Study|did not receive allocated placebo|3|||
147645243|NCT00513357|532520200|FG000|Overall Study|Adverse Event|4|||
147645244|NCT00513357|532520201|FG001|Overall Study|Adverse Event|2|||
147645245|NCT00513357|532520200|FG000|Overall Study|Death|2|||
147645246|NCT00513357|532520201|FG001|Overall Study|Death|0|||
147645247|NCT00513357|532520200|FG000|Overall Study|Withdrawal by Subject|5|||
147645248|NCT00513357|532520201|FG001|Overall Study|Withdrawal by Subject|4|||
147645249|NCT00513357|532520200|FG000|Overall Study|Disease Progression|2|||
147645250|NCT00513357|532520201|FG001|Overall Study|Disease Progression|1|||
147645251|NCT00926536|532520205|FG000|Overall Study|Physician Decision|1|||
147645252|NCT00926536|532520206|FG001|Overall Study|Physician Decision|2|||
147645253|NCT03301844|532520207|FG000|Overall Study|suspected colon cancer|1|||
147645254|NCT03301844|532520208|FG001|Overall Study|suspected colon cancer|1|||
147645255|NCT05087966|532520209|FG000|Overall Study|Lost to Follow-up|1|||
147645256|NCT05087966|532520209|FG000|Overall Study|Withdrawal by Subject|5|||
147645257|NCT01267201|532520210|FG000|First Intervention Period|Withdrawal by Subject|1|||
147645258|NCT01267201|532520211|FG001|First Intervention Period|Withdrawal by Subject|0|||
147645259|NCT01267201|532520212|FG002|First Intervention Period|Withdrawal by Subject|0|||
147645260|NCT01267201|532520213|FG003|First Intervention Period|Withdrawal by Subject|0|||
147645261|NCT01267201|532520214|FG004|First Intervention Period|Withdrawal by Subject|0|||
147645262|NCT01267201|532520215|FG005|First Intervention Period|Withdrawal by Subject|0|||
147645263|NCT01267201|532520210|FG000|Second Intervention Period|Withdrawal by Subject|0|||
147645264|NCT01267201|532520211|FG001|Second Intervention Period|Withdrawal by Subject|1|||
147645265|NCT01267201|532520212|FG002|Second Intervention Period|Withdrawal by Subject|0|||
147645266|NCT01267201|532520213|FG003|Second Intervention Period|Withdrawal by Subject|0|||
147645267|NCT01267201|532520214|FG004|Second Intervention Period|Withdrawal by Subject|0|||
147645268|NCT01267201|532520215|FG005|Second Intervention Period|Withdrawal by Subject|0|||
147645269|NCT00501059|532520216|FG000|Overall Study|Protocol Violation|80|||
147645270|NCT00501059|532520217|FG001|Overall Study|Protocol Violation|69|||
147645271|NCT00501059|532520216|FG000|Overall Study|Death|140|||
147645272|NCT00501059|532520217|FG001|Overall Study|Death|137|||
147645273|NCT00501059|532520216|FG000|Overall Study|Other|236|||
147645274|NCT00501059|532520217|FG001|Overall Study|Other|239|||
147645275|NCT00501059|532520216|FG000|Overall Study|Missing end-of-study page|91|||
147645276|NCT00501059|532520217|FG001|Overall Study|Missing end-of-study page|92|||
147645277|NCT00501059|532520216|FG000|Overall Study|Clinical endpoint reached|110|||
147645278|NCT00501059|532520217|FG001|Overall Study|Clinical endpoint reached|123|||
147645279|NCT00501059|532520216|FG000|Overall Study|Insufficient therapeutic effect|4|||
147645280|NCT00501059|532520217|FG001|Overall Study|Insufficient therapeutic effect|5|||
147645281|NCT00501059|532520216|FG000|Overall Study|Consent withdrawn by subject|817|||
147645282|NCT00501059|532520217|FG001|Overall Study|Consent withdrawn by subject|873|||
147645283|NCT00501059|532520216|FG000|Overall Study|Non-compliant with study treatment|23|||
147645284|NCT00501059|532520217|FG001|Overall Study|Non-compliant with study treatment|16|||
147645285|NCT00501059|532520216|FG000|Overall Study|Reason not given|3|||
147645286|NCT00501059|532520217|FG001|Overall Study|Reason not given|1|||
147645287|NCT00501059|532520216|FG000|Overall Study|Adverse Event|129|||
147645288|NCT00501059|532520217|FG001|Overall Study|Adverse Event|122|||
147645289|NCT00501059|532520216|FG000|Overall Study|Lost to Follow-up|210|||
147645290|NCT00501059|532520217|FG001|Overall Study|Lost to Follow-up|198|||
147645291|NCT00501059|532520216|FG000|Overall Study|Not treated|25|||
147645292|NCT00501059|532520217|FG001|Overall Study|Not treated|17|||
147645293|NCT02124759|532520218|FG000|Overall Study|Withdrawal by Subject|3|||
147645294|NCT02124759|532520219|FG001|Overall Study|Withdrawal by Subject|1|||
147645295|NCT02124759|532520220|FG002|Overall Study|Withdrawal by Subject|1|||
147645296|NCT02124759|532520218|FG000|Overall Study|Screen Fail|2|||
147645297|NCT02124759|532520219|FG001|Overall Study|Screen Fail|2|||
147645298|NCT02124759|532520220|FG002|Overall Study|Screen Fail|3|||
147645299|NCT04249622|532520223|FG000|Overall Study|Withdrawal by Subject|1|||
147645300|NCT04249622|532520224|FG001|Overall Study|Withdrawal by Subject|1|||
147645301|NCT04249622|532520223|FG000|Overall Study|Alternative therapy|1|||
147645302|NCT04249622|532520224|FG001|Overall Study|Alternative therapy|0|||
147645303|NCT04249622|532520223|FG000|Overall Study|Discontinuation of pertuzumab|1|||
147645304|NCT04249622|532520224|FG001|Overall Study|Discontinuation of pertuzumab|0|||
147645305|NCT03689543|532520227|FG000|Overall Study|Adverse Event|0|||
147645306|NCT03689543|532520228|FG001|Overall Study|Adverse Event|0|||
147645307|NCT03689543|532520229|FG002|Overall Study|Adverse Event|1|||
147645308|NCT00932451|532520230|FG000|Overall Study|Withdrawal by Subject|69|||
147645309|NCT00932451|532520230|FG000|Overall Study|Lost to Follow-up|22|||
147645310|NCT00932451|532520230|FG000|Overall Study|Death|726|||
147645311|NCT00932451|532520230|FG000|Overall Study|Other reasons|5|||
147645312|NCT01634659|532520248|FG000|Period 2 - Second 8 Days of Wear|Adverse Event|2|||
147645313|NCT01634659|532520249|FG001|Period 2 - Second 8 Days of Wear|Adverse Event|0|||
147645314|NCT01634659|532520248|FG000|Period 2 - Second 8 Days of Wear|Physician Decision|1|||
147645315|NCT01634659|532520249|FG001|Period 2 - Second 8 Days of Wear|Physician Decision|0|||
147645316|NCT02968433|532520250|FG000|Overall Study|Withdrawal by Subject|1|||
147645317|NCT01294371|532520251|FG000|Overall Study|Adverse Event|1|||
147645318|NCT01294371|532520251|FG000|Overall Study|Withdrawal by Subject|12|||
147645319|NCT01294371|532520251|FG000|Overall Study|Lost to Follow-up|6|||
147645320|NCT01294371|532520251|FG000|Overall Study|Administrative Reason|1|||
147645321|NCT01294371|532520251|FG000|Overall Study|Other|14|||
147645322|NCT05619536|532520252|FG000|Overall Study|Withdrawal by Subject|0|||
147645323|NCT05619536|532520253|FG001|Overall Study|Withdrawal by Subject|1|||
147645324|NCT05619536|532520254|FG002|Overall Study|Withdrawal by Subject|0|||
147645325|NCT05619536|532520255|FG003|Overall Study|Withdrawal by Subject|1|||
147645326|NCT05619536|532520252|FG000|Overall Study|Lost to Follow-up|0|||
147645327|NCT05619536|532520253|FG001|Overall Study|Lost to Follow-up|1|||
147645328|NCT05619536|532520254|FG002|Overall Study|Lost to Follow-up|1|||
147645329|NCT05619536|532520255|FG003|Overall Study|Lost to Follow-up|0|||
147645330|NCT00875433|532520256|FG000|Overall Study|Progressive disease|41|||
147645331|NCT00875433|532520256|FG000|Overall Study|Other Adverse Event|14|||
147645332|NCT00875433|532520256|FG000|Overall Study|Withdrawal by Subject|2|||
147645333|NCT00875433|532520256|FG000|Overall Study|Other|3|||
147645334|NCT04272606|532520257|FG000|Overall Study|Protocol Violation|1|||
147645335|NCT04272606|532520258|FG001|Overall Study|Protocol Violation|1|||
147645336|NCT04272606|532520257|FG000|Overall Study|Physician Decision|0|||
147645337|NCT04272606|532520258|FG001|Overall Study|Physician Decision|1|||
147645338|NCT00637806|532520259|FG000|Double-blind Phase|Study Discontinued|2|||
147645339|NCT00637806|532520260|FG001|Double-blind Phase|Study Discontinued|0|||
147645340|NCT00637806|532520261|FG002|Double-blind Phase|Study Discontinued|1|||
147645341|NCT00637806|532520262|FG003|Double-blind Phase|Study Discontinued|0|||
147645342|NCT00637806|532520259|FG000|Extension Phase|Study Discontinued|0|||
147645343|NCT00637806|532520260|FG001|Extension Phase|Study Discontinued|0|||
147645344|NCT00637806|532520261|FG002|Extension Phase|Study Discontinued|0|||
147645345|NCT00637806|532520262|FG003|Extension Phase|Study Discontinued|1|||
147645346|NCT00725101|532520263|FG000|Overall Study|Death|3|||
147645347|NCT00725101|532520263|FG000|Overall Study|Lost to Follow-up|353|||
147645348|NCT00725101|532520263|FG000|Overall Study|Protocol Violation|1|||
147645349|NCT00725101|532520263|FG000|Overall Study|Withdrawal by Subject|127|||
147645350|NCT00725101|532520263|FG000|Overall Study|not specified/no reason given|11|||
147645351|NCT01592292|532520264|FG000|Overall Study|Follow-up loss|3|||
147645352|NCT01592292|532520265|FG001|Overall Study|Follow-up loss|3|||
147645353|NCT01592292|532520266|FG002|Overall Study|Follow-up loss|1|||
147645354|NCT01592292|532520267|FG003|Overall Study|Follow-up loss|0|||
147645355|NCT01592292|532520264|FG000|Overall Study|Withdrew consent|2|||
147645356|NCT01592292|532520265|FG001|Overall Study|Withdrew consent|1|||
147645357|NCT01592292|532520266|FG002|Overall Study|Withdrew consent|0|||
147645358|NCT01592292|532520267|FG003|Overall Study|Withdrew consent|0|||
147645359|NCT01592292|532520264|FG000|Overall Study|Other|1|||
147645360|NCT01592292|532520265|FG001|Overall Study|Other|1|||
147645361|NCT01592292|532520266|FG002|Overall Study|Other|2|||
147645362|NCT01592292|532520267|FG003|Overall Study|Other|1|||
147645363|NCT00622336|532520270|FG000|Treatment Phase|Progression of Disease|181|||
147645364|NCT00622336|532520270|FG000|Treatment Phase|Adverse Event|46|||
147645365|NCT00622336|532520270|FG000|Treatment Phase|Other|40|||
147645366|NCT00622336|532520270|FG000|Treatment Phase|Death|14|||
147645367|NCT00622336|532520270|FG000|Treatment Phase|Lack of therapeutic effect|13|||
147645368|NCT00622336|532520270|FG000|Treatment Phase|Withdrawal by Subject|13|||
147645369|NCT00622336|532520270|FG000|Treatment Phase|Lost to Follow-up|2|||
147645370|NCT00622336|532520270|FG000|Extension Phase|Adverse Event|2|||
147645371|NCT00622336|532520270|FG000|Extension Phase|Progressive Disease|6|||
147645372|NCT00622336|532520270|FG000|Extension Phase|Lack of therapeutic effect|2|||
147645373|NCT00622336|532520270|FG000|Extension Phase|Withdrawal by Subject|1|||
147645374|NCT00622336|532520270|FG000|Extension Phase|Lost to Follow-up|1|||
147645375|NCT00622336|532520270|FG000|Extension Phase|Other|9|||
147645376|NCT00819780|532520271|FG000|Overall Study|Did not receive study drug|3|||
147645377|NCT00819780|532520272|FG001|Overall Study|Did not receive study drug|4|||
147645378|NCT00819780|532520271|FG000|Overall Study|Still in treatment|25|||
147645379|NCT00819780|532520272|FG001|Overall Study|Still in treatment|17|||
147645380|NCT02923245|532520273|FG000|Overall Study|ultrasound order was cancelled|2|||
147645381|NCT02923245|532520274|FG001|Overall Study|ultrasound order was cancelled|1|||
147645382|NCT01764997|532520275|FG000|Run-in Period|Adverse Event|15|||
147645383|NCT01764997|532520276|FG001|Run-in Period|Adverse Event|0|||
147645384|NCT01764997|532520277|FG002|Run-in Period|Adverse Event|0|||
147645385|NCT01764997|532520278|FG003|Run-in Period|Adverse Event|0|||
147645386|NCT01764997|532520279|FG004|Run-in Period|Adverse Event|0|||
147645387|NCT01764997|532520275|FG000|Run-in Period|Lack of Efficacy|5|||
147645388|NCT01764997|532520276|FG001|Run-in Period|Lack of Efficacy|0|||
147645389|NCT01764997|532520277|FG002|Run-in Period|Lack of Efficacy|0|||
147645390|NCT01764997|532520278|FG003|Run-in Period|Lack of Efficacy|0|||
147645391|NCT01764997|532520279|FG004|Run-in Period|Lack of Efficacy|0|||
147645392|NCT01764997|532520275|FG000|Run-in Period|Poor compliance to protocol|1|||
147645393|NCT01764997|532520276|FG001|Run-in Period|Poor compliance to protocol|0|||
147645394|NCT01764997|532520277|FG002|Run-in Period|Poor compliance to protocol|0|||
147645395|NCT01764997|532520278|FG003|Run-in Period|Poor compliance to protocol|0|||
147645396|NCT01764997|532520279|FG004|Run-in Period|Poor compliance to protocol|0|||
147645397|NCT01764997|532520275|FG000|Run-in Period|Other than specified above|17|||
147645398|NCT01764997|532520276|FG001|Run-in Period|Other than specified above|0|||
147645399|NCT01764997|532520277|FG002|Run-in Period|Other than specified above|0|||
147645400|NCT01764997|532520278|FG003|Run-in Period|Other than specified above|0|||
147645401|NCT01764997|532520279|FG004|Run-in Period|Other than specified above|0|||
147645402|NCT01764997|532520275|FG000|Study Drug Treatment Period|Adverse Event|0|||
147645403|NCT01764997|532520276|FG001|Study Drug Treatment Period|Adverse Event|1|||
147645404|NCT01764997|532520277|FG002|Study Drug Treatment Period|Adverse Event|0|||
147645405|NCT01764997|532520278|FG003|Study Drug Treatment Period|Adverse Event|0|||
147645406|NCT01764997|532520279|FG004|Study Drug Treatment Period|Adverse Event|24|||
147645407|NCT01764997|532520275|FG000|Study Drug Treatment Period|Lack of Efficacy|0|||
147645408|NCT01764997|532520276|FG001|Study Drug Treatment Period|Lack of Efficacy|0|||
147645409|NCT01764997|532520277|FG002|Study Drug Treatment Period|Lack of Efficacy|0|||
147645410|NCT01764997|532520278|FG003|Study Drug Treatment Period|Lack of Efficacy|0|||
147645411|NCT01764997|532520279|FG004|Study Drug Treatment Period|Lack of Efficacy|2|||
147645412|NCT01764997|532520275|FG000|Study Drug Treatment Period|Other than specified above|0|||
147645413|NCT01764997|532520276|FG001|Study Drug Treatment Period|Other than specified above|0|||
147645414|NCT01764997|532520277|FG002|Study Drug Treatment Period|Other than specified above|0|||
147645415|NCT01764997|532520278|FG003|Study Drug Treatment Period|Other than specified above|0|||
147645416|NCT01764997|532520279|FG004|Study Drug Treatment Period|Other than specified above|10|||
147645417|NCT00787917|532520280|FG000|Blinded Treatment|Adverse Event|1|||
147645418|NCT00787917|532520281|FG001|Blinded Treatment|Adverse Event|0|||
147645419|NCT00787917|532520280|FG000|Blinded Treatment|Lack of Efficacy|1|||
147645420|NCT00787917|532520281|FG001|Blinded Treatment|Lack of Efficacy|0|||
147645421|NCT00787917|532520280|FG000|Blinded Treatment|Administrative problems|3|||
147645422|NCT00787917|532520281|FG001|Blinded Treatment|Administrative problems|2|||
147645423|NCT00787917|532520280|FG000|Open Label|Unsatisfactory therapeutic effect|1|||
147645424|NCT00787917|532520281|FG001|Open Label|Unsatisfactory therapeutic effect|0|||
147645425|NCT00787917|532520280|FG000|Open Label|Administrative problems|3|||
147645426|NCT00787917|532520281|FG001|Open Label|Administrative problems|0|||
147645427|NCT02172040|532520283|FG000|Overall Study|Adverse Event|0|||
147645428|NCT02172040|532520284|FG001|Overall Study|Adverse Event|2|||
147645429|NCT02172040|532520285|FG002|Overall Study|Adverse Event|0|||
147645430|NCT02172040|532520286|FG003|Overall Study|Adverse Event|0|||
147645431|NCT02172040|532520283|FG000|Overall Study|Protocol Violation|0|||
147645432|NCT02172040|532520284|FG001|Overall Study|Protocol Violation|1|||
147645433|NCT02172040|532520285|FG002|Overall Study|Protocol Violation|0|||
147645434|NCT02172040|532520286|FG003|Overall Study|Protocol Violation|0|||
147645435|NCT02172040|532520283|FG000|Overall Study|Withdrawal by Subject|0|||
147645436|NCT02172040|532520284|FG001|Overall Study|Withdrawal by Subject|0|||
147645437|NCT02172040|532520285|FG002|Overall Study|Withdrawal by Subject|1|||
147645438|NCT02172040|532520286|FG003|Overall Study|Withdrawal by Subject|0|||
147645439|NCT02172040|532520283|FG000|Overall Study|Not available for Day 13 & 14 visits|0|||
147645440|NCT02172040|532520284|FG001|Overall Study|Not available for Day 13 & 14 visits|0|||
147645441|NCT02172040|532520285|FG002|Overall Study|Not available for Day 13 & 14 visits|1|||
147645442|NCT02172040|532520286|FG003|Overall Study|Not available for Day 13 & 14 visits|0|||
147645443|NCT02172040|532520283|FG000|Overall Study|Family emergency abroad|0|||
147529036|NCT00151775|532090551|FG006|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
147529037|NCT00151775|532090552|FG007|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
147529038|NCT00151775|532090553|FG008|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
147645444|NCT02172040|532520284|FG001|Overall Study|Family emergency abroad|0|||
147645445|NCT02172040|532520285|FG002|Overall Study|Family emergency abroad|0|||
147645446|NCT02172040|532520286|FG003|Overall Study|Family emergency abroad|1|||
147645447|NCT04438499|532520294|FG000|Overall Study|Lack of Efficacy|3|||
147645448|NCT02093390|532520295|FG000|Overall Study|Withdrawal by Subject|0|||
147645449|NCT02093390|532520296|FG001|Overall Study|Withdrawal by Subject|1|||
147529039|NCT00151775|532090554|FG009|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
147529040|NCT00151775|532090555|FG010|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
147529041|NCT00151775|532090556|FG011|Period 3: Double-blind, Withdrawal|Adverse Event|0|||
147529042|NCT00151775|532090545|FG000|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
147529043|NCT00151775|532090546|FG001|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
147529044|NCT00151775|532090547|FG002|Period 3: Double-blind, Withdrawal|Protocol Violation|1|||
147529045|NCT00151775|532090548|FG003|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
147529046|NCT00151775|532090549|FG004|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
147529047|NCT00151775|532090550|FG005|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
147529048|NCT00151775|532090551|FG006|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
147529049|NCT00151775|532090552|FG007|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
147529050|NCT00151775|532090553|FG008|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
147529051|NCT00151775|532090554|FG009|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
147529052|NCT00151775|532090555|FG010|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
147529053|NCT00151775|532090556|FG011|Period 3: Double-blind, Withdrawal|Protocol Violation|0|||
147529054|NCT00151775|532090545|FG000|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
147529055|NCT00151775|532090546|FG001|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
147529056|NCT00151775|532090547|FG002|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
147529057|NCT00151775|532090548|FG003|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
147529058|NCT00151775|532090549|FG004|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
147529059|NCT00151775|532090550|FG005|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
147529060|NCT00151775|532090551|FG006|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
147529061|NCT00151775|532090552|FG007|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
147529062|NCT00151775|532090553|FG008|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
147529063|NCT00151775|532090554|FG009|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
147529064|NCT00151775|532090555|FG010|Period 3: Double-blind, Withdrawal|Lost to Follow-up|0|||
147529065|NCT00151775|532090556|FG011|Period 3: Double-blind, Withdrawal|Lost to Follow-up|1|||
147529066|NCT00151775|532090545|FG000|Period 4: Open Label|Increased blood pressure|0|||
147529067|NCT00151775|532090546|FG001|Period 4: Open Label|Increased blood pressure|0|||
147529068|NCT00151775|532090547|FG002|Period 4: Open Label|Increased blood pressure|0|||
147529069|NCT00151775|532090548|FG003|Period 4: Open Label|Increased blood pressure|0|||
147529070|NCT00151775|532090549|FG004|Period 4: Open Label|Increased blood pressure|1|||
147529071|NCT00151775|532090550|FG005|Period 4: Open Label|Increased blood pressure|0|||
147529072|NCT00151775|532090551|FG006|Period 4: Open Label|Increased blood pressure|0|||
147529073|NCT00151775|532090552|FG007|Period 4: Open Label|Increased blood pressure|0|||
147529074|NCT00151775|532090553|FG008|Period 4: Open Label|Increased blood pressure|0|||
147529075|NCT00151775|532090554|FG009|Period 4: Open Label|Increased blood pressure|1|||
147529076|NCT00151775|532090555|FG010|Period 4: Open Label|Increased blood pressure|0|||
147529077|NCT00151775|532090556|FG011|Period 4: Open Label|Increased blood pressure|0|||
147529078|NCT00151775|532090545|FG000|Period 4: Open Label|Withdrawal by Subject|0|||
147529079|NCT00151775|532090546|FG001|Period 4: Open Label|Withdrawal by Subject|0|||
147529080|NCT00151775|532090547|FG002|Period 4: Open Label|Withdrawal by Subject|0|||
147529081|NCT00151775|532090548|FG003|Period 4: Open Label|Withdrawal by Subject|0|||
147529082|NCT00151775|532090549|FG004|Period 4: Open Label|Withdrawal by Subject|5|||
147529083|NCT00151775|532090550|FG005|Period 4: Open Label|Withdrawal by Subject|0|||
147529084|NCT00151775|532090551|FG006|Period 4: Open Label|Withdrawal by Subject|0|||
147529085|NCT00151775|532090552|FG007|Period 4: Open Label|Withdrawal by Subject|0|||
147529086|NCT00151775|532090553|FG008|Period 4: Open Label|Withdrawal by Subject|0|||
147529087|NCT00151775|532090554|FG009|Period 4: Open Label|Withdrawal by Subject|2|||
147529088|NCT00151775|532090555|FG010|Period 4: Open Label|Withdrawal by Subject|0|||
147529089|NCT00151775|532090556|FG011|Period 4: Open Label|Withdrawal by Subject|0|||
147529090|NCT00151775|532090545|FG000|Period 4: Open Label|Adverse Event|0|||
147529091|NCT00151775|532090546|FG001|Period 4: Open Label|Adverse Event|0|||
147529092|NCT00151775|532090547|FG002|Period 4: Open Label|Adverse Event|0|||
147529093|NCT00151775|532090548|FG003|Period 4: Open Label|Adverse Event|0|||
147529094|NCT00151775|532090549|FG004|Period 4: Open Label|Adverse Event|1|||
147529095|NCT00151775|532090550|FG005|Period 4: Open Label|Adverse Event|0|||
147529096|NCT00151775|532090551|FG006|Period 4: Open Label|Adverse Event|0|||
147529097|NCT00151775|532090552|FG007|Period 4: Open Label|Adverse Event|0|||
147529098|NCT00151775|532090553|FG008|Period 4: Open Label|Adverse Event|0|||
147529099|NCT00151775|532090554|FG009|Period 4: Open Label|Adverse Event|2|||
147529100|NCT00151775|532090555|FG010|Period 4: Open Label|Adverse Event|0|||
147529101|NCT00151775|532090556|FG011|Period 4: Open Label|Adverse Event|0|||
147529102|NCT00151775|532090545|FG000|Period 4: Open Label|Lost to Follow-up|0|||
147529103|NCT00151775|532090546|FG001|Period 4: Open Label|Lost to Follow-up|0|||
147529104|NCT00151775|532090547|FG002|Period 4: Open Label|Lost to Follow-up|0|||
147529105|NCT00151775|532090548|FG003|Period 4: Open Label|Lost to Follow-up|0|||
147529106|NCT00151775|532090549|FG004|Period 4: Open Label|Lost to Follow-up|17|||
147529107|NCT00151775|532090550|FG005|Period 4: Open Label|Lost to Follow-up|0|||
147529108|NCT00151775|532090551|FG006|Period 4: Open Label|Lost to Follow-up|0|||
147529109|NCT00151775|532090552|FG007|Period 4: Open Label|Lost to Follow-up|0|||
147529110|NCT00151775|532090553|FG008|Period 4: Open Label|Lost to Follow-up|0|||
147529111|NCT00151775|532090554|FG009|Period 4: Open Label|Lost to Follow-up|7|||
147529112|NCT00151775|532090555|FG010|Period 4: Open Label|Lost to Follow-up|0|||
147529113|NCT00151775|532090556|FG011|Period 4: Open Label|Lost to Follow-up|0|||
147529114|NCT00151775|532090545|FG000|Period 4: Open Label|Non-compliance with protocol|0|||
147529115|NCT00151775|532090546|FG001|Period 4: Open Label|Non-compliance with protocol|0|||
147529116|NCT00151775|532090547|FG002|Period 4: Open Label|Non-compliance with protocol|0|||
147529117|NCT00151775|532090548|FG003|Period 4: Open Label|Non-compliance with protocol|0|||
147529118|NCT00151775|532090549|FG004|Period 4: Open Label|Non-compliance with protocol|4|||
147529119|NCT00151775|532090550|FG005|Period 4: Open Label|Non-compliance with protocol|0|||
147529120|NCT00151775|532090551|FG006|Period 4: Open Label|Non-compliance with protocol|0|||
147529121|NCT00151775|532090552|FG007|Period 4: Open Label|Non-compliance with protocol|0|||
147529122|NCT00151775|532090553|FG008|Period 4: Open Label|Non-compliance with protocol|0|||
147529123|NCT00151775|532090554|FG009|Period 4: Open Label|Non-compliance with protocol|4|||
147529124|NCT00151775|532090555|FG010|Period 4: Open Label|Non-compliance with protocol|0|||
147529125|NCT00151775|532090556|FG011|Period 4: Open Label|Non-compliance with protocol|0|||
147529126|NCT00151775|532090545|FG000|Period 4: Open Label|Other|0|||
147529127|NCT00151775|532090546|FG001|Period 4: Open Label|Other|0|||
147529128|NCT00151775|532090547|FG002|Period 4: Open Label|Other|0|||
147529129|NCT00151775|532090548|FG003|Period 4: Open Label|Other|0|||
147529130|NCT00151775|532090549|FG004|Period 4: Open Label|Other|1|||
147529131|NCT00151775|532090550|FG005|Period 4: Open Label|Other|0|||
147529132|NCT00151775|532090551|FG006|Period 4: Open Label|Other|0|||
147529133|NCT00151775|532090552|FG007|Period 4: Open Label|Other|0|||
147529134|NCT00151775|532090553|FG008|Period 4: Open Label|Other|0|||
147529135|NCT00151775|532090554|FG009|Period 4: Open Label|Other|3|||
147529136|NCT00151775|532090555|FG010|Period 4: Open Label|Other|0|||
147529137|NCT00151775|532090556|FG011|Period 4: Open Label|Other|0|||
147529138|NCT00151775|532090545|FG000|Period 4: Open Label|Physician Decision|0|||
147529139|NCT00151775|532090546|FG001|Period 4: Open Label|Physician Decision|0|||
147529140|NCT00151775|532090547|FG002|Period 4: Open Label|Physician Decision|0|||
147529141|NCT00151775|532090548|FG003|Period 4: Open Label|Physician Decision|0|||
147529142|NCT00151775|532090549|FG004|Period 4: Open Label|Physician Decision|0|||
147529143|NCT00151775|532090550|FG005|Period 4: Open Label|Physician Decision|0|||
147529144|NCT00151775|532090551|FG006|Period 4: Open Label|Physician Decision|0|||
147529145|NCT00151775|532090552|FG007|Period 4: Open Label|Physician Decision|0|||
147529146|NCT00151775|532090553|FG008|Period 4: Open Label|Physician Decision|0|||
147529147|NCT00151775|532090554|FG009|Period 4: Open Label|Physician Decision|2|||
147529148|NCT00151775|532090555|FG010|Period 4: Open Label|Physician Decision|0|||
147529149|NCT00151775|532090556|FG011|Period 4: Open Label|Physician Decision|0|||
147529150|NCT00151775|532090545|FG000|Period 4: Open Label|Protocol Violation|0|||
147529151|NCT00151775|532090546|FG001|Period 4: Open Label|Protocol Violation|0|||
147529152|NCT00151775|532090547|FG002|Period 4: Open Label|Protocol Violation|0|||
147529153|NCT00151775|532090548|FG003|Period 4: Open Label|Protocol Violation|0|||
147529154|NCT00151775|532090549|FG004|Period 4: Open Label|Protocol Violation|1|||
147529155|NCT00151775|532090550|FG005|Period 4: Open Label|Protocol Violation|0|||
147529156|NCT00151775|532090551|FG006|Period 4: Open Label|Protocol Violation|0|||
147529157|NCT00151775|532090552|FG007|Period 4: Open Label|Protocol Violation|0|||
147529158|NCT00151775|532090553|FG008|Period 4: Open Label|Protocol Violation|0|||
147529159|NCT00151775|532090554|FG009|Period 4: Open Label|Protocol Violation|0|||
147529160|NCT00151775|532090555|FG010|Period 4: Open Label|Protocol Violation|0|||
147529161|NCT00151775|532090556|FG011|Period 4: Open Label|Protocol Violation|0|||
147529162|NCT04516291|532090557|FG000|Treatment Period (24 Weeks)|Other|1|||
147529163|NCT04516291|532090558|FG001|Treatment Period (24 Weeks)|Other|0|||
147529164|NCT04516291|532090559|FG002|Treatment Period (24 Weeks)|Other|0|||
147529165|NCT04516291|532090560|FG003|Treatment Period (24 Weeks)|Other|2|||
147529166|NCT04516291|532090561|FG004|Treatment Period (24 Weeks)|Other|2|||
147529167|NCT04516291|532090562|FG005|Treatment Period (24 Weeks)|Other|4|||
147529168|NCT04516291|532090563|FG006|Treatment Period (24 Weeks)|Other|2|||
147529169|NCT04516291|532090564|FG007|Treatment Period (24 Weeks)|Other|0|||
147529170|NCT04516291|532090557|FG000|Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
147529171|NCT04516291|532090558|FG001|Treatment Period (24 Weeks)|Withdrawal by Subject|2|||
147529172|NCT04516291|532090559|FG002|Treatment Period (24 Weeks)|Withdrawal by Subject|1|||
147529173|NCT04516291|532090560|FG003|Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
147529174|NCT04516291|532090561|FG004|Treatment Period (24 Weeks)|Withdrawal by Subject|1|||
147529175|NCT04516291|532090562|FG005|Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
147529176|NCT04516291|532090563|FG006|Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
147529177|NCT04516291|532090564|FG007|Treatment Period (24 Weeks)|Withdrawal by Subject|0|||
147529178|NCT04516291|532090557|FG000|Treatment Period (24 Weeks)|Protocol Violation|0|||
147529179|NCT04516291|532090558|FG001|Treatment Period (24 Weeks)|Protocol Violation|0|||
147529180|NCT04516291|532090559|FG002|Treatment Period (24 Weeks)|Protocol Violation|0|||
147529181|NCT04516291|532090560|FG003|Treatment Period (24 Weeks)|Protocol Violation|1|||
147529182|NCT04516291|532090561|FG004|Treatment Period (24 Weeks)|Protocol Violation|0|||
147529183|NCT04516291|532090562|FG005|Treatment Period (24 Weeks)|Protocol Violation|0|||
147529184|NCT04516291|532090563|FG006|Treatment Period (24 Weeks)|Protocol Violation|0|||
147529185|NCT04516291|532090564|FG007|Treatment Period (24 Weeks)|Protocol Violation|0|||
147529186|NCT04516291|532090557|FG000|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
147529187|NCT04516291|532090558|FG001|Treatment Period (24 Weeks)|Lost to Follow-up|1|||
147529188|NCT04516291|532090559|FG002|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
147529189|NCT04516291|532090560|FG003|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
147529190|NCT04516291|532090561|FG004|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
147529191|NCT04516291|532090562|FG005|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
147529192|NCT04516291|532090563|FG006|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
147529193|NCT04516291|532090564|FG007|Treatment Period (24 Weeks)|Lost to Follow-up|0|||
147529194|NCT04516291|532090557|FG000|Treatment Period (24 Weeks)|Adverse Event|1|||
147529195|NCT04516291|532090558|FG001|Treatment Period (24 Weeks)|Adverse Event|2|||
147529196|NCT04516291|532090559|FG002|Treatment Period (24 Weeks)|Adverse Event|3|||
147529197|NCT04516291|532090560|FG003|Treatment Period (24 Weeks)|Adverse Event|3|||
147529198|NCT04516291|532090561|FG004|Treatment Period (24 Weeks)|Adverse Event|9|||
147529199|NCT04516291|532090562|FG005|Treatment Period (24 Weeks)|Adverse Event|4|||
147529200|NCT04516291|532090563|FG006|Treatment Period (24 Weeks)|Adverse Event|7|||
147529201|NCT04516291|532090564|FG007|Treatment Period (24 Weeks)|Adverse Event|14|||
147529202|NCT04516291|532090557|FG000|Follow-up Period (12 Weeks)|Other|0|||
147529203|NCT04516291|532090558|FG001|Follow-up Period (12 Weeks)|Other|1|||
147529204|NCT04516291|532090559|FG002|Follow-up Period (12 Weeks)|Other|0|||
147529205|NCT04516291|532090560|FG003|Follow-up Period (12 Weeks)|Other|2|||
147529206|NCT04516291|532090561|FG004|Follow-up Period (12 Weeks)|Other|0|||
147529207|NCT04516291|532090562|FG005|Follow-up Period (12 Weeks)|Other|0|||
147529208|NCT04516291|532090563|FG006|Follow-up Period (12 Weeks)|Other|0|||
147529209|NCT04516291|532090564|FG007|Follow-up Period (12 Weeks)|Other|0|||
147529210|NCT04516291|532090557|FG000|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
147529211|NCT04516291|532090558|FG001|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
147529212|NCT04516291|532090559|FG002|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
147529213|NCT04516291|532090560|FG003|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
147529214|NCT04516291|532090561|FG004|Follow-up Period (12 Weeks)|Withdrawal by Subject|1|||
147529215|NCT04516291|532090562|FG005|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
147529216|NCT04516291|532090563|FG006|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
147529217|NCT04516291|532090564|FG007|Follow-up Period (12 Weeks)|Withdrawal by Subject|0|||
147529218|NCT04516291|532090557|FG000|Follow-up Period (12 Weeks)|Adverse Event|0|||
147529219|NCT04516291|532090558|FG001|Follow-up Period (12 Weeks)|Adverse Event|0|||
147529220|NCT04516291|532090559|FG002|Follow-up Period (12 Weeks)|Adverse Event|1|||
147529221|NCT04516291|532090560|FG003|Follow-up Period (12 Weeks)|Adverse Event|0|||
147529222|NCT04516291|532090561|FG004|Follow-up Period (12 Weeks)|Adverse Event|1|||
147529223|NCT04516291|532090562|FG005|Follow-up Period (12 Weeks)|Adverse Event|0|||
147529224|NCT04516291|532090563|FG006|Follow-up Period (12 Weeks)|Adverse Event|0|||
147529225|NCT04516291|532090564|FG007|Follow-up Period (12 Weeks)|Adverse Event|0|||
147529226|NCT02158949|532090565|FG000|Overall Study|Withdrawal by Subject|1|||
147529227|NCT02158949|532090566|FG001|Overall Study|Withdrawal by Subject|0|||
147529228|NCT02158949|532090565|FG000|Overall Study|Lost to Follow-up|5|||
147529229|NCT02158949|532090566|FG001|Overall Study|Lost to Follow-up|11|||
147529230|NCT01161173|532090582|FG000|Overall Study|Protocol Violation|13|||
147529231|NCT01161173|532090582|FG000|Overall Study|Lost to Follow-up|7|||
147529232|NCT01161173|532090582|FG000|Overall Study|Progressive Disease|82|||
147529233|NCT01161173|532090582|FG000|Overall Study|Withdrawal of Consent|5|||
147529234|NCT01161173|532090582|FG000|Overall Study|Unacceptable Toxicity|21|||
147529235|NCT01161173|532090582|FG000|Overall Study|Death|194|||
147529236|NCT01161173|532090582|FG000|Overall Study|End of Study|2|||
147529237|NCT01161173|532090582|FG000|Overall Study|Reasons Not Specified|23|||
147529238|NCT00792467|532090583|FG000|Overall Study|progression of disease|17|||
147529239|NCT00792467|532090583|FG000|Overall Study|Adverse Event|1|||
147529240|NCT00792467|532090583|FG000|Overall Study|patient request|1|||
147529241|NCT00792467|532090583|FG000|Overall Study|Lost to Follow-up|1|||
147529242|NCT00792467|532090583|FG000|Overall Study|Patient achieved a PR and allogenic transplant was performed|1|||
147529243|NCT00792467|532090583|FG000|Overall Study|Patient in CR and HLA-matched donor available. Allogenic SCT performed|1|||
147529244|NCT00351611|532090584|FG000|Overall Study|Adverse Event|11|||
147529245|NCT00351611|532090585|FG001|Overall Study|Adverse Event|3|||
147529246|NCT00351611|532090584|FG000|Overall Study|Death|1|||
147529247|NCT00351611|532090585|FG001|Overall Study|Death|0|||
147529248|NCT00351611|532090584|FG000|Overall Study|Lost to Follow-up|1|||
147529249|NCT00351611|532090585|FG001|Overall Study|Lost to Follow-up|0|||
147529250|NCT00351611|532090584|FG000|Overall Study|No Longer Willing to Participate in Study|0|||
147529251|NCT00351611|532090585|FG001|Overall Study|No Longer Willing to Participate in Study|5|||
147529252|NCT00351611|532090584|FG000|Overall Study|Other|1|||
147529253|NCT00351611|532090585|FG001|Overall Study|Other|0|||
147529254|NCT00351611|532090584|FG000|Overall Study|Protocol Violation|0|||
147529255|NCT00351611|532090585|FG001|Overall Study|Protocol Violation|2|||
147529256|NCT02046993|532090586|FG000|Overall Study|Withdrawal by Subject|2|||
147529257|NCT02046993|532090587|FG001|Overall Study|Withdrawal by Subject|10|||
147529258|NCT02046993|532090586|FG000|Overall Study|Lost to Follow-up|1|||
147529259|NCT02046993|532090587|FG001|Overall Study|Lost to Follow-up|1|||
147529260|NCT00598442|532090588|FG000|Overall Study|Adverse Event|3|||
147529261|NCT00598442|532090589|FG001|Overall Study|Adverse Event|0|||
147529262|NCT00598442|532090590|FG002|Overall Study|Adverse Event|0|||
147529263|NCT00598442|532090588|FG000|Overall Study|Death|19|||
147529264|NCT00598442|532090589|FG001|Overall Study|Death|11|||
147529265|NCT00598442|532090590|FG002|Overall Study|Death|11|||
147529266|NCT00598442|532090588|FG000|Overall Study|Lost to Follow-up|4|||
147529267|NCT00598442|532090589|FG001|Overall Study|Lost to Follow-up|3|||
147529268|NCT00598442|532090590|FG002|Overall Study|Lost to Follow-up|3|||
147529269|NCT00598442|532090588|FG000|Overall Study|Physician Decision|2|||
147529270|NCT00598442|532090589|FG001|Overall Study|Physician Decision|1|||
147529271|NCT00598442|532090590|FG002|Overall Study|Physician Decision|1|||
147529272|NCT00598442|532090588|FG000|Overall Study|Withdrawal by Subject|8|||
147529273|NCT00598442|532090589|FG001|Overall Study|Withdrawal by Subject|16|||
147529274|NCT00598442|532090590|FG002|Overall Study|Withdrawal by Subject|6|||
147529275|NCT00598442|532090588|FG000|Overall Study|Noncompliance|0|||
147529276|NCT00598442|532090589|FG001|Overall Study|Noncompliance|2|||
147529277|NCT00598442|532090590|FG002|Overall Study|Noncompliance|1|||
147529278|NCT00598442|532090588|FG000|Overall Study|Relocation|1|||
147529279|NCT00598442|532090589|FG001|Overall Study|Relocation|4|||
147529280|NCT00598442|532090590|FG002|Overall Study|Relocation|0|||
147529281|NCT00598442|532090588|FG000|Overall Study|Renal transplant|0|||
147529282|NCT00598442|532090589|FG001|Overall Study|Renal transplant|0|||
147529283|NCT00598442|532090590|FG002|Overall Study|Renal transplant|1|||
147529284|NCT00598442|532090588|FG000|Overall Study|Site closed by sponsor|5|||
147529285|NCT00598442|532090589|FG001|Overall Study|Site closed by sponsor|2|||
147529286|NCT00598442|532090590|FG002|Overall Study|Site closed by sponsor|1|||
147529287|NCT00598442|532090588|FG000|Overall Study|Started dialysis|1|||
147529288|NCT00598442|532090589|FG001|Overall Study|Started dialysis|0|||
147529289|NCT00598442|532090590|FG002|Overall Study|Started dialysis|0|||
147529290|NCT03781167|532090602|FG000|Overall Study|Adverse Event|23|||
147529291|NCT03781167|532090603|FG001|Overall Study|Adverse Event|25|||
147529292|NCT03781167|532090602|FG000|Overall Study|Withdrew consent|16|||
147529293|NCT03781167|532090603|FG001|Overall Study|Withdrew consent|12|||
147529294|NCT03781167|532090602|FG000|Overall Study|Lost to Follow-up|0|||
147529295|NCT03781167|532090603|FG001|Overall Study|Lost to Follow-up|1|||
147529296|NCT03781167|532090602|FG000|Overall Study|Lack of Efficacy|4|||
147529297|NCT03781167|532090603|FG001|Overall Study|Lack of Efficacy|5|||
147529298|NCT03781167|532090602|FG000|Overall Study|Difficulty with drug delivery system|2|||
147529299|NCT03781167|532090603|FG001|Overall Study|Difficulty with drug delivery system|3|||
147529300|NCT03781167|532090602|FG000|Overall Study|Other, not specified|2|||
147529301|NCT03781167|532090603|FG001|Overall Study|Other, not specified|2|||
147529302|NCT00462501|532090604|FG000|Overall Study|Not treated|3|||
147529303|NCT00462501|532090604|FG000|Overall Study|Adverse Event|2|||
147529304|NCT00679354|532090606|FG000|Overall Study|Death|3|||
147529305|NCT00679354|532090606|FG000|Overall Study|Lack of Efficacy|22|||
147529306|NCT00679354|532090606|FG000|Overall Study|Physician Decision|4|||
147529307|NCT00679354|532090606|FG000|Overall Study|Ineligible|1|||
147529308|NCT00408408|532090607|FG000|Overall Study|No follow up data|2|||
147529309|NCT00408408|532090608|FG001|Overall Study|No follow up data|3|||
147529310|NCT00408408|532090609|FG002|Overall Study|No follow up data|0|||
147529311|NCT00408408|532090610|FG003|Overall Study|No follow up data|7|||
147529312|NCT00408408|532090611|FG004|Overall Study|No follow up data|5|||
147529313|NCT00408408|532090612|FG005|Overall Study|No follow up data|3|||
147529314|NCT00267202|532090621|FG000|Overall Study|Unsatisfactory therapeutic effect|21|||
147529315|NCT00267202|532090622|FG001|Overall Study|Unsatisfactory therapeutic effect|8|||
147529316|NCT00267202|532090621|FG000|Overall Study|Withdrawal by Subject|12|||
147529317|NCT00267202|532090622|FG001|Overall Study|Withdrawal by Subject|15|||
147529318|NCT00267202|532090621|FG000|Overall Study|Adverse Event|13|||
147529319|NCT00267202|532090622|FG001|Overall Study|Adverse Event|7|||
147529320|NCT00267202|532090621|FG000|Overall Study|Protocol Violation|2|||
147529321|NCT00267202|532090622|FG001|Overall Study|Protocol Violation|3|||
147529322|NCT00267202|532090621|FG000|Overall Study|Administrative problems|2|||
147529323|NCT00267202|532090622|FG001|Overall Study|Administrative problems|1|||
147529324|NCT00267202|532090621|FG000|Overall Study|Lost to Follow-up|3|||
147529325|NCT00267202|532090622|FG001|Overall Study|Lost to Follow-up|0|||
147529326|NCT00399542|532090623|FG000|Overall Study|Adverse Event|18|||
147529327|NCT00399542|532090624|FG001|Overall Study|Adverse Event|15|||
147529328|NCT00399542|532090623|FG000|Overall Study|Protocol Violation|13|||
147529329|NCT00399542|532090624|FG001|Overall Study|Protocol Violation|3|||
147529330|NCT00399542|532090623|FG000|Overall Study|Withdrawal by Subject|28|||
147529331|NCT00399542|532090624|FG001|Overall Study|Withdrawal by Subject|10|||
147529332|NCT00399542|532090623|FG000|Overall Study|Lack of Efficacy|18|||
147529333|NCT00399542|532090624|FG001|Overall Study|Lack of Efficacy|8|||
147529334|NCT00399542|532090623|FG000|Overall Study|Lost to Follow-up|6|||
147529335|NCT00399542|532090624|FG001|Overall Study|Lost to Follow-up|6|||
147529336|NCT00399542|532090623|FG000|Overall Study|Other|1|||
147529337|NCT00399542|532090624|FG001|Overall Study|Other|0|||
147529338|NCT00399542|532090623|FG000|Overall Study|Physician Decision|0|||
147529339|NCT00399542|532090624|FG001|Overall Study|Physician Decision|1|||
147529340|NCT00612456|532090625|FG000|Overall Study|Adverse Event|1|||
147529341|NCT00612456|532090626|FG001|Overall Study|Adverse Event|0|||
147529342|NCT00612456|532090627|FG002|Overall Study|Adverse Event|0|||
147529343|NCT00612456|532090625|FG000|Overall Study|Lack of Efficacy|1|||
147529344|NCT00612456|532090626|FG001|Overall Study|Lack of Efficacy|1|||
147529345|NCT00612456|532090627|FG002|Overall Study|Lack of Efficacy|0|||
147529346|NCT00612456|532090625|FG000|Overall Study|Withdrawal by Subject|0|||
147529347|NCT00612456|532090626|FG001|Overall Study|Withdrawal by Subject|1|||
147529348|NCT00612456|532090627|FG002|Overall Study|Withdrawal by Subject|0|||
147529349|NCT00808665|532090628|FG000|Overall Study|Withdrawal by Subject|1|||
147529350|NCT00808665|532090629|FG001|Overall Study|Withdrawal by Subject|0|||
147529351|NCT00808665|532090628|FG000|Overall Study|only required minimally invasive surgery|1|||
147529352|NCT00808665|532090629|FG001|Overall Study|only required minimally invasive surgery|0|||
147529353|NCT00808665|532090628|FG000|Overall Study|surgery cancelled|1|||
147529354|NCT00808665|532090629|FG001|Overall Study|surgery cancelled|0|||
147529355|NCT00808665|532090628|FG000|Overall Study|required an additional procedure|0|||
147529356|NCT00808665|532090629|FG001|Overall Study|required an additional procedure|1|||
147529357|NCT00808665|532090628|FG000|Overall Study|Physician Decision|3|||
147529358|NCT00808665|532090629|FG001|Overall Study|Physician Decision|1|||
147529359|NCT00808665|532090628|FG000|Overall Study|Medication stopped by resident|0|||
147529360|NCT00808665|532090629|FG001|Overall Study|Medication stopped by resident|1|||
147529361|NCT01757821|532090630|FG000|Overall Study|Adverse Event|1|||
147529362|NCT03831282|532090631|FG000|Overall Study|Could not place sensor|1|||
147529363|NCT01258803|532090632|FG000|Treatment Period 2 (1 Dose)|Protocol Violation|1|||
147529364|NCT01258803|532090633|FG001|Treatment Period 2 (1 Dose)|Protocol Violation|1|||
147529365|NCT01258803|532090634|FG002|Treatment Period 2 (1 Dose)|Protocol Violation|0|||
147529366|NCT01258803|532090635|FG003|Treatment Period 2 (1 Dose)|Protocol Violation|0|||
147529367|NCT01258803|532090636|FG004|Treatment Period 2 (1 Dose)|Protocol Violation|0|||
147529368|NCT01258803|532090637|FG005|Treatment Period 2 (1 Dose)|Protocol Violation|1|||
147529369|NCT01258803|532090632|FG000|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0|||
147529370|NCT01258803|532090633|FG001|Treatment Period 2 (1 Dose)|Withdrawal by Subject|1|||
147529371|NCT01258803|532090634|FG002|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0|||
147529372|NCT01258803|532090635|FG003|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0|||
147529373|NCT01258803|532090636|FG004|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0|||
147529374|NCT01258803|532090637|FG005|Treatment Period 2 (1 Dose)|Withdrawal by Subject|0|||
147529375|NCT01258803|532090632|FG000|Treatment Period 3 (1 Dose)|Protocol Violation|0|||
147529376|NCT01258803|532090633|FG001|Treatment Period 3 (1 Dose)|Protocol Violation|0|||
147529377|NCT01258803|532090634|FG002|Treatment Period 3 (1 Dose)|Protocol Violation|1|||
147529378|NCT01258803|532090635|FG003|Treatment Period 3 (1 Dose)|Protocol Violation|0|||
147529379|NCT01258803|532090636|FG004|Treatment Period 3 (1 Dose)|Protocol Violation|0|||
147529380|NCT01258803|532090637|FG005|Treatment Period 3 (1 Dose)|Protocol Violation|0|||
147529381|NCT00920582|532090638|FG000|Overall Study|Lost to Follow-up|5|||
147529382|NCT00920582|532090639|FG001|Overall Study|Lost to Follow-up|1|||
147529383|NCT00920582|532090640|FG002|Overall Study|Lost to Follow-up|2|||
147529384|NCT00920582|532090641|FG003|Overall Study|Lost to Follow-up|0|||
147529385|NCT00920582|532090638|FG000|Overall Study|Withdrawal by Subject|5|||
147529386|NCT00920582|532090639|FG001|Overall Study|Withdrawal by Subject|4|||
147529387|NCT00920582|532090640|FG002|Overall Study|Withdrawal by Subject|6|||
147529388|NCT00920582|532090641|FG003|Overall Study|Withdrawal by Subject|3|||
147529389|NCT00920582|532090638|FG000|Overall Study|Protocol Violation|1|||
147529390|NCT00920582|532090639|FG001|Overall Study|Protocol Violation|0|||
147529391|NCT00920582|532090640|FG002|Overall Study|Protocol Violation|0|||
147529392|NCT00920582|532090641|FG003|Overall Study|Protocol Violation|0|||
147529393|NCT00920582|532090638|FG000|Overall Study|Other|2|||
147529394|NCT00920582|532090639|FG001|Overall Study|Other|1|||
147529395|NCT00920582|532090640|FG002|Overall Study|Other|3|||
147529396|NCT00920582|532090641|FG003|Overall Study|Other|2|||
147529397|NCT05146999|532090648|FG000|Overall Study|Withdrew consent|6|||
147529398|NCT05146999|532090649|FG001|Overall Study|Withdrew consent|1|||
147529399|NCT05146999|532090648|FG000|Overall Study|Lost to Follow-up|3|||
147529400|NCT05146999|532090649|FG001|Overall Study|Lost to Follow-up|2|||
147529401|NCT05146999|532090648|FG000|Overall Study|Other|1|||
147529402|NCT05146999|532090649|FG001|Overall Study|Other|3|||
147529403|NCT03319160|532090650|FG000|Overall Study|Data not available.|7|||
147529404|NCT03604159|532090651|FG000|Overall Study|Lost to Follow-up|6|||
147529405|NCT03604159|532090652|FG001|Overall Study|Lost to Follow-up|7|||
147529406|NCT00851721|532090653|FG000|Overall Study|planned surgery|1|||
147529407|NCT00851721|532090654|FG001|Overall Study|planned surgery|0|||
147529408|NCT00851721|532090653|FG000|Overall Study|Death|1|||
147529409|NCT00851721|532090654|FG001|Overall Study|Death|0|||
147529410|NCT00851721|532090653|FG000|Overall Study|Adverse Event|0|||
147529411|NCT00851721|532090654|FG001|Overall Study|Adverse Event|1|||
147529412|NCT00665002|532090655|FG000|Overall Study|Progression/relapse during treatment|11|||
147529413|NCT00665002|532090655|FG000|Overall Study|Cytogenetic resistance|1|||
147529414|NCT04533204|532090656|FG000|Overall Study|Unable to understand training instructions|1|||
147529415|NCT04533204|532090657|FG001|Overall Study|Unable to understand training instructions|1|||
147529416|NCT00383292|532090658|FG000|Overall Study|Adverse Event|4|||
147529417|NCT00383292|532090659|FG001|Overall Study|Adverse Event|1|||
147529418|NCT00383292|532090660|FG002|Overall Study|Adverse Event|2|||
147529419|NCT00383292|532090658|FG000|Overall Study|Death|3|||
147529420|NCT00383292|532090659|FG001|Overall Study|Death|3|||
147529421|NCT00383292|532090660|FG002|Overall Study|Death|3|||
147529422|NCT00383292|532090658|FG000|Overall Study|Physician Decision|4|||
147529423|NCT00383292|532090659|FG001|Overall Study|Physician Decision|0|||
147529424|NCT00383292|532090660|FG002|Overall Study|Physician Decision|1|||
147529425|NCT00383292|532090658|FG000|Overall Study|Withdrawal by Subject|3|||
147529426|NCT00383292|532090659|FG001|Overall Study|Withdrawal by Subject|2|||
147529427|NCT00383292|532090660|FG002|Overall Study|Withdrawal by Subject|2|||
147529428|NCT00383292|532090658|FG000|Overall Study|Other|1|||
147529429|NCT00383292|532090659|FG001|Overall Study|Other|0|||
147529430|NCT00383292|532090660|FG002|Overall Study|Other|0|||
147529431|NCT00697255|532090661|FG000|Stage 1a|Insufficient ovarian response|1|||
147529432|NCT00697255|532090662|FG001|Stage 1a|Insufficient ovarian response|0|||
147529433|NCT00697255|532090661|FG000|Stage 1a|Multifollicular growth|1|||
147529434|NCT00697255|532090662|FG001|Stage 1a|Multifollicular growth|0|||
147529435|NCT00697255|532090661|FG000|Stage 1a|Not growing of dominant follicle|1|||
147529436|NCT00697255|532090662|FG001|Stage 1a|Not growing of dominant follicle|0|||
147529437|NCT00697255|532090661|FG000|Stage 1b|Not growing of dominant follicle|0|||
147529438|NCT00697255|532090662|FG001|Stage 1b|Not growing of dominant follicle|1|||
147529439|NCT00697255|532090661|FG000|Stage 1b|Insufficient ovarian response|0|||
147529440|NCT00697255|532090662|FG001|Stage 1b|Insufficient ovarian response|1|||
147529441|NCT01333501|532090670|FG000|Overall Study|Adverse Event|3|||
147529442|NCT01333501|532090671|FG001|Overall Study|Adverse Event|1|||
147529443|NCT01333501|532090670|FG000|Overall Study|Abnormal laboratory value|2|||
147529444|NCT01333501|532090671|FG001|Overall Study|Abnormal laboratory value|1|||
147529445|NCT01333501|532090670|FG000|Overall Study|Unsatisfactory therapeutic effect|1|||
147529446|NCT01333501|532090671|FG001|Overall Study|Unsatisfactory therapeutic effect|7|||
147529447|NCT01333501|532090670|FG000|Overall Study|Withdrawn consent|3|||
147529448|NCT01333501|532090671|FG001|Overall Study|Withdrawn consent|12|||
147529449|NCT04246996|532090672|FG000|Overall Study|Physician Decision|1|||
147529450|NCT04246996|532090673|FG001|Overall Study|Physician Decision|1|||
147529451|NCT04246996|532090672|FG000|Overall Study|Did not meet eligibility criteria|1|||
147529452|NCT04246996|532090673|FG001|Overall Study|Did not meet eligibility criteria|4|||
147529453|NCT00280059|532090676|FG000|Efficacy Assessment Phase|Death|2|||
147529454|NCT00280059|532090677|FG001|Efficacy Assessment Phase|Death|0|||
147529455|NCT00280059|532090676|FG000|Efficacy Assessment Phase|Adverse Event|33|||
147529456|NCT00280059|532090677|FG001|Efficacy Assessment Phase|Adverse Event|31|||
147529457|NCT00280059|532090676|FG000|Efficacy Assessment Phase|Laboratory abnormaility|1|||
147529458|NCT00280059|532090677|FG001|Efficacy Assessment Phase|Laboratory abnormaility|0|||
147529459|NCT00280059|532090676|FG000|Efficacy Assessment Phase|Lack of Efficacy|19|||
147529460|NCT00280059|532090677|FG001|Efficacy Assessment Phase|Lack of Efficacy|3|||
147529461|NCT00280059|532090676|FG000|Efficacy Assessment Phase|Lost to Follow-up|6|||
147529462|NCT00280059|532090677|FG001|Efficacy Assessment Phase|Lost to Follow-up|13|||
147529463|NCT00280059|532090676|FG000|Efficacy Assessment Phase|Other|7|||
147529464|NCT00280059|532090677|FG001|Efficacy Assessment Phase|Other|8|||
147529465|NCT00280059|532090676|FG000|Efficacy Assessment Phase|Withdrawal by Subject|26|||
147529466|NCT00280059|532090677|FG001|Efficacy Assessment Phase|Withdrawal by Subject|25|||
147529467|NCT00765726|532090679|FG000|Overall Study|Withdrawal by Subject|1|||
147529468|NCT00765726|532090679|FG000|Overall Study|Discontinuation of study by sponsor|8|||
147529469|NCT01674010|532092462|FG000|Open Treatment Phase 1|Adverse Event|10|||
147529470|NCT01674010|532092463|FG001|Open Treatment Phase 1|Adverse Event|0|||
147529471|NCT01674010|532092464|FG002|Open Treatment Phase 1|Adverse Event|0|||
147529472|NCT01674010|532092462|FG000|Open Treatment Phase 1|Death|1|||
147529473|NCT01674010|532092463|FG001|Open Treatment Phase 1|Death|0|||
147529474|NCT01674010|532092464|FG002|Open Treatment Phase 1|Death|0|||
147529475|NCT01674010|532092462|FG000|Open Treatment Phase 1|Lost to Follow-up|19|||
147529476|NCT01674010|532092463|FG001|Open Treatment Phase 1|Lost to Follow-up|0|||
147529477|NCT01674010|532092464|FG002|Open Treatment Phase 1|Lost to Follow-up|0|||
147529478|NCT01674010|532092462|FG000|Open Treatment Phase 1|Physician Decision|9|||
147529479|NCT01674010|532092463|FG001|Open Treatment Phase 1|Physician Decision|0|||
147529480|NCT01674010|532092464|FG002|Open Treatment Phase 1|Physician Decision|0|||
147529481|NCT01674010|532092462|FG000|Open Treatment Phase 1|Protocol Violation|7|||
147529482|NCT01674010|532092463|FG001|Open Treatment Phase 1|Protocol Violation|0|||
147529483|NCT01674010|532092464|FG002|Open Treatment Phase 1|Protocol Violation|0|||
147529484|NCT01674010|532092462|FG000|Open Treatment Phase 1|Sponsor Decision|79|||
147529485|NCT01674010|532092463|FG001|Open Treatment Phase 1|Sponsor Decision|0|||
147529486|NCT01674010|532092464|FG002|Open Treatment Phase 1|Sponsor Decision|0|||
147529487|NCT01674010|532092462|FG000|Open Treatment Phase 1|Did not remain in a stable remission|30|||
147529488|NCT01674010|532092463|FG001|Open Treatment Phase 1|Did not remain in a stable remission|0|||
147529489|NCT01674010|532092464|FG002|Open Treatment Phase 1|Did not remain in a stable remission|0|||
147529490|NCT01674010|532092462|FG000|Open Treatment Phase 1|Withdrawal by Subject|25|||
147529491|NCT01674010|532092463|FG001|Open Treatment Phase 1|Withdrawal by Subject|0|||
147529492|NCT01674010|532092464|FG002|Open Treatment Phase 1|Withdrawal by Subject|0|||
147529493|NCT01674010|532092462|FG000|Randomization Phase 2|Adverse Event|0|||
147529494|NCT01674010|532092463|FG001|Randomization Phase 2|Adverse Event|1|||
147529495|NCT01674010|532092464|FG002|Randomization Phase 2|Adverse Event|1|||
147529496|NCT01674010|532092462|FG000|Randomization Phase 2|Lost to Follow-up|0|||
147529497|NCT01674010|532092463|FG001|Randomization Phase 2|Lost to Follow-up|1|||
147529498|NCT01674010|532092464|FG002|Randomization Phase 2|Lost to Follow-up|2|||
147529499|NCT01674010|532092462|FG000|Randomization Phase 2|Mood episode recurrence|0|||
147529500|NCT01674010|532092463|FG001|Randomization Phase 2|Mood episode recurrence|8|||
147529501|NCT01674010|532092464|FG002|Randomization Phase 2|Mood episode recurrence|2|||
147529502|NCT01674010|532092462|FG000|Randomization Phase 2|Physician Decision|0|||
147529503|NCT01674010|532092463|FG001|Randomization Phase 2|Physician Decision|0|||
147529504|NCT01674010|532092464|FG002|Randomization Phase 2|Physician Decision|2|||
147529505|NCT01674010|532092462|FG000|Randomization Phase 2|Pregnancy|0|||
147529506|NCT01674010|532092463|FG001|Randomization Phase 2|Pregnancy|1|||
147529507|NCT01674010|532092464|FG002|Randomization Phase 2|Pregnancy|1|||
147529508|NCT01674010|532092462|FG000|Randomization Phase 2|Protocol Violation|0|||
147529509|NCT01674010|532092463|FG001|Randomization Phase 2|Protocol Violation|1|||
147529510|NCT01674010|532092464|FG002|Randomization Phase 2|Protocol Violation|1|||
147529511|NCT01674010|532092462|FG000|Randomization Phase 2|Sponsor Decision|0|||
147529512|NCT01674010|532092463|FG001|Randomization Phase 2|Sponsor Decision|42|||
147529513|NCT01674010|532092464|FG002|Randomization Phase 2|Sponsor Decision|45|||
147529514|NCT01674010|532092462|FG000|Randomization Phase 2|Withdrawal by Subject|0|||
147529515|NCT01674010|532092463|FG001|Randomization Phase 2|Withdrawal by Subject|8|||
147529516|NCT01674010|532092464|FG002|Randomization Phase 2|Withdrawal by Subject|7|||
147529517|NCT03159455|532092465|FG000|Overall Study|Adverse Event|0|||
147529518|NCT03159455|532092466|FG001|Overall Study|Adverse Event|0|||
147529519|NCT03159455|532092467|FG002|Overall Study|Adverse Event|0|||
147529520|NCT03159455|532092468|FG003|Overall Study|Adverse Event|0|||
147529521|NCT03159455|532092469|FG004|Overall Study|Adverse Event|0|||
147529522|NCT03159455|532092470|FG005|Overall Study|Adverse Event|1|||
147529523|NCT05056311|532092471|FG000|Overall Study|Lost to Follow-up|14|||
147529524|NCT05056311|532092471|FG000|Overall Study|Withdrawal by Subject|1|||
147529525|NCT05056311|532092471|FG000|Overall Study|Dropped from study due to no Hypospadias|23|||
147529526|NCT03799198|532092473|FG000|Overall Study|Lost to Follow-up|4|||
147529527|NCT03799198|532092474|FG001|Overall Study|Lost to Follow-up|8|||
147529528|NCT03799198|532092473|FG000|Overall Study|Death|0|||
147529529|NCT03799198|532092474|FG001|Overall Study|Death|1|||
147529530|NCT00960869|532092475|FG000|Overall Study|Adverse Event|17|||
147529531|NCT00960869|532092476|FG001|Overall Study|Adverse Event|26|||
147529532|NCT00960869|532092475|FG000|Overall Study|Withdrawal by Subject|16|||
147529533|NCT00960869|532092476|FG001|Overall Study|Withdrawal by Subject|14|||
147529534|NCT00960869|532092475|FG000|Overall Study|Lost to Follow-up|1|||
147529535|NCT00960869|532092476|FG001|Overall Study|Lost to Follow-up|4|||
147529536|NCT00960869|532092475|FG000|Overall Study|Misc|19|||
147529537|NCT00960869|532092476|FG001|Overall Study|Misc|18|||
147529538|NCT01714726|532092477|FG000|Double-Blinded Induction Period|Subject not in open label period|3|||
147529539|NCT01714726|532092478|FG001|Double-Blinded Induction Period|Subject not in open label period|1|||
147529540|NCT01714726|532092479|FG002|Double-Blinded Induction Period|Subject not in open label period|0|||
147529541|NCT01714726|532092480|FG003|Double-Blinded Induction Period|Subject not in open label period|0|||
147529542|NCT01714726|532092477|FG000|Double-Blinded Induction Period|Adverse Event|0|||
147529543|NCT01714726|532092478|FG001|Double-Blinded Induction Period|Adverse Event|1|||
147529544|NCT01714726|532092479|FG002|Double-Blinded Induction Period|Adverse Event|0|||
147529545|NCT01714726|532092480|FG003|Double-Blinded Induction Period|Adverse Event|0|||
147529546|NCT01714726|532092477|FG000|Double-Blinded Induction Period|Withdrawal by Subject|5|||
147529547|NCT01714726|532092478|FG001|Double-Blinded Induction Period|Withdrawal by Subject|3|||
147529548|NCT01714726|532092479|FG002|Double-Blinded Induction Period|Withdrawal by Subject|0|||
147529549|NCT01714726|532092480|FG003|Double-Blinded Induction Period|Withdrawal by Subject|0|||
147529550|NCT01714726|532092477|FG000|Double-Blinded Induction Period|Lost to Follow-up|0|||
147529551|NCT01714726|532092478|FG001|Double-Blinded Induction Period|Lost to Follow-up|2|||
147529552|NCT01714726|532092479|FG002|Double-Blinded Induction Period|Lost to Follow-up|0|||
147529553|NCT01714726|532092480|FG003|Double-Blinded Induction Period|Lost to Follow-up|0|||
147529554|NCT01714726|532092477|FG000|Open-Label Period|Other|0|||
147529555|NCT01714726|532092478|FG001|Open-Label Period|Other|0|||
147529556|NCT01714726|532092479|FG002|Open-Label Period|Other|1|||
147529557|NCT01714726|532092480|FG003|Open-Label Period|Other|3|||
147529558|NCT01714726|532092477|FG000|Open-Label Period|Adverse Event|0|||
147529559|NCT01714726|532092478|FG001|Open-Label Period|Adverse Event|0|||
147529560|NCT01714726|532092479|FG002|Open-Label Period|Adverse Event|1|||
147529561|NCT01714726|532092480|FG003|Open-Label Period|Adverse Event|0|||
147529562|NCT01714726|532092477|FG000|Open-Label Period|Withdrawal by Subject|0|||
147529563|NCT01714726|532092478|FG001|Open-Label Period|Withdrawal by Subject|0|||
147529564|NCT01714726|532092479|FG002|Open-Label Period|Withdrawal by Subject|9|||
147529565|NCT01714726|532092480|FG003|Open-Label Period|Withdrawal by Subject|19|||
147529566|NCT01714726|532092477|FG000|Open-Label Period|Developed specific withdrawal criteria|0|||
147529567|NCT01714726|532092478|FG001|Open-Label Period|Developed specific withdrawal criteria|0|||
147529568|NCT01714726|532092479|FG002|Open-Label Period|Developed specific withdrawal criteria|5|||
147529569|NCT01714726|532092480|FG003|Open-Label Period|Developed specific withdrawal criteria|2|||
147529570|NCT01714726|532092477|FG000|Open-Label Period|Lost to Follow-up|0|||
147529571|NCT01714726|532092478|FG001|Open-Label Period|Lost to Follow-up|0|||
147529572|NCT01714726|532092479|FG002|Open-Label Period|Lost to Follow-up|3|||
147529573|NCT01714726|532092480|FG003|Open-Label Period|Lost to Follow-up|4|||
147529574|NCT02501642|532092481|FG000|Overall Study|Lost to Follow-up|7|||
147529575|NCT02501642|532092482|FG001|Overall Study|Lost to Follow-up|11|||
147529576|NCT01153971|532092488|FG000|Induction Phase (Months 1 to 7 of Study)|Adverse Event|2|||
147529577|NCT01153971|532092488|FG000|Induction Phase (Months 1 to 7 of Study)|Withdrawal by Subject|1|||
147529578|NCT01153971|532092488|FG000|Maintenance Phase (Months 8-16 of Study)|Adverse Event|2|||
147529579|NCT01153971|532092488|FG000|Maintenance Phase (Months 8-16 of Study)|Clinical relapse|1|||
147529580|NCT01153971|532092488|FG000|Follow-up (Months 17-40 of Study)|Adverse Event|1|||
147529581|NCT01153971|532092488|FG000|Follow-up (Months 17-40 of Study)|Protocol Violation|1|||
147529582|NCT01153971|532092488|FG000|Follow-up (Months 17-40 of Study)|Disease progression|2|||
147529583|NCT03628781|532092489|FG000|Overall Study|Lost to Follow-up|16|||
147529584|NCT03628781|532092490|FG001|Overall Study|Lost to Follow-up|8|||
147529585|NCT03628781|532092489|FG000|Overall Study|Withdrawal by Subject|16|||
147529586|NCT03628781|532092490|FG001|Overall Study|Withdrawal by Subject|1|||
147529587|NCT00679042|532092494|FG000|Transplant + 1 Year Follow Up|Withdrawal by Subject|2|||
147529588|NCT00679042|532092494|FG000|5-Year Follow Up|In follow-up (ongoing)|6|||
147529589|NCT00679042|532092494|FG000|5-Year Follow Up|Death|1|||
147529590|NCT00679042|532092494|FG000|5-Year Follow Up|Did not consent to continue into 10-year follow up|7|||
147529591|NCT00679042|532092494|FG000|10-Year Follow Up|In follow-up (ongoing)|5|||
147529592|NCT00379639|532092495|FG000|Overall Study|Disease Progression|3|||
147529593|NCT00379639|532092496|FG001|Overall Study|Disease Progression|3|||
147529594|NCT00379639|532092497|FG002|Overall Study|Disease Progression|3|||
147529595|NCT00379639|532092498|FG003|Overall Study|Disease Progression|4|||
147529596|NCT00379639|532092499|FG004|Overall Study|Disease Progression|4|||
147529597|NCT00379639|532092495|FG000|Overall Study|Physician Decision|0|||
147529598|NCT00379639|532092496|FG001|Overall Study|Physician Decision|2|||
147529599|NCT00379639|532092497|FG002|Overall Study|Physician Decision|1|||
147529600|NCT00379639|532092498|FG003|Overall Study|Physician Decision|1|||
147529601|NCT00379639|532092499|FG004|Overall Study|Physician Decision|0|||
147529602|NCT00379639|532092495|FG000|Overall Study|Symptomatic Deterioration|0|||
147529603|NCT00379639|532092496|FG001|Overall Study|Symptomatic Deterioration|0|||
147529604|NCT00379639|532092497|FG002|Overall Study|Symptomatic Deterioration|1|||
147529605|NCT00379639|532092498|FG003|Overall Study|Symptomatic Deterioration|0|||
147529606|NCT00379639|532092499|FG004|Overall Study|Symptomatic Deterioration|1|||
147529607|NCT00379639|532092495|FG000|Overall Study|Adverse Event|0|||
147529608|NCT00379639|532092496|FG001|Overall Study|Adverse Event|0|||
147529609|NCT00379639|532092497|FG002|Overall Study|Adverse Event|1|||
147529610|NCT00379639|532092498|FG003|Overall Study|Adverse Event|0|||
147529611|NCT00379639|532092499|FG004|Overall Study|Adverse Event|1|||
147529612|NCT00379639|532092495|FG000|Overall Study|Lost to Follow-up|0|||
147529613|NCT00379639|532092496|FG001|Overall Study|Lost to Follow-up|0|||
147529614|NCT00379639|532092497|FG002|Overall Study|Lost to Follow-up|0|||
147529615|NCT00379639|532092498|FG003|Overall Study|Lost to Follow-up|1|||
147529616|NCT00379639|532092499|FG004|Overall Study|Lost to Follow-up|0|||
147529617|NCT00379639|532092495|FG000|Overall Study|Other|0|||
147529618|NCT00379639|532092496|FG001|Overall Study|Other|0|||
147529619|NCT00379639|532092497|FG002|Overall Study|Other|3|||
147529620|NCT00379639|532092498|FG003|Overall Study|Other|0|||
147529621|NCT00379639|532092499|FG004|Overall Study|Other|0|||
147529622|NCT03053102|532092500|FG000|Study Part 2: 84-Day Treatment|Adverse Event|1|||
147529623|NCT03053102|532092500|FG000|Study Part 2: 84-Day Treatment|Withdrawal by Subject|1|||
147529624|NCT01798056|532092501|FG000|Overall Study|Serious Adverse Event|13|||
147529625|NCT01798056|532092502|FG001|Overall Study|Serious Adverse Event|12|||
147529626|NCT01798056|532092501|FG000|Overall Study|Withdrawal by Subject|12|||
147529627|NCT01798056|532092502|FG001|Overall Study|Withdrawal by Subject|9|||
147529628|NCT01798056|532092501|FG000|Overall Study|Migrated/moved from study area|1|||
147529629|NCT01798056|532092502|FG001|Overall Study|Migrated/moved from study area|1|||
147529630|NCT01798056|532092501|FG000|Overall Study|Lost to Follow-up|1|||
147529631|NCT01798056|532092502|FG001|Overall Study|Lost to Follow-up|1|||
147529632|NCT01798056|532092501|FG000|Overall Study|Other|0|||
147529633|NCT01798056|532092502|FG001|Overall Study|Other|2|||
147529634|NCT01238861|532092505|FG000|Overall Study|Lost to Follow-up|4|||
147529635|NCT01238861|532092506|FG001|Overall Study|Lost to Follow-up|2|||
147529636|NCT01238861|532092507|FG002|Overall Study|Lost to Follow-up|3|||
147529637|NCT01238861|532092508|FG003|Overall Study|Lost to Follow-up|1|||
147529638|NCT01238861|532092509|FG004|Overall Study|Lost to Follow-up|1|||
147529639|NCT01238861|532092510|FG005|Overall Study|Lost to Follow-up|2|||
147529640|NCT01238861|532092505|FG000|Overall Study|Unplanned surgery|1|||
147529641|NCT01238861|532092506|FG001|Overall Study|Unplanned surgery|0|||
147529642|NCT01238861|532092507|FG002|Overall Study|Unplanned surgery|0|||
147529643|NCT01238861|532092508|FG003|Overall Study|Unplanned surgery|0|||
147529644|NCT01238861|532092509|FG004|Overall Study|Unplanned surgery|0|||
147529645|NCT01238861|532092510|FG005|Overall Study|Unplanned surgery|0|||
147529646|NCT01238861|532092505|FG000|Overall Study|Did not meet entry ACQ-6 criteria|0|||
147529647|NCT01238861|532092506|FG001|Overall Study|Did not meet entry ACQ-6 criteria|0|||
147529648|NCT01238861|532092507|FG002|Overall Study|Did not meet entry ACQ-6 criteria|1|||
147529649|NCT01238861|532092508|FG003|Overall Study|Did not meet entry ACQ-6 criteria|0|||
147529650|NCT01238861|532092509|FG004|Overall Study|Did not meet entry ACQ-6 criteria|1|||
147529651|NCT01238861|532092510|FG005|Overall Study|Did not meet entry ACQ-6 criteria|1|||
147529652|NCT01238861|532092505|FG000|Overall Study|Incorrect enrollment/randomization|0|||
147529653|NCT01238861|532092506|FG001|Overall Study|Incorrect enrollment/randomization|0|||
147529654|NCT01238861|532092507|FG002|Overall Study|Incorrect enrollment/randomization|1|||
147529655|NCT01238861|532092508|FG003|Overall Study|Incorrect enrollment/randomization|0|||
147529656|NCT01238861|532092509|FG004|Overall Study|Incorrect enrollment/randomization|1|||
147529657|NCT01238861|532092510|FG005|Overall Study|Incorrect enrollment/randomization|0|||
147529658|NCT01238861|532092505|FG000|Overall Study|Subject traveled to Argentina by 1 year|0|||
147529659|NCT01238861|532092506|FG001|Overall Study|Subject traveled to Argentina by 1 year|0|||
147529660|NCT01238861|532092507|FG002|Overall Study|Subject traveled to Argentina by 1 year|1|||
147529661|NCT01238861|532092508|FG003|Overall Study|Subject traveled to Argentina by 1 year|0|||
147529662|NCT01238861|532092509|FG004|Overall Study|Subject traveled to Argentina by 1 year|0|||
147529663|NCT01238861|532092510|FG005|Overall Study|Subject traveled to Argentina by 1 year|0|||
147529664|NCT01238861|532092505|FG000|Overall Study|Subject moved out of state/area|0|||
147529665|NCT01238861|532092506|FG001|Overall Study|Subject moved out of state/area|0|||
147529666|NCT01238861|532092507|FG002|Overall Study|Subject moved out of state/area|1|||
147529667|NCT01238861|532092508|FG003|Overall Study|Subject moved out of state/area|1|||
147529668|NCT01238861|532092509|FG004|Overall Study|Subject moved out of state/area|0|||
147529669|NCT01238861|532092510|FG005|Overall Study|Subject moved out of state/area|0|||
147529670|NCT01238861|532092505|FG000|Overall Study|Strongyloides stercoralis antibodies +|0|||
147529671|NCT01238861|532092506|FG001|Overall Study|Strongyloides stercoralis antibodies +|0|||
147529672|NCT01238861|532092507|FG002|Overall Study|Strongyloides stercoralis antibodies +|0|||
147529673|NCT01238861|532092508|FG003|Overall Study|Strongyloides stercoralis antibodies +|1|||
147529674|NCT01238861|532092509|FG004|Overall Study|Strongyloides stercoralis antibodies +|0|||
147529675|NCT01238861|532092510|FG005|Overall Study|Strongyloides stercoralis antibodies +|0|||
147529676|NCT01238861|532092505|FG000|Overall Study|Personal problems|0|||
147529677|NCT01238861|532092506|FG001|Overall Study|Personal problems|0|||
147529678|NCT01238861|532092507|FG002|Overall Study|Personal problems|0|||
147529679|NCT01238861|532092508|FG003|Overall Study|Personal problems|1|||
147529680|NCT01238861|532092509|FG004|Overall Study|Personal problems|0|||
147529681|NCT01238861|532092510|FG005|Overall Study|Personal problems|0|||
147529682|NCT01238861|532092505|FG000|Overall Study|Unable to continue visits|0|||
147529683|NCT01238861|532092506|FG001|Overall Study|Unable to continue visits|0|||
147529684|NCT01238861|532092507|FG002|Overall Study|Unable to continue visits|0|||
147529685|NCT01238861|532092508|FG003|Overall Study|Unable to continue visits|1|||
147529686|NCT01238861|532092509|FG004|Overall Study|Unable to continue visits|0|||
147529687|NCT01238861|532092510|FG005|Overall Study|Unable to continue visits|1|||
147529688|NCT01238861|532092505|FG000|Overall Study|Serious adverse event|0|||
147529689|NCT01238861|532092506|FG001|Overall Study|Serious adverse event|0|||
147529690|NCT01238861|532092507|FG002|Overall Study|Serious adverse event|0|||
147529691|NCT01238861|532092508|FG003|Overall Study|Serious adverse event|0|||
147529692|NCT01238861|532092509|FG004|Overall Study|Serious adverse event|0|||
147529693|NCT01238861|532092510|FG005|Overall Study|Serious adverse event|1|||
147529694|NCT01238861|532092505|FG000|Overall Study|Lack of compliance|0|||
147529695|NCT01238861|532092506|FG001|Overall Study|Lack of compliance|0|||
147529696|NCT01238861|532092507|FG002|Overall Study|Lack of compliance|0|||
147529697|NCT01238861|532092508|FG003|Overall Study|Lack of compliance|0|||
147529698|NCT01238861|532092509|FG004|Overall Study|Lack of compliance|0|||
147529699|NCT01238861|532092510|FG005|Overall Study|Lack of compliance|1|||
147529700|NCT01238861|532092505|FG000|Overall Study|Adverse Event|0|||
147529701|NCT01238861|532092506|FG001|Overall Study|Adverse Event|1|||
147529702|NCT01238861|532092507|FG002|Overall Study|Adverse Event|0|||
147529703|NCT01238861|532092508|FG003|Overall Study|Adverse Event|0|||
147529704|NCT01238861|532092509|FG004|Overall Study|Adverse Event|0|||
147529705|NCT01238861|532092510|FG005|Overall Study|Adverse Event|0|||
147529706|NCT01238861|532092505|FG000|Overall Study|Withdrawal by Subject|6|||
147529707|NCT01238861|532092506|FG001|Overall Study|Withdrawal by Subject|5|||
147529708|NCT01238861|532092507|FG002|Overall Study|Withdrawal by Subject|4|||
147529709|NCT01238861|532092508|FG003|Overall Study|Withdrawal by Subject|8|||
147529710|NCT01238861|532092509|FG004|Overall Study|Withdrawal by Subject|10|||
147529711|NCT01238861|532092510|FG005|Overall Study|Withdrawal by Subject|9|||
147529712|NCT01269346|532092511|FG000|Treatment Phase|Disease progression|3|||
147529713|NCT01269346|532092511|FG000|Treatment Phase|Adverse Event|3|||
147529714|NCT01269346|532092511|FG000|Treatment Phase|Withdrawal by Subject|1|||
147529715|NCT01269346|532092511|FG000|Treatment Phase|Other|2|||
147529716|NCT01269346|532092511|FG000|Extension Phase|Adverse Event|6|||
147529717|NCT01269346|532092511|FG000|Extension Phase|Withdrawal by Subject|4|||
147529718|NCT01269346|532092511|FG000|Extension Phase|Disease progression|22|||
147529719|NCT01269346|532092511|FG000|Extension Phase|Physician decision or participant choice|9|||
147529720|NCT01269346|532092511|FG000|Extension Phase|Clinical progression|1|||
147529721|NCT01269346|532092511|FG000|Extension Phase|Started a prohibited con med|1|||
147529722|NCT00247416|532092512|FG000|Overall Study|3 patients were found to be ineligible|1|||
147529723|NCT00247416|532092513|FG001|Overall Study|3 patients were found to be ineligible|2|||
147529724|NCT04963231|532092515|FG000|Stage 1 (Open-Label, Duration: 16 Weeks)|Adverse Event|43|||
147529725|NCT04963231|532092516|FG001|Stage 1 (Open-Label, Duration: 16 Weeks)|Adverse Event|0|||
147529726|NCT04963231|532092517|FG002|Stage 1 (Open-Label, Duration: 16 Weeks)|Adverse Event|0|||
147529727|NCT04963231|532092515|FG000|Stage 1 (Open-Label, Duration: 16 Weeks)|Protocol Violation|3|||
147529728|NCT04963231|532092516|FG001|Stage 1 (Open-Label, Duration: 16 Weeks)|Protocol Violation|0|||
147529729|NCT04963231|532092517|FG002|Stage 1 (Open-Label, Duration: 16 Weeks)|Protocol Violation|0|||
147529730|NCT04963231|532092515|FG000|Stage 1 (Open-Label, Duration: 16 Weeks)|Withdrawal by Subject|16|||
147529731|NCT04963231|532092516|FG001|Stage 1 (Open-Label, Duration: 16 Weeks)|Withdrawal by Subject|0|||
147529732|NCT04963231|532092517|FG002|Stage 1 (Open-Label, Duration: 16 Weeks)|Withdrawal by Subject|0|||
147529733|NCT04963231|532092515|FG000|Stage 1 (Open-Label, Duration: 16 Weeks)|Lost to Follow-up|2|||
147529734|NCT04963231|532092516|FG001|Stage 1 (Open-Label, Duration: 16 Weeks)|Lost to Follow-up|0|||
147529735|NCT04963231|532092517|FG002|Stage 1 (Open-Label, Duration: 16 Weeks)|Lost to Follow-up|0|||
147529736|NCT04963231|532092515|FG000|Stage 2 (Double-Blind, Duration:24 Week)|Adverse Event|0|||
147529737|NCT04963231|532092516|FG001|Stage 2 (Double-Blind, Duration:24 Week)|Adverse Event|0|||
147529738|NCT04963231|532092517|FG002|Stage 2 (Double-Blind, Duration:24 Week)|Adverse Event|1|||
147529739|NCT04963231|532092515|FG000|Stage 2 (Double-Blind, Duration:24 Week)|Withdrawal by Subject|0|||
147529740|NCT04963231|532092516|FG001|Stage 2 (Double-Blind, Duration:24 Week)|Withdrawal by Subject|2|||
147529741|NCT04963231|532092517|FG002|Stage 2 (Double-Blind, Duration:24 Week)|Withdrawal by Subject|2|||
147529742|NCT04963231|532092515|FG000|Stage 2 (Double-Blind, Duration:24 Week)|Other than specified|0|||
147529743|NCT04963231|532092516|FG001|Stage 2 (Double-Blind, Duration:24 Week)|Other than specified|1|||
147529744|NCT04963231|532092517|FG002|Stage 2 (Double-Blind, Duration:24 Week)|Other than specified|4|||
147529745|NCT01059175|532092518|FG000|Overall Study|Death|17|||
147529746|NCT01059175|532092519|FG001|Overall Study|Death|17|||
147529747|NCT01059175|532092518|FG000|Overall Study|Adverse Event|4|||
147529748|NCT01059175|532092519|FG001|Overall Study|Adverse Event|2|||
147529749|NCT01059175|532092518|FG000|Overall Study|Lost to Follow-up|0|||
147529750|NCT01059175|532092519|FG001|Overall Study|Lost to Follow-up|1|||
147529751|NCT02957149|532092520|FG000|Overall Study|Withdrawal by Subject|5|||
147529752|NCT01097057|532092526|FG000|Overall Study|Physician Decision|3|||
147529753|NCT03198559|532092530|FG000|Overall Study|Adverse Event|2|||
147529754|NCT03737812|532092531|FG000|Overall Study|Withdrawal by Subject|1|||
147529755|NCT03737812|532092532|FG001|Overall Study|Withdrawal by Subject|2|||
147529756|NCT03737812|532092533|FG002|Overall Study|Withdrawal by Subject|1|||
147529757|NCT03737812|532092531|FG000|Overall Study|Sponsor Discontinued the Study|4|||
147529758|NCT03737812|532092532|FG001|Overall Study|Sponsor Discontinued the Study|3|||
147529759|NCT03737812|532092533|FG002|Overall Study|Sponsor Discontinued the Study|2|||
147529760|NCT03737812|532092531|FG000|Overall Study|Adverse Event|0|||
147529761|NCT03737812|532092532|FG001|Overall Study|Adverse Event|1|||
147529762|NCT03737812|532092533|FG002|Overall Study|Adverse Event|0|||
147529763|NCT03737812|532092531|FG000|Overall Study|COVID -19 Logistical Restrictions|0|||
147529764|NCT03737812|532092532|FG001|Overall Study|COVID -19 Logistical Restrictions|0|||
147529765|NCT03737812|532092533|FG002|Overall Study|COVID -19 Logistical Restrictions|1|||
147529766|NCT02624713|532092534|FG000|Overall Study|Lost to Follow-up|14|||
147529767|NCT02624713|532092535|FG001|Overall Study|Lost to Follow-up|0|||
147529768|NCT01911546|532092539|FG000|Overall Study|Lost to Follow-up|1|||
147529769|NCT01911546|532092539|FG000|Overall Study|Everolimus was discontinued|5|||
147529770|NCT01474291|532092544|FG000|Overall Study|Not Evaluable for Efficacy|26|||
147529771|NCT01474291|532092544|FG000|Overall Study|Lack of Treatment Efficacy|88|||
147529772|NCT01474291|532092544|FG000|Overall Study|Adverse Event|53|||
147529773|NCT01474291|532092544|FG000|Overall Study|Lost to Follow-up|29|||
147529774|NCT01474291|532092544|FG000|Overall Study|Patient No Longer Wanted to Participate|12|||
147529775|NCT01474291|532092544|FG000|Overall Study|No Reason Reported|10|||
147529776|NCT01474291|532092544|FG000|Overall Study|Death|2|||
147529777|NCT03471507|532092545|FG000|Overall Study|Lost to Follow-up|1|||
147529778|NCT03471507|532092546|FG001|Overall Study|Lost to Follow-up|3|||
147529779|NCT03471507|532092545|FG000|Overall Study|Physician Decision|0|||
147529780|NCT03471507|532092546|FG001|Overall Study|Physician Decision|1|||
147529781|NCT03471507|532092545|FG000|Overall Study|Withdrawal by Subject|2|||
147529782|NCT03471507|532092546|FG001|Overall Study|Withdrawal by Subject|1|||
147529783|NCT02213666|532092547|FG000|Overall Study|Withdrawal by Subject|1|||
147529784|NCT01399619|532092548|FG000|Overall Study|Adverse Event|10|||
147529785|NCT01399619|532092549|FG001|Overall Study|Adverse Event|0|||
147529786|NCT01399619|532092550|FG002|Overall Study|Adverse Event|4|||
147529787|NCT01399619|532092551|FG003|Overall Study|Adverse Event|10|||
147529788|NCT01399619|532092548|FG000|Overall Study|Lack of Efficacy|9|||
147529789|NCT01399619|532092549|FG001|Overall Study|Lack of Efficacy|0|||
147529790|NCT01399619|532092550|FG002|Overall Study|Lack of Efficacy|5|||
147529791|NCT01399619|532092551|FG003|Overall Study|Lack of Efficacy|0|||
147529792|NCT01399619|532092548|FG000|Overall Study|Withdrawal by Subject|6|||
147529793|NCT01399619|532092549|FG001|Overall Study|Withdrawal by Subject|0|||
147529794|NCT01399619|532092550|FG002|Overall Study|Withdrawal by Subject|3|||
147529795|NCT01399619|532092551|FG003|Overall Study|Withdrawal by Subject|4|||
147529796|NCT01399619|532092548|FG000|Overall Study|Protocol Violation|0|||
147529797|NCT01399619|532092549|FG001|Overall Study|Protocol Violation|0|||
147529798|NCT01399619|532092550|FG002|Overall Study|Protocol Violation|0|||
147529799|NCT01399619|532092551|FG003|Overall Study|Protocol Violation|1|||
147529800|NCT01399619|532092548|FG000|Overall Study|Not treated|0|||
147529801|NCT01399619|532092549|FG001|Overall Study|Not treated|0|||
147529802|NCT01399619|532092550|FG002|Overall Study|Not treated|0|||
147529803|NCT01399619|532092551|FG003|Overall Study|Not treated|2|||
147529804|NCT00750061|532092552|FG000|Overall Study|Adverse Event|2|||
147529805|NCT00750061|532092553|FG001|Overall Study|Adverse Event|0|||
147529806|NCT00750061|532092552|FG000|Overall Study|Withdrawal by Subject|0|||
147529807|NCT00750061|532092553|FG001|Overall Study|Withdrawal by Subject|1|||
147529808|NCT00750061|532092552|FG000|Overall Study|Physician Decision|0|||
147529809|NCT00750061|532092553|FG001|Overall Study|Physician Decision|1|||
147529810|NCT01590628|532092577|FG000|Overall Study|Death|2|||
147529811|NCT01590628|532092578|FG001|Overall Study|Death|0|||
147529812|NCT00229931|532092579|FG000|Overall Study|Death|1|||
147529813|NCT00229931|532092580|FG001|Overall Study|Death|0|||
147529814|NCT00229931|532092579|FG000|Overall Study|Lost to Follow-up|3|||
147529815|NCT00229931|532092580|FG001|Overall Study|Lost to Follow-up|2|||
147529816|NCT00475657|532092581|FG000|Overall Study|Death|1|||
147529817|NCT00475657|532092581|FG000|Overall Study|Sponsor's Decision|3|||
147529818|NCT02992743|532092582|FG000|Overall Study|Withdrawal by Subject|1|||
147529819|NCT02992743|532092583|FG001|Overall Study|Withdrawal by Subject|1|||
147529820|NCT02992743|532092582|FG000|Overall Study|Death-Prior to T-Cell Infusion|1|||
147529821|NCT02992743|532092583|FG001|Overall Study|Death-Prior to T-Cell Infusion|0|||
147529822|NCT02992743|532092582|FG000|Overall Study|Did Not Meet Inclusion/Exclusion|1|||
147529823|NCT02992743|532092583|FG001|Overall Study|Did Not Meet Inclusion/Exclusion|0|||
147529824|NCT02992743|532092582|FG000|Overall Study|No measurable disease|1|||
147529825|NCT02992743|532092583|FG001|Overall Study|No measurable disease|0|||
147529826|NCT02992743|532092582|FG000|Overall Study|Lost to Follow-up|0|||
147529827|NCT02992743|532092583|FG001|Overall Study|Lost to Follow-up|1|||
147529828|NCT00998166|532092586|FG000|Overall Study|Early Study Termination|8|||
147529829|NCT02354599|532092589|FG000|Overall Study|Pretreatment Event/Adverse Event|0|||
147529830|NCT02354599|532092590|FG001|Overall Study|Pretreatment Event/Adverse Event|0|||
147529831|NCT02354599|532092591|FG002|Overall Study|Pretreatment Event/Adverse Event|0|||
147529832|NCT02354599|532092592|FG003|Overall Study|Pretreatment Event/Adverse Event|0|||
147529833|NCT02354599|532092593|FG004|Overall Study|Pretreatment Event/Adverse Event|0|||
147529834|NCT02354599|532092594|FG005|Overall Study|Pretreatment Event/Adverse Event|1|||
147529835|NCT02354599|532092589|FG000|Overall Study|Withdrawal by Subject|1|||
147529836|NCT02354599|532092590|FG001|Overall Study|Withdrawal by Subject|1|||
147529837|NCT02354599|532092591|FG002|Overall Study|Withdrawal by Subject|0|||
147529838|NCT02354599|532092592|FG003|Overall Study|Withdrawal by Subject|0|||
147529839|NCT02354599|532092593|FG004|Overall Study|Withdrawal by Subject|0|||
147529840|NCT02354599|532092594|FG005|Overall Study|Withdrawal by Subject|0|||
147529841|NCT04806334|532092595|FG000|Overall Study|Withdrawal by Subject|1|||
147529842|NCT00660829|532092596|FG000|Overall Study|Adverse Event|3|||
147529843|NCT00660829|532092597|FG001|Overall Study|Adverse Event|4|||
147529844|NCT00660829|532092596|FG000|Overall Study|Lack of Efficacy|2|||
147529845|NCT00660829|532092597|FG001|Overall Study|Lack of Efficacy|3|||
147529846|NCT00660829|532092596|FG000|Overall Study|Non-Compliance|0|||
147529847|NCT00660829|532092597|FG001|Overall Study|Non-Compliance|4|||
147529848|NCT00660829|532092596|FG000|Overall Study|Withdrawal by Subject|1|||
147529849|NCT00660829|532092597|FG001|Overall Study|Withdrawal by Subject|2|||
147529850|NCT00660829|532092596|FG000|Overall Study|Lost to Follow-up|3|||
147529851|NCT00660829|532092597|FG001|Overall Study|Lost to Follow-up|2|||
147529852|NCT00660829|532092596|FG000|Overall Study|Other|9|||
147529853|NCT00660829|532092597|FG001|Overall Study|Other|4|||
147529854|NCT03590613|532092598|FG000|Period 2, 4 Days|Physician Decision|0|||
147529855|NCT03590613|532092599|FG001|Period 2, 4 Days|Physician Decision|0|||
147529856|NCT03590613|532092600|FG002|Period 2, 4 Days|Physician Decision|0|||
147529857|NCT03590613|532092601|FG003|Period 2, 4 Days|Physician Decision|1|||
147529858|NCT04369742|532092602|FG000|Overall Study|Lost to Follow-Up (Day 14)|7|||
147529859|NCT04369742|532092603|FG001|Overall Study|Lost to Follow-Up (Day 14)|4|||
147529860|NCT04369742|532092602|FG000|Overall Study|Lost to Follow-Up (Day 30)|7|||
147529861|NCT04369742|532092603|FG001|Overall Study|Lost to Follow-Up (Day 30)|7|||
147529862|NCT00495794|532092606|FG000|Overall Study|Pharmacist did not activate patient|522|||
147529863|NCT00495794|532092607|FG001|Overall Study|Pharmacist did not activate patient|0|||
147529864|NCT01130831|532092608|FG000|Overall Study|Withdrawal by Subject|7|||
147529865|NCT01130831|532092608|FG000|Overall Study|Death|4|||
147529866|NCT01130831|532092608|FG000|Overall Study|Information was missing|3|||
147529867|NCT00951912|532092609|FG000|Overall Study|Lack of Efficacy|1|||
147529868|NCT00951912|532092610|FG001|Overall Study|Lack of Efficacy|0|||
147529869|NCT00951912|532092611|FG002|Overall Study|Lack of Efficacy|0|||
147529870|NCT00951912|532092609|FG000|Overall Study|Adverse Event|0|||
147529871|NCT00951912|532092610|FG001|Overall Study|Adverse Event|1|||
147529872|NCT00951912|532092611|FG002|Overall Study|Adverse Event|1|||
147529873|NCT00951912|532092609|FG000|Overall Study|Lost to Follow-up|2|||
147529874|NCT00951912|532092610|FG001|Overall Study|Lost to Follow-up|2|||
147529875|NCT00951912|532092611|FG002|Overall Study|Lost to Follow-up|0|||
147529876|NCT00951912|532092609|FG000|Overall Study|Physician Decision|1|||
147529877|NCT00951912|532092610|FG001|Overall Study|Physician Decision|0|||
147529878|NCT00951912|532092611|FG002|Overall Study|Physician Decision|1|||
147529879|NCT00951912|532092609|FG000|Overall Study|Withdrawal by Subject|1|||
147529880|NCT00951912|532092610|FG001|Overall Study|Withdrawal by Subject|1|||
147529881|NCT00951912|532092611|FG002|Overall Study|Withdrawal by Subject|0|||
147529882|NCT00951912|532092609|FG000|Overall Study|Other:Depression|1|||
147529883|NCT00951912|532092610|FG001|Overall Study|Other:Depression|0|||
147529884|NCT00951912|532092611|FG002|Overall Study|Other:Depression|0|||
147529885|NCT00951912|532092609|FG000|Overall Study|Other: Colon cancer|1|||
147529886|NCT00951912|532092610|FG001|Overall Study|Other: Colon cancer|0|||
147529887|NCT00951912|532092611|FG002|Overall Study|Other: Colon cancer|0|||
147529888|NCT00951912|532092609|FG000|Overall Study|Other: Stroke|0|||
147529889|NCT00951912|532092610|FG001|Overall Study|Other: Stroke|1|||
147529890|NCT00951912|532092611|FG002|Overall Study|Other: Stroke|0|||
147529891|NCT02173158|532092612|FG000|Efficacy Phase|Adverse Event|1|||
147529892|NCT01728454|532092613|FG000|Stage 1 and 2|Pregnancy|1|||
147529893|NCT01728454|532092614|FG001|Stage 1 and 2|Pregnancy|0|||
147529894|NCT01728454|532092615|FG002|Stage 1 and 2|Pregnancy|0|||
147529895|NCT01728454|532092613|FG000|Stage 1 and 2|Non-compliance with Protocol|0|||
147529896|NCT01728454|532092614|FG001|Stage 1 and 2|Non-compliance with Protocol|0|||
147529897|NCT01728454|532092615|FG002|Stage 1 and 2|Non-compliance with Protocol|1|||
147529898|NCT01728454|532092613|FG000|Stage 1 and 2|Moved to Active Drug/ Lack of Efficacy|1|||
147529899|NCT01728454|532092614|FG001|Stage 1 and 2|Moved to Active Drug/ Lack of Efficacy|0|||
147529900|NCT01728454|532092615|FG002|Stage 1 and 2|Moved to Active Drug/ Lack of Efficacy|0|||
147529901|NCT01728454|532092613|FG000|Stage 1 and 2|Lost to Follow-up|1|||
147529902|NCT01728454|532092614|FG001|Stage 1 and 2|Lost to Follow-up|1|||
147529903|NCT01728454|532092615|FG002|Stage 1 and 2|Lost to Follow-up|0|||
147529904|NCT01728454|532092613|FG000|Stage 1 and 2|Withdrew due to Adverse Events/Toxicity|2|||
147529905|NCT01728454|532092614|FG001|Stage 1 and 2|Withdrew due to Adverse Events/Toxicity|3|||
147529906|NCT01728454|532092615|FG002|Stage 1 and 2|Withdrew due to Adverse Events/Toxicity|3|||
147529907|NCT01728454|532092613|FG000|Stage 3|Reason Missing|0|||
147529908|NCT01728454|532092614|FG001|Stage 3|Reason Missing|0|||
147529909|NCT01728454|532092615|FG002|Stage 3|Reason Missing|1|||
147529910|NCT01728454|532092613|FG000|Stage 3|Subject Required Other Treatment|0|||
147529911|NCT01728454|532092614|FG001|Stage 3|Subject Required Other Treatment|1|||
147529912|NCT01728454|532092615|FG002|Stage 3|Subject Required Other Treatment|0|||
147529913|NCT01728454|532092613|FG000|Stage 3|Pregnancy|1|||
147529914|NCT01728454|532092614|FG001|Stage 3|Pregnancy|0|||
147529915|NCT01728454|532092615|FG002|Stage 3|Pregnancy|0|||
147529916|NCT01728454|532092613|FG000|Stage 3|Withdrew Consent|1|||
147529917|NCT01728454|532092614|FG001|Stage 3|Withdrew Consent|0|||
147529918|NCT01728454|532092615|FG002|Stage 3|Withdrew Consent|1|||
147529919|NCT01728454|532092613|FG000|Stage 3|Non-compliance with Protocol|0|||
147529920|NCT01728454|532092614|FG001|Stage 3|Non-compliance with Protocol|0|||
147529921|NCT01728454|532092615|FG002|Stage 3|Non-compliance with Protocol|1|||
147529922|NCT01728454|532092613|FG000|Stage 3|Lost to Follow-up|0|||
147529923|NCT01728454|532092614|FG001|Stage 3|Lost to Follow-up|3|||
147529924|NCT01728454|532092615|FG002|Stage 3|Lost to Follow-up|1|||
147529925|NCT01728454|532092613|FG000|Stage 3|Withdrew due to Adverse Events/Toxicity|1|||
147529926|NCT01728454|532092614|FG001|Stage 3|Withdrew due to Adverse Events/Toxicity|0|||
147529927|NCT01728454|532092615|FG002|Stage 3|Withdrew due to Adverse Events/Toxicity|0|||
147529928|NCT03077646|532092619|FG000|Overall Study|Lost to Follow-up|29|||
147529929|NCT03077646|532092620|FG001|Overall Study|Lost to Follow-up|30|||
147529930|NCT03077646|532092621|FG002|Overall Study|Lost to Follow-up|31|||
147529931|NCT02058966|532092622|FG000|Open-Label Methamphetamine|Adverse Event|1|||
147529932|NCT02058966|532092622|FG000|First Intervention|Withdrawal by Subject|1|||
147529933|NCT01265511|532092623|FG000|Overall Study|Lack of Efficacy|2|||
147529934|NCT01265511|532092624|FG001|Overall Study|Lack of Efficacy|1|||
147529935|NCT01265511|532092623|FG000|Overall Study|Met stopping rules|0|||
147529936|NCT01265511|532092624|FG001|Overall Study|Met stopping rules|2|||
147529937|NCT03044730|532092629|FG000|3 Cycles of Pembro + Capecitab|Progressive Disease|1|||
147529938|NCT03044730|532092629|FG000|3 Cycles of Pembro + Capecitab|Patient non-compliant with capecitabine|1|||
147529939|NCT03044730|532092629|FG000|3 Cycles of Pembro + Capecitab|Death|1|||
147529940|NCT03044730|532092629|FG000|3 Cycles of Pembro + Capecitab|Adverse Event|1|||
147529941|NCT03044730|532092629|FG000|Cycles 4 and Beyond|Progressive Disease|9|||
147529942|NCT03044730|532092629|FG000|Cycles 4 and Beyond|Adverse Event|1|||
147529943|NCT03044730|532092629|FG000|On Follow-up for 2 Years|Still in follow-up|7|||
147529944|NCT03044730|532092629|FG000|On Follow-up for 2 Years|Lost to Follow-up|1|||
147529945|NCT03044730|532092629|FG000|On Follow-up for 2 Years|Death|17|||
147529946|NCT01018680|532094299|FG000|Overall Study|Adverse Event|23|||
147529947|NCT01018680|532094300|FG001|Overall Study|Adverse Event|40|||
147529948|NCT01018680|532094299|FG000|Overall Study|Withdrawal by Subject|10|||
147529949|NCT01018680|532094300|FG001|Overall Study|Withdrawal by Subject|10|||
147529950|NCT01018680|532094299|FG000|Overall Study|Protocol Violation|5|||
147529951|NCT01018680|532094300|FG001|Overall Study|Protocol Violation|8|||
147529952|NCT01018680|532094299|FG000|Overall Study|Sponsor Decision|6|||
147529953|NCT01018680|532094300|FG001|Overall Study|Sponsor Decision|7|||
147529954|NCT01018680|532094299|FG000|Overall Study|Lack of Efficacy|8|||
147529955|NCT01018680|532094300|FG001|Overall Study|Lack of Efficacy|2|||
147529956|NCT01018680|532094299|FG000|Overall Study|Lost to Follow-up|5|||
147529957|NCT01018680|532094300|FG001|Overall Study|Lost to Follow-up|3|||
147529958|NCT01018680|532094299|FG000|Overall Study|Entry Criteria Not Met|1|||
147529959|NCT01018680|532094300|FG001|Overall Study|Entry Criteria Not Met|4|||
147529960|NCT01018680|532094299|FG000|Overall Study|Physician Decision|3|||
147529961|NCT01018680|532094300|FG001|Overall Study|Physician Decision|1|||
147529962|NCT02930889|532094301|FG000|Overall Study|Lost to Follow-up|2|||
147529963|NCT02930889|532094301|FG000|Overall Study|Withdrawal by Subject|6|||
147529964|NCT02930889|532094301|FG000|Overall Study|Did not meet inclusion/exclusion criteria|8|||
147529965|NCT01846442|532094305|FG000|Overall Study|Adverse Event|2|||
147529966|NCT01846442|532094306|FG001|Overall Study|Adverse Event|4|||
147529967|NCT01846442|532094307|FG002|Overall Study|Adverse Event|2|||
147529968|NCT01846442|532094308|FG003|Overall Study|Adverse Event|1|||
147529969|NCT01846442|532094305|FG000|Overall Study|Lost to Follow-up|0|||
147529970|NCT01846442|532094306|FG001|Overall Study|Lost to Follow-up|0|||
147529971|NCT01846442|532094307|FG002|Overall Study|Lost to Follow-up|1|||
147529972|NCT01846442|532094308|FG003|Overall Study|Lost to Follow-up|0|||
147529973|NCT01846442|532094305|FG000|Overall Study|Withdrawal by Subject|3|||
147529974|NCT01846442|532094306|FG001|Overall Study|Withdrawal by Subject|2|||
147529975|NCT01846442|532094307|FG002|Overall Study|Withdrawal by Subject|0|||
147529976|NCT01846442|532094308|FG003|Overall Study|Withdrawal by Subject|1|||
147529977|NCT01846442|532094305|FG000|Overall Study|Left the city/Lost medication|1|||
147529978|NCT01846442|532094306|FG001|Overall Study|Left the city/Lost medication|0|||
147529979|NCT01846442|532094307|FG002|Overall Study|Left the city/Lost medication|1|||
147529980|NCT01846442|532094308|FG003|Overall Study|Left the city/Lost medication|1|||
147529981|NCT00474994|532094323|FG000|Overall Study|Patient Not treated|1|||
147529982|NCT00474994|532094323|FG000|Overall Study|Patient evaluable for toxicity only|3|||
147529983|NCT00474994|532094323|FG000|Overall Study|Patient found to be ineligible|1|||
147529984|NCT02660489|532094324|FG000|Overall Study|Lost to Follow-up|1|||
147529985|NCT02660489|532094325|FG001|Overall Study|Lost to Follow-up|1|||
147529986|NCT02660489|532094324|FG000|Overall Study|Adverse Event|1|||
147529987|NCT02660489|532094325|FG001|Overall Study|Adverse Event|3|||
147529988|NCT02660489|532094324|FG000|Overall Study|no rhinovirus infection|4|||
147529989|NCT02660489|532094325|FG001|Overall Study|no rhinovirus infection|4|||
147529990|NCT00278473|532094326|FG000|Overall Study|drop out|4|||
147529991|NCT00278473|532094327|FG001|Overall Study|drop out|3|||
147529992|NCT00761761|532094331|FG000|Overall Study|Lost to Follow-up|3|||
147529993|NCT00761761|532094332|FG001|Overall Study|Lost to Follow-up|1|||
147529994|NCT00761761|532094331|FG000|Overall Study|Withdrawal by Subject|3|||
147529995|NCT00761761|532094332|FG001|Overall Study|Withdrawal by Subject|0|||
147529996|NCT03472586|532094339|FG000|Overall Study|Physician Decision|6|||
147529997|NCT03472586|532094339|FG000|Overall Study|Death|6|||
147529998|NCT03472586|532094339|FG000|Overall Study|Adverse Event|1|||
147529999|NCT02706327|532094340|FG000|Overall Study|Lost to Follow-up|1|||
147530000|NCT02706327|532094341|FG001|Overall Study|Lost to Follow-up|1|||
147530001|NCT02706327|532094342|FG002|Overall Study|Lost to Follow-up|2|||
147530002|NCT03868410|532094347|FG000|Overall Study|Physician Decision|0|||
147530003|NCT03868410|532094348|FG001|Overall Study|Physician Decision|1|||
147530004|NCT06045026|532094349|FG000|Overall Study|Lost to Follow-up|60|||
147530005|NCT06045026|532094349|FG000|Overall Study|Adverse Event|12|||
147530006|NCT06045026|532094349|FG000|Overall Study|Withdrawal by Subject|3|||
147530007|NCT06045026|532094349|FG000|Overall Study|Enrollment closed|1|||
147530008|NCT04511533|532094350|FG000|Treatment|Other|2|||
147530009|NCT04511533|532094350|FG000|Treatment|Withdrawal by Subject|11|||
147530010|NCT04511533|532094350|FG000|Treatment|Death|5|||
147530011|NCT04511533|532094350|FG000|Treatment|Physician Decision|1|||
147530012|NCT04511533|532094350|FG000|Treatment|Progressive Disease|61|||
147530013|NCT04511533|532094350|FG000|Follow-Up|Other|7|||
147530014|NCT04511533|532094350|FG000|Follow-Up|Withdrawal by Subject|5|||
147530015|NCT04511533|532094350|FG000|Follow-Up|Lost to Follow-up|2|||
147530016|NCT04511533|532094350|FG000|Follow-Up|Death|4|||
147530017|NCT01224171|532094351|FG000|Overall Study|Adverse Event|8|||
147530018|NCT01224171|532094352|FG001|Overall Study|Adverse Event|4|||
147530019|NCT01224171|532094351|FG000|Overall Study|Protocol Violation|0|||
147530020|NCT01224171|532094352|FG001|Overall Study|Protocol Violation|1|||
147530021|NCT01224171|532094351|FG000|Overall Study|Lack of Efficacy|5|||
147530022|NCT01224171|532094352|FG001|Overall Study|Lack of Efficacy|1|||
147530023|NCT01224171|532094351|FG000|Overall Study|Withdrawal of Consent|2|||
147530024|NCT01224171|532094352|FG001|Overall Study|Withdrawal of Consent|4|||
147530025|NCT01224171|532094351|FG000|Overall Study|Lost to Follow-up|0|||
147530026|NCT01224171|532094352|FG001|Overall Study|Lost to Follow-up|3|||
147530027|NCT01928758|532094353|FG000|Overall Study|Lost to Follow-up|14|||
147530028|NCT01928758|532094354|FG001|Overall Study|Lost to Follow-up|9|||
147530029|NCT01928758|532094353|FG000|Overall Study|Withdrawal by Subject|5|||
147530030|NCT01928758|532094354|FG001|Overall Study|Withdrawal by Subject|2|||
147530031|NCT01928758|532094353|FG000|Overall Study|Adverse Event|3|||
147530032|NCT01928758|532094354|FG001|Overall Study|Adverse Event|5|||
147530033|NCT01928758|532094353|FG000|Overall Study|Protocol Violation|3|||
147530034|NCT01928758|532094354|FG001|Overall Study|Protocol Violation|4|||
147530035|NCT02718131|532094355|FG000|Overall Study|Withdrawal by Subject|1|||
147530036|NCT02718131|532094356|FG001|Overall Study|Withdrawal by Subject|0|||
147530037|NCT02718131|532094355|FG000|Overall Study|Adverse Event|1|||
147530038|NCT02718131|532094356|FG001|Overall Study|Adverse Event|0|||
147530039|NCT02718131|532094355|FG000|Overall Study|Data was incomplete. Patient was inevaluable|1|||
147530040|NCT02718131|532094356|FG001|Overall Study|Data was incomplete. Patient was inevaluable|0|||
147530041|NCT03417245|532094358|FG000|Overall Study|Adverse Event|1|||
147530042|NCT03417245|532094359|FG001|Overall Study|Adverse Event|0|||
147530043|NCT03417245|532094358|FG000|Overall Study|Protocol Violation|1|||
147530044|NCT03417245|532094359|FG001|Overall Study|Protocol Violation|0|||
147530045|NCT03417245|532094358|FG000|Overall Study|Withdrawal by Subject|1|||
147530046|NCT03417245|532094359|FG001|Overall Study|Withdrawal by Subject|1|||
147530047|NCT02708524|532094360|FG000|Overall Study|Adverse Event|0|||
147530048|NCT02708524|532094361|FG001|Overall Study|Adverse Event|1|||
147530049|NCT02708524|532094362|FG002|Overall Study|Adverse Event|0|||
147530050|NCT02708524|532094363|FG003|Overall Study|Adverse Event|0|||
147530051|NCT02708524|532094360|FG000|Overall Study|Lens Discomfort|1|||
147530052|NCT02708524|532094361|FG001|Overall Study|Lens Discomfort|0|||
147530053|NCT02708524|532094362|FG002|Overall Study|Lens Discomfort|1|||
147530054|NCT02708524|532094363|FG003|Overall Study|Lens Discomfort|0|||
147530055|NCT02708524|532094360|FG000|Overall Study|Lost to Follow-up|1|||
147530056|NCT02708524|532094361|FG001|Overall Study|Lost to Follow-up|1|||
147530057|NCT02708524|532094362|FG002|Overall Study|Lost to Follow-up|1|||
147530058|NCT02708524|532094363|FG003|Overall Study|Lost to Follow-up|0|||
147530059|NCT02708524|532094360|FG000|Overall Study|Protocol Violation|0|||
147530060|NCT02708524|532094361|FG001|Overall Study|Protocol Violation|1|||
147530061|NCT02708524|532094362|FG002|Overall Study|Protocol Violation|0|||
147530062|NCT02708524|532094363|FG003|Overall Study|Protocol Violation|0|||
147530063|NCT02708524|532094360|FG000|Overall Study|Withdrawal by Subject|1|||
147530064|NCT02708524|532094361|FG001|Overall Study|Withdrawal by Subject|1|||
147530065|NCT02708524|532094362|FG002|Overall Study|Withdrawal by Subject|0|||
147530066|NCT02708524|532094363|FG003|Overall Study|Withdrawal by Subject|0|||
147530067|NCT02708524|532094360|FG000|Overall Study|Dispensed incorrect study lens|0|||
147530068|NCT02708524|532094361|FG001|Overall Study|Dispensed incorrect study lens|1|||
147530069|NCT02708524|532094362|FG002|Overall Study|Dispensed incorrect study lens|1|||
147530070|NCT02708524|532094363|FG003|Overall Study|Dispensed incorrect study lens|0|||
147530071|NCT02708524|532094360|FG000|Overall Study|Did not wear lens at final visit|0|||
147530072|NCT02708524|532094361|FG001|Overall Study|Did not wear lens at final visit|1|||
147530073|NCT02708524|532094362|FG002|Overall Study|Did not wear lens at final visit|0|||
147530074|NCT02708524|532094363|FG003|Overall Study|Did not wear lens at final visit|0|||
147530075|NCT02708524|532094360|FG000|Overall Study|Subject lost study lens|1|||
147530076|NCT02708524|532094361|FG001|Overall Study|Subject lost study lens|0|||
147530077|NCT02708524|532094362|FG002|Overall Study|Subject lost study lens|0|||
147530078|NCT02708524|532094363|FG003|Overall Study|Subject lost study lens|0|||
147530079|NCT00761735|532094368|FG000|Overall Study|Lost to Follow-up|6|||
147530080|NCT00761735|532094368|FG000|Overall Study|Withdrawal by Subject|6|||
147530081|NCT00761735|532094368|FG000|Overall Study|Non-compliance with protocol|1|||
147530082|NCT00761735|532094368|FG000|Overall Study|Administrative|1|||
147530083|NCT00381680|532094369|FG000|Overall Study|Adverse Event|9|||
147530084|NCT00381680|532094370|FG001|Overall Study|Adverse Event|3|||
147530085|NCT00381680|532094369|FG000|Overall Study|Death|10|||
147530086|NCT00381680|532094370|FG001|Overall Study|Death|7|||
147530087|NCT00381680|532094369|FG000|Overall Study|Lost to Follow-up|3|||
147530088|NCT00381680|532094370|FG001|Overall Study|Lost to Follow-up|2|||
147530089|NCT00381680|532094369|FG000|Overall Study|Physician Decision|25|||
147530090|NCT00381680|532094370|FG001|Overall Study|Physician Decision|6|||
147530091|NCT00381680|532094369|FG000|Overall Study|Withdrawal by Subject|3|||
147530092|NCT00381680|532094370|FG001|Overall Study|Withdrawal by Subject|1|||
147530093|NCT00381680|532094369|FG000|Overall Study|Entry onto another COG Trial|1|||
147530094|NCT00381680|532094370|FG001|Overall Study|Entry onto another COG Trial|2|||
147530095|NCT00381680|532094369|FG000|Overall Study|Alternative Therapy|11|||
147530096|NCT00381680|532094370|FG001|Overall Study|Alternative Therapy|5|||
147530097|NCT00381680|532094369|FG000|Overall Study|Secondary Malignancy|3|||
147530098|NCT00381680|532094370|FG001|Overall Study|Secondary Malignancy|0|||
147530099|NCT00381680|532094369|FG000|Overall Study|Delay initiation|1|||
147530100|NCT00381680|532094370|FG001|Overall Study|Delay initiation|0|||
147530101|NCT00381680|532094369|FG000|Overall Study|Stem Cell Transplant|26|||
147530102|NCT00381680|532094370|FG001|Overall Study|Stem Cell Transplant|10|||
147530103|NCT00381680|532094369|FG000|Overall Study|Relapse|18|||
147530104|NCT00381680|532094370|FG001|Overall Study|Relapse|9|||
147530105|NCT00381680|532094369|FG000|Overall Study|Induction Failure|4|||
147530106|NCT00381680|532094370|FG001|Overall Study|Induction Failure|1|||
147530107|NCT00381680|532094369|FG000|Overall Study|Progression|1|||
147530108|NCT00381680|532094370|FG001|Overall Study|Progression|1|||
147530109|NCT00381680|532094369|FG000|Overall Study|Other not otherwise specified|7|||
147530110|NCT00381680|532094370|FG001|Overall Study|Other not otherwise specified|2|||
147530111|NCT00381680|532094369|FG000|Overall Study|Ineligible|3|||
147530112|NCT00381680|532094370|FG001|Overall Study|Ineligible|1|||
147530113|NCT03290131|532094371|FG000|Overall Study|Adverse Event|22|||
147530114|NCT03290131|532094372|FG001|Overall Study|Adverse Event|57|||
147530115|NCT03290131|532094373|FG002|Overall Study|Adverse Event|11|||
147530116|NCT03290131|532094371|FG000|Overall Study|Withdrawal by Subject|18|||
147530117|NCT03290131|532094372|FG001|Overall Study|Withdrawal by Subject|13|||
147530118|NCT03290131|532094373|FG002|Overall Study|Withdrawal by Subject|8|||
147530119|NCT03290131|532094371|FG000|Overall Study|MS Relapse|2|||
147530120|NCT03290131|532094372|FG001|Overall Study|MS Relapse|1|||
147530121|NCT03290131|532094373|FG002|Overall Study|MS Relapse|0|||
147530122|NCT03290131|532094371|FG000|Overall Study|Unknown reason|0|||
147530123|NCT03290131|532094372|FG001|Overall Study|Unknown reason|1|||
147530124|NCT03290131|532094373|FG002|Overall Study|Unknown reason|0|||
147530125|NCT00361504|532094376|FG000|Overall Study|Withdrawal by Subject|94|||
147530126|NCT00361504|532094377|FG001|Overall Study|Withdrawal by Subject|31|||
147530127|NCT00361504|532094376|FG000|Overall Study|Lost to Follow-up|40|||
147530128|NCT00361504|532094377|FG001|Overall Study|Lost to Follow-up|7|||
147530129|NCT00361504|532094376|FG000|Overall Study|Adverse Event|203|||
147530130|NCT00361504|532094377|FG001|Overall Study|Adverse Event|82|||
147530131|NCT00361504|532094376|FG000|Overall Study|Lack of Efficacy|72|||
147530132|NCT00361504|532094377|FG001|Overall Study|Lack of Efficacy|7|||
147530133|NCT00361504|532094376|FG000|Overall Study|Resolution of Pain|2|||
147530134|NCT00361504|532094377|FG001|Overall Study|Resolution of Pain|0|||
147530135|NCT00361504|532094376|FG000|Overall Study|Study medication non compliant|42|||
147530136|NCT00361504|532094377|FG001|Overall Study|Study medication non compliant|15|||
147530137|NCT00361504|532094376|FG000|Overall Study|All other|28|||
147530138|NCT00361504|532094377|FG001|Overall Study|All other|3|||
147530139|NCT01374516|532094392|FG000|Vaccination Phase (Up to 25 Months)|Protocol Violation|43|||
147530140|NCT01374516|532094393|FG001|Vaccination Phase (Up to 25 Months)|Protocol Violation|14|||
147530141|NCT01374516|532094392|FG000|Vaccination Phase (Up to 25 Months)|Adverse Event|3|||
147530142|NCT01374516|532094393|FG001|Vaccination Phase (Up to 25 Months)|Adverse Event|0|||
147530143|NCT01374516|532094392|FG000|Vaccination Phase (Up to 25 Months)|Withdrawal by Subject|480|||
147530144|NCT01374516|532094393|FG001|Vaccination Phase (Up to 25 Months)|Withdrawal by Subject|240|||
147530145|NCT01374516|532094392|FG000|Vaccination Phase (Up to 25 Months)|Lost to Follow-up|106|||
147530146|NCT01374516|532094393|FG001|Vaccination Phase (Up to 25 Months)|Lost to Follow-up|46|||
147530147|NCT01374516|532094392|FG000|Vaccination Phase (Up to 25 Months)|Serious adverse event|7|||
147530148|NCT01374516|532094393|FG001|Vaccination Phase (Up to 25 Months)|Serious adverse event|9|||
147530149|NCT01374516|532094392|FG000|Surveillance Expansion Period|Protocol Violation|386|||
147530150|NCT01374516|532094393|FG001|Surveillance Expansion Period|Protocol Violation|217|||
147530151|NCT01374516|532094392|FG000|Surveillance Expansion Period|Withdrawal by Subject|1870|||
147530152|NCT01374516|532094393|FG001|Surveillance Expansion Period|Withdrawal by Subject|986|||
147530153|NCT01374516|532094392|FG000|Surveillance Expansion Period|Lost to Follow-up|73|||
147530154|NCT01374516|532094393|FG001|Surveillance Expansion Period|Lost to Follow-up|45|||
147530155|NCT01374516|532094392|FG000|Surveillance Expansion Period|Serious adverse event|20|||
147530156|NCT01374516|532094393|FG001|Surveillance Expansion Period|Serious adverse event|5|||
147530157|NCT00450814|532094398|FG000|Overall Study|Failed to complete the initial therapy|0|||
147530158|NCT00450814|532094399|FG001|Overall Study|Failed to complete the initial therapy|0|||
147530159|NCT00450814|532094400|FG002|Overall Study|Failed to complete the initial therapy|0|||
147530160|NCT00450814|532094401|FG003|Overall Study|Failed to complete the initial therapy|1|||
147530161|NCT00450814|532094402|FG004|Overall Study|Failed to complete the initial therapy|1|||
147530162|NCT00450814|532094403|FG005|Overall Study|Failed to complete the initial therapy|1|||
147530163|NCT00450814|532094404|FG006|Overall Study|Failed to complete the initial therapy|0|||
147530164|NCT00450814|532094405|FG007|Overall Study|Failed to complete the initial therapy|0|||
147530165|NCT00450814|532094406|FG008|Overall Study|Failed to complete the initial therapy|0|||
147530166|NCT00450814|532094407|FG009|Overall Study|Failed to complete the initial therapy|0|||
147530167|NCT00450814|532094408|FG010|Overall Study|Failed to complete the initial therapy|0|||
147530168|NCT00450814|532094398|FG000|Overall Study|Patient withdrawal prior to treatment|0|||
147530169|NCT00450814|532094399|FG001|Overall Study|Patient withdrawal prior to treatment|0|||
147530170|NCT00450814|532094400|FG002|Overall Study|Patient withdrawal prior to treatment|0|||
147530171|NCT00450814|532094401|FG003|Overall Study|Patient withdrawal prior to treatment|0|||
147530172|NCT00450814|532094402|FG004|Overall Study|Patient withdrawal prior to treatment|0|||
147530173|NCT00450814|532094403|FG005|Overall Study|Patient withdrawal prior to treatment|0|||
147530174|NCT00450814|532094404|FG006|Overall Study|Patient withdrawal prior to treatment|0|||
147530175|NCT00450814|532094405|FG007|Overall Study|Patient withdrawal prior to treatment|0|||
147530176|NCT00450814|532094406|FG008|Overall Study|Patient withdrawal prior to treatment|0|||
147530177|NCT00450814|532094407|FG009|Overall Study|Patient withdrawal prior to treatment|1|||
147530178|NCT00450814|532094408|FG010|Overall Study|Patient withdrawal prior to treatment|0|||
147530179|NCT04145531|532094409|FG000|Part A|Adverse Event|2|||
147530180|NCT04145531|532094410|FG001|Part A|Adverse Event|12|||
147530181|NCT04145531|532094411|FG002|Part A|Adverse Event|6|||
147530182|NCT04145531|532094412|FG003|Part A|Adverse Event|0|||
147530183|NCT04145531|532094409|FG000|Part A|Death|1|||
147530184|NCT04145531|532094410|FG001|Part A|Death|2|||
147530185|NCT04145531|532094411|FG002|Part A|Death|0|||
147530186|NCT04145531|532094412|FG003|Part A|Death|0|||
147530187|NCT04145531|532094409|FG000|Part A|Physician Decision|2|||
147530188|NCT04145531|532094410|FG001|Part A|Physician Decision|5|||
147530189|NCT04145531|532094411|FG002|Part A|Physician Decision|2|||
147530190|NCT04145531|532094412|FG003|Part A|Physician Decision|0|||
147530191|NCT04145531|532094409|FG000|Part A|Progressive disease|0|||
147530192|NCT04145531|532094410|FG001|Part A|Progressive disease|2|||
147530193|NCT04145531|532094411|FG002|Part A|Progressive disease|1|||
147530194|NCT04145531|532094412|FG003|Part A|Progressive disease|0|||
147530195|NCT04145531|532094409|FG000|Part A|Protocol deviation|0|||
147530196|NCT04145531|532094410|FG001|Part A|Protocol deviation|0|||
147530197|NCT04145531|532094411|FG002|Part A|Protocol deviation|1|||
147530198|NCT04145531|532094412|FG003|Part A|Protocol deviation|0|||
147530199|NCT04145531|532094409|FG000|Part A|Withdrawal by parent or guardian|1|||
147530200|NCT04145531|532094410|FG001|Part A|Withdrawal by parent or guardian|0|||
147530201|NCT04145531|532094411|FG002|Part A|Withdrawal by parent or guardian|0|||
147530202|NCT04145531|532094412|FG003|Part A|Withdrawal by parent or guardian|0|||
147530203|NCT04145531|532094409|FG000|Part A|Withdrawal by participant|0|||
147530204|NCT04145531|532094410|FG001|Part A|Withdrawal by participant|0|||
147530205|NCT04145531|532094411|FG002|Part A|Withdrawal by participant|1|||
147530206|NCT04145531|532094412|FG003|Part A|Withdrawal by participant|0|||
147530207|NCT04145531|532094409|FG000|Part A|Other|0|||
147530208|NCT04145531|532094410|FG001|Part A|Other|0|||
147530209|NCT04145531|532094411|FG002|Part A|Other|1|||
147530210|NCT04145531|532094412|FG003|Part A|Other|0|||
147530211|NCT04145531|532094409|FG000|Part B|Adverse Event|0|||
147530212|NCT04145531|532094410|FG001|Part B|Adverse Event|0|||
147530213|NCT04145531|532094411|FG002|Part B|Adverse Event|0|||
147530214|NCT04145531|532094412|FG003|Part B|Adverse Event|21|||
147530215|NCT04145531|532094409|FG000|Part B|Physician Decision|0|||
147530216|NCT04145531|532094410|FG001|Part B|Physician Decision|0|||
147530217|NCT04145531|532094411|FG002|Part B|Physician Decision|0|||
147530218|NCT04145531|532094412|FG003|Part B|Physician Decision|7|||
147530219|NCT04145531|532094409|FG000|Part B|Progressive disease|0|||
147530220|NCT04145531|532094410|FG001|Part B|Progressive disease|0|||
147530221|NCT04145531|532094411|FG002|Part B|Progressive disease|0|||
147530222|NCT04145531|532094412|FG003|Part B|Progressive disease|1|||
147530223|NCT04145531|532094409|FG000|Part B|Recurrent disease|0|||
147530224|NCT04145531|532094410|FG001|Part B|Recurrent disease|0|||
147530225|NCT04145531|532094411|FG002|Part B|Recurrent disease|0|||
147530226|NCT04145531|532094412|FG003|Part B|Recurrent disease|1|||
147530227|NCT04145531|532094409|FG000|Part B|Withdrawal by parent or guardian|0|||
147530228|NCT04145531|532094410|FG001|Part B|Withdrawal by parent or guardian|0|||
147530229|NCT04145531|532094411|FG002|Part B|Withdrawal by parent or guardian|0|||
147530230|NCT04145531|532094412|FG003|Part B|Withdrawal by parent or guardian|3|||
147530231|NCT04145531|532094409|FG000|Part B|Withdrawal by participant|0|||
147530232|NCT04145531|532094410|FG001|Part B|Withdrawal by participant|0|||
147530233|NCT04145531|532094411|FG002|Part B|Withdrawal by participant|0|||
147530234|NCT04145531|532094412|FG003|Part B|Withdrawal by participant|1|||
147530235|NCT04145531|532094409|FG000|Part B|Other|0|||
147530236|NCT04145531|532094410|FG001|Part B|Other|0|||
147530237|NCT04145531|532094411|FG002|Part B|Other|0|||
147530238|NCT04145531|532094412|FG003|Part B|Other|1|||
147530239|NCT04988035|532094413|FG000|Overall Study|Death|19|||
147530240|NCT04988035|532094414|FG001|Overall Study|Death|13|||
147530241|NCT04988035|532094413|FG000|Overall Study|Lost to Follow-up|12|||
147530242|NCT04988035|532094414|FG001|Overall Study|Lost to Follow-up|6|||
147530243|NCT04988035|532094413|FG000|Overall Study|Protocol Violation|0|||
147530244|NCT04988035|532094414|FG001|Overall Study|Protocol Violation|1|||
147530245|NCT04988035|532094413|FG000|Overall Study|Withdrawal by Subject|2|||
147530246|NCT04988035|532094414|FG001|Overall Study|Withdrawal by Subject|4|||
147530247|NCT04988035|532094413|FG000|Overall Study|Other include randomized but not dosed and participant condition change (improvement)|2|||
147530248|NCT04988035|532094414|FG001|Overall Study|Other include randomized but not dosed and participant condition change (improvement)|2|||
147530249|NCT03602976|532094415|FG000|Overall Study|Withdrawal by Subject|1|||
147530250|NCT03732534|532094416|FG000|Overall Study|Study terminated by Sponsor|6|||
147530251|NCT02190604|532094417|FG000|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
147530252|NCT02190604|532094418|FG001|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
147530253|NCT02190604|532094419|FG002|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
147530254|NCT02190604|532094420|FG003|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
147530255|NCT02190604|532094421|FG004|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
147530256|NCT02190604|532094422|FG005|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
147530257|NCT02190604|532094423|FG006|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
147530258|NCT02190604|532094424|FG007|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
147530259|NCT02190604|532094425|FG008|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
147530260|NCT02190604|532094426|FG009|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
147530261|NCT02190604|532094427|FG010|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
147530262|NCT02190604|532094428|FG011|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
147530263|NCT02190604|532094429|FG012|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
147530264|NCT02190604|532094430|FG013|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
147530265|NCT02190604|532094431|FG014|Part 1 and 2 (Healthy Volunteers)|Adverse Event|2|||
147530266|NCT02190604|532094432|FG015|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
147530267|NCT02190604|532094433|FG016|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
147530268|NCT02190604|532094434|FG017|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
147530269|NCT02190604|532094435|FG018|Part 1 and 2 (Healthy Volunteers)|Adverse Event|0|||
147530270|NCT02190604|532094417|FG000|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
147530271|NCT02190604|532094418|FG001|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
147530272|NCT02190604|532094419|FG002|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
147530273|NCT02190604|532094420|FG003|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
147530274|NCT02190604|532094421|FG004|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
147530275|NCT02190604|532094422|FG005|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
147530276|NCT02190604|532094423|FG006|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
147530277|NCT02190604|532094424|FG007|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
147530278|NCT02190604|532094425|FG008|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
147530279|NCT02190604|532094426|FG009|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
147530280|NCT02190604|532094427|FG010|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
147530281|NCT02190604|532094428|FG011|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
147530282|NCT02190604|532094429|FG012|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
147530283|NCT02190604|532094430|FG013|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|1|||
147530284|NCT02190604|532094431|FG014|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
147530285|NCT02190604|532094432|FG015|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
147530286|NCT02190604|532094433|FG016|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
147530287|NCT02190604|532094434|FG017|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
147530288|NCT02190604|532094435|FG018|Part 1 and 2 (Healthy Volunteers)|Lost to Follow-up|0|||
147530289|NCT02797951|532094436|FG000|Overall Study|Adverse Event|4|||
147530290|NCT02797951|532094436|FG000|Overall Study|Death|1|||
147530291|NCT02797951|532094436|FG000|Overall Study|Lack of Efficacy|19|||
147530292|NCT02797951|532094436|FG000|Overall Study|Lost to Follow-up|4|||
147530293|NCT02797951|532094436|FG000|Overall Study|Physician Decision|6|||
147530294|NCT02797951|532094436|FG000|Overall Study|Withdrawal by Subject|15|||
147530295|NCT03735849|532094437|FG000|Overall Study|Lost to Follow-up|1|||
147530296|NCT03735849|532094438|FG001|Overall Study|Lost to Follow-up|0|||
147530297|NCT03735849|532094439|FG002|Overall Study|Lost to Follow-up|0|||
147530298|NCT03735849|532094437|FG000|Overall Study|Participant unable to adhere to visit|1|||
147530299|NCT03735849|532094438|FG001|Overall Study|Participant unable to adhere to visit|0|||
147530300|NCT03735849|532094439|FG002|Overall Study|Participant unable to adhere to visit|0|||
147530301|NCT03735849|532094437|FG000|Overall Study|Not Randomized|0|||
147530302|NCT03735849|532094438|FG001|Overall Study|Not Randomized|0|||
147530303|NCT03735849|532094439|FG002|Overall Study|Not Randomized|4|||
147530304|NCT04585906|532094442|FG000|Overall Study|Lost to Follow-up|8|||
147530305|NCT04585906|532094443|FG001|Overall Study|Lost to Follow-up|5|||
147530306|NCT04626947|532094444|FG000|Overall Study|Study terminated|14|||
147530307|NCT03907072|532094451|FG000|Overall Study|Study Terminated by Sponsor|2|||
147530308|NCT03907072|532094452|FG001|Overall Study|Study Terminated by Sponsor|2|||
147530309|NCT03907072|532094453|FG002|Overall Study|Study Terminated by Sponsor|2|||
147530310|NCT02463097|532094456|FG000|Overall Study|Withdrawal by Subject|1|||
147530311|NCT03326323|532094457|FG000|Overall Study|Unable to receive ANH protocol|3|||
147530312|NCT03556202|532094461|FG000|Extension Treatment Period|Adverse Event|18|||
147530313|NCT03556202|532094462|FG001|Extension Treatment Period|Adverse Event|14|||
147530314|NCT03556202|532094463|FG002|Extension Treatment Period|Adverse Event|9|||
147530315|NCT03556202|532094461|FG000|Extension Treatment Period|Death|2|||
147530316|NCT03556202|532094462|FG001|Extension Treatment Period|Death|6|||
147530317|NCT03556202|532094463|FG002|Extension Treatment Period|Death|0|||
147530318|NCT03556202|532094461|FG000|Extension Treatment Period|Lack of Efficacy|5|||
147530319|NCT03556202|532094462|FG001|Extension Treatment Period|Lack of Efficacy|12|||
147530320|NCT03556202|532094463|FG002|Extension Treatment Period|Lack of Efficacy|18|||
147530321|NCT03556202|532094461|FG000|Extension Treatment Period|Lost to Follow-up|9|||
147530322|NCT03556202|532094462|FG001|Extension Treatment Period|Lost to Follow-up|20|||
147530323|NCT03556202|532094463|FG002|Extension Treatment Period|Lost to Follow-up|2|||
147530324|NCT03556202|532094461|FG000|Extension Treatment Period|Pregnancy|2|||
147530325|NCT03556202|532094462|FG001|Extension Treatment Period|Pregnancy|4|||
147530326|NCT03556202|532094463|FG002|Extension Treatment Period|Pregnancy|3|||
147530327|NCT03556202|532094461|FG000|Extension Treatment Period|Study Terminated by Sponsor|469|||
147530328|NCT03556202|532094462|FG001|Extension Treatment Period|Study Terminated by Sponsor|907|||
147530329|NCT03556202|532094463|FG002|Extension Treatment Period|Study Terminated by Sponsor|331|||
147530330|NCT03556202|532094461|FG000|Extension Treatment Period|Withdrawal by Subject|22|||
147530331|NCT03556202|532094462|FG001|Extension Treatment Period|Withdrawal by Subject|47|||
147530332|NCT03556202|532094463|FG002|Extension Treatment Period|Withdrawal by Subject|22|||
147530333|NCT03556202|532094461|FG000|Extension Treatment Period|Due to Exclusion Criteria of AMAJ study|0|||
147530334|NCT03556202|532094462|FG001|Extension Treatment Period|Due to Exclusion Criteria of AMAJ study|0|||
147530335|NCT03556202|532094463|FG002|Extension Treatment Period|Due to Exclusion Criteria of AMAJ study|1|||
147530336|NCT03556202|532094461|FG000|Extension Treatment Period|Physician Decision|0|||
147530337|NCT03556202|532094462|FG001|Extension Treatment Period|Physician Decision|8|||
147530338|NCT03556202|532094463|FG002|Extension Treatment Period|Physician Decision|2|||
147530339|NCT03556202|532094461|FG000|Extension Treatment Period|Protocol Violation|0|||
147530340|NCT03556202|532094462|FG001|Extension Treatment Period|Protocol Violation|1|||
147530341|NCT03556202|532094463|FG002|Extension Treatment Period|Protocol Violation|1|||
147530342|NCT03556202|532094461|FG000|Extension Treatment Period|Sponsor Decision|0|||
147530343|NCT03556202|532094462|FG001|Extension Treatment Period|Sponsor Decision|1|||
147530344|NCT03556202|532094463|FG002|Extension Treatment Period|Sponsor Decision|0|||
147530345|NCT03556202|532094461|FG000|Follow-Up Period (12 Weeks)|Adverse Event|11|||
147530346|NCT03556202|532094462|FG001|Follow-Up Period (12 Weeks)|Adverse Event|11|||
147530347|NCT03556202|532094463|FG002|Follow-Up Period (12 Weeks)|Adverse Event|8|||
147530348|NCT03556202|532094461|FG000|Follow-Up Period (12 Weeks)|Death|1|||
147530349|NCT03556202|532094462|FG001|Follow-Up Period (12 Weeks)|Death|0|||
147530350|NCT03556202|532094463|FG002|Follow-Up Period (12 Weeks)|Death|0|||
147530351|NCT03556202|532094461|FG000|Follow-Up Period (12 Weeks)|Lack of Efficacy|4|||
147530352|NCT03556202|532094462|FG001|Follow-Up Period (12 Weeks)|Lack of Efficacy|9|||
147530353|NCT03556202|532094463|FG002|Follow-Up Period (12 Weeks)|Lack of Efficacy|13|||
147530354|NCT03556202|532094461|FG000|Follow-Up Period (12 Weeks)|Lost to Follow-up|4|||
147530355|NCT03556202|532094462|FG001|Follow-Up Period (12 Weeks)|Lost to Follow-up|14|||
147530356|NCT03556202|532094463|FG002|Follow-Up Period (12 Weeks)|Lost to Follow-up|3|||
147530357|NCT03556202|532094461|FG000|Follow-Up Period (12 Weeks)|Pregnancy|1|||
147530358|NCT03556202|532094462|FG001|Follow-Up Period (12 Weeks)|Pregnancy|4|||
147530359|NCT03556202|532094463|FG002|Follow-Up Period (12 Weeks)|Pregnancy|1|||
147530360|NCT03556202|532094461|FG000|Follow-Up Period (12 Weeks)|Study Terminated by Sponsor|396|||
147530361|NCT03556202|532094462|FG001|Follow-Up Period (12 Weeks)|Study Terminated by Sponsor|750|||
147530362|NCT03556202|532094463|FG002|Follow-Up Period (12 Weeks)|Study Terminated by Sponsor|273|||
147530363|NCT03556202|532094461|FG000|Follow-Up Period (12 Weeks)|Withdrawal by Subject|36|||
147530364|NCT03556202|532094462|FG001|Follow-Up Period (12 Weeks)|Withdrawal by Subject|65|||
147530365|NCT03556202|532094463|FG002|Follow-Up Period (12 Weeks)|Withdrawal by Subject|31|||
147530366|NCT03556202|532094461|FG000|Follow-Up Period (12 Weeks)|Physician Decision|0|||
147530367|NCT03556202|532094462|FG001|Follow-Up Period (12 Weeks)|Physician Decision|3|||
147530368|NCT03556202|532094463|FG002|Follow-Up Period (12 Weeks)|Physician Decision|1|||
147530369|NCT03556202|532094461|FG000|Follow-Up Period (12 Weeks)|Site Terminated by Sponsor|0|||
147530370|NCT03556202|532094462|FG001|Follow-Up Period (12 Weeks)|Site Terminated by Sponsor|1|||
147530371|NCT03556202|532094463|FG002|Follow-Up Period (12 Weeks)|Site Terminated by Sponsor|0|||
147530372|NCT03556202|532094461|FG000|Follow-Up Period (12 Weeks)|Study Discontinued by Sponsor|0|||
147530373|NCT03556202|532094462|FG001|Follow-Up Period (12 Weeks)|Study Discontinued by Sponsor|2|||
147530374|NCT03556202|532094463|FG002|Follow-Up Period (12 Weeks)|Study Discontinued by Sponsor|1|||
147530375|NCT03556202|532094461|FG000|Follow-Up Period (12 Weeks)|Second Follow-up Visit: Patient Refused|0|||
147530376|NCT03556202|532094462|FG001|Follow-Up Period (12 Weeks)|Second Follow-up Visit: Patient Refused|1|||
147530377|NCT03556202|532094463|FG002|Follow-Up Period (12 Weeks)|Second Follow-up Visit: Patient Refused|0|||
147530378|NCT03556202|532094461|FG000|Follow-Up Period (12 Weeks)|Study terminated & Subject Missed Follow-up Visit|0|||
147530379|NCT03556202|532094462|FG001|Follow-Up Period (12 Weeks)|Study terminated & Subject Missed Follow-up Visit|1|||
147530380|NCT03556202|532094463|FG002|Follow-Up Period (12 Weeks)|Study terminated & Subject Missed Follow-up Visit|0|||
147530381|NCT03556202|532094461|FG000|Follow-Up Period (12 Weeks)|To Meet Exclusion Criteria of the AMAJ Study|0|||
147530382|NCT03556202|532094462|FG001|Follow-Up Period (12 Weeks)|To Meet Exclusion Criteria of the AMAJ Study|0|||
147530383|NCT03556202|532094463|FG002|Follow-Up Period (12 Weeks)|To Meet Exclusion Criteria of the AMAJ Study|1|||
147530384|NCT03556202|532094461|FG000|Follow-Up Period (12 Weeks)|Second Follow-up Not Done, unable to reach Patient|0|||
147530385|NCT03556202|532094462|FG001|Follow-Up Period (12 Weeks)|Second Follow-up Not Done, unable to reach Patient|0|||
147530386|NCT03556202|532094463|FG002|Follow-Up Period (12 Weeks)|Second Follow-up Not Done, unable to reach Patient|1|||
147530387|NCT02243306|532094466|FG000|Overall Study|Adverse Event|0|||
147530388|NCT02243306|532094467|FG001|Overall Study|Adverse Event|1|||
147530389|NCT02243306|532094466|FG000|Overall Study|Other: Reached stopping criteria|0|||
147530390|NCT02243306|532094467|FG001|Overall Study|Other: Reached stopping criteria|1|||
147530391|NCT02243306|532094466|FG000|Overall Study|Physician Decision|0|||
147530392|NCT02243306|532094467|FG001|Overall Study|Physician Decision|1|||
147530393|NCT02221882|532094468|FG000|Overall Study|Withdrawal by Subject|0|||
147530394|NCT02221882|532094469|FG001|Overall Study|Withdrawal by Subject|0|||
147530395|NCT02221882|532094470|FG002|Overall Study|Withdrawal by Subject|4|||
147530396|NCT02221882|532094471|FG003|Overall Study|Withdrawal by Subject|2|||
147530397|NCT02221882|532094472|FG004|Overall Study|Withdrawal by Subject|2|||
147530398|NCT02221882|532094473|FG005|Overall Study|Withdrawal by Subject|2|||
147530399|NCT02221882|532094468|FG000|Overall Study|Death|0|||
147530400|NCT02221882|532094469|FG001|Overall Study|Death|1|||
147530401|NCT02221882|532094470|FG002|Overall Study|Death|0|||
147530402|NCT02221882|532094471|FG003|Overall Study|Death|0|||
147530403|NCT02221882|532094472|FG004|Overall Study|Death|0|||
147530404|NCT02221882|532094473|FG005|Overall Study|Death|0|||
147530405|NCT00796367|532094474|FG000|Overall Study|Adverse Event|6|||
147530406|NCT00796367|532094475|FG001|Overall Study|Adverse Event|4|||
147530407|NCT00796367|532094476|FG002|Overall Study|Adverse Event|7|||
147530408|NCT00796367|532094474|FG000|Overall Study|Lost to Follow-up|5|||
147530409|NCT00796367|532094475|FG001|Overall Study|Lost to Follow-up|4|||
147530410|NCT00796367|532094476|FG002|Overall Study|Lost to Follow-up|21|||
147530411|NCT00796367|532094474|FG000|Overall Study|Withdrawal by Subject|9|||
147530412|NCT00796367|532094475|FG001|Overall Study|Withdrawal by Subject|11|||
147530413|NCT00796367|532094476|FG002|Overall Study|Withdrawal by Subject|12|||
147530414|NCT00796367|532094474|FG000|Overall Study|Lack of Efficacy|2|||
147530415|NCT00796367|532094475|FG001|Overall Study|Lack of Efficacy|1|||
147530416|NCT00796367|532094476|FG002|Overall Study|Lack of Efficacy|0|||
147530417|NCT00796367|532094474|FG000|Overall Study|non compliance|3|||
147530418|NCT00796367|532094475|FG001|Overall Study|non compliance|1|||
147530419|NCT00796367|532094476|FG002|Overall Study|non compliance|1|||
147530420|NCT00796367|532094474|FG000|Overall Study|Pregnancy|1|||
147530421|NCT00796367|532094475|FG001|Overall Study|Pregnancy|0|||
147530422|NCT00796367|532094476|FG002|Overall Study|Pregnancy|1|||
147530423|NCT00796367|532094474|FG000|Overall Study|Requirement for restricted medication|2|||
147530424|NCT00796367|532094475|FG001|Overall Study|Requirement for restricted medication|0|||
147530425|NCT00796367|532094476|FG002|Overall Study|Requirement for restricted medication|2|||
147530426|NCT00796367|532094474|FG000|Overall Study|other|2|||
147530427|NCT00796367|532094475|FG001|Overall Study|other|4|||
147530428|NCT00796367|532094476|FG002|Overall Study|other|3|||
147530429|NCT01815099|532094477|FG000|Overall Study|Lack of Efficacy|1|||
147530430|NCT01815099|532094477|FG000|Overall Study|unable to attend study visits|1|||
147530431|NCT01475214|532094478|FG000|Overall Study|Lost to Follow-up|1|||
147530432|NCT01475214|532094479|FG001|Overall Study|Lost to Follow-up|0|||
147530433|NCT01475214|532094480|FG002|Overall Study|Lost to Follow-up|1|||
147530434|NCT01475214|532094478|FG000|Overall Study|Physician Decision|2|||
147530435|NCT01475214|532094479|FG001|Overall Study|Physician Decision|0|||
147530436|NCT01475214|532094480|FG002|Overall Study|Physician Decision|0|||
147530437|NCT01475214|532094478|FG000|Overall Study|Withdrawal by Subject|2|||
147530438|NCT01475214|532094479|FG001|Overall Study|Withdrawal by Subject|4|||
147530439|NCT01475214|532094480|FG002|Overall Study|Withdrawal by Subject|1|||
147530440|NCT00643851|532094481|FG000|Overall Study|Death|0|||
147530441|NCT00643851|532094482|FG001|Overall Study|Death|1|||
147530442|NCT00643851|532094483|FG002|Overall Study|Death|0|||
147530443|NCT00643851|532094481|FG000|Overall Study|Lack of Efficacy|0|||
147530444|NCT00643851|532094482|FG001|Overall Study|Lack of Efficacy|1|||
147530445|NCT00643851|532094483|FG002|Overall Study|Lack of Efficacy|0|||
147530446|NCT00643851|532094481|FG000|Overall Study|Adverse Event|2|||
147530447|NCT00643851|532094482|FG001|Overall Study|Adverse Event|6|||
147530448|NCT00643851|532094483|FG002|Overall Study|Adverse Event|6|||
147530449|NCT00643851|532094481|FG000|Overall Study|Lost to Follow-up|4|||
147530450|NCT00643851|532094482|FG001|Overall Study|Lost to Follow-up|6|||
147530451|NCT00643851|532094483|FG002|Overall Study|Lost to Follow-up|9|||
147530452|NCT00643851|532094481|FG000|Overall Study|Withdrawal by Subject|8|||
147530453|NCT00643851|532094482|FG001|Overall Study|Withdrawal by Subject|15|||
147530454|NCT00643851|532094483|FG002|Overall Study|Withdrawal by Subject|9|||
147530455|NCT00643851|532094481|FG000|Overall Study|Non-compl., not met criteria, etc.|3|||
147530456|NCT00643851|532094482|FG001|Overall Study|Non-compl., not met criteria, etc.|4|||
147530457|NCT00643851|532094483|FG002|Overall Study|Non-compl., not met criteria, etc.|6|||
147530458|NCT03289676|532094484|FG000|Overall Study|Withdrawal by Subject|2|||
147530459|NCT03289676|532094485|FG001|Overall Study|Withdrawal by Subject|0|||
147530460|NCT03289676|532094484|FG000|Overall Study|Protocol Violation|2|||
147530461|NCT03289676|532094485|FG001|Overall Study|Protocol Violation|0|||
147530462|NCT03289676|532094484|FG000|Overall Study|Lost to Follow-up|0|||
147530463|NCT03289676|532094485|FG001|Overall Study|Lost to Follow-up|1|||
147530464|NCT00465894|532094486|FG000|Treatment For 12 Weeks|Lost to Follow-up|4|||
147530465|NCT00465894|532094487|FG001|Treatment For 12 Weeks|Lost to Follow-up|1|||
147530466|NCT00465894|532094486|FG000|Treatment For 12 Weeks|Family Issues|1|||
147530467|NCT00465894|532094487|FG001|Treatment For 12 Weeks|Family Issues|1|||
147530468|NCT00465894|532094486|FG000|Treatment For 12 Weeks|Withdrawal by Subject|0|||
147530469|NCT00465894|532094487|FG001|Treatment For 12 Weeks|Withdrawal by Subject|1|||
147530470|NCT01636076|532094488|FG000|Overall Study|Terminated by sponsor|1|||
147530471|NCT01636076|532094489|FG001|Overall Study|Terminated by sponsor|1|||
147530472|NCT01636076|532094488|FG000|Overall Study|Lack of Efficacy|0|||
147530473|NCT01636076|532094489|FG001|Overall Study|Lack of Efficacy|1|||
147530474|NCT01636076|532094488|FG000|Overall Study|Lost to Follow-up|1|||
147530475|NCT01636076|532094489|FG001|Overall Study|Lost to Follow-up|0|||
147530476|NCT01636076|532094488|FG000|Overall Study|Physician Decision|1|||
147530477|NCT01636076|532094489|FG001|Overall Study|Physician Decision|1|||
147530478|NCT01636076|532094488|FG000|Overall Study|Non-compliance with study treatment|1|||
147530479|NCT01636076|532094489|FG001|Overall Study|Non-compliance with study treatment|1|||
147530480|NCT01636076|532094488|FG000|Overall Study|Adverse Event|6|||
147530481|NCT01636076|532094489|FG001|Overall Study|Adverse Event|11|||
147530482|NCT01636076|532094488|FG000|Overall Study|Withdrawal by Subject|7|||
147530483|NCT01636076|532094489|FG001|Overall Study|Withdrawal by Subject|10|||
147530484|NCT01159665|532094490|FG000|Overall Study|Withdrawal by Subject|0|||
147530485|NCT01159665|532094491|FG001|Overall Study|Withdrawal by Subject|1|||
147530486|NCT01159665|532094492|FG002|Overall Study|Withdrawal by Subject|0|||
147530487|NCT01159665|532094493|FG003|Overall Study|Withdrawal by Subject|0|||
147530488|NCT01159665|532094494|FG004|Overall Study|Withdrawal by Subject|0|||
147530489|NCT01159665|532094495|FG005|Overall Study|Withdrawal by Subject|0|||
147530490|NCT00934661|532096040|FG000|Overall Study|Failure of Combined/Spinal Epidural|1|||
147530491|NCT00934661|532096041|FG001|Overall Study|Failure of Combined/Spinal Epidural|0|||
147530492|NCT05064436|532096046|FG000|Overall Study|Other Reasons|1|||
147530493|NCT05064436|532096047|FG001|Overall Study|Other Reasons|0|||
147530494|NCT01711736|532096048|FG000|Overall Study|Lost to Follow-up|4|||
147530495|NCT01711736|532096049|FG001|Overall Study|Lost to Follow-up|1|||
147530496|NCT01711736|532096048|FG000|Overall Study|Withdrawal by Subject|6|||
147530497|NCT01711736|532096049|FG001|Overall Study|Withdrawal by Subject|6|||
147530498|NCT01711736|532096048|FG000|Overall Study|Migrated/moved from study area|2|||
147530499|NCT01711736|532096049|FG001|Overall Study|Migrated/moved from study area|1|||
147530500|NCT01342445|532096050|FG000|Overall Study|Experienced side effects|0|||
147530501|NCT01342445|532096051|FG001|Overall Study|Experienced side effects|2|||
147530502|NCT02652793|532096052|FG000|Overall Study|Adverse Event|1|||
147530503|NCT02652793|532096052|FG000|Overall Study|Lost to Follow-up|2|||
147530504|NCT02652793|532096052|FG000|Overall Study|Withdrawal by Subject|1|||
147530505|NCT05450198|532096057|FG000|Overall Study|Withdrawal by Subject|1|||
147530506|NCT05450198|532096058|FG001|Overall Study|Withdrawal by Subject|1|||
147530507|NCT05450198|532096059|FG002|Overall Study|Withdrawal by Subject|2|||
147530508|NCT05450198|532096060|FG003|Overall Study|Withdrawal by Subject|0|||
147530509|NCT05450198|532096057|FG000|Overall Study|Lost to Follow-up|1|||
147530510|NCT05450198|532096058|FG001|Overall Study|Lost to Follow-up|0|||
147530511|NCT05450198|532096059|FG002|Overall Study|Lost to Follow-up|2|||
147530512|NCT05450198|532096060|FG003|Overall Study|Lost to Follow-up|1|||
147530513|NCT01319422|532096061|FG000|Overall Study|Withdrawal by Subject|1|||
147530514|NCT01319422|532096062|FG001|Overall Study|Withdrawal by Subject|0|||
147530515|NCT00933543|532096063|FG000|Overall Study|Adverse Event|2|||
147530516|NCT00933543|532096064|FG001|Overall Study|Adverse Event|1|||
147530517|NCT00933543|532096063|FG000|Overall Study|Lost to Follow-up|0|||
147530518|NCT00933543|532096064|FG001|Overall Study|Lost to Follow-up|1|||
147530519|NCT00933543|532096063|FG000|Overall Study|Withdrawal by Subject|0|||
147530520|NCT00933543|532096064|FG001|Overall Study|Withdrawal by Subject|1|||
147530521|NCT00933543|532096063|FG000|Overall Study|Lack of Efficacy|0|||
147530522|NCT00933543|532096064|FG001|Overall Study|Lack of Efficacy|3|||
147530523|NCT00933543|532096063|FG000|Overall Study|Other|1|||
147530524|NCT00933543|532096064|FG001|Overall Study|Other|1|||
147530525|NCT04837807|532096067|FG000|First Sequence (Week 1)|Withdrawal by Subject|0|||
147530526|NCT04837807|532096068|FG001|First Sequence (Week 1)|Withdrawal by Subject|1|||
147530527|NCT00308555|532096069|FG000|Overall Study|Withdrawal by Subject|1|||
147530528|NCT00308555|532096070|FG001|Overall Study|Withdrawal by Subject|0|||
147530529|NCT00308555|532096069|FG000|Overall Study|Physician Decision|2|||
147530530|NCT00308555|532096070|FG001|Overall Study|Physician Decision|0|||
147530531|NCT00814502|532096071|FG000|Overall Study|Adverse Event|1|||
147530532|NCT00814502|532096072|FG001|Overall Study|Adverse Event|0|||
147530533|NCT00814502|532096071|FG000|Overall Study|Withdrawal by Subject|0|||
147530534|NCT00814502|532096072|FG001|Overall Study|Withdrawal by Subject|2|||
147530535|NCT01012765|532096079|FG000|Treatment Period 1|Adverse Event|1|||
147530536|NCT01012765|532096080|FG001|Treatment Period 1|Adverse Event|0|||
147530537|NCT01012765|532096081|FG002|Treatment Period 1|Adverse Event|1|||
147530538|NCT01012765|532096082|FG003|Treatment Period 1|Adverse Event|0|||
147530539|NCT01012765|532096083|FG004|Treatment Period 1|Adverse Event|0|||
147530540|NCT01012765|532096084|FG005|Treatment Period 1|Adverse Event|0|||
147530541|NCT01012765|532096079|FG000|Treatment Period 1|Withdrawal by Subject|2|||
147530542|NCT01012765|532096080|FG001|Treatment Period 1|Withdrawal by Subject|0|||
147530543|NCT01012765|532096081|FG002|Treatment Period 1|Withdrawal by Subject|0|||
147530544|NCT01012765|532096082|FG003|Treatment Period 1|Withdrawal by Subject|0|||
147530545|NCT01012765|532096083|FG004|Treatment Period 1|Withdrawal by Subject|0|||
147530546|NCT01012765|532096084|FG005|Treatment Period 1|Withdrawal by Subject|0|||
147530547|NCT01012765|532096079|FG000|Treatment Period 1|Administrative problems|0|||
147530548|NCT01012765|532096080|FG001|Treatment Period 1|Administrative problems|0|||
147530549|NCT01012765|532096081|FG002|Treatment Period 1|Administrative problems|1|||
147530550|NCT01012765|532096082|FG003|Treatment Period 1|Administrative problems|1|||
147530551|NCT01012765|532096083|FG004|Treatment Period 1|Administrative problems|1|||
147530552|NCT01012765|532096084|FG005|Treatment Period 1|Administrative problems|0|||
147530553|NCT01012765|532096079|FG000|Treatment Period 1|Protocol Violation|0|||
147530554|NCT01012765|532096080|FG001|Treatment Period 1|Protocol Violation|0|||
147530555|NCT01012765|532096081|FG002|Treatment Period 1|Protocol Violation|0|||
147530556|NCT01012765|532096082|FG003|Treatment Period 1|Protocol Violation|2|||
147530557|NCT01012765|532096083|FG004|Treatment Period 1|Protocol Violation|1|||
147530558|NCT01012765|532096084|FG005|Treatment Period 1|Protocol Violation|0|||
147530559|NCT01012765|532096079|FG000|Treatment Period 1|Unsatisfactory therapeutic effect|0|||
147530560|NCT01012765|532096080|FG001|Treatment Period 1|Unsatisfactory therapeutic effect|0|||
147530561|NCT01012765|532096081|FG002|Treatment Period 1|Unsatisfactory therapeutic effect|0|||
147530562|NCT01012765|532096082|FG003|Treatment Period 1|Unsatisfactory therapeutic effect|0|||
147530563|NCT01012765|532096083|FG004|Treatment Period 1|Unsatisfactory therapeutic effect|1|||
147530564|NCT01012765|532096084|FG005|Treatment Period 1|Unsatisfactory therapeutic effect|0|||
147530565|NCT01012765|532096079|FG000|Treatment Period 2|Withdrawal by Subject|1|||
147530566|NCT01012765|532096080|FG001|Treatment Period 2|Withdrawal by Subject|0|||
147530567|NCT01012765|532096081|FG002|Treatment Period 2|Withdrawal by Subject|1|||
147530568|NCT01012765|532096082|FG003|Treatment Period 2|Withdrawal by Subject|0|||
147530569|NCT01012765|532096083|FG004|Treatment Period 2|Withdrawal by Subject|1|||
147530570|NCT01012765|532096084|FG005|Treatment Period 2|Withdrawal by Subject|0|||
147530571|NCT01012765|532096079|FG000|Treatment Period 2|Abnormal laboratory value(s)|0|||
147530572|NCT01012765|532096080|FG001|Treatment Period 2|Abnormal laboratory value(s)|0|||
147530573|NCT01012765|532096081|FG002|Treatment Period 2|Abnormal laboratory value(s)|0|||
147530574|NCT01012765|532096082|FG003|Treatment Period 2|Abnormal laboratory value(s)|0|||
147530575|NCT01012765|532096083|FG004|Treatment Period 2|Abnormal laboratory value(s)|0|||
147530576|NCT01012765|532096084|FG005|Treatment Period 2|Abnormal laboratory value(s)|1|||
147530577|NCT01012765|532096079|FG000|Treatment Period 2|Adverse Event|0|||
147530578|NCT01012765|532096080|FG001|Treatment Period 2|Adverse Event|1|||
147530579|NCT01012765|532096081|FG002|Treatment Period 2|Adverse Event|1|||
147530580|NCT01012765|532096082|FG003|Treatment Period 2|Adverse Event|0|||
147530581|NCT01012765|532096083|FG004|Treatment Period 2|Adverse Event|0|||
147530582|NCT01012765|532096084|FG005|Treatment Period 2|Adverse Event|0|||
147530583|NCT01012765|532096079|FG000|Treatment Period 2|Unsatisfactory therapeutic effect|0|||
147530584|NCT01012765|532096080|FG001|Treatment Period 2|Unsatisfactory therapeutic effect|1|||
147530585|NCT01012765|532096081|FG002|Treatment Period 2|Unsatisfactory therapeutic effect|1|||
147530586|NCT01012765|532096082|FG003|Treatment Period 2|Unsatisfactory therapeutic effect|0|||
147530587|NCT01012765|532096083|FG004|Treatment Period 2|Unsatisfactory therapeutic effect|0|||
147530588|NCT01012765|532096084|FG005|Treatment Period 2|Unsatisfactory therapeutic effect|0|||
147530589|NCT01326312|532096085|FG000|Overall Study|Adverse Event|11|||
147530590|NCT01326312|532096086|FG001|Overall Study|Adverse Event|11|||
147530591|NCT01326312|532096087|FG002|Overall Study|Adverse Event|1|||
147530592|NCT01326312|532096085|FG000|Overall Study|Withdrawal by Subject|1|||
147530593|NCT01326312|532096086|FG001|Overall Study|Withdrawal by Subject|2|||
147530594|NCT01326312|532096087|FG002|Overall Study|Withdrawal by Subject|1|||
147530595|NCT01326312|532096085|FG000|Overall Study|Protocol Violation|0|||
147530596|NCT01326312|532096086|FG001|Overall Study|Protocol Violation|1|||
147530597|NCT01326312|532096087|FG002|Overall Study|Protocol Violation|0|||
147530598|NCT01326312|532096085|FG000|Overall Study|Lack of Efficacy|13|||
147530599|NCT01326312|532096086|FG001|Overall Study|Lack of Efficacy|7|||
147530600|NCT01326312|532096087|FG002|Overall Study|Lack of Efficacy|1|||
147530601|NCT01326312|532096085|FG000|Overall Study|Death|1|||
147530602|NCT01326312|532096086|FG001|Overall Study|Death|0|||
147530603|NCT01326312|532096087|FG002|Overall Study|Death|1|||
147530604|NCT01326312|532096085|FG000|Overall Study|progressive disease|0|||
147530605|NCT01326312|532096086|FG001|Overall Study|progressive disease|1|||
147530606|NCT01326312|532096087|FG002|Overall Study|progressive disease|1|||
147530607|NCT01326312|532096085|FG000|Overall Study|Study terminated by Sponsor|8|||
147530608|NCT01326312|532096086|FG001|Overall Study|Study terminated by Sponsor|32|||
147530609|NCT01326312|532096087|FG002|Overall Study|Study terminated by Sponsor|46|||
147530610|NCT01326312|532096085|FG000|Overall Study|Treatment arm terminated|19|||
147530611|NCT01326312|532096086|FG001|Overall Study|Treatment arm terminated|0|||
147530612|NCT01326312|532096087|FG002|Overall Study|Treatment arm terminated|0|||
147530613|NCT01326312|532096085|FG000|Overall Study|QTc > 500|0|||
147530614|NCT01326312|532096086|FG001|Overall Study|QTc > 500|1|||
147530615|NCT01326312|532096087|FG002|Overall Study|QTc > 500|0|||
147530616|NCT00499694|532096098|FG000|Overall Study|Patient never received treatment.|1|||
147530617|NCT02370173|532096107|FG000|Overall Study|Protocol Violation|1|||
147530618|NCT02370173|532096108|FG001|Overall Study|Protocol Violation|1|||
147530619|NCT02370173|532096107|FG000|Overall Study|Withdrawal by Subject|2|||
147530620|NCT02370173|532096108|FG001|Overall Study|Withdrawal by Subject|2|||
147530621|NCT04034225|532096109|FG000|Overall Study|Death|3|||
147530622|NCT04034225|532096109|FG000|Overall Study|Withdrawal by Subject|2|||
147530623|NCT04034225|532096109|FG000|Overall Study|Study termination by Sponsor|18|||
147530624|NCT04034225|532096109|FG000|Overall Study|Physician Decision|1|||
147530625|NCT04034225|532096109|FG000|Overall Study|Lack of Efficacy|1|||
147530626|NCT00307736|532096115|FG000|Overall Study|Adverse Event|0|||
147530627|NCT00307736|532096116|FG001|Overall Study|Adverse Event|0|||
147530628|NCT00307736|532096117|FG002|Overall Study|Adverse Event|1|||
147530629|NCT00307736|532096118|FG003|Overall Study|Adverse Event|3|||
147530630|NCT00307736|532096115|FG000|Overall Study|Withdrawal by Subject|0|||
147530631|NCT00307736|532096116|FG001|Overall Study|Withdrawal by Subject|0|||
147530632|NCT00307736|532096117|FG002|Overall Study|Withdrawal by Subject|2|||
147530633|NCT00307736|532096118|FG003|Overall Study|Withdrawal by Subject|0|||
147530634|NCT01365182|532096120|FG000|Overall Study|Withdrawal by Subject|10|||
147530635|NCT01365182|532096121|FG001|Overall Study|Withdrawal by Subject|13|||
147530636|NCT01365182|532096122|FG002|Overall Study|Withdrawal by Subject|12|||
147530637|NCT00736840|532096123|FG000|Overall Study|Lost to Follow-up|13|||
147530638|NCT01411917|532096124|FG000|Overall Study|Patient did not undergo scheduled surger|0|||
147530639|NCT01411917|532096125|FG001|Overall Study|Patient did not undergo scheduled surger|1|||
147530640|NCT01728194|532096130|FG000|Overall Study|Lost to Follow-up|4|||
147530641|NCT01728194|532096131|FG001|Overall Study|Lost to Follow-up|3|||
147530642|NCT01728194|532096130|FG000|Overall Study|Physician Decision|4|||
147530643|NCT01728194|532096131|FG001|Overall Study|Physician Decision|0|||
147530644|NCT01728194|532096130|FG000|Overall Study|Withdrawal by Subject|7|||
147530645|NCT01728194|532096131|FG001|Overall Study|Withdrawal by Subject|3|||
147530646|NCT01728194|532096130|FG000|Overall Study|Perceived Medication Side Effects|4|||
147530647|NCT01728194|532096131|FG001|Overall Study|Perceived Medication Side Effects|0|||
147530648|NCT01728194|532096130|FG000|Overall Study|Family Member Request|1|||
147530649|NCT01728194|532096131|FG001|Overall Study|Family Member Request|0|||
147530650|NCT02309372|532096134|FG000|Overall Study|Lost to Follow-up|3|||
147530651|NCT02309372|532096135|FG001|Overall Study|Lost to Follow-up|2|||
147530652|NCT00242658|532096136|FG000|Overall Study|Lost to Follow-up|22|||
147530653|NCT00242658|532096137|FG001|Overall Study|Lost to Follow-up|19|||
147530654|NCT04604015|532096140|FG000|Overall Study|Incomplete Data Collection|33|||
147530655|NCT02576652|532096143|FG000|Overall Study|Withdrawal by Subject|2|||
147530656|NCT02811640|532096148|FG000|Overall Study|Technology malfunction|2|||
147530657|NCT04557189|532096153|FG000|Overall Study|Adverse Event|0|||
147530658|NCT04557189|532096154|FG001|Overall Study|Adverse Event|1|||
147530659|NCT04557189|532096153|FG000|Overall Study|Lost to Follow-up|1|||
147530660|NCT04557189|532096154|FG001|Overall Study|Lost to Follow-up|1|||
147530661|NCT04557189|532096153|FG000|Overall Study|Withdrawal by Subject|2|||
147530662|NCT04557189|532096154|FG001|Overall Study|Withdrawal by Subject|1|||
147530663|NCT04557189|532096153|FG000|Overall Study|Reason not Specified|3|||
147530664|NCT04557189|532096154|FG001|Overall Study|Reason not Specified|6|||
147530665|NCT01087944|532096173|FG000|Period 1 (Week 1-3)|Adverse Event|1|||
147530666|NCT01087944|532096174|FG001|Period 1 (Week 1-3)|Adverse Event|0|||
147530667|NCT01087944|532096173|FG000|Period 2 (Week 4-6)|Adverse Event|0|||
147530668|NCT01087944|532096174|FG001|Period 2 (Week 4-6)|Adverse Event|2|||
147530669|NCT00553319|532096175|FG000|Overall Study|Lost to Follow-up|10|||
147530670|NCT00553319|532096176|FG001|Overall Study|Lost to Follow-up|9|||
147530671|NCT00553319|532096177|FG002|Overall Study|Lost to Follow-up|5|||
147530672|NCT00553319|532096175|FG000|Overall Study|wanted treatment elsewhere|2|||
147530673|NCT00553319|532096176|FG001|Overall Study|wanted treatment elsewhere|1|||
147530674|NCT00553319|532096177|FG002|Overall Study|wanted treatment elsewhere|1|||
147530675|NCT00553319|532096175|FG000|Overall Study|non-compliance|0|||
147530676|NCT00553319|532096176|FG001|Overall Study|non-compliance|0|||
147530677|NCT00553319|532096177|FG002|Overall Study|non-compliance|2|||
147530678|NCT00553319|532096175|FG000|Overall Study|incarceration|1|||
147530679|NCT00553319|532096176|FG001|Overall Study|incarceration|0|||
147530680|NCT00553319|532096177|FG002|Overall Study|incarceration|0|||
147530681|NCT00553319|532096175|FG000|Overall Study|moved|1|||
147530682|NCT00553319|532096176|FG001|Overall Study|moved|0|||
147530683|NCT00553319|532096177|FG002|Overall Study|moved|1|||
147530684|NCT01731600|532096183|FG000|Overall Study|Adverse Event|2|||
147530685|NCT01731600|532096184|FG001|Overall Study|Adverse Event|0|||
147530686|NCT01731600|532096183|FG000|Overall Study|Withdrawal criteria|1|||
147530687|NCT01731600|532096184|FG001|Overall Study|Withdrawal criteria|0|||
147530688|NCT01731600|532096183|FG000|Overall Study|Other reasons|3|||
147530689|NCT01731600|532096184|FG001|Overall Study|Other reasons|0|||
147530690|NCT03575975|532096185|FG000|Overall Study|Lost to Follow-up|1|||
147530691|NCT03575975|532096186|FG001|Overall Study|Lost to Follow-up|0|||
147530692|NCT03575975|532096187|FG002|Overall Study|Lost to Follow-up|0|||
147530693|NCT00129220|532096189|FG000|Study Period II|Adverse Event|9|||
147530694|NCT00129220|532096190|FG001|Study Period II|Adverse Event|5|||
147530695|NCT00129220|532096191|FG002|Study Period II|Adverse Event|7|||
147530696|NCT00129220|532096189|FG000|Study Period II|Lack of Efficacy|15|||
147530697|NCT00129220|532096190|FG001|Study Period II|Lack of Efficacy|1|||
147530698|NCT00129220|532096191|FG002|Study Period II|Lack of Efficacy|28|||
147530699|NCT00129220|532096189|FG000|Study Period II|Entry Criteria Not Met|2|||
147530700|NCT00129220|532096190|FG001|Study Period II|Entry Criteria Not Met|0|||
147530701|NCT00129220|532096191|FG002|Study Period II|Entry Criteria Not Met|2|||
147530702|NCT00129220|532096189|FG000|Study Period II|Protocol Violation|4|||
147530703|NCT00129220|532096190|FG001|Study Period II|Protocol Violation|2|||
147530704|NCT00129220|532096191|FG002|Study Period II|Protocol Violation|1|||
147530705|NCT00129220|532096189|FG000|Study Period II|Physician Decision|0|||
147530706|NCT00129220|532096190|FG001|Study Period II|Physician Decision|1|||
147530707|NCT00129220|532096191|FG002|Study Period II|Physician Decision|0|||
147530708|NCT00129220|532096189|FG000|Study Period II|Withdrawal by Subject|1|||
147530709|NCT00129220|532096190|FG001|Study Period II|Withdrawal by Subject|3|||
147530710|NCT00129220|532096191|FG002|Study Period II|Withdrawal by Subject|4|||
147530711|NCT00129220|532096189|FG000|Study Period II|Reason Not Specified|2|||
147530712|NCT00129220|532096190|FG001|Study Period II|Reason Not Specified|0|||
147530713|NCT00129220|532096191|FG002|Study Period II|Reason Not Specified|5|||
147530714|NCT00129220|532096189|FG000|Study Period III|Adverse Event|1|||
147530715|NCT00129220|532096190|FG001|Study Period III|Adverse Event|0|||
147530716|NCT00129220|532096191|FG002|Study Period III|Adverse Event|3|||
147530717|NCT00129220|532096189|FG000|Study Period III|Protocol Violation|1|||
147530718|NCT00129220|532096190|FG001|Study Period III|Protocol Violation|1|||
147530719|NCT00129220|532096191|FG002|Study Period III|Protocol Violation|2|||
147530720|NCT00129220|532096189|FG000|Study Period III|Withdrawal by Subject|1|||
147530721|NCT00129220|532096190|FG001|Study Period III|Withdrawal by Subject|0|||
147530722|NCT00129220|532096191|FG002|Study Period III|Withdrawal by Subject|3|||
147530723|NCT00129220|532096189|FG000|Study Period III|Sponsor Decision|1|||
147530724|NCT00129220|532096190|FG001|Study Period III|Sponsor Decision|0|||
147530725|NCT00129220|532096191|FG002|Study Period III|Sponsor Decision|0|||
147530726|NCT00129220|532096189|FG000|Study Period III|Reason Not Specified|9|||
147530727|NCT00129220|532096190|FG001|Study Period III|Reason Not Specified|0|||
147530728|NCT00129220|532096191|FG002|Study Period III|Reason Not Specified|2|||
147530729|NCT00540228|532096193|FG000|Overall Study|Adverse Event|2|||
147530730|NCT00540228|532096194|FG001|Overall Study|Adverse Event|0|||
147530731|NCT00540228|532096195|FG002|Overall Study|Adverse Event|0|||
147530732|NCT00540228|532096196|FG003|Overall Study|Adverse Event|0|||
147530733|NCT00540228|532096197|FG004|Overall Study|Adverse Event|0|||
147530734|NCT00540228|532096193|FG000|Overall Study|Lost to Follow-up|1|||
147530735|NCT00540228|532096194|FG001|Overall Study|Lost to Follow-up|1|||
147530736|NCT00540228|532096195|FG002|Overall Study|Lost to Follow-up|0|||
147530737|NCT00540228|532096196|FG003|Overall Study|Lost to Follow-up|0|||
147530738|NCT00540228|532096197|FG004|Overall Study|Lost to Follow-up|0|||
147530739|NCT01883362|532096198|FG000|Treatment|Adverse Event|1|||
147530740|NCT01883362|532096199|FG001|Treatment|Adverse Event|8|||
147530741|NCT01883362|532096198|FG000|Treatment|Withdrawal by Subject|6|||
147530742|NCT01883362|532096199|FG001|Treatment|Withdrawal by Subject|2|||
147530743|NCT01883362|532096198|FG000|Treatment|Administrative problems|4|||
147530744|NCT01883362|532096199|FG001|Treatment|Administrative problems|1|||
147530745|NCT01883362|532096198|FG000|Treatment|Relapse|4|||
147530746|NCT01883362|532096199|FG001|Treatment|Relapse|2|||
147530747|NCT01883362|532096198|FG000|Treatment|Randomized, not treated|1|||
147530748|NCT01883362|532096199|FG001|Treatment|Randomized, not treated|1|||
147530749|NCT01883362|532096198|FG000|Post Treatment Follow-up|Protocol Violation|0|||
147530750|NCT01883362|532096199|FG001|Post Treatment Follow-up|Protocol Violation|1|||
147530751|NCT01883362|532096198|FG000|Post Treatment Follow-up|Withdrawal by Subject|4|||
147530752|NCT01883362|532096199|FG001|Post Treatment Follow-up|Withdrawal by Subject|3|||
147530753|NCT01883362|532096198|FG000|Post Treatment Follow-up|Lost to Follow-up|1|||
147530754|NCT01883362|532096199|FG001|Post Treatment Follow-up|Lost to Follow-up|4|||
147530755|NCT01883362|532096198|FG000|Post Treatment Follow-up|Administrative problems|2|||
147530756|NCT01883362|532096199|FG001|Post Treatment Follow-up|Administrative problems|0|||
147530757|NCT01883362|532096198|FG000|Post Treatment Follow-up|Death|8|||
147530758|NCT01883362|532096199|FG001|Post Treatment Follow-up|Death|4|||
147530759|NCT01883362|532096198|FG000|Post Treatment Follow-up|Relapse|1|||
147530760|NCT01883362|532096199|FG001|Post Treatment Follow-up|Relapse|2|||
147530761|NCT01230489|532096201|FG000|Overall Study|Death|2|||
147530762|NCT01230489|532096201|FG000|Overall Study|Adverse Event|2|||
147530763|NCT01230489|532096201|FG000|Overall Study|Treatment modality changed|1|||
147530764|NCT02451137|532096202|FG000|Overall Study|Randomized but not treated|19|||
147530765|NCT02451137|532096203|FG001|Overall Study|Randomized but not treated|27|||
147530766|NCT02451137|532096202|FG000|Overall Study|Adverse Event|43|||
147530767|NCT02451137|532096203|FG001|Overall Study|Adverse Event|42|||
147530768|NCT02451137|532096202|FG000|Overall Study|Lack of Efficacy|4|||
147530769|NCT02451137|532096203|FG001|Overall Study|Lack of Efficacy|9|||
147530770|NCT02451137|532096202|FG000|Overall Study|Participant decision:discontinue insulin|41|||
147530771|NCT02451137|532096203|FG001|Overall Study|Participant decision:discontinue insulin|43|||
147530772|NCT02451137|532096202|FG000|Overall Study|Hypoglycemia|2|||
147530773|NCT02451137|532096203|FG001|Overall Study|Hypoglycemia|1|||
147530774|NCT02451137|532096202|FG000|Overall Study|Investigator's decision|23|||
147530775|NCT02451137|532096203|FG001|Overall Study|Investigator's decision|19|||
147530776|NCT02451137|532096202|FG000|Overall Study|Lost to Follow-up|53|||
147530777|NCT02451137|532096203|FG001|Overall Study|Lost to Follow-up|61|||
147530778|NCT02451137|532096202|FG000|Overall Study|Physician Decision|6|||
147530779|NCT02451137|532096203|FG001|Overall Study|Physician Decision|5|||
147530780|NCT02451137|532096202|FG000|Overall Study|Sponsor decision|13|||
147530781|NCT02451137|532096203|FG001|Overall Study|Sponsor decision|25|||
147530782|NCT02451137|532096202|FG000|Overall Study|Withdrawal by Subject|40|||
147530783|NCT02451137|532096203|FG001|Overall Study|Withdrawal by Subject|63|||
147530784|NCT02451137|532096202|FG000|Overall Study|Other than specified above|2|||
147530785|NCT02451137|532096203|FG001|Overall Study|Other than specified above|3|||
147530786|NCT01977573|532096206|FG000|Overall Study|Adverse Event|7|||
147530787|NCT01977573|532096207|FG001|Overall Study|Adverse Event|0|||
147530788|NCT01977573|532096208|FG002|Overall Study|Adverse Event|2|||
147530789|NCT01977573|532096209|FG003|Overall Study|Adverse Event|1|||
147530790|NCT01977573|532096206|FG000|Overall Study|Lost to Follow-up|1|||
147530791|NCT01977573|532096207|FG001|Overall Study|Lost to Follow-up|0|||
147530792|NCT01977573|532096208|FG002|Overall Study|Lost to Follow-up|0|||
147530793|NCT01977573|532096209|FG003|Overall Study|Lost to Follow-up|1|||
147530794|NCT01977573|532096206|FG000|Overall Study|Physician Decision|1|||
147530795|NCT01977573|532096207|FG001|Overall Study|Physician Decision|0|||
147530796|NCT01977573|532096208|FG002|Overall Study|Physician Decision|0|||
147530797|NCT01977573|532096209|FG003|Overall Study|Physician Decision|0|||
147530798|NCT01977573|532096206|FG000|Overall Study|Protocol Violation|3|||
147530799|NCT01977573|532096207|FG001|Overall Study|Protocol Violation|1|||
147530800|NCT01977573|532096208|FG002|Overall Study|Protocol Violation|0|||
147530801|NCT01977573|532096209|FG003|Overall Study|Protocol Violation|0|||
147530802|NCT01977573|532096206|FG000|Overall Study|Reached Defined Stopping Criteria|2|||
147530803|NCT01977573|532096207|FG001|Overall Study|Reached Defined Stopping Criteria|1|||
147530804|NCT01977573|532096208|FG002|Overall Study|Reached Defined Stopping Criteria|1|||
147530805|NCT01977573|532096209|FG003|Overall Study|Reached Defined Stopping Criteria|0|||
147530806|NCT01977573|532096206|FG000|Overall Study|Withdrawal by Subject|6|||
147530807|NCT01977573|532096207|FG001|Overall Study|Withdrawal by Subject|1|||
147530808|NCT01977573|532096208|FG002|Overall Study|Withdrawal by Subject|1|||
147530809|NCT01977573|532096209|FG003|Overall Study|Withdrawal by Subject|1|||
147530810|NCT00198107|532098048|FG000|Double-Blind Period|Adverse Event|1|||
147530811|NCT00198107|532098049|FG001|Double-Blind Period|Adverse Event|1|||
147530812|NCT00198107|532098050|FG002|Double-Blind Period|Adverse Event|0|||
147530813|NCT00198107|532098048|FG000|Double-Blind Period|Lack of Efficacy|2|||
147530814|NCT00198107|532098049|FG001|Double-Blind Period|Lack of Efficacy|0|||
147530815|NCT00198107|532098050|FG002|Double-Blind Period|Lack of Efficacy|0|||
147530816|NCT00198107|532098048|FG000|Double-Blind Period|Lost to Follow-up|2|||
147530817|NCT00198107|532098049|FG001|Double-Blind Period|Lost to Follow-up|1|||
147530818|NCT00198107|532098050|FG002|Double-Blind Period|Lost to Follow-up|0|||
147530819|NCT00198107|532098048|FG000|Double-Blind Period|Physician Decision|1|||
147530820|NCT00198107|532098049|FG001|Double-Blind Period|Physician Decision|0|||
147530821|NCT00198107|532098050|FG002|Double-Blind Period|Physician Decision|0|||
147530822|NCT00198107|532098048|FG000|Double-Blind Period|Withdrawal by Subject|0|||
147530823|NCT00198107|532098049|FG001|Double-Blind Period|Withdrawal by Subject|1|||
147530824|NCT00198107|532098050|FG002|Double-Blind Period|Withdrawal by Subject|0|||
147530825|NCT00198107|532098048|FG000|Pilot Add-On Aripiprazole +D-cycloserine|Withdrawal by Subject|0|||
147530826|NCT00198107|532098049|FG001|Pilot Add-On Aripiprazole +D-cycloserine|Withdrawal by Subject|0|||
147530827|NCT00198107|532098050|FG002|Pilot Add-On Aripiprazole +D-cycloserine|Withdrawal by Subject|2|||
147530828|NCT02513732|532098051|FG000|Overall Study|Lost to Follow-up|11|||
147530829|NCT02513732|532098051|FG000|Overall Study|Death|9|||
147530830|NCT02513732|532098051|FG000|Overall Study|Changing hospital|2|||
147530831|NCT03996694|532098057|FG000|First Washout (7 Days)|positive urine drug screen|0|||
147530832|NCT03996694|532098058|FG001|First Washout (7 Days)|positive urine drug screen|0|||
147530833|NCT03996694|532098059|FG002|First Washout (7 Days)|positive urine drug screen|1|||
147530834|NCT03996694|532098060|FG003|First Washout (7 Days)|positive urine drug screen|0|||
147530835|NCT03996694|532098061|FG004|First Washout (7 Days)|positive urine drug screen|0|||
147530836|NCT03996694|532098062|FG005|First Washout (7 Days)|positive urine drug screen|0|||
147530837|NCT03996694|532098057|FG000|First Washout (7 Days)|Adverse Event|0|||
147530838|NCT03996694|532098058|FG001|First Washout (7 Days)|Adverse Event|1|||
147530839|NCT03996694|532098059|FG002|First Washout (7 Days)|Adverse Event|0|||
147530840|NCT03996694|532098060|FG003|First Washout (7 Days)|Adverse Event|0|||
147530841|NCT03996694|532098061|FG004|First Washout (7 Days)|Adverse Event|0|||
147530842|NCT03996694|532098062|FG005|First Washout (7 Days)|Adverse Event|0|||
147530843|NCT03996694|532098057|FG000|First Washout (7 Days)|Lost to Follow-up|0|||
147530844|NCT03996694|532098058|FG001|First Washout (7 Days)|Lost to Follow-up|0|||
147530845|NCT03996694|532098059|FG002|First Washout (7 Days)|Lost to Follow-up|1|||
147530846|NCT03996694|532098060|FG003|First Washout (7 Days)|Lost to Follow-up|0|||
147530847|NCT03996694|532098061|FG004|First Washout (7 Days)|Lost to Follow-up|0|||
147530848|NCT03996694|532098062|FG005|First Washout (7 Days)|Lost to Follow-up|0|||
147530849|NCT03996694|532098057|FG000|Third Washout (7 Days)|Withdrawal by Subject|0|||
147530850|NCT03996694|532098058|FG001|Third Washout (7 Days)|Withdrawal by Subject|0|||
147530851|NCT03996694|532098059|FG002|Third Washout (7 Days)|Withdrawal by Subject|0|||
147530852|NCT03996694|532098060|FG003|Third Washout (7 Days)|Withdrawal by Subject|0|||
147530853|NCT03996694|532098061|FG004|Third Washout (7 Days)|Withdrawal by Subject|1|||
147530854|NCT03996694|532098062|FG005|Third Washout (7 Days)|Withdrawal by Subject|0|||
147530855|NCT00656669|532098067|FG000|Paclitaxel/Sunitinib (Cycles 2-5)|Adverse Event|4|||
147530856|NCT00656669|532098067|FG000|Paclitaxel/Sunitinib (Cycles 2-5)|Physician Decision|2|||
147530857|NCT00656669|532098067|FG000|AC (Cycles 6-9)|Adverse Event|1|||
147530858|NCT00656669|532098067|FG000|AC (Cycles 6-9)|Did not start segment 3|1|||
147530859|NCT02777554|532098070|FG000|Overall Study|Adverse Event|4|||
147530860|NCT02777554|532098071|FG001|Overall Study|Adverse Event|4|||
147530861|NCT02777554|532098072|FG002|Overall Study|Adverse Event|0|||
147530862|NCT02777554|532098073|FG003|Overall Study|Adverse Event|1|||
147530863|NCT02777554|532098074|FG004|Overall Study|Adverse Event|0|||
147530864|NCT02777554|532098075|FG005|Overall Study|Adverse Event|0|||
147530865|NCT02777554|532098070|FG000|Overall Study|Withdrawal by Subject|3|||
147530866|NCT02777554|532098071|FG001|Overall Study|Withdrawal by Subject|1|||
147530867|NCT02777554|532098072|FG002|Overall Study|Withdrawal by Subject|1|||
147530868|NCT02777554|532098073|FG003|Overall Study|Withdrawal by Subject|0|||
147530869|NCT02777554|532098074|FG004|Overall Study|Withdrawal by Subject|0|||
147530870|NCT02777554|532098075|FG005|Overall Study|Withdrawal by Subject|0|||
147530871|NCT02777554|532098070|FG000|Overall Study|Discharged early due to hurricane|22|||
147530872|NCT02777554|532098071|FG001|Overall Study|Discharged early due to hurricane|20|||
147530873|NCT02777554|532098072|FG002|Overall Study|Discharged early due to hurricane|0|||
147530874|NCT02777554|532098073|FG003|Overall Study|Discharged early due to hurricane|0|||
147530875|NCT02777554|532098074|FG004|Overall Study|Discharged early due to hurricane|0|||
147530876|NCT02777554|532098075|FG005|Overall Study|Discharged early due to hurricane|0|||
147530877|NCT02777554|532098070|FG000|Overall Study|Other - Miscellaneous|1|||
147530878|NCT02777554|532098071|FG001|Overall Study|Other - Miscellaneous|0|||
147530879|NCT02777554|532098072|FG002|Overall Study|Other - Miscellaneous|0|||
147530880|NCT02777554|532098073|FG003|Overall Study|Other - Miscellaneous|0|||
147530881|NCT02777554|532098074|FG004|Overall Study|Other - Miscellaneous|0|||
147530882|NCT02777554|532098075|FG005|Overall Study|Other - Miscellaneous|0|||
147530883|NCT02147132|532098076|FG000|Overall Study|Lost to Follow-up|1|||
147530884|NCT02147132|532098077|FG001|Overall Study|Lost to Follow-up|0|||
147530885|NCT02147132|532098078|FG002|Overall Study|Lost to Follow-up|0|||
147530886|NCT02147132|532098079|FG003|Overall Study|Lost to Follow-up|0|||
147530887|NCT01013207|532098080|FG000|CPAP Post Nexus (S9)|Lost to Follow-up|6|||
147530888|NCT01541644|532098085|FG000|Overall Study|Withdrawal by Subject|3|||
147530889|NCT01458535|532098088|FG000|Overall Study|Other|0|||
147530890|NCT01458535|532098089|FG001|Overall Study|Other|0|||
147530891|NCT01458535|532098090|FG002|Overall Study|Other|0|||
147530892|NCT01458535|532098091|FG003|Overall Study|Other|0|||
147530893|NCT01458535|532098092|FG004|Overall Study|Other|1|||
147530894|NCT01458535|532098093|FG005|Overall Study|Other|1|||
147530895|NCT01458535|532098088|FG000|Overall Study|Withdrawal by Subject|0|||
147530896|NCT01458535|532098089|FG001|Overall Study|Withdrawal by Subject|0|||
147530897|NCT01458535|532098090|FG002|Overall Study|Withdrawal by Subject|2|||
147530898|NCT01458535|532098091|FG003|Overall Study|Withdrawal by Subject|0|||
147530899|NCT01458535|532098092|FG004|Overall Study|Withdrawal by Subject|1|||
147530900|NCT01458535|532098093|FG005|Overall Study|Withdrawal by Subject|1|||
147530901|NCT01458535|532098088|FG000|Overall Study|Lost to Follow-up|0|||
147530902|NCT01458535|532098089|FG001|Overall Study|Lost to Follow-up|2|||
147530903|NCT01458535|532098090|FG002|Overall Study|Lost to Follow-up|0|||
147530904|NCT01458535|532098091|FG003|Overall Study|Lost to Follow-up|3|||
147530905|NCT01458535|532098092|FG004|Overall Study|Lost to Follow-up|2|||
147530906|NCT01458535|532098093|FG005|Overall Study|Lost to Follow-up|2|||
147530907|NCT01458535|532098088|FG000|Overall Study|Adverse Event|0|||
147530908|NCT01458535|532098089|FG001|Overall Study|Adverse Event|0|||
147530909|NCT01458535|532098090|FG002|Overall Study|Adverse Event|0|||
147530910|NCT01458535|532098091|FG003|Overall Study|Adverse Event|1|||
147530911|NCT01458535|532098092|FG004|Overall Study|Adverse Event|0|||
147530912|NCT01458535|532098093|FG005|Overall Study|Adverse Event|0|||
147530913|NCT02842736|532098094|FG000|Overall Study|Lost to Follow-up|13|||
147530914|NCT02842736|532098094|FG000|Overall Study|Intervention for menstrual bleeding|17|||
147530915|NCT02842736|532098094|FG000|Overall Study|Withdrawal by Subject|4|||
147530916|NCT02842736|532098094|FG000|Overall Study|Pregnancy|3|||
147530917|NCT02842736|532098094|FG000|Overall Study|Hysterectomy for fibroids|2|||
147530918|NCT02842736|532098094|FG000|Overall Study|Hysterectomy for uterine prolapse|1|||
147530919|NCT02842736|532098094|FG000|Overall Study|IUD: Mirena|1|||
147530920|NCT02064231|532098098|FG000|First Test Period (Test A or Test C)|Lack of Efficacy|5|||
147530921|NCT02064231|532098099|FG001|First Test Period (Test A or Test C)|Lack of Efficacy|3|||
147530922|NCT02064231|532098100|FG002|First Test Period (Test A or Test C)|Lack of Efficacy|0|||
147530923|NCT02064231|532098101|FG003|First Test Period (Test A or Test C)|Lack of Efficacy|0|||
147530924|NCT02064231|532098098|FG000|First Test Period (Test A or Test C)|Withdrawal by Subject|1|||
147530925|NCT02064231|532098099|FG001|First Test Period (Test A or Test C)|Withdrawal by Subject|1|||
147530926|NCT02064231|532098100|FG002|First Test Period (Test A or Test C)|Withdrawal by Subject|0|||
147530927|NCT02064231|532098101|FG003|First Test Period (Test A or Test C)|Withdrawal by Subject|0|||
147530928|NCT02064231|532098098|FG000|First Test Period (Test A or Test C)|Adverse Event|1|||
147530929|NCT02064231|532098099|FG001|First Test Period (Test A or Test C)|Adverse Event|0|||
147530930|NCT02064231|532098100|FG002|First Test Period (Test A or Test C)|Adverse Event|1|||
147530931|NCT02064231|532098101|FG003|First Test Period (Test A or Test C)|Adverse Event|0|||
147530932|NCT02064231|532098098|FG000|Second Test Period (Test B or Test D)|Lack of Efficacy|1|||
147530933|NCT02064231|532098099|FG001|Second Test Period (Test B or Test D)|Lack of Efficacy|1|||
147530934|NCT02064231|532098100|FG002|Second Test Period (Test B or Test D)|Lack of Efficacy|0|||
147530935|NCT02064231|532098101|FG003|Second Test Period (Test B or Test D)|Lack of Efficacy|0|||
147530936|NCT04854421|532098103|FG000|Overall Study|Removed from the final analysis due to poor image quality.|2|||
147530937|NCT04854421|532098104|FG001|Overall Study|Removed from the final analysis due to poor image quality.|2|||
147530938|NCT02322866|532098105|FG000|Overall Study|Adverse Event|6|||
147530939|NCT02322866|532098106|FG001|Overall Study|Adverse Event|11|||
147530940|NCT02322866|532098105|FG000|Overall Study|Withdrawal of Consent|16|||
147530941|NCT02322866|532098106|FG001|Overall Study|Withdrawal of Consent|25|||
147530942|NCT02322866|532098105|FG000|Overall Study|Lost to Follow-up|36|||
147530943|NCT02322866|532098106|FG001|Overall Study|Lost to Follow-up|39|||
147530944|NCT02322866|532098105|FG000|Overall Study|Protocol Violation|1|||
147530945|NCT02322866|532098106|FG001|Overall Study|Protocol Violation|0|||
147530946|NCT02322866|532098105|FG000|Overall Study|Noncompliance with Treatment|3|||
147530947|NCT02322866|532098106|FG001|Overall Study|Noncompliance with Treatment|4|||
147530948|NCT02322866|532098105|FG000|Overall Study|Lack of Efficacy|3|||
147530949|NCT02322866|532098106|FG001|Overall Study|Lack of Efficacy|1|||
147530950|NCT02322866|532098105|FG000|Overall Study|Other Miscellaneous Reasons|6|||
147530951|NCT02322866|532098106|FG001|Overall Study|Other Miscellaneous Reasons|6|||
147530952|NCT00718809|532098107|FG000|Overall Study|Disease progression|9|||
147530953|NCT00718809|532098108|FG001|Overall Study|Disease progression|7|||
147530954|NCT00718809|532098107|FG000|Overall Study|Adverse Event|1|||
147530955|NCT00718809|532098108|FG001|Overall Study|Adverse Event|1|||
147530956|NCT00718809|532098107|FG000|Overall Study|Withdrawal by Subject|0|||
147530957|NCT00718809|532098108|FG001|Overall Study|Withdrawal by Subject|1|||
147530958|NCT00718809|532098107|FG000|Overall Study|Lost to Follow-up|1|||
147530959|NCT00718809|532098108|FG001|Overall Study|Lost to Follow-up|0|||
147530960|NCT00718809|532098107|FG000|Overall Study|Noncompliance|1|||
147530961|NCT00718809|532098108|FG001|Overall Study|Noncompliance|0|||
147530962|NCT00463385|532098109|FG000|Overall Study|Other|4|||
147530963|NCT00463385|532098110|FG001|Overall Study|Other|3|||
147530964|NCT00463385|532098111|FG002|Overall Study|Other|6|||
147530965|NCT00463385|532098112|FG003|Overall Study|Other|4|||
147530966|NCT00463385|532098109|FG000|Overall Study|Adverse Event|5|||
147530967|NCT00463385|532098110|FG001|Overall Study|Adverse Event|8|||
147530968|NCT00463385|532098111|FG002|Overall Study|Adverse Event|4|||
147530969|NCT00463385|532098112|FG003|Overall Study|Adverse Event|2|||
147530970|NCT00463385|532098109|FG000|Overall Study|Lack of Efficacy|6|||
147530971|NCT00463385|532098110|FG001|Overall Study|Lack of Efficacy|6|||
147530972|NCT00463385|532098111|FG002|Overall Study|Lack of Efficacy|7|||
147530973|NCT00463385|532098112|FG003|Overall Study|Lack of Efficacy|9|||
147530974|NCT00463385|532098109|FG000|Overall Study|Withdrawal by Subject|3|||
147530975|NCT00463385|532098110|FG001|Overall Study|Withdrawal by Subject|3|||
147530976|NCT00463385|532098111|FG002|Overall Study|Withdrawal by Subject|3|||
147530977|NCT00463385|532098112|FG003|Overall Study|Withdrawal by Subject|4|||
147530978|NCT00463385|532098109|FG000|Overall Study|Lost to Follow-up|0|||
147530979|NCT00463385|532098110|FG001|Overall Study|Lost to Follow-up|0|||
147530980|NCT00463385|532098111|FG002|Overall Study|Lost to Follow-up|0|||
147530981|NCT00463385|532098112|FG003|Overall Study|Lost to Follow-up|1|||
147530982|NCT00463385|532098109|FG000|Overall Study|Death|2|||
147530983|NCT00463385|532098110|FG001|Overall Study|Death|1|||
147530984|NCT00463385|532098111|FG002|Overall Study|Death|2|||
147530985|NCT00463385|532098112|FG003|Overall Study|Death|0|||
147530986|NCT00463385|532098109|FG000|Overall Study|Missing|2|||
147530987|NCT00463385|532098110|FG001|Overall Study|Missing|0|||
147530988|NCT00463385|532098111|FG002|Overall Study|Missing|0|||
147530989|NCT00463385|532098112|FG003|Overall Study|Missing|2|||
147530990|NCT00463385|532098109|FG000|Overall Study|1 participant received commercial drug|0|||
147530991|NCT00463385|532098110|FG001|Overall Study|1 participant received commercial drug|1|||
147530992|NCT00463385|532098111|FG002|Overall Study|1 participant received commercial drug|0|||
147530993|NCT00463385|532098112|FG003|Overall Study|1 participant received commercial drug|0|||
147530994|NCT00798161|532098113|FG000|Overall Study|Adverse Event|3|||
147530995|NCT00798161|532098114|FG001|Overall Study|Adverse Event|4|||
147530996|NCT00798161|532098115|FG002|Overall Study|Adverse Event|6|||
147530997|NCT00798161|532098116|FG003|Overall Study|Adverse Event|6|||
147530998|NCT00798161|532098117|FG004|Overall Study|Adverse Event|5|||
147530999|NCT00798161|532098118|FG005|Overall Study|Adverse Event|2|||
147531000|NCT00798161|532098119|FG006|Overall Study|Adverse Event|4|||
147531001|NCT00798161|532098113|FG000|Overall Study|Protocol Violation|2|||
147531002|NCT00798161|532098114|FG001|Overall Study|Protocol Violation|1|||
147531003|NCT00798161|532098115|FG002|Overall Study|Protocol Violation|3|||
147531004|NCT00798161|532098116|FG003|Overall Study|Protocol Violation|3|||
147531005|NCT00798161|532098117|FG004|Overall Study|Protocol Violation|3|||
147531006|NCT00798161|532098118|FG005|Overall Study|Protocol Violation|2|||
147531007|NCT00798161|532098119|FG006|Overall Study|Protocol Violation|0|||
147531008|NCT00798161|532098113|FG000|Overall Study|Lost to Follow-up|1|||
147531009|NCT00798161|532098114|FG001|Overall Study|Lost to Follow-up|3|||
147531010|NCT00798161|532098115|FG002|Overall Study|Lost to Follow-up|4|||
147531011|NCT00798161|532098116|FG003|Overall Study|Lost to Follow-up|3|||
147531012|NCT00798161|532098117|FG004|Overall Study|Lost to Follow-up|4|||
147531013|NCT00798161|532098118|FG005|Overall Study|Lost to Follow-up|0|||
147531014|NCT00798161|532098119|FG006|Overall Study|Lost to Follow-up|0|||
147531015|NCT00798161|532098113|FG000|Overall Study|Withdrawal by Subject|5|||
147531016|NCT00798161|532098114|FG001|Overall Study|Withdrawal by Subject|4|||
147531017|NCT00798161|532098115|FG002|Overall Study|Withdrawal by Subject|5|||
147531018|NCT00798161|532098116|FG003|Overall Study|Withdrawal by Subject|4|||
147531019|NCT00798161|532098117|FG004|Overall Study|Withdrawal by Subject|2|||
147531020|NCT00798161|532098118|FG005|Overall Study|Withdrawal by Subject|3|||
147531021|NCT00798161|532098119|FG006|Overall Study|Withdrawal by Subject|1|||
147531022|NCT00798161|532098113|FG000|Overall Study|Other reason (incl. lack of efficacy)|7|||
147531023|NCT00798161|532098114|FG001|Overall Study|Other reason (incl. lack of efficacy)|5|||
147531024|NCT00798161|532098115|FG002|Overall Study|Other reason (incl. lack of efficacy)|3|||
147531025|NCT00798161|532098116|FG003|Overall Study|Other reason (incl. lack of efficacy)|5|||
147531026|NCT00798161|532098117|FG004|Overall Study|Other reason (incl. lack of efficacy)|2|||
147531027|NCT00798161|532098118|FG005|Overall Study|Other reason (incl. lack of efficacy)|4|||
147531028|NCT00798161|532098119|FG006|Overall Study|Other reason (incl. lack of efficacy)|5|||
147531029|NCT00344968|532098120|FG000|Overall Study|Adverse Event|5|||
147531030|NCT00344968|532098121|FG001|Overall Study|Adverse Event|4|||
147531031|NCT00344968|532098122|FG002|Overall Study|Adverse Event|15|||
147531032|NCT00344968|532098120|FG000|Overall Study|Unsatisfactory Therapeutic Effect|3|||
147531033|NCT00344968|532098121|FG001|Overall Study|Unsatisfactory Therapeutic Effect|0|||
147531034|NCT00344968|532098122|FG002|Overall Study|Unsatisfactory Therapeutic Effect|1|||
147531035|NCT00344968|532098120|FG000|Overall Study|Protocol Violation|2|||
147531036|NCT00344968|532098121|FG001|Overall Study|Protocol Violation|2|||
147531037|NCT00344968|532098122|FG002|Overall Study|Protocol Violation|5|||
147531038|NCT00344968|532098120|FG000|Overall Study|Withdrawal by Subject|14|||
147531039|NCT00344968|532098121|FG001|Overall Study|Withdrawal by Subject|31|||
147531040|NCT00344968|532098122|FG002|Overall Study|Withdrawal by Subject|27|||
147531041|NCT00344968|532098120|FG000|Overall Study|Lost to Follow-up|24|||
147531042|NCT00344968|532098121|FG001|Overall Study|Lost to Follow-up|37|||
147531043|NCT00344968|532098122|FG002|Overall Study|Lost to Follow-up|37|||
147531044|NCT00344968|532098120|FG000|Overall Study|Death|11|||
147531045|NCT00344968|532098121|FG001|Overall Study|Death|27|||
147531046|NCT00344968|532098122|FG002|Overall Study|Death|31|||
147531047|NCT00344968|532098120|FG000|Overall Study|Other|0|||
147531048|NCT00344968|532098121|FG001|Overall Study|Other|1|||
147531049|NCT00344968|532098122|FG002|Overall Study|Other|0|||
147531050|NCT03735680|532098123|FG000|Overall Study|Withdrawal by Subject|0|||
147531051|NCT03735680|532098124|FG001|Overall Study|Withdrawal by Subject|1|||
147531052|NCT03735680|532098125|FG002|Overall Study|Withdrawal by Subject|0|||
147531053|NCT03735680|532098126|FG003|Overall Study|Withdrawal by Subject|0|||
147531054|NCT03735680|532098127|FG004|Overall Study|Withdrawal by Subject|0|||
147531055|NCT03735680|532098128|FG005|Overall Study|Withdrawal by Subject|1|||
147531056|NCT03735680|532098123|FG000|Overall Study|Patient unable or unwilling to continue|0|||
147531057|NCT03735680|532098124|FG001|Overall Study|Patient unable or unwilling to continue|0|||
147531058|NCT03735680|532098125|FG002|Overall Study|Patient unable or unwilling to continue|1|||
147531059|NCT03735680|532098126|FG003|Overall Study|Patient unable or unwilling to continue|0|||
147531060|NCT03735680|532098127|FG004|Overall Study|Patient unable or unwilling to continue|0|||
147531061|NCT03735680|532098128|FG005|Overall Study|Patient unable or unwilling to continue|0|||
147531062|NCT04001790|532098140|FG000|Overall Study|Withdrawal by Subject|1|||
147531063|NCT04001790|532098141|FG001|Overall Study|Withdrawal by Subject|2|||
147531064|NCT05028816|532098143|FG000|Overall Study|Lost to Follow-up|5|||
147531065|NCT05028816|532098144|FG001|Overall Study|Lost to Follow-up|3|||
147531066|NCT05028816|532098143|FG000|Overall Study|Withdrawal by Subject|4|||
147531067|NCT05028816|532098144|FG001|Overall Study|Withdrawal by Subject|1|||
147531068|NCT05028816|532098143|FG000|Overall Study|Physician Decision|1|||
147531069|NCT05028816|532098144|FG001|Overall Study|Physician Decision|0|||
147531070|NCT04576702|532098146|FG000|Overall Study|Death|1|||
147531071|NCT04576702|532098147|FG001|Overall Study|Death|0|||
147531072|NCT04576702|532098148|FG002|Overall Study|Death|0|||
147531073|NCT04576702|532098149|FG003|Overall Study|Death|0|||
147531074|NCT04576702|532098146|FG000|Overall Study|Withdrawal by Subject|0|||
147531075|NCT04576702|532098147|FG001|Overall Study|Withdrawal by Subject|2|||
147531076|NCT04576702|532098148|FG002|Overall Study|Withdrawal by Subject|1|||
147531077|NCT04576702|532098149|FG003|Overall Study|Withdrawal by Subject|0|||
147531078|NCT04576702|532098146|FG000|Overall Study|Lost to Follow-up|3|||
147531079|NCT04576702|532098147|FG001|Overall Study|Lost to Follow-up|3|||
147531080|NCT04576702|532098148|FG002|Overall Study|Lost to Follow-up|3|||
147531081|NCT04576702|532098149|FG003|Overall Study|Lost to Follow-up|4|||
147531082|NCT02985996|532098153|FG000|Overall Study|Withdrawal by Subject|0|||
147531083|NCT02985996|532098154|FG001|Overall Study|Withdrawal by Subject|0|||
147531084|NCT02985996|532098155|FG002|Overall Study|Withdrawal by Subject|1|||
147531085|NCT02985996|532098156|FG003|Overall Study|Withdrawal by Subject|0|||
147531086|NCT02985996|532098157|FG004|Overall Study|Withdrawal by Subject|0|||
147531087|NCT02985996|532098153|FG000|Overall Study|Protocol Violation|0|||
147531088|NCT02985996|532098154|FG001|Overall Study|Protocol Violation|1|||
147531089|NCT02985996|532098155|FG002|Overall Study|Protocol Violation|0|||
147531090|NCT02985996|532098156|FG003|Overall Study|Protocol Violation|0|||
147531091|NCT02985996|532098157|FG004|Overall Study|Protocol Violation|0|||
147531092|NCT00401726|532098158|FG000|Overall Study|Adverse Event|34|||
147531093|NCT00401726|532098159|FG001|Overall Study|Adverse Event|45|||
147531094|NCT00401726|532098158|FG000|Overall Study|Death|0|||
147531095|NCT00401726|532098159|FG001|Overall Study|Death|3|||
147531096|NCT00401726|532098158|FG000|Overall Study|Sponsor Request|0|||
147531097|NCT00401726|532098159|FG001|Overall Study|Sponsor Request|1|||
147531098|NCT00401726|532098158|FG000|Overall Study|Physician Decision|3|||
147531099|NCT00401726|532098159|FG001|Overall Study|Physician Decision|6|||
147531100|NCT00401726|532098158|FG000|Overall Study|Lost to Follow-up|23|||
147531101|NCT00401726|532098159|FG001|Overall Study|Lost to Follow-up|20|||
147531102|NCT00401726|532098158|FG000|Overall Study|Protocol Violation|6|||
147531103|NCT00401726|532098159|FG001|Overall Study|Protocol Violation|3|||
147531104|NCT00401726|532098158|FG000|Overall Study|Withdrawal by Subject|18|||
147531105|NCT00401726|532098159|FG001|Overall Study|Withdrawal by Subject|24|||
147531106|NCT00401726|532098158|FG000|Overall Study|Lack of Efficacy|4|||
147531107|NCT00401726|532098159|FG001|Overall Study|Lack of Efficacy|6|||
147531108|NCT00401726|532098158|FG000|Overall Study|Protocol Deviation|9|||
147531109|NCT00401726|532098159|FG001|Overall Study|Protocol Deviation|4|||
147531110|NCT02067728|532098160|FG000|Baseline - 1 Month Follow up Survey|Lost to Follow-up|7|||
147531111|NCT02067728|532098161|FG001|Baseline - 1 Month Follow up Survey|Lost to Follow-up|28|||
147531112|NCT02067728|532098160|FG000|6 Month Follow up Survey|Lost to Follow-up|48|||
147531113|NCT02067728|532098161|FG001|6 Month Follow up Survey|Lost to Follow-up|60|||
147531114|NCT02067728|532098160|FG000|6 Month Measurements|Unable to attend|114|||
147531115|NCT02067728|532098161|FG001|6 Month Measurements|Unable to attend|97|||
147531116|NCT03532048|532098164|FG000|Overall Study|Lost to Follow-up|12|||
147531117|NCT03532048|532098165|FG001|Overall Study|Lost to Follow-up|17|||
147531118|NCT03532048|532098164|FG000|Overall Study|Withdrawal by Subject|7|||
147531119|NCT03532048|532098165|FG001|Overall Study|Withdrawal by Subject|0|||
147531120|NCT04629534|532098166|FG000|Overall Study|Physician Decision|1|||
147531121|NCT04629534|532098167|FG001|Overall Study|Physician Decision|0|||
147531122|NCT04629534|532098166|FG000|Overall Study|Protocol Violation|0|||
147531123|NCT04629534|532098167|FG001|Overall Study|Protocol Violation|2|||
147531124|NCT01901393|532098168|FG000|Overall Study|Adverse Event|1|||
147531125|NCT01901393|532098169|FG001|Overall Study|Adverse Event|0|||
147531126|NCT04113746|532098174|FG000|Overall Study|Lost to Follow-up|4|||
147531127|NCT04113746|532098175|FG001|Overall Study|Lost to Follow-up|4|||
147531128|NCT03125382|532098176|FG000|Randomization|screening failure|1|||
147531129|NCT03125382|532098177|FG001|Randomization|screening failure|4|||
147531130|NCT03125382|532098178|FG002|Randomization|screening failure|2|||
147531131|NCT03125382|532098179|FG003|Randomization|screening failure|0|||
147531132|NCT03125382|532098176|FG000|Follow-up|Death|1|||
147531133|NCT03125382|532098177|FG001|Follow-up|Death|2|||
147531134|NCT03125382|532098178|FG002|Follow-up|Death|1|||
147531135|NCT03125382|532098179|FG003|Follow-up|Death|2|||
147531136|NCT03125382|532098176|FG000|Follow-up|Lost to Follow-up|1|||
147531137|NCT03125382|532098177|FG001|Follow-up|Lost to Follow-up|4|||
147531138|NCT03125382|532098178|FG002|Follow-up|Lost to Follow-up|3|||
147531139|NCT03125382|532098179|FG003|Follow-up|Lost to Follow-up|1|||
147531140|NCT04246593|532098185|FG000|Overall Study|Withdrawal by Subject|14|||
147531141|NCT04246593|532098186|FG001|Overall Study|Withdrawal by Subject|13|||
147531142|NCT04246593|532098185|FG000|Overall Study|Lost to Follow-up|124|||
147531143|NCT04246593|532098186|FG001|Overall Study|Lost to Follow-up|71|||
147531144|NCT04246593|532098185|FG000|Overall Study|Moved out of area/became ineligible|3|||
147531145|NCT04246593|532098186|FG001|Overall Study|Moved out of area/became ineligible|1|||
147531146|NCT04246593|532098185|FG000|Overall Study|Reason unknown|4|||
147531147|NCT04246593|532098186|FG001|Overall Study|Reason unknown|2|||
147531148|NCT00265109|532098187|FG000|Overall Study|Withdrawal by Subject|5|||
147531149|NCT00265109|532098187|FG000|Overall Study|Adverse Event|1|||
147531150|NCT01049360|532098190|FG000|Period 1|Adverse Event|0|||
147531151|NCT01049360|532098191|FG001|Period 1|Adverse Event|1|||
147531152|NCT01049360|532098192|FG002|Period 1|Adverse Event|0|||
147531153|NCT01049360|532098193|FG003|Period 1|Adverse Event|1|||
147531154|NCT01049360|532098194|FG004|Period 1|Adverse Event|0|||
147531155|NCT01049360|532098195|FG005|Period 1|Adverse Event|0|||
147531156|NCT01049360|532098196|FG006|Period 1|Adverse Event|0|||
147531157|NCT01049360|532098197|FG007|Period 1|Adverse Event|1|||
147531158|NCT01049360|532098198|FG008|Period 1|Adverse Event|0|||
147531159|NCT01049360|532098199|FG009|Period 1|Adverse Event|0|||
147531160|NCT01049360|532098200|FG010|Period 1|Adverse Event|0|||
147531161|NCT01049360|532098201|FG011|Period 1|Adverse Event|0|||
147531162|NCT01049360|532098202|FG012|Period 1|Adverse Event|1|||
147531163|NCT01049360|532098203|FG013|Period 1|Adverse Event|1|||
147531164|NCT01049360|532098204|FG014|Period 1|Adverse Event|0|||
147531165|NCT01049360|532098205|FG015|Period 1|Adverse Event|0|||
147531166|NCT01049360|532098206|FG016|Period 1|Adverse Event|1|||
147531167|NCT01049360|532098207|FG017|Period 1|Adverse Event|0|||
147531168|NCT01049360|532098208|FG018|Period 1|Adverse Event|1|||
147531169|NCT01049360|532098209|FG019|Period 1|Adverse Event|0|||
147531170|NCT01049360|532098190|FG000|Period 1|Did not meet inc/exc criteria|0|||
147531171|NCT01049360|532098191|FG001|Period 1|Did not meet inc/exc criteria|0|||
147531172|NCT01049360|532098192|FG002|Period 1|Did not meet inc/exc criteria|0|||
147531173|NCT01049360|532098193|FG003|Period 1|Did not meet inc/exc criteria|0|||
147531174|NCT01049360|532098194|FG004|Period 1|Did not meet inc/exc criteria|0|||
147531175|NCT01049360|532098195|FG005|Period 1|Did not meet inc/exc criteria|0|||
147531176|NCT01049360|532098196|FG006|Period 1|Did not meet inc/exc criteria|0|||
147531177|NCT01049360|532098197|FG007|Period 1|Did not meet inc/exc criteria|1|||
147531178|NCT01049360|532098198|FG008|Period 1|Did not meet inc/exc criteria|1|||
147531179|NCT01049360|532098199|FG009|Period 1|Did not meet inc/exc criteria|0|||
147531180|NCT01049360|532098200|FG010|Period 1|Did not meet inc/exc criteria|0|||
147531181|NCT01049360|532098201|FG011|Period 1|Did not meet inc/exc criteria|0|||
147531182|NCT01049360|532098202|FG012|Period 1|Did not meet inc/exc criteria|0|||
147531183|NCT01049360|532098203|FG013|Period 1|Did not meet inc/exc criteria|0|||
147531184|NCT01049360|532098204|FG014|Period 1|Did not meet inc/exc criteria|0|||
147531185|NCT01049360|532098205|FG015|Period 1|Did not meet inc/exc criteria|0|||
147531186|NCT01049360|532098206|FG016|Period 1|Did not meet inc/exc criteria|0|||
147531187|NCT01049360|532098207|FG017|Period 1|Did not meet inc/exc criteria|0|||
147531188|NCT01049360|532098208|FG018|Period 1|Did not meet inc/exc criteria|0|||
147531189|NCT01049360|532098209|FG019|Period 1|Did not meet inc/exc criteria|0|||
147531190|NCT01049360|532098190|FG000|Period 1|Withdrawal by Subject|0|||
147531191|NCT01049360|532098191|FG001|Period 1|Withdrawal by Subject|0|||
147531192|NCT01049360|532098192|FG002|Period 1|Withdrawal by Subject|0|||
147531193|NCT01049360|532098193|FG003|Period 1|Withdrawal by Subject|0|||
147531194|NCT01049360|532098194|FG004|Period 1|Withdrawal by Subject|0|||
147531195|NCT01049360|532098195|FG005|Period 1|Withdrawal by Subject|0|||
147531196|NCT01049360|532098196|FG006|Period 1|Withdrawal by Subject|0|||
147531197|NCT01049360|532098197|FG007|Period 1|Withdrawal by Subject|0|||
147531198|NCT01049360|532098198|FG008|Period 1|Withdrawal by Subject|1|||
147531199|NCT01049360|532098199|FG009|Period 1|Withdrawal by Subject|0|||
147531200|NCT01049360|532098200|FG010|Period 1|Withdrawal by Subject|1|||
147531201|NCT01049360|532098201|FG011|Period 1|Withdrawal by Subject|0|||
147531202|NCT01049360|532098202|FG012|Period 1|Withdrawal by Subject|1|||
147531203|NCT01049360|532098203|FG013|Period 1|Withdrawal by Subject|0|||
147531204|NCT01049360|532098204|FG014|Period 1|Withdrawal by Subject|0|||
147531205|NCT01049360|532098205|FG015|Period 1|Withdrawal by Subject|0|||
147531206|NCT01049360|532098206|FG016|Period 1|Withdrawal by Subject|0|||
147531207|NCT01049360|532098207|FG017|Period 1|Withdrawal by Subject|0|||
147531208|NCT01049360|532098208|FG018|Period 1|Withdrawal by Subject|0|||
147531209|NCT01049360|532098209|FG019|Period 1|Withdrawal by Subject|0|||
147531210|NCT01049360|532098190|FG000|Period 2|Protocol Violation|0|||
147531211|NCT01049360|532098191|FG001|Period 2|Protocol Violation|0|||
147531212|NCT01049360|532098192|FG002|Period 2|Protocol Violation|0|||
147531213|NCT01049360|532098193|FG003|Period 2|Protocol Violation|1|||
147531214|NCT01049360|532098194|FG004|Period 2|Protocol Violation|0|||
147531215|NCT01049360|532098195|FG005|Period 2|Protocol Violation|0|||
147531216|NCT01049360|532098196|FG006|Period 2|Protocol Violation|0|||
147531217|NCT01049360|532098197|FG007|Period 2|Protocol Violation|0|||
147531218|NCT01049360|532098198|FG008|Period 2|Protocol Violation|0|||
147531219|NCT01049360|532098199|FG009|Period 2|Protocol Violation|0|||
147531220|NCT01049360|532098200|FG010|Period 2|Protocol Violation|0|||
147531221|NCT01049360|532098201|FG011|Period 2|Protocol Violation|0|||
147531222|NCT01049360|532098202|FG012|Period 2|Protocol Violation|0|||
147531223|NCT01049360|532098203|FG013|Period 2|Protocol Violation|0|||
147531224|NCT01049360|532098204|FG014|Period 2|Protocol Violation|1|||
147531225|NCT01049360|532098205|FG015|Period 2|Protocol Violation|1|||
147531226|NCT01049360|532098206|FG016|Period 2|Protocol Violation|0|||
147531227|NCT01049360|532098207|FG017|Period 2|Protocol Violation|0|||
147531228|NCT01049360|532098208|FG018|Period 2|Protocol Violation|0|||
147531229|NCT01049360|532098209|FG019|Period 2|Protocol Violation|0|||
147531230|NCT01049360|532098190|FG000|Period 2|Adverse Event|0|||
147531231|NCT01049360|532098191|FG001|Period 2|Adverse Event|1|||
147531232|NCT01049360|532098192|FG002|Period 2|Adverse Event|0|||
147531233|NCT01049360|532098193|FG003|Period 2|Adverse Event|0|||
147531234|NCT01049360|532098194|FG004|Period 2|Adverse Event|0|||
147531235|NCT01049360|532098195|FG005|Period 2|Adverse Event|0|||
147531236|NCT01049360|532098196|FG006|Period 2|Adverse Event|0|||
147531237|NCT01049360|532098197|FG007|Period 2|Adverse Event|0|||
147531238|NCT01049360|532098198|FG008|Period 2|Adverse Event|1|||
147531239|NCT01049360|532098199|FG009|Period 2|Adverse Event|0|||
147531240|NCT01049360|532098200|FG010|Period 2|Adverse Event|0|||
147531241|NCT01049360|532098201|FG011|Period 2|Adverse Event|0|||
147531242|NCT01049360|532098202|FG012|Period 2|Adverse Event|0|||
147531243|NCT01049360|532098203|FG013|Period 2|Adverse Event|0|||
147531244|NCT01049360|532098204|FG014|Period 2|Adverse Event|0|||
147531245|NCT01049360|532098205|FG015|Period 2|Adverse Event|0|||
147531246|NCT01049360|532098206|FG016|Period 2|Adverse Event|0|||
147531247|NCT01049360|532098207|FG017|Period 2|Adverse Event|0|||
147531248|NCT01049360|532098208|FG018|Period 2|Adverse Event|0|||
147531249|NCT01049360|532098209|FG019|Period 2|Adverse Event|1|||
147531250|NCT01049360|532098190|FG000|Period 2|Withdrawal by Subject|0|||
147531251|NCT01049360|532098191|FG001|Period 2|Withdrawal by Subject|0|||
147531252|NCT01049360|532098192|FG002|Period 2|Withdrawal by Subject|0|||
147531253|NCT01049360|532098193|FG003|Period 2|Withdrawal by Subject|1|||
147531254|NCT01049360|532098194|FG004|Period 2|Withdrawal by Subject|0|||
147531255|NCT01049360|532098195|FG005|Period 2|Withdrawal by Subject|0|||
147531256|NCT01049360|532098196|FG006|Period 2|Withdrawal by Subject|0|||
147531257|NCT01049360|532098197|FG007|Period 2|Withdrawal by Subject|0|||
147531258|NCT01049360|532098198|FG008|Period 2|Withdrawal by Subject|0|||
147531259|NCT01049360|532098199|FG009|Period 2|Withdrawal by Subject|0|||
147531260|NCT01049360|532098200|FG010|Period 2|Withdrawal by Subject|0|||
147531261|NCT01049360|532098201|FG011|Period 2|Withdrawal by Subject|0|||
147531262|NCT01049360|532098202|FG012|Period 2|Withdrawal by Subject|0|||
147531263|NCT01049360|532098203|FG013|Period 2|Withdrawal by Subject|0|||
147531264|NCT01049360|532098204|FG014|Period 2|Withdrawal by Subject|1|||
147531265|NCT01049360|532098205|FG015|Period 2|Withdrawal by Subject|0|||
147531266|NCT01049360|532098206|FG016|Period 2|Withdrawal by Subject|0|||
147531267|NCT01049360|532098207|FG017|Period 2|Withdrawal by Subject|0|||
147531268|NCT01049360|532098208|FG018|Period 2|Withdrawal by Subject|0|||
147531269|NCT01049360|532098209|FG019|Period 2|Withdrawal by Subject|1|||
147531270|NCT01049360|532098190|FG000|Period 2|Lack of Efficacy|0|||
147531271|NCT01049360|532098191|FG001|Period 2|Lack of Efficacy|0|||
147531272|NCT01049360|532098192|FG002|Period 2|Lack of Efficacy|0|||
147531273|NCT01049360|532098193|FG003|Period 2|Lack of Efficacy|0|||
147531274|NCT01049360|532098194|FG004|Period 2|Lack of Efficacy|0|||
147531275|NCT01049360|532098195|FG005|Period 2|Lack of Efficacy|1|||
147531276|NCT01049360|532098196|FG006|Period 2|Lack of Efficacy|0|||
147531277|NCT01049360|532098197|FG007|Period 2|Lack of Efficacy|0|||
147531278|NCT01049360|532098198|FG008|Period 2|Lack of Efficacy|0|||
147531279|NCT01049360|532098199|FG009|Period 2|Lack of Efficacy|0|||
147531280|NCT01049360|532098200|FG010|Period 2|Lack of Efficacy|0|||
147531281|NCT01049360|532098201|FG011|Period 2|Lack of Efficacy|0|||
147531282|NCT01049360|532098202|FG012|Period 2|Lack of Efficacy|0|||
147531283|NCT01049360|532098203|FG013|Period 2|Lack of Efficacy|0|||
147531284|NCT01049360|532098204|FG014|Period 2|Lack of Efficacy|0|||
147531285|NCT01049360|532098205|FG015|Period 2|Lack of Efficacy|0|||
147531286|NCT01049360|532098206|FG016|Period 2|Lack of Efficacy|0|||
147531287|NCT01049360|532098207|FG017|Period 2|Lack of Efficacy|0|||
147531288|NCT01049360|532098208|FG018|Period 2|Lack of Efficacy|0|||
147531289|NCT01049360|532098209|FG019|Period 2|Lack of Efficacy|0|||
147531290|NCT01049360|532098190|FG000|Period 4|Protocol Violation|0|||
147531291|NCT01049360|532098191|FG001|Period 4|Protocol Violation|0|||
147531292|NCT01049360|532098192|FG002|Period 4|Protocol Violation|0|||
147531293|NCT01049360|532098193|FG003|Period 4|Protocol Violation|0|||
147531294|NCT01049360|532098194|FG004|Period 4|Protocol Violation|0|||
147531295|NCT01049360|532098195|FG005|Period 4|Protocol Violation|0|||
147531296|NCT01049360|532098196|FG006|Period 4|Protocol Violation|0|||
147531297|NCT01049360|532098197|FG007|Period 4|Protocol Violation|0|||
147531298|NCT01049360|532098198|FG008|Period 4|Protocol Violation|0|||
147531299|NCT01049360|532098199|FG009|Period 4|Protocol Violation|0|||
147531300|NCT01049360|532098200|FG010|Period 4|Protocol Violation|0|||
147531301|NCT01049360|532098201|FG011|Period 4|Protocol Violation|0|||
147531302|NCT01049360|532098202|FG012|Period 4|Protocol Violation|0|||
147531303|NCT01049360|532098203|FG013|Period 4|Protocol Violation|0|||
147531304|NCT01049360|532098204|FG014|Period 4|Protocol Violation|0|||
147531305|NCT01049360|532098205|FG015|Period 4|Protocol Violation|0|||
147531306|NCT01049360|532098206|FG016|Period 4|Protocol Violation|0|||
147531307|NCT01049360|532098207|FG017|Period 4|Protocol Violation|1|||
147531308|NCT01049360|532098208|FG018|Period 4|Protocol Violation|0|||
147531309|NCT01049360|532098209|FG019|Period 4|Protocol Violation|0|||
147531310|NCT01049360|532098190|FG000|Period 4|Withdrawal by Subject|0|||
147531311|NCT01049360|532098191|FG001|Period 4|Withdrawal by Subject|0|||
147531312|NCT01049360|532098192|FG002|Period 4|Withdrawal by Subject|0|||
147531313|NCT01049360|532098193|FG003|Period 4|Withdrawal by Subject|1|||
147531314|NCT01049360|532098194|FG004|Period 4|Withdrawal by Subject|0|||
147531315|NCT01049360|532098195|FG005|Period 4|Withdrawal by Subject|0|||
147531316|NCT01049360|532098196|FG006|Period 4|Withdrawal by Subject|0|||
147531317|NCT01049360|532098197|FG007|Period 4|Withdrawal by Subject|0|||
147531318|NCT01049360|532098198|FG008|Period 4|Withdrawal by Subject|0|||
147531319|NCT01049360|532098199|FG009|Period 4|Withdrawal by Subject|0|||
147531320|NCT01049360|532098200|FG010|Period 4|Withdrawal by Subject|0|||
147531321|NCT01049360|532098201|FG011|Period 4|Withdrawal by Subject|0|||
147531322|NCT01049360|532098202|FG012|Period 4|Withdrawal by Subject|0|||
147531323|NCT01049360|532098203|FG013|Period 4|Withdrawal by Subject|0|||
147531324|NCT01049360|532098204|FG014|Period 4|Withdrawal by Subject|0|||
147531325|NCT01049360|532098205|FG015|Period 4|Withdrawal by Subject|0|||
147531326|NCT01049360|532098206|FG016|Period 4|Withdrawal by Subject|0|||
147531327|NCT01049360|532098207|FG017|Period 4|Withdrawal by Subject|0|||
147531328|NCT01049360|532098208|FG018|Period 4|Withdrawal by Subject|0|||
147531329|NCT01049360|532098209|FG019|Period 4|Withdrawal by Subject|0|||
147531330|NCT00429026|532098210|FG000|Overall Study|Inevaluable for response.|40|||
147531331|NCT00903357|532098213|FG000|First Intervention|Withdrawal by Subject|5|||
147531332|NCT00903357|532098214|FG001|First Intervention|Withdrawal by Subject|3|||
147531333|NCT00903357|532098213|FG000|First Intervention|Flu|0|||
147531334|NCT00903357|532098214|FG001|First Intervention|Flu|1|||
147531335|NCT00903357|532098213|FG000|Wash Out Period of 2 Weeks|Flu|0|||
147531336|NCT00903357|532098214|FG001|Wash Out Period of 2 Weeks|Flu|1|||
147531337|NCT00903357|532098213|FG000|Second Intervention|Lost to Follow-up|1|||
147531338|NCT00903357|532098214|FG001|Second Intervention|Lost to Follow-up|0|||
147531339|NCT00678652|532098217|FG000|Overall Study|Protocol Violation|2|||
147531340|NCT00678652|532098218|FG001|Overall Study|Protocol Violation|0|||
147531341|NCT00678652|532098219|FG002|Overall Study|Protocol Violation|0|||
147531342|NCT00678652|532098220|FG003|Overall Study|Protocol Violation|0|||
147531343|NCT00678652|532098217|FG000|Overall Study|Pregnancy|0|||
147531344|NCT00678652|532098218|FG001|Overall Study|Pregnancy|0|||
147531345|NCT00678652|532098219|FG002|Overall Study|Pregnancy|1|||
147531346|NCT00678652|532098220|FG003|Overall Study|Pregnancy|0|||
147531347|NCT00678652|532098217|FG000|Overall Study|Relocation|1|||
147531348|NCT00678652|532098218|FG001|Overall Study|Relocation|0|||
147531349|NCT00678652|532098219|FG002|Overall Study|Relocation|0|||
147531350|NCT00678652|532098220|FG003|Overall Study|Relocation|0|||
147531351|NCT00674440|532098221|FG000|Overall Study|consented but not scanned (Withdrawn due to genetics)|1|||
147531352|NCT00674440|532098221|FG000|Overall Study|did not have surgery, so unevaluable|7|||
147531353|NCT00674440|532098221|FG000|Overall Study|had atypical histology or had second PET scan after initial surgery - not counted twice|3|||
147531354|NCT01990339|532098224|FG000|Overall Study|Data Not Available|49|||
147531355|NCT01990339|532098224|FG000|Overall Study|Voluntary Withdrawal|1402|||
147531356|NCT01990339|532098224|FG000|Overall Study|Lost to Follow-up|861|||
147531357|NCT02129192|532098225|FG000|Period 1 Including Washout Period|Withdrawal by Subject|0|||
147531358|NCT02129192|532098226|FG001|Period 1 Including Washout Period|Withdrawal by Subject|1|||
147531359|NCT01231620|532098227|FG000|Overall Study|Physician Decision|3|||
147531360|NCT01231620|532098228|FG001|Overall Study|Physician Decision|5|||
147531361|NCT01231620|532098229|FG002|Overall Study|Physician Decision|10|||
147531362|NCT01231620|532098227|FG000|Overall Study|Death|12|||
147531363|NCT01231620|532098228|FG001|Overall Study|Death|14|||
147531364|NCT01231620|532098229|FG002|Overall Study|Death|11|||
147531365|NCT01231620|532098227|FG000|Overall Study|Adverse Event|2|||
147531366|NCT01231620|532098228|FG001|Overall Study|Adverse Event|2|||
147531367|NCT01231620|532098229|FG002|Overall Study|Adverse Event|1|||
147531368|NCT01231620|532098227|FG000|Overall Study|Withdrawal by Subject|6|||
147531369|NCT01231620|532098228|FG001|Overall Study|Withdrawal by Subject|6|||
147531370|NCT01231620|532098229|FG002|Overall Study|Withdrawal by Subject|8|||
147531371|NCT01231620|532098227|FG000|Overall Study|Lost to Follow-up|3|||
147531372|NCT01231620|532098228|FG001|Overall Study|Lost to Follow-up|4|||
147531373|NCT01231620|532098229|FG002|Overall Study|Lost to Follow-up|9|||
147531374|NCT02441517|532098232|FG000|Overall Study|Lost to Follow-up|1|||
147531375|NCT02441517|532098232|FG000|Overall Study|Withdrawal by Subject|2|||
147531376|NCT02441517|532098232|FG000|Overall Study|Study Terminated by Sponsor|1|||
147531377|NCT01393444|532098233|FG000|Overall Study|Withdrawal by Subject|1|||
147531378|NCT01393444|532098233|FG000|Overall Study|Determined ineligible during screening.|2|||
147531379|NCT03039699|532098234|FG000|Overall Study|Incorrect inclusion|5|||
147531380|NCT03039699|532098235|FG001|Overall Study|Incorrect inclusion|4|||
147531381|NCT03039699|532098234|FG000|Overall Study|Lack of data to assess study endpoint|5|||
147531382|NCT03039699|532098235|FG001|Overall Study|Lack of data to assess study endpoint|3|||
147531383|NCT03039699|532098234|FG000|Overall Study|Bacterial infection|12|||
147531384|NCT03039699|532098235|FG001|Overall Study|Bacterial infection|28|||
147531385|NCT01302366|532099685|FG000|Overall Study|patient choice or noncompliance|5|||
147531386|NCT00467051|532099686|FG000|Overall Study|Adverse Event|2|||
147531387|NCT00066573|532099689|FG000|Overall Study|Did not received protocol treatment|28|||
147531388|NCT00066573|532099690|FG001|Overall Study|Did not received protocol treatment|28|||
147531389|NCT00503035|532099691|FG000|Overall Study|Lost to Follow-up|2|||
147531390|NCT00503035|532099691|FG000|Overall Study|Physician Decision|3|||
147531391|NCT00503035|532099691|FG000|Overall Study|Ineligible|15|||
147531392|NCT04579666|532099692|FG000|RTP (Up to Week 52)|Adverse Event|4|||
147531393|NCT04579666|532099693|FG001|RTP (Up to Week 52)|Adverse Event|3|||
147531394|NCT04579666|532099694|FG002|RTP (Up to Week 52)|Adverse Event|0|||
147531395|NCT04579666|532099695|FG003|RTP (Up to Week 52)|Adverse Event|0|||
147531396|NCT04579666|532099692|FG000|RTP (Up to Week 52)|Death|24|||
147531397|NCT04579666|532099693|FG001|RTP (Up to Week 52)|Death|9|||
147531398|NCT04579666|532099694|FG002|RTP (Up to Week 52)|Death|0|||
147531399|NCT04579666|532099695|FG003|RTP (Up to Week 52)|Death|0|||
147531400|NCT04579666|532099692|FG000|RTP (Up to Week 52)|Lost to Follow-up|1|||
147531401|NCT04579666|532099693|FG001|RTP (Up to Week 52)|Lost to Follow-up|0|||
147531402|NCT04579666|532099694|FG002|RTP (Up to Week 52)|Lost to Follow-up|0|||
147531403|NCT04579666|532099695|FG003|RTP (Up to Week 52)|Lost to Follow-up|0|||
147531404|NCT04579666|532099692|FG000|RTP (Up to Week 52)|Physician Decision|4|||
147531405|NCT04579666|532099693|FG001|RTP (Up to Week 52)|Physician Decision|1|||
147531406|NCT04579666|532099694|FG002|RTP (Up to Week 52)|Physician Decision|0|||
147531407|NCT04579666|532099695|FG003|RTP (Up to Week 52)|Physician Decision|0|||
147531408|NCT04579666|532099692|FG000|RTP (Up to Week 52)|Progressive disease|1|||
147531409|NCT04579666|532099693|FG001|RTP (Up to Week 52)|Progressive disease|0|||
147531410|NCT04579666|532099694|FG002|RTP (Up to Week 52)|Progressive disease|0|||
147531411|NCT04579666|532099695|FG003|RTP (Up to Week 52)|Progressive disease|0|||
147531412|NCT04579666|532099692|FG000|RTP (Up to Week 52)|Site terminated by sponsor|7|||
147531413|NCT04579666|532099693|FG001|RTP (Up to Week 52)|Site terminated by sponsor|5|||
147531414|NCT04579666|532099694|FG002|RTP (Up to Week 52)|Site terminated by sponsor|0|||
147531415|NCT04579666|532099695|FG003|RTP (Up to Week 52)|Site terminated by sponsor|0|||
147531416|NCT04579666|532099692|FG000|RTP (Up to Week 52)|Study terminated by sponsor|2|||
147531417|NCT04579666|532099693|FG001|RTP (Up to Week 52)|Study terminated by sponsor|0|||
147531418|NCT04579666|532099694|FG002|RTP (Up to Week 52)|Study terminated by sponsor|0|||
147531419|NCT04579666|532099695|FG003|RTP (Up to Week 52)|Study terminated by sponsor|0|||
147531420|NCT04579666|532099692|FG000|RTP (Up to Week 52)|Withdrawal by Subject|25|||
147531421|NCT04579666|532099693|FG001|RTP (Up to Week 52)|Withdrawal by Subject|11|||
147531422|NCT04579666|532099694|FG002|RTP (Up to Week 52)|Withdrawal by Subject|0|||
147531423|NCT04579666|532099695|FG003|RTP (Up to Week 52)|Withdrawal by Subject|0|||
147531424|NCT04579666|532099692|FG000|RTP (Up to Week 52)|Other|2|||
147531425|NCT04579666|532099693|FG001|RTP (Up to Week 52)|Other|0|||
147531426|NCT04579666|532099694|FG002|RTP (Up to Week 52)|Other|0|||
147531427|NCT04579666|532099695|FG003|RTP (Up to Week 52)|Other|0|||
147531428|NCT04579666|532099692|FG000|OLP (From Week 52 up to Week 104)|Adverse Event|0|||
147531429|NCT04579666|532099693|FG001|OLP (From Week 52 up to Week 104)|Adverse Event|0|||
147531430|NCT04579666|532099694|FG002|OLP (From Week 52 up to Week 104)|Adverse Event|2|||
147531431|NCT04579666|532099695|FG003|OLP (From Week 52 up to Week 104)|Adverse Event|0|||
147531432|NCT04579666|532099692|FG000|OLP (From Week 52 up to Week 104)|Withdrawal by Subject|0|||
147531433|NCT04579666|532099693|FG001|OLP (From Week 52 up to Week 104)|Withdrawal by Subject|0|||
147531434|NCT04579666|532099694|FG002|OLP (From Week 52 up to Week 104)|Withdrawal by Subject|19|||
147531435|NCT04579666|532099695|FG003|OLP (From Week 52 up to Week 104)|Withdrawal by Subject|12|||
147531436|NCT04579666|532099692|FG000|OLP (From Week 52 up to Week 104)|Sponsor request|0|||
147531437|NCT04579666|532099693|FG001|OLP (From Week 52 up to Week 104)|Sponsor request|0|||
147531438|NCT04579666|532099694|FG002|OLP (From Week 52 up to Week 104)|Sponsor request|63|||
147531439|NCT04579666|532099695|FG003|OLP (From Week 52 up to Week 104)|Sponsor request|31|||
147531440|NCT04579666|532099692|FG000|OLP (From Week 52 up to Week 104)|Physician Decision|0|||
147531441|NCT04579666|532099693|FG001|OLP (From Week 52 up to Week 104)|Physician Decision|0|||
147531442|NCT04579666|532099694|FG002|OLP (From Week 52 up to Week 104)|Physician Decision|3|||
147531443|NCT04579666|532099695|FG003|OLP (From Week 52 up to Week 104)|Physician Decision|1|||
147531444|NCT04579666|532099692|FG000|OLP (From Week 52 up to Week 104)|Death|0|||
147531445|NCT04579666|532099693|FG001|OLP (From Week 52 up to Week 104)|Death|0|||
147531446|NCT04579666|532099694|FG002|OLP (From Week 52 up to Week 104)|Death|10|||
147531447|NCT04579666|532099695|FG003|OLP (From Week 52 up to Week 104)|Death|6|||
147531448|NCT00465101|532099696|FG000|Overall Study|Aborted Proc./Treatment Not Attempted|3|||
147531449|NCT00465101|532099696|FG000|Overall Study|Change in health precluded follow up|4|||
147531450|NCT00465101|532099696|FG000|Overall Study|Did not meet study criteria|4|||
147531451|NCT00465101|532099696|FG000|Overall Study|Lost to Follow-up|5|||
147531452|NCT00465101|532099696|FG000|Overall Study|Other|6|||
147531453|NCT00465101|532099696|FG000|Overall Study|Pt. Insurance not accepted at center|2|||
147531454|NCT00465101|532099696|FG000|Overall Study|Patient postponed procedure|1|||
147531455|NCT00465101|532099696|FG000|Overall Study|Site closed due to IRB expiration|1|||
147531456|NCT00465101|532099696|FG000|Overall Study|Unable to obtain IRB approval|1|||
147531457|NCT00465101|532099696|FG000|Overall Study|Death|3|||
147531458|NCT00465101|532099696|FG000|Overall Study|Withdrawal by Subject|25|||
147531459|NCT00465101|532099696|FG000|Overall Study|Physician Decision|1|||
147531460|NCT00465101|532099696|FG000|Overall Study|Withdrew consent prior to procedure|3|||
147531461|NCT03099096|532099697|FG000|Overall Study|Adverse Event|1|||
147531462|NCT03099096|532099697|FG000|Overall Study|Physician Decision|1|||
147531463|NCT01050998|532099699|FG000|Overall Study|Adverse Event|1|||
147531464|NCT01050998|532099700|FG001|Overall Study|Adverse Event|0|||
147531465|NCT01050998|532099701|FG002|Overall Study|Adverse Event|1|||
147531466|NCT01050998|532099702|FG003|Overall Study|Adverse Event|0|||
147531467|NCT01050998|532099703|FG004|Overall Study|Adverse Event|2|||
147531468|NCT01050998|532099699|FG000|Overall Study|Withdrawal by Subject|0|||
147531469|NCT01050998|532099700|FG001|Overall Study|Withdrawal by Subject|0|||
147531470|NCT01050998|532099701|FG002|Overall Study|Withdrawal by Subject|0|||
147531471|NCT01050998|532099702|FG003|Overall Study|Withdrawal by Subject|1|||
147531472|NCT01050998|532099703|FG004|Overall Study|Withdrawal by Subject|3|||
147531473|NCT01050998|532099699|FG000|Overall Study|Other|3|||
147531474|NCT01050998|532099700|FG001|Overall Study|Other|2|||
147531475|NCT01050998|532099701|FG002|Overall Study|Other|1|||
147531476|NCT01050998|532099702|FG003|Overall Study|Other|1|||
147531477|NCT01050998|532099703|FG004|Overall Study|Other|5|||
147531478|NCT01050998|532099699|FG000|Overall Study|Data integrity issues|0|||
147531479|NCT01050998|532099700|FG001|Overall Study|Data integrity issues|0|||
147531480|NCT01050998|532099701|FG002|Overall Study|Data integrity issues|1|||
147531481|NCT01050998|532099702|FG003|Overall Study|Data integrity issues|1|||
147531482|NCT01050998|532099703|FG004|Overall Study|Data integrity issues|4|||
147531483|NCT00234533|532099706|FG000|Overall Study|Withdrawal by Subject|6|||
147531484|NCT00234533|532099706|FG000|Overall Study|Adverse Event|2|||
147531485|NCT00234533|532099706|FG000|Overall Study|Enrolled but not treated|3|||
147531486|NCT02967055|532099707|FG000|Overall Study|Excluded|40|||
147531487|NCT02967055|532099707|FG000|Overall Study|Screen fail|3|||
147531488|NCT02967055|532099707|FG000|Overall Study|Lost to Follow-up|2|||
147531489|NCT02967055|532099707|FG000|Overall Study|Stopped due to side effects|3|||
147531490|NCT02967055|532099707|FG000|Overall Study|Stopped due to drug cost|1|||
147531491|NCT00976989|532099708|FG000|Overall Study|Violation of Selection Criteria at Entry|1|||
147531492|NCT00976989|532099709|FG001|Overall Study|Violation of Selection Criteria at Entry|0|||
147531493|NCT00976989|532099710|FG002|Overall Study|Violation of Selection Criteria at Entry|1|||
147531494|NCT00976989|532099708|FG000|Overall Study|Death|5|||
147531495|NCT00976989|532099709|FG001|Overall Study|Death|7|||
147531496|NCT00976989|532099710|FG002|Overall Study|Death|10|||
147531497|NCT00976989|532099708|FG000|Overall Study|Refused Treatment|4|||
147531498|NCT00976989|532099709|FG001|Overall Study|Refused Treatment|3|||
147531499|NCT00976989|532099710|FG002|Overall Study|Refused Treatment|5|||
147531500|NCT00976989|532099708|FG000|Overall Study|Failure to Return|2|||
147531501|NCT00976989|532099709|FG001|Overall Study|Failure to Return|1|||
147531502|NCT00976989|532099710|FG002|Overall Study|Failure to Return|0|||
147531503|NCT00976989|532099708|FG000|Overall Study|Recurrence of Disease|0|||
147531504|NCT00976989|532099709|FG001|Overall Study|Recurrence of Disease|1|||
147531505|NCT00976989|532099710|FG002|Overall Study|Recurrence of Disease|0|||
147531506|NCT00976989|532099708|FG000|Overall Study|Other|1|||
147531507|NCT00976989|532099709|FG001|Overall Study|Other|0|||
147531508|NCT00976989|532099710|FG002|Overall Study|Other|1|||
147531509|NCT01539512|532099711|FG000|Overall Study|Adverse Event|9|||
147531510|NCT01539512|532099712|FG001|Overall Study|Adverse Event|7|||
147531511|NCT01539512|532099711|FG000|Overall Study|Physician Decision|1|||
147531512|NCT01539512|532099712|FG001|Overall Study|Physician Decision|1|||
147531513|NCT01539512|532099711|FG000|Overall Study|Withdrawal by Subject|12|||
147531514|NCT01539512|532099712|FG001|Overall Study|Withdrawal by Subject|5|||
147531515|NCT01539512|532099711|FG000|Overall Study|Richter's Transformation|1|||
147531516|NCT01539512|532099712|FG001|Overall Study|Richter's Transformation|0|||
147531517|NCT04668157|532099717|FG000|Run-in Period (2 Weeks)|Withdrawal by Subject|1|||
147531518|NCT04668157|532099718|FG001|Run-in Period (2 Weeks)|Withdrawal by Subject|0|||
147531519|NCT04668157|532099717|FG000|Treatment Period (52 Weeks)|Other|0|||
147531520|NCT04668157|532099718|FG001|Treatment Period (52 Weeks)|Other|2|||
147531521|NCT03958045|532099719|FG000|Overall Study|Withdrawal by Subject|1|||
147531522|NCT03457701|532099724|FG000|Treatment Period 1 (up to Day 28)|Participant reached protocol-defined stopping criteria|1|||
147531523|NCT03457701|532099725|FG001|Treatment Period 1 (up to Day 28)|Participant reached protocol-defined stopping criteria|1|||
147531524|NCT03457701|532099724|FG000|Treatment Period 2 (Up to Day 28)|Participant reached protocol-defined stopping criteria|0|||
147531525|NCT03457701|532099725|FG001|Treatment Period 2 (Up to Day 28)|Participant reached protocol-defined stopping criteria|1|||
147531526|NCT03329404|532099726|FG000|Overall Study|The study was suspended.|1|||
147531527|NCT03329404|532099727|FG001|Overall Study|The study was suspended.|4|||
147531528|NCT05664672|532099731|FG000|Overall Study|Adverse Event|0|||
147531529|NCT05664672|532099732|FG001|Overall Study|Adverse Event|0|||
147531530|NCT05664672|532099733|FG002|Overall Study|Adverse Event|0|||
147531531|NCT05664672|532099734|FG003|Overall Study|Adverse Event|0|||
147531532|NCT05664672|532099735|FG004|Overall Study|Adverse Event|0|||
147531533|NCT05664672|532099736|FG005|Overall Study|Adverse Event|1|||
147531534|NCT05664672|532099731|FG000|Overall Study|Withdrawal by Subject|0|||
147531535|NCT05664672|532099732|FG001|Overall Study|Withdrawal by Subject|1|||
147531536|NCT05664672|532099733|FG002|Overall Study|Withdrawal by Subject|3|||
147531537|NCT05664672|532099734|FG003|Overall Study|Withdrawal by Subject|0|||
147531538|NCT05664672|532099735|FG004|Overall Study|Withdrawal by Subject|5|||
147531539|NCT05664672|532099736|FG005|Overall Study|Withdrawal by Subject|6|||
147531540|NCT05664672|532099731|FG000|Overall Study|Failure to Meet Randomization Criteria|2|||
147531541|NCT05664672|532099732|FG001|Overall Study|Failure to Meet Randomization Criteria|0|||
147531542|NCT05664672|532099733|FG002|Overall Study|Failure to Meet Randomization Criteria|0|||
147531543|NCT05664672|532099734|FG003|Overall Study|Failure to Meet Randomization Criteria|0|||
147531544|NCT05664672|532099735|FG004|Overall Study|Failure to Meet Randomization Criteria|0|||
147531545|NCT05664672|532099736|FG005|Overall Study|Failure to Meet Randomization Criteria|0|||
147531546|NCT05664672|532099731|FG000|Overall Study|Met Eligibility Criteria But Not Needed|1|||
147531547|NCT05664672|532099732|FG001|Overall Study|Met Eligibility Criteria But Not Needed|0|||
147531548|NCT05664672|532099733|FG002|Overall Study|Met Eligibility Criteria But Not Needed|0|||
147531549|NCT05664672|532099734|FG003|Overall Study|Met Eligibility Criteria But Not Needed|0|||
147531550|NCT05664672|532099735|FG004|Overall Study|Met Eligibility Criteria But Not Needed|0|||
147531551|NCT05664672|532099736|FG005|Overall Study|Met Eligibility Criteria But Not Needed|0|||
147531552|NCT04095039|532099739|FG000|Overall Study|Withdrawal by Subject|2|||
147531553|NCT04095039|532099740|FG001|Overall Study|Withdrawal by Subject|16|||
147531554|NCT04095039|532099739|FG000|Overall Study|Transplanted|21|||
147531555|NCT04095039|532099740|FG001|Overall Study|Transplanted|24|||
147531556|NCT04095039|532099739|FG000|Overall Study|Transferred to Non-study Facility|47|||
147531557|NCT04095039|532099740|FG001|Overall Study|Transferred to Non-study Facility|44|||
147531558|NCT04095039|532099739|FG000|Overall Study|Withdrawal from internvention target|0|||
147531559|NCT04095039|532099740|FG001|Overall Study|Withdrawal from internvention target|2|||
147531560|NCT04095039|532099739|FG000|Overall Study|Switch to peritoneal dialysis or home hemodialysis|2|||
147531561|NCT04095039|532099740|FG001|Overall Study|Switch to peritoneal dialysis or home hemodialysis|4|||
147531562|NCT04095039|532099739|FG000|Overall Study|Cacliphylaxis|0|||
147531563|NCT04095039|532099740|FG001|Overall Study|Cacliphylaxis|1|||
147531564|NCT04095039|532099739|FG000|Overall Study|Pregnancy|1|||
147531565|NCT04095039|532099740|FG001|Overall Study|Pregnancy|0|||
147531566|NCT04768881|532099741|FG000|Overall Study|Completed Study Follow-up|0|||
147531567|NCT04768881|532099742|FG001|Overall Study|Completed Study Follow-up|2|||
147531568|NCT04768881|532099741|FG000|Overall Study|Death|3|||
147531569|NCT04768881|532099742|FG001|Overall Study|Death|2|||
147531570|NCT04768881|532099741|FG000|Overall Study|Study Terminated by Sponsor|2|||
147531571|NCT04768881|532099742|FG001|Overall Study|Study Terminated by Sponsor|2|||
147531572|NCT04768881|532099741|FG000|Overall Study|Withdrawal by Subject|2|||
147531573|NCT04768881|532099742|FG001|Overall Study|Withdrawal by Subject|0|||
147531574|NCT04768881|532099741|FG000|Overall Study|Other|2|||
147531575|NCT04768881|532099742|FG001|Overall Study|Other|0|||
147531576|NCT04236986|532099743|FG000|Overall Study|Withdrawal by Subject|3|||
147531577|NCT04236986|532099744|FG001|Overall Study|Withdrawal by Subject|1|||
147531578|NCT01326481|532099745|FG000|7.5 mg/kg TRC105, 1000 mg/m2 Cape|Adverse Event|1|||
147531579|NCT01038609|532099752|FG000|Overall Study|Adverse Event|0|||
147531580|NCT01038609|532099753|FG001|Overall Study|Adverse Event|0|||
147531581|NCT01038609|532099754|FG002|Overall Study|Adverse Event|1|||
147531582|NCT01038609|532099755|FG003|Overall Study|Adverse Event|0|||
147531583|NCT01038609|532099756|FG004|Overall Study|Adverse Event|0|||
147531584|NCT01038609|532099752|FG000|Overall Study|Dosing Error|0|||
147531585|NCT01038609|532099753|FG001|Overall Study|Dosing Error|0|||
147531586|NCT01038609|532099754|FG002|Overall Study|Dosing Error|0|||
147531587|NCT01038609|532099755|FG003|Overall Study|Dosing Error|1|||
147531588|NCT01038609|532099756|FG004|Overall Study|Dosing Error|1|||
147531589|NCT01038609|532099752|FG000|Overall Study|Death in the Family|1|||
147531590|NCT01038609|532099753|FG001|Overall Study|Death in the Family|0|||
147531591|NCT01038609|532099754|FG002|Overall Study|Death in the Family|0|||
147531592|NCT01038609|532099755|FG003|Overall Study|Death in the Family|0|||
147531593|NCT01038609|532099756|FG004|Overall Study|Death in the Family|0|||
147531594|NCT01038609|532099752|FG000|Overall Study|Refusal of Blood Draws|0|||
147531595|NCT01038609|532099753|FG001|Overall Study|Refusal of Blood Draws|1|||
147531596|NCT01038609|532099754|FG002|Overall Study|Refusal of Blood Draws|0|||
147531597|NCT01038609|532099755|FG003|Overall Study|Refusal of Blood Draws|0|||
147531598|NCT01038609|532099756|FG004|Overall Study|Refusal of Blood Draws|0|||
147531599|NCT01314261|532099757|FG000|Overall Study|Adverse Event|1|||
147531600|NCT01314261|532099758|FG001|Overall Study|Adverse Event|0|||
147531601|NCT01314261|532099759|FG002|Overall Study|Adverse Event|0|||
147531602|NCT01314261|532099760|FG003|Overall Study|Adverse Event|0|||
147531603|NCT01314261|532099757|FG000|Overall Study|Withdrawal by Subject|0|||
147531604|NCT01314261|532099758|FG001|Overall Study|Withdrawal by Subject|3|||
147531605|NCT01314261|532099759|FG002|Overall Study|Withdrawal by Subject|1|||
147531606|NCT01314261|532099760|FG003|Overall Study|Withdrawal by Subject|0|||
147531607|NCT01314261|532099757|FG000|Overall Study|Lost to Follow-up|1|||
147531608|NCT01314261|532099758|FG001|Overall Study|Lost to Follow-up|0|||
147531609|NCT01314261|532099759|FG002|Overall Study|Lost to Follow-up|2|||
147531610|NCT01314261|532099760|FG003|Overall Study|Lost to Follow-up|2|||
147531611|NCT01314261|532099757|FG000|Overall Study|Virologic Failure|0|||
147531612|NCT01314261|532099758|FG001|Overall Study|Virologic Failure|1|||
147531613|NCT01314261|532099759|FG002|Overall Study|Virologic Failure|0|||
147531614|NCT01314261|532099760|FG003|Overall Study|Virologic Failure|1|||
147531615|NCT04524507|532099762|FG000|Overall Study|Lost to Follow-up|2|||
147531616|NCT04524507|532099763|FG001|Overall Study|Lost to Follow-up|4|||
147531617|NCT04524507|532099762|FG000|Overall Study|Withdrawal by Subject|2|||
147531618|NCT04524507|532099763|FG001|Overall Study|Withdrawal by Subject|9|||
147531619|NCT04524507|532099762|FG000|Overall Study|Death|2|||
147531620|NCT04524507|532099763|FG001|Overall Study|Death|10|||
147531621|NCT01078974|532099772|FG000|Overall Study|Adverse Event|3|||
147531622|NCT02569996|532099773|FG000|Overall Study|Adverse Event|6|||
147531623|NCT02569996|532099773|FG000|Overall Study|Physician Decision|3|||
147531624|NCT02569996|532099773|FG000|Overall Study|Progression of the disease|18|||
147531625|NCT02569996|532099773|FG000|Overall Study|New anti-lymphoma treatment|1|||
147531626|NCT02569996|532099773|FG000|Overall Study|Non-compliance|9|||
147531627|NCT02569996|532099773|FG000|Overall Study|Withdrawal by Subject|5|||
147531628|NCT02569996|532099773|FG000|Overall Study|Lost to Follow-up|5|||
147531629|NCT02569996|532099773|FG000|Overall Study|Complete remission|7|||
147531630|NCT02569996|532099773|FG000|Overall Study|Unknown reason|1|||
147531631|NCT01383317|532099774|FG000|Overall Study|Lost to Follow-up|2|||
147531632|NCT01383317|532099775|FG001|Overall Study|Lost to Follow-up|1|||
147531633|NCT01383317|532099774|FG000|Overall Study|Death|1|||
147531634|NCT01383317|532099775|FG001|Overall Study|Death|0|||
147531635|NCT01383317|532099774|FG000|Overall Study|Adverse Event|0|||
147531636|NCT01383317|532099775|FG001|Overall Study|Adverse Event|1|||
147531637|NCT01349816|532099776|FG000|Overall Study|Withdrawal by Subject|4|||
147531638|NCT01349816|532099776|FG000|Overall Study|Physician Decision|1|||
147531639|NCT01349816|532099776|FG000|Overall Study|Adverse Event|14|||
147531640|NCT01349816|532099776|FG000|Overall Study|Lost to Follow-up|2|||
147531641|NCT01349816|532099776|FG000|Overall Study|Protocol Violation|1|||
147531642|NCT01349816|532099776|FG000|Overall Study|Protocol-specified criteria|8|||
147531643|NCT01397409|532099778|FG000|Stage 2|Adverse Event|0|||
147531644|NCT01397409|532099779|FG001|Stage 2|Adverse Event|0|||
147531645|NCT01397409|532099780|FG002|Stage 2|Adverse Event|0|||
147531646|NCT01397409|532099781|FG003|Stage 2|Adverse Event|0|||
147531647|NCT01397409|532099782|FG004|Stage 2|Adverse Event|6|||
147531648|NCT01397409|532099783|FG005|Stage 2|Adverse Event|3|||
147531649|NCT01397409|532099784|FG006|Stage 2|Adverse Event|0|||
147531650|NCT01397409|532099785|FG007|Stage 2|Adverse Event|0|||
147531651|NCT01397409|532099786|FG008|Stage 2|Adverse Event|0|||
147531652|NCT01397409|532099787|FG009|Stage 2|Adverse Event|0|||
147531653|NCT01397409|532099778|FG000|Stage 2|Personal Reasons|0|||
147531654|NCT01397409|532099779|FG001|Stage 2|Personal Reasons|0|||
147531655|NCT01397409|532099780|FG002|Stage 2|Personal Reasons|0|||
147531656|NCT01397409|532099781|FG003|Stage 2|Personal Reasons|0|||
147531657|NCT01397409|532099782|FG004|Stage 2|Personal Reasons|1|||
147531658|NCT01397409|532099783|FG005|Stage 2|Personal Reasons|0|||
147531659|NCT01397409|532099784|FG006|Stage 2|Personal Reasons|0|||
147531660|NCT01397409|532099785|FG007|Stage 2|Personal Reasons|0|||
147531661|NCT01397409|532099786|FG008|Stage 2|Personal Reasons|0|||
147531662|NCT01397409|532099787|FG009|Stage 2|Personal Reasons|0|||
147531663|NCT01397409|532099778|FG000|Stage 2|Other Miscellaneous Reasons|0|||
147531664|NCT01397409|532099779|FG001|Stage 2|Other Miscellaneous Reasons|0|||
147531665|NCT01397409|532099780|FG002|Stage 2|Other Miscellaneous Reasons|0|||
147531666|NCT01397409|532099781|FG003|Stage 2|Other Miscellaneous Reasons|0|||
147531667|NCT01397409|532099782|FG004|Stage 2|Other Miscellaneous Reasons|1|||
147531668|NCT01397409|532099783|FG005|Stage 2|Other Miscellaneous Reasons|1|||
147531669|NCT01397409|532099784|FG006|Stage 2|Other Miscellaneous Reasons|0|||
147531670|NCT01397409|532099785|FG007|Stage 2|Other Miscellaneous Reasons|0|||
147531671|NCT01397409|532099786|FG008|Stage 2|Other Miscellaneous Reasons|0|||
147531672|NCT01397409|532099787|FG009|Stage 2|Other Miscellaneous Reasons|0|||
147531673|NCT01397409|532099778|FG000|Stage 3|Adverse Event|0|||
147531674|NCT01397409|532099779|FG001|Stage 3|Adverse Event|0|||
147531675|NCT01397409|532099780|FG002|Stage 3|Adverse Event|0|||
147531676|NCT01397409|532099781|FG003|Stage 3|Adverse Event|0|||
147531677|NCT01397409|532099782|FG004|Stage 3|Adverse Event|0|||
147531678|NCT01397409|532099783|FG005|Stage 3|Adverse Event|0|||
147531679|NCT01397409|532099784|FG006|Stage 3|Adverse Event|0|||
147531680|NCT01397409|532099785|FG007|Stage 3|Adverse Event|1|||
147531681|NCT01397409|532099786|FG008|Stage 3|Adverse Event|0|||
147531682|NCT01397409|532099787|FG009|Stage 3|Adverse Event|0|||
147531683|NCT01397409|532099778|FG000|Stage 3|Other Miscellaneous Reasons|0|||
147531684|NCT01397409|532099779|FG001|Stage 3|Other Miscellaneous Reasons|0|||
147531685|NCT01397409|532099780|FG002|Stage 3|Other Miscellaneous Reasons|0|||
147531686|NCT01397409|532099781|FG003|Stage 3|Other Miscellaneous Reasons|0|||
147531687|NCT01397409|532099782|FG004|Stage 3|Other Miscellaneous Reasons|0|||
147531688|NCT01397409|532099783|FG005|Stage 3|Other Miscellaneous Reasons|0|||
147531689|NCT01397409|532099784|FG006|Stage 3|Other Miscellaneous Reasons|0|||
147531690|NCT01397409|532099785|FG007|Stage 3|Other Miscellaneous Reasons|1|||
147531691|NCT01397409|532099786|FG008|Stage 3|Other Miscellaneous Reasons|0|||
147531692|NCT01397409|532099787|FG009|Stage 3|Other Miscellaneous Reasons|0|||
147531693|NCT02911285|532099788|FG000|Overall Study|Lost to Follow-up|8|||
147531694|NCT02911285|532099789|FG001|Overall Study|Lost to Follow-up|5|||
147531695|NCT02911285|532099788|FG000|Overall Study|Participant got a job and no longer had time to participate.|1|||
147531696|NCT02911285|532099789|FG001|Overall Study|Participant got a job and no longer had time to participate.|0|||
147531697|NCT01207427|532099790|FG000|Double-blind Treatment Period|Adverse Event|0|||
147531698|NCT01207427|532099791|FG001|Double-blind Treatment Period|Adverse Event|1|||
147531699|NCT01207427|532099792|FG002|Double-blind Treatment Period|Adverse Event|0|||
147531700|NCT01207427|532099790|FG000|Double-blind Treatment Period|Lost to Follow-up|0|||
147531701|NCT01207427|532099791|FG001|Double-blind Treatment Period|Lost to Follow-up|0|||
147531702|NCT01207427|532099792|FG002|Double-blind Treatment Period|Lost to Follow-up|1|||
147531703|NCT01207427|532099790|FG000|Double-blind Treatment Period|Protocol Violation|2|||
147531704|NCT01207427|532099791|FG001|Double-blind Treatment Period|Protocol Violation|1|||
147531705|NCT01207427|532099792|FG002|Double-blind Treatment Period|Protocol Violation|1|||
147531706|NCT01207427|532099790|FG000|Double-blind Treatment Period|Withdrawal by Subject|1|||
147531707|NCT01207427|532099791|FG001|Double-blind Treatment Period|Withdrawal by Subject|0|||
147531708|NCT01207427|532099792|FG002|Double-blind Treatment Period|Withdrawal by Subject|0|||
147531709|NCT00422227|532099793|FG000|Overall Study|Adverse Event|3|||
147531710|NCT00422227|532099794|FG001|Overall Study|Adverse Event|8|||
147531711|NCT00422227|532099793|FG000|Overall Study|Lost to Follow-up|1|||
147531712|NCT00422227|532099794|FG001|Overall Study|Lost to Follow-up|3|||
147531713|NCT00422227|532099793|FG000|Overall Study|Withdrawal by Subject|0|||
147531714|NCT00422227|532099794|FG001|Overall Study|Withdrawal by Subject|4|||
147531715|NCT03418727|532099795|FG000|Overall Study|Adverse Event|1|||
147531716|NCT03418727|532099796|FG001|Overall Study|Adverse Event|2|||
147531717|NCT03418727|532099797|FG002|Overall Study|Adverse Event|0|||
147531718|NCT03418727|532099795|FG000|Overall Study|Withdrawal by Subject|0|||
147531719|NCT03418727|532099796|FG001|Overall Study|Withdrawal by Subject|0|||
147531720|NCT03418727|532099797|FG002|Overall Study|Withdrawal by Subject|2|||
147531721|NCT00686894|532099799|FG000|Overall Study|Relapse|2|||
147531722|NCT00686894|532099799|FG000|Overall Study|Protocol Violation|4|||
147531723|NCT01791543|532099800|FG000|Overall Study|Lost to Follow-up|1|||
147531724|NCT01791543|532099800|FG000|Overall Study|Adverse Event|1|||
147531725|NCT01790633|532099805|FG000|Overall Study|Protocol Violation|1|||
147531726|NCT01790633|532099806|FG001|Overall Study|Protocol Violation|2|||
147531727|NCT01790633|532099805|FG000|Overall Study|Did not have serology performed|47|||
147531728|NCT01790633|532099806|FG001|Overall Study|Did not have serology performed|0|||
147531729|NCT01790633|532099805|FG000|Overall Study|RT failure and no follow-up ELISA|0|||
147531730|NCT01790633|532099806|FG001|Overall Study|RT failure and no follow-up ELISA|3|||
147531731|NCT01740297|532101735|FG000|Overall Study|Withdrawal by Subject|4|||
147531732|NCT01740297|532101736|FG001|Overall Study|Withdrawal by Subject|16|||
147531733|NCT01740297|532101737|FG002|Overall Study|Withdrawal by Subject|17|||
147531734|NCT01740297|532101735|FG000|Overall Study|Death|8|||
147531735|NCT01740297|532101736|FG001|Overall Study|Death|46|||
147531736|NCT01740297|532101737|FG002|Overall Study|Death|40|||
147531737|NCT01740297|532101735|FG000|Overall Study|Lost to Follow-up|1|||
147531738|NCT01740297|532101736|FG001|Overall Study|Lost to Follow-up|2|||
147531739|NCT01740297|532101737|FG002|Overall Study|Lost to Follow-up|4|||
147531740|NCT00761462|532101738|FG000|Treatment|Subjects never received study medication|23|||
147531741|NCT00761462|532101739|FG001|Treatment|Subjects never received study medication|12|||
147531742|NCT00761462|532101738|FG000|2 or 5 Years Long-term Safety Follow-up|Death|4|||
147531743|NCT00761462|532101739|FG001|2 or 5 Years Long-term Safety Follow-up|Death|0|||
147531744|NCT00761462|532101738|FG000|2 or 5 Years Long-term Safety Follow-up|Lost to Follow-up|75|||
147531745|NCT00761462|532101739|FG001|2 or 5 Years Long-term Safety Follow-up|Lost to Follow-up|30|||
147531746|NCT00761462|532101738|FG000|2 or 5 Years Long-term Safety Follow-up|Withdrawal by Subject|75|||
147531747|NCT00761462|532101739|FG001|2 or 5 Years Long-term Safety Follow-up|Withdrawal by Subject|21|||
147531748|NCT02985541|532101743|FG000|Overall Study|Withdrawal by Subject|33|||
147531749|NCT02985541|532101743|FG000|Overall Study|Lost to Follow-up|26|||
147531750|NCT02985541|532101743|FG000|Overall Study|Adverse Event|27|||
147531751|NCT02985541|532101743|FG000|Overall Study|Physician Decision|2|||
147531752|NCT02985541|532101743|FG000|Overall Study|Pregnancy|2|||
147531753|NCT02985541|532101743|FG000|Overall Study|Wish for pregnancy|44|||
147531754|NCT02985541|532101743|FG000|Overall Study|Other reason|5|||
147531755|NCT02985541|532101743|FG000|Overall Study|Not valid for analysis|2|||
147531756|NCT02383966|532101744|FG000|Overall Study|Ongoing at clinical cut-off date|25|||
147531757|NCT02383966|532101745|FG001|Overall Study|Ongoing at clinical cut-off date|4|||
147531758|NCT02383966|532101744|FG000|Overall Study|Randomized, but not treated|1|||
147531759|NCT02383966|532101745|FG001|Overall Study|Randomized, but not treated|3|||
147531760|NCT02163759|532101746|FG000|Overall Study|Withdrawal by Subject|1|||
147531761|NCT02163759|532101747|FG001|Overall Study|Withdrawal by Subject|5|||
147531762|NCT02163759|532101748|FG002|Overall Study|Withdrawal by Subject|1|||
147531763|NCT02163759|532101746|FG000|Overall Study|Adverse Event|0|||
147531764|NCT02163759|532101747|FG001|Overall Study|Adverse Event|0|||
147531765|NCT02163759|532101748|FG002|Overall Study|Adverse Event|1|||
147531766|NCT02163759|532101746|FG000|Overall Study|Death|0|||
147531767|NCT02163759|532101747|FG001|Overall Study|Death|0|||
147531768|NCT02163759|532101748|FG002|Overall Study|Death|1|||
147531769|NCT01479777|532101757|FG000|Overall Study|Physician Decision|2|||
147531770|NCT00451191|532101761|FG000|Overall Study|withdrawal or received alternate tx|15|||
147531771|NCT00451191|532101762|FG001|Overall Study|withdrawal or received alternate tx|11|||
147531772|NCT03575806|532101774|FG000|Overall Study|Withdrawal by Subject|0|||
147531773|NCT03575806|532101775|FG001|Overall Study|Withdrawal by Subject|2|||
147531774|NCT03575806|532101774|FG000|Overall Study|Protocol Violation|0|||
147531775|NCT03575806|532101775|FG001|Overall Study|Protocol Violation|2|||
147531776|NCT00219349|532101776|FG000|Cognitive Behavioral Therapy Phase|Lost to Follow-up|6|||
147531777|NCT00219349|532101776|FG000|Cognitive Behavioral Therapy Phase|Withdrawal by Subject|2|||
147531778|NCT00219349|532101776|FG000|Cognitive Behavioral Therapy Phase|Protocol Violation|2|||
147531779|NCT00219349|532101776|FG000|Escitalopram Phase|Withdrawal by Subject|3|||
147531780|NCT00270205|532101778|FG000|Overall Study|Lost to Follow-up|1|||
147531781|NCT00270205|532101779|FG001|Overall Study|Lost to Follow-up|0|||
147531782|NCT00270205|532101780|FG002|Overall Study|Lost to Follow-up|0|||
147531783|NCT00270205|532101781|FG003|Overall Study|Lost to Follow-up|1|||
147531784|NCT00869362|532101785|FG000|Overall Study|Death|0|||
147531785|NCT00869362|532101786|FG001|Overall Study|Death|2|||
147531786|NCT00869362|532101785|FG000|Overall Study|Lost to Follow-up|1|||
147531787|NCT00869362|532101786|FG001|Overall Study|Lost to Follow-up|3|||
147531788|NCT02646566|532101788|FG000|Overall Study|Lost to Follow-up|5|||
147531789|NCT02646566|532101789|FG001|Overall Study|Lost to Follow-up|4|||
147531790|NCT02646566|532101790|FG002|Overall Study|Lost to Follow-up|5|||
147531791|NCT02646566|532101788|FG000|Overall Study|Treatment failure|1|||
147531792|NCT02646566|532101789|FG001|Overall Study|Treatment failure|0|||
147531793|NCT02646566|532101790|FG002|Overall Study|Treatment failure|0|||
147531794|NCT02815540|532101795|FG000|Overall Study|Physician left institution and study was discontinued. No other PI was available.|2|||
147531795|NCT02222246|532101796|FG000|Overall Study|No Emergency Department Visits|27|||
147531796|NCT02222246|532101797|FG001|Overall Study|No Emergency Department Visits|26|||
147531797|NCT02222246|532101796|FG000|Overall Study|Physician Decision|0|||
147531798|NCT02222246|532101797|FG001|Overall Study|Physician Decision|1|||
147531799|NCT04887922|532101805|FG000|1st Randomization|Decided not to have surgery|0|||
147531800|NCT04887922|532101806|FG001|1st Randomization|Decided not to have surgery|1|||
147531801|NCT04887922|532101807|FG002|1st Randomization|Decided not to have surgery|0|||
147531802|NCT04887922|532101808|FG003|1st Randomization|Decided not to have surgery|0|||
147531803|NCT04887922|532101809|FG004|1st Randomization|Decided not to have surgery|0|||
147531804|NCT00953017|532101810|FG000|Overall Study|DId not show up for colonoscopy|4|||
147531805|NCT00953017|532101811|FG001|Overall Study|DId not show up for colonoscopy|4|||
147531806|NCT00953017|532101812|FG002|Overall Study|DId not show up for colonoscopy|5|||
147531807|NCT00953017|532101813|FG003|Overall Study|DId not show up for colonoscopy|4|||
147531808|NCT00953017|532101810|FG000|Overall Study|Incomplete data|1|||
147531809|NCT00953017|532101811|FG001|Overall Study|Incomplete data|1|||
147531810|NCT00953017|532101812|FG002|Overall Study|Incomplete data|0|||
147531811|NCT00953017|532101813|FG003|Overall Study|Incomplete data|0|||
147531812|NCT00953017|532101810|FG000|Overall Study|Procedure incomplete due to pain/looping|0|||
147531813|NCT00953017|532101811|FG001|Overall Study|Procedure incomplete due to pain/looping|1|||
147531814|NCT00953017|532101812|FG002|Overall Study|Procedure incomplete due to pain/looping|0|||
147531815|NCT00953017|532101813|FG003|Overall Study|Procedure incomplete due to pain/looping|1|||
147531816|NCT00953017|532101810|FG000|Overall Study|Brown stool prior to procedure|0|||
147531817|NCT00953017|532101811|FG001|Overall Study|Brown stool prior to procedure|0|||
147531818|NCT00953017|532101812|FG002|Overall Study|Brown stool prior to procedure|1|||
147531819|NCT00953017|532101813|FG003|Overall Study|Brown stool prior to procedure|0|||
147531820|NCT01300741|532101814|FG000|Overall Study|Lens deposits|1|||
147531821|NCT01300741|532101814|FG000|Overall Study|Lost to Follow-up|1|||
147531822|NCT01300741|532101814|FG000|Overall Study|Discomfort|1|||
147531823|NCT01548573|532101819|FG000|Overall Study|Death|3|||
147531824|NCT01548573|532101819|FG000|Overall Study|Withdrawal by Subject|2|||
147531825|NCT00290511|532101827|FG000|Overall Study|Adverse Event|1|||
147531826|NCT00290511|532101827|FG000|Overall Study|Death|1|||
147531827|NCT00290511|532101827|FG000|Overall Study|Physician Decision|1|||
147531828|NCT00290511|532101827|FG000|Overall Study|Withdrawal by Subject|1|||
147531829|NCT00558831|532101828|FG000|Overall Study|Lost to Follow-up|1|||
147531830|NCT00447265|532101829|FG000|Overall Study|Physician Decision|1|||
147531831|NCT00447265|532101830|FG001|Overall Study|Physician Decision|0|||
147531832|NCT02204449|532101831|FG000|Overall Study|Lost to Follow-up|7|||
147531833|NCT02204449|532101832|FG001|Overall Study|Lost to Follow-up|9|||
147531834|NCT02204449|532101831|FG000|Overall Study|Death|0|||
147531835|NCT02204449|532101832|FG001|Overall Study|Death|1|||
147531836|NCT02204449|532101831|FG000|Overall Study|Withdrawal by Subject|0|||
147531837|NCT02204449|532101832|FG001|Overall Study|Withdrawal by Subject|1|||
147531838|NCT04311411|532101835|FG000|Overall Study|Adverse Event|2|||
147531839|NCT04311411|532101836|FG001|Overall Study|Adverse Event|3|||
147531840|NCT04311411|532101837|FG002|Overall Study|Adverse Event|2|||
147531841|NCT04311411|532101835|FG000|Overall Study|Withdrawal by Subject|3|||
147531842|NCT04311411|532101836|FG001|Overall Study|Withdrawal by Subject|3|||
147531843|NCT04311411|532101837|FG002|Overall Study|Withdrawal by Subject|0|||
147531844|NCT01976663|532101841|FG000|Overall Study|Completed 18 mos but no repeat treatment|24|||
147531845|NCT01976663|532101841|FG000|Overall Study|Personal Reasons|6|||
147531846|NCT01976663|532101841|FG000|Overall Study|Withdrawal by Subject|4|||
147531847|NCT01976663|532101841|FG000|Overall Study|Screen Failure|3|||
147531848|NCT01976663|532101841|FG000|Overall Study|Adverse Event|2|||
147531849|NCT01976663|532101841|FG000|Overall Study|Lost to Follow-up|3|||
147531850|NCT01982942|532101843|FG000|Overall Study|Adverse Event|10|||
147531851|NCT01982942|532101844|FG001|Overall Study|Adverse Event|5|||
147531852|NCT01982942|532101843|FG000|Overall Study|Lost to Follow-up|4|||
147531853|NCT01982942|532101844|FG001|Overall Study|Lost to Follow-up|3|||
147531854|NCT01982942|532101843|FG000|Overall Study|Multiple sclerosis progression|3|||
147531855|NCT01982942|532101844|FG001|Overall Study|Multiple sclerosis progression|2|||
147531856|NCT01982942|532101843|FG000|Overall Study|Wanted to try therapy not permitted|1|||
147531857|NCT01982942|532101844|FG001|Overall Study|Wanted to try therapy not permitted|0|||
147531858|NCT01982942|532101843|FG000|Overall Study|Subject declined future visits|0|||
147531859|NCT01982942|532101844|FG001|Overall Study|Subject declined future visits|1|||
147531860|NCT01982942|532101843|FG000|Overall Study|Left geographical area|2|||
147531861|NCT01982942|532101844|FG001|Overall Study|Left geographical area|0|||
147531862|NCT01982942|532101843|FG000|Overall Study|Too many pills|1|||
147531863|NCT01982942|532101844|FG001|Overall Study|Too many pills|0|||
147531864|NCT01982942|532101843|FG000|Overall Study|MS Relapse|0|||
147531865|NCT01982942|532101844|FG001|Overall Study|MS Relapse|1|||
147531866|NCT01982942|532101843|FG000|Overall Study|Chose to join a stem cell trial|0|||
147531867|NCT01982942|532101844|FG001|Overall Study|Chose to join a stem cell trial|1|||
147531868|NCT01982942|532101843|FG000|Overall Study|Subject bedridden, rapidly declining|0|||
147531869|NCT01982942|532101844|FG001|Overall Study|Subject bedridden, rapidly declining|1|||
147531870|NCT01151085|532101847|FG000|Overall Study|Lost to Follow-up|31|||
147531871|NCT01151085|532101847|FG000|Overall Study|Protocol Violation|25|||
147531872|NCT00489411|532101850|FG000|Initial Treatment Period (Weeks 1-5)|Withdrew consent prior to intervention|6|||
147531873|NCT00489411|532101851|FG001|Initial Treatment Period (Weeks 1-5)|Withdrew consent prior to intervention|5|||
147531874|NCT00489411|532101850|FG000|Initial Treatment Period (Weeks 1-5)|Discontinued study drug early|21|||
147531875|NCT00489411|532101851|FG001|Initial Treatment Period (Weeks 1-5)|Discontinued study drug early|12|||
147531876|NCT00489411|532101850|FG000|Initial Treatment Period (Weeks 1-5)|Incomplete data|1|||
147531877|NCT00489411|532101851|FG001|Initial Treatment Period (Weeks 1-5)|Incomplete data|5|||
147531878|NCT00489411|532101850|FG000|Crossover Treatment Period (Weeks 8-12)|Discontinued intervention early|11|||
147531879|NCT00489411|532101851|FG001|Crossover Treatment Period (Weeks 8-12)|Discontinued intervention early|12|||
147531880|NCT00489411|532101850|FG000|Crossover Treatment Period (Weeks 8-12)|Incomplete data|7|||
147531881|NCT00489411|532101851|FG001|Crossover Treatment Period (Weeks 8-12)|Incomplete data|7|||
147531882|NCT01748162|532101853|FG000|Overall Study|no additional croup episodes to evaluate|2|||
147531883|NCT01748162|532101854|FG001|Overall Study|no additional croup episodes to evaluate|2|||
147531884|NCT01748162|532101853|FG000|Overall Study|participant consented but did not begin|0|||
147531885|NCT01748162|532101854|FG001|Overall Study|participant consented but did not begin|1|||
147531886|NCT01748162|532101853|FG000|Overall Study|reasons not available|3|||
147531887|NCT01748162|532101854|FG001|Overall Study|reasons not available|2|||
147531888|NCT03219372|532101855|FG000|Overall Study|Withdrawal by Subject|1|||
147531889|NCT03219372|532101856|FG001|Overall Study|Withdrawal by Subject|0|||
147531890|NCT03841331|532101857|FG000|Overall Study|Withdrawal by Subject|4|||
147531891|NCT03841331|532101858|FG001|Overall Study|Withdrawal by Subject|9|||
147531892|NCT03841331|532101857|FG000|Overall Study|Lost to Follow-up|5|||
147531893|NCT03841331|532101858|FG001|Overall Study|Lost to Follow-up|1|||
147531894|NCT00779857|532101859|FG000|Overall Study|Death|1|||
147531895|NCT00779857|532101859|FG000|Overall Study|Withdrawal by Subject|3|||
147531896|NCT00779857|532101859|FG000|Overall Study|Missed Visit|2|||
147531897|NCT04640168|532101860|FG000|Overall Study|Withdrawal by Subject|8|||
147531898|NCT04640168|532101861|FG001|Overall Study|Withdrawal by Subject|7|||
147531899|NCT04640168|532101860|FG000|Overall Study|Lost to Follow-up|1|||
147531900|NCT04640168|532101861|FG001|Overall Study|Lost to Follow-up|0|||
147531901|NCT04640168|532101860|FG000|Overall Study|Enrolled but not treated|12|||
147531902|NCT04640168|532101861|FG001|Overall Study|Enrolled but not treated|12|||
147531903|NCT00442572|532101869|FG000|Overall Study|Relapse|8|||
147531904|NCT00442572|532101870|FG001|Overall Study|Relapse|1|||
147531905|NCT00442572|532101869|FG000|Overall Study|Lost to Follow-up|0|||
147531906|NCT00442572|532101870|FG001|Overall Study|Lost to Follow-up|1|||
147531907|NCT00442572|532101869|FG000|Overall Study|Withdrawal by Subject|0|||
147531908|NCT00442572|532101870|FG001|Overall Study|Withdrawal by Subject|1|||
147531909|NCT03557775|532101871|FG000|Overall Study|Withdrawal by Subject|1|||
147531910|NCT03557775|532101872|FG001|Overall Study|Withdrawal by Subject|2|||
147531911|NCT03557775|532101873|FG002|Overall Study|Withdrawal by Subject|4|||
147531912|NCT03557775|532101871|FG000|Overall Study|Physician Decision|0|||
147531913|NCT03557775|532101872|FG001|Overall Study|Physician Decision|1|||
147531914|NCT03557775|532101873|FG002|Overall Study|Physician Decision|0|||
147531915|NCT00276458|532101880|FG000|Overall Study|Adverse Event|0|||
147531916|NCT00276458|532101881|FG001|Overall Study|Adverse Event|2|||
147531917|NCT00276458|532101880|FG000|Overall Study|Lost to Follow-up|2|||
147531918|NCT00276458|532101881|FG001|Overall Study|Lost to Follow-up|2|||
147531919|NCT00276458|532101880|FG000|Overall Study|Protocol Violation|4|||
147531920|NCT00276458|532101881|FG001|Overall Study|Protocol Violation|3|||
147531921|NCT01428882|532101882|FG000|Overall Study|Lack of Efficacy|2|||
147531922|NCT01428882|532101883|FG001|Overall Study|Lack of Efficacy|7|||
147531923|NCT01428882|532101882|FG000|Overall Study|Protocol Violation|4|||
147531924|NCT01428882|532101883|FG001|Overall Study|Protocol Violation|3|||
147531925|NCT02304484|532101884|FG000|Overall Study|Death|9|||
147531926|NCT02304484|532101884|FG000|Overall Study|Withdrawal by Subject|14|||
147531927|NCT02304484|532101884|FG000|Overall Study|Lost to Follow-up|2|||
147531928|NCT04338685|532101885|FG000|Overall Study|Death|3|||
147531929|NCT04338685|532101886|FG001|Overall Study|Death|4|||
147531930|NCT04338685|532101887|FG002|Overall Study|Death|2|||
147531931|NCT04338685|532101888|FG003|Overall Study|Death|4|||
147531932|NCT04338685|532101889|FG004|Overall Study|Death|4|||
147531933|NCT04338685|532101890|FG005|Overall Study|Death|8|||
147531934|NCT04338685|532101891|FG006|Overall Study|Death|1|||
147531935|NCT04338685|532101892|FG007|Overall Study|Death|0|||
147531936|NCT04338685|532101893|FG008|Overall Study|Death|0|||
147531937|NCT04338685|532101885|FG000|Overall Study|Study terminated by Sponsor|0|||
147531938|NCT04338685|532101886|FG001|Overall Study|Study terminated by Sponsor|0|||
147531939|NCT04338685|532101887|FG002|Overall Study|Study terminated by Sponsor|1|||
147531940|NCT04338685|532101888|FG003|Overall Study|Study terminated by Sponsor|4|||
147531941|NCT04338685|532101889|FG004|Overall Study|Study terminated by Sponsor|0|||
147531942|NCT04338685|532101890|FG005|Overall Study|Study terminated by Sponsor|5|||
147531943|NCT04338685|532101891|FG006|Overall Study|Study terminated by Sponsor|2|||
147531944|NCT04338685|532101892|FG007|Overall Study|Study terminated by Sponsor|4|||
147531945|NCT04338685|532101893|FG008|Overall Study|Study terminated by Sponsor|1|||
147531946|NCT04338685|532101885|FG000|Overall Study|Withdrawal by Subject|1|||
147531947|NCT04338685|532101886|FG001|Overall Study|Withdrawal by Subject|2|||
147531948|NCT04338685|532101887|FG002|Overall Study|Withdrawal by Subject|0|||
147531949|NCT04338685|532101888|FG003|Overall Study|Withdrawal by Subject|2|||
147531950|NCT04338685|532101889|FG004|Overall Study|Withdrawal by Subject|0|||
147531951|NCT04338685|532101890|FG005|Overall Study|Withdrawal by Subject|5|||
147531952|NCT04338685|532101891|FG006|Overall Study|Withdrawal by Subject|1|||
147531953|NCT04338685|532101892|FG007|Overall Study|Withdrawal by Subject|1|||
147531954|NCT04338685|532101893|FG008|Overall Study|Withdrawal by Subject|0|||
147531955|NCT00570492|532101894|FG000|16-week Single-blind Baseline Period|Didn't Meet Inclusion/Exclusion Criteria|98|||
147531956|NCT00570492|532101895|FG001|16-week Single-blind Baseline Period|Didn't Meet Inclusion/Exclusion Criteria|0|||
147531957|NCT00570492|532101896|FG002|16-week Single-blind Baseline Period|Didn't Meet Inclusion/Exclusion Criteria|0|||
147531958|NCT00570492|532101894|FG000|16-week Single-blind Baseline Period|Didn't Meet Randomization Criteria|263|||
147531959|NCT00570492|532101895|FG001|16-week Single-blind Baseline Period|Didn't Meet Randomization Criteria|0|||
147531960|NCT00570492|532101896|FG002|16-week Single-blind Baseline Period|Didn't Meet Randomization Criteria|0|||
147531961|NCT00570492|532101894|FG000|16-week Single-blind Baseline Period|Withdrawal by Subject|56|||
147531962|NCT00570492|532101895|FG001|16-week Single-blind Baseline Period|Withdrawal by Subject|0|||
147531963|NCT00570492|532101896|FG002|16-week Single-blind Baseline Period|Withdrawal by Subject|0|||
147531964|NCT00570492|532101894|FG000|16-week Single-blind Baseline Period|Protocol Violation|15|||
147531965|NCT00570492|532101895|FG001|16-week Single-blind Baseline Period|Protocol Violation|0|||
147531966|NCT00570492|532101896|FG002|16-week Single-blind Baseline Period|Protocol Violation|0|||
147531967|NCT00570492|532101894|FG000|16-week Single-blind Baseline Period|Lost to Follow-up|2|||
147531968|NCT00570492|532101895|FG001|16-week Single-blind Baseline Period|Lost to Follow-up|0|||
147531969|NCT00570492|532101896|FG002|16-week Single-blind Baseline Period|Lost to Follow-up|0|||
147531970|NCT00570492|532101894|FG000|16-week Single-blind Baseline Period|Adverse Event|1|||
147531971|NCT00570492|532101895|FG001|16-week Single-blind Baseline Period|Adverse Event|0|||
147531972|NCT00570492|532101896|FG002|16-week Single-blind Baseline Period|Adverse Event|0|||
147531973|NCT00570492|532101894|FG000|16-week Single-blind Baseline Period|Randomized but Did'nt Receive Treatment|1|||
147531974|NCT00570492|532101895|FG001|16-week Single-blind Baseline Period|Randomized but Did'nt Receive Treatment|0|||
147531975|NCT00570492|532101896|FG002|16-week Single-blind Baseline Period|Randomized but Did'nt Receive Treatment|0|||
147531976|NCT00570492|532101894|FG000|52-week Double-blind Treatment Period|Withdrawal by Subject|0|||
147531977|NCT00570492|532101895|FG001|52-week Double-blind Treatment Period|Withdrawal by Subject|20|||
147531978|NCT00570492|532101896|FG002|52-week Double-blind Treatment Period|Withdrawal by Subject|20|||
147531979|NCT00570492|532101894|FG000|52-week Double-blind Treatment Period|Protocol Violation|0|||
147531980|NCT00570492|532101895|FG001|52-week Double-blind Treatment Period|Protocol Violation|12|||
147531983|NCT00570492|532101895|FG001|52-week Double-blind Treatment Period|Lost to Follow-up|5|||
147531984|NCT00570492|532101896|FG002|52-week Double-blind Treatment Period|Lost to Follow-up|7|||
147531985|NCT00570492|532101894|FG000|52-week Double-blind Treatment Period|Adverse Event|0|||
147531986|NCT00570492|532101895|FG001|52-week Double-blind Treatment Period|Adverse Event|5|||
147531987|NCT00570492|532101896|FG002|52-week Double-blind Treatment Period|Adverse Event|5|||
147531988|NCT00570492|532101894|FG000|52-week Double-blind Treatment Period|Physician Decision|0|||
147531989|NCT00570492|532101895|FG001|52-week Double-blind Treatment Period|Physician Decision|2|||
147531990|NCT00570492|532101896|FG002|52-week Double-blind Treatment Period|Physician Decision|4|||
147531991|NCT00570492|532101894|FG000|52-week Double-blind Treatment Period|Lack of Efficacy|0|||
147531992|NCT00570492|532101895|FG001|52-week Double-blind Treatment Period|Lack of Efficacy|3|||
147531993|NCT00570492|532101896|FG002|52-week Double-blind Treatment Period|Lack of Efficacy|0|||
147531994|NCT00570492|532101894|FG000|52-week Double-blind Treatment Period|Reached Protocol-defined Stop Criteria|0|||
147531995|NCT00570492|532101895|FG001|52-week Double-blind Treatment Period|Reached Protocol-defined Stop Criteria|3|||
147531996|NCT00570492|532101896|FG002|52-week Double-blind Treatment Period|Reached Protocol-defined Stop Criteria|0|||
147531997|NCT00908375|532101897|FG000|Overall Study|Withdrawal by Subject|2|||
147531998|NCT00908375|532101898|FG001|Overall Study|Withdrawal by Subject|4|||
147531999|NCT00908375|532101897|FG000|Overall Study|Lost to Follow-up|8|||
147532000|NCT00908375|532101898|FG001|Overall Study|Lost to Follow-up|6|||
147532001|NCT04419558|532101899|FG000|DB Period (48 Weeks)|Adverse Event|6|||
147532002|NCT04419558|532101900|FG001|DB Period (48 Weeks)|Adverse Event|6|||
147532003|NCT04419558|532101899|FG000|DB Period (48 Weeks)|Death|14|||
147532004|NCT04419558|532101900|FG001|DB Period (48 Weeks)|Death|11|||
147532005|NCT04419558|532101899|FG000|DB Period (48 Weeks)|Lost to Follow-up|1|||
147532006|NCT04419558|532101900|FG001|DB Period (48 Weeks)|Lost to Follow-up|3|||
147532007|NCT04419558|532101899|FG000|DB Period (48 Weeks)|Investigator Decision|0|||
147532008|NCT04419558|532101900|FG001|DB Period (48 Weeks)|Investigator Decision|1|||
147532009|NCT04419558|532101899|FG000|DB Period (48 Weeks)|Study terminated by sponsor|99|||
147532010|NCT04419558|532101900|FG001|DB Period (48 Weeks)|Study terminated by sponsor|101|||
147532011|NCT04419558|532101899|FG000|DB Period (48 Weeks)|Disease Progression|1|||
147532012|NCT04419558|532101900|FG001|DB Period (48 Weeks)|Disease Progression|0|||
147532013|NCT04419558|532101899|FG000|DB Period (48 Weeks)|Withdrawal by Subject|11|||
147532014|NCT04419558|532101900|FG001|DB Period (48 Weeks)|Withdrawal by Subject|7|||
147532015|NCT04419558|532101899|FG000|DB Period (48 Weeks)|Lung Transplant|1|||
147532016|NCT04419558|532101900|FG001|DB Period (48 Weeks)|Lung Transplant|0|||
147532017|NCT04419558|532101899|FG000|DB Period (48 Weeks)|Participant Decision|4|||
147532018|NCT04419558|532101900|FG001|DB Period (48 Weeks)|Participant Decision|3|||
147532019|NCT04419558|532101899|FG000|OLE Period (48 Weeks)|Adverse Event|3|||
147532020|NCT04419558|532101900|FG001|OLE Period (48 Weeks)|Adverse Event|1|||
147532021|NCT04419558|532101899|FG000|OLE Period (48 Weeks)|Death|4|||
147532022|NCT04419558|532101900|FG001|OLE Period (48 Weeks)|Death|6|||
147532023|NCT04419558|532101899|FG000|OLE Period (48 Weeks)|Study terminated by sponsor|34|||
147532024|NCT04419558|532101900|FG001|OLE Period (48 Weeks)|Study terminated by sponsor|37|||
147532025|NCT04419558|532101899|FG000|OLE Period (48 Weeks)|Withdrawal by Subject|0|||
147532026|NCT04419558|532101900|FG001|OLE Period (48 Weeks)|Withdrawal by Subject|1|||
147532027|NCT00752206|532101901|FG000|Overall Study|Disease progression|8|||
147532028|NCT00752206|532101902|FG001|Overall Study|Disease progression|11|||
147532029|NCT00752206|532101901|FG000|Overall Study|Pregnancy|1|||
147532030|NCT00752206|532101902|FG001|Overall Study|Pregnancy|0|||
147532031|NCT01484691|532101903|FG000|Overall Study|Withdrawal by Subject|1|||
147532032|NCT01484691|532101904|FG001|Overall Study|Withdrawal by Subject|1|||
147532033|NCT01484691|532101905|FG002|Overall Study|Withdrawal by Subject|1|||
147532034|NCT01484691|532101903|FG000|Overall Study|Physician Decision|0|||
147532035|NCT01484691|532101904|FG001|Overall Study|Physician Decision|2|||
147532036|NCT01484691|532101905|FG002|Overall Study|Physician Decision|1|||
147532037|NCT02283411|532101910|FG000|Overall Study|Withdrawal by Subject|3|||
147532038|NCT02283411|532101910|FG000|Overall Study|Screen Failed|28|||
147532039|NCT05437211|532101911|FG000|Overall Study|Patient's decision|1|||
147532040|NCT05437211|532101912|FG001|Overall Study|Patient's decision|1|||
147532041|NCT03282123|532101913|FG000|Overall Study|Withdrawal by Subject|5|||
147532042|NCT01463631|532101917|FG000|Overall Study|Withdrawal by Subject|0|||
147532043|NCT01463631|532101918|FG001|Overall Study|Withdrawal by Subject|0|||
147532044|NCT01463631|532101919|FG002|Overall Study|Withdrawal by Subject|0|||
147532045|NCT01463631|532101920|FG003|Overall Study|Withdrawal by Subject|1|||
147532046|NCT01463631|532101917|FG000|Overall Study|Death|0|||
147532047|NCT01463631|532101918|FG001|Overall Study|Death|0|||
147532048|NCT01463631|532101919|FG002|Overall Study|Death|1|||
147532049|NCT01463631|532101920|FG003|Overall Study|Death|0|||
147532050|NCT01463631|532101917|FG000|Overall Study|Progressive Disease|0|||
147532051|NCT01463631|532101918|FG001|Overall Study|Progressive Disease|0|||
147532052|NCT01463631|532101919|FG002|Overall Study|Progressive Disease|0|||
147532053|NCT01463631|532101920|FG003|Overall Study|Progressive Disease|5|||
147532054|NCT05966129|532101923|FG000|Overall Study|Death|1|||
147532055|NCT05966129|532101924|FG001|Overall Study|Death|2|||
147532056|NCT05966129|532101923|FG000|Overall Study|Lost to Follow-up|63|||
147532060|NCT05966129|532101923|FG000|Overall Study|Withdrawal by Subject|26|||
147532061|NCT05966129|532101924|FG001|Overall Study|Withdrawal by Subject|25|||
147532062|NCT05966129|532101923|FG000|Overall Study|Surgery not completed|63|||
147532063|NCT05966129|532101924|FG001|Overall Study|Surgery not completed|69|||
147532064|NCT05966129|532101923|FG000|Overall Study|Surgery logistics issue|2|||
147532065|NCT05966129|532101924|FG001|Overall Study|Surgery logistics issue|1|||
147532066|NCT01298323|532101925|FG000|Overall Study|Adverse Event|2|||
147532067|NCT01298323|532101926|FG001|Overall Study|Adverse Event|4|||
147532068|NCT01298323|532101925|FG000|Overall Study|Death|11|||
147532069|NCT01298323|532101926|FG001|Overall Study|Death|16|||
147532070|NCT01298323|532101925|FG000|Overall Study|Lost to Follow-up|1|||
147532071|NCT01298323|532101926|FG001|Overall Study|Lost to Follow-up|0|||
147532072|NCT01298323|532101925|FG000|Overall Study|Withdrawal by Subject|6|||
147532073|NCT01298323|532101926|FG001|Overall Study|Withdrawal by Subject|3|||
147532074|NCT01298323|532101925|FG000|Overall Study|Protocol Violation|1|||
147532075|NCT01298323|532101926|FG001|Overall Study|Protocol Violation|0|||
147532076|NCT01298323|532101925|FG000|Overall Study|Other|10|||
147532077|NCT01298323|532101926|FG001|Overall Study|Other|9|||
147532078|NCT01298323|532101925|FG000|Overall Study|Ongoing|55|||
147532079|NCT01298323|532101926|FG001|Overall Study|Ongoing|55|||
147532080|NCT01298323|532101925|FG000|Overall Study|Eligibility criteria not fulfilled|0|||
147532081|NCT01298323|532101926|FG001|Overall Study|Eligibility criteria not fulfilled|1|||
